id|nct_id|name|downcase_name
898348|NCT04180592|MRI|mri
898570|NCT04179474|ubrogepant|ubrogepant
898840|NCT04153149|TTR|ttr
899075|NCT04072354|acute psychosis|acute psychosis
899593|NCT03876769|ALL|all
899722|NCT03809416|PRP|prp
900470|NCT03406884|stem cells|stem cells
900471|NCT03406884|pediatric|pediatric
900472|NCT03401398|hydrocortisone|hydrocortisone
900473|NCT03401398|refractory septic shock|refractory septic shock
900474|NCT03401398|sepsis|sepsis
900475|NCT03401398|new/progressive MODS|new/progressive mods
900476|NCT03401398|mortality|mortality
900477|NCT03401398|health-related quality of life|health-related quality of life
900478|NCT03401398|corticosteroid adverse events|corticosteroid adverse events
900479|NCT03401398|sepsis biomarkers|sepsis biomarkers
900480|NCT03395886|noninvasive ventilation|noninvasive ventilation
900481|NCT03395886|remifentanil|remifentanil
900482|NCT03395886|dexmedetomidine|dexmedetomidine
900483|NCT03395886|cardiac surgery|cardiac surgery
900484|NCT03395405|Efficacy|efficacy
900485|NCT03395405|Hematopoietic Stem Cell|hematopoietic stem cell
900486|NCT03395405|Nitazoxanide|nitazoxanide
900487|NCT03395405|Norovirus|norovirus
900488|NCT03395405|Prospective, Randomized, Double-Blind Study|prospective, randomized, double-blind study
900489|NCT03395405|Safety|safety
900490|NCT03395405|Solid Organ Transplant Recipients|solid organ transplant recipients
900491|NCT03395405|Treatment|treatment
900492|NCT03395314|Borderline Personality Disorder|borderline personality disorder
900493|NCT03395314|Ketamine|ketamine
900494|NCT03395314|Suicide|suicide
900495|NCT03395314|Social Cognition|social cognition
900496|NCT03394053|SCID|scid
900501|NCT03393520|Agitation|agitation
898193|NCT04181788|Advanced solid tumors|advanced solid tumors
898194|NCT04181788|NSCLC|nsclc
898195|NCT04181762|SLE|sle
898196|NCT04181762|LN|ln
898197|NCT04181762|secukinumab|secukinumab
898198|NCT04181762|renal biopsy|renal biopsy
898199|NCT04181762|eGFR|egfr
898200|NCT04181762|UPCR|upcr
898201|NCT04181762|SoC background therapy|soc background therapy
898202|NCT04181736|guanfacine, dorsolateral prefrontal cortex, DLPFC, MDD, cognitive dysfunction|guanfacine, dorsolateral prefrontal cortex, dlpfc, mdd, cognitive dysfunction
898203|NCT04181710|Kidney transplantation|kidney transplantation
898204|NCT04181710|Organ preservation|organ preservation
898205|NCT04181684|Gliomas, Laser Interstitial Thermal Therapy, Brain, Brain Tumor, Radiotherapy, Proton Therapy, Hypofractionated Radiation Therapy, Malignant, Glioblastoma|gliomas, laser interstitial thermal therapy, brain, brain tumor, radiotherapy, proton therapy, hypofractionated radiation therapy, malignant, glioblastoma
898206|NCT04181671|Exercise Training|exercise training
898207|NCT04181645|pancreatic cancer|pancreatic cancer
898208|NCT04181619|coffeeberry|coffeeberry
898209|NCT04181619|caffeine|caffeine
898210|NCT04181619|polyphenols|polyphenols
898211|NCT04181619|chlorogenic acid|chlorogenic acid
898212|NCT04181619|exercise|exercise
898213|NCT04181619|soccer|soccer
898214|NCT04181619|skill|skill
898215|NCT04181619|performance|performance
898216|NCT04181606|Esmolol hydrochloride|esmolol hydrochloride
898217|NCT04181606|Coronary blood flow|coronary blood flow
898218|NCT04181593|Dry Eye Disease|dry eye disease
898219|NCT04181593|Ocular Surface Disease|ocular surface disease
898220|NCT04181567|electroconvulsive therapy|electroconvulsive therapy
898221|NCT04181567|agomelatine|agomelatine
898222|NCT04181567|relapse|relapse
898223|NCT04181567|major depressive disorder|major depressive disorder
898224|NCT04181567|response|response
898225|NCT04181541|Midlevel provider|midlevel provider
898226|NCT04181502|Remote ischemic preconditioning|remote ischemic preconditioning
898227|NCT04181502|liver resection|liver resection
898228|NCT04181502|liver clearance.|liver clearance.
898229|NCT04181489|Sintilimab|sintilimab
898230|NCT04181489|R-CHOP|r-chop
898231|NCT04181489|EBV-Positive DLBCL, nos|ebv-positive dlbcl, nos
898232|NCT04181489|treatment-naive|treatment-naive
898233|NCT04181385|olanzapine|olanzapine
898234|NCT04181372|Stage III Non-small-cell Lung Cancer|stage iii non-small-cell lung cancer
898235|NCT04181372|Anlotinib Hydrochloride|anlotinib hydrochloride
898236|NCT04181372|Neoadjuvant|neoadjuvant
898237|NCT04181346|pregabalin|pregabalin
898238|NCT04181346|nausea|nausea
898239|NCT04181320|Granulox|granulox
898240|NCT04181320|venous ulcers|venous ulcers
898241|NCT04181320|wound healing|wound healing
898242|NCT04181320|wound reduction|wound reduction
898243|NCT04181294|Palliative Care|palliative care
898244|NCT04181294|Medical Futility|medical futility
898245|NCT04181294|Intensive Care|intensive care
898246|NCT04181281|CEUS|ceus
898247|NCT04181281|MRI|mri
898248|NCT04181281|kidney perfusion|kidney perfusion
898249|NCT04181255|Norwood procedure|norwood procedure
898250|NCT04181242|Epidemiology, Incidence, Athletic Injuries, Racquet Sports, Badminton|epidemiology, incidence, athletic injuries, racquet sports, badminton
898251|NCT04181203|Apalutamide|apalutamide
898252|NCT04181203|Salvage radiotherapy|salvage radiotherapy
898253|NCT04181203|Radical prostatectomy|radical prostatectomy
898254|NCT04181203|PSA|psa
898255|NCT04181190|IgE|ige
898256|NCT04181190|Eosinophils|eosinophils
898257|NCT04181190|Mepolizumab|mepolizumab
898258|NCT04181190|Benralizumab|benralizumab
898259|NCT04181190|Severe Asthma|severe asthma
898260|NCT04181177|anticancer treatment|anticancer treatment
898261|NCT04181177|targeted educational action|targeted educational action
898262|NCT04181177|pruritus|pruritus
898263|NCT04181177|quality of life|quality of life
898264|NCT04181177|NCI CTCAE|nci ctcae
898265|NCT04181177|Patient Global Assessment|patient global assessment
898266|NCT04181177|Investigator Global Assessment|investigator global assessment
898267|NCT04181177|Dermatology Life Quality Index (DLQI)|dermatology life quality index (dlqi)
898268|NCT04181177|Hydration Index (HI)|hydration index (hi)
898269|NCT04181177|Numeric Scale (NS)|numeric scale (ns)
898270|NCT04181151|latissimus dorsi|latissimus dorsi
898271|NCT04181151|functional reach|functional reach
898272|NCT04181151|stroke|stroke
898273|NCT04181151|electromyography|electromyography
898274|NCT04181138|Pediatric Liver Disease|pediatric liver disease
898275|NCT04181138|Primary Sclerosing Cholangitis|primary sclerosing cholangitis
898276|NCT04181112|Fecal Microbiota Transplantation|fecal microbiota transplantation
898277|NCT04181099|dental implant|dental implant
898278|NCT04181099|zirconia|zirconia
898279|NCT04181099|biofilm|biofilm
898280|NCT04181073|nebulisation|nebulisation
898281|NCT04181073|vibrating mesh nebuliser|vibrating mesh nebuliser
898282|NCT04181047|Eye movement desensitization and Reprocessing|eye movement desensitization and reprocessing
898283|NCT04181034|Teen pregnancy prevention|teen pregnancy prevention
898284|NCT04181034|Home visiting|home visiting
898285|NCT04181034|Positive youth development|positive youth development
400487|NCT01866670|spiritual distress|spiritual distress
898286|NCT04181034|Adolescent Family Life Program Positive Youth Development|adolescent family life program positive youth development
898287|NCT04180930|Assessment|assessment
898288|NCT04180930|Post-Traumatic Stress Disorder|post-traumatic stress disorder
898289|NCT04180930|PTSD|ptsd
898290|NCT04180930|Veterans|veterans
898291|NCT04180930|Military|military
898292|NCT04180904|PsA (Psoriatic Arthritis), Diet, Food, Nutrition|psa (psoriatic arthritis), diet, food, nutrition
898293|NCT04180891|empathy|empathy
898294|NCT04180891|emotional intelligence|emotional intelligence
898295|NCT04180891|multiple mini-interviews|multiple mini-interviews
898296|NCT04180878|Gestational weight gain|gestational weight gain
898297|NCT04180878|Physical activity|physical activity
898298|NCT04180865|Parkinson Disease|parkinson disease
898299|NCT04180865|Treatment naive|treatment naive
898300|NCT04180865|Cognition|cognition
898301|NCT04180865|PET imaging|pet imaging
898302|NCT04180865|Acetylcholine|acetylcholine
898303|NCT04180865|Magnetic Resonance Imaging|magnetic resonance imaging
898304|NCT04180865|Ophthalmology|ophthalmology
898305|NCT04180865|Gastrointestinal Microbiome|gastrointestinal microbiome
898306|NCT04180865|Neurodegenerative Diseases|neurodegenerative diseases
898307|NCT04180865|Genetic subtyping|genetic subtyping
898308|NCT04180774|gene modified vaccine|gene modified vaccine
898309|NCT04180774|tag-7|tag-7
898310|NCT04180774|immunotherapy|immunotherapy
898311|NCT04180774|tumor cells-based vaccine|tumor cells-based vaccine
898312|NCT04180748|Microbiome|microbiome
898313|NCT04180748|Dermatology|dermatology
898314|NCT04180748|Cosmetics|cosmetics
898315|NCT04180748|Autofluorescence|autofluorescence
898316|NCT04180735|Risk Factors|risk factors
898317|NCT04180735|Survival|survival
898318|NCT04180722|Home mechanical ventilation|home mechanical ventilation
898319|NCT04180722|Ventilator assisted individuals|ventilator assisted individuals
898320|NCT04180722|Virtual Intervention|virtual intervention
898321|NCT04180709|Cognition|cognition
898322|NCT04180709|Social Recovery|social recovery
898323|NCT04180709|Immunopsychiatry|immunopsychiatry
898324|NCT04180709|Daily function|daily function
898325|NCT04180709|Sleep disturbances|sleep disturbances
898326|NCT04180709|Insomnia|insomnia
898327|NCT04180683|Depression|depression
898328|NCT04180683|Depressive Disorder|depressive disorder
898329|NCT04180683|Neurocognitive Disorders|neurocognitive disorders
898330|NCT04180683|Dementia|dementia
898331|NCT04180683|Elderly|elderly
898332|NCT04180683|Geriatric Depression Scale|geriatric depression scale
898333|NCT04180683|Beck Depression Inventory - II|beck depression inventory - ii
898334|NCT04180670|chronic Obstructive Pulmonary Disease|chronic obstructive pulmonary disease
898335|NCT04180670|urinary incontinence|urinary incontinence
898336|NCT04180670|self-activity assesment|self-activity assesment
898337|NCT04180657|ghrelin|ghrelin
898338|NCT04180657|growth hormone|growth hormone
898339|NCT04180657|protein C deficiency|protein c deficiency
898340|NCT04180657|appetite|appetite
898341|NCT04180605|Atrial fibrillation|atrial fibrillation
898342|NCT04180605|Left atrial appendage|left atrial appendage
898343|NCT04180605|Transcatheter closure|transcatheter closure
898344|NCT04180605|Stroke prevention|stroke prevention
898345|NCT04180605|Computed tomography|computed tomography
898346|NCT04180605|Computational simulation|computational simulation
898347|NCT04180605|Preoperative planning|preoperative planning
898349|NCT04180592|Prostate Biopsy|prostate biopsy
898350|NCT04180579|alopecia|alopecia
898351|NCT04180579|breast cancer|breast cancer
898352|NCT04180579|hair loss|hair loss
898353|NCT04180579|chemotherapy induced alopecia|chemotherapy induced alopecia
898354|NCT04180579|19-277|19-277
898355|NCT04180579|Memorial Sloan Kettering Cancer Center|memorial sloan kettering cancer center
898356|NCT04180566|Pregnant|pregnant
898357|NCT04180566|Pregnancy|pregnancy
898358|NCT04180566|Ultrasound|ultrasound
898359|NCT04180566|Antepartum testing|antepartum testing
898360|NCT04180566|Neonatal outcome|neonatal outcome
898361|NCT04180566|Antenatal complications|antenatal complications
898362|NCT04180553|Ultrasound|ultrasound
898363|NCT04180553|Goal-directed resuscitation|goal-directed resuscitation
898364|NCT04180540|Cardiology|cardiology
898365|NCT04180540|Electrophysiology|electrophysiology
898366|NCT04180527|preoperative|preoperative
898367|NCT04180527|sleep|sleep
898368|NCT04180527|anxiety|anxiety
898369|NCT04180527|hip surgery|hip surgery
898370|NCT04180527|knee surgery|knee surgery
898371|NCT04180527|storytelling|storytelling
898372|NCT04180514|intradialytic hypotension|intradialytic hypotension
898373|NCT04180514|pulse wave analysis|pulse wave analysis
898374|NCT04180514|heart rate variability|heart rate variability
898375|NCT04180514|Constitution in Chinese Medicine Questionnaire|constitution in chinese medicine questionnaire
898376|NCT04180475|Remote monitoring|remote monitoring
898377|NCT04180462|Implementation Strategy|implementation strategy
898378|NCT04180462|Quality Improvement|quality improvement
898379|NCT04180436|sleeve gastrectomy, gastric bypass, morbid obesity|sleeve gastrectomy, gastric bypass, morbid obesity
898380|NCT04180397|Fluid overload|fluid overload
898381|NCT04180397|Fluid removal|fluid removal
898382|NCT04180397|Oedema|oedema
898383|NCT04180397|Deresuscitation|deresuscitation
898384|NCT04180371|EphA2|epha2
898385|NCT04180358|Navajo|navajo
898386|NCT04180358|Sex|sex
898387|NCT04180358|Abstain|abstain
898388|NCT04180358|Culture|culture
898389|NCT04180358|Random|random
898390|NCT04180358|Control|control
898391|NCT04180358|Trial|trial
898392|NCT04180358|PREIS|preis
898393|NCT04180345|Flare|flare
898394|NCT04180345|Inflammatory Bowel Diseases|inflammatory bowel diseases
898395|NCT04180345|Questionnaire|questionnaire
898396|NCT04180345|Internet|internet
898397|NCT04180345|Mixed methods|mixed methods
898398|NCT04180332|superoxide dismutase|superoxide dismutase
898399|NCT04180332|catalase|catalase
898400|NCT04180332|anti-oxidant|anti-oxidant
898401|NCT04180332|diabetes mellitus|diabetes mellitus
898402|NCT04180332|type 2|type 2
898403|NCT04180332|periodontitis|periodontitis
898404|NCT04180319|Natural History|natural history
898405|NCT04180319|Epidemiology|epidemiology
898406|NCT04180319|Registry|registry
898407|NCT04180319|alpha 1-Antitrypsin Deficiency|alpha 1-antitrypsin deficiency
898408|NCT04180293|Military|military
898409|NCT04180293|Veteran|veteran
898410|NCT04180293|Family|family
898411|NCT04180293|Psychoeducation|psychoeducation
898412|NCT04180293|Resiliency|resiliency
898413|NCT04180293|Operational stress injuries|operational stress injuries
898414|NCT04180293|Post traumatic stress disorder|post traumatic stress disorder
898415|NCT04180267|Osteoporosis|osteoporosis
898416|NCT04180267|Vibration Therapy|vibration therapy
898417|NCT04180267|Disabled patient|disabled patient
898418|NCT04180267|Vertebral BMD|vertebral bmd
898419|NCT04180215|Vaccine|vaccine
898420|NCT04180215|Gene Therepy|gene therepy
898421|NCT04180215|TheraT®|therat®
898422|NCT04180215|E7E6|e7e6
898423|NCT04180215|HPV 16 E7E6|hpv 16 e7e6
898424|NCT04180215|HNSCC|hnscc
898425|NCT04180215|HPV 16+ head and neck squamous cell cancer|hpv 16+ head and neck squamous cell cancer
898426|NCT04180215|Oropharyngeal cancer|oropharyngeal cancer
898427|NCT04180215|Penile cancer|penile cancer
898428|NCT04180215|Anal cancer|anal cancer
898429|NCT04180215|Cervical cancer|cervical cancer
898430|NCT04180215|Vaginal cancer|vaginal cancer
898431|NCT04180215|Vulvar cancer|vulvar cancer
898432|NCT04180189|children|children
898433|NCT04180189|non-pharmacological intervention|non-pharmacological intervention
898434|NCT04180189|ADHD|adhd
898435|NCT04180189|sleep|sleep
898436|NCT04180124|Gait pattern|gait pattern
898437|NCT04180124|Treadmill walking|treadmill walking
898438|NCT04180124|Arm swing|arm swing
898439|NCT04180098|hereditary spastic paraplegia|hereditary spastic paraplegia
898440|NCT04180098|C-mill|c-mill
898441|NCT04180098|gait adaptability|gait adaptability
898442|NCT04180098|rehabilitation|rehabilitation
898443|NCT04180072|HCC , HBV infection|hcc , hbv infection
898444|NCT04180059|hematopoietic stem cell transplantation|hematopoietic stem cell transplantation
898445|NCT04180059|lymphocyte infusion|lymphocyte infusion
898446|NCT04180059|cytotoxic T lymphocyte|cytotoxic t lymphocyte
898447|NCT04180059|HLA-DP|hla-dp
898448|NCT04180059|T cell therapy|t cell therapy
898449|NCT04180046|glioblastoma|glioblastoma
898450|NCT04180046|cell|cell
898451|NCT04180046|mutation|mutation
898452|NCT04180033|Colonoscopy surveillance|colonoscopy surveillance
898453|NCT04179981|Apnea|apnea
898454|NCT04179981|Sleep Apnea Syndromes|sleep apnea syndromes
898455|NCT04179981|Sleep Apnea, Obstructive|sleep apnea, obstructive
898456|NCT04179981|Nervous System Diseases|nervous system diseases
898457|NCT04179981|Respiration Disorders|respiration disorders
898458|NCT04179981|Respiratory Tract Diseases|respiratory tract diseases
898459|NCT04179981|Signs and Symptoms, Respiratory|signs and symptoms, respiratory
898460|NCT04179981|positive airway pressure|positive airway pressure
898461|NCT04179981|cognitive function|cognitive function
898462|NCT04179981|quality of life|quality of life
898463|NCT04179981|sleepiness|sleepiness
898464|NCT04179968|PET/CT|pet/ct
898465|NCT04179968|prostate cancer|prostate cancer
898466|NCT04179968|Gallium-68|gallium-68
898467|NCT04179968|PSMA-11|psma-11
898468|NCT04179942|FeNO; ;;|feno; ;;
898469|NCT04179942|Hs-CRP|hs-crp
898470|NCT04179942|CPAP|cpap
898471|NCT04179942|OSA|osa
898472|NCT04179929|ALL|all
898473|NCT04179929|adult|adult
898474|NCT04179929|Ph-negative|ph-negative
898475|NCT04179929|minimal residual disease|minimal residual disease
898476|NCT04179929|transplantation|transplantation
898477|NCT04179916|virtual reality|virtual reality
898478|NCT04179916|VR|vr
898479|NCT04179916|COPD|copd
898480|NCT04179916|coronary heart disease|coronary heart disease
898481|NCT04179916|HRV|hrv
898482|NCT04179916|microcirculation|microcirculation
898483|NCT04179903|osteoporosis|osteoporosis
898484|NCT04179903|Gym Training|gym training
898485|NCT04179903|physical activity|physical activity
898486|NCT04179903|home training|home training
898487|NCT04179864|metastatic castration resistant prostate cancer|metastatic castration resistant prostate cancer
898488|NCT04179799|SCI|sci
898489|NCT04179799|diaphragm pacing|diaphragm pacing
898490|NCT04179799|respiratory impairment|respiratory impairment
898491|NCT04179799|diaphragm stimulation|diaphragm stimulation
898492|NCT04179786|SciB018|scib018
898493|NCT04179786|Prophylactic vaccine|prophylactic vaccine
898494|NCT04179786|Sci-B-Vac|sci-b-vac
898495|NCT04179786|HepB vaccines|hepb vaccines
898496|NCT04179786|Phase 4|phase 4
898497|NCT04179786|pre-S1|pre-s1
898498|NCT04179786|pre-S2|pre-s2
898499|NCT04179786|Surface antigen|surface antigen
898500|NCT04179773|Liver cirrhosis|liver cirrhosis
898501|NCT04179773|chemotherapy|chemotherapy
898502|NCT04179773|ENT cancers|ent cancers
898503|NCT04179773|upper-digestive tract cancers|upper-digestive tract cancers
898504|NCT04179773|colorectal cancers|colorectal cancers
898505|NCT04179747|Sexual Dysfunctions, Men Health|sexual dysfunctions, men health
898506|NCT04179734|Hypoactive Sexual Desire Disorder|hypoactive sexual desire disorder
898507|NCT04179734|Bremelanotide|bremelanotide
898508|NCT04179734|Functional MRI|functional mri
898509|NCT04179734|Melanocortin-4 receptor|melanocortin-4 receptor
898510|NCT04179721|Behavioral and Psychological Symptoms of Dementia|behavioral and psychological symptoms of dementia
898511|NCT04179721|Alzheimer's Disease and Related Dementias|alzheimer's disease and related dementias
898512|NCT04179721|Hospitalization|hospitalization
898513|NCT04179708|Therapeutic Patient Education|therapeutic patient education
898514|NCT04179708|Chronic Low Back Pain|chronic low back pain
898515|NCT04179708|Chronic Pain|chronic pain
898516|NCT04179708|Pain Neuroscience Education|pain neuroscience education
898517|NCT04179708|Pain Neurophysiology Education|pain neurophysiology education
898518|NCT04179708|Pain biology education|pain biology education
898519|NCT04179695|Health pathway|health pathway
898520|NCT04179695|patient centered care|patient centered care
898521|NCT04179695|communication aid- tool|communication aid- tool
898522|NCT04179695|primary care|primary care
898523|NCT04179695|secondary care|secondary care
898524|NCT04179682|cerebral palsy|cerebral palsy
898525|NCT04179682|constraint-induced movement therapy|constraint-induced movement therapy
898526|NCT04179682|botulinum toxin|botulinum toxin
898527|NCT04179682|rehabilitation|rehabilitation
898528|NCT04179682|occupational therapy|occupational therapy
898529|NCT04179617|JUUL|juul
898530|NCT04179617|dual use|dual use
898531|NCT04179617|multiple tobacco product use|multiple tobacco product use
898532|NCT04179617|flavors|flavors
898533|NCT04179617|tobacco regulatory science|tobacco regulatory science
898534|NCT04179604|Poor left ventricule eyection fraction|poor left ventricule eyection fraction
898535|NCT04179604|Levosimendan|levosimendan
898536|NCT04179604|Cardiac surgery|cardiac surgery
898537|NCT04179604|Preoperative Treatment|preoperative treatment
898538|NCT04179604|Low cardiac output syndrome|low cardiac output syndrome
898539|NCT04179604|Clinical Trial|clinical trial
898540|NCT04179591|Pes planus|pes planus
898541|NCT04179591|Foot posture|foot posture
898542|NCT04179591|Plantar pressure variables|plantar pressure variables
898543|NCT04179591|Balance|balance
898544|NCT04179591|Short foot exercises|short foot exercises
898545|NCT04179591|Tibials posterior strengthening|tibials posterior strengthening
898546|NCT04179591|Intrinsic foot muscles|intrinsic foot muscles
898547|NCT04179591|Custom-made insole|custom-made insole
898548|NCT04179591|Arch support insole|arch support insole
898549|NCT04179565|childhood obesity|childhood obesity
898550|NCT04179565|parenting practices|parenting practices
898551|NCT04179565|food and physical activity|food and physical activity
898552|NCT04179526|transdiagnostic|transdiagnostic
898553|NCT04179526|anxiety|anxiety
898554|NCT04179526|depression|depression
898555|NCT04179526|REBT|rebt
898556|NCT04179526|adolescents|adolescents
898557|NCT04179526|Internet intervention|internet intervention
898558|NCT04179500|tuberculosis|tuberculosis
898559|NCT04179500|TB|tb
898560|NCT04179500|DR-TB|dr-tb
898561|NCT04179500|pretomanid (PA)|pretomanid (pa)
898562|NCT04179500|PA-824|pa-824
898563|NCT04179500|XDR TB|xdr tb
898564|NCT04179500|Pa|pa
898565|NCT04179487|pulmonary embolism|pulmonary embolism
898566|NCT04179487|pregnancy|pregnancy
898567|NCT04179487|tomography xray computed|tomography xray computed
898568|NCT04179487|radiation dosage|radiation dosage
898569|NCT04179487|negative predictive value|negative predictive value
898571|NCT04179474|erenumab|erenumab
898572|NCT04179474|galcanezumab|galcanezumab
898573|NCT04179474|safety|safety
898574|NCT04179474|tolerability|tolerability
898575|NCT04179474|interaction|interaction
898576|NCT04179448|Keratinized Tissue|keratinized tissue
898577|NCT04179448|Keratinized Gingiva|keratinized gingiva
898578|NCT04179448|Gingival recession|gingival recession
898579|NCT04179448|Mucogingival defect|mucogingival defect
898580|NCT04179448|SAMRI|samri
898581|NCT04179448|Acellular Dermal Matrix|acellular dermal matrix
898582|NCT04179448|Sulcular tunnel technique|sulcular tunnel technique
898583|NCT04179448|Patient-centered outcomes|patient-centered outcomes
898584|NCT04179409|DMD|dmd
898585|NCT04179409|Exon Skipping|exon skipping
898586|NCT04179396|CRPC|crpc
898587|NCT04179396|PARP inhibitor|parp inhibitor
898588|NCT04179396|RAMP|ramp
898589|NCT04179396|homologous recombination|homologous recombination
898590|NCT04179396|DNA repair|dna repair
898591|NCT04179396|DNA defect|dna defect
898592|NCT04179396|DNA anomaly|dna anomaly
898593|NCT04179396|mCRPC|mcrpc
898594|NCT04179396|enzalutamide|enzalutamide
898595|NCT04179396|abiraterone|abiraterone
898596|NCT04179396|Zytiga|zytiga
898597|NCT04179396|Xtandi|xtandi
898598|NCT04179396|ADT|adt
898599|NCT04179396|AR|ar
898600|NCT04179396|ARi|ari
898601|NCT04179383|Thunderclap headache|thunderclap headache
898602|NCT04179370|vitamin D OR 25(OH)D|vitamin d or 25(oh)d
898603|NCT04179370|African-Caribbean OR Afro-Caribbean|african-caribbean or afro-caribbean
898604|NCT04179344|Pharmaceutical care|pharmaceutical care
898605|NCT04179344|HIV|hiv
898606|NCT04179344|TB|tb
898607|NCT04179344|Internet|internet
898608|NCT04179344|Surveys and questionnaires|surveys and questionnaires
898609|NCT04179344|Humans|humans
898610|NCT04179344|Pharmacovigilance|pharmacovigilance
898611|NCT04179331|Appetite regulation|appetite regulation
898612|NCT04179331|Food intake|food intake
898613|NCT04179331|Ad libitum|ad libitum
898614|NCT04179331|Hormone secretion|hormone secretion
898615|NCT04179292|Scleroderma|scleroderma
898616|NCT04179292|Systemic sclerosis|systemic sclerosis
898617|NCT04179292|Hand therapy|hand therapy
898618|NCT04179240|biosample|biosample
898619|NCT04179240|child and adolescent|child and adolescent
898620|NCT04179240|cartoon|cartoon
898621|NCT04179240|questionnaire|questionnaire
898622|NCT04179240|concent|concent
898623|NCT04179214|Trigger Area|trigger area
898624|NCT04179188|obesity|obesity
898625|NCT04179188|Bariatric Surgery|bariatric surgery
898626|NCT04179188|Obstructive Sleep Apnea|obstructive sleep apnea
898627|NCT04179175|acne inversa|acne inversa
898628|NCT04179175|Hidradenitis suppurativa|hidradenitis suppurativa
898629|NCT04179175|maladie de Vemeuil|maladie de vemeuil
898630|NCT04179175|inflammatory disease|inflammatory disease
898631|NCT04179175|AIN457|ain457
898632|NCT04179175|AIN457M|ain457m
898633|NCT04179175|secukinumab|secukinumab
898634|NCT04179175|Loss of response|loss of response
898635|NCT04179175|HiSCR|hiscr
898636|NCT04179175|IL-17A|il-17a
898637|NCT04179162|Bacillus Calmette-Guérin (BCG)|bacillus calmette-guérin (bcg)
898638|NCT04179162|Gemcitabine|gemcitabine
898639|NCT04179162|19-374|19-374
898640|NCT04179149|endometriosis|endometriosis
898641|NCT04179149|chronic pelvic pain|chronic pelvic pain
898642|NCT04179149|quality of life|quality of life
898643|NCT04179149|inflammation|inflammation
898644|NCT04179149|stress|stress
898645|NCT04179136|Cardiovascular system Polyphenols|cardiovascular system polyphenols
898646|NCT04179006|Major depressive disorder|major depressive disorder
898647|NCT04179006|Supplement nutrients|supplement nutrients
898648|NCT04179006|Antidepressants|antidepressants
898649|NCT04178798|CLL|cll
898650|NCT04178538|Anterior cruciate ligament tear|anterior cruciate ligament tear
898651|NCT04178538|ACL|acl
898652|NCT04178291|Periodontitis|periodontitis
898653|NCT04178291|air polishing|air polishing
898654|NCT04178291|randomised clinical trial|randomised clinical trial
898655|NCT04178291|adjunct|adjunct
898656|NCT04178291|debridement|debridement
898657|NCT04177563|whole-body cryotherapy|whole-body cryotherapy
898658|NCT04177563|healthy men|healthy men
898659|NCT04177563|blood components|blood components
898660|NCT04177550|empyema thoracis|empyema thoracis
898661|NCT04177550|Thoracoscopic|thoracoscopic
898662|NCT04177550|VATS|vats
898663|NCT04177550|Video-assisted Thoracoscopic Surgery|video-assisted thoracoscopic surgery
898664|NCT04177550|Pediatric Empyema Thoracis|pediatric empyema thoracis
898665|NCT04176770|Laparoscopic cholecystectomy|laparoscopic cholecystectomy
898666|NCT04176770|Post Operative|post operative
898667|NCT04176770|Analgesia|analgesia
898668|NCT04176731|T1D|t1d
898669|NCT04176731|Omnipod|omnipod
898670|NCT04176614|cereal-based snack fortified with legumes|cereal-based snack fortified with legumes
898671|NCT04176614|body weight reduction|body weight reduction
898672|NCT04176484|ovarian cancer|ovarian cancer
898673|NCT04176484|Opportunistic salpingectomy|opportunistic salpingectomy
898674|NCT04175873|music therapy|music therapy
898675|NCT04175873|pain|pain
898676|NCT04175873|oxidative stress|oxidative stress
898677|NCT04175808|Thorough QT|thorough qt
898678|NCT04175808|QTc study|qtc study
898679|NCT04175756|colorectal cancer|colorectal cancer
898680|NCT04175756|laparoscopic surgery|laparoscopic surgery
898681|NCT04175756|Seal & Cut|seal & cut
898682|NCT04175756|Total Mesorectal Excision (TME)|total mesorectal excision (tme)
898683|NCT04175756|Partial Mesorectal Excision (PME)|partial mesorectal excision (pme)
898684|NCT04175756|Complete Mesocolic Excision (CME)|complete mesocolic excision (cme)
898685|NCT04175678|Hispanic Men|hispanic men
898686|NCT04175678|Healthy Men|healthy men
898687|NCT04175678|Obese Men|obese men
898688|NCT04175678|Exercise|exercise
898689|NCT04175678|Diet|diet
898690|NCT04175639|cancer|cancer
898691|NCT04175639|pain|pain
898692|NCT04175639|fatigue|fatigue
898693|NCT04175639|distress|distress
898694|NCT04175639|coping|coping
898695|NCT04175639|mHealth|mhealth
898696|NCT04175639|symptom management|symptom management
898697|NCT04175639|physical disability|physical disability
898698|NCT04175587|Realgar-Indigo Naturalis Formula, Retinoic Acid|realgar-indigo naturalis formula, retinoic acid
898699|NCT04175366|Shared Decision Making|shared decision making
898700|NCT04175366|Compulsory Care|compulsory care
898701|NCT04175366|Psychiatric Care|psychiatric care
898702|NCT04174755|obesity|obesity
898703|NCT04174755|HIV|hiv
898704|NCT04174755|weight loss|weight loss
898705|NCT04174755|GLP-1 analogue|glp-1 analogue
898706|NCT04174755|immune activation|immune activation
898707|NCT04174755|viral reservoir|viral reservoir
898708|NCT04174755|gut microbiome|gut microbiome
898709|NCT04173806|Education, Medical|education, medical
898710|NCT04173806|Online Social Networking|online social networking
898711|NCT04173806|Computer User Training|computer user training
898712|NCT04173806|Telemedicine|telemedicine
898713|NCT04173689|Sarcoidosis|sarcoidosis
898714|NCT04172870|Ebstein Barr Virus|ebstein barr virus
898715|NCT04172870|Cytomegalovirus|cytomegalovirus
898716|NCT04172870|Herpes Simplex Virus|herpes simplex virus
898717|NCT04172870|Pentraxins|pentraxins
898718|NCT04172870|Toll Like Receptors|toll like receptors
898719|NCT04172597|EGFR activating mutations|egfr activating mutations
898720|NCT04172597|HER2 activating mutations|her2 activating mutations
898721|NCT04172597|HER2-positive breast cancer|her2-positive breast cancer
898722|NCT04172597|HER2-negative breast cancer|her2-negative breast cancer
898723|NCT04172246|relapsed/refractory chronic lymphocytic leukemia|relapsed/refractory chronic lymphocytic leukemia
898724|NCT04172246|relapsed/refractory small lymphocytic lymphoma|relapsed/refractory small lymphocytic lymphoma
898725|NCT04172246|treatment-naïve chronic lymphocytic leukemia|treatment-naïve chronic lymphocytic leukemia
898726|NCT04172246|treatment-naïve /small lymphocytic lymphoma|treatment-naïve /small lymphocytic lymphoma
898727|NCT04172246|relapsed/refractory mantle cell lymphoma|relapsed/refractory mantle cell lymphoma
898728|NCT04172246|relapsed/refractory marginal zone lymphoma|relapsed/refractory marginal zone lymphoma
898729|NCT04172246|relapsed/refractory follicular lymphoma|relapsed/refractory follicular lymphoma
898730|NCT04172246|relapsed/refractory Waldenström macroglobulinemia|relapsed/refractory waldenström macroglobulinemia
898731|NCT04172246|treatment-naïve Waldenström macroglobulinemia|treatment-naïve waldenström macroglobulinemia
898732|NCT04172129|Nanos|nanos
898733|NCT04172129|THA|tha
898734|NCT04172129|MBRSA|mbrsa
898735|NCT04171856|Acute stroke|acute stroke
898736|NCT04171856|Motor skill learning|motor skill learning
898737|NCT04171856|Upper limb|upper limb
898738|NCT04171856|Rehabilitation|rehabilitation
898739|NCT04171856|Subacute stroke|subacute stroke
898740|NCT04171232|Cerebral Palsy|cerebral palsy
898741|NCT04171232|Child|child
898742|NCT04171232|Hemiplegia|hemiplegia
898743|NCT04171232|Motor Activity|motor activity
898744|NCT04171232|Upper Extremity|upper extremity
898745|NCT04170946|Talazoparib|talazoparib
898746|NCT04170946|Thoracic Radiotherapy|thoracic radiotherapy
898747|NCT04170946|Chemotherapy|chemotherapy
898748|NCT04170738|ADHD|adhd
898749|NCT04170738|substance abuse risk|substance abuse risk
898750|NCT04170738|Adderall|adderall
898751|NCT04170738|fMRI|fmri
898752|NCT04170738|ADHD Treatment|adhd treatment
898753|NCT04170738|Medication|medication
898754|NCT04169581|Deep Learning|deep learning
898755|NCT04169581|Temporal Lobe Epilepsy|temporal lobe epilepsy
898756|NCT04169581|Positron-Emission Tomography|positron-emission tomography
898757|NCT04169373|Upadacitinib|upadacitinib
898758|NCT04169373|Axial Spondyloarthritis (axSpA)|axial spondyloarthritis (axspa)
898759|NCT04169373|Spondyloarthritis|spondyloarthritis
898760|NCT04169373|Ankylosing Spondylitis (AS)|ankylosing spondylitis (as)
898761|NCT04168840|ultrasound|ultrasound
898762|NCT04168840|difficult airway|difficult airway
898763|NCT04168840|difficult intubation|difficult intubation
898764|NCT04168814|Nutritional status|nutritional status
898765|NCT04168814|Oncology Patients|oncology patients
898766|NCT04168814|Anticancer treatments|anticancer treatments
898767|NCT04168814|Quality of Life|quality of life
898768|NCT04167943|indirect pulp capping|indirect pulp capping
898769|NCT04167943|direct pulp capping|direct pulp capping
898770|NCT04167943|partial pulpotomy|partial pulpotomy
898771|NCT04167943|pulpotomy|pulpotomy
898772|NCT04167943|TheraCal|theracal
898773|NCT04167943|primary molars|primary molars
898774|NCT04167540|PD|pd
898775|NCT04167540|Parkinson's disease|parkinson's disease
898776|NCT04167540|Neurotrophic factor|neurotrophic factor
898777|NCT04167540|Growth factor|growth factor
898778|NCT04167540|Glial cell line-derived neurotrophic factor|glial cell line-derived neurotrophic factor
898779|NCT04167540|GDNF|gdnf
898780|NCT04167540|AAV|aav
898781|NCT04167540|Gene therapy|gene therapy
898782|NCT04166747|virtual reality|virtual reality
898783|NCT04166747|older population|older population
898784|NCT04166747|functional fitness|functional fitness
898785|NCT04166747|quality of life|quality of life
898786|NCT04166747|happiness|happiness
898787|NCT04166383|Nonreplicating adenovirus|nonreplicating adenovirus
898788|NCT04166383|Antitumor Immunity|antitumor immunity
898789|NCT04166383|PD-1 inhibition|pd-1 inhibition
898790|NCT04166383|Immune Checkpoint Inhibition|immune checkpoint inhibition
898791|NCT04164823|Primary Dysmenorrhea|primary dysmenorrhea
898792|NCT04164823|Taping|taping
898793|NCT04164823|Pain|pain
898794|NCT04164108|intensive care unit|intensive care unit
898795|NCT04163991|Rheumatoid Arthritis|rheumatoid arthritis
898796|NCT04163991|RA|ra
898797|NCT04163991|VIB4920|vib4920
898798|NCT04163991|MEDI4920|medi4920
898799|NCT04163458|Controlled Ovarian Stimulation|controlled ovarian stimulation
898800|NCT04163458|Assisted Reproductive Technology|assisted reproductive technology
898801|NCT04161391|Non small cell lung cancer|non small cell lung cancer
898802|NCT04161391|Non-small cell lung cancer|non-small cell lung cancer
898803|NCT04161391|NSCLC|nsclc
898804|NCT04161391|Medullary Thyroid Cancer|medullary thyroid cancer
898805|NCT04161391|MTC|mtc
898806|NCT04161391|RET gene mutation|ret gene mutation
898807|NCT04161391|RET gene alteration|ret gene alteration
898808|NCT04161391|Advanced non small cell lung cancer|advanced non small cell lung cancer
898809|NCT04161391|Advanced/metastatic disease|advanced/metastatic disease
898810|NCT04161391|lung cancer|lung cancer
898811|NCT04161391|lung adenocarcinoma|lung adenocarcinoma
898812|NCT04161391|Metastatic solid tumor|metastatic solid tumor
898813|NCT04161391|Advanced Solid Tumors|advanced solid tumors
898814|NCT04161391|RET gene fusion|ret gene fusion
898815|NCT04161391|RET inhibitor|ret inhibitor
898816|NCT04161391|SRC|src
898817|NCT04161391|TPX-0046|tpx-0046
898818|NCT04161391|Thyroid cancer|thyroid cancer
898819|NCT04160234|elderly|elderly
898820|NCT04160234|surgery|surgery
898821|NCT04160234|preoperative risk|preoperative risk
898822|NCT04160195|Autologous T Cells Infusion|autologous t cells infusion
898823|NCT04160195|Hu1928-Hu20BB|hu1928-hu20bb
898824|NCT04160195|Hodgkin Reed-Sternberg Cells|hodgkin reed-sternberg cells
898825|NCT04160195|Adoptive T Cell Therapy|adoptive t cell therapy
898826|NCT04160195|Gene Therapy|gene therapy
898827|NCT04160039|Cycle Ergometry|cycle ergometry
898828|NCT04160039|Physical Therapy|physical therapy
898829|NCT04160039|Rehabilitation|rehabilitation
898830|NCT04157517|Drug Therapy|drug therapy
898831|NCT04155931|perioperative body tempreture|perioperative body tempreture
898832|NCT04155931|hypothermia|hypothermia
898833|NCT04155931|PONV|ponv
898834|NCT04155931|Postoperative nausea and vomiting|postoperative nausea and vomiting
898835|NCT04153565|Programmed Cell Death-1 (PD1, PD-1)|programmed cell death-1 (pd1, pd-1)
898836|NCT04153565|Programmed Death-Ligand 1 (PDL1, PD-L1)|programmed death-ligand 1 (pdl1, pd-l1)
898837|NCT04153149|ATTR|attr
898838|NCT04153149|Cardiomyopathy|cardiomyopathy
898839|NCT04153149|Amyloidosis|amyloidosis
898841|NCT04153149|Transthyretin|transthyretin
898842|NCT04153149|TTR-mediated amyloidosis|ttr-mediated amyloidosis
898843|NCT04153149|Amyloidosis, Hereditary|amyloidosis, hereditary
898844|NCT04153149|Amyloidosis, Hereditary, Transthyretin-Related|amyloidosis, hereditary, transthyretin-related
898845|NCT04153149|Familial Amyloidosis|familial amyloidosis
898846|NCT04153149|RNAi therapeutic|rnai therapeutic
898847|NCT04153149|Transthyretin amyloid cardiomyopathy|transthyretin amyloid cardiomyopathy
898848|NCT04153149|TTR cardiomyopathy|ttr cardiomyopathy
898849|NCT04153149|ATTR-CM|attr-cm
898850|NCT04153149|Wild-type TTR|wild-type ttr
898851|NCT04153149|V122I|v122i
898852|NCT04153149|TTR amyloidosis|ttr amyloidosis
898853|NCT04153149|Amyloidosis, Wild Type|amyloidosis, wild type
898854|NCT04150562|Antibody Dependent Cellular Cytotoxicity (ADCC)|antibody dependent cellular cytotoxicity (adcc)
898855|NCT04150562|Anti-PD-L1 monoclonal antibody|anti-pd-l1 monoclonal antibody
898856|NCT04149028|Premature ovarian insuffiency|premature ovarian insuffiency
898857|NCT04149028|Infertility|infertility
898858|NCT04149028|PRP|prp
898859|NCT04145141|Molecular Markers|molecular markers
898860|NCT04145141|Predictors for Response or Resistance to Immunotherapy|predictors for response or resistance to immunotherapy
898861|NCT04145141|Sample Collection|sample collection
898862|NCT04145141|Genetic Analysis|genetic analysis
898863|NCT04142619|Multiple Myeloma|multiple myeloma
898864|NCT04142619|Chimeric Antigen Receptor T-Cell (CART-T) therapy|chimeric antigen receptor t-cell (cart-t) therapy
898865|NCT04142619|Transcription Activator-Like Effector Nuclease (TALEN)|transcription activator-like effector nuclease (talen)
898866|NCT04142619|Allogeneic|allogeneic
898867|NCT04141696|Anesthetics|anesthetics
898868|NCT04141696|Signs and Symptoms|signs and symptoms
898869|NCT04141696|Midazolam|midazolam
898870|NCT04141696|Physiological Effects of Drugs|physiological effects of drugs
898871|NCT04138212|esophageal squamous cell carcinoma|esophageal squamous cell carcinoma
898872|NCT04138212|neoadjuvant chemotherapy|neoadjuvant chemotherapy
898873|NCT04138212|neoadjuvant chemoradiation therapy|neoadjuvant chemoradiation therapy
898874|NCT04138212|randomized controlled|randomized controlled
898875|NCT04138212|survival|survival
898876|NCT04138121|cricothyroid membrane|cricothyroid membrane
898877|NCT04138121|pregnancy|pregnancy
898878|NCT04138121|ultrasound|ultrasound
898879|NCT04137458|Psychiatry|psychiatry
898880|NCT04137458|Blood Brain Barrie|blood brain barrie
898881|NCT04137458|Suicide attempt|suicide attempt
898882|NCT04137458|Inflammation|inflammation
898883|NCT04136808|Locally Advanced or Metastatic Urothelial Carcinoma|locally advanced or metastatic urothelial carcinoma
898884|NCT04136808|enfortumab vedotin (EV)|enfortumab vedotin (ev)
898885|NCT04136808|ASG-22CE|asg-22ce
898886|NCT04136808|Expanded Access|expanded access
898887|NCT04136808|EV-901|ev-901
898888|NCT04136093|Weight Loss Maintenance|weight loss maintenance
898889|NCT04136093|Metabolic Disorders|metabolic disorders
898890|NCT04136093|Postmenopausal Women|postmenopausal women
898891|NCT04136093|Cardiometabolic Parameters|cardiometabolic parameters
898892|NCT04136093|Diet Therapy|diet therapy
898893|NCT04136093|Metabolic Syndrome|metabolic syndrome
898894|NCT04135768|Distal radius fracture|distal radius fracture
898895|NCT04135768|Articular fracture|articular fracture
898896|NCT04135768|Joint haematoma|joint haematoma
898897|NCT04135768|Volar wrist plating|volar wrist plating
898898|NCT04134260|Prostate Cancer|prostate cancer
898899|NCT04134260|Apalutamide|apalutamide
898900|NCT04134260|Abiraterone Acetate|abiraterone acetate
898901|NCT04132765|cerebral palsy|cerebral palsy
898902|NCT04132765|drooling impact scale|drooling impact scale
898903|NCT04132765|hypersalivation|hypersalivation
898904|NCT04132765|validity|validity
898905|NCT04132518|PLLA|plla
898906|NCT04132518|Midface Volume Deficit|midface volume deficit
898907|NCT04130646|stroke|stroke
898908|NCT04130646|recovery|recovery
898909|NCT04130646|TMS|tms
898910|NCT04130646|VNS|vns
898911|NCT04130646|motor|motor
898912|NCT04130646|motor cortex|motor cortex
898913|NCT04129567|Trans-nasal therapy|trans-nasal therapy
898914|NCT04129567|acute migraine attack|acute migraine attack
898915|NCT04129151|Relapsed or refractory Ewing sarcoma|relapsed or refractory ewing sarcoma
898916|NCT04129151|Solid Tumor, Childhood|solid tumor, childhood
898917|NCT04129151|Sarcoma|sarcoma
898918|NCT04129151|Ewing sarcoma|ewing sarcoma
898919|NCT04128319|Steroid-refractory acute GVHD|steroid-refractory acute gvhd
898920|NCT04128319|Acute GVHD|acute gvhd
898921|NCT04128319|GVHD treatment|gvhd treatment
898922|NCT04126837|Ankle|ankle
898923|NCT04126837|Foot|foot
898924|NCT04126837|Injuries|injuries
898925|NCT04126837|Ottawa Rules|ottawa rules
898926|NCT04126837|nurse|nurse
898927|NCT04124926|Erosive Esophagitis|erosive esophagitis
898928|NCT04124926|Vonoprazan|vonoprazan
898929|NCT04124926|Lansoprazole|lansoprazole
898930|NCT04123626|adRP|adrp
898931|NCT04123626|Retinitis Pigmentosa|retinitis pigmentosa
898932|NCT04123626|P23H mutation|p23h mutation
898933|NCT04123626|Rhodopsin|rhodopsin
898934|NCT04123626|antisense oligonucleotide|antisense oligonucleotide
898935|NCT04123626|IVT|ivt
898936|NCT04123626|autosomal dominant|autosomal dominant
898937|NCT04123314|Psilocybin|psilocybin
898938|NCT04123314|Hallucinogen|hallucinogen
898939|NCT04123314|Psychedelic|psychedelic
898940|NCT04123197|Cardiovascular disease|cardiovascular disease
898941|NCT04123197|Daily life stressors|daily life stressors
898942|NCT04123197|Mental stress-induced myocardial ischemia (MSI)|mental stress-induced myocardial ischemia (msi)
898943|NCT04122573|Chest pain|chest pain
898944|NCT04122573|Acute Aortic Dissection|acute aortic dissection
898945|NCT04122573|Pulmonary Embolism|pulmonary embolism
898946|NCT04122573|Acute Coronary Syndrome|acute coronary syndrome
898947|NCT04122573|Acute myocardial infarction|acute myocardial infarction
898948|NCT04122573|Risk stratification|risk stratification
898949|NCT04122573|Prognosis|prognosis
898950|NCT04122573|Biomarkers|biomarkers
898951|NCT04122235|follow-up|follow-up
898952|NCT04122235|app|app
898953|NCT04122235|lifestyle|lifestyle
898954|NCT04122235|empowerment|empowerment
898955|NCT04122235|nurse-led|nurse-led
898956|NCT04117347|Circadian timing|circadian timing
898957|NCT04117347|Mood|mood
898958|NCT04117347|Light|light
898959|NCT04114786|Radiation|radiation
898960|NCT04114786|Brain Cancer|brain cancer
898961|NCT04114786|Glioblastoma|glioblastoma
898962|NCT04114786|3D printed mask|3d printed mask
898963|NCT04110028|Nicotinamide riboside|nicotinamide riboside
898964|NCT04110028|NAD+|nad+
898965|NCT04110028|Epigenetics|epigenetics
898966|NCT04110028|Aging|aging
898967|NCT04110028|PARP|parp
898968|NCT04109066|Nivolumab|nivolumab
898969|NCT04109066|Breast Cancer|breast cancer
898970|NCT04109066|Cancer|cancer
898971|NCT04109066|Estrogen Receptor-Positive (ER+)|estrogen receptor-positive (er+)
898972|NCT04109066|Human Epidermal Growth Factor 2 Negative (HER2-)|human epidermal growth factor 2 negative (her2-)
898973|NCT04109066|Neoadjuvant|neoadjuvant
898974|NCT04109066|Adjuvant|adjuvant
898975|NCT04109066|Primary Breast Cancer|primary breast cancer
898976|NCT04105855|Organism|organism
898977|NCT04105855|Seasonal|seasonal
898978|NCT04105855|Blood Smear|blood smear
898979|NCT04105855|Burden|burden
898980|NCT04105855|Infections|infections
898981|NCT04102436|Adoptive Cell Therapy|adoptive cell therapy
898982|NCT04102436|Cell Therapy|cell therapy
898983|NCT04102436|Immunotherapy|immunotherapy
898984|NCT04102436|Gene Therapy|gene therapy
898985|NCT04102423|Cytopenia|cytopenia
898986|NCT04102423|Myelodysplastic Syndrome|myelodysplastic syndrome
898987|NCT04102423|Somatic Mutations|somatic mutations
898988|NCT04099836|EGFR Mutation|egfr mutation
898989|NCT04099836|Atezolizumab|atezolizumab
898990|NCT04099836|Bevacizumab|bevacizumab
898991|NCT04099836|exon L858R|exon l858r
898992|NCT04099836|exon 21 L858R|exon 21 l858r
898993|NCT04099667|Stroke|stroke
898994|NCT04099667|Traumatic Brain Injury (TBI)|traumatic brain injury (tbi)
898995|NCT04099667|Monoplegia|monoplegia
898996|NCT04099667|Hemiplegia|hemiplegia
898997|NCT04099667|Lower limb|lower limb
898998|NCT04099238|Ischemic stroke|ischemic stroke
898999|NCT04099238|Non-valvular atrial fibrillation (NVAF)|non-valvular atrial fibrillation (nvaf)
899000|NCT04099238|Oral anticoagulants (OAC)|oral anticoagulants (oac)
899001|NCT04099238|Vitamin K antagonists (NKA)|vitamin k antagonists (nka)
899002|NCT04099238|Non-vitamin K antagonist oral anticoagulants (NOAC)|non-vitamin k antagonist oral anticoagulants (noac)
899003|NCT04099238|Discontinuation|discontinuation
899004|NCT04098744|treatment study|treatment study
899005|NCT04098744|cancer prevention|cancer prevention
899006|NCT04098744|non-surgical|non-surgical
899007|NCT04098744|HPV disease|hpv disease
899008|NCT04098744|CIN|cin
899009|NCT04098744|topical treatment|topical treatment
899010|NCT04098744|vaginal inserts|vaginal inserts
899011|NCT04098744|artesunate|artesunate
899012|NCT04098744|artemisinin|artemisinin
899013|NCT04098744|non-invasive|non-invasive
899014|NCT04098744|high risk HPV|high risk hpv
899015|NCT04097821|myelofibrosis|myelofibrosis
899016|NCT04097821|ruxolitinib|ruxolitinib
899017|NCT04097821|INC424|inc424
899018|NCT04097821|siremadlin|siremadlin
899019|NCT04097821|HDM201|hdm201
899020|NCT04097821|crizanlizumab|crizanlizumab
899021|NCT04097821|SEG101|seg101
899022|NCT04097821|MBG453|mbg453
899023|NCT04097821|platform study|platform study
899024|NCT04097561|CD8 Counts|cd8 counts
899025|NCT04097561|B-Cell Activating Factor (BAFF)|b-cell activating factor (baff)
899026|NCT04097561|Heterogeneous Disorder|heterogeneous disorder
899027|NCT04097561|Autoimmune Disease|autoimmune disease
899028|NCT04094519|ASP9785|asp9785
899029|NCT04094519|enzalutamide|enzalutamide
899030|NCT04094519|prostate cancer|prostate cancer
899031|NCT04091607|lumbar medial branch block|lumbar medial branch block
899032|NCT04091607|chronic back pain|chronic back pain
899033|NCT04091607|lower back pain|lower back pain
899034|NCT04091607|lumbar spondylosis|lumbar spondylosis
899035|NCT04091269|patient-ventilator interation|patient-ventilator interation
899036|NCT04091269|automatic adjustmen of inspiratory triger and cycling-off|automatic adjustmen of inspiratory triger and cycling-off
899037|NCT04091269|Neurally controlled PS|neurally controlled ps
899038|NCT04090736|Leukemia|leukemia
899039|NCT04090736|Myeloid|myeloid
899040|NCT04090736|Acute|acute
899041|NCT04090736|Pevonedistat|pevonedistat
899042|NCT04090736|Azacitidine|azacitidine
899043|NCT04090736|Randomized|randomized
899044|NCT04090736|Clinical trial|clinical trial
899045|NCT04090307|Group Prenatal Care|group prenatal care
899046|NCT04090307|Diabetes|diabetes
899047|NCT04089956|spinal cord injury|spinal cord injury
899048|NCT04089956|weaning|weaning
899049|NCT04087681|Extraintestinal pathogenic Escherichia coli (ExPEC)|extraintestinal pathogenic escherichia coli (expec)
899050|NCT04087681|Invasive ExPEC disease (IED)|invasive expec disease (ied)
899051|NCT04087681|Pilot study|pilot study
899052|NCT04087174|Metastatic|metastatic
899053|NCT04087174|Castration Resistant|castration resistant
899054|NCT04087174|Prostate Cancer|prostate cancer
899055|NCT04086485|Carcinoids|carcinoids
899056|NCT04086485|Somatostatin Receptors|somatostatin receptors
899057|NCT04086485|Ionizing Radiation|ionizing radiation
899058|NCT04084366|antibody drug conjugate (ADC)|antibody drug conjugate (adc)
899059|NCT04081415|FPIES|fpies
899060|NCT04081415|microbiota|microbiota
899061|NCT04081415|gut|gut
899062|NCT04081415|stool|stool
899063|NCT04081415|calprotectin saliva|calprotectin saliva
899064|NCT04081415|skin|skin
899065|NCT04076020|Adherence|adherence
899066|NCT04076020|Health Literacy|health literacy
899067|NCT04076020|quality of life|quality of life
899068|NCT04075825|Drug therapy|drug therapy
899069|NCT04074135|Pancreatic tumors|pancreatic tumors
899070|NCT04074135|68-Gallium DOTATATE|68-gallium dotatate
899071|NCT04074135|MEN1 syndrome|men1 syndrome
899072|NCT04074135|NETest|netest
899073|NCT04074135|PNET|pnet
899074|NCT04072835|PSVT|psvt
899076|NCT04072354|schizophrenia|schizophrenia
899077|NCT04072211|Hepatitis B Virus|hepatitis b virus
899078|NCT04072211|Vaccination|vaccination
899079|NCT04072211|Health Personnel|health personnel
899080|NCT04071158|Respiratory tract infection|respiratory tract infection
899081|NCT04071158|Respiratory Syncytial Virus|respiratory syncytial virus
899082|NCT04071158|RSV|rsv
899083|NCT04071158|Tdap|tdap
899084|NCT04071158|Tetanus|tetanus
899085|NCT04071158|Diphtheria|diphtheria
899086|NCT04071158|Acellular Pertussis|acellular pertussis
899087|NCT04071158|Vaccine|vaccine
899088|NCT04070651|Sleep|sleep
899089|NCT04070651|Fatigue|fatigue
899090|NCT04070651|Depressive symptoms|depressive symptoms
899091|NCT04070651|Immune Checkpoint Inhibitors|immune checkpoint inhibitors
899092|NCT04070651|Lung Cancer|lung cancer
899093|NCT04070651|Clinical response|clinical response
899094|NCT04070456|Physician Burnout|physician burnout
899095|NCT04070456|social determinants of health|social determinants of health
899096|NCT04070456|Mini-Z|mini-z
899097|NCT04067661|HIV Prevention|hiv prevention
899098|NCT04067661|Transgender Women|transgender women
899099|NCT04067661|Intervention|intervention
899100|NCT04067453|Anal Canal|anal canal
899101|NCT04067453|External Anal Sphincter|external anal sphincter
899102|NCT04067453|Muscle fatigue|muscle fatigue
899103|NCT04067453|Electromyography|electromyography
899104|NCT04067453|Anorectal Manometry|anorectal manometry
899105|NCT04065334|Resistance training|resistance training
899106|NCT04065334|Endurance training|endurance training
899107|NCT04065269|Clear cell ovarian carcinoma|clear cell ovarian carcinoma
899108|NCT04065269|Clear cell endometrial carcinoma|clear cell endometrial carcinoma
899109|NCT04065269|Endometrioid carcinoma|endometrioid carcinoma
899110|NCT04065269|Carcinosarcoma|carcinosarcoma
899111|NCT04065269|Cervical carcinoma|cervical carcinoma
899112|NCT04065269|ARID1A|arid1a
899113|NCT04058561|Spinal deformity, early onset scoliosis|spinal deformity, early onset scoliosis
899114|NCT04058028|Standard of Care therapies|standard of care therapies
899115|NCT04058028|Oral Corticosteroids|oral corticosteroids
899116|NCT04058028|Inmunosuppressants|inmunosuppressants
899117|NCT04058028|Inmunodulators|inmunodulators
899118|NCT04058028|Systemic Lupus Erythematosus|systemic lupus erythematosus
899119|NCT04058028|B cell Activating Factor (BAFF)|b cell activating factor (baff)
899120|NCT04058028|Inducible T cell costimulator ligand (ICOSL)|inducible t cell costimulator ligand (icosl)
899121|NCT04057222|Rectal sensory function|rectal sensory function
899122|NCT04057222|Multiple sclerosis|multiple sclerosis
899123|NCT04057222|anorectal disorders|anorectal disorders
899124|NCT04057222|Fecal incontinence|fecal incontinence
899125|NCT04057222|constipation|constipation
899126|NCT04057222|bladder sensation|bladder sensation
899127|NCT04056689|LRRK2|lrrk2
899128|NCT04056689|Parkinson's Disease|parkinson's disease
899129|NCT04056689|Movement Disorders|movement disorders
899130|NCT04055467|smoking cessation|smoking cessation
899131|NCT04055467|neuroimaging|neuroimaging
899132|NCT04055467|nicotinic acetylcholine receptors|nicotinic acetylcholine receptors
899133|NCT04055467|abstinence|abstinence
899134|NCT04055168|Dyslipidemia|dyslipidemia
899135|NCT04055168|Single Ascending Dose|single ascending dose
899136|NCT04055168|Safety|safety
899137|NCT04055168|Tolerability|tolerability
899138|NCT04054869|neck stiffness|neck stiffness
899139|NCT04054869|manual therapy|manual therapy
899140|NCT04054869|joint mobilization|joint mobilization
899141|NCT04054752|Breast Cancer|breast cancer
899142|NCT04054752|Colorectal Cancer|colorectal cancer
899143|NCT04054752|Immune Insufficiency|immune insufficiency
899144|NCT04054752|Bladder Cancer|bladder cancer
899145|NCT04054752|Immunocompromised Host|immunocompromised host
899146|NCT04053478|vasopressor|vasopressor
899147|NCT04053478|ephedrine|ephedrine
899148|NCT04053478|phenylephrine|phenylephrine
899149|NCT04053478|norepinephrine|norepinephrine
899150|NCT04053478|umbilical arteries|umbilical arteries
899151|NCT04053478|uterine contraction|uterine contraction
899152|NCT04053478|fetal acidosis|fetal acidosis
899153|NCT04053283|metastatic; epithelial; virus; advanced|metastatic; epithelial; virus; advanced
899154|NCT04052997|Camidanlumab Tesirine; Relapsed or Refractory Hodgkins Lymphoma; Classical Hodgkins Lymphoma; Lymphoma|camidanlumab tesirine; relapsed or refractory hodgkins lymphoma; classical hodgkins lymphoma; lymphoma
899155|NCT04052854|WM|wm
899156|NCT04052854|Treatment naive|treatment naive
899157|NCT04052854|Relapsed/refractory|relapsed/refractory
899158|NCT04052022|Auto-Antibody Production|auto-antibody production
899159|NCT04052022|Host Genetic Predisposition|host genetic predisposition
899160|NCT04052022|Immune Reconstitution Inflammatory Syndrome|immune reconstitution inflammatory syndrome
899161|NCT04052022|Biomarkers|biomarkers
899162|NCT04052022|Pathogenesis|pathogenesis
899163|NCT04051047|Glioma|glioma
899164|NCT04049604|Prenatal Clinical Care|prenatal clinical care
899165|NCT04049604|Prenatal Screen|prenatal screen
899166|NCT04049604|Cell-Free DNA (cfDNA) test|cell-free dna (cfdna) test
899167|NCT04049604|Pregnant Women|pregnant women
899168|NCT04049604|Predictive Values|predictive values
899169|NCT04044950|Intratumoral Injection|intratumoral injection
899170|NCT04044950|Biomarkers|biomarkers
899171|NCT04044950|T Cell Receptor|t cell receptor
899172|NCT04044950|Immunotherapy|immunotherapy
899173|NCT04044950|Neoadjuvant therapy|neoadjuvant therapy
899174|NCT04044872|Cardiotoxicity|cardiotoxicity
899175|NCT04044872|Cardiac injury|cardiac injury
899176|NCT04044872|Radiation induced heart disease (RIHD)|radiation induced heart disease (rihd)
899177|NCT04044053|PF-06865571|pf-06865571
899178|NCT04044053|Relative bioavailability|relative bioavailability
899179|NCT04044053|Modified release|modified release
899180|NCT04044053|Diacylglycerol acyltransferase|diacylglycerol acyltransferase
899181|NCT04044053|DGAT2|dgat2
899182|NCT04044053|Japanese|japanese
899183|NCT04042740|Acute Hepatitis C Infection|acute hepatitis c infection
899184|NCT04042740|Glecaprevir|glecaprevir
899185|NCT04042740|Pibrentasvir|pibrentasvir
899186|NCT04042740|4 weeks|4 weeks
899187|NCT04042740|Direct-acting antivirals|direct-acting antivirals
899188|NCT04042506|immune checkpoint blockade|immune checkpoint blockade
899189|NCT04042506|SBRT|sbrt
899190|NCT04042506|Nivolumab|nivolumab
899191|NCT04042480|HER2-negative breast cancer|her2-negative breast cancer
899192|NCT04037215|eye tracking|eye tracking
899193|NCT04037215|cognitive processing|cognitive processing
899194|NCT04034264|Next Generation Sequencing|next generation sequencing
899195|NCT04034264|Vector-Borne Diseases|vector-borne diseases
899196|NCT04034264|Southeast Asia|southeast asia
899197|NCT04034264|Agnostic Tools|agnostic tools
899198|NCT04034264|Febrile Surveillance|febrile surveillance
899199|NCT04034251|Gastroesophageal Junction (Siewert III) Adenocarcinoma|gastroesophageal junction (siewert iii) adenocarcinoma
899200|NCT04034251|Intravenous Chemotherapy|intravenous chemotherapy
899201|NCT04034251|Progression Free Survival|progression free survival
899202|NCT04034251|Peritoneal Metastasis|peritoneal metastasis
899203|NCT04034251|Intraperitoneal Chemotherapy|intraperitoneal chemotherapy
899204|NCT04032626|Alzheimer's disease|alzheimer's disease
899205|NCT04032626|Biomarkers|biomarkers
899206|NCT04032626|Brain Amyloid|brain amyloid
899207|NCT04032626|Brain Imaging|brain imaging
899208|NCT04032626|Cognition|cognition
899209|NCT04032626|Immunomodulation|immunomodulation
899210|NCT04032119|Gastric Endoscopic submucosal dissection|gastric endoscopic submucosal dissection
899211|NCT04032119|Epinephrine|epinephrine
899212|NCT04031898|EGFR TKI|egfr tki
899213|NCT04031898|retrospective|retrospective
899214|NCT04031898|treatment patterns|treatment patterns
899215|NCT04031898|real world evidence|real world evidence
899216|NCT04031131|Haemorrhoid|haemorrhoid
899217|NCT04031131|Banding|banding
899218|NCT04031131|Topical Anaesthetic|topical anaesthetic
899219|NCT04028973|COPD|copd
899220|NCT04028973|Neuromuscular fatigue|neuromuscular fatigue
899221|NCT04028973|Muscle|muscle
899222|NCT04028973|Dual-task|dual-task
899223|NCT04028973|Mental fatigue|mental fatigue
899224|NCT04027426|Habituation|habituation
899225|NCT04026451|Sedation|sedation
899226|NCT04026451|EEG|eeg
899227|NCT04026451|Mechanical Ventilation|mechanical ventilation
899228|NCT04026451|Critical Care|critical care
899229|NCT04026451|Propofol|propofol
899230|NCT04025567|Gut Bacteria|gut bacteria
899231|NCT04025567|Anti-Tumor Effects|anti-tumor effects
899232|NCT04025567|NKT cells|nkt cells
899233|NCT04025554|Chronic Active Lesions|chronic active lesions
899234|NCT04025554|Ultra-high-field (7T) MRI|ultra-high-field (7t) mri
899235|NCT04025554|Interleukin-1 (IL-1)|interleukin-1 (il-1)
899236|NCT04025554|White Matter|white matter
899237|NCT04025554|Paramagnetic Rim|paramagnetic rim
899238|NCT04024761|Leukemia|leukemia
899239|NCT04018157|ketodex, ketofol , agitation , nasal surgery|ketodex, ketofol , agitation , nasal surgery
899240|NCT04018027|Atopic Dermatitis|atopic dermatitis
899241|NCT04018027|Pruritus|pruritus
899242|NCT04018027|CR845|cr845
899243|NCT04018027|Chronic Itch|chronic itch
899244|NCT04018027|difelikefalin|difelikefalin
899245|NCT04018027|Itch|itch
899246|NCT04018027|Itching|itching
899247|NCT04018027|Generalized pruritus|generalized pruritus
899248|NCT04018027|Eczema|eczema
899249|NCT04017780|Noninvasive Ventilation|noninvasive ventilation
899250|NCT04017780|Acute Respiratory Failure|acute respiratory failure
899251|NCT04017780|Pediatrics|pediatrics
899252|NCT04017767|Neuroplasticity|neuroplasticity
899253|NCT04017767|Respiratory Function|respiratory function
899254|NCT04017767|Motor Function|motor function
899255|NCT04016077|PF-06651600|pf-06651600
899256|NCT04016077|Pharmacokinetics|pharmacokinetics
899257|NCT04016077|Hepatic impairment|hepatic impairment
899258|NCT04014868|Chronic obstructive pulmonary disease|chronic obstructive pulmonary disease
899259|NCT04014868|Exercise|exercise
899260|NCT04014868|Nasal high flow|nasal high flow
899261|NCT04014868|Muscle|muscle
899262|NCT04014517|Inflammatory Bowel Diseases|inflammatory bowel diseases
899263|NCT04014517|Crohn's Disease|crohn's disease
899264|NCT04014517|Immunonutrition|immunonutrition
899265|NCT04014348|Neighborhood Environment|neighborhood environment
899266|NCT04014348|Cardiovascular Disease Risk|cardiovascular disease risk
899267|NCT04014348|Social Determinants of Health|social determinants of health
899268|NCT04014348|Diagnostic Behavioral study|diagnostic behavioral study
899269|NCT04014348|Socio-Economic|socio-economic
899270|NCT04014309|distress screening|distress screening
899271|NCT04014309|supportive care|supportive care
899272|NCT04014309|survivorship|survivorship
899273|NCT04014309|health service|health service
899274|NCT04014309|triage|triage
899275|NCT04014309|breast cancer|breast cancer
899276|NCT04014309|gynecologic Cancer|gynecologic cancer
899277|NCT04012970|lower back pain|lower back pain
899278|NCT04012970|myometer|myometer
899279|NCT04012970|muscle stiffness|muscle stiffness
899280|NCT04012970|spinal mobilisations|spinal mobilisations
899281|NCT04011670|Plasticity|plasticity
899282|NCT04011670|Variability|variability
899283|NCT04011670|Non-invasive brain stimulation|non-invasive brain stimulation
899284|NCT04011670|Caffeine|caffeine
899285|NCT04010825|Dyspnea|dyspnea
899286|NCT04010825|Pulmonary rehabilitation|pulmonary rehabilitation
899287|NCT04010825|Physical activity|physical activity
899288|NCT04010825|Hypnosis|hypnosis
899289|NCT04010825|Anxiety|anxiety
899290|NCT04010825|COPD|copd
899291|NCT04009291|Hypoparathyroidism|hypoparathyroidism
899292|NCT04009291|Parathyroid Hormone|parathyroid hormone
899293|NCT04009291|PTH(1-34)|pth(1-34)
899294|NCT04009291|Prodrug|prodrug
899295|NCT04009291|Sustained Release|sustained release
899296|NCT04009291|TransCon PTH|transcon pth
899297|NCT04009291|Parathyroid Hormone Replacement Therapy|parathyroid hormone replacement therapy
899298|NCT04006457|Alopecia|alopecia
899299|NCT04006457|Alopecia Areata|alopecia areata
899300|NCT04006457|Alopecia totalis|alopecia totalis
899301|NCT04006457|Alopecia universalis|alopecia universalis
899302|NCT04006457|Patchy hair loss|patchy hair loss
899303|NCT04006457|Diffuse hair loss|diffuse hair loss
899304|NCT04006457|Hair loss|hair loss
899305|NCT04006457|Hair disease|hair disease
899306|NCT04006457|PF-06651600|pf-06651600
899307|NCT04003974|FSHD, FSHD1|fshd, fshd1
899308|NCT04003974|Muscular Dystrophies|muscular dystrophies
899309|NCT04003974|Muscular Dystrophy|muscular dystrophy
899310|NCT04003974|Facioscapulohumeral Muscular Disorders|facioscapulohumeral muscular disorders
899311|NCT04003974|Musculoskeletal Diseases|musculoskeletal diseases
899312|NCT04003974|Neuromuscular Diseases|neuromuscular diseases
899313|NCT04003389|menopause|menopause
899314|NCT04003389|fezolinetant|fezolinetant
899315|NCT04003389|ESN364|esn364
899316|NCT04003389|vasomotor symptoms|vasomotor symptoms
899317|NCT04003155|menopause|menopause
899318|NCT04003155|ESN364|esn364
899319|NCT04003155|vasomotor symptoms|vasomotor symptoms
899320|NCT04003155|fezolinetant|fezolinetant
899321|NCT04003142|ESN364|esn364
899322|NCT04003142|menopause|menopause
899323|NCT04003142|fezolinetant|fezolinetant
899324|NCT04003142|vasomotor symptoms|vasomotor symptoms
899325|NCT03998358|Circadian Rhythm|circadian rhythm
899326|NCT03998358|Biomarkers|biomarkers
899327|NCT03998358|Neuroendocrine|neuroendocrine
899328|NCT03998358|Sleep|sleep
899329|NCT03998358|Traumatic Brain Injury|traumatic brain injury
899330|NCT03995901|Kidney Transplant|kidney transplant
899331|NCT03995901|Stem cell therapy|stem cell therapy
899332|NCT03995901|Anti-rejection medications|anti-rejection medications
899333|NCT03995901|Living donor kidney transplant|living donor kidney transplant
899334|NCT03995212|Primary Biliary Cholangitis|primary biliary cholangitis
899335|NCT03995212|Pruritus|pruritus
899336|NCT03995212|CR845|cr845
899337|NCT03995212|Chronic Itch|chronic itch
899338|NCT03995212|difelikefalin|difelikefalin
899339|NCT03995212|Itch|itch
899340|NCT03995212|Itching|itching
899341|NCT03995212|Generalized pruritus|generalized pruritus
899342|NCT03993522|Chronic Total Occlusion (CTO)|chronic total occlusion (cto)
899343|NCT03993379|Combination|combination
899344|NCT03993379|ipilimumab|ipilimumab
899345|NCT03993379|Cancer|cancer
899346|NCT03993379|checkpoint inhibitor|checkpoint inhibitor
899347|NCT03993379|PD-L1|pd-l1
899348|NCT03993379|CTLA-4|ctla-4
899349|NCT03993379|PROCLAIM|proclaim
899350|NCT03993379|PROCLAIM-CX-072|proclaim-cx-072
899351|NCT03989102|Pregnancy|pregnancy
899352|NCT03989102|Tolerability|tolerability
899353|NCT03989102|Immune|immune
899354|NCT03989102|Response|response
899355|NCT03989102|Vaccination|vaccination
899356|NCT03988400|stroke|stroke
899357|NCT03988400|gait|gait
899358|NCT03987919|T2DM|t2dm
899359|NCT03987919|GLP-1 RA|glp-1 ra
899360|NCT03987919|Glucose-dependent insulinotropic polypeptide (GIP)|glucose-dependent insulinotropic polypeptide (gip)
899361|NCT03987919|glucagon-like peptide-1 (GLP-1)|glucagon-like peptide-1 (glp-1)
899362|NCT03987919|GIP/GLP-1 dual receptor agonist|gip/glp-1 dual receptor agonist
899363|NCT03986021|Menarche|menarche
899364|NCT03986021|Adolescent|adolescent
899365|NCT03986021|Physiology|physiology
899366|NCT03986021|Hormones|hormones
899367|NCT03983863|NIH|nih
899368|NCT03983863|Panel|panel
899369|NCT03983863|Member/Staff|member/staff
899370|NCT03983837|Inflammatory Bowel Disease|inflammatory bowel disease
899371|NCT03983837|Crohn's Disease|crohn's disease
899372|NCT03983837|Ulcerative Colitis|ulcerative colitis
899373|NCT03983837|Glucocorticoids|glucocorticoids
899374|NCT03983837|Microbiome|microbiome
899375|NCT03979274|Eutirox|eutirox
899376|NCT03979274|Levothyroxine|levothyroxine
899377|NCT03977610|Prostate cancer|prostate cancer
899378|NCT03977610|Androgen deprivation therapy|androgen deprivation therapy
899379|NCT03977610|Ga-68 PSMA Ligand|ga-68 psma ligand
899380|NCT03977610|Treatment response|treatment response
899381|NCT03976843|PSMA|psma
899382|NCT03976843|PET agent|pet agent
899383|NCT03976843|Prostatectomy|prostatectomy
899384|NCT03976843|Progression Free Survival|progression free survival
899385|NCT03974165|cereal-based products fortified with legumes|cereal-based products fortified with legumes
899386|NCT03974165|appetite regulation|appetite regulation
899387|NCT03974165|postprandial glucose response|postprandial glucose response
899388|NCT03974165|postprandial hormone responses|postprandial hormone responses
899389|NCT03973268|Biomarker|biomarker
899390|NCT03973268|AMPA Antagonist|ampa antagonist
899391|NCT03973268|Magnetoenephalography|magnetoenephalography
899392|NCT03973268|Neuropharmacology|neuropharmacology
899393|NCT03973268|Neurobiology|neurobiology
899394|NCT03971071|Chronic Migraine (CM)|chronic migraine (cm)
899395|NCT03971071|Medication Overuse Headache (MOH)|medication overuse headache (moh)
899396|NCT03960398|iatrogenic|iatrogenic
899397|NCT03960398|emergency|emergency
899398|NCT03960398|incidence|incidence
899399|NCT03960398|adverse drug reaction|adverse drug reaction
899400|NCT03957096|HNSCC|hnscc
899401|NCT03957096|NSCLC|nsclc
899402|NCT03953235|neoantigen cancer vaccine|neoantigen cancer vaccine
899403|NCT03953235|shared neoantigen|shared neoantigen
899404|NCT03953235|GRT-C903|grt-c903
899405|NCT03953235|GRT-R904|grt-r904
899406|NCT03953235|immunotherapy|immunotherapy
899407|NCT03953235|PD-1|pd-1
899408|NCT03953235|CTLA-4|ctla-4
899409|NCT03953235|nivolumab|nivolumab
899410|NCT03953235|ipilimumab|ipilimumab
899411|NCT03952650|Field|field
899412|NCT03952650|Immunity|immunity
899413|NCT03952650|Chemoprophylaxis with Sporozoites|chemoprophylaxis with sporozoites
899414|NCT03952650|Vaccine|vaccine
899415|NCT03952650|Malaria-Experienced|malaria-experienced
899416|NCT03952598|Imaging|imaging
899417|NCT03952598|Higher-Grade Transformation|higher-grade transformation
899418|NCT03952598|Biomarker for Cancer|biomarker for cancer
899419|NCT03952598|High Grade Gliomas|high grade gliomas
899420|NCT03952377|Sciatica|sciatica
899421|NCT03952377|Low Back Pain|low back pain
899422|NCT03952377|Lumbosacral Radiculopathy|lumbosacral radiculopathy
899423|NCT03952377|Leg Pain|leg pain
899424|NCT03949647|LGR|lgr
899425|NCT03949647|Aging|aging
899426|NCT03949647|CD44|cd44
899427|NCT03949647|Stem Cells|stem cells
899428|NCT03949647|Progenitor Cells|progenitor cells
899429|NCT03949166|labor|labor
899430|NCT03949166|delivery|delivery
899431|NCT03949166|eating|eating
899432|NCT03947814|Pimodivir,|pimodivir,
899433|NCT03947814|JNJ-63623872,|jnj-63623872,
899434|NCT03947814|Pharmacokinetics,|pharmacokinetics,
899435|NCT03947814|Renal impairment,|renal impairment,
899436|NCT03947814|Kidney disease|kidney disease
899437|NCT03937830|Combined Treatment|combined treatment
899438|NCT03937830|Immunotherapy|immunotherapy
899439|NCT03937830|Anti-Tumor Immunity|anti-tumor immunity
899440|NCT03937830|Inhinition of the Blood Vessels Surrounding a Tumor|inhinition of the blood vessels surrounding a tumor
899441|NCT03937245|Hospital-acquired infection|hospital-acquired infection
899442|NCT03937245|Blood stream infection|blood stream infection
899443|NCT03937245|Bacteremia|bacteremia
899444|NCT03937245|Intensive care|intensive care
899445|NCT03935256|Cancer|cancer
899446|NCT03935256|High Risk Endometrial Cancer|high risk endometrial cancer
899447|NCT03933202|Multiple Sclerosis|multiple sclerosis
899448|NCT03933202|Cladribine Tablets|cladribine tablets
899449|NCT03933202|Observational|observational
899450|NCT03933202|Mavenclad|mavenclad
899451|NCT03933098|Typhoid conjugate vaccine|typhoid conjugate vaccine
899452|NCT03933098|Vi-DT|vi-dt
899453|NCT03933098|Safety|safety
899454|NCT03933098|Immunogenicity|immunogenicity
899455|NCT03929913|Ventricular Dysfunction|ventricular dysfunction
899456|NCT03929913|Functional Mitral Regurgitation|functional mitral regurgitation
899457|NCT03929913|Heart Failure|heart failure
899458|NCT03929913|Mitral Implant|mitral implant
899459|NCT03929913|Secondary Mitral Regurgitation|secondary mitral regurgitation
899460|NCT03928951|Urinary infections|urinary infections
899461|NCT03928951|Antibiotherapy|antibiotherapy
899462|NCT03928951|Emergency|emergency
899463|NCT03928951|Reassessment|reassessment
899464|NCT03928639|Transcatheter Aortic Valve Replacement|transcatheter aortic valve replacement
899465|NCT03928639|Mitral Valve Disease|mitral valve disease
899466|NCT03928639|Transcatheter Mitral Valve Replacement|transcatheter mitral valve replacement
899467|NCT03928639|Tricuspid Valve Disease|tricuspid valve disease
899468|NCT03926494|Carbon monoxide poisoning|carbon monoxide poisoning
899469|NCT03926494|Oxygen|oxygen
899470|NCT03926494|Coma|coma
899471|NCT03926494|Hyperbaric oxygen|hyperbaric oxygen
899472|NCT03926143|Solid tumors|solid tumors
899473|NCT03926143|Mesothelin|mesothelin
899474|NCT03926143|Mesothelioma|mesothelioma
899475|NCT03923478|Phase 1B|phase 1b
899476|NCT03923478|Randomized|randomized
899477|NCT03923478|Placebo Controlled|placebo controlled
899478|NCT03922438|Cleft lip and palate|cleft lip and palate
899479|NCT03922438|Cleft lip|cleft lip
899480|NCT03922438|Cleft alveolus|cleft alveolus
899481|NCT03922438|Cheiloplasty|cheiloplasty
899482|NCT03922438|Nasoalveolar fistula|nasoalveolar fistula
899483|NCT03921515|Hyper-Immunuglobulin E.Syndrome|hyper-immunuglobulin e.syndrome
899484|NCT03921515|Chronic Granulomatous Disease|chronic granulomatous disease
899485|NCT03921515|Tumor Necrosis Factor Alpha|tumor necrosis factor alpha
899486|NCT03921515|Staphylococcus Aureus|staphylococcus aureus
899487|NCT03918187|nalbuphine|nalbuphine
899488|NCT03918187|midazolam|midazolam
899489|NCT03917654|Randomized|randomized
899490|NCT03917654|Assays|assays
899491|NCT03917654|Blood Smear|blood smear
899492|NCT03917654|Antibody|antibody
899493|NCT03917654|Parasites|parasites
899494|NCT03914079|Coronary Artery Disease|coronary artery disease
899495|NCT03914079|Cardiovascular Disease|cardiovascular disease
899496|NCT03914079|Atherosclerosis|atherosclerosis
899497|NCT03914079|Coronary Occlusion|coronary occlusion
899498|NCT03914079|Non-Invasive Medical Device|non-invasive medical device
899499|NCT03914079|Cardiac Diagnostics|cardiac diagnostics
899500|NCT03912337|Episodic migraine|episodic migraine
899501|NCT03912337|Disability|disability
899502|NCT03912337|Migraine-related disability|migraine-related disability
899503|NCT03912337|Work productivity|work productivity
899504|NCT03912337|Erenumab|erenumab
899505|NCT03912337|AIMOVIG|aimovig
899506|NCT03911869|BRAFV600-mutant|brafv600-mutant
899507|NCT03911869|melanoma|melanoma
899508|NCT03911869|brain metastasis|brain metastasis
899509|NCT03910907|mycoplasma genitalium|mycoplasma genitalium
899510|NCT03910907|urethritis|urethritis
899511|NCT03910907|NGU|ngu
899512|NCT03910907|treatment|treatment
899513|NCT03910205|interleukin-18|interleukin-18
899514|NCT03910205|gingival crevicular fluid|gingival crevicular fluid
899515|NCT03910205|tumor necrosis factor alpha|tumor necrosis factor alpha
899516|NCT03910075|P-CIMT|p-cimt
899517|NCT03910075|Pediatric Constraint-Induced Movement Therapy|pediatric constraint-induced movement therapy
899518|NCT03910075|Hemiparesis|hemiparesis
899519|NCT03910075|Perinatal Stroke|perinatal stroke
899520|NCT03910075|Neonatal Stroke|neonatal stroke
899521|NCT03910075|Pediatric rehabilitation|pediatric rehabilitation
899522|NCT03910075|Infant therapy|infant therapy
899523|NCT03910075|Cerebral Palsy|cerebral palsy
899524|NCT03910075|ACQUIRE|acquire
899525|NCT03910075|I-ACQUIRE|i-acquire
899526|NCT03909893|Adaptive|adaptive
899527|NCT03909893|Radiation Therapy|radiation therapy
899528|NCT03909464|chemotherapy|chemotherapy
899529|NCT03909464|neurosensory|neurosensory
899530|NCT03909464|neurosensory testing|neurosensory testing
899531|NCT03908138|multiple myeloma|multiple myeloma
899532|NCT03908138|lenalidomide|lenalidomide
899533|NCT03905330|Cholestasis|cholestasis
899534|NCT03905330|Maralixibat|maralixibat
899535|NCT03905330|Mutation|mutation
899536|NCT03905330|PFIC|pfic
899537|NCT03905330|PFIC2|pfic2
899538|NCT03905330|Bile Duct Diseases|bile duct diseases
899539|NCT03905330|Liver Diseases|liver diseases
899540|NCT03905330|Biliary Tract Diseases|biliary tract diseases
899541|NCT03905330|Digestive System Diseases|digestive system diseases
899542|NCT03905330|Pediatric|pediatric
899543|NCT03903822|Mild-to-Moderate Atopic Dermatitis|mild-to-moderate atopic dermatitis
899544|NCT03903822|topical|topical
899545|NCT03900962|Severe obesity|severe obesity
899546|NCT03900962|Exercise|exercise
899547|NCT03900962|Weight management|weight management
899548|NCT03900962|Resistance training|resistance training
899549|NCT03900962|Power training|power training
899550|NCT03900962|Physical function|physical function
899551|NCT03897972|Personalised nutrition|personalised nutrition
899552|NCT03896945|Negative Symptoms|negative symptoms
899553|NCT03896945|Schizophrenia|schizophrenia
899554|NCT03896945|AVP-786|avp-786
899555|NCT03896789|guideline adherence|guideline adherence
899556|NCT03896789|implementation fidelity|implementation fidelity
899557|NCT03896516|Alcohol Problems|alcohol problems
899558|NCT03896516|Alcohol Craving|alcohol craving
899559|NCT03896516|Food-Seeking Behaviors|food-seeking behaviors
899560|NCT03896516|Ghrelin|ghrelin
899561|NCT03896516|Ghrelin 0-acyltransferase|ghrelin 0-acyltransferase
899562|NCT03896490|Learning|learning
899563|NCT03896490|Memory|memory
899564|NCT03896490|Memory Training|memory training
899565|NCT03896490|Attention|attention
899566|NCT03896490|Computerized Cognitive Training|computerized cognitive training
899567|NCT03895658|Brain Stimulation|brain stimulation
899568|NCT03895658|Neurocognitive|neurocognitive
899569|NCT03895658|Major Depressive Disorder (MDD)|major depressive disorder (mdd)
899570|NCT03895645|Stored Samples|stored samples
899571|NCT03887533|2-Hydroxypropyl-Beta-Cyclodextrin|2-hydroxypropyl-beta-cyclodextrin
899572|NCT03883386|Granulocyte-colony stimulating factor|granulocyte-colony stimulating factor
899573|NCT03881696|peanut allergic|peanut allergic
899574|NCT03881696|multi-food allergic|multi-food allergic
899575|NCT03881696|omalizumab|omalizumab
899576|NCT03881696|placebo|placebo
899577|NCT03881696|multi-allergen oral immunotherapy (OIT)|multi-allergen oral immunotherapy (oit)
400488|NCT01866670|nursing|nursing
796357|NCT00268996|hs-CRP|hs-crp
899578|NCT03881696|double-blind placebo-controlled food challenge (DBPCFC)|double-blind placebo-controlled food challenge (dbpcfc)
899579|NCT03881241|Tibia|tibia
899580|NCT03881241|fracture|fracture
899581|NCT03881241|EVOS|evos
899582|NCT03881241|EVOS SMALL|evos small
899583|NCT03881241|plating system|plating system
899584|NCT03881241|plates|plates
899585|NCT03881241|tibial fracture|tibial fracture
899586|NCT03881241|surgery|surgery
899587|NCT03881241|open reduction|open reduction
899588|NCT03881241|internal fixation|internal fixation
899589|NCT03880656|mononuclear cells|mononuclear cells
899590|NCT03876769|CTL019|ctl019
899591|NCT03876769|Kymriah|kymriah
899592|NCT03876769|B-Cell Acute Lymphoblastic Leukemia|b-cell acute lymphoblastic leukemia
899594|NCT03876769|tisagenlecleucel|tisagenlecleucel
899595|NCT03876769|HR B-ALL EOC MRD|hr b-all eoc mrd
899596|NCT03876769|Minimal Residual Disease (MRD)|minimal residual disease (mrd)
899597|NCT03876769|Positive at the End of Consolidation (EOC)|positive at the end of consolidation (eoc)
899598|NCT03875482|Risankizumab|risankizumab
899599|NCT03875482|Psoriasis|psoriasis
899600|NCT03875482|Plaque Psoriasis|plaque psoriasis
899601|NCT03875469|Contrast-enhanced computed tomography (CECT)|contrast-enhanced computed tomography (cect)
899602|NCT03875469|Injector|injector
899603|NCT03867682|Lintuzumab-Ac225|lintuzumab-ac225
899604|NCT03867682|Venetoclax|venetoclax
899605|NCT03867682|Lintuzumab|lintuzumab
899606|NCT03867682|Refractory AML|refractory aml
899607|NCT03867435|Muscle Weakness|muscle weakness
899608|NCT03867435|Muscular Dystrophy|muscular dystrophy
899609|NCT03867435|Neuromuscular Disease|neuromuscular disease
899610|NCT03867435|Myotonia|myotonia
899611|NCT03867344|Hypoglycemia|hypoglycemia
899612|NCT03867344|Stress|stress
899613|NCT03867344|Brain|brain
899614|NCT03866174|Psilocybin, Psychedelics, Depression, MDD|psilocybin, psychedelics, depression, mdd
899615|NCT03865732|refractory seizures|refractory seizures
899616|NCT03865732|epilepsy in children|epilepsy in children
899617|NCT03865732|seizure disorder|seizure disorder
899618|NCT03864835|fatty liver|fatty liver
899619|NCT03864835|NASH|nash
899620|NCT03864835|NAFLD|nafld
899621|NCT03861923|dry needling|dry needling
899622|NCT03861923|physical therapy|physical therapy
899623|NCT03861923|trigger point|trigger point
899624|NCT03861676|focal therapy|focal therapy
899625|NCT03861676|brachytherapy|brachytherapy
899626|NCT03861676|PSMA|psma
899627|NCT03861676|DCF-Pyl|dcf-pyl
899628|NCT03854149|Congenital Heart Disease|congenital heart disease
899629|NCT03854149|Atrial Fibrillation|atrial fibrillation
899630|NCT03854149|Thromboembolism|thromboembolism
899631|NCT03854149|NOAC|noac
899632|NCT03854149|Apixaban|apixaban
899633|NCT03854149|Atrial arrhythmias|atrial arrhythmias
899634|NCT03853915|Cervical Cancer|cervical cancer
899635|NCT03853915|PET Scan|pet scan
899636|NCT03853915|HPV DNA|hpv dna
899637|NCT03853694|bupivacaine|bupivacaine
899638|NCT03853694|EXPAREL|exparel
899639|NCT03853694|analgesic|analgesic
899640|NCT03853694|TAP Block|tap block
899641|NCT03853694|C-Section|c-section
899642|NCT03853694|Cesarean Section|cesarean section
899643|NCT03853694|elective c-section|elective c-section
899644|NCT03853694|TAP|tap
899645|NCT03852316|Chlamydia trachomatis|chlamydia trachomatis
899646|NCT03852316|Device|device
899647|NCT03852316|Diagnostic|diagnostic
899648|NCT03852316|Neisseria gonorrohoeae|neisseria gonorrohoeae
899649|NCT03852316|Trichomonas vaginalis|trichomonas vaginalis
899650|NCT03847181|Oral anticoagulants|oral anticoagulants
899651|NCT03847181|Under-dosing|under-dosing
899652|NCT03847181|Stroke prevention in atrial fibrillation|stroke prevention in atrial fibrillation
899653|NCT03847181|Safety|safety
899654|NCT03847181|Effectiveness|effectiveness
899655|NCT03842163|Scintigraphy|scintigraphy
899656|NCT03842163|Gammagraphy|gammagraphy
899657|NCT03842163|TTR|ttr
899658|NCT03842163|ATTR|attr
899659|NCT03842163|Hipertrophic cardiomyopathy (HCM)|hipertrophic cardiomyopathy (hcm)
899660|NCT03842163|HCM|hcm
899661|NCT03836040|Migraine|migraine
899662|NCT03836040|Headache|headache
899663|NCT03836040|Prevention|prevention
899664|NCT03836040|Pediatric|pediatric
899665|NCT03836040|Episodic Migraine|episodic migraine
899666|NCT03836014|Multiple myeloma|multiple myeloma
899667|NCT03836014|Relapse|relapse
899668|NCT03836014|daratumumab,|daratumumab,
899669|NCT03836014|lenalidomide|lenalidomide
899670|NCT03836014|dexamethasone|dexamethasone
899671|NCT03835754|Heart preservation|heart preservation
899672|NCT03835754|Beating heart transplant|beating heart transplant
899673|NCT03834740|recurrent GBM|recurrent gbm
899674|NCT03834740|brain tumor|brain tumor
899675|NCT03834740|GBM|gbm
899676|NCT03834740|glioma|glioma
899677|NCT03834714|Noise induced hearing loss|noise induced hearing loss
899678|NCT03834714|Near infrared energy|near infrared energy
899679|NCT03834714|Hering test|hering test
899680|NCT03834194|excessive weight gain|excessive weight gain
899681|NCT03834194|pregnancy|pregnancy
899682|NCT03833999|ondansetron|ondansetron
899683|NCT03833999|small bowel water|small bowel water
899684|NCT03832998|Migraine|migraine
899685|NCT03832998|Headache|headache
899686|NCT03832998|Prevention|prevention
899687|NCT03832998|Pediatric|pediatric
899688|NCT03832998|Chronic Migraine|chronic migraine
899689|NCT03827954|Heart failure|heart failure
899690|NCT03827954|cognitive impairment|cognitive impairment
899691|NCT03827954|HeartMapp Mobile app|heartmapp mobile app
899692|NCT03827954|Self-care|self-care
899693|NCT03827330|Candida Parapsilosis|candida parapsilosis
899694|NCT03827330|Candida Auris|candida auris
899695|NCT03827330|Candida Lusitaniae|candida lusitaniae
899696|NCT03827330|Candida Glabrata|candida glabrata
899697|NCT03827330|Candida Albicans|candida albicans
899698|NCT03826030|stroke|stroke
899699|NCT03826030|stroke recovery|stroke recovery
899700|NCT03826030|brain stimulation|brain stimulation
899701|NCT03826030|transcranial direct current stimulation|transcranial direct current stimulation
899702|NCT03823300|AMD|amd
899703|NCT03823300|nAMD|namd
899704|NCT03823300|neovascular age-related macular degeneration|neovascular age-related macular degeneration
899705|NCT03823300|choroidal neovascularization secondary to age-related macular degeneration|choroidal neovascularization secondary to age-related macular degeneration
899706|NCT03820830|hormone receptor positive breast cancer|hormone receptor positive breast cancer
899707|NCT03820830|HER2 receptor negative|her2 receptor negative
899708|NCT03820830|CDK4/6 inhibitor|cdk4/6 inhibitor
899709|NCT03818607|Marchiafava-Micheli Syndrome|marchiafava-micheli syndrome
899710|NCT03818607|Paroxysmal Cold Hemoglobinuria|paroxysmal cold hemoglobinuria
899711|NCT03818308|Acute hepatitis C virus (HCV) infection|acute hepatitis c virus (hcv) infection
899712|NCT03816163|metastatic pancreatic cancer|metastatic pancreatic cancer
899713|NCT03816163|IMAB362|imab362
899714|NCT03816163|nab-paclitaxel|nab-paclitaxel
899715|NCT03816163|gemcitabine|gemcitabine
899716|NCT03816163|zolbetuximab|zolbetuximab
899717|NCT03816163|metastatic pancreatic adenocarcinoma|metastatic pancreatic adenocarcinoma
899718|NCT03816163|pancreatic cancer|pancreatic cancer
899719|NCT03816163|CLDN 18.2|cldn 18.2
899720|NCT03809416|Acne scars|acne scars
899721|NCT03809416|fractional lasers|fractional lasers
899723|NCT03806491|veteran|veteran
899724|NCT03806491|alcohol|alcohol
899725|NCT03806491|insomnia|insomnia
899726|NCT03806491|sleep|sleep
899727|NCT03806491|drinking|drinking
899728|NCT03805919|BRCA1|brca1
899729|NCT03805919|BRCA2|brca2
899730|NCT03805919|MMR genes|mmr genes
899731|NCT03805919|Lynch Syndrome|lynch syndrome
899732|NCT03804788|alcohol|alcohol
899733|NCT03804788|drinking|drinking
899734|NCT03804788|sleep|sleep
899735|NCT03804788|insomnia|insomnia
899736|NCT03804788|veteran|veteran
899737|NCT03803384|hypoxemia, exercise, oxygen, automatic oxygen-titration|hypoxemia, exercise, oxygen, automatic oxygen-titration
899738|NCT03794726|Orthodontic tooth movement|orthodontic tooth movement
899739|NCT03794726|Molar protraction|molar protraction
899740|NCT03794726|Periodontally accelerated osteogenic orthodontics|periodontally accelerated osteogenic orthodontics
899741|NCT03794726|Patient-centered outcomes|patient-centered outcomes
899742|NCT03789188|Inflammation|inflammation
899743|NCT03789188|Nutrition|nutrition
899744|NCT03789188|Shift Work|shift work
899745|NCT03789188|Sleep|sleep
899746|NCT03789188|Cognitive Performance|cognitive performance
899747|NCT03787732|Intubation|intubation
899748|NCT03785925|Bladder|bladder
899749|NCT03785925|Bladder Cancer|bladder cancer
899750|NCT03785925|CD122|cd122
899751|NCT03785925|Cisplatin Ineligible|cisplatin ineligible
899752|NCT03785925|Immuno-oncology|immuno-oncology
899753|NCT03785925|Immunotherapy|immunotherapy
899754|NCT03785925|Locally Advanced Urothelial Cancer|locally advanced urothelial cancer
899755|NCT03785925|Metastatic Urothelial Cancer|metastatic urothelial cancer
899756|NCT03785925|mUC|muc
899757|NCT03785925|Natural Killer Cells|natural killer cells
899758|NCT03785925|Nivolumab|nivolumab
899759|NCT03785925|NKTR-214|nktr-214
899760|NCT03785925|Opdivo®|opdivo®
899761|NCT03785925|PD-L1|pd-l1
899762|NCT03785925|Urothelial Cancer|urothelial cancer
899763|NCT03785925|Urothelial|urothelial
899764|NCT03785925|Metastatic Urothelial Carcinoma|metastatic urothelial carcinoma
899765|NCT03785925|Urothelial Carcinoma|urothelial carcinoma
899766|NCT03785925|Bempegaldesleukin|bempegaldesleukin
899767|NCT03783325|Sun Exposure|sun exposure
899768|NCT03783325|UV Dosimetry|uv dosimetry
899769|NCT03783325|Biomarkers|biomarkers
899770|NCT03783325|Behaviors|behaviors
899771|NCT03783325|Genetics|genetics
899772|NCT03783143|Febrile|febrile
899773|NCT03783143|Human|human
899774|NCT03783143|Lassa Fever|lassa fever
899775|NCT03783143|Seroconversion|seroconversion
899776|NCT03778229|Non Small Cell Lung Cancer|non small cell lung cancer
899777|NCT03778229|epidermal growth factor receptor mutation positive|epidermal growth factor receptor mutation positive
899778|NCT03778229|hepatocyte growth factor receptor|hepatocyte growth factor receptor
899779|NCT03778229|savolitinib|savolitinib
899780|NCT03778229|Osimertinib|osimertinib
899781|NCT03778229|AZD9291|azd9291
899782|NCT03778229|AZD6094|azd6094
899783|NCT03778229|volitinib|volitinib
899784|NCT03777059|Migraine|migraine
899785|NCT03777059|Aura|aura
899786|NCT03775421|Congenital Heart Failure|congenital heart failure
899787|NCT03775421|macitentan|macitentan
899788|NCT03775421|Univentricular Heart|univentricular heart
899789|NCT03775421|Cavopulmonary Anastomosis|cavopulmonary anastomosis
899790|NCT03775421|Fontan circulation|fontan circulation
899791|NCT03774446|Cushing disease|cushing disease
899792|NCT03774446|R-roscovitine|r-roscovitine
899793|NCT03774446|Seliciclib|seliciclib
899794|NCT03770000|T cell Lymphoma|t cell lymphoma
899795|NCT03770000|RP6530|rp6530
899796|NCT03770000|Tenalisib|tenalisib
899797|NCT03770000|Romidepsin|romidepsin
899798|NCT03769506|Rakuten Medical|rakuten medical
899799|NCT03769506|ASP-1929|asp-1929
899800|NCT03769506|PIT|pit
899801|NCT03769506|photoimmunotherapy|photoimmunotherapy
899802|NCT03769506|HNC|hnc
899803|NCT03769506|HNSCC|hnscc
899804|NCT03769506|head and neck|head and neck
899805|NCT03767933|Pediatrics|pediatrics
899806|NCT03767933|Emergency|emergency
899807|NCT03767933|Analgesia|analgesia
899808|NCT03767933|Opioids|opioids
899809|NCT03767933|Combination therapy|combination therapy
899810|NCT03767933|Ibuprofen|ibuprofen
899811|NCT03767933|Acetaminophen|acetaminophen
899812|NCT03767933|Hydromorphone|hydromorphone
899813|NCT03767621|Left Main Coronary Artery|left main coronary artery
899814|NCT03767621|Intermediate Coronary Lesions|intermediate coronary lesions
899815|NCT03767621|iFR|ifr
899816|NCT03767621|Coronary Physiology|coronary physiology
899817|NCT03767621|IVUS|ivus
899818|NCT03766399|Inhaled JAK inhibitor|inhaled jak inhibitor
899819|NCT03765541|dexamethasone|dexamethasone
899820|NCT03765541|acute myeloid leukemia|acute myeloid leukemia
899821|NCT03765541|relapse|relapse
899822|NCT03765541|refractory|refractory
899823|NCT03765541|azacitidine|azacitidine
899824|NCT03765541|amsacrine|amsacrine
899825|NCT03765541|cytarabine|cytarabine
899826|NCT03765541|randomized controlled trial|randomized controlled trial
899827|NCT03763838|Acupressure|acupressure
899828|NCT03762733|Biobanking|biobanking
899829|NCT03762733|Tissue Repository|tissue repository
899830|NCT03762733|Genetic Analysis|genetic analysis
899831|NCT03762018|MPM|mpm
899832|NCT03756792|Mohs Micographic Surgery|mohs micographic surgery
899833|NCT03756792|skin cancer|skin cancer
899834|NCT03756792|melanoma|melanoma
899835|NCT03754582|Partial Onset Seizures|partial onset seizures
899836|NCT03754582|Secondarily Generalized Seizures|secondarily generalized seizures
899837|NCT03754582|Primary Generalized Tonic-Clonic Seizures|primary generalized tonic-clonic seizures
899838|NCT03752216|Ovarian Cancer|ovarian cancer
899839|NCT03752216|Anti-PARP (poly-ADP ribose polymerase)|anti-parp (poly-adp ribose polymerase)
899840|NCT03752216|Late Relapse|late relapse
899841|NCT03747133|Stereotactic Body Radiation Therapy|stereotactic body radiation therapy
899842|NCT03747133|SABR|sabr
899843|NCT03747133|Radiation Therapy|radiation therapy
899844|NCT03747133|Renal Cell Carcinoma|renal cell carcinoma
899845|NCT03747133|RCC|rcc
899846|NCT03745859|Bronchoscopy|bronchoscopy
899847|NCT03745859|Navigation|navigation
899848|NCT03745859|Feasibility Studies|feasibility studies
899849|NCT03743844|weight management|weight management
899850|NCT03743844|compassion-focused treatment|compassion-focused treatment
899851|NCT03743844|internalized weight bias|internalized weight bias
899852|NCT03743844|depressive symptoms|depressive symptoms
899853|NCT03743012|rehabilitation|rehabilitation
899854|NCT03743012|metabolomics|metabolomics
899855|NCT03739827|Service to the Patients|service to the patients
899856|NCT03739827|Knowledge about the Nature of Cancer|knowledge about the nature of cancer
899857|NCT03739827|Cancer Evaluations|cancer evaluations
899858|NCT03738241|AS03|as03
899859|NCT03738241|H7N9|h7n9
899860|NCT03738241|Immunogenicity|immunogenicity
899861|NCT03738241|Influenza|influenza
899862|NCT03738241|Phase II|phase ii
899863|NCT03738241|Reactogenicity|reactogenicity
899864|NCT03738241|Safety|safety
899865|NCT03738241|Vaccine|vaccine
899866|NCT03735290|immunotherapy|immunotherapy
899867|NCT03735290|ilixadencel|ilixadencel
899868|NCT03735290|checkpoint inhibitor|checkpoint inhibitor
899869|NCT03735290|allogeneic|allogeneic
899870|NCT03735290|somatic cell therapy|somatic cell therapy
899871|NCT03735290|dendritic cell|dendritic cell
899872|NCT03735290|intratumoral|intratumoral
899873|NCT03735290|in situ|in situ
899874|NCT03733093|HIV|hiv
899875|NCT03733093|Opportunistic Diseases|opportunistic diseases
899876|NCT03733093|Tuberculosis|tuberculosis
899877|NCT03733093|AIDS|aids
899878|NCT03733093|Sexually Transmitted Infection|sexually transmitted infection
899879|NCT03733067|Regulatory T Cells|regulatory t cells
899880|NCT03733067|T-cell hyperactivation|t-cell hyperactivation
899881|NCT03733067|Autoimmune Cytopenia|autoimmune cytopenia
899882|NCT03733067|Adult Rheumatoid Arthritis|adult rheumatoid arthritis
899883|NCT03733067|Juvenile Idiopathic Arthritis|juvenile idiopathic arthritis
899884|NCT03731702|Oral Microbiota|oral microbiota
899885|NCT03731702|Fecal Microbiota|fecal microbiota
899886|NCT03731702|Stability|stability
899887|NCT03729310|Propel Implant|propel implant
899888|NCT03729310|Nasopore|nasopore
899889|NCT03729310|Triamcinolone|triamcinolone
899890|NCT03727841|Proteasome Inhibitor|proteasome inhibitor
899891|NCT03727841|Penetration Across the Blood-Brain-Barrier (BBB)|penetration across the blood-brain-barrier (bbb)
899892|NCT03727841|Apoptosis Induction|apoptosis induction
899893|NCT03727841|Targeted Therapeutic Effect|targeted therapeutic effect
899894|NCT03727841|Tumor Progression|tumor progression
899895|NCT03724890|Palliative Radiotherapy|palliative radiotherapy
899896|NCT03724890|Advanced solid tumors|advanced solid tumors
899897|NCT03724890|M3814|m3814
899898|NCT03724890|Avelumab|avelumab
899899|NCT03719599|Malaria|malaria
899900|NCT03719599|Infection|infection
899901|NCT03719599|Seasonal|seasonal
899902|NCT03719599|Parasitemia|parasitemia
899903|NCT03719599|Organisms|organisms
899904|NCT03718767|PD 1 Pathway|pd 1 pathway
899905|NCT03718767|High Tumor Mutational Load|high tumor mutational load
899906|NCT03718767|Immune Checkpoint|immune checkpoint
899907|NCT03718767|Quality of Life|quality of life
899908|NCT03717155|Avelumab|avelumab
899909|NCT03717155|Cetuximab|cetuximab
899910|NCT03717155|Cisplatin|cisplatin
899911|NCT03717155|Gemcitabine|gemcitabine
899912|NCT03717155|Non-Small Cell Lung Cancer|non-small cell lung cancer
899913|NCT03717051|intervention|intervention
899914|NCT03717051|nicotine replacement sample|nicotine replacement sample
899915|NCT03717051|smoking cessation|smoking cessation
899916|NCT03717051|smoking hotspots|smoking hotspots
899917|NCT03716726|Sickle Cell Disease|sickle cell disease
899918|NCT03716726|Social Determinants of Health|social determinants of health
899919|NCT03716726|Unmet Social Needs|unmet social needs
899920|NCT03716726|WE CARE|we care
899921|NCT03716518|Colon Cancer|colon cancer
899922|NCT03716518|Traditional Chinese Medicine|traditional chinese medicine
899923|NCT03716518|Adverse Effect of Chemotherapy|adverse effect of chemotherapy
899924|NCT03716518|Chemotherapy|chemotherapy
899925|NCT03716505|Prevention|prevention
899926|NCT03716505|Episodic|episodic
899927|NCT03716505|Chronic|chronic
899928|NCT03714815|pulmonary vascular disease|pulmonary vascular disease
899929|NCT03714815|macitentan|macitentan
899930|NCT03714815|heart failure with preserved ejection fraction|heart failure with preserved ejection fraction
899931|NCT03714308|Neovascular age-related macular degeneration|neovascular age-related macular degeneration
899932|NCT03709303|Informed Consent|informed consent
899933|NCT03709303|Stem Cell Transplantation|stem cell transplantation
899934|NCT03709303|Understanding|understanding
899935|NCT03709303|Optimism|optimism
899936|NCT03709303|Sickle Cell Disease|sickle cell disease
899937|NCT03707600|Nicotine Abstinence|nicotine abstinence
899938|NCT03707600|Metaplasticity|metaplasticity
899939|NCT03707600|Nicotine|nicotine
899940|NCT03707600|Functional Magnetic Resonance Imaging (fMRI)|functional magnetic resonance imaging (fmri)
899941|NCT03707600|Transcranial Magnetic Stimulation (TMS)|transcranial magnetic stimulation (tms)
899942|NCT03705910|proprioception|proprioception
899943|NCT03705910|manual therapies|manual therapies
899944|NCT03705910|pain|pain
899945|NCT03705910|health status|health status
899946|NCT03705910|posture|posture
899947|NCT03705910|sleep|sleep
899948|NCT03705910|fatigue|fatigue
899949|NCT03705910|depression|depression
899950|NCT03705819|[11C]-NOP46|[11c]-nop46
899951|NCT03705351|temozolomide|temozolomide
899952|NCT03705351|tumor treating fields|tumor treating fields
899953|NCT03705351|optune|optune
899954|NCT03705351|novocure|novocure
899955|NCT03705351|glioblastoma|glioblastoma
899956|NCT03705351|brain tumor|brain tumor
899957|NCT03705234|Inclisiran|inclisiran
899958|NCT03705234|PCSK9|pcsk9
899959|NCT03705234|Cardiovascular|cardiovascular
899960|NCT03705234|LDL Cholesterol|ldl cholesterol
899961|NCT03705234|Cholesterol|cholesterol
899962|NCT03705234|Lipid|lipid
899963|NCT03705234|RNA interference|rna interference
899964|NCT03701334|early breast cancer (EBC)|early breast cancer (ebc)
899965|NCT03701334|HR+/HER2-|hr+/her2-
899966|NCT03701334|adjuvant|adjuvant
899967|NCT03701334|LEE011|lee011
899968|NCT03701334|ribociclib|ribociclib
899969|NCT03701334|CDK4/6 inhibitor|cdk4/6 inhibitor
899970|NCT03700359|extensive-stage small-cell lung cancer|extensive-stage small-cell lung cancer
899971|NCT03700359|lobaplatin/etoposide|lobaplatin/etoposide
899972|NCT03700359|Anlotinib maintenance therapy|anlotinib maintenance therapy
899973|NCT03699202|RSV,AK0529,Chinese|rsv,ak0529,chinese
899974|NCT03696017|Opioid Abuse|opioid abuse
899975|NCT03696017|Benzodiazepine abuse|benzodiazepine abuse
899976|NCT03689244|CTEPH|cteph
899977|NCT03689244|selexipag|selexipag
899978|NCT03686215|breast cancer surgery|breast cancer surgery
899979|NCT03686215|lumpectomy|lumpectomy
899980|NCT03682120|A/H7N9|a/h7n9
899981|NCT03682120|Healthy Adults|healthy adults
899982|NCT03682120|Immunogenicity|immunogenicity
796621|NCT00267969|Psoriasis|psoriasis
899983|NCT03682120|Influenza vaccine|influenza vaccine
899984|NCT03682120|MF59(R) adjuvant|mf59(r) adjuvant
899985|NCT03682120|Reactogenicity|reactogenicity
899986|NCT03682120|Safety|safety
899987|NCT03682068|renal pelvis|renal pelvis
899988|NCT03682068|ureters|ureters
899989|NCT03682068|urinary bladder|urinary bladder
899990|NCT03682068|urethra|urethra
899991|NCT03682068|bladder cancer|bladder cancer
899992|NCT03681210|Heart Failure|heart failure
899993|NCT03681210|Heart Diseases|heart diseases
899994|NCT03681210|Cardiovascular Diseases|cardiovascular diseases
899995|NCT03674970|smoking cessation|smoking cessation
899996|NCT03674970|nicotine film|nicotine film
899997|NCT03674970|nicotine delivery|nicotine delivery
899998|NCT03674970|random nicotine delivery|random nicotine delivery
899999|NCT03674567|Non-small Cell Lung Cancer|non-small cell lung cancer
900000|NCT03674567|Head and Neck Squamous Cell Carcinoma|head and neck squamous cell carcinoma
900001|NCT03674567|Breast Cancer|breast cancer
900002|NCT03674567|Urothelial Carcinoma|urothelial carcinoma
900003|NCT03674567|Gastric Cancer|gastric cancer
900004|NCT03672864|Walking|walking
900005|NCT03672864|Intensive exercise|intensive exercise
900006|NCT03672864|Rehabilitation|rehabilitation
900007|NCT03672864|Cerebral Palsy|cerebral palsy
900008|NCT03672864|Early intervention|early intervention
900009|NCT03671551|Eating Disorders in Children|eating disorders in children
900010|NCT03671551|Psychomotor Development Impaired|psychomotor development impaired
900011|NCT03671499|sedentary behavior|sedentary behavior
900012|NCT03671499|physical activity|physical activity
900013|NCT03667690|Mycoses|mycoses
900014|NCT03667690|Candidiasis|candidiasis
900015|NCT03667690|Candidiasis, Invasive|candidiasis, invasive
900016|NCT03667690|Candidemia|candidemia
900017|NCT03667690|Fungemia|fungemia
900018|NCT03667690|Sepsis|sepsis
900019|NCT03667690|Invasive Fungal Infections|invasive fungal infections
900020|NCT03667690|Systemic Inflammatory Response Syndrome|systemic inflammatory response syndrome
900021|NCT03667690|Pathologic Processes|pathologic processes
900022|NCT03667690|Fluconazole|fluconazole
900023|NCT03667690|Caspofungin|caspofungin
900024|NCT03667690|Echinocandins|echinocandins
900025|NCT03667690|Antifungal Agents|antifungal agents
900026|NCT03667690|Anti-infective Agents|anti-infective agents
900027|NCT03667690|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors
900028|NCT03667690|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors
900029|NCT03667690|Enzyme Inhibitors|enzyme inhibitors
900030|NCT03667690|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action
900031|NCT03667690|Steroid Synthesis Inhibitors|steroid synthesis inhibitors
900032|NCT03667690|Physiological Effects of Drugs|physiological effects of drugs
900033|NCT03667690|Cytochrome P-450 CYP2C9 Inhibitors|cytochrome p-450 cyp2c9 inhibitors
900034|NCT03667690|Cytochrome P-450 CYP2C19 Inhibitors|cytochrome p-450 cyp2c19 inhibitors
900035|NCT03666273|Neoplasm|neoplasm
900036|NCT03666273|Immuno oncology drug|immuno oncology drug
900037|NCT03666273|Urothelial cancer|urothelial cancer
900038|NCT03666273|Head and neck squamous cell carcinoma (HNSCC)|head and neck squamous cell carcinoma (hnscc)
900039|NCT03666273|Cervical cancer|cervical cancer
900040|NCT03666273|Gastric/ Gastroesophageal junction adenocarcinoma|gastric/ gastroesophageal junction adenocarcinoma
900041|NCT03662308|Hypothermia|hypothermia
900042|NCT03662308|Body Temperature Regulation|body temperature regulation
900043|NCT03662308|Cognition|cognition
900044|NCT03661840|Acceptance and Commitment Therapy|acceptance and commitment therapy
900045|NCT03661840|Cancer|cancer
900046|NCT03661840|Survivor|survivor
900047|NCT03661840|Group Based|group based
900048|NCT03661840|Pain Management|pain management
900049|NCT03656848|Quantitative Coronary Angiography|quantitative coronary angiography
900050|NCT03656848|Quantitative Flow Ratio|quantitative flow ratio
900051|NCT03656848|Coronary Artery Disease|coronary artery disease
900052|NCT03656848|Myocardial Ischaemia|myocardial ischaemia
900053|NCT03656848|Percutaneous Coronary Intervention|percutaneous coronary intervention
900054|NCT03656848|Coronary Circulation|coronary circulation
900055|NCT03653507|CLDN 18.2|cldn 18.2
900056|NCT03653507|gastroesophageal junction cancer|gastroesophageal junction cancer
900057|NCT03653507|adenocarcinoma|adenocarcinoma
900058|NCT03653507|IMAB362|imab362
900059|NCT03653507|oxaliplatin|oxaliplatin
900060|NCT03653507|HER2|her2
900061|NCT03653507|claudiximab|claudiximab
900062|NCT03653507|capecitabine|capecitabine
900063|NCT03653507|gastric cancer|gastric cancer
900064|NCT03653507|HER2 Negative|her2 negative
900065|NCT03653507|zolbetuximab|zolbetuximab
900066|NCT03648892|Dopamine Response|dopamine response
900067|NCT03648892|Energy Expenditure|energy expenditure
900068|NCT03648892|Neurocognitive Function|neurocognitive function
900069|NCT03648892|Obesity|obesity
900070|NCT03647228|ION-827359|ion-827359
900071|NCT03647228|ENaC|enac
900072|NCT03645824|Hemato-Oncology|hemato-oncology
900073|NCT03645824|Allogeneic Stem Cell Transplantation|allogeneic stem cell transplantation
900074|NCT03645824|Pacritinib|pacritinib
900075|NCT03645824|JAK2 inhibitor|jak2 inhibitor
900076|NCT03645824|Myelofibrosis|myelofibrosis
900077|NCT03644186|hormone receptor positive early breast cancer|hormone receptor positive early breast cancer
900078|NCT03644186|HER2 receptor positive early breast cancer|her2 receptor positive early breast cancer
900079|NCT03638128|OI|oi
900080|NCT03638128|Bone.|bone.
900081|NCT03635983|NKTR-214|nktr-214
900082|NCT03635983|Nivolumab|nivolumab
900083|NCT03635983|Immunotherapy|immunotherapy
900084|NCT03635957|gout|gout
900085|NCT03635957|uncontrolled gout|uncontrolled gout
900086|NCT03635112|TD-1473|td-1473
900087|NCT03635112|Janus kinase inhibitor|janus kinase inhibitor
900088|NCT03635112|JAK inhibitor|jak inhibitor
900089|NCT03635112|Inflammatory Bowel Disease|inflammatory bowel disease
900090|NCT03635112|IBD|ibd
900091|NCT03635112|Crohn's Disease|crohn's disease
900092|NCT03635112|Intestinal restriction|intestinal restriction
900093|NCT03632239|Resource|resource
900094|NCT03632239|Variant|variant
900095|NCT03632239|Sequencing|sequencing
900096|NCT03632239|Genome|genome
900097|NCT03632239|Phenotype|phenotype
900098|NCT03631199|ACZ885|acz885
900099|NCT03631199|canakinumab|canakinumab
900100|NCT03631199|pembrolizumab|pembrolizumab
900101|NCT03631199|carboplatin|carboplatin
900102|NCT03631199|cisplatin|cisplatin
900103|NCT03631199|paclitaxel|paclitaxel
900104|NCT03631199|nab-paclitaxel|nab-paclitaxel
900105|NCT03631199|pemetrexed|pemetrexed
900106|NCT03631199|NSCLC|nsclc
900107|NCT03631199|non-small cell lung cancer|non-small cell lung cancer
900108|NCT03631199|non small cell lung cancer|non small cell lung cancer
900109|NCT03631199|squamous|squamous
900110|NCT03631199|non-squamous|non-squamous
900111|NCT03631199|hsCRP|hscrp
900112|NCT03631199|IL-1β|il-1β
900113|NCT03631199|PD-L1|pd-l1
900114|NCT03631199|CANOPY|canopy
900115|NCT03631199|CANOPY-1|canopy-1
900116|NCT03631199|platinum-based doublet chemotherapy|platinum-based doublet chemotherapy
900117|NCT03631199|first line therapy|first line therapy
900118|NCT03631199|locally advanced|locally advanced
900119|NCT03631199|metastatic|metastatic
900120|NCT03627832|alcohol|alcohol
900121|NCT03627832|drinking|drinking
900122|NCT03627832|sleep|sleep
900123|NCT03627832|insomnia|insomnia
900124|NCT03627832|young adult|young adult
900125|NCT03627208|LYMPHOBLASTIC LYMPHOMA|lymphoblastic lymphoma
900126|NCT03627208|Minimal Residual Disease|minimal residual disease
900127|NCT03627208|Childhood All|childhood all
900128|NCT03627208|B-Cell Malignancies|b-cell malignancies
900129|NCT03626506|spironolactone|spironolactone
900130|NCT03626506|Indapamide|indapamide
900131|NCT03626506|Obesity|obesity
900132|NCT03626506|Hypertension|hypertension
900133|NCT03626506|Target organ damage|target organ damage
900134|NCT03621397|Spanish-speakers|spanish-speakers
900135|NCT03621397|Subarachnoid hemorrhage|subarachnoid hemorrhage
900136|NCT03621397|Cognitive Intervention|cognitive intervention
900137|NCT03615495|Esophageal|esophageal
900138|NCT03615495|Atresia|atresia
900139|NCT03615495|Congential|congential
900140|NCT03610620|Basal cell carcinoma|basal cell carcinoma
900141|NCT03610620|Mohs surgery|mohs surgery
900142|NCT03610620|Vivascope 2500 ex-vivo fluorescent confocal microscope|vivascope 2500 ex-vivo fluorescent confocal microscope
900143|NCT03610620|Frozen section Mohs histology|frozen section mohs histology
900144|NCT03607695|gait|gait
900145|NCT03607695|exercise|exercise
900146|NCT03607695|cognition|cognition
900147|NCT03607695|genetics|genetics
900148|NCT03607422|Atopic Dermatitis|atopic dermatitis
900149|NCT03607422|Upadacitinib|upadacitinib
900150|NCT03607422|ABT-494|abt-494
900151|NCT03606642|Cardiovascular disease|cardiovascular disease
900152|NCT03606642|peripheral vascular disease (PVD)|peripheral vascular disease (pvd)
900153|NCT03606642|Ischemia|ischemia
900154|NCT03599141|adolescent|adolescent
900155|NCT03599141|parent|parent
900156|NCT03597282|Checkpoint Inhibitor|checkpoint inhibitor
900157|NCT03597282|Immunotherapy|immunotherapy
900158|NCT03597282|Personalized Vaccine|personalized vaccine
900159|NCT03597282|Neoantigen|neoantigen
900160|NCT03597282|POLY-ICLC|poly-iclc
900161|NCT03597282|Peptide|peptide
900162|NCT03596242|high blood pressure|high blood pressure
900163|NCT03596242|SMS|sms
900164|NCT03596242|text messaging|text messaging
900165|NCT03596242|monitoring|monitoring
900166|NCT03589807|A/H7N9|a/h7n9
900167|NCT03589807|Adults|adults
900168|NCT03589807|AS03|as03
900169|NCT03589807|Immunogenicity|immunogenicity
900170|NCT03589807|Influenza|influenza
900171|NCT03589807|Prime-Boost|prime-boost
900172|NCT03589807|Reactogenicity|reactogenicity
900173|NCT03589807|Safety|safety
900174|NCT03589807|Vaccine|vaccine
900175|NCT03589768|BOOSTRIX|boostrix
900176|NCT03589768|Immunogenicity|immunogenicity
900177|NCT03589768|Infant|infant
900178|NCT03589768|Mali|mali
900179|NCT03589768|Phase II|phase ii
900180|NCT03589768|Pregnant Women|pregnant women
900181|NCT03589768|Safety|safety
900182|NCT03589768|Tdap|tdap
900183|NCT03587740|Breast Cancer|breast cancer
900184|NCT03583944|E7389|e7389
900185|NCT03583944|Tumors, Breast|tumors, breast
900186|NCT03583944|Breast Cancer|breast cancer
900187|NCT03583944|Breast Carcinoma|breast carcinoma
900188|NCT03583944|Neoplasms, Breast|neoplasms, breast
900189|NCT03583606|Adenovirus vector|adenovirus vector
900190|NCT03583606|Ebola Virus|ebola virus
900191|NCT03583606|Immunogenicity|immunogenicity
900192|NCT03583606|Non-Human Primates Vaccination/Challenge Studies|non-human primates vaccination/challenge studies
900193|NCT03583606|Phase 1|phase 1
900194|NCT03583606|Reactogenicity|reactogenicity
900195|NCT03583606|Safety|safety
900196|NCT03583606|Zaire ebolavirus vaccine|zaire ebolavirus vaccine
900197|NCT03575364|ClotTriever|clottriever
900198|NCT03575364|Thrombectomy|thrombectomy
900199|NCT03569020|Diet|diet
900200|NCT03569020|Nutrition|nutrition
900201|NCT03569020|DASH|dash
900202|NCT03569020|Gout|gout
900203|NCT03569020|Hyperuricemia|hyperuricemia
900204|NCT03569020|Potassium|potassium
900205|NCT03569020|Uric acid|uric acid
900206|NCT03569020|Trial|trial
900207|NCT03569020|Blood pressure|blood pressure
900208|NCT03569020|Glucose|glucose
900209|NCT03569020|Lipid|lipid
900210|NCT03569020|Cholesterol|cholesterol
900211|NCT03569020|Weight|weight
900212|NCT03569020|Arthritis|arthritis
900213|NCT03569020|BMI|bmi
900214|NCT03569020|Body mass index|body mass index
900215|NCT03569020|Fruit|fruit
900216|NCT03569020|Vegetable|vegetable
900217|NCT03569020|Low fat dairy|low fat dairy
900218|NCT03569020|Lean meat|lean meat
900219|NCT03569020|Fiber|fiber
900220|NCT03567733|Dual antiplatelet treatment|dual antiplatelet treatment
900221|NCT03567733|Elderly patients|elderly patients
900222|NCT03565445|NSCLC|nsclc
900223|NCT03565445|Tumors|tumors
900224|NCT03565445|squamous cell carcinoma of the head and neck (SCCHN)|squamous cell carcinoma of the head and neck (scchn)
900225|NCT03565445|Oncology|oncology
900226|NCT03565445|breast cancer|breast cancer
900227|NCT03565445|ASP1948|asp1948
900228|NCT03565445|mCRPC|mcrpc
900229|NCT03565445|ovarian cancer|ovarian cancer
900230|NCT03565445|Locally advanced or metastatic solid tumor malignancies|locally advanced or metastatic solid tumor malignancies
900231|NCT03565445|pancreatic cancer|pancreatic cancer
900232|NCT03565445|Advanced solid tumors|advanced solid tumors
900233|NCT03562871|PD-1|pd-1
900234|NCT03562871|PD-L1|pd-l1
900235|NCT03562871|Programmed Cell Death 1|programmed cell death 1
900236|NCT03562871|Chemotherapy|chemotherapy
900237|NCT03562871|Pemetrexed|pemetrexed
900238|NCT03562871|Carboplatin|carboplatin
900239|NCT03562871|Pembrolizumab|pembrolizumab
900240|NCT03562871|Immunotherapy|immunotherapy
900241|NCT03562871|IO102|io102
900242|NCT03562871|Keytruda|keytruda
900243|NCT03560960|Early AD diagnosis|early ad diagnosis
900244|NCT03560960|Pramlintide challenge test|pramlintide challenge test
900245|NCT03560960|Amyloid|amyloid
900246|NCT03560960|Amyloid PET imaging|amyloid pet imaging
900247|NCT03560960|CSF Aβ|csf aβ
900248|NCT03560960|CSF pTau|csf ptau
900249|NCT03560960|Cognitive evaluation|cognitive evaluation
900250|NCT03560622|focused ultrasound|focused ultrasound
900251|NCT03560622|fMRI|fmri
900252|NCT03556930|Non-sedated radiotherapy treatment|non-sedated radiotherapy treatment
900253|NCT03554564|peripheral artery disease|peripheral artery disease
900254|NCT03554564|claudication|claudication
900255|NCT03554564|supervised exercise therapy|supervised exercise therapy
900256|NCT03554564|walking|walking
900257|NCT03554564|quality of life|quality of life
900258|NCT03554473|Chemosensitivity|chemosensitivity
900259|NCT03554473|DNA Damage and Replication|dna damage and replication
900260|NCT03554473|PD-1/PD-L1|pd-1/pd-l1
900261|NCT03554473|Solid Tumors|solid tumors
900262|NCT03554473|Checkpoint Inhibitors|checkpoint inhibitors
900263|NCT03553940|H3N2 M2SR Prime|h3n2 m2sr prime
900264|NCT03553940|Immunogenicity|immunogenicity
900265|NCT03553940|Influenza|influenza
900266|NCT03553940|Pediatric|pediatric
900267|NCT03553940|QIV|qiv
900268|NCT03553940|Safety|safety
900269|NCT03553940|Vaccine|vaccine
900270|NCT03552692|BCL-2 positive|bcl-2 positive
900271|NCT03552692|PTCL-NOS|ptcl-nos
900272|NCT03552692|angioimmunoblastic T-cell lymphoma (AITL)|angioimmunoblastic t-cell lymphoma (aitl)
900273|NCT03552692|T-follicular helper origin (TFH)|t-follicular helper origin (tfh)
900274|NCT03552692|Venetoclax|venetoclax
900275|NCT03552692|single agent|single agent
900276|NCT03545113|graft|graft
900277|NCT03545113|fistula|fistula
900278|NCT03545113|hemodialysis|hemodialysis
900279|NCT03545113|Vascular access|vascular access
900280|NCT03541499|B. pertussis Vaccine|b. pertussis vaccine
900281|NCT03541499|BPZE1|bpze1
900282|NCT03541499|Immunogenicity|immunogenicity
900283|NCT03541499|Safety|safety
900284|NCT03539848|TBI|tbi
900285|NCT03539848|Community Setting|community setting
900286|NCT03539848|Mild TBI|mild tbi
900287|NCT03539575|K2|k2
900288|NCT03539575|Spice|spice
900289|NCT03539575|Synthetic Marijuana|synthetic marijuana
797532|NCT00264381|Ibuprofen|ibuprofen
900290|NCT03539536|Non-small Cell Lung Cancer (NSCLC)|non-small cell lung cancer (nsclc)
900291|NCT03539536|Cancer|cancer
900292|NCT03539536|Telisotuzumab vedotin|telisotuzumab vedotin
900293|NCT03539536|ABBV-399|abbv-399
900294|NCT03539536|c-Met, c-Met overexpression|c-met, c-met overexpression
900295|NCT03539536|metastatic|metastatic
900296|NCT03539536|MET gene amplification|met gene amplification
900297|NCT03538665|Endometrial Cancer|endometrial cancer
900298|NCT03538665|Somatic Mutations|somatic mutations
900299|NCT03538665|Early Detection|early detection
900300|NCT03538665|Tampon Sampling|tampon sampling
900301|NCT03538665|Tissue Discovery|tissue discovery
900302|NCT03538652|CBT|cbt
900303|NCT03538652|Mindfulness|mindfulness
900304|NCT03538652|Opiates|opiates
900305|NCT03538652|Ecological Monetary Assessment (EMA)|ecological monetary assessment (ema)
900306|NCT03538652|Microrandomized Trial|microrandomized trial
900307|NCT03537495|tuberculous meningitis|tuberculous meningitis
900308|NCT03537495|linezolid|linezolid
900309|NCT03537495|pharmacokinetic study|pharmacokinetic study
900310|NCT03531086|dopamine transporter binding|dopamine transporter binding
900311|NCT03527589|Prostatic Artery Embolization|prostatic artery embolization
900312|NCT03527589|Benign Prostatic Hyperplasia|benign prostatic hyperplasia
900313|NCT03527589|Lower Urinary Tract Symptoms|lower urinary tract symptoms
900314|NCT03527589|PAE|pae
900315|NCT03527589|BPH|bph
900316|NCT03527589|LUTS|luts
900317|NCT03527589|Embolization|embolization
900318|NCT03527589|Embolic|embolic
900319|NCT03527589|Embosphere Microsphere|embosphere microsphere
900320|NCT03518034|hypogonadism|hypogonadism
900321|NCT03518034|cardiovascular (CV) disease|cardiovascular (cv) disease
900322|NCT03518034|AndroGel|androgel
900323|NCT03518034|testosterone replacement therapy (TRT)|testosterone replacement therapy (trt)
900324|NCT03514433|Patient Navigation|patient navigation
900325|NCT03514433|Disparity|disparity
900326|NCT03514433|Social Determinants|social determinants
900327|NCT03511794|Hepatitis B Reactivation|hepatitis b reactivation
900328|NCT03511794|Allogenic Stem Cell Transplant|allogenic stem cell transplant
900329|NCT03507439|Heart failure with preserved ejection fraction (HFpEF)|heart failure with preserved ejection fraction (hfpef)
900330|NCT03507439|Heart failure with reduced ejection fraction (HFrEF)|heart failure with reduced ejection fraction (hfref)
900331|NCT03505320|zolbetuximab|zolbetuximab
900332|NCT03505320|oxaliplatin|oxaliplatin
900333|NCT03505320|fluorouracil|fluorouracil
900334|NCT03505320|claudiximab|claudiximab
900335|NCT03505320|IMAB362|imab362
900336|NCT03505320|Gastro-Esophageal Junction cancer|gastro-esophageal junction cancer
900337|NCT03505320|Gastric cancer|gastric cancer
900338|NCT03499899|advanced triple-negative breast cancer|advanced triple-negative breast cancer
900339|NCT03499899|triple-negative breast cancer|triple-negative breast cancer
900340|NCT03499899|checkpoint inhibition|checkpoint inhibition
900341|NCT03499899|LAG525|lag525
900342|NCT03499899|spartalizumab|spartalizumab
900343|NCT03499899|PDR001|pdr001
900344|NCT03499899|carboplatin|carboplatin
900345|NCT03499249|Biliary Atresia|biliary atresia
900346|NCT03499249|N-Acetylcysteine|n-acetylcysteine
900347|NCT03499249|Glutathione|glutathione
900348|NCT03499249|Kasai portoenterostomy|kasai portoenterostomy
900349|NCT03499249|Bile flow|bile flow
900350|NCT03499249|Serum bile acids|serum bile acids
900351|NCT03499249|Serum bilirubin|serum bilirubin
900352|NCT03496077|Dual Use|dual use
900353|NCT03496077|Little Cigars and Cigarillos|little cigars and cigarillos
900354|NCT03496077|Cigarettes|cigarettes
900355|NCT03496077|Flavored Tobacco Use|flavored tobacco use
900356|NCT03496077|Addiction Potential|addiction potential
900357|NCT03480139|Prematurity|prematurity
900358|NCT03480139|Perinatal Mortality|perinatal mortality
900359|NCT03480139|Pregnancy Complications|pregnancy complications
900360|NCT03480139|Prediction of Adverse Pregnancy Outcome|prediction of adverse pregnancy outcome
900361|NCT03480139|Premature Rupture of Membranes|premature rupture of membranes
900362|NCT03478917|Vasoocclusive Crisis|vasoocclusive crisis
900363|NCT03478917|Sickle Cell Disease|sickle cell disease
900364|NCT03478917|Acute Chest Syndrome|acute chest syndrome
900365|NCT03478917|Pulmonary Syndrome|pulmonary syndrome
900366|NCT03478917|Pneumonia|pneumonia
900367|NCT03478904|Castration Resistant Prostate Cancer|castration resistant prostate cancer
900368|NCT03478904|Androgen Receptor|androgen receptor
900369|NCT03475563|Drug-eluting stent|drug-eluting stent
900370|NCT03475563|Dedicated bifurcation stent|dedicated bifurcation stent
900371|NCT03475563|Cobalt-chromium|cobalt-chromium
900372|NCT03475563|Sirolimus-eluting stent|sirolimus-eluting stent
900373|NCT03474718|scalp|scalp
900374|NCT03474718|hair loss|hair loss
900375|NCT03474718|platelet-rich plasma therapy|platelet-rich plasma therapy
900376|NCT03474107|antibody drug conjugate|antibody drug conjugate
900377|NCT03474107|enfortumab vedotin (EV)|enfortumab vedotin (ev)
900378|NCT03474107|ASG-22ME|asg-22me
900379|NCT03474107|ASG-22CE|asg-22ce
900380|NCT03474107|urothelial cancer|urothelial cancer
900381|NCT03465722|Other Relapsed or Refractory Solid Tumors|other relapsed or refractory solid tumors
900382|NCT03465722|BLU-285|blu-285
900383|NCT03465722|BLU 285|blu 285
900384|NCT03465722|BLUE-285|blue-285
900385|NCT03465722|BLUE 285|blue 285
900386|NCT03465722|Avapritinib|avapritinib
900387|NCT03465722|GIST imatinib relapse|gist imatinib relapse
900388|NCT03465722|GIST gleevec relapse|gist gleevec relapse
900389|NCT03465722|GIST KIT|gist kit
900390|NCT03465722|GIST relapse|gist relapse
900391|NCT03465722|GIST refractory|gist refractory
900392|NCT03465722|GIST imatinib intolerance|gist imatinib intolerance
900393|NCT03465722|GIST TKI treatment|gist tki treatment
900394|NCT03465722|GIST tyrosine kinase inhibitor treatment|gist tyrosine kinase inhibitor treatment
900395|NCT03465722|GIST TKI|gist tki
900396|NCT03465722|GIST tyrosine kinase inhibitor|gist tyrosine kinase inhibitor
900397|NCT03465722|Advanced GIST|advanced gist
900398|NCT03465722|GIST mutations|gist mutations
900399|NCT03465722|GIST treatments|gist treatments
900400|NCT03465722|Blueprint GIST|blueprint gist
900401|NCT03465722|Relapsed GIST clinical trial|relapsed gist clinical trial
900402|NCT03465722|Refractory GIST clinical trial|refractory gist clinical trial
900403|NCT03465722|KIT-mutant GIST|kit-mutant gist
900404|NCT03465722|cancer gist|cancer gist
900405|NCT03465722|gastrointestinal stromal tumor|gastrointestinal stromal tumor
900406|NCT03465722|gist cancer|gist cancer
900407|NCT03465722|PDGFRA|pdgfra
900408|NCT03463616|Rectal Cancer|rectal cancer
900409|NCT03463616|Liver Metastases|liver metastases
900410|NCT03463616|CT abdomen|ct abdomen
900411|NCT03463616|MRI Liver|mri liver
900412|NCT03462004|Healthy Volunteer|healthy volunteer
900413|NCT03458039|mental health capacity building|mental health capacity building
900414|NCT03458039|low and middle-income country|low and middle-income country
900415|NCT03458039|train the trainer strategy|train the trainer strategy
900416|NCT03458039|technology-based training|technology-based training
900417|NCT03448692|Proteinuria|proteinuria
900418|NCT03445663|Relapsed/ Refractory Multiple Myeloma|relapsed/ refractory multiple myeloma
900419|NCT03445663|Multiple Myeloma|multiple myeloma
900420|NCT03445663|Oncology/Hematology|oncology/hematology
900421|NCT03445663|Immunotherapy|immunotherapy
900422|NCT03445533|Melanoma|melanoma
900423|NCT03445533|PD1|pd1
900424|NCT03445533|PD-1|pd-1
900425|NCT03445533|refractory|refractory
900426|NCT03445533|metastatic|metastatic
900427|NCT03445533|IMO-2125|imo-2125
900428|NCT03445533|illuminate 301|illuminate 301
900429|NCT03445533|TLR9 agonist|tlr9 agonist
900430|NCT03445533|advanced melanoma|advanced melanoma
900431|NCT03445533|CTLA4|ctla4
900432|NCT03445533|CTLA-4|ctla-4
900433|NCT03445533|immunotherapy|immunotherapy
900434|NCT03445533|skin cancer|skin cancer
900435|NCT03445533|ILLUMINATE-301|illuminate-301
900436|NCT03439514|cardiomyopathy|cardiomyopathy
900437|NCT03439514|Lamin Type A|lamin type a
900438|NCT03439514|heart failure|heart failure
900439|NCT03439514|ARRY-797|arry-797
900440|NCT03430011|JCARH125|jcarh125
900441|NCT03430011|chimeric antigen receptor|chimeric antigen receptor
900442|NCT03430011|multiple myeloma|multiple myeloma
900443|NCT03430011|CAR T cells|car t cells
900444|NCT03430011|B-cell maturation antigen|b-cell maturation antigen
900445|NCT03430011|BCMA|bcma
900446|NCT03430011|autologous T-cell therapy|autologous t-cell therapy
900447|NCT03430011|immunotherapy|immunotherapy
900448|NCT03429712|CT Scan|ct scan
900449|NCT03427164|Transjugular Intrahepatic Portosystemic Shunt|transjugular intrahepatic portosystemic shunt
900450|NCT03427164|TIPS|tips
900451|NCT03427164|cirrhosis|cirrhosis
900452|NCT03427164|hepatitis|hepatitis
900453|NCT03427164|portal vein thrombosis|portal vein thrombosis
900454|NCT03427164|Budd-Chiari Disease|budd-chiari disease
900455|NCT03427164|Elastography|elastography
900456|NCT03425253|Lower Face Contouring|lower face contouring
900457|NCT03424941|Aortic Stenosis (AS)|aortic stenosis (as)
900458|NCT03424941|Multi Vessel Coronary Artery Disease (MVD)|multi vessel coronary artery disease (mvd)
900459|NCT03424941|TransCatheter Aortic Valve Implantation (TAVI)|transcatheter aortic valve implantation (tavi)
900460|NCT03424941|Coronary Artery By-pass Grafting (CABG)|coronary artery by-pass grafting (cabg)
900461|NCT03424941|Percutaneous Coronary Intervention (PCI)|percutaneous coronary intervention (pci)
900462|NCT03424941|Fractional Flow Reserve (FFR)|fractional flow reserve (ffr)
900463|NCT03424941|Surgical Aortic Valve Replacement (SAVR)|surgical aortic valve replacement (savr)
900464|NCT03410693|Urothelial carcinoma|urothelial carcinoma
900465|NCT03409900|Lumbar Plexus Block|lumbar plexus block
900466|NCT03409900|Quadratus Lumborum Block|quadratus lumborum block
900467|NCT03409900|Direct Anterior Approach|direct anterior approach
900468|NCT03409900|Post-Operative|post-operative
900469|NCT03409900|Pain Management|pain management
900497|NCT03394053|Natural Killer (NK) cell defieciency|natural killer (nk) cell defieciency
900498|NCT03394053|Combined Immunodeficiency|combined immunodeficiency
900499|NCT03394053|T-Cell Lymphocytopenia|t-cell lymphocytopenia
900500|NCT03394053|Of Immune Pathways|of immune pathways
900502|NCT03393520|Dementia of the Alzheimer's type|dementia of the alzheimer's type
900503|NCT03393520|Alzheimer's disease|alzheimer's disease
900504|NCT03393520|AVP-786|avp-786
7472|NCT04152109|cancer|cancer
900505|NCT03393520|Deudextromethorphan hydrobromide|deudextromethorphan hydrobromide
900506|NCT03393520|Quinidine sulfate|quinidine sulfate
900507|NCT03392324|atrophic macular degeneration|atrophic macular degeneration
900508|NCT03392324|geographic atrophy|geographic atrophy
900509|NCT03392324|retina implant|retina implant
900510|NCT03392324|retinal prosthesis|retinal prosthesis
900511|NCT03392324|visual prosthesis|visual prosthesis
900512|NCT03392324|macular degeneration|macular degeneration
900513|NCT03392324|dry macular degeneration|dry macular degeneration
900514|NCT03392324|AMD|amd
900515|NCT03384875|CytoSorb device|cytosorb device
900516|NCT03384875|Plasma free hemoglobin|plasma free hemoglobin
900517|NCT03384875|inflammation|inflammation
900518|NCT03384875|extracorporeal cardiopulmonary bypass|extracorporeal cardiopulmonary bypass
900519|NCT03384875|cardiopulmonary bypass|cardiopulmonary bypass
900520|NCT03384875|Acute Kidney Injury|acute kidney injury
900521|NCT03380871|Personal Vaccine|personal vaccine
900522|NCT03380871|Neoantigen|neoantigen
900523|NCT03380871|Immunotherapy|immunotherapy
900524|NCT03380871|Poly-ICLC|poly-iclc
900525|NCT03380871|Peptide|peptide
900526|NCT03380871|Checkpoint Inhibitor|checkpoint inhibitor
900527|NCT03369223|Antibodies|antibodies
900528|NCT03369223|Antineoplastic Agents|antineoplastic agents
900529|NCT03369223|Immunologic Factors|immunologic factors
900530|NCT03369223|Nivolumab|nivolumab
900531|NCT03369223|Antibodies, Monoclonal|antibodies, monoclonal
900532|NCT03369223|Physiological Effects of Drugs|physiological effects of drugs
900533|NCT03367247|Ovarian Cancer|ovarian cancer
900534|NCT03367247|Bowel blockage|bowel blockage
900535|NCT03367247|Ascites|ascites
900536|NCT03367247|Supportive care|supportive care
900537|NCT03367247|Nursing|nursing
900538|NCT03367247|Mobile health|mobile health
900539|NCT03367247|m-Health|m-health
900540|NCT03367247|Tele-health|tele-health
900541|NCT03367247|Palliative Care|palliative care
900542|NCT03367247|Symptom management|symptom management
900543|NCT03364673|Ovarian Cancer|ovarian cancer
900544|NCT03364673|Physical Activity|physical activity
900545|NCT03364673|Mobile Health|mobile health
900546|NCT03364673|Fitness Tracker|fitness tracker
900547|NCT03364673|Survivorship|survivorship
900548|NCT03364673|Quality of Life|quality of life
900549|NCT03358329|corticosteroid|corticosteroid
900550|NCT03358329|implant|implant
900551|NCT03347214|dbGaP|dbgap
900552|NCT03347058|immunotherapy|immunotherapy
900553|NCT03345836|Upadacitinib|upadacitinib
900554|NCT03345836|Crohn's Disease|crohn's disease
900555|NCT03345836|Efficacy|efficacy
900556|NCT03345836|Safety|safety
900557|NCT03343067|Endometriosis associated pain|endometriosis associated pain
900558|NCT03343067|Elagolix|elagolix
900559|NCT03343067|Non-menstrual pelvic pain (NMPP)|non-menstrual pelvic pain (nmpp)
900560|NCT03343067|Dysmenorrhea (DYS)|dysmenorrhea (dys)
5093|NCT04165655|ASC|asc
5581|NCT04163263|BOS-356|bos-356
6688|NCT04156269|CS1|cs1
7104|NCT04154059|Feet|feet
2813|NCT04178954|Infertility; male; semen|infertility; male; semen
2815|NCT04178902|Relapse/Refractory|relapse/refractory
2816|NCT04178902|Cancer|cancer
2817|NCT04178889|Lung cancer|lung cancer
2818|NCT04178889|Non-small cell lung cancer|non-small cell lung cancer
2819|NCT04178876|endometrioma|endometrioma
2820|NCT04178876|ethanol|ethanol
2821|NCT04178876|sclerotherapy|sclerotherapy
2822|NCT04178876|aspiration|aspiration
2823|NCT04178876|ovarian reserve|ovarian reserve
2824|NCT04178876|endometriosis|endometriosis
2825|NCT04178876|AMH|amh
2826|NCT04178824|Nutrition|nutrition
2828|NCT04178785|laparoscopic|laparoscopic
2836|NCT04178746|IVH|ivh
2837|NCT04178746|stroke|stroke
2838|NCT04178681|Humans|humans
2839|NCT04178681|Milk fat|milk fat
2840|NCT04178681|Clinical Trial|clinical trial
2841|NCT04178681|Genomics|genomics
2842|NCT04178681|Metabolism|metabolism
2843|NCT04178681|Nutrition|nutrition
2844|NCT04178668|molecular mobility|molecular mobility
2845|NCT04178668|collagen denaturation|collagen denaturation
2846|NCT04178668|oral mucosa|oral mucosa
2847|NCT04178668|saliva|saliva
2848|NCT04178668|ageing|ageing
2849|NCT04178655|Tendon Injury, Tranexamic Acid|tendon injury, tranexamic acid
2850|NCT04178629|Ceftobiprole|ceftobiprole
2851|NCT04178629|External Ventricular Derivation|external ventricular derivation
2852|NCT04178629|Cerebrospinal fluid penetration|cerebrospinal fluid penetration
2853|NCT04178629|ATP Binding Cassette Transporter, Subfamily B, Member 1|atp binding cassette transporter, subfamily b, member 1
2854|NCT04178629|Tissue Distribution|tissue distribution
2855|NCT04178603|Exercise|exercise
2856|NCT04178603|Insulin Resistance|insulin resistance
2857|NCT04178603|Type 2 Diabetes|type 2 diabetes
2858|NCT04178603|Glucose Uptake|glucose uptake
2859|NCT04178603|Insulin Sensitivity|insulin sensitivity
2860|NCT04178590|periodontitis|periodontitis
2861|NCT04178590|therapy|therapy
2862|NCT04178590|Platelet|platelet
2863|NCT04178590|Rich|rich
2864|NCT04178590|Fibrin|fibrin
2865|NCT04178590|Nonsurgical|nonsurgical
2866|NCT04178577|End State Renal Disease (ESRD)|end state renal disease (esrd)
2867|NCT04178577|Renal Insufficiency|renal insufficiency
2868|NCT04178577|Renal Impairment|renal impairment
2869|NCT04178577|Renal Disease|renal disease
2870|NCT04178577|Hemodialysis|hemodialysis
2871|NCT04178564|Neurocognitive Disorders|neurocognitive disorders
2872|NCT04178564|Dementia|dementia
2873|NCT04178564|Cognitive Impairment|cognitive impairment
2874|NCT04178564|Cognitive Decline|cognitive decline
2875|NCT04178564|Elderly|elderly
2876|NCT04178564|Cognitive Stimulation|cognitive stimulation
2877|NCT04178564|Group Intervention|group intervention
2878|NCT04178564|Cognition|cognition
2879|NCT04178564|Depression|depression
2880|NCT04178551|Opioid Medication Assisted Treatment|opioid medication assisted treatment
2881|NCT04178551|Addiction, Opioid|addiction, opioid
2884|NCT04178525|Chronic wounds|chronic wounds
2885|NCT04178525|Diabetic foot ulcer|diabetic foot ulcer
2886|NCT04178525|Chitosan gel|chitosan gel
2887|NCT04178486|Overweight|overweight
2888|NCT04178486|Obesity|obesity
2889|NCT04178486|Weight loss|weight loss
2890|NCT04178486|Hypnosis|hypnosis
2891|NCT04178486|Eating Behavior|eating behavior
2892|NCT04178486|Free Will|free will
2893|NCT04178473|hysterectomy|hysterectomy
2894|NCT04178473|sacrocolpopexy|sacrocolpopexy
2895|NCT04178434|Myocardial infarction|myocardial infarction
2896|NCT04178434|Non-obstructive coronary arteries|non-obstructive coronary arteries
2897|NCT04178434|Takotsubo syndrome|takotsubo syndrome
2898|NCT04178421|Sustained attention|sustained attention
2899|NCT04178421|Impulse control|impulse control
2900|NCT04178421|Eye-tracking|eye-tracking
2901|NCT04178421|Special needs|special needs
2902|NCT04178421|Computerized training|computerized training
2903|NCT04178395|transcranial direct current stimulation|transcranial direct current stimulation
2904|NCT04178395|stroke rehabilitation|stroke rehabilitation
2905|NCT04178395|neuromodulation|neuromodulation
2906|NCT04178395|corticomotor excitability|corticomotor excitability
2907|NCT04178395|repetitive peripheral nerve stimulation|repetitive peripheral nerve stimulation
2908|NCT04178382|rapid diagnosis|rapid diagnosis
2909|NCT04178382|severe pneumonia|severe pneumonia
2910|NCT04178343|tomotherapy|tomotherapy
2911|NCT04178343|leptomeningeal metastases|leptomeningeal metastases
2912|NCT04178343|fractionated stereotactic radiotherapy|fractionated stereotactic radiotherapy
2913|NCT04178330|multiple brain metastases|multiple brain metastases
2914|NCT04178330|Tomotherapy|tomotherapy
2915|NCT04178330|fractionated stereotactic radiotheray|fractionated stereotactic radiotheray
2916|NCT04178317|Cancer|cancer
2917|NCT04178317|Chronic Lymphocytic Leukemia (CLL)|chronic lymphocytic leukemia (cll)
2918|NCT04178317|Venetoclax|venetoclax
2919|NCT04178304|primary knee osteoarthritis,|primary knee osteoarthritis,
2920|NCT04178304|prolotherapy,|prolotherapy,
2921|NCT04178304|musculoskeletal ultrasound|musculoskeletal ultrasound
2927|NCT04178265|electroacupuncture|electroacupuncture
2928|NCT04178265|triangular fibrocartilage complex tears|triangular fibrocartilage complex tears
2929|NCT04178265|TFCC tears|tfcc tears
2930|NCT04178265|pain|pain
2931|NCT04178265|wrist functionality|wrist functionality
2932|NCT04178239|Fatigue|fatigue
2933|NCT04178239|fMRI|fmri
2934|NCT04178226|acupuncture|acupuncture
2935|NCT04178226|laser acupuncture|laser acupuncture
2936|NCT04178226|Autonomic nerve activity|autonomic nerve activity
2937|NCT04178226|dysmenorrhea|dysmenorrhea
2938|NCT04178226|prostaglandin|prostaglandin
2939|NCT04178226|quality of life|quality of life
2940|NCT04178213|ADAPT|adapt
2941|NCT04178213|aortic leaflet repair|aortic leaflet repair
2942|NCT04178213|aortic valve|aortic valve
2943|NCT04178200|Cataract|cataract
2944|NCT04178200|Retrobulbar Block|retrobulbar block
2945|NCT04178200|Ocular and eyelid|ocular and eyelid
2946|NCT04178200|Akinesia|akinesia
2947|NCT04178200|Anesthesia Recovery Period|anesthesia recovery period
2948|NCT04178200|Patient Satisfaction|patient satisfaction
2949|NCT04178200|Pain Score|pain score
2950|NCT04178174|head and neck cander|head and neck cander
2951|NCT04178174|Oropharynx cancer|oropharynx cancer
2952|NCT04178174|Human papilloma virus|human papilloma virus
2953|NCT04178174|Radiotherapy|radiotherapy
2954|NCT04178174|Stereotactic body radiotherapy|stereotactic body radiotherapy
2955|NCT04178174|Chemotherapy|chemotherapy
2956|NCT04178174|De-intensification|de-intensification
2957|NCT04178148|Pharmacokinetics|pharmacokinetics
2958|NCT04178148|dose optimisation|dose optimisation
2959|NCT04178148|aminoglycosides|aminoglycosides
2960|NCT04178135|poor or suboptimal ovarian response,GnRH agonist long protocol|poor or suboptimal ovarian response,gnrh agonist long protocol
2961|NCT04178096|Hepatitis C|hepatitis c
2962|NCT04178096|Liver Diseases|liver diseases
2963|NCT04178096|Hepatitis|hepatitis
2964|NCT04178096|Virus Diseases|virus diseases
2965|NCT04178096|Cirrhosis, Liver|cirrhosis, liver
2966|NCT04178096|Liver Cirrhoses|liver cirrhoses
2967|NCT04178096|Hepatic Cirrhoses|hepatic cirrhoses
7838|NCT04149652|copd|copd
2968|NCT04178096|Implementation Science|implementation science
2969|NCT04178096|Strategies|strategies
2970|NCT04178096|Evaluation|evaluation
2971|NCT04178083|laparoscopy|laparoscopy
2972|NCT04178083|pelvic organ prolapse|pelvic organ prolapse
2973|NCT04178083|modified lateral süspension|modified lateral süspension
2974|NCT04178083|pectopexy|pectopexy
2975|NCT04178083|sacrohysteropexy|sacrohysteropexy
2976|NCT04178083|hysteropexy|hysteropexy
2977|NCT04178083|sacropexy|sacropexy
2978|NCT04178083|cervicopexy|cervicopexy
2979|NCT04178083|sacrocervicopexy|sacrocervicopexy
2980|NCT04177992|Neonatology|neonatology
2981|NCT04177992|Servo-control|servo-control
2982|NCT04177992|Transcutaneous oxygen|transcutaneous oxygen
2983|NCT04177992|Saturation monitoring|saturation monitoring
2984|NCT04177979|Near-assisted learning|near-assisted learning
2985|NCT04177979|Cost|cost
2986|NCT04177979|Education environment|education environment
2987|NCT04177979|OSCE|osce
2988|NCT04177979|Problem-based learning|problem-based learning
2989|NCT04177914|Hydrocephalus|hydrocephalus
2990|NCT04177914|Infants|infants
2991|NCT04177914|Ventriculoperitoneal Shunt|ventriculoperitoneal shunt
2992|NCT04177914|ETV+CPC|etv+cpc
2993|NCT04177914|endoscopic third ventriculostomy|endoscopic third ventriculostomy
2994|NCT04177914|choroid plexus cauterization|choroid plexus cauterization
2995|NCT04177888|Hot pack, Labor pain, Duration of labor, Satisfaction, Primigravid women|hot pack, labor pain, duration of labor, satisfaction, primigravid women
2996|NCT04177875|neoadjuvant therapy；pd-1 antibody combined with Chemoradiotherapy|neoadjuvant therapy；pd-1 antibody combined with chemoradiotherapy
2997|NCT04177849|Pain|pain
2998|NCT04177849|Nerve root dysfunction|nerve root dysfunction
2999|NCT04177849|Anterior Cervical Decompression and Fusion|anterior cervical decompression and fusion
3000|NCT04177849|Posterior Foraminotomy|posterior foraminotomy
3001|NCT04177836|Romantic relationship quality|romantic relationship quality
3002|NCT04177836|Mindfulness|mindfulness
3003|NCT04177823|belantamab mafodotin|belantamab mafodotin
3004|NCT04177823|DLT|dlt
3005|NCT04177823|RRMM|rrmm
3006|NCT04177810|Plerixafor|plerixafor
3007|NCT04177810|Cemiplimab|cemiplimab
3008|NCT04177810|Immunotherapy|immunotherapy
3009|NCT04177810|PD-L1 (receptor blocking antibody)|pd-l1 (receptor blocking antibody)
3010|NCT04177810|Anti-PD-L1|anti-pd-l1
3011|NCT04177810|CXCR4 (chemokine receptor)|cxcr4 (chemokine receptor)
3012|NCT04177810|Antibodies|antibodies
3013|NCT04177810|Metastatic pancreatic cancer|metastatic pancreatic cancer
3014|NCT04177797|Esophageal squamous cell carcinoma|esophageal squamous cell carcinoma
3015|NCT04177797|Toripalimab|toripalimab
3016|NCT04177797|Neoadjuvant treatment|neoadjuvant treatment
3017|NCT04177797|Chemotherapy|chemotherapy
3018|NCT04177745|Peripheral venous catheter|peripheral venous catheter
3019|NCT04177745|hot application|hot application
3020|NCT04177745|cold application|cold application
3021|NCT04177745|pain|pain
3022|NCT04177745|anxiety|anxiety
3023|NCT04177732|biomarkers|biomarkers
3024|NCT04177732|Calprotectin|calprotectin
3035|NCT04177654|diagnosis|diagnosis
3036|NCT04177654|drug efficacy|drug efficacy
3037|NCT04177641|thiol disulfide balance|thiol disulfide balance
3038|NCT04177641|preinvasive lesion|preinvasive lesion
3039|NCT04177641|cervix|cervix
3040|NCT04177641|oxidative stress|oxidative stress
3041|NCT04177615|Ischemic stroke|ischemic stroke
3042|NCT04177615|Basilar Artery Occlusion|basilar artery occlusion
3043|NCT04177602|trifluridine tipiracil chemoradiation|trifluridine tipiracil chemoradiation
3044|NCT04177602|locally advanced rectal cancer|locally advanced rectal cancer
3045|NCT04177602|neoadjuvant|neoadjuvant
3046|NCT04177602|adenocarcinoma of the rectum|adenocarcinoma of the rectum
3047|NCT04177576|Polycythemia Vera (PV)|polycythemia vera (pv)
3048|NCT04177576|Essential Thrombocythemia (ET)|essential thrombocythemia (et)
3049|NCT04177576|Neutrophil Extracellular Trap (NET)|neutrophil extracellular trap (net)
3050|NCT04177576|Thrombosis|thrombosis
3059|NCT04177537|low-intensity ultrasound|low-intensity ultrasound
3060|NCT04177537|continuous ultrasound|continuous ultrasound
3061|NCT04177537|long-duration ultrasound|long-duration ultrasound
3062|NCT04177537|athletic training|athletic training
3063|NCT04177537|clinical trial|clinical trial
3064|NCT04177537|soft tissue|soft tissue
3065|NCT04177537|pain|pain
3066|NCT04177537|Musculoskeletal tissue|musculoskeletal tissue
3067|NCT04177537|ZetrOZ System LLC|zetroz system llc
3068|NCT04177511|Chronic pelvic pain|chronic pelvic pain
3069|NCT04177511|Transcutaneous Auricular Vagus Nerve Stimulation|transcutaneous auricular vagus nerve stimulation
3070|NCT04177485|SMS reminder|sms reminder
3071|NCT04177485|vaccination|vaccination
3072|NCT04177485|immunization|immunization
3073|NCT04177485|vaccination drop-out|vaccination drop-out
3074|NCT04177485|vaccination timeliness|vaccination timeliness
3075|NCT04177485|text reminder|text reminder
3076|NCT04177485|mHealth|mhealth
3077|NCT04177485|cell phone|cell phone
3078|NCT04177485|mobile phone|mobile phone
3079|NCT04177472|nutrition|nutrition
3080|NCT04177472|parenting|parenting
3081|NCT04177472|intergenerational feeding influences|intergenerational feeding influences
3082|NCT04177472|sensitive feeding|sensitive feeding
3083|NCT04177459|Adolescent|adolescent
3084|NCT04177459|Fatigue|fatigue
3085|NCT04177459|Rehabilitation|rehabilitation
3086|NCT04177459|Health Promotion|health promotion
3087|NCT04177459|Health-related Quality of Life|health-related quality of life
3088|NCT04177459|Sense of Coherence|sense of coherence
3089|NCT04177459|Emotions|emotions
3090|NCT04177459|Mood|mood
3091|NCT04177459|Leisure Activities|leisure activities
3092|NCT04177446|national support|national support
3093|NCT04177446|protein|protein
3094|NCT04177446|critical illness|critical illness
3095|NCT04177420|Types 2 Diabetes Mellitus|types 2 diabetes mellitus
3096|NCT04177420|Glycation|glycation
3097|NCT04177420|AGEs|ages
3098|NCT04177420|hemoglobin A1c, HbA1c|hemoglobin a1c, hba1c
3099|NCT04177420|Fasting blood sugar, GLU-AC|fasting blood sugar, glu-ac
3100|NCT04177420|Insulin|insulin
3101|NCT04177420|Procollagen-I N-telopeptide, PINP|procollagen-i n-telopeptide, pinp
3102|NCT04177420|C-telopeptide of type I collagen, CTx|c-telopeptide of type i collagen, ctx
3103|NCT04177420|osteocalcin|osteocalcin
3104|NCT04177420|Pittsburgh sleep quality index, PSQI|pittsburgh sleep quality index, psqi
3105|NCT04177420|numeric rating scale-knee, NRS-knee|numeric rating scale-knee, nrs-knee
3106|NCT04177420|Geriatric depression Scale-15, GDS-15|geriatric depression scale-15, gds-15
3107|NCT04177420|Total Antioxidant Capacity, TAC|total antioxidant capacity, tac
3108|NCT04177420|Infrared-C|infrared-c
3109|NCT04177420|Hyperglycemia|hyperglycemia
3110|NCT04177407|Extralevator abdominoperineal excision|extralevator abdominoperineal excision
3111|NCT04177394|MitraClip|mitraclip
3112|NCT04177394|MitraClip G4|mitraclip g4
3113|NCT04177394|Mitral Regurgitation|mitral regurgitation
3114|NCT04177342|achalasia|achalasia
3115|NCT04177342|Peroral endoscopic myotomy|peroral endoscopic myotomy
3116|NCT04177342|post-operative pain|post-operative pain
3117|NCT04177316|VTRNA2-1 promoter|vtrna2-1 promoter
3118|NCT04177316|recurrence|recurrence
3119|NCT04177316|methylation|methylation
3120|NCT04177303|Metformin|metformin
3125|NCT04177277|mHealth|mhealth
3126|NCT04177264|osteopathic manipulative treatment|osteopathic manipulative treatment
3127|NCT04177264|transcutaneous auricular vagus nerve stimulation|transcutaneous auricular vagus nerve stimulation
3128|NCT04177264|cytokines|cytokines
3129|NCT04177264|immune cells|immune cells
3130|NCT04177264|parasympathetic nervous system|parasympathetic nervous system
3131|NCT04177264|heart rate variability|heart rate variability
3132|NCT04177186|Cerebral palsy|cerebral palsy
3133|NCT04177186|Botox|botox
3134|NCT04177173|Methotrexate|methotrexate
3135|NCT04177173|Statins|statins
3136|NCT04177173|Rheumatoid Arthritis|rheumatoid arthritis
3137|NCT04177160|music|music
3138|NCT04177160|anxiety|anxiety
3139|NCT04177160|autonomic nervous system|autonomic nervous system
3140|NCT04177160|subjective cognition decline|subjective cognition decline
3141|NCT04177147|Hypoglycemia|hypoglycemia
3142|NCT04177147|Diabetes mellitus|diabetes mellitus
3143|NCT04177147|Clinical decision support|clinical decision support
3144|NCT04177147|Electronic health records|electronic health records
3145|NCT04177134|spinal muscular atrophy|spinal muscular atrophy
3146|NCT04177121|Musculoskeletal disorders|musculoskeletal disorders
3147|NCT04177121|Physician|physician
3148|NCT04177121|Physiotherapy|physiotherapy
3149|NCT04177121|Referral|referral
3150|NCT04177108|Breast Neoplasms|breast neoplasms
3151|NCT04177108|Triple Negative Breast Neoplasms|triple negative breast neoplasms
3152|NCT04177108|Neoplasms by Site|neoplasms by site
3153|NCT04177108|Neoplasms|neoplasms
3154|NCT04177108|Breast Diseases|breast diseases
3155|NCT04177108|Skin Diseases|skin diseases
3156|NCT04177108|Paclitaxel|paclitaxel
3157|NCT04177108|Atezolizumab|atezolizumab
3158|NCT04177108|Ipatasertib|ipatasertib
3159|NCT04177108|Antibodies, Monoclonal|antibodies, monoclonal
3160|NCT04177108|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic
3161|NCT04177108|Antineoplastic Agents|antineoplastic agents
3162|NCT04177108|Tubulin Modulators|tubulin modulators
3163|NCT04177108|Antimitotic Agents|antimitotic agents
3164|NCT04177108|Mitosis Modulators|mitosis modulators
3165|NCT04177056|stereotactic|stereotactic
3166|NCT04177056|SBRT|sbrt
3167|NCT04177056|Bone mets|bone mets
3168|NCT04177056|palliation|palliation
3169|NCT04177056|pain relief|pain relief
3170|NCT04177056|quality of life|quality of life
3171|NCT04177030|circadian clock|circadian clock
3172|NCT04177030|pesticides|pesticides
3173|NCT04177030|fruits|fruits
3174|NCT04177030|vegetables|vegetables
3175|NCT04177030|diet|diet
3176|NCT04177030|time|time
3177|NCT04177017|stress|stress
3178|NCT04177017|empathy|empathy
3179|NCT04177017|sociality|sociality
3180|NCT04177017|cortisol|cortisol
3181|NCT04176900|Radiation Therapy|radiation therapy
3182|NCT04176900|Radiation Dosimetry|radiation dosimetry
3183|NCT04176900|Patient Reported Outcomes|patient reported outcomes
3184|NCT04176900|3D-printed bolus|3d-printed bolus
3185|NCT04176887|Levetireacetam|levetireacetam
3186|NCT04176887|Phenytoin|phenytoin
3187|NCT04176887|status epilepticus|status epilepticus
3188|NCT04176887|children|children
3189|NCT04176874|Diastasis recti|diastasis recti
3190|NCT04176874|Rectus abdominis diastasis|rectus abdominis diastasis
3191|NCT04176874|Robotic surgical procedure|robotic surgical procedure
3192|NCT04176861|audio-visual stimulation|audio-visual stimulation
3193|NCT04176861|brainwave entrainment|brainwave entrainment
3194|NCT04176822|pediatric surgery|pediatric surgery
3195|NCT04176822|preoperative preparation|preoperative preparation
3196|NCT04176822|animation|animation
3197|NCT04176822|fear|fear
3198|NCT04176822|pain|pain
3199|NCT04176822|nursing|nursing
3200|NCT04176809|Health Related Quality of Life|health related quality of life
3201|NCT04176809|Compliance|compliance
3202|NCT04176809|Endocrine Therapy|endocrine therapy
3203|NCT04176809|Therapeutic Information|therapeutic information
3204|NCT04176796|Heart Transplant|heart transplant
3205|NCT04176796|Transplant Survival|transplant survival
3206|NCT04176796|Applied Ethics|applied ethics
3207|NCT04176796|Medical Students|medical students
3208|NCT04176796|Human Behavior|human behavior
3209|NCT04176796|Decision Psychology|decision psychology
3215|NCT04176718|Multiple Myeloma|multiple myeloma
3216|NCT04176718|Refractory Multiple Myeloma|refractory multiple myeloma
3217|NCT04176718|Multiple Myeloma in Relapse|multiple myeloma in relapse
3218|NCT04176718|Relapse|relapse
3219|NCT04176705|Fractional laser|fractional laser
3220|NCT04176705|Ablative Laser|ablative laser
3221|NCT04176705|Carbon Dioxide Laser|carbon dioxide laser
3222|NCT04176692|scapula dyskinesia|scapula dyskinesia
3227|NCT04176679|Retained Products of conception, Arterio venous malformation|retained products of conception, arterio venous malformation
3229|NCT04176679|embolization|embolization
3230|NCT04176679|fertility|fertility
3231|NCT04176666|cyberbullying|cyberbullying
3232|NCT04176666|cyberaggression|cyberaggression
3233|NCT04176666|mobile application|mobile application
3234|NCT04176640|pediatric traumatic brain injury|pediatric traumatic brain injury
3235|NCT04176627|fluid overload|fluid overload
3236|NCT04176627|peritoneal dialysis|peritoneal dialysis
3237|NCT04176627|lung ultrasound|lung ultrasound
3240|NCT04176549|Ectopic Pregnancy|ectopic pregnancy
3241|NCT04176549|Biomarker|biomarker
3242|NCT04176510|Comorbidity|comorbidity
3243|NCT04176510|Self-Management|self-management
3244|NCT04176510|Charlson Comorbidity Index|charlson comorbidity index
3245|NCT04176510|Health Coach|health coach
3248|NCT04176445|Critical Care|critical care
3249|NCT04176445|Sitting Position|sitting position
3250|NCT04176445|Tilt Table|tilt table
3251|NCT04176445|Ultrasonography|ultrasonography
3252|NCT04176432|Emergency surgery|emergency surgery
3253|NCT04176432|Frailty|frailty
3254|NCT04176432|Elderly|elderly
3255|NCT04176432|Postoperative complications|postoperative complications
3256|NCT04176419|Head & neck cancer|head & neck cancer
3257|NCT04176419|Microvascular free flap reconstruction|microvascular free flap reconstruction
3258|NCT04176380|Multiple Myeloma|multiple myeloma
3259|NCT04176380|Autologous Th1/Tc1 cell Therapy|autologous th1/tc1 cell therapy
3260|NCT04176380|RAPA-201|rapa-201
3261|NCT04176367|Pharmacokinetics|pharmacokinetics
3262|NCT04176354|Breast cancer|breast cancer
3263|NCT04176354|Palbociclib|palbociclib
3264|NCT04176354|Real-world data|real-world data
3265|NCT04176354|Retrospective study|retrospective study
3266|NCT04176354|Effectiveness|effectiveness
3267|NCT04176341|non pharmacological interventions|non pharmacological interventions
3268|NCT04176341|chronic pain|chronic pain
3269|NCT04176341|slackline|slackline
3270|NCT04176341|mindfulness|mindfulness
3271|NCT04176341|adapted physical activity|adapted physical activity
3272|NCT04176341|self-hypnosis|self-hypnosis
3273|NCT04176341|Qi Gong|qi gong
3274|NCT04176341|shared decision making|shared decision making
3275|NCT04176328|Cystic Fibrosis|cystic fibrosis
3276|NCT04176328|Methicillin-resistant Staphylococcus aureus|methicillin-resistant staphylococcus aureus
3277|NCT04176328|Teicoplanin|teicoplanin
3278|NCT04176302|Motor fluctuation|motor fluctuation
3279|NCT04176302|Parkinson|parkinson
3280|NCT04176302|Accelerometer|accelerometer
3281|NCT04176302|Parkinson diary|parkinson diary
3282|NCT04176289|Pupillary Pain Index|pupillary pain index
3283|NCT04176289|Postoperative Pain|postoperative pain
3284|NCT04176289|Infrared Pupillometry|infrared pupillometry
3285|NCT04176289|Postoperative Opioid Consumption|postoperative opioid consumption
3286|NCT04176276|DKD|dkd
3287|NCT04176276|miRNA-25|mirna-25
3288|NCT04176276|miRNA-192|mirna-192
3289|NCT04176263|Parkinson Disease|parkinson disease
3290|NCT04176263|Freezing of Gait|freezing of gait
3291|NCT04176263|Rehabilitation|rehabilitation
3292|NCT04176263|Gait adaptation|gait adaptation
3293|NCT04176263|Split-belt|split-belt
3294|NCT04176263|Treadmill training|treadmill training
3295|NCT04176250|Rifampicin-sensitive pulmonary tuberculosis|rifampicin-sensitive pulmonary tuberculosis
3296|NCT04176250|TBA-7371|tba-7371
3297|NCT04176250|Pulmonary tuberculosis|pulmonary tuberculosis
3298|NCT04176211|Myasthenia Gravis Disease|myasthenia gravis disease
3299|NCT04176211|Neuromuscular Diseases|neuromuscular diseases
3300|NCT04176211|Neuromuscular Junction Diseases|neuromuscular junction diseases
3301|NCT04176211|Nervous System Diseases|nervous system diseases
3302|NCT04176211|Autoimmune Diseases|autoimmune diseases
3303|NCT04176211|Autoimmune Diseases of the Nervous System|autoimmune diseases of the nervous system
3304|NCT04176211|Ocular Myasthenia Gravis|ocular myasthenia gravis
3305|NCT04176211|Generalized Myasthenia Gravis|generalized myasthenia gravis
3306|NCT04176211|Myasthenia Gravis, Generalized|myasthenia gravis, generalized
3307|NCT04176185|House Dust Mite|house dust mite
3308|NCT04176185|Allergic rhinitis|allergic rhinitis
3309|NCT04176185|Allergic conjunctivitis|allergic conjunctivitis
3310|NCT04176185|China|china
3311|NCT04176185|Environmental exposure chamber|environmental exposure chamber
3312|NCT04176172|Smoking Cessation|smoking cessation
3313|NCT04176172|Nicotine Dependence|nicotine dependence
3314|NCT04176172|HIV/AIDS|hiv/aids
3315|NCT04176172|Varenicline|varenicline
3316|NCT04176172|Nicotine Patch|nicotine patch
3317|NCT04176172|Cigarette Smoking|cigarette smoking
3334|NCT04176081|Radiation therapy|radiation therapy
3335|NCT04176042|Daytime Sleepiness|daytime sleepiness
3336|NCT04176042|Environmental Determinants|environmental determinants
3337|NCT04176042|Sleep Beliefs|sleep beliefs
3338|NCT04176042|Sleep Attitudes|sleep attitudes
3339|NCT04176042|Educational Intervention|educational intervention
3340|NCT04176042|Focus Group|focus group
3341|NCT04176042|Epworth Sleepiness Scale|epworth sleepiness scale
3342|NCT04176029|severe malaria|severe malaria
3343|NCT04176029|lung ultrasound|lung ultrasound
3344|NCT04176029|prevalence of pulmonary diagnoses|prevalence of pulmonary diagnoses
3345|NCT04176003|Calcium Pyrophosphate Deposition Disease|calcium pyrophosphate deposition disease
3346|NCT04176003|Outcome measures|outcome measures
3347|NCT04176003|Qualitative research|qualitative research
3348|NCT04175990|progestogen|progestogen
3349|NCT04175990|ovarian stimulation regime|ovarian stimulation regime
3350|NCT04175990|IVF outcome|ivf outcome
3351|NCT04175951|cataract|cataract
3352|NCT04175951|intraocular lens|intraocular lens
3353|NCT04175951|intermediate vision|intermediate vision
3354|NCT04175938|Fuch's Dystrophy, FECD, Fuch's Endothelial Corneal Dystrophy|fuch's dystrophy, fecd, fuch's endothelial corneal dystrophy
3355|NCT04175899|Capecitabine|capecitabine
3356|NCT04175899|Pharmacist Intervention|pharmacist intervention
3357|NCT04175899|Adherence|adherence
3358|NCT04175899|Relative Dose Intensity|relative dose intensity
3359|NCT04175899|Medication Knowledge|medication knowledge
3361|NCT04175886|rheumatoid arthritis|rheumatoid arthritis
3362|NCT04175886|tofacitinib|tofacitinib
3363|NCT04175886|body composition|body composition
3364|NCT04175886|bone marrow adiposity|bone marrow adiposity
3365|NCT04175886|bone marrow density|bone marrow density
3369|NCT04175834|cetirizine|cetirizine
3370|NCT04175834|diphenhydramine|diphenhydramine
3371|NCT04175821|Breast cancer|breast cancer
3372|NCT04175821|Hypofractionated radiotherapy|hypofractionated radiotherapy
3373|NCT04175821|Post mastectomy|post mastectomy
3376|NCT04175795|Goal-setting|goal-setting
3377|NCT04175795|Goal specificity|goal specificity
3378|NCT04175795|Chronic conditions|chronic conditions
3379|NCT04175795|Health outcome profile|health outcome profile
3386|NCT04175743|Safety|safety
3387|NCT04175743|Tolerability|tolerability
3388|NCT04175743|Escalation|escalation
3389|NCT04175743|Pharmacokinetics|pharmacokinetics
3390|NCT04175743|PK|pk
3391|NCT04175743|CT-044 HCl|ct-044 hcl
3392|NCT04175743|Ascending|ascending
3393|NCT04175743|Plasma|plasma
3394|NCT04175743|Surgical Pain|surgical pain
3395|NCT04175743|Acute Pain|acute pain
3396|NCT04175743|Non-Opioid|non-opioid
3397|NCT04175743|Neuropathy|neuropathy
3398|NCT04175743|Chronic Neuropathy|chronic neuropathy
3399|NCT04175691|acute ischemic stroke|acute ischemic stroke
3400|NCT04175691|noncoding RNA|noncoding rna
3401|NCT04175691|clinical significance|clinical significance
3402|NCT04175691|outcome|outcome
3408|NCT04175665|semaglutide|semaglutide
3409|NCT04175665|retrospective study|retrospective study
3410|NCT04175665|hemoglobin A1c|hemoglobin a1c
3411|NCT04175665|body weight|body weight
3412|NCT04175652|Laughter Yoga|laughter yoga
3413|NCT04175652|Hemodialysis|hemodialysis
3414|NCT04175652|Pain|pain
3415|NCT04175652|Sleep|sleep
3416|NCT04175652|Beta Endorphin|beta endorphin
3435|NCT04175574|post-operative pain relief|post-operative pain relief
3436|NCT04175574|post-operative anxiety|post-operative anxiety
798506|NCT00259870|Cognition|cognition
3437|NCT04175574|non-pharmacological adjuvant|non-pharmacological adjuvant
3438|NCT04175574|closed shaft femur fracture|closed shaft femur fracture
3439|NCT04175574|randomised controlled trial|randomised controlled trial
3441|NCT04175561|Nature-based health intervention|nature-based health intervention
3442|NCT04175561|Nature on prescription|nature on prescription
3443|NCT04175561|Mental health|mental health
3444|NCT04175561|Nature connectedness|nature connectedness
3445|NCT04175561|Nature relatedness|nature relatedness
3446|NCT04175561|Therapeutic horticulture|therapeutic horticulture
3447|NCT04175535|cervical disc herniation|cervical disc herniation
3448|NCT04175535|endoscope|endoscope
3449|NCT04175535|posterior|posterior
3450|NCT04175535|minimally invasive spine surgery|minimally invasive spine surgery
3451|NCT04175509|Postoperative Pain|postoperative pain
3452|NCT04175509|Minimally-invasive Hysterectomy|minimally-invasive hysterectomy
3453|NCT04175509|Opioid Use|opioid use
3454|NCT04175509|Acetaminophen|acetaminophen
3455|NCT04175509|Hysterectomy|hysterectomy
3456|NCT04175496|Glycemic index|glycemic index
3457|NCT04175496|Insulinemic index|insulinemic index
3458|NCT04175496|Low carbohydrate|low carbohydrate
3459|NCT04175496|Snack|snack
3460|NCT04175496|Type 1 diabetes|type 1 diabetes
3461|NCT04175418|Multiple Sclerosis|multiple sclerosis
3462|NCT04175418|Rehabilitation|rehabilitation
3463|NCT04175418|Physical Activity|physical activity
3464|NCT04175418|Exercise|exercise
3465|NCT04175405|ATP, biostimulation, micro-screw, Periotest, semiconductor laser|atp, biostimulation, micro-screw, periotest, semiconductor laser
3466|NCT04175392|Fatty Liver|fatty liver
3467|NCT04175392|Fibrosis|fibrosis
3468|NCT04175392|Cirrhosis|cirrhosis
3469|NCT04175392|Probiotic|probiotic
3470|NCT04175392|Steatohepatitis|steatohepatitis
3471|NCT04175392|Elastography|elastography
3475|NCT04175353|older people|older people
3476|NCT04175353|nutrition|nutrition
3477|NCT04175353|dairy|dairy
3478|NCT04175353|berries|berries
3479|NCT04175353|postprandial|postprandial
3480|NCT04175353|glucose|glucose
3481|NCT04175353|insulin|insulin
3482|NCT04175301|neuroprotection|neuroprotection
3483|NCT04175301|hydrogen|hydrogen
3484|NCT04175301|antioxidant|antioxidant
3485|NCT04175301|malignant glioma|malignant glioma
3486|NCT04175249|Salt challenge|salt challenge
3487|NCT04175249|Immune cell metabolism|immune cell metabolism
3488|NCT04175249|Oxygen consumption rate|oxygen consumption rate
3489|NCT04175249|Extracellular acidification rate|extracellular acidification rate
3490|NCT04175249|Cytokine production|cytokine production
3491|NCT04175197|Stenosis|stenosis
3492|NCT04175197|Drug Coated Balloon|drug coated balloon
3493|NCT04175197|Paclitaxel|paclitaxel
3494|NCT04175197|Artery Disease|artery disease
3495|NCT04175184|rotator cuff pain|rotator cuff pain
3496|NCT04175184|mobilisation with movement|mobilisation with movement
3497|NCT04175184|exercises|exercises
3498|NCT04175145|Adolescent idiopathic scoliosis|adolescent idiopathic scoliosis
3499|NCT04175145|posterior instrumentation|posterior instrumentation
3500|NCT04175145|metal density|metal density
3501|NCT04175145|correction|correction
3502|NCT04175145|Pakistan|pakistan
3503|NCT04175119|Brain|brain
3504|NCT04175067|Early stage|early stage
3505|NCT04175067|thiol disulfide hemostasis|thiol disulfide hemostasis
3506|NCT04175067|malignancy|malignancy
3507|NCT04175041|Transcranial Direct Current Stimulation|transcranial direct current stimulation
3508|NCT04175028|Executive Function|executive function
3509|NCT04175015|Education|education
3510|NCT04175015|Randomised trial|randomised trial
3511|NCT04175015|Children|children
3512|NCT04175015|SMARTY|smarty
3513|NCT04175002|heparin-binding epidermal growth factor|heparin-binding epidermal growth factor
3514|NCT04175002|polycystic ovarian syndrome|polycystic ovarian syndrome
3515|NCT04175002|implantation window|implantation window
3516|NCT04175002|obese|obese
3517|NCT04174989|Acute Upper Gastrointestinal Hemorrhage|acute upper gastrointestinal hemorrhage
3524|NCT04174950|enhanced recovery after surgery|enhanced recovery after surgery
3525|NCT04174950|hope level|hope level
3526|NCT04174937|Safety|safety
3527|NCT04174937|Iodine complex|iodine complex
3528|NCT04174937|Pharmacokinetics|pharmacokinetics
3529|NCT04174937|Antibiotic potentiator|antibiotic potentiator
3530|NCT04174898|human Mesenchymal Stem Cells (hMSC)|human mesenchymal stem cells (hmsc)
3531|NCT04174898|Anti-Aging|anti-aging
3532|NCT04174898|Regenerative Medicine|regenerative medicine
3533|NCT04174898|Adipose Derived MSCs|adipose derived mscs
3534|NCT04174898|Umbilical Cord Derived MSCs|umbilical cord derived mscs
3535|NCT04174898|Autologous hMSC|autologous hmsc
3536|NCT04174898|Allogenic hMSC|allogenic hmsc
3537|NCT04174859|Atrial Fibrillation (AF)|atrial fibrillation (af)
3538|NCT04174859|NVAF|nvaf
3539|NCT04174833|GlideScope|glidescope
3540|NCT04174833|Airway Management|airway management
3541|NCT04174833|Videolaryngoscopic Intubation|videolaryngoscopic intubation
400489|NCT01866670|breast neoplasms|breast neoplasms
3542|NCT04174820|Functional Magnetic Resonance Imaging|functional magnetic resonance imaging
3543|NCT04174807|gastroschisis|gastroschisis
3544|NCT04174807|prenatal diagnosis|prenatal diagnosis
3545|NCT04174807|gastrointestinal complications|gastrointestinal complications
3546|NCT04174807|wall defect|wall defect
3547|NCT04174807|predictive factors|predictive factors
3548|NCT04174794|Acute heart failure|acute heart failure
3549|NCT04174794|Lung ultrasound|lung ultrasound
3550|NCT04174781|Hepatocellular carcinoma|hepatocellular carcinoma
3551|NCT04174781|Transarterial chemoembolization|transarterial chemoembolization
3552|NCT04174781|Immunotherapy|immunotherapy
3560|NCT04174716|HRR|hrr
3561|NCT04174690|Center of pressure|center of pressure
3562|NCT04174690|Dynamic postural balance|dynamic postural balance
3563|NCT04174690|Force platform|force platform
3564|NCT04174690|Posturography|posturography
3565|NCT04174690|Electromyography|electromyography
3566|NCT04174677|cPRA, HLA antibodies, kidney transplantation|cpra, hla antibodies, kidney transplantation
3567|NCT04174664|pulmonary exacerbation|pulmonary exacerbation
3568|NCT04174638|Compliance|compliance
3569|NCT04174638|Motivational Interviewing|motivational interviewing
3570|NCT04174638|Models, Nursing|models, nursing
3571|NCT04174638|Nursing|nursing
3572|NCT04174638|Patient Satisfaction|patient satisfaction
3573|NCT04174638|Quality of Life|quality of life
3574|NCT04174638|Randomized Controlled Trial|randomized controlled trial
3575|NCT04174638|Renal Dialysis|renal dialysis
3576|NCT04174625|omega 3|omega 3
3577|NCT04174625|25 hydroxyvitamin D|25 hydroxyvitamin d
3578|NCT04174625|25OHD|25ohd
3579|NCT04174625|Vitamin D|vitamin d
3580|NCT04174586|Cord blood microtransplatation|cord blood microtransplatation
3581|NCT04174586|mobilized prepheral stem cell microtransplatation|mobilized prepheral stem cell microtransplatation
3582|NCT04174573|tDCS|tdcs
3583|NCT04174573|Quality of Life|quality of life
3584|NCT04174573|Parkinson Disease|parkinson disease
3585|NCT04174573|Neuronal Plasticity|neuronal plasticity
3586|NCT04174560|Adults|adults
3587|NCT04174560|CIN-3 Batch No.: 01-16C3|cin-3 batch no.: 01-16c3
3588|NCT04174560|GII.4|gii.4
3589|NCT04174560|Healthy|healthy
3590|NCT04174560|Norovirus|norovirus
3591|NCT04174547|Somatic mutations|somatic mutations
3592|NCT04174547|Clonal hematopoiesis|clonal hematopoiesis
3593|NCT04174547|Biomarkers|biomarkers
3594|NCT04174547|Immune escape|immune escape
3595|NCT04174547|Innovative predictive models|innovative predictive models
3596|NCT04174547|EuroBloodNet|eurobloodnet
3597|NCT04174469|ivermectin|ivermectin
3598|NCT04174469|neurotoxicity|neurotoxicity
3599|NCT04174469|ATP binding cassette subfamily B member 1|atp binding cassette subfamily b member 1
3600|NCT04174469|ABCB1/P-glycoprotein (P-gp)|abcb1/p-glycoprotein (p-gp)
3601|NCT04174469|multidrug transporter|multidrug transporter
3602|NCT04174469|drug adverse event|drug adverse event
3603|NCT04174469|Ivermectin toxicity|ivermectin toxicity
3604|NCT04174443|Trigeminal neuralgia|trigeminal neuralgia
3605|NCT04174443|Pulsed radiofrequency|pulsed radiofrequency
3606|NCT04174443|Continuous radiofrequency|continuous radiofrequency
3607|NCT04174443|High-voltage pulsed radiofrequency combined with low-temperature continuous radiofrequency|high-voltage pulsed radiofrequency combined with low-temperature continuous radiofrequency
3608|NCT04174417|hypotensive anesthesia|hypotensive anesthesia
3609|NCT04174417|HIF 1a|hif 1a
3610|NCT04174417|Brain Hypoxia|brain hypoxia
3614|NCT04174404|Children|children
3615|NCT04174404|Parent|parent
3616|NCT04174404|perioperative care|perioperative care
3617|NCT04174404|randomised controlled trial|randomised controlled trial
3618|NCT04174404|Self-efficacy|self-efficacy
3619|NCT04174404|Preoperative anxiety|preoperative anxiety
3620|NCT04174391|breast cancer prognosis|breast cancer prognosis
3621|NCT04174391|Mediterranean diet|mediterranean diet
3622|NCT04174391|extra-virgin olive oil|extra-virgin olive oil
3623|NCT04174391|low-fat diet|low-fat diet
3624|NCT04174378|Luteal phase support|luteal phase support
3625|NCT04174378|GnRH agonist|gnrh agonist
3626|NCT04174378|in vitro fertilization|in vitro fertilization
3627|NCT04174365|Autism|autism
3628|NCT04174365|Irritability|irritability
3629|NCT04174365|Autism Spectrum Disorder|autism spectrum disorder
3630|NCT04174365|ASD|asd
3631|NCT04174326|Cognitive Behavioral Therapy|cognitive behavioral therapy
3632|NCT04174300|Manual Therapy|manual therapy
3633|NCT04174300|Physiotherapy|physiotherapy
3634|NCT04174300|Chronic Fatigue Syndrome (CFS)|chronic fatigue syndrome (cfs)
3635|NCT04174300|Fibromyalgia (FM)|fibromyalgia (fm)
3636|NCT04174300|RNAseq|rnaseq
3637|NCT04174300|microRNA|microrna
3638|NCT04174300|mechanomiR|mechanomir
3639|NCT04174287|18F-FDG PET scan|18f-fdg pet scan
3640|NCT04174287|amyloid PET|amyloid pet
3641|NCT04174287|Amyloid beta|amyloid beta
3642|NCT04174287|Alzheimer's disease|alzheimer's disease
3643|NCT04174287|metabolic connectivity|metabolic connectivity
3644|NCT04174287|functional connectivity|functional connectivity
3645|NCT04174248|breast cancer|breast cancer
3646|NCT04174248|m-Health application|m-health application
3647|NCT04174248|self-management|self-management
3648|NCT04174248|life of quality|life of quality
3649|NCT04174235|Fetal anomalies|fetal anomalies
3650|NCT04174209|Keratoconus|keratoconus
3651|NCT04174209|Corneal Topography|corneal topography
3652|NCT04174209|Eyeglasses|eyeglasses
3653|NCT04174209|Ocular Refraction|ocular refraction
3654|NCT04174209|Jackson Cross Cylinder|jackson cross cylinder
3655|NCT04174209|Astigmatic Dial Technique|astigmatic dial technique
3656|NCT04174209|Stenopeic slit|stenopeic slit
3657|NCT04174196|CC-486|cc-486
3658|NCT04174196|Plasmacytoma|plasmacytoma
3659|NCT04174196|lenalidomide|lenalidomide
3660|NCT04174196|Plasmacytoma of Bone|plasmacytoma of bone
3661|NCT04174196|Memorial Sloan Kettering Cancer Center|memorial sloan kettering cancer center
3662|NCT04174196|19-284|19-284
3663|NCT04174196|multiple myeloma with plasmacytomas|multiple myeloma with plasmacytomas
3664|NCT04174196|multiple myeloma|multiple myeloma
3665|NCT04174170|PTSD|ptsd
3666|NCT04174144|Sagittal balance|sagittal balance
3667|NCT04174144|Lumbar lordosis|lumbar lordosis
3668|NCT04174144|Clinical outcomes|clinical outcomes
3669|NCT04174092|Catastrophism|catastrophism
3670|NCT04174079|adjuvant chemotherapy|adjuvant chemotherapy
3671|NCT04174053|Temperature measurement|temperature measurement
3672|NCT04174053|capsule thermometers|capsule thermometers
3673|NCT04174053|Haematology|haematology
3674|NCT04174040|music|music
3675|NCT04174040|Cognitive Behavioral Therapy|cognitive behavioral therapy
3676|NCT04174040|randomized controlled trial|randomized controlled trial
3677|NCT04174040|rhythm|rhythm
3678|NCT04174027|Chronic ankle instability ( CAI )|chronic ankle instability ( cai )
3679|NCT04174027|Perturbration|perturbration
3680|NCT04174027|reactive postural control|reactive postural control
3681|NCT04174027|balance|balance
3682|NCT04174027|center of pressure - COP|center of pressure - cop
3683|NCT04173988|Allogeneic CAR-T19|allogeneic car-t19
3684|NCT04173962|Ketamine|ketamine
3685|NCT04173962|Resilience|resilience
3686|NCT04173962|Stress|stress
3687|NCT04173962|Healthy Volunteers|healthy volunteers
3688|NCT04173923|Cervical Myelopathy|cervical myelopathy
3689|NCT04173923|Korean medicine treatment|korean medicine treatment
3690|NCT04173858|Naloxegol, PAMORA|naloxegol, pamora
3695|NCT04173793|HeFH|hefh
3696|NCT04173793|LDL-C|ldl-c
3697|NCT04173780|Myopia (Progressing)|myopia (progressing)
3698|NCT04173780|Childhood|childhood
3699|NCT04173780|Atropine 0,01%|atropine 0,01%
3700|NCT04173754|Shoulder joints|shoulder joints
3701|NCT04173754|ROM|rom
3702|NCT04173754|Shoulder disorder|shoulder disorder
3703|NCT04173754|MSAT|msat
3704|NCT04173754|Motion Style Acupuncture Treatment|motion style acupuncture treatment
3705|NCT04173754|Shoulder pains|shoulder pains
3706|NCT04173741|Positive Pressure Ventilation|positive pressure ventilation
3707|NCT04173741|Fluid Responsiveness|fluid responsiveness
3708|NCT04173741|Passive Leg Raise|passive leg raise
3709|NCT04173741|Inferior Vena Cava|inferior vena cava
3710|NCT04173741|Internal Jugular Vein|internal jugular vein
4504|NCT04169074|nivolumab|nivolumab
3711|NCT04173741|Interobserver Variability|interobserver variability
3713|NCT04173728|Healthy|healthy
3714|NCT04173728|Mets|mets
3715|NCT04173728|Homeostasis|homeostasis
3716|NCT04173715|Cut-Points|cut-points
3717|NCT04173715|Accelerometry|accelerometry
3718|NCT04173715|Physical Activity Quantification|physical activity quantification
3719|NCT04173715|Physical Function|physical function
3720|NCT04173715|Frailty Syndrome|frailty syndrome
3721|NCT04173715|Energy Expenditure|energy expenditure
3722|NCT04173715|Aging|aging
3723|NCT04173702|Balance|balance
3724|NCT04173702|Stance width|stance width
3725|NCT04173702|Postural sway|postural sway
3726|NCT04173702|Limits of stability|limits of stability
3728|NCT04173650|Exosomes|exosomes
3729|NCT04173637|IL12/23|il12/23
3730|NCT04173624|EUS|eus
3731|NCT04173624|MRCP|mrcp
3732|NCT04173624|Intermediate Probability|intermediate probability
3733|NCT04173611|Pharmacodynamics|pharmacodynamics
3734|NCT04173611|Pharmacokinetics|pharmacokinetics
3735|NCT04173611|Safety|safety
3736|NCT04173611|Efficacy|efficacy
3737|NCT04173598|Cognitive remediation program|cognitive remediation program
3738|NCT04173585|Acute Myeloid Leukemia|acute myeloid leukemia
3739|NCT04173585|therapy resistance|therapy resistance
3740|NCT04173585|refractory/relapsed|refractory/relapsed
3741|NCT04173585|AML|aml
3742|NCT04173572|Walking|walking
3743|NCT04173572|Exercise|exercise
3744|NCT04173572|Physical Health|physical health
3745|NCT04173494|Myelofibrosis|myelofibrosis
3746|NCT04173494|JAK inhibitor|jak inhibitor
3747|NCT04173494|Danazol|danazol
3748|NCT04173494|Momelotinib|momelotinib
3749|NCT04173494|Functional Iron deficiency|functional iron deficiency
3750|NCT04173494|ACVR1|acvr1
3751|NCT04173494|Anemia|anemia
3752|NCT04173494|Transfusion|transfusion
3753|NCT04173494|Hepcidin|hepcidin
3754|NCT04173494|Myeloproliferative Disorders|myeloproliferative disorders
3755|NCT04173494|Bone Marrow Diseases|bone marrow diseases
3756|NCT04173494|Hematologic Diseases|hematologic diseases
3757|NCT04173481|Stroke|stroke
3758|NCT04173481|Proprioceptive Neuromuscular Facility|proprioceptive neuromuscular facility
3759|NCT04173481|Hemiplegia|hemiplegia
3760|NCT04173481|Neurorehabilitation|neurorehabilitation
3761|NCT04173481|Neural Plasticity|neural plasticity
3762|NCT04173468|Anterior Knee Pain Syndrome|anterior knee pain syndrome
3763|NCT04173429|Low molecular weight heparin|low molecular weight heparin
3764|NCT04173429|warfarin|warfarin
3765|NCT04173377|Orthopedic Surgery|orthopedic surgery
3766|NCT04173377|Elbow|elbow
3767|NCT04173377|Trauma|trauma
3768|NCT04173377|Arthroplasty|arthroplasty
3769|NCT04173377|Osteosynthesis|osteosynthesis
3770|NCT04173364|interscalene block|interscalene block
3771|NCT04173364|shoulder surgery|shoulder surgery
3772|NCT04173364|local anesthesic|local anesthesic
3773|NCT04173364|respiratory function|respiratory function
3774|NCT04173364|diaphragmatic dysfunction|diaphragmatic dysfunction
3775|NCT04173364|echography|echography
3776|NCT04173364|locoregional anesthesia|locoregional anesthesia
3777|NCT04173351|childbirth|childbirth
3778|NCT04173351|nulliparous|nulliparous
3779|NCT04173351|childbirth fear|childbirth fear
3780|NCT04173351|antenatal education|antenatal education
3781|NCT04173351|counseling|counseling
3782|NCT04173351|attitude|attitude
3783|NCT04173351|pain|pain
3784|NCT04173325|Lung cancer|lung cancer
3785|NCT04173325|Relapsed lung cancer|relapsed lung cancer
3786|NCT04173312|local anesthetic|local anesthetic
3787|NCT04173312|continuous infusion|continuous infusion
3788|NCT04173312|pain control|pain control
3789|NCT04173273|Etrasimod|etrasimod
3790|NCT04173273|Crohn's disease|crohn's disease
3791|NCT04173273|APD334|apd334
3792|NCT04173273|Inflammatory bowel disease|inflammatory bowel disease
3793|NCT04173234|Duchenne Muscular Dystrophy|duchenne muscular dystrophy
3794|NCT04173234|Aerobic Training|aerobic training
3795|NCT04173234|Ultrasonography|ultrasonography
3796|NCT04173234|Motor Function|motor function
3797|NCT04173221|Microcirculation|microcirculation
3798|NCT04173221|Intensive Care|intensive care
3799|NCT04173221|Critical care|critical care
3800|NCT04173221|shock|shock
3801|NCT04173221|risk stratification|risk stratification
3802|NCT04173221|SDF-measurement|sdf-measurement
3803|NCT04173221|fluid resuscitation|fluid resuscitation
3804|NCT04173208|Transplant|transplant
3805|NCT04173208|Cesarean section|cesarean section
3806|NCT04173208|inflammatory response|inflammatory response
3807|NCT04173208|Infant|infant
3808|NCT04173195|Comfort talk|comfort talk
3809|NCT04173195|Outpatient clinic|outpatient clinic
3810|NCT04173195|Emotional support|emotional support
3811|NCT04173195|Pain|pain
3812|NCT04173195|Nursing care|nursing care
3813|NCT04173182|colonoscopy|colonoscopy
3814|NCT04173182|diverticular disease|diverticular disease
3815|NCT04173143|endurance training,|endurance training,
3826|NCT04173052|Electrical shock|electrical shock
3827|NCT04173052|sperms activation|sperms activation
3828|NCT04173052|Semen Analysis|semen analysis
3829|NCT04172935|Presbyopia|presbyopia
3830|NCT04172935|textile worker|textile worker
3831|NCT04172896|Pelvic Reconstructive Surgery|pelvic reconstructive surgery
3832|NCT04172896|Prolapse Surgery|prolapse surgery
3833|NCT04172883|Reactive ATP|reactive atp
3834|NCT04172883|device based Management of Atrial fibrilation|device based management of atrial fibrilation
3835|NCT04172883|AF Management|af management
3841|NCT04172844|leukemia|leukemia
3842|NCT04172844|acute myeloid leukemia|acute myeloid leukemia
3844|NCT04172831|Sleep|sleep
3845|NCT04172831|Fibromyalgia|fibromyalgia
3846|NCT04172831|FM|fm
3847|NCT04172818|allogenic hematopoietic stem cell transplantation|allogenic hematopoietic stem cell transplantation
3848|NCT04172818|diary|diary
3849|NCT04172818|psychological disorders|psychological disorders
3850|NCT04172779|hepatocellular carcinoma|hepatocellular carcinoma
3851|NCT04172779|chemoprevention|chemoprevention
3852|NCT04172766|Hearing Loss|hearing loss
3853|NCT04172766|Noise Exposure|noise exposure
3854|NCT04172766|Noise Induced Hearing Loss|noise induced hearing loss
3855|NCT04172766|Listening Volume|listening volume
3856|NCT04172766|Environmental Noise|environmental noise
3857|NCT04172766|Music|music
3858|NCT04172766|Audiometry|audiometry
3859|NCT04172766|Speech-in-Noise|speech-in-noise
3860|NCT04172766|Hearing Ability|hearing ability
3861|NCT04172753|Radiotherapy|radiotherapy
3862|NCT04172753|Adaptive Radiotherapy|adaptive radiotherapy
3863|NCT04172714|Cancer|cancer
3864|NCT04172714|Radiation therapy|radiation therapy
3865|NCT04172714|Liver Diseases|liver diseases
3866|NCT04172714|Radiology, Interventional|radiology, interventional
3867|NCT04172714|Radiology|radiology
3868|NCT04172688|Pain|pain
3869|NCT04172688|Gut microbiota|gut microbiota
3870|NCT04172688|Prebiotic|prebiotic
3871|NCT04172675|Non muscle invasive bladder cancer (NMIBC)|non muscle invasive bladder cancer (nmibc)
3872|NCT04172675|Bacillus calmette- guerin (BCG) failure|bacillus calmette- guerin (bcg) failure
3873|NCT04172675|BCG unresponsive|bcg unresponsive
3874|NCT04172649|prostate cancer|prostate cancer
3875|NCT04172649|pain management|pain management
3876|NCT04172649|acupuncture|acupuncture
3877|NCT04172649|acupressure|acupressure
3882|NCT04172571|VEGF|vegf
3883|NCT04172571|Anti-PD-1|anti-pd-1
3884|NCT04172571|Tyrosine Kinase Inhibitor (TKI)|tyrosine kinase inhibitor (tki)
3885|NCT04172571|Angiogenesis-related kinases|angiogenesis-related kinases
3886|NCT04172558|Botulimium Toxin|botulimium toxin
3887|NCT04172558|Eractile Dysfunction|eractile dysfunction
3888|NCT04172558|ICI|ici
3889|NCT04172519|pelvic floor muscles training|pelvic floor muscles training
3890|NCT04172519|laparoscopic radical prostatectomy|laparoscopic radical prostatectomy
3891|NCT04172519|adenomectomy|adenomectomy
3892|NCT04172506|Anti-PD-1|anti-pd-1
3893|NCT04172506|immunotherapy|immunotherapy
3894|NCT04172467|Secondary immunodeficiencies (SID)|secondary immunodeficiencies (sid)
3895|NCT04172467|Chronic lymphocytic leukemia (CLL)|chronic lymphocytic leukemia (cll)
3896|NCT04172467|Multiple myeloma (MM)|multiple myeloma (mm)
3897|NCT04172454|Bispecific|bispecific
3898|NCT04172454|PD1/CTLA4|pd1/ctla4
3899|NCT04172454|PD-1/PD-L1 relapsed/refractory tumors|pd-1/pd-l1 relapsed/refractory tumors
3900|NCT04172415|Procedural Sedation|procedural sedation
3901|NCT04172415|Chart Review|chart review
3902|NCT04172402|Advanced Biliary Tract Cancer|advanced biliary tract cancer
3903|NCT04172402|Nivolumab|nivolumab
3904|NCT04172402|Phase 2|phase 2
3905|NCT04172376|basal ganglion hemorrhage|basal ganglion hemorrhage
3906|NCT04172376|stereotactic surgery|stereotactic surgery
3907|NCT04172376|thrombolysis|thrombolysis
3908|NCT04172350|women|women
3909|NCT04172350|breast cancer|breast cancer
3910|NCT04172350|surgery|surgery
3927|NCT04172272|Transversus abdominis plane block|transversus abdominis plane block
3929|NCT04172272|Hysterectomy|hysterectomy
3930|NCT04172272|Postoperative pain|postoperative pain
3931|NCT04172272|Cytokines|cytokines
3932|NCT04172272|Visual analogue scale|visual analogue scale
3933|NCT04172272|Quality of recovery|quality of recovery
3934|NCT04172259|Human epidermal growth factor receptor 2|human epidermal growth factor receptor 2
3935|NCT04172259|Pathology complete response|pathology complete response
4069|NCT04171700|bladder cancer|bladder cancer
3945|NCT04172233|IL12/23|il12/23
3946|NCT04172220|Breast Cancer|breast cancer
3947|NCT04172220|PECS|pecs
3948|NCT04172220|Neutrophil to Lymphocyte ratio|neutrophil to lymphocyte ratio
3949|NCT04172220|Quadrantectomy|quadrantectomy
3950|NCT04172181|cord blood stem cell transplantation|cord blood stem cell transplantation
3951|NCT04172181|severe combined immunodeficiency disease|severe combined immunodeficiency disease
3952|NCT04172181|primary immunodeficiency|primary immunodeficiency
3953|NCT04172168|Left Ventricular Free-wall Ruptrue|left ventricular free-wall ruptrue
3954|NCT04172168|Acute myocardial infarction|acute myocardial infarction
3955|NCT04172168|Coronary angiography|coronary angiography
3956|NCT04172142|Pectus Carinatum|pectus carinatum
3957|NCT04172142|Pectus Excavatum|pectus excavatum
3958|NCT04172142|Physical Impairment|physical impairment
3959|NCT04172142|Psychosocial Impairment|psychosocial impairment
3963|NCT04172116|metabolic surgery|metabolic surgery
3964|NCT04172103|acute kidney injury|acute kidney injury
3965|NCT04172103|chronic kidney disease|chronic kidney disease
3966|NCT04172103|cardiac surgery|cardiac surgery
3967|NCT04172103|thoracic aortic surgery|thoracic aortic surgery
3968|NCT04172077|Self Efficacy|self efficacy
3969|NCT04172077|Resiliency|resiliency
3970|NCT04172077|Attachment style and youth with type 1 diabetes|attachment style and youth with type 1 diabetes
3971|NCT04172038|stepped care|stepped care
3972|NCT04172038|physical therapy|physical therapy
3973|NCT04172038|mindfulness|mindfulness
3974|NCT04172038|holistic health|holistic health
3975|NCT04172038|military medicine|military medicine
3976|NCT04172025|Epidemiology|epidemiology
3977|NCT04172025|surveillance|surveillance
3978|NCT04172025|bacterial pathogens|bacterial pathogens
3979|NCT04172025|Database|database
3980|NCT04172025|Genotyping|genotyping
3981|NCT04172012|Tanzania|tanzania
3982|NCT04172012|East Africa|east africa
3983|NCT04172012|Antimicrobial resistance|antimicrobial resistance
3984|NCT04172012|Probiotics|probiotics
3985|NCT04172012|Extended Spectrum Beta-Lactamase Producing Bacteria|extended spectrum beta-lactamase producing bacteria
3986|NCT04171999|Food Insecurity|food insecurity
3987|NCT04171999|Caregivers|caregivers
3988|NCT04171999|Clinical Trial|clinical trial
3989|NCT04171999|Hunger|hunger
3990|NCT04171999|Self-Efficacy|self-efficacy
3991|NCT04171999|Health-Related Social Needs|health-related social needs
3992|NCT04171986|Small Cell Lung Cancer|small cell lung cancer
3993|NCT04171986|HHPG-19K|hhpg-19k
9034|NCT04141930|flu|flu
3994|NCT04171960|i-STAT|i-stat
3995|NCT04171960|Traumatic Brain Injury|traumatic brain injury
3996|NCT04171960|Biomarkers|biomarkers
3997|NCT04171947|Tea|tea
3998|NCT04171947|Polyphenols|polyphenols
3999|NCT04171947|Nugent score|nugent score
4000|NCT04171947|Antioxidants|antioxidants
4001|NCT04171947|Vaginal pH|vaginal ph
4002|NCT04171947|complementary medicine|complementary medicine
4003|NCT04171921|Open ventral hernia repair|open ventral hernia repair
4008|NCT04171921|Pain-killers consumption|pain-killers consumption
4010|NCT04171921|Operative time|operative time
4011|NCT04171921|Early hernia recurrence|early hernia recurrence
4012|NCT04171921|General complications|general complications
4013|NCT04171895|Communication training|communication training
4014|NCT04171895|19-398|19-398
4020|NCT04171830|palliative care|palliative care
4021|NCT04171830|end of life|end of life
4022|NCT04171830|clinical surveillance|clinical surveillance
4023|NCT04171817|therapy dog|therapy dog
4024|NCT04171817|canine|canine
4025|NCT04171817|animal assisted intervention|animal assisted intervention
4026|NCT04171817|chlorhexidine|chlorhexidine
4027|NCT04171817|child|child
4028|NCT04171804|Parkinson's Disease|parkinson's disease
4029|NCT04171804|Mild Cognitive Impairment|mild cognitive impairment
4030|NCT04171804|Transcranial Direct Current Stimulation|transcranial direct current stimulation
4031|NCT04171804|Cognitive functions|cognitive functions
4032|NCT04171804|Electrophysiology|electrophysiology
4033|NCT04171804|Event related potentials|event related potentials
4034|NCT04171778|CKD|ckd
4035|NCT04171778|proteinuria|proteinuria
4036|NCT04171778|diet|diet
4037|NCT04171778|plant-based diet|plant-based diet
4038|NCT04171778|vegan|vegan
4039|NCT04171778|randomized controlled trial|randomized controlled trial
4040|NCT04171752|elafibranor|elafibranor
4041|NCT04171726|Thrombosis|thrombosis
4042|NCT04171726|Aortic Valve Stenosis|aortic valve stenosis
4043|NCT04171726|Heart Valve Diseases|heart valve diseases
4044|NCT04171726|Ventricular Outflow Obstruction|ventricular outflow obstruction
4045|NCT04171726|Cardiovascular Diseases|cardiovascular diseases
4046|NCT04171726|Embolism and Thrombosis|embolism and thrombosis
4047|NCT04171726|Vascular Diseases|vascular diseases
4048|NCT04171726|Heart Diseases|heart diseases
4049|NCT04171726|Factor Xa Inhibitors|factor xa inhibitors
4050|NCT04171726|Anticoagulants|anticoagulants
4051|NCT04171713|bariatric surgery|bariatric surgery
4052|NCT04171713|weight regain|weight regain
4053|NCT04171713|food behavior|food behavior
4054|NCT04171713|mindfulness|mindfulness
4055|NCT04171713|compassion|compassion
4056|NCT04171713|empathy|empathy
4057|NCT04171700|rucaparib|rucaparib
4058|NCT04171700|PARPi|parpi
4059|NCT04171700|rare tumor|rare tumor
4060|NCT04171700|solid tumor|solid tumor
4061|NCT04171700|CO-338|co-338
4062|NCT04171700|ovarian cancer|ovarian cancer
4063|NCT04171700|prostate cancer|prostate cancer
4064|NCT04171700|pancreatic cancer|pancreatic cancer
4065|NCT04171700|breast cancer|breast cancer
4066|NCT04171700|lung cancer|lung cancer
4067|NCT04171700|colon cancer|colon cancer
4068|NCT04171700|gastric cancer|gastric cancer
4070|NCT04171700|colorectal cancer|colorectal cancer
4071|NCT04171700|PARP inhibitor|parp inhibitor
4072|NCT04171700|homologous recombination|homologous recombination
4073|NCT04171700|DNA repair|dna repair
4074|NCT04171700|LODESTAR|lodestar
4075|NCT04171700|germline|germline
4076|NCT04171700|somatic|somatic
4077|NCT04171700|BRCA1|brca1
4078|NCT04171700|BRCA2|brca2
4079|NCT04171700|PALB2|palb2
4080|NCT04171700|RAD51C|rad51c
4081|NCT04171700|RAD51D|rad51d
4082|NCT04171700|BARD1|bard1
4083|NCT04171700|BRIP1|brip1
4084|NCT04171700|FANCA|fanca
4085|NCT04171700|RAD51|rad51
4086|NCT04171700|RAD51B|rad51b
4087|NCT04171700|sarcoma|sarcoma
4088|NCT04171700|HRR|hrr
4089|NCT04171700|HRD|hrd
4090|NCT04171700|platinum sensitive|platinum sensitive
4091|NCT04171700|platinum resistant|platinum resistant
4092|NCT04171700|primary peritoneal cancer|primary peritoneal cancer
4093|NCT04171700|fallopian tube cancer|fallopian tube cancer
4094|NCT04171700|tumor agnostic|tumor agnostic
4095|NCT04171700|basket study|basket study
4096|NCT04171700|basket trial|basket trial
4097|NCT04171700|metastatic|metastatic
4098|NCT04171700|locally advanced|locally advanced
4099|NCT04171700|esophageal cancer|esophageal cancer
4100|NCT04171700|leiomyosarcoma|leiomyosarcoma
4101|NCT04171700|ampullary carcinoma|ampullary carcinoma
4102|NCT04171700|carcinosarcoma|carcinosarcoma
4103|NCT04171700|endometrial cancer|endometrial cancer
4104|NCT04171700|cervical cancer|cervical cancer
4105|NCT04171674|community-acquired pneumonia|community-acquired pneumonia
4106|NCT04171661|Dystrophic Epidermolysis Bullosa|dystrophic epidermolysis bullosa
4107|NCT04171661|Recessive Dystrophic Epidermolysis Bullosa|recessive dystrophic epidermolysis bullosa
4108|NCT04171661|Tissue Engineering|tissue engineering
4115|NCT04171635|Liver iron concentration|liver iron concentration
4116|NCT04171635|erythrocyte transfusion|erythrocyte transfusion
4117|NCT04171635|liver transplantation|liver transplantation
4118|NCT04171635|magnetic resonance imaging|magnetic resonance imaging
4119|NCT04171635|thalassemia major|thalassemia major
4120|NCT04171583|cystic fibrosis|cystic fibrosis
4121|NCT04171583|staphylococcus aureus|staphylococcus aureus
4122|NCT04171583|mucoid|mucoid
4123|NCT04171570|Distal Transradial Access|distal transradial access
4124|NCT04171570|Randomized Multicenter Trial|randomized multicenter trial
4125|NCT04171570|Radial Access|radial access
4126|NCT04171557|Exercise|exercise
4127|NCT04171557|Physical Activity|physical activity
4128|NCT04171557|Bicycling|bicycling
4129|NCT04171531|urinary incontinence|urinary incontinence
4130|NCT04171531|midurethral sling|midurethral sling
4131|NCT04171531|Botulinum toxin A (Botox A ®)|botulinum toxin a (botox a ®)
4132|NCT04171466|Gut microbiome|gut microbiome
4133|NCT04171466|Dysbiosis|dysbiosis
4134|NCT04171466|Antibiotic therapy|antibiotic therapy
4135|NCT04171466|Rationally-defined consortia|rationally-defined consortia
4136|NCT04171466|Short-chain fatty acids|short-chain fatty acids
4137|NCT04171466|Gut metabolome|gut metabolome
4138|NCT04171466|Metagenomic sequencing|metagenomic sequencing
4139|NCT04171466|Ciproflozacin|ciproflozacin
4140|NCT04171466|Metronidazole|metronidazole
4141|NCT04171466|Probiotic Therapy|probiotic therapy
4142|NCT04171440|minimal invasive, robotic, laparoscopic,open|minimal invasive, robotic, laparoscopic,open
4143|NCT04171388|Low birthweight|low birthweight
4144|NCT04171388|Preterm birth|preterm birth
4145|NCT04171388|Maternal nutrition|maternal nutrition
4146|NCT04171388|Small for gestational age|small for gestational age
4147|NCT04171388|Chlamydia|chlamydia
4148|NCT04171388|Gonorrhea|gonorrhea
4149|NCT04171388|Urinary tract infection|urinary tract infection
4150|NCT04171388|Presumptive antibiotics|presumptive antibiotics
4151|NCT04171349|Hemodialysis|hemodialysis
4152|NCT04171284|Non-small cell lung cancer|non-small cell lung cancer
4153|NCT04171284|Squamous cell carcinoma|squamous cell carcinoma
4154|NCT04171245|Sleep, laughter, well-being, mental health|sleep, laughter, well-being, mental health
4160|NCT04171206|Interpersonal partner violence|interpersonal partner violence
4161|NCT04171206|Dating violence|dating violence
4162|NCT04171206|Internet-delivered intervention|internet-delivered intervention
4163|NCT04171193|Isoflurane|isoflurane
4164|NCT04171193|Anesthesia|anesthesia
4165|NCT04171193|Treatment resistant depression|treatment resistant depression
4166|NCT04171193|Deep anesthesia|deep anesthesia
4167|NCT04171193|Burst suppression|burst suppression
4168|NCT04171193|Depressive episode|depressive episode
4169|NCT04171167|Nasal nitric oxide|nasal nitric oxide
4170|NCT04171167|Nitric oxide metabolites|nitric oxide metabolites
4171|NCT04171141|Gastric cancer|gastric cancer
4172|NCT04171141|Esophageal cancer|esophageal cancer
4173|NCT04171141|Colorectal cancer|colorectal cancer
4174|NCT04171141|Advanced esophageal cancer|advanced esophageal cancer
4175|NCT04171141|Metastatic esophageal cancer|metastatic esophageal cancer
4176|NCT04171141|Advanced colorectal cancer|advanced colorectal cancer
4177|NCT04171141|Metastatic gastric cancer|metastatic gastric cancer
4178|NCT04171141|Advanced gastric cancer|advanced gastric cancer
4179|NCT04171141|Metastatic colorectal cancer|metastatic colorectal cancer
4180|NCT04171141|GUCY2c|gucy2c
4181|NCT04171141|Anti-PD1|anti-pd1
4182|NCT04171141|Anti-VEGF|anti-vegf
4183|NCT04171141|Measurable disease|measurable disease
4184|NCT04171141|PF-07062119|pf-07062119
4185|NCT04171141|PF-06801591|pf-06801591
4186|NCT04171141|Bevacizumab|bevacizumab
4187|NCT04171128|procalcitonin|procalcitonin
4188|NCT04171063|Braces|braces
4189|NCT04171063|Conservative treatment|conservative treatment
4190|NCT04171063|Thoracic wall|thoracic wall
4191|NCT04171063|Pectus carinatum|pectus carinatum
4192|NCT04171050|Pain Management|pain management
4193|NCT04171050|Pudendal Nerve Block (PNB)|pudendal nerve block (pnb)
4194|NCT04171050|Vaginal Reconstruction|vaginal reconstruction
4195|NCT04171024|Diaphragm dysfunction|diaphragm dysfunction
4196|NCT04171024|Transcutaneous Electrical Stimulation|transcutaneous electrical stimulation
4197|NCT04171024|Intensive care unit|intensive care unit
4198|NCT04171024|Mechanical ventilation|mechanical ventilation
4199|NCT04170959|Tumor Hypoxia|tumor hypoxia
4200|NCT04170959|Metformin|metformin
4201|NCT04170959|Radiotherapy|radiotherapy
4210|NCT04170920|DCIS|dcis
4211|NCT04170920|aromatase inhibitor|aromatase inhibitor
4212|NCT04170907|nicotine|nicotine
4213|NCT04170907|pharmacokinetics|pharmacokinetics
4214|NCT04170907|pharmacodynamics|pharmacodynamics
4215|NCT04170894|Atrial Fibrillation|atrial fibrillation
4216|NCT04170894|Radiofrequency Ablation|radiofrequency ablation
4217|NCT04170894|Ablation|ablation
4218|NCT04170894|Arrhythmia|arrhythmia
4219|NCT04170881|cleaning products|cleaning products
4220|NCT04170881|respiratory health|respiratory health
4221|NCT04170881|young children|young children
4222|NCT04170881|nursery workers|nursery workers
4223|NCT04170881|nursery environment|nursery environment
4224|NCT04170855|kidney sodium content|kidney sodium content
4225|NCT04170855|Sodium MRI|sodium mri
4226|NCT04170842|Wound dressing|wound dressing
4227|NCT04170829|MERS-CoV|mers-cov
4228|NCT04170829|ChAdOx1 MERS|chadox1 mers
4229|NCT04170816|Dry needling|dry needling
4230|NCT04170816|Kinesiotape|kinesiotape
4231|NCT04170816|Low-back pain|low-back pain
4232|NCT04170803|Chronic Pain|chronic pain
4233|NCT04170803|Musculoskeletal Injury|musculoskeletal injury
4234|NCT04170803|Functional near-infrared spectroscopy|functional near-infrared spectroscopy
4235|NCT04170803|Structural health monitoring|structural health monitoring
4236|NCT04170803|Dry needling|dry needling
4237|NCT04170777|Advanced cancer|advanced cancer
4238|NCT04170777|Imaging study|imaging study
4239|NCT04170777|Stereotactic Radiosurgery|stereotactic radiosurgery
4240|NCT04170777|GammaKnife|gammaknife
4241|NCT04170777|Cone-beam computed tomography (CBCT)|cone-beam computed tomography (cbct)
4242|NCT04170751|lobectomy|lobectomy
4249|NCT04170725|POTS|pots
4250|NCT04170712|tampons; ovarian cancer|tampons; ovarian cancer
4251|NCT04170686|cognitive behavioral therapy|cognitive behavioral therapy
4252|NCT04170686|self-help|self-help
4253|NCT04170686|irritable bowel syndrome|irritable bowel syndrome
4254|NCT04170647|reperfusion|reperfusion
4255|NCT04170647|IVT|ivt
4256|NCT04170634|osteolytic secondary tumoral lesion|osteolytic secondary tumoral lesion
4257|NCT04170634|femur|femur
4258|NCT04170634|vertebrae|vertebrae
4259|NCT04170634|qCT routine imagery|qct routine imagery
4260|NCT04170582|Hemorrhage|hemorrhage
4261|NCT04170582|Subdural|subdural
4262|NCT04170582|Chronic Subdural Hematoma|chronic subdural hematoma
4263|NCT04170582|Chronic|chronic
4264|NCT04170556|hepatocellular|hepatocellular
4265|NCT04170556|sorafenib|sorafenib
4266|NCT04170556|regorafenib|regorafenib
4267|NCT04170556|nivolumab|nivolumab
4268|NCT04170530|Extramural Vascular Invasion|extramural vascular invasion
4269|NCT04170530|Neoadjuvant|neoadjuvant
4270|NCT04170530|chemotherapy|chemotherapy
4271|NCT04170530|mFOLFOXIRI|mfolfoxiri
4272|NCT04170504|Rheumatoid Arthritis|rheumatoid arthritis
4273|NCT04170504|Qing Re Huo Xue|qing re huo xue
4274|NCT04170504|Methotrexate|methotrexate
4275|NCT04170504|Randomized controlled trial|randomized controlled trial
4276|NCT04170478|Prostate Cancer|prostate cancer
4277|NCT04170478|Transperineal laser ablation|transperineal laser ablation
4278|NCT04170478|Prostate neoplasma|prostate neoplasma
4279|NCT04170478|Focal laser ablation|focal laser ablation
4280|NCT04170465|Metformin|metformin
4281|NCT04170465|locally advanced breast cancer|locally advanced breast cancer
4282|NCT04170465|neoadjuvant|neoadjuvant
4283|NCT04170452|Viral hepatitis B|viral hepatitis b
4284|NCT04170452|HBV DNA|hbv dna
4285|NCT04170452|Viral hepatitis Delta|viral hepatitis delta
4286|NCT04170452|iver biopsy|iver biopsy
4287|NCT04170452|PCR|pcr
4288|NCT04170413|contrast ultrasound|contrast ultrasound
4289|NCT04170413|urodynamics|urodynamics
4290|NCT04170387|Relaxometer|relaxometer
4291|NCT04170387|Mini Mental State Examination|mini mental state examination
4292|NCT04170387|Fibromyalgia Impact Questionnaire|fibromyalgia impact questionnaire
4293|NCT04170387|Discognition|discognition
4294|NCT04170387|Rehabilitation|rehabilitation
4295|NCT04170361|COPD|copd
4296|NCT04170361|incentive spirometer|incentive spirometer
4297|NCT04170361|length of stay|length of stay
4298|NCT04170361|hemodynamic responses|hemodynamic responses
4299|NCT04170348|Sickle Cell Disease|sickle cell disease
4300|NCT04170348|Acute Chest Syndrome|acute chest syndrome
4301|NCT04170348|Respiratory Complication|respiratory complication
4302|NCT04170348|Vitamin D Deficiency|vitamin d deficiency
4303|NCT04170335|Breast cancer|breast cancer
4304|NCT04170335|Morbid obesity|morbid obesity
4305|NCT04170335|Bariatric surgery|bariatric surgery
4306|NCT04170335|Mammography|mammography
4307|NCT04170335|Inflammatory markers|inflammatory markers
4308|NCT04170309|Cephalosporins|cephalosporins
4309|NCT04170309|Retrospective Studies|retrospective studies
4310|NCT04170309|Safety|safety
4311|NCT04170283|Zanubrutinib|zanubrutinib
4312|NCT04170283|BTK inhibitor|btk inhibitor
4313|NCT04170283|long-term extension|long-term extension
4314|NCT04170257|Esophageal Squamous Cell Carcinoma|esophageal squamous cell carcinoma
4315|NCT04170257|Population-level screening|population-level screening
4316|NCT04170257|Narrow Band Imaging|narrow band imaging
4317|NCT04170257|Iodine Staining|iodine staining
4318|NCT04170257|Sensitivity and Specificity|sensitivity and specificity
4319|NCT04170231|Critically Ill Children|critically ill children
4320|NCT04170231|19-407|19-407
4321|NCT04170218|knee osteoarthritis|knee osteoarthritis
4322|NCT04170218|hip osteoarthritis|hip osteoarthritis
4323|NCT04170218|quality of healthcare|quality of healthcare
4324|NCT04170218|elderly|elderly
4325|NCT04170192|Umbilical Cord Blood Stem Cell Transplantation|umbilical cord blood stem cell transplantation
4326|NCT04170192|Inflammatory Bowel Disease|inflammatory bowel disease
4327|NCT04170192|Interleukin 10 Receptor|interleukin 10 receptor
4328|NCT04170179|Hepatocellular Carcinoma|hepatocellular carcinoma
4329|NCT04170179|Lenvatinib|lenvatinib
4330|NCT04170179|Toripalimab|toripalimab
4331|NCT04170179|Systemic chemotherapy|systemic chemotherapy
4332|NCT04170179|Oxaliplatin, leucovorin, 5-fluorouracil|oxaliplatin, leucovorin, 5-fluorouracil
4333|NCT04170179|Extrahepatic metastasis|extrahepatic metastasis
4334|NCT04170153|M1774|m1774
4335|NCT04170153|ATR inhibitor|atr inhibitor
4336|NCT04170153|Metastatic or Locally Advanced Unresectable Solid Tumors|metastatic or locally advanced unresectable solid tumors
4337|NCT04170127|ATP, biostimulation, micro-screw, Periotest, semiconductor laser|atp, biostimulation, micro-screw, periotest, semiconductor laser
4338|NCT04170114|Cystic Fibrosis|cystic fibrosis
4339|NCT04170114|Bronchiectasis|bronchiectasis
4340|NCT04170114|Respiratory Physiotherapy|respiratory physiotherapy
4341|NCT04170114|Pulmonary Function|pulmonary function
4342|NCT04170114|Exercise Capacity|exercise capacity
4343|NCT04170114|Six Minute Walk Test|six minute walk test
4344|NCT04170114|Muscle Strength|muscle strength
4345|NCT04170088|Melasma, Tranexamic acid , Mesotherapy|melasma, tranexamic acid , mesotherapy
4346|NCT04170036|Protein supplement|protein supplement
4347|NCT04170036|Serum creatinine|serum creatinine
4348|NCT04170036|Serum sodium|serum sodium
4349|NCT04170036|Glucose metabolism|glucose metabolism
4350|NCT04170036|Lipid profile|lipid profile
4351|NCT04170036|C-reactive protein|c-reactive protein
4352|NCT04170010|Weight loss|weight loss
4353|NCT04170010|Gut peptides|gut peptides
4354|NCT04170010|Meal-induced thermogenesis|meal-induced thermogenesis
4355|NCT04170010|Glycemia|glycemia
4356|NCT04169971|trial|trial
4357|NCT04169971|Anxiety|anxiety
4358|NCT04169971|music|music
4359|NCT04169971|intraoperative period|intraoperative period
4360|NCT04169971|spinal anaesthesia|spinal anaesthesia
4361|NCT04169945|periodontitis|periodontitis
4362|NCT04169945|air polishing|air polishing
4363|NCT04169945|randomised clinical trial|randomised clinical trial
4364|NCT04169945|debridement|debridement
4365|NCT04169932|CD20 CAR T Cells|cd20 car t cells
4366|NCT04169932|Safety, tolerance and efficacy|safety, tolerance and efficacy
4367|NCT04169880|Subacromial impingement syndrome|subacromial impingement syndrome
4368|NCT04169880|High Intensity Laser Therapy|high intensity laser therapy
4369|NCT04169880|Laser Therapy|laser therapy
4370|NCT04169880|Shoulder Pain|shoulder pain
4371|NCT04169867|Microbiome|microbiome
4372|NCT04169867|Melanoma|melanoma
4373|NCT04169867|Healthy Volunteers|healthy volunteers
4374|NCT04169867|Immunotherapy|immunotherapy
4375|NCT04169867|Stool samples|stool samples
4376|NCT04169867|Cancer|cancer
4377|NCT04169867|Metagenome|metagenome
4378|NCT04169867|Neoplasms|neoplasms
4379|NCT04169867|Intestinal microbiota|intestinal microbiota
4380|NCT04169867|Nivolumab|nivolumab
4381|NCT04169867|Ipilimumab|ipilimumab
4382|NCT04169867|Atezolizumab|atezolizumab
4383|NCT04169854|Postoperative Pain|postoperative pain
4384|NCT04169854|Postcraniotomy Pain|postcraniotomy pain
4385|NCT04169854|Lidocaine Patch|lidocaine patch
4386|NCT04169841|immunotherapy|immunotherapy
4387|NCT04169841|olaparib|olaparib
4388|NCT04169841|durvalumab|durvalumab
4389|NCT04169841|tremelimumab|tremelimumab
4390|NCT04169841|genes mutation|genes mutation
4391|NCT04169828|Arthritis|arthritis
4392|NCT04169828|Arthritis, Juvenile|arthritis, juvenile
4393|NCT04169828|Joint Diseases|joint diseases
4394|NCT04169828|Rheumatic diseases|rheumatic diseases
4395|NCT04169828|Pragmatic Trials|pragmatic trials
4396|NCT04169828|Ondansetron|ondansetron
4397|NCT04169828|Methotrexate|methotrexate
4398|NCT04169828|Nausea|nausea
4399|NCT04169815|Natriuretic Peptide|natriuretic peptide
4400|NCT04169802|Age-Related Macular Degeneration|age-related macular degeneration
4401|NCT04169802|visual acuity|visual acuity
4410|NCT04169698|renal transplant|renal transplant
4411|NCT04169659|Kyphoplasty|kyphoplasty
4412|NCT04169659|EBM|ebm
4413|NCT04169659|Titanium|titanium
4414|NCT04169659|Microsphere|microsphere
4415|NCT04169659|Vertebral fracture|vertebral fracture
4416|NCT04169646|office-worker|office-worker
4417|NCT04169646|neck-specific exercises|neck-specific exercises
4418|NCT04169646|stepped wedge design|stepped wedge design
4419|NCT04169646|productivity|productivity
4420|NCT04169633|Everyday cognition|everyday cognition
4421|NCT04169633|Older adult, aging|older adult, aging
4422|NCT04169633|test Validation|test validation
4423|NCT04169607|lung protective ventilation strategy|lung protective ventilation strategy
4424|NCT04169607|individualized positive end-expiratory pressure|individualized positive end-expiratory pressure
4425|NCT04169607|Laparoscopic bariatric surgery|laparoscopic bariatric surgery
4426|NCT04169607|Mechanical ventilation|mechanical ventilation
4427|NCT04169607|Anesthetic management|anesthetic management
4428|NCT04169607|Lung dynamic compliance|lung dynamic compliance
4429|NCT04169607|Postoperative Atelectasis|postoperative atelectasis
4433|NCT04169555|ultrasound|ultrasound
4434|NCT04169555|renal colic|renal colic
4435|NCT04169555|emergency room|emergency room
4436|NCT04169555|point of care|point of care
4437|NCT04169529|COPD|copd
4438|NCT04169516|microcirculation|microcirculation
4439|NCT04169490|Scar|scar
4440|NCT04169490|Keloid|keloid
4441|NCT04169490|Hypertrophic Scar|hypertrophic scar
4442|NCT04169490|Cicatrix|cicatrix
4443|NCT04169477|TENS|tens
4444|NCT04169464|HCV|hcv
4445|NCT04169464|DAAs|daas
4446|NCT04169464|Egyptian patients|egyptian patients
4447|NCT04169464|creatinine|creatinine
4448|NCT04169464|insulin resistence|insulin resistence
4449|NCT04169464|GFR|gfr
4450|NCT04169438|Wound Heal|wound heal
4451|NCT04169438|Scar|scar
4452|NCT04169438|Keloid|keloid
4453|NCT04169438|Surgical Wound|surgical wound
4454|NCT04169399|Hepatocellular carcinoma|hepatocellular carcinoma
4455|NCT04169399|Toripalimab|toripalimab
4456|NCT04169399|Stereotactic body radiotherapy|stereotactic body radiotherapy
4457|NCT04169399|Portal vein tumor thrombus|portal vein tumor thrombus
4462|NCT04169321|cancer immunotherapy|cancer immunotherapy
4463|NCT04169321|biomarkers, tumor|biomarkers, tumor
4464|NCT04169321|positron-emission tomography|positron-emission tomography
4465|NCT04169321|Granzymes|granzymes
4466|NCT04169282|tracheobronchomalacia|tracheobronchomalacia
4467|NCT04169282|TBM|tbm
4468|NCT04169282|cough|cough
4469|NCT04169256|pain|pain
4470|NCT04169256|postoperative|postoperative
4471|NCT04169256|local anesthesia|local anesthesia
4472|NCT04169256|long-action|long-action
4473|NCT04169230|Citalopram|citalopram
4474|NCT04169230|Emotional Processing|emotional processing
4475|NCT04169230|Antidepressants|antidepressants
4476|NCT04169230|Self Processing|self processing
4477|NCT04169230|Healthy Volunteers|healthy volunteers
4478|NCT04169217|Prehabilitation|prehabilitation
4479|NCT04169204|Microcirculation|microcirculation
4480|NCT04169204|Intensive Care|intensive care
4481|NCT04169204|Critical care|critical care
4482|NCT04169204|shock|shock
4483|NCT04169204|Very Old Intensive Care Patients|very old intensive care patients
4484|NCT04169204|risk stratification|risk stratification
4485|NCT04169204|SDF-measurement|sdf-measurement
4486|NCT04169165|kidney stone|kidney stone
4487|NCT04169165|calcium oxalate stone|calcium oxalate stone
4488|NCT04169165|patient compliance|patient compliance
4489|NCT04169165|nephrolithiasis|nephrolithiasis
4490|NCT04169152|Cap-assisted endoscopic sclerotherapy|cap-assisted endoscopic sclerotherapy
4491|NCT04169152|Internal Hemorrhoid|internal hemorrhoid
4492|NCT04169152|Rectal Prolapse|rectal prolapse
4493|NCT04169126|Dementia|dementia
4494|NCT04169126|Tau PET scan|tau pet scan
4495|NCT04169126|Tau neurofibrillary tangles|tau neurofibrillary tangles
4496|NCT04169126|Amyloid deposition|amyloid deposition
4497|NCT04169113|Hip Arthroscopy|hip arthroscopy
4498|NCT04169113|Opiate Use|opiate use
4499|NCT04169100|cytokines|cytokines
4500|NCT04169074|Head and Neck Cancer|head and neck cancer
4501|NCT04169074|HNSCC|hnscc
4502|NCT04169074|Squamous Cell Cancer|squamous cell cancer
4503|NCT04169074|abemaciclib|abemaciclib
4511|NCT04168944|Liver Transplantation|liver transplantation
4513|NCT04168931|HER2|her2
4514|NCT04168931|trastuzumab|trastuzumab
4515|NCT04168931|circulating tumor cells|circulating tumor cells
4516|NCT04168905|chronic wounds Topical wound oxygen therapy|chronic wounds topical wound oxygen therapy
4517|NCT04168853|cardiopulmonary bypass|cardiopulmonary bypass
4518|NCT04168853|pulsatility|pulsatility
4519|NCT04168853|systemic inflammatory response|systemic inflammatory response
4520|NCT04168853|arterial graft|arterial graft
4524|NCT04168827|Severe trauma|severe trauma
4525|NCT04168827|Post-traumatic stress|post-traumatic stress
4526|NCT04168827|Anxiety|anxiety
4527|NCT04168827|Depression|depression
4528|NCT04168827|Intensive care|intensive care
4533|NCT04168801|Mild acute pancreatitis|mild acute pancreatitis
4534|NCT04168801|Oral refeeding|oral refeeding
4535|NCT04168801|Non inferiority clinical trial|non inferiority clinical trial
4536|NCT04168788|Pharmacogenetics|pharmacogenetics
4537|NCT04168775|peak inspiratory flow rate|peak inspiratory flow rate
4538|NCT04168762|Ultrasound|ultrasound
4539|NCT04168762|Neuromodulation|neuromodulation
4540|NCT04168762|Transcranial Magnetic Stimulation|transcranial magnetic stimulation
4541|NCT04168762|Transcranial Ultrasound Stimulation|transcranial ultrasound stimulation
4542|NCT04168736|genetic testing|genetic testing
4543|NCT04168736|cascade|cascade
4544|NCT04168736|family disclosure|family disclosure
4545|NCT04168658|Osteoporosis|osteoporosis
4546|NCT04168658|Chinese women|chinese women
4547|NCT04168658|nursing home|nursing home
4548|NCT04168658|physical activity|physical activity
4549|NCT04168658|RCT|rct
4550|NCT04168632|children|children
4551|NCT04168632|public meals|public meals
4552|NCT04168632|sustainable diets|sustainable diets
4553|NCT04168632|Agenda 2030|agenda 2030
4554|NCT04168619|Liver Fibrosis|liver fibrosis
4555|NCT04168619|Psoriasis|psoriasis
4556|NCT04168619|Methotrexate|methotrexate
4557|NCT04168619|Transient elastography|transient elastography
4558|NCT04168619|Two-dimensional shear wave elastrography|two-dimensional shear wave elastrography
4559|NCT04168606|placental abruption|placental abruption
4560|NCT04168593|Acupuncture|acupuncture
4561|NCT04168593|Cupping|cupping
4562|NCT04168593|Osteoarthritis|osteoarthritis
4563|NCT04168593|Pain|pain
4564|NCT04168567|Microbiome|microbiome
4565|NCT04168567|Microbiota|microbiota
4566|NCT04168567|Obesity|obesity
4567|NCT04168554|Telemedicine|telemedicine
4568|NCT04168554|Respiratory distress|respiratory distress
4569|NCT04168554|Pediatric|pediatric
4570|NCT04168554|General practitioner|general practitioner
4571|NCT04168528|PET/CT|pet/ct
4572|NCT04168528|MMR-PET/CT|mmr-pet/ct
4573|NCT04168528|Macrophage PET/CT|macrophage pet/ct
4574|NCT04168502|De-novo|de-novo
4575|NCT04168502|Favorable risk|favorable risk
4576|NCT04168502|Intermediate risk|intermediate risk
4577|NCT04168502|Gemtuzumab ozogamicin|gemtuzumab ozogamicin
4578|NCT04168502|Glasdegib|glasdegib
4579|NCT04168502|Acute Myeloid Leukemia|acute myeloid leukemia
4580|NCT04168489|rTMS|rtms
4581|NCT04168489|Primary Dysmenorrhea|primary dysmenorrhea
4582|NCT04168476|Median Nerve|median nerve
4583|NCT04168476|Hand Strength|hand strength
4584|NCT04168476|Brachial plexus|brachial plexus
4585|NCT04168476|Physical Therapy Modalities|physical therapy modalities
4586|NCT04168476|Neck Pain|neck pain
4587|NCT04168463|Dementia|dementia
4588|NCT04168463|Social robots|social robots
4589|NCT04168463|Companion robots|companion robots
4590|NCT04168463|Robot pets|robot pets
4591|NCT04168463|Wellbeing|wellbeing
4592|NCT04168463|Older adults|older adults
4593|NCT04168463|Long-term care|long-term care
4594|NCT04168463|Residential care|residential care
4595|NCT04168437|Back Pain|back pain
4596|NCT04168437|Quality of Life|quality of life
4597|NCT04168437|PROMIS-29|promis-29
4598|NCT04168437|PRECISION Pain Research Registry|precision pain research registry
4599|NCT04168424|resource use|resource use
4600|NCT04168424|assessment|assessment
4601|NCT04168424|elderly|elderly
4602|NCT04168411|metatarsal, fracture, muscle weakness, isokinetic test,|metatarsal, fracture, muscle weakness, isokinetic test,
4603|NCT04168398|Clopidogrel, Apixiban and Lower Limb Revascularization|clopidogrel, apixiban and lower limb revascularization
4604|NCT04168385|PFIC|pfic
4610|NCT04168385|Digestive System Diseases|digestive system diseases
4612|NCT04168372|Fructose|fructose
4613|NCT04168372|Glucose|glucose
4614|NCT04168372|Lipogenesis|lipogenesis
4615|NCT04168333|Hepatitis B virus (HBV) infection|hepatitis b virus (hbv) infection
4616|NCT04168320|Phase I|phase i
4617|NCT04168320|Bystander effect|bystander effect
4618|NCT04168320|Abscopal effect|abscopal effect
4619|NCT04168320|Tumor hypoxia|tumor hypoxia
4620|NCT04168307|ankle fracture|ankle fracture
4621|NCT04168307|rehabilitation|rehabilitation
4622|NCT04168294|Esophagogastroduodenoscopy|esophagogastroduodenoscopy
4623|NCT04168294|Deep Sedation|deep sedation
4624|NCT04168294|Cognition Disorders|cognition disorders
4625|NCT04168294|Patient Discharge|patient discharge
4626|NCT04168294|Automobile Driving|automobile driving
4627|NCT04168242|Gynecologic cancer|gynecologic cancer
4628|NCT04168242|chemotherapy-induced alopecia|chemotherapy-induced alopecia
4629|NCT04168242|scalp cooling|scalp cooling
4630|NCT04168216|Chronic Obstructive Pulmonary Disease, COPD|chronic obstructive pulmonary disease, copd
4631|NCT04168203|pulmonary embolism|pulmonary embolism
4632|NCT04168203|deep vein thrombosis|deep vein thrombosis
4633|NCT04168203|venous thromboembolism|venous thromboembolism
4634|NCT04168203|secondary prevention|secondary prevention
4635|NCT04168203|anticoagulation|anticoagulation
4636|NCT04168164|aquatic therapy; balance; acquired brain injury.|aquatic therapy; balance; acquired brain injury.
4637|NCT04168151|post cardiac surgery,|post cardiac surgery,
4638|NCT04168151|lung recruitment|lung recruitment
4639|NCT04168151|trans alveolar pressure|trans alveolar pressure
4640|NCT04168138|D-CTAG|d-ctag
4641|NCT04168138|Acute Myeloid Leukemia|acute myeloid leukemia
4642|NCT04168138|rhTPO|rhtpo
4643|NCT04168112|Collagen Crosslinking|collagen crosslinking
4644|NCT04168112|Keratoconus|keratoconus
4645|NCT04168112|Dexamethasone|dexamethasone
4646|NCT04168112|Intracanalicular Insert|intracanalicular insert
4647|NCT04168086|Ultrasound|ultrasound
4648|NCT04168086|Neuromodulation|neuromodulation
4649|NCT04168086|Cerebellum|cerebellum
4650|NCT04168086|Transcranial Ultrasound Stimulation|transcranial ultrasound stimulation
4651|NCT04168073|low sodium diet|low sodium diet
4652|NCT04168073|high sodium diet|high sodium diet
4653|NCT04168073|biomarker|biomarker
4654|NCT04168073|aldosterone|aldosterone
4655|NCT04168073|mineralocorticoid|mineralocorticoid
9765|NCT04137692|G1D|g1d
4656|NCT04168073|mineralocorticoid receptor|mineralocorticoid receptor
4657|NCT04168060|sleeve gastrectomy|sleeve gastrectomy
4658|NCT04168060|crura dissection|crura dissection
4659|NCT04168060|bariatric surgery|bariatric surgery
4660|NCT04168047|visceral hypersensitivity|visceral hypersensitivity
4661|NCT04168047|Insomnia|insomnia
4662|NCT04167995|Hyperactivity|hyperactivity
4663|NCT04167995|Inattention|inattention
4664|NCT04167995|Probiotics|probiotics
4665|NCT04167982|Acne|acne
4666|NCT04167982|low-dose isotretinoin|low-dose isotretinoin
4667|NCT04167982|Photodynamic Therapy|photodynamic therapy
4668|NCT04167982|Painless|painless
4669|NCT04167969|Molecular Phenotyping|molecular phenotyping
4670|NCT04167969|Ultrasmall Silica Nanoparticles|ultrasmall silica nanoparticles
4671|NCT04167969|PET/MRI|pet/mri
4672|NCT04167969|64Cu-NOTA-PSMA-PEG-Cy5.5-C' dot tracer|64cu-nota-psma-peg-cy5.5-c' dot tracer
4673|NCT04167969|19-333|19-333
4674|NCT04167956|lumbar sympathetic|lumbar sympathetic
4675|NCT04167956|ultrasound|ultrasound
4682|NCT04167930|traffic accident|traffic accident
4683|NCT04167930|traditional Korean medicine|traditional korean medicine
4684|NCT04167930|car insurance|car insurance
4685|NCT04167930|whiplash injury|whiplash injury
4686|NCT04167904|Troponin I|troponin i
4687|NCT04167904|Myocardial Infarction|myocardial infarction
4688|NCT04167904|Sensitivity and Specificity|sensitivity and specificity
4689|NCT04167904|Receiver operation characteristics curve|receiver operation characteristics curve
4690|NCT04167904|Biomarkers|biomarkers
4691|NCT04167891|cardiac arrest|cardiac arrest
4692|NCT04167891|hypothermia induced|hypothermia induced
4693|NCT04167891|intensive care unit|intensive care unit
4694|NCT04167865|Pectus Excavatum|pectus excavatum
4695|NCT04167865|Orthosis|orthosis
4696|NCT04167865|Exercise|exercise
4697|NCT04167852|Pain|pain
4698|NCT04167852|postoperative|postoperative
4699|NCT04167852|meditation|meditation
4700|NCT04167852|opioid use|opioid use
4701|NCT04167852|bariatric|bariatric
4702|NCT04167800|Pectus Carinatum|pectus carinatum
4703|NCT04167800|orthosis|orthosis
4704|NCT04167800|exercise|exercise
4713|NCT04167709|postpartum depression|postpartum depression
4714|NCT04167709|immigrant women|immigrant women
4715|NCT04167709|Child Health Services|child health services
4716|NCT04167709|nurse|nurse
4717|NCT04167709|Edinburgh Postnatal Depression Scale|edinburgh postnatal depression scale
4718|NCT04167683|Muscle mass|muscle mass
4719|NCT04167683|Muscle strength|muscle strength
4720|NCT04167683|Complications|complications
4721|NCT04167683|Patient reported outcomes|patient reported outcomes
4722|NCT04167683|PRO|pro
4723|NCT04167683|Physical function|physical function
4724|NCT04167683|hematopoietic stem cell transplant|hematopoietic stem cell transplant
4725|NCT04167670|Vonoprazan|vonoprazan
4726|NCT04167670|Lansoprazole|lansoprazole
4727|NCT04167657|Advanced non-small cell lung cancer|advanced non-small cell lung cancer
4728|NCT04167657|Immunotherapy|immunotherapy
4729|NCT04167657|Radiation|radiation
4730|NCT04167657|PD-1|pd-1
4731|NCT04167657|Sintilimab|sintilimab
4732|NCT04167644|ICH, Hypertension, GCS , and mRS.|ich, hypertension, gcs , and mrs.
4733|NCT04167631|VI-RADS|vi-rads
4734|NCT04167631|Multiparametric MRI|multiparametric mri
4735|NCT04167631|Non-muscle invasive bladder cancer (NMIBC)|non-muscle invasive bladder cancer (nmibc)
4736|NCT04167631|Muscle invasive bladder cancer (MIBC)|muscle invasive bladder cancer (mibc)
4737|NCT04167605|Breast cancer|breast cancer
4738|NCT04167605|Bone metastases|bone metastases
4739|NCT04167605|SENP1|senp1
4740|NCT04167592|propofol|propofol
4741|NCT04167592|benzydamine hydrochloride|benzydamine hydrochloride
4742|NCT04167592|sore throat|sore throat
4743|NCT04167592|Endoscopic Retrograde Cholangiopancreatography|endoscopic retrograde cholangiopancreatography
4744|NCT04167566|Impact|impact
4745|NCT04167566|mass testing|mass testing
4746|NCT04167566|treatment|treatment
4747|NCT04167566|tracking|tracking
4748|NCT04167566|Malaria prevalence|malaria prevalence
4749|NCT04167566|Children|children
4750|NCT04167566|Pakro Ghana|pakro ghana
4759|NCT04167527|Immediate Mechanical Thrombectomy|immediate mechanical thrombectomy
4760|NCT04167527|Initial medical management|initial medical management
4761|NCT04167527|Large vessel occlusion|large vessel occlusion
4762|NCT04167527|Efficacy|efficacy
4763|NCT04167527|Safety|safety
4764|NCT04167501|cervical precancerous lesion|cervical precancerous lesion
4765|NCT04167501|HPV|hpv
4766|NCT04167501|vaccination|vaccination
4767|NCT04167501|Impact study|impact study
4768|NCT04167501|France|france
4769|NCT04167475|Bifidobacterium longum 1714™|bifidobacterium longum 1714™
4770|NCT04167475|probiotic|probiotic
4771|NCT04167475|sleep quality|sleep quality
4772|NCT04167475|PSQI|psqi
4773|NCT04167475|actigraphy|actigraphy
4774|NCT04167475|sleep latency|sleep latency
4775|NCT04167475|sleep efficiency|sleep efficiency
4776|NCT04167436|Prehabilitation|prehabilitation
4777|NCT04167436|Colon cancer|colon cancer
4778|NCT04167436|WHO performance status|who performance status
4779|NCT04167436|Rectal cancer|rectal cancer
4780|NCT04167436|Exercise|exercise
4781|NCT04167436|Nutritional supplement|nutritional supplement
4782|NCT04167423|quality of life|quality of life
4783|NCT04167423|EQ5D|eq5d
4784|NCT04167423|ThyPRO-39|thypro-39
4785|NCT04167423|pregnancy|pregnancy
4786|NCT04167423|thyroid disease|thyroid disease
4787|NCT04167423|thyrotropin|thyrotropin
4788|NCT04167423|thyroxine|thyroxine
4789|NCT04167423|thyroid autoantibodies|thyroid autoantibodies
4790|NCT04167410|Perioperative glycaemic management|perioperative glycaemic management
4791|NCT04167410|Nursing|nursing
4792|NCT04167410|Glycaemic protocol|glycaemic protocol
4793|NCT04167410|Glycaemic management|glycaemic management
4794|NCT04167410|Stress hyperglycaemia|stress hyperglycaemia
4795|NCT04167410|Surgery and diabetes|surgery and diabetes
4796|NCT04167397|Collaborative learning|collaborative learning
4797|NCT04167358|Linerixibat|linerixibat
4798|NCT04167358|Cholestasis|cholestasis
4799|NCT04167358|Cholestatic pruritus|cholestatic pruritus
4800|NCT04167358|Primary biliary cholangitis|primary biliary cholangitis
4801|NCT04167332|Non-muscle-invasive bladder cancer|non-muscle-invasive bladder cancer
4802|NCT04167332|Progression|progression
4803|NCT04167332|Recurrence|recurrence
4804|NCT04167332|Registry|registry
4805|NCT04167332|Prospective|prospective
4812|NCT04167293|PD-1|pd-1
4813|NCT04167293|stereotactic body radiotherapy|stereotactic body radiotherapy
4814|NCT04167280|ipratropium bromide|ipratropium bromide
4815|NCT04167280|methacholine PD20|methacholine pd20
4816|NCT04167280|tolerance|tolerance
4817|NCT04167241|Right Ventricle Disfunction|right ventricle disfunction
4818|NCT04167241|Pneumonectomy|pneumonectomy
4819|NCT04167241|Echocardiography|echocardiography
4820|NCT04167228|ceftazidime / avibactam|ceftazidime / avibactam
4821|NCT04167228|carbapenem resistant enterobacteria|carbapenem resistant enterobacteria
4822|NCT04167176|Cholecystectomy|cholecystectomy
4823|NCT04167176|ESP block|esp block
4824|NCT04167176|Port Site Infiltration|port site infiltration
4825|NCT04167150|osteoporosis|osteoporosis
4826|NCT04167150|biomarkers|biomarkers
4827|NCT04167150|tart cherry|tart cherry
4828|NCT04167150|functional food|functional food
4829|NCT04167137|solid tumor|solid tumor
4830|NCT04167098|Platelet-Rich Plasma|platelet-rich plasma
4831|NCT04167098|Trigger Finger|trigger finger
4832|NCT04167085|Epistaxis|epistaxis
4833|NCT04167085|Hereditary Hemorrhagic Telangiectasia|hereditary hemorrhagic telangiectasia
4834|NCT04167085|HHT|hht
4835|NCT04167085|Doxycycline|doxycycline
4836|NCT04167085|Nosebleed|nosebleed
4837|NCT04167059|Sedentary behaviour|sedentary behaviour
4838|NCT04167059|Physical activity|physical activity
4839|NCT04167059|Quality of life|quality of life
4840|NCT04167059|Telehealth|telehealth
4841|NCT04167033|Premature ovarian insufficiency|premature ovarian insufficiency
4842|NCT04167033|QTc|qtc
4843|NCT04167033|Torsade de pointe|torsade de pointe
4844|NCT04167033|Hormone replacement therapy|hormone replacement therapy
4845|NCT04167020|Muscle aging|muscle aging
4846|NCT04167020|Hip fracture|hip fracture
4847|NCT04167007|Pancreatic adenocarcinoma|pancreatic adenocarcinoma
4848|NCT04167007|Metastasis|metastasis
4849|NCT04167007|Gemcitabine|gemcitabine
4850|NCT04167007|FOLFOX|folfox
4851|NCT04167007|first-line|first-line
4852|NCT04166994|Diet|diet
4853|NCT04166994|Exercise|exercise
4854|NCT04166968|transcranial direct current stimulation|transcranial direct current stimulation
4855|NCT04166968|stroke rehabilitation|stroke rehabilitation
4856|NCT04166903|Prolonged exercise, marathon, cardiovascular disease, long term|prolonged exercise, marathon, cardiovascular disease, long term
4857|NCT04166890|Articaine|articaine
4858|NCT04166890|IANB|ianb
4859|NCT04166890|Third molar surgery|third molar surgery
4860|NCT04166890|Non-inferiority|non-inferiority
4861|NCT04166890|Local anesthesia|local anesthesia
4862|NCT04166877|magnesium sulfate|magnesium sulfate
4863|NCT04166877|trauma|trauma
4864|NCT04166877|acute pain|acute pain
4865|NCT04166864|Depression|depression
4866|NCT04166864|TMS|tms
4867|NCT04166851|Pre-exposure prophylaxis|pre-exposure prophylaxis
4868|NCT04166851|Health Promotion|health promotion
4869|NCT04166851|HIV/AIDS primary prevention|hiv/aids primary prevention
4870|NCT04166851|men who have sex with men|men who have sex with men
4871|NCT04166851|Neuroimaging|neuroimaging
4872|NCT04166825|coagulation|coagulation
4873|NCT04166825|fibrinolysis|fibrinolysis
4874|NCT04166825|ovarian hyperstimulation|ovarian hyperstimulation
4875|NCT04166825|infertility|infertility
4876|NCT04166812|small airway disease|small airway disease
4877|NCT04166812|peripheral airway tone|peripheral airway tone
4878|NCT04166799|Barrier Film|barrier film
4879|NCT04166799|Mepitel|mepitel
4880|NCT04166799|Quality of life|quality of life
798507|NCT00259857|Fracture|fracture
4881|NCT04166799|Radiation Dermatitis|radiation dermatitis
4882|NCT04166799|Skin toxicity|skin toxicity
4883|NCT04166786|Testosterone|testosterone
4884|NCT04166786|Ethanol|ethanol
4885|NCT04166786|Anti-doping control|anti-doping control
4886|NCT04166786|Athletic performance|athletic performance
4892|NCT04166734|Advanced malignant pleural mesothelioma|advanced malignant pleural mesothelioma
4893|NCT04166734|mesothelioma|mesothelioma
4894|NCT04166734|pembrolizumab|pembrolizumab
4895|NCT04166734|radiotherapy|radiotherapy
4896|NCT04166734|SBRT|sbrt
4897|NCT04166734|External Beam Stereotactic Body Radiotherapy|external beam stereotactic body radiotherapy
4898|NCT04166708|Professional Flamenco Dancer|professional flamenco dancer
4899|NCT04166708|Footwork step|footwork step
4900|NCT04166708|Ground Reaction Force|ground reaction force
4901|NCT04166708|Center of mass|center of mass
4902|NCT04166656|Meningococcal B vaccine|meningococcal b vaccine
4903|NCT04166656|vaccine strategies|vaccine strategies
4904|NCT04166656|splenectomized individuals|splenectomized individuals
4905|NCT04166630|Biofeedback|biofeedback
4910|NCT04166604|G-CSF|g-csf
4911|NCT04166604|neutropenia|neutropenia
4912|NCT04166552|Scleroderma|scleroderma
4913|NCT04166552|Systemic sclerosis|systemic sclerosis
4914|NCT04166552|EHP-101 Oral Solution|ehp-101 oral solution
4915|NCT04166539|Revision Surgery|revision surgery
4916|NCT04166539|Hip|hip
4917|NCT04166539|Knee|knee
4918|NCT04166539|Metals|metals
4919|NCT04166539|Metallosis|metallosis
4920|NCT04166539|Toxicity|toxicity
4921|NCT04166526|Sickle Cell|sickle cell
4922|NCT04166526|MRI|mri
4923|NCT04166526|Near Infrared Spectroscopy (NIRS)|near infrared spectroscopy (nirs)
4924|NCT04166513|tDCS|tdcs
4925|NCT04166513|treatment|treatment
4926|NCT04166513|brain stimulation|brain stimulation
4927|NCT04166500|Induced abortion|induced abortion
4928|NCT04166500|Uterine adhesions|uterine adhesions
4929|NCT04166500|Reproductive infertility|reproductive infertility
4930|NCT04166500|Hysteroscopy|hysteroscopy
4931|NCT04166487|NSCLC Stage IV|nsclc stage iv
4932|NCT04166487|Metastatic Non-Small Cell Lung Cancer|metastatic non-small cell lung cancer
4933|NCT04166461|Mucosal impedance|mucosal impedance
4934|NCT04166461|Sleeve gastrectomy|sleeve gastrectomy
4935|NCT04166461|GERD|gerd
4936|NCT04166396|resveratrol|resveratrol
4937|NCT04166396|nicotinamide riboside|nicotinamide riboside
4938|NCT04166396|exercise intolerance|exercise intolerance
4943|NCT04166370|Bangladesh|bangladesh
4944|NCT04166370|Multisectoral|multisectoral
4945|NCT04166370|Cash Transfer|cash transfer
4946|NCT04166370|Randomized|randomized
4947|NCT04166357|Guillain Barre Syndrome, neuromuscular ultrasound|guillain barre syndrome, neuromuscular ultrasound
4948|NCT04166331|sepsis|sepsis
4949|NCT04166331|Cardiomyopathies|cardiomyopathies
4950|NCT04166331|Hypoperfusion|hypoperfusion
4951|NCT04166331|Left Ventricular Systolic Dysfunction|left ventricular systolic dysfunction
4952|NCT04166305|Epilepsy, genetic and drug resistant|epilepsy, genetic and drug resistant
4953|NCT04166292|augmentation|augmentation
4954|NCT04166292|restoration|restoration
4955|NCT04166292|dermal filler|dermal filler
4956|NCT04166292|face|face
4957|NCT04166292|cheekbone|cheekbone
4958|NCT04166292|chin|chin
4959|NCT04166292|mandibular angle|mandibular angle
4960|NCT04166292|hyaluronic acid|hyaluronic acid
4961|NCT04166279|Breast Cancer|breast cancer
4962|NCT04166279|Pain Chronic and Postoperative|pain chronic and postoperative
4963|NCT04166279|Lymphedema|lymphedema
4964|NCT04166279|Posture|posture
4965|NCT04166279|Target - Reaching movement|target - reaching movement
4966|NCT04166279|Breast surgery|breast surgery
4967|NCT04166279|Functional impotence|functional impotence
4968|NCT04166279|Rehabilitive treatment|rehabilitive treatment
4969|NCT04166279|Physiotherapy|physiotherapy
4970|NCT04166279|Scapula tilting|scapula tilting
4971|NCT04166266|fibrosis|fibrosis
4972|NCT04166266|bulevirtide|bulevirtide
4973|NCT04166266|safety|safety
4974|NCT04166266|efficacy|efficacy
4975|NCT04166240|Diagnostic Errors|diagnostic errors
4976|NCT04166240|Quality Improvement|quality improvement
4977|NCT04166240|Patient Safety|patient safety
4978|NCT04166240|Delayed Diagnosis|delayed diagnosis
4979|NCT04166227|Hip Scope|hip scope
4980|NCT04166227|Total Hip Replacement|total hip replacement
4981|NCT04166162|Underage Drinking|underage drinking
4982|NCT04166136|musculoskeletal pain|musculoskeletal pain
4983|NCT04166136|physiotherapy|physiotherapy
4984|NCT04166136|military|military
4985|NCT04166136|running|running
4986|NCT04166123|frailty|frailty
4987|NCT04166123|older adults|older adults
4988|NCT04166123|instrument|instrument
4989|NCT04166123|community|community
4990|NCT04166110|community-acquired pneumonia|community-acquired pneumonia
4991|NCT04166110|antibiotic therapy duration strategy|antibiotic therapy duration strategy
4992|NCT04166110|non-inferiority trial|non-inferiority trial
4993|NCT04166084|lipedema|lipedema
4994|NCT04166084|postural stability|postural stability
4995|NCT04166084|trunk stabilization exercises|trunk stabilization exercises
4996|NCT04166071|social support|social support
4997|NCT04166071|fear extinction|fear extinction
4998|NCT04166019|first-onset psychosis|first-onset psychosis
4999|NCT04166019|randomized controlled trial|randomized controlled trial
5000|NCT04166019|peer support|peer support
5001|NCT04166019|self management|self management
5002|NCT04166019|recovery|recovery
5003|NCT04166019|re-hospitalization|re-hospitalization
5004|NCT04166006|Head Neck Tumors|head neck tumors
5005|NCT04166006|Neuroendocrine Tumors|neuroendocrine tumors
5006|NCT04166006|Soft Tissue Sarcoma|soft tissue sarcoma
5007|NCT04166006|rare cancer|rare cancer
5008|NCT04166006|vaccination|vaccination
5009|NCT04166006|autologous dendritic cells|autologous dendritic cells
5010|NCT04166006|adjuvant|adjuvant
5011|NCT04166006|Interleukin-2|interleukin-2
5012|NCT04165967|Tumor-infiltrating Lymphocyte (TIL) Transfer|tumor-infiltrating lymphocyte (til) transfer
5013|NCT04165967|Nivolumab|nivolumab
5014|NCT04165967|metastatic melanoma|metastatic melanoma
5015|NCT04165967|anti-PD-1 therapy|anti-pd-1 therapy
5016|NCT04165967|failed immunotherapy|failed immunotherapy
5017|NCT04165967|personalized Investigational Medicinal Product (IMP)|personalized investigational medicinal product (imp)
5018|NCT04165941|Newly diagnosed brain tumor|newly diagnosed brain tumor
5019|NCT04165941|Phase 1|phase 1
5020|NCT04165941|Drug Resistant Immunotherapy|drug resistant immunotherapy
5021|NCT04165941|Temozolomide|temozolomide
5022|NCT04165928|neonatal tetanus|neonatal tetanus
5023|NCT04165928|tetanus immunization program|tetanus immunization program
5024|NCT04165928|drug-induced|drug-induced
5025|NCT04165928|tetanus antitoxin|tetanus antitoxin
5026|NCT04165928|critical care medicine|critical care medicine
5027|NCT04165928|artificial airway|artificial airway
5028|NCT04165915|Aged of 60 years and more|aged of 60 years and more
5029|NCT04165915|living in the Est-Héraultais territory|living in the est-héraultais territory
5030|NCT04165915|seniors'health paths|seniors'health paths
5031|NCT04165915|PAERPA|paerpa
5032|NCT04165902|knee osteoarthritis, hyaluronic acid, steroid, dextrose|knee osteoarthritis, hyaluronic acid, steroid, dextrose
5033|NCT04165889|hospitalized in internal medicine unit|hospitalized in internal medicine unit
5034|NCT04165889|adult patient|adult patient
5035|NCT04165889|Medication Error|medication error
5036|NCT04165889|Clinical Pharmacist|clinical pharmacist
5037|NCT04165876|tDCS|tdcs
5038|NCT04165876|HD-tDCS|hd-tdcs
5039|NCT04165876|Somatosensory function|somatosensory function
5040|NCT04165876|QST|qst
5041|NCT04165876|quantitative sensory testing|quantitative sensory testing
5042|NCT04165876|Non-invasive brain stimulation|non-invasive brain stimulation
5043|NCT04165876|NIBS|nibs
5044|NCT04165876|Transcranial Direct Current Stimulation|transcranial direct current stimulation
5045|NCT04165811|bariatric surgey|bariatric surgey
5046|NCT04165811|morbid obesity|morbid obesity
5047|NCT04165811|aerobic exercise|aerobic exercise
5048|NCT04165811|lower extremity functions|lower extremity functions
5049|NCT04165798|Programmed Cell Death-1 (PD1, PD-1)|programmed cell death-1 (pd1, pd-1)
5050|NCT04165798|Programmed Death-Ligand 1 (PDL1, PD-L1)|programmed death-ligand 1 (pdl1, pd-l1)
5051|NCT04165785|Optimal pulsed technology intense pulsed light|optimal pulsed technology intense pulsed light
5052|NCT04165785|meibomian gland dysfunction|meibomian gland dysfunction
5053|NCT04165785|demodicosis|demodicosis
5054|NCT04165785|Dry Eye Disease|dry eye disease
5055|NCT04165772|PD1 blockade|pd1 blockade
5056|NCT04165772|TSR-042|tsr-042
5057|NCT04165772|Radiation|radiation
5058|NCT04165772|Capecitabine|capecitabine
5059|NCT04165772|5-FU|5-fu
5060|NCT04165772|19-288|19-288
5061|NCT04165746|Brazil|brazil
5062|NCT04165746|children|children
5063|NCT04165746|foster care|foster care
5064|NCT04165746|institutionalization|institutionalization
5065|NCT04165746|attachment|attachment
5066|NCT04165746|brain function|brain function
5067|NCT04165746|language|language
5068|NCT04165746|growth|growth
5069|NCT04165746|Intelligence Quotient (IQ)|intelligence quotient (iq)
5070|NCT04165746|early intervention|early intervention
5071|NCT04165733|Professional quality of life|professional quality of life
5072|NCT04165733|Compassion satisfaction|compassion satisfaction
5073|NCT04165733|Burnout|burnout
5074|NCT04165733|Psychiatrists|psychiatrists
5075|NCT04165733|Mental disorders|mental disorders
5076|NCT04165733|Mental health|mental health
5077|NCT04165720|Physical Activity|physical activity
5078|NCT04165720|Mental Disorder|mental disorder
5079|NCT04165720|Recommendation Behaviour|recommendation behaviour
5080|NCT04165720|Mental Health|mental health
5081|NCT04165720|Exercise|exercise
5082|NCT04165707|diet|diet
5083|NCT04165707|weight loss|weight loss
5084|NCT04165707|ketogenic diet|ketogenic diet
5085|NCT04165707|low carbohydrate|low carbohydrate
400490|NCT01866657|cerebral oximetry|cerebral oximetry
5086|NCT04165694|weight loss failure, laparoscopic sleeve gastrectomy|weight loss failure, laparoscopic sleeve gastrectomy
5087|NCT04165681|Adolescence|adolescence
5088|NCT04165681|Cognitive Behavioral Therapy|cognitive behavioral therapy
5089|NCT04165681|Virtual Reality|virtual reality
5090|NCT04165681|Depression|depression
5091|NCT04165681|Behavioral Activation|behavioral activation
5092|NCT04165655|Autism spectrum condition|autism spectrum condition
5094|NCT04165655|Children and young people|children and young people
5095|NCT04165655|Social skills|social skills
5096|NCT04165655|Problem behaviours|problem behaviours
5097|NCT04165655|Activity intervention|activity intervention
5098|NCT04165655|Wellbeing|wellbeing
5099|NCT04165655|Self image|self image
5100|NCT04165655|Social connectedness|social connectedness
5101|NCT04165642|laser ballon ablation|laser ballon ablation
5102|NCT04165642|laser ballon|laser ballon
5103|NCT04165642|pulmonary vein isolation|pulmonary vein isolation
5104|NCT04165642|atrial fibrillation|atrial fibrillation
5105|NCT04165642|paroxysmal AF|paroxysmal af
5106|NCT04165642|persistent AF|persistent af
5107|NCT04165642|AF ablation|af ablation
5108|NCT04165590|advanced malignant solid tumor|advanced malignant solid tumor
5109|NCT04165590|Plasmodium immunotherapy|plasmodium immunotherapy
5110|NCT04165590|Plasmodiun vivax|plasmodiun vivax
5111|NCT04165564|Indeterminate pulmonary nodules|indeterminate pulmonary nodules
5112|NCT04165564|Molecular biomarkers for lung cancer diagnosis|molecular biomarkers for lung cancer diagnosis
5113|NCT04165564|Imaging for lung cancer diagnosis|imaging for lung cancer diagnosis
5114|NCT04165564|High risk smokers|high risk smokers
5115|NCT04165551|Streptococcus agalactiae|streptococcus agalactiae
5116|NCT04165551|ProbioticsPrevention|probioticsprevention
5117|NCT04165538|Hip Fracture|hip fracture
5118|NCT04165538|Clopidogrel|clopidogrel
5119|NCT04165538|Withdrawal|withdrawal
5120|NCT04165538|surgical timing|surgical timing
5121|NCT04165538|Thromboelastogram|thromboelastogram
5122|NCT04165525|comparison of ablation devices|comparison of ablation devices
5123|NCT04165512|lymphedema|lymphedema
5124|NCT04165512|breast cancer|breast cancer
5125|NCT04165512|stellate ganglion|stellate ganglion
5126|NCT04165512|treatment|treatment
5127|NCT04165512|ultrasound|ultrasound
5128|NCT04165499|Hyperuricemia|hyperuricemia
5129|NCT04165499|Plant extracts|plant extracts
5130|NCT04165473|Training Program|training program
5131|NCT04165473|Personal Resources|personal resources
5132|NCT04165473|Social Resources|social resources
5133|NCT04165473|Adults|adults
5134|NCT04165473|Emotional Wellbeing|emotional wellbeing
5135|NCT04165473|Physical Wellbeing|physical wellbeing
5136|NCT04165473|Social Wellbeing|social wellbeing
5137|NCT04165473|Perceived Stress|perceived stress
5138|NCT04165473|Satisfaction with Life|satisfaction with life
5139|NCT04165473|Health Behavior|health behavior
5140|NCT04165473|Quality of Relationships|quality of relationships
5141|NCT04165473|Health Status|health status
5142|NCT04165473|Sense of Coherence|sense of coherence
5143|NCT04165473|Life Goals|life goals
5144|NCT04165473|Meaning in Life|meaning in life
5145|NCT04165473|Transcendence|transcendence
5146|NCT04165473|Evaluation|evaluation
5147|NCT04165460|Cervical cancer|cervical cancer
5148|NCT04165460|Quality of life|quality of life
5149|NCT04165460|Coping|coping
5150|NCT04165460|Distress|distress
5151|NCT04165460|Anxiety|anxiety
5152|NCT04165460|Depression|depression
5153|NCT04165460|Therapeutic adherence|therapeutic adherence
5154|NCT04165460|Sexual Satisfaction|sexual satisfaction
5155|NCT04165447|nutrition|nutrition
5156|NCT04165447|front-of-pack label|front-of-pack label
5157|NCT04165447|calories|calories
5158|NCT04165447|online grocery store|online grocery store
5159|NCT04165447|diet|diet
5160|NCT04165447|groceries|groceries
5161|NCT04165447|obesity|obesity
5162|NCT04165434|Concurrent Training|concurrent training
5163|NCT04165434|Rehabilitation|rehabilitation
5164|NCT04165395|Pressure Ulcers|pressure ulcers
5165|NCT04165395|Pressure Injury|pressure injury
5166|NCT04165395|Spinal Cord Injury|spinal cord injury
5167|NCT04165395|Prophylactic|prophylactic
5168|NCT04165395|Dressing|dressing
5169|NCT04165382|nurse care|nurse care
5170|NCT04165382|non-invasive ventilation|non-invasive ventilation
5171|NCT04165382|preterm infants|preterm infants
5172|NCT04165369|Acute kidney injury|acute kidney injury
5173|NCT04165369|injury|injury
5174|NCT04165369|surgery|surgery
5175|NCT04165356|Chlorhexidine mouthwashes|chlorhexidine mouthwashes
5176|NCT04165356|chlorhexidine efficacy|chlorhexidine efficacy
5177|NCT04165356|artificial respiration|artificial respiration
5178|NCT04165356|cross infection|cross infection
5179|NCT04165356|ventilator-associated pneumonia|ventilator-associated pneumonia
5180|NCT04165317|PF-06801591, Bacillus Calmette Guerin, BCG, bladder cancer|pf-06801591, bacillus calmette guerin, bcg, bladder cancer
5181|NCT04165278|Parkinson's disease, temperature, hyperthermic baths|parkinson's disease, temperature, hyperthermic baths
5182|NCT04165265|Hospitalization|hospitalization
5183|NCT04165265|Reduction in stay|reduction in stay
5184|NCT04165265|Ulcerative Colitis|ulcerative colitis
5185|NCT04165265|Inflammatory Bowel Disease|inflammatory bowel disease
5186|NCT04165265|eHealth|ehealth
5187|NCT04165265|Colectomy|colectomy
5188|NCT04165265|Rescue therapy|rescue therapy
5189|NCT04165265|Infliximab|infliximab
5190|NCT04165252|Preterm birth|preterm birth
5191|NCT04165252|Microbiota|microbiota
5192|NCT04165252|Mycobiota|mycobiota
5193|NCT04165252|Short Cervix|short cervix
5194|NCT04165252|Progesterone|progesterone
5195|NCT04165239|Mitochondrial|mitochondrial
5196|NCT04165239|Oxidative Phosphorylation (OXPHOS)|oxidative phosphorylation (oxphos)
5197|NCT04165239|MELAS|melas
5198|NCT04165239|MIDD|midd
5199|NCT04165239|KH176|kh176
5200|NCT04165226|Stria alba|stria alba
5201|NCT04165226|Fractional CO2|fractional co2
5202|NCT04165226|Fractional carbon dioxide laser 00|fractional carbon dioxide laser 00
5205|NCT04165226|Infra red diode laser|infra red diode laser
5206|NCT04165226|808 nm|808 nm
5207|NCT04165226|915 nm|915 nm
5208|NCT04165226|10600 nm|10600 nm
5209|NCT04165200|HIV infection, fecal microbiota transplantation|hiv infection, fecal microbiota transplantation
5210|NCT04165187|knee osteoarthritis|knee osteoarthritis
5211|NCT04165187|body awareness therapy|body awareness therapy
5212|NCT04165187|pain|pain
5213|NCT04165187|functional capacity|functional capacity
5214|NCT04165174|HCC|hcc
5215|NCT04165174|PVTT|pvtt
5216|NCT04165174|PD-1|pd-1
5217|NCT04165174|Apatinib|apatinib
5218|NCT04165174|SBRT|sbrt
5219|NCT04165148|Low Impact Laparoscopy|low impact laparoscopy
5220|NCT04165148|laparoscopy|laparoscopy
5221|NCT04165148|hysterectomy|hysterectomy
5222|NCT04165148|ambulatory|ambulatory
5223|NCT04165135|Hemophilia A|hemophilia a
5224|NCT04165135|Factor VIII|factor viii
5225|NCT04165122|Herpes Genitalis|herpes genitalis
5226|NCT04165109|Trial-Ready Cohort|trial-ready cohort
5227|NCT04165109|Observational|observational
5228|NCT04165109|Alzheimer's|alzheimer's
5229|NCT04165109|Prevention|prevention
5230|NCT04165109|Down Syndrome|down syndrome
5231|NCT04165096|Programmed Cell Death Receptor 1 (PD-1, PD1)|programmed cell death receptor 1 (pd-1, pd1)
5232|NCT04165096|Programmed Cell Death Receptor Ligand 1 (PD-L1, PDL1)|programmed cell death receptor ligand 1 (pd-l1, pdl1)
5233|NCT04165096|Programmed Cell Death Receptor Ligand 2 (PD-L2, PDL2)|programmed cell death receptor ligand 2 (pd-l2, pdl2)
5234|NCT04165083|Programmed Cell Death Receptor 1 (PD-1, PD1)|programmed cell death receptor 1 (pd-1, pd1)
5235|NCT04165083|Programmed Cell Death Receptor Ligand 1 (PD-L1, PDL1)|programmed cell death receptor ligand 1 (pd-l1, pdl1)
5236|NCT04165083|Programmed Cell Death Receptor Ligand 2 (PD-L2, PDL2)|programmed cell death receptor ligand 2 (pd-l2, pdl2)
5237|NCT04165070|Programmed Cell Death-1 (PD1, PD-1)|programmed cell death-1 (pd1, pd-1)
5238|NCT04165070|Programmed Death-Ligand 1 (PDL1, PD-L1)|programmed death-ligand 1 (pdl1, pd-l1)
5239|NCT04165057|Laparoscopic surgery|laparoscopic surgery
5240|NCT04165057|Optimal muscle tension|optimal muscle tension
5241|NCT04165057|Neuromuscular monitoring|neuromuscular monitoring
5242|NCT04165057|Neuromuscular blockade|neuromuscular blockade
5243|NCT04165057|Sugammadex|sugammadex
5244|NCT04165044|Leukocyte and Platelet Rich Fibrin|leukocyte and platelet rich fibrin
5245|NCT04165044|Connective tissue graft|connective tissue graft
5246|NCT04165044|Gingival recession|gingival recession
5247|NCT04165018|Pancreatic masses and lesions|pancreatic masses and lesions
5248|NCT04165005|elderly|elderly
5249|NCT04165005|MBSR|mbsr
5250|NCT04165005|cognitive functions|cognitive functions
5251|NCT04165005|psychological status|psychological status
5252|NCT04164992|endoscopic ultrasound radiofrequency ablation|endoscopic ultrasound radiofrequency ablation
5253|NCT04164979|Gastric Adenocarcinoma|gastric adenocarcinoma
5254|NCT04164979|Gastroesophageal Adenocarcinoma|gastroesophageal adenocarcinoma
5255|NCT04164979|Cabozantinib|cabozantinib
5256|NCT04164979|Pembrolizumab|pembrolizumab
5257|NCT04164914|intestinal gas|intestinal gas
5258|NCT04164914|healthy subjects|healthy subjects
5259|NCT04164914|microbiota|microbiota
5260|NCT04164914|prebiotics|prebiotics
5261|NCT04164901|vorasidenib|vorasidenib
5262|NCT04164875|fever|fever
5263|NCT04164875|epidural|epidural
5264|NCT04164875|birth|birth
5265|NCT04164875|labour|labour
5266|NCT04164862|AccuVein AV400 device|accuvein av400 device
5267|NCT04164862|ultrasound-guided cannulation|ultrasound-guided cannulation
5268|NCT04164849|Crohns Disease|crohns disease
5269|NCT04164849|Photopheresis|photopheresis
5270|NCT04164849|5-aminolevulinic acid|5-aminolevulinic acid
5271|NCT04164849|Gliolan|gliolan
5272|NCT04164849|UVA-PIT|uva-pit
5273|NCT04164836|epistaxis|epistaxis
5274|NCT04164836|rhinoscope|rhinoscope
5278|NCT04164810|Spinal cord injury|spinal cord injury
5279|NCT04164810|Neuropathic pain|neuropathic pain
5280|NCT04164810|Quality of life|quality of life
5281|NCT04164810|Catastrophization|catastrophization
5282|NCT04164797|endostar Esophageal Cancer|endostar esophageal cancer
5283|NCT04164771|Aerobic training|aerobic training
5284|NCT04164771|Moringa|moringa
5285|NCT04164771|Cardioprotection|cardioprotection
5286|NCT04164732|non-obstructive|non-obstructive
5287|NCT04164732|hypertrophic cardiomyopathy|hypertrophic cardiomyopathy
5288|NCT04164732|genetic cardiomyopathy|genetic cardiomyopathy
5289|NCT04164706|Colorectal Cancer|colorectal cancer
5290|NCT04164706|Colorectal Surgery|colorectal surgery
5291|NCT04164706|Laparoscopic|laparoscopic
5292|NCT04164706|Hypothermia|hypothermia
5293|NCT04164693|manitenance hemodialysis patients|manitenance hemodialysis patients
5294|NCT04164693|arteriovenous fistula operation|arteriovenous fistula operation
5295|NCT04164693|Thrombosis|thrombosis
5296|NCT04164693|anticoagulant therapy|anticoagulant therapy
5297|NCT04164693|Efficacy|efficacy
5298|NCT04164693|safety|safety
5299|NCT04164680|Disorder of Consciousness|disorder of consciousness
5300|NCT04164680|Unresponsive wakefulness syndrome|unresponsive wakefulness syndrome
5301|NCT04164680|Multimodal Neuroimaging|multimodal neuroimaging
5302|NCT04164667|Telehealth|telehealth
5303|NCT04164667|Veterans|veterans
5304|NCT04164667|Exercise|exercise
5305|NCT04164667|Mindfulness|mindfulness
5306|NCT04164667|Health Coaching|health coaching
5307|NCT04164628|quality of life|quality of life
5308|NCT04164628|depression|depression
5309|NCT04164628|anxiety|anxiety
5310|NCT04164628|social function|social function
5311|NCT04164602|new-onset diabetes mellitus|new-onset diabetes mellitus
5312|NCT04164602|pancreatic cancer|pancreatic cancer
5313|NCT04164602|biomarker|biomarker
5314|NCT04164602|screening|screening
5315|NCT04164576|Lung transplantation|lung transplantation
5316|NCT04164576|BKV|bkv
5317|NCT04164576|Nephropathy|nephropathy
5318|NCT04164576|Immunosuppression|immunosuppression
5319|NCT04164563|Joint pain|joint pain
5320|NCT04164563|Ankle fracture|ankle fracture
5321|NCT04164563|Leg length discrepancy|leg length discrepancy
5322|NCT04164563|CAM boot|cam boot
5323|NCT04164563|Even-Up|even-up
5324|NCT04164537|Hispanic Americans, Adolescent|hispanic americans, adolescent
5325|NCT04164524|SSI|ssi
5326|NCT04164524|Wound infection|wound infection
5327|NCT04164511|pediatric|pediatric
5328|NCT04164511|tonsillectomy|tonsillectomy
5329|NCT04164511|ice cream|ice cream
5330|NCT04164511|cryotherapy|cryotherapy
5331|NCT04164511|postoperative pain|postoperative pain
5332|NCT04164498|Noise ICU|noise icu
5333|NCT04164498|delirium|delirium
5334|NCT04164498|depression|depression
5335|NCT04164498|burnout|burnout
5336|NCT04164498|music|music
5337|NCT04164472|Relational Aggression|relational aggression
5338|NCT04164472|Aggression|aggression
5339|NCT04164472|Indicated intervention|indicated intervention
5340|NCT04164472|Universal prevention|universal prevention
5341|NCT04164472|School-based|school-based
5342|NCT04164472|Urban|urban
5343|NCT04164446|oil palm phenolics|oil palm phenolics
5344|NCT04164446|lipid profile|lipid profile
5345|NCT04164446|LDL cholesterol|ldl cholesterol
5346|NCT04164446|HDL cholesterol|hdl cholesterol
5347|NCT04164433|HIV self-testing|hiv self-testing
5348|NCT04164433|Men|men
5349|NCT04164433|Workplace|workplace
5350|NCT04164433|Security Services|security services
5351|NCT04164433|Linkage|linkage
5352|NCT04164420|Stroke|stroke
5353|NCT04164420|Dysphagia|dysphagia
5354|NCT04164420|Treatment|treatment
5355|NCT04164420|Intervention|intervention
5356|NCT04164407|Pseudophakic and aphakic bullous keratopathy|pseudophakic and aphakic bullous keratopathy
5357|NCT04164407|Ophthalmology|ophthalmology
5358|NCT04164407|Cornea|cornea
5359|NCT04164407|Keratoconus|keratoconus
5360|NCT04164407|Cornea transplant|cornea transplant
5361|NCT04164407|Corneal dystrophies|corneal dystrophies
5362|NCT04164407|Crosslinking|crosslinking
5363|NCT04164394|Probiotic|probiotic
5364|NCT04164394|Diarrhea|diarrhea
5365|NCT04164394|Abdominal pain|abdominal pain
5366|NCT04164394|Flatulence|flatulence
5367|NCT04164381|Rehabilitation|rehabilitation
5368|NCT04164381|Robotics|robotics
5369|NCT04164381|Cognitive Function|cognitive function
5370|NCT04164342|pain|pain
5371|NCT04164342|critically ill|critically ill
5372|NCT04164329|Neurotoxicity|neurotoxicity
5373|NCT04164329|anesthesia|anesthesia
5374|NCT04164329|Neurofilament Light|neurofilament light
5375|NCT04164316|Kinesio Taping|kinesio taping
5376|NCT04164316|Biomechanics|biomechanics
5377|NCT04164316|Iliotibial Band Friction Syndrome|iliotibial band friction syndrome
5378|NCT04164316|Clinical Outcomes|clinical outcomes
5379|NCT04164303|DeQuervain's tendinopathy|dequervain's tendinopathy
5380|NCT04164303|CMC manipulation|cmc manipulation
5381|NCT04164303|Physical Therapy|physical therapy
5382|NCT04164277|Obesity prevention, early childhood, intergenerational, family-based|obesity prevention, early childhood, intergenerational, family-based
5383|NCT04164264|Propofol|propofol
5384|NCT04164251|Breast Cancer Screening|breast cancer screening
5385|NCT04164251|Mammography|mammography
5386|NCT04164238|HNSCC|hnscc
5387|NCT04164238|PD-1 antibody|pd-1 antibody
5388|NCT04164238|Neoadjuvant|neoadjuvant
5389|NCT04164238|Major pathologic response|major pathologic response
5390|NCT04164160|Integrated care|integrated care
5391|NCT04164160|Health and social care|health and social care
5392|NCT04164160|Chronic disease|chronic disease
5393|NCT04164160|Primary Health Care|primary health care
5394|NCT04164160|Quality of life|quality of life
5395|NCT04164147|Total Knee Arthroplasty|total knee arthroplasty
5396|NCT04164147|Nexgen|nexgen
5397|NCT04164147|Persona|persona
5398|NCT04164147|Knee osteoarthritis|knee osteoarthritis
5399|NCT04164134|Retinoblastoma|retinoblastoma
5400|NCT04164134|blood test|blood test
5401|NCT04164134|liquid biopsy|liquid biopsy
5402|NCT04164134|RB1|rb1
5403|NCT04164134|cancer|cancer
6004|NCT04160871|relatives|relatives
5408|NCT04164121|Pharmacokinetic characteristics|pharmacokinetic characteristics
5411|NCT04164043|Community Based|community based
5412|NCT04164043|Movement Disorder|movement disorder
5413|NCT04164043|Wellness Recovery Program|wellness recovery program
5414|NCT04164030|low income adults|low income adults
5415|NCT04164030|feasibility pilot study|feasibility pilot study
5416|NCT04164030|occupational therapy|occupational therapy
5417|NCT04164030|nutrition education|nutrition education
5418|NCT04164030|yoga|yoga
5419|NCT04164004|Quality of life|quality of life
5420|NCT04164004|Patient-reported outcomes|patient-reported outcomes
5421|NCT04164004|Quality of care|quality of care
5422|NCT04164004|Implementation research|implementation research
5427|NCT04163978|nitric oxide, sinusitis|nitric oxide, sinusitis
5428|NCT04163939|Neck pain|neck pain
5429|NCT04163926|follow up|follow up
5430|NCT04163926|post surgery|post surgery
5431|NCT04163926|patient satisfaction|patient satisfaction
5432|NCT04163926|optometrist|optometrist
5433|NCT04163926|ophthalmologist|ophthalmologist
5434|NCT04163926|community care|community care
5435|NCT04163900|Adenocarcinoma|adenocarcinoma
5436|NCT04163900|Ampullary|ampullary
5437|NCT04163900|Antineoplastic Agents|antineoplastic agents
5438|NCT04163900|Biliary Tract Cancer|biliary tract cancer
5439|NCT04163900|Chemotherapy|chemotherapy
5440|NCT04163900|Cholangiocarcinoma|cholangiocarcinoma
5441|NCT04163900|Cisplatin|cisplatin
5442|NCT04163900|Digestive System Neoplasms|digestive system neoplasms
5443|NCT04163900|Distal Bile Duct|distal bile duct
5444|NCT04163900|Extrahepatic|extrahepatic
5445|NCT04163900|First-line Chemotherapy|first-line chemotherapy
5446|NCT04163900|Gallbladder|gallbladder
5447|NCT04163900|Gastrointestinal|gastrointestinal
5448|NCT04163900|Gemcitabine|gemcitabine
5449|NCT04163900|Hepatobiliary|hepatobiliary
5450|NCT04163900|Intrahepatic|intrahepatic
5451|NCT04163900|Locally advanced|locally advanced
5452|NCT04163900|Metastatic|metastatic
5453|NCT04163900|Neoplasm|neoplasm
5454|NCT04163900|NUC-1031|nuc-1031
5455|NCT04163900|ProTides|protides
5456|NCT04163900|Untreated|untreated
5457|NCT04163887|Liver resection|liver resection
5458|NCT04163887|Laparoscopy|laparoscopy
5459|NCT04163874|type 1 diabetes|type 1 diabetes
5460|NCT04163874|artificial pancreas|artificial pancreas
5461|NCT04163874|pramlintide|pramlintide
5462|NCT04163874|fiasp|fiasp
5463|NCT04163874|hyperglycemia|hyperglycemia
5464|NCT04163874|closed-loop|closed-loop
5465|NCT04163861|Heart failure with preserved ejection fraction|heart failure with preserved ejection fraction
5466|NCT04163861|global longitudinal strain|global longitudinal strain
5467|NCT04163861|2D speckle tracking echocardiography|2d speckle tracking echocardiography
5468|NCT04163861|subclinical systolic dysfunction|subclinical systolic dysfunction
5469|NCT04163861|GLS|gls
5470|NCT04163848|Desflurane|desflurane
5471|NCT04163848|Sevoflurane|sevoflurane
5472|NCT04163848|Fresh gas flow|fresh gas flow
5473|NCT04163848|Environment|environment
5474|NCT04163835|Wenxin Granules|wenxin granules
5475|NCT04163835|Dose-effect relationship|dose-effect relationship
5476|NCT04163835|Deficiency of both Qi and Yin Syndrome|deficiency of both qi and yin syndrome
5477|NCT04163835|Heart Vessel Stasis and Obstruction Syndrome|heart vessel stasis and obstruction syndrome
5478|NCT04163835|Traditional Chinese Medicine|traditional chinese medicine
5479|NCT04163835|arrhythmia|arrhythmia
5480|NCT04163822|bronchopulmonary dysplasia|bronchopulmonary dysplasia
5481|NCT04163822|fibrosis|fibrosis
5482|NCT04163822|cyst|cyst
5483|NCT04163822|radiograph|radiograph
5484|NCT04163809|virtual reality|virtual reality
5485|NCT04163809|anxiety|anxiety
5486|NCT04163809|pain|pain
5487|NCT04163809|regional anesthesia|regional anesthesia
5488|NCT04163783|Phase 1|phase 1
5489|NCT04163783|Pharmacokinetics|pharmacokinetics
5490|NCT04163783|Safety|safety
5491|NCT04163744|Induction of labour|induction of labour
5492|NCT04163744|Double balloon catheter|double balloon catheter
5493|NCT04163744|Vaginal delivery rate|vaginal delivery rate
5494|NCT04163744|Mechanical method|mechanical method
5495|NCT04163744|in-patient|in-patient
5496|NCT04163744|out-patient|out-patient
5497|NCT04163718|CLL|cll
5498|NCT04163705|Multiple organ dysfunctions|multiple organ dysfunctions
5499|NCT04163692|Muscle Relaxation|muscle relaxation
5500|NCT04163692|Pain|pain
5501|NCT04163692|Quality of Life|quality of life
5502|NCT04163666|Stroke|stroke
5503|NCT04163666|Upper member|upper member
5504|NCT04163666|Neurorehabilitation|neurorehabilitation
5505|NCT04163666|Mirror therapy|mirror therapy
5508|NCT04163627|Technical procedure for treatment of HCC: either liver transplantation, liver resection, thermal ablation, chemoembolization, or radioembolization|technical procedure for treatment of hcc: either liver transplantation, liver resection, thermal ablation, chemoembolization, or radioembolization
5509|NCT04163627|Chronic liver diseases|chronic liver diseases
5510|NCT04163627|Interventional Radiology|interventional radiology
5511|NCT04163627|Liver surgery|liver surgery
5512|NCT04163614|End Stage Renal Disease|end stage renal disease
5513|NCT04163614|Hypertension|hypertension
5514|NCT04163614|Extracellular Volume|extracellular volume
5515|NCT04163614|Intradialytic Hypotension|intradialytic hypotension
5516|NCT04163614|Bioimpedance Spectroscopy|bioimpedance spectroscopy
5517|NCT04163588|acute heart failure|acute heart failure
5518|NCT04163588|decongestion|decongestion
5520|NCT04163588|outcomes|outcomes
5521|NCT04163575|CAR-T|car-t
5522|NCT04163575|Leukemia|leukemia
5523|NCT04163575|lymphoma|lymphoma
5524|NCT04163523|Phase 1, pharmacokinetics safety|phase 1, pharmacokinetics safety
5525|NCT04163484|coronary artery disease|coronary artery disease
5526|NCT04163484|iodinated contrast media|iodinated contrast media
5527|NCT04163484|stable angina|stable angina
5528|NCT04163484|unstable angina|unstable angina
5529|NCT04163484|STEMI|stemi
5530|NCT04163484|NSTEMI|nstemi
5531|NCT04163484|PCI|pci
5532|NCT04163484|acute kidney injury|acute kidney injury
5533|NCT04163471|VasoStat|vasostat
5534|NCT04163471|TR Band|tr band
5535|NCT04163471|Transradial access|transradial access
5536|NCT04163471|Coronary angiography|coronary angiography
5537|NCT04163471|Peripheral arterial disease|peripheral arterial disease
5538|NCT04163471|Coronary artery disease|coronary artery disease
5539|NCT04163471|Peripheral angiography|peripheral angiography
5540|NCT04163471|Stents|stents
5543|NCT04163419|schwannoma|schwannoma
5544|NCT04163419|nerve growth factor|nerve growth factor
5545|NCT04163419|antibody|antibody
5546|NCT04163419|NGF|ngf
5547|NCT04163406|Anemia|anemia
5548|NCT04163406|Iron-deficiency|iron-deficiency
5549|NCT04163406|Iron absorption|iron absorption
5550|NCT04163406|Prebiotic|prebiotic
5551|NCT04163406|Galacto-oligosaccharides|galacto-oligosaccharides
5552|NCT04163406|Human milk oligosaccharides|human milk oligosaccharides
5553|NCT04163406|Infants|infants
5554|NCT04163406|Kenya|kenya
5555|NCT04163393|Coronary Artery Disease|coronary artery disease
5556|NCT04163393|Percutaneous Coronary Intervention|percutaneous coronary intervention
5557|NCT04163380|Estrogen|estrogen
5558|NCT04163380|Progesterone|progesterone
5559|NCT04163380|Menstrual Cycle|menstrual cycle
5560|NCT04163380|Resistance Training|resistance training
5561|NCT04163367|Parenting|parenting
5562|NCT04163367|Randomized controlled trial|randomized controlled trial
5563|NCT04163367|Parent-Child relations|parent-child relations
5564|NCT04163367|Social services|social services
5565|NCT04163367|Prevention|prevention
5566|NCT04163354|Pit and Fissure Sealant|pit and fissure sealant
5567|NCT04163354|Fluorides, Topical|fluorides, topical
5568|NCT04163328|HydroEye®|hydroeye®
5569|NCT04163328|Contact Lens Discomfort|contact lens discomfort
5570|NCT04163328|Dry Eye|dry eye
5571|NCT04163328|Supplement|supplement
5572|NCT04163302|Lymphoma|lymphoma
5573|NCT04163302|Chimeric antigen receptor T cell|chimeric antigen receptor t cell
5574|NCT04163302|Chimeric antigen receptor|chimeric antigen receptor
5575|NCT04163302|Immunotherapy|immunotherapy
5576|NCT04163302|PD-1|pd-1
5577|NCT04163302|CD19|cd19
5578|NCT04163276|neurodegenerative disease|neurodegenerative disease
5579|NCT04163276|digital brain PET exam|digital brain pet exam
5580|NCT04163276|database|database
5582|NCT04163263|acne|acne
5583|NCT04163250|Contrast media|contrast media
5584|NCT04163250|Urinary cell-cycle arrest biomarkers|urinary cell-cycle arrest biomarkers
5585|NCT04163250|Acute Kidney Injury|acute kidney injury
5586|NCT04163224|multiple rib fractures|multiple rib fractures
5587|NCT04163224|chest stabilization|chest stabilization
5588|NCT04163224|rib plates|rib plates
5589|NCT04163185|Migraine|migraine
5590|NCT04163185|AXS-07|axs-07
5591|NCT04163185|Meloxicam|meloxicam
5592|NCT04163185|Rizatriptan|rizatriptan
5593|NCT04163146|Asthma|asthma
5594|NCT04163146|Lung function variability|lung function variability
5595|NCT04163146|Children|children
5596|NCT04163146|Adolescents|adolescents
5597|NCT04163133|delay of trigger, ovarian stimulation, antagonist protocol, in vitro fertilization|delay of trigger, ovarian stimulation, antagonist protocol, in vitro fertilization
10857|NCT04130763|FMT|fmt
5598|NCT04163107|Drug Therapy|drug therapy
5599|NCT04163107|Administration and Dosage|administration and dosage
5600|NCT04163107|Hydroxychloroquine|hydroxychloroquine
5601|NCT04163107|Carfilzomib|carfilzomib
5602|NCT04163107|Dexamethasone|dexamethasone
6005|NCT04160871|dbt|dbt
5603|NCT04163107|Drug Therapy, Combination|drug therapy, combination
5604|NCT04163081|Nicotine Replacement Therapy|nicotine replacement therapy
5605|NCT04163081|Emergency Department|emergency department
5606|NCT04163081|Nicotine Dependence|nicotine dependence
5607|NCT04163081|Tobacco Abstinence|tobacco abstinence
5608|NCT04163081|Tobacco Treatment|tobacco treatment
5609|NCT04163081|Cigarette|cigarette
5610|NCT04163068|cancer|cancer
5611|NCT04163068|survivorship|survivorship
5612|NCT04163068|qualitative interviews|qualitative interviews
5613|NCT04163068|treatment burden|treatment burden
5614|NCT04163068|cancer aftercare|cancer aftercare
5615|NCT04163068|self management|self management
5616|NCT04163055|Diabetes|diabetes
5617|NCT04163055|Foot Ulcer|foot ulcer
5618|NCT04163055|Non-healing wound|non-healing wound
5619|NCT04163055|Targeted debridement|targeted debridement
5620|NCT04163042|Physical activity|physical activity
5621|NCT04163042|Behavioural support|behavioural support
5622|NCT04163042|Oncology|oncology
5623|NCT04163042|Telehealth|telehealth
5624|NCT04163042|Self-determination theory|self-determination theory
5625|NCT04163042|Behaviour change techniques|behaviour change techniques
5626|NCT04163042|Young adult cancer survivors|young adult cancer survivors
5627|NCT04163016|Cimzia|cimzia
5628|NCT04163016|Certolizumab Pegol|certolizumab pegol
5629|NCT04163016|Pregnant Women|pregnant women
5630|NCT04163016|Crohn's Disease (CD)|crohn's disease (cd)
5631|NCT04163016|Rheumatoid Arthritis (RA)|rheumatoid arthritis (ra)
5632|NCT04163016|Psoriatic Arthritis (PsA)|psoriatic arthritis (psa)
5633|NCT04163016|Plaque Psoriasis (PSO)|plaque psoriasis (pso)
5634|NCT04163016|Axial Spondyloarthritis (AxSpA)|axial spondyloarthritis (axspa)
5635|NCT04163016|Pharmacokinetics|pharmacokinetics
5636|NCT04163016|CZP|czp
5637|NCT04162990|Subjective Memory Complaint|subjective memory complaint
5638|NCT04162990|Alzheimer's disease|alzheimer's disease
5639|NCT04162990|mild cognitive impairment|mild cognitive impairment
5640|NCT04162990|Neuroinflammation|neuroinflammation
5641|NCT04162990|lifestyle|lifestyle
5642|NCT04162977|Substance Use and Misuse|substance use and misuse
5643|NCT04162977|Prevention|prevention
5644|NCT04162977|Early Intervention|early intervention
5645|NCT04162977|Mental Health|mental health
5646|NCT04162977|Complex Trauma|complex trauma
5647|NCT04162977|Youth Protection Services.|youth protection services.
5648|NCT04162977|Adolescence|adolescence
5649|NCT04162977|Personality-targeted Interventions|personality-targeted interventions
5650|NCT04162964|Dementia|dementia
5651|NCT04162964|Stress|stress
5652|NCT04162964|Caregiving|caregiving
5653|NCT04162964|Mind-body therapy|mind-body therapy
5654|NCT04162964|Anxiety|anxiety
5655|NCT04162964|Depression|depression
5656|NCT04162951|Retrolaminar|retrolaminar
5657|NCT04162951|Paravertebral|paravertebral
5658|NCT04162951|Breast surgery|breast surgery
5659|NCT04162951|Postoperative pain|postoperative pain
5660|NCT04162938|HCV Linkage to Care|hcv linkage to care
5661|NCT04162938|HCV Education|hcv education
5662|NCT04162912|Advance Care Planning|advance care planning
5663|NCT04162912|Motivational Interviewing|motivational interviewing
5664|NCT04162912|Pallative Care|pallative care
5665|NCT04162886|Exercise|exercise
5666|NCT04162886|power|power
5667|NCT04162886|muscle strength|muscle strength
5668|NCT04162886|balance|balance
5669|NCT04162808|bleeding|bleeding
5670|NCT04162808|antithrombosis|antithrombosis
5671|NCT04162795|Allergy|allergy
5672|NCT04162795|Upper respiratory allergies|upper respiratory allergies
5673|NCT04162769|Moderate-to-severe atopic dermatitis|moderate-to-severe atopic dermatitis
5674|NCT04162769|Etrasimod|etrasimod
5675|NCT04162769|APD334|apd334
5676|NCT04162717|Patients with cancer|patients with cancer
5677|NCT04162717|Symptom triage|symptom triage
5678|NCT04162717|Self care|self care
5679|NCT04162717|Symptom management|symptom management
5680|NCT04162717|Quality of life|quality of life
5681|NCT04162626|public health nurse|public health nurse
5682|NCT04162626|intervention|intervention
5683|NCT04162626|home visit|home visit
5684|NCT04162613|anterior cruciate ligament injury|anterior cruciate ligament injury
5685|NCT04162613|re-injury|re-injury
5686|NCT04162613|muscle function|muscle function
5687|NCT04162613|functional performance|functional performance
5688|NCT04162613|rehabilitation|rehabilitation
5689|NCT04162613|physiotherapy|physiotherapy
5690|NCT04162613|sensorimotor control|sensorimotor control
5691|NCT04162600|Vaccine|vaccine
5692|NCT04162587|Ischemic Stroke|ischemic stroke
5693|NCT04162587|carotid stenosis|carotid stenosis
5694|NCT04162561|quality of therapy|quality of therapy
5695|NCT04162561|current clinical guidelines|current clinical guidelines
5696|NCT04162548|frail|frail
5697|NCT04162548|public health|public health
5698|NCT04162535|Anesthesia|anesthesia
5699|NCT04162535|Propofol|propofol
5700|NCT04162535|Sevoflurane|sevoflurane
5701|NCT04162535|Lidocaine|lidocaine
5702|NCT04162535|Cell Culture|cell culture
5703|NCT04162522|major depression|major depression
5704|NCT04162522|major depressive disorder|major depressive disorder
5706|NCT04162522|escitalopram|escitalopram
5707|NCT04162522|brexpiprazole|brexpiprazole
5708|NCT04162522|neuroimaging|neuroimaging
5709|NCT04162522|genomics|genomics
5710|NCT04162522|proteomics|proteomics
5711|NCT04162522|metabolomics|metabolomics
5712|NCT04162496|Hyaluronic Acid Filler|hyaluronic acid filler
5713|NCT04162496|Neck Rhytides|neck rhytides
5714|NCT04162496|Transverse Neck Lines|transverse neck lines
5715|NCT04162496|Tech Neck|tech neck
5716|NCT04162496|Necklace Lines|necklace lines
5717|NCT04162496|Restylane|restylane
5718|NCT04162496|Restylane Refyne|restylane refyne
5719|NCT04162470|PNH|pnh
5720|NCT04162444|Aortic Valve Insufficiency/surgery|aortic valve insufficiency/surgery
5721|NCT04162444|Aortic Valve/surgery|aortic valve/surgery
5722|NCT04162444|Child|child
5723|NCT04162444|Reconstructive Surgical Procedures/methods|reconstructive surgical procedures/methods
5724|NCT04162444|Cardiac Surgical Procedures|cardiac surgical procedures
5725|NCT04162444|Hemodynamics|hemodynamics
5726|NCT04162444|Pericardium/transplantation|pericardium/transplantation
5727|NCT04162444|Transplantation, Autologous|transplantation, autologous
5728|NCT04162444|Treatment Outcome|treatment outcome
5729|NCT04162444|Heart Valve Prosthesis Implantation|heart valve prosthesis implantation
5730|NCT04162431|Raman|raman
5731|NCT04162431|Lymphoma|lymphoma
5732|NCT04162418|peripheral arterial disease|peripheral arterial disease
5733|NCT04162418|critical limb ischemia|critical limb ischemia
5734|NCT04162418|infrapopliteal disease|infrapopliteal disease
5735|NCT04162405|tinnitus|tinnitus
5736|NCT04162405|sensorineural hearing loss|sensorineural hearing loss
5737|NCT04162405|otoacoustic emission|otoacoustic emission
5738|NCT04162405|normacusis|normacusis
5739|NCT04162405|questionnaire|questionnaire
5740|NCT04162379|Steroid, analgesia, Prednisolone, Cancer, cancer Pain, pain WHO stepladder.|steroid, analgesia, prednisolone, cancer, cancer pain, pain who stepladder.
5741|NCT04162366|Chronic kidney disease|chronic kidney disease
5742|NCT04162353|BCMA|bcma
5743|NCT04162353|CD19|cd19
5744|NCT04162353|BCMA-CD19 cCAR T cells|bcma-cd19 ccar t cells
5745|NCT04162353|multiple myeloma|multiple myeloma
5746|NCT04162353|plasmacytoid lymphoma|plasmacytoid lymphoma
5747|NCT04162340|CD4-specific CAR T|cd4-specific car t
5748|NCT04162340|T cell leukemia|t cell leukemia
5749|NCT04162340|T cell lymphoma|t cell lymphoma
5750|NCT04162340|CD4CAR|cd4car
5751|NCT04162314|non-infectious uveitis|non-infectious uveitis
5752|NCT04162314|idiopathic uveitis|idiopathic uveitis
5753|NCT04162288|Shared Decision Making|shared decision making
5754|NCT04162288|Decision aid|decision aid
5755|NCT04162288|Nurse|nurse
5756|NCT04162288|Online Training|online training
5757|NCT04162262|Plantar Fascitis|plantar fascitis
5758|NCT04162262|Instrument-assisted soft tissue mobilization|instrument-assisted soft tissue mobilization
5759|NCT04162262|Stretch and strengthening exercise|stretch and strengthening exercise
5760|NCT04162262|Plantar fasciopathy|plantar fasciopathy
5761|NCT04162249|Atrial fibrillation|atrial fibrillation
5762|NCT04162249|Ablatión|ablatión
5763|NCT04162249|High-power|high-power
5764|NCT04162249|Radiofrequency|radiofrequency
5765|NCT04162249|Esophageal lesion|esophageal lesion
5766|NCT04162210|Belantamab mafodotin|belantamab mafodotin
5767|NCT04162210|Pomalidomide|pomalidomide
5768|NCT04162210|Dexamethasone|dexamethasone
5769|NCT04162210|Relapsed/Refractory Multiple Myeloma|relapsed/refractory multiple myeloma
5770|NCT04162197|Stroke|stroke
5771|NCT04162197|Robotics|robotics
5772|NCT04162197|Gait Training|gait training
5773|NCT04162197|Rehabilitation|rehabilitation
5774|NCT04162197|Balance|balance
5775|NCT04162197|Functional Recovery|functional recovery
5776|NCT04162197|Robot-Assisted Gait Training|robot-assisted gait training
5777|NCT04162184|family planning|family planning
5778|NCT04162184|opioid use disorder|opioid use disorder
5779|NCT04162184|patient navigation|patient navigation
5780|NCT04162184|reproductive health|reproductive health
5781|NCT04162184|sexual health|sexual health
5782|NCT04162145|opioid withdrawal|opioid withdrawal
5783|NCT04162145|opioid|opioid
5784|NCT04162145|pain|pain
5785|NCT04162145|craving|craving
5786|NCT04162145|NSS-2 BRIDGE|nss-2 bridge
5787|NCT04162145|percutaneous electrical nerve field stimulator (PENFS)|percutaneous electrical nerve field stimulator (penfs)
5788|NCT04162132|contingency management|contingency management
5789|NCT04162132|smartphone app|smartphone app
5790|NCT04162132|substance use disorder|substance use disorder
5791|NCT04162132|outpatient addiction treatment|outpatient addiction treatment
5792|NCT04162132|BrightView|brightview
5793|NCT04162132|DynamiCare|dynamicare
5794|NCT04162119|BCMA|bcma
5795|NCT04162119|Myeloma|myeloma
5796|NCT04162119|PD-1|pd-1
5797|NCT04162119|Immunotherapy|immunotherapy
5798|NCT04162119|Plasmocytoma|plasmocytoma
5799|NCT04162119|Chimeric antigen receptor T cell|chimeric antigen receptor t cell
5800|NCT04162119|Chimeric antigen receptor|chimeric antigen receptor
5801|NCT04162119|B cell maturation antigen|b cell maturation antigen
5802|NCT04162093|Bladder Cancer|bladder cancer
5803|NCT04162093|Orthotopic diversion|orthotopic diversion
5804|NCT04162093|Wallace|wallace
5805|NCT04162093|sub-serous extramural tunnel.|sub-serous extramural tunnel.
5806|NCT04162080|kayak polo|kayak polo
5807|NCT04162067|Diabetes Mellitus, Type 1|diabetes mellitus, type 1
5808|NCT04162067|hypoglycemia|hypoglycemia
5809|NCT04162067|hemoglobin A1c|hemoglobin a1c
5810|NCT04162067|time in range|time in range
5811|NCT04162067|continuous glucose monitor|continuous glucose monitor
5812|NCT04162015|Nivolumab|nivolumab
5813|NCT04162015|Surgery|surgery
5814|NCT04162015|Pemetrexed|pemetrexed
5815|NCT04162015|Cisplatin|cisplatin
5816|NCT04162015|Carboplatin|carboplatin
5817|NCT04162015|19-272|19-272
5818|NCT04161963|Cataract|cataract
5819|NCT04161963|Glaucoma|glaucoma
5820|NCT04161963|cystroid macular edema|cystroid macular edema
5821|NCT04161950|echoendoscope|echoendoscope
5822|NCT04161950|endoscopic ultrasonography|endoscopic ultrasonography
5823|NCT04161937|Work-site|work-site
5824|NCT04161937|Diabetes|diabetes
5825|NCT04161937|Nepal|nepal
5826|NCT04161898|Takayasu Arteritis (TAK)|takayasu arteritis (tak)
5827|NCT04161898|Upadacitinib|upadacitinib
5828|NCT04161898|Placebo|placebo
5829|NCT04161898|Corticosteroid|corticosteroid
5830|NCT04161898|Prednisolone|prednisolone
5831|NCT04161885|Acute Myeloid Leukemia (AML)|acute myeloid leukemia (aml)
5832|NCT04161885|Venetoclax|venetoclax
5833|NCT04161885|Azacitidine|azacitidine
5834|NCT04161885|Stem Cell Transplantation (SCT)|stem cell transplantation (sct)
5835|NCT04161885|Best Support Care (BSC)|best support care (bsc)
5836|NCT04161885|Cancer|cancer
5837|NCT04161833|breast cancer|breast cancer
5838|NCT04161833|luminal tumor|luminal tumor
5839|NCT04161833|anti-aromatase inhibitors|anti-aromatase inhibitors
5840|NCT04161833|arthralgia|arthralgia
5841|NCT04161833|dietary supplement|dietary supplement
5842|NCT04161820|Chronic Care Model|chronic care model
5843|NCT04161820|Self-management|self-management
5844|NCT04161820|Stroke|stroke
5845|NCT04161820|Quality of Life|quality of life
5846|NCT04161794|cachexia|cachexia
5847|NCT04161794|cancer|cancer
5848|NCT04161794|multimodal intervention|multimodal intervention
5849|NCT04161781|18F-BMS-986229|18f-bms-986229
5850|NCT04161781|Memorial Sloan Kettering Cancer Center|memorial sloan kettering cancer center
5851|NCT04161781|19-122|19-122
5852|NCT04161755|personalized tumor vaccines|personalized tumor vaccines
5853|NCT04161755|PCVs|pcvs
5854|NCT04161755|PD-L1 Blocker|pd-l1 blocker
5855|NCT04161755|Memorial Sloan Kettering Cancer Center|memorial sloan kettering cancer center
5856|NCT04161755|19-039|19-039
5857|NCT04161729|magnesium|magnesium
5858|NCT04161729|analgesia|analgesia
5859|NCT04161729|pain score|pain score
5860|NCT04161729|opioid consumption|opioid consumption
5861|NCT04161729|spine surgery|spine surgery
5862|NCT04161716|Urodynamic|urodynamic
5863|NCT04161716|bladder|bladder
5864|NCT04161716|detrusor|detrusor
5865|NCT04161716|urinary disorder|urinary disorder
5866|NCT04161677|Adverse event|adverse event
5867|NCT04161677|Electronic reporting system|electronic reporting system
5868|NCT04161677|Chiropractic|chiropractic
5869|NCT04161677|Spinal manipulation|spinal manipulation
5870|NCT04161651|eversense|eversense
5871|NCT04161651|type 1 diabetes|type 1 diabetes
5872|NCT04161625|Prevention and control|prevention and control
5873|NCT04161625|Exercise therapy/methods*|exercise therapy/methods*
5874|NCT04161625|Aged 70 and over|aged 70 and over
5875|NCT04161625|Smartphone|smartphone
5876|NCT04161625|Computers handheld|computers handheld
5877|NCT04161625|Motivation|motivation
5878|NCT04161625|Behaviour change|behaviour change
5879|NCT04161625|Postural balance|postural balance
5880|NCT04161625|Health behaviour|health behaviour
5881|NCT04161625|mHealth|mhealth
5882|NCT04161625|eHealth|ehealth
5883|NCT04161625|Digital health|digital health
5884|NCT04161625|Self-management|self-management
5885|NCT04161625|Re-aim|re-aim
5886|NCT04161612|Sleep quality|sleep quality
5887|NCT04161586|Spinal Anesthesia|spinal anesthesia
5888|NCT04161586|Prilocaine|prilocaine
5889|NCT04161586|Ambulatory Surgery|ambulatory surgery
5890|NCT04161586|Safety|safety
5891|NCT04161573|Irony comprehension|irony comprehension
5892|NCT04161560|Cetuximab-IRDye800|cetuximab-irdye800
5893|NCT04161560|EGFR|egfr
5894|NCT04161560|esophageal squamous cell carcinoma|esophageal squamous cell carcinoma
5895|NCT04161560|real-time imaging|real-time imaging
5896|NCT04161547|CSPCHA115|cspcha115
5897|NCT04161547|Asthma|asthma
5898|NCT04161547|CRTH2|crth2
5899|NCT04161534|arm sling|arm sling
5900|NCT04161534|Kinesiology tape|kinesiology tape
5901|NCT04161508|sugammadex, anterior cervical spine surgery|sugammadex, anterior cervical spine surgery
5902|NCT04161469|sphincter injury|sphincter injury
5903|NCT04161469|anal abscess|anal abscess
5904|NCT04161469|incontinence|incontinence
5939|NCT04161313|respiratory functions|respiratory functions
5941|NCT04161313|muscle strength|muscle strength
5942|NCT04161287|CyberKnife|cyberknife
5943|NCT04161287|SBRT|sbrt
5944|NCT04161287|TACE|tace
5945|NCT04161287|prognosis|prognosis
5946|NCT04161274|minor surgery procedures|minor surgery procedures
5947|NCT04161274|wounds and injuries|wounds and injuries
5948|NCT04161274|moist healing environment|moist healing environment
5949|NCT04161274|fibroma|fibroma
5950|NCT04161274|nursing|nursing
5951|NCT04161274|skin diseases|skin diseases
5952|NCT04161222|Knee stability.|knee stability.
5953|NCT04161222|Core|core
5954|NCT04161222|Gluteus medius|gluteus medius
5955|NCT04161222|Warm-up|warm-up
5956|NCT04161222|Football|football
5957|NCT04161209|Citalopram|citalopram
5958|NCT04161209|Stress induction paradigm|stress induction paradigm
5959|NCT04161209|Healthy volunteers|healthy volunteers
5960|NCT04161183|shock wave|shock wave
5961|NCT04161183|detrusor underactivity|detrusor underactivity
5962|NCT04161183|underactive bladder|underactive bladder
5963|NCT04161170|Continuous glucose monitoring system|continuous glucose monitoring system
5964|NCT04161170|Artificial intelligence|artificial intelligence
5965|NCT04161170|Diabetes|diabetes
5966|NCT04161170|Digital healthcare|digital healthcare
5967|NCT04161170|Education|education
5968|NCT04161105|Dry needling|dry needling
5969|NCT04161105|Strength|strength
5970|NCT04161105|Latent trigger points|latent trigger points
5971|NCT04161092|colorectal cancer|colorectal cancer
5972|NCT04161092|liver metastases|liver metastases
5973|NCT04161092|liver transplant|liver transplant
5974|NCT04161092|non-resectable colorectal cancer metastases|non-resectable colorectal cancer metastases
5975|NCT04161079|Mitral valve|mitral valve
5976|NCT04161079|Mitral surgery|mitral surgery
5977|NCT04161079|Mitral repair|mitral repair
5978|NCT04161079|Mitral annuloplasty|mitral annuloplasty
5979|NCT04161079|Mitral valve surgery|mitral valve surgery
5980|NCT04161079|Mitral valve repair|mitral valve repair
5981|NCT04161079|Mitral valve annuloplasty|mitral valve annuloplasty
5982|NCT04161066|Suboxone|suboxone
5983|NCT04161066|Buprenorphine|buprenorphine
5984|NCT04161040|Relapse|relapse
5985|NCT04161040|Physical Activity|physical activity
5986|NCT04161040|Sedentary Behavior|sedentary behavior
5987|NCT04161040|Behavioral Momentum Theory|behavioral momentum theory
5988|NCT04161040|Incentives|incentives
5989|NCT04161027|Restless legs syndrome; pregabalin; Willis-Ekbom disease|restless legs syndrome; pregabalin; willis-ekbom disease
5990|NCT04160975|Belief Updating|belief updating
5991|NCT04160975|Preventive Care|preventive care
5992|NCT04160975|Racial Disparity|racial disparity
5993|NCT04160897|chronic hepatitis B|chronic hepatitis b
5994|NCT04160897|hepatocellular carcinoma|hepatocellular carcinoma
5995|NCT04160897|compensated cirrhosis|compensated cirrhosis
5996|NCT04160897|Chinese|chinese
5997|NCT04160897|entecavir|entecavir
5998|NCT04160897|tenofovir disopropyl|tenofovir disopropyl
5999|NCT04160897|multi-center|multi-center
6000|NCT04160897|real-world|real-world
6001|NCT04160897|respective|respective
6002|NCT04160871|borderline personality disorder|borderline personality disorder
6003|NCT04160871|family connections|family connections
6006|NCT04160871|intervention|intervention
6008|NCT04160871|caregivers|caregivers
6009|NCT04160832|genetics|genetics
6010|NCT04160832|polyps|polyps
6011|NCT04160832|cancer|cancer
6012|NCT04160832|multi-gene panel|multi-gene panel
6013|NCT04160819|nutritional intervention|nutritional intervention
6014|NCT04160819|malnutrition|malnutrition
6015|NCT04160819|respiratory disease|respiratory disease
6016|NCT04160806|Anxiety disorders|anxiety disorders
6017|NCT04160806|Panic disorder|panic disorder
6018|NCT04160806|Transcranial Direct Current Stimulation|transcranial direct current stimulation
6019|NCT04160806|Interoceptive accuracy|interoceptive accuracy
6020|NCT04160806|Attention bias|attention bias
6021|NCT04160806|Emotion recognition|emotion recognition
6022|NCT04160806|Brain Stimulation|brain stimulation
6023|NCT04160767|Celiac disease|celiac disease
6024|NCT04160767|Gut microbiota|gut microbiota
6025|NCT04160754|Trauma|trauma
6026|NCT04160754|Delinquency|delinquency
6027|NCT04160754|Substance Use|substance use
6028|NCT04160754|Emotion Regulation|emotion regulation
6029|NCT04160754|Impulsivity|impulsivity
6030|NCT04160754|Executive Functioning|executive functioning
6031|NCT04160741|heat stress|heat stress
6032|NCT04160741|heat strain|heat strain
6033|NCT04160741|solar radiation|solar radiation
6034|NCT04160741|responses|responses
6035|NCT04160741|cognition|cognition
6036|NCT04160741|thermal|thermal
6037|NCT04160728|heat stress|heat stress
6038|NCT04160728|heat strain|heat strain
6039|NCT04160728|productivity|productivity
6040|NCT04160728|labor|labor
6041|NCT04160728|occupation|occupation
6042|NCT04160728|work|work
6043|NCT04160728|thermal|thermal
6044|NCT04160702|sexual assault prevention|sexual assault prevention
6045|NCT04160702|motivational interviewing|motivational interviewing
6046|NCT04160702|bystander intervention|bystander intervention
6047|NCT04160676|Hydrocortison|hydrocortison
6048|NCT04160676|Ascorbic acid|ascorbic acid
6049|NCT04160676|Thiamine|thiamine
6050|NCT04160637|parathyroid hormone|parathyroid hormone
6051|NCT04160637|total thyroidectomy|total thyroidectomy
6052|NCT04160637|hypocalcemia|hypocalcemia
6053|NCT04160637|postoperative|postoperative
6054|NCT04160637|predictive factor|predictive factor
6055|NCT04160611|IVF|ivf
6056|NCT04160611|stress|stress
6057|NCT04160611|midazolam|midazolam
6058|NCT04160611|premedication|premedication
6059|NCT04160598|Neuraxial opioids, post-operative itching, intrathecal Fentanyl pruritus, Spinal anesthesia|neuraxial opioids, post-operative itching, intrathecal fentanyl pruritus, spinal anesthesia
6060|NCT04160559|Non-small cell lung cancer， green tea, chemotherapy，QOL|non-small cell lung cancer， green tea, chemotherapy，qol
6061|NCT04160546|Chronic Myeloid Leukemia|chronic myeloid leukemia
6062|NCT04160546|Ponatinib|ponatinib
6063|NCT04160520|morphine|morphine
6064|NCT04160520|Pramipexole|pramipexole
6065|NCT04160520|Renal Colic|renal colic
6066|NCT04160520|Kidney Stone|kidney stone
6067|NCT04160520|opioids|opioids
6068|NCT04160520|analgesia|analgesia
6069|NCT04160520|pain relief|pain relief
6070|NCT04160507|ESKD|eskd
6071|NCT04160507|APOL 1 gene|apol 1 gene
6072|NCT04160507|Kidney Disease|kidney disease
6073|NCT04160494|D2C7|d2c7
6074|NCT04160494|D2C7-IT|d2c7-it
6075|NCT04160494|Atezolizumab|atezolizumab
6076|NCT04160494|Randazzo|randazzo
6077|NCT04160494|Glioblastoma|glioblastoma
6078|NCT04160494|Glioma|glioma
6079|NCT04160494|Bigner|bigner
6080|NCT04160494|Pro00101898|pro00101898
6081|NCT04160494|Genentech|genentech
6082|NCT04160494|CTEP|ctep
6083|NCT04160494|Duke|duke
6084|NCT04160481|gut microbiome|gut microbiome
6085|NCT04160481|carciovascular risk factor|carciovascular risk factor
6086|NCT04160468|S. aureus bloodstream infection|s. aureus bloodstream infection
6087|NCT04160468|S. aureus bacteremia|s. aureus bacteremia
6088|NCT04160468|S. aureus right-sided infective endocarditis|s. aureus right-sided infective endocarditis
6089|NCT04160455|Antiretroviral therapy|antiretroviral therapy
6090|NCT04160455|basal autophagy|basal autophagy
6091|NCT04160455|GALIG gene|galig gene
6092|NCT04160455|HIV|hiv
6093|NCT04160455|apoptosis|apoptosis
6094|NCT04160403|Cerebral palsy, spastic, motor function, socioeconomic status, progress, physical therapy|cerebral palsy, spastic, motor function, socioeconomic status, progress, physical therapy
6095|NCT04160364|children|children
6096|NCT04160364|adolescents|adolescents
6097|NCT04160364|parents|parents
6098|NCT04160351|Hemodialysis-Associated Amyloidosis|hemodialysis-associated amyloidosis
6099|NCT04160351|Dialysis Amyloidosis|dialysis amyloidosis
6100|NCT04160351|Quality of Life|quality of life
6101|NCT04160286|Hippocampus|hippocampus
6102|NCT04160286|Depression|depression
6103|NCT04160286|Electroconvulsive therapy|electroconvulsive therapy
6104|NCT04160286|Brain-Derived Neurotrophic Factor|brain-derived neurotrophic factor
6105|NCT04160286|Magnetic Resonance Imaging|magnetic resonance imaging
6106|NCT04160273|Posttraumatic stress disorder|posttraumatic stress disorder
6125|NCT04160169|Tanzania|tanzania
6126|NCT04160156|Continuous glucose monitoring|continuous glucose monitoring
6127|NCT04160156|sensor|sensor
6128|NCT04160156|glycated hemoglobin|glycated hemoglobin
6129|NCT04160156|Time in range|time in range
6130|NCT04160143|Surgical resection|surgical resection
6131|NCT04160143|Stereotactic body radiation therapy|stereotactic body radiation therapy
6132|NCT04160143|Pulmonary metastasectomy|pulmonary metastasectomy
6133|NCT04160143|Lung Cancers|lung cancers
6134|NCT04160130|Research in woman|research in woman
6135|NCT04160130|Transcatheter Aortic Valve Implantation (TAVI)|transcatheter aortic valve implantation (tavi)
6136|NCT04160130|surgical aortic valve replacement (SAVR)|surgical aortic valve replacement (savr)
6137|NCT04160130|cardiovascular disease|cardiovascular disease
6138|NCT04160130|heart disease|heart disease
6139|NCT04160130|Sapien 3|sapien 3
6140|NCT04160104|Bowel preparation|bowel preparation
6141|NCT04160104|BBPS|bbps
6142|NCT04160091|Osteoarthritis|osteoarthritis
6143|NCT04160091|Adhesive Capsulitis|adhesive capsulitis
6144|NCT04160091|Shoulder|shoulder
6145|NCT04160091|Pain|pain
6146|NCT04160091|Intra-articular|intra-articular
6147|NCT04160091|Injection|injection
6148|NCT04160091|Steroid|steroid
6149|NCT04160078|Diabetes|diabetes
6150|NCT04160078|Mindfulness|mindfulness
6151|NCT04160078|Public health|public health
6152|NCT04160078|Sleep|sleep
6153|NCT04160065|Advanced|advanced
6154|NCT04160065|MCC|mcc
6155|NCT04160065|cSCC|cscc
6156|NCT04160065|pDNA|pdna
6157|NCT04160065|plasmid DNA|plasmid dna
6158|NCT04160065|pAc/emm55|pac/emm55
6159|NCT04160065|Gene Therapy|gene therapy
6160|NCT04160065|Immuno-Oncology|immuno-oncology
6161|NCT04160065|Therapeutic Cancer Vaccine|therapeutic cancer vaccine
6162|NCT04160065|Immunotherapy|immunotherapy
6166|NCT04160000|Atrial fibrillation|atrial fibrillation
6167|NCT04160000|Heart failure|heart failure
6168|NCT04160000|Diastolic heart failure|diastolic heart failure
6169|NCT04160000|Catheter Ablation|catheter ablation
6170|NCT04160000|Antiarrhythmic Drugs|antiarrhythmic drugs
6171|NCT04159948|Carbodydrate drink|carbodydrate drink
6172|NCT04159909|vagus nerve stimulation (VNS), non-invasive intervention|vagus nerve stimulation (vns), non-invasive intervention
6173|NCT04159857|hand forceps, cesarean section, one-hand technique, two-hand technique, fetal head extraction|hand forceps, cesarean section, one-hand technique, two-hand technique, fetal head extraction
6174|NCT04159818|Triple negative|triple negative
6175|NCT04159818|Metastatic disease|metastatic disease
6176|NCT04159805|Drug therapy|drug therapy
6177|NCT04159792|stroke|stroke
6178|NCT04159792|upper limb|upper limb
6179|NCT04159792|lower limb|lower limb
6180|NCT04159792|mobility|mobility
6181|NCT04159792|posture|posture
6182|NCT04159779|Chronic Lymphocytic Leukemia (CLL)|chronic lymphocytic leukemia (cll)
6183|NCT04159779|Venetoclax|venetoclax
6184|NCT04159779|Relapsed/Refractory|relapsed/refractory
6185|NCT04159753|Spinal cord stimulator (SCS)|spinal cord stimulator (scs)
6186|NCT04159727|gut microbiota|gut microbiota
6187|NCT04159727|Bacterial translocation|bacterial translocation
6188|NCT04159610|Excessive sweating|excessive sweating
6189|NCT04159597|Expanded Access|expanded access
6190|NCT04159597|Pre-approval Access|pre-approval access
6191|NCT04159597|Compassionate Use|compassionate use
6192|NCT04159597|Special Access Program|special access program
6193|NCT04159597|Named Patient Basis|named patient basis
6194|NCT04159597|Special Access Scheme|special access scheme
6195|NCT04159571|Transcranial Magnetic Stimulation|transcranial magnetic stimulation
6196|NCT04159571|Brain Stimulation|brain stimulation
6197|NCT04159571|Treatment|treatment
6198|NCT04159571|Neuroimaging|neuroimaging
6199|NCT04159519|Anti-Inflammatory|anti-inflammatory
6200|NCT04159519|Reduction period|reduction period
6201|NCT04159519|Inhaled corticosteroids|inhaled corticosteroids
6202|NCT04159519|long-acting β2 agonist|long-acting β2 agonist
6203|NCT04159506|equine therapy|equine therapy
6204|NCT04159506|social functioning|social functioning
6205|NCT04159506|emotion regulation|emotion regulation
6206|NCT04159467|Urinary Incontinence|urinary incontinence
6207|NCT04159467|Obesity|obesity
6208|NCT04159467|Diet|diet
6209|NCT04159467|Pelvic floor muscles training|pelvic floor muscles training
6210|NCT04159454|Pacing|pacing
6211|NCT04159454|Heart failure|heart failure
6212|NCT04159454|Dyssynchrony|dyssynchrony
6213|NCT04159441|Hepatotoxicity of Antituberculosis Therapy|hepatotoxicity of antituberculosis therapy
6214|NCT04159441|DILI|dili
6215|NCT04159428|hearing loss|hearing loss
6216|NCT04159428|screening|screening
6217|NCT04159428|elderly|elderly
6218|NCT04159428|hidden hearing loss|hidden hearing loss
6219|NCT04159428|speech in noise audiometry|speech in noise audiometry
6220|NCT04159428|HHIE-S survey|hhie-s survey
6221|NCT04159389|airway management|airway management
6222|NCT04159389|pedagogy|pedagogy
6223|NCT04159389|learning process|learning process
6224|NCT04159389|mental visualization|mental visualization
6225|NCT04159389|rapide sequence induction|rapide sequence induction
6226|NCT04159363|psychosocial intervention|psychosocial intervention
6227|NCT04159363|smartphone-based|smartphone-based
6228|NCT04159363|patient|patient
6229|NCT04159363|colorectal cancer|colorectal cancer
6230|NCT04159363|caregiver|caregiver
6231|NCT04159363|randomised controlled trial|randomised controlled trial
6232|NCT04159324|Stroke|stroke
6233|NCT04159324|Patient-reported outcomes (PROs)|patient-reported outcomes (pros)
6234|NCT04159324|Cross-sectoral care|cross-sectoral care
6235|NCT04159324|Stroke aftercare|stroke aftercare
6236|NCT04159324|Aftercare coordination|aftercare coordination
6237|NCT04159324|Post-rehabilitation support|post-rehabilitation support
6238|NCT04159324|Evidence based treatment|evidence based treatment
6239|NCT04159324|Patient-centred care|patient-centred care
6240|NCT04159324|Quality of life|quality of life
6241|NCT04159324|Morbidity|morbidity
6242|NCT04159324|Mortality|mortality
6243|NCT04159324|Functional status|functional status
6244|NCT04159324|Feasibility|feasibility
6245|NCT04159324|Acceptance|acceptance
6246|NCT04159324|Process evaluation|process evaluation
6247|NCT04159324|Health economics|health economics
6248|NCT04159298|rehabilitation|rehabilitation
6249|NCT04159298|sports medicine|sports medicine
6250|NCT04159298|Test a New Treatment|test a new treatment
6251|NCT04159298|randomized control trial|randomized control trial
6252|NCT04159233|sleep|sleep
6253|NCT04159233|pain|pain
6254|NCT04159233|professional athlete|professional athlete
6255|NCT04159233|National Football League|national football league
6256|NCT04159233|Behavioral intervention|behavioral intervention
6257|NCT04159207|Depression|depression
6258|NCT04159207|Suicide|suicide
6259|NCT04159207|Inflammation|inflammation
6260|NCT04159207|Kynurenine|kynurenine
6261|NCT04159207|Cytokine|cytokine
6262|NCT04159194|soccer|soccer
6263|NCT04159194|overtime|overtime
6264|NCT04159194|performance|performance
6265|NCT04159194|recovery|recovery
6266|NCT04159181|Colon|colon
6267|NCT04159181|PYYs|pyys
6268|NCT04159181|GLP-1|glp-1
6269|NCT04159181|Gut peptides|gut peptides
6270|NCT04159181|Fermentation|fermentation
6271|NCT04159181|Lactulose|lactulose
6272|NCT04159181|human|human
6273|NCT04159168|Attention [F02.830.104.214]|attention [f02.830.104.214]
6274|NCT04159168|Temperament [F01.752.898]|temperament [f01.752.898]
6275|NCT04159168|Problem Behavior [F01.145.179.750]|problem behavior [f01.145.179.750]
6276|NCT04159168|Social Behavior [F01.145.813]|social behavior [f01.145.813]
6277|NCT04159168|Electroencephalography [E01.370.405.245]|electroencephalography [e01.370.405.245]
6278|NCT04159168|Neuropsychological Tests [F04.711.513]|neuropsychological tests [f04.711.513]
6279|NCT04159142|Nab-paclitaxel|nab-paclitaxel
6280|NCT04159142|Carboplatin|carboplatin
6281|NCT04159142|Capecitabine|capecitabine
6282|NCT04159142|Triple Negative Breast Cancer|triple negative breast cancer
6283|NCT04159142|Maintenance therapy|maintenance therapy
6284|NCT04159129|walking speed|walking speed
6285|NCT04159129|dyspnoe|dyspnoe
6286|NCT04159129|stress|stress
6287|NCT04159129|anxiety|anxiety
6288|NCT04159129|traffic light|traffic light
6289|NCT04159103|mRNA-3927|mrna-3927
6290|NCT04159103|Propionic Aciduria|propionic aciduria
6291|NCT04159103|Metabolism, Inborn Errors|metabolism, inborn errors
6292|NCT04159103|Genetic Diseases|genetic diseases
6293|NCT04159103|Inborn Amino Acid Metabolism, Inborn Errors|inborn amino acid metabolism, inborn errors
6294|NCT04159103|Acidosis|acidosis
6295|NCT04159103|Acid-Base Imbalance|acid-base imbalance
6296|NCT04159103|Metabolic Diseases|metabolic diseases
6297|NCT04159103|Organic Acidemias|organic acidemias
6298|NCT04159103|Moderna|moderna
6299|NCT04159077|Post-operative urinary retention|post-operative urinary retention
6300|NCT04159077|Tamsulosin|tamsulosin
6301|NCT04159077|urinary tract infections|urinary tract infections
6302|NCT04159077|catheter|catheter
6303|NCT04159064|extracorporeal circulation|extracorporeal circulation
6304|NCT04159064|coagulation disorder|coagulation disorder
6305|NCT04159064|Extracorporeal Circulation of Blood; Thrombocytopenia|extracorporeal circulation of blood; thrombocytopenia
6306|NCT04159038|Pilot Projects|pilot projects
6307|NCT04159038|Randomized Controlled Trial|randomized controlled trial
6308|NCT04158947|HER2-positive Breast Cancer|her2-positive breast cancer
6309|NCT04158947|Brain metastases|brain metastases
6310|NCT04158947|T-DM1|t-dm1
6311|NCT04158947|Afatinib|afatinib
6312|NCT04158921|Diabetes Mellitus|diabetes mellitus
6313|NCT04158921|Insulin Therapy|insulin therapy
6314|NCT04158921|Glycemic Control|glycemic control
6315|NCT04158921|Hyperglycemia|hyperglycemia
6316|NCT04158921|Hypoglycemia|hypoglycemia
6317|NCT04158921|Health Education|health education
6318|NCT04158921|Self-Management|self-management
6319|NCT04158921|Lifestyle|lifestyle
6320|NCT04158895|HIV|hiv
6321|NCT04158895|Malawi|malawi
6322|NCT04158895|Differentiated service delivery|differentiated service delivery
6323|NCT04158895|Antiretroviral therapy|antiretroviral therapy
6324|NCT04158882|HIV|hiv
6325|NCT04158882|Zambia|zambia
6326|NCT04158882|Differentiated service delivery|differentiated service delivery
6327|NCT04158882|Antiretroviral therapy|antiretroviral therapy
6328|NCT04158869|n-3 fatty acids|n-3 fatty acids
6329|NCT04158869|pediatric Major Depressive Disorder|pediatric major depressive disorder
6330|NCT04158843|Breast Cancer|breast cancer
6331|NCT04158843|Oligometastasis|oligometastasis
6332|NCT04158843|Humerus|humerus
6333|NCT04158843|Sternum|sternum
6334|NCT04158830|prevention|prevention
6335|NCT04158830|aspirin therapy|aspirin therapy
6336|NCT04158817|68Ga-THP-PSMA|68ga-thp-psma
6337|NCT04158817|PET/CT|pet/ct
6338|NCT04158791|Ophthalmology|ophthalmology
6339|NCT04158791|Epimacular membrane|epimacular membrane
6340|NCT04158791|ILM peeling|ilm peeling
6341|NCT04158791|mfERG|mferg
6342|NCT04158791|OCT|oct
6343|NCT04158778|Alcohol Use Disorder|alcohol use disorder
6344|NCT04158700|TGF-beta|tgf-beta
6345|NCT04158700|Urothelial carcinoma|urothelial carcinoma
6346|NCT04158700|Hepatocellular carcinoma|hepatocellular carcinoma
6347|NCT04158700|Non-small cell lung cancer|non-small cell lung cancer
799164|NCT00257114|Retreatment|retreatment
6348|NCT04158700|TGF- beta receptor type I inhibitor|tgf- beta receptor type i inhibitor
6349|NCT04158661|Myasthenia Gravis|myasthenia gravis
6350|NCT04158661|Robotic-assisted minimally-invasive thymectomy|robotic-assisted minimally-invasive thymectomy
6351|NCT04158661|Mean daily prednisone dose|mean daily prednisone dose
6352|NCT04158648|Mild Hemophilia A Without Factor VIII Inhibitors|mild hemophilia a without factor viii inhibitors
6353|NCT04158648|Moderate Hemophilia A Without Factor VIII Inhibitors|moderate hemophilia a without factor viii inhibitors
6354|NCT04158609|term pregnancy|term pregnancy
6355|NCT04158609|Doppler parameters|doppler parameters
6356|NCT04158609|Cerebroplacental ratio|cerebroplacental ratio
6357|NCT04158609|Induction of labor|induction of labor
6358|NCT04158583|RG6292|rg6292
6359|NCT04158544|Immune monitoring|immune monitoring
6360|NCT04158544|Immunotherapy|immunotherapy
6361|NCT04158531|cortical electrical stimulation|cortical electrical stimulation
6362|NCT04158531|seizure detection|seizure detection
6363|NCT04158531|network stimulation|network stimulation
6364|NCT04158518|Nasopharyngeal Carcinoma|nasopharyngeal carcinoma
6365|NCT04158518|De-escalation|de-escalation
6366|NCT04158505|pyrotinib|pyrotinib
6367|NCT04158492|antimicrobial stewardship|antimicrobial stewardship
6368|NCT04158492|point-of-care test|point-of-care test
6369|NCT04158492|comprehensive molecular tests|comprehensive molecular tests
6370|NCT04158492|multiple PCR|multiple pcr
6371|NCT04158453|Healthy Volunteer|healthy volunteer
6372|NCT04158453|Schizophrenia|schizophrenia
6373|NCT04158427|fatigue|fatigue
6374|NCT04158427|microbiome|microbiome
6375|NCT04158388|micronutrients|micronutrients
6376|NCT04158388|nutrition|nutrition
6377|NCT04158388|therapy|therapy
6378|NCT04158388|chronic disease|chronic disease
6379|NCT04158375|Resistance Exercise|resistance exercise
6380|NCT04158362|Abemaciclib|abemaciclib
6381|NCT04158362|Breast Cancer|breast cancer
6382|NCT04158362|High Burden Disease|high burden disease
6383|NCT04158362|Visceral Metastasis|visceral metastasis
6384|NCT04158336|Solid tumor|solid tumor
6385|NCT04158323|flexible endoscopy|flexible endoscopy
6386|NCT04158323|awake intubation|awake intubation
6387|NCT04158297|Extracorporeal shock wave lithotripsy|extracorporeal shock wave lithotripsy
6388|NCT04158297|Intraductal lithotripsy|intraductal lithotripsy
6389|NCT04158284|Quality of life|quality of life
6390|NCT04158284|Endocrinology|endocrinology
6391|NCT04158284|Oncology|oncology
6392|NCT04158284|Hypothalamus|hypothalamus
6393|NCT04158284|Irradiation|irradiation
6394|NCT04158284|Neurosurgery|neurosurgery
6395|NCT04158284|Pediatric Brain tumors|pediatric brain tumors
6396|NCT04158271|Airway Management|airway management
6397|NCT04158271|Tube Exchange|tube exchange
6398|NCT04158219|Behavioral randomized control trial|behavioral randomized control trial
6399|NCT04158219|Behavioral activation|behavioral activation
6400|NCT04158219|Multiple health behavior change|multiple health behavior change
6401|NCT04158219|Integrated care|integrated care
6402|NCT04158154|Hypertension|hypertension
6403|NCT04158154|Nigeria|nigeria
8002|NCT04148794|ultrasound|ultrasound
6404|NCT04158154|Primary Health Center|primary health center
6406|NCT04158141|IMPRINT|imprint
6407|NCT04158115|Lumber Spondylosis|lumber spondylosis
6408|NCT04158115|Segmental Mobilization|segmental mobilization
6409|NCT04158115|Spine Mobilization|spine mobilization
6410|NCT04158037|mHealth App|mhealth app
6411|NCT04158024|Erector Spinae Plane Blockade|erector spinae plane blockade
6412|NCT04158024|Pediatric Congenital Heart Disease|pediatric congenital heart disease
6413|NCT04158011|CAR T cells|car t cells
6414|NCT04158011|CNS leukemia|cns leukemia
6415|NCT04157946|Respiratory Insufficiency|respiratory insufficiency
6416|NCT04157946|Ventilator-Induced Lung Injury|ventilator-induced lung injury
6417|NCT04157946|Ventilators, Mechanical|ventilators, mechanical
6418|NCT04157920|Aortic stenosis|aortic stenosis
6419|NCT04157920|DIRECT|direct
6420|NCT04157920|ACURATE|acurate
6421|NCT04157920|TAVI|tavi
6422|NCT04157920|TAVR|tavr
6423|NCT04157920|transcatheter|transcatheter
6424|NCT04157920|valve|valve
6425|NCT04157894|Long-lasting insecticidal net|long-lasting insecticidal net
6426|NCT04157894|LLIN|llin
6427|NCT04157894|Insecticide treated net|insecticide treated net
6428|NCT04157894|ITN|itn
6429|NCT04157894|Malaria|malaria
6430|NCT04157894|Epidemiology|epidemiology
6431|NCT04157894|Anthropology|anthropology
6432|NCT04157894|Durability|durability
6433|NCT04157894|Cost-effectiveness|cost-effectiveness
6434|NCT04157868|ST-Segment Elevated Myocardial Infarction|st-segment elevated myocardial infarction
6435|NCT04157868|rhBNP|rhbnp
6436|NCT04157868|non-invasive myocardial work|non-invasive myocardial work
6437|NCT04157829|Dyslexia|dyslexia
6438|NCT04157829|Reading disorder|reading disorder
6439|NCT04157816|health worker training|health worker training
6440|NCT04157816|non-specialist health worker|non-specialist health worker
6441|NCT04157816|community health worker|community health worker
6442|NCT04157816|task sharing|task sharing
799165|NCT00257114|VELCADE|velcade
6443|NCT04157816|common mental disorders|common mental disorders
6444|NCT04157816|low-resource setting|low-resource setting
6445|NCT04157816|primary care|primary care
6446|NCT04157816|global mental health|global mental health
6447|NCT04157816|digital technology|digital technology
6448|NCT04157816|mobile health|mobile health
6449|NCT04157777|Perineum massage, perineal trauma,perineal laceration|perineum massage, perineal trauma,perineal laceration
6450|NCT04157764|Telehealth|telehealth
6451|NCT04157764|automated peritoneal dialysis|automated peritoneal dialysis
6452|NCT04157738|Diabetes|diabetes
6453|NCT04157738|Glycemic variability|glycemic variability
6454|NCT04157738|Insulin|insulin
6455|NCT04157738|Parental Stress|parental stress
6456|NCT04157738|Advanced carbohydrates counting|advanced carbohydrates counting
6457|NCT04157738|Insulin for meals|insulin for meals
6458|NCT04157699|HBeAg-positive chronic hepatitis B|hbeag-positive chronic hepatitis b
6459|NCT04157647|hemadsorption|hemadsorption
6460|NCT04157634|outcome|outcome
6461|NCT04157634|paediatric critical care|paediatric critical care
6462|NCT04157595|reproductive genetics|reproductive genetics
6463|NCT04157595|carrier screening|carrier screening
6464|NCT04157595|rare disease|rare disease
6466|NCT04157504|Burn Injury|burn injury
6467|NCT04157504|Balance|balance
6468|NCT04157504|Lower extremity function|lower extremity function
6469|NCT04157504|burn scar|burn scar
6470|NCT04157491|endometrial cancer|endometrial cancer
6471|NCT04157491|anlotinib|anlotinib
6472|NCT04157491|anti PD-1 antibody|anti pd-1 antibody
6473|NCT04157478|Glioblastoma|glioblastoma
6474|NCT04157478|Anlotinib hydrochloride|anlotinib hydrochloride
6475|NCT04157478|Stupp regimen|stupp regimen
6476|NCT04157478|Temozolomide|temozolomide
6477|NCT04157478|Radiation therapy|radiation therapy
6478|NCT04157478|Tyrosine kinase inhibitor|tyrosine kinase inhibitor
6479|NCT04157465|cirrhosis|cirrhosis
6480|NCT04157465|Acute-On-Chronic Liver Failure|acute-on-chronic liver failure
6481|NCT04157465|liposomal amphotericin B|liposomal amphotericin b
6482|NCT04157465|Invasive Fungal Infections|invasive fungal infections
6483|NCT04157465|empiric antifungal|empiric antifungal
6484|NCT04157465|pre-emptive antifungal|pre-emptive antifungal
6485|NCT04157439|Integrated Neuromuscular Inhibition Technique|integrated neuromuscular inhibition technique
6486|NCT04157439|Muscle Energy Technique|muscle energy technique
6487|NCT04157439|Neck Disability Index|neck disability index
6488|NCT04157413|amino acid intake|amino acid intake
6489|NCT04157413|blood amino acid|blood amino acid
6490|NCT04157413|stunting|stunting
6491|NCT04157413|linear growth|linear growth
6492|NCT04157413|intestinal permeability|intestinal permeability
6493|NCT04157413|lactulose mannitol ratio|lactulose mannitol ratio
6494|NCT04157387|Adhesive Capsulitis|adhesive capsulitis
6495|NCT04157387|Cyriax Manual Therapy|cyriax manual therapy
6496|NCT04157387|Stretching|stretching
6497|NCT04157361|Breath condensate|breath condensate
6498|NCT04157361|Bronchial asthma|bronchial asthma
6499|NCT04157361|Cystic Fibrosis|cystic fibrosis
6500|NCT04157348|Benralizumab|benralizumab
6501|NCT04157348|Inhaled corticosteroids|inhaled corticosteroids
6502|NCT04157348|Eosinophilic Granulomatous Vasculitis|eosinophilic granulomatous vasculitis
6503|NCT04157335|Benralizumab|benralizumab
6504|NCT04157335|Nasal Polyposis|nasal polyposis
6505|NCT04157335|Eosinophilic Chronic Rhinosinusitis with Nasal Polyposis|eosinophilic chronic rhinosinusitis with nasal polyposis
6506|NCT04157335|Nasal Polyps|nasal polyps
6507|NCT04157296|anxious|anxious
6508|NCT04157296|Cognitive behavioral therapy|cognitive behavioral therapy
6509|NCT04157296|Computerized cognitive training|computerized cognitive training
6510|NCT04157270|Large Vessel Occlusion|large vessel occlusion
6511|NCT04157270|LVO|lvo
6512|NCT04157270|Mechanical Thrombectomy|mechanical thrombectomy
6513|NCT04157270|Penumbra System|penumbra system
6514|NCT04157257|nucleoside (acid) therapy|nucleoside (acid) therapy
6515|NCT04157231|Stroke|stroke
6516|NCT04157231|Ischemic stroke|ischemic stroke
6517|NCT04157231|hemorrhagic stroke|hemorrhagic stroke
6518|NCT04157231|stroke package|stroke package
6519|NCT04157205|sudden cardiac arrest|sudden cardiac arrest
6520|NCT04157205|defibrillator|defibrillator
6521|NCT04157192|Acupuncture|acupuncture
6522|NCT04157179|extracorporeal membrane oxygenation|extracorporeal membrane oxygenation
6523|NCT04157166|Bone scan|bone scan
6524|NCT04157166|solid state gama camera CZT-based detector|solid state gama camera czt-based detector
6525|NCT04157166|hybrid SPECT/CT imaging|hybrid spect/ct imaging
6526|NCT04157166|bone metastasis|bone metastasis
6527|NCT04157140|anlotinib|anlotinib
6528|NCT04157140|HCC|hcc
6529|NCT04157140|TACE|tace
6530|NCT04157140|RFA|rfa
6531|NCT04157127|Immunotherapy|immunotherapy
6532|NCT04157127|Adjuvant therapy|adjuvant therapy
6533|NCT04157114|Alcohol-Related Disorders|alcohol-related disorders
6534|NCT04157114|Substance-Related Disorders|substance-related disorders
6535|NCT04157114|MAP4343|map4343
6536|NCT04157114|Alcohol Treatment|alcohol treatment
6537|NCT04157114|Alcohol|alcohol
11998|NCT04123483|PMS|pms
6538|NCT04157101|Pain|pain
6539|NCT04157101|Veteran|veteran
6540|NCT04157101|Health Coaching|health coaching
6541|NCT04157101|Clinical Trial|clinical trial
6542|NCT04157101|Supportive Psychotherapy|supportive psychotherapy
6543|NCT04157101|Illness beliefs|illness beliefs
6544|NCT04157062|Transcranial Magnetic Stimulation|transcranial magnetic stimulation
6545|NCT04157049|AATTD|aattd
6546|NCT04157049|ALPHA 1|alpha 1
6547|NCT04157049|COPD|copd
6548|NCT04157049|AAT|aat
6549|NCT04157049|ZZ|zz
6550|NCT04157049|MZ|mz
6551|NCT04157049|CARRIER|carrier
6552|NCT04157049|MM|mm
6553|NCT04157049|MS|ms
6554|NCT04157049|PiZZ|pizz
6555|NCT04157036|Inferior alveolar nerve block|inferior alveolar nerve block
6556|NCT04157036|Symptomatic irreversible pulpitis|symptomatic irreversible pulpitis
6557|NCT04157036|Preoperative steroid|preoperative steroid
6558|NCT04157036|Preoperative NSAID|preoperative nsaid
6559|NCT04157023|simulator|simulator
6560|NCT04157023|medical skills|medical skills
6561|NCT04156997|Lipoproteins|lipoproteins
6562|NCT04156997|Cholesterol|cholesterol
6563|NCT04156997|High Density Lipoproteins|high density lipoproteins
6564|NCT04156984|Pharmacokinetics|pharmacokinetics
6565|NCT04156984|Pharmacodynamics|pharmacodynamics
6566|NCT04156984|Safety|safety
6567|NCT04156984|Golimumab|golimumab
6568|NCT04156984|Reactive dose optimisation|reactive dose optimisation
6569|NCT04156984|Proactive dose optimisation|proactive dose optimisation
6570|NCT04156984|Golimumab concentration|golimumab concentration
6571|NCT04156984|Mucosal healing|mucosal healing
6572|NCT04156984|Therapeutic drug monitoring|therapeutic drug monitoring
6573|NCT04156984|Inflammatory bowel disease|inflammatory bowel disease
6574|NCT04156984|Personalized medicine|personalized medicine
6575|NCT04156984|Comparisons of European with US label|comparisons of european with us label
6576|NCT04156971|Childhood obesity|childhood obesity
6577|NCT04156971|Life style modification|life style modification
6578|NCT04156971|Omega 3|omega 3
6579|NCT04156971|supplementation|supplementation
6580|NCT04156958|biliary tract adenocarcinoma|biliary tract adenocarcinoma
6581|NCT04156958|fruquintinib|fruquintinib
6582|NCT04156958|anti-angiogenesis|anti-angiogenesis
6583|NCT04156945|Hepatitis C virus (HCV) reinfection|hepatitis c virus (hcv) reinfection
6584|NCT04156945|Men who have sex with men (MSM)|men who have sex with men (msm)
6585|NCT04156906|Chronic Transfusion|chronic transfusion
6586|NCT04156893|Chronic Transfusion|chronic transfusion
6587|NCT04156880|mammography|mammography
6588|NCT04156880|artificial intelligence|artificial intelligence
6589|NCT04156880|deep learning|deep learning
6590|NCT04156815|Acne vulgaris|acne vulgaris
6591|NCT04156815|Acne scars|acne scars
6592|NCT04156815|1,565 nm non-ablative fractional laser|1,565 nm non-ablative fractional laser
6593|NCT04156815|Isotretinoin|isotretinoin
6594|NCT04156815|pricking blood therapy|pricking blood therapy
6595|NCT04156802|Transcranial Magnetic Stimulation|transcranial magnetic stimulation
6596|NCT04156802|Brain Stimulation|brain stimulation
6597|NCT04156802|Treatment|treatment
6598|NCT04156802|Neuroimaging|neuroimaging
6599|NCT04156802|Alternative|alternative
6600|NCT04156776|Active Isolated Stretching|active isolated stretching
6601|NCT04156776|Muscle Energy Technique|muscle energy technique
6602|NCT04156776|Mechanical Low Back Pain|mechanical low back pain
6603|NCT04156763|Strabismus Virtual Reality Prism Cover Test|strabismus virtual reality prism cover test
6604|NCT04156711|Remote ISchemic Preconditioning (RIPC)|remote ischemic preconditioning (ripc)
6605|NCT04156711|Acute surgery|acute surgery
6606|NCT04156711|Acute cholecystitis|acute cholecystitis
6607|NCT04156711|Endothelial dysfunction|endothelial dysfunction
6608|NCT04156711|Heart Rate Variability (HRV)|heart rate variability (hrv)
6609|NCT04156685|Type2 Diabetes Mellitus|type2 diabetes mellitus
6610|NCT04156685|CKD-387|ckd-387
6611|NCT04156659|r/r B-cell ALL|r/r b-cell all
6612|NCT04156659|tisagenlecleucel|tisagenlecleucel
6613|NCT04156659|CTL019|ctl019
6614|NCT04156659|China|china
6615|NCT04156633|MALDI-TOF MS|maldi-tof ms
6616|NCT04156633|Biofire FilmArray© Blood Culture Identification (BCID) panel|biofire filmarray© blood culture identification (bcid) panel
6617|NCT04156633|shotgun metagenomic approach|shotgun metagenomic approach
6618|NCT04156620|Active axSpA, Axial spondyloarthritis, non-radiographic-axSpA, nr-axSpA, ankylosing spondylitis, AS, inflammatory back pain, sacroiliitis|active axspa, axial spondyloarthritis, non-radiographic-axspa, nr-axspa, ankylosing spondylitis, as, inflammatory back pain, sacroiliitis
6619|NCT04156607|Down Syndrome|down syndrome
6620|NCT04156607|Postural Balance|postural balance
6621|NCT04156607|Kinesio Taping|kinesio taping
6622|NCT04156594|self-assessment|self-assessment
6623|NCT04156594|post operative pulmonary complication|post operative pulmonary complication
6624|NCT04156594|ExerciseTest|exercisetest
6625|NCT04156568|Children|children
6626|NCT04156568|LTBI|ltbi
6627|NCT04156568|Intervention|intervention
6628|NCT04156555|amoxicillin-clavulanate|amoxicillin-clavulanate
6629|NCT04156555|diarrhea|diarrhea
6630|NCT04156555|Gut microbiome|gut microbiome
6631|NCT04156542|Behavioral nudges|behavioral nudges
6632|NCT04156542|Food environment|food environment
6633|NCT04156542|Choice architecture|choice architecture
6634|NCT04156542|Lasting behavior change|lasting behavior change
6635|NCT04156542|Child nutrition|child nutrition
6636|NCT04156542|National School Lunch Program|national school lunch program
6637|NCT04156529|body position|body position
6638|NCT04156529|enteral feeding intolerance|enteral feeding intolerance
6639|NCT04156529|nursing care|nursing care
6640|NCT04156529|pain|pain
6641|NCT04156529|stress|stress
6642|NCT04156503|Chylomicron|chylomicron
6643|NCT04156503|fatty acid composition|fatty acid composition
6644|NCT04156503|lard|lard
6645|NCT04156503|palm olein|palm olein
6646|NCT04156490|Ischemic stroke|ischemic stroke
6647|NCT04156490|midline shift|midline shift
6648|NCT04156464|lorazepam|lorazepam
6649|NCT04156464|phenobarbital|phenobarbital
6650|NCT04156464|ativan|ativan
6651|NCT04156464|alcohol withdrawal syndrome|alcohol withdrawal syndrome
6652|NCT04156464|alcohol withdrawal|alcohol withdrawal
6653|NCT04156464|intensive care unit|intensive care unit
6654|NCT04156464|delirium tremens|delirium tremens
6655|NCT04156464|refractory alcohol withdrawal|refractory alcohol withdrawal
6656|NCT04156464|benzodiazepine|benzodiazepine
6657|NCT04156451|Deresuscitation|deresuscitation
6658|NCT04156451|Central Venous Pressure|central venous pressure
6659|NCT04156451|Septic Shock|septic shock
6660|NCT04156451|Furosemide|furosemide
6661|NCT04156438|Airway pressure release ventilation|airway pressure release ventilation
6662|NCT04156438|low tidal volume ventilation|low tidal volume ventilation
6663|NCT04156438|APRV|aprv
6664|NCT04156438|ARDSNet ventilation|ardsnet ventilation
6665|NCT04156438|LTVV|ltvv
6666|NCT04156438|acute respiratory distress syndrome|acute respiratory distress syndrome
6667|NCT04156438|ARDS|ards
6668|NCT04156425|Major Depressive Disorder|major depressive disorder
6669|NCT04156425|neuroimmunology|neuroimmunology
6670|NCT04156425|Protein Kinase C|protein kinase c
6671|NCT04156412|quadripolar LV leads|quadripolar lv leads
6672|NCT04156399|sickle cell disease|sickle cell disease
6673|NCT04156399|pain|pain
6674|NCT04156399|chronic pain|chronic pain
6675|NCT04156399|acupuncture|acupuncture
6676|NCT04156386|Muscle Strength|muscle strength
6677|NCT04156386|Musculoskeletal Physiology|musculoskeletal physiology
6678|NCT04156386|Muscle, Skeletal|muscle, skeletal
6679|NCT04156386|Whey Proteins|whey proteins
6680|NCT04156386|Plant Proteins|plant proteins
6681|NCT04156386|Dietary supplements|dietary supplements
6682|NCT04156373|immigration|immigration
6683|NCT04156373|cultural factors|cultural factors
6684|NCT04156373|prevention|prevention
6685|NCT04156321|Moringa, quasi-experimental, vitamin A, haemoglobin|moringa, quasi-experimental, vitamin a, haemoglobin
6686|NCT04156308|osteopathy, osteopathic treatment, non-specific|osteopathy, osteopathic treatment, non-specific
6687|NCT04156269|BCMA|bcma
6689|NCT04156269|BCMA-CS1 cCAR T cells|bcma-cs1 ccar t cells
6690|NCT04156269|CD269|cd269
6691|NCT04156269|SLAMF7|slamf7
6692|NCT04156256|CD123|cd123
6693|NCT04156256|CD33|cd33
6694|NCT04156256|CD123-CD33 cCAR|cd123-cd33 ccar
6695|NCT04156256|Leukemia|leukemia
6700|NCT04156230|Ultrasonography|ultrasonography
6701|NCT04156230|Platelet Activation|platelet activation
6702|NCT04156230|Data Accuracy|data accuracy
6703|NCT04156178|CD20|cd20
6704|NCT04156178|CD19|cd19
6705|NCT04156178|cCAR|ccar
6706|NCT04156178|Leukemia|leukemia
6707|NCT04156178|Lymphoma|lymphoma
6708|NCT04156165|Body composition|body composition
6709|NCT04156165|Metabolism|metabolism
6710|NCT04156139|NPPV|nppv
6711|NCT04156139|HFNC|hfnc
6712|NCT04156139|Weaning|weaning
6713|NCT04156139|COPD|copd
6714|NCT04156139|PIC|pic
6715|NCT04156113|Beige fat cell|beige fat cell
6716|NCT04156113|Fat tissue|fat tissue
6717|NCT04156113|Athletes|athletes
6718|NCT04156113|Sedentary people|sedentary people
6719|NCT04156113|Irisin|irisin
6720|NCT04156074|Vitamin D|vitamin d
6721|NCT04156074|Bioavailability|bioavailability
6722|NCT04156074|Aging|aging
6723|NCT04156074|Fortified foods|fortified foods
6724|NCT04156074|Vitamin D status|vitamin d status
6725|NCT04156074|25-hydroxyvitamin D|25-hydroxyvitamin d
6726|NCT04156048|HIV|hiv
6727|NCT04156048|AIDS|aids
6728|NCT04156048|Antiretroviral therapy|antiretroviral therapy
6729|NCT04156048|Aging|aging
6730|NCT04156048|Heart failure|heart failure
6731|NCT04156048|coronary heart disease|coronary heart disease
6732|NCT04156048|myocardial infarction|myocardial infarction
6733|NCT04156048|HIV-associated neurocognitive disorders|hiv-associated neurocognitive disorders
6734|NCT04156022|Cervical dystonia|cervical dystonia
6735|NCT04156022|Cranial dystonia|cranial dystonia
6736|NCT04156022|Limb dystonia|limb dystonia
799166|NCT00257088|development|development
6737|NCT04156009|aromatherapy|aromatherapy
6738|NCT04156009|lavender|lavender
6739|NCT04156009|anxiety|anxiety
6740|NCT04156009|spine intervention|spine intervention
6741|NCT04155983|gonarthrosis|gonarthrosis
6742|NCT04155983|osteoarthritis|osteoarthritis
6743|NCT04155983|knee|knee
6744|NCT04155983|total knee arthroplasty|total knee arthroplasty
6745|NCT04155983|adductor canal block|adductor canal block
6746|NCT04155983|saphenous nerve block|saphenous nerve block
6747|NCT04155983|multimodal pain control|multimodal pain control
6748|NCT04155970|Manual Therapy|manual therapy
6749|NCT04155970|Fluoroscope|fluoroscope
6750|NCT04155970|Mechanics|mechanics
6751|NCT04155970|Kinematics|kinematics
6752|NCT04155944|M-PCR|m-pcr
6753|NCT04155944|FISH|fish
6754|NCT04155944|MLPA|mlpa
6755|NCT04155944|deletion|deletion
6756|NCT04155944|uniparental disomy|uniparental disomy
6757|NCT04155944|imprinting mutation|imprinting mutation
6762|NCT04155918|Hyperuricemia|hyperuricemia
6763|NCT04155918|Gout|gout
6764|NCT04155918|URAT1|urat1
6765|NCT04155905|simple anal fistula|simple anal fistula
6766|NCT04155905|marsupialization|marsupialization
6767|NCT04155892|Extubation criteria|extubation criteria
6768|NCT04155892|Pediatric Anesthesia|pediatric anesthesia
6769|NCT04155892|Outpatient surgery|outpatient surgery
6770|NCT04155853|trapeziectomy|trapeziectomy
6771|NCT04155853|fascia lata|fascia lata
6772|NCT04155853|interposition|interposition
6773|NCT04155801|Gastrointestinal Disorders, Functional|gastrointestinal disorders, functional
6774|NCT04155788|eating disorder|eating disorder
6775|NCT04155788|food exposure|food exposure
6776|NCT04155788|feared food|feared food
6777|NCT04155775|Electronic Health Records|electronic health records
6778|NCT04155775|Best Practice Alerts|best practice alerts
6779|NCT04155762|Amputees|amputees
6780|NCT04155762|Artificial Limbs|artificial limbs
6781|NCT04155762|Prosthetic designs|prosthetic designs
6782|NCT04155762|Rehabilitation of prostheses users|rehabilitation of prostheses users
6783|NCT04155762|Prosthetic suspension systems|prosthetic suspension systems
6784|NCT04155749|BCMA|bcma
6785|NCT04155749|Myeloma|myeloma
6786|NCT04155749|Chimeric|chimeric
6787|NCT04155723|Midlines|midlines
6788|NCT04155710|Autologous Peripheral Blood Lymphocytes|autologous peripheral blood lymphocytes
6789|NCT04155710|PBL|pbl
6790|NCT04155710|IOV-2001|iov-2001
6791|NCT04155710|CLL|cll
6792|NCT04155710|IL-2|il-2
6793|NCT04155710|Adoptive Cell Therapy|adoptive cell therapy
6794|NCT04155710|SLL|sll
6795|NCT04155684|microbiome|microbiome
6796|NCT04155645|Multiple Ascending Dose|multiple ascending dose
6797|NCT04155645|AZD8233|azd8233
6798|NCT04155645|Safety|safety
6799|NCT04155645|Tolerability|tolerability
6800|NCT04155645|PK|pk
6801|NCT04155645|PD|pd
6802|NCT04155606|Unruptured Intracranial Aneurysm|unruptured intracranial aneurysm
6803|NCT04155606|Endovascular treatment|endovascular treatment
6804|NCT04155606|Surgical treatment|surgical treatment
6805|NCT04155606|Conservative management|conservative management
6806|NCT04155580|AML|aml
6807|NCT04155580|Bone marrow|bone marrow
6808|NCT04155580|CMML|cmml
6809|NCT04155580|MDS|mds
6810|NCT04155580|ASTX727|astx727
6811|NCT04155580|ASTX660|astx660
6812|NCT04155580|cIAP1|ciap1
6813|NCT04155580|Cellular inhibitor of apoptosis protein|cellular inhibitor of apoptosis protein
6814|NCT04155580|XIAP|xiap
6815|NCT04155580|CDAi|cdai
6816|NCT04155580|Cytidine deaminase inhibitor|cytidine deaminase inhibitor
6817|NCT04155580|Cedazuridine|cedazuridine
6818|NCT04155580|Decitabine|decitabine
6819|NCT04155580|Acute myeloid leukemia|acute myeloid leukemia
6820|NCT04155580|Chronic myelomonocytic leukemia|chronic myelomonocytic leukemia
6821|NCT04155580|Myelodysplastic syndrome|myelodysplastic syndrome
6822|NCT04155554|HIV|hiv
6823|NCT04155554|Neurocognitive functions|neurocognitive functions
6824|NCT04155554|Neuropsychiatric side effects|neuropsychiatric side effects
6825|NCT04155554|Bictegravir|bictegravir
6826|NCT04155554|INSTI|insti
6827|NCT04155541|VIZIMPRO|vizimpro
6828|NCT04155541|EGFR mutation-positive inoperable or recurrent NSCLC|egfr mutation-positive inoperable or recurrent nsclc
6829|NCT04155541|non-small cell lung cancer|non-small cell lung cancer
6830|NCT04155528|Music therapy|music therapy
6831|NCT04155528|Pain|pain
6832|NCT04155528|Sleep quality|sleep quality
6833|NCT04155528|Abdominal surgery|abdominal surgery
6834|NCT04155515|Chronic Hepatics C Virus (HCV) Genotype 1|chronic hepatics c virus (hcv) genotype 1
6835|NCT04155515|Non-Cirrhotic|non-cirrhotic
6836|NCT04155515|Cirrhosis|cirrhosis
6837|NCT04155515|Treatment naïve|treatment naïve
6838|NCT04155515|efficacy|efficacy
6839|NCT04155515|safety|safety
6840|NCT04155515|TG-2349|tg-2349
6841|NCT04155515|DAG181|dag181
6842|NCT04155515|Ribavirin|ribavirin
6843|NCT04155502|HIV|hiv
6844|NCT04155502|Pre-exposure prophylaxis|pre-exposure prophylaxis
6845|NCT04155502|Social media|social media
6846|NCT04155502|Online advertising|online advertising
6847|NCT04155463|Dietary Intervention|dietary intervention
6848|NCT04155463|Glyphosate|glyphosate
6849|NCT04155463|Herbicide|herbicide
6850|NCT04155463|Pregnancy|pregnancy
6851|NCT04155463|Agricultural Communities|agricultural communities
6852|NCT04155463|Organic food|organic food
6853|NCT04155450|exercise|exercise
6854|NCT04155450|manipulation, spinal|manipulation, spinal
6855|NCT04155450|rehabilitation|rehabilitation
6856|NCT04155450|therapy, manual|therapy, manual
6857|NCT04155450|manual therapy|manual therapy
6858|NCT04155437|maternal nutrition|maternal nutrition
6859|NCT04155437|antenatal care|antenatal care
6860|NCT04155437|Burkina Faso|burkina faso
6861|NCT04155424|Neuromyelitis Optica|neuromyelitis optica
6862|NCT04155424|Neuromyelitis Optica Spectrum Disorder|neuromyelitis optica spectrum disorder
6863|NCT04155424|Devic's Disease|devic's disease
6864|NCT04155424|Transverse Myelitis|transverse myelitis
6865|NCT04155424|Optic Neuritis|optic neuritis
6866|NCT04155424|Relapse|relapse
6867|NCT04155424|Eculizumab|eculizumab
6868|NCT04155424|Soliris|soliris
6869|NCT04155424|CNS Autoimmune Disorders|cns autoimmune disorders
6870|NCT04155424|Demyelinating Disorders|demyelinating disorders
6871|NCT04155424|NMO|nmo
6872|NCT04155424|NMOSD|nmosd
6873|NCT04155411|Dasatinib, CML-CP|dasatinib, cml-cp
6874|NCT04155398|liver stiffness|liver stiffness
6875|NCT04155398|EUS elastography|eus elastography
6876|NCT04155372|sports nutrition|sports nutrition
6877|NCT04155372|dehydration|dehydration
6878|NCT04155372|sports medicine|sports medicine
6879|NCT04155372|rehydration|rehydration
6880|NCT04155372|ingestion rate|ingestion rate
6881|NCT04155346|Exercise|exercise
6882|NCT04155346|Nutrition|nutrition
6883|NCT04155346|Psychology|psychology
6884|NCT04155346|Prehabilitation|prehabilitation
6885|NCT04155320|contact tracing|contact tracing
6886|NCT04155320|HIV prevention|hiv prevention
6887|NCT04155320|partner notification|partner notification
6888|NCT04155294|HPV infection|hpv infection
6889|NCT04155294|Women|women
6890|NCT04155294|HIV Infection|hiv infection
6891|NCT04155294|Cervical cancer|cervical cancer
6892|NCT04155294|Screening|screening
6893|NCT04155268|Healthy|healthy
6894|NCT04155268|Virtual Reality|virtual reality
6895|NCT04155268|Floatation-REST|floatation-rest
6896|NCT04155268|Float Tank|float tank
6897|NCT04155268|Floating|floating
6898|NCT04155268|Overview Effect|overview effect
6899|NCT04155242|Barrett's oesophagus|barrett's oesophagus
6900|NCT04155242|Radiofrequency ablation|radiofrequency ablation
6901|NCT04155242|Early Oesophageal Neoplasia|early oesophageal neoplasia
6902|NCT04155190|High Frequency Basal Cell Carcinoma|high frequency basal cell carcinoma
6903|NCT04155190|non-gorlin|non-gorlin
6904|NCT04155190|HF-BCC|hf-bcc
6905|NCT04155190|Bazex-Dupré-Christol Syndrome|bazex-dupré-christol syndrome
6906|NCT04155190|Rombo Syndrome|rombo syndrome
6907|NCT04155190|Oley Syndrome|oley syndrome
6908|NCT04155190|Xeroderma Pigmentosum (XP) Syndrome|xeroderma pigmentosum (xp) syndrome
6909|NCT04155190|BCC|bcc
6910|NCT04155190|SEB|seb
6911|NCT04155190|Hedgehog inhibitor|hedgehog inhibitor
6912|NCT04155190|Basal Cell Nevus Syndrome|basal cell nevus syndrome
6913|NCT04155190|Basal Cell Carcinoma|basal cell carcinoma
6914|NCT04155190|Surgically Eligible Basal Cell Carcinoma|surgically eligible basal cell carcinoma
6915|NCT04155190|patidegib|patidegib
6916|NCT04155190|HFBCC|hfbcc
6917|NCT04155190|HHI|hhi
6918|NCT04155177|Caesarean|caesarean
6919|NCT04155177|surgery|surgery
6920|NCT04155177|training|training
6921|NCT04155177|obstetrics|obstetrics
6922|NCT04155164|Primary Open Angle Glaucoma|primary open angle glaucoma
6923|NCT04155164|Metformin|metformin
6924|NCT04155164|Visual function|visual function
6925|NCT04155138|cochlear implant|cochlear implant
6926|NCT04155138|hearing aid|hearing aid
6927|NCT04155138|cros device|cros device
6928|NCT04155138|bimodal|bimodal
6929|NCT04155099|encephalopathy|encephalopathy
6930|NCT04155086|autoimmune disease|autoimmune disease
6931|NCT04155086|pregnancy|pregnancy
6932|NCT04155086|free fetal DNA circulant|free fetal dna circulant
6933|NCT04155060|hyperlactatemia|hyperlactatemia
6934|NCT04155047|Chronic Obstructive Pulmonary Disease (COPD)|chronic obstructive pulmonary disease (copd)
6935|NCT04154995|Long-term recovery|long-term recovery
6936|NCT04154995|Critical Illness|critical illness
6937|NCT04154982|Electrophysiology|electrophysiology
6938|NCT04154982|Arrhythmias|arrhythmias
6939|NCT04154982|Arrhythmia ablation|arrhythmia ablation
6940|NCT04154982|Ionizing radiation risk|ionizing radiation risk
6941|NCT04154982|Oxidative stress|oxidative stress
6942|NCT04154982|DNA damage biomarkers|dna damage biomarkers
6943|NCT04154969|balance|balance
6944|NCT04154969|gait|gait
6945|NCT04154969|post stroke rehabilitation|post stroke rehabilitation
6946|NCT04154943|CSCC|cscc
6947|NCT04154943|Stage II|stage ii
12549|NCT04120233|PK|pk
6948|NCT04154943|Stage III|stage iii
6949|NCT04154943|Stage IV|stage iv
6950|NCT04154943|CSCC of Head/neck|cscc of head/neck
6951|NCT04154943|CSCC of Extremity|cscc of extremity
6952|NCT04154943|CSCC of Trunk|cscc of trunk
6953|NCT04154930|Tear Trough|tear trough
6954|NCT04154917|Discharge planning|discharge planning
6955|NCT04154917|Frail older adults|frail older adults
6956|NCT04154917|Comprehensive approach|comprehensive approach
6957|NCT04154917|Patient-centered intervention|patient-centered intervention
6958|NCT04154904|automated insulin delivery systems|automated insulin delivery systems
6959|NCT04154904|Context patterns|context patterns
6960|NCT04154891|Rare disease|rare disease
6961|NCT04154891|Next generation sequencing genome|next generation sequencing genome
6962|NCT04154891|Diagnostic study|diagnostic study
6963|NCT04154891|Medico-economic study|medico-economic study
6964|NCT04154839|Atopic dermatitis|atopic dermatitis
6965|NCT04154839|Genetics|genetics
6966|NCT04154839|Eczema|eczema
6967|NCT04154839|Epidemiology|epidemiology
6968|NCT04154800|Healthy Volunteers|healthy volunteers
6969|NCT04154787|Idiopathic membranous nephropathy, MN.|idiopathic membranous nephropathy, mn.
6970|NCT04154761|Inferior vena cava|inferior vena cava
6971|NCT04154761|radical resection|radical resection
6972|NCT04154761|Vascular reconstruction|vascular reconstruction
6973|NCT04154748|Barretts Esophagus|barretts esophagus
6974|NCT04154748|Dysplasia|dysplasia
6975|NCT04154748|Argon Plasma Coagulation|argon plasma coagulation
6976|NCT04154748|Endoscopic Treatment|endoscopic treatment
6977|NCT04154735|Autologous Stem Cell Transplantation|autologous stem cell transplantation
6978|NCT04154735|Hematopoietic Stem Cell Transplant|hematopoietic stem cell transplant
6979|NCT04154722|XDR TYPHOID FEVER|xdr typhoid fever
6980|NCT04154696|Steatotic liver graft|steatotic liver graft
6981|NCT04154696|Liver transplantation|liver transplantation
6982|NCT04154696|Normothermic perfusion|normothermic perfusion
6983|NCT04154683|salpingectomy|salpingectomy
6984|NCT04154683|Cellvizio®|cellvizio®
6985|NCT04154683|optical biopsy|optical biopsy
6986|NCT04154683|unilateral or bilateral salpingectomy|unilateral or bilateral salpingectomy
6987|NCT04154683|ovariectomy|ovariectomy
6988|NCT04154683|Endometriosis|endometriosis
6989|NCT04154683|surgery for cervical|surgery for cervical
6990|NCT04154683|ovarian cancer|ovarian cancer
6991|NCT04154657|HFpEF|hfpef
6992|NCT04154657|pulmonary hypertension|pulmonary hypertension
6993|NCT04154644|Cryotherapy|cryotherapy
6994|NCT04154605|Cryotherapy|cryotherapy
6995|NCT04154605|Cryoablation|cryoablation
6996|NCT04154592|rotator cuff|rotator cuff
6997|NCT04154592|tear|tear
6998|NCT04154592|rehabilitation|rehabilitation
6999|NCT04154579|Chronic health conditions|chronic health conditions
7000|NCT04154579|Arts-based program|arts-based program
7001|NCT04154579|Health education program|health education program
7002|NCT04154579|Health|health
7003|NCT04154579|Resilience|resilience
7004|NCT04154579|Well-being|well-being
7005|NCT04154566|Hemiplegic cerebral palsy|hemiplegic cerebral palsy
7006|NCT04154566|inhibitory control of executive functions.|inhibitory control of executive functions.
7007|NCT04154566|aerobic exercise.|aerobic exercise.
7008|NCT04154553|pharmacogenetics|pharmacogenetics
7009|NCT04154553|single nucleotide polymorphism|single nucleotide polymorphism
7010|NCT04154553|absorption, distribution, metabolism and excretion (ADME)|absorption, distribution, metabolism and excretion (adme)
7011|NCT04154553|genotyping|genotyping
7012|NCT04154553|pharmacogenetic testing|pharmacogenetic testing
7013|NCT04154540|Gait|gait
7014|NCT04154540|Balance|balance
7015|NCT04154540|Posture|posture
7016|NCT04154540|Charcot-Marie-Tooth|charcot-marie-tooth
7017|NCT04154540|Chronic inflammatory demyelinating polyneuropathy|chronic inflammatory demyelinating polyneuropathy
7018|NCT04154527|pelvic floor|pelvic floor
7019|NCT04154527|abdominal muscles|abdominal muscles
7020|NCT04154527|ultrasonography|ultrasonography
7021|NCT04154527|postpartum|postpartum
7022|NCT04154501|Chronic Pain|chronic pain
7023|NCT04154501|Nociceptive Pain|nociceptive pain
7024|NCT04154501|Mixed Pain|mixed pain
7025|NCT04154501|Cannabinoid|cannabinoid
7026|NCT04154501|Cannabinoid-2 Receptor Agonist|cannabinoid-2 receptor agonist
7027|NCT04154475|yogurt|yogurt
7028|NCT04154475|dairy|dairy
7029|NCT04154475|calcium|calcium
7030|NCT04154475|weight reduction|weight reduction
7031|NCT04154475|obesity|obesity
7032|NCT04154475|randomized controlled trial|randomized controlled trial
7033|NCT04154475|body composition|body composition
7034|NCT04154475|microbiome|microbiome
7035|NCT04154462|workforce|workforce
7036|NCT04154462|medical records|medical records
7037|NCT04154462|documentation|documentation
7038|NCT04154462|efficiency|efficiency
7039|NCT04154462|patient satisfaction|patient satisfaction
7040|NCT04154423|Premature Birth|premature birth
7041|NCT04154423|Group Prenatal Care|group prenatal care
799266|NCT00256724|blood loss|blood loss
7042|NCT04154423|Respectful Care|respectful care
7043|NCT04154423|Patient Satisfaction|patient satisfaction
7044|NCT04154423|Prenatal Depression and Anxiety|prenatal depression and anxiety
7045|NCT04154423|Low Income|low income
7046|NCT04154423|Health Inequity|health inequity
7047|NCT04154423|Prenatal Care|prenatal care
7048|NCT04154410|Pre-operative anxiety|pre-operative anxiety
7049|NCT04154410|pupillometry|pupillometry
7050|NCT04154410|heart rate variability|heart rate variability
7051|NCT04154410|cardiac coherence state|cardiac coherence state
7052|NCT04154410|ambulatory surgery|ambulatory surgery
7053|NCT04154397|Motor learning|motor learning
7054|NCT04154397|Cerebellum transcranial electrical stimulation|cerebellum transcranial electrical stimulation
7055|NCT04154397|Postural balance|postural balance
7056|NCT04154397|Error feedback|error feedback
7057|NCT04154397|Electroencephalography|electroencephalography
7058|NCT04154397|Elderly|elderly
7059|NCT04154384|Orthopedic surgery|orthopedic surgery
7060|NCT04154384|Opioid addiction|opioid addiction
7061|NCT04154384|Rehabilitation|rehabilitation
7062|NCT04154384|Behavioral research|behavioral research
7063|NCT04154371|Electromyography|electromyography
7064|NCT04154371|Virtual Reality|virtual reality
7065|NCT04154319|HPV vaccination|hpv vaccination
7066|NCT04154319|Healthy Eating|healthy eating
7067|NCT04154319|Latina immigrants|latina immigrants
7068|NCT04154306|Isoflavones|isoflavones
7069|NCT04154306|Red clover|red clover
7070|NCT04154306|Muscle Function|muscle function
7071|NCT04154306|Postmenopausal women|postmenopausal women
7072|NCT04154267|Kidney Transplantation|kidney transplantation
7073|NCT04154267|Protocol Biopsies|protocol biopsies
7074|NCT04154267|Kidney Transplant Rejection|kidney transplant rejection
7075|NCT04154228|Lymphoma|lymphoma
7076|NCT04154228|Non Hodgkin Lymphoma|non hodgkin lymphoma
7077|NCT04154228|Follicular Lymphoma|follicular lymphoma
7078|NCT04154189|Osteosarcoma|osteosarcoma
7079|NCT04154189|Lenvatinib|lenvatinib
7080|NCT04154189|Ifosfamide|ifosfamide
7081|NCT04154189|Etoposide|etoposide
7082|NCT04154189|E7080|e7080
7083|NCT04154189|Relapsed or Refractory Osteosarcoma|relapsed or refractory osteosarcoma
7084|NCT04154189|Pediatrics|pediatrics
7085|NCT04154189|Chemotherapy|chemotherapy
7086|NCT04154137|non-celiac wheat sensitivity|non-celiac wheat sensitivity
7087|NCT04154137|celiac disease|celiac disease
7088|NCT04154137|wheat allergy|wheat allergy
7089|NCT04154111|Transcranial Magnetic Stimulation|transcranial magnetic stimulation
7090|NCT04154111|Brain Stimulation|brain stimulation
7091|NCT04154111|Treatment|treatment
7092|NCT04154111|Neuroimaging|neuroimaging
7093|NCT04154098|Scapula alata|scapula alata
7094|NCT04154098|Scapular winging|scapular winging
7095|NCT04154098|Scapula orthosis|scapula orthosis
7096|NCT04154098|Range of Motion|range of motion
7097|NCT04154098|Movement control|movement control
7098|NCT04154098|Manual Scapula Assistance|manual scapula assistance
7099|NCT04154085|Narrative therapy|narrative therapy
7100|NCT04154085|Group therapy|group therapy
7101|NCT04154059|Rehabilitation|rehabilitation
7102|NCT04154059|Arthrosis|arthrosis
7103|NCT04154059|Therapeutic exercises|therapeutic exercises
7105|NCT04154020|tenotomy|tenotomy
7109|NCT04153955|Thrombectomy|thrombectomy
7110|NCT04153955|Ischemia|ischemia
7111|NCT04153955|Cerebrovascular Disorders|cerebrovascular disorders
7112|NCT04153955|Brain Diseases|brain diseases
7113|NCT04153955|Recovery|recovery
7114|NCT04153942|Mobilization|mobilization
7115|NCT04153942|Thrombolysis|thrombolysis
7116|NCT04153942|Ischemia|ischemia
7117|NCT04153942|Cerebrovascular Disorders|cerebrovascular disorders
7118|NCT04153942|Brain Diseases|brain diseases
7119|NCT04153942|Recovery|recovery
7120|NCT04153916|Eye blinking, facial nerve paralysis, nano electrode|eye blinking, facial nerve paralysis, nano electrode
7121|NCT04153890|advanced heart failure, breathlessness, supportive care|advanced heart failure, breathlessness, supportive care
7122|NCT04153864|Depression|depression
7123|NCT04153864|Anxiety|anxiety
7124|NCT04153864|Maternal mental health|maternal mental health
7125|NCT04153864|Behavioral Activation|behavioral activation
7126|NCT04153838|Neuropsychology|neuropsychology
7127|NCT04153825|Physical therapy modalities|physical therapy modalities
7128|NCT04153825|Osteoarthritis knee|osteoarthritis knee
7129|NCT04153825|Central nervous system sensitization|central nervous system sensitization
7130|NCT04153825|Pain|pain
7131|NCT04153825|Electric Stimulation Therapy|electric stimulation therapy
7132|NCT04153799|EGFR|egfr
7133|NCT04153799|CAR-T cells|car-t cells
7134|NCT04153799|NSCLC|nsclc
7135|NCT04153760|deep vein thrombosis|deep vein thrombosis
7136|NCT04153760|pulmonary embolism|pulmonary embolism
7137|NCT04153760|postpartum|postpartum
7138|NCT04153760|pregnancy|pregnancy
7139|NCT04153760|thrombophilia|thrombophilia
7140|NCT04153760|cesarean delivery|cesarean delivery
7141|NCT04153760|pre-eclampsia|pre-eclampsia
7142|NCT04153760|postpartum hemorrhage|postpartum hemorrhage
7143|NCT04153734|Pembrolizumab|pembrolizumab
7144|NCT04153734|Platinum doublets|platinum doublets
7145|NCT04153734|Non-small cell lung cancer|non-small cell lung cancer
7146|NCT04153734|Without radiation|without radiation
7147|NCT04153734|Locally advanced|locally advanced
7148|NCT04153734|PD-L1 ≥50%|pd-l1 ≥50%
7149|NCT04153721|enhanced recovery|enhanced recovery
7150|NCT04153721|rehabilitation|rehabilitation
7151|NCT04153721|prehabilitation|prehabilitation
7152|NCT04153721|patient engagement|patient engagement
7153|NCT04153721|digital health|digital health
7154|NCT04153721|e-health|e-health
7155|NCT04153721|colorectal surgery|colorectal surgery
7156|NCT04153721|preparation|preparation
7157|NCT04153721|follow-up|follow-up
7158|NCT04153721|patient empowerment|patient empowerment
7159|NCT04153708|hepatitis C|hepatitis c
7160|NCT04153708|lost to follow-up|lost to follow-up
7161|NCT04153708|microelimination|microelimination
7162|NCT04153695|Pregnant|pregnant
7163|NCT04153695|Anxiety|anxiety
7164|NCT04153695|Depression.|depression.
7165|NCT04153695|Flamenco music|flamenco music
7166|NCT04153682|Antimicrobial stewardship|antimicrobial stewardship
7167|NCT04153682|hospital-acquired pneumonia|hospital-acquired pneumonia
7168|NCT04153682|syndromic approach|syndromic approach
7169|NCT04153682|rapid diagnostic testing|rapid diagnostic testing
7170|NCT04153669|Cystic Fibrosis|cystic fibrosis
7171|NCT04153669|Electrostimulation|electrostimulation
7172|NCT04153669|Combined Training|combined training
7173|NCT04153669|Physical Fitness|physical fitness
7174|NCT04153656|Burnout|burnout
7175|NCT04153656|Nurse wellbeing|nurse wellbeing
7176|NCT04153656|Physician burnout|physician burnout
7177|NCT04153656|Nurse burnout|nurse burnout
7178|NCT04153617|Saciety|saciety
7179|NCT04153617|Honey|honey
7180|NCT04153617|Fiber|fiber
7181|NCT04153617|Polyphenols|polyphenols
7182|NCT04153617|Visual Analogue Scale|visual analogue scale
7183|NCT04153617|Cross-over|cross-over
7184|NCT04153617|Parallel|parallel
7187|NCT04153552|Natural|natural
7188|NCT04153552|Supplement|supplement
7189|NCT04153539|Traffic-related pollution|traffic-related pollution
7190|NCT04153539|Randomized controlled trial|randomized controlled trial
7191|NCT04153539|Acute health effects|acute health effects
7192|NCT04153487|Transfusion Reaction|transfusion reaction
7193|NCT04153487|Transfusion Related Complication|transfusion related complication
7194|NCT04153487|Acute Lung Injury|acute lung injury
7195|NCT04153487|Critical Care|critical care
7196|NCT04153474|Percutaneous nephrolithotomy (PNL)|percutaneous nephrolithotomy (pnl)
7197|NCT04153474|Nephrostomy tube (NT)|nephrostomy tube (nt)
7198|NCT04153474|Pain|pain
7199|NCT04153474|Patient satisfaction|patient satisfaction
7200|NCT04153461|urolithiasis|urolithiasis
7201|NCT04153461|stone, renal|stone, renal
7202|NCT04153461|nephrolithiasis|nephrolithiasis
7203|NCT04153461|PNL|pnl
7204|NCT04153461|PCNL|pcnl
7216|NCT04153422|Intravenous Immunoglobulin|intravenous immunoglobulin
7218|NCT04153422|Gammagard|gammagard
7219|NCT04153422|TS-HDS antibody|ts-hds antibody
7220|NCT04153422|FGFR-3 antibody|fgfr-3 antibody
7221|NCT04153422|FGFR3 antibody|fgfr3 antibody
7222|NCT04153422|Immune mediated small fiber neuropathy|immune mediated small fiber neuropathy
7223|NCT04153396|Pain, Postoperative|pain, postoperative
7224|NCT04153396|Betamethasone;|betamethasone;
7225|NCT04153396|Ropivacaine;|ropivacaine;
7226|NCT04153396|Wound Infiltration|wound infiltration
7227|NCT04153396|Laminoplasty or Laminectomy|laminoplasty or laminectomy
7228|NCT04153383|Milrinone|milrinone
7229|NCT04153383|diastolic function|diastolic function
7230|NCT04153370|airtraq|airtraq
7231|NCT04153370|glidescope|glidescope
7232|NCT04153370|c-mac|c-mac
7233|NCT04153370|videolaryngoscope|videolaryngoscope
7234|NCT04153370|intubation|intubation
7235|NCT04153370|infant|infant
7236|NCT04153357|airtraq|airtraq
7237|NCT04153357|glidescope|glidescope
7238|NCT04153357|c-mac|c-mac
7239|NCT04153357|videolaryngoscope|videolaryngoscope
7240|NCT04153357|pediatric|pediatric
7241|NCT04153357|intubatioon|intubatioon
7242|NCT04153344|Neurofibromatosis type 1|neurofibromatosis type 1
7243|NCT04153344|Infrared hyperreflective areas|infrared hyperreflective areas
7244|NCT04153344|Hyperactivity of the pigment epithelium|hyperactivity of the pigment epithelium
7245|NCT04153344|Electro-oculogram|electro-oculogram
7246|NCT04153344|Electroretinogram|electroretinogram
7247|NCT04153305|survival|survival
7248|NCT04153305|acute leukemia|acute leukemia
7249|NCT04153305|second cancer|second cancer
7250|NCT04153305|cardiovascular complication|cardiovascular complication
7251|NCT04153305|update|update
7252|NCT04153305|disease management|disease management
7253|NCT04153266|oral epithelial dysplasia|oral epithelial dysplasia
7254|NCT04153266|Precancerous Conditions|precancerous conditions
7255|NCT04153266|Precancerous Lesions|precancerous lesions
7256|NCT04153266|Information Seeking Behavior|information seeking behavior
7257|NCT04153266|Patient Preference|patient preference
7258|NCT04153266|Oral Disease|oral disease
7259|NCT04153266|Dental Diseases|dental diseases
7260|NCT04153266|Dysplasia|dysplasia
7261|NCT04153266|Quality of Life|quality of life
7262|NCT04153266|Patient Satisfaction|patient satisfaction
7263|NCT04153266|Patient Participation|patient participation
7264|NCT04153266|information needs|information needs
7265|NCT04153266|patient education|patient education
7266|NCT04153266|patient information leaflet|patient information leaflet
7267|NCT04153253|Aflibercept|aflibercept
7268|NCT04153253|panretinal photocoagulation|panretinal photocoagulation
7269|NCT04153253|vitrectomy|vitrectomy
7270|NCT04153240|Positional Therapy|positional therapy
7271|NCT04153240|Quality of Life|quality of life
7272|NCT04153227|Osteoporosis|osteoporosis
7273|NCT04153227|Trabecular bone score|trabecular bone score
7274|NCT04153227|FRAX|frax
7275|NCT04153227|Radical cystectomy|radical cystectomy
7276|NCT04153227|Fracture risk|fracture risk
7277|NCT04153227|Metabolic acidosis|metabolic acidosis
7278|NCT04153227|Vertebral fracture assessment|vertebral fracture assessment
7279|NCT04153214|Cardiometabolic health|cardiometabolic health
7280|NCT04153214|Sedentary Behavior|sedentary behavior
7281|NCT04153214|Active workstation|active workstation
7282|NCT04153214|Cycling desk|cycling desk
7283|NCT04153201|antiphospholipid antibody titers|antiphospholipid antibody titers
7284|NCT04153201|thrombosis prevention|thrombosis prevention
7285|NCT04153201|hydroxychloroquine|hydroxychloroquine
7286|NCT04153201|antimalarials|antimalarials
7287|NCT04153201|antiphospholipid syndrome|antiphospholipid syndrome
7288|NCT04153188|Erythema|erythema
7289|NCT04153188|Rosacea|rosacea
7290|NCT04153188|Telangiectasia|telangiectasia
7291|NCT04153188|pulsed dye laser|pulsed dye laser
7292|NCT04153188|oxymetazoline hydrochloride 1% cream|oxymetazoline hydrochloride 1% cream
7314|NCT04153136|Natriuretic Peptides|natriuretic peptides
7315|NCT04153136|Myocardial Dysfunction|myocardial dysfunction
7316|NCT04153136|Cardiovascular Disease|cardiovascular disease
7318|NCT04153123|cataract surgery|cataract surgery
7319|NCT04153123|peribulbar block|peribulbar block
7320|NCT04153123|ocular Doppler|ocular doppler
7321|NCT04153110|Transcranial direct current stimulation|transcranial direct current stimulation
7322|NCT04153110|Transcranial magnetic stimulation|transcranial magnetic stimulation
7323|NCT04153110|Spinocerebellar ataxia|spinocerebellar ataxia
7324|NCT04153110|Cerebellar ataxia|cerebellar ataxia
7325|NCT04153097|Non-small Cell Lung Cancer|non-small cell lung cancer
7326|NCT04153084|Pediatric colonoscopy|pediatric colonoscopy
7327|NCT04153084|Endoscopic preparations|endoscopic preparations
7328|NCT04153084|PEG|peg
7329|NCT04153084|Sodium picosulfate|sodium picosulfate
7330|NCT04153084|Bohm solution|bohm solution
7331|NCT04153084|Movicol|movicol
7332|NCT04153084|Picoprep|picoprep
7333|NCT04153084|Colonoscopic examination|colonoscopic examination
7334|NCT04153032|Anal fissure|anal fissure
7335|NCT04153032|MEBO|mebo
7336|NCT04153032|topical diltiazem|topical diltiazem
7337|NCT04153032|MEBO/Diltiazem combination|mebo/diltiazem combination
7338|NCT04153019|cancer cachexia|cancer cachexia
7339|NCT04153019|psychoeducational intervention|psychoeducational intervention
7340|NCT04153019|rehabilitative intervention|rehabilitative intervention
7341|NCT04153019|dyad|dyad
7342|NCT04153019|palliative care|palliative care
7343|NCT04153006|Troponin|troponin
7344|NCT04153006|Point-of-care|point-of-care
7345|NCT04153006|Minicare|minicare
7346|NCT04152980|Pentoxifylline|pentoxifylline
7347|NCT04152980|preterm infants|preterm infants
7348|NCT04152980|sepsis treatment|sepsis treatment
7349|NCT04152980|dose optimization|dose optimization
7350|NCT04152967|PTFE valved conduit|ptfe valved conduit
7351|NCT04152967|right ventricular outflow tract|right ventricular outflow tract
7352|NCT04152863|programmed cell death 1 (PD-1, PD1)|programmed cell death 1 (pd-1, pd1)
7353|NCT04152863|programmed cell death ligand 1 (PD-L1, PDL1)|programmed cell death ligand 1 (pd-l1, pdl1)
7354|NCT04152863|programmed cell death ligand 2 (PD-L2, PDL2)|programmed cell death ligand 2 (pd-l2, pdl2)
7355|NCT04152863|Coxsackievirus A21|coxsackievirus a21
7356|NCT04152863|Intracellular Adhesion Molecule-1 (ICAM-1)|intracellular adhesion molecule-1 (icam-1)
7357|NCT04152850|Depression|depression
7358|NCT04152850|Anxiety|anxiety
7359|NCT04152850|Lifestyle Medicine|lifestyle medicine
7360|NCT04152850|Self-help|self-help
7361|NCT04152824|Physical Health|physical health
7362|NCT04152824|Psychological Health|psychological health
7363|NCT04152824|Well-Being|well-being
7364|NCT04152824|Resilience|resilience
7365|NCT04152824|Readiness|readiness
7366|NCT04152824|Military|military
7367|NCT04152824|Service Member|service member
7368|NCT04152811|nutrition|nutrition
7369|NCT04152811|cooking|cooking
7370|NCT04152811|diabetes self-management education|diabetes self-management education
7371|NCT04152785|environmental concerns|environmental concerns
7372|NCT04152785|nutrient profiling|nutrient profiling
7373|NCT04152772|safety memory|safety memory
7374|NCT04152772|PTSD|ptsd
7375|NCT04152772|tDCS|tdcs
7376|NCT04152772|ventromedial prefrontal cortex|ventromedial prefrontal cortex
7377|NCT04152772|fear conditioning|fear conditioning
7378|NCT04152746|Adenoid Hypertrophy|adenoid hypertrophy
7379|NCT04152746|Periostin|periostin
7380|NCT04152720|CAUTI|cauti
7381|NCT04152720|Catheter-associated urinary tract infection|catheter-associated urinary tract infection
7382|NCT04152720|Prevention of infection Foley Catheter|prevention of infection foley catheter
7383|NCT04152681|Apatinib|apatinib
7384|NCT04152681|Radiation-induced brain injury|radiation-induced brain injury
7385|NCT04152668|Peri-implantitis|peri-implantitis
7386|NCT04152668|Air-polishing|air-polishing
7387|NCT04152668|Erythritol|erythritol
7388|NCT04152616|Stroke|stroke
7389|NCT04152616|postural asymmetry|postural asymmetry
7390|NCT04152616|sitting balance|sitting balance
7391|NCT04152577|Lenalidomide，rituximab，chemotherapy，highly aggressive B-NHL|lenalidomide，rituximab，chemotherapy，highly aggressive b-nhl
7392|NCT04152551|hearing loss|hearing loss
7393|NCT04152551|bisphosphonate|bisphosphonate
7394|NCT04152551|skeletal dysplasia|skeletal dysplasia
7395|NCT04152551|brittle bone disorder|brittle bone disorder
7396|NCT04152551|osteogenesis imperfecta|osteogenesis imperfecta
7397|NCT04152551|OI|oi
7398|NCT04152525|Mindfulness|mindfulness
7399|NCT04152525|Theory|theory
7400|NCT04152512|Questionnaire|questionnaire
7401|NCT04152512|EORTC QLQ C30 + VU34|eortc qlq c30 + vu34
7402|NCT04152512|Hospital Depression and Anxiety Scale|hospital depression and anxiety scale
7403|NCT04152512|EORTC-PATSAT|eortc-patsat
7404|NCT04152512|Supportive Care Needs Survey Short Form|supportive care needs survey short form
7405|NCT04152499|TROP2, ADC|trop2, adc
7406|NCT04152473|non-alcoholic steatohepatitis|non-alcoholic steatohepatitis
7407|NCT04152460|Bulk-fill resin Composite|bulk-fill resin composite
7408|NCT04152460|Thermo-Viscous resin Composite|thermo-viscous resin composite
7409|NCT04152460|Proximal Compound Cavities|proximal compound cavities
7410|NCT04152408|diabetes management|diabetes management
7411|NCT04152408|continuous glucose monitoring|continuous glucose monitoring
7412|NCT04152395|Metabolic Syndrome|metabolic syndrome
7413|NCT04152395|EVAR|evar
7414|NCT04152369|ESBL+|esbl+
7415|NCT04152369|Antimicrobial prophylaxis|antimicrobial prophylaxis
7416|NCT04152343|Radiofrequency Ablation|radiofrequency ablation
7417|NCT04152330|Congenital heart disease|congenital heart disease
7418|NCT04152330|Children developmental|children developmental
7419|NCT04152330|Parents training|parents training
7420|NCT04152317|Operative Hysteroscopy|operative hysteroscopy
7421|NCT04152317|Misoprostol|misoprostol
7422|NCT04152304|shoulder instability|shoulder instability
7423|NCT04152304|feasibility studies|feasibility studies
7424|NCT04152304|neuromuscular exercise|neuromuscular exercise
7425|NCT04152291|Atherosclerosis|atherosclerosis
7426|NCT04152291|E-EPA|e-epa
7427|NCT04152291|LDL aggregation susceptibility|ldl aggregation susceptibility
7428|NCT04152291|Lipidomics|lipidomics
7429|NCT04152291|Resolvins|resolvins
7430|NCT04152291|PON-1|pon-1
7431|NCT04152291|LCAT|lcat
7432|NCT04152291|PLTP|pltp
7433|NCT04152291|CETP|cetp
7434|NCT04152291|Proteglycan binding|proteglycan binding
7435|NCT04152265|colorectal cancer|colorectal cancer
7436|NCT04152265|zearalenone|zearalenone
7437|NCT04152265|mycotoxin|mycotoxin
7438|NCT04152265|gastrointestinal bacterial|gastrointestinal bacterial
7439|NCT04152252|OHCA|ohca
7440|NCT04152252|Feedback|feedback
7441|NCT04152252|CPR quality|cpr quality
7442|NCT04152239|enteroscopy|enteroscopy
7443|NCT04152226|Dermatophytes|dermatophytes
7444|NCT04152226|Dysbiosis|dysbiosis
7445|NCT04152226|Microbiome|microbiome
7446|NCT04152213|Chinese adult|chinese adult
7447|NCT04152213|obesity|obesity
7448|NCT04152213|low glycemic index diet|low glycemic index diet
7449|NCT04152213|cardiometabolic|cardiometabolic
7450|NCT04152200|PH1|ph1
7451|NCT04152200|Primary Hyperoxaluria|primary hyperoxaluria
7452|NCT04152200|Hyperoxaluria|hyperoxaluria
7453|NCT04152200|RNAi Therapeutic|rnai therapeutic
7454|NCT04152200|siRNA|sirna
7455|NCT04152200|AGT|agt
7456|NCT04152200|Systemic Oxalosis|systemic oxalosis
7457|NCT04152187|pulmonary hypertension|pulmonary hypertension
7458|NCT04152187|inspiratory muscle training|inspiratory muscle training
7459|NCT04152187|muscle weakness|muscle weakness
7460|NCT04152174|blood purification|blood purification
7461|NCT04152174|CRRT|crrt
7462|NCT04152174|septic shock|septic shock
7463|NCT04152174|neurosurgery|neurosurgery
7464|NCT04152174|cytokine removal|cytokine removal
7465|NCT04152161|Mycobacterium tuberculosis infection|mycobacterium tuberculosis infection
7466|NCT04152161|Healthy adolescents|healthy adolescents
7467|NCT04152161|Healthy participants|healthy participants
7468|NCT04152161|BCG vaccine|bcg vaccine
7469|NCT04152135|passive leg raising maneuver, vena cava inferior diameter|passive leg raising maneuver, vena cava inferior diameter
7470|NCT04152109|complementary medicine|complementary medicine
7471|NCT04152109|laying on of hands|laying on of hands
7473|NCT04152109|epilepsy|epilepsy
7474|NCT04152109|complementary therapies|complementary therapies
7475|NCT04152070|Frailty|frailty
7476|NCT04152070|Spanish|spanish
7477|NCT04152070|Older adults|older adults
7478|NCT04152057|Pyrotinib Maleate Tablets|pyrotinib maleate tablets
7479|NCT04152057|Trastuzumab|trastuzumab
7480|NCT04152057|Albumin Paclitaxel|albumin paclitaxel
7481|NCT04152057|Early or Locally Advanced|early or locally advanced
7482|NCT04152057|neoadjuvant|neoadjuvant
7483|NCT04151979|placenta accreta spectrum|placenta accreta spectrum
7484|NCT04151979|MRI|mri
7485|NCT04151979|score scale|score scale
7486|NCT04151979|diagnosis|diagnosis
7487|NCT04151953|Pacemaker|pacemaker
7488|NCT04151953|Implantable Cardioverter Defibrillator (ICD)|implantable cardioverter defibrillator (icd)
7489|NCT04151953|Cardiac implantable electronic device (CIED)|cardiac implantable electronic device (cied)
7490|NCT04151940|Lung|lung
7491|NCT04151927|High altitude|high altitude
7492|NCT04151927|Metabolic adaptations|metabolic adaptations
7493|NCT04151927|Energy balance|energy balance
7494|NCT04151875|orthodontics|orthodontics
7495|NCT04151875|vertical dimension|vertical dimension
7496|NCT04151875|premolars extraction|premolars extraction
7497|NCT04151875|long face|long face
7498|NCT04151849|GLP-1 receptor agonist|glp-1 receptor agonist
7499|NCT04151849|SGLT-2 inhibitor|sglt-2 inhibitor
7500|NCT04151836|Morbid obesity|morbid obesity
7501|NCT04151836|Bariatric surgery|bariatric surgery
7502|NCT04151836|Walking exercise|walking exercise
7503|NCT04151836|Quality of life|quality of life
7504|NCT04151836|Body composition|body composition
7505|NCT04151823|Childhood obesity|childhood obesity
7506|NCT04151823|Nutrition|nutrition
7507|NCT04151823|Gut microbiota|gut microbiota
7508|NCT04151823|Postbiotics|postbiotics
7509|NCT04151797|Medication review|medication review
7510|NCT04151797|clinical pharmacy|clinical pharmacy
7511|NCT04151797|polypharmacy|polypharmacy
7512|NCT04151797|older people|older people
7513|NCT04151797|collaboration|collaboration
7514|NCT04151797|inappropriate prescribing|inappropriate prescribing
7515|NCT04151784|Susceptibility to Electronic Cigarette Use|susceptibility to electronic cigarette use
7516|NCT04151771|blood flow restriction training|blood flow restriction training
7517|NCT04151771|pulmonary rehabilitation|pulmonary rehabilitation
7518|NCT04151771|COPD|copd
7519|NCT04151771|muscle weakness|muscle weakness
7520|NCT04151758|Childhood obesity|childhood obesity
7521|NCT04151758|Gut microbiota|gut microbiota
7522|NCT04151758|Nutrition|nutrition
7523|NCT04151758|PUFA supplementation|pufa supplementation
7524|NCT04151693|Psychological intervention|psychological intervention
7525|NCT04151693|Cognitive Behavioral Therapy (CBT)|cognitive behavioral therapy (cbt)
7526|NCT04151693|Accept and Commitment Therapy (ACT)|accept and commitment therapy (act)
7527|NCT04151693|Cognitive functioning|cognitive functioning
7528|NCT04151693|Fatigue|fatigue
7529|NCT04151693|Autonomic nervous system|autonomic nervous system
7530|NCT04151693|Autonomic nervous system ganglio antibodies|autonomic nervous system ganglio antibodies
7531|NCT04151693|Deep breathing|deep breathing
7532|NCT04151693|Relaxation|relaxation
7533|NCT04151680|coronary artery disease|coronary artery disease
7534|NCT04151667|myeloma|myeloma
7535|NCT04151667|daratumumab|daratumumab
7536|NCT04151654|aged|aged
7537|NCT04151654|shoe|shoe
7538|NCT04151654|postural balance|postural balance
7539|NCT04151654|accidental falls|accidental falls
7540|NCT04151628|Intravascular Lithotripsy|intravascular lithotripsy
7541|NCT04151628|Percutaneous Coronary Intervention|percutaneous coronary intervention
7542|NCT04151615|Multiple Myeloma|multiple myeloma
7543|NCT04151615|Treatment-naïve patients|treatment-naïve patients
7544|NCT04151576|aromatherapy|aromatherapy
7545|NCT04151576|massage|massage
7546|NCT04151550|Presbyopia|presbyopia
7547|NCT04151550|Sclera|sclera
7548|NCT04151550|Laser Scleral Microporation|laser scleral microporation
7549|NCT04151537|Hypertension|hypertension
7550|NCT04151537|Exercise Therapy|exercise therapy
7551|NCT04151537|Blood Pressure Monitoring, Ambulatory|blood pressure monitoring, ambulatory
7552|NCT04151537|Physical activity monitoring|physical activity monitoring
7553|NCT04151485|female infertility|female infertility
7554|NCT04151485|assisted reproductive technology|assisted reproductive technology
7555|NCT04151485|in vitro fertilization|in vitro fertilization
7556|NCT04151485|intra-cytoplasmic sperm injection|intra-cytoplasmic sperm injection
7557|NCT04151485|pregnancy|pregnancy
7558|NCT04151485|stress|stress
7559|NCT04151485|depression|depression
7560|NCT04151485|anxiety|anxiety
7561|NCT04151485|quality of life|quality of life
7562|NCT04151485|sleep quality|sleep quality
7563|NCT04151485|circadian rhythm|circadian rhythm
7564|NCT04151485|mind/body|mind/body
7565|NCT04151472|Migraine Prophylaxis|migraine prophylaxis
799371|NCT00256204|Parkinson's|parkinson's
7566|NCT04151472|Mitochondrial Dysfunction|mitochondrial dysfunction
7567|NCT04151472|Idebenone|idebenone
7568|NCT04151472|Individualized Treatment|individualized treatment
7569|NCT04151459|Polycystic Ovary Syndrome|polycystic ovary syndrome
7570|NCT04151459|Severe Obesity|severe obesity
7571|NCT04151459|Laparoscopic Sleeve Gastrectomy|laparoscopic sleeve gastrectomy
7572|NCT04151459|Live Birth Rate|live birth rate
7573|NCT04151446|Presbyopia|presbyopia
7574|NCT04151446|Sclera|sclera
7575|NCT04151446|Laser Scleral Microporation|laser scleral microporation
7576|NCT04151407|VEGF; DME; bevacizumab; safety|vegf; dme; bevacizumab; safety
7577|NCT04151368|breast surgery|breast surgery
7578|NCT04151368|robotic surgery|robotic surgery
7579|NCT04151368|nipple sparing mastectomy|nipple sparing mastectomy
7580|NCT04151368|genetic predisposition|genetic predisposition
7581|NCT04151368|breast cancer|breast cancer
7582|NCT04151342|observational study|observational study
7583|NCT04151342|cancer|cancer
7584|NCT04151342|cancer therapies|cancer therapies
7585|NCT04151342|molecular alterations|molecular alterations
7586|NCT04151342|real-world evidence|real-world evidence
7587|NCT04151342|real-world data|real-world data
7588|NCT04151342|tyrosine kinase inhibitors|tyrosine kinase inhibitors
7589|NCT04151342|ambispective|ambispective
7590|NCT04151303|RDS|rds
7591|NCT04151303|CERCLAGE|cerclage
7592|NCT04151303|CERVIX INSUFFICIENCY|cervix insufficiency
7593|NCT04151264|Hypotension|hypotension
7594|NCT04151264|tumor of the oropharynx|tumor of the oropharynx
7595|NCT04151264|tumor of the nasopharynx|tumor of the nasopharynx
7596|NCT04151264|creatinine|creatinine
7597|NCT04151225|Monoclonal antibody|monoclonal antibody
7601|NCT04151186|CAR-T cells|car-t cells
7602|NCT04151186|Immunologic Factors|immunologic factors
7603|NCT04151186|TM4SF1;EpCAM|tm4sf1;epcam
7604|NCT04151160|MuscleSound|musclesound
7605|NCT04151147|Third molar surgery|third molar surgery
7606|NCT04151147|Alveolar osteitis|alveolar osteitis
7607|NCT04151147|Platelet concentrates|platelet concentrates
7608|NCT04151121|chest pain|chest pain
7609|NCT04151121|non-cardiac|non-cardiac
7610|NCT04151121|mindfulness|mindfulness
7611|NCT04151095|Mitochondria|mitochondria
7612|NCT04151095|Exercise training|exercise training
7613|NCT04151095|VO2|vo2
7614|NCT04151095|Aerobic exercise|aerobic exercise
7615|NCT04151095|Citrate Synthase|citrate synthase
7616|NCT04151095|Blood flow restriction|blood flow restriction
7617|NCT04151069|Tree Nut Allergy|tree nut allergy
7618|NCT04151069|Walnut Allergy|walnut allergy
7619|NCT04151069|Pistachio Allergy|pistachio allergy
7620|NCT04151069|Cashew Allergy|cashew allergy
7621|NCT04151069|Tree Nut Hypersensitivity|tree nut hypersensitivity
7622|NCT04151069|Tree Nut Anaphylaxis|tree nut anaphylaxis
7623|NCT04151056|social determinants of health, reporting socials problems|social determinants of health, reporting socials problems
7624|NCT04150991|Fiber|fiber
7625|NCT04150991|Gut microbiome|gut microbiome
7626|NCT04150991|Hyperphagia|hyperphagia
7627|NCT04150991|Prader-Willi Syndrome|prader-willi syndrome
7628|NCT04150978|High Protein Polymeric Feeding|high protein polymeric feeding
7629|NCT04150978|APACHE II Score|apache ii score
7630|NCT04150978|SOFA Score|sofa score
7631|NCT04150978|NUTRIC Score|nutric score
7632|NCT04150978|Critical Illness|critical illness
7633|NCT04150978|Intensive Care Unit|intensive care unit
7634|NCT04150978|Oligomeric Protein Feeding|oligomeric protein feeding
7635|NCT04150965|Multiple Myeloma|multiple myeloma
7636|NCT04150965|Relapsed|relapsed
7637|NCT04150965|Refractory|refractory
7638|NCT04150965|MM|mm
7639|NCT04150965|Multiple Myeloma Research Consortium|multiple myeloma research consortium
7640|NCT04150965|Multiple Myeloma Research Foundation|multiple myeloma research foundation
7641|NCT04150965|MMRC|mmrc
7642|NCT04150965|MMRF|mmrf
7643|NCT04150952|Heart rate variability|heart rate variability
7644|NCT04150952|Training|training
7645|NCT04150952|Endurance|endurance
7646|NCT04150952|Mood|mood
7647|NCT04150952|Anxiety|anxiety
7648|NCT04150952|Stress|stress
7649|NCT04150926|berries|berries
7650|NCT04150926|black currant|black currant
7651|NCT04150926|glucose|glucose
7652|NCT04150926|glycemia|glycemia
7653|NCT04150926|quinoa|quinoa
7654|NCT04150913|Non Hodgkin Lymphoma|non hodgkin lymphoma
7655|NCT04150913|Refractory Non-Hodgkin Lymphoma|refractory non-hodgkin lymphoma
7656|NCT04150913|Relapsed Non Hodgkin Lymphoma|relapsed non hodgkin lymphoma
7657|NCT04150913|Neurotoxicity|neurotoxicity
7658|NCT04150913|Neurotoxicity Syndromes|neurotoxicity syndromes
7659|NCT04150913|Cytokine Release Syndrome|cytokine release syndrome
7660|NCT04150874|Hepatic Artery Embolization|hepatic artery embolization
7661|NCT04150874|Liver Metastases|liver metastases
7662|NCT04150874|Radioembolization|radioembolization
7663|NCT04150861|In vitro fertilisation|in vitro fertilisation
7664|NCT04150861|Controlled ovarian stimulation|controlled ovarian stimulation
7665|NCT04150835|Acute ischemic stroke|acute ischemic stroke
7666|NCT04150835|Xingnaojing injection|xingnaojing injection
13373|NCT04115553|MRI|mri
7667|NCT04150835|Traditional Chinese Medicine|traditional chinese medicine
7668|NCT04150835|Double-Blind|double-blind
7669|NCT04150835|Randomized Controlled Trial|randomized controlled trial
7670|NCT04150796|Hernia Repair|hernia repair
7671|NCT04150796|Minimally-invasive surgery|minimally-invasive surgery
7672|NCT04150796|General surgery|general surgery
7673|NCT04150744|RFA|rfa
7674|NCT04150744|immunosuppressant|immunosuppressant
7675|NCT04150744|hepatocellular carcinoma|hepatocellular carcinoma
7676|NCT04150731|Breast cancer|breast cancer
7677|NCT04150731|Liver metastases|liver metastases
7678|NCT04150731|FES-PET/CT|fes-pet/ct
7679|NCT04150731|Dynamic scan|dynamic scan
7680|NCT04150679|bile duct injury|bile duct injury
7681|NCT04150679|duodenal access|duodenal access
7682|NCT04150679|hepaticojejonostomy|hepaticojejonostomy
7683|NCT04150666|primary aldosteronism|primary aldosteronism
7684|NCT04150666|surgery therapy|surgery therapy
7685|NCT04150666|water intake|water intake
7686|NCT04150666|renal function|renal function
7687|NCT04150653|Abdominal aortic aneurysm rupture prevention|abdominal aortic aneurysm rupture prevention
7688|NCT04150653|Non-invasive vascular elastography by ultrasound|non-invasive vascular elastography by ultrasound
7689|NCT04150653|3D mapping of AAA strain|3d mapping of aaa strain
7690|NCT04150653|Vascular vulnerability assessment|vascular vulnerability assessment
7693|NCT04150497|BALLI-01|balli-01
8101|NCT04147923|Healthy|healthy
7694|NCT04150497|B-cell Acute Lymphoblastic Leukemia (B-ALL)|b-cell acute lymphoblastic leukemia (b-all)
7695|NCT04150497|Universal Chimeric Antigen Receptor T-Cell (UCAR-T) Therapy|universal chimeric antigen receptor t-cell (ucar-t) therapy
7696|NCT04150497|Allogeneic|allogeneic
7697|NCT04150497|Transcription Activator-Like Effector Nuclease (TALEN®)|transcription activator-like effector nuclease (talen®)
7698|NCT04150484|breast cancer survival|breast cancer survival
7699|NCT04150484|mediterranean diet|mediterranean diet
7700|NCT04150484|physical activity|physical activity
7701|NCT04150484|mindfulness|mindfulness
7702|NCT04150445|Overweight|overweight
7703|NCT04150445|Obesity|obesity
7704|NCT04150445|Body Weight|body weight
7705|NCT04150419|Attentional bias modification training|attentional bias modification training
7706|NCT04150419|chronic pelvi-perinal pain.|chronic pelvi-perinal pain.
7707|NCT04150406|Curcuma|curcuma
7708|NCT04150406|Endometriosis-associated pain|endometriosis-associated pain
7709|NCT04150393|microbiota|microbiota
7710|NCT04150393|microbiotherapy|microbiotherapy
7711|NCT04150341|TD-8236|td-8236
7712|NCT04150341|Asthma|asthma
7713|NCT04150341|Proof of concept|proof of concept
7714|NCT04150315|Targeted proteomics|targeted proteomics
7715|NCT04150289|Farydak|farydak
7716|NCT04150289|panobinostat|panobinostat
7717|NCT04150276|Oxygenation|oxygenation
7718|NCT04150276|Positive end-expiratory pressure|positive end-expiratory pressure
7719|NCT04150276|General anaesthesia|general anaesthesia
7720|NCT04150276|Obesity|obesity
7721|NCT04150276|Atelectasis|atelectasis
7722|NCT04150276|Mechanical ventilation|mechanical ventilation
7723|NCT04150263|intraocular lens, dislocation|intraocular lens, dislocation
7724|NCT04150224|PBTZ169|pbtz169
7725|NCT04150224|Macozinone|macozinone
7726|NCT04150224|Antimycobacterial|antimycobacterial
7727|NCT04150224|Tuberculosis|tuberculosis
7728|NCT04150224|Drug Resistant Tubercolosis|drug resistant tubercolosis
7729|NCT04150224|MDR-TB|mdr-tb
7730|NCT04150224|XDR-TB|xdr-tb
7731|NCT04150211|Harpagophytum|harpagophytum
7732|NCT04150211|Zingiber officinae|zingiber officinae
7733|NCT04150211|Bixa orellana|bixa orellana
7734|NCT04150211|Joint pain|joint pain
7735|NCT04150211|Inflammation|inflammation
7736|NCT04150211|Biomechanics|biomechanics
7737|NCT04150133|low residue diet|low residue diet
7738|NCT04150120|e-health|e-health
7739|NCT04150120|children|children
7740|NCT04150120|culture|culture
7741|NCT04150120|health economy|health economy
7742|NCT04150120|quality of life|quality of life
7743|NCT04150120|home care|home care
7744|NCT04150081|T1 Colorectal Cancer|t1 colorectal cancer
7745|NCT04150081|Early Colorectal Cancer|early colorectal cancer
7746|NCT04150081|Endoscopic polypectomy|endoscopic polypectomy
7747|NCT04150081|Oncological Surgery|oncological surgery
7748|NCT04150081|Lymph node metastasis|lymph node metastasis
7749|NCT04150081|Molecular signatures|molecular signatures
7750|NCT04150081|Disease free survival|disease free survival
7751|NCT04150055|mindfulness|mindfulness
7752|NCT04150055|caregiver|caregiver
7753|NCT04150055|palliative care|palliative care
7754|NCT04150042|pancreatic adenocarcinoma|pancreatic adenocarcinoma
7755|NCT04150042|pancreatic cancer|pancreatic cancer
7756|NCT04150042|BRCA|brca
7757|NCT04150042|BRCA1|brca1
7758|NCT04150042|BRCA2|brca2
7759|NCT04150042|melphalan|melphalan
7760|NCT04150042|BCNU|bcnu
7761|NCT04150042|carmustine|carmustine
7762|NCT04150042|vitamin C|vitamin c
7763|NCT04150042|vitamin B12b|vitamin b12b
802749|NCT00244465|Misuse|misuse
7764|NCT04150042|autologous stem cell infusion|autologous stem cell infusion
7765|NCT04150042|oligometastatic pancreatic cancer|oligometastatic pancreatic cancer
7766|NCT04150042|stage 4 pancreatic cancer|stage 4 pancreatic cancer
7767|NCT04150042|metastatic pancreatic cancer|metastatic pancreatic cancer
7768|NCT04150029|MBG453|mbg453
7769|NCT04150029|Venetoclax|venetoclax
7770|NCT04150029|Azacitidine|azacitidine
7771|NCT04150029|Phase 2|phase 2
7772|NCT04150029|AML|aml
7773|NCT04150029|Acute myeloid Leukemia|acute myeloid leukemia
7774|NCT04150003|Venous Thromboembolic Disease|venous thromboembolic disease
7775|NCT04150003|Pulmonary Embolism|pulmonary embolism
7776|NCT04150003|Rehabilitation program|rehabilitation program
7777|NCT04150003|Exercise training|exercise training
7778|NCT04149964|Post-operative pain|post-operative pain
7779|NCT04149964|Sinus pain|sinus pain
7780|NCT04149964|Sinus surgery|sinus surgery
7781|NCT04149964|Septum Pain|septum pain
7782|NCT04149964|deviated septum|deviated septum
7783|NCT04149912|Professional quality of life|professional quality of life
7784|NCT04149912|Compassion satisfaction|compassion satisfaction
7785|NCT04149912|Burnout|burnout
7786|NCT04149912|Psychologists|psychologists
7787|NCT04149912|Mental disorders|mental disorders
7788|NCT04149912|Mental health|mental health
7789|NCT04149899|POAG|poag
7790|NCT04149899|OHT|oht
7791|NCT04149899|Primary open-angle glaucoma|primary open-angle glaucoma
7792|NCT04149899|ocular hypertension|ocular hypertension
7793|NCT04149886|Cardioneuromablation|cardioneuromablation
7794|NCT04149886|Ganglionated plexus|ganglionated plexus
7795|NCT04149886|Sick Sinus Syndrome|sick sinus syndrome
7796|NCT04149886|Pacing percentage|pacing percentage
7797|NCT04149847|inguinal hernia|inguinal hernia
7798|NCT04149847|quality of life|quality of life
7799|NCT04149847|COMI-hernia|comi-hernia
7800|NCT04149847|polypropylene mesh repair|polypropylene mesh repair
7801|NCT04149847|nylon darn repair|nylon darn repair
7802|NCT04149847|patient-reported outcomes|patient-reported outcomes
7803|NCT04149834|Intraossous defects|intraossous defects
7804|NCT04149834|Periodontitis|periodontitis
7805|NCT04149821|CLL|cll
7806|NCT04149821|progression|progression
7807|NCT04149795|Physical activity|physical activity
7808|NCT04149795|Mental disorder|mental disorder
7809|NCT04149795|Recommendation behaviour|recommendation behaviour
7810|NCT04149795|Prescription Behaviour|prescription behaviour
7811|NCT04149795|Mental health|mental health
7812|NCT04149795|Exercise|exercise
7813|NCT04149782|HIV|hiv
7814|NCT04149782|South Africa|south africa
7815|NCT04149782|Differentiated service delivery|differentiated service delivery
7816|NCT04149782|Antiretroviral therapy|antiretroviral therapy
7817|NCT04149730|Epinephrine|epinephrine
7818|NCT04149730|Pulseless electrical activity|pulseless electrical activity
7819|NCT04149717|caffeine|caffeine
7820|NCT04149717|taurine|taurine
7821|NCT04149717|carnitine|carnitine
7822|NCT04149717|energy drink|energy drink
7823|NCT04149704|Advanced Cancer|advanced cancer
7824|NCT04149691|FGFR|fgfr
7825|NCT04149691|kinase inhibitor|kinase inhibitor
7826|NCT04149691|advanced solid tumors|advanced solid tumors
7827|NCT04149691|carcinoma|carcinoma
7828|NCT04149691|neoplasms|neoplasms
7829|NCT04149691|gastric cancer|gastric cancer
7830|NCT04149691|bladder cancer|bladder cancer
7831|NCT04149691|squamous non-small cell lung cancer|squamous non-small cell lung cancer
7832|NCT04149691|squamous immunophenotype|squamous immunophenotype
7833|NCT04149678|Healthy Subjects|healthy subjects
7834|NCT04149678|Ozanimod|ozanimod
7835|NCT04149678|Cyclosporine|cyclosporine
7836|NCT04149652|elastography|elastography
7837|NCT04149652|ultrasound|ultrasound
7839|NCT04149652|smoke|smoke
7840|NCT04149652|lung stiffness|lung stiffness
7841|NCT04149652|lung ultrasound|lung ultrasound
7842|NCT04149639|NeuroQ|neuroq
7843|NCT04149639|Dr. Bredesen|dr. bredesen
7844|NCT04149639|PreCODE protocol|precode protocol
7845|NCT04149639|ReCODE method|recode method
7846|NCT04149639|cognitive decline|cognitive decline
7847|NCT04149639|The End of Alzheimer's|the end of alzheimer's
7848|NCT04149639|cognitive support|cognitive support
7849|NCT04149639|cognitive health|cognitive health
7850|NCT04149613|biomarker|biomarker
7851|NCT04149613|colorectal cancer|colorectal cancer
7852|NCT04149613|prognosis|prognosis
7853|NCT04149613|prediction|prediction
7854|NCT04149613|microRNA|microrna
7855|NCT04149613|inflammation|inflammation
7856|NCT04149613|dietary pattern|dietary pattern
7857|NCT04149561|cerebral palsy|cerebral palsy
7858|NCT04149561|communication|communication
7859|NCT04149522|Radiotherapy breast|radiotherapy breast
7860|NCT04149522|Mepitel Film|mepitel film
7861|NCT04149509|NOWS|nows
7862|NCT04149496|IVM|ivm
7863|NCT04149496|in vitro maturation|in vitro maturation
7864|NCT04149496|polycystic ovarian syndrome|polycystic ovarian syndrome
7865|NCT04149496|PCOS|pcos
7866|NCT04149496|Steiner-Tan needle|steiner-tan needle
7867|NCT04149496|oocyte maturation|oocyte maturation
7868|NCT04149483|High resolution magnetic resonance|high resolution magnetic resonance
7869|NCT04149483|Atorvastatin|atorvastatin
7870|NCT04149483|Ruptured risk|ruptured risk
7871|NCT04149470|EoE|eoe
7872|NCT04149470|PPI|ppi
7873|NCT04149470|Proton Pump Inhibitor|proton pump inhibitor
7874|NCT04149470|Omeprazole|omeprazole
7875|NCT04149470|eosinophil|eosinophil
7876|NCT04149470|TNE|tne
7877|NCT04149470|Transnasal Endoscopy|transnasal endoscopy
7878|NCT04149470|Esophageal Diseases|esophageal diseases
7879|NCT04149470|Esophagitis|esophagitis
7880|NCT04149470|Gastrointestinal Diseases|gastrointestinal diseases
7881|NCT04149470|Eosinophilia|eosinophilia
7882|NCT04149470|Gastroenteritis|gastroenteritis
7883|NCT04149470|Eosinophilic Oesophagitis|eosinophilic oesophagitis
7884|NCT04149470|Transnasal Esophagogastroduodenoscopy|transnasal esophagogastroduodenoscopy
7885|NCT04149470|Transnasal Esophagoscopy|transnasal esophagoscopy
7886|NCT04149431|Derinat|derinat
7887|NCT04149431|Respiratory infection|respiratory infection
7888|NCT04149431|Children|children
7889|NCT04149418|yogurt|yogurt
7890|NCT04149418|obesity|obesity
7891|NCT04149418|intestine|intestine
7892|NCT04149405|sclerostin|sclerostin
7893|NCT04149405|dickkopf-related protein-1|dickkopf-related protein-1
7894|NCT04149392|CGM Diabetes Heart Failure|cgm diabetes heart failure
7895|NCT04149379|Stroke|stroke
7896|NCT04149379|Hyperbaric oxygen|hyperbaric oxygen
7897|NCT04149314|HPI|hpi
7898|NCT04149314|Thoracic Surgery|thoracic surgery
7899|NCT04149314|Single-Lung ventilation|single-lung ventilation
7902|NCT04149275|Cabozantinib|cabozantinib
7903|NCT04149275|Nivolumab|nivolumab
7904|NCT04149275|Ipilimumab|ipilimumab
7905|NCT04149275|tyrosine-kinase inhibitor|tyrosine-kinase inhibitor
7906|NCT04149275|anti-PD-1|anti-pd-1
7907|NCT04149275|anti-CTLA-4|anti-ctla-4
7908|NCT04149249|quitting|quitting
7909|NCT04149249|smoking|smoking
7910|NCT04149249|smoking cessation tool|smoking cessation tool
7911|NCT04149249|smoking cessation|smoking cessation
7912|NCT04149249|quit smoking|quit smoking
7913|NCT04149249|smoking cessation resources|smoking cessation resources
7914|NCT04149249|smoking cessation barriers|smoking cessation barriers
7915|NCT04149249|smoking cessation intervention tool|smoking cessation intervention tool
7916|NCT04149236|Culture|culture
7917|NCT04149210|fluorometholone 0.1%|fluorometholone 0.1%
7918|NCT04149210|trachomatous trichiasis|trachomatous trichiasis
7919|NCT04149210|Eye Diseases|eye diseases
7920|NCT04149210|Eyelid Diseases|eyelid diseases
7921|NCT04149210|trachomatous|trachomatous
7922|NCT04149210|trichiasis|trichiasis
7923|NCT04149210|FLAME|flame
7924|NCT04149210|TT Surgery|tt surgery
7925|NCT04149197|Down Syndrome|down syndrome
7926|NCT04149197|Alzheimer's Disease|alzheimer's disease
7927|NCT04149145|Ovarian Cancer|ovarian cancer
7928|NCT04149145|PARP Resistant|parp resistant
7929|NCT04149145|ATR inhibitor|atr inhibitor
7930|NCT04149145|M4344|m4344
7931|NCT04149145|Niraparib|niraparib
7932|NCT04149132|early diagnosis|early diagnosis
7933|NCT04149132|infection|infection
7934|NCT04149132|pulse photoplethysmography|pulse photoplethysmography
7935|NCT04149119|Malaria|malaria
7936|NCT04149119|Vector control|vector control
7937|NCT04149119|ATSB|atsb
7938|NCT04149119|Transmission|transmission
7939|NCT04149119|Mali|mali
7941|NCT04149106|Effectiveness|effectiveness
7942|NCT04149106|SPAQ|spaq
7943|NCT04149106|DHAPQ|dhapq
7944|NCT04149106|Drug resistance|drug resistance
7945|NCT04149080|Simvastatin|simvastatin
7946|NCT04149080|Tooth extraction|tooth extraction
7947|NCT04149080|Alveolar socket preservation|alveolar socket preservation
7948|NCT04149080|Bone regeneration|bone regeneration
7952|NCT04148989|Sepsis|sepsis
7953|NCT04148989|Clinical Protocols|clinical protocols
7954|NCT04148989|Emergency Medicine|emergency medicine
7955|NCT04148976|hypercholesterolemia|hypercholesterolemia
7956|NCT04148976|dietary portfolio|dietary portfolio
7957|NCT04148976|soy protein|soy protein
7958|NCT04148976|LDL-C|ldl-c
7959|NCT04148976|lipoprotein subclasses|lipoprotein subclasses
7960|NCT04148976|nopal|nopal
7961|NCT04148976|chia seed|chia seed
7962|NCT04148976|functional foods|functional foods
7963|NCT04148963|schizophrenia|schizophrenia
7964|NCT04148963|bipolar disorder|bipolar disorder
7965|NCT04148963|agitation|agitation
7966|NCT04148963|inhaled loxapine|inhaled loxapine
7967|NCT04148963|ADASUVE|adasuve
7968|NCT04148950|Chronic Venous Disease|chronic venous disease
7969|NCT04148950|Kinesio Taping|kinesio taping
7970|NCT04148950|Compression Stockings|compression stockings
7971|NCT04148950|Pain|pain
7972|NCT04148950|Edema|edema
7973|NCT04148950|Functional Capacity|functional capacity
7974|NCT04148937|Triple Negative Breast Cancer|triple negative breast cancer
7975|NCT04148937|Pancreatic Cancer|pancreatic cancer
802750|NCT00244465|Safety|safety
7976|NCT04148937|Non-small Cell Lung Cancer|non-small cell lung cancer
7977|NCT04148937|Renal Cell Carcinoma, Clear Cell|renal cell carcinoma, clear cell
7978|NCT04148937|Cutaneous Melanoma|cutaneous melanoma
7979|NCT04148937|Castrate Resistant Prostate Cancer|castrate resistant prostate cancer
7980|NCT04148937|Epithelial Ovarian Cancer|epithelial ovarian cancer
7981|NCT04148937|Metastatic Cancer|metastatic cancer
7982|NCT04148898|leptomeningeal metastasis|leptomeningeal metastasis
7983|NCT04148898|non small cell lung cancer|non small cell lung cancer
7984|NCT04148898|EGFR Activating Mutation|egfr activating mutation
7985|NCT04148898|Osimertinib|osimertinib
7986|NCT04148898|Bevacizumab|bevacizumab
7987|NCT04148885|castration-resistant prostate cancer|castration-resistant prostate cancer
7988|NCT04148885|paclitaxel (albumin-binding)|paclitaxel (albumin-binding)
7989|NCT04148885|carboplatin|carboplatin
7990|NCT04148859|TTTS|ttts
7991|NCT04148859|controlled amnioreduction|controlled amnioreduction
7992|NCT04148859|amniotic pressure|amniotic pressure
7993|NCT04148833|ATHEROSCLEROSIS|atherosclerosis
7994|NCT04148833|CORONARY ARTERY DISEASE|coronary artery disease
7995|NCT04148833|INFLAMATION|inflamation
7996|NCT04148833|NANOPARTICLES|nanoparticles
7997|NCT04148833|PACLITAXEL|paclitaxel
7998|NCT04148833|DRUG TARGETING|drug targeting
7999|NCT04148833|DRUG DELIVERY SYSTEM|drug delivery system
8000|NCT04148820|coronary artery disease|coronary artery disease
8001|NCT04148794|advanced life support|advanced life support
8003|NCT04148794|point-of-care ultrasound|point-of-care ultrasound
8004|NCT04148794|echo-assisted advanced life support|echo-assisted advanced life support
8005|NCT04148781|Multiple sclerosis|multiple sclerosis
8006|NCT04148781|Optic Neuritis|optic neuritis
8007|NCT04148781|Fampyra|fampyra
8008|NCT04148768|Knee pain|knee pain
8009|NCT04148768|osteoarthritis,|osteoarthritis,
8010|NCT04148768|patello-femoral pain,|patello-femoral pain,
8011|NCT04148768|Anetrior cruciate repair|anetrior cruciate repair
8012|NCT04148768|Balance|balance
8013|NCT04148768|Dynamic and static balance|dynamic and static balance
8014|NCT04148768|Proprioception|proprioception
8015|NCT04148755|EUS. Elastography, FNA|eus. elastography, fna
8016|NCT04148729|erector spinae plane block|erector spinae plane block
8017|NCT04148729|postoperative analgesia|postoperative analgesia
8018|NCT04148729|spinal surgery|spinal surgery
8019|NCT04148703|Pacemaker, home monitoring, remote monitoring, ecocomic|pacemaker, home monitoring, remote monitoring, ecocomic
8020|NCT04148690|Group antenatal care|group antenatal care
8021|NCT04148690|Surveillance|surveillance
8022|NCT04148690|Tanzania|tanzania
8023|NCT04148690|Malaria in Pregnancy|malaria in pregnancy
8024|NCT04148664|Atrial Fibrillation|atrial fibrillation
8025|NCT04148651|vulvar dystrophy|vulvar dystrophy
8026|NCT04148651|vulvar atrophy|vulvar atrophy
8027|NCT04148651|persistent itching|persistent itching
8028|NCT04148651|leukoplakia|leukoplakia
8029|NCT04148651|hyperkeratosis|hyperkeratosis
8030|NCT04148651|sexual function|sexual function
8031|NCT04148625|hybrid, LAA ligation|hybrid, laa ligation
8032|NCT04148547|Transcranial direct current stimulation|transcranial direct current stimulation
8033|NCT04148508|Promotion|promotion
8034|NCT04148508|Prevention|prevention
8035|NCT04148508|Mobile App|mobile app
8036|NCT04148508|Emotional Competence|emotional competence
8037|NCT04148508|Emotional Resiliance|emotional resiliance
8038|NCT04148508|Wellbeing|wellbeing
8039|NCT04148495|Morphine|morphine
8040|NCT04148495|acetaminophen|acetaminophen
8041|NCT04148495|Acute pain|acute pain
8042|NCT04148495|Analgesics|analgesics
8043|NCT04148469|Miofascial pain syndrom.|miofascial pain syndrom.
8044|NCT04148469|Trigger point.|trigger point.
8045|NCT04148469|Dry needling.|dry needling.
8046|NCT04148469|Transcotaneous Nerve Stimuilation.|transcotaneous nerve stimuilation.
8047|NCT04148469|Hipoalgesia|hipoalgesia
8048|NCT04148443|preoxygenation|preoxygenation
8049|NCT04148443|intubation|intubation
8050|NCT04148443|end-tidal of oxygen concentration|end-tidal of oxygen concentration
8051|NCT04148443|intensive care unit|intensive care unit
8052|NCT04148443|critically ill patients|critically ill patients
8053|NCT04148365|Paediatrics|paediatrics
8054|NCT04148352|Food allergy|food allergy
8055|NCT04148352|Milk allergy|milk allergy
8056|NCT04148352|Oral Immunotherapy|oral immunotherapy
8057|NCT04148300|Oral health literacy|oral health literacy
8058|NCT04148300|Dental anxiety|dental anxiety
8059|NCT04148300|Utilization of oral health services|utilization of oral health services
8060|NCT04148300|Dental patients|dental patients
8061|NCT04148209|First-in-human study|first-in-human study
8062|NCT04148196|Older people|older people
8063|NCT04148196|Adaptation|adaptation
8064|NCT04148196|Life quality|life quality
8065|NCT04148196|Nursing home|nursing home
8066|NCT04148170|Endodiathermy Probe and Intubation Versus Intubation Only|endodiathermy probe and intubation versus intubation only
8067|NCT04148157|Quality of Life|quality of life
8068|NCT04148157|Questionnaire|questionnaire
8069|NCT04148144|Low back pain|low back pain
8070|NCT04148144|Adolescent|adolescent
8071|NCT04148144|Parent|parent
8072|NCT04148144|Prognosis|prognosis
8073|NCT04148144|General practice|general practice
8074|NCT04148131|Brachial Plexus|brachial plexus
8075|NCT04148131|birth injury|birth injury
8076|NCT04148118|Anthrax|anthrax
8077|NCT04148118|Nanoemulsion adjuvant|nanoemulsion adjuvant
8078|NCT04148118|Nasal Vaccine|nasal vaccine
8079|NCT04148118|Recombinant Protective Antigen|recombinant protective antigen
8080|NCT04148105|Delayed cerebral ischemia|delayed cerebral ischemia
8081|NCT04148105|Cerebral vasospasm|cerebral vasospasm
8082|NCT04148105|Cilostazol|cilostazol
8083|NCT04148027|emergency medicine|emergency medicine
8084|NCT04148027|geriatrics|geriatrics
8085|NCT04148027|telemedicine|telemedicine
8086|NCT04148014|eating disorders|eating disorders
8087|NCT04148014|young adults|young adults
8088|NCT04148014|emotion regulation skills|emotion regulation skills
8089|NCT04148001|LDL Receptors|ldl receptors
8090|NCT04148001|Gene Therapy|gene therapy
8091|NCT04148001|Metabolic Diseases|metabolic diseases
8092|NCT04148001|Rare Diseases|rare diseases
8093|NCT04148001|Genetic Diseases|genetic diseases
8094|NCT04148001|Atherosclerosis|atherosclerosis
8095|NCT04148001|Cardiovascular Disease|cardiovascular disease
8096|NCT04148001|Genotype|genotype
8097|NCT04147962|intense pulsed light|intense pulsed light
8098|NCT04147936|Amino acids, food study|amino acids, food study
8099|NCT04147923|Probiotic|probiotic
8100|NCT04147923|Digestive Health|digestive health
8102|NCT04147923|Nutrient analysis|nutrient analysis
8103|NCT04147923|Constipation|constipation
8104|NCT04147910|Healthy Male Subjects|healthy male subjects
8105|NCT04147884|Functional Mitral Regurgitation|functional mitral regurgitation
8106|NCT04147884|Mitral Repair|mitral repair
8107|NCT04147845|Alopecia Areata|alopecia areata
8108|NCT04147845|Transepidermal drug delivery|transepidermal drug delivery
8109|NCT04147845|Fractional Carbon Dioxide Laser|fractional carbon dioxide laser
8110|NCT04147845|Platelet-Rich Plasma|platelet-rich plasma
8111|NCT04147845|Microneedling|microneedling
8112|NCT04147845|Triamcinolone acetonide|triamcinolone acetonide
8113|NCT04147819|Human epidermal growth factor receptor 2(HER2)|human epidermal growth factor receptor 2(her2)
8114|NCT04147819|Targeted alpha therapy|targeted alpha therapy
8115|NCT04147819|Thorium-227|thorium-227
8116|NCT04147793|child|child
8117|NCT04147793|Adolescent|adolescent
8118|NCT04147793|urinary incontinence|urinary incontinence
8119|NCT04147767|oxysterol|oxysterol
8120|NCT04147767|breast cancer|breast cancer
8121|NCT04147767|phytosterols|phytosterols
8122|NCT04147767|cholesterol metabolism|cholesterol metabolism
8123|NCT04147741|Fatigue|fatigue
8124|NCT04147741|Supplement|supplement
8125|NCT04147741|Pre-Workout|pre-workout
8126|NCT04147741|Muscle|muscle
8127|NCT04147741|Recovery|recovery
8128|NCT04147741|Training|training
8129|NCT04147741|Strength|strength
8130|NCT04147741|Endurance|endurance
8131|NCT04147741|Perceptual Response|perceptual response
8132|NCT04147715|Pharmacokinetics|pharmacokinetics
8133|NCT04147715|S-648414|s-648414
8134|NCT04147715|Food effect|food effect
8135|NCT04147715|Antiretroviral|antiretroviral
8136|NCT04147715|Drug-drug interaction|drug-drug interaction
8137|NCT04147702|Balance|balance
8138|NCT04147702|Dancer|dancer
8139|NCT04147702|Respiratory muscle|respiratory muscle
8140|NCT04147702|Trunk muscle|trunk muscle
8141|NCT04147689|hyaluronic acid|hyaluronic acid
8142|NCT04147689|labia majora|labia majora
8143|NCT04147689|vulvar|vulvar
8144|NCT04147689|filler|filler
8145|NCT04147689|hypotrophy|hypotrophy
8146|NCT04147689|atrophy|atrophy
8147|NCT04147663|emergency|emergency
8148|NCT04147663|epileptic seizure|epileptic seizure
8149|NCT04147663|epilepsy|epilepsy
8150|NCT04147663|neurology|neurology
8151|NCT04147650|Dry Eye Calcineurin Inhibitors|dry eye calcineurin inhibitors
8152|NCT04147650|Dry Eye Disease|dry eye disease
8153|NCT04147637|Hytpoglycemia|hytpoglycemia
8154|NCT04147637|FreeStyle Libre|freestyle libre
8155|NCT04147637|Flash Glucose Monitoring|flash glucose monitoring
8156|NCT04147637|MiaoMiao|miaomiao
8157|NCT04147637|Time in Range|time in range
8158|NCT04147624|Memory|memory
8159|NCT04147624|Cognitive Aging|cognitive aging
8160|NCT04147598|Inflammatory bowel disease|inflammatory bowel disease
8161|NCT04147598|diet|diet
8162|NCT04147598|low fat|low fat
8164|NCT04147598|IBD|ibd
8165|NCT04147585|IBD|ibd
8166|NCT04147585|Crohn's disease|crohn's disease
8167|NCT04147585|Diet|diet
8168|NCT04147585|Fasting|fasting
8169|NCT04147585|Intermittent Reduced Calorie Diet|intermittent reduced calorie diet
8170|NCT04147585|CD|cd
8171|NCT04147585|intermittent fasting|intermittent fasting
8172|NCT04147559|Osteoarthritis|osteoarthritis
8173|NCT04147559|avascular necrosis|avascular necrosis
8174|NCT04147559|ankylosis|ankylosis
8175|NCT04147559|protrusio acetabuli|protrusio acetabuli
8176|NCT04147559|painful hip dysplasia|painful hip dysplasia
8177|NCT04147533|tyrosine kinase inhibitors|tyrosine kinase inhibitors
8178|NCT04147533|drug withdrawal|drug withdrawal
8179|NCT04147533|chronic myeloid leukemia, chronic phase|chronic myeloid leukemia, chronic phase
8180|NCT04147468|Virtual Reality|virtual reality
8181|NCT04147468|Functional Strength Training|functional strength training
8182|NCT04147468|Arm Function|arm function
8183|NCT04147455|Behavioral intervention|behavioral intervention
8184|NCT04147455|Violent behavior|violent behavior
8185|NCT04147403|pancreatic head adenocarcinoma; total mesopancreas excision;pancreaticoduodenectomy|pancreatic head adenocarcinoma; total mesopancreas excision;pancreaticoduodenectomy
8186|NCT04147377|Parkinson's disease|parkinson's disease
8187|NCT04147377|Freezing of gait|freezing of gait
8188|NCT04147377|visual cue|visual cue
8189|NCT04147377|auditory cue|auditory cue
8190|NCT04147312|traditional Chinese medicine|traditional chinese medicine
8191|NCT04147312|Fufang E'Jiao Jiang|fufang e'jiao jiang
8192|NCT04147299|Right Ventricular Function|right ventricular function
8193|NCT04147286|tuberculosis|tuberculosis
8194|NCT04147286|HIV|hiv
8195|NCT04147286|COPD|copd
8196|NCT04147286|inflammation|inflammation
8197|NCT04147221|beta-lactam|beta-lactam
8198|NCT04147221|pharmacokinetics|pharmacokinetics
8199|NCT04147208|Chronic HBeAg positive HBV Infection|chronic hbeag positive hbv infection
8200|NCT04147195|Non-alcoholic fatty liver disease|non-alcoholic fatty liver disease
8201|NCT04147195|NAFLD|nafld
8202|NCT04147195|Non-alcoholic steatohepatitis|non-alcoholic steatohepatitis
8203|NCT04147195|NASH|nash
8204|NCT04147195|Platform design|platform design
8205|NCT04147195|LYS006|lys006
8206|NCT04147195|LJN452|ljn452
8207|NCT04147195|Tropifexor|tropifexor
8208|NCT04147169|Compassionate|compassionate
8209|NCT04147169|End-of-Life Care|end-of-life care
8210|NCT04147169|Interpersonal connections|interpersonal connections
8211|NCT04147156|Benign Paroxysmal Positional Vertigo|benign paroxysmal positional vertigo
8212|NCT04147156|Vertigo|vertigo
8213|NCT04147156|Dizziness|dizziness
8214|NCT04147156|Vestibular diseases|vestibular diseases
8215|NCT04147156|Epley Maneuver|epley maneuver
8216|NCT04147156|Semont Maneuver|semont maneuver
8217|NCT04147156|Repositioning chair|repositioning chair
8218|NCT04147130|Primary Health Care|primary health care
8219|NCT04147130|Medication Adherence|medication adherence
8220|NCT04147130|Disability|disability
8221|NCT04147130|Patient-Centered Care|patient-centered care
8222|NCT04147130|Ariadne Principles|ariadne principles
8223|NCT04147117|Preterm Birth|preterm birth
8224|NCT04147117|Cervical Pessary|cervical pessary
8225|NCT04147117|Obstetrical history|obstetrical history
8226|NCT04147117|Cervical length|cervical length
8227|NCT04147078|Cell therapy|cell therapy
8228|NCT04147078|safety|safety
8229|NCT04147078|clinical efficacy|clinical efficacy
8230|NCT04147078|adjuvant treatment|adjuvant treatment
8231|NCT04147078|locally advanced cancer|locally advanced cancer
8232|NCT04147026|Biological therapy|biological therapy
8233|NCT04147026|Predictive software|predictive software
8234|NCT04147026|Quality of life|quality of life
8235|NCT04147013|Analgesia|analgesia
8236|NCT04147013|Analgesic opioids|analgesic opioids
8237|NCT04147013|Nasal Polyposis|nasal polyposis
8238|NCT04147013|Treatment|treatment
8239|NCT04147000|Pharmacokinetics|pharmacokinetics
8240|NCT04147000|Pharmacodynamics|pharmacodynamics
8241|NCT04146987|Rotator Cuff|rotator cuff
8242|NCT04146987|Rotator Cuff Tear|rotator cuff tear
8243|NCT04146987|Rotator Cuff Tendinopathy|rotator cuff tendinopathy
8244|NCT04146987|Shoulder Arthroscopy|shoulder arthroscopy
8245|NCT04146987|Rotator Cuff Repair|rotator cuff repair
8246|NCT04146987|Open Rotator Cuff Repair|open rotator cuff repair
8247|NCT04146974|Social services|social services
8248|NCT04146974|Coordination|coordination
8249|NCT04146974|Early childhood education|early childhood education
8250|NCT04146974|State and local agencies|state and local agencies
8251|NCT04146948|activities of daily living|activities of daily living
8252|NCT04146948|accessory inspiratory muscles|accessory inspiratory muscles
8253|NCT04146948|oxygen consumption|oxygen consumption
8254|NCT04146948|minute ventilation volume|minute ventilation volume
8255|NCT04146935|Crysvita|crysvita
8256|NCT04146935|Burosumab|burosumab
8257|NCT04146922|Enterobacteriaceae, bacteremia, step down oral therapy|enterobacteriaceae, bacteremia, step down oral therapy
8258|NCT04146883|Prophylactic antibiotics|prophylactic antibiotics
8259|NCT04146883|Cardiac implantable electronic device infection|cardiac implantable electronic device infection
8260|NCT04146857|Hypoxia|hypoxia
8261|NCT04146857|Sleep|sleep
8262|NCT04146857|Heart rate variability|heart rate variability
8263|NCT04146857|Sleep architecture|sleep architecture
8264|NCT04146831|FH-deficient|fh-deficient
8265|NCT04146831|Sintilimab|sintilimab
8266|NCT04146831|Second-line|second-line
8267|NCT04146818|Mild Cognitive Impairment|mild cognitive impairment
8268|NCT04146818|adapted Tango dancing|adapted tango dancing
8269|NCT04146818|elderly people|elderly people
8270|NCT04146818|music therapy|music therapy
8271|NCT04146818|psycho-education|psycho-education
8272|NCT04146753|Chest physiotherapy|chest physiotherapy
8273|NCT04146753|Paediatric intensive care unit|paediatric intensive care unit
8274|NCT04146753|Physiological instability|physiological instability
8275|NCT04146753|Adverse events|adverse events
8276|NCT04146740|exercise|exercise
8277|NCT04146740|pregnancy|pregnancy
8278|NCT04146688|Music|music
8279|NCT04146688|Communication|communication
8280|NCT04146688|Emotion|emotion
8281|NCT04146688|Behavior|behavior
8282|NCT04146688|Neurodegeneration disease|neurodegeneration disease
8283|NCT04146675|Gerontology|gerontology
8284|NCT04146675|elderly,|elderly,
8285|NCT04146675|falls|falls
8286|NCT04146675|balance and walking disorders.|balance and walking disorders.
8287|NCT04146623|live-attenuated vaccine|live-attenuated vaccine
8288|NCT04146623|influenza vaccine|influenza vaccine
8289|NCT04146584|Skin Laxity|skin laxity
8290|NCT04146584|Submental|submental
8291|NCT04146584|Neck|neck
8292|NCT04146584|Brow Lifting|brow lifting
8293|NCT04146584|Laxity|laxity
8294|NCT04146584|Saggy|saggy
8295|NCT04146571|ensartinib|ensartinib
8296|NCT04146571|X-396|x-396
8297|NCT04146571|X396|x396
8298|NCT04146571|anaplastic lymphoma kinase|anaplastic lymphoma kinase
8299|NCT04146571|ALK+|alk+
8300|NCT04146571|ALK positive|alk positive
8301|NCT04146571|NSCLC|nsclc
8302|NCT04146571|Non-Small Cell Lung Cancer|non-small cell lung cancer
8303|NCT04146571|ALK inhibitor|alk inhibitor
8304|NCT04146571|carcinoma|carcinoma
8305|NCT04146545|caregivers|caregivers
8306|NCT04146545|dementia|dementia
8307|NCT04146545|information-sharing|information-sharing
8308|NCT04146545|Alzheimer's Disease|alzheimer's disease
8309|NCT04146545|caregiving|caregiving
8310|NCT04146545|community resources|community resources
8311|NCT04146532|Aspirin|aspirin
8312|NCT04146532|Acetylsalicylic acid|acetylsalicylic acid
8313|NCT04146532|Emotional reactivity|emotional reactivity
8314|NCT04146532|Memory|memory
8315|NCT04146532|Risk-taking|risk-taking
8316|NCT04146532|Inflammation|inflammation
8317|NCT04146519|Parkinson's disease|parkinson's disease
8318|NCT04146519|mesenchymal stem cells|mesenchymal stem cells
8319|NCT04146519|intranasal transplantation|intranasal transplantation
8320|NCT04146519|intravenous transplantation|intravenous transplantation
8321|NCT04146519|combined transplantation|combined transplantation
8322|NCT04146493|Heparin-binding protein|heparin-binding protein
8323|NCT04146493|Heparin|heparin
8324|NCT04146493|Biomarker|biomarker
8325|NCT04146454|Parkinson's disease|parkinson's disease
8326|NCT04146454|In-home balance training|in-home balance training
8327|NCT04146454|Smartphone-based wearable telerehabilitation|smartphone-based wearable telerehabilitation
8328|NCT04146441|Contrast agent BR|contrast agent br
8329|NCT04146441|SonoVue|sonovue
8330|NCT04146441|Ultrasonic therapy|ultrasonic therapy
8331|NCT04146441|Microbubbles|microbubbles
8332|NCT04146428|BOSCC|boscc
8333|NCT04146428|ELSA-T|elsa-t
8334|NCT04146428|JASPER|jasper
8335|NCT04146428|autism|autism
8336|NCT04146389|adrenal steroidogenesis|adrenal steroidogenesis
8337|NCT04146389|doping|doping
8338|NCT04146376|von Willebrand Disease|von willebrand disease
8339|NCT04146376|von Willebrand Factor|von willebrand factor
8340|NCT04146376|postpartum hemorrhage|postpartum hemorrhage
8341|NCT04146363|Eczema|eczema
8342|NCT04146363|Dermatitis|dermatitis
8343|NCT04146363|Dermatitis, Atopic|dermatitis, atopic
8344|NCT04146363|Skin Diseases|skin diseases
8345|NCT04146324|Adjuvant|adjuvant
8346|NCT04146324|nivolumab|nivolumab
8347|NCT04146298|pancreatic cancer|pancreatic cancer
8348|NCT04146298|TCR transduced T cells|tcr transduced t cells
8349|NCT04146298|adoptive cell therapy|adoptive cell therapy
8350|NCT04146298|KRAS|kras
8351|NCT04146259|Sclerostin|sclerostin
8352|NCT04146259|Hypoparathyroidism|hypoparathyroidism
8353|NCT04146246|G6PD|g6pd
8354|NCT04146246|Neonate|neonate
8355|NCT04146168|Venaseal|venaseal
8356|NCT04146168|cyanoacrylate closure|cyanoacrylate closure
8357|NCT04146155|Glucagon-like peptide-1|glucagon-like peptide-1
8358|NCT04146155|Claudication|claudication
8359|NCT04146155|Peripheral vascular disease|peripheral vascular disease
8360|NCT04146142|Prostate Cancer|prostate cancer
8361|NCT04146142|Biopsy|biopsy
8362|NCT04146142|Complication|complication
8363|NCT04146142|Randomization|randomization
8364|NCT04146129|CDX-0159|cdx-0159
8365|NCT04146116|nasal decolonization|nasal decolonization
8366|NCT04146116|Orthopedic trauma surgery|orthopedic trauma surgery
8367|NCT04146077|prostate cancer|prostate cancer
8368|NCT04146077|active surveillance|active surveillance
8369|NCT04146077|low oncological risk|low oncological risk
8370|NCT04146064|breathprint analysis|breathprint analysis
8371|NCT04146064|immunotherapy|immunotherapy
8372|NCT04146064|predictive biomarker|predictive biomarker
8373|NCT04146051|Descartes-08|descartes-08
8374|NCT04146051|CART|cart
8375|NCT04146051|CAR-T|car-t
8376|NCT04146051|Autoimmune|autoimmune
8377|NCT04146051|Auto-antibody|auto-antibody
8378|NCT04146051|Auto antibody|auto antibody
8379|NCT04145934|fall prevention|fall prevention
8380|NCT04145934|walking aid|walking aid
8381|NCT04145934|physical therapy|physical therapy
8382|NCT04145908|midline reinforcement|midline reinforcement
8383|NCT04145908|incisional hernia|incisional hernia
8384|NCT04145908|mesh|mesh
8385|NCT04145895|Post-operative activity restriction|post-operative activity restriction
8386|NCT04145895|Pediatric inguinal hernia repair|pediatric inguinal hernia repair
8387|NCT04145895|Pediatric laparoscopic appendectomy|pediatric laparoscopic appendectomy
8388|NCT04145869|Fluorescence|fluorescence
8389|NCT04145869|Cholangriography|cholangriography
8390|NCT04145869|Cholecystectomy|cholecystectomy
8391|NCT04145856|Probiotic|probiotic
8392|NCT04145856|Antispasmodic|antispasmodic
8393|NCT04145856|Rome-IV|rome-iv
8394|NCT04145830|Glaucoma, ciliary body, ultrasound|glaucoma, ciliary body, ultrasound
8395|NCT04145817|Related women to index case|related women to index case
8396|NCT04145817|Risk estimation|risk estimation
8397|NCT04145817|Breast cancer|breast cancer
8398|NCT04145817|Ovarian cancer|ovarian cancer
8399|NCT04145804|Time in range|time in range
8400|NCT04145804|Hybrid closed loop system|hybrid closed loop system
8401|NCT04145804|Multiple daily insulin injection|multiple daily insulin injection
8402|NCT04145752|femoral nerve block|femoral nerve block
8403|NCT04145752|Ultrasound guided|ultrasound guided
8404|NCT04145752|Nurse-led|nurse-led
8405|NCT04145739|Breast Cancer|breast cancer
8406|NCT04145739|Pain, Chronic and Postoperative|pain, chronic and postoperative
8407|NCT04145739|Posture|posture
8408|NCT04145739|Target - Reaching movement|target - reaching movement
8409|NCT04145739|Mastectomy|mastectomy
8410|NCT04145739|Quadrantectomy|quadrantectomy
8411|NCT04145739|Lymphedema|lymphedema
8412|NCT04145739|Rehabilitation|rehabilitation
8413|NCT04145739|Scapula tilting|scapula tilting
8414|NCT04145739|Shoulder|shoulder
8415|NCT04145739|Biomechanics|biomechanics
8416|NCT04145739|Upper limb|upper limb
8417|NCT04145700|soft tissue sarcoma|soft tissue sarcoma
8418|NCT04145700|adolescents and young adults (AYAs)|adolescents and young adults (ayas)
8419|NCT04145700|adolescent|adolescent
8420|NCT04145635|mechanical circulatory support, percutaneous|mechanical circulatory support, percutaneous
8421|NCT04145622|Advanced Solid Tumor|advanced solid tumor
8422|NCT04145622|Malignant Tumor|malignant tumor
8423|NCT04145622|DS-7300a|ds-7300a
8424|NCT04145609|Acute Kidney Injury|acute kidney injury
8425|NCT04145609|Acute Kidney Disease|acute kidney disease
8426|NCT04145609|Chronic Kidney Disease|chronic kidney disease
8427|NCT04145609|AKI|aki
8428|NCT04145609|AKD|akd
8429|NCT04145609|CKD|ckd
8430|NCT04145609|Decision Support Systems, Clinical|decision support systems, clinical
8431|NCT04145609|CDS|cds
8432|NCT04145557|periodontitis|periodontitis
8433|NCT04145557|diode laser|diode laser
8434|NCT04145557|Myocardial infarction|myocardial infarction
8435|NCT04145531|ALL|all
8436|NCT04145531|LBL|lbl
8437|NCT04145531|Asparaginase|asparaginase
8438|NCT04145531|Leukemia|leukemia
8439|NCT04145531|Childhood acute lymphoblastic leukemia|childhood acute lymphoblastic leukemia
8440|NCT04145518|pain|pain
8441|NCT04145518|NSAID|nsaid
8442|NCT04145518|women's health|women's health
8443|NCT04145518|uterus|uterus
8444|NCT04145518|MRI|mri
8445|NCT04145505|SENTINEL NODE|sentinel node
8446|NCT04145492|Hemodialysis and Vitamin K2|hemodialysis and vitamin k2
8447|NCT04145479|gestational diabetes|gestational diabetes
8448|NCT04145479|pregnancy|pregnancy
8449|NCT04145479|exercise|exercise
8450|NCT04145453|TAS2R38 Polymorphism|tas2r38 polymorphism
8451|NCT04145453|bitter|bitter
8452|NCT04145453|taste|taste
8453|NCT04145453|PAV|pav
8454|NCT04145453|AVI|avi
8455|NCT04145453|vegetables|vegetables
8456|NCT04145427|Liver Transplant, Low Carbohydrate Diet|liver transplant, low carbohydrate diet
8457|NCT04145414|CSF|csf
8458|NCT04145414|PC-MRI|pc-mri
8459|NCT04145414|interventricular foramina|interventricular foramina
8460|NCT04145401|Osteoarthritis|osteoarthritis
8461|NCT04145401|traumatic arthritis|traumatic arthritis
8462|NCT04145401|avascular necrosis|avascular necrosis
8463|NCT04145401|rheumatoid arthritis|rheumatoid arthritis
8464|NCT04145401|correction of functional deformity|correction of functional deformity
8465|NCT04145401|revision procedures|revision procedures
8466|NCT04145388|cancer|cancer
8467|NCT04145388|family characteristics|family characteristics
8468|NCT04145388|genetic predisposition|genetic predisposition
8469|NCT04145388|primary care|primary care
8470|NCT04145375|Zenith|zenith
8471|NCT04145375|prostate cancer|prostate cancer
8472|NCT04145362|preterm|preterm
8473|NCT04145362|actigraphy|actigraphy
8474|NCT04145362|sleep|sleep
8475|NCT04145349|soft tissue sarcoma|soft tissue sarcoma
8476|NCT04145349|adolescents and young adults (AYAs)|adolescents and young adults (ayas)
8477|NCT04145349|adolescent|adolescent
8478|NCT04145336|ERCP|ercp
8479|NCT04145336|PEP|pep
8480|NCT04145336|Post-ERCP pancreatitis|post-ercp pancreatitis
8481|NCT04145336|Pancreatic duct stent|pancreatic duct stent
8482|NCT04145323|mastectomy|mastectomy
8483|NCT04145323|Breast reconstruction|breast reconstruction
8484|NCT04145323|necrosis|necrosis
8485|NCT04145323|Indocyanine Green|indocyanine green
8486|NCT04145258|Tuberculous Meningitis|tuberculous meningitis
8487|NCT04145258|Intensified treatment|intensified treatment
8488|NCT04145258|High dose Rifampicin|high dose rifampicin
8489|NCT04145258|Linezolid|linezolid
8490|NCT04145258|Aspirin|aspirin
8491|NCT04145258|Subsaharan Africa|subsaharan africa
8492|NCT04145245|DPN, Levocarnitine|dpn, levocarnitine
8493|NCT04145232|Cancer|cancer
8494|NCT04145232|Non Small Cell Lung Cancer|non small cell lung cancer
8495|NCT04145232|Neoepitopes|neoepitopes
8496|NCT04145232|Neoantigens|neoantigens
8497|NCT04145232|Immunotherapy|immunotherapy
8498|NCT04145232|Nivolumab|nivolumab
8499|NCT04145232|Ipilimumab|ipilimumab
8500|NCT04145232|Atezolizumab|atezolizumab
8501|NCT04145232|Neoantigen cancer vaccine|neoantigen cancer vaccine
8502|NCT04145232|Personalized neoantigen cancer vaccine|personalized neoantigen cancer vaccine
8503|NCT04145232|FFPE|ffpe
8504|NCT04145232|PBMC|pbmc
8505|NCT04145232|Stool|stool
8506|NCT04145232|Immuno-Oncology|immuno-oncology
8507|NCT04145232|Next generation sequencing (NGS)|next generation sequencing (ngs)
8508|NCT04145219|Allergic rhinitis|allergic rhinitis
8509|NCT04145219|HDM|hdm
8515|NCT04145193|colorectal cancer|colorectal cancer
8516|NCT04145193|MSS-CRC|mss-crc
8517|NCT04145193|adjuvant|adjuvant
8518|NCT04145180|Pain|pain
8519|NCT04145180|Function|function
8520|NCT04145180|Quality of Life|quality of life
8521|NCT04145180|Head and Neck Cancer|head and neck cancer
8522|NCT04145167|chronic total occlusion|chronic total occlusion
8523|NCT04145167|coronary percutaneous intervention|coronary percutaneous intervention
8524|NCT04145167|ischemic heart disease|ischemic heart disease
8525|NCT04145154|Platelet|platelet
8526|NCT04145154|Diabetic foot|diabetic foot
8531|NCT04145128|Pharmacokinetic study|pharmacokinetic study
8532|NCT04145128|AG-881|ag-881
8533|NCT04145102|remineralization|remineralization
8534|NCT04145102|carious dentin|carious dentin
8535|NCT04145102|natural products|natural products
8536|NCT04145102|antibacterial effect|antibacterial effect
8537|NCT04145076|citalopram|citalopram
8538|NCT04145076|tianeptine|tianeptine
8539|NCT04145076|pharmacological imaging|pharmacological imaging
8540|NCT04145011|Randomized clinical trial|randomized clinical trial
8541|NCT04145011|Osteoarthritis|osteoarthritis
8542|NCT04145011|Radiofrequency Ablation|radiofrequency ablation
8543|NCT04145011|Knee|knee
8544|NCT04145011|Genicular|genicular
8545|NCT04145011|Coolief|coolief
8546|NCT04144985|Discomfort|discomfort
8547|NCT04144985|Visual Analog Scale|visual analog scale
8548|NCT04144985|Speculum|speculum
8549|NCT04144985|Eyelid retraction|eyelid retraction
8550|NCT04144985|Cotton tipped applicator|cotton tipped applicator
8551|NCT04144985|Eyelid Speculum|eyelid speculum
8552|NCT04144985|Unimanual eyelid retraction|unimanual eyelid retraction
8553|NCT04144972|Chronic Pain|chronic pain
8554|NCT04144933|Opioid-free|opioid-free
8555|NCT04144933|Opioid-sparing|opioid-sparing
8556|NCT04144920|Interrupting sitting|interrupting sitting
8557|NCT04144920|Continuous glucose monitroing|continuous glucose monitroing
8558|NCT04144920|Pattern of sitting breaks|pattern of sitting breaks
8559|NCT04144868|Cerebral Hemorrhage|cerebral hemorrhage
8560|NCT04144868|Normobaric oxygen therapy|normobaric oxygen therapy
8561|NCT04144868|Mask oxygen|mask oxygen
8562|NCT04144868|edema|edema
8563|NCT04144777|Smokers|smokers
8564|NCT04144777|Prediabetes|prediabetes
8565|NCT04144777|Cognitive Health|cognitive health
8566|NCT04144764|upper trapezius|upper trapezius
8567|NCT04144764|muscle stiffness|muscle stiffness
8568|NCT04144751|Blood Draw|blood draw
8569|NCT04144738|Sample Collection|sample collection
8570|NCT04144738|Stool DNA|stool dna
8571|NCT04144738|Colonoscopy|colonoscopy
8572|NCT04144699|wheeze|wheeze
8573|NCT04144699|rhonchus|rhonchus
8574|NCT04144686|Vestibular|vestibular
8575|NCT04144686|dual-tasking|dual-tasking
8576|NCT04144686|Gait|gait
8577|NCT04144686|rehabilitation|rehabilitation
8578|NCT04144686|dizziness|dizziness
8579|NCT04144673|Immune Support|immune support
8580|NCT04144673|Active lifestyle|active lifestyle
8581|NCT04144673|Silver|silver
8582|NCT04144673|Healthy Adults|healthy adults
8583|NCT04144673|Cold|cold
8584|NCT04144673|WURSS|wurss
8585|NCT04144647|dual-tasking|dual-tasking
8586|NCT04144647|CANTAB|cantab
8587|NCT04144647|Gait|gait
8588|NCT04144647|Cognition|cognition
8589|NCT04144647|Sleep|sleep
8590|NCT04144647|activity|activity
8591|NCT04144621|Sperm DNA fragmentation|sperm dna fragmentation
8592|NCT04144621|Implantation rate|implantation rate
8593|NCT04144621|Pregnancy rate|pregnancy rate
8594|NCT04144621|Blastocyst grading|blastocyst grading
8595|NCT04144608|Toripalimab NSCLC|toripalimab nsclc
8596|NCT04144595|Glucose Tolerance Test|glucose tolerance test
8597|NCT04144595|Low Birth Weight|low birth weight
8598|NCT04144556|Stroke|stroke
8599|NCT04144556|virtual reality|virtual reality
8600|NCT04144556|physical therapy|physical therapy
8601|NCT04144517|Alkermes|alkermes
8602|NCT04144517|IL-2|il-2
8603|NCT04144517|Interleukin-2|interleukin-2
8604|NCT04144517|Oncology|oncology
8605|NCT04144517|Immuno-oncology|immuno-oncology
8606|NCT04144517|Cytokine Immunotherapy|cytokine immunotherapy
8607|NCT04144517|ALKS 4230|alks 4230
8608|NCT04144517|Pembrolizumab|pembrolizumab
8609|NCT04144517|Keytruda|keytruda
8610|NCT04144517|PD-L1|pd-l1
8611|NCT04144517|Solid Tumors|solid tumors
8612|NCT04144491|Lactobacillus rhamnosus yoba 2012|lactobacillus rhamnosus yoba 2012
8613|NCT04144491|Children|children
8614|NCT04144478|Epilepsy|epilepsy
8810|NCT04143243|Veterans|veterans
8615|NCT04144478|Web based education|web based education
8616|NCT04144478|Pediatric Nursing|pediatric nursing
8617|NCT04144478|Parent|parent
8618|NCT04144478|Adolescence|adolescence
8619|NCT04144452|Back Pain|back pain
8620|NCT04144452|Exercise Therapy|exercise therapy
8621|NCT04144452|Functionality|functionality
8622|NCT04144452|Microdiscectomy|microdiscectomy
8623|NCT04144452|Patient Education|patient education
8624|NCT04144452|Quality of Life|quality of life
8625|NCT04144361|post sleeve gastrectomy leak|post sleeve gastrectomy leak
8626|NCT04144361|post sleeve gastrectomy|post sleeve gastrectomy
8627|NCT04144348|ModernaTX|modernatx
8628|NCT04144348|mRNA-1653|mrna-1653
8629|NCT04144348|human metapneumovirus|human metapneumovirus
8630|NCT04144348|human parainfluenza|human parainfluenza
8631|NCT04144348|human parainfluenza vaccine|human parainfluenza vaccine
8632|NCT04144348|virus diseases|virus diseases
8633|NCT04144348|RNA virus infections|rna virus infections
8634|NCT04144348|paramyxoviridae infections|paramyxoviridae infections
8635|NCT04144348|mononegavirales infections|mononegavirales infections
8636|NCT04144309|Acupuncture|acupuncture
8637|NCT04144309|Insomnia|insomnia
8638|NCT04144309|Breast cancer|breast cancer
8639|NCT04144309|Chemotherapy|chemotherapy
8640|NCT04144296|Arterial blood gas analysis|arterial blood gas analysis
8641|NCT04144296|Capillary blood gas analysis|capillary blood gas analysis
8642|NCT04144283|Parkinson's disease|parkinson's disease
8643|NCT04144283|Ageing|ageing
8644|NCT04144283|Rehabilitation|rehabilitation
8645|NCT04144283|Sleep|sleep
8646|NCT04144283|Motor learning|motor learning
8647|NCT04144283|Targeted Memory Reactivation|targeted memory reactivation
8648|NCT04144270|Urinary Bladder Neoplasm|urinary bladder neoplasm
8649|NCT04144270|Urothelium Neoplasm|urothelium neoplasm
8650|NCT04144270|Oncology|oncology
8651|NCT04144270|Muscle function|muscle function
8652|NCT04144270|Sarcopenia|sarcopenia
8653|NCT04144244|microfluid chip|microfluid chip
8654|NCT04144244|gradient-density|gradient-density
8655|NCT04144244|intrauterine insemination|intrauterine insemination
8656|NCT04144166|capillary refill time|capillary refill time
8657|NCT04144166|peripheral perfusion|peripheral perfusion
8658|NCT04144140|Advanced Solid Tumors|advanced solid tumors
8659|NCT04144140|E7766|e7766
8660|NCT04144140|Intratumoral Injection|intratumoral injection
8661|NCT04144140|Stimulator of Interferon Genes Agonist|stimulator of interferon genes agonist
8662|NCT04144140|Interferons|interferons
8663|NCT04144140|Antineoplastic Agents|antineoplastic agents
8664|NCT04144140|Lymphoma|lymphoma
8665|NCT04144140|Melanoma|melanoma
8666|NCT04144140|Head and Neck Squamous Cell Carcinoma|head and neck squamous cell carcinoma
8667|NCT04144140|Breast Cancer|breast cancer
8668|NCT04144140|Colorectal Cancer|colorectal cancer
8669|NCT04144114|Amino Acids|amino acids
8670|NCT04144114|Intramuscular Anabolic Signaling|intramuscular anabolic signaling
8671|NCT04144114|Endocrine Response|endocrine response
8672|NCT04144114|Resistance Training|resistance training
8673|NCT04144101|etoricoxib aceclofenac efficacy safety Taiwanese|etoricoxib aceclofenac efficacy safety taiwanese
8674|NCT04144075|Psychosis|psychosis
8675|NCT04144075|Quality of life|quality of life
8676|NCT04144075|Mindfulness|mindfulness
8677|NCT04144075|Compassion|compassion
8678|NCT04144075|Self-compassion|self-compassion
8679|NCT04144075|Schizophrenia|schizophrenia
8680|NCT04144062|Crowns|crowns
8681|NCT04144062|Zirconium|zirconium
8682|NCT04144062|Computer-Aided Design|computer-aided design
8683|NCT04144036|Graft-versus-host disease|graft-versus-host disease
8684|NCT04144036|Neihulizumab|neihulizumab
8685|NCT04143971|intermittent fasting|intermittent fasting
8686|NCT04143971|hypertriglyceridemia|hypertriglyceridemia
8687|NCT04143932|multiple myeloma|multiple myeloma
8688|NCT04143932|MM|mm
8689|NCT04143932|Registry|registry
8690|NCT04143932|Turkey|turkey
8691|NCT04143919|Heart failure|heart failure
8692|NCT04143919|Cardiovascular risk factors|cardiovascular risk factors
8693|NCT04143919|NT-proBNP|nt-probnp
8694|NCT04143919|NYHA assessment|nyha assessment
8695|NCT04143906|MBC, Vinorelbine, Carboplatin, Gemcitabine, PFS|mbc, vinorelbine, carboplatin, gemcitabine, pfs
8696|NCT04143893|Cardiogenic shock|cardiogenic shock
8697|NCT04143893|Mechanical Circulatory Support|mechanical circulatory support
8698|NCT04143828|Infertility|infertility
8699|NCT04143828|Mobile Health|mobile health
8700|NCT04143828|Mindfulness|mindfulness
8701|NCT04143776|hernia|hernia
8702|NCT04143776|abdominal reconstruction|abdominal reconstruction
8703|NCT04143776|intraabdominal pressure|intraabdominal pressure
8704|NCT04143776|acute kidney injury|acute kidney injury
8705|NCT04143776|restrictive lung disease|restrictive lung disease
8706|NCT04143737|Community-based intervention|community-based intervention
8707|NCT04143737|Arab women|arab women
8708|NCT04143737|East jerusalem|east jerusalem
8709|NCT04143737|Diabetes prevention|diabetes prevention
8710|NCT04143737|Lifestyle intervention|lifestyle intervention
8711|NCT04143737|Quasi-Experiment|quasi-experiment
8712|NCT04143724|ACE-536|ace-536
8713|NCT04143724|Luspatercept|luspatercept
8714|NCT04143724|Pharmacokinetics|pharmacokinetics
8715|NCT04143724|Beta-Thalassemia|beta-thalassemia
8716|NCT04143724|Red Blood Cell Transfusion|red blood cell transfusion
8717|NCT04143711|HER-2|her-2
8718|NCT04143711|NK Cell|nk cell
8719|NCT04143711|Immunotherapy|immunotherapy
8720|NCT04143711|Metastatic Breast Cancer|metastatic breast cancer
8721|NCT04143711|Urothelial Bladder Cancer|urothelial bladder cancer
8722|NCT04143698|duodenoscopes; ERCP|duodenoscopes; ercp
8723|NCT04143685|PROM|prom
8724|NCT04143672|postoperative pain|postoperative pain
8725|NCT04143672|pain sensitivity|pain sensitivity
8726|NCT04143633|Irritable Bowel Syndrome|irritable bowel syndrome
8727|NCT04143633|Ulcerative Colitis|ulcerative colitis
8728|NCT04143633|Low FODMAP diet|low fodmap diet
8729|NCT04143633|Nutritional status|nutritional status
8730|NCT04143633|Standard diet|standard diet
8731|NCT04143581|GFR decline|gfr decline
8732|NCT04143581|Glomerular hyperfiltration|glomerular hyperfiltration
8733|NCT04143581|SGLT2 inhibitors|sglt2 inhibitors
8734|NCT04143581|Residual proteinuria|residual proteinuria
8735|NCT04143581|Obesity|obesity
8736|NCT04143555|endoscopic submucosal injection|endoscopic submucosal injection
8737|NCT04143555|indocyanine green|indocyanine green
8738|NCT04143542|quadratus lumborum block|quadratus lumborum block
8739|NCT04143542|transversus abdominis block|transversus abdominis block
8740|NCT04143542|postoperative analgesia|postoperative analgesia
8741|NCT04143529|Musculoskeletal malignancy|musculoskeletal malignancy
8742|NCT04143516|Optimizing Thermal Ablation|optimizing thermal ablation
8743|NCT04143516|Rapid Tissue Analysis|rapid tissue analysis
8744|NCT04143516|Metabolic Imaging Biomarker Validation|metabolic imaging biomarker validation
8745|NCT04143516|Predictive Genetic Signatures|predictive genetic signatures
8746|NCT04143516|19-332|19-332
8748|NCT04143503|parenteral nutrition|parenteral nutrition
8749|NCT04143503|enteral nutrition|enteral nutrition
8750|NCT04143503|energy intake|energy intake
8751|NCT04143503|protein intake|protein intake
8752|NCT04143490|Ulcerative Colitis|ulcerative colitis
8753|NCT04143490|Inflammatory Bowel Disease|inflammatory bowel disease
8754|NCT04143490|Exercise|exercise
8755|NCT04143490|Gastric emptying rate|gastric emptying rate
8756|NCT04143490|Inflammatory markers|inflammatory markers
8757|NCT04143490|Gastrointestinal integrity|gastrointestinal integrity
8758|NCT04143477|peficitinib|peficitinib
8759|NCT04143477|ASP015K|asp015k
8760|NCT04143477|pharmacokinetics|pharmacokinetics
8761|NCT04143464|Thoracic Hyperkyphosis|thoracic hyperkyphosis
8762|NCT04143464|Exercise|exercise
8763|NCT04143464|Older Adults|older adults
8764|NCT04143451|influenza, intradermal, imiquimod, high-dose, vaccine|influenza, intradermal, imiquimod, high-dose, vaccine
8765|NCT04143438|patella|patella
8766|NCT04143438|EOS 3D imaging|eos 3d imaging
8767|NCT04143425|Recurrent Glioblastoma; Bevacizumab; Imaging|recurrent glioblastoma; bevacizumab; imaging
8768|NCT04143412|microalbuminuria|microalbuminuria
8769|NCT04143412|Diabetic nephropathy|diabetic nephropathy
8770|NCT04143412|Hperkalemia|hperkalemia
8771|NCT04143412|Eplerenone|eplerenone
8772|NCT04143412|Ramipril|ramipril
8773|NCT04143399|BPH|bph
8774|NCT04143399|enucleation|enucleation
8775|NCT04143399|Large Prostate|large prostate
8776|NCT04143399|LUTS|luts
8777|NCT04143399|IPSS|ipss
8778|NCT04143399|quality of life|quality of life
8779|NCT04143386|lower extremity arterial disease|lower extremity arterial disease
8780|NCT04143386|hemodynamics|hemodynamics
803734|NCT00239551|Prevacid|prevacid
8781|NCT04143386|arterial stiffness|arterial stiffness
8782|NCT04143386|metabolism|metabolism
8783|NCT04143386|metabolomics|metabolomics
8784|NCT04143386|inflammation|inflammation
8785|NCT04143386|oxidative stress|oxidative stress
8786|NCT04143386|biomarkers|biomarkers
8787|NCT04143386|prognosis|prognosis
8788|NCT04143373|Warm Saline|warm saline
8789|NCT04143347|TBI|tbi
8790|NCT04143347|Traumatic Brain injury|traumatic brain injury
8791|NCT04143347|Transfer|transfer
8792|NCT04143347|Blunt|blunt
8793|NCT04143334|blindness|blindness
8794|NCT04143334|cataract blindness|cataract blindness
8795|NCT04143334|diagnostic accuracy|diagnostic accuracy
8796|NCT04143321|diabetes mellitus-refractory angina-empagliflozine|diabetes mellitus-refractory angina-empagliflozine
8797|NCT04143308|Schizophrenia|schizophrenia
8798|NCT04143308|Cognitive functional training|cognitive functional training
8799|NCT04143308|Dual-task training|dual-task training
8800|NCT04143308|Aerobic exercise|aerobic exercise
8801|NCT04143308|Mobile application|mobile application
8802|NCT04143269|Vagal nerve stimulation|vagal nerve stimulation
8803|NCT04143269|Diabetes type 2|diabetes type 2
8804|NCT04143269|Gastrointestinal symptoms|gastrointestinal symptoms
8805|NCT04143256|Electronic Nicotine Delivery|electronic nicotine delivery
8806|NCT04143256|Combustible Cigarettes|combustible cigarettes
8807|NCT04143256|Nicotine|nicotine
8808|NCT04143256|Exhaled Breath|exhaled breath
8809|NCT04143243|Acceptance and Commitment Therapy|acceptance and commitment therapy
8811|NCT04143243|polytrauma|polytrauma
8812|NCT04143243|traumatic brain injury|traumatic brain injury
8813|NCT04143243|chronic pain|chronic pain
8814|NCT04143243|Post Traumatic Stress Disorder|post traumatic stress disorder
8815|NCT04143243|depression|depression
8816|NCT04143243|Anxiety|anxiety
8817|NCT04143230|palliative care|palliative care
8818|NCT04143230|palliative care team|palliative care team
8819|NCT04143230|palliative care unit|palliative care unit
8820|NCT04143230|screening tool|screening tool
8821|NCT04143230|end of life|end of life
8822|NCT04143230|unplanned hospital admission|unplanned hospital admission
8823|NCT04143230|end-stage disease|end-stage disease
8824|NCT04143230|cancer|cancer
8825|NCT04143230|survival|survival
8826|NCT04143230|prognostic score|prognostic score
8827|NCT04143230|palliative sedation|palliative sedation
8828|NCT04143178|Expressive writing|expressive writing
8829|NCT04143178|Kidney transplant|kidney transplant
8830|NCT04143178|Adherence|adherence
8831|NCT04143178|Alexithymia|alexithymia
8832|NCT04143178|Healthcare spending|healthcare spending
8833|NCT04143139|Bone mineral density|bone mineral density
8834|NCT04143139|Ileostomists|ileostomists
8835|NCT04143139|Vitamin D|vitamin d
8836|NCT04143139|Observational study|observational study
8837|NCT04143139|Calcium|calcium
8838|NCT04143139|Phytochemical|phytochemical
8839|NCT04143126|Negative Symptoms|negative symptoms
8840|NCT04143126|Cognition|cognition
8841|NCT04143126|Social Cognition|social cognition
8842|NCT04143113|stroke|stroke
8843|NCT04143113|hemorrhagic stroke|hemorrhagic stroke
8844|NCT04143113|shared decision making|shared decision making
8845|NCT04143113|neurocritical care|neurocritical care
8846|NCT04143113|decision aid|decision aid
8847|NCT04143113|goals of care|goals of care
8848|NCT04143113|palliative care|palliative care
8849|NCT04143113|family communication|family communication
8850|NCT04143113|end of life|end of life
8851|NCT04143113|critical care|critical care
8852|NCT04143113|neuroICU|neuroicu
8853|NCT04143113|patient-centered care|patient-centered care
8854|NCT04143022|acupuncture press needle|acupuncture press needle
8855|NCT04143022|obstructive sleep apnea|obstructive sleep apnea
8856|NCT04143022|polysomnography|polysomnography
8857|NCT04143009|HIV|hiv
8858|NCT04143009|Depression|depression
8859|NCT04142970|Mild renal impairment|mild renal impairment
8860|NCT04142970|Moderate renal impairment|moderate renal impairment
8861|NCT04142957|COPD|copd
8862|NCT04142957|Self-management|self-management
8863|NCT04142957|Qualitative|qualitative
8864|NCT04142957|Empowerment|empowerment
8865|NCT04142957|Telehealth|telehealth
8866|NCT04142944|Type1 diabetes|type1 diabetes
8867|NCT04142944|device with predictive hypo alert|device with predictive hypo alert
8868|NCT04142918|painful post-traumatic trigeminal neuropathy|painful post-traumatic trigeminal neuropathy
8869|NCT04142918|neuropathic pain|neuropathic pain
8870|NCT04142918|neuropathic odontalgia|neuropathic odontalgia
8871|NCT04142918|gingival biopsy|gingival biopsy
8872|NCT04142879|Large Vessel Occlusion|large vessel occlusion
8873|NCT04142866|aphasia|aphasia
8874|NCT04142866|stroke|stroke
8875|NCT04142866|tDCS|tdcs
8876|NCT04142866|language|language
8877|NCT04142866|stimulation|stimulation
8878|NCT04142866|brain|brain
8879|NCT04142866|speech therapy|speech therapy
8880|NCT04142827|Bronchiectasis|bronchiectasis
8881|NCT04142827|High Flow Therapy|high flow therapy
8882|NCT04142827|Humidifcation|humidifcation
8883|NCT04142827|Lung Infection|lung infection
8884|NCT04142827|Quality of life|quality of life
8885|NCT04142814|Lower respiratory airways clearance|lower respiratory airways clearance
8886|NCT04142814|Deep lung clearance|deep lung clearance
8887|NCT04142814|Secretions overproduction|secretions overproduction
8888|NCT04142814|Positive Expiratory Pressure|positive expiratory pressure
8889|NCT04142814|Intrapulmonary Percussive Ventilation|intrapulmonary percussive ventilation
8890|NCT04142814|Tetraplegia|tetraplegia
8891|NCT04142814|Tracheotomy|tracheotomy
8892|NCT04142814|Critical Care Unit|critical care unit
8893|NCT04142814|Mechanical ventilation|mechanical ventilation
8894|NCT04142814|Respiratory physiotherapy|respiratory physiotherapy
8895|NCT04142801|Cognition|cognition
8896|NCT04142801|motivation|motivation
8897|NCT04142801|technology|technology
8898|NCT04142801|non pharmacological intervention|non pharmacological intervention
8899|NCT04142736|Prone position|prone position
8900|NCT04142736|High flow oxygen therapy|high flow oxygen therapy
8901|NCT04142723|alcoholic, liver disease, cirrhosis|alcoholic, liver disease, cirrhosis
8902|NCT04142710|telemedicine|telemedicine
8903|NCT04142710|telehealth|telehealth
8904|NCT04142710|randomized control trial|randomized control trial
8905|NCT04142710|chronic disease|chronic disease
8906|NCT04142710|health services research|health services research
8907|NCT04142710|primary health care|primary health care
8908|NCT04142710|primary care nursing|primary care nursing
8909|NCT04142684|Unilateral Diaphragmatic Paralysis|unilateral diaphragmatic paralysis
8910|NCT04142684|Diagnose|diagnose
8920|NCT04142593|Decision Tree|decision tree
8921|NCT04142593|Risk Factors Assessment|risk factors assessment
8922|NCT04142580|discopathy|discopathy
8923|NCT04142580|chronic lumbago|chronic lumbago
8924|NCT04142580|degenerative|degenerative
8925|NCT04142580|Modic 1|modic 1
8926|NCT04142567|Drug drug interactions|drug drug interactions
8927|NCT04142567|Pharmacist interventions|pharmacist interventions
8928|NCT04142567|Cancer patients|cancer patients
8929|NCT04142567|Out patient setting|out patient setting
8930|NCT04142554|breast|breast
8931|NCT04142554|triple negative|triple negative
8932|NCT04142554|HER2-positive|her2-positive
8933|NCT04142554|parsaclisib|parsaclisib
8934|NCT04142502|spinal anesthesia|spinal anesthesia
8935|NCT04142502|autonomic nervous system|autonomic nervous system
8936|NCT04142502|dexmedetomidine|dexmedetomidine
8937|NCT04142502|propofol|propofol
8938|NCT04142476|Hormonotherpy|hormonotherpy
8939|NCT04142476|Compliance|compliance
8940|NCT04142463|Oral anticancer drugs|oral anticancer drugs
8941|NCT04142463|Self-management|self-management
8942|NCT04142463|Care pathway|care pathway
8943|NCT04142463|Before-after study|before-after study
8944|NCT04142463|Self-management support|self-management support
8945|NCT04142424|Single-ascending-dose (SAD)|single-ascending-dose (sad)
8946|NCT04142424|First-in-human (FiH)|first-in-human (fih)
8947|NCT04142372|leukemia|leukemia
8948|NCT04142372|lymphoma|lymphoma
8949|NCT04142372|biomarker|biomarker
8950|NCT04142372|prognosis|prognosis
8951|NCT04142372|myeloma|myeloma
8952|NCT04142372|myelodysplasia|myelodysplasia
8953|NCT04142372|myeloproliferative disorder|myeloproliferative disorder
8954|NCT04142372|diagnostics|diagnostics
8955|NCT04142372|tissue microarray|tissue microarray
8956|NCT04142372|proteomics|proteomics
8957|NCT04142372|genomics|genomics
8958|NCT04142372|clinical outcome|clinical outcome
8959|NCT04142372|biobanking|biobanking
8960|NCT04142372|digitalization|digitalization
8961|NCT04142372|data mining|data mining
8962|NCT04142372|hematology|hematology
8963|NCT04142372|oncology|oncology
8964|NCT04142372|pathology|pathology
8965|NCT04142372|bioinformatics|bioinformatics
8966|NCT04142372|real world data|real world data
8967|NCT04142372|hematological malignancy|hematological malignancy
8968|NCT04142372|survival|survival
8969|NCT04142372|treatment response|treatment response
8970|NCT04142346|sitting time|sitting time
8971|NCT04142346|physical inactivity|physical inactivity
8972|NCT04142346|breaks|breaks
8973|NCT04142346|glycemic control|glycemic control
8974|NCT04142346|continuous glucose monitoring|continuous glucose monitoring
8975|NCT04142346|older adults|older adults
8976|NCT04142333|genetic counseling|genetic counseling
8977|NCT04142333|genetic testing|genetic testing
8978|NCT04142307|biofeedback|biofeedback
8979|NCT04142307|vision rehabilitation|vision rehabilitation
8980|NCT04142307|nystagmus|nystagmus
8981|NCT04142307|paediatric|paediatric
8982|NCT04142281|Energy Balance|energy balance
8983|NCT04142281|Metabolism|metabolism
8984|NCT04142268|Preelampsia|preelampsia
8985|NCT04142268|Cardio-ankle vascular index (CAVI)|cardio-ankle vascular index (cavi)
8986|NCT04142268|Aortic stiffness|aortic stiffness
8987|NCT04142268|Blood pressure|blood pressure
8988|NCT04142268|LDL-cholesterol|ldl-cholesterol
8989|NCT04142229|type 1 diabetes|type 1 diabetes
8990|NCT04142229|automated insulin delivery|automated insulin delivery
8991|NCT04142229|artificial pancreas|artificial pancreas
8992|NCT04142229|stress|stress
8993|NCT04142216|Thirst|thirst
8994|NCT04142216|Weight gain|weight gain
8995|NCT04142203|23 h surgery|23 h surgery
8996|NCT04142203|recovery|recovery
8997|NCT04142203|outcome|outcome
8998|NCT04142203|patient satisfaction|patient satisfaction
8999|NCT04142190|follicle-stimulating hormone|follicle-stimulating hormone
9000|NCT04142190|embryo morphokinetics|embryo morphokinetics
9001|NCT04142190|reproductive medicine|reproductive medicine
9002|NCT04142177|chronic low back pain|chronic low back pain
9003|NCT04142177|severe low back pain|severe low back pain
9004|NCT04142177|pain|pain
9005|NCT04142177|non-pharmacological treatment|non-pharmacological treatment
9006|NCT04142177|self-management|self-management
9007|NCT04142177|physical therapy|physical therapy
9008|NCT04142177|exercise|exercise
9009|NCT04142177|yoga|yoga
9010|NCT04142177|cognitive behavioral therapy|cognitive behavioral therapy
9011|NCT04142177|spinal manipulation therapy|spinal manipulation therapy
9015|NCT04142138|nutrition|nutrition
9016|NCT04142125|Pilot study|pilot study
9017|NCT04142125|Rivaroxaban|rivaroxaban
9018|NCT04142125|Factor Xa Inhibitors|factor xa inhibitors
9019|NCT04142125|Intracranial Atherosclerotic Disease|intracranial atherosclerotic disease
9020|NCT04142099|early maternal and child skin contact, neonatal sucking|early maternal and child skin contact, neonatal sucking
9021|NCT04142073|wireless vitals|wireless vitals
9022|NCT04142073|vitals monitor|vitals monitor
9023|NCT04142073|cardiac|cardiac
9024|NCT04142021|coronary artery bypass graft|coronary artery bypass graft
9025|NCT04142021|coronary computed tomography angiography|coronary computed tomography angiography
9026|NCT04142021|fractional flow reserve derived from computed tomography angiography|fractional flow reserve derived from computed tomography angiography
9027|NCT04142021|invasive coronary angiography, revascularization|invasive coronary angiography, revascularization
9028|NCT04141995|Resectable|resectable
9029|NCT04141969|Lyme|lyme
9030|NCT04141943|Breast cancer|breast cancer
9031|NCT04141943|radiotherapy|radiotherapy
9032|NCT04141943|virtual reality|virtual reality
9033|NCT04141930|influenza|influenza
9035|NCT04141930|antiviral|antiviral
9036|NCT04141930|baloxavir|baloxavir
9037|NCT04141930|Xofluza|xofluza
9038|NCT04141930|rapid delivery|rapid delivery
9039|NCT04141930|self-test|self-test
9040|NCT04141917|Tamiflu|tamiflu
9041|NCT04141917|Oseltamivir|oseltamivir
9042|NCT04141917|Baloxavir|baloxavir
9043|NCT04141917|Influenza|influenza
9044|NCT04141917|Flu|flu
9045|NCT04141917|Rapid Test|rapid test
9046|NCT04141917|Xofluza|xofluza
9047|NCT04141904|Depression|depression
9048|NCT04141878|Diabetes|diabetes
9049|NCT04141878|Dementia|dementia
9050|NCT04141878|Prevention|prevention
9051|NCT04141852|artero-venous fistula|artero-venous fistula
9052|NCT04141852|non-Contrast Enhanced MRI|non-contrast enhanced mri
9053|NCT04141852|hemodynamics|hemodynamics
9054|NCT04141852|CFD simulations|cfd simulations
9055|NCT04141852|VasQ|vasq
9056|NCT04141813|mindfulness|mindfulness
9057|NCT04141813|mental health|mental health
9058|NCT04141813|well-being|well-being
9059|NCT04141813|peregrination|peregrination
9060|NCT04141813|walking|walking
9061|NCT04141813|forest-bathing|forest-bathing
9062|NCT04141813|outdoor therapy|outdoor therapy
9063|NCT04141813|wilderness therapy|wilderness therapy
9064|NCT04141813|adventure therapy|adventure therapy
9065|NCT04141800|Hyperkalemia|hyperkalemia
9066|NCT04141800|Heart failure|heart failure
9067|NCT04141800|Incidence|incidence
9068|NCT04141800|Ejection fraction|ejection fraction
9069|NCT04141787|Ceftriaxone|ceftriaxone
9070|NCT04141787|Deep-seated Infections|deep-seated infections
9071|NCT04141787|Staphylococcus aureus|staphylococcus aureus
9072|NCT04141787|Coagulase-negative Staphylococcus species|coagulase-negative staphylococcus species
9073|NCT04141787|MSSA|mssa
9074|NCT04141787|CoNS|cons
9075|NCT04141774|aneurysm|aneurysm
9076|NCT04141774|transient ischemic attack|transient ischemic attack
9077|NCT04141761|Newly diagnosed|newly diagnosed
9078|NCT04141761|Recent onset|recent onset
9079|NCT04141761|Visbiome|visbiome
9080|NCT04141761|Probiotic|probiotic
9081|NCT04141748|shape capture|shape capture
9082|NCT04141748|prosthetic sockets|prosthetic sockets
9083|NCT04141735|SOS|sos
9084|NCT04141722|Emotional Memory|emotional memory
9085|NCT04141722|Memory Consolidation|memory consolidation
9086|NCT04141722|Age-Related Positivity Effect|age-related positivity effect
9087|NCT04141709|Oligometastasis|oligometastasis
9088|NCT04141709|Prostate Cancer|prostate cancer
9089|NCT04141709|high-dose radiation therapy|high-dose radiation therapy
9090|NCT04141709|resistant prostate cancer|resistant prostate cancer
9095|NCT04141683|tricuspid regurgitation|tricuspid regurgitation
9096|NCT04141683|heart failure|heart failure
9097|NCT04141683|right heart|right heart
9098|NCT04141683|stress echocardiography|stress echocardiography
9099|NCT04141683|tricuspid repair|tricuspid repair
9100|NCT04141683|tricuspid replacement|tricuspid replacement
9101|NCT04141670|RYR1|ryr1
9102|NCT04141670|Myopathy|myopathy
9103|NCT04141657|neonates|neonates
9104|NCT04141657|antimicrobial pharmacotherapy|antimicrobial pharmacotherapy
9105|NCT04141657|pharmacotherapy adverse events|pharmacotherapy adverse events
9106|NCT04141657|neonatal Intensive Care Unit|neonatal intensive care unit
9107|NCT04141657|safety|safety
9108|NCT04141631|Perioperative Erythropoietin|perioperative erythropoietin
9109|NCT04141631|Perioperative Iron|perioperative iron
9110|NCT04141631|ScVO2|scvo2
9111|NCT04141631|Patient blood Management|patient blood management
9112|NCT04141631|Blood Transfusion|blood transfusion
9113|NCT04141618|recurrent miscarriage|recurrent miscarriage
9114|NCT04141618|infertility|infertility
9115|NCT04141566|Pseudocontinent perineal colostomy|pseudocontinent perineal colostomy
9116|NCT04141566|Abdominoperineal resection|abdominoperineal resection
9117|NCT04141566|colostomy|colostomy
9118|NCT04141566|Cost effectiveness|cost effectiveness
9119|NCT04141566|quality of life|quality of life
9120|NCT04141540|22q11.2 Microdeletional|22q11.2 microdeletional
9121|NCT04141527|Labor|labor
9122|NCT04141527|Intrathecal sufentanil|intrathecal sufentanil
9123|NCT04141527|Obstetrical|obstetrical
9124|NCT04141527|Spinal analgesia|spinal analgesia
9125|NCT04141501|Alcoholism|alcoholism
9126|NCT04141501|Psilocybin|psilocybin
9127|NCT04141501|Psychedelics|psychedelics
9128|NCT04141501|clinical efficacy|clinical efficacy
9129|NCT04141501|autobiographical memory|autobiographical memory
9130|NCT04141501|cue-reactivity exposure|cue-reactivity exposure
9131|NCT04141501|placebo-controlled|placebo-controlled
9132|NCT04141501|proof-of-concept|proof-of-concept
9133|NCT04141488|Lateral Epicondylitis|lateral epicondylitis
9134|NCT04141488|electromyography|electromyography
9135|NCT04141488|pain|pain
9136|NCT04141488|scapula|scapula
9137|NCT04141462|genetic mutations|genetic mutations
9138|NCT04141462|early sporadic or familial cancer|early sporadic or familial cancer
9139|NCT04141462|gene panel|gene panel
9140|NCT04141462|exome analysis|exome analysis
9141|NCT04141462|high-throughput exome sequencing|high-throughput exome sequencing
9142|NCT04141436|Hypnofertility|hypnofertility
9143|NCT04141436|fertility preparedness|fertility preparedness
9144|NCT04141436|cortisol level|cortisol level
9145|NCT04141436|pregnancy outcome|pregnancy outcome
9146|NCT04141423|Oral Insulin|oral insulin
9147|NCT04141410|Sepsis|sepsis
9148|NCT04141410|Septic Shock|septic shock
9149|NCT04141410|Cardiogenic Shock|cardiogenic shock
9150|NCT04141410|Speckle Tracking Echocardiography|speckle tracking echocardiography
9151|NCT04141410|Levosimendan|levosimendan
9152|NCT04141397|precision medicine|precision medicine
9153|NCT04141397|genomic sequencing|genomic sequencing
9154|NCT04141397|administrative data|administrative data
9155|NCT04141397|quasi-experimental methods|quasi-experimental methods
9156|NCT04141397|matching|matching
9157|NCT04141397|clinical effectiveness|clinical effectiveness
9158|NCT04141384|Modular Interactive Tiles System, MITS|modular interactive tiles system, mits
9159|NCT04141384|Stroke|stroke
9160|NCT04141358|Vascular Access|vascular access
9161|NCT04141358|Endothelial Dysfunction|endothelial dysfunction
9162|NCT04141358|Vascular Stiffness|vascular stiffness
9163|NCT04141358|Arteriovenous Fistula|arteriovenous fistula
9164|NCT04141306|Radioiodine Bone Metastases|radioiodine bone metastases
9165|NCT04141306|Thyroid Cancer|thyroid cancer
9166|NCT04141280|Insomnia|insomnia
9167|NCT04141280|Syndrome|syndrome
9168|NCT04141280|Material basis|material basis
9169|NCT04141280|Infrared image|infrared image
9170|NCT04141280|Relativity|relativity
9171|NCT04141254|Anticoagulant|anticoagulant
9172|NCT04141254|Direct oral anticoagulant|direct oral anticoagulant
9173|NCT04141254|Debriefing|debriefing
9174|NCT04141254|Recurrent venous thromboembolism|recurrent venous thromboembolism
9175|NCT04141254|anticoagulant-related bleeding|anticoagulant-related bleeding
9176|NCT04141241|T2DM with Recent Cardiovascular Complications|t2dm with recent cardiovascular complications
9177|NCT04141202|Exercise therapy|exercise therapy
9178|NCT04141202|Exercise physiology|exercise physiology
9179|NCT04141189|Intrauterine Growth Restriction|intrauterine growth restriction
9180|NCT04141189|fetal surveillance|fetal surveillance
9181|NCT04141189|fetal doppler|fetal doppler
9182|NCT04141189|fetal growth|fetal growth
9183|NCT04141176|Continuous positive airway pressure|continuous positive airway pressure
9184|NCT04141150|AD|ad
9185|NCT04141150|MDAD|mdad
9186|NCT04141150|HV|hv
9187|NCT04141137|Tricuspid Valve Insufficiency|tricuspid valve insufficiency
9188|NCT04141137|Heart Valve Diseases|heart valve diseases
9189|NCT04141137|Heart Diseases|heart diseases
9190|NCT04141137|Cardiovascular Diseases|cardiovascular diseases
9191|NCT04141124|medical education|medical education
9192|NCT04141124|simulated critical situation|simulated critical situation
9193|NCT04141124|stress management and performance|stress management and performance
9194|NCT04141111|continuous glucose monitoring|continuous glucose monitoring
9195|NCT04141098|Degenerative Disc Disease|degenerative disc disease
9196|NCT04141098|DDD|ddd
9197|NCT04141098|Chronic Low-back Pain|chronic low-back pain
9198|NCT04141098|Disc Herniation|disc herniation
9199|NCT04141098|Nucleus Replacement|nucleus replacement
9200|NCT04141098|Low back pain|low back pain
9201|NCT04141072|CKD|ckd
9202|NCT04141072|Creatinine|creatinine
9203|NCT04141072|Cystatin C|cystatin c
9204|NCT04141072|Cardiac surgery|cardiac surgery
9205|NCT04141072|GFR|gfr
9206|NCT04141059|Photoaging|photoaging
9207|NCT04141059|Polyphenols|polyphenols
9208|NCT04141059|Natural extracts|natural extracts
9209|NCT04141059|Collagen metabolism|collagen metabolism
9210|NCT04141046|Systemic lupus erythematosus|systemic lupus erythematosus
9211|NCT04141046|Lupus|lupus
9212|NCT04141046|SLE|sle
9213|NCT04141046|Depression|depression
9214|NCT04141046|Pain|pain
9215|NCT04141046|Brain fog|brain fog
9216|NCT04141046|Mood|mood
9217|NCT04141033|Periodontitis|periodontitis
9218|NCT04141033|Neopterin|neopterin
9219|NCT04141033|Menopausal women|menopausal women
9220|NCT04141033|Non-surgical periodontal therapy|non-surgical periodontal therapy
9221|NCT04140968|Resting energy expenditure|resting energy expenditure
9222|NCT04140955|Opioid tapering|opioid tapering
9223|NCT04140955|Withdrawal symptoms|withdrawal symptoms
9224|NCT04140955|Spine surgery|spine surgery
9225|NCT04140955|Patient satisfaction|patient satisfaction
9226|NCT04140929|nursing homes|nursing homes
9227|NCT04140929|oral hygiene|oral hygiene
9228|NCT04140929|quality of life|quality of life
9229|NCT04140929|health services research|health services research
9230|NCT04140903|Oral antibiotics|oral antibiotics
9231|NCT04140890|prefrail|prefrail
9232|NCT04140890|habit|habit
9233|NCT04140890|exercise|exercise
9234|NCT04140890|diet|diet
9235|NCT04140877|Choroidal thickness|choroidal thickness
9236|NCT04140877|Virtual reality|virtual reality
9237|NCT04140864|Prevalence|prevalence
9238|NCT04140864|Community Dwelling Elderly|community dwelling elderly
9239|NCT04140864|Sarcopenia|sarcopenia
9240|NCT04140864|Obesity|obesity
9241|NCT04140851|Dietary Interventions|dietary interventions
9242|NCT04140851|Intestinal Flora|intestinal flora
9243|NCT04140851|Metabolism|metabolism
9244|NCT04140812|Preterm|preterm
9245|NCT04140812|Coagulation|coagulation
9246|NCT04140812|LC-MS/MS|lc-ms/ms
9247|NCT04140812|ICH|ich
9248|NCT04140812|IVH|ivh
9249|NCT04140812|Neonatal|neonatal
9250|NCT04140786|Nonsense mutation|nonsense mutation
9251|NCT04140734|Retraction Repair|retraction repair
9252|NCT04140734|Hard Palate|hard palate
9253|NCT04140734|Autologous Ear Cartilage|autologous ear cartilage
9254|NCT04140734|porcine acellular dermal matrix|porcine acellular dermal matrix
9255|NCT04140734|spacer graft|spacer graft
9256|NCT04140721|postural tachycardia syndrome|postural tachycardia syndrome
9257|NCT04140721|hyperadrenergic|hyperadrenergic
9258|NCT04140721|moxonidine|moxonidine
9259|NCT04140721|sympatholytic|sympatholytic
9260|NCT04140721|orthostatic symptoms|orthostatic symptoms
9261|NCT04140721|POTS|pots
9262|NCT04140708|Exercise|exercise
9263|NCT04140708|Parkinson's|parkinson's
9264|NCT04140708|Glymphatic System|glymphatic system
9265|NCT04140695|Chronic Pruritus|chronic pruritus
9266|NCT04140695|Eczema|eczema
9267|NCT04140682|Proportional assist ventilation|proportional assist ventilation
9268|NCT04140682|Pressure support ventilation|pressure support ventilation
9269|NCT04140682|Weaning|weaning
9270|NCT04140682|Prolonged mechanical ventilation|prolonged mechanical ventilation
9271|NCT04140656|elderly|elderly
9272|NCT04140656|balance|balance
9273|NCT04140656|falling|falling
9274|NCT04140656|plantar sensitivity|plantar sensitivity
9275|NCT04140656|insole|insole
9276|NCT04140643|Pregnancy|pregnancy
9277|NCT04140643|Oral Health|oral health
9278|NCT04140643|Ozone therapy|ozone therapy
9279|NCT04140643|Gingivitis|gingivitis
9280|NCT04140630|vaping|vaping
9281|NCT04140630|electronic cigarette|electronic cigarette
9282|NCT04140630|passive exposure|passive exposure
9283|NCT04140617|vaping|vaping
9284|NCT04140617|electronic cigarette|electronic cigarette
9285|NCT04140617|passive exposure|passive exposure
9286|NCT04140617|e-cigarette|e-cigarette
9287|NCT04140604|Probiotic|probiotic
9288|NCT04140604|Lactobacillus salivarius AP-32|lactobacillus salivarius ap-32
9289|NCT04140604|Bifidobacterium lactis CP-9|bifidobacterium lactis cp-9
9290|NCT04140604|Safety|safety
9291|NCT04140604|Healthy infant|healthy infant
9292|NCT04140591|Portal hypertension|portal hypertension
9293|NCT04140591|Peptic ulcer|peptic ulcer
9294|NCT04140591|Non-selective beta-blocker|non-selective beta-blocker
9295|NCT04140591|Proton pump inhibitor|proton pump inhibitor
9296|NCT04140578|Gastric variceal rebleeding|gastric variceal rebleeding
9297|NCT04140578|Sepsis|sepsis
9298|NCT04140578|cyanoacrylate injection|cyanoacrylate injection
9299|NCT04140565|Machine learning, deep neural networks, PET/CT|machine learning, deep neural networks, pet/ct
9300|NCT04140552|gallbladder neoplasms|gallbladder neoplasms
9301|NCT04140552|gallbladder cancer|gallbladder cancer
9302|NCT04140474|bronchoscopy|bronchoscopy
9303|NCT04140474|Lung Cancer|lung cancer
9304|NCT04140474|Solitary Pulmonary Nodule|solitary pulmonary nodule
9305|NCT04140461|HIV infection|hiv infection
9306|NCT04140461|Cryptococcal Meningitis|cryptococcal meningitis
9307|NCT04140461|Amphotericin B|amphotericin b
9308|NCT04140448|Ultra-wide field fundus fluorescein angiography|ultra-wide field fundus fluorescein angiography
9309|NCT04140448|ischemic index|ischemic index
9310|NCT04140448|vascular leakage index|vascular leakage index
9311|NCT04140435|EUS-guided through the needle biopsy (EUS-guided TTNB)|eus-guided through the needle biopsy (eus-guided ttnb)
9312|NCT04140435|Pancreatic cyst lesions (PCLs)|pancreatic cyst lesions (pcls)
9313|NCT04140422|Corneal edema|corneal edema
9314|NCT04140422|Descemet membrane endothelial keratoplasty (DMEK)|descemet membrane endothelial keratoplasty (dmek)
9315|NCT04140422|Hyperosmolar eye drops|hyperosmolar eye drops
9316|NCT04140409|NET|net
9317|NCT04140383|geriatry|geriatry
9318|NCT04140383|cataract surgery|cataract surgery
9319|NCT04140383|advanced age|advanced age
9320|NCT04140344|Lumbar Fusion|lumbar fusion
9321|NCT04140344|Text Message|text message
9322|NCT04140331|Post-operative evolution|post-operative evolution
9323|NCT04140331|Accelerometer|accelerometer
9324|NCT04140331|Cardiac surgery|cardiac surgery
9325|NCT04140331|Accelerometry|accelerometry
9326|NCT04140331|Preoperative physical activity|preoperative physical activity
9327|NCT04140318|second line|second line
9328|NCT04140318|PD-1|pd-1
9329|NCT04140318|nab-paclitaxel|nab-paclitaxel
9330|NCT04140305|Multiple Sclerosis|multiple sclerosis
9331|NCT04140305|RPC-1063|rpc-1063
9332|NCT04140305|Ozanimod|ozanimod
9333|NCT04140279|Eye Diseases|eye diseases
9334|NCT04140253|Stress urinary incontinence|stress urinary incontinence
9335|NCT04140253|Pelvic floor muscle training|pelvic floor muscle training
9336|NCT04140240|menopause management|menopause management
9337|NCT04140240|progressive muscle relaxation|progressive muscle relaxation
9338|NCT04140240|nursing|nursing
9339|NCT04140214|Respiratory|respiratory
9340|NCT04140214|Mucoactive|mucoactive
9341|NCT04140214|Exacerbation|exacerbation
9342|NCT04140214|Hypertonic Saline|hypertonic saline
9343|NCT04140214|Carbocisteine|carbocisteine
9344|NCT04140214|Airway Clearance|airway clearance
9345|NCT04140175|Endometriosis|endometriosis
9346|NCT04140175|Chronic Pelvic Pain|chronic pelvic pain
9347|NCT04140175|Dysmenorrhea|dysmenorrhea
9348|NCT04140162|Dara-R|dara-r
9349|NCT04140162|DaraRd|darard
9350|NCT04140162|Dara-RVd|dara-rvd
9351|NCT04140162|MRD|mrd
9352|NCT04140149|Suicide|suicide
9353|NCT04140149|Suicide Attempt|suicide attempt
9354|NCT04140149|Suicidal Ideation|suicidal ideation
9355|NCT04140149|Pilot|pilot
9356|NCT04140149|Intervention|intervention
9357|NCT04140136|ALS|als
9358|NCT04140110|Acute ischemic stroke|acute ischemic stroke
9359|NCT04140110|Large vessel occlusion|large vessel occlusion
9360|NCT04140110|Mechanical thrombectomy|mechanical thrombectomy
9361|NCT04140110|Blood pressure management|blood pressure management
9362|NCT04140110|Antiplatelet therapy|antiplatelet therapy
9363|NCT04140110|Anticoagulation therapy|anticoagulation therapy
9364|NCT04140110|Randomised clinical trial|randomised clinical trial
9365|NCT04140097|Predictor|predictor
9366|NCT04140097|Development|development
9367|NCT04140097|Pulmonary Rehabilitation|pulmonary rehabilitation
9368|NCT04140084|Emergency Department|emergency department
9369|NCT04140084|Mild Traumatic Brain Injury|mild traumatic brain injury
9370|NCT04140084|Shared decision-making|shared decision-making
9371|NCT04140084|Decision aids|decision aids
9372|NCT04140084|Head computed tomography|head computed tomography
9373|NCT04140071|Eating habits|eating habits
9374|NCT04140071|Web-based prospective cohort study|web-based prospective cohort study
9375|NCT04140071|Lifestyle habits|lifestyle habits
9376|NCT04140071|Health|health
9377|NCT04140071|Diet quality|diet quality
9378|NCT04140058|Ondansetron|ondansetron
9379|NCT04140058|hypotension|hypotension
9380|NCT04140058|nausea and vomiting|nausea and vomiting
9381|NCT04140058|cesarean section|cesarean section
9382|NCT04140032|obesity|obesity
9383|NCT04140032|nutrition|nutrition
9384|NCT04140032|physical activity|physical activity
9385|NCT04140032|preschool|preschool
9386|NCT04140032|child care centers|child care centers
9387|NCT04140032|policy-system-environment intervention|policy-system-environment intervention
9388|NCT04140019|NSTEMI|nstemi
9389|NCT04140019|NSTE-ACS|nste-acs
9390|NCT04140019|CMR|cmr
9391|NCT04140019|Troponin T|troponin t
9392|NCT04140019|Cardiac Magnetic Resonance Imaging|cardiac magnetic resonance imaging
9393|NCT04139993|RBX7455|rbx7455
9394|NCT04139993|adenocarcinoma|adenocarcinoma
9395|NCT04139993|hormone receptor positive|hormone receptor positive
9396|NCT04139993|HER2 positive|her2 positive
9397|NCT04139993|triple negative|triple negative
9398|NCT04139928|Magnesium|magnesium
9399|NCT04139915|Mechanistic Target of Rapamycin (mTOR)|mechanistic target of rapamycin (mtor)
9400|NCT04139915|Influenza|influenza
9401|NCT04139915|Virus|virus
9402|NCT04139915|Pneumonia|pneumonia
9403|NCT04139915|Immunosenescence|immunosenescence
9404|NCT04139915|Respiratory Tract Infections|respiratory tract infections
9405|NCT04139889|Probe-based confocal laser endomicroscopy|probe-based confocal laser endomicroscopy
9406|NCT04139889|Optical biopsy|optical biopsy
9407|NCT04139876|Hemorrhoidectomy|hemorrhoidectomy
9408|NCT04139876|Minimal Open hemorrhoidectomy|minimal open hemorrhoidectomy
9409|NCT04139876|LigaSure hemorrhoidectomy|ligasure hemorrhoidectomy
9410|NCT04139850|chronic hepatitis B|chronic hepatitis b
9411|NCT04139850|cohort|cohort
9412|NCT04139850|nationwide|nationwide
9413|NCT04139850|prospective|prospective
9414|NCT04139850|antiviral therapy|antiviral therapy
9415|NCT04139811|Internal limiting membrane|internal limiting membrane
9416|NCT04139811|multifocal electoretinogram (ERG)|multifocal electoretinogram (erg)
9417|NCT04139811|OCT-Angiography|oct-angiography
9418|NCT04139785|Depression|depression
9419|NCT04139785|Anxiety|anxiety
9420|NCT04139785|Prevention|prevention
9421|NCT04139785|Public Mental Health|public mental health
9422|NCT04139785|Primary Care|primary care
9423|NCT04139772|metastatic castration-resistent prostate cancer|metastatic castration-resistent prostate cancer
9424|NCT04139772|asymptomatic or oligosymptomatic|asymptomatic or oligosymptomatic
9425|NCT04139772|hormone therapy|hormone therapy
9426|NCT04139772|docetaxel|docetaxel
9427|NCT04139759|Nursing|nursing
9428|NCT04139759|Hemodialysis|hemodialysis
9429|NCT04139759|Fatigue|fatigue
9430|NCT04139759|Hand massage|hand massage
9431|NCT04139759|Foot massage|foot massage
9432|NCT04139733|Acute respiratory distress syndrome|acute respiratory distress syndrome
9433|NCT04139733|Extracorporeal Membrane Oxygenation|extracorporeal membrane oxygenation
9434|NCT04139733|Prone Position|prone position
9435|NCT04139720|sexual harassment prevention|sexual harassment prevention
9436|NCT04139720|nurse|nurse
9437|NCT04139720|education|education
9438|NCT04139720|e-book|e-book
9439|NCT04139707|dementia|dementia
9440|NCT04139707|care-giving|care-giving
9441|NCT04139707|communication|communication
9442|NCT04139707|mobile application|mobile application
9443|NCT04139655|MINS|mins
9444|NCT04139655|Colchicine|colchicine
9445|NCT04139655|Myocardial Injury|myocardial injury
9446|NCT04139655|Major Adverse Cardiac Events|major adverse cardiac events
9447|NCT04139655|Myocardial Injury after Non-Cardiac Surgery|myocardial injury after non-cardiac surgery
9448|NCT04139655|MACE|mace
9449|NCT04139642|descriptive observational study|descriptive observational study
9450|NCT04139642|balance measurement|balance measurement
9451|NCT04139629|Antichlamydial antibodies|antichlamydial antibodies
9452|NCT04139629|in vitro fertilization|in vitro fertilization
9453|NCT04139629|ovarian stimulation|ovarian stimulation
9454|NCT04139629|tubal factor infertility|tubal factor infertility
9455|NCT04139616|atrioventricular block|atrioventricular block
9456|NCT04139616|complete heart block|complete heart block
9457|NCT04139616|high-degree atrioventricular block|high-degree atrioventricular block
9458|NCT04139616|intraventricular conduction delay|intraventricular conduction delay
9459|NCT04139616|left bundle branch block|left bundle branch block
9460|NCT04139616|Permanent pacemaker implantation|permanent pacemaker implantation
9461|NCT04139616|Right bundle branch block|right bundle branch block
9462|NCT04139603|kinesio tape|kinesio tape
9463|NCT04139603|pain|pain
9464|NCT04139603|functional mobility|functional mobility
9465|NCT04139603|ergonomic education|ergonomic education
9466|NCT04139603|pelvic girdle questionnaire|pelvic girdle questionnaire
9467|NCT04139603|five times sit to stand test|five times sit to stand test
9468|NCT04139603|timed up and go test|timed up and go test
9469|NCT04139603|stair climb test|stair climb test
9470|NCT04139590|postoperative pain|postoperative pain
9471|NCT04139590|Visual Analogue Scale|visual analogue scale
9472|NCT04139590|Numeric Rating Scale|numeric rating scale
9473|NCT04139590|Smartphone|smartphone
9474|NCT04139577|Acute Graft-Versus-Host Disease (Gvhd) Grade|acute graft-versus-host disease (gvhd) grade
9475|NCT04139577|Hematopoietic Cell Transplantation|hematopoietic cell transplantation
9476|NCT04139577|Fecal Microbiota Transplant|fecal microbiota transplant
9477|NCT04139551|wearable technology|wearable technology
9478|NCT04139551|Saccadic eye movements|saccadic eye movements
9479|NCT04139551|Gait assessment|gait assessment
9480|NCT04139551|Cognitive tests|cognitive tests
9481|NCT04139499|sleep apnea|sleep apnea
9482|NCT04139499|Continuous positive airway pressure (CPAP)|continuous positive airway pressure (cpap)
9483|NCT04139499|Sleep manometry|sleep manometry
9484|NCT04139486|Contact aspiration (CA)|contact aspiration (ca)
9485|NCT04139486|Embotrap II|embotrap ii
9486|NCT04139486|Susceptibility vessel sign (SVS)|susceptibility vessel sign (svs)
9487|NCT04139486|Thrombus|thrombus
9488|NCT04139460|Non-ischemic cardiomyopathy|non-ischemic cardiomyopathy
9489|NCT04139460|Heart failure|heart failure
9490|NCT04139460|Implantable cardioverter-defibrillator|implantable cardioverter-defibrillator
9491|NCT04139460|Cardiac resynchronization therapy|cardiac resynchronization therapy
9492|NCT04139460|Magnetic resonance imaging|magnetic resonance imaging
9493|NCT04139460|Late gadolinium enhancement|late gadolinium enhancement
9494|NCT04139447|Adrenal steroids|adrenal steroids
9495|NCT04139447|mass spectroscopy|mass spectroscopy
9496|NCT04139447|liquid chromatography|liquid chromatography
9497|NCT04139434|BCL-2 inhibitor|bcl-2 inhibitor
9498|NCT04139434|AML|aml
9499|NCT04139434|MDS|mds
9500|NCT04139434|CMML|cmml
9501|NCT04139434|relapse|relapse
9502|NCT04139434|refractory|refractory
9503|NCT04139434|LP-108|lp-108
9504|NCT04139421|Shinrin-Yoku|shinrin-yoku
9505|NCT04139421|Forest Bathing|forest bathing
9506|NCT04139421|Psychological Well-being|psychological well-being
9507|NCT04139421|Natural Environment|natural environment
9508|NCT04139408|Pulmonary Nodule|pulmonary nodule
9509|NCT04139408|Localization|localization
9510|NCT04139408|Marker|marker
9511|NCT04139382|Telemedicine|telemedicine
9512|NCT04139382|Telephone|telephone
9513|NCT04139382|Remote|remote
9514|NCT04139369|INS gene|ins gene
9515|NCT04139369|methylation|methylation
9516|NCT04139369|next generation sequencing|next generation sequencing
9517|NCT04139356|pulseoxymetry|pulseoxymetry
9518|NCT04139356|capnography|capnography
9519|NCT04139356|Dead space|dead space
9520|NCT04139356|cardiac output|cardiac output
9521|NCT04139356|lung recruitment|lung recruitment
9522|NCT04139356|deep breaths|deep breaths
9523|NCT04139343|nusinersen|nusinersen
9524|NCT04139343|Spinraza|spinraza
9525|NCT04139343|MUNE|mune
9526|NCT04139343|CMAP|cmap
9527|NCT04139317|capmatinib, pembrolizumab, NSCLC, PD-L1, EGFR, ALK, MET, squamous, non-squamous|capmatinib, pembrolizumab, nsclc, pd-l1, egfr, alk, met, squamous, non-squamous
9528|NCT04139291|breast cancer related lymphedema|breast cancer related lymphedema
9529|NCT04139291|complex decongestive therapy|complex decongestive therapy
9530|NCT04139291|ultrasound|ultrasound
9531|NCT04139239|Disorders of consciousness|disorders of consciousness
9532|NCT04139239|Coma Recovery Scale-revision|coma recovery scale-revision
9533|NCT04139239|Diagnostic accuracy|diagnostic accuracy
9534|NCT04139226|CC-11050|cc-11050
9535|NCT04139226|Safety|safety
9536|NCT04139226|Healthy Subjects|healthy subjects
9537|NCT04139200|Physical activity|physical activity
9538|NCT04139200|Tele coaching|tele coaching
9539|NCT04139187|Adult|adult
9540|NCT04139187|Anterior Cruciate Ligament Injuries|anterior cruciate ligament injuries
9541|NCT04139187|Lower Extremity|lower extremity
9542|NCT04139109|accidental falls|accidental falls
9543|NCT04139109|activity restriction|activity restriction
9544|NCT04139109|fear of falling|fear of falling
9545|NCT04139109|participation restriction|participation restriction
9546|NCT04139109|psychometrics|psychometrics
9547|NCT04139083|Pelvic organ prolapse|pelvic organ prolapse
9548|NCT04139083|Transvaginal mesh|transvaginal mesh
9549|NCT04139083|Laparoscopic mesh suspension|laparoscopic mesh suspension
9550|NCT04139070|Electrochemotherapy|electrochemotherapy
9551|NCT04139070|Palliative treatment|palliative treatment
9552|NCT04139044|ankle, joint instability, cross-education, rehabilitation|ankle, joint instability, cross-education, rehabilitation
9553|NCT04139018|Epistaxis|epistaxis
9554|NCT04138992|Bevacizumab|bevacizumab
9555|NCT04138992|local advanced cervical cancer|local advanced cervical cancer
9556|NCT04138992|concurrent chemoradiotherapy|concurrent chemoradiotherapy
9557|NCT04138979|gut microbiota|gut microbiota
9558|NCT04138979|16S rRNA gene|16s rrna gene
9559|NCT04138979|breast cancer chemotherapy|breast cancer chemotherapy
9560|NCT04138953|Electrophysiology|electrophysiology
9561|NCT04138953|Magnetic Resonance imaging (MRI)|magnetic resonance imaging (mri)
9562|NCT04138953|Neuroanatomy|neuroanatomy
9563|NCT04138953|Neuroscience|neuroscience
9564|NCT04138940|Stroke|stroke
9565|NCT04138940|Speech and Language Therapy|speech and language therapy
9566|NCT04138940|Speech and Language Treatment|speech and language treatment
9567|NCT04138940|Communication Disorders|communication disorders
9568|NCT04138940|Language Disorders|language disorders
9569|NCT04138927|wAIHA|waiha
9570|NCT04138927|Warm Antibody Autoimmune Hemolytic Anemia|warm antibody autoimmune hemolytic anemia
9571|NCT04138927|Warm Autoimmune Hemolytic Anemia|warm autoimmune hemolytic anemia
9572|NCT04138901|Postoperative pain|postoperative pain
9573|NCT04138901|Stomach neoplasms|stomach neoplasms
9574|NCT04138901|Nerve block|nerve block
9575|NCT04138888|Olmesartan medoxomil/hydrochlorothiazide|olmesartan medoxomil/hydrochlorothiazide
9576|NCT04138888|Bioequivalence|bioequivalence
9577|NCT04138888|Olmetec Plus®|olmetec plus®
9578|NCT04138797|Signal Averaging ECG|signal averaging ecg
9579|NCT04138797|HV interval|hv interval
9580|NCT04138771|conjunctival hyperemia|conjunctival hyperemia
9581|NCT04138771|pterygium|pterygium
9582|NCT04138771|intraocular lens dislocation|intraocular lens dislocation
9583|NCT04138771|posterior capsule opacification|posterior capsule opacification
9584|NCT04138732|Community|community
9585|NCT04138732|Health|health
9586|NCT04138732|Hospital|hospital
9587|NCT04138719|Triple-negative Breast Cancer|triple-negative breast cancer
9588|NCT04138719|Nab-paclitaxel|nab-paclitaxel
9589|NCT04138719|Carboplatin|carboplatin
9590|NCT04138719|Epirubicin|epirubicin
9591|NCT04138693|Blood/Urine/Hair lead|blood/urine/hair lead
9592|NCT04138693|Lead uptake & Lead bioavailability|lead uptake & lead bioavailability
9593|NCT04138680|Brain Imaging|brain imaging
9594|NCT04138680|Biofeedback|biofeedback
9595|NCT04138667|breast cancer related lymphedema|breast cancer related lymphedema
9596|NCT04138667|lymphedema|lymphedema
9597|NCT04138667|outcome measurement|outcome measurement
9598|NCT04138667|responsiveness|responsiveness
9599|NCT04138628|Muscle Invasive Bladder Cancer (MIBC)|muscle invasive bladder cancer (mibc)
9608|NCT04138589|lumacaftor/ ivacaftor|lumacaftor/ ivacaftor
9609|NCT04138589|tezacaftor/ ivacaftor|tezacaftor/ ivacaftor
9610|NCT04138589|Multiple breath washout|multiple breath washout
9611|NCT04138589|Lung clearance index|lung clearance index
9612|NCT04138589|PRAGMA CF score|pragma cf score
9614|NCT04138563|Magnetic Resonance Imaging|magnetic resonance imaging
9615|NCT04138563|Cerebrovascular physiology|cerebrovascular physiology
9616|NCT04138563|Cardiovascular physiology|cardiovascular physiology
9617|NCT04138563|Supine ergometric stepper|supine ergometric stepper
9618|NCT04138550|Social determinants|social determinants
9619|NCT04138550|Oral health|oral health
9620|NCT04138550|Women|women
9621|NCT04138550|Egypt|egypt
9622|NCT04138537|Acromegaly|acromegaly
9623|NCT04138537|Olfaction|olfaction
9624|NCT04138537|Olfactory disorder|olfactory disorder
9625|NCT04138524|Acquired Brain Injury|acquired brain injury
9626|NCT04138524|Family|family
9627|NCT04138524|Nursing interventions|nursing interventions
9628|NCT04138524|Stroke|stroke
9629|NCT04138524|Traumatic Brain Injury|traumatic brain injury
9630|NCT04138524|Oncology|oncology
9631|NCT04138524|caregivers|caregivers
9632|NCT04138498|ADHD|adhd
9633|NCT04138498|bioavailability|bioavailability
9634|NCT04138498|dexmethylphenidate|dexmethylphenidate
9635|NCT04138498|BA study|ba study
9636|NCT04138498|dMPH|dmph
9637|NCT04138498|d-MPH|d-mph
9638|NCT04138472|Dexmedetomidine|dexmedetomidine
9639|NCT04138472|Fentanyl|fentanyl
9640|NCT04138472|Lignocaine|lignocaine
9641|NCT04138472|Laryngoscopy|laryngoscopy
9642|NCT04138472|Hemodynamic Response|hemodynamic response
9643|NCT04138472|Laparoscopic Cholecystectomy|laparoscopic cholecystectomy
9644|NCT04138420|optical coherence tomography angiography|optical coherence tomography angiography
9645|NCT04138420|optical coherence tomography angiography angiography|optical coherence tomography angiography angiography
9646|NCT04138420|bevacizumab|bevacizumab
9647|NCT04138420|vascular endothelial growth factor antagonists|vascular endothelial growth factor antagonists
9648|NCT04138420|intravitreal injection|intravitreal injection
9649|NCT04138381|GIST|gist
9650|NCT04138381|MTD|mtd
9651|NCT04138381|Imatinib|imatinib
9652|NCT04138381|Selinexor|selinexor
9653|NCT04138381|Phase II|phase ii
9654|NCT04138381|Unresectable|unresectable
9655|NCT04138381|Metastatic|metastatic
9656|NCT04138316|headache disorders|headache disorders
9657|NCT04138277|Pompe|pompe
9658|NCT04138277|rhGAA|rhgaa
9659|NCT04138251|Empaglifozin|empaglifozin
9660|NCT04138238|Supraflex Cruz|supraflex cruz
9661|NCT04138238|Sirolimus-eluting Stent|sirolimus-eluting stent
9662|NCT04138238|High Bleeding Risk|high bleeding risk
9663|NCT04138238|Coronary Artery Disease|coronary artery disease
9664|NCT04138238|Arteriosclerosis|arteriosclerosis
9665|NCT04138238|Myocardial Ischemia|myocardial ischemia
9666|NCT04138238|Vascular Diseases|vascular diseases
9667|NCT04138238|Coronary Intervention|coronary intervention
9668|NCT04138238|Observational Registry|observational registry
9669|NCT04138238|Ultra-thin Strut Biodegradable Polymer|ultra-thin strut biodegradable polymer
9670|NCT04138225|yeast|yeast
9671|NCT04138225|mycology|mycology
9672|NCT04138225|gut|gut
9673|NCT04138225|microbiota|microbiota
9674|NCT04138225|gastrointestinal disorders|gastrointestinal disorders
9680|NCT04138199|Lopinavir/ritonavir (LPV/r)|lopinavir/ritonavir (lpv/r)
9681|NCT04138199|Kaletra|kaletra
9682|NCT04138199|Human Immunodeficiency Virus (HIV)|human immunodeficiency virus (hiv)
9683|NCT04138199|Generic Product|generic product
9684|NCT04138199|Highly Active Anti-Retroviral Therapy (HAART)|highly active anti-retroviral therapy (haart)
9685|NCT04138186|IBS|ibs
9686|NCT04138186|Diarrhea|diarrhea
9687|NCT04138186|Gastrointestinal function disorder|gastrointestinal function disorder
9688|NCT04138173|physical activity|physical activity
9689|NCT04138173|tele coaching|tele coaching
9690|NCT04138160|obesity dietary restriction|obesity dietary restriction
9691|NCT04138147|Cervical plexus,|cervical plexus,
9692|NCT04138147|Retrolaminar,|retrolaminar,
9693|NCT04138147|Auriculotemporal,|auriculotemporal,
9694|NCT04138147|Parotid|parotid
9695|NCT04138134|autophagy|autophagy
9696|NCT04138134|spermidine|spermidine
9700|NCT04138108|Childhood illness|childhood illness
9702|NCT04138108|Parents|parents
9703|NCT04138108|Psychiatric Nursing|psychiatric nursing
9704|NCT04138095|Palliative Care|palliative care
9705|NCT04138095|Virtual Reality|virtual reality
9706|NCT04138095|Pain|pain
9707|NCT04138095|Anxiety|anxiety
9708|NCT04138082|Situational Awareness|situational awareness
9709|NCT04138082|Randomized-Control Trial|randomized-control trial
9710|NCT04138082|Medical Simulation|medical simulation
9711|NCT04138082|Patient Security|patient security
9712|NCT04138069|COPD|copd
9713|NCT04138069|Pursed Lips Breathing|pursed lips breathing
9714|NCT04138069|Dyspnea|dyspnea
9715|NCT04138069|Pulmonary Function Test (PFT)|pulmonary function test (pft)
9716|NCT04138069|Aerobic Training|aerobic training
9717|NCT04138043|GSK2330811|gsk2330811
9718|NCT04138043|Healthy participants|healthy participants
9719|NCT04138043|Japanese|japanese
9720|NCT04138043|Pharmacokinetics|pharmacokinetics
9721|NCT04138043|Safety|safety
9722|NCT04138043|Subcutaneous dose|subcutaneous dose
9723|NCT04138030|Colonoscopy|colonoscopy
9724|NCT04138030|Polypectomy|polypectomy
9725|NCT04138030|Adenoma|adenoma
9726|NCT04138030|Colorectal cancer|colorectal cancer
9727|NCT04138017|Arthrodesis|arthrodesis
9728|NCT04138004|colonoscopy|colonoscopy
9729|NCT04138004|polyethylene glycols|polyethylene glycols
9730|NCT04138004|lubiprostone|lubiprostone
9731|NCT04137965|Fertility|fertility
9732|NCT04137965|Testicular Torsion|testicular torsion
9733|NCT04137965|Testicular function|testicular function
9734|NCT04137952|Posture training, Motor generalization, Aging, Cognition, High-density electroencephalography|posture training, motor generalization, aging, cognition, high-density electroencephalography
9735|NCT04137913|mild cognitive impairment|mild cognitive impairment
9736|NCT04137913|musical arts|musical arts
9737|NCT04137913|whole brain network|whole brain network
9738|NCT04137913|cognition|cognition
9739|NCT04137913|aging|aging
9740|NCT04137900|immunotherapy|immunotherapy
9741|NCT04137900|BTLA|btla
9742|NCT04137900|HVEM|hvem
9743|NCT04137900|check point inhibitor|check point inhibitor
9744|NCT04137900|solid tumor|solid tumor
9745|NCT04137900|non-small cell lung cancer|non-small cell lung cancer
9746|NCT04137900|NSCLC|nsclc
9747|NCT04137900|melanoma|melanoma
9748|NCT04137900|lymphoma|lymphoma
9749|NCT04137900|monoclonal antibody|monoclonal antibody
9750|NCT04137900|phase 1 trial|phase 1 trial
9751|NCT04137835|osteoarthritis|osteoarthritis
9752|NCT04137796|breastfeeding prevalence|breastfeeding prevalence
9753|NCT04137796|infant nutrition|infant nutrition
9754|NCT04137796|complimentary feeding|complimentary feeding
9755|NCT04137783|respiratory distress syndrome|respiratory distress syndrome
9756|NCT04137783|ABCA3 gene|abca3 gene
9757|NCT04137783|exome sequencing|exome sequencing
9758|NCT04137744|axillary reverse mapping|axillary reverse mapping
9759|NCT04137744|arm lymphedema|arm lymphedema
9760|NCT04137744|early breast cancer|early breast cancer
9761|NCT04137718|Multicenter|multicenter
9762|NCT04137718|Observational Study|observational study
9763|NCT04137718|NSCLC|nsclc
9764|NCT04137718|Rare Driver Gene|rare driver gene
9766|NCT04137692|Glucose transporter|glucose transporter
9767|NCT04137666|Cancer Hospitalized Patients|cancer hospitalized patients
9768|NCT04137666|Nutrition Disorders|nutrition disorders
9769|NCT04137666|Scoring System|scoring system
9770|NCT04137666|Nutrition Surveys|nutrition surveys
9771|NCT04137666|Nutrition Assessment|nutrition assessment
9772|NCT04137653|paclitaxel|paclitaxel
9773|NCT04137653|albumin-bound paclitaxel|albumin-bound paclitaxel
9774|NCT04137653|neoadjuvant therapy|neoadjuvant therapy
9775|NCT04137640|adjuvant chemotherapy|adjuvant chemotherapy
9776|NCT04137640|estrogen receptor|estrogen receptor
9777|NCT04137640|palbociclib|palbociclib
9778|NCT04137640|letrozole|letrozole
9779|NCT04137627|Melatonin|melatonin
9780|NCT04137627|Locally Advanced Oral Squamous Cell Carcinoma|locally advanced oral squamous cell carcinoma
9781|NCT04137627|Neoadjuvant Chemotherapy|neoadjuvant chemotherapy
9782|NCT04137601|Congenital syphilis|congenital syphilis
9783|NCT04137601|VDRL|vdrl
9784|NCT04137601|CSF|csf
9785|NCT04137601|Clinical manifestations|clinical manifestations
9786|NCT04137575|Fear of Cancer Recurrence|fear of cancer recurrence
9787|NCT04137575|Cancer Survivorship|cancer survivorship
9788|NCT04137575|Breast Cancer|breast cancer
9789|NCT04137575|Distress|distress
9790|NCT04137575|Emotion Regulation|emotion regulation
9791|NCT04137562|Adipose Derived Mesenchymal Stem cell|adipose derived mesenchymal stem cell
9792|NCT04137562|ADMSC|admsc
9793|NCT04137562|AD|ad
9794|NCT04137562|Inflammatory disease|inflammatory disease
9795|NCT04137562|Auto immune disease|auto immune disease
9796|NCT04137549|ambulatory blood pressure monitoring|ambulatory blood pressure monitoring
9797|NCT04137549|nocturnal hypertension|nocturnal hypertension
9798|NCT04137549|cardiovascular risk|cardiovascular risk
9799|NCT04137536|EGFR-BAT|egfr-bat
9802|NCT04137536|memorial sloan kettering cancer center|memorial sloan kettering cancer center
9804|NCT04137523|potential marker|potential marker
9805|NCT04137523|cytokine/adipokine|cytokine/adipokine
9806|NCT04137523|multiple myeloma|multiple myeloma
9807|NCT04137510|DAPT|dapt
9808|NCT04137510|Dual antiplatelet therapy|dual antiplatelet therapy
9809|NCT04137510|high bleeding risk|high bleeding risk
9810|NCT04137510|HBR|hbr
9811|NCT04137510|Coronary artery disease|coronary artery disease
9812|NCT04137510|Percutaneous coronary intervention|percutaneous coronary intervention
9813|NCT04137510|PCI|pci
9814|NCT04137497|disorders of consciousness|disorders of consciousness
9815|NCT04137497|unresponsive wakefulness syndrome|unresponsive wakefulness syndrome
9816|NCT04137497|minimally conscious state|minimally conscious state
9817|NCT04137497|Nociception Coma Scale-Revised|nociception coma scale-revised
9818|NCT04137484|Patient Blood Management Program|patient blood management program
9819|NCT04137484|Transfusion|transfusion
9820|NCT04137484|Postoperative anemia|postoperative anemia
9825|NCT04137445|Complementary Feeding|complementary feeding
9826|NCT04137432|loneliness|loneliness
9827|NCT04137432|oxytocin-augmented intervention|oxytocin-augmented intervention
9828|NCT04137432|fMRI|fmri
9829|NCT04137419|Periodontitis|periodontitis
9830|NCT04137419|Probiotic|probiotic
9831|NCT04137419|Non-surgical therapy|non-surgical therapy
9832|NCT04137406|Luminal A breast cancer|luminal a breast cancer
9833|NCT04137406|Sirt 1|sirt 1
9834|NCT04137406|lymph node metastasis|lymph node metastasis
9835|NCT04137406|EMT|emt
9836|NCT04137367|Rumination|rumination
9837|NCT04137367|Attention bias modification|attention bias modification
9838|NCT04137367|Transdiagnostic|transdiagnostic
9839|NCT04137354|Intermittent Iron supplementation|intermittent iron supplementation
9840|NCT04137354|Vitamin A|vitamin a
9841|NCT04137354|Cognitive Development|cognitive development
9842|NCT04137354|Anemia|anemia
9843|NCT04137302|Hydrocortisone (cortisol)|hydrocortisone (cortisol)
9844|NCT04137302|local administration of cortisol|local administration of cortisol
9845|NCT04137302|systemic administration of cortisol|systemic administration of cortisol
9846|NCT04137302|biomarkers|biomarkers
9847|NCT04137276|sepsis|sepsis
9848|NCT04137276|intravenous vitamin C|intravenous vitamin c
9849|NCT04137276|SOFA score|sofa score
9850|NCT04137250|ANTERIOR CRUCIATE LIGAMENT|anterior cruciate ligament
9851|NCT04137250|INJURY|injury
9852|NCT04137250|HAMSTRING|hamstring
9853|NCT04137250|AUTOGRAFT|autograft
9854|NCT04137250|QUADRICEPS|quadriceps
9855|NCT04137237|Hand|hand
9856|NCT04137237|Wrist|wrist
9857|NCT04137237|Surgery|surgery
9858|NCT04137224|scleroderma|scleroderma
9859|NCT04137198|emergency|emergency
9860|NCT04137198|pain|pain
9861|NCT04137198|analgesia|analgesia
9862|NCT04137198|intranasal|intranasal
9863|NCT04137198|sufentanil|sufentanil
9864|NCT04137172|ventral hernia - LVHR-transfacial repair|ventral hernia - lvhr-transfacial repair
9865|NCT04137120|Aflibercept|aflibercept
9866|NCT04137120|Intravitreal injection|intravitreal injection
9867|NCT04137120|Ocular disease|ocular disease
9868|NCT04137120|Wet age-related macular degeneration (wAMD)|wet age-related macular degeneration (wamd)
9869|NCT04137120|Diabetic macular edema (DME)|diabetic macular edema (dme)
9870|NCT04137120|Macular edema secondary to central retinal vein occlusion (CRVO)|macular edema secondary to central retinal vein occlusion (crvo)
9871|NCT04137120|Macular edema secondary to branch retinal vein occlusion (BRVO)|macular edema secondary to branch retinal vein occlusion (brvo)
9872|NCT04137120|Myopic choroidal neovascularization (mCNV)|myopic choroidal neovascularization (mcnv)
9873|NCT04137120|Mexico|mexico
9874|NCT04137081|Physicians|physicians
9875|NCT04137068|Physical Activity|physical activity
9876|NCT04137068|Sleep|sleep
9877|NCT04137068|Sedentary|sedentary
9878|NCT04137068|Cardiovascular|cardiovascular
9879|NCT04137055|NASH|nash
9880|NCT04137042|Metabolomics|metabolomics
9881|NCT04137042|Fluid therapy|fluid therapy
9882|NCT04137029|beta-receptors|beta-receptors
9883|NCT04137029|metacholine|metacholine
9884|NCT04137029|formoterol|formoterol
9885|NCT04137029|tiotropium|tiotropium
9886|NCT04137016|APP, old|app, old
9887|NCT04137003|Acl|acl
9888|NCT04137003|Anterior cruciate ligament|anterior cruciate ligament
9889|NCT04137003|Post surgery|post surgery
9890|NCT04136990|Anterior Cruciate Ligament Reconstruction|anterior cruciate ligament reconstruction
9891|NCT04136990|Lateral Extra-Articular Tenodesis|lateral extra-articular tenodesis
9892|NCT04136990|Knee Laxity|knee laxity
9893|NCT04136990|Porto Knee Testing Device|porto knee testing device
9894|NCT04136964|Neck pain|neck pain
9895|NCT04136964|COMI|comi
16117|NCT04097639|anemia|anemia
9896|NCT04136964|Quality of life|quality of life
9902|NCT04136951|clinical decisions support|clinical decisions support
9903|NCT04136951|care transitions|care transitions
9904|NCT04136951|patient prioritization|patient prioritization
9905|NCT04136951|health informatics|health informatics
9906|NCT04136951|home care|home care
9907|NCT04136938|Fall|fall
9908|NCT04136938|Seniors|seniors
9909|NCT04136938|Physical activity|physical activity
9910|NCT04136938|Prevention|prevention
9911|NCT04136912|Cancer Screening|cancer screening
9912|NCT04136899|burn out|burn out
9913|NCT04136899|quality of life|quality of life
9914|NCT04136899|general practioners|general practioners
9915|NCT04136899|french|french
9916|NCT04136886|concurrent chemotherapy|concurrent chemotherapy
9917|NCT04136886|IMRT|imrt
9918|NCT04136886|recurrent NPC|recurrent npc
9919|NCT04136847|Signs of Hand Aging|signs of hand aging
9920|NCT04136821|Oxidative Stress|oxidative stress
9921|NCT04136821|Muscle Strength|muscle strength
9922|NCT04136821|Resistance Training|resistance training
9923|NCT04136821|Antioxidants|antioxidants
9929|NCT04136795|esophageal atresia|esophageal atresia
9930|NCT04136795|thoracoscopy|thoracoscopy
9931|NCT04136795|rib fusion|rib fusion
9932|NCT04136795|scoliosis|scoliosis
9933|NCT04136795|Respiratory function|respiratory function
9934|NCT04136782|adjuvant chemotherapy|adjuvant chemotherapy
9935|NCT04136782|paclitaxel|paclitaxel
9936|NCT04136782|albumin-bound paclitaxel|albumin-bound paclitaxel
9937|NCT04136782|carboplatin|carboplatin
9938|NCT04136782|docetaxel|docetaxel
9939|NCT04136782|epirubicin|epirubicin
9940|NCT04136769|Arterial Invasion|arterial invasion
9941|NCT04136769|Arterial reconstruction|arterial reconstruction
9942|NCT04136769|Neoadjuvant chemotherapy|neoadjuvant chemotherapy
9943|NCT04136769|Tumor resection|tumor resection
9944|NCT04136756|relapsed|relapsed
9945|NCT04136756|refractory|refractory
9946|NCT04136756|NKTR-255|nktr-255
9947|NCT04136756|CAR-T|car-t
9948|NCT04136756|daratumumab|daratumumab
9949|NCT04136756|interleukin-15 (IL-15)|interleukin-15 (il-15)
9950|NCT04136756|MM|mm
9951|NCT04136756|NHL|nhl
9952|NCT04136743|Rehabilitation|rehabilitation
9953|NCT04136743|Regenerative Medicine|regenerative medicine
9954|NCT04136743|Regenerative Rehabilitation|regenerative rehabilitation
9955|NCT04136691|Simulation|simulation
9956|NCT04136691|Nursing education|nursing education
9957|NCT04136691|Burns|burns
9958|NCT04136691|Nursing process|nursing process
9959|NCT04136678|cerebral palsy|cerebral palsy
9960|NCT04136678|treadmill|treadmill
9961|NCT04136678|backward walking|backward walking
9962|NCT04136678|balance|balance
9963|NCT04136678|spasticity|spasticity
9964|NCT04136665|children|children
9965|NCT04136665|leukemia|leukemia
9966|NCT04136665|physical activity adapted|physical activity adapted
9967|NCT04136652|vaginal laser CO2|vaginal laser co2
9968|NCT04136613|Long acting reversible contraception|long acting reversible contraception
9969|NCT04136613|Post placental insertion of intrauterine device|post placental insertion of intrauterine device
9970|NCT04136613|Cesearean section|cesearean section
9971|NCT04136613|Safety|safety
9972|NCT04136613|Feasibility|feasibility
9973|NCT04136574|hand dermatoses|hand dermatoses
9974|NCT04136574|hand dermatitis|hand dermatitis
9975|NCT04136574|occupationnal|occupationnal
9976|NCT04136574|caregivers|caregivers
9977|NCT04136574|hand hygiene|hand hygiene
9978|NCT04136561|intravenous access|intravenous access
9979|NCT04136561|vascular access|vascular access
9980|NCT04136561|IV survival|iv survival
9981|NCT04136561|IV catheter complication|iv catheter complication
9982|NCT04136561|Central venous access|central venous access
9983|NCT04136561|Central Line-associated Bloodstream Infection (CLABSI)|central line-associated bloodstream infection (clabsi)
9984|NCT04136509|cone beam computed tomography (CBCT)|cone beam computed tomography (cbct)
9985|NCT04136509|microcomputed tomography (micro-CT)|microcomputed tomography (micro-ct)
9986|NCT04136509|histomorphometry|histomorphometry
9987|NCT04136509|sinus floor elevation|sinus floor elevation
9988|NCT04136509|allograft|allograft
9989|NCT04136509|xenograft|xenograft
9990|NCT04136470|Microbiome|microbiome
9991|NCT04136470|Cancer|cancer
9992|NCT04136470|Metagenome|metagenome
9993|NCT04136470|Non Small Cell Lung Cancer|non small cell lung cancer
9994|NCT04136470|Renal Cell Carcinoma|renal cell carcinoma
9995|NCT04136470|Immunotherapy|immunotherapy
9996|NCT04136470|Neoplasms|neoplasms
9997|NCT04136470|Nivolumab|nivolumab
9998|NCT04136470|Ipilimumab|ipilimumab
10011|NCT04136366|ADX-2191|adx-2191
10012|NCT04136366|recurrent retinal detachment|recurrent retinal detachment
10013|NCT04136366|open globe injury|open globe injury
10014|NCT04136353|clinically localised prostate cancer|clinically localised prostate cancer
10015|NCT04136353|very high risk|very high risk
10016|NCT04136353|darolutamide|darolutamide
10017|NCT04136340|Telemedicine|telemedicine
10018|NCT04136340|Virtual Visits|virtual visits
10019|NCT04136340|19-382|19-382
10020|NCT04136314|Decision-Framing|decision-framing
10021|NCT04136314|Prospect Theory|prospect theory
10022|NCT04136314|Medication Preferences|medication preferences
10023|NCT04136275|Leukemia|leukemia
10024|NCT04136275|Hematologic Malignancy|hematologic malignancy
10025|NCT04136275|Lymphoma|lymphoma
10026|NCT04136275|CAR-T|car-t
10027|NCT04136262|rheumatoid arthritis|rheumatoid arthritis
10028|NCT04136262|Tripterygium wilfordii Hook F|tripterygium wilfordii hook f
10029|NCT04136262|methotrexate|methotrexate
10030|NCT04136262|postmenopausal women|postmenopausal women
10031|NCT04136262|randomized controlled trial|randomized controlled trial
10032|NCT04136249|cancer|cancer
10033|NCT04136249|cachexia|cachexia
10034|NCT04136249|nutrition|nutrition
10035|NCT04136249|physical exercice|physical exercice
10036|NCT04136184|Polyneuropathy|polyneuropathy
10037|NCT04136184|Amyloidosis|amyloidosis
10038|NCT04136184|ATTR|attr
10039|NCT04136184|TTR|ttr
10040|NCT04136171|TTR|ttr
10041|NCT04136171|Amyloidosis|amyloidosis
10042|NCT04136171|Cardiomyopathy|cardiomyopathy
10043|NCT04136145|belimumab|belimumab
10044|NCT04136145|Chinese|chinese
10045|NCT04136145|intravenous|intravenous
10046|NCT04136145|subcutaneous|subcutaneous
10047|NCT04136145|auto-injector|auto-injector
10048|NCT04136132|oncology|oncology
10049|NCT04136132|Pancreatic|pancreatic
10050|NCT04136119|micronutrient supplementation|micronutrient supplementation
10051|NCT04136119|vitamins|vitamins
10058|NCT04136054|Cognitive Behaviour Therapy|cognitive behaviour therapy
10059|NCT04136054|Psychological Intervention|psychological intervention
10060|NCT04136028|Chronic Granulomatous Disease|chronic granulomatous disease
10061|NCT04136028|Anakinra|anakinra
10062|NCT04136028|Kineret|kineret
10063|NCT04135976|physiotherapy|physiotherapy
10064|NCT04135976|primary health care|primary health care
10065|NCT04135976|ICF|icf
10066|NCT04135976|core set validation|core set validation
10067|NCT04135976|musculoskeletal conditions|musculoskeletal conditions
10068|NCT04135937|Human Immunodeficiency Virus|human immunodeficiency virus
10069|NCT04135937|Smoking|smoking
10070|NCT04135937|Veterans|veterans
10071|NCT04135924|Rehabilitation|rehabilitation
10072|NCT04135924|Neurological disease|neurological disease
10073|NCT04135885|Folic Acid|folic acid
10074|NCT04135885|Placebo|placebo
10075|NCT04135859|congenital heart disease|congenital heart disease
10076|NCT04135859|physical activity|physical activity
10077|NCT04135846|Alcohol use disorder, stress|alcohol use disorder, stress
10078|NCT04135807|Grade II Glioma|grade ii glioma
10079|NCT04135807|Grade III Glioma|grade iii glioma
10080|NCT04135807|Grade IV Glioma|grade iv glioma
10081|NCT04135807|Astrocytoma|astrocytoma
10082|NCT04135807|Oligodendroglioma of Brain|oligodendroglioma of brain
10083|NCT04135807|Anaplastic Astrocytoma of Brain|anaplastic astrocytoma of brain
10084|NCT04135807|Glioblastoma|glioblastoma
10085|NCT04135794|MRL|mrl
10086|NCT04135781|nab-paclitaxel|nab-paclitaxel
10087|NCT04135781|gastric cancer|gastric cancer
10092|NCT04135742|Transcranial Alternating Current Stimulation|transcranial alternating current stimulation
10093|NCT04135742|Cognitive Training|cognitive training
10094|NCT04135742|Aerobic Exercise|aerobic exercise
10095|NCT04135729|Mental health|mental health
10096|NCT04135729|Eating disorders|eating disorders
10097|NCT04135729|Depression|depression
10098|NCT04135729|Anxiety|anxiety
10099|NCT04135729|Body dissatisfaction|body dissatisfaction
10100|NCT04135729|Body image|body image
10101|NCT04135729|Thinness|thinness
10102|NCT04135729|Leanness|leanness
10103|NCT04135729|Muscularity|muscularity
10104|NCT04135729|Compulsive exercise|compulsive exercise
10105|NCT04135729|Eating behavior|eating behavior
10106|NCT04135729|Dieting|dieting
10107|NCT04135729|Exercise|exercise
10108|NCT04135729|Sexual harassment|sexual harassment
10109|NCT04135690|Hepatocellular Carcinoma|hepatocellular carcinoma
10110|NCT04135690|Hepatic arterial infusion chemotherapy|hepatic arterial infusion chemotherapy
10111|NCT04135690|Oxaliplatin, 5-Fluorouracil and Leucovorin|oxaliplatin, 5-fluorouracil and leucovorin
10112|NCT04135690|Toripalimab|toripalimab
10113|NCT04135690|Sorafenib|sorafenib
10114|NCT04135664|esophagectomy|esophagectomy
10115|NCT04135664|chemoradiation|chemoradiation
10116|NCT04135664|esophageal cancer|esophageal cancer
10117|NCT04135664|endoscopic submucosal dissection|endoscopic submucosal dissection
10118|NCT04135651|Paratracheal pressure|paratracheal pressure
10119|NCT04135651|Glottic view|glottic view
10120|NCT04135651|Cricoid pressure|cricoid pressure
10121|NCT04135651|Pentax|pentax
10122|NCT04135586|exercise|exercise
10123|NCT04135586|high interval training|high interval training
10124|NCT04135586|resistance exercise|resistance exercise
10125|NCT04135573|Atuoimmune thyroid disease|atuoimmune thyroid disease
10126|NCT04135573|Graves' disease|graves' disease
10127|NCT04135573|Natural killer cell|natural killer cell
10128|NCT04135560|Eczema|eczema
10129|NCT04135534|nalbuphine dose|nalbuphine dose
10130|NCT04135495|cystic fibrosis|cystic fibrosis
10131|NCT04135495|ELX-02|elx-02
10132|NCT04135495|G542X allele|g542x allele
10133|NCT04135495|eukaryotic ribosomal selective glycoside|eukaryotic ribosomal selective glycoside
10134|NCT04135482|singcel cell sequencing|singcel cell sequencing
10135|NCT04135469|Tax preparation service|tax preparation service
10136|NCT04135469|Tax filing|tax filing
10137|NCT04135469|Earned Income Tax Credit (EITC)|earned income tax credit (eitc)
10138|NCT04135469|Child tax credit|child tax credit
10139|NCT04135443|Healthy relationships|healthy relationships
10140|NCT04135430|Bronchiolitis|bronchiolitis
10141|NCT04135430|Infants|infants
10142|NCT04135430|Chest physiotherapy|chest physiotherapy
10143|NCT04135391|Stroke|stroke
10144|NCT04135391|Oxygen consumption|oxygen consumption
10145|NCT04135391|BDNF|bdnf
10146|NCT04135391|Dendrites|dendrites
10147|NCT04135378|vitamin C , salivary cortisol , heart rate , blood pressure|vitamin c , salivary cortisol , heart rate , blood pressure
10148|NCT04135352|Programmed Cell Death-1 (PD1, PD-1)|programmed cell death-1 (pd1, pd-1)
10149|NCT04135352|Programmed Death-Ligand 1 (PDL1, PD-L1)|programmed death-ligand 1 (pdl1, pd-l1)
10150|NCT04135339|pain|pain
10151|NCT04135339|trigger points|trigger points
10152|NCT04135339|physical therapy|physical therapy
10153|NCT04135339|dry needling|dry needling
10154|NCT04135339|therapeutic exercise|therapeutic exercise
10155|NCT04135313|rectal cancer|rectal cancer
10156|NCT04135313|induction chemotherapy|induction chemotherapy
10157|NCT04135313|consolidation chemotherapy|consolidation chemotherapy
10158|NCT04135313|neoadjuvant chemotherapy|neoadjuvant chemotherapy
10159|NCT04135300|Hemophilia B|hemophilia b
10160|NCT04135300|gene therapy|gene therapy
10161|NCT04135300|ADENO-ASSOCIATED VIRUSES|adeno-associated viruses
10162|NCT04135287|GLP-1 RA|glp-1 ra
10163|NCT04135261|advanced solid tumors|advanced solid tumors
10164|NCT04135248|Flash Glucose Monitoring, Time-in-Range, Fasting, Ramadan|flash glucose monitoring, time-in-range, fasting, ramadan
10165|NCT04135235|Chronic Hepatitis B|chronic hepatitis b
10166|NCT04135235|Pregnant woman|pregnant woman
10167|NCT04135235|High viral load|high viral load
10168|NCT04135235|Tenofovir fumarate|tenofovir fumarate
10169|NCT04135209|Optical coherence tomography|optical coherence tomography
10170|NCT04135209|Angiography|angiography
10171|NCT04135209|Myopia|myopia
10172|NCT04135196|bone|bone
10173|NCT04135196|adaptation|adaptation
10174|NCT04135196|mechanical stimuli|mechanical stimuli
10175|NCT04135196|women|women
10176|NCT04135196|peak bone mass|peak bone mass
10177|NCT04135183|Community-acquired Pneumonia|community-acquired pneumonia
10178|NCT04135183|Pneumonia severity scores|pneumonia severity scores
10179|NCT04135170|Register based randomized control trial|register based randomized control trial
10180|NCT04135170|Non-inferiority|non-inferiority
10181|NCT04135170|Total knee arthroplasty|total knee arthroplasty
10182|NCT04135170|Antibiotic loaded bone cement|antibiotic loaded bone cement
10183|NCT04135170|Plain bone cement|plain bone cement
10184|NCT04135170|Antibiotic resistance bacteria|antibiotic resistance bacteria
10185|NCT04135170|Periprosthetic joint infection|periprosthetic joint infection
10186|NCT04135170|Patient reported outcome measure|patient reported outcome measure
10187|NCT04135170|Health related quality of life|health related quality of life
10188|NCT04135170|Pain|pain
10189|NCT04135170|Function|function
10190|NCT04135170|Satisfaction|satisfaction
10191|NCT04135170|Revision surgery|revision surgery
10192|NCT04135170|Primary surgery|primary surgery
10193|NCT04135157|Regional Anesthesia|regional anesthesia
10194|NCT04135157|Acute and chronical pain|acute and chronical pain
10195|NCT04135157|Pectoralis nerve block|pectoralis nerve block
10598|NCT04132752|motivation|motivation
10196|NCT04135157|Erector spine plane block|erector spine plane block
10197|NCT04135131|Abdominal Muscles|abdominal muscles
10198|NCT04135131|Exercise Therapy|exercise therapy
10199|NCT04135131|Low back pain|low back pain
10200|NCT04135131|Paraspinal Muscles|paraspinal muscles
10201|NCT04135105|Speech Perception|speech perception
10202|NCT04135105|Neuroimaging|neuroimaging
10203|NCT04135105|Lexical Tone|lexical tone
10204|NCT04135105|Chinese|chinese
10205|NCT04135079|immune transcriptome profile|immune transcriptome profile
10206|NCT04135079|Drop-seq|drop-seq
10207|NCT04135079|immune signatures|immune signatures
10208|NCT04135079|CyTOF|cytof
10209|NCT04135079|cytokine profile|cytokine profile
10210|NCT04135066|Brain structure and function|brain structure and function
10211|NCT04135066|Nutrition|nutrition
10212|NCT04135066|Microbiome|microbiome
10213|NCT04135066|Continuous blood glucose monitoring|continuous blood glucose monitoring
10214|NCT04135053|meningitis|meningitis
10215|NCT04135053|healthy volunteer|healthy volunteer
10216|NCT04135040|IAAO|iaao
10217|NCT04135040|Lysine|lysine
10218|NCT04135040|Children|children
10219|NCT04135040|Cereal Grains|cereal grains
10220|NCT04134988|Fall|fall
10221|NCT04134988|Older adults|older adults
10222|NCT04134988|Fear of falling|fear of falling
10223|NCT04134988|Serious games|serious games
10224|NCT04134988|Technology|technology
10225|NCT04134988|Randomized controlled trial|randomized controlled trial
10226|NCT04134975|spin surgery|spin surgery
10227|NCT04134975|lumbar surgery|lumbar surgery
10228|NCT04134975|image guided surgery|image guided surgery
10229|NCT04134975|radiation exposure|radiation exposure
10230|NCT04134975|intraoperative navigation|intraoperative navigation
10231|NCT04134936|DLBCL|dlbcl
10232|NCT04134936|CD19|cd19
10233|NCT04134936|monoclonal antibody|monoclonal antibody
10234|NCT04134936|tafasitamab|tafasitamab
10235|NCT04134936|lenalidomide|lenalidomide
10236|NCT04134936|MOR208|mor208
10237|NCT04134936|MOR00208|mor00208
10238|NCT04134923|Alzheimer's disease|alzheimer's disease
10239|NCT04134923|neurology|neurology
10240|NCT04134923|radiology|radiology
10241|NCT04134923|Nuclear medicine|nuclear medicine
10242|NCT04134910|spine|spine
10243|NCT04134910|intervertebral disc|intervertebral disc
10244|NCT04134910|physical therapy|physical therapy
10245|NCT04134910|imaging|imaging
10246|NCT04134897|rectal cancer|rectal cancer
10247|NCT04134897|neoadjuvant chemotherapy|neoadjuvant chemotherapy
10248|NCT04134897|neoadjuvant radiotherapy|neoadjuvant radiotherapy
10249|NCT04134884|Breast Cancer|breast cancer
10250|NCT04134884|Phase 1|phase 1
10251|NCT04134858|coaching|coaching
10252|NCT04134858|primary health care|primary health care
10253|NCT04134845|Ventricul Tachycardia ablation|ventricul tachycardia ablation
10254|NCT04134832|Pancreatic neuroendocrine tumors|pancreatic neuroendocrine tumors
10255|NCT04134832|Neutrophil-to-lymphocyte ratio|neutrophil-to-lymphocyte ratio
10256|NCT04134793|atrial fibrillation, ablation, microRNA|atrial fibrillation, ablation, microrna
10257|NCT04134780|Ultrasound|ultrasound
10258|NCT04134780|Spectroscopy|spectroscopy
10259|NCT04134780|Characterization|characterization
10260|NCT04134754|Epilepsy|epilepsy
10261|NCT04134741|prevention|prevention
10262|NCT04134741|back pain|back pain
10263|NCT04134741|soccer|soccer
10264|NCT04134741|football|football
10265|NCT04134741|female|female
10266|NCT04134741|sport injury|sport injury
10267|NCT04134741|kinetic control|kinetic control
10268|NCT04134728|bDMARD, GM-CSF, GSK3196165, Rheumatoid Arthritis, sarilumab, Otilimab|bdmard, gm-csf, gsk3196165, rheumatoid arthritis, sarilumab, otilimab
10269|NCT04134715|Oral contraceptive|oral contraceptive
10270|NCT04134715|Drug-Drug Interaction (DDI)|drug-drug interaction (ddi)
10271|NCT04134715|PF-06826647|pf-06826647
10272|NCT04134689|Tuberculosis,|tuberculosis,
10273|NCT04134689|Video Directly Observed Treatment|video directly observed treatment
10274|NCT04134689|Directly Observed Treatment|directly observed treatment
10275|NCT04134689|Uganda|uganda
10276|NCT04134689|Treatment adherence|treatment adherence
10277|NCT04134689|mHealth|mhealth
10278|NCT04134676|Stem Cell|stem cell
10279|NCT04134676|Conditioned Medium|conditioned medium
10280|NCT04134663|vasoconstrictor|vasoconstrictor
10281|NCT04134663|oxytocin|oxytocin
10282|NCT04134663|EEG|eeg
10283|NCT04134663|peripheral nervous system response|peripheral nervous system response
10284|NCT04134650|Prediabetes|prediabetes
10285|NCT04134637|pecto intercostal fascial plane block|pecto intercostal fascial plane block
10286|NCT04134637|sternotomy|sternotomy
10287|NCT04134611|Hyaluronic acid injection|hyaluronic acid injection
10288|NCT04134611|Knee Arthroscopy|knee arthroscopy
10289|NCT04134611|lateral patellar retinaculae.|lateral patellar retinaculae.
10290|NCT04134611|lateral patellar compression syndrome|lateral patellar compression syndrome
10291|NCT04134598|Partial Breast Irradiation|partial breast irradiation
10292|NCT04134598|Radiation Therapy|radiation therapy
10293|NCT04134598|Endocrine Therapy|endocrine therapy
10294|NCT04134598|Breast Conserving Surgery|breast conserving surgery
10295|NCT04134598|Elderly|elderly
10298|NCT04134598|Breast Cancer|breast cancer
10299|NCT04134585|Fall|fall
10300|NCT04134585|Prevention|prevention
10301|NCT04134585|Seniors|seniors
10302|NCT04134585|Physical activity|physical activity
10303|NCT04134585|Interviews|interviews
10304|NCT04134572|Disease Registry|disease registry
10305|NCT04134572|Natural History Study|natural history study
10306|NCT04134572|Genotype-Phenotype Correlation|genotype-phenotype correlation
10307|NCT04134559|Hepatocellular Carcinoma, Childhood|hepatocellular carcinoma, childhood
10308|NCT04134559|Hepatocellular Carcinoma|hepatocellular carcinoma
10309|NCT04134559|Liver Cancer|liver cancer
10310|NCT04134559|Liver Cancer Pediatric|liver cancer pediatric
10311|NCT04134507|Post-LASIK|post-lasik
10312|NCT04134507|Presbyopia-correcting IOL|presbyopia-correcting iol
10313|NCT04134507|Monofocal IOL|monofocal iol
10314|NCT04134481|clustered nursing interventions|clustered nursing interventions
10315|NCT04134455|Mesh|mesh
10316|NCT04134455|RTL(reinforced tension line)|rtl(reinforced tension line)
10317|NCT04134455|Prevention|prevention
10318|NCT04134455|Prophylactic Mesh|prophylactic mesh
10319|NCT04134442|Exparel|exparel
10320|NCT04134442|Bupivacaine Liposome|bupivacaine liposome
10321|NCT04134442|Total Shoulder Replacement|total shoulder replacement
10322|NCT04134442|Pain Management|pain management
10323|NCT04134429|wearable device|wearable device
10324|NCT04134429|Everion®|everion®
10325|NCT04134429|Fever and Neutropenia|fever and neutropenia
10326|NCT04134429|Pediatric Oncology|pediatric oncology
10327|NCT04134416|Aphasia|aphasia
10328|NCT04134416|Stroke|stroke
10329|NCT04134416|Rehabilitation|rehabilitation
10330|NCT04134416|Non-invasive brain stimulation|non-invasive brain stimulation
10331|NCT04134416|Cognitive enhancing drug|cognitive enhancing drug
10332|NCT04134416|Intensive Language-Action Therapy|intensive language-action therapy
10333|NCT04134403|Steroids|steroids
10334|NCT04134403|Thiamine|thiamine
10335|NCT04134403|Ascorbic Acid Supplementation|ascorbic acid supplementation
10336|NCT04134403|Septic Shock|septic shock
10337|NCT04134403|STASIS|stasis
10338|NCT04134390|fragile|fragile
10339|NCT04134390|renal carcinoma|renal carcinoma
10340|NCT04134390|old age|old age
10341|NCT04134325|Classic Hodgkin Lymphoma|classic hodgkin lymphoma
10342|NCT04134325|Relapsed Hodgkin Lymphoma|relapsed hodgkin lymphoma
10343|NCT04134325|Refractory Hodgkin Lymphoma|refractory hodgkin lymphoma
10344|NCT04134325|Relapsed/Refractory Hodgkin Lymphoma|relapsed/refractory hodgkin lymphoma
10345|NCT04134325|CD30|cd30
10346|NCT04134325|cell therapy|cell therapy
10347|NCT04134325|CAR-T|car-t
10348|NCT04134325|modified T cells|modified t cells
10349|NCT04134299|Amino Acid|amino acid
10350|NCT04134299|Food Study|food study
10354|NCT04134195|Transcranial direct current stimulation|transcranial direct current stimulation
10355|NCT04134195|Healthy seniors|healthy seniors
10356|NCT04134195|Healthy adults|healthy adults
10357|NCT04134117|Primary CNS Lymphoma|primary cns lymphoma
10358|NCT04134117|Refractory Primary CNS Lymphoma|refractory primary cns lymphoma
10359|NCT04134117|Relapsed Primary CNS Lymphoma|relapsed primary cns lymphoma
10360|NCT04134065|Vitamin D|vitamin d
10361|NCT04134065|Crohn Disease|crohn disease
10362|NCT04134065|recurrence|recurrence
10363|NCT04134052|ketamine|ketamine
10364|NCT04134052|midazolam|midazolam
10365|NCT04134052|cognitive dysfunction|cognitive dysfunction
10366|NCT04134013|Chiropractic manipulation|chiropractic manipulation
10367|NCT04134013|spinal manipulation therapy|spinal manipulation therapy
10368|NCT04134013|osteopathic manipulation|osteopathic manipulation
10369|NCT04134000|non-muscle|non-muscle
10370|NCT04134000|bladder cancer|bladder cancer
10371|NCT04134000|näive|näive
10372|NCT04133987|tetravalent dengue vaccine|tetravalent dengue vaccine
10373|NCT04133987|Phase II clinical trial|phase ii clinical trial
10374|NCT04133961|Phenylephrine|phenylephrine
10375|NCT04133961|Spinal anaesthesia|spinal anaesthesia
10376|NCT04133948|Melanoma|melanoma
10377|NCT04133948|Neo-adjuvant|neo-adjuvant
10378|NCT04133948|Domatinostat|domatinostat
10379|NCT04133948|Nivolumab|nivolumab
10380|NCT04133948|Ipilimumab|ipilimumab
10381|NCT04133909|COPD|copd
10382|NCT04133909|Mepolizumab|mepolizumab
10383|NCT04133909|Exacerbations|exacerbations
10384|NCT04133909|MATINEE|matinee
10385|NCT04133883|joint health|joint health
10386|NCT04133844|extracorporeal membrane oxygenation|extracorporeal membrane oxygenation
10387|NCT04133831|Heart Transplant|heart transplant
10388|NCT04133831|Transplant Survival|transplant survival
10389|NCT04133831|Applied Ethics|applied ethics
10390|NCT04133831|Decision Psychology|decision psychology
10391|NCT04133831|Human Behavior|human behavior
10392|NCT04133818|Multidisciplinary education and exercise therapy program.|multidisciplinary education and exercise therapy program.
10393|NCT04133818|Physical activity|physical activity
10394|NCT04133818|Rehabilitation|rehabilitation
10395|NCT04133805|viscous fiber|viscous fiber
10396|NCT04133805|barley b-glucan|barley b-glucan
10397|NCT04133805|oat b-glucan|oat b-glucan
10398|NCT04133805|konjac glucomannan|konjac glucomannan
10399|NCT04133805|psyllium|psyllium
10400|NCT04133805|guar gum|guar gum
10401|NCT04133805|pectin|pectin
10402|NCT04133766|Nutrition|nutrition
10403|NCT04133766|Breastfeeding|breastfeeding
10404|NCT04133766|Handwashing|handwashing
10405|NCT04133766|Food security|food security
10406|NCT04133766|Low and Middle Income Country|low and middle income country
10407|NCT04133766|Infant and Young Child Feeding|infant and young child feeding
10408|NCT04133740|A before-and-after study|a before-and-after study
10409|NCT04133740|Oxygenation targeting|oxygenation targeting
10410|NCT04133727|randomised|randomised
10411|NCT04133727|simulation|simulation
10412|NCT04133701|Meal Timing|meal timing
10413|NCT04133701|Blood Pressure|blood pressure
10414|NCT04133701|Time-Restricted Feeding|time-restricted feeding
10415|NCT04133701|Sympathetic Nerve Activity|sympathetic nerve activity
10416|NCT04133688|mobile app, pilot study, addiction, sleep, ePRO|mobile app, pilot study, addiction, sleep, epro
10417|NCT04133675|urinary incontinence|urinary incontinence
10418|NCT04133675|urine leakage|urine leakage
10419|NCT04133649|Aging|aging
10420|NCT04133649|Gene therapy|gene therapy
10421|NCT04133649|AAV|aav
10422|NCT04133649|hTert|htert
10423|NCT04133649|telomere|telomere
10424|NCT04133649|Telomerase|telomerase
10425|NCT04133623|osteoarticular acute pain|osteoarticular acute pain
10426|NCT04133623|ketorolac|ketorolac
10427|NCT04133623|ibuprofen|ibuprofen
10428|NCT04133610|human papillomavirus|human papillomavirus
10429|NCT04133610|HPV|hpv
10430|NCT04133610|self-sampling|self-sampling
10431|NCT04133610|cervical swab|cervical swab
10432|NCT04133610|cervicovaginal swab|cervicovaginal swab
10433|NCT04133610|cervical cancer screening|cervical cancer screening
10434|NCT04133597|skin conductance|skin conductance
10435|NCT04133597|anxiety|anxiety
10436|NCT04133597|smartphone users|smartphone users
10437|NCT04133597|smartphone addiction|smartphone addiction
10438|NCT04133584|Immunogenicity|immunogenicity
10439|NCT04133584|Safety|safety
10440|NCT04133584|Enterovirus 71 Vaccine|enterovirus 71 vaccine
10441|NCT04133584|seasonal influenza vaccine|seasonal influenza vaccine
10442|NCT04133571|catheter-related bladder discomfort|catheter-related bladder discomfort
10443|NCT04133571|lidocaine|lidocaine
10444|NCT04133558|acute respiratory distress syndrome|acute respiratory distress syndrome
10445|NCT04133558|microbiota|microbiota
10446|NCT04133558|intensive care unit|intensive care unit
10447|NCT04133532|Exercise tolerance|exercise tolerance
10448|NCT04133532|NTproBNP|ntprobnp
10449|NCT04133532|Left ventricular outflow tract obstruction|left ventricular outflow tract obstruction
10450|NCT04133532|Quality of life|quality of life
10451|NCT04133532|Diastolic dysfunction|diastolic dysfunction
10452|NCT04133519|IBS - Irritable Bowel Syndrome|ibs - irritable bowel syndrome
10453|NCT04133519|IBS|ibs
10454|NCT04133519|Irritable Bowel|irritable bowel
10455|NCT04133493|fish skin graft|fish skin graft
10456|NCT04133493|omega3 fatty acids|omega3 fatty acids
10457|NCT04133480|GWP42003-P|gwp42003-p
10458|NCT04133480|EPIDIOLEX®|epidiolex®
10459|NCT04133480|cannabidiol|cannabidiol
10460|NCT04133480|CBD|cbd
10461|NCT04133480|cognition|cognition
10462|NCT04133454|Cognition Disorders|cognition disorders
10463|NCT04133454|Alzheimer Disease|alzheimer disease
10464|NCT04133454|AAV|aav
10465|NCT04133454|Dementia|dementia
10466|NCT04133454|Gene therapy|gene therapy
10467|NCT04133454|telomere|telomere
10468|NCT04133454|telomerase|telomerase
10469|NCT04133428|Heart failure|heart failure
10470|NCT04133428|Severe systolic disfunction|severe systolic disfunction
10471|NCT04133428|Sacubitril-Valsartan|sacubitril-valsartan
10472|NCT04133402|Hemorrhage Post-partum|hemorrhage post-partum
10473|NCT04133402|Fertility|fertility
10474|NCT04133402|Uterine balloon tamponade|uterine balloon tamponade
10475|NCT04133402|Vaginal Birth|vaginal birth
10476|NCT04133389|Growth mindset|growth mindset
10477|NCT04133389|Implicit theory|implicit theory
10478|NCT04133389|Adolescence|adolescence
10479|NCT04133389|Mental Health|mental health
10480|NCT04133389|Well-being|well-being
10481|NCT04133389|students|students
10482|NCT04133389|Secondary Schools|secondary schools
10483|NCT04133389|Educational intervention|educational intervention
10484|NCT04133363|L-PRF|l-prf
10485|NCT04133363|Bone Allograft|bone allograft
10486|NCT04133363|Ridge Preservation|ridge preservation
10487|NCT04133363|Socket grafting|socket grafting
10488|NCT04133363|Bone regeneration|bone regeneration
10489|NCT04133337|Apatinib|apatinib
10490|NCT04133337|SHR-1210|shr-1210
10491|NCT04133337|NSCLC|nsclc
10492|NCT04133337|neoadjuvant|neoadjuvant
10493|NCT04133311|IOP|iop
10494|NCT04133311|OSD|osd
10495|NCT04133285|Disease Registry|disease registry
10496|NCT04133285|Natural History Study|natural history study
10698|NCT04131972|Lumpectomy|lumpectomy
10500|NCT04133272|Natural History Study|natural history study
10501|NCT04133272|Genotype-Phenotype Correlation|genotype-phenotype correlation
10502|NCT04133259|Hepatitis B, Chronic|hepatitis b, chronic
10503|NCT04133259|Monoclonal antibody|monoclonal antibody
10504|NCT04133246|cystic fibrosis|cystic fibrosis
10505|NCT04133246|parenthood|parenthood
10506|NCT04133246|Psycho-social|psycho-social
10507|NCT04133246|Qualitative study|qualitative study
10508|NCT04133233|Low dose of IL-2|low dose of il-2
10509|NCT04133233|Treg response|treg response
10510|NCT04133220|hemostasis|hemostasis
10511|NCT04133207|CDK|cdk
10512|NCT04133207|Breast cancer|breast cancer
10513|NCT04133207|toxicity|toxicity
10514|NCT04133207|outcome|outcome
10515|NCT04133181|Endodontic surgery|endodontic surgery
10516|NCT04133181|Guided surgery|guided surgery
10517|NCT04133181|3D guide|3d guide
10518|NCT04133168|cryoablation|cryoablation
10519|NCT04133155|Pancreatic cancer|pancreatic cancer
10520|NCT04133155|FOLFIRINOX|folfirinox
10521|NCT04133155|nab-paclitaxel plus gemcitabine|nab-paclitaxel plus gemcitabine
10522|NCT04133142|Zoster,|zoster,
10523|NCT04133142|Pain relief|pain relief
10524|NCT04133142|regional anesthesia|regional anesthesia
10525|NCT04133142|Prevention post herpetic neuralgia|prevention post herpetic neuralgia
10526|NCT04133129|HIIT|hiit
10527|NCT04133129|High Intensity Interval Training|high intensity interval training
10528|NCT04133129|Medium Intensity Continuous Training|medium intensity continuous training
10529|NCT04133129|Interval Training|interval training
10530|NCT04133129|Exercise|exercise
10531|NCT04133129|Physical Activity|physical activity
10532|NCT04133129|Exercise Training|exercise training
10533|NCT04133103|early mobilisation|early mobilisation
10534|NCT04133103|robot|robot
10535|NCT04133103|spine|spine
10536|NCT04133103|enhanced recovery|enhanced recovery
10537|NCT04133090|Bone augmentation|bone augmentation
10538|NCT04133090|Autogenous block bone graft|autogenous block bone graft
10539|NCT04133090|Leukocytes and platelet-rich fibrin|leukocytes and platelet-rich fibrin
10540|NCT04133090|Injectable platelet rich fibrin|injectable platelet rich fibrin
10541|NCT04133090|Tent-pole technique|tent-pole technique
10542|NCT04133077|PDX|pdx
10543|NCT04133051|quadratus lumborum block|quadratus lumborum block
10544|NCT04133051|epidural analgesia|epidural analgesia
10545|NCT04133051|bladder cancer|bladder cancer
10546|NCT04133051|radical cystectomy|radical cystectomy
10547|NCT04133038|Feeding disorders|feeding disorders
10548|NCT04133038|Eating disorders|eating disorders
10549|NCT04133038|Evaluation|evaluation
10550|NCT04133025|Vestibular Rehabilitation|vestibular rehabilitation
10551|NCT04133025|Unilateral vestibular hypofunction|unilateral vestibular hypofunction
10552|NCT04133012|Viral cartography|viral cartography
10553|NCT04133012|Viral reservoir|viral reservoir
10554|NCT04133012|Antiretroviral treatments diffusion|antiretroviral treatments diffusion
10555|NCT04132999|Down Syndrome|down syndrome
10556|NCT04132999|Obstructive Sleep Apnea|obstructive sleep apnea
10557|NCT04132999|PAP|pap
10558|NCT04132999|Positive Airway Pressure|positive airway pressure
10559|NCT04132986|Ventral hernia repair|ventral hernia repair
10560|NCT04132986|Contaminated surgery|contaminated surgery
10561|NCT04132986|Biosynthetic absorbable mesh|biosynthetic absorbable mesh
10562|NCT04132986|Descriptive study|descriptive study
10563|NCT04132973|acceptability|acceptability
10564|NCT04132973|feasibility|feasibility
10565|NCT04132973|self-management|self-management
10566|NCT04132960|DS-8201a|ds-8201a
10567|NCT04132960|ADC|adc
10568|NCT04132960|HER2|her2
10569|NCT04132960|metastatic breast cancer|metastatic breast cancer
10570|NCT04132895|Osteosarcoma|osteosarcoma
10571|NCT04132895|Biobank|biobank
10572|NCT04132895|Genomics|genomics
10573|NCT04132895|Tumour markers|tumour markers
10574|NCT04132882|Cisplatin|cisplatin
10575|NCT04132882|Hearing Loss|hearing loss
10576|NCT04132882|Hepatoblastoma|hepatoblastoma
10577|NCT04132869|physical activity|physical activity
10578|NCT04132869|social emotional learning|social emotional learning
10579|NCT04132869|healthy eating|healthy eating
10580|NCT04132869|sports readiness|sports readiness
10581|NCT04132856|pediatric|pediatric
10582|NCT04132856|oncology|oncology
10583|NCT04132830|HIV-exposed Uninfected|hiv-exposed uninfected
10584|NCT04132830|In Utero Exposure|in utero exposure
10585|NCT04132830|Metabolic|metabolic
10586|NCT04132830|Immune|immune
10587|NCT04132791|Aspirin|aspirin
10588|NCT04132791|Chronotherapy|chronotherapy
10589|NCT04132778|Asthma|asthma
10590|NCT04132778|AsthmaTuner|asthmatuner
10591|NCT04132778|Management|management
10596|NCT04132752|obstetric paralysis|obstetric paralysis
10597|NCT04132752|home exercise|home exercise
10601|NCT04132726|Massage|massage
10602|NCT04132713|skin microbiota|skin microbiota
10603|NCT04132713|16S rRNA gene|16s rrna gene
10604|NCT04132713|hand foot sysdom|hand foot sysdom
10605|NCT04132713|breast cancer chemotherapy|breast cancer chemotherapy
10606|NCT04132700|energy expenditure|energy expenditure
10607|NCT04132700|respiratory quotient|respiratory quotient
10608|NCT04132700|Intensive Care Unit (ICU)|intensive care unit (icu)
10609|NCT04132700|indirect calorimetry|indirect calorimetry
10610|NCT04132687|digital chest drain device|digital chest drain device
10612|NCT04132648|Exercise|exercise
10613|NCT04132648|Vasoconstrictor Responsiveness|vasoconstrictor responsiveness
10614|NCT04132622|Euthyrox|euthyrox
10615|NCT04132622|Paraquat Intoxication|paraquat intoxication
10616|NCT04132583|Deflox®|deflox®
10617|NCT04132583|Cataflam® DD|cataflam® dd
10618|NCT04132583|Diclofenac potassium|diclofenac potassium
10619|NCT04132583|Healthy|healthy
10620|NCT04132570|Airborne pollution|airborne pollution
10621|NCT04132570|Rhinitis|rhinitis
10622|NCT04132570|Budesonide|budesonide
10623|NCT04132544|risks factors|risks factors
10624|NCT04132544|risks of falling|risks of falling
10625|NCT04132544|elderly|elderly
10626|NCT04132544|Urgent Medical Assistance Service|urgent medical assistance service
10627|NCT04132544|Emergency Care|emergency care
10628|NCT04132544|911|911
10629|NCT04132531|Stem Cells|stem cells
10630|NCT04132531|Obesity|obesity
10631|NCT04132531|Cardiovascular Events|cardiovascular events
10632|NCT04132531|Type 2 Diabetes|type 2 diabetes
10635|NCT04132427|microbiota transfer therapy|microbiota transfer therapy
10636|NCT04132427|fecal transplant|fecal transplant
10637|NCT04132427|fecal microbiota transplant|fecal microbiota transplant
10638|NCT04132427|intestinal microbiota|intestinal microbiota
10639|NCT04132401|fundus oculi|fundus oculi
10640|NCT04132401|artificial intelligence|artificial intelligence
10641|NCT04132401|computer assisted diagnosis|computer assisted diagnosis
10642|NCT04132401|neural network computer|neural network computer
10643|NCT04132401|Diabetic Retinopathy|diabetic retinopathy
10644|NCT04132388|adalimumab|adalimumab
10645|NCT04132388|medical adherence|medical adherence
10646|NCT04132362|music|music
10647|NCT04132362|dementia|dementia
10648|NCT04132362|emotional responses|emotional responses
10649|NCT04132349|Ulipristal Acetate|ulipristal acetate
10650|NCT04132336|Dental pain|dental pain
10651|NCT04132323|sclerotherapy, hypertonic glucose, sodium tetradecyl sulfate|sclerotherapy, hypertonic glucose, sodium tetradecyl sulfate
10652|NCT04132310|Pregnancy|pregnancy
10653|NCT04132310|body composition|body composition
10654|NCT04132310|infant adiposity|infant adiposity
10655|NCT04132271|oropharyngeal, dysphagia, nutrition|oropharyngeal, dysphagia, nutrition
10656|NCT04132245|childhood obesity|childhood obesity
10657|NCT04132245|minorities|minorities
10658|NCT04132245|diet|diet
10659|NCT04132245|physical activity|physical activity
10660|NCT04132245|parents|parents
10661|NCT04132232|smoking in pregnancy|smoking in pregnancy
10662|NCT04132232|substance use disorder|substance use disorder
10663|NCT04132232|carbon monoxide|carbon monoxide
10664|NCT04132232|fetal carboxyhemoglobin|fetal carboxyhemoglobin
10665|NCT04132219|cancer survivor|cancer survivor
10666|NCT04132219|overweight|overweight
10667|NCT04132219|obesity|obesity
10668|NCT04132167|Rehabilitation|rehabilitation
10669|NCT04132167|Multiple sclerosis|multiple sclerosis
10670|NCT04132167|Tailored interventions|tailored interventions
10671|NCT04132154|cesarean section|cesarean section
10672|NCT04132154|C-Section|c-section
10673|NCT04132154|Hypothermia|hypothermia
10674|NCT04132154|Spinal Anesthesia|spinal anesthesia
10675|NCT04132154|caesarean section|caesarean section
10676|NCT04132154|zero heat flux technology|zero heat flux technology
10677|NCT04132154|active warming|active warming
10678|NCT04132115|Intracerebral Hemorrhage|intracerebral hemorrhage
10679|NCT04132115|Subarachnoid Hemorrhage|subarachnoid hemorrhage
10680|NCT04132115|Therapeutic Drug Monitoring|therapeutic drug monitoring
10681|NCT04132102|LSQC|lsqc
10682|NCT04132102|EGFR mutation|egfr mutation
10683|NCT04132063|Epilepsy|epilepsy
10684|NCT04132063|Generic|generic
10685|NCT04132063|Levetiracetam|levetiracetam
10686|NCT04132063|Therapeutic equivalency|therapeutic equivalency
10687|NCT04132037|Multiple Sclerosis|multiple sclerosis
10688|NCT04132037|Urinary disorders|urinary disorders
10689|NCT04132037|Intermittent Self Catheterisation|intermittent self catheterisation
10690|NCT04132024|Cognitive Behavioral Therapy for Insomnia (CBT-I)|cognitive behavioral therapy for insomnia (cbt-i)
10691|NCT04132024|Insomnia|insomnia
10692|NCT04132024|Sleep|sleep
10693|NCT04132024|Crohn's Disease|crohn's disease
10694|NCT04132024|Ulcerative Colitis|ulcerative colitis
10695|NCT04132011|opioid|opioid
10696|NCT04131985|Laparoscopic inguinal hernia surgery,|laparoscopic inguinal hernia surgery,
10697|NCT04131985|postoperative pain|postoperative pain
10699|NCT04131972|Bio-absorbable|bio-absorbable
10700|NCT04131933|Predict 2.1|predict 2.1
10701|NCT04131933|Oncotype DX|oncotype dx
10702|NCT04131920|Joint Bleed|joint bleed
10703|NCT04131920|Hemophilia A|hemophilia a
10704|NCT04131920|Handheld Ultrasound|handheld ultrasound
10705|NCT04131894|augmentation|augmentation
10706|NCT04131894|dentin graft|dentin graft
10707|NCT04131894|socket preservation|socket preservation
10708|NCT04131855|self etch primers|self etch primers
10710|NCT04131855|orthodontic bracket failure|orthodontic bracket failure
10711|NCT04131816|Cardiac Rehabilitation|cardiac rehabilitation
10712|NCT04131790|Loneliness|loneliness
10713|NCT04131790|Homebound|homebound
10714|NCT04131790|Behavioral Activation|behavioral activation
10715|NCT04131764|multiple sclerosis|multiple sclerosis
10716|NCT04131764|MS|ms
10717|NCT04131764|Neuromyelitis optica spectrum disorder|neuromyelitis optica spectrum disorder
10718|NCT04131764|NMOSD|nmosd
10719|NCT04131764|optic neuritis|optic neuritis
10720|NCT04131764|pupillary response|pupillary response
10721|NCT04131764|RAPD|rapd
10722|NCT04131764|rapid afferent pupillary defect|rapid afferent pupillary defect
10723|NCT04131751|Metagenomics|metagenomics
10724|NCT04131712|Massage|massage
10725|NCT04131712|Muscle|muscle
10726|NCT04131712|Extracellular Vesicles|extracellular vesicles
10727|NCT04131712|Atrophy|atrophy
10728|NCT04131699|pediatric|pediatric
10729|NCT04131699|thoracoscopic|thoracoscopic
10730|NCT04131699|cardiometry|cardiometry
10731|NCT04131699|cardiac output|cardiac output
10732|NCT04131699|hemodynamics|hemodynamics
10733|NCT04131686|rhinosinusitis|rhinosinusitis
10734|NCT04131686|N-acetylcysteine|n-acetylcysteine
10735|NCT04131673|multiple sclerosis|multiple sclerosis
10736|NCT04131673|MS|ms
10737|NCT04131673|Neuromyelitis optica spectrum disorder|neuromyelitis optica spectrum disorder
10738|NCT04131673|NMOSD|nmosd
10739|NCT04131673|African Americans|african americans
10740|NCT04131660|non-invasive ventilation|non-invasive ventilation
10741|NCT04131660|respiratory failure|respiratory failure
10742|NCT04131660|obese|obese
10743|NCT04131660|obesity|obesity
10744|NCT04131660|Hypoventilation Syndrome|hypoventilation syndrome
10745|NCT04131660|apnea|apnea
10746|NCT04131660|hypercapnic|hypercapnic
10747|NCT04131660|acidosis|acidosis
10748|NCT04131660|AVAPS-AE|avaps-ae
10749|NCT04131660|VONIVOO|vonivoo
10750|NCT04131647|Exercise|exercise
10751|NCT04131647|Diet|diet
10752|NCT04131647|Obesity|obesity
10753|NCT04131582|prediabetes|prediabetes
10754|NCT04131569|ESBL-E|esbl-e
10755|NCT04131569|fecal carriage|fecal carriage
10756|NCT04131569|microbiota|microbiota
10757|NCT04131569|nosocomial infection|nosocomial infection
10758|NCT04131517|Padsevonil|padsevonil
10759|NCT04131517|Contraceptives|contraceptives
10760|NCT04131517|Healthy female participants|healthy female participants
10761|NCT04131478|cancer cachexia|cancer cachexia
10762|NCT04131478|TNF alfa|tnf alfa
10763|NCT04131478|pharmacogenetics|pharmacogenetics
10764|NCT04131478|mi-RNA|mi-rna
10765|NCT04131465|HIV testing|hiv testing
10766|NCT04131465|HIV status knowledge|hiv status knowledge
10767|NCT04131465|Health system|health system
10768|NCT04131465|Community health workers|community health workers
10769|NCT04131426|Cachexia; Cancer|cachexia; cancer
10770|NCT04131426|Weight Loss|weight loss
10771|NCT04131426|Exercise|exercise
10772|NCT04131426|Nutritional Supplement|nutritional supplement
10773|NCT04131426|Lung Cancer|lung cancer
10774|NCT04131426|Gastrointestinal Cancer|gastrointestinal cancer
10775|NCT04131387|Female Stress Urinary Incontinence|female stress urinary incontinence
10776|NCT04131374|Caregivers|caregivers
10777|NCT04131322|Loss of response|loss of response
10778|NCT04131322|Switching|switching
10779|NCT04131322|Adalimumab original|adalimumab original
10780|NCT04131322|Adalimumab biosimilar|adalimumab biosimilar
10781|NCT04131296|influenza|influenza
10782|NCT04131296|microbiota|microbiota
10783|NCT04131296|intensive care unit|intensive care unit
10784|NCT04131283|spreading vasoconstriction|spreading vasoconstriction
10785|NCT04131283|gingival microcirculation|gingival microcirculation
10786|NCT04131270|Planning|planning
10787|NCT04131270|Physical Activity|physical activity
10788|NCT04131257|Continuum of care|continuum of care
10789|NCT04131257|Diabetes|diabetes
10790|NCT04131257|Pre-diabetes|pre-diabetes
10791|NCT04131231|microparticles packaging chemotherapeutic drugs|microparticles packaging chemotherapeutic drugs
10792|NCT04131231|MPCD|mpcd
10793|NCT04131231|malignant pleural effusion|malignant pleural effusion
10794|NCT04131231|MPE|mpe
10795|NCT04131218|Sugammadex|sugammadex
10796|NCT04131218|Obese|obese
10797|NCT04131179|Self Harm, adolescents, culturally adapted therapy, problem solving therapy, low and middle income countries|self harm, adolescents, culturally adapted therapy, problem solving therapy, low and middle income countries
10798|NCT04131140|Advance Care Planning|advance care planning
10799|NCT04131140|Resuscitation Orders|resuscitation orders
10800|NCT04131140|Palliative Care|palliative care
10805|NCT04131101|Community organizing|community organizing
10806|NCT04131101|Advocacy|advocacy
10807|NCT04131088|Midline catheter|midline catheter
10808|NCT04131088|adverse event|adverse event
10809|NCT04131088|catheter-related bloodstream infections|catheter-related bloodstream infections
10810|NCT04131088|thrombosis|thrombosis
10811|NCT04131075|Coronary microvascular dysfunction|coronary microvascular dysfunction
10812|NCT04131075|Cerebral Small Vessel Diseases|cerebral small vessel diseases
10813|NCT04131062|Inherited conditions|inherited conditions
10814|NCT04131062|Biobank enrollment|biobank enrollment
10815|NCT04131049|Adolescent|adolescent
10816|NCT04131049|Carbohydrate Counting|carbohydrate counting
10817|NCT04131049|Food Insulin Index|food insulin index
10818|NCT04131049|Glycemic Index|glycemic index
10819|NCT04131049|Type 1 diabetes|type 1 diabetes
10820|NCT04131036|Hemophilia A|hemophilia a
10821|NCT04131036|Joint Health|joint health
10822|NCT04131036|Bone Density|bone density
10823|NCT04131036|Emicizumab|emicizumab
10824|NCT04131036|factor VIII prophylaxis|factor viii prophylaxis
10825|NCT04130984|Out-of-Hospital Cardiac Arrest|out-of-hospital cardiac arrest
10826|NCT04130984|Intraosseous|intraosseous
10827|NCT04130984|Intravenous|intravenous
10828|NCT04130984|Resuscitation|resuscitation
10829|NCT04130958|Transcranial Magnetic Stimulation|transcranial magnetic stimulation
10830|NCT04130958|Intermittent Theta Burst|intermittent theta burst
10831|NCT04130906|Binge Eating|binge eating
10832|NCT04130906|Transcranial Magnetic Stimulation|transcranial magnetic stimulation
10833|NCT04130906|Theta Burst Stimulation|theta burst stimulation
10834|NCT04130906|Neuromodulation|neuromodulation
10835|NCT04130906|Psychiatric Disorders|psychiatric disorders
10836|NCT04130906|Eating Disorders|eating disorders
10837|NCT04130893|ear acupuncture, auricular acupuncture|ear acupuncture, auricular acupuncture
10838|NCT04130841|Internal limiting membrane peeling|internal limiting membrane peeling
10839|NCT04130828|ferrous fumarate|ferrous fumarate
10840|NCT04130828|oral iron treatment|oral iron treatment
10841|NCT04130828|thrice-weekly|thrice-weekly
10842|NCT04130828|thrice-daily|thrice-daily
10843|NCT04130828|iron deficiency anemia|iron deficiency anemia
10844|NCT04130802|post-cataract,|post-cataract,
10845|NCT04130802|inflammation|inflammation
10847|NCT04130802|post-surgery|post-surgery
10848|NCT04130802|corticosteroid|corticosteroid
10849|NCT04130802|anterior chamber cells|anterior chamber cells
10850|NCT04130802|flares|flares
10851|NCT04130789|clinical data warehouse (CDWH)|clinical data warehouse (cdwh)
10852|NCT04130789|machine learning|machine learning
10853|NCT04130789|data-driven algorithms|data-driven algorithms
10854|NCT04130789|multi-dimensional modelling|multi-dimensional modelling
10855|NCT04130763|Immuno-checkpoint inhibitor therapy|immuno-checkpoint inhibitor therapy
10856|NCT04130763|GI cancer|gi cancer
10858|NCT04130737|Peripheral Artery Disease|peripheral artery disease
10859|NCT04130737|Superficial Femoral Artery|superficial femoral artery
10860|NCT04130737|Popliteal Artery|popliteal artery
10861|NCT04130737|Stent Graft|stent graft
10862|NCT04130711|stroke|stroke
10863|NCT04130711|neurofeedback|neurofeedback
10864|NCT04130711|tendon vibration|tendon vibration
10865|NCT04130711|virtual reality|virtual reality
10866|NCT04130711|haptic|haptic
10867|NCT04130672|Hot tampon|hot tampon
10868|NCT04130672|hot saline|hot saline
10869|NCT04130672|adenoidectomy|adenoidectomy
10870|NCT04130672|hemostasis|hemostasis
10871|NCT04130672|bleeding control|bleeding control
10878|NCT04130620|Magnesium deficiency|magnesium deficiency
10879|NCT04130620|Applied Kinesiology|applied kinesiology
10880|NCT04130607|Teaching Strategies, Diagnostic reasoning|teaching strategies, diagnostic reasoning
10881|NCT04130594|vaccine|vaccine
10882|NCT04130594|vector based vaccine|vector based vaccine
10883|NCT04130594|Middle East respiratory syndrome|middle east respiratory syndrome
10884|NCT04130594|Immunologic Factors|immunologic factors
10885|NCT04130594|Physiological Effects of Drugs|physiological effects of drugs
10886|NCT04130594|MERS-Cov|mers-cov
10887|NCT04130555|ventral rectopexy|ventral rectopexy
10888|NCT04130555|biological mesh|biological mesh
10889|NCT04130529|Cognitive Behaviour Therapy|cognitive behaviour therapy
10890|NCT04130529|Psychological Intervention|psychological intervention
10891|NCT04130464|Intraperitoneal|intraperitoneal
10892|NCT04130464|Pain Pump|pain pump
10893|NCT04130464|Ropivacaine|ropivacaine
10894|NCT04130464|Ketorolac Tromethamine|ketorolac tromethamine
10895|NCT04130412|Lateral patellar compression syndrome|lateral patellar compression syndrome
10896|NCT04130412|Arthroscopic release|arthroscopic release
10897|NCT04130412|Open release|open release
10898|NCT04130399|Folfirinox|folfirinox
10899|NCT04130399|Cancer|cancer
10900|NCT04130399|Radiation Therapy|radiation therapy
10901|NCT04130399|neoadjuvent chemotherapy|neoadjuvent chemotherapy
10902|NCT04130399|Stereotactic Body Radiation Therapy (SBRT)|stereotactic body radiation therapy (sbrt)
10903|NCT04130373|Autologous fat grafting|autologous fat grafting
10904|NCT04130373|Lipofilling|lipofilling
10905|NCT04130373|Breast cancer|breast cancer
10906|NCT04130373|Breast reconstruction|breast reconstruction
10907|NCT04130360|problem-solving|problem-solving
10908|NCT04130360|youth|youth
10909|NCT04130360|brief intervention|brief intervention
10910|NCT04130360|online intervention|online intervention
10911|NCT04130360|young people|young people
10912|NCT04130360|aggressive behaviour|aggressive behaviour
10913|NCT04130282|Pfs25|pfs25
10914|NCT04130256|Medication adherence|medication adherence
10915|NCT04130243|Biomarker|biomarker
10916|NCT04130243|Congenital Heart Disease|congenital heart disease
10917|NCT04130243|Pulmonary Arterial Hypertension|pulmonary arterial hypertension
10918|NCT04130165|preterm infants|preterm infants
10919|NCT04130165|human milk|human milk
10920|NCT04130165|microbiome|microbiome
10921|NCT04130165|donor human milk|donor human milk
10922|NCT04130165|breastmilk|breastmilk
10923|NCT04130152|Palbociclib, residual disease, Neoadjuvant treatment, Ki67|palbociclib, residual disease, neoadjuvant treatment, ki67
10924|NCT04130087|Reward|reward
10925|NCT04130087|Selegiline|selegiline
10926|NCT04130087|Cognition|cognition
10927|NCT04130048|Elasticity Imaging Techniques|elasticity imaging techniques
10928|NCT04130048|Venous Thromboembolism|venous thromboembolism
10929|NCT04130035|decision making|decision making
10930|NCT04130035|degenerative lumbar disease|degenerative lumbar disease
10931|NCT04130035|CT|ct
10932|NCT04130035|MRI|mri
10933|NCT04130009|Thigh pain|thigh pain
10934|NCT04130009|Total knee Arthroplasty|total knee arthroplasty
10935|NCT04130009|Tourniquet|tourniquet
10936|NCT04129983|Hearing Loss, Sudden|hearing loss, sudden
10937|NCT04129983|Prednisone acetate|prednisone acetate
10938|NCT04129983|Hyperbaric oxygen|hyperbaric oxygen
10939|NCT04129983|Somatic stimulus|somatic stimulus
10940|NCT04129970|Binge Eating|binge eating
10941|NCT04129970|Transcranial Magnetic Stimulation|transcranial magnetic stimulation
10942|NCT04129970|Theta Burst Stimulation|theta burst stimulation
10943|NCT04129970|Neuromodulation|neuromodulation
10944|NCT04129970|Psychiatric Disorders|psychiatric disorders
10945|NCT04129970|Eating Disorders|eating disorders
10946|NCT04129957|prediction|prediction
10947|NCT04129957|dental implants|dental implants
10948|NCT04129957|failure|failure
10949|NCT04129957|peri-implantitis|peri-implantitis
10950|NCT04129944|Osteoarthritis|osteoarthritis
10951|NCT04129944|Painful Osteoarthritis|painful osteoarthritis
10952|NCT04129944|Osteoarthritis, Knee|osteoarthritis, knee
10953|NCT04129944|Senescence|senescence
10954|NCT04129918|intensive care unit|intensive care unit
10955|NCT04129918|sleep quality|sleep quality
10956|NCT04129918|circadian rhythm|circadian rhythm
10957|NCT04129905|Hypertrophic Cardiomyopathy|hypertrophic cardiomyopathy
10958|NCT04129905|Endothelial Dysfunction|endothelial dysfunction
10959|NCT04129905|Venous return|venous return
10960|NCT04129905|Left ventricular outflow-tract obstruction|left ventricular outflow-tract obstruction
10961|NCT04129905|Sudden cardiac death risk|sudden cardiac death risk
10962|NCT04129892|Resilience|resilience
10963|NCT04129892|Academic course|academic course
10964|NCT04129892|College students|college students
10965|NCT04129879|endometriosis|endometriosis
10966|NCT04129879|methylene blue dye|methylene blue dye
10967|NCT04129853|Wearable robotics|wearable robotics
10968|NCT04129853|Unilateral Lower Limb Amputation|unilateral lower limb amputation
10969|NCT04129840|antihypertensive treatment|antihypertensive treatment
10970|NCT04129827|Return to Sport|return to sport
10971|NCT04129827|ACL reconstruction|acl reconstruction
10972|NCT04129827|Knee|knee
10973|NCT04129827|Athletes|athletes
10974|NCT04129814|Chronic periodontitis|chronic periodontitis
10975|NCT04129814|Prognosis|prognosis
10976|NCT04129814|Erectile Dysfunction|erectile dysfunction
10977|NCT04129801|Severe obesity|severe obesity
10978|NCT04129801|Body Composition|body composition
10979|NCT04129801|Muscle Strength|muscle strength
10980|NCT04129801|Electrical bioimpedance analysis|electrical bioimpedance analysis
10981|NCT04129775|hearing loss|hearing loss
10982|NCT04129775|speech-in-noise|speech-in-noise
10983|NCT04129775|synaptopathy|synaptopathy
10984|NCT04129775|hearing impairment|hearing impairment
10985|NCT04129775|hidden hearing loss|hidden hearing loss
10986|NCT04129645|Ureteral|ureteral
10987|NCT04129645|ureteral stent|ureteral stent
10988|NCT04129645|ureteral stricture|ureteral stricture
10989|NCT04129632|burnout|burnout
10990|NCT04129632|wellness|wellness
10991|NCT04129632|mindfulness|mindfulness
10992|NCT04129632|physician burnout|physician burnout
10993|NCT04129619|Irritable Bowel Syndrome|irritable bowel syndrome
10994|NCT04129619|IBS|ibs
10995|NCT04129606|Perforation of Bladder|perforation of bladder
10996|NCT04129606|Bladder Cancer|bladder cancer
10997|NCT04129606|Resection Margin|resection margin
11006|NCT04129463|SST|sst
11007|NCT04129463|IOP|iop
11008|NCT04129463|AXL|axl
11009|NCT04129450|Mindfulness-Based Stress Reduction|mindfulness-based stress reduction
11010|NCT04129450|Medical group visits|medical group visits
11011|NCT04129450|Primary care setting|primary care setting
11012|NCT04129424|Diabetes mellitus|diabetes mellitus
11013|NCT04129424|Insulin pump|insulin pump
11014|NCT04129424|Continuous subcutaneous insulin infusion|continuous subcutaneous insulin infusion
11015|NCT04129411|RFA|rfa
11016|NCT04129411|Radiofrequency|radiofrequency
11017|NCT04129411|Thyroid Cancer|thyroid cancer
11018|NCT04129411|Ablation techniques|ablation techniques
11019|NCT04129411|Ultrasonography|ultrasonography
11020|NCT04129385|laparoscopy|laparoscopy
11021|NCT04129385|shoulder pain|shoulder pain
11022|NCT04129385|trendelenburg position|trendelenburg position
11023|NCT04129372|fruits|fruits
11024|NCT04129372|vegetables|vegetables
11025|NCT04129372|food neophobia|food neophobia
11026|NCT04129372|preschool|preschool
11027|NCT04129372|children|children
11028|NCT04129346|Inactivity|inactivity
11029|NCT04129346|Breast Cancer|breast cancer
11030|NCT04129346|Metastatic Breast Cancer|metastatic breast cancer
11031|NCT04129346|Quality of life|quality of life
11032|NCT04129346|Sedentary|sedentary
11033|NCT04129320|SCCHN|scchn
11034|NCT04129320|head and neck|head and neck
11035|NCT04129320|oropharyngeal|oropharyngeal
11036|NCT04129320|oral cavity|oral cavity
11037|NCT04129320|hypopharyngeal|hypopharyngeal
11038|NCT04129320|laryngeal cancer|laryngeal cancer
11039|NCT04129320|immunotherapy|immunotherapy
11040|NCT04129320|PD-1|pd-1
11041|NCT04129320|B7-H3|b7-h3
11042|NCT04129307|Motor imagery|motor imagery
11043|NCT04129307|Action observation|action observation
11044|NCT04129294|Duchenne Muscular Dystrophy|duchenne muscular dystrophy
11045|NCT04129281|Papillary Microcarcinoma of the Thyroid|papillary microcarcinoma of the thyroid
11046|NCT04129281|Surgery|surgery
11047|NCT04129281|Outcome|outcome
11048|NCT04129281|Follow up|follow up
11049|NCT04129255|Octreotide|octreotide
11050|NCT04129255|neuroendocrine tumors|neuroendocrine tumors
11051|NCT04129255|immunological response|immunological response
11052|NCT04129242|Stroke|stroke
11053|NCT04129242|Rehabilitation|rehabilitation
11054|NCT04129242|Vagus Nerve Stimulation|vagus nerve stimulation
11055|NCT04129242|Brain Stimulation|brain stimulation
11056|NCT04129242|Occupational Therapy|occupational therapy
11057|NCT04129216|breast cancer|breast cancer
11058|NCT04129216|genomic assay|genomic assay
11059|NCT04129216|hormone therapy|hormone therapy
11060|NCT04129203|acute ischemic stroke|acute ischemic stroke
11061|NCT04129177|Surgical site infection|surgical site infection
11062|NCT04129177|Colorectal surgery|colorectal surgery
11063|NCT04129177|Surveillance|surveillance
11064|NCT04129177|Bundle approach|bundle approach
11065|NCT04129164|Sjögren's Syndrome|sjögren's syndrome
11066|NCT04129164|SS|ss
11067|NCT04129164|VIB4920|vib4920
11068|NCT04129164|MEDI4920|medi4920
11073|NCT04129086|Multimodal Pain Therapy|multimodal pain therapy
11074|NCT04129086|Ketamine|ketamine
11075|NCT04129086|Trauma|trauma
11076|NCT04129073|Comparative Effectiveness Research|comparative effectiveness research
11077|NCT04129034|chronic low back pain|chronic low back pain
11078|NCT04129034|zygapophyseal joint syndrome|zygapophyseal joint syndrome
11079|NCT04129034|Facet syndrome|facet syndrome
11080|NCT04129008|coronary heart disease|coronary heart disease
11081|NCT04129008|gastroesophageal reflux disease|gastroesophageal reflux disease
11082|NCT04129008|indobufen|indobufen
11083|NCT04129008|aspirin|aspirin
11084|NCT04128969|dyslipidemia|dyslipidemia
11085|NCT04128969|arterial stiffness|arterial stiffness
11086|NCT04128969|pediatric obesity|pediatric obesity
11087|NCT04128969|metabolic syndrome|metabolic syndrome
11088|NCT04128969|insulin resistance|insulin resistance
11089|NCT04128956|Aspirin plus rivaroxaban vs. rivaroxaban for the prevention|aspirin plus rivaroxaban vs. rivaroxaban for the prevention
11090|NCT04128943|electronic patient-reported outcomes|electronic patient-reported outcomes
11091|NCT04128943|electronic health (eHealth) technology|electronic health (ehealth) technology
11092|NCT04128943|app utilization|app utilization
11093|NCT04128943|ePRO application|epro application
11094|NCT04128904|Infertility|infertility
11095|NCT04128904|Non-male factor infertility|non-male factor infertility
11096|NCT04128904|In vitro fertilisation (IVF)|in vitro fertilisation (ivf)
11293|NCT04127617|Nervous System Diseases|nervous system diseases
11097|NCT04128904|Intracytoplasmic sperm injection (ICSI)|intracytoplasmic sperm injection (icsi)
11098|NCT04128904|Assisted reproductive technologies (ART)|assisted reproductive technologies (art)
11099|NCT04128904|Live birth rate|live birth rate
11100|NCT04128904|Reproductive outcome|reproductive outcome
11101|NCT04128865|phytotherapy|phytotherapy
11102|NCT04128865|dietary supplement|dietary supplement
11103|NCT04128865|food interaction|food interaction
11104|NCT04128865|herb-drug interactions|herb-drug interactions
11105|NCT04128839|gut microbiome|gut microbiome
11106|NCT04128839|metabolome|metabolome
11107|NCT04128839|postprandial hypertriglyceridemia|postprandial hypertriglyceridemia
11108|NCT04128839|low-grade inflammation|low-grade inflammation
11109|NCT04128839|visceral adipose tissue|visceral adipose tissue
11110|NCT04128826|Partial Range of Motion|partial range of motion
11111|NCT04128826|Full Range of Motion|full range of motion
11112|NCT04128800|apatinib S-1|apatinib s-1
11113|NCT04128800|Advanced lung cancer|advanced lung cancer
11114|NCT04128787|Bioavailability Study|bioavailability study
11115|NCT04128787|Pharmacokinetic study|pharmacokinetic study
11116|NCT04128787|AG-881|ag-881
11117|NCT04128774|Glioma|glioma
11118|NCT04128774|Glioblastoma|glioblastoma
11119|NCT04128774|Adult|adult
11120|NCT04128774|Dexamethasone|dexamethasone
11121|NCT04128774|B cells|b cells
11122|NCT04128774|Regulatory B cells|regulatory b cells
11123|NCT04128761|Delay Discounting|delay discounting
11124|NCT04128761|Behavioral Economic Demand|behavioral economic demand
11125|NCT04128761|Scarcity Narrative|scarcity narrative
11126|NCT04128761|Self-Administration|self-administration
11127|NCT04128761|Functional MRI|functional mri
11128|NCT04128761|Alcohol Craving|alcohol craving
11129|NCT04128735|Diastolic dysfunction|diastolic dysfunction
11130|NCT04128735|Morbid Obesity|morbid obesity
11131|NCT04128735|Bariatric surgery|bariatric surgery
11132|NCT04128722|LMLM|lmlm
11133|NCT04128722|Sirolimus|sirolimus
11134|NCT04128709|urodynamics|urodynamics
11135|NCT04128709|neurogenic|neurogenic
11136|NCT04128709|bladder|bladder
11137|NCT04128696|GSK3359609|gsk3359609
11138|NCT04128696|Pembrolizumab|pembrolizumab
11139|NCT04128696|Programmed death receptor 1-ligand 1|programmed death receptor 1-ligand 1
11140|NCT04128696|Head and neck squamous cell carcinoma/cancer|head and neck squamous cell carcinoma/cancer
11141|NCT04128696|Inducible T cell co-stimulatory receptor|inducible t cell co-stimulatory receptor
11142|NCT04128696|Keynote-A01|keynote-a01
11143|NCT04128696|Head & neck|head & neck
11144|NCT04128670|kinesio tape|kinesio tape
11145|NCT04128670|muscle soreness|muscle soreness
11146|NCT04128670|eccentric exercise|eccentric exercise
11147|NCT04128670|muscle pain|muscle pain
11148|NCT04128657|Quality of life|quality of life
11149|NCT04128657|Sphincter sparing surgery|sphincter sparing surgery
11150|NCT04128657|Wexner score|wexner score
11151|NCT04128657|LARS score|lars score
11152|NCT04128644|depression|depression
11153|NCT04128644|prevention|prevention
11154|NCT04128644|school|school
11155|NCT04128618|knee OA|knee oa
11156|NCT04128618|arthritis|arthritis
11157|NCT04128618|knee pain|knee pain
11158|NCT04128579|Systemic Lupus Erythematosus|systemic lupus erythematosus
11159|NCT04128579|Active Proliferative Lupus Nephritis|active proliferative lupus nephritis
11160|NCT04128566|articular cartilage|articular cartilage
11161|NCT04128566|mechanosensitive blood markers of articular cartilage|mechanosensitive blood markers of articular cartilage
11162|NCT04128566|walking stress test|walking stress test
11163|NCT04128566|ambulatory load|ambulatory load
11164|NCT04128566|articular cartilage thinning|articular cartilage thinning
11165|NCT04128566|anterior cruciate ligament (ACL) injury|anterior cruciate ligament (acl) injury
11166|NCT04128566|articular cartilage quality|articular cartilage quality
11167|NCT04128553|elderly|elderly
11168|NCT04128553|motivational interview|motivational interview
11169|NCT04128553|Transtheoretical model|transtheoretical model
11170|NCT04128553|exercise|exercise
11171|NCT04128553|community health nursing|community health nursing
11172|NCT04128514|Toric IOL|toric iol
11173|NCT04128514|Panoptix|panoptix
11174|NCT04128514|multifocal IOL|multifocal iol
11175|NCT04128514|trifocal IOL|trifocal iol
11176|NCT04128475|Cardiovascular events|cardiovascular events
11177|NCT04128475|Coronary heart disease|coronary heart disease
11178|NCT04128475|Cardiovascular death|cardiovascular death
11179|NCT04128475|Low density lipoprotein cholesterol (LDL-c)|low density lipoprotein cholesterol (ldl-c)
11180|NCT04128475|Evolocumab|evolocumab
11181|NCT04128475|FOURIER OUTCOMES|fourier outcomes
11182|NCT04128462|Overt HE diagnosis|overt he diagnosis
11183|NCT04128449|performance|performance
11184|NCT04128449|cyclists|cyclists
11185|NCT04128449|docosahexaenoic acid|docosahexaenoic acid
11186|NCT04128449|anaerobic threshold|anaerobic threshold
11187|NCT04128436|luteal phase|luteal phase
11188|NCT04128436|progesterone|progesterone
11189|NCT04128436|in vitro fertilization|in vitro fertilization
11190|NCT04128423|immunotherapy|immunotherapy
11191|NCT04128423|anti-CD33|anti-cd33
11192|NCT04128423|T-cell engager|t-cell engager
11294|NCT04127617|Nursing|nursing
11196|NCT04128397|transcranial magnetic stimulation|transcranial magnetic stimulation
11197|NCT04128397|fMRI|fmri
11198|NCT04128384|Transcatheter valve replacement|transcatheter valve replacement
11199|NCT04128384|Infranodal conduction time|infranodal conduction time
11200|NCT04128384|High-degree AV block|high-degree av block
11201|NCT04128384|Left Bundle-Branch Block|left bundle-branch block
11202|NCT04128371|Absolute Neutrophil Count|absolute neutrophil count
11203|NCT04128371|Cycling|cycling
11204|NCT04128371|Gleich's Syndrome|gleich's syndrome
11205|NCT04128371|Urticaria|urticaria
11206|NCT04128371|Serum Interleukin 5|serum interleukin 5
11210|NCT04128306|Time to contact estimation|time to contact estimation
11211|NCT04128306|awake brain surgery|awake brain surgery
11212|NCT04128306|brain tumor|brain tumor
11213|NCT04128306|cerebral mapping|cerebral mapping
11214|NCT04128293|Healthy participants|healthy participants
11215|NCT04128293|GSK3640254|gsk3640254
11216|NCT04128293|Human immunodeficiency virus (HIV)|human immunodeficiency virus (hiv)
11217|NCT04128293|Safety|safety
11218|NCT04128280|Chronic Prostatitis|chronic prostatitis
11219|NCT04128241|Knowledge|knowledge
11220|NCT04128241|Attitudes|attitudes
11221|NCT04128241|Practice|practice
11222|NCT04128241|Behaviours|behaviours
11223|NCT04128241|Fad diets|fad diets
11224|NCT04128241|Kap survey|kap survey
11225|NCT04128228|Alcohol use disorder|alcohol use disorder
11226|NCT04128228|Early trauma|early trauma
11227|NCT04128228|fMRI|fmri
11228|NCT04128228|Stress hormone|stress hormone
11229|NCT04128228|Alcohol relapse|alcohol relapse
11230|NCT04128215|High-Intensity Interval Training|high-intensity interval training
11231|NCT04128215|Aerobic exercise|aerobic exercise
11232|NCT04128215|Acute exercise|acute exercise
11233|NCT04128176|Omalizumab|omalizumab
11234|NCT04128176|Rituximab|rituximab
11235|NCT04128176|Bullous Pemphigoid|bullous pemphigoid
11236|NCT04128124|asynchronies|asynchronies
11237|NCT04128124|mechanical ventilation|mechanical ventilation
11238|NCT04128124|irregularity|irregularity
11239|NCT04128124|complexity|complexity
11240|NCT04128124|breathing pattern|breathing pattern
11241|NCT04128124|self-extubation|self-extubation
11242|NCT04128124|weaning|weaning
11243|NCT04128111|Bronchial Asthma|bronchial asthma
11244|NCT04128111|TCM Syndrome|tcm syndrome
11245|NCT04128111|Inflammation Phenotype|inflammation phenotype
11246|NCT04128111|Biomarker|biomarker
11247|NCT04128072|Cutaneous T-Cell Lymphoma|cutaneous t-cell lymphoma
11248|NCT04128072|Mogamulizumab|mogamulizumab
11249|NCT04128072|Total Skin Electron Beam therapy|total skin electron beam therapy
11250|NCT04128059|vaccine|vaccine
11251|NCT04128059|vector based vaccine|vector based vaccine
11252|NCT04128059|Immunologic Factors|immunologic factors
11253|NCT04128059|MERS-CoV|mers-cov
11254|NCT04128059|Middle East respiratory syndrome|middle east respiratory syndrome
11255|NCT04128033|acupuncture|acupuncture
11256|NCT04128033|perineum injury|perineum injury
11257|NCT04128033|delivery|delivery
11258|NCT04127981|18F-FDG PET Scan|18f-fdg pet scan
11259|NCT04127981|Dexa Scan|dexa scan
11260|NCT04127981|Quality of Life assessment tools|quality of life assessment tools
11261|NCT04127942|platelet-rich plasma|platelet-rich plasma
11262|NCT04127942|ultrasound guided injection.|ultrasound guided injection.
11263|NCT04127942|Temporomandibular disorder|temporomandibular disorder
11264|NCT04127929|glass ionomer, composite, clinical|glass ionomer, composite, clinical
11265|NCT04127890|oxygen-enriched water|oxygen-enriched water
11266|NCT04127812|mindfullness|mindfullness
11267|NCT04127812|eating|eating
11268|NCT04127812|snacking|snacking
11269|NCT04127812|obesity|obesity
11270|NCT04127812|children|children
11271|NCT04127773|VLBW - Very Low Birth Weight Infant|vlbw - very low birth weight infant
11272|NCT04127773|Gastric tube|gastric tube
11273|NCT04127773|Enteral nutrition|enteral nutrition
11274|NCT04127773|Prematurity|prematurity
11275|NCT04127773|Nursing|nursing
11276|NCT04127760|Meningioma Atypical|meningioma atypical
11277|NCT04127760|radiotherapy|radiotherapy
11278|NCT04127747|Systemic lupus erythematosus|systemic lupus erythematosus
11279|NCT04127747|rituximab|rituximab
11280|NCT04127708|tinnitus|tinnitus
11281|NCT04127708|acupuncture|acupuncture
11282|NCT04127708|otology|otology
11283|NCT04127708|prospective study|prospective study
11284|NCT04127695|Parkinson's Disease|parkinson's disease
11285|NCT04127669|residual symptoms|residual symptoms
11286|NCT04127669|mental fatigue|mental fatigue
11287|NCT04127669|dopamine stabilizer|dopamine stabilizer
11288|NCT04127643|S-ICD|s-icd
11289|NCT04127643|safety|safety
11290|NCT04127643|feasibility|feasibility
11291|NCT04127617|Manipulation, Osteopathic|manipulation, osteopathic
11292|NCT04127617|Neurogenic Bowel|neurogenic bowel
11295|NCT04127604|Bipolar Disorder|bipolar disorder
11296|NCT04127604|Substance Use Disorders|substance use disorders
11297|NCT04127604|Treatment Adherence|treatment adherence
11298|NCT04127604|Veterans|veterans
11299|NCT04127604|Psychosocial intervention|psychosocial intervention
11300|NCT04127578|Parkinson's Disease|parkinson's disease
11301|NCT04127578|GBA1 mutation|gba1 mutation
11302|NCT04127578|Glucocerebrosidase|glucocerebrosidase
11303|NCT04127578|PD-GBA|pd-gba
11304|NCT04127578|Parkinson's Disease Gene Therapy|parkinson's disease gene therapy
11305|NCT04127578|AAV9|aav9
11306|NCT04127578|Gene Therapy|gene therapy
11307|NCT04127578|GBA|gba
11308|NCT04127565|Telemedicine|telemedicine
11309|NCT04127565|Emergency Medical Service|emergency medical service
11310|NCT04127539|Exercise|exercise
11311|NCT04127539|Fall prevention|fall prevention
11312|NCT04127526|Dissociation|dissociation
11313|NCT04127526|Psychosis|psychosis
11314|NCT04127526|Trauma|trauma
11315|NCT04127526|Hallucinations|hallucinations
11316|NCT04127526|Psychological Therapies|psychological therapies
11317|NCT04127513|xerosis cutis|xerosis cutis
11318|NCT04127513|geriatric|geriatric
11319|NCT04127513|12% ammonium lactate|12% ammonium lactate
11320|NCT04127513|10% urea|10% urea
11321|NCT04127487|NLRP3 (rs4612666), CARD8 (rs20432111)|nlrp3 (rs4612666), card8 (rs20432111)
11322|NCT04127474|periodontitis|periodontitis
11323|NCT04127474|saliva|saliva
11324|NCT04127474|trefoil factor|trefoil factor
11325|NCT04127474|adrenomedullin|adrenomedullin
11326|NCT04127474|Coronary heart disease|coronary heart disease
11327|NCT04127448|Aerobic Exercise|aerobic exercise
11328|NCT04127448|Cognitive dysfunction|cognitive dysfunction
11329|NCT04127448|Exergaming|exergaming
11330|NCT04127448|T2DM.|t2dm.
11331|NCT04127422|Benign breast disease|benign breast disease
11332|NCT04127422|Fibrocystic disease|fibrocystic disease
11333|NCT04127409|Omega-3 Polyunsaturated Fatty Acids|omega-3 polyunsaturated fatty acids
11334|NCT04127396|Transarterial chemoembolization|transarterial chemoembolization
11335|NCT04127396|hepatocellular carcinoma|hepatocellular carcinoma
11336|NCT04127396|portal vein tumor thrombus|portal vein tumor thrombus
11337|NCT04127357|Pit and fissure sealants|pit and fissure sealants
11338|NCT04127357|Pediatric dentistry|pediatric dentistry
11339|NCT04127357|Toothbrushing|toothbrushing
11340|NCT04127318|Sarcopenia|sarcopenia
11341|NCT04127318|Quality of Life|quality of life
11342|NCT04127318|Immunologic Markers|immunologic markers
11343|NCT04127305|drug monitoring|drug monitoring
11344|NCT04127305|antiinfectives|antiinfectives
11345|NCT04127305|intensive care|intensive care
11346|NCT04127305|ECMO|ecmo
11347|NCT04127292|Suicide|suicide
11348|NCT04127292|Empathy|empathy
11349|NCT04127292|Emotional Self-Awareness|emotional self-awareness
11350|NCT04127279|autonomic nervous system|autonomic nervous system
11351|NCT04127279|HPA axis|hpa axis
11352|NCT04127279|anxiety|anxiety
11353|NCT04127279|non verbal behavior|non verbal behavior
11354|NCT04127266|Donor pool|donor pool
11355|NCT04127266|Brain death|brain death
11356|NCT04127266|Unallocated organs|unallocated organs
11357|NCT04127266|Histopathological quality|histopathological quality
11358|NCT04127253|Motor imagery|motor imagery
11359|NCT04127253|Transcranial direct current stimulation|transcranial direct current stimulation
11360|NCT04127253|Action observation|action observation
11361|NCT04127214|eating disorders|eating disorders
11362|NCT04127214|anorexia nervosa|anorexia nervosa
11363|NCT04127214|bulimia nervosa|bulimia nervosa
11364|NCT04127214|binge eating|binge eating
11365|NCT04127214|routine outcome monitoring|routine outcome monitoring
11366|NCT04127214|psychological interventions|psychological interventions
11367|NCT04127214|integrated treatment|integrated treatment
11368|NCT04127214|effectiveness|effectiveness
11369|NCT04127201|"online therapy"|"online therapy"
11370|NCT04127201|"weight loss control program"|"weight loss control program"
11371|NCT04127201|Internet|internet
11372|NCT04127175|Breast cancer|breast cancer
11373|NCT04127175|Breast density|breast density
11374|NCT04127175|Volpara|volpara
11375|NCT04127175|Quantra|quantra
11376|NCT04127175|BI-RADS|bi-rads
11377|NCT04127175|Digital Mammography|digital mammography
11378|NCT04127175|Digital Breast Tomosynthesis|digital breast tomosynthesis
11379|NCT04127162|Temporal Dispersion of Repolarization Phase|temporal dispersion of repolarization phase
11380|NCT04127162|proBNP|probnp
11381|NCT04127162|QTVI|qtvi
11382|NCT04127162|QT|qt
11383|NCT04127162|Tpeak-Tend|tpeak-tend
11384|NCT04127149|ultrasound scanner|ultrasound scanner
11385|NCT04127149|sonogram|sonogram
11386|NCT04127149|general practice|general practice
11387|NCT04127136|obesity|obesity
11388|NCT04127136|weight loss|weight loss
11389|NCT04127136|Binge-Eating Disorder|binge-eating disorder
11390|NCT04127123|arrhythmia|arrhythmia
11391|NCT04127123|cardiac electrophysiology|cardiac electrophysiology
11392|NCT04127123|ablation|ablation
11393|NCT04127110|Anaplastic lymphoma kinase (ALK) positive non small cell lung cancer (NSCLC)|anaplastic lymphoma kinase (alk) positive non small cell lung cancer (nsclc)
11394|NCT04127097|anxiety|anxiety
11399|NCT04127084|Albuminuria|albuminuria
11400|NCT04127084|SGLT2 inhibitor|sglt2 inhibitor
11401|NCT04127071|Ultrasound Guided Needle Aspiration|ultrasound guided needle aspiration
11402|NCT04127071|Incision and Drainage|incision and drainage
11403|NCT04127045|gait analysis|gait analysis
11404|NCT04127045|hip fracture|hip fracture
11405|NCT04127045|elderly|elderly
11406|NCT04127045|mobility|mobility
11407|NCT04127032|Internet|internet
11408|NCT04127032|Cognitive Behavioral Therapy|cognitive behavioral therapy
11409|NCT04127032|Telemedicine|telemedicine
11410|NCT04127006|EYS mutation|eys mutation
11411|NCT04127006|Retinitis Pigmentosa|retinitis pigmentosa
11412|NCT04126993|SHR-1210|shr-1210
11413|NCT04126993|Camrelizumab|camrelizumab
11414|NCT04126993|Apatinib|apatinib
11415|NCT04126993|Sarcoma|sarcoma
11416|NCT04126993|Jilong Yang|jilong yang
11418|NCT04126967|MRD|mrd
11419|NCT04126967|Allo-PBSCT|allo-pbsct
11420|NCT04126954|Hyperparathyroidism|hyperparathyroidism
11421|NCT04126954|pathology phosphocalcic|pathology phosphocalcic
11422|NCT04126941|Hypoparathyroidism|hypoparathyroidism
11423|NCT04126941|Teriparatide|teriparatide
11424|NCT04126928|orthopantomograph|orthopantomograph
11425|NCT04126928|periapical index|periapical index
11426|NCT04126928|reliability|reliability
11427|NCT04126928|sensitivity|sensitivity
11428|NCT04126928|specificity|specificity
11429|NCT04126915|Castration-Resistant Prostatic Cancer|castration-resistant prostatic cancer
11430|NCT04126915|Whole Exome Sequencing|whole exome sequencing
11431|NCT04126902|innate immunity|innate immunity
11432|NCT04126902|macrophage|macrophage
11433|NCT04126902|toll-like receptors|toll-like receptors
11434|NCT04126902|trophoblasts|trophoblasts
11435|NCT04126902|phagocytos|phagocytos
11436|NCT04126850|Microbiome|microbiome
11437|NCT04126850|Autoimmune Uveitis|autoimmune uveitis
11438|NCT04126850|Vogt-Koyanagi-Harada Disease|vogt-koyanagi-harada disease
11439|NCT04126850|Behçet Disease|behçet disease
11440|NCT04126850|Idiopathic Uveitis|idiopathic uveitis
11441|NCT04126850|Metatranscriptomic|metatranscriptomic
11442|NCT04126850|Amplicon|amplicon
11448|NCT04126824|Uterine Artery Embolization|uterine artery embolization
11449|NCT04126811|Soft tissue sarcoma|soft tissue sarcoma
11450|NCT04126811|apatinib|apatinib
11451|NCT04126811|Jilong Yang|jilong yang
11452|NCT04126798|Cognition|cognition
11453|NCT04126798|Motor performance|motor performance
11454|NCT04126798|Dual-task|dual-task
11455|NCT04126785|Aging|aging
11456|NCT04126785|Blood Pressure|blood pressure
11457|NCT04126785|Endothelial function|endothelial function
11458|NCT04126785|Exercise|exercise
11459|NCT04126785|Heart rate variability|heart rate variability
11460|NCT04126759|Non-invasive glucose monitoring|non-invasive glucose monitoring
11461|NCT04126759|Raman spectroscopy|raman spectroscopy
11462|NCT04126746|Lung transplantation|lung transplantation
11463|NCT04126746|Chronic lung allograft dysfunction|chronic lung allograft dysfunction
11464|NCT04126707|Chronic Myeloid Leukemia|chronic myeloid leukemia
11465|NCT04126707|HQP1351|hqp1351
11466|NCT04126681|Chronic Myeloid Leukemia|chronic myeloid leukemia
11467|NCT04126681|HQP1351|hqp1351
11468|NCT04126681|CML|cml
11469|NCT04126681|CML-CP|cml-cp
11470|NCT04126655|Colorectal cancer,|colorectal cancer,
11471|NCT04126655|Liver metastases|liver metastases
11472|NCT04126655|5-FU|5-fu
11473|NCT04126655|Arfolitixorin|arfolitixorin
11474|NCT04126655|Calciumfolinate|calciumfolinate
11475|NCT04126655|TS-inhibtion|ts-inhibtion
11476|NCT04126642|improve symptom management|improve symptom management
11477|NCT04126642|reduce treatment non-adherence|reduce treatment non-adherence
11478|NCT04126629|Hypertensive Disorder of Pregnancy|hypertensive disorder of pregnancy
11479|NCT04126629|Sleep-disordered Breathing|sleep-disordered breathing
11480|NCT04126629|HDP|hdp
11481|NCT04126629|SDB|sdb
11482|NCT04126590|Adverse Event|adverse event
11483|NCT04126590|Anti-Drug Antibodies|anti-drug antibodies
11484|NCT04126590|Complete Response|complete response
11485|NCT04126564|Burnout|burnout
11486|NCT04126564|Stress|stress
11487|NCT04126564|Anxiety|anxiety
11488|NCT04126564|Depression|depression
11489|NCT04126564|Meditation|meditation
11490|NCT04126564|Inner Engineering Online|inner engineering online
11491|NCT04126525|neoadjuvant|neoadjuvant
11492|NCT04126525|pyrotinib|pyrotinib
11493|NCT04126525|trastuzumab|trastuzumab
11494|NCT04126525|paclitaxel|paclitaxel
11495|NCT04126525|cisplatin|cisplatin
11496|NCT04126473|aminoglycoside|aminoglycoside
11497|NCT04126473|Nonsense Mutation|nonsense mutation
11498|NCT04126473|Translational read through|translational read through
11499|NCT04126460|Head and neck|head and neck
11500|NCT04126460|recurrent disease|recurrent disease
11501|NCT04126460|PD-1|pd-1
11502|NCT04126460|salvage surgery|salvage surgery
11503|NCT04126460|Second Primary|second primary
11504|NCT04126421|Highly cross-linked polyethylene (HXLPE)|highly cross-linked polyethylene (hxlpe)
11505|NCT04126421|Vitamin E infused polyethylene|vitamin e infused polyethylene
11506|NCT04126395|motor development|motor development
11507|NCT04126395|baby|baby
11508|NCT04126395|infant|infant
11509|NCT04126395|motor milestones|motor milestones
11510|NCT04126395|crawling|crawling
11511|NCT04126395|independent walking|independent walking
11512|NCT04126382|NRDS|nrds
11513|NCT04126382|preterm infants|preterm infants
11514|NCT04126382|LISA|lisa
11515|NCT04126382|INSURE|insure
11516|NCT04126369|Drug Resistant Epilepsy|drug resistant epilepsy
11517|NCT04126369|mindfulness|mindfulness
11518|NCT04126369|self management|self management
11519|NCT04126343|Healthy study participants|healthy study participants
11520|NCT04126343|Padsevonil|padsevonil
11521|NCT04126343|Moxifloxacin|moxifloxacin
11522|NCT04126343|Cardiac repolarization|cardiac repolarization
11523|NCT04126304|community-acquired pneumonia|community-acquired pneumonia
11524|NCT04126304|common cold|common cold
11525|NCT04126304|acute bronchitis|acute bronchitis
11526|NCT04126304|Post-infection cough|post-infection cough
11527|NCT04126304|Mycoplasma infection rate|mycoplasma infection rate
11528|NCT04126304|macrolides resistance|macrolides resistance
11529|NCT04126291|education|education
11530|NCT04126291|health care professionals|health care professionals
11531|NCT04126291|type 2 diabetes|type 2 diabetes
11532|NCT04126291|prevention|prevention
11533|NCT04126239|food Addiction|food addiction
11534|NCT04126239|Obesity|obesity
11535|NCT04126226|Speech therapy|speech therapy
11536|NCT04126226|Dysphagia|dysphagia
11537|NCT04126226|Speech Intelligibility|speech intelligibility
11538|NCT04126226|Quality of Life|quality of life
11539|NCT04126200|Relapsed/Refractory Multiple Myeloma|relapsed/refractory multiple myeloma
11540|NCT04126200|Belantamab mafodotin|belantamab mafodotin
11541|NCT04126200|GSK2857916|gsk2857916
11542|NCT04126200|Platform study|platform study
11543|NCT04126200|GSK3174998|gsk3174998
11544|NCT04126200|GSK3359609|gsk3359609
11545|NCT04126200|a(OX40)|a(ox40)
11546|NCT04126200|a(ICOS)|a(icos)
11547|NCT04126187|Panoptix|panoptix
11548|NCT04126187|Trifocal IOL|trifocal iol
11549|NCT04126187|Multifocal IOL|multifocal iol
11550|NCT04126174|astigmatism, limbal relaxing incisions|astigmatism, limbal relaxing incisions
11551|NCT04126161|muscle|muscle
11552|NCT04126161|ultrasound|ultrasound
11553|NCT04126161|CT|ct
11554|NCT04126135|Smoking Cessation, Nicotine Replacement Therapy, Cytisine|smoking cessation, nicotine replacement therapy, cytisine
11555|NCT04126083|Opioid tapering|opioid tapering
11556|NCT04126083|Spine surgery|spine surgery
11557|NCT04126070|Hormone Sensitive Prostate Cancer|hormone sensitive prostate cancer
11558|NCT04126070|Prostate Adenocarcinoma|prostate adenocarcinoma
11559|NCT04126070|Metastasis Prostate Adenocarcinoma|metastasis prostate adenocarcinoma
11560|NCT04126057|Myopia|myopia
11561|NCT04126044|Pharmacokinetics|pharmacokinetics
11562|NCT04126031|Gram-negative, ceftazidime-avibactam, neonate, infant|gram-negative, ceftazidime-avibactam, neonate, infant
11563|NCT04126005|Canavan Disease|canavan disease
11564|NCT04126005|leukodystrophy|leukodystrophy
11565|NCT04126005|natural history|natural history
11566|NCT04126005|non-interventional|non-interventional
11567|NCT04125992|cardiac catheterization|cardiac catheterization
11568|NCT04125992|coronary angiography|coronary angiography
11569|NCT04125992|coronary angioplasty|coronary angioplasty
11570|NCT04125992|snuff-box|snuff-box
11571|NCT04125992|snuffbox|snuffbox
11572|NCT04125992|snuff box|snuff box
11573|NCT04125992|radial fossa|radial fossa
11574|NCT04125992|distal radial artery|distal radial artery
11575|NCT04125992|radial artery|radial artery
11576|NCT04125992|safeguard|safeguard
11577|NCT04125992|distal radial access|distal radial access
11578|NCT04125992|distal radial angiography|distal radial angiography
11579|NCT04125992|radial access|radial access
11580|NCT04125992|angiography|angiography
11581|NCT04125992|distal radial|distal radial
11582|NCT04125992|radial|radial
11583|NCT04125992|coronary arteries|coronary arteries
11584|NCT04125992|randomized controlled trial|randomized controlled trial
11585|NCT04125992|left distal radial artery|left distal radial artery
11586|NCT04125992|Percutaneous Coronary Intervention|percutaneous coronary intervention
11587|NCT04125992|radial artery occlusion|radial artery occlusion
11588|NCT04125992|forearm radial access|forearm radial access
11589|NCT04125992|forearm radial artery|forearm radial artery
11590|NCT04125992|coronary catheterization|coronary catheterization
11591|NCT04125992|catheterization|catheterization
11592|NCT04125992|left distal radial|left distal radial
11593|NCT04125992|angioplasty|angioplasty
11594|NCT04125992|coronary artery disease|coronary artery disease
11595|NCT04125992|radial vs distal|radial vs distal
11596|NCT04125966|NT-proBNP|nt-probnp
11597|NCT04125966|Atrial Fibrillation|atrial fibrillation
12576|NCT04120103|Agitation|agitation
11598|NCT04125966|Heart Failure|heart failure
11599|NCT04125940|Resync|resync
11600|NCT04125940|Nitrate|nitrate
11601|NCT04125940|Nitrite|nitrite
11602|NCT04125940|Healthy|healthy
11603|NCT04125901|Chronic Neck Pain|chronic neck pain
11604|NCT04125901|Adolescents|adolescents
11605|NCT04125901|Pain Neuroscience Education|pain neuroscience education
11606|NCT04125901|Exercise|exercise
11607|NCT04125849|Mediastinoscopy-assisted transhiatal esophagectomy (MATHE)|mediastinoscopy-assisted transhiatal esophagectomy (mathe)
11608|NCT04125849|Minimally invasive esophagectomy (MIE)|minimally invasive esophagectomy (mie)
11609|NCT04125836|Acromegaly|acromegaly
11610|NCT04125836|octreotide|octreotide
11611|NCT04125836|CAM2029|cam2029
11612|NCT04125836|phase 3|phase 3
11613|NCT04125810|Probiotic|probiotic
11614|NCT04125810|Stress|stress
11615|NCT04125810|Gut-brain axis|gut-brain axis
11617|NCT04125784|HIV infection|hiv infection
11618|NCT04125784|Dyslipidaemia|dyslipidaemia
11619|NCT04125784|Diabetes mellitus|diabetes mellitus
11620|NCT04125784|Diabetes mellitus type 2|diabetes mellitus type 2
11621|NCT04125784|Cardiovascular Risk factor|cardiovascular risk factor
11622|NCT04125784|Lipid profile|lipid profile
11623|NCT04125784|Austria|austria
11624|NCT04125784|HIV related treatment|hiv related treatment
11625|NCT04125784|Antiretroviral therapy|antiretroviral therapy
11626|NCT04125784|Follow-up Study|follow-up study
11627|NCT04125732|Refractory angina|refractory angina
11628|NCT04125732|Coronary Artery Disease|coronary artery disease
11629|NCT04125732|Gene Therapy|gene therapy
11630|NCT04125693|Fibroblast growth factor receptors (FGFR) Inhibitor|fibroblast growth factor receptors (fgfr) inhibitor
11631|NCT04125693|FGFR 1-4|fgfr 1-4
11632|NCT04125693|Non-small-cell lung cancer|non-small-cell lung cancer
11633|NCT04125693|Small-cell lung cancer|small-cell lung cancer
11634|NCT04125693|Urothelial carcinoma|urothelial carcinoma
11635|NCT04125693|Adenoidcystic carcinoma|adenoidcystic carcinoma
11636|NCT04125693|Head cancer|head cancer
11637|NCT04125693|Neck cancer|neck cancer
11638|NCT04125693|Breast cancer|breast cancer
11639|NCT04125667|Circulating cancer cells|circulating cancer cells
11640|NCT04125667|Biomedical polymer material|biomedical polymer material
11641|NCT04125667|Cell affinity difference|cell affinity difference
11642|NCT04125667|White blood cell attachment|white blood cell attachment
11643|NCT04125654|Ascites infection|ascites infection
11644|NCT04125654|ascites|ascites
11645|NCT04125654|mNGS|mngs
11646|NCT04125641|Elxaban|elxaban
11647|NCT04125628|Uthoff's phenomenon|uthoff's phenomenon
11648|NCT04125628|Thermosensitivity|thermosensitivity
11649|NCT04125628|Functional capacity|functional capacity
11650|NCT04125628|Exercise intolerance|exercise intolerance
11651|NCT04125602|Personalized Nutrition|personalized nutrition
11652|NCT04125602|Glucose Metabolism|glucose metabolism
11653|NCT04125602|Gut Microbiota|gut microbiota
11654|NCT04125589|Binge-Eating Disorder|binge-eating disorder
11655|NCT04125589|Decision-Making|decision-making
11656|NCT04125589|Brain Activity|brain activity
11657|NCT04125576|burn|burn
11658|NCT04125576|neuropathic pain|neuropathic pain
11659|NCT04125576|cerebral blood volume|cerebral blood volume
11660|NCT04125563|Cough hypersensitivity syndrome|cough hypersensitivity syndrome
11661|NCT04125563|Capsaicin cough sensitivity|capsaicin cough sensitivity
11662|NCT04125563|Cough monitor|cough monitor
11663|NCT04125537|Shared-Decision Making|shared-decision making
11664|NCT04125537|Supportive Kidney Care|supportive kidney care
11665|NCT04125537|Goals of Care Conversations|goals of care conversations
11666|NCT04125537|Palliative Care|palliative care
11667|NCT04125537|Palliative Medicine|palliative medicine
11668|NCT04125537|Advanced Care Planning|advanced care planning
11669|NCT04125537|Medical Management without Dialysis|medical management without dialysis
11670|NCT04125537|Palliative Dialysis|palliative dialysis
11671|NCT04125537|Conservative Kidney Management|conservative kidney management
11672|NCT04125524|Tumour markers|tumour markers
11673|NCT04125498|adhesions|adhesions
11674|NCT04125498|cicatrix|cicatrix
11675|NCT04125498|c-section|c-section
11676|NCT04125498|scar|scar
11677|NCT04125498|manual treatment|manual treatment
11678|NCT04125472|Hyperoxaluria|hyperoxaluria
11679|NCT04125472|Primary Hyperoxaluria|primary hyperoxaluria
11680|NCT04125472|Kidney Diseases|kidney diseases
11681|NCT04125472|Urologic Diseases|urologic diseases
11682|NCT04125472|Metabolism, Inborn Errors|metabolism, inborn errors
11683|NCT04125472|Genetic Diseases, Inborn|genetic diseases, inborn
11684|NCT04125472|Metabolic Diseases|metabolic diseases
11685|NCT04125472|RNA Therapeutic|rna therapeutic
11686|NCT04125472|siRNA|sirna
11687|NCT04125446|cancer in pregnancy|cancer in pregnancy
11688|NCT04125446|chemotherapy|chemotherapy
11689|NCT04125446|offspring|offspring
11690|NCT04125446|genotoxicity|genotoxicity
11691|NCT04125394|corneal edema|corneal edema
11692|NCT04125394|sodium chloride|sodium chloride
11693|NCT04125394|single-dose|single-dose
11694|NCT04125368|Maternal Nutrition|maternal nutrition
11695|NCT04125368|Antenatal Care|antenatal care
11696|NCT04125368|Ethiopia|ethiopia
11699|NCT04125316|Asthma|asthma
11700|NCT04125303|cannabis|cannabis
11701|NCT04125303|cocaine|cocaine
11702|NCT04125303|alcohol|alcohol
11703|NCT04125303|entertainment workers|entertainment workers
11704|NCT04125303|nursing interventions|nursing interventions
11705|NCT04125290|capillary leak syndrome|capillary leak syndrome
11706|NCT04125290|hemolytic uremic syndrome|hemolytic uremic syndrome
11707|NCT04125290|renal toxicity|renal toxicity
11708|NCT04125290|infusion-related reaction|infusion-related reaction
11709|NCT04125290|electrolyte abnormalities|electrolyte abnormalities
11710|NCT04125290|HCL and all relevant indications where LUMOXITI will be prescribed|hcl and all relevant indications where lumoxiti will be prescribed
11711|NCT04125251|Maternal Depression|maternal depression
11712|NCT04125251|Women Empowerment|women empowerment
11713|NCT04125251|Life Skills Building|life skills building
11714|NCT04125238|Delay Discounting|delay discounting
11715|NCT04125238|Behavioral Economic Demand|behavioral economic demand
11716|NCT04125238|Episodic Future Thinking|episodic future thinking
11717|NCT04125238|Self-Administration|self-administration
11718|NCT04125238|Functional MRI|functional mri
11719|NCT04125238|Alcohol Craving|alcohol craving
11720|NCT04125186|Bladder diary|bladder diary
11721|NCT04125134|Dry Eye|dry eye
11722|NCT04125134|artifical tear|artifical tear
11723|NCT04125121|Neuroplasticity|neuroplasticity
11724|NCT04125121|Neuroplastic changes|neuroplastic changes
11725|NCT04125121|General anaesthesia|general anaesthesia
11726|NCT04125121|Magnetic resonance imaging|magnetic resonance imaging
11727|NCT04125121|Sevoflurane|sevoflurane
11728|NCT04125121|Propofol|propofol
11729|NCT04125121|Healthy volunteers|healthy volunteers
11730|NCT04125121|Consciousness|consciousness
11731|NCT04125121|Cognitive|cognitive
11732|NCT04125121|Fatigue|fatigue
11733|NCT04125108|burn|burn
11734|NCT04125108|Pulmonary Function Test|pulmonary function test
11735|NCT04125108|Pulmonary Rehabilitation|pulmonary rehabilitation
11736|NCT04125095|Proton therapy, Children and adolescents, Image guidance, Setup uncertainty|proton therapy, children and adolescents, image guidance, setup uncertainty
11737|NCT04125069|Mitochondrial dysfunction|mitochondrial dysfunction
11738|NCT04125069|Acute Kidney Injury (AKI)|acute kidney injury (aki)
11739|NCT04125069|Coronary Artery Bypass Graft (CABG) Surgery|coronary artery bypass graft (cabg) surgery
11740|NCT04125069|Extracorporeal circulation|extracorporeal circulation
11741|NCT04125069|Inflammatory response|inflammatory response
11742|NCT04125069|Type 2 diabete|type 2 diabete
11743|NCT04125043|Red reflex|red reflex
11744|NCT04125043|Posterior ocular abnormalities|posterior ocular abnormalities
11745|NCT04125004|virtual reality|virtual reality
11746|NCT04125004|pediatric surgery|pediatric surgery
11747|NCT04125004|general anesthesia|general anesthesia
11748|NCT04125004|distraction technique|distraction technique
11749|NCT04124991|HCC|hcc
11750|NCT04124991|Durvalumab|durvalumab
804398|NCT00236951|Anemia|anemia
11751|NCT04124978|obstructive sleep apnea|obstructive sleep apnea
11752|NCT04124978|mandibular advancement device|mandibular advancement device
11753|NCT04124978|thermoplastic|thermoplastic
11754|NCT04124978|adjustable|adjustable
11755|NCT04124978|MyTAP|mytap
11756|NCT04124965|UCB7665|ucb7665
11757|NCT04124965|Myasthenia Gravis|myasthenia gravis
11758|NCT04124965|Rozanolixizumab|rozanolixizumab
11759|NCT04124952|Panoptix, trifocal IOL, multifocal IOL|panoptix, trifocal iol, multifocal iol
11760|NCT04124939|Overactive Bladder|overactive bladder
11761|NCT04124939|Botox/OnabotulinumtoxinA|botox/onabotulinumtoxina
11762|NCT04124939|Pain|pain
11763|NCT04124939|OAB|oab
11764|NCT04124939|Non-neurogenic Overactive bladder|non-neurogenic overactive bladder
11768|NCT04124913|oral dydrogesterone|oral dydrogesterone
11769|NCT04124913|luteal phase support|luteal phase support
11770|NCT04124913|vaginal progesterone gel|vaginal progesterone gel
11771|NCT04124913|frozen-thawed embryo transfer|frozen-thawed embryo transfer
11772|NCT04124900|prostate cancer|prostate cancer
11773|NCT04124900|prostate biopsy|prostate biopsy
11774|NCT04124900|telomere|telomere
11775|NCT04124900|biomarker|biomarker
11776|NCT04124900|screening|screening
11777|NCT04124900|prostate|prostate
11778|NCT04124900|cancer|cancer
11779|NCT04124900|biopsy|biopsy
11780|NCT04124861|Immunoglobulin G4-Related Disease|immunoglobulin g4-related disease
11781|NCT04124848|Somali-Americans|somali-americans
11782|NCT04124848|Sleep Disordered Breathing|sleep disordered breathing
11783|NCT04124848|Cardiovascular Diseases|cardiovascular diseases
11784|NCT04124848|Sex and Racial Differences|sex and racial differences
11785|NCT04124848|Respiratory Disorders|respiratory disorders
11786|NCT04124848|Hypertension|hypertension
11787|NCT04124848|Diabetes|diabetes
11788|NCT04124848|Health Disparities|health disparities
11789|NCT04124835|Labor, Obstetric|labor, obstetric
11790|NCT04124835|Physical Therapy Modalities|physical therapy modalities
11791|NCT04124809|blastocyst|blastocyst
11792|NCT04124809|Vitrification|vitrification
11793|NCT04124809|artificial collapse|artificial collapse
11794|NCT04124809|survival rate|survival rate
11795|NCT04124796|Carcinoma, Basal Cell|carcinoma, basal cell
11796|NCT04124796|psycho-social factors|psycho-social factors
11797|NCT04124757|Laparoscopy|laparoscopy
11798|NCT04124731|Advanced|advanced
11799|NCT04124731|Non-Small Cell Lung Cancer|non-small cell lung cancer
11800|NCT04124731|Sintilimab|sintilimab
11801|NCT04124731|PD-1|pd-1
11802|NCT04124731|Anlotinib|anlotinib
11803|NCT04124731|Anti-angiogenisis|anti-angiogenisis
11804|NCT04124718|caries experience, VDR, TFIP11, enviromental risk factor|caries experience, vdr, tfip11, enviromental risk factor
11805|NCT04124653|PF-06842874|pf-06842874
11806|NCT04124653|first in human|first in human
11807|NCT04124653|cyclin-dependent kinase 4|cyclin-dependent kinase 4
11808|NCT04124653|cyclin-dependent kinase 6|cyclin-dependent kinase 6
11809|NCT04124653|CDK4/6|cdk4/6
11810|NCT04124653|healthy participants|healthy participants
11811|NCT04124653|immediate release|immediate release
11812|NCT04124653|modified release|modified release
11813|NCT04124653|relative bioavailability|relative bioavailability
11814|NCT04124627|Ultrasound guidance|ultrasound guidance
11815|NCT04124627|surgery for lumbar spine|surgery for lumbar spine
11816|NCT04124627|irradiation|irradiation
11817|NCT04124627|wrong site surgery|wrong site surgery
11818|NCT04124614|PTSD|ptsd
11819|NCT04124601|Ipilimumab|ipilimumab
11820|NCT04124601|Nivolumab|nivolumab
11821|NCT04124601|Chemoradiotherapy|chemoradiotherapy
11822|NCT04124601|Rectal cancer|rectal cancer
11823|NCT04124575|Prevalence|prevalence
11824|NCT04124575|Sarcopenia|sarcopenia
11825|NCT04124575|Geriatric|geriatric
11826|NCT04124562|Nitrous oxide|nitrous oxide
11827|NCT04124562|Prevalence|prevalence
11828|NCT04124562|Turkey|turkey
11829|NCT04124549|End-Stage Renal Disease|end-stage renal disease
11830|NCT04124549|Exercise|exercise
11831|NCT04124549|Dialysis Efficacy|dialysis efficacy
11832|NCT04124549|Physical Fitness|physical fitness
11833|NCT04124536|Self Testing|self testing
11834|NCT04124536|Partner notification|partner notification
11835|NCT04124536|Secondary Distribution|secondary distribution
11836|NCT04124523|skull base surger|skull base surger
11837|NCT04124523|CSF leaks|csf leaks
11838|NCT04124523|intracranial pressure|intracranial pressure
11839|NCT04124523|endoscopic skull base surgery|endoscopic skull base surgery
11840|NCT04124523|CSF depletion|csf depletion
11841|NCT04124523|ENT surgeon or neurosurgeon|ent surgeon or neurosurgeon
11842|NCT04124497|Multiple Myeloma|multiple myeloma
11843|NCT04124497|Monoclonal antibody|monoclonal antibody
11844|NCT04124497|Immunomodulating agents|immunomodulating agents
11845|NCT04124484|DBPR108|dbpr108
11846|NCT04124484|type 2 diabetes mellitus|type 2 diabetes mellitus
11847|NCT04124484|DPP4 inhibitor|dpp4 inhibitor
11848|NCT04124471|Down Syndrome|down syndrome
11849|NCT04124471|Obstructive Sleep Apnea|obstructive sleep apnea
11850|NCT04124445|Faceto-genic Cervical pain|faceto-genic cervical pain
18487|NCT04082364|PD-1|pd-1
11851|NCT04124445|Chronic pain|chronic pain
11852|NCT04124445|Pulsed Radiofrequency ablation|pulsed radiofrequency ablation
11853|NCT04124445|Continues Radiofrequency ablation|continues radiofrequency ablation
11854|NCT04124445|Medial Brunch Block|medial brunch block
11855|NCT04124315|peripheral artery disease|peripheral artery disease
11856|NCT04124315|accelerometer|accelerometer
11857|NCT04124315|smartphone|smartphone
11858|NCT04124315|supervised exercise therapy|supervised exercise therapy
11859|NCT04124302|diabetes type 1|diabetes type 1
11860|NCT04124302|insulin bolus|insulin bolus
11861|NCT04124302|prandial insulin requirement|prandial insulin requirement
11862|NCT04124302|postprandial glycemia|postprandial glycemia
11863|NCT04124302|insulin pump therapy|insulin pump therapy
11864|NCT04124302|mixed meal|mixed meal
11865|NCT04124276|Major Depressive Disorder|major depressive disorder
11866|NCT04124276|Lycium barbarum polysaccharide|lycium barbarum polysaccharide
11867|NCT04124263|Hypertension|hypertension
11868|NCT04124263|Primary Health Care|primary health care
11869|NCT04124237|Inherited Heart Rhythms|inherited heart rhythms
11870|NCT04124237|Genetic Heart Conditions|genetic heart conditions
11871|NCT04124237|Sudden Cardiac Arrest|sudden cardiac arrest
11872|NCT04124237|Sudden Cardiac Death|sudden cardiac death
11873|NCT04124211|Fecal Microbiome Transplantation (FMT)|fecal microbiome transplantation (fmt)
11874|NCT04124198|Oropharyngeal squamous cell carcinoma T1-T2, N0-1|oropharyngeal squamous cell carcinoma t1-t2, n0-1
11875|NCT04124198|Transoral robotic surgery|transoral robotic surgery
11876|NCT04124198|Intensity Modulated Radiation Therapy|intensity modulated radiation therapy
11877|NCT04124185|Achromatopsia|achromatopsia
11878|NCT04124185|CNGB3|cngb3
11879|NCT04124185|CNGA3|cnga3
11880|NCT04124172|stroke|stroke
11881|NCT04124172|rTMS|rtms
11882|NCT04124172|upper limb rehabilitation|upper limb rehabilitation
11883|NCT04124094|bioequivalence|bioequivalence
11884|NCT04124094|fluticasone propionate|fluticasone propionate
11885|NCT04124094|salmeterol xinafoate|salmeterol xinafoate
11886|NCT04124094|SERETIDE|seretide
11887|NCT04124094|charcoal blockade|charcoal blockade
11895|NCT04124042|plasmid DNA|plasmid dna
11896|NCT04124029|Mild Traumatic Brain Injury|mild traumatic brain injury
11897|NCT04124029|Moderate Traumatic Brain Injury|moderate traumatic brain injury
11898|NCT04124029|Alzheimer's Disease|alzheimer's disease
11899|NCT04124029|Chronic Traumatic Encephalopathy|chronic traumatic encephalopathy
11900|NCT04124029|Neurodegeneration|neurodegeneration
11901|NCT04124016|flavan-3-ol|flavan-3-ol
11902|NCT04124016|phenyl-y-valerolactones|phenyl-y-valerolactones
11903|NCT04124016|catechins|catechins
11904|NCT04124016|metabotype|metabotype
11905|NCT04124016|gas production|gas production
11906|NCT04124016|gut microbiota|gut microbiota
11907|NCT04123977|thorax trauma|thorax trauma
11908|NCT04123977|head injury|head injury
11909|NCT04123977|Multi-modal analgesia|multi-modal analgesia
11910|NCT04123977|Paravertebral block|paravertebral block
11911|NCT04123977|Thoracic epidural|thoracic epidural
11912|NCT04123977|Serratus Block|serratus block
11913|NCT04123964|Peri-prosthetic infection|peri-prosthetic infection
11914|NCT04123964|Joint infection|joint infection
11915|NCT04123964|One-stage replacement|one-stage replacement
11916|NCT04123964|Broad-spectrum β -lactam|broad-spectrum β -lactam
11917|NCT04123951|Kidney Transplant|kidney transplant
11918|NCT04123951|Cardiovascular Disease|cardiovascular disease
11919|NCT04123951|Home-based Exercise|home-based exercise
11920|NCT04123951|Exercise|exercise
11921|NCT04123925|locally advanced colon|locally advanced colon
11922|NCT04123925|neoadjuvant|neoadjuvant
11923|NCT04123925|nivolumab|nivolumab
11924|NCT04123873|RECIPE|recipe
11925|NCT04123873|Hip arthroplasty|hip arthroplasty
11926|NCT04123873|Postoperative pain|postoperative pain
11927|NCT04123873|Analgesia|analgesia
11928|NCT04123873|Multimodal analgesia|multimodal analgesia
11929|NCT04123873|Non-opioid analgesia|non-opioid analgesia
11930|NCT04123873|Acute pain|acute pain
11931|NCT04123860|intralift|intralift
11932|NCT04123860|maxillery sinus lift|maxillery sinus lift
11933|NCT04123860|hydrodynamic ultrasonic|hydrodynamic ultrasonic
11934|NCT04123860|buccal pad fat|buccal pad fat
11935|NCT04123860|platelet rich fibrin|platelet rich fibrin
11936|NCT04123860|immediate dental implant|immediate dental implant
11937|NCT04123847|epidural stimulation|epidural stimulation
11938|NCT04123834|anterior cruciate ligament|anterior cruciate ligament
11939|NCT04123834|anterior cruciate ligament injury|anterior cruciate ligament injury
11940|NCT04123834|implantless ACL reconstruction|implantless acl reconstruction
11941|NCT04123834|press-fit fixation|press-fit fixation
11942|NCT04123808|Stroke|stroke
11943|NCT04123808|Hemiparesis|hemiparesis
11944|NCT04123808|Rehabilitation|rehabilitation
11945|NCT04123808|Upper Extremity|upper extremity
11946|NCT04123808|Neurological Rehabilitation|neurological rehabilitation
11947|NCT04123808|Neuronal Plasticity|neuronal plasticity
11948|NCT04123808|Brain-Computer Interfaces|brain-computer interfaces
11949|NCT04123808|Robotics|robotics
11950|NCT04123795|Chronic plaque psoriasis|chronic plaque psoriasis
11951|NCT04123795|Certolizumab pegol|certolizumab pegol
11952|NCT04123795|Cimzia|cimzia
11953|NCT04123795|Pediatric study|pediatric study
11954|NCT04123795|Phase 3|phase 3
11955|NCT04123730|Long Term Oxygen Treatment|long term oxygen treatment
11956|NCT04123730|Dyspnea|dyspnea
11957|NCT04123730|Physiotherapy|physiotherapy
11958|NCT04123704|triple negative|triple negative
11959|NCT04123704|metastatic breast cancer|metastatic breast cancer
11960|NCT04123704|sitravatinib|sitravatinib
11961|NCT04123691|cardio-respiratory events|cardio-respiratory events
11962|NCT04123691|preterm infants|preterm infants
11963|NCT04123691|transitional period|transitional period
11964|NCT04123691|desaturation|desaturation
11965|NCT04123691|bradycardia|bradycardia
11966|NCT04123691|apnea|apnea
11967|NCT04123665|Oral Health|oral health
11968|NCT04123665|Antiplaque|antiplaque
11969|NCT04123665|Gingivitis|gingivitis
11970|NCT04123652|Neuropathic pain|neuropathic pain
11971|NCT04123652|Fibromyalgia|fibromyalgia
11972|NCT04123652|Lidocaine infusion|lidocaine infusion
11973|NCT04123652|Ketamine infusion|ketamine infusion
11974|NCT04123652|Chronic pain|chronic pain
11982|NCT04123600|Hip Replacement|hip replacement
11983|NCT04123587|Sulfonylurea|sulfonylurea
11984|NCT04123574|Pancreas|pancreas
11985|NCT04123574|Cancer|cancer
11986|NCT04123574|Neoplasms|neoplasms
11987|NCT04123574|Pancreatic|pancreatic
11988|NCT04123548|Alternative for Autograft|alternative for autograft
11996|NCT04123496|memory|memory
11997|NCT04123496|attention|attention
11999|NCT04123483|Folate|folate
12000|NCT04123483|Omega-3 Fatty Acids|omega-3 fatty acids
12001|NCT04123483|Vitamins|vitamins
12002|NCT04123483|Women's Health|women's health
12003|NCT04123483|Dietary Supplements|dietary supplements
12004|NCT04123483|PMDD|pmdd
12005|NCT04123483|MRMD|mrmd
12006|NCT04123483|Menstrual Related Mood Disorder|menstrual related mood disorder
12007|NCT04123483|Premenstrual Tension|premenstrual tension
12008|NCT04123431|Total Hip Replacement|total hip replacement
12009|NCT04123431|Patient reported outcome measures|patient reported outcome measures
12010|NCT04123431|Post Market Clinical Follow-up / Post Market Surveillance|post market clinical follow-up / post market surveillance
12011|NCT04123418|Multiple Myeloma, phase 1|multiple myeloma, phase 1
12012|NCT04123405|acute uncomplicated rhinosinusitis, acetylcysteine|acute uncomplicated rhinosinusitis, acetylcysteine
12013|NCT04123379|Nivolumab|nivolumab
12014|NCT04123379|CCR2/5-inhibitor|ccr2/5-inhibitor
12015|NCT04123379|anti-IL-8|anti-il-8
12016|NCT04123327|Symptom preoccupation|symptom preoccupation
12017|NCT04123327|Atrial fibrillation|atrial fibrillation
12018|NCT04123327|Quality of Life|quality of life
12019|NCT04123327|Cardiac anxiety|cardiac anxiety
12023|NCT04123301|mixed depression|mixed depression
12024|NCT04123301|depressive disorder|depressive disorder
12025|NCT04123301|bipolar disorder|bipolar disorder
12026|NCT04123301|transcranial magnetic stimulation|transcranial magnetic stimulation
12027|NCT04123275|Validation studies|validation studies
12028|NCT04123275|Withholding treatment|withholding treatment
12029|NCT04123262|Tamoxifen|tamoxifen
12033|NCT04123184|Therapeutic patient education|therapeutic patient education
12034|NCT04123184|Having one child who as less than 6 years old|having one child who as less than 6 years old
12035|NCT04123184|Pediatric Dentistry|pediatric dentistry
12036|NCT04123184|Oral Health|oral health
12037|NCT04123184|Chronic Disease|chronic disease
12038|NCT04123171|Dementia|dementia
12039|NCT04123171|Cognitive performance|cognitive performance
12040|NCT04123171|Vascular diseases|vascular diseases
12041|NCT04123171|Rural Ecuador|rural ecuador
12042|NCT04123171|Atahualpa|atahualpa
12043|NCT04123171|El Tambo|el tambo
12044|NCT04123171|Prosperidad|prosperidad
12045|NCT04123171|Three villages study|three villages study
12046|NCT04123158|Ultrasound|ultrasound
12047|NCT04123158|Myoma|myoma
12048|NCT04123158|MRI|mri
12049|NCT04123132|kinesiophobia|kinesiophobia
12050|NCT04123132|metabolic syndrome|metabolic syndrome
12051|NCT04123132|exercise|exercise
12052|NCT04123106|Analgesia, Patient-Controlled|analgesia, patient-controlled
12053|NCT04123106|Anesthetics, Local|anesthetics, local
12054|NCT04123106|Pain, Postoperative|pain, postoperative
12055|NCT04123080|Colonic Polyp|colonic polyp
12056|NCT04123080|Endoscopic mucosal resection|endoscopic mucosal resection
12057|NCT04123054|Multiple Daily Injections,|multiple daily injections,
12058|NCT04123054|Type 1 diabetes|type 1 diabetes
12059|NCT04123054|Optimization algorithm|optimization algorithm
12060|NCT04123041|Electronic Nicotine Delivery System|electronic nicotine delivery system
12061|NCT04123041|Combustible Cigarettes|combustible cigarettes
12062|NCT04123041|Nicotine|nicotine
12063|NCT04123002|P.gingivalis|p.gingivalis
12064|NCT04123002|Miswak|miswak
12065|NCT04122950|Exercise therapy|exercise therapy
12066|NCT04122950|Physical fitness|physical fitness
12067|NCT04122950|Gaming|gaming
12068|NCT04122950|Child|child
12069|NCT04122950|Healthy lifestyle|healthy lifestyle
12070|NCT04122950|Fitness testing|fitness testing
12071|NCT04122937|peritoneal carcinomatosis|peritoneal carcinomatosis
12072|NCT04122937|colon cancer|colon cancer
12073|NCT04122937|ovarian cancer|ovarian cancer
12074|NCT04122937|P2X7R-inflammasome|p2x7r-inflammasome
12075|NCT04122924|Postpartum|postpartum
12076|NCT04122924|Abdominal Muscle Training|abdominal muscle training
12077|NCT04122924|Exercise|exercise
12078|NCT04122911|Temozolomide|temozolomide
12079|NCT04122911|second-line chemotherapy|second-line chemotherapy
12080|NCT04122885|HIPEC|hipec
12081|NCT04122885|PIPAC|pipac
12082|NCT04122885|cytoreductive surgery|cytoreductive surgery
12083|NCT04122885|immune function|immune function
12084|NCT04122885|cytokines|cytokines
12085|NCT04122885|plasma proteins|plasma proteins
12086|NCT04122872|Sarcoma|sarcoma
12087|NCT04122872|Soft Tissue Sarcoma|soft tissue sarcoma
12094|NCT04122820|Specific Developmental Disorders of Speech and Language|specific developmental disorders of speech and language
12096|NCT04122820|Dyspraxia|dyspraxia
12097|NCT04122807|AVNRT|avnrt
12098|NCT04122807|Cryoablation|cryoablation
12099|NCT04122807|PR interval|pr interval
12100|NCT04122794|Endothelial Cells|endothelial cells
12101|NCT04122781|supracondylar humerus fracture|supracondylar humerus fracture
12102|NCT04122781|Kirschner wire|kirschner wire
12103|NCT04122768|physical activity|physical activity
12104|NCT04122768|tele coaching|tele coaching
12105|NCT04122768|comorbidities|comorbidities
12106|NCT04122742|Epigenetics|epigenetics
12107|NCT04122742|Acetylation|acetylation
12108|NCT04122742|Diagnostic|diagnostic
12109|NCT04122742|Induced pluripotent stem cells|induced pluripotent stem cells
12110|NCT04122742|Rubinstein-Taybi syndrome|rubinstein-taybi syndrome
12111|NCT04122729|Highly purified human follicle stimulating hormone (HP-FSH)|highly purified human follicle stimulating hormone (hp-fsh)
12112|NCT04122729|Recombinant follicle stimulating hormone (rFSH)|recombinant follicle stimulating hormone (rfsh)
12113|NCT04122729|FSH receptor (FSHR)|fsh receptor (fshr)
12114|NCT04122729|Polymorphism N680S of the FSHR|polymorphism n680s of the fshr
12115|NCT04122729|Polymorphism N312S of the LHCGR|polymorphism n312s of the lhcgr
12116|NCT04122729|LHCG receptor (LHCGR)|lhcg receptor (lhcgr)
12117|NCT04122729|Polymorphism c.2039G>A|polymorphism c.2039g>a
12118|NCT04122729|Polymorphism c.935A>G|polymorphism c.935a>g
12119|NCT04122716|Weight loss maintenance|weight loss maintenance
12120|NCT04122716|Immunometabolic health|immunometabolic health
12121|NCT04122716|Exercise intervention|exercise intervention
12122|NCT04122716|GLP-1 receptor agonist (liraglutide)|glp-1 receptor agonist (liraglutide)
12123|NCT04122703|Percutaneous Tibial Nerve Stimulation|percutaneous tibial nerve stimulation
12124|NCT04122703|Female Sexual Dysfunction|female sexual dysfunction
12125|NCT04122703|Sexual dysfunction|sexual dysfunction
12126|NCT04122703|peripheral neuromodulation|peripheral neuromodulation
12127|NCT04122690|motor control|motor control
12128|NCT04122690|Parkinson disease|parkinson disease
12129|NCT04122690|exercise|exercise
12130|NCT04122690|neural imaging|neural imaging
12131|NCT04122690|dance|dance
12132|NCT04122690|spatial cognition|spatial cognition
12133|NCT04122690|executive function|executive function
12134|NCT04122690|substantia nigra|substantia nigra
12135|NCT04122690|neurodegeneration|neurodegeneration
12136|NCT04122690|rehabilitation|rehabilitation
12137|NCT04122677|Knee Ligament Injury|knee ligament injury
12138|NCT04122677|Anterior Cruciate Ligament Rupture|anterior cruciate ligament rupture
12139|NCT04122677|Anterior Cruciate Ligament Reconstruction|anterior cruciate ligament reconstruction
12140|NCT04122677|Knee Ligament Rupture|knee ligament rupture
12141|NCT04122677|Knee Ligament Reconstruction|knee ligament reconstruction
12142|NCT04122638|Older adults|older adults
12143|NCT04122612|microbiota|microbiota
12144|NCT04122612|1000 days|1000 days
12145|NCT04122612|maternal lifestyle|maternal lifestyle
12146|NCT04122612|diet|diet
12147|NCT04122612|pregnancy|pregnancy
12148|NCT04122599|Melatonin|melatonin
12149|NCT04122586|IBS-D|ibs-d
12158|NCT04122560|fluconazole|fluconazole
12159|NCT04122560|candidiasis|candidiasis
12160|NCT04122560|invasive fungal infections|invasive fungal infections
12161|NCT04122560|mycoses|mycoses
12162|NCT04122560|antifungal agents|antifungal agents
12163|NCT04122547|Bronchiectasis|bronchiectasis
12164|NCT04122547|roflumilast|roflumilast
12165|NCT04122547|exacerbation|exacerbation
12166|NCT04122547|lung function|lung function
12167|NCT04122508|anxiety|anxiety
12168|NCT04122508|siblings|siblings
12169|NCT04122508|dental caries|dental caries
12170|NCT04122508|oral health|oral health
12171|NCT04122508|child abuse|child abuse
12172|NCT04122495|probiotic|probiotic
12173|NCT04122495|respiratory tract infections|respiratory tract infections
12174|NCT04122495|Bifidobacterium|bifidobacterium
12175|NCT04122495|children|children
12176|NCT04122482|Mental health accommodation|mental health accommodation
12177|NCT04122482|Small- to mid-sized enterprises|small- to mid-sized enterprises
12178|NCT04122482|Psychoeducation|psychoeducation
12179|NCT04122482|ICBT|icbt
12180|NCT04122469|SBRT|sbrt
12181|NCT04122417|Therapeutic touch|therapeutic touch
12182|NCT04122417|yakson|yakson
12183|NCT04122417|gentle human touch|gentle human touch
12187|NCT04122404|Tuberculosis/Diagnosis|tuberculosis/diagnosis
12189|NCT04122404|Lipopolysaccharides/urine|lipopolysaccharides/urine
12190|NCT04122404|Audit intervention|audit intervention
12191|NCT04122404|Diagnostic tests/Routine|diagnostic tests/routine
12192|NCT04122404|Ultrasound|ultrasound
12193|NCT04122404|Bedside|bedside
12194|NCT04122404|Biobank|biobank
12195|NCT04122404|Stepped wedge cluster randomised trial|stepped wedge cluster randomised trial
12196|NCT04122404|Multicenter study|multicenter study
12197|NCT04122404|Audit and feedback|audit and feedback
12198|NCT04122404|Ghana|ghana
12199|NCT04122404|Adult|adult
12200|NCT04122404|Hospitalization|hospitalization
12201|NCT04122391|simulation|simulation
12202|NCT04122391|cardiac arrest|cardiac arrest
12203|NCT04122391|perioperative cardiac arrest|perioperative cardiac arrest
12204|NCT04122378|Pain, Acupuncture|pain, acupuncture
12205|NCT04122365|Chest Wall Mobilization Program|chest wall mobilization program
12206|NCT04122365|Respiratory Function|respiratory function
12207|NCT04122352|temporomandibular joint|temporomandibular joint
12208|NCT04122352|trigger points|trigger points
12209|NCT04122352|myofascial pain syndrome|myofascial pain syndrome
12210|NCT04122339|PD-1/L1|pd-1/l1
12211|NCT04122339|immunotherapy|immunotherapy
12212|NCT04122339|advanced solid tumors|advanced solid tumors
12213|NCT04122287|Allergic|allergic
12214|NCT04122287|Penicillin|penicillin
12215|NCT04122287|Helicobacter pylori|helicobacter pylori
12216|NCT04122287|Eradication|eradication
12217|NCT04122287|Tetracycline|tetracycline
12218|NCT04122274|Concussion, Education|concussion, education
12224|NCT04122222|ESRD|esrd
12225|NCT04122222|hemodialysis|hemodialysis
12226|NCT04122222|hemodiafiltration|hemodiafiltration
12227|NCT04122222|influenza vaccine|influenza vaccine
12228|NCT04122222|immune response|immune response
12229|NCT04122209|Nutritional|nutritional
12230|NCT04122209|Metabolic|metabolic
12231|NCT04122209|Endocrine|endocrine
12232|NCT04122183|Hearing Screening, Auditory Rehabilitation|hearing screening, auditory rehabilitation
12233|NCT04122157|Uncoated SL PLUS® MIA stem|uncoated sl plus® mia stem
12234|NCT04122144|pregnant woman|pregnant woman
12235|NCT04122092|Multiple myeloma|multiple myeloma
12236|NCT04122092|Minimal residual disease|minimal residual disease
12237|NCT04122092|Chromosomal aneuploidy detection|chromosomal aneuploidy detection
12238|NCT04122092|Chromosomal instability|chromosomal instability
12239|NCT04122079|CORE-OM|core-om
12240|NCT04122079|Outcome measures|outcome measures
12241|NCT04122079|Psychometric validation|psychometric validation
12242|NCT04122079|Psychological distress|psychological distress
12243|NCT04122053|intake|intake
12244|NCT04122053|caffeine|caffeine
12245|NCT04122053|coffee|coffee
12246|NCT04122053|genotype|genotype
12247|NCT04122053|personalized nutrition|personalized nutrition
12248|NCT04122040|Bronchiectasis|bronchiectasis
12249|NCT04122040|quality of life|quality of life
12250|NCT04122040|pulmonary function tests|pulmonary function tests
12251|NCT04122001|transcranial direct current stimulation (tDCS)|transcranial direct current stimulation (tdcs)
12252|NCT04122001|Alzheimer's Disease (AD)|alzheimer's disease (ad)
12253|NCT04122001|verbal learning treatment|verbal learning treatment
12254|NCT04122001|word list learning|word list learning
12255|NCT04122001|logopenic Progressive Aphasia|logopenic progressive aphasia
12256|NCT04122001|episodic memory|episodic memory
12257|NCT04121962|Black MSM|black msm
12258|NCT04121962|Social network|social network
12259|NCT04121949|coronary artery disease|coronary artery disease
12260|NCT04121949|diagnostic strategies|diagnostic strategies
12261|NCT04121910|Pharmacokinetics|pharmacokinetics
12262|NCT04121910|Safety|safety
12263|NCT04121910|Small molecule kinase inhibitor|small molecule kinase inhibitor
12264|NCT04121910|Open-label|open-label
12265|NCT04121884|Heart Rate Variability|heart rate variability
12266|NCT04121884|Sleep|sleep
12267|NCT04121884|Electrocardiogram|electrocardiogram
12268|NCT04121884|Electroencephlogram|electroencephlogram
12269|NCT04121884|Alcohol Abuse|alcohol abuse
12270|NCT04121884|Prolonged Grief Disorder|prolonged grief disorder
12271|NCT04121884|Stress Disorder, Acute|stress disorder, acute
12272|NCT04121884|Stress Disorders, Post-Traumatic|stress disorders, post-traumatic
12273|NCT04121884|Depressive Symptoms|depressive symptoms
12274|NCT04121884|Power Spectral Density|power spectral density
12275|NCT04121871|Candida auris|candida auris
12276|NCT04121871|Oral Fungal Infection|oral fungal infection
12277|NCT04121871|Candidiasis|candidiasis
12278|NCT04121858|anticholinergic|anticholinergic
12279|NCT04121858|cognitive function|cognitive function
12280|NCT04121858|brain|brain
12281|NCT04121858|aging|aging
12282|NCT04121845|angina pectoris|angina pectoris
12283|NCT04121845|coronary sinus reducer|coronary sinus reducer
12284|NCT04121845|quality of life|quality of life
12285|NCT04121845|reversible ischemia|reversible ischemia
12286|NCT04121845|exercise testing|exercise testing
12287|NCT04121845|oxygen consumption|oxygen consumption
12288|NCT04121819|Langerhans cell histiocytosis|langerhans cell histiocytosis
12289|NCT04121819|adult|adult
12290|NCT04121819|newly diagnosed|newly diagnosed
12292|NCT04121780|GHD|ghd
12293|NCT04121780|Growth Hormone|growth hormone
12294|NCT04121780|Norditropin Flexpro|norditropin flexpro
12295|NCT04121780|cognition disorders|cognition disorders
12296|NCT04121767|atrial fibrillation|atrial fibrillation
12297|NCT04121767|thoracoscopic ablation|thoracoscopic ablation
12298|NCT04121767|anticoagulation|anticoagulation
12299|NCT04121741|Singing|singing
12300|NCT04121728|metrological characteristics of EEG-ERP|metrological characteristics of eeg-erp
12301|NCT04121728|Ginkgo Biloba|ginkgo biloba
12302|NCT04121715|coronary heart disease|coronary heart disease
12303|NCT04121715|fastigial nucleus stimulation|fastigial nucleus stimulation
12304|NCT04121715|inflammatory factors|inflammatory factors
12305|NCT04121702|Cardiac Rehabilitation|cardiac rehabilitation
12306|NCT04121702|Telerehabilitation|telerehabilitation
12307|NCT04121702|Secondary Prevention|secondary prevention
12308|NCT04121702|Wearable Electronic Devices|wearable electronic devices
12309|NCT04121702|Exercise Therapy|exercise therapy
12310|NCT04121689|Protein|protein
12311|NCT04121689|Amino Acids|amino acids
12312|NCT04121689|Anabolic Signaling|anabolic signaling
12313|NCT04121689|Muscle Mass|muscle mass
12314|NCT04121663|Shoulder instability|shoulder instability
12315|NCT04121663|Rotator cuff injury|rotator cuff injury
12316|NCT04121650|Executive Functioning|executive functioning
12317|NCT04121650|ADHD|adhd
12318|NCT04121650|Behavior Problems|behavior problems
12319|NCT04121650|Youth|youth
12320|NCT04121650|CPS|cps
12321|NCT04121650|Collaborative Problem Solving|collaborative problem solving
12322|NCT04121650|Disruptive Behavior|disruptive behavior
12323|NCT04121650|Parenting|parenting
12324|NCT04121611|Basilar|basilar
12325|NCT04121611|Stroke|stroke
12326|NCT04121611|Thrombus|thrombus
12327|NCT04121611|Optical Coherence Tomography|optical coherence tomography
12328|NCT04121598|Working Memory|working memory
12329|NCT04121598|Executive Functioning|executive functioning
12330|NCT04121598|Loss of Control Eating|loss of control eating
12331|NCT04121585|HA (hydroxylapatite) coated SL-PLUS™ stem|ha (hydroxylapatite) coated sl-plus™ stem
12332|NCT04121572|Diabetic ketoacidosis|diabetic ketoacidosis
12333|NCT04121572|End tidal carbon dioxide|end tidal carbon dioxide
12334|NCT04121572|Capnography|capnography
12335|NCT04121559|Adolescent Nutrition|adolescent nutrition
12336|NCT04121559|Ethiopia|ethiopia
12337|NCT04121494|ChAdOx1 85A|chadox1 85a
12338|NCT04121494|Tuberculosis|tuberculosis
12339|NCT04121494|vaccination|vaccination
12340|NCT04121494|BCG|bcg
12341|NCT04121494|Mucosal|mucosal
12342|NCT04121494|Inhaled vaccine|inhaled vaccine
12343|NCT04121481|Prodovite VMP35; RCT; Athletic Performance|prodovite vmp35; rct; athletic performance
12344|NCT04121468|remyelination|remyelination
12345|NCT04121468|youth|youth
12346|NCT04121468|white matter|white matter
12347|NCT04121468|neural precursor cells|neural precursor cells
12348|NCT04121468|clinical trial|clinical trial
12349|NCT04121468|metformin|metformin
12350|NCT04121455|Glioblastoma|glioblastoma
12351|NCT04121455|NOX-A12|nox-a12
12352|NCT04121455|Olaptesed pegol|olaptesed pegol
12353|NCT04121455|Spiegelmer|spiegelmer
12354|NCT04121455|Stromal cell-derived factor-1 (SDF-1)|stromal cell-derived factor-1 (sdf-1)
12355|NCT04121455|CXCL12|cxcl12
12356|NCT04121455|Radiation|radiation
12357|NCT04121455|MGMT promoter|mgmt promoter
12358|NCT04121455|Brain tumor|brain tumor
12359|NCT04121455|Radiotherapy|radiotherapy
12360|NCT04121455|Brain cancer|brain cancer
12361|NCT04121455|Tumor microenvironment|tumor microenvironment
12362|NCT04121416|Oxycodone|oxycodone
12363|NCT04121416|Sufentanil|sufentanil
12364|NCT04121416|tracheal intubation|tracheal intubation
12365|NCT04121403|multiple sclerosis|multiple sclerosis
12366|NCT04121403|ms|ms
12367|NCT04121403|rms|rms
12368|NCT04121403|rituximab|rituximab
12369|NCT04121403|cladribine|cladribine
12370|NCT04121403|probe|probe
12371|NCT04121390|Newborn care|newborn care
12372|NCT04121390|Maternal anxiety|maternal anxiety
12373|NCT04121390|Maternal self-efficacy|maternal self-efficacy
12374|NCT04121390|Newborn care knowledge|newborn care knowledge
12375|NCT04121390|Developmental trajectory|developmental trajectory
12376|NCT04121390|Positive parenting|positive parenting
12377|NCT04121351|Lung Health|lung health
12378|NCT04121351|Exercises|exercises
12379|NCT04121338|celiac ganglion block|celiac ganglion block
12380|NCT04121338|resection|resection
12381|NCT04121338|bowel dysmotility|bowel dysmotility
12382|NCT04121286|Src homology phosphatase 2 (SHP2)|src homology phosphatase 2 (shp2)
12383|NCT04121286|PTPN11|ptpn11
12577|NCT04120103|Cognitive status|cognitive status
12384|NCT04121286|Kirsten rat sarcoma (KRAS) proto-oncogene, GTPase|kirsten rat sarcoma (kras) proto-oncogene, gtpase
12385|NCT04121286|epidermal growth factor receptor (EGFR)|epidermal growth factor receptor (egfr)
12386|NCT04121273|chimeric antigen receptor T cell (CAR- T)|chimeric antigen receptor t cell (car- t)
12387|NCT04121273|glypican-3 (GPC3)|glypican-3 (gpc3)
12388|NCT04121273|hepatocellular carcinoma (HCC)|hepatocellular carcinoma (hcc)
12389|NCT04121247|sickle cell disease|sickle cell disease
12390|NCT04121247|nonpharmacological approaches|nonpharmacological approaches
12391|NCT04121247|pain|pain
12392|NCT04121247|parent|parent
12393|NCT04121247|nurse|nurse
12394|NCT04121234|High dependency unit; critical care; obstetric critical care; maternal mortality.|high dependency unit; critical care; obstetric critical care; maternal mortality.
12395|NCT04121221|Multiple Sclerosis|multiple sclerosis
12396|NCT04121221|RMS|rms
12397|NCT04121221|GA Depot|ga depot
12398|NCT04121221|Multiple Sclerosis, Relapsing-Remitting|multiple sclerosis, relapsing-remitting
12399|NCT04121182|Nursing home|nursing home
12400|NCT04121182|Prevention|prevention
12401|NCT04121117|Chronic obstructive pulmonary disease|chronic obstructive pulmonary disease
12402|NCT04121117|COPD|copd
12403|NCT04121117|Chronic obstructive pulmonary disease population questionnaire|chronic obstructive pulmonary disease population questionnaire
12404|NCT04121117|COPD-PS|copd-ps
12405|NCT04121117|COPD-6|copd-6
12406|NCT04121104|Spinal cord stimulation|spinal cord stimulation
12407|NCT04121104|Electrodermal activity|electrodermal activity
12408|NCT04121078|Drug Therapy|drug therapy
12409|NCT04121065|ADA|ada
12410|NCT04121065|Genetic polymorphism|genetic polymorphism
12411|NCT04121065|Relapsing Multiple Sclerosis|relapsing multiple sclerosis
12412|NCT04121065|Immune-reconstitution therapy|immune-reconstitution therapy
12413|NCT04121065|2-CdA|2-cda
12414|NCT04121065|single nucleotide polymorphisms|single nucleotide polymorphisms
12415|NCT04121065|lymphopenia induced by 2-CdA treatment|lymphopenia induced by 2-cda treatment
12416|NCT04121065|ADA genetic variant rs244072|ada genetic variant rs244072
12417|NCT04121065|non-risk/risk allele T/C|non-risk/risk allele t/c
12418|NCT04121013|thrombectomy|thrombectomy
12419|NCT04121013|drip'n'ship versus mothership|drip'n'ship versus mothership
12420|NCT04121013|cost/effectiveness|cost/effectiveness
12421|NCT04121000|Erector Spinae Block,|erector spinae block,
12422|NCT04121000|VATS|vats
12423|NCT04120987|cataract|cataract
12424|NCT04120987|lifitegrast|lifitegrast
12425|NCT04120987|dry eye syndrome|dry eye syndrome
12426|NCT04120987|ocular surface inflammation|ocular surface inflammation
12427|NCT04120987|hyperosmolarity|hyperosmolarity
12428|NCT04120987|MMP-9|mmp-9
12429|NCT04120961|bivalirudin|bivalirudin
12430|NCT04120961|delayed use|delayed use
12431|NCT04120961|peri-operative myocardial injury|peri-operative myocardial injury
12432|NCT04120961|percutaneous coronary intervention|percutaneous coronary intervention
12433|NCT04120922|Dialysis|dialysis
12434|NCT04120922|chronic kidney disease stage 4-5|chronic kidney disease stage 4-5
12435|NCT04120922|calcium isotope ratio|calcium isotope ratio
12436|NCT04120922|bone mineral content|bone mineral content
12437|NCT04120922|Calcium isotope fractions δ44/42Ca|calcium isotope fractions δ44/42ca
12438|NCT04120909|cardiac resynchronization therapy, non-LBBB, QRS area|cardiac resynchronization therapy, non-lbbb, qrs area
12439|NCT04120883|P23H-RHO|p23h-rho
12440|NCT04120883|eye disease|eye disease
12441|NCT04120870|etomidate|etomidate
12442|NCT04120870|ketamine|ketamine
12443|NCT04120870|rapid sequence intubation|rapid sequence intubation
12444|NCT04120870|trauma|trauma
12445|NCT04120870|hemodynamics|hemodynamics
12446|NCT04120857|stretching|stretching
12447|NCT04120857|exercise|exercise
12448|NCT04120844|Type 2 diabete|type 2 diabete
12449|NCT04120844|Motivational interviewing|motivational interviewing
12450|NCT04120844|Patient empowerment|patient empowerment
12451|NCT04120844|Self-management|self-management
12452|NCT04120844|China|china
12453|NCT04120818|inflammatory cytokines|inflammatory cytokines
12454|NCT04120779|e-health intervention|e-health intervention
12455|NCT04120779|self-management|self-management
12456|NCT04120779|primary care|primary care
12457|NCT04120779|chronic care model|chronic care model
12458|NCT04120766|TDP-43|tdp-43
12459|NCT04120766|Hippocampal sclerosis|hippocampal sclerosis
12460|NCT04120740|Validility|validility
12461|NCT04120740|Activity moitoring|activity moitoring
12462|NCT04120727|Osteoarthritis|osteoarthritis
12463|NCT04120727|eHealth|ehealth
12464|NCT04120727|therapeutic education|therapeutic education
12465|NCT04120727|Connected objects|connected objects
12466|NCT04120675|extra virgin olive oil|extra virgin olive oil
12467|NCT04120675|primary (PPMS) progressive multiple sclerosis|primary (ppms) progressive multiple sclerosis
12468|NCT04120675|secondary (SPMS) progressive multiple sclerosis|secondary (spms) progressive multiple sclerosis
12469|NCT04120675|randomized double blind clinical trial|randomized double blind clinical trial
12470|NCT04120675|cognition|cognition
12471|NCT04120636|Macula Edema|macula edema
12472|NCT04120636|Radiation Retinopathy|radiation retinopathy
12473|NCT04120636|Branch Retinal Vein Occlusion|branch retinal vein occlusion
12474|NCT04120636|Epiretinal Membrane|epiretinal membrane
19239|NCT04077320|memory|memory
12475|NCT04120636|Central Serous Retinopathy with Pit of Optic Disc|central serous retinopathy with pit of optic disc
12476|NCT04120636|Commotio Retinae|commotio retinae
12477|NCT04120636|Vitritis|vitritis
12478|NCT04120623|Continuous Glucose Monitoring System (CGMS)|continuous glucose monitoring system (cgms)
12479|NCT04120623|Dapagliflozin|dapagliflozin
12480|NCT04120623|Continuous Subcutaneous Insulin Infusion ( CSII)|continuous subcutaneous insulin infusion ( csii)
12481|NCT04120610|Peripheral Artery Disease|peripheral artery disease
12482|NCT04120610|Claudication|claudication
12483|NCT04120610|Critical Limb Ischemia|critical limb ischemia
12484|NCT04120545|physical therapy modality|physical therapy modality
12485|NCT04120545|Electric Stimulation Therapy|electric stimulation therapy
12486|NCT04120545|Urologic Diseases|urologic diseases
12487|NCT04120545|Pelvic Floor Disorders|pelvic floor disorders
12488|NCT04120532|rehabilitation|rehabilitation
12489|NCT04120532|Lumbar degenerative disease|lumbar degenerative disease
12490|NCT04120532|Low Back Pain|low back pain
12491|NCT04120519|Langerhans cell histiocytosis|langerhans cell histiocytosis
12492|NCT04120519|adult|adult
12493|NCT04120519|recurrent/refractory|recurrent/refractory
12494|NCT04120493|Gene therapy|gene therapy
12495|NCT04120493|AAV (adeno-associated virus)|aav (adeno-associated virus)
12496|NCT04120493|serotype 5 AAV (adeno-associated virus)|serotype 5 aav (adeno-associated virus)
12497|NCT04120493|serotype 5|serotype 5
12498|NCT04120493|Viral vector|viral vector
12499|NCT04120493|miHTT|mihtt
12500|NCT04120493|muHTT|muhtt
12501|NCT04120493|Huntington Disease (HD)|huntington disease (hd)
12502|NCT04120480|Genomics|genomics
12503|NCT04120467|Stroke|stroke
12504|NCT04120467|Rehabilitation|rehabilitation
12505|NCT04120467|Dance|dance
12506|NCT04120428|Aquatic exercise|aquatic exercise
12507|NCT04120428|Obstructive sleep apnea syndrome|obstructive sleep apnea syndrome
12508|NCT04120428|Sleep|sleep
12509|NCT04120389|Bandage contact lens|bandage contact lens
12510|NCT04120389|cataract surgery|cataract surgery
12511|NCT04120389|dry eye|dry eye
12512|NCT04120376|Contraception counseling|contraception counseling
12513|NCT04120376|Adolescent pregnancy|adolescent pregnancy
12514|NCT04120376|Contraception initiation|contraception initiation
12515|NCT04120363|testosterone|testosterone
12516|NCT04120363|anabolism|anabolism
12517|NCT04120363|muscle mass|muscle mass
12518|NCT04120363|military operational stress|military operational stress
12519|NCT04120350|lenalidomide|lenalidomide
12520|NCT04120350|rituximab|rituximab
12521|NCT04120350|methorexate|methorexate
12522|NCT04120350|Primary Central Nervous System Lymphoma|primary central nervous system lymphoma
12523|NCT04120350|maintenance therapy|maintenance therapy
12524|NCT04120324|complication|complication
12525|NCT04120324|surgery|surgery
12526|NCT04120311|Macular Edema|macular edema
12527|NCT04120311|Radiation Retinopathy|radiation retinopathy
12528|NCT04120311|Branch Retinal Vein Occlusion|branch retinal vein occlusion
12529|NCT04120311|Epiretinal Membrane|epiretinal membrane
12530|NCT04120311|Central Serous Retinopathy with Pit of Optic Disc|central serous retinopathy with pit of optic disc
12531|NCT04120311|Commotio Retinae|commotio retinae
12532|NCT04120311|Vitritis|vitritis
12533|NCT04120298|exercise|exercise
12534|NCT04120298|cancer-related fatigue|cancer-related fatigue
12535|NCT04120298|quality of life|quality of life
12536|NCT04120285|Depression|depression
12537|NCT04120285|eCBT|ecbt
12538|NCT04120246|Breast - Female|breast - female
12539|NCT04120246|Breast - Male|breast - male
12540|NCT04120246|HER2+|her2+
12541|NCT04120246|metastatic|metastatic
12542|NCT04120246|refractory|refractory
12543|NCT04120246|immunotherapy|immunotherapy
12544|NCT04120246|breast|breast
12545|NCT04120233|cognitive disorder|cognitive disorder
12546|NCT04120233|pharmacokinetics|pharmacokinetics
12547|NCT04120233|MW151|mw151
12548|NCT04120233|MW01-2-151SRM|mw01-2-151srm
12550|NCT04120233|dose escalation|dose escalation
12551|NCT04120220|Normal weight|normal weight
12552|NCT04120207|Pilates|pilates
12553|NCT04120207|Home-based|home-based
12554|NCT04120207|Anxiety|anxiety
12555|NCT04120207|Depression|depression
12556|NCT04120207|Fatigue|fatigue
12557|NCT04120181|Neutrophil-to-lymphocyte ratio|neutrophil-to-lymphocyte ratio
12558|NCT04120181|Platelet-to-lymphocyte ratio|platelet-to-lymphocyte ratio
12559|NCT04120181|cochlear implant|cochlear implant
12560|NCT04120181|artificial implant|artificial implant
12561|NCT04120181|infection|infection
12562|NCT04120168|CPK|cpk
12563|NCT04120168|Transaminase|transaminase
12564|NCT04120168|DMD|dmd
12565|NCT04120168|Pompe|pompe
12566|NCT04120142|COPD|copd
12567|NCT04120142|IMT|imt
12568|NCT04120142|6MWT|6mwt
12569|NCT04120142|Dyspoea|dyspoea
12570|NCT04120142|SGRQ|sgrq
12571|NCT04120129|trigmenial neuralgia|trigmenial neuralgia
12572|NCT04120129|Chronic orofacial pain|chronic orofacial pain
804399|NCT00236951|Cancer|cancer
12573|NCT04120116|Intratympanic Administration|intratympanic administration
12574|NCT04120116|Restoration of Hearing Function|restoration of hearing function
12575|NCT04120103|Dementia|dementia
12578|NCT04120103|Doll therapy|doll therapy
12579|NCT04120051|Gut Microbiota|gut microbiota
12580|NCT04120051|Metabolic syndrome|metabolic syndrome
12581|NCT04120051|Obesity|obesity
12582|NCT04120051|Supplement|supplement
12583|NCT04120038|Occupational Therapy|occupational therapy
12584|NCT04120038|Rehabilitation|rehabilitation
12585|NCT04120038|Lower-Limb Amputations|lower-limb amputations
12586|NCT04120038|Amputees|amputees
12587|NCT04120038|Telehealth|telehealth
12588|NCT04120038|Remote Rehabilitation|remote rehabilitation
12589|NCT04120038|Telerehabilitation|telerehabilitation
12590|NCT04120038|E-learning|e-learning
12591|NCT04120038|Education|education
12592|NCT04120038|Self-Management|self-management
12593|NCT04120038|Ambulation|ambulation
12594|NCT04120038|Coping Strategies|coping strategies
12595|NCT04120038|Outcomes|outcomes
12596|NCT04120038|Prevalence|prevalence
12597|NCT04120025|Reflux|reflux
12598|NCT04120025|Heartburn|heartburn
12599|NCT04120012|Frailty|frailty
12600|NCT04120012|Intraoperative Hypotension|intraoperative hypotension
12601|NCT04120012|Perioperative Complication|perioperative complication
12602|NCT04120012|Elderly|elderly
12603|NCT04119999|sleep|sleep
12604|NCT04119999|remodeling|remodeling
12605|NCT04119999|blood pressure|blood pressure
12606|NCT04119999|trial|trial
12607|NCT04119986|Quantitative flow ratio|quantitative flow ratio
12608|NCT04119986|drug coated balloon|drug coated balloon
12609|NCT04119986|Drug eluted stent|drug eluted stent
12610|NCT04119986|In-stent restenosis|in-stent restenosis
12611|NCT04119973|Thrombelastography|thrombelastography
12612|NCT04119973|Acute on Chronic Liver Failure|acute on chronic liver failure
12613|NCT04119973|Platelet|platelet
12614|NCT04119973|Multicenter Prospective Study|multicenter prospective study
12615|NCT04119934|Chronic obstructive pulmonary disease|chronic obstructive pulmonary disease
12616|NCT04119934|COPD|copd
12617|NCT04119934|smoking cessation|smoking cessation
12618|NCT04119934|smoking|smoking
12619|NCT04119908|constitutional haemorrhagic diseases, Videomicroscopy, prediction, bleeding|constitutional haemorrhagic diseases, videomicroscopy, prediction, bleeding
12620|NCT04119908|Videomicroscopy|videomicroscopy
12621|NCT04119908|prediction|prediction
12622|NCT04119908|bleeding|bleeding
12623|NCT04119895|Electric stimulation|electric stimulation
12624|NCT04119895|Ultrasonography|ultrasonography
12625|NCT04119895|Exercise Therapy|exercise therapy
12626|NCT04119895|Rehabilitation|rehabilitation
12627|NCT04119882|Acute Coronary Syndrome|acute coronary syndrome
12628|NCT04119882|Myocardial Infarction|myocardial infarction
12629|NCT04119882|Diagnosis|diagnosis
12630|NCT04119882|Prognosis|prognosis
12631|NCT04119882|Risk stratification|risk stratification
12632|NCT04119869|Cancer|cancer
12633|NCT04119869|Young Adults|young adults
12634|NCT04119869|Behavioral Intervention|behavioral intervention
12635|NCT04119869|Smartphone Application|smartphone application
12636|NCT04119856|Cross-sectorial|cross-sectorial
12637|NCT04119856|Hospitalization|hospitalization
12638|NCT04119856|Self-efficacy|self-efficacy
12639|NCT04119856|Patient Involvement|patient involvement
12640|NCT04119856|Health Literacy|health literacy
12641|NCT04119856|Anxiety|anxiety
12642|NCT04119817|Gastrointestinal symptoms|gastrointestinal symptoms
12643|NCT04119817|Nausea|nausea
12644|NCT04119817|Heartburn|heartburn
12645|NCT04119817|Reflux|reflux
12646|NCT04119804|periprosthetic hip infection|periprosthetic hip infection
12647|NCT04119804|cellular neural networks|cellular neural networks
12648|NCT04119804|genetic algorithm|genetic algorithm
12649|NCT04119804|radiography|radiography
12650|NCT04119804|accuracy|accuracy
12651|NCT04119804|early discrimination|early discrimination
12652|NCT04119752|Curcumin|curcumin
12653|NCT04119752|Endothelial dysfunction|endothelial dysfunction
12654|NCT04119752|Aging|aging
12655|NCT04119752|muscle oxygen saturation|muscle oxygen saturation
12656|NCT04119739|Ibuprofen|ibuprofen
12657|NCT04119739|Median nerve neural mobilization|median nerve neural mobilization
12658|NCT04119739|Waiting list control group|waiting list control group
12659|NCT04119739|Physiotherapy|physiotherapy
12660|NCT04119739|Pain management|pain management
12661|NCT04119726|Mobile health|mobile health
12662|NCT04119726|Acute myocardial infarction|acute myocardial infarction
12663|NCT04119726|Cardioprotective medications|cardioprotective medications
12664|NCT04119726|Randomized Controlled Trial|randomized controlled trial
12665|NCT04119700|fistulectomy|fistulectomy
12666|NCT04119700|fistula|fistula
12667|NCT04119700|advancement flap|advancement flap
12668|NCT04119700|transsphincteric fistula|transsphincteric fistula
12669|NCT04119700|sphincteroplasty|sphincteroplasty
12670|NCT04119700|primary sphincter reconstruction|primary sphincter reconstruction
12671|NCT04119700|high fistula|high fistula
12672|NCT04119700|endorectal flap|endorectal flap
19490|NCT04076137|CEA|cea
12673|NCT04119648|Suicide|suicide
12674|NCT04119648|Child|child
12675|NCT04119648|CAMS|cams
12676|NCT04119635|Crohn's disease|crohn's disease
12677|NCT04119635|Penetrating complication|penetrating complication
12678|NCT04119635|Pediatric|pediatric
12679|NCT04119635|Inflammatory bowel disease|inflammatory bowel disease
12680|NCT04119622|Toripalimab|toripalimab
12681|NCT04119622|JS001|js001
12682|NCT04119622|Gastric Cancer|gastric cancer
12683|NCT04119622|neoadjvant chemotherapy|neoadjvant chemotherapy
12684|NCT04119596|Gut Microbiota|gut microbiota
12685|NCT04119596|Parkinson's disease|parkinson's disease
12686|NCT04119596|Genetics|genetics
12687|NCT04119596|Microbiome|microbiome
12688|NCT04119596|FFQ|ffq
12689|NCT04119596|GPAQ|gpaq
12690|NCT04119596|HADS|hads
12691|NCT04119596|MOCA|moca
12692|NCT04119544|stroke|stroke
12693|NCT04119544|mirror therapy|mirror therapy
12694|NCT04119544|rehabilitation|rehabilitation
12695|NCT04119544|hemiparesis|hemiparesis
12696|NCT04119544|upper limb|upper limb
12697|NCT04119544|function|function
12698|NCT04119544|motor control|motor control
12699|NCT04119531|anesthesia|anesthesia
12700|NCT04119531|recovery|recovery
12701|NCT04119531|insomnia|insomnia
12702|NCT04119505|Diaphragmatic Excursion|diaphragmatic excursion
12703|NCT04119505|Diaphragmatic Dysfunction|diaphragmatic dysfunction
12704|NCT04119505|Emergency Department|emergency department
12705|NCT04119505|Respiratory insufficiency|respiratory insufficiency
12706|NCT04119505|Acute respiratory failure|acute respiratory failure
12707|NCT04119492|developmental coordination disorder|developmental coordination disorder
12708|NCT04119492|autism|autism
12709|NCT04119492|brain imaging|brain imaging
12710|NCT04119492|MRI|mri
12711|NCT04119492|rehabilitation|rehabilitation
12712|NCT04119492|CO-OP|co-op
12713|NCT04119479|Functional recovery|functional recovery
12714|NCT04119479|Neurorehabilitation|neurorehabilitation
12715|NCT04119479|Stroke|stroke
12716|NCT04119466|degenerative disc disease|degenerative disc disease
12717|NCT04119466|stabilizing training|stabilizing training
12718|NCT04119466|protrusion|protrusion
12719|NCT04119466|extrusion|extrusion
12720|NCT04119440|MERS-CoV|mers-cov
12721|NCT04119440|CEPI|cepi
12722|NCT04119440|viral vector vaccine|viral vector vaccine
12723|NCT04119414|Early Infant Male Circumcision|early infant male circumcision
12724|NCT04119414|HIV infection|hiv infection
12725|NCT04119401|hemorrhoids|hemorrhoids
12726|NCT04119401|hemorrhoidal piles|hemorrhoidal piles
12727|NCT04119401|prolapse|prolapse
12728|NCT04119401|doppler guided ligation|doppler guided ligation
12729|NCT04119401|finger-guided artery ligation|finger-guided artery ligation
12730|NCT04119388|osteogenesis imperfecta|osteogenesis imperfecta
12731|NCT04119388|Adapted sport|adapted sport
12732|NCT04119388|Quality of life|quality of life
12733|NCT04119375|Keheala|keheala
12734|NCT04119375|tuberculosis|tuberculosis
12735|NCT04119375|adherence|adherence
12736|NCT04119375|behavior change|behavior change
12737|NCT04119375|mobile health|mobile health
12738|NCT04119375|mhealth|mhealth
12739|NCT04119375|behavioral interventions|behavioral interventions
12740|NCT04119375|patient-centered care|patient-centered care
12741|NCT04119362|pancreas|pancreas
12742|NCT04119362|quality of life|quality of life
12743|NCT04119362|PRO|pro
12744|NCT04119362|Pancreatic Adenocarcinoma|pancreatic adenocarcinoma
12745|NCT04119336|Refractory Multiple Myeloma|refractory multiple myeloma
12746|NCT04119336|Relapsed Multiple Myeloma|relapsed multiple myeloma
12747|NCT04119297|Cold application|cold application
12748|NCT04119297|Craniotomy|craniotomy
12749|NCT04119297|Heparinoid|heparinoid
12750|NCT04119297|Periorbital edema|periorbital edema
12751|NCT04119297|Periorbital ecchymosis|periorbital ecchymosis
12752|NCT04119284|scoliosis|scoliosis
12753|NCT04119284|Vertebral Body Tethering|vertebral body tethering
12754|NCT04119284|curve|curve
12755|NCT04119284|Shah|shah
12756|NCT04119245|obesity|obesity
12757|NCT04119245|Igel|igel
12758|NCT04119245|suraglotic device|suraglotic device
12759|NCT04119219|fundus diseases|fundus diseases
12760|NCT04119219|antiangiogenic therapy|antiangiogenic therapy
12761|NCT04119219|subretinal neovascular membrane|subretinal neovascular membrane
12762|NCT04119219|intravitreal injection|intravitreal injection
12763|NCT04119219|anti-VEGF|anti-vegf
12764|NCT04119219|angioid streaks|angioid streaks
12765|NCT04119206|hyponatremia|hyponatremia
12766|NCT04119206|vasopressin|vasopressin
12767|NCT04119206|anti-diuretic hormone|anti-diuretic hormone
12768|NCT04119206|fluid restriction|fluid restriction
12769|NCT04119206|tolvaptan|tolvaptan
12770|NCT04119206|pituitary surgery|pituitary surgery
12771|NCT04119180|Dental Anxiety|dental anxiety
12772|NCT04119180|Dental Caries|dental caries
12773|NCT04119180|Conscious Sedation|conscious sedation
12774|NCT04119180|Physical Restraint|physical restraint
804502|NCT00236717|Topiramate|topiramate
12775|NCT04119180|Cost-Efficacy Analysis|cost-efficacy analysis
12776|NCT04119167|Diabetes Mellitus, Type 2|diabetes mellitus, type 2
12777|NCT04119167|Diabetic Polyneuropathy|diabetic polyneuropathy
12778|NCT04119167|Diabetic Nephropathy|diabetic nephropathy
12779|NCT04119167|Growth Differentiation Factor 15|growth differentiation factor 15
12780|NCT04119128|Sjogren's Syndrome|sjogren's syndrome
12781|NCT04119128|fatigue|fatigue
12782|NCT04119128|tDCS|tdcs
12783|NCT04119115|lung disease|lung disease
12784|NCT04119115|pulmonary fibrosis|pulmonary fibrosis
12785|NCT04119115|precision medicine|precision medicine
12786|NCT04119115|metabolomics|metabolomics
12787|NCT04119076|school-based intervention|school-based intervention
12788|NCT04119076|active classroom|active classroom
12789|NCT04119050|Warm Autoimmune Hemolytic Anemia|warm autoimmune hemolytic anemia
12790|NCT04119050|M281|m281
12791|NCT04119050|wAIHA|waiha
12792|NCT04119050|Nipocalimab|nipocalimab
12793|NCT04119011|probiotics|probiotics
12794|NCT04118998|Rehabilitation|rehabilitation
12795|NCT04118998|Arm|arm
12796|NCT04118998|Flexion Synergy|flexion synergy
12797|NCT04118998|Longitudinal|longitudinal
12798|NCT04118998|Targetted|targetted
12799|NCT04118998|Quantitative|quantitative
12800|NCT04118985|Subjective cognitive complaint|subjective cognitive complaint
12801|NCT04118959|Recurrent implantation failure|recurrent implantation failure
12802|NCT04118959|IVF|ivf
12803|NCT04118959|Atosiban|atosiban
12804|NCT04118959|Embryo Transfer|embryo transfer
12805|NCT04118920|Topical insulin|topical insulin
12806|NCT04118920|Dendrite regeneration|dendrite regeneration
12807|NCT04118907|tinnitus|tinnitus
12808|NCT04118907|stimulation|stimulation
12809|NCT04118868|CTCL|ctcl
12810|NCT04118868|Cutaneous T-cell Lymphoma|cutaneous t-cell lymphoma
12811|NCT04118868|MF/SS|mf/ss
12812|NCT04118868|Mycosis Fungoides|mycosis fungoides
12813|NCT04118868|Sezary Syndrome|sezary syndrome
12814|NCT04118868|pembrolizumab|pembrolizumab
12815|NCT04118868|PD-L1|pd-l1
12816|NCT04118855|neoadjuvant therapy|neoadjuvant therapy
12817|NCT04118855|Toripalimab|toripalimab
12818|NCT04118855|axitinib|axitinib
12819|NCT04118855|nephrectomy|nephrectomy
12820|NCT04118855|partial nephrectomy|partial nephrectomy
12821|NCT04118842|Solid tumors|solid tumors
12822|NCT04118842|Small-molecule kinase inhibitor|small-molecule kinase inhibitor
12823|NCT04118829|Perampanel|perampanel
12824|NCT04118790|Fatigue|fatigue
12825|NCT04118790|minor stroke|minor stroke
12826|NCT04118790|TIA|tia
12827|NCT04118790|Diffusion|diffusion
12828|NCT04118790|MRI|mri
12829|NCT04118790|Quantitative|quantitative
12830|NCT04118790|Sequence|sequence
12831|NCT04118790|Microstructure|microstructure
12832|NCT04118790|Axon|axon
12833|NCT04118790|Myelin|myelin
12834|NCT04118790|Degeneration|degeneration
12835|NCT04118764|focused ultrasound|focused ultrasound
12836|NCT04118764|blood-brain barrier opening|blood-brain barrier opening
12837|NCT04118764|non-invasive therapy|non-invasive therapy
12838|NCT04118751|Parental outcomes|parental outcomes
12839|NCT04118751|Bonding|bonding
12840|NCT04118751|NICU|nicu
12841|NCT04118738|ZIKA|zika
12842|NCT04118699|Rifaximin|rifaximin
12843|NCT04118699|L-105|l-105
12844|NCT04118699|phase 2 trial|phase 2 trial
12845|NCT04118699|CIPO|cipo
12846|NCT04118699|small intestinal bacterial overgrowth|small intestinal bacterial overgrowth
12847|NCT04118699|systemic scleroderma|systemic scleroderma
12848|NCT04118686|Neurodegenerative disease|neurodegenerative disease
12849|NCT04118686|Cognitive decline|cognitive decline
12850|NCT04118686|Non-pharmacological treatments|non-pharmacological treatments
12851|NCT04118686|Cognitive training|cognitive training
12852|NCT04118686|Non-invasive brain stimulation|non-invasive brain stimulation
12853|NCT04118595|Musculoskeletal Pain|musculoskeletal pain
12854|NCT04118595|Acute Pain|acute pain
12855|NCT04118595|Emergency Department|emergency department
12856|NCT04118595|Elderly|elderly
12857|NCT04118595|Video|video
12858|NCT04118582|severe obesity|severe obesity
12859|NCT04118582|resting metabolic rate|resting metabolic rate
12860|NCT04118582|indirect calorimetry|indirect calorimetry
12861|NCT04118582|body composition|body composition
12862|NCT04118582|electrical bioimpedance analisys|electrical bioimpedance analisys
12863|NCT04118556|DSC|dsc
12864|NCT04118556|BAT|bat
12865|NCT04118556|GVHD|gvhd
12866|NCT04118556|HSCT|hsct
12867|NCT04118543|Obesity|obesity
12868|NCT04118543|Cardiometabolic|cardiometabolic
12869|NCT04118543|Adolescence|adolescence
12870|NCT04118543|Exercise|exercise
12871|NCT04118530|Atrial Fibrillation|atrial fibrillation
12872|NCT04118530|Hematopoietic Stem Cell Transplant|hematopoietic stem cell transplant
12873|NCT04118530|Atrial Flutter|atrial flutter
12874|NCT04118517|protein quality, legume|protein quality, legume
12875|NCT04118504|Coronary disease|coronary disease
12876|NCT04118504|Life style|life style
12877|NCT04118504|Mobile application|mobile application
12878|NCT04118504|Clinical trial|clinical trial
12879|NCT04118478|fitness|fitness
12880|NCT04118478|program training|program training
12881|NCT04118478|exercise|exercise
12882|NCT04118478|health|health
12883|NCT04118478|physical condition|physical condition
12884|NCT04118478|qualilty of Life|qualilty of life
12885|NCT04118478|Functional capacity|functional capacity
12886|NCT04118478|physiological status|physiological status
12887|NCT04118478|physical activity|physical activity
12888|NCT04118478|elderly|elderly
12889|NCT04118465|breech; ECV; version|breech; ecv; version
12890|NCT04118452|early childhood development|early childhood development
12891|NCT04118452|developmental screening|developmental screening
12892|NCT04118452|care coordination|care coordination
12893|NCT04118439|Motor Imaginery|motor imaginery
12894|NCT04118439|Shoulder Pain|shoulder pain
12895|NCT04118439|Chronic Pain|chronic pain
12896|NCT04118439|Prehabilitation|prehabilitation
12897|NCT04118426|Cognitive function|cognitive function
12898|NCT04118387|Central sleep apnea|central sleep apnea
12899|NCT04118387|Polysomnography (PSG)|polysomnography (psg)
12900|NCT04118387|Respiratory arousal threshold|respiratory arousal threshold
12901|NCT04118387|Apnea Hypopnea index|apnea hypopnea index
12902|NCT04118387|Central Apnea Hypopnea Index|central apnea hypopnea index
12903|NCT04118387|Breathing instability|breathing instability
12904|NCT04118387|Apneic Threshold (AT)|apneic threshold (at)
12905|NCT04118387|Peripheral chemoreflex sensitivity|peripheral chemoreflex sensitivity
12906|NCT04118387|CO2 reserve|co2 reserve
12907|NCT04118387|Plant gain|plant gain
12908|NCT04118387|Controller gain|controller gain
12909|NCT04118374|low carbohydrate diet|low carbohydrate diet
12910|NCT04118374|hyperinsulinemia|hyperinsulinemia
12911|NCT04118374|insulin resistance|insulin resistance
12912|NCT04118374|endothelial dysfunction|endothelial dysfunction
12913|NCT04118374|vascular health|vascular health
12914|NCT04118348|Optimal default|optimal default
12915|NCT04118348|Best practice alert|best practice alert
12916|NCT04118348|Health maintenance topic|health maintenance topic
12917|NCT04118335|Oral mucositis in COPD patients|oral mucositis in copd patients
12918|NCT04118335|complementary therapies|complementary therapies
12919|NCT04118335|nursing interventions|nursing interventions
12920|NCT04118335|oral care with black mulberry syrup|oral care with black mulberry syrup
12921|NCT04118322|Aromatherapy|aromatherapy
12922|NCT04118322|Chemotherapy|chemotherapy
12923|NCT04118322|Nausea-Vomiting|nausea-vomiting
12924|NCT04118322|Nursing|nursing
12925|NCT04118322|Peppermint Oil|peppermint oil
12926|NCT04118283|Veterans|veterans
12927|NCT04118283|chronic pain|chronic pain
12928|NCT04118283|psychotic disorders|psychotic disorders
12929|NCT04118283|affective disorders, psychotic|affective disorders, psychotic
12930|NCT04118283|cognitive behavioral therapy|cognitive behavioral therapy
12931|NCT04118283|ecological momentary assessment|ecological momentary assessment
12932|NCT04118257|Glucose control|glucose control
12933|NCT04118257|Cardiovascular disease risk factors|cardiovascular disease risk factors
12934|NCT04118257|Sugary beverages|sugary beverages
12935|NCT04118257|Pulmonary function|pulmonary function
12936|NCT04118231|Hamstring Shortness|hamstring shortness
12937|NCT04118231|Dry Needling|dry needling
12938|NCT04118231|Elastography|elastography
12939|NCT04118218|DLF Questionnaire|dlf questionnaire
12940|NCT04118218|rhizolysis|rhizolysis
12941|NCT04118192|breast cancer|breast cancer
12942|NCT04118192|HER2 positive|her2 positive
12943|NCT04118192|ER negative|er negative
12944|NCT04118192|Tumour bed core biopsies|tumour bed core biopsies
12945|NCT04118140|Cancer|cancer
12946|NCT04118140|acupressure|acupressure
12947|NCT04118140|fatigue|fatigue
12948|NCT04118140|depression|depression
12949|NCT04118140|insomnia|insomnia
12950|NCT04118140|symptom cluster|symptom cluster
12951|NCT04118127|Schizophrenia,brexpiprazole,open-label,linical pharmacology|schizophrenia,brexpiprazole,open-label,linical pharmacology
12952|NCT04118088|Drug therapy|drug therapy
12953|NCT04118075|aGVHD, cGVHD, PT-CY|agvhd, cgvhd, pt-cy
12954|NCT04118049|Pessary use|pessary use
12955|NCT04118049|Probiotics|probiotics
12956|NCT04118049|Cytokines|cytokines
12957|NCT04118049|Microenvironment|microenvironment
12958|NCT04118036|Glioblastoma|glioblastoma
12959|NCT04118023|7T Magnetic Resonance Imaging|7t magnetic resonance imaging
12960|NCT04118023|Clinical|clinical
12961|NCT04118023|Cartilaginous Lesion|cartilaginous lesion
12962|NCT04118010|Cystic Fibrosis|cystic fibrosis
12963|NCT04118010|Gastrointestinal Dysbiosis|gastrointestinal dysbiosis
12964|NCT04118010|Vitamin D|vitamin d
12965|NCT04118010|Prebiotic|prebiotic
12966|NCT04118010|Inulin|inulin
12967|NCT04118010|Gut microbiome|gut microbiome
12968|NCT04118010|Intestinal inflammation|intestinal inflammation
12969|NCT04118010|Intestinal absorption|intestinal absorption
12970|NCT04117984|Population-based survey|population-based survey
12971|NCT04117984|HIV|hiv
12972|NCT04117984|Antenatal care|antenatal care
12973|NCT04117984|PMTCT|pmtct
12974|NCT04117984|Intimate Partner Violence (IPV)|intimate partner violence (ipv)
12975|NCT04117984|Tuberculosis|tuberculosis
19863|NCT04073433|Mood|mood
12976|NCT04117971|Child abuse|child abuse
12977|NCT04117971|Abuse diagnosis|abuse diagnosis
12978|NCT04117971|Abuse report|abuse report
12979|NCT04117971|dentists' knowledge|dentists' knowledge
12980|NCT04117932|bullous pemphigoid|bullous pemphigoid
12981|NCT04117932|ustekinumab|ustekinumab
12982|NCT04117932|superpotent topical corticosteroids|superpotent topical corticosteroids
12983|NCT04117932|efficacy|efficacy
12984|NCT04117932|safety|safety
12985|NCT04117893|Osteoarthritis, Knee|osteoarthritis, knee
12986|NCT04117893|Chronic Pain|chronic pain
12987|NCT04117893|hyaluronic acid|hyaluronic acid
12988|NCT04117893|corticosteroid|corticosteroid
12989|NCT04117893|duloxetine|duloxetine
12990|NCT04117893|Intra-articular injection|intra-articular injection
12991|NCT04117854|spinal cord injury|spinal cord injury
12992|NCT04117854|pediatric|pediatric
12993|NCT04117854|qualitative interviews|qualitative interviews
12994|NCT04117854|web survey|web survey
12995|NCT04117854|international|international
12996|NCT04117854|multicenter|multicenter
12997|NCT04117854|traumatic SCI|traumatic sci
12998|NCT04117854|atraumatic SCI|atraumatic sci
12999|NCT04117776|Central venous catheter-related bacteremias|central venous catheter-related bacteremias
13000|NCT04117776|Skin decolonization|skin decolonization
13001|NCT04117776|Intensive care unit hospitalization|intensive care unit hospitalization
13002|NCT04117763|empagliflozin|empagliflozin
13003|NCT04117763|Diabetes|diabetes
13004|NCT04117763|coronary heart disease|coronary heart disease
13005|NCT04117750|PCOS|pcos
13006|NCT04117750|VD supplementation|vd supplementation
13007|NCT04117750|androgen level|androgen level
13008|NCT04117750|cardio metabolic|cardio metabolic
13009|NCT04117737|Parkinson|parkinson
13010|NCT04117737|Virtual reality|virtual reality
13011|NCT04117737|Anti-gravity treadmill|anti-gravity treadmill
13012|NCT04117737|Rehabilitation|rehabilitation
13013|NCT04117737|Gait disorders|gait disorders
13014|NCT04117711|Classic Galactosemia|classic galactosemia
13015|NCT04117711|Aldose Reductase Inhibition|aldose reductase inhibition
13016|NCT04117711|Galactose, Galactitol|galactose, galactitol
13017|NCT04117685|hip dysplasia|hip dysplasia
13018|NCT04117685|ddh|ddh
13019|NCT04117685|developmental dysplasia of the hip|developmental dysplasia of the hip
13020|NCT04117685|congenital hip dysplasia|congenital hip dysplasia
13021|NCT04117672|traumatic brain injury|traumatic brain injury
13022|NCT04117672|cerebral edema|cerebral edema
13023|NCT04117672|antisecretory factor|antisecretory factor
13024|NCT04117672|inflammatory cytokines|inflammatory cytokines
13025|NCT04117672|cerebral oxygen monitoring|cerebral oxygen monitoring
13026|NCT04117672|intracranial pressure|intracranial pressure
13027|NCT04117672|microdialysis|microdialysis
13028|NCT04117659|Left ventricular assist device|left ventricular assist device
13029|NCT04117659|postoperative right heart failure|postoperative right heart failure
13030|NCT04117646|Chronic rhinosinusitis of children|chronic rhinosinusitis of children
13031|NCT04117646|Sinus and nasal quality of life survey questionnaire (SN-5)|sinus and nasal quality of life survey questionnaire (sn-5)
13032|NCT04117646|Translation in French of the SN-5|translation in french of the sn-5
13033|NCT04117633|Rectal Prolapse|rectal prolapse
13034|NCT04117633|Laparoscopy|laparoscopy
13035|NCT04117633|Mesh|mesh
13036|NCT04117633|Rectopexy|rectopexy
13037|NCT04117633|pediatrics|pediatrics
13038|NCT04117620|Pediatric vestibular symptom|pediatric vestibular symptom
13039|NCT04117620|Pediatric vestibular symptom questionnaire in french|pediatric vestibular symptom questionnaire in french
13040|NCT04117607|Adults|adults
13041|NCT04117607|CD101|cd101
13042|NCT04117607|Healthy|healthy
13043|NCT04117607|Intravenous|intravenous
13044|NCT04117607|Rezafungin|rezafungin
13045|NCT04117607|Subcutaneous|subcutaneous
13046|NCT04117594|Prostate cancer|prostate cancer
13047|NCT04117594|WB-MRI|wb-mri
13048|NCT04117594|Bone disease|bone disease
13049|NCT04117581|Vitamin D|vitamin d
13050|NCT04117581|Asthma|asthma
13051|NCT04117581|Lung function|lung function
13052|NCT04117581|Inflammation|inflammation
13053|NCT04117542|Loss of Control Eating|loss of control eating
13054|NCT04117542|Working Memory|working memory
13055|NCT04117529|Pemphigus Vulgaris|pemphigus vulgaris
13056|NCT04117529|Pemphigus Foliaceus|pemphigus foliaceus
13057|NCT04117529|B-cell|b-cell
13058|NCT04117529|Dermatology|dermatology
13059|NCT04117516|Percutaneous carpal tunnel release|percutaneous carpal tunnel release
13060|NCT04117464|anxiety|anxiety
13061|NCT04117464|depression|depression
13062|NCT04117464|behavioral activation therapy|behavioral activation therapy
13063|NCT04117464|acceptance and commitment therapy|acceptance and commitment therapy
13064|NCT04117464|cognitive-behavioral therapy|cognitive-behavioral therapy
13065|NCT04117464|transdiagnostic|transdiagnostic
13066|NCT04117464|group therapy|group therapy
13067|NCT04117425|Epilepsy|epilepsy
13068|NCT04117425|pharmacokinetic|pharmacokinetic
13069|NCT04117425|levetiracetam|levetiracetam
13070|NCT04117425|placental transfer.|placental transfer.
13071|NCT04117399|COPD|copd
13072|NCT04117399|IMT|imt
13073|NCT04117399|CoP ML|cop ml
13074|NCT04117399|CoP AP|cop ap
13075|NCT04117399|Posture|posture
13076|NCT04117386|HPV infection|hpv infection
13077|NCT04117386|Pterygium|pterygium
13078|NCT04117386|Cytokine|cytokine
13079|NCT04117386|VEGF|vegf
13080|NCT04117386|auto-inoculation|auto-inoculation
13081|NCT04117360|Dentofacial Disharmony|dentofacial disharmony
13082|NCT04117360|Skeletal malocclusion|skeletal malocclusion
13083|NCT04117360|Speech Sound Disorder|speech sound disorder
13084|NCT04117360|Spectral Moment Analysis|spectral moment analysis
13085|NCT04117360|Tongue Ultrasound|tongue ultrasound
13091|NCT04117334|Cost-effectiveness|cost-effectiveness
13092|NCT04117334|Adolescent idiopathic scoliosis|adolescent idiopathic scoliosis
13094|NCT04117308|Perinatal morbidity|perinatal morbidity
13095|NCT04117308|Prolonged pregnancy|prolonged pregnancy
13096|NCT04117308|Fetal active movement count|fetal active movement count
13097|NCT04117295|Heart Replacement Therapy|heart replacement therapy
13098|NCT04117295|Total Artificial Heart|total artificial heart
13099|NCT04117295|Biventricular Heart Failure|biventricular heart failure
13100|NCT04117256|Direct Current Stimulation|direct current stimulation
13101|NCT04117256|Conditioned Pain Modulation|conditioned pain modulation
13102|NCT04117256|Endogenous Pain Modulation|endogenous pain modulation
13103|NCT04117256|Temporal Summation|temporal summation
13104|NCT04117256|Pressure Pain Threshold|pressure pain threshold
13105|NCT04117256|Pain|pain
13106|NCT04117243|tranexamic acid|tranexamic acid
13107|NCT04117243|misoprostol|misoprostol
13108|NCT04117243|high risk pregnancy|high risk pregnancy
13109|NCT04117204|CVD|cvd
13110|NCT04117204|Dietary Intervention|dietary intervention
13111|NCT04117178|Therapeutic Drug Monitoring|therapeutic drug monitoring
13112|NCT04117178|TDM|tdm
13113|NCT04117178|Adverse effects|adverse effects
13114|NCT04117178|Dementia|dementia
13115|NCT04117178|Alzheimer's disease|alzheimer's disease
13116|NCT04117165|predictive software|predictive software
13117|NCT04117165|quality of life|quality of life
13118|NCT04117139|Positron-Emission-Tomography/Magnetic Resonance Imaging|positron-emission-tomography/magnetic resonance imaging
13119|NCT04117139|PET/MRI|pet/mri
13120|NCT04117139|Cancer staging|cancer staging
13121|NCT04117126|aged|aged
13122|NCT04117126|Therapeutics|therapeutics
13123|NCT04117126|hospitalization|hospitalization
13124|NCT04117126|nursing care|nursing care
13125|NCT04117126|rehabilitation|rehabilitation
13126|NCT04117126|prompted voiding|prompted voiding
13127|NCT04117087|KRAS Peptide Vaccine|kras peptide vaccine
13128|NCT04117087|Nivolumab|nivolumab
13129|NCT04117087|Ipilimumab|ipilimumab
13130|NCT04117087|Anti-PD-1|anti-pd-1
13131|NCT04117087|Anti-CTLA-4|anti-ctla-4
13132|NCT04117087|Neoantigen Vaccines|neoantigen vaccines
13133|NCT04117087|Cancer Vaccines|cancer vaccines
13134|NCT04117087|Immunotherapy|immunotherapy
13135|NCT04117087|Colon Cancer|colon cancer
13136|NCT04117087|Pancreatic Ductal Adenocarcinoma (PDAC)|pancreatic ductal adenocarcinoma (pdac)
13137|NCT04117087|Resected MMR-p Colorectal Cancer|resected mmr-p colorectal cancer
13138|NCT04117087|Resected MMR-p Pancreatic Cancer|resected mmr-p pancreatic cancer
13139|NCT04117048|INR|inr
13140|NCT04117048|Labpad®|labpad®
13141|NCT04117048|VKA|vka
13142|NCT04117035|multiple sclerosis|multiple sclerosis
13143|NCT04117035|trigeminal neuralgia|trigeminal neuralgia
13144|NCT04117035|Pain|pain
13145|NCT04117035|Quality of life|quality of life
13146|NCT04117009|diastolic dysfunction|diastolic dysfunction
13147|NCT04117009|remifentanil|remifentanil
13148|NCT04116944|anxiety|anxiety
13149|NCT04116931|Dual antiplatelet therapy (DAPT)|dual antiplatelet therapy (dapt)
13150|NCT04116931|Platelet function|platelet function
13151|NCT04116931|Clopidogrel|clopidogrel
13152|NCT04116931|Ticagrelor|ticagrelor
13153|NCT04116931|Switch|switch
13154|NCT04116905|Metablolic syndrome|metablolic syndrome
13155|NCT04116905|remission|remission
13156|NCT04116905|life style|life style
13157|NCT04116905|weight loss|weight loss
13158|NCT04116892|Inverted Internal Limiting Membrane Flap Technique|inverted internal limiting membrane flap technique
13159|NCT04116892|Large Macular Hole|large macular hole
13160|NCT04116892|Macular hole surgery|macular hole surgery
13161|NCT04116853|Weight Loss|weight loss
13162|NCT04116853|Weight Maintenance|weight maintenance
13163|NCT04116827|sleep disorder|sleep disorder
13164|NCT04116827|breast cancer|breast cancer
13165|NCT04116827|pre-menopausal|pre-menopausal
13166|NCT04116827|tamoxifen|tamoxifen
13167|NCT04116827|hormone therapy|hormone therapy
13168|NCT04116775|Microbiota|microbiota
13169|NCT04116775|Prostate|prostate
13170|NCT04116775|Metastatic|metastatic
13171|NCT04116775|Programmed cell death protein 1|programmed cell death protein 1
13172|NCT04116775|Pembrolizumab|pembrolizumab
13173|NCT04116775|Prostatic Neoplasms|prostatic neoplasms
13174|NCT04116723|Flexible brace|flexible brace
13175|NCT04116710|Cancer|cancer
13176|NCT04116710|Immunotherapy|immunotherapy
13177|NCT04116710|Vaccine|vaccine
13178|NCT04116710|Intradermal|intradermal
13179|NCT04116710|gp96|gp96
13180|NCT04116710|OX40|ox40
13181|NCT04116710|Combination Therapy|combination therapy
13182|NCT04116710|Co-stimulation|co-stimulation
13183|NCT04116710|Heat Biologics|heat biologics
13184|NCT04116684|Withings Blood Pressure Monitor|withings blood pressure monitor
13185|NCT04116684|Heart Rate|heart rate
13186|NCT04116684|Ambulatory Blood Pressure|ambulatory blood pressure
13287|NCT04116151|CANCER|cancer
13187|NCT04116671|neuromuscular electrical stimulation|neuromuscular electrical stimulation
13188|NCT04116671|stroke|stroke
13189|NCT04116671|hemiparesis|hemiparesis
13190|NCT04116671|walking|walking
13191|NCT04116671|powered orthosis|powered orthosis
13192|NCT04116658|Glioblastoma|glioblastoma
13193|NCT04116658|Vaccine|vaccine
13194|NCT04116658|Nivolumab|nivolumab
13195|NCT04116658|Bevacizumab|bevacizumab
13196|NCT04116658|Safety|safety
13197|NCT04116658|Tolerability|tolerability
13198|NCT04116606|P2X7|p2x7
13199|NCT04116606|Major Depressive Disorder|major depressive disorder
13200|NCT04116593|Nutrition education|nutrition education
13201|NCT04116593|Dietary diversity|dietary diversity
13202|NCT04116593|Adolescent girls|adolescent girls
13203|NCT04116580|Food Allergy|food allergy
13204|NCT04116580|Apple Allergy|apple allergy
13205|NCT04116580|Oral Allergic Syndrome|oral allergic syndrome
13206|NCT04116580|Ultra-Rush|ultra-rush
13207|NCT04116580|Tolerance induction|tolerance induction
13208|NCT04116580|Cross-Allergy|cross-allergy
13209|NCT04116567|Pulmonary Atelectasis|pulmonary atelectasis
13210|NCT04116567|Lung Ultrasound|lung ultrasound
13211|NCT04116567|Laparoscopic Surgery|laparoscopic surgery
13212|NCT04116554|transversus thoracic muscle plane block.|transversus thoracic muscle plane block.
13213|NCT04116554|analgesic after open heart surgery.|analgesic after open heart surgery.
13214|NCT04116541|Metastatic Solid Neoplasm|metastatic solid neoplasm
13215|NCT04116541|Advanced Solid Tumor|advanced solid tumor
13216|NCT04116541|Genomic alteration|genomic alteration
13217|NCT04116541|Targeted therapy|targeted therapy
13218|NCT04116541|Cabozantinib|cabozantinib
13219|NCT04116541|Ribociclib|ribociclib
13220|NCT04116541|HDM201|hdm201
13221|NCT04116515|Active Video Game|active video game
13222|NCT04116515|Physical Activity|physical activity
13223|NCT04116515|Narrative|narrative
13224|NCT04116515|Child Obesity|child obesity
13225|NCT04116463|lower-wage workers|lower-wage workers
13226|NCT04116463|chronic disease|chronic disease
13227|NCT04116463|self-management|self-management
13228|NCT04116437|BGB-3111|bgb-3111
13229|NCT04116437|Zanubrutinib|zanubrutinib
13230|NCT04116437|Ibrutinib Intolerance|ibrutinib intolerance
13231|NCT04116437|BTK Inhibitor|btk inhibitor
13232|NCT04116411|cytomegalovirus|cytomegalovirus
13233|NCT04116411|valganciclovir|valganciclovir
13234|NCT04116398|dexamethasone,|dexamethasone,
13235|NCT04116398|loading dose,|loading dose,
13236|NCT04116398|diabetic macular edema|diabetic macular edema
13237|NCT04116398|pseudophakic|pseudophakic
13238|NCT04116385|Viscoelastic testing|viscoelastic testing
13239|NCT04116385|Coagulation|coagulation
13240|NCT04116385|Quantra|quantra
13241|NCT04116385|Hemostasis|hemostasis
13242|NCT04116346|Fasting|fasting
13243|NCT04116346|Cardiac Catheterization|cardiac catheterization
13244|NCT04116346|Percutaneous coronary intervention|percutaneous coronary intervention
13245|NCT04116320|Echopulse|echopulse
13246|NCT04116320|Focused Ultrasound Ablation|focused ultrasound ablation
13247|NCT04116320|FUSA|fusa
13248|NCT04116320|imiquimod|imiquimod
13249|NCT04116320|Aldara|aldara
13250|NCT04116320|Pembrolizumab|pembrolizumab
13251|NCT04116320|Keytruda|keytruda
13252|NCT04116320|Atezolizumab|atezolizumab
13253|NCT04116320|Tecentriq|tecentriq
13254|NCT04116281|Upper limb function|upper limb function
13255|NCT04116281|Heart hate variability|heart hate variability
13256|NCT04116281|Physical therapy|physical therapy
13257|NCT04116281|Breast neoplasms|breast neoplasms
13258|NCT04116281|Pressure pain threshold|pressure pain threshold
13259|NCT04116281|Perceived pain|perceived pain
13260|NCT04116255|Temporomandibular joint disorders|temporomandibular joint disorders
13261|NCT04116255|exercise therapy|exercise therapy
13262|NCT04116255|occlusal splint|occlusal splint
13263|NCT04116255|neuropathic pain|neuropathic pain
13264|NCT04116242|immunoparesis|immunoparesis
13265|NCT04116242|monocyte dysfunction|monocyte dysfunction
13266|NCT04116242|MER receptor tyrosine kinase (MERTK)|mer receptor tyrosine kinase (mertk)
13267|NCT04116242|innate immune dysfunction|innate immune dysfunction
13268|NCT04116242|circulating monocytes/macrophages|circulating monocytes/macrophages
13269|NCT04116242|MERTK signalling|mertk signalling
13270|NCT04116229|Obesity|obesity
13271|NCT04116229|Inflammation|inflammation
13272|NCT04116229|Cognitive impairment|cognitive impairment
13273|NCT04116229|Neuroimaging|neuroimaging
13274|NCT04116229|Magnetic resonance imaging|magnetic resonance imaging
13275|NCT04116216|Parkinson's disease|parkinson's disease
13276|NCT04116203|Polycystic Ovary Syndrome|polycystic ovary syndrome
13277|NCT04116203|metabolic and cardiovascular diseases|metabolic and cardiovascular diseases
13278|NCT04116203|diabetes|diabetes
13279|NCT04116203|obesity|obesity
13280|NCT04116190|rehabilitation|rehabilitation
13281|NCT04116190|stroke|stroke
13282|NCT04116177|Deep brain stimulation|deep brain stimulation
13283|NCT04116177|Parkinson disease|parkinson disease
13284|NCT04116177|Novel strategies|novel strategies
13285|NCT04116164|Radiolabeled antibody|radiolabeled antibody
13286|NCT04116164|Imaging|imaging
13288|NCT04116151|DERMATITIS|dermatitis
13289|NCT04116125|Breast cancer|breast cancer
13290|NCT04116125|cN1, ycN0|cn1, ycn0
13291|NCT04116125|Neoadjuvant cheotherapy|neoadjuvant cheotherapy
13292|NCT04116125|Sentinel Lymph Node|sentinel lymph node
13293|NCT04116125|Radiotherapy|radiotherapy
13294|NCT04116112|Blood Pressure Control|blood pressure control
13295|NCT04116099|Lymphedema of Leg|lymphedema of leg
13296|NCT04116099|Chronic Venous Insufficiency|chronic venous insufficiency
13297|NCT04116099|Primary Lymphedema|primary lymphedema
13298|NCT04116099|Secondary Lymphedema|secondary lymphedema
13299|NCT04116073|Antibody|antibody
13300|NCT04116073|Anti-PD-1|anti-pd-1
13301|NCT04116073|Human monoclonal immunoglobulin antibody|human monoclonal immunoglobulin antibody
13302|NCT04116073|Immunotherapy|immunotherapy
13303|NCT04116073|INCMGA00012 (anti-PD-1 antibody)|incmga00012 (anti-pd-1 antibody)
13304|NCT04116073|Anti-PD-1 antibody (MGA012)|anti-pd-1 antibody (mga012)
13305|NCT04116073|Metastatic adenosquamous pancreatic cancer|metastatic adenosquamous pancreatic cancer
13306|NCT04116073|Unresectable adenosquamous pancreatic cancer|unresectable adenosquamous pancreatic cancer
13307|NCT04116073|Adenosquamous pancreatic cancer|adenosquamous pancreatic cancer
13308|NCT04116073|Programmed cell death protein 1 (PD-1)|programmed cell death protein 1 (pd-1)
13309|NCT04116073|Programmed death-ligand 1 (PD-L1)|programmed death-ligand 1 (pd-l1)
13310|NCT04116047|Oropharyngeal cancer|oropharyngeal cancer
13311|NCT04116047|HPV|hpv
13312|NCT04116021|mastectomy|mastectomy
13313|NCT04115995|Breast reconstruction|breast reconstruction
13314|NCT04115995|Perforator flaps|perforator flaps
13315|NCT04115995|Computer Tomography|computer tomography
13316|NCT04115995|Indocyanine green|indocyanine green
13317|NCT04115995|Fluorescence angiography|fluorescence angiography
13318|NCT04115995|Infrared thermography|infrared thermography
13319|NCT04115995|Dynamic infrared thermography|dynamic infrared thermography
13320|NCT04115995|Doppler ultrasound|doppler ultrasound
13321|NCT04115995|Angiosome|angiosome
13322|NCT04115995|Perforasome|perforasome
13323|NCT04115995|Flap perfusion|flap perfusion
13324|NCT04115982|digital nerve injury|digital nerve injury
13325|NCT04115982|neuroma|neuroma
13326|NCT04115982|cholecalciferol|cholecalciferol
13327|NCT04115969|non-invasive ventilation|non-invasive ventilation
13328|NCT04115969|critical care|critical care
13329|NCT04115917|Scleral Depression|scleral depression
13330|NCT04115917|Visual Analog Scale|visual analog scale
13331|NCT04115917|Pain|pain
13332|NCT04115917|Discomfort|discomfort
13333|NCT04115917|Schocket Scleral Depressor|schocket scleral depressor
13334|NCT04115917|Cotton Tipped Applicator|cotton tipped applicator
13335|NCT04115917|Diabetes|diabetes
13336|NCT04115891|lavandula|lavandula
13337|NCT04115891|phytotherapy|phytotherapy
13338|NCT04115891|aromatherapy|aromatherapy
13339|NCT04115891|dental anxiety|dental anxiety
13340|NCT04115891|anaesthesia|anaesthesia
13341|NCT04115878|atomoxetine|atomoxetine
13342|NCT04115878|oxybutynin|oxybutynin
13343|NCT04115852|fmri|fmri
13344|NCT04115852|interoceptive food processing|interoceptive food processing
13345|NCT04115826|pancreatic duct stone|pancreatic duct stone
13346|NCT04115826|extracorporeal shock-wave lithotripsy|extracorporeal shock-wave lithotripsy
13347|NCT04115826|pancreatoscopy|pancreatoscopy
13348|NCT04115826|quality of life|quality of life
13349|NCT04115826|chronic pancreatitis|chronic pancreatitis
13350|NCT04115813|Adolescents|adolescents
13351|NCT04115813|Young Adults|young adults
13352|NCT04115813|Antiretroviral Therapy|antiretroviral therapy
13353|NCT04115813|Caregivers|caregivers
13354|NCT04115813|Support Groups|support groups
13355|NCT04115800|Sirolimus|sirolimus
13356|NCT04115800|Liposomal|liposomal
13357|NCT04115800|Subconjunctival|subconjunctival
13358|NCT04115774|Disease Registry|disease registry
13359|NCT04115774|Natural History Study|natural history study
13360|NCT04115774|Genotype-Phenotype Correlation|genotype-phenotype correlation
13361|NCT04115774|Brittle Bone Disease|brittle bone disease
13362|NCT04115709|Acute Respiratory Distress Syndrome|acute respiratory distress syndrome
13363|NCT04115709|Intensive Care|intensive care
13364|NCT04115709|Device|device
13365|NCT04115709|Beacon Caresystem©|beacon caresystem©
13366|NCT04115709|Ventilation|ventilation
13367|NCT04115618|esophageal cancer|esophageal cancer
13368|NCT04115618|Chemoradiotherapy|chemoradiotherapy
13369|NCT04115618|Simultaneous Integrated Boost Intensity|simultaneous integrated boost intensity
13370|NCT04115605|Single Incision Sling|single incision sling
13371|NCT04115553|Intracranial Hypertension|intracranial hypertension
13372|NCT04115553|venous drainage|venous drainage
13374|NCT04115553|blood flow|blood flow
13375|NCT04115553|cerebrospinal fluid flow|cerebrospinal fluid flow
13376|NCT04115527|RCT|rct
13377|NCT04115527|Standard lymphadenectomy|standard lymphadenectomy
13378|NCT04115527|Extended lymphadenectomy|extended lymphadenectomy
13379|NCT04115527|Pancreaticoduodenectomy|pancreaticoduodenectomy
13380|NCT04115475|Muscular Diseases, Spinal Muscular Atrophy (SMA), MSOT|muscular diseases, spinal muscular atrophy (sma), msot
13381|NCT04115449|dexmedetomidine, shoulder pain, spinal anesthesia.|dexmedetomidine, shoulder pain, spinal anesthesia.
13579|NCT04114305|eSwatini|eswatini
13382|NCT04115436|LAA isolation, stroke, anticoagulation|laa isolation, stroke, anticoagulation
13383|NCT04115423|Tocilizumab|tocilizumab
13384|NCT04115423|Serious Infection|serious infection
13385|NCT04115423|Rheumatoid Arthritis|rheumatoid arthritis
13386|NCT04115423|Tumor necrosis factor inhibitors|tumor necrosis factor inhibitors
13387|NCT04115410|PD-1 inhibitor|pd-1 inhibitor
13388|NCT04115410|Nivolumab|nivolumab
13389|NCT04115410|Pembrolizumab|pembrolizumab
13390|NCT04115410|Atezolizumab|atezolizumab
13391|NCT04115410|Immune-Related Adverse Events|immune-related adverse events
13392|NCT04115410|Carcinoma, Non-Small-Cell Lung|carcinoma, non-small-cell lung
13393|NCT04115384|intranasal|intranasal
13394|NCT04115384|insulin|insulin
13395|NCT04115358|pulpotomy|pulpotomy
13396|NCT04115332|psychiatric nurses|psychiatric nurses
13397|NCT04115332|workplace violence|workplace violence
13398|NCT04115332|resilience|resilience
13399|NCT04115332|biofeedback training|biofeedback training
13400|NCT04115332|physiological indicators|physiological indicators
13401|NCT04115319|schizophrenia|schizophrenia
13402|NCT04115267|Combined effect|combined effect
13403|NCT04115267|Registry|registry
13404|NCT04115267|Side effects|side effects
13405|NCT04115267|Patient reported outcome|patient reported outcome
13406|NCT04115267|Cancer|cancer
13407|NCT04115254|Magnetic Resonance Imaging (MRI)|magnetic resonance imaging (mri)
13408|NCT04115254|MRIdian Linear Accelerator|mridian linear accelerator
13409|NCT04115254|Pancreas Cancer|pancreas cancer
13410|NCT04115254|Lung Cancer|lung cancer
13411|NCT04115254|Renal Cancer|renal cancer
13412|NCT04115241|leukemia|leukemia
13413|NCT04115241|multiple myeloma|multiple myeloma
13414|NCT04115241|myelodysplastic syndrome|myelodysplastic syndrome
13415|NCT04115241|stem cell transplant|stem cell transplant
13416|NCT04115215|Older adults|older adults
13417|NCT04115215|Cognitive impairment|cognitive impairment
13418|NCT04115215|Motoric Cognitive Risk Syndrome|motoric cognitive risk syndrome
13419|NCT04115215|Physical disfunction|physical disfunction
13420|NCT04115215|Multi-component physical exercise program|multi-component physical exercise program
13421|NCT04115215|Transcranial electrical stimulation|transcranial electrical stimulation
13422|NCT04115189|Sunitinib -|sunitinib -
13423|NCT04115176|chronic periodontitis|chronic periodontitis
13424|NCT04115176|smoking,|smoking,
13425|NCT04115176|periodontal treatment,|periodontal treatment,
13426|NCT04115176|IL-17,|il-17,
13427|NCT04115176|oxidative stress|oxidative stress
13428|NCT04115137|Pelvic Congestion Syndrome|pelvic congestion syndrome
13429|NCT04115137|amplatzer vascular plug|amplatzer vascular plug
13430|NCT04115137|Vascular plug|vascular plug
13431|NCT04115137|metallic embolization device|metallic embolization device
13432|NCT04115137|Chronic pelvic pain|chronic pelvic pain
13433|NCT04115137|embolization procedure|embolization procedure
13434|NCT04115111|malignant pleural mesothelioma|malignant pleural mesothelioma
13435|NCT04115098|spondylitis|spondylitis
13436|NCT04115085|Degeneration|degeneration
13437|NCT04115085|Trapeziometacarpal osteoarthritis|trapeziometacarpal osteoarthritis
13438|NCT04115085|Basal Joint Arthritis|basal joint arthritis
13439|NCT04115085|Arthrosis|arthrosis
13440|NCT04115085|Hand|hand
13441|NCT04115085|Thumb|thumb
13442|NCT04115072|Schistosomiasis|schistosomiasis
13443|NCT04115072|Praziquantel|praziquantel
13444|NCT04115072|Gynaecology|gynaecology
13445|NCT04115072|Female|female
13446|NCT04115059|Waldenstrom Macroglobulinemia|waldenstrom macroglobulinemia
13447|NCT04115059|DASATINIB|dasatinib
13448|NCT04115033|Pain|pain
13449|NCT04115033|Fibromyalgia|fibromyalgia
13450|NCT04115033|Magnetic Resonance Imaging|magnetic resonance imaging
13451|NCT04115033|Percutaneous Electrical Nerve Stimulation|percutaneous electrical nerve stimulation
13452|NCT04115033|Myofascial Pain Syndromes|myofascial pain syndromes
13453|NCT04115033|Veterans|veterans
13454|NCT04114968|HPV self-sampling, cervical cancer screening in older women|hpv self-sampling, cervical cancer screening in older women
13455|NCT04114955|transgender women|transgender women
13456|NCT04114955|HIV prevention|hiv prevention
13457|NCT04114955|HIV testing|hiv testing
13458|NCT04114955|pre-exposure prophylaxis|pre-exposure prophylaxis
13459|NCT04114955|Brazil|brazil
13460|NCT04114942|young adult|young adult
13461|NCT04114942|college|college
13462|NCT04114942|transitions|transitions
13463|NCT04114942|career development|career development
13464|NCT04114942|social skills|social skills
13465|NCT04114929|ventilatory anaerobic threshold|ventilatory anaerobic threshold
13466|NCT04114929|Intensity|intensity
13467|NCT04114929|Exercise Dose|exercise dose
13468|NCT04114929|Standard care|standard care
13469|NCT04114903|Diabetes|diabetes
13470|NCT04114903|Obesity|obesity
13471|NCT04114903|Cannabis|cannabis
13472|NCT04114903|Insulin Sensitivity|insulin sensitivity
13473|NCT04114864|Adolescent|adolescent
13474|NCT04114864|Acceptance and Commitment Therapy, Cognitive therapy|acceptance and commitment therapy, cognitive therapy
13475|NCT04114864|Mindfulness|mindfulness
13476|NCT04114864|Europe|europe
13477|NCT04114825|Biochemical relapse|biochemical relapse
13780|NCT04112888|Pain|pain
13485|NCT04114773|Rehabilitation|rehabilitation
13486|NCT04114773|Fatigue|fatigue
13487|NCT04114773|Relatives|relatives
13488|NCT04114760|12-lead electrocardiography|12-lead electrocardiography
13489|NCT04114760|Emergency medical technician|emergency medical technician
13490|NCT04114760|chest pain|chest pain
13491|NCT04114760|wireless technology|wireless technology
13492|NCT04114760|simulation study|simulation study
13493|NCT04114721|intubation|intubation
13494|NCT04114721|cardiopulmonary resuscitation|cardiopulmonary resuscitation
13495|NCT04114721|Learning curve|learning curve
13496|NCT04114721|videolaryngoscope|videolaryngoscope
13497|NCT04114682|Type 2 diabetes|type 2 diabetes
13498|NCT04114682|NAFLD|nafld
13499|NCT04114682|Metformin|metformin
13500|NCT04114682|Multiparametric MRI|multiparametric mri
13501|NCT04114656|GSK3858279, Pain assessment, Crossover|gsk3858279, pain assessment, crossover
13502|NCT04114643|Frozen Plasma (FP)|frozen plasma (fp)
13503|NCT04114643|Prothrombin Complex Concentrate (PCC)|prothrombin complex concentrate (pcc)
13504|NCT04114643|Octaplex|octaplex
13505|NCT04114643|Coagulation Factor Replacement|coagulation factor replacement
13506|NCT04114643|Transfusion|transfusion
13507|NCT04114643|Bleeding Cardiac Surgical Patients|bleeding cardiac surgical patients
13508|NCT04114643|Pilot|pilot
13509|NCT04114643|Phase 2|phase 2
13510|NCT04114630|Chronic migraine|chronic migraine
13511|NCT04114630|Migraine|migraine
13512|NCT04114630|Transformative migraine|transformative migraine
13513|NCT04114630|Neurologic disease|neurologic disease
13514|NCT04114630|Unremitting pain|unremitting pain
13515|NCT04114630|Progressive over time|progressive over time
13516|NCT04114630|Nausea|nausea
13517|NCT04114630|Vomiting|vomiting
13518|NCT04114630|Sensitivity to light,|sensitivity to light,
13519|NCT04114630|Sensitivity to sound|sensitivity to sound
13520|NCT04114630|Pain localized to one side of head,|pain localized to one side of head,
13521|NCT04114630|Painful headache|painful headache
13522|NCT04114630|Pain in head|pain in head
13523|NCT04114630|Head throbbing|head throbbing
13524|NCT04114630|Sinus headache|sinus headache
13525|NCT04114630|Pounding headache|pounding headache
13526|NCT04114617|Swallowing|swallowing
13527|NCT04114617|Deglutition|deglutition
13528|NCT04114565|prevalence|prevalence
13529|NCT04114565|mood disorders|mood disorders
13530|NCT04114565|affective disorders|affective disorders
13531|NCT04114565|major depressive disorder|major depressive disorder
13532|NCT04114565|service use|service use
13533|NCT04114565|migration health|migration health
13534|NCT04114565|global mental health|global mental health
13535|NCT04114552|inversion trauma|inversion trauma
13536|NCT04114552|Ankle sprain|ankle sprain
13537|NCT04114552|physical examination|physical examination
13538|NCT04114552|therapy|therapy
13539|NCT04114552|recurrence|recurrence
13540|NCT04114539|Tourette Syndrome|tourette syndrome
13541|NCT04114513|Dietary fiber|dietary fiber
13542|NCT04114513|Gut Microbiota|gut microbiota
13543|NCT04114513|Cardiovascular risk factors|cardiovascular risk factors
13544|NCT04114513|Lipid metabolism|lipid metabolism
13545|NCT04114500|Estradiol|estradiol
13546|NCT04114500|FET|fet
13547|NCT04114500|IVF|ivf
13548|NCT04114500|Progesterone|progesterone
13549|NCT04114487|Cognitive rehabilitation|cognitive rehabilitation
13550|NCT04114487|Dual task|dual task
13551|NCT04114487|Balance|balance
13552|NCT04114487|Motor skills|motor skills
13553|NCT04114448|Hemophilia|hemophilia
13554|NCT04114448|Therapeutic exercise|therapeutic exercise
13555|NCT04114448|Physical therapy|physical therapy
13556|NCT04114448|Randomized controlled trial|randomized controlled trial
13557|NCT04114448|Pain perception|pain perception
13558|NCT04114448|Range of movement|range of movement
13559|NCT04114422|cancer|cancer
13560|NCT04114422|surgery|surgery
13561|NCT04114422|exercise training|exercise training
13562|NCT04114422|physical therapy|physical therapy
13563|NCT04114396|Severe Asthma|severe asthma
13564|NCT04114396|Anti-IL5|anti-il5
13565|NCT04114396|Asthma|asthma
13566|NCT04114344|Woman|woman
13567|NCT04114344|Inguinal Hernia|inguinal hernia
13568|NCT04114344|TAPP|tapp
13569|NCT04114344|TEP|tep
13570|NCT04114344|Outpatient Surgery|outpatient surgery
804503|NCT00236717|Prophylaxis|prophylaxis
13571|NCT04114344|Ambulatory Surgery|ambulatory surgery
13572|NCT04114331|forward head posture|forward head posture
13573|NCT04114305|Human Immunodeficiency Virus|human immunodeficiency virus
13574|NCT04114305|HIV-Exposed Uninfected Children|hiv-exposed uninfected children
13575|NCT04114305|Prevention of Mother to Child Transmission of HIV|prevention of mother to child transmission of hiv
13576|NCT04114305|Orphans and Vulnerable Children|orphans and vulnerable children
13577|NCT04114305|Mentor Mothers|mentor mothers
13578|NCT04114305|Swaziland|swaziland
13580|NCT04114292|Ulcerative Colitis|ulcerative colitis
13581|NCT04114292|tudca|tudca
13582|NCT04114292|tauroursodeoxycholic acid|tauroursodeoxycholic acid
13583|NCT04114279|surgical simulator|surgical simulator
13584|NCT04114266|Urologic Surgical Procedure|urologic surgical procedure
13585|NCT04114266|Female|female
13586|NCT04114253|Viscoelastic testing|viscoelastic testing
13587|NCT04114253|Coagulation|coagulation
13588|NCT04114253|Quantra|quantra
13589|NCT04114253|Hemostasis|hemostasis
13590|NCT04114240|erectil dysfunction|erectil dysfunction
13591|NCT04114240|sildenafil|sildenafil
13592|NCT04114240|xybilun|xybilun
13593|NCT04114188|transplant medicine|transplant medicine
13594|NCT04114175|amputees|amputees
13595|NCT04114175|rehabilitation|rehabilitation
13596|NCT04114175|energy expenditure|energy expenditure
13597|NCT04114175|deep muscles of the back|deep muscles of the back
13599|NCT04114162|Septic shock|septic shock
13600|NCT04114162|Fluid overload|fluid overload
13601|NCT04114162|Quantification|quantification
13602|NCT04114162|Bioimpedancemetry|bioimpedancemetry
13603|NCT04114162|Capillary leak|capillary leak
13604|NCT04114162|Fluid responsiveness|fluid responsiveness
13605|NCT04114149|Pain|pain
13606|NCT04114149|Transcutaneous Electric Nerve Stimulation|transcutaneous electric nerve stimulation
13607|NCT04114149|Analgesics, Opioid|analgesics, opioid
13608|NCT04114136|Anti-PD-1 monoclonal antibody (mAb)|anti-pd-1 monoclonal antibody (mab)
13609|NCT04114136|tumor infiltrating lymphocytes (TIL)|tumor infiltrating lymphocytes (til)
13610|NCT04114123|Reward-driven Eating|reward-driven eating
13611|NCT04114123|Infant|infant
13612|NCT04114123|Maternal|maternal
13613|NCT04114097|topical corticosteroids|topical corticosteroids
13614|NCT04114097|topical calcineurin inhibitors|topical calcineurin inhibitors
13615|NCT04114071|physical activity|physical activity
13616|NCT04114071|older Black women|older black women
13617|NCT04114071|overweight|overweight
13618|NCT04114071|obesity|obesity
13619|NCT04114071|text messages|text messages
13620|NCT04114058|hip arthroscopy|hip arthroscopy
13621|NCT04114032|High risk surgical patients|high risk surgical patients
13622|NCT04114032|Risk stratification|risk stratification
13623|NCT04114032|Natriuretic peptide testing|natriuretic peptide testing
13624|NCT04114006|gastric intestinal metaplasia|gastric intestinal metaplasia
13625|NCT04114006|gastric neoplasia|gastric neoplasia
13626|NCT04113980|acute pain|acute pain
13627|NCT04113980|anxiety|anxiety
13628|NCT04113980|children|children
13629|NCT04113980|blood collection|blood collection
13630|NCT04113980|nursing|nursing
13631|NCT04113967|Biodanza|biodanza
13632|NCT04113967|Alzheimer Dementia|alzheimer dementia
13633|NCT04113967|dance therapy|dance therapy
13634|NCT04113967|complementary therapies|complementary therapies
13635|NCT04113967|physical activity|physical activity
13636|NCT04113954|Healthy volunteer|healthy volunteer
13637|NCT04113954|Regional anesthesia|regional anesthesia
13638|NCT04113954|Compartment Syndrome|compartment syndrome
13639|NCT04113928|Broccoli|broccoli
13640|NCT04113928|Bioavailability|bioavailability
13641|NCT04113928|Ileostomists|ileostomists
13642|NCT04113928|Randomised controlled trial|randomised controlled trial
13643|NCT04113928|Phytochemical|phytochemical
13644|NCT04113902|Human Papilloma Virus vaccine|human papilloma virus vaccine
13645|NCT04113902|Health education|health education
13646|NCT04113902|Nursing|nursing
13647|NCT04113902|Adolescent Health|adolescent health
13648|NCT04113889|PCOS|pcos
13649|NCT04113889|Acetyl-L-Carnitine|acetyl-l-carnitine
13650|NCT04113876|sleep quality|sleep quality
13651|NCT04113876|circadian rhythm|circadian rhythm
13652|NCT04113876|nursing activities|nursing activities
13653|NCT04113837|foods, nutrient profile, dietary fiber, omega 3 fatty acids|foods, nutrient profile, dietary fiber, omega 3 fatty acids
13654|NCT04113811|Prostate cancer|prostate cancer
13655|NCT04113811|Focal therapy|focal therapy
13656|NCT04113811|Microwave ablation|microwave ablation
13657|NCT04113798|women|women
13658|NCT04113798|exercise|exercise
13659|NCT04113798|mental health|mental health
13660|NCT04113785|total knee arthroplasty|total knee arthroplasty
13661|NCT04113785|knee implant|knee implant
13662|NCT04113785|osteoarthritis|osteoarthritis
13663|NCT04113746|Asthma|asthma
13664|NCT04113746|Obesity|obesity
13665|NCT04113746|Self-management behaviors|self-management behaviors
13666|NCT04113681|Embolization, Osteoarthritis, Knee, Geniculate Artery|embolization, osteoarthritis, knee, geniculate artery
13667|NCT04113655|TDA202|tda202
804609|NCT00236444|Child|child
13668|NCT04113655|acellular pertussis vaccine|acellular pertussis vaccine
13669|NCT04113655|antibody persistence at 2 years after vaccination|antibody persistence at 2 years after vaccination
13670|NCT04113655|Pertagen|pertagen
13671|NCT04113655|Boostagen|boostagen
13672|NCT04113655|aP vaccine|ap vaccine
13673|NCT04113642|abdominal muscles|abdominal muscles
13674|NCT04113642|ultrasonography|ultrasonography
13675|NCT04113642|exercise|exercise
13676|NCT04113642|lumbar fascia|lumbar fascia
13677|NCT04113590|cholecystectomy|cholecystectomy
13678|NCT04113590|gall stone surgery|gall stone surgery
13679|NCT04113590|scarless surgery|scarless surgery
13680|NCT04113590|cholelithiasis|cholelithiasis
13681|NCT04113577|old people|old people
13682|NCT04113577|elderly|elderly
13683|NCT04113577|minor neurocognitive disorder|minor neurocognitive disorder
13684|NCT04113577|major neurocognitive disorder|major neurocognitive disorder
13685|NCT04113577|neurocognitive disorder|neurocognitive disorder
13686|NCT04113577|mild cogntitive impairment|mild cogntitive impairment
13687|NCT04113577|MCI|mci
13688|NCT04113577|alzheimer disease|alzheimer disease
13689|NCT04113577|app|app
13690|NCT04113577|usability|usability
13691|NCT04113577|ergonomic|ergonomic
13692|NCT04113577|satisfaction|satisfaction
13693|NCT04113525|Stroke Rehabilitation|stroke rehabilitation
13694|NCT04113525|Neuromodulation|neuromodulation
13695|NCT04113525|Transcutaneous Spinal Direct Current Stimulation|transcutaneous spinal direct current stimulation
13696|NCT04113525|Robotic Therapy|robotic therapy
13697|NCT04113525|Transcutaneous Peripheral Direct Current Stimulation|transcutaneous peripheral direct current stimulation
13698|NCT04113525|Spasticity|spasticity
13699|NCT04113525|Hemiparesis|hemiparesis
13700|NCT04113499|pancreatic necrosis|pancreatic necrosis
13701|NCT04113499|pancreatic necrotic collection|pancreatic necrotic collection
13702|NCT04113499|transenteric drainage|transenteric drainage
13703|NCT04113499|necrosectomy|necrosectomy
13704|NCT04113486|renal cancer|renal cancer
13705|NCT04113486|tumor biomarker|tumor biomarker
13706|NCT04113434|Acute Respiratory Distress Syndrome|acute respiratory distress syndrome
13707|NCT04113434|ARDS|ards
13708|NCT04113421|pulmonary embolism|pulmonary embolism
13709|NCT04113421|anticoagulation|anticoagulation
13710|NCT04113382|Colon Cleansing|colon cleansing
13711|NCT04113382|Preparation for Colonoscopy|preparation for colonoscopy
13712|NCT04113369|Cross-education|cross-education
13713|NCT04113369|Interlimb transfer|interlimb transfer
13714|NCT04113369|Electro muscular stimulation|electro muscular stimulation
13715|NCT04113369|Muscle strength|muscle strength
13716|NCT04113343|remimazolam|remimazolam
13717|NCT04113304|Parenting Interventions|parenting interventions
13718|NCT04113304|Parent Training|parent training
13719|NCT04113304|Technology-based intervention|technology-based intervention
13720|NCT04113304|Disruptive Behavior Problems|disruptive behavior problems
13721|NCT04113304|Early Childhood|early childhood
13722|NCT04113291|DASH Diet|dash diet
13723|NCT04113291|Low socioeconomic status|low socioeconomic status
13724|NCT04113291|HFPEF|hfpef
13725|NCT04113252|opioid buyback|opioid buyback
13726|NCT04113252|opioid misuse prevention|opioid misuse prevention
13727|NCT04113239|Gut Metagenetics|gut metagenetics
13728|NCT04113239|Diabetes Mellitus, Type 2|diabetes mellitus, type 2
13729|NCT04113239|Genetics|genetics
13730|NCT04113239|Microbiome|microbiome
13731|NCT04113239|FFQ|ffq
13732|NCT04113239|GPAQ|gpaq
13733|NCT04113226|chemotherapy|chemotherapy
13734|NCT04113226|Diffuse large B cell lymphoma (DLBCL)|diffuse large b cell lymphoma (dlbcl)
13735|NCT04113226|Relapse|relapse
13736|NCT04113226|activities of patients daily living|activities of patients daily living
13737|NCT04113226|Elderly|elderly
13738|NCT04113226|Lenalidomide|lenalidomide
13739|NCT04113187|angiogenesis|angiogenesis
13740|NCT04113187|epistaxis|epistaxis
13741|NCT04113187|propranolol|propranolol
13742|NCT04113161|Peer Navigators|peer navigators
13743|NCT04113161|Disruptive Behavior Disorder|disruptive behavior disorder
13744|NCT04113161|Access Inequalities|access inequalities
13745|NCT04113070|Child health care|child health care
13746|NCT04113070|Weight status|weight status
13747|NCT04113070|Environment|environment
13748|NCT04113070|puberty|puberty
13749|NCT04113044|PRO|pro
13750|NCT04113044|HOOS|hoos
13751|NCT04113044|KOOS|koos
13752|NCT04113044|FAAM|faam
13753|NCT04113044|PROMIS|promis
13754|NCT04113044|QuickDASH|quickdash
13755|NCT04113044|PSEQ|pseq
13756|NCT04113044|PAM|pam
13757|NCT04113031|Sprint|sprint
13758|NCT04113031|Jump|jump
13759|NCT04113031|Maximal Strength|maximal strength
13760|NCT04113031|Power|power
13761|NCT04112992|long bone defect|long bone defect
13762|NCT04112979|Auditory stimulation|auditory stimulation
13763|NCT04112979|adenotonsillectomy|adenotonsillectomy
13764|NCT04112979|pain|pain
13765|NCT04112979|agitation|agitation
13766|NCT04112979|awakening|awakening
13767|NCT04112966|Lymphedema|lymphedema
13768|NCT04112966|Prevention|prevention
20871|NCT04067011|Vaccine|vaccine
13769|NCT04112953|transesophagel echocardiography cardiac surgery kidney function|transesophagel echocardiography cardiac surgery kidney function
13770|NCT04112940|Swallowing|swallowing
13771|NCT04112927|Obstructive Sleep Apnea|obstructive sleep apnea
13772|NCT04112927|OSA|osa
13773|NCT04112927|Respiratory Sound Analysis|respiratory sound analysis
13774|NCT04112927|AwakeOSA|awakeosa
13775|NCT04112901|Trans-femoral amputation|trans-femoral amputation
13776|NCT04112901|Limb prosthesis|limb prosthesis
13777|NCT04112901|Microprocessor Controlled Knee Joints|microprocessor controlled knee joints
13778|NCT04112901|Community Outcome Measures|community outcome measures
13779|NCT04112888|Episiotomy|episiotomy
13781|NCT04112888|Colagen|colagen
13782|NCT04112875|L-arginine|l-arginine
13783|NCT04112875|Asymmetric Dimethylarginine|asymmetric dimethylarginine
13784|NCT04112875|Arginase|arginase
13785|NCT04112875|Sarcopenia|sarcopenia
13786|NCT04112875|Myostatin|myostatin
13787|NCT04112875|Follistatin|follistatin
13788|NCT04112875|Type 2 diabetes mellitus|type 2 diabetes mellitus
13789|NCT04112875|Vascular smooth muscle|vascular smooth muscle
13790|NCT04112875|endothelial function|endothelial function
13791|NCT04112862|GLUT1 deficiency syndrome|glut1 deficiency syndrome
13792|NCT04112862|sodium lactate infusion|sodium lactate infusion
13793|NCT04112862|epilepsy|epilepsy
13794|NCT04112849|Heart Failure|heart failure
13795|NCT04112836|pancreatic cancer|pancreatic cancer
13796|NCT04112836|locally advanced|locally advanced
13797|NCT04112836|metastatic|metastatic
13798|NCT04112836|nutritional status|nutritional status
13799|NCT04112836|exocrine pancreatic insufficiency|exocrine pancreatic insufficiency
13800|NCT04112836|chemotherapy|chemotherapy
13801|NCT04112836|dose-intensity|dose-intensity
13802|NCT04112810|Graft-versus-host disease|graft-versus-host disease
13803|NCT04112771|Penehyclidine|penehyclidine
13804|NCT04112771|Postoperative nausea and vomiting|postoperative nausea and vomiting
13805|NCT04112771|Bimaxillary surgery|bimaxillary surgery
13806|NCT04112758|HIIT|hiit
13807|NCT04112758|executive function|executive function
13808|NCT04112758|ADHD|adhd
13809|NCT04112758|chronic exercise|chronic exercise
13810|NCT04112745|Complementary Therapy|complementary therapy
13811|NCT04112745|Static Magnet|static magnet
13812|NCT04112745|Pain Relief|pain relief
13813|NCT04112745|Hospitalized Patients|hospitalized patients
13814|NCT04112732|Multivitamin|multivitamin
13815|NCT04112732|Aging|aging
13816|NCT04112732|Stress|stress
13817|NCT04112732|Everyday Function|everyday function
13818|NCT04112732|Well-Being|well-being
13819|NCT04112693|Achalasia|achalasia
13820|NCT04112693|peroral endoscopic myotomy|peroral endoscopic myotomy
13821|NCT04112693|neuro-glio-epithelial unit|neuro-glio-epithelial unit
13822|NCT04112680|Misinformation|misinformation
13823|NCT04112680|Communication|communication
13824|NCT04112680|Infectious diseases|infectious diseases
13825|NCT04112667|vision|vision
13826|NCT04112667|retina|retina
13827|NCT04112667|dark adaptation|dark adaptation
13828|NCT04112667|light sensitivity|light sensitivity
13829|NCT04112667|spectral domain optical coherence tomography|spectral domain optical coherence tomography
13830|NCT04112667|quantitative autofluorescence|quantitative autofluorescence
13831|NCT04112667|optical coherence tomography angiography|optical coherence tomography angiography
13832|NCT04112641|peripheral neuropathy|peripheral neuropathy
13833|NCT04112641|chemotherapy|chemotherapy
13834|NCT04112641|taxane|taxane
13835|NCT04112641|platinum compound|platinum compound
13836|NCT04112602|mucopolysaccharidosis|mucopolysaccharidosis
13837|NCT04112602|lung cathepsins|lung cathepsins
13838|NCT04112602|proteases inhibitors|proteases inhibitors
13839|NCT04112602|glycosaminoglycans|glycosaminoglycans
13840|NCT04112576|echocardiogram|echocardiogram
13841|NCT04112550|lateral lumbar interbody fusion|lateral lumbar interbody fusion
13842|NCT04112550|minimally invasive spinal surgery|minimally invasive spinal surgery
13843|NCT04112537|Tuberous Sclerosis Complex|tuberous sclerosis complex
13844|NCT04112537|MTOR associated protein|mtor associated protein
13845|NCT04112537|Neurocutaneous Syndromes|neurocutaneous syndromes
13846|NCT04112537|High-Throughput Nucleotide Sequencing|high-throughput nucleotide sequencing
13847|NCT04112485|Lumbar disc herniation , Open Discectomy, Micrdiscectomy|lumbar disc herniation , open discectomy, micrdiscectomy
13848|NCT04112433|Cardiac Signal|cardiac signal
13849|NCT04112433|Ablation|ablation
13850|NCT04112433|Signal Processing|signal processing
13851|NCT04112433|Intracardiac Electrogram|intracardiac electrogram
13852|NCT04112407|P. Acnes|p. acnes
13853|NCT04112407|shoulder arthroplasty|shoulder arthroplasty
13854|NCT04112407|blue light therapy|blue light therapy
13855|NCT04112407|benzoyl peroxide|benzoyl peroxide
13856|NCT04112342|pO2 Measurements, EPR, Carcinoma; India Ink; OxySPOT|po2 measurements, epr, carcinoma; india ink; oxyspot
13857|NCT04112329|Exercise therapy|exercise therapy
13858|NCT04112329|Physical fitness|physical fitness
13859|NCT04112329|Gaming|gaming
13860|NCT04112329|Child|child
13861|NCT04112329|Healthy lifestyle|healthy lifestyle
13862|NCT04112329|Fitness testing|fitness testing
13863|NCT04112316|Heart Failure, HFrEF, Low T3 Syndrome|heart failure, hfref, low t3 syndrome
13864|NCT04112290|Atrial fibrillation|atrial fibrillation
13865|NCT04112290|Ventricular tachycardia|ventricular tachycardia
13866|NCT04112290|Arrhythmia|arrhythmia
13867|NCT04112290|Hypertrophic cardiomyopathy|hypertrophic cardiomyopathy
13868|NCT04112251|Childhood Obesity|childhood obesity
13869|NCT04112251|Cocoa Flavanols|cocoa flavanols
13870|NCT04112251|Adolescent Obesity|adolescent obesity
13871|NCT04112212|Fluorescence|fluorescence
13872|NCT04112212|Endoscopy|endoscopy
13873|NCT04112212|Vedolizumab-800CW|vedolizumab-800cw
13874|NCT04112186|Mindfulness|mindfulness
13875|NCT04112186|Opiate Use Disorder|opiate use disorder
13973|NCT04111679|Laparoscopy|laparoscopy
13876|NCT04112186|Drug Cue Reactivity|drug cue reactivity
13877|NCT04112186|Inhibitory Control|inhibitory control
13878|NCT04112186|Salience Attribution|salience attribution
13879|NCT04112173|balance|balance
13880|NCT04112173|self-efficacy|self-efficacy
13881|NCT04112173|exercise|exercise
13882|NCT04112173|postural control|postural control
13883|NCT04112160|stent removal, pain, kidney stones|stent removal, pain, kidney stones
13884|NCT04112147|antroquinonol, Chronic Hepatitis B|antroquinonol, chronic hepatitis b
13885|NCT04112121|faith|faith
13886|NCT04112121|religion|religion
13887|NCT04112121|hospitalization|hospitalization
13888|NCT04112121|immunology|immunology
13889|NCT04112121|psychoneuroimmunology|psychoneuroimmunology
13890|NCT04112121|theology|theology
13891|NCT04112121|fMRI|fmri
13892|NCT04112108|percutaneous mitral commissurotomy|percutaneous mitral commissurotomy
13893|NCT04112108|follow up|follow up
13894|NCT04112095|Daily birth control|daily birth control
13895|NCT04112082|neurofeedback|neurofeedback
13896|NCT04112082|Attention Deficit Hyperactivity Disorder (ADHD)|attention deficit hyperactivity disorder (adhd)
13897|NCT04112082|attention|attention
13898|NCT04112082|executive function|executive function
13899|NCT04112082|electroencephalogram (EEG)|electroencephalogram (eeg)
13900|NCT04112082|adult ADHD|adult adhd
13901|NCT04112082|wearable sensors|wearable sensors
13902|NCT04112069|Bionic pancreas|bionic pancreas
13903|NCT04112069|Closed loop|closed loop
13904|NCT04112069|Insulin|insulin
13905|NCT04112069|Continuous glucose monitor|continuous glucose monitor
13906|NCT04112056|Mild gastrointestinal disorders|mild gastrointestinal disorders
13907|NCT04112056|Infant formula|infant formula
13908|NCT04112056|Infant gastrointestinal symptoms questionnaire|infant gastrointestinal symptoms questionnaire
13909|NCT04112043|systolic blood pressure (SBP)|systolic blood pressure (sbp)
13910|NCT04112043|cardiovascular (CV) disease|cardiovascular (cv) disease
13911|NCT04112017|Hyalunic acid|hyalunic acid
13912|NCT04112017|Filler|filler
13913|NCT04112017|Dorsal hand|dorsal hand
13914|NCT04112017|Medical device|medical device
13915|NCT04112004|liver transplantation|liver transplantation
13916|NCT04112004|perioperative sodium|perioperative sodium
13917|NCT04112004|sodium|sodium
13918|NCT04111991|Behavior Therapy, Cognitive|behavior therapy, cognitive
13919|NCT04111991|Post-Concussion Syndrome|post-concussion syndrome
13920|NCT04111978|maintenance therapy|maintenance therapy
13921|NCT04111978|aromatase inhibitor|aromatase inhibitor
13922|NCT04111978|primary ovarian cancer|primary ovarian cancer
13923|NCT04111978|estrogen-receptor|estrogen-receptor
13924|NCT04111965|Dry eye|dry eye
13925|NCT04111965|propylene glycol|propylene glycol
13926|NCT04111939|opioid|opioid
13927|NCT04111939|Opioid Use Disorder (OUD)|opioid use disorder (oud)
13928|NCT04111939|overdose|overdose
13929|NCT04111939|addiction|addiction
13930|NCT04111939|Naloxone|naloxone
13931|NCT04111939|Buprenorphine|buprenorphine
13932|NCT04111939|methadone|methadone
13933|NCT04111939|evidence based practices|evidence based practices
13934|NCT04111939|community engagement|community engagement
13935|NCT04111926|Elderly patients|elderly patients
13936|NCT04111926|Major non-cardiac surgery|major non-cardiac surgery
13937|NCT04111926|Dexmedetomidine|dexmedetomidine
13938|NCT04111926|long-term survival|long-term survival
13939|NCT04111913|anlotinib|anlotinib
13940|NCT04111848|Magnisum sulfate|magnisum sulfate
13941|NCT04111848|Ketamine|ketamine
13942|NCT04111848|Analgesia|analgesia
13943|NCT04111848|Breast Cancer Surgeries|breast cancer surgeries
13944|NCT04111835|cervical cancer|cervical cancer
13945|NCT04111835|cervical screening|cervical screening
13946|NCT04111835|HPV testing|hpv testing
13947|NCT04111809|Multiple Myeloma|multiple myeloma
13948|NCT04111809|intravenous bisphosphonate|intravenous bisphosphonate
13949|NCT04111809|bone markers|bone markers
13950|NCT04111783|anesthesia|anesthesia
13951|NCT04111783|Preoperative rapid POU ultrasound|preoperative rapid pou ultrasound
13952|NCT04111783|clinical trials|clinical trials
13953|NCT04111770|IVUS, PCI, Left Main|ivus, pci, left main
13954|NCT04111744|Coronary Artery Bypass Graft Surgery|coronary artery bypass graft surgery
13955|NCT04111744|Physical Activity|physical activity
804610|NCT00236444|adolescent|adolescent
13956|NCT04111744|Coronary Artery Disease|coronary artery disease
13957|NCT04111744|Physical Training|physical training
13958|NCT04111731|Radiofrequency catheter ablation|radiofrequency catheter ablation
13959|NCT04111731|Cryoballoon pulmonary vein isolation|cryoballoon pulmonary vein isolation
13960|NCT04111731|Rhythmia|rhythmia
13961|NCT04111731|Orion catheter|orion catheter
13962|NCT04111731|Posterior wall isolation|posterior wall isolation
13963|NCT04111731|Electrophysiological study|electrophysiological study
13964|NCT04111731|Omron device|omron device
13965|NCT04111705|IFCT|ifct
13966|NCT04111705|ORAKLE|orakle
13967|NCT04111705|NSCLC|nsclc
13968|NCT04111705|ALK-positive|alk-positive
13969|NCT04111705|monotherapy|monotherapy
13970|NCT04111692|hepatic cyst, kidney cyst, polycystic liver disease, ADPKD|hepatic cyst, kidney cyst, polycystic liver disease, adpkd
13971|NCT04111679|Surgical skill|surgical skill
13972|NCT04111679|Music|music
13974|NCT04111653|mud therapy|mud therapy
13975|NCT04111653|natural mineral water|natural mineral water
13976|NCT04111653|barium|barium
13977|NCT04111653|poultices|poultices
13978|NCT04111653|skin transfer|skin transfer
13979|NCT04111640|neurodegenerative diseas|neurodegenerative diseas
13980|NCT04111640|non-pharmacological treatments|non-pharmacological treatments
13981|NCT04111640|cognitive training|cognitive training
13982|NCT04111588|Diagnosis|diagnosis
13983|NCT04111588|Magnetic Resonance Imaging|magnetic resonance imaging
13984|NCT04111588|Positron-Emission Tomography|positron-emission tomography
13985|NCT04111588|PET-tracer|pet-tracer
13986|NCT04111575|cesarean section|cesarean section
13987|NCT04111575|Music therapy|music therapy
13988|NCT04111575|Anxiety|anxiety
13989|NCT04111575|Pain|pain
13990|NCT04111562|Cranial defect|cranial defect
13991|NCT04111562|skull bone defects|skull bone defects
13992|NCT04111549|Veterans|veterans
13993|NCT04111549|Rehabilitation|rehabilitation
13994|NCT04111549|Cognitive training|cognitive training
13995|NCT04111549|Telehealth|telehealth
13996|NCT04111536|Heart Failure, HFpEF, Low T3 Syndrome|heart failure, hfpef, low t3 syndrome
13997|NCT04111471|Microbiome|microbiome
13998|NCT04111471|Prebiotic|prebiotic
13999|NCT04111432|Inactivated Enterovirus Type 71 (EV71) Vaccine|inactivated enterovirus type 71 (ev71) vaccine
14000|NCT04111432|Concomitant vaccination|concomitant vaccination
14001|NCT04111432|Safety|safety
14002|NCT04111432|Immunogenicity|immunogenicity
14003|NCT04111432|Infant|infant
14004|NCT04111419|intensive management|intensive management
14005|NCT04111419|blood pressure|blood pressure
14006|NCT04111419|blood cholesterol|blood cholesterol
14007|NCT04111406|Epidural Analgesia|epidural analgesia
14008|NCT04111406|Postoperative Pain|postoperative pain
14009|NCT04111354|pacemaker|pacemaker
14010|NCT04111354|implantation|implantation
14011|NCT04111354|mobilization|mobilization
14012|NCT04111354|complication|complication
14013|NCT04111341|Sjögren's syndrome|sjögren's syndrome
14014|NCT04111341|Traditional Chinese Medicine|traditional chinese medicine
14015|NCT04111341|Herbs|herbs
14016|NCT04111341|Clinical trial|clinical trial
14017|NCT04111341|Gan-Lu-Yin|gan-lu-yin
14018|NCT04111341|Jia-wei-Xiao-yao-San|jia-wei-xiao-yao-san
14019|NCT04111341|Ye-Jiao-Teng|ye-jiao-teng
14020|NCT04111341|Suan-Zao-Ren|suan-zao-ren
14021|NCT04111315|Pain medications|pain medications
14022|NCT04111315|Non-opioid pain medications|non-opioid pain medications
14023|NCT04111315|Educational intervention|educational intervention
14024|NCT04111263|Microbiome|microbiome
14025|NCT04111263|Intestinal permeability|intestinal permeability
14026|NCT04111263|Cognition|cognition
14027|NCT04111263|Immune|immune
14028|NCT04111263|Fiber|fiber
14029|NCT04111263|Military|military
14030|NCT04111263|Altitude|altitude
14031|NCT04111263|Polyphenol|polyphenol
14032|NCT04111250|Dental implants|dental implants
14033|NCT04111250|Maxillary sinus augmentation|maxillary sinus augmentation
14034|NCT04111250|Crestal approach|crestal approach
14035|NCT04111211|Alzheimer's disease|alzheimer's disease
14036|NCT04111211|related disorders|related disorders
14037|NCT04111211|Mild Cognitive Impairment|mild cognitive impairment
14038|NCT04111198|Epicardial fat tissue|epicardial fat tissue
14039|NCT04111198|Cardiac MRI|cardiac mri
14040|NCT04111198|Coronary Artery disease|coronary artery disease
14041|NCT04111159|Sedation anesthesia fiberoptic bronchoscopy|sedation anesthesia fiberoptic bronchoscopy
14042|NCT04111146|vitamin D|vitamin d
14043|NCT04111146|liver transplant|liver transplant
14044|NCT04111146|hospital stay|hospital stay
14045|NCT04111133|Cirrhotic cardiomyopathy|cirrhotic cardiomyopathy
14046|NCT04111133|Left ventricular diatolic dysfunction|left ventricular diatolic dysfunction
14047|NCT04111133|Carvedilol|carvedilol
14048|NCT04111133|Ivabradine|ivabradine
14049|NCT04111120|thromboelastography|thromboelastography
14050|NCT04111120|variceal bleeding|variceal bleeding
14051|NCT04111081|hemorrhoidectiomy|hemorrhoidectiomy
14052|NCT04111081|postoperative pain|postoperative pain
14053|NCT04111081|auricular pressure|auricular pressure
14054|NCT04111068|Macular Degeneration|macular degeneration
14055|NCT04111068|Brain Stimulation|brain stimulation
14056|NCT04111068|Psychophysics|psychophysics
14057|NCT04111068|Reading|reading
14058|NCT04111068|tDCS|tdcs
14059|NCT04111068|RSVP|rsvp
14060|NCT04111068|Visual Acuity|visual acuity
14061|NCT04111068|Uncrowded Visual Acuity|uncrowded visual acuity
14062|NCT04111068|Crowded Visual Acuity|crowded visual acuity
14063|NCT04111042|Malignant colonic obstruction|malignant colonic obstruction
14064|NCT04111042|self-expandable metallic stent|self-expandable metallic stent
14065|NCT04111029|Hepatocellular carcinoma|hepatocellular carcinoma
14066|NCT04111029|Cell Free tumor DNA|cell free tumor dna
14067|NCT04111029|Liquid Biopsy|liquid biopsy
14068|NCT04111016|Early childhood development|early childhood development
14069|NCT04111016|Responsive parenting|responsive parenting
14070|NCT04111016|Nutrition|nutrition
14071|NCT04111016|WASH|wash
14072|NCT04111016|Stimulation|stimulation
14073|NCT04111016|Parenting|parenting
14074|NCT04111016|Integrated Interventions|integrated interventions
14075|NCT04111003|fiber-reinforced composite|fiber-reinforced composite
14076|NCT04110990|Influenza|influenza
14077|NCT04110990|Grippe|grippe
14078|NCT04110990|Emergency Services|emergency services
14079|NCT04110990|Influenza, Human|influenza, human
14080|NCT04110977|Head-and-neck cancer|head-and-neck cancer
14081|NCT04110977|radiotherapy|radiotherapy
14082|NCT04110977|radiation dermatitis|radiation dermatitis
14083|NCT04110977|oral mucositis|oral mucositis
14084|NCT04110977|reminder app|reminder app
14085|NCT04110964|Telomeres|telomeres
14086|NCT04110964|Telomerase|telomerase
14087|NCT04110964|Critical limb ischemia|critical limb ischemia
14088|NCT04110964|PAD|pad
14089|NCT04110964|AAV|aav
14090|NCT04110964|Gene therapy|gene therapy
14091|NCT04110951|Asthma|asthma
14092|NCT04110951|Yoga|yoga
14093|NCT04110951|Breathing exercises|breathing exercises
14094|NCT04110951|Quality of life|quality of life
14095|NCT04110951|Nursing|nursing
14096|NCT04110938|PICU|picu
14097|NCT04110938|Paediatric|paediatric
14098|NCT04110938|Early mobilisation|early mobilisation
14099|NCT04110938|Early rehabilitation|early rehabilitation
14100|NCT04110938|Observational|observational
14101|NCT04110925|CT imaging|ct imaging
14102|NCT04110925|next generation sequencing|next generation sequencing
14103|NCT04110925|myelodysplastic syndrome|myelodysplastic syndrome
14104|NCT04110912|Cardiac arrest, Trauma, Acute stroke, and Sepsis|cardiac arrest, trauma, acute stroke, and sepsis
14105|NCT04110886|Pain|pain
14106|NCT04110886|Postoperative Pain|postoperative pain
14107|NCT04110873|antroquinonol, Atopic dermatitis|antroquinonol, atopic dermatitis
14108|NCT04110782|223-Radium-dicloride|223-radium-dicloride
14109|NCT04110782|Radical prostatectomy|radical prostatectomy
14110|NCT04110782|overall survival|overall survival
14111|NCT04110756|Alcohol- Prevention/Control|alcohol- prevention/control
14112|NCT04110756|Adolescent behavior|adolescent behavior
14113|NCT04110756|Video games- psychology|video games- psychology
14114|NCT04110678|Parkinson Disease|parkinson disease
14115|NCT04110678|Tolerance|tolerance
14116|NCT04110678|NeuroEPO|neuroepo
14117|NCT04110678|side effects|side effects
14118|NCT04110678|UPDRS|updrs
14119|NCT04110678|Cognition|cognition
14120|NCT04110665|shoulder|shoulder
14121|NCT04110665|surgery|surgery
14122|NCT04110665|analgesia|analgesia
14123|NCT04110665|opioid|opioid
14124|NCT04110652|stroke|stroke
14125|NCT04110652|rehabilitation|rehabilitation
14126|NCT04110652|mortality|mortality
14127|NCT04110626|Addiction|addiction
14128|NCT04110626|Primary prevention|primary prevention
14129|NCT04110626|School-based programme|school-based programme
14130|NCT04110600|Bowel movements|bowel movements
14131|NCT04110600|Cesarean section|cesarean section
14132|NCT04110600|Oral hydration|oral hydration
14133|NCT04110587|hyaluronic acid|hyaluronic acid
14134|NCT04110587|temporomandibular joint arthroscopy|temporomandibular joint arthroscopy
14135|NCT04110587|internal derangements|internal derangements
14136|NCT04110587|disc displacement|disc displacement
14137|NCT04110587|temporomandibular disorders|temporomandibular disorders
14138|NCT04110561|Spinal Cord Injuries|spinal cord injuries
14139|NCT04110561|Paraplegia|paraplegia
14140|NCT04110561|Paralysis, Lower Limbs|paralysis, lower limbs
14141|NCT04110561|Lower Extremity|lower extremity
14142|NCT04110561|Robotics|robotics
14143|NCT04110561|Physiotherapy|physiotherapy
14144|NCT04110561|Rehabilitation|rehabilitation
14145|NCT04110561|Powered Exoskeleton|powered exoskeleton
14146|NCT04110561|Walking|walking
14147|NCT04110561|Ambulation|ambulation
14148|NCT04110548|Emotion and craving regulation|emotion and craving regulation
14149|NCT04110535|remimazolam|remimazolam
14150|NCT04110522|Psoriasis|psoriasis
14151|NCT04110509|Imaging biomarkers|imaging biomarkers
14152|NCT04110509|Ultrasonography|ultrasonography
14153|NCT04110509|Fragility|fragility
14154|NCT04110509|Intensive Care Unit|intensive care unit
14155|NCT04110431|cardiac resynchronization therapy|cardiac resynchronization therapy
14156|NCT04110431|chronic heart failure|chronic heart failure
14157|NCT04110431|left bundle branch pacing|left bundle branch pacing
14158|NCT04110431|biventricular pacing|biventricular pacing
14159|NCT04110418|methylene blue|methylene blue
14160|NCT04110418|terlipressin|terlipressin
14161|NCT04110418|septic shock|septic shock
14162|NCT04110418|preterm neonate|preterm neonate
14163|NCT04110379|virtual reality|virtual reality
14164|NCT04110379|distraction|distraction
14165|NCT04110379|salivary cortisol|salivary cortisol
14166|NCT04110366|influenza|influenza
14167|NCT04110366|vaccine|vaccine
14168|NCT04110366|virus|virus
14169|NCT04110366|antibody|antibody
14170|NCT04110366|cytokine|cytokine
14171|NCT04110366|respiratory|respiratory
14172|NCT04110353|Surgical Site infections|surgical site infections
14173|NCT04110353|Negative Pressure Wound Therapy|negative pressure wound therapy
14174|NCT04110353|Contaminated abdominal wounds|contaminated abdominal wounds
14175|NCT04110353|Closed incision abdominal wound|closed incision abdominal wound
14180|NCT04110314|Vaccination|vaccination
14181|NCT04110314|Reminder recall|reminder recall
14182|NCT04110314|Patient Portal|patient portal
14183|NCT04110301|CD20 ,Follicular Lymphoma,Marginal Zone Lymphoma,MIL62|cd20 ,follicular lymphoma,marginal zone lymphoma,mil62
14184|NCT04110275|Acute Pulmonary Embolism|acute pulmonary embolism
14185|NCT04110262|Blood pressure|blood pressure
14186|NCT04110262|Sodium|sodium
14187|NCT04110262|Salt|salt
14188|NCT04110262|Randomized controlled trial|randomized controlled trial
14189|NCT04110262|balance|balance
14190|NCT04110262|humans|humans
14191|NCT04110236|Child behavior problems|child behavior problems
14192|NCT04110236|Caregiver child relationship|caregiver child relationship
14193|NCT04110236|Primary care|primary care
14194|NCT04110223|radiotherapy|radiotherapy
14195|NCT04110223|radiosensitivity|radiosensitivity
14196|NCT04110223|radiation toxity|radiation toxity
14198|NCT04110145|Functional constipation in children|functional constipation in children
14199|NCT04110145|LINZESS|linzess
14200|NCT04110119|Mechanical Low Back Pain|mechanical low back pain
14201|NCT04110119|Chiropractics|chiropractics
14202|NCT04110119|Analgesic-anti-inflammatory|analgesic-anti-inflammatory
14203|NCT04110119|myorelaxant|myorelaxant
14204|NCT04110119|Thiocolchicoside|thiocolchicoside
14205|NCT04110093|Colorectal Cancer|colorectal cancer
14206|NCT04110093|Immunotherapy|immunotherapy
14207|NCT04110093|Regorafenib|regorafenib
14208|NCT04110093|Nivoluamb|nivoluamb
14209|NCT04110093|microsatellite stable|microsatellite stable
14210|NCT04110080|enhanced recovery after surgery|enhanced recovery after surgery
14211|NCT04110080|living donor kidney transplant|living donor kidney transplant
14212|NCT04110080|multimodal analgesia|multimodal analgesia
14213|NCT04110067|Myopia|myopia
14214|NCT04110067|Refractive Surgery|refractive surgery
14215|NCT04110067|Small Incision Lenticule Extraction|small incision lenticule extraction
14216|NCT04110067|SMILE|smile
14217|NCT04110054|P2X3 receptor antagonist|p2x3 receptor antagonist
14218|NCT04110054|Refractory chronic cough|refractory chronic cough
14219|NCT04110054|S-600918|s-600918
14220|NCT04110041|Transitional-aged youth|transitional-aged youth
14221|NCT04110041|Exercise therapy|exercise therapy
14222|NCT04110041|Neurocognition|neurocognition
14223|NCT04110041|fMRI|fmri
14224|NCT04110041|EEG|eeg
14230|NCT04110002|injury prevention program; professional ballet|injury prevention program; professional ballet
14231|NCT04109976|Psoriatic Arthritis|psoriatic arthritis
14232|NCT04109976|PsA|psa
14233|NCT04109976|Auto-Injector|auto-injector
14234|NCT04109976|Bimekizumab|bimekizumab
14235|NCT04109963|vascular cognitive impairment, cerebral small vessel diseases, remote ischemic conditioning|vascular cognitive impairment, cerebral small vessel diseases, remote ischemic conditioning
14236|NCT04109950|schizophrenia|schizophrenia
14237|NCT04109898|airway management|airway management
14238|NCT04109898|I-gel|i-gel
14239|NCT04109898|anaesthesia|anaesthesia
14240|NCT04109872|Lenalidomide|lenalidomide
14241|NCT04109872|Mantle Cell Lymphoma|mantle cell lymphoma
14242|NCT04109872|Relapsed|relapsed
14243|NCT04109872|Refractory|refractory
14244|NCT04109872|RRMCL spanish program|rrmcl spanish program
14245|NCT04109846|Preimplantation Genetic Testing for Aneuploidy|preimplantation genetic testing for aneuploidy
14246|NCT04109846|Preimplantation Genetic Screening|preimplantation genetic screening
14247|NCT04109820|Basal platelet activation|basal platelet activation
14248|NCT04109820|MitoQ|mitoq
14249|NCT04109820|mitochondrial ROS (Reactive Oxygen Species)|mitochondrial ros (reactive oxygen species)
14250|NCT04109781|short-term clinical outcome|short-term clinical outcome
14251|NCT04109781|microscopic assisted discectomy|microscopic assisted discectomy
14252|NCT04109781|lumbar disc herniation|lumbar disc herniation
14253|NCT04109755|Rectal cancer|rectal cancer
14254|NCT04109755|Immunotherapy|immunotherapy
14255|NCT04109755|Short course radiotherapy|short course radiotherapy
14256|NCT04109755|5x5Gy|5x5gy
14257|NCT04109755|Pembrolizumab|pembrolizumab
14258|NCT04109755|Localised rectal cancer|localised rectal cancer
14259|NCT04109742|Pediatric|pediatric
14260|NCT04109742|NAFLD - nonalcoholic fatty liver disease|nafld - nonalcoholic fatty liver disease
14261|NCT04109742|Curcumin|curcumin
14262|NCT04109742|Fatty liver|fatty liver
14263|NCT04109703|chronic pain|chronic pain
14264|NCT04109703|low back pain|low back pain
14265|NCT04109703|heat|heat
14266|NCT04109703|thermal|thermal
14267|NCT04109703|analgesia|analgesia
14268|NCT04109690|MDS|mds
14269|NCT04109677|Handball, sport injuries, concussion, acute overload injury|handball, sport injuries, concussion, acute overload injury
14270|NCT04109664|antral resection|antral resection
14271|NCT04109664|sleeve gastrectomy|sleeve gastrectomy
14272|NCT04109664|excess weight loss|excess weight loss
14273|NCT04109664|total body weight loss|total body weight loss
14274|NCT04109638|PEMF|pemf
14275|NCT04109612|stroke|stroke
14276|NCT04109612|stroke care|stroke care
14277|NCT04109612|stroke units|stroke units
14278|NCT04109612|value of stroke care|value of stroke care
14279|NCT04109573|laser ablation|laser ablation
14280|NCT04109573|anal intraepithelial neoplasia|anal intraepithelial neoplasia
14281|NCT04109573|AIN|ain
14282|NCT04109573|fecal incontinence|fecal incontinence
14283|NCT04109573|anal function|anal function
14284|NCT04109534|allergic asthma,|allergic asthma,
14285|NCT04109534|house dust mite allergy|house dust mite allergy
14286|NCT04109534|bronchial allergen provocation|bronchial allergen provocation
14287|NCT04109534|LCPUFAs|lcpufas
14288|NCT04109521|milk safety|milk safety
14289|NCT04109521|child|child
14290|NCT04109521|nutrition|nutrition
14291|NCT04109521|informal sector|informal sector
14292|NCT04109521|dairy|dairy
14293|NCT04109482|CD123 CAR-T|cd123 car-t
14294|NCT04109482|AML|aml
14295|NCT04109482|BPDCN|bpdcn
14296|NCT04109482|high risk MDS|high risk mds
14297|NCT04109482|blastic plasmacytoid dendridic cell neoplasm|blastic plasmacytoid dendridic cell neoplasm
14298|NCT04109443|Adolescent sexual minority males (ASMM)|adolescent sexual minority males (asmm)
14299|NCT04109443|gay, bisexual, and other men who have sex with me (GBMSM)|gay, bisexual, and other men who have sex with me (gbmsm)
14300|NCT04109443|Online sexual health media literacy intervention|online sexual health media literacy intervention
14301|NCT04109443|HIV prevention|hiv prevention
14302|NCT04109443|Healthy sexual behaviors|healthy sexual behaviors
14303|NCT04109430|PbtO2|pbto2
14304|NCT04109430|hypothermia|hypothermia
14305|NCT04109430|trauma brain injury|trauma brain injury
14306|NCT04109430|targeted control temperature|targeted control temperature
14307|NCT04109430|refractory brain hypertension|refractory brain hypertension
14308|NCT04109404|meningioma,|meningioma,
14309|NCT04109404|progestin,|progestin,
14310|NCT04109404|cyproterone acetate|cyproterone acetate
14311|NCT04109378|Fertility|fertility
14312|NCT04109378|Colorectal endometriosis|colorectal endometriosis
14313|NCT04109378|Surgery|surgery
14314|NCT04109365|Electrical Epidural Stimulation Test|electrical epidural stimulation test
14315|NCT04109339|Oxytocin|oxytocin
14316|NCT04109339|Hemodynamic|hemodynamic
14317|NCT04109339|Myomectomy|myomectomy
14318|NCT04109326|Physical activity|physical activity
14319|NCT04109326|Nutrition|nutrition
14320|NCT04109326|Therapeutic education|therapeutic education
14321|NCT04109326|Breast cancer|breast cancer
14322|NCT04109313|Chronic spontaneous urticaria|chronic spontaneous urticaria
14323|NCT04109313|BTK Inhibitor|btk inhibitor
14324|NCT04109313|Long term safety|long term safety
14325|NCT04109313|Urticaria activity score|urticaria activity score
14326|NCT04109300|Pharmacogenomics|pharmacogenomics
14327|NCT04109300|Combination therapy|combination therapy
14328|NCT04109300|Infliximab|infliximab
14329|NCT04109287|Femoral-popliteal|femoral-popliteal
14330|NCT04109287|Bypass|bypass
14331|NCT04109287|Graft|graft
14332|NCT04109287|PAD|pad
14333|NCT04109287|PVD|pvd
14334|NCT04109287|NMES|nmes
14335|NCT04109287|Time-averaged mean velocity|time-averaged mean velocity
14336|NCT04109287|Volume flow rate|volume flow rate
14337|NCT04109287|Volume flow|volume flow
14338|NCT04109287|TAMV|tamv
14339|NCT04109287|VFR|vfr
14340|NCT04109287|Peak systolic velocity|peak systolic velocity
14341|NCT04109287|PSV|psv
14342|NCT04109287|Peak velocity|peak velocity
14343|NCT04109287|PV|pv
14344|NCT04109287|Neuromuscular electrical stimulation|neuromuscular electrical stimulation
14345|NCT04109274|exercise|exercise
14346|NCT04109274|physical activity|physical activity
14347|NCT04109274|self-management|self-management
14348|NCT04109235|HbA1C|hba1c
14349|NCT04109235|blood pressure|blood pressure
14350|NCT04109235|blood glucose|blood glucose
14351|NCT04109235|physical activity|physical activity
14352|NCT04109235|HIIT|hiit
14353|NCT04109209|Malignant Glioma|malignant glioma
14354|NCT04109209|Caregiver Anxiety|caregiver anxiety
14355|NCT04109209|Caregiver Burden|caregiver burden
14356|NCT04109209|Psychological distress|psychological distress
14357|NCT04109183|HIV/AIDS|hiv/aids
14358|NCT04109170|Dry Eye|dry eye
14359|NCT04109170|Bioinformatics|bioinformatics
14360|NCT04109170|Data mining|data mining
14361|NCT04109157|Pad test|pad test
14362|NCT04109157|Test-retest reliability|test-retest reliability
14363|NCT04109144|Paracentesis|paracentesis
14364|NCT04109144|Albumin|albumin
14365|NCT04109144|Plasma|plasma
14366|NCT04109118|Opioid agonist therapy|opioid agonist therapy
14367|NCT04109118|Benzodiazepine|benzodiazepine
14368|NCT04109118|Distress tolerance|distress tolerance
14369|NCT04109118|Distress Tolerance - Benzodiazepine Discontinuation (DT-BD)|distress tolerance - benzodiazepine discontinuation (dt-bd)
14370|NCT04109118|Relaxation Therapy (RT)|relaxation therapy (rt)
14371|NCT04109105|Colon neoplasia|colon neoplasia
14372|NCT04109105|Ascendant colon|ascendant colon
14373|NCT04109105|Surgical anastomosis|surgical anastomosis
14574|NCT04108026|Savimmune|savimmune
14382|NCT04109092|Stimulator of Interferon Genes Agonist|stimulator of interferon genes agonist
14383|NCT04109092|Carcinoma in situ|carcinoma in situ
14384|NCT04109092|BCG Unresponsive|bcg unresponsive
14385|NCT04109079|neoadjuvant chemotherapy|neoadjuvant chemotherapy
14386|NCT04109079|sentinel node biopsy|sentinel node biopsy
14387|NCT04109079|breast cancer|breast cancer
14388|NCT04109079|tattooing node|tattooing node
14389|NCT04109079|marking node|marking node
14390|NCT04109079|clip node|clip node
14391|NCT04109079|axillary ultrasound|axillary ultrasound
14392|NCT04109079|node positive|node positive
14393|NCT04109079|axillary lymph node dissection|axillary lymph node dissection
14394|NCT04109079|axillary radiotherapy|axillary radiotherapy
14395|NCT04109079|axillary treatment|axillary treatment
14404|NCT04109027|attention|attention
14405|NCT04109027|working memory|working memory
14406|NCT04109027|executive functioning|executive functioning
14407|NCT04109014|Cognitive Behavioral|cognitive behavioral
14408|NCT04109014|Qualitative Interviews|qualitative interviews
14409|NCT04109014|Motivational Interviewing|motivational interviewing
14410|NCT04108988|Black adolescent girls|black adolescent girls
14411|NCT04108962|ABPA|abpa
14412|NCT04108962|Benralizumab|benralizumab
14413|NCT04108936|CRS|crs
14414|NCT04108936|HIPEC|hipec
14415|NCT04108936|cellular immune response|cellular immune response
14416|NCT04108936|microbiomes|microbiomes
14417|NCT04108923|Thyroidectomy|thyroidectomy
14418|NCT04108923|Ligasure|ligasure
14419|NCT04108923|Vessel ligation|vessel ligation
14420|NCT04108910|UTI|uti
14421|NCT04108910|Home Care|home care
14422|NCT04108897|rosacea|rosacea
14423|NCT04108897|skin microbiome|skin microbiome
14424|NCT04108897|gut microbiome|gut microbiome
14425|NCT04108897|antimicrobial therapy|antimicrobial therapy
14426|NCT04108884|Atrial Fibrillation|atrial fibrillation
14427|NCT04108884|Smartphone App|smartphone app
14428|NCT04108884|CHA2DS2-VASc-Score|cha2ds2-vasc-score
14429|NCT04108884|Screening|screening
14430|NCT04108884|Cardiovascular risk factors|cardiovascular risk factors
14431|NCT04108884|Outpatient setting|outpatient setting
14432|NCT04108884|Congestive heart failure|congestive heart failure
14433|NCT04108884|Stroke|stroke
14434|NCT04108884|Diabetes|diabetes
14435|NCT04108884|Vascular disease|vascular disease
14436|NCT04108871|Biopsy|biopsy
14437|NCT04108871|Transperineal Prostate Biopsy|transperineal prostate biopsy
14438|NCT04108871|Prostate Cancer Detection|prostate cancer detection
14439|NCT04108871|Transrectal Prostate Biopsy|transrectal prostate biopsy
14440|NCT04108832|Traditional Chinese Medicine|traditional chinese medicine
14441|NCT04108832|Herbs|herbs
14442|NCT04108832|Liu-wei-die-Huang-Wan|liu-wei-die-huang-wan
14443|NCT04108741|Parkinson Disease|parkinson disease
14444|NCT04108689|internet intervention|internet intervention
14445|NCT04108689|applied sport psychology|applied sport psychology
14446|NCT04108689|performance enhancement|performance enhancement
14447|NCT04108689|acceptance and commitment training|acceptance and commitment training
14448|NCT04108689|elite ice hockey|elite ice hockey
14449|NCT04108663|Brain stimulation|brain stimulation
14450|NCT04108663|Cognitive training|cognitive training
14451|NCT04108663|Cognition|cognition
14452|NCT04108663|Cognitive enhancement|cognitive enhancement
14453|NCT04108663|Transcranial direct current stimulation|transcranial direct current stimulation
14454|NCT04108650|Physical Activity|physical activity
14455|NCT04108650|Health Education|health education
14456|NCT04108650|Fit & Strong!|fit & strong!
14457|NCT04108637|penicillin|penicillin
14458|NCT04108637|allergy|allergy
14459|NCT04108637|antimicrobial|antimicrobial
14460|NCT04108637|resistance|resistance
14461|NCT04108611|hemodiafiltration with endogenous re infusion|hemodiafiltration with endogenous re infusion
14462|NCT04108611|immune adsorption In Lupus nephritis|immune adsorption in lupus nephritis
14463|NCT04108598|Otolaryngology|otolaryngology
14464|NCT04108598|Sudden onset sensorineural hearing loss|sudden onset sensorineural hearing loss
14465|NCT04108598|Sensorineural hearing loss|sensorineural hearing loss
14466|NCT04108572|Child Obesity|child obesity
14467|NCT04108572|Infant Feeding|infant feeding
14468|NCT04108572|Feasibility study|feasibility study
14469|NCT04108559|Kinesiology tape|kinesiology tape
14470|NCT04108559|Surgical drain|surgical drain
14472|NCT04108559|Swelling|swelling
14473|NCT04108559|Trismus|trismus
14474|NCT04108507|Percutaneous kyphoplasty（PKP）|percutaneous kyphoplasty（pkp）
14475|NCT04108507|nerve block|nerve block
14476|NCT04108507|posterior branch of spinal nerve|posterior branch of spinal nerve
14477|NCT04108494|Gastric Cancer|gastric cancer
14478|NCT04108494|Omentectomy|omentectomy
14479|NCT04108494|Prognosis|prognosis
14480|NCT04108481|Y90|y90
14481|NCT04108481|Y90-RE|y90-re
14482|NCT04108481|Radioembolization|radioembolization
14483|NCT04108481|Y90-Radioembolization|y90-radioembolization
14484|NCT04108481|y-90|y-90
14485|NCT04108481|Yttrium|yttrium
14486|NCT04108481|Yttrium-90|yttrium-90
14487|NCT04108481|Microsatellite Stable|microsatellite stable
14488|NCT04108481|MSS|mss
14489|NCT04108481|CRC|crc
14490|NCT04108481|mCRC|mcrc
14491|NCT04108481|Colorectal|colorectal
14492|NCT04108481|Liver Metastases|liver metastases
14493|NCT04108481|Liver Metastasis|liver metastasis
14494|NCT04108481|Durvalumab|durvalumab
14495|NCT04108481|Anti-PD1|anti-pd1
14496|NCT04108481|Anti-PDL1|anti-pdl1
14497|NCT04108481|Immunotherapy|immunotherapy
14498|NCT04108481|Colorectal Cancer|colorectal cancer
14499|NCT04108481|Mismatch repair proficient|mismatch repair proficient
14500|NCT04108481|pMMR|pmmr
14501|NCT04108481|KRAS|kras
14502|NCT04108481|NRAS|nras
14503|NCT04108481|BRAF|braf
14504|NCT04108481|BRAF-V600E|braf-v600e
14505|NCT04108429|Mental health|mental health
14506|NCT04108429|App|app
14507|NCT04108429|Mobile phone|mobile phone
14508|NCT04108429|Stress management|stress management
14509|NCT04108416|cleft lip|cleft lip
14510|NCT04108416|cleft palate|cleft palate
14511|NCT04108416|cleft lip and palate|cleft lip and palate
14512|NCT04108416|orofacial cleft|orofacial cleft
14513|NCT04108390|ankle|ankle
14514|NCT04108390|dry needling|dry needling
14515|NCT04108390|trigger point|trigger point
14516|NCT04108377|Hyperinsulinemia|hyperinsulinemia
14517|NCT04108377|Phosphodiesterase 4 Inhibitor|phosphodiesterase 4 inhibitor
14518|NCT04108364|aphasia|aphasia
14519|NCT04108364|anomia|anomia
14520|NCT04108364|rehabilitation|rehabilitation
14521|NCT04108364|speech-language pathology|speech-language pathology
14522|NCT04108364|mobile applications|mobile applications
14523|NCT04108364|language therapy|language therapy
14524|NCT04108364|stroke|stroke
14525|NCT04108364|stroke rehabilitation|stroke rehabilitation
14526|NCT04108338|Clinical trial|clinical trial
14527|NCT04108338|Real-world study|real-world study
14528|NCT04108338|Nasopharyngeal carcinoma|nasopharyngeal carcinoma
14529|NCT04108338|Pragmatism|pragmatism
14530|NCT04108338|Survival|survival
14531|NCT04108338|Return to society|return to society
14532|NCT04108299|Chinese Americans|chinese americans
14533|NCT04108247|Castration-resistant Prostate Cancer|castration-resistant prostate cancer
14534|NCT04108247|Abiraterone|abiraterone
14535|NCT04108247|SHR3162|shr3162
14536|NCT04108182|heart failure|heart failure
14537|NCT04108169|Coronary artery bypass graft|coronary artery bypass graft
14538|NCT04108169|Left Atrial Appendage Occlusion|left atrial appendage occlusion
14539|NCT04108169|stroke|stroke
14540|NCT04108169|prevention|prevention
14541|NCT04108156|Port Delivery System|port delivery system
14542|NCT04108143|Telehealth|telehealth
14543|NCT04108143|Telemonitoring|telemonitoring
14544|NCT04108143|COPD|copd
14545|NCT04108117|Robotic mastectomy|robotic mastectomy
14546|NCT04108117|Breast neoplasms|breast neoplasms
14547|NCT04108117|Postoperative complications|postoperative complications
14548|NCT04108117|Recurrence|recurrence
14549|NCT04108117|Prognosis|prognosis
14550|NCT04108117|Survivals|survivals
14551|NCT04108117|Nipple sparing mastectomy|nipple sparing mastectomy
14552|NCT04108117|Immediate reconstruction|immediate reconstruction
14553|NCT04108091|transthyretin amyloid cardiomyopathy;|transthyretin amyloid cardiomyopathy;
14554|NCT04108091|TTR Cardiomyopathy;|ttr cardiomyopathy;
14555|NCT04108091|Transthyretin (TTR) Amyloid Cardiomyopathy;|transthyretin (ttr) amyloid cardiomyopathy;
14556|NCT04108091|Vyndaqel;|vyndaqel;
14557|NCT04108091|Tafamidis meglumine;|tafamidis meglumine;
14558|NCT04108091|ATTR-CM|attr-cm
14559|NCT04108078|HIV|hiv
14560|NCT04108078|Stigma|stigma
14561|NCT04108078|Intersectional Stigma|intersectional stigma
14562|NCT04108078|Men who have sex with men|men who have sex with men
14563|NCT04108065|gestational diabetes mellitus|gestational diabetes mellitus
14564|NCT04108065|gallbladder motility|gallbladder motility
14565|NCT04108065|glp-1|glp-1
14566|NCT04108065|pregnancy|pregnancy
14567|NCT04108052|HHT|hht
14568|NCT04108052|diagnosis,|diagnosis,
14569|NCT04108052|arteriovenous malformation|arteriovenous malformation
14570|NCT04108052|interventional radiology|interventional radiology
14571|NCT04108052|pulmonary arteriovenous fistulas|pulmonary arteriovenous fistulas
14572|NCT04108052|embolization|embolization
14573|NCT04108026|IFCT|ifct
14575|NCT04108026|Non small cell Lung Cancer|non small cell lung cancer
14576|NCT04108026|PS|ps
14577|NCT04108026|Poor General condition|poor general condition
14578|NCT04108026|Lung Cancer|lung cancer
14579|NCT04108026|Durvalumab|durvalumab
14580|NCT04108000|Dementia|dementia
14581|NCT04108000|Nursing|nursing
14582|NCT04108000|Nephrology|nephrology
14583|NCT04108000|Behavioral research|behavioral research
14584|NCT04108000|Social research|social research
14585|NCT04107974|Gastropexy|gastropexy
14586|NCT04107974|Percutaneous Radiologic Gastrostomy|percutaneous radiologic gastrostomy
14587|NCT04107974|Interventional Radiology|interventional radiology
14588|NCT04107948|sedentary time|sedentary time
14589|NCT04107948|therapeutic education sessions|therapeutic education sessions
14590|NCT04107935|Self management education and support|self management education and support
14591|NCT04107935|Telemedicine|telemedicine
14592|NCT04107935|Rural|rural
14593|NCT04107883|endothelial|endothelial
14594|NCT04107883|plasma|plasma
14595|NCT04107870|ANOREXIA NERVOSA|anorexia nervosa
14596|NCT04107870|FEMALE ADOLESCENTS|female adolescents
14597|NCT04107870|BODY DYSMORPHIC DISORDER|body dysmorphic disorder
14598|NCT04107870|VIRTUAL REALITY EXPOSURE THERAPY|virtual reality exposure therapy
14599|NCT04107844|return to play|return to play
14600|NCT04107844|pain catastrophizing|pain catastrophizing
14601|NCT04107844|athletes|athletes
14602|NCT04107831|Pulmonary rehabilitation|pulmonary rehabilitation
14603|NCT04107831|Exercise|exercise
14604|NCT04107831|Field walk test|field walk test
14605|NCT04107831|Physical performance test|physical performance test
14606|NCT04107818|polytrauma|polytrauma
14607|NCT04107818|coagulopathy|coagulopathy
14608|NCT04107818|viscoelastic tests|viscoelastic tests
14609|NCT04107792|parenting|parenting
14610|NCT04107792|parental sense of competence|parental sense of competence
14611|NCT04107792|children|children
14612|NCT04107792|sensory processing issues|sensory processing issues
14613|NCT04107779|Electronic Nicotine Delivery System|electronic nicotine delivery system
14614|NCT04107779|Combustible Cigarettes|combustible cigarettes
14615|NCT04107779|Nicotine|nicotine
14616|NCT04107740|Spinocerebellar degeneration|spinocerebellar degeneration
14617|NCT04107740|Ataxia|ataxia
14618|NCT04107727|Quizartinib|quizartinib
14619|NCT04107714|Stigma|stigma
14620|NCT04107714|Parents of children with mental illness|parents of children with mental illness
14621|NCT04107714|Disclosure|disclosure
14622|NCT04107714|Secrecy|secrecy
14623|NCT04107714|Group intervention|group intervention
14624|NCT04107701|BPD|bpd
14625|NCT04107701|bronchopulmonary dysplasia|bronchopulmonary dysplasia
14626|NCT04107701|children and environment|children and environment
14627|NCT04107701|environment|environment
14628|NCT04107701|bronchopulmonary dysplasia and environment|bronchopulmonary dysplasia and environment
14629|NCT04107701|environment and children|environment and children
14630|NCT04107701|chronic lung disease of newborn|chronic lung disease of newborn
14631|NCT04107701|environment and chronic lung disease of the newborn|environment and chronic lung disease of the newborn
14632|NCT04107688|Oral Microbiome|oral microbiome
14633|NCT04107662|brain|brain
14634|NCT04107662|injuries|injuries
14635|NCT04107662|disease|disease
14636|NCT04107662|trauma|trauma
14637|NCT04107662|nervous system|nervous system
14638|NCT04107662|wounds|wounds
14639|NCT04107649|Physical Activity|physical activity
14640|NCT04107649|Total Knee Replacement|total knee replacement
14641|NCT04107649|Knee Osteoarthritis|knee osteoarthritis
14642|NCT04107636|Minimal invasive|minimal invasive
14643|NCT04107636|Biopsy|biopsy
14644|NCT04107623|Gastric Conduit|gastric conduit
14645|NCT04107623|Cardia resection|cardia resection
14646|NCT04107623|Indocyanine Green|indocyanine green
14647|NCT04107623|quantative perfusion|quantative perfusion
14648|NCT04107610|oculomotor,|oculomotor,
14649|NCT04107610|vestibular,|vestibular,
14650|NCT04107610|concussion,|concussion,
14651|NCT04107610|mild traumatic brain injury|mild traumatic brain injury
14652|NCT04107597|Chronic Low-back Pain|chronic low-back pain
14653|NCT04107597|Myofascial Trigger Point Release|myofascial trigger point release
14654|NCT04107597|Core Stabilization Exercises|core stabilization exercises
14655|NCT04107597|Paced Breathing Training|paced breathing training
14656|NCT04107597|Pain Severity|pain severity
14657|NCT04107597|Anxiety|anxiety
14658|NCT04107597|Heart Rate Variability|heart rate variability
14659|NCT04107571|Coronary artery bypass graft|coronary artery bypass graft
14660|NCT04107571|Biomarker|biomarker
14661|NCT04107571|Prognosis|prognosis
14662|NCT04107558|Virtual reality , hypnosis, pain, anxiety, anesthesia|virtual reality , hypnosis, pain, anxiety, anesthesia
14663|NCT04107545|weight cycling|weight cycling
14664|NCT04107545|sport|sport
14665|NCT04107545|appetite|appetite
14666|NCT04107545|energy metabolism|energy metabolism
14667|NCT04107519|Chronic Pain|chronic pain
14668|NCT04107519|Resilience|resilience
14669|NCT04107519|Football Players|football players
14670|NCT04107506|parent training|parent training
14671|NCT04107506|early adversity|early adversity
14672|NCT04107506|early intervention|early intervention
14673|NCT04107506|manualized intervention|manualized intervention
14674|NCT04107506|high-risk children|high-risk children
14675|NCT04107506|parenting|parenting
14676|NCT04107506|fMRI|fmri
14677|NCT04107480|prolactinoma|prolactinoma
14678|NCT04107480|dopamine agonist|dopamine agonist
14679|NCT04107480|endoscopic trans-sphenoidal adenoma resection|endoscopic trans-sphenoidal adenoma resection
14680|NCT04107480|remission rate|remission rate
14681|NCT04107480|health-related quality of life|health-related quality of life
14682|NCT04107454|Lichen sclerosus|lichen sclerosus
14683|NCT04107441|open-label|open-label
14684|NCT04107441|phase 1|phase 1
14685|NCT04107441|safety|safety
14686|NCT04107441|tolerability|tolerability
14687|NCT04107441|pharmacokinetics|pharmacokinetics
14688|NCT04107441|healthy volunteers|healthy volunteers
14689|NCT04107441|AX-8|ax-8
14690|NCT04107428|adult-to-adult living donor liver transplantation|adult-to-adult living donor liver transplantation
14691|NCT04107428|small-for-size syndrome|small-for-size syndrome
14692|NCT04107428|graft hyperperfusion|graft hyperperfusion
14693|NCT04107415|Asthma|asthma
14694|NCT04107415|nursing|nursing
14695|NCT04107415|patient|patient
14696|NCT04107415|yoga|yoga
14697|NCT04107402|Septic shock|septic shock
14698|NCT04107402|Platelets|platelets
14699|NCT04107402|Acetyl CoA Carboxylase|acetyl coa carboxylase
14700|NCT04107389|Art Psychotherapy|art psychotherapy
14701|NCT04107389|Art Therapy|art therapy
14702|NCT04107389|Perinatal Mental Health|perinatal mental health
14703|NCT04107389|Mother and baby unit|mother and baby unit
14704|NCT04107389|Mental health and wellbeing|mental health and wellbeing
14705|NCT04107389|Pregnancy|pregnancy
14706|NCT04107389|Post-Partum|post-partum
14707|NCT04107389|Creative Intervention|creative intervention
14708|NCT04107389|Randomised Control Trial|randomised control trial
14709|NCT04107389|ReQol|reqol
14710|NCT04107389|WEMWBS|wemwbs
14711|NCT04107376|retroviewing|retroviewing
14712|NCT04107376|endoscopy|endoscopy
14713|NCT04107376|adenoma detection|adenoma detection
14714|NCT04107376|polyp detection|polyp detection
14715|NCT04107337|Nodules|nodules
14716|NCT04107337|Dysodia|dysodia
14717|NCT04107337|Singers|singers
14718|NCT04107337|Straw|straw
14719|NCT04107337|Estimated subglottal pressure|estimated subglottal pressure
14720|NCT04107337|Aerodynamic measurements|aerodynamic measurements
14721|NCT04107337|Oral airflow|oral airflow
14722|NCT04107311|solid tumor|solid tumor
14723|NCT04107311|immunooncology|immunooncology
14724|NCT04107285|Neurocognitive Evaluations|neurocognitive evaluations
14725|NCT04107285|Neuroimaging Evaluations|neuroimaging evaluations
14726|NCT04107285|19-268|19-268
14727|NCT04107272|Oxaliplatin-induced peripheral neuropathy|oxaliplatin-induced peripheral neuropathy
14728|NCT04107272|Repetitive transcranial magnetic stimulation|repetitive transcranial magnetic stimulation
14729|NCT04107272|Pain|pain
14730|NCT04107272|Feasibility|feasibility
14731|NCT04107259|Type 2 diabetes mellitus|type 2 diabetes mellitus
14732|NCT04107259|IL-34|il-34
14733|NCT04107259|Irisin|irisin
14734|NCT04107259|IRAPe|irape
14735|NCT04107259|Visfatin|visfatin
14736|NCT04107259|Insulin resistance|insulin resistance
14737|NCT04107259|HOMA-IR|homa-ir
14738|NCT04107220|BNP|bnp
14739|NCT04107220|NT-proBNP|nt-probnp
14740|NCT04107220|ARNI|arni
14741|NCT04107220|Sacubitril/Valsartan|sacubitril/valsartan
14742|NCT04107181|Pap smear|pap smear
14743|NCT04107168|NSCLC|nsclc
14744|NCT04107168|Advanced|advanced
14745|NCT04107168|Unresectable|unresectable
14746|NCT04107168|Microbiome|microbiome
14747|NCT04107168|Adjuvant|adjuvant
14748|NCT04107168|Resected|resected
14749|NCT04107168|Immune checkpoint inhibitors|immune checkpoint inhibitors
14750|NCT04107142|NKG2D|nkg2d
14751|NCT04107142|gamma|gamma
14752|NCT04107142|delta|delta
14753|NCT04107142|T cell|t cell
14754|NCT04107142|CAR|car
14755|NCT04107142|chimeric antigen receptor|chimeric antigen receptor
14756|NCT04107142|solid tumour|solid tumour
14757|NCT04107142|cancer immunotherapy|cancer immunotherapy
14758|NCT04107142|adoptive cell transfer|adoptive cell transfer
14759|NCT04107129|Infertility|infertility
14760|NCT04107129|Endometriosis|endometriosis
14761|NCT04107129|BLC6|blc6
14762|NCT04107129|SIRT1|sirt1
14763|NCT04107129|In Vitro Fertilization (IVF)|in vitro fertilization (ivf)
14764|NCT04107129|Embryo Transfer (ET)|embryo transfer (et)
14765|NCT04107129|Frozen Embryo Transfer (FET)|frozen embryo transfer (fet)
14766|NCT04107129|Assisted Reproductive Technology (ART)|assisted reproductive technology (art)
14767|NCT04107116|cancer end of life patient-centered|cancer end of life patient-centered
14768|NCT04107064|Neurodiversity|neurodiversity
14769|NCT04107064|ASD|asd
14770|NCT04107064|Employment|employment
14771|NCT04107064|Neurodiverse|neurodiverse
400491|NCT01866657|randomized controlled pilot study|randomized controlled pilot study
14772|NCT04107038|Anesthesia, TAVR, Cardiothoracic, Cardiology|anesthesia, tavr, cardiothoracic, cardiology
14773|NCT04107012|White spot lesion|white spot lesion
14774|NCT04107012|QLF|qlf
14775|NCT04107012|Clear aligners|clear aligners
14776|NCT04106986|Knee osteoarthritis|knee osteoarthritis
14777|NCT04106986|Pulsed Electromagnetic Field|pulsed electromagnetic field
14778|NCT04106986|Progressive Resistance Exercise|progressive resistance exercise
14779|NCT04106973|Pleural Mesothelioma|pleural mesothelioma
14780|NCT04106973|Bilateral Pleural Plaques|bilateral pleural plaques
14781|NCT04106973|Asbestos Exposure|asbestos exposure
14782|NCT04106973|Exhaled breath analysis|exhaled breath analysis
14783|NCT04106973|VOCs|vocs
14784|NCT04106921|community health workers|community health workers
14785|NCT04106921|primary health care|primary health care
14786|NCT04106921|mobile applications|mobile applications
14787|NCT04106882|insulin resistance|insulin resistance
14788|NCT04106882|exogenous ketone|exogenous ketone
14789|NCT04106882|glucose|glucose
14790|NCT04106882|diet|diet
14791|NCT04106882|aging|aging
14792|NCT04106804|Psoriatic arthritis; Bone|psoriatic arthritis; bone
14793|NCT04106739|Alcohol dependence|alcohol dependence
14794|NCT04106739|Peripheral electrical nerve field stimulation (PENFS)|peripheral electrical nerve field stimulation (penfs)
14795|NCT04106739|Auricular nerve stimulation|auricular nerve stimulation
14796|NCT04106739|Vagus nerve stimulation|vagus nerve stimulation
14797|NCT04106739|relapse prevention|relapse prevention
14798|NCT04106726|Ivermectin|ivermectin
14799|NCT04106713|Psychotherapy|psychotherapy
14800|NCT04106713|Cognitive behavioural therapy|cognitive behavioural therapy
14801|NCT04106713|Group psychotherapy|group psychotherapy
14802|NCT04106713|Internet-based psychotherapy|internet-based psychotherapy
14803|NCT04106700|Multiple Myeloma|multiple myeloma
14804|NCT04106700|Venous Thromboembolism|venous thromboembolism
14805|NCT04106674|Proximal humerus fracture|proximal humerus fracture
14806|NCT04106674|Non-operative versus operative treatment|non-operative versus operative treatment
14807|NCT04106674|Conservative versus surgical treatment|conservative versus surgical treatment
14808|NCT04106674|Surgical versus non-surgical treatment|surgical versus non-surgical treatment
14809|NCT04106661|Tai Chi|tai chi
14810|NCT04106661|physical activity|physical activity
14811|NCT04106661|morbid obesity|morbid obesity
14812|NCT04106648|Ischemic Mitral Regurgitation|ischemic mitral regurgitation
14813|NCT04106648|primary percutaneous coronary intervention|primary percutaneous coronary intervention
14814|NCT04106648|STEMI|stemi
14815|NCT04106635|Laryngeal mask airway|laryngeal mask airway
14816|NCT04106635|Paratracheal esophageal pressure|paratracheal esophageal pressure
14817|NCT04106635|Cricoid pressure|cricoid pressure
14818|NCT04106622|Wolff-Parkinson-White Syndrome|wolff-parkinson-white syndrome
14819|NCT04106570|Obese|obese
14820|NCT04106570|Torque production|torque production
14821|NCT04106570|Neuromuscular fatigue|neuromuscular fatigue
14822|NCT04106570|Electrical muscle stimulation|electrical muscle stimulation
14823|NCT04106570|Knee extensors|knee extensors
14824|NCT04106570|Metabolic disorders|metabolic disorders
14825|NCT04106518|Cohort|cohort
14826|NCT04106518|alcoholic hepatitis|alcoholic hepatitis
14827|NCT04106518|alcoholic cirrhosis|alcoholic cirrhosis
14828|NCT04106518|pathophysiology|pathophysiology
14829|NCT04106518|bio bank|bio bank
14830|NCT04106518|pan-genomic study|pan-genomic study
14831|NCT04106505|Biofeedback|biofeedback
14832|NCT04106505|smartphone app|smartphone app
14833|NCT04106466|Deep Brain Stimulation|deep brain stimulation
14834|NCT04106466|Major Depressive Disorder|major depressive disorder
14835|NCT04106466|Treatment resistant depression|treatment resistant depression
14836|NCT04106466|subcallosal cingulate white matter|subcallosal cingulate white matter
14837|NCT04106466|Depression|depression
14838|NCT04106453|laparoscopy|laparoscopy
14839|NCT04106453|navigation|navigation
14840|NCT04106453|microwave ablation|microwave ablation
14841|NCT04106453|ultrasound guidance|ultrasound guidance
14842|NCT04106427|gesture|gesture
14843|NCT04106427|rTMS|rtms
14844|NCT04106427|cognitive remediation|cognitive remediation
14845|NCT04106427|social cognitive remediation therapy|social cognitive remediation therapy
14846|NCT04106414|Nivolumab|nivolumab
14847|NCT04106414|IDO-Inhibitor|ido-inhibitor
14848|NCT04106414|BMS-986205|bms-986205
14849|NCT04106401|total red blood cell volume|total red blood cell volume
14850|NCT04106401|plasma volume|plasma volume
14851|NCT04106401|total hemoglobin mass|total hemoglobin mass
14852|NCT04106401|total blood volume|total blood volume
14853|NCT04106375|major depression|major depression
14854|NCT04106375|Mindfulness based cognitive therapy|mindfulness based cognitive therapy
14855|NCT04106375|MBCT|mbct
14856|NCT04106375|fMRI|fmri
14857|NCT04106375|recurrent depression|recurrent depression
14858|NCT04106375|brain|brain
14859|NCT04106323|Upper Egypt|upper egypt
14860|NCT04106323|Factor|factor
14861|NCT04106323|Inhibitor|inhibitor
14862|NCT04106271|Chronic Pain|chronic pain
14863|NCT04106271|dyadic pain management program|dyadic pain management program
14864|NCT04106271|older adults|older adults
14865|NCT04106271|informal caregiver|informal caregiver
14866|NCT04106219|aurora kinase A|aurora kinase a
14867|NCT04106219|kinase|kinase
14868|NCT04106219|aurora A|aurora a
14869|NCT04106219|aurora kinase inhibitor|aurora kinase inhibitor
14970|NCT04105465|lymphedema|lymphedema
14874|NCT04106219|pediatric neuroblastoma|pediatric neuroblastoma
14875|NCT04106219|children|children
14876|NCT04106193|intimate partner violence|intimate partner violence
14877|NCT04106193|women Veterans|women veterans
14878|NCT04106193|screening|screening
14879|NCT04106193|primary care|primary care
14880|NCT04106154|Physical Activity|physical activity
14881|NCT04106154|Activity Motivation|activity motivation
14882|NCT04106154|Activity Confidence|activity confidence
14883|NCT04106154|Children|children
14884|NCT04106154|Adolescents|adolescents
14885|NCT04106154|Sleep|sleep
14886|NCT04106154|Screen Time|screen time
14887|NCT04106115|Non-Muscle Invasive Bladder Cancer (NMIBC)|non-muscle invasive bladder cancer (nmibc)
14888|NCT04106115|Durvalumab|durvalumab
14889|NCT04106115|S-488210/S-488211|s-488210/s-488211
14890|NCT04106115|Immunotherapy|immunotherapy
14891|NCT04106115|Vaccine|vaccine
14892|NCT04106115|PD-L1 Inhibitor|pd-l1 inhibitor
14893|NCT04106115|BCG unresponsive|bcg unresponsive
14894|NCT04106076|Acute Myeloid Leukaemia|acute myeloid leukaemia
14895|NCT04106076|Newly diagnosed AML|newly diagnosed aml
14896|NCT04106076|ELN adverse genetic risk group|eln adverse genetic risk group
14897|NCT04106076|Chimeric Antigen Receptor T-Cell (CAR-T) therapy|chimeric antigen receptor t-cell (car-t) therapy
14898|NCT04106076|Allogeneic|allogeneic
14899|NCT04106076|Transcription Activator-Like Effector Nuclease (TALEN)|transcription activator-like effector nuclease (talen)
14900|NCT04105998|Healthy Volunteer|healthy volunteer
14901|NCT04105998|Oxytocin|oxytocin
14902|NCT04105998|Pupillometry|pupillometry
14903|NCT04105985|Necrotic teeth, root canals|necrotic teeth, root canals
14904|NCT04105946|FESS|fess
14905|NCT04105946|Opioid Free Anesthesia|opioid free anesthesia
14906|NCT04105946|Opioid Consumption|opioid consumption
14907|NCT04105907|GentleWave|gentlewave
14908|NCT04105907|Multisonication|multisonication
14909|NCT04105907|Sonendo|sonendo
14915|NCT04105829|tooth color change|tooth color change
14916|NCT04105816|rectus femoris|rectus femoris
14917|NCT04105816|ACL repair recovery|acl repair recovery
14918|NCT04105816|musculoskeletal ultrasound|musculoskeletal ultrasound
14919|NCT04105816|quadriceps atrophy|quadriceps atrophy
14920|NCT04105816|validation|validation
14921|NCT04105790|Stepped Model of Care|stepped model of care
14922|NCT04105790|Class-Based Intervention|class-based intervention
14923|NCT04105738|Difficult Intubation|difficult intubation
14924|NCT04105738|Preoperative Surgical Assessment|preoperative surgical assessment
14925|NCT04105738|Speech Dysfunction|speech dysfunction
14926|NCT04105738|Difficult Airway|difficult airway
14927|NCT04105712|withdrawal|withdrawal
14928|NCT04105712|highly processed food|highly processed food
14929|NCT04105712|food addiction|food addiction
14930|NCT04105699|Sepsis|sepsis
14931|NCT04105699|Pancreatic Stone Protein|pancreatic stone protein
14932|NCT04105699|Point-of-care device|point-of-care device
14933|NCT04105699|Immunoassay|immunoassay
14934|NCT04105699|Intensive care unit|intensive care unit
14935|NCT04105699|Abionic|abionic
14936|NCT04105673|Shaken Baby Syndrome|shaken baby syndrome
14937|NCT04105673|long-term outcome|long-term outcome
14938|NCT04105673|severity criteria in the admission to hospital for a Shaken Baby Syndrome|severity criteria in the admission to hospital for a shaken baby syndrome
14939|NCT04105673|sequelae|sequelae
14940|NCT04105673|brain injury|brain injury
14941|NCT04105673|abusive head trauma|abusive head trauma
14942|NCT04105647|Lifestyle modification|lifestyle modification
14943|NCT04105647|physical activity|physical activity
14944|NCT04105647|messages|messages
14945|NCT04105621|Personalized nutrition|personalized nutrition
14946|NCT04105621|Drug addicts|drug addicts
14947|NCT04105621|Gut microbiota|gut microbiota
14948|NCT04105608|Diabetes|diabetes
14949|NCT04105608|GLP-1|glp-1
14950|NCT04105608|Oxyntomodulin|oxyntomodulin
14951|NCT04105608|Diet|diet
14952|NCT04105608|Visual Analogue Scale|visual analogue scale
14953|NCT04105582|Dendritic cells|dendritic cells
14954|NCT04105582|Neo-antigen|neo-antigen
14955|NCT04105582|Personalized medicine|personalized medicine
14956|NCT04105582|immunotherapy|immunotherapy
14957|NCT04105556|Male Child|male child
14958|NCT04105556|Comfort Theory|comfort theory
14959|NCT04105556|Fear|fear
14960|NCT04105556|Male Circimcision|male circimcision
14961|NCT04105556|Pain|pain
14962|NCT04105517|Proliferative infantile hemangiomas|proliferative infantile hemangiomas
14963|NCT04105517|Hemangiol|hemangiol
14964|NCT04105517|Propranolol|propranolol
14965|NCT04105504|glutathione|glutathione
14966|NCT04105504|whitening|whitening
14967|NCT04105465|vulvar cancer|vulvar cancer
14968|NCT04105465|groin node dissection|groin node dissection
400492|NCT01866657|thoracic surgery|thoracic surgery
14969|NCT04105465|bilateral groin node dissection|bilateral groin node dissection
14971|NCT04105465|lymphocyst|lymphocyst
14972|NCT04105465|lymphorrea|lymphorrea
14973|NCT04105374|Toca 511|toca 511
14974|NCT04105374|Toca FC|toca fc
14975|NCT04105335|Oligonucleotide|oligonucleotide
14976|NCT04105335|saRNA|sarna
14977|NCT04105335|Pembrolizumab|pembrolizumab
14978|NCT04105335|Tumour microenvironment|tumour microenvironment
14979|NCT04105335|Myeloid-derived suppressor cells|myeloid-derived suppressor cells
14980|NCT04105335|C/EBP-a|c/ebp-a
14981|NCT04105335|CEBPA|cebpa
14982|NCT04105322|Acute stroke|acute stroke
14983|NCT04105322|Balance|balance
14984|NCT04105322|Rehabilitation|rehabilitation
14985|NCT04105322|Postural control|postural control
14986|NCT04105309|Obesity|obesity
14987|NCT04105309|College Students|college students
14988|NCT04105309|Implementation Intentions|implementation intentions
14989|NCT04105283|Lung Cancer|lung cancer
14990|NCT04105244|Mental Health|mental health
14991|NCT04105244|Physical Health|physical health
14992|NCT04105244|Technology-Dependent Children|technology-dependent children
14993|NCT04105205|Anti-Bacterial Agents|anti-bacterial agents
14994|NCT04105166|hemolytic anemia|hemolytic anemia
14995|NCT04105166|anemia|anemia
14996|NCT04105166|gene therapy|gene therapy
14997|NCT04105153|Non-small cell lung carcinoma|non-small cell lung carcinoma
14998|NCT04105153|EGFR mutation|egfr mutation
14999|NCT04105153|Tyrosine Kinase Inhibitor|tyrosine kinase inhibitor
15000|NCT04105153|Osimertinib|osimertinib
15001|NCT04105153|EGFR T790M|egfr t790m
15002|NCT04105140|oxytocin|oxytocin
15003|NCT04105140|prosocial learning|prosocial learning
15004|NCT04105114|Walking|walking
15005|NCT04105114|Transcutaneous Stimulation|transcutaneous stimulation
15006|NCT04105114|Locomotion|locomotion
15007|NCT04105114|Paralysis|paralysis
15008|NCT04105114|Buspirone|buspirone
15009|NCT04105114|Motor Control|motor control
15010|NCT04105114|Spinal Stimulation|spinal stimulation
15011|NCT04105101|Human-centered robotics|human-centered robotics
15012|NCT04105101|Prototype evaluation|prototype evaluation
15013|NCT04105101|Industry|industry
15014|NCT04105088|First Nations|first nations
15015|NCT04105088|Indigenous|indigenous
15016|NCT04105088|Epidemiology|epidemiology
15017|NCT04105088|Risk Factors|risk factors
15018|NCT04105088|Community-based Research|community-based research
15019|NCT04105075|spirometry|spirometry
15020|NCT04105075|inflammation|inflammation
15021|NCT04105075|copd|copd
15022|NCT04105023|genistein|genistein
15023|NCT04105023|gut microbiota|gut microbiota
15024|NCT04105023|AMPK|ampk
15025|NCT04105023|fatty acid oxidation|fatty acid oxidation
15026|NCT04104932|surgical stabilization|surgical stabilization
15027|NCT04104932|conservative treatment|conservative treatment
15028|NCT04104919|Mastectomy|mastectomy
15029|NCT04104906|Shoulder rehabilitation|shoulder rehabilitation
15030|NCT04104906|Electromyography|electromyography
15031|NCT04104906|Posture analysis|posture analysis
15032|NCT04104893|Metastatic Prostate Cancer|metastatic prostate cancer
15033|NCT04104893|Pembrolizumab|pembrolizumab
15034|NCT04104893|Checkpoint Inhibitor|checkpoint inhibitor
15035|NCT04104893|Mismatch Repair Deficiency|mismatch repair deficiency
15036|NCT04104893|CDK12|cdk12
15037|NCT04104880|obstructive sleep apnea|obstructive sleep apnea
15038|NCT04104854|Quantitative flow ratio|quantitative flow ratio
15039|NCT04104854|drug coated balloon|drug coated balloon
15040|NCT04104854|Drug eluted stent|drug eluted stent
15041|NCT04104854|percutaneous coronary intervention|percutaneous coronary intervention
15042|NCT04104828|Allergy immunotherapy|allergy immunotherapy
15043|NCT04104828|Adjuvant|adjuvant
15044|NCT04104828|Innate immunity|innate immunity
15045|NCT04104789|Cavities, crowns|cavities, crowns
15046|NCT04104711|Diabetes|diabetes
15047|NCT04104711|public health nursing|public health nursing
15048|NCT04104711|randomized controlled trials|randomized controlled trials
15049|NCT04104711|chronic illness|chronic illness
15050|NCT04104711|Health Belief Model|health belief model
15051|NCT04104698|Suicide, Major depression, quantitative EEG|suicide, major depression, quantitative eeg
15052|NCT04104659|tau|tau
15053|NCT04104659|PET|pet
15054|NCT04104659|MK 6240|mk 6240
15055|NCT04104659|ADAD|adad
15056|NCT04104633|ctDNA|ctdna
15057|NCT04104633|Molecular karyotype|molecular karyotype
15058|NCT04104607|PSMA|psma
15059|NCT04104607|Resistant Prostate Cancer|resistant prostate cancer
15060|NCT04104607|PSMAxCD3|psmaxcd3
15061|NCT04104607|CC-1|cc-1
15062|NCT04104594|TNF alpha|tnf alpha
15063|NCT04104568|Informal caregivers|informal caregivers
15064|NCT04104568|People with Dementia|people with dementia
15065|NCT04104568|Mental Health|mental health
15066|NCT04104568|Online training and support|online training and support
15067|NCT04104568|Intervention Study|intervention study
15068|NCT04104555|Pes planus|pes planus
15069|NCT04104555|Randomised controlled trial|randomised controlled trial
15070|NCT04104555|Orthoses|orthoses
15071|NCT04104555|Exercise|exercise
15072|NCT04104555|Children|children
15073|NCT04104529|thyroid cancer|thyroid cancer
15074|NCT04104529|prostate cancer|prostate cancer
15075|NCT04104529|neuroendocrine tumors|neuroendocrine tumors
15076|NCT04104529|nuclear medecine|nuclear medecine
15077|NCT04104516|Lifestyle modification|lifestyle modification
15078|NCT04104516|Lung Cancer|lung cancer
15079|NCT04104516|Preferences|preferences
15080|NCT04104464|vascular malformation|vascular malformation
15081|NCT04104464|VM|vm
15082|NCT04104412|lumbar discogenic pain|lumbar discogenic pain
15083|NCT04104412|mesenchymal stem cell|mesenchymal stem cell
15084|NCT04104347|schizophrenia spectrum disorders|schizophrenia spectrum disorders
15085|NCT04104347|metacognitive training|metacognitive training
15086|NCT04104347|insight|insight
15087|NCT04104347|ecological momentary assessment|ecological momentary assessment
15088|NCT04104334|Cytoreduction|cytoreduction
15089|NCT04104334|HIPEC|hipec
15090|NCT04104334|Oxaliplatin|oxaliplatin
15091|NCT04104334|Colorectal|colorectal
15092|NCT04104334|Peritoneal|peritoneal
15093|NCT04104334|Carcinomatosis|carcinomatosis
15094|NCT04104334|Monitoring|monitoring
15095|NCT04104334|Anesthesia|anesthesia
15096|NCT04104321|fibrosis|fibrosis
15097|NCT04104321|liver fibrosis|liver fibrosis
15098|NCT04104321|diabetes|diabetes
15099|NCT04104321|obesity|obesity
15100|NCT04104295|nasogastric tube|nasogastric tube
15101|NCT04104295|ultrasound|ultrasound
15102|NCT04104282|Nonalcoholic fatty liver disease|nonalcoholic fatty liver disease
15103|NCT04104282|Lipid droplets|lipid droplets
15104|NCT04104282|Plin5|plin5
15105|NCT04104269|Heart rupture|heart rupture
15106|NCT04104269|Acute myocardial infarction|acute myocardial infarction
15107|NCT04104256|Low Value Care|low value care
15108|NCT04104256|Cataract Surgery|cataract surgery
15109|NCT04104256|Behavioral Economics|behavioral economics
15110|NCT04104243|Pre-Diabetes|pre-diabetes
15111|NCT04104243|Men's Health|men's health
15112|NCT04104243|Type 2 Diabetes|type 2 diabetes
15113|NCT04104243|Racial Disparities|racial disparities
15114|NCT04104230|Cancer Genetics|cancer genetics
15115|NCT04104217|Music therapy|music therapy
15116|NCT04104217|19-270|19-270
15117|NCT04104204|Total hip replacement|total hip replacement
15118|NCT04104204|Ultrasound guided supra-inguinal fascia iliaca block|ultrasound guided supra-inguinal fascia iliaca block
15119|NCT04104204|Intrathecal morphine|intrathecal morphine
15120|NCT04104204|postoperative pain|postoperative pain
15121|NCT04104113|Breast Cancer|breast cancer
15122|NCT04104113|Cancer Related Fatigue|cancer related fatigue
15123|NCT04104113|Cognitive Impairment|cognitive impairment
15124|NCT04104113|Survivorship|survivorship
15125|NCT04104113|Traditional Chinese Medicine|traditional chinese medicine
15126|NCT04104100|Nocturnal polyuria|nocturnal polyuria
15127|NCT04104100|Bladder diary|bladder diary
15128|NCT04104087|tunneling technique, gingival recession, deepithelialized free gingival graft, sub epithelial connective tissue graft,|tunneling technique, gingival recession, deepithelialized free gingival graft, sub epithelial connective tissue graft,
15129|NCT04104035|Chronic Myeloid Leukemia|chronic myeloid leukemia
15130|NCT04104035|BCR-ABL|bcr-abl
15131|NCT04104022|Post Traumatic Stress Disorder|post traumatic stress disorder
15132|NCT04104022|Opioid-use Disorder|opioid-use disorder
15133|NCT04104022|Prolonged Exposure Therapy|prolonged exposure therapy
15134|NCT04104022|Opioid Agonist Therapy|opioid agonist therapy
15135|NCT04104022|Financial Incentives|financial incentives
15136|NCT04104022|Substance Use|substance use
15137|NCT04104009|midwifery|midwifery
15138|NCT04104009|education|education
15139|NCT04104009|pregnancy|pregnancy
15140|NCT04104009|delivery mode|delivery mode
15141|NCT04104009|music therapy|music therapy
15142|NCT04104009|breastfeeding|breastfeeding
15143|NCT04104009|pain score|pain score
15144|NCT04104009|postnatal mental health|postnatal mental health
15145|NCT04104009|Apgar score|apgar score
15146|NCT04103970|Low back pain|low back pain
15147|NCT04103970|Back surgery|back surgery
15148|NCT04103970|Lumbar spinal fusion|lumbar spinal fusion
15149|NCT04103970|Postoperative rehabilitation|postoperative rehabilitation
15150|NCT04103970|Graded activity|graded activity
15151|NCT04103970|Pain education|pain education
15152|NCT04103970|Disability|disability
15153|NCT04103970|Pain|pain
15154|NCT04103970|Fear of movement|fear of movement
15155|NCT04103970|Self-efficacy for exercise|self-efficacy for exercise
15156|NCT04103970|Health related quality of life|health related quality of life
15157|NCT04103970|Sedentary behavior|sedentary behavior
15158|NCT04103957|Virtual reality|virtual reality
15159|NCT04103944|osteonecrosis|osteonecrosis
15160|NCT04103944|osteonecrotic repair device|osteonecrotic repair device
15161|NCT04103931|Shared Decision Making|shared decision making
15162|NCT04103905|1. CD20-positive 2. lymphomas 3. MIL62|1. cd20-positive 2. lymphomas 3. mil62
15163|NCT04103892|MDD|mdd
15164|NCT04103892|depression|depression
15165|NCT04103892|depressive disorder|depressive disorder
15166|NCT04103892|major depression|major depression
15167|NCT04103892|adjunct therapy|adjunct therapy
15168|NCT04103892|oral|oral
15169|NCT04103853|AR-positive metastatic breast cancer|ar-positive metastatic breast cancer
15170|NCT04103853|Proxalutamide|proxalutamide
15171|NCT04103853|metastatic breast cancer|metastatic breast cancer
15172|NCT04103853|GT0918|gt0918
15173|NCT04103827|Usability|usability
15174|NCT04103827|Elderly|elderly
15175|NCT04103827|Old people|old people
15176|NCT04103827|Physical activity|physical activity
15177|NCT04103827|Balance|balance
15178|NCT04103801|Sucrose,|sucrose,
15179|NCT04103801|Substance P,|substance p,
15180|NCT04103801|Pain,|pain,
15181|NCT04103801|Immunization.|immunization.
15182|NCT04103788|Bioavailability|bioavailability
15183|NCT04103788|Absorption|absorption
15184|NCT04103762|acute lithiasis cholecystitis|acute lithiasis cholecystitis
15185|NCT04103762|intraoperative cholangiography|intraoperative cholangiography
15186|NCT04103762|indocyanine green|indocyanine green
15187|NCT04103762|cholecystectomy|cholecystectomy
15188|NCT04103736|chronic kidney disease|chronic kidney disease
15189|NCT04103736|dietary nitrates|dietary nitrates
15190|NCT04103736|beetroot juice|beetroot juice
15191|NCT04103736|endothelium, vascular|endothelium, vascular
15192|NCT04103736|cardiovascular disease|cardiovascular disease
15193|NCT04103736|exercise capacity|exercise capacity
15194|NCT04103723|Midazolam|midazolam
15195|NCT04103723|Premedication|premedication
15196|NCT04103723|Preoperative anxiety|preoperative anxiety
15197|NCT04103723|Surgery|surgery
15198|NCT04103710|MIH|mih
15199|NCT04103710|asthmatic drugs|asthmatic drugs
15200|NCT04103697|rectal cancer|rectal cancer
15201|NCT04103697|neoadjuvant chemotherapy|neoadjuvant chemotherapy
15202|NCT04103697|mesorectal excision|mesorectal excision
15203|NCT04103671|NPDR|npdr
15204|NCT04103671|Pars-plana vitrectomy|pars-plana vitrectomy
15205|NCT04103671|panretinal photocoagulation|panretinal photocoagulation
15206|NCT04103645|Anemia|anemia
15207|NCT04103632|Athletes|athletes
15208|NCT04103593|exercise training|exercise training
15209|NCT04103593|video telehealth|video telehealth
15210|NCT04103593|DNA methylation|dna methylation
15211|NCT04103593|Aging|aging
15212|NCT04103593|HIV|hiv
15213|NCT04103567|rectal|rectal
15214|NCT04103567|cancer|cancer
15215|NCT04103554|LVAD (Left Ventricular Assist Device)|lvad (left ventricular assist device)
15216|NCT04103554|sacubitril/valsartan|sacubitril/valsartan
15217|NCT04103554|heart failure|heart failure
15218|NCT04103528|Postoperative sleep disturbances|postoperative sleep disturbances
15219|NCT04103528|Postoperative recovery|postoperative recovery
15220|NCT04103528|General anesthesia|general anesthesia
15221|NCT04103528|Early postoperative sleep|early postoperative sleep
15222|NCT04103528|Procedure started in the morning and afternoon|procedure started in the morning and afternoon
15223|NCT04103463|square stepping exercise|square stepping exercise
15224|NCT04103463|Amnestic mild cognitive impairment|amnestic mild cognitive impairment
15225|NCT04103463|Interactive stepping exercise|interactive stepping exercise
15226|NCT04103463|memory|memory
15227|NCT04103463|cognitive function|cognitive function
15228|NCT04103463|executive function|executive function
15229|NCT04103450|Overactive Bladder|overactive bladder
15230|NCT04103450|Benign Prostatic Hyperplasia|benign prostatic hyperplasia
15231|NCT04103450|Vibegron|vibegron
15232|NCT04103450|Beta-3 adrenergic receptor (β3-AR)|beta-3 adrenergic receptor (β3-ar)
15233|NCT04103450|β3-AR agonist|β3-ar agonist
15234|NCT04103437|running harmonicity|running harmonicity
15235|NCT04103437|running related injuries|running related injuries
15236|NCT04103385|interoception|interoception
15237|NCT04103385|suicidal ideation|suicidal ideation
15238|NCT04103385|suicide|suicide
15239|NCT04103385|military|military
15240|NCT04103385|intervention|intervention
15241|NCT04103385|clinical trial|clinical trial
15242|NCT04103372|early stage|early stage
15243|NCT04103372|early phase|early phase
15244|NCT04103359|Myelodysplatic syndromes|myelodysplatic syndromes
15245|NCT04103359|elderly|elderly
15246|NCT04103359|fatigue|fatigue
15247|NCT04103359|blood transfusion|blood transfusion
15248|NCT04103359|physiopathology|physiopathology
15249|NCT04103320|Infertility|infertility
15250|NCT04103320|In Vitro Fertilization|in vitro fertilization
15251|NCT04103320|Endometriosis|endometriosis
15252|NCT04103320|pain evaluation|pain evaluation
15253|NCT04103307|Cooling|cooling
15254|NCT04103307|CRRT|crrt
15255|NCT04103229|Urine Leakage|urine leakage
15256|NCT04103229|Indwelling urethral catheter|indwelling urethral catheter
15257|NCT04103229|silicone catheter|silicone catheter
15258|NCT04103229|Saline|saline
15259|NCT04103229|Balloon|balloon
15260|NCT04103229|Distilled water|distilled water
15261|NCT04103216|Cryptosporidiosis|cryptosporidiosis
15262|NCT04103216|Treatment|treatment
15263|NCT04103216|Bangladesh|bangladesh
15264|NCT04103216|Nitazoxanide|nitazoxanide
15265|NCT04103112|Deep Vein Thrombosis|deep vein thrombosis
15266|NCT04103086|Percutaneous Coronary Intervention|percutaneous coronary intervention
15267|NCT04103086|Aromatherapy|aromatherapy
15268|NCT04103086|Cognitive function|cognitive function
15269|NCT04103086|Randomized Controlled Trial|randomized controlled trial
15270|NCT04103073|obstructive sleep apnea|obstructive sleep apnea
15271|NCT04103073|emg|emg
15272|NCT04103073|inspiratory muscles|inspiratory muscles
15273|NCT04103073|expiratory muscles|expiratory muscles
15274|NCT04103047|Temporomandibular joint disorder|temporomandibular joint disorder
15275|NCT04103034|Secondary Stroke Prevention|secondary stroke prevention
15276|NCT04103008|Speckle tracking|speckle tracking
15277|NCT04103008|2D echocardiography|2d echocardiography
15278|NCT04103008|Left ventricle residual function|left ventricle residual function
15279|NCT04103008|PCI, percutaneous coronary intervention|pci, percutaneous coronary intervention
15280|NCT04103008|single coronary artery|single coronary artery
15281|NCT04103008|multiple coronary arteries|multiple coronary arteries
15282|NCT04102982|NSCLC|nsclc
15283|NCT04102982|Camrelizumab|camrelizumab
15284|NCT04102982|Microwave ablation|microwave ablation
15285|NCT04102982|Overall survival|overall survival
15286|NCT04102982|Progression free survival|progression free survival
15287|NCT04102982|Objective response rate|objective response rate
15288|NCT04102982|Safety|safety
15289|NCT04102969|Benson relaxation|benson relaxation
15290|NCT04102969|Benson response|benson response
15291|NCT04102969|Relaxation response|relaxation response
15292|NCT04102917|QFR|qfr
15293|NCT04102917|quantitative flow ratio|quantitative flow ratio
15294|NCT04102891|Metabolic syndrome|metabolic syndrome
15295|NCT04102891|Gut microbiota|gut microbiota
15296|NCT04102891|Personalized dietary advice|personalized dietary advice
15297|NCT04102891|Food literacy|food literacy
15298|NCT04102878|oculoplastic surgery|oculoplastic surgery
15299|NCT04102865|surgical complication|surgical complication
15300|NCT04102865|NPWT|npwt
15301|NCT04102865|negative pressure|negative pressure
15302|NCT04102865|knee arthroplasty|knee arthroplasty
15303|NCT04102865|abdominal incision|abdominal incision
15304|NCT04102852|probiotic|probiotic
15305|NCT04102852|Lactobacillus rhamnosus GG|lactobacillus rhamnosus gg
15306|NCT04102852|ATCC 53103|atcc 53103
15307|NCT04102852|cytokines|cytokines
15308|NCT04102852|adhesion|adhesion
15309|NCT04102839|Prader-Willi Syndrome|prader-willi syndrome
15310|NCT04102839|PWS|pws
15311|NCT04102813|deep diaphragmatic breathing|deep diaphragmatic breathing
15312|NCT04102813|cortisol|cortisol
15313|NCT04102813|sympathetic nervous system|sympathetic nervous system
15314|NCT04102813|parasympathetic nervous system|parasympathetic nervous system
15315|NCT04102813|inflammatory cytokines|inflammatory cytokines
15316|NCT04102813|Functional psychotherapy|functional psychotherapy
15317|NCT04102800|benralizumab|benralizumab
15318|NCT04102800|exacerbation|exacerbation
15319|NCT04102800|eosinophilic|eosinophilic
15320|NCT04102787|coronary artery disease, educational program, patient satisfaction, patient knowledge.|coronary artery disease, educational program, patient satisfaction, patient knowledge.
15321|NCT04102774|airway warm humidification|airway warm humidification
15322|NCT04102774|exacerbation|exacerbation
15323|NCT04102774|airway clearance|airway clearance
15324|NCT04102735|facial pressure ulcers|facial pressure ulcers
15325|NCT04102735|noninvasive ventilation|noninvasive ventilation
15326|NCT04102735|acute hypercapnic respiratory failure|acute hypercapnic respiratory failure
15327|NCT04102722|tomography|tomography
15328|NCT04102722|ultrasound|ultrasound
15329|NCT04102722|mammogram|mammogram
15330|NCT04102722|breast|breast
15331|NCT04102696|Coronary Artery Bypass Grafting|coronary artery bypass grafting
15332|NCT04102696|Aromatherapy|aromatherapy
15333|NCT04102696|Cognitive Function|cognitive function
15334|NCT04102696|Randomized Controlled Trial|randomized controlled trial
15335|NCT04102696|Myocardial Infarction|myocardial infarction
15336|NCT04102683|Game|game
15337|NCT04102683|Therapeutic Recreation|therapeutic recreation
15338|NCT04102683|Intellectual Disability|intellectual disability
15339|NCT04102657|CGM|cgm
15340|NCT04102657|Glucose Monitoring|glucose monitoring
15341|NCT04102657|Intermittent Fasting|intermittent fasting
15342|NCT04102657|Fasting|fasting
15343|NCT04102657|Exercise|exercise
15344|NCT04102644|Labor and Delivery|labor and delivery
15345|NCT04102644|Childbirth in limited resource setting|childbirth in limited resource setting
15346|NCT04102631|colonoscopy|colonoscopy
15347|NCT04102631|computer vision|computer vision
15348|NCT04102631|adenoma detection rate|adenoma detection rate
15349|NCT04102631|Endo.Angel|endo.angel
15350|NCT04102618|Breast|breast
15351|NCT04102618|Breast Cancer|breast cancer
15352|NCT04102618|Primary Breast|primary breast
15353|NCT04102618|Primary Breast Cancer|primary breast cancer
15354|NCT04102618|Pelareorep|pelareorep
15355|NCT04102618|Atezolizumab|atezolizumab
15356|NCT04102618|Reovirus|reovirus
15357|NCT04102618|Oncolytic virus|oncolytic virus
15358|NCT04102618|Letrozole|letrozole
15359|NCT04102618|Early Breast Cancer|early breast cancer
15360|NCT04102618|Triple-negative breast cancer|triple-negative breast cancer
804711|NCT00236041|Sickle Cell|sickle cell
15361|NCT04102618|HR+ breast cancer|hr+ breast cancer
15362|NCT04102618|HER2+ breast cancer|her2+ breast cancer
15363|NCT04102605|Visual field defect|visual field defect
15364|NCT04102605|visual perceptual learning|visual perceptual learning
15365|NCT04102605|Humphrey visual field|humphrey visual field
15366|NCT04102592|Malaria|malaria
15367|NCT04102592|P. Falciparum|p. falciparum
15374|NCT04102514|Physical Activity|physical activity
15375|NCT04102514|Exercise|exercise
15376|NCT04102488|reduction of bacterial counts|reduction of bacterial counts
15377|NCT04102488|hand hygiene technique|hand hygiene technique
15378|NCT04102449|Ultrasound|ultrasound
15379|NCT04102449|Psoriatic arthritis|psoriatic arthritis
15380|NCT04102449|Outcome measures|outcome measures
15381|NCT04102449|Apremilast|apremilast
15382|NCT04102449|Disease activity|disease activity
15390|NCT04102410|Cardiac rehabilitation|cardiac rehabilitation
15391|NCT04102410|Physical activity|physical activity
15392|NCT04102410|Force-velocity profile|force-velocity profile
15393|NCT04102410|Autonomic nervous system|autonomic nervous system
15394|NCT04102410|Coronary artery disease|coronary artery disease
15395|NCT04102397|Subacromial Impingement Syndrome; Vojta therapy; pain|subacromial impingement syndrome; vojta therapy; pain
15396|NCT04102384|Electronic Patient Reported Outcomes|electronic patient reported outcomes
15397|NCT04102371|Sepsis|sepsis
15398|NCT04102371|Septic Shock|septic shock
15399|NCT04102371|Fluid resuscitation|fluid resuscitation
15400|NCT04102371|Saline|saline
15401|NCT04102371|Balanced Fluid|balanced fluid
15402|NCT04102371|Mortality|mortality
15403|NCT04102371|Feasibility|feasibility
15404|NCT04102371|Crystalloid|crystalloid
15405|NCT04102371|PlasmaLyte|plasmalyte
15406|NCT04102371|Lactated Ringer's|lactated ringer's
15407|NCT04102358|Vertical infraclavicular block|vertical infraclavicular block
15408|NCT04102358|brachial plexus anatomy|brachial plexus anatomy
15409|NCT04102345|aromatherapy|aromatherapy
15410|NCT04102345|diagnostic sleep study|diagnostic sleep study
15411|NCT04102345|zolpidem|zolpidem
15412|NCT04102332|Antineoplastic Agents|antineoplastic agents
15413|NCT04102332|Cancer|cancer
15414|NCT04102332|Drug administration|drug administration
15415|NCT04102332|Infusion device|infusion device
15416|NCT04102332|Occupational Exposure|occupational exposure
15417|NCT04102332|Nursing|nursing
15418|NCT04102306|orofacial myotherapies;|orofacial myotherapies;
15419|NCT04102306|physical therapy;|physical therapy;
15420|NCT04102306|assessment;|assessment;
15421|NCT04102306|questionnaire validation|questionnaire validation
15422|NCT04102293|rotatry instrumentation|rotatry instrumentation
15423|NCT04102280|Hemodialysis|hemodialysis
15424|NCT04102280|Hemodiafiltration|hemodiafiltration
15425|NCT04102280|Renal replacement therapy|renal replacement therapy
15426|NCT04102267|herniorrhaphy|herniorrhaphy
15427|NCT04102267|inguinal hernia|inguinal hernia
15428|NCT04102267|hernia|hernia
15429|NCT04102267|hernia surgery|hernia surgery
15430|NCT04102267|postoperative pain|postoperative pain
15431|NCT04102241|psoriasis|psoriasis
15432|NCT04102241|PDE4|pde4
15433|NCT04102228|Non-invasive brain stimulation|non-invasive brain stimulation
15434|NCT04102228|Transcranial Magnetic Stimulation|transcranial magnetic stimulation
15435|NCT04102228|Multi-modality aphasia therapy|multi-modality aphasia therapy
15436|NCT04102228|Neuroimaging|neuroimaging
15437|NCT04102176|chronic hepatitis B|chronic hepatitis b
15438|NCT04102176|nucleoside analogues|nucleoside analogues
15439|NCT04102176|stopping|stopping
15440|NCT04102176|discontinuing|discontinuing
15441|NCT04102163|Drug Therapy|drug therapy
15442|NCT04102137|TDA202|tda202
15443|NCT04102137|acellular pertussis vaccine|acellular pertussis vaccine
15444|NCT04102137|antibody persistence at 3 years after vaccination|antibody persistence at 3 years after vaccination
15445|NCT04102137|Pertagen|pertagen
15446|NCT04102137|Boostagen|boostagen
15447|NCT04102137|aP vaccine|ap vaccine
15448|NCT04102124|Castration-resistant Prostate Cancer|castration-resistant prostate cancer
15449|NCT04102124|SHR3680|shr3680
15450|NCT04102124|SHR3162|shr3162
15451|NCT04102072|pulmonary artery catheter|pulmonary artery catheter
15452|NCT04102072|echocardiography|echocardiography
15453|NCT04102072|fluid responsiveness|fluid responsiveness
15454|NCT04102072|extracorporeal membrane oxygenation|extracorporeal membrane oxygenation
15455|NCT04102020|Acute myeloid leukemia (AML)|acute myeloid leukemia (aml)
15456|NCT04102020|Venetoclax|venetoclax
15457|NCT04102020|Azacitidine|azacitidine
15458|NCT04102020|Maintenance Therapy|maintenance therapy
15459|NCT04102020|Conventional Chemotherapy|conventional chemotherapy
15460|NCT04102020|Best supportive care (BSC)|best supportive care (bsc)
15461|NCT04102007|Plaque Psoriasis|plaque psoriasis
15462|NCT04102007|Risankizumab|risankizumab
15463|NCT04102007|Secukinumab|secukinumab
15464|NCT04102007|Ixekizumab|ixekizumab
15465|NCT04102007|Psoriasis|psoriasis
15466|NCT04102007|Biologic|biologic
15467|NCT04101994|virtual cycling training|virtual cycling training
15468|NCT04101994|Non-invasive brain stimulation|non-invasive brain stimulation
15469|NCT04101994|repetitive transcranial magnetic stimulation|repetitive transcranial magnetic stimulation
15470|NCT04101994|transcranial electric stimulation|transcranial electric stimulation
15471|NCT04101968|Parkinson|parkinson
15472|NCT04101929|metastatic pancreatic cancer|metastatic pancreatic cancer
15473|NCT04101929|pancreatic adenocarcinoma|pancreatic adenocarcinoma
15474|NCT04101929|apatinib|apatinib
15475|NCT04101929|S-1|s-1
15476|NCT04101929|irinotecan|irinotecan
15477|NCT04101864|navigation|navigation
15478|NCT04101864|hip arthroplasty|hip arthroplasty
15479|NCT04101864|surgical time|surgical time
15480|NCT04101864|landmark|landmark
15481|NCT04101851|sentinel lymph node biopsy|sentinel lymph node biopsy
15482|NCT04101851|neoadjuvant systemic therapy|neoadjuvant systemic therapy
15483|NCT04101838|vaccine|vaccine
15484|NCT04101799|Prison|prison
15485|NCT04101799|Criminality|criminality
15486|NCT04101799|Child|child
15487|NCT04101786|sport|sport
15488|NCT04101786|injury|injury
15489|NCT04101786|prevention|prevention
15490|NCT04101786|rehabilitation|rehabilitation
15491|NCT04101786|groin pain|groin pain
15492|NCT04101786|adductor strain|adductor strain
15493|NCT04101773|hemorrhoids|hemorrhoids
15494|NCT04101773|haemorrhoidal disease|haemorrhoidal disease
15495|NCT04101773|recurrence|recurrence
15496|NCT04101773|rubber band ligation|rubber band ligation
15497|NCT04101773|haemorrhoidectomy|haemorrhoidectomy
15498|NCT04101747|Advanced hepatocellular carcinoma|advanced hepatocellular carcinoma
15499|NCT04101747|Combination of PD-1/PD-L1 Inhibitors and Targeted Drugs|combination of pd-1/pd-l1 inhibitors and targeted drugs
15500|NCT04101747|Diversity of intestinal flora|diversity of intestinal flora
15501|NCT04101747|Metabolites|metabolites
15502|NCT04101734|Difficult Intubation|difficult intubation
15503|NCT04101734|Thyromental Height Test|thyromental height test
15504|NCT04101734|Double Lumen Video Tube|double lumen video tube
15505|NCT04101708|elderly,helicobacter pylori eradication,dual therapy,half-dose clarithromycin|elderly,helicobacter pylori eradication,dual therapy,half-dose clarithromycin
15506|NCT04101669|Type 2 Diabetes|type 2 diabetes
15507|NCT04101669|Obesity|obesity
15508|NCT04101656|Breast Cancer|breast cancer
15509|NCT04101656|Radiotherapy|radiotherapy
15510|NCT04101656|Accelerated Partial Breast Irradiation|accelerated partial breast irradiation
15511|NCT04101656|APBI|apbi
15512|NCT04101656|Modulated Intensity Radiotherapy|modulated intensity radiotherapy
15513|NCT04101656|IMRT|imrt
15514|NCT04101656|Positive estrogen receptor|positive estrogen receptor
15515|NCT04101630|Pulmonary Hypertension|pulmonary hypertension
15516|NCT04101565|Fatherhood|fatherhood
15517|NCT04101539|catheter ablation; atrial fibrillation|catheter ablation; atrial fibrillation
15518|NCT04101487|Cash Transfers|cash transfers
15519|NCT04101487|Liberia|liberia
15520|NCT04101487|Stunting|stunting
15521|NCT04101487|Dietary diversity|dietary diversity
15522|NCT04101448|Bronchiectasis|bronchiectasis
15523|NCT04101448|COPD|copd
15524|NCT04101448|Prevalence|prevalence
15525|NCT04101448|Prognosis|prognosis
15526|NCT04101435|Influenza Vaccine|influenza vaccine
15527|NCT04101435|Immunogenicity|immunogenicity
15528|NCT04101422|Quit Smoking|quit smoking
15529|NCT04101422|Augmented Reality|augmented reality
15530|NCT04101422|Smoking|smoking
15531|NCT04101409|decision aids|decision aids
15532|NCT04101409|shared decision making|shared decision making
15533|NCT04101396|diet modification, 4 and 7 points monitoring|diet modification, 4 and 7 points monitoring
15534|NCT04101383|Pharmacokinetics|pharmacokinetics
15535|NCT04101383|Pharmacodynamics|pharmacodynamics
15536|NCT04101383|Insulin glargine|insulin glargine
15537|NCT04101370|AUC|auc
15538|NCT04101370|Cmax|cmax
15539|NCT04101370|Pharmacokinetics|pharmacokinetics
15540|NCT04101370|bosentan|bosentan
15541|NCT04101370|fasting|fasting
15542|NCT04101357|Solid Tumor|solid tumor
15543|NCT04101357|Extensive-stage Small Cell Lung Cancer|extensive-stage small cell lung cancer
15544|NCT04101305|Prostate cancer, biomarker|prostate cancer, biomarker
15545|NCT04101292|Fluorescence|fluorescence
15546|NCT04101292|Antibody|antibody
15547|NCT04101292|Bevacizumab|bevacizumab
15548|NCT04101292|IRDye800|irdye800
15549|NCT04101292|Hyperspectral imaging|hyperspectral imaging
15550|NCT04101292|Light-CT Scanner|light-ct scanner
15551|NCT04101292|Tumour detection|tumour detection
15552|NCT04101292|Colorectal cancer|colorectal cancer
15553|NCT04101279|stress urinary incontinence|stress urinary incontinence
15554|NCT04101279|midurethral tension free tape|midurethral tension free tape
15555|NCT04101279|patient reported outcome|patient reported outcome
15556|NCT04101279|bladder outlet obstruction|bladder outlet obstruction
15557|NCT04101279|complications|complications
15558|NCT04101279|tension control mechanism|tension control mechanism
15559|NCT04101240|red blood cells transfusion|red blood cells transfusion
15560|NCT04101214|Dry needling|dry needling
15561|NCT04101214|Parkinson Disease|parkinson disease
15562|NCT04101214|myofascial trigger point|myofascial trigger point
15563|NCT04101188|Dietary Potassium|dietary potassium
15564|NCT04101188|Dietary Sodium|dietary sodium
15565|NCT04101188|Vascular Health|vascular health
15566|NCT04101175|First-trimester pregnancy|first-trimester pregnancy
15567|NCT04101175|Abortions|abortions
15568|NCT04101136|statin|statin
15569|NCT04101136|atherosclerosis|atherosclerosis
15570|NCT04101123|Social inequalities|social inequalities
15571|NCT04101123|Social dimensions of health|social dimensions of health
15572|NCT04101123|Brain tumors|brain tumors
15573|NCT04101123|Leukemia|leukemia
15574|NCT04101123|Sarcomas|sarcomas
15575|NCT04101123|Childhood Cancer|childhood cancer
15576|NCT04101123|Children and adolescents with cancer|children and adolescents with cancer
15577|NCT04101097|factors;bowel preparation;colonoscopy|factors;bowel preparation;colonoscopy
15578|NCT04101071|Critical care|critical care
15579|NCT04101071|enteral feeding|enteral feeding
15580|NCT04101071|nasogastric|nasogastric
15581|NCT04101071|ketogenic feed|ketogenic feed
15582|NCT04101071|feasibility|feasibility
15583|NCT04101032|Mindfulness|mindfulness
15584|NCT04101032|Self-compassion|self-compassion
15585|NCT04101032|Values|values
15586|NCT04101032|Binge Eating|binge eating
15587|NCT04100967|sleep|sleep
15588|NCT04100967|obesity|obesity
15589|NCT04100967|body fat composition|body fat composition
15590|NCT04100967|young adults|young adults
15591|NCT04100967|diet|diet
15592|NCT04100967|activity|activity
15593|NCT04100967|Dual X-ray Absorptiometry|dual x-ray absorptiometry
15594|NCT04100954|phonatory prosthesis|phonatory prosthesis
15595|NCT04100954|voice rehabilitation|voice rehabilitation
15596|NCT04100954|reinforced voice prosthesis|reinforced voice prosthesis
15597|NCT04100954|laryngectomy|laryngectomy
15598|NCT04100954|total pharyngolaryngectomy|total pharyngolaryngectomy
15599|NCT04100954|total circular pharyngolaryngectomy|total circular pharyngolaryngectomy
15600|NCT04100902|allergic asthma, allergen immunotherapy, anti-viral immunity, house dust mite|allergic asthma, allergen immunotherapy, anti-viral immunity, house dust mite
15601|NCT04100889|Microbiome|microbiome
15602|NCT04100850|hydrotherapy|hydrotherapy
15603|NCT04100850|depression|depression
15604|NCT04100850|anxiety|anxiety
15605|NCT04100772|PCV13i|pcv13i
15606|NCT04100772|PCV13|pcv13
15607|NCT04100772|Pneumococcal conjugate vaccine|pneumococcal conjugate vaccine
15608|NCT04100733|Flexible cystoscopy|flexible cystoscopy
15609|NCT04100733|Xpert Bladder Cancer Monitor|xpert bladder cancer monitor
15610|NCT04100707|Genicular nerve|genicular nerve
15611|NCT04100707|Knee pain|knee pain
15612|NCT04100707|Ultrasound|ultrasound
15613|NCT04100694|Early Access|early access
15614|NCT04100694|NRG1|nrg1
15615|NCT04100694|Pancreas cancer|pancreas cancer
15616|NCT04100694|Non Small Cell Lung Cancer|non small cell lung cancer
15617|NCT04100694|Solid tumor|solid tumor
15618|NCT04100694|Compassionate use|compassionate use
15619|NCT04100694|Expanded access|expanded access
15620|NCT04100655|GM-CSF|gm-csf
15621|NCT04100655|frozen embryo transfer|frozen embryo transfer
15622|NCT04100642|first in human|first in human
15623|NCT04100642|atopic dermatitis|atopic dermatitis
15624|NCT04100577|TNT-PISP|tnt-pisp
15625|NCT04100564|intubation|intubation
15626|NCT04100564|supraglottic airway|supraglottic airway
15627|NCT04100538|Health coaching|health coaching
15628|NCT04100538|Quality of Life|quality of life
15629|NCT04100525|Employment|employment
15630|NCT04100525|Vocational Rehabilitation|vocational rehabilitation
15631|NCT04100499|Endoanchors|endoanchors
15632|NCT04100499|EVAR|evar
15633|NCT04100499|TEVAR|tevar
15634|NCT04100486|Vagus Nerve Stimulation|vagus nerve stimulation
15635|NCT04100486|Noninvasive|noninvasive
15636|NCT04100486|Autonomic Nervous System|autonomic nervous system
15637|NCT04100486|Biosensors|biosensors
15638|NCT04100486|Vitals Monitoring|vitals monitoring
15639|NCT04100486|Machine Learning|machine learning
15640|NCT04100486|Deep Learning|deep learning
15641|NCT04100473|Inhaled Insulin|inhaled insulin
15642|NCT04100460|Fecal Microbiota|fecal microbiota
15643|NCT04100460|Gastrointestinal tolerance|gastrointestinal tolerance
15644|NCT04100460|Bowel habits|bowel habits
15645|NCT04100447|post-operative|post-operative
15646|NCT04100447|abdominal|abdominal
15647|NCT04100434|Acute Coronary Syndrome|acute coronary syndrome
15648|NCT04100434|Proprotein Convertase Subtilisin/Kexin Type 9 Inhibitor|proprotein convertase subtilisin/kexin type 9 inhibitor
15649|NCT04100434|Lipid-lowering Drug|lipid-lowering drug
15650|NCT04100434|Major Cardiovascular Adverse Events|major cardiovascular adverse events
15651|NCT04100421|bisphenol|bisphenol
15652|NCT04100421|human exposure|human exposure
15653|NCT04100421|chronic kidney disease|chronic kidney disease
15654|NCT04100421|blood purification|blood purification
15655|NCT04100369|shock , poly trauma , serum lactate|shock , poly trauma , serum lactate
15656|NCT04100356|Low-carbohydrate-high-fat diet (LCHF)|low-carbohydrate-high-fat diet (lchf)
15657|NCT04100356|Low-density-lipoprotein (LDL)|low-density-lipoprotein (ldl)
15658|NCT04100356|High-density-lipoprotein (HDL)|high-density-lipoprotein (hdl)
15663|NCT04100356|Body composition|body composition
15664|NCT04100356|Weight|weight
23245|NCT04052581|POEM|poem
15665|NCT04100317|Pridge plate|pridge plate
15666|NCT04100291|FMT|fmt
15667|NCT04100291|Microbiota|microbiota
15668|NCT04100278|Type 2 Diabetes|type 2 diabetes
15669|NCT04100278|Diabetes Education and Management|diabetes education and management
15670|NCT04100239|inflammatory bowel disease|inflammatory bowel disease
15671|NCT04100239|mindfulness|mindfulness
15672|NCT04100239|self-compassion|self-compassion
15673|NCT04100239|young people|young people
15674|NCT04100239|pilot study|pilot study
15675|NCT04100226|Interstitial Lung Diseases|interstitial lung diseases
15676|NCT04100226|Vitamin D Deficiency|vitamin d deficiency
15677|NCT04100213|Stress, Stress Reaction, Trier Social Stress Test, Digital Phenotyping|stress, stress reaction, trier social stress test, digital phenotyping
15678|NCT04100200|Strawberry|strawberry
15679|NCT04100200|Raspberry|raspberry
15680|NCT04100200|Metabolic responses|metabolic responses
15681|NCT04100200|Gut microbiome|gut microbiome
15682|NCT04100200|Inflammatory markers|inflammatory markers
15683|NCT04100187|CAR-T|car-t
15684|NCT04100187|Leukemia|leukemia
15685|NCT04100187|Lymphoma|lymphoma
15686|NCT04100161|muscle strain, atrophy, protein, rehabilitation|muscle strain, atrophy, protein, rehabilitation
15687|NCT04100148|SyncAV feature|syncav feature
15688|NCT04100148|CRT optimization|crt optimization
15689|NCT04100148|CRT non-responders|crt non-responders
15690|NCT04100148|ECG optimization|ecg optimization
15691|NCT04100148|Cardiac remodeling|cardiac remodeling
15692|NCT04100148|CRT with SyncAV|crt with syncav
15693|NCT04100122|Major allergen|major allergen
15694|NCT04099992|Mindfulness|mindfulness
15695|NCT04099992|Transcutaneous Vagus Nerve Stimulation|transcutaneous vagus nerve stimulation
15696|NCT04099992|tVNS|tvns
15697|NCT04099992|Sympatho-inhibitory effects|sympatho-inhibitory effects
15698|NCT04099966|allogeneic stem cell transplantation|allogeneic stem cell transplantation
15699|NCT04099966|t-cell depletion|t-cell depletion
15700|NCT04099966|alpha beta cell depletion|alpha beta cell depletion
15701|NCT04099953|Hemodialysis|hemodialysis
15702|NCT04099953|chronic renal failure|chronic renal failure
15703|NCT04099953|upper extremity|upper extremity
15704|NCT04099953|physical activity|physical activity
15705|NCT04099953|physical function|physical function
15706|NCT04099940|Hearing Voices, Virtual Reality Avatar Therapy, Cognitive Behavioural Therapy|hearing voices, virtual reality avatar therapy, cognitive behavioural therapy
15707|NCT04099914|Cerebellar ataxia|cerebellar ataxia
15708|NCT04099914|Neurogenetics|neurogenetics
15709|NCT04099914|Next generation sequence|next generation sequence
15710|NCT04099914|Clinical algorithm|clinical algorithm
15711|NCT04099901|Anakinra|anakinra
15712|NCT04099901|Mucositis|mucositis
15713|NCT04099901|Hematopoietic stem cell transplantation|hematopoietic stem cell transplantation
15714|NCT04099901|Febrile neutropenia|febrile neutropenia
15715|NCT04099888|Phase II|phase ii
15716|NCT04099888|Safety|safety
15717|NCT04099888|Tolerability|tolerability
15718|NCT04099888|Efficacy|efficacy
15719|NCT04099888|Amphinex-induced Photochemical Internalisation|amphinex-induced photochemical internalisation
15720|NCT04099888|PCI|pci
15721|NCT04099888|Amphinex|amphinex
15722|NCT04099888|Gemcitabine|gemcitabine
15723|NCT04099888|Cisplatin|cisplatin
15724|NCT04099888|Inoperable|inoperable
15725|NCT04099888|CCA|cca
15726|NCT04099888|Cholangiocarcinoma|cholangiocarcinoma
15727|NCT04099888|Bile duct cancer|bile duct cancer
15728|NCT04099888|Photodynamic therapy|photodynamic therapy
15729|NCT04099888|Extrahepatic|extrahepatic
15730|NCT04099888|Perihilar|perihilar
15731|NCT04099888|Distal|distal
15732|NCT04099888|Fimaporfin|fimaporfin
15733|NCT04099888|Pivotal|pivotal
15734|NCT04099888|RELEASE|release
15735|NCT04099888|PDT|pdt
15736|NCT04099888|FimaChem|fimachem
15737|NCT04099888|Klatskin|klatskin
15738|NCT04099875|nutrition,cirrhosis|nutrition,cirrhosis
15739|NCT04099849|Rice|rice
15740|NCT04099849|biofortification,|biofortification,
15741|NCT04099849|Bangladeshi children|bangladeshi children
15742|NCT04099849|zinc|zinc
15748|NCT04099810|three-dimensional echocardiography|three-dimensional echocardiography
15749|NCT04099810|right ventricular volumes|right ventricular volumes
15750|NCT04099810|cardiac magnetic resonance|cardiac magnetic resonance
15751|NCT04099797|Gene Therapy|gene therapy
15752|NCT04099797|CAR T-cells|car t-cells
15753|NCT04099797|chimeric antigen receptor|chimeric antigen receptor
15754|NCT04099797|Brain Cancer|brain cancer
15755|NCT04099797|Immunotherapy|immunotherapy
15756|NCT04099797|Glioma|glioma
15757|NCT04099797|Brain tumor|brain tumor
15859|NCT04099303|DTcP|dtcp
15762|NCT04099706|Postherpetic Neuralgia|postherpetic neuralgia
15768|NCT04099654|obese|obese
15769|NCT04099654|core stabilization|core stabilization
15770|NCT04099654|bariatric surgery|bariatric surgery
15771|NCT04099654|exercise|exercise
15772|NCT04099628|monitoring|monitoring
15773|NCT04099628|surveillance|surveillance
15774|NCT04099628|re-emergence|re-emergence
23411|NCT04051411|MRI|mri
15775|NCT04099628|rapid diagnostic test|rapid diagnostic test
15776|NCT04099628|trypanolysis|trypanolysis
15777|NCT04099628|LAMP|lamp
15778|NCT04099628|ELISA|elisa
15779|NCT04099628|molecular biology|molecular biology
15780|NCT04099628|RT-PCR|rt-pcr
15781|NCT04099628|serology|serology
15782|NCT04099628|diagnosis|diagnosis
15783|NCT04099628|specificity|specificity
15784|NCT04099628|sensitivity|sensitivity
15785|NCT04099615|Evoked Potentials, Somatosensory|evoked potentials, somatosensory
15786|NCT04099615|Acute Cerebrovascular Accident|acute cerebrovascular accident
15787|NCT04099615|Endovascular Procedures|endovascular procedures
15788|NCT04099602|neonatal jaundice|neonatal jaundice
15789|NCT04099602|baby massage|baby massage
15790|NCT04099602|transcutaneous bilirubin level|transcutaneous bilirubin level
15791|NCT04099602|premature infant|premature infant
15792|NCT04099576|therapeutic neuroscience education|therapeutic neuroscience education
15793|NCT04099576|chronic low back pain|chronic low back pain
15794|NCT04099576|kinesiophobia|kinesiophobia
15795|NCT04099576|pain|pain
15796|NCT04099537|skin picking|skin picking
15797|NCT04099537|cognitive training|cognitive training
15798|NCT04099537|approach-avoidance|approach-avoidance
15799|NCT04099511|Stroke|stroke
15800|NCT04099511|Occupational therapy|occupational therapy
15801|NCT04099511|Rehabilitation|rehabilitation
15802|NCT04099511|Participation|participation
15803|NCT04099498|Self-regulation|self-regulation
15804|NCT04099498|Healthy eating|healthy eating
15805|NCT04099498|Online|online
15806|NCT04099498|Promotion|promotion
15807|NCT04099485|anticoagulation|anticoagulation
15808|NCT04099485|decision sciences|decision sciences
15809|NCT04099485|clinical informatics|clinical informatics
15810|NCT04099485|implementation research|implementation research
15811|NCT04099472|delirium|delirium
15812|NCT04099472|intensive care unit|intensive care unit
15813|NCT04099472|critically ill|critically ill
15814|NCT04099472|delirium detection|delirium detection
15815|NCT04099472|delirium prevention|delirium prevention
15816|NCT04099472|delirium education|delirium education
15817|NCT04099472|delirium management|delirium management
15818|NCT04099472|psychological distress|psychological distress
15819|NCT04099472|post intensive care syndrome|post intensive care syndrome
15820|NCT04099472|post intensive care syndrome family|post intensive care syndrome family
15821|NCT04099433|HIV|hiv
15822|NCT04099433|HPV|hpv
15823|NCT04099433|Probiotics|probiotics
15824|NCT04099433|High Resolution Anoscopy|high resolution anoscopy
15825|NCT04099433|Anal dysplasia|anal dysplasia
15826|NCT04099420|Self-medication|self-medication
15827|NCT04099420|Adherence to Mediterranean diet|adherence to mediterranean diet
15828|NCT04099420|Orthorexia|orthorexia
15829|NCT04099420|Relationship lifestyle and metabolic status biomarkers|relationship lifestyle and metabolic status biomarkers
15830|NCT04099420|Oral microbiota composition|oral microbiota composition
15831|NCT04099420|Relationship lifestyle and immunological status biomarkers|relationship lifestyle and immunological status biomarkers
15832|NCT04099407|Liver fibrosis|liver fibrosis
15833|NCT04099407|Fibrosis treatment|fibrosis treatment
15834|NCT04099407|Fibrosis reversibility|fibrosis reversibility
15835|NCT04099407|Pirfenidone|pirfenidone
15836|NCT04099394|Osteoarthritis|osteoarthritis
15837|NCT04099394|chronic pain|chronic pain
15838|NCT04099394|behavioral health|behavioral health
15839|NCT04099394|exercise|exercise
15840|NCT04099394|physical activity|physical activity
15841|NCT04099394|older adults|older adults
15842|NCT04099381|Autism, ASD, Cord blood, HLA|autism, asd, cord blood, hla
15843|NCT04099329|Soccer|soccer
15844|NCT04099329|Football|football
15845|NCT04099329|Injury|injury
15846|NCT04099329|Prevention|prevention
15847|NCT04099329|Concussion|concussion
15848|NCT04099329|Education|education
15849|NCT04099329|Huddles|huddles
15850|NCT04099329|Primary prevention|primary prevention
15851|NCT04099329|Secondary prevention|secondary prevention
15852|NCT04099329|Behavioral intervention|behavioral intervention
15853|NCT04099316|Aging|aging
15854|NCT04099316|Eccentric training|eccentric training
15855|NCT04099316|Muscle strength|muscle strength
15856|NCT04099316|Physical function|physical function
15857|NCT04099316|Sarcopenia|sarcopenia
15858|NCT04099303|Infection|infection
15882|NCT04099173|Veterans' Affairs|veterans' affairs
15883|NCT04099160|neurophysiology pain questionnaire|neurophysiology pain questionnaire
15885|NCT04099160|validity|validity
15886|NCT04099160|pain|pain
15887|NCT04099160|low back pain|low back pain
15888|NCT04099147|non-alcoholic fatty liver disease|non-alcoholic fatty liver disease
15889|NCT04099147|NAFLD|nafld
15890|NCT04099147|Artificial Intelligence|artificial intelligence
15891|NCT04099147|Deep Learning System|deep learning system
15892|NCT04099095|Wait-list|wait-list
15893|NCT04099069|Transbronchial Cryobiopsy|transbronchial cryobiopsy
15894|NCT04099069|anesthesia|anesthesia
15895|NCT04099069|tracheal intubation|tracheal intubation
15896|NCT04099069|rigid bronchoscopy|rigid bronchoscopy
15897|NCT04099069|safety|safety
15898|NCT04099069|interstitial lung disease|interstitial lung disease
15899|NCT04099030|drug shortage|drug shortage
15900|NCT04099017|manual therapy|manual therapy
15901|NCT04099017|kinesiotape|kinesiotape
15902|NCT04099017|Excercise therapies|excercise therapies
15903|NCT04099017|isometric contraction|isometric contraction
15904|NCT04099017|muscle strength|muscle strength
15905|NCT04098991|neuroimaging|neuroimaging
15906|NCT04098991|thyroid|thyroid
15907|NCT04098991|white matter|white matter
15908|NCT04098978|Children|children
15909|NCT04098978|Adolescents|adolescents
15910|NCT04098978|Young Adults|young adults
15911|NCT04098978|Pediatric Hypertension|pediatric hypertension
15912|NCT04098978|Pharmacoeconomics|pharmacoeconomics
15913|NCT04098978|Pharmacist|pharmacist
15914|NCT04098952|temporomandibular disorders|temporomandibular disorders
15915|NCT04098952|electric massage|electric massage
15916|NCT04098952|temporomandibular joint|temporomandibular joint
15917|NCT04098952|local techniques|local techniques
15918|NCT04098926|Older women|older women
15919|NCT04098926|Accelerated radiotherapy|accelerated radiotherapy
15920|NCT04098926|Dose-integrated radiotherapy|dose-integrated radiotherapy
15921|NCT04098913|screen time|screen time
15922|NCT04098913|physical activity|physical activity
15923|NCT04098913|sleep|sleep
15924|NCT04098913|stress|stress
15925|NCT04098822|Urinary Incontinence, Stress|urinary incontinence, stress
15926|NCT04098822|Suburethral Slings|suburethral slings
15927|NCT04098822|Prostatectomy|prostatectomy
15928|NCT04098796|Gastric or gastroesophageal junction adenocarcinoma|gastric or gastroesophageal junction adenocarcinoma
15929|NCT04098796|AFP|afp
15930|NCT04098796|PD-1|pd-1
15931|NCT04098796|chemotherapy|chemotherapy
15932|NCT04098796|first-line|first-line
15933|NCT04098783|Breast Cancer|breast cancer
15934|NCT04098783|Lymphedema|lymphedema
15935|NCT04098783|Health Belief Model|health belief model
15936|NCT04098783|Nursing|nursing
15937|NCT04098783|Home Visit|home visit
15938|NCT04098770|AIDS patients|aids patients
15939|NCT04098770|Safety|safety
15940|NCT04098770|Efficiency|efficiency
15941|NCT04098770|Immune Therapy|immune therapy
15942|NCT04098757|Fibromyalgia|fibromyalgia
15943|NCT04098757|Fibromyalgic Sindrome (FMS)|fibromyalgic sindrome (fms)
15944|NCT04098757|Pain|pain
15945|NCT04098757|Acupuncture|acupuncture
15946|NCT04098757|Nutraceutical products|nutraceutical products
15958|NCT04098731|Fibromyalgia|fibromyalgia
15959|NCT04098731|Respiratory function|respiratory function
15960|NCT04098718|Exacerbations|exacerbations
15961|NCT04098718|Interleukin 5|interleukin 5
15962|NCT04098718|Prednisolone|prednisolone
15963|NCT04098718|Randomised Clinical Trial|randomised clinical trial
15964|NCT04098679|Type 1 diabetes|type 1 diabetes
15965|NCT04098679|Offspring|offspring
15966|NCT04098679|Continuous glucose monitoring|continuous glucose monitoring
15967|NCT04098640|Young patient|young patient
15968|NCT04098640|Asian|asian
15969|NCT04098627|laughter|laughter
15970|NCT04098627|depression|depression
15971|NCT04098627|hemodialysis|hemodialysis
15972|NCT04098614|recovery coaching|recovery coaching
15973|NCT04098614|risk factors|risk factors
15974|NCT04098614|substance abuse|substance abuse
15975|NCT04098614|EEG|eeg
15976|NCT04098601|recovery coaching|recovery coaching
15977|NCT04098601|substance abuse|substance abuse
15978|NCT04098549|Type 1 Diabetes|type 1 diabetes
15979|NCT04098549|Glucose Metabolism|glucose metabolism
15980|NCT04098549|Hypoglycemia|hypoglycemia
15981|NCT04098549|Glucagon|glucagon
15982|NCT04098523|Carotid Artery Stenosis|carotid artery stenosis
15983|NCT04098523|Abdominal Aortic Aneurysm|abdominal aortic aneurysm
15984|NCT04098523|Epidemiology|epidemiology
15985|NCT04098523|Stenosis|stenosis
15986|NCT04098523|Population screening|population screening
15987|NCT04098510|Mitochondria-targeted antioxidant|mitochondria-targeted antioxidant
15988|NCT04098510|Skeletal muscle biopsies|skeletal muscle biopsies
15989|NCT04098497|mood|mood
15990|NCT04098497|stress|stress
15991|NCT04098497|sleep|sleep
15992|NCT04098497|circadian rhythm|circadian rhythm
15993|NCT04098497|medical adherence|medical adherence
15994|NCT04098497|acceptance and commitment therapy|acceptance and commitment therapy
15995|NCT04098497|microintervention|microintervention
15996|NCT04098484|Obesity, strength training, cardiovascular training, inflammation, Liver, oxidative stress|obesity, strength training, cardiovascular training, inflammation, liver, oxidative stress
15997|NCT04098471|transanal local excision|transanal local excision
15998|NCT04098471|T2N0M0|t2n0m0
15999|NCT04098432|Stereotactic radiotherapy|stereotactic radiotherapy
16000|NCT04098432|Nivolumab|nivolumab
16001|NCT04098432|Anti PD-1|anti pd-1
16002|NCT04098432|Pancreatic cancer|pancreatic cancer
16003|NCT04098432|Pancreatic Adenocarcinoma|pancreatic adenocarcinoma
16004|NCT04098406|Gold|gold
16005|NCT04098406|Nanocrystal|nanocrystal
16006|NCT04098406|electromyography|electromyography
16007|NCT04098393|Busulfan|busulfan
16008|NCT04098393|Melphalan|melphalan
16009|NCT04098393|Fludarabine|fludarabine
16010|NCT04098393|Allogeneic Hematopoietic Cell Transplantation|allogeneic hematopoietic cell transplantation
16011|NCT04098393|19-245|19-245
16012|NCT04098315|HIV|hiv
16013|NCT04098315|AIDS|aids
16014|NCT04098315|DRUG RESISTANCE|drug resistance
16015|NCT04098289|Hysteroscopy|hysteroscopy
16016|NCT04098289|Metroplasty|metroplasty
16017|NCT04098289|Primary infertility|primary infertility
16018|NCT04098289|Preterm delivery|preterm delivery
16019|NCT04098276|Intimate partner violence|intimate partner violence
16020|NCT04098276|safety planning|safety planning
16021|NCT04098276|immigrant|immigrant
16022|NCT04098276|risk for future violence|risk for future violence
16023|NCT04098276|risk for intimate partner homicide|risk for intimate partner homicide
16024|NCT04098276|empowerment|empowerment
16025|NCT04098276|mental health|mental health
16026|NCT04098276|safety|safety
16027|NCT04098250|headache|headache
16028|NCT04098250|post-traumatic headache|post-traumatic headache
16029|NCT04098211|Neuronal Ceroid Lipofuscinosis|neuronal ceroid lipofuscinosis
16030|NCT04098211|Atypical CLN2 Disease|atypical cln2 disease
16031|NCT04098211|Natural History|natural history
16032|NCT04098198|Inborn Error of Metabolism|inborn error of metabolism
16033|NCT04098198|Biomarker|biomarker
16034|NCT04098133|Carbapenemase-producing Klebsiella pneumoniae|carbapenemase-producing klebsiella pneumoniae
16035|NCT04098133|antibiotic resistancy|antibiotic resistancy
16036|NCT04098133|infections with Carbapenemase-producing Bacteria (CPB)|infections with carbapenemase-producing bacteria (cpb)
16037|NCT04098133|Carbapenemase-producing Bacteria|carbapenemase-producing bacteria
16038|NCT04098107|Healthy subjects|healthy subjects
16039|NCT04098107|Athletes|athletes
16040|NCT04098107|Baseball|baseball
16041|NCT04098107|Sports research|sports research
16042|NCT04098107|overuse injuries|overuse injuries
16043|NCT04098081|pancreatic cancer|pancreatic cancer
16044|NCT04098068|BRAF pv600E (human gene that encodes a protein called B-Raf)|braf pv600e (human gene that encodes a protein called b-raf)
16045|NCT04098068|TGFBR2 (transforming growth factor-beta (TGF-β) receptor type 2)|tgfbr2 (transforming growth factor-beta (tgf-β) receptor type 2)
16046|NCT04098068|Mutation load|mutation load
16047|NCT04098068|Tumor mutation load|tumor mutation load
16048|NCT04098068|Mutation burden|mutation burden
16049|NCT04098068|Tumor mutation burden (TMB)|tumor mutation burden (tmb)
16050|NCT04098068|Hypermutation|hypermutation
16051|NCT04098068|POLE|pole
16052|NCT04098068|MSI Negative with Mutator Phenotype (High Tumor Mutation Burden)|msi negative with mutator phenotype (high tumor mutation burden)
16053|NCT04098068|TMB (Tumor Mutation Burden)|tmb (tumor mutation burden)
16054|NCT04098055|Lupus Erythematosus, Systemic|lupus erythematosus, systemic
16065|NCT04098029|Cerebral palsy|cerebral palsy
16066|NCT04098029|CP|cp
16067|NCT04098029|Cord Blood|cord blood
16068|NCT04098029|Stem cells|stem cells
16069|NCT04098029|HLA|hla
16070|NCT04098003|gut microbiome|gut microbiome
16071|NCT04098003|statins|statins
16072|NCT04098003|cholesterol|cholesterol
16073|NCT04097977|User involvement|user involvement
16074|NCT04097977|Patient-reported outcomes|patient-reported outcomes
16075|NCT04097977|Networked-based recovery|networked-based recovery
16076|NCT04097964|SBIRT|sbirt
16077|NCT04097925|Doravirine|doravirine
16078|NCT04097886|circadian|circadian
16079|NCT04097886|phase shift|phase shift
16080|NCT04097886|exercise|exercise
16090|NCT04097808|bioavailability|bioavailability
16091|NCT04097808|collagen peptides|collagen peptides
16092|NCT04097808|polyphenols|polyphenols
16093|NCT04097782|antenatal education|antenatal education
16094|NCT04097782|fear of childbirth|fear of childbirth
16095|NCT04097782|depression|depression
16096|NCT04097782|anxiety|anxiety
16097|NCT04097782|stress|stress
16098|NCT04097782|childbirth self-efficacy|childbirth self-efficacy
16099|NCT04097782|mode of delivery|mode of delivery
16100|NCT04097717|Tubal Ligation|tubal ligation
16101|NCT04097717|Decision Aid|decision aid
16102|NCT04097704|Hepatic impairment|hepatic impairment
16103|NCT04097704|CC-90007-CP-003|cc-90007-cp-003
16104|NCT04097704|Healthy Subject|healthy subject
16105|NCT04097691|diabetes mellitus|diabetes mellitus
16106|NCT04097691|diabetic neuropathy|diabetic neuropathy
16107|NCT04097691|pain|pain
16108|NCT04097691|glucose 10%|glucose 10%
16109|NCT04097678|lumbar spine surgery|lumbar spine surgery
16110|NCT04097678|radiographic imaging|radiographic imaging
16111|NCT04097665|ICGA|icga
16112|NCT04097665|necrosis|necrosis
16113|NCT04097665|blood supply|blood supply
16114|NCT04097665|expanded flap|expanded flap
16115|NCT04097652|acute ischemic stroke|acute ischemic stroke
16116|NCT04097639|low-grade inflammation|low-grade inflammation
16118|NCT04097639|erythroferrone|erythroferrone
16119|NCT04097613|Betadine|betadine
16120|NCT04097613|Povidone Iodine|povidone iodine
16121|NCT04097613|CRS|crs
16122|NCT04097613|Biofilm|biofilm
16123|NCT04097613|Recalcitrant|recalcitrant
16128|NCT04097548|Pregnancy|pregnancy
16129|NCT04097535|PET/MRI|pet/mri
16130|NCT04097535|Fatty Acid Oxidation|fatty acid oxidation
16131|NCT04097522|neurofeedback|neurofeedback
16132|NCT04097483|Comorbidity|comorbidity
16133|NCT04097483|Depression|depression
16134|NCT04097483|Type 2 Diabetes|type 2 diabetes
16135|NCT04097483|Primary Health Care|primary health care
16136|NCT04097483|Randomized-Controlled Trial|randomized-controlled trial
16137|NCT04097483|Treatment Adherence|treatment adherence
16138|NCT04097483|Telephone-Based Intervention|telephone-based intervention
16139|NCT04097444|Metastatic colorectal cancer|metastatic colorectal cancer
16140|NCT04097444|bevacizumab|bevacizumab
16141|NCT04097444|CAPOXIRI|capoxiri
16142|NCT04097444|FOLFOXIRI|folfoxiri
16143|NCT04097418|Multiple Sclerosis|multiple sclerosis
16144|NCT04097418|Aerobic Training|aerobic training
16145|NCT04097418|rehabilitation|rehabilitation
16146|NCT04097379|Knee osteoarthritis|knee osteoarthritis
16147|NCT04097379|Chondroanabolic drug|chondroanabolic drug
16148|NCT04097379|Magnetic resonance imaging|magnetic resonance imaging
16149|NCT04097379|Patient Reported Outcomes|patient reported outcomes
16150|NCT04097379|Biosensors|biosensors
16151|NCT04097353|Behavioral|behavioral
16152|NCT04097353|Obesity|obesity
16153|NCT04097353|Neoplasm|neoplasm
16154|NCT04097327|Ectoin|ectoin
16155|NCT04097327|Ectoin Dermatitis Cream|ectoin dermatitis cream
16156|NCT04097327|Atopic dermatitis|atopic dermatitis
16157|NCT04097314|Microvascular Angina|microvascular angina
16158|NCT04097314|Angina|angina
16159|NCT04097314|Endothelin|endothelin
16160|NCT04097314|MVA|mva
16848|NCT04093037|Fluorescein|fluorescein
16161|NCT04097314|Impaired Exercise Intolerance|impaired exercise intolerance
16162|NCT04097288|stress urinary incontinence|stress urinary incontinence
16163|NCT04097288|pharmacologic treatment|pharmacologic treatment
16164|NCT04097288|fecal incontinence|fecal incontinence
16165|NCT04097249|Musculoskeletal pain|musculoskeletal pain
16166|NCT04097249|Delayed Onset Muscle Soreness|delayed onset muscle soreness
16167|NCT04097249|Pain sensitivity|pain sensitivity
16168|NCT04097249|Infrared thermography|infrared thermography
16169|NCT04097249|Referred pain|referred pain
16170|NCT04097210|Q-CRP|q-crp
16171|NCT04097210|lactate|lactate
16172|NCT04097210|suPAR|supar
16173|NCT04097210|POC|poc
16174|NCT04097210|ambulance|ambulance
16175|NCT04097197|Influenza Vaccines|influenza vaccines
16176|NCT04097197|Influenza, Human|influenza, human
16177|NCT04097197|Primary Health Care|primary health care
16178|NCT04097119|HDL function|hdl function
16179|NCT04097119|HDL dysfunction|hdl dysfunction
16180|NCT04097119|nutritional supplement|nutritional supplement
16181|NCT04097119|quality of life|quality of life
16182|NCT04097119|dietary supplement|dietary supplement
16183|NCT04097067|Lymphoma|lymphoma
16184|NCT04097067|Lymphoma, B-Cell, Marginal Zone|lymphoma, b-cell, marginal zone
16185|NCT04097067|Neoplasms by Histologic Type|neoplasms by histologic type
16186|NCT04097067|Neoplasms|neoplasms
16187|NCT04097067|Lymphoproliferative Disorders|lymphoproliferative disorders
16188|NCT04097067|Lymphatic Diseases|lymphatic diseases
16189|NCT04097067|Immunoproliferative Disorders|immunoproliferative disorders
16190|NCT04097067|Immune System Diseases|immune system diseases
16191|NCT04097067|Lymphoma, B-Cell|lymphoma, b-cell
16192|NCT04097067|Lymphoma, Non-Hodgkin|lymphoma, non-hodgkin
16193|NCT04097067|Lymphoma, follicular|lymphoma, follicular
16194|NCT04097054|operative procedures|operative procedures
16195|NCT04097054|intraoperative monitoring|intraoperative monitoring
16196|NCT04097054|budgetary control|budgetary control
16197|NCT04097015|Electrical Stimulation, Transcutaneous|electrical stimulation, transcutaneous
16198|NCT04097015|Spinal Cord Injury|spinal cord injury
16199|NCT04097015|Neutrophic Pain|neutrophic pain
16200|NCT04097015|Functional Movements|functional movements
16201|NCT04097002|Prostate cancer|prostate cancer
16202|NCT04097002|Intratumoral|intratumoral
16203|NCT04097002|ORCA|orca
16204|NCT04097002|Adenovirus|adenovirus
16205|NCT04097002|Localized Prostate cancer|localized prostate cancer
16206|NCT04097002|Intraprostatic|intraprostatic
16207|NCT04096989|prediabetes|prediabetes
16208|NCT04096989|TCM|tcm
16209|NCT04096989|body constitution|body constitution
16210|NCT04096989|meridian energy|meridian energy
16211|NCT04096989|APP|app
16212|NCT04096937|Resilience|resilience
16213|NCT04096937|Appalachian youth|appalachian youth
16214|NCT04096937|Community-based participatory research|community-based participatory research
16215|NCT04096924|ASD|asd
16216|NCT04096924|Atrial septal defects|atrial septal defects
16217|NCT04096924|amplatzer|amplatzer
16218|NCT04096911|HPV vaccine|hpv vaccine
16219|NCT04096911|PD-1 Monoclonal Antibody|pd-1 monoclonal antibody
16220|NCT04096911|Cervical Cancer|cervical cancer
16221|NCT04096898|dry eye|dry eye
16222|NCT04096885|cohort|cohort
16223|NCT04096885|visceral surgery|visceral surgery
16224|NCT04096885|biobank|biobank
16225|NCT04096859|elective surgery|elective surgery
804907|NCT00235014|diabetes|diabetes
16226|NCT04096859|minimally invasive surgery|minimally invasive surgery
16227|NCT04096859|cardiac valve reconstruction|cardiac valve reconstruction
16228|NCT04096859|cardiac valve replacement|cardiac valve replacement
16229|NCT04096807|Pulmonary wedge pressure|pulmonary wedge pressure
16230|NCT04096807|Atrial pressure|atrial pressure
16231|NCT04096807|Left ventricle|left ventricle
16232|NCT04096807|Left ventricular function|left ventricular function
16233|NCT04096807|Left atrial function|left atrial function
16234|NCT04096755|Deep Vein Thrombosis|deep vein thrombosis
16235|NCT04096742|Skin|skin
16236|NCT04096742|Chest|chest
16237|NCT04096742|Photodamage|photodamage
16238|NCT04096742|Sun Damage|sun damage
16239|NCT04096729|commitment to treatment|commitment to treatment
16240|NCT04096729|compression stockings|compression stockings
16241|NCT04096729|varicose veins|varicose veins
16242|NCT04096703|Idiopathic Esophagogastric Junction Outflow Obstruction|idiopathic esophagogastric junction outflow obstruction
16243|NCT04096703|Esophageal Sphincter Function|esophageal sphincter function
16244|NCT04096703|Esophagogastric Junction|esophagogastric junction
16245|NCT04096703|Pneumatic Dilation|pneumatic dilation
16246|NCT04096690|Anti-PD-1 antibody|anti-pd-1 antibody
16247|NCT04096690|Nasal Type Extranodal NK/T-Cell Lymphoma|nasal type extranodal nk/t-cell lymphoma
16248|NCT04096690|Complete response rate|complete response rate
16249|NCT04096690|Safety|safety
16250|NCT04096677|post cesarean scar defect|post cesarean scar defect
16251|NCT04096677|hysteroscopy|hysteroscopy
16252|NCT04096677|transvaginal intervention|transvaginal intervention
16253|NCT04096677|endometrial receptive|endometrial receptive
16254|NCT04096664|bronchial clearance|bronchial clearance
16255|NCT04096664|cystic fibrosis|cystic fibrosis
16256|NCT04096651|progressive supranuclear palsy PSP|progressive supranuclear palsy psp
16257|NCT04096651|atypical parkinsonism|atypical parkinsonism
16258|NCT04096651|gait disorders|gait disorders
16259|NCT04096651|neurophysiology|neurophysiology
16260|NCT04096651|imaging|imaging
16261|NCT04096625|Brain Stimulation, tDCS, Psychotherapy, Psychiatric Disorder|brain stimulation, tdcs, psychotherapy, psychiatric disorder
16262|NCT04096560|Drug therapy|drug therapy
16263|NCT04096534|partial nephrectomy|partial nephrectomy
16264|NCT04096534|zero ischaemia|zero ischaemia
16265|NCT04096534|renal function|renal function
16266|NCT04096521|serum folic acid|serum folic acid
16267|NCT04096521|genotyping|genotyping
16268|NCT04096521|dna methylation of IGF2|dna methylation of igf2
16269|NCT04096521|East Jakarta Cohort Study|east jakarta cohort study
16270|NCT04096521|mother-children|mother-children
16271|NCT04096482|Nasal endoscopy|nasal endoscopy
16272|NCT04096469|breast cancer survivors|breast cancer survivors
16273|NCT04096469|diet|diet
16274|NCT04096469|physical activity|physical activity
16275|NCT04096469|motivational interviewing|motivational interviewing
16276|NCT04096469|body weight|body weight
16277|NCT04096469|quality of life|quality of life
16278|NCT04096469|biomarkers|biomarkers
16279|NCT04096456|Gastropexy|gastropexy
16280|NCT04096456|Endoscopic Gastropexy|endoscopic gastropexy
16281|NCT04096456|Gastrostomy Tube|gastrostomy tube
16282|NCT04096443|Fecal microbial transplant|fecal microbial transplant
16284|NCT04096443|Pilot study|pilot study
16285|NCT04096391|Truncal Pain|truncal pain
16286|NCT04096391|Lower Extremity Limb Pain|lower extremity limb pain
16287|NCT04096391|Refractory Pain|refractory pain
16288|NCT04096378|Racial Socialization|racial socialization
16289|NCT04096378|Family Functioning|family functioning
16290|NCT04096378|Stress and Coping|stress and coping
16291|NCT04096365|Temporary|temporary
16292|NCT04096365|Ventricular|ventricular
16293|NCT04096365|Pacing|pacing
16294|NCT04096352|Speech Therapy|speech therapy
16295|NCT04096352|Virtual Reality|virtual reality
16296|NCT04096352|Teacher's voice|teacher's voice
16297|NCT04096352|Background Noise|background noise
16298|NCT04096352|School Teachers|school teachers
16299|NCT04096339|Colonoscopy|colonoscopy
16300|NCT04096339|EGD|egd
16301|NCT04096339|Sedation|sedation
16302|NCT04096339|procedural sequence|procedural sequence
16303|NCT04096300|Integrative Medicine|integrative medicine
16304|NCT04096300|Ethnomedicine|ethnomedicine
16305|NCT04096300|Hirudotherapy|hirudotherapy
16306|NCT04096300|Idiopathic Granulomatous Mastitis|idiopathic granulomatous mastitis
16307|NCT04096300|Medical Cupping Therapy|medical cupping therapy
16308|NCT04096300|Traditional and Complementary Medicine|traditional and complementary medicine
16309|NCT04096274|LOCI|loci
16310|NCT04096274|measurement based care|measurement based care
16311|NCT04096274|evidence-based practice|evidence-based practice
16312|NCT04096274|behavioral health|behavioral health
16313|NCT04096274|youth mental health|youth mental health
16314|NCT04096274|leadership|leadership
16315|NCT04096274|implementation science|implementation science
16316|NCT04096248|Large vessel occlusion|large vessel occlusion
16317|NCT04096248|CT [Computed Tomography]|ct [computed tomography]
16318|NCT04096248|CTP [Computed Tomography (CT) Perfusion]|ctp [computed tomography (ct) perfusion]
16319|NCT04096248|Modified Rankin score|modified rankin score
16320|NCT04096248|ASPECTS (Alberta Stroke Program Early CT Score)|aspects (alberta stroke program early ct score)
16321|NCT04096222|pemphigus|pemphigus
16322|NCT04096222|Th17|th17
16323|NCT04096222|IL-23|il-23
16324|NCT04096222|IL-17|il-17
16325|NCT04096222|autoimmune bullous disease|autoimmune bullous disease
16326|NCT04096157|Cresemba|cresemba
16327|NCT04096157|isavuconazonium sulfate|isavuconazonium sulfate
16328|NCT04096157|isavuconazole|isavuconazole
16329|NCT04096144|Post anesthesia care unit|post anesthesia care unit
16330|NCT04096144|sugammadex|sugammadex
16331|NCT04096144|neostigmine|neostigmine
16332|NCT04096144|neuromuscular reversal|neuromuscular reversal
16333|NCT04096131|diabetic macular edema|diabetic macular edema
16334|NCT04096131|cataract|cataract
16335|NCT04096131|surgery|surgery
16336|NCT04096118|Rectal cancer|rectal cancer
16337|NCT04096118|Lymph node after neoadjuvant rectal cancer|lymph node after neoadjuvant rectal cancer
16338|NCT04096105|Healthy subjects|healthy subjects
16339|NCT04096105|CC-93538|cc-93538
16340|NCT04096105|Japanese PK bridging|japanese pk bridging
16341|NCT04096092|Teicoplanin|teicoplanin
16342|NCT04096092|Pharmacokinetics|pharmacokinetics
16343|NCT04096092|Critically ill|critically ill
16344|NCT04096079|Out-Of-Hospital Cardiac Arrest, STEMI, coronary angiography, post-ROSC ECG|out-of-hospital cardiac arrest, stemi, coronary angiography, post-rosc ecg
16345|NCT04096066|Multiple Myeloma|multiple myeloma
16346|NCT04096066|AUTOLOGOUS STEM CELL TRANSPLANTATION INELIGIBLE|autologous stem cell transplantation ineligible
16347|NCT04096066|Proteasome inhibitor|proteasome inhibitor
16348|NCT04096066|Immunomodulating agents|immunomodulating agents
16349|NCT04095988|Allogeneic microbiota reconstitution|allogeneic microbiota reconstitution
16350|NCT04095988|diarrhea-predominant irritable bowel syndrome|diarrhea-predominant irritable bowel syndrome
16351|NCT04095988|microbiome|microbiome
16352|NCT04095962|Active Ageing|active ageing
16353|NCT04095962|Exercise|exercise
16354|NCT04095962|Health|health
16355|NCT04095936|aplastic anemia|aplastic anemia
16356|NCT04095936|romiplostim|romiplostim
16357|NCT04095923|Physical activity|physical activity
16358|NCT04095923|Social media|social media
16359|NCT04095923|Wearable|wearable
16360|NCT04095923|Intrinsic motivation|intrinsic motivation
16361|NCT04095923|Game|game
16362|NCT04095923|Women's health|women's health
16363|NCT04095910|Prevention|prevention
16364|NCT04095910|Obesity|obesity
16365|NCT04095910|Childhood|childhood
16366|NCT04095910|School-based Program|school-based program
16367|NCT04095910|Lifestyle|lifestyle
16368|NCT04095910|Nutrition Education|nutrition education
16369|NCT04095897|PMPS|pmps
16370|NCT04095897|Pecs II|pecs ii
16371|NCT04095897|Pectoral Nerve Block|pectoral nerve block
16372|NCT04095897|CPSP|cpsp
16373|NCT04095871|Intermittent urethral catheterization|intermittent urethral catheterization
16374|NCT04095871|Treatment adherence and compliance|treatment adherence and compliance
16375|NCT04095871|Lower urinary tract symptoms|lower urinary tract symptoms
16376|NCT04095871|Urinary retention|urinary retention
16377|NCT04095871|Patient satisfaction|patient satisfaction
16378|NCT04095845|total hip arthroplasty|total hip arthroplasty
16379|NCT04095845|total hip replacement|total hip replacement
16380|NCT04095845|implant position|implant position
16381|NCT04095845|computerised tomography|computerised tomography
16382|NCT04095845|makoplasty|makoplasty
16383|NCT04095845|robotic surgery|robotic surgery
16384|NCT04095793|Symptomatic Neurogenic Orthostatic Hypotension|symptomatic neurogenic orthostatic hypotension
16385|NCT04095793|snOH|snoh
16386|NCT04095793|multiple symptom atrophy|multiple symptom atrophy
16387|NCT04095793|MSA|msa
16388|NCT04095793|Parkinson's disease|parkinson's disease
16389|NCT04095793|PD|pd
16390|NCT04095793|pure autonomic failure|pure autonomic failure
16391|NCT04095793|PAF|paf
16392|NCT04095793|orthostatic hypotension|orthostatic hypotension
16393|NCT04095793|OH|oh
16394|NCT04095793|ampreloxetine|ampreloxetine
16395|NCT04095793|171|171
16396|NCT04095793|low blood pressure|low blood pressure
16397|NCT04095793|dizziness|dizziness
16398|NCT04095793|fainting|fainting
16399|NCT04095793|blacking out|blacking out
16400|NCT04095793|lightheadedness|lightheadedness
16401|NCT04095793|norepinephrine|norepinephrine
16402|NCT04095793|hypotension|hypotension
16403|NCT04095793|OAK|oak
16404|NCT04095780|Oral opportunistic pathogens|oral opportunistic pathogens
16405|NCT04095780|Oral health promotion|oral health promotion
16406|NCT04095780|Pneumonia complicating stroke|pneumonia complicating stroke
16407|NCT04095780|Metagenome|metagenome
16408|NCT04095767|Thrombectomy|thrombectomy
16409|NCT04095728|Cognition|cognition
16410|NCT04095728|Healthy|healthy
16411|NCT04095728|Brain Octane Oil|brain octane oil
16412|NCT04095728|Caprylic acid triglycerides|caprylic acid triglycerides
16413|NCT04095728|Physical performance|physical performance
16414|NCT04095715|Dense platelet granules|dense platelet granules
16415|NCT04095715|Thrombopathy|thrombopathy
16416|NCT04095715|Hemorrhagic symptomatology|hemorrhagic symptomatology
16417|NCT04095689|triple negative breast cancer, neoadjuvant, pembrolizumab|triple negative breast cancer, neoadjuvant, pembrolizumab
16418|NCT04095637|alignment|alignment
16419|NCT04095637|computer navigation|computer navigation
16420|NCT04095637|implant position|implant position
16421|NCT04095637|mako robot|mako robot
16422|NCT04095637|makoplasty|makoplasty
16423|NCT04095637|unicondylar knee replacement|unicondylar knee replacement
16424|NCT04095611|Hemiarthroplasty|hemiarthroplasty
16425|NCT04095611|Hip fracture|hip fracture
16426|NCT04095611|Modified Muscle Sparing Posterior Technique (SPAIRE)|modified muscle sparing posterior technique (spaire)
16427|NCT04095611|Displaced Intracapsular Hip Fracture|displaced intracapsular hip fracture
16428|NCT04095598|High ankle sprain|high ankle sprain
16429|NCT04095598|Syndesmotic instability|syndesmotic instability
16430|NCT04095598|Computed Tomography|computed tomography
16431|NCT04095598|Stress maneuver|stress maneuver
16432|NCT04095585|Williams Beuren Syndrome|williams beuren syndrome
16433|NCT04095585|Autism Spectrum Disorder|autism spectrum disorder
16434|NCT04095572|Hyaluronic acid (HA)|hyaluronic acid (ha)
16435|NCT04095572|Chondroitin sulphate (CS)|chondroitin sulphate (cs)
16436|NCT04095572|antimicrobial resistance rates|antimicrobial resistance rates
16437|NCT04095572|Intravesical instillation|intravesical instillation
16438|NCT04095572|HA-CS instillations|ha-cs instillations
16439|NCT04095572|Recurrent Urinary Tract Infection (rUTI)|recurrent urinary tract infection (ruti)
16440|NCT04095559|left atrial (LA) substrate-based ablation|left atrial (la) substrate-based ablation
16441|NCT04095559|focal ablation catheter|focal ablation catheter
16442|NCT04095559|bipolar voltage amplitude|bipolar voltage amplitude
16443|NCT04095559|micro-electrode catheter|micro-electrode catheter
16444|NCT04095559|IntellaMap Orion|intellamap orion
16445|NCT04095559|IntellaNav MIFI OI|intellanav mifi oi
16446|NCT04095559|bipolar voltage maps|bipolar voltage maps
16447|NCT04095559|irrigated-tip ablation catheter|irrigated-tip ablation catheter
16448|NCT04095559|ring-electrode circular mapping catheter|ring-electrode circular mapping catheter
16449|NCT04095559|microelectrode multipolar catheter|microelectrode multipolar catheter
16450|NCT04095546|epigenetic changes|epigenetic changes
16451|NCT04095546|Psychotherapy|psychotherapy
16452|NCT04095546|epigenetic regulation|epigenetic regulation
16453|NCT04095546|methylation patterns|methylation patterns
16454|NCT04095546|change in methylation of genes|change in methylation of genes
16455|NCT04095546|FKBP5 gene|fkbp5 gene
16456|NCT04095533|critical care|critical care
16457|NCT04095494|EMONO|emono
16458|NCT04095494|Health students|health students
16459|NCT04095468|rectal cancer|rectal cancer
16460|NCT04095468|preoperative radiotherapy|preoperative radiotherapy
16461|NCT04095468|organ preservation|organ preservation
16462|NCT04095468|watch-and-wait|watch-and-wait
16463|NCT04095442|muscle power|muscle power
16464|NCT04095442|nitric oxide|nitric oxide
16465|NCT04095442|muscle speed|muscle speed
16466|NCT04095442|oral microbiome|oral microbiome
16467|NCT04095416|Compression stockings|compression stockings
16468|NCT04095416|heart failure|heart failure
16469|NCT04095416|systolic|systolic
16470|NCT04095416|edema|edema
16471|NCT04095416|wrap|wrap
16472|NCT04095403|Heat|heat
16473|NCT04095403|Cooling|cooling
16474|NCT04095338|hip fracture|hip fracture
16475|NCT04095338|rehabilitation|rehabilitation
16476|NCT04095338|robotics|robotics
16477|NCT04095286|Ambrisentan|ambrisentan
16478|NCT04095286|Oral dosage forms|oral dosage forms
16479|NCT04095286|Pulmonary arterial hypertension|pulmonary arterial hypertension
16480|NCT04095286|Bioavailability|bioavailability
16481|NCT04095273|DDR (Deoxyribonucleic acid damage repair),|ddr (deoxyribonucleic acid damage repair),
16482|NCT04095273|ATR (ataxia-telangiectasia and Rad3 related protein)inhibitor,|atr (ataxia-telangiectasia and rad3 related protein)inhibitor,
16483|NCT04095234|acupuncture|acupuncture
16484|NCT04095234|massage|massage
16485|NCT04095234|IMPACT|impact
16486|NCT04095234|19-341|19-341
16487|NCT04095221|Prexasertib|prexasertib
16488|NCT04095221|Irinotecan|irinotecan
16489|NCT04095221|Temozolomide|temozolomide
16490|NCT04095221|19-120|19-120
16491|NCT04095208|soft-tissue sarcoma|soft-tissue sarcoma
16492|NCT04095208|tertiary lymphoid structure|tertiary lymphoid structure
16493|NCT04095208|immunotherapy|immunotherapy
16494|NCT04095208|oncology|oncology
16495|NCT04095208|metastatic|metastatic
16496|NCT04095195|Familial Pancreatic Cancer|familial pancreatic cancer
16497|NCT04095195|BRCA Mutation|brca mutation
16498|NCT04095195|Lynch Syndrome|lynch syndrome
16499|NCT04095195|Screening pancreatic cancer|screening pancreatic cancer
16500|NCT04095195|Surveillance pancreatic cancer|surveillance pancreatic cancer
16501|NCT04095156|Membranous nephropathy|membranous nephropathy
16502|NCT04095156|B cells|b cells
16503|NCT04095156|Anti-PLA2R|anti-pla2r
16504|NCT04095156|Anti-CD20 antibodies|anti-cd20 antibodies
16505|NCT04095143|Point-Of-Care ultrasound|point-of-care ultrasound
16506|NCT04095143|Doppler|doppler
16507|NCT04095143|Major adverse kidney events|major adverse kidney events
16508|NCT04095143|Portal flow pulsatility|portal flow pulsatility
16509|NCT04095143|IVC ultrasound|ivc ultrasound
16510|NCT04095143|Cardiac ultrasound|cardiac ultrasound
16511|NCT04095143|Right ventricular failure|right ventricular failure
16512|NCT04095143|Intensive care|intensive care
16513|NCT04095130|Psoriasis|psoriasis
16514|NCT04095130|Sodium|sodium
16515|NCT04095130|Skin|skin
16516|NCT04095104|Pilot|pilot
16517|NCT04095104|Feasibility|feasibility
16518|NCT04095104|Initial Efficacy|initial efficacy
16519|NCT04095104|Randomized Controlled Trial|randomized controlled trial
16520|NCT04095091|Radiotherapy|radiotherapy
16521|NCT04095078|bronchial clearance|bronchial clearance
16522|NCT04095078|cystic fibrosis|cystic fibrosis
16523|NCT04095065|Multiphase optimization strategy (MOST)|multiphase optimization strategy (most)
16524|NCT04095065|College students|college students
16525|NCT04095039|All-cause hopitalization|all-cause hopitalization
16526|NCT04095026|Epilepsy|epilepsy
16527|NCT04095026|Cognitive Function|cognitive function
16528|NCT04095026|Memory|memory
16529|NCT04095026|Seizures|seizures
16530|NCT04095026|Surgery|surgery
16531|NCT04095013|Elective low segment caesarean section|elective low segment caesarean section
16532|NCT04095013|Intrathecal|intrathecal
16533|NCT04095013|bupivacaine-fentanyl|bupivacaine-fentanyl
16534|NCT04095013|bupivacaine-dexmedetomidine|bupivacaine-dexmedetomidine
16535|NCT04095013|sensory block|sensory block
16536|NCT04095013|complications|complications
16537|NCT04095013|hemodynamics|hemodynamics
16538|NCT04094974|Heart rate variability,|heart rate variability,
16539|NCT04094974|supratentorial brain tumors|supratentorial brain tumors
16540|NCT04094974|optic nerve sheath diameter|optic nerve sheath diameter
16541|NCT04094961|Multiple Myeloma|multiple myeloma
16542|NCT04094961|Multiple Myeloma in Relapse|multiple myeloma in relapse
16543|NCT04094948|Pompe disease|pompe disease
16544|NCT04094948|LOPD|lopd
16545|NCT04094948|Late-onset Pompe Disease|late-onset pompe disease
16546|NCT04094935|Fracture of the radius|fracture of the radius
16549|NCT04094896|Neoadjuvant Treatment|neoadjuvant treatment
16550|NCT04094896|HER2-Positive Breast Cancer|her2-positive breast cancer
16551|NCT04094883|Neisseria gonorrhoeae|neisseria gonorrhoeae
16552|NCT04094883|Cross-reactive|cross-reactive
16553|NCT04094883|Immune|immune
16554|NCT04094883|Responses|responses
16555|NCT04094883|Neisseria meningitidis|neisseria meningitidis
16556|NCT04094883|Vaccine|vaccine
16557|NCT04094870|perinatal depression|perinatal depression
16558|NCT04094870|HIV|hiv
16559|NCT04094870|Antiretroviral Treatment|antiretroviral treatment
16560|NCT04094870|Interpersonal psychotherapy|interpersonal psychotherapy
16561|NCT04094857|therapeutic temperature management; therapeutic hypothermia|therapeutic temperature management; therapeutic hypothermia
16562|NCT04094844|Hematopoietic Cell Transplantation|hematopoietic cell transplantation
16563|NCT04094844|Mobile Health Technology|mobile health technology
16564|NCT04094818|Infection|infection
16565|NCT04094818|mRNA|mrna
16566|NCT04094818|Procalcitonin|procalcitonin
16567|NCT04094818|C-Reactive Protein|c-reactive protein
16568|NCT04094818|Lactate|lactate
16569|NCT04094792|heart rate variability|heart rate variability
16570|NCT04094792|autonomic function|autonomic function
16571|NCT04094792|biofeedback|biofeedback
16572|NCT04094792|mobile health|mobile health
16573|NCT04094779|Agitation|agitation
16574|NCT04094779|Flash activity|flash activity
16575|NCT04094779|Breath of fresh air|breath of fresh air
16576|NCT04094766|Chimeric Antigen Receptor T cells|chimeric antigen receptor t cells
16577|NCT04094766|CD19 and CD22|cd19 and cd22
16578|NCT04094727|malaria|malaria
16579|NCT04094727|Namibia|namibia
16580|NCT04094675|PTEN|pten
16581|NCT04094675|Cowden syndrome|cowden syndrome
16582|NCT04094675|PHTS|phts
16583|NCT04094675|Colon polyposis|colon polyposis
16584|NCT04094675|sirolimus|sirolimus
16585|NCT04094675|Rapamycin|rapamycin
16586|NCT04094675|mTOR inhibitor|mtor inhibitor
16587|NCT04094636|Physical training|physical training
16588|NCT04094610|ALK|alk
16589|NCT04094610|ROS1|ros1
16590|NCT04094610|NTRK1-3|ntrk1-3
16591|NCT04094610|Primary CNS tumor|primary cns tumor
16592|NCT04094610|anaplastic large cell lymphoma|anaplastic large cell lymphoma
16593|NCT04094610|metastatic solid tumor|metastatic solid tumor
16594|NCT04094610|advanced solid tumor|advanced solid tumor
16595|NCT04094610|sarcoma|sarcoma
16596|NCT04094610|infantile fibrosarcoma|infantile fibrosarcoma
16597|NCT04094610|glioblastoma|glioblastoma
16598|NCT04094610|soft tissue schwannoma|soft tissue schwannoma
16599|NCT04094610|solitary fibrous tumor|solitary fibrous tumor
16600|NCT04094610|glioma|glioma
16601|NCT04094610|inflammatory myofibroblastic tumor|inflammatory myofibroblastic tumor
16602|NCT04094610|pediatric|pediatric
16603|NCT04094597|lactoferrin|lactoferrin
16604|NCT04094584|Emergency Department|emergency department
16605|NCT04094584|Naltrexone|naltrexone
16606|NCT04094571|functional electrical stimulation|functional electrical stimulation
16607|NCT04094571|rehabilitation|rehabilitation
16608|NCT04094545|Biomarker|biomarker
16609|NCT04094545|nasopharyngeal carcinoma|nasopharyngeal carcinoma
24382|NCT04046172|SLE|sle
16610|NCT04094545|familial|familial
16611|NCT04094545|sporadic|sporadic
16612|NCT04094545|intestinal flora|intestinal flora
16616|NCT04094506|safety|safety
16617|NCT04094506|ASP1948|asp1948
16618|NCT04094506|pharmacokinetics|pharmacokinetics
16619|NCT04094493|thyroid - thyroidectomy - hypocalcemia - Vit D administiration|thyroid - thyroidectomy - hypocalcemia - vit d administiration
16620|NCT04094454|female patients|female patients
16621|NCT04094454|quality of life|quality of life
16622|NCT04094454|vaginal dilator|vaginal dilator
16623|NCT04094454|vaginal fibrosis|vaginal fibrosis
16624|NCT04094428|burden|burden
16625|NCT04094428|mortality|mortality
16626|NCT04094428|end-of-life care|end-of-life care
16627|NCT04094428|intensive care unit|intensive care unit
16628|NCT04094428|critically ill patient|critically ill patient
16629|NCT04094428|frailty|frailty
16630|NCT04094428|Multiple Organ Failure|multiple organ failure
16631|NCT04094376|morning operation|morning operation
16632|NCT04094376|evening operation|evening operation
16633|NCT04094376|sleep quality|sleep quality
16634|NCT04094376|general anesthesia|general anesthesia
16635|NCT04094376|circadian rhythm|circadian rhythm
16636|NCT04094350|Tuberculosis|tuberculosis
16637|NCT04094350|Community health services|community health services
16638|NCT04094350|Cambodia|cambodia
16639|NCT04094350|Contact tracing|contact tracing
16640|NCT04094350|Mass screening|mass screening
16641|NCT04094350|Referral and consultation|referral and consultation
16642|NCT04094350|Peer group|peer group
16643|NCT04094337|non-cardiac chest pain|non-cardiac chest pain
16644|NCT04094337|NCCP|nccp
16645|NCT04094337|anxiety|anxiety
16646|NCT04094337|internet-assisted treatment|internet-assisted treatment
16647|NCT04094324|Mental health, pediatric medicine, obesity, IBD|mental health, pediatric medicine, obesity, ibd
16648|NCT04094311|out of specification|out of specification
16649|NCT04094311|tisagenlecleucel|tisagenlecleucel
16650|NCT04094311|acute lymphoblastic leukemia|acute lymphoblastic leukemia
16651|NCT04094311|large B-cell lymphoma|large b-cell lymphoma
16652|NCT04094311|relapsed/refractory|relapsed/refractory
16653|NCT04094311|pediatric|pediatric
16654|NCT04094311|young adult patients|young adult patients
16655|NCT04094233|Beetroot|beetroot
16656|NCT04094233|Heart rate variability|heart rate variability
16657|NCT04094233|Blood pressure|blood pressure
16658|NCT04094233|Strenght Exercise|strenght exercise
16659|NCT04094220|indirect decompression|indirect decompression
16660|NCT04094220|lateral interbody fusion|lateral interbody fusion
16661|NCT04094220|lumbar|lumbar
16662|NCT04094220|direct decompression|direct decompression
16663|NCT04094194|Nordic diet|nordic diet
16664|NCT04094194|Cardiometabolic risk factors|cardiometabolic risk factors
16665|NCT04094194|Mortality|mortality
16666|NCT04094194|Cardiovascular diseases|cardiovascular diseases
16667|NCT04094194|Type 2 diabetes|type 2 diabetes
16668|NCT04094194|Hypertension|hypertension
16669|NCT04094194|Systematic review and meta-analysis|systematic review and meta-analysis
16670|NCT04094194|Randomized controlled trials|randomized controlled trials
16671|NCT04094194|Prospective cohort studies|prospective cohort studies
16672|NCT04094168|Del Nido Cardioplegia|del nido cardioplegia
16673|NCT04094168|Cardioplegia|cardioplegia
16674|NCT04094168|Adult Cardiac Surgery|adult cardiac surgery
16675|NCT04094168|Myocardial protection|myocardial protection
16676|NCT04094168|Heart surgery|heart surgery
16677|NCT04094129|Alzheimer's disease|alzheimer's disease
16678|NCT04094129|Dementia|dementia
16679|NCT04094129|Intestinal microbiota|intestinal microbiota
16680|NCT04094129|Chronic inflammation|chronic inflammation
16681|NCT04094129|Probiotics|probiotics
16682|NCT04094077|Stereotactic Radiation|stereotactic radiation
16683|NCT04094077|Nanoparticles|nanoparticles
16684|NCT04094064|Dialysis|dialysis
16685|NCT04094064|Hemodialysis|hemodialysis
16686|NCT04094064|Diabetes|diabetes
16687|NCT04094064|Continuous Glucose Monitor (CGM)|continuous glucose monitor (cgm)
16688|NCT04094012|isoniazid|isoniazid
16689|NCT04094012|latent tuberculosis infection|latent tuberculosis infection
16690|NCT04094012|preventive therapy|preventive therapy
16691|NCT04094012|rifapentine|rifapentine
16692|NCT04094012|systemic drug reaction|systemic drug reaction
16693|NCT04094012|therapeutic drug monitoring|therapeutic drug monitoring
16694|NCT04093999|Breast reconstruction|breast reconstruction
16695|NCT04093999|DIEP flap|diep flap
16696|NCT04093999|Sensory recovery|sensory recovery
16697|NCT04093999|Breast sensation|breast sensation
16698|NCT04093999|Nerve coaptation|nerve coaptation
16699|NCT04093986|Hydroxyurea|hydroxyurea
16700|NCT04093960|psychobiotics|psychobiotics
16701|NCT04093960|major depressive disorder|major depressive disorder
16702|NCT04093960|escitalopram|escitalopram
16703|NCT04093934|Early childhood development|early childhood development
16704|NCT04093934|Psychosociaal stimulation|psychosociaal stimulation
16705|NCT04093934|Bayley test|bayley test
16706|NCT04093934|Bangladesh|bangladesh
24532|NCT04045314|CBD|cbd
16707|NCT04093934|Undernutrition|undernutrition
16708|NCT04093934|Stepped wedge design|stepped wedge design
16709|NCT04093934|Cluster randomized controlled trial|cluster randomized controlled trial
16710|NCT04093921|chronic pain|chronic pain
16711|NCT04093921|pediatric|pediatric
16712|NCT04093908|deep brain stimulation|deep brain stimulation
16713|NCT04093908|motor outcome|motor outcome
16714|NCT04093908|prediction model|prediction model
16715|NCT04093908|machine learning|machine learning
16716|NCT04093908|Subthalamic nucleus|subthalamic nucleus
16717|NCT04093895|Periodontitis|periodontitis
16718|NCT04093895|taurolidine|taurolidine
16719|NCT04093895|PerioSept|periosept
16720|NCT04093856|Advanced glycation end products|advanced glycation end products
16721|NCT04093856|Advanced imaging|advanced imaging
16722|NCT04093856|Mobility|mobility
16723|NCT04093856|Strength|strength
16724|NCT04093830|Hearing Loss|hearing loss
16725|NCT04093791|postpartum|postpartum
16726|NCT04093791|stress|stress
16727|NCT04093791|depression|depression
16728|NCT04093791|self efficacy|self efficacy
16729|NCT04093791|Mother-Infant Relations|mother-infant relations
16730|NCT04093765|Ultrasensitive Rapid Diagnostic Test|ultrasensitive rapid diagnostic test
16731|NCT04093765|Mass Screening and Treatment|mass screening and treatment
16732|NCT04093765|Greater Mekong Subregion|greater mekong subregion
16733|NCT04093765|Malaria Elimination Task Force|malaria elimination task force
16734|NCT04093752|T2DM|t2dm
16735|NCT04093713|Anaesthesia|anaesthesia
16736|NCT04093713|Technique|technique
16737|NCT04093713|extraoral|extraoral
16738|NCT04093713|Landmarks|landmarks
16739|NCT04093687|Colorectal Cancer Screening|colorectal cancer screening
16740|NCT04093687|Screening Colonoscopy|screening colonoscopy
16741|NCT04093687|Pain During Colonoscopy|pain during colonoscopy
16742|NCT04093674|connective tissue|connective tissue
16743|NCT04093674|randomized controlled trial|randomized controlled trial
16744|NCT04093674|gingival recession|gingival recession
16745|NCT04093674|patient outcome assessment|patient outcome assessment
16746|NCT04093648|Hepatocellular Carcinoma|hepatocellular carcinoma
16747|NCT04093648|Hepatoblastoma|hepatoblastoma
16748|NCT04093648|GPC3-CAR T cells|gpc3-car t cells
16749|NCT04093583|exodontia|exodontia
16750|NCT04093583|PRGF|prgf
16751|NCT04093583|alveolar ridge preservation|alveolar ridge preservation
16752|NCT04093570|cedazuridine|cedazuridine
16753|NCT04093570|decitabine|decitabine
16754|NCT04093570|MDS|mds
16755|NCT04093570|CMML|cmml
16756|NCT04093570|AML|aml
16757|NCT04093570|myelodysplastic syndromes|myelodysplastic syndromes
16758|NCT04093570|chronic myelomonocytic leukemia|chronic myelomonocytic leukemia
16759|NCT04093570|acute myeloid leukemia|acute myeloid leukemia
16760|NCT04093570|ASTX727|astx727
16761|NCT04093557|colonoscopy|colonoscopy
16762|NCT04093557|bowel prep|bowel prep
16763|NCT04093557|screening|screening
16764|NCT04093544|deep brain stimulation|deep brain stimulation
16765|NCT04093531|primary sjogren syndrome|primary sjogren syndrome
16766|NCT04093531|PSS|pss
16767|NCT04093531|SjS|sjs
16768|NCT04093531|Sjogren|sjogren
16769|NCT04093531|Ustekinumab|ustekinumab
16770|NCT04093531|SS|ss
16771|NCT04093492|gestational age|gestational age
16772|NCT04093492|multi-media|multi-media
16773|NCT04093492|mobile application|mobile application
16774|NCT04093492|anxiety|anxiety
16775|NCT04093492|clinical trial|clinical trial
16776|NCT04093492|random allocation|random allocation
16777|NCT04093479|labor|labor
16778|NCT04093479|obesity|obesity
16779|NCT04093479|oxytocin|oxytocin
16780|NCT04093453|Short Chain Fatty Acids|short chain fatty acids
16781|NCT04093453|Propionate|propionate
16782|NCT04093453|Energy Expenditure|energy expenditure
16783|NCT04093453|Lipid Oxidation|lipid oxidation
16784|NCT04093440|cardiometabolic clinic|cardiometabolic clinic
16785|NCT04093414|Pacemaker|pacemaker
16786|NCT04093414|Bundle of His|bundle of his
16787|NCT04093414|Left Bundle Branch|left bundle branch
16788|NCT04093388|Pap smear|pap smear
16789|NCT04093388|Papanicolaou|papanicolaou
16790|NCT04093388|self-collection|self-collection
16791|NCT04093388|cervical cancer screening|cervical cancer screening
16792|NCT04093362|Futibatinib|futibatinib
16793|NCT04093362|Advanced Cholangiocarcinoma|advanced cholangiocarcinoma
16794|NCT04093362|FGFR2|fgfr2
16795|NCT04093362|Fusion|fusion
16796|NCT04093362|Rearrangement|rearrangement
16797|NCT04093362|TAS-120|tas-120
16798|NCT04093336|Acute cerebral infarction ,Mesenchymal Stem Cells,prognosis|acute cerebral infarction ,mesenchymal stem cells,prognosis
16799|NCT04093310|incision-drainage|incision-drainage
16800|NCT04093310|Bartholin's abscess|bartholin's abscess
16801|NCT04093310|Word catheter|word catheter
16802|NCT04093310|Marsupialization|marsupialization
16803|NCT04093310|Cost-utility analysis|cost-utility analysis
16804|NCT04093284|Needle-free jet injection|needle-free jet injection
16805|NCT04093284|Insulin glargine|insulin glargine
805316|NCT00232947|safety|safety
16806|NCT04093284|Flash Glucose Monitoring|flash glucose monitoring
16807|NCT04093271|Sleep|sleep
16808|NCT04093271|Healthy|healthy
16809|NCT04093271|Rest-ZZZ|rest-zzz
16810|NCT04093271|randomized controlled trial|randomized controlled trial
16811|NCT04093271|RCT|rct
16812|NCT04093271|dietary supplement|dietary supplement
16813|NCT04093271|natural health product|natural health product
16814|NCT04093245|Emergency Department|emergency department
16815|NCT04093245|Care Transition|care transition
16816|NCT04093245|Elderly Frailty|elderly frailty
16817|NCT04093219|Acetaminophen|acetaminophen
16818|NCT04093219|Postoperative|postoperative
16819|NCT04093219|Delirium|delirium
16820|NCT04093219|Cardiac Surgery|cardiac surgery
16821|NCT04093193|Functional Endoscopic Sinus Surgery|functional endoscopic sinus surgery
16822|NCT04093180|Rehabilitation|rehabilitation
16823|NCT04093180|Motor skills|motor skills
16824|NCT04093180|Activities of Daily living|activities of daily living
16825|NCT04093141|locally advances pancreatic cancer|locally advances pancreatic cancer
16826|NCT04093141|irreversible electroporation|irreversible electroporation
16827|NCT04093141|nanoknife|nanoknife
16828|NCT04093141|phase II|phase ii
16829|NCT04093141|efficacy|efficacy
16830|NCT04093128|herbal tea|herbal tea
16831|NCT04093128|infusion|infusion
16832|NCT04093128|carob|carob
16833|NCT04093128|green tea|green tea
16834|NCT04093128|anise|anise
16835|NCT04093128|insulin resistance|insulin resistance
16836|NCT04093128|inflammation|inflammation
16837|NCT04093128|health|health
16838|NCT04093128|lipid profile|lipid profile
16839|NCT04093128|manuka honey|manuka honey
16840|NCT04093076|Healthy volunteer|healthy volunteer
16841|NCT04093063|microsurgery|microsurgery
16842|NCT04093063|ophthalmology|ophthalmology
16843|NCT04093063|medical education|medical education
16844|NCT04093063|surgical skills|surgical skills
16845|NCT04093063|surgical practice|surgical practice
16846|NCT04093037|Dry eye|dry eye
16847|NCT04093037|LacryDiag|lacrydiag
16849|NCT04093037|Break-Up Time (BUT)|break-up time (but)
16850|NCT04093037|Schirmer test|schirmer test
16851|NCT04093037|Lacrimal film|lacrimal film
16852|NCT04093037|Oxford score|oxford score
16853|NCT04093037|Meibomian Gland|meibomian gland
16854|NCT04093037|Tear Meniscus (TM)|tear meniscus (tm)
16855|NCT04093037|Non Invasive Break-Up Time (NIBUT)|non invasive break-up time (nibut)
16856|NCT04092985|Arrhythmias, Cardiac|arrhythmias, cardiac
16857|NCT04092985|Cardiovascular App|cardiovascular app
16858|NCT04092985|Rhythm monitoring|rhythm monitoring
16859|NCT04092959|Hypertension|hypertension
16860|NCT04092959|Hypertension Complicated With Type 2 Diabetes|hypertension complicated with type 2 diabetes
16861|NCT04092959|Walking|walking
16862|NCT04092959|Chinese Square Dancing|chinese square dancing
16863|NCT04092946|Home-based rehabilitation|home-based rehabilitation
16864|NCT04092946|Biofeedback|biofeedback
16865|NCT04092946|Telerehabilitation|telerehabilitation
16866|NCT04092933|machine learning|machine learning
16867|NCT04092933|decision support|decision support
16868|NCT04092933|risk calculator|risk calculator
16869|NCT04092933|anesthesia|anesthesia
16870|NCT04092894|Suvorexant|suvorexant
16871|NCT04092894|Sleep architecture|sleep architecture
16872|NCT04092894|Delirium|delirium
16873|NCT04092894|Intensive care unit|intensive care unit
16874|NCT04092881|Striae Distensae|striae distensae
16875|NCT04092881|Striae; Albicantes|striae; albicantes
16876|NCT04092881|Striae Alba|striae alba
16877|NCT04092881|Nd-YAG Laser|nd-yag laser
16878|NCT04092881|Fractional CO2 Laser|fractional co2 laser
16879|NCT04092881|High Frequency Skin Ultrasound|high frequency skin ultrasound
16880|NCT04092881|Short Pulsed Nd-YAG|short pulsed nd-yag
16881|NCT04092881|Carbon Dioxide Laser|carbon dioxide laser
16882|NCT04092881|Neodymium-Doped Yttrium Aluminum Garnet Laser|neodymium-doped yttrium aluminum garnet laser
16883|NCT04092855|Right Ventricular Pressure Waveform|right ventricular pressure waveform
16884|NCT04092842|Breast Neoplasms|breast neoplasms
16885|NCT04092842|Breast Conserving Surgery|breast conserving surgery
16886|NCT04092829|Pre-Eclampsia|pre-eclampsia
16887|NCT04092829|Corpus Luteum|corpus luteum
16888|NCT04092829|Frozen embryo transfer|frozen embryo transfer
16889|NCT04092829|Endometrial preparation|endometrial preparation
16890|NCT04092816|Parenting|parenting
16891|NCT04092777|ACOs|acos
16892|NCT04092777|Medicaid|medicaid
16893|NCT04092777|Racial|racial
16894|NCT04092777|Ethnic|ethnic
16895|NCT04092777|Linguistic|linguistic
16896|NCT04092777|Minorities|minorities
16897|NCT04092764|Numbness|numbness
16898|NCT04092764|Pain|pain
16899|NCT04092764|Tingling|tingling
16900|NCT04092764|Reduced sense of touch|reduced sense of touch
16901|NCT04092764|Reduced proprioception|reduced proprioception
16902|NCT04092764|Sensory Neuropathy|sensory neuropathy
16903|NCT04092751|SCY-078|scy-078
16904|NCT04092751|Ibrexafungerp|ibrexafungerp
16905|NCT04092751|Pravastatin|pravastatin
16906|NCT04092751|Healthy Subjects|healthy subjects
805317|NCT00232934|Myeloma|myeloma
16907|NCT04092751|Pharmacokinetics|pharmacokinetics
16908|NCT04092738|mHealth|mhealth
16909|NCT04092738|Physical Activity|physical activity
16910|NCT04092738|Glucose, Blood|glucose, blood
16911|NCT04092738|Glycated Hemoglobin A1c|glycated hemoglobin a1c
16912|NCT04092738|Health-Related Quality Of Life|health-related quality of life
16913|NCT04092738|Quality of Life|quality of life
16914|NCT04092738|Triglycerides|triglycerides
16915|NCT04092738|HDL Cholesterol|hdl cholesterol
16916|NCT04092738|LDL Cholesterol|ldl cholesterol
16917|NCT04092738|Blood Pressure, Arterial|blood pressure, arterial
16918|NCT04092738|Presenteeism|presenteeism
16919|NCT04092738|Sitting time|sitting time
16920|NCT04092738|Sedentary Behaviour|sedentary behaviour
16921|NCT04092738|Workplace|workplace
16922|NCT04092725|SCY-078|scy-078
16923|NCT04092725|Dabigatran|dabigatran
16924|NCT04092725|Ibrexafungerp|ibrexafungerp
16925|NCT04092725|Pharmacokinetics|pharmacokinetics
16926|NCT04092725|Healthy Subjects|healthy subjects
16927|NCT04092712|Mass Balance|mass balance
16928|NCT04092712|Radiolabeled|radiolabeled
16929|NCT04092712|Pharmacokinetics|pharmacokinetics
16930|NCT04092699|CBCT|cbct
16931|NCT04092699|maxillary sinus|maxillary sinus
16932|NCT04092699|segmentation|segmentation
16933|NCT04092686|acute psychosis|acute psychosis
16934|NCT04092686|Schizophrenia|schizophrenia
16935|NCT04092647|ashwagandha|ashwagandha
16936|NCT04092647|cognitive dysfunction|cognitive dysfunction
16937|NCT04092647|breast cancer chemotherapy|breast cancer chemotherapy
16938|NCT04092621|new onsent atrial fibrillation|new onsent atrial fibrillation
16939|NCT04092621|sepsis|sepsis
16940|NCT04092621|critical care|critical care
16941|NCT04092621|direct current cardioversion|direct current cardioversion
16942|NCT04092621|atrial fibrillation treatment|atrial fibrillation treatment
16943|NCT04092595|pharmacokinetics (PK)|pharmacokinetics (pk)
16944|NCT04092569|Pre-medical Consultation self-care education|pre-medical consultation self-care education
16945|NCT04092569|Glycemic control|glycemic control
16946|NCT04092556|Multiple System Atrophy|multiple system atrophy
16947|NCT04092556|Cerebellar Ataxia|cerebellar ataxia
16948|NCT04092556|Transcranial Direct Current Stimulation|transcranial direct current stimulation
16949|NCT04092543|CT-DRAGON score|ct-dragon score
16950|NCT04092517|phytochemicals|phytochemicals
16951|NCT04092517|systemic circulation|systemic circulation
16952|NCT04092491|IgA nephropathy|iga nephropathy
16953|NCT04092465|NSCLC|nsclc
16954|NCT04092465|Locally Advanced NSCLC|locally advanced nsclc
16955|NCT04092465|Induction treatment|induction treatment
16956|NCT04092465|Induction chemotherapy|induction chemotherapy
16957|NCT04092465|Induction chemoradiotherapy|induction chemoradiotherapy
16958|NCT04092465|Pulmonary Parenchyma Resection|pulmonary parenchyma resection
16959|NCT04092465|Surgical Outcomes|surgical outcomes
16960|NCT04092465|Survival|survival
16961|NCT04092465|Morbidity|morbidity
16962|NCT04092465|Thoracotomy|thoracotomy
16963|NCT04092400|Glaucoma|glaucoma
16964|NCT04092400|Glaucoma Surgery|glaucoma surgery
16965|NCT04092400|Minimally Invasive Surgery|minimally invasive surgery
16966|NCT04092387|Biomarkers of Exposure|biomarkers of exposure
16967|NCT04092387|Compensatory Smoking|compensatory smoking
16968|NCT04092387|Nicotine Dependence|nicotine dependence
16969|NCT04092387|Reduced Nicotine Cigarettes|reduced nicotine cigarettes
16970|NCT04092387|Tobacco Withdrawal|tobacco withdrawal
16971|NCT04092387|Women|women
16972|NCT04092387|Health Disparities|health disparities
16973|NCT04092387|Vulnerable Populations|vulnerable populations
16974|NCT04092387|E-Cigarettes|e-cigarettes
16975|NCT04092322|stroke|stroke
16976|NCT04092322|physical activity|physical activity
16977|NCT04092322|accelerometer|accelerometer
16978|NCT04092322|physical activity scale for elderly|physical activity scale for elderly
16979|NCT04092309|Cardio-oncology|cardio-oncology
16980|NCT04092257|Visual inspection with acetic acid (VIA)|visual inspection with acetic acid (via)
16981|NCT04092231|Hearing loss|hearing loss
16982|NCT04092218|parenting style|parenting style
16983|NCT04092218|child behavior|child behavior
16984|NCT04092218|first dental visit|first dental visit
16985|NCT04092218|caries experience|caries experience
17107|NCT04091347|Women's Health|women's health
16986|NCT04092192|IVC filter, filter removal, filter retrieval|ivc filter, filter removal, filter retrieval
16987|NCT04092153|total knee arthroplasty|total knee arthroplasty
16988|NCT04092153|total knee replacement|total knee replacement
16989|NCT04092153|functional alignment|functional alignment
16990|NCT04092153|kinematic alignment|kinematic alignment
16991|NCT04092153|robotic surgery|robotic surgery
16992|NCT04092153|mako robot|mako robot
16993|NCT04092153|makoplasty|makoplasty
16994|NCT04092153|patient outcomes|patient outcomes
16995|NCT04092127|RetCam|retcam
16996|NCT04092127|Pain evaluation|pain evaluation
16997|NCT04092127|PIPP (Premature Infant Pain Profile) Score|pipp (premature infant pain profile) score
16998|NCT04092127|Screening for Retinopathy of Prematurity|screening for retinopathy of prematurity
16999|NCT04092114|PrEP (Pre-exposure Prophylaxis)|prep (pre-exposure prophylaxis)
17000|NCT04092114|HIV prevention|hiv prevention
17001|NCT04092114|Intimate Partner Violence (IPV)|intimate partner violence (ipv)
17002|NCT04092101|Biomarkers of Exposure|biomarkers of exposure
17003|NCT04092101|Compensatory Smoking|compensatory smoking
17004|NCT04092101|Nicotine Dependence|nicotine dependence
17005|NCT04092101|Reduced Nicotine Cigarettes|reduced nicotine cigarettes
17006|NCT04092101|Affective Disorders|affective disorders
17007|NCT04092101|Tobacco Withdrawal|tobacco withdrawal
17008|NCT04092101|Vulnerable Populations|vulnerable populations
17009|NCT04092101|E-Cigarettes|e-cigarettes
17010|NCT04092088|Transcranial Direct Current Stimulation (tDCS)|transcranial direct current stimulation (tdcs)
17011|NCT04092088|Transcutaneous Electrical Nerve Stimulation (TENS)|transcutaneous electrical nerve stimulation (tens)
17012|NCT04092088|analgesic effect|analgesic effect
17013|NCT04092088|functional disability|functional disability
17014|NCT04092010|Stepped care intervention|stepped care intervention
17015|NCT04092010|Problem solving education|problem solving education
17016|NCT04092010|Engagement session|engagement session
17017|NCT04092010|Head Start|head start
17018|NCT04092010|Preschool children|preschool children
17019|NCT04091997|Macrophage migration inhibitory factor|macrophage migration inhibitory factor
17020|NCT04091997|Endometriosis|endometriosis
17021|NCT04091997|Laparoscopy|laparoscopy
17022|NCT04091984|donor-derived cfDNA|donor-derived cfdna
17023|NCT04091958|Breast conserving surgery|breast conserving surgery
17024|NCT04091958|Pectoralis major muscle|pectoralis major muscle
17025|NCT04091932|PD-1 inhibitor|pd-1 inhibitor
17026|NCT04091932|Pembrolizumab|pembrolizumab
17027|NCT04091932|Progressive Multifocal Leukoencephalopathy|progressive multifocal leukoencephalopathy
17028|NCT04091932|AIDS|aids
17029|NCT04091919|Left and right ventricular global longitudinal strain|left and right ventricular global longitudinal strain
17030|NCT04091919|ASD device closure|asd device closure
17031|NCT04091880|EV71 vaccine|ev71 vaccine
17032|NCT04091880|influenza vaccine|influenza vaccine
17033|NCT04091880|simultaneously administration|simultaneously administration
17034|NCT04091854|Glucokinase Activator|glucokinase activator
17035|NCT04091854|Glucose control|glucose control
17036|NCT04091841|Protein supplement|protein supplement
17037|NCT04091841|Protein diet|protein diet
17046|NCT04091802|interdental papilla reconstruction|interdental papilla reconstruction
17047|NCT04091802|Leucocyte-Platelet Rich Fibrin (L-PRF)|leucocyte-platelet rich fibrin (l-prf)
17048|NCT04091789|Pain Associated with Dysmenorrhea|pain associated with dysmenorrhea
17049|NCT04091789|CBD|cbd
17050|NCT04091789|Cannabidiol|cannabidiol
17051|NCT04091763|Sclerotherapy|sclerotherapy
17052|NCT04091763|Rubber band ligation|rubber band ligation
17053|NCT04091763|Polidocanol foam|polidocanol foam
17054|NCT04091763|Hemorrhoidal disease|hemorrhoidal disease
17055|NCT04091750|melanoma|melanoma
17056|NCT04091698|co enzymeQ10 - Antioxidant- Corticosteroids|co enzymeq10 - antioxidant- corticosteroids
17061|NCT04091568|Awake fibre-optic tracheal intubation|awake fibre-optic tracheal intubation
17062|NCT04091568|Asleep fibre-optic tracheal intubation|asleep fibre-optic tracheal intubation
17063|NCT04091568|Patient experience|patient experience
17064|NCT04091542|breath hold|breath hold
17065|NCT04091542|hyperventilation|hyperventilation
17066|NCT04091542|oxygenation|oxygenation
17067|NCT04091516|weight loss|weight loss
17068|NCT04091516|body composition|body composition
17069|NCT04091516|lipids|lipids
17070|NCT04091516|hemoglobin A1c|hemoglobin a1c
17071|NCT04091516|blood pressure|blood pressure
17072|NCT04091503|TMZ|tmz
17073|NCT04091503|Temozolomide|temozolomide
17074|NCT04091503|Intranasal Administration|intranasal administration
17075|NCT04091503|Nasal Spray|nasal spray
17076|NCT04091503|Intranasal Modified Temozolomide|intranasal modified temozolomide
17077|NCT04091477|Anorexia nervosa|anorexia nervosa
17078|NCT04091477|Bulimia|bulimia
17079|NCT04091477|Binge eating disorders|binge eating disorders
17080|NCT04091477|Neuropsychology|neuropsychology
17081|NCT04091477|neurocognition|neurocognition
17082|NCT04091477|Daily functioning|daily functioning
17083|NCT04091464|Backward Walking|backward walking
17084|NCT04091464|Neurorehabilitation|neurorehabilitation
17085|NCT04091451|Shingles|shingles
17086|NCT04091451|Shingles recurrence|shingles recurrence
17087|NCT04091451|HZ|hz
17088|NCT04091451|Vaccine response rate|vaccine response rate
17089|NCT04091438|Drug therapy|drug therapy
17090|NCT04091425|Drug therapy|drug therapy
17091|NCT04091399|first-man-study|first-man-study
17092|NCT04091399|alveolitis sicca dolorosa|alveolitis sicca dolorosa
17093|NCT04091399|alveolar osteitis|alveolar osteitis
17094|NCT04091399|alveolalgia|alveolalgia
17095|NCT04091399|sodium hyaluronate|sodium hyaluronate
17096|NCT04091399|octenidine hydrochlorid|octenidine hydrochlorid
17097|NCT04091399|clinical study|clinical study
17098|NCT04091386|Physical activity|physical activity
17099|NCT04091386|Coagulation factor VIII|coagulation factor viii
17100|NCT04091386|Joint health|joint health
17101|NCT04091360|COPD|copd
17102|NCT04091360|Adults|adults
17103|NCT04091360|Phase II|phase ii
17104|NCT04091360|RPL554|rpl554
24991|NCT04042675|fatigue|fatigue
17105|NCT04091360|Ensifentrine|ensifentrine
17106|NCT04091347|African American|african american
17108|NCT04091334|Dyspnea|dyspnea
17109|NCT04091334|Ultrasound|ultrasound
17110|NCT04091334|Point-of-care|point-of-care
17111|NCT04091334|Focused|focused
17112|NCT04091334|Serial|serial
17113|NCT04091334|Monitoring|monitoring
17114|NCT04091308|Exercise|exercise
17115|NCT04091308|Protein supplementation|protein supplementation
17116|NCT04091308|Physical exercise training|physical exercise training
17117|NCT04091295|tumor targeted gene therapy|tumor targeted gene therapy
17118|NCT04091295|human cyclin G1 inhibitor|human cyclin g1 inhibitor
17119|NCT04091295|cell cycle control|cell cycle control
17120|NCT04091295|CCNG1 inhibitor|ccng1 inhibitor
17121|NCT04091282|Metagenome|metagenome
17122|NCT04091282|Infants|infants
17126|NCT04091256|Biorepair sensitive toothpaste|biorepair sensitive toothpaste
17127|NCT04091256|Clinical trial|clinical trial
17128|NCT04091256|Dentinal Hypersensitivity|dentinal hypersensitivity
17129|NCT04091256|Schiff Sensitivity Scale|schiff sensitivity scale
17130|NCT04091256|Zinc-carbonate hydroxyapatite nanocrystals|zinc-carbonate hydroxyapatite nanocrystals
17131|NCT04091243|glucocorticoid|glucocorticoid
17132|NCT04091243|osteoporosis|osteoporosis
17133|NCT04091243|rheumatic diseases|rheumatic diseases
17134|NCT04091230|biopsy quality|biopsy quality
17135|NCT04091204|wild-type BRCA 1 and 2|wild-type brca 1 and 2
17238|NCT04090515|Obesity|obesity
17141|NCT04091165|malnutrition|malnutrition
17142|NCT04091152|old poeple|old poeple
17144|NCT04091152|usability|usability
17145|NCT04091152|ergonomy|ergonomy
17146|NCT04091152|tablet PC|tablet pc
17147|NCT04091139|Unified Protocol|unified protocol
17148|NCT04091139|Cognitive Behavioural Therapy|cognitive behavioural therapy
17149|NCT04091139|Depression|depression
17150|NCT04091139|Anxiety|anxiety
17151|NCT04091139|Adolescents|adolescents
17152|NCT04091126|Bortezomib, lenalidomide and dexamethasone|bortezomib, lenalidomide and dexamethasone
17153|NCT04091126|Belantamab mafodotin|belantamab mafodotin
17154|NCT04091126|Dose escalation|dose escalation
17155|NCT04091126|Newly diagnosed multiple myeloma|newly diagnosed multiple myeloma
17156|NCT04091113|Hereditary Angioedema|hereditary angioedema
17157|NCT04091113|Cleaved high-molecular weight kininogen|cleaved high-molecular weight kininogen
17158|NCT04091100|Pain|pain
17159|NCT04091100|Acupuncture|acupuncture
17160|NCT04091100|Tension-Type Headache|tension-type headache
17161|NCT04091100|Myofascial Releasing|myofascial releasing
17162|NCT04091100|Depression|depression
17163|NCT04091087|Stasis Dermatitis; venous hypertension; venous insufficiency|stasis dermatitis; venous hypertension; venous insufficiency
17164|NCT04091061|Non-alcoholic Fatty Liver Disease|non-alcoholic fatty liver disease
17165|NCT04091061|Non-alcoholic steatohepatitis|non-alcoholic steatohepatitis
17166|NCT04091022|topical chemoprevention|topical chemoprevention
17167|NCT04090957|Estetrol|estetrol
17168|NCT04090957|Hot Flushes|hot flushes
17169|NCT04090957|Vasomotor symptoms|vasomotor symptoms
17170|NCT04090918|post-operative atrial fibrillation|post-operative atrial fibrillation
17171|NCT04090918|abdominal surgery|abdominal surgery
17172|NCT04090918|left atrial strain|left atrial strain
17173|NCT04090918|atrial remodelling|atrial remodelling
17174|NCT04090905|post-operative atrial fibrillation|post-operative atrial fibrillation
17175|NCT04090905|abdominal surgery|abdominal surgery
17176|NCT04090879|Biomarkers of Exposure|biomarkers of exposure
17177|NCT04090879|Compensatory Smoking|compensatory smoking
17178|NCT04090879|Nicotine Dependence|nicotine dependence
17179|NCT04090879|Reduced Nicotine Cigarettes|reduced nicotine cigarettes
17180|NCT04090879|Affective Disorders|affective disorders
17181|NCT04090879|Tobacco Withdrawal|tobacco withdrawal
17182|NCT04090879|Vulnerable Populations|vulnerable populations
17183|NCT04090879|E-Cigarettes|e-cigarettes
17184|NCT04090866|pulmonary arterial hypertension|pulmonary arterial hypertension
17185|NCT04090866|right-sided heart failure|right-sided heart failure
17186|NCT04090866|metabolism|metabolism
17187|NCT04090866|PET/MRI|pet/mri
17188|NCT04090840|obesity|obesity
17189|NCT04090840|fasting|fasting
17190|NCT04090840|diet|diet
17191|NCT04090827|transition|transition
17192|NCT04090827|Congenital heart disease|congenital heart disease
17193|NCT04090827|education|education
17194|NCT04090827|adolescence|adolescence
17195|NCT04090801|Female pattern hair loss|female pattern hair loss
17196|NCT04090801|Minoxidil.|minoxidil.
17197|NCT04090788|bitter gourd|bitter gourd
17198|NCT04090788|pre-diabetics|pre-diabetics
17199|NCT04090788|glucose response|glucose response
17200|NCT04090749|coping|coping
17201|NCT04090749|resilience|resilience
17202|NCT04090749|quality of life|quality of life
17210|NCT04090710|SBRT|sbrt
17211|NCT04090710|Ipilimumab|ipilimumab
17212|NCT04090710|Nivolumab|nivolumab
17213|NCT04090671|Dyspnoea|dyspnoea
17214|NCT04090671|MDP|mdp
17215|NCT04090632|CKCUEST|ckcuest
17216|NCT04090632|Physical activity|physical activity
25134|NCT04041921|CTO|cto
17217|NCT04090632|rehabilitation|rehabilitation
17218|NCT04090580|dapagliflozin|dapagliflozin
17219|NCT04090580|glycemic variability|glycemic variability
17220|NCT04090554|esophagus|esophagus
17221|NCT04090554|esophageal cancer|esophageal cancer
17222|NCT04090554|cytosponge|cytosponge
17223|NCT04090554|Tanzania|tanzania
17224|NCT04090541|Kinesiology Tape|kinesiology tape
17225|NCT04090541|Biomechanical Tape|biomechanical tape
17226|NCT04090541|Performance|performance
17227|NCT04090541|Muscle Strength|muscle strength
17228|NCT04090541|Vertical Jump|vertical jump
17229|NCT04090528|immunotherapy|immunotherapy
17230|NCT04090528|prostate cancer|prostate cancer
17231|NCT04090528|vaccine|vaccine
17232|NCT04090528|DNA vaccine|dna vaccine
17233|NCT04090528|pTVG-HP|ptvg-hp
17234|NCT04090528|pTVG-AR|ptvg-ar
17235|NCT04090528|androgen receptor|androgen receptor
17236|NCT04090528|prostatic acid phosphatase|prostatic acid phosphatase
17237|NCT04090528|pembrolizumab|pembrolizumab
17243|NCT04090502|Back|back
17244|NCT04090502|Hamstrings|hamstrings
17245|NCT04090476|community exercise group|community exercise group
17246|NCT04090463|Pancreatic cancer|pancreatic cancer
17247|NCT04090463|Borderline resectable pancreatic cancer|borderline resectable pancreatic cancer
17248|NCT04090463|Intraoperative radiotherapy (IORT)|intraoperative radiotherapy (iort)
17249|NCT04090463|Total neoadjuvant therapy|total neoadjuvant therapy
17250|NCT04090372|Osteoarthritis|osteoarthritis
17251|NCT04090372|Hip|hip
17252|NCT04090372|Total hip arthroplasty|total hip arthroplasty
17253|NCT04090372|leg discrepancy|leg discrepancy
17254|NCT04090372|preoperative planning|preoperative planning
17255|NCT04090346|CDiff|cdiff
17256|NCT04090346|Fecal Microbiota Transplant|fecal microbiota transplant
17257|NCT04090346|Infection Control|infection control
17258|NCT04090346|Antibiotic Stewardship|antibiotic stewardship
17259|NCT04090320|Arterial Embolization|arterial embolization
17260|NCT04090320|Vascular Plug|vascular plug
17263|NCT04090281|precision medicine|precision medicine
17264|NCT04090281|antiplatelet|antiplatelet
17265|NCT04090281|pharmacogenetics|pharmacogenetics
17266|NCT04090281|de-escalation|de-escalation
17267|NCT04090281|dual antiplatelet therapy (DAPT)|dual antiplatelet therapy (dapt)
17268|NCT04090281|percutaneous coronary intervention (PCI)|percutaneous coronary intervention (pci)
17269|NCT04090268|exercise|exercise
17270|NCT04090268|children|children
17271|NCT04090268|adolescent|adolescent
17272|NCT04090268|cancer|cancer
17273|NCT04090268|malignant hemopathies|malignant hemopathies
17274|NCT04090268|leukemia|leukemia
17275|NCT04090268|lymphoma|lymphoma
17276|NCT04090268|hematopoietic stem cell transplant|hematopoietic stem cell transplant
17277|NCT04090268|survivor|survivor
17278|NCT04090268|oxidative metabolism|oxidative metabolism
17279|NCT04090268|strength|strength
17280|NCT04090268|balance|balance
17281|NCT04090268|flexibility|flexibility
17282|NCT04090268|quality of life|quality of life
17283|NCT04090203|Peanut|peanut
17284|NCT04090203|Allergy|allergy
17285|NCT04090190|Urinary Incontinence|urinary incontinence
17286|NCT04090190|Urgency Urinary|urgency urinary
17287|NCT04090190|Anticholinergic Treatment|anticholinergic treatment
17288|NCT04090190|Urinary Microbiome|urinary microbiome
17289|NCT04090164|Breast cancer|breast cancer
17290|NCT04090164|Hepatitis C virus|hepatitis c virus
17291|NCT04090164|Prognosis|prognosis
17292|NCT04090164|Epidemiology|epidemiology
17293|NCT04090151|HIV|hiv
17294|NCT04090151|Prospective|prospective
17295|NCT04090151|Cohort|cohort
17296|NCT04090151|HCV|hcv
17297|NCT04090138|endurance performance, l-citrulline, glutathione|endurance performance, l-citrulline, glutathione
17298|NCT04090125|knee|knee
17299|NCT04090125|total knee replacement|total knee replacement
17300|NCT04090125|physical therapy|physical therapy
17301|NCT04090099|Erector Spinae Block, Parasternal block, Cardiac surgery|erector spinae block, parasternal block, cardiac surgery
17302|NCT04090060|Anus neoplasm|anus neoplasm
17303|NCT04090060|Digital anal rectal examination|digital anal rectal examination
17304|NCT04090060|Self anal examination|self anal examination
17305|NCT04090021|H. pylori|h. pylori
17306|NCT04090021|genotypic resistance|genotypic resistance
17307|NCT04090021|tailored therapy|tailored therapy
17308|NCT04090021|concomitant therapy|concomitant therapy
17309|NCT04089995|Coats|coats
17310|NCT04089995|leukencephalopathy with calcifications and cysts|leukencephalopathy with calcifications and cysts
17311|NCT04089969|CTA, FFRct, CAD|cta, ffrct, cad
17312|NCT04089969|End Stage Liver DIsease|end stage liver disease
17313|NCT04089969|Liver failure, Liver transplant|liver failure, liver transplant
17316|NCT04089943|peripheral artery disease|peripheral artery disease
17317|NCT04089943|microRNA|microrna
17318|NCT04089930|herpes zoster|herpes zoster
17319|NCT04089930|vaccine|vaccine
17320|NCT04089930|lupus|lupus
17321|NCT04089917|Mechanical thrombectomy|mechanical thrombectomy
17322|NCT04089917|Acute ischemic stroke|acute ischemic stroke
17323|NCT04089917|neurovascular intervention|neurovascular intervention
17324|NCT04089787|Community-acquired pneumonia|community-acquired pneumonia
17325|NCT04089787|Treatment duration|treatment duration
17326|NCT04089787|Pneumonia|pneumonia
17327|NCT04089787|Lung Diseases|lung diseases
17328|NCT04089787|Respiratory Tract Diseases|respiratory tract diseases
17329|NCT04089787|Respiratory Tract Infections|respiratory tract infections
17330|NCT04089787|Bacterial Infections|bacterial infections
17331|NCT04089787|Pneumonia, Bacterial|pneumonia, bacterial
17332|NCT04089787|Anti-Infective Agents|anti-infective agents
17333|NCT04089787|Anti-Bacterial Agents|anti-bacterial agents
17334|NCT04089761|Migraine treatment, Adolescence|migraine treatment, adolescence
17335|NCT04089748|neoadjuvant chemotherapy|neoadjuvant chemotherapy
17336|NCT04089748|cisplatine|cisplatine
17337|NCT04089709|Distal radius fracture|distal radius fracture
17338|NCT04089709|cross-education|cross-education
17339|NCT04089709|immobilization|immobilization
17340|NCT04089696|ALS|als
17341|NCT04089683|Operation Theatre|operation theatre
17342|NCT04089683|Bacterial Contamination|bacterial contamination
17343|NCT04089683|Web-space|web-space
17344|NCT04089683|OT Dress|ot dress
17345|NCT04089683|Anterior Nares|anterior nares
17346|NCT04089670|Chronic Pain|chronic pain
17347|NCT04089670|Acceptance and Commitment Therapy|acceptance and commitment therapy
17348|NCT04089670|Sleep Dysfunction|sleep dysfunction
17349|NCT04089670|Online Intervention|online intervention
17350|NCT04089631|circulating tumour DNA|circulating tumour dna
17351|NCT04089631|ctDNA|ctdna
17352|NCT04089631|adjuvant chemotherapy|adjuvant chemotherapy
17353|NCT04089618|Yoga|yoga
17354|NCT04089618|Meditation|meditation
17355|NCT04089618|Yoga Philosophy|yoga philosophy
17356|NCT04089618|Mantra|mantra
17357|NCT04089618|Mind-Body|mind-body
17358|NCT04089605|dexamethasone implant|dexamethasone implant
17359|NCT04089605|vitrectomized|vitrectomized
17360|NCT04089605|diabetic macular edema|diabetic macular edema
17361|NCT04089605|ranibizumab|ranibizumab
17362|NCT04089592|Laparoscopic Cholecystectomy|laparoscopic cholecystectomy
17363|NCT04089592|Dexmedetomidine|dexmedetomidine
17364|NCT04089592|Fentanyl|fentanyl
17365|NCT04089592|Hemodynamics response|hemodynamics response
17366|NCT04089592|Direct laryngoscopy|direct laryngoscopy
17367|NCT04089592|Intubation|intubation
17368|NCT04089579|Autism|autism
17369|NCT04089579|Autism Spectrum Disorder|autism spectrum disorder
17370|NCT04089579|Stem cell|stem cell
17371|NCT04089579|Mesenchymal Stromal Cells|mesenchymal stromal cells
17372|NCT04089553|Prostate cancer|prostate cancer
17373|NCT04089553|AZD4635|azd4635
17374|NCT04089553|oleclumab|oleclumab
17375|NCT04089553|durvalumab|durvalumab
17376|NCT04089553|MEDI9447|medi9447
17377|NCT04089553|Adenosine 2A Receptor Antagonist|adenosine 2a receptor antagonist
17378|NCT04089553|A2AR|a2ar
17379|NCT04089527|Lymphoma|lymphoma
17380|NCT04089527|Non-Hodgkin's Lymphoma|non-hodgkin's lymphoma
17381|NCT04089527|CC-95775|cc-95775
17382|NCT04089527|Solid Tumors|solid tumors
17383|NCT04089527|Safety|safety
17384|NCT04089527|Relapsed/Refractory|relapsed/refractory
17385|NCT04089514|Biologics|biologics
17386|NCT04089514|Non-interventional|non-interventional
17387|NCT04089514|Real-world|real-world
17388|NCT04089514|Adalimumab|adalimumab
17389|NCT04089514|Europe|europe
17390|NCT04089462|Exercise|exercise
17391|NCT04089462|Insulin pump|insulin pump
17392|NCT04089462|Diabetes Mellitus, Type 1|diabetes mellitus, type 1
17393|NCT04089462|Guidelines|guidelines
17394|NCT04089436|Encephalitis|encephalitis
17395|NCT04089436|Southeast Asia|southeast asia
17396|NCT04089436|Japanese encephalitis|japanese encephalitis
17397|NCT04089436|Next Generation sequencing|next generation sequencing
17398|NCT04089423|tuberculosis, PLHIV|tuberculosis, plhiv
17399|NCT04089410|Adaptation|adaptation
17400|NCT04089410|Systemic hyperthermia|systemic hyperthermia
17401|NCT04089410|Quality of life|quality of life
17402|NCT04089410|Neuro-visceral interactions|neuro-visceral interactions
17403|NCT04089410|Preventive medical technologies|preventive medical technologies
17404|NCT04089410|Personalized approach|personalized approach
17405|NCT04089410|Neuroplasticity|neuroplasticity
17406|NCT04089410|Brain derived neurotrophic factor|brain derived neurotrophic factor
17407|NCT04089410|Irisin|irisin
17408|NCT04089410|Heat Shock proteins|heat shock proteins
17409|NCT04089397|light therapy in sleep disorders of dialysis patients|light therapy in sleep disorders of dialysis patients
17410|NCT04089384|Obesity|obesity
17411|NCT04089384|Auriculotherapy|auriculotherapy
17412|NCT04089384|Weight Loss|weight loss
17413|NCT04089384|Nutrition Therapy|nutrition therapy
17414|NCT04089371|Arthroplasty|arthroplasty
17415|NCT04089371|Hemiarthroplasty|hemiarthroplasty
17416|NCT04089371|Shoulder|shoulder
17417|NCT04089371|Replacement|replacement
17418|NCT04089319|Chronic Pain|chronic pain
17419|NCT04089319|Acupuncture|acupuncture
17420|NCT04089319|Mindfulness|mindfulness
17421|NCT04089319|Interoceptive Awareness|interoceptive awareness
17422|NCT04089306|Advanced Cancer|advanced cancer
17423|NCT04089306|End of Life|end of life
17424|NCT04089306|Agressiveness of Care|agressiveness of care
17425|NCT04089306|Palliative Care integration|palliative care integration
17426|NCT04089293|GLENOID CAVITY|glenoid cavity
17427|NCT04089293|HUMERAL HEAD|humeral head
17428|NCT04089293|SHOULDER JOINT|shoulder joint
17429|NCT04089293|SUPRASPINATUS MUSCLE|supraspinatus muscle
17430|NCT04089293|LABRUM|labrum
17431|NCT04089293|ABER POSITION|aber position
17432|NCT04089293|SCAPULOHUMERAL|scapulohumeral
17433|NCT04089293|INTERNAL IMPINGEMENT|internal impingement
17434|NCT04089293|ABDUCTED POSITION|abducted position
17435|NCT04089293|SCAPULOHUMERAL JOINT|scapulohumeral joint
17436|NCT04089280|diabetes type 2|diabetes type 2
17437|NCT04089280|probiotics|probiotics
17538|NCT04088734|MPS IIIA|mps iiia
17438|NCT04089280|metformin intolerance|metformin intolerance
17439|NCT04089254|Suicide|suicide
17440|NCT04089254|Suicidal|suicidal
17441|NCT04089254|Adolescent|adolescent
17442|NCT04089228|Myofascial trigger points|myofascial trigger points
17443|NCT04089228|Kinesiotaping|kinesiotaping
17444|NCT04089228|Integrated Neuromuscular Inhibition Technique|integrated neuromuscular inhibition technique
17445|NCT04089215|JWCAR029|jwcar029
17446|NCT04089215|B-Cell Malignancies|b-cell malignancies
17447|NCT04089215|non-Hodgkin lymphoma|non-hodgkin lymphoma
17448|NCT04089215|CAR T cells|car t cells
17449|NCT04089215|Chimeric antigen receptor|chimeric antigen receptor
17450|NCT04089215|Relapsed/Refractory|relapsed/refractory
17451|NCT04089202|Diabetes specialty care|diabetes specialty care
17452|NCT04089202|Flash glucose monitoring|flash glucose monitoring
17453|NCT04089202|Clinical pharmacists|clinical pharmacists
17454|NCT04089202|eConsults|econsults
17455|NCT04089202|Freestyle Libre sensor|freestyle libre sensor
17456|NCT04089163|non-muscle invasive bladder cancer|non-muscle invasive bladder cancer
17457|NCT04089163|bladder cancer|bladder cancer
17458|NCT04089163|high grade non-muscle invasive bladder cancer|high grade non-muscle invasive bladder cancer
17459|NCT04089163|HG NMIBC|hg nmibc
17460|NCT04089163|NMIBC|nmibc
17461|NCT04089163|high grade NMIBC|high grade nmibc
17462|NCT04089150|stereotactic body radiotherapy|stereotactic body radiotherapy
17463|NCT04089150|SBRT|sbrt
17464|NCT04089150|chemotherapy|chemotherapy
17465|NCT04089150|radiotherapy|radiotherapy
17466|NCT04089150|surgery|surgery
17467|NCT04089111|Mechanical ventilation|mechanical ventilation
17468|NCT04089111|Adaptive Support Ventilation|adaptive support ventilation
17469|NCT04089111|Transpulmonary pressure|transpulmonary pressure
17470|NCT04089111|Intrinsic PEEP|intrinsic peep
17471|NCT04089111|Safety|safety
17472|NCT04089098|fluid resuscitation|fluid resuscitation
17473|NCT04089098|shock|shock
17474|NCT04089098|volume challenge|volume challenge
17475|NCT04089098|passive leg raising|passive leg raising
17476|NCT04089098|renal perfusion|renal perfusion
17477|NCT04089098|fluid responsiveness|fluid responsiveness
17478|NCT04089085|Childhood Asthma|childhood asthma
17479|NCT04089085|Childhood Anxiety/depression|childhood anxiety/depression
17480|NCT04089085|Educational and Behavioral Intervention for Children|educational and behavioral intervention for children
17481|NCT04089072|Methylene Blue|methylene blue
17482|NCT04089072|Vasopressors|vasopressors
17483|NCT04089072|Septic Shock|septic shock
17484|NCT04089072|Provay Blue®|provay blue®
17485|NCT04089059|Heart Failure|heart failure
17486|NCT04089059|Heart Disease|heart disease
17487|NCT04089059|Cardiovascular Disease|cardiovascular disease
17488|NCT04089059|Pulmonary Artery Pressure|pulmonary artery pressure
17489|NCT04089033|Retinal detachment|retinal detachment
17490|NCT04089033|Metamorphopsia|metamorphopsia
17491|NCT04089033|Aniseikonia|aniseikonia
17492|NCT04089033|Retinal displacement|retinal displacement
17493|NCT04088994|Hemiplegic Cerebral Palsy|hemiplegic cerebral palsy
17494|NCT04088994|Mirror neuron System|mirror neuron system
17495|NCT04088994|Action Observation|action observation
17496|NCT04088994|Rehabilitation|rehabilitation
17497|NCT04088994|fMRI|fmri
17498|NCT04088981|insulin sensitivity|insulin sensitivity
17499|NCT04088981|glycemic control|glycemic control
17500|NCT04088981|intramyocellular|intramyocellular
17501|NCT04088981|nutrition|nutrition
17502|NCT04088955|DigiMeds|digimeds
17503|NCT04088955|Capecitabine|capecitabine
17504|NCT04088955|Standard of Care|standard of care
17505|NCT04088942|Chronic Obstructive Pulmonary Disease|chronic obstructive pulmonary disease
17506|NCT04088942|Randomized Controlled Trial|randomized controlled trial
17507|NCT04088942|Smoking Cessation|smoking cessation
17508|NCT04088942|Behavioural support|behavioural support
17509|NCT04088942|varenicline|varenicline
17510|NCT04088942|exacerbations|exacerbations
17511|NCT04088929|Pain|pain
17512|NCT04088929|Neuropathy|neuropathy
17513|NCT04088929|Neuropathic Pain|neuropathic pain
17514|NCT04088929|Diabetes|diabetes
17515|NCT04088916|ADNproviral|adnproviral
17516|NCT04088916|HIV|hiv
17517|NCT04088916|Resistance|resistance
17518|NCT04088916|genotyping|genotyping
17519|NCT04088903|Immunotherapy, anti-CD38 antibody|immunotherapy, anti-cd38 antibody
17520|NCT04088890|CD22|cd22
17521|NCT04088890|CAR T cells|car t cells
17522|NCT04088877|Exercise|exercise
17523|NCT04088877|Art sculpture|art sculpture
17524|NCT04088877|Breast neoplasms|breast neoplasms
17525|NCT04088877|Body Image|body image
17526|NCT04088812|Satiety|satiety
17527|NCT04088812|Meat derivative|meat derivative
17528|NCT04088812|Fiber|fiber
17529|NCT04088812|Visual Analogue Scale|visual analogue scale
17530|NCT04088812|Parallel|parallel
17531|NCT04088786|HIPEC|hipec
17532|NCT04088786|nal-irinotecan|nal-irinotecan
17533|NCT04088747|Fibromyalgia|fibromyalgia
17534|NCT04088747|Ultrasound|ultrasound
17535|NCT04088747|Regularization|regularization
17536|NCT04088747|Logistic Regression|logistic regression
17537|NCT04088747|Imaging|imaging
17539|NCT04088734|Sanfilippo|sanfilippo
17540|NCT04088734|Gene therapy|gene therapy
17541|NCT04088708|breast cancer|breast cancer
17542|NCT04088708|fatigue|fatigue
17543|NCT04088708|exercise|exercise
17544|NCT04088708|psychosocial outcomes|psychosocial outcomes
17545|NCT04088708|inflammation|inflammation
17546|NCT04088708|gut microbiome|gut microbiome
17547|NCT04088695|Blood|blood
17548|NCT04088695|Donation|donation
17549|NCT04088695|Voluntary|voluntary
17550|NCT04088682|clinical performance|clinical performance
17551|NCT04088682|quality measures|quality measures
17552|NCT04088682|ST-Elevation myocardial infarction|st-elevation myocardial infarction
17553|NCT04088669|asthma|asthma
17554|NCT04088669|pulmonary rehabilitation|pulmonary rehabilitation
17555|NCT04088669|home-based pulmonary rehabilitation|home-based pulmonary rehabilitation
17556|NCT04088669|home-based rehabilitation|home-based rehabilitation
17557|NCT04088630|Fingolimod|fingolimod
17558|NCT04088630|Neurologic Deficits|neurologic deficits
17559|NCT04088630|Brain Injury|brain injury
17560|NCT04088630|Stroke|stroke
17561|NCT04088630|Intracerebral hemorrhage|intracerebral hemorrhage
17562|NCT04088630|Neuroimmunomodulation|neuroimmunomodulation
17563|NCT04088604|LY01610|ly01610
17564|NCT04088604|5-Fu|5-fu
17565|NCT04088604|Safety|safety
17566|NCT04088604|Tolerability|tolerability
17567|NCT04088604|Pharmacokinetics|pharmacokinetics
17568|NCT04088591|Sepsis; Shock, Septic; ascorbic acid;|sepsis; shock, septic; ascorbic acid;
17569|NCT04088565|Neuromodulation|neuromodulation
17570|NCT04088565|Paresis|paresis
17571|NCT04088565|Neurorehabilitation|neurorehabilitation
17572|NCT04088539|Smoking cessation|smoking cessation
17573|NCT04088539|Brief intervention|brief intervention
17574|NCT04088539|Correctional institution|correctional institution
17575|NCT04088513|G6PD Deficiency|g6pd deficiency
17576|NCT04088513|Acute ischemic stroke|acute ischemic stroke
17577|NCT04088513|Aspirin|aspirin
17578|NCT04088513|Hemolysis|hemolysis
17579|NCT04088513|Clopidogrel|clopidogrel
17580|NCT04088513|Anti-platelet therapy|anti-platelet therapy
17581|NCT04088474|gut microflora|gut microflora
17582|NCT04088474|Lactobacillus paracasei subsp. paracasei NTU 101|lactobacillus paracasei subsp. paracasei ntu 101
17583|NCT04088474|probiotics|probiotics
17584|NCT04088461|Prediabetes|prediabetes
17585|NCT04088461|Insulin resistance|insulin resistance
17586|NCT04088461|hyperglucemia|hyperglucemia
17587|NCT04088396|Systemic|systemic
17588|NCT04088396|Fever|fever
17589|NCT04088396|Flare|flare
17590|NCT04088396|sJIA|sjia
17591|NCT04088396|JIA|jia
17592|NCT04088357|Healthy Participants|healthy participants
17593|NCT04088357|Skin|skin
17594|NCT04088357|Dermal|dermal
17595|NCT04088357|Biopsy|biopsy
17596|NCT04088305|pneumonia|pneumonia
17597|NCT04088305|vancomycin|vancomycin
17598|NCT04088305|trough concentration|trough concentration
17599|NCT04088305|elderly patients|elderly patients
17600|NCT04088279|MRI|mri
17601|NCT04088279|oxygen enhanced|oxygen enhanced
17602|NCT04088279|fourier decomposition|fourier decomposition
17603|NCT04088240|omega-3|omega-3
17604|NCT04088214|Arthroscopy|arthroscopy
17605|NCT04088175|Topography|topography
17606|NCT04088136|everyday memory|everyday memory
17607|NCT04088136|ecological momentary assessment|ecological momentary assessment
17608|NCT04088136|memory complaint|memory complaint
17609|NCT04088136|metacognition|metacognition
17610|NCT04088136|mnemonics|mnemonics
17611|NCT04088136|external aids|external aids
17612|NCT04088097|adolescent|adolescent
17613|NCT04088097|cognitive-behavioral therapy|cognitive-behavioral therapy
17614|NCT04088097|loss of control eating|loss of control eating
17615|NCT04088045|Osteoarthritis; Autologous Platelet Rich Plasma|osteoarthritis; autologous platelet rich plasma
17616|NCT04088019|Idiopathic uveitis|idiopathic uveitis
17617|NCT04088019|IGRA positive|igra positive
17618|NCT04088019|Type 1 interferon|type 1 interferon
17619|NCT04088019|Transcriptomic analysis|transcriptomic analysis
17620|NCT04088019|Anti-Tuberculosis Therapy|anti-tuberculosis therapy
17621|NCT04088006|Aging|aging
17622|NCT04088006|Skin dryness|skin dryness
17623|NCT04088006|Skin elasticity|skin elasticity
17624|NCT04088006|Hyaluronic acid|hyaluronic acid
17625|NCT04088006|Injection|injection
17626|NCT04088006|Cheek|cheek
17627|NCT04088006|Neckline area|neckline area
17628|NCT04088006|Healthy subjects|healthy subjects
17629|NCT04088006|Intra-individual|intra-individual
17630|NCT04088006|Independent evaluators|independent evaluators
17631|NCT04088006|Prospective|prospective
17632|NCT04088006|Randomized study|randomized study
17633|NCT04087993|pre surgery iron treatment|pre surgery iron treatment
17634|NCT04087967|Decitabine|decitabine
17635|NCT04087967|HAAG|haag
17636|NCT04087967|AML|aml
17637|NCT04087928|Stroke|stroke
17638|NCT04087928|Upper limb|upper limb
17639|NCT04087928|Rehabilitation|rehabilitation
17640|NCT04087928|Focal Muscular Vibration|focal muscular vibration
17641|NCT04087915|High cholesterol|high cholesterol
17735|NCT04087330|Spastic|spastic
17645|NCT04087915|Hypercholesterolemia|hypercholesterolemia
17646|NCT04087902|Endoscopic Endonasal Approach Surgery|endoscopic endonasal approach surgery
17647|NCT04087889|Cancer|cancer
17648|NCT04087889|Pancreas|pancreas
17649|NCT04087889|Adenocarcinoma|adenocarcinoma
17650|NCT04087876|intrahepatic cholangiocarcinoma|intrahepatic cholangiocarcinoma
17651|NCT04087876|iCCA|icca
17652|NCT04087876|Metastatic cholangiocarcinoma|metastatic cholangiocarcinoma
17653|NCT04087876|FGFR genomic alteration|fgfr genomic alteration
17654|NCT04087876|biliary cancer|biliary cancer
17655|NCT04087876|bile duct cancer|bile duct cancer
17656|NCT04087876|liver cancer|liver cancer
17657|NCT04087850|peer relationships|peer relationships
17658|NCT04087837|bougie, nasotracheal tube|bougie, nasotracheal tube
17659|NCT04087837|Endotracheal Tube intubation General Anesthesia (ETGA)|endotracheal tube intubation general anesthesia (etga)
17660|NCT04087824|Deep learning|deep learning
17661|NCT04087824|Colonoscopy|colonoscopy
17662|NCT04087824|Central Neural Networks|central neural networks
17663|NCT04087811|LSS|lss
17664|NCT04087785|miRNAs|mirnas
17665|NCT04087785|cervical cancer|cervical cancer
17666|NCT04087785|lymph node metastasis|lymph node metastasis
17667|NCT04087694|Microdecompression|microdecompression
17668|NCT04087694|laminectomy|laminectomy
17669|NCT04087694|pain|pain
17670|NCT04087694|stenosis|stenosis
17674|NCT04087668|ERCP|ercp
17675|NCT04087668|General anesthesia|general anesthesia
17676|NCT04087668|Endoscopy|endoscopy
17677|NCT04087668|MAC|mac
17678|NCT04087629|CTCL|ctcl
17679|NCT04087629|GVHD|gvhd
17680|NCT04087629|topical steroids|topical steroids
17681|NCT04087629|StrataXRT|strataxrt
17682|NCT04087629|cutaneous|cutaneous
17683|NCT04087629|steroid sparing|steroid sparing
17684|NCT04087616|tics|tics
17685|NCT04087616|tourette Syndrome|tourette syndrome
17686|NCT04087603|Circadian rhythms|circadian rhythms
17687|NCT04087603|Sleep|sleep
17688|NCT04087603|Adolescence|adolescence
17689|NCT04087590|long acting bronchodilator|long acting bronchodilator
17690|NCT04087590|tidal breathing|tidal breathing
17691|NCT04087590|variability|variability
17692|NCT04087590|impulse oscillometry spirometry|impulse oscillometry spirometry
17693|NCT04087590|plethysmography|plethysmography
17694|NCT04087590|dyspnea|dyspnea
17695|NCT04087577|peripheral nerve injury|peripheral nerve injury
17696|NCT04087577|motor learning|motor learning
17697|NCT04087577|mirror therapy|mirror therapy
17698|NCT04087577|physical therapy|physical therapy
17699|NCT04087564|Music|music
17700|NCT04087538|troponin|troponin
17701|NCT04087512|perturbation-based balance training|perturbation-based balance training
17702|NCT04087512|exercise|exercise
17703|NCT04087486|Multiple errands tests|multiple errands tests
17704|NCT04087473|ALK inhibitor (ALKi)|alk inhibitor (alki)
17705|NCT04087473|NSCLC|nsclc
17706|NCT04087473|Anaplastic lymphoma kinase (ALK) fusion oncogene NSCLC|anaplastic lymphoma kinase (alk) fusion oncogene nsclc
17707|NCT04087473|Guardant360 assay|guardant360 assay
17708|NCT04087473|Next-Generation Sequencing (NGS) DNA sequencing test|next-generation sequencing (ngs) dna sequencing test
17709|NCT04087473|Cell-free circulating tumor DNA (ctDNA)|cell-free circulating tumor dna (ctdna)
17710|NCT04087473|Plasma profiling|plasma profiling
17711|NCT04087473|Blood-based assay|blood-based assay
17712|NCT04087473|Mutational testing|mutational testing
17713|NCT04087473|74 genetic alterations (point mutations, copy number variants, fusions, insertions, deletions)|74 genetic alterations (point mutations, copy number variants, fusions, insertions, deletions)
17714|NCT04087473|ALK resistance mutations|alk resistance mutations
17715|NCT04087460|Vaccnie|vaccnie
17716|NCT04087460|PspA|pspa
17717|NCT04087460|Pneomolysin|pneomolysin
17718|NCT04087434|concussion|concussion
17719|NCT04087421|Low Anterior Resection Syndrome|low anterior resection syndrome
17720|NCT04087421|Transanal irrigation|transanal irrigation
17721|NCT04087421|Glycerol suppositories|glycerol suppositories
17722|NCT04087408|GnRHa , LPD, antagonist, progesterone and ART|gnrha , lpd, antagonist, progesterone and art
17723|NCT04087369|implementation research|implementation research
17724|NCT04087369|low- and middle-income countries|low- and middle-income countries
17725|NCT04087369|Nepal|nepal
17726|NCT04087369|Package of Essential Noncommunicable disease interventions for primary care in low-resource settings|package of essential noncommunicable disease interventions for primary care in low-resource settings
17727|NCT04087369|task-shifting|task-shifting
17728|NCT04087369|non-physician health workers|non-physician health workers
17729|NCT04087369|digital tools|digital tools
17730|NCT04087369|motivational interviewing|motivational interviewing
17731|NCT04087343|homebound patients|homebound patients
17732|NCT04087343|exercise|exercise
17733|NCT04087343|nutrition|nutrition
17734|NCT04087330|Cerebral Palsy|cerebral palsy
17739|NCT04087291|manipulation, chiropractic|manipulation, chiropractic
17740|NCT04087278|Cardiovascular system|cardiovascular system
17741|NCT04087278|Polyphenols|polyphenols
17742|NCT04087265|transabdominal ultrasound|transabdominal ultrasound
17743|NCT04087265|bowel preparation|bowel preparation
17744|NCT04087265|colonoscopy|colonoscopy
17745|NCT04087239|HAART exposure|haart exposure
17746|NCT04087239|infant immune/metabolic dyregulation,|infant immune/metabolic dyregulation,
17747|NCT04087239|gut dysbiosis|gut dysbiosis
17748|NCT04087239|breastfeeding|breastfeeding
17749|NCT04087239|CMV|cmv
17750|NCT04087239|HBV|hbv
17751|NCT04087239|Syphilis|syphilis
17752|NCT04087239|malnutrition|malnutrition
17753|NCT04087226|Polytetrafluoroethylene|polytetrafluoroethylene
17754|NCT04087226|Retraction|retraction
17755|NCT04087226|Soft tissue Management|soft tissue management
17756|NCT04087226|Retraction cord|retraction cord
17757|NCT04087213|HemoCare™ Hemodialysis System|hemocare™ hemodialysis system
17758|NCT04087213|Hemodialysis|hemodialysis
17759|NCT04087200|STEMI|stemi
17760|NCT04087200|NSTEMI|nstemi
17761|NCT04087200|Acute kidney injury|acute kidney injury
17762|NCT04087200|Renal function|renal function
17763|NCT04087200|Statin therapy|statin therapy
17764|NCT04087187|Pharmacokinetics|pharmacokinetics
17768|NCT04087135|videolaryngoscopy|videolaryngoscopy
17769|NCT04087135|Thiel's embalmed cadaver|thiel's embalmed cadaver
17770|NCT04087083|stroke|stroke
17771|NCT04087083|robotic rehabilitation|robotic rehabilitation
17772|NCT04087083|frail elderly|frail elderly
17773|NCT04087083|gait performance|gait performance
17774|NCT04087083|balance|balance
17775|NCT04087083|risk of falling|risk of falling
17776|NCT04087083|quality of life|quality of life
17777|NCT04087044|vestibular neuritis|vestibular neuritis
17778|NCT04087044|vestibular migraine|vestibular migraine
17779|NCT04087031|Parkinson disease|parkinson disease
17780|NCT04087031|robotics|robotics
17781|NCT04087031|elderly|elderly
17782|NCT04087031|rehabilitation|rehabilitation
17783|NCT04086992|Infantile Spasms|infantile spasms
17784|NCT04086992|parental stress|parental stress
17785|NCT04086992|ACTH|acth
17786|NCT04086992|remote monitoring|remote monitoring
17787|NCT04086979|friendship|friendship
17788|NCT04086953|Exercise Test|exercise test
17789|NCT04086953|Walking Test|walking test
17790|NCT04086953|Chronic Disease|chronic disease
17791|NCT04086953|Endurance Time|endurance time
17792|NCT04086953|Rehabilitation|rehabilitation
17793|NCT04086940|role|role
17794|NCT04086940|INTRAOPERATIVE|intraoperative
17795|NCT04086940|beta blocker|beta blocker
17796|NCT04086940|bariatric surgery|bariatric surgery
17797|NCT04086940|morbid obese|morbid obese
17798|NCT04086901|Radiotherapy|radiotherapy
17799|NCT04086901|Dose escalation|dose escalation
17800|NCT04086901|Definitive chemo-radiotherapy|definitive chemo-radiotherapy
17801|NCT04086888|Immune checkpoint inhibitors|immune checkpoint inhibitors
17802|NCT04086862|temporomandibular disorders|temporomandibular disorders
17803|NCT04086862|masseter myalgia|masseter myalgia
17804|NCT04086862|adult female|adult female
17805|NCT04086849|radiomics|radiomics
17806|NCT04086849|pathomics|pathomics
17807|NCT04086849|head and neck cancer|head and neck cancer
17808|NCT04086849|biomarkers|biomarkers
17809|NCT04086849|machine learning|machine learning
17810|NCT04086849|artificial intelligence|artificial intelligence
17811|NCT04086849|squamous cell carcinoma|squamous cell carcinoma
17812|NCT04086836|TAVR|tavr
17813|NCT04086836|Stroke|stroke
17814|NCT04086810|PWS|pws
17815|NCT04086810|Prader-Willi Syndrome|prader-willi syndrome
17816|NCT04086797|IQP-AE-103|iqp-ae-103
17817|NCT04086797|overweight treatment|overweight treatment
17818|NCT04086797|obesity treatment|obesity treatment
17819|NCT04086784|3D-printed Porous Titanium Alloy cage;PEEK cage;Osteoporosis|3d-printed porous titanium alloy cage;peek cage;osteoporosis
17820|NCT04086758|Pharmacokinetic|pharmacokinetic
17821|NCT04086758|MDV3100|mdv3100
17822|NCT04086758|zolbetuximab|zolbetuximab
17823|NCT04086732|central sensitization|central sensitization
17824|NCT04086732|high-frequency stimulation|high-frequency stimulation
17825|NCT04086706|Colonoscopy|colonoscopy
17826|NCT04086706|Retroflexion|retroflexion
17827|NCT04086706|Adenoma Detection Rate|adenoma detection rate
17828|NCT04086706|Adenoma Miss Rate|adenoma miss rate
17829|NCT04086693|intravenous access|intravenous access
17830|NCT04086693|vascular access|vascular access
17831|NCT04086693|IV survival|iv survival
17832|NCT04086693|IV catheter complication|iv catheter complication
17833|NCT04086667|LBP|lbp
17834|NCT04086667|SMT|smt
17835|NCT04086641|Ankle disarticulation|ankle disarticulation
17836|NCT04086641|Syme|syme
17837|NCT04086641|Amputation|amputation
17838|NCT04086641|Prosthesis|prosthesis
17842|NCT04086589|healthy, young, elderly|healthy, young, elderly
17843|NCT04086537|Pulmonary Arterial Hypertension|pulmonary arterial hypertension
17844|NCT04086537|BMPR2|bmpr2
17845|NCT04086537|Iron Metabolism|iron metabolism
17846|NCT04086537|Hepcidin|hepcidin
17847|NCT04086537|Mutations|mutations
17848|NCT04086524|Amblyopia|amblyopia
17849|NCT04086524|Binocular treatment|binocular treatment
17850|NCT04086524|Visual acuity|visual acuity
17851|NCT04086524|Stereopsis|stereopsis
17852|NCT04086524|Motor function|motor function
17853|NCT04086498|ketogenic diet|ketogenic diet
17854|NCT04086498|Mediterranean diet|mediterranean diet
17855|NCT04086498|ketones|ketones
17856|NCT04086498|glycaemia|glycaemia
17857|NCT04086498|executive functions|executive functions
17861|NCT04086459|Repetitive transcranial magnetic stimulation|repetitive transcranial magnetic stimulation
17862|NCT04086459|Functional magnetic resonance imaging|functional magnetic resonance imaging
17863|NCT04086459|Positron emission tomography|positron emission tomography
17864|NCT04086394|Pain|pain
17865|NCT04086394|Narcotics|narcotics
17866|NCT04086394|Nerve block|nerve block
17867|NCT04086381|Brown adipose tissue|brown adipose tissue
17868|NCT04086381|Creatine monohydrate|creatine monohydrate
17869|NCT04086381|Diet-induced thermogenesis|diet-induced thermogenesis
17870|NCT04086355|Dysphagia; electrical stimulation; cerebral palsy|dysphagia; electrical stimulation; cerebral palsy
17871|NCT04086342|Anxiety|anxiety
17872|NCT04086342|Cannabis|cannabis
17873|NCT04086342|Cannabidiol|cannabidiol
17874|NCT04086342|CBD|cbd
17875|NCT04086316|Menstrual Cycle|menstrual cycle
17876|NCT04086316|Major Depressive Disorder|major depressive disorder
17877|NCT04086316|Stress|stress
17878|NCT04086316|Sex hormones|sex hormones
17879|NCT04086316|Depression|depression
17880|NCT04086316|Female|female
17881|NCT04086316|Ambulatory Assessment|ambulatory assessment
17882|NCT04086290|radiotherapy|radiotherapy
17883|NCT04086290|prostatectomy|prostatectomy
17884|NCT04086290|androgen deprivation therapy|androgen deprivation therapy
17885|NCT04086277|cesarean section|cesarean section
17886|NCT04086277|Continuous intrapartum support|continuous intrapartum support
17887|NCT04086277|nulliparous|nulliparous
17888|NCT04086264|Acute Myeloid Leukemia|acute myeloid leukemia
17889|NCT04086264|AML|aml
17890|NCT04086264|Minimal detectable disease|minimal detectable disease
17891|NCT04086264|MRD|mrd
17892|NCT04086264|CD123|cd123
17893|NCT04086264|Relapsed/refractory|relapsed/refractory
17894|NCT04086251|Neoplasm|neoplasm
17895|NCT04086251|Malignancy|malignancy
17896|NCT04086251|Oncology|oncology
17897|NCT04086251|Remote patient monitoring|remote patient monitoring
17898|NCT04086147|acute ischemic stroke|acute ischemic stroke
17899|NCT04086147|large vessel occlusion|large vessel occlusion
17900|NCT04086147|thrombolysis|thrombolysis
17901|NCT04086147|tenecteplase|tenecteplase
17902|NCT04086147|dosage|dosage
17903|NCT04086147|computed tomography|computed tomography
17904|NCT04086147|magnetic resonance imaging|magnetic resonance imaging
17905|NCT04086147|diffusion weighted imaging|diffusion weighted imaging
17906|NCT04086147|early combined imaging outcomes|early combined imaging outcomes
17907|NCT04086147|modified Rankin scale|modified rankin scale
17908|NCT04086147|time window beyond 4.5 hours|time window beyond 4.5 hours
17909|NCT04086134|constipation|constipation
17910|NCT04086108|GABA|gaba
17911|NCT04086108|Glutamate|glutamate
17912|NCT04086108|Tomato|tomato
17913|NCT04086108|Plasmakinetics|plasmakinetics
17914|NCT04086108|Bioavailability|bioavailability
17915|NCT04086095|Respiratory Distress Syndrome|respiratory distress syndrome
17916|NCT04086095|Less Invasive Surfactant Administration|less invasive surfactant administration
17917|NCT04086095|Neofact|neofact
17918|NCT04086095|Preterm babies|preterm babies
17919|NCT04086082|Lung cancer|lung cancer
17920|NCT04086082|NSCLC|nsclc
17921|NCT04086082|Oligometastases|oligometastases
17922|NCT04086069|unilateral lower-lim amputation|unilateral lower-lim amputation
17923|NCT04086069|sit-to-stand trainer device|sit-to-stand trainer device
17924|NCT04086069|30-Second Chair Stand Test|30-second chair stand test
17925|NCT04086069|kinesiological analysis|kinesiological analysis
17926|NCT04086017|symptom management|symptom management
17927|NCT04086017|Reiki therapy|reiki therapy
17928|NCT04086017|self-care|self-care
17929|NCT04086004|Motor Imagery practice|motor imagery practice
17930|NCT04086004|Stroke|stroke
17931|NCT04086004|Dual task training|dual task training
17932|NCT04085991|Radioligand therapy|radioligand therapy
17933|NCT04085991|PSMA|psma
17934|NCT04085991|PSMA therapy|psma therapy
17935|NCT04085991|1095|1095
17936|NCT04085965|Summer Camp|summer camp
17937|NCT04085965|Child overweight / obesity|child overweight / obesity
17938|NCT04085965|Diet|diet
17939|NCT04085965|Physical Activity|physical activity
17940|NCT04085952|pelvic organ prolapse, vaginal graft|pelvic organ prolapse, vaginal graft
17941|NCT04085926|Wound Healing|wound healing
17942|NCT04085926|Casts, Surgical|casts, surgical
17943|NCT04085926|Shoes|shoes
17944|NCT04085900|Screening|screening
17945|NCT04085900|Nasopharyngeal Carcinoma|nasopharyngeal carcinoma
17946|NCT04085900|Biomarker|biomarker
17947|NCT04085874|Nutrition intervention|nutrition intervention
17948|NCT04085874|Food-Based Recommendations|food-based recommendations
17949|NCT04085874|dietary practices|dietary practices
17950|NCT04085874|women of reproductive age|women of reproductive age
17951|NCT04085874|dyslipidemia|dyslipidemia
17952|NCT04085861|Mental health|mental health
17953|NCT04085861|Eating disorders|eating disorders
17954|NCT04085861|Perfectionism|perfectionism
17955|NCT04085861|Body image|body image
17956|NCT04085861|Body dissatisfaction|body dissatisfaction
17957|NCT04085861|Body appreciation|body appreciation
17958|NCT04085861|Depression|depression
17959|NCT04085861|Energy availability|energy availability
17960|NCT04085835|endometrium|endometrium
17961|NCT04085835|comparative genomics|comparative genomics
17962|NCT04085783|Recurrent implantation failure|recurrent implantation failure
17963|NCT04085783|implantation|implantation
17964|NCT04085783|IVF|ivf
17965|NCT04085783|platelet rich plasma (PRP)|platelet rich plasma (prp)
17966|NCT04085770|LOS|los
17967|NCT04085770|mediastinitis|mediastinitis
17968|NCT04085770|secondary myocardial infection|secondary myocardial infection
17969|NCT04085744|intubation|intubation
17970|NCT04085744|anesthesia|anesthesia
17971|NCT04085744|corticosteroids|corticosteroids
17972|NCT04085744|lidocaine|lidocaine
17973|NCT04085744|complication of intubation|complication of intubation
17974|NCT04085718|endomyocardial biopsy|endomyocardial biopsy
17975|NCT04085718|myocarditis|myocarditis
17976|NCT04085718|anti-heart autoantibodies|anti-heart autoantibodies
17977|NCT04085718|biomarker|biomarker
17978|NCT04085718|positron emission computed tomography|positron emission computed tomography
17979|NCT04085718|heart failure|heart failure
17980|NCT04085718|cardiomyopathy|cardiomyopathy
17981|NCT04085718|magnetic resonance imaging|magnetic resonance imaging
17982|NCT04085705|Wound Dressing|wound dressing
17983|NCT04085679|Multidisciplinary care|multidisciplinary care
17984|NCT04085679|Hospital-community care integration|hospital-community care integration
17985|NCT04085679|Mobile specialist team|mobile specialist team
17986|NCT04085679|Personalization of care|personalization of care
17987|NCT04085679|Nursing home|nursing home
17988|NCT04085653|adult, pediatric, BYL719,PIK3CA-Related Overgrowth Spectrum, PIK3CA, Related Overgrowth Spectrum,PROS|adult, pediatric, byl719,pik3ca-related overgrowth spectrum, pik3ca, related overgrowth spectrum,pros
17989|NCT04085640|Hip Arthroplasty|hip arthroplasty
17990|NCT04085640|regional anesthesia|regional anesthesia
17991|NCT04085640|obturator nerve block|obturator nerve block
17992|NCT04085588|Pain|pain
17993|NCT04085588|analgesia|analgesia
17994|NCT04085588|Postoperative|postoperative
17995|NCT04085588|Ketamine|ketamine
17996|NCT04085588|Morphine|morphine
17997|NCT04085523|Achondroplasia|achondroplasia
17998|NCT04085523|Dwarfism|dwarfism
17999|NCT04085510|breast cancer screening|breast cancer screening
18000|NCT04085510|digital breast tomosynthesis|digital breast tomosynthesis
18001|NCT04085510|contrast-enhanced mammogram|contrast-enhanced mammogram
18002|NCT04085497|Medial Plica Syndrome|medial plica syndrome
18003|NCT04085497|Kinesio Tape|kinesio tape
18004|NCT04085484|preterm|preterm
18005|NCT04085445|Agent DCB|agent dcb
18006|NCT04085419|zoledronic acid|zoledronic acid
18007|NCT04085419|denosumab|denosumab
18008|NCT04085419|primary hyperparathyroidism|primary hyperparathyroidism
18009|NCT04085419|osteoporosis|osteoporosis
18010|NCT04085380|Clostridium difficile|clostridium difficile
18011|NCT04085380|Multidrug resistant bacteria|multidrug resistant bacteria
18012|NCT04085380|Risks factor|risks factor
18013|NCT04085380|highly resistant bacteria|highly resistant bacteria
18014|NCT04085380|eXDR|exdr
18015|NCT04085380|ESBL|esbl
18016|NCT04085354|Premature Ejaculation|premature ejaculation
18017|NCT04085341|Macular Edema|macular edema
18018|NCT04085263|Radical Mastectomy|radical mastectomy
18019|NCT04085263|Postoperative pain|postoperative pain
18020|NCT04085263|Morphine consumption|morphine consumption
18021|NCT04085263|subserratus plane block|subserratus plane block
18022|NCT04085250|Stage III Non-Small Cell Lung Cancer|stage iii non-small cell lung cancer
18023|NCT04085250|Neoadjuvant Chemotherapy plus nivolumab|neoadjuvant chemotherapy plus nivolumab
18024|NCT04085250|Chemoradiotherapy|chemoradiotherapy
18025|NCT04085250|Nivolumab consolidation|nivolumab consolidation
18026|NCT04085211|endoscopy|endoscopy
18027|NCT04085159|immunotherapy T cell cancer gene therapy|immunotherapy t cell cancer gene therapy
18028|NCT04085146|robot-assisted surgery|robot-assisted surgery
18029|NCT04085146|prostatectomy|prostatectomy
18030|NCT04085146|laparoscopy|laparoscopy
18031|NCT04085146|positive end-expiratory pressure|positive end-expiratory pressure
18032|NCT04085146|individualized|individualized
18033|NCT04085146|atelectasis|atelectasis
18034|NCT04085146|general anesthesia|general anesthesia
18035|NCT04085107|mild cognitive impairment|mild cognitive impairment
18036|NCT04085107|neuropsychiatric symptoms|neuropsychiatric symptoms
18037|NCT04085107|instrument validation|instrument validation
18038|NCT04085107|coping styles|coping styles
18039|NCT04085107|cognitive deficit|cognitive deficit
18040|NCT04085107|neuroticism|neuroticism
18041|NCT04085107|social support|social support
18042|NCT04085094|BOLD-RMI|bold-rmi
18043|NCT04085094|Contrast-enhanced ultrasound (CEUS)|contrast-enhanced ultrasound (ceus)
18044|NCT04085094|Salt storage|salt storage
18045|NCT04085094|Perfusion index|perfusion index
18046|NCT04085094|Resistance index|resistance index
18047|NCT04085094|Renal functional reserve|renal functional reserve
18048|NCT04085094|Renal oxygenation|renal oxygenation
18049|NCT04085081|Lung cancer|lung cancer
18050|NCT04085081|geriatric oncology|geriatric oncology
18051|NCT04085081|physical activity|physical activity
18052|NCT04085081|family caregivers|family caregivers
18053|NCT04085081|functional status|functional status
18054|NCT04085055|pancreatic mass, pancreatic solid mass, pancreatic lesion|pancreatic mass, pancreatic solid mass, pancreatic lesion
18055|NCT04085042|Catheterization, Peripheral|catheterization, peripheral
18056|NCT04085029|Ablative radiotherapy|ablative radiotherapy
18057|NCT04084990|aPAP|apap
18058|NCT04084990|OSA|osa
18059|NCT04084990|FGR|fgr
18060|NCT04084951|Solid tumors cancer|solid tumors cancer
18061|NCT04084951|metastatic|metastatic
18062|NCT04084951|locally advanced|locally advanced
18063|NCT04084951|cancer|cancer
18064|NCT04084951|cervical|cervical
18065|NCT04084951|head and neck|head and neck
18066|NCT04084951|anal|anal
18067|NCT04084951|penile|penile
18068|NCT04084951|SQZ-PBMC-HPV|sqz-pbmc-hpv
18069|NCT04084951|atezolizumab|atezolizumab
18070|NCT04084951|HPV16|hpv16
18071|NCT04084951|APC|apc
18072|NCT04084951|cell therapy|cell therapy
18073|NCT04084938|Prostate|prostate
18074|NCT04084938|Embolization|embolization
18075|NCT04084938|Complication|complication
18076|NCT04084938|Operation|operation
18077|NCT04084938|Randomization|randomization
18078|NCT04084899|Obstructive Sleep Apnea|obstructive sleep apnea
18079|NCT04084899|Continuous Positive Airway Pressure|continuous positive airway pressure
18080|NCT04084899|Lung hyperinflation|lung hyperinflation
18081|NCT04084847|Barberry|barberry
18082|NCT04084847|Berberis vulgaris|berberis vulgaris
18083|NCT04084847|Blood pressure|blood pressure
18084|NCT04084847|Lipids|lipids
18085|NCT04084847|Inflammation|inflammation
18086|NCT04084834|Exercise|exercise
18087|NCT04084795|Fibromyalgia|fibromyalgia
18088|NCT04084795|Psychological trauma|psychological trauma
18089|NCT04084795|Posttraumatic stress disorder|posttraumatic stress disorder
18090|NCT04084795|Major depressive disorder|major depressive disorder
18091|NCT04084795|Anxiety disorder|anxiety disorder
18092|NCT04084795|Eye Movement Desensitization and Reprocessing|eye movement desensitization and reprocessing
18093|NCT04084795|Transcranial Direct Current Stimulation|transcranial direct current stimulation
18094|NCT04084782|Fungal Nail Infection|fungal nail infection
18095|NCT04084782|Internet Mediated Research Study|internet mediated research study
18096|NCT04084743|Virtual reality|virtual reality
18097|NCT04084743|Targeted therapy|targeted therapy
18098|NCT04084743|Computer game|computer game
18099|NCT04084730|Unicentric pathological stage I breast invasive ductal breast cancer|unicentric pathological stage i breast invasive ductal breast cancer
18100|NCT04084730|Breast Cancer|breast cancer
18101|NCT04084730|Memorial Sloan Kettering Cancer Center|memorial sloan kettering cancer center
18102|NCT04084730|19-300|19-300
18103|NCT04084678|Prostacyclin|prostacyclin
18104|NCT04084678|Connective Tissue Disease-Associated|connective tissue disease-associated
18105|NCT04084678|Cardiopulmonary Exercise Capacity (CPET)|cardiopulmonary exercise capacity (cpet)
18106|NCT04084678|IP Receptor Agonist|ip receptor agonist
18107|NCT04084613|Severe Eosinophilic Asthma|severe eosinophilic asthma
18108|NCT04084613|Mepolizumab|mepolizumab
18109|NCT04084613|Anti-IL5 treatment|anti-il5 treatment
18110|NCT04084587|Rehabilitation|rehabilitation
18111|NCT04084587|Biofeedback|biofeedback
18112|NCT04084587|Retimax Vision Trainer|retimax vision trainer
18113|NCT04084587|Age-Related Macular Degeneration|age-related macular degeneration
18114|NCT04084587|Age-Related Maculopathy|age-related maculopathy
18115|NCT04084587|Maculopathies, Age-Related|maculopathies, age-related
18116|NCT04084587|Retinal Degeneration|retinal degeneration
18117|NCT04084587|Evoked Potentials, Visual|evoked potentials, visual
18118|NCT04084574|Racial disparities|racial disparities
18119|NCT04084574|Hypertension|hypertension
18120|NCT04084574|Diet|diet
18121|NCT04084574|Kidney disease|kidney disease
18122|NCT04084548|Multimodal analgesia|multimodal analgesia
18123|NCT04084548|Lidocaine|lidocaine
18124|NCT04084548|Ketamine|ketamine
18125|NCT04084548|Abdominal surgery|abdominal surgery
18126|NCT04084522|Alcoholic Hepatitis|alcoholic hepatitis
18127|NCT04084522|Gut Microbiota|gut microbiota
18128|NCT04084522|Dysbiosis|dysbiosis
18129|NCT04084522|Malnutrition|malnutrition
18130|NCT04084522|Saturated Fat|saturated fat
18132|NCT04084496|adjuvant chemotherapy|adjuvant chemotherapy
18133|NCT04084496|FOLFIRINOX|folfirinox
18134|NCT04084470|Non-Coeliac Gluten Sensitivity|non-coeliac gluten sensitivity
18135|NCT04084470|Non-Coeliac Wheat Sensitivity|non-coeliac wheat sensitivity
18136|NCT04084470|Gluten Sensitivity|gluten sensitivity
18137|NCT04084470|Bread|bread
18138|NCT04084470|Wheat|wheat
18139|NCT04084470|Gastrointestinal symptoms|gastrointestinal symptoms
18140|NCT04084470|Microbiota|microbiota
18141|NCT04084470|Immune response|immune response
18142|NCT04084470|Gluten|gluten
18143|NCT04084457|polyphenols|polyphenols
18144|NCT04084457|Blueberries|blueberries
18145|NCT04084457|cognition|cognition
18146|NCT04084457|vascular function|vascular function
18147|NCT04084457|vascular health|vascular health
18148|NCT04084457|cognitive function|cognitive function
18149|NCT04084457|anthocyanins|anthocyanins
18150|NCT04084457|flavonoids|flavonoids
18151|NCT04084444|Chronic abnormal immune activation|chronic abnormal immune activation
18152|NCT04084444|AIDS|aids
18153|NCT04084444|T8|t8
18154|NCT04084444|Efficacy|efficacy
18155|NCT04084444|Safety|safety
18156|NCT04084431|repeated whole brain radiation therapy|repeated whole brain radiation therapy
18157|NCT04084405|COPD|copd
18158|NCT04084405|IMT|imt
18159|NCT04084405|ABC|abc
18160|NCT04084405|BBS|bbs
18161|NCT04084405|TUG|tug
18162|NCT04084405|SLS|sls
18163|NCT04084379|congenital chagas disease|congenital chagas disease
18164|NCT04084379|congenital syphilis|congenital syphilis
18165|NCT04084379|Chagas PCR diagnose|chagas pcr diagnose
18166|NCT04084379|Syphilis PCR diagnose|syphilis pcr diagnose
18167|NCT04084379|Children|children
18169|NCT04084353|intra partum fetal monitoring|intra partum fetal monitoring
18170|NCT04084353|training|training
18171|NCT04084353|quality improvement|quality improvement
18172|NCT04084353|intermittent cardiotocography (CTG)|intermittent cardiotocography (ctg)
18173|NCT04084353|intermittent auscultation|intermittent auscultation
18174|NCT04084353|perinatal outcomes|perinatal outcomes
18175|NCT04084353|caesarean section rate|caesarean section rate
18176|NCT04084353|obstetric outcomes|obstetric outcomes
18177|NCT04084353|India|india
18178|NCT04084314|migraine|migraine
18179|NCT04084314|episodic migraine|episodic migraine
18180|NCT04084314|headache|headache
18181|NCT04084314|erenumab|erenumab
18182|NCT04084314|AMG334|amg334
18183|NCT04084314|aimovig|aimovig
18184|NCT04084314|monoclonal antibody|monoclonal antibody
18185|NCT04084314|CGRP-receptor antibody|cgrp-receptor antibody
18186|NCT04084301|renal oxygenation|renal oxygenation
18187|NCT04084301|renal blood flow|renal blood flow
18188|NCT04084301|cardiopulmonary bypass|cardiopulmonary bypass
18189|NCT04084301|tubular cell injury|tubular cell injury
18190|NCT04084301|N-acetyl-beta-D-glucosaminidase|n-acetyl-beta-d-glucosaminidase
18191|NCT04084301|nephrocheck|nephrocheck
18192|NCT04084301|inflammation|inflammation
18193|NCT04084301|hemolysis|hemolysis
18194|NCT04084288|Acupuncture, Total Knee Replacement|acupuncture, total knee replacement
18195|NCT04084275|nursing care|nursing care
18196|NCT04084275|Levine's conservation model|levine's conservation model
18197|NCT04084275|postpartum care|postpartum care
18198|NCT04084275|postpartum quality of life|postpartum quality of life
18199|NCT04084275|postpartum problems|postpartum problems
18200|NCT04084262|bunion|bunion
18201|NCT04084262|supinating reduction|supinating reduction
18202|NCT04084262|multi-plane|multi-plane
18203|NCT04084262|lapidus|lapidus
18204|NCT04084262|arthrodesis|arthrodesis
18205|NCT04084262|intramedullary nail|intramedullary nail
18206|NCT04084262|hallux valgus|hallux valgus
18207|NCT04084223|JAK Inhibitors|jak inhibitors
18208|NCT04084223|Ultrasound|ultrasound
18209|NCT04084223|Patients Reported Outcomes (PROs)|patients reported outcomes (pros)
18210|NCT04084223|Disease activity|disease activity
18211|NCT04084223|Predictors|predictors
18212|NCT04084223|Therapeutic response|therapeutic response
18213|NCT04084158|Esophageal Squamous Cell Carcinoma|esophageal squamous cell carcinoma
18214|NCT04084158|PD-1 antibody|pd-1 antibody
18215|NCT04084119|postpartum|postpartum
18216|NCT04084119|inter-rectus distance|inter-rectus distance
18217|NCT04084119|diastasis recti|diastasis recti
18218|NCT04084119|Lumbar disability|lumbar disability
18219|NCT04084119|urinary incontinence|urinary incontinence
18220|NCT04084119|pelvic floor|pelvic floor
18221|NCT04084119|quality of life|quality of life
18222|NCT04084106|randomized trial|randomized trial
18223|NCT04084106|antibiotic resistant genes|antibiotic resistant genes
18224|NCT04084106|gut microbiota|gut microbiota
18225|NCT04084106|healthy volunteers|healthy volunteers
18226|NCT04084106|metagenomics|metagenomics
18227|NCT04084067|Ewing Sarcoma|ewing sarcoma
18228|NCT04084067|Liver tumor|liver tumor
18229|NCT04084067|Lymphoma|lymphoma
18230|NCT04084067|Metastatic pulmonary deposits|metastatic pulmonary deposits
18231|NCT04084067|Neoplastic Disease|neoplastic disease
18232|NCT04084067|Neuroblastoma|neuroblastoma
18233|NCT04084067|Non-Rhabdomyosarcoma Soft Tissue Sarcoma|non-rhabdomyosarcoma soft tissue sarcoma
18234|NCT04084067|Nodules of unknown etiology|nodules of unknown etiology
18235|NCT04084067|Osteosarcoma|osteosarcoma
18236|NCT04084067|Solid Tumor|solid tumor
18237|NCT04084067|Rhabdomyosarcoma|rhabdomyosarcoma
18238|NCT04084067|Renal tumors|renal tumors
18239|NCT04084067|Rare tumors|rare tumors
18240|NCT04084041|Airway clearance technique|airway clearance technique
18241|NCT04084028|food agency|food agency
18242|NCT04084028|cooking|cooking
18243|NCT04084015|Extracorporeal membrane oxygenation|extracorporeal membrane oxygenation
18244|NCT04084015|Left ventricular unloading|left ventricular unloading
18245|NCT04084015|Impella®|impella®
18246|NCT04084002|stroke|stroke
18247|NCT04084002|physical activity|physical activity
18248|NCT04083989|Anorexia nervosa|anorexia nervosa
18249|NCT04083989|Eating disorder|eating disorder
18250|NCT04083989|Adolescents|adolescents
18251|NCT04083989|Inpatient treatment|inpatient treatment
18252|NCT04083989|Integrative medicine|integrative medicine
18253|NCT04083989|Anthroposophic medicine|anthroposophic medicine
18254|NCT04083989|Heart rate variability|heart rate variability
18255|NCT04083989|Thermography|thermography
18256|NCT04083950|Gastrointestinal Health|gastrointestinal health
18257|NCT04083950|Intestinal Permeability|intestinal permeability
18258|NCT04083950|Inflammation|inflammation
18259|NCT04083950|Vaccine Response|vaccine response
18260|NCT04083950|Ty21a Typhoid Vaccine|ty21a typhoid vaccine
18261|NCT04083950|Typhoid Fever|typhoid fever
18262|NCT04083924|Preclinical medical students|preclinical medical students
18263|NCT04083924|Handheld ultrasound|handheld ultrasound
18264|NCT04083924|Butterfly iQ|butterfly iq
18265|NCT04083924|Basic cardiac ultrasound|basic cardiac ultrasound
18266|NCT04083924|Focused cardiac ultrasound|focused cardiac ultrasound
18267|NCT04083924|Point of care|point of care
18268|NCT04083924|Training|training
18269|NCT04083924|Education|education
18270|NCT04083924|Flipped classroom|flipped classroom
18271|NCT04083911|Decitabine, HAAG, AML|decitabine, haag, aml
18272|NCT04083885|rehabilitation|rehabilitation
18273|NCT04083885|virtual reality|virtual reality
18274|NCT04083885|telerehabilitation|telerehabilitation
18275|NCT04083885|technology|technology
18276|NCT04083859|Mass screening|mass screening
18277|NCT04083859|Early detection of cancer|early detection of cancer
18278|NCT04083859|Digital health interventions|digital health interventions
18279|NCT04083859|Decision making, computer assisted|decision making, computer assisted
18280|NCT04083833|TQT TTX Halneuron cardiac safety|tqt ttx halneuron cardiac safety
18281|NCT04083807|haemostasis|haemostasis
18282|NCT04083807|tissue glue|tissue glue
18283|NCT04083807|tissue sealing|tissue sealing
18284|NCT04083807|Ilio-femoral bypass|ilio-femoral bypass
18285|NCT04083807|Femoro-femoral bypass|femoro-femoral bypass
18286|NCT04083807|Ilio-popliteal bypass|ilio-popliteal bypass
18287|NCT04083807|Femoro-popliteal bypass|femoro-popliteal bypass
18288|NCT04083807|Femoro-tibial vessel bypass|femoro-tibial vessel bypass
18289|NCT04083807|Arterio-arterial-bypass|arterio-arterial-bypass
18290|NCT04083807|Arteriovenous shunting for dialysis|arteriovenous shunting for dialysis
18291|NCT04083794|bone perfusion|bone perfusion
18292|NCT04083794|bone blood flow regulation|bone blood flow regulation
18293|NCT04083794|vascular sympathetic activity|vascular sympathetic activity
18294|NCT04083794|skeletal loading|skeletal loading
18295|NCT04083794|spinal cord injury|spinal cord injury
18296|NCT04083768|Position|position
18297|NCT04083755|anemia|anemia
18298|NCT04083755|iron|iron
18299|NCT04083755|surgery|surgery
18300|NCT04083755|PAD|pad
18301|NCT04083703|Interbody Cage|interbody cage
18302|NCT04083690|Cardiac Resynchronization Therapy|cardiac resynchronization therapy
18303|NCT04083690|Pacing|pacing
18304|NCT04083690|Echocardiography|echocardiography
18305|NCT04083690|Electrocardiography|electrocardiography
18306|NCT04083690|Optimization|optimization
18307|NCT04083690|Heart Failure|heart failure
18308|NCT04083612|Psoriasis|psoriasis
18309|NCT04083612|Therapeutic drug monitoring|therapeutic drug monitoring
18310|NCT04083612|Ixekizumab|ixekizumab
18311|NCT04083521|Bowel movement regulation|bowel movement regulation
18312|NCT04083521|Occasional constipation|occasional constipation
18313|NCT04083521|Occasional diarrhea|occasional diarrhea
18314|NCT04083521|Gastrointestinal health|gastrointestinal health
18315|NCT04083495|lymphoma|lymphoma
18316|NCT04083495|CD30|cd30
18317|NCT04083495|peripheral T cell lymphoma|peripheral t cell lymphoma
18318|NCT04083482|Mitochondrial DNA|mitochondrial dna
18319|NCT04083482|Sepsis|sepsis
18320|NCT04083482|Continous venovenous hemofiltation|continous venovenous hemofiltation
18321|NCT04083482|Intensive Care Unit|intensive care unit
18322|NCT04083456|Amputation|amputation
18323|NCT04083456|Dysvascular Amputation|dysvascular amputation
18324|NCT04083456|Diabetes|diabetes
18325|NCT04083456|Peripheral Artery Disease|peripheral artery disease
18326|NCT04083456|Physical Activity|physical activity
18327|NCT04083417|sore throat|sore throat
18328|NCT04083417|tonsillitis|tonsillitis
18329|NCT04083417|randomized controlled trial|randomized controlled trial
18330|NCT04083417|primary care|primary care
18331|NCT04083417|phenoxymethylpenicillin|phenoxymethylpenicillin
18332|NCT04083404|Complex mental health|complex mental health
18333|NCT04083404|employment|employment
18334|NCT04083404|Enhanced Individual Placement & Support|enhanced individual placement & support
18335|NCT04083404|Model of Human Occupation|model of human occupation
18336|NCT04083404|Worker Role Interview|worker role interview
18337|NCT04083391|chronic ankle instability|chronic ankle instability
18338|NCT04083391|Hamstring|hamstring
18339|NCT04083391|flexibility|flexibility
18340|NCT04083339|Type 2 Diabetes|type 2 diabetes
18341|NCT04083339|Aldose Reductase Inhibitor|aldose reductase inhibitor
18342|NCT04083339|Stage B Heart Failure|stage b heart failure
18343|NCT04083339|Stage C Heart Failure|stage c heart failure
18344|NCT04083339|Cardiopulmonary Exercise Test|cardiopulmonary exercise test
18345|NCT04083313|Laparoscopic appendectomy|laparoscopic appendectomy
18346|NCT04083313|Endoloop|endoloop
18347|NCT04083313|Endostapler|endostapler
18348|NCT04083313|Endoclip|endoclip
18349|NCT04083287|Shoulder surgery|shoulder surgery
18350|NCT04083287|Postoperative pain management|postoperative pain management
18351|NCT04083287|Erector spina plane block|erector spina plane block
18352|NCT04083274|Upper extremity surgery|upper extremity surgery
18353|NCT04083274|Postoperative pain management|postoperative pain management
18354|NCT04083274|Erector spina plane block|erector spina plane block
18355|NCT04083261|Medical cannabis|medical cannabis
18356|NCT04083261|Medical marijuana|medical marijuana
18357|NCT04083222|Hypertension|hypertension
18358|NCT04083222|Hypertensive|hypertensive
18360|NCT04083222|Angiotensinogen|angiotensinogen
18361|NCT04083222|Blood Pressure|blood pressure
18362|NCT04083144|smoking cessation|smoking cessation
18363|NCT04083144|varenicline|varenicline
18364|NCT04083144|deep rTMS|deep rtms
18365|NCT04083144|insula|insula
18366|NCT04083144|addiction|addiction
18367|NCT04083144|tobacco use disorder|tobacco use disorder
18368|NCT04083131|Sens of coherence|sens of coherence
18369|NCT04083131|Primary dysmenorrhea|primary dysmenorrhea
18370|NCT04083131|Salutogenesis|salutogenesis
18371|NCT04083131|Teenagers|teenagers
18372|NCT04083118|positron emission tomography|positron emission tomography
18373|NCT04083118|sodium fluoride|sodium fluoride
18374|NCT04083118|bicuspid aortic valve|bicuspid aortic valve
18375|NCT04083118|thoracic aortic aneurysm|thoracic aortic aneurysm
18376|NCT04083118|aortopathy|aortopathy
18377|NCT04083105|nitrous oxide|nitrous oxide
18378|NCT04083105|intranasal midazolam|intranasal midazolam
18379|NCT04083066|rituximab|rituximab
18380|NCT04083066|fotemustine|fotemustine
18381|NCT04083066|pemetrexed|pemetrexed
18382|NCT04083066|ORR|orr
18383|NCT04083066|OS|os
18384|NCT04083066|PFS|pfs
18385|NCT04083053|anoscopy|anoscopy
18386|NCT04083053|screening|screening
18387|NCT04083053|perianal examination|perianal examination
18388|NCT04083014|warm autoimmune hemolytic anemia|warm autoimmune hemolytic anemia
18389|NCT04083014|relapsed|relapsed
18390|NCT04083014|refractory|refractory
18391|NCT04083014|EVANS syndrome|evans syndrome
18392|NCT04083014|anti-CD20 monoclonal antibody|anti-cd20 monoclonal antibody
18393|NCT04083014|bortezomib|bortezomib
18394|NCT04083001|Stroke|stroke
18395|NCT04083001|FIM|fim
18396|NCT04083001|OTR3|otr3
18397|NCT04082988|PD-L1 expression|pd-l1 expression
18398|NCT04082988|eligible for treatment with nivolumab|eligible for treatment with nivolumab
18399|NCT04082962|Dexamethasone|dexamethasone
18400|NCT04082962|Uveal Melanoma|uveal melanoma
18401|NCT04082962|Steroid-Implant|steroid-implant
18402|NCT04082962|Exudative Retinal Detachment|exudative retinal detachment
18403|NCT04082949|Chronic Periodontitis|chronic periodontitis
18404|NCT04082949|Autologous fibrin tissue adhesive|autologous fibrin tissue adhesive
18405|NCT04082949|Blood Platelets|blood platelets
18406|NCT04082949|Non-surgical periodontal therapy|non-surgical periodontal therapy
18407|NCT04082936|Lymphoma|lymphoma
18408|NCT04082936|Non-Hodgkin Lymphoma|non-hodgkin lymphoma
18409|NCT04082936|DLBCL|dlbcl
18410|NCT04082936|Follicular Lymphoma|follicular lymphoma
18411|NCT04082936|relapsed or refractory|relapsed or refractory
18412|NCT04082910|Metoprolol|metoprolol
18413|NCT04082910|cytokine release syndrome|cytokine release syndrome
18414|NCT04082910|chimeric antigen receptor T cells|chimeric antigen receptor t cells
18415|NCT04082897|Richter Transformation|richter transformation
18416|NCT04082897|Safety|safety
18417|NCT04082897|Efficacy|efficacy
18418|NCT04082897|Obinutuzumab|obinutuzumab
18419|NCT04082897|Venetoclax|venetoclax
18420|NCT04082897|Atezolizumab|atezolizumab
18421|NCT04082884|very low carbohydrate diet|very low carbohydrate diet
18422|NCT04082871|Medication management review service|medication management review service
18423|NCT04082871|Pharmaceutical care|pharmaceutical care
18424|NCT04082871|Clinical pharmacist|clinical pharmacist
18425|NCT04082858|Ketamine|ketamine
18426|NCT04082858|Electroconvulsive Therapy|electroconvulsive therapy
18427|NCT04082793|Electrotherapy|electrotherapy
18428|NCT04082793|Photobiomodulation|photobiomodulation
18429|NCT04082793|Quality of life|quality of life
18430|NCT04082780|brain MRI|brain mri
18431|NCT04082780|cognitive testing|cognitive testing
18432|NCT04082780|microbiota|microbiota
18433|NCT04082780|metabolomics|metabolomics
18434|NCT04082780|pharmacokinetics|pharmacokinetics
18435|NCT04082767|sedation, delirium, pediatric, critical care|sedation, delirium, pediatric, critical care
18436|NCT04082728|ambulant surgery|ambulant surgery
18437|NCT04082728|post-operative medication|post-operative medication
18438|NCT04082728|recovery|recovery
18439|NCT04082715|Pain|pain
18440|NCT04082702|CBPR|cbpr
18441|NCT04082702|DPP|dpp
18442|NCT04082702|African-American|african-american
18443|NCT04082702|Women|women
18444|NCT04082702|Obesity|obesity
18445|NCT04082702|Pre-diabetes|pre-diabetes
18446|NCT04082689|Colic|colic
18447|NCT04082689|Constipation|constipation
18448|NCT04082689|Bladder dysfunction|bladder dysfunction
18449|NCT04082689|Toilet traning|toilet traning
18450|NCT04082637|Buprenorphine|buprenorphine
18451|NCT04082637|Medication-assisted treatment|medication-assisted treatment
18452|NCT04082637|Mind-body therapies|mind-body therapies
18453|NCT04082637|Mindfulness|mindfulness
18454|NCT04082637|Interoception|interoception
18455|NCT04082637|Mindful Awareness in Body-oriented Therapy|mindful awareness in body-oriented therapy
18456|NCT04082611|Alzheimer Disease|alzheimer disease
18457|NCT04082611|Mild Cognitive Impairment|mild cognitive impairment
18458|NCT04082611|Precision Medicine|precision medicine
18459|NCT04082611|Health Coaching|health coaching
18460|NCT04082611|Multi-Modal Intervention|multi-modal intervention
18461|NCT04082611|Personal, Dense, Dynamic Data (PD3) Clouds|personal, dense, dynamic data (pd3) clouds
18462|NCT04082611|Cognitive decline|cognitive decline
18463|NCT04082598|tooth extraction|tooth extraction
18464|NCT04082598|antibiotics|antibiotics
18465|NCT04082598|probiotics|probiotics
18466|NCT04082598|tooth infection|tooth infection
18467|NCT04082598|complications|complications
18468|NCT04082559|IBD|ibd
18469|NCT04082546|Coronary abnormalities|coronary abnormalities
18470|NCT04082546|Angina|angina
18471|NCT04082546|Global longitudinal strain|global longitudinal strain
18472|NCT04082546|Speckle-traking echocardiography|speckle-traking echocardiography
18473|NCT04082546|Myocardial ischemia|myocardial ischemia
18474|NCT04082533|total knee replacement|total knee replacement
18475|NCT04082533|hydrocortisone|hydrocortisone
18476|NCT04082494|wellbeing|wellbeing
18477|NCT04082494|Postoperative Pain|postoperative pain
18478|NCT04082494|postoperative disturbances after anaesthesia|postoperative disturbances after anaesthesia
18479|NCT04082481|Drug Therapy|drug therapy
18480|NCT04082468|Relapsing remitting Multiple Sclerosis|relapsing remitting multiple sclerosis
18481|NCT04082455|carbon ion radiotherapy|carbon ion radiotherapy
18482|NCT04082364|gastric cancer|gastric cancer
18483|NCT04082364|gastroesophageal junction cancer|gastroesophageal junction cancer
18484|NCT04082364|HER2-positive gastroesophageal cancer|her2-positive gastroesophageal cancer
18485|NCT04082364|anti-HER2 therapy|anti-her2 therapy
18486|NCT04082364|checkpoint inhibitors|checkpoint inhibitors
18488|NCT04082364|LAG-3|lag-3
18489|NCT04082351|Nanotechnology water|nanotechnology water
18490|NCT04082351|HbA1c|hba1c
18491|NCT04082351|Type 2 Diabetes mellitus|type 2 diabetes mellitus
18492|NCT04082312|Acute Kidney Injury|acute kidney injury
18493|NCT04082312|ECMO|ecmo
18494|NCT04082312|Post Cardiogenic Shock Syndrome|post cardiogenic shock syndrome
18495|NCT04082273|Induced corneal Astigmatism|induced corneal astigmatism
18496|NCT04082273|Clear corneal incisions|clear corneal incisions
18497|NCT04082273|Femto-laser|femto-laser
18498|NCT04082234|Behavior Therapy|behavior therapy
18499|NCT04082234|Integrated Primary Care|integrated primary care
18500|NCT04082234|Reducing Disparities|reducing disparities
18501|NCT04082208|ERCP|ercp
18502|NCT04082208|High Flow nasal cannula|high flow nasal cannula
18503|NCT04082208|deep sedation|deep sedation
18504|NCT04082182|dendritic cell|dendritic cell
18505|NCT04082182|vaccine|vaccine
18506|NCT04082182|immunotherapy|immunotherapy
18507|NCT04082156|TENS, DOMS, soreness, fatigue|tens, doms, soreness, fatigue
18508|NCT04082130|Xenogenic collagen matrix (XCM).|xenogenic collagen matrix (xcm).
18509|NCT04082130|subepithelial connective tissue graft (SCGT).|subepithelial connective tissue graft (scgt).
18510|NCT04082130|coronally advanced flap (CAF).|coronally advanced flap (caf).
18511|NCT04082130|Root coverage.|root coverage.
18512|NCT04082091|mHealth|mhealth
18513|NCT04082091|mixed method|mixed method
18514|NCT04082091|feasibility study|feasibility study
18515|NCT04082091|Malir district|malir district
18516|NCT04082065|Conventional physical therapy(CPT)|conventional physical therapy(cpt)
18517|NCT04082065|.Low back pain (LBP),|.low back pain (lbp),
18518|NCT04082065|Oswestery disability index (ODI),|oswestery disability index (odi),
18519|NCT04082065|Quality of life (QOL),|quality of life (qol),
18520|NCT04082065|Range of motion (ROM)|range of motion (rom)
18521|NCT04082065|Visual analogue scale (VAS)|visual analogue scale (vas)
18522|NCT04082052|depression|depression
18523|NCT04082052|self-dislike|self-dislike
18528|NCT04081987|Non-invasive monitoring|non-invasive monitoring
18530|NCT04081987|Blood pressure|blood pressure
18531|NCT04081974|Minimally invasive cardiac surgery|minimally invasive cardiac surgery
18532|NCT04081974|Distal leg perfusion|distal leg perfusion
18533|NCT04081974|Ischemia|ischemia
18534|NCT04081948|Arthroscopic shoulder surgery|arthroscopic shoulder surgery
18535|NCT04081948|Postoperative pain management|postoperative pain management
18536|NCT04081948|Erector spina plane block|erector spina plane block
18537|NCT04081935|school-age children, emergency treatment, intravenous placement, virtual reality, pain, fear|school-age children, emergency treatment, intravenous placement, virtual reality, pain, fear
18538|NCT04081909|Opioid|opioid
18539|NCT04081909|Ketamine|ketamine
18540|NCT04081909|Dexmedetomidine|dexmedetomidine
18541|NCT04081909|Sevoflurane|sevoflurane
18542|NCT04081909|Perioperative complications|perioperative complications
18543|NCT04081883|Continuous Glucose Monitoring|continuous glucose monitoring
18544|NCT04081883|Biosensor|biosensor
18545|NCT04081870|doppler,endometrial,implantation|doppler,endometrial,implantation
18546|NCT04081831|Esophageal cancer|esophageal cancer
18547|NCT04081831|Gastric cancer|gastric cancer
18548|NCT04081831|Colorectal cancer|colorectal cancer
18549|NCT04081805|LASER|laser
18550|NCT04081805|Radiofrequency|radiofrequency
18551|NCT04081805|Vulvovaginal atrophy|vulvovaginal atrophy
18552|NCT04081805|breast cancer|breast cancer
18553|NCT04081805|treatment|treatment
18554|NCT04081792|diabetic foot; osteomyelitis; amputation; antibiotics|diabetic foot; osteomyelitis; amputation; antibiotics
18555|NCT04081779|Cancer survivors|cancer survivors
18556|NCT04081779|survivorship care plans|survivorship care plans
18557|NCT04081779|primary care|primary care
18558|NCT04081766|Diabetes Mellitus, Type 2|diabetes mellitus, type 2
18559|NCT04081766|Diabetes Mellitus|diabetes mellitus
18560|NCT04081766|Hypoglycemia|hypoglycemia
18561|NCT04081766|Counseling|counseling
18562|NCT04081766|Older Adults|older adults
18563|NCT04081753|HiDAC|hidac
18564|NCT04081753|Neutropenia|neutropenia
18565|NCT04081753|Fever|fever
18566|NCT04081753|AML|aml
18567|NCT04081753|Leukemia|leukemia
18568|NCT04081675|orthotics|orthotics
18569|NCT04081675|gait analysis|gait analysis
18570|NCT04081662|Acceptance and commitment therapy|acceptance and commitment therapy
18571|NCT04081662|Micro-intervention|micro-intervention
18572|NCT04081662|Mobile intervention|mobile intervention
18573|NCT04081610|Dry eye|dry eye
18574|NCT04081610|eye lubricant|eye lubricant
18575|NCT04081610|sodium hyaluronate|sodium hyaluronate
18576|NCT04081571|NAFLD|nafld
18577|NCT04081571|Insulin Resistance|insulin resistance
18578|NCT04081571|Hepatic Steatosis|hepatic steatosis
18579|NCT04081571|EGYPTIAN|egyptian
18580|NCT04081545|Opioid Free Anesthesia|opioid free anesthesia
18581|NCT04081545|Bariatric Surgery|bariatric surgery
18582|NCT04081545|Non-Opioid Anesthesia|non-opioid anesthesia
18583|NCT04081545|Ketamine|ketamine
18584|NCT04081545|Dexmedetomidine|dexmedetomidine
18585|NCT04081545|Lidocaine|lidocaine
18586|NCT04081532|endometriosis|endometriosis
18587|NCT04081532|laparoscopy|laparoscopy
18588|NCT04081532|pelvic pain|pelvic pain
18589|NCT04081519|Repetitive Transcranial Magnetic Stimulation|repetitive transcranial magnetic stimulation
18590|NCT04081519|Theta Burst Stimulation|theta burst stimulation
18591|NCT04081519|rTMS|rtms
18592|NCT04081519|TBS|tbs
18593|NCT04081519|resting-state fMRI|resting-state fmri
18594|NCT04081519|functional connectivity|functional connectivity
18595|NCT04081493|Low-load blood flow restricted exercise|low-load blood flow restricted exercise
18596|NCT04081493|Preconditioning|preconditioning
18597|NCT04081493|Functional capacity|functional capacity
18598|NCT04081441|gender-based violence|gender-based violence
18599|NCT04081441|intimate-partner violence|intimate-partner violence
18600|NCT04081441|empowerment|empowerment
18601|NCT04081441|food insecurity|food insecurity
18602|NCT04081441|humanitarian settings|humanitarian settings
18603|NCT04081441|depression|depression
18604|NCT04081441|fuel use|fuel use
18605|NCT04081441|clean cookstoves|clean cookstoves
18606|NCT04081428|Prostate cancer|prostate cancer
18607|NCT04081428|Cell free DNA|cell free dna
18608|NCT04081428|Volatile organic compounds|volatile organic compounds
18609|NCT04081428|Stereotactic Body Radiotherapy|stereotactic body radiotherapy
18610|NCT04081428|Radiotherapy side effects|radiotherapy side effects
18611|NCT04081428|Imaging biomarkers|imaging biomarkers
18618|NCT04081376|Hydromorphone|hydromorphone
18619|NCT04081376|Opiates|opiates
26885|NCT04032132|CBCT|cbct
18620|NCT04081376|Anti-doping control|anti-doping control
18621|NCT04081363|ADHD|adhd
18622|NCT04081311|dental implants|dental implants
18623|NCT04081311|water flosser|water flosser
18624|NCT04081272|transfusion|transfusion
18625|NCT04081272|post-transfusion recovery|post-transfusion recovery
18626|NCT04081259|Acute Myeloid Leukemia|acute myeloid leukemia
18627|NCT04081259|AML|aml
18628|NCT04081259|ERK|erk
18629|NCT04081259|Relapsed|relapsed
18630|NCT04081259|Refractory|refractory
18631|NCT04081259|LY3214996|ly3214996
18632|NCT04081246|Bladder cancer, bladder tumour, en bloc resection|bladder cancer, bladder tumour, en bloc resection
18633|NCT04081207|augmentative and alternative communication|augmentative and alternative communication
18634|NCT04081207|aphasia|aphasia
18635|NCT04081207|fMRI|fmri
18636|NCT04081207|DTI|dti
18637|NCT04081207|neuroimaging|neuroimaging
18638|NCT04081155|EIT|eit
18639|NCT04081155|pulmonary perfusion|pulmonary perfusion
18640|NCT04081155|ventilation|ventilation
18641|NCT04081142|EIT, pulmonary perfusion|eit, pulmonary perfusion
18642|NCT04081129|EIT|eit
18643|NCT04081129|early mobilization|early mobilization
18644|NCT04081077|Pharmacokinetics|pharmacokinetics
18645|NCT04081077|Pharmcogenomics|pharmcogenomics
18646|NCT04081077|Pharmacodynamics|pharmacodynamics
18647|NCT04081077|Bedaquiline|bedaquiline
18648|NCT04081077|Pretomanid|pretomanid
18649|NCT04081077|Linezolid|linezolid
18650|NCT04081077|Clofazimine|clofazimine
18651|NCT04081077|Moxifloxacin|moxifloxacin
18652|NCT04081064|Obese|obese
18653|NCT04081064|Non-obese|non-obese
18654|NCT04081064|Qatar|qatar
18655|NCT04081038|oral cancer screening|oral cancer screening
18656|NCT04080999|r-TMS|r-tms
18657|NCT04080999|Hemispatial Neglect|hemispatial neglect
18658|NCT04080999|Visual Scanning|visual scanning
18659|NCT04080986|Resuscitation|resuscitation
18660|NCT04080986|Arrhythmia, Cardiac|arrhythmia, cardiac
18661|NCT04080986|Heart Diseases|heart diseases
18662|NCT04080986|Heart Arrest|heart arrest
18663|NCT04080973|urolithiasis|urolithiasis
18664|NCT04080973|metabolic abnormalities|metabolic abnormalities
18665|NCT04080973|osteopenia|osteopenia
18666|NCT04080973|hypercalcemia|hypercalcemia
18667|NCT04080973|hypercalcuria|hypercalcuria
18668|NCT04080973|bone density|bone density
18669|NCT04080921|encephalitis|encephalitis
18670|NCT04080921|meningitis|meningitis
18671|NCT04080921|neurological sequelae due|neurological sequelae due
18672|NCT04080895|Artemether-lumefantrine|artemether-lumefantrine
18673|NCT04080895|Amodiaquine|amodiaquine
18674|NCT04080869|acne vulgaris|acne vulgaris
18675|NCT04080869|retinoids|retinoids
18676|NCT04080869|retinyl palmitate|retinyl palmitate
18677|NCT04080869|ethosomes|ethosomes
18678|NCT04080856|Endometriosis|endometriosis
18679|NCT04080856|Elagolix|elagolix
18680|NCT04080856|Real-World|real-world
18681|NCT04080856|Effectiveness|effectiveness
18682|NCT04080830|Registration Study|registration study
18683|NCT04080830|Acute Ischemic Stroke|acute ischemic stroke
18684|NCT04080830|Atrial Fibrillation|atrial fibrillation
18685|NCT04080817|Stroke|stroke
18686|NCT04080817|Aphasia|aphasia
18687|NCT04080817|Speech therapy|speech therapy
18688|NCT04080817|Computer based|computer based
18689|NCT04080804|anti-PD1 antibody|anti-pd1 antibody
18690|NCT04080804|anti-CTLA4 antibody|anti-ctla4 antibody
18691|NCT04080804|anti-LAG3 antibody|anti-lag3 antibody
18692|NCT04080804|tumor infiltrating lymphocyte (TIL)|tumor infiltrating lymphocyte (til)
18693|NCT04080791|Virtual Reality|virtual reality
18694|NCT04080791|Stroke|stroke
18695|NCT04080791|National Stroke Association|national stroke association
18696|NCT04080791|Stroke Rehabilitation|stroke rehabilitation
18697|NCT04080765|decision analysis|decision analysis
18698|NCT04080765|HIV|hiv
18699|NCT04080765|education|education
18700|NCT04080713|Budesonide|budesonide
18701|NCT04080713|Healthy|healthy
18702|NCT04080713|Pharmacokinetic|pharmacokinetic
18703|NCT04080687|ankle-foot orthoses|ankle-foot orthoses
18704|NCT04080687|lower limbs|lower limbs
18705|NCT04080687|rehabilitation outpatients|rehabilitation outpatients
18706|NCT04080687|balance confidence|balance confidence
18707|NCT04080687|falls|falls
18708|NCT04080661|Therapeutic drug monitoring|therapeutic drug monitoring
18709|NCT04080661|Psoriasis|psoriasis
18710|NCT04080661|Secukinumab|secukinumab
18711|NCT04080648|Therapeutic drug monitoring|therapeutic drug monitoring
18712|NCT04080648|Psoriasis|psoriasis
18713|NCT04080648|Guselkumab|guselkumab
18714|NCT04080635|Psoriasis|psoriasis
18715|NCT04080635|Therapeutic drug monitoring|therapeutic drug monitoring
18716|NCT04080635|Brodalumab|brodalumab
18717|NCT04080583|Physical activity|physical activity
18718|NCT04080583|Health Status|health status
18719|NCT04080570|home hospital|home hospital
18720|NCT04080570|hospital at home|hospital at home
18721|NCT04080570|hospital in the home|hospital in the home
18722|NCT04080557|delirium|delirium
805318|NCT00232934|Thalidomide|thalidomide
18723|NCT04080557|intensive care unit|intensive care unit
18724|NCT04080557|surgical ward|surgical ward
18725|NCT04080557|abdominal aortic aneurysm surgery|abdominal aortic aneurysm surgery
18726|NCT04080544|Positron Emission Tomography|positron emission tomography
18727|NCT04080479|bolus enteral feeding|bolus enteral feeding
18728|NCT04080479|continuous enteral feeding|continuous enteral feeding
18729|NCT04080479|protein synthesis|protein synthesis
18730|NCT04080479|nutritional parameters|nutritional parameters
18732|NCT04080466|Cam deformity|cam deformity
18733|NCT04080453|Blood platelets|blood platelets
18734|NCT04080453|CD40 ligand|cd40 ligand
18735|NCT04080453|Multiple Organ Failure|multiple organ failure
18736|NCT04080440|Coma|coma
18737|NCT04080440|Intensive care units|intensive care units
18738|NCT04080440|Critical care|critical care
18739|NCT04080440|Stroke|stroke
18740|NCT04080440|Traumatic brain injury|traumatic brain injury
18741|NCT04080440|Anoxic ischemic encephalopathy|anoxic ischemic encephalopathy
18742|NCT04080440|Glasgow coma scale|glasgow coma scale
18743|NCT04080401|Rehabilitation|rehabilitation
18744|NCT04080401|Gaming|gaming
18745|NCT04080401|Exercise|exercise
18746|NCT04080401|Knee Arthroplasty|knee arthroplasty
18747|NCT04080362|Mitral Regurgitation|mitral regurgitation
18748|NCT04080362|Mitral Valve Repair|mitral valve repair
18749|NCT04080362|Transapical|transapical
18750|NCT04080284|Niraparib|niraparib
18751|NCT04080284|uterine Cancer|uterine cancer
18752|NCT04080284|papillary serous uterine cancer|papillary serous uterine cancer
18753|NCT04080284|endometrial cancer|endometrial cancer
18754|NCT04080284|serous uterine cancer|serous uterine cancer
18755|NCT04080284|Endometrial|endometrial
18756|NCT04080284|Endometrial Carcinoma|endometrial carcinoma
18757|NCT04080284|Recurrent Uterine Carcinoma|recurrent uterine carcinoma
18758|NCT04080284|platinum-sensitive|platinum-sensitive
18759|NCT04080258|Headache Disorders|headache disorders
18760|NCT04080258|Primary Headache|primary headache
18761|NCT04080245|Vaccine|vaccine
18762|NCT04080245|Influenza|influenza
18763|NCT04080245|Efficacy|efficacy
18764|NCT04080232|lung MRI performance|lung mri performance
18765|NCT04080232|UTE|ute
18766|NCT04080232|quantification|quantification
18767|NCT04080232|oxygen transfer|oxygen transfer
18768|NCT04080232|Bronchiolitis Obliterans syndrome|bronchiolitis obliterans syndrome
18769|NCT04080232|allogeneic stem cell transplantation|allogeneic stem cell transplantation
18770|NCT04080219|valvular heart surgery|valvular heart surgery
18771|NCT04080219|cardiopulmonary bypass|cardiopulmonary bypass
18772|NCT04080193|Gender|gender
18773|NCT04080193|Overweight|overweight
18774|NCT04080193|Obesity|obesity
18775|NCT04080193|Intervention|intervention
18776|NCT04080193|Smartphone-App|smartphone-app
18777|NCT04080180|opioid use disorder|opioid use disorder
18778|NCT04080180|buprenorphine|buprenorphine
18779|NCT04080180|treatment adherence|treatment adherence
18780|NCT04080167|implementation science|implementation science
18781|NCT04080167|sickle cell anemia|sickle cell anemia
18782|NCT04080167|digital medicine|digital medicine
18783|NCT04080167|adherence|adherence
18784|NCT04080167|hydroxycarbamide|hydroxycarbamide
18785|NCT04080167|health innovation|health innovation
18786|NCT04080141|Therapeutic Abortion|therapeutic abortion
18787|NCT04080141|Personality Disorders|personality disorders
18788|NCT04080141|Childhood Trauma|childhood trauma
18789|NCT04080141|Post Traumatic Stress Disorder|post traumatic stress disorder
18790|NCT04080141|Depression|depression
18791|NCT04080050|LDL Receptors|ldl receptors
18792|NCT04080050|Gene Therapy|gene therapy
18793|NCT04080050|Metabolic Diseases|metabolic diseases
18794|NCT04080050|Rare Diseases|rare diseases
18795|NCT04080050|Genetic Diseases|genetic diseases
18796|NCT04080050|Atherosclerosis|atherosclerosis
18797|NCT04080050|Cardiovascular Disease|cardiovascular disease
18798|NCT04079985|Animal-assisted therapy|animal-assisted therapy
18799|NCT04079985|Chronic Pain|chronic pain
18800|NCT04079985|Elderly|elderly
18801|NCT04079985|Primary Health Care|primary health care
18802|NCT04079946|cancer colon|cancer colon
18803|NCT04079894|Accelerometry|accelerometry
18804|NCT04079894|Walking|walking
18805|NCT04079881|glucagon|glucagon
18806|NCT04079881|post-prandial glucose|post-prandial glucose
18807|NCT04079881|type 1 diabetes|type 1 diabetes
18808|NCT04079868|Osteoporosis|osteoporosis
18809|NCT04079868|Osteopenia|osteopenia
18810|NCT04079868|Osteoporotic fracture|osteoporotic fracture
18811|NCT04079868|Age-Related Osteoporosis|age-related osteoporosis
18812|NCT04079868|Bone Loss, Age-Related|bone loss, age-related
18813|NCT04079790|GSK2140944|gsk2140944
18814|NCT04079790|Gepotidacin|gepotidacin
18815|NCT04079790|Pharmacokinetics|pharmacokinetics
18816|NCT04079790|Healthy Adult|healthy adult
18817|NCT04079790|Healthy adolescent|healthy adolescent
18818|NCT04079777|Mitochondrial DNA ;mtDNA;|mitochondrial dna ;mtdna;
18819|NCT04079777|Acute pancreatitis;SAP;severe acute pancreatitis;|acute pancreatitis;sap;severe acute pancreatitis;
18820|NCT04079777|Acute pancreatic necrosis;|acute pancreatic necrosis;
18821|NCT04079777|Inflammatory necrosis;|inflammatory necrosis;
18822|NCT04079764|bosniak classification|bosniak classification
18823|NCT04079764|Bosniak III cyst|bosniak iii cyst
18824|NCT04079764|Bosniak IV cyst|bosniak iv cyst
18825|NCT04079764|complex renal mass|complex renal mass
18826|NCT04079673|epidural anesthesia|epidural anesthesia
18827|NCT04079673|microbiota|microbiota
18828|NCT04079660|hemoglobinA1c|hemoglobina1c
18829|NCT04079660|serum fructosamine|serum fructosamine
18830|NCT04079660|glycemic control|glycemic control
18831|NCT04079608|Pregnancy|pregnancy
18832|NCT04079608|Adolescents|adolescents
18833|NCT04079608|STD|std
18834|NCT04079608|Decision making|decision making
18835|NCT04079608|Harm reduction|harm reduction
18836|NCT04079608|Prevention education|prevention education
18837|NCT04079582|Dialysate Magnesium|dialysate magnesium
18838|NCT04079582|Kidney Disease|kidney disease
18839|NCT04079582|Renal Insufficiency, Chronic|renal insufficiency, chronic
18840|NCT04079582|Kidney Failure, Chronic|kidney failure, chronic
18841|NCT04079582|Cluster Randomized Controlled Trial|cluster randomized controlled trial
18842|NCT04079569|tobacco|tobacco
18843|NCT04079569|smoking cessation|smoking cessation
18844|NCT04079569|Asian Americans|asian americans
18845|NCT04079543|Nil per os (NPO)|nil per os (npo)
18846|NCT04079543|TAVR|tavr
18847|NCT04079543|arrhythmia ablation|arrhythmia ablation
18848|NCT04079517|Tamoxifen|tamoxifen
18849|NCT04079517|Low-dose|low-dose
18850|NCT04079517|Randomized Clinical Trial|randomized clinical trial
18851|NCT04079504|Indirect inguinal hernia|indirect inguinal hernia
18852|NCT04079504|Ligation of sac|ligation of sac
18853|NCT04079504|Postoperative pain|postoperative pain
18854|NCT04079491|oral mucosal lesions|oral mucosal lesions
18855|NCT04079491|dental hygienist|dental hygienist
18856|NCT04079478|Artificial Intelligence|artificial intelligence
18857|NCT04079465|closed-loop|closed-loop
18858|NCT04079465|oxygen treatment|oxygen treatment
18859|NCT04079452|Doravirine|doravirine
18860|NCT04079426|inflammasome|inflammasome
18861|NCT04079426|Caspase|caspase
18862|NCT04079426|NLRP3|nlrp3
18863|NCT04079426|Antibiotics|antibiotics
18864|NCT04079426|Tetracycline|tetracycline
18865|NCT04079413|Insulin|insulin
18866|NCT04079413|Insulin aspart|insulin aspart
18867|NCT04079413|Aspart|aspart
18868|NCT04079374|Etanercept|etanercept
18869|NCT04079374|Enbrel|enbrel
18870|NCT04079348|Donor Site Wound|donor site wound
18871|NCT04079309|Perioperative Anxiety|perioperative anxiety
18872|NCT04079309|Lavender Oil|lavender oil
18873|NCT04079309|Orange Oil|orange oil
18874|NCT04079309|Pediatric Dentistry|pediatric dentistry
18875|NCT04079309|Deep Sedation|deep sedation
18876|NCT04079296|ASP7517|asp7517
18877|NCT04079296|Safety|safety
18878|NCT04079296|Efficacy|efficacy
18879|NCT04079296|Tolerability|tolerability
18880|NCT04079283|Response Evaluation Criteria in Solid Tumors|response evaluation criteria in solid tumors
18881|NCT04079283|Computed Tomography|computed tomography
18882|NCT04079283|Radiomics|radiomics
18883|NCT04079283|Immunotherapy|immunotherapy
18884|NCT04079270|Weight gain|weight gain
18885|NCT04079270|Endocrine treatment|endocrine treatment
18886|NCT04079244|Preoperative anxiety|preoperative anxiety
18887|NCT04079244|Distractions|distractions
18888|NCT04079244|Flow|flow
18889|NCT04079244|Child|child
18890|NCT04079231|Diabetic Macula Edema|diabetic macula edema
18891|NCT04079231|Intravitreal injection|intravitreal injection
18892|NCT04079231|brolucizumab|brolucizumab
18893|NCT04079231|aflibercept|aflibercept
18894|NCT04079231|double-masked|double-masked
18895|NCT04079218|HIV Infection|hiv infection
18896|NCT04079218|Vaginal Atrophy|vaginal atrophy
18897|NCT04079218|Menopause|menopause
18898|NCT04079218|Vaginal Microbiome|vaginal microbiome
18899|NCT04079218|Microbiome|microbiome
18900|NCT04079218|Dysbiosis|dysbiosis
18901|NCT04079218|Aging|aging
18902|NCT04079218|Premature Aging|premature aging
18903|NCT04079218|Atrophic Vaginitis|atrophic vaginitis
18904|NCT04079205|Anterior Cruciate Ligament Reconstruction|anterior cruciate ligament reconstruction
18905|NCT04079205|Wearable device|wearable device
18906|NCT04079205|Knee|knee
18907|NCT04079205|Neuromuscular Electrical Stimulation|neuromuscular electrical stimulation
18908|NCT04079205|Exercise|exercise
18909|NCT04079192|Drug-Coated Balloon|drug-coated balloon
18910|NCT04079179|Cobimetinib|cobimetinib
18911|NCT04079179|Langerhans Cell Histiocytosis (LCH)|langerhans cell histiocytosis (lch)
18912|NCT04079153|mandibular advancement appliance, protrusion|mandibular advancement appliance, protrusion
18913|NCT04079075|Correction of Hearing Impairment|correction of hearing impairment
18914|NCT04079075|Cognitive Dysfunction|cognitive dysfunction
18915|NCT04079075|Diet, Healthy|diet, healthy
18916|NCT04079075|Exercise Therapy|exercise therapy
18917|NCT04079075|Cognition Disorders|cognition disorders
18918|NCT04079075|Neuropsychological Tests|neuropsychological tests
18919|NCT04079075|Hearing Loss|hearing loss
18920|NCT04079075|Memory Disorders|memory disorders
18921|NCT04079075|Cognitive Remediation|cognitive remediation
18922|NCT04079075|Non-Randomized Controlled Trials as Topic|non-randomized controlled trials as topic
18923|NCT04079036|General Anesthesia|general anesthesia
18924|NCT04079036|Anesthesia Awareness|anesthesia awareness
18925|NCT04079036|Anesthesia overdose|anesthesia overdose
18926|NCT04079010|blood flow restriction|blood flow restriction
18927|NCT04079010|growth hormone|growth hormone
18928|NCT04079010|strength outcomes|strength outcomes
18929|NCT04079010|arginine|arginine
18930|NCT04078997|Pneumococcal carriage|pneumococcal carriage
18931|NCT04078997|Pneumococcal conjugate vaccine|pneumococcal conjugate vaccine
18932|NCT04078997|Vaccine schedule|vaccine schedule
18933|NCT04078997|Evaluation|evaluation
18934|NCT04078997|Children|children
18935|NCT04078997|Herd immunity|herd immunity
18936|NCT04078997|Malawi|malawi
18937|NCT04078984|Pressure Support Ventilation|pressure support ventilation
18938|NCT04078984|Mechanical Ventilation Weaning Time|mechanical ventilation weaning time
18939|NCT04078984|Driving Pressure|driving pressure
18940|NCT04078984|Respiratory Weaning|respiratory weaning
18941|NCT04078984|Acute Respiratory Distress Syndrome|acute respiratory distress syndrome
18942|NCT04078984|Ventilation Induced Lung Injury|ventilation induced lung injury
18943|NCT04078971|ketogenic diet|ketogenic diet
18944|NCT04078971|western diet|western diet
18945|NCT04078971|soccer|soccer
18946|NCT04078971|sport performance|sport performance
18947|NCT04078971|muscle mass|muscle mass
18948|NCT04078971|body composition|body composition
18949|NCT04078945|strength|strength
18950|NCT04078945|risk factors|risk factors
18951|NCT04078945|youth volleyball players|youth volleyball players
18952|NCT04078906|Intravenous lipid emulsions|intravenous lipid emulsions
18953|NCT04078906|SMOF|smof
18954|NCT04078906|Preterm Infants|preterm infants
18955|NCT04078893|inactivated donors recruitment, on need ,communication|inactivated donors recruitment, on need ,communication
18956|NCT04078867|Tricuspid valve|tricuspid valve
18957|NCT04078867|Functional tricuspid regurgitation|functional tricuspid regurgitation
18958|NCT04078867|Suture annuloplasty|suture annuloplasty
18959|NCT04078867|Ring annuloplasty|ring annuloplasty
18960|NCT04078854|Diabetic Foot|diabetic foot
18961|NCT04078854|Sexual Dysfunction|sexual dysfunction
18962|NCT04078854|Amputation|amputation
18963|NCT04078828|minimally invasive surgical|minimally invasive surgical
18964|NCT04078815|Advance Directive|advance directive
18965|NCT04078815|Advance Care Planning|advance care planning
18966|NCT04078815|Decision Making|decision making
18967|NCT04078815|Autonomy|autonomy
18968|NCT04078815|Justice|justice
18969|NCT04078815|Emergency Care|emergency care
18970|NCT04078815|Beneficence|beneficence
18971|NCT04078815|Nonmaleficence|nonmaleficence
18972|NCT04078815|Dignity|dignity
18973|NCT04078815|Honesty|honesty
18974|NCT04078789|sex offenses|sex offenses
18975|NCT04078789|sexually transmitted diseases|sexually transmitted diseases
18976|NCT04078789|traumatic injury|traumatic injury
18977|NCT04078763|Spatial hearing perception|spatial hearing perception
18978|NCT04078763|cochlear prosthesis implantation users|cochlear prosthesis implantation users
18979|NCT04078763|virtual reality|virtual reality
18980|NCT04078763|rehabilitation|rehabilitation
18981|NCT04078737|stroke|stroke
18982|NCT04078737|transient ischemic attack|transient ischemic attack
18983|NCT04078737|acute treatment|acute treatment
18984|NCT04078737|acute non-disabling cerebrovascular event|acute non-disabling cerebrovascular event
18985|NCT04078737|clopidogrel|clopidogrel
18986|NCT04078737|ticagrelor|ticagrelor
18987|NCT04078737|clopidogrel combined with ASA|clopidogrel combined with asa
18988|NCT04078737|ticagrelor combined with ASA|ticagrelor combined with asa
18989|NCT04078737|recurrence of stroke and other vascular events|recurrence of stroke and other vascular events
18990|NCT04078737|CYP2C19 loss-of-function allele(s) carrier|cyp2c19 loss-of-function allele(s) carrier
18991|NCT04078724|Nutritional supplementation|nutritional supplementation
18992|NCT04078724|Sleep quality|sleep quality
18993|NCT04078724|Cognitive function|cognitive function
18994|NCT04078724|Gut microbiome|gut microbiome
18995|NCT04078711|hypertension|hypertension
18996|NCT04078711|chronic kidney disease|chronic kidney disease
18997|NCT04078711|traditional chinese medicine|traditional chinese medicine
18998|NCT04078711|early renal injury|early renal injury
18999|NCT04078711|albumin to creatinine ratio(UACR)|albumin to creatinine ratio(uacr)
19000|NCT04078698|Therapeutic apheresis|therapeutic apheresis
19001|NCT04078698|Immune apheresis|immune apheresis
19002|NCT04078646|Carotenoids|carotenoids
19003|NCT04078646|Postprandial absorption|postprandial absorption
19004|NCT04078646|Area-under-curve|area-under-curve
19005|NCT04078646|Bioavailability|bioavailability
19006|NCT04078646|Proteins|proteins
19007|NCT04078646|Tomato juice|tomato juice
19008|NCT04078646|Carrot juice|carrot juice
19009|NCT04078646|Randomized cross-over|randomized cross-over
19010|NCT04078607|Distraction|distraction
19011|NCT04078607|Eating behavior|eating behavior
19012|NCT04078607|Fullness|fullness
19013|NCT04078607|Hunger|hunger
19014|NCT04078607|Ingestive behavior|ingestive behavior
19015|NCT04078607|Rapid visual information processing|rapid visual information processing
19016|NCT04078594|sepsis|sepsis
19017|NCT04078594|ward patients|ward patients
19018|NCT04078594|Screening|screening
19019|NCT04078594|qSOFA|qsofa
19020|NCT04078581|Selection of healthy donors|selection of healthy donors
19021|NCT04078581|Healthy volunteers|healthy volunteers
19022|NCT04078581|Stool donors|stool donors
19124|NCT04078087|Follicular phase|follicular phase
19023|NCT04078581|Fecal microbiota transplantation|fecal microbiota transplantation
19024|NCT04078568|Kawasaki disease|kawasaki disease
19025|NCT04078568|prednisolone|prednisolone
19026|NCT04078568|coronary artery lesion|coronary artery lesion
19027|NCT04078516|diabetes|diabetes
19028|NCT04078516|neuropathy|neuropathy
19029|NCT04078516|early detection|early detection
19030|NCT04078516|small nerve fibers|small nerve fibers
19031|NCT04078503|neuroinflammation|neuroinflammation
19032|NCT04078503|fMRI|fmri
19033|NCT04078503|Functional MRI|functional mri
19034|NCT04078503|ICU related delirium|icu related delirium
19035|NCT04078477|Presure Ulcer|presure ulcer
19036|NCT04078477|Neurocritical Care|neurocritical care
19037|NCT04078477|Acute Brain Disease|acute brain disease
19038|NCT04078477|Unconsciousness|unconsciousness
19039|NCT04078477|Preventive Strategy|preventive strategy
19040|NCT04078464|Mindfulness|mindfulness
19041|NCT04078464|Physical Activity|physical activity
19042|NCT04078451|cholecystectomy|cholecystectomy
19043|NCT04078451|Laparoscopic|laparoscopic
19044|NCT04078438|Treatment-resistant depression|treatment-resistant depression
19045|NCT04078438|Neurofeedback|neurofeedback
19046|NCT04078438|Functional recovery|functional recovery
19047|NCT04078425|Heart failure|heart failure
19048|NCT04078425|Echocardiography|echocardiography
19049|NCT04078412|Nontuberculous mycobacteria|nontuberculous mycobacteria
19050|NCT04078412|pulmonary|pulmonary
19051|NCT04078412|cohort|cohort
19052|NCT04078399|azacitidine|azacitidine
19053|NCT04078399|HSCT|hsct
19054|NCT04078399|interferon|interferon
19055|NCT04078399|safety|safety
19056|NCT04078399|Efficacy|efficacy
19057|NCT04078373|stroke|stroke
19058|NCT04078373|inpatient rehabilitation|inpatient rehabilitation
19059|NCT04078373|urinary disorders|urinary disorders
19060|NCT04078373|treatment|treatment
19061|NCT04078360|Hazardous Drinking, mHealth, India, Brief intervention|hazardous drinking, mhealth, india, brief intervention
19062|NCT04078347|Peripheral nerve block|peripheral nerve block
19063|NCT04078347|laser speckle contrast imaging|laser speckle contrast imaging
19064|NCT04078347|thermography|thermography
19065|NCT04078334|Frail older adults|frail older adults
19066|NCT04078334|Physical activity|physical activity
19067|NCT04078334|exercise|exercise
19068|NCT04078334|Hospitalization|hospitalization
19069|NCT04078308|Diabetes Mellitus|diabetes mellitus
19070|NCT04078308|Diabetes Mellitus, Type 1|diabetes mellitus, type 1
19071|NCT04078308|Cell Transplantation|cell transplantation
19072|NCT04078308|Autologous Transplantation|autologous transplantation
19073|NCT04078308|Mesenchymal Stem Cell|mesenchymal stem cell
19074|NCT04078295|E7389 liposomal formulation|e7389 liposomal formulation
19075|NCT04078295|Nivolumab|nivolumab
19076|NCT04078295|Neoplasms|neoplasms
19077|NCT04078295|Solid Tumor|solid tumor
19078|NCT04078282|Depression|depression
19079|NCT04078282|Elderly|elderly
19080|NCT04078282|Family Practice|family practice
19081|NCT04078269|dendritic cell|dendritic cell
19082|NCT04078269|vaccine|vaccine
19083|NCT04078269|immunotherapy|immunotherapy
19084|NCT04078256|proprioception|proprioception
19085|NCT04078256|running|running
19086|NCT04078256|prevention|prevention
19087|NCT04078256|injuries|injuries
19088|NCT04078217|home-based exercise program|home-based exercise program
19089|NCT04078217|gait|gait
19090|NCT04078217|mobility|mobility
19091|NCT04078204|Butylphthalide|butylphthalide
19092|NCT04078204|Cerebral Small Vessel Diseases|cerebral small vessel diseases
19093|NCT04078204|Clinical Study|clinical study
19094|NCT04078191|tilmanocept|tilmanocept
19095|NCT04078191|RA imaging|ra imaging
19096|NCT04078191|synovial biopsy|synovial biopsy
19097|NCT04078165|radiation protection|radiation protection
19098|NCT04078165|EVAR|evar
19099|NCT04078165|endovascular surgery|endovascular surgery
19100|NCT04078152|non-small cell lung cancer (NSCLC)|non-small cell lung cancer (nsclc)
19101|NCT04078152|urothelial cancer|urothelial cancer
19102|NCT04078152|durvalumab|durvalumab
19103|NCT04078152|long-term safety, efficacy|long-term safety, efficacy
19104|NCT04078152|overall survival|overall survival
19105|NCT04078152|immunotherapy|immunotherapy
19106|NCT04078152|checkpoint inhibitor|checkpoint inhibitor
19107|NCT04078152|PD-L1|pd-l1
19108|NCT04078152|retreatment|retreatment
19109|NCT04078152|Gastric adenocarcinoma|gastric adenocarcinoma
19110|NCT04078139|Postoperative Pain;|postoperative pain;
19111|NCT04078139|Post-Craniotomy;|post-craniotomy;
19112|NCT04078139|Methylprednisolone|methylprednisolone
19113|NCT04078139|Ropivacaine|ropivacaine
19114|NCT04078139|Scalp Infiltration|scalp infiltration
19115|NCT04078126|COPD|copd
19116|NCT04078113|Pupillary dilation|pupillary dilation
19117|NCT04078113|Analgosedated|analgosedated
19118|NCT04078113|Mechanically ventilation|mechanically ventilation
19119|NCT04078100|mitral valve replacement|mitral valve replacement
19120|NCT04078100|transseptal approach|transseptal approach
19121|NCT04078100|left atrial approach|left atrial approach
19122|NCT04078100|mital valve repair|mital valve repair
19123|NCT04078087|Body mass index|body mass index
19125|NCT04078087|Injection pain|injection pain
19126|NCT04078087|Luteal phase|luteal phase
19127|NCT04078087|Menopause|menopause
19128|NCT04078087|Menstrual cycle|menstrual cycle
19129|NCT04078087|Visual analogue scale|visual analogue scale
19130|NCT04078061|Autism Spectrum Disorder|autism spectrum disorder
19131|NCT04078061|EIBI|eibi
19132|NCT04078061|ABA|aba
19133|NCT04078048|Positive and Negative syndrome scale (PANSS)|positive and negative syndrome scale (panss)
19134|NCT04078048|Antioxidants|antioxidants
19135|NCT04078048|Schizophrenia|schizophrenia
19136|NCT04078009|Grass pollen allergy|grass pollen allergy
19137|NCT04078009|Hayfever|hayfever
19138|NCT04078009|Atopy|atopy
19139|NCT04078009|Allergic rhinitis|allergic rhinitis
19140|NCT04078009|Nasal allergen challenge|nasal allergen challenge
19141|NCT04077996|PERITONITIS|peritonitis
19142|NCT04077996|AUTOMATED PERITONEAL DIALYSIS|automated peritoneal dialysis
19143|NCT04077996|TREATMENT OF PERITONITIS|treatment of peritonitis
19144|NCT04077983|intrahepatic cholangiocarcinoma|intrahepatic cholangiocarcinoma
19145|NCT04077983|nab-paclitaxel and gemcitabine chemotherapy|nab-paclitaxel and gemcitabine chemotherapy
19146|NCT04077957|disease modifying anti-rheumatic drugs(DMARDs)|disease modifying anti-rheumatic drugs(dmards)
19147|NCT04077957|etanercept|etanercept
19148|NCT04077957|ankylosing spondylitis|ankylosing spondylitis
19149|NCT04077957|spondyloarthritis|spondyloarthritis
19150|NCT04077957|treat-to-target|treat-to-target
19151|NCT04077931|Aerobic|aerobic
19152|NCT04077931|Exercises|exercises
19153|NCT04077931|Blood Oxygenation|blood oxygenation
19154|NCT04077931|Pregnancy|pregnancy
19155|NCT04077905|pegylated liposomal doxorubicin|pegylated liposomal doxorubicin
19156|NCT04077892|budesonide|budesonide
19157|NCT04077892|montelukast|montelukast
19158|NCT04077892|combination therapy|combination therapy
19159|NCT04077892|monotherapy|monotherapy
19160|NCT04077879|ASP1617|asp1617
19161|NCT04077879|Food Effect|food effect
19162|NCT04077879|Pharmacokinetics|pharmacokinetics
19163|NCT04077879|Healthy Volunteers|healthy volunteers
19164|NCT04077827|Admnistration Fat Transfer|admnistration fat transfer
19165|NCT04077827|Autologous Fat Transfer|autologous fat transfer
19166|NCT04077827|Breast Reconstruction|breast reconstruction
19167|NCT04077827|TIVA|tiva
19168|NCT04077827|volatile anesthesia|volatile anesthesia
19169|NCT04077827|stress levels|stress levels
19170|NCT04077827|pain levels|pain levels
19171|NCT04077814|Cerebrovascular Accident|cerebrovascular accident
19172|NCT04077814|Cerebrovascular Stroke|cerebrovascular stroke
19173|NCT04077814|Cerebral Stroke|cerebral stroke
19174|NCT04077736|Relapsing polychondritis，IL-2|relapsing polychondritis，il-2
19175|NCT04077710|radioactive iodine-125 seeds implantation|radioactive iodine-125 seeds implantation
19176|NCT04077710|3D-printing template|3d-printing template
19177|NCT04077710|chest wall malignancies|chest wall malignancies
19178|NCT04077697|invasive pulmonary aspergillosis|invasive pulmonary aspergillosis
19179|NCT04077697|Invasive TracheoBronchial Aspergillosis|invasive tracheobronchial aspergillosis
19180|NCT04077697|galactomannan|galactomannan
19181|NCT04077697|1,3-β-D-Glucan|1,3-β-d-glucan
19182|NCT04077697|influenza|influenza
19183|NCT04077697|Intensive Care Unit|intensive care unit
19184|NCT04077697|mortality|mortality
19185|NCT04077671|DFU|dfu
19186|NCT04077671|Diabetic Foot Ulcers|diabetic foot ulcers
19187|NCT04077671|Diabetic Neuropathic Foot Ulcers|diabetic neuropathic foot ulcers
19188|NCT04077658|HeartMath app|heartmath app
19189|NCT04077658|Inner Balance Sensor|inner balance sensor
19190|NCT04077645|physical activity|physical activity
19191|NCT04077645|walking|walking
19192|NCT04077645|moderate intensity|moderate intensity
19193|NCT04077645|acute intervention|acute intervention
19194|NCT04077606|interleukin 1 beta, bacterial adhesion,monolithic zirconia|interleukin 1 beta, bacterial adhesion,monolithic zirconia
19195|NCT04077593|Respiratory Rate|respiratory rate
19196|NCT04077593|Telemedicine|telemedicine
19197|NCT04077593|Dyspnea|dyspnea
19198|NCT04077593|Emergencies|emergencies
19199|NCT04077580|blinded randomized trial|blinded randomized trial
19200|NCT04077580|frail elderly women|frail elderly women
19201|NCT04077580|prevention|prevention
19202|NCT04077567|RA|ra
19203|NCT04077554|VEGF gene expression|vegf gene expression
19204|NCT04077554|VEGF gene polymorphism|vegf gene polymorphism
19205|NCT04077554|leptin|leptin
19206|NCT04077541|trauma care bundles|trauma care bundles
19207|NCT04077541|internet paltform|internet paltform
400493|NCT01866657|single lung ventilation|single lung ventilation
19208|NCT04077541|patients with extremity injuries|patients with extremity injuries
19209|NCT04077541|experimental design|experimental design
19210|NCT04077528|Severe asthma|severe asthma
19211|NCT04077528|Adult|adult
19212|NCT04077528|Respiratory disease|respiratory disease
19213|NCT04077515|Kaposiform Hemangioendothelioma|kaposiform hemangioendothelioma
19214|NCT04077515|Kasabach-Merritt Syndrome|kasabach-merritt syndrome
19215|NCT04077515|Sirolimus|sirolimus
19216|NCT04077515|Rapamycin|rapamycin
19217|NCT04077502|binge eating disorder|binge eating disorder
19218|NCT04077502|craving|craving
19219|NCT04077502|repetitive transcranial magnetic stimulation|repetitive transcranial magnetic stimulation
19220|NCT04077489|macular thickness|macular thickness
19221|NCT04077450|Stress|stress
19222|NCT04077450|Caregiver Burden|caregiver burden
19223|NCT04077450|Alzheimer's Disease Caregiver|alzheimer's disease caregiver
19224|NCT04077450|Informal Caregiver|informal caregiver
19225|NCT04077450|Anxiety|anxiety
19226|NCT04077450|Heart-Focused Breathing|heart-focused breathing
19227|NCT04077424|adult 65 and older|adult 65 and older
19228|NCT04077411|Severe Traumatic Brain Injury|severe traumatic brain injury
19229|NCT04077411|TBI|tbi
19230|NCT04077411|Intracranial hypertension|intracranial hypertension
19231|NCT04077411|Cerebrospinal fluid|cerebrospinal fluid
19232|NCT04077411|Hypersmolar therapies|hypersmolar therapies
19233|NCT04077411|Prophylactic hyperventilation|prophylactic hyperventilation
19234|NCT04077411|Metabolism|metabolism
19235|NCT04077411|Neuropsychology|neuropsychology
19236|NCT04077346|Pediatric-onset|pediatric-onset
19237|NCT04077346|Transcutaneous spinal stimulation|transcutaneous spinal stimulation
19238|NCT04077346|Stepping|stepping
19240|NCT04077320|older adults|older adults
19241|NCT04077320|randomized control trial|randomized control trial
19242|NCT04077320|MRI|mri
19243|NCT04077320|memory education|memory education
19244|NCT04077307|AML|aml
19245|NCT04077307|ALL|all
19246|NCT04077307|MDS|mds
19247|NCT04077294|Preoperative BNP|preoperative bnp
19248|NCT04077294|Perioperative cardiac risk stratification|perioperative cardiac risk stratification
19249|NCT04077294|Myocardial injury after non-cardiac surgery (MINS)|myocardial injury after non-cardiac surgery (mins)
19250|NCT04077294|Canadian Cardiovascular Society (CCS) guidelines|canadian cardiovascular society (ccs) guidelines
19251|NCT04077281|Polypharmacy|polypharmacy
19252|NCT04077255|EGFR|egfr
19253|NCT04077255|FGFR2|fgfr2
19254|NCT04077242|hysteroscopy|hysteroscopy
19255|NCT04077242|Parryscope|parryscope
19256|NCT04077242|chromopertubation|chromopertubation
19257|NCT04077229|ACS|acs
19258|NCT04077229|Text Message|text message
19259|NCT04077229|Positive Psychology|positive psychology
19260|NCT04077229|Health Behavior|health behavior
19261|NCT04077216|Diabetes Mellitus Type 2|diabetes mellitus type 2
19262|NCT04077216|Diet therapy|diet therapy
19263|NCT04077216|Extra virgin olive oil|extra virgin olive oil
19264|NCT04077164|Couples|couples
19265|NCT04077164|Relationships|relationships
19266|NCT04077164|Physical Activity|physical activity
19267|NCT04077151|Transgender|transgender
19268|NCT04077151|Pre-exposure Prophylaxis (PrEP)|pre-exposure prophylaxis (prep)
19269|NCT04077151|HIV Prevention|hiv prevention
19270|NCT04077151|Tenofovir Disoproxil Fumarate/Emtricitabine (TDF/FTC)|tenofovir disoproxil fumarate/emtricitabine (tdf/ftc)
19271|NCT04077151|Cross-sex Hormone Therapy|cross-sex hormone therapy
19272|NCT04077151|Adherence|adherence
19273|NCT04077151|Behavior Change|behavior change
19274|NCT04077151|Gender Affirmation|gender affirmation
19275|NCT04077138|Transgender|transgender
19276|NCT04077138|Pre-exposure Prophylaxis (PrEP)|pre-exposure prophylaxis (prep)
19277|NCT04077138|HIV Prevention|hiv prevention
19278|NCT04077138|Tenofovir Disoproxil Fumarate/Emtricitabine (TDF/FTC)|tenofovir disoproxil fumarate/emtricitabine (tdf/ftc)
19279|NCT04077138|Cross-sex Hormone Therapy|cross-sex hormone therapy
19280|NCT04077138|Adherence|adherence
19281|NCT04077138|Behavior Change|behavior change
19282|NCT04077138|Gender Affirmation|gender affirmation
19283|NCT04077099|MET (mesenchymal-epithelial transition factor)|met (mesenchymal-epithelial transition factor)
19284|NCT04077099|HGF (Hepatocyte Growth Factor)|hgf (hepatocyte growth factor)
19285|NCT04077099|NSCLC (non-small cell lung cancer)|nsclc (non-small cell lung cancer)
19286|NCT04077099|MET-altered advanced|met-altered advanced
19287|NCT04077099|Unresectable|unresectable
19288|NCT04077099|Metastatic disease|metastatic disease
19289|NCT04077086|Refractive error|refractive error
19290|NCT04077086|Myopia|myopia
19291|NCT04077086|Academic high school attendance|academic high school attendance
19292|NCT04077086|Education attainment|education attainment
19293|NCT04077086|Spectacle wear compliance|spectacle wear compliance
19294|NCT04077073|stroke rehabilitation|stroke rehabilitation
19295|NCT04077073|hand opening|hand opening
19296|NCT04077073|flexion synergy|flexion synergy
19297|NCT04077073|robot assisted treatment|robot assisted treatment
19298|NCT04077073|functional electrical stimulation|functional electrical stimulation
19299|NCT04077073|motor recovery|motor recovery
19300|NCT04077073|brain plasticity|brain plasticity
19301|NCT04077047|Adolescents|adolescents
19302|NCT04076995|dehydration|dehydration
19303|NCT04076995|vasopressin|vasopressin
19304|NCT04076995|copeptin|copeptin
19305|NCT04076982|vegetarian|vegetarian
19306|NCT04076982|vegan|vegan
19307|NCT04076982|plant-based|plant-based
19308|NCT04076982|protein|protein
19309|NCT04076982|strength|strength
19310|NCT04076969|Iron deficiency|iron deficiency
19311|NCT04076969|Moderate anemia|moderate anemia
19312|NCT04076969|Compliance|compliance
19313|NCT04076956|Knee ligament injury|knee ligament injury
19314|NCT04076956|Anterior cruciate ligament rupture|anterior cruciate ligament rupture
19315|NCT04076956|Anterior cruciate ligament reconstruction|anterior cruciate ligament reconstruction
19316|NCT04076956|Knee ligament rupture|knee ligament rupture
19816|NCT04073914|Diabetes|diabetes
19317|NCT04076956|Knee ligament reconstruction|knee ligament reconstruction
19318|NCT04076943|Anemia|anemia
19319|NCT04076943|Chemotherapy induced anemia|chemotherapy induced anemia
19320|NCT04076943|Myelosuppressive chemotherapy|myelosuppressive chemotherapy
19321|NCT04076943|Non-Myeloid malignances|non-myeloid malignances
19322|NCT04076930|Cardiovascular|cardiovascular
19323|NCT04076930|Hyperkalemia|hyperkalemia
19324|NCT04076930|Mortality|mortality
19325|NCT04076930|Peritoneal dialysis|peritoneal dialysis
19326|NCT04076930|Renin-angiotensin system|renin-angiotensin system
19327|NCT04076930|Retrospective cohort|retrospective cohort
19328|NCT04076878|Spasticity|spasticity
19329|NCT04076878|Stroke|stroke
19330|NCT04076878|Functioning|functioning
19331|NCT04076878|Disability|disability
19332|NCT04076878|Intervention|intervention
19333|NCT04076878|electrical stimulation therapy|electrical stimulation therapy
19334|NCT04076839|cognitive remediation|cognitive remediation
19335|NCT04076839|public safety personnel|public safety personnel
19336|NCT04076839|Goal Management Training|goal management training
19337|NCT04076839|Group therapy|group therapy
19338|NCT04076839|first responders|first responders
19339|NCT04076839|military|military
19340|NCT04076826|Sepsis|sepsis
19341|NCT04076826|Dexmedetomidine|dexmedetomidine
19342|NCT04076826|Sedation|sedation
19343|NCT04076826|S-100beta|s-100beta
19344|NCT04076826|Encephalopathy|encephalopathy
19345|NCT04076800|acupuncture|acupuncture
19346|NCT04076800|insulin sensitivity|insulin sensitivity
19347|NCT04076787|Vascular endothelial growth factor (VEGF)|vascular endothelial growth factor (vegf)
19348|NCT04076787|Sunitinib|sunitinib
19349|NCT04076774|female condom|female condom
19350|NCT04076774|HIV and STI prevention|hiv and sti prevention
19351|NCT04076774|Condom acceptability|condom acceptability
19352|NCT04076774|Wondaleaf|wondaleaf
19353|NCT04076774|FC2|fc2
19354|NCT04076761|Cholangiocarcinoma|cholangiocarcinoma
19355|NCT04076761|Bile Duct Cancer|bile duct cancer
19356|NCT04076761|FTD/TPI|ftd/tpi
19357|NCT04076761|TRIFLURIDINE/TIPIRACIL|trifluridine/tipiracil
19358|NCT04076748|analgesia|analgesia
19359|NCT04076748|vaso-occlusive crisis|vaso-occlusive crisis
19360|NCT04076748|sufentanil|sufentanil
19361|NCT04076748|intra-nasal|intra-nasal
19362|NCT04076735|Distal Femur Fracture; Geriatric fracture|distal femur fracture; geriatric fracture
19363|NCT04076722|Obesity|obesity
19364|NCT04076722|Weight Loss|weight loss
19365|NCT04076722|Adverse childhood experiences|adverse childhood experiences
19366|NCT04076722|Executive function|executive function
19367|NCT04076722|Brain health|brain health
19368|NCT04076696|Chest|chest
19369|NCT04076696|Lung|lung
19370|NCT04076696|Tomography|tomography
19371|NCT04076696|Scatter|scatter
19372|NCT04076683|Algorithm|algorithm
19373|NCT04076683|Apherisis|apherisis
19374|NCT04076683|Sickle cell patients|sickle cell patients
19375|NCT04076670|Intervention study|intervention study
19376|NCT04076670|Family caregiver|family caregiver
19377|NCT04076670|Overburden|overburden
19378|NCT04076670|Anxiety|anxiety
19379|NCT04076670|Depression|depression
19380|NCT04076657|brock string|brock string
19381|NCT04076657|sport-concussion|sport-concussion
19382|NCT04076657|concussion therapy|concussion therapy
19383|NCT04076657|receded near point of convergence|receded near point of convergence
19384|NCT04076644|TMS|tms
19385|NCT04076618|nutrition|nutrition
19386|NCT04076618|vest|vest
19387|NCT04076605|Decompensated|decompensated
19388|NCT04076605|Liver|liver
19389|NCT04076605|Coagulopathy|coagulopathy
19390|NCT04076605|ACLF|aclf
19391|NCT04076592|Nutritional Intake,|nutritional intake,
19392|NCT04076592|Child Growth and Development|child growth and development
19393|NCT04076592|Bone Density|bone density
19394|NCT04076592|Antibiotics|antibiotics
19395|NCT04076566|OVARIAN|ovarian
19396|NCT04076566|COLORECTAL|colorectal
19397|NCT04076566|PARACENTESIS|paracentesis
19398|NCT04076540|Safety|safety
19399|NCT04076540|Tolerability|tolerability
19400|NCT04076540|Pharmacokinetics|pharmacokinetics
19401|NCT04076540|Healthy Volunteers|healthy volunteers
19402|NCT04076527|ursodeoxycholic acid|ursodeoxycholic acid
19403|NCT04076527|UDCA|udca
19404|NCT04076527|obeticholic acid|obeticholic acid
19405|NCT04076527|OCALIVA|ocaliva
19406|NCT04076527|Cohort|cohort
19407|NCT04076527|observational study|observational study
19408|NCT04076527|Bezafibrat|bezafibrat
19409|NCT04076527|Budesonide|budesonide
19410|NCT04076488|Telemedicine|telemedicine
19411|NCT04076488|Exercise|exercise
19412|NCT04076488|Feasibility|feasibility
19413|NCT04076475|neuromuscular electrical stimulation|neuromuscular electrical stimulation
19414|NCT04076475|tissue oxygenation|tissue oxygenation
19415|NCT04076475|prolonged mechanical ventilation|prolonged mechanical ventilation
19416|NCT04076475|metabolic|metabolic
19417|NCT04076462|Acromegaly|acromegaly
19418|NCT04076462|octreotide|octreotide
19419|NCT04076462|CAM2029|cam2029
19420|NCT04076462|phase 3|phase 3
19817|NCT04073914|Adolescence|adolescence
19423|NCT04076449|Quantitative Susceptibility Mapping (QSM)|quantitative susceptibility mapping (qsm)
19424|NCT04076449|Brain Connectome|brain connectome
19425|NCT04076449|Cerebral Structure|cerebral structure
19426|NCT04076436|Prospective follow-up study|prospective follow-up study
19427|NCT04076436|Real-life conditions|real-life conditions
19428|NCT04076436|Complicated urinary tract infection|complicated urinary tract infection
19429|NCT04076436|Escherichia coli infection|escherichia coli infection
19430|NCT04076436|Fosfomycin efficacy|fosfomycin efficacy
19431|NCT04076436|Quinolones|quinolones
19432|NCT04076436|Beta-lactams|beta-lactams
19433|NCT04076436|Microbiological failure|microbiological failure
19434|NCT04076436|Resistance development|resistance development
19435|NCT04076410|photosensitivity|photosensitivity
19436|NCT04076410|pattern sensitivity|pattern sensitivity
19437|NCT04076410|Electroencephalography|electroencephalography
19438|NCT04076410|Photic Stimulation|photic stimulation
19439|NCT04076410|Pattern Stimulation|pattern stimulation
19440|NCT04076410|photoparoxysmal response|photoparoxysmal response
19441|NCT04076410|Light, Visible|light, visible
19442|NCT04076410|Red Colour|red colour
19443|NCT04076410|Blue Light|blue light
19444|NCT04076410|Retina|retina
19445|NCT04076410|Macular Degeneration|macular degeneration
19446|NCT04076397|annoying pulpal dysesthesia|annoying pulpal dysesthesia
19447|NCT04076397|lipofilling|lipofilling
19448|NCT04076397|amputation|amputation
19449|NCT04076397|sequelae|sequelae
19450|NCT04076371|schizophrenia|schizophrenia
19451|NCT04076371|sertraline|sertraline
19452|NCT04076371|olanzapine|olanzapine
19453|NCT04076371|risperidone|risperidone
19454|NCT04076371|paliperidone|paliperidone
19455|NCT04076371|ziprasidone|ziprasidone
19456|NCT04076358|Rheumatoid Arthritis, fatigue|rheumatoid arthritis, fatigue
19457|NCT04076345|presepsin|presepsin
19458|NCT04076345|biomarker|biomarker
19459|NCT04076345|newborns|newborns
19460|NCT04076345|infants under 3 months of age|infants under 3 months of age
19461|NCT04076345|fever|fever
19462|NCT04076345|paediatric emergency|paediatric emergency
19463|NCT04076280|Hypertension|hypertension
19464|NCT04076280|Low Sodium Diet|low sodium diet
19465|NCT04076254|albumin 5%|albumin 5%
19466|NCT04076254|resuscitation|resuscitation
19467|NCT04076241|Osteopathic Manipulative Treatment|osteopathic manipulative treatment
19468|NCT04076241|Pranayama|pranayama
19469|NCT04076241|Nitric Oxide|nitric oxide
19470|NCT04076241|Cardiopulmonary|cardiopulmonary
19471|NCT04076241|Complementary Therapy|complementary therapy
19472|NCT04076228|NSCLC|nsclc
19473|NCT04076228|PD-L1|pd-l1
19474|NCT04076228|Biomarkers|biomarkers
19475|NCT04076202|Knee replacement|knee replacement
19476|NCT04076202|Knee Osteoarthritis|knee osteoarthritis
19477|NCT04076189|Infant newborn|infant newborn
19478|NCT04076189|Meconium Aspiration Syndrome|meconium aspiration syndrome
19479|NCT04076189|Neonatal Resuscitation|neonatal resuscitation
19480|NCT04076189|Positive Pressure Ventilation|positive pressure ventilation
19481|NCT04076176|Phenylketonuria|phenylketonuria
19483|NCT04076176|Child|child
19484|NCT04076176|Adult|adult
19485|NCT04076176|GMP|gmp
19486|NCT04076176|Glycomacropeptide|glycomacropeptide
19487|NCT04076137|Targeted T-cell|targeted t-cell
19488|NCT04076137|HER2|her2
19489|NCT04076137|MUC1|muc1
19491|NCT04076137|EGFR|egfr
19492|NCT04076137|GPC3|gpc3
19493|NCT04076072|vitrectomy|vitrectomy
19494|NCT04076059|Metastatic hormone sensitive prostate cancer|metastatic hormone sensitive prostate cancer
19495|NCT04076059|Androgen Deprivation Therapy (ADT)|androgen deprivation therapy (adt)
19496|NCT04076059|Xtandi|xtandi
19497|NCT04076059|MDV3100|mdv3100
19498|NCT04076059|Enzalutamide|enzalutamide
19499|NCT04076046|pituitary adenoma endoscopic surgery zurich pituitary score|pituitary adenoma endoscopic surgery zurich pituitary score
19500|NCT04076033|Functional Compressive Bandage|functional compressive bandage
19501|NCT04076033|Lymphedema|lymphedema
19502|NCT04076033|Physiotherapy|physiotherapy
19506|NCT04076007|nitrate|nitrate
19507|NCT04076007|nitrite|nitrite
19508|NCT04076007|nitric oxide|nitric oxide
19509|NCT04076007|diabetes|diabetes
28019|NCT04024813|PSC|psc
19510|NCT04076007|hypertension|hypertension
19511|NCT04075994|Quality of Life (QoL)|quality of life (qol)
19512|NCT04075994|Adherence|adherence
19513|NCT04075994|Health Literacy|health literacy
19514|NCT04075981|Xeomin®|xeomin®
19515|NCT04075981|Botox|botox
19516|NCT04075981|Botulinum|botulinum
19517|NCT04075981|Atrial Fibrillation|atrial fibrillation
19518|NCT04075981|Cardiac surgery|cardiac surgery
19519|NCT04075929|Cycling|cycling
19520|NCT04075929|endurance performance|endurance performance
19521|NCT04075929|intermittent exercise|intermittent exercise
19522|NCT04075929|maximal oxygen consumption|maximal oxygen consumption
19818|NCT04073914|Parents|parents
19524|NCT04075929|well-trained athletes|well-trained athletes
19525|NCT04075877|Pediatric cancer|pediatric cancer
19526|NCT04075877|Pediatric Sickle Cell Disease|pediatric sickle cell disease
19527|NCT04075877|Quality of Life|quality of life
19528|NCT04075877|Randomized Controlled Trial|randomized controlled trial
19529|NCT04075877|Intervention|intervention
19530|NCT04075877|Photography|photography
19531|NCT04075877|Narrative Psychology|narrative psychology
19532|NCT04075877|Adolescence|adolescence
19533|NCT04075851|Autoimmune thyroid disease|autoimmune thyroid disease
19534|NCT04075851|Thyroid hormone autoantibodies|thyroid hormone autoantibodies
19535|NCT04075851|Hashimoto's thyroiditis|hashimoto's thyroiditis
19536|NCT04075851|Grave's disease|grave's disease
19538|NCT04075812|reanimation|reanimation
19539|NCT04075812|stimulation|stimulation
19540|NCT04075799|obesity|obesity
19541|NCT04075799|insulin resistance|insulin resistance
19542|NCT04075799|high-intensity interval training|high-intensity interval training
19543|NCT04075786|Uterine malformations|uterine malformations
19544|NCT04075786|Hysteroscopy|hysteroscopy
19545|NCT04075786|3D ultrasound|3d ultrasound
19546|NCT04075786|Infertility|infertility
19547|NCT04075721|M3258|m3258
19548|NCT04075721|Dexamethasone|dexamethasone
19549|NCT04075721|Pharmacokinetics|pharmacokinetics
19550|NCT04075721|Relapsed Refractory Multiple Myeloma|relapsed refractory multiple myeloma
19551|NCT04075695|ischemic index|ischemic index
19552|NCT04075695|Ultra-wide field fundus fluorescein angiography|ultra-wide field fundus fluorescein angiography
19553|NCT04075695|vascular leakage index|vascular leakage index
19554|NCT04075669|Multiplex solid-phase strip PCR|multiplex solid-phase strip pcr
19555|NCT04075669|Eye Infections|eye infections
19556|NCT04075669|Endophthalmitis|endophthalmitis
19557|NCT04075669|Corneal Ulcer|corneal ulcer
19558|NCT04075669|Keratitis|keratitis
19559|NCT04075669|Corneal Scraping Samples|corneal scraping samples
19560|NCT04075656|Pediatrics|pediatrics
19561|NCT04075656|mHealth|mhealth
19562|NCT04075656|Behavioral intervention|behavioral intervention
19563|NCT04075630|childbirth|childbirth
19564|NCT04075630|oxytocin|oxytocin
19565|NCT04075630|prostaglandin|prostaglandin
19566|NCT04075630|cervical ripening balloon|cervical ripening balloon
19567|NCT04075604|Nivolumab|nivolumab
19568|NCT04075604|Breast Cancer|breast cancer
19569|NCT04075604|Cancer|cancer
19570|NCT04075604|ER+|er+
19571|NCT04075604|HER2-|her2-
19572|NCT04075604|Neoadjuvant|neoadjuvant
19573|NCT04075578|idiopathic overactive bladder|idiopathic overactive bladder
19574|NCT04075578|Botox|botox
19575|NCT04075578|Onabotulinum toxinA|onabotulinum toxina
19576|NCT04075578|50 units|50 units
19577|NCT04075565|hypoxia|hypoxia
19578|NCT04075565|altitude|altitude
19579|NCT04075565|physiology|physiology
19580|NCT04075565|cognition|cognition
19581|NCT04075539|Lumbar spinal stenosis|lumbar spinal stenosis
19582|NCT04075539|Neurogenic claudication|neurogenic claudication
19583|NCT04075539|Low back pain|low back pain
19584|NCT04075539|Exercise therapy|exercise therapy
19585|NCT04075539|Endurance training|endurance training
19586|NCT04075539|Cycling|cycling
19587|NCT04075539|Randomized trial|randomized trial
19588|NCT04075500|atrial fibrillation|atrial fibrillation
19589|NCT04075500|monitoring|monitoring
19590|NCT04075500|ECG|ecg
19591|NCT04075500|ischemic attack|ischemic attack
19592|NCT04075487|Low back pain|low back pain
19593|NCT04075448|Flavonoid|flavonoid
19594|NCT04075448|Omega 3 Fatty Acid|omega 3 fatty acid
19595|NCT04075435|cannabidiol|cannabidiol
19596|NCT04075435|older adults|older adults
19597|NCT04075409|Padsevonil|padsevonil
19598|NCT04075409|CYP2C19|cyp2c19
19599|NCT04075409|Healthy Japanese Participants|healthy japanese participants
19600|NCT04075409|Pharmacokinetics|pharmacokinetics
19601|NCT04075383|dental implant|dental implant
19602|NCT04075383|esthetics|esthetics
19603|NCT04075383|quality of life|quality of life
19604|NCT04075357|Amniotic membrane transplantation|amniotic membrane transplantation
19605|NCT04075344|infection control ; bacterial contamination|infection control ; bacterial contamination
19606|NCT04075331|COPD|copd
19607|NCT04075331|eosinophilia|eosinophilia
19608|NCT04075331|Chronic Obstructive Pulmonary Disorder|chronic obstructive pulmonary disorder
19609|NCT04075331|Mepolizumab|mepolizumab
19610|NCT04075292|Chronic Lymphocytic Leukemia|chronic lymphocytic leukemia
19611|NCT04075292|Acalabrutinib|acalabrutinib
19612|NCT04075292|Progression-free Survival|progression-free survival
19613|NCT04075253|Exercise Training|exercise training
19614|NCT04075240|total hip and knee arthroplasty|total hip and knee arthroplasty
19615|NCT04075227|Impending recurrent pterygium|impending recurrent pterygium
19616|NCT04075227|0.2% loteprednol etabonate|0.2% loteprednol etabonate
19617|NCT04075227|0.1% dexamethasone|0.1% dexamethasone
19618|NCT04075188|pachychoroid|pachychoroid
19619|NCT04075188|polypoidal choroidal vasculopathy|polypoidal choroidal vasculopathy
19620|NCT04075188|Aflibercept|aflibercept
19621|NCT04075188|photodynamic therapy|photodynamic therapy
19622|NCT04075188|Swept source OCT|swept source oct
19623|NCT04075149|PCOS|pcos
19624|NCT04075149|Polycystic Ovary Syndrome|polycystic ovary syndrome
19625|NCT04075149|ovulation|ovulation
19626|NCT04075149|puberty|puberty
19627|NCT04075149|hyperandrogenemia|hyperandrogenemia
19628|NCT04075149|androgen excess|androgen excess
19629|NCT04075136|Macular degeneration|macular degeneration
19630|NCT04075136|Lucentis|lucentis
19631|NCT04075136|Triescense|triescense
19632|NCT04075136|Photodynamic laser treatment|photodynamic laser treatment
19633|NCT04075123|CPAP|cpap
19634|NCT04075123|NIPPV|nippv
19635|NCT04075123|INFANT, PREMATURE|infant, premature
19636|NCT04075123|RESPIRATORY MANAGEMENT|respiratory management
19637|NCT04075123|POST-ESTUBATION|post-estubation
19638|NCT04075084|Implantable Cardiac Monitor|implantable cardiac monitor
19639|NCT04075084|BIOMONITOR III|biomonitor iii
19640|NCT04075071|Teacher-Child Interaction Training|teacher-child interaction training
19641|NCT04075071|teacher-child relationships|teacher-child relationships
19642|NCT04075071|child behavior|child behavior
19643|NCT04075071|child social-emotional skills|child social-emotional skills
19644|NCT04075071|preschool|preschool
19645|NCT04075071|teaching self-efficacy|teaching self-efficacy
19646|NCT04075071|teacher behavior|teacher behavior
19647|NCT04075058|Breast cancer|breast cancer
19648|NCT04075058|hypofractionated radiotherapy|hypofractionated radiotherapy
19649|NCT04075058|Hypofractionated radiation|hypofractionated radiation
19650|NCT04075045|High blood pressure|high blood pressure
19651|NCT04075045|mobile health|mobile health
19652|NCT04075045|behavioral economics|behavioral economics
19653|NCT04075045|adherence|adherence
19654|NCT04075045|non-compliance|non-compliance
19655|NCT04075032|metabolic syndrome|metabolic syndrome
19656|NCT04075032|pomegranate|pomegranate
19657|NCT04075032|gut microbiota|gut microbiota
19658|NCT04075032|polyphenol|polyphenol
19659|NCT04075032|polymedication|polymedication
19660|NCT04075032|inflammation|inflammation
19661|NCT04075032|obesity|obesity
19662|NCT04075032|diabetes|diabetes
19663|NCT04075032|hypertension|hypertension
19664|NCT04075032|hyperlipidemia|hyperlipidemia
19665|NCT04075032|urolithins|urolithins
19666|NCT04075019|Proactive classroom management|proactive classroom management
19667|NCT04075019|Interactive teaching|interactive teaching
19668|NCT04075019|Cooperative learning|cooperative learning
19669|NCT04075019|Interpersonal problem solving skills|interpersonal problem solving skills
19670|NCT04075019|Refusal skills|refusal skills
19671|NCT04075019|Behavior management skills|behavior management skills
19672|NCT04075019|Academic support skills|academic support skills
19673|NCT04075019|Skills to reduce risks for drug use|skills to reduce risks for drug use
19674|NCT04075006|Ketamine, standard of care, critically ill, mechanically ventilation, ATTAINMENT, propofol, Fentanyl , midazolam , delirium, vasopressors|ketamine, standard of care, critically ill, mechanically ventilation, attainment, propofol, fentanyl , midazolam , delirium, vasopressors
19675|NCT04074941|Sodium Intake|sodium intake
19676|NCT04074941|Blood Pressure|blood pressure
19677|NCT04074941|Hypertension|hypertension
19678|NCT04074941|Physical Function|physical function
19679|NCT04074941|Older Adults|older adults
19680|NCT04074941|Randomized Controlled Trial|randomized controlled trial
19681|NCT04074928|Influenza Vaccine|influenza vaccine
19682|NCT04074889|Probiotics|probiotics
19683|NCT04074889|Gut Liver Axis|gut liver axis
19684|NCT04074876|pulmonary ultrasound|pulmonary ultrasound
19685|NCT04074876|urgency orthopedic surgery|urgency orthopedic surgery
19686|NCT04074876|major adverse cardiac events|major adverse cardiac events
19687|NCT04074863|Distal radioulnar joint|distal radioulnar joint
19688|NCT04074863|Darrach procedure|darrach procedure
19689|NCT04074863|Ulnar head resection|ulnar head resection
19690|NCT04074863|Herbert prosthesis|herbert prosthesis
19691|NCT04074863|Ulnar head replacement|ulnar head replacement
19692|NCT04074850|Traumatic Brain Injury|traumatic brain injury
19693|NCT04074850|Elderly|elderly
19694|NCT04074850|Cognitive Impairment|cognitive impairment
19695|NCT04074850|Quality of life|quality of life
19696|NCT04074850|Impact|impact
19697|NCT04074850|Health care economic costs|health care economic costs
19698|NCT04074785|Abemaciclib|abemaciclib
19699|NCT04074785|Bevacizumab|bevacizumab
19700|NCT04074785|CDKN2A/B|cdkn2a/b
19701|NCT04074785|CDK4/6|cdk4/6
19702|NCT04074785|Verzenio|verzenio
19703|NCT04074785|Avastin|avastin
19704|NCT04074733|ULD|uld
19705|NCT04074694|Parotitis|parotitis
19706|NCT04074694|Juvenile|juvenile
19707|NCT04074694|Sialoendoscopy|sialoendoscopy
19708|NCT04074694|Watchfull waiting|watchfull waiting
19709|NCT04074681|Gambling|gambling
19710|NCT04074681|CBT|cbt
19711|NCT04074681|Internet program|internet program
19712|NCT04074681|Efficacy|efficacy
19713|NCT04074655|Driving Simulator|driving simulator
19714|NCT04074655|Virtual Reality|virtual reality
19715|NCT04074642|macroadenoma|macroadenoma
19716|NCT04074629|Multiple Sclerosis|multiple sclerosis
19717|NCT04074629|Skin volatile organic compounds (VOCs)|skin volatile organic compounds (vocs)
19718|NCT04074616|electric stimulation|electric stimulation
19723|NCT04074564|the Efficacy|the efficacy
19724|NCT04074564|Combined therapy|combined therapy
19725|NCT04074538|colorectal cancer|colorectal cancer
19726|NCT04074538|cohort study|cohort study
19727|NCT04074538|CRC screening|crc screening
19728|NCT04074525|Decisional regret|decisional regret
19729|NCT04074525|Comfort care|comfort care
19730|NCT04074525|Palliative care|palliative care
19731|NCT04074525|Infant resuscitation|infant resuscitation
19732|NCT04074486|Concussion|concussion
19733|NCT04074486|Mild Traumatic Brain Injury|mild traumatic brain injury
19734|NCT04074486|Automated/Electronic Near Point Convergence|automated/electronic near point convergence
19735|NCT04074473|portal hypertension, esophageal varices, non-selective beta-blocker, acute kidney injury.|portal hypertension, esophageal varices, non-selective beta-blocker, acute kidney injury.
19861|NCT04073446|Spinal Cord Stimulation|spinal cord stimulation
19736|NCT04074460|major surgeries lasting >2 hours|major surgeries lasting >2 hours
19737|NCT04074421|Rifaximin|rifaximin
19738|NCT04074421|Probiotics|probiotics
19739|NCT04074421|IBS-D|ibs-d
19740|NCT04074421|gut microbiota|gut microbiota
19741|NCT04074395|oral pathology|oral pathology
19742|NCT04074382|Patient Reported Outcome Measures|patient reported outcome measures
19743|NCT04074382|Recovery of Function|recovery of function
19744|NCT04074382|Rehabilitation|rehabilitation
19745|NCT04074382|Disability Evaluation|disability evaluation
19746|NCT04074382|Trauma Centers|trauma centers
19747|NCT04074382|Trauma Severity Indices|trauma severity indices
19748|NCT04074382|Advanced Trauma Life Support Care|advanced trauma life support care
19749|NCT04074382|Multiple Trauma/Injuries|multiple trauma/injuries
19750|NCT04074382|Wounds and Injuries|wounds and injuries
19751|NCT04074382|Orthopedic Disorder|orthopedic disorder
19752|NCT04074382|Surgery|surgery
19753|NCT04074343|Gastric Adenocarcinoma|gastric adenocarcinoma
19754|NCT04074343|TAS-102|tas-102
19755|NCT04074343|Irinotecan|irinotecan
19756|NCT04074343|Gastroesophageal Adenocarcinoma|gastroesophageal adenocarcinoma
19757|NCT04074330|Drug Therapy|drug therapy
19758|NCT04074278|mid-arm muscle circumference|mid-arm muscle circumference
19759|NCT04074278|handgrip strength|handgrip strength
19760|NCT04074278|dual-energy x-ray absorptiometry|dual-energy x-ray absorptiometry
19761|NCT04074265|cerebral palsy|cerebral palsy
19762|NCT04074265|randomized controlled trial|randomized controlled trial
19763|NCT04074265|pediatric|pediatric
19764|NCT04074265|pain management|pain management
19765|NCT04074265|perioperative medicine|perioperative medicine
19766|NCT04074239|telemedicine|telemedicine
19767|NCT04074239|Triage|triage
19768|NCT04074239|Call centers|call centers
19769|NCT04074239|Fever|fever
19770|NCT04074239|Pediatrics|pediatrics
19771|NCT04074226|regional anesthesia|regional anesthesia
19772|NCT04074226|postoperative pain|postoperative pain
19773|NCT04074226|erector spinae plane block|erector spinae plane block
19774|NCT04074226|quadratus lumborum block|quadratus lumborum block
19775|NCT04074148|Patient Education|patient education
19776|NCT04074148|Nepal|nepal
19777|NCT04074148|Diabetes prevention|diabetes prevention
19783|NCT04074122|Electromechanical Mapping|electromechanical mapping
19784|NCT04074122|Risk Stratification|risk stratification
19785|NCT04074109|telehealth|telehealth
19786|NCT04074109|yoga|yoga
19787|NCT04074083|Child health|child health
19788|NCT04074083|Clinical guidelines|clinical guidelines
19789|NCT04074083|South Africa|south africa
19790|NCT04074083|Africa|africa
19791|NCT04074083|electronic health intervention|electronic health intervention
19792|NCT04074070|psoriasis|psoriasis
19793|NCT04074070|psoriatic arthritis|psoriatic arthritis
19794|NCT04074070|ultrasound|ultrasound
19795|NCT04074044|Prevention|prevention
19796|NCT04074044|Pregnancy|pregnancy
19797|NCT04074044|Mobile Health App|mobile health app
19798|NCT04074044|PEMAT questionnaire|pemat questionnaire
19799|NCT04074005|Epidural analgesia|epidural analgesia
19800|NCT04074005|Labor pain|labor pain
19801|NCT04074005|Cesarean section rate|cesarean section rate
19802|NCT04073953|G6PD|g6pd
19803|NCT04073953|Hemolysis|hemolysis
19804|NCT04073953|Primaquine|primaquine
19805|NCT04073953|Pharmacokinetics|pharmacokinetics
19806|NCT04073953|Malaria|malaria
19807|NCT04073940|multiple sclerosis|multiple sclerosis
19808|NCT04073940|ataxia|ataxia
19809|NCT04073940|magnetic resonance imaging|magnetic resonance imaging
19810|NCT04073940|structural connectivity|structural connectivity
19811|NCT04073940|resting state functional connectivity|resting state functional connectivity
19812|NCT04073940|dance|dance
19813|NCT04073940|wellness|wellness
19814|NCT04073940|balance|balance
19815|NCT04073940|mobility|mobility
19819|NCT04073901|Aesthetic|aesthetic
19820|NCT04073901|Endo-crowns|endo-crowns
19821|NCT04073901|primary|primary
19822|NCT04073901|molars|molars
19823|NCT04073901|pulpotomy|pulpotomy
19824|NCT04073901|zirconium|zirconium
19825|NCT04073901|crowns|crowns
19826|NCT04073862|Stepped-Care Trauma-Focused Cognitive Behavioral Therapy|stepped-care trauma-focused cognitive behavioral therapy
19827|NCT04073784|Toripalimab|toripalimab
19828|NCT04073784|Gemcitabine|gemcitabine
19829|NCT04073784|Apatinib|apatinib
19830|NCT04073784|recurrent NPC|recurrent npc
19831|NCT04073784|metastatic NPC|metastatic npc
19832|NCT04073771|Septic shock, AKI, CRRT|septic shock, aki, crrt
19833|NCT04073758|Pectus Excavatum|pectus excavatum
19834|NCT04073732|family physician contract services|family physician contract services
19835|NCT04073732|physician agency theory|physician agency theory
19836|NCT04073732|physician Behavior|physician behavior
19837|NCT04073732|family physician|family physician
19838|NCT04073732|health service supply|health service supply
19839|NCT04073719|Kidney Stones, Urolithiasis, Hypocitraturia, Apple Cider Vinegar|kidney stones, urolithiasis, hypocitraturia, apple cider vinegar
19840|NCT04073706|uterine cancer|uterine cancer
19841|NCT04073706|sentinel node biopsy|sentinel node biopsy
19842|NCT04073667|balance|balance
19843|NCT04073667|proprioception|proprioception
19844|NCT04073667|exercise|exercise
19845|NCT04073667|cervical region|cervical region
19846|NCT04073667|chiari malformation|chiari malformation
19847|NCT04073667|rehabilitation|rehabilitation
19848|NCT04073654|Dental implants|dental implants
19849|NCT04073654|Implant surfaces|implant surfaces
19850|NCT04073654|Marginal bone loss|marginal bone loss
19851|NCT04073628|Mild Cognitive Impairment, sleep and memory|mild cognitive impairment, sleep and memory
19852|NCT04073524|Supportive Environment Theory (SET)|supportive environment theory (set)
19853|NCT04073524|Aesthetic Affective Theory (AAT)|aesthetic affective theory (aat)
19854|NCT04073524|Attention Restoration Theory (ART)|attention restoration theory (art)
19855|NCT04073524|Nature-Body-Mind-Community (NBMC)|nature-body-mind-community (nbmc)
19856|NCT04073511|Eungyosan|eungyosan
19857|NCT04073511|Samsoeum|samsoeum
19858|NCT04073472|crohn disease|crohn disease
19859|NCT04073472|mesenchymal stem cells|mesenchymal stem cells
19860|NCT04073472|pouch fistulas|pouch fistulas
19862|NCT04073446|Chronic Pain|chronic pain
19864|NCT04073433|Subjective Effects|subjective effects
19865|NCT04073433|MDMA|mdma
19866|NCT04073381|Blood Flow Restriction Training|blood flow restriction training
19867|NCT04073381|Ergogenic Aids|ergogenic aids
19868|NCT04073381|Abdominal Cancer|abdominal cancer
19869|NCT04073355|exercise|exercise
19870|NCT04073355|African American women|african american women
19871|NCT04073355|mHealth|mhealth
19872|NCT04073355|eHealth|ehealth
19873|NCT04073355|smartphone|smartphone
19874|NCT04073290|Rifaximin|rifaximin
19875|NCT04073290|Lactulose|lactulose
19876|NCT04073290|post-TIPS HE|post-tips he
19877|NCT04073290|Prevention|prevention
19878|NCT04073277|Acupuncture needle|acupuncture needle
19879|NCT04073277|Supercritical fluid|supercritical fluid
19880|NCT04073277|De-qi|de-qi
19881|NCT04073277|Chinese medicine|chinese medicine
19882|NCT04073251|Persistent cough|persistent cough
19883|NCT04073251|Children|children
19884|NCT04073212|dry needling|dry needling
19885|NCT04073212|eccentric exercise|eccentric exercise
19886|NCT04073212|concentric exercise|concentric exercise
19887|NCT04073212|physical therapy|physical therapy
19888|NCT04073199|stretching,teres major, subacromial syndrome, manual therapy|stretching,teres major, subacromial syndrome, manual therapy
19889|NCT04073173|RDS|rds
19890|NCT04073173|Preterm Infants|preterm infants
19891|NCT04073173|Surfactant|surfactant
19892|NCT04073173|LISA|lisa
19893|NCT04073173|INSURE|insure
19894|NCT04073173|Analgesia|analgesia
19895|NCT04073173|Stress|stress
19896|NCT04073160|Muscle-invasive bladder cancer|muscle-invasive bladder cancer
19897|NCT04073160|Decipher bladder test|decipher bladder test
19898|NCT04073160|Durvalumab|durvalumab
19899|NCT04073160|Tremelimumab|tremelimumab
19900|NCT04073160|Bladder radiation|bladder radiation
19901|NCT04073160|Urothelial carcinoma of the bladder|urothelial carcinoma of the bladder
19902|NCT04073147|venetoclax|venetoclax
19903|NCT04073147|obinutuzumab|obinutuzumab
19904|NCT04073147|pharmacokinetics|pharmacokinetics
19905|NCT04073134|Coronary Artery Disease|coronary artery disease
19906|NCT04073134|Atherosclerosis|atherosclerosis
19907|NCT04073121|Angioplasty|angioplasty
19908|NCT04073121|Drug Coated Balloon|drug coated balloon
19909|NCT04073121|Drug Coated Stents|drug coated stents
19910|NCT04073095|Lumbar spinal surgery|lumbar spinal surgery
19911|NCT04073095|Postoperative pain management|postoperative pain management
19912|NCT04073095|Erector spina plane block|erector spina plane block
19913|NCT04073095|Modified thoracolumbar interfacial plane block|modified thoracolumbar interfacial plane block
19914|NCT04073069|Postoperative Pain;|postoperative pain;
19915|NCT04073069|Post-Craniotomy Headache|post-craniotomy headache
19916|NCT04073069|Ropivacaine|ropivacaine
19917|NCT04073069|Pre-emptive Scalp Infiltration|pre-emptive scalp infiltration
19919|NCT04073056|Sleeve gastrectomy|sleeve gastrectomy
19920|NCT04073056|Quadratus lumborum block|quadratus lumborum block
19921|NCT04073056|Bariatric surgery|bariatric surgery
19923|NCT04073043|Self-management|self-management
19924|NCT04073043|Resources|resources
19925|NCT04073004|PTSD|ptsd
19926|NCT04073004|Psychotherapy|psychotherapy
19927|NCT04073004|Rape|rape
19928|NCT04072952|Breast Cancer|breast cancer
19929|NCT04072952|Metastatic Breast Cancer|metastatic breast cancer
19930|NCT04072952|Malignant Neoplasm of the Breast|malignant neoplasm of the breast
19931|NCT04072952|mBC|mbc
19932|NCT04072952|ER+/HER2-|er+/her2-
19933|NCT04072952|Locally Advanced Breast Cancer|locally advanced breast cancer
19934|NCT04072939|Phacoemulsification|phacoemulsification
19935|NCT04072926|Biomaterials|biomaterials
19936|NCT04072926|irrigation protocol|irrigation protocol
19937|NCT04072926|pariapical healing|pariapical healing
19938|NCT04072913|Matrix metalloproteinases|matrix metalloproteinases
19939|NCT04072900|Melanoma, Metastasis|melanoma, metastasis
19940|NCT04072887|COPD|copd
19941|NCT04072874|Leishmaniasis|leishmaniasis
19942|NCT04072874|Curaleish|curaleish
19944|NCT04072809|Fetal Alcohol Syndrome|fetal alcohol syndrome
19945|NCT04072809|Alcohol Related Neurodevelopmental Disorder|alcohol related neurodevelopmental disorder
19946|NCT04072809|Alcohol-Related Birth Defects|alcohol-related birth defects
19947|NCT04072809|FAE (Fetal Alcohol Effects)|fae (fetal alcohol effects)
19948|NCT04072809|FASD|fasd
19949|NCT04072809|Partial Fetal Alcohol Syndrome|partial fetal alcohol syndrome
19950|NCT04072809|ND-PAE|nd-pae
19951|NCT04072809|Prenatal Alcohol Exposure|prenatal alcohol exposure
19952|NCT04072809|fetal exposure to ethanol during pregnancy|fetal exposure to ethanol during pregnancy
19953|NCT04072809|FAS|fas
19954|NCT04072796|urinary bladder, neurogenic|urinary bladder, neurogenic
19955|NCT04072796|quality of life|quality of life
19956|NCT04072796|socioeconomic factors|socioeconomic factors
19957|NCT04072796|stroke rehabilitation|stroke rehabilitation
19958|NCT04072783|Craniosynostosis|craniosynostosis
19959|NCT04072783|MRI|mri
19960|NCT04072783|DTI|dti
19961|NCT04072783|Neurodevelopment|neurodevelopment
19962|NCT04072770|Pea protein|pea protein
19963|NCT04072770|Casein|casein
19964|NCT04072770|Amino acid bioavailability|amino acid bioavailability
19965|NCT04072770|Protein digestibility|protein digestibility
19966|NCT04072770|Isotopic tracers|isotopic tracers
19967|NCT04072744|Peripheral oedema|peripheral oedema
19968|NCT04072744|Peripheral edema|peripheral edema
19969|NCT04072744|Heart failure|heart failure
19970|NCT04072744|Decompensation|decompensation
19971|NCT04072744|Weight|weight
19972|NCT04072744|Hospital admissions|hospital admissions
19973|NCT04072731|thyroid cancer|thyroid cancer
19974|NCT04072731|SREBP1|srebp1
19975|NCT04072718|Hypofractioned radiotherapy|hypofractioned radiotherapy
19976|NCT04072718|Simultaneous integrated boost|simultaneous integrated boost
19977|NCT04072705|Pharmacogenetics|pharmacogenetics
19978|NCT04072705|Cytochrome P450 2C19|cytochrome p450 2c19
19979|NCT04072705|Clopidogrel|clopidogrel
19980|NCT04072705|Stroke|stroke
19981|NCT04072679|Advanced Hepatocellular Carcinoma|advanced hepatocellular carcinoma
19982|NCT04072679|Sintilimab|sintilimab
19983|NCT04072679|IBI305|ibi305
19984|NCT04072666|Suicide Prevention|suicide prevention
19985|NCT04072666|Suicide Attempt|suicide attempt
19986|NCT04072666|Brief Intervention|brief intervention
19987|NCT04072640|Voriconazole;amphotericin ;cryptococcal meningitis|voriconazole;amphotericin ;cryptococcal meningitis
19988|NCT04072627|breast milk|breast milk
19989|NCT04072627|microbiota|microbiota
19990|NCT04072614|Spatial neglect|spatial neglect
19991|NCT04072614|Perceptual disorders|perceptual disorders
19992|NCT04072614|Diagnostic techniques and procedures|diagnostic techniques and procedures
19993|NCT04072614|Symptom assessment|symptom assessment
19994|NCT04072614|Rehabilitation|rehabilitation
19995|NCT04072614|Acute care|acute care
19996|NCT04072562|Bioavailability|bioavailability
19997|NCT04072562|Pharmacokinetics|pharmacokinetics
19998|NCT04072562|Safety|safety
19999|NCT04072562|Selective glucocorticoid receptor modulator|selective glucocorticoid receptor modulator
20000|NCT04072523|Type 2 Diabetes, Heart Failure|type 2 diabetes, heart failure
20001|NCT04072497|VZV|vzv
20002|NCT04072419|esophageal atresia|esophageal atresia
20003|NCT04072419|enhanced recovery after surgery|enhanced recovery after surgery
20004|NCT04072419|perioperative management|perioperative management
20005|NCT04072406|mindfulness|mindfulness
20006|NCT04072406|meditation|meditation
20007|NCT04072406|behavioral treatment|behavioral treatment
20008|NCT04072380|SUVN-G3031|suvn-g3031
28628|NCT04020731|MEG|meg
20009|NCT04072380|Narcolepsy with and without cataplexy|narcolepsy with and without cataplexy
20010|NCT04072380|Cataplexy|cataplexy
20011|NCT04072380|Narcolepsy Type 1|narcolepsy type 1
20012|NCT04072380|Narcolepsy Type 2|narcolepsy type 2
20013|NCT04072380|Excessive Daytime Sleepiness (EDS)|excessive daytime sleepiness (eds)
20014|NCT04072380|Histamine H3 receptor|histamine h3 receptor
20021|NCT04072328|Midazolam|midazolam
20022|NCT04072328|Propofol|propofol
20023|NCT04072328|Sedation|sedation
20024|NCT04072302|Malaria|malaria
20025|NCT04072302|KAF156|kaf156
20026|NCT04072302|P. falciparum|p. falciparum
20027|NCT04072289|refractive surgery|refractive surgery
20028|NCT04072289|small incision lenticule extraction|small incision lenticule extraction
20029|NCT04072289|femtosecond laser|femtosecond laser
20030|NCT04072289|myopia|myopia
20031|NCT04072289|astigmatism|astigmatism
20032|NCT04072276|EV71 Vaccine|ev71 vaccine
20033|NCT04072250|Recurrent intrahepatic cholangiocarcinoma|recurrent intrahepatic cholangiocarcinoma
20034|NCT04072250|Intrahepatic cholangiocarcinoma|intrahepatic cholangiocarcinoma
20035|NCT04072250|Repeat hepatectomy|repeat hepatectomy
20036|NCT04072250|Metastasectomy|metastasectomy
20040|NCT04072185|Physical activity|physical activity
20041|NCT04072185|Primary Care|primary care
20042|NCT04072185|elderly people|elderly people
20043|NCT04072185|anxiety|anxiety
20044|NCT04072185|depression|depression
20045|NCT04072185|social isolation|social isolation
20046|NCT04072133|Midlife Women|midlife women
20047|NCT04072133|Body Composition|body composition
20048|NCT04072133|Meditative Movement|meditative movement
20049|NCT04072133|Emotional Eating|emotional eating
20050|NCT04072133|Sleep Quality|sleep quality
20051|NCT04072133|Body Fat Percentage|body fat percentage
20052|NCT04072133|Tai Chi Easy|tai chi easy
20053|NCT04072120|Stroke|stroke
20054|NCT04072120|Post-acute stroke|post-acute stroke
20055|NCT04072120|Geographical proximity|geographical proximity
20056|NCT04072120|Family|family
20057|NCT04072120|Relatives|relatives
20058|NCT04072120|Survival analysis|survival analysis
20059|NCT04072107|nasopharyngeal carcinoma|nasopharyngeal carcinoma
20060|NCT04072107|EBV DNA|ebv dna
20061|NCT04072107|Biomarker-guided|biomarker-guided
20062|NCT04072107|Treatment adaptation|treatment adaptation
20063|NCT04072055|Unicompartmental Knee Arthroplasty|unicompartmental knee arthroplasty
20064|NCT04072055|UKA|uka
20065|NCT04072055|antomic femoral component|antomic femoral component
20066|NCT04072055|anatomic tibial component|anatomic tibial component
20067|NCT04072003|Left main, bifurcation, IVUS,PCI|left main, bifurcation, ivus,pci
20068|NCT04071990|Family based intervention|family based intervention
20069|NCT04071990|Cognitive behavioral group therapy|cognitive behavioral group therapy
20070|NCT04071990|Exposure and response prevention|exposure and response prevention
20071|NCT04071990|Family accommodation|family accommodation
20072|NCT04071977|Vitreous humor|vitreous humor
20073|NCT04071977|Vitrectomy|vitrectomy
20074|NCT04071977|Aqueous humor|aqueous humor
20075|NCT04071977|Antioxidant therapy|antioxidant therapy
20076|NCT04071977|Oxidative markers|oxidative markers
20077|NCT04071964|Microbiota|microbiota
20078|NCT04071925|urethral stricture disease|urethral stricture disease
20079|NCT04071925|urethral stricture|urethral stricture
20080|NCT04071925|urethra|urethra
20081|NCT04071925|urethroplasty|urethroplasty
20082|NCT04071899|REM Sleep Behavior Disorder|rem sleep behavior disorder
20083|NCT04071899|Validation scale|validation scale
20084|NCT04071886|eye-tracking|eye-tracking
20085|NCT04071886|eye movement|eye movement
20086|NCT04071886|mindfulness|mindfulness
20087|NCT04071782|Angioplasty|angioplasty
20088|NCT04071756|Solid Tumor|solid tumor
20089|NCT04071756|Hand-Foot Skin Reaction (HFSR)|hand-foot skin reaction (hfsr)
20090|NCT04071730|Immulina|immulina
20091|NCT04071730|Natural Killer Cells (NK)|natural killer cells (nk)
20092|NCT04071730|Dietary supplementation|dietary supplementation
20093|NCT04071717|NIRS|nirs
20094|NCT04071717|fNIRS|fnirs
20095|NCT04071717|Neurofeedback|neurofeedback
20096|NCT04071717|Obesity|obesity
20097|NCT04071704|health-related quality of life|health-related quality of life
20098|NCT04071704|life satisfaction|life satisfaction
20099|NCT04071704|treatment-related effects|treatment-related effects
20100|NCT04071704|quality of life measure|quality of life measure
20101|NCT04071626|ertugliflozin|ertugliflozin
20102|NCT04071626|SGLT2 inhibtion|sglt2 inhibtion
20103|NCT04071626|Cardiovascular Diseases|cardiovascular diseases
20104|NCT04071626|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors
20105|NCT04071626|Glucose Metabolism Disorders|glucose metabolism disorders
20106|NCT04071626|Physiological Effects of Drugs|physiological effects of drugs
20107|NCT04071626|Diabetes Mellitus|diabetes mellitus
20108|NCT04071626|Diabetes Mellitus, Type 2|diabetes mellitus, type 2
20358|NCT04070092|Quality of life|quality of life
20109|NCT04071626|Endocrine System Diseases|endocrine system diseases
20110|NCT04071600|neuropeptide Y|neuropeptide y
20111|NCT04071600|intranasal|intranasal
20112|NCT04071600|biomarkers|biomarkers
20120|NCT04071561|Adrenalectomy|adrenalectomy
20121|NCT04071561|Minimally invasive surgery|minimally invasive surgery
20122|NCT04071561|Posterior Retroperitoneoscopic adrenalectomy|posterior retroperitoneoscopic adrenalectomy
20123|NCT04071561|Retroperitoneal fat mass|retroperitoneal fat mass
20124|NCT04071535|Small fiber neuropathy|small fiber neuropathy
20125|NCT04071535|Diabetic neuropathies|diabetic neuropathies
20126|NCT04071535|Skin biopsy|skin biopsy
20127|NCT04071522|low back pain|low back pain
20128|NCT04071522|turkish language|turkish language
20129|NCT04071522|pain beliefs|pain beliefs
20130|NCT04071522|validity|validity
20131|NCT04071509|Lung Biopsy, pneumothorax, interventional radiology|lung biopsy, pneumothorax, interventional radiology
20132|NCT04071444|Baduanjin program|baduanjin program
20133|NCT04071444|constipation|constipation
20134|NCT04071444|intestinal peristalsis|intestinal peristalsis
20135|NCT04071444|schizophrenia spectrum|schizophrenia spectrum
20136|NCT04071431|Early Detection of cancer|early detection of cancer
20137|NCT04071431|Gastrointestinal Neoplasms|gastrointestinal neoplasms
20138|NCT04071431|Endoscopy, Gastrointestinal|endoscopy, gastrointestinal
20139|NCT04071418|recurrent lung cancer|recurrent lung cancer
20140|NCT04071418|I-125 seeds implantation|i-125 seeds implantation
20141|NCT04071418|radiotherapy|radiotherapy
20142|NCT04071405|Ulcerative colitis|ulcerative colitis
20143|NCT04071405|Autoimmune Diseases|autoimmune diseases
20144|NCT04071405|Immune System Diseases|immune system diseases
20145|NCT04071405|Tofacitinib|tofacitinib
20146|NCT04071405|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action
20147|NCT04071405|Jak inhibitor|jak inhibitor
20148|NCT04071405|safety|safety
20149|NCT04071392|hysterosalpingogram (HSG)|hysterosalpingogram (hsg)
20150|NCT04071392|permanent contraception|permanent contraception
20151|NCT04071392|tubal occlusion|tubal occlusion
20152|NCT04071392|tubal patency|tubal patency
20153|NCT04071366|Cytokine release syndrome|cytokine release syndrome
20154|NCT04071366|immune effector cell-associated neurotoxicity syndrome|immune effector cell-associated neurotoxicity syndrome
20155|NCT04071366|Janus kinase inhibitor|janus kinase inhibitor
20156|NCT04071366|tisagenlecleucel|tisagenlecleucel
20157|NCT04071366|axicabtagene ciloleucel|axicabtagene ciloleucel
20158|NCT04071366|immune effector cell therapy|immune effector cell therapy
20159|NCT04071353|chronic hepatitis C|chronic hepatitis c
20160|NCT04071353|Interferon|interferon
20161|NCT04071353|Ribavirin|ribavirin
20162|NCT04071353|Clinical outcome|clinical outcome
20163|NCT04071314|Microbiota|microbiota
20164|NCT04071314|Gastrointestinal Microbiome|gastrointestinal microbiome
20165|NCT04071314|Diet|diet
20166|NCT04071314|Signs and Symptoms|signs and symptoms
20167|NCT04071314|Quality of Life|quality of life
20168|NCT04071314|Anxiety|anxiety
20169|NCT04071314|Depression|depression
20170|NCT04071249|Combined Symptom and Medication Score (CSMS)|combined symptom and medication score (csms)
20171|NCT04071249|Validation|validation
20172|NCT04071197|bile canalicular transport disorders|bile canalicular transport disorders
20173|NCT04071184|gastric cancer|gastric cancer
20174|NCT04071184|metastases|metastases
20175|NCT04071184|patients with previous treatment failures|patients with previous treatment failures
20176|NCT04071184|FGFR2 abnormalities|fgfr2 abnormalities
20185|NCT04071119|oxytocin|oxytocin
20186|NCT04071119|craving|craving
20187|NCT04071119|alcohol use disorder|alcohol use disorder
20188|NCT04071119|smoking|smoking
20189|NCT04071119|cigarettes|cigarettes
20190|NCT04071119|drinking|drinking
20191|NCT04071119|functional magnetic resonance imaging|functional magnetic resonance imaging
20192|NCT04071119|cue-reactivity|cue-reactivity
20193|NCT04071106|Psoriasis|psoriasis
20194|NCT04071106|Turmeric|turmeric
20195|NCT04071106|Curcumin|curcumin
20196|NCT04071106|Olive oil|olive oil
20197|NCT04071106|Dermoscopy|dermoscopy
20198|NCT04071106|NFkB|nfkb
20199|NCT04071041|Community-acquired Pneumonia|community-acquired pneumonia
20200|NCT04071041|Albumin|albumin
20201|NCT04071041|Inflammation|inflammation
20202|NCT04071028|footbath|footbath
20203|NCT04071028|parasympathetic activity|parasympathetic activity
20204|NCT04071028|primary dysmenorrhea|primary dysmenorrhea
20205|NCT04071028|sympathetic activity|sympathetic activity
20206|NCT04071015|vital signs|vital signs
20207|NCT04071015|blood pressure|blood pressure
20208|NCT04071015|cardiac surgery|cardiac surgery
20216|NCT04070963|Incidence of Diabetes Mellitus|incidence of diabetes mellitus
20218|NCT04070911|Perioperative nursing|perioperative nursing
20219|NCT04070911|Postanesthesia care|postanesthesia care
20220|NCT04070911|Thirst|thirst
20221|NCT04070911|Water|water
20222|NCT04070911|Ice|ice
20223|NCT04070898|Laparoscopic colectomy|laparoscopic colectomy
20224|NCT04070898|urinary catheter|urinary catheter
20225|NCT04070898|acute urinary retention|acute urinary retention
20226|NCT04070859|internal fixation|internal fixation
20227|NCT04070833|stroke|stroke
20228|NCT04070833|stroke outcomes|stroke outcomes
20229|NCT04070833|vitamin D|vitamin d
20230|NCT04070833|omega-3 fatty acid|omega-3 fatty acid
20231|NCT04070820|Combination therapy|combination therapy
20232|NCT04070820|Bloodstream Infection|bloodstream infection
20233|NCT04070820|Enterococcus faecalis Infection|enterococcus faecalis infection
20234|NCT04070820|Endocarditis|endocarditis
20235|NCT04070807|AML|aml
20236|NCT04070807|BCL-2|bcl-2
20237|NCT04070807|anti BCL2 inhibitors|anti bcl2 inhibitors
20238|NCT04070807|clinical practice|clinical practice
20239|NCT04070781|Steroid Refractory GVHD|steroid refractory gvhd
20240|NCT04070768|relapsed|relapsed
20241|NCT04070768|refractory|refractory
20242|NCT04070768|CD33+|cd33+
20243|NCT04070703|Cognitive function|cognitive function
20244|NCT04070703|mild cognitive impairment|mild cognitive impairment
20245|NCT04070703|Tai Ji Quan|tai ji quan
20246|NCT04070690|metabolic acidosis|metabolic acidosis
20247|NCT04070690|sodium bicarbonate|sodium bicarbonate
20248|NCT04070690|hemodialysis|hemodialysis
20249|NCT04070690|dialysate|dialysate
20250|NCT04070677|Acute Esophagitis|acute esophagitis
20251|NCT04070677|Radiotherapy|radiotherapy
20252|NCT04070677|Ziverel|ziverel
20253|NCT04070677|Chondroitin sulfate|chondroitin sulfate
20254|NCT04070677|Hyaluronic acid|hyaluronic acid
20255|NCT04070677|Poloxamer 407|poloxamer 407
20256|NCT04070677|Chemoradiotherapy|chemoradiotherapy
20257|NCT04070677|Chemotherapy|chemotherapy
20258|NCT04070664|Vertigo|vertigo
20259|NCT04070664|Central vertigo|central vertigo
20260|NCT04070664|Peripheral vertigo|peripheral vertigo
20261|NCT04070664|Thiol/disulfide homeostasis|thiol/disulfide homeostasis
20262|NCT04070664|Ischemia modified albumin|ischemia modified albumin
20263|NCT04070664|Differential diagnosis|differential diagnosis
20270|NCT04070612|Children|children
20271|NCT04070586|Lung cancer|lung cancer
20272|NCT04070586|Radiotherapy|radiotherapy
20273|NCT04070586|4DCBCT|4dcbct
20274|NCT04070573|Preterm preeclampsia|preterm preeclampsia
20275|NCT04070573|Preeclampsia with severe features|preeclampsia with severe features
20276|NCT04070573|High risk pregnancy|high risk pregnancy
20277|NCT04070573|Low dose aspirin|low dose aspirin
20278|NCT04070573|Cell free RNA|cell free rna
20279|NCT04070560|umbilical cord|umbilical cord
20280|NCT04070547|Cognitive function|cognitive function
20281|NCT04070547|transcutaneous vagal nerve stimulation|transcutaneous vagal nerve stimulation
20282|NCT04070547|autonomic nervous system|autonomic nervous system
20283|NCT04070547|cognitive health/impairment|cognitive health/impairment
20284|NCT04070521|Electroencephalogram|electroencephalogram
20285|NCT04070521|Opioids|opioids
20286|NCT04070521|Alcohol|alcohol
20287|NCT04070521|Benzodiazepines|benzodiazepines
20288|NCT04070521|Alpha-2 agonists|alpha-2 agonists
20289|NCT04070521|Propofol|propofol
20290|NCT04070521|Ketamine|ketamine
20291|NCT04070521|Marijuana|marijuana
20292|NCT04070521|Neuromechanisms of intoxicants|neuromechanisms of intoxicants
20293|NCT04070508|early detection|early detection
20294|NCT04070508|alcoholic liver disease|alcoholic liver disease
20295|NCT04070508|alcohol|alcohol
20296|NCT04070482|Tenofovir|tenofovir
20297|NCT04070482|HIV-exposed infants|hiv-exposed infants
20298|NCT04070482|renal injury|renal injury
20299|NCT04070469|amoxycillin|amoxycillin
20300|NCT04070469|drug kinetics|drug kinetics
20301|NCT04070469|drug toxicity|drug toxicity
20302|NCT04070469|crystalluria|crystalluria
20306|NCT04070443|Clinical Trial, Phase II|clinical trial, phase ii
20307|NCT04070443|Tyrosine Kinase Inhibitors|tyrosine kinase inhibitors
20308|NCT04070443|Induction phase|induction phase
20309|NCT04070443|Consolidation phase|consolidation phase
20310|NCT04070430|Arthroscopic hip surgery|arthroscopic hip surgery
20311|NCT04070417|Depression|depression
20312|NCT04070417|Lifestyle Medicine|lifestyle medicine
20313|NCT04070404|Anaesthesia|anaesthesia
20314|NCT04070404|Preoxygenation|preoxygenation
20315|NCT04070391|vitamin B6|vitamin b6
20316|NCT04070391|contraception|contraception
20317|NCT04070391|depression|depression
20318|NCT04070326|Lanadelumab|lanadelumab
20319|NCT04070300|Exercise Training|exercise training
20320|NCT04070287|HIV Prevention|hiv prevention
20321|NCT04070287|HIV self-testing|hiv self-testing
20322|NCT04070287|young people|young people
20323|NCT04070287|Nigeria|nigeria
20324|NCT04070248|Lung Microbiome|lung microbiome
20325|NCT04070248|COPD|copd
20326|NCT04070248|HIV/AIDS|hiv/aids
20327|NCT04070235|Hepatitis C virus|hepatitis c virus
20328|NCT04070235|SH229|sh229
20329|NCT04070222|Secondary infertility, cesarean section, post-cesarean section scar diverticulum , endometrial microflora, inflammatory markers, clinical pregnancy, live birth|secondary infertility, cesarean section, post-cesarean section scar diverticulum , endometrial microflora, inflammatory markers, clinical pregnancy, live birth
20330|NCT04070196|Peritonitis|peritonitis
20331|NCT04070196|point-of-care test|point-of-care test
20332|NCT04070196|Peritoneal Dialysis|peritoneal dialysis
20333|NCT04070170|Low-Level Light Therapy|low-level light therapy
20334|NCT04070170|Tooth Movement|tooth movement
20335|NCT04070170|Bone Remodeling|bone remodeling
20336|NCT04070157|Opioid Withdrawal Syndrome|opioid withdrawal syndrome
20337|NCT04070157|OWS|ows
20338|NCT04070157|Opioid taper|opioid taper
20339|NCT04070157|Opioid withdrawal|opioid withdrawal
20340|NCT04070157|Opioid reduction|opioid reduction
20341|NCT04070157|Stopping opioids|stopping opioids
20342|NCT04070157|Opioid discontinuation|opioid discontinuation
20343|NCT04070157|non-opioid pain management|non-opioid pain management
20344|NCT04070144|Spinal puncture|spinal puncture
20345|NCT04070144|Lumbar puncture|lumbar puncture
20346|NCT04070131|Child Behavior|child behavior
20347|NCT04070131|Neurologic Gait Disorder|neurologic gait disorder
20348|NCT04070131|Cancer|cancer
20349|NCT04070131|Physical Therapy Modalities|physical therapy modalities
20350|NCT04070131|Physical Therapy Specialty|physical therapy specialty
20351|NCT04070131|Physical and Rehabilitation Medicine|physical and rehabilitation medicine
20352|NCT04070131|Rehabilitation|rehabilitation
20353|NCT04070092|Traumatic Brain Injury|traumatic brain injury
20354|NCT04070092|Elderly|elderly
20355|NCT04070092|Cognitive Impairment|cognitive impairment
20356|NCT04070092|Motor impairment|motor impairment
20357|NCT04070092|Brain injury|brain injury
20359|NCT04070092|Impact|impact
20360|NCT04070092|Health care economic costs|health care economic costs
20361|NCT04070066|Newborn, infant|newborn, infant
20362|NCT04070066|exchange-transfusion|exchange-transfusion
20363|NCT04070027|Total Hip Arthroplasty|total hip arthroplasty
20364|NCT04070027|Total Hip Replacement|total hip replacement
20365|NCT04070027|Exercise|exercise
20366|NCT04070027|Progressive Resistance Training|progressive resistance training
20367|NCT04070027|Strength Training|strength training
20368|NCT04070027|Hip Joint|hip joint
20369|NCT04070001|Pain|pain
20370|NCT04070001|Elastomeric separator|elastomeric separator
20371|NCT04070001|Laser|laser
20372|NCT04070001|Ibuprofen|ibuprofen
20373|NCT04070001|Gingival crevicular fluid|gingival crevicular fluid
20374|NCT04069988|Baduanjin|baduanjin
20375|NCT04069988|body mass index|body mass index
20376|NCT04069988|metabolic parameters|metabolic parameters
20377|NCT04069988|metabolic syndrome|metabolic syndrome
20378|NCT04069988|schizophrenia|schizophrenia
20379|NCT04069975|Early Detection of cancer|early detection of cancer
20380|NCT04069975|Gastrointestinal Neoplasms|gastrointestinal neoplasms
20381|NCT04069975|Endoscopy, Gastrointestinal|endoscopy, gastrointestinal
20382|NCT04069962|cancer|cancer
20383|NCT04069962|older persons|older persons
20384|NCT04069962|comprehensive geriatric assessment|comprehensive geriatric assessment
20385|NCT04069962|geriatric interventions|geriatric interventions
20386|NCT04069962|patient compliance|patient compliance
20387|NCT04069949|Sorafenib|sorafenib
20388|NCT04069949|Toripalimab|toripalimab
20389|NCT04069949|Unresectable|unresectable
20390|NCT04069949|Hepatocellular Cancer|hepatocellular cancer
20391|NCT04069949|Portal Vein Tumor Thrombus|portal vein tumor thrombus
20392|NCT04069936|metastatic|metastatic
20393|NCT04069936|locally advanced|locally advanced
20394|NCT04069936|lung cancer|lung cancer
20395|NCT04069936|non-small cell lung cancer|non-small cell lung cancer
20396|NCT04069936|unresectable|unresectable
20397|NCT04069936|NSCLC|nsclc
20398|NCT04069897|Botulinum Toxin Type A|botulinum toxin type a
20399|NCT04069897|Sphenopalatine Ganglion Block|sphenopalatine ganglion block
20400|NCT04069897|Autonomic Nerve Block|autonomic nerve block
20401|NCT04069897|Injections|injections
20402|NCT04069806|Nausea|nausea
20403|NCT04069806|Vomiting|vomiting
20404|NCT04069806|Oral carbohydrate|oral carbohydrate
20405|NCT04069806|Fasting|fasting
20406|NCT04069793|Transradial Amputee|transradial amputee
20407|NCT04069780|Suprachoroidal injection|suprachoroidal injection
20408|NCT04069780|Diabetic macular edema|diabetic macular edema
20409|NCT04069780|Tiamicinolone acetonide|tiamicinolone acetonide
20410|NCT04069767|Physiotherapy|physiotherapy
20411|NCT04069767|Rehabilitation|rehabilitation
20412|NCT04069767|Trunk Stability|trunk stability
20414|NCT04069767|Sub-acute|sub-acute
20415|NCT04069767|Innovative|innovative
20416|NCT04069767|Randomized controlled trial|randomized controlled trial
20417|NCT04069767|Qualitative study|qualitative study
20418|NCT04069767|Gait|gait
20419|NCT04069767|Balance|balance
20420|NCT04069754|trauma|trauma
20421|NCT04069754|stress|stress
20422|NCT04069754|depression|depression
20423|NCT04069754|coping|coping
20424|NCT04069754|mindfulness|mindfulness
20425|NCT04069715|LDL-C|ldl-c
20426|NCT04069715|Blood pressure|blood pressure
20427|NCT04069715|triglycerides|triglycerides
20428|NCT04069715|HDL-C|hdl-c
20429|NCT04069715|total cholesterol|total cholesterol
20430|NCT04069715|endothelial vasodilation|endothelial vasodilation
20431|NCT04069715|Hyperlipidemias|hyperlipidemias
20432|NCT04069715|Hypertension|hypertension
20433|NCT04069689|Clemizole|clemizole
20434|NCT04069676|Autism Spectrum Condition|autism spectrum condition
20435|NCT04069676|predictive coding|predictive coding
20436|NCT04069676|visual perception|visual perception
20437|NCT04069676|electroencephalography|electroencephalography
20438|NCT04069676|autonomous nervous system|autonomous nervous system
20439|NCT04069676|heart rate variability|heart rate variability
20440|NCT04069676|electrodermal reactivity|electrodermal reactivity
20441|NCT04069637|Titanium Levels|titanium levels
20442|NCT04069624|MOUD|moud
20443|NCT04069624|OUD|oud
20444|NCT04069624|Telehealth|telehealth
20445|NCT04069624|Navigator|navigator
20446|NCT04069559|Refugees health|refugees health
20447|NCT04069559|Contact hypothesis|contact hypothesis
20448|NCT04069559|Nursing students|nursing students
20449|NCT04069559|Attitudes|attitudes
20450|NCT04069559|Randomized controlled trial|randomized controlled trial
20451|NCT04069546|Acute Ischemic Stroke|acute ischemic stroke
20452|NCT04069546|Remote ischemic preconditioning|remote ischemic preconditioning
20453|NCT04069546|Stroke-induced immunodeficiency|stroke-induced immunodeficiency
20454|NCT04069546|Stroke-associated Pneumonia|stroke-associated pneumonia
20455|NCT04069546|inflammation response|inflammation response
20456|NCT04069533|anemia|anemia
20457|NCT04069533|bone marrow failure|bone marrow failure
20458|NCT04069533|gene therapy|gene therapy
20459|NCT04069507|Biopsychosocial health|biopsychosocial health
20460|NCT04069507|Clinical prediction tool|clinical prediction tool
20461|NCT04069507|Patient-reported outcomes|patient-reported outcomes
20462|NCT04069507|Movement pattern training|movement pattern training
20463|NCT04069494|symptoms|symptoms
20464|NCT04069494|predictor|predictor
20465|NCT04069494|information needs|information needs
20466|NCT04069494|self-management at home|self-management at home
20467|NCT04069494|palliative radiotherapy|palliative radiotherapy
20468|NCT04069481|Dance|dance
20469|NCT04069481|Stroke|stroke
20470|NCT04069481|Randomized Controlled Trial|randomized controlled trial
20471|NCT04069481|Rehabilitation|rehabilitation
20472|NCT04069481|Gait|gait
20473|NCT04069481|Balance|balance
20474|NCT04069468|Prospective Registry|prospective registry
20475|NCT04069468|TheraSphere®|therasphere®
20476|NCT04069468|France|france
20477|NCT04069468|SIRT|sirt
20478|NCT04069468|Liver Cancer, Adult|liver cancer, adult
20479|NCT04069468|Liver Cell Carcinoma|liver cell carcinoma
20480|NCT04069468|Hepatoma|hepatoma
20481|NCT04069468|Intra arterial treatment|intra arterial treatment
20482|NCT04069455|electronic patient reported outcomes|electronic patient reported outcomes
20483|NCT04069455|gastric carcinoma|gastric carcinoma
20484|NCT04069455|colorectal carcinoma|colorectal carcinoma
20485|NCT04069455|adjuvant chemotherapy|adjuvant chemotherapy
20486|NCT04069455|quality of life|quality of life
20487|NCT04069416|liver transplant|liver transplant
20488|NCT04069416|HCC|hcc
20489|NCT04069416|Extended milan|extended milan
20490|NCT04069416|Living donor liver transplantation|living donor liver transplantation
20491|NCT04069403|Opioids|opioids
20492|NCT04069403|Prescription|prescription
20493|NCT04069403|Patterns|patterns
20494|NCT04069403|Nudge|nudge
20495|NCT04069403|Practices|practices
20496|NCT04069377|Cardiopulmonary Resuscitation|cardiopulmonary resuscitation
20497|NCT04069377|Chest compression|chest compression
20498|NCT04069377|Manuel|manuel
20499|NCT04069377|Mechanical|mechanical
20500|NCT04069338|Lithotripsy|lithotripsy
20501|NCT04069338|Extracorporeal shockwave lithotripsy|extracorporeal shockwave lithotripsy
20502|NCT04069325|gout|gout
20503|NCT04069325|acute flares|acute flares
20504|NCT04069325|prevention|prevention
20505|NCT04069325|febuxostat|febuxostat
20506|NCT04069312|Chronic Obstructive Pulmonary Disease|chronic obstructive pulmonary disease
20507|NCT04069312|Chronic Bronchitis|chronic bronchitis
20508|NCT04069312|COPD|copd
20509|NCT04069312|Roflumilast|roflumilast
20510|NCT04069312|Daliresp|daliresp
20511|NCT04069312|Azithromycin|azithromycin
20512|NCT04069260|aminoglycoside|aminoglycoside
20513|NCT04069260|translational read-through|translational read-through
20514|NCT04069260|cystinosis|cystinosis
20515|NCT04069260|nonsense mutation|nonsense mutation
20516|NCT04069247|cognitive behavioral therapy|cognitive behavioral therapy
20517|NCT04069247|insomnia|insomnia
20518|NCT04069247|depression|depression
20519|NCT04069247|suicide|suicide
20520|NCT04069247|youth|youth
20521|NCT04069234|myocardial infarction|myocardial infarction
20522|NCT04069234|percutaneous coronary invervention|percutaneous coronary invervention
20523|NCT04069234|coronary flow velocity reserve (CFR)|coronary flow velocity reserve (cfr)
20524|NCT04069208|Acute Myeloid Leukemia|acute myeloid leukemia
20525|NCT04069208|ultra-high dose idarubicin|ultra-high dose idarubicin
20526|NCT04069208|induction|induction
20527|NCT04069195|Inflammation|inflammation
20528|NCT04069195|DHA|dha
20529|NCT04069195|Pregnancy|pregnancy
20530|NCT04069195|preterm|preterm
20531|NCT04069195|overweight|overweight
20532|NCT04069182|Depression|depression
20533|NCT04069182|Anxiety|anxiety
20534|NCT04069182|Medicine students|medicine students
20535|NCT04069156|heart failure|heart failure
805319|NCT00232934|Diagnosis|diagnosis
20536|NCT04069156|ventricular assist device|ventricular assist device
20537|NCT04069156|LVAD|lvad
20538|NCT04069156|aspirin|aspirin
20539|NCT04069104|Melanoma identification|melanoma identification
20540|NCT04069052|Dyspnea|dyspnea
20541|NCT04069052|Exertional Dyspnea|exertional dyspnea
20542|NCT04069052|Dead Space|dead space
20543|NCT04069052|Exercise|exercise
20544|NCT04069052|Inspiratory Neural Drive|inspiratory neural drive
20545|NCT04069039|Stroke|stroke
20546|NCT04069039|Trunk|trunk
20547|NCT04069039|Lower Extremities|lower extremities
20548|NCT04069039|Gait|gait
20549|NCT04069026|Non-small cell lung cancer (NSCLC)|non-small cell lung cancer (nsclc)
20550|NCT04069026|Head and neck squamous cell carcinoma (HNSCC)|head and neck squamous cell carcinoma (hnscc)
20551|NCT04069026|Colorectal cancer microsatellite stable (MSS)|colorectal cancer microsatellite stable (mss)
20552|NCT04069026|Advanced cancer|advanced cancer
20553|NCT04069026|Immunotherapy|immunotherapy
20554|NCT04069026|Immuno oncology|immuno oncology
20555|NCT04069026|Aryl Hydrocarbon Receptor inhibitor(AhRi)|aryl hydrocarbon receptor inhibitor(ahri)
20556|NCT04069026|Aryl Hydrocarbon Receptor|aryl hydrocarbon receptor
20557|NCT04069013|Percutaneous Nephrolithotomy|percutaneous nephrolithotomy
20558|NCT04069013|PCNL|pcnl
20559|NCT04069000|Social-Emotional Learning|social-emotional learning
20560|NCT04069000|Classroom Climate|classroom climate
20561|NCT04069000|Self-concept|self-concept
20562|NCT04069000|Academic Skills|academic skills
20563|NCT04068987|magnetic resonance imaging|magnetic resonance imaging
20564|NCT04068987|parametric mapping|parametric mapping
20565|NCT04068974|Ovarian Cancer|ovarian cancer
20566|NCT04068974|Recurrent Platinum-resistant|recurrent platinum-resistant
20567|NCT04068961|CGH array chip|cgh array chip
20568|NCT04068961|Homozygosity mapping|homozygosity mapping
20569|NCT04068922|aging|aging
20570|NCT04068922|resilience|resilience
20571|NCT04068922|low back pain|low back pain
20572|NCT04068922|positive affect|positive affect
20573|NCT04068922|hope|hope
20574|NCT04068922|self-efficacy|self-efficacy
20575|NCT04068922|acceptance|acceptance
20576|NCT04068909|coronary artery disease|coronary artery disease
20577|NCT04068909|death|death
20578|NCT04068909|gene|gene
20579|NCT04068909|bleeding|bleeding
20580|NCT04068909|atherosclerosis|atherosclerosis
20581|NCT04068857|schizophrenia|schizophrenia
20582|NCT04068857|schizoaffective disorder|schizoaffective disorder
20583|NCT04068857|psychosis|psychosis
20584|NCT04068857|early phase|early phase
20585|NCT04068844|Exercise|exercise
20586|NCT04068844|Hemodynamics,|hemodynamics,
20587|NCT04068844|Heart failure|heart failure
20588|NCT04068831|Talazoparib|talazoparib
20589|NCT04068831|Avelumab|avelumab
20590|NCT04068831|19-195|19-195
20591|NCT04068753|Cervix Cancer|cervix cancer
20592|NCT04068753|Niraparib|niraparib
20593|NCT04068753|TSR-042|tsr-042
20594|NCT04068701|ACL|acl
20595|NCT04068701|Biofeedback|biofeedback
20596|NCT04068701|Injury Prevention|injury prevention
20597|NCT04068701|Virtual Reality|virtual reality
20598|NCT04068688|NDBI|ndbi
20599|NCT04068688|Autism|autism
20600|NCT04068662|intimate partner violence|intimate partner violence
20601|NCT04068662|resilience, psychological|resilience, psychological
20602|NCT04068623|Triple negative breast cancer|triple negative breast cancer
20603|NCT04068623|NLR (Neutrophil-to-Lymphocyte Ratio)|nlr (neutrophil-to-lymphocyte ratio)
20604|NCT04068623|TILs (Tumor Infiltrating Lymphocytes)|tils (tumor infiltrating lymphocytes)
20605|NCT04068623|Peripheral blood cells|peripheral blood cells
20606|NCT04068610|Microsatellite|microsatellite
20607|NCT04068610|colorectal|colorectal
20608|NCT04068610|MSS-CRC|mss-crc
20609|NCT04068610|colon cancer|colon cancer
20610|NCT04068480|capsule endoscopy|capsule endoscopy
21209|NCT04064957|stem cells|stem cells
20611|NCT04068480|magnetically assisted capsule endoscopy|magnetically assisted capsule endoscopy
20612|NCT04068480|MACE|mace
20613|NCT04068480|Esophagus|esophagus
20614|NCT04068467|Schizophrenia|schizophrenia
20615|NCT04068467|Schizoaffective Disorder|schizoaffective disorder
20616|NCT04068467|Mobile Application|mobile application
20617|NCT04068467|SMI|smi
20618|NCT04068467|EHealth|ehealth
20619|NCT04068467|E-Health|e-health
20620|NCT04068467|Health Technology|health technology
20621|NCT04068467|mHealth|mhealth
20622|NCT04068467|m-Health|m-health
20623|NCT04068467|Mobile Health|mobile health
20624|NCT04068467|Serious Mental Illness|serious mental illness
20625|NCT04068467|Electronic Health|electronic health
20626|NCT04068428|Reproductive Health|reproductive health
20627|NCT04068428|Time to Pregnancy|time to pregnancy
20628|NCT04068428|Infertility|infertility
20629|NCT04068428|Risk Factor|risk factor
20630|NCT04068428|Assisted Reproductive Technology|assisted reproductive technology
20631|NCT04068428|Prospective Cohort|prospective cohort
20632|NCT04068415|Hospitalized patients|hospitalized patients
20633|NCT04068389|Atmospheric particles|atmospheric particles
20634|NCT04068376|cognitive decline|cognitive decline
20635|NCT04068376|double task|double task
20636|NCT04068376|older adults|older adults
20637|NCT04068350|Pediatrics|pediatrics
20638|NCT04068337|hemiarch replacement|hemiarch replacement
20639|NCT04068337|cardiopulmonary bypass|cardiopulmonary bypass
20640|NCT04068337|cannulation technique|cannulation technique
20641|NCT04068337|selective cerebral perfusion|selective cerebral perfusion
20642|NCT04068311|Geriatrics|geriatrics
20643|NCT04068311|Emergency Medicine|emergency medicine
20644|NCT04068311|Implementation|implementation
20645|NCT04068311|Consolidated Framework for Implementation Research|consolidated framework for implementation research
20646|NCT04068298|sepsis|sepsis
20647|NCT04068298|temperature gradient|temperature gradient
20648|NCT04068298|microcirculation|microcirculation
20649|NCT04068285|Type 2 diabetes mellitus|type 2 diabetes mellitus
20650|NCT04068285|exercise|exercise
20651|NCT04068285|aerobic|aerobic
20652|NCT04068285|interval|interval
20653|NCT04068285|continuous|continuous
20654|NCT04068285|gait|gait
20655|NCT04068272|Diabetes|diabetes
20656|NCT04068233|Diastolic function|diastolic function
20657|NCT04068233|Cardiac output|cardiac output
20658|NCT04068233|Pacemaker stimulation mode|pacemaker stimulation mode
20659|NCT04068233|Stroke volume|stroke volume
20660|NCT04068220|chiasmal, prechiasmal, lesion, endoscopic skull base surgery|chiasmal, prechiasmal, lesion, endoscopic skull base surgery
20661|NCT04068207|Retinitis Pigmentosa|retinitis pigmentosa
20662|NCT04068207|Minocycline|minocycline
20663|NCT04068207|ERG|erg
20664|NCT04068207|Inherited Retinal Dystrophy|inherited retinal dystrophy
20665|NCT04068207|Retinal Degenerative Disease|retinal degenerative disease
20666|NCT04068181|Melanoma|melanoma
20667|NCT04068181|Talimogene Laherparepvec|talimogene laherparepvec
20668|NCT04068181|Pembrolizumab|pembrolizumab
20669|NCT04068181|Oncolytic immunotherapy|oncolytic immunotherapy
20670|NCT04068181|Anti-PD-1|anti-pd-1
20671|NCT04068181|Checkpoint inhibitor|checkpoint inhibitor
20672|NCT04068181|MASTERKEY-115|masterkey-115
20673|NCT04068155|Squamous Cell Carcinoma|squamous cell carcinoma
20674|NCT04068155|Basal Cell Carcinoma|basal cell carcinoma
20675|NCT04068155|Skin Cancer|skin cancer
20676|NCT04068155|Skin Metastasis|skin metastasis
20677|NCT04068155|Superficial Sarcoma|superficial sarcoma
20678|NCT04068155|Alpha Radiation|alpha radiation
20679|NCT04068155|Cutaneous Lesion|cutaneous lesion
20680|NCT04068155|Brachytherapy|brachytherapy
20681|NCT04068155|Radiotherapy|radiotherapy
20682|NCT04068155|Lentigo maligna melanoma|lentigo maligna melanoma
20683|NCT04068155|Carcinosarcom|carcinosarcom
20684|NCT04068155|scalp cancer|scalp cancer
20685|NCT04068155|Lip cancer|lip cancer
20686|NCT04068155|Eyelid cancer|eyelid cancer
20687|NCT04068155|SCC|scc
20688|NCT04068142|Suicide|suicide
20689|NCT04068142|Suicide Prevention|suicide prevention
20690|NCT04068142|Safety Planning|safety planning
20691|NCT04068077|optical coherence tomography (OCT)|optical coherence tomography (oct)
20692|NCT04068077|amyloidosis|amyloidosis
20693|NCT04068077|pigmented diseases|pigmented diseases
20694|NCT04068077|skin diseases|skin diseases
20695|NCT04068077|dermatology|dermatology
20696|NCT04068077|pathology|pathology
20697|NCT04068077|H&E stain|h&e stain
20698|NCT04068051|Axsome|axsome
20699|NCT04068051|AXS-07|axs-07
20700|NCT04068051|MoSEIC meloxicam|moseic meloxicam
20701|NCT04068051|rizatriptan|rizatriptan
20702|NCT04068025|incontinence|incontinence
20703|NCT04068025|male|male
20704|NCT04068025|overactive bladder|overactive bladder
20705|NCT04068025|quality of life|quality of life
20706|NCT04067973|optic nerve|optic nerve
20707|NCT04067973|premature|premature
20708|NCT04067934|Paediatrics|paediatrics
20709|NCT04067934|Exercise|exercise
20710|NCT04067921|Precision Nutrition|precision nutrition
20711|NCT04067921|Nutritional Genetics|nutritional genetics
21617|NCT04062539|stroke|stroke
20719|NCT04067882|Genetic signature|genetic signature
20720|NCT04067882|Treatment response|treatment response
20721|NCT04067817|Goal-directed Fluid Therapy|goal-directed fluid therapy
20722|NCT04067817|norepinephrine|norepinephrine
20723|NCT04067817|phenylephrine|phenylephrine
20725|NCT04067804|Implementation Research|implementation research
20726|NCT04067804|School-based research|school-based research
20727|NCT04067804|Restorative Practices|restorative practices
20728|NCT04067791|Healthy|healthy
20729|NCT04067791|Adult|adult
20730|NCT04067791|Melatonin|melatonin
20731|NCT04067791|Pharmacokinetic|pharmacokinetic
20732|NCT04067791|Absorption|absorption
20733|NCT04067791|prolonged-release|prolonged-release
20734|NCT04067791|immediate-release|immediate-release
20735|NCT04067778|IBD|ibd
20736|NCT04067778|Dysplasia|dysplasia
20737|NCT04067778|Biopsy|biopsy
20738|NCT04067778|Colonoscopy|colonoscopy
20739|NCT04067765|Alcohol|alcohol
20740|NCT04067765|Neuroeconomics|neuroeconomics
20741|NCT04067765|Demand|demand
20742|NCT04067765|Cues|cues
20743|NCT04067752|dialysis|dialysis
20744|NCT04067752|ESRD|esrd
20745|NCT04067752|hemodialysis|hemodialysis
20746|NCT04067752|MRI|mri
20747|NCT04067726|Mammographic density|mammographic density
20748|NCT04067726|Breast cancer|breast cancer
20749|NCT04067726|RANKL|rankl
20750|NCT04067726|Denosumab|denosumab
20751|NCT04067726|Prevention|prevention
20752|NCT04067726|Premenopausal|premenopausal
20753|NCT04067687|palliative|palliative
20754|NCT04067687|cancer|cancer
20755|NCT04067687|pediatric|pediatric
20759|NCT04067648|Sufentanil|sufentanil
20760|NCT04067648|perfusion index|perfusion index
20761|NCT04067635|Mitral Valve Annuloplasty|mitral valve annuloplasty
20762|NCT04067635|Mitral Regurgitation|mitral regurgitation
20763|NCT04067635|Primary Mitral Regurgitation|primary mitral regurgitation
20764|NCT04067635|Chronic Mitral Regurgitation|chronic mitral regurgitation
20765|NCT04067635|Ventricular Reverse Remodeling|ventricular reverse remodeling
20766|NCT04067635|Ventricular Recovery|ventricular recovery
20767|NCT04067570|Prostate cancer|prostate cancer
20768|NCT04067570|PSA|psa
20769|NCT04067570|Radiation|radiation
20770|NCT04067544|paclitaxel|paclitaxel
20771|NCT04067544|chemotherapy-induced peripheral neuropathy|chemotherapy-induced peripheral neuropathy
20772|NCT04067544|breast cancer|breast cancer
20773|NCT04067544|gynecologic cancer|gynecologic cancer
20774|NCT04067518|Acute Lymphoblastic Leukemia|acute lymphoblastic leukemia
20775|NCT04067505|May-Thurner Syndrome|may-thurner syndrome
20776|NCT04067505|warfarin|warfarin
20777|NCT04067505|rivaroxaban|rivaroxaban
20778|NCT04067505|stent implantation|stent implantation
20779|NCT04067492|hyperuricemia|hyperuricemia
20780|NCT04067492|acute arthritis|acute arthritis
20781|NCT04067479|tendon|tendon
20782|NCT04067479|amino acid|amino acid
20783|NCT04067479|exercise|exercise
20789|NCT04067440|Microbiome|microbiome
20790|NCT04067440|Obesity|obesity
20791|NCT04067440|Chronic Liver Disease|chronic liver disease
20792|NCT04067388|iKnife|iknife
20793|NCT04067388|Mass sprectronomy|mass sprectronomy
20794|NCT04067349|laparoscopic|laparoscopic
20795|NCT04067349|minimal invasive|minimal invasive
20796|NCT04067349|physical recovery|physical recovery
20797|NCT04067349|liver surgery|liver surgery
20798|NCT04067336|AML|aml
20799|NCT04067336|Hematological malignancy|hematological malignancy
20800|NCT04067336|KMT2A|kmt2a
20801|NCT04067336|NPM1|npm1
20802|NCT04067323|obesity|obesity
20803|NCT04067323|medium chain triglycerides|medium chain triglycerides
20804|NCT04067323|blood lipid profile|blood lipid profile
20805|NCT04067310|barrier film|barrier film
20806|NCT04067310|spray skin protection|spray skin protection
20807|NCT04067310|liquid-film|liquid-film
20808|NCT04067310|barrier product|barrier product
20809|NCT04067297|Primary Prevention|primary prevention
20810|NCT04067297|Cardiovascular disease|cardiovascular disease
20811|NCT04067297|Lipids|lipids
20812|NCT04067297|Statins|statins
20813|NCT04067297|Lipid management|lipid management
20814|NCT04067297|Lipid screening|lipid screening
20815|NCT04067258|beta-thalassemia|beta-thalassemia
20816|NCT04067258|choroidal thickness|choroidal thickness
20817|NCT04067258|enhanced depth imaging|enhanced depth imaging
20818|NCT04067258|optical coherence tomography|optical coherence tomography
20819|NCT04067245|Home Total Parenteral Nutrition|home total parenteral nutrition
20820|NCT04067245|Tetrasodium EDTA catheter lock solution|tetrasodium edta catheter lock solution
20821|NCT04067245|Catheter Complications|catheter complications
20822|NCT04067245|Catheter-Related Thrombosis|catheter-related thrombosis
20823|NCT04067245|Catheter-Related Infections|catheter-related infections
20824|NCT04067232|Four Dimensional Computed Tomography (4D-CT)|four dimensional computed tomography (4d-ct)
20825|NCT04067219|Alterations|alterations
20826|NCT04067206|Premature|premature
20827|NCT04067206|Pain|pain
20828|NCT04067206|Comfort|comfort
20829|NCT04067206|Auditory Interventions|auditory interventions
20830|NCT04067193|old people|old people
20831|NCT04067193|fall|fall
20832|NCT04067193|elderly|elderly
20833|NCT04067193|fall detection|fall detection
20834|NCT04067193|usability|usability
20835|NCT04067193|satisfaction|satisfaction
20836|NCT04067193|ergonomy|ergonomy
20837|NCT04067193|shoes|shoes
20838|NCT04067180|allogeneic stem cell transplantation|allogeneic stem cell transplantation
20839|NCT04067180|Haplo-identical donors|haplo-identical donors
20840|NCT04067180|Matched unrelated donors|matched unrelated donors
20841|NCT04067180|Alternative stem cell donors|alternative stem cell donors
20842|NCT04067180|Post-transplantation cyclophosphamide|post-transplantation cyclophosphamide
20843|NCT04067180|Haplo-identical stem cell transplantation|haplo-identical stem cell transplantation
20844|NCT04067167|Cancer|cancer
20845|NCT04067167|Cachexia|cachexia
20846|NCT04067167|Muscular strength|muscular strength
20847|NCT04067167|Resistance training|resistance training
20848|NCT04067167|Body composition|body composition
20849|NCT04067167|Muscle mass|muscle mass
20850|NCT04067167|Physical exercise|physical exercise
20851|NCT04067167|Nutrition|nutrition
20852|NCT04067167|whole-body electromyostimulation|whole-body electromyostimulation
20853|NCT04067089|aortic stenosis|aortic stenosis
20854|NCT04067076|Mass Screening|mass screening
20855|NCT04067076|Health Surveys|health surveys
20856|NCT04067076|Mental Health|mental health
20857|NCT04067076|Suicidal Ideation|suicidal ideation
20858|NCT04067076|Young Adult|young adult
20859|NCT04067076|Interpersonal Relations|interpersonal relations
20860|NCT04067076|Smartphone|smartphone
20861|NCT04067063|Mass Screening|mass screening
20862|NCT04067063|Health Surveys|health surveys
20863|NCT04067063|Mental Health|mental health
20864|NCT04067063|Suicidal Ideation|suicidal ideation
20865|NCT04067037|Classical Hodgkin Lymphoma|classical hodgkin lymphoma
20866|NCT04067037|PD-1/PD-L1 Signaling Pathway|pd-1/pd-l1 signaling pathway
20867|NCT04067037|Camrelizumab|camrelizumab
20868|NCT04067024|regional anesthesia|regional anesthesia
20869|NCT04067011|Antibiotics|antibiotics
20870|NCT04067011|Pharmacokinetics|pharmacokinetics
20872|NCT04067011|Ciprofloxacin|ciprofloxacin
20873|NCT04067011|Doxycycline|doxycycline
20874|NCT04067011|CPG 7909|cpg 7909
20875|NCT04067011|Bacillus anthracis|bacillus anthracis
20876|NCT04067011|Anthrax Vaccine Adsorbed|anthrax vaccine adsorbed
20877|NCT04067011|Post-exposure Prophylaxis|post-exposure prophylaxis
20878|NCT04067011|Adjuvant|adjuvant
20879|NCT04066985|Depression|depression
20880|NCT04066985|Adolescent|adolescent
20881|NCT04066985|Therapeutics|therapeutics
20882|NCT04066985|Mental Health|mental health
20883|NCT04066959|emerging adults|emerging adults
20884|NCT04066959|ehealth intervention|ehealth intervention
20885|NCT04066959|diabetes|diabetes
20886|NCT04066959|diabetes management|diabetes management
20887|NCT04066959|adolescents|adolescents
20888|NCT04066959|self-determination theory|self-determination theory
20889|NCT04066946|scar|scar
20890|NCT04066946|arm|arm
20891|NCT04066946|brachioplasty|brachioplasty
20892|NCT04066946|microcurrent|microcurrent
20893|NCT04066946|interventional study|interventional study
20894|NCT04066933|Alpha 2 macroglobulin|alpha 2 macroglobulin
20895|NCT04066881|HIV|hiv
20896|NCT04066881|Vaccine|vaccine
20897|NCT04066881|Pre-exposure prophylaxis|pre-exposure prophylaxis
20898|NCT04066881|Africa|africa
20899|NCT04066868|patient-reported outcomes (PRO)|patient-reported outcomes (pro)
20900|NCT04066868|common terminology criteria for adverse events (CTCAE)|common terminology criteria for adverse events (ctcae)
20901|NCT04066868|quality of life|quality of life
20902|NCT04066868|electronic data assessment|electronic data assessment
20903|NCT04066829|Default settings|default settings
20904|NCT04066829|Opioid prescribing|opioid prescribing
20905|NCT04066829|Electronic Health Record|electronic health record
20906|NCT04066829|Opioid|opioid
20907|NCT04066829|Opioid Use|opioid use
20908|NCT04066829|Behavioral intervention|behavioral intervention
20909|NCT04066816|Colorectal cancer|colorectal cancer
20910|NCT04066816|Microbiome|microbiome
20911|NCT04066816|Urolithins|urolithins
20912|NCT04066816|Walnuts|walnuts
20913|NCT04066790|HER2-positive|her2-positive
20914|NCT04066790|neoadjuvant|neoadjuvant
20915|NCT04066764|venous thromboembolism|venous thromboembolism
20916|NCT04066764|rivaroxaban|rivaroxaban
20917|NCT04066764|vena cava filters|vena cava filters
20918|NCT04066738|MultiPoint Pacing|multipoint pacing
20919|NCT04066738|Acute Haemodynamic Response|acute haemodynamic response
20920|NCT04066699|Surgical Lung Resection|surgical lung resection
20921|NCT04066699|Percutaneous Localization|percutaneous localization
20922|NCT04066699|Electromagnetic Navigation|electromagnetic navigation
20923|NCT04066699|Transthoracic Localization|transthoracic localization
20924|NCT04066699|Peripheral Pulmonary Nodule(s)|peripheral pulmonary nodule(s)
20925|NCT04066686|Neck Injuries|neck injuries
20926|NCT04066660|Oligo Fucoidan|oligo fucoidan
20927|NCT04066608|Non-invasive Diagnostics|non-invasive diagnostics
20928|NCT04066582|optical coherence tomography (OCT)|optical coherence tomography (oct)
20929|NCT04066582|dermatology|dermatology
20930|NCT04066582|skin diseases|skin diseases
20931|NCT04066582|pathology|pathology
20932|NCT04066582|H&E stain|h&e stain
20933|NCT04066569|Diagnostic test|diagnostic test
20934|NCT04066569|Growth hormone|growth hormone
20935|NCT04066569|oral glucose tolerance test|oral glucose tolerance test
20936|NCT04066556|Stroke|stroke
20937|NCT04066556|Recanalization treatment|recanalization treatment
20938|NCT04066556|Outcome|outcome
20939|NCT04066556|Collateral|collateral
20940|NCT04066556|Thrombus|thrombus
20941|NCT04066556|CT|ct
20942|NCT04066556|Comorbidity|comorbidity
20943|NCT04066504|locally advanced basal cell carcinoma|locally advanced basal cell carcinoma
20944|NCT04066504|laBCC|labcc
20945|NCT04066491|Metastatic Biliary Tract Cancer|metastatic biliary tract cancer
20946|NCT04066491|Cholangiocarcinoma|cholangiocarcinoma
20947|NCT04066491|Gallbladder Cancer|gallbladder cancer
20948|NCT04066491|Ampullary cancer|ampullary cancer
20949|NCT04066491|M7824|m7824
20950|NCT04066491|Bintrafusp alfa|bintrafusp alfa
20951|NCT04066491|Transforming growth factor-beta|transforming growth factor-beta
20952|NCT04066491|Programmed death-ligand 1|programmed death-ligand 1
20953|NCT04066465|Brain Tumor|brain tumor
20954|NCT04066465|children and adolescents|children and adolescents
20955|NCT04066465|neurocognitive function|neurocognitive function
20956|NCT04066465|neurocognitive or neuropsychological outcome|neurocognitive or neuropsychological outcome
20957|NCT04066465|quality of life, LOQ|quality of life, loq
20958|NCT04066465|EEG|eeg
20959|NCT04066465|Neuropsychological Tests|neuropsychological tests
20960|NCT04066465|Proton Therapy|proton therapy
20961|NCT04066465|Neurosurgical Treatment|neurosurgical treatment
20962|NCT04066452|Amyloidosis|amyloidosis
20963|NCT04066426|naproxen sodium|naproxen sodium
20964|NCT04066426|codeine phosphate|codeine phosphate
20965|NCT04066426|dexamethasone|dexamethasone
20966|NCT04066426|pain|pain
20967|NCT04066426|trismus|trismus
20968|NCT04066426|temporomandibular joint|temporomandibular joint
20969|NCT04066413|infant formula|infant formula
20970|NCT04066413|human milk oligosaccharide|human milk oligosaccharide
20971|NCT04066413|HMO|hmo
20972|NCT04066413|growth|growth
20973|NCT04066400|hepatic inflammation|hepatic inflammation
20974|NCT04066361|Other Cancer|other cancer
20975|NCT04066348|tinnitus|tinnitus
20976|NCT04066348|etanercept|etanercept
20977|NCT04066348|tinnitus function index|tinnitus function index
20978|NCT04066348|tinnitus primary function|tinnitus primary function
20979|NCT04066348|functional MRI|functional mri
20980|NCT04066348|audiological evaluation|audiological evaluation
20981|NCT04066335|Observational Study, Safety, Nanoxel M, Docetaxel|observational study, safety, nanoxel m, docetaxel
20982|NCT04066309|Dental Implants|dental implants
20983|NCT04066309|Bone-Implant Interface|bone-implant interface
20984|NCT04066309|Mouth Rehabilitation|mouth rehabilitation
20985|NCT04066257|Drug-Drug interaction|drug-drug interaction
20986|NCT04066257|pharmacokinetic|pharmacokinetic
20987|NCT04066244|PET|pet
20988|NCT04066244|ALS|als
20989|NCT04066244|Microglia|microglia
20990|NCT04066205|Sleep deficiency, self-management|sleep deficiency, self-management
20991|NCT04066153|Palliative care|palliative care
20992|NCT04066153|Physical functioning|physical functioning
20993|NCT04066153|Unmet needs|unmet needs
20994|NCT04066140|patient activation|patient activation
20995|NCT04066140|self management|self management
20996|NCT04066127|Heart preservation|heart preservation
20997|NCT04066127|Ex-vivo perfusion|ex-vivo perfusion
20998|NCT04066127|Heart transplantation|heart transplantation
20999|NCT04066127|Acute cellular rejection|acute cellular rejection
21000|NCT04066127|Survival|survival
21001|NCT04066114|adult living-donor kidney transplant recipients|adult living-donor kidney transplant recipients
21002|NCT04066114|novel immunosuppressive (IS) therapy regimen|novel immunosuppressive (is) therapy regimen
21003|NCT04066114|lulizumab pegol (BMS-931699)|lulizumab pegol (bms-931699)
21004|NCT04066114|CD28 and IL-6 biologic blockade|cd28 and il-6 biologic blockade
21005|NCT04066114|CD28 and IL-6 receptor antagonists|cd28 and il-6 receptor antagonists
21006|NCT04066114|T regulatory cells (Treg) modulation|t regulatory cells (treg) modulation
21007|NCT04066101|caries risk, gene polymorphisms|caries risk, gene polymorphisms
21008|NCT04066062|CAD|cad
21009|NCT04066049|Spanish-speaking|spanish-speaking
21010|NCT04066049|caregiver-implemented intervention|caregiver-implemented intervention
21011|NCT04066049|bilingual|bilingual
21012|NCT04066036|HIV Integrase Inhibitors|hiv integrase inhibitors
21013|NCT04066036|Sub-Saharan Africa|sub-saharan africa
21014|NCT04066036|Anti-HIV Agents|anti-hiv agents
21015|NCT04066036|Medication Adherence|medication adherence
21016|NCT04066036|Virologic Failure|virologic failure
21017|NCT04066036|Viral Drug Resistance|viral drug resistance
21018|NCT04066036|South Africa|south africa
21019|NCT04066036|Uganda|uganda
21020|NCT04066036|HIV-1|hiv-1
21021|NCT04066023|Episodic cluster headache|episodic cluster headache
21022|NCT04066023|Chronic cluster headache|chronic cluster headache
21023|NCT04065984|Rectal Cancer|rectal cancer
21024|NCT04065984|Colorectal Cancer|colorectal cancer
21025|NCT04065984|Recurrent Rectal Cancer|recurrent rectal cancer
21026|NCT04065984|Advanced Rectal Cancer|advanced rectal cancer
21027|NCT04065984|Myopenia|myopenia
21028|NCT04065984|Sarcopenia|sarcopenia
21029|NCT04065984|Myosteatosis|myosteatosis
21030|NCT04065906|NIRS|nirs
21031|NCT04065906|fNIRS|fnirs
21032|NCT04065906|neurofeedback|neurofeedback
21033|NCT04065906|attention deficit hyperactivity disorder (ADHD)|attention deficit hyperactivity disorder (adhd)
21034|NCT04065906|children|children
21035|NCT04065880|lung resection|lung resection
21036|NCT04065880|TachoSil®|tachosil®
21037|NCT04065880|Neoveil®|neoveil®
21038|NCT04065880|air leak closure|air leak closure
21039|NCT04065880|drainage time|drainage time
21040|NCT04065867|Family|family
21041|NCT04065841|NASH|nash
21042|NCT04065841|Non alcoholic steatohepatitis|non alcoholic steatohepatitis
21043|NCT04065841|Tropifexor (LJN452)|tropifexor (ljn452)
21044|NCT04065841|Licogliflozin (LIK066)|licogliflozin (lik066)
21045|NCT04065815|Cancer|cancer
21046|NCT04065815|Cachexia|cachexia
21047|NCT04065815|Cardiorespiratory Fitness|cardiorespiratory fitness
21048|NCT04065815|Nutrition|nutrition
21049|NCT04065815|Protein intake|protein intake
21050|NCT04065815|Muscular strength|muscular strength
21051|NCT04065815|Body composition|body composition
21052|NCT04065815|High-intensity interval training|high-intensity interval training
21053|NCT04065815|Physical exercise|physical exercise
21054|NCT04065815|Resistance exercise|resistance exercise
21055|NCT04065815|whole-body electromyostimulation|whole-body electromyostimulation
21056|NCT04065789|multiple myeloma (MM)|multiple myeloma (mm)
21057|NCT04065789|Myeloma|myeloma
21058|NCT04065789|NDMM|ndmm
21059|NCT04065789|RRMM|rrmm
21060|NCT04065750|bacteremia|bacteremia
21061|NCT04065750|resistant bacteria|resistant bacteria
21062|NCT04065750|antibiotic|antibiotic
21063|NCT04065737|high-risk oral pre-malignant lesions|high-risk oral pre-malignant lesions
21064|NCT04065737|history of invasive oral cancer|history of invasive oral cancer
21065|NCT04065737|sintilimab|sintilimab
21066|NCT04065724|diabetes mellitus|diabetes mellitus
21067|NCT04065724|foot ulcer|foot ulcer
21068|NCT04065724|resistance training|resistance training
21069|NCT04065724|exercise|exercise
21070|NCT04065672|ulcers|ulcers
21071|NCT04065646|Food Access|food access
21072|NCT04065646|Food Security|food security
21073|NCT04065646|Fruits and Vegetables|fruits and vegetables
21074|NCT04065646|Low-Income|low-income
21075|NCT04065633|Phase 1 Bioequivalence Study|phase 1 bioequivalence study
21076|NCT04065633|Healthy Participants|healthy participants
21077|NCT04065633|Estimation of the Effect of Food|estimation of the effect of food
21078|NCT04065633|Relative Bioavailability|relative bioavailability
21079|NCT04065620|Heart Failure with Preserved Ejection Fraction|heart failure with preserved ejection fraction
21080|NCT04065607|Laparotomy|laparotomy
21081|NCT04065607|Laparostomy|laparostomy
21082|NCT04065607|Open abdomen (OA)|open abdomen (oa)
21083|NCT04065607|Temporary abdominal closure (TAC)|temporary abdominal closure (tac)
21084|NCT04065607|Relook laparotomy|relook laparotomy
21085|NCT04065594|ulcers|ulcers
21086|NCT04065594|platelet rich plasma|platelet rich plasma
21087|NCT04065594|ordinary dressing|ordinary dressing
21088|NCT04065594|non-healing|non-healing
21089|NCT04065568|Stroke|stroke
21090|NCT04065568|Rehabilitation|rehabilitation
21091|NCT04065568|Medical technology|medical technology
21092|NCT04065555|precision oncology|precision oncology
21093|NCT04065555|intratumoral microdosing|intratumoral microdosing
21094|NCT04065555|microdose injection|microdose injection
21095|NCT04065555|microinjection|microinjection
21096|NCT04065555|microdosing|microdosing
21097|NCT04065555|in vivo oncology|in vivo oncology
21098|NCT04065555|in vivo drug sensitivity|in vivo drug sensitivity
21099|NCT04065555|tumor microenvironment|tumor microenvironment
21100|NCT04065555|multiplexed immunohistochemistry|multiplexed immunohistochemistry
21101|NCT04065555|HNSCC|hnscc
21102|NCT04065555|SCCHN|scchn
21103|NCT04065542|Social behaviour|social behaviour
21104|NCT04065542|Qualitative research|qualitative research
21105|NCT04065542|Child|child
21106|NCT04065542|Cancer|cancer
21107|NCT04065529|Diarrhea; gastroenterology; acute gastroenteritis; gastroenteritis; acute; gelatin; tannate|diarrhea; gastroenterology; acute gastroenteritis; gastroenteritis; acute; gelatin; tannate
21108|NCT04065516|Achalasia|achalasia
21109|NCT04065516|Gastroesophageal Reflux|gastroesophageal reflux
21117|NCT04065490|Contrast Sensitivity|contrast sensitivity
21119|NCT04065490|Optical coherence tomography|optical coherence tomography
21120|NCT04065477|Traumatic Brain Injury|traumatic brain injury
21121|NCT04065477|TBI|tbi
21122|NCT04065477|Brain Injury|brain injury
21123|NCT04065438|FSGS|fsgs
21124|NCT04065438|Liposorber|liposorber
21125|NCT04065399|AML|aml
21126|NCT04065399|ALL|all
21127|NCT04065399|acute leukemia|acute leukemia
21128|NCT04065399|MLLr|mllr
21129|NCT04065399|KMT2A|kmt2a
21130|NCT04065399|NPM1|npm1
21131|NCT04065386|Vagus nerve stimulation|vagus nerve stimulation
21132|NCT04065386|Transcutaneous electrical nerve stimulation|transcutaneous electrical nerve stimulation
21133|NCT04065386|Non-invasive brain stimulation|non-invasive brain stimulation
21134|NCT04065386|Neuromodulation|neuromodulation
21135|NCT04065386|High-density EEG|high-density eeg
21136|NCT04065386|Unresponsive wakefulness syndrome|unresponsive wakefulness syndrome
21137|NCT04065386|Vegetative state|vegetative state
21138|NCT04065386|Minimally Conscious state|minimally conscious state
21139|NCT04065386|Consciousness disorder|consciousness disorder
21140|NCT04065360|Schizophrenia|schizophrenia
21141|NCT04065360|Psychosis|psychosis
21142|NCT04065360|Family intervention|family intervention
21143|NCT04065360|Cognitive behavioural therapy|cognitive behavioural therapy
21144|NCT04065360|CBT|cbt
21145|NCT04065347|Adherence|adherence
21146|NCT04065347|Dried Blood Spots|dried blood spots
21147|NCT04065347|Tenofovir-diphosphate|tenofovir-diphosphate
21148|NCT04065347|Antiretroviral therapy|antiretroviral therapy
21149|NCT04065347|Tenofovir alafenamide|tenofovir alafenamide
30001|NCT04012528|Surgery|surgery
21152|NCT04065321|Circulating tumor cells|circulating tumor cells
21153|NCT04065321|PET|pet
21160|NCT04065256|music therapy|music therapy
21161|NCT04065256|intensive care unit|intensive care unit
21162|NCT04065256|delirium|delirium
21163|NCT04065217|Hemangioma|hemangioma
21164|NCT04065217|Randomized within patient|randomized within patient
21165|NCT04065217|Diode laser|diode laser
21166|NCT04065217|Histogram|histogram
21167|NCT04065204|Pediatric Medulloblastoma|pediatric medulloblastoma
21168|NCT04065204|Metabolomics|metabolomics
21169|NCT04065204|Radiation Therapy|radiation therapy
21170|NCT04065191|Aerobic exercise|aerobic exercise
21171|NCT04065191|Cardiorespiratory Fitness|cardiorespiratory fitness
21172|NCT04065191|High-intensity interval training (HIIT)|high-intensity interval training (hiit)
21173|NCT04065191|Workability|workability
21174|NCT04065191|Prevention|prevention
21175|NCT04065165|intestinal NET|intestinal net
21176|NCT04065165|carcinoid syndrome|carcinoid syndrome
21177|NCT04065165|somatostatin analogues|somatostatin analogues
21178|NCT04065165|tryptophan hydroxylase inhibitor|tryptophan hydroxylase inhibitor
21179|NCT04065139|pressurized intraperitoneal aerosol chemotherapy (PIPAC)|pressurized intraperitoneal aerosol chemotherapy (pipac)
21180|NCT04065139|gastric adenocarcinoma|gastric adenocarcinoma
21181|NCT04065139|metastasis|metastasis
21182|NCT04065126|Mental health|mental health
21183|NCT04065126|Physical activity|physical activity
21184|NCT04065074|Osteoarthritis|osteoarthritis
21185|NCT04065074|Hip|hip
21186|NCT04065074|Intra-articular|intra-articular
21187|NCT04065074|Injection|injection
21188|NCT04065061|Erinacine A, supplement, Alzheimer's disease|erinacine a, supplement, alzheimer's disease
21189|NCT04065048|diet|diet
21190|NCT04065048|inflammatory bowel disease|inflammatory bowel disease
21191|NCT04065048|gut microbiome|gut microbiome
21192|NCT04065035|Body|body
21193|NCT04065035|moisturizer|moisturizer
21194|NCT04065035|Firming|firming
21195|NCT04065009|Anesthesia Local|anesthesia local
21196|NCT04065009|Time to adjuvant chemotherapy|time to adjuvant chemotherapy
21197|NCT04065009|ovarian cancer|ovarian cancer
21198|NCT04064996|foot exercise|foot exercise
21199|NCT04064996|pain|pain
21200|NCT04064983|movement disorders|movement disorders
21201|NCT04064983|neurodegenerative|neurodegenerative
21202|NCT04064983|MSCs|mscs
21203|NCT04064983|stem cells|stem cells
21204|NCT04064983|brain|brain
21205|NCT04064957|spinal cord injury|spinal cord injury
21206|NCT04064957|MSCs|mscs
21207|NCT04064957|HB-adMSCs|hb-admscs
21208|NCT04064957|chronic SCI|chronic sci
21210|NCT04064944|Neuromyelitis Optica Spectrum Disorder|neuromyelitis optica spectrum disorder
21211|NCT04064944|immunoadsorption|immunoadsorption
21212|NCT04064944|plasma exchange|plasma exchange
21213|NCT04064944|acute attack|acute attack
21214|NCT04064944|refractory|refractory
21215|NCT04064931|recurrent miscarriage|recurrent miscarriage
21216|NCT04064931|vitamins|vitamins
21217|NCT04064905|mRNA-1893|mrna-1893
21218|NCT04064905|zika vaccine|zika vaccine
21219|NCT04064905|Moderna|moderna
21220|NCT04064866|Lumbar Spine|lumbar spine
21221|NCT04064866|Thoracic Spine|thoracic spine
21222|NCT04064866|Cervical Spine|cervical spine
21223|NCT04064853|grounded theory|grounded theory
21224|NCT04064853|child|child
21225|NCT04064853|adolescent|adolescent
21226|NCT04064853|postoperative pain|postoperative pain
21227|NCT04064853|procedural pain|procedural pain
21228|NCT04064853|tooth extraction|tooth extraction
21229|NCT04064840|subfertility|subfertility
21230|NCT04064840|IVF|ivf
21231|NCT04064840|FET|fet
21232|NCT04064840|dual trigger|dual trigger
21233|NCT04064840|luteal phase support|luteal phase support
21234|NCT04064840|Gonadotrophin releasing hormone agonist|gonadotrophin releasing hormone agonist
21235|NCT04064840|live birth rate|live birth rate
21236|NCT04064827|Chronic Kidney Disease|chronic kidney disease
21237|NCT04064827|Paricalcitol|paricalcitol
21238|NCT04064827|Hyperparathyroidism|hyperparathyroidism
21239|NCT04064827|Pediatric Subjects|pediatric subjects
21240|NCT04064827|Peritoneal Dialysis (PD)|peritoneal dialysis (pd)
21241|NCT04064827|Hemodialysis (HD)|hemodialysis (hd)
21242|NCT04064827|Intact parathyroid hormone (iPTH)|intact parathyroid hormone (ipth)
21243|NCT04064814|Adolescent Migraine|adolescent migraine
21244|NCT04064814|Flunarizine|flunarizine
21245|NCT04064814|Alpha Lipoic Acid|alpha lipoic acid
21246|NCT04064814|Thiol Level|thiol level
21247|NCT04064814|Calcitonin gene regulated peptide|calcitonin gene regulated peptide
21248|NCT04064775|Social influence|social influence
21249|NCT04064775|Peer influence|peer influence
21250|NCT04064762|Vagus Nerve Stimulation (VNS)|vagus nerve stimulation (vns)
21251|NCT04064762|Prolonged Exposure Therapy (PE)|prolonged exposure therapy (pe)
21252|NCT04064762|PTSD|ptsd
21253|NCT04064762|Post Traumatic Stress Disorder|post traumatic stress disorder
21254|NCT04064736|Menstrual Health|menstrual health
21255|NCT04064736|School attendance|school attendance
21256|NCT04064736|Adolescent health|adolescent health
21257|NCT04064723|Osteoarthritis|osteoarthritis
21258|NCT04064723|Total hip arthroplasty|total hip arthroplasty
21259|NCT04064723|Uncemented total hip arthroplasty|uncemented total hip arthroplasty
21260|NCT04064697|Ulcerative Colitis (UC)|ulcerative colitis (uc)
21261|NCT04064697|CytoMegaloVirus (CMV)|cytomegalovirus (cmv)
21262|NCT04064697|Vedolizumab|vedolizumab
21263|NCT04064697|Valganciclovir|valganciclovir
21264|NCT04064697|Anti-TNF|anti-tnf
21265|NCT04064697|Mayo score|mayo score
21266|NCT04064684|Pediatric acute respiratory distress syndrome|pediatric acute respiratory distress syndrome
21267|NCT04064684|PARDS|pards
21268|NCT04064684|Budesonide|budesonide
21269|NCT04064684|inhaled steroids|inhaled steroids
21270|NCT04064671|female-to-male|female-to-male
21271|NCT04064671|transgender|transgender
21272|NCT04064671|transsexual|transsexual
21273|NCT04064671|Zephyr|zephyr
21274|NCT04064671|erectile device|erectile device
21275|NCT04064671|erectile implant|erectile implant
21276|NCT04064671|neophallus|neophallus
21277|NCT04064671|phalloplasty|phalloplasty
21278|NCT04064671|gender reassignment surgery|gender reassignment surgery
21279|NCT04064671|sex reassignment surgery|sex reassignment surgery
21280|NCT04064658|Moyamoya Disease|moyamoya disease
21281|NCT04064658|Cerebrovascular Disorders|cerebrovascular disorders
21282|NCT04064658|Arterial Occlusive Diseases|arterial occlusive diseases
21283|NCT04064658|Ischemia|ischemia
21284|NCT04064632|Switch therapy|switch therapy
21285|NCT04064632|HIV|hiv
21286|NCT04064632|Dual ART|dual art
21287|NCT04064632|Rilpivirine|rilpivirine
21288|NCT04064632|Darunavir/cobicistat|darunavir/cobicistat
21289|NCT04064632|NNRTI|nnrti
21290|NCT04064632|PI|pi
21291|NCT04064632|virologically suppressed patients|virologically suppressed patients
21292|NCT04064619|OAB|oab
21293|NCT04064593|Acute Myocardial Infarction|acute myocardial infarction
21294|NCT04064593|Sleep Apnea|sleep apnea
21295|NCT04064593|Outcomes|outcomes
21296|NCT04064580|capnography|capnography
21297|NCT04064567|PrEP|prep
21298|NCT04064567|Community Health Worker|community health worker
21299|NCT04064567|Criminal Justice|criminal justice
21300|NCT04064554|Tuberculosis|tuberculosis
21301|NCT04064554|BCG vaccination|bcg vaccination
21302|NCT04064541|Heart Failure|heart failure
21303|NCT04064541|Distance Health|distance health
21304|NCT04064541|Virtual Visits|virtual visits
21305|NCT04064541|Functional Assessment|functional assessment
21306|NCT04064541|Quality of Life|quality of life
21307|NCT04064541|Cognitive Assessment|cognitive assessment
21308|NCT04064528|amino acid|amino acid
21309|NCT04064528|tendon|tendon
21310|NCT04064528|aging|aging
21710|NCT04061980|Binimetinib|binimetinib
21311|NCT04064502|Chronic Ankle Instability|chronic ankle instability
21312|NCT04064502|Cumberland Ankle Instability Tool|cumberland ankle instability tool
21313|NCT04064502|Pain|pain
21314|NCT04064476|schizophrenia|schizophrenia
21315|NCT04064476|violence risk|violence risk
21316|NCT04064476|long-acting antipsychotics|long-acting antipsychotics
21317|NCT04064450|Heart Failure|heart failure
21318|NCT04064411|Osteoporosis|osteoporosis
21319|NCT04064411|transdermal delivery|transdermal delivery
21320|NCT04064411|microneedle|microneedle
21321|NCT04064411|solid microstructured transdermal system|solid microstructured transdermal system
21322|NCT04064411|abaloparatide-sMTS|abaloparatide-smts
21323|NCT04064411|patch|patch
21324|NCT04064411|abaloparatide|abaloparatide
21325|NCT04064411|fracture|fracture
21326|NCT04064411|bone loss|bone loss
21327|NCT04064411|TYMLOS®|tymlos®
21328|NCT04064385|Functional Electrical Stimulation Cycling|functional electrical stimulation cycling
21329|NCT04064385|Physical Therapy|physical therapy
21330|NCT04064372|Mindfulness|mindfulness
21331|NCT04064372|Resilience|resilience
21332|NCT04064372|Equanimity|equanimity
21333|NCT04064372|Inflammation|inflammation
21334|NCT04064372|Wise Intervention|wise intervention
21335|NCT04064333|EMST|emst
21336|NCT04064333|RMST|rmst
21337|NCT04064333|Expiratory Muscle Strength Training|expiratory muscle strength training
21338|NCT04064333|Respiratory Muscle Strength Training|respiratory muscle strength training
21339|NCT04064333|Videofluoroscopy|videofluoroscopy
21340|NCT04064333|Aspiration Pneumonia|aspiration pneumonia
21341|NCT04064333|Rehabilitation|rehabilitation
21342|NCT04064333|Dysphagia|dysphagia
21343|NCT04064333|Cough|cough
21344|NCT04064333|Geriatric|geriatric
21345|NCT04064333|Aging|aging
21346|NCT04064333|Older Adults|older adults
21347|NCT04064320|pregnancy|pregnancy
21348|NCT04064320|high-risk|high-risk
21349|NCT04064320|anxiety|anxiety
21350|NCT04064320|prenatal attachment|prenatal attachment
21351|NCT04064320|bonding|bonding
21352|NCT04064320|lullaby|lullaby
21353|NCT04064320|music|music
21354|NCT04064307|Registry|registry
21355|NCT04064307|Patient Registry|patient registry
21356|NCT04064307|Myotubular|myotubular
21357|NCT04064307|Centronuclear|centronuclear
21358|NCT04064307|Myopathy|myopathy
21359|NCT04064281|DASH|dash
21360|NCT04064281|diet|diet
21361|NCT04064281|trial|trial
21362|NCT04064281|cardiovascular disease|cardiovascular disease
21363|NCT04064281|blood pressure|blood pressure
21364|NCT04064268|endotoxemia|endotoxemia
21365|NCT04064268|muscle loss|muscle loss
21366|NCT04064268|catabolic state|catabolic state
21367|NCT04064268|whey protein|whey protein
21368|NCT04064268|3-hydroxy butyrate|3-hydroxy butyrate
21369|NCT04064255|Body Image|body image
21370|NCT04064255|Anorexia Nervosa|anorexia nervosa
21371|NCT04064255|Adolescents|adolescents
21372|NCT04064255|Mirror exposure|mirror exposure
21373|NCT04064242|chronic pulmonary sarcoidosis|chronic pulmonary sarcoidosis
21374|NCT04064216|Cosmesis|cosmesis
21375|NCT04064216|Laparoscopic surgery|laparoscopic surgery
21376|NCT04064216|Patient satisfaction|patient satisfaction
21377|NCT04064216|Scar assessment|scar assessment
21378|NCT04064216|Quality of life|quality of life
21379|NCT04064203|glucagon|glucagon
21380|NCT04064177|Blood Pressure|blood pressure
21381|NCT04064164|Nursing home|nursing home
21382|NCT04064164|Dementia|dementia
21383|NCT04064164|Technology|technology
21384|NCT04064151|eHealth|ehealth
21385|NCT04064151|Health Related Quality of Life|health related quality of life
21386|NCT04064151|Symptom Burden|symptom burden
21387|NCT04064151|Breast Cancer|breast cancer
21388|NCT04064151|Hispanic|hispanic
21389|NCT04064099|dental trauma|dental trauma
21390|NCT04064099|rugby|rugby
21391|NCT04064099|mouthguard|mouthguard
21392|NCT04064099|speech|speech
21393|NCT04064099|contact sports|contact sports
21394|NCT04064086|Chronic kidney disease|chronic kidney disease
21395|NCT04064086|Pre-dialysis education|pre-dialysis education
21396|NCT04064086|Kidney Disease Education|kidney disease education
21397|NCT04064086|Patient Education|patient education
21398|NCT04064086|Decision Making|decision making
21399|NCT04064060|ACE-536|ace-536
21400|NCT04064060|Luspatercept|luspatercept
21401|NCT04064060|MDS|mds
21402|NCT04064060|Beta-thalassemia|beta-thalassemia
21403|NCT04064060|Myeloproliferative neoplasm (MPN)-associated myelofibrosis|myeloproliferative neoplasm (mpn)-associated myelofibrosis
21404|NCT04064021|Acupunture|acupunture
21405|NCT04063995|Spasticity|spasticity
21406|NCT04063995|Stroke|stroke
21407|NCT04063995|Repetitive transcranial magnetic stimulation|repetitive transcranial magnetic stimulation
21408|NCT04063995|Premotor cortex|premotor cortex
21409|NCT04063969|Radiation safety|radiation safety
21410|NCT04063969|Radiation safety climate|radiation safety climate
21411|NCT04063969|Radiation safety behavior|radiation safety behavior
21412|NCT04063969|Quality improvement|quality improvement
21413|NCT04063969|Patient safety|patient safety
21414|NCT04063930|Hyperkalemia|hyperkalemia
21415|NCT04063930|Renin angiotensin system|renin angiotensin system
21416|NCT04063904|medical abortion|medical abortion
21417|NCT04063904|mifepristone|mifepristone
21418|NCT04063891|Fracture healing, Osteoporosis, Vibration treatment|fracture healing, osteoporosis, vibration treatment
21419|NCT04063826|PET MR Imaging|pet mr imaging
21420|NCT04063826|Steatohepatitis|steatohepatitis
21421|NCT04063826|Chemotherapy associated steatohepatitis|chemotherapy associated steatohepatitis
21422|NCT04063774|diagnostics|diagnostics
21423|NCT04063774|sensitivity|sensitivity
21424|NCT04063774|specificity|specificity
21425|NCT04063774|clinical algorithm|clinical algorithm
21426|NCT04063748|auditory rehabilitation|auditory rehabilitation
21427|NCT04063735|Dry Eye|dry eye
21428|NCT04063735|Cordyceps cicadae mycelia|cordyceps cicadae mycelia
21429|NCT04063696|tooth extraction|tooth extraction
21430|NCT04063696|dental anxiety|dental anxiety
21431|NCT04063696|antibiotic|antibiotic
21432|NCT04063696|oral health|oral health
21433|NCT04063670|Pain|pain
21434|NCT04063670|Function|function
21435|NCT04063670|Pediatric|pediatric
21436|NCT04063670|Scoliosis|scoliosis
21437|NCT04063670|Scoliosis Surgery|scoliosis surgery
21438|NCT04063670|Spinal Fusion|spinal fusion
21439|NCT04063670|Idiopathic Scoliosis|idiopathic scoliosis
21440|NCT04063670|Coping|coping
21441|NCT04063670|Coping Skills|coping skills
21442|NCT04063670|Education|education
21443|NCT04063670|Video Intervention|video intervention
21444|NCT04063670|Randomized|randomized
21445|NCT04063670|Prospective|prospective
21446|NCT04063670|Satisfaction|satisfaction
21447|NCT04063670|Adolescent|adolescent
21448|NCT04063670|Opioid|opioid
21449|NCT04063657|Staged External Fixation|staged external fixation
21450|NCT04063657|Splinting|splinting
21451|NCT04063657|Soft tissue complications|soft tissue complications
21452|NCT04063644|Dry eye|dry eye
21453|NCT04063644|Cataract|cataract
21454|NCT04063644|Visual acuity|visual acuity
21455|NCT04063644|Quality of life|quality of life
21456|NCT04063644|Eye drops|eye drops
21457|NCT04063644|Dry eye symptomatology|dry eye symptomatology
21458|NCT04063644|N-acetylcarnosine|n-acetylcarnosine
21459|NCT04063644|Vaccinium myrtillus|vaccinium myrtillus
21460|NCT04063644|Chondroitin sulfate|chondroitin sulfate
21461|NCT04063644|Chondroitin sulphate|chondroitin sulphate
21462|NCT04063644|N-Acetylcharnosine|n-acetylcharnosine
21463|NCT04063631|Asthma|asthma
21464|NCT04063592|Amputation|amputation
21465|NCT04063592|Residual limb pain|residual limb pain
21466|NCT04063592|Phantom pain|phantom pain
21467|NCT04063592|Residual limb atrophy|residual limb atrophy
21468|NCT04063592|Prosthesis control|prosthesis control
21469|NCT04063566|Prostate Cancer|prostate cancer
21470|NCT04063566|MRI|mri
21471|NCT04063566|PSA|psa
21472|NCT04063540|migraine|migraine
21473|NCT04063540|aura|aura
21474|NCT04063540|Amiloride|amiloride
21475|NCT04063540|acid-sensing ion channel|acid-sensing ion channel
21476|NCT04063527|epithelial ovarian cancer|epithelial ovarian cancer
21477|NCT04063527|FIGO stage I|figo stage i
21478|NCT04063527|staging surgery|staging surgery
21479|NCT04063527|adjuvant chemotherapy|adjuvant chemotherapy
21480|NCT04063449|Non-squamous NSCLC；endostar;PD-1 inhibitor;chemotherapy|non-squamous nsclc；endostar;pd-1 inhibitor;chemotherapy
21481|NCT04063423|clotting|clotting
21482|NCT04063423|coagulation|coagulation
21483|NCT04063345|STEMI|stemi
21484|NCT04063345|Intravascular ultrasound|intravascular ultrasound
21485|NCT04063345|Angiography|angiography
21486|NCT04063345|Primary percutaneous intervention|primary percutaneous intervention
21487|NCT04063332|circadian|circadian
21488|NCT04063332|sepsis|sepsis
21489|NCT04063332|clock|clock
21490|NCT04063332|melatonin|melatonin
21491|NCT04063319|High-fidelity simulation|high-fidelity simulation
21492|NCT04063319|Self-confidence|self-confidence
21493|NCT04063319|Deteriorating patients|deteriorating patients
21494|NCT04063319|Ordinal data|ordinal data
21495|NCT04063319|Questionnaire|questionnaire
21496|NCT04063293|fecal incontinence|fecal incontinence
21497|NCT04063293|platelet rich plasma|platelet rich plasma
21498|NCT04063293|PRP|prp
21499|NCT04063293|injection|injection
21500|NCT04063280|Endoscopic mucosal resection|endoscopic mucosal resection
21501|NCT04063228|non-progressive central neurological injury|non-progressive central neurological injury
21502|NCT04063215|severe|severe
21503|NCT04063215|hypoxic-ischemic encephalopathy|hypoxic-ischemic encephalopathy
21504|NCT04063215|stroke|stroke
21505|NCT04063215|intracranial hemorrhage|intracranial hemorrhage
21506|NCT04063215|cerebral palsy|cerebral palsy
21507|NCT04063215|chronic|chronic
21508|NCT04063215|neurological injury|neurological injury
21509|NCT04063202|Adolescent|adolescent
21510|NCT04063202|Depression|depression
21511|NCT04063202|Stress|stress
21512|NCT04063202|Resilience|resilience
21513|NCT04063189|Clarithromycin Lenalidomide Dexamethasone Regimen|clarithromycin lenalidomide dexamethasone regimen
21514|NCT04063189|Treatment Response|treatment response
21515|NCT04063189|Survival|survival
21516|NCT04063176|myocardial infarction, registry|myocardial infarction, registry
21517|NCT04063163|Extensive Stage|extensive stage
21518|NCT04063163|Small Cell Lung Cancer|small cell lung cancer
21519|NCT04063163|Anti-PD-1 Monoclonal Antibody|anti-pd-1 monoclonal antibody
21520|NCT04063150|inactivated poliovirus vaccine|inactivated poliovirus vaccine
21521|NCT04063150|fractional inactivated poliovirus vaccine|fractional inactivated poliovirus vaccine
21522|NCT04063150|intradermal|intradermal
21523|NCT04063150|intramuscular|intramuscular
21524|NCT04063137|Black rice|black rice
21525|NCT04063137|Anthocyanin|anthocyanin
21526|NCT04063137|Lipidemia|lipidemia
21527|NCT04063137|High-fat diet|high-fat diet
21528|NCT04063124|Dementia|dementia
21529|NCT04063124|Alzheimer|alzheimer
21530|NCT04063124|Cognitive decline|cognitive decline
21531|NCT04063124|dasatinib|dasatinib
21532|NCT04063085|Hyaluronan|hyaluronan
21534|NCT04063085|adhesion agent|adhesion agent
21535|NCT04063072|Hysterectomy|hysterectomy
21536|NCT04063072|Uterine Cervical Neoplasms|uterine cervical neoplasms
21537|NCT04063072|Endometrial Neoplasms|endometrial neoplasms
21538|NCT04063072|Quality Improvement|quality improvement
21539|NCT04063072|Perioperative Care|perioperative care
21540|NCT04063072|Recovery of Function|recovery of function
21541|NCT04063059|Weight Management|weight management
21542|NCT04063059|Obesity|obesity
21543|NCT04063059|African American|african american
21544|NCT04063059|Women|women
21545|NCT04063020|Ear aplasia|ear aplasia
21546|NCT04063020|Reconstructive plastic surgery|reconstructive plastic surgery
21547|NCT04063020|Subjective experience|subjective experience
21548|NCT04063020|Psychic stakes|psychic stakes
21549|NCT04063020|Psychodynamic evaluation|psychodynamic evaluation
21550|NCT04062994|Hypotension|hypotension
21551|NCT04062994|AKI|aki
21552|NCT04062916|endometriosis|endometriosis
21553|NCT04062903|Waitlist|waitlist
21554|NCT04062890|Type II Diabetes|type ii diabetes
21555|NCT04062890|Hyperinsulinism|hyperinsulinism
21556|NCT04062890|Insulin Resistance|insulin resistance
21557|NCT04062890|Hypertension|hypertension
21558|NCT04062877|Fluid biopsy|fluid biopsy
21559|NCT04062877|lymphoma|lymphoma
21560|NCT04062877|accurate diagnosis|accurate diagnosis
21561|NCT04062851|gastric residuals, feeding, very low birth weight infants|gastric residuals, feeding, very low birth weight infants
21562|NCT04062838|partial|partial
21563|NCT04062838|prolotherapy|prolotherapy
21564|NCT04062838|steroids|steroids
21565|NCT04062838|tendon healing|tendon healing
21566|NCT04062825|HIV|hiv
21567|NCT04062825|platelets|platelets
21568|NCT04062825|lymphocytes|lymphocytes
21569|NCT04062825|cART|cart
21570|NCT04062825|InRs|inrs
21571|NCT04062812|citrate anticoagulation|citrate anticoagulation
21572|NCT04062812|calcemia control|calcemia control
21573|NCT04062760|Acute Heart Failure|acute heart failure
21574|NCT04062760|Diuretics|diuretics
21575|NCT04062760|Sequential nephron blockade|sequential nephron blockade
21576|NCT04062760|Fluid balance|fluid balance
21577|NCT04062760|Worsening kidney failure|worsening kidney failure
21578|NCT04062747|Laryngeal Mask|laryngeal mask
21579|NCT04062747|I-gel|i-gel
21580|NCT04062747|Ambu Aura i|ambu aura i
21581|NCT04062747|Flexible bronchoscopy|flexible bronchoscopy
21582|NCT04062747|Laryngopharyngeal damage|laryngopharyngeal damage
21583|NCT04062747|Infant|infant
21584|NCT04062734|Peripheral artery disease|peripheral artery disease
21585|NCT04062734|abdominal aortic aneurysm|abdominal aortic aneurysm
21586|NCT04062734|in situ fenestration|in situ fenestration
21587|NCT04062734|endovascular treatment|endovascular treatment
21588|NCT04062721|colorectal cancer|colorectal cancer
21589|NCT04062721|liver metastases|liver metastases
21590|NCT04062721|radiofrequency|radiofrequency
21591|NCT04062721|immunotherapy|immunotherapy
21592|NCT04062708|Stage IIIA/IIIB (T1-3,N2) Non-Small Cell Lung Cancer (NSCLC)|stage iiia/iiib (t1-3,n2) non-small cell lung cancer (nsclc)
21593|NCT04062695|Psoriatic Arthritis|psoriatic arthritis
21594|NCT04062695|Sacroiliitis|sacroiliitis
21595|NCT04062695|Spondylitis|spondylitis
21596|NCT04062695|MRI|mri
21597|NCT04062669|First Time in Human|first time in human
21598|NCT04062669|Vaccine|vaccine
21599|NCT04062669|Healthy subjects|healthy subjects
21600|NCT04062669|Rabies|rabies
21601|NCT04062643|obesity|obesity
21602|NCT04062643|recurrent stroke|recurrent stroke
21603|NCT04062643|ischemic stroke|ischemic stroke
21604|NCT04062643|hemorrhagic stroke|hemorrhagic stroke
21605|NCT04062643|cardiovascular events|cardiovascular events
21606|NCT04062643|vascular death|vascular death
21607|NCT04062630|Adult Scoliotic Spinal Deformity|adult scoliotic spinal deformity
21608|NCT04062630|Sacroiliac joint pain|sacroiliac joint pain
21609|NCT04062630|multilevel lumbar surgery|multilevel lumbar surgery
21610|NCT04062630|si joint pain|si joint pain
21611|NCT04062591|piroxicam|piroxicam
21612|NCT04062591|VAS|vas
21613|NCT04062591|fractures|fractures
21614|NCT04062578|Anterior Cruciate Ligament Injuries|anterior cruciate ligament injuries
21615|NCT04062578|Injuries, Knee, Female Football|injuries, knee, female football
21616|NCT04062578|Prevention & Control|prevention & control
21618|NCT04062539|cerebral embolic protection device|cerebral embolic protection device
21619|NCT04062500|Heart Failure,prognostic, registry|heart failure,prognostic, registry
21620|NCT04062435|Cross-linking, Riboflavin, Fluorophotometry, FluorotronTM Master|cross-linking, riboflavin, fluorophotometry, fluorotrontm master
21621|NCT04062422|ulna; healthy children; height predicted|ulna; healthy children; height predicted
21622|NCT04062409|sickle cell disease; asthma; beta-agonist; hear rate variability|sickle cell disease; asthma; beta-agonist; hear rate variability
21624|NCT04062383|Positive Psychology|positive psychology
21625|NCT04062383|Motivational Interviewing|motivational interviewing
21626|NCT04062383|Positive emotions|positive emotions
21627|NCT04062357|Premature Ejaculation|premature ejaculation
21628|NCT04062344|Betalactams hypersensitivity|betalactams hypersensitivity
21629|NCT04062344|Children|children
21630|NCT04062344|Drug provocation testing|drug provocation testing
21631|NCT04062344|Bacterial resistances|bacterial resistances
21632|NCT04062331|clinical trial|clinical trial
21633|NCT04062331|multiple sclerosis|multiple sclerosis
21634|NCT04062331|neurodegenerative diseases|neurodegenerative diseases
21635|NCT04062331|transcranial magnetic stimulation|transcranial magnetic stimulation
21636|NCT04062331|deep brain stimulation|deep brain stimulation
21637|NCT04062331|neurochemistry|neurochemistry
21638|NCT04062318|somatosensory|somatosensory
21639|NCT04062318|tactile|tactile
21640|NCT04062318|perception|perception
21641|NCT04062318|electroencephalography|electroencephalography
21642|NCT04062318|transcranial magnetic stimulation|transcranial magnetic stimulation
21643|NCT04062318|beta rhythm|beta rhythm
21644|NCT04062292|balance|balance
21645|NCT04062292|chronic obstructive diseases|chronic obstructive diseases
21646|NCT04062279|Parkinson's disease|parkinson's disease
21647|NCT04062279|cognitive dysfunction|cognitive dysfunction
21648|NCT04062279|alpha synuclein|alpha synuclein
21649|NCT04062279|autoantibodies|autoantibodies
21650|NCT04062279|progression|progression
21651|NCT04062253|HIV|hiv
21652|NCT04062253|HCV|hcv
21653|NCT04062253|PWID (Persons who inject drugs)|pwid (persons who inject drugs)
21654|NCT04062253|Screening|screening
21655|NCT04062253|Diagnosis|diagnosis
21656|NCT04062253|Linkage to care|linkage to care
21657|NCT04062253|Treatment|treatment
21658|NCT04062240|BIS|bis
21659|NCT04062240|Bispectral Index|bispectral index
21660|NCT04062240|Paralysis|paralysis
21661|NCT04062227|Mindfulness|mindfulness
21662|NCT04062227|Dementia|dementia
21663|NCT04062201|Tuberculosis|tuberculosis
21664|NCT04062201|Drug-resistant Tuberculosis|drug-resistant tuberculosis
21665|NCT04062201|Randomized Controlled Trial|randomized controlled trial
21666|NCT04062201|Rifampicin Resistant Tuberculosis|rifampicin resistant tuberculosis
21667|NCT04062201|Multi Drug Resistant Tuberculosis|multi drug resistant tuberculosis
21668|NCT04062201|Extensively Drug-Resistant Tuberculosis|extensively drug-resistant tuberculosis
21669|NCT04062201|Pre-XDR-TB (fluoroquinolone resistant)|pre-xdr-tb (fluoroquinolone resistant)
21670|NCT04062201|Open label|open label
21671|NCT04062201|South Africa|south africa
21672|NCT04062188|Barthel Index|barthel index
21673|NCT04062188|modified Rankin Scale|modified rankin scale
21674|NCT04062188|validity|validity
21675|NCT04062188|reliability|reliability
21676|NCT04062162|Prostate Cancer|prostate cancer
21677|NCT04062162|Androgen Deprivation Therapy|androgen deprivation therapy
21678|NCT04062162|Walking football|walking football
21679|NCT04062136|Bronchopulmonary dysplasia|bronchopulmonary dysplasia
21680|NCT04062136|umbilical cord mesenchymal stem cells|umbilical cord mesenchymal stem cells
21681|NCT04062123|propofol|propofol
21682|NCT04062123|dexmedetomidine|dexmedetomidine
21683|NCT04062123|fentanyl|fentanyl
21684|NCT04062123|functional MRI|functional mri
21685|NCT04062123|electric nerve stimulation|electric nerve stimulation
21686|NCT04062123|sedation|sedation
21687|NCT04062123|functional connectivity|functional connectivity
21688|NCT04062110|distal radius fractures|distal radius fractures
21689|NCT04062110|above-elbow cast|above-elbow cast
21690|NCT04062110|below-elbow cast|below-elbow cast
21691|NCT04062110|conservative treatment|conservative treatment
21692|NCT04062110|extra-articular fractures|extra-articular fractures
21693|NCT04062097|intracranial/intracerebral bleeding|intracranial/intracerebral bleeding
21694|NCT04062097|stroke|stroke
21695|NCT04062097|transient ischemic attack (TIA)|transient ischemic attack (tia)
21696|NCT04062097|myocardial infarction|myocardial infarction
21697|NCT04062097|anticoagulation|anticoagulation
21698|NCT04062097|dabigatran|dabigatran
21699|NCT04062097|idarucizumab|idarucizumab
21700|NCT04062097|vitamin-k antagonists|vitamin-k antagonists
21701|NCT04062071|anticoagulants|anticoagulants
21702|NCT04062058|gastric cancer|gastric cancer
21703|NCT04062058|neoadjuvant chemoradiotherapy|neoadjuvant chemoradiotherapy
21704|NCT04062058|neoadjuvant chemotherapy|neoadjuvant chemotherapy
21705|NCT04062045|Anesthesia, Conduction|anesthesia, conduction
21706|NCT04061993|Total hip arthroplasty|total hip arthroplasty
21707|NCT04061993|Early postoperative exercise|early postoperative exercise
21708|NCT04061993|Home-based training|home-based training
21709|NCT04061980|Encorafenib|encorafenib
21711|NCT04061980|Nivolumab|nivolumab
21712|NCT04061980|BRAF V600|braf v600
21713|NCT04061980|Thyroid cancer|thyroid cancer
21714|NCT04061980|Radiodine refractory Thyroid Cancer|radiodine refractory thyroid cancer
21715|NCT04061980|Phase 2|phase 2
21716|NCT04061980|IST-818-210X|ist-818-210x
21717|NCT04061980|CA209-73R|ca209-73r
21718|NCT04061967|participation|participation
21719|NCT04061967|self sampling|self sampling
21720|NCT04061967|screening|screening
21721|NCT04061915|HIV Prevention|hiv prevention
21722|NCT04061915|Sexual and Gender Minorities|sexual and gender minorities
21723|NCT04061915|Consumer Health Informatics|consumer health informatics
21724|NCT04061876|aGVHD|agvhd
21725|NCT04061863|breast cancer|breast cancer
21726|NCT04061863|eribulin|eribulin
21727|NCT04061863|nivolumab|nivolumab
21728|NCT04061863|immunotherapy|immunotherapy
21729|NCT04061863|immune checkpoint inhibitor|immune checkpoint inhibitor
21730|NCT04061863|metastatic breast cancer|metastatic breast cancer
21731|NCT04061863|PD-1|pd-1
21732|NCT04061811|congestive heart failure (HF)|congestive heart failure (hf)
21733|NCT04061811|biomarker|biomarker
21734|NCT04061811|chronic kidney disease (CKD)|chronic kidney disease (ckd)
21735|NCT04061811|hemodialysis (HD)|hemodialysis (hd)
21736|NCT04061811|peritoneal dialysis (PD)|peritoneal dialysis (pd)
21737|NCT04061811|neprilysin (NEP)|neprilysin (nep)
21738|NCT04061811|growth differentiation factor-15 (GDF15)|growth differentiation factor-15 (gdf15)
21739|NCT04061798|ACT guided heparinization in open aortic surgery|act guided heparinization in open aortic surgery
21740|NCT04061785|Fall prevention|fall prevention
21741|NCT04061785|Physical training|physical training
21742|NCT04061785|judo|judo
21743|NCT04061785|exercise|exercise
21744|NCT04061785|Judo4Balance|judo4balance
21745|NCT04061785|Break falls|break falls
21746|NCT04061785|Preventive Exercise|preventive exercise
21747|NCT04061772|Bortezomib|bortezomib
21748|NCT04061772|CHEP|chep
21749|NCT04061746|mesenchymal stem cells|mesenchymal stem cells
21750|NCT04061746|diabetes|diabetes
21751|NCT04061746|autoantibodies|autoantibodies
21752|NCT04061746|C-peptide|c-peptide
21753|NCT04061746|Type 1 diabetes mellitus|type 1 diabetes mellitus
21754|NCT04061733|osteoarthritis, pain, knee|osteoarthritis, pain, knee
21755|NCT04061720|Tobacco dependence|tobacco dependence
21756|NCT04061720|Clinical Trial|clinical trial
21757|NCT04061720|Veterans|veterans
21758|NCT04061707|Focal Epilepsy|focal epilepsy
21759|NCT04061707|Longterm EEG Monitoring|longterm eeg monitoring
21760|NCT04061707|Wearable Devices|wearable devices
21761|NCT04061707|mHealth|mhealth
21762|NCT04061707|Seizure Forecasting|seizure forecasting
21763|NCT04061681|Physical Activity|physical activity
21764|NCT04061668|PECS, Breast surgery, Bupivacaine, VAS|pecs, breast surgery, bupivacaine, vas
21765|NCT04061655|CABG|cabg
21766|NCT04061655|iron therapy|iron therapy
21767|NCT04061655|blood transfusion|blood transfusion
21768|NCT04061642|Artificial intelligence|artificial intelligence
21769|NCT04061642|Deep learning|deep learning
21770|NCT04061642|Clinical decision aid|clinical decision aid
21771|NCT04061577|Transcranial direct current stimulation|transcranial direct current stimulation
21772|NCT04061577|Bridging neuroprotection|bridging neuroprotection
21773|NCT04061577|Adjunctive neuroprotection|adjunctive neuroprotection
21774|NCT04061538|zinc sulfate|zinc sulfate
21775|NCT04061538|Children|children
21776|NCT04061538|acute diarrheal diseases|acute diarrheal diseases
21777|NCT04061499|muscle|muscle
21778|NCT04061499|ultrasound|ultrasound
21779|NCT04061499|hip|hip
21780|NCT04061486|MACS|macs
21781|NCT04061486|DNA fragmentation|dna fragmentation
21782|NCT04061486|Sperm selection|sperm selection
21783|NCT04061473|Pancreatectomy|pancreatectomy
21784|NCT04061473|Diabetes|diabetes
21785|NCT04061473|SGLT-2 inhibitor|sglt-2 inhibitor
21786|NCT04061473|DPP4 inhibitor|dpp4 inhibitor
21787|NCT04061473|glucagon|glucagon
21788|NCT04061460|smoking|smoking
21789|NCT04061460|oral hygiene|oral hygiene
21790|NCT04061447|gastric juice guided therapy|gastric juice guided therapy
21791|NCT04061447|H.pylori eradication|h.pylori eradication
21792|NCT04061434|Cardiac Resynchronization Therapy|cardiac resynchronization therapy
21793|NCT04061434|ECG Algorithms|ecg algorithms
21794|NCT04061434|Machine based learning|machine based learning
21795|NCT04061369|thermic effect of feeding|thermic effect of feeding
21796|NCT04061369|thermogenesis|thermogenesis
21797|NCT04061369|calorimeter|calorimeter
21798|NCT04061369|fuel utilization|fuel utilization
21799|NCT04061304|rTMS|rtms
21800|NCT04061278|Nasopharyngeal Carcinoma|nasopharyngeal carcinoma
21801|NCT04061278|Neoadjuvant Chemotherapy|neoadjuvant chemotherapy
21802|NCT04061278|Concurrent Chemoradiotherapy|concurrent chemoradiotherapy
21803|NCT04061265|Articaine, local anaesthesia, child, pain|articaine, local anaesthesia, child, pain
21804|NCT04061252|Palmoplantar Pustulosis|palmoplantar pustulosis
21805|NCT04061252|brodalumab|brodalumab
21806|NCT04061252|KHK4827|khk4827
21807|NCT04061226|obstructive sleep apnea, normal weight obesity|obstructive sleep apnea, normal weight obesity
21808|NCT04061187|Dispatcher|dispatcher
21809|NCT04061187|Dispatcher-assisted cardiopulmonary resuscitation|dispatcher-assisted cardiopulmonary resuscitation
21810|NCT04061187|Emergency call|emergency call
21811|NCT04061187|Live video footage|live video footage
21812|NCT04061174|shoulder|shoulder
21813|NCT04061174|proprioception|proprioception
21814|NCT04061174|vibration|vibration
21815|NCT04061174|posture|posture
21816|NCT04061174|stabilization|stabilization
21817|NCT04061161|Tiotropium|tiotropium
21818|NCT04061161|Anti-inflammatory effects|anti-inflammatory effects
21819|NCT04061161|TNF-alpha mRNA in induced sputum|tnf-alpha mrna in induced sputum
21820|NCT04061148|Near Infrared Spectroscopy|near infrared spectroscopy
21821|NCT04061148|Depression|depression
21822|NCT04061148|NIRS|nirs
21823|NCT04061148|Major Depressive Disorder|major depressive disorder
21824|NCT04061096|Anesthesia|anesthesia
21825|NCT04061096|Cold test|cold test
21826|NCT04061096|Electrical pulp test|electrical pulp test
21827|NCT04061083|Intensive Care|intensive care
21828|NCT04061031|Self-regulation, adoption, parent-child realtionship|self-regulation, adoption, parent-child realtionship
21829|NCT04061018|HDL|hdl
21830|NCT04061018|Atherosclerotic Cardiovascular Disease|atherosclerotic cardiovascular disease
21831|NCT04061018|Cholesterol efflux|cholesterol efflux
21832|NCT04061005|Cold snare polypectomy|cold snare polypectomy
21833|NCT04061005|Hot snare polypectomy|hot snare polypectomy
21834|NCT04061005|Colorectal polyps|colorectal polyps
21835|NCT04061005|CARE Study|care study
21836|NCT04061005|Complete resection rate|complete resection rate
21837|NCT04060940|Emotion Regulation|emotion regulation
21838|NCT04060940|Distress Disorders|distress disorders
21839|NCT04060940|Anxiety|anxiety
21840|NCT04060940|Depression|depression
21841|NCT04060914|ticagrelor|ticagrelor
21842|NCT04060914|clopidogrel|clopidogrel
21843|NCT04060914|Percutaneous Coronary Intervention|percutaneous coronary intervention
21844|NCT04060914|Coronary Artery Disease|coronary artery disease
21845|NCT04060914|Adenosine|adenosine
21846|NCT04060901|Spiritual health clinician|spiritual health clinician
21847|NCT04060784|Immediate implant placement and provisionalization|immediate implant placement and provisionalization
21848|NCT04060784|Socket shield technique|socket shield technique
21849|NCT04060784|Root shield|root shield
21850|NCT04060784|Soft tissue level change|soft tissue level change
21851|NCT04060784|Soft tissue volume change|soft tissue volume change
21852|NCT04060784|IIPP|iipp
21853|NCT04060784|SST|sst
21854|NCT04060771|Anesthesia|anesthesia
21855|NCT04060771|Strabismus|strabismus
21856|NCT04060771|PONV|ponv
21857|NCT04060745|brown adipose tissue|brown adipose tissue
21858|NCT04060745|deuterium metabolic imaging|deuterium metabolic imaging
21859|NCT04060745|FDG PET/CT|fdg pet/ct
21860|NCT04060745|individualized cooling protocol|individualized cooling protocol
21861|NCT04060732|Flash Glucose Monitoring|flash glucose monitoring
21862|NCT04060732|Glucose Monitoring|glucose monitoring
21863|NCT04060732|Diabetes Mellitus Type 1|diabetes mellitus type 1
21864|NCT04060706|Radiotherapy|radiotherapy
21865|NCT04060706|Image-guided|image-guided
21866|NCT04060706|Head & Neck|head & neck
21867|NCT04060706|Brain|brain
21868|NCT04060706|Lung|lung
21869|NCT04060706|Prostate|prostate
21870|NCT04060706|Adults|adults
21871|NCT04060693|Non-invasive glucose monitoring|non-invasive glucose monitoring
21872|NCT04060667|vital sign monitoring|vital sign monitoring
21873|NCT04060667|maternal near miss|maternal near miss
21874|NCT04060667|maternal mortality|maternal mortality
21875|NCT04060667|maternal morbidity|maternal morbidity
21876|NCT04060667|physiologic monitoring|physiologic monitoring
21877|NCT04060667|quality of care|quality of care
21878|NCT04060667|inpatient monitoring|inpatient monitoring
21879|NCT04060615|chronic total occlusion|chronic total occlusion
21880|NCT04060615|coronary flow reserve|coronary flow reserve
21881|NCT04060589|Prostate cancer|prostate cancer
21882|NCT04060589|Magnetic resonance imaging-targeted biopsy|magnetic resonance imaging-targeted biopsy
21883|NCT04060589|Biomarker|biomarker
21884|NCT04060589|MRI-based diagnostic pathway|mri-based diagnostic pathway
21885|NCT04060589|magnetic resonance imaging|magnetic resonance imaging
21886|NCT04060589|targeted biopsy|targeted biopsy
21887|NCT04060563|diastasis recti|diastasis recti
21888|NCT04060563|postpartum|postpartum
21889|NCT04060563|family medicine|family medicine
21890|NCT04060563|microcurrent|microcurrent
21891|NCT04060550|Atopic dermatitis|atopic dermatitis
21892|NCT04060550|Eczema herpeticum|eczema herpeticum
21893|NCT04060550|Immunoglobulin E|immunoglobulin e
21894|NCT04060550|Herpes simplex virus|herpes simplex virus
21895|NCT04060537|Cancer|cancer
21896|NCT04060537|Renal|renal
21897|NCT04060537|Tyrosine Kinase Inhibitors|tyrosine kinase inhibitors
21898|NCT04060537|Systemic Treatments|systemic treatments
21899|NCT04060537|Biomarkers|biomarkers
21900|NCT04060511|HS-10342; CDK4/6 inhibitor, advanced solid tumor|hs-10342; cdk4/6 inhibitor, advanced solid tumor
21901|NCT04060498|Mindfulness, Prevention, Relapse, Psychosis, Schizophrenia, Psychotic Disorders, Mental Disorders, Schizophrenia and Disorders with Psychotic Features|mindfulness, prevention, relapse, psychosis, schizophrenia, psychotic disorders, mental disorders, schizophrenia and disorders with psychotic features
21902|NCT04060485|Next generation sequencing|next generation sequencing
21903|NCT04060485|Acute Myeloid Leukemia|acute myeloid leukemia
21904|NCT04060485|Myelodysplastic Syndromes|myelodysplastic syndromes
21905|NCT04060485|Myeloproliferative Neoplasm|myeloproliferative neoplasm
21906|NCT04060485|Aplastic Anemia|aplastic anemia
21907|NCT04060485|Genetic mutation|genetic mutation
21908|NCT04060485|Prognosis|prognosis
21909|NCT04060459|Bladder cancer；Paclitaxel-binding albumin；Cisplatin；Neoadjuvant Chemotherapy|bladder cancer；paclitaxel-binding albumin；cisplatin；neoadjuvant chemotherapy
21910|NCT04060433|Family Therapy|family therapy
21911|NCT04060433|Health Plan Implementation|health plan implementation
21912|NCT04060433|Outpatients|outpatients
21913|NCT04060381|Speckle tracking echocardiography|speckle tracking echocardiography
21914|NCT04060381|Tissue doppler|tissue doppler
21915|NCT04060381|Neonates|neonates
21917|NCT04060381|Maternal obesity|maternal obesity
21918|NCT04060368|NASH|nash
21919|NCT04060368|Obesity|obesity
21920|NCT04060368|Endoscopic Sleeve Gastroplasty|endoscopic sleeve gastroplasty
21921|NCT04060368|Laparoscopic Sleeve Gastrectomy|laparoscopic sleeve gastrectomy
21922|NCT04060355|People Living With Disability|people living with disability
21923|NCT04060355|PLWD|plwd
21924|NCT04060355|Caregiver|caregiver
21925|NCT04060355|Interventionist|interventionist
21926|NCT04060355|Distance education|distance education
21927|NCT04060355|Savvy|savvy
21928|NCT04060342|GEJ adenocarcinoma|gej adenocarcinoma
21929|NCT04060342|TNBC|tnbc
21930|NCT04060342|MSS mCRC|mss mcrc
21931|NCT04060342|PD-L1 + gastric cancer|pd-l1 + gastric cancer
21932|NCT04060342|PD-L1 positive gastric cancer|pd-l1 positive gastric cancer
21933|NCT04060316|Surgery|surgery
21934|NCT04060303|Pediatric Surgery|pediatric surgery
21935|NCT04060303|Implementation|implementation
21936|NCT04060303|Quality Improvement|quality improvement
21937|NCT04060303|Enhanced Recovery Protocols|enhanced recovery protocols
805720|NCT00230984|Survival|survival
21938|NCT04060251|Total knee arthroplasty|total knee arthroplasty
21939|NCT04060251|Physical therapy|physical therapy
21940|NCT04060251|Neuromuscular electrical stimulation|neuromuscular electrical stimulation
21941|NCT04060251|Telemedicine|telemedicine
21942|NCT04060238|protanopia|protanopia
21943|NCT04060238|taillight|taillight
21944|NCT04060238|brake light|brake light
21945|NCT04060238|differential luminance sensitivity|differential luminance sensitivity
21946|NCT04060238|contrast sensitivity|contrast sensitivity
21947|NCT04060238|colour vision|colour vision
21948|NCT04060238|colour vision defect|colour vision defect
21949|NCT04060238|perimetry|perimetry
21950|NCT04060238|semi-automated kinetic perimetry|semi-automated kinetic perimetry
21951|NCT04060238|traffic|traffic
21952|NCT04060238|motorist|motorist
21953|NCT04060238|reaction time|reaction time
21954|NCT04060186|Recurrence rate of cSDH|recurrence rate of csdh
21955|NCT04060186|Outcome|outcome
21956|NCT04060173|Gout|gout
21957|NCT04060173|Hyperuricemia|hyperuricemia
21958|NCT04060160|machine learning|machine learning
21959|NCT04060160|self-learning software|self-learning software
21960|NCT04060160|image-detecting software|image-detecting software
21961|NCT04060121|early adverse life events|early adverse life events
21962|NCT04060121|ptsd|ptsd
21963|NCT04060121|cognitive behavioral therapy|cognitive behavioral therapy
21964|NCT04060095|NOL index, anesthesia, β1-adrenergic antagonist|nol index, anesthesia, β1-adrenergic antagonist
21965|NCT04060082|FTD|ftd
21966|NCT04060082|Interview|interview
21967|NCT04060082|Genetics|genetics
21968|NCT04060082|Persons diagnosed|persons diagnosed
21969|NCT04060082|Frontotemporal degeneration|frontotemporal degeneration
21970|NCT04060082|bvFTD|bvftd
21971|NCT04060082|Chromosome 9 open reading frame 72 (C9ORF72)|chromosome 9 open reading frame 72 (c9orf72)
21972|NCT04060082|Microtubule-associated protein tau (MAPT)|microtubule-associated protein tau (mapt)
21973|NCT04060082|Progranulin (GRN)|progranulin (grn)
21974|NCT04060082|TAR DNA-binding protein (TARDBP)|tar dna-binding protein (tardbp)
21975|NCT04060082|Valosin-Containing Protein (VCP)|valosin-containing protein (vcp)
21976|NCT04060082|Charged multivesicular body protein 2B (CHMP2B)|charged multivesicular body protein 2b (chmp2b)
21977|NCT04060056|Precision Nutrition|precision nutrition
21978|NCT04060056|Host and Microbiome|host and microbiome
21979|NCT04060056|Birth Outcomes|birth outcomes
21980|NCT04060043|goserelin|goserelin
21981|NCT04060043|testosterone|testosterone
21982|NCT04060004|physical therapy|physical therapy
21983|NCT04059978|Cannabidiol|cannabidiol
21984|NCT04059978|Remifentanil|remifentanil
21985|NCT04059952|Electroconvulsive Therapy|electroconvulsive therapy
21986|NCT04059952|Magnetic Resonance Imaging|magnetic resonance imaging
21987|NCT04059913|Anemia|anemia
21988|NCT04059913|Chronic Kidney Disease Dialysis|chronic kidney disease dialysis
21989|NCT04059913|hemoglobin|hemoglobin
21990|NCT04059913|End stage renal disease|end stage renal disease
21991|NCT04059887|Non-small cell lung cancer|non-small cell lung cancer
21992|NCT04059887|Immune checkpoint inhibitor|immune checkpoint inhibitor
21993|NCT04059887|Tumor mutation burden|tumor mutation burden
21994|NCT04059874|non-small cell lung cancer|non-small cell lung cancer
21995|NCT04059861|ultrasound|ultrasound
21996|NCT04059861|depth of invasion|depth of invasion
21997|NCT04059861|tongue cancer|tongue cancer
21998|NCT04059861|floor of the mouth cancer|floor of the mouth cancer
21999|NCT04059861|resection margin|resection margin
22000|NCT04059861|thickness|thickness
22001|NCT04059861|tongue carcinoma|tongue carcinoma
22002|NCT04059861|tongue neoplasm|tongue neoplasm
22003|NCT04059861|cancer of the tongue|cancer of the tongue
22004|NCT04059848|Transcranial direct current stimulation|transcranial direct current stimulation
22005|NCT04059848|Neuromuscular electrical stimulation|neuromuscular electrical stimulation
22006|NCT04059848|Stroke|stroke
22007|NCT04059848|Rehabilitation|rehabilitation
22008|NCT04059822|Slow and deep breathing|slow and deep breathing
22009|NCT04059822|Feasibility study|feasibility study
22010|NCT04059809|Laser|laser
22011|NCT04059809|Photobiomodulation|photobiomodulation
22012|NCT04059809|Radiodermatitis|radiodermatitis
22013|NCT04059809|Breast Cancer|breast cancer
22014|NCT04059770|Histoplasmosis|histoplasmosis
22015|NCT04059770|AIDS|aids
22016|NCT04059770|Liposomal amphotericin B|liposomal amphotericin b
22017|NCT04059770|High dose therapy|high dose therapy
22018|NCT04059757|Graft Versus Host Disease (GVHD)|graft versus host disease (gvhd)
22019|NCT04059705|motor function|motor function
22020|NCT04059705|cognitive|cognitive
22021|NCT04059705|attention|attention
22022|NCT04059705|dual-task|dual-task
22023|NCT04059705|physical activity|physical activity
22024|NCT04059705|cognition|cognition
22025|NCT04059705|older adult|older adult
22026|NCT04059705|mild cognitive impairment|mild cognitive impairment
22027|NCT04059692|neck pain|neck pain
22028|NCT04059692|manual therapy|manual therapy
22029|NCT04059692|movement|movement
22030|NCT04059653|neuromuscular electrical stimulation|neuromuscular electrical stimulation
22031|NCT04059653|incontinence|incontinence
22032|NCT04059640|Inguinal Hernia|inguinal hernia
22033|NCT04059640|Mesh Fixation|mesh fixation
22034|NCT04059640|Surgical Site Wound Closure|surgical site wound closure
22035|NCT04059627|Cardiac Rehab|cardiac rehab
22036|NCT04059614|HFNC|hfnc
22037|NCT04059614|conventional oxygen|conventional oxygen
22038|NCT04059614|EIT|eit
22039|NCT04059614|diaphragm thickness|diaphragm thickness
22040|NCT04059601|common bile duct stones|common bile duct stones
22041|NCT04059601|cholecystectomy|cholecystectomy
22042|NCT04059588|Solid Tumors|solid tumors
22043|NCT04059588|Skin lesions|skin lesions
22044|NCT04059588|Immunotherapy|immunotherapy
22045|NCT04059588|CD40 antibody|cd40 antibody
22046|NCT04059588|Cancer|cancer
22047|NCT04059588|intratumoral|intratumoral
22048|NCT04059588|intralesional|intralesional
22049|NCT04059588|metastases|metastases
22050|NCT04059588|metastasis|metastasis
22051|NCT04059575|tennis|tennis
22052|NCT04059575|vertical jump|vertical jump
22053|NCT04059575|kinesio taping|kinesio taping
22054|NCT04059575|thermography|thermography
22055|NCT04059536|Stenotic Lesions|stenotic lesions
22056|NCT04059510|Streptococcus agalactiae|streptococcus agalactiae
22057|NCT04059510|GBS|gbs
22058|NCT04059497|Craving|craving
22059|NCT04059497|Smoking urge|smoking urge
22060|NCT04059497|Withdrawal|withdrawal
22061|NCT04059497|Nicotine|nicotine
22062|NCT04059497|Exercise|exercise
22063|NCT04059497|Isometric|isometric
22064|NCT04059497|Handgrip|handgrip
22065|NCT04059471|Yellow Fever vaccine|yellow fever vaccine
22066|NCT04059471|Fractional doses|fractional doses
22067|NCT04059471|Yellow Fever|yellow fever
22068|NCT04059471|Vaccine dose|vaccine dose
22069|NCT04059432|Tooth Wear|tooth wear
22070|NCT04059432|Musculoskeletal Disorders|musculoskeletal disorders
22071|NCT04059419|Osteoarthritis|osteoarthritis
22072|NCT04059419|Quality of Life|quality of life
22073|NCT04059419|Sleep disorder|sleep disorder
22074|NCT04059406|Thalassaemia|thalassaemia
22075|NCT04059406|Beta Thalassemia|beta thalassemia
22076|NCT04059406|IONIS TMPRSS6-LRx|ionis tmprss6-lrx
22077|NCT04059380|parathormone|parathormone
22078|NCT04059380|hypoparathyroidism|hypoparathyroidism
22079|NCT04059380|parathyroid|parathyroid
22080|NCT04059380|hypocalcemia|hypocalcemia
22081|NCT04059380|immunity|immunity
22082|NCT04059380|immune function|immune function
22083|NCT04059380|quality of life|quality of life
22084|NCT04059380|sleep disturbances|sleep disturbances
22085|NCT04059380|parathyroid hormone|parathyroid hormone
22086|NCT04059354|Speech intelligibility|speech intelligibility
22087|NCT04059341|Radical Prostatectomy|radical prostatectomy
22088|NCT04059341|Prostatectomy|prostatectomy
22089|NCT04059341|Nerve-sparing|nerve-sparing
22090|NCT04059341|Non nerve-sparing|non nerve-sparing
22091|NCT04059341|Erectile dysfunction|erectile dysfunction
22092|NCT04059341|Erectile function|erectile function
22093|NCT04059341|Shockwave|shockwave
22094|NCT04059341|LI-ESWT|li-eswt
22095|NCT04059341|ESWT|eswt
22096|NCT04059341|Low intensity extracorporeal shockwave therapy|low intensity extracorporeal shockwave therapy
22097|NCT04059341|extracorporeal shockwave therapy|extracorporeal shockwave therapy
22098|NCT04059315|motor vehicle accident, epidemiology, facial fracture|motor vehicle accident, epidemiology, facial fracture
22099|NCT04059289|glare|glare
22100|NCT04059289|contrast sensitivity|contrast sensitivity
22101|NCT04059289|driving simulator|driving simulator
22102|NCT04059289|intermediate visual acuity|intermediate visual acuity
22103|NCT04059289|pseudophakia|pseudophakia
22104|NCT04059289|posterior chamber intraocular lenses|posterior chamber intraocular lenses
22105|NCT04059289|benchmark|benchmark
22106|NCT04059289|straylight|straylight
22107|NCT04059289|nighttime driving|nighttime driving
22108|NCT04059250|composite bactericidal|composite bactericidal
22109|NCT04059250|caries prevention|caries prevention
22110|NCT04059224|NRAS mutant|nras mutant
22111|NCT04059224|NRAS wild-type|nras wild-type
22112|NCT04059224|BRAF V600 wild-type|braf v600 wild-type
22113|NCT04059224|Unresectable stage III melanoma|unresectable stage iii melanoma
22114|NCT04059224|Stage IV melanoma|stage iv melanoma
22115|NCT04059224|low-dose dabrafenib|low-dose dabrafenib
22116|NCT04059224|dabrafenib|dabrafenib
22117|NCT04059224|trametinib|trametinib
22118|NCT04059224|Mekinist|mekinist
22119|NCT04059224|Tafinlar|tafinlar
22120|NCT04059211|urinary dipstick|urinary dipstick
22121|NCT04059211|emergency department|emergency department
22122|NCT04059185|Child abuse|child abuse
22123|NCT04059185|Child maltreatment|child maltreatment
22124|NCT04059159|catheter|catheter
22125|NCT04059133|low intensity extracorporeal low energy shock wave therapy|low intensity extracorporeal low energy shock wave therapy
22126|NCT04059133|stress urinary incontinence|stress urinary incontinence
22127|NCT04059133|overactive bladder|overactive bladder
22128|NCT04059133|urine leakage|urine leakage
22129|NCT04059120|Exercise|exercise
22130|NCT04059120|Overtraining|overtraining
31259|NCT04004910|TNBC|tnbc
22131|NCT04059120|BDNF|bdnf
22132|NCT04059120|Stretching|stretching
22133|NCT04059068|macrophage|macrophage
22134|NCT04059068|adipose tissue|adipose tissue
22135|NCT04059068|fibroblast|fibroblast
22136|NCT04059068|liver disease|liver disease
22137|NCT04059068|RNA sequencing|rna sequencing
22138|NCT04059042|Pain|pain
22139|NCT04059042|Music|music
22140|NCT04059042|Analgesia|analgesia
22141|NCT04059029|Nonalcoholic fatty liver disease|nonalcoholic fatty liver disease
22142|NCT04059029|morbidly obese|morbidly obese
22143|NCT04059029|Bariatric surgery|bariatric surgery
22144|NCT04059016|opioid use disorder|opioid use disorder
22145|NCT04059016|buprenorphine waiver training|buprenorphine waiver training
22146|NCT04059016|VitalSign6|vitalsign6
22147|NCT04059016|measurement based care|measurement based care
22148|NCT04059016|primary care|primary care
22149|NCT04059003|Biomarkers|biomarkers
22150|NCT04059003|Tumor|tumor
22151|NCT04059003|Positron Emission Tomography|positron emission tomography
22152|NCT04059003|Computed Tomography|computed tomography
22153|NCT04058938|opioid use|opioid use
22154|NCT04058938|breast reconstruction|breast reconstruction
22155|NCT04058938|pain control|pain control
22156|NCT04058938|mastectomy|mastectomy
22157|NCT04058925|Out-Of-Hospital Cardiac Arrest|out-of-hospital cardiac arrest
22158|NCT04058925|Near-infrared spectroscopy|near-infrared spectroscopy
22159|NCT04058899|dexmedetomidine|dexmedetomidine
22160|NCT04058899|emergence agitation|emergence agitation
22161|NCT04058899|adenotonsillectomy|adenotonsillectomy
22162|NCT04058860|Microcirculation|microcirculation
22163|NCT04058860|Cardiac Surgery|cardiac surgery
22164|NCT04058847|Risk communication|risk communication
22165|NCT04058847|CVD-risk|cvd-risk
22166|NCT04058847|General practice|general practice
22167|NCT04058847|Primary care|primary care
22168|NCT04058847|Visual communication|visual communication
22169|NCT04058847|Interactive communication|interactive communication
22170|NCT04058847|Cardiovascular risk|cardiovascular risk
22171|NCT04058795|PTSD|ptsd
22172|NCT04058795|Depression|depression
22173|NCT04058795|Anxiety|anxiety
22174|NCT04058795|Distress|distress
22175|NCT04058795|Digital Health|digital health
22176|NCT04058795|mHealth|mhealth
22177|NCT04058782|Prognosis|prognosis
22178|NCT04058782|Vascular stiffness|vascular stiffness
22179|NCT04058782|Heart failure|heart failure
22180|NCT04058782|Myocardial infarction|myocardial infarction
22181|NCT04058756|Phase Ib|phase ib
22182|NCT04058756|PDR001|pdr001
22183|NCT04058756|PD-1|pd-1
22184|NCT04058756|continued access|continued access
22185|NCT04058704|EGFR-TKI|egfr-tki
22186|NCT04058704|NSCLC|nsclc
22187|NCT04058704|Icotinib|icotinib
22188|NCT04058704|radiotherapy|radiotherapy
22189|NCT04058691|Aortic aneurysms|aortic aneurysms
22190|NCT04058691|aortic dissections|aortic dissections
22191|NCT04058691|thoracic|thoracic
22192|NCT04058678|Ovarian reserve.|ovarian reserve.
22193|NCT04058678|Telomeric factor|telomeric factor
22194|NCT04058678|Blood|blood
22195|NCT04058678|Granulosa cells|granulosa cells
22196|NCT04058665|Lumbar spine surgery|lumbar spine surgery
22197|NCT04058665|Blood loss|blood loss
22198|NCT04058639|Bandages|bandages
22199|NCT04058639|Wound Healing|wound healing
22204|NCT04058626|Critical Limb Ischemia|critical limb ischemia
22205|NCT04058600|virtual reality|virtual reality
22206|NCT04058600|anxiety|anxiety
22207|NCT04058600|colorectal cancer|colorectal cancer
22208|NCT04058600|surgery|surgery
22209|NCT04058600|VR|vr
22211|NCT04058548|cystic fibrosis|cystic fibrosis
22212|NCT04058548|walk test|walk test
22213|NCT04058522|Physiotherapy|physiotherapy
22214|NCT04058522|Group Treatment|group treatment
22215|NCT04058509|Greater Trochanter Pain Syndrome|greater trochanter pain syndrome
22216|NCT04058509|Lateral hip pain|lateral hip pain
22217|NCT04058496|Cardia surgery|cardia surgery
22218|NCT04058496|Cardio-pulmonary bypass|cardio-pulmonary bypass
22219|NCT04058496|Inflammation|inflammation
22220|NCT04058496|WNT|wnt
22221|NCT04058496|Cytokines|cytokines
22222|NCT04058483|hypnosis|hypnosis
22223|NCT04058483|hypnotizability|hypnotizability
22224|NCT04058483|validation|validation
22225|NCT04058483|remote|remote
22226|NCT04058483|Hypnotic Induction Profile|hypnotic induction profile
22227|NCT04058470|DLBCL,HGL|dlbcl,hgl
22228|NCT04058457|Parkinson disease|parkinson disease
22229|NCT04058457|movement disorder|movement disorder
22230|NCT04058457|dyspnoea|dyspnoea
22231|NCT04058457|dyspnea|dyspnea
22232|NCT04058457|breathlessness|breathlessness
22233|NCT04058457|respiratory|respiratory
22234|NCT04058444|cesarean delivery|cesarean delivery
22235|NCT04058444|ERAS protocol|eras protocol
22236|NCT04058431|cognitive decline|cognitive decline
22237|NCT04058431|pain|pain
22238|NCT04058431|osteopathic manipulative treatment|osteopathic manipulative treatment
22489|NCT04057014|pediatrics|pediatrics
22239|NCT04058327|neurophysiological/psychological tests|neurophysiological/psychological tests
22240|NCT04058327|blood ammonia|blood ammonia
22241|NCT04058327|early Diagnosis|early diagnosis
22242|NCT04058327|Minimal Hepatic Encephalopathy|minimal hepatic encephalopathy
22243|NCT04058327|Hepatic Encephalopathy|hepatic encephalopathy
22244|NCT04058327|Liver Diseases|liver diseases
22245|NCT04058327|Cirrhosis, Liver|cirrhosis, liver
22246|NCT04058327|Acute-On-Chronic Liver Failure|acute-on-chronic liver failure
22247|NCT04058327|early treatment|early treatment
22248|NCT04058288|stroke|stroke
22249|NCT04058288|HD-tDCS|hd-tdcs
22250|NCT04058288|musicglove|musicglove
22251|NCT04058288|Upper-limb rehab|upper-limb rehab
22252|NCT04058262|in vitro fertilization|in vitro fertilization
22253|NCT04058262|assisted reproduction|assisted reproduction
22254|NCT04058262|pregnancy rate|pregnancy rate
22255|NCT04058262|meditation|meditation
22256|NCT04058262|Reiki|reiki
22257|NCT04058236|Glycocalyx levels|glycocalyx levels
22258|NCT04058236|pancreatectomy|pancreatectomy
22259|NCT04058236|human albumin 5%|human albumin 5%
22260|NCT04058236|gelofusine|gelofusine
22261|NCT04058236|pancreatic fistula|pancreatic fistula
22262|NCT04058197|chronic sickle cell leg ulcer|chronic sickle cell leg ulcer
22263|NCT04058184|Prepulse Inhibition|prepulse inhibition
22264|NCT04058184|Startle Response|startle response
22265|NCT04058171|Walking capacity|walking capacity
22266|NCT04058171|Walking posture|walking posture
22267|NCT04058171|Diagnostic test|diagnostic test
22268|NCT04058145|Head and Neck Cancer|head and neck cancer
22269|NCT04058132|traumatic cerebrovascular injury|traumatic cerebrovascular injury
22270|NCT04058132|Functional Near Infrared Spectroscopy (fNIRS)|functional near infrared spectroscopy (fnirs)
22271|NCT04058119|Mind-body therapies|mind-body therapies
22272|NCT04058119|Yoga|yoga
22273|NCT04058119|Qigong|qigong
22274|NCT04058119|Pilates|pilates
22275|NCT04058119|Primary health care|primary health care
22276|NCT04058093|Exercise|exercise
22277|NCT04058093|Physical activity|physical activity
22278|NCT04058093|Nutrition|nutrition
22279|NCT04058093|Counselling|counselling
22280|NCT04058093|Primary health care|primary health care
22281|NCT04058080|Major depression|major depression
22282|NCT04058080|yoga|yoga
22283|NCT04058080|Bikram yoga|bikram yoga
22284|NCT04058080|aerobic exercise|aerobic exercise
22285|NCT04058080|complementary and alternative treatment approaches|complementary and alternative treatment approaches
22286|NCT04058080|nontraditional treatment approaches|nontraditional treatment approaches
22287|NCT04058080|mindfulness|mindfulness
22288|NCT04058080|rumination|rumination
22289|NCT04058080|stress reactivity|stress reactivity
22290|NCT04058080|cardiovascular functioning|cardiovascular functioning
22291|NCT04058067|Diabetic Macular Edema|diabetic macular edema
22292|NCT04058067|Intravitreal injection|intravitreal injection
22293|NCT04058067|brolucizumab|brolucizumab
22294|NCT04058067|aflibercept|aflibercept
22295|NCT04058041|Neural mobilization|neural mobilization
22296|NCT04058041|Surgery|surgery
22297|NCT04058041|Pain modulation|pain modulation
22311|NCT04058002|Osteoarthritis|osteoarthritis
22312|NCT04058002|Knee|knee
22313|NCT04058002|Quality of Life|quality of life
22314|NCT04058002|Sarcopenia|sarcopenia
22315|NCT04057989|battlefield injury|battlefield injury
22316|NCT04057989|ketamine infusion|ketamine infusion
22317|NCT04057989|regional anesthesia|regional anesthesia
22318|NCT04057989|opioids|opioids
22319|NCT04057963|Inspiratory Muscle Training|inspiratory muscle training
22320|NCT04057963|Exercise|exercise
22321|NCT04057963|Cervical Posture|cervical posture
22322|NCT04057950|seborrheic dermatitis|seborrheic dermatitis
22323|NCT04057950|microbiota|microbiota
22324|NCT04057950|malassezia|malassezia
22325|NCT04057950|bacteria|bacteria
22326|NCT04057950|diversity|diversity
22327|NCT04057937|Palmoplantar Pustulosis|palmoplantar pustulosis
22328|NCT04057937|CC-10004|cc-10004
22329|NCT04057937|Apremilast|apremilast
22330|NCT04057937|Only Japanese|only japanese
22331|NCT04057937|Efficacy|efficacy
22332|NCT04057937|Safety|safety
22333|NCT04057937|Phase 2|phase 2
22334|NCT04057924|HPV|hpv
22335|NCT04057924|alternative to surgery|alternative to surgery
22336|NCT04057924|cervical cancer|cervical cancer
22337|NCT04057911|Cervical dystonia|cervical dystonia
22338|NCT04057911|Non-invasive stimulation|non-invasive stimulation
22339|NCT04057898|ALS|als
22340|NCT04057898|MN-166|mn-166
22341|NCT04057898|ibudilast|ibudilast
22342|NCT04057898|amyotrophic lateral sclerosis|amyotrophic lateral sclerosis
22343|NCT04057872|Therapeutic Plasma Exchange (TPE)|therapeutic plasma exchange (tpe)
22344|NCT04057872|Septic Shock|septic shock
22345|NCT04057872|Severe Sepsis|severe sepsis
22346|NCT04057872|Albumin|albumin
22347|NCT04057872|Fresh Frozen Plasma|fresh frozen plasma
22348|NCT04057846|Walled of necrosis|walled of necrosis
22349|NCT04057846|Endoscopic drainage|endoscopic drainage
22350|NCT04057846|Lumen apposing metal stents|lumen apposing metal stents
22351|NCT04057833|Cell Therapy|cell therapy
22352|NCT04057833|Supraspinatus tendon|supraspinatus tendon
22353|NCT04057833|Systemic safety and toxicity|systemic safety and toxicity
22354|NCT04057833|Muscle and Tendon quality|muscle and tendon quality
22355|NCT04057820|NOWS|nows
22356|NCT04057794|Parkinson's|parkinson's
22357|NCT04057794|Genetics|genetics
22358|NCT04057794|PD Genetics|pd genetics
22359|NCT04057768|acne scars|acne scars
22360|NCT04057768|wrinkles|wrinkles
22361|NCT04057768|rhytids|rhytids
22362|NCT04057768|fractional RF|fractional rf
22363|NCT04057755|botulinum toxin A|botulinum toxin a
22364|NCT04057755|treatment|treatment
22365|NCT04057742|Chronic Active Antibody Mediated Rejection|chronic active antibody mediated rejection
22366|NCT04057742|cAMR|camr
22367|NCT04057703|CEREVANCE|cerevance
22368|NCT04057703|Pediatrics|pediatrics
22369|NCT04057703|Cohort|cohort
22370|NCT04057690|Malignant Brain Edema|malignant brain edema
22371|NCT04057690|Stroke, Acute|stroke, acute
22372|NCT04057690|Prediction|prediction
22373|NCT04057664|Coping|coping
22374|NCT04057664|Multidisciplinary|multidisciplinary
22375|NCT04057664|Group Therapy|group therapy
22376|NCT04057664|Psychotherapy|psychotherapy
22377|NCT04057664|Physiotherapy|physiotherapy
22378|NCT04057638|Transplants|transplants
22379|NCT04057638|Transplantation|transplantation
22380|NCT04057638|Craniomaxillofacial Transplantation|craniomaxillofacial transplantation
22381|NCT04057638|Upper Extremity Transplantation|upper extremity transplantation
22382|NCT04057638|Vascularized Composite Allotransplantation (VCA)|vascularized composite allotransplantation (vca)
22383|NCT04057612|pediatric|pediatric
22384|NCT04057612|temperature|temperature
22385|NCT04057612|general anesthesia|general anesthesia
22386|NCT04057599|post-operative ileus,lumbar spine surgery|post-operative ileus,lumbar spine surgery
22387|NCT04057586|postoperative cognition|postoperative cognition
22388|NCT04057586|nonintubated thoracic surgery|nonintubated thoracic surgery
22389|NCT04057573|Vitiligo|vitiligo
22390|NCT04057573|non-segmental|non-segmental
22391|NCT04057573|JAK inhibitor|jak inhibitor
22392|NCT04057534|Alcohol Dependence|alcohol dependence
22393|NCT04057534|Alcoholism|alcoholism
22394|NCT04057534|Craving|craving
22395|NCT04057534|Cognitive Change|cognitive change
22396|NCT04057534|cognitive remediation|cognitive remediation
22397|NCT04057534|Chess based cognitive training|chess based cognitive training
22398|NCT04057534|Working Memory|working memory
22399|NCT04057534|Decision Making|decision making
22407|NCT04057508|Heart rate variability, MSNA, vagus nerve, sympathetic nervous system|heart rate variability, msna, vagus nerve, sympathetic nervous system
22408|NCT04057495|Blood glucose|blood glucose
22409|NCT04057495|Insulin|insulin
22410|NCT04057482|Bacterial vaginosis, polymerase chain reaction, molecular diagnostic|bacterial vaginosis, polymerase chain reaction, molecular diagnostic
22411|NCT04057443|older|older
22412|NCT04057443|physical exercise|physical exercise
22413|NCT04057443|nutrition support|nutrition support
22414|NCT04057443|hematologic malignancies|hematologic malignancies
22415|NCT04057443|geriatric assessment|geriatric assessment
22416|NCT04057443|geriatric intervention|geriatric intervention
22417|NCT04057430|Interdental plaque|interdental plaque
22418|NCT04057430|Flossing aid|flossing aid
22419|NCT04057430|Children|children
22420|NCT04057430|Gingival inflammation|gingival inflammation
22421|NCT04057417|physical activity|physical activity
22422|NCT04057417|built environment|built environment
22423|NCT04057365|Biliary Tract Cancer|biliary tract cancer
22424|NCT04057339|Time Restricted Eating|time restricted eating
22425|NCT04057339|Circadian Rhythm|circadian rhythm
22426|NCT04057339|Glucose Homeostasis|glucose homeostasis
22427|NCT04057339|Mitochondrial Function|mitochondrial function
22428|NCT04057339|Fasting|fasting
22429|NCT04057313|Coffee|coffee
22430|NCT04057313|Headache|headache
22431|NCT04057313|Intra-dialytic hypotension|intra-dialytic hypotension
22432|NCT04057300|Cardiovascular disease|cardiovascular disease
22433|NCT04057300|Myocardial Infarction|myocardial infarction
22434|NCT04057300|Stroke|stroke
22435|NCT04057300|Clopidogrel|clopidogrel
22436|NCT04057300|Ticagrelor|ticagrelor
22437|NCT04057300|Platelet Aggregation Inhibitors|platelet aggregation inhibitors
22438|NCT04057300|Pragmatic Trial|pragmatic trial
22439|NCT04057274|Colon cancer|colon cancer
22440|NCT04057274|Aerobic exercise|aerobic exercise
22441|NCT04057261|Liraglutide|liraglutide
22442|NCT04057261|Type 2 Diabetes|type 2 diabetes
22443|NCT04057261|High Cardiovascular Risk|high cardiovascular risk
22444|NCT04057261|Myocardial Infarction|myocardial infarction
22445|NCT04057261|Metabolic Profile|metabolic profile
22452|NCT04057209|head and neck cancer|head and neck cancer
22453|NCT04057209|squamous cell carcinoma|squamous cell carcinoma
22454|NCT04057209|carcinoma in situ|carcinoma in situ
22455|NCT04057209|radiotherapy|radiotherapy
22456|NCT04057209|surgery|surgery
22457|NCT04057209|transoral laser microsurgery|transoral laser microsurgery
22458|NCT04057209|patient reported outcome|patient reported outcome
22459|NCT04057209|quality of life|quality of life
22460|NCT04057209|voice|voice
22461|NCT04057183|Carotid|carotid
22462|NCT04057183|Stenosis|stenosis
22463|NCT04057183|Noninvasive|noninvasive
22464|NCT04057170|shoulder pain|shoulder pain
22465|NCT04057157|dura mater repair|dura mater repair
22466|NCT04057157|cerebrospinal fluid leak|cerebrospinal fluid leak
22467|NCT04057157|CSF leak|csf leak
22468|NCT04057157|Biodesign® Dural Repair Graft|biodesign® dural repair graft
22469|NCT04057157|Biodesign® Duraplasty Repair Graft|biodesign® duraplasty repair graft
22470|NCT04057144|Mindfulness|mindfulness
22471|NCT04057144|Psychotherapy, Group|psychotherapy, group
22472|NCT04057144|Behavior Therapy|behavior therapy
22473|NCT04057092|perioperative immunonutrition|perioperative immunonutrition
22474|NCT04057092|clinical nutrition|clinical nutrition
22475|NCT04057092|infection prevention|infection prevention
22476|NCT04057079|Hemoroidectomy|hemoroidectomy
22477|NCT04057066|multiple sclerosis|multiple sclerosis
22478|NCT04057066|e-health|e-health
22479|NCT04057066|physical activity promotion|physical activity promotion
22480|NCT04057066|exercise|exercise
22481|NCT04057066|feasibility|feasibility
22482|NCT04057066|online|online
22483|NCT04057066|internet based|internet based
22484|NCT04057053|DWEK, Netarsudil|dwek, netarsudil
22485|NCT04057040|polycythemia vera|polycythemia vera
22486|NCT04057014|Dentistry|dentistry
22487|NCT04057014|Antibiotic|antibiotic
22488|NCT04057014|Penicillin|penicillin
22490|NCT04056949|SCLC|sclc
22491|NCT04056936|Breastfeeding|breastfeeding
22492|NCT04056936|Lactational mastitis|lactational mastitis
22493|NCT04056936|Infant nutrition|infant nutrition
22494|NCT04056936|Infant growth|infant growth
22495|NCT04056936|Speech development|speech development
22496|NCT04056936|Frenotomy|frenotomy
22497|NCT04056923|Pulmonary Nodules|pulmonary nodules
22498|NCT04056923|Lung Neoplasms|lung neoplasms
22501|NCT04056871|post-operative delirium|post-operative delirium
22502|NCT04056871|post-operative cognitive dysfunction|post-operative cognitive dysfunction
22504|NCT04056871|nutritional status|nutritional status
22505|NCT04056871|depression|depression
22506|NCT04056858|array-CGH|array-cgh
22507|NCT04056858|exome sequencing|exome sequencing
22508|NCT04056832|Aortic Stenosis|aortic stenosis
22509|NCT04056832|Aortic Valve Replacement|aortic valve replacement
22510|NCT04056832|Single Strip Pericardium|single strip pericardium
22511|NCT04056832|Autologous Pericardium|autologous pericardium
22512|NCT04056832|Mechanical Valve Replacement|mechanical valve replacement
22513|NCT04056832|Comparison of Left Ventricle Remodeling|comparison of left ventricle remodeling
22514|NCT04056793|Birthing position|birthing position
22515|NCT04056793|Dystocia|dystocia
22516|NCT04056741|Neonatal RDS|neonatal rds
22517|NCT04056741|RDS|rds
22518|NCT04056741|Surfactant Deficiency|surfactant deficiency
22519|NCT04056715|electrocardiography|electrocardiography
22520|NCT04056715|electrocardiogram|electrocardiogram
22521|NCT04056715|mobile cardiac monitoring|mobile cardiac monitoring
22522|NCT04056715|ambulatory monitoring|ambulatory monitoring
22523|NCT04056715|ECG|ecg
22524|NCT04056715|EKG|ekg
22525|NCT04056702|Chronic Sinusitis|chronic sinusitis
22529|NCT04056676|Postoperative pain|postoperative pain
22530|NCT04056676|Thoracic paravertebral block|thoracic paravertebral block
22531|NCT04056676|Modified PEC block|modified pec block
22532|NCT04056676|Breast cancer|breast cancer
22533|NCT04056676|Total mastectomy with sentinel lymph node clearance|total mastectomy with sentinel lymph node clearance
22534|NCT04056663|Artificial Intelligence|artificial intelligence
22535|NCT04056663|Continuity of Patient Care|continuity of patient care
22536|NCT04056650|N-of-1|n-of-1
22537|NCT04056650|Caffeine|caffeine
22538|NCT04056650|L-theanine|l-theanine
22539|NCT04056650|Nootropic|nootropic
22540|NCT04056650|Cognition|cognition
22541|NCT04056650|Individualized|individualized
22542|NCT04056637|MLPT|mlpt
22543|NCT04056637|multi-level pregnancy test|multi-level pregnancy test
22544|NCT04056637|medication abortion|medication abortion
22545|NCT04056637|first trimester abortion|first trimester abortion
22546|NCT04056637|abortion follow-up|abortion follow-up
22547|NCT04056598|P. acnes|p. acnes
22548|NCT04056598|acne vulgaris|acne vulgaris
22549|NCT04056598|humoral immune response|humoral immune response
22550|NCT04056598|microbiome|microbiome
22551|NCT04056598|SLST|slst
22552|NCT04056585|brachial plexus block|brachial plexus block
22553|NCT04056585|intermittent pneumatic compression maneuver|intermittent pneumatic compression maneuver
22554|NCT04056559|Prototype|prototype
22555|NCT04056559|Adaptable mouthguards|adaptable mouthguards
22556|NCT04056546|Real-time Polymerase-Chain Reaction|real-time polymerase-chain reaction
22557|NCT04056533|Citomegalovirus, Haploidentical, Hematopoietic Stem Cell Transplantation|citomegalovirus, haploidentical, hematopoietic stem cell transplantation
22558|NCT04056507|Immunological parameters|immunological parameters
22559|NCT04056507|Histological parameters|histological parameters
22560|NCT04056481|Acute Hepatic Porphyria (AHP)|acute hepatic porphyria (ahp)
400569|NCT01866228|Consultation Recording|consultation recording
22561|NCT04056481|Acute Intermittent Porphyria (AIP)|acute intermittent porphyria (aip)
22562|NCT04056481|Porphyria|porphyria
22563|NCT04056481|Acute Intermittent|acute intermittent
22564|NCT04056481|Acute Porphyria|acute porphyria
22565|NCT04056481|Hereditary Coproporphyria (HCP)|hereditary coproporphyria (hcp)
22566|NCT04056481|Variegate Porphyria (VP)|variegate porphyria (vp)
22567|NCT04056481|ALA Dehydratase Deficient Porphyria (ADP)|ala dehydratase deficient porphyria (adp)
22568|NCT04056481|Givosiran|givosiran
22569|NCT04056481|Expanded Access|expanded access
22570|NCT04056481|EAP|eap
22571|NCT04056468|Drug Therapy|drug therapy
22572|NCT04056455|Drug Therapy|drug therapy
22573|NCT04056403|labor epidural|labor epidural
22574|NCT04056403|ultrasound|ultrasound
22575|NCT04056390|catheter ablation|catheter ablation
22576|NCT04056377|Hypertension|hypertension
22577|NCT04056377|Retinopathy|retinopathy
22578|NCT04056377|Obesity|obesity
22579|NCT04056377|Arterial stiffness|arterial stiffness
22580|NCT04056377|Physical inactivity|physical inactivity
22581|NCT04056351|humerus|humerus
22582|NCT04056351|fracture|fracture
22583|NCT04056351|locking plate|locking plate
22584|NCT04056351|PHILOS|philos
22585|NCT04056351|fixation failure risk|fixation failure risk
22586|NCT04056351|computer simulation|computer simulation
22587|NCT04056351|patient activity tracking|patient activity tracking
22588|NCT04056338|delirium|delirium
22589|NCT04056312|memory|memory
22590|NCT04056312|learning|learning
22591|NCT04056312|cognition|cognition
22592|NCT04056312|traumatic brain injury|traumatic brain injury
22593|NCT04056312|treatment and therapy|treatment and therapy
22694|NCT04055454|Lassa Virus Infection|lassa virus infection
22596|NCT04056299|Desensitization|desensitization
22597|NCT04056299|AR201|ar201
22598|NCT04056299|Allergy|allergy
22599|NCT04056299|Hen Egg Allergy|hen egg allergy
22600|NCT04056299|Characterized Hen Egg Allergen|characterized hen egg allergen
22601|NCT04056299|Oral Immunotherapy|oral immunotherapy
22602|NCT04056299|CHEA (Characterized Hen Egg Allergen)|chea (characterized hen egg allergen)
22603|NCT04056299|Food Allergy|food allergy
22604|NCT04056286|gastric emptying|gastric emptying
22605|NCT04056286|gastro-intestinal motility|gastro-intestinal motility
22606|NCT04056286|endotoxemia|endotoxemia
22607|NCT04056286|catabolism|catabolism
22608|NCT04056286|GLP-1|glp-1
22609|NCT04056286|GIP|gip
22610|NCT04056273|guide sheath, bronchoscopic biopsy|guide sheath, bronchoscopic biopsy
22611|NCT04056234|Translocation|translocation
22612|NCT04056234|Synovial microbiota|synovial microbiota
22613|NCT04056221|Sjogren`s syndrome|sjogren`s syndrome
22614|NCT04056221|xerostomia|xerostomia
22615|NCT04056221|xerophthalmia|xerophthalmia
22616|NCT04056221|acupuncture|acupuncture
22617|NCT04056182|opioid use disorder|opioid use disorder
22618|NCT04056182|lofexidine|lofexidine
22619|NCT04056182|naltrexon-xr|naltrexon-xr
22620|NCT04056169|rosuvastatin|rosuvastatin
22621|NCT04056169|ezetimibe/rosuvastatin|ezetimibe/rosuvastatin
22622|NCT04056169|carotid plaque inflammation|carotid plaque inflammation
22623|NCT04056169|fluorodeoxyglucose F18|fluorodeoxyglucose f18
22624|NCT04056169|positron emission tomography|positron emission tomography
22625|NCT04056156|HIV|hiv
22626|NCT04056156|HIV-testing|hiv-testing
22627|NCT04056156|Prevention|prevention
22628|NCT04056156|Primary Care|primary care
22629|NCT04056143|Thromboembolism|thromboembolism
22630|NCT04056143|Oral anticoagulants|oral anticoagulants
22631|NCT04056143|Adverse events|adverse events
22632|NCT04056143|Pharmacogenomics|pharmacogenomics
22633|NCT04056143|Precision Medicine|precision medicine
22634|NCT04056091|Neonatal resuscitation|neonatal resuscitation
22635|NCT04056091|Stimulation|stimulation
22636|NCT04056091|Asphyxia|asphyxia
22637|NCT04056065|Resuscitative agent|resuscitative agent
22638|NCT04056065|Vasopressor|vasopressor
22639|NCT04056052|Children|children
22640|NCT04056052|Family-based intervention|family-based intervention
22641|NCT04056039|rheumatoid arthritis|rheumatoid arthritis
22642|NCT04056039|Troponin I|troponin i
22643|NCT04056039|Atorvastatin|atorvastatin
22644|NCT04056039|Colchicine|colchicine
22645|NCT04056039|Cardiovascular disease risk|cardiovascular disease risk
22646|NCT04056013|Traumatic lacerations|traumatic lacerations
22647|NCT04056013|Vicryl Rapide|vicryl rapide
22648|NCT04056013|nonabsorbable suture|nonabsorbable suture
22649|NCT04056013|Suture|suture
22650|NCT04055974|positive mental health|positive mental health
22651|NCT04055974|cognitive behavioral therapy|cognitive behavioral therapy
22652|NCT04055974|eHealth|ehealth
22653|NCT04055974|postpartum period|postpartum period
22654|NCT04055909|Septic Shock|septic shock
22655|NCT04055844|AML|aml
22656|NCT04055844|MDS|mds
22657|NCT04055831|Gaucher disease|gaucher disease
22658|NCT04055831|Osteoporosis|osteoporosis
22659|NCT04055792|small cell lung cancer|small cell lung cancer
22660|NCT04055792|PD-1 inhibitor|pd-1 inhibitor
22661|NCT04055792|anti-angiogenesis|anti-angiogenesis
22662|NCT04055792|third-line or beyond treatment|third-line or beyond treatment
22663|NCT04055766|Artificial Intelligence|artificial intelligence
22664|NCT04055740|CIED|cied
22665|NCT04055727|treatment|treatment
22666|NCT04055714|Eustachian tube dysfunction|eustachian tube dysfunction
22667|NCT04055688|Orbeye Surgical Microscope|orbeye surgical microscope
22668|NCT04055688|fluorescence-guided surgery|fluorescence-guided surgery
22669|NCT04055688|5-ALA|5-ala
22670|NCT04055623|Lou Gehrig's Disease|lou gehrig's disease
22671|NCT04055610|H-MEX powered exoskeleton|h-mex powered exoskeleton
22672|NCT04055610|Exoskeleton|exoskeleton
22673|NCT04055597|cerebellar stroke|cerebellar stroke
22674|NCT04055597|upper extremity rehabilitation robot|upper extremity rehabilitation robot
22675|NCT04055597|transcranial direct current stimulation|transcranial direct current stimulation
22676|NCT04055597|stroke rehabilitation|stroke rehabilitation
22677|NCT04055558|childhood leukemia|childhood leukemia
22678|NCT04055558|lymphoproliferative disorders|lymphoproliferative disorders
22679|NCT04055558|EBV|ebv
22680|NCT04055493|early breast cancer|early breast cancer
22681|NCT04055493|ADAPT|adapt
22682|NCT04055493|endocrine therapy|endocrine therapy
22683|NCT04055493|ribociclib|ribociclib
22684|NCT04055493|intermediate risk|intermediate risk
22685|NCT04055493|HER2 negative|her2 negative
22686|NCT04055493|HR positive|hr positive
22687|NCT04055480|closed-loop|closed-loop
22688|NCT04055480|artificial pancreas|artificial pancreas
22689|NCT04055480|insulin|insulin
22699|NCT04055428|Natriuretic Peptides|natriuretic peptides
22700|NCT04055428|Diabetes|diabetes
22701|NCT04055428|Insulin Sensitivity|insulin sensitivity
22702|NCT04055428|Energy Expenditure|energy expenditure
22703|NCT04055415|Pulmonary hypertension（PH）mesenchymal stem cells(MSC)|pulmonary hypertension（ph）mesenchymal stem cells(msc)
22705|NCT04055376|Alzheimer Disease|alzheimer disease
22706|NCT04055376|Cognitive Impairment|cognitive impairment
22707|NCT04055376|Non-invasive Sensory Stimulation|non-invasive sensory stimulation
22708|NCT04055376|Light and Sound Stimulation|light and sound stimulation
22709|NCT04055376|Gamma|gamma
22710|NCT04055363|Growth|growth
22711|NCT04055363|Tolerance|tolerance
22712|NCT04055363|Adverse Event|adverse event
22713|NCT04055363|Gastrointestinal disorder|gastrointestinal disorder
22714|NCT04055363|Respiratory infection|respiratory infection
22715|NCT04055363|Gastrointestinal infection|gastrointestinal infection
22716|NCT04055350|National early warning score|national early warning score
22717|NCT04055350|Prevention of serious adverse events|prevention of serious adverse events
22718|NCT04055350|Patient deterioration|patient deterioration
22719|NCT04055311|patient focused intervention|patient focused intervention
22720|NCT04055311|caregiver|caregiver
22721|NCT04055311|Internet based information|internet based information
22722|NCT04055311|recovery support|recovery support
22723|NCT04055311|bladder cancer|bladder cancer
22724|NCT04055311|urinary diversion|urinary diversion
22725|NCT04055311|neobladder|neobladder
22726|NCT04055285|arterial hypertension|arterial hypertension
22727|NCT04055285|atrial fibrillation|atrial fibrillation
22728|NCT04055285|renal denervation|renal denervation
22729|NCT04055285|autonomous nervous system|autonomous nervous system
22730|NCT04055285|implantable loop recorder|implantable loop recorder
22731|NCT04055285|continuous monitoring|continuous monitoring
22732|NCT04055285|burden|burden
22733|NCT04055285|insertable cardiac monitor|insertable cardiac monitor
22734|NCT04055285|resistant hypertension|resistant hypertension
22735|NCT04055272|indoor tanning|indoor tanning
22736|NCT04055272|skin cancer|skin cancer
22737|NCT04055272|mobile health|mobile health
22738|NCT04055272|text messaging|text messaging
22739|NCT04055259|Health and Wellness Coaching|health and wellness coaching
22740|NCT04055220|Maintenance therapy|maintenance therapy
22741|NCT04055220|First line therapy|first line therapy
22742|NCT04055220|Regorafenib|regorafenib
22743|NCT04055220|Randomization|randomization
22744|NCT04055220|Double-blinded|double-blinded
22745|NCT04055220|Placebo controlled|placebo controlled
22746|NCT04055220|Relapse-free survival|relapse-free survival
22747|NCT04055220|Time to treatment failure|time to treatment failure
22748|NCT04055220|Overall survival|overall survival
22749|NCT04055220|Quality of life|quality of life
22750|NCT04055220|Tolerance|tolerance
22751|NCT04055220|Compliance|compliance
22752|NCT04055220|Bone sarcoma|bone sarcoma
22753|NCT04055220|Osteosarcoma|osteosarcoma
22754|NCT04055220|Efficacy|efficacy
22755|NCT04055220|Complete response|complete response
22756|NCT04055220|Tyrosine kinase inhibitor|tyrosine kinase inhibitor
22757|NCT04055220|Multi-target inhibitor|multi-target inhibitor
22758|NCT04055207|HIV|hiv
22759|NCT04055207|Telemedicine|telemedicine
22760|NCT04055181|schizophrenia|schizophrenia
22761|NCT04055181|smoking|smoking
22762|NCT04055181|rTMS|rtms
22763|NCT04055181|major depressive disorder|major depressive disorder
22768|NCT04055103|Total Hip/Knee Arthroplasty;Dutch Arthroplasty Register; Quality Improvement.|total hip/knee arthroplasty;dutch arthroplasty register; quality improvement.
22769|NCT04055090|diabetic|diabetic
22770|NCT04055090|neuropathy|neuropathy
22771|NCT04055090|shooting pain|shooting pain
22772|NCT04055090|burning pain|burning pain
22773|NCT04055090|pins and needles pain|pins and needles pain
22774|NCT04055090|foot pain|foot pain
22775|NCT04055090|ViroMed|viromed
22776|NCT04055077|Noninvasive Ventilation|noninvasive ventilation
22777|NCT04055077|Airway management|airway management
22778|NCT04055077|Vitrectomy|vitrectomy
22779|NCT04055077|Adult|adult
22780|NCT04055077|Moderate Sedation|moderate sedation
22781|NCT04055077|Hypoxia|hypoxia
22782|NCT04055064|DFU, wound healing, nutrition education,supplementation|dfu, wound healing, nutrition education,supplementation
22783|NCT04055051|Hemophilia A|hemophilia a
22784|NCT04055051|Hemophilia B|hemophilia b
22785|NCT04055051|Liver Transplantation|liver transplantation
22786|NCT04055051|Quality of Life|quality of life
22787|NCT04055051|Hemophilia Treatment Centers (HTCs)|hemophilia treatment centers (htcs)
22788|NCT04055025|Ghrelin|ghrelin
22789|NCT04055025|Sleeve gastrectomy|sleeve gastrectomy
22790|NCT04055025|Laparoscopic sleeve gastrectomy|laparoscopic sleeve gastrectomy
22791|NCT04055012|Low Back Pain|low back pain
22800|NCT04054986|Memorial Sloan Kettering Cancer Center|memorial sloan kettering cancer center
22802|NCT04054973|psychosis|psychosis
22803|NCT04054973|Treatment resistant|treatment resistant
22804|NCT04054973|L-arginine|l-arginine
22805|NCT04054973|MRS|mrs
22806|NCT04054960|Parkinson disease OFF state, Noninvasive stimulation|parkinson disease off state, noninvasive stimulation
22807|NCT04054947|Suicidal and Self-injurious Behavior|suicidal and self-injurious behavior
22808|NCT04054934|T1DM|t1dm
22809|NCT04054934|Hypothalamus|hypothalamus
22810|NCT04054934|CORTICAL BRAIN|cortical brain
22811|NCT04054934|Glucose variability|glucose variability
22812|NCT04054934|Biological clock|biological clock
22813|NCT04054934|Pediatrics|pediatrics
22814|NCT04054921|Chronic anemia|chronic anemia
22815|NCT04054921|β-thalassemia|β-thalassemia
22816|NCT04054908|Gut Microbiome|gut microbiome
22817|NCT04054908|Colorectal Cancer|colorectal cancer
22818|NCT04054908|Oral Fluoropyrimidine|oral fluoropyrimidine
22819|NCT04054895|His pacing|his pacing
22820|NCT04054895|Resynchronization therapy|resynchronization therapy
22821|NCT04054895|Electrocardiographic imaging|electrocardiographic imaging
22825|NCT04054830|Trabeculectomy|trabeculectomy
22826|NCT04054830|NSAID|nsaid
22827|NCT04054830|Steroid|steroid
22828|NCT04054830|Anti-Inflammatory Agents|anti-inflammatory agents
22829|NCT04054830|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal
22830|NCT04054830|Eye Diseases|eye diseases
22831|NCT04054804|risk factor|risk factor
22832|NCT04054804|software|software
22833|NCT04054804|orthotics|orthotics
22834|NCT04054778|Auditory verbal hallucinations|auditory verbal hallucinations
22835|NCT04054778|Schizophrenia|schizophrenia
22836|NCT04054778|Treatment-resistant|treatment-resistant
22837|NCT04054778|Psychotherapy|psychotherapy
22838|NCT04054778|Cognitive Behavioral Therapy|cognitive behavioral therapy
22839|NCT04054778|Avatar Therapy|avatar therapy
22840|NCT04054778|Virtual reality|virtual reality
22841|NCT04054765|prevention|prevention
22842|NCT04054765|intervention|intervention
22848|NCT04054739|robot-assisted gait training|robot-assisted gait training
22849|NCT04054739|cortical activity|cortical activity
22850|NCT04054739|gait kinematics|gait kinematics
22851|NCT04054739|stroke|stroke
22852|NCT04054726|Cerebellar ataxia|cerebellar ataxia
22853|NCT04054726|Non-invasive stimulation|non-invasive stimulation
22854|NCT04054726|Transcranial pulsed current stimulation|transcranial pulsed current stimulation
22855|NCT04054713|Barrett Esophagus|barrett esophagus
22856|NCT04054713|Dysplasia|dysplasia
22857|NCT04054713|acetic acid|acetic acid
22858|NCT04054713|Seattle protocol|seattle protocol
22859|NCT04054713|Chromoendoscopy|chromoendoscopy
22860|NCT04054700|upper limb rehabilitation|upper limb rehabilitation
22861|NCT04054700|stroke|stroke
22862|NCT04054700|proximal upper rehabilitation robot|proximal upper rehabilitation robot
22863|NCT04054700|distal upper rehabilitation robot|distal upper rehabilitation robot
22864|NCT04054674|e.max, occlusal scheme, endodntically treated teeth,|e.max, occlusal scheme, endodntically treated teeth,
22865|NCT04054661|G6PD Deficiency|g6pd deficiency
22866|NCT04054648|Pragmatic|pragmatic
22867|NCT04054648|Primary Care|primary care
22868|NCT04054648|Chronotherapy|chronotherapy
22869|NCT04054648|Administrative Data|administrative data
22870|NCT04054648|Behaviourism|behaviourism
22871|NCT04054648|Sundowning|sundowning
22872|NCT04054648|Stroke|stroke
22873|NCT04054648|Myocardial Infarction|myocardial infarction
22874|NCT04054648|Heart Failure|heart failure
22875|NCT04054648|Hip Fracture|hip fracture
22876|NCT04054648|Nursing Home|nursing home
22877|NCT04054648|Long Term Care|long term care
22878|NCT04054635|silver diamine fluoride|silver diamine fluoride
22879|NCT04054635|randomized clinical trial|randomized clinical trial
22880|NCT04054635|early childhood caries|early childhood caries
22881|NCT04054635|severe early childhood caries|severe early childhood caries
22882|NCT04054635|oral microbiome|oral microbiome
22883|NCT04054635|treatment|treatment
22884|NCT04054635|arrest|arrest
22885|NCT04054635|application|application
22886|NCT04054635|frequency|frequency
22887|NCT04054635|regimen|regimen
22888|NCT04054635|cariogenic bacteria|cariogenic bacteria
22889|NCT04054635|early childhood oral health impact scale|early childhood oral health impact scale
22890|NCT04054635|oral health-related quality of of life|oral health-related quality of of life
22891|NCT04054635|caries|caries
22892|NCT04054635|oral bacteriome|oral bacteriome
22893|NCT04054635|oral mycobiome|oral mycobiome
22894|NCT04054635|cavitated lesions|cavitated lesions
22895|NCT04054622|patient-ventilator asynchrony|patient-ventilator asynchrony
22896|NCT04054596|Traumatic Brain Injury|traumatic brain injury
22897|NCT04054596|Cognitive Impairment|cognitive impairment
22898|NCT04054596|Intervention|intervention
22899|NCT04054583|Long-term care|long-term care
22900|NCT04054583|Renovations|renovations
22901|NCT04054583|Residents|residents
22902|NCT04054583|Family|family
22903|NCT04054583|Staff|staff
22904|NCT04054544|Celiac disease|celiac disease
22905|NCT04054479|Penehyclidine|penehyclidine
22906|NCT04054479|PONV|ponv
22907|NCT04054466|HIV|hiv
22908|NCT04054466|Counseling|counseling
22909|NCT04054466|Antiretroviral Therapy|antiretroviral therapy
22910|NCT04054466|Alcohol Drinking|alcohol drinking
22911|NCT04054466|Nursing Care|nursing care
22912|NCT04054440|office based angiosuite|office based angiosuite
22913|NCT04054427|Intraocular Lens|intraocular lens
22914|NCT04054427|Trifocal|trifocal
22915|NCT04054427|hydrophobic|hydrophobic
22916|NCT04054427|Post refractive surgery|post refractive surgery
22917|NCT04054414|Endothelin|endothelin
22918|NCT04054414|Neurogenesis|neurogenesis
22919|NCT04054388|LINE|line
22920|NCT04054388|Colonoscopy|colonoscopy
22921|NCT04054388|Bowel cleansing|bowel cleansing
22922|NCT04054375|Steroids, Prednisone|steroids, prednisone
22923|NCT04054336|Approach and Avoidance Task, Inhibition|approach and avoidance task, inhibition
22924|NCT04054323|Exercise|exercise
22925|NCT04054323|CKD|ckd
22926|NCT04054323|Graft Survival|graft survival
22927|NCT04054323|Transplant Waitlist|transplant waitlist
22928|NCT04054297|NAFLD|nafld
22929|NCT04054297|Diet|diet
22930|NCT04054297|Glycemic index|glycemic index
22931|NCT04054284|Type 2 Diabetes|type 2 diabetes
22932|NCT04054284|Herbal Medicine|herbal medicine
22933|NCT04054284|Safety|safety
22934|NCT04054284|Glycaemia Control|glycaemia control
22935|NCT04054284|Alternative Therapy|alternative therapy
22936|NCT04054271|Blood types, Dental implant, Marginal Bone Resorption, Implant Survival|blood types, dental implant, marginal bone resorption, implant survival
22937|NCT04054258|coronary heart disease|coronary heart disease
22938|NCT04054258|e-health|e-health
22939|NCT04054258|self-efficacy|self-efficacy
22940|NCT04054180|Continuous positive airway pressure|continuous positive airway pressure
22941|NCT04054180|Connected devices|connected devices
22942|NCT04054128|Sodium bicarbonate lock|sodium bicarbonate lock
22943|NCT04054128|Heparin lock|heparin lock
22944|NCT04054128|Vascular access complication|vascular access complication
22945|NCT04054102|stroke|stroke
22946|NCT04054102|transcranial direct current stimulation|transcranial direct current stimulation
22947|NCT04054102|upper extremity rehabilitation robot|upper extremity rehabilitation robot
22948|NCT04054076|orthotics|orthotics
22949|NCT04054076|kinematics|kinematics
22950|NCT04054076|kinetics|kinetics
22951|NCT04054050|sleep disturbance|sleep disturbance
22952|NCT04054050|insomnia|insomnia
22953|NCT04054050|fatigue|fatigue
22954|NCT04054037|APASL ACLF Research Consortium|apasl aclf research consortium
22955|NCT04054037|Diagnosis and treatment standard|diagnosis and treatment standard
22956|NCT04054037|HBV-ACLF|hbv-aclf
22957|NCT04054037|acute on chronic liver failure|acute on chronic liver failure
22958|NCT04053998|Pancreaticoduodenectomy|pancreaticoduodenectomy
22959|NCT04053998|Portal vein resection|portal vein resection
22960|NCT04053998|Benchmarks|benchmarks
22961|NCT04053998|Outcomes|outcomes
22962|NCT04053946|BKA|bka
22963|NCT04053946|biofilm|biofilm
22964|NCT04053946|Next Science|next science
22965|NCT04053933|QUALMS|qualms
22966|NCT04053933|MDS|mds
22967|NCT04053933|Be-QUALMS|be-qualms
22968|NCT04053933|Quality of life|quality of life
22969|NCT04053933|QoL|qol
22970|NCT04053907|falciparum|falciparum
22971|NCT04053907|gametocyte|gametocyte
22972|NCT04053907|elimination|elimination
22973|NCT04053907|anopheles|anopheles
22974|NCT04053907|transmission|transmission
22975|NCT04053907|diagnostic|diagnostic
22976|NCT04053894|vascular surgery|vascular surgery
22977|NCT04053894|aspirin resistance|aspirin resistance
22978|NCT04053894|MINS|mins
22979|NCT04053881|Plaque psoriasis|plaque psoriasis
22980|NCT04053881|Cimzia|cimzia
22981|NCT04053881|Certolizumab pegol|certolizumab pegol
22982|NCT04053855|Clear cell renal cell carcinoma|clear cell renal cell carcinoma
22983|NCT04053855|Urinary exosomes|urinary exosomes
22984|NCT04053855|Detection|detection
22985|NCT04053855|Electron microscopy technique|electron microscopy technique
22986|NCT04053855|Flow cytometry|flow cytometry
22987|NCT04053855|RT-qPCR|rt-qpcr
22988|NCT04053842|Prostate Cancer|prostate cancer
22989|NCT04053842|PSMA PET|psma pet
22990|NCT04053842|[18F]DCFPyL PET/CT imaging|[18f]dcfpyl pet/ct imaging
22991|NCT04053842|Radical Prostatectomy|radical prostatectomy
22992|NCT04053842|Sodium MRI|sodium mri
22993|NCT04053842|Sodium Imaging|sodium imaging
22994|NCT04053829|Rehabilitation|rehabilitation
22995|NCT04053829|Tele-rehabilitation|tele-rehabilitation
22996|NCT04053829|Physical Therapy|physical therapy
22997|NCT04053829|Coaching|coaching
22998|NCT04053829|Physical Activity|physical activity
22999|NCT04053816|cardiovascular|cardiovascular
23000|NCT04053816|potassium supplementation|potassium supplementation
23001|NCT04053816|coronary artery by pass surgery|coronary artery by pass surgery
23002|NCT04053790|irritable bowel syndrome with diarrhea|irritable bowel syndrome with diarrhea
23003|NCT04053790|Lactobacillus LB|lactobacillus lb
23004|NCT04053790|treatment|treatment
23005|NCT04053790|safety|safety
23006|NCT04053790|efficacy|efficacy
23007|NCT04053764|SEG101|seg101
23008|NCT04053764|SCD|scd
23009|NCT04053764|Crizanlizumab|crizanlizumab
23010|NCT04053764|Sickle cell nephropathy|sickle cell nephropathy
23011|NCT04053764|chronic kidney disease|chronic kidney disease
23012|NCT04053764|CKD|ckd
23013|NCT04053764|albuminuria (ACR)|albuminuria (acr)
23014|NCT04053764|renal function|renal function
23015|NCT04053764|standard of care|standard of care
23016|NCT04053751|intensive care unit|intensive care unit
23017|NCT04053751|endotracheal suctioning|endotracheal suctioning
23018|NCT04053751|open suctioning system|open suctioning system
23019|NCT04053751|closed suctioning system|closed suctioning system
23020|NCT04053751|nursing|nursing
23021|NCT04053712|Closed-loop|closed-loop
23022|NCT04053712|Dual-hormone|dual-hormone
23023|NCT04053712|Glucagon|glucagon
23024|NCT04053712|FiAsp|fiasp
23025|NCT04053712|Artificial pancreas|artificial pancreas
23026|NCT04053673|Phase 1|phase 1
23027|NCT04053673|PARP7 inhibition|parp7 inhibition
23028|NCT04053673|First in Human|first in human
23029|NCT04053673|Solid Tumors|solid tumors
23030|NCT04053673|Interferon|interferon
23031|NCT04053660|Gingival Crevicular Fluid|gingival crevicular fluid
23032|NCT04053660|Lipid Mediator|lipid mediator
23033|NCT04053660|Periodontal Treatment|periodontal treatment
23034|NCT04053634|Chronic Obstructive Pulmonary Disease|chronic obstructive pulmonary disease
23035|NCT04053634|COPD|copd
23036|NCT04053634|benralizumab|benralizumab
23037|NCT04053634|Fasenra|fasenra
23038|NCT04053634|ICS|ics
23039|NCT04053634|inhaled corticosteroids|inhaled corticosteroids
23040|NCT04053634|exacerbations|exacerbations
23041|NCT04053634|Lung Disease|lung disease
23042|NCT04053634|LABA/LAMA|laba/lama
23043|NCT04053621|metformin|metformin
23044|NCT04053621|thiamine pyrophosphate|thiamine pyrophosphate
23045|NCT04053621|B1 vitamin|b1 vitamin
23046|NCT04053621|type 2 diabetes mellitus|type 2 diabetes mellitus
23047|NCT04053621|metabolic pathways|metabolic pathways
23048|NCT04053595|Peri-operative goal-directed therapy|peri-operative goal-directed therapy
23049|NCT04053595|Hemodynamic optimization|hemodynamic optimization
23050|NCT04053595|Postoperative complications|postoperative complications
23051|NCT04053595|Mortality|mortality
23052|NCT04053582|Early life stress|early life stress
23053|NCT04053582|Adolescent|adolescent
23054|NCT04053582|Mindfulness|mindfulness
23055|NCT04053582|Neurobiological|neurobiological
23056|NCT04053582|Stress and resilience|stress and resilience
23057|NCT04053569|polyphenols|polyphenols
23058|NCT04053569|diet|diet
23059|NCT04053569|lipidomics|lipidomics
23060|NCT04053569|metabolic syndrome|metabolic syndrome
23061|NCT04053556|sleep deprivation|sleep deprivation
23062|NCT04053556|internal medicine residency|internal medicine residency
23063|NCT04053556|on call|on call
23064|NCT04053556|cognitive impairment|cognitive impairment
23065|NCT04053556|burn out|burn out
23066|NCT04053556|safety|safety
23067|NCT04053556|depression|depression
23068|NCT04053543|Pulmonary Arterial Hypertension|pulmonary arterial hypertension
23069|NCT04053543|Pulmonary Hypertension|pulmonary hypertension
23070|NCT04053543|PAH|pah
23071|NCT04053543|Connective Tissue Disease- Associated|connective tissue disease- associated
23072|NCT04053543|6 Minute Walk Test|6 minute walk test
23073|NCT04053543|6 Minute Walk Distance|6 minute walk distance
23074|NCT04053543|Pulmonary Vascular Resistance|pulmonary vascular resistance
23075|NCT04053543|Cardiac MRI|cardiac mri
23076|NCT04053543|Right Ventricular Function|right ventricular function
23077|NCT04053543|Hypertension|hypertension
23078|NCT04053543|Familial Primary Pulmonary Hypertension|familial primary pulmonary hypertension
23079|NCT04053543|Connective Tissue Diseases|connective tissue diseases
23080|NCT04053543|Vascular Diseases|vascular diseases
23081|NCT04053543|Hypertension, Pulmonary|hypertension, pulmonary
23082|NCT04053543|Lung Diseases|lung diseases
23083|NCT04053543|Cardiovascular Diseases|cardiovascular diseases
32389|NCT03998163|CKD|ckd
23084|NCT04053504|Health disparities|health disparities
23085|NCT04053504|Family teamwork|family teamwork
23086|NCT04053504|Peer-delivered intervention|peer-delivered intervention
23087|NCT04053504|Facilitators to diabetes management|facilitators to diabetes management
23088|NCT04053504|Barriers to diabetes management|barriers to diabetes management
23089|NCT04053504|Community-based intervention|community-based intervention
23090|NCT04053491|Hand surgery|hand surgery
23091|NCT04053491|Anesthesia, Regional|anesthesia, regional
23109|NCT04053387|phase 3|phase 3
23110|NCT04053387|topical|topical
23111|NCT04053387|open-label|open-label
23112|NCT04053387|efficacy|efficacy
23113|NCT04053387|safety|safety
23114|NCT04053387|psoriasis|psoriasis
23115|NCT04053387|long-term|long-term
23116|NCT04053387|therapeutic aryl hydrocarbon receptor modulating agent|therapeutic aryl hydrocarbon receptor modulating agent
23117|NCT04053361|Atrial Fibrillation|atrial fibrillation
23118|NCT04053361|Pulmonary Hypertension|pulmonary hypertension
23119|NCT04053361|Catheter Ablation|catheter ablation
23120|NCT04053348|Mobile App|mobile app
23121|NCT04053348|Telerehabilitation|telerehabilitation
23122|NCT04053348|Physiotherapy|physiotherapy
23123|NCT04053348|Hip Fractures|hip fractures
23125|NCT04053270|Erythropoietic Protoporphyria|erythropoietic protoporphyria
23127|NCT04053270|Afamelanotide|afamelanotide
23128|NCT04053244|iCBT|icbt
23129|NCT04053244|cardiac event|cardiac event
23130|NCT04053244|cognitive behavioural therapy|cognitive behavioural therapy
23131|NCT04053244|depression|depression
23132|NCT04053231|liver|liver
23133|NCT04053231|hcc|hcc
23134|NCT04053231|hepatocarcinoma|hepatocarcinoma
23135|NCT04053231|surgery|surgery
23136|NCT04053231|redo surgery|redo surgery
23137|NCT04053231|recurrence|recurrence
23138|NCT04053231|cirrhosis|cirrhosis
23139|NCT04053218|Adult survivors of severe acute malnutrition|adult survivors of severe acute malnutrition
23140|NCT04053218|Cognition|cognition
23141|NCT04053192|Balloon Aortic Valvuloplasty|balloon aortic valvuloplasty
23142|NCT04053192|Severe Aortic Valve Stenosis|severe aortic valve stenosis
23143|NCT04053166|Intraplaque haemorrhage|intraplaque haemorrhage
23144|NCT04053166|MRI|mri
23145|NCT04053166|home-based Physical activity|home-based physical activity
23146|NCT04053166|carotic plaque vulnerability|carotic plaque vulnerability
23147|NCT04053140|Pharmacokinetics|pharmacokinetics
23148|NCT04053140|Penicillin G|penicillin g
23149|NCT04053140|Penicillins|penicillins
23150|NCT04053140|Proof of Concept Study|proof of concept study
23151|NCT04053140|Clinical Trial, Phase I|clinical trial, phase i
23152|NCT04053140|Microneedle array|microneedle array
23153|NCT04053127|vagus nerve stimulation|vagus nerve stimulation
23154|NCT04053114|Ovarian teratoma|ovarian teratoma
23155|NCT04053114|struma ovarii|struma ovarii
23156|NCT04053114|thyroid carcinoma|thyroid carcinoma
23157|NCT04053114|next generation sequencing|next generation sequencing
23158|NCT04053101|Bladder cancer|bladder cancer
23159|NCT04053101|PET CT|pet ct
23160|NCT04053101|CT scan|ct scan
23161|NCT04053101|Lymph node staging|lymph node staging
23162|NCT04053101|TNM staging|tnm staging
23163|NCT04053088|Surgical Aortic Valve Replacement (SAVR)|surgical aortic valve replacement (savr)
23164|NCT04053088|INSPIRIS RESILIA|inspiris resilia
23165|NCT04053088|Durability|durability
23166|NCT04053088|Hemodynamics|hemodynamics
23167|NCT04053075|Hospital Outbreak Detection|hospital outbreak detection
23168|NCT04053075|Hospital Outbreak Response|hospital outbreak response
23169|NCT04053075|Cluster|cluster
23170|NCT04053075|Multidrug Resistant Organism|multidrug resistant organism
23171|NCT04053075|Genetic Relatedness|genetic relatedness
23172|NCT04053075|Whole Genome Sequencing|whole genome sequencing
23173|NCT04053062|Castrate-Resistant|castrate-resistant
23174|NCT04053023|linerixibat (GSK2330672), obeticholic acid, drug interaction, primary biliary cholangitis, pharmacokinetics|linerixibat (gsk2330672), obeticholic acid, drug interaction, primary biliary cholangitis, pharmacokinetics
23176|NCT04052984|Cesarean Section|cesarean section
23177|NCT04052984|Umbilical cord|umbilical cord
23178|NCT04052984|Breastfeeding|breastfeeding
23179|NCT04052945|Acupuncture|acupuncture
23180|NCT04052945|sphenopalatine ganglion|sphenopalatine ganglion
23181|NCT04052945|seasonal allergic rhinitis|seasonal allergic rhinitis
23182|NCT04052945|neuropeptides|neuropeptides
23183|NCT04052945|inflammatory cytokines|inflammatory cytokines
23184|NCT04052945|neuro-immune interactions|neuro-immune interactions
23185|NCT04052906|COPD|copd
23186|NCT04052906|dyspnea|dyspnea
23485|NCT04051008|diabetes|diabetes
23190|NCT04052893|Plastic|plastic
23191|NCT04052880|Multiple myeloma|multiple myeloma
23192|NCT04052880|Newly diagnosed multiple myeloma|newly diagnosed multiple myeloma
23193|NCT04052880|Myeloma|myeloma
23194|NCT04052880|Elderly|elderly
23195|NCT04052880|Daratumumab|daratumumab
23196|NCT04052867|Intravenous lignocaine|intravenous lignocaine
23197|NCT04052867|Multimodal anagesic approach|multimodal anagesic approach
23198|NCT04052867|Postoperative Pain|postoperative pain
23199|NCT04052867|living related renal transplantation|living related renal transplantation
23200|NCT04052867|Morphine|morphine
23204|NCT04052828|pregnant|pregnant
23205|NCT04052828|fetal endoscopic tracheal occlusion|fetal endoscopic tracheal occlusion
23206|NCT04052815|pre-diabetes|pre-diabetes
23207|NCT04052815|female|female
23208|NCT04052815|Diabetes type 2|diabetes type 2
23209|NCT04052815|Hispanic/Latino|hispanic/latino
23210|NCT04052815|community based programs|community based programs
23211|NCT04052815|diabetes prevention program|diabetes prevention program
23212|NCT04052776|Pharmacology|pharmacology
23213|NCT04052776|Neuromodulation|neuromodulation
23214|NCT04052776|Epidural electrical stimulation|epidural electrical stimulation
23215|NCT04052763|NSTE-ACS|nste-acs
23216|NCT04052763|FFR-CT|ffr-ct
23217|NCT04052763|FFRangio™|ffrangio™
23218|NCT04052750|Functional Gastrointestinal Disorders, Adherence|functional gastrointestinal disorders, adherence
23219|NCT04052737|Endothelin|endothelin
23220|NCT04052737|Neurogenesis|neurogenesis
23221|NCT04052737|Neural progenitor cells|neural progenitor cells
23222|NCT04052724|informal caregivers|informal caregivers
23223|NCT04052724|internet-based cognitive behaviour therapy|internet-based cognitive behaviour therapy
23224|NCT04052724|culturally adapted psychotherapy|culturally adapted psychotherapy
23225|NCT04052724|eHealth|ehealth
23226|NCT04052724|caregiver burden|caregiver burden
23227|NCT04052672|Exercise|exercise
23228|NCT04052672|Nutritional Supplement|nutritional supplement
23229|NCT04052672|Physical Function|physical function
23230|NCT04052672|Quality of Life|quality of life
23231|NCT04052672|Cardiac Device|cardiac device
23232|NCT04052672|Physical Activity|physical activity
23233|NCT04052672|Defibrillators|defibrillators
23234|NCT04052672|Pacemakers|pacemakers
23235|NCT04052672|Biomarkers|biomarkers
23236|NCT04052646|Subarachnoid hemorrhage|subarachnoid hemorrhage
23237|NCT04052646|Emergency medical coordination center|emergency medical coordination center
23238|NCT04052646|Emergency Medical Service|emergency medical service
23239|NCT04052633|c arm cholangiography|c arm cholangiography
23240|NCT04052633|cholecystectomy|cholecystectomy
23241|NCT04052620|Ankle sprain|ankle sprain
23242|NCT04052620|diclofenac diethylamine|diclofenac diethylamine
23243|NCT04052581|Per oral Endoscopic Myotomy|per oral endoscopic myotomy
23244|NCT04052581|Transoral Incisionless Fundoplication|transoral incisionless fundoplication
23247|NCT04052542|Noninvasive ventilation|noninvasive ventilation
23248|NCT04052542|Education|education
23249|NCT04052542|Intensive care unit|intensive care unit
23250|NCT04052542|Mechanical ventilation|mechanical ventilation
23251|NCT04052542|Evidence-based practice|evidence-based practice
23252|NCT04052503|physical therapy|physical therapy
23253|NCT04052503|knowledge translation|knowledge translation
23254|NCT04052503|outcome measures|outcome measures
23255|NCT04052503|knowledge brokering|knowledge brokering
23256|NCT04052490|Zirconia,|zirconia,
23257|NCT04052490|occlusal scheme,|occlusal scheme,
23258|NCT04052490|endodontically treated teeth,|endodontically treated teeth,
23259|NCT04052490|finishline designs.|finishline designs.
23260|NCT04052477|Suicide|suicide
23261|NCT04052477|Prevention|prevention
23262|NCT04052477|Social network|social network
23263|NCT04052464|gene expression|gene expression
23264|NCT04052464|biomarkers|biomarkers
23265|NCT04052464|implantation window|implantation window
23266|NCT04052464|embryo transfer|embryo transfer
23267|NCT04052464|endometrium|endometrium
23268|NCT04052464|biopsy|biopsy
23269|NCT04052464|lavage|lavage
23270|NCT04052464|liquid biopsy|liquid biopsy
23271|NCT04052425|Vitiligo|vitiligo
23272|NCT04052425|non-segmental|non-segmental
23273|NCT04052425|JAK inhibitor|jak inhibitor
23274|NCT04052334|Soft Tissue Sarcoma|soft tissue sarcoma
23275|NCT04052334|Adoptive Cell Therapy|adoptive cell therapy
23276|NCT04052321|Three-dimensional optical surface imaging|three-dimensional optical surface imaging
23277|NCT04052321|Chest wall changes|chest wall changes
23278|NCT04052308|Knee Osteoarthritis|knee osteoarthritis
23279|NCT04052308|Blood Pressure|blood pressure
23280|NCT04052308|HIIT|hiit
23281|NCT04052282|Technology|technology
23282|NCT04052282|Physical Function|physical function
23283|NCT04052269|Glaucoma|glaucoma
23284|NCT04052256|Fractional flow reserve|fractional flow reserve
23285|NCT04052256|Coronary computed tomography angiography|coronary computed tomography angiography
23292|NCT04052178|Stroke|stroke
23293|NCT04052178|Sensory stimulation|sensory stimulation
23294|NCT04052165|Effectiveness|effectiveness
23295|NCT04052165|Glaucoma Drainage Device|glaucoma drainage device
23296|NCT04052165|Intraocular pressure|intraocular pressure
23297|NCT04052165|Tissue Response|tissue response
23298|NCT04052152|HCC|hcc
23299|NCT04052152|Antiangiogenic agents combined with PD-1 antibody|antiangiogenic agents combined with pd-1 antibody
23300|NCT04052139|Pain|pain
23301|NCT04052139|Alcohol|alcohol
23302|NCT04052139|HIV|hiv
23303|NCT04052139|Inflammation|inflammation
23304|NCT04052139|Low-dose naltrexone|low-dose naltrexone
23305|NCT04052139|Gabapentin|gabapentin
23306|NCT04052113|Real world, PD-L1, TMB, Stage IV, urothelial cancer, Japanese|real world, pd-l1, tmb, stage iv, urothelial cancer, japanese
23307|NCT04052100|Prehabilitation|prehabilitation
23308|NCT04052100|Exercise training|exercise training
23309|NCT04052100|Physical activity|physical activity
23310|NCT04052100|Nutrition|nutrition
23311|NCT04052100|Mindfulness|mindfulness
23312|NCT04052100|Smoking cessation|smoking cessation
23313|NCT04052087|Brain Damage Acquired|brain damage acquired
23314|NCT04052087|BDA in subacute and chronic stage|bda in subacute and chronic stage
23315|NCT04052087|BESTest|bestest
23316|NCT04052087|Mini-BESTest|mini-bestest
23317|NCT04052087|Balance|balance
23318|NCT04052087|Postural control|postural control
23319|NCT04052087|Brain Stroke|brain stroke
23320|NCT04052087|Stroke|stroke
23321|NCT04052087|Cross-cultural adaptation|cross-cultural adaptation
23322|NCT04052074|Music Therapy|music therapy
23323|NCT04052074|Palliative Care|palliative care
23324|NCT04052074|Caregivers|caregivers
23325|NCT04052074|Nurses|nurses
23326|NCT04052074|Quality of Life|quality of life
23327|NCT04052074|Cost efficiency analysis|cost efficiency analysis
23328|NCT04052035|follicle size|follicle size
23329|NCT04052035|maturity|maturity
23330|NCT04052035|euploid|euploid
23336|NCT04052009|Spinal cord injury|spinal cord injury
23337|NCT04052009|Gait|gait
23338|NCT04052009|Training|training
23339|NCT04052009|Comparison|comparison
23340|NCT04052009|Robotic-assisted|robotic-assisted
23341|NCT04051957|Kidney Injury|kidney injury
23342|NCT04051957|Proteinuria|proteinuria
23343|NCT04051957|Hypertension|hypertension
23344|NCT04051957|Anti-VEGF|anti-vegf
23345|NCT04051944|Chronic inflammatory demyelinating polyradiculoneuropathy|chronic inflammatory demyelinating polyradiculoneuropathy
23346|NCT04051944|CIDP|cidp
23347|NCT04051944|UCB7665|ucb7665
23348|NCT04051944|rozanolixizumab|rozanolixizumab
23349|NCT04051918|cognitive training|cognitive training
23350|NCT04051918|socially assistive robotics|socially assistive robotics
23351|NCT04051918|music learning|music learning
23352|NCT04051905|Regeneration|regeneration
23353|NCT04051866|Dentist|dentist
23354|NCT04051866|Primary Health Care|primary health care
23355|NCT04051866|Chronic Periodontitis|chronic periodontitis
23356|NCT04051866|Diabetes Mellitus, Type 2|diabetes mellitus, type 2
23357|NCT04051866|Root planing|root planing
23358|NCT04051866|Dental Scaling|dental scaling
23359|NCT04051853|HCC|hcc
23360|NCT04051853|Liver cirrhosis|liver cirrhosis
23361|NCT04051827|Drug therapy|drug therapy
23362|NCT04051788|Sedentary Lifestyle|sedentary lifestyle
23363|NCT04051788|Step Aerobics|step aerobics
23364|NCT04051788|Pulmonary Function|pulmonary function
23365|NCT04051697|Head and Neck Cancer|head and neck cancer
23366|NCT04051697|Self-management|self-management
23367|NCT04051697|Intervention|intervention
23368|NCT04051697|Pilot Randomised Control Trial|pilot randomised control trial
23369|NCT04051697|Behavioural intervention|behavioural intervention
23370|NCT04051697|Quality of Life|quality of life
23371|NCT04051645|Work of breathing|work of breathing
23372|NCT04051645|Pressure Time Product|pressure time product
23373|NCT04051645|imposed WoB|imposed wob
23374|NCT04051645|imposed PTP|imposed ptp
23375|NCT04051645|flow resistance|flow resistance
23376|NCT04051632|Medtronic 670G|medtronic 670g
23377|NCT04051593|cervical stabilization exercise|cervical stabilization exercise
23378|NCT04051580|myocardial protection|myocardial protection
23379|NCT04051580|cardiac surgery|cardiac surgery
23380|NCT04051580|del Nido cardioplegia|del nido cardioplegia
23381|NCT04051554|ACL Injury|acl injury
23382|NCT04051554|Landing Error Score System|landing error score system
23383|NCT04051554|Neuromuscular Training|neuromuscular training
23384|NCT04051554|Proprioceptive Training|proprioceptive training
23385|NCT04051554|Soccer|soccer
23386|NCT04051528|combinatorial training|combinatorial training
23388|NCT04051515|Hemodialysis|hemodialysis
23389|NCT04051502|Ovarian Cancer|ovarian cancer
23390|NCT04051502|Adnexal Mass|adnexal mass
23391|NCT04051502|Ovarian Sentinal Lymph Nodes|ovarian sentinal lymph nodes
23392|NCT04051502|19-271|19-271
23393|NCT04051502|Memorial Sloan Kettering Cancer Center|memorial sloan kettering cancer center
23394|NCT04051502|Sentinal Lymph Nodes|sentinal lymph nodes
23395|NCT04051502|indocyanine green dye|indocyanine green dye
23396|NCT04051502|ICG Dye|icg dye
23397|NCT04051489|Chronic Diseaase|chronic diseaase
23398|NCT04051489|Technology|technology
23399|NCT04051489|Pain|pain
23400|NCT04051489|Function|function
23401|NCT04051476|Ginger flour footbaths|ginger flour footbaths
23402|NCT04051476|Dose-response relationship|dose-response relationship
23403|NCT04051476|Thermogenesis|thermogenesis
23404|NCT04051476|Infrared thermography|infrared thermography
23405|NCT04051476|Heart rate variability|heart rate variability
23406|NCT04051476|Healthy volunteers|healthy volunteers
23407|NCT04051437|Plasma exchange|plasma exchange
23408|NCT04051437|Acute on chronic liver failure|acute on chronic liver failure
23409|NCT04051411|mitral regurgitation|mitral regurgitation
23410|NCT04051411|echocardiography|echocardiography
23412|NCT04051398|Acupuncture|acupuncture
23413|NCT04051398|Lung|lung
23414|NCT04051385|periodontal disease|periodontal disease
23415|NCT04051385|gingival crevicular fluid|gingival crevicular fluid
23416|NCT04051385|macrophage|macrophage
23417|NCT04051385|ErbB-4|erbb-4
23418|NCT04051385|neuregulin-4|neuregulin-4
23419|NCT04051372|Idiopathic Pneumonia Syndrome|idiopathic pneumonia syndrome
23420|NCT04051372|CMV Pneumonia|cmv pneumonia
23421|NCT04051372|Pneumocystis Jiroveci Pneumonia|pneumocystis jiroveci pneumonia
23422|NCT04051372|Invasive Pulmonary Aspergillosis|invasive pulmonary aspergillosis
23423|NCT04051346|dietary oxalate|dietary oxalate
23424|NCT04051346|diet therapy|diet therapy
23425|NCT04051320|Irritability|irritability
23426|NCT04051320|Estrogen|estrogen
23427|NCT04051320|Progesterone|progesterone
23428|NCT04051320|Lupron Depot|lupron depot
23429|NCT04051320|Mood Disorders|mood disorders
23430|NCT04051320|Perinatal Depression|perinatal depression
23431|NCT04051320|Postpartum|postpartum
23432|NCT04051320|Hormones|hormones
23433|NCT04051320|Physiological effects of drugs|physiological effects of drugs
23434|NCT04051320|Reproductive Control Agents|reproductive control agents
23435|NCT04051320|Mental Disorders|mental disorders
23436|NCT04051320|Hormone Intervention|hormone intervention
23437|NCT04051320|Functional Magnetic Resonance Imaging|functional magnetic resonance imaging
23438|NCT04051294|kombucha|kombucha
23439|NCT04051294|kombucha tea|kombucha tea
23440|NCT04051294|tea|tea
23441|NCT04051294|fermented food|fermented food
23442|NCT04051281|antimicrobial resistance|antimicrobial resistance
23443|NCT04051281|social norms feedback|social norms feedback
23444|NCT04051281|behavioural science|behavioural science
23445|NCT04051281|feedback and monitoring|feedback and monitoring
23446|NCT04051268|Vaccine|vaccine
23447|NCT04051268|Typhoid Conjugate Vaccine|typhoid conjugate vaccine
23448|NCT04051229|Metabolic Flexibility|metabolic flexibility
23449|NCT04051229|Exercise Induced Metabolic Flexibility|exercise induced metabolic flexibility
23450|NCT04051216|caregivers|caregivers
23451|NCT04051216|health information technology|health information technology
23452|NCT04051216|patient-centered care|patient-centered care
23453|NCT04051203|GON|gon
23454|NCT04051203|greater occipital neuralgia|greater occipital neuralgia
23455|NCT04051203|post traumatic headache|post traumatic headache
23456|NCT04051203|post concussive headache|post concussive headache
23457|NCT04051190|diet|diet
23458|NCT04051190|bariatric surgery|bariatric surgery
23459|NCT04051190|appetite|appetite
23460|NCT04051177|parental HIV disclosure|parental hiv disclosure
23461|NCT04051177|China|china
23462|NCT04051177|intervention|intervention
23463|NCT04051164|Amputation|amputation
23464|NCT04051164|Progressive Muscle Relaxation Technique|progressive muscle relaxation technique
23465|NCT04051164|Pulmonary Function|pulmonary function
23466|NCT04051164|Stress|stress
23467|NCT04051151|Physical Activity|physical activity
23468|NCT04051151|Social Incentives|social incentives
23469|NCT04051151|Behavioral Economics|behavioral economics
23470|NCT04051151|Goal-Directed Behavior|goal-directed behavior
23471|NCT04051151|Motivation|motivation
23472|NCT04051099|bilateral superficial cervical plexus block|bilateral superficial cervical plexus block
23473|NCT04051099|thyroid surgery|thyroid surgery
23474|NCT04051099|parathyroid surgery|parathyroid surgery
23475|NCT04051086|Williams-Beuren Syndrome|williams-beuren syndrome
23476|NCT04051086|Micro-duplication 7q11.23 syndrome|micro-duplication 7q11.23 syndrome
23477|NCT04051086|Vasculopathy|vasculopathy
23479|NCT04051021|Surgery|surgery
23480|NCT04051021|Cardiac|cardiac
23481|NCT04051021|Opioids|opioids
23482|NCT04051021|Anxiety|anxiety
23483|NCT04051008|grocery shopping|grocery shopping
23484|NCT04051008|online shopping|online shopping
23486|NCT04051008|behavioral economics|behavioral economics
23487|NCT04051008|diet|diet
23488|NCT04050982|Text Messaging|text messaging
23489|NCT04050982|Patient Education|patient education
23490|NCT04050982|Psychometric|psychometric
23491|NCT04050956|Acute Myocardial Infarction|acute myocardial infarction
23492|NCT04050956|Registry|registry
23493|NCT04050956|Outcomes|outcomes
23494|NCT04050956|Medico-economic evaluation|medico-economic evaluation
23495|NCT04050956|Comorbidities|comorbidities
23496|NCT04050930|mastication|mastication
23497|NCT04050930|postprandial thermogenesis|postprandial thermogenesis
23498|NCT04050930|autonomic nervous system|autonomic nervous system
23499|NCT04050930|cephalic phase reflex|cephalic phase reflex
23500|NCT04050930|food texture|food texture
23501|NCT04050917|physical stimulation|physical stimulation
23502|NCT04050917|Subliminal stimulation|subliminal stimulation
23503|NCT04050917|stroke rehabilitation|stroke rehabilitation
23504|NCT04050917|upper extremity|upper extremity
23505|NCT04050917|paresis|paresis
23506|NCT04050917|hand function|hand function
23507|NCT04050917|occupational therapy|occupational therapy
23508|NCT04050917|physical therapy|physical therapy
23509|NCT04050904|heart failure|heart failure
23510|NCT04050904|algorithm|algorithm
23511|NCT04050878|Imaging, Three-Dimensional|imaging, three-dimensional
23512|NCT04050878|Technology, Dental|technology, dental
23513|NCT04050878|accuracy|accuracy
23514|NCT04050878|extra-oral scanner|extra-oral scanner
23515|NCT04050839|pain neuroscience education|pain neuroscience education
23516|NCT04050839|patient education|patient education
23517|NCT04050826|Dermal open flow microperfusion|dermal open flow microperfusion
23518|NCT04050813|Hamstring Injury|hamstring injury
23519|NCT04050813|Flywheel Inertial Resistance|flywheel inertial resistance
23520|NCT04050813|Hamstring architecture|hamstring architecture
23521|NCT04050813|Ultrasound|ultrasound
23522|NCT04050813|Eccentric|eccentric
23523|NCT04050696|chronic SCI|chronic sci
23524|NCT04050696|incomplete SCI|incomplete sci
23525|NCT04050696|central cord syndrome|central cord syndrome
23526|NCT04050696|electromagnetic field|electromagnetic field
23527|NCT04050696|physical therapy|physical therapy
23528|NCT04050696|cervical SCI|cervical sci
23529|NCT04050696|paraplegia|paraplegia
23530|NCT04050696|tetraplegia|tetraplegia
23531|NCT04050696|upper limb impairment|upper limb impairment
23532|NCT04050696|GRASSP|grassp
23533|NCT04050696|ISNCSCI|isncsci
23534|NCT04050683|TIPS|tips
23535|NCT04050683|Hemodynamic|hemodynamic
23536|NCT04050683|Ascites|ascites
23537|NCT04050683|Hepatic|hepatic
23538|NCT04050683|Hydrothorax|hydrothorax
23539|NCT04050657|orthodontic treatment|orthodontic treatment
23540|NCT04050657|alignment|alignment
23541|NCT04050657|rate of tooth movement|rate of tooth movement
23542|NCT04050644|Preservative-free ocular drops|preservative-free ocular drops
23543|NCT04050644|Preserved ocular drops|preserved ocular drops
23544|NCT04050592|Randomized Controlled Trial|randomized controlled trial
23545|NCT04050592|Menopause|menopause
23546|NCT04050592|Hormone Therapy|hormone therapy
23547|NCT04050592|Vasomotor symptoms|vasomotor symptoms
23548|NCT04050592|Quality of Life|quality of life
23549|NCT04050592|Cardiovascular diseases|cardiovascular diseases
23550|NCT04050592|Endothelium|endothelium
23551|NCT04050566|Malaria|malaria
23552|NCT04050566|Immunity development|immunity development
23553|NCT04050566|Plasmodium diversity|plasmodium diversity
23554|NCT04050566|Microbiota|microbiota
23555|NCT04050566|Endothelial cell activation|endothelial cell activation
23556|NCT04050566|Poverty|poverty
23557|NCT04050540|Sexually Transmitted Infections|sexually transmitted infections
23558|NCT04050514|side effects|side effects
23559|NCT04050514|mandibular advancement device|mandibular advancement device
23560|NCT04050514|clinical intervention|clinical intervention
23561|NCT04050514|snoring|snoring
23562|NCT04050514|treatment|treatment
23563|NCT04050501|Brain infarction|brain infarction
23564|NCT04050501|Brain ischemia|brain ischemia
23565|NCT04050501|Vagus nerve stimulation|vagus nerve stimulation
23566|NCT04050501|Penumbra|penumbra
23567|NCT04050475|Depression|depression
23568|NCT04050475|Fasting Mimicking Diet|fasting mimicking diet
23569|NCT04050475|Functional Therapy|functional therapy
23570|NCT04050475|Lifestyle Medicine|lifestyle medicine
23571|NCT04050475|Health Psychology|health psychology
23572|NCT04050475|Psychosomatic|psychosomatic
23573|NCT04050436|Oncolytic Virus|oncolytic virus
23574|NCT04050436|Carcinoma|carcinoma
23575|NCT04050436|Carcinoma, Squamous Cell|carcinoma, squamous cell
23576|NCT04050436|Cemiplimab|cemiplimab
23577|NCT04050436|Metastatic Cutaneous Squamous Cell Carcinoma|metastatic cutaneous squamous cell carcinoma
23578|NCT04050436|Oncolytic Immuno-gene therapy|oncolytic immuno-gene therapy
23579|NCT04050423|Ultrasound|ultrasound
23580|NCT04050423|Spectroscopy|spectroscopy
23581|NCT04050423|Characterization|characterization
23582|NCT04050410|postural tachycardia syndrome|postural tachycardia syndrome
23583|NCT04050410|hyperadrenergic|hyperadrenergic
23584|NCT04050410|moxonidine|moxonidine
23585|NCT04050410|sympatholytic|sympatholytic
23586|NCT04050410|orthostatic symptoms|orthostatic symptoms
23587|NCT04050410|POTS|pots
23588|NCT04050397|androgen deprivation therapy|androgen deprivation therapy
23589|NCT04050397|exercise|exercise
23590|NCT04050397|quality of life|quality of life
23591|NCT04050397|blood glucose|blood glucose
23592|NCT04050397|cholesterol|cholesterol
23593|NCT04050397|prostate cancer|prostate cancer
23594|NCT04050371|Pre Exposure Prophylaxis|pre exposure prophylaxis
23595|NCT04050371|HIV prevention|hiv prevention
23596|NCT04050371|Emtricitabine, Tenofovir Disoproxil Fumarate|emtricitabine, tenofovir disoproxil fumarate
23597|NCT04050371|transgender health|transgender health
23598|NCT04050371|transgender persons|transgender persons
23599|NCT04050371|drug combination|drug combination
23600|NCT04050371|androgens|androgens
23601|NCT04050371|estrogens|estrogens
23602|NCT04050371|drug combinations|drug combinations
23603|NCT04050371|transmen|transmen
23604|NCT04050371|non binary|non binary
23605|NCT04050371|Truvada|truvada
23606|NCT04050371|daily observed therapy|daily observed therapy
400570|NCT01866228|Brain Tumor|brain tumor
23607|NCT04050332|Radio Frequency Identification Device|radio frequency identification device
23608|NCT04050319|concussions|concussions
23609|NCT04050319|Fractures|fractures
23610|NCT04050319|Instability|instability
23611|NCT04050319|Sprains|sprains
23612|NCT04050319|Strains|strains
23613|NCT04050306|Quantitative Light-Induced Fluorescence|quantitative light-induced fluorescence
23614|NCT04050306|Oral Health|oral health
23615|NCT04050306|Dental Caries|dental caries
23616|NCT04050306|Tooth Wear|tooth wear
23617|NCT04050306|Optical Imaging|optical imaging
23618|NCT04050267|nitrous oxide|nitrous oxide
23619|NCT04050267|tracing gas|tracing gas
23620|NCT04050267|breathing experiments|breathing experiments
23621|NCT04050267|cognitive tests|cognitive tests
23622|NCT04050254|tDCS|tdcs
23623|NCT04050254|Therapeutic exercise|therapeutic exercise
23624|NCT04050254|Referred pain|referred pain
23625|NCT04050254|Central sensitization|central sensitization
23626|NCT04050241|Mental workload|mental workload
23627|NCT04050241|Anesthesia|anesthesia
23628|NCT04050241|Laryngoscopy|laryngoscopy
23629|NCT04050241|Intubation|intubation
23630|NCT04050241|Perceived workload|perceived workload
23631|NCT04050228|Ultrasound, Chemotherapy|ultrasound, chemotherapy
23632|NCT04050189|probiotic|probiotic
23633|NCT04050189|in-utero transmission|in-utero transmission
23634|NCT04050189|pilot study|pilot study
23635|NCT04050176|insomnia|insomnia
23636|NCT04050176|sedative hypnotics|sedative hypnotics
23637|NCT04050176|hypnotic tapering|hypnotic tapering
23638|NCT04050163|Heart Attack|heart attack
23639|NCT04050150|Rehabilitation|rehabilitation
23640|NCT04050150|Upper Extremity|upper extremity
23641|NCT04050137|Gaucher Disease|gaucher disease
23642|NCT04050137|Exercise|exercise
23643|NCT04050137|Terapheutic|terapheutic
23644|NCT04050124|Donor site pain after skin graft harvesting|donor site pain after skin graft harvesting
23645|NCT04050111|SVF|svf
23646|NCT04050111|stromal-vascular fraction|stromal-vascular fraction
23647|NCT04050111|Stem cell therapy|stem cell therapy
23648|NCT04050072|Adverse Events|adverse events
23649|NCT04050046|non-invasive brain stimulation|non-invasive brain stimulation
23650|NCT04050046|cognition|cognition
23651|NCT04050046|transcranial direct current stimulation (tDCS)|transcranial direct current stimulation (tdcs)
23652|NCT04050020|PRP|prp
23653|NCT04050020|Platelet-Rich Plasma|platelet-rich plasma
23654|NCT04049994|spinal cord injury|spinal cord injury
23655|NCT04049994|neurogenic lower urinary tract dysfunction|neurogenic lower urinary tract dysfunction
23656|NCT04049994|urinary tract infection|urinary tract infection
23657|NCT04049994|immunotherapy|immunotherapy
23658|NCT04049994|immunomodulation|immunomodulation
23659|NCT04049994|immunostimulation|immunostimulation
23660|NCT04049994|E. coli|e. coli
23661|NCT04049994|Uro-Vaxom|uro-vaxom
23662|NCT04049981|digital|digital
23663|NCT04049981|autism|autism
23664|NCT04049981|mobile health|mobile health
23665|NCT04049981|ASD|asd
23666|NCT04049981|mobile therapy|mobile therapy
23667|NCT04049981|Google Glass|google glass
23668|NCT04049981|wearable computing|wearable computing
23669|NCT04049981|technology|technology
23670|NCT04049968|Oral cancer、Post-Operation Needs、Quality of Life、APP|oral cancer、post-operation needs、quality of life、app
23671|NCT04049955|sleeve gastrostomy|sleeve gastrostomy
23672|NCT04049955|endoscopy|endoscopy
23673|NCT04049955|fistula|fistula
23674|NCT04049955|double pig tail stents|double pig tail stents
23675|NCT04049942|Perioperative|perioperative
23676|NCT04049942|Functional capability|functional capability
23677|NCT04049942|Prehabilitation|prehabilitation
23678|NCT04049942|Thoracoscopic lobectomy|thoracoscopic lobectomy
23679|NCT04049942|Lung Cancer|lung cancer
23680|NCT04049929|YY-20394|yy-20394
23681|NCT04049929|Advanced solid tumor|advanced solid tumor
23682|NCT04049916|Primaquine|primaquine
23683|NCT04049916|Pyramax|pyramax
23684|NCT04049916|Euartesim|euartesim
23685|NCT04049916|Dihydroartemisinin-piperaquine|dihydroartemisinin-piperaquine
23686|NCT04049916|Pyronaridine-artesunate|pyronaridine-artesunate
23693|NCT04049864|Salmonella vaccine|salmonella vaccine
23694|NCT04049864|polyethylenimine|polyethylenimine
23695|NCT04049786|bariatric surgery|bariatric surgery
23696|NCT04049786|pharmacokinetics|pharmacokinetics
23697|NCT04049786|carvedilol|carvedilol
23698|NCT04049786|simvastatin|simvastatin
23699|NCT04049786|CYP3A4|cyp3a4
23700|NCT04049786|P-glycoprotein|p-glycoprotein
23701|NCT04049773|fatigue|fatigue
23702|NCT04049773|haemodialysis|haemodialysis
23703|NCT04049773|ecological momentary assessment|ecological momentary assessment
23704|NCT04049760|Lysosomal storage disease|lysosomal storage disease
23705|NCT04049760|migalastat|migalastat
23706|NCT04049747|Prostate Cancer|prostate cancer
23707|NCT04049747|prostate adenocarcinoma|prostate adenocarcinoma
23708|NCT04049682|Sleep|sleep
23709|NCT04049682|Sleep Deprivation|sleep deprivation
23710|NCT04049682|School|school
23711|NCT04049669|IDO|ido
23712|NCT04049669|indoleamine 2,3-dioxygenase|indoleamine 2,3-dioxygenase
23713|NCT04049669|indoximod|indoximod
23714|NCT04049669|pediatric|pediatric
23715|NCT04049669|childhood|childhood
23716|NCT04049669|brain tumor|brain tumor
23717|NCT04049669|glioblastoma|glioblastoma
23718|NCT04049669|medulloblastoma|medulloblastoma
23719|NCT04049669|ependymoma|ependymoma
23720|NCT04049669|diffuse intrinsic pontine glioma|diffuse intrinsic pontine glioma
23721|NCT04049669|DIPG|dipg
23722|NCT04049669|radiation|radiation
23723|NCT04049669|temozolomide|temozolomide
23724|NCT04049669|cyclophosphamide|cyclophosphamide
23725|NCT04049669|etoposide|etoposide
23726|NCT04049669|lomustine|lomustine
23727|NCT04049669|immunotherapy|immunotherapy
23728|NCT04049669|immune|immune
23729|NCT04049669|central nervous system|central nervous system
23730|NCT04049669|CNS|cns
23731|NCT04049656|Sevoflurane-Fentanyl Anesthesia|sevoflurane-fentanyl anesthesia
23732|NCT04049643|Presbycusis|presbycusis
23733|NCT04049643|Hearing aid|hearing aid
23734|NCT04049643|Alzheimer Disease|alzheimer disease
23740|NCT04049526|Music|music
23741|NCT04049526|Preterm infants|preterm infants
23742|NCT04049526|Heart Rate Variability|heart rate variability
23743|NCT04049513|Lymphomas Non-Hodgkin's B-Cell|lymphomas non-hodgkin's b-cell
23744|NCT04049513|Chimeric antigen receptor T-cell|chimeric antigen receptor t-cell
23745|NCT04049500|Physicians|physicians
23746|NCT04049500|Nurses|nurses
23747|NCT04049500|Practice assistants|practice assistants
23748|NCT04049500|Health coaches|health coaches
23749|NCT04049500|Population health managers|population health managers
23750|NCT04049500|Patient navigators|patient navigators
23751|NCT04049487|postpartum|postpartum
23752|NCT04049487|diastasis recti|diastasis recti
23753|NCT04049487|diastasis rectus|diastasis rectus
23754|NCT04049461|Cancer of Pancreas|cancer of pancreas
23755|NCT04049461|Ossification, Heterotopic|ossification, heterotopic
23756|NCT04049461|Abdominal incision|abdominal incision
23757|NCT04049448|moderate to severe Rheumatoid Arthritis|moderate to severe rheumatoid arthritis
23758|NCT04049396|NAFLD, Berberine, ALP, AST, ALT, FBS, HDL,LDL|nafld, berberine, alp, ast, alt, fbs, hdl,ldl
23759|NCT04049383|ALL, B-cell, CAR-T|all, b-cell, car-t
23760|NCT04049370|pulmonary embolism|pulmonary embolism
23761|NCT04049370|clinical decision tool|clinical decision tool
23762|NCT04049370|standard operating procedure|standard operating procedure
23763|NCT04049357|Camera Capsule Endoscopy|camera capsule endoscopy
23764|NCT04049357|Colorectal cancer screening|colorectal cancer screening
23765|NCT04049357|Optical colonoscopy|optical colonoscopy
23766|NCT04049357|Colorectal cancer|colorectal cancer
23767|NCT04049344|renal cell carcinoma|renal cell carcinoma
23768|NCT04049344|chemotherapy|chemotherapy
23769|NCT04049344|decitabine|decitabine
23770|NCT04049344|oxaliplatin|oxaliplatin
23771|NCT04049331|testosterone|testosterone
23772|NCT04049331|hypogonadism|hypogonadism
23773|NCT04049331|cancer related fatigue|cancer related fatigue
23774|NCT04049318|Exercise|exercise
23775|NCT04049318|Education|education
23776|NCT04049318|Digital treatment|digital treatment
23777|NCT04049305|nipple sparing mastectomy|nipple sparing mastectomy
23778|NCT04049305|robotic nipple sparing mastectomy (R-NSM)|robotic nipple sparing mastectomy (r-nsm)
23779|NCT04049305|conventional nipple sparing mastectomy (C-NSM)|conventional nipple sparing mastectomy (c-nsm)
23780|NCT04049305|endoscopic assisted nipple sparing mastectomy (E-NSM)|endoscopic assisted nipple sparing mastectomy (e-nsm)
23781|NCT04049305|immediate breast reconstruction|immediate breast reconstruction
23782|NCT04049305|immediate prothesis breast reconstruction|immediate prothesis breast reconstruction
23783|NCT04049292|anterior cruciate ligament|anterior cruciate ligament
23784|NCT04049292|return to sport|return to sport
23785|NCT04049292|anterior cruciate ligament reconstruction|anterior cruciate ligament reconstruction
23786|NCT04049292|rehabilitation|rehabilitation
23787|NCT04049279|primary total hip arthroplasty|primary total hip arthroplasty
23788|NCT04049279|RSA|rsa
23789|NCT04049279|cement|cement
23790|NCT04049279|Dual mobility cup|dual mobility cup
23791|NCT04049266|AMD|amd
23792|NCT04049266|Wet AMD|wet amd
23793|NCT04049266|choroidal neovascularization secondary to age-related macular degeneration|choroidal neovascularization secondary to age-related macular degeneration
23794|NCT04049266|KSI-301|ksi-301
23795|NCT04049266|Aflibercept|aflibercept
23796|NCT04049266|Vascular endothelial growth factor|vascular endothelial growth factor
23797|NCT04049266|VEGF|vegf
23798|NCT04049266|Anti-VEGF|anti-vegf
23799|NCT04049266|Antibody biopolymer conjugate|antibody biopolymer conjugate
23800|NCT04049266|Macular Degeneration|macular degeneration
23801|NCT04049266|Wet Macular Degeneration|wet macular degeneration
23802|NCT04049266|Retinal Degeneration|retinal degeneration
23803|NCT04049266|Retinal Diseases|retinal diseases
23804|NCT04049266|Eye Diseases|eye diseases
23805|NCT04049266|Vision Disorders|vision disorders
23806|NCT04049266|Vision, low|vision, low
23807|NCT04049266|Kodiak|kodiak
23808|NCT04049253|sngceptin|sngceptin
23809|NCT04049253|soreness|soreness
23810|NCT04049253|muscle acidosis|muscle acidosis
23811|NCT04049240|Noninvasive Ventilation|noninvasive ventilation
23812|NCT04049240|Obesity|obesity
23813|NCT04049240|Moderate sedation|moderate sedation
23814|NCT04049240|Adult|adult
23815|NCT04049240|High-flow nasal oxygenation|high-flow nasal oxygenation
23816|NCT04049240|Vitrectomy|vitrectomy
23817|NCT04049240|Airway management|airway management
23818|NCT04049188|Cancer Patients Hospice Care|cancer patients hospice care
23819|NCT04049188|Palliative Radiation Therapy|palliative radiation therapy
23820|NCT04049162|Blueberries|blueberries
23821|NCT04049162|Pulse Wave Velocity|pulse wave velocity
23822|NCT04049162|Aging|aging
23823|NCT04049162|Exercise|exercise
23824|NCT04049162|Cognition|cognition
23825|NCT04049149|Young-onset type 2 diabetes|young-onset type 2 diabetes
23826|NCT04049084|OTL-101|otl-101
23827|NCT04049071|Tocilizumab|tocilizumab
23828|NCT04049071|Giant Cell Arteritis|giant cell arteritis
23829|NCT04049045|acute decompensated heart failure|acute decompensated heart failure
23830|NCT04049045|empagliflozin|empagliflozin
23831|NCT04049045|diuresis|diuresis
23832|NCT04049045|renal function|renal function
23833|NCT04049032|pregnancy|pregnancy
23834|NCT04049032|prescription opioids|prescription opioids
23835|NCT04049006|Quality of life|quality of life
23836|NCT04049006|randomized Controlled trials|randomized controlled trials
23837|NCT04049006|Costs and Cost analysis|costs and cost analysis
23838|NCT04049006|Primary Health Care|primary health care
23839|NCT04048980|intervention|intervention
23840|NCT04048980|elderly|elderly
23841|NCT04048980|nursing care|nursing care
23842|NCT04048967|Young children|young children
23843|NCT04048967|Preschool|preschool
23844|NCT04048967|Professional development|professional development
23845|NCT04048967|Physical activity|physical activity
23846|NCT04048967|Physical fitness|physical fitness
23847|NCT04048967|Motor skills|motor skills
23848|NCT04048967|Cognition|cognition
23849|NCT04048954|Screening|screening
23850|NCT04048954|Tabagism|tabagism
23851|NCT04048954|Chronic Obstructive Pulmonary Disease|chronic obstructive pulmonary disease
23852|NCT04048954|Cancer|cancer
23853|NCT04048954|Lung|lung
23854|NCT04048915|Family well-being|family well-being
23855|NCT04048915|Healthy Eating|healthy eating
23856|NCT04048915|Physical activity|physical activity
23857|NCT04048902|Exercise Therapy|exercise therapy
23858|NCT04048902|Clinical Trial|clinical trial
23859|NCT04048902|Diathermy|diathermy
23860|NCT04048902|Physical Therapy Modalities|physical therapy modalities
23861|NCT04048876|Non-Alcoholic Steatohepatitia|non-alcoholic steatohepatitia
23862|NCT04048876|NASH|nash
23863|NCT04048876|Non-Alcoholic Fatty Liver|non-alcoholic fatty liver
23864|NCT04048876|Liver Fibrosis|liver fibrosis
23865|NCT04048876|CC-90001|cc-90001
23866|NCT04048850|HCV|hcv
23867|NCT04048850|HIV-HCV coinfection|hiv-hcv coinfection
23868|NCT04048850|DAA|daa
23869|NCT04048850|Elbasvir/grazoprevir|elbasvir/grazoprevir
23870|NCT04048837|Dengue|dengue
23871|NCT04048824|inhibitory learning|inhibitory learning
23872|NCT04048824|exposure|exposure
23873|NCT04048824|anxiety|anxiety
23874|NCT04048824|habituation|habituation
23875|NCT04048824|social anxiety|social anxiety
23876|NCT04048824|panic|panic
23877|NCT04048798|morbid obesity|morbid obesity
23878|NCT04048798|bariatric surgery|bariatric surgery
23879|NCT04048798|high frequency nasal cannula|high frequency nasal cannula
23880|NCT04048798|oxygenation|oxygenation
23881|NCT04048785|Child health care|child health care
23882|NCT04048785|Behavior sleep intervention|behavior sleep intervention
23883|NCT04048785|Mental health|mental health
23884|NCT04048785|Social-emotional development|social-emotional development
23885|NCT04048772|Relaxation|relaxation
23886|NCT04048772|Education|education
23887|NCT04048772|Support|support
23888|NCT04048772|Group|group
23889|NCT04048772|Knowledge|knowledge
23890|NCT04048772|Therapy|therapy
23891|NCT04048772|In vitro fertilization|in vitro fertilization
23892|NCT04048772|Stress|stress
23893|NCT04048772|Relationships|relationships
23894|NCT04048772|IVF|ivf
23895|NCT04048759|Physical Activity|physical activity
23896|NCT04048759|Exercise|exercise
23897|NCT04048733|Electrocardiography|electrocardiography
23898|NCT04048733|Chest pain|chest pain
23899|NCT04048733|Emergency Service,Hospital|emergency service,hospital
23900|NCT04048733|Wireless Technology|wireless technology
23901|NCT04048720|Family Nurture Intervention|family nurture intervention
23902|NCT04048720|Martha G. Welch MD|martha g. welch md
23903|NCT04048720|Feasibility Study|feasibility study
23904|NCT04048720|Preschool intervention|preschool intervention
23905|NCT04048720|Co-regulation|co-regulation
23906|NCT04048720|Emotional Connection|emotional connection
23907|NCT04048720|Multiple Family Group Intervention|multiple family group intervention
23908|NCT04048681|artificial sweeteners|artificial sweeteners
23909|NCT04048681|diet soda|diet soda
23910|NCT04048668|non-invasive brain stimulation|non-invasive brain stimulation
23911|NCT04048668|tDCS|tdcs
23912|NCT04048655|neuromuscular blockade|neuromuscular blockade
23913|NCT04048655|neostigmine|neostigmine
808078|NCT00219986|HIV|hiv
23914|NCT04048655|muscle relaxation|muscle relaxation
23915|NCT04048655|train of four|train of four
23916|NCT04048655|rocuronium|rocuronium
23917|NCT04048629|Zimbabwe|zimbabwe
23918|NCT04048629|HIV|hiv
23919|NCT04048629|Viral load|viral load
23920|NCT04048629|Point-of-care|point-of-care
23921|NCT04048629|GeneXpert|genexpert
23922|NCT04048603|REM sleep behavior disorder|rem sleep behavior disorder
23923|NCT04048603|Neurodegeneration|neurodegeneration
23924|NCT04048603|α-synucleinopathy|α-synucleinopathy
23925|NCT04048603|Prodromal markers|prodromal markers
23926|NCT04048590|Skilled Nursing Facilities|skilled nursing facilities
23927|NCT04048590|Home-based care|home-based care
23928|NCT04048590|Rehabilitation|rehabilitation
23929|NCT04048577|Natalizumab|natalizumab
23930|NCT04048577|Drug Holiday|drug holiday
23931|NCT04048577|Alternative Dosing|alternative dosing
23932|NCT04048577|Extended Dosing|extended dosing
23933|NCT04048564|Chronic myeloid leukemia|chronic myeloid leukemia
23934|NCT04048564|Iclusig|iclusig
23935|NCT04048564|ponatinib|ponatinib
23936|NCT04048551|PrEP (Pre-exposure Prophylaxis)|prep (pre-exposure prophylaxis)
23937|NCT04048551|HIV (Human Immunodeficiency Virus)|hiv (human immunodeficiency virus)
23938|NCT04048551|Adolescent Girls and Young Women (AGYW)|adolescent girls and young women (agyw)
23939|NCT04048551|Stigma and Discrimination (S&D)|stigma and discrimination (s&d)
23940|NCT04048551|Gender-based violence (GBV)|gender-based violence (gbv)
23941|NCT04048551|Substance use|substance use
23942|NCT04048538|patient education|patient education
23943|NCT04048538|surgical education|surgical education
23944|NCT04048538|multimedia|multimedia
23945|NCT04048538|animation|animation
23946|NCT04048538|guide|guide
23947|NCT04048525|CRRT|crrt
23948|NCT04048525|CVVHD|cvvhd
23949|NCT04048525|CVVH|cvvh
23950|NCT04048460|telehealth|telehealth
23951|NCT04048460|eAudiology|eaudiology
23952|NCT04048460|accessibility|accessibility
23953|NCT04048460|Age-related hearing loss|age-related hearing loss
23954|NCT04048382|HIV Seroprevalence|hiv seroprevalence
23955|NCT04048382|Pre-Exposure Prophylaxis|pre-exposure prophylaxis
23956|NCT04048382|Patient Navigation|patient navigation
23957|NCT04048369|influenza|influenza
23958|NCT04048369|point-of-care testing|point-of-care testing
23959|NCT04048369|polymerase chain reaction|polymerase chain reaction
23960|NCT04048369|emergency medicine|emergency medicine
23961|NCT04048356|Urogynecology|urogynecology
23962|NCT04048356|Surgery|surgery
23963|NCT04048356|Antiseptic Preparation|antiseptic preparation
23964|NCT04048343|Asthma|asthma
23965|NCT04048343|Uncontrolled Asthma|uncontrolled asthma
23966|NCT04048343|Severe Uncontrolled Asthma|severe uncontrolled asthma
23967|NCT04048330|Anemia|anemia
23968|NCT04048330|Periconceptional|periconceptional
23969|NCT04048330|Vitamin B12|vitamin b12
23970|NCT04048330|Folate|folate
23971|NCT04048330|Surveillance|surveillance
23972|NCT04048330|India|india
23973|NCT04048291|rehabilitation|rehabilitation
23974|NCT04048291|exercise|exercise
23975|NCT04048291|postural balance|postural balance
23976|NCT04048278|Pancreas|pancreas
23977|NCT04048278|Pancreatic Cancer|pancreatic cancer
23978|NCT04048278|Lidocaine|lidocaine
23979|NCT04048278|Enzymatic Activity|enzymatic activity
23980|NCT04048278|Cytokines|cytokines
23981|NCT04048278|Chemokines|chemokines
23982|NCT04048278|Gene Expression|gene expression
23983|NCT04048265|TMS|tms
23984|NCT04048265|Parkinson's disease|parkinson's disease
23985|NCT04048265|pain|pain
23986|NCT04048239|cochlear implant|cochlear implant
23987|NCT04048239|robotic|robotic
23988|NCT04048239|mini-invasive|mini-invasive
23989|NCT04048226|Dexmedetomidine|dexmedetomidine
23990|NCT04048226|Ketamine|ketamine
23991|NCT04048226|Radical Mastectomy|radical mastectomy
23992|NCT04048226|Chronic pain|chronic pain
23993|NCT04048213|doose syndrome|doose syndrome
23994|NCT04048213|Epileptic Syndromes|epileptic syndromes
23995|NCT04048213|Learning Disabilities|learning disabilities
23996|NCT04048200|Dexmedetomidine|dexmedetomidine
23997|NCT04048200|Ketamine|ketamine
23998|NCT04048200|Fentanyl|fentanyl
23999|NCT04048200|Bariatric surgeries|bariatric surgeries
24000|NCT04048174|Probiotics|probiotics
24001|NCT04048174|Chronic rhinosinusitis|chronic rhinosinusitis
24002|NCT04048174|Irrigation|irrigation
24003|NCT04048174|Microbiome|microbiome
24004|NCT04048161|Nephrotic Syndrome|nephrotic syndrome
24005|NCT04048161|Frequently Relapsing Nephrotic Syndrome|frequently relapsing nephrotic syndrome
24006|NCT04048161|Steroid Dependent Nephrotic Syndrome|steroid dependent nephrotic syndrome
24007|NCT04048161|Tacrolimus|tacrolimus
24008|NCT04048161|Mycophenolate mofetil|mycophenolate mofetil
24009|NCT04048135|NASH, NAFLD|nash, nafld
24010|NCT04048135|Liver diseases|liver diseases
24011|NCT04048135|Fatty Liver|fatty liver
24012|NCT04048135|Metabolic diseases|metabolic diseases
24013|NCT04048122|occupational therapy|occupational therapy
24014|NCT04048122|cognition|cognition
400494|NCT01866644|Liver transplantation, n-acetylcysteine|liver transplantation, n-acetylcysteine
24015|NCT04048083|bilateral upper limb congenital transverse deficiency|bilateral upper limb congenital transverse deficiency
24016|NCT04048083|neuroplasticity|neuroplasticity
24017|NCT04048083|sensorimotor cortex|sensorimotor cortex
24018|NCT04048083|mental training|mental training
24019|NCT04048083|virtual environment|virtual environment
24020|NCT04048031|Hair thinning|hair thinning
24021|NCT04048031|Hair Loss|hair loss
24022|NCT04048031|Women|women
24023|NCT04048031|Perimenopausal, Menopausal and Post Menopausal Women|perimenopausal, menopausal and post menopausal women
24024|NCT04048031|Nutraceutical supplement|nutraceutical supplement
24025|NCT04048018|Interferon Gamma Release Assay|interferon gamma release assay
24026|NCT04048018|Tuberculosis|tuberculosis
24027|NCT04047979|Zoster|zoster
24028|NCT04047979|Immune responses|immune responses
24029|NCT04047979|Vaccine|vaccine
24030|NCT04047979|Vaccine Trials|vaccine trials
24031|NCT04047979|Clinical Trials|clinical trials
24032|NCT04047979|Chicken Pox|chicken pox
24033|NCT04047979|Shingles|shingles
24034|NCT04047966|Intrauterine Growth restriction|intrauterine growth restriction
24035|NCT04047966|Gastrointestinal microbiome|gastrointestinal microbiome
24036|NCT04047966|Inflammatory biomarkers|inflammatory biomarkers
24037|NCT04047953|Paclitaxel (albumin-bound)|paclitaxel (albumin-bound)
24038|NCT04047953|gastric cancer|gastric cancer
24039|NCT04047953|conversion therapy|conversion therapy
24040|NCT04047914|photodynamic therapy|photodynamic therapy
24041|NCT04047914|Staphylococcus aureus|staphylococcus aureus
24042|NCT04047914|nasal decolonization|nasal decolonization
24043|NCT04047914|hemodialysis|hemodialysis
24044|NCT04047914|chronic kidney disease|chronic kidney disease
24045|NCT04047914|mupirocin|mupirocin
24046|NCT04047901|autonomic dysfunction|autonomic dysfunction
24047|NCT04047901|baroreflex control|baroreflex control
24048|NCT04047901|ergorreflex control|ergorreflex control
24049|NCT04047901|muscle myopaty|muscle myopaty
24050|NCT04047875|norethisterone|norethisterone
24051|NCT04047875|uterine bleeding|uterine bleeding
24052|NCT04047875|progestogen-only contraceptives|progestogen-only contraceptives
24053|NCT04047875|etonogestrel-releasing implant|etonogestrel-releasing implant
24054|NCT04047862|BGB-A1217|bgb-a1217
24055|NCT04047862|Anti-TIGIT antibody|anti-tigit antibody
24056|NCT04047862|Tislelizumab|tislelizumab
24057|NCT04047862|anti-PD-1|anti-pd-1
24058|NCT04047849|Previable|previable
24059|NCT04047849|PPROM|pprom
24060|NCT04047849|Premature prelabor rupture of membranes|premature prelabor rupture of membranes
24061|NCT04047849|Preterm|preterm
24062|NCT04047849|Preterm birth|preterm birth
24063|NCT04047849|Latency antibiotics|latency antibiotics
24064|NCT04047836|E-Cigarettes|e-cigarettes
24065|NCT04047836|Vaping|vaping
24066|NCT04047836|E-Cig Mods|e-cig mods
24067|NCT04047836|E-Liquid|e-liquid
24068|NCT04047784|EBUS|ebus
24069|NCT04047784|Acute Pulmonary Embolism|acute pulmonary embolism
24070|NCT04047784|Endobronchial Ultrasound|endobronchial ultrasound
24071|NCT04047784|Pilot|pilot
24072|NCT04047758|palbociclib|palbociclib
24073|NCT04047758|aromatase inhibitors|aromatase inhibitors
24074|NCT04047719|Pneumonia|pneumonia
24075|NCT04047719|NGS|ngs
24076|NCT04047719|cell free DNA|cell free dna
24077|NCT04047719|microbial cell free DNA|microbial cell free dna
24078|NCT04047719|immunocompromised|immunocompromised
24079|NCT04047693|dose dense MVAC|dose dense mvac
24080|NCT04047693|neoadjuvant chemotherapy|neoadjuvant chemotherapy
24081|NCT04047693|Urothelial carcinoma|urothelial carcinoma
24082|NCT04047680|Viral hepatitis C|viral hepatitis c
24083|NCT04047680|Glomerular filtration rate|glomerular filtration rate
24084|NCT04047680|Direct acting antiviral agent|direct acting antiviral agent
24085|NCT04047680|Sofosbuvir|sofosbuvir
24086|NCT04047654|anticoagulant drugs|anticoagulant drugs
24770|NCT04043910|fNIRS|fnirs
24087|NCT04047628|Treatment-Resistant Relapsing Multiple Sclerosis (MS)|treatment-resistant relapsing multiple sclerosis (ms)
24088|NCT04047628|Autologous Hematopoietic Stem Cell Transplantation (AHSCT)|autologous hematopoietic stem cell transplantation (ahsct)
24089|NCT04047628|Autologous Peripheral Blood Stem Cells (PBMCs) Graft|autologous peripheral blood stem cells (pbmcs) graft
24090|NCT04047628|Best Available Therapy (BAT)|best available therapy (bat)
24091|NCT04047628|Disease-Modifying Therapy (DMT)|disease-modifying therapy (dmt)
24092|NCT04047628|BAT DMT|bat dmt
24093|NCT04047602|Radiation|radiation
24094|NCT04047602|Immune therapy|immune therapy
24095|NCT04047602|Stereotactic Radiosurgery|stereotactic radiosurgery
24096|NCT04047589|solid tumor|solid tumor
24097|NCT04047589|exercise|exercise
24098|NCT04047576|mTOR inhibitor|mtor inhibitor
24099|NCT04047576|Sirolimus|sirolimus
24100|NCT04047576|Retroperitoneal Fibrosis|retroperitoneal fibrosis
24101|NCT04047563|Endothelin|endothelin
24102|NCT04047563|Neurogenesis|neurogenesis
24103|NCT04047563|Neural progenitor cells|neural progenitor cells
24104|NCT04047511|virtual reality|virtual reality
24105|NCT04047511|depression|depression
24106|NCT04047511|anxiety|anxiety
24107|NCT04047511|mental health|mental health
24108|NCT04047511|elderly|elderly
24109|NCT04047511|psychotherapy|psychotherapy
24110|NCT04047511|rehabilitation|rehabilitation
24111|NCT04047485|Cataract|cataract
24112|NCT04047485|Mild Cognitive Impairment (MCI)|mild cognitive impairment (mci)
24113|NCT04047485|Cataract Surgery|cataract surgery
24114|NCT04047485|BMICS (Bi-Manual Microincisional Cataract Surgery)|bmics (bi-manual microincisional cataract surgery)
24115|NCT04047485|Post-operative Delirium|post-operative delirium
24116|NCT04047459|Organ specific endothelium|organ specific endothelium
24117|NCT04047459|Microfluidics|microfluidics
24118|NCT04047459|Cancer cell extravasation|cancer cell extravasation
24119|NCT04047407|Reffered pain|reffered pain
24120|NCT04047407|Pain sensitivity|pain sensitivity
24121|NCT04047407|Fibromyalgia|fibromyalgia
24122|NCT04047407|Suprathreshold|suprathreshold
24123|NCT04047407|Central sensitization|central sensitization
24124|NCT04047381|Atrial fibrillation|atrial fibrillation
24125|NCT04047381|Quality of life|quality of life
24126|NCT04047368|Percutaneous coronary intervention|percutaneous coronary intervention
24127|NCT04047368|Rotablation|rotablation
24128|NCT04047368|Coronary lithoplasty|coronary lithoplasty
24129|NCT04047368|Optical coherence tomography|optical coherence tomography
24130|NCT04047355|Propranolol|propranolol
24131|NCT04047355|Beta Blocker|beta blocker
24132|NCT04047355|Psychopharmacology|psychopharmacology
24133|NCT04047355|Inderal|inderal
24134|NCT04047342|Prospect theory|prospect theory
24135|NCT04047303|Diffuse Astrocytoma|diffuse astrocytoma
24136|NCT04047303|Anaplastic Astrocytoma|anaplastic astrocytoma
24137|NCT04047303|Glioblastoma|glioblastoma
24138|NCT04047303|CC-90010|cc-90010
24139|NCT04047303|CNS|cns
24140|NCT04047303|2nd line or relapsed|2nd line or relapsed
24141|NCT04047290|anti-PD-1/VEGF bispecific antibody|anti-pd-1/vegf bispecific antibody
24142|NCT04047290|immunotherapy|immunotherapy
24143|NCT04047290|immuno-oncology|immuno-oncology
24144|NCT04047290|advanced solid tumors|advanced solid tumors
24145|NCT04047290|bispecific|bispecific
24146|NCT04047290|PD-1/VEGF|pd-1/vegf
24147|NCT04047277|Nightmares|nightmares
24148|NCT04047277|Children|children
24149|NCT04047277|Trauma|trauma
24150|NCT04047277|CBT|cbt
24151|NCT04047277|Exposure|exposure
24152|NCT04047277|Relaxation|relaxation
24153|NCT04047277|Rescripting|rescripting
24154|NCT04047277|Cognitive|cognitive
24155|NCT04047277|Behavioral|behavioral
24156|NCT04047277|Therapy|therapy
24157|NCT04047238|Dementia|dementia
24158|NCT04047238|Cognitive Impairment|cognitive impairment
24159|NCT04047238|Cognitive Decline|cognitive decline
24160|NCT04047238|Neurocognitive Disorders|neurocognitive disorders
24161|NCT04047238|Elderly|elderly
24162|NCT04047238|Reminiscence Therapy|reminiscence therapy
24163|NCT04047238|Individual Intervention|individual intervention
24164|NCT04047238|Cognition|cognition
24165|NCT04047238|Depression|depression
24166|NCT04047238|Quality of Life|quality of life
24167|NCT04047199|Percutaneous Coronary Intervention|percutaneous coronary intervention
24168|NCT04047186|immunotherapy|immunotherapy
24169|NCT04047186|Multiple Pulmonary Nodules|multiple pulmonary nodules
24170|NCT04047186|Lung Neoplasms|lung neoplasms
24171|NCT04047173|recurrent small hepatocellular carcinoma|recurrent small hepatocellular carcinoma
24172|NCT04047173|Radiofrequency Ablation|radiofrequency ablation
24173|NCT04047173|Stereotactic Body Radiotherapy|stereotactic body radiotherapy
24174|NCT04047160|Primary Biliary Cholangitis (PBC)|primary biliary cholangitis (pbc)
24175|NCT04047160|Liver Cirrhosis, Biliary|liver cirrhosis, biliary
24176|NCT04047160|Cholangitis, Chronic Nonsuppurative Destructive|cholangitis, chronic nonsuppurative destructive
24177|NCT04047160|Liver Cirrhosis, Obstructive|liver cirrhosis, obstructive
24178|NCT04047160|Secondary Biliary Cholangitis|secondary biliary cholangitis
24179|NCT04047160|Primary Biliary Cirrhosis|primary biliary cirrhosis
24180|NCT04047160|Secondary Biliary Cirrhosis|secondary biliary cirrhosis
25581|NCT04039620|Acute care|acute care
24181|NCT04047134|Prevention and treatment of movement|prevention and treatment of movement
24182|NCT04047134|Motor Function|motor function
24183|NCT04047134|Action Observation Therapy|action observation therapy
24184|NCT04047134|Mirror Neuron System|mirror neuron system
24185|NCT04047134|Upper Limb Rehabilitation|upper limb rehabilitation
24186|NCT04047095|Cardiac surgery|cardiac surgery
24187|NCT04047095|Immunonutrition Glutamine Bioelectrical impedance|immunonutrition glutamine bioelectrical impedance
24188|NCT04047095|Immunological status|immunological status
24189|NCT04047056|physiotherapy|physiotherapy
24190|NCT04047056|prevention|prevention
24191|NCT04047056|pain|pain
24192|NCT04047056|upper limb|upper limb
24193|NCT04047056|exercises|exercises
24194|NCT04047056|musculoskeletal disorders|musculoskeletal disorders
24195|NCT04047043|Taurine/graft function/LDLT|taurine/graft function/ldlt
24196|NCT04047004|Gastric adenocarcinoma|gastric adenocarcinoma
24197|NCT04047004|Intraperitoneal chemotherapy|intraperitoneal chemotherapy
24198|NCT04047004|Laparoscopic gastrectomy|laparoscopic gastrectomy
24199|NCT04047004|Gastric cancer|gastric cancer
24200|NCT04047004|Surgery|surgery
24201|NCT04046991|non-invasive brain stimulation|non-invasive brain stimulation
24202|NCT04046991|transcranial direct current stimulation (tDCS)|transcranial direct current stimulation (tdcs)
24203|NCT04046991|aphasia|aphasia
24204|NCT04046978|Virus Diseases|virus diseases
24205|NCT04046965|Alaska natives|alaska natives
24206|NCT04046965|child care|child care
24207|NCT04046965|child development|child development
24208|NCT04046965|child health|child health
24209|NCT04046965|child rearing|child rearing
24210|NCT04046965|children|children
24211|NCT04046965|curriculum|curriculum
24212|NCT04046965|early childhood education|early childhood education
24213|NCT04046965|families|families
24214|NCT04046965|Head Start|head start
24215|NCT04046965|Native Americans|native americans
24216|NCT04046965|parenting skills|parenting skills
24217|NCT04046965|parents|parents
24218|NCT04046965|programs|programs
24219|NCT04046965|school readiness|school readiness
24220|NCT04046965|teachers|teachers
24221|NCT04046952|Radial Artery Occlusion|radial artery occlusion
24222|NCT04046952|Time to Hemostasis|time to hemostasis
24223|NCT04046952|Statseal|statseal
24224|NCT04046952|TR Band|tr band
24225|NCT04046952|cardiac catheterization|cardiac catheterization
24226|NCT04046952|transradial catheterization|transradial catheterization
24227|NCT04046952|percutaneous coronary intervention|percutaneous coronary intervention
24228|NCT04046939|Eosinophilic Asthma|eosinophilic asthma
24229|NCT04046939|Asthma|asthma
24230|NCT04046939|dexpramipexole|dexpramipexole
24231|NCT04046926|anorexia nervosa|anorexia nervosa
24232|NCT04046926|relapse|relapse
24233|NCT04046926|inpatient|inpatient
24234|NCT04046926|cognitive behavioral therapy|cognitive behavioral therapy
24235|NCT04046926|prospective study|prospective study
24236|NCT04046913|Dietary intervention|dietary intervention
24237|NCT04046887|Pancreatic Ductal Adenocarcinoma|pancreatic ductal adenocarcinoma
24238|NCT04046887|Pancreatic Cancer|pancreatic cancer
24239|NCT04046887|Metastatic Pancreatic Cancer|metastatic pancreatic cancer
24362|NCT04046276|Aerobic Exercises|aerobic exercises
24240|NCT04046887|Locally Advanced Pancreatic Cancer|locally advanced pancreatic cancer
24241|NCT04046874|Low Back Pain|low back pain
24242|NCT04046874|Risk-stratification|risk-stratification
24243|NCT04046874|STarT Back|start back
24244|NCT04046874|Patient outcomes|patient outcomes
24245|NCT04046874|Cost-effectiveness;|cost-effectiveness;
24246|NCT04046874|Barriers and Facilitators|barriers and facilitators
24247|NCT04046861|cardiac surgery|cardiac surgery
24248|NCT04046861|cardiopulmonary bypass|cardiopulmonary bypass
24249|NCT04046861|hyperlactatemia|hyperlactatemia
24250|NCT04046861|vitamin C|vitamin c
24251|NCT04046848|Hemophilia A|hemophilia a
24252|NCT04046848|Blood Coagulation Disorders, Inherited|blood coagulation disorders, inherited
24253|NCT04046848|Blood Coagulation Disorders|blood coagulation disorders
24254|NCT04046848|Hematologic Diseases|hematologic diseases
24255|NCT04046848|Coagulation Protein Disorders|coagulation protein disorders
24256|NCT04046848|Hemorrhagic Disorders|hemorrhagic disorders
24257|NCT04046848|Genetic Diseases, Inborn|genetic diseases, inborn
24258|NCT04046848|Factor VIII|factor viii
24259|NCT04046835|Three-dimensional optical surface scanning|three-dimensional optical surface scanning
24260|NCT04046835|Patient position|patient position
24261|NCT04046822|obesity|obesity
24262|NCT04046822|liraglutide|liraglutide
24263|NCT04046822|gut microbiome|gut microbiome
24264|NCT04046796|Rare Diseases|rare diseases
24265|NCT04046796|Genetic Predisposition|genetic predisposition
24266|NCT04046796|Omics Technology|omics technology
24267|NCT04046796|Next Generation Sequencing (NGS)|next generation sequencing (ngs)
24268|NCT04046783|Natural products|natural products
24269|NCT04046783|Wound healing|wound healing
24270|NCT04046783|Cesarean delivery|cesarean delivery
24271|NCT04046770|safety|safety
24272|NCT04046770|Effectiveness|effectiveness
24273|NCT04046770|Double-chamber syringe|double-chamber syringe
24274|NCT04046770|Clinical research|clinical research
24275|NCT04046770|medical devices|medical devices
24277|NCT04046770|hospital setting|hospital setting
24278|NCT04046757|Ischemic stroke|ischemic stroke
24279|NCT04046757|Mechanical Thrombectomy|mechanical thrombectomy
24280|NCT04046744|Regional anesthesia|regional anesthesia
24281|NCT04046744|Analgesia|analgesia
24282|NCT04046744|Ultrasound|ultrasound
24283|NCT04046692|hospital school|hospital school
24284|NCT04046692|pain|pain
24285|NCT04046692|distress|distress
24286|NCT04046692|negative emotions|negative emotions
24287|NCT04046692|school continuity|school continuity
24288|NCT04046692|child|child
24289|NCT04046679|MMP|mmp
24290|NCT04046679|DRUG DELIVERY|drug delivery
24291|NCT04046679|BLEOMYCIN|bleomycin
24292|NCT04046679|PIGMENTATION DISORDERS|pigmentation disorders
24293|NCT04046666|meridians|meridians
24294|NCT04046666|acupuncture|acupuncture
24295|NCT04046666|chronic obstructive pulmonary disease|chronic obstructive pulmonary disease
24296|NCT04046666|meridian phenomenon|meridian phenomenon
24297|NCT04046666|near infrared spectroscopy|near infrared spectroscopy
24298|NCT04046640|meridians|meridians
24299|NCT04046640|acupuncture|acupuncture
24300|NCT04046640|chronic obstructive pulmonary disease|chronic obstructive pulmonary disease
24301|NCT04046640|meridian phenomenon|meridian phenomenon
24302|NCT04046640|infrared thermography|infrared thermography
24303|NCT04046601|impedance, Barrett´s cancer, early detection of cancer|impedance, barrett´s cancer, early detection of cancer
24304|NCT04046588|meridians|meridians
24305|NCT04046588|acupuncture|acupuncture
24306|NCT04046588|chronic obstructive pulmonary disease|chronic obstructive pulmonary disease
24307|NCT04046588|meridian phenomenon|meridian phenomenon
24308|NCT04046588|infrared thermography|infrared thermography
24309|NCT04046549|Renal allograft dysfunction|renal allograft dysfunction
24310|NCT04046549|Cell-mediated rejection|cell-mediated rejection
24311|NCT04046549|Antibody mediated rejection|antibody mediated rejection
24312|NCT04046549|Immunosuppression|immunosuppression
24313|NCT04046549|Acute rejection|acute rejection
24314|NCT04046549|VIB4920|vib4920
24315|NCT04046549|MEDI4920|medi4920
24316|NCT04046549|Belatacept|belatacept
24317|NCT04046549|Thymoglobulin|thymoglobulin
24318|NCT04046549|Methylprednisolone|methylprednisolone
24319|NCT04046549|Corticosteroids|corticosteroids
24320|NCT04046536|rTMS|rtms
24321|NCT04046536|Transcranial Magnetic Stimulation|transcranial magnetic stimulation
24322|NCT04046536|Gulf War Illness|gulf war illness
24323|NCT04046536|Depression|depression
24324|NCT04046523|video ophthalmoscope|video ophthalmoscope
24325|NCT04046523|intraocular pressure|intraocular pressure
24326|NCT04046523|electrocardiogram|electrocardiogram
24327|NCT04046523|photoplethysmography|photoplethysmography
24328|NCT04046523|retinal pulsatility|retinal pulsatility
24329|NCT04046523|spontaneous venous pulsation|spontaneous venous pulsation
24330|NCT04046523|blind source separation|blind source separation
24331|NCT04046510|Cesarean section, ocytocin, uterine tone, side effects|cesarean section, ocytocin, uterine tone, side effects
24332|NCT04046471|Weight Loss|weight loss
24333|NCT04046471|Physical Activity|physical activity
24334|NCT04046471|Diet|diet
24335|NCT04046445|CRC|crc
24336|NCT04046445|Colorectal Cancer|colorectal cancer
24337|NCT04046445|MSS|mss
24338|NCT04046445|Metastatic Colorectal Cancer|metastatic colorectal cancer
24339|NCT04046445|Liver Metastasis Colon Cancer|liver metastasis colon cancer
24340|NCT04046445|Stage IV Colon Cancer|stage iv colon cancer
24341|NCT04046445|Stage IV Rectal Cancer|stage iv rectal cancer
24342|NCT04046445|KISIMA-01|kisima-01
24343|NCT04046445|ATP128|atp128
24344|NCT04046445|BI 754091|bi 754091
24345|NCT04046445|MMRp|mmrp
24346|NCT04046432|gut microflora|gut microflora
24347|NCT04046432|immunity|immunity
24348|NCT04046432|anti-oxidative capacity|anti-oxidative capacity
24349|NCT04046432|Lactobacillus paracasei subsp. paracasei NTU 101|lactobacillus paracasei subsp. paracasei ntu 101
24350|NCT04046432|probiotics|probiotics
24351|NCT04046419|validity, reliability, Turkish version, HC-PAIRS|validity, reliability, turkish version, hc-pairs
24352|NCT04046393|rhinitis, sinusitis, nasal irrigation, TCM|rhinitis, sinusitis, nasal irrigation, tcm
24353|NCT04046367|nutrition|nutrition
24354|NCT04046367|physical activity|physical activity
24355|NCT04046367|prehabilitation|prehabilitation
24356|NCT04046354|microwave|microwave
24357|NCT04046354|thyroid|thyroid
24358|NCT04046341|Difficulty falling asleep|difficulty falling asleep
24359|NCT04046341|Difficulty staying asleep|difficulty staying asleep
24360|NCT04046341|Not getting enough sleep|not getting enough sleep
24361|NCT04046276|Parkinson's disease|parkinson's disease
24363|NCT04046276|High Intensity Training|high intensity training
24364|NCT04046276|Neuroprotection|neuroprotection
24365|NCT04046250|Mucositis|mucositis
24366|NCT04046250|Methotrexate|methotrexate
24367|NCT04046250|Uridine Phosphorylase Inhibitor|uridine phosphorylase inhibitor
24368|NCT04046250|Head and Neck Cancer|head and neck cancer
24369|NCT04046237|Acute Myocardial Infarction|acute myocardial infarction
24370|NCT04046237|Severe Periodontitis|severe periodontitis
24371|NCT04046237|FDG-PET|fdg-pet
24372|NCT04046237|Carotid Atherosclerosis|carotid atherosclerosis
24373|NCT04046224|Sangamo|sangamo
24374|NCT04046224|Rare|rare
24375|NCT04046224|Lysosomal Storage Disease|lysosomal storage disease
24376|NCT04046224|Gene Therapy|gene therapy
24377|NCT04046198|Professional Values Model|professional values model
24378|NCT04046198|professional values|professional values
24379|NCT04046198|job satisfaction|job satisfaction
24380|NCT04046198|pediatric nursing|pediatric nursing
24381|NCT04046172|Periodontitis|periodontitis
24383|NCT04046172|Lupus|lupus
24384|NCT04046146|Healthy Volunteers|healthy volunteers
24385|NCT04046146|Lymphatic Transport|lymphatic transport
24386|NCT04046146|Imaging|imaging
24387|NCT04046146|Indocyanine Green|indocyanine green
24388|NCT04046146|Gadolinium|gadolinium
24389|NCT04046146|ICG|icg
24390|NCT04046146|GAD|gad
24391|NCT04046146|NIR-ICG|nir-icg
24392|NCT04046146|rhuematoid arthritis|rhuematoid arthritis
24393|NCT04046146|NIR|nir
24394|NCT04046120|varicose ulcer|varicose ulcer
400495|NCT01866618|Natural|natural
24395|NCT04046120|compression bandages|compression bandages
24396|NCT04046120|patient compliance|patient compliance
24397|NCT04046120|heel|heel
24398|NCT04046120|methods|methods
24399|NCT04046107|Hepatitis B|hepatitis b
24400|NCT04046107|Chronic hepatitis B|chronic hepatitis b
24401|NCT04046107|Functional cure|functional cure
24402|NCT04046107|Immunotherapy|immunotherapy
24403|NCT04046107|Checkpoint inhibitor therapy|checkpoint inhibitor therapy
24404|NCT04046094|Intravenous (IV) Ascorbic Acid (Vitamin C)|intravenous (iv) ascorbic acid (vitamin c)
24405|NCT04046081|Endometriosis|endometriosis
24406|NCT04046081|Dichloroacetate|dichloroacetate
24407|NCT04046055|transcranial direct current stimulation|transcranial direct current stimulation
24408|NCT04046055|walking|walking
24409|NCT04046055|balance|balance
24410|NCT04046042|Exercise|exercise
24411|NCT04046042|Virtual reality|virtual reality
24412|NCT04046042|physical function|physical function
24413|NCT04046042|health-related quality of life|health-related quality of life
24414|NCT04046042|hemodynamic instability|hemodynamic instability
24415|NCT04046029|Acute Coronary Syndrome|acute coronary syndrome
24416|NCT04046029|Percutaneous Coronary Intervention|percutaneous coronary intervention
24417|NCT04046029|Elderly|elderly
24418|NCT04046029|Bivalirudin|bivalirudin
24419|NCT04045977|virtual reality|virtual reality
24420|NCT04045977|cardiac rehabilitation|cardiac rehabilitation
24421|NCT04045977|psychotherapy|psychotherapy
24422|NCT04045977|cardiac surgery|cardiac surgery
24423|NCT04045977|depression|depression
24424|NCT04045977|anxiety|anxiety
24425|NCT04045977|stress|stress
24426|NCT04045977|elderly|elderly
24427|NCT04045977|Coronary Artery Disease|coronary artery disease
24428|NCT04045977|Ischemic Heart Disease|ischemic heart disease
24429|NCT04045951|Vision Disorders|vision disorders
24430|NCT04045951|Artificial intelligence|artificial intelligence
24431|NCT04045951|Myopia prediction|myopia prediction
24432|NCT04045938|glycemic index|glycemic index
24433|NCT04045938|glycemic load|glycemic load
24434|NCT04045938|glycaemic index|glycaemic index
24435|NCT04045938|glycaemic load|glycaemic load
24436|NCT04045938|cardiovascular disease|cardiovascular disease
24437|NCT04045938|cardiometabolic risk|cardiometabolic risk
24438|NCT04045938|glycemic control|glycemic control
24439|NCT04045925|Taïso|taïso
24440|NCT04045925|Physical therapy|physical therapy
24441|NCT04045925|Exercice therapy|exercice therapy
24442|NCT04045925|Parkinson disease|parkinson disease
24443|NCT04045912|HIV self-testing|hiv self-testing
24444|NCT04045912|Accredited drug dispensing outlets|accredited drug dispensing outlets
24445|NCT04045912|Adolescent girls and young women|adolescent girls and young women
24446|NCT04045899|Comparison of device|comparison of device
24447|NCT04045873|Complex high-risk patients|complex high-risk patients
24448|NCT04045873|Percutaneous coronary intervention|percutaneous coronary intervention
24449|NCT04045873|Extracorporeal membrane oxygenation|extracorporeal membrane oxygenation
24450|NCT04045873|Intra-aortic balloon pump|intra-aortic balloon pump
24451|NCT04045847|glioma|glioma
24452|NCT04045847|CD147|cd147
24453|NCT04045847|CAR-T|car-t
24454|NCT04045808|coronary angiography|coronary angiography
24455|NCT04045808|coronary artery disease|coronary artery disease
24456|NCT04045808|edentulism|edentulism
24457|NCT04045808|periodontitis|periodontitis
24458|NCT04045808|periodontal disease|periodontal disease
24459|NCT04045782|biologic|biologic
24460|NCT04045782|biosimilar|biosimilar
24461|NCT04045782|switch|switch
24462|NCT04045782|IBD|ibd
24463|NCT04045756|prostate cancer|prostate cancer
24464|NCT04045756|laser ablation|laser ablation
24465|NCT04045756|mpMRI|mpmri
24466|NCT04045756|interventional radiology|interventional radiology
24467|NCT04045717|Stereotactic Body Radiotherapy|stereotactic body radiotherapy
24468|NCT04045691|BERING|bering
24469|NCT04045691|Encorafenib|encorafenib
24470|NCT04045691|Binimetinib|binimetinib
24471|NCT04045678|parkinson disease|parkinson disease
24472|NCT04045678|LY03003|ly03003
24473|NCT04045665|Anticoagulation|anticoagulation
24474|NCT04045665|Antiplatelet Therapy|antiplatelet therapy
24475|NCT04045665|Post Operative Atrial Fibrillation|post operative atrial fibrillation
24476|NCT04045652|HPV|hpv
24477|NCT04045652|HIV|hiv
24478|NCT04045613|metastatic urothelial cancer|metastatic urothelial cancer
24479|NCT04045613|bladder cancer|bladder cancer
24480|NCT04045613|Fibroblast Growth Factor Receptor|fibroblast growth factor receptor
24481|NCT04045613|FGFR genetic aberration|fgfr genetic aberration
24482|NCT04045613|targeted therapy|targeted therapy
24483|NCT04045613|derazantinib|derazantinib
24484|NCT04045613|checkpoint inhibitor|checkpoint inhibitor
24485|NCT04045613|immune checkpoint blockade|immune checkpoint blockade
24486|NCT04045613|atezolizumab|atezolizumab
24487|NCT04045613|Tecentriq|tecentriq
24488|NCT04045613|solid tumor|solid tumor
24489|NCT04045574|CAD-CAM system|cad-cam system
24490|NCT04045574|Immediate dental implant loading|immediate dental implant loading
24491|NCT04045574|PICN|picn
24492|NCT04045574|Comparative study|comparative study
24493|NCT04045535|Primary Health Care|primary health care
24494|NCT04045535|Nursing Intervention|nursing intervention
24495|NCT04045535|Physical Activity|physical activity
24496|NCT04045522|triple-negative breast cancer|triple-negative breast cancer
24497|NCT04045522|zoledronic acid|zoledronic acid
24498|NCT04045522|real-world study|real-world study
24499|NCT04045509|corneal sensation|corneal sensation
24500|NCT04045509|subbasal nerve plexus|subbasal nerve plexus
24501|NCT04045496|Src homology phosphatase 2 (SHP2)|src homology phosphatase 2 (shp2)
24502|NCT04045496|PTPN11|ptpn11
24503|NCT04045496|Kirsten rat sarcoma (KRAS) proto-oncogene, GTPase|kirsten rat sarcoma (kras) proto-oncogene, gtpase
24504|NCT04045496|epidermal growth factor receptor (EGFR)|epidermal growth factor receptor (egfr)
24505|NCT04045483|virtual reality|virtual reality
24506|NCT04045470|Cutaneous T Cell Lymphoma|cutaneous t cell lymphoma
24507|NCT04045470|Peripheral T Cell Lymphoma|peripheral t cell lymphoma
24508|NCT04045457|active trigger points|active trigger points
24509|NCT04045444|physical activity|physical activity
24510|NCT04045444|cognitive function|cognitive function
24511|NCT04045444|elderly|elderly
24512|NCT04045444|parkinson|parkinson
24513|NCT04045444|muscle oxygenation|muscle oxygenation
24514|NCT04045444|gait parameters|gait parameters
24515|NCT04045418|meridians|meridians
24516|NCT04045418|acupuncture|acupuncture
24517|NCT04045418|chronic stable angina pectoris|chronic stable angina pectoris
24518|NCT04045418|meridian phenomenon|meridian phenomenon
24519|NCT04045418|laser doppler|laser doppler
24520|NCT04045379|postmenopause|postmenopause
24521|NCT04045379|atrophic vaginitis|atrophic vaginitis
24522|NCT04045379|vulvovaginal atrophy|vulvovaginal atrophy
24523|NCT04045379|treatment|treatment
24524|NCT04045379|LASER|laser
24525|NCT04045379|Radiofrequency|radiofrequency
24526|NCT04045379|estriol|estriol
24527|NCT04045379|strogen therapy|strogen therapy
24528|NCT04045366|Pharmacokinetics|pharmacokinetics
24529|NCT04045366|Echinocandins|echinocandins
24530|NCT04045366|Critically ill patients|critically ill patients
24531|NCT04045353|Low carbohydrate diet|low carbohydrate diet
24533|NCT04045314|Cosmetics|cosmetics
24534|NCT04045314|Dry skin|dry skin
24535|NCT04045301|multi-food OIT|multi-food oit
24536|NCT04045301|oral immunotherapy|oral immunotherapy
24537|NCT04045301|omalizumab|omalizumab
24538|NCT04045301|symptom-driven protocol|symptom-driven protocol
24539|NCT04045301|double-Blind, randomized controlled trial|double-blind, randomized controlled trial
24540|NCT04045288|School Wellness Policy|school wellness policy
24541|NCT04045288|Professional Development|professional development
24542|NCT04045288|Comprehensive School Physical Activity Programs|comprehensive school physical activity programs
24543|NCT04045288|Whole-of-School Intervention|whole-of-school intervention
24544|NCT04045288|Screen Time|screen time
24545|NCT04045288|Physical Activity|physical activity
24546|NCT04045249|Malnutrition|malnutrition
24547|NCT04045249|RUTF|rutf
24548|NCT04045249|Children|children
24549|NCT04045249|Home base food|home base food
24550|NCT04045197|Relaxation|relaxation
24551|NCT04045171|Nephrotic Syndrome|nephrotic syndrome
24552|NCT04045171|Tacrolimus|tacrolimus
24553|NCT04045171|Population Pharmacokinetics|population pharmacokinetics
24554|NCT04045158|diaphragm|diaphragm
24555|NCT04045158|ultrasound|ultrasound
24556|NCT04045158|echocardiography|echocardiography
24557|NCT04045132|Social Media|social media
24558|NCT04045132|Postpartum Depression|postpartum depression
24559|NCT04045132|Parenting|parenting
24560|NCT04045132|Infants|infants
24561|NCT04045132|Mothers|mothers
24562|NCT04045119|CBD|cbd
24563|NCT04045119|Cosmetics|cosmetics
24564|NCT04045119|Acne-prone skin|acne-prone skin
24565|NCT04045119|Oily Skin|oily skin
24566|NCT04045106|Proprioception|proprioception
24567|NCT04045106|Proprioceptive Neuromuscular Facilitation,|proprioceptive neuromuscular facilitation,
24568|NCT04045106|Cervical spine|cervical spine
24569|NCT04045106|stretching|stretching
24570|NCT04045067|Ablation|ablation
24571|NCT04045067|Low voltage areas|low voltage areas
24572|NCT04045041|Provoked vestibulodynia|provoked vestibulodynia
24573|NCT04045041|Exposure treatment|exposure treatment
24581|NCT04045002|dietary iron intake|dietary iron intake
24582|NCT04045002|knowledge level|knowledge level
24583|NCT04045002|Theory of Planned Behavior construct|theory of planned behavior construct
24584|NCT04044989|photobiomodulation|photobiomodulation
24585|NCT04044989|laser|laser
24587|NCT04044989|resorption|resorption
24588|NCT04044989|micro-CT|micro-ct
24589|NCT04044976|Caffeine|caffeine
24590|NCT04044976|delivery room|delivery room
24591|NCT04044976|preterm infant|preterm infant
24592|NCT04044963|Renal transplantation|renal transplantation
24593|NCT04044963|Prehabilitation|prehabilitation
24599|NCT04044911|Activity of daily living|activity of daily living
24600|NCT04044911|Stroke|stroke
24601|NCT04044911|Apraxia|apraxia
24602|NCT04044911|Action of daily living|action of daily living
24603|NCT04044911|Cup of tea|cup of tea
24604|NCT04044898|Acne vulgaris|acne vulgaris
24605|NCT04044885|Nap|nap
24606|NCT04044885|Recovery sleep|recovery sleep
24607|NCT04044885|Cognitive functions|cognitive functions
24608|NCT04044885|Neurobehavioural functions|neurobehavioural functions
24609|NCT04044885|Mood|mood
24610|NCT04044885|Subjective sleepiness|subjective sleepiness
24614|NCT04044859|Cell Therapy|cell therapy
24615|NCT04044859|T Cell Therapy|t cell therapy
24616|NCT04044859|SPEAR T Cell|spear t cell
24617|NCT04044859|MAGE-A4|mage-a4
24618|NCT04044859|Immuno-oncology|immuno-oncology
24619|NCT04044859|Metastatic|metastatic
24620|NCT04044859|Synovial Sarcoma|synovial sarcoma
24621|NCT04044859|Myxoid/Round Cell Liposarcoma (MRCLS)|myxoid/round cell liposarcoma (mrcls)
24622|NCT04044859|Melanoma|melanoma
24623|NCT04044859|Urothelial|urothelial
24624|NCT04044859|Head and Neck|head and neck
24625|NCT04044859|Ovarian|ovarian
24626|NCT04044859|Gastric (stomach)|gastric (stomach)
24627|NCT04044859|Esophagogastric Junction (EGJ)|esophagogastric junction (egj)
24628|NCT04044859|Non-small Cell Lung (NSCLC)|non-small cell lung (nsclc)
24629|NCT04044859|Esophageal Cancer|esophageal cancer
24630|NCT04044794|weight management|weight management
24631|NCT04044794|body weight|body weight
24632|NCT04044794|behavioral|behavioral
24633|NCT04044794|weighing|weighing
24634|NCT04044768|Cell Therapy|cell therapy
24635|NCT04044768|T Cell Therapy|t cell therapy
24636|NCT04044768|SPEAR T Cell|spear t cell
24637|NCT04044716|auricular acupressure|auricular acupressure
24638|NCT04044716|anesthesia|anesthesia
24639|NCT04044651|Hepatocellular Carcinoma|hepatocellular carcinoma
24640|NCT04044651|Lenvatinib|lenvatinib
24641|NCT04044651|Nivolumab|nivolumab
24642|NCT04044651|Hepatitis B virus|hepatitis b virus
24643|NCT04044586|HIV|hiv
24644|NCT04044586|HCV|hcv
24645|NCT04044586|outbreak|outbreak
24646|NCT04044586|prevalence|prevalence
24647|NCT04044573|BPH|bph
24648|NCT04044573|mpMRI|mpmri
24649|NCT04044573|interventional radiology|interventional radiology
24650|NCT04044560|acute lymphoblastic leukemia, blinatumomab, minimal residual disease, stem cell transplant|acute lymphoblastic leukemia, blinatumomab, minimal residual disease, stem cell transplant
24651|NCT04044547|Parkinson disease|parkinson disease
24652|NCT04044547|LY03003|ly03003
24653|NCT04044534|Intranasal insulin|intranasal insulin
24654|NCT04044534|PTSD|ptsd
24655|NCT04044521|implementation|implementation
24656|NCT04044521|primary care|primary care
24657|NCT04044521|organizational change|organizational change
24658|NCT04044521|Centers for Disease Control opioid prescribing guidelines|centers for disease control opioid prescribing guidelines
24659|NCT04044521|clinical guidelines|clinical guidelines
24660|NCT04044521|systems consultation|systems consultation
24661|NCT04044495|Aging|aging
24662|NCT04044495|Sleep/wake Cycle|sleep/wake cycle
24663|NCT04044495|Hippocampal connectivity|hippocampal connectivity
24664|NCT04044495|Hippocampal dependant Memory tests|hippocampal dependant memory tests
24665|NCT04044495|Actigraphy|actigraphy
24666|NCT04044495|Functional and structural MRI|functional and structural mri
24667|NCT04044456|Brain Injury|brain injury
24668|NCT04044456|Cognition|cognition
24669|NCT04044456|Veteran|veteran
24670|NCT04044456|Attention|attention
24671|NCT04044456|Metacognition|metacognition
24672|NCT04044430|BRAFV600E|brafv600e
24673|NCT04044430|Metastatic Colorectal Cancer (mCRC)|metastatic colorectal cancer (mcrc)
24680|NCT04044404|Ultrasound Integrated Precision Diagnosis Technology|ultrasound integrated precision diagnosis technology
24681|NCT04044404|Acute on Chronic Kidney Disease|acute on chronic kidney disease
24682|NCT04044404|Kidney transplantation|kidney transplantation
24683|NCT04044404|kidney fibrosis|kidney fibrosis
24684|NCT04044391|Coronary Artery Disease|coronary artery disease
24685|NCT04044391|Myocardial ischemia|myocardial ischemia
24686|NCT04044378|famitinib|famitinib
24687|NCT04044378|camrelizumab|camrelizumab
24688|NCT04044378|advanced osteosarcoma|advanced osteosarcoma
24689|NCT04044378|recommended phase 2 dose|recommended phase 2 dose
24690|NCT04044378|efficacy|efficacy
24691|NCT04044365|Hematopoietic Stem Cell Transplantation (HSCT)|hematopoietic stem cell transplantation (hsct)
24692|NCT04044365|Allogeneic Stem Cell Transplant|allogeneic stem cell transplant
24693|NCT04044365|Phototherapies|phototherapies
24694|NCT04044365|Graft Vs Host Disease|graft vs host disease
24695|NCT04044352|A/Bethesda/MM2/H1N1 Virus|a/bethesda/mm2/h1n1 virus
24696|NCT04044352|Challenge|challenge
24697|NCT04044352|Dose Escalation|dose escalation
24698|NCT04044352|Healthy Subjects|healthy subjects
24699|NCT04044352|Influenza|influenza
24700|NCT04044352|Live virus|live virus
24701|NCT04044339|TD-5202|td-5202
24702|NCT04044339|0177|0177
24703|NCT04044339|single ascending dose|single ascending dose
24704|NCT04044339|SAD|sad
24705|NCT04044339|multiple ascending dose|multiple ascending dose
24706|NCT04044339|MAD|mad
24707|NCT04044339|first-in-human|first-in-human
24708|NCT04044339|Phase 1|phase 1
24709|NCT04044326|消融|消融
24710|NCT04044313|Hepatocellular Carcinoma|hepatocellular carcinoma
24711|NCT04044313|Hepatic artery infusion chemotherapy|hepatic artery infusion chemotherapy
24712|NCT04044313|Oxaliplatin, 5-Fluorouracil and Leucovorin|oxaliplatin, 5-fluorouracil and leucovorin
24713|NCT04044313|Lenvatinib|lenvatinib
24714|NCT04044313|Toripalimab|toripalimab
24715|NCT04044300|sacral fracture, function, pain|sacral fracture, function, pain
24716|NCT04044261|Emotional Response|emotional response
24717|NCT04044248|Liver cirrhosis|liver cirrhosis
24718|NCT04044248|Portal hypertension|portal hypertension
24719|NCT04044248|Gastric varices|gastric varices
24720|NCT04044248|Bleeding|bleeding
24721|NCT04044248|Hepatic encephalopathy|hepatic encephalopathy
24722|NCT04044248|Transjugular intrahepatic portosystemic shunt (TIPS)|transjugular intrahepatic portosystemic shunt (tips)
24723|NCT04044248|Transvenous obliteration|transvenous obliteration
24724|NCT04044183|Chronic Pain|chronic pain
24725|NCT04044183|Mild Cognitive Impairment|mild cognitive impairment
24726|NCT04044183|Older Adults|older adults
24727|NCT04044183|Physical Activity|physical activity
24728|NCT04044118|gut microbiota|gut microbiota
24729|NCT04044118|calorie restrition dietary intervention|calorie restrition dietary intervention
24730|NCT04044092|Cervical Disc Protrusion|cervical disc protrusion
24731|NCT04044092|ELDOA,|eldoa,
24732|NCT04044092|Neck Pain|neck pain
24733|NCT04044092|Neck Disability|neck disability
24740|NCT04044040|Palliative care|palliative care
24741|NCT04044040|Symptom control|symptom control
24742|NCT04044040|Quality of life|quality of life
24743|NCT04044040|Satisfaction with care|satisfaction with care
24744|NCT04044040|Targeted referral|targeted referral
24745|NCT04044014|Gellan, thermal injury, healthy volunteers, skin|gellan, thermal injury, healthy volunteers, skin
24746|NCT04044001|Tuberculosis, Pulmonary|tuberculosis, pulmonary
24747|NCT04044001|Randomized Controlled Trial (RCT)|randomized controlled trial (rct)
24748|NCT04044001|BTZ-043|btz-043
24749|NCT04044001|Tuberculosis|tuberculosis
24750|NCT04044001|Antitubercular Agents|antitubercular agents
24751|NCT04044001|Gram-positive Bacterial Infections|gram-positive bacterial infections
24752|NCT04044001|Escalating dose|escalating dose
24753|NCT04044001|Drug-sensitive TB|drug-sensitive tb
24754|NCT04044001|Early Bactericidal Activity (EBA)|early bactericidal activity (eba)
24755|NCT04044001|Drug-drug-interaction|drug-drug-interaction
24756|NCT04044001|Pharmacokinetics (PK)|pharmacokinetics (pk)
24757|NCT04044001|Safety|safety
24758|NCT04044001|Tolerability|tolerability
24759|NCT04044001|Bactericidal Activity|bactericidal activity
24760|NCT04043962|chronic pain|chronic pain
24761|NCT04043962|internet intervention|internet intervention
24762|NCT04043962|pain management|pain management
24763|NCT04043962|CBT|cbt
24764|NCT04043962|adolescent|adolescent
24765|NCT04043962|sleep|sleep
24766|NCT04043936|suicide prevention|suicide prevention
24767|NCT04043936|reducing stigma|reducing stigma
24768|NCT04043910|Functional Neuroimaging|functional neuroimaging
24769|NCT04043910|Pediatrics|pediatrics
24771|NCT04043910|Single-sided deafness|single-sided deafness
24772|NCT04043897|Microscopic Colitis|microscopic colitis
24773|NCT04043884|Shoulder rehabilitation|shoulder rehabilitation
24774|NCT04043884|Electromyography|electromyography
24775|NCT04043884|Posture analysis|posture analysis
24776|NCT04043845|Chronic Lymphocytic Leukemia|chronic lymphocytic leukemia
24777|NCT04043845|Waldenstrom Macroglobulinemia|waldenstrom macroglobulinemia
24778|NCT04043845|Mantle Cell Lymphoma|mantle cell lymphoma
24779|NCT04043845|Marginal Zone Lymphoma|marginal zone lymphoma
24780|NCT04043845|CLL|cll
24781|NCT04043845|WM|wm
24782|NCT04043845|MCL|mcl
24783|NCT04043845|MZL|mzl
24784|NCT04043845|ERK|erk
24785|NCT04043845|Ibrutinib|ibrutinib
24786|NCT04043845|BTKCys481|btkcys481
24787|NCT04043845|PLCG2|plcg2
24788|NCT04043845|PLCγ2|plcγ2
24789|NCT04043845|LY3214996|ly3214996
24790|NCT04043819|cellular therapy|cellular therapy
24791|NCT04043819|stromal vascular fraction|stromal vascular fraction
24792|NCT04043819|SVF|svf
24793|NCT04043819|KOOS|koos
24794|NCT04043819|autologous|autologous
24795|NCT04043819|mesenchymal stem cell|mesenchymal stem cell
24796|NCT04043819|MSC|msc
24797|NCT04043819|knee|knee
24798|NCT04043819|osteoarthritis|osteoarthritis
24799|NCT04043819|adipose-derived mesenchymal stem cells|adipose-derived mesenchymal stem cells
24800|NCT04043819|Ad-MSC|ad-msc
24801|NCT04043819|intraarticular|intraarticular
24802|NCT04043793|Immunocompromised Host|immunocompromised host
24803|NCT04043793|Critical care|critical care
24804|NCT04043793|Drug Resistance, Multiple|drug resistance, multiple
24805|NCT04043767|predictors, difficult intubation, pediatric patient|predictors, difficult intubation, pediatric patient
24806|NCT04043741|Dry Needling|dry needling
24807|NCT04043741|Oswestry disability index,|oswestry disability index,
24808|NCT04043741|Paraspinal muscle length|paraspinal muscle length
24809|NCT04043741|Pain pressure threshold|pain pressure threshold
24810|NCT04043728|COPD|copd
24811|NCT04043728|Smoking cessation|smoking cessation
24812|NCT04043728|Nicotine dependence|nicotine dependence
24813|NCT04043728|Tobacco use|tobacco use
24814|NCT04043728|Cigarette smoking|cigarette smoking
24815|NCT04043728|Behavioral treatment|behavioral treatment
24816|NCT04043715|transcutaneous spinal stimulation|transcutaneous spinal stimulation
24817|NCT04043715|epidural spinal stimulation|epidural spinal stimulation
24818|NCT04043715|physical therapy|physical therapy
24819|NCT04043715|lower extremity|lower extremity
24820|NCT04043702|obesity|obesity
24821|NCT04043702|drug combination|drug combination
24822|NCT04043702|empagliflozin(jardiance)|empagliflozin(jardiance)
24823|NCT04043702|topiramate(conviban)|topiramate(conviban)
24824|NCT04043676|Leukemia|leukemia
24825|NCT04043676|BCR-ABL positive|bcr-abl positive
24826|NCT04043676|Myeloide|myeloide
24827|NCT04043676|Philadelphia-positive|philadelphia-positive
24828|NCT04043676|Chronic|chronic
24829|NCT04043663|virtual reality|virtual reality
24830|NCT04043663|pediatric surgery|pediatric surgery
24831|NCT04043650|Physical Activity|physical activity
24832|NCT04043650|Mobile Health|mobile health
24833|NCT04043650|Self Monitoring|self monitoring
24834|NCT04043650|Wearable Sensors|wearable sensors
24835|NCT04043650|Tailored Health Communication|tailored health communication
24836|NCT04043650|Implementation Intentions|implementation intentions
24837|NCT04043650|Mobile Apps|mobile apps
24838|NCT04043650|Anti-Sedentary Behavior|anti-sedentary behavior
24839|NCT04043650|Opportunistic Physical Activity|opportunistic physical activity
24840|NCT04043650|Health Belief Model|health belief model
24841|NCT04043624|single-port thoracoscopic surgery|single-port thoracoscopic surgery
24842|NCT04043624|lidocaine|lidocaine
24843|NCT04043624|postoperative pain|postoperative pain
24844|NCT04043624|opioid|opioid
24845|NCT04043611|Lumbar Disc Protrusion|lumbar disc protrusion
24846|NCT04043611|ELDOA|eldoa
24847|NCT04043611|Oswestry Disability Index|oswestry disability index
24848|NCT04043572|Fetus|fetus
24849|NCT04043572|Neurological Development|neurological development
24850|NCT04043572|Teratogenicity|teratogenicity
24851|NCT04043572|Anti-Epileptic Drugs|anti-epileptic drugs
24852|NCT04043572|Epilepsy|epilepsy
24853|NCT04043507|Heme|heme
24854|NCT04043507|Cardiac|cardiac
24855|NCT04043507|Surgery|surgery
24856|NCT04043481|Perfusion index|perfusion index
24857|NCT04043481|modified Allen's test|modified allen's test
24858|NCT04043468|audit and feedback|audit and feedback
24859|NCT04043468|process indicators|process indicators
24860|NCT04043468|quality|quality
24861|NCT04043455|Abdominal pain|abdominal pain
24862|NCT04043455|Olorinab|olorinab
24863|NCT04043455|APD371|apd371
24988|NCT04042675|parkinson disease|parkinson disease
24864|NCT04043455|IBS-C (predominant constipation)|ibs-c (predominant constipation)
24865|NCT04043455|IBS-D (predominant diarrhea)|ibs-d (predominant diarrhea)
24866|NCT04043455|Irritable bowel syndrome (IBS)|irritable bowel syndrome (ibs)
24867|NCT04043416|Long Term Care|long term care
24868|NCT04043416|Motivating Reminiscence Technology|motivating reminiscence technology
24869|NCT04043416|Feasibility|feasibility
24870|NCT04043390|Xpert MTB/RIF|xpert mtb/rif
24871|NCT04043390|tuberculosis|tuberculosis
24872|NCT04043390|diagnostics|diagnostics
24873|NCT04043390|Xpert Ultra|xpert ultra
24874|NCT04043390|Truenat MTB|truenat mtb
24875|NCT04043390|Truenat MTB RIF|truenat mtb rif
24876|NCT04043390|C Reactive Protein|c reactive protein
24877|NCT04043390|Xpert HIV-1 VL|xpert hiv-1 vl
24878|NCT04043390|Truenat HIV-1 VL|truenat hiv-1 vl
24879|NCT04043390|C Reactive Protein QUBE|c reactive protein qube
24880|NCT04043377|Coronary atherosclerosis|coronary atherosclerosis
24881|NCT04043377|68Ga-DOTATATE|68ga-dotatate
24882|NCT04043377|PET-CTA imaging|pet-cta imaging
24883|NCT04043377|No significant myocardial ischemia|no significant myocardial ischemia
24884|NCT04043364|Learning|learning
24885|NCT04043364|Innovation|innovation
24886|NCT04043364|Volunteers|volunteers
24887|NCT04043364|Empowerment|empowerment
24888|NCT04043299|Intrapartum oxygen administration|intrapartum oxygen administration
24889|NCT04043286|One abutment one time|one abutment one time
24890|NCT04043286|Disconnection reconnection|disconnection reconnection
24891|NCT04043286|Definitive abutment|definitive abutment
24892|NCT04043260|Diabetes Type 1|diabetes type 1
24893|NCT04043260|Multiple Daily Injections|multiple daily injections
24894|NCT04043247|Postoperative Nausea and Vomiting;TEAS|postoperative nausea and vomiting;teas
24895|NCT04043195|NSCLC|nsclc
24896|NCT04043195|Ipilimumab|ipilimumab
24897|NCT04043195|Nivolumab|nivolumab
24898|NCT04043195|Oxaliplatin|oxaliplatin
24899|NCT04043156|spinal cord compression, radiotherapy|spinal cord compression, radiotherapy
24900|NCT04043143|opioids|opioids
24901|NCT04043130|Reproductive and Sexual Health Care Utilization|reproductive and sexual health care utilization
24902|NCT04043117|Dimorphism|dimorphism
24903|NCT04043117|self-esteem|self-esteem
24904|NCT04043117|oncological treatments|oncological treatments
24905|NCT04043091|Type 2 myocardial infarction|type 2 myocardial infarction
24906|NCT04043091|Percutaneous Coronary Intervention|percutaneous coronary intervention
24907|NCT04043091|Critical Illness|critical illness
24908|NCT04043052|Stroke|stroke
24909|NCT04043052|e-health|e-health
24910|NCT04043052|Depression|depression
24911|NCT04043052|Anxiety|anxiety
24912|NCT04043052|Prevention|prevention
24913|NCT04043026|Warfarin|warfarin
24914|NCT04043026|Fibrin clot structure and function|fibrin clot structure and function
24915|NCT04043026|Lipids/lipoproteins|lipids/lipoproteins
24916|NCT04043026|Statin|statin
24917|NCT04043013|ARCH|arch
24918|NCT04043013|TORQUE|torque
24919|NCT04043013|BRACKET|bracket
24920|NCT04043013|PRESCRIPTION|prescription
24921|NCT04043000|Prebiotics|prebiotics
24922|NCT04043000|Probiotics|probiotics
24923|NCT04043000|Microbiota|microbiota
24924|NCT04042948|lumbar spinal stenosis|lumbar spinal stenosis
24925|NCT04042948|lumbar fusion surgery|lumbar fusion surgery
24926|NCT04042948|drainage tube|drainage tube
24927|NCT04042948|removal of drainage tube|removal of drainage tube
24928|NCT04042948|fever|fever
24929|NCT04042948|prevention of fever|prevention of fever
24930|NCT04042948|preventive use of non-steroidal inflammatory drug|preventive use of non-steroidal inflammatory drug
24931|NCT04042922|Alzheimer Disease|alzheimer disease
24932|NCT04042922|Cognitive Impairment|cognitive impairment
24933|NCT04042922|Non-invasive Sensory Stimulation|non-invasive sensory stimulation
24934|NCT04042922|Light and Sound Stimulation|light and sound stimulation
24935|NCT04042922|Gamma|gamma
24936|NCT04042909|brief intervention|brief intervention
24937|NCT04042909|college students|college students
24938|NCT04042896|Aerobic exercise|aerobic exercise
24939|NCT04042896|Exergame|exergame
24940|NCT04042896|cardiorespiratory fitness|cardiorespiratory fitness
24941|NCT04042896|endothelial function|endothelial function
24942|NCT04042896|epicardial fat|epicardial fat
24943|NCT04042883|Perfusion|perfusion
24944|NCT04042870|Breast Cancer|breast cancer
24945|NCT04042870|Yoga|yoga
24946|NCT04042870|Aromatase Inhibitor|aromatase inhibitor
24947|NCT04042870|Arthralgia|arthralgia
24948|NCT04042870|Sukshma Vyayama|sukshma vyayama
24949|NCT04042857|DSO|dso
24950|NCT04042857|toenail|toenail
24951|NCT04042857|onychomycosis|onychomycosis
24952|NCT04042818|Sarcopenia|sarcopenia
24953|NCT04042818|Stroke|stroke
24954|NCT04042818|Quadriceps Muscle Atrophy|quadriceps muscle atrophy
24955|NCT04042818|Hemiplegia|hemiplegia
24956|NCT04042818|Ultrasonography|ultrasonography
24957|NCT04042818|Hand Strength|hand strength
24958|NCT04042792|pharmacokinetics|pharmacokinetics
24959|NCT04042792|pharmacodynamics|pharmacodynamics
24960|NCT04042792|Adalimumab|adalimumab
24961|NCT04042792|methotrexate|methotrexate
24962|NCT04042792|drug-drug interaction|drug-drug interaction
24963|NCT04042792|trough ADA concentration|trough ada concentration
24964|NCT04042792|peak ADA concentration|peak ada concentration
24965|NCT04042792|Pediatric inflammatory rheumatic diseases|pediatric inflammatory rheumatic diseases
24966|NCT04042779|Multiple task training|multiple task training
24967|NCT04042779|Single task training|single task training
24968|NCT04042779|Model-based working memory training|model-based working memory training
24982|NCT04042727|Dexmedetomidine|dexmedetomidine
24983|NCT04042727|Critical Care|critical care
24984|NCT04042727|Atrial Fibrillation|atrial fibrillation
24985|NCT04042701|Human epidermal receptor 2 positive|human epidermal receptor 2 positive
24986|NCT04042701|HER2|her2
24987|NCT04042701|NSCLC|nsclc
24989|NCT04042675|respiratuary muscle strength|respiratuary muscle strength
24990|NCT04042675|physical activity level|physical activity level
24992|NCT04042675|exercise capacity|exercise capacity
24993|NCT04042649|intensive care unit|intensive care unit
24994|NCT04042649|critically ill patients|critically ill patients
24995|NCT04042649|environmental intervention|environmental intervention
24996|NCT04042636|trauma|trauma
24997|NCT04042636|CLABSI|clabsi
24998|NCT04042623|IgAN|igan
24999|NCT04042623|AXL inhibitor|axl inhibitor
25000|NCT04042623|Berger's Disease|berger's disease
25001|NCT04042623|Proteinuria|proteinuria
25002|NCT04042623|Kidney Disease|kidney disease
25003|NCT04042597|chordoma|chordoma
25004|NCT04042597|unresectable|unresectable
25005|NCT04042597|anlotinib|anlotinib
25006|NCT04042597|imatinib|imatinib
25007|NCT04042597|survival|survival
25008|NCT04042597|quality of life|quality of life
25009|NCT04042584|Stroke|stroke
25010|NCT04042584|Mechanical thrombectomy|mechanical thrombectomy
25011|NCT04042584|Tele-evaluation|tele-evaluation
25012|NCT04042584|Emergency medical service|emergency medical service
25013|NCT04042584|Pre hospital|pre hospital
25014|NCT04042571|Intracranial oxymetry|intracranial oxymetry
25015|NCT04042571|Subarachnoid Hemorrhage|subarachnoid hemorrhage
25016|NCT04042571|Vasospasm|vasospasm
25017|NCT04042532|Young-onset dementia|young-onset dementia
25018|NCT04042532|Alzheimer's disease|alzheimer's disease
25019|NCT04042532|rTMS|rtms
25020|NCT04042532|TBS|tbs
25021|NCT04042519|Metabolomics|metabolomics
25022|NCT04042519|Omega 6|omega 6
25023|NCT04042519|Omega 3|omega 3
25024|NCT04042519|COPD|copd
25025|NCT04042519|lung function tests|lung function tests
25029|NCT04042493|Overweight|overweight
25030|NCT04042493|Obesity|obesity
25031|NCT04042493|Pediatric|pediatric
25032|NCT04042493|Implementation|implementation
25033|NCT04042493|Dissemination|dissemination
25035|NCT04042428|Somatropin|somatropin
25036|NCT04042428|Growth hormone|growth hormone
25037|NCT04042428|Anti-doping control|anti-doping control
25038|NCT04042428|Athletic performance|athletic performance
25039|NCT04042415|Multiple Sclerosis|multiple sclerosis
25040|NCT04042415|Immuno-metabolism|immuno-metabolism
25041|NCT04042415|Calorie restriction|calorie restriction
25042|NCT04042415|Treg cells|treg cells
25043|NCT04042415|Inflammation|inflammation
25044|NCT04042402|Primary Hyperoxaluria|primary hyperoxaluria
25045|NCT04042402|PH1|ph1
25046|NCT04042402|PH2|ph2
25047|NCT04042402|RNAi|rnai
25048|NCT04042402|GalNAc|galnac
25049|NCT04042402|LDHA|ldha
25050|NCT04042402|LDH|ldh
25051|NCT04042402|siRNA|sirna
25052|NCT04042389|WhatsApp|whatsapp
25053|NCT04042389|Email|email
25054|NCT04042389|Oral hygiene|oral hygiene
25055|NCT04042389|Compliance|compliance
25056|NCT04042389|Orthodontics|orthodontics
25057|NCT04042389|Planimetry|planimetry
25058|NCT04042389|Reminders|reminders
25059|NCT04042363|multiple sclerosis|multiple sclerosis
25060|NCT04042363|optic neuritis|optic neuritis
25061|NCT04042363|transorbital stimulation|transorbital stimulation
25062|NCT04042363|remyelination|remyelination
25063|NCT04042363|nervous system disease|nervous system disease
25064|NCT04042363|peripheral nervous system disease|peripheral nervous system disease
25065|NCT04042363|optic nerve disease|optic nerve disease
25066|NCT04042363|adaptive optic|adaptive optic
25067|NCT04042350|AURORA|aurora
25068|NCT04042350|Cardiovascular Events|cardiovascular events
25069|NCT04042350|Chronic Kidney Disease|chronic kidney disease
25070|NCT04042311|Exercise|exercise
25071|NCT04042311|High-intensity interval training|high-intensity interval training
25072|NCT04042311|interval training|interval training
25073|NCT04042285|Diabetic Foot Wound|diabetic foot wound
25074|NCT04042272|kidney transplantation|kidney transplantation
25075|NCT04042272|s100β|s100β
25076|NCT04042272|neuron specific enolase|neuron specific enolase
25077|NCT04042272|glial fibrillary acidic protein|glial fibrillary acidic protein
25078|NCT04042233|total hip arthroplasty|total hip arthroplasty
25079|NCT04042233|vancomycin|vancomycin
25080|NCT04042233|intraosseous vancomycin|intraosseous vancomycin
25081|NCT04042207|Artificial pancreas|artificial pancreas
25082|NCT04042207|Very Unstable Type 1 diabetes|very unstable type 1 diabetes
25083|NCT04042194|clinical research|clinical research
25084|NCT04042194|Implant|implant
25085|NCT04042194|Implantology|implantology
25086|NCT04042194|Prospective|prospective
25087|NCT04042194|Randomized controlled trial|randomized controlled trial
25088|NCT04042194|Soft Tissue Grafting|soft tissue grafting
25089|NCT04042194|Single-Tooth Implants|single-tooth implants
25090|NCT04042168|COPD|copd
25091|NCT04042168|Inhalers|inhalers
25092|NCT04042155|dabigatran|dabigatran
25093|NCT04042155|rivaroxaban|rivaroxaban
25094|NCT04042155|apixaban|apixaban
25095|NCT04042155|edoxaban|edoxaban
25096|NCT04042116|lucitanib|lucitanib
25097|NCT04042116|nivolumab|nivolumab
25098|NCT04042116|antineoplastic agents immunological|antineoplastic agents immunological
25099|NCT04042116|antineoplastic agents|antineoplastic agents
25100|NCT04042116|tyrosine kinase inhibitors|tyrosine kinase inhibitors
25101|NCT04042116|gynecologic neoplasms|gynecologic neoplasms
25102|NCT04042116|checkpoint inhibitor|checkpoint inhibitor
25103|NCT04042090|Virtual reality|virtual reality
25104|NCT04042090|Quality of life|quality of life
25105|NCT04042090|Back pain|back pain
25106|NCT04042077|Infection, Surgical Infection|infection, surgical infection
25108|NCT04042064|Anesthesia for the elderly|anesthesia for the elderly
25109|NCT04042051|HER2|her2
25110|NCT04042051|HER2-positive|her2-positive
25111|NCT04042051|Metastatic|metastatic
25112|NCT04042051|Breast|breast
25113|NCT04042051|Cancer|cancer
25114|NCT04042038|Obsessive compulsive disorder|obsessive compulsive disorder
25115|NCT04042038|Intensive cognitive-behavioral therapy|intensive cognitive-behavioral therapy
25116|NCT04042038|Neuroimaging|neuroimaging
25117|NCT04042038|Response prediction|response prediction
25118|NCT04042038|Response mechanisms|response mechanisms
25119|NCT04042038|Functional magnetic resonance imaging|functional magnetic resonance imaging
25120|NCT04042025|Gene replacement|gene replacement
25121|NCT04041999|Occupational therapy|occupational therapy
25122|NCT04041999|cognition|cognition
25123|NCT04041999|rehabilitation|rehabilitation
25124|NCT04041986|stroke|stroke
25125|NCT04041986|non-invasive brain stimulation|non-invasive brain stimulation
25126|NCT04041986|transcranial direct current stimulation (tDCS)|transcranial direct current stimulation (tdcs)
25127|NCT04041947|Delirium|delirium
25128|NCT04041947|Pediatric intensive care|pediatric intensive care
25129|NCT04041934|sleep|sleep
25130|NCT04041934|adolescent|adolescent
35007|NCT03982992|MRD|mrd
25131|NCT04041934|tryptophan|tryptophan
25132|NCT04041934|athletes|athletes
25133|NCT04041934|obeses|obeses
25135|NCT04041921|PCI|pci
25136|NCT04041921|CABG|cabg
25137|NCT04041921|Medical treatment|medical treatment
25138|NCT04041921|Decision CTO|decision cto
25139|NCT04041895|Alzheimer's Disease|alzheimer's disease
25140|NCT04041895|Dementia|dementia
25141|NCT04041895|Linguistics|linguistics
25142|NCT04041869|Older adults|older adults
25143|NCT04041869|Walking|walking
25144|NCT04041869|Fitbit|fitbit
25145|NCT04041830|Appetite|appetite
25146|NCT04041830|Food Reward|food reward
25147|NCT04041830|Methodological approach|methodological approach
25148|NCT04041817|ICU|icu
25149|NCT04041817|Pressure support ventilation|pressure support ventilation
25150|NCT04041817|Spontaneous breathing|spontaneous breathing
25151|NCT04041817|Trigger|trigger
25152|NCT04041817|Weaning of mechanical ventilation|weaning of mechanical ventilation
25153|NCT04041804|Palatal Expansion Technique|palatal expansion technique
25154|NCT04041804|Cone-Beam Computed Tomography|cone-beam computed tomography
25155|NCT04041791|severe pneumonia|severe pneumonia
25156|NCT04041791|supportive care|supportive care
25157|NCT04041791|antibiotics|antibiotics
25158|NCT04041791|World Health Organisation|world health organisation
25159|NCT04041791|intravenous fluids|intravenous fluids
25160|NCT04041791|nutrition|nutrition
25161|NCT04041791|children|children
25162|NCT04041765|IgM-enriched Intravenous Immunoglobulin|igm-enriched intravenous immunoglobulin
25163|NCT04041752|Meal texture|meal texture
25164|NCT04041752|Appetite|appetite
25165|NCT04041752|Energy compensation|energy compensation
25166|NCT04041752|Food reward|food reward
25167|NCT04041739|fungal infection|fungal infection
25168|NCT04041713|Rett Syndrome|rett syndrome
25169|NCT04041713|Rett|rett
25170|NCT04041713|RTT|rtt
25171|NCT04041700|Hearing Loss, Conductive|hearing loss, conductive
25172|NCT04041700|Hearing Loss, Mixed|hearing loss, mixed
25173|NCT04041700|Deafness, sensorineural single-sided|deafness, sensorineural single-sided
25174|NCT04041687|induction|induction
25175|NCT04041661|Dual task performance|dual task performance
25176|NCT04041661|Executive function|executive function
25177|NCT04041661|Transcrainal direct current stimulation (tDCS)|transcrainal direct current stimulation (tdcs)
25178|NCT04041635|Pain|pain
25179|NCT04041635|Premature|premature
25180|NCT04041635|Visual stimuli|visual stimuli
25181|NCT04041635|Auditory stimuli|auditory stimuli
25182|NCT04041622|Prevalence|prevalence
25183|NCT04041622|General population|general population
25184|NCT04041622|Diagnosis|diagnosis
25185|NCT04041622|Prognosis|prognosis
25186|NCT04041622|Etiology|etiology
25187|NCT04041622|Genes|genes
25188|NCT04041570|Ebola virus|ebola virus
25189|NCT04041570|Ebola vaccine|ebola vaccine
25190|NCT04041570|cAd3-EBO S|cad3-ebo s
25191|NCT04041518|Autotransplantation|autotransplantation
25192|NCT04041518|extraoral apicoectomy|extraoral apicoectomy
25193|NCT04041518|revascularization|revascularization
25194|NCT04041505|responsive feeding|responsive feeding
25195|NCT04041505|expressing/pumping human milk|expressing/pumping human milk
25196|NCT04041492|diabetes|diabetes
25197|NCT04041492|osteocalcin|osteocalcin
25198|NCT04041492|insulin|insulin
25199|NCT04041466|Atrial Fibrillation|atrial fibrillation
25200|NCT04041466|Arrhythmias, Cardiac|arrhythmias, cardiac
25201|NCT04041466|Cardiovascular diseases|cardiovascular diseases
25202|NCT04041466|Heart diseases|heart diseases
25203|NCT04041466|Wearable Electronic Devices|wearable electronic devices
25204|NCT04041466|Electrocardiography|electrocardiography
25205|NCT04041453|TRICHURIS|trichuris
25206|NCT04041453|STH|sth
25207|NCT04041453|IVERMECTIN|ivermectin
25208|NCT04041453|ALBENDAZOLE|albendazole
25209|NCT04041440|Auditory training|auditory training
25210|NCT04041440|Children with hearing loss|children with hearing loss
25211|NCT04041401|paediatric intensive care unit|paediatric intensive care unit
25212|NCT04041401|intervention|intervention
25213|NCT04041401|PTSD|ptsd
25214|NCT04041401|storybook|storybook
25215|NCT04041401|Narrative|narrative
25216|NCT04041401|Feasibility|feasibility
25217|NCT04041401|Case-series|case-series
25218|NCT04041388|Transpalatal|transpalatal
25219|NCT04041388|Maxillary expansion|maxillary expansion
25220|NCT04041388|Tooth-borne|tooth-borne
25221|NCT04041388|Bone-borne|bone-borne
25222|NCT04041388|Distractor|distractor
25223|NCT04041388|Tipping|tipping
25224|NCT04041388|Osteotomy height|osteotomy height
25225|NCT04041375|peer support|peer support
25226|NCT04041375|mental health|mental health
25227|NCT04041375|diabetes self-management|diabetes self-management
25228|NCT04041375|community-based participatory research|community-based participatory research
25229|NCT04041362|HIV|hiv
25230|NCT04041362|UB-421|ub-421
25231|NCT04041349|Cerebral Small Vessel Diseases|cerebral small vessel diseases
25232|NCT04041349|Mouse Nerve Growth Factor|mouse nerve growth factor
35085|NCT03982433|HIV|hiv
25233|NCT04041349|cognitive impairment|cognitive impairment
25234|NCT04041336|Older|older
25235|NCT04041336|Hip fracture surgery|hip fracture surgery
25236|NCT04041336|Optical coherence tomography|optical coherence tomography
25237|NCT04041323|AKI|aki
25238|NCT04041323|KDIGO|kdigo
25239|NCT04041323|ICU|icu
25240|NCT04041323|postoperative|postoperative
25241|NCT04041297|Non Small Cell Lung Cancer|non small cell lung cancer
25242|NCT04041297|Preoperative training|preoperative training
25243|NCT04041297|Prehabilitation|prehabilitation
25244|NCT04041297|oxygen-uptake kinetics|oxygen-uptake kinetics
25245|NCT04041271|Temporomandibular disorder|temporomandibular disorder
25246|NCT04041271|Nonspecific chronic neck pain|nonspecific chronic neck pain
25247|NCT04041271|Jaw kinematics|jaw kinematics
25248|NCT04041271|Muscle activity|muscle activity
25249|NCT04041271|Muscle sensitivity|muscle sensitivity
25250|NCT04041271|Forward head|forward head
25251|NCT04041258|pseudoarthrosis|pseudoarthrosis
25252|NCT04041258|clavicle|clavicle
25253|NCT04041245|meridians|meridians
25254|NCT04041245|acupuncture|acupuncture
25255|NCT04041245|chronic stable angina pectoris|chronic stable angina pectoris
25256|NCT04041245|meridian phenomenon|meridian phenomenon
25257|NCT04041245|near infrared spectroscopy|near infrared spectroscopy
25258|NCT04041232|achromatopsia|achromatopsia
25259|NCT04041232|PBA|pba
25260|NCT04041232|ATF6|atf6
25261|NCT04041232|color blindness|color blindness
25262|NCT04041206|meridians|meridians
25263|NCT04041206|acupuncture|acupuncture
25264|NCT04041206|chronic stable angina pectoris|chronic stable angina pectoris
25265|NCT04041206|meridian phenomenon|meridian phenomenon
25266|NCT04041206|laser doppler|laser doppler
25267|NCT04041180|Sickle cell disease|sickle cell disease
25268|NCT04041180|incentive spirometry|incentive spirometry
25269|NCT04041180|pain|pain
25270|NCT04041180|children|children
25271|NCT04041167|Reperfusion|reperfusion
25272|NCT04041167|Lipoic acid|lipoic acid
25273|NCT04041167|Stroke|stroke
25274|NCT04041141|tongue tumor|tongue tumor
25275|NCT04041141|tongue cancer|tongue cancer
25276|NCT04041141|oral cancer|oral cancer
25277|NCT04041115|cirrhosis|cirrhosis
25278|NCT04041115|nutrition|nutrition
25279|NCT04041115|sarcopenia|sarcopenia
25280|NCT04041115|non-alcoholic beer|non-alcoholic beer
25281|NCT04041102|GM1|gm1
25282|NCT04041102|GM1 gangliosidosis|gm1 gangliosidosis
25283|NCT04041102|GM1 Type 1|gm1 type 1
25284|NCT04041102|GM1 Type 2|gm1 type 2
25285|NCT04041102|GM1 gangliosidosis Type 1|gm1 gangliosidosis type 1
25286|NCT04041102|GM1 gangliosidosis Type 2|gm1 gangliosidosis type 2
25287|NCT04041102|GM1 natural history study|gm1 natural history study
25288|NCT04041102|GM1 gangliosidosis natural history study|gm1 gangliosidosis natural history study
25289|NCT04041102|Lysosomal Storage Disorders|lysosomal storage disorders
25290|NCT04041102|Lysosomal Disorders|lysosomal disorders
25291|NCT04041076|preoperative parameters|preoperative parameters
25292|NCT04041076|risk prediction|risk prediction
25293|NCT04041076|postoperative mortality|postoperative mortality
25294|NCT04041076|elective major general surgery|elective major general surgery
25295|NCT04041063|robotics, hand function|robotics, hand function
25296|NCT04041050|Myeloproliferative Neoplasm (MPN)|myeloproliferative neoplasm (mpn)
25297|NCT04041050|Polycythemia Vera (PV)|polycythemia vera (pv)
25298|NCT04041050|Essential Thrombocythemia (ET)|essential thrombocythemia (et)
25299|NCT04041050|Myelofibrosis (MF)|myelofibrosis (mf)
25301|NCT04041050|navitoclax|navitoclax
25302|NCT04041050|ruxolitinib|ruxolitinib
25303|NCT04041037|ACell|acell
25304|NCT04041037|ACell MicroMatrix®|acell micromatrix®
25305|NCT04041037|ACell Cytal® Wound Matrix|acell cytal® wound matrix
25306|NCT04041037|Urinary Bladder Matrix|urinary bladder matrix
25307|NCT04041024|computational psychiatry|computational psychiatry
25308|NCT04041024|decision making|decision making
25309|NCT04041024|risk|risk
25310|NCT04041024|food|food
25311|NCT04041024|monetary|monetary
25312|NCT04041024|eating disorder|eating disorder
25313|NCT04040998|schizophrenia|schizophrenia
25314|NCT04040998|compensatory cognitive training|compensatory cognitive training
25315|NCT04040998|generalized estimating equation|generalized estimating equation
25316|NCT04040998|psychosocial correlates|psychosocial correlates
25317|NCT04040998|self-stigma|self-stigma
25318|NCT04040985|Legion Primary|legion primary
25319|NCT04040985|TKA|tka
25320|NCT04040985|Osteoarthritis of Knee|osteoarthritis of knee
25321|NCT04040959|stiffness|stiffness
25322|NCT04040959|chronic kidney disease|chronic kidney disease
25323|NCT04040959|Hypertension|hypertension
25324|NCT04040920|Ozone|ozone
25325|NCT04040920|Pits and fissures sealants|pits and fissures sealants
25326|NCT04040920|Prevention|prevention
25327|NCT04040894|Proptosis|proptosis
25328|NCT04040894|Human monoclonal antibody|human monoclonal antibody
25329|NCT04040894|insulin-like growth factor-1 receptor|insulin-like growth factor-1 receptor
25330|NCT04040894|Thyroid-Associated Ophthalmopathy|thyroid-associated ophthalmopathy
35216|NCT03981497|MWA|mwa
25331|NCT04040894|Hyperthyroidism|hyperthyroidism
25332|NCT04040894|Autoimmune Thyroid Disease|autoimmune thyroid disease
25333|NCT04040881|Older adults|older adults
25334|NCT04040881|Smartphones|smartphones
25335|NCT04040881|eHealth|ehealth
25336|NCT04040881|mHealth|mhealth
25337|NCT04040881|Remote monitoring|remote monitoring
25338|NCT04040855|medication reviews, elderly, primary care|medication reviews, elderly, primary care
25339|NCT04040842|Rectal cancer|rectal cancer
25340|NCT04040842|low anterior resection|low anterior resection
25341|NCT04040842|low anterior resection syndrome|low anterior resection syndrome
25342|NCT04040829|Cognitive remediation therapy|cognitive remediation therapy
25343|NCT04040829|Supported education|supported education
25344|NCT04040829|Academic functioning|academic functioning
25345|NCT04040829|Schizophrenia|schizophrenia
25346|NCT04040829|Cognition|cognition
25347|NCT04040829|Photovoice|photovoice
25348|NCT04040829|Mixed qualitative and quantitative methodology|mixed qualitative and quantitative methodology
25349|NCT04040803|transcranial alternating current stimulation|transcranial alternating current stimulation
25350|NCT04040803|transcranial random noise stimulation|transcranial random noise stimulation
25351|NCT04040803|frequency|frequency
25352|NCT04040803|full spectrum|full spectrum
25353|NCT04040790|visual acuity|visual acuity
25354|NCT04040790|contrast sensitivity|contrast sensitivity
25355|NCT04040790|scleral contact lens|scleral contact lens
25356|NCT04040790|artificial iris|artificial iris
25357|NCT04040777|Subclinical Atherosclerosis|subclinical atherosclerosis
25358|NCT04040777|Metabolic Syndrome|metabolic syndrome
25359|NCT04040777|Primary Prevention|primary prevention
25360|NCT04040764|Knee replacement|knee replacement
25361|NCT04040751|Telehealth|telehealth
25362|NCT04040751|Rehabilitation|rehabilitation
25363|NCT04040751|Care partner|care partner
25364|NCT04040751|Sub-acute stroke|sub-acute stroke
25365|NCT04040751|CARE-CITE|care-cite
25366|NCT04040751|Stroke survivors|stroke survivors
25367|NCT04040725|Bladder Cancer|bladder cancer
25368|NCT04040712|fecal microbiota transplantation|fecal microbiota transplantation
25369|NCT04040712|microbiota|microbiota
25370|NCT04040712|chemotherapy|chemotherapy
25371|NCT04040712|diarrhea|diarrhea
25372|NCT04040712|renal cell carcinoma|renal cell carcinoma
25373|NCT04040699|KN026|kn026
25374|NCT04040699|KN046|kn046
25375|NCT04040699|HER2 Positive Solid Tumor|her2 positive solid tumor
25376|NCT04040686|HER2|her2
25377|NCT04040686|single domain antibody (sdAb)|single domain antibody (sdab)
25378|NCT04040686|SPECT/CT imaging|spect/ct imaging
25379|NCT04040673|cancer|cancer
25380|NCT04040673|Raman|raman
25381|NCT04040673|thyroid|thyroid
25382|NCT04040621|nosocomial pneumonia, NP|nosocomial pneumonia, np
25383|NCT04040608|visual analog scale|visual analog scale
25384|NCT04040608|stress|stress
25385|NCT04040595|Type 2 diabetes|type 2 diabetes
25386|NCT04040595|adipocyte|adipocyte
25387|NCT04040595|adipocyte tissue dysfunction|adipocyte tissue dysfunction
25388|NCT04040595|adiposity|adiposity
25389|NCT04040595|favourable adiposity|favourable adiposity
25390|NCT04040595|gene expression|gene expression
25391|NCT04040595|adipose tissue|adipose tissue
25392|NCT04040582|Psychedelics, Wellness|psychedelics, wellness
25393|NCT04040530|Renal Cell Carcinoma|renal cell carcinoma
25394|NCT04040530|Nephron sparing treatment|nephron sparing treatment
25395|NCT04040530|Quality of life|quality of life
25396|NCT04040530|Patient Reported Outcome Measures|patient reported outcome measures
25397|NCT04040530|Kidney Neoplasms|kidney neoplasms
25398|NCT04040530|Cryosurgery|cryosurgery
25399|NCT04040517|Hearing Loss|hearing loss
25400|NCT04040491|PD-1|pd-1
25401|NCT04040491|chidamide|chidamide
25402|NCT04040491|lenalidomide|lenalidomide
25403|NCT04040491|etoposide|etoposide
25404|NCT04040491|Peripheral T-cell Lymphoma|peripheral t-cell lymphoma
25405|NCT04040452|pain control|pain control
25406|NCT04040452|cardiac surgery|cardiac surgery
25407|NCT04040452|pediatric|pediatric
25408|NCT04040452|opioid|opioid
25409|NCT04040452|NSAID|nsaid
25410|NCT04040452|congenital heart disease|congenital heart disease
25411|NCT04040439|Precedex;|precedex;
25412|NCT04040439|Dexmedetomidine Hydrochloride;|dexmedetomidine hydrochloride;
25413|NCT04040439|Sedation;|sedation;
25414|NCT04040439|intensive care;|intensive care;
25415|NCT04040439|pediatric|pediatric
25416|NCT04040426|Theraskin|theraskin
25417|NCT04040426|Skin Graft|skin graft
25418|NCT04040426|DFU|dfu
25419|NCT04040426|Ulcer|ulcer
25420|NCT04040387|PTSD|ptsd
25421|NCT04040387|Nightmare|nightmare
25422|NCT04040387|Nightmare Disorder|nightmare disorder
25423|NCT04040387|Post-traumatic stress disorder|post-traumatic stress disorder
25424|NCT04040387|Veteran|veteran
25425|NCT04040387|Digital therapeutic|digital therapeutic
25426|NCT04040387|Digital medicine|digital medicine
25427|NCT04040374|artificial intelligence|artificial intelligence
25428|NCT04040374|gastric cancer|gastric cancer
25429|NCT04040348|Dementia|dementia
25430|NCT04040348|Stem cells|stem cells
25431|NCT04040348|Alzheimer's Disease|alzheimer's disease
25432|NCT04040335|overweight|overweight
25433|NCT04040335|physical activity|physical activity
25434|NCT04040335|sedentary|sedentary
25435|NCT04040335|hispanic men|hispanic men
25436|NCT04040322|systemic sclerosis|systemic sclerosis
25437|NCT04040322|raynaud's phenomenon|raynaud's phenomenon
25438|NCT04040283|Growth factors|growth factors
25439|NCT04040283|Meniscal injury|meniscal injury
25440|NCT04040270|Family well-being|family well-being
25441|NCT04040270|Healthy Eating|healthy eating
25442|NCT04040270|Physical activity|physical activity
25443|NCT04040231|Mesothelioma|mesothelioma
25444|NCT04040231|Pleural Mesothelioma|pleural mesothelioma
25445|NCT04040231|Wilms Tumor Protein 1|wilms tumor protein 1
25446|NCT04040231|WT1|wt1
25447|NCT04040231|galinpepimut-S|galinpepimut-s
25448|NCT04040231|Montanide|montanide
25449|NCT04040231|Nivolumab|nivolumab
25450|NCT04040231|Phase I|phase i
25451|NCT04040231|17-654|17-654
25452|NCT04040231|Memorial Sloan Kettering Cancer Center|memorial sloan kettering cancer center
25453|NCT04040218|dry needling|dry needling
25454|NCT04040218|physical therapy|physical therapy
25455|NCT04040205|Rb|rb
25456|NCT04040205|Retinoblastoma|retinoblastoma
25457|NCT04040205|Chondrosarcoma|chondrosarcoma
25458|NCT04040205|Osteosarcoma|osteosarcoma
25459|NCT04040205|Soft Tissue Sarcoma|soft tissue sarcoma
25460|NCT04040192|Eczema|eczema
25461|NCT04040192|Crisaborole|crisaborole
25462|NCT04040153|Substance|substance
25463|NCT04040153|Alcohol|alcohol
25464|NCT04040153|Tobacco|tobacco
25465|NCT04040153|E-cigarette|e-cigarette
25466|NCT04040153|Marijuana|marijuana
25467|NCT04040153|Adolescent|adolescent
25468|NCT04040140|Auricular Point Acupressure|auricular point acupressure
25469|NCT04040140|Cancer-related Pain|cancer-related pain
25470|NCT04040140|Acupressure|acupressure
25471|NCT04040140|Nursing education|nursing education
25472|NCT04040127|Pulpal regeneration|pulpal regeneration
25473|NCT04040127|Stem cells|stem cells
25474|NCT04040127|Residual Pulpal Tissue|residual pulpal tissue
25475|NCT04040127|Irreversible Pulpitis|irreversible pulpitis
25476|NCT04040114|Artificial Intelligence|artificial intelligence
25477|NCT04040114|Surveillance|surveillance
25478|NCT04040114|Melanoma|melanoma
25479|NCT04040114|Skin Cancer|skin cancer
25480|NCT04040114|photography|photography
25481|NCT04040049|Gene Therapy|gene therapy
25482|NCT04040036|blood draw|blood draw
25483|NCT04040023|Red Blood Cell transfusion|red blood cell transfusion
25484|NCT04040023|Anemia|anemia
25485|NCT04040023|Iron deficiency|iron deficiency
25486|NCT04040023|Extracorporeal circulation|extracorporeal circulation
25487|NCT04040023|Cardiac Surgery|cardiac surgery
25488|NCT04040010|bone metabolism|bone metabolism
25489|NCT04040010|Postmenopausal women|postmenopausal women
25490|NCT04040010|bone markers|bone markers
25491|NCT04040010|bovine colostrum|bovine colostrum
25492|NCT04040010|DXA|dxa
25493|NCT04039997|cardiopulmonary resuscitation|cardiopulmonary resuscitation
25494|NCT04039997|medical simulation|medical simulation
25495|NCT04039997|basic life support|basic life support
25496|NCT04039997|chest compression|chest compression
25497|NCT04039997|feedback device|feedback device
25498|NCT04039984|radiostereometric analysis|radiostereometric analysis
25499|NCT04039984|implant migration|implant migration
25500|NCT04039984|total hip replacement|total hip replacement
25501|NCT04039984|arthroplasty|arthroplasty
25502|NCT04039971|ACL|acl
25503|NCT04039971|ACL Tear|acl tear
25504|NCT04039971|ACL Injury|acl injury
25505|NCT04039971|ACL Rupture|acl rupture
25506|NCT04039971|Anterior Cruciate Ligament Tear|anterior cruciate ligament tear
25507|NCT04039971|Anterior Cruciate Ligament Rupture|anterior cruciate ligament rupture
25508|NCT04039971|Anterior Cruciate Ligament Injuries|anterior cruciate ligament injuries
25509|NCT04039971|Anterior Cruciate Ligament|anterior cruciate ligament
25510|NCT04039971|ACL Repair|acl repair
25511|NCT04039971|ACL Reconstruction|acl reconstruction
25512|NCT04039971|ACL Surgery|acl surgery
25513|NCT04039971|Anterior Cruciate Ligament Repair|anterior cruciate ligament repair
25514|NCT04039971|Anterior Cruciate Ligament Reconstruction|anterior cruciate ligament reconstruction
25515|NCT04039971|Anterior Cruciate Ligament Surgery|anterior cruciate ligament surgery
25516|NCT04039945|Fr1da|fr1da
25517|NCT04039945|Fr1da-Plus|fr1da-plus
25518|NCT04039945|type 1 diabetes|type 1 diabetes
25519|NCT04039945|islet autoantibodies|islet autoantibodies
25520|NCT04039919|Ethanol|ethanol
25521|NCT04039919|Cannabidiol|cannabidiol
25522|NCT04039919|Padsevonil|padsevonil
25523|NCT04039906|Efficiency,Usability,Safety|efficiency,usability,safety
25524|NCT04039893|axillary node clearance|axillary node clearance
25525|NCT04039893|axillary ultrasound imaging|axillary ultrasound imaging
25526|NCT04039893|sentinel node|sentinel node
25527|NCT04039893|tumor load|tumor load
25528|NCT04039867|Carcinoma, Transitional Cell|carcinoma, transitional cell
400496|NCT01866618|IVF Cycle|ivf cycle
35414|NCT03980340|Sleep|sleep
25529|NCT04039867|Bladder Cancer|bladder cancer
25530|NCT04039867|oxaliplatin|oxaliplatin
25531|NCT04039867|Gemcitabine|gemcitabine
25532|NCT04039854|Anaesthesia|anaesthesia
25533|NCT04039854|Coronary Artery Bypass Surgery|coronary artery bypass surgery
25534|NCT04039854|Cardioprotection|cardioprotection
25535|NCT04039828|Diarrhea|diarrhea
25536|NCT04039828|3 to 59 months children|3 to 59 months children
25537|NCT04039828|Zinc tablet|zinc tablet
25538|NCT04039828|acceptability|acceptability
25539|NCT04039828|adherence|adherence
25540|NCT04039828|palatability|palatability
25541|NCT04039802|Single-stage surgery|single-stage surgery
25542|NCT04039802|Bone conduction devices|bone conduction devices
25543|NCT04039802|Pediatric population|pediatric population
25544|NCT04039802|Implant loss|implant loss
25545|NCT04039789|Varicose ulcer|varicose ulcer
25546|NCT04039789|Exercise|exercise
25547|NCT04039789|Nurses|nurses
25548|NCT04039789|Healthy Aging|healthy aging
25549|NCT04039776|CT|ct
25550|NCT04039763|Type 1 Diabetes Mellitus|type 1 diabetes mellitus
25551|NCT04039737|Qingpeng Ointment|qingpeng ointment
25552|NCT04039737|Shoulder Syndrome|shoulder syndrome
25553|NCT04039737|Rehabilitation Period of Cerebral Hemorrhage|rehabilitation period of cerebral hemorrhage
25554|NCT04039711|Vaginal self-sampling|vaginal self-sampling
25555|NCT04039711|STI|sti
25556|NCT04039711|Genital infection|genital infection
25557|NCT04039711|Group B streptococcus|group b streptococcus
25558|NCT04039698|Hepatitis C|hepatitis c
25559|NCT04039698|Telemedicine|telemedicine
25560|NCT04039698|Direct acting antivirals|direct acting antivirals
25561|NCT04039698|Public Health|public health
25562|NCT04039685|uncoupling protein 1|uncoupling protein 1
25563|NCT04039685|uncoupling protein one|uncoupling protein one
25564|NCT04039685|resistance exercise|resistance exercise
25565|NCT04039685|aerobic exercise|aerobic exercise
25566|NCT04039685|browning formation|browning formation
25567|NCT04039685|white fat|white fat
25568|NCT04039672|Melanoma|melanoma
25569|NCT04039672|Avian embryo|avian embryo
25570|NCT04039659|wound complications|wound complications
25571|NCT04039659|negative-pressure wound therapy|negative-pressure wound therapy
25572|NCT04039646|Perforated peptic ulcer|perforated peptic ulcer
25573|NCT04039646|Enhanced recovery after surgery|enhanced recovery after surgery
25574|NCT04039646|Laparoscopic repair|laparoscopic repair
25575|NCT04039646|Complications|complications
25576|NCT04039633|Spinal Cord Stimulation|spinal cord stimulation
25577|NCT04039620|Sarcopenia|sarcopenia
25578|NCT04039620|Malnutrition|malnutrition
25579|NCT04039620|EWGSOP2|ewgsop2
25580|NCT04039620|Older people|older people
25582|NCT04039620|Hospitalized|hospitalized
25583|NCT04039594|extracorporeal life support, extracorporeal membrane oxygenation, cardiogenic shock, cardiac arrest|extracorporeal life support, extracorporeal membrane oxygenation, cardiogenic shock, cardiac arrest
25584|NCT04039581|Kinesio Tape|kinesio tape
25585|NCT04039581|Pain|pain
25586|NCT04039581|Functionality|functionality
25587|NCT04039581|Cervical Spine Surgery|cervical spine surgery
25588|NCT04039568|Opioid Therapy|opioid therapy
25589|NCT04039568|Sahaj Samadhi Meditation|sahaj samadhi meditation
25590|NCT04039568|Health Enhancement Program|health enhancement program
25591|NCT04039542|Feasibility|feasibility
25592|NCT04039542|Compassion Focussed Therapy|compassion focussed therapy
25593|NCT04039542|Older adults|older adults
25594|NCT04039529|lung biopsy|lung biopsy
25595|NCT04039529|kidney biopsy|kidney biopsy
25596|NCT04039529|liver biopsy|liver biopsy
25597|NCT04039529|image fusion|image fusion
25598|NCT04039503|glucose-dependent insulinotropic polypeptide (GIP)|glucose-dependent insulinotropic polypeptide (gip)
25599|NCT04039503|glucagon-like peptide-1 (GLP-1)|glucagon-like peptide-1 (glp-1)
25600|NCT04039503|GIP/GLP-1 dual receptor agonist|gip/glp-1 dual receptor agonist
25601|NCT04039503|T2DM|t2dm
25602|NCT04039490|pediatrics|pediatrics
25603|NCT04039490|vessel cannulations|vessel cannulations
25604|NCT04039490|ultrasound-guided|ultrasound-guided
25605|NCT04039477|Autoimmune|autoimmune
25606|NCT04039477|Hemolytic|hemolytic
25607|NCT04039477|Anemia|anemia
25608|NCT04039477|Autoimmune Hemolytic Anemia|autoimmune hemolytic anemia
25609|NCT04039477|AIHA|aiha
25610|NCT04039477|Immune|immune
25611|NCT04039477|Thrombocytopenia|thrombocytopenia
25612|NCT04039477|Immune Thrombocytopenia|immune thrombocytopenia
25613|NCT04039477|ITP|itp
25614|NCT04039477|Blood disorders|blood disorders
25615|NCT04039477|Hematology|hematology
25616|NCT04039412|Helicobacter Pylori Infection|helicobacter pylori infection
25617|NCT04039412|Quadruple Therapy|quadruple therapy
25618|NCT04039412|Egypt|egypt
25619|NCT04039386|Hip Pain|hip pain
25620|NCT04039386|Hip Instability|hip instability
25621|NCT04039386|Hip Impingement|hip impingement
25622|NCT04039386|Cognitive Based Therapy|cognitive based therapy
25623|NCT04039386|Psychosocial Conditions|psychosocial conditions
25624|NCT04039360|Left-sided colonic tumor|left-sided colonic tumor
400497|NCT01866605|anxiety|anxiety
25625|NCT04039360|Intestinal obstruction|intestinal obstruction
25626|NCT04039360|Self-expanding metallic stent|self-expanding metallic stent
25627|NCT04039360|Neoadjuvant chemotherapy|neoadjuvant chemotherapy
25628|NCT04039360|Stoma|stoma
25629|NCT04039334|COPD|copd
25630|NCT04039334|Creative Dance|creative dance
25631|NCT04039334|Exercise Training|exercise training
25632|NCT04039334|6 Minute Walk Test|6 minute walk test
25633|NCT04039334|Pulmonary Function Test|pulmonary function test
25634|NCT04039334|Postural Stability|postural stability
25635|NCT04039334|Cognitive Functions|cognitive functions
25636|NCT04039334|Muscle Strength|muscle strength
25637|NCT04039321|Erector spina plane block|erector spina plane block
25638|NCT04039321|Laparoscopic sleeve gastrectomy|laparoscopic sleeve gastrectomy
25639|NCT04039321|Obesity|obesity
25640|NCT04039321|Postoperative pain|postoperative pain
25641|NCT04039321|Pulmonary functions|pulmonary functions
25642|NCT04039282|nutrition|nutrition
25643|NCT04039282|dietary recall|dietary recall
25644|NCT04039269|Post operative Behavioral Changes|post operative behavioral changes
25645|NCT04039269|Pediatric|pediatric
25646|NCT04039269|Long term memory|long term memory
25647|NCT04039269|video|video
25648|NCT04039243|Anxiety disorders|anxiety disorders
25649|NCT04039243|Toddlers|toddlers
25650|NCT04039243|Preschoolers|preschoolers
25651|NCT04039243|Cognitive-behavioral therapy|cognitive-behavioral therapy
25652|NCT04039230|Breast Cancer|breast cancer
25653|NCT04039217|PrEP|prep
25654|NCT04039217|PEP|pep
25655|NCT04039217|MSM|msm
25656|NCT04039217|Short-course regimen|short-course regimen
25657|NCT04039217|Pharmacokinetics|pharmacokinetics
25658|NCT04039191|SMS|sms
25659|NCT04039191|Education|education
25660|NCT04039191|Opioid Use|opioid use
25661|NCT04039191|Pain|pain
25662|NCT04039191|postoperative|postoperative
25663|NCT04039178|BCI|bci
25664|NCT04039178|BQ|bq
25665|NCT04039178|motor function|motor function
25666|NCT04039178|acute stroke|acute stroke
25667|NCT04039178|EMF|emf
25668|NCT04039126|MALIGNANT PLEURAL EFFUSSION|malignant pleural effussion
25669|NCT04039113|COPD|copd
25670|NCT04039113|Moderate COPD|moderate copd
25671|NCT04039113|Severe COPD|severe copd
25672|NCT04039113|chronic obstructive pulmonary disease|chronic obstructive pulmonary disease
25673|NCT04039100|Peer to Peer|peer to peer
25674|NCT04039100|Psychosocial Support|psychosocial support
25675|NCT04039100|Caregivers|caregivers
25676|NCT04039087|Exercise intolerance|exercise intolerance
25677|NCT04039087|Quality of life|quality of life
25678|NCT04039087|Cardiac function|cardiac function
25679|NCT04039074|Yoga|yoga
25680|NCT04039074|Meditation|meditation
25681|NCT04039074|Progressive muscle relaxation|progressive muscle relaxation
25682|NCT04039074|Stress|stress
25683|NCT04039074|Education|education
25684|NCT04039048|Biodex balance system|biodex balance system
25685|NCT04039048|Posture control|posture control
25686|NCT04039048|Ataxia' severity|ataxia' severity
25687|NCT04039048|ctDCS|ctdcs
25688|NCT04039035|Nutritional Risk Index|nutritional risk index
25689|NCT04039035|Body mass Index|body mass index
25690|NCT04039035|Postoperative Complications|postoperative complications
25691|NCT04039035|Length of Hospital Stay and Cost.|length of hospital stay and cost.
25692|NCT04039022|Depression|depression
25693|NCT04039022|AXS-05|axs-05
25694|NCT04039022|Dextromethorphan|dextromethorphan
25695|NCT04039022|Bupropion|bupropion
25696|NCT04039022|Dopamine Reuptake Inhibitor|dopamine reuptake inhibitor
25697|NCT04039022|NMDA Receptor Antagonist|nmda receptor antagonist
25698|NCT04039022|Nicotinic Acetylcholine Receptor Antagonist|nicotinic acetylcholine receptor antagonist
25699|NCT04039022|Serotonin Reuptake Inhibitor|serotonin reuptake inhibitor
25700|NCT04039022|Axsome Therapeutics|axsome therapeutics
25701|NCT04039022|Norepinephrine Reuptake Inhibitor|norepinephrine reuptake inhibitor
25702|NCT04039022|Sigma-1 Receptor Agonist|sigma-1 receptor agonist
25703|NCT04039022|Glutamate Modulator|glutamate modulator
25704|NCT04039022|Antidepressant|antidepressant
25705|NCT04039009|Pelvic organ prolapse|pelvic organ prolapse
25706|NCT04039009|Infertility|infertility
25707|NCT04039009|Apical pelvic support|apical pelvic support
25708|NCT04038996|immune checkpoint inhibitor|immune checkpoint inhibitor
25709|NCT04038996|single nucleotide polymorphism|single nucleotide polymorphism
25710|NCT04038996|microRNA|microrna
25711|NCT04038983|Emergency, Old patients , Survey Questionnaire|emergency, old patients , survey questionnaire
25712|NCT04038957|schizophrenia|schizophrenia
25713|NCT04038918|Total knee arthroplasty|total knee arthroplasty
25714|NCT04038918|progressive muscle relaxation exercise|progressive muscle relaxation exercise
25715|NCT04038918|pain|pain
25716|NCT04038918|functional outcomes|functional outcomes
25717|NCT04038918|muscle strength|muscle strength
25718|NCT04038892|Bronchiectasis|bronchiectasis
25719|NCT04038892|Virtual Reality|virtual reality
25720|NCT04038892|Exercise Training|exercise training
25721|NCT04038892|Pulmonary Function|pulmonary function
25722|NCT04038892|Functional Capacity|functional capacity
25723|NCT04038892|6 Minute Walk Test|6 minute walk test
25724|NCT04038892|Balance|balance
25725|NCT04038892|Muscle Strength|muscle strength
25726|NCT04038866|gait biomechanics|gait biomechanics
25727|NCT04038866|physical rehabilitation|physical rehabilitation
25728|NCT04038866|physical therapy|physical therapy
25729|NCT04038866|dual task|dual task
25730|NCT04038827|Circulating Endothelial Cells|circulating endothelial cells
25731|NCT04038827|Graft versus Host Disease|graft versus host disease
25732|NCT04038827|Neovascularization|neovascularization
25733|NCT04038827|Allotransplantation|allotransplantation
25734|NCT04038814|VAP|vap
25735|NCT04038814|Evac Endotracheal Tube with TaperGuard Cuff|evac endotracheal tube with taperguard cuff
25736|NCT04038814|MDR - multi drug resistant pathogens|mdr - multi drug resistant pathogens
25737|NCT04038814|SSD - subglottic secretion drainage,|ssd - subglottic secretion drainage,
25738|NCT04038775|medically uninsured|medically uninsured
25739|NCT04038723|Fibrosis|fibrosis
25740|NCT04038723|Ventricle Remodeling|ventricle remodeling
25741|NCT04038723|Exercise Training|exercise training
25742|NCT04038723|Proteomics|proteomics
25743|NCT04038697|Stroke|stroke
25744|NCT04038697|Rehabilitation|rehabilitation
25745|NCT04038697|Ischemic Conditioning|ischemic conditioning
25746|NCT04038697|Treadmill Training|treadmill training
25747|NCT04038684|Emotional Eating|emotional eating
25748|NCT04038684|Low-income|low-income
25749|NCT04038684|Stress Biomarkers|stress biomarkers
25750|NCT04038684|Mindfulness|mindfulness
25751|NCT04038684|Adolescent|adolescent
25752|NCT04038684|Obesity|obesity
25753|NCT04038684|Weight Management|weight management
25754|NCT04038684|Stress|stress
25755|NCT04038684|Pediatric|pediatric
25756|NCT04038658|exercise|exercise
25757|NCT04038658|worksite|worksite
25758|NCT04038658|digital|digital
25759|NCT04038658|health promotion|health promotion
25760|NCT04038645|Nasal Fracture|nasal fracture
25761|NCT04038645|Photobiomodulation|photobiomodulation
25762|NCT04038645|Laser|laser
25763|NCT04038645|Edema|edema
25764|NCT04038632|Childhood TB|childhood tb
25765|NCT04038632|Decentralized Diagnosis approaches|decentralized diagnosis approaches
25766|NCT04038632|Case detection|case detection
25767|NCT04038593|Pain|pain
25768|NCT04038593|Anxiety|anxiety
25769|NCT04038593|Complex dressing|complex dressing
25770|NCT04038593|Home hospitalization|home hospitalization
25771|NCT04038593|Music|music
25772|NCT04038580|Socket|socket
25773|NCT04038580|Transfemoral|transfemoral
25774|NCT04038567|cardiorespiratory failure|cardiorespiratory failure
25775|NCT04038567|critical illness|critical illness
25776|NCT04038567|psychological distress|psychological distress
25777|NCT04038567|depression|depression
25778|NCT04038567|anxiety|anxiety
25779|NCT04038567|post-traumatic stress disorder|post-traumatic stress disorder
25780|NCT04038567|intensive care units|intensive care units
25782|NCT04038567|mechanical ventilation|mechanical ventilation
25783|NCT04038541|Prebiotics|prebiotics
25784|NCT04038541|Probiotics|probiotics
25785|NCT04038541|Gut microbiome|gut microbiome
25786|NCT04038541|Multiple Sclerosis|multiple sclerosis
25787|NCT04038515|Menthol|menthol
25788|NCT04038515|Electronic Nicotine Delivery Systems|electronic nicotine delivery systems
25789|NCT04038502|metastatic prostate cancer|metastatic prostate cancer
25790|NCT04038489|ER+/HER2- Breast Cancer|er+/her2- breast cancer
25791|NCT04038476|electrophysiology|electrophysiology
25792|NCT04038476|conscious sedation|conscious sedation
25793|NCT04038476|transcutaneous CO2 measurement|transcutaneous co2 measurement
25794|NCT04038476|sedation monitoring|sedation monitoring
25795|NCT04038476|ablation of arrhythmia|ablation of arrhythmia
25796|NCT04038463|Menstrual Cycle|menstrual cycle
25797|NCT04038463|Resistance Training|resistance training
25798|NCT04038463|Body Composition|body composition
25799|NCT04038463|Intervention|intervention
25800|NCT04038463|Exercise|exercise
25801|NCT04038437|CPX-351|cpx-351
25802|NCT04038437|Vyxeos|vyxeos
25803|NCT04038437|Venetoclax|venetoclax
25804|NCT04038437|Unfit|unfit
25805|NCT04038411|PD-1 Antibody|pd-1 antibody
25806|NCT04038411|chidamide|chidamide
25807|NCT04038411|lenalidomide|lenalidomide
25808|NCT04038411|etoposide|etoposide
25809|NCT04038411|NK/T-cell Lymphoma|nk/t-cell lymphoma
25810|NCT04038372|HDV|hdv
25811|NCT04038372|HBsAg|hbsag
25812|NCT04038372|prevalence|prevalence
25813|NCT04038372|Upper Egypt|upper egypt
25814|NCT04038359|PI3K Inhibitor|pi3k inhibitor
25815|NCT04038346|Lyme Arthritis|lyme arthritis
25816|NCT04038346|Lyme|lyme
25817|NCT04038346|Lyme Disease|lyme disease
25818|NCT04038346|Arthritis|arthritis
25819|NCT04038346|NSAID|nsaid
25820|NCT04038320|Hepatitis C Virus|hepatitis c virus
25821|NCT04038320|HIV|hiv
25822|NCT04038320|Key Population|key population
25823|NCT04038307|shoulder tip pain|shoulder tip pain
25824|NCT04038294|Cardiac Surgery|cardiac surgery
25825|NCT04038294|Protein supplementation|protein supplementation
400498|NCT01866605|midazolam|midazolam
25826|NCT04038294|Pre-Frail and Frail older adults|pre-frail and frail older adults
25827|NCT04038268|Immunotherapy|immunotherapy
25828|NCT04038268|Real Clinical Practice|real clinical practice
25829|NCT04038268|Respiratory disease|respiratory disease
25830|NCT04038268|Aeroallergens|aeroallergens
25831|NCT04038268|IgE-dependent hypersensitivity|ige-dependent hypersensitivity
25832|NCT04038255|cancer|cancer
25833|NCT04038255|nicotine replacement therapy|nicotine replacement therapy
25834|NCT04038255|mindfulness|mindfulness
25835|NCT04038229|enhanced recovery pathway|enhanced recovery pathway
25836|NCT04038229|analgesia|analgesia
25837|NCT04038229|tele-monitoring|tele-monitoring
25838|NCT04038229|biopsychosocial evaluation|biopsychosocial evaluation
25839|NCT04038216|Single-stage surgery|single-stage surgery
25840|NCT04038216|Bone conduction devices|bone conduction devices
25841|NCT04038216|Pediatric population|pediatric population
25842|NCT04038216|Implant loss|implant loss
25843|NCT04038203|neonates|neonates
25844|NCT04038203|low birth weight|low birth weight
25845|NCT04038203|spectroscopy|spectroscopy
25846|NCT04038203|Umbilical Artery Catheter (UAC)|umbilical artery catheter (uac)
25847|NCT04038190|behavioral activation|behavioral activation
25848|NCT04038190|prevention|prevention
25849|NCT04038190|reinforcement|reinforcement
25850|NCT04038190|college students|college students
25851|NCT04038177|Resistance training|resistance training
25852|NCT04038177|Muscle strength|muscle strength
25853|NCT04038164|FASD|fasd
25854|NCT04038164|animal-assisted therapy|animal-assisted therapy
25855|NCT04038164|dog-assisted therapy|dog-assisted therapy
25856|NCT04038151|Transfemoral Amputation|transfemoral amputation
25857|NCT04038125|Diabetic Macula Edema|diabetic macula edema
25858|NCT04038125|Diabetic Retinopathy|diabetic retinopathy
25859|NCT04038125|Retina Ischemia|retina ischemia
25860|NCT04038060|pre-exposure prophylaxis|pre-exposure prophylaxis
25861|NCT04038060|young women|young women
25862|NCT04038060|HIV infections/prevention|hiv infections/prevention
25863|NCT04038060|SMART design|smart design
25864|NCT04038047|CF|cf
25865|NCT04038047|CFTR modulator|cftr modulator
25866|NCT04038047|triple combination therapy|triple combination therapy
25867|NCT04038021|Unstably Housed|unstably housed
25868|NCT04038021|Homeless|homeless
25869|NCT04038008|fluconazole|fluconazole
25870|NCT04038008|Diflucan®|diflucan®
25871|NCT04038008|bioequivalence|bioequivalence
25872|NCT04037956|Tubeless NOSES|tubeless noses
25873|NCT04037956|traditional laparoscopic radical resection|traditional laparoscopic radical resection
25874|NCT04037956|Rectosigmoid Cancers|rectosigmoid cancers
25875|NCT04037943|Alpha linolenic acid|alpha linolenic acid
25876|NCT04037904|Helicobacter pylori|helicobacter pylori
25877|NCT04037904|Interleukin-1 beta|interleukin-1 beta
25878|NCT04037904|Gastric H+, K+- APTase|gastric h+, k+- aptase
25879|NCT04037878|TAP block|tap block
25880|NCT04037878|Local infiltration|local infiltration
25881|NCT04037878|Tramadol|tramadol
25882|NCT04037878|Gynecological surgery|gynecological surgery
25883|NCT04037878|Pain control|pain control
25884|NCT04037852|nipple sparing mastectomy|nipple sparing mastectomy
25885|NCT04037852|robotic nipple sparing mastectomy (R-NSM)|robotic nipple sparing mastectomy (r-nsm)
25886|NCT04037852|conventional nipple sparing mastectomy (C-NSM)|conventional nipple sparing mastectomy (c-nsm)
25887|NCT04037852|endoscopic assisted nipple sparing mastectomy (E-NSM)|endoscopic assisted nipple sparing mastectomy (e-nsm)
25888|NCT04037852|immediate breast reconstruction (IBR)|immediate breast reconstruction (ibr)
25889|NCT04037852|immediate prothesis breast reconstruction (IPBR)|immediate prothesis breast reconstruction (ipbr)
25890|NCT04037826|irritable bowel syndrome, adults, L. reuteri|irritable bowel syndrome, adults, l. reuteri
25891|NCT04037813|Hysteroscopy|hysteroscopy
25892|NCT04037813|Laparoscopy|laparoscopy
25893|NCT04037813|Hydrosalpinx|hydrosalpinx
25894|NCT04037800|Prostate cancer|prostate cancer
25895|NCT04037800|Prostatectomy|prostatectomy
25896|NCT04037800|Robotic surgery|robotic surgery
25897|NCT04037800|Urinary incontinence|urinary incontinence
25898|NCT04037800|Sustainable functional urethral reconstruction|sustainable functional urethral reconstruction
25899|NCT04037774|analgesia,|analgesia,
25900|NCT04037774|spinal block|spinal block
25901|NCT04037774|dexmedetomidine|dexmedetomidine
25902|NCT04037774|bupivacaine|bupivacaine
25903|NCT04037774|selective spinal anesthesia|selective spinal anesthesia
25904|NCT04037761|early child development|early child development
25905|NCT04037761|cohort study|cohort study
25906|NCT04037761|education|education
25907|NCT04037748|Eutirox®|eutirox®
25908|NCT04037748|Puran T4®|puran t4®
25909|NCT04037748|Levothyroxine|levothyroxine
25910|NCT04037735|Comparative Study|comparative study
25911|NCT04037735|Knee Prosthesis|knee prosthesis
25912|NCT04037735|Prosthesis Design|prosthesis design
25913|NCT04037735|Treatment Outcome|treatment outcome
25914|NCT04037735|Follow-Up Studies|follow-up studies
25915|NCT04037722|Cardiac Output|cardiac output
25916|NCT04037722|Endotoxemia|endotoxemia
25917|NCT04037722|Ketone bodies|ketone bodies
809345|NCT00213083|Women|women
25918|NCT04037722|3-hydroxy butyrate|3-hydroxy butyrate
25919|NCT04037722|Whey protein|whey protein
25920|NCT04037722|Catabolic State|catabolic state
25921|NCT04037683|induction of labour|induction of labour
25922|NCT04037683|intrapartum fetal monitoring|intrapartum fetal monitoring
25923|NCT04037683|qualitative|qualitative
25924|NCT04037683|semi-structured interview|semi-structured interview
25925|NCT04037683|focus groups|focus groups
25926|NCT04037605|Testosterone|testosterone
25927|NCT04037605|Cortisol|cortisol
25928|NCT04037579|physical activity|physical activity
25929|NCT04037579|self-determination|self-determination
25930|NCT04037579|Social inclusion|social inclusion
25931|NCT04037579|Well-being|well-being
25932|NCT04037579|Rights|rights
25933|NCT04037579|Interpersonal relations|interpersonal relations
25934|NCT04037566|Leukemia Lymphocytic Acute|leukemia lymphocytic acute
25935|NCT04037566|Lymphoma, B-Cell|lymphoma, b-cell
25936|NCT04037553|Endotracheal tube cuff pressure|endotracheal tube cuff pressure
25937|NCT04037553|Ear Surgery|ear surgery
25938|NCT04037553|Head and Neck Surgery|head and neck surgery
25939|NCT04037553|Position|position
25940|NCT04037540|Jones fracture|jones fracture
25941|NCT04037540|The American Orthopaedic Foot & Ankle Society (AOFAS)|the american orthopaedic foot & ankle society (aofas)
25942|NCT04037540|Herbert screw|herbert screw
25943|NCT04037527|Grade II sarcoma|grade ii sarcoma
25944|NCT04037527|Grade III sarcoma|grade iii sarcoma
25945|NCT04037501|Caregiver of people with dementia|caregiver of people with dementia
25946|NCT04037501|Caregiver health|caregiver health
25947|NCT04037501|Care management system|care management system
25948|NCT04037501|Collaborative care|collaborative care
25949|NCT04037501|Informal care coordination|informal care coordination
25950|NCT04037501|Dementia|dementia
25951|NCT04037501|Medical management|medical management
25952|NCT04037501|Unmet needs|unmet needs
25953|NCT04037488|Androgen deprivation therapy|androgen deprivation therapy
25954|NCT04037488|Prostate cancer|prostate cancer
25955|NCT04037488|Body composition|body composition
25956|NCT04037488|Lean body mass|lean body mass
25957|NCT04037475|photodynamic therapy|photodynamic therapy
25958|NCT04037475|herpes labialis|herpes labialis
25959|NCT04037475|herpes simplex|herpes simplex
25960|NCT04037475|laser|laser
25961|NCT04037436|Strength Training|strength training
25962|NCT04037436|Balance Training|balance training
25963|NCT04037436|Nutrition Education|nutrition education
25964|NCT04037436|Older adults|older adults
25965|NCT04037436|Frailty|frailty
25966|NCT04037436|Feasibility|feasibility
25967|NCT04037397|Pulmonary Vein Isolation|pulmonary vein isolation
25968|NCT04037371|Cold exposure|cold exposure
25969|NCT04037371|white fat cells|white fat cells
25970|NCT04037371|thermoregulation|thermoregulation
25971|NCT04037371|winter|winter
25972|NCT04037345|human umbilical cord blood derived mesenchymal stem cells|human umbilical cord blood derived mesenchymal stem cells
25973|NCT04037345|Knee Osteoarthritis|knee osteoarthritis
25974|NCT04037306|Fiber|fiber
25975|NCT04037293|SLE|sle
26470|NCT04034355|cancer|cancer
25978|NCT04037293|brachial-ankle pulse wave velocity|brachial-ankle pulse wave velocity
25979|NCT04037293|risk factors|risk factors
25980|NCT04037293|Cohort|cohort
25981|NCT04037280|Urinary|urinary
25982|NCT04037280|Exercise|exercise
25983|NCT04037280|Posology|posology
25986|NCT04037202|analgesia|analgesia
25987|NCT04037202|massage|massage
25988|NCT04037202|midwifery|midwifery
25989|NCT04037202|pain|pain
25990|NCT04037202|postpartum period|postpartum period
25991|NCT04037176|Omalizumab|omalizumab
25992|NCT04037176|Xolair|xolair
25993|NCT04037163|Fractional flow reserve|fractional flow reserve
25994|NCT04037163|Coronary CT angiography|coronary ct angiography
25995|NCT04037163|Atherosclerosis|atherosclerosis
25996|NCT04037150|NSCLC|nsclc
25997|NCT04037150|cfDNA|cfdna
25998|NCT04037137|Caregiver Diffuculties Scale|caregiver diffuculties scale
25999|NCT04037137|reliability|reliability
26000|NCT04037137|validity|validity
26001|NCT04037137|Turkish version|turkish version
26002|NCT04037124|Cervical cancer|cervical cancer
26003|NCT04037124|Lymph node involvement|lymph node involvement
26004|NCT04037124|Radical hysterectomy|radical hysterectomy
26005|NCT04037124|Radiotherapy|radiotherapy
26006|NCT04037072|Complex|complex
26007|NCT04037059|Activities of Daily Living (ADL)|activities of daily living (adl)
26008|NCT04037059|Complex Spinal Fusion|complex spinal fusion
26009|NCT04037007|Precut sphincterotomy|precut sphincterotomy
26010|NCT04037007|Fistulotomy|fistulotomy
26011|NCT04037007|Biliary cannulation|biliary cannulation
26012|NCT04037007|Efficacy|efficacy
26013|NCT04036994|photomodulation therapy|photomodulation therapy
26014|NCT04036994|supportive cancer care|supportive cancer care
26015|NCT04036994|epirubicin cyclophosphamide|epirubicin cyclophosphamide
26016|NCT04036981|Stroke|stroke
26017|NCT04036981|Muscle spasticity|muscle spasticity
26018|NCT04036981|Botulinum toxin A|botulinum toxin a
26019|NCT04036968|Clinical Trial|clinical trial
26020|NCT04036968|Analgesia|analgesia
26021|NCT04036968|Phase II|phase ii
26022|NCT04036955|dementia|dementia
26023|NCT04036955|Alzheimer's disease|alzheimer's disease
26024|NCT04036955|patient care|patient care
26025|NCT04036955|home care|home care
26026|NCT04036942|Gastroesophageal Reflux Disease (GERD)|gastroesophageal reflux disease (gerd)
26027|NCT04036942|ARAT|arat
26028|NCT04036942|ARMS|arms
26029|NCT04036916|Concussion|concussion
26030|NCT04036916|Injury prevention|injury prevention
26031|NCT04036903|Lung nodules|lung nodules
26032|NCT04036903|Deep learning|deep learning
26033|NCT04036890|Recurrent periodontitis|recurrent periodontitis
26034|NCT04036890|Periodontal therapy|periodontal therapy
26035|NCT04036864|Singers|singers
26036|NCT04036825|Liquid Nutritional Supplement|liquid nutritional supplement
26037|NCT04036799|Pediatric|pediatric
26038|NCT04036799|Risk Prediction|risk prediction
26039|NCT04036786|pre-eclampsia|pre-eclampsia
26040|NCT04036786|pregnancy|pregnancy
26041|NCT04036786|healthy lifestyle|healthy lifestyle
26042|NCT04036786|self efficacy|self efficacy
26043|NCT04036773|diet|diet
26044|NCT04036773|nutrition|nutrition
26045|NCT04036773|hyperlipidemia|hyperlipidemia
26046|NCT04036773|produce|produce
26047|NCT04036721|anti-PD-1|anti-pd-1
26048|NCT04036721|anti-PD-L1|anti-pd-l1
26049|NCT04036721|pneumonitis|pneumonitis
26050|NCT04036721|NSCLC|nsclc
26051|NCT04036721|treatment|treatment
26052|NCT04036721|programmed-death receptor|programmed-death receptor
26053|NCT04036682|NSCLC|nsclc
26054|NCT04036682|EGFR|egfr
26055|NCT04036682|Exon 20 insertions|exon 20 insertions
26056|NCT04036682|CLN-081|cln-081
26057|NCT04036682|TAS6417|tas6417
26058|NCT04036669|rheumatoid arthritis, adipokines, foot function index, f-BMD|rheumatoid arthritis, adipokines, foot function index, f-bmd
26059|NCT04036643|Rectal neoplasm|rectal neoplasm
26060|NCT04036643|Imaging TEP/MRI|imaging tep/mri
26061|NCT04036643|response assessement|response assessement
26062|NCT04036604|Pelvic floor exercise|pelvic floor exercise
26063|NCT04036604|Urinary incontinence|urinary incontinence
26064|NCT04036604|Sexual dysfunction|sexual dysfunction
26065|NCT04036591|Clinical scale|clinical scale
26066|NCT04036591|infant|infant
26067|NCT04036591|respiratory therapy|respiratory therapy
26068|NCT04036578|pelvic floor dysfunction|pelvic floor dysfunction
26069|NCT04036578|pelvic floor muscle training|pelvic floor muscle training
26070|NCT04036578|pelvic organ prolapse|pelvic organ prolapse
26071|NCT04036578|surface electromyographic program|surface electromyographic program
26072|NCT04036565|Sunlight|sunlight
26073|NCT04036565|depression|depression
26074|NCT04036565|daily active function|daily active function
26075|NCT04036565|stroke|stroke
26076|NCT04036539|orthodontic treatment,|orthodontic treatment,
26077|NCT04036539|photobiomodulation,|photobiomodulation,
26078|NCT04036539|mini-implant,|mini-implant,
26079|NCT04036539|verticalization of molars|verticalization of molars
26080|NCT04036526|Bordetella pertussis|bordetella pertussis
26081|NCT04036526|Live vaccine|live vaccine
26082|NCT04036526|Immunological factors|immunological factors
26083|NCT04036526|antibody response|antibody response
26084|NCT04036526|cell immune response|cell immune response
26085|NCT04036526|whooping cough|whooping cough
26086|NCT04036513|Periodontitis|periodontitis
26087|NCT04036513|MINST|minst
26088|NCT04036513|Scaling and root planing|scaling and root planing
26089|NCT04036513|Split mouth|split mouth
26090|NCT04036513|3D analysis|3d analysis
26091|NCT04036461|Multiple Myeloma|multiple myeloma
26092|NCT04036461|Relapsed and refractory|relapsed and refractory
26093|NCT04036461|CC-99712|cc-99712
26094|NCT04036461|BCMA|bcma
26095|NCT04036461|Antibody drug conjugate|antibody drug conjugate
26096|NCT04036448|REVLIMID®|revlimid®
26097|NCT04036448|Lenalidomide|lenalidomide
26098|NCT04036448|Observational|observational
26099|NCT04036448|Korea|korea
26100|NCT04036448|Post Marketing Surveillance[PMS]|post marketing surveillance[pms]
26101|NCT04036448|Relapsed and Refractory Mantle cell lymphoma|relapsed and refractory mantle cell lymphoma
26102|NCT04036448|IPSS Low- or intermediate-1-risk Myelodysplastic Syndromes Associated with a deletion 5q|ipss low- or intermediate-1-risk myelodysplastic syndromes associated with a deletion 5q
26103|NCT04036422|stroke|stroke
26104|NCT04036422|neuronal plasticity|neuronal plasticity
26105|NCT04036422|cognition|cognition
26106|NCT04036422|hemiplegia|hemiplegia
26107|NCT04036422|Remote rehabilitation|remote rehabilitation
26108|NCT04036396|HIV prevention and testing|hiv prevention and testing
26109|NCT04036396|sexually transmitted disease (STD) prevention and testing|sexually transmitted disease (std) prevention and testing
26110|NCT04036396|HIV pre-exposure prophylaxis (PrEP)|hiv pre-exposure prophylaxis (prep)
26111|NCT04036396|Incarceration|incarceration
26112|NCT04036370|pectoral nerve block (pecs block)|pectoral nerve block (pecs block)
26113|NCT04036370|breast cancer|breast cancer
26114|NCT04036370|postoperative pain|postoperative pain
26115|NCT04036370|numeric rating scale score (NRS score)|numeric rating scale score (nrs score)
26116|NCT04036357|NAFLD|nafld
26117|NCT04036357|Liver fibrosis|liver fibrosis
26118|NCT04036357|Cardiovascular|cardiovascular
26119|NCT04036318|Sexually Transmitted Infections|sexually transmitted infections
26120|NCT04036318|Periodic Presumptive Treatment|periodic presumptive treatment
26121|NCT04036305|Ehlers-Danlos Syndrome|ehlers-danlos syndrome
26122|NCT04036305|Local Anesthesia Resistance|local anesthesia resistance
26123|NCT04036279|NANOS|nanos
26124|NCT04036279|Hip|hip
26125|NCT04036279|Neck Preserving Stem|neck preserving stem
26126|NCT04036253|epoetin|epoetin
26127|NCT04036253|erythropoietin|erythropoietin
26128|NCT04036253|Eprex|eprex
26129|NCT04036253|Hemax|hemax
26130|NCT04036253|Anemia|anemia
26131|NCT04036253|Chronic Kidney Disease|chronic kidney disease
26132|NCT04036253|pre-dialysis|pre-dialysis
26133|NCT04036240|low birth weight infant|low birth weight infant
26134|NCT04036240|breast milk supplementation|breast milk supplementation
26135|NCT04036240|finger feeding|finger feeding
26136|NCT04036201|Peribulbar block|peribulbar block
26137|NCT04036201|minimum effective volume|minimum effective volume
26138|NCT04036201|axial eye length|axial eye length
26139|NCT04036162|Aging|aging
26140|NCT04036162|Task-Positive Network (TPN)|task-positive network (tpn)
26141|NCT04036162|Task-Negative Network (TNN)|task-negative network (tnn)
26142|NCT04036162|MagnetoEncephaloGraphy (MEG)|magnetoencephalography (meg)
26143|NCT04036162|Verticality|verticality
26144|NCT04036162|Language|language
26145|NCT04036162|Hemispheric asymmetry|hemispheric asymmetry
26146|NCT04036123|Urodynamic investigation|urodynamic investigation
26147|NCT04036123|Lower urinary tract dysfunction|lower urinary tract dysfunction
26148|NCT04036123|Water-perfused catheter|water-perfused catheter
26149|NCT04036123|Air-charged catheter|air-charged catheter
26150|NCT04036110|Vitamin C supplementation|vitamin c supplementation
26151|NCT04036097|secondary immunodeficiencies|secondary immunodeficiencies
26152|NCT04036097|disease-modifying treatments (DMT)|disease-modifying treatments (dmt)
26153|NCT04036097|immunosuppressive therapy|immunosuppressive therapy
26154|NCT04036097|serious infection|serious infection
26155|NCT04036097|respiratory tract infections (RTI)|respiratory tract infections (rti)
26156|NCT04036097|urinary tract infections|urinary tract infections
26157|NCT04036097|infection diary|infection diary
26158|NCT04036097|Swiss MS Cohort (SMSC)|swiss ms cohort (smsc)
26159|NCT04036097|SUMMIT (Serially Unified Multicenter Multiple Sclerosis Investigation) studies|summit (serially unified multicenter multiple sclerosis investigation) studies
26160|NCT04036071|HA (hydroxylapatite) coated SL-PLUS™ MIA stem|ha (hydroxylapatite) coated sl-plus™ mia stem
26161|NCT04036058|Clostridium difficile|clostridium difficile
26162|NCT04036058|Barrier Precautions|barrier precautions
26163|NCT04036045|Anthracycline induced cardiotoxicity|anthracycline induced cardiotoxicity
26164|NCT04036019|B cell lymphoma received prior CD19 CAR-T therapy|b cell lymphoma received prior cd19 car-t therapy
26165|NCT04036006|Behavioral intervention|behavioral intervention
26166|NCT04036006|Lifestyle|lifestyle
26167|NCT04035993|Automotive Technology|automotive technology
26168|NCT04035993|Hypoglycemia|hypoglycemia
26169|NCT04035993|Hypoglycaemia|hypoglycaemia
26170|NCT04035993|Driving|driving
26171|NCT04035993|Driving simulator|driving simulator
26172|NCT04035980|Screening|screening
26173|NCT04035980|Telemedicine|telemedicine
26174|NCT04035980|Diagnosis|diagnosis
26175|NCT04035967|Physical Disabilities|physical disabilities
26176|NCT04035967|Anxiety Level|anxiety level
26177|NCT04035967|Health Related Quality of Life|health related quality of life
26178|NCT04035967|Parents'|parents'
26179|NCT04035967|cerebral palsy|cerebral palsy
26180|NCT04035954|Cerebral Palsy|cerebral palsy
26181|NCT04035954|modified pilates|modified pilates
26182|NCT04035954|trunk|trunk
26183|NCT04035954|gait|gait
26184|NCT04035954|function|function
26185|NCT04035954|core stability|core stability
26186|NCT04035941|physical activity|physical activity
26187|NCT04035941|cycling|cycling
26188|NCT04035928|prosthetic treatment|prosthetic treatment
26189|NCT04035928|rhinectomy|rhinectomy
26190|NCT04035915|Limited driving pressure|limited driving pressure
26191|NCT04035915|Low tidal volume|low tidal volume
26192|NCT04035915|Lung injury score|lung injury score
26193|NCT04035902|iron|iron
26194|NCT04035902|arthroplasty|arthroplasty
26195|NCT04035902|red blood cell|red blood cell
26196|NCT04035889|Sleep|sleep
26197|NCT04035889|Melatonin|melatonin
26198|NCT04035889|Sleep disturbance|sleep disturbance
26199|NCT04035876|Camrelizumab|camrelizumab
26200|NCT04035876|Apatinib|apatinib
26201|NCT04035876|HCC|hcc
26202|NCT04035876|Liver transplantation|liver transplantation
26203|NCT04035824|Gastrodia and Uncaria|gastrodia and uncaria
26204|NCT04035824|Stage one Hypertension|stage one hypertension
26205|NCT04035824|Liver yang hyperactivity|liver yang hyperactivity
26206|NCT04035811|Skeletal dysplasia|skeletal dysplasia
26207|NCT04035811|Endochondral ossification|endochondral ossification
26208|NCT04035811|ACH|ach
26209|NCT04035811|Shortened proximal limbs|shortened proximal limbs
26210|NCT04035811|Fibroblast growth factor receptor 3|fibroblast growth factor receptor 3
26211|NCT04035811|FGFR3|fgfr3
26212|NCT04035811|Endochondral bone formation|endochondral bone formation
26213|NCT04035811|Short-limb disproportionate dwarfism|short-limb disproportionate dwarfism
26214|NCT04035811|Bone disease|bone disease
26215|NCT04035811|Dwarfism|dwarfism
26216|NCT04035811|Bone diseases|bone diseases
26217|NCT04035811|Musculoskeletal diseases|musculoskeletal diseases
26218|NCT04035811|Osteochondrodysplasia|osteochondrodysplasia
26219|NCT04035811|Genetic diseases|genetic diseases
26220|NCT04035811|Inborn|inborn
26221|NCT04035785|Kangfu Anti-inflammatory Suppository|kangfu anti-inflammatory suppository
26222|NCT04035785|efficacy and safety|efficacy and safety
26223|NCT04035785|recurrence rate|recurrence rate
26224|NCT04035785|randomized|randomized
26225|NCT04035785|double blind|double blind
26226|NCT04035785|parallel control|parallel control
26227|NCT04035785|multi-center clinical study|multi-center clinical study
26228|NCT04035772|interrupted time series|interrupted time series
26229|NCT04035772|wiki|wiki
26230|NCT04035772|quality improvement|quality improvement
26231|NCT04035772|knowledge translation|knowledge translation
26232|NCT04035772|trauma care|trauma care
26233|NCT04035772|stakeholder engagement|stakeholder engagement
26234|NCT04035772|adaptating knowledge tools|adaptating knowledge tools
26235|NCT04035746|Microcirculation|microcirculation
26236|NCT04035746|Plasticity|plasticity
26237|NCT04035746|Cohort studies|cohort studies
26238|NCT04035720|decision making|decision making
26239|NCT04035720|therapeutic|therapeutic
26240|NCT04035720|disease modifying agents|disease modifying agents
26241|NCT04035720|monoclonal antobodies|monoclonal antobodies
26242|NCT04035720|physicians|physicians
26243|NCT04035720|neurologists|neurologists
26244|NCT04035720|uncertainty|uncertainty
26245|NCT04035720|neuroeconomics|neuroeconomics
26246|NCT04035707|general anaesthesia|general anaesthesia
26247|NCT04035707|mast cell|mast cell
26248|NCT04035707|rocuronium|rocuronium
26249|NCT04035707|tryptase|tryptase
26250|NCT04035694|Adolescent sexual health|adolescent sexual health
26251|NCT04035694|Media literacy education|media literacy education
26252|NCT04035694|Web-based programming|web-based programming
26253|NCT04035668|Sjogren Syndrome|sjogren syndrome
26254|NCT04035668|Dry Eye Syndromes|dry eye syndromes
26255|NCT04035668|Pathological Processes|pathological processes
26256|NCT04035668|Arthritis, Rheumatoid|arthritis, rheumatoid
26257|NCT04035668|Arthritis|arthritis
26258|NCT04035668|Joint Diseases|joint diseases
26259|NCT04035668|Musculoskeletal Diseases|musculoskeletal diseases
26260|NCT04035668|Rheumatic Diseases|rheumatic diseases
26261|NCT04035668|Xerostomia|xerostomia
26262|NCT04035668|Salivary Gland Diseases|salivary gland diseases
26263|NCT04035668|Mouth Diseases|mouth diseases
26264|NCT04035668|Stomatognathic Diseases|stomatognathic diseases
26265|NCT04035668|Lacrimal Apparatus Diseases|lacrimal apparatus diseases
26266|NCT04035668|Eye Diseases|eye diseases
26267|NCT04035668|Connective Tissue Diseases|connective tissue diseases
26268|NCT04035668|Autoimmune Diseases|autoimmune diseases
26269|NCT04035668|Immune System Diseases|immune system diseases
26270|NCT04035655|Disorders of consciousness|disorders of consciousness
26271|NCT04035655|Transcranial direct current stimulation|transcranial direct current stimulation
26272|NCT04035655|Electroencephalography|electroencephalography
26273|NCT04035655|Electrophysiological signatures of consciousness|electrophysiological signatures of consciousness
26274|NCT04035655|Coma Recovery Scale - Revised|coma recovery scale - revised
26275|NCT04035629|BPD|bpd
26276|NCT04035616|microbial cell preparation|microbial cell preparation
26277|NCT04035616|Hexbio®|hexbio®
26278|NCT04035616|probiotics|probiotics
26279|NCT04035616|elderly|elderly
26280|NCT04035616|chronic medical conditions|chronic medical conditions
26281|NCT04035616|constipation,|constipation,
26282|NCT04035590|Mastectomy|mastectomy
26283|NCT04035590|Drain|drain
26284|NCT04035577|Mental health|mental health
26285|NCT04035577|App|app
26286|NCT04035577|Mobile phone|mobile phone
26287|NCT04035577|Stress management|stress management
26288|NCT04035564|Preterm infant|preterm infant
26289|NCT04035564|Sodium|sodium
26290|NCT04035564|Hyponatremia|hyponatremia
26291|NCT04035551|Home|home
26292|NCT04035551|HPN|hpn
26293|NCT04035551|Homecare|homecare
26294|NCT04035538|CKD-320|ckd-320
26295|NCT04035512|Bariatric surgery|bariatric surgery
26296|NCT04035512|Expressive writing|expressive writing
26297|NCT04035512|Obesity|obesity
26298|NCT04035512|Alexithymia|alexithymia
26299|NCT04035512|Adherence|adherence
26300|NCT04035486|Locally|locally
26301|NCT04035486|Advanced|advanced
26302|NCT04035486|Metastatic|metastatic
26303|NCT04035486|Carcinoma|carcinoma
26304|NCT04035486|Non-Small Cell Lung Cancer|non-small cell lung cancer
26305|NCT04035486|Osimertinib|osimertinib
26306|NCT04035486|Tagrisso|tagrisso
26307|NCT04035460|non-invasive ventilation|non-invasive ventilation
26308|NCT04035447|Cancer|cancer
26309|NCT04035447|Young Adult|young adult
26310|NCT04035447|Behavioral Symptom Management|behavioral symptom management
26311|NCT04035434|CAR T|car t
26312|NCT04035434|Non-Hodgkin Lymphoma|non-hodgkin lymphoma
26313|NCT04035434|NHL|nhl
26314|NCT04035434|Lymphoma|lymphoma
26315|NCT04035434|Allogeneic|allogeneic
26316|NCT04035421|Social Rhythm Metric|social rhythm metric
26317|NCT04035421|Chronotype|chronotype
26318|NCT04035421|Young adult|young adult
26319|NCT04035395|Integrated Behavioral Health|integrated behavioral health
26320|NCT04035395|Community Health Workers|community health workers
26321|NCT04035382|BMI|bmi
26322|NCT04035382|Obesity|obesity
26323|NCT04035382|Labor induction|labor induction
26324|NCT04035382|Cesarean section|cesarean section
26325|NCT04035356|aortic valve repair|aortic valve repair
26326|NCT04035356|aortic valve annuloplasty|aortic valve annuloplasty
26327|NCT04035330|etidronate|etidronate
26328|NCT04035330|postoperative pain|postoperative pain
26329|NCT04035330|bacterial load reduction|bacterial load reduction
26330|NCT04035330|sodium hypochlorite irrigation|sodium hypochlorite irrigation
26331|NCT04035317|Fontan operation|fontan operation
26332|NCT04035317|Aesculus hippocastanum|aesculus hippocastanum
26333|NCT04035317|mesenteric artery resistance|mesenteric artery resistance
26334|NCT04035291|Family Collaboration,|family collaboration,
26335|NCT04035291|high risk of CP|high risk of cp
26336|NCT04035291|physiotherapy|physiotherapy
26337|NCT04035252|Functional response|functional response
26338|NCT04035252|Abdominal aortic aneurysm|abdominal aortic aneurysm
26339|NCT04035252|Carotid artery|carotid artery
26340|NCT04035174|Health Public|health public
26341|NCT04035109|asthma|asthma
26342|NCT04035109|nasal allergy|nasal allergy
26343|NCT04035109|house dust mite|house dust mite
26344|NCT04035109|cat|cat
26345|NCT04035096|high dose vitamin C|high dose vitamin c
26346|NCT04035096|very low carbohydrate diet|very low carbohydrate diet
26347|NCT04035070|antibiotic-containg solution|antibiotic-containg solution
26348|NCT04035070|co-amoxiclav-clindamycin solution|co-amoxiclav-clindamycin solution
26349|NCT04035070|MTAD|mtad
26350|NCT04035070|sodium hypochlorite|sodium hypochlorite
26351|NCT04035070|postoperative pain|postoperative pain
26352|NCT04035070|antimicrobial efficacy|antimicrobial efficacy
26353|NCT04035070|root canal irrigation|root canal irrigation
26354|NCT04035057|Therapist Training|therapist training
26355|NCT04035057|Exposure Therapy|exposure therapy
26356|NCT04035057|Experimental Therapeutics|experimental therapeutics
26357|NCT04034992|Observational study|observational study
26358|NCT04034992|Real-world data|real-world data
26359|NCT04034992|Prospective and retrospective data capture|prospective and retrospective data capture
26360|NCT04034992|DISCOVER CKD|discover ckd
26361|NCT04034979|decision aid|decision aid
26362|NCT04034979|ICU|icu
26363|NCT04034979|goals-of-care|goals-of-care
26364|NCT04034979|videotaping|videotaping
26365|NCT04034979|shared-decision making|shared-decision making
26366|NCT04034966|peritoneal dialysis|peritoneal dialysis
26367|NCT04034966|Claria|claria
26368|NCT04034966|telemedicine|telemedicine
26861|NCT04032275|HBsAg|hbsag
26369|NCT04034953|Cancer Screening|cancer screening
26370|NCT04034953|Colorectal Cancer|colorectal cancer
26371|NCT04034953|Breast Cancer|breast cancer
26372|NCT04034953|Prostate Cancer|prostate cancer
26373|NCT04034953|Obesity|obesity
26374|NCT04034953|Obesity-related Cancer|obesity-related cancer
26375|NCT04034953|Multi-Cancer Screening|multi-cancer screening
26376|NCT04034875|Acquired cerebral lesion|acquired cerebral lesion
26377|NCT04034875|Anger|anger
26378|NCT04034875|Agression|agression
26379|NCT04034849|Low-level Laser Therapy|low-level laser therapy
26380|NCT04034849|Burning Mouth Syndrome|burning mouth syndrome
26381|NCT04034849|Photobiomodulation|photobiomodulation
26382|NCT04034849|Visual Analogue Scale|visual analogue scale
26383|NCT04034849|Oral Health Impact Profile|oral health impact profile
26384|NCT04034849|Clinical Trial|clinical trial
26385|NCT04034836|Pain, Postoperative|pain, postoperative
26386|NCT04034836|Parecoxib|parecoxib
26387|NCT04034836|Ropivacaine|ropivacaine
26388|NCT04034836|Scalp nerve blocks|scalp nerve blocks
26389|NCT04034836|Craniotomy|craniotomy
26390|NCT04034823|HER2-positive breast cancer|her2-positive breast cancer
26391|NCT04034823|PD-L1 immune checkpoint|pd-l1 immune checkpoint
26392|NCT04034771|melatonin|melatonin
26393|NCT04034758|Fecal microbiota transplantation|fecal microbiota transplantation
26394|NCT04034758|SQIMC-md|sqimc-md
26395|NCT04034758|Ulcerative colitis|ulcerative colitis
26396|NCT04034732|Mindfulness-based intervention|mindfulness-based intervention
26397|NCT04034732|Mindfulness|mindfulness
26398|NCT04034732|Relapse prevention|relapse prevention
26399|NCT04034719|Newborn|newborn
26400|NCT04034719|Parents|parents
26401|NCT04034719|Carrying|carrying
26402|NCT04034719|Skin-to-skin|skin-to-skin
26403|NCT04034719|Scarf|scarf
26404|NCT04034680|Behavioral symptoms|behavioral symptoms
26405|NCT04034680|Dementia|dementia
809543|NCT00212147|cobalamin|cobalamin
26406|NCT04034680|Nevropsychiatric symptoms|nevropsychiatric symptoms
26407|NCT04034680|Psychological symptoms|psychological symptoms
26408|NCT04034680|The TIME model|the time model
26409|NCT04034667|Lung Cancer|lung cancer
26410|NCT04034667|Imaging features|imaging features
26411|NCT04034667|Driving genes|driving genes
26412|NCT04034667|Prediction|prediction
26413|NCT04034667|Therapy response|therapy response
26414|NCT04034654|preschool child|preschool child
26415|NCT04034654|behavior|behavior
26416|NCT04034654|anesthesia|anesthesia
26417|NCT04034654|surgery|surgery
26418|NCT04034615|Mesenchyme Stem Cells|mesenchyme stem cells
26419|NCT04034615|Cesarean Section|cesarean section
26420|NCT04034615|Scars|scars
26421|NCT04034602|stroke vibration fall risk postural stability|stroke vibration fall risk postural stability
26422|NCT04034602|immediate effect|immediate effect
26423|NCT04034602|fall risk|fall risk
26424|NCT04034602|postural stability|postural stability
26425|NCT04034576|Mindfulness-based intervention|mindfulness-based intervention
26426|NCT04034576|Session-introducing interventions|session-introducing interventions
26427|NCT04034576|Child and adolescent psychotherapy|child and adolescent psychotherapy
26428|NCT04034576|Cognitive-behavioral therapy|cognitive-behavioral therapy
26429|NCT04034576|Therapeutic alliance|therapeutic alliance
26430|NCT04034576|Depressive disorder|depressive disorder
26431|NCT04034576|Hyperkinetic disorder|hyperkinetic disorder
26432|NCT04034576|Anxiety disorder|anxiety disorder
26433|NCT04034550|leptospirosis|leptospirosis
26434|NCT04034550|hospitalization|hospitalization
26435|NCT04034537|Coronary Artery Disease|coronary artery disease
26436|NCT04034537|cardiac Phase Space Tomography Analysis|cardiac phase space tomography analysis
26437|NCT04034537|ischemia|ischemia
26438|NCT04034511|nutrition|nutrition
26439|NCT04034511|medically-tailored meals|medically-tailored meals
26440|NCT04034485|LDL cholesterol|ldl cholesterol
26441|NCT04034485|PCSK9 inhibition|pcsk9 inhibition
26442|NCT04034472|obesity|obesity
26443|NCT04034472|comorbidities|comorbidities
26444|NCT04034472|inflammation|inflammation
26445|NCT04034472|digital technology|digital technology
26446|NCT04034472|metabolic alterations|metabolic alterations
26447|NCT04034459|FIRE|fire
26448|NCT04034459|mCRC|mcrc
26450|NCT04034459|BRAF|braf
26451|NCT04034459|FOLFOXIRI|folfoxiri
26452|NCT04034459|Cetuximab|cetuximab
26453|NCT04034459|Bevacizumab|bevacizumab
26454|NCT04034446|Relapsed|relapsed
26455|NCT04034446|Refractory|refractory
26456|NCT04034446|B-ALL|b-all
26457|NCT04034433|Arteriovenous Fistula Diameter|arteriovenous fistula diameter
26458|NCT04034433|Handgrip|handgrip
26459|NCT04034433|Program exercise|program exercise
26460|NCT04034433|Maturation|maturation
26461|NCT04034420|Online platform|online platform
26462|NCT04034420|ICT|ict
26463|NCT04034420|Family services|family services
26464|NCT04034394|Knee Osteoarthritis|knee osteoarthritis
26465|NCT04034381|Micronutrient deficiency|micronutrient deficiency
26466|NCT04034381|Dietary intake|dietary intake
26467|NCT04034381|Food fortification|food fortification
26468|NCT04034381|National survey|national survey
26469|NCT04034355|colorectal cancer|colorectal cancer
26482|NCT04034316|Proteinuria|proteinuria
26483|NCT04034316|Immunosuppressive treatment|immunosuppressive treatment
26484|NCT04034290|influenza|influenza
26485|NCT04034290|vaccine|vaccine
26486|NCT04034290|Immunologic Factors|immunologic factors
26487|NCT04034290|Respiratory Tract Infections|respiratory tract infections
26488|NCT04034290|vector vaccines|vector vaccines
26489|NCT04034277|Voice Disorders|voice disorders
26490|NCT04034277|Speech and language therapy|speech and language therapy
26491|NCT04034277|Lee Silverman voice treatment|lee silverman voice treatment
26502|NCT04034238|Advanced Cancer|advanced cancer
26503|NCT04034238|Immunotoxin|immunotoxin
26504|NCT04034238|Antibody Based Therapeutics|antibody based therapeutics
26505|NCT04034238|Mesothelin|mesothelin
26506|NCT04034212|COPD|copd
26507|NCT04034199|denosumab|denosumab
26508|NCT04034199|zoledronic acid|zoledronic acid
26509|NCT04034186|low back pain|low back pain
26510|NCT04034186|rehabilitation|rehabilitation
26511|NCT04034186|assessment|assessment
26512|NCT04034186|quality|quality
26513|NCT04034173|colorectal cancer|colorectal cancer
26514|NCT04034173|FIRE|fire
26515|NCT04034173|low-RAS|low-ras
26516|NCT04034173|mCRC|mcrc
26517|NCT04034173|Panitumumab|panitumumab
26518|NCT04034147|subjective cognition|subjective cognition
26519|NCT04034147|metacognition|metacognition
26520|NCT04034147|functioning|functioning
26521|NCT04034147|objective cognition|objective cognition
26522|NCT04034147|quality of life|quality of life
26523|NCT04034147|medication adherence|medication adherence
26524|NCT04034121|biorersorbable scaffold|biorersorbable scaffold
26525|NCT04034121|drug eluting|drug eluting
26526|NCT04034121|novolimus|novolimus
26527|NCT04034108|surgical intervention|surgical intervention
26528|NCT04034108|decompression|decompression
26529|NCT04034108|walking training|walking training
26530|NCT04034108|functional recovery|functional recovery
26531|NCT04034108|spinal cord injury|spinal cord injury
26532|NCT04034082|cardiovascular disease|cardiovascular disease
26533|NCT04034082|rehabilitation|rehabilitation
26534|NCT04034082|exercise|exercise
26535|NCT04034069|stroke|stroke
26536|NCT04034069|theta burst stimulation|theta burst stimulation
26537|NCT04034069|upper limb|upper limb
26538|NCT04034069|metaplasticity|metaplasticity
26539|NCT04034069|priming|priming
26540|NCT04034043|ceramic-on-ceramic|ceramic-on-ceramic
26541|NCT04034043|total hip arthroplasty|total hip arthroplasty
26542|NCT04034043|acetabular fracture|acetabular fracture
26543|NCT04034043|post-traumatic hip osteoarthritis|post-traumatic hip osteoarthritis
26544|NCT04034030|magnetic brain stimulation|magnetic brain stimulation
26545|NCT04034017|College students|college students
26546|NCT04034017|Gastroesophageal reflux disease|gastroesophageal reflux disease
26547|NCT04034017|GERD|gerd
26548|NCT04034017|Prevalence|prevalence
26549|NCT04034017|Perceived stress|perceived stress
26550|NCT04034004|Mindfulness|mindfulness
26551|NCT04034004|Opioids|opioids
26552|NCT04034004|Pain|pain
26553|NCT04034004|Naloxone|naloxone
26554|NCT04033991|Carcinoma, renal cell, cancer, kidney, sunitinib, axitinib|carcinoma, renal cell, cancer, kidney, sunitinib, axitinib
26555|NCT04033978|Schizophrenia|schizophrenia
26556|NCT04033978|Cognitive remediation|cognitive remediation
26557|NCT04033978|Jumping to Conclusion|jumping to conclusion
26558|NCT04033926|Myositis|myositis
26559|NCT04033926|Idiopathic inflammatory myopathies|idiopathic inflammatory myopathies
26560|NCT04033926|Polymyositis|polymyositis
26561|NCT04033926|Dermatomyositis|dermatomyositis
26562|NCT04033926|Musculoskeletal Diseases|musculoskeletal diseases
26563|NCT04033926|Muscular Diseases|muscular diseases
26564|NCT04033900|Active preoperative warming|active preoperative warming
26565|NCT04033900|Inadvertent hypothermia|inadvertent hypothermia
26566|NCT04033900|Perioperative hypothermia|perioperative hypothermia
26567|NCT04033900|Surgical prewarming|surgical prewarming
26862|NCT04032275|HBeAg|hbeag
26568|NCT04033900|Forced air warming|forced air warming
26569|NCT04033887|Diagnosis|diagnosis
26570|NCT04033887|HIV coinfection|hiv coinfection
26571|NCT04033887|Rapid diagnostic test|rapid diagnostic test
26572|NCT04033874|Heel stick|heel stick
26573|NCT04033874|Newborn|newborn
26574|NCT04033874|NIPS|nips
26575|NCT04033874|Pain levels|pain levels
26576|NCT04033874|Crying times|crying times
26577|NCT04033874|Voice decibels|voice decibels
26578|NCT04033861|ST Segment Elevated Myocardial Infarction|st segment elevated myocardial infarction
26579|NCT04033861|rhBNP|rhbnp
26580|NCT04033861|cardiac magnetic resonance|cardiac magnetic resonance
26581|NCT04033861|Microvascular disease|microvascular disease
26582|NCT04033861|ventricular remodeling|ventricular remodeling
26583|NCT04033848|Arthroscopy|arthroscopy
26584|NCT04033848|Ankle Fracture|ankle fracture
26585|NCT04033848|Patient rated outcome|patient rated outcome
26586|NCT04033822|cholecystitis|cholecystitis
26587|NCT04033822|cholecystectomy|cholecystectomy
26588|NCT04033822|accelerated surgery|accelerated surgery
26589|NCT04033822|feasibility study|feasibility study
26590|NCT04033809|Rheumatoid Arthritis|rheumatoid arthritis
26591|NCT04033809|Fiber|fiber
26592|NCT04033809|Multigrain|multigrain
26593|NCT04033783|Six minute walk test|six minute walk test
26594|NCT04033783|Field test|field test
26595|NCT04033783|Exercise capacity|exercise capacity
26596|NCT04033783|Functional capacity|functional capacity
26597|NCT04033770|Urodynamic investigation|urodynamic investigation
26598|NCT04033770|Lower urinary tract dysfunction|lower urinary tract dysfunction
26599|NCT04033770|Water-perfused catheter|water-perfused catheter
26600|NCT04033770|Air-charged catheter|air-charged catheter
26601|NCT04033757|osteoarthritis|osteoarthritis
26602|NCT04033757|cohort study|cohort study
26603|NCT04033757|population-based|population-based
26604|NCT04033744|Molar, Third|molar, third
26605|NCT04033744|Platelet-Rich Fibrin|platelet-rich fibrin
26606|NCT04033731|cognitive process|cognitive process
26607|NCT04033731|visuospatial attention|visuospatial attention
26608|NCT04033705|Perioperative|perioperative
26609|NCT04033705|Continuous glucose monitoring|continuous glucose monitoring
26610|NCT04033705|CGM|cgm
26611|NCT04033679|Magnetic resonance imaging|magnetic resonance imaging
26612|NCT04033679|Brain stimulation|brain stimulation
26613|NCT04033679|Medication adherence|medication adherence
26614|NCT04033666|asthma|asthma
26615|NCT04033666|High flow nasal cannula|high flow nasal cannula
26616|NCT04033666|Non invasive ventilation|non invasive ventilation
26617|NCT04033640|G6PD deficiency|g6pd deficiency
26618|NCT04033627|In Vitro T cell depletion|in vitro t cell depletion
26619|NCT04033627|haploidentical transplantation|haploidentical transplantation
26620|NCT04033627|GVHD|gvhd
26621|NCT04033627|leukemia|leukemia
26622|NCT04033627|TCRab|tcrab
26623|NCT04033627|CD45RA|cd45ra
26624|NCT04033627|CliniMACS|clinimacs
400499|NCT01866605|forced-air warming|forced-air warming
26625|NCT04033614|Laparotomy, open abdomen, fascia, retraction, intraabdominal oedema|laparotomy, open abdomen, fascia, retraction, intraabdominal oedema
26626|NCT04033601|latent class analysis|latent class analysis
26627|NCT04033601|causal-pie analysis|causal-pie analysis
26628|NCT04033601|sleep quality|sleep quality
26629|NCT04033601|precision medicine|precision medicine
26630|NCT04033601|older adults|older adults
26631|NCT04033601|sleep medicine|sleep medicine
26632|NCT04033549|Acute pancreatitis|acute pancreatitis
26633|NCT04033549|Thoracic ultrasound|thoracic ultrasound
26634|NCT04033536|Spine metastasis|spine metastasis
26635|NCT04033536|Stereotactic spine radiosurgery|stereotactic spine radiosurgery
26636|NCT04033536|Target definition|target definition
26637|NCT04033523|heart failure|heart failure
26638|NCT04033523|exercise|exercise
26639|NCT04033523|microparticles|microparticles
26640|NCT04033523|thrombin|thrombin
26641|NCT04033510|atrial fibrillation|atrial fibrillation
26642|NCT04033510|cognitive symptoms|cognitive symptoms
26643|NCT04033510|executive dysfunction|executive dysfunction
26644|NCT04033510|cognitive change|cognitive change
26645|NCT04033510|cognitive impairment|cognitive impairment
26646|NCT04033510|tablet-based cognitive evaluation|tablet-based cognitive evaluation
26647|NCT04033510|Cambridge Cognition|cambridge cognition
26648|NCT04033510|CANTAB|cantab
26649|NCT04033510|Afib|afib
26650|NCT04033497|Brain Tumor|brain tumor
26651|NCT04033484|extralevator abdominoperineal excision|extralevator abdominoperineal excision
26652|NCT04033484|Perineal wound healing|perineal wound healing
26653|NCT04033484|negative pressure wound therapy|negative pressure wound therapy
26654|NCT04033484|biological mesh|biological mesh
26655|NCT04033471|epidural, morphine, midazolam, acute postoperative pain, abdominal cancer surgery|epidural, morphine, midazolam, acute postoperative pain, abdominal cancer surgery
26656|NCT04033406|Influenza A|influenza a
26657|NCT04033393|Executive function|executive function
26658|NCT04033393|Dual-task performance|dual-task performance
26659|NCT04033393|Dual-task training|dual-task training
26660|NCT04033380|Ceramic, Resin Bloc, Endocrown , Root Canal Treatment, Molar|ceramic, resin bloc, endocrown , root canal treatment, molar
26661|NCT04033354|Locally Advanced or Metastatic|locally advanced or metastatic
26863|NCT04032275|HBV DNA|hbv dna
26662|NCT04033354|Squamous Non Small Cell Lung Cancer|squamous non small cell lung cancer
26663|NCT04033302|T-ALL|t-all
26664|NCT04033302|TCL|tcl
26665|NCT04033302|AML|aml
26666|NCT04033302|NK lymphoma|nk lymphoma
26667|NCT04033302|CAR T|car t
26668|NCT04033302|CD7|cd7
26669|NCT04033237|Biomarkers of exposure|biomarkers of exposure
26670|NCT04033237|Compensatory smoking|compensatory smoking
26671|NCT04033237|Nicotine dependence|nicotine dependence
26672|NCT04033237|Reduced nicotine cigarettes|reduced nicotine cigarettes
26673|NCT04033237|Tobacco withdrawal|tobacco withdrawal
26674|NCT04033237|Women|women
26675|NCT04033237|Pregnancy|pregnancy
26676|NCT04033237|Health disparities|health disparities
26677|NCT04033237|Vulnerable populations|vulnerable populations
26678|NCT04033211|Minimal invasive surgery|minimal invasive surgery
26679|NCT04033211|Appendectomy|appendectomy
26680|NCT04033211|Cholecystectomy|cholecystectomy
26681|NCT04033198|Clinico-pathology , acute appendicitis , elderly , aging , histopathology|clinico-pathology , acute appendicitis , elderly , aging , histopathology
26682|NCT04033185|joint position sense|joint position sense
26683|NCT04033185|stroke|stroke
26684|NCT04033185|virtual reality|virtual reality
26685|NCT04033185|robot assisted gait training|robot assisted gait training
26686|NCT04033172|Metastatic Breast Cancer, Pyrotinib, Fulvestrant|metastatic breast cancer, pyrotinib, fulvestrant
26687|NCT04033146|Walking|walking
26688|NCT04033146|Aging|aging
26689|NCT04033146|Exoskeleton Device|exoskeleton device
26690|NCT04033133|Multiple Sclerosis|multiple sclerosis
26691|NCT04033133|tDCS|tdcs
26692|NCT04033133|Cerebral Blood Flow|cerebral blood flow
26693|NCT04033120|HIV|hiv
26694|NCT04033120|talaromycosis|talaromycosis
26695|NCT04033120|endemic mycoses|endemic mycoses
26696|NCT04033120|opportunistic infections|opportunistic infections
26697|NCT04033120|penicilliosis|penicilliosis
26698|NCT04033120|Southeast Asia|southeast asia
26699|NCT04033094|Abuse|abuse
26700|NCT04033094|Misuse|misuse
26701|NCT04033094|Overdose|overdose
26702|NCT04033081|CivaSheet|civasheet
26703|NCT04033081|IORT|iort
26704|NCT04033081|Intraoperative Radiation Therapy|intraoperative radiation therapy
26705|NCT04033081|Brachytherapy|brachytherapy
26706|NCT04033068|Zika virus|zika virus
26707|NCT04033068|mosquito-borne pathogen|mosquito-borne pathogen
26708|NCT04033068|Zika fever|zika fever
26709|NCT04033042|Non-invasive glucose monitoring|non-invasive glucose monitoring
26710|NCT04033042|Raman spectroscopy|raman spectroscopy
26711|NCT04033029|Acute kidney Injury|acute kidney injury
26712|NCT04033029|Sepsis|sepsis
26713|NCT04033029|Antibiotic plasma level|antibiotic plasma level
26714|NCT04033029|CRRT|crrt
26715|NCT04033029|oXiris®|oxiris®
26716|NCT04033003|Antenatal care|antenatal care
26717|NCT04033003|Sub-Saharan Africa|sub-saharan africa
26718|NCT04033003|Ghana|ghana
26719|NCT04032990|pediatric-onset|pediatric-onset
26720|NCT04032990|transcutaneous spinal stimulation|transcutaneous spinal stimulation
26721|NCT04032990|upper extremity function|upper extremity function
26722|NCT04032951|EUS-guided biopsy|eus-guided biopsy
26723|NCT04032938|Cardiopulmonary Bypass|cardiopulmonary bypass
26724|NCT04032938|Gastrointestinal Microbiome|gastrointestinal microbiome
26725|NCT04032938|Thoracic Surgery|thoracic surgery
26726|NCT04032938|Metagenomics|metagenomics
26727|NCT04032938|Metabolomics|metabolomics
26728|NCT04032938|sepsis|sepsis
26729|NCT04032912|Polyp resection|polyp resection
26730|NCT04032912|Colorectal cancer|colorectal cancer
26731|NCT04032899|Probiotics|probiotics
26732|NCT04032899|Gestation|gestation
26733|NCT04032899|Lactation|lactation
26734|NCT04032899|Mastitis|mastitis
26735|NCT04032886|kinesio tape|kinesio tape
26736|NCT04032886|posture|posture
26737|NCT04032886|elastography|elastography
26738|NCT04032873|Distal Radius Fracture|distal radius fracture
26739|NCT04032873|Cost|cost
26740|NCT04032873|Buckle Fracture|buckle fracture
26741|NCT04032860|tenofovir, HBV, HCC, nucleo(t)side analogues, Entecavir|tenofovir, hbv, hcc, nucleo(t)side analogues, entecavir
26742|NCT04032834|Asthma|asthma
26743|NCT04032834|Budesonide|budesonide
26744|NCT04032834|Nebulizer|nebulizer
26745|NCT04032834|Pharmacokinetics|pharmacokinetics
26746|NCT04032834|AKITA JET|akita jet
26747|NCT04032821|Pharmacokinetics|pharmacokinetics
26748|NCT04032821|Alkotinib|alkotinib
26749|NCT04032795|Major Depressive Disorder|major depressive disorder
26750|NCT04032795|Lycium barbarum polysaccharide|lycium barbarum polysaccharide
26751|NCT04032795|depressive symptoms|depressive symptoms
26752|NCT04032795|anxious symptoms|anxious symptoms
26753|NCT04032769|Pulmonary embolism|pulmonary embolism
26754|NCT04032769|PERC Rule|perc rule
26755|NCT04032769|Years Rule|years rule
26756|NCT04032769|Peps Rule|peps rule
26757|NCT04032769|Emergency department|emergency department
26758|NCT04032717|microbicide|microbicide
26759|NCT04032717|enema|enema
26760|NCT04032717|receptive anal intercourse|receptive anal intercourse
26761|NCT04032717|HIV prevention|hiv prevention
26762|NCT04032717|HIV transmission|hiv transmission
26763|NCT04032704|SCLC|sclc
26770|NCT04032678|Myocardial Injury|myocardial injury
26771|NCT04032678|Defibrillators|defibrillators
26772|NCT04032678|Biomarkers|biomarkers
26773|NCT04032652|Pharmacokinetics|pharmacokinetics
26774|NCT04032652|Aminosalicylates|aminosalicylates
26775|NCT04032652|Mucosal levels|mucosal levels
26776|NCT04032652|Rectal dialysis|rectal dialysis
26777|NCT04032639|Prader-Willi Syndrome|prader-willi syndrome
26778|NCT04032639|Magnetoencephalography|magnetoencephalography
26779|NCT04032639|Food Cue Reactivity|food cue reactivity
26780|NCT04032639|Stress|stress
26787|NCT04032613|Hemodialysis|hemodialysis
26788|NCT04032613|Vascular access|vascular access
26789|NCT04032613|Arteriovenous|arteriovenous
26790|NCT04032613|Dialysis|dialysis
26791|NCT04032613|End Stage Renal Disease|end stage renal disease
26792|NCT04032613|Patient-reported outcomes|patient-reported outcomes
26793|NCT04032613|Feasibility|feasibility
26794|NCT04032613|Care process|care process
26795|NCT04032613|Patient education|patient education
26796|NCT04032613|Health system navigation|health system navigation
26797|NCT04032613|Chronic kidney disease|chronic kidney disease
26798|NCT04032587|approach / avoidance|approach / avoidance
26799|NCT04032587|alcohol use disorder|alcohol use disorder
26800|NCT04032587|stress|stress
26801|NCT04032587|stress reduction|stress reduction
26802|NCT04032587|goal-directed decision-making|goal-directed decision-making
26803|NCT04032561|HbA1c|hba1c
26804|NCT04032561|Sleep Quality|sleep quality
26805|NCT04032561|Sleep Duration|sleep duration
26806|NCT04032561|PSQI|psqi
26807|NCT04032535|anti-inflamatory|anti-inflamatory
26808|NCT04032535|PI3K|pi3k
26809|NCT04032535|Sputum|sputum
26810|NCT04032535|COPD|copd
26811|NCT04032535|inhaled|inhaled
26812|NCT04032470|Deep Brain Stimulation|deep brain stimulation
26813|NCT04032470|Boston Scientific|boston scientific
26814|NCT04032470|Essential Tremor|essential tremor
26815|NCT04032457|Contact Lens|contact lens
26816|NCT04032444|Orthopedic Surgery|orthopedic surgery
26817|NCT04032431|Rehabilitation|rehabilitation
26818|NCT04032431|Virtual Reality|virtual reality
26819|NCT04032431|Upper limb|upper limb
26820|NCT04032431|Neurorehabilitation|neurorehabilitation
26821|NCT04032405|connective tissue graft|connective tissue graft
26822|NCT04032392|Hepatocellular carcinoma|hepatocellular carcinoma
26823|NCT04032392|Hepatitis B|hepatitis b
26824|NCT04032366|Hypoxemia|hypoxemia
26825|NCT04032366|Type A acute aortic dissection|type a acute aortic dissection
26826|NCT04032366|inhaled nitric oxide|inhaled nitric oxide
26827|NCT04032301|ketamine|ketamine
26828|NCT04032301|stress disorders, post-traumatic|stress disorders, post-traumatic
26829|NCT04032301|stress disorders, traumatic|stress disorders, traumatic
26830|NCT04032301|anxiety disorders|anxiety disorders
26831|NCT04032301|mental disorders|mental disorders
26832|NCT04032301|adjuvants, anesthesia|adjuvants, anesthesia
26833|NCT04032301|analgesics|analgesics
26834|NCT04032301|anesthetics|anesthetics
26835|NCT04032301|anesthetics, dissociative|anesthetics, dissociative
26836|NCT04032301|anesthetics, general|anesthetics, general
26837|NCT04032301|anesthetics, intravenous|anesthetics, intravenous
26838|NCT04032301|excitatory amino acid agents|excitatory amino acid agents
26839|NCT04032301|excitatory amino acid antagonists|excitatory amino acid antagonists
26840|NCT04032301|hypnotics and sedatives|hypnotics and sedatives
26841|NCT04032301|molecular mechanisms of pharmacological action|molecular mechanisms of pharmacological action
26842|NCT04032301|neurotransmitter agents|neurotransmitter agents
26843|NCT04032301|peripheral nervous system agents|peripheral nervous system agents
26844|NCT04032301|pharmacologic actions|pharmacologic actions
26845|NCT04032301|physiological effects of drugs|physiological effects of drugs
26846|NCT04032301|psychotropic drugs|psychotropic drugs
26847|NCT04032301|sensory system agents|sensory system agents
26848|NCT04032301|central nervous system agents|central nervous system agents
26849|NCT04032301|central nervous system depressants|central nervous system depressants
26850|NCT04032301|depression|depression
26851|NCT04032301|depressive disorder|depressive disorder
26852|NCT04032301|depressive disorder, treatment-resistant|depressive disorder, treatment-resistant
26853|NCT04032301|behavioral symptoms|behavioral symptoms
26854|NCT04032301|mood disorders|mood disorders
26855|NCT04032301|therapeutic uses|therapeutic uses
26856|NCT04032288|ARDS|ards
26857|NCT04032288|Low tidal volume ventilation|low tidal volume ventilation
26858|NCT04032288|Outcomes|outcomes
26859|NCT04032275|chronic hepatitis B|chronic hepatitis b
26860|NCT04032275|HBV|hbv
26870|NCT04032249|Mobile health|mobile health
26871|NCT04032236|caffeine|caffeine
26872|NCT04032236|nicotin|nicotin
26873|NCT04032236|pH|ph
26874|NCT04032223|3D printed coping , overdenture, Implant , cast metal|3d printed coping , overdenture, implant , cast metal
26875|NCT04032171|Evobrutinib|evobrutinib
26876|NCT04032171|Avonex®|avonex®
26877|NCT04032171|Interferon-beta 1a|interferon-beta 1a
26878|NCT04032171|Relapsing Multiple Sclerosis|relapsing multiple sclerosis
26879|NCT04032158|Evobrutinib|evobrutinib
26880|NCT04032158|Avonex®|avonex®
26881|NCT04032158|Interferon-beta 1a|interferon-beta 1a
26882|NCT04032158|Relapsing Multiple Sclerosis|relapsing multiple sclerosis
26883|NCT04032145|Prevention, museum, art|prevention, museum, art
26884|NCT04032132|curcumin|curcumin
26886|NCT04032132|HPLC|hplc
26887|NCT04032132|periodontitis|periodontitis
26890|NCT04032106|HPV|hpv
26891|NCT04032106|Men|men
26892|NCT04032106|Vaccine|vaccine
26893|NCT04032093|Respiratory tract infection|respiratory tract infection
26894|NCT04032093|Respiratory Syncytial Virus|respiratory syncytial virus
26895|NCT04032093|RSV|rsv
26896|NCT04032093|Vaccine|vaccine
26897|NCT04032067|Benign Prostatic Hyperplasia|benign prostatic hyperplasia
26898|NCT04032067|GV1001|gv1001
26899|NCT04032054|thoracolumbar fractures|thoracolumbar fractures
26900|NCT04032041|Ankle Foot Orthosis|ankle foot orthosis
26901|NCT04032041|Adult|adult
26902|NCT04032041|3D Limb Scanning|3d limb scanning
26903|NCT04032041|Limb Geometry|limb geometry
26904|NCT04031963|Novel Biophotonic Methodology for Colon Cancer Screening.|novel biophotonic methodology for colon cancer screening.
26905|NCT04031937|depression|depression
26906|NCT04031937|psychomotor assessment|psychomotor assessment
26907|NCT04031937|sensory profile|sensory profile
26908|NCT04031937|perception|perception
26909|NCT04031937|motricity|motricity
26910|NCT04031924|liver transplantation|liver transplantation
26911|NCT04031924|functional capacity|functional capacity
26912|NCT04031924|kinesiophobia|kinesiophobia
26913|NCT04031924|balance|balance
26914|NCT04031924|physical fitness|physical fitness
26915|NCT04031924|physical activity|physical activity
26916|NCT04031924|muscle strength|muscle strength
26917|NCT04031911|Urinary lithiasis|urinary lithiasis
26918|NCT04031911|Urological treatments|urological treatments
26919|NCT04031911|Spa treatment|spa treatment
26920|NCT04031911|Posturotherapy|posturotherapy
26921|NCT04031911|Lumbar percussions|lumbar percussions
26922|NCT04031911|Hyperdiuresis|hyperdiuresis
26927|NCT04031872|TGF- beta activated|tgf- beta activated
26928|NCT04031859|Total Knee Replacement|total knee replacement
26929|NCT04031859|Venous thromboembolism (VTE)|venous thromboembolism (vte)
26930|NCT04031859|Risk Stratification|risk stratification
26931|NCT04031820|Primary total hip arthroplasty|primary total hip arthroplasty
26932|NCT04031820|Dual Mobility cup|dual mobility cup
26933|NCT04031807|Single-Incision Sling|single-incision sling
26934|NCT04031807|Stress Urinary Incontinence|stress urinary incontinence
26935|NCT04031807|Failure|failure
26936|NCT04031794|Veno-venous ECMO|veno-venous ecmo
26937|NCT04031794|Severe ARDS|severe ards
26938|NCT04031794|Refractory Hypoxemia|refractory hypoxemia
26939|NCT04031781|rTMS = repetitive transcranial magnetic stimulation|rtms = repetitive transcranial magnetic stimulation
26940|NCT04031781|LDLPFC = Left dorsolateral prefrontal cortex|ldlpfc = left dorsolateral prefrontal cortex
26941|NCT04031781|HIT 6 = Headache Impact test|hit 6 = headache impact test
26942|NCT04031781|NPRS = Numeric Pain Rating Scale|nprs = numeric pain rating scale
26943|NCT04031781|ICHD = The international classfication of Headache disorder|ichd = the international classfication of headache disorder
26944|NCT04031781|MT= Motor threshold|mt= motor threshold
26945|NCT04031755|Autism|autism
26946|NCT04031755|Autism Spectrum Disorder|autism spectrum disorder
26947|NCT04031755|Minocycline|minocycline
26948|NCT04031729|Aspirin|aspirin
26949|NCT04031729|Liver Disease|liver disease
26950|NCT04031729|Anti-inflammatory|anti-inflammatory
26951|NCT04031716|Meditation|meditation
26952|NCT04031716|Pectus Excavatum|pectus excavatum
26953|NCT04031716|Scoliosis|scoliosis
26954|NCT04031664|Qianjin Capsule of Gynaecology|qianjin capsule of gynaecology
26955|NCT04031664|efficacy and safety|efficacy and safety
26956|NCT04031664|recurrence rate|recurrence rate
26957|NCT04031664|randomized|randomized
26958|NCT04031664|double blind|double blind
26959|NCT04031664|parallel control|parallel control
26960|NCT04031664|multi-center clinical study|multi-center clinical study
26961|NCT04031651|Pudilan Xiaoyan Oral Liquid|pudilan xiaoyan oral liquid
26964|NCT04031625|Metastatic Colorectal Cancer|metastatic colorectal cancer
26965|NCT04031612|Cancer; Breast, Neoadjuvant|cancer; breast, neoadjuvant
26966|NCT04031599|Type 1 diabetes|type 1 diabetes
26967|NCT04031599|Artificial pancreas|artificial pancreas
26968|NCT04031599|Closed-loop system|closed-loop system
26969|NCT04031599|Insulin|insulin
26970|NCT04031599|Postprandial glucose|postprandial glucose
26971|NCT04031586|Malnutrition|malnutrition
26972|NCT04031586|Childhood Cancer|childhood cancer
26973|NCT04031586|Central America|central america
26974|NCT04031586|Nicaragua|nicaragua
26975|NCT04031573|Septic shock|septic shock
26976|NCT04031573|Ivabradine|ivabradine
26977|NCT04031560|mindfulness|mindfulness
26978|NCT04031560|cognitive therapy|cognitive therapy
26979|NCT04031560|psychoeducation|psychoeducation
26980|NCT04031560|functional remediation|functional remediation
26981|NCT04031534|F-Miso PET scan|f-miso pet scan
26982|NCT04031534|Magnetic resonance imaging|magnetic resonance imaging
26983|NCT04031534|immunohistochemistry|immunohistochemistry
26984|NCT04031534|Head and neck cancer|head and neck cancer
26985|NCT04031508|PPHN|pphn
26986|NCT04031508|Diaphragmatic Hernia|diaphragmatic hernia
26987|NCT04031508|omega 3|omega 3
26988|NCT04031508|DHA and EPA|dha and epa
26989|NCT04031469|Microbiome|microbiome
26990|NCT04031443|prescription pattern|prescription pattern
26991|NCT04031443|antibiotic prophylaxis|antibiotic prophylaxis
26992|NCT04031443|antibiotic resistance|antibiotic resistance
26993|NCT04031430|remote monitoring|remote monitoring
26994|NCT04031430|gestational hypertensive disorders|gestational hypertensive disorders
26995|NCT04031430|pregnancy outcomes|pregnancy outcomes
26996|NCT04031391|physical activity|physical activity
26997|NCT04031391|fibromyalgia|fibromyalgia
26998|NCT04031391|pain|pain
26999|NCT04031391|exercice|exercice
27000|NCT04031391|quality of live|quality of live
27001|NCT04031378|Single Dose Radiotherapy|single dose radiotherapy
27002|NCT04031378|Systemic Therapy|systemic therapy
27003|NCT04031378|IGRT|igrt
27004|NCT04031352|attitude|attitude
27005|NCT04031352|CATCH|catch
27006|NCT04031352|children|children
27007|NCT04031352|disability|disability
27008|NCT04031352|peers|peers
27009|NCT04031339|papillary thyroid cancer|papillary thyroid cancer
27010|NCT04031339|follicular thyroid cancer|follicular thyroid cancer
27011|NCT04031339|poorly differentiated thyroid cancer|poorly differentiated thyroid cancer
27012|NCT04031339|anaplastic thyroid cancer|anaplastic thyroid cancer
27013|NCT04031339|medullary thyroid cancer|medullary thyroid cancer
27014|NCT04031326|home visiting|home visiting
27015|NCT04031326|LENA|lena
27016|NCT04031326|infant language development|infant language development
27017|NCT04031326|parenting|parenting
27018|NCT04031300|Non-invasive glucose monitoring|non-invasive glucose monitoring
27019|NCT04031300|Raman spectroscopy|raman spectroscopy
27020|NCT04031261|Quality of Life|quality of life
27021|NCT04031261|Patient Reported Outcomes|patient reported outcomes
27022|NCT04031248|knee|knee
27023|NCT04031248|whole body vibration|whole body vibration
27024|NCT04031248|therapeutic exercise|therapeutic exercise
27025|NCT04031196|Pediatric|pediatric
27026|NCT04031196|Quadratus Lumborum|quadratus lumborum
27027|NCT04031196|regional anesthesia|regional anesthesia
27028|NCT04031170|Filipino Families|filipino families
27029|NCT04031170|Incredible Years|incredible years
27030|NCT04031157|MDD|mdd
27034|NCT04031092|Exercise|exercise
27035|NCT04031092|Biomedical Technology|biomedical technology
27036|NCT04031079|Weight Loss|weight loss
27037|NCT04031079|Rehabilitation|rehabilitation
27038|NCT04031079|Exercise|exercise
27039|NCT04031079|Biomedical Technology|biomedical technology
27040|NCT04031066|Alpha-Mannosidosis|alpha-mannosidosis
27041|NCT04031066|velmanase alfa|velmanase alfa
27042|NCT04031053|Pharmacokinetics|pharmacokinetics
27043|NCT04031053|Efavirenz|efavirenz
27044|NCT04031053|Penicilliosis|penicilliosis
27045|NCT04031027|apremilast|apremilast
27046|NCT04031027|DARWIN|darwin
27047|NCT04031027|dermatology|dermatology
27048|NCT04031027|retrospective|retrospective
27049|NCT04031027|observational|observational
27050|NCT04031027|psoriasis|psoriasis
27051|NCT04031027|cross-sectional|cross-sectional
27052|NCT04031014|Stress urinary incontinence, urge urinary incontinence, overactive bladder|stress urinary incontinence, urge urinary incontinence, overactive bladder
27053|NCT04030988|Vitiligo|vitiligo
27054|NCT04030988|Narrow-band UVB|narrow-band uvb
27055|NCT04030988|Skin color|skin color
27056|NCT04030988|Minipulse|minipulse
27057|NCT04030975|diagnostic error|diagnostic error
27058|NCT04030949|pediatric proctoscope|pediatric proctoscope
27059|NCT04030949|oral sex,|oral sex,
27060|NCT04030949|anal sex,|anal sex,
27061|NCT04030949|MLST,|mlst,
27062|NCT04030949|vPCR|vpcr
27063|NCT04030949|discordance|discordance
27064|NCT04030949|concordance|concordance
27065|NCT04030936|MIH, knowledge , Molar Incisor Hypomineralization|mih, knowledge , molar incisor hypomineralization
27066|NCT04030910|Life review|life review
27067|NCT04030910|Reminiscence|reminiscence
27068|NCT04030910|Technology|technology
27069|NCT04030910|Existential distress|existential distress
27070|NCT04030910|Virtual travel|virtual travel
27071|NCT04030910|Well-being|well-being
27072|NCT04030884|postoperative nausea and vomiting|postoperative nausea and vomiting
27073|NCT04030884|nursing|nursing
27074|NCT04030884|oral carbohydrate|oral carbohydrate
27075|NCT04030884|honey|honey
27076|NCT04030819|anxiety|anxiety
27077|NCT04030819|multiple sclerosis|multiple sclerosis
27078|NCT04030819|schema therapy|schema therapy
27079|NCT04030806|stroke|stroke
27080|NCT04030806|mirror therapy|mirror therapy
27081|NCT04030806|upper extremity|upper extremity
27082|NCT04030793|Brain Stimulation|brain stimulation
27083|NCT04030793|Transcranial direct current stimulation|transcranial direct current stimulation
27084|NCT04030793|Motor function|motor function
27085|NCT04030780|spore-forming probiotic|spore-forming probiotic
27086|NCT04030780|sporebiotic|sporebiotic
27087|NCT04030780|proton pump inhibitor|proton pump inhibitor
27088|NCT04030780|dyspepsia|dyspepsia
27089|NCT04030754|pediatric burns, dressings, amniotic membrane, duoderm|pediatric burns, dressings, amniotic membrane, duoderm
27090|NCT04030741|Acute Appendicitis.|acute appendicitis.
27091|NCT04030741|Pediatric Appendicitis Score (PAS).|pediatric appendicitis score (pas).
27092|NCT04030741|Visual Analogue Scale (VAS) Score.|visual analogue scale (vas) score.
27093|NCT04030728|patient coaching|patient coaching
27094|NCT04030728|Advanced or metastatic breast cancer|advanced or metastatic breast cancer
27095|NCT04030728|Abemaciclib|abemaciclib
27096|NCT04030728|hormone receptor positive (HR+)|hormone receptor positive (hr+)
27097|NCT04030728|human epidermal growth factor receptor 2 (HER2) negative|human epidermal growth factor receptor 2 (her2) negative
27098|NCT04030715|Gastric Mucosal Pathology|gastric mucosal pathology
27099|NCT04030715|Eradication Rate|eradication rate
27100|NCT04030689|HIV Testing|hiv testing
27101|NCT04030689|Combined HIV prevention|combined hiv prevention
27102|NCT04030689|Linkage to care|linkage to care
27103|NCT04030689|Implementation plan|implementation plan
27104|NCT04030689|Cost-effectiveness|cost-effectiveness
27105|NCT04030676|Immune response against|immune response against
27106|NCT04030676|QuantiFERON-CytoMegaloVirus (QF-CMV)|quantiferon-cytomegalovirus (qf-cmv)
27107|NCT04030676|Ulcerative Colitis (UC)|ulcerative colitis (uc)
27108|NCT04030676|CytoMegaloVirus (CMV)|cytomegalovirus (cmv)
27109|NCT04030676|quantitative PolymeraseChainReaction (qPCR)|quantitative polymerasechainreaction (qpcr)
27110|NCT04030676|ImmunoHistoChemistry (IHC)|immunohistochemistry (ihc)
27111|NCT04030611|Diabetic retinopathy, traditional Chinese medicine(TCM), Diagnositic tools, sensitivity, Blood stasis|diabetic retinopathy, traditional chinese medicine(tcm), diagnositic tools, sensitivity, blood stasis
27112|NCT04030598|IONIS PKK-LRx|ionis pkk-lrx
27113|NCT04030546|anthracycline chemotherapy|anthracycline chemotherapy
27114|NCT04030546|cardiotoxicity|cardiotoxicity
27115|NCT04030546|heart failure|heart failure
27116|NCT04030507|Breast Cancer|breast cancer
27117|NCT04030507|HER2-positive Breast Cancer|her2-positive breast cancer
27118|NCT04030507|Triple Negative Breast Cancer|triple negative breast cancer
27119|NCT04030507|Hormone Receptor Positive Malignant Neoplasm of Breast|hormone receptor positive malignant neoplasm of breast
27120|NCT04030507|Inflammatory Breast Cancer|inflammatory breast cancer
27121|NCT04030507|Metastatic breast cancer|metastatic breast cancer
27122|NCT04030494|blood pressure|blood pressure
27123|NCT04030494|Arrhythmias, Cardiac|arrhythmias, cardiac
27124|NCT04030494|atrial fibrillation|atrial fibrillation
27125|NCT04030494|valvular disease|valvular disease
27126|NCT04030494|blood pressure monitors|blood pressure monitors
27127|NCT04030494|electrocardiography|electrocardiography
27128|NCT04030494|Doppler echocardiography|doppler echocardiography
27129|NCT04030494|Heart diseases|heart diseases
400500|NCT01866592|Psoriasis|psoriasis
37417|NCT03968419|CD8|cd8
27130|NCT04030494|Cardiovascular diseases|cardiovascular diseases
27131|NCT04030481|propofol,sevoflurane|propofol,sevoflurane
27132|NCT04030403|next-generation sequencing|next-generation sequencing
27133|NCT04030403|metagenomics|metagenomics
27134|NCT04030403|microorganism targeted polymerase chain reaction|microorganism targeted polymerase chain reaction
27135|NCT04030403|conventional diagnostic culture|conventional diagnostic culture
27136|NCT04030403|corneal impression membrane|corneal impression membrane
27137|NCT04030338|prostate cancer|prostate cancer
27138|NCT04030338|Metastatic Prostate Cancer|metastatic prostate cancer
27139|NCT04030338|PCWG3|pcwg3
27140|NCT04030338|18 F-DCFPyL|18 f-dcfpyl
27141|NCT04030338|68 Ga-PSMA|68 ga-psma
27142|NCT04030338|19-170|19-170
27143|NCT04030338|Memorial Sloan Kettering Cancer Center|memorial sloan kettering cancer center
27144|NCT04030312|neonatal|neonatal
27145|NCT04030312|newborn|newborn
27146|NCT04030312|hypoglycemia|hypoglycemia
27147|NCT04030312|human milk|human milk
27148|NCT04030312|breastfed|breastfed
27149|NCT04030312|donor milk|donor milk
27150|NCT04030299|Presbycusis|presbycusis
27151|NCT04030299|Hearing aid|hearing aid
27152|NCT04030273|Intrauterine adhesions|intrauterine adhesions
27153|NCT04030273|Abdominal myomectomy|abdominal myomectomy
27154|NCT04030273|Hysteroscopy|hysteroscopy
27155|NCT04030234|Hypertension|hypertension
27156|NCT04030234|Blood pressure target|blood pressure target
27157|NCT04030221|the pressure gradient for venous return|the pressure gradient for venous return
27158|NCT04030221|fluid responsiveness|fluid responsiveness
27159|NCT04030208|respiratory disease|respiratory disease
27160|NCT04030208|low resource settings|low resource settings
27161|NCT04030208|mechanical ventilation|mechanical ventilation
27162|NCT04030208|ventilator performance|ventilator performance
27163|NCT04030208|comparative study|comparative study
27164|NCT04030208|patient safety|patient safety
27165|NCT04030208|ease of use|ease of use
27166|NCT04030169|MDMA|mdma
27167|NCT04030169|methylenedioxymethamphetamine|methylenedioxymethamphetamine
27168|NCT04030169|psychotherapy|psychotherapy
27169|NCT04030156|Size|size
27170|NCT04030156|tonsil|tonsil
27171|NCT04030156|tonsillectomy|tonsillectomy
27172|NCT04030156|ultrasonography|ultrasonography
27173|NCT04030143|Aripiprazole|aripiprazole
27174|NCT04030143|Aripiprazole Intramuscular Depot|aripiprazole intramuscular depot
27175|NCT04030143|Gluteal Muscle|gluteal muscle
27176|NCT04030143|Long Acting Injection|long acting injection
27177|NCT04030078|PEEP|peep
27178|NCT04030078|Alveolar Recruitment Manoeuvres|alveolar recruitment manoeuvres
27179|NCT04030078|Survey|survey
27180|NCT04030052|safety|safety
27181|NCT04030052|immunogenicity|immunogenicity
27182|NCT04030052|hemostatic efficacy|hemostatic efficacy
27183|NCT04030052|prophylactic|prophylactic
27184|NCT04030052|infants|infants
27185|NCT04030052|children|children
27186|NCT04030052|hemostasis|hemostasis
27187|NCT04030039|Chronic hepatitis B|chronic hepatitis b
27188|NCT04030039|interferon|interferon
27189|NCT04030039|nucleotide|nucleotide
27190|NCT04030039|HBV|hbv
27191|NCT04030039|HBsAg|hbsag
27192|NCT04030039|HBV DNA|hbv dna
27193|NCT04030026|Nalbuphine|nalbuphine
27194|NCT04030026|Cough|cough
27195|NCT04030026|Idiopathic Pulmonary Fibrosis|idiopathic pulmonary fibrosis
27196|NCT04030026|Pharmacokinetics|pharmacokinetics
27197|NCT04030013|renal|renal
27198|NCT04030013|diabetes|diabetes
27199|NCT04030013|outcome|outcome
27200|NCT04030013|transplant|transplant
27201|NCT04030013|Education|education
27202|NCT04029974|Spinal cord injury|spinal cord injury
27203|NCT04029974|Orthostatic hypotension|orthostatic hypotension
27204|NCT04029974|Verticalization|verticalization
27205|NCT04029974|ErigoPro|erigopro
27206|NCT04029974|Finapres Nova|finapres nova
27207|NCT04029961|Patient education|patient education
27208|NCT04029896|CP|cp
27209|NCT04029896|stem cells|stem cells
27210|NCT04029896|MSCs|mscs
27211|NCT04029896|spastic|spastic
27212|NCT04029896|paralysis|paralysis
27213|NCT04029896|cerebral palsy|cerebral palsy
27214|NCT04029870|Osteoporosis|osteoporosis
27215|NCT04029870|adherence to therapy|adherence to therapy
27216|NCT04029870|psychological determinants|psychological determinants
27217|NCT04029870|self regulation model|self regulation model
27218|NCT04029818|LDL-cholesterol|ldl-cholesterol
27219|NCT04029818|Probiotics|probiotics
27220|NCT04029805|Polycystic ovarian syndrome|polycystic ovarian syndrome
27221|NCT04029805|Extract plant|extract plant
27222|NCT04029805|Probiotics|probiotics
27223|NCT04029805|Insulin resistance|insulin resistance
27224|NCT04029792|Plant extract|plant extract
27225|NCT04029792|Joint Mobility|joint mobility
27226|NCT04029792|Physical performance|physical performance
27227|NCT04029792|Vitality|vitality
27228|NCT04029779|Injectable platelet rich fibrin|injectable platelet rich fibrin
27229|NCT04029779|Bone density|bone density
27230|NCT04029779|Crestal bone loss|crestal bone loss
27231|NCT04029779|Immediate implants|immediate implants
27232|NCT04029753|Early Mobilization|early mobilization
27233|NCT04029727|Plant extract|plant extract
27234|NCT04029727|LDL cholesterol|ldl cholesterol
27235|NCT04029727|Dietary supplement|dietary supplement
27236|NCT04029714|Prostate Cancer|prostate cancer
27237|NCT04029714|Active Surveillance|active surveillance
27238|NCT04029714|MRI|mri
27239|NCT04029714|standardised treatment triggers|standardised treatment triggers
27240|NCT04029714|randomized|randomized
27241|NCT04029701|Ruyizhenbao Pill|ruyizhenbao pill
27242|NCT04029701|Post-stroke|post-stroke
27243|NCT04029701|Motor dysfunction|motor dysfunction
27244|NCT04029701|Sensory dysfunction|sensory dysfunction
27245|NCT04029675|Vitamin C|vitamin c
27246|NCT04029675|Sepsis|sepsis
27247|NCT04029675|Intensive care unit|intensive care unit
27248|NCT04029675|Mechanically ventilation|mechanically ventilation
27249|NCT04029675|VAP|vap
27250|NCT04029649|Beta-1,3/1,6-D-Glucan|beta-1,3/1,6-d-glucan
27251|NCT04029649|Ganoderma lucidum|ganoderma lucidum
27252|NCT04029649|Ulcerative colitis|ulcerative colitis
27253|NCT04029584|drug-drug interaction|drug-drug interaction
27254|NCT04029584|statin|statin
27255|NCT04029584|rifampin|rifampin
27256|NCT04029571|Obesity|obesity
27257|NCT04029571|Fasting-mimicking diet|fasting-mimicking diet
27262|NCT04029532|Respiratory exchange ratio|respiratory exchange ratio
27263|NCT04029532|Body image|body image
27264|NCT04029532|Heart rate variability|heart rate variability
27265|NCT04029493|Re-infection|re-infection
27266|NCT04029467|ESP block|esp block
27267|NCT04029467|erector spinae plane block|erector spinae plane block
27268|NCT04029467|mastectomy|mastectomy
27269|NCT04029467|ropivacaine|ropivacaine
27270|NCT04029467|dexmedetomidine|dexmedetomidine
27271|NCT04029467|pain|pain
27272|NCT04029467|breast|breast
27273|NCT04029454|Infectious Disease Transmission, Vertical|infectious disease transmission, vertical
27274|NCT04029454|immunization programs|immunization programs
27275|NCT04029428|PRRT - Peptide Receptor Radionuclide Therapy,|prrt - peptide receptor radionuclide therapy,
27276|NCT04029428|GEP-NET - Gastro-Entero-Pancreatic Neuroendocrine Tumours;|gep-net - gastro-entero-pancreatic neuroendocrine tumours;
27277|NCT04029428|BPCs - Bronchopulmonary Carcinoids (Atypical & Typical)|bpcs - bronchopulmonary carcinoids (atypical & typical)
27278|NCT04029428|PPGLs - Pheochromocytomas/Paragangliomas;|ppgls - pheochromocytomas/paragangliomas;
27279|NCT04029428|NET-CUP - Neuroendocrine Tumours of unknown primary|net-cup - neuroendocrine tumours of unknown primary
27280|NCT04029428|clinical efficacy|clinical efficacy
27281|NCT04029428|toxcity - adverse events (AEs)|toxcity - adverse events (aes)
27282|NCT04029428|OS - overall survival|os - overall survival
27283|NCT04029428|PFS - progression free survival|pfs - progression free survival
27284|NCT04029415|antimicrobial resistance|antimicrobial resistance
27285|NCT04029389|Plantar Fascitis|plantar fascitis
27286|NCT04029389|Tibial Nerve|tibial nerve
27287|NCT04029389|Injections|injections
27288|NCT04029389|Ultrasonography|ultrasonography
27289|NCT04029285|Exergaming|exergaming
27290|NCT04029285|Exercise Therapy|exercise therapy
27291|NCT04029285|Musculoskeletal Pain|musculoskeletal pain
27292|NCT04029285|Aged, Aged 80 and Over|aged, aged 80 and over
27293|NCT04029285|Postural Balance|postural balance
27294|NCT04029285|Flow state experience|flow state experience
27295|NCT04029285|Technology acceptance|technology acceptance
27296|NCT04029285|Heart Rate|heart rate
27297|NCT04029272|PCOS|pcos
27298|NCT04029272|GLP-1|glp-1
27299|NCT04029272|GLP-1RA|glp-1ra
27300|NCT04029272|exenatide|exenatide
27301|NCT04029272|Metformin|metformin
27302|NCT04029272|glucagon-like peptide 1|glucagon-like peptide 1
27303|NCT04029272|glucagon-like peptide 1 receptor agonist|glucagon-like peptide 1 receptor agonist
27304|NCT04029220|Patient Navigation|patient navigation
27305|NCT04029220|Mental Health Services|mental health services
27306|NCT04029155|peripheral pulmonary nodules|peripheral pulmonary nodules
27307|NCT04029155|ultrathin bronchoscope|ultrathin bronchoscope
27308|NCT04029155|transbronchial needle aspiration|transbronchial needle aspiration
27309|NCT04029142|thalassemia|thalassemia
27310|NCT04029142|sickle cell anaemia|sickle cell anaemia
27311|NCT04029142|molecular genetic analysis|molecular genetic analysis
27312|NCT04029129|Traffic-related air pollution|traffic-related air pollution
27313|NCT04029129|Air filtration|air filtration
27314|NCT04029129|Blood pressure|blood pressure
27315|NCT04029129|Controlled exposure|controlled exposure
27316|NCT04029116|Recurrent yeast infection|recurrent yeast infection
27317|NCT04029116|Recurrent yeast vaginitis|recurrent yeast vaginitis
27318|NCT04029116|Chronic yeast vaginitis|chronic yeast vaginitis
27319|NCT04029116|Ibrexafungerp|ibrexafungerp
27320|NCT04029116|SCY-078|scy-078
27321|NCT04029116|RVVC|rvvc
27322|NCT04029103|Diabetic foot|diabetic foot
27323|NCT04029103|health technology|health technology
27324|NCT04029103|mobile application|mobile application
27325|NCT04029064|right aortic arch|right aortic arch
27326|NCT04029064|congenital heart disease|congenital heart disease
27327|NCT04029064|pediatrics|pediatrics
27328|NCT04029064|cardiology|cardiology
27329|NCT04029064|prenatal diagnosis|prenatal diagnosis
27330|NCT04029025|conventional porcelain-fused-to metal iFDP|conventional porcelain-fused-to metal ifdp
27331|NCT04029025|Dentalwings DWOS Intraoral Scan|dentalwings dwos intraoral scan
27332|NCT04029025|3Shape TRIOS Pod Intraoral Scan|3shape trios pod intraoral scan
27333|NCT04029025|Dentalwings DWOS Implant Prosthetics Lab-Software|dentalwings dwos implant prosthetics lab-software
27334|NCT04029025|Straumann CARES Lab-Software|straumann cares lab-software
27335|NCT04029025|digital implant workflow|digital implant workflow
27336|NCT04029025|CAD/CAM-technology|cad/cam-technology
27337|NCT04028999|Cerebrovascular Accident|cerebrovascular accident
27338|NCT04028999|sling|sling
27339|NCT04028999|Upper limb impairment|upper limb impairment
27340|NCT04028986|ulipristalacetate|ulipristalacetate
27341|NCT04028986|fertility treatment|fertility treatment
27342|NCT04028986|IVF/ICSI|ivf/icsi
27343|NCT04028986|fibroid|fibroid
27446|NCT04028453|karyotype analysis|karyotype analysis
27349|NCT04028908|ventral tilting of the tibial plateau|ventral tilting of the tibial plateau
27350|NCT04028908|anterior tilt angle|anterior tilt angle
27351|NCT04028908|proximal tibia epiphyseal plate|proximal tibia epiphyseal plate
27352|NCT04028895|IRAP|irap
27353|NCT04028895|Insulin Regulated Amino Peptidase|insulin regulated amino peptidase
27354|NCT04028869|Autoimmune liver disease|autoimmune liver disease
27355|NCT04028869|glycyrrhizic acid|glycyrrhizic acid
27356|NCT04028869|liver function|liver function
27357|NCT04028856|Chronic hepatitis B|chronic hepatitis b
27358|NCT04028856|interferon|interferon
27359|NCT04028856|intermittent|intermittent
27360|NCT04028856|HBV|hbv
27361|NCT04028856|HBsAg|hbsag
27362|NCT04028856|HBV DNA|hbv dna
27363|NCT04028817|parkinson's disease|parkinson's disease
27364|NCT04028817|Photobiomodulation|photobiomodulation
27365|NCT04028817|Inflammation|inflammation
27366|NCT04028817|Oxidative stress|oxidative stress
27367|NCT04028804|Hodgkin's Lymphoma|hodgkin's lymphoma
27368|NCT04028804|Non-Hodgkin's Lymphoma|non-hodgkin's lymphoma
27369|NCT04028804|Possitron Emission Therapy (PET)|possitron emission therapy (pet)
27370|NCT04028804|FDG PET|fdg pet
27371|NCT04028804|FLT PET|flt pet
27372|NCT04028804|Pediatrics|pediatrics
27373|NCT04028791|Exercise, sickling, rhamdomyolysis, oxidative stress|exercise, sickling, rhamdomyolysis, oxidative stress
27374|NCT04028752|macrophage|macrophage
27375|NCT04028752|microgravity|microgravity
27376|NCT04028752|blood|blood
27377|NCT04028752|cardiovascular disease|cardiovascular disease
27378|NCT04028713|Therapeutic drug monitoring|therapeutic drug monitoring
27379|NCT04028713|Psoriasis|psoriasis
27380|NCT04028713|Adalimumab|adalimumab
27381|NCT04028622|ambulatory|ambulatory
27382|NCT04028622|anesthesia|anesthesia
27383|NCT04028622|consultation|consultation
27384|NCT04028622|telemedicine|telemedicine
27385|NCT04028609|30-day readmission|30-day readmission
27386|NCT04028609|primary care|primary care
27387|NCT04028609|community health worker|community health worker
27388|NCT04028609|health education|health education
27389|NCT04028596|Epilepsy|epilepsy
27390|NCT04028596|Depression|depression
27391|NCT04028596|Electroconvulsive Therapy|electroconvulsive therapy
27392|NCT04028596|Postictal|postictal
27393|NCT04028596|Clinical Trial|clinical trial
27394|NCT04028596|Postictal hypoperfusion/hypoxia|postictal hypoperfusion/hypoxia
27395|NCT04028583|Inappropriate Prescribing|inappropriate prescribing
27396|NCT04028583|Potentially Inappropriate Medication List|potentially inappropriate medication list
27397|NCT04028583|Aged|aged
27398|NCT04028583|Practice Guideline|practice guideline
27399|NCT04028583|Education, Medical|education, medical
27400|NCT04028570|Radiation|radiation
27401|NCT04028570|Boost Radiation Therapy|boost radiation therapy
27402|NCT04028570|Background Radiation Therapy|background radiation therapy
27403|NCT04028570|Surgery|surgery
27404|NCT04028570|Extensive Pleural Resection|extensive pleural resection
27405|NCT04028544|heart failure|heart failure
27406|NCT04028544|traditional Chinese medicine|traditional chinese medicine
27407|NCT04028544|prognosis|prognosis
27408|NCT04028544|Qishenyiqi|qishenyiqi
27409|NCT04028531|Chronic Lymphocytic Leukemia|chronic lymphocytic leukemia
27410|NCT04028505|Terlipressin Drug|terlipressin drug
27411|NCT04028505|Continuous Infusion|continuous infusion
27412|NCT04028505|Bolus Form|bolus form
27413|NCT04028492|gastroparesis|gastroparesis
27414|NCT04028492|idiopathic|idiopathic
27415|NCT04028492|diabetic|diabetic
27416|NCT04028492|tradipitant|tradipitant
27417|NCT04028492|nausea|nausea
27418|NCT04028492|vomiting|vomiting
27419|NCT04028492|stomach|stomach
27420|NCT04028492|motility|motility
27421|NCT04028492|functional|functional
27422|NCT04028492|NK-1 antagonist|nk-1 antagonist
27423|NCT04028492|neurokinin 1 receptor|neurokinin 1 receptor
27424|NCT04028492|substance p|substance p
27425|NCT04028479|Precision Medicine|precision medicine
27426|NCT04028479|Molecular Sequence Data|molecular sequence data
27427|NCT04028479|Databases, Genetic|databases, genetic
809544|NCT00212147|anesthesia|anesthesia
27428|NCT04028479|High-Throughput Nucleotide Sequencing|high-throughput nucleotide sequencing
27429|NCT04028479|Massively-Parallel Sequencing|massively-parallel sequencing
27430|NCT04028479|Observational Study|observational study
27431|NCT04028479|Treatment|treatment
27432|NCT04028479|Patient Outcome Assessment|patient outcome assessment
27433|NCT04028479|Adaptive clinical trial|adaptive clinical trial
27434|NCT04028479|Molecular Typing|molecular typing
27435|NCT04028479|Response Rate|response rate
27436|NCT04028479|Progression Free Survival|progression free survival
27437|NCT04028479|Overall Survival|overall survival
27438|NCT04028466|GERD|gerd
27439|NCT04028466|gastro esophageal reflux|gastro esophageal reflux
27440|NCT04028466|proton pump inhibitor|proton pump inhibitor
27441|NCT04028466|Potassium-Competitive Acid Blocker|potassium-competitive acid blocker
27442|NCT04028466|H(+)-K(+)-Exchanging ATPase|h(+)-k(+)-exchanging atpase
27443|NCT04028466|Randomized Controlled Trial|randomized controlled trial
27444|NCT04028453|Increased nuchal translucency|increased nuchal translucency
27445|NCT04028453|prenatal diagnosis|prenatal diagnosis
27646|NCT04026880|Androgens|androgens
27447|NCT04028453|chromosome micro-array analysis|chromosome micro-array analysis
27448|NCT04028453|neurodevelopmental disorders|neurodevelopmental disorders
27449|NCT04028453|euploid children|euploid children
27450|NCT04028375|Gastric Cancer|gastric cancer
27451|NCT04028375|MRI|mri
27452|NCT04028375|MSCT|msct
27453|NCT04028375|Staging|staging
27454|NCT04028375|Prediction and Prognosis|prediction and prognosis
27455|NCT04028323|Functional MRI|functional mri
27456|NCT04028323|Terlipressin|terlipressin
27457|NCT04028323|Octreotide|octreotide
27458|NCT04028323|Renal function disorder|renal function disorder
27459|NCT04028323|Acute variceal bleeding|acute variceal bleeding
27460|NCT04028297|Shock|shock
27461|NCT04028297|emergency|emergency
27462|NCT04028297|undifferentiated|undifferentiated
27463|NCT04028297|ultrasound|ultrasound
27464|NCT04028284|epidural|epidural
27465|NCT04028284|analgesia|analgesia
27466|NCT04028284|Virtual reality|virtual reality
27467|NCT04028271|needle-free injection|needle-free injection
27468|NCT04028271|pain|pain
27469|NCT04028258|Constipation|constipation
27470|NCT04028258|Fiber|fiber
27471|NCT04028232|Multiple Sclerosis|multiple sclerosis
27472|NCT04028232|Epidemiology|epidemiology
27473|NCT04028232|Socio-Economic Status|socio-economic status
27474|NCT04028232|Net Survival|net survival
27475|NCT04028206|vibration treatment|vibration treatment
27476|NCT04028206|sarcopenia|sarcopenia
27477|NCT04028206|elastic-band resistance|elastic-band resistance
27478|NCT04028206|hydroxylmethylbutyrate|hydroxylmethylbutyrate
27479|NCT04028206|elderly|elderly
27480|NCT04028206|randomized control trial|randomized control trial
27481|NCT04028193|Dumping syndrome|dumping syndrome
27482|NCT04028193|Fat supplement|fat supplement
27483|NCT04028193|post bariatric surgery|post bariatric surgery
27484|NCT04028167|Resectable|resectable
27485|NCT04028141|ketofol|ketofol
27486|NCT04028141|propofol|propofol
27487|NCT04028141|ketamine|ketamine
27488|NCT04028141|emergency department|emergency department
27489|NCT04028128|Nutritional Supplement|nutritional supplement
27490|NCT04028128|High in flavanoids cocoa|high in flavanoids cocoa
27491|NCT04028128|Body Fat composition|body fat composition
27492|NCT04028128|Physical Exercise performance|physical exercise performance
27493|NCT04028115|WH 540|wh 540
27494|NCT04028102|sepsis|sepsis
27495|NCT04028102|treatment|treatment
27496|NCT04028102|fluid challenge|fluid challenge
27497|NCT04028076|Peer Support|peer support
27498|NCT04028076|Type2 Diabetes|type2 diabetes
27499|NCT04028076|African American|african american
27500|NCT04027985|Kinesiotaping|kinesiotaping
27501|NCT04027985|Spasticity|spasticity
27502|NCT04027985|Elastosonography|elastosonography
27503|NCT04027985|Stroke|stroke
27504|NCT04027972|Neostigmine, Glycopyrrolate, Transdermal, Intravenous, Pharmacokinetic, Constipation, Bowel Control, Mass Spectroscopy, Stool Incontinence|neostigmine, glycopyrrolate, transdermal, intravenous, pharmacokinetic, constipation, bowel control, mass spectroscopy, stool incontinence
27505|NCT04027946|Immunotherapy|immunotherapy
27506|NCT04027946|Checkpoint Inhibitor|checkpoint inhibitor
27507|NCT04027946|Monoclonal Antibody|monoclonal antibody
27508|NCT04027946|Lung Adenocarcinoma|lung adenocarcinoma
27509|NCT04027933|Psychiatric nursing|psychiatric nursing
27510|NCT04027933|Simulation|simulation
27511|NCT04027933|Standardized patients|standardized patients
27512|NCT04027920|postpartum hemorrhage|postpartum hemorrhage
27513|NCT04027842|Perioperative hypothermia|perioperative hypothermia
27514|NCT04027842|Core body temperature|core body temperature
27515|NCT04027842|Prewarming|prewarming
27516|NCT04027842|Gynecologic laparoscopic surgery|gynecologic laparoscopic surgery
27517|NCT04027829|dexmedetomidine|dexmedetomidine
27518|NCT04027829|pediatric|pediatric
27519|NCT04027829|sedation|sedation
27520|NCT04027816|PLA2G6-related NBIA|pla2g6-related nbia
27521|NCT04027816|INAD|inad
27522|NCT04027816|PLA2G6|pla2g6
27523|NCT04027790|plasma|plasma
27524|NCT04027790|cell-free DNA|cell-free dna
27525|NCT04027790|DNA Methylation|dna methylation
27526|NCT04027764|advanced biliary tract cancer|advanced biliary tract cancer
27527|NCT04027764|Albumin Paclitaxel|albumin paclitaxel
27528|NCT04027764|s1|s1
27529|NCT04027764|Toripalimab|toripalimab
27530|NCT04027751|tropisetron|tropisetron
27531|NCT04027751|emergence delirium|emergence delirium
27532|NCT04027751|postoperative delirium|postoperative delirium
27533|NCT04027738|knee|knee
27534|NCT04027738|Osteoarthritis|osteoarthritis
27535|NCT04027738|Platelet rich plasma|platelet rich plasma
27536|NCT04027725|Mild cognitive Impairment|mild cognitive impairment
27537|NCT04027725|Neurofeedback|neurofeedback
27538|NCT04027725|Electroencephalography|electroencephalography
27539|NCT04027725|Memory|memory
27540|NCT04027725|Attention|attention
27541|NCT04027699|Mini-bolus challenge|mini-bolus challenge
27542|NCT04027699|fluid responsiveness|fluid responsiveness
27543|NCT04027699|volemic expansion|volemic expansion
27544|NCT04027699|pediatric septic shock|pediatric septic shock
27545|NCT04027699|severe sepsis|severe sepsis
27546|NCT04027699|microcirculation|microcirculation
27548|NCT04027686|Non-surgical periodontal therapy|non-surgical periodontal therapy
27549|NCT04027686|Scaling and root planing|scaling and root planing
27550|NCT04027660|dentistry|dentistry
27551|NCT04027660|zirconia|zirconia
27552|NCT04027660|implants|implants
27553|NCT04027647|Stage 3B NSCLC|stage 3b nsclc
27554|NCT04027647|Stage 4 NSCLC|stage 4 nsclc
27555|NCT04027647|Vizimpro|vizimpro
27556|NCT04027647|EGFR TKI|egfr tki
27557|NCT04027647|Tyrosine Kinase Inhibitor|tyrosine kinase inhibitor
27558|NCT04027634|Baduanjin program|baduanjin program
27559|NCT04027634|body mass index|body mass index
27560|NCT04027634|metabolic parameters|metabolic parameters
27561|NCT04027634|schizophrenia|schizophrenia
27562|NCT04027608|adolescent, obesity, food reinforcement, sensitization|adolescent, obesity, food reinforcement, sensitization
27563|NCT04027582|ORSIM|orsim
27564|NCT04027582|Entrustable Professional Activity|entrustable professional activity
27565|NCT04027543|Neoadjuvant chemoradiotherapy|neoadjuvant chemoradiotherapy
27566|NCT04027543|Neoadjuvant chemotherapy|neoadjuvant chemotherapy
27567|NCT04027543|Resectable oesophageal carcinoma|resectable oesophageal carcinoma
27568|NCT04027543|Effective|effective
27569|NCT04027543|Safety|safety
27570|NCT04027491|Rehabilitation|rehabilitation
27571|NCT04027491|Upper limbs|upper limbs
27572|NCT04027491|Virtual Reality|virtual reality
27573|NCT04027478|fasting|fasting
27574|NCT04027478|chemotherapy|chemotherapy
27575|NCT04027452|electroconvulsive therapy|electroconvulsive therapy
27576|NCT04027452|post traumatic stress disorder|post traumatic stress disorder
27578|NCT04027413|Pulmonary Rehabilitation|pulmonary rehabilitation
27579|NCT04027413|Nutrtional supplements|nutrtional supplements
27580|NCT04027400|survivor|survivor
27581|NCT04027400|cognitive rehabilitation|cognitive rehabilitation
27582|NCT04027348|bowel obstruction|bowel obstruction
27583|NCT04027335|Fecal incontinence|fecal incontinence
27584|NCT04027335|Women|women
27585|NCT04027322|Pharyngitis|pharyngitis
27586|NCT04027322|Sore Throat|sore throat
27587|NCT04027322|Glucocorticoids|glucocorticoids
27588|NCT04027322|Nebulizers|nebulizers
27589|NCT04027244|Peripheral arterial disease|peripheral arterial disease
27590|NCT04027244|Limb salvage|limb salvage
27591|NCT04027244|Frailty|frailty
27592|NCT04027244|Cognitive dysfunction|cognitive dysfunction
27593|NCT04027244|Myocardial perfusion imaging|myocardial perfusion imaging
27594|NCT04027244|Biomarkers|biomarkers
27595|NCT04027218|venipuncture|venipuncture
27596|NCT04027218|hemolysis|hemolysis
27597|NCT04027218|heat|heat
27598|NCT04027218|pressure|pressure
27599|NCT04027218|safety|safety
27600|NCT04027127|netrin-1|netrin-1
27601|NCT04027127|acs|acs
27602|NCT04027127|reperfuzion|reperfuzion
27603|NCT04027114|randomized controlled trial|randomized controlled trial
27604|NCT04027114|multiple sclerosis|multiple sclerosis
27605|NCT04027114|physiotherapy|physiotherapy
27606|NCT04027114|behaviour change|behaviour change
27607|NCT04027114|physical activity|physical activity
27608|NCT04027114|exercise|exercise
27609|NCT04027114|disability progression|disability progression
27610|NCT04027114|walking function|walking function
27611|NCT04027088|immunonutrition|immunonutrition
27612|NCT04027088|surgery|surgery
27613|NCT04027088|postoperative complications|postoperative complications
27614|NCT04027088|length of hospital stay|length of hospital stay
27615|NCT04027088|nutritional status|nutritional status
27616|NCT04027075|Adolescent|adolescent
27617|NCT04027075|Alcohol|alcohol
27618|NCT04027075|Marijuana|marijuana
27619|NCT04027075|Mindfulness|mindfulness
27620|NCT04027062|Diabetes, Continuing education, Attitude, Practice, Health care physicians|diabetes, continuing education, attitude, practice, health care physicians
27621|NCT04027049|rehabilitation|rehabilitation
27622|NCT04027049|cycle ergometry|cycle ergometry
27623|NCT04027036|Vaccine|vaccine
27624|NCT04027036|Polio Virus|polio virus
38043|NCT03964493|ABSSSI|absssi
27625|NCT04027010|juvenile justice|juvenile justice
27626|NCT04027010|male-focused intervention|male-focused intervention
27627|NCT04027010|unplanned teen fatherhood|unplanned teen fatherhood
27628|NCT04027010|technology-based intervention|technology-based intervention
27629|NCT04026971|obesity|obesity
27630|NCT04026971|phone application|phone application
27631|NCT04026971|nutrition education|nutrition education
27632|NCT04026958|Neurology|neurology
27633|NCT04026945|chronic scrotal pain|chronic scrotal pain
27634|NCT04026945|chronic testicular pain|chronic testicular pain
27635|NCT04026945|spermatic cord|spermatic cord
27636|NCT04026945|orchialgia|orchialgia
27637|NCT04026945|chronic scrotal content pain|chronic scrotal content pain
27638|NCT04026932|subjective tinnitus|subjective tinnitus
27639|NCT04026932|tinnitus relieving sound|tinnitus relieving sound
27640|NCT04026932|clinical effects|clinical effects
27641|NCT04026906|skin glue|skin glue
27642|NCT04026906|dermabond|dermabond
27643|NCT04026906|randomized controlled trial|randomized controlled trial
27644|NCT04026906|intravenous catheter|intravenous catheter
27645|NCT04026893|AUFI|aufi
27650|NCT04026854|Quality of life at work;Nurse;Quality of care;psychiatric|quality of life at work;nurse;quality of care;psychiatric
27652|NCT04026841|ground-glass density|ground-glass density
27653|NCT04026828|chronic periodontitis|chronic periodontitis
27654|NCT04026828|aggressive periodontitis|aggressive periodontitis
27655|NCT04026828|expression|expression
27656|NCT04026828|polymorphism|polymorphism
27657|NCT04026828|mutation|mutation
27658|NCT04026802|deconditioning of elderly inpatients|deconditioning of elderly inpatients
27659|NCT04026802|loss of functionality|loss of functionality
27660|NCT04026776|Uric Acid sensitivity|uric acid sensitivity
27661|NCT04026776|Salt sensitivity|salt sensitivity
27662|NCT04026776|Blood Pressure Influences|blood pressure influences
27663|NCT04026763|Targeted Prostate Biopsy|targeted prostate biopsy
27664|NCT04026737|Cardiotoxicity of Cancer Therapy|cardiotoxicity of cancer therapy
27665|NCT04026737|Cardio-Oncology|cardio-oncology
27666|NCT04026737|CART Cell Therapy|cart cell therapy
27667|NCT04026685|caesarean delivery|caesarean delivery
27668|NCT04026685|phenylephrine|phenylephrine
27669|NCT04026685|spinal anaesthesia|spinal anaesthesia
27670|NCT04026685|vasopressor administration|vasopressor administration
27671|NCT04026685|pregnancy|pregnancy
27672|NCT04026685|non invasive cardiac output (CO) monitoring (NICOM)|non invasive cardiac output (co) monitoring (nicom)
27673|NCT04026659|Exercise|exercise
27674|NCT04026659|Rehabilitation|rehabilitation
27675|NCT04026646|Flexibility|flexibility
27676|NCT04026646|Proprioception|proprioception
27677|NCT04026646|Physical Performance|physical performance
27678|NCT04026633|Alcohol Intervention|alcohol intervention
27679|NCT04026633|College Students|college students
27680|NCT04026620|alcohol use and abuse|alcohol use and abuse
27681|NCT04026620|prenatal alcohol use|prenatal alcohol use
27682|NCT04026607|Sarcopenia|sarcopenia
27684|NCT04026607|Aging|aging
27685|NCT04026607|Muscle Protein Synthesis|muscle protein synthesis
27686|NCT04026594|burnout prevention|burnout prevention
27687|NCT04026594|emotional exhaustion|emotional exhaustion
27688|NCT04026594|mindfulness|mindfulness
27689|NCT04026594|medical students|medical students
27690|NCT04026594|empathy|empathy
27691|NCT04026568|Peripheral nerve trauma|peripheral nerve trauma
27692|NCT04026568|laceration|laceration
27693|NCT04026568|blast injury|blast injury
27694|NCT04026568|mangled limb|mangled limb
27695|NCT04026555|Medical Early Warning Systems|medical early warning systems
27696|NCT04026555|Patient Monitoring|patient monitoring
27697|NCT04026555|Electronic Health Record|electronic health record
27698|NCT04026555|Big Data|big data
27699|NCT04026555|Critical Care|critical care
27700|NCT04026555|Machine Learning|machine learning
27701|NCT04026542|VO2max|vo2max
27702|NCT04026542|Fontan|fontan
27703|NCT04026542|Congenital heart disease|congenital heart disease
27704|NCT04026542|Single ventricle|single ventricle
27705|NCT04026529|pulmonary rehabilitation|pulmonary rehabilitation
27706|NCT04026516|eye movements|eye movements
27707|NCT04026516|Electronystagmograpy|electronystagmograpy
27708|NCT04026516|nystagmus|nystagmus
27709|NCT04026516|electrooculogram|electrooculogram
27710|NCT04026516|vestibular assessment|vestibular assessment
27711|NCT04026516|ambulatory monitoring|ambulatory monitoring
27712|NCT04026503|Rehabilitation|rehabilitation
27713|NCT04026503|Aging|aging
27714|NCT04026503|Mobility Skills|mobility skills
27720|NCT04026425|cardiopulmonary exercise test (CPET)|cardiopulmonary exercise test (cpet)
27721|NCT04026425|post-exertional malaise (PEM)|post-exertional malaise (pem)
27722|NCT04026399|physical stimulation|physical stimulation
27723|NCT04026399|Subliminal stimulation|subliminal stimulation
27724|NCT04026399|stroke rehabilitation|stroke rehabilitation
27725|NCT04026399|upper extremity|upper extremity
27726|NCT04026399|paresis|paresis
27727|NCT04026399|hand function|hand function
27728|NCT04026399|occupational therapy|occupational therapy
27729|NCT04026399|physical therapy|physical therapy
27730|NCT04026360|Infants|infants
27731|NCT04026360|Cystic Fibrosis|cystic fibrosis
27732|NCT04026360|Inflammation|inflammation
27733|NCT04026360|Microbiome|microbiome
27734|NCT04026360|Airway growth|airway growth
27735|NCT04026360|Airway development|airway development
27736|NCT04026360|Genetic predisposition|genetic predisposition
27737|NCT04026360|Tobacco|tobacco
27738|NCT04026347|SUI|sui
27739|NCT04026347|Women|women
27740|NCT04026347|Incontinence|incontinence
27741|NCT04026308|Suicide|suicide
27742|NCT04026308|Suicide Prevention|suicide prevention
27743|NCT04026308|Safety Planning|safety planning
27744|NCT04026308|My3 App|my3 app
27745|NCT04026295|treadmill training|treadmill training
27746|NCT04026295|gait|gait
27747|NCT04026295|short burst interval locomotor training|short burst interval locomotor training
27748|NCT04026295|spastic|spastic
27749|NCT04026282|assisted reproductive technology|assisted reproductive technology
27750|NCT04026282|live birth|live birth
27751|NCT04026282|fertilization|fertilization
27752|NCT04026269|MOAP; Relapsed/Refractory; Hodgkin Lymphoma; DP;|moap; relapsed/refractory; hodgkin lymphoma; dp;
27753|NCT04026256|osteoporosis|osteoporosis
27754|NCT04026256|histomorphometry|histomorphometry
27755|NCT04026256|bone density|bone density
27756|NCT04026256|teriparatide|teriparatide
27757|NCT04026256|denosumab|denosumab
27758|NCT04026243|ultrasound guided regional blocks|ultrasound guided regional blocks
27759|NCT04026243|Transversalis Fascia Plane Block|transversalis fascia plane block
27760|NCT04026243|Quadratus Lumborum Block|quadratus lumborum block
27761|NCT04026243|inguinal herniorrhaphy|inguinal herniorrhaphy
27762|NCT04026243|Pain management|pain management
27763|NCT04026230|Prostate cancer|prostate cancer
27764|NCT04026230|Castration resistance|castration resistance
27765|NCT04026230|Cholesterol lowering drug|cholesterol lowering drug
27766|NCT04026230|Cholesterol|cholesterol
27767|NCT04026230|Atorvastatin|atorvastatin
27768|NCT04026230|Survival|survival
27769|NCT04026230|Mortality|mortality
27770|NCT04026204|TAVR|tavr
27771|NCT04026204|Coronary cannulation|coronary cannulation
27772|NCT04026204|Transcatheter aortic prosthesis|transcatheter aortic prosthesis
27773|NCT04026191|Hyaluronic Acid|hyaluronic acid
27774|NCT04026191|Sodium Hyaluronate|sodium hyaluronate
27775|NCT04026178|Immunogenicity|immunogenicity
27776|NCT04026178|Antibodies|antibodies
27777|NCT04026178|Lipodystrophy|lipodystrophy
27778|NCT04026152|Anxiety-Related Disorder|anxiety-related disorder
27779|NCT04026152|Exercise|exercise
27780|NCT04026152|Resistance Training|resistance training
27781|NCT04026152|Unified Protocol|unified protocol
27782|NCT04026152|Adherence|adherence
27783|NCT04026152|Randomized Controlled Trial|randomized controlled trial
27784|NCT04026152|Physical Activity|physical activity
27785|NCT04026139|home-based exercise, resistance band, cartilage degeneration, glycated haemoglobin control, diabetes mellitus|home-based exercise, resistance band, cartilage degeneration, glycated haemoglobin control, diabetes mellitus
27786|NCT04026126|Heat Therapy|heat therapy
27787|NCT04026113|Functional constipation in children|functional constipation in children
27788|NCT04026113|LINZESS|linzess
27789|NCT04026087|Renal transplantation|renal transplantation
27790|NCT04026087|antibody-mediated rejection|antibody-mediated rejection
27792|NCT04026087|mass spectrometry technique|mass spectrometry technique
27793|NCT04026061|Medical Research Framework|medical research framework
27794|NCT04026061|Hand-held touchscreen devices|hand-held touchscreen devices
27795|NCT04026061|Self-management|self-management
27796|NCT04026061|Meaningful activities|meaningful activities
27797|NCT04026048|Cognitive Behaviour Therapy for Insomnia|cognitive behaviour therapy for insomnia
27798|NCT04026048|Actigraphy|actigraphy
27799|NCT04026048|CBT-I|cbt-i
27800|NCT04026048|Cancer|cancer
27801|NCT04026048|Insomnia|insomnia
27802|NCT04026048|Sleep|sleep
27803|NCT04026048|Perceived Cognitive Impairment|perceived cognitive impairment
27804|NCT04026035|PCR|pcr
27805|NCT04026035|hemoculture|hemoculture
27806|NCT04026035|septicemia|septicemia
27807|NCT04025983|Helicobacter pylori|helicobacter pylori
27808|NCT04025983|peptic ulcer|peptic ulcer
27809|NCT04025983|Lactobacillus johnsonii|lactobacillus johnsonii
27810|NCT04025983|immunoglobin Y|immunoglobin y
27811|NCT04025970|Germ line DNA, gDNA|germ line dna, gdna
27812|NCT04025970|Circulating tumor cell, CTC|circulating tumor cell, ctc
27813|NCT04025970|Circulating cell free DNA, cfDNA, ctDNA|circulating cell free dna, cfdna, ctdna
27814|NCT04025970|Screening|screening
27815|NCT04025970|Diagnostic|diagnostic
27816|NCT04025970|Predictive|predictive
27817|NCT04025918|hypotension|hypotension
27818|NCT04025918|spinal anesthesia|spinal anesthesia
27819|NCT04025918|cesarean section|cesarean section
27820|NCT04025918|phenylephrine|phenylephrine
27821|NCT04025918|ephedrine|ephedrine
27822|NCT04025918|closed-loop system|closed-loop system
27823|NCT04025918|continuous non-invasive monitor|continuous non-invasive monitor
27824|NCT04025892|pregnancy|pregnancy
38287|NCT03963167|COPD|copd
27825|NCT04025892|digital health|digital health
27826|NCT04025892|daily weighing|daily weighing
27827|NCT04025866|conventional rehabilitation|conventional rehabilitation
27828|NCT04025866|arm ergometer|arm ergometer
27829|NCT04025866|aerobic exercise|aerobic exercise
27830|NCT04025866|intertrochanteric fractures|intertrochanteric fractures
27831|NCT04025840|Pancreatic cancer|pancreatic cancer
27832|NCT04025840|Radical resection|radical resection
27833|NCT04025840|Epidural block|epidural block
27834|NCT04025840|Dexamethasone|dexamethasone
27835|NCT04025840|Overall survival|overall survival
27836|NCT04025801|confocal microscopy,cornea|confocal microscopy,cornea
27837|NCT04025749|Cerebral Palsy|cerebral palsy
27838|NCT04025749|Executive Functions|executive functions
27839|NCT04025749|Cognitive Training|cognitive training
27848|NCT04025684|Oral Hygiene|oral hygiene
27850|NCT04025671|opioid use disorder|opioid use disorder
27851|NCT04025671|harm reduction|harm reduction
27852|NCT04025658|pregnancy|pregnancy
27853|NCT04025658|twin|twin
27854|NCT04025658|postpartum hemorrhage|postpartum hemorrhage
27855|NCT04025658|oxytocin|oxytocin
27856|NCT04025658|Cesarean delivery|cesarean delivery
27857|NCT04025645|Cholelithiasis|cholelithiasis
27858|NCT04025645|Common Bile Duct|common bile duct
27859|NCT04025645|Sphincter of Oddi|sphincter of oddi
27860|NCT04025645|Amylase|amylase
27861|NCT04025645|Lipase|lipase
27862|NCT04025606|Epidural analgesia|epidural analgesia
27863|NCT04025606|Pneumonectomy|pneumonectomy
27864|NCT04025580|Systems Biology|systems biology
27865|NCT04025580|Immunology|immunology
27874|NCT04025515|Oncomine Focus Panel Assay|oncomine focus panel assay
27875|NCT04025515|Molecular profiling|molecular profiling
27876|NCT04025515|Targeted therapies|targeted therapies
27877|NCT04025515|Driver oncogene|driver oncogene
27878|NCT04025515|Next-Generation Sequencing (NGS)|next-generation sequencing (ngs)
27879|NCT04025515|PD-L1 Immunohistochemistry (IHC, Dako 22C3)|pd-l1 immunohistochemistry (ihc, dako 22c3)
27880|NCT04025515|Hotspots|hotspots
27881|NCT04025515|Single Nucleotide Variants (SNVs)|single nucleotide variants (snvs)
27882|NCT04025515|Insertions/ Deletions (Indels)|insertions/ deletions (indels)
27883|NCT04025515|Copy Number Variation (CNVs),|copy number variation (cnvs),
27884|NCT04025515|Gene Fusions|gene fusions
27885|NCT04025515|Formalin-Fixed|formalin-fixed
27886|NCT04025515|Paraffin Embedded (FFPE) extracted DNA and RNA|paraffin embedded (ffpe) extracted dna and rna
27887|NCT04025515|Ion PGM™ System|ion pgm™ system
27888|NCT04025502|ERP|erp
27889|NCT04025502|EEG|eeg
27890|NCT04025502|Event-related potential|event-related potential
27891|NCT04025502|MMN|mmn
27892|NCT04025502|Schizophrenia|schizophrenia
27893|NCT04025502|Electroencephalogram|electroencephalogram
27894|NCT04025502|Mismatch Negativity|mismatch negativity
27895|NCT04025502|N100|n100
27896|NCT04025502|P3a|p3a
27897|NCT04025502|P3b|p3b
27898|NCT04025489|Pre-diabetes|pre-diabetes
27899|NCT04025489|Type 2 Diabetes|type 2 diabetes
27900|NCT04025489|Genes|genes
27901|NCT04025489|Supplementation|supplementation
27902|NCT04025476|VKH; immune profile;|vkh; immune profile;
27903|NCT04025463|Implementation science|implementation science
27904|NCT04025463|Organizational readiness|organizational readiness
27905|NCT04025463|African American|african american
27906|NCT04025463|Latino|latino
27907|NCT04025411|Stroke|stroke
27908|NCT04025411|Upper limb rehabilitation|upper limb rehabilitation
27909|NCT04025411|Computerized mirror therapy|computerized mirror therapy
27910|NCT04025411|Hemiparetic|hemiparetic
27911|NCT04025411|Mirror therapy|mirror therapy
27912|NCT04025372|Prostate Cancer|prostate cancer
27913|NCT04025333|Smoking Cessation|smoking cessation
27914|NCT04025255|Brain Health|brain health
27915|NCT04025255|Cognitive Abilities|cognitive abilities
27916|NCT04025255|Mental Orientation|mental orientation
27917|NCT04025255|Short-term Memory|short-term memory
27918|NCT04025255|Executive Function|executive function
27919|NCT04025216|Chimeric Antigen Receptor (CAR)|chimeric antigen receptor (car)
27920|NCT04025216|T-cells|t-cells
27921|NCT04025216|TnMUC1|tnmuc1
27922|NCT04025203|Ibuprofen Arginine|ibuprofen arginine
27923|NCT04025203|Gabapentin|gabapentin
27924|NCT04025203|Median nerve neural mobilization|median nerve neural mobilization
27925|NCT04025203|Physiotherapy|physiotherapy
27926|NCT04025203|Pain management|pain management
27927|NCT04025190|anxiety|anxiety
27928|NCT04025190|depression|depression
27929|NCT04025190|collaborative care|collaborative care
27930|NCT04025190|psycho-oncology|psycho-oncology
27931|NCT04025190|bone marrow transplant|bone marrow transplant
27932|NCT04025177|Indomethacin|indomethacin
27933|NCT04025177|Pharmacokinetics|pharmacokinetics
27934|NCT04025177|Preterm birth|preterm birth
27935|NCT04025177|Pharmacodynamics|pharmacodynamics
27936|NCT04025164|Hypofractionated radiotherapy|hypofractionated radiotherapy
27937|NCT04025164|Breast Conserving Surery|breast conserving surery
27938|NCT04025151|chat-based IM|chat-based im
27939|NCT04025151|alcohol brief intervention|alcohol brief intervention
27940|NCT04025151|alcohol misuse|alcohol misuse
27941|NCT04025151|university students|university students
27942|NCT04025138|Sex differences|sex differences
27943|NCT04025138|Ultra-endurance running|ultra-endurance running
27944|NCT04025138|Mont Blanc Ultra Trail|mont blanc ultra trail
27945|NCT04025138|Transcranial Magnetic Stimulation (TMS)|transcranial magnetic stimulation (tms)
27946|NCT04025138|Neuromuscular tests|neuromuscular tests
27947|NCT04025138|Plantar flexors|plantar flexors
27948|NCT04025138|Knee extensors|knee extensors
27949|NCT04025138|Force/Velocity Profile (FVP)|force/velocity profile (fvp)
27950|NCT04025112|Breast cancer|breast cancer
27951|NCT04025112|Rehabilitation|rehabilitation
27952|NCT04025112|Robotics|robotics
27953|NCT04025099|intuitive eating|intuitive eating
27954|NCT04025099|body positive yoga|body positive yoga
27955|NCT04025099|weight management|weight management
27956|NCT04025099|cardiovascular fitness|cardiovascular fitness
27957|NCT04025099|interoceptive awareness|interoceptive awareness
27958|NCT04025099|embodiment|embodiment
27959|NCT04025099|internal cues|internal cues
27960|NCT04025099|external cues|external cues
27961|NCT04025086|Spinal Surgery|spinal surgery
27962|NCT04025073|Metabolic syndrome|metabolic syndrome
27963|NCT04025073|Schizophrenia|schizophrenia
27964|NCT04025073|Nutrition Therapy|nutrition therapy
27965|NCT04025060|sugar-sweetened beverages|sugar-sweetened beverages
27966|NCT04025060|caffeine withdrawal|caffeine withdrawal
27967|NCT04025060|beverages|beverages
27969|NCT04025047|trans-vaginal mesh|trans-vaginal mesh
27970|NCT04025047|pelvic reconstruction surgery|pelvic reconstruction surgery
27971|NCT04025047|complications|complications
27972|NCT04025047|the CTS(category-time-site) coding system|the cts(category-time-site) coding system
27973|NCT04025034|Decompression|decompression
27974|NCT04025034|Thyroid-related|thyroid-related
27975|NCT04025034|Orbitopathy|orbitopathy
27976|NCT04025021|Targeted Fortification|targeted fortification
27977|NCT04025021|Human Milk Analysis|human milk analysis
27978|NCT04025021|Neonatal Nutrition|neonatal nutrition
27979|NCT04024995|Invasive Fungal Infections|invasive fungal infections
27980|NCT04024995|EORTC/MSG criteria|eortc/msg criteria
27981|NCT04024982|Transoesophageal Echocardiography (TEE)|transoesophageal echocardiography (tee)
27982|NCT04024982|Learning|learning
27983|NCT04024969|Central Vein Sign|central vein sign
27984|NCT04024969|Translational Neuroimaging|translational neuroimaging
27985|NCT04024969|Multiple Sclerosis|multiple sclerosis
27986|NCT04024956|Hepatic resection|hepatic resection
27987|NCT04024956|Distal pancreatectomy|distal pancreatectomy
27988|NCT04024956|Sealant|sealant
27989|NCT04024930|EUS guided biliairy drainage|eus guided biliairy drainage
27990|NCT04024930|EUS Choledoco-duodenostomy|eus choledoco-duodenostomy
27991|NCT04024930|Axios stent|axios stent
27992|NCT04024930|Lumen Apposing Metal Stent|lumen apposing metal stent
27993|NCT04024917|Colon|colon
27994|NCT04024917|Rectum|rectum
27995|NCT04024917|Stomach|stomach
27996|NCT04024917|Ovary|ovary
27997|NCT04024904|regional anesthesia|regional anesthesia
27998|NCT04024904|virtual reality|virtual reality
27999|NCT04024904|hypnosis|hypnosis
28000|NCT04024904|distraction|distraction
28001|NCT04024891|Nyxol|nyxol
28002|NCT04024891|Pharmacologically Induced Mydriasis|pharmacologically induced mydriasis
28003|NCT04024891|Dilation|dilation
28004|NCT04024878|Ovarian Cancer|ovarian cancer
28005|NCT04024865|Domperidone|domperidone
28006|NCT04024865|Postpartum|postpartum
28007|NCT04024865|Ventricular Tachyarrhythmia|ventricular tachyarrhythmia
28008|NCT04024865|Sudden Cardiac Death|sudden cardiac death
28009|NCT04024852|Implanted cardioverter defibrillator|implanted cardioverter defibrillator
28010|NCT04024852|physical activity|physical activity
28011|NCT04024852|air pollution|air pollution
28012|NCT04024839|Active isolated stretch|active isolated stretch
28013|NCT04024839|Active knee extension|active knee extension
28014|NCT04024839|Post isometric relaxation|post isometric relaxation
28015|NCT04024839|Sit and reach test|sit and reach test
28016|NCT04024826|resistance training|resistance training
28017|NCT04024826|carbohydrate metabolism|carbohydrate metabolism
28018|NCT04024826|fat oxidation|fat oxidation
28020|NCT04024813|Cholangitis, Sclerosing|cholangitis, sclerosing
28021|NCT04024813|Cholangitis|cholangitis
28022|NCT04024813|Bile Duct Diseases|bile duct diseases
28023|NCT04024813|Biliary Tract Diseases|biliary tract diseases
28024|NCT04024813|Digestive System Diseases|digestive system diseases
28025|NCT04024800|Triple-negative Breast Cancer|triple-negative breast cancer
28026|NCT04024800|Tumor-specific immune response|tumor-specific immune response
28027|NCT04024800|Open-Label|open-label
28028|NCT04024800|Pembrolizumab|pembrolizumab
28029|NCT04024800|Peptide vaccine|peptide vaccine
28030|NCT04024800|Metastatic Breast Cancer|metastatic breast cancer
28031|NCT04024800|Dose limiting toxicity|dose limiting toxicity
28032|NCT04024800|RECIST 1.1|recist 1.1
28033|NCT04024800|AE37|ae37
28035|NCT04024709|G-POEM|g-poem
28036|NCT04024709|gastroparesis|gastroparesis
28037|NCT04024709|POP|pop
28333|NCT04022668|Acute Coronary Occlusion|acute coronary occlusion
28038|NCT04024709|oral endoscopic pyloromyotomy|oral endoscopic pyloromyotomy
28039|NCT04024670|arts in medicine|arts in medicine
28040|NCT04024670|sewing|sewing
28041|NCT04024644|third molar|third molar
28042|NCT04024644|dental caries|dental caries
28043|NCT04024644|periodontal disease|periodontal disease
28044|NCT04024644|quality of life|quality of life
28045|NCT04024631|polygenic risk for type 2 diabetes|polygenic risk for type 2 diabetes
28046|NCT04024618|Non- Hodgkin's Lymphoma|non- hodgkin's lymphoma
28047|NCT04024618|Hodgkin's Lymphoma|hodgkin's lymphoma
28048|NCT04024618|Multiple Myeloma|multiple myeloma
28049|NCT04024618|AHSCT|ahsct
28050|NCT04024592|child|child
28051|NCT04024592|dynamometry|dynamometry
28052|NCT04024592|knee joint|knee joint
28053|NCT04024592|reproducability of results|reproducability of results
28054|NCT04024592|strength testing|strength testing
28055|NCT04024566|echocardiography|echocardiography
28056|NCT04024553|bipolar disorder|bipolar disorder
28057|NCT04024553|family|family
28058|NCT04024553|genetic|genetic
28059|NCT04024514|CT|ct
28060|NCT04024514|Spectral|spectral
28061|NCT04024501|URAT1 inhibitor|urat1 inhibitor
28062|NCT04024501|Uric acid transporter 1|uric acid transporter 1
28063|NCT04024501|Verinurad|verinurad
28064|NCT04024501|Crossover study|crossover study
28065|NCT04024501|Relative bioavailability|relative bioavailability
28066|NCT04024501|Pharmacokinetics|pharmacokinetics
28067|NCT04024488|Mental Health|mental health
28068|NCT04024488|Adherence|adherence
28069|NCT04024488|Trauma-Informed Cognitive Behavioral Therapy|trauma-informed cognitive behavioral therapy
28070|NCT04024475|Radical prostatectomy|radical prostatectomy
28071|NCT04024475|Metastatic castration resistant prostate cancer|metastatic castration resistant prostate cancer
28072|NCT04024475|Oligometastatic prostate cancer|oligometastatic prostate cancer
28073|NCT04024475|Radiotherapy|radiotherapy
28074|NCT04024475|Prostate cancer screening|prostate cancer screening
28075|NCT04024475|Prostate-specific antigen (PSA)|prostate-specific antigen (psa)
28076|NCT04024475|Prostate cancer (PCa)|prostate cancer (pca)
28077|NCT04024475|Opportunistic screening|opportunistic screening
28078|NCT04024436|Futibatinib|futibatinib
28079|NCT04024436|Metastatic Breast Cancer|metastatic breast cancer
28080|NCT04024436|FGFR|fgfr
28081|NCT04024436|TAS-120|tas-120
28082|NCT04024410|prone position|prone position
28083|NCT04024410|anesthesia, general|anesthesia, general
28084|NCT04024410|end-expiratory pressure, positive|end-expiratory pressure, positive
28085|NCT04024410|respiration, artificial|respiration, artificial
28086|NCT04024384|Myeloma|myeloma
28087|NCT04024358|neural invasion|neural invasion
28088|NCT04024358|vascular invasion|vascular invasion
28089|NCT04024319|Total Knee Replacement|total knee replacement
28090|NCT04024319|Genicular nerves block|genicular nerves block
28091|NCT04024319|Postoperative pain|postoperative pain
28092|NCT04024254|ovarian cancer|ovarian cancer
28093|NCT04024254|breast cancer|breast cancer
28094|NCT04024254|olaparib|olaparib
28095|NCT04024254|folic acid deficiency|folic acid deficiency
28096|NCT04024241|AML HAM|aml ham
28097|NCT04024215|intravascular ultrasound|intravascular ultrasound
28098|NCT04024150|Anti-integrases treatment|anti-integrases treatment
28099|NCT04024150|Antiretroviral treatment|antiretroviral treatment
28100|NCT04024150|Pregnancy|pregnancy
28101|NCT04024124|Atrial fibrillation|atrial fibrillation
28102|NCT04024124|Deep learning|deep learning
28103|NCT04024124|Diagnosis|diagnosis
28104|NCT04024124|Photoplethysmography|photoplethysmography
28105|NCT04024124|Wearable electronic devices|wearable electronic devices
28106|NCT04024111|Social groups|social groups
28107|NCT04024111|Active contol group|active contol group
28108|NCT04024111|Children|children
28109|NCT04024111|Australian|australian
28110|NCT04024033|perennial allergic rhinitis|perennial allergic rhinitis
28111|NCT04023981|Parafricta|parafricta
28112|NCT04023981|Pressure ulcer|pressure ulcer
28113|NCT04023955|vaccination|vaccination
28114|NCT04023955|feasibility|feasibility
28115|NCT04023955|public housing|public housing
28116|NCT04023942|Obesity|obesity
28117|NCT04023942|Weight loss|weight loss
28118|NCT04023942|Weight maintenance|weight maintenance
28119|NCT04023942|Lifestyle intervention|lifestyle intervention
28120|NCT04023942|Dietary intervention|dietary intervention
28121|NCT04023942|Formula diet|formula diet
28122|NCT04023942|App|app
28123|NCT04023942|Newsletter|newsletter
28124|NCT04023942|Digital tool|digital tool
28125|NCT04023942|Low carb|low carb
28126|NCT04023942|Low fat|low fat
28127|NCT04023942|Meal challenges|meal challenges
28128|NCT04023916|DLBCL|dlbcl
28129|NCT04023916|Sintilimab|sintilimab
28130|NCT04023916|R-CHOP|r-chop
28131|NCT04023916|TP53|tp53
28132|NCT04023916|PD-L1|pd-l1
28133|NCT04023903|Bardoxolone Methyl|bardoxolone methyl
28134|NCT04023903|Healthy subject|healthy subject
28135|NCT04023903|Food effect|food effect
28136|NCT04023877|E2027|e2027
28137|NCT04023877|[14C]E2027|[14c]e2027
28138|NCT04023877|Dementia with Lewy bodies|dementia with lewy bodies
28139|NCT04023877|Dementia|dementia
28140|NCT04023864|Platycodon Grandiflorus Extract|platycodon grandiflorus extract
28141|NCT04023864|Body Fat|body fat
28142|NCT04023851|Epilepsy|epilepsy
28143|NCT04023851|Seizure diary|seizure diary
28144|NCT04023851|Mobile application|mobile application
28145|NCT04023838|Radiation|radiation
28146|NCT04023838|Snuffbox approach|snuffbox approach
28147|NCT04023838|Radial approach|radial approach
28148|NCT04023838|Vascular access|vascular access
28149|NCT04023825|cleft palate|cleft palate
28150|NCT04023825|surgery|surgery
28151|NCT04023825|maxillary nerve block|maxillary nerve block
28152|NCT04023825|local anesthetic|local anesthetic
28153|NCT04023825|loco regional anesthesia|loco regional anesthesia
28154|NCT04023825|face nerve block|face nerve block
28155|NCT04023812|prospective|prospective
28156|NCT04023812|observational|observational
28157|NCT04023812|stage III NSCLC|stage iii nsclc
28158|NCT04023786|PEEP test preload dependancy fluid responsiveness|peep test preload dependancy fluid responsiveness
28159|NCT04023747|Monoclonal B-Cell Lymphocytosis|monoclonal b-cell lymphocytosis
28160|NCT04023747|Asymptomatic Chronic Lymphocytic Leukaemia|asymptomatic chronic lymphocytic leukaemia
28161|NCT04023747|IgM Monoclonal Gammopathy|igm monoclonal gammopathy
28162|NCT04023747|Asymptomatic Waldenstrom's Macroglobulinaemia|asymptomatic waldenstrom's macroglobulinaemia
28163|NCT04023747|Immunoglobulin A or G Monoclonal Gammopathy|immunoglobulin a or g monoclonal gammopathy
28164|NCT04023747|Smouldering Myeloma|smouldering myeloma
28165|NCT04023747|Pre-cancerous|pre-cancerous
28166|NCT04023747|Lymphoproliferative Disorders|lymphoproliferative disorders
28167|NCT04023734|Medication non-adherence|medication non-adherence
28168|NCT04023734|Type 2 diabetes|type 2 diabetes
28169|NCT04023734|Antihypertensive agents|antihypertensive agents
28170|NCT04023682|Hand hygiene|hand hygiene
28171|NCT04023682|Provodine|provodine
28172|NCT04023682|Hand contamination|hand contamination
28173|NCT04023669|Brain Tumors in Adolescents|brain tumors in adolescents
28174|NCT04023669|Brain Tumors in Children|brain tumors in children
28175|NCT04023669|Brain Tumors in Young Adults|brain tumors in young adults
28176|NCT04023669|CHK1/2 Inhibitor|chk1/2 inhibitor
28177|NCT04023669|Combination therapy|combination therapy
28178|NCT04023669|Indeterminate molecular subgroup|indeterminate molecular subgroup
28179|NCT04023669|Medulloblastoma, Group 3|medulloblastoma, group 3
28180|NCT04023669|Medulloblastoma, Group 4|medulloblastoma, group 4
28181|NCT04023669|Medulloblastoma, G3/G4|medulloblastoma, g3/g4
28182|NCT04023669|Progressive brain tumor|progressive brain tumor
28183|NCT04023669|Recurrent brain tumor|recurrent brain tumor
28184|NCT04023669|Refractory brain tumor|refractory brain tumor
28185|NCT04023669|Sonic hedgehog|sonic hedgehog
28186|NCT04023669|SHH Medulloblastoma|shh medulloblastoma
28187|NCT04023669|St. Jude Brain Tumor Studies|st. jude brain tumor studies
28188|NCT04023669|St. Jude Studies|st. jude studies
28189|NCT04023669|St. Jude Treatment|st. jude treatment
28190|NCT04023669|Molecular|molecular
28191|NCT04023669|Molecular therapy|molecular therapy
28192|NCT04023656|paroxysmal kinesigenic choreoathetosis|paroxysmal kinesigenic choreoathetosis
28193|NCT04023656|Prognosis|prognosis
28194|NCT04023656|Korean population|korean population
28195|NCT04023604|antibiotics|antibiotics
28196|NCT04023604|gut microbiome|gut microbiome
28197|NCT04023604|antimicrobial resistance|antimicrobial resistance
28198|NCT04023604|beef|beef
28199|NCT04023591|tetraplegia|tetraplegia
28200|NCT04023591|spinal cord injury|spinal cord injury
28201|NCT04023591|quadriplegia|quadriplegia
28202|NCT04023591|nerve transfer|nerve transfer
28203|NCT04023565|perindopril|perindopril
28204|NCT04023565|moxonidine|moxonidine
28205|NCT04023552|Lipoprotein(a), Lp(a),CVD, myocardial infarction, PAD,Stroke|lipoprotein(a), lp(a),cvd, myocardial infarction, pad,stroke
28206|NCT04023539|Cinnamon|cinnamon
28207|NCT04023539|Type 2 diabetes|type 2 diabetes
28208|NCT04023539|Diabetes|diabetes
28209|NCT04023539|México|méxico
28210|NCT04023539|Cinnamomum zeylanicum|cinnamomum zeylanicum
28211|NCT04023539|Randomized Controlled Trial|randomized controlled trial
28212|NCT04023539|Glycated hemoglobin|glycated hemoglobin
28213|NCT04023539|Glucose control|glucose control
28214|NCT04023513|aging|aging
28215|NCT04023513|protein intake|protein intake
28216|NCT04023513|reistance training|reistance training
28217|NCT04023487|Diabetes Mellitus, Type 1, randomized controlled trial|diabetes mellitus, type 1, randomized controlled trial
28218|NCT04023474|Platelet-Rich Fibrin (PRF)|platelet-rich fibrin (prf)
28219|NCT04023461|Radiofrequency Ablation|radiofrequency ablation
28220|NCT04023461|Atrial Fibrilation|atrial fibrilation
28221|NCT04023461|PVAC GOLD catheter|pvac gold catheter
28222|NCT04023461|Elderly patients|elderly patients
28223|NCT04023448|rectal cancer|rectal cancer
28224|NCT04023435|chronic|chronic
28225|NCT04023435|Low-Back Pain|low-back pain
28226|NCT04023435|Depression|depression
28227|NCT04023396|moderate to severe ulcerative colitis|moderate to severe ulcerative colitis
28228|NCT04023344|Diabetes Mellitus, Type 2|diabetes mellitus, type 2
28229|NCT04023344|Lispro Biphasic|lispro biphasic
28230|NCT04023344|Insulin|insulin
28231|NCT04023305|Nonfocal Acute respiratory distress syndrome|nonfocal acute respiratory distress syndrome
28232|NCT04023305|Focal Acute respiratory distress syndrome|focal acute respiratory distress syndrome
28233|NCT04023305|Sevoflurane|sevoflurane
28234|NCT04023305|Pharmacokinetics|pharmacokinetics
28235|NCT04023305|Mechanical ventilation|mechanical ventilation
28236|NCT04023292|Hormone receptors-positive breast neoplasms|hormone receptors-positive breast neoplasms
28237|NCT04023292|preoperative endocrine therapy|preoperative endocrine therapy
28238|NCT04023292|Ki-67|ki-67
28239|NCT04023279|Manual therapy|manual therapy
28240|NCT04023279|Myofascial release|myofascial release
28241|NCT04023279|Lateral epicondylitis|lateral epicondylitis
28242|NCT04023279|Transcutaneous electrical nerve stimulation|transcutaneous electrical nerve stimulation
28243|NCT04023279|Pain|pain
28244|NCT04023279|Strength|strength
28245|NCT04023279|Functionality|functionality
28246|NCT04023266|STEMI|stemi
28247|NCT04023227|Chagas' disease|chagas' disease
28248|NCT04023227|heart failure|heart failure
28249|NCT04023227|angiotensin receptor-neprilysin inhibitor|angiotensin receptor-neprilysin inhibitor
28250|NCT04023227|ARNI|arni
28251|NCT04023227|ARB|arb
28252|NCT04023227|ACEI|acei
28253|NCT04023227|sacubitril/valsartan|sacubitril/valsartan
28254|NCT04023227|enalapril|enalapril
28255|NCT04023188|atrial fibrillation|atrial fibrillation
28256|NCT04023188|deep learning|deep learning
28257|NCT04023188|diagnosis|diagnosis
28258|NCT04023188|photoplethysmography|photoplethysmography
28259|NCT04023188|wearable electronic devices|wearable electronic devices
28260|NCT04023175|Virtual visit|virtual visit
28261|NCT04023175|Preoperative counseling|preoperative counseling
28262|NCT04023175|Preoperative preparedness|preoperative preparedness
28263|NCT04023162|Low Back Pain|low back pain
28264|NCT04023162|Exercise Therapy|exercise therapy
28265|NCT04023162|Operant Conditioning|operant conditioning
28266|NCT04023149|pemphigus vulgaris|pemphigus vulgaris
28267|NCT04023149|oral mucosal lesion|oral mucosal lesion
28268|NCT04023149|interleukin-2|interleukin-2
28269|NCT04023110|Risk-Guided Intervention|risk-guided intervention
28270|NCT04023110|Carvedilol|carvedilol
28271|NCT04023110|Cardiotoxicity of Chemotherapy|cardiotoxicity of chemotherapy
28272|NCT04023110|Cardio-Oncology|cardio-oncology
28273|NCT04023110|Cardiomyopathy|cardiomyopathy
28274|NCT04023084|dermatologic agents|dermatologic agents
28275|NCT04023084|surveys|surveys
28276|NCT04023084|questionnaires|questionnaires
28277|NCT04023084|topical therapy|topical therapy
28278|NCT04023071|AML|aml
28279|NCT04023071|Lymphoma|lymphoma
28280|NCT04023058|ischemic mitral regurgitation|ischemic mitral regurgitation
28281|NCT04023058|mitral surgery|mitral surgery
28282|NCT04023058|stress echo|stress echo
28283|NCT04023019|Blood disorders|blood disorders
28284|NCT04023006|Denture|denture
28285|NCT04022993|Diabetes Mellitus, Type 1|diabetes mellitus, type 1
28286|NCT04022993|Insulin|insulin
28287|NCT04022993|Glargine|glargine
28288|NCT04022967|Africa|africa
28289|NCT04022967|Antiretroviral Treatment|antiretroviral treatment
28290|NCT04022967|HIV-1|hiv-1
28291|NCT04022967|Adults|adults
28292|NCT04022967|Dual maintenance therapy|dual maintenance therapy
28293|NCT04022967|Dolutegravir|dolutegravir
28294|NCT04022967|Atazanavir|atazanavir
28295|NCT04022928|Ankle joint|ankle joint
28296|NCT04022928|Osteoarthritis|osteoarthritis
28297|NCT04022928|Platelet rich plasma|platelet rich plasma
28298|NCT04022902|Pneumoconiosis|pneumoconiosis
28299|NCT04022902|Self-care|self-care
28300|NCT04022902|Care-giving|care-giving
28301|NCT04022889|INTERCEPT|intercept
28302|NCT04022889|Recovery|recovery
28303|NCT04022889|Survival|survival
28304|NCT04022889|5 days|5 days
28305|NCT04022889|6 days|6 days
28306|NCT04022889|7 days|7 days
28307|NCT04022889|Radiolabeled|radiolabeled
28308|NCT04022889|Autologous|autologous
28309|NCT04022863|TEP|tep
28310|NCT04022863|ctDNA|ctdna
28311|NCT04022863|ovarian cancer|ovarian cancer
28312|NCT04022824|Coronary artery disease|coronary artery disease
28313|NCT04022824|Obstructive sleep apnea|obstructive sleep apnea
28314|NCT04022824|Optical coherence tomography|optical coherence tomography
28315|NCT04022824|Vascular response|vascular response
28316|NCT04022811|Pterygium|pterygium
28317|NCT04022811|Bromofenac|bromofenac
28318|NCT04022811|Pain|pain
28319|NCT04022798|Low back pain|low back pain
28320|NCT04022798|Neural mobilization|neural mobilization
28321|NCT04022798|lumbar stabilization exercise|lumbar stabilization exercise
28322|NCT04022798|Radial extracorporeal shock wave therapy|radial extracorporeal shock wave therapy
28323|NCT04022759|Attachment|attachment
28324|NCT04022759|Improving Access to Psychological Therapies|improving access to psychological therapies
28325|NCT04022759|Security priming|security priming
28326|NCT04022720|platelet rich fibrin (PRF)|platelet rich fibrin (prf)
28327|NCT04022707|Elderly|elderly
28328|NCT04022707|Circuit training|circuit training
39022|NCT03958461|AMD|amd
28329|NCT04022707|Cognitive ability|cognitive ability
28330|NCT04022707|Cardiovascular condition|cardiovascular condition
28331|NCT04022694|Food Labeling|food labeling
28332|NCT04022694|Adolescents|adolescents
29034|NCT04018339|body weight|body weight
28334|NCT04022668|Occlusive Myocardial Infarction|occlusive myocardial infarction
28335|NCT04022668|Non-occlusive Myocardial Infarction|non-occlusive myocardial infarction
28336|NCT04022668|ST Elevation Myocardial Infarction|st elevation myocardial infarction
28337|NCT04022668|Non-ST Elevated Myocardial Infarction|non-st elevated myocardial infarction
28338|NCT04022668|Coronary Occlusion|coronary occlusion
28339|NCT04022668|Coronary Thrombosis|coronary thrombosis
28340|NCT04022668|Myocardial Ischemia|myocardial ischemia
28341|NCT04022668|Coronary Disease|coronary disease
28342|NCT04022655|Intensive Care Unit|intensive care unit
28343|NCT04022655|Mortality|mortality
28344|NCT04022655|Autoimmune Diseases|autoimmune diseases
28345|NCT04022642|HIIT|hiit
28346|NCT04022642|Adolescents|adolescents
28347|NCT04022642|Physical Exercise|physical exercise
28348|NCT04022642|Health|health
28349|NCT04022642|Motivation|motivation
28350|NCT04022577|Adherence Therapy|adherence therapy
28351|NCT04022577|Insight|insight
28352|NCT04022577|Medication Adherence|medication adherence
28353|NCT04022577|Motivational Interviewing|motivational interviewing
28354|NCT04022577|Schizophrenia Spectrum Disorder|schizophrenia spectrum disorder
28355|NCT04022577|Symptom severity|symptom severity
28356|NCT04022577|Randomized controlled trial|randomized controlled trial
28357|NCT04022564|multiple sclerosis|multiple sclerosis
28358|NCT04022564|Survival Analysis|survival analysis
28359|NCT04022564|cause of death|cause of death
28360|NCT04022564|medical resources|medical resources
28361|NCT04022538|Vertical bone augmentation|vertical bone augmentation
28362|NCT04022538|Inlay bone graft|inlay bone graft
28363|NCT04022538|Dental Implants|dental implants
28364|NCT04022538|Sandwich Osteotomy|sandwich osteotomy
28365|NCT04022512|Lung nodules|lung nodules
28366|NCT04022512|Deep learning|deep learning
28367|NCT04022512|Artificial intelligence|artificial intelligence
28368|NCT04022512|Computer-aided diagnosis|computer-aided diagnosis
28369|NCT04022486|Infant|infant
28370|NCT04022473|Gastrointestinal|gastrointestinal
28371|NCT04022460|Polysomnography|polysomnography
28372|NCT04022460|Pediatric|pediatric
28373|NCT04022460|Down syndrome|down syndrome
28374|NCT04022460|Obstructive sleep apnea|obstructive sleep apnea
28375|NCT04022460|Screening tool|screening tool
28376|NCT04022460|Mobile technology|mobile technology
28377|NCT04022447|dupilumab|dupilumab
28378|NCT04022447|asthma|asthma
28379|NCT04022447|real life|real life
28380|NCT04022447|safety|safety
28381|NCT04022382|Dry Eye Disease|dry eye disease
28382|NCT04022382|Restylane-Defyne|restylane-defyne
28383|NCT04022369|Aging|aging
28384|NCT04022369|Randomized Controlled Trials (RCT)|randomized controlled trials (rct)
28385|NCT04022369|Nursing|nursing
28386|NCT04022369|Physical Activity|physical activity
28387|NCT04022356|counting|counting
28388|NCT04022356|steps|steps
28389|NCT04022356|Connected Soles|connected soles
28390|NCT04022330|Left Ventricular Hypertrophy|left ventricular hypertrophy
28391|NCT04022330|Cardiac macrophages|cardiac macrophages
28392|NCT04022317|Recombinant Human Insulin R (rhi R)|recombinant human insulin r (rhi r)
28393|NCT04022304|Recombinant Human Insulin N (rhi N)|recombinant human insulin n (rhi n)
28394|NCT04022252|orthodontics|orthodontics
28395|NCT04022252|tooth movement|tooth movement
28396|NCT04022213|Solid Tumor|solid tumor
28397|NCT04022213|Peritoneal Solid Tumor|peritoneal solid tumor
28398|NCT04022213|DSRC|dsrc
28399|NCT04022213|I131-Omburtamab|i131-omburtamab
28400|NCT04022213|Memorial Sloan Kettering Cancer Center|memorial sloan kettering cancer center
28401|NCT04022213|19-182|19-182
28402|NCT04022200|drug-coated balloon|drug-coated balloon
28403|NCT04022200|angioplasty|angioplasty
28404|NCT04022200|de novo lesions|de novo lesions
28405|NCT04022187|Bulbocavernosus reflex|bulbocavernosus reflex
28406|NCT04022187|Spasticity assessment|spasticity assessment
28407|NCT04022187|Motoneurone excitability|motoneurone excitability
28408|NCT04022187|Stimulus-response curves|stimulus-response curves
28409|NCT04022174|Motor Imagery|motor imagery
28410|NCT04022174|Action observation|action observation
28411|NCT04022161|Cardiac surgery|cardiac surgery
28412|NCT04022161|Nitric oxide|nitric oxide
28413|NCT04022161|Oxidative Stress|oxidative stress
28414|NCT04022161|Redox Thiols couples|redox thiols couples
28415|NCT04022161|Lipids peroxidation|lipids peroxidation
28416|NCT04022161|Protein Oxidation|protein oxidation
28417|NCT04022148|uterine cervical cancer|uterine cervical cancer
28418|NCT04022148|HPV vaccine|hpv vaccine
28419|NCT04022148|cancer screening|cancer screening
28420|NCT04022135|folate|folate
28421|NCT04022135|folic acid|folic acid
28422|NCT04022135|nutrition|nutrition
28423|NCT04022135|pregnancy|pregnancy
28424|NCT04022122|Socioeconomic Level|socioeconomic level
28425|NCT04022122|Disease Management|disease management
28426|NCT04022122|Chronic Care Model|chronic care model
28427|NCT04022122|Transitional Care|transitional care
28428|NCT04022109|Volatile organic compounds|volatile organic compounds
28429|NCT04022109|Breath testing|breath testing
28430|NCT04022109|Gastric cancer|gastric cancer
28431|NCT04022109|Atrophic gastritis|atrophic gastritis
29437|NCT04015830|HIV/AIDS|hiv/aids
28432|NCT04022109|Precancerous lesions|precancerous lesions
28433|NCT04022109|Screening|screening
28434|NCT04022109|Nanosensor technology|nanosensor technology
28435|NCT04022109|GC-MS|gc-ms
28436|NCT04022070|foot|foot
28437|NCT04022070|fasciitis|fasciitis
28438|NCT04022070|tapping|tapping
28439|NCT04022018|cervical cancer|cervical cancer
28440|NCT04022018|adaptive radiotherapy|adaptive radiotherapy
28441|NCT04022018|side effects|side effects
28442|NCT04021953|HIV Testing|hiv testing
28443|NCT04021953|STI Testing|sti testing
28444|NCT04021953|Homophobia|homophobia
28445|NCT04021953|eHealth|ehealth
28446|NCT04021953|Singapore|singapore
28447|NCT04021914|CVD|cvd
28448|NCT04021914|color vision deficiency|color vision deficiency
28449|NCT04021914|healthcare providers|healthcare providers
28450|NCT04021914|emergency department|emergency department
28451|NCT04021914|Enchroma glasses|enchroma glasses
28452|NCT04021901|benign ureteral stricture|benign ureteral stricture
28453|NCT04021901|balloon dilatation|balloon dilatation
28454|NCT04021849|Sexual Harassment|sexual harassment
28455|NCT04021849|Virtual Course|virtual course
28456|NCT04021849|Training|training
28457|NCT04021823|Treatment Resistant Depression|treatment resistant depression
28458|NCT04021823|Neurobiological correlates of treatment resistant depression|neurobiological correlates of treatment resistant depression
28459|NCT04021823|Predictors of treatment response in DBS|predictors of treatment response in dbs
28460|NCT04021810|Sleep Apnea|sleep apnea
28461|NCT04021810|CPAP|cpap
28462|NCT04021810|Mandibular Advancement Device|mandibular advancement device
28463|NCT04021810|Arterial Hypertension|arterial hypertension
28464|NCT04021758|Suicide prevention|suicide prevention
28465|NCT04021758|Peer mentoring|peer mentoring
28466|NCT04021719|First Episode Psychosis|first episode psychosis
28467|NCT04021719|Learning Healthcare system|learning healthcare system
28468|NCT04021719|Stakeholders|stakeholders
28469|NCT04021719|Data infrastructure|data infrastructure
28470|NCT04021719|Psychotic disorders|psychotic disorders
28471|NCT04021719|Mental disorders|mental disorders
28472|NCT04021719|Schizophrenia Spectrum and Other Psychotic Disorders|schizophrenia spectrum and other psychotic disorders
28473|NCT04021693|Medical Education|medical education
28474|NCT04021667|Breastfeeding|breastfeeding
28475|NCT04021667|Parents Training|parents training
28476|NCT04021667|Self-Effıcacy|self-effıcacy
28477|NCT04021667|Attitude|attitude
28478|NCT04021654|Preterm birth; growth; neonatology; Pregnancy; Delivery|preterm birth; growth; neonatology; pregnancy; delivery
28479|NCT04021628|cmv|cmv
28480|NCT04021628|cytomegalovirus|cytomegalovirus
28481|NCT04021628|shedding|shedding
28482|NCT04021628|excretion|excretion
28483|NCT04021628|congenital|congenital
28484|NCT04021628|cCMV|ccmv
28485|NCT04021628|seropositive|seropositive
28486|NCT04021628|maternal|maternal
28487|NCT04021615|rehabilitation|rehabilitation
28488|NCT04021615|general surgery|general surgery
28489|NCT04021615|difficult weaning|difficult weaning
28490|NCT04021602|diabetes prevention program|diabetes prevention program
28491|NCT04021602|breastfeeding|breastfeeding
28492|NCT04021602|prediabetes|prediabetes
28493|NCT04021550|Telmisartan|telmisartan
28494|NCT04021550|Alpha-Lipoic Acid|alpha-lipoic acid
28495|NCT04021550|Continuous Positive Airway Pressure|continuous positive airway pressure
28496|NCT04021550|24-hour blood pressure|24-hour blood pressure
28497|NCT04021511|overcrowding|overcrowding
28498|NCT04021511|x rays|x rays
28499|NCT04021511|emergency department|emergency department
28500|NCT04021511|Ottawa Ankle Rules|ottawa ankle rules
28501|NCT04021511|nurse practitioner|nurse practitioner
28502|NCT04021498|Pancreatitis|pancreatitis
28503|NCT04021498|Acute pancreatitis|acute pancreatitis
28504|NCT04021498|Chronic pancreatitis|chronic pancreatitis
28505|NCT04021498|Simvastatin|simvastatin
28506|NCT04021498|Recurrent|recurrent
28507|NCT04021472|Disease prevention|disease prevention
28508|NCT04021472|Peer health coaching|peer health coaching
28509|NCT04021472|Digital health|digital health
28510|NCT04021472|Text messaging|text messaging
28511|NCT04021459|endometrial cancer|endometrial cancer
28512|NCT04021459|circulating tumor cells|circulating tumor cells
28513|NCT04021459|laparoscopy|laparoscopy
28514|NCT04021407|AirQ|airq
28515|NCT04021407|LMA|lma
28516|NCT04021407|dacrocystorhinostomy surgery|dacrocystorhinostomy surgery
28517|NCT04021394|circulating tumor cell|circulating tumor cell
28518|NCT04021394|epithelial-to-mesenchymal transition|epithelial-to-mesenchymal transition
28519|NCT04021394|treatment response|treatment response
28520|NCT04021394|phenotype|phenotype
809545|NCT00212147|cognition|cognition
28521|NCT04021381|Urolithiasis|urolithiasis
28522|NCT04021381|Urinary Calculi|urinary calculi
28523|NCT04021381|Ureteroscopy|ureteroscopy
28524|NCT04021381|Residual fragments|residual fragments
28525|NCT04021381|Morphoconstitutional analysis|morphoconstitutional analysis
28526|NCT04021381|Citrate|citrate
28527|NCT04021368|Acute Myeloid Leukemia|acute myeloid leukemia
28528|NCT04021368|Myelodysplastic Syndrome|myelodysplastic syndrome
28529|NCT04021368|CDK8/19 Inhibitor|cdk8/19 inhibitor
28530|NCT04021368|SEL120|sel120
28531|NCT04021368|Clinical Trial, Phase Ib|clinical trial, phase ib
28532|NCT04021342|Tart cherry|tart cherry
28533|NCT04021342|Montmorency cherries|montmorency cherries
28534|NCT04021342|Prunus Cerasus|prunus cerasus
28535|NCT04021329|Post-traumatic Stress Disorder, Major Depressive Disorder, Comorbidity, Eye Movement Desensitization & Reprocessing, Cognitive Behavioral Therapy|post-traumatic stress disorder, major depressive disorder, comorbidity, eye movement desensitization & reprocessing, cognitive behavioral therapy
28536|NCT04021316|Compression therapy|compression therapy
28537|NCT04021316|Ulcer|ulcer
28538|NCT04021303|Gluten|gluten
28539|NCT04021303|Probiotic|probiotic
28540|NCT04021303|Prebiotic|prebiotic
28541|NCT04021290|Current antiretroviral regimen (CAR), HIV-1, Long-term antiviral activity, Dolutegravir/lamivudine, Fixed dose combination|current antiretroviral regimen (car), hiv-1, long-term antiviral activity, dolutegravir/lamivudine, fixed dose combination
28542|NCT04021264|Major abdominal surgery|major abdominal surgery
28543|NCT04021264|epidural|epidural
28544|NCT04021264|environmental footprint|environmental footprint
28545|NCT04021225|According to section 23b Medical Devices Act|according to section 23b medical devices act
28546|NCT04021225|environmental disorder eye|environmental disorder eye
28547|NCT04021225|allergen exposure|allergen exposure
28548|NCT04021225|Ectoin® Allergy Eye Drops 2%|ectoin® allergy eye drops 2%
28549|NCT04021225|Ectoin® Eye Spray Colloidal|ectoin® eye spray colloidal
28550|NCT04021225|Ectoin|ectoin
28551|NCT04021212|Pituitary|pituitary
28552|NCT04021212|Pituitary Adenoma|pituitary adenoma
28553|NCT04021212|Serum Lipid Levels|serum lipid levels
28554|NCT04021212|Resection|resection
28555|NCT04021212|Recurrence|recurrence
28556|NCT04021160|Transcranial Magnetic Stimulation|transcranial magnetic stimulation
28557|NCT04021147|Motor Imagery|motor imagery
28558|NCT04021147|Action observation|action observation
28559|NCT04021147|Visual mirror feedback|visual mirror feedback
28560|NCT04021147|Pain pressure thresholds|pain pressure thresholds
28561|NCT04021082|Non-Hodgkin's Lymphoma|non-hodgkin's lymphoma
28562|NCT04021082|T-Cell Leukemia|t-cell leukemia
28563|NCT04021082|Peripheral T-Cell Lymphoma|peripheral t-cell lymphoma
28564|NCT04021082|Nodal|nodal
28565|NCT04021082|PTCL|ptcl
28566|NCT04021082|Angioimmunoblastic|angioimmunoblastic
28567|NCT04021082|AITL|aitl
28568|NCT04021082|Anaplastic|anaplastic
28569|NCT04021082|ALCL|alcl
28570|NCT04021082|EATL|eatl
28571|NCT04021082|Follicular|follicular
28572|NCT04021082|FTCL|ftcl
28573|NCT04021082|hepatosplenic|hepatosplenic
28574|NCT04021082|HSTCL|hstcl
28575|NCT04021082|TFL|tfl
28576|NCT04021082|SYK|syk
28577|NCT04021082|JAK/STAT|jak/stat
28578|NCT04021069|radiomics|radiomics
28579|NCT04021069|pathomics|pathomics
28580|NCT04021069|breast cancer|breast cancer
28581|NCT04021069|machine learning|machine learning
28582|NCT04021069|biomarkers|biomarkers
28583|NCT04021030|Cognitive Behavioral Therapy|cognitive behavioral therapy
28584|NCT04021017|estrogen|estrogen
28585|NCT04021017|anorexia|anorexia
28586|NCT04021017|bone health|bone health
28587|NCT04021017|bone accrual|bone accrual
28588|NCT04021017|IGF-1|igf-1
28589|NCT04020978|Functional Imaging|functional imaging
28590|NCT04020978|Dynamic PET|dynamic pet
28591|NCT04020978|tracer kinetic modeling|tracer kinetic modeling
28592|NCT04020978|treatment response|treatment response
28593|NCT04020952|canine retraction|canine retraction
28594|NCT04020952|archwire gauge|archwire gauge
28595|NCT04020939|SPY imaging|spy imaging
28596|NCT04020939|indocyanine green|indocyanine green
28597|NCT04020939|pediatric surgery|pediatric surgery
28598|NCT04020939|ICG|icg
28599|NCT04020939|intestinal resections|intestinal resections
28600|NCT04020939|intestinal perfusion|intestinal perfusion
28601|NCT04020926|hyponatremia|hyponatremia
28602|NCT04020913|GH|gh
28603|NCT04020913|muscle strength|muscle strength
28604|NCT04020913|prepubertal|prepubertal
28605|NCT04020913|boys|boys
28606|NCT04020913|short stature|short stature
28607|NCT04020913|GH treatment|gh treatment
28608|NCT04020913|muscle agility|muscle agility
28609|NCT04020900|Children|children
28610|NCT04020900|Respiratory|respiratory
28611|NCT04020887|Telemedicine|telemedicine
28737|NCT04020120|Descriptive|descriptive
28612|NCT04020887|Post Anesthesia Care Unit (PACU)|post anesthesia care unit (pacu)
28613|NCT04020874|concussion|concussion
28614|NCT04020874|tackle|tackle
28615|NCT04020874|youth sports|youth sports
28616|NCT04020861|Electrophysical agents|electrophysical agents
28617|NCT04020861|Low-level laser therapy|low-level laser therapy
28618|NCT04020861|TENS|tens
28619|NCT04020861|Neck pain|neck pain
28620|NCT04020861|Chronic pain|chronic pain
28621|NCT04020822|Acetaminophen|acetaminophen
28622|NCT04020809|atezolizumab|atezolizumab
28623|NCT04020809|neoadjuvant|neoadjuvant
28624|NCT04020809|cutaneous melanoma|cutaneous melanoma
28625|NCT04020783|Primary aldosteronism|primary aldosteronism
28626|NCT04020783|Screening|screening
28627|NCT04020731|Hypnosis|hypnosis
28629|NCT04020731|Auditory Evoked Magnetic Fields|auditory evoked magnetic fields
28630|NCT04020731|Oscillatory activity|oscillatory activity
28631|NCT04020731|Networks|networks
28632|NCT04020718|mobile health|mobile health
28633|NCT04020705|Glaucoma|glaucoma
28634|NCT04020705|Glaucoma Open Angle|glaucoma open angle
28635|NCT04020705|Pseudoexfoliation Glaucoma|pseudoexfoliation glaucoma
28636|NCT04020692|Multicenter study|multicenter study
28637|NCT04020692|Before-and-after type study|before-and-after type study
28638|NCT04020692|Minimal risks and constraints|minimal risks and constraints
28639|NCT04020653|Uncomplicated malaria|uncomplicated malaria
28640|NCT04020653|sodium ferrous citrate (SFC)|sodium ferrous citrate (sfc)
28641|NCT04020653|5-aminolevulinic acid hydrochloride (5-ALA HCl)|5-aminolevulinic acid hydrochloride (5-ala hcl)
28642|NCT04020653|artemisinin-based combination therapy|artemisinin-based combination therapy
28643|NCT04020640|human milk intake|human milk intake
28644|NCT04020640|dose-to-mother deuterium oxide|dose-to-mother deuterium oxide
28645|NCT04020640|exclusive breastfeeding|exclusive breastfeeding
28646|NCT04020640|predominant breastfeeding|predominant breastfeeding
28647|NCT04020640|partial breastfeeding|partial breastfeeding
28648|NCT04020627|Respiratory failure|respiratory failure
28649|NCT04020627|BiPap|bipap
28650|NCT04020627|CPap|cpap
28651|NCT04020627|Respiratory Parameters|respiratory parameters
28652|NCT04020627|Hemodynamics|hemodynamics
28653|NCT04020614|Colorectal Cancer|colorectal cancer
28654|NCT04020614|Awareness|awareness
28655|NCT04020614|Screening|screening
28656|NCT04020588|schizophrenia|schizophrenia
28657|NCT04020588|adolescents|adolescents
28658|NCT04020588|inflammation|inflammation
28659|NCT04020588|anti-inflammatory|anti-inflammatory
28660|NCT04020562|Pulmonary Function Test|pulmonary function test
28661|NCT04020562|Spinal Cord|spinal cord
28662|NCT04020562|Breathing Exercise|breathing exercise
28663|NCT04020562|Expiratory|expiratory
28664|NCT04020536|real world study|real world study
28665|NCT04020523|MRI|mri
28666|NCT04020523|breast|breast
28667|NCT04020523|cancer|cancer
28668|NCT04020523|screening|screening
28669|NCT04020523|innovative sequences|innovative sequences
28670|NCT04020497|target support|target support
28671|NCT04020497|informal caregiver|informal caregiver
28672|NCT04020497|recovery|recovery
28673|NCT04020497|well-being|well-being
28674|NCT04020497|burden|burden
28675|NCT04020497|quality of life|quality of life
28676|NCT04020471|Pharmacogenomic Profile|pharmacogenomic profile
28677|NCT04020471|Knee Osteoarthritis|knee osteoarthritis
28678|NCT04020471|Total Knee Arthroplasty (TKA)|total knee arthroplasty (tka)
28679|NCT04020471|Narcotic Use|narcotic use
28680|NCT04020458|Kidney transplant, Immunoprofiling|kidney transplant, immunoprofiling
28681|NCT04020445|iDegLira|ideglira
28682|NCT04020445|deintensification|deintensification
28683|NCT04020445|overtreatment|overtreatment
28684|NCT04020445|simplification|simplification
28685|NCT04020445|type 2 diabetes|type 2 diabetes
28686|NCT04020432|knowledge|knowledge
28687|NCT04020432|medicine|medicine
28688|NCT04020432|pictogram|pictogram
28689|NCT04020432|pregnant woman|pregnant woman
28690|NCT04020432|childbearing age woman|childbearing age woman
28691|NCT04020419|miR126|mir126
28692|NCT04020419|Pediaberry|pediaberry
28693|NCT04020393|septorhinoplasty|septorhinoplasty
28694|NCT04020393|sphenopalatine ganglion|sphenopalatine ganglion
28695|NCT04020393|postoperative pain|postoperative pain
28696|NCT04020354|motor skill learning|motor skill learning
28697|NCT04020354|functional changes|functional changes
28698|NCT04020354|neuroplastic changes|neuroplastic changes
28699|NCT04020354|biomechanical changes|biomechanical changes
28700|NCT04020341|Gepotidacin, Phase 3, Urinary Tract Infection, Nitrofurantoin, Efficacy, Acute cystitis|gepotidacin, phase 3, urinary tract infection, nitrofurantoin, efficacy, acute cystitis
28701|NCT04020328|Leflunomide|leflunomide
28702|NCT04020328|Glucocorticoids|glucocorticoids
28703|NCT04020328|Conservative Treatment|conservative treatment
28704|NCT04020328|Glomerulonephritis, IGA|glomerulonephritis, iga
28705|NCT04020328|Renal Insufficiency, Chronic|renal insufficiency, chronic
28706|NCT04020315|aggressive periodontitis|aggressive periodontitis
28707|NCT04020315|gingival crevicular fluid|gingival crevicular fluid
28708|NCT04020315|hypoxia|hypoxia
28709|NCT04020315|cytokines|cytokines
28710|NCT04020302|Shopping|shopping
28711|NCT04020302|Activities of Daily Living|activities of daily living
28712|NCT04020289|bipolar disorder|bipolar disorder
28713|NCT04020289|depression|depression
28714|NCT04020289|manic|manic
28715|NCT04020289|illness perception|illness perception
28716|NCT04020263|heart failure|heart failure
28717|NCT04020263|levosimendan|levosimendan
28718|NCT04020224|anemia|anemia
28719|NCT04020224|transfusion|transfusion
28720|NCT04020224|pathogen inactivation|pathogen inactivation
28721|NCT04020224|pathogen reduction|pathogen reduction
28722|NCT04020224|low-resource|low-resource
28723|NCT04020224|sub-saharan africa|sub-saharan africa
28724|NCT04020224|transfusion-transmitted infection|transfusion-transmitted infection
28725|NCT04020224|whole blood|whole blood
28726|NCT04020198|Alpha-synuclein|alpha-synuclein
28727|NCT04020172|tissue flap oxygenation|tissue flap oxygenation
28728|NCT04020172|DIEP flap breast reconstruction surgery|diep flap breast reconstruction surgery
28729|NCT04020146|periodontitis|periodontitis
28730|NCT04020146|periimplantitis|periimplantitis
28731|NCT04020146|RXR|rxr
28732|NCT04020146|VDR|vdr
28733|NCT04020133|ACL|acl
28734|NCT04020133|popliteal plexus block|popliteal plexus block
28735|NCT04020133|saphenous nerve block|saphenous nerve block
28736|NCT04020120|Prospective|prospective
28738|NCT04020120|Non-interventional|non-interventional
28739|NCT04020120|Monocentric|monocentric
28740|NCT04020094|intermediate-risk prostate cancer|intermediate-risk prostate cancer
28741|NCT04020094|high-risk prostate cancer|high-risk prostate cancer
28742|NCT04020094|very high-risk prostate cancer|very high-risk prostate cancer
28743|NCT04020081|Yoga|yoga
28744|NCT04020081|Meditation|meditation
28745|NCT04020081|COPD|copd
28746|NCT04020081|Lung function|lung function
28747|NCT04020068|Diabete|diabete
28748|NCT04020068|French Guiana|french guiana
28749|NCT04020016|nalbuphine|nalbuphine
28750|NCT04020016|Pharmacokinetic|pharmacokinetic
28751|NCT04020016|hepatic impairment|hepatic impairment
28752|NCT04020003|Levosimendan|levosimendan
28753|NCT04019990|Sports for Persons with Disabilities|sports for persons with disabilities
28754|NCT04019990|Basketball|basketball
28755|NCT04019990|Exercise|exercise
28756|NCT04019977|Nurse Home Visiting|nurse home visiting
28757|NCT04019964|Prostate cancer|prostate cancer
28758|NCT04019964|MMR-deficient prostate cancer|mmr-deficient prostate cancer
28759|NCT04019964|Biochemically recurrent prostate cancer|biochemically recurrent prostate cancer
28760|NCT04019964|non-castrating therapy|non-castrating therapy
28761|NCT04019964|Nivolumab|nivolumab
28762|NCT04019912|Gait rehabilitation|gait rehabilitation
28763|NCT04019912|Rhythmic auditory stimulation|rhythmic auditory stimulation
28764|NCT04019912|GaitTrainer3|gaittrainer3
28765|NCT04019912|Multiple sclerosis|multiple sclerosis
28766|NCT04019886|Preterm|preterm
28767|NCT04019886|Neonates|neonates
28768|NCT04019886|Neurofacilitation Technique|neurofacilitation technique
28769|NCT04019886|Respiration|respiration
28770|NCT04019873|2DR|2dr
28771|NCT04019873|HIV|hiv
28772|NCT04019873|Lamivudine|lamivudine
28773|NCT04019873|COMBINE-2|combine-2
28774|NCT04019873|Dolutegravir|dolutegravir
28775|NCT04019860|Exercise|exercise
28776|NCT04019860|Diet|diet
28777|NCT04019860|Overweight|overweight
28778|NCT04019860|Glycaemic control|glycaemic control
28779|NCT04019860|Fitness|fitness
28780|NCT04019860|Body composition|body composition
28781|NCT04019821|super bolus|super bolus
28782|NCT04019821|diabetes type 1|diabetes type 1
28783|NCT04019821|insulin bolus|insulin bolus
28784|NCT04019821|high glycemic index meal|high glycemic index meal
28785|NCT04019821|prandial insulin requirement|prandial insulin requirement
28786|NCT04019821|postprandial glycemia|postprandial glycemia
28787|NCT04019821|insulin pump therapy|insulin pump therapy
28788|NCT04019808|Gastric Cancer|gastric cancer
28789|NCT04019808|Personalized medicine|personalized medicine
28790|NCT04019808|Oncology|oncology
28791|NCT04019808|Solid tumor|solid tumor
28792|NCT04019808|Primary Intervention|primary intervention
28793|NCT04019795|Hair Loss|hair loss
28794|NCT04019795|Pattern Hair Loss|pattern hair loss
28795|NCT04019795|LED|led
28796|NCT04019795|Modulated Light Therapy|modulated light therapy
28797|NCT04019795|Red Light|red light
28798|NCT04019782|Osteoarthritis|osteoarthritis
28799|NCT04019782|Intraarticular Injections|intraarticular injections
28800|NCT04019782|Viscosupplementations|viscosupplementations
28801|NCT04019782|Type I Collagen|type i collagen
28802|NCT04019782|Patient Outcome Assessment|patient outcome assessment
28803|NCT04019782|Patient Reported Outcome Measures|patient reported outcome measures
28804|NCT04019769|Eczema|eczema
28805|NCT04019769|MTORC1 Signaling|mtorc1 signaling
28806|NCT04019769|CBM Complex|cbm complex
28807|NCT04019704|Depressive Disorder|depressive disorder
28808|NCT04019704|Depressive Disorder, Major|depressive disorder, major
28809|NCT04019704|Bupropion|bupropion
28810|NCT04019704|Dextromethorphan|dextromethorphan
28811|NCT04019704|MDD|mdd
28812|NCT04019704|Dopamine Reuptake Inhibitor|dopamine reuptake inhibitor
28813|NCT04019704|AXS-05|axs-05
28814|NCT04019704|NMDA Receptor Antagonist|nmda receptor antagonist
28815|NCT04019704|Central Nervous System|central nervous system
28816|NCT04019704|CNS|cns
28817|NCT04019704|Sigma-1 Receptor Agonist|sigma-1 receptor agonist
28818|NCT04019704|Nicotinic Acetylcholine Receptor Antagonist|nicotinic acetylcholine receptor antagonist
28819|NCT04019704|Norepinephrine Reuptake Inhibitor|norepinephrine reuptake inhibitor
28820|NCT04019704|Glutamate Modulator|glutamate modulator
28821|NCT04019704|Axsome Therapeutics|axsome therapeutics
28822|NCT04019704|GEMINI|gemini
28823|NCT04019704|Serotonin Reuptake Inhibitor|serotonin reuptake inhibitor
28824|NCT04019691|multifocal intraocular lens|multifocal intraocular lens
28825|NCT04019665|Cognition Disorder|cognition disorder
28826|NCT04019665|Alzheimer Disease|alzheimer disease
28827|NCT04019665|MMSE|mmse
28828|NCT04019665|SAGE|sage
28829|NCT04019652|Hypertension|hypertension
28830|NCT04019652|Mineralocorticoid receptor antagonist|mineralocorticoid receptor antagonist
28832|NCT04019639|acellular dermal matrix|acellular dermal matrix
28833|NCT04019613|dyspnea|dyspnea
28834|NCT04019613|heart failure with preserved ejection fraction|heart failure with preserved ejection fraction
28835|NCT04019613|pulmonary edema|pulmonary edema
28836|NCT04019613|lung ultrasound|lung ultrasound
28837|NCT04019613|extravascular lung water|extravascular lung water
28838|NCT04019574|Difelikefalin|difelikefalin
28839|NCT04019574|CR845|cr845
28840|NCT04019574|QTc|qtc
28841|NCT04019574|TQT|tqt
28842|NCT04019561|Non-alcoholic fatty liver disease|non-alcoholic fatty liver disease
28843|NCT04019561|NAFLD|nafld
28844|NCT04019561|Non-alcoholic steatohepatitis|non-alcoholic steatohepatitis
28845|NCT04019561|NASH|nash
28846|NCT04019561|0382|0382
28847|NCT04019535|Physiologic assessment|physiologic assessment
28848|NCT04019496|blink reflex|blink reflex
28849|NCT04019496|electroencephalography|electroencephalography
28850|NCT04019496|functional magnetic resonance imaging|functional magnetic resonance imaging
28851|NCT04019496|evoked potentials|evoked potentials
28852|NCT04019483|Recurrence|recurrence
28853|NCT04019483|Infarct detection|infarct detection
28854|NCT04019483|CT|ct
28855|NCT04019483|MRI|mri
28856|NCT04019483|Diagnosis|diagnosis
28857|NCT04019483|Prognosis|prognosis
28858|NCT04019444|Adults|adults
28859|NCT04019444|ChAd155-RG|chad155-rg
28860|NCT04019444|Dosage-Escalation|dosage-escalation
28861|NCT04019444|Healthy|healthy
28862|NCT04019444|Immunogenicity|immunogenicity
28863|NCT04019444|RABAVERT|rabavert
28864|NCT04019444|Rabies|rabies
28865|NCT04019444|Safety|safety
28866|NCT04019444|Vaccine|vaccine
28867|NCT04019418|carbohydrate|carbohydrate
28868|NCT04019418|exercise|exercise
28869|NCT04019418|PYY|pyy
28870|NCT04019418|GLP-1|glp-1
28871|NCT04019418|ghrelin|ghrelin
28872|NCT04019418|hormones|hormones
28873|NCT04019405|coronary artery disease|coronary artery disease
28874|NCT04019405|elderly|elderly
28875|NCT04019405|revascularisation|revascularisation
28876|NCT04019405|frailty|frailty
28877|NCT04019392|cooling rates|cooling rates
28878|NCT04019379|Whole-body balance|whole-body balance
28879|NCT04019379|Kinetic modeling|kinetic modeling
28880|NCT04019379|Intestinal absorption|intestinal absorption
28881|NCT04019366|Balance Training|balance training
28882|NCT04019366|Biodex stability system|biodex stability system
28883|NCT04019366|Osteoarthrosis|osteoarthrosis
28884|NCT04019366|Degenerative|degenerative
28885|NCT04019366|Stability exercises|stability exercises
28886|NCT04019340|patient education|patient education
28887|NCT04019327|talazoparib|talazoparib
28888|NCT04019327|temozolomide|temozolomide
28889|NCT04019327|Prostate cancer|prostate cancer
28890|NCT04019327|Memorial Sloan Kettering Cancer Center|memorial sloan kettering cancer center
28891|NCT04019327|19-041|19-041
28892|NCT04019301|Cancer Caregiver|cancer caregiver
28893|NCT04019301|Qigong|qigong
28894|NCT04019301|Feasibility|feasibility
28895|NCT04019301|Caregiver distress|caregiver distress
28896|NCT04019275|disability, rehabilitation|disability, rehabilitation
28897|NCT04019262|Chemo-Radiation Therapy|chemo-radiation therapy
28898|NCT04019262|temozolomide|temozolomide
28899|NCT04019262|lymphocytopenia|lymphocytopenia
28900|NCT04019249|eHealth, web-based, internet-based, digital, body weight|ehealth, web-based, internet-based, digital, body weight
28901|NCT04019197|HIV|hiv
28902|NCT04019197|lipohypertrophy|lipohypertrophy
28903|NCT04019197|semaglutide|semaglutide
28904|NCT04019197|GLP-1 receptor agonist|glp-1 receptor agonist
28905|NCT04019197|obesity|obesity
28906|NCT04019184|Cardiac surgery|cardiac surgery
28907|NCT04019184|glutamine|glutamine
28908|NCT04019158|Parkinson's Disease|parkinson's disease
28909|NCT04019158|Virtual reality|virtual reality
28910|NCT04019158|Gait|gait
28911|NCT04019158|Variability|variability
28912|NCT04019158|Fractal|fractal
28913|NCT04019132|Muscle Power|muscle power
28914|NCT04019132|Functional capacity|functional capacity
28915|NCT04019106|Surfactant|surfactant
28916|NCT04019106|Budesonide|budesonide
28917|NCT04019106|Steroid|steroid
28918|NCT04019106|Intratracheal|intratracheal
28919|NCT04019106|Preterm|preterm
810049|NCT00210249|elderly|elderly
28920|NCT04019106|Bronchopulmonary Dysplasia|bronchopulmonary dysplasia
28921|NCT04019106|Respiratory Distress Syndrome|respiratory distress syndrome
28922|NCT04019106|Bovine Lipid Extract Surfactant|bovine lipid extract surfactant
28923|NCT04019093|alcohol effects|alcohol effects
28924|NCT04019067|magnetically controlled capsule endoscopy|magnetically controlled capsule endoscopy
28925|NCT04019067|detection algorithm|detection algorithm
28926|NCT04019054|Transcranial Magnetic Stimulation (TMS)|transcranial magnetic stimulation (tms)
28927|NCT04019054|Exposure Therapy|exposure therapy
28928|NCT04019054|Phobia|phobia
28929|NCT04019054|Intermittent Theta-Burst Stimulation (iTBS)|intermittent theta-burst stimulation (itbs)
28930|NCT04019028|low frequency rTMS|low frequency rtms
28931|NCT04019028|fNIRS|fnirs
28932|NCT04019028|Hemodynamic Response|hemodynamic response
28933|NCT04019028|Non-invasive brain stimulation|non-invasive brain stimulation
28934|NCT04019015|Shock, Hemorrhagic|shock, hemorrhagic
28935|NCT04019015|Trauma|trauma
28936|NCT04019015|Mortality|mortality
28937|NCT04019015|Wounds and Injuries|wounds and injuries
28938|NCT04019015|Hemorrhage|hemorrhage
28939|NCT04019002|Glioblastoma Multiforme|glioblastoma multiforme
28940|NCT04019002|Hyperpolarized Pyruvate|hyperpolarized pyruvate
28941|NCT04019002|Magnetic Resonance|magnetic resonance
28942|NCT04019002|Magnetic Resonance Spectroscopic Imaging|magnetic resonance spectroscopic imaging
28943|NCT04019002|Glioblastoma|glioblastoma
28944|NCT04018963|Pituitary tumor|pituitary tumor
28945|NCT04018963|Neuroendoscope|neuroendoscope
28946|NCT04018963|Surgical approach|surgical approach
28947|NCT04018963|Computational Fluid Dynamics|computational fluid dynamics
28948|NCT04018963|Numerical simulation|numerical simulation
28949|NCT04018950|Acinetobacter baumannii-calcoaceticus|acinetobacter baumannii-calcoaceticus
28950|NCT04018950|complex infections|complex infections
28951|NCT04018950|ETX2514|etx2514
28952|NCT04018950|excretion|excretion
28953|NCT04018950|metabolism|metabolism
28954|NCT04018937|Pediatrics|pediatrics
28955|NCT04018937|Hematopoietic stem cell transplantation|hematopoietic stem cell transplantation
28956|NCT04018937|HLA matched sibling|hla matched sibling
28957|NCT04018924|Blue Light|blue light
28958|NCT04018924|Photo-bio-modulation|photo-bio-modulation
28959|NCT04018924|ulcers|ulcers
28960|NCT04018924|leg ulcers Venous|leg ulcers venous
28961|NCT04018924|dehiscence surgical wound|dehiscence surgical wound
28962|NCT04018924|non healing wound|non healing wound
28963|NCT04018872|itraconazole|itraconazole
28964|NCT04018872|esophageal neoplasms|esophageal neoplasms
28965|NCT04018872|esophagus|esophagus
28966|NCT04018872|esophagogastric junction|esophagogastric junction
28967|NCT04018872|adenocarcinoma|adenocarcinoma
28968|NCT04018872|squamous cell carcinoma|squamous cell carcinoma
28969|NCT04018846|Peripheral Artery Disease|peripheral artery disease
28970|NCT04018846|Revascularization|revascularization
28971|NCT04018846|Graft|graft
28972|NCT04018846|Vein|vein
28973|NCT04018846|Artery|artery
28974|NCT04018846|Limb|limb
28975|NCT04018846|Amputation|amputation
28976|NCT04018833|Diabetic Macular Edema|diabetic macular edema
28977|NCT04018833|Bevacizumab|bevacizumab
28978|NCT04018833|Ranibizumab|ranibizumab
28979|NCT04018833|Aflibercept|aflibercept
28980|NCT04018833|BCVA|bcva
28981|NCT04018833|OCT|oct
28982|NCT04018781|Medication reconciliation|medication reconciliation
28983|NCT04018781|clinical pharmacy|clinical pharmacy
28984|NCT04018716|deep dentin caries|deep dentin caries
28985|NCT04018716|randomized clinical trial|randomized clinical trial
28986|NCT04018716|mineral trioxide aggregate|mineral trioxide aggregate
28987|NCT04018716|calcium hydroxide|calcium hydroxide
28988|NCT04018716|total caries excavation|total caries excavation
28989|NCT04018703|Monitored anesthesia care|monitored anesthesia care
28990|NCT04018703|Ophthalmic surgery|ophthalmic surgery
28991|NCT04018703|Dexmedetomidine|dexmedetomidine
28992|NCT04018703|Midazolam|midazolam
28993|NCT04018690|Hip Osteoarthritis|hip osteoarthritis
28994|NCT04018690|Quality of Life|quality of life
28995|NCT04018690|Function|function
28996|NCT04018690|Viscosuplementação|viscosuplementação
28997|NCT04018664|nalbuphine|nalbuphine
28998|NCT04018664|abuse potential|abuse potential
28999|NCT04018651|Pre-Exposure Prophylaxis|pre-exposure prophylaxis
29000|NCT04018651|PrEP|prep
29001|NCT04018625|Prenatal Maternal Stress|prenatal maternal stress
29002|NCT04018625|Perinatal Mental Health|perinatal mental health
29003|NCT04018625|Pregnancy|pregnancy
29004|NCT04018625|Perinatal Anxiety|perinatal anxiety
29005|NCT04018625|Perinatal Depression|perinatal depression
29006|NCT04018599|Biosimilar|biosimilar
29007|NCT04018599|Adalimumab|adalimumab
29008|NCT04018599|MSB11022|msb11022
29009|NCT04018547|Screening, patient convenience|screening, patient convenience
29010|NCT04018508|left ventricular assist device|left ventricular assist device
29011|NCT04018508|massage|massage
29012|NCT04018508|coping|coping
29013|NCT04018508|self efficacy|self efficacy
29014|NCT04018482|intravitreal|intravitreal
29015|NCT04018482|injection|injection
29016|NCT04018482|disinfectant|disinfectant
29017|NCT04018482|comfort|comfort
29018|NCT04018482|Povidone Iodine|povidone iodine
29019|NCT04018482|Avenova|avenova
29020|NCT04018469|PED Wound Dressing|ped wound dressing
29021|NCT04018456|Necrotic pulp,|necrotic pulp,
29022|NCT04018456|Apical periodontitis|apical periodontitis
29023|NCT04018456|Regeneration|regeneration
29024|NCT04018456|MTA|mta
29025|NCT04018456|Biodentine|biodentine
29026|NCT04018430|glucose, insulin, HbA1c|glucose, insulin, hba1c
29027|NCT04018391|HIV treatment|hiv treatment
29028|NCT04018391|Depression|depression
29029|NCT04018391|Medication Adherence|medication adherence
29030|NCT04018365|insulin resistance|insulin resistance
29031|NCT04018365|refractory diabetes mellitus|refractory diabetes mellitus
29032|NCT04018339|Bardoxolone Methyl|bardoxolone methyl
29033|NCT04018339|Obese adult|obese adult
29043|NCT04018300|oral iron supplement|oral iron supplement
29044|NCT04018300|oral iron supplement side effects|oral iron supplement side effects
29045|NCT04018287|microRNAs, bone microstructure|micrornas, bone microstructure
29046|NCT04018261|CMV|cmv
29047|NCT04018261|Bone marrow transplant|bone marrow transplant
29048|NCT04018261|Activated T-Lymphocytes|activated t-lymphocytes
29049|NCT04018261|Cell therapy|cell therapy
29050|NCT04018261|Virus infection|virus infection
29051|NCT04018261|immunosuppression|immunosuppression
29052|NCT04018222|Systemic Lupus Erythematosus|systemic lupus erythematosus
29053|NCT04018222|SLE|sle
29054|NCT04018222|Lupus Flare|lupus flare
29055|NCT04018222|Flare Prediction|flare prediction
29056|NCT04018222|Lupus|lupus
29057|NCT04018209|Pruritus|pruritus
29058|NCT04018209|Myeloproliferative Neoplasms|myeloproliferative neoplasms
29059|NCT04018196|Very old adults|very old adults
29060|NCT04018196|Memorizing|memorizing
29061|NCT04018196|Motor imagery|motor imagery
29062|NCT04018196|Motor learning|motor learning
29063|NCT04018196|Upper limb|upper limb
29064|NCT04018196|Lower limb|lower limb
29065|NCT04018196|Motor task|motor task
29066|NCT04018196|Manual task|manual task
29067|NCT04018183|non-small cell lung cancer|non-small cell lung cancer
29068|NCT04018183|epidermal growth factor receptor tyrosine inhibitor|epidermal growth factor receptor tyrosine inhibitor
29070|NCT04018144|Periodontitis, PPAR-γ, RXR-α, VDR|periodontitis, ppar-γ, rxr-α, vdr
29071|NCT04018131|Atopic Dermatitis|atopic dermatitis
29072|NCT04018131|Cimetidine|cimetidine
29073|NCT04018131|Immunoglobulin E|immunoglobulin e
29074|NCT04018131|Interleukin-4|interleukin-4
29075|NCT04018131|Interleukin-12|interleukin-12
29076|NCT04018131|Interferon Gamma|interferon gamma
29077|NCT04018131|SCORAD|scorad
29078|NCT04018131|Treatment|treatment
29079|NCT04018118|Eosinophilia|eosinophilia
29080|NCT04018118|Hypereosinophilia|hypereosinophilia
29081|NCT04018118|Hypereosinophilic Syndrome|hypereosinophilic syndrome
29082|NCT04018105|Impaired glucose tolerance|impaired glucose tolerance
29083|NCT04018105|type 2 diabetes|type 2 diabetes
29084|NCT04018105|obesity|obesity
29085|NCT04018105|carbohydrate absorption|carbohydrate absorption
29086|NCT04018105|metformin|metformin
29087|NCT04018079|PDA|pda
29088|NCT04018079|Echo|echo
29089|NCT04018066|gut microbiome|gut microbiome
29090|NCT04018066|metabolome|metabolome
29091|NCT04018066|dietary polyphenols|dietary polyphenols
29092|NCT04018066|grape|grape
29093|NCT04018066|nutrition|nutrition
29094|NCT04018053|Bladder cancer|bladder cancer
29095|NCT04018053|urothelial carcinoma|urothelial carcinoma
29096|NCT04018053|cystectomy|cystectomy
29106|NCT04018014|Pulmonary embolism|pulmonary embolism
29107|NCT04018014|Obesity|obesity
29108|NCT04018014|CT scanner|ct scanner
29109|NCT04018014|Iterative reconstructions|iterative reconstructions
29110|NCT04017988|Porphyra Tenera|porphyra tenera
29111|NCT04017975|fiberoptic confocal microscopy|fiberoptic confocal microscopy
29112|NCT04017975|cardiac surgery|cardiac surgery
29113|NCT04017962|HCT|hct
29114|NCT04017962|CMV infection|cmv infection
29115|NCT04017962|Letermovir|letermovir
29116|NCT04017962|LTV|ltv
29117|NCT04017962|Memorial Sloan Kettering Cancer Center|memorial sloan kettering cancer center
29118|NCT04017962|19-174|19-174
29119|NCT04017949|viscosupplementation injection|viscosupplementation injection
29120|NCT04017949|corticosteroid injection|corticosteroid injection
29121|NCT04017923|Nasal tip|nasal tip
29122|NCT04017923|Tip support|tip support
29123|NCT04017923|Rhinoplasty|rhinoplasty
29124|NCT04017923|Nasal cartilage|nasal cartilage
29125|NCT04017923|Age|age
29126|NCT04017884|Remineralization|remineralization
29127|NCT04017884|caries regression|caries regression
29128|NCT04017884|color improvement|color improvement
29129|NCT04017871|Cerebral Palsy (CP)|cerebral palsy (cp)
29130|NCT04017871|pre-school children with unilateral and bilateral CP|pre-school children with unilateral and bilateral cp
29131|NCT04017858|Total knee arthroplasty|total knee arthroplasty
29132|NCT04017858|Exercise|exercise
29133|NCT04017858|Preoperative|preoperative
29134|NCT04017858|Complications|complications
29438|NCT04015830|Aging|aging
29140|NCT04017806|luminal pressure|luminal pressure
29147|NCT04017754|Mannose binding lectin|mannose binding lectin
29148|NCT04017754|Perinatal outcome|perinatal outcome
29149|NCT04017754|Recurrent pregnancy loss|recurrent pregnancy loss
29150|NCT04017741|Chronic migraine, GON blocks|chronic migraine, gon blocks
29151|NCT04017715|cricket injury prevention program,sports injuries,|cricket injury prevention program,sports injuries,
29152|NCT04017663|Rehabilitation|rehabilitation
29153|NCT04017663|Surveys and Questionnaires|surveys and questionnaires
29154|NCT04017663|Treatment Adherence and Compliance|treatment adherence and compliance
29155|NCT04017663|Patient Compliance|patient compliance
29156|NCT04017637|Inflammatory Bowel Disease|inflammatory bowel disease
29157|NCT04017637|Resistance Training|resistance training
29158|NCT04017637|Lean Body Mass|lean body mass
29159|NCT04017637|Pediatric|pediatric
29160|NCT04017624|Mobile produce market|mobile produce market
29161|NCT04017624|Boston Accountable Care Organization (BACO)|boston accountable care organization (baco)
29162|NCT04017624|Medicaid ACO|medicaid aco
29163|NCT04017624|Accountable Care Organization|accountable care organization
29164|NCT04017624|ACO|aco
29165|NCT04017624|Social determinants of health|social determinants of health
29166|NCT04017624|THRIVE|thrive
29167|NCT04017624|Healthcare utilization|healthcare utilization
29168|NCT04017624|Cost of care|cost of care
29169|NCT04017624|Fruit and vegetable consumption|fruit and vegetable consumption
29170|NCT04017598|anemia|anemia
29171|NCT04017598|gut inflammation|gut inflammation
29172|NCT04017598|iron deficiency|iron deficiency
29173|NCT04017598|iron|iron
29174|NCT04017598|iron supplementation|iron supplementation
29175|NCT04017585|gluten free diet|gluten free diet
29176|NCT04017585|FODMAPs|fodmaps
29177|NCT04017585|gastrointestinal symptoms|gastrointestinal symptoms
29178|NCT04017572|dialysis|dialysis
29179|NCT04017572|peritoneal dialysis|peritoneal dialysis
29180|NCT04017546|CYC065|cyc065
29181|NCT04017546|CDK2/9|cdk2/9
29182|NCT04017546|venetoclax|venetoclax
29183|NCT04017546|BCL-2|bcl-2
29184|NCT04017546|MCL-1|mcl-1
29185|NCT04017546|Relapsed|relapsed
29186|NCT04017546|Refractory|refractory
29187|NCT04017546|acute myeloid leukemia|acute myeloid leukemia
29188|NCT04017546|myelodysplastic syndromes|myelodysplastic syndromes
29189|NCT04017546|AML|aml
29190|NCT04017546|MDS|mds
29191|NCT04017533|Total Knee Arthroplasty (TKA)|total knee arthroplasty (tka)
29192|NCT04017533|Total Knee Replacement (TKR)|total knee replacement (tkr)
29193|NCT04017533|Radiostereometric Analysis|radiostereometric analysis
29194|NCT04017533|RSA|rsa
29195|NCT04017533|Medial Pivot|medial pivot
29196|NCT04017533|Medially stabilized|medially stabilized
29197|NCT04017533|Medial pivoting|medial pivoting
29198|NCT04017533|GMK Sphere|gmk sphere
29199|NCT04017533|Global Medacta Knee Sphere|global medacta knee sphere
29200|NCT04017520|Atopy|atopy
29201|NCT04017520|Wheezing|wheezing
29202|NCT04017520|Eczema|eczema
29203|NCT04017520|Allergy|allergy
29204|NCT04017520|Food allergies|food allergies
29205|NCT04017494|Fontan|fontan
29206|NCT04017494|Congenital heart defects|congenital heart defects
29207|NCT04017494|Non-invasive cardiac imaging|non-invasive cardiac imaging
29208|NCT04017494|Biomarkers|biomarkers
29209|NCT04017481|neuromodulation|neuromodulation
29210|NCT04017481|TMS|tms
29211|NCT04017481|NFB|nfb
29212|NCT04017455|short term immunotherapy|short term immunotherapy
29213|NCT04017455|atezolizumab|atezolizumab
29214|NCT04017455|bevacizumab|bevacizumab
29215|NCT04017455|radiotherapy|radiotherapy
29216|NCT04017442|Postpartum depression|postpartum depression
29217|NCT04017442|Postpartum anxiety|postpartum anxiety
29218|NCT04017442|Postpartum opioids|postpartum opioids
29219|NCT04017403|postoperative cognitive dysfunction|postoperative cognitive dysfunction
29220|NCT04017403|postopeartive delirium|postopeartive delirium
29221|NCT04017403|Probiotics|probiotics
29222|NCT04017390|Hand Pain/Numbness|hand pain/numbness
29223|NCT04017364|drug coated balloon|drug coated balloon
29224|NCT04017364|Paclitaxel|paclitaxel
29225|NCT04017364|sirolimus|sirolimus
29226|NCT04017351|Plastic|plastic
29227|NCT04017351|Virtual Assistant|virtual assistant
29228|NCT04017338|Organ Transplant|organ transplant
29229|NCT04017338|Hepatitis C Virus|hepatitis c virus
29230|NCT04017338|Direct-Acting Antivirals (DAAs)|direct-acting antivirals (daas)
29231|NCT04017312|HFCWO|hfcwo
29232|NCT04017312|Airway Clearance therapy|airway clearance therapy
29233|NCT04017312|PEP|pep
29234|NCT04017312|The Vest®|the vest®
29235|NCT04017312|Non Cystic Fibrosis Bronchiectasis|non cystic fibrosis bronchiectasis
29236|NCT04017312|HFCWC|hfcwc
29237|NCT04017312|High frequency chest wall oscillation|high frequency chest wall oscillation
29238|NCT04017299|ICU|icu
29239|NCT04017299|Pain|pain
29240|NCT04017299|Anxiety|anxiety
29241|NCT04017299|Thirst|thirst
29242|NCT04017299|Dyspnea|dyspnea
29243|NCT04017299|Sleep|sleep
29244|NCT04017299|Discomfort|discomfort
29245|NCT04017299|Distress|distress
29246|NCT04017299|Virtual Reality|virtual reality
29247|NCT04017299|Music Therapy|music therapy
29248|NCT04017286|Developmental assessment|developmental assessment
29249|NCT04017286|Homocysteine|homocysteine
29250|NCT04017286|physique growth|physique growth
29251|NCT04017286|nutrients|nutrients
29252|NCT04017260|pilonidal sinus, combined, sutures, drain|pilonidal sinus, combined, sutures, drain
29253|NCT04017221|Sodium-glucose cotransporter 2 inhibitors|sodium-glucose cotransporter 2 inhibitors
29254|NCT04017221|Diabetes mellitus, type 2|diabetes mellitus, type 2
29255|NCT04017221|Urosepsis|urosepsis
29256|NCT04017221|Diabetic ketoacidosis|diabetic ketoacidosis
29257|NCT04017221|Lower extremity amputation|lower extremity amputation
29258|NCT04017182|central venous oxygen saturation|central venous oxygen saturation
29259|NCT04017182|external jugular venous oxygen saturation|external jugular venous oxygen saturation
29260|NCT04017182|central venous catheter|central venous catheter
29261|NCT04017182|external jugular vein|external jugular vein
29262|NCT04017182|internal jugular vein|internal jugular vein
29263|NCT04017182|superior vena cava oxygen saturation|superior vena cava oxygen saturation
29264|NCT04017130|Drug therapy|drug therapy
29265|NCT04017091|Virtual Reality Exposure Therapy|virtual reality exposure therapy
29266|NCT04017091|Executive Function|executive function
29267|NCT04017091|Rehabilitation|rehabilitation
29268|NCT04017078|carotid artery calcification|carotid artery calcification
29269|NCT04017078|panoramic radiography|panoramic radiography
29270|NCT04017078|periodontitis|periodontitis
29271|NCT04017078|periodontal disease|periodontal disease
29272|NCT04017078|systemic diseases|systemic diseases
29273|NCT04017065|limb deformity correction|limb deformity correction
29274|NCT04017065|limb lengthening|limb lengthening
29275|NCT04017065|MAXFRAME system|maxframe system
29276|NCT04017026|Short dental implant|short dental implant
29277|NCT04017026|Partially edentulous jaw|partially edentulous jaw
29278|NCT04017013|Pain|pain
29279|NCT04017013|Abdominal Surgery|abdominal surgery
29280|NCT04017013|Epidural analgesia|epidural analgesia
29281|NCT04017013|lidocaine|lidocaine
29282|NCT04016948|Rectal cancer|rectal cancer
29283|NCT04016948|distal margin|distal margin
29284|NCT04016948|confocal laser endomicroscopy|confocal laser endomicroscopy
29285|NCT04016948|real-time|real-time
29286|NCT04016948|in vivo|in vivo
29287|NCT04016948|optical biopsy|optical biopsy
29288|NCT04016935|ER+ and HER2- Breast Cancer patients|er+ and her2- breast cancer patients
29289|NCT04016935|Extended Endocrine Therapy|extended endocrine therapy
29290|NCT04016935|EndoPredict|endopredict
29291|NCT04016922|Fetal hemodynamics.|fetal hemodynamics.
29292|NCT04016922|Intrauterine growth restriction|intrauterine growth restriction
29293|NCT04016922|Amniotic fluid index|amniotic fluid index
29294|NCT04016909|brain activity|brain activity
29295|NCT04016909|cognitive function|cognitive function
29296|NCT04016909|diet|diet
29297|NCT04016909|exercise|exercise
29298|NCT04016909|motor behavior|motor behavior
29299|NCT04016909|psychosocial state|psychosocial state
29300|NCT04016857|remote ischemic preconditioning|remote ischemic preconditioning
29301|NCT04016857|lower limb revascularization|lower limb revascularization
29302|NCT04016857|TIMP-2|timp-2
29303|NCT04016857|IGFBP-7|igfbp-7
29304|NCT04016844|Multiple Scerosis|multiple scerosis
29305|NCT04016844|PET|pet
29306|NCT04016844|tDCS|tdcs
29307|NCT04016805|umbralisib|umbralisib
29308|NCT04016805|ublituximab|ublituximab
29309|NCT04016805|venetoclax|venetoclax
29310|NCT04016805|ibrutinib|ibrutinib
29311|NCT04016805|CLL|cll
29312|NCT04016740|Cardiopulmonary Bypass|cardiopulmonary bypass
29313|NCT04016740|Cardiac Surgery|cardiac surgery
29314|NCT04016740|analgesics|analgesics
29315|NCT04016727|tooth movement|tooth movement
29316|NCT04016727|platelet rich plasma|platelet rich plasma
29317|NCT04016597|diffusing capacity|diffusing capacity
29318|NCT04016597|reliability|reliability
29319|NCT04016597|healthy|healthy
29320|NCT04016597|adults|adults
29321|NCT04016597|nitric oxide|nitric oxide
29322|NCT04016584|Type 2 Diabetes|type 2 diabetes
29323|NCT04016584|Latino/Hispanic|latino/hispanic
29324|NCT04016584|Promotore|promotore
29325|NCT04016584|Community health worker|community health worker
29326|NCT04016571|Cystic Fibrosis|cystic fibrosis
29327|NCT04016571|Pulmonary Exacerbation|pulmonary exacerbation
29328|NCT04016571|Antibiotics|antibiotics
29329|NCT04016571|Outcome measures|outcome measures
29330|NCT04016532|Elderly peopole|elderly peopole
29331|NCT04016532|Undernutrition|undernutrition
29332|NCT04016532|Acute Geriatric|acute geriatric
29333|NCT04016506|Pancreas Injury|pancreas injury
29334|NCT04016506|Child|child
29338|NCT04016454|anesthesia|anesthesia
29339|NCT04016454|adverse outcomes|adverse outcomes
29340|NCT04016441|sunscreen|sunscreen
29342|NCT04016428|pregnancy|pregnancy
29343|NCT04016428|insomnia|insomnia
29344|NCT04016428|depression|depression
29345|NCT04016428|mindfulness|mindfulness
29346|NCT04016415|Stress, Psychological|stress, psychological
29347|NCT04016415|Mindfulness|mindfulness
29348|NCT04016415|Meditation|meditation
29349|NCT04016415|Mind-Body Therapies|mind-body therapies
29350|NCT04016415|Diabetes Mellitus, Type 2|diabetes mellitus, type 2
29351|NCT04016402|Transcranial Magnetic Stimulation|transcranial magnetic stimulation
29352|NCT04016402|Magnetic Resonance Imaging|magnetic resonance imaging
29353|NCT04016376|Mastectomy|mastectomy
29354|NCT04016376|Double Mastectomy|double mastectomy
29355|NCT04016376|Mastectomy with reconstruction|mastectomy with reconstruction
29356|NCT04016376|Double mastectomy with reconstruction|double mastectomy with reconstruction
29357|NCT04016376|Double mastectomy with immediate reconstruction|double mastectomy with immediate reconstruction
29358|NCT04016376|Mastectomy with immediate reconstruction|mastectomy with immediate reconstruction
29359|NCT04016376|Memorial Sloan Kettering Cancer Center|memorial sloan kettering cancer center
29360|NCT04016376|19-238|19-238
29361|NCT04016350|Exercise,|exercise,
29362|NCT04016350|Inulin Propionate Ester|inulin propionate ester
29363|NCT04016350|Gut hormones|gut hormones
29364|NCT04016350|Body weigh|body weigh
29365|NCT04016350|Fat oxidation|fat oxidation
29366|NCT04016350|Overweight women|overweight women
29367|NCT04016337|sweeteners|sweeteners
29368|NCT04016337|stevia|stevia
29369|NCT04016337|sucralose|sucralose
29370|NCT04016337|polyphenols|polyphenols
29371|NCT04016337|maqui|maqui
29372|NCT04016337|bioavailability|bioavailability
29373|NCT04016337|inflammation|inflammation
29374|NCT04016337|gut hormones|gut hormones
29375|NCT04016337|biomarkers|biomarkers
29376|NCT04016324|Overactive Bladder|overactive bladder
29377|NCT04016324|Urinary Urge Incontinence|urinary urge incontinence
29378|NCT04016324|Urgency-frequency Syndrome|urgency-frequency syndrome
29379|NCT04016298|Bladder Health|bladder health
29380|NCT04016298|LUTS|luts
29381|NCT04016298|PLUS|plus
29382|NCT04016298|VIEW|view
29383|NCT04016285|Tourniquet|tourniquet
29384|NCT04016285|Aquamantys|aquamantys
29385|NCT04016285|Arthroplasty|arthroplasty
29386|NCT04016285|Total Knee|total knee
29387|NCT04016285|Standard of Care Tourniquet|standard of care tourniquet
29388|NCT04016246|LISA|lisa
29389|NCT04016246|propofol|propofol
29390|NCT04016246|medialipide|medialipide
29391|NCT04016246|ketamin|ketamin
29392|NCT04016246|sedation|sedation
29393|NCT04016246|premature infant|premature infant
29394|NCT04016246|surfactant|surfactant
29395|NCT04016233|Tenofovir|tenofovir
29396|NCT04016233|Tenofovir douche|tenofovir douche
29397|NCT04016220|asthma|asthma
29398|NCT04016220|budesonide|budesonide
29399|NCT04016220|nebulized|nebulized
29400|NCT04016220|adult|adult
29401|NCT04016194|Multiple-breath washout, MBW|multiple-breath washout, mbw
29402|NCT04016194|Lung clearance index, LCI|lung clearance index, lci
29403|NCT04016194|Prediction|prediction
29404|NCT04016194|Survival|survival
29405|NCT04016194|Cystic Fibrosis, CF|cystic fibrosis, cf
29406|NCT04016168|Biomarkers|biomarkers
29407|NCT04016168|CD163|cd163
29408|NCT04016142|Adjuvant Chemotherapy|adjuvant chemotherapy
29409|NCT04016142|Cervical cancer|cervical cancer
29410|NCT04016129|CD19- B-ALL|cd19- b-all
29411|NCT04016129|CART|cart
29412|NCT04016129|CD22, CD123, CD38, CD10, CD20, TSLPR|cd22, cd123, cd38, cd10, cd20, tslpr
29413|NCT04016103|Acute Compartment Syndrome|acute compartment syndrome
29414|NCT04016090|Postmenopausal women|postmenopausal women
29415|NCT04016090|Vascular health|vascular health
29416|NCT04016090|Folic acid|folic acid
29420|NCT04016064|gingival enlargement, Er:YAG, Nd:YAG, electrosurgery|gingival enlargement, er:yag, nd:yag, electrosurgery
29421|NCT04015934|predictive factors|predictive factors
29422|NCT04015921|self-concept|self-concept
29423|NCT04015921|self referencing bias|self referencing bias
29424|NCT04015895|Cancer|cancer
29425|NCT04015895|Social fragilities|social fragilities
29426|NCT04015895|Social inequalities|social inequalities
29427|NCT04015895|DEFCO|defco
29428|NCT04015895|machine learning|machine learning
29429|NCT04015895|cancer care pathway|cancer care pathway
29430|NCT04015882|acute lymphoblastic leukemia|acute lymphoblastic leukemia
29431|NCT04015882|bone density|bone density
29432|NCT04015882|total fat|total fat
29433|NCT04015882|exercise|exercise
29434|NCT04015856|Social research|social research
29435|NCT04015830|Sleep|sleep
29436|NCT04015830|Neurocognitive Disorders|neurocognitive disorders
29439|NCT04015817|Dyspnea|dyspnea
29440|NCT04015817|Well being|well being
29441|NCT04015817|respiratory care team non-specialized in palliative care|respiratory care team non-specialized in palliative care
29442|NCT04015804|cancer|cancer
29443|NCT04015804|rectum|rectum
29444|NCT04015804|robot|robot
29445|NCT04015791|lumbar disc disease|lumbar disc disease
29446|NCT04015791|MR Spectroscopy|mr spectroscopy
29447|NCT04015791|Nociscan|nociscan
29448|NCT04015739|Bevacizumab|bevacizumab
29449|NCT04015739|Olaparib|olaparib
29450|NCT04015739|Durvalumab|durvalumab
29451|NCT04015739|Tri association|tri association
29452|NCT04015687|Pharmacokinetic study|pharmacokinetic study
29453|NCT04015674|Exercise|exercise
810151|NCT00209768|SIRS|sirs
29454|NCT04015674|Vasodilation|vasodilation
29455|NCT04015648|Vaccine|vaccine
29456|NCT04015635|blood pressure|blood pressure
29457|NCT04015635|hypertension|hypertension
29458|NCT04015635|inflammation|inflammation
29459|NCT04015635|immune dysfunction|immune dysfunction
29460|NCT04015635|endothelial dysfunction|endothelial dysfunction
29461|NCT04015622|circulating tumor DNA|circulating tumor dna
29462|NCT04015622|Enzalutamide|enzalutamide
29463|NCT04015622|Docetaxel|docetaxel
29464|NCT04015609|Stage III solid tumor cancer|stage iii solid tumor cancer
29465|NCT04015609|Stage IV solid tumor cancer|stage iv solid tumor cancer
29466|NCT04015609|Stage III cancer|stage iii cancer
29467|NCT04015609|Stage IV cancer|stage iv cancer
29468|NCT04015609|Spanish|spanish
29469|NCT04015609|Memorial Sloan Kettering Cancer Center|memorial sloan kettering cancer center
29470|NCT04015609|15-076|15-076
29471|NCT04015596|PANDAS|pandas
29472|NCT04015596|Children|children
29473|NCT04015596|Obsessive-Compulsive Disorder|obsessive-compulsive disorder
29474|NCT04015596|Anxiety|anxiety
29475|NCT04015596|NSAID|nsaid
29476|NCT04015583|exergaming|exergaming
29477|NCT04015583|executive functions|executive functions
29478|NCT04015583|event-related potential|event-related potential
29479|NCT04015583|metabolic syndrome|metabolic syndrome
29480|NCT04015557|Homocystinuria|homocystinuria
29481|NCT04015557|Glutathione|glutathione
29482|NCT04015557|Acetaminophen|acetaminophen
29483|NCT04015557|N-acetylcysteine|n-acetylcysteine
29484|NCT04015557|Cysteine|cysteine
29485|NCT04015557|Homocysteine|homocysteine
29486|NCT04015544|insulin|insulin
29487|NCT04015544|glucose|glucose
29488|NCT04015544|cardiovascular disease|cardiovascular disease
29489|NCT04015544|inflammation|inflammation
29490|NCT04015544|watermelon|watermelon
29491|NCT04015544|L-citrulline|l-citrulline
29492|NCT04015544|L-arginine|l-arginine
29493|NCT04015531|breast cancer|breast cancer
29494|NCT04015531|radiotherapy|radiotherapy
29495|NCT04015531|hypofractionated therapy|hypofractionated therapy
29496|NCT04015531|nodal irradiation|nodal irradiation
29497|NCT04015479|muscle protein synthesis|muscle protein synthesis
29498|NCT04015479|resistance training|resistance training
29499|NCT04015479|protein supplementation|protein supplementation
29500|NCT04015479|skeletal muscle physiology|skeletal muscle physiology
29501|NCT04015479|inflammatory cytokines|inflammatory cytokines
29502|NCT04015479|fecal microbiome|fecal microbiome
29503|NCT04015479|plant protein|plant protein
29504|NCT04015466|Gastric Cancer|gastric cancer
29505|NCT04015466|Personalized medicine|personalized medicine
29506|NCT04015466|Oncology|oncology
29507|NCT04015466|Solid tumor|solid tumor
29508|NCT04015466|Primary Intervention|primary intervention
29509|NCT04015440|attention bias|attention bias
29510|NCT04015440|hostile attribution bias|hostile attribution bias
29511|NCT04015440|hostile bias modification|hostile bias modification
29512|NCT04015427|cement|cement
29513|NCT04015427|dental|dental
29514|NCT04015427|implant|implant
29515|NCT04015427|implant prosthodontics|implant prosthodontics
29516|NCT04015401|Quantitative sensory testing|quantitative sensory testing
29517|NCT04015401|Jamaica|jamaica
29518|NCT04015375|acne vulgaris|acne vulgaris
29519|NCT04015362|Spasticity|spasticity
29520|NCT04015349|grind|grind
29521|NCT04015349|polysomnography|polysomnography
29522|NCT04015349|rhythmic masticatory muscle activity|rhythmic masticatory muscle activity
29523|NCT04015349|sleep bruxism|sleep bruxism
29524|NCT04015336|T Cell Receptor|t cell receptor
29525|NCT04015336|Fludarabine|fludarabine
29526|NCT04015336|Cyclophosphamide|cyclophosphamide
29527|NCT04015336|Immunotherapy|immunotherapy
29528|NCT04015336|Aldesleukin|aldesleukin
29529|NCT04015323|interferential current|interferential current
29530|NCT04015323|knee osteoarthritis|knee osteoarthritis
29531|NCT04015323|pain|pain
29532|NCT04015310|MRCP|mrcp
29533|NCT04015310|MRCP+|mrcp+
29534|NCT04015310|PSC|psc
29535|NCT04015310|Health economic|health economic
29536|NCT04015297|endometriosis|endometriosis
29537|NCT04015297|raman analaysis|raman analaysis
29538|NCT04015284|NOL monitoring|nol monitoring
29539|NCT04015284|regional anesthesia|regional anesthesia
29540|NCT04015284|interscalene brachial plexus block|interscalene brachial plexus block
29541|NCT04015284|shoulder arthroscopy|shoulder arthroscopy
29542|NCT04015271|stroke|stroke
29548|NCT04015258|metabolomics|metabolomics
29549|NCT04015258|genomics|genomics
29550|NCT04015245|TACE|tace
29551|NCT04015232|Pegfilgrastim|pegfilgrastim
29552|NCT04015232|Biosimilar|biosimilar
29553|NCT04015232|Immunogenicity|immunogenicity
29554|NCT04015232|Pharmacokinetics|pharmacokinetics
29555|NCT04015232|Pharmacodynamics|pharmacodynamics
29556|NCT04015232|Safety|safety
29557|NCT04015232|Healthy Volunteers|healthy volunteers
29558|NCT04015206|Major Depressive Disorder|major depressive disorder
29559|NCT04015206|Group Interpersonal Psychotherapy (IPT-G)|group interpersonal psychotherapy (ipt-g)
29560|NCT04015141|Partial-onset seizures|partial-onset seizures
29561|NCT04015141|Pediatric epileptic syndrome|pediatric epileptic syndrome
29562|NCT04015141|Epilepsy|epilepsy
29563|NCT04015141|Childhood epilepsy|childhood epilepsy
29564|NCT04015141|Epilepsy in children|epilepsy in children
29565|NCT04015141|Refractory seizures|refractory seizures
29566|NCT04015141|Inadequately controlled seizures|inadequately controlled seizures
29567|NCT04015141|E2007|e2007
29568|NCT04015141|Fycompa|fycompa
29569|NCT04015141|Perampanel|perampanel
29570|NCT04015115|Buprenorphine|buprenorphine
29571|NCT04015115|Central Nervous System Depressants|central nervous system depressants
29572|NCT04015115|Chemically-Induced Disorders|chemically-induced disorders
29573|NCT04015115|Community Mental Health Services|community mental health services
29574|NCT04015115|Drug Partial Agonism|drug partial agonism
29575|NCT04015115|Heroin Dependence|heroin dependence
29576|NCT04015115|Medication Adherence|medication adherence
29577|NCT04015115|Mental Disorders|mental disorders
29578|NCT04015115|Naltrexone|naltrexone
29579|NCT04015115|Narcotic Antagonists|narcotic antagonists
29580|NCT04015115|Narcotics|narcotics
29581|NCT04015115|Opioid-Related Disorders|opioid-related disorders
29582|NCT04015115|Opioid Substitution Treatment|opioid substitution treatment
29583|NCT04015115|Patient Compliance|patient compliance
29584|NCT04015102|Prostate Cancer Patients|prostate cancer patients
29585|NCT04015102|myRisk genetic testing|myrisk genetic testing
29586|NCT04015089|Infant formula|infant formula
29587|NCT04015089|Partially hydrolized protein infant formula|partially hydrolized protein infant formula
29588|NCT04015063|Dermatology|dermatology
29589|NCT04015063|Skin Care|skin care
29590|NCT04015024|Acute myeloid leukemia|acute myeloid leukemia
29591|NCT04015024|monotherapy|monotherapy
29592|NCT04015024|SKLB1028|sklb1028
29593|NCT04014998|neck pain|neck pain
29594|NCT04014998|virtual reality|virtual reality
29595|NCT04014998|proprioception|proprioception
29596|NCT04014998|balance|balance
29597|NCT04014959|depression|depression
29598|NCT04014959|TMS|tms
29599|NCT04014959|fMRI|fmri
29600|NCT04014933|glaucoma|glaucoma
29601|NCT04014933|retinal blood flow|retinal blood flow
29602|NCT04014933|ocular perfusion pressure|ocular perfusion pressure
29607|NCT04014829|Hysterectomy|hysterectomy
29608|NCT04014829|Chronic Pain|chronic pain
29609|NCT04014829|Fear-Avoidance|fear-avoidance
29610|NCT04014829|Central Sensitization|central sensitization
29611|NCT04014829|Pain-Pressure Threshold|pain-pressure threshold
29612|NCT04014829|Mechanical Temporal Summation|mechanical temporal summation
29613|NCT04014816|ICU|icu
29614|NCT04014803|Percutaneous Coronary Intervention|percutaneous coronary intervention
29615|NCT04014803|Dual Antiplatelet Therapy|dual antiplatelet therapy
29616|NCT04014803|Complex Coronary Lesion|complex coronary lesion
29617|NCT04014751|Symptom-monitoring|symptom-monitoring
29618|NCT04014712|BH4|bh4
29619|NCT04014712|Exercise|exercise
29620|NCT04014712|Mitochondria|mitochondria
29621|NCT04014712|Vascular function|vascular function
29622|NCT04014686|postmenopausal|postmenopausal
29623|NCT04014686|exercise|exercise
29624|NCT04014673|Frontotemporal Dementia,|frontotemporal dementia,
29625|NCT04014673|biomarkers,|biomarkers,
29626|NCT04014673|brain Imaging PET|brain imaging pet
29627|NCT04014660|celiac disease autoimmunity|celiac disease autoimmunity
29628|NCT04014660|islet autoimmunity|islet autoimmunity
29629|NCT04014660|auto-antibodies|auto-antibodies
29630|NCT04014647|Vascular Surgical Procedure|vascular surgical procedure
29631|NCT04014647|Pro-brain natriuretic peptide (1-76)|pro-brain natriuretic peptide (1-76)
29632|NCT04014647|Natriuretic Peptide, Brain|natriuretic peptide, brain
29633|NCT04014647|Troponin I|troponin i
29634|NCT04014647|Galectin 3|galectin 3
29635|NCT04014647|Biomarkers|biomarkers
29636|NCT04014647|Risk|risk
29637|NCT04014621|acute ischemic stroke|acute ischemic stroke
29638|NCT04014621|randomized clinical trial|randomized clinical trial
29639|NCT04014621|anterior circulation|anterior circulation
29640|NCT04014621|penumbra|penumbra
29658|NCT04014504|Pethidine|pethidine
29659|NCT04014504|False positive|false positive
29660|NCT04014491|Shoulder impingement syndrome|shoulder impingement syndrome
29661|NCT04014491|Transcranial magnetic stimulation|transcranial magnetic stimulation
29662|NCT04014491|Corticospinal system|corticospinal system
29663|NCT04014491|Scapular control exercise|scapular control exercise
29664|NCT04014491|Kinematics|kinematics
29665|NCT04014478|Cancer； Pain|cancer； pain
29666|NCT04014465|lung cancer|lung cancer
29667|NCT04014465|esophageal cancer|esophageal cancer
29668|NCT04014465|radiotherapy|radiotherapy
29669|NCT04014465|ctDNA|ctdna
29670|NCT04014452|Complicated Monochorionic Pregnancies|complicated monochorionic pregnancies
29671|NCT04014452|Selective feticide|selective feticide
29672|NCT04014439|diaphragm thickness|diaphragm thickness
29673|NCT04014439|neutrophil to lymphocyte ratio|neutrophil to lymphocyte ratio
29674|NCT04014439|mechanical ventilation|mechanical ventilation
29675|NCT04014426|Peritoneal Carcinomatosis|peritoneal carcinomatosis
29676|NCT04014426|Healthcare Workers|healthcare workers
29677|NCT04014426|Security|security
29678|NCT04014426|Pressurized Intraperitoneal Aerosol Chemotherapy|pressurized intraperitoneal aerosol chemotherapy
29679|NCT04014426|Aerosols/administration & dosage|aerosols/administration & dosage
29680|NCT04014426|Oxaliplatin|oxaliplatin
29681|NCT04014400|skin graft|skin graft
29682|NCT04014400|suprathel|suprathel
29683|NCT04014400|xeroform|xeroform
29684|NCT04014400|burn|burn
29685|NCT04014400|donor site|donor site
29691|NCT04014322|electronic cigarette use|electronic cigarette use
29692|NCT04014322|smoking behavior|smoking behavior
29700|NCT04014296|weight loss|weight loss
29701|NCT04014296|dietary protein|dietary protein
29702|NCT04014296|resistance training|resistance training
29703|NCT04014283|Selenium|selenium
29704|NCT04014283|Supplement|supplement
29705|NCT04014283|Prevention|prevention
29706|NCT04014283|Females|females
29707|NCT04014283|Risk|risk
29708|NCT04014270|Electrical stimulation|electrical stimulation
29709|NCT04014270|Upper limb rehabilitation|upper limb rehabilitation
29710|NCT04014270|Hemiplegia|hemiplegia
29711|NCT04014257|tropomyosin receptor kinase|tropomyosin receptor kinase
29712|NCT04014257|Solid organ malignancies|solid organ malignancies
29713|NCT04014244|Carpal Tunnel Syndrome|carpal tunnel syndrome
29714|NCT04014244|Electromyography|electromyography
29715|NCT04014244|Ultrasonography|ultrasonography
29716|NCT04014244|Surgery|surgery
29717|NCT04014244|Dextrose|dextrose
29718|NCT04014244|Corticosteroids|corticosteroids
29719|NCT04014218|sedation|sedation
29720|NCT04014218|ARDS|ards
29721|NCT04014218|sepsis|sepsis
29722|NCT04014218|outcome|outcome
29723|NCT04014192|Sodium and Glucose Synergistic Transporter 2 Inhibitor|sodium and glucose synergistic transporter 2 inhibitor
29724|NCT04014192|Beta Cell Function|beta cell function
29725|NCT04014192|Alpha Cell Function|alpha cell function
29726|NCT04014192|Insulin Sensitivity|insulin sensitivity
29727|NCT04014166|Thrombocytopenia|thrombocytopenia
29728|NCT04014153|acute kidney injury|acute kidney injury
29729|NCT04014153|coronary artery disease|coronary artery disease
29730|NCT04014153|contrast-induced acute kidney injury|contrast-induced acute kidney injury
29731|NCT04014153|comorbidity|comorbidity
29732|NCT04014153|CI-AKI|ci-aki
29733|NCT04014153|stable CAD|stable cad
29734|NCT04014140|Instantaneous wave-free ratio (iFR)|instantaneous wave-free ratio (ifr)
29735|NCT04014140|Coronary Artery Bypass Grafting (CABG)|coronary artery bypass grafting (cabg)
29736|NCT04014127|coronary flow reserve|coronary flow reserve
30426|NCT04009980|neuropathy|neuropathy
29737|NCT04014127|living kidney donation|living kidney donation
29738|NCT04014127|peritoneal dialysis|peritoneal dialysis
29739|NCT04014088|helmet CPAP|helmet cpap
29740|NCT04014088|facemask CPAP|facemask cpap
29741|NCT04014088|pulmonary edema|pulmonary edema
29742|NCT04014088|non invasive ventilation|non invasive ventilation
29743|NCT04014075|Human epidermal receptor 2 positive|human epidermal receptor 2 positive
29744|NCT04014075|Unresectable or metastatic|unresectable or metastatic
29745|NCT04014075|HER2|her2
29746|NCT04014075|Prior treatment regimen included trastuzumab|prior treatment regimen included trastuzumab
29747|NCT04014062|Pegfilgrastim|pegfilgrastim
29748|NCT04014062|Biosimilar|biosimilar
29749|NCT04014062|Bioequivalence|bioequivalence
29750|NCT04014062|Pharmacokinetics|pharmacokinetics
29751|NCT04014062|Pharmacodynamics|pharmacodynamics
29752|NCT04014062|Safety|safety
29753|NCT04014062|Healthy Volunteers|healthy volunteers
29754|NCT04014049|Temporary Hebergement (TH)|temporary hebergement (th)
29755|NCT04014049|Retirement Home (EHPAD)|retirement home (ehpad)
29756|NCT04014049|Discharge at home|discharge at home
29757|NCT04014036|chronic prostatitis/ pelvic pain syndrome|chronic prostatitis/ pelvic pain syndrome
29758|NCT04014036|low-intensity extracorporeal shockwave therapy|low-intensity extracorporeal shockwave therapy
29759|NCT04014010|Perioperative|perioperative
29760|NCT04014010|Anesthesia|anesthesia
29761|NCT04014010|Hemodynamics|hemodynamics
29762|NCT04014010|Machine Learning|machine learning
29763|NCT04014010|Non-cardiac Surgery|non-cardiac surgery
29764|NCT04013997|Rehabilitation|rehabilitation
29765|NCT04013997|Walking|walking
29766|NCT04013997|Equipment and Supplies|equipment and supplies
29767|NCT04013971|stroke|stroke
29768|NCT04013971|gait rehabilitation|gait rehabilitation
29769|NCT04013971|game|game
29770|NCT04013958|Morphine|morphine
29771|NCT04013958|Ketamine|ketamine
29772|NCT04013958|Renal colic|renal colic
29773|NCT04013932|Family Psychoeducation|family psychoeducation
29774|NCT04013932|Schizophrenia|schizophrenia
29775|NCT04013932|Tanzania|tanzania
29776|NCT04013932|Severe and Persistent Mental Illness|severe and persistent mental illness
29777|NCT04013932|Culturally tailored|culturally tailored
29778|NCT04013906|coronary artery disease|coronary artery disease
29779|NCT04013906|calcium|calcium
29780|NCT04013906|percutaneous coronary intervention|percutaneous coronary intervention
29781|NCT04013893|Enteral feeding|enteral feeding
29782|NCT04013893|vasopressor|vasopressor
29783|NCT04013893|lactate|lactate
29784|NCT04013867|psoriasis|psoriasis
29785|NCT04013867|depression|depression
29786|NCT04013867|validation|validation
29787|NCT04013867|self-questionnaire|self-questionnaire
29788|NCT04013854|nivolumab|nivolumab
29789|NCT04013854|ipilimumab|ipilimumab
29790|NCT04013854|adjuvant|adjuvant
29791|NCT04013854|neoadjuvant|neoadjuvant
29792|NCT04013854|surgery|surgery
29793|NCT04013828|High-grade glioma|high-grade glioma
29794|NCT04013828|Patient experiences|patient experiences
29795|NCT04013828|Decision-making|decision-making
29796|NCT04013828|Patient involvement|patient involvement
29797|NCT04013815|erector spinae plane block|erector spinae plane block
29798|NCT04013815|thoracotomy|thoracotomy
29799|NCT04013815|ultrasound guided nerve block|ultrasound guided nerve block
29800|NCT04013815|analgesia|analgesia
29801|NCT04013802|cytomegalovirus (CMV)|cytomegalovirus (cmv)
29802|NCT04013802|BK virus|bk virus
29803|NCT04013802|Epstein-Barr virus (EBV)|epstein-barr virus (ebv)
29804|NCT04013802|adenovirus|adenovirus
29805|NCT04013789|eye strain|eye strain
29806|NCT04013789|eye fatigue|eye fatigue
29807|NCT04013763|wheat allergy|wheat allergy
29808|NCT04013763|skin sensitization|skin sensitization
29809|NCT04013763|specific IgE|specific ige
29810|NCT04013763|wheat containing skin care|wheat containing skin care
29811|NCT04013737|Antimicrobial Resistance|antimicrobial resistance
29812|NCT04013737|Antibiotic prescribing|antibiotic prescribing
29813|NCT04013737|Clinical Decision Support Systems|clinical decision support systems
29814|NCT04013724|Tobacco cessation, mental illness, tobacco dependence, Kenya|tobacco cessation, mental illness, tobacco dependence, kenya
29815|NCT04013698|ventilation|ventilation
29816|NCT04013698|brain injuries|brain injuries
29817|NCT04013698|PEEP|peep
29818|NCT04013698|esophageal pressure|esophageal pressure
29819|NCT04013685|hematopoietic stem cell transplantation|hematopoietic stem cell transplantation
29820|NCT04013685|acute leukemia|acute leukemia
29821|NCT04013685|Myelodysplastic syndromes|myelodysplastic syndromes
29822|NCT04013685|matched related donor|matched related donor
29823|NCT04013685|matched unrelated donor|matched unrelated donor
29824|NCT04013633|Cardiopulmonary resuscitation (CPR)|cardiopulmonary resuscitation (cpr)
29825|NCT04013633|Basic life support (BLS)|basic life support (bls)
29826|NCT04013633|Virtual reality (VR)|virtual reality (vr)
29827|NCT04013633|Education|education
29828|NCT04013633|Lay-person training|lay-person training
29829|NCT04013607|short chain fatty acid|short chain fatty acid
29830|NCT04013607|dietary fiber|dietary fiber
29831|NCT04013516|Immunization|immunization
29832|NCT04013516|Incentives|incentives
29833|NCT04013503|NATURE-HTN|nature-htn
29837|NCT04013490|food supplement|food supplement
29838|NCT04013490|overweight female|overweight female
29839|NCT04013451|kindness|kindness
29840|NCT04013451|social interaction anxiety|social interaction anxiety
29842|NCT04013451|affect|affect
29843|NCT04013451|resilience|resilience
29844|NCT04013451|undergraduate students|undergraduate students
29845|NCT04013451|graduate students|graduate students
29846|NCT04013438|Ongoing pregnancy rate|ongoing pregnancy rate
29847|NCT04013438|Estrogen|estrogen
29848|NCT04013438|Frozen embryo transfer|frozen embryo transfer
29849|NCT04013438|Luteal phase support|luteal phase support
29850|NCT04013425|Socket preservation|socket preservation
29851|NCT04013425|Alveolar Ridge Preservation|alveolar ridge preservation
29852|NCT04013425|Ridge Preservation|ridge preservation
29853|NCT04013360|Cardiac Surgery|cardiac surgery
29854|NCT04013360|Positive End Expiratory Pressure|positive end expiratory pressure
29855|NCT04013360|Physical Therapy Techniques|physical therapy techniques
29856|NCT04013360|Pulmonary Funtcion|pulmonary funtcion
29857|NCT04013308|Iontophoresis|iontophoresis
29858|NCT04013308|potassium iodine|potassium iodine
29859|NCT04013308|thyroid|thyroid
29860|NCT04013295|HIV|hiv
29861|NCT04013295|transactional sex|transactional sex
29862|NCT04013295|prize-linked savings|prize-linked savings
29863|NCT04013295|savings|savings
29864|NCT04013269|Sepsis|sepsis
29865|NCT04013269|Critically ill|critically ill
29866|NCT04013269|Intensive care medicine|intensive care medicine
29867|NCT04013269|CytoSorb|cytosorb
29868|NCT04013269|Hemoadsorption|hemoadsorption
29869|NCT04013269|Pharmacokinetic|pharmacokinetic
29870|NCT04013243|Magnesium|magnesium
29871|NCT04013230|Childhood obesity|childhood obesity
29872|NCT04013230|BMI SDS|bmi sds
29873|NCT04013204|non invasive endothelial function test|non invasive endothelial function test
29874|NCT04013204|non-obstructive coronary artery disease|non-obstructive coronary artery disease
29875|NCT04013204|Major Adverse Cardiovascular Events|major adverse cardiovascular events
29876|NCT04013191|Padsevonil|padsevonil
29877|NCT04013191|Phase 1|phase 1
29878|NCT04013191|Pharmacokinetic|pharmacokinetic
29879|NCT04013165|Old-aged|old-aged
29880|NCT04013165|Community-based intervention|community-based intervention
29881|NCT04013165|Late-life depression|late-life depression
29882|NCT04013165|Suicide|suicide
29883|NCT04013152|CROHN|crohn
29884|NCT04013152|Diverticulitis|diverticulitis
29885|NCT04013152|Rectal|rectal
40795|NCT03947099|ptsd|ptsd
29886|NCT04013152|colorectal|colorectal
29887|NCT04013152|ulcerative|ulcerative
29888|NCT04013152|colitis|colitis
29889|NCT04013152|polyposis|polyposis
29890|NCT04013152|rectum|rectum
29891|NCT04013152|prolapse|prolapse
29892|NCT04013100|primary hyperparathyroidism|primary hyperparathyroidism
29893|NCT04013100|parathyroidectomy|parathyroidectomy
29894|NCT04013100|3D reconstruction|3d reconstruction
29895|NCT04013100|Virtual neck exploration|virtual neck exploration
29896|NCT04013048|Solid Tumor|solid tumor
29897|NCT04013048|14C-Fluzoparib|14c-fluzoparib
29898|NCT04013035|Cervix|cervix
29899|NCT04013035|Length|length
29900|NCT04013035|Viability|viability
29901|NCT04013035|prostaglandin|prostaglandin
29902|NCT04013035|Termination|termination
29903|NCT04013022|Exercise Pressor Reflex|exercise pressor reflex
29904|NCT04013022|Metaboreflex|metaboreflex
29905|NCT04013022|Mechanoreflex|mechanoreflex
29906|NCT04013022|Lifelong exercise training|lifelong exercise training
29907|NCT04013009|incisional hernia|incisional hernia
29908|NCT04013009|prevention|prevention
29909|NCT04013009|laparotomy closure|laparotomy closure
29910|NCT04013009|quality improvement|quality improvement
29911|NCT04013009|survey|survey
29912|NCT04013009|guideline|guideline
29913|NCT04012996|symptomatic cervical disc disease|symptomatic cervical disc disease
29914|NCT04012996|SCDD|scdd
29915|NCT04012996|neck pain|neck pain
29916|NCT04012996|radiculopathy|radiculopathy
29917|NCT04012996|myelopathy|myelopathy
29918|NCT04012996|cervical spine pain|cervical spine pain
29923|NCT04012957|DREAM-ND|dream-nd
29924|NCT04012944|Heart Failure|heart failure
29925|NCT04012944|Heart Diseases|heart diseases
29926|NCT04012944|Cardiovascular Disease|cardiovascular disease
29927|NCT04012918|chemotherapy|chemotherapy
29928|NCT04012918|aromatase inhibitor|aromatase inhibitor
29929|NCT04012918|capecitabine|capecitabine
29930|NCT04012918|hormonal therapy|hormonal therapy
29931|NCT04012905|Giant Cell Arteritis|giant cell arteritis
29932|NCT04012905|Horton disease|horton disease
29933|NCT04012905|Corticosteroids treatment|corticosteroids treatment
29934|NCT04012905|Prednisone|prednisone
29935|NCT04012905|Relapse|relapse
29936|NCT04012905|Side effect|side effect
30830|NCT04007614|Bone health|bone health
29937|NCT04012866|Cognitive Rehabilitation|cognitive rehabilitation
29938|NCT04012866|Aerobic Exercise|aerobic exercise
29939|NCT04012866|Computerized Cognitive Training|computerized cognitive training
29940|NCT04012840|Frailty|frailty
29941|NCT04012840|Fried's criteria|fried's criteria
29942|NCT04012840|Rockwood's criteria|rockwood's criteria
29943|NCT04012840|Loss of autonomy,|loss of autonomy,
29944|NCT04012840|elderly|elderly
29945|NCT04012814|fat|fat
29946|NCT04012814|abdomen fat|abdomen fat
29947|NCT04012814|flank fat|flank fat
29948|NCT04012814|body contouring|body contouring
29949|NCT04012788|probiotics|probiotics
29950|NCT04012788|prebiotics|prebiotics
29951|NCT04012788|synbiotics|synbiotics
29952|NCT04012775|diabetes mellitus|diabetes mellitus
29953|NCT04012775|insulin|insulin
29954|NCT04012762|Muscle Power, Muscle Flexibility, Muscle Tone, Whole-Body Vibration Training.|muscle power, muscle flexibility, muscle tone, whole-body vibration training.
29955|NCT04012749|serious illness|serious illness
29956|NCT04012749|POLST|polst
29957|NCT04012749|population health|population health
29958|NCT04012749|primary care|primary care
29959|NCT04012736|gluten free diet|gluten free diet
29960|NCT04012736|fitness|fitness
29961|NCT04012736|pediatric|pediatric
29962|NCT04012723|Acute Compartment Syndrome|acute compartment syndrome
29963|NCT04012710|Transvaginal natural orifice transluminal endoscopic surgery|transvaginal natural orifice transluminal endoscopic surgery
29964|NCT04012710|Salpingo-oophorectomy|salpingo-oophorectomy
29965|NCT04012710|Laparoscopy|laparoscopy
29966|NCT04012697|Survival analysis|survival analysis
29967|NCT04012697|Quantitative analysis|quantitative analysis
29968|NCT04012697|Patient-reported outcomes|patient-reported outcomes
29969|NCT04012697|Randomized-controlled trial|randomized-controlled trial
29970|NCT04012697|Homelessness|homelessness
29971|NCT04012697|Health services research|health services research
29972|NCT04012697|Administrative health data|administrative health data
29973|NCT04012697|Peer support|peer support
29974|NCT04012684|Repetitive transcranial stimulation|repetitive transcranial stimulation
29975|NCT04012684|Inferior frontal gyrus|inferior frontal gyrus
29976|NCT04012658|Wilson's Disease|wilson's disease
29977|NCT04012658|Nature history|nature history
29978|NCT04012658|Genetics|genetics
29979|NCT04012645|Rectal Neoplasms|rectal neoplasms
29980|NCT04012645|Indocyanine Green|indocyanine green
29981|NCT04012645|Anastomotic Leakage|anastomotic leakage
29982|NCT04012632|SNP|snp
29983|NCT04012632|kisspeptin|kisspeptin
29984|NCT04012632|GPR54|gpr54
29985|NCT04012580|postpartum|postpartum
29986|NCT04012580|depression|depression
29987|NCT04012580|anxiety|anxiety
810152|NCT00209768|thrombosis|thrombosis
29988|NCT04012580|internet-delivered cognitive behaviour therapy|internet-delivered cognitive behaviour therapy
29989|NCT04012580|randomized controlled trial|randomized controlled trial
29990|NCT04012580|therapist-assistance|therapist-assistance
29991|NCT04012567|Biosure Regenesorb|biosure regenesorb
29992|NCT04012567|Chinese|chinese
29993|NCT04012567|Cruciate ligaments reconstruction|cruciate ligaments reconstruction
29994|NCT04012567|Prospective|prospective
29995|NCT04012567|Randomize|randomize
29996|NCT04012567|Evaluator-blinded|evaluator-blinded
29997|NCT04012554|Postoperative pain|postoperative pain
29998|NCT04012554|Avoiding chest drainage placement|avoiding chest drainage placement
29999|NCT04012554|Hospital cost|hospital cost
30000|NCT04012528|Pediatric|pediatric
30002|NCT04012528|Rehabilitation|rehabilitation
30003|NCT04012515|ECG Electrodes|ecg electrodes
30004|NCT04012515|ambulatory monitoring|ambulatory monitoring
30005|NCT04012515|dermatology|dermatology
30006|NCT04012489|Physical Therapy Modalities|physical therapy modalities
30007|NCT04012489|Respiratory Care Units|respiratory care units
30008|NCT04012489|Respiratory Mechanics|respiratory mechanics
30009|NCT04012476|Hypocalcemia post-thyroidectomy|hypocalcemia post-thyroidectomy
30010|NCT04012476|Indocyanine green|indocyanine green
30011|NCT04012476|Fluorescence guided surgery|fluorescence guided surgery
30012|NCT04012476|Parathyroid fluorescence|parathyroid fluorescence
30013|NCT04012437|Premature ejaculation|premature ejaculation
30014|NCT04012437|IELT|ielt
30015|NCT04012437|Medical device|medical device
30016|NCT04012424|curcumin as premedication - root canal treatment|curcumin as premedication - root canal treatment
30017|NCT04012411|Huntington Disease|huntington disease
30018|NCT04012411|CSF|csf
30019|NCT04012411|Biomarkers|biomarkers
30020|NCT04012411|BDNF|bdnf
30021|NCT04012411|P42|p42
30022|NCT04012385|Lifestyle|lifestyle
30023|NCT04012385|Fertility|fertility
30024|NCT04012385|Nutrition|nutrition
30025|NCT04012385|Environmental Pollution|environmental pollution
30026|NCT04012372|Infants|infants
30027|NCT04012372|Water|water
30028|NCT04012372|Safety|safety
30029|NCT04012359|Lung ultrasound|lung ultrasound
30030|NCT04012307|Candesartan Cilexetil|candesartan cilexetil
30031|NCT04012307|Bioequivalence|bioequivalence
30032|NCT04012307|Atacand PROTECT|atacand protect
30033|NCT04012294|allopurinol|allopurinol
30034|NCT04012294|ultrasound|ultrasound
30035|NCT04012294|morphostructural changes|morphostructural changes
30036|NCT04012281|drug eluting stent|drug eluting stent
30037|NCT04012281|coronary atherosclerosis|coronary atherosclerosis
30038|NCT04012268|moyamoya disease|moyamoya disease
30039|NCT04012268|remote ischemic conditioning|remote ischemic conditioning
30040|NCT04012268|cerebral blood flow|cerebral blood flow
30041|NCT04012242|Nonalcoholic Steatohepatitis|nonalcoholic steatohepatitis
30042|NCT04012242|Ultrasound|ultrasound
30043|NCT04012242|Elastography|elastography
30044|NCT04012242|Dispersion|dispersion
30045|NCT04012229|Breast cancer|breast cancer
30047|NCT04012229|BRCA2|brca2
30048|NCT04012229|Chemotherapy|chemotherapy
30049|NCT04012203|Musculoskeletal pain|musculoskeletal pain
30050|NCT04012203|Delayed Onset Muscle Soreness|delayed onset muscle soreness
30051|NCT04012203|Pain mechanisms|pain mechanisms
30052|NCT04012203|Pressure Pain Threshold|pressure pain threshold
30053|NCT04012203|Myotonometer|myotonometer
30054|NCT04012203|Maximal isometric strength|maximal isometric strength
30055|NCT04012203|Manual dexterity|manual dexterity
30056|NCT04012190|Severe infection|severe infection
30057|NCT04012190|Sepsis|sepsis
30058|NCT04012190|Microbiome|microbiome
30059|NCT04012190|Bangladesh|bangladesh
30060|NCT04012190|Young infants|young infants
30061|NCT04012164|microbiome|microbiome
30062|NCT04012164|virome|virome
30063|NCT04012164|zoonotic disease|zoonotic disease
30064|NCT04012164|ecological gradient|ecological gradient
30065|NCT04012164|human-animal relations|human-animal relations
30066|NCT04012164|anthropology|anthropology
30067|NCT04012164|social sciences|social sciences
30068|NCT04012151|Blood pressure measurement|blood pressure measurement
30069|NCT04012151|Conicity index|conicity index
30070|NCT04012151|Mid arm circumference|mid arm circumference
30071|NCT04012151|Cuff size|cuff size
30072|NCT04012138|hyperkaliema|hyperkaliema
30073|NCT04012138|insulin|insulin
30074|NCT04012138|salbutamol|salbutamol
30075|NCT04012125|Cerebral palsy|cerebral palsy
30076|NCT04012125|Brace|brace
30077|NCT04012125|Scoliosis|scoliosis
30078|NCT04012112|brace|brace
30079|NCT04012112|neuromuscular disease|neuromuscular disease
30080|NCT04012112|scoliosis|scoliosis
30081|NCT04012099|scar prevention|scar prevention
30082|NCT04012099|siRNA|sirna
30083|NCT04012099|scar|scar
30084|NCT04012086|Cognitive decline|cognitive decline
30085|NCT04012086|Physical therapy|physical therapy
30086|NCT04012086|Parkinson's Disease|parkinson's disease
30087|NCT04012073|Positive end-expiratory pressure|positive end-expiratory pressure
30088|NCT04012073|Ventilator-induced lung injury|ventilator-induced lung injury
30089|NCT04012073|Mechanical ventilation|mechanical ventilation
30090|NCT04012073|Respiratory mechanics|respiratory mechanics
30091|NCT04012060|Limited access|limited access
30092|NCT04012060|Aortic valve replacement|aortic valve replacement
30093|NCT04012060|upper hemisternotomy|upper hemisternotomy
30094|NCT04012060|patient reported outcomes|patient reported outcomes
30095|NCT04012060|randomized clinical trial|randomized clinical trial
30096|NCT04012047|Levcromakalim|levcromakalim
30097|NCT04012021|liver|liver
30098|NCT04012021|cirrhosis|cirrhosis
30099|NCT04012021|steatosis|steatosis
30100|NCT04012021|hepatocellular carcinoma|hepatocellular carcinoma
30101|NCT04012021|pancreatic cancer|pancreatic cancer
30102|NCT04012021|7 tesla|7 tesla
30103|NCT04012021|magnetic resonance imaging|magnetic resonance imaging
30104|NCT04011995|Intermittent caloric restriction|intermittent caloric restriction
30105|NCT04011995|Children|children
30106|NCT04011995|Youth|youth
30107|NCT04011982|Pancreatic cancer|pancreatic cancer
30108|NCT04011982|Immune infiltrate|immune infiltrate
30109|NCT04011982|Molecular alterations|molecular alterations
30110|NCT04011982|Tumor stroma|tumor stroma
30111|NCT04011969|chronic inflammation|chronic inflammation
30112|NCT04011969|young-onset colorectal cancer|young-onset colorectal cancer
30113|NCT04011969|gut microbiome|gut microbiome
30114|NCT04011969|NGS|ngs
30115|NCT04011917|Minor Musculoskeletal Injuries|minor musculoskeletal injuries
30116|NCT04011917|Emergency Department|emergency department
30117|NCT04011917|Prediction outcome|prediction outcome
30118|NCT04011917|Extended Scope Physiotherapists|extended scope physiotherapists
30119|NCT04011904|Greenland Inuit|greenland inuit
30120|NCT04011904|Traditional diet|traditional diet
30121|NCT04011904|TBC1D4|tbc1d4
30122|NCT04011891|Minimally Invasive Surgery|minimally invasive surgery
30123|NCT04011891|Robotic Surgery|robotic surgery
30124|NCT04011891|Partial Nephrectomy|partial nephrectomy
30125|NCT04011891|Feasibility|feasibility
30126|NCT04011865|laparoscopic radical prostatectomy|laparoscopic radical prostatectomy
30127|NCT04011865|robotic-assisted laparoscopic radical prostatectomy|robotic-assisted laparoscopic radical prostatectomy
30128|NCT04011865|prostate cancer|prostate cancer
30129|NCT04011852|Ventilator Weaning|ventilator weaning
30130|NCT04011852|Child|child
30131|NCT04011852|Electrical Impedance Tomography|electrical impedance tomography
30132|NCT04011852|Respiration, artificial|respiration, artificial
30133|NCT04011852|Intensive Care units|intensive care units
30134|NCT04011813|cryopreservation|cryopreservation
30137|NCT04011813|antioxidant hypotaurine supplementation|antioxidant hypotaurine supplementation
30139|NCT04011813|human spermatozoa fertilizing ability|human spermatozoa fertilizing ability
30140|NCT04011800|atrial fibrillation|atrial fibrillation
30141|NCT04011800|catheter ablation|catheter ablation
30142|NCT04011800|risk factor modification|risk factor modification
30143|NCT04011722|Aortic Stenosis|aortic stenosis
30144|NCT04011722|Transcatheter Aortic Valve Replacement|transcatheter aortic valve replacement
30145|NCT04011722|Heart Valve Disease|heart valve disease
30146|NCT04011722|High surgical risk|high surgical risk
30147|NCT04011722|Portico NG|portico ng
30148|NCT04011709|Nebulizer|nebulizer
30149|NCT04011709|Pediatric|pediatric
30150|NCT04011709|Methodological study|methodological study
30151|NCT04011696|pseudoaccommodation|pseudoaccommodation
30152|NCT04011696|monofocal IOL|monofocal iol
30153|NCT04011696|cataract surgery|cataract surgery
30158|NCT04011657|computerized decision support|computerized decision support
30159|NCT04011657|prospective review and feedback|prospective review and feedback
30160|NCT04011657|antimicrobial stewardship|antimicrobial stewardship
30161|NCT04011644|implementation|implementation
30162|NCT04011644|alcohol drinking|alcohol drinking
30163|NCT04011644|mHealth|mhealth
30164|NCT04011644|wellness|wellness
30165|NCT04011618|ellagic acid|ellagic acid
30166|NCT04011618|metabolic syndrome|metabolic syndrome
30167|NCT04011618|insulin resistance|insulin resistance
30168|NCT04011618|insulin secretion|insulin secretion
30169|NCT04011579|Physical activity|physical activity
30170|NCT04011579|Pilates|pilates
30171|NCT04011579|Fitness|fitness
30172|NCT04011566|Asymptomatic Normal Pressure Hydrocephalus|asymptomatic normal pressure hydrocephalus
30173|NCT04011566|Ventriculoperitoneal Shunt|ventriculoperitoneal shunt
30174|NCT04011553|Knee osteoarthritis|knee osteoarthritis
30175|NCT04011553|Virtual reality|virtual reality
30176|NCT04011553|Rehabilitation|rehabilitation
30177|NCT04011553|Balance|balance
30178|NCT04011553|Kinesiophobia|kinesiophobia
30179|NCT04011527|Calcified coronary artery lesions|calcified coronary artery lesions
30180|NCT04011501|erector spinae plane block|erector spinae plane block
30181|NCT04011501|thoracic surgery|thoracic surgery
30182|NCT04011501|cardiac surgical procedures|cardiac surgical procedures
30183|NCT04011501|pain, postoperative|pain, postoperative
30184|NCT04011488|shared decision making|shared decision making
30185|NCT04011462|Nursing|nursing
30186|NCT04011462|Hypothermia|hypothermia
30187|NCT04011462|Perioperative Nursing|perioperative nursing
30188|NCT04011436|anterior knee pain|anterior knee pain
30189|NCT04011436|patellofemoral pain syndrome AND treatment|patellofemoral pain syndrome and treatment
30190|NCT04011436|patellofemoral pain AND diagnosis|patellofemoral pain and diagnosis
30191|NCT04011436|patellofemoral pain syndrome AND exercise|patellofemoral pain syndrome and exercise
30192|NCT04011436|patellofemoral pain AND physiotherapy|patellofemoral pain and physiotherapy
30193|NCT04011423|Unstable Shoes|unstable shoes
30194|NCT04011423|Whole Body Vibration|whole body vibration
30195|NCT04011410|Prostate Cancer|prostate cancer
30196|NCT04011410|Oligometastatic Prostate Cancer|oligometastatic prostate cancer
30197|NCT04011410|Limited Metastatic Disease|limited metastatic disease
30198|NCT04011410|Metastatic Prostate Cancer|metastatic prostate cancer
30199|NCT04011397|Diabetes|diabetes
30200|NCT04011397|Exercise|exercise
30201|NCT04011397|Feasibility|feasibility
30202|NCT04011397|HbA1c|hba1c
30203|NCT04011397|Interval training|interval training
30204|NCT04011384|Food Assistance|food assistance
30205|NCT04011384|Economics, Behavioral|economics, behavioral
30206|NCT04011384|Food Labeling|food labeling
30207|NCT04011384|Diet Records|diet records
30208|NCT04011384|Biomarkers|biomarkers
30209|NCT04011358|Retinal Vein Occlusion|retinal vein occlusion
30210|NCT04011358|central retinal vein occlusion|central retinal vein occlusion
30211|NCT04011358|branch retinal vein occlusion|branch retinal vein occlusion
30212|NCT04011358|obstructive sleep apnea|obstructive sleep apnea
30213|NCT04011358|sleep apnea|sleep apnea
30214|NCT04011345|Folic Acid|folic acid
30215|NCT04011345|Unmetabolized Folic Acid|unmetabolized folic acid
30216|NCT04011345|Pediatrics|pediatrics
30217|NCT04011332|integrated care|integrated care
30218|NCT04011332|self-management|self-management
30219|NCT04011319|Group culture|group culture
30220|NCT04011319|Embryo quality|embryo quality
30221|NCT04011319|Implantation rate|implantation rate
30222|NCT04011319|Clinical pregnancy|clinical pregnancy
30223|NCT04011293|Relapsed|relapsed
30224|NCT04011293|Refractory|refractory
30225|NCT04011293|Malignancy|malignancy
30226|NCT04011280|nicotine|nicotine
30227|NCT04011280|varenicline|varenicline
30228|NCT04011280|Acceptance and Commitment Therapy|acceptance and commitment therapy
30235|NCT04011267|foot-related exercises|foot-related exercises
30236|NCT04011267|self-management|self-management
30237|NCT04011267|software|software
30238|NCT04011267|musculoskeletal function|musculoskeletal function
30239|NCT04011254|salt taste preference|salt taste preference
30240|NCT04011254|salt taste sensitivity|salt taste sensitivity
30241|NCT04011254|functional Magnetic Resonance Imaging|functional magnetic resonance imaging
30242|NCT04011254|Dialysis|dialysis
30243|NCT04011254|Salt taste|salt taste
30244|NCT04011254|salt intake|salt intake
30245|NCT04011202|Stroke|stroke
30246|NCT04011202|Virtual reality|virtual reality
30247|NCT04011202|Depressive symptoms|depressive symptoms
30248|NCT04011202|Sedentary behaviour|sedentary behaviour
30249|NCT04011189|Postoperative pain|postoperative pain
30250|NCT04011189|Automated video analysis|automated video analysis
30251|NCT04011189|Pain score|pain score
30252|NCT04011189|Face recognition|face recognition
30253|NCT04011163|Postoperative pain|postoperative pain
30254|NCT04011163|Respiratory depression|respiratory depression
30255|NCT04011163|Bradypnoea|bradypnoea
30256|NCT04011163|Morphine|morphine
30257|NCT04011163|Infusion pump|infusion pump
30258|NCT04011150|Labor Pain|labor pain
30259|NCT04011150|Breakthrough Pain|breakthrough pain
30260|NCT04011150|Infusion pump|infusion pump
30261|NCT04011137|high-intensity interval training|high-intensity interval training
30262|NCT04011137|postprandial metabolism|postprandial metabolism
30263|NCT04011111|voice|voice
30264|NCT04011111|intubation|intubation
30265|NCT04011111|subjective|subjective
30266|NCT04011111|objective|objective
30267|NCT04011098|Epidural|epidural
30268|NCT04011098|Opioids|opioids
30269|NCT04011098|Fentanyl|fentanyl
30270|NCT04011098|Labour Induction|labour induction
30271|NCT04011098|Labour Pain|labour pain
30272|NCT04011098|Obstetric Pain|obstetric pain
30273|NCT04011098|Induction of Labour|induction of labour
30274|NCT04011098|Anesthesia|anesthesia
30275|NCT04011098|Obstetric Anesthesia|obstetric anesthesia
30276|NCT04011085|HER2-positive Breast Cancer|her2-positive breast cancer
30277|NCT04011085|work productivity|work productivity
30278|NCT04011085|health-related quality of life|health-related quality of life
30279|NCT04011072|Hemodialysis|hemodialysis
30280|NCT04011072|Infrared therapy|infrared therapy
30281|NCT04011072|Stenosis|stenosis
30282|NCT04011072|Maturation|maturation
30283|NCT04011072|Arteriovenous fistula survival|arteriovenous fistula survival
30284|NCT04011059|Heart Failure|heart failure
30285|NCT04011059|Cardiomyopathies|cardiomyopathies
30286|NCT04011059|Coronary Artery Disease|coronary artery disease
30287|NCT04011059|Ischemic Dilated Cardiomyopathy|ischemic dilated cardiomyopathy
30288|NCT04010981|Pediatric Chronic Kidney Disease,|pediatric chronic kidney disease,
30289|NCT04010981|virtual reality|virtual reality
30290|NCT04010981|physical therapy|physical therapy
30291|NCT04010981|exercise|exercise
30292|NCT04010981|Nintendo wii|nintendo wii
30293|NCT04010981|Video based exercise|video based exercise
30294|NCT04010916|Postoperative analgesia|postoperative analgesia
30295|NCT04010916|Adductor canal block|adductor canal block
30296|NCT04010916|Knee arthroscopy|knee arthroscopy
30297|NCT04010903|INSULIN RESISTANCE|insulin resistance
30298|NCT04010890|culture|culture
30299|NCT04010890|cognitive therapy|cognitive therapy
30300|NCT04010890|Canada|canada
30301|NCT04010877|AML|aml
30302|NCT04010877|CAR T|car t
30303|NCT04010877|CD33, CD123, CLL-1|cd33, cd123, cll-1
30304|NCT04010851|Parental activation|parental activation
30305|NCT04010851|Peer co-led education|peer co-led education
30306|NCT04010838|disorders of consciousness|disorders of consciousness
30307|NCT04010838|spinal cord stimulation|spinal cord stimulation
30308|NCT04010838|DoC|doc
30309|NCT04010838|SCS|scs
30316|NCT04010773|Empowerment|empowerment
30317|NCT04010773|leadership|leadership
30318|NCT04010773|intervention|intervention
30319|NCT04010773|psycho-social intervention|psycho-social intervention
30320|NCT04010773|motivation|motivation
30321|NCT04010773|working conditions|working conditions
30322|NCT04010773|occupational health|occupational health
30323|NCT04010734|suspected malignant biliary stricture|suspected malignant biliary stricture
30324|NCT04010734|primary peroral cholangiscopy|primary peroral cholangiscopy
30325|NCT04010734|endoscopic retrograde cholangiopancreatography|endoscopic retrograde cholangiopancreatography
30326|NCT04010734|fluorescence in situ hybridization|fluorescence in situ hybridization
30327|NCT04010721|Cochlear implant|cochlear implant
30328|NCT04010695|G6PD deficiency|g6pd deficiency
30329|NCT04010669|Portal Hypertension|portal hypertension
30330|NCT04010669|Liver resection|liver resection
30331|NCT04010669|Somatostatin|somatostatin
30332|NCT04010656|Urogynecologic surgery|urogynecologic surgery
30333|NCT04010656|Urinary retention postoperative|urinary retention postoperative
30334|NCT04010643|online cognitive behavioural therapy|online cognitive behavioural therapy
30335|NCT04010643|online neurocognitive remediation|online neurocognitive remediation
30336|NCT04010643|memory|memory
30337|NCT04010643|sustained attention|sustained attention
30338|NCT04010643|everyday occupational function|everyday occupational function
30339|NCT04010643|economic evaluation|economic evaluation
30340|NCT04010617|Pharyngeal Electrical Stimulation|pharyngeal electrical stimulation
30341|NCT04010617|Stroke|stroke
30342|NCT04010617|Dysphagia|dysphagia
30343|NCT04010617|Re-intubation|re-intubation
30344|NCT04010591|Pediatric patients|pediatric patients
30345|NCT04010591|Voiding Dysfunction|voiding dysfunction
30346|NCT04010591|urodynamic study|urodynamic study
30347|NCT04010578|Vitamin K2|vitamin k2
30348|NCT04010578|18F-NaF|18f-naf
30349|NCT04010578|hybrid PET/MRI|hybrid pet/mri
30350|NCT04010578|Coronary artery calcification score|coronary artery calcification score
30351|NCT04010578|Menaquinone-7|menaquinone-7
30352|NCT04010578|Carotid Artery Disease|carotid artery disease
30353|NCT04010578|Coronary Artery Disease|coronary artery disease
30354|NCT04010565|Cholesterol LDL|cholesterol ldl
30355|NCT04010565|Black garlic extract|black garlic extract
30356|NCT04010565|S-allyl cysteine|s-allyl cysteine
30357|NCT04010539|Urogenital Gonorrhea, Gepotidacin, Neisseria gonorrhoeae, Efficacy, Phase 3|urogenital gonorrhea, gepotidacin, neisseria gonorrhoeae, efficacy, phase 3
30358|NCT04010500|dental trauma|dental trauma
30359|NCT04010500|rugby|rugby
30360|NCT04010500|mouthguard|mouthguard
30361|NCT04010500|speech|speech
30362|NCT04010500|contact sports|contact sports
30363|NCT04010474|Complication|complication
30364|NCT04010474|Mortality|mortality
30365|NCT04010474|Modified|modified
30366|NCT04010474|Surgical Apgar Score|surgical apgar score
30367|NCT04010461|functional magnetic resonance imaging|functional magnetic resonance imaging
30368|NCT04010461|Transcranial Magnetic Stimulation|transcranial magnetic stimulation
30369|NCT04010461|dorsolateral prefrontal cortex|dorsolateral prefrontal cortex
30370|NCT04010383|Perimetry|perimetry
30371|NCT04010383|Virtual reality device|virtual reality device
30372|NCT04010370|Insulin sensitivity|insulin sensitivity
30373|NCT04010370|PREDIM|predim
30374|NCT04010370|Correlation|correlation
30375|NCT04010370|Healthy individuals|healthy individuals
30376|NCT04010357|platinum refractory disease|platinum refractory disease
30377|NCT04010357|Wild Type Rb Extensive Stage SCLC|wild type rb extensive stage sclc
30378|NCT04010331|Nokyong|nokyong
30379|NCT04010279|preoxygenation|preoxygenation
30380|NCT04010279|CPAP(continuous positive airway pressure)|cpap(continuous positive airway pressure)
30381|NCT04010279|APL (airway pressure release) valve|apl (airway pressure release) valve
30382|NCT04010253|Cystic Fibrosis|cystic fibrosis
30383|NCT04010253|Physiotherapy|physiotherapy
30384|NCT04010253|Drainage|drainage
30385|NCT04010240|Solid tumor|solid tumor
30386|NCT04010240|Metastatic|metastatic
30387|NCT04010240|NTRK|ntrk
30388|NCT04010227|Acceptance and Commitment Therapy|acceptance and commitment therapy
30389|NCT04010227|Fatigue|fatigue
30390|NCT04010227|Family Caregivers|family caregivers
30391|NCT04010227|Psychotherapy|psychotherapy
30392|NCT04010201|brain calcification|brain calcification
30393|NCT04010201|natural history|natural history
30394|NCT04010201|genetics|genetics
30395|NCT04010175|Cognitive training|cognitive training
30396|NCT04010175|Distance training|distance training
30397|NCT04010175|Alzheimer's disease|alzheimer's disease
30398|NCT04010162|mesh complications|mesh complications
30399|NCT04010162|social media awareness|social media awareness
30400|NCT04010162|knowledge of doctors|knowledge of doctors
30401|NCT04010149|Working memory|working memory
30402|NCT04010149|cognitive training|cognitive training
30403|NCT04010149|tDCS|tdcs
30404|NCT04010136|Palliative care|palliative care
30405|NCT04010136|Primary health care|primary health care
30406|NCT04010136|Palliative care training|palliative care training
30407|NCT04010136|Prevalence|prevalence
30408|NCT04010136|Geriatrics|geriatrics
30409|NCT04010110|Hydroxychloroquine|hydroxychloroquine
30410|NCT04010110|Toxic retinopathy|toxic retinopathy
30411|NCT04010110|Hydroxychloroquine screening|hydroxychloroquine screening
30412|NCT04010084|Chronic Obstructive Pulmonary Disease|chronic obstructive pulmonary disease
30413|NCT04010084|Photobiomodulation|photobiomodulation
30414|NCT04010071|Hepatobiliary Neoplasm|hepatobiliary neoplasm
30415|NCT04010071|axitinib|axitinib
30416|NCT04010071|toripalimab|toripalimab
30417|NCT04010071|biomarker|biomarker
30418|NCT04010045|lower extremity PAD|lower extremity pad
30419|NCT04010006|Stomach Neoplasms|stomach neoplasms
30420|NCT04010006|Laparoscopy|laparoscopy
30421|NCT04009993|digital tool|digital tool
30422|NCT04009993|decision making|decision making
30423|NCT04009993|labour process|labour process
30424|NCT04009993|birth results|birth results
30425|NCT04009980|citicoline|citicoline
30427|NCT04009967|Prostate Cancer|prostate cancer
30428|NCT04009967|Pembrolizumab|pembrolizumab
30429|NCT04009967|18FDG-PET Scanning|18fdg-pet scanning
30430|NCT04009954|Post-operative Ileus|post-operative ileus
30431|NCT04009954|Gut Microbiota|gut microbiota
30432|NCT04009954|perioperative period|perioperative period
30433|NCT04009837|older adult|older adult
30434|NCT04009837|geriatrics|geriatrics
30435|NCT04009837|chronic low back pain|chronic low back pain
30436|NCT04009837|low back pain|low back pain
30437|NCT04009837|hip-spine|hip-spine
30438|NCT04009837|rehabilitation|rehabilitation
30439|NCT04009837|physical therapy|physical therapy
30440|NCT04009837|spine|spine
30441|NCT04009837|hip pain|hip pain
30442|NCT04009811|Randomized controlled trial|randomized controlled trial
30443|NCT04009811|Palatal obturators|palatal obturators
30444|NCT04009798|heart failure|heart failure
30445|NCT04009798|risk prediction|risk prediction
30446|NCT04009798|prognosis|prognosis
30447|NCT04009772|Cefepime, Cefuroxime, Metronidazole, Cesarean, Intrapartum|cefepime, cefuroxime, metronidazole, cesarean, intrapartum
30448|NCT04009759|cardiac arrest|cardiac arrest
30449|NCT04009759|Morphine|morphine
30450|NCT04009759|Ketamine|ketamine
30451|NCT04009759|Survival rate|survival rate
30452|NCT04009733|Osteogenesis imperfecta|osteogenesis imperfecta
30453|NCT04009733|micro Ribonucleic acids|micro ribonucleic acids
30454|NCT04009733|epigenetics|epigenetics
30455|NCT04009707|MoCA|moca
30456|NCT04009707|BEARNI|bearni
30457|NCT04009694|Pelvic floor muscle training|pelvic floor muscle training
30458|NCT04009694|pelvic physiotherapy|pelvic physiotherapy
30459|NCT04009694|pelvic floor exercises|pelvic floor exercises
30460|NCT04009681|Synthorx|synthorx
30461|NCT04009681|THOR-707|thor-707
30462|NCT04009681|THOR 707|thor 707
30463|NCT04009681|Interleukin 2|interleukin 2
30464|NCT04009681|Interleukin-2|interleukin-2
30465|NCT04009681|IL2|il2
30466|NCT04009681|oncology|oncology
30467|NCT04009681|immuno-oncology|immuno-oncology
30468|NCT04009681|immunotherapy|immunotherapy
30469|NCT04009681|IL-2|il-2
30470|NCT04009668|Kidney Disease|kidney disease
30471|NCT04009668|Minimal Change Disease|minimal change disease
30472|NCT04009668|Nephrotic Syndrome|nephrotic syndrome
30473|NCT04009668|Focal Segmental Glomerulosclerosis|focal segmental glomerulosclerosis
30474|NCT04009668|FSGS|fsgs
30475|NCT04009616|Aloe vera mouthwash|aloe vera mouthwash
30476|NCT04009577|Insomnia|insomnia
30477|NCT04009577|Sleep Initiation and Maintenance Disorders|sleep initiation and maintenance disorders
30478|NCT04009577|Insomnia Disorder|insomnia disorder
30479|NCT04009577|Sleeplessness|sleeplessness
30480|NCT04009577|E2006|e2006
30481|NCT04009577|Zolpidem|zolpidem
30482|NCT04009577|Lemborexant|lemborexant
30483|NCT04009551|meningitis|meningitis
30484|NCT04009551|epidemiology|epidemiology
30485|NCT04009551|neonate|neonate
30486|NCT04009551|newborn|newborn
30487|NCT04009538|copd|copd
30488|NCT04009538|smoking|smoking
30489|NCT04009538|Smoking Cessation|smoking cessation
30490|NCT04009538|Rehabilitation; Tobacco Use|rehabilitation; tobacco use
30491|NCT04009525|thalassemia major|thalassemia major
30492|NCT04009525|hematopoietic stem cell transplantation|hematopoietic stem cell transplantation
30493|NCT04009499|Psoriatic Arthritis|psoriatic arthritis
30494|NCT04009499|PsA|psa
30495|NCT04009499|Bimekizumab|bimekizumab
30496|NCT04009473|platelet rich plasma|platelet rich plasma
30497|NCT04009473|growth factors|growth factors
30498|NCT04009473|stem cells|stem cells
30499|NCT04009473|bone marrow|bone marrow
30500|NCT04009473|in vitro activation|in vitro activation
30501|NCT04009473|ovarian cortex transplantation|ovarian cortex transplantation
30502|NCT04009473|hippo signalling pathway|hippo signalling pathway
30503|NCT04009460|ES101|es101
30504|NCT04009460|solid tumor|solid tumor
30505|NCT04009460|phase 1|phase 1
30506|NCT04009460|PD-L1|pd-l1
30507|NCT04009460|4-1BB|4-1bb
30508|NCT04009460|INBRX-105|inbrx-105
30509|NCT04009460|PD-L1×4-1BB|pd-l1×4-1bb
30510|NCT04009460|41BB|41bb
30511|NCT04009460|PDL1|pdl1
30512|NCT04009434|Aortic Stenosis|aortic stenosis
30513|NCT04009434|Aortic Disease|aortic disease
30514|NCT04009434|Transcatheter Aortic Valve Implantation|transcatheter aortic valve implantation
30515|NCT04009434|Mitral Regurgitation|mitral regurgitation
30516|NCT04009434|Mitral Valve Regurgitation|mitral valve regurgitation
30517|NCT04009434|Mitral Disease|mitral disease
30518|NCT04009434|Mitral valve clipping|mitral valve clipping
30519|NCT04009434|MitraClip|mitraclip
30520|NCT04009434|Heart Valve Diseases|heart valve diseases
30521|NCT04009421|coronary artery disease|coronary artery disease
30522|NCT04009421|plaque burden|plaque burden
30523|NCT04009421|prognosis|prognosis
30524|NCT04009408|Dysphagia|dysphagia
30525|NCT04009408|Myopathy|myopathy
30526|NCT04009408|Muscular Dystrophy|muscular dystrophy
30527|NCT04009369|Health care access|health care access
30528|NCT04009369|Health services|health services
30529|NCT04009369|Professional practices|professional practices
31327|NCT04004455|children|children
30543|NCT04009265|esophageal squamous cell carcinoma|esophageal squamous cell carcinoma
30545|NCT04009265|adjuvant chemoradiotherapy|adjuvant chemoradiotherapy
30546|NCT04009265|surgery|surgery
30547|NCT04009239|Weight loss|weight loss
30548|NCT04009239|Diet|diet
30549|NCT04009226|Distal Myopathies|distal myopathies
30550|NCT04009226|Neuromuscular Diseases|neuromuscular diseases
30551|NCT04009226|Muscular Dystrophies|muscular dystrophies
30552|NCT04009226|GNE Myopathy|gne myopathy
30553|NCT04009226|Hereditary Inclusion Body Myopathy|hereditary inclusion body myopathy
30554|NCT04009213|Laparoacopic|laparoacopic
30555|NCT04009213|Peritoneal Closure|peritoneal closure
30556|NCT04009187|manual wheelchair|manual wheelchair
30557|NCT04009187|wheelchair propulsion|wheelchair propulsion
30558|NCT04009187|motor learning|motor learning
30559|NCT04009174|Prostate Cancer|prostate cancer
30560|NCT04009174|PET/CT|pet/ct
30561|NCT04009174|PET/MRI|pet/mri
30562|NCT04009174|Fluorocholine|fluorocholine
30563|NCT04009174|PSMA|psma
30564|NCT04009174|Sodium (Na) MRI|sodium (na) mri
30565|NCT04009174|[18-F]-FCH|[18-f]-fch
30566|NCT04009174|[18-F]-DCFPyL|[18-f]-dcfpyl
30567|NCT04009174|Hybrid imaging|hybrid imaging
30568|NCT04009174|Whole mount histopathology|whole mount histopathology
30569|NCT04009135|Chronic non-cancer pain|chronic non-cancer pain
30570|NCT04009135|Major depression|major depression
30571|NCT04009135|Internet therapies|internet therapies
30572|NCT04009135|Cognitive behaviour therapy|cognitive behaviour therapy
30573|NCT04009135|Acceptance and commitment therapy|acceptance and commitment therapy
30574|NCT04009096|PvDBP|pvdbp
30575|NCT04009096|efficacy|efficacy
30576|NCT04009083|18F-Fluciclovine PET imaging|18f-fluciclovine pet imaging
30577|NCT04009083|Focal Cryo Ablation|focal cryo ablation
30578|NCT04009031|video games|video games
30579|NCT04009031|upper extremity|upper extremity
30580|NCT04009031|rehabilitation|rehabilitation
30581|NCT04009031|cerebral palsy|cerebral palsy
30582|NCT04009018|scale|scale
30583|NCT04009018|validity|validity
30584|NCT04009018|reliability|reliability
30585|NCT04008953|volume assessment|volume assessment
30586|NCT04008940|VA-LCP DF|va-lcp df
30587|NCT04008940|LCP DF|lcp df
30588|NCT04008940|LISS DF|liss df
30589|NCT04008940|various angle locking plate|various angle locking plate
30590|NCT04008927|Hepatitis C|hepatitis c
30591|NCT04008927|RDS survey|rds survey
30592|NCT04008927|Communauty-based intervention|communauty-based intervention
30593|NCT04008927|Viral hepatitis C|viral hepatitis c
30594|NCT04008914|Heart Failure|heart failure
30595|NCT04008914|Readmission Risks|readmission risks
30596|NCT04008901|Functional dyspepsia|functional dyspepsia
30597|NCT04008901|Irritable Bowel Syndrome|irritable bowel syndrome
30598|NCT04008901|Lonicera Flos|lonicera flos
30599|NCT04008901|GSRS|gsrs
30600|NCT04008901|Antioxidant|antioxidant
30601|NCT04008875|diaphragm ultrasound|diaphragm ultrasound
30602|NCT04008875|mechanical ventilation|mechanical ventilation
30603|NCT04008875|diaphragm function|diaphragm function
30604|NCT04008862|Chronic Obstructive Pulmonary Disease|chronic obstructive pulmonary disease
30605|NCT04008862|Self-management|self-management
30606|NCT04008862|Palliative care|palliative care
41674|NCT03941873|HCC|hcc
30607|NCT04008862|Family|family
30608|NCT04008862|Chronic Disease|chronic disease
30609|NCT04008862|Nursing practice|nursing practice
30610|NCT04008849|Inherited Metabolic Disorders|inherited metabolic disorders
30611|NCT04008849|Hematopoietic Stem Cell Transplant|hematopoietic stem cell transplant
30612|NCT04008849|MGTA-456|mgta-456
30613|NCT04008849|Umbilical Cord Blood Transplant|umbilical cord blood transplant
30614|NCT04008849|Hurler Syndrome|hurler syndrome
30615|NCT04008849|Cerebral Adrenoleukodystrophy|cerebral adrenoleukodystrophy
30616|NCT04008849|Globoid Cell Leukodystrophy|globoid cell leukodystrophy
30617|NCT04008849|Metachromatic Leukodystrophy|metachromatic leukodystrophy
30618|NCT04008810|renal insufficiency|renal insufficiency
30619|NCT04008810|renal failure|renal failure
30620|NCT04008810|acute kidney injury|acute kidney injury
30621|NCT04008810|AKI|aki
30622|NCT04008797|Solid Tumor|solid tumor
30623|NCT04008797|Hepatocellular carcinoma|hepatocellular carcinoma
30624|NCT04008797|E7386|e7386
30625|NCT04008797|Lenvatinib|lenvatinib
30626|NCT04008758|recruitment|recruitment
30627|NCT04008758|ultrasound|ultrasound
30628|NCT04008758|trauma|trauma
30629|NCT04008758|pulmonary contusion|pulmonary contusion
30630|NCT04008745|exercise therapy|exercise therapy
30631|NCT04008745|diabetic foot|diabetic foot
30632|NCT04008745|preventive care|preventive care
30633|NCT04008745|foot-related exercise|foot-related exercise
30634|NCT04008745|self-management|self-management
30635|NCT04008745|musculoskeletal function|musculoskeletal function
30637|NCT04008745|Primary Health Care|primary health care
30638|NCT04008719|Depression|depression
30639|NCT04008706|Chronic lymphocytic leukemia|chronic lymphocytic leukemia
30640|NCT04008706|Acalabrutinib|acalabrutinib
30641|NCT04008693|Aging|aging
30642|NCT04008693|Aged Garlic|aged garlic
30643|NCT04008693|Functional Food|functional food
30644|NCT04008693|Vascular Function|vascular function
30645|NCT04008693|Muscle oxygenation|muscle oxygenation
30646|NCT04008693|Exercise performance|exercise performance
30647|NCT04008680|consistency|consistency
30648|NCT04008680|reliability|reliability
30649|NCT04008680|burden|burden
30650|NCT04008680|response|response
30651|NCT04008680|methodology|methodology
30652|NCT04008667|Postoperative ileus|postoperative ileus
30653|NCT04008667|acupoint|acupoint
30654|NCT04008667|ERAS|eras
30655|NCT04008667|Chinese medicine|chinese medicine
30656|NCT04008641|pediatric consultation|pediatric consultation
30657|NCT04008641|psychological|psychological
30658|NCT04008641|comprehension|comprehension
30659|NCT04008628|Pain|pain
30660|NCT04008628|nasogastric tube|nasogastric tube
30661|NCT04008628|children|children
30662|NCT04008628|infants|infants
30663|NCT04008628|analgesia|analgesia
30664|NCT04008628|nitrous oxide|nitrous oxide
30665|NCT04008602|Cooling|cooling
30666|NCT04008602|Criotherapy|criotherapy
30667|NCT04008602|Strenght|strenght
30668|NCT04008602|Plyometric exercise|plyometric exercise
30669|NCT04008576|Transdiagnostic CBT|transdiagnostic cbt
30670|NCT04008576|Internet-delivered CBT|internet-delivered cbt
30671|NCT04008576|Blended CBT|blended cbt
30672|NCT04008576|Group CBT|group cbt
30673|NCT04008576|Negative affect|negative affect
30674|NCT04008576|Positive affect|positive affect
30675|NCT04008550|TAVI (Transcatheter Aortic Valve Implantation)|tavi (transcatheter aortic valve implantation)
30676|NCT04008550|Aortic Stenosis|aortic stenosis
30677|NCT04008550|Pulmonary Arterial Hypertension|pulmonary arterial hypertension
30678|NCT04008550|Right Heart Catheterization|right heart catheterization
30679|NCT04008524|Relapsed|relapsed
30680|NCT04008524|Refractory|refractory
30681|NCT04008524|Hematological malignancy|hematological malignancy
30682|NCT04008524|CAR-T cells|car-t cells
30683|NCT04008511|Metastatic Colorectal Cancer|metastatic colorectal cancer
30684|NCT04008511|Regorafenib|regorafenib
30685|NCT04008511|Second line|second line
30686|NCT04008511|XELOX|xelox
30687|NCT04008472|Telemedecine|telemedecine
30688|NCT04008394|CD-30 CART|cd-30 cart
30689|NCT04008394|Refractory/Relapsed|refractory/relapsed
30690|NCT04008394|lymphocyte malignancies|lymphocyte malignancies
30691|NCT04008381|gamma-delta T|gamma-delta t
30692|NCT04008381|Refractory/Relapsed|refractory/relapsed
30693|NCT04008368|Graft-Versus-Host Disease|graft-versus-host disease
30694|NCT04008368|Donor Apheresis|donor apheresis
30695|NCT04008368|Host-Donor Chimerism|host-donor chimerism
30696|NCT04008342|aged|aged
30697|NCT04008342|nonpharmacological intervention|nonpharmacological intervention
30698|NCT04008342|multisensory stimulation|multisensory stimulation
30699|NCT04008342|neuropsychiatric symptoms|neuropsychiatric symptoms
30700|NCT04008342|long-term care|long-term care
30701|NCT04008329|amyotrophic lateral sclerosis|amyotrophic lateral sclerosis
30702|NCT04008329|natural history|natural history
30703|NCT04008329|genetics|genetics
30704|NCT04008329|prognostic factors|prognostic factors
30705|NCT04008290|Liraglutide|liraglutide
30706|NCT04008290|MMC|mmc
30707|NCT04008290|Motilin|motilin
30708|NCT04008290|Ghrelin|ghrelin
30709|NCT04008290|Hunger|hunger
30710|NCT04008290|glucose|glucose
30711|NCT04008290|ad libitum food intake|ad libitum food intake
30712|NCT04008238|Soft-tissue sarcoma|soft-tissue sarcoma
30713|NCT04008238|Predictive biomarkers|predictive biomarkers
30714|NCT04008238|Next-generation sequencing|next-generation sequencing
30715|NCT04008225|Bronchoalveolar lavage|bronchoalveolar lavage
30716|NCT04008186|RTA 408|rta 408
30717|NCT04008186|RTA 408 capsules|rta 408 capsules
30718|NCT04008186|omaveloxolone|omaveloxolone
30719|NCT04008186|omaveloxolone capsules|omaveloxolone capsules
30720|NCT04008186|DDI|ddi
30721|NCT04008160|perfusion|perfusion
30722|NCT04008160|oxygenation|oxygenation
30723|NCT04008160|non invasive measurement|non invasive measurement
30724|NCT04008134|handwashing with soap|handwashing with soap
30725|NCT04008134|water treatment|water treatment
30726|NCT04008134|behavior change|behavior change
30727|NCT04008134|water, sanitation and hygiene|water, sanitation and hygiene
30728|NCT04008121|Fluorescein angiography|fluorescein angiography
30729|NCT04008108|urinary incontinence|urinary incontinence
30730|NCT04008108|artificial urinary sphincter|artificial urinary sphincter
30731|NCT04008108|physcial activity|physcial activity
30732|NCT04008108|number of steps per day|number of steps per day
30733|NCT04008108|activity tracker|activity tracker
30734|NCT04008095|cervical cancer|cervical cancer
30736|NCT04008095|post-therapeutic|post-therapeutic
30737|NCT04008095|advanced stage|advanced stage
30738|NCT04008095|management|management
30739|NCT04008082|Hepatocellular Carcinoma|hepatocellular carcinoma
30740|NCT04008082|Lenvatinib Mesilate|lenvatinib mesilate
30741|NCT04008082|Lenvima|lenvima
30742|NCT04008082|LEN03T|len03t
30743|NCT04008069|glucocorticoid-dependent|glucocorticoid-dependent
30744|NCT04008043|Dexamethasone|dexamethasone
30745|NCT04008043|Vicodin|vicodin
30746|NCT04008043|Pain management|pain management
30747|NCT04008004|"First-in-Human"|"first-in-human"
30748|NCT04008004|Single Ascending Dose|single ascending dose
30749|NCT04008004|Multiple Ascending Dose|multiple ascending dose
30750|NCT04007965|PCO|pco
30751|NCT04007952|paraesophageal hernia|paraesophageal hernia
30752|NCT04007952|gastropexy|gastropexy
30753|NCT04007952|minimally invasive surgery|minimally invasive surgery
30754|NCT04007939|wellness|wellness
30755|NCT04007939|personalized medicine|personalized medicine
30756|NCT04007939|functional medicine|functional medicine
30757|NCT04007939|4P medicine|4p medicine
30758|NCT04007939|employee wellness program|employee wellness program
30759|NCT04007939|functional capacity|functional capacity
30760|NCT04007939|smart phone application|smart phone application
30761|NCT04007926|insulin resistance|insulin resistance
30762|NCT04007926|aerobic exercise|aerobic exercise
30763|NCT04007926|resistance exercise|resistance exercise
30764|NCT04007926|exercise training|exercise training
30765|NCT04007926|South Asians|south asians
30766|NCT04007900|positive affect treatment|positive affect treatment
30767|NCT04007874|Migraine|migraine
30768|NCT04007874|Women|women
30769|NCT04007874|Hormones|hormones
30770|NCT04007874|Oral contraceptive pill|oral contraceptive pill
30771|NCT04007874|Vitamin E|vitamin e
30772|NCT04007822|low back pain|low back pain
30773|NCT04007822|self-efficacy|self-efficacy
30774|NCT04007822|therapeutic alliance|therapeutic alliance
30775|NCT04007822|communication|communication
30776|NCT04007809|type 1 diabetes|type 1 diabetes
30777|NCT04007809|children|children
30778|NCT04007809|biomarkers|biomarkers
30779|NCT04007796|Sleep Apnea Syndromes|sleep apnea syndromes
30780|NCT04007796|Sleep Apnea, Central|sleep apnea, central
30781|NCT04007796|Sleep Apnea, Obstructive|sleep apnea, obstructive
30782|NCT04007796|Sleep Initiation and Maintenance Disorders|sleep initiation and maintenance disorders
30783|NCT04007796|Insomnia|insomnia
30784|NCT04007796|Insomnia Disorder|insomnia disorder
30785|NCT04007796|Stress Disorders, Post-Traumatic|stress disorders, post-traumatic
30786|NCT04007796|PTSD|ptsd
30787|NCT04007796|Veterans|veterans
30788|NCT04007770|Breast Cancer|breast cancer
30789|NCT04007770|Colorectal Cancer|colorectal cancer
30790|NCT04007770|Gynecologic Cancer|gynecologic cancer
30791|NCT04007770|Acupuncture|acupuncture
30792|NCT04007770|Memorial Sloan Kettering Cancer Center|memorial sloan kettering cancer center
30793|NCT04007770|19-179|19-179
30794|NCT04007757|Intracerebral Hemorrhage|intracerebral hemorrhage
30795|NCT04007757|Hemorrhagic Stroke|hemorrhagic stroke
30796|NCT04007757|Intracerebral Hematoma|intracerebral hematoma
30797|NCT04007731|protein bar|protein bar
30798|NCT04007731|physical activity|physical activity
30799|NCT04007731|muscle|muscle
30800|NCT04007705|Antiinflammatory diet|antiinflammatory diet
30801|NCT04007705|Low FODMAPs diet|low fodmaps diet
30802|NCT04007705|Gluten, casein, sugar and processed-foods free diet|gluten, casein, sugar and processed-foods free diet
30803|NCT04007705|Nutrition|nutrition
30804|NCT04007692|Esophageal stenosis|esophageal stenosis
30805|NCT04007692|Endoscopic suturing|endoscopic suturing
30806|NCT04007692|Esophageal stent fixation|esophageal stent fixation
30807|NCT04007692|Stent migration|stent migration
30808|NCT04007679|pain neuroscience education|pain neuroscience education
30809|NCT04007679|chronic pain|chronic pain
30810|NCT04007679|physiotherapy students|physiotherapy students
30811|NCT04007666|Incarcerated|incarcerated
30812|NCT04007666|Prisoners|prisoners
30813|NCT04007666|Implementation Science|implementation science
30814|NCT04007653|Post thrombotic syndrome|post thrombotic syndrome
30815|NCT04007653|Edoxaban|edoxaban
30816|NCT04007653|Vitamin K antagonist|vitamin k antagonist
30817|NCT04007653|Chronic Thromboembolic Pulmonary Hypertension|chronic thromboembolic pulmonary hypertension
30818|NCT04007653|Quality of Life|quality of life
30819|NCT04007640|Obesity|obesity
30820|NCT04007640|Diabetes|diabetes
30821|NCT04007640|metabolic syndrome|metabolic syndrome
30822|NCT04007640|Magnetic Resonance imaging,|magnetic resonance imaging,
30823|NCT04007640|Pancreatic Cancer|pancreatic cancer
30824|NCT04007640|preneoplastic lesions|preneoplastic lesions
30825|NCT04007640|acino-ductal metaplasia,|acino-ductal metaplasia,
30826|NCT04007627|ALADA|alada
30827|NCT04007627|IQ|iq
30828|NCT04007627|Pediatric Radiology|pediatric radiology
30829|NCT04007614|Macro-progestins|macro-progestins
30831|NCT04007601|Acute Lymphoblastic Leukemia|acute lymphoblastic leukemia
30832|NCT04007601|Neurocognitive impairment|neurocognitive impairment
30833|NCT04007601|Executive dysfunction|executive dysfunction
30834|NCT04007601|Survivorship|survivorship
30835|NCT04007588|Melanoma|melanoma
30836|NCT04007562|LIPIN1 deficiency|lipin1 deficiency
30837|NCT04007562|Acute episodes of rhabdomyolysis|acute episodes of rhabdomyolysis
30838|NCT04007562|Myoglobinuria|myoglobinuria
30839|NCT04007562|Hydroxychloroquine Sulfate|hydroxychloroquine sulfate
30840|NCT04007562|Orphan drug|orphan drug
30841|NCT04007549|Breast cancer|breast cancer
30842|NCT04007549|Smoking cessation|smoking cessation
30843|NCT04007549|Alcohol risk reduction|alcohol risk reduction
30844|NCT04007549|Couple intervention|couple intervention
30845|NCT04007549|Screening|screening
30846|NCT04007549|Brief intervention|brief intervention
30847|NCT04007549|Referral to treatment|referral to treatment
30848|NCT04007549|Randomized Trial|randomized trial
30849|NCT04007536|MPS-II|mps-ii
30850|NCT04007536|Mucopolysaccharidosis-II|mucopolysaccharidosis-ii
30851|NCT04007536|Lysosomal Storage Disease|lysosomal storage disease
30852|NCT04007523|Caregivers|caregivers
30853|NCT04007523|Clinical Decision Support Systems|clinical decision support systems
30854|NCT04007523|Cognitive Dysfunction|cognitive dysfunction
30855|NCT04007523|Confusion|confusion
30856|NCT04007523|Delirium|delirium
30857|NCT04007523|Feasibility Studies|feasibility studies
30858|NCT04007523|Geriatric Assessment|geriatric assessment
30859|NCT04007523|Neurocognitive Disorders|neurocognitive disorders
30860|NCT04007510|Psychosis|psychosis
30861|NCT04007510|first episode|first episode
30862|NCT04007510|clinical high risk|clinical high risk
30863|NCT04007510|outcomes|outcomes
30864|NCT04007510|mobile health|mobile health
30865|NCT04007510|data driven care|data driven care
30866|NCT04007510|learning healthcare network|learning healthcare network
30867|NCT04007471|Dysmenorrhea|dysmenorrhea
30868|NCT04007471|Primary dysmenorrhea|primary dysmenorrhea
30869|NCT04007471|Secondary dysmenorrhea|secondary dysmenorrhea
30870|NCT04007471|Pelvic pain|pelvic pain
30871|NCT04007471|Menstrual pain|menstrual pain
30872|NCT04007471|Adolescent|adolescent
30873|NCT04007471|Endometriosis|endometriosis
30874|NCT04007458|Screening|screening
30875|NCT04007445|spinal cord injury|spinal cord injury
30876|NCT04007445|exercise|exercise
30877|NCT04007445|occupational therapy|occupational therapy
30878|NCT04007432|nocturnal hypoxia|nocturnal hypoxia
30879|NCT04007432|delirum developpement|delirum developpement
30880|NCT04007419|Organ donation|organ donation
30881|NCT04007419|Donor designation/registration|donor designation/registration
30882|NCT04007419|Train-the-trainer|train-the-trainer
30883|NCT04007419|Promotora|promotora
30884|NCT04007419|Community health worker|community health worker
30885|NCT04007419|Lay health educator|lay health educator
30886|NCT04007419|Program development|program development
30887|NCT04007419|Program evaluation|program evaluation
30888|NCT04007380|Spinal cord injuries|spinal cord injuries
30889|NCT04007380|Sleep-related breathing disorders|sleep-related breathing disorders
30890|NCT04007328|sphingosine-1-phosphate|sphingosine-1-phosphate
30891|NCT04007328|corticosteroids adjuvant therapy|corticosteroids adjuvant therapy
30892|NCT04007315|rehabilitation|rehabilitation
30893|NCT04007315|hand|hand
30894|NCT04007263|NMDA|nmda
30895|NCT04007263|GluN2B|glun2b
30896|NCT04007250|Magnetic Anal Sphincter Augmentation|magnetic anal sphincter augmentation
30897|NCT04007250|FENIX™ continence restoration system|fenix™ continence restoration system
30898|NCT04007250|Magnetic Anal Sphincter|magnetic anal sphincter
30899|NCT04007237|mycological efficacy|mycological efficacy
30900|NCT04007237|ketoconazole|ketoconazole
810446|NCT00208377|Hip|hip
30901|NCT04007237|selenium disulfide 1,8%|selenium disulfide 1,8%
30902|NCT04007237|Pityriasis versicolor|pityriasis versicolor
30903|NCT04007198|moderate-to-severe asthma|moderate-to-severe asthma
30904|NCT04007185|quality of life|quality of life
30905|NCT04007185|cognitive function|cognitive function
30906|NCT04007185|visual function|visual function
30907|NCT04007185|surgery|surgery
30908|NCT04007172|neural therapy|neural therapy
30909|NCT04007172|physical theraphy|physical theraphy
30910|NCT04007172|lidocain injection|lidocain injection
30911|NCT04007159|Skin Care, Cosmetic Facial Product|skin care, cosmetic facial product
30912|NCT04007146|Cardiac Output|cardiac output
30913|NCT04007146|vascular medicine|vascular medicine
30914|NCT04007146|Transcutaneous Oxymetry|transcutaneous oxymetry
30915|NCT04007133|Non-insulin-dependent diabetes|non-insulin-dependent diabetes
30916|NCT04007133|Statins|statins
30917|NCT04007133|Compliance|compliance
30918|NCT04007081|Dry Mouth|dry mouth
30919|NCT04007081|MSC|msc
30920|NCT04007081|mesenchymal stem cells|mesenchymal stem cells
30921|NCT04007081|adult stem cells|adult stem cells
30922|NCT04007081|head and neck cancer|head and neck cancer
30923|NCT04007081|salivary gland|salivary gland
30924|NCT04007081|radiation|radiation
30925|NCT04007081|HNC|hnc
30926|NCT04006977|probiotics; psychological disorder;DSF|probiotics; psychological disorder;dsf
30927|NCT04006951|Cancer|cancer
30935|NCT04006847|Eicosapentaenoic Acid|eicosapentaenoic acid
30936|NCT04006847|Tyrosine Kinase Inhibitors|tyrosine kinase inhibitors
30937|NCT04006847|TKI|tki
30938|NCT04006847|GoldAID Eicosapentaenoic Acid|goldaid eicosapentaenoic acid
30939|NCT04006847|Fish Oil|fish oil
30940|NCT04006795|Skin Care, Cosmetic Facial Product|skin care, cosmetic facial product
30941|NCT04006782|edentulous|edentulous
30942|NCT04006782|narrow alveolar ridges|narrow alveolar ridges
30943|NCT04006769|entacapone|entacapone
30944|NCT04006769|Imatinib mesylate|imatinib mesylate
30945|NCT04006769|GIST|gist
30946|NCT04006769|treatment|treatment
30947|NCT04006743|pain|pain
30948|NCT04006743|preterm|preterm
30949|NCT04006743|premature|premature
30950|NCT04006743|orogastric tube|orogastric tube
30951|NCT04006743|newborn nurse|newborn nurse
30952|NCT04006717|Post-endodontic pain|post-endodontic pain
30953|NCT04006717|Low-level laser|low-level laser
30954|NCT04006717|Intracanal cryotherapy|intracanal cryotherapy
30955|NCT04006691|TC-3|tc-3
30956|NCT04006691|MitoGel|mitogel
30957|NCT04006691|UGN-101|ugn-101
30958|NCT04006691|UTUC|utuc
30959|NCT04006691|Ureteral|ureteral
30960|NCT04006691|Upper Tract|upper tract
30961|NCT04006691|Carcinoma|carcinoma
30962|NCT04006691|Kidney|kidney
30963|NCT04006691|Renal|renal
30964|NCT04006691|Ureter|ureter
30965|NCT04006691|Gel|gel
30966|NCT04006691|Local|local
30967|NCT04006691|Mitomycin C|mitomycin c
30968|NCT04006691|Prolonged Release|prolonged release
30969|NCT04006691|Slow Release|slow release
30970|NCT04006691|Kidney Sparing|kidney sparing
30971|NCT04006691|T1|t1
30972|NCT04006691|T0|t0
30973|NCT04006691|Low Grade|low grade
30974|NCT04006691|Transitional Cell Carcinoma of Renal Pelvis|transitional cell carcinoma of renal pelvis
30975|NCT04006691|TCC|tcc
30976|NCT04006665|Lung Ultrasonography|lung ultrasonography
30977|NCT04006665|Step Trendelenburg position|step trendelenburg position
30978|NCT04006639|local infiltration|local infiltration
30979|NCT04006639|bilateral superficial cervical plexus block|bilateral superficial cervical plexus block
30980|NCT04006639|lidocaine|lidocaine
30981|NCT04006639|bupivacaine|bupivacaine
30982|NCT04006639|substance-p|substance-p
30983|NCT04006613|Fatigue|fatigue
30984|NCT04006613|Balance|balance
30985|NCT04006613|Aerobic training|aerobic training
30986|NCT04006587|incentive spirometer|incentive spirometer
30987|NCT04006587|Hemothorax; Traumatic|hemothorax; traumatic
30988|NCT04006587|trauma|trauma
30989|NCT04006587|rib Fractures|rib fractures
30990|NCT04006574|Developmental Hip Dysplasia|developmental hip dysplasia
30991|NCT04006574|Physiotherapy|physiotherapy
30992|NCT04006574|Gait|gait
30993|NCT04006574|Core Stabilization|core stabilization
30994|NCT04006574|Balance|balance
30995|NCT04006561|Primary CNS Lymphoma|primary cns lymphoma
30996|NCT04006561|Neurobehavioral Assessment|neurobehavioral assessment
30997|NCT04006561|Neurocognitive Function (NCF)|neurocognitive function (ncf)
30998|NCT04006561|Whole-Brain Radiation Therapy (WBRT)|whole-brain radiation therapy (wbrt)
30999|NCT04006561|Simultaneous Integrated Boost (SIB)|simultaneous integrated boost (sib)
31000|NCT04006561|Hyperfractionation|hyperfractionation
31001|NCT04006561|Radiotherapy|radiotherapy
31002|NCT04006561|Chemotherapy|chemotherapy
31003|NCT04006561|Neurotoxicity|neurotoxicity
31004|NCT04006535|Vasculitis|vasculitis
31005|NCT04006522|renal cell carcinoma|renal cell carcinoma
31006|NCT04006522|atezolizumab|atezolizumab
31007|NCT04006522|PET/CT|pet/ct
31008|NCT04006509|preterm breast milk|preterm breast milk
31018|NCT04006366|bariatrics|bariatrics
810547|NCT00207948|Pediatrics|pediatrics
31019|NCT04006314|platelet rich plasma; neural prolotherapy|platelet rich plasma; neural prolotherapy
31020|NCT04006301|KRAS G12C|kras g12c
31021|NCT04006288|dual antiplatelet therapy|dual antiplatelet therapy
31022|NCT04006288|rivaroxaban|rivaroxaban
31023|NCT04006288|pharmacodynamic|pharmacodynamic
31024|NCT04006275|Hepatocellular Carcinoma|hepatocellular carcinoma
31025|NCT04006275|cirhossi|cirhossi
31026|NCT04006275|Contrast-enhanced ultrasound|contrast-enhanced ultrasound
31027|NCT04006275|LI-RADS|li-rads
31028|NCT04006197|vocal folds dysplasia|vocal folds dysplasia
31029|NCT04006184|Venaseal|venaseal
31030|NCT04006184|Symptomatic Varicose Veins|symptomatic varicose veins
31031|NCT04006171|c type natriuretic peptide|c type natriuretic peptide
31032|NCT04006171|polycystic ovary syndrome|polycystic ovary syndrome
31033|NCT04006171|menstrual cycle|menstrual cycle
31034|NCT04006132|Bone anchored hearing systems|bone anchored hearing systems
31035|NCT04006132|BAHS|bahs
31036|NCT04006132|Bilateral benefit|bilateral benefit
31037|NCT04006132|Ponto 3 SuperPower|ponto 3 superpower
31038|NCT04006132|Minimum Audible Angle|minimum audible angle
31039|NCT04006132|Auditory working memory|auditory working memory
31040|NCT04006106|Drug hypersensitivity|drug hypersensitivity
31041|NCT04006106|Endotypes|endotypes
31042|NCT04006106|Anaphylaxis|anaphylaxis
31043|NCT04006041|Esophageal squamous cell carcinoma|esophageal squamous cell carcinoma
31044|NCT04006041|Neoadjuvant chemoradiotherapy|neoadjuvant chemoradiotherapy
31045|NCT04006041|Toripalimab|toripalimab
31046|NCT04006041|Pathologic complete response|pathologic complete response
31047|NCT04006028|Type 2 diabetes|type 2 diabetes
31048|NCT04006028|renal biopsy|renal biopsy
31049|NCT04006028|diabetic nephropathy|diabetic nephropathy
31050|NCT04006028|proteinuria|proteinuria
31051|NCT04006028|hematuria|hematuria
31052|NCT04005989|STROMAL CELLS|stromal cells
31053|NCT04005989|ADIPOSE STROMAL CELLS|adipose stromal cells
31054|NCT04005989|REVASCULARIZATION|revascularization
31055|NCT04005989|MYOCARDIUM REVASCULARIZATION|myocardium revascularization
31056|NCT04005989|CARDIAC SURGERY|cardiac surgery
31057|NCT04005989|CORONARY ARTERY DISEASE|coronary artery disease
31058|NCT04005937|muscle spindle|muscle spindle
31059|NCT04005937|H reflex|h reflex
31060|NCT04005937|spasticity|spasticity
31061|NCT04005924|blood glucose|blood glucose
31062|NCT04005924|blood insulin|blood insulin
31063|NCT04005924|postprandial|postprandial
31064|NCT04005924|fiber|fiber
31065|NCT04005911|Post-surgical|post-surgical
31066|NCT04005833|Pulmonary disease|pulmonary disease
31067|NCT04005833|chronic obstructive|chronic obstructive
31068|NCT04005833|Primary Health Care|primary health care
31069|NCT04005833|Fibrocyte|fibrocyte
31070|NCT04005833|Respiratory Function Tests|respiratory function tests
31071|NCT04005820|pediatric|pediatric
31072|NCT04005794|schizophrenia|schizophrenia
31073|NCT04005794|social skills training|social skills training
31074|NCT04005794|social brain network|social brain network
31075|NCT04005794|virtual reality|virtual reality
31076|NCT04005794|simulation|simulation
31077|NCT04005794|functional outcome|functional outcome
31078|NCT04005781|bitter|bitter
31079|NCT04005781|quinine|quinine
31080|NCT04005781|ghrelin|ghrelin
31081|NCT04005781|motilin|motilin
31082|NCT04005781|food intake|food intake
31083|NCT04005768|Bitter|bitter
31084|NCT04005768|Quinine|quinine
31085|NCT04005768|Motilin|motilin
31086|NCT04005768|Ghrelin|ghrelin
31087|NCT04005768|Food intake|food intake
31088|NCT04005755|Analgesic|analgesic
31089|NCT04005742|colorectal cancer|colorectal cancer
31090|NCT04005742|biomarkers|biomarkers
31091|NCT04005742|cancer risk|cancer risk
31092|NCT04005742|cancer prevention|cancer prevention
31093|NCT04005742|ageing|ageing
31094|NCT04005742|diet|diet
31095|NCT04005742|obesity|obesity
31096|NCT04005742|physical activity|physical activity
31097|NCT04005742|colorectal adenoma|colorectal adenoma
31098|NCT04005729|cangrelor|cangrelor
31099|NCT04005729|P2Y12|p2y12
31100|NCT04005729|out-of-hospital cardiac arrest|out-of-hospital cardiac arrest
31101|NCT04005729|induced hypothermia|induced hypothermia
31102|NCT04005729|primary percutaneous coronary intervention|primary percutaneous coronary intervention
31103|NCT04005703|Malignant lymphoma|malignant lymphoma
31104|NCT04005703|Hodgkin's disease|hodgkin's disease
31105|NCT04005703|Imaging|imaging
31106|NCT04005703|Whole-Body MRI|whole-body mri
31107|NCT04005703|PET/CT|pet/ct
31108|NCT04005703|Radiation|radiation
31109|NCT04005638|Biological collection|biological collection
31110|NCT04005625|Crystal-Induced Arthritis|crystal-induced arthritis
31111|NCT04005612|Vitamin D Deficiency|vitamin d deficiency
31112|NCT04005612|plama osteocalcin|plama osteocalcin
31113|NCT04005612|omega-3 fatty acids|omega-3 fatty acids
31114|NCT04005599|Postoperative pain|postoperative pain
31115|NCT04005599|opioid|opioid
31116|NCT04005599|Postoperative analgesia|postoperative analgesia
31117|NCT04005573|vitamin D3|vitamin d3
31118|NCT04005573|Vitamin D Deficiency|vitamin d deficiency
31119|NCT04005573|Lipid profile|lipid profile
31120|NCT04005573|oxidized low density Lipoprotein|oxidized low density lipoprotein
31121|NCT04005573|omega-3 fatty acids|omega-3 fatty acids
31122|NCT04005560|severe bacterial infection|severe bacterial infection
31123|NCT04005560|quality of life|quality of life
31124|NCT04005560|long term sequela|long term sequela
31125|NCT04005560|pediatric intensive care unit|pediatric intensive care unit
31126|NCT04005560|children|children
31127|NCT04005547|sexual health|sexual health
31128|NCT04005547|Autism Spectrum Disorders|autism spectrum disorders
31129|NCT04005534|Postoperative pain|postoperative pain
31130|NCT04005534|Rotator cuff injuries|rotator cuff injuries
31131|NCT04005534|Preemptive analgesia|preemptive analgesia
31132|NCT04005508|sleep|sleep
31133|NCT04005508|cardiovascular outcomes|cardiovascular outcomes
31134|NCT04005508|high cardiovascular risk|high cardiovascular risk
31135|NCT04005508|observational|observational
31136|NCT04005495|Kitchen Collaborative|kitchen collaborative
31137|NCT04005495|Healthful habits|healthful habits
31138|NCT04005495|Worksite wellness program|worksite wellness program
31139|NCT04005495|Mindfulness|mindfulness
31140|NCT04005469|Ischemia-reperfusion injury|ischemia-reperfusion injury
31141|NCT04005469|kidney transplantation|kidney transplantation
31142|NCT04005469|prostacyclin|prostacyclin
31143|NCT04005469|treprostinil|treprostinil
31144|NCT04005469|delayed graft function|delayed graft function
31145|NCT04005456|wellness|wellness
31146|NCT04005456|n-of-1 trial|n-of-1 trial
31147|NCT04005456|detoxification|detoxification
31148|NCT04005456|personalized medicine|personalized medicine
31149|NCT04005456|functional medicine|functional medicine
31150|NCT04005456|4P medicine|4p medicine
31151|NCT04005456|lifestyle medicine|lifestyle medicine
31152|NCT04005456|homocysteine|homocysteine
31153|NCT04005456|dietary supplement|dietary supplement
31154|NCT04005456|medical food|medical food
31155|NCT04005456|behavioral change|behavioral change
31156|NCT04005456|lifestyle modification|lifestyle modification
31157|NCT04005456|employee wellness program|employee wellness program
31158|NCT04005456|functional capacity|functional capacity
31159|NCT04005456|food plan|food plan
31160|NCT04005404|Regional Anesthesia|regional anesthesia
31161|NCT04005404|Ultrasonography|ultrasonography
31162|NCT04005404|Hip Fractures|hip fractures
31163|NCT04005404|Lumbosacral Plexus|lumbosacral plexus
31164|NCT04005391|postpartum contraception|postpartum contraception
31165|NCT04005391|long-acting reversible contraceptives|long-acting reversible contraceptives
31166|NCT04005391|implant|implant
31167|NCT04005391|nursing|nursing
31168|NCT04005391|community programming|community programming
31169|NCT04005391|cluster-randomized trial|cluster-randomized trial
31170|NCT04005365|propranolol|propranolol
31171|NCT04005365|gastric cancer|gastric cancer
31172|NCT04005352|AMD, nAMD, wet AMD, RTH258, brolucizumab, double blind|amd, namd, wet amd, rth258, brolucizumab, double blind
31173|NCT04005339|Advanced Biliary Tract Cancer|advanced biliary tract cancer
31174|NCT04005339|Biliary Tract Cancer|biliary tract cancer
31175|NCT04005339|GI Cancer|gi cancer
31176|NCT04005339|Biliary Cancer|biliary cancer
31177|NCT04005339|NAPOLI-2|napoli-2
31178|NCT04005313|Electromyographic activity|electromyographic activity
31179|NCT04005313|Neck pain|neck pain
31180|NCT04005313|Electroencephalographic activity|electroencephalographic activity
31181|NCT04005313|dementia|dementia
31182|NCT04005300|Refeeding syndrome|refeeding syndrome
31183|NCT04005300|Enteral nutrition|enteral nutrition
31184|NCT04005300|Critical illness|critical illness
31185|NCT04005261|Type 2 diabetes|type 2 diabetes
31186|NCT04005261|C-peptide|c-peptide
31187|NCT04005261|beta-cell reserve|beta-cell reserve
31188|NCT04005261|insulin use|insulin use
31189|NCT04005235|phrenic nerve|phrenic nerve
31190|NCT04005235|nerve block|nerve block
31191|NCT04005235|ultrasonography|ultrasonography
31192|NCT04005235|breath tests|breath tests
31193|NCT04005235|oscillometry|oscillometry
31194|NCT04005235|brachial plexus|brachial plexus
31195|NCT04005222|Ocular ischemic syndrome|ocular ischemic syndrome
31196|NCT04005222|selenium|selenium
31197|NCT04005222|melatonin|melatonin
31198|NCT04005222|MDA|mda
31199|NCT04005222|GSH|gsh
31200|NCT04005209|Ketamine|ketamine
31201|NCT04005209|Intravenous Infusions|intravenous infusions
31202|NCT04005209|Anemia; Sickle-Cell, with Crisis|anemia; sickle-cell, with crisis
31203|NCT04005209|Acute Pain|acute pain
31204|NCT04005183|Renal Cell Carcinoma|renal cell carcinoma
31205|NCT04005183|Genomics|genomics
31206|NCT04005183|Single-cell|single-cell
31207|NCT04005183|Microenvironment|microenvironment
31208|NCT04005183|Immunotherapy|immunotherapy
31209|NCT04005183|Neoplasms, Glandular and Epithelial|neoplasms, glandular and epithelial
31210|NCT04005183|Neoplasms by Histologic Type|neoplasms by histologic type
31211|NCT04005183|Kidney Neoplasms|kidney neoplasms
31212|NCT04005183|Urologic Neoplasms|urologic neoplasms
31213|NCT04005183|Urogenital Neoplasms|urogenital neoplasms
31214|NCT04005183|Neoplasms by Site|neoplasms by site
31215|NCT04005183|Kidney Diseases|kidney diseases
31216|NCT04005183|Urologic Diseases|urologic diseases
31217|NCT04005170|Esophageal squamous cell carcinoma|esophageal squamous cell carcinoma
31218|NCT04005170|Definitive chemoradiotherapy|definitive chemoradiotherapy
31219|NCT04005170|Toripalimab|toripalimab
31220|NCT04005170|Clinical complete response|clinical complete response
31221|NCT04005157|Electromagnetic navigation bronchoscopy(ENB)|electromagnetic navigation bronchoscopy(enb)
31222|NCT04005157|Microwave ablation|microwave ablation
31223|NCT04005157|Peripheral lung cancer|peripheral lung cancer
31224|NCT04005131|stroke|stroke
31225|NCT04005131|transcranial direct current stimulation|transcranial direct current stimulation
31226|NCT04005131|upper extremity rehabilitation robot|upper extremity rehabilitation robot
31227|NCT04005118|Intestinal microbiome|intestinal microbiome
31228|NCT04005118|colorectal cancer|colorectal cancer
31229|NCT04005118|mechanical bowel preparation|mechanical bowel preparation
31230|NCT04005118|postoperative complications|postoperative complications
31231|NCT04005118|anastomotic leakage|anastomotic leakage
31232|NCT04005092|non invasive ventilation|non invasive ventilation
31233|NCT04005092|pulmonary edema|pulmonary edema
31234|NCT04005092|high flow nasal cannula|high flow nasal cannula
31235|NCT04005092|helmet CPAP|helmet cpap
31236|NCT04005092|respiratory failure|respiratory failure
31237|NCT04005092|hyperaemia|hyperaemia
31238|NCT04005079|Cataract surgery|cataract surgery
31239|NCT04005079|Trabectome|trabectome
31240|NCT04005079|Eye Surgery|eye surgery
31241|NCT04005079|Vision|vision
31242|NCT04005079|Glaucoma Surgery|glaucoma surgery
31243|NCT04005027|QT interval|qt interval
31244|NCT04005027|Intermittent Exercise|intermittent exercise
31245|NCT04005027|Continuous Exercise|continuous exercise
31246|NCT04005027|Cardiac|cardiac
31247|NCT04005027|Electrocardiogram|electrocardiogram
31248|NCT04005001|Sepsis|sepsis
31249|NCT04005001|Dascena|dascena
31250|NCT04005001|Machine learning algorithm|machine learning algorithm
31251|NCT04004975|anlotinib Recurrent Glioblastoma|anlotinib recurrent glioblastoma
31252|NCT04004936|Emergency Department|emergency department
31253|NCT04004936|Potentially Inappropriate Medications|potentially inappropriate medications
31254|NCT04004936|Inappropriate Prescribing|inappropriate prescribing
31255|NCT04004936|Quality Improvement|quality improvement
31256|NCT04004936|Veteran Health|veteran health
31257|NCT04004936|Older Adults|older adults
31258|NCT04004910|Triple Negative Breast Cancer|triple negative breast cancer
31260|NCT04004884|Ulipristal Acetate|ulipristal acetate
31261|NCT04004884|Selective Progesterone Receptor Modulators|selective progesterone receptor modulators
31262|NCT04004884|Leiomyoma|leiomyoma
31263|NCT04004884|Liver injury|liver injury
31264|NCT04004858|Radiation toxicity|radiation toxicity
31265|NCT04004858|Hypofractionation|hypofractionation
31266|NCT04004858|Margin reduction|margin reduction
31267|NCT04004780|Self-medication-drug interactions|self-medication-drug interactions
31268|NCT04004767|Alzheimer's|alzheimer's
31269|NCT04004767|Prevention|prevention
31270|NCT04004767|Observational|observational
31271|NCT04004767|Trial-Ready Cohort|trial-ready cohort
31272|NCT04004741|Osteopathic Manipulative Medicine|osteopathic manipulative medicine
31273|NCT04004728|laser|laser
31274|NCT04004728|telangiectasias|telangiectasias
31275|NCT04004728|leg veins|leg veins
31276|NCT04004728|sclerotherapy|sclerotherapy
31277|NCT04004702|neuro-psychiatric symptoms|neuro-psychiatric symptoms
31278|NCT04004676|Ketones|ketones
31279|NCT04004676|Glycogen replenishment|glycogen replenishment
31280|NCT04004676|Exercise Performance|exercise performance
31281|NCT04004663|pharmacokinetics|pharmacokinetics
31282|NCT04004663|JAK inhibitor|jak inhibitor
31283|NCT04004663|PF-06651600|pf-06651600
31284|NCT04004637|NK/T cell lymphoma|nk/t cell lymphoma
31285|NCT04004637|T-lymphoblastic lymphoma|t-lymphoblastic lymphoma
31286|NCT04004611|Interleukin-23 (IL-23) antibody|interleukin-23 (il-23) antibody
31287|NCT04004611|IL-23p19|il-23p19
31288|NCT04004611|Pediatric|pediatric
31289|NCT04004598|aging, exercise, golf, intervention|aging, exercise, golf, intervention
31290|NCT04004585|Sedentary behaviour|sedentary behaviour
31291|NCT04004585|Behaviour change|behaviour change
31292|NCT04004585|Theoretical Domains Framework|theoretical domains framework
31293|NCT04004572|Natural killer/T-cell lymphoma|natural killer/t-cell lymphoma
31294|NCT04004572|Sintilimab|sintilimab
31295|NCT04004572|Pegaspargase|pegaspargase
31296|NCT04004572|Anlotinib|anlotinib
31297|NCT04004559|Invasive Breast Cancer|invasive breast cancer
31298|NCT04004559|Neoadjuvant Chemotherapy|neoadjuvant chemotherapy
31299|NCT04004559|Radiomics|radiomics
31300|NCT04004559|Axillary Lymph Node Metastasis|axillary lymph node metastasis
31301|NCT04004559|Survival|survival
31302|NCT04004559|Machine Learning Analysis|machine learning analysis
31303|NCT04004533|endoscope|endoscope
31304|NCT04004533|duodenoscope|duodenoscope
31305|NCT04004520|stress|stress
31306|NCT04004520|cortisol|cortisol
31307|NCT04004520|alpha-amylase|alpha-amylase
31308|NCT04004520|homelessness|homelessness
31309|NCT04004520|biomarkers|biomarkers
31310|NCT04004520|virtual reality|virtual reality
31311|NCT04004520|meditation|meditation
31312|NCT04004507|Night Vision Disturbances|night vision disturbances
31313|NCT04004507|NVD|nvd
31314|NCT04004507|Glare|glare
31315|NCT04004507|Halos|halos
31316|NCT04004507|Starbursts|starbursts
31317|NCT04004507|Nyxol|nyxol
31318|NCT04004494|segmentectomy|segmentectomy
31319|NCT04004494|Video-assisted thoracoscopic surgery|video-assisted thoracoscopic surgery
31320|NCT04004494|lung cancer|lung cancer
31321|NCT04004494|ground-glass opacity|ground-glass opacity
31322|NCT04004481|Tramadol|tramadol
31323|NCT04004481|CYP2D6 polymorphism|cyp2d6 polymorphism
31324|NCT04004481|analgesia|analgesia
31325|NCT04004481|intensive care|intensive care
31326|NCT04004481|organ failure|organ failure
31329|NCT04004455|pressure pain threshold|pressure pain threshold
31330|NCT04004455|energy-balance related behavior|energy-balance related behavior
31331|NCT04004455|pain catastrophizing|pain catastrophizing
31332|NCT04004455|body composition|body composition
31334|NCT04004442|AVB-S6-500|avb-s6-500
31335|NCT04004442|renal pelvis cancer|renal pelvis cancer
31336|NCT04004442|ureter cancer|ureter cancer
31337|NCT04004442|urinary bladder cancer|urinary bladder cancer
31338|NCT04004442|urethra cancer|urethra cancer
31339|NCT04004390|Pre- and post-therapeutic evaluation carried out|pre- and post-therapeutic evaluation carried out
31340|NCT04004390|Data transcribed in the computerized patient file|data transcribed in the computerized patient file
31341|NCT04004390|post-poliomyelitis syndrome|post-poliomyelitis syndrome
31342|NCT04004390|Intravenous immunoglobulins|intravenous immunoglobulins
31343|NCT04004390|walking test|walking test
31344|NCT04004390|isokinetics|isokinetics
31345|NCT04004338|Carfilzomib|carfilzomib
31346|NCT04004338|Multiple Myeloma|multiple myeloma
31347|NCT04004312|single fraction|single fraction
31348|NCT04004312|SBRT|sbrt
31349|NCT04004312|Space OAR Gel|space oar gel
31350|NCT04004299|Hepatitis C re-infection|hepatitis c re-infection
31351|NCT04004286|Pain PASTOR Biobank|pain pastor biobank
31352|NCT04004273|Type 2 diabetes|type 2 diabetes
31353|NCT04004273|Non-alcohol fatty liver disease|non-alcohol fatty liver disease
31354|NCT04004273|Exercise|exercise
31355|NCT04004273|Saturated fat|saturated fat
31356|NCT04004273|MRI|mri
31357|NCT04004273|Proton magnetic resonance spectroscopy|proton magnetic resonance spectroscopy
31358|NCT04004247|High Flow Oxygenation|high flow oxygenation
31359|NCT04004247|Electrical Impedance Tomography|electrical impedance tomography
31360|NCT04004247|Non invasive ventilation|non invasive ventilation
31361|NCT04004234|local advanced|local advanced
31362|NCT04004234|metastatic|metastatic
31363|NCT04004234|anti-PD-1 antibody|anti-pd-1 antibody
31364|NCT04004234|Manganese|manganese
31365|NCT04004234|gemcitabine|gemcitabine
31366|NCT04004234|cisplatin|cisplatin
31367|NCT04004169|Major Depressive Disorder|major depressive disorder
31368|NCT04004169|Depression|depression
31369|NCT04004169|Treatment-resistance|treatment-resistance
31370|NCT04004169|Deep brain stimulation|deep brain stimulation
31371|NCT04004169|Closed-loop|closed-loop
31372|NCT04004169|Biomarker|biomarker
31373|NCT04004169|Responsive neurostimulation|responsive neurostimulation
31374|NCT04004169|Brain surgery|brain surgery
31375|NCT04004156|Degenerative Disc Disease|degenerative disc disease
31376|NCT04004156|DDD|ddd
31377|NCT04004156|Chronic Low-back Pain|chronic low-back pain
31378|NCT04004156|Low Back Pain|low back pain
31379|NCT04004156|Nucleus Replacement Device|nucleus replacement device
31380|NCT04004156|Nucleus Pulposus|nucleus pulposus
31381|NCT04004156|Disc Replacement|disc replacement
31382|NCT04004156|Back pain|back pain
31383|NCT04004156|Leg pain|leg pain
31384|NCT04004156|Lumbar Spinal Fusion|lumbar spinal fusion
31385|NCT04004104|Supine Exercise|supine exercise
31386|NCT04004104|Orthodeoxia|orthodeoxia
31387|NCT04004091|Premature Birth|premature birth
31388|NCT04004091|Spermine|spermine
31389|NCT04004091|Necrotizing Enterocolitis|necrotizing enterocolitis
31390|NCT04004091|Tight Junction|tight junction
31391|NCT04004065|DMD|dmd
31392|NCT04004065|Duchenne|duchenne
31393|NCT04004065|Dystrophy|dystrophy
31394|NCT04004065|Dystrophin|dystrophin
31395|NCT04004065|Exon Skipping|exon skipping
31396|NCT04004065|Ambulatory|ambulatory
31397|NCT04004065|Duchenne Muscular Dystrophy|duchenne muscular dystrophy
31398|NCT04004065|Exon 51|exon 51
31399|NCT04004065|Nonambulatory|nonambulatory
31400|NCT04004065|Pediatric|pediatric
31401|NCT04004065|Peptide-conjugated phosphorodiamidate morpholino oligomer (PPMO)|peptide-conjugated phosphorodiamidate morpholino oligomer (ppmo)
31402|NCT04004065|Momentum|momentum
31403|NCT04004052|Meralgia paresthetica|meralgia paresthetica
31404|NCT04004052|Ultrasound-guided injection|ultrasound-guided injection
31405|NCT04004052|Transcutaneous electrical nerve stimulation|transcutaneous electrical nerve stimulation
31406|NCT04004039|Satellite cells|satellite cells
31407|NCT04004039|Therapeutic|therapeutic
31408|NCT04004039|Aromatic plants|aromatic plants
31409|NCT04004026|Multiple Sclerosis|multiple sclerosis
31410|NCT04004026|3-m backwards walk|3-m backwards walk
31411|NCT04004026|Balance|balance
31412|NCT04004026|Fall risk|fall risk
31413|NCT04004026|validity|validity
31414|NCT04004026|reliability|reliability
31415|NCT04004013|osteopenia|osteopenia
31416|NCT04004013|phytoestrogen|phytoestrogen
31417|NCT04004013|hop|hop
31418|NCT04004013|menopause|menopause
31419|NCT04004000|FSHD, FSHD1|fshd, fshd1
31420|NCT04004000|Muscular Dystrophies|muscular dystrophies
31421|NCT04004000|Facioscapulohumeral Muscular Disorders|facioscapulohumeral muscular disorders
31422|NCT04004000|Atrophic Muscular Diseases|atrophic muscular diseases
31423|NCT04004000|Musculoskeletal Diseases|musculoskeletal diseases
31424|NCT04004000|Neuromuscular Diseases|neuromuscular diseases
31438|NCT04003935|aging|aging
31439|NCT04003935|CVD prevention|cvd prevention
31440|NCT04003896|Biliary Tract Carcinoma|biliary tract carcinoma
31441|NCT04003896|Abemaciclib|abemaciclib
31442|NCT04003883|ST segment|st segment
31443|NCT04003883|preclinical emergency medicine|preclinical emergency medicine
31444|NCT04003883|stress|stress
31445|NCT04003883|occupational health|occupational health
31446|NCT04003883|emergency medicine|emergency medicine
31447|NCT04003883|24h ECG|24h ecg
31448|NCT04003857|Human Umbilical Cord Blood Derived Mesenchymal Stem Cells|human umbilical cord blood derived mesenchymal stem cells
31449|NCT04003857|Bronchopulmonary dysplasia|bronchopulmonary dysplasia
31450|NCT04003857|Premature infants|premature infants
31451|NCT04003766|percutaneous biopsy|percutaneous biopsy
31452|NCT04003766|endoscopic guided biopsy|endoscopic guided biopsy
31453|NCT04003766|liver|liver
31454|NCT04003766|hepatic conditions|hepatic conditions
31455|NCT04003714|repetitive transcranial magnetic stimulation|repetitive transcranial magnetic stimulation
31456|NCT04003714|back pain|back pain
31457|NCT04003714|failed back surgery syndrome|failed back surgery syndrome
31458|NCT04003701|children|children
31459|NCT04003701|cancer|cancer
31460|NCT04003701|humanoid robot|humanoid robot
31461|NCT04003701|distraction|distraction
31462|NCT04003701|pain|pain
31463|NCT04003701|pain memory|pain memory
31464|NCT04003636|programmed cell death 1 (PD-1)|programmed cell death 1 (pd-1)
31465|NCT04003636|Pembrolizumab|pembrolizumab
31466|NCT04003636|cholangiocarcinoma|cholangiocarcinoma
31467|NCT04003636|gall bladder cancer|gall bladder cancer
31468|NCT04003636|check point inhibitor|check point inhibitor
31469|NCT04003636|immunotherapy|immunotherapy
31470|NCT04003636|Biliary|biliary
31471|NCT04003636|Keytruda|keytruda
31472|NCT04003636|Bile Duct Cancer|bile duct cancer
31473|NCT04003623|Advanced solid tumor|advanced solid tumor
31474|NCT04003623|metastatic solid tumor|metastatic solid tumor
31475|NCT04003623|FGFR inhibitor|fgfr inhibitor
31476|NCT04003623|FGFR mutation|fgfr mutation
31477|NCT04003623|FGFR translocation|fgfr translocation
31478|NCT04003610|Urothelial carcinoma|urothelial carcinoma
31479|NCT04003610|fibroblast growth factor receptor (FGFR) inhibitor|fibroblast growth factor receptor (fgfr) inhibitor
31480|NCT04003610|FGFR3 mutation|fgfr3 mutation
31481|NCT04003610|FGFR3 rearrangement|fgfr3 rearrangement
31482|NCT04003610|metastatic|metastatic
31483|NCT04003610|unresectable|unresectable
31484|NCT04003610|cisplatin-ineligible|cisplatin-ineligible
31485|NCT04003597|Low-salt bread|low-salt bread
31486|NCT04003597|Dietary sodium restriction|dietary sodium restriction
31487|NCT04003597|Pre-hypertension|pre-hypertension
31488|NCT04003597|Hypertension stage 1|hypertension stage 1
31489|NCT04003584|Minimally invasive|minimally invasive
31490|NCT04003584|Cardiac Surgery|cardiac surgery
31491|NCT04003584|Postoperative Pain|postoperative pain
31492|NCT04003571|stroke|stroke
31493|NCT04003571|augmented reality|augmented reality
31494|NCT04003571|functional electrical stimulation|functional electrical stimulation
31495|NCT04003558|Early-stage Breast Cancer|early-stage breast cancer
31496|NCT04003558|Radiomics|radiomics
31497|NCT04003558|Axillary lymph node metastasis|axillary lymph node metastasis
31498|NCT04003558|Tumor microenvironment|tumor microenvironment
31499|NCT04003558|Survival|survival
31500|NCT04003558|Deep learning|deep learning
31501|NCT04003532|Diagnosis|diagnosis
31502|NCT04003532|Test-of-Cure|test-of-cure
31503|NCT04003532|HIV co-infection|hiv co-infection
31504|NCT04003532|Loop-mediated amplification assay|loop-mediated amplification assay
31505|NCT04003532|PCR|pcr
31506|NCT04003532|Nucleic-acid Lateral Flow Immunoassay|nucleic-acid lateral flow immunoassay
31507|NCT04003506|bupivacaine|bupivacaine
31508|NCT04003506|LIA|lia
31509|NCT04003506|ACB|acb
31510|NCT04003506|total knee replacement|total knee replacement
31511|NCT04003506|post operative pain|post operative pain
31512|NCT04003506|acute pain|acute pain
31513|NCT04003506|anaesthesia|anaesthesia
31514|NCT04003493|Nutrition|nutrition
31515|NCT04003493|Oral health|oral health
31516|NCT04003493|Care givers|care givers
31517|NCT04003493|Home care clients|home care clients
31518|NCT04003493|Quality of life|quality of life
31519|NCT04003480|Saphenous vein graft|saphenous vein graft
31520|NCT04003480|PAD|pad
31521|NCT04003480|Peripheral bypass surgery|peripheral bypass surgery
31522|NCT04003480|external support|external support
31523|NCT04003467|Osteoporosis|osteoporosis
31534|NCT04003402|Healthy Volunteer|healthy volunteer
31535|NCT04003402|ASP8062|asp8062
31540|NCT04003376|fractional carbon dioxide laser|fractional carbon dioxide laser
31541|NCT04003363|Myotonic Dystrophy|myotonic dystrophy
31542|NCT04003363|Myotonic Dystrophy Type 1|myotonic dystrophy type 1
31543|NCT04003363|Myotonic Dystrophy Type 2|myotonic dystrophy type 2
31544|NCT04003363|DM|dm
31545|NCT04003363|DM1|dm1
31546|NCT04003363|DM2|dm2
31547|NCT04003285|Brain Injuries, Traumatic|brain injuries, traumatic
31548|NCT04003285|Depression|depression
31549|NCT04003285|Pain|pain
31550|NCT04003259|Diet|diet
31551|NCT04003259|Exercise|exercise
31552|NCT04003259|Lifestyle|lifestyle
31553|NCT04003259|Weight control|weight control
31554|NCT04003246|Lung|lung
31555|NCT04003233|Growth friendly system|growth friendly system
31556|NCT04003233|Distraction system|distraction system
31557|NCT04003233|Early Onset Scoliosis|early onset scoliosis
31558|NCT04003233|Unilateral|unilateral
31559|NCT04003207|Phelan McDermid Syndrome|phelan mcdermid syndrome
31560|NCT04003207|22q13 deletion Syndrome|22q13 deletion syndrome
31561|NCT04003207|Growth hormone|growth hormone
31562|NCT04003207|Autism|autism
31563|NCT04003207|Insulin like growth factor 1|insulin like growth factor 1
31564|NCT04003194|pulses|pulses
31565|NCT04003194|legumes|legumes
31566|NCT04003194|Phaseolus vulgaris L.|phaseolus vulgaris l.
31567|NCT04003194|glycemic response|glycemic response
31568|NCT04003181|Bile acid malabsorption|bile acid malabsorption
31569|NCT04003181|Bacterial overgrowth|bacterial overgrowth
31570|NCT04003168|BCMA|bcma
31571|NCT04003168|CAR-T|car-t
31572|NCT04003168|multiple myeloma|multiple myeloma
31573|NCT04003168|Relapsed/Refractory|relapsed/refractory
31582|NCT04003129|paediatrician|paediatrician
31583|NCT04003129|early childhood caries|early childhood caries
31584|NCT04003090|ophthalmic solution|ophthalmic solution
31585|NCT04003090|glaucoma|glaucoma
31586|NCT04003090|retinal ganglion cells|retinal ganglion cells
31587|NCT04003090|neuroprotective effect|neuroprotective effect
31588|NCT04003077|Laser meridian massage|laser meridian massage
31589|NCT04003077|heroin addicts|heroin addicts
31590|NCT04003077|methadone treatment|methadone treatment
31591|NCT04003077|traditional Chinese medicine|traditional chinese medicine
31592|NCT04003051|Head and neck cancer|head and neck cancer
31593|NCT04003051|swallowing|swallowing
31594|NCT04003051|trismus|trismus
31595|NCT04003051|adherence|adherence
31596|NCT04003051|coping|coping
31597|NCT04003051|rural|rural
31598|NCT04003051|website|website
31599|NCT04003051|access|access
31600|NCT04002999|3D printing|3d printing
31601|NCT04002999|Virtual treatment planning|virtual treatment planning
31602|NCT04002986|increased risk of breast cancer|increased risk of breast cancer
31603|NCT04002947|BTK Inhibitor|btk inhibitor
31604|NCT04002947|Calquence|calquence
31605|NCT04002947|ACP-196|acp-196
31606|NCT04002947|Monoclonal Antibody|monoclonal antibody
31607|NCT04002934|MS|ms
31608|NCT04002934|RRMS|rrms
31609|NCT04002934|Remyelination|remyelination
31610|NCT04002934|Repair|repair
31611|NCT04002934|Multiple Sclerosis|multiple sclerosis
31612|NCT04002934|SERM|serm
31613|NCT04002934|Estrogen|estrogen
31614|NCT04002934|BZA|bza
31615|NCT04002934|Bazedoxifene|bazedoxifene
31616|NCT04002934|Myelin Repair|myelin repair
31617|NCT04002934|Conbriza|conbriza
31618|NCT04002921|right colectomy|right colectomy
31619|NCT04002921|calcification|calcification
31620|NCT04002921|anastomotic leakage|anastomotic leakage
31621|NCT04002908|Infant Health|infant health
31622|NCT04002908|Low and Middle Income Countries [LMIC]|low and middle income countries [lmic]
31623|NCT04002908|Maternal Health|maternal health
31624|NCT04002908|Infant Feeding|infant feeding
31625|NCT04002908|Low Birthweight|low birthweight
31626|NCT04002843|jitter|jitter
31627|NCT04002843|single fiber EMG|single fiber emg
31628|NCT04002843|botulinum toxin|botulinum toxin
31629|NCT04002778|EUS-FNA|eus-fna
31630|NCT04002778|pancreatic solid lesions|pancreatic solid lesions
31631|NCT04002778|sample adequacy|sample adequacy
31632|NCT04002778|cytopathology|cytopathology
31633|NCT04002778|endosonography|endosonography
31634|NCT04002739|STEMI|stemi
31635|NCT04002739|NSTEMI|nstemi
31636|NCT04002739|Sleep Apnea|sleep apnea
31637|NCT04002739|OSA|osa
31638|NCT04002713|Anterolateral thigh (ALT)|anterolateral thigh (alt)
31639|NCT04002713|anteromedial thigh (AMT)|anteromedial thigh (amt)
31640|NCT04002713|free flap reconstruction|free flap reconstruction
31641|NCT04002713|microsurgery|microsurgery
31642|NCT04002713|head and neck cancer|head and neck cancer
31643|NCT04002713|outcomes|outcomes
31644|NCT04002661|Low libido|low libido
31645|NCT04002661|Erectile Dysfunction|erectile dysfunction
31646|NCT04002661|Sexual desire|sexual desire
31647|NCT04002635|frozen embryo transfer|frozen embryo transfer
31648|NCT04002609|bronchoscopy, NIRS|bronchoscopy, nirs
31649|NCT04002570|breast cancer|breast cancer
31650|NCT04002570|circulating bone marrow-derived cells|circulating bone marrow-derived cells
31651|NCT04002570|circulating immune cells|circulating immune cells
31652|NCT04002570|radiotherapy|radiotherapy
31653|NCT04002570|conservative treatment|conservative treatment
31654|NCT04002570|disease control|disease control
31655|NCT04002557|diebetes|diebetes
31656|NCT04002492|sarcopenia|sarcopenia
31657|NCT04002492|osteopenia|osteopenia
31658|NCT04002492|exercise|exercise
31659|NCT04002492|body weight training|body weight training
31660|NCT04002492|bone density|bone density
31661|NCT04002492|demyelination|demyelination
31662|NCT04002492|cognition|cognition
31663|NCT04002479|pancreatic cancer|pancreatic cancer
31664|NCT04002479|Unresectable Pancreatic Cancer|unresectable pancreatic cancer
31665|NCT04002479|Metastatic Pancreatic Cancer|metastatic pancreatic cancer
31666|NCT04002479|Pancreatic Adenocarcinoma|pancreatic adenocarcinoma
31667|NCT04002479|Pancreas Neoplasm|pancreas neoplasm
31668|NCT04002479|Alpha radiation|alpha radiation
31669|NCT04002479|Pancreas Cancer|pancreas cancer
31670|NCT04002479|Pancreas Metastases|pancreas metastases
31671|NCT04002453|OPAT|opat
31672|NCT04002453|infectious diseases|infectious diseases
31673|NCT04002453|implementation|implementation
31674|NCT04002440|Estimated Dry Weight|estimated dry weight
31675|NCT04002440|Peritoneal Dialysis|peritoneal dialysis
31676|NCT04002440|AMIA|amia
31677|NCT04002440|Sharesource|sharesource
31678|NCT04002440|CCPD|ccpd
31679|NCT04002440|Peritoneal Dialysis Cycler|peritoneal dialysis cycler
31680|NCT04002440|HomeChoice PRO|homechoice pro
31681|NCT04002414|Physical Activity|physical activity
31682|NCT04002414|In Vitro Fertilization|in vitro fertilization
31683|NCT04002414|Ovarian Stimulation|ovarian stimulation
31684|NCT04002414|Exercise|exercise
31685|NCT04002375|pectouteropexy|pectouteropexy
31686|NCT04002362|Asthma|asthma
31687|NCT04002362|Pediatrics|pediatrics
31688|NCT04002336|adherence|adherence
31689|NCT04002297|MCL, NHL|mcl, nhl
31690|NCT04002271|TIVA|tiva
31691|NCT04002271|total knee replacement|total knee replacement
31692|NCT04002271|post operative pain|post operative pain
31693|NCT04002271|acute pain|acute pain
31694|NCT04002271|anaesthesia|anaesthesia
31695|NCT04002245|vascular access|vascular access
31696|NCT04002245|skin antisepsis|skin antisepsis
31697|NCT04002245|cutaneous antisepsis|cutaneous antisepsis
31698|NCT04002206|Muscle Energy Technique|muscle energy technique
31699|NCT04002206|Post isometric relaxation technique.|post isometric relaxation technique.
31700|NCT04002193|Pleth variability index|pleth variability index
31701|NCT04002167|ADHD|adhd
31702|NCT04002167|Working memory|working memory
31703|NCT04002167|functional near infrared spectroscopy (fNIRS)|functional near infrared spectroscopy (fnirs)
31704|NCT04002167|magnetic resonance imaging (MRI)|magnetic resonance imaging (mri)
31705|NCT04002167|Neurofeedback|neurofeedback
31706|NCT04002167|Cognitive training|cognitive training
31707|NCT04002167|Neuromonitoring|neuromonitoring
31708|NCT04002154|HPV|hpv
31709|NCT04002141|Endometriosis|endometriosis
31710|NCT04002141|Letrozole|letrozole
31711|NCT04002128|tracheal colonization;|tracheal colonization;
31712|NCT04002128|Bacteria;|bacteria;
31713|NCT04002128|Survival|survival
31714|NCT04002128|Anesthesia, General;|anesthesia, general;
31715|NCT04002115|Clofarabine|clofarabine
31716|NCT04002115|Haploidentical stem cell transplantation|haploidentical stem cell transplantation
31717|NCT04002115|Non-remission AML|non-remission aml
31718|NCT04002102|Placebo|placebo
31719|NCT04002102|Open-Label|open-label
31720|NCT04002076|stroke|stroke
31721|NCT04002076|Robot-assisted Rehabilitation|robot-assisted rehabilitation
31722|NCT04002063|Depression|depression
31723|NCT04002063|OEF/OIF|oef/oif
31724|NCT04002063|Mobile Apps|mobile apps
31725|NCT04002063|Cognitive Behavioral Therapy|cognitive behavioral therapy
31726|NCT04002050|Resilience|resilience
31727|NCT04002050|Workplace Engagement|workplace engagement
31728|NCT04002050|Public Safety Personnel|public safety personnel
31729|NCT04002050|Stress Disorders|stress disorders
31730|NCT04002037|Trigger Finger|trigger finger
31731|NCT04002024|acne vulgaris|acne vulgaris
31732|NCT04002024|acne|acne
31733|NCT04002024|licochalcone A|licochalcone a
31734|NCT04002024|decanediol|decanediol
31735|NCT04002024|L-carnitine|l-carnitine
31736|NCT04002024|salicylic acid|salicylic acid
31737|NCT04002011|direct oral anticoagulant|direct oral anticoagulant
31738|NCT04002011|vitamin K antagonist|vitamin k antagonist
31739|NCT04002011|cardiac surgery|cardiac surgery
31740|NCT04002011|perioperative care|perioperative care
31741|NCT04001972|tobacco dependence treatment|tobacco dependence treatment
31742|NCT04001972|combined brief intervention|combined brief intervention
31743|NCT04001972|AWARD advice|award advice
31744|NCT04001972|active referral|active referral
31745|NCT04001972|nicotine replacement therapy|nicotine replacement therapy
400501|NCT01866592|Cardiovascular Disease|cardiovascular disease
31746|NCT04001972|information and communication technologies|information and communication technologies
31747|NCT04001959|Carostats|carostats
31748|NCT04001959|Clinical trial|clinical trial
31749|NCT04001959|Preventive dentistry|preventive dentistry
31750|NCT04001959|Preschoolers|preschoolers
31751|NCT04001946|Gastrostomy|gastrostomy
31752|NCT04001933|Pregnancy|pregnancy
31753|NCT04001933|Oral Health|oral health
31754|NCT04001933|Maternal Oral Health|maternal oral health
31755|NCT04001933|Infant Oral Health|infant oral health
31756|NCT04001894|Ticagrelor|ticagrelor
31757|NCT04001894|Clopidogrel|clopidogrel
31758|NCT04001894|Coronary artery disease|coronary artery disease
31759|NCT04001894|platelet function tests|platelet function tests
31760|NCT04001881|inferior vena cava|inferior vena cava
31761|NCT04001881|spinal anesthesia|spinal anesthesia
31762|NCT04001881|echocardiography|echocardiography
31763|NCT04001855|Atopic Dermatitis|atopic dermatitis
31764|NCT04001855|Eczema|eczema
31765|NCT04001842|Mandibular reconstruction|mandibular reconstruction
31766|NCT04001842|Mandibular regeneration|mandibular regeneration
31767|NCT04001842|Regenerative Medicine|regenerative medicine
31768|NCT04001842|Tissue Engineering|tissue engineering
31769|NCT04001842|Axial vascularization|axial vascularization
31770|NCT04001842|Arterio-venous loop|arterio-venous loop
31771|NCT04001803|Antiretroviral therapy, HIV infections, cabotegravir, rilpivirine, long-acting intramuscular injection,|antiretroviral therapy, hiv infections, cabotegravir, rilpivirine, long-acting intramuscular injection,
31772|NCT04001790|Autism Spectrum Disorder|autism spectrum disorder
31773|NCT04001790|Transition to Employment|transition to employment
31774|NCT04001790|Employment|employment
31775|NCT04001790|Project Search Plus ASD Supports|project search plus asd supports
31776|NCT04001764|Arterial Catheterization|arterial catheterization
31777|NCT04001764|Peripheral Ultrasonography|peripheral ultrasonography
31778|NCT04001751|breast cancer|breast cancer
31779|NCT04001751|hormonotherapy|hormonotherapy
31780|NCT04001751|osteoarticular pain|osteoarticular pain
31781|NCT04001751|yoga|yoga
31782|NCT04001751|therapeutic patient education|therapeutic patient education
31783|NCT04001738|Endovascular treatment|endovascular treatment
31784|NCT04001738|Large Vessel Occlusion|large vessel occlusion
31785|NCT04001725|Metformin|metformin
31786|NCT04001725|Dexamethasone|dexamethasone
31787|NCT04001725|Diabetes|diabetes
31788|NCT04001725|Glucocorticoids|glucocorticoids
31789|NCT04001725|Phase II|phase ii
31790|NCT04001725|Tumor|tumor
31791|NCT04001725|Immune system|immune system
31792|NCT04001725|Immunological Effects|immunological effects
31793|NCT04001725|Metabolic Effects|metabolic effects
31794|NCT04001725|Anticancer Effects|anticancer effects
31795|NCT04001725|Randomization|randomization
31796|NCT04001725|Quality of Life|quality of life
31797|NCT04001712|early caffeine preterm|early caffeine preterm
31798|NCT04001699|preoperative|preoperative
31799|NCT04001699|geriatric assessment|geriatric assessment
31800|NCT04001699|interprofessional team|interprofessional team
31801|NCT04001647|ER stress|er stress
31802|NCT04001647|Unfolded protein response|unfolded protein response
31803|NCT04001647|Vascular function|vascular function
31804|NCT04001647|Aging|aging
31805|NCT04001647|Obesity|obesity
31806|NCT04001647|TUDCA|tudca
31807|NCT04001595|LGMD2I|lgmd2i
31808|NCT04001595|LGMDR9|lgmdr9
31809|NCT04001595|Limb Girdle Muscular Dystrophy|limb girdle muscular dystrophy
31810|NCT04001595|Congenital Muscular Dystrophy|congenital muscular dystrophy
31811|NCT04001595|Muscle-Eye-Brain Disease|muscle-eye-brain disease
31812|NCT04001595|Walker-Warburg Syndrome|walker-warburg syndrome
31813|NCT04001595|FKRP gene mutation|fkrp gene mutation
31814|NCT04001582|FSHD|fshd
31815|NCT04001582|Facioscapulohumeral Muscular Dystrophy|facioscapulohumeral muscular dystrophy
31816|NCT04001582|Facioscapulohumeral Muscular Dystrophy Type 1|facioscapulohumeral muscular dystrophy type 1
31817|NCT04001582|Facioscapulohumeral Muscular Dystrophy Type 2|facioscapulohumeral muscular dystrophy type 2
31818|NCT04001582|Muscular Dystrophy|muscular dystrophy
31819|NCT04001543|head and neck squamous cell carcinoma (HNSCC)|head and neck squamous cell carcinoma (hnscc)
31820|NCT04001543|immunomodulatory nutrient|immunomodulatory nutrient
31821|NCT04001543|concomitant chemoradiotherapy|concomitant chemoradiotherapy
31822|NCT04001543|survival|survival
31823|NCT04001504|Unstable angina|unstable angina
31824|NCT04001504|Non-ST-Elevation Myocardial Infarction - NSTEMI|non-st-elevation myocardial infarction - nstemi
31825|NCT04001504|ST-Elevation Myocardial Infarction - STEMI|st-elevation myocardial infarction - stemi
31826|NCT04001504|Quadrivalent Influenza Vaccine - QIV|quadrivalent influenza vaccine - qiv
31827|NCT04001491|Inflammation|inflammation
31828|NCT04001491|Inflammatory syndromes|inflammatory syndromes
31829|NCT04001491|fever|fever
31830|NCT04001491|Tomography|tomography
31831|NCT04001491|Positron emission at 18F-FDG|positron emission at 18f-fdg
31832|NCT04001491|Elderly patients|elderly patients
31833|NCT04001491|Internal medicine|internal medicine
31834|NCT04001491|Pet-Scan|pet-scan
31835|NCT04001478|Oesophageal Cancer|oesophageal cancer
810750|NCT00206960|fMRI|fmri
43163|NCT03932773|CPT|cpt
31836|NCT04001478|Barretts Esophagus with Dysplasia|barretts esophagus with dysplasia
31837|NCT04001426|Overactive Bladder|overactive bladder
31838|NCT04001426|Women|women
31839|NCT04001426|Neuromodulation|neuromodulation
31840|NCT04001426|Bioelectronic Medicine|bioelectronic medicine
31841|NCT04001400|Gastroesophageal Reflux|gastroesophageal reflux
31842|NCT04001374|Thrombosis|thrombosis
31843|NCT04001374|Platelets|platelets
31844|NCT04001374|Platelet Aggregation|platelet aggregation
31845|NCT04001374|Blood Thrombogenicity|blood thrombogenicity
31846|NCT04001348|safety lancets|safety lancets
31847|NCT04001348|lancet|lancet
31848|NCT04001348|capillary blood|capillary blood
31849|NCT04001348|capillary blood sampling|capillary blood sampling
31850|NCT04001348|blood volume|blood volume
31851|NCT04001348|pain|pain
31852|NCT04001309|antimicrobial stewardship|antimicrobial stewardship
31853|NCT04001309|prospective audit and feedback|prospective audit and feedback
31854|NCT04001309|infectious diseases|infectious diseases
31855|NCT04001309|randomized trial|randomized trial
31856|NCT04001296|Behavior|behavior
31857|NCT04001296|Toothbrushing|toothbrushing
31858|NCT04001296|Toothpastes|toothpastes
31859|NCT04001296|Dental Caries|dental caries
31860|NCT04001296|Education, Dental|education, dental
31861|NCT04001270|LGI1 encephalitis|lgi1 encephalitis
31862|NCT04001270|Biomarkers|biomarkers
31863|NCT04001270|Cerebrospinal Fluid (CSF)|cerebrospinal fluid (csf)
31864|NCT04001270|Neurology|neurology
31865|NCT04001257|18F-FET PET|18f-fet pet
31866|NCT04001257|glioma|glioma
31867|NCT04001257|grading|grading
31868|NCT04001231|Pharmacokinetics|pharmacokinetics
31869|NCT04001231|Safety|safety
31870|NCT04001231|Tolerability|tolerability
31871|NCT04001231|exenatide once weekly|exenatide once weekly
31872|NCT04001231|Chinese|chinese
31873|NCT04001192|exercise|exercise
31874|NCT04001192|exercise therapy|exercise therapy
31875|NCT04001192|treadmill|treadmill
31876|NCT04001192|symptom threshold|symptom threshold
31877|NCT04001192|Postconcussion symptoms|postconcussion symptoms
31878|NCT04001179|Early diagnosis|early diagnosis
31879|NCT04001179|Mass spectrometry|mass spectrometry
31880|NCT04001179|Volatile Organic Compounds|volatile organic compounds
31881|NCT04001179|Metabolomics|metabolomics
31882|NCT04001179|Breath Tests|breath tests
31883|NCT04001179|Biomarkers|biomarkers
31884|NCT04001153|Hall Technique|hall technique
31885|NCT04001153|Primary Molar|primary molar
31886|NCT04001153|Vertical Dimension|vertical dimension
31887|NCT04001140|Emotion regulation|emotion regulation
31888|NCT04001140|Prevention program|prevention program
31889|NCT04001140|Adolescents|adolescents
31890|NCT04001140|Physiological measurements|physiological measurements
31891|NCT04001140|Internalizing problems|internalizing problems
31892|NCT04001140|Externalizing problems|externalizing problems
31893|NCT04001127|high intensity functional training|high intensity functional training
31894|NCT04001127|crossfit|crossfit
31895|NCT04001127|cancer survivors|cancer survivors
31896|NCT04001101|Solid tumor|solid tumor
31897|NCT04001101|Colorectal cancer|colorectal cancer
31898|NCT04001101|Unresectable or metastatic|unresectable or metastatic
31899|NCT04001088|Probiotics|probiotics
31900|NCT04001088|Menopausal symptoms|menopausal symptoms
31901|NCT04001088|Bone health|bone health
31902|NCT04001088|Vulvar and vaginal atrophy|vulvar and vaginal atrophy
31903|NCT04001088|Vaginal microflora|vaginal microflora
31904|NCT04001088|Anxiety|anxiety
31905|NCT04001088|Depression|depression
31906|NCT04001088|Urinary incontinence|urinary incontinence
31907|NCT04001088|Metabolic syndrome biomarkers|metabolic syndrome biomarkers
31908|NCT04001088|Sleep quality|sleep quality
31909|NCT04001088|Gut microflora|gut microflora
31910|NCT04001088|Bone resorption markers|bone resorption markers
31911|NCT04001088|Bone formation markers|bone formation markers
31912|NCT04001088|Bone Mineral Density (BMD)|bone mineral density (bmd)
31913|NCT04001088|Fracture risk assessment|fracture risk assessment
31914|NCT04001062|Metacarpal Shaft Fracture|metacarpal shaft fracture
31915|NCT04001023|advanced ovarian cancer|advanced ovarian cancer
31916|NCT04001023|EF5-PET/CT|ef5-pet/ct
31917|NCT04001023|hypoxia|hypoxia
31918|NCT04001010|cannabinoids|cannabinoids
31919|NCT04001010|palliative care|palliative care
31920|NCT04001010|QoL|qol
31921|NCT04000997|endotracheal tube|endotracheal tube
31922|NCT04000997|extubation|extubation
31923|NCT04000997|peak cough flow|peak cough flow
31924|NCT04000997|predictive value|predictive value
31925|NCT04000984|Mindfulness|mindfulness
31926|NCT04000984|Cognitive Rehabilitation|cognitive rehabilitation
31927|NCT04000971|Technology-enabled|technology-enabled
31928|NCT04000971|Engagement, caregiver|engagement, caregiver
31929|NCT04000971|Team-based|team-based
31930|NCT04000971|Integrated Care|integrated care
31931|NCT04000932|Carpal tunnel syndrome|carpal tunnel syndrome
31932|NCT04000932|Injection|injection
31933|NCT04000932|Platelet rich plasma|platelet rich plasma
43305|NCT03931941|CDI|cdi
31934|NCT04000906|pancreatic cancer|pancreatic cancer
31935|NCT04000906|oeso-gastric cancer|oeso-gastric cancer
31936|NCT04000906|epithelial ovarian cancer|epithelial ovarian cancer
31937|NCT04000906|primitive peritoneal mesothelioma|primitive peritoneal mesothelioma
31938|NCT04000880|Cancer survivor|cancer survivor
31939|NCT04000880|Lifestyle behaviors|lifestyle behaviors
31940|NCT04000880|Web-based intervention|web-based intervention
31941|NCT04000880|Diet|diet
31942|NCT04000880|Exercise|exercise
31943|NCT04000880|Weight Control|weight control
31944|NCT04000880|Physical Activity|physical activity
31945|NCT04000880|Distance Medicine|distance medicine
31946|NCT04000880|Rural|rural
31947|NCT04000880|Older|older
31948|NCT04000880|Minority|minority
31949|NCT04000880|African American|african american
31950|NCT04000867|diabetic foot pain|diabetic foot pain
31951|NCT04000867|diabetic foot neuropathy|diabetic foot neuropathy
31952|NCT04000867|diabetic foot numbness|diabetic foot numbness
31953|NCT04000854|Dental trauma|dental trauma
31954|NCT04000854|pulp necrosis|pulp necrosis
31955|NCT04000854|regenerative|regenerative
31956|NCT04000854|endodontics|endodontics
31957|NCT04000841|stress|stress
31958|NCT04000841|emotion regulation|emotion regulation
31959|NCT04000815|c type natriuretic peptide|c type natriuretic peptide
31960|NCT04000815|duration of menopause|duration of menopause
31961|NCT04000815|menstrual cycle|menstrual cycle
31962|NCT04000789|Diabetes Mellitus|diabetes mellitus
31963|NCT04000789|Proliferative Diabetic Retinopathy|proliferative diabetic retinopathy
31964|NCT04000789|Non-Proliferative Diabetic Retinopathy|non-proliferative diabetic retinopathy
31965|NCT04000789|Dry Eye Syndromes|dry eye syndromes
31966|NCT04000789|Sodium Hyaluronate|sodium hyaluronate
31967|NCT04000789|Vitamin A|vitamin a
31968|NCT04000789|Vitamin E|vitamin e
31969|NCT04000763|Bladder|bladder
31970|NCT04000750|Hypertrophy|hypertrophy
31971|NCT04000750|Intermittent Fasting|intermittent fasting
31972|NCT04000750|Time Restricted Eating|time restricted eating
31973|NCT04000750|Protein Signaling|protein signaling
31974|NCT04000750|Anabolic|anabolic
31975|NCT04000737|Adult Primary Hepatocellular Carcinoma|adult primary hepatocellular carcinoma
31976|NCT04000737|Advanced Adult Primary Liver Cancer|advanced adult primary liver cancer
31977|NCT04000737|Advanced Adult Hepatocellular Carcinoma|advanced adult hepatocellular carcinoma
31978|NCT04000737|BCLC Stage B Adult Hepatocellular Carcinoma|bclc stage b adult hepatocellular carcinoma
31979|NCT04000737|BCLC Stage C Adult Hepatocellular Carcinoma|bclc stage c adult hepatocellular carcinoma
31980|NCT04000737|Hepatitis B (+) Associated Advanced Hepatocellular Carcinoma|hepatitis b (+) associated advanced hepatocellular carcinoma
31981|NCT04000737|Child-Plough A Hepatocellular Carcinoma|child-plough a hepatocellular carcinoma
31982|NCT04000724|Text Messaging|text messaging
31983|NCT04000724|mHealth|mhealth
31984|NCT04000724|HIV|hiv
31985|NCT04000724|AIDS|aids
31986|NCT04000724|PrEP|prep
31987|NCT04000711|Fever and neutropenia|fever and neutropenia
31988|NCT04000711|Febrile neutropenia|febrile neutropenia
31989|NCT04000711|Cancer|cancer
31990|NCT04000711|Outpatient treatment|outpatient treatment
31991|NCT04000711|Children|children
31992|NCT04000685|low back pain|low back pain
31993|NCT04000685|exercise|exercise
31994|NCT04000685|cognitive|cognitive
31995|NCT04000685|aerobic|aerobic
31996|NCT04000685|yoga|yoga
31997|NCT04000672|Patient Specific Instrumentation|patient specific instrumentation
31998|NCT04000672|Randomized controlled trial|randomized controlled trial
31999|NCT04000672|High Tibial Osteotomy|high tibial osteotomy
32000|NCT04000659|Knee|knee
32001|NCT04000659|Cartilage|cartilage
32002|NCT04000646|anxiety, children|anxiety, children
32003|NCT04000568|Preterm Infant|preterm infant
32004|NCT04000568|Respiratory Distress Syndrome|respiratory distress syndrome
32005|NCT04000568|Non-invasive respiratory Support|non-invasive respiratory support
32006|NCT04000568|Neurally Adjust Respiratory Assist (NAVA)|neurally adjust respiratory assist (nava)
32007|NCT04000568|Nasal Intermittent Positive Pressure Ventilation|nasal intermittent positive pressure ventilation
32008|NCT04000555|prophylaxis|prophylaxis
32009|NCT04000529|TNO155, spartalizumab, ribociclib, checkpoint inhibitor, SHP2, PD-1, CDK4/6, NSCLC, CRC, HNSCC, KRAS, esophageal SCC, GIST|tno155, spartalizumab, ribociclib, checkpoint inhibitor, shp2, pd-1, cdk4/6, nsclc, crc, hnscc, kras, esophageal scc, gist
32010|NCT04000503|Human Papillomavirus DNA Tests|human papillomavirus dna tests
32011|NCT04000503|Visual inspection with acetic acid|visual inspection with acetic acid
32012|NCT04000503|Global Health|global health
32013|NCT04000503|Developing Countries|developing countries
32014|NCT04000503|Self-collection|self-collection
32015|NCT04000503|Cervical Cancer Screening|cervical cancer screening
32016|NCT04000490|Assessment|assessment
32017|NCT04000490|chest pain|chest pain
32018|NCT04000490|ACS predictive score|acs predictive score
32019|NCT04000490|physician's belief|physician's belief
32020|NCT04000477|Endocervical curettage|endocervical curettage
32021|NCT04000477|Kevorkian|kevorkian
32022|NCT04000477|Cytobrush|cytobrush
32023|NCT04000477|FCV|fcv
32024|NCT04000451|Copd Exacerbation Acute|copd exacerbation acute
32025|NCT04000451|oxygen|oxygen
32026|NCT04000451|oxyhydrogen|oxyhydrogen
32027|NCT04000438|labor induction|labor induction
32028|NCT04000438|cervical ripening|cervical ripening
32029|NCT04000425|Gastric Cancer|gastric cancer
32030|NCT04000425|Circulating Tumor DNA|circulating tumor dna
32031|NCT04000425|Minimal Residue Disease|minimal residue disease
32032|NCT04000425|Chemotherapy Response|chemotherapy response
32033|NCT04000412|electrical impedance|electrical impedance
32034|NCT04000412|cardiac radiofrequency ablation|cardiac radiofrequency ablation
32035|NCT04000386|Pitted keratolysis|pitted keratolysis
32036|NCT04000386|zinc oxide|zinc oxide
32037|NCT04000386|Foot Odor|foot odor
32038|NCT04000386|preventsion|preventsion
32039|NCT04000360|Exercise|exercise
32040|NCT04000347|benzoyl peroxide|benzoyl peroxide
32041|NCT04000347|Pitted keratolysis|pitted keratolysis
32042|NCT04000347|Foot Odor|foot odor
32043|NCT04000334|cardiac arrest|cardiac arrest
32044|NCT04000334|cerebral blood flow|cerebral blood flow
32045|NCT04000334|cerebral autoregulation|cerebral autoregulation
32046|NCT04000334|transcranial doppler|transcranial doppler
32047|NCT04000308|Analgesia|analgesia
32048|NCT04000308|Cesarean Section|cesarean section
32049|NCT04000308|Quadratus Lumborum Block type 2|quadratus lumborum block type 2
32050|NCT04000308|Wound Infiltration|wound infiltration
32051|NCT04000256|Spinal cord injuries|spinal cord injuries
32052|NCT04000256|Telerehabilitation|telerehabilitation
32053|NCT04000256|Qualitative|qualitative
32054|NCT04000230|Early Education Program|early education program
32055|NCT04000230|Developmental Delay|developmental delay
32056|NCT04000230|Behavior Management|behavior management
32057|NCT04000230|Social Emotional Development|social emotional development
32058|NCT04000230|Special Education|special education
32059|NCT04000204|Osteoarthritis|osteoarthritis
32060|NCT04000204|synovial fluid supplement|synovial fluid supplement
32061|NCT04000204|hyaluronic acid|hyaluronic acid
32062|NCT04000191|ice|ice
32063|NCT04000191|elective anorectal surgery|elective anorectal surgery
32064|NCT04000191|anesthesia care|anesthesia care
32065|NCT04000165|HbS polymerization|hbs polymerization
32066|NCT04000165|pyruvate kinase|pyruvate kinase
32067|NCT04000165|2,3- diphosphoglycerate|2,3- diphosphoglycerate
32068|NCT04000165|ATP in red blood cells|atp in red blood cells
32069|NCT04000165|acute sickle pain|acute sickle pain
32070|NCT04000152|Blastocyst|blastocyst
32071|NCT04000152|Non-invasive|non-invasive
32072|NCT04000152|PGT-A|pgt-a
32073|NCT04000152|Aneuploidy|aneuploidy
32074|NCT04000152|Spent culture medium|spent culture medium
32075|NCT04000152|Trophectoderm biopsy|trophectoderm biopsy
32076|NCT04000152|Sustained implantation|sustained implantation
32077|NCT04000152|Miscarriage|miscarriage
32078|NCT04000152|Livebirth|livebirth
32079|NCT04000139|bilberry|bilberry
32080|NCT04000139|anthocyanin|anthocyanin
32081|NCT04000139|anthocyanin-rich extract|anthocyanin-rich extract
32082|NCT04000139|ulcerative colitis|ulcerative colitis
32083|NCT04000126|lidocaine|lidocaine
32084|NCT04000126|intubation|intubation
32085|NCT04000126|pupillometry|pupillometry
32086|NCT04000126|hemodynamic response|hemodynamic response
32087|NCT04000126|pain|pain
32088|NCT04000126|reflex|reflex
32089|NCT04000126|pupillary monitoring|pupillary monitoring
32090|NCT04000126|intraoperative|intraoperative
32091|NCT04000126|analgesia|analgesia
32092|NCT04000126|general anesthesia|general anesthesia
32093|NCT04000113|menopause|menopause
32094|NCT04000113|insomnia|insomnia
32095|NCT04000113|sleep disorder|sleep disorder
32096|NCT04000100|Neostigmine|neostigmine
32097|NCT04000100|Bupivacaine|bupivacaine
32098|NCT04000100|Supraclavicular brachial plexus block|supraclavicular brachial plexus block
32099|NCT04000074|Social Determinants of Health|social determinants of health
32100|NCT04000074|High-Needs, High-Cost Populations|high-needs, high-cost populations
32101|NCT04000074|Case Management|case management
32102|NCT04000074|Social Prescribing|social prescribing
32103|NCT04000074|Linkage Services|linkage services
32104|NCT04000048|Low-grade diffuse glioma|low-grade diffuse glioma
32105|NCT04000048|DNA extraction|dna extraction
32106|NCT04000048|sequencing|sequencing
32107|NCT04000035|sickness absence|sickness absence
32108|NCT04000035|psychosocial work environment|psychosocial work environment
32109|NCT04000022|Major Depressive Disorder|major depressive disorder
32110|NCT04000022|rTMS|rtms
32111|NCT04000022|TBS|tbs
32112|NCT04000022|Theta Burst Stimulation|theta burst stimulation
32113|NCT04000022|Neuronavigation|neuronavigation
32114|NCT04000022|Non-Treatment Resistant|non-treatment resistant
32115|NCT04000022|Pharmaco-Naïve|pharmaco-naïve
32116|NCT03999996|Vaccine|vaccine
32117|NCT03999970|Cutaneous Leishmaniasis|cutaneous leishmaniasis
32118|NCT03999970|Controlled Human Infection Model|controlled human infection model
32119|NCT03999970|Sand Fly|sand fly
32120|NCT03999970|Human Challenge|human challenge
32121|NCT03999957|hospice|hospice
43543|NCT03930381|Asthma|asthma
32122|NCT03999957|pediatric|pediatric
32123|NCT03999905|Patient counseling|patient counseling
32124|NCT03999905|Mystery patient|mystery patient
32125|NCT03999905|Oral anticoagulant|oral anticoagulant
32126|NCT03999905|Pharmacist|pharmacist
32127|NCT03999905|Warfarin|warfarin
32128|NCT03999905|Adverse drug reaction|adverse drug reaction
32129|NCT03999905|Nigeria|nigeria
32130|NCT03999905|Community pharmacists|community pharmacists
32131|NCT03999866|airtraq|airtraq
32132|NCT03999866|c-mac|c-mac
32133|NCT03999866|d-blade|d-blade
32134|NCT03999866|mcgarth mac x-blade|mcgarth mac x-blade
32135|NCT03999866|prediction|prediction
32136|NCT03999866|difficult airway|difficult airway
32137|NCT03999853|Butyrate|butyrate
32138|NCT03999840|aHUS|ahus
32139|NCT03999840|cemdisiran|cemdisiran
32140|NCT03999840|synthetic RNA interference|synthetic rna interference
32141|NCT03999814|Infantile Neuroaxonal Dystrophy|infantile neuroaxonal dystrophy
32142|NCT03999814|INAD|inad
32143|NCT03999814|PLA2G6|pla2g6
32144|NCT03999801|gene therapy|gene therapy
32145|NCT03999801|wet AMD|wet amd
32146|NCT03999801|nAMD|namd
32147|NCT03999788|microRNA|microrna
32148|NCT03999788|Multiple Sclerosis|multiple sclerosis
32149|NCT03999788|synaptopathy|synaptopathy
32150|NCT03999788|lower limb spasticity|lower limb spasticity
32151|NCT03999788|transcranial magnetic stimulation|transcranial magnetic stimulation
32152|NCT03999788|repetitive TMS stimulation protocol|repetitive tms stimulation protocol
32153|NCT03999788|GLAST/EAAT1|glast/eaat1
32154|NCT03999788|single nucleotide polymorphisms|single nucleotide polymorphisms
32155|NCT03999788|Intermittent theta burst stimulation (iTBS)|intermittent theta burst stimulation (itbs)
32156|NCT03999775|Collagen peptides|collagen peptides
32157|NCT03999775|Bone turnover markers|bone turnover markers
32158|NCT03999775|Calcium supplement|calcium supplement
32159|NCT03999775|Postmenopausal women|postmenopausal women
32160|NCT03999736|tDCS|tdcs
32161|NCT03999736|fMRI|fmri
32162|NCT03999736|fear|fear
32163|NCT03999736|vigilance|vigilance
32164|NCT03999736|biomarkers|biomarkers
32165|NCT03999723|Vitamin C|vitamin c
32166|NCT03999723|Ascorbic acid|ascorbic acid
32167|NCT03999723|Azacitidine|azacitidine
32168|NCT03999723|Hypomethylating agents|hypomethylating agents
32169|NCT03999723|Randomized, Placebo-Controlled Trial|randomized, placebo-controlled trial
32170|NCT03999710|Lung Cancer|lung cancer
32171|NCT03999710|Non Small Cell Lung Cancer|non small cell lung cancer
32172|NCT03999710|Radiation therapy|radiation therapy
32173|NCT03999710|durvalumab|durvalumab
32174|NCT03999710|19-218|19-218
32175|NCT03999710|Memorial Sloan Kettering Cancer Center|memorial sloan kettering cancer center
32176|NCT03999684|Adenoid Cystic Carcinoma|adenoid cystic carcinoma
32177|NCT03999671|Effect, Nursing, Process, Functional, Patterns,health|effect, nursing, process, functional, patterns,health
32178|NCT03999658|ENKTL|enktl
32179|NCT03999658|DLBCL|dlbcl
32180|NCT03999658|PTCL|ptcl
32181|NCT03999658|cholangiocarcinoma|cholangiocarcinoma
32182|NCT03999658|gall bladder cancer|gall bladder cancer
32183|NCT03999658|relapsed|relapsed
32184|NCT03999658|refractory|refractory
32185|NCT03999658|T/NK-cell|t/nk-cell
32186|NCT03999658|NK/T-cell|nk/t-cell
32187|NCT03999658|peripheral T-cell|peripheral t-cell
32188|NCT03999658|PD-L1|pd-l1
32189|NCT03999658|anti-PD-L1 antibody|anti-pd-l1 antibody
32190|NCT03999645|Acute cholecystitis|acute cholecystitis
32191|NCT03999645|Early laparoscopic cholecystectomy|early laparoscopic cholecystectomy
32192|NCT03999645|Gallbladder disease|gallbladder disease
32193|NCT03999645|Late laparoscopic cholecystectomy|late laparoscopic cholecystectomy
32194|NCT03999632|Bariatric surgery|bariatric surgery
32195|NCT03999632|Sleeve gastrectomy|sleeve gastrectomy
32196|NCT03999632|Preoperative diet|preoperative diet
32197|NCT03999632|Hepatic steatosis|hepatic steatosis
32198|NCT03999632|Wolffia Globosa|wolffia globosa
32199|NCT03999632|Hyperglycemia|hyperglycemia
32200|NCT03999619|Pre-Literacy Skills|pre-literacy skills
32201|NCT03999580|Crohn|crohn
32202|NCT03999580|vitamin D|vitamin d
32203|NCT03999580|remission|remission
32204|NCT03999580|inflammation|inflammation
32205|NCT03999580|tolerance|tolerance
32206|NCT03999528|14-3-3η Protein|14-3-3η protein
32207|NCT03999515|Prostate|prostate
32208|NCT03999502|Endoscopy|endoscopy
32209|NCT03999502|Mini invasive|mini invasive
32210|NCT03999411|nicotine replacement therapy|nicotine replacement therapy
32211|NCT03999411|antiretroviral|antiretroviral
32212|NCT03999411|smartphone|smartphone
32213|NCT03999398|Saphenous Vein|saphenous vein
32214|NCT03999398|No-touch|no-touch
32215|NCT03999398|Percutaneous Coronary Intervention|percutaneous coronary intervention
32216|NCT03999385|Mindfulness|mindfulness
32217|NCT03999385|Mindful Self-compassion|mindful self-compassion
32218|NCT03999385|Self-compassion|self-compassion
32219|NCT03999385|Diabetes|diabetes
32220|NCT03999385|Self-care|self-care
32221|NCT03999346|Swiss Polytrauma Registry|swiss polytrauma registry
32222|NCT03999346|quality control|quality control
32223|NCT03999346|standardized identification procedures|standardized identification procedures
32224|NCT03999346|data capture|data capture
32225|NCT03999307|Orthodontic Tooth Movement Acceleration|orthodontic tooth movement acceleration
32226|NCT03999294|Music Therapy|music therapy
32227|NCT03999268|Psychological insulin resistance|psychological insulin resistance
32228|NCT03999268|Diabetes self-management|diabetes self-management
32229|NCT03999268|Mobile application|mobile application
32230|NCT03999242|nasal polyposis|nasal polyposis
32231|NCT03999242|rhinosinusitis|rhinosinusitis
32232|NCT03999242|Charcot Leyden Crystals|charcot leyden crystals
32233|NCT03999242|Eosinophils|eosinophils
32234|NCT03999229|S-Nitrosylation|s-nitrosylation
32235|NCT03999229|Tissue Oxygenation|tissue oxygenation
32236|NCT03999229|Anemia-induced tissue hypoxia|anemia-induced tissue hypoxia
32237|NCT03999229|Red blood cell Transfusion|red blood cell transfusion
32238|NCT03999216|diuretics|diuretics
32239|NCT03999164|neuroinflammation|neuroinflammation
32240|NCT03999164|activated microglia|activated microglia
32241|NCT03999164|TSPO|tspo
32242|NCT03999164|Traumatic Brain Injury|traumatic brain injury
32244|NCT03999164|Positron emission tomography|positron emission tomography
32245|NCT03999151|Exercise|exercise
32246|NCT03999151|Diet|diet
32247|NCT03999151|Lifestyle|lifestyle
32248|NCT03999151|Digital|digital
32249|NCT03999151|Text messaging|text messaging
32250|NCT03999151|Coach|coach
32251|NCT03999112|psychological therapy|psychological therapy
32252|NCT03999112|metacognitive reflection|metacognitive reflection
32253|NCT03999034|screening test|screening test
32254|NCT03999034|XO test|xo test
32255|NCT03998995|Immersive Virtual Reality (IVR)|immersive virtual reality (ivr)
32256|NCT03998995|Patient-Centred Design|patient-centred design
32257|NCT03998995|Upper Limb Injury|upper limb injury
32258|NCT03998995|Children Rehabilitation|children rehabilitation
32259|NCT03998982|ITP；glycyrrhetinic acid；dexamethasone|itp；glycyrrhetinic acid；dexamethasone
32260|NCT03998969|Gastroesophageal Reflux|gastroesophageal reflux
32261|NCT03998969|Esophagitis, Peptic|esophagitis, peptic
32262|NCT03998956|catheter ablation|catheter ablation
32263|NCT03998930|Disorders of consciousness,|disorders of consciousness,
32264|NCT03998930|Brain Computer Interface|brain computer interface
32265|NCT03998930|P300|p300
32266|NCT03998930|Motor imagery|motor imagery
32267|NCT03998917|Chronic Kidney Failure|chronic kidney failure
32268|NCT03998917|Fatigue|fatigue
32269|NCT03998917|Adapted Physical Activity|adapted physical activity
32270|NCT03998878|Weight Loss|weight loss
32271|NCT03998878|Diet Modification|diet modification
32272|NCT03998878|Body Weight|body weight
32273|NCT03998878|Body Weight Changes|body weight changes
32274|NCT03998878|Ketogenic diet|ketogenic diet
32275|NCT03998878|Diet, Carbohydrate-Restricted|diet, carbohydrate-restricted
32276|NCT03998878|Fasting|fasting
32277|NCT03998878|Intermittent Fasting|intermittent fasting
32278|NCT03998878|Hunger training|hunger training
32279|NCT03998865|Implant-supported Provisional Abutment|implant-supported provisional abutment
32280|NCT03998865|Poly-ether-ether-ketone|poly-ether-ether-ketone
32281|NCT03998865|Titanium|titanium
32282|NCT03998865|Bacterial Microbiota|bacterial microbiota
32283|NCT03998865|Antimicrobial Resistance Genes|antimicrobial resistance genes
32284|NCT03998852|Apathy|apathy
32285|NCT03998852|Stroke|stroke
32286|NCT03998852|Cholinergic neurotransmission|cholinergic neurotransmission
32287|NCT03998852|Dopaminergic neurotransmission|dopaminergic neurotransmission
32288|NCT03998839|drug resistance; Sulfadoxine-pyrimethamine|drug resistance; sulfadoxine-pyrimethamine
32289|NCT03998826|Piroxicam|piroxicam
32290|NCT03998826|Postendodontic pain|postendodontic pain
32291|NCT03998826|analgesic intake|analgesic intake
32292|NCT03998800|Endurance performance|endurance performance
32293|NCT03998800|Mitochondrial function|mitochondrial function
32294|NCT03998800|L-arginine|l-arginine
32295|NCT03998800|L-citrulline|l-citrulline
32296|NCT03998800|Healthy males|healthy males
32297|NCT03998787|Parkinson's disease|parkinson's disease
32298|NCT03998787|Neurophysiology|neurophysiology
32299|NCT03998774|Nitrous oxide|nitrous oxide
32300|NCT03998774|Conscious sedation|conscious sedation
32301|NCT03998774|Paediatric dentistry|paediatric dentistry
32302|NCT03998761|FET|fet
32303|NCT03998761|Micronized Progesterone|micronized progesterone
32304|NCT03998761|Dydrogesterone|dydrogesterone
32305|NCT03998696|Locally advanced|locally advanced
32306|NCT03998696|Head and Neck Cancer|head and neck cancer
32307|NCT03998696|Concurrent|concurrent
32308|NCT03998696|Weekly Cisplatin|weekly cisplatin
32309|NCT03998696|Three weekly Cisplatin|three weekly cisplatin
32310|NCT03998696|Radiotherapy|radiotherapy
32311|NCT03998670|Prism|prism
32312|NCT03998618|psychotherapy|psychotherapy
32313|NCT03998618|fatigue|fatigue
32314|NCT03998618|quality of life|quality of life
32315|NCT03998605|intellectual disabilities|intellectual disabilities
32316|NCT03998605|abuse|abuse
32321|NCT03998566|Radiotherapy|radiotherapy
32323|NCT03998566|SBRT|sbrt
32324|NCT03998553|OOCYTE ACTIVATION|oocyte activation
32325|NCT03998553|IN VITRO MATURATION|in vitro maturation
32326|NCT03998553|OOCYTE RETRIEVAL|oocyte retrieval
32327|NCT03998553|DONNOR|donnor
32328|NCT03998553|hMG-HP|hmg-hp
32329|NCT03998540|titine|titine
32330|NCT03998540|western blot|western blot
32331|NCT03998527|Respiration|respiration
32332|NCT03998527|Motor control|motor control
32333|NCT03998514|Fatty Liver Disease|fatty liver disease
32334|NCT03998514|Liver Disease|liver disease
32335|NCT03998514|Fatty Liver|fatty liver
32336|NCT03998514|Nonalcoholic Liver|nonalcoholic liver
32337|NCT03998488|FMT|fmt
32338|NCT03998488|Fecal Microbiota Transplantation|fecal microbiota transplantation
32339|NCT03998488|Inflammatory Bowel Diseases|inflammatory bowel diseases
32340|NCT03998475|Transition|transition
32341|NCT03998475|Young Adult|young adult
32342|NCT03998462|Mindfulness|mindfulness
32343|NCT03998462|Parkinson's disease|parkinson's disease
32344|NCT03998462|Intervention|intervention
32345|NCT03998410|ADHF Dyspnea ED|adhf dyspnea ed
32346|NCT03998397|blood alcohol concentration|blood alcohol concentration
32347|NCT03998397|Emergency Department|emergency department
32348|NCT03998397|Alcohol use disorders|alcohol use disorders
32349|NCT03998371|Urothelial Carcinoma|urothelial carcinoma
32350|NCT03998371|diagnosis|diagnosis
32351|NCT03998371|Chromosomal Aneuploidy Detection|chromosomal aneuploidy detection
32352|NCT03998371|marker|marker
32353|NCT03998371|urine|urine
32359|NCT03998332|LCNEC-Large cell neuroendocrine carcinoma|lcnec-large cell neuroendocrine carcinoma
32360|NCT03998332|Lung cancer|lung cancer
32361|NCT03998319|STEMI|stemi
32362|NCT03998319|IMR|imr
32363|NCT03998319|microcirculation|microcirculation
32364|NCT03998319|microvascular obstruction|microvascular obstruction
32365|NCT03998319|myocardial infarction|myocardial infarction
32366|NCT03998319|physiology|physiology
32367|NCT03998319|angioplasty|angioplasty
32368|NCT03998319|PCI|pci
32369|NCT03998319|thrombolysis treatment|thrombolysis treatment
32370|NCT03998319|thrombolysis|thrombolysis
32371|NCT03998280|fatigue ,deep neck flexor|fatigue ,deep neck flexor
32372|NCT03998267|mobile health|mobile health
32373|NCT03998267|m-health|m-health
32374|NCT03998241|patellofemoral pain|patellofemoral pain
32375|NCT03998241|joint position sense|joint position sense
32376|NCT03998241|movement analysis|movement analysis
32377|NCT03998202|Colorectal Cancer|colorectal cancer
32378|NCT03998202|Myopenia|myopenia
32379|NCT03998202|Sarcopenia|sarcopenia
32380|NCT03998202|Chemotherapy|chemotherapy
32381|NCT03998202|Geriatric-Oncology|geriatric-oncology
32382|NCT03998176|Substance use|substance use
32383|NCT03998163|Hemodialysis|hemodialysis
32384|NCT03998163|Pruritus|pruritus
32385|NCT03998163|Uremic Pruritus|uremic pruritus
32386|NCT03998163|Dialysis|dialysis
32387|NCT03998163|CR845|cr845
32388|NCT03998163|Chronic Itch|chronic itch
32390|NCT03998163|CKD-associated pruritus|ckd-associated pruritus
32391|NCT03998163|CKD-aP|ckd-ap
32392|NCT03998163|ESRD (end stage renal disease)|esrd (end stage renal disease)
32393|NCT03998163|difelikefalin|difelikefalin
32394|NCT03998163|Itch|itch
32395|NCT03998163|Itching|itching
32396|NCT03998163|KALM|kalm
32397|NCT03998163|Chronic Kidney Disease|chronic kidney disease
32398|NCT03998163|Kidney failure, chronic|kidney failure, chronic
32399|NCT03998163|Kidney dysfunction|kidney dysfunction
32400|NCT03998163|Generalized pruritus|generalized pruritus
32401|NCT03998150|BPH|bph
32402|NCT03998150|enucleation|enucleation
32403|NCT03998150|Prostate|prostate
32404|NCT03998150|LUTS|luts
32405|NCT03998150|IPSS|ipss
32406|NCT03998150|quality of life|quality of life
32407|NCT03998150|Large prostate|large prostate
32408|NCT03998137|Ankle Fusions|ankle fusions
32409|NCT03998137|AUGMENT® Injectable Bone Graft|augment® injectable bone graft
32410|NCT03998137|Autologous Bone Graft|autologous bone graft
32411|NCT03998137|arthritis|arthritis
32412|NCT03998137|ankle pain|ankle pain
32413|NCT03998137|foot pain|foot pain
32414|NCT03998137|hindfoot fracture|hindfoot fracture
32415|NCT03998137|ankle fracture|ankle fracture
32416|NCT03998111|Glucose|glucose
32417|NCT03998111|Genetic variation|genetic variation
32418|NCT03998111|CHC22|chc22
32419|NCT03998111|CLTCL1|cltcl1
32420|NCT03998098|Blood Pressure|blood pressure
32421|NCT03998098|SPO2|spo2
32422|NCT03998098|Oxygen Saturation|oxygen saturation
32423|NCT03998098|Respiratory Rate|respiratory rate
32424|NCT03998098|Pulse|pulse
32425|NCT03998098|Breathing Rate|breathing rate
32426|NCT03998098|Heart Rate|heart rate
32427|NCT03998072|psychology|psychology
32428|NCT03998072|cognitive analytic therapy|cognitive analytic therapy
32429|NCT03998059|Thrombocytopenia|thrombocytopenia
32430|NCT03998059|splenectomy|splenectomy
32431|NCT03998046|overweight|overweight
32432|NCT03998046|obesity|obesity
32433|NCT03998046|prediabetes|prediabetes
32434|NCT03998046|type 2 diabetes|type 2 diabetes
32435|NCT03998046|hypertension|hypertension
32436|NCT03998046|dyslipidemia|dyslipidemia
32437|NCT03998046|cardiovascular risk factor|cardiovascular risk factor
32438|NCT03998046|adult|adult
32439|NCT03998046|primary care|primary care
32440|NCT03998033|Hepatocellular Carcinoma|hepatocellular carcinoma
32442|NCT03998033|Advanced HCC|advanced hcc
32443|NCT03998033|Late-Stage HCC|late-stage hcc
32444|NCT03998033|Liver Cancer|liver cancer
32445|NCT03998033|Liver Neoplasm|liver neoplasm
32446|NCT03998033|Metastatic Liver Cancer|metastatic liver cancer
32447|NCT03998033|Metastatic HCC|metastatic hcc
32448|NCT03998033|T-cell therapy|t-cell therapy
32449|NCT03998033|Immunotherapy|immunotherapy
32450|NCT03997981|CIPN|cipn
32451|NCT03997968|Oral RAD51-inhibitor; refractory; B-cell; solid tumor|oral rad51-inhibitor; refractory; b-cell; solid tumor
32452|NCT03997968|DNA Damage Repair inhibitor|dna damage repair inhibitor
32453|NCT03997968|cancer|cancer
32454|NCT03997942|burn, physiotherapy|burn, physiotherapy
32455|NCT03997916|Belun Ring|belun ring
32456|NCT03997916|pulse oximeter|pulse oximeter
32457|NCT03997916|obstructive sleep apnea|obstructive sleep apnea
32458|NCT03997890|Extended depth of focus|extended depth of focus
32459|NCT03997890|Multifocal intraocular lens|multifocal intraocular lens
32460|NCT03997890|Presbyopia|presbyopia
32461|NCT03997890|Cataract surgery|cataract surgery
32462|NCT03997877|sleep apnea syndrome|sleep apnea syndrome
32463|NCT03997877|physical activity|physical activity
32464|NCT03997877|mediterranean diet|mediterranean diet
32465|NCT03997877|metabolism|metabolism
32466|NCT03997877|impact on sleep|impact on sleep
32467|NCT03997864|Sexual Assault|sexual assault
32468|NCT03997864|Trauma|trauma
32469|NCT03997864|prevention|prevention
32470|NCT03997799|lung cancer|lung cancer
32471|NCT03997799|mediastinum|mediastinum
32472|NCT03997799|pulmonary resection|pulmonary resection
32473|NCT03997773|Gestational Diabetes|gestational diabetes
32474|NCT03997773|Type 2 Diabetes|type 2 diabetes
32475|NCT03997773|Family Intervention|family intervention
32476|NCT03997773|Denmark|denmark
32477|NCT03997773|Health Promotion|health promotion
32478|NCT03997773|Postpartum Intervention|postpartum intervention
32479|NCT03997773|Quality of Life|quality of life
32480|NCT03997773|Wellbeing|wellbeing
32481|NCT03997747|genomic biomarkers|genomic biomarkers
32482|NCT03997747|famitinib|famitinib
32483|NCT03997747|camrelizumab|camrelizumab
32484|NCT03997747|tumor mutation burden|tumor mutation burden
32485|NCT03997747|PD-L1 expression|pd-l1 expression
32486|NCT03997747|Tcell-inflamed gene expression profile (GEP)|tcell-inflamed gene expression profile (gep)
32487|NCT03997721|emergency laparotomy|emergency laparotomy
32488|NCT03997721|ileus|ileus
32489|NCT03997721|perforated ulcer|perforated ulcer
32490|NCT03997721|intestinal perforation|intestinal perforation
32491|NCT03997721|perioperative fluid management|perioperative fluid management
32492|NCT03997721|pathophysiology|pathophysiology
32493|NCT03997721|fluid overload|fluid overload
32494|NCT03997708|IBS|ibs
32495|NCT03997708|Quality of life|quality of life
32496|NCT03997708|FODMAP|fodmap
32497|NCT03997708|Mediterranean Diet|mediterranean diet
32498|NCT03997708|Nutrition|nutrition
32499|NCT03997695|Fibromyalgia|fibromyalgia
32500|NCT03997695|Exercise|exercise
32501|NCT03997695|Kinesio Taping|kinesio taping
32502|NCT03997643|Radiation Therapy|radiation therapy
32503|NCT03997643|Oral Cavity Squamous Cell Carcinoma|oral cavity squamous cell carcinoma
32504|NCT03997643|Randomized Trial|randomized trial
32505|NCT03997591|eating|eating
32506|NCT03997591|upper limb|upper limb
32507|NCT03997591|reeducation|reeducation
32508|NCT03997526|3C Patch|3c patch
32509|NCT03997526|Reapplix|reapplix
32510|NCT03997526|LeucoPatch|leucopatch
32511|NCT03997513|pulmonary disease, chronic obstructive|pulmonary disease, chronic obstructive
32512|NCT03997513|pulmonary rehabilitation|pulmonary rehabilitation
32513|NCT03997513|muscle atrophy|muscle atrophy
32514|NCT03997500|Norepinephrine|norepinephrine
32515|NCT03997500|Hypotension|hypotension
32516|NCT03997500|Inferior Vena Cava Collapsibility Index|inferior vena cava collapsibility index
32517|NCT03997500|Cesarean Delivery|cesarean delivery
32518|NCT03997461|Blood Pressure|blood pressure
32519|NCT03997409|Low Carbohydrate Diet|low carbohydrate diet
32520|NCT03997409|Standard Carbohydrate Diet|standard carbohydrate diet
32521|NCT03997396|gestational diabetes mellitus|gestational diabetes mellitus
32522|NCT03997396|children|children
32523|NCT03997396|neuropsychological|neuropsychological
32524|NCT03997396|physique growth|physique growth
32525|NCT03997383|RNAi therapeutic|rnai therapeutic
32526|NCT03997383|Transthyretin|transthyretin
32527|NCT03997383|TTR|ttr
32528|NCT03997383|Amyloidosis|amyloidosis
32529|NCT03997383|Cardiomyopathy|cardiomyopathy
32530|NCT03997383|ATTR|attr
32531|NCT03997344|posttraumatic stress disorders|posttraumatic stress disorders
32532|NCT03997344|randomized controlled trial|randomized controlled trial
32533|NCT03997344|pilot study|pilot study
32534|NCT03997344|feasibility|feasibility
32535|NCT03997344|nature|nature
32536|NCT03997344|physical activity|physical activity
32537|NCT03997318|Urinary Incontinence|urinary incontinence
32538|NCT03997318|Urinary Stress Incontinence|urinary stress incontinence
32539|NCT03997318|Lower Urinary Tract Symptoms|lower urinary tract symptoms
32540|NCT03997318|Urinary Bladder|urinary bladder
32541|NCT03997318|Urinary Tract Diseases|urinary tract diseases
32542|NCT03997318|Bladder|bladder
32543|NCT03997318|Urinary Leak|urinary leak
32544|NCT03997318|Urine Leak|urine leak
32545|NCT03997318|Bladder Leak|bladder leak
32546|NCT03997318|Urethra|urethra
32547|NCT03997318|Urethral Spincter|urethral spincter
32548|NCT03997305|Mitral Regurgitation|mitral regurgitation
32549|NCT03997305|TMVR|tmvr
32550|NCT03997305|Functional Regurgitation|functional regurgitation
32551|NCT03997305|Degenerative Regurgitation|degenerative regurgitation
32552|NCT03997305|Transcathether Mitral Valve Replacement|transcathether mitral valve replacement
32553|NCT03997305|Primary Regurgitation|primary regurgitation
32554|NCT03997305|Secondary Regurgitation|secondary regurgitation
32555|NCT03997292|alteplase; urokinase; intravenous thrombolysis|alteplase; urokinase; intravenous thrombolysis
32556|NCT03997279|Helicobacter Pylori|helicobacter pylori
32557|NCT03997279|Saccharomyces boulardi|saccharomyces boulardi
32558|NCT03997279|Eradication therapy|eradication therapy
32559|NCT03997266|premature birth|premature birth
32560|NCT03997266|human microbiome|human microbiome
32561|NCT03997266|antibiotics|antibiotics
32562|NCT03997253|organ transplantation, graft, biological collection.|organ transplantation, graft, biological collection.
32563|NCT03997201|Ventricular|ventricular
32564|NCT03997201|Tachycardia|tachycardia
32565|NCT03997201|Ischaemic|ischaemic
32566|NCT03997201|Mapping|mapping
32567|NCT03997201|Ablation|ablation
32568|NCT03997175|biodiversity intervention|biodiversity intervention
32569|NCT03997175|sand box|sand box
32570|NCT03997175|guidance|guidance
32571|NCT03997149|Trier Social Stress Test|trier social stress test
32572|NCT03997123|Breast Cancer;|breast cancer;
32573|NCT03997123|Triple-negative Breast Cancer|triple-negative breast cancer
32574|NCT03997110|Cervical Cancer|cervical cancer
32575|NCT03997110|Palliative treatment|palliative treatment
32576|NCT03997110|Radiation Therapy|radiation therapy
32577|NCT03997097|Congenital heart defect|congenital heart defect
32578|NCT03997097|single ventricle|single ventricle
32579|NCT03997097|Pulmonary hypertension|pulmonary hypertension
32580|NCT03997097|sildenafil|sildenafil
32581|NCT03997097|pulmonary vasodilator|pulmonary vasodilator
32582|NCT03997097|Eexercise capacity|eexercise capacity
32583|NCT03997071|ACL repair|acl repair
32584|NCT03997071|Internal Brace Ligament Augmentation|internal brace ligament augmentation
32585|NCT03997071|ACL reconstruction|acl reconstruction
32586|NCT03997071|Anterior Cruciate Ligament Rupture|anterior cruciate ligament rupture
32587|NCT03997045|Pregnancy|pregnancy
32588|NCT03997045|Physical exercise|physical exercise
32589|NCT03997045|Urinary incontinence|urinary incontinence
32590|NCT03997006|Atropine|atropine
32591|NCT03997006|Neostigmine|neostigmine
32592|NCT03997006|Post-dural puncture headache|post-dural puncture headache
32593|NCT03997006|Spinal anesthesia|spinal anesthesia
32594|NCT03997006|Theophylline|theophylline
32595|NCT03996993|prostate cancer|prostate cancer
32596|NCT03996993|Axumin|axumin
32597|NCT03996980|Low back pain|low back pain
32598|NCT03996980|custom-made foot orthoses|custom-made foot orthoses
32599|NCT03996980|Foot|foot
32600|NCT03996980|pronation|pronation
32601|NCT03996980|posture|posture
32602|NCT03996967|Biosignature proteins|biosignature proteins
32603|NCT03996967|Luminex®-based immunoassays|luminex®-based immunoassays
32604|NCT03996967|Point-of-care test|point-of-care test
32605|NCT03996967|Children|children
32606|NCT03996967|Sub-Saharan Africa|sub-saharan africa
32607|NCT03996967|Diagnostic Biomarkers|diagnostic biomarkers
32608|NCT03996967|Prognostic Biomarkers|prognostic biomarkers
32609|NCT03996967|Mediators of Inflammation|mediators of inflammation
32610|NCT03996941|PrEP|prep
32611|NCT03996941|Community setting|community setting
32612|NCT03996941|point of care|point of care
32613|NCT03996928|Epicondylitis|epicondylitis
32614|NCT03996928|Tennis elbow|tennis elbow
32615|NCT03996928|Eccentric exercise|eccentric exercise
32616|NCT03996915|photodynamic therapy|photodynamic therapy
32617|NCT03996915|periodontal disease|periodontal disease
32618|NCT03996915|randomized controlled clinical study|randomized controlled clinical study
32619|NCT03996902|Chronic Pain|chronic pain
32620|NCT03996902|Tobacco|tobacco
32621|NCT03996902|Smoking|smoking
32622|NCT03996902|Smoking cessation|smoking cessation
32623|NCT03996902|Motivation|motivation
32624|NCT03996876|Attention Bias Modification|attention bias modification
32625|NCT03996876|PTSD|ptsd
32626|NCT03996876|Digital Health|digital health
32627|NCT03996876|Alcohol Use Disorder|alcohol use disorder
32628|NCT03996863|Nausea|nausea
32629|NCT03996863|Chemotherapy|chemotherapy
32630|NCT03996863|cisplatin|cisplatin
32631|NCT03996863|Emesis|emesis
32632|NCT03996837|Platelet rich plasma|platelet rich plasma
32633|NCT03996837|Recurrent implantation failure|recurrent implantation failure
32634|NCT03996837|Infertility|infertility
32635|NCT03996837|Assisted reproduction technology|assisted reproduction technology
32636|NCT03996798|vocational rehabilitation|vocational rehabilitation
32637|NCT03996798|back-to-work|back-to-work
32638|NCT03996798|social participation|social participation
32639|NCT03996798|disability case manager|disability case manager
32640|NCT03996785|Clinical depression|clinical depression
32641|NCT03996785|Stress|stress
32642|NCT03996785|Group-walking|group-walking
32643|NCT03996785|Walking condition (nature vs urban)|walking condition (nature vs urban)
32644|NCT03996772|Atrial fibrillation|atrial fibrillation
32645|NCT03996772|Arrhythmias|arrhythmias
32646|NCT03996772|Cardiac|cardiac
32647|NCT03996772|Cerebral Hemorrhage|cerebral hemorrhage
32648|NCT03996772|Brain haemorrhage|brain haemorrhage
32649|NCT03996772|Intracerebral hemorrhage|intracerebral hemorrhage
32650|NCT03996772|Cerebral haemorrhage|cerebral haemorrhage
32651|NCT03996772|Basal ganglia haemorrhage|basal ganglia haemorrhage
32652|NCT03996772|Putaminal haemorrhage|putaminal haemorrhage
32653|NCT03996772|Anticoagulants|anticoagulants
32654|NCT03996772|Oral anticoagulant|oral anticoagulant
32655|NCT03996772|Direct oral anticoagulant|direct oral anticoagulant
32656|NCT03996772|New oral anticoagulant|new oral anticoagulant
32657|NCT03996772|Factor Xa inhibitors|factor xa inhibitors
32658|NCT03996772|Direct thrombin inhibitor|direct thrombin inhibitor
32659|NCT03996772|Dabigatran|dabigatran
32660|NCT03996772|Apixaban|apixaban
32661|NCT03996772|Rivaroxaban|rivaroxaban
32662|NCT03996772|Edoxaban|edoxaban
32663|NCT03996772|DOAC|doac
32664|NCT03996772|NOAC|noac
32665|NCT03996772|Intracerebral haemorrhage|intracerebral haemorrhage
32666|NCT03996772|Brain hemorrhage|brain hemorrhage
32667|NCT03996759|Sepsis|sepsis
32668|NCT03996759|metabolomics|metabolomics
32669|NCT03996759|biomarker|biomarker
32670|NCT03996759|prediction|prediction
32671|NCT03996759|clinical data analysis|clinical data analysis
32672|NCT03996746|Klotho|klotho
32673|NCT03996746|Cardiovascular Calcification|cardiovascular calcification
32674|NCT03996733|Training|training
32675|NCT03996733|Education|education
32676|NCT03996733|Homemade|homemade
32677|NCT03996733|Model|model
32678|NCT03996733|Central Venous Catheterization|central venous catheterization
32679|NCT03996733|Ultrasound Guidance|ultrasound guidance
32680|NCT03996720|metabolomics|metabolomics
32681|NCT03996720|biomarkers|biomarkers
32682|NCT03996720|inflammatory mediator profile|inflammatory mediator profile
32683|NCT03996720|MODS|mods
32684|NCT03996720|predictive model|predictive model
32685|NCT03996707|Ankle surgery|ankle surgery
32686|NCT03996707|Foot surgery|foot surgery
32687|NCT03996694|Chronic Pain|chronic pain
32688|NCT03996694|Ventilatory Response to Hypercapnia (VRH)|ventilatory response to hypercapnia (vrh)
32689|NCT03996681|Transarterial Chemoembolization|transarterial chemoembolization
32690|NCT03996681|Methylcantharidimide|methylcantharidimide
32691|NCT03996681|Large and unresectable HCC|large and unresectable hcc
32692|NCT03996642|active|active
32693|NCT03996642|cancer|cancer
32694|NCT03996642|avatar|avatar
32695|NCT03996642|life-limiting|life-limiting
32696|NCT03996642|palliative care|palliative care
32697|NCT03996629|pharmacist-managed anticoagulation|pharmacist-managed anticoagulation
32698|NCT03996629|warfarin|warfarin
32699|NCT03996629|acenocoumarol|acenocoumarol
32700|NCT03996616|Cardiac Arrest|cardiac arrest
32701|NCT03996616|Cardiopulmonary Resuscitation|cardiopulmonary resuscitation
32702|NCT03996616|Head-up position|head-up position
32703|NCT03996603|Genitourinary Syndrome of Menopause|genitourinary syndrome of menopause
32704|NCT03996603|Vaginal Atrophy|vaginal atrophy
32705|NCT03996603|Vaginal Estrogen Therapy|vaginal estrogen therapy
32706|NCT03996603|Inflammatory Response|inflammatory response
32707|NCT03996603|Microbial Colonization|microbial colonization
32708|NCT03996603|Urinary Microbiome|urinary microbiome
32709|NCT03996603|Vaginal Microbiome|vaginal microbiome
32710|NCT03996603|Rectal Microbiome|rectal microbiome
32711|NCT03996603|Conjugated Estrogen Cream|conjugated estrogen cream
32712|NCT03996590|Difficult Asthma|difficult asthma
32713|NCT03996590|Severe Asthma|severe asthma
32714|NCT03996577|lidocaine propofol ercp|lidocaine propofol ercp
32715|NCT03996564|Battlefield Acupuncture|battlefield acupuncture
32716|NCT03996564|Auricular Acupuncture|auricular acupuncture
32717|NCT03996564|Complementary Alternative Medicine|complementary alternative medicine
32718|NCT03996564|Military, Service Members|military, service members
32719|NCT03996564|Emergency Medicine|emergency medicine
32720|NCT03996564|Back Pain|back pain
32721|NCT03996564|Acute Back Pain|acute back pain
32726|NCT03996551|behavior change techniques|behavior change techniques
32727|NCT03996551|dietary advice|dietary advice
32728|NCT03996551|physical activity advice|physical activity advice
32729|NCT03996525|unilateral facial nerve palsy|unilateral facial nerve palsy
32730|NCT03996525|facial nerve palsy|facial nerve palsy
32731|NCT03996525|facial palsy|facial palsy
32732|NCT03996525|facial paralysis|facial paralysis
32733|NCT03996525|cross facial nerve graft|cross facial nerve graft
32734|NCT03996525|CFNG|cfng
32735|NCT03996525|peripheral nerve stimulation|peripheral nerve stimulation
32736|NCT03996525|electrical stimulation|electrical stimulation
32737|NCT03996525|e-stim|e-stim
32738|NCT03996525|free muscle transfer|free muscle transfer
32739|NCT03996525|FMT|fmt
32740|NCT03996486|Coagulation Factor VIII (FVIII)|coagulation factor viii (fviii)
32741|NCT03996486|Coagulation Factor IX (FIX)|coagulation factor ix (fix)
32742|NCT03996486|Anti-tissue factor pathway inhibitor (aTFPI)|anti-tissue factor pathway inhibitor (atfpi)
32743|NCT03996486|Human monoclonal immunoglobulin G2 antibody|human monoclonal immunoglobulin g2 antibody
32744|NCT03996473|NSCLC|nsclc
32745|NCT03996421|Low iron stores|low iron stores
32746|NCT03996421|Prebiotics|prebiotics
32747|NCT03996421|Galacto-oligosaccharides|galacto-oligosaccharides
32748|NCT03996395|infant|infant
32749|NCT03996395|biomarker|biomarker
32750|NCT03996395|fruit|fruit
32751|NCT03996395|vegetable|vegetable
32752|NCT03996395|complementary feeding|complementary feeding
32753|NCT03996395|nutrition|nutrition
32754|NCT03996395|reflectance spectroscopy|reflectance spectroscopy
32755|NCT03996369|Ulcerative Colitis|ulcerative colitis
32756|NCT03996369|Etrasimod|etrasimod
32757|NCT03996369|APD334|apd334
32758|NCT03996343|Laryngeal mask airway|laryngeal mask airway
32759|NCT03996343|Endotracheal intubation|endotracheal intubation
32760|NCT03996343|Obese|obese
32761|NCT03996304|Birth cohort|birth cohort
32762|NCT03996304|Intestinal microbiota|intestinal microbiota
32763|NCT03996304|Child health|child health
32764|NCT03996278|THYMOGLOBULINE®|thymoglobuline®
32765|NCT03996278|GRAFALON®|grafalon®
32766|NCT03996239|Aerobic Exercise|aerobic exercise
32767|NCT03996239|19-126|19-126
32768|NCT03996226|Healthy Participants|healthy participants
32769|NCT03996226|E7386|e7386
32770|NCT03996226|Bioavailability|bioavailability
32771|NCT03996226|Food Effect|food effect
32772|NCT03996200|glaucoma|glaucoma
32773|NCT03996200|medical device|medical device
32774|NCT03996200|MIGS|migs
32775|NCT03996200|drainage device|drainage device
32776|NCT03996200|eye|eye
32777|NCT03996200|reduction IOP|reduction iop
32778|NCT03996174|Palliative care|palliative care
32779|NCT03996174|needs assessment|needs assessment
32780|NCT03996174|Mayotte|mayotte
32781|NCT03996174|terminal care|terminal care
32782|NCT03996122|schizo-affective disorder|schizo-affective disorder
32783|NCT03996122|utra-resistance|utra-resistance
32784|NCT03996122|clozapine|clozapine
32785|NCT03996122|biomarker|biomarker
32786|NCT03996122|fMRI|fmri
32787|NCT03996083|aging|aging
32788|NCT03996083|nursing homes|nursing homes
32789|NCT03996083|accidental falls|accidental falls
32790|NCT03996083|exercise|exercise
32791|NCT03996057|Urinary tract infection|urinary tract infection
32792|NCT03996057|UTI|uti
32793|NCT03996057|Women|women
32794|NCT03996057|Postmenopausal women|postmenopausal women
32795|NCT03996057|Prevention|prevention
32796|NCT03996057|Non-antibiotic|non-antibiotic
32797|NCT03995953|HIV prevention|hiv prevention
32798|NCT03995953|HIV treatment|hiv treatment
32799|NCT03995953|Zambia|zambia
32800|NCT03995927|Difficult to treat cancers|difficult to treat cancers
32801|NCT03995914|MACCEs|macces
32802|NCT03995914|Major cardiac and cerebrovascular events|major cardiac and cerebrovascular events
32803|NCT03995914|TAVI|tavi
32804|NCT03995914|Older|older
32809|NCT03995875|NSCLC, stageIII, Durvalumab, Japanese, Real world|nsclc, stageiii, durvalumab, japanese, real world
32810|NCT03995862|tenofovir disoproxil fumarate and emtricitabine combination|tenofovir disoproxil fumarate and emtricitabine combination
32811|NCT03995836|Obstructive Sleep Apnea|obstructive sleep apnea
32812|NCT03995836|Morbid Obesity|morbid obesity
32813|NCT03995836|Epigenetics|epigenetics
32814|NCT03995836|Bariatric Surgery|bariatric surgery
32815|NCT03995823|arteriovenous malformation|arteriovenous malformation
32816|NCT03995823|MRI|mri
32817|NCT03995823|DSA|dsa
32818|NCT03995823|Gamma Knife|gamma knife
32819|NCT03995719|colostomy|colostomy
32820|NCT03995719|education|education
32821|NCT03995693|eccentric exercise|eccentric exercise
32822|NCT03995693|13C-glucose|13c-glucose
32830|NCT03995680|Acceptability|acceptability
32831|NCT03995667|Tumor Treating Fields|tumor treating fields
32832|NCT03995667|TTF|ttf
32833|NCT03995654|Interstitial Lung Diseases|interstitial lung diseases
32834|NCT03995654|Fibrotic Lung|fibrotic lung
32835|NCT03995654|Prevalence|prevalence
32836|NCT03995602|vascular function|vascular function
32837|NCT03995602|endothelial function|endothelial function
32838|NCT03995602|betalains|betalains
32839|NCT03995602|dragon fruit|dragon fruit
32840|NCT03995602|pitaya|pitaya
32841|NCT03995537|liver transplantation|liver transplantation
32842|NCT03995537|Liver Diseases|liver diseases
32843|NCT03995511|Sensory deficit|sensory deficit
32844|NCT03995511|Orthognathic surgery|orthognathic surgery
32845|NCT03995511|Mandibular osteotomy|mandibular osteotomy
32846|NCT03995511|Inferior alveolar nerve|inferior alveolar nerve
32847|NCT03995498|Exercise|exercise
32848|NCT03995498|Physical activity|physical activity
32849|NCT03995498|Carbohydrates|carbohydrates
32850|NCT03995498|Hypoglycemia|hypoglycemia
32851|NCT03995485|Chronic hepatitis C|chronic hepatitis c
32852|NCT03995485|Hepatitis C virus|hepatitis c virus
32853|NCT03995485|Eradication|eradication
32854|NCT03995485|KW-136|kw-136
32855|NCT03995485|Sofosbuvir|sofosbuvir
32856|NCT03995485|Nonstructural protein 5A|nonstructural protein 5a
32857|NCT03995485|Nonstructural protein 5B|nonstructural protein 5b
32858|NCT03995485|Panogentypic regimen|panogentypic regimen
32859|NCT03995485|Confirmatory study|confirmatory study
32860|NCT03995446|Acupuncture points, low-level laser, postoperative pain, total knee arthroplasty|acupuncture points, low-level laser, postoperative pain, total knee arthroplasty
32861|NCT03995407|Pressure ulcer|pressure ulcer
32862|NCT03995407|Whey protein|whey protein
32863|NCT03995407|Wound healing|wound healing
32864|NCT03995381|Haemostasis|haemostasis
32865|NCT03995368|Schizophrenia|schizophrenia
32866|NCT03995368|Traumatic Brain Injury|traumatic brain injury
32867|NCT03995368|Neuroplasticity|neuroplasticity
32868|NCT03995368|EEG|eeg
32869|NCT03995342|frailty, flora|frailty, flora
32870|NCT03995329|pulmonary function|pulmonary function
32871|NCT03995329|heated tobacco|heated tobacco
32872|NCT03995329|IQOS|iqos
32873|NCT03995303|Malnutrition|malnutrition
32874|NCT03995303|Old adults|old adults
32875|NCT03995303|Home-delivered meals|home-delivered meals
32876|NCT03995303|NCP - Nutrition Care Process|ncp - nutrition care process
32877|NCT03995303|Food|food
32878|NCT03995277|Biotin|biotin
32879|NCT03995238|Amputation|amputation
32880|NCT03995238|Rehabilitation|rehabilitation
32881|NCT03995238|Gait Training|gait training
32882|NCT03995238|Diabetes|diabetes
32883|NCT03995238|Peripheral Artery Disease|peripheral artery disease
32892|NCT03995199|speech evaluation|speech evaluation
32893|NCT03995199|modified Furlow palatoplasty|modified furlow palatoplasty
32894|NCT03995199|Sommerlad intravelar veloplasty|sommerlad intravelar veloplasty
32895|NCT03995186|behavioural activation|behavioural activation
32896|NCT03995173|alcoholism|alcoholism
32897|NCT03995173|brain concussion|brain concussion
32898|NCT03995173|post-traumatic stress disorder|post-traumatic stress disorder
32899|NCT03995160|total|total
32900|NCT03995160|knee|knee
32901|NCT03995160|arthroplasty|arthroplasty
32902|NCT03995160|tkr|tkr
32903|NCT03995160|drainage|drainage
32904|NCT03995160|haematoma|haematoma
32905|NCT03995134|Use of propofol and remifentanil administered with TCI pump|use of propofol and remifentanil administered with tci pump
32906|NCT03995095|Spirituality|spirituality
32907|NCT03995095|Intervention Study|intervention study
32908|NCT03995069|Hand Strength|hand strength
32909|NCT03995069|Electromyography|electromyography
32910|NCT03995056|NAFLD|nafld
32911|NCT03995056|Gut microbiota|gut microbiota
32912|NCT03995056|high-intensity training|high-intensity training
32913|NCT03995004|melatonin|melatonin
32914|NCT03995004|orthognathic|orthognathic
32915|NCT03995004|pain|pain
32916|NCT03995004|surgery|surgery
32917|NCT03994965|Pimavanserin|pimavanserin
32918|NCT03994965|serotonin 2AR|serotonin 2ar
32919|NCT03994965|MR|mr
32920|NCT03994965|PET|pet
32921|NCT03994952|Balance, postural|balance, postural
32922|NCT03994952|Non-linear dynamics|non-linear dynamics
32923|NCT03994939|Sexual and reproductive health|sexual and reproductive health
32924|NCT03994939|Promotores de Salud|promotores de salud
33223|NCT03993470|pronation|pronation
32925|NCT03994939|Parent-adolescent communication|parent-adolescent communication
32926|NCT03994939|Health care insurance enrollment|health care insurance enrollment
32927|NCT03994926|cannabis|cannabis
32928|NCT03994913|Relapsed and/or Refractory B-cell Non-Hodgkin Lymphoma|relapsed and/or refractory b-cell non-hodgkin lymphoma
32929|NCT03994913|CAR T|car t
32930|NCT03994900|cardiovascular nitric oxide erythrocyte|cardiovascular nitric oxide erythrocyte
32931|NCT03994887|General anesthesia|general anesthesia
32932|NCT03994887|Surgery|surgery
32933|NCT03994887|Free Head|free head
32934|NCT03994835|HIV|hiv
32935|NCT03994835|Non-alcoholic fatty liver disease|non-alcoholic fatty liver disease
32936|NCT03994835|Cardiovascular disease|cardiovascular disease
32937|NCT03994835|Omics data|omics data
32938|NCT03994835|Inflammation|inflammation
32939|NCT03994822|Brain|brain
32940|NCT03994822|Brain Clot|brain clot
32941|NCT03994822|Brain Infarction|brain infarction
32942|NCT03994822|Cerebral Ischemia|cerebral ischemia
32943|NCT03994822|Cerebrovascular Disorders|cerebrovascular disorders
32944|NCT03994822|Ischemia|ischemia
32945|NCT03994822|Ischemic|ischemic
32946|NCT03994822|Ischemic Stroke|ischemic stroke
810863|NCT00206349|Children|children
44552|NCT03923660|COPD|copd
32947|NCT03994822|Mechanical Thrombectomy|mechanical thrombectomy
32948|NCT03994822|Neurovascular Intervention|neurovascular intervention
32949|NCT03994822|phenox|phenox
32950|NCT03994822|pRESET|preset
32951|NCT03994822|pRESET Thrombectomy Device|preset thrombectomy device
32952|NCT03994822|Revascularization|revascularization
32953|NCT03994822|Randomized Control|randomized control
32954|NCT03994822|Solitaire|solitaire
32955|NCT03994822|Stent Retriever|stent retriever
32956|NCT03994822|Stroke|stroke
32957|NCT03994822|Vascular Diseases|vascular diseases
32958|NCT03994809|biofield therapy|biofield therapy
32959|NCT03994809|ethnic differences|ethnic differences
32960|NCT03994809|Okada Purifying Therapy|okada purifying therapy
32961|NCT03994809|effectiveness|effectiveness
32962|NCT03994809|safety|safety
32963|NCT03994783|Rituximab|rituximab
32964|NCT03994783|AMR|amr
32965|NCT03994770|Balance|balance
32966|NCT03994757|Autism Spectrum Disorder|autism spectrum disorder
32967|NCT03994757|Routine-Based Early Intervention|routine-based early intervention
32968|NCT03994744|immunotherapy|immunotherapy
32969|NCT03994744|metformin|metformin
32970|NCT03994744|PD-L1|pd-l1
32971|NCT03994744|PD-1 checkpoint inhibitor|pd-1 checkpoint inhibitor
32972|NCT03994731|gout|gout
32973|NCT03994731|uncontrolled gout|uncontrolled gout
32974|NCT03994718|art|art
32975|NCT03994718|music|music
32976|NCT03994718|visual art|visual art
32977|NCT03994718|writing|writing
32978|NCT03994718|epilepsy|epilepsy
32979|NCT03994705|CAR-T|car-t
32980|NCT03994705|CART|cart
32981|NCT03994705|CAR T Cell|car t cell
32982|NCT03994705|CAR T-Cell|car t-cell
32983|NCT03994705|Multiple Myeloma|multiple myeloma
32984|NCT03994705|BCMA|bcma
32985|NCT03994705|B cell maturation antigen|b cell maturation antigen
32986|NCT03994705|B-cell maturation antigen|b-cell maturation antigen
32987|NCT03994705|Descartes-11|descartes-11
32988|NCT03994692|PEEK eminoplasty ,autogenous inlay (sandwich) eminoplasty|peek eminoplasty ,autogenous inlay (sandwich) eminoplasty
32989|NCT03994679|3D virtual software|3d virtual software
32990|NCT03994679|bone graft|bone graft
32991|NCT03994653|Ovarian cancer|ovarian cancer
32992|NCT03994653|Cancer of the ovary|cancer of the ovary
32993|NCT03994653|Observational study|observational study
32994|NCT03994653|Case-control study|case-control study
32995|NCT03994653|Cancer Loyalty Card Study|cancer loyalty card study
32996|NCT03994653|CLOCS|clocs
32997|NCT03994640|temporomandibular disorder|temporomandibular disorder
32998|NCT03994640|Cannabis|cannabis
32999|NCT03994640|Electromyography|electromyography
33000|NCT03994640|Masticatory muscles|masticatory muscles
33001|NCT03994640|Topical application|topical application
33002|NCT03994614|acupuncture|acupuncture
33003|NCT03994614|quality|quality
33004|NCT03994614|oocyte|oocyte
33005|NCT03994614|poor ovarian response|poor ovarian response
33006|NCT03994588|Complex ventral hernia|complex ventral hernia
33007|NCT03994588|Polypropylene soft mesh|polypropylene soft mesh
33008|NCT03994588|Intraperitoneal repair|intraperitoneal repair
33009|NCT03994588|Recurrence|recurrence
33010|NCT03994588|Loss of Domain|loss of domain
33011|NCT03994562|Frailty|frailty
33012|NCT03994562|Caregivers|caregivers
33013|NCT03994562|Zarit scale|zarit scale
33014|NCT03994549|Dual GLP-1R/GLP-2 Receptor agonist|dual glp-1r/glp-2 receptor agonist
33015|NCT03994536|Transfer to adult care|transfer to adult care
33016|NCT03994536|Continuity of patient care|continuity of patient care
33017|NCT03994536|Transition program|transition program
33018|NCT03994536|Empowerment|empowerment
33019|NCT03994536|Adolescents|adolescents
33020|NCT03994510|Psychiatry|psychiatry
33021|NCT03994510|Suicidal Behavior|suicidal behavior
33022|NCT03994510|Borderline Personality Disorder|borderline personality disorder
33023|NCT03994510|Follow-Up Study|follow-up study
33024|NCT03994458|Musculoskeletal Rehabilitation|musculoskeletal rehabilitation
33025|NCT03994458|Smartphone application|smartphone application
33026|NCT03994458|Occupational Stress|occupational stress
33027|NCT03994432|mediterranean diet|mediterranean diet
33028|NCT03994432|endometriosis|endometriosis
33029|NCT03994432|physical activity|physical activity
33030|NCT03994432|7 minutes work-out|7 minutes work-out
33031|NCT03994419|Paediatric|paediatric
33032|NCT03994419|Anaesthesia|anaesthesia
33033|NCT03994406|contact lens|contact lens
33034|NCT03994406|ocular erythema|ocular erythema
33035|NCT03994406|contact lens discomfort|contact lens discomfort
33036|NCT03994367|High Protein|high protein
33037|NCT03994367|Metabolism|metabolism
33038|NCT03994367|Diet|diet
33039|NCT03994341|Neonates|neonates
33040|NCT03994341|Thermography imaging|thermography imaging
33041|NCT03994328|Parkinson's|parkinson's
33042|NCT03994328|PD|pd
33043|NCT03994328|Safinamide|safinamide
33044|NCT03994328|Rasagiline|rasagiline
33045|NCT03994328|Levodopa|levodopa
33046|NCT03994328|L-DOPA|l-dopa
33047|NCT03994328|Fluctuating Patients|fluctuating patients
33048|NCT03994328|Add-on Therapy|add-on therapy
33049|NCT03994328|PDQ|pdq
33050|NCT03994328|UPDRS|updrs
33051|NCT03994328|NRS|nrs
33052|NCT03994328|MMAS-8|mmas-8
33053|NCT03994328|Morisky|morisky
33054|NCT03994328|quality of life|quality of life
33055|NCT03994328|observational|observational
33056|NCT03994289|exercise|exercise
33057|NCT03994289|FES|fes
33058|NCT03994276|Chickpea|chickpea
33059|NCT03994276|Cell Wall|cell wall
33060|NCT03994276|Dietary Fibre|dietary fibre
33061|NCT03994276|Postprandial|postprandial
33062|NCT03994276|Metabolism|metabolism
33063|NCT03994276|Enteroendocrine|enteroendocrine
33064|NCT03994250|kinematic|kinematic
33065|NCT03994250|mechanical|mechanical
33066|NCT03994250|total knee replacement|total knee replacement
33067|NCT03994185|PAOD|paod
33068|NCT03994185|Peripheral Arterial Occlusive Disease|peripheral arterial occlusive disease
33069|NCT03994185|Iliac Artery Disease|iliac artery disease
33070|NCT03994185|Stent Graft|stent graft
33071|NCT03994172|male osteoporosis|male osteoporosis
33072|NCT03994172|anabolic therapy|anabolic therapy
33073|NCT03994172|teriparatide|teriparatide
33074|NCT03994172|calcimimetic|calcimimetic
33075|NCT03994172|calcium-sensing receptor|calcium-sensing receptor
33076|NCT03994172|PTH receptor|pth receptor
33077|NCT03994172|bone formation|bone formation
33078|NCT03994133|Dialysis|dialysis
33079|NCT03994133|BCM|bcm
33080|NCT03994133|Daily Home Dialysis|daily home dialysis
33081|NCT03994133|low-flow dialysate|low-flow dialysate
33082|NCT03994133|Fluid Overload|fluid overload
33083|NCT03994133|kt/V|kt/v
33084|NCT03994133|dialysis dose|dialysis dose
33085|NCT03994133|Nutritional Status|nutritional status
33086|NCT03994133|blood pressure|blood pressure
33087|NCT03994120|Memory Systems|memory systems
33088|NCT03994120|Repetitive Transcranial Magnetic Stimulation|repetitive transcranial magnetic stimulation
33089|NCT03994120|Behavioral Efficiency|behavioral efficiency
33090|NCT03994120|Hippocampal and Striatal Memory Networks|hippocampal and striatal memory networks
33091|NCT03994081|tACS|tacs
33092|NCT03994081|Major Depressive Disorder|major depressive disorder
33093|NCT03994081|MDD|mdd
33094|NCT03994081|mood symptoms|mood symptoms
33095|NCT03994081|sham|sham
33096|NCT03994055|Cancer|cancer
33097|NCT03994055|Intestinal inflammation|intestinal inflammation
33098|NCT03994055|Diet|diet
33099|NCT03994016|Adolescent dating violence|adolescent dating violence
33100|NCT03994016|Positive mental health|positive mental health
33101|NCT03994016|Sexual health|sexual health
33102|NCT03993990|Diabetes、Foot ulcer、Self-care、glycemic control、Empowerment|diabetes、foot ulcer、self-care、glycemic control、empowerment
33103|NCT03993977|ROTEM|rotem
33104|NCT03993977|thromboelastometry|thromboelastometry
33105|NCT03993977|blood transfusion|blood transfusion
33106|NCT03993977|cancer|cancer
33107|NCT03993977|surgery|surgery
33108|NCT03993977|abdominal|abdominal
33109|NCT03993977|oncological|oncological
33110|NCT03993951|Family|family
33111|NCT03993938|transcatheter mitral valve repair|transcatheter mitral valve repair
33112|NCT03993938|pleth variability index|pleth variability index
33113|NCT03993938|Mitraclip|mitraclip
33114|NCT03993925|chronic hepatitis c|chronic hepatitis c
33115|NCT03993925|people who inject drugs|people who inject drugs
33116|NCT03993925|access to care|access to care
33117|NCT03993912|Newly diagnosed Multiple Myeloma|newly diagnosed multiple myeloma
33118|NCT03993912|Frail elderly patients|frail elderly patients
33119|NCT03993912|Dexamethasone-sparing regimen|dexamethasone-sparing regimen
33120|NCT03993912|Daratumumab|daratumumab
33121|NCT03993912|Toxicity|toxicity
33122|NCT03993899|cochlear implant stimulation strategy sound coding strategy|cochlear implant stimulation strategy sound coding strategy
33123|NCT03993886|Hemodialysis|hemodialysis
33124|NCT03993873|Non Small Cell Lung|non small cell lung
33125|NCT03993873|Non Small Cell Lung Cancer|non small cell lung cancer
33126|NCT03993873|Non-small cell lung cancer|non-small cell lung cancer
33127|NCT03993873|NSCLC|nsclc
33128|NCT03993873|TPX-0022|tpx-0022
33130|NCT03993873|advanced non-small cell lung cancer|advanced non-small cell lung cancer
33131|NCT03993873|advanced/metastatic disease|advanced/metastatic disease
33132|NCT03993873|Non-small cell lung carcinoma (NSCLC)|non-small cell lung carcinoma (nsclc)
33133|NCT03993873|treatment of lung cancer after first metastasis|treatment of lung cancer after first metastasis
33134|NCT03993873|treatment of gastric cancer after first metastasis|treatment of gastric cancer after first metastasis
33263|NCT03993301|Allergy|allergy
33135|NCT03993873|treatment of hepatocellular cancer after first metastasis|treatment of hepatocellular cancer after first metastasis
33136|NCT03993873|lung cancer|lung cancer
33137|NCT03993873|lung adenocarcinoma|lung adenocarcinoma
33138|NCT03993873|Non small cell lung carcinoma|non small cell lung carcinoma
33139|NCT03993873|MET exon 14 deletion|met exon 14 deletion
33140|NCT03993873|MET exon 14 skipping|met exon 14 skipping
33141|NCT03993873|MET exon 14 mutation|met exon 14 mutation
33142|NCT03993873|MET mutation|met mutation
33143|NCT03993873|MET amplification|met amplification
33144|NCT03993873|MET inhibitor|met inhibitor
33145|NCT03993873|MET dysregulation|met dysregulation
33146|NCT03993873|MET activation|met activation
33147|NCT03993873|MET signaling|met signaling
33148|NCT03993873|MET pathway|met pathway
33149|NCT03993873|MET fusion|met fusion
33150|NCT03993873|gastric cancer|gastric cancer
33151|NCT03993873|hepatocellular cancer|hepatocellular cancer
33152|NCT03993873|SRC|src
33153|NCT03993873|CSF1R|csf1r
33154|NCT03993873|cancer|cancer
33155|NCT03993873|first in human|first in human
33156|NCT03993860|Infants|infants
33157|NCT03993860|Growth|growth
33158|NCT03993860|Stunting|stunting
33159|NCT03993860|Fish|fish
33160|NCT03993860|Intervention|intervention
33161|NCT03993847|Spondyloarthritis|spondyloarthritis
33162|NCT03993847|SPARTAN|spartan
33163|NCT03993847|ASAS|asas
33164|NCT03993847|SpA|spa
33165|NCT03993847|Undiagnosed Back Pain|undiagnosed back pain
33166|NCT03993834|Transradial catheterization|transradial catheterization
33167|NCT03993834|Transradial access|transradial access
33168|NCT03993834|Radial artery occlusion|radial artery occlusion
33169|NCT03993834|Palmar arch collateral circulation|palmar arch collateral circulation
33170|NCT03993834|Collateral flow index|collateral flow index
33171|NCT03993821|CSHS|cshs
33172|NCT03993821|Cutaneous Skeletal Hypophosphatemia Syndrome|cutaneous skeletal hypophosphatemia syndrome
33173|NCT03993821|Epidermal Nevus Syndrome|epidermal nevus syndrome
33174|NCT03993808|Nutrition, micro-nutrients, implementation, food insecurity|nutrition, micro-nutrients, implementation, food insecurity
33175|NCT03993743|liver cancer|liver cancer
33176|NCT03993743|CD147|cd147
33177|NCT03993743|CAR-T|car-t
33178|NCT03993717|shingles vaccine|shingles vaccine
33179|NCT03993717|immune responses|immune responses
33180|NCT03993717|Clinical Trials|clinical trials
33181|NCT03993717|Immunology|immunology
33182|NCT03993717|Kidney Transplant|kidney transplant
33183|NCT03993704|Lassa fever|lassa fever
33184|NCT03993704|viral hemorrhagic fever|viral hemorrhagic fever
33185|NCT03993691|Scaphoid Fracture|scaphoid fracture
33186|NCT03993691|Wrist Fracture|wrist fracture
33187|NCT03993691|Distal Radius Fracture|distal radius fracture
33188|NCT03993678|advanced solid tumors|advanced solid tumors
33189|NCT03993678|Intratumoral injection|intratumoral injection
33190|NCT03993678|IP-001|ip-001
33191|NCT03993678|thermal ablation|thermal ablation
33192|NCT03993678|phase Ib/IIa|phase ib/iia
33193|NCT03993678|melanoma|melanoma
33194|NCT03993678|soft tissue sarcoma|soft tissue sarcoma
33195|NCT03993678|tumor ablation|tumor ablation
33196|NCT03993678|systemic immune response|systemic immune response
33197|NCT03993678|interventional immuno-oncology|interventional immuno-oncology
33198|NCT03993678|abscopal effect|abscopal effect
33199|NCT03993678|T cell stimulation|t cell stimulation
33200|NCT03993639|Hematopoietic Stem Cells Mobilization|hematopoietic stem cells mobilization
33201|NCT03993639|Healthy Volunteer (HV)|healthy volunteer (hv)
33202|NCT03993639|filgrastim|filgrastim
33203|NCT03993639|allogenic hematopoetic stem cell transplantation|allogenic hematopoetic stem cell transplantation
33204|NCT03993600|cystic fibrosis|cystic fibrosis
33205|NCT03993600|sweat|sweat
33206|NCT03993600|sweat glands|sweat glands
33207|NCT03993600|omics analysis|omics analysis
33208|NCT03993561|treatment summary and survivorship care plan|treatment summary and survivorship care plan
33209|NCT03993561|intervention|intervention
33210|NCT03993561|head and neck cancer survivors|head and neck cancer survivors
33211|NCT03993548|Wellness|wellness
33212|NCT03993548|Mental Wellness|mental wellness
33213|NCT03993548|Well-Being|well-being
33214|NCT03993535|obsessive-compulsive disorder|obsessive-compulsive disorder
33215|NCT03993535|predictors|predictors
33216|NCT03993535|neuroimaging|neuroimaging
33218|NCT03993496|Abdominal Aortic Aneurysm|abdominal aortic aneurysm
33219|NCT03993496|Endovascular Abdominal Aortic Aneurysm Repair|endovascular abdominal aortic aneurysm repair
33220|NCT03993496|Ultrasound|ultrasound
33221|NCT03993496|M-mode|m-mode
33222|NCT03993496|EVAR|evar
33231|NCT03993457|bupropion|bupropion
33232|NCT03993457|depression treatment|depression treatment
33233|NCT03993431|Cementation|cementation
33234|NCT03993431|Zirconia crowns|zirconia crowns
33235|NCT03993405|older people|older people
33236|NCT03993405|muscle|muscle
33237|NCT03993405|ultrasound|ultrasound
33246|NCT03993366|type 1 diabetes|type 1 diabetes
33247|NCT03993366|artificial pancreas|artificial pancreas
33248|NCT03993366|pramlintide|pramlintide
33249|NCT03993366|closed-loop|closed-loop
33250|NCT03993353|cancer|cancer
33251|NCT03993353|pembrolizumab|pembrolizumab
33252|NCT03993353|tadalafil|tadalafil
33253|NCT03993353|cialis|cialis
33254|NCT03993353|opdivo|opdivo
33255|NCT03993353|immunotherapy|immunotherapy
33256|NCT03993353|metastatic|metastatic
33257|NCT03993353|carcinoma|carcinoma
33258|NCT03993353|pd-1|pd-1
33259|NCT03993353|pde|pde
33260|NCT03993301|Probiotics|probiotics
33261|NCT03993301|Infant formula|infant formula
810864|NCT00206349|Adolescents|adolescents
33262|NCT03993301|Gastroenteritis|gastroenteritis
33264|NCT03993301|Respiratory infection|respiratory infection
33265|NCT03993288|Ferrum Lek® (iron (III) hydroxide polymaltosate), mild and moderate iron-deficiency anaemia|ferrum lek® (iron (iii) hydroxide polymaltosate), mild and moderate iron-deficiency anaemia
33266|NCT03993275|Trunk Control|trunk control
33267|NCT03993275|Exergames|exergames
33268|NCT03993262|autoimmune disease|autoimmune disease
33269|NCT03993262|autoimmune encephalitis|autoimmune encephalitis
33270|NCT03993262|bortezomib|bortezomib
33271|NCT03993262|NMDAR|nmdar
33272|NCT03993262|LGI1|lgi1
33273|NCT03993262|encephalitis|encephalitis
33274|NCT03993236|Stroke, Ischemic|stroke, ischemic
33275|NCT03993236|Rosuvastatin|rosuvastatin
33276|NCT03993236|Ezetimibe|ezetimibe
33277|NCT03993223|Upper trapezius|upper trapezius
33278|NCT03993223|Myofascial Trigger Point|myofascial trigger point
33279|NCT03993223|Muscle fatigue|muscle fatigue
33280|NCT03993223|Overhead athlete|overhead athlete
33281|NCT03993210|Gynecologic Tumor|gynecologic tumor
33282|NCT03993197|Endometriosis|endometriosis
33283|NCT03993197|Pain|pain
33284|NCT03993197|group management|group management
33285|NCT03993197|quality of life|quality of life
33286|NCT03993171|neurodegeneration|neurodegeneration
33287|NCT03993171|gold|gold
33288|NCT03993171|nanoparticle|nanoparticle
33289|NCT03993171|NAD+|nad+
33290|NCT03993171|redox|redox
33291|NCT03993171|31P-MRS|31p-mrs
33292|NCT03993171|multiple sclerosis|multiple sclerosis
33293|NCT03993171|magnetic resonance spectroscopy|magnetic resonance spectroscopy
33294|NCT03993171|nanocrystal|nanocrystal
33295|NCT03993171|NADH|nadh
33296|NCT03993145|Mentoring|mentoring
33297|NCT03993145|Healthy life style|healthy life style
33298|NCT03993145|Postpartum Period|postpartum period
33299|NCT03993093|HIV|hiv
33300|NCT03993093|Opportunistic infection|opportunistic infection
33301|NCT03993093|CD4+ T cells|cd4+ t cells
33302|NCT03993093|AIDS defining condition|aids defining condition
33303|NCT03993080|dental anxiety|dental anxiety
33304|NCT03993080|virtual reality|virtual reality
33305|NCT03993015|Viable pregnancy|viable pregnancy
33306|NCT03993015|miscarriage|miscarriage
33307|NCT03993015|ectopic pregnancy|ectopic pregnancy
33308|NCT03993015|early pregnancy|early pregnancy
33309|NCT03993002|Mechanical Ventilation|mechanical ventilation
33310|NCT03993002|Alevolar stretch|alevolar stretch
33311|NCT03993002|Hyperoxia|hyperoxia
33312|NCT03993002|Normoxia|normoxia
33313|NCT03993002|Hypercarbia|hypercarbia
33314|NCT03993002|Normocarbia|normocarbia
33315|NCT03992976|Chronic Pain|chronic pain
33316|NCT03992976|Paediatric Pain|paediatric pain
33317|NCT03992976|Pain Management|pain management
33318|NCT03992976|Qualitative Research|qualitative research
33319|NCT03992911|Neuroendocrine Carcinoma|neuroendocrine carcinoma
33320|NCT03992911|Simmtecan|simmtecan
33321|NCT03992911|Toripalimab|toripalimab
33322|NCT03992885|the combination therapy of targeted therapy and chemotherapy|the combination therapy of targeted therapy and chemotherapy
33323|NCT03992885|metastatic non-squamous non-small cell lung cancer with EGFR mutations|metastatic non-squamous non-small cell lung cancer with egfr mutations
33324|NCT03992885|ectiecinib|ectiecinib
33325|NCT03992859|regional anesthesia|regional anesthesia
33326|NCT03992846|Dysmenorrhea|dysmenorrhea
33327|NCT03992846|Dyspareunia|dyspareunia
33328|NCT03992846|Dyschezia|dyschezia
33329|NCT03992846|Non-menstrual pelvic pain|non-menstrual pelvic pain
33330|NCT03992820|TENS|tens
33331|NCT03992820|local anaesthetic cream|local anaesthetic cream
33332|NCT03992820|skin graft donor site|skin graft donor site
33333|NCT03992794|Sepsis|sepsis
33334|NCT03992794|Emergency department|emergency department
33335|NCT03992794|Sepsis biomarkers|sepsis biomarkers
33336|NCT03992794|MR-proADM|mr-proadm
33337|NCT03992755|Pulmonary Arterial Hypertension|pulmonary arterial hypertension
33338|NCT03992755|Idiopathic Pulmonary Arterial Hypertension|idiopathic pulmonary arterial hypertension
33339|NCT03992755|Heritable Pulmonary Arterial Hypertension|heritable pulmonary arterial hypertension
33340|NCT03992755|Drug Induced Pulmonary Arterial Hypertension|drug induced pulmonary arterial hypertension
33341|NCT03992755|Toxin Induced Pulmonary Arterial Hypertension|toxin induced pulmonary arterial hypertension
33342|NCT03992755|Connective tissue disease|connective tissue disease
33343|NCT03992742|Smoking cessation|smoking cessation
33344|NCT03992742|Quit to Win|quit to win
33345|NCT03992742|Cocktail intervention|cocktail intervention
33346|NCT03992742|SMART design|smart design
33347|NCT03992703|Clinical impact|clinical impact
33348|NCT03992703|Bacteremia|bacteremia
33349|NCT03992703|Antibiotic|antibiotic
33350|NCT03992703|Blood cultures|blood cultures
33351|NCT03992703|Enterobacteriaceae|enterobacteriaceae
33352|NCT03992703|Staphylococcus aureus|staphylococcus aureus
33353|NCT03992677|Brugada Syndrome|brugada syndrome
33354|NCT03992677|Ventricular Ectopic Beat|ventricular ectopic beat
33355|NCT03992625|Deep brain stimulation|deep brain stimulation
33356|NCT03992612|Fibromyalgia|fibromyalgia
33357|NCT03992612|Chronic Pain|chronic pain
33358|NCT03992612|Psychological Treatment|psychological treatment
33359|NCT03992612|Effectiveness|effectiveness
33360|NCT03992612|CBT|cbt
33361|NCT03992612|MBPM|mbpm
33362|NCT03992599|Adenocarcinoma in right colon|adenocarcinoma in right colon
33363|NCT03992599|mCME|mcme
33364|NCT03992599|oncologic outcomes|oncologic outcomes
33365|NCT03992599|right-sided colon cancer|right-sided colon cancer
33366|NCT03992547|funcional near infrared spectroscopy|funcional near infrared spectroscopy
33367|NCT03992547|Robot-assisted gait training|robot-assisted gait training
33368|NCT03992534|Pregnancy|pregnancy
33369|NCT03992534|Preterm labour|preterm labour
33370|NCT03992534|Preterm delivery|preterm delivery
33371|NCT03992534|Vaginal microbiome|vaginal microbiome
33372|NCT03992534|Infection|infection
33373|NCT03992534|Next generation sequencing|next generation sequencing
33374|NCT03992534|Lactobacillus|lactobacillus
33375|NCT03992495|Exercise|exercise
33376|NCT03992495|Neck pain|neck pain
33377|NCT03992495|Pain sensitivity|pain sensitivity
33378|NCT03992482|Dry Eye|dry eye
33379|NCT03992482|Intravenous Immunoglobulin (IVIG) Eye Drops|intravenous immunoglobulin (ivig) eye drops
33380|NCT03992482|Treatment|treatment
33381|NCT03992482|ocular Graft-vs-Host Disease (oGVHD)|ocular graft-vs-host disease (ogvhd)
33382|NCT03992469|Entocort EC induction|entocort ec induction
33383|NCT03992469|double blind, controlled safety/tolerability trial|double blind, controlled safety/tolerability trial
33384|NCT03992469|open label exploratory efficacy trial|open label exploratory efficacy trial
33385|NCT03992469|mild-to-moderate crohn's disease|mild-to-moderate crohn's disease
33386|NCT03992469|Chinese Herbal Therapy|chinese herbal therapy
33387|NCT03992443|CVAD|cvad
33388|NCT03992443|CUSA-081|cusa-081
33389|NCT03992443|reteplase|reteplase
33390|NCT03992430|Duchenne muscular dystrophy|duchenne muscular dystrophy
33391|NCT03992430|Exon Skipping|exon skipping
33392|NCT03992430|Exon 51|exon 51
33393|NCT03992430|North Star Ambulatory Assessment|north star ambulatory assessment
33394|NCT03992430|Ambulatory|ambulatory
33395|NCT03992430|DMD|dmd
33396|NCT03992430|Pediatric|pediatric
33397|NCT03992430|Duchenne|duchenne
33398|NCT03992430|EXONDYS|exondys
33399|NCT03992378|Sepsis|sepsis
33400|NCT03992365|non-inferiority|non-inferiority
33401|NCT03992274|HIV prevention|hiv prevention
33402|NCT03992274|Implementation science|implementation science
33403|NCT03992274|Pre-Exposure Prophylaxis|pre-exposure prophylaxis
33404|NCT03992274|Men who have sex with men|men who have sex with men
33405|NCT03992274|China|china
33406|NCT03992248|TRF; hepatic glycogen; type 2 diabetes; insulin sensitivity|trf; hepatic glycogen; type 2 diabetes; insulin sensitivity
33407|NCT03992235|chest physiotherapy|chest physiotherapy
33408|NCT03992235|physiotherapy|physiotherapy
33409|NCT03992235|education|education
33410|NCT03992235|educational material|educational material
33411|NCT03992235|thoracotomy|thoracotomy
33412|NCT03992235|chest|chest
33413|NCT03992235|surgery|surgery
33414|NCT03992235|lung|lung
33415|NCT03992235|exercise|exercise
33416|NCT03992196|RLS|rls
33417|NCT03992196|Neupro|neupro
33418|NCT03992196|Rotigotine|rotigotine
33419|NCT03992183|CAML|caml
33420|NCT03992183|Early Detection|early detection
33421|NCT03992170|Myeloma Multiple|myeloma multiple
33422|NCT03992170|Daratumumab|daratumumab
33423|NCT03992157|stroke|stroke
33424|NCT03992157|ECG|ecg
33425|NCT03992157|telemetry|telemetry
33426|NCT03992157|atrial fibrillation|atrial fibrillation
33427|NCT03992144|dry socket|dry socket
33428|NCT03992144|metronidazole|metronidazole
33429|NCT03992144|amoxicillin|amoxicillin
33430|NCT03992144|lower 3rd molars|lower 3rd molars
33431|NCT03992092|cervical spine injury|cervical spine injury
33432|NCT03992066|Anemia|anemia
33433|NCT03992066|Chronic kidney disease|chronic kidney disease
33434|NCT03992066|Vadadustat|vadadustat
33435|NCT03992066|Hemodialysis|hemodialysis
33436|NCT03992066|Erythropoiesis-stimulating agent|erythropoiesis-stimulating agent
33437|NCT03992053|2-dimensional (2-D) fluoroscopy|2-dimensional (2-d) fluoroscopy
33438|NCT03992053|3-dimensional (3-D) Computed Tomography (CT) guidance|3-dimensional (3-d) computed tomography (ct) guidance
33439|NCT03992053|sacroiliac joint injection|sacroiliac joint injection
33440|NCT03992040|Regional Public Health authorities (ARS) score|regional public health authorities (ars) score
33441|NCT03992040|Reinforced Home Nursing Care Services (SSIADR)|reinforced home nursing care services (ssiadr)
33442|NCT03992027|cystic fibrosis|cystic fibrosis
33443|NCT03992027|cognitive-behavioral therapy|cognitive-behavioral therapy
33444|NCT03992027|prevention|prevention
33445|NCT03992027|coping|coping
33446|NCT03992014|[14C]-linerixibat|[14c]-linerixibat
33447|NCT03992014|GSK2330672|gsk2330672
33448|NCT03992014|Microtracer dose|microtracer dose
33449|NCT03992001|Packed RBCs|packed rbcs
33450|NCT03992001|leukodepletion|leukodepletion
33451|NCT03992001|buffy-coat|buffy-coat
33452|NCT03992001|transfusion|transfusion
33453|NCT03991988|Alzheimer|alzheimer
33454|NCT03991936|Nail Psoriasis|nail psoriasis
33455|NCT03991936|Nail Diseases|nail diseases
33456|NCT03991936|Triamcinolone acetonide|triamcinolone acetonide
33457|NCT03991936|Triamcinolone|triamcinolone
33458|NCT03991923|Non Ischemic Heart Preservation (NIHP)|non ischemic heart preservation (nihp)
33459|NCT03991923|Ischemic cold static storage of donor hearts (ICSS)|ischemic cold static storage of donor hearts (icss)
33460|NCT03991910|Rheumatic Heart Disease|rheumatic heart disease
33461|NCT03991910|Mitral Stenosis|mitral stenosis
33462|NCT03991910|Rheumatic Mitral Stenosis|rheumatic mitral stenosis
33463|NCT03991910|Valve Fibrosis|valve fibrosis
33464|NCT03991910|ramipril|ramipril
33465|NCT03991910|ST2|st2
33466|NCT03991871|Refractory Angina|refractory angina
33467|NCT03991871|Angiogenesis|angiogenesis
33468|NCT03991871|External Counterpulsation|external counterpulsation
33469|NCT03991871|Angiopoietin|angiopoietin
33470|NCT03991858|Rehabilitation|rehabilitation
33471|NCT03991858|Telerehabilitation|telerehabilitation
33472|NCT03991858|Waiting list|waiting list
33473|NCT03991858|follow-up|follow-up
33474|NCT03991793|Granzyme A|granzyme a
33475|NCT03991793|Sepsis|sepsis
33476|NCT03991793|Pathogenesis|pathogenesis
33477|NCT03991793|Escherichia coli Bloodstream Infection|escherichia coli bloodstream infection
33478|NCT03991793|Immunopathology|immunopathology
33479|NCT03991780|Renal transplant rejection|renal transplant rejection
33480|NCT03991780|donor specific antibody|donor specific antibody
33481|NCT03991780|antibody mediated rejection|antibody mediated rejection
33482|NCT03991780|spleen tyrosine kinase|spleen tyrosine kinase
33483|NCT03991780|fostamatinib|fostamatinib
33484|NCT03991767|medical practices|medical practices
33485|NCT03991767|HIV|hiv
33486|NCT03991767|Electronic Alert|electronic alert
33487|NCT03991741|melanoma|melanoma
33488|NCT03991741|metastatic|metastatic
33489|NCT03991741|head and neck cancer|head and neck cancer
33490|NCT03991741|solid tumor|solid tumor
33491|NCT03991741|adoptive cell therapy|adoptive cell therapy
33492|NCT03991741|autologous|autologous
33493|NCT03991741|locally advanced refractory/recurrent melanoma|locally advanced refractory/recurrent melanoma
33494|NCT03991741|locally advanced refractory/recurrent head and neck cancer|locally advanced refractory/recurrent head and neck cancer
33495|NCT03991741|IL-2|il-2
33496|NCT03991728|Temporomandibular joint|temporomandibular joint
33497|NCT03991728|TMJ replacement|tmj replacement
33498|NCT03991728|Trauma|trauma
33499|NCT03991728|Ankylosis|ankylosis
33500|NCT03991728|Degenerative joint disease|degenerative joint disease
33501|NCT03991728|Registry|registry
33502|NCT03991689|spinal cord injury|spinal cord injury
33503|NCT03991689|pain management|pain management
33504|NCT03991689|pain intensity|pain intensity
33505|NCT03991689|pain self-efficacy|pain self-efficacy
33506|NCT03991689|solution-focused group therapy|solution-focused group therapy
33507|NCT03991676|Obesity|obesity
33508|NCT03991676|Weight Loss|weight loss
33509|NCT03991676|Behavioral treatment|behavioral treatment
33510|NCT03991676|Values|values
33511|NCT03991676|Values-based behavior change|values-based behavior change
33512|NCT03991676|Autonomous motivation|autonomous motivation
33513|NCT03991676|Acceptance and Commitment Therapy|acceptance and commitment therapy
33514|NCT03991650|wearable|wearable
33515|NCT03991650|sensor|sensor
33516|NCT03991650|anxiety|anxiety
33517|NCT03991650|monitoring|monitoring
33518|NCT03991650|ehealth|ehealth
33519|NCT03991650|Alcohol Use Disorder|alcohol use disorder
33520|NCT03991650|depression|depression
33521|NCT03991624|decision making|decision making
33522|NCT03991624|Iowa Gambling Task|iowa gambling task
33523|NCT03991611|Critical care|critical care
33524|NCT03991611|Post-traumatic stress disorder|post-traumatic stress disorder
33525|NCT03991611|Discomfort|discomfort
33526|NCT03991611|Tailored program|tailored program
33527|NCT03991611|Patient-reported outcome|patient-reported outcome
33528|NCT03991611|ICU|icu
33529|NCT03991598|Frail|frail
33530|NCT03991598|Prefrail|prefrail
33531|NCT03991598|Mobile decline|mobile decline
33532|NCT03991585|At-risk preschoolers|at-risk preschoolers
33533|NCT03991585|Head Start|head start
33534|NCT03991585|Emotion regulation|emotion regulation
33535|NCT03991559|anti-PD-1 antibody|anti-pd-1 antibody
33536|NCT03991559|Manganese|manganese
33537|NCT03991559|unresectable|unresectable
33538|NCT03991559|metastatic|metastatic
33539|NCT03991546|Opioid Pain Medication|opioid pain medication
33540|NCT03991546|PROMIS|promis
33541|NCT03991429|Voiding dysfunction|voiding dysfunction
33542|NCT03991429|Benign Prostatic Hyperplasia (BPH)|benign prostatic hyperplasia (bph)
33543|NCT03991429|Lower urinary tract symptoms (LUTS)|lower urinary tract symptoms (luts)
33544|NCT03991429|Functional Magnetic Resonance Imaging|functional magnetic resonance imaging
33545|NCT03991429|Urodynamic studies|urodynamic studies
33546|NCT03991416|Universal|universal
33547|NCT03991416|Prevention|prevention
33548|NCT03991416|Parental competence|parental competence
33549|NCT03991416|Socioemotional|socioemotional
33550|NCT03991416|Public health nurses|public health nurses
33551|NCT03991390|Pusher syndrome|pusher syndrome
33552|NCT03991390|Core stability|core stability
33553|NCT03991390|Visual feedback|visual feedback
33554|NCT03991390|Postural control|postural control
33555|NCT03991390|Balance|balance
33556|NCT03991390|Rehabilitation stroke|rehabilitation stroke
33557|NCT03991377|First psychotic episode, psychological trauma, EMDR therapy, Treatment as usual|first psychotic episode, psychological trauma, emdr therapy, treatment as usual
33558|NCT03991364|Robot-assisted gait training|robot-assisted gait training
33559|NCT03991364|stroke|stroke
33560|NCT03991364|gait speed|gait speed
33561|NCT03991351|Body Image|body image
33562|NCT03991351|Mood, anxiety, depression|mood, anxiety, depression
33563|NCT03991351|Self-esteem|self-esteem
33564|NCT03991351|Body Dysmorphia|body dysmorphia
33565|NCT03991351|Men|men
33566|NCT03991351|Deit|deit
33567|NCT03991351|Exercise|exercise
33568|NCT03991286|PCOS|pcos
33569|NCT03991286|Astaxanthin|astaxanthin
33570|NCT03991286|ROS|ros
33571|NCT03991273|disability|disability
33572|NCT03991273|disabilities|disabilities
33573|NCT03991273|teleexercise|teleexercise
33574|NCT03991273|movement-to-music|movement-to-music
33575|NCT03991273|physical activity|physical activity
33576|NCT03991260|99mTc-ADAPT6|99mtc-adapt6
33577|NCT03991260|Breast Cancer|breast cancer
33578|NCT03991260|HER2 expression|her2 expression
33579|NCT03991247|Spa treatment|spa treatment
33580|NCT03991247|Cognitive Behavioral Therapy|cognitive behavioral therapy
33581|NCT03991247|Internet delivered self-help program|internet delivered self-help program
33582|NCT03991247|Insomnia|insomnia
33583|NCT03991247|Sleep restriction|sleep restriction
33584|NCT03991247|stimulus control|stimulus control
33585|NCT03991247|crenotherapy|crenotherapy
33586|NCT03991221|Prevention|prevention
33587|NCT03991221|Early treatment|early treatment
33588|NCT03991221|Skeletal discrepancy|skeletal discrepancy
33589|NCT03991221|Malocclusion|malocclusion
33590|NCT03991208|Pharmacokinetics|pharmacokinetics
33591|NCT03991208|Exercise|exercise
33592|NCT03991208|Malaria Prophylaxis|malaria prophylaxis
33593|NCT03991208|Bioequivalence|bioequivalence
33594|NCT03991208|Bioavailability|bioavailability
33595|NCT03991195|mild cognitive impairment|mild cognitive impairment
33596|NCT03991195|intestinal microorganism|intestinal microorganism
33597|NCT03991195|regulation|regulation
33598|NCT03991195|magnetic resonance imaging|magnetic resonance imaging
33599|NCT03991182|Community based parenting|community based parenting
33600|NCT03991182|Developmental outcomes|developmental outcomes
33601|NCT03991182|Maternity waiting homes (MWHs)|maternity waiting homes (mwhs)
33602|NCT03991182|Safe Motherhood Action Group leaders (SMAGs)|safe motherhood action group leaders (smags)
33603|NCT03991182|Zambia|zambia
33604|NCT03991169|Anemia|anemia
33605|NCT03991169|Iron|iron
33606|NCT03991169|Children|children
33607|NCT03991169|Chronic kidney disease (CKD)|chronic kidney disease (ckd)
33608|NCT03991169|Appetite|appetite
33609|NCT03991169|Physical activity|physical activity
33610|NCT03991169|Muscle strength|muscle strength
33611|NCT03991156|Radiotherapy|radiotherapy
33612|NCT03991130|melanoma|melanoma
33613|NCT03991130|renal cell carcinoma|renal cell carcinoma
33614|NCT03991117|muscle fibre activation|muscle fibre activation
33615|NCT03991117|electromyography|electromyography
33616|NCT03991104|esophageal cancer|esophageal cancer
33617|NCT03991104|chemoradiotherapy|chemoradiotherapy
33618|NCT03991104|oxaliplatin|oxaliplatin
33619|NCT03991104|S-1|s-1
33620|NCT03991091|Multicenter|multicenter
33621|NCT03991091|randomized|randomized
33622|NCT03991091|control study|control study
33623|NCT03991091|Oxytocin discontinuation|oxytocin discontinuation
33624|NCT03991091|Neonatal acidosis|neonatal acidosis
33625|NCT03991039|Trigeminal neuralgia, treatment|trigeminal neuralgia, treatment
33626|NCT03991013|second line antiretroviral therapy|second line antiretroviral therapy
33627|NCT03991013|dolutegravir|dolutegravir
33628|NCT03991000|Iron deficiency|iron deficiency
33629|NCT03991000|Atrial fibrillation|atrial fibrillation
33630|NCT03991000|Acute myocardial infarction|acute myocardial infarction
33631|NCT03991000|Systolic heart failure|systolic heart failure
33632|NCT03991000|Anemia|anemia
33633|NCT03990987|postoperative pain|postoperative pain
33634|NCT03990987|postoperative sleep quality|postoperative sleep quality
33635|NCT03990987|dexmedetomidine|dexmedetomidine
33636|NCT03990987|general anesthesia|general anesthesia
33637|NCT03990896|Breast Cancer|breast cancer
33638|NCT03990883|nasolabial folds|nasolabial folds
33639|NCT03990883|correction|correction
33640|NCT03990857|comorbidities comprehensive care|comorbidities comprehensive care
33641|NCT03990844|Glucose|glucose
33642|NCT03990844|Insulin|insulin
33643|NCT03990844|Ghrelin|ghrelin
33644|NCT03990844|GLP-1|glp-1
33645|NCT03990831|Burn|burn
33646|NCT03990831|Near-infrared spectroscopy (NIRS)|near-infrared spectroscopy (nirs)
33647|NCT03990805|Stem Cell|stem cell
33648|NCT03990805|Adipose tissue derived mesenchymal stem cell|adipose tissue derived mesenchymal stem cell
33649|NCT03990805|osteoarthritis|osteoarthritis
33650|NCT03990805|degenerative arthritis|degenerative arthritis
33651|NCT03990805|biostar|biostar
33652|NCT03990805|Rbio|rbio
33653|NCT03990792|Depression|depression
33654|NCT03990792|Primary Prevention|primary prevention
33655|NCT03990792|Primary Health Care|primary health care
33656|NCT03990792|Randomized controlled trial|randomized controlled trial
33657|NCT03990792|mHealth|mhealth
33658|NCT03990792|App|app
33659|NCT03990766|Olfactory dysfunction|olfactory dysfunction
33660|NCT03990766|Anosmia|anosmia
33661|NCT03990766|Hyposmia|hyposmia
33662|NCT03990766|Post-viral|post-viral
33663|NCT03990766|Theophylline|theophylline
33664|NCT03990766|Adverse effects|adverse effects
33665|NCT03990766|Smell|smell
33666|NCT03990753|Microbiome/Peptidome|microbiome/peptidome
33667|NCT03990753|High-risk Gastroesophageal Varices|high-risk gastroesophageal varices
33668|NCT03990753|Compensated Cirrhosis|compensated cirrhosis
33669|NCT03990740|Metalloproteinase|metalloproteinase
33670|NCT03990740|Glycoprotein|glycoprotein
33671|NCT03990740|Cornea|cornea
33672|NCT03990740|Direct epithelial-stromal interactions|direct epithelial-stromal interactions
33673|NCT03990740|Fibroblasts|fibroblasts
33674|NCT03990740|Myofibroblasts|myofibroblasts
33675|NCT03990714|Right hemicolectomy|right hemicolectomy
33676|NCT03990714|Intracorporeal anastomosis|intracorporeal anastomosis
33677|NCT03990714|Extracorporeal anastomosis|extracorporeal anastomosis
33678|NCT03990714|Laparoscopy|laparoscopy
33679|NCT03990701|11-C Metomidate PET/CT|11-c metomidate pet/ct
33680|NCT03990701|Hypertension|hypertension
33681|NCT03990701|Adrenalectomy|adrenalectomy
33682|NCT03990701|Adrenal Vein Sampling|adrenal vein sampling
33683|NCT03990701|Subtyping|subtyping
33684|NCT03990662|Temporomandibular Joint Dysfunction Syndrome|temporomandibular joint dysfunction syndrome
33685|NCT03990662|Manual Therapy|manual therapy
33686|NCT03990662|Prediction|prediction
33687|NCT03990662|Pain|pain
33688|NCT03990649|Drug Therapy|drug therapy
33689|NCT03990636|PDT|pdt
33690|NCT03990636|Actinic Cheilitis|actinic cheilitis
33691|NCT03990636|Phase 2 Clinical Trial|phase 2 clinical trial
33692|NCT03990584|Chronic apical periodontitis|chronic apical periodontitis
33693|NCT03990584|irrigation activation methods|irrigation activation methods
33694|NCT03990584|periapical index|periapical index
33695|NCT03990584|postoperative pain|postoperative pain
33696|NCT03990584|treatment outcome|treatment outcome
33697|NCT03990545|intracranial atherosclerotic disease|intracranial atherosclerotic disease
33698|NCT03990545|acute stroke|acute stroke
33699|NCT03990545|transient ischemic attack|transient ischemic attack
33700|NCT03990545|vessel wall imaging|vessel wall imaging
33701|NCT03990454|AXL Inhibitor|axl inhibitor
33702|NCT03990454|Solid Tumor|solid tumor
33703|NCT03990428|Supportive care|supportive care
33704|NCT03990428|Erdheim-Chester Disease|erdheim-chester disease
33705|NCT03990428|Other Histiocytic Diseases|other histiocytic diseases
33706|NCT03990428|19-213|19-213
33707|NCT03990415|Elderly|elderly
33708|NCT03990415|Balance|balance
33709|NCT03990415|Strength Training|strength training
33710|NCT03990402|FeNO|feno
33711|NCT03990402|Africa|africa
33712|NCT03990402|Spirometry|spirometry
33713|NCT03990402|Asthma Control|asthma control
33714|NCT03990402|ACT|act
33715|NCT03990402|Prevalence|prevalence
33716|NCT03990376|Scoliosis|scoliosis
33717|NCT03990376|Pediatric surgery|pediatric surgery
33718|NCT03990376|Orthopedics|orthopedics
33719|NCT03990376|Blood loss|blood loss
33720|NCT03990363|Chronic Kidney Disease|chronic kidney disease
33721|NCT03990350|Gut Microbiome|gut microbiome
33722|NCT03990337|Ultrasound|ultrasound
33723|NCT03990337|Cricoid Cartilage|cricoid cartilage
33724|NCT03990337|Cricoid Pressure|cricoid pressure
33725|NCT03990337|General Anesthesia|general anesthesia
33726|NCT03990337|Endotracheal Intubation|endotracheal intubation
33727|NCT03990324|range of motion|range of motion
33728|NCT03990324|muscle sensitivity|muscle sensitivity
33729|NCT03990324|muscle stretching|muscle stretching
33730|NCT03990259|Ultraendurance|ultraendurance
33731|NCT03990259|Sex differences|sex differences
33732|NCT03990259|Performance|performance
33733|NCT03990259|Genetics|genetics
33734|NCT03990259|Physiological damage|physiological damage
33735|NCT03990233|Checkpoint inhibitor (ICI)|checkpoint inhibitor (ici)
33736|NCT03990233|SIRPα|sirpα
33737|NCT03990233|Advanced solid tumors|advanced solid tumors
33738|NCT03990233|Anti-PD-1|anti-pd-1
33739|NCT03990220|probiotics|probiotics
33740|NCT03990220|Lactobacillus rhamnosus yoba 2012|lactobacillus rhamnosus yoba 2012
33741|NCT03990220|Skin diseases|skin diseases
33742|NCT03990220|Respiratory Tract Infections|respiratory tract infections
33743|NCT03990220|School absenteeism|school absenteeism
33744|NCT03990220|Diarrhea|diarrhea
33745|NCT03990220|Anthropometric indicators|anthropometric indicators
33746|NCT03990129|Metamizole|metamizole
33747|NCT03990129|Dipyrone|dipyrone
33748|NCT03990129|Basel Cocktail|basel cocktail
33749|NCT03990129|Drug-Drug Interaction|drug-drug interaction
33750|NCT03990129|Phenotyping|phenotyping
33751|NCT03990116|Patient Positioning|patient positioning
33752|NCT03990116|Kangaroo-Mother Care Method|kangaroo-mother care method
33753|NCT03990116|skin to skin|skin to skin
33754|NCT03990116|Extremely Premature infant|extremely premature infant
33755|NCT03990103|Gastric Carcinoma|gastric carcinoma
33756|NCT03990103|Malignant Ascites|malignant ascites
33757|NCT03990103|Intraperitoneal Chemotherapy|intraperitoneal chemotherapy
33758|NCT03990103|Bevacizumab|bevacizumab
33759|NCT03990090|TG103|tg103
33760|NCT03990090|Pharmacokinetic|pharmacokinetic
33761|NCT03990090|Pharmacodynamic|pharmacodynamic
33762|NCT03990090|Safety|safety
33763|NCT03990090|Tolerability|tolerability
33764|NCT03990064|effective connectomic neurological soft signs|effective connectomic neurological soft signs
33765|NCT03989999|Transcranial Doppler|transcranial doppler
33766|NCT03989973|Liver cirrhosis|liver cirrhosis
33767|NCT03989973|Esophageal Varices|esophageal varices
33768|NCT03989973|Liver Stiffness|liver stiffness
33769|NCT03989973|Spleen Stiffness|spleen stiffness
33770|NCT03989960|InSurE|insure
33771|NCT03989960|LISA|lisa
33772|NCT03989960|SNIPPV|snippv
33773|NCT03989947|Dwarfism|dwarfism
33774|NCT03989947|Bone Disease|bone disease
33775|NCT03989947|ACH|ach
33776|NCT03989947|Natriuretic Peptide C-Type|natriuretic peptide c-type
33777|NCT03989947|Musculoskeletal Diseases|musculoskeletal diseases
33778|NCT03989947|Skeletal Dysplasias|skeletal dysplasias
33779|NCT03989934|mindfulness; stress physiology; urban youth|mindfulness; stress physiology; urban youth
33780|NCT03989908|microfludic|microfludic
33781|NCT03989882|wheat germ|wheat germ
33782|NCT03989882|overweight|overweight
33783|NCT03989882|gut microbiome|gut microbiome
33784|NCT03989882|inflammation|inflammation
33785|NCT03989882|insulin resistance|insulin resistance
33786|NCT03989843|ART|art
33787|NCT03989843|Birthweight|birthweight
33788|NCT03989843|Siblings|siblings
33789|NCT03989843|Cryopreservation|cryopreservation
33790|NCT03989843|Epigenetic|epigenetic
33791|NCT03989843|Medical assistance to procreation|medical assistance to procreation
33792|NCT03989830|Endostatins|endostatins
33793|NCT03989830|Head and Neck Neoplasms|head and neck neoplasms
33794|NCT03989804|Fitness center|fitness center
33795|NCT03989804|Physical activity|physical activity
33796|NCT03989804|Follow-up|follow-up
33797|NCT03989804|Members|members
33798|NCT03989804|Visits|visits
33799|NCT03989804|Membership terminations|membership terminations
33800|NCT03989804|Training advisors|training advisors
33801|NCT03989752|Assistive Technology|assistive technology
33802|NCT03989752|Locomotion|locomotion
33803|NCT03989752|Rehabilitation|rehabilitation
33804|NCT03989752|Robotics|robotics
33805|NCT03989739|Cost-effectiveness|cost-effectiveness
33806|NCT03989739|Pancreatectomy|pancreatectomy
33807|NCT03989739|Willingness to pay|willingness to pay
33808|NCT03989739|Robotic|robotic
33809|NCT03989700|Diuretic drugs|diuretic drugs
33810|NCT03989700|Thiamin deficiency|thiamin deficiency
33811|NCT03989674|Glycemic index|glycemic index
33812|NCT03989674|Postprandial hyperglycemia|postprandial hyperglycemia
33813|NCT03989674|Anthocyanin|anthocyanin
33814|NCT03989674|Black rice|black rice
33815|NCT03989635|QAW039|qaw039
33816|NCT03989635|Asthma|asthma
33817|NCT03989635|Sputum|sputum
33818|NCT03989635|Eosinophilia|eosinophilia
33819|NCT03989635|eosinophillic|eosinophillic
33820|NCT03989635|Prostaglandin D2 receptor|prostaglandin d2 receptor
33821|NCT03989635|DP2|dp2
33822|NCT03989635|Fevipiprant.|fevipiprant.
33823|NCT03989622|Retinitis Pigmentosa|retinitis pigmentosa
33824|NCT03989596|Dose Hypofractionation|dose hypofractionation
33825|NCT03989596|Neoadjuvant Therapy|neoadjuvant therapy
33826|NCT03989596|Sarcoma|sarcoma
33827|NCT03989596|Hyperthermia|hyperthermia
33828|NCT03989596|Dose Fractionation|dose fractionation
33829|NCT03989583|Thermography|thermography
33830|NCT03989583|Children|children
33831|NCT03989583|Foot|foot
33832|NCT03989583|Shoes|shoes
33833|NCT03989570|Erector Spinae Plane Block|erector spinae plane block
33834|NCT03989570|Transversus Abdominis Plane Block|transversus abdominis plane block
33835|NCT03989557|Platelet function test|platelet function test
33836|NCT03989557|high platelet reactivity|high platelet reactivity
33837|NCT03989557|light transmittance platelet aggregometry|light transmittance platelet aggregometry
33838|NCT03989544|Pharmacokinetics|pharmacokinetics
33839|NCT03989544|Human monoclonal antibody|human monoclonal antibody
33840|NCT03989544|Tezepelumab|tezepelumab
33841|NCT03989544|Accessorized Pre-filled Syringe|accessorized pre-filled syringe
33842|NCT03989544|Autoinjector|autoinjector
33843|NCT03989531|Cardiogenic Shock|cardiogenic shock
33844|NCT03989531|Adrecizumab|adrecizumab
33845|NCT03989531|Vascular integrity|vascular integrity
33846|NCT03989531|Endothelial dysfunction|endothelial dysfunction
33847|NCT03989518|Imaginal extinction, imaginal exposure, mental imagery|imaginal extinction, imaginal exposure, mental imagery
33849|NCT03989505|Coronary Angiography|coronary angiography
33850|NCT03989505|Contrast|contrast
33851|NCT03989505|Angiography|angiography
33852|NCT03989492|autonomic nervous system|autonomic nervous system
33853|NCT03989492|skin blood flow|skin blood flow
33854|NCT03989492|skin sympathetic nerve activity|skin sympathetic nerve activity
33855|NCT03989479|toothbrush|toothbrush
33856|NCT03989479|plaque removal|plaque removal
33857|NCT03989479|gingival health|gingival health
33858|NCT03989440|myelin-associated inhibitor|myelin-associated inhibitor
33859|NCT03989440|Nogo-A|nogo-a
33860|NCT03989440|MAG|mag
33861|NCT03989440|OMgp|omgp
33862|NCT03989440|Nogo Receptor|nogo receptor
33863|NCT03989427|Gingiva|gingiva
33864|NCT03989427|Gingivitis|gingivitis
33865|NCT03989427|Flossing|flossing
33866|NCT03989427|Brushing|brushing
33867|NCT03989427|Plaque control|plaque control
33868|NCT03989427|Gingival bleeding|gingival bleeding
33869|NCT03989427|Bleeding point index|bleeding point index
33870|NCT03989427|Plaque control record|plaque control record
33871|NCT03989427|Rustogi Modified Navy Plaque Index|rustogi modified navy plaque index
33872|NCT03989427|Dental Plaque|dental plaque
33873|NCT03989427|Tooth brushing|tooth brushing
33874|NCT03989414|Relapsed or Refractory Multiple Myeloma|relapsed or refractory multiple myeloma
33875|NCT03989414|Newly Diagnosed Multiple Myeloma|newly diagnosed multiple myeloma
33876|NCT03989414|Multiple Myeloma|multiple myeloma
33877|NCT03989414|CC-92480|cc-92480
33878|NCT03989401|Nurse|nurse
33879|NCT03989401|Workload|workload
33880|NCT03989401|Multimedia|multimedia
33881|NCT03989401|Patients Satisfaction|patients satisfaction
33882|NCT03989401|Surgery|surgery
33883|NCT03989401|Health Education|health education
33884|NCT03989375|postoperative Cognitive Dysfunction|postoperative cognitive dysfunction
33885|NCT03989375|hip- and knee arthroplasty|hip- and knee arthroplasty
33886|NCT03989375|transcutaneous vagus nerve stimulation|transcutaneous vagus nerve stimulation
33887|NCT03989362|ICOS|icos
33888|NCT03989362|ICOS agonist monoclonal antibody|icos agonist monoclonal antibody
33889|NCT03989362|JTX-2011|jtx-2011
33890|NCT03989362|Vopratelimab|vopratelimab
33891|NCT03989362|Anti-CTLA-4|anti-ctla-4
33892|NCT03989362|Ipilimumab|ipilimumab
33893|NCT03989362|EMERGE|emerge
33894|NCT03989362|Immunotherapy|immunotherapy
33895|NCT03989362|Immuno-Oncology|immuno-oncology
33896|NCT03989362|Cancer|cancer
33897|NCT03989362|Non-small Cell Lung Cancer|non-small cell lung cancer
33898|NCT03989362|Urothelial Cancer|urothelial cancer
33899|NCT03989336|relapsed|relapsed
33900|NCT03989336|refractory|refractory
33901|NCT03989336|anti-PD-1 antibody|anti-pd-1 antibody
33902|NCT03989336|Manganese|manganese
33903|NCT03989336|chemotherapy|chemotherapy
33904|NCT03989310|local advanced|local advanced
33905|NCT03989310|metastatic|metastatic
33906|NCT03989310|anti-PD-1 antibody|anti-pd-1 antibody
33907|NCT03989310|Manganese|manganese
33908|NCT03989310|chemotherapy|chemotherapy
33909|NCT03989297|nasopharyngeal carcinoma|nasopharyngeal carcinoma
33910|NCT03989297|programmed death-ligand 1|programmed death-ligand 1
33911|NCT03989297|prognosis|prognosis
33912|NCT03989271|Inflammation|inflammation
33913|NCT03989271|Oxidative stress|oxidative stress
33914|NCT03989271|Plant polyphenol|plant polyphenol
33915|NCT03989271|Flavonols|flavonols
33916|NCT03989258|Breast cancer|breast cancer
33917|NCT03989258|Screening|screening
33918|NCT03989258|Genetic risk|genetic risk
33919|NCT03989258|Polygenic risk score|polygenic risk score
33920|NCT03989245|Severe disruptive behaviour disorders|severe disruptive behaviour disorders
33921|NCT03989245|Cognitive Behavioural Unit|cognitive behavioural unit
33922|NCT03989245|Geriatric Follow-up and Rehabilitation Care Unit|geriatric follow-up and rehabilitation care unit
33923|NCT03989219|cfDNA methylation|cfdna methylation
33924|NCT03989219|CT follow-up|ct follow-up
33925|NCT03989219|plasma|plasma
33929|NCT03989167|Clinical decision support|clinical decision support
33930|NCT03989141|Buttonhole cannulation|buttonhole cannulation
33931|NCT03989141|Cannulation technique|cannulation technique
33933|NCT03989141|Hemodialysis|hemodialysis
33934|NCT03989141|Arterio venous fistula|arterio venous fistula
33935|NCT03989115|SHP2|shp2
33936|NCT03989115|PTPN11|ptpn11
33937|NCT03989115|NSCLC|nsclc
33938|NCT03989115|KRAS G12|kras g12
33939|NCT03989115|BRAF Class 3|braf class 3
33940|NCT03989115|NF1 LOF|nf1 lof
33941|NCT03989115|KRAS amplification|kras amplification
33942|NCT03989115|KRAS mutations|kras mutations
33943|NCT03989115|advanced solid tumor|advanced solid tumor
33944|NCT03989115|advanced solid malignancies|advanced solid malignancies
33945|NCT03989115|melanoma|melanoma
33946|NCT03989115|skin cancer|skin cancer
33947|NCT03989115|ovarian cancer|ovarian cancer
33948|NCT03989115|pancreatic cancer|pancreatic cancer
33949|NCT03989115|endometrium/uterus cancer|endometrium/uterus cancer
33950|NCT03989115|bladder cancer|bladder cancer
33951|NCT03989115|cervical cancer|cervical cancer
33952|NCT03989115|carcinoma, non-small-cell lung|carcinoma, non-small-cell lung
33953|NCT03989115|neoplasm, squamous cell|neoplasm, squamous cell
33954|NCT03989115|carcinoma, squamous cell|carcinoma, squamous cell
811260|NCT00203892|Pancreas|pancreas
33955|NCT03989115|esophageal neoplasms carcinoma, bronchogenic|esophageal neoplasms carcinoma, bronchogenic
33956|NCT03989115|bronchial neoplasms|bronchial neoplasms
33957|NCT03989115|lung neoplasms|lung neoplasms
33958|NCT03989115|respiratory tract neoplasms|respiratory tract neoplasms
33959|NCT03989115|thoracic neoplasms|thoracic neoplasms
33960|NCT03989115|neoplasms by site|neoplasms by site
33961|NCT03989115|neoplasms|neoplasms
33962|NCT03989115|lung diseases|lung diseases
33963|NCT03989115|respiratory tract diseases|respiratory tract diseases
33969|NCT03989089|Germline APOBEC3B mutation|germline apobec3b mutation
33970|NCT03989089|Pembrolizumab|pembrolizumab
33971|NCT03989063|Motor Learning|motor learning
33972|NCT03989063|Attentional Focus|attentional focus
33973|NCT03989063|Limb Loss|limb loss
33974|NCT03989063|Diabetes|diabetes
33975|NCT03989063|Balance|balance
33976|NCT03989050|Immune Checkpoint Inhibitor|immune checkpoint inhibitor
33977|NCT03989050|Pneumococcal Vaccination|pneumococcal vaccination
33978|NCT03989011|Functional response|functional response
33979|NCT03989011|Abdominal Aortic Aneurysm|abdominal aortic aneurysm
33980|NCT03989011|Cardiovascular events|cardiovascular events
33981|NCT03988985|Depression|depression
33982|NCT03988985|Screening|screening
33983|NCT03988985|Primary Care|primary care
33984|NCT03988985|General Practice|general practice
33985|NCT03988985|Feedback|feedback
33986|NCT03988959|salivary gland tumor|salivary gland tumor
33987|NCT03988933|Latent Tuberculosis|latent tuberculosis
33988|NCT03988933|Rifampin|rifampin
33989|NCT03988933|Short Treatment for Latent Tuberculosis|short treatment for latent tuberculosis
33990|NCT03988933|High dose rifampin|high dose rifampin
33991|NCT03988881|Dobutamine stress echocardiography|dobutamine stress echocardiography
33992|NCT03988881|Fractional flow reserve|fractional flow reserve
33993|NCT03988881|Computed tomography-fractional flow reserve|computed tomography-fractional flow reserve
33994|NCT03988881|Non-culprit lesions|non-culprit lesions
33995|NCT03988881|Myocardial infarction|myocardial infarction
33996|NCT03988881|Lesion specific ischemia|lesion specific ischemia
33997|NCT03988868|optic nerve sheath diameter|optic nerve sheath diameter
33998|NCT03988868|end-tidal carbon dioxide|end-tidal carbon dioxide
33999|NCT03988868|trans-orbital ultrasonography|trans-orbital ultrasonography
34000|NCT03988829|randomized control trial|randomized control trial
34001|NCT03988829|cognitive training|cognitive training
34002|NCT03988829|simulation games|simulation games
34003|NCT03988829|improving brain function|improving brain function
34004|NCT03988829|improving cognition|improving cognition
34005|NCT03988829|functional magnetic resonance imaging|functional magnetic resonance imaging
34006|NCT03988816|bronchiectasis|bronchiectasis
34007|NCT03988816|lung function|lung function
34008|NCT03988816|quality of life|quality of life
34009|NCT03988816|mucus properties|mucus properties
34010|NCT03988777|Breast cancer|breast cancer
34011|NCT03988777|Nonpalpable breast lesions|nonpalpable breast lesions
34012|NCT03988777|Hooked-wire localisation|hooked-wire localisation
34013|NCT03988777|Magnetic seed localisation|magnetic seed localisation
34014|NCT03988738|Blood Donors|blood donors
34015|NCT03988738|Social Media|social media
34016|NCT03988738|Blood Donation|blood donation
34017|NCT03988738|Facebook|facebook
34018|NCT03988738|WhatsApp|whatsapp
34019|NCT03988712|Anaemia|anaemia
34020|NCT03988712|colorectal cancer|colorectal cancer
34021|NCT03988712|Iron deficiency anaemia|iron deficiency anaemia
34023|NCT03988686|prostate cancer|prostate cancer
34024|NCT03988686|radical prostatectomy|radical prostatectomy
34025|NCT03988686|progression-free survival|progression-free survival
34026|NCT03988686|quality of life|quality of life
34027|NCT03988660|Appendicitis|appendicitis
34028|NCT03988660|Fibrocytes|fibrocytes
34029|NCT03988660|Biomarker|biomarker
34030|NCT03988634|Heart failure with preserved ejection fraction (HFpEF)|heart failure with preserved ejection fraction (hfpef)
34031|NCT03988634|Heart failure hospitalization|heart failure hospitalization
34032|NCT03988634|NYHA|nyha
34033|NCT03988634|NT-proBNP|nt-probnp
34034|NCT03988634|Acute decompensated heart failure|acute decompensated heart failure
34035|NCT03988634|Sacubitril/valsartan|sacubitril/valsartan
34036|NCT03988634|Global evaluation of treatment effectiveness (GETE)|global evaluation of treatment effectiveness (gete)
34037|NCT03988621|Self-care|self-care
34038|NCT03988621|Self-efficacy|self-efficacy
34039|NCT03988621|Heart Failure|heart failure
34040|NCT03988621|Stress|stress
34041|NCT03988621|Support Systems|support systems
34042|NCT03988608|Severe Aplastic Anemia|severe aplastic anemia
34043|NCT03988608|Eltrombopag|eltrombopag
34044|NCT03988608|ETB115|etb115
34045|NCT03988608|Chinese subject|chinese subject
34046|NCT03988608|Chinese refractory or relapsed SAA subjects|chinese refractory or relapsed saa subjects
34047|NCT03988608|refractory severe aplastic anemia|refractory severe aplastic anemia
34048|NCT03988608|relapsed severe aplastic anemia|relapsed severe aplastic anemia
34049|NCT03988595|Exercise|exercise
34050|NCT03988595|19-113|19-113
34051|NCT03988582|cytotoxic T cells|cytotoxic t cells
811565|NCT00202228|HAART|haart
34052|NCT03988582|HLA-haplotype|hla-haplotype
34053|NCT03988582|18-315|18-315
34054|NCT03988556|Photobiomodulation|photobiomodulation
34055|NCT03988556|Oral Mucositis|oral mucositis
34056|NCT03988556|Radiation Dermatitis|radiation dermatitis
34057|NCT03988556|Radiotherapy|radiotherapy
34058|NCT03988556|Head and neck cancer|head and neck cancer
34059|NCT03988556|Breast cancer|breast cancer
34060|NCT03988543|Curative Intent|curative intent
34061|NCT03988543|Non-curative Intent|non-curative intent
34062|NCT03988543|Survivorship Care|survivorship care
34063|NCT03988530|Anticholinergic|anticholinergic
34064|NCT03988530|Scopolamine|scopolamine
34065|NCT03988517|fasting|fasting
34066|NCT03988491|Kidney Failure, Chronic|kidney failure, chronic
34067|NCT03988491|Mortality|mortality
34068|NCT03988491|Survival|survival
34069|NCT03988491|Observational Study|observational study
34070|NCT03988491|Incidence|incidence
34071|NCT03988491|Renal Dialysis|renal dialysis
34072|NCT03988465|Viscoelastic testing|viscoelastic testing
34073|NCT03988465|Coagulation|coagulation
34074|NCT03988465|Quantra|quantra
34075|NCT03988465|Hemostasis|hemostasis
34076|NCT03988439|Plaque psoriasis|plaque psoriasis
34079|NCT03988387|Pre-exposure prophylaxis (PrEP)|pre-exposure prophylaxis (prep)
34080|NCT03988387|HIV prevention|hiv prevention
34081|NCT03988387|Adherence|adherence
34082|NCT03988335|PPP|ppp
34083|NCT03988296|Monkey malaria|monkey malaria
34084|NCT03988270|Hemodialysis|hemodialysis
34085|NCT03988270|Fistula|fistula
34086|NCT03988270|Access Failure|access failure
34087|NCT03988270|Hemodialysis Fistula Creation|hemodialysis fistula creation
34088|NCT03988257|Acute diarrhoea|acute diarrhoea
34089|NCT03988257|Infectious diarrhoea|infectious diarrhoea
34090|NCT03988257|Pleuran|pleuran
34091|NCT03988257|Beta-glucan|beta-glucan
34092|NCT03988257|Duration of diarrhoea|duration of diarrhoea
34093|NCT03988257|Severity of diarrhoea|severity of diarrhoea
34094|NCT03988257|Randomized Controlled Trails as Topic|randomized controlled trails as topic
34095|NCT03988218|Body awareness|body awareness
34096|NCT03988218|Interoceptive awareness|interoceptive awareness
34097|NCT03988218|Anorexia Nervosa|anorexia nervosa
34098|NCT03988218|Adolescent|adolescent
34099|NCT03988218|Body image|body image
34100|NCT03988205|Acute Myeloid Leukemia|acute myeloid leukemia
34101|NCT03988205|Outpatient|outpatient
34102|NCT03988205|CPX-351|cpx-351
34103|NCT03988205|VYXEOS|vyxeos
34104|NCT03988179|Attention|attention
34105|NCT03988179|Attentional dysfunction|attentional dysfunction
34106|NCT03988179|Delirium|delirium
34107|NCT03988179|Preoperative|preoperative
34108|NCT03988166|Chronic Total Occlusion|chronic total occlusion
34109|NCT03988166|Percutaneous revascularization|percutaneous revascularization
34110|NCT03988153|Probiotics|probiotics
34111|NCT03988153|cholesterol|cholesterol
34112|NCT03988153|LDL-c|ldl-c
34113|NCT03988153|Hypercholesterolemic|hypercholesterolemic
34114|NCT03988153|Fecal movement|fecal movement
34115|NCT03988140|dental prosthesis|dental prosthesis
34116|NCT03988140|biological markers|biological markers
34117|NCT03988140|dental implants|dental implants
34118|NCT03988036|HR positive|hr positive
34119|NCT03988036|HER2 negative|her2 negative
34120|NCT03988036|Early breast cancer|early breast cancer
34121|NCT03988036|Neoadjuvant|neoadjuvant
34122|NCT03988036|Anti-HER2 therapy|anti-her2 therapy
34123|NCT03988036|Pertuzumab|pertuzumab
34130|NCT03988036|Phase 2|phase 2
34131|NCT03988010|amantadine sulphate|amantadine sulphate
34132|NCT03988010|postoperative cognitive dysfunction|postoperative cognitive dysfunction
34133|NCT03988010|laparoscopic radical prostatectomy|laparoscopic radical prostatectomy
34134|NCT03987997|Intensive Care Units|intensive care units
34135|NCT03987997|Critical Illness|critical illness
34136|NCT03987997|Rehabilitation|rehabilitation
34137|NCT03987997|Muscle atrophy|muscle atrophy
34138|NCT03987997|Muscle weakness|muscle weakness
34139|NCT03987997|Cyclo-ergometer|cyclo-ergometer
34140|NCT03987997|Electrical muscle stimulation|electrical muscle stimulation
34141|NCT03987984|Sensory Feeding Problems|sensory feeding problems
34142|NCT03987958|Acute Myeloid Leukemia|acute myeloid leukemia
34143|NCT03987958|Venetoclax|venetoclax
34144|NCT03987945|atrial fibrillation; left atrial appendage occlusion|atrial fibrillation; left atrial appendage occlusion
34150|NCT03987906|Palliative Care|palliative care
34151|NCT03987906|Symptom control|symptom control
34152|NCT03987906|Quality of life|quality of life
34153|NCT03987906|Satisfaction with care|satisfaction with care
34154|NCT03987906|Targeted referral|targeted referral
34155|NCT03987906|Randomized controlled trial|randomized controlled trial
34156|NCT03987893|PEG3350|peg3350
34157|NCT03987893|hepatic encephalopathy|hepatic encephalopathy
34158|NCT03987893|acute on chronic liver failure|acute on chronic liver failure
34159|NCT03987893|lactulose|lactulose
34160|NCT03987893|rifaximin|rifaximin
34161|NCT03987893|HESA|hesa
34162|NCT03987854|nutrition|nutrition
34163|NCT03987841|Diabetes distress|diabetes distress
34164|NCT03987841|Mindfulness-based intervention|mindfulness-based intervention
34165|NCT03987841|Diabetes self-management education|diabetes self-management education
34166|NCT03987789|Mechanical Ventilation|mechanical ventilation
34167|NCT03987789|Lung-Protective Ventilation|lung-protective ventilation
34168|NCT03987789|Postoperative Pulmonary Complications|postoperative pulmonary complications
34169|NCT03987789|Postoperative morbidity|postoperative morbidity
34170|NCT03987776|anti-inflammatory diet|anti-inflammatory diet
34171|NCT03987776|obesity|obesity
34172|NCT03987776|low-grade inflammation|low-grade inflammation
34173|NCT03987776|cardiometabolic|cardiometabolic
34174|NCT03987776|immunity|immunity
34175|NCT03987763|Plaque psoriasis|plaque psoriasis
34176|NCT03987737|Prostatic neoplasm|prostatic neoplasm
34177|NCT03987737|Prostate|prostate
34178|NCT03987737|bp MRI of the prostate|bp mri of the prostate
34179|NCT03987737|small rectal catheter placement|small rectal catheter placement
34180|NCT03987724|Clinical trial|clinical trial
34181|NCT03987724|Positron emission tomography|positron emission tomography
34182|NCT03987724|Exercise|exercise
34183|NCT03987646|xenograft cortical flexible sheet|xenograft cortical flexible sheet
34184|NCT03987646|fresh extraction socket|fresh extraction socket
34185|NCT03987633|genetic disparity|genetic disparity
34186|NCT03987633|health inequality|health inequality
34187|NCT03987633|genetics|genetics
34188|NCT03987633|health outcomes|health outcomes
34189|NCT03987633|equality|equality
34190|NCT03987620|Vaginitis|vaginitis
34191|NCT03987620|Yeast infection|yeast infection
34192|NCT03987607|neuromuscular monitoring|neuromuscular monitoring
34193|NCT03987607|acceleromyography|acceleromyography
34194|NCT03987607|electromyography|electromyography
34195|NCT03987594|Interstitial Cystitis|interstitial cystitis
34196|NCT03987594|Painful Bladder Syndrome|painful bladder syndrome
34197|NCT03987594|Hydrodistension|hydrodistension
34198|NCT03987594|Transurethral Fulguration|transurethral fulguration
34199|NCT03987542|Acute lymphoblastic leukemia|acute lymphoblastic leukemia
34200|NCT03987542|Asparaginase|asparaginase
34201|NCT03987542|Truncation|truncation
34202|NCT03987542|Toxicitities|toxicitities
34203|NCT03987503|People who inject drugs|people who inject drugs
34204|NCT03987503|Homeless|homeless
34205|NCT03987503|Community-based testing and treatment|community-based testing and treatment
34206|NCT03987490|vaccine|vaccine
34207|NCT03987477|Cognitive Biases|cognitive biases
34208|NCT03987477|Cognitive Bias Modification|cognitive bias modification
34209|NCT03987477|Depression|depression
34210|NCT03987477|Online intervention|online intervention
34211|NCT03987477|Cognitive Bias Interpretation|cognitive bias interpretation
34212|NCT03987464|Alzheimer's Disease|alzheimer's disease
34213|NCT03987464|maladaptive|maladaptive
34214|NCT03987464|behavior|behavior
34215|NCT03987438|Behavioral intervention|behavioral intervention
34216|NCT03987438|Imparied glucose tolerance|imparied glucose tolerance
34217|NCT03987438|Diabetes|diabetes
34218|NCT03987412|Behavioral intervention|behavioral intervention
34219|NCT03987412|First trimester|first trimester
34220|NCT03987412|Gestational diabetes mellitus|gestational diabetes mellitus
34221|NCT03987399|pediatric pain|pediatric pain
34222|NCT03987399|postoperative pain|postoperative pain
34223|NCT03987399|pain assessment|pain assessment
34224|NCT03987399|pain management|pain management
34225|NCT03987399|healthcare providers|healthcare providers
34226|NCT03987399|children|children
34227|NCT03987399|nurses|nurses
34228|NCT03987399|physicians|physicians
34229|NCT03987399|tailored educational intervention|tailored educational intervention
34230|NCT03987399|surgical wards|surgical wards
34231|NCT03987373|CABG|cabg
34232|NCT03987373|Antiplatelet|antiplatelet
34233|NCT03987373|MACE|mace
34234|NCT03987373|grafts patency|grafts patency
34235|NCT03987334|Virtual Reality|virtual reality
34236|NCT03987334|Motor Control|motor control
34237|NCT03987334|Augmented Feedback|augmented feedback
34238|NCT03987334|Chronic Neck Pain|chronic neck pain
34239|NCT03987334|Whiplash|whiplash
34240|NCT03987321|Inferior vena cava|inferior vena cava
34241|NCT03987321|filter|filter
34242|NCT03987321|deep venous thrombosis|deep venous thrombosis
34243|NCT03987321|pulmonary embolism|pulmonary embolism
34244|NCT03987321|complex retrieval|complex retrieval
34245|NCT03987308|Type 2 diabetic patients|type 2 diabetic patients
34246|NCT03987308|Beinaglutide injection solution|beinaglutide injection solution
34247|NCT03987308|Insulin aspart injection solution|insulin aspart injection solution
34248|NCT03987256|tennis elbow|tennis elbow
34249|NCT03987256|PRP|prp
34250|NCT03987256|Focussed shockwave therapy|focussed shockwave therapy
34251|NCT03987256|needling|needling
34252|NCT03987256|tendinopathy|tendinopathy
34253|NCT03987243|Spinal Cord Injury|spinal cord injury
34254|NCT03987243|Seating Pressure Mapping|seating pressure mapping
34255|NCT03987243|Pressure Injury Prevention|pressure injury prevention
34256|NCT03987243|Seating Interface Pressure|seating interface pressure
34257|NCT03987243|Wheelchair User|wheelchair user
34258|NCT03987178|hot tub|hot tub
34259|NCT03987178|conjunctival cultures|conjunctival cultures
34260|NCT03987178|bacterial keratitis|bacterial keratitis
34261|NCT03987165|Neonatal Opioid Withdrawal Syndrome|neonatal opioid withdrawal syndrome
34262|NCT03987152|Sirolimus|sirolimus
34263|NCT03987152|mTor inhibitor|mtor inhibitor
34264|NCT03987152|Quality of life|quality of life
34265|NCT03987152|mammalian target of rapamycin (mTOR)|mammalian target of rapamycin (mtor)
34266|NCT03987139|cerebral autoregulation|cerebral autoregulation
34267|NCT03987022|Anti-inflammatory agents non-steroidal|anti-inflammatory agents non-steroidal
34268|NCT03986996|Ulcerative Colitis|ulcerative colitis
34269|NCT03986983|Gynoid Lipodystrophy|gynoid lipodystrophy
34270|NCT03986983|Shock Wave Therapy|shock wave therapy
34271|NCT03986983|Aerobic Exercise|aerobic exercise
34272|NCT03986970|Pre-exposure prophylaxis|pre-exposure prophylaxis
34273|NCT03986957|Vascular Cognitive Impairment|vascular cognitive impairment
34274|NCT03986957|Magnetic Resonance Imaging|magnetic resonance imaging
34275|NCT03986957|Blood Pressure Variability|blood pressure variability
34276|NCT03986944|Dysmenorrhea|dysmenorrhea
34277|NCT03986944|Dyspareunia|dyspareunia
34278|NCT03986944|Dyschezia|dyschezia
34279|NCT03986944|Non-menstrual pelvic pain|non-menstrual pelvic pain
34280|NCT03986892|fitness|fitness
34281|NCT03986892|exercise|exercise
34282|NCT03986892|vascular function|vascular function
34283|NCT03986879|Physical Activity|physical activity
34284|NCT03986879|Cardiovascular Health|cardiovascular health
34285|NCT03986879|Epidemiological|epidemiological
34286|NCT03986840|Frailty|frailty
34287|NCT03986840|Exercise|exercise
34288|NCT03986840|Aging|aging
34289|NCT03986827|Social anxiety disorder|social anxiety disorder
34290|NCT03986827|Social phobia|social phobia
34291|NCT03986827|Youth|youth
34292|NCT03986827|Cognitive behavioral therapy|cognitive behavioral therapy
34293|NCT03986827|Adolescents|adolescents
34294|NCT03986775|Glycemic Index|glycemic index
34295|NCT03986775|Overweight|overweight
34296|NCT03986775|Endothelial function|endothelial function
34297|NCT03986775|carbohydrate|carbohydrate
34298|NCT03986749|arthroscopic rotator cuff repair|arthroscopic rotator cuff repair
34299|NCT03986749|bursa augmentation|bursa augmentation
34300|NCT03986749|neovascularization|neovascularization
34301|NCT03986749|Doppler ultrasonography|doppler ultrasonography
34302|NCT03986736|rhabdomyolysis|rhabdomyolysis
34303|NCT03986736|tissue injury|tissue injury
34304|NCT03986736|alarmins|alarmins
34305|NCT03986736|major trauma|major trauma
34306|NCT03986736|acute kidney injury|acute kidney injury
34307|NCT03986723|traditional plaster model|traditional plaster model
34308|NCT03986723|3D printed model|3d printed model
34309|NCT03986723|digital workflow|digital workflow
34310|NCT03986723|reliability|reliability
34311|NCT03986723|time efficiency|time efficiency
34312|NCT03986710|3D virtual planning software|3d virtual planning software
34313|NCT03986710|timing|timing
34314|NCT03986697|HIV|hiv
34315|NCT03986697|Coronary Artery Disease|coronary artery disease
34316|NCT03986697|Atherosclerosis|atherosclerosis
34526|NCT03985618|C-section|c-section
34317|NCT03986697|Antiretroviral therapy|antiretroviral therapy
34318|NCT03986697|Computed tomography|computed tomography
34319|NCT03986658|Major Depressive Disorder|major depressive disorder
34320|NCT03986658|Repetitive Transcranial Magnetic Stimulation (rTMS)|repetitive transcranial magnetic stimulation (rtms)
34321|NCT03986658|Treatment-Resistant Depression|treatment-resistant depression
34322|NCT03986658|Adolescents|adolescents
34323|NCT03986645|4DFlow|4dflow
34324|NCT03986632|Healthy Eating|healthy eating
34325|NCT03986632|Alaska Native|alaska native
34326|NCT03986632|Traditional Foods|traditional foods
34327|NCT03986619|Food preferences|food preferences
34328|NCT03986619|Food reward|food reward
34329|NCT03986606|neoplasm|neoplasm
34330|NCT03986606|checkpoint inhibitor|checkpoint inhibitor
34331|NCT03986606|combination|combination
34332|NCT03986606|immunotherapy|immunotherapy
34333|NCT03986567|Mobile Applications|mobile applications
34334|NCT03986567|Contact Tracing|contact tracing
34335|NCT03986567|Game Theory|game theory
34336|NCT03986567|Adolescent|adolescent
34337|NCT03986554|Swallowing|swallowing
34338|NCT03986541|colorectal cancer|colorectal cancer
34339|NCT03986541|anti-EGFR agents|anti-egfr agents
34340|NCT03986541|cetuximab|cetuximab
34341|NCT03986541|panitumumab|panitumumab
34342|NCT03986541|amphiregulin|amphiregulin
34343|NCT03986541|epiregulin|epiregulin
34344|NCT03986541|EGFR|egfr
34345|NCT03986528|Advanced Non-Small Cell Lung Cancer|advanced non-small cell lung cancer
34346|NCT03986528|Kanglaite Injection|kanglaite injection
34347|NCT03986489|Dance/movement therapy|dance/movement therapy
34348|NCT03986489|Mindfulness-based dance/movement therapy|mindfulness-based dance/movement therapy
34349|NCT03986489|Chronic pain management|chronic pain management
34350|NCT03986489|Creative Arts Therapies|creative arts therapies
34351|NCT03986489|Non-pharmacological intervention|non-pharmacological intervention
34352|NCT03986450|Enhanced recovery after surgery|enhanced recovery after surgery
34353|NCT03986450|Laparoscopic hysterectomy|laparoscopic hysterectomy
811675|NCT00201877|Follicular|follicular
34354|NCT03986437|Differentiated Thyroid Cancer|differentiated thyroid cancer
34355|NCT03986437|Iodine-131|iodine-131
34356|NCT03986437|Thyroidectomy|thyroidectomy
34357|NCT03986411|urinary incontinence|urinary incontinence
34358|NCT03986411|pelvic floor|pelvic floor
34359|NCT03986411|athlete|athlete
34360|NCT03986359|low-intensity extracorporeal shockwave therapy|low-intensity extracorporeal shockwave therapy
34361|NCT03986359|Erectile Dysfunction|erectile dysfunction
34362|NCT03986346|scar|scar
34363|NCT03986346|pulsed dye laser|pulsed dye laser
34364|NCT03986320|Keeogo™|keeogo™
34365|NCT03986320|Dermoskeleton|dermoskeleton
34366|NCT03986320|Powered dermoskeleton|powered dermoskeleton
34367|NCT03986320|Lower limb dermoskeleton|lower limb dermoskeleton
34368|NCT03986320|Assistive exoskeleton|assistive exoskeleton
34369|NCT03986320|Orthotic dermoskeleton|orthotic dermoskeleton
34370|NCT03986307|muscle metabolism|muscle metabolism
34371|NCT03986307|inflammation|inflammation
34372|NCT03986307|muscle molecular signaling|muscle molecular signaling
34373|NCT03986307|muscle functioning|muscle functioning
34374|NCT03986294|Liposomal irinotecan|liposomal irinotecan
34375|NCT03986294|S1|s1
34376|NCT03986294|Pancreatic cancer|pancreatic cancer
34377|NCT03986294|Second line|second line
34378|NCT03986281|Wearable devices|wearable devices
34379|NCT03986281|Blood pressure|blood pressure
34380|NCT03986281|Arterial line|arterial line
34381|NCT03986281|Hypertension|hypertension
34382|NCT03986281|Post Operative|post operative
34383|NCT03986281|Cardiac Surgery|cardiac surgery
34384|NCT03986268|neoadjuvant treatment|neoadjuvant treatment
34385|NCT03986268|Breast Cancer|breast cancer
34386|NCT03986268|Vitamin D3|vitamin d3
34387|NCT03986242|Delayed-onset muscle soreness|delayed-onset muscle soreness
34388|NCT03986242|vibration therapy|vibration therapy
34389|NCT03986242|foam roller|foam roller
34390|NCT03986242|stretching exercise|stretching exercise
34391|NCT03986242|recovery|recovery
34392|NCT03986242|performance|performance
34393|NCT03986229|ehlers-danlos syndrome|ehlers-danlos syndrome
34394|NCT03986229|static balance|static balance
34395|NCT03986229|custom compression garments|custom compression garments
34396|NCT03986216|Stroke rehabilitation|stroke rehabilitation
34397|NCT03986216|Hand opening|hand opening
34398|NCT03986216|Functional electrical stimulation|functional electrical stimulation
34399|NCT03986216|Home-based intervention|home-based intervention
34400|NCT03986216|Task-specific practice|task-specific practice
34401|NCT03986216|Device-assisted practice|device-assisted practice
34402|NCT03986203|Low bone mass|low bone mass
34403|NCT03986203|Osteoporosis|osteoporosis
34404|NCT03986190|Hispanic|hispanic
34405|NCT03986190|family|family
34406|NCT03986190|digital health|digital health
34407|NCT03986190|obesity prevention|obesity prevention
34408|NCT03986190|physical activity|physical activity
34409|NCT03986190|nutrition|nutrition
34410|NCT03986177|Implementation Science|implementation science
34411|NCT03986177|Global Health|global health
34412|NCT03986177|Peru|peru
34413|NCT03986164|Guided Surgery|guided surgery
34414|NCT03986164|Linear Shifts|linear shifts
34418|NCT03986151|radial access|radial access
34419|NCT03986151|distal radial access|distal radial access
34420|NCT03986151|anatomical snuffbox|anatomical snuffbox
34421|NCT03986151|radial artery occlusion|radial artery occlusion
34422|NCT03986125|college students|college students
34423|NCT03986125|anxiety|anxiety
34424|NCT03986125|somatic symptoms|somatic symptoms
34425|NCT03986112|carotid sonography|carotid sonography
34426|NCT03986112|inferior vena cava sonography|inferior vena cava sonography
34427|NCT03986112|hypertension|hypertension
34428|NCT03986112|general anesthesia|general anesthesia
34429|NCT03986112|predictive power|predictive power
34430|NCT03986099|Children and adolescents|children and adolescents
34431|NCT03986099|HIV therapy|hiv therapy
34432|NCT03986099|Virologic suppression|virologic suppression
34433|NCT03986099|Zimbabwe|zimbabwe
34434|NCT03986099|Rural|rural
34435|NCT03986099|GeneXpert|genexpert
34436|NCT03986099|Point of care|point of care
34437|NCT03986099|SAMBA|samba
34438|NCT03986047|Thermal therapy|thermal therapy
34439|NCT03986047|Exercises|exercises
34440|NCT03986047|Pain|pain
34441|NCT03986047|Disability|disability
34442|NCT03986047|Acute pain|acute pain
34443|NCT03986034|ramp up|ramp up
34444|NCT03986034|Rituximab|rituximab
34445|NCT03986034|Tumor|tumor
34446|NCT03986034|Treatment|treatment
34447|NCT03986034|Cancer|cancer
34452|NCT03985995|Cannabidiol (CBD)|cannabidiol (cbd)
34453|NCT03985969|Healthy volunteers|healthy volunteers
34454|NCT03985969|Elafibranor|elafibranor
34455|NCT03985956|Daily Living Activities|daily living activities
34456|NCT03985956|Exercise|exercise
34457|NCT03985930|Infant|infant
34458|NCT03985930|Child|child
34459|NCT03985930|Virtual Reality|virtual reality
34460|NCT03985930|Procedural Pain|procedural pain
34461|NCT03985917|Singing Group|singing group
34462|NCT03985917|Choir|choir
34463|NCT03985917|Intervention|intervention
34464|NCT03985917|Older Adults|older adults
34465|NCT03985917|Well-Being|well-being
34466|NCT03985917|Cognitive Function|cognitive function
34467|NCT03985917|General Health|general health
34468|NCT03985904|mental health recovery|mental health recovery
34469|NCT03985904|art therapy|art therapy
34470|NCT03985904|museum|museum
34471|NCT03985891|Colon cancer|colon cancer
34472|NCT03985891|PD-1|pd-1
34473|NCT03985891|Chemotherapy|chemotherapy
34474|NCT03985878|DMD|dmd
34475|NCT03985878|Duchenne|duchenne
34476|NCT03985878|Eteplirsen|eteplirsen
34477|NCT03985878|Dystrophy|dystrophy
34478|NCT03985878|Dystrophin|dystrophin
34479|NCT03985878|Exon Skipping|exon skipping
34480|NCT03985878|Exon 51|exon 51
34481|NCT03985878|Ambulatory|ambulatory
34482|NCT03985878|Pediatric|pediatric
34483|NCT03985865|Bitter|bitter
34484|NCT03985865|Motilin|motilin
34485|NCT03985865|Ghrelin|ghrelin
34486|NCT03985865|CCK|cck
34487|NCT03985865|GLP-1|glp-1
34488|NCT03985865|SST|sst
34489|NCT03985865|Denatonium benzoate|denatonium benzoate
34490|NCT03985865|Quinine hydrochloride|quinine hydrochloride
34491|NCT03985839|Microraptor, suture anchor, knotted, Smith and Nephew|microraptor, suture anchor, knotted, smith and nephew
34492|NCT03985787|Resistance Exercise|resistance exercise
34493|NCT03985787|Appetite Regulation|appetite regulation
34494|NCT03985761|Stroke|stroke
34495|NCT03985761|Upper extremity|upper extremity
34496|NCT03985761|Hand|hand
34497|NCT03985761|Arm|arm
34498|NCT03985761|Virtual reality|virtual reality
34499|NCT03985761|Telerehabilitation|telerehabilitation
34500|NCT03985761|Gaming|gaming
34501|NCT03985761|Hemiparesis|hemiparesis
34502|NCT03985761|Dexterity|dexterity
34503|NCT03985748|Nebulizer|nebulizer
34504|NCT03985748|Breath Actuated Nebulizer|breath actuated nebulizer
34505|NCT03985722|advanced soft-tissue sarcoma|advanced soft-tissue sarcoma
34506|NCT03985709|Osteoarthritis|osteoarthritis
34507|NCT03985709|Microbiota|microbiota
34508|NCT03985709|Probiotic|probiotic
34509|NCT03985696|B cells|b cells
34510|NCT03985696|exosomes|exosomes
34511|NCT03985696|immunotherapy|immunotherapy
34512|NCT03985696|Lymphomas|lymphomas
34513|NCT03985696|DLBCL|dlbcl
34514|NCT03985683|Agility training|agility training
34515|NCT03985683|Carbohydrate loading|carbohydrate loading
34516|NCT03985683|Effects on performance|effects on performance
34517|NCT03985631|Tai Chi|tai chi
34518|NCT03985631|Telerehabilitation|telerehabilitation
34519|NCT03985631|Parkinson Disease|parkinson disease
34520|NCT03985618|obesity|obesity
34521|NCT03985618|pregnancy|pregnancy
34522|NCT03985618|labour|labour
34523|NCT03985618|labor|labor
34524|NCT03985618|caesarean|caesarean
34525|NCT03985618|cesarean|cesarean
34527|NCT03985618|induction|induction
34528|NCT03985605|TDM|tdm
34529|NCT03985605|Routine|routine
34530|NCT03985605|intensive care patients|intensive care patients
34531|NCT03985553|Parenting|parenting
34532|NCT03985553|Spinal Cord Injuries|spinal cord injuries
34533|NCT03985553|Self-Management|self-management
34534|NCT03985553|Occupational Therapy|occupational therapy
34535|NCT03985488|endoscopy|endoscopy
34536|NCT03985488|fluoroscopy|fluoroscopy
34537|NCT03985488|radiation exposure|radiation exposure
34538|NCT03985449|Implementation|implementation
34539|NCT03985449|Shared decision making|shared decision making
34540|NCT03985449|Patient Decision Aids|patient decision aids
34541|NCT03985449|Decision Support Intervention|decision support intervention
34542|NCT03985449|Uterine Fibroids|uterine fibroids
34543|NCT03985449|Normalization Process Theory|normalization process theory
34544|NCT03985449|Consolidated Framework for Implementation Research|consolidated framework for implementation research
34545|NCT03985449|Picture Superiority|picture superiority
34546|NCT03985449|Electronic Health Record|electronic health record
34547|NCT03985449|Coproduction|coproduction
34548|NCT03985423|interferon gamma|interferon gamma
34549|NCT03985423|emapalumab|emapalumab
34550|NCT03985423|adult HLH|adult hlh
34551|NCT03985423|malignancy-associated HLH|malignancy-associated hlh
34552|NCT03985423|CXCL9|cxcl9
34553|NCT03985410|Acinetobacter baumannii-calcoaceticus|acinetobacter baumannii-calcoaceticus
34554|NCT03985410|complex infections|complex infections
34555|NCT03985410|ETX2514|etx2514
34556|NCT03985410|cardiac repolarization|cardiac repolarization
34557|NCT03985410|heart rate-corrected QT interval (QTc)|heart rate-corrected qt interval (qtc)
34558|NCT03985397|discharge training|discharge training
34559|NCT03985397|acute myocardial infarction|acute myocardial infarction
34560|NCT03985397|compliance to drug|compliance to drug
34561|NCT03985397|compliance to diet|compliance to diet
34562|NCT03985397|CARRF-KL.|carrf-kl.
34563|NCT03985371|Band Keratopathy|band keratopathy
34564|NCT03985358|opioid counseling|opioid counseling
34565|NCT03985358|bilateral reduction mammoplasty|bilateral reduction mammoplasty
34566|NCT03985332|evolution of the rate|evolution of the rate
811676|NCT00201877|Mantle Cell|mantle cell
34567|NCT03985332|causes of death in geriatric SSR|causes of death in geriatric ssr
34568|NCT03985306|Diabetic foot ulcer|diabetic foot ulcer
34569|NCT03985306|Wound treatment|wound treatment
34570|NCT03985306|Inforatio technique|inforatio technique
34571|NCT03985306|Diabetes|diabetes
34572|NCT03985306|Foot ulcer|foot ulcer
34573|NCT03985306|Outpatient clinic|outpatient clinic
34574|NCT03985306|Feasibility trial|feasibility trial
34575|NCT03985306|Punch biopsy|punch biopsy
34576|NCT03985306|Foot ulcer treatment|foot ulcer treatment
34577|NCT03985280|Cooled radiofrequency|cooled radiofrequency
34578|NCT03985280|Radiofrequency|radiofrequency
34579|NCT03985280|Hip pain|hip pain
34580|NCT03985267|mindfulness|mindfulness
34581|NCT03985267|breast cancer|breast cancer
34582|NCT03985267|psycho-oncology|psycho-oncology
34583|NCT03985267|clinical health psychology|clinical health psychology
34584|NCT03985267|ontology|ontology
34585|NCT03985267|swinging effect intervention|swinging effect intervention
34586|NCT03985267|breathing technique|breathing technique
34587|NCT03985267|guided imagery|guided imagery
34588|NCT03985267|cognitive behavioural therapy|cognitive behavioural therapy
34589|NCT03985241|Intracoronary Electrocardiogram|intracoronary electrocardiogram
34590|NCT03985241|Fractional Flow Reserve|fractional flow reserve
34591|NCT03985241|Collateral Flow Index|collateral flow index
34592|NCT03985241|Dobutamine|dobutamine
34593|NCT03985228|golden milk, insomnia, gut-brain axis|golden milk, insomnia, gut-brain axis
34594|NCT03985215|Aftercare|aftercare
34595|NCT03985202|exercise programme|exercise programme
34596|NCT03985176|aneurysmal subarachnoid hemorrhage|aneurysmal subarachnoid hemorrhage
34597|NCT03985176|delayed cerebral ischemia|delayed cerebral ischemia
34598|NCT03985176|Intensive Care Unit|intensive care unit
34599|NCT03985176|Neurosurgery|neurosurgery
34600|NCT03985163|Patient Reported Outcomes|patient reported outcomes
34601|NCT03985163|Clinical Data Research|clinical data research
34602|NCT03985163|Electronic Health Records|electronic health records
34603|NCT03985111|perioperative care|perioperative care
34604|NCT03985111|perioperative blood pressure management|perioperative blood pressure management
34605|NCT03985111|perioperative fluid management|perioperative fluid management
34606|NCT03985098|Motivational interviewing|motivational interviewing
34607|NCT03985098|trajectory modeling|trajectory modeling
34608|NCT03985098|medication adherence|medication adherence
34609|NCT03985085|female sex workers|female sex workers
34610|NCT03985072|Neoplasm|neoplasm
34611|NCT03985072|Solid Tumor|solid tumor
34612|NCT03985072|Cancer|cancer
34613|NCT03985059|Verticalization|verticalization
34614|NCT03985059|Doppler|doppler
34615|NCT03985059|Intracranial hemodynamic|intracranial hemodynamic
34616|NCT03985059|Cerebral artery velocity|cerebral artery velocity
34617|NCT03985007|chidamide|chidamide
34618|NCT03985007|decitabine|decitabine
34619|NCT03985007|priming regimen|priming regimen
34620|NCT03984994|muscle|muscle
34621|NCT03984994|capillary|capillary
34622|NCT03984994|exercise|exercise
34623|NCT03984981|diagnosis of brain death|diagnosis of brain death
34624|NCT03984968|feeding T cell|feeding t cell
34625|NCT03984968|CD19 CAR-T therapy|cd19 car-t therapy
34626|NCT03984942|Knee Arthroplasty|knee arthroplasty
34627|NCT03984942|Hip Arthroplasty|hip arthroplasty
34628|NCT03984942|Postoperative Anaesthesia Care Unit|postoperative anaesthesia care unit
34629|NCT03984929|Conexion|conexion
34630|NCT03984929|Diabetes|diabetes
34631|NCT03984929|Depression|depression
34632|NCT03984929|Low-income|low-income
34633|NCT03984929|Hispanic|hispanic
34634|NCT03984916|hesperidin|hesperidin
34635|NCT03984916|orange extract|orange extract
34636|NCT03984903|Back Pain without Radiation|back pain without radiation
34637|NCT03984903|Low Back Pain, Mechanical|low back pain, mechanical
34638|NCT03984877|TAVI|tavi
34639|NCT03984877|Aortic Stenosis|aortic stenosis
34640|NCT03984877|Cardiac amyloidosis|cardiac amyloidosis
34641|NCT03984851|tonsillectomy|tonsillectomy
34642|NCT03984851|primary hemostasis tonsillectomy|primary hemostasis tonsillectomy
34643|NCT03984851|surgicel|surgicel
34768|NCT03984253|Asthma|asthma
34644|NCT03984838|Dolutegravir, Rilpivirine, HIV infection, Fixed-dose combination, Japanese, Pharmacokinetics|dolutegravir, rilpivirine, hiv infection, fixed-dose combination, japanese, pharmacokinetics
34645|NCT03984825|GSK3640254|gsk3640254
34646|NCT03984825|ethinyl estradiol|ethinyl estradiol
34647|NCT03984825|levonorgestrel|levonorgestrel
34648|NCT03984825|oral contraceptive|oral contraceptive
34649|NCT03984825|drug-drug interaction|drug-drug interaction
34650|NCT03984812|DAIDS, FTIH, HIV-1, MAD, SAD|daids, ftih, hiv-1, mad, sad
34651|NCT03984786|alcohol misuse|alcohol misuse
34652|NCT03984786|internet|internet
34653|NCT03984786|guidance|guidance
34654|NCT03984786|ICBT|icbt
34655|NCT03984786|cognitive behaviour therapy|cognitive behaviour therapy
34656|NCT03984786|assessment|assessment
34657|NCT03984773|serious illness conversations|serious illness conversations
34658|NCT03984773|advance care planning|advance care planning
34659|NCT03984773|mortality estimates|mortality estimates
34660|NCT03984773|nudge|nudge
34661|NCT03984773|pre-commitment|pre-commitment
34662|NCT03984773|opt-out|opt-out
34663|NCT03984760|Kidney Diseases|kidney diseases
34664|NCT03984760|Kidney Failure, Chronic|kidney failure, chronic
34665|NCT03984760|Hyperphosphatemia|hyperphosphatemia
34666|NCT03984760|Urologic Diseases|urologic diseases
34667|NCT03984760|Renal Insufficiency, Chronic|renal insufficiency, chronic
34668|NCT03984760|Renal Insufficiency|renal insufficiency
34669|NCT03984760|Phosphorus Metabolism Disorder|phosphorus metabolism disorder
34670|NCT03984747|transplant|transplant
34671|NCT03984747|kidney|kidney
34672|NCT03984747|renal|renal
34673|NCT03984747|allograft|allograft
34674|NCT03984747|cell-free DNA|cell-free dna
34675|NCT03984734|Delayed Gastric Emptying|delayed gastric emptying
34676|NCT03984734|Pylorus-preserving pancreatoduodenectomy|pylorus-preserving pancreatoduodenectomy
34677|NCT03984721|Mass spectrometry based proteomic analysis|mass spectrometry based proteomic analysis
34678|NCT03984721|NanoLC-MS/MS|nanolc-ms/ms
34679|NCT03984721|Amyloidosis typing|amyloidosis typing
34680|NCT03984708|Amyotrophic Lateral Sclerosis|amyotrophic lateral sclerosis
34681|NCT03984708|Metabolomics|metabolomics
34682|NCT03984708|Transcriptomics|transcriptomics
34683|NCT03984708|Biomarkers|biomarkers
34684|NCT03984708|Fibroblast|fibroblast
34685|NCT03984695|Jail|jail
34686|NCT03984695|Vulnerable Populations|vulnerable populations
34687|NCT03984695|STD Screening|std screening
34688|NCT03984695|unintended pregnancy|unintended pregnancy
34689|NCT03984682|Joint Crisis Plan|joint crisis plan
34690|NCT03984682|Internalized Stigma of Mental Illness (ISMI)|internalized stigma of mental illness (ismi)
34691|NCT03984682|Isolation|isolation
34692|NCT03984682|physical restraint|physical restraint
34693|NCT03984682|Psychiatry|psychiatry
34694|NCT03984669|juvenile idiopathic arthritis|juvenile idiopathic arthritis
34695|NCT03984669|(1,3)-beta-D-glucan|(1,3)-beta-d-glucan
34696|NCT03984669|children|children
34697|NCT03984669|inflammatory status|inflammatory status
34698|NCT03984669|intestinal microbiota|intestinal microbiota
34699|NCT03984669|activity od the disease|activity od the disease
34700|NCT03984656|serratus plane block|serratus plane block
34701|NCT03984656|analgesia|analgesia
34702|NCT03984656|pleural drainage|pleural drainage
34703|NCT03984656|lidocaine|lidocaine
34704|NCT03984656|intensive care unit|intensive care unit
34705|NCT03984630|Dietary Fiber|dietary fiber
34706|NCT03984630|Gestational weight gain|gestational weight gain
34707|NCT03984604|sleep|sleep
34708|NCT03984604|cannabis|cannabis
34709|NCT03984604|primary insomnia|primary insomnia
34710|NCT03984591|aldosterone antagonists|aldosterone antagonists
34711|NCT03984591|spironolactone|spironolactone
34712|NCT03984591|eplerenone|eplerenone
34713|NCT03984591|mortality|mortality
34714|NCT03984565|Cannabidiol|cannabidiol
34715|NCT03984565|Medical Marijuana|medical marijuana
34717|NCT03984552|rapid test|rapid test
34718|NCT03984552|HIV infection|hiv infection
34719|NCT03984552|vertical transmission|vertical transmission
34720|NCT03984500|Sickle Cell Trait|sickle cell trait
34721|NCT03984500|Education|education
34722|NCT03984474|Anterior Cruciate Ligament Reconstruction|anterior cruciate ligament reconstruction
34723|NCT03984474|Patient-reported outcome|patient-reported outcome
34724|NCT03984474|Meniscus|meniscus
34725|NCT03984474|Cartilage|cartilage
34726|NCT03984461|Osteoarthritis|osteoarthritis
34727|NCT03984461|Platelet Rich Plasma (PRP)|platelet rich plasma (prp)
34728|NCT03984461|Micronized Lipoaspirate (MAT)|micronized lipoaspirate (mat)
34729|NCT03984461|Bone Marrow Aspirate (BMA)|bone marrow aspirate (bma)
34730|NCT03984435|Radiotherapy|radiotherapy
34731|NCT03984435|Experiences|experiences
34732|NCT03984435|Comfort management|comfort management
34733|NCT03984435|Patients|patients
34734|NCT03984435|Radiographers|radiographers
34735|NCT03984422|smartphone application|smartphone application
34736|NCT03984422|monitoring|monitoring
34737|NCT03984396|dementia|dementia
34738|NCT03984396|cognitive impairment|cognitive impairment
34739|NCT03984396|multimorbidity/comorbidity|multimorbidity/comorbidity
34740|NCT03984396|polypharmacy|polypharmacy
34741|NCT03984396|deprescriptions|deprescriptions
34742|NCT03984396|patient education|patient education
34743|NCT03984383|Endothelial cells|endothelial cells
34744|NCT03984383|inflammation|inflammation
34745|NCT03984383|endothelial dysfunction|endothelial dysfunction
34746|NCT03984383|IL-33|il-33
34747|NCT03984383|Endocan|endocan
34748|NCT03984357|PD-1 blockade|pd-1 blockade
34749|NCT03984357|immune checkpoint inhibitor|immune checkpoint inhibitor
34750|NCT03984357|induction chemotherapy|induction chemotherapy
34751|NCT03984357|radiotherapy|radiotherapy
34752|NCT03984344|Theta Burst Stimulation|theta burst stimulation
34753|NCT03984344|Neuromodulation|neuromodulation
34754|NCT03984344|Psychiatric Disorders|psychiatric disorders
34755|NCT03984344|Transcranial Magnetic Stimulation|transcranial magnetic stimulation
34756|NCT03984344|Anorexia Nervosa|anorexia nervosa
34757|NCT03984344|Eating Disorders|eating disorders
34758|NCT03984331|Fish skin|fish skin
34759|NCT03984331|Full thickness burn|full thickness burn
34760|NCT03984331|Burns|burns
34761|NCT03984331|Cadaver Skin|cadaver skin
34762|NCT03984331|Split Thickness Skin Graft|split thickness skin graft
34763|NCT03984331|Temporary Cover|temporary cover
34764|NCT03984331|Blaze|blaze
34765|NCT03984331|Kerecis|kerecis
34766|NCT03984305|Personal KinetiGraph (PKG) Movement Recording System|personal kinetigraph (pkg) movement recording system
34767|NCT03984305|Objective Measurement|objective measurement
34769|NCT03984253|Severe|severe
34770|NCT03984253|Register|register
34771|NCT03984240|midazolam, dexmedetomidine, motor function|midazolam, dexmedetomidine, motor function
34772|NCT03984214|Dronabinol|dronabinol
34773|NCT03984214|THC|thc
34774|NCT03984214|Placebo|placebo
34775|NCT03984214|Pancreatic Cancer|pancreatic cancer
34776|NCT03984214|Chemotherapy-induced Nausea and Vomiting|chemotherapy-induced nausea and vomiting
34777|NCT03984214|Tumor related symptoms|tumor related symptoms
34778|NCT03984214|Quality of life|quality of life
34779|NCT03984214|EORTC QLQ-C30|eortc qlq-c30
34780|NCT03984214|FOLFIRINOX|folfirinox
34781|NCT03984214|Abraxane|abraxane
34782|NCT03984214|Gemcitabine|gemcitabine
34783|NCT03984201|Chronic Pain|chronic pain
34784|NCT03984201|Repetitive Transcranial Magnetic Stimulation (rTMS)|repetitive transcranial magnetic stimulation (rtms)
34785|NCT03984201|Accelerated Theta Burst Stimulation (aTBS)|accelerated theta burst stimulation (atbs)
34786|NCT03984201|Stanford Accelerated Intelligent Neuromodulation Therapy (SAINT)|stanford accelerated intelligent neuromodulation therapy (saint)
34787|NCT03984188|Biomass Associated COPD|biomass associated copd
34788|NCT03984188|Low-dose Theophylline|low-dose theophylline
34789|NCT03984175|ARDS|ards
34790|NCT03984175|Lung Protective Mechanical Ventilation|lung protective mechanical ventilation
34791|NCT03984175|Clinical Decision Support|clinical decision support
34792|NCT03984149|Atherosclerosis|atherosclerosis
34793|NCT03984149|Familial hypercholesterolemia|familial hypercholesterolemia
34794|NCT03984149|LIPA|lipa
34795|NCT03984149|Lysosomal acid lipase deficiency|lysosomal acid lipase deficiency
34796|NCT03984149|Wolman disease|wolman disease
34797|NCT03984136|HIV testing|hiv testing
34798|NCT03984136|Men who have sex with men|men who have sex with men
34799|NCT03984123|Remote Ischemic Conditioning|remote ischemic conditioning
34800|NCT03984123|Endothelial glycocalyx|endothelial glycocalyx
34801|NCT03984123|Arterial stiffness|arterial stiffness
34802|NCT03984123|micro RNA|micro rna
34803|NCT03984123|NO pathway|no pathway
34804|NCT03984097|Drug Therapy|drug therapy
34805|NCT03984097|TAK-079|tak-079
34806|NCT03984097|CD38|cd38
34807|NCT03984097|Monoclonal Antibody|monoclonal antibody
34808|NCT03984097|Lenalidomide|lenalidomide
34809|NCT03984097|Bortezomib|bortezomib
34810|NCT03984097|Velcade|velcade
34811|NCT03984097|Stem Cell Transplant|stem cell transplant
34812|NCT03984097|Neoplasms, Plasma Cell|neoplasms, plasma cell
34813|NCT03984084|biomarkers|biomarkers
34814|NCT03984084|translational medical research|translational medical research
34815|NCT03984084|psychiatry|psychiatry
34823|NCT03984058|Obstructive Sleep Apnea|obstructive sleep apnea
34824|NCT03984032|LMA Protector Cuff Pilot|lma protector cuff pilot
34825|NCT03984032|LMA Supreme|lma supreme
34826|NCT03984032|Clinical Performance|clinical performance
34827|NCT03984006|Exosome|exosome
34828|NCT03984006|Urine|urine
34829|NCT03984006|Biological marker|biological marker
34830|NCT03983980|Tapinarof|tapinarof
34831|NCT03983980|plaque psoriasis|plaque psoriasis
34832|NCT03983980|adult|adult
34833|NCT03983980|phase 3|phase 3
34834|NCT03983980|topical|topical
34835|NCT03983980|double-blind|double-blind
34836|NCT03983980|efficacy|efficacy
34837|NCT03983980|safety|safety
34838|NCT03983980|psoriasis|psoriasis
34839|NCT03983902|stem cell|stem cell
34840|NCT03983902|newborn|newborn
34841|NCT03983902|endothelial progenitor cell|endothelial progenitor cell
34842|NCT03983902|CD34+ hematopoietic stem cell|cd34+ hematopoietic stem cell
34843|NCT03983902|delayed cord clamping|delayed cord clamping
34844|NCT03983902|umbilical cord milking|umbilical cord milking
34845|NCT03983902|immediate cord clamping|immediate cord clamping
34849|NCT03983850|Human Leukocyte Antigen|human leukocyte antigen
34850|NCT03983850|Busulfan|busulfan
34851|NCT03983850|Fludarabine|fludarabine
34852|NCT03983850|Mycophenolate Mofetil|mycophenolate mofetil
34853|NCT03983850|Sirolimus|sirolimus
34859|NCT03983798|Simulation training|simulation training
34860|NCT03983798|Patient simulation|patient simulation
34861|NCT03983798|Psychiatric|psychiatric
34862|NCT03983798|Medical students|medical students
34863|NCT03983798|Educational|educational
34864|NCT03983798|Medical|medical
34865|NCT03983785|Pilates|pilates
34866|NCT03983785|Elastic Taping|elastic taping
34867|NCT03983785|Balance|balance
34868|NCT03983785|Postural control|postural control
34869|NCT03983785|Early Parkinson`s Disease|early parkinson`s disease
34870|NCT03983772|Prebiotics|prebiotics
34871|NCT03983772|Resistant starch|resistant starch
34872|NCT03983772|Gut microbiota|gut microbiota
34873|NCT03983772|Microbial diversity|microbial diversity
34874|NCT03983772|Dietary fiber|dietary fiber
34875|NCT03983772|Short-chain fatty acid|short-chain fatty acid
34876|NCT03983772|Gastrointestinal symptom|gastrointestinal symptom
34877|NCT03983772|Dose-ramping design|dose-ramping design
34878|NCT03983772|Resistant starch blend|resistant starch blend
34879|NCT03983772|Fecal consistency|fecal consistency
34880|NCT03983772|Fecal frequency|fecal frequency
34881|NCT03983772|PROMIS|promis
34882|NCT03983772|Microbiome analysis|microbiome analysis
34883|NCT03983733|Gut microbiome|gut microbiome
34884|NCT03983733|Personalised Nutrition|personalised nutrition
34885|NCT03983733|Metabolic health|metabolic health
34886|NCT03983733|Postprandial metabolism|postprandial metabolism
34887|NCT03983720|Sleep assessment|sleep assessment
34888|NCT03983720|Neuromuscular Fatigability|neuromuscular fatigability
34889|NCT03983720|Multiple sclerosis|multiple sclerosis
34890|NCT03983720|Chronic fatigue|chronic fatigue
34891|NCT03983707|Purastat|purastat
34892|NCT03983681|Multiple Sclerosis|multiple sclerosis
34894|NCT03983681|Relapsing-Remitting MS|relapsing-remitting ms
34895|NCT03983681|Progressive MS|progressive ms
34896|NCT03983681|RRMS|rrms
34897|NCT03983681|PPMS|ppms
34898|NCT03983681|SPMS|spms
34899|NCT03983681|Primary Progressive|primary progressive
34900|NCT03983681|Secondary Progressive|secondary progressive
34901|NCT03983642|Dynamic balance|dynamic balance
34902|NCT03983642|Static balance|static balance
34903|NCT03983642|Wii Fit|wii fit
34904|NCT03983642|Elderly|elderly
34905|NCT03983629|Congenital Dyserythropoietic Anemia|congenital dyserythropoietic anemia
34906|NCT03983629|French registry|french registry
34907|NCT03983616|Pneumococcal Infections|pneumococcal infections
34908|NCT03983603|Plant stanols|plant stanols
34909|NCT03983603|Asthma|asthma
34910|NCT03983603|Immune system|immune system
34911|NCT03983603|Metabolic health|metabolic health
34912|NCT03983590|pain|pain
34913|NCT03983590|anxiety|anxiety
34914|NCT03983590|communicative|communicative
34915|NCT03983590|palliative care|palliative care
34916|NCT03983577|genetic counseling|genetic counseling
34917|NCT03983551|Type 2 diabetes mellitus|type 2 diabetes mellitus
34918|NCT03983551|dipeptidyl peptidase 4 inhibitors|dipeptidyl peptidase 4 inhibitors
34919|NCT03983551|sulfonylureas|sulfonylureas
34920|NCT03983551|proteinuria|proteinuria
34921|NCT03983486|IS-FISH|is-fish
34922|NCT03983486|Imaging flow cytometry|imaging flow cytometry
34923|NCT03983486|Multiple Myeloma|multiple myeloma
34924|NCT03983434|microbiome|microbiome
34925|NCT03983434|microbiota|microbiota
34926|NCT03983434|short chain fatty acids|short chain fatty acids
34927|NCT03983434|prebiotic|prebiotic
34928|NCT03983434|bile acids|bile acids
34929|NCT03983408|Sjögren's Syndrome|sjögren's syndrome
34930|NCT03983408|Korean Red Ginseng|korean red ginseng
34931|NCT03983395|Breast Cancer|breast cancer
34932|NCT03983395|GBR 1302|gbr 1302
34933|NCT03983395|HER2|her2
34934|NCT03983382|non-anthracycline trastuzumab|non-anthracycline trastuzumab
34935|NCT03983382|trastuzumab|trastuzumab
34936|NCT03983382|Memorial Sloan Kettering Cancer Center|memorial sloan kettering cancer center
34937|NCT03983382|19-045|19-045
34938|NCT03983356|General Practitioner|general practitioner
34939|NCT03983356|Training Program|training program
34940|NCT03983343|Adhesive glue|adhesive glue
34941|NCT03983343|Episiotomy|episiotomy
34942|NCT03983343|Pain sensation|pain sensation
34943|NCT03983343|Perineal tears|perineal tears
34944|NCT03983343|Running sutures|running sutures
34945|NCT03983343|Skin closure|skin closure
34946|NCT03983343|Visual Analogue Scale|visual analogue scale
34947|NCT03983278|Child|child
34948|NCT03983278|Refractive Error|refractive error
34949|NCT03983278|Myopia|myopia
34950|NCT03983278|School screening|school screening
34951|NCT03983278|Cost effectiveness|cost effectiveness
34952|NCT03983278|India|india
34953|NCT03983239|Healthy Subject|healthy subject
34954|NCT03983239|Fedratinib|fedratinib
34955|NCT03983239|Rifampin|rifampin
34956|NCT03983239|Efavirenz|efavirenz
34957|NCT03983239|Drug Interaction|drug interaction
34958|NCT03983226|reurrent Ovarian Cancer|reurrent ovarian cancer
34959|NCT03983226|Secondary Cytoreductive Surgery|secondary cytoreductive surgery
34960|NCT03983226|Chemotherapy|chemotherapy
34961|NCT03983213|Patellar instability|patellar instability
34962|NCT03983213|Recurrent patellar dislocation|recurrent patellar dislocation
34963|NCT03983213|Isokinetics|isokinetics
34964|NCT03983213|Children|children
34965|NCT03983213|MPFL reconstruction|mpfl reconstruction
34966|NCT03983161|Healthy Subjects|healthy subjects
34967|NCT03983161|Fedratinib|fedratinib
34968|NCT03983161|Hepatic impairment|hepatic impairment
34969|NCT03983161|Pharmacokinetics|pharmacokinetics
34970|NCT03983148|Motivational Interviewing|motivational interviewing
34971|NCT03983148|Parent|parent
34972|NCT03983148|Children|children
34973|NCT03983148|Cancer|cancer
811776|NCT00201357|thalidomide|thalidomide
34974|NCT03983148|Physical activity|physical activity
34975|NCT03983109|EpiFaith|epifaith
34976|NCT03983109|Epidural localization|epidural localization
34977|NCT03983096|invasive breast cancer|invasive breast cancer
34978|NCT03983096|neoadjuvant|neoadjuvant
34979|NCT03983096|adjuvant|adjuvant
34980|NCT03983096|Anthracycline|anthracycline
34981|NCT03983083|physical activity|physical activity
34982|NCT03983083|sedentary behavior|sedentary behavior
34983|NCT03983070|Strength|strength
34984|NCT03983070|Hypertrophy|hypertrophy
34985|NCT03983070|Oxygen consumption|oxygen consumption
34986|NCT03983057|Pancreatic cancer|pancreatic cancer
34987|NCT03983057|PD-1|pd-1
34988|NCT03983057|FOLFIRINOX|folfirinox
34989|NCT03983057|combination therapy|combination therapy
34990|NCT03983044|cough evaluation|cough evaluation
34991|NCT03983044|intensive care unit|intensive care unit
34992|NCT03983044|utrasound evaluation|utrasound evaluation
34993|NCT03983031|Immunopsychiatry|immunopsychiatry
34994|NCT03983031|pediatric acute-onset neuropsychiatric syndrome|pediatric acute-onset neuropsychiatric syndrome
34995|NCT03983018|Immunopsychiatry|immunopsychiatry
34996|NCT03983018|Schizophrenia spectrum disorder|schizophrenia spectrum disorder
34997|NCT03983018|treatment-resistant|treatment-resistant
34998|NCT03983005|Lung cancer|lung cancer
34999|NCT03983005|Endoscopic ultrasound|endoscopic ultrasound
35000|NCT03983005|EUS-B-FNA|eus-b-fna
35001|NCT03983005|Molecular analysis|molecular analysis
35002|NCT03983005|Rapid on-site evaluation|rapid on-site evaluation
35003|NCT03982992|donor lymphocyte infusion|donor lymphocyte infusion
35004|NCT03982992|blinatumomab|blinatumomab
35005|NCT03982992|combinatorial|combinatorial
35006|NCT03982992|minimal residual disease|minimal residual disease
35008|NCT03982992|mixed chimerism|mixed chimerism
35009|NCT03982992|MC|mc
35010|NCT03982992|DLI-TARGET|dli-target
35011|NCT03982992|acute lymphoblastic leukemia|acute lymphoblastic leukemia
35012|NCT03982914|biomarker|biomarker
35013|NCT03982914|HE4|he4
35014|NCT03982914|CA-125|ca-125
35015|NCT03982914|IOTA|iota
35016|NCT03982914|ROMA|roma
35017|NCT03982914|RMI|rmi
35018|NCT03982914|pelvic mass|pelvic mass
35019|NCT03982914|ovarian cancer|ovarian cancer
35020|NCT03982901|Stress|stress
35021|NCT03982901|Ischemia|ischemia
35022|NCT03982901|PET-CT|pet-ct
35023|NCT03982888|deep brain stimulation|deep brain stimulation
35024|NCT03982875|remote monitoring|remote monitoring
35025|NCT03982875|digital health|digital health
35026|NCT03982875|ostomy|ostomy
35027|NCT03982862|Botulinum toxin type A|botulinum toxin type a
35028|NCT03982862|Triamcinolone|triamcinolone
35029|NCT03982862|scar pain|scar pain
35030|NCT03982862|scar itch|scar itch
35031|NCT03982849|melasma|melasma
35032|NCT03982849|hydroquinone|hydroquinone
35033|NCT03982849|silymarin|silymarin
35034|NCT03982836|Gastric Emptying|gastric emptying
35035|NCT03982836|Scintigraphy|scintigraphy
35036|NCT03982836|Intestinal Transit Time|intestinal transit time
35037|NCT03982836|Prebiotic|prebiotic
35038|NCT03982836|Soluble Dietary Fiber|soluble dietary fiber
35039|NCT03982836|Technetium-99m|technetium-99m
35040|NCT03982823|morbid obesity|morbid obesity
35041|NCT03982823|surgical stapling|surgical stapling
35042|NCT03982823|suture techniques|suture techniques
35043|NCT03982823|natural orifice surgery|natural orifice surgery
35044|NCT03982823|transoral|transoral
35045|NCT03982823|mini-laparoscopy|mini-laparoscopy
35046|NCT03982797|non-muscle invasive bladder tumors|non-muscle invasive bladder tumors
35047|NCT03982771|Idiopathic Multicentric Castleman's Disease|idiopathic multicentric castleman's disease
35048|NCT03982771|BCD Regimen|bcd regimen
35049|NCT03982771|Efficacy|efficacy
35050|NCT03982771|Safety|safety
35051|NCT03982745|bonfils fiberoptic stylet|bonfils fiberoptic stylet
35052|NCT03982745|double lumen intubation|double lumen intubation
35053|NCT03982745|thoracic surgery|thoracic surgery
35054|NCT03982745|difficult intubation|difficult intubation
35055|NCT03982745|difficult airway|difficult airway
35056|NCT03982719|Dupuytren's disease|dupuytren's disease
35057|NCT03982719|rehabilitation|rehabilitation
35058|NCT03982719|fasciectomy|fasciectomy
35059|NCT03982719|hand therapy|hand therapy
35060|NCT03982706|MRI-targeted prostate biopsy|mri-targeted prostate biopsy
35061|NCT03982706|focal treatment|focal treatment
35062|NCT03982693|Chelation|chelation
35063|NCT03982693|Critical Limb Ischemia|critical limb ischemia
35064|NCT03982693|Diabetes|diabetes
35065|NCT03982641|colorectal cancer surgery|colorectal cancer surgery
35066|NCT03982641|auditing activity|auditing activity
35067|NCT03982641|economical analysis|economical analysis
35068|NCT03982641|surgical performance indicators|surgical performance indicators
35069|NCT03982615|RNASeq|rnaseq
35070|NCT03982615|mucosal integration|mucosal integration
35071|NCT03982537|Head and neck squamous cell cancer|head and neck squamous cell cancer
35072|NCT03982524|somatoform symptoms|somatoform symptoms
35073|NCT03982524|somatic symptoms|somatic symptoms
35074|NCT03982524|somatoform disorder|somatoform disorder
35075|NCT03982524|somatic symptom disorder|somatic symptom disorder
35076|NCT03982524|cognitive-behavioral therapy|cognitive-behavioral therapy
35077|NCT03982524|emotion regulation training|emotion regulation training
35078|NCT03982524|3-year follow-up|3-year follow-up
35079|NCT03982485|Apatinib|apatinib
35080|NCT03982485|Neoadjuvant chemotherapy|neoadjuvant chemotherapy
35081|NCT03982485|Breast cancer|breast cancer
35082|NCT03982472|heart rate|heart rate
35083|NCT03982472|TENS|tens
35084|NCT03982472|vagus nerve|vagus nerve
35086|NCT03982394|Chronic Plaque Psoriasis|chronic plaque psoriasis
35087|NCT03982394|Risankizumab|risankizumab
35088|NCT03982394|Biologics|biologics
35089|NCT03982394|Psoriasis Vulgaris|psoriasis vulgaris
35090|NCT03982355|Cancer|cancer
35091|NCT03982342|catheter closure|catheter closure
35092|NCT03982342|conservative treatment|conservative treatment
35093|NCT03982342|percutaneous closure|percutaneous closure
35094|NCT03982290|autism|autism
35095|NCT03982290|preschool children|preschool children
35096|NCT03982277|High dose rifampicin|high dose rifampicin
35097|NCT03982277|TB/HIV co-infected persons|tb/hiv co-infected persons
35098|NCT03982277|safety|safety
35099|NCT03982277|pharmacokinetics|pharmacokinetics
35100|NCT03982277|efficacy|efficacy
35101|NCT03982251|vibration|vibration
35102|NCT03982251|bone|bone
35103|NCT03982251|mucle|mucle
35104|NCT03982251|cerebrovascular accident|cerebrovascular accident
35105|NCT03982251|rehabilitation|rehabilitation
35106|NCT03982225|Apoptosis|apoptosis
35107|NCT03982225|Lipolysis|lipolysis
35108|NCT03982225|Fat reduction|fat reduction
35109|NCT03982225|Submental fat|submental fat
35110|NCT03982225|Polyene Phosphatidylcholine|polyene phosphatidylcholine
35111|NCT03982212|Copaxone|copaxone
35112|NCT03982212|Window of Opportunity Trial|window of opportunity trial
35113|NCT03982160|L-arginine|l-arginine
35114|NCT03982160|blood pressure|blood pressure
35115|NCT03982160|ADMA|adma
35116|NCT03982147|Diffusion tensor imaging|diffusion tensor imaging
35117|NCT03982108|shoulder|shoulder
35118|NCT03982108|rotator cuff tear|rotator cuff tear
35119|NCT03982108|arthroscopic repair|arthroscopic repair
35120|NCT03982108|suture-bridge technique|suture-bridge technique
35121|NCT03982108|retear|retear
35122|NCT03982108|knotless|knotless
35123|NCT03982108|knot-tying|knot-tying
35124|NCT03982095|Prostatic neoplasm|prostatic neoplasm
35125|NCT03982095|Physical therapy modalities|physical therapy modalities
35126|NCT03982095|Healthy lifestyle|healthy lifestyle
35333|NCT03980912|Steatosis|steatosis
35127|NCT03982095|Biobehavioral Sciences|biobehavioral sciences
35128|NCT03982056|Floating|floating
35129|NCT03982056|Sculling|sculling
35130|NCT03982056|water safety|water safety
35131|NCT03982030|Dalbavacin|dalbavacin
35132|NCT03982017|readmission|readmission
35133|NCT03982017|quality of life|quality of life
35134|NCT03982017|self-care|self-care
35135|NCT03981991|EHP 30|ehp 30
35136|NCT03981991|Endometriosis|endometriosis
35137|NCT03981991|Quality of Life|quality of life
35138|NCT03981991|Uterosacral Ligament|uterosacral ligament
35139|NCT03981978|physical activity|physical activity
35140|NCT03981978|accelerometer|accelerometer
35141|NCT03981978|bariatric surgery|bariatric surgery
35142|NCT03981978|obesity|obesity
35143|NCT03981965|physical activity|physical activity
35144|NCT03981965|adherence|adherence
35145|NCT03981965|Frailty|frailty
35146|NCT03981965|Mood|mood
35147|NCT03981965|Socialisation|socialisation
35148|NCT03981965|Quality of life|quality of life
35149|NCT03981965|Cognition|cognition
35150|NCT03981939|Drug therapy|drug therapy
35151|NCT03981926|Telemedicine|telemedicine
35152|NCT03981926|Pragmatic|pragmatic
35153|NCT03981926|Equivalency|equivalency
35154|NCT03981926|Skin diseases|skin diseases
35155|NCT03981913|Cognitive action control|cognitive action control
35156|NCT03981913|Parkinson's disease|parkinson's disease
35157|NCT03981913|high-density EEG|high-density eeg
35158|NCT03981913|theta oscillations|theta oscillations
35159|NCT03981913|medial frontal cortex|medial frontal cortex
35160|NCT03981874|neuroborreliosis|neuroborreliosis
35161|NCT03981874|facial palsy|facial palsy
35162|NCT03981874|children|children
35163|NCT03981822|Human Papilloma Virus (HPV)|human papilloma virus (hpv)
35164|NCT03981822|Genital Warts|genital warts
35165|NCT03981822|Sexually Transmitted Disease (STD)|sexually transmitted disease (std)
35166|NCT03981822|Viral Disease|viral disease
35167|NCT03981809|Pain|pain
35168|NCT03981809|Cancer|cancer
35169|NCT03981809|Chronic pain|chronic pain
35170|NCT03981809|Persistent pain|persistent pain
35171|NCT03981783|COPD|copd
35172|NCT03981783|Pulmonary Rehabilitation|pulmonary rehabilitation
35173|NCT03981783|Telerehabilitation|telerehabilitation
35174|NCT03981783|Clinical Decision Support|clinical decision support
35175|NCT03981783|Adherence|adherence
35176|NCT03981757|carotid surgery|carotid surgery
811885|NCT00200694|ARB|arb
35177|NCT03981757|cerebral oxygenation|cerebral oxygenation
35178|NCT03981757|brain blood volume|brain blood volume
35179|NCT03981705|Breast Cancer|breast cancer
35180|NCT03981692|Geriatrics|geriatrics
35181|NCT03981692|quality of life|quality of life
35182|NCT03981692|balance|balance
35183|NCT03981692|fear of falling|fear of falling
35184|NCT03981692|dual activity|dual activity
35185|NCT03981679|colonoscopy|colonoscopy
35186|NCT03981679|CRC screening|crc screening
35187|NCT03981679|cfDNA|cfdna
35188|NCT03981679|Intplex|intplex
35189|NCT03981679|colorectal cancer|colorectal cancer
35190|NCT03981640|Exercise|exercise
35191|NCT03981640|Cold stress|cold stress
35192|NCT03981640|Mental stress|mental stress
35193|NCT03981575|Myotonic Dystrophy|myotonic dystrophy
35194|NCT03981575|END DM-1|end dm-1
35195|NCT03981575|Muscular Dystophy|muscular dystophy
35196|NCT03981575|DMCRN|dmcrn
35197|NCT03981562|Epistaxis|epistaxis
35198|NCT03981549|Central Retinal Vein Occlusion|central retinal vein occlusion
35199|NCT03981549|Retinal Vein Occlusion|retinal vein occlusion
35200|NCT03981549|Retinal Diseases|retinal diseases
35201|NCT03981549|Eye Diseases|eye diseases
35202|NCT03981549|CD34+ Stem Cell Therapy|cd34+ stem cell therapy
35203|NCT03981549|Autologous Bone Marrow Stem Cells|autologous bone marrow stem cells
35204|NCT03981549|Stem Cells|stem cells
35205|NCT03981536|Familial Amyotrophic Lateral Sclerosis|familial amyotrophic lateral sclerosis
35206|NCT03981536|Sporadic Amyotrophic Lateral Sclerosis|sporadic amyotrophic lateral sclerosis
35207|NCT03981523|Chagas disease|chagas disease
35208|NCT03981523|Trypanosoma cruzi|trypanosoma cruzi
35209|NCT03981523|Chemotherapy|chemotherapy
35210|NCT03981523|Benznidazole|benznidazole
35211|NCT03981523|Nifurtimox|nifurtimox
35212|NCT03981523|Biomarkers|biomarkers
35213|NCT03981523|Bolivia|bolivia
35214|NCT03981523|Antiparasitic Agents|antiparasitic agents
35215|NCT03981523|Parasitic Diseases|parasitic diseases
35217|NCT03981445|PrEP|prep
35218|NCT03981445|HCV Treatment|hcv treatment
35219|NCT03981445|Injection Drug Use|injection drug use
35220|NCT03981432|appetite control|appetite control
35221|NCT03981432|leanness|leanness
35222|NCT03981432|physical fitness|physical fitness
35223|NCT03981419|Total hip replacement|total hip replacement
35224|NCT03981419|Total knee replacement|total knee replacement
35225|NCT03981406|Palliative Care|palliative care
35226|NCT03981380|Alzheimer Disease|alzheimer disease
35227|NCT03981380|Cognitive Impairment|cognitive impairment
35228|NCT03981380|11C-PiB|11c-pib
35229|NCT03981380|Atherosclerosis|atherosclerosis
35230|NCT03981367|External root resorption|external root resorption
35231|NCT03981367|Distal caries|distal caries
35232|NCT03981367|Mandibular third molar|mandibular third molar
35233|NCT03981367|Mandibular second molar|mandibular second molar
35234|NCT03981367|Cone beam computed tomography|cone beam computed tomography
35235|NCT03981341|sleep apnea|sleep apnea
35236|NCT03981341|post menopausal|post menopausal
35237|NCT03981341|oxidative stress|oxidative stress
35238|NCT03981302|Chronic Nonmalignant Pain|chronic nonmalignant pain
35239|NCT03981302|Family Nursing|family nursing
35240|NCT03981302|Multidisciplinary Pain Center|multidisciplinary pain center
35241|NCT03981302|Quasi-Experimental Study|quasi-experimental study
35242|NCT03981289|LGMD|lgmd
35243|NCT03981289|Limb Girdle Muscular Dystrophy|limb girdle muscular dystrophy
35244|NCT03981289|CAPN3|capn3
35245|NCT03981289|AN05|an05
35246|NCT03981289|DYSF|dysf
35247|NCT03981289|DNAJB6|dnajb6
35248|NCT03981276|Hereditary Spastic Paraplegia|hereditary spastic paraplegia
35249|NCT03981276|Biomarker|biomarker
35250|NCT03981276|Genetic etiology|genetic etiology
35251|NCT03981276|Molecular mechanisms|molecular mechanisms
35252|NCT03981263|Prospective study|prospective study
35253|NCT03981263|Cross over|cross over
35254|NCT03981263|Quality of life|quality of life
35255|NCT03981263|Breast|breast
35256|NCT03981263|Mastectomy|mastectomy
35257|NCT03981263|Breast external prothesis|breast external prothesis
35258|NCT03981263|MEAVANTI prothesis|meavanti prothesis
35259|NCT03981250|Resistance training|resistance training
35260|NCT03981250|Strength Training|strength training
35261|NCT03981250|Muscle Strength|muscle strength
35262|NCT03981250|voluntary failure|voluntary failure
35263|NCT03981237|root canal treatment|root canal treatment
35264|NCT03981237|root canal irrigation|root canal irrigation
35265|NCT03981224|Nasopharyngeal carcinoma|nasopharyngeal carcinoma
35266|NCT03981224|Radiotherapy|radiotherapy
35267|NCT03981224|Epstein-Barr virus|epstein-barr virus
35268|NCT03981211|people who inject drugs|people who inject drugs
35269|NCT03981211|injecting related infectious diseases|injecting related infectious diseases
35270|NCT03981185|depression|depression
35271|NCT03981185|TMS|tms
35272|NCT03981185|transcranial magnetic stimulation|transcranial magnetic stimulation
35273|NCT03981185|theta burst|theta burst
35274|NCT03981185|alcohol use disorder|alcohol use disorder
35275|NCT03981185|alcohol addiction|alcohol addiction
35276|NCT03981172|food reinforcement|food reinforcement
35277|NCT03981172|food liking|food liking
35278|NCT03981172|motivation|motivation
35279|NCT03981172|dopamine|dopamine
35280|NCT03981172|obesity|obesity
35281|NCT03981172|energy density|energy density
35282|NCT03981172|snacks|snacks
35283|NCT03981146|Strong Class II Microsatellite Status|strong class ii microsatellite status
35284|NCT03981133|pacifier|pacifier
35285|NCT03981133|breastfeeding|breastfeeding
35286|NCT03981133|sudden unexpected infant death|sudden unexpected infant death
35287|NCT03981120|In-vitro fertilization|in-vitro fertilization
35288|NCT03981120|acupuncture|acupuncture
35289|NCT03981120|preimplantation genetic screening|preimplantation genetic screening
35290|NCT03981120|pregnancy|pregnancy
35291|NCT03981120|laser|laser
35292|NCT03981120|miscarriage|miscarriage
35293|NCT03981107|Cardiopulmonary Resuscitation|cardiopulmonary resuscitation
35294|NCT03981107|Chest compressions only CPR|chest compressions only cpr
35295|NCT03981107|Dispatcher assisted CPR|dispatcher assisted cpr
35296|NCT03981107|Cardiac Arrest|cardiac arrest
35297|NCT03981081|COPD|copd
35298|NCT03981081|Acute hypercapnic respiratory failure|acute hypercapnic respiratory failure
35299|NCT03981081|Steroids|steroids
35300|NCT03981068|recurrent|recurrent
35301|NCT03981068|reirradiation|reirradiation
35302|NCT03981068|second primary|second primary
35303|NCT03981042|laryngoscopy|laryngoscopy
35304|NCT03981042|anesthesic aduction|anesthesic aduction
35305|NCT03981042|neuromuscular blockade monitoring|neuromuscular blockade monitoring
35306|NCT03981029|Folate|folate
35307|NCT03981029|One Carbon Metabolism|one carbon metabolism
35308|NCT03981029|Preeclampsia|preeclampsia
35309|NCT03981029|Folic Acid|folic acid
35310|NCT03981029|Pregnancy|pregnancy
35311|NCT03981016|Nervous|nervous
35312|NCT03981016|Central|central
35313|NCT03981016|Tumor|tumor
35314|NCT03981016|System|system
35315|NCT03980990|metformin|metformin
35316|NCT03980990|diabetes|diabetes
35317|NCT03980990|pci|pci
35318|NCT03980990|percutaneous coronary intervention|percutaneous coronary intervention
35319|NCT03980990|unstable angina|unstable angina
35320|NCT03980990|acute coronary syndrome|acute coronary syndrome
35321|NCT03980977|unusual toxicity|unusual toxicity
35322|NCT03980977|radiosensitivity|radiosensitivity
35323|NCT03980977|radiotherapy|radiotherapy
35324|NCT03980977|fibroblast cell|fibroblast cell
35325|NCT03980977|indirect immunofluorescence test|indirect immunofluorescence test
35326|NCT03980964|NMES|nmes
35327|NCT03980964|arthritis|arthritis
35328|NCT03980964|knee pain|knee pain
35329|NCT03980964|osteoarthritis|osteoarthritis
35330|NCT03980964|electrical stimulation therapy|electrical stimulation therapy
35331|NCT03980912|LiverFASt|liverfast
35332|NCT03980912|Fibrosis|fibrosis
35334|NCT03980912|Activity|activity
35335|NCT03980912|Liver Biopsy|liver biopsy
35336|NCT03980912|Algorithm|algorithm
35337|NCT03980912|LiverFASt select|liverfast select
35338|NCT03980912|Liver Disease|liver disease
35339|NCT03980873|minority stress|minority stress
35340|NCT03980873|LGB|lgb
35341|NCT03980873|stigma|stigma
35342|NCT03980873|cognitive behavioral therapy (CBT)|cognitive behavioral therapy (cbt)
35343|NCT03980808|Diabetes|diabetes
35344|NCT03980808|Deafness|deafness
35345|NCT03980795|exercise|exercise
35346|NCT03980795|physical function|physical function
35347|NCT03980795|patient reported outcomes|patient reported outcomes
35348|NCT03980782|Delirium elderly Music therapy|delirium elderly music therapy
35349|NCT03980782|Elderly|elderly
35350|NCT03980782|Music Therapy|music therapy
35351|NCT03980743|Obesity|obesity
35352|NCT03980743|Overweight|overweight
35353|NCT03980743|Severe Mental illness|severe mental illness
35354|NCT03980730|Receptor for Advanced Glycation Endproducts (RAGE)|receptor for advanced glycation endproducts (rage)
35355|NCT03980730|ADAS-cog|adas-cog
35356|NCT03980730|CDR-sb|cdr-sb
35357|NCT03980717|Fetal Tracheal Occlusion|fetal tracheal occlusion
35358|NCT03980717|FETO plug-unplug|feto plug-unplug
35359|NCT03980717|Goldvalve balloon|goldvalve balloon
35360|NCT03980717|Severe Congenital Diaphragmatic Hernia|severe congenital diaphragmatic hernia
35361|NCT03980717|Goldbal balloon|goldbal balloon
35362|NCT03980717|FETO|feto
35363|NCT03980704|immunonutrition|immunonutrition
35364|NCT03980704|preoperative nutrition|preoperative nutrition
35365|NCT03980691|Chidamide,CAR cell therapy,TCR cell therapy|chidamide,car cell therapy,tcr cell therapy
35366|NCT03980678|Mineral Rich Algae|mineral rich algae
35367|NCT03980678|Mineral Nutrition|mineral nutrition
35368|NCT03980665|Arsenic Trioxide|arsenic trioxide
35369|NCT03980665|cART|cart
35370|NCT03980665|HIV-1 reservoir|hiv-1 reservoir
35371|NCT03980665|functional cure|functional cure
35372|NCT03980626|physical activity|physical activity
35373|NCT03980626|exercise|exercise
35374|NCT03980626|cognition|cognition
35375|NCT03980626|brain health|brain health
35376|NCT03980626|breast cancer|breast cancer
35377|NCT03980613|Emergency Medical Service|emergency medical service
35378|NCT03980613|Triage|triage
35379|NCT03980613|Telephone visitation|telephone visitation
35380|NCT03980587|ctDNA|ctdna
35381|NCT03980574|Diabetes Mellitus|diabetes mellitus
35382|NCT03980561|marijuana|marijuana
35383|NCT03980561|substance use|substance use
35384|NCT03980496|CYP2C19|cyp2c19
35385|NCT03980496|Helicobacter pylori|helicobacter pylori
35386|NCT03980496|non-variceal upper gastrointestinal bleeding|non-variceal upper gastrointestinal bleeding
35387|NCT03980496|intragastric pH|intragastric ph
35388|NCT03980496|proton pump inhibitor|proton pump inhibitor
35389|NCT03980483|Rheumatoid arthritis|rheumatoid arthritis
35390|NCT03980483|GSK3196165|gsk3196165
35391|NCT03980483|Tofacitinib|tofacitinib
35392|NCT03980483|Methotrexate|methotrexate
35393|NCT03980483|Placebo|placebo
35394|NCT03980457|Stroke|stroke
35395|NCT03980457|leg weakness|leg weakness
35396|NCT03980457|Exoskeleton|exoskeleton
35397|NCT03980444|Ureterolithiasis|ureterolithiasis
35398|NCT03980444|Manganese Poisoning|manganese poisoning
35399|NCT03980444|Lithotripsy|lithotripsy
35400|NCT03980444|Ureteroscopy|ureteroscopy
35401|NCT03980444|stone baske|stone baske
35402|NCT03980431|Brain Tumor|brain tumor
35403|NCT03980431|FBY-Positron Emission Computed Tomography (FBY-PET)|fby-positron emission computed tomography (fby-pet)
35404|NCT03980431|glioma|glioma
35405|NCT03980431|brain metastasis|brain metastasis
35406|NCT03980418|Parkinson Disease|parkinson disease
35407|NCT03980418|DaTSCAN™ SPECT/CT scintigraphy|datscan™ spect/ct scintigraphy
35408|NCT03980418|"Semiconductor CZT camera with large field"|"semiconductor czt camera with large field"
35409|NCT03980392|prevention|prevention
35410|NCT03980392|dementia|dementia
35411|NCT03980392|intervention|intervention
35412|NCT03980392|mild cognitive impairment|mild cognitive impairment
35413|NCT03980366|Electroconvulsive Therapy|electroconvulsive therapy
35415|NCT03980340|Circadian Rhythms|circadian rhythms
35416|NCT03980340|Circadian Rhythm Disorder|circadian rhythm disorder
35417|NCT03980288|Advanced hepatocellular Carcinoma|advanced hepatocellular carcinoma
35418|NCT03980288|CAR-T|car-t
35419|NCT03980288|GPC3|gpc3
35420|NCT03980275|Bilateral vocal fold paralysis|bilateral vocal fold paralysis
35421|NCT03980275|Tracheostomy dependency|tracheostomy dependency
35422|NCT03980275|Glottic airway obstruction|glottic airway obstruction
35423|NCT03980275|Stridor|stridor
35424|NCT03980262|Obesity|obesity
35425|NCT03980262|Self-efficacy|self-efficacy
35426|NCT03980262|Nutrition|nutrition
35427|NCT03980262|Physical Activity|physical activity
35428|NCT03980262|Family-based|family-based
35429|NCT03980262|Community-Based Participatory Research (CBPR)|community-based participatory research (cbpr)
35430|NCT03980262|Faith-based organizations|faith-based organizations
35431|NCT03980223|HIV|hiv
35432|NCT03980223|Post-Exposure Prophylaxis|post-exposure prophylaxis
35433|NCT03980223|Men who have sex with men (MSM)|men who have sex with men (msm)
35434|NCT03980223|Doxycycline|doxycycline
35435|NCT03980223|HIV Pre-Exposure Prophylaxis|hiv pre-exposure prophylaxis
35436|NCT03980223|Sexually transmitted infection|sexually transmitted infection
35437|NCT03980210|Hyperbaric oxygen therapy|hyperbaric oxygen therapy
35438|NCT03980210|Normobaric oxygen therapy|normobaric oxygen therapy
35439|NCT03980210|Hyperoxia|hyperoxia
35440|NCT03980210|Sidestream dark field videomicroscopy|sidestream dark field videomicroscopy
35441|NCT03980210|Microcirculation|microcirculation
35442|NCT03980145|Robotics|robotics
35443|NCT03980145|Gait Training|gait training
35444|NCT03980132|Thyroid Surgery|thyroid surgery
35445|NCT03980132|Grave' Disease|grave' disease
35446|NCT03980132|Lugol Solution|lugol solution
35447|NCT03980106|Spinal Reflex Excitability|spinal reflex excitability
35448|NCT03980106|Muscle Relaxation|muscle relaxation
35449|NCT03980106|H reflex|h reflex
35450|NCT03980080|CD127/IL-7Rα Antagonist|cd127/il-7rα antagonist
35451|NCT03980080|Auto-Immune Diseases|auto-immune diseases
35452|NCT03980080|inflammatory bowel diseases|inflammatory bowel diseases
35453|NCT03980080|Ulcerative Colitis|ulcerative colitis
35454|NCT03980067|Virtual Reality|virtual reality
35455|NCT03980067|Procedural Sedation|procedural sedation
35456|NCT03980067|Modified Yale Preoperative Anxiety Scale|modified yale preoperative anxiety scale
35457|NCT03980067|Post-Hospitalization Behavior Questionnaire|post-hospitalization behavior questionnaire
35458|NCT03980067|Pediatric|pediatric
35459|NCT03980067|Emergency Department|emergency department
35460|NCT03980067|Ketamine|ketamine
35461|NCT03980028|surgery|surgery
35462|NCT03980028|cancer|cancer
35463|NCT03980028|ovarian|ovarian
35464|NCT03980028|advanced|advanced
35465|NCT03980002|Chronic Lymphocytic Leukemia|chronic lymphocytic leukemia
35466|NCT03980002|Therapeutics|therapeutics
35467|NCT03980002|ibrutinib|ibrutinib
35468|NCT03980002|fludarabine|fludarabine
35469|NCT03980002|rituximab|rituximab
35470|NCT03980002|bendamustine|bendamustine
35471|NCT03980002|cyclophosphamide|cyclophosphamide
35472|NCT03980002|treatment-naive|treatment-naive
35473|NCT03979976|systemic lupus erythematosus|systemic lupus erythematosus
35474|NCT03979976|endothelium|endothelium
35475|NCT03979976|ramipril|ramipril
35476|NCT03979963|Depression|depression
35477|NCT03979963|Emotion Regulation|emotion regulation
35478|NCT03979963|Cognitive Behavioral Therapy|cognitive behavioral therapy
35479|NCT03979963|Ecological Momentary Assessment|ecological momentary assessment
35480|NCT03979950|organ transplant|organ transplant
35481|NCT03979924|Trismus|trismus
35482|NCT03979924|prevention|prevention
35483|NCT03979924|education|education
35484|NCT03979924|nutrition|nutrition
35485|NCT03979924|preventive rehabilitation|preventive rehabilitation
35486|NCT03979924|mouth|mouth
35487|NCT03979911|Pertuzumab|pertuzumab
35488|NCT03979911|Breast Neoplasms/pathology|breast neoplasms/pathology
35489|NCT03979911|Real life|real life
35490|NCT03979911|Trastuzumab|trastuzumab
35491|NCT03979911|Receptor, ErbB-2/antagonists & inhibitors*|receptor, erbb-2/antagonists & inhibitors*
35492|NCT03979911|Breast Neoplasms/drug therapy*|breast neoplasms/drug therapy*
35493|NCT03979911|Multicenter Study|multicenter study
35494|NCT03979911|Taxoids|taxoids
35495|NCT03979911|Antibodies, Monoclonal, Humanized|antibodies, monoclonal, humanized
35496|NCT03979872|Education Prevention|education prevention
35497|NCT03979872|MC1R Genetic Testing|mc1r genetic testing
35498|NCT03979742|Spinal Cord Injury|spinal cord injury
35499|NCT03979742|Umbilical Cord Blood|umbilical cord blood
35500|NCT03979742|Injured Spinal Cord|injured spinal cord
35501|NCT03979742|Lithium Carbonate|lithium carbonate
35502|NCT03979703|fibrosing interstitial lung disease|fibrosing interstitial lung disease
35503|NCT03979703|Idiopathic Pulmonary Fibrosis|idiopathic pulmonary fibrosis
35504|NCT03979703|Yoga|yoga
35505|NCT03979690|Robotic Colonoscopy|robotic colonoscopy
35506|NCT03979690|Tandem Colonoscopy|tandem colonoscopy
35507|NCT03979690|NISInspire-C System|nisinspire-c system
35508|NCT03979690|Single Use Colonoscope|single use colonoscope
35509|NCT03979690|Colonoscopy|colonoscopy
35510|NCT03979677|vestibular migraine, dizziness, vertigo|vestibular migraine, dizziness, vertigo
35511|NCT03979664|Skin Lesions|skin lesions
35512|NCT03979651|MEK inhibitor|mek inhibitor
35513|NCT03979651|Autophagy inhibition|autophagy inhibition
35514|NCT03979651|Metastatic NRAs Melanoma|metastatic nras melanoma
35515|NCT03979638|Unexplained or refractory chronic cough, P2X3 antagonists|unexplained or refractory chronic cough, p2x3 antagonists
35516|NCT03979612|breast|breast
35517|NCT03979612|hereditary|hereditary
35518|NCT03979612|cancer|cancer
35519|NCT03979612|ovarian|ovarian
35520|NCT03979612|predisposition|predisposition
35521|NCT03979599|TAP, magnisum sulphate|tap, magnisum sulphate
35522|NCT03979573|Prospective Study|prospective study
35523|NCT03979573|Multiparametric MRI|multiparametric mri
35524|NCT03979573|Radiomics|radiomics
35525|NCT03979573|MR-guided Biopsy|mr-guided biopsy
35526|NCT03979573|Molecular Markers|molecular markers
35527|NCT03979573|Active Surveillance|active surveillance
35528|NCT03979573|Prostate Cancer|prostate cancer
35529|NCT03979560|Autonomy|autonomy
35531|NCT03979560|Adapted physical activity|adapted physical activity
35533|NCT03979560|Older people|older people
35534|NCT03979560|Hospital discharge|hospital discharge
35535|NCT03979560|Under-nutrition|under-nutrition
35536|NCT03979547|liver cancer|liver cancer
35537|NCT03979534|low-protein diet|low-protein diet
35538|NCT03979534|pre-dialysis|pre-dialysis
35539|NCT03979534|chronic kidney disease|chronic kidney disease
35540|NCT03979534|nutritional care|nutritional care
35541|NCT03979534|start of dialysis|start of dialysis
35542|NCT03979534|incremental dialysis|incremental dialysis
35543|NCT03979521|Myasthenia Gravis|myasthenia gravis
35544|NCT03979521|Quality of life|quality of life
35545|NCT03979521|Burden of disease|burden of disease
35546|NCT03979521|Social support|social support
35547|NCT03979495|Abnormal Screening Results|abnormal screening results
35548|NCT03979482|skeletal muscle mitochondrial abnormalities|skeletal muscle mitochondrial abnormalities
35549|NCT03979482|metabolic syndrome|metabolic syndrome
35550|NCT03979482|insulin resistance|insulin resistance
35551|NCT03979456|Multiple sclerosis|multiple sclerosis
35552|NCT03979456|Relapsing-Remitting|relapsing-remitting
35553|NCT03979456|Dosing protocols|dosing protocols
35554|NCT03979456|Randomized trial|randomized trial
35555|NCT03979443|Anterior cervical decompression and fusion|anterior cervical decompression and fusion
35556|NCT03979443|cervical fusion|cervical fusion
35557|NCT03979443|cervical spine|cervical spine
35558|NCT03979443|spinal surgery|spinal surgery
35559|NCT03979443|outpatient care|outpatient care
35560|NCT03979443|randomized controlled trial|randomized controlled trial
35561|NCT03979443|Protocol|protocol
35562|NCT03979430|Acute Exacerbation|acute exacerbation
35563|NCT03979430|Idiopathic Pulmonary Fibrosis|idiopathic pulmonary fibrosis
35564|NCT03979430|Home Spirometry|home spirometry
35565|NCT03979417|Biomarkers|biomarkers
35566|NCT03979404|Theta Burst Stimulation|theta burst stimulation
35567|NCT03979404|Neuromodulation|neuromodulation
35568|NCT03979404|Psychiatric Disorders|psychiatric disorders
35569|NCT03979404|Transcranial Magnetic Stimulation|transcranial magnetic stimulation
35570|NCT03979404|Anorexia Nervosa|anorexia nervosa
35571|NCT03979404|Eating Disorders|eating disorders
35572|NCT03979391|Clinically Isolated Syndrome|clinically isolated syndrome
35573|NCT03979391|Radiologically Isolated Syndrome|radiologically isolated syndrome
35574|NCT03979391|Multiple Sclerosis|multiple sclerosis
35575|NCT03979391|Children|children
35576|NCT03979391|Tear analysis|tear analysis
35577|NCT03979365|tacrolimus|tacrolimus
35578|NCT03979365|envarsus xr|envarsus xr
35579|NCT03979365|renal transplant|renal transplant
35580|NCT03979365|kidney transplant|kidney transplant
35581|NCT03979352|Type 1 Diabetes Mellitus|type 1 diabetes mellitus
35582|NCT03979352|Empagliflozin|empagliflozin
35583|NCT03979352|Artificial Pancreas|artificial pancreas
35584|NCT03979352|SGLT2 inhibitor|sglt2 inhibitor
35585|NCT03979352|insulin pump|insulin pump
35586|NCT03979352|closed loop|closed loop
35587|NCT03979339|Circulating Tumour Cells|circulating tumour cells
35588|NCT03979339|Selected cancer patients|selected cancer patients
35589|NCT03979339|New technology|new technology
35590|NCT03979313|Respiratory Syncytial Virus|respiratory syncytial virus
35591|NCT03979313|RSV|rsv
35592|NCT03979313|Late Preterm Infants|late preterm infants
35593|NCT03979313|Healthy Infants|healthy infants
35594|NCT03979313|Lower Respiratory Tract Infection|lower respiratory tract infection
35595|NCT03979300|Simulation training|simulation training
35596|NCT03979300|Role-play|role-play
35597|NCT03979300|Psychiatry|psychiatry
35598|NCT03979300|Students|students
35599|NCT03979300|Medical|medical
35600|NCT03979300|Psychology|psychology
35601|NCT03979300|Educational|educational
35602|NCT03979300|Learning|learning
35603|NCT03979287|Chronic Neck Pain|chronic neck pain
35604|NCT03979287|Interferential Current Electrotherapy|interferential current electrotherapy
35605|NCT03979287|Therapeutic Exercise|therapeutic exercise
35606|NCT03979287|Physical Therapy|physical therapy
35609|NCT03979222|ECMO|ecmo
35610|NCT03979222|ARDS|ards
35611|NCT03979222|Acute respiratory failure|acute respiratory failure
35612|NCT03979209|Cortisol Suppression|cortisol suppression
35613|NCT03979209|Mometasone|mometasone
35614|NCT03979209|Chronic Rhinosinusitis|chronic rhinosinusitis
35615|NCT03979209|Steroid Irrigations|steroid irrigations
35616|NCT03979196|Preterm Birth|preterm birth
35617|NCT03979196|Pregnancy, High Risk|pregnancy, high risk
35618|NCT03979196|Short Cervix|short cervix
35619|NCT03979183|Pain|pain
35620|NCT03979183|Therapeutic exercise|therapeutic exercise
35621|NCT03979183|Physiotherapy|physiotherapy
35622|NCT03979183|Rehabilitation|rehabilitation
35623|NCT03979183|Quality of life|quality of life
35624|NCT03979157|Muscular Diseases|muscular diseases
35625|NCT03979157|Duchenne muscular disease|duchenne muscular disease
35626|NCT03979157|MSOT|msot
35627|NCT03979144|Usability|usability
35628|NCT03979144|HIV self-test|hiv self-test
35629|NCT03979144|Prototype|prototype
35630|NCT03979118|Physical Activity|physical activity
35631|NCT03979118|Skeletal Related Events|skeletal related events
35632|NCT03979092|Collaborative skills|collaborative skills
35633|NCT03979092|Emotion regulation|emotion regulation
35634|NCT03979092|Self-efficacy|self-efficacy
35635|NCT03979092|Interprofessional education|interprofessional education
35636|NCT03979092|Advanced Cardiac Life Support|advanced cardiac life support
35637|NCT03979092|Nursing students|nursing students
35638|NCT03979066|Neoadjuvant therapy|neoadjuvant therapy
35639|NCT03979066|PEGPH20|pegph20
35640|NCT03979066|Atezolizumab|atezolizumab
35641|NCT03979066|Columbia|columbia
35642|NCT03979066|Pancreatic Ductal Adenocarcinoma|pancreatic ductal adenocarcinoma
35643|NCT03979053|Auto Immune Hepatitis, Magnetic Resonance Imaging|auto immune hepatitis, magnetic resonance imaging
35644|NCT03979027|Cognition|cognition
35645|NCT03979014|neoplasia|neoplasia
35646|NCT03979014|cervix cancer|cervix cancer
35647|NCT03979014|vaccination|vaccination
35648|NCT03978988|stroke|stroke
35649|NCT03978988|tandem occlusion|tandem occlusion
35650|NCT03978988|carotid stenting|carotid stenting
35651|NCT03978988|thrombectomy|thrombectomy
35652|NCT03978975|Energy expenditure|energy expenditure
35653|NCT03978975|Food intake|food intake
35654|NCT03978975|Women|women
35655|NCT03978975|aquacycling|aquacycling
35656|NCT03978962|Periodontal defects|periodontal defects
35657|NCT03978962|Alveolar bone preservation|alveolar bone preservation
35658|NCT03978962|Collagen membrane|collagen membrane
35659|NCT03978962|Mucosa healing|mucosa healing
35660|NCT03978936|Bronchial Diseases|bronchial diseases
35661|NCT03978936|Respiratory Tract Diseases|respiratory tract diseases
35662|NCT03978936|Lung Diseases|lung diseases
35663|NCT03978936|Obstructive Lung Diseases|obstructive lung diseases
35664|NCT03978923|ultrasonic surgery|ultrasonic surgery
35665|NCT03978923|piezosurgery|piezosurgery
35666|NCT03978923|implant bed preparation|implant bed preparation
35667|NCT03978923|microcracks|microcracks
35668|NCT03978923|pain|pain
35669|NCT03978923|crestal bone resorption|crestal bone resorption
35670|NCT03978897|lateral epicondylitis|lateral epicondylitis
35671|NCT03978897|tennis elbow|tennis elbow
35672|NCT03978897|blood flow restriction|blood flow restriction
35673|NCT03978897|physical therapy|physical therapy
35674|NCT03978871|Brain|brain
35675|NCT03978871|Functional Neuroimaging|functional neuroimaging
35676|NCT03978871|Stress, Psychological|stress, psychological
35677|NCT03978871|Emotions|emotions
35678|NCT03978871|Psychology, Developmental|psychology, developmental
35679|NCT03978819|Analgesia nociception index|analgesia nociception index
35680|NCT03978819|Parasympathetic nerve stimulation|parasympathetic nerve stimulation
35681|NCT03978819|Excessive analgesia|excessive analgesia
35682|NCT03978780|Spinae fascial plane block|spinae fascial plane block
35683|NCT03978780|Serratus block|serratus block
35684|NCT03978780|Breast surgery|breast surgery
35685|NCT03978767|NSAIDs|nsaids
35686|NCT03978767|Ibuprofen|ibuprofen
35687|NCT03978754|Lymphedema of Upper Arm|lymphedema of upper arm
35688|NCT03978754|Breast Neoplasms|breast neoplasms
35689|NCT03978702|Pancreatectomy|pancreatectomy
35690|NCT03978702|Immune system|immune system
35691|NCT03978663|locally advanced breast cancer|locally advanced breast cancer
35692|NCT03978663|immune priming|immune priming
35693|NCT03978663|radiation therapy|radiation therapy
35694|NCT03978663|neoadjuvant radiation|neoadjuvant radiation
35695|NCT03978663|radiotherapy|radiotherapy
35696|NCT03978663|immuno-oncology|immuno-oncology
35697|NCT03978637|Bronchiolitis obliterans syndrome|bronchiolitis obliterans syndrome
35698|NCT03978637|lung transplant|lung transplant
35699|NCT03978637|JAK1 inhibitor|jak1 inhibitor
35700|NCT03978624|Muscle Invasive Bladder Cancer|muscle invasive bladder cancer
35701|NCT03978624|MIBC|mibc
35702|NCT03978624|pembrolizumab|pembrolizumab
35703|NCT03978624|entinostat|entinostat
35704|NCT03978585|HTEMS|htems
35705|NCT03978585|peripheral neuropathy|peripheral neuropathy
35706|NCT03978585|chemotherapy|chemotherapy
35707|NCT03978585|TENS therapy|tens therapy
35708|NCT03978572|Exercise|exercise
35709|NCT03978546|glaucoma|glaucoma
35710|NCT03978520|Systemic Lupus Erythematosus (SLE)|systemic lupus erythematosus (sle)
35711|NCT03978520|ABBV-105|abbv-105
35712|NCT03978520|Upadacitinib|upadacitinib
35713|NCT03978520|ABBV-599|abbv-599
35714|NCT03978507|Freezing of Gait, Intelligent cueing, Detection of freezing of gait, Home environment, Free-living gait monitoring|freezing of gait, intelligent cueing, detection of freezing of gait, home environment, free-living gait monitoring
35715|NCT03978494|Kidney transplant; Renal transplant|kidney transplant; renal transplant
35716|NCT03978481|Gastric cancer|gastric cancer
35717|NCT03978481|Helicobacter pylori|helicobacter pylori
35718|NCT03978481|Subtotal gastrectomy|subtotal gastrectomy
35719|NCT03978481|Overall survival|overall survival
35720|NCT03978481|Metachronous cancer|metachronous cancer
35721|NCT03978468|Collaboration, Home Health Nurse, Providers|collaboration, home health nurse, providers
35722|NCT03978455|Mobile app|mobile app
35927|NCT03977415|RA|ra
35723|NCT03978442|Stress Disorders, Post-Traumatic|stress disorders, post-traumatic
35724|NCT03978442|Smoking|smoking
35725|NCT03978429|Pre-eclampsia|pre-eclampsia
35726|NCT03978429|Eclampsia|eclampsia
35727|NCT03978429|mHealth|mhealth
35728|NCT03978429|mobile health|mobile health
35729|NCT03978429|Gestosis|gestosis
35730|NCT03978429|Hypertension, Pregnancy-Induced|hypertension, pregnancy-induced
35731|NCT03978416|Obesity|obesity
35732|NCT03978416|Weight loss|weight loss
35733|NCT03978416|Hispanic / Latino|hispanic / latino
35734|NCT03978416|Older adults|older adults
35735|NCT03978416|Eating habits|eating habits
35736|NCT03978403|Pharmacokinetics|pharmacokinetics
35737|NCT03978403|Healthy|healthy
35738|NCT03978403|Volunteer|volunteer
35739|NCT03978390|Dental Injection|dental injection
35740|NCT03978390|Behavioral Intervention|behavioral intervention
35741|NCT03978390|Behavioral Priming|behavioral priming
35742|NCT03978390|Endowment Effect|endowment effect
35743|NCT03978390|Personality Traits|personality traits
35744|NCT03978377|Radiotherapy|radiotherapy
35745|NCT03978377|Pulmonary hypertension|pulmonary hypertension
35746|NCT03978338|Alzheimer Disease|alzheimer disease
35747|NCT03978338|Brain polypeptide|brain polypeptide
35748|NCT03978325|Prehabilitation|prehabilitation
35749|NCT03978325|Exercise|exercise
35750|NCT03978325|Surgery|surgery
35751|NCT03978312|Nutrition|nutrition
35752|NCT03978312|Health|health
35753|NCT03978312|Literacy|literacy
35754|NCT03978312|Education|education
35755|NCT03978312|Information|information
35756|NCT03978312|Knowledge|knowledge
35757|NCT03978299|Prostatic Neoplasms|prostatic neoplasms
35758|NCT03978299|False Positive Reactions|false positive reactions
35759|NCT03978299|False Negative Reactions|false negative reactions
35760|NCT03978299|Disease Management|disease management
35761|NCT03978286|depression|depression
35762|NCT03978286|Type 2 diabetes Mellitus|type 2 diabetes mellitus
35763|NCT03978286|vortioxetine|vortioxetine
35764|NCT03978286|sertraline|sertraline
35765|NCT03978273|Vertebral column|vertebral column
35766|NCT03978273|Rehabilitation|rehabilitation
48053|NCT03901859|ADHD|adhd
35767|NCT03978273|Virtual-brace|virtual-brace
35768|NCT03978273|Posture|posture
35769|NCT03978260|Anemia|anemia
35770|NCT03978221|Diaphragmatic Tissue Doppler|diaphragmatic tissue doppler
35771|NCT03978221|Non invasive ventilation|non invasive ventilation
35772|NCT03978221|Spontaneous breathing|spontaneous breathing
35773|NCT03978221|Post-extubation|post-extubation
35774|NCT03978208|Knee|knee
35775|NCT03978208|WOMAC|womac
35776|NCT03978208|NSAID|nsaid
35777|NCT03978208|Pain|pain
35778|NCT03978182|repetitive Transcranial Magnetic Stimulation|repetitive transcranial magnetic stimulation
35779|NCT03978169|anaesthetic modality|anaesthetic modality
35780|NCT03978169|Lung|lung
35781|NCT03978143|Adult|adult
35782|NCT03978143|Bioavailability|bioavailability
35783|NCT03978143|Crizotinib|crizotinib
35784|NCT03978143|Drug Interactions|drug interactions
35785|NCT03978143|Esomeprazole|esomeprazole
35786|NCT03978143|Humans|humans
35787|NCT03978143|Microsphere|microsphere
35788|NCT03978143|Pharmacokinetics|pharmacokinetics
35789|NCT03978143|Safety|safety
35790|NCT03978143|Taste|taste
35791|NCT03978104|Okara|okara
35792|NCT03978104|Soybean pulp|soybean pulp
35793|NCT03978104|Soybean|soybean
35794|NCT03978104|Fibre|fibre
35795|NCT03978104|Gut microbiome|gut microbiome
35796|NCT03978104|Microbiota|microbiota
35797|NCT03978104|Gastrointestinal microbiome|gastrointestinal microbiome
35798|NCT03978104|Glycemic|glycemic
35799|NCT03978104|Glycaemic|glycaemic
35800|NCT03978104|Middle-aged and older adults|middle-aged and older adults
35801|NCT03978104|Singapore|singapore
35802|NCT03978091|Aztreonam|aztreonam
35803|NCT03978091|Ceftazidime-Avibactam|ceftazidime-avibactam
35804|NCT03978091|Efficacy|efficacy
35805|NCT03978091|Healthy|healthy
35806|NCT03978091|Pharmacokinetics|pharmacokinetics
35807|NCT03978091|Population|population
35808|NCT03978091|Safety|safety
35809|NCT03978078|colorectal|colorectal
35810|NCT03978078|pancreas|pancreas
35811|NCT03978078|stomach|stomach
35812|NCT03978078|oesophagus|oesophagus
35813|NCT03978078|bile duct|bile duct
35814|NCT03978078|small intestine|small intestine
35815|NCT03978078|cancer|cancer
35816|NCT03978052|EGCG Epigallocatechin gallate,|egcg epigallocatechin gallate,
35817|NCT03978052|Dietary supplement|dietary supplement
35818|NCT03978052|personalized medicine,|personalized medicine,
35819|NCT03978052|Subjective Cognitive Complaints (SCD)|subjective cognitive complaints (scd)
35820|NCT03978052|Apolipoprotein E4|apolipoprotein e4
35821|NCT03978039|patterns of care|patterns of care
35822|NCT03978039|access to care|access to care
35823|NCT03978039|survival|survival
35824|NCT03978039|experts' network|experts' network
35825|NCT03978026|Nap|nap
35826|NCT03978026|vigilance|vigilance
35827|NCT03978026|cognition|cognition
35828|NCT03978026|driving simulation|driving simulation
35829|NCT03977987|hepatitis B|hepatitis b
35833|NCT03977948|cardiac surgery pediatric|cardiac surgery pediatric
35835|NCT03977935|SG-MCCG|sg-mccg
35836|NCT03977935|Z-line visualization|z-line visualization
35837|NCT03977935|Image quality|image quality
35838|NCT03977935|Gastric examination time|gastric examination time
35839|NCT03977935|Manipulation performance|manipulation performance
35840|NCT03977909|Early Maladaptative Schemas|early maladaptative schemas
35841|NCT03977909|Cognition|cognition
35842|NCT03977909|Functioning|functioning
35843|NCT03977896|PET/MRI|pet/mri
35844|NCT03977896|11C-MET|11c-met
35845|NCT03977896|posterior brain fossa tumors|posterior brain fossa tumors
35846|NCT03977896|children|children
35847|NCT03977896|surgery|surgery
35848|NCT03977896|feasibility|feasibility
35849|NCT03977883|New onset atrial fibrillation|new onset atrial fibrillation
35850|NCT03977883|Paroxystic atrial fibrillation|paroxystic atrial fibrillation
35851|NCT03977883|ICU patients|icu patients
35852|NCT03977883|Rate control|rate control
35853|NCT03977883|Rhythm control|rhythm control
35854|NCT03977857|Hepatitis B|hepatitis b
35855|NCT03977857|Acute-on-Chronic liver failure|acute-on-chronic liver failure
35856|NCT03977857|liver volume|liver volume
35857|NCT03977857|prognostic model|prognostic model
35858|NCT03977831|Bladder Cancer|bladder cancer
35859|NCT03977831|Radical cystectomy|radical cystectomy
35860|NCT03977818|outcome|outcome
35861|NCT03977818|time to next treatment|time to next treatment
35862|NCT03977818|overall survival|overall survival
35863|NCT03977818|patterns of care|patterns of care
35864|NCT03977792|Herpes Simplex|herpes simplex
35865|NCT03977792|Skin Diseases, Infectious|skin diseases, infectious
35866|NCT03977792|Herpesviridae Infections|herpesviridae infections
35867|NCT03977779|biodegradable stent|biodegradable stent
35868|NCT03977779|Post-Endoscopic Retrograde CholoangioPancreatography Pancreatitis|post-endoscopic retrograde choloangiopancreatography pancreatitis
35869|NCT03977766|digital application|digital application
35870|NCT03977766|outpatients chemotherapy|outpatients chemotherapy
35871|NCT03977766|chemotherapy validation|chemotherapy validation
35872|NCT03977714|peri-implantitis|peri-implantitis
35873|NCT03977714|ceramic dental implant|ceramic dental implant
35874|NCT03977714|non-invasive|non-invasive
35875|NCT03977714|periodontal disease|periodontal disease
35876|NCT03977714|metal-free|metal-free
35877|NCT03977701|PHONOLOGY|phonology
35878|NCT03977701|MORPHOLOGY|morphology
35879|NCT03977688|sepsis|sepsis
35880|NCT03977688|septic shock|septic shock
35881|NCT03977688|cytokin adsorption|cytokin adsorption
35882|NCT03977675|Magnetic Resonance Spectroscopy|magnetic resonance spectroscopy
35883|NCT03977675|Ketamine|ketamine
35884|NCT03977649|AMG334|amg334
35885|NCT03977649|erenumab|erenumab
35886|NCT03977649|functional MRI|functional mri
35887|NCT03977649|connectivity|connectivity
35888|NCT03977636|Diagnosis-related groups|diagnosis-related groups
35889|NCT03977636|Activity-based funding|activity-based funding
35894|NCT03977597|lung transplant|lung transplant
35895|NCT03977597|diaphragm evaluation|diaphragm evaluation
35896|NCT03977597|ultrasound|ultrasound
35897|NCT03977571|Cytoreduction Surgical Procedures|cytoreduction surgical procedures
35898|NCT03977571|Nephrectomy|nephrectomy
35899|NCT03977571|Ipilimumab|ipilimumab
35900|NCT03977571|Nivolumab|nivolumab
35901|NCT03977571|Laboratory biomarker analysis|laboratory biomarker analysis
35902|NCT03977571|Gene Expression|gene expression
35903|NCT03977571|Liquid Biopsy|liquid biopsy
35904|NCT03977558|Shift Work|shift work
35905|NCT03977558|Night Work|night work
35906|NCT03977558|Rotating Shift Work|rotating shift work
35907|NCT03977558|Metabolic Syndrome|metabolic syndrome
35908|NCT03977558|Diet Therapy|diet therapy
35909|NCT03977558|Canola oil|canola oil
35910|NCT03977558|Fatty Acids|fatty acids
35911|NCT03977558|Cardiometabolic parameters|cardiometabolic parameters
35912|NCT03977519|primary dysmenorrhea|primary dysmenorrhea
35913|NCT03977519|manual acupuncture|manual acupuncture
35914|NCT03977519|transcutaneous electric nerve stimulation|transcutaneous electric nerve stimulation
35915|NCT03977519|randomized controlled trial|randomized controlled trial
35916|NCT03977506|driving capacity|driving capacity
35917|NCT03977506|cerebrovascular accident|cerebrovascular accident
35918|NCT03977506|grid|grid
35919|NCT03977467|atezolizumab|atezolizumab
35920|NCT03977467|NSCLC|nsclc
35921|NCT03977467|Non-Small Cell Lung Cancer|non-small cell lung cancer
35922|NCT03977467|advanced solid tumors|advanced solid tumors
35923|NCT03977415|Interstitial Lung Disease|interstitial lung disease
35924|NCT03977415|ILD|ild
35925|NCT03977415|Pulmonary Fibrosis|pulmonary fibrosis
35926|NCT03977415|Rheumatoid Arthritis|rheumatoid arthritis
35928|NCT03977415|Rheumatology|rheumatology
35929|NCT03977389|Long-term result|long-term result
35930|NCT03977389|Denervation|denervation
35931|NCT03977376|anxiety|anxiety
35932|NCT03977376|Urogical|urogical
35933|NCT03977376|Guide of Hosting|guide of hosting
35934|NCT03977376|Comunication instrument|comunication instrument
35935|NCT03977376|Patients|patients
35936|NCT03977363|Anticoagulation|anticoagulation
35937|NCT03977363|Anticoagulants|anticoagulants
35938|NCT03977363|Vitamin K antagonists|vitamin k antagonists
35939|NCT03977363|Warfarin|warfarin
35940|NCT03977363|Low molecular weight heparin|low molecular weight heparin
35941|NCT03977363|Direct oral anticoagulants|direct oral anticoagulants
35942|NCT03977363|dabigatran|dabigatran
35943|NCT03977363|rivaroxaban|rivaroxaban
35944|NCT03977363|apixaban|apixaban
35945|NCT03977363|edoxaban|edoxaban
35946|NCT03977363|Atrial Fibrillation|atrial fibrillation
35947|NCT03977363|Thromboembolism|thromboembolism
35948|NCT03977363|Venous Thromboembolism|venous thromboembolism
35949|NCT03977363|Heart Valve Diseases|heart valve diseases
35950|NCT03977363|Arrhythmia|arrhythmia
35951|NCT03977363|Heart Diseases|heart diseases
35952|NCT03977363|Cardiovascular Diseases|cardiovascular diseases
35953|NCT03977363|Vascular Diseases|vascular diseases
35954|NCT03977363|Embolism and Thrombosis|embolism and thrombosis
35955|NCT03977324|CTG|ctg
35956|NCT03977324|peri-implantitis|peri-implantitis
35957|NCT03977324|surgical treatment|surgical treatment
35958|NCT03977324|horizontal defect|horizontal defect
35959|NCT03977324|keratinised tissue|keratinised tissue
35960|NCT03977298|peri-implantitis|peri-implantitis
35961|NCT03977298|CTG|ctg
35962|NCT03977298|Chlorhexidine|chlorhexidine
35963|NCT03977298|surgical treatment|surgical treatment
35964|NCT03977298|Keratinised tissue|keratinised tissue
35965|NCT03977285|peri-implantitis|peri-implantitis
35966|NCT03977285|surgical treatment|surgical treatment
35967|NCT03977285|Er:Yag laser|er:yag laser
35968|NCT03977285|Air-flow|air-flow
35969|NCT03977285|chlorhexidine|chlorhexidine
35970|NCT03977272|Pancreatic Cancer|pancreatic cancer
35971|NCT03977272|Anti-PD-1 Antibody|anti-pd-1 antibody
35972|NCT03977233|Pancreatic Ductal Adenocarcinoma|pancreatic ductal adenocarcinoma
35973|NCT03977233|Pancreatic Cancer Non-resectable|pancreatic cancer non-resectable
35974|NCT03977233|Pancreatic Cancer Resectable|pancreatic cancer resectable
35975|NCT03977233|neoadjuvant FOLFIRNOX|neoadjuvant folfirnox
35976|NCT03977233|FOLFIRINOX|folfirinox
35977|NCT03977233|Pancreatic Cancer, Adult|pancreatic cancer, adult
35978|NCT03977194|IFCT|ifct
35979|NCT03977194|ELDERLY|elderly
35980|NCT03977194|NSCLC|nsclc
35981|NCT03977194|immunotherapy|immunotherapy
35982|NCT03977194|chemotherapy|chemotherapy
35983|NCT03977181|PrEP|prep
35984|NCT03977181|HIV Prevention|hiv prevention
35985|NCT03977181|Adherence Support|adherence support
35986|NCT03977181|Adolescence|adolescence
35987|NCT03977181|South Africa|south africa
35988|NCT03977155|Irritable Bowel Sydrome|irritable bowel sydrome
35989|NCT03977155|diarrhea|diarrhea
35990|NCT03977155|BOS-589|bos-589
35991|NCT03977038|Repetitive Transcranial Magnetic Stimulation|repetitive transcranial magnetic stimulation
35992|NCT03977038|Hot Cognition|hot cognition
35993|NCT03977038|Cold Cognition|cold cognition
35994|NCT03977038|Attentional Imaging|attentional imaging
35995|NCT03977038|Eye tracking|eye tracking
35996|NCT03977038|Cognitive impairment|cognitive impairment
35997|NCT03977038|Cognition|cognition
35998|NCT03976999|Biological Specimen Banks|biological specimen banks
35999|NCT03976999|Cancer|cancer
36000|NCT03976999|Gynecology|gynecology
36001|NCT03976986|Infants|infants
36002|NCT03976986|Hypoxia Altitude Simulation Test|hypoxia altitude simulation test
36003|NCT03976986|Oxygen Delivery Device|oxygen delivery device
36004|NCT03976986|Portable Oxygen Concentrator|portable oxygen concentrator
36005|NCT03976986|Hypoxic Challenge Testing|hypoxic challenge testing
36006|NCT03976960|cancer|cancer
36007|NCT03976960|colon|colon
36008|NCT03976960|tumor|tumor
36009|NCT03976960|colic|colic
36010|NCT03976947|Driving pressure|driving pressure
36011|NCT03976947|Postoperative pulmonary complications|postoperative pulmonary complications
36012|NCT03976934|open inguinal hernia repair|open inguinal hernia repair
36013|NCT03976934|spinal anaesthesia|spinal anaesthesia
36014|NCT03976934|urinary retention|urinary retention
36015|NCT03976934|elective alpha blockers|elective alpha blockers
36016|NCT03976921|Computed Tomography Perfusion|computed tomography perfusion
36017|NCT03976921|Cardiovascular Outcomes|cardiovascular outcomes
36018|NCT03976921|Cost-effectiveness|cost-effectiveness
36019|NCT03976908|Tinnitus|tinnitus
36020|NCT03976908|Deep Brain Stimulation|deep brain stimulation
36021|NCT03976895|viral bronchiolitis|viral bronchiolitis
36022|NCT03976895|Prone position|prone position
36023|NCT03976895|high flow nasal cannula|high flow nasal cannula
36024|NCT03976895|noninvasive ventilation|noninvasive ventilation
36025|NCT03976895|Randomized controlled trial|randomized controlled trial
36026|NCT03976869|glucocorticoid receptor (GR) modulator (SGRM)|glucocorticoid receptor (gr) modulator (sgrm)
36035|NCT03976830|Childhood Cancer|childhood cancer
36036|NCT03976830|Central America|central america
36037|NCT03976817|bioprosthesis|bioprosthesis
36038|NCT03976817|surgery|surgery
36039|NCT03976817|supra-annular|supra-annular
36040|NCT03976804|Cancer|cancer
36041|NCT03976804|Tobacco|tobacco
36042|NCT03976778|Well-child|well-child
36043|NCT03976778|Pediatric health maintenance|pediatric health maintenance
36044|NCT03976778|Health supervision for children|health supervision for children
36045|NCT03976752|HIV|hiv
36046|NCT03976752|MSM|msm
36047|NCT03976752|Anti-retrovirals|anti-retrovirals
36048|NCT03976752|Pharmacokinetics|pharmacokinetics
36049|NCT03976752|Peri-exposure HIV prophylaxis|peri-exposure hiv prophylaxis
36050|NCT03976739|gastric cancer; helicobacter pylori; precancerous lesion; bile reflux|gastric cancer; helicobacter pylori; precancerous lesion; bile reflux
36051|NCT03976726|Laryngel Mask|laryngel mask
36052|NCT03976713|Chronic Obstructive Pulmonary Disease|chronic obstructive pulmonary disease
36053|NCT03976713|Bufei Yishen Granule|bufei yishen granule
36054|NCT03976713|Randomized Controlled Trial|randomized controlled trial
36055|NCT03976700|Chronic Obstructive Pulmonary Disease|chronic obstructive pulmonary disease
36056|NCT03976700|Bufei Jianpi Granule|bufei jianpi granule
36057|NCT03976700|Randomized Controlled Trial|randomized controlled trial
36058|NCT03976674|Bariatric Surgery Candidate|bariatric surgery candidate
36059|NCT03976674|Cognitive and Behavioural Emotional Therapies|cognitive and behavioural emotional therapies
36060|NCT03976674|Obesity|obesity
36061|NCT03976661|No severe behavioural disorders, EHPAD (retirement home), Older patients, loss of autonomy, Groupe-Iso-Ressources (GIR)|no severe behavioural disorders, ehpad (retirement home), older patients, loss of autonomy, groupe-iso-ressources (gir)
36062|NCT03976635|Removable Mandibular Retractor|removable mandibular retractor
36063|NCT03976635|Bone-anchored Intermaxillary Traction|bone-anchored intermaxillary traction
36064|NCT03976622|Skin inflammation|skin inflammation
36065|NCT03976622|Cytokines|cytokines
36066|NCT03976609|Nasak Septum|nasak septum
36067|NCT03976609|Cleft Lip|cleft lip
36068|NCT03976609|Cleft palate|cleft palate
36069|NCT03976609|Palatal expansion technique|palatal expansion technique
36070|NCT03976596|neonates|neonates
36071|NCT03976596|mitochondria|mitochondria
36072|NCT03976596|MRI|mri
36073|NCT03976544|frozen-thawed embryo transfer|frozen-thawed embryo transfer
36074|NCT03976544|FET|fet
36075|NCT03976544|natural cycle|natural cycle
36076|NCT03976544|hormone replacement therapy cycle|hormone replacement therapy cycle
36077|NCT03976544|miscarriage|miscarriage
36078|NCT03976531|cancer|cancer
36079|NCT03976531|elderly|elderly
36080|NCT03976531|randomized trial|randomized trial
36081|NCT03976531|consensus|consensus
36082|NCT03976518|Advanced Non-Small Cell Lung Cancer|advanced non-small cell lung cancer
36083|NCT03976518|NSCLC Rare Histological Subtypes|nsclc rare histological subtypes
36084|NCT03976505|medication prescriptions|medication prescriptions
36085|NCT03976505|eye-tracking|eye-tracking
36086|NCT03976505|non-adherence|non-adherence
36087|NCT03976505|medication schedule|medication schedule
36088|NCT03976479|Body composition|body composition
36089|NCT03976479|Nutritional status|nutritional status
36090|NCT03976479|Lipids|lipids
36091|NCT03976479|Blood pressure|blood pressure
36092|NCT03976479|Lifestyle factors|lifestyle factors
36093|NCT03976466|periprosthetic joint infection|periprosthetic joint infection
36094|NCT03976466|Prophylaxis|prophylaxis
36095|NCT03976466|Joint Replacement|joint replacement
36096|NCT03976466|calcium sulfate beds|calcium sulfate beds
36097|NCT03976440|Acute kidney injury|acute kidney injury
36098|NCT03976440|Regional citrate anticoagulation|regional citrate anticoagulation
36099|NCT03976440|Continuous renal replacement therapy|continuous renal replacement therapy
36100|NCT03976440|Prolonged intermittent renal replacement therapy|prolonged intermittent renal replacement therapy
36101|NCT03976388|Virtual reality|virtual reality
36102|NCT03976388|Clinical simulation|clinical simulation
36103|NCT03976388|Adherence|adherence
36104|NCT03976388|Guidelines|guidelines
36105|NCT03976375|programmed cell death 1 (PD-1, PD1)|programmed cell death 1 (pd-1, pd1)
36106|NCT03976375|programmed cell death-ligand 1 (PD-L1, PDL1)|programmed cell death-ligand 1 (pd-l1, pdl1)
36107|NCT03976375|programmed cell death-ligand 2 (PD-L2, PDL2)|programmed cell death-ligand 2 (pd-l2, pdl2)
36108|NCT03976362|PD-1|pd-1
36109|NCT03976362|PD L1|pd l1
36110|NCT03976362|PD L2|pd l2
36111|NCT03976323|Lung cancer|lung cancer
36112|NCT03976323|PD-1|pd-1
36113|NCT03976323|PD L1|pd l1
36114|NCT03976323|PD L2|pd l2
36115|NCT03976297|Machine learning|machine learning
36116|NCT03976297|Artificial Intelligence|artificial intelligence
36117|NCT03976297|Pragmatic Clinical Trial|pragmatic clinical trial
36118|NCT03976297|Healthcare Delivery|healthcare delivery
36119|NCT03976258|heroin|heroin
36120|NCT03976258|HIV|hiv
36121|NCT03976258|inflammation|inflammation
36122|NCT03976258|cardiovascular|cardiovascular
36123|NCT03976245|Tumour Necrosis Factor|tumour necrosis factor
36124|NCT03976245|Janus kinase inhibitor|janus kinase inhibitor
36125|NCT03976193|active treatment|active treatment
36126|NCT03976193|Recent treatment|recent treatment
36127|NCT03976180|Sickle Cell Disease|sickle cell disease
36128|NCT03976180|vaso-occlusive pain crisis|vaso-occlusive pain crisis
36129|NCT03976180|HFNO|hfno
36130|NCT03976180|ACS|acs
36131|NCT03976167|Children|children
36132|NCT03976167|Desaturations|desaturations
36133|NCT03976167|Bronchoscopy|bronchoscopy
36134|NCT03976167|Oxygen|oxygen
36135|NCT03976167|High flow oxygen|high flow oxygen
36136|NCT03976128|endurance training|endurance training
36137|NCT03976128|nordic walking|nordic walking
36138|NCT03976128|walking ability|walking ability
36139|NCT03976128|fatigue|fatigue
36140|NCT03976102|Follicular Lymphoma|follicular lymphoma
36141|NCT03976102|Dr. Reddy's Rituximab|dr. reddy's rituximab
36142|NCT03976102|Biosimiliar (DRL_RI)|biosimiliar (drl_ri)
36143|NCT03976102|FLINTER|flinter
36144|NCT03976063|Preterm premature rupture of membranes|preterm premature rupture of membranes
36145|NCT03976063|Tocolysis|tocolysis
36146|NCT03976063|Nifedipine|nifedipine
36147|NCT03976063|Latency|latency
36148|NCT03976063|Neonatal outcome|neonatal outcome
36149|NCT03976063|Preterm birth|preterm birth
36150|NCT03976063|Randomized controlled trial|randomized controlled trial
36151|NCT03976011|Postoperative dysphonia|postoperative dysphonia
36152|NCT03976011|Thyroidectomy|thyroidectomy
36153|NCT03976011|Parathyroidectomy|parathyroidectomy
36154|NCT03976011|Inferior laryngeal nerve palsy|inferior laryngeal nerve palsy
36155|NCT03976011|Trans laryngeal ultrasonography|trans laryngeal ultrasonography
36156|NCT03976011|Quantitative vocal fold motion evaluation|quantitative vocal fold motion evaluation
36157|NCT03976011|Postoperative recurrent Laryngeal Nerve Palsy|postoperative recurrent laryngeal nerve palsy
36158|NCT03975998|Mitral regurgitation|mitral regurgitation
36159|NCT03975998|Mitral repair|mitral repair
36160|NCT03975998|Watchful waiting|watchful waiting
36161|NCT03975998|Asymptomatic|asymptomatic
36162|NCT03975985|stroke|stroke
36163|NCT03975985|core stability|core stability
36164|NCT03975985|trunk control|trunk control
36165|NCT03975985|sitting balance|sitting balance
36166|NCT03975985|gait|gait
36167|NCT03975985|spasticity|spasticity
36168|NCT03975985|falls|falls
36169|NCT03975985|activities of daily living|activities of daily living
36170|NCT03975985|standing balance|standing balance
36171|NCT03975959|PROMESSE|promesse
36172|NCT03975959|PROSPECTIVE MEMORY|prospective memory
36173|NCT03975959|RETROSPECTIVE MEMORY|retrospective memory
36174|NCT03975933|Reproductive Health|reproductive health
36175|NCT03975933|Family Planning|family planning
36176|NCT03975933|Randomization Trial|randomization trial
36177|NCT03975933|Uganda|uganda
36178|NCT03975920|jaw support device|jaw support device
36179|NCT03975920|wisdom teeth|wisdom teeth
36180|NCT03975920|impacted|impacted
36181|NCT03975920|Temporomandibular Disorders|temporomandibular disorders
36182|NCT03975907|multiple myeloma|multiple myeloma
36183|NCT03975907|car-T|car-t
36184|NCT03975894|pregnancy|pregnancy
36185|NCT03975894|exchange transfusion|exchange transfusion
36186|NCT03975894|perinatal complications|perinatal complications
36187|NCT03975881|Suicide attempts|suicide attempts
36188|NCT03975881|digital device|digital device
36189|NCT03975881|adolescent|adolescent
36190|NCT03975881|adults|adults
36191|NCT03975868|Cut-out|cut-out
36192|NCT03975868|Gamma nail|gamma nail
36193|NCT03975868|Lag-screw|lag-screw
36194|NCT03975868|Tip-apex distance|tip-apex distance
36195|NCT03975868|Trochanteric fracture|trochanteric fracture
36196|NCT03975855|Breast Cancer|breast cancer
36197|NCT03975855|Axillary Lymph Nodes|axillary lymph nodes
36198|NCT03975855|Biopsy|biopsy
36199|NCT03975842|otitis media with effusion (OME)|otitis media with effusion (ome)
36200|NCT03975842|prevalence|prevalence
36201|NCT03975842|risk factor|risk factor
36202|NCT03975842|endoscopic nasal examination|endoscopic nasal examination
36203|NCT03975842|otoscopic examination|otoscopic examination
36204|NCT03975842|pure-tone audiometry|pure-tone audiometry
36205|NCT03975842|tympanometry|tympanometry
36206|NCT03975829|v600-mutation|v600-mutation
36207|NCT03975829|neuroblastoma|neuroblastoma
36208|NCT03975829|Trametinib|trametinib
36209|NCT03975829|pediatrics|pediatrics
36210|NCT03975829|Langerhans Cell Histiocytosis|langerhans cell histiocytosis
36211|NCT03975829|low grade glioma|low grade glioma
36212|NCT03975829|plexiform neurofibromas|plexiform neurofibromas
36213|NCT03975829|high grade glioma|high grade glioma
36214|NCT03975829|dabrafenib|dabrafenib
36215|NCT03975829|NF-1|nf-1
36216|NCT03975816|Analgesia nociception index|analgesia nociception index
36217|NCT03975816|Painless labor|painless labor
36218|NCT03975816|epidural analgesia|epidural analgesia
36219|NCT03975803|return to work|return to work
36220|NCT03975803|readiness for return to work|readiness for return to work
36221|NCT03975803|occupational injury|occupational injury
36222|NCT03975803|work hardening|work hardening
36223|NCT03975751|severe brain injuries|severe brain injuries
36224|NCT03975751|sedation and analgesia|sedation and analgesia
36225|NCT03975751|intensive care unit|intensive care unit
36226|NCT03975751|survey|survey
36227|NCT03975699|paediatric-psychological partnership|paediatric-psychological partnership
36228|NCT03975699|child|child
36229|NCT03975699|mental health|mental health
36230|NCT03975699|integrated care|integrated care
36231|NCT03975699|well-being|well-being
36232|NCT03975673|hip arthroplasty|hip arthroplasty
36233|NCT03975673|spine hip relation|spine hip relation
36234|NCT03975634|pediatric-onset|pediatric-onset
36235|NCT03975634|transcutaneous spinal stimulation|transcutaneous spinal stimulation
36236|NCT03975634|trunk control|trunk control
36237|NCT03975621|Exercise|exercise
36238|NCT03975621|Feasibility|feasibility
36239|NCT03975621|Acceptability|acceptability
36240|NCT03975621|Supportive Care Platform|supportive care platform
36241|NCT03975569|vaginal, yeast infection, candida, candidosis|vaginal, yeast infection, candida, candidosis
36242|NCT03975543|Retinitis Pigmentosa|retinitis pigmentosa
36243|NCT03975543|RHO|rho
36244|NCT03975543|PDE6A|pde6a
36245|NCT03975543|PDE6B|pde6b
36246|NCT03975543|Pathogenic mutation|pathogenic mutation
36247|NCT03975543|Retrospective|retrospective
36248|NCT03975543|Natural History|natural history
36249|NCT03975543|Retinal Disease|retinal disease
36250|NCT03975543|Eye Diseases|eye diseases
36251|NCT03975543|Blindness|blindness
36252|NCT03975543|Inherited Eye Diseases|inherited eye diseases
36253|NCT03975543|Vision Disorders|vision disorders
36254|NCT03975543|Inherited Retinal Disorders|inherited retinal disorders
36255|NCT03975543|Rod-Cone Dystrophy|rod-cone dystrophy
36256|NCT03975530|Home visiting interventions|home visiting interventions
36257|NCT03975530|American Indian|american indian
36258|NCT03975530|Community based participatory research|community based participatory research
36259|NCT03975530|Pregnancy|pregnancy
36260|NCT03975517|Prep|prep
36261|NCT03975517|Sexual behavior|sexual behavior
36262|NCT03975517|HIV|hiv
36263|NCT03975517|Syphilis|syphilis
36264|NCT03975517|Chlamydia infection|chlamydia infection
36265|NCT03975517|Hepatitis|hepatitis
36266|NCT03975517|Gonococcus|gonococcus
36267|NCT03975478|bariatric surgery|bariatric surgery
36268|NCT03975478|gastric bypass|gastric bypass
36269|NCT03975478|sleeve gastrectomy|sleeve gastrectomy
36270|NCT03975478|LDL cholesterol|ldl cholesterol
36271|NCT03975478|morbid obesity|morbid obesity
36272|NCT03975465|oropharyngeal cancer|oropharyngeal cancer
36273|NCT03975465|laryngeal cancer|laryngeal cancer
36274|NCT03975465|swallow|swallow
36275|NCT03975465|chemoradiation|chemoradiation
36276|NCT03975465|expiratory muscle strength training|expiratory muscle strength training
36277|NCT03975465|long-term survivor|long-term survivor
36278|NCT03975413|FMT|fmt
36279|NCT03975413|Microbiome|microbiome
36280|NCT03975413|Gait|gait
36281|NCT03975413|Longitudinal|longitudinal
36282|NCT03975413|Multiple Sclerosis|multiple sclerosis
36283|NCT03975387|solid tumor|solid tumor
36284|NCT03975387|mesothelioma|mesothelioma
36285|NCT03975387|TP53|tp53
36286|NCT03975361|Rituximab|rituximab
36287|NCT03975348|High flow nasal cannula|high flow nasal cannula
36288|NCT03975348|Bariatric surgery|bariatric surgery
36289|NCT03975348|Postoperative atelectasis|postoperative atelectasis
36290|NCT03975348|Electrical impedance tomography|electrical impedance tomography
36291|NCT03975335|NCDs|ncds
36292|NCT03975335|Risk behaviors|risk behaviors
36293|NCT03975335|Adolescents|adolescents
36294|NCT03975335|Health education intervention|health education intervention
36295|NCT03975322|OLP|olp
36296|NCT03975322|oral cancer|oral cancer
36297|NCT03975322|OSCC|oscc
36298|NCT03975322|oral squamous cell carcinoma|oral squamous cell carcinoma
36299|NCT03975309|Cognition, Dementia, Mild Cognitive Impairment, European American, African American|cognition, dementia, mild cognitive impairment, european american, african american
36300|NCT03975192|Opiate Withdrawal|opiate withdrawal
36301|NCT03975192|Neurostimulation|neurostimulation
36302|NCT03975192|Percutaneous Electric Nerve Field Stimulation|percutaneous electric nerve field stimulation
36303|NCT03975192|Pediatrics|pediatrics
36304|NCT03975192|Pediatric Intensive Care Unit|pediatric intensive care unit
36305|NCT03975179|frozen section biopsy|frozen section biopsy
36306|NCT03975179|resection margin|resection margin
36307|NCT03975179|breast conserving surgery|breast conserving surgery
36308|NCT03975166|bioequivalence|bioequivalence
36309|NCT03975166|fluticasone propionate|fluticasone propionate
36310|NCT03975166|salmeterol xinafoate|salmeterol xinafoate
36311|NCT03975166|ADVAIR|advair
36312|NCT03975153|Interleukin-23, IL-23, guselkumab, Tremfya|interleukin-23, il-23, guselkumab, tremfya
36313|NCT03975127|population screening|population screening
36314|NCT03975114|Eldelry|eldelry
36315|NCT03975114|metastatic Non-Small-Cell Lung Cancer|metastatic non-small-cell lung cancer
36316|NCT03975114|Durvalumab|durvalumab
36317|NCT03975114|Immunotherapy|immunotherapy
36318|NCT03975062|atrial fibrillation|atrial fibrillation
36319|NCT03975062|cardioversion|cardioversion
36320|NCT03975062|anticoagulation|anticoagulation
36321|NCT03975062|dabigatran|dabigatran
36322|NCT03975062|magnetic resonance imaging|magnetic resonance imaging
36323|NCT03974945|Rehabilitation|rehabilitation
36324|NCT03974932|total knee arthroplasty|total knee arthroplasty
36325|NCT03974932|postoperative pain|postoperative pain
36326|NCT03974932|multimodal analgesia|multimodal analgesia
36327|NCT03974919|Pulmonary Hypertension, major cardiovascular event, non-cardiac surgery,threshold|pulmonary hypertension, major cardiovascular event, non-cardiac surgery,threshold
36328|NCT03974906|goal-directed fluid therapy|goal-directed fluid therapy
36329|NCT03974906|intraoperative hemodynamics|intraoperative hemodynamics
36330|NCT03974906|postoperative complications|postoperative complications
36331|NCT03974906|elderly patient|elderly patient
36332|NCT03974906|prone position|prone position
36333|NCT03974893|Dietary intake|dietary intake
36334|NCT03974893|Diet|diet
36335|NCT03974893|Acute lymphoblastic leukemia|acute lymphoblastic leukemia
36336|NCT03974867|idiopathic sudden sensorineural hearing loss|idiopathic sudden sensorineural hearing loss
36337|NCT03974867|vestibular dysfunction|vestibular dysfunction
36338|NCT03974867|glucocorticoids|glucocorticoids
36339|NCT03974828|Telemedicine|telemedicine
36340|NCT03974828|Anesthesia Control Tower|anesthesia control tower
36341|NCT03974828|Machine Learning|machine learning
36342|NCT03974828|Forecasting Algorithms|forecasting algorithms
36343|NCT03974828|Randomized Controlled Trial|randomized controlled trial
36344|NCT03974828|PACU|pacu
36345|NCT03974815|tDCS|tdcs
36346|NCT03974815|Bipolar disorder|bipolar disorder
36347|NCT03974815|Depression|depression
36348|NCT03974763|Facial Paralysis|facial paralysis
36349|NCT03974763|Bell's Palsy|bell's palsy
36350|NCT03974763|unilateral|unilateral
36351|NCT03974763|3D|3d
36352|NCT03974763|3D imaging|3d imaging
36353|NCT03974763|Facial form|facial form
36354|NCT03974763|Facial function|facial function
36355|NCT03974737|POTS|pots
36356|NCT03974737|Postural Orthostatic Tachycardia Syndrome|postural orthostatic tachycardia syndrome
36357|NCT03974737|Dysautonomia|dysautonomia
36358|NCT03974737|CRI|cri
36359|NCT03974737|Compensatory Reserve Index|compensatory reserve index
36360|NCT03974724|Preterm birth|preterm birth
36361|NCT03974724|Prediction|prediction
36362|NCT03974724|Cervical vaginal fluid|cervical vaginal fluid
36363|NCT03974698|femoral offset|femoral offset
811886|NCT00200694|diuretics|diuretics
36364|NCT03974698|leg length discrepancy|leg length discrepancy
36365|NCT03974698|valgus/varus position|valgus/varus position
36366|NCT03974698|Lateral approach|lateral approach
36367|NCT03974698|Anterolateral approach|anterolateral approach
36368|NCT03974685|99mTc-3PRGD2|99mtc-3prgd2
36369|NCT03974685|Integrin ανβ3|integrin ανβ3
36370|NCT03974685|Dosimetry|dosimetry
36371|NCT03974646|chronic kidney disease|chronic kidney disease
36372|NCT03974646|health related quality of life|health related quality of life
36373|NCT03974646|knowledge|knowledge
36374|NCT03974646|randomized controlled trial|randomized controlled trial
36375|NCT03974646|self-management|self-management
36376|NCT03974646|self-efficacy|self-efficacy
36377|NCT03974646|social cognitive theory|social cognitive theory
36378|NCT03974633|Analgesia|analgesia
36379|NCT03974633|Cryoanalgesia|cryoanalgesia
36380|NCT03974633|Vibration analgesia|vibration analgesia
36381|NCT03974633|Local anesthetic|local anesthetic
36382|NCT03974581|pharmacoinvasive strategy|pharmacoinvasive strategy
36383|NCT03974581|Mexico|mexico
36384|NCT03974581|registry|registry
36385|NCT03974529|Intensive running|intensive running
36386|NCT03974529|Gait|gait
36387|NCT03974529|Balance|balance
36388|NCT03974529|Motor symptoms of Parkinson's disease|motor symptoms of parkinson's disease
36389|NCT03974529|Non-motor symptoms of Parkinson's disease|non-motor symptoms of parkinson's disease
36390|NCT03974529|UPDRS score|updrs score
36391|NCT03974529|Physiotherapy|physiotherapy
36392|NCT03974529|Quality of life|quality of life
36393|NCT03974503|Nightmares|nightmares
36394|NCT03974503|Cognitive Behavioral Therapy|cognitive behavioral therapy
36395|NCT03974503|PTSD|ptsd
36396|NCT03974503|Veterans|veterans
36397|NCT03974490|rhythm|rhythm
36398|NCT03974490|musicotherapy|musicotherapy
36399|NCT03974490|balance|balance
36400|NCT03974490|gait|gait
36401|NCT03974490|stroke|stroke
36402|NCT03974490|physiotherapy|physiotherapy
36403|NCT03974477|Dietary Salt|dietary salt
36404|NCT03974477|Urinary sodium excretion|urinary sodium excretion
36405|NCT03974477|Cooking|cooking
36406|NCT03974477|Hypertension|hypertension
36407|NCT03974477|Randomized Controlled Trial|randomized controlled trial
36408|NCT03974477|Sodium|sodium
36409|NCT03974477|Diet|diet
36410|NCT03974477|Patient Education|patient education
36411|NCT03974464|vertigo|vertigo
36412|NCT03974464|stroke|stroke
36413|NCT03974464|copeptin|copeptin
36414|NCT03974464|S-100b protein|s-100b protein
36415|NCT03974464|biomarkers|biomarkers
36416|NCT03974451|Intraocular Lens|intraocular lens
36417|NCT03974451|trifocal|trifocal
36418|NCT03974451|extended range of vision|extended range of vision
36424|NCT03974438|autologous fat grafting|autologous fat grafting
36425|NCT03974438|autologous fat transplant|autologous fat transplant
36426|NCT03974412|syncope|syncope
36427|NCT03974412|head-up tilt table|head-up tilt table
36428|NCT03974412|implantable loop recorder|implantable loop recorder
36429|NCT03974412|pragmatic|pragmatic
36430|NCT03974386|critical care|critical care
36431|NCT03974386|septic shock|septic shock
36432|NCT03974386|hemofiltration|hemofiltration
36433|NCT03974386|endotoxin|endotoxin
36434|NCT03974386|cytokine storm|cytokine storm
36435|NCT03974386|prognosis|prognosis
36436|NCT03974373|Buccal mucosa|buccal mucosa
36437|NCT03974347|cardiac surgery|cardiac surgery
36438|NCT03974347|renal resistive index|renal resistive index
36439|NCT03974347|creatinine clearance|creatinine clearance
36440|NCT03974334|Blood Pressure, High|blood pressure, high
36441|NCT03974308|Balneotherapy|balneotherapy
36442|NCT03974308|Health Resorts|health resorts
36443|NCT03974308|Quality of life|quality of life
36444|NCT03974269|Hypnosis|hypnosis
36445|NCT03974269|Delirium|delirium
36446|NCT03974269|Transcatheter aortic valve implantation|transcatheter aortic valve implantation
36447|NCT03974256|Automaton|automaton
36448|NCT03974256|Dosimetry|dosimetry
36449|NCT03974256|Radiopharmaceutical|radiopharmaceutical
36450|NCT03974256|Technetium-99m|technetium-99m
36451|NCT03974230|Cornea|cornea
36452|NCT03974230|Fuchs Endothelial Corneal Dystrophy (FECD)|fuchs endothelial corneal dystrophy (fecd)
36453|NCT03974230|slit lamp|slit lamp
36454|NCT03974230|Transcription Factor 4 (TCF4)|transcription factor 4 (tcf4)
36455|NCT03974230|chromosome 18|chromosome 18
36456|NCT03974230|genetic|genetic
36457|NCT03974217|Leukemia|leukemia
36458|NCT03974204|Cerebrospinal fluid|cerebrospinal fluid
36459|NCT03974204|Proteomic profile|proteomic profile
36460|NCT03974191|Low Back Pain|low back pain
36461|NCT03974191|Pain|pain
36462|NCT03974191|Physical Activity|physical activity
36463|NCT03974191|Physical Capacity|physical capacity
36464|NCT03974191|Work Ability|work ability
36465|NCT03974191|Primary Health Care|primary health care
36466|NCT03974178|Human African trypanosomiasis|human african trypanosomiasis
36467|NCT03974178|neglected tropical disease|neglected tropical disease
36468|NCT03974178|t.b. rhodesiense|t.b. rhodesiense
36473|NCT03974139|metformin|metformin
36474|NCT03974139|leptin|leptin
36475|NCT03974139|cerebrospinal fluid|cerebrospinal fluid
36476|NCT03974087|Mild Cognitive Impairment|mild cognitive impairment
36477|NCT03974087|Transcranial direct current stimulation|transcranial direct current stimulation
36478|NCT03974061|Brief Acceptance and Commitment Therapy|brief acceptance and commitment therapy
36479|NCT03974061|HIV|hiv
36480|NCT03974061|Alcohol|alcohol
36481|NCT03974061|Randomized Controlled Trial|randomized controlled trial
36482|NCT03974048|Epigenetics|epigenetics
36483|NCT03974048|DNA methylation|dna methylation
36484|NCT03974048|Trauma|trauma
36485|NCT03974035|Local anesthesia|local anesthesia
36486|NCT03974035|Ropivacaine|ropivacaine
36487|NCT03974022|NonSmall Cell Lung Cancer|nonsmall cell lung cancer
36488|NCT03974022|EGFR|egfr
36489|NCT03974022|HER2|her2
36490|NCT03974022|mutation|mutation
36491|NCT03974009|Calcaneal taping|calcaneal taping
36492|NCT03974009|Balance|balance
36493|NCT03974009|Gait|gait
36494|NCT03973996|Green tea|green tea
36495|NCT03973996|Gut barrier function|gut barrier function
36496|NCT03973996|Gut dysbiosis|gut dysbiosis
36497|NCT03973996|Inflammation|inflammation
36498|NCT03973996|Metabolic endotoxemia|metabolic endotoxemia
36499|NCT03973996|Metabolic syndrome|metabolic syndrome
36500|NCT03973996|Microbiome|microbiome
36501|NCT03973983|neuralgia|neuralgia
36502|NCT03973983|pudendal nerve|pudendal nerve
36503|NCT03973983|pudendal nerve block|pudendal nerve block
36504|NCT03973983|therapeutic local anaesthesia|therapeutic local anaesthesia
36505|NCT03973983|transvaginal|transvaginal
36506|NCT03973970|TB|tb
36507|NCT03973957|Pleural effusion|pleural effusion
36508|NCT03973957|Pleural diseases|pleural diseases
36509|NCT03973957|Pleurodesis|pleurodesis
36510|NCT03973957|Malignant pleural effusion|malignant pleural effusion
36511|NCT03973931|cardiovascular disease|cardiovascular disease
36512|NCT03973931|telemedicine|telemedicine
36513|NCT03973931|medication adherence|medication adherence
36514|NCT03973931|behavioral health|behavioral health
36515|NCT03973918|BRAF V600E/K|braf v600e/k
36516|NCT03973918|High Grade Primary Brain Tumor|high grade primary brain tumor
36517|NCT03973918|High Grade Glioma|high grade glioma
36518|NCT03973918|Glioblastoma|glioblastoma
36519|NCT03973905|Whooping Cough|whooping cough
36520|NCT03973905|Boostrix|boostrix
36521|NCT03973905|Tdap|tdap
36522|NCT03973905|effectiveness|effectiveness
36523|NCT03973905|pregnancy|pregnancy
36524|NCT03973905|infants|infants
36525|NCT03973879|PVSRIPO|pvsripo
36526|NCT03973879|Atezolizumab|atezolizumab
36527|NCT03973879|Glioblastoma|glioblastoma
36528|NCT03973879|Glioma|glioma
36529|NCT03973879|Bigner|bigner
36530|NCT03973879|Randazzo|randazzo
36531|NCT03973879|Brain tumor|brain tumor
36532|NCT03973879|Duke|duke
36533|NCT03973879|Istari|istari
36534|NCT03973879|Pro00100677|pro00100677
36535|NCT03973879|Genentech|genentech
36536|NCT03973853|virtual reality|virtual reality
36537|NCT03973853|social autonomy|social autonomy
36538|NCT03973853|road safety|road safety
36539|NCT03973853|driving abilities|driving abilities
36540|NCT03973853|schizophrenia|schizophrenia
36541|NCT03973853|cognitive functioning|cognitive functioning
36542|NCT03973827|type 1 diabetes|type 1 diabetes
36543|NCT03973827|diabetes|diabetes
36544|NCT03973827|MSC's|msc's
36545|NCT03973827|Mesenchymal|mesenchymal
36546|NCT03973827|Stem Cells|stem cells
36547|NCT03973827|Stromal|stromal
36548|NCT03973827|Wharton´s Jelly|wharton´s jelly
36549|NCT03973814|continuous renal replacement therapy|continuous renal replacement therapy
36550|NCT03973801|Acupressure|acupressure
36551|NCT03973762|Diabetic Retinography, CAD|diabetic retinography, cad
36552|NCT03973723|Nasopharyngeal Carcinoma|nasopharyngeal carcinoma
36553|NCT03973723|NPC|npc
36554|NCT03973723|EBV|ebv
36555|NCT03973723|Radiotherapy|radiotherapy
36556|NCT03973723|Plasma Epstein-Barr virus DNA|plasma epstein-barr virus dna
36557|NCT03973710|Probiotics|probiotics
36558|NCT03973710|Prevention|prevention
36559|NCT03973710|Hypertension|hypertension
36560|NCT03973684|bronchiectasis:|bronchiectasis:
36561|NCT03973684|photodynamic therapy|photodynamic therapy
36562|NCT03973684|periodontal disease|periodontal disease
36563|NCT03973684|randomized controlled clinical study|randomized controlled clinical study
36564|NCT03973671|Risk stratification|risk stratification
36565|NCT03973671|Recurrence|recurrence
36566|NCT03973671|Progression|progression
36567|NCT03973671|Non-muscle-invasive bladder cancer|non-muscle-invasive bladder cancer
36568|NCT03973671|Muscle-invasive bladder cancer|muscle-invasive bladder cancer
36569|NCT03973619|urethral stricture|urethral stricture
36570|NCT03973619|mucosa graft|mucosa graft
36571|NCT03973619|jugal graft,|jugal graft,
36572|NCT03973619|labial graft|labial graft
36573|NCT03973619|success rate|success rate
36574|NCT03973606|Health literacy|health literacy
36575|NCT03973606|East Jerusalem|east jerusalem
36576|NCT03973606|Focus groups|focus groups
36577|NCT03973606|Arabic Women|arabic women
36578|NCT03973580|Attentional Bias|attentional bias
36579|NCT03973580|Anxiety risk|anxiety risk
36580|NCT03973580|Adolescence|adolescence
36581|NCT03973580|Eye-tracking|eye-tracking
36582|NCT03973580|Resting-state functional magnetic resonance imaging|resting-state functional magnetic resonance imaging
36583|NCT03973567|antidepressants|antidepressants
36584|NCT03973567|refractory functional dyspepsia|refractory functional dyspepsia
36585|NCT03973567|resting fMRI|resting fmri
36586|NCT03973554|white spot lesions,|white spot lesions,
36587|NCT03973554|pearl powder|pearl powder
36588|NCT03973554|CPP-ACP|cpp-acp
36589|NCT03973541|Social Anxiety Disorder|social anxiety disorder
36590|NCT03973541|Virtual Reality|virtual reality
36591|NCT03973541|Exposure Therapy|exposure therapy
36592|NCT03973541|Randomized Controlled Trial|randomized controlled trial
36593|NCT03973528|anti-Mullerian hormone (AMH)|anti-mullerian hormone (amh)
36594|NCT03973528|Traditional Chinese Medicine(TCM)|traditional chinese medicine(tcm)
36595|NCT03973528|Infertility|infertility
36596|NCT03973515|Glucokinase activator(GKA)|glucokinase activator(gka)
36597|NCT03973515|hypoglycemia|hypoglycemia
36598|NCT03973502|Hepatitis C|hepatitis c
36599|NCT03973502|Hepatitis B|hepatitis b
36600|NCT03973502|Parkinson's disease|parkinson's disease
36601|NCT03973502|18F-FDOPA PET, MRS|18f-fdopa pet, mrs
36602|NCT03973502|MRS|mrs
36603|NCT03973489|Methamphetamine|methamphetamine
36604|NCT03973476|phone support; midwife; early abandonment of breastfeeding|phone support; midwife; early abandonment of breastfeeding
36605|NCT03973437|Ulcerative Colitis|ulcerative colitis
36606|NCT03973437|Deep Learning|deep learning
36607|NCT03973437|Convolutional Neural Network|convolutional neural network
36608|NCT03973411|Ondansetron|ondansetron
36609|NCT03973411|Hypotension|hypotension
36610|NCT03973411|Spinal anesthesia|spinal anesthesia
36611|NCT03973385|cryotherapy|cryotherapy
36612|NCT03973385|vapocoolant spray|vapocoolant spray
36613|NCT03973385|arterial puncture|arterial puncture
36614|NCT03973385|intensive care unit|intensive care unit
36615|NCT03973346|risk prediction|risk prediction
36616|NCT03973294|jet ventilation|jet ventilation
36617|NCT03973294|electroimpedance tomography|electroimpedance tomography
36618|NCT03973294|supraglottic jet ventilation|supraglottic jet ventilation
36826|NCT03971968|Scar|scar
36626|NCT03973255|Vestibular rehabilitation|vestibular rehabilitation
36627|NCT03973255|Vestibular weakness|vestibular weakness
36628|NCT03973255|Whole Body Vibration|whole body vibration
36629|NCT03973255|Biofeedback|biofeedback
36630|NCT03973255|Posturography|posturography
36631|NCT03973229|Estrogen|estrogen
36632|NCT03973229|Stress Disorder|stress disorder
36633|NCT03973216|Anxiety|anxiety
36634|NCT03973216|Yoga|yoga
36635|NCT03973216|Mindfulness|mindfulness
36636|NCT03973216|Group-based therapy|group-based therapy
36637|NCT03973203|vitamin B3|vitamin b3
36638|NCT03973203|niacin|niacin
36639|NCT03973203|mitochondrial myopathy|mitochondrial myopathy
36640|NCT03973203|mitochondria|mitochondria
36641|NCT03973203|muscle|muscle
36642|NCT03973203|muscle strength|muscle strength
36643|NCT03973203|NAD+ precursor|nad+ precursor
36644|NCT03973203|NAD+|nad+
36645|NCT03973203|NAD-booster|nad-booster
36646|NCT03973177|Total knee arthroplasty|total knee arthroplasty
36647|NCT03973177|Chronic Pain|chronic pain
36648|NCT03973151|Melanoma|melanoma
36649|NCT03973151|NRAS|nras
36650|NCT03973138|Macular edema|macular edema
36651|NCT03973138|ranibizumab|ranibizumab
36652|NCT03973138|Mpredictive factor|mpredictive factor
36653|NCT03973125|circumscribed choroidal haemangioma|circumscribed choroidal haemangioma
36654|NCT03973125|conbercept|conbercept
36655|NCT03973125|effectiveness|effectiveness
36656|NCT03973125|safety|safety
36657|NCT03973060|Jump test|jump test
36658|NCT03973060|Genetic polymorphism|genetic polymorphism
36659|NCT03973060|Muscle strength|muscle strength
36660|NCT03973060|Physiotherapies techniques|physiotherapies techniques
36661|NCT03973047|Nausea|nausea
36662|NCT03973047|Bremelanotide|bremelanotide
36663|NCT03973047|BMT|bmt
36664|NCT03973047|Zofran|zofran
36665|NCT03973047|ondansetron|ondansetron
36666|NCT03973047|premenopausal|premenopausal
36667|NCT03973047|healthy women|healthy women
36668|NCT03973034|ctDNA|ctdna
36669|NCT03973034|early screening|early screening
36670|NCT03973034|Copy Number Variants (CNV)|copy number variants (cnv)
36671|NCT03973034|Low Depth Whole Genome Sequencing (LDWGS)|low depth whole genome sequencing (ldwgs)
36672|NCT03973021|erectile dysfunction|erectile dysfunction
36673|NCT03973021|very small embryonic-like stem cell|very small embryonic-like stem cell
36674|NCT03973008|Gastric Adenocarcinoma|gastric adenocarcinoma
36675|NCT03973008|Adjuvant Radiotherapy|adjuvant radiotherapy
36676|NCT03972969|Parkinson's disease|parkinson's disease
36677|NCT03972969|Exercise therapy|exercise therapy
36678|NCT03972969|Accidental falls|accidental falls
36679|NCT03972930|Stereotactic Body Radiotherapy|stereotactic body radiotherapy
36680|NCT03972930|SBRT|sbrt
36681|NCT03972917|ulipristal acetate|ulipristal acetate
49207|NCT03895125|EEG|eeg
36682|NCT03972917|myoma|myoma
36683|NCT03972917|leiomyoma|leiomyoma
36684|NCT03972917|endometrial patterns|endometrial patterns
36685|NCT03972917|symptomatology|symptomatology
36686|NCT03972904|Diabetes Mellitus,Type 2|diabetes mellitus,type 2
36687|NCT03972904|Overweight|overweight
36688|NCT03972904|Obesity|obesity
36689|NCT03972891|speech sound disorders|speech sound disorders
36690|NCT03972891|children|children
36691|NCT03972839|Blood Coagulation|blood coagulation
36692|NCT03972839|DDimers|ddimers
36693|NCT03972826|hand hygiene|hand hygiene
36694|NCT03972826|healthcare worker self-contamination|healthcare worker self-contamination
36695|NCT03972813|HPV Vaccines|hpv vaccines
36696|NCT03972813|China|china
36697|NCT03972748|Itraconazole|itraconazole
36698|NCT03972683|Exercise|exercise
36699|NCT03972631|Lifestyle interventions|lifestyle interventions
36700|NCT03972631|Low-carbohydrate diet|low-carbohydrate diet
36701|NCT03972605|Breast Screening|breast screening
36702|NCT03972605|Breast Imaging|breast imaging
36703|NCT03972605|SoftVue|softvue
36704|NCT03972605|Mammography|mammography
36705|NCT03972605|Ultrasound|ultrasound
36706|NCT03972605|Reader Study|reader study
36707|NCT03972605|ROC AUC|roc auc
36708|NCT03972605|Dense Breasts|dense breasts
36709|NCT03972605|Breast Density|breast density
36710|NCT03972605|Dense Breast Tissue|dense breast tissue
36711|NCT03972605|Breast Neoplasms|breast neoplasms
36712|NCT03972592|Cutaneous Microcystic Lymphatic Malformations|cutaneous microcystic lymphatic malformations
36713|NCT03972566|Nitric Oxide|nitric oxide
36714|NCT03972566|Photobiomodulation|photobiomodulation
36715|NCT03972566|LLLT|lllt
36716|NCT03972566|Photomedicine|photomedicine
36717|NCT03972553|Sugarbaker|sugarbaker
36718|NCT03972553|keyhole|keyhole
36719|NCT03972553|Open parastomal hernia repair|open parastomal hernia repair
36720|NCT03972540|Obesity|obesity
36721|NCT03972540|Mindful eating|mindful eating
36722|NCT03972540|Postmenopausal breast cancer survivors|postmenopausal breast cancer survivors
36723|NCT03972540|Weight management|weight management
36724|NCT03972540|Cardiovascular health|cardiovascular health
36725|NCT03972527|photobiomodulation|photobiomodulation
36726|NCT03972527|LLLT|lllt
36727|NCT03972527|low-level laser therapy|low-level laser therapy
36728|NCT03972527|oral mucositis|oral mucositis
36729|NCT03972527|wound healing|wound healing
36730|NCT03972527|radiation therapy|radiation therapy
36731|NCT03972527|chemotherapy|chemotherapy
36732|NCT03972527|antineoplastic therapy|antineoplastic therapy
36733|NCT03972527|side effects|side effects
36734|NCT03972527|phototherapy|phototherapy
36735|NCT03972527|low-level light therapy|low-level light therapy
36736|NCT03972514|brain|brain
36737|NCT03972514|pediatrics brain cancer|pediatrics brain cancer
36738|NCT03972514|pediatrics|pediatrics
36739|NCT03972514|skull|skull
36740|NCT03972423|checklist|checklist
36741|NCT03972423|postoperative complication|postoperative complication
36742|NCT03972423|anesthesia|anesthesia
36743|NCT03972423|information transmission|information transmission
36744|NCT03972423|care unit|care unit
36745|NCT03972410|childbirth trauma|childbirth trauma
36746|NCT03972410|post-traumatic stress|post-traumatic stress
36747|NCT03972410|depression|depression
36748|NCT03972410|post-partum PTSD|post-partum ptsd
36749|NCT03972410|EMDR|emdr
36750|NCT03972410|Supportive Expressive Dynamic Psychotherapy|supportive expressive dynamic psychotherapy
36751|NCT03972397|Cryoablation|cryoablation
36752|NCT03972384|Post-ICU Syndrome|post-icu syndrome
36753|NCT03972384|Recovery|recovery
36754|NCT03972384|Home Discharge|home discharge
36755|NCT03972384|Problem Solving|problem solving
36756|NCT03972384|Adaptation|adaptation
36757|NCT03972332|Low Back Pain|low back pain
36758|NCT03972332|Central Sensitisation|central sensitisation
36759|NCT03972332|Hyperalgesia|hyperalgesia
36760|NCT03972332|Hypersensitivity|hypersensitivity
36761|NCT03972319|omega 3|omega 3
36762|NCT03972319|bariatric surgery|bariatric surgery
36763|NCT03972319|fatty liver|fatty liver
36764|NCT03972319|vlcd|vlcd
36765|NCT03972267|Wound Healing|wound healing
36766|NCT03972267|Enamel Matrix Derivative|enamel matrix derivative
36767|NCT03972267|Palatal|palatal
36768|NCT03972254|Modified Interaction Guidance|modified interaction guidance
36769|NCT03972241|Parkinson disease|parkinson disease
36770|NCT03972241|Quality of life|quality of life
36771|NCT03972241|Physical therapy|physical therapy
36772|NCT03972241|tremor|tremor
36773|NCT03972241|coordination|coordination
36774|NCT03972241|gait analysis|gait analysis
36775|NCT03972228|microdevice|microdevice
36776|NCT03972228|chemotherapy|chemotherapy
36777|NCT03972228|lung lesions|lung lesions
36778|NCT03972215|Hyperglycemic Clamp|hyperglycemic clamp
36779|NCT03972202|dysarthria|dysarthria
36780|NCT03972202|ataxia|ataxia
36781|NCT03972202|cerebellum|cerebellum
36782|NCT03972202|cerebellar|cerebellar
36783|NCT03972202|adult|adult
36784|NCT03972202|speaking|speaking
36785|NCT03972202|language|language
36786|NCT03972202|TMS|tms
36787|NCT03972202|MRI|mri
36788|NCT03972202|speech|speech
36789|NCT03972176|non-caloric sweetener|non-caloric sweetener
36790|NCT03972176|Amniotic liquid|amniotic liquid
36791|NCT03972176|Breastmilk|breastmilk
36792|NCT03972176|Infant gain weight|infant gain weight
36793|NCT03972176|Sweet taste preferences|sweet taste preferences
36794|NCT03972176|Taste receptor polymorphism|taste receptor polymorphism
36795|NCT03972176|Breastmilk microbiota|breastmilk microbiota
36796|NCT03972176|Infant gut microbiota|infant gut microbiota
36797|NCT03972176|Salivary insulin|salivary insulin
36798|NCT03972098|uromodulin|uromodulin
36799|NCT03972085|Low Back Pain|low back pain
36800|NCT03972085|Neurodynamics|neurodynamics
36801|NCT03972046|T-VEC|t-vec
36802|NCT03972046|BRAF/MEK inhibition|braf/mek inhibition
36803|NCT03972046|Melanoma|melanoma
36804|NCT03972046|Nodal metastasis|nodal metastasis
36805|NCT03972046|Neoadjuvant treatment|neoadjuvant treatment
36806|NCT03972046|BRAF mutant|braf mutant
36807|NCT03972020|breast cancer|breast cancer
36808|NCT03972020|mindfulness based intervention|mindfulness based intervention
36809|NCT03972020|cognitive behavioral therapy|cognitive behavioral therapy
36810|NCT03972020|depressive symptoms|depressive symptoms
36811|NCT03972007|Physiotherapy|physiotherapy
36812|NCT03972007|Muscle resistance|muscle resistance
36813|NCT03972007|LED|led
36814|NCT03972007|Athletic performance|athletic performance
36815|NCT03971994|attention|attention
36816|NCT03971994|emotion|emotion
36817|NCT03971994|eye movements|eye movements
36818|NCT03971994|amygdala|amygdala
36819|NCT03971981|Xylitol|xylitol
36820|NCT03971981|Saliva|saliva
36821|NCT03971981|Bacteria|bacteria
36822|NCT03971981|Dental Plaque|dental plaque
36823|NCT03971981|Antimicrobial effect|antimicrobial effect
36824|NCT03971981|Chewing gum|chewing gum
36825|NCT03971968|Burn|burn
36827|NCT03971968|Face|face
36828|NCT03971968|Observational Study|observational study
36829|NCT03971968|Integra Artificial Skin|integra artificial skin
36830|NCT03971942|attention bias modification|attention bias modification
36831|NCT03971942|positive attention bias|positive attention bias
36832|NCT03971942|depressive symptoms|depressive symptoms
36833|NCT03971942|prevention|prevention
36834|NCT03971903|Attenion bias modification, major depression, treatment|attenion bias modification, major depression, treatment
36835|NCT03971890|Balance|balance
36836|NCT03971890|Pain|pain
36837|NCT03971890|TUG|tug
36838|NCT03971890|Dance|dance
36839|NCT03971877|Colistin resistance in bacteria|colistin resistance in bacteria
36840|NCT03971877|Rectal swab|rectal swab
36841|NCT03971877|ICU|icu
36842|NCT03971877|Oncohaematology|oncohaematology
36843|NCT03971877|Gram negative bacteria|gram negative bacteria
36844|NCT03971825|Psoriasis|psoriasis
36845|NCT03971825|Healthy Volunteer|healthy volunteer
36846|NCT03971825|Safety|safety
36847|NCT03971825|CC-92252|cc-92252
36848|NCT03971799|CD33CART cells|cd33cart cells
36849|NCT03971799|Children/young adults|children/young adults
36850|NCT03971747|Liver Cancer|liver cancer
36851|NCT03971708|Lidocaine|lidocaine
36852|NCT03971708|TAP block|tap block
36853|NCT03971708|nephrectomy|nephrectomy
36854|NCT03971708|acute pain|acute pain
36855|NCT03971682|Conduct Disorder|conduct disorder
36856|NCT03971682|Compassion Focused Therapy|compassion focused therapy
36857|NCT03971682|Detained Youth|detained youth
36858|NCT03971682|Psychopathic Traits|psychopathic traits
36859|NCT03971682|PSYCHOPATHY.COMP|psychopathy.comp
36860|NCT03971669|Typhoid|typhoid
36861|NCT03971656|Cancer|cancer
36862|NCT03971656|Surgery|surgery
36863|NCT03971656|Malnutrition|malnutrition
36864|NCT03971656|Preoperative|preoperative
36865|NCT03971656|Nutrition|nutrition
36866|NCT03971630|HMV|hmv
36867|NCT03971630|Tele-monitoring|tele-monitoring
36868|NCT03971630|Telemedicine|telemedicine
36869|NCT03971630|Chronic hypercapnic respiratory failure|chronic hypercapnic respiratory failure
36870|NCT03971578|Autism Spectrum Disorder|autism spectrum disorder
36871|NCT03971552|Mechanical thrombectomy|mechanical thrombectomy
36872|NCT03971552|Magnetic resonance angiography|magnetic resonance angiography
36873|NCT03971552|Angiogram|angiogram
36874|NCT03971552|Angiography|angiography
36875|NCT03971552|Magnetic resonance imaging|magnetic resonance imaging
36876|NCT03971552|Revascularization|revascularization
36877|NCT03971526|Cerebrovascular disorders|cerebrovascular disorders
36878|NCT03971526|Magnetic resonance imaging|magnetic resonance imaging
36879|NCT03971526|Neuroimaging|neuroimaging
36880|NCT03971526|Prognosis|prognosis
36881|NCT03971526|Stroke|stroke
36882|NCT03971513|Prospective randomized pilot study|prospective randomized pilot study
36883|NCT03971513|Trans abdominal plane block|trans abdominal plane block
36884|NCT03971513|Quo R 40 score|quo r 40 score
36885|NCT03971513|Post operative pain|post operative pain
36886|NCT03971487|schizo-affective psychosis|schizo-affective psychosis
36887|NCT03971487|schizophrenia|schizophrenia
36888|NCT03971448|Cast|cast
36889|NCT03971448|Removable device/boot|removable device/boot
36890|NCT03971448|Immobilization strategy|immobilization strategy
36891|NCT03971448|Emergency Department|emergency department
36892|NCT03971435|child care|child care
36893|NCT03971435|child development|child development
36894|NCT03971435|child health|child health
36895|NCT03971435|child nutrition|child nutrition
36896|NCT03971435|child rearing|child rearing
36897|NCT03971435|children|children
36898|NCT03971435|curriculum|curriculum
36899|NCT03971435|early childhood education|early childhood education
36900|NCT03971435|families|families
36901|NCT03971435|Head Start|head start
36902|NCT03971435|parenting skills|parenting skills
36903|NCT03971435|parents|parents
36904|NCT03971435|school readiness|school readiness
36905|NCT03971422|UCB7665|ucb7665
36906|NCT03971422|Myasthenia Gravis|myasthenia gravis
36907|NCT03971422|Rozanolixizumab|rozanolixizumab
36908|NCT03971396|open cardiac surgery|open cardiac surgery
36909|NCT03971396|breathing exercises|breathing exercises
36910|NCT03971396|chest physiotherapy|chest physiotherapy
36911|NCT03971331|acute respiratory distress syndrome|acute respiratory distress syndrome
36912|NCT03971331|right ventricular dysfunction|right ventricular dysfunction
36913|NCT03971331|critical care ultrasound|critical care ultrasound
36914|NCT03971331|pulmonary artery catheter|pulmonary artery catheter
36915|NCT03971279|dexamethasone;VKH|dexamethasone;vkh
36916|NCT03971253|Post-Marketing Surveillance|post-marketing surveillance
36917|NCT03971253|ASP015K|asp015k
36918|NCT03971253|Smyraf|smyraf
36919|NCT03971253|Rheumatoid arthritis (RA)|rheumatoid arthritis (ra)
36920|NCT03971253|Peficitinib|peficitinib
36921|NCT03971227|refractive|refractive
36922|NCT03971227|permeable|permeable
36923|NCT03971227|lens|lens
36924|NCT03971227|rigid|rigid
36925|NCT03971227|gas|gas
36926|NCT03971227|myopia|myopia
36927|NCT03971214|small cell lung cancer|small cell lung cancer
36928|NCT03971214|radiotherapy|radiotherapy
36931|NCT03971162|Choroidal Neovascularisation|choroidal neovascularisation
36933|NCT03971162|anti-VEGF|anti-vegf
36934|NCT03971097|Substance abuse|substance abuse
36935|NCT03971097|Addiction|addiction
36936|NCT03971097|Opiates|opiates
36937|NCT03971097|Alcohol|alcohol
36938|NCT03971097|Cocaine|cocaine
36939|NCT03971097|Benzodiazepine|benzodiazepine
36940|NCT03971097|Heroin|heroin
36941|NCT03971097|Self-forgiveness|self-forgiveness
36942|NCT03971097|Self-stigma|self-stigma
36943|NCT03971084|casein phosphopeptide-amorphous calcium phosphate|casein phosphopeptide-amorphous calcium phosphate
36944|NCT03971084|CPP-ACP|cpp-acp
36945|NCT03971084|in situ appliance|in situ appliance
36946|NCT03971084|Transverse Microradiography, TMR|transverse microradiography, tmr
36947|NCT03971084|Recaldent|recaldent
36948|NCT03971084|Tooth Remineralization|tooth remineralization
36951|NCT03971058|Japanese Encephalitis vaccine|japanese encephalitis vaccine
36952|NCT03971058|immune responses|immune responses
36953|NCT03971045|Pembrolizumab|pembrolizumab
36954|NCT03971045|Immunotherapy|immunotherapy
36955|NCT03971019|breast cancer|breast cancer
36956|NCT03971019|statins|statins
36957|NCT03971019|abnormal lipid metabolism|abnormal lipid metabolism
36958|NCT03971006|Acute respiratory distress syndrome (ARDS)|acute respiratory distress syndrome (ards)
36959|NCT03971006|Pneumonia|pneumonia
36960|NCT03971006|Septic Shock|septic shock
36961|NCT03971006|bronchoalveolar lavage|bronchoalveolar lavage
36962|NCT03970980|Fick Principle|fick principle
36963|NCT03970967|Breast carcinoma|breast carcinoma
36964|NCT03970967|Metastatic breast cancer|metastatic breast cancer
36965|NCT03970967|Invasive breast cancer|invasive breast cancer
36966|NCT03970967|Alpha radiation|alpha radiation
36967|NCT03970967|Luminal A|luminal a
36968|NCT03970967|Luminal B|luminal b
36969|NCT03970967|Triple negative|triple negative
36970|NCT03970967|HER2|her2
36971|NCT03970967|Breast cancer|breast cancer
36972|NCT03970967|Breast metastases|breast metastases
36973|NCT03970954|Low-dose Interleukin-2|low-dose interleukin-2
36974|NCT03970954|Miscarriage|miscarriage
36975|NCT03970954|Regulatory T cells|regulatory t cells
36976|NCT03970915|body warmer|body warmer
36977|NCT03970915|pre-hospital|pre-hospital
36978|NCT03970902|Integrated Care|integrated care
36979|NCT03970902|Complex intervention|complex intervention
36980|NCT03970902|Primary care|primary care
36981|NCT03970902|Quality of Life|quality of life
36982|NCT03970837|Rheumatoid Arthritis|rheumatoid arthritis
36983|NCT03970837|GSK3196165|gsk3196165
36984|NCT03970837|Tofacitinib|tofacitinib
36985|NCT03970837|Placebo|placebo
36986|NCT03970837|DMARDs|dmards
36987|NCT03970811|temporization immediate implants peri-implant soft tissue|temporization immediate implants peri-implant soft tissue
36988|NCT03970785|fluorescein|fluorescein
36989|NCT03970785|gangliogliomas|gangliogliomas
36990|NCT03970785|glioneuronal|glioneuronal
36991|NCT03970785|Dysembryoplastic Neuroepithelial Tumor|dysembryoplastic neuroepithelial tumor
36992|NCT03970772|Type 1 diabetes mellitus|type 1 diabetes mellitus
36993|NCT03970772|Fasting|fasting
36994|NCT03970772|Ramadan|ramadan
36995|NCT03970772|Glucagon|glucagon
36996|NCT03970772|Mini-dose|mini-dose
36997|NCT03970772|Hypoglycemia|hypoglycemia
36998|NCT03970746|Anti-PD-1|anti-pd-1
36999|NCT03970733|VLA15|vla15
37000|NCT03970733|Lyme Borreliosis|lyme borreliosis
37001|NCT03970733|Vaccine|vaccine
37002|NCT03970720|Type 1 Diabetes Mellitus|type 1 diabetes mellitus
37003|NCT03970694|Neoadjuvant chemoradiotherapy|neoadjuvant chemoradiotherapy
37004|NCT03970694|Colon Cancer|colon cancer
37005|NCT03970694|Initial Diagnosed Unresectable Locally Advanced Stage|initial diagnosed unresectable locally advanced stage
37006|NCT03970694|Phase 3 Clinical Trial|phase 3 clinical trial
37007|NCT03970681|Acoustic neuroma|acoustic neuroma
37008|NCT03970681|Vestibular schwannoma|vestibular schwannoma
37009|NCT03970681|Spontaneous shrinkage|spontaneous shrinkage
37010|NCT03970681|Neoplasm regression|neoplasm regression
37011|NCT03970681|Volume quantification|volume quantification
37012|NCT03970681|Tridimensional measurements|tridimensional measurements
37013|NCT03970681|Volumetric measurements|volumetric measurements
37014|NCT03970642|video directly observed therapy|video directly observed therapy
37015|NCT03970590|hypertension|hypertension
37016|NCT03970590|Minority Health|minority health
37017|NCT03970590|health behavior|health behavior
37018|NCT03970590|text messaging|text messaging
37019|NCT03970577|Minimal Change Nephrotic syndrome|minimal change nephrotic syndrome
37020|NCT03970577|Rituximab|rituximab
37021|NCT03970577|Relapse rate|relapse rate
37022|NCT03970564|ultrasound|ultrasound
37023|NCT03970564|lymphadenopathy|lymphadenopathy
37024|NCT03970564|lung cancer|lung cancer
37025|NCT03970551|Initial Orthostatic Hypotension|initial orthostatic hypotension
37026|NCT03970551|IOH|ioh
37027|NCT03970551|Physical Counter-maneuver|physical counter-maneuver
37028|NCT03970551|Refractory Period|refractory period
37029|NCT03970551|Active Stand|active stand
37030|NCT03970551|Muscle Tensing|muscle tensing
37031|NCT03970551|Leg Crossing|leg crossing
37032|NCT03970551|Lower Body Muscle Tensing|lower body muscle tensing
37033|NCT03970538|CLI|cli
37034|NCT03970538|CLTI|clti
37035|NCT03970538|Amputation|amputation
37036|NCT03970538|Desert Foot|desert foot
37037|NCT03970512|contact lens|contact lens
37038|NCT03970512|soft contact lens|soft contact lens
37039|NCT03970499|glioma|glioma
37040|NCT03970473|gynecologic laparoscopic surgery|gynecologic laparoscopic surgery
37041|NCT03970473|post-laparoscopic shoulder pain|post-laparoscopic shoulder pain
37042|NCT03970473|pulmonary recruitment manoeuvre|pulmonary recruitment manoeuvre
37043|NCT03970447|Glioblastoma|glioblastoma
37044|NCT03970447|Newly diagnosed|newly diagnosed
37045|NCT03970447|recurrent|recurrent
37046|NCT03970447|O6-methylguanine-DNA-methyltransferase (MGMT) methylated|o6-methylguanine-dna-methyltransferase (mgmt) methylated
37047|NCT03970447|MGMT unmethylated|mgmt unmethylated
37048|NCT03970447|isocitrate dehydrogenase (IDH) wild-type|isocitrate dehydrogenase (idh) wild-type
37049|NCT03970447|Bayesian|bayesian
37050|NCT03970447|adaptive randomization|adaptive randomization
37051|NCT03970447|Master Protocol|master protocol
37052|NCT03970447|Platform Trial|platform trial
37053|NCT03970447|Phase 2|phase 2
37054|NCT03970447|Phase 3|phase 3
37055|NCT03970408|Median nerve,|median nerve,
37056|NCT03970408|Carpal tunnel syndrome|carpal tunnel syndrome
37057|NCT03970408|Neurodynamic mobilization|neurodynamic mobilization
37058|NCT03970395|Positional Plagiocephaly, Deformational Plagiocephaly,|positional plagiocephaly, deformational plagiocephaly,
37059|NCT03970382|melanoma|melanoma
37060|NCT03970382|HR+ breast cancer|hr+ breast cancer
37061|NCT03970382|ovarian cancer|ovarian cancer
37062|NCT03970382|prostate cancer|prostate cancer
37063|NCT03970382|colorectal cancer|colorectal cancer
37064|NCT03970382|urothelial carcinoma|urothelial carcinoma
37065|NCT03970382|adoptive cell therapy|adoptive cell therapy
37066|NCT03970382|neoantigen|neoantigen
37067|NCT03970382|T cell receptor|t cell receptor
37068|NCT03970382|T lymphocyte|t lymphocyte
37069|NCT03970382|TCR-engineered T cells|tcr-engineered t cells
37070|NCT03970382|personalized cell therapy|personalized cell therapy
37071|NCT03970382|cell therapy|cell therapy
37072|NCT03970382|immunotherapy|immunotherapy
37073|NCT03970382|gene therapy|gene therapy
37074|NCT03970382|PD-1|pd-1
37075|NCT03970356|cluster randomized trial|cluster randomized trial
37076|NCT03970356|antibiotic stewardship|antibiotic stewardship
37077|NCT03970356|frail elderly|frail elderly
37078|NCT03970343|OPTIMIZER|optimizer
37079|NCT03970343|Heart Failure|heart failure
37080|NCT03970343|CCM|ccm
37081|NCT03970343|Post-Approval Study|post-approval study
37082|NCT03970343|NYHA class III|nyha class iii
37083|NCT03970343|FIX-HF-5C|fix-hf-5c
37084|NCT03970343|Chronic heart failure|chronic heart failure
37085|NCT03970343|Ejection fraction between 25 and 45|ejection fraction between 25 and 45
37086|NCT03970343|cardiac contractility modulation|cardiac contractility modulation
37087|NCT03970330|endometriosis|endometriosis
37088|NCT03970330|pelvic pain|pelvic pain
37089|NCT03970330|opioid|opioid
37090|NCT03970330|narcotic|narcotic
37091|NCT03970278|AAV|aav
37092|NCT03970278|gene therapy|gene therapy
37093|NCT03970278|glucose metabolism disorder|glucose metabolism disorder
37094|NCT03970278|carbohydrate metabolism, inborn errors|carbohydrate metabolism, inborn errors
37095|NCT03970278|genetic diseases|genetic diseases
37096|NCT03970278|Inborn Metabolic Diseases|inborn metabolic diseases
37097|NCT03970265|Interstitial lung fluid|interstitial lung fluid
37098|NCT03970265|Epithelial lining fluid|epithelial lining fluid
37099|NCT03970265|Antibiotic concentration in the lung|antibiotic concentration in the lung
37100|NCT03970239|Parkinson's disease|parkinson's disease
37101|NCT03970239|Impulse control disorders|impulse control disorders
37102|NCT03970239|Serotoninergic system|serotoninergic system
37103|NCT03970239|Positron Emission Tomography (PET)|positron emission tomography (pet)
37104|NCT03970226|Phase 0|phase 0
37105|NCT03970226|Feasibility|feasibility
37106|NCT03970226|Tocilizumab|tocilizumab
37107|NCT03970213|Tranexamic acid|tranexamic acid
37108|NCT03970213|Rhytidectomy|rhytidectomy
37109|NCT03970213|Facelift|facelift
37110|NCT03970174|Patient experience|patient experience
37111|NCT03970122|Glomerulosclerosis|glomerulosclerosis
37112|NCT03970122|proteinuria|proteinuria
37113|NCT03970122|nephrotic syndrome|nephrotic syndrome
37114|NCT03970122|nephrosis|nephrosis
37115|NCT03970122|focal segmental glomerulosclerosis|focal segmental glomerulosclerosis
37116|NCT03970122|kidney diseases|kidney diseases
37117|NCT03970122|urologic diseases|urologic diseases
37118|NCT03970122|glomerulonephritis|glomerulonephritis
37119|NCT03970122|nephritis|nephritis
37120|NCT03970122|diabetic kidney disease|diabetic kidney disease
37121|NCT03970122|diabetic nephropathies|diabetic nephropathies
37122|NCT03970122|endocrine system diseases|endocrine system diseases
37220|NCT03969459|stool|stool
37123|NCT03970122|diabetes complications|diabetes complications
37124|NCT03970083|Gynecologic Cancer|gynecologic cancer
37125|NCT03970083|Cervical Cancer|cervical cancer
37126|NCT03970057|Psychological outcomes|psychological outcomes
37127|NCT03970057|Internet-based cognitive behavioural therapy|internet-based cognitive behavioural therapy
37128|NCT03970057|Perinatal women|perinatal women
37129|NCT03970031|Diabetes|diabetes
37130|NCT03970031|NASH|nash
37131|NCT03970018|Autosomal dominant polycystic kidney disease|autosomal dominant polycystic kidney disease
37132|NCT03970018|peritoneal dialysis|peritoneal dialysis
37133|NCT03970018|peritoneal pressure|peritoneal pressure
37134|NCT03970005|psychosis|psychosis
37135|NCT03970005|treatment|treatment
37136|NCT03970005|clinical high-risk|clinical high-risk
37137|NCT03969992|Respiratory Distress Syndrome|respiratory distress syndrome
37139|NCT03969992|surfactant|surfactant
37140|NCT03969992|Preterm Infant|preterm infant
37141|NCT03969979|epididymo-orchitis|epididymo-orchitis
37142|NCT03969979|shear wave elastography|shear wave elastography
37143|NCT03969953|Rivaroxaban|rivaroxaban
37144|NCT03969927|Simulation|simulation
37145|NCT03969927|Driving Simulation|driving simulation
37146|NCT03969888|Cystic Fibrosis|cystic fibrosis
37147|NCT03969888|ABBV-3067|abbv-3067
37148|NCT03969888|ABBV-2222|abbv-2222
37149|NCT03969888|F508del Mutation|f508del mutation
37150|NCT03969862|Allergy diagnostic tool|allergy diagnostic tool
37151|NCT03969862|Specific IgE assays|specific ige assays
37152|NCT03969862|Allergens|allergens
37153|NCT03969836|cardiac surgery cerebral oxygenation, brain blood volume|cardiac surgery cerebral oxygenation, brain blood volume
37154|NCT03969836|cerebral oxygenation|cerebral oxygenation
37155|NCT03969836|brain blood volume|brain blood volume
37156|NCT03969823|NSCLC|nsclc
37157|NCT03969823|Osimertinib|osimertinib
37158|NCT03969823|EGFR exon 19 deletion or L858R mutation|egfr exon 19 deletion or l858r mutation
37159|NCT03969771|Mindfulness-Based Stress Reduction|mindfulness-based stress reduction
37160|NCT03969771|Mindfulness|mindfulness
37161|NCT03969745|chrononutrition|chrononutrition
37162|NCT03969745|metabolism|metabolism
37163|NCT03969745|body composition|body composition
37164|NCT03969732|Stroke|stroke
37165|NCT03969732|intracerebral hemorrhage|intracerebral hemorrhage
37166|NCT03969732|cerebral amyloid angiopathy|cerebral amyloid angiopathy
37167|NCT03969732|amyloid PET|amyloid pet
37168|NCT03969732|tau PET|tau pet
37169|NCT03969732|MRI|mri
37170|NCT03969732|Aβ|aβ
37171|NCT03969732|ApoE|apoe
37172|NCT03969719|Non-alcoholic steatohepatitis; Type 2 Diabetes Mellitus|non-alcoholic steatohepatitis; type 2 diabetes mellitus
37173|NCT03969693|Lymphoma|lymphoma
37174|NCT03969693|Radiotherapy|radiotherapy
37175|NCT03969693|Mediastinum|mediastinum
37176|NCT03969693|Adverse effects|adverse effects
37177|NCT03969693|Longitudinal|longitudinal
37178|NCT03969693|Cardiac toxicities|cardiac toxicities
37179|NCT03969693|Lung|lung
37180|NCT03969693|Breast|breast
37181|NCT03969667|fatigue, assessment, reliability, validity|fatigue, assessment, reliability, validity
37182|NCT03969641|Vaccination|vaccination
37183|NCT03969641|Safety|safety
37184|NCT03969641|Birth outcomes|birth outcomes
37185|NCT03969641|Flublok|flublok
37186|NCT03969641|Pregnant|pregnant
37187|NCT03969641|Influenza|influenza
37188|NCT03969602|Pain Catastrophizing|pain catastrophizing
37189|NCT03969602|Cognitive Behavioral Therapy|cognitive behavioral therapy
37190|NCT03969602|Rehabilitation|rehabilitation
37191|NCT03969602|Spinal disease|spinal disease
37192|NCT03969602|Spinal fusion|spinal fusion
37193|NCT03969576|Hepatocellular Carcinoma|hepatocellular carcinoma
37194|NCT03969576|Drug-eluting bead transarterial chemoembolization|drug-eluting bead transarterial chemoembolization
37195|NCT03969576|Conventional transarterial chemoembolization|conventional transarterial chemoembolization
37196|NCT03969576|Objective response|objective response
37197|NCT03969563|stroke|stroke
37198|NCT03969563|MBSR|mbsr
37199|NCT03969563|meditation|meditation
37200|NCT03969563|mindfulness|mindfulness
37201|NCT03969563|yoga|yoga
37202|NCT03969550|Maraviroc|maraviroc
37203|NCT03969550|John Cunningham virus (JCV)|john cunningham virus (jcv)
37204|NCT03969550|Immune reconstitution inflammatory syndrome (IRIS)|immune reconstitution inflammatory syndrome (iris)
37205|NCT03969550|Combined antiretroviral treatment (cART)|combined antiretroviral treatment (cart)
37206|NCT03969550|Overall survival (OS)|overall survival (os)
37207|NCT03969537|Cervical Dystonia|cervical dystonia
37208|NCT03969537|Telemedicine|telemedicine
37209|NCT03969537|Telehealth|telehealth
37210|NCT03969511|large-vessel occlusion|large-vessel occlusion
37211|NCT03969511|reperfusion therapy|reperfusion therapy
37212|NCT03969472|probiotic|probiotic
37213|NCT03969472|Electrophysiologic Therapy|electrophysiologic therapy
37214|NCT03969472|uterine endometrial repair|uterine endometrial repair
37215|NCT03969472|intrauterine adhesion|intrauterine adhesion
37216|NCT03969459|pesticide exposure|pesticide exposure
37217|NCT03969459|persistent organic pollutants|persistent organic pollutants
37218|NCT03969459|breast milk|breast milk
37219|NCT03969459|meconium|meconium
37221|NCT03969459|microbiota|microbiota
37222|NCT03969459|newborn|newborn
37223|NCT03969420|Tolero, Phase 2, AML, Relapsed, Refractory, Alvocidib, Venetoclax|tolero, phase 2, aml, relapsed, refractory, alvocidib, venetoclax
37224|NCT03969394|strain|strain
37225|NCT03969394|MRI|mri
37226|NCT03969394|echocardiography|echocardiography
37227|NCT03969355|Paediatric|paediatric
37228|NCT03969355|Intensive care|intensive care
37229|NCT03969355|Mortality|mortality
37230|NCT03969342|Pediatric|pediatric
37231|NCT03969342|Pneumonia|pneumonia
37232|NCT03969342|Ultrasound|ultrasound
37233|NCT03969342|Point of Care Ultrasound|point of care ultrasound
37234|NCT03969342|Diagnostic Imaging|diagnostic imaging
37235|NCT03969342|Global Health|global health
37236|NCT03969342|Uganda|uganda
37237|NCT03969342|Rural Healthcare|rural healthcare
37238|NCT03969329|Secondary hyperparathyroidism (sHPT)|secondary hyperparathyroidism (shpt)
37239|NCT03969329|Chronic kidney disease (CKD)|chronic kidney disease (ckd)
37240|NCT03969329|Pediatric|pediatric
37241|NCT03969316|quadratus lumborum block|quadratus lumborum block
37242|NCT03969316|transversus abdominis plane block|transversus abdominis plane block
37243|NCT03969316|pediatric patient|pediatric patient
37244|NCT03969316|orchiopexy|orchiopexy
37245|NCT03969316|regional anesthesia|regional anesthesia
37246|NCT03969316|pain|pain
37247|NCT03969290|Contact lens|contact lens
37248|NCT03969290|Vision correction|vision correction
37249|NCT03969290|Visual acuity|visual acuity
37250|NCT03969290|Daily disposable contact lens|daily disposable contact lens
37251|NCT03969277|Imagery|imagery
37252|NCT03969277|Mirror Neurons|mirror neurons
37253|NCT03969277|Immobilization|immobilization
37254|NCT03969277|Exercise|exercise
37255|NCT03969277|Rehabilitation|rehabilitation
37256|NCT03969251|alcohol|alcohol
37257|NCT03969251|alcohol dependence|alcohol dependence
37258|NCT03969251|addiction|addiction
37259|NCT03969251|alcohol use disorder|alcohol use disorder
37260|NCT03969238|opioid dependence|opioid dependence
37261|NCT03969238|pain management|pain management
37262|NCT03969225|Haemodialysis vascular access|haemodialysis vascular access
37263|NCT03969225|Core outcome|core outcome
37264|NCT03969225|Vascular access function|vascular access function
37265|NCT03969225|Validation|validation
37266|NCT03969225|Haemodialysis|haemodialysis
37267|NCT03969225|Hemodialysis|hemodialysis
37268|NCT03969225|Vascular access intervention|vascular access intervention
37269|NCT03969225|Vascular access procedure|vascular access procedure
37270|NCT03969225|Standardised outcomes in nephrology (SONG)|standardised outcomes in nephrology (song)
37271|NCT03969199|MANNA|manna
37272|NCT03969199|Nutrition|nutrition
37273|NCT03969199|Cirrhosis, Liver|cirrhosis, liver
37274|NCT03969199|Liver Diseases|liver diseases
37275|NCT03969199|Dietary compliance|dietary compliance
37276|NCT03969199|Low sodium diet|low sodium diet
37277|NCT03969199|Non-profit|non-profit
37278|NCT03969199|Salt affinity|salt affinity
37279|NCT03969199|Behavioral changes|behavioral changes
37280|NCT03969186|Telehealth|telehealth
37281|NCT03969186|Cirrhosis|cirrhosis
37282|NCT03969186|Ascites|ascites
37283|NCT03969186|Hepatic encephalopathy|hepatic encephalopathy
37284|NCT03969186|Readmissions|readmissions
37285|NCT03969186|Preventable readmissions|preventable readmissions
37286|NCT03969186|Liver diseases|liver diseases
37287|NCT03969186|Variceal bleeding|variceal bleeding
37288|NCT03969173|Children undergoing pediatric general surgery or pediatric urology surgery|children undergoing pediatric general surgery or pediatric urology surgery
37289|NCT03969160|Imaginal exposure|imaginal exposure
37290|NCT03969160|brain imaging|brain imaging
37291|NCT03969160|mental imagery|mental imagery
37292|NCT03969121|Palbociclib|palbociclib
37293|NCT03969121|Breast Cancer|breast cancer
37294|NCT03969121|PEPI|pepi
37295|NCT03969108|Thyroid surgery|thyroid surgery
37296|NCT03969108|Indocyanine green (ICG)|indocyanine green (icg)
37297|NCT03969108|Hypoparathyroidism|hypoparathyroidism
37298|NCT03969095|Stroke|stroke
37299|NCT03969095|Dysphagia|dysphagia
37300|NCT03969095|Rehabilitation|rehabilitation
37301|NCT03969095|Videofluoroscopy|videofluoroscopy
37302|NCT03969082|Bibliotherapy|bibliotherapy
37303|NCT03969082|Cancer|cancer
37304|NCT03969069|Adult|adult
37305|NCT03969069|Human|human
37306|NCT03969069|Cohort|cohort
37307|NCT03969030|HIV|hiv
37308|NCT03969030|Sub-Sahara Africa|sub-sahara africa
37309|NCT03969030|Lesotho|lesotho
37310|NCT03969030|Differentiated Service Delivery|differentiated service delivery
37311|NCT03969030|Adolescents and young adults living with HIV|adolescents and young adults living with hiv
37312|NCT03969030|ART service|art service
37313|NCT03969030|Preference-based|preference-based
37314|NCT03969004|High risk|high risk
37315|NCT03968991|Blinded population|blinded population
37316|NCT03968991|Pain evaluation|pain evaluation
37317|NCT03968991|Diagnostic tool|diagnostic tool
37318|NCT03968978|Asthma, Severe Uncontrolled Asthma|asthma, severe uncontrolled asthma
37319|NCT03968965|Image guided surgery|image guided surgery
37320|NCT03968965|Computer-assisted surgery|computer-assisted surgery
37321|NCT03968965|Machine vision|machine vision
37322|NCT03968965|Navigation|navigation
37323|NCT03968965|Image guidance|image guidance
37324|NCT03968965|Spine|spine
37325|NCT03968965|Lumbar spine|lumbar spine
37326|NCT03968952|Digital health|digital health
37327|NCT03968952|Gestational Diabetes|gestational diabetes
37328|NCT03968952|Hypertension|hypertension
37329|NCT03968952|Pre-Eclampsia|pre-eclampsia
37330|NCT03968926|Cardiogenic shock|cardiogenic shock
37331|NCT03968926|Temporary circulatory support|temporary circulatory support
37332|NCT03968926|Vasoplegia|vasoplegia
37333|NCT03968926|Inflammatory response|inflammatory response
37334|NCT03968913|Osteoarthritis|osteoarthritis
37335|NCT03968913|ACL|acl
37336|NCT03968913|Anakinra|anakinra
37337|NCT03968900|smoking|smoking
37338|NCT03968900|sleep deficiencies|sleep deficiencies
37339|NCT03968900|socioeconomic disadvantage|socioeconomic disadvantage
37340|NCT03968900|Race|race
37341|NCT03968887|Postoperative Delirium|postoperative delirium
37342|NCT03968874|Veterans|veterans
37343|NCT03968848|Hepatic|hepatic
37344|NCT03968848|Acalabrutinib|acalabrutinib
37345|NCT03968809|Coronary Artery Disease|coronary artery disease
37346|NCT03968809|Cardiac Imaging|cardiac imaging
37347|NCT03968796|Kinesio Taping|kinesio taping
37348|NCT03968796|Lateral epicondylitis|lateral epicondylitis
37349|NCT03968796|Tennis elbow|tennis elbow
37350|NCT03968796|TENS|tens
37351|NCT03968783|cesarean section|cesarean section
37352|NCT03968783|scar heal|scar heal
37353|NCT03968783|isthmocele|isthmocele
37354|NCT03968783|suture material|suture material
37355|NCT03968783|saline infusion sonography|saline infusion sonography
37356|NCT03968770|Osteoarthritis|osteoarthritis
37357|NCT03968770|Pain|pain
37358|NCT03968770|Microbiota|microbiota
37359|NCT03968731|contact lens discomfort|contact lens discomfort
37360|NCT03968718|Patient Reported Outcome Measures|patient reported outcome measures
37361|NCT03968718|Feasibility study|feasibility study
37362|NCT03968692|Prostatic Neoplasms|prostatic neoplasms
37363|NCT03968692|Practice Guideline|practice guideline
37364|NCT03968692|Early Detection of Cancer|early detection of cancer
37365|NCT03968679|head and neck cancer|head and neck cancer
37366|NCT03968679|lymph drainage mapping|lymph drainage mapping
37367|NCT03968679|sentinel node procedure|sentinel node procedure
37368|NCT03968679|radiotherapy|radiotherapy
37369|NCT03968679|unilateral elective neck irradiation|unilateral elective neck irradiation
37370|NCT03968640|MODS|mods
37371|NCT03968627|Stroke|stroke
37372|NCT03968627|Rehabilitation|rehabilitation
37373|NCT03968627|Protocol|protocol
37374|NCT03968627|Evidence-based|evidence-based
37375|NCT03968601|Severe mitral regurgitation|severe mitral regurgitation
37376|NCT03968601|Preserved ventricular ejection fraction|preserved ventricular ejection fraction
37377|NCT03968601|Global Longitudinal Strain|global longitudinal strain
37378|NCT03968601|Post-operative ventricular dysfunction|post-operative ventricular dysfunction
37379|NCT03968601|Echocardiography|echocardiography
37380|NCT03968601|Mitral surgery|mitral surgery
37381|NCT03968549|Probiotics|probiotics
37382|NCT03968549|Inflammation|inflammation
37383|NCT03968549|Heart failure|heart failure
37384|NCT03968549|Intestinal microbiota|intestinal microbiota
37385|NCT03968523|Postoperative pain|postoperative pain
37386|NCT03968523|Laparoscopic inguinal hernioplasty|laparoscopic inguinal hernioplasty
37387|NCT03968523|TAP block|tap block
37388|NCT03968497|pain|pain
37389|NCT03968497|gender|gender
37390|NCT03968497|visual analog scale|visual analog scale
37391|NCT03968497|numeric rating scale|numeric rating scale
37392|NCT03968458|appetite control|appetite control
37393|NCT03968458|obesity|obesity
37394|NCT03968458|Adolescents|adolescents
37395|NCT03968458|exercise timing|exercise timing
37396|NCT03968432|Childhood Vaccination,|childhood vaccination,
37397|NCT03968432|Knowledge Translation,|knowledge translation,
37398|NCT03968432|Pain management,|pain management,
37399|NCT03968432|Parents.|parents.
37400|NCT03968419|ACZ885|acz885
37401|NCT03968419|canakinumab|canakinumab
37402|NCT03968419|pembrolizumab|pembrolizumab
37403|NCT03968419|NSCLC|nsclc
37404|NCT03968419|non-small cell lung cancer|non-small cell lung cancer
37405|NCT03968419|non small cell lung cancer|non small cell lung cancer
37406|NCT03968419|early stage NSCLC|early stage nsclc
37407|NCT03968419|squamous|squamous
37408|NCT03968419|non-squamous,|non-squamous,
37409|NCT03968419|MPR|mpr
37410|NCT03968419|major pathological response|major pathological response
37411|NCT03968419|hs-CRP|hs-crp
37412|NCT03968419|PD-L1|pd-l1
37413|NCT03968419|hsCRP|hscrp
37414|NCT03968419|surgery|surgery
37415|NCT03968419|neo-adjuvant|neo-adjuvant
37416|NCT03968419|neo adjuvant|neo adjuvant
37418|NCT03968419|hs-IL-6|hs-il-6
37419|NCT03968419|CANOPY|canopy
37420|NCT03968393|Transient Atrial Fibrillation|transient atrial fibrillation
37421|NCT03968393|Perioperative Atrial Fibrillation|perioperative atrial fibrillation
37422|NCT03968393|Non-vitamin K Oral Anticoagulation|non-vitamin k oral anticoagulation
37423|NCT03968393|Noncardiac Surgery|noncardiac surgery
37424|NCT03968393|PROBE Design|probe design
37425|NCT03968380|Implementation science|implementation science
37426|NCT03968380|Noncommunicable disease|noncommunicable disease
37427|NCT03968380|Diabetes Mellitus, Type 2|diabetes mellitus, type 2
37428|NCT03968380|Public Policy|public policy
37429|NCT03968380|Delivery of Health Care|delivery of health care
37430|NCT03968367|magnetic activated sperm sorting|magnetic activated sperm sorting
37431|NCT03968367|DNA fragmentation index|dna fragmentation index
37432|NCT03968367|sperm up|sperm up
37433|NCT03968367|density differential centrifugation|density differential centrifugation
37434|NCT03968367|clinical outcome|clinical outcome
37435|NCT03968354|NAFLD|nafld
37436|NCT03968354|NASH|nash
37437|NCT03968354|Diabetes type2|diabetes type2
37438|NCT03968341|intraocular concentrations of antibiotics|intraocular concentrations of antibiotics
37439|NCT03968302|H pylori; eradication; amoxicillin; clarithromycin; esomeprazole; colloidal bismuth subcitrate|h pylori; eradication; amoxicillin; clarithromycin; esomeprazole; colloidal bismuth subcitrate
37440|NCT03968276|antithrombotic treatment|antithrombotic treatment
37441|NCT03968276|digital therapeutic application assistance|digital therapeutic application assistance
37442|NCT03968263|Vibration|vibration
37443|NCT03968263|Tooth movement acceleration|tooth movement acceleration
37444|NCT03968224|Metformin|metformin
37445|NCT03968224|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors
37446|NCT03968224|PreDiabetes|prediabetes
37447|NCT03968224|Obesity, Morbid|obesity, morbid
37448|NCT03968224|Diabetes Mellitus, Type 2|diabetes mellitus, type 2
37449|NCT03968211|immunodeficiency|immunodeficiency
37450|NCT03968211|IgE|ige
37451|NCT03968198|Cell therapy|cell therapy
37452|NCT03968198|ASC autologous|asc autologous
37453|NCT03968198|CLI|cli
37454|NCT03968198|PAD|pad
37455|NCT03968198|No option|no option
37456|NCT03968185|Low back pain|low back pain
37457|NCT03968185|Pain|pain
37458|NCT03968185|Disability|disability
37459|NCT03968185|Interfascial infiltration|interfascial infiltration
37460|NCT03968185|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal
37461|NCT03968185|Analgesics|analgesics
37462|NCT03968185|Emergency department / emergency room / emergency management|emergency department / emergency room / emergency management
37463|NCT03968172|Multiple Sclerosis|multiple sclerosis
37464|NCT03968172|Complex Intervention|complex intervention
37465|NCT03968172|Lifestyle Intervention|lifestyle intervention
37466|NCT03968172|Randomized Controlled Trial|randomized controlled trial
37467|NCT03968172|Evidence-based Medicine|evidence-based medicine
37468|NCT03968133|probiotic|probiotic
37469|NCT03968133|mood|mood
37470|NCT03968107|malrotation|malrotation
37471|NCT03968107|intestinal structures|intestinal structures
37472|NCT03968107|mesenteric vessels|mesenteric vessels
37473|NCT03968094|Respiratory Compromise|respiratory compromise
37474|NCT03968081|theory of mind|theory of mind
37475|NCT03968081|mentalisation|mentalisation
37476|NCT03968081|ostracism|ostracism
37477|NCT03968081|cyberball|cyberball
37478|NCT03968055|pediatrics|pediatrics
37479|NCT03968042|Alcohol-induced brain injury, atrophy, demyelination|alcohol-induced brain injury, atrophy, demyelination
37480|NCT03968016|Acute Myocardial Infarction|acute myocardial infarction
37481|NCT03968016|Cardiac marker|cardiac marker
37482|NCT03968016|Troponin|troponin
37483|NCT03968003|Prebiotics|prebiotics
37484|NCT03968003|Intestinal Microbiota|intestinal microbiota
37485|NCT03967990|cholesterol|cholesterol
37486|NCT03967990|gut microbiome|gut microbiome
37487|NCT03967990|gut microbiota|gut microbiota
37488|NCT03967990|dietary fiber|dietary fiber
37489|NCT03967990|whole grain|whole grain
37490|NCT03967964|Gynaecology|gynaecology
37491|NCT03967964|Obstetrics|obstetrics
37492|NCT03967951|Radiomics|radiomics
37493|NCT03967951|Pancretic neuroendocrine neoplasms (panNEN)|pancretic neuroendocrine neoplasms (pannen)
37494|NCT03967925|proteinase 3|proteinase 3
37495|NCT03967860|CT Scan|ct scan
37496|NCT03967847|Rotator Cuff Tear|rotator cuff tear
37497|NCT03967847|Postoperative Pain|postoperative pain
37498|NCT03967834|Soft Tissue Sarcoma|soft tissue sarcoma
37499|NCT03967834|Clear Cell Sarcoma|clear cell sarcoma
37500|NCT03967834|Epithelioid Sarcoma|epithelioid sarcoma
37501|NCT03967834|Perivascular Epithelioid Cell Neoplasms|perivascular epithelioid cell neoplasms
37502|NCT03967834|Desmoplastic Small Round Cell Tumor|desmoplastic small round cell tumor
37503|NCT03967834|Solitary Fibrous Tumors|solitary fibrous tumors
37504|NCT03967834|Alveolar Soft Part Sarcoma|alveolar soft part sarcoma
37505|NCT03967834|Epithelioid Hemangioendothelioma|epithelioid hemangioendothelioma
37506|NCT03967834|Low Grade Fibromyxoid Sarcoma|low grade fibromyxoid sarcoma
37507|NCT03967834|Sclerosing Epithelioid Fibrosarcoma|sclerosing epithelioid fibrosarcoma
37508|NCT03967808|Registry|registry
37509|NCT03967808|Renal replacement therapy|renal replacement therapy
37510|NCT03967795|ICU|icu
37511|NCT03967795|enteral nutrition|enteral nutrition
37512|NCT03967795|tolerance|tolerance
37513|NCT03967795|prediction|prediction
37514|NCT03967782|appetite control|appetite control
37515|NCT03967782|obesity|obesity
37516|NCT03967782|adolescents|adolescents
37517|NCT03967782|exercise timing|exercise timing
37518|NCT03967769|Apnoeic oxygenation|apnoeic oxygenation
37519|NCT03967769|Airway management|airway management
37520|NCT03967769|Oxygen insufflation|oxygen insufflation
37521|NCT03967769|Paediatric general anaesthesia|paediatric general anaesthesia
37522|NCT03967743|Genetics|genetics
37523|NCT03967743|Infant Development|infant development
37524|NCT03967717|Edema|edema
37525|NCT03967691|Interleukin-6|interleukin-6
37526|NCT03967691|Tocilizumab|tocilizumab
37527|NCT03967691|Exercise|exercise
37528|NCT03967691|Substrate Metabolism|substrate metabolism
37529|NCT03967691|Lipolysis|lipolysis
37530|NCT03967678|enriched beef|enriched beef
37531|NCT03967678|omega|omega
37532|NCT03967678|poly unsaturated fatty acids (PUFA)|poly unsaturated fatty acids (pufa)
37533|NCT03967678|cholesterol|cholesterol
37534|NCT03967678|grass fed|grass fed
37535|NCT03967665|N-acetyl-L-cysteine|n-acetyl-l-cysteine
37536|NCT03967665|Poor hematopoietic reconstitution|poor hematopoietic reconstitution
37537|NCT03967665|Unmanipulated Haploidentical stem cell Transplantation|unmanipulated haploidentical stem cell transplantation
37538|NCT03967652|Volatile organic chemicals|volatile organic chemicals
37539|NCT03967652|Cancer|cancer
37540|NCT03967652|Diagnose Disease|diagnose disease
37541|NCT03967652|Na-nose|na-nose
37542|NCT03967652|breath diagnoses|breath diagnoses
37543|NCT03967639|cardiac surgical procedures|cardiac surgical procedures
37544|NCT03967639|respiratory mechanics|respiratory mechanics
37545|NCT03967639|seasonal variation|seasonal variation
37546|NCT03967626|Temperature targeted management (TTM)|temperature targeted management (ttm)
37547|NCT03967626|close loop|close loop
37548|NCT03967626|brain temperature|brain temperature
37549|NCT03967626|cerebral temperature|cerebral temperature
37550|NCT03967626|systemic temperature|systemic temperature
37551|NCT03967626|neuroprotection|neuroprotection
37552|NCT03967626|fever control|fever control
37553|NCT03967613|Functional eletrical stimulation|functional eletrical stimulation
37554|NCT03967613|Stroke|stroke
37555|NCT03967613|Upper limb|upper limb
37556|NCT03967587|Neonatal|neonatal
37557|NCT03967587|Umbilical Arteries|umbilical arteries
37558|NCT03967587|Umbilical Veins|umbilical veins
37559|NCT03967587|Oxygen Partial Pressure|oxygen partial pressure
37560|NCT03967574|transcranial direct current stimulation|transcranial direct current stimulation
37561|NCT03967574|non invasive brain stimulation|non invasive brain stimulation
37562|NCT03967574|tDCS|tdcs
37563|NCT03967574|NIBS|nibs
37564|NCT03967574|subacromial corticosteroid injection|subacromial corticosteroid injection
37565|NCT03967561|Exercise|exercise
37566|NCT03967561|Water-based exercise|water-based exercise
37567|NCT03967561|Aerobic exercise|aerobic exercise
37568|NCT03967561|Glucose control|glucose control
37569|NCT03967561|Type 2 diabetes|type 2 diabetes
37570|NCT03967522|mRCC|mrcc
37571|NCT03967522|cabozantinib|cabozantinib
37572|NCT03967522|brain metastases|brain metastases
37573|NCT03967509|Externalizing behavior problems|externalizing behavior problems
37574|NCT03967509|Social competence|social competence
37575|NCT03967509|School readiness|school readiness
37576|NCT03967509|Teacher management training|teacher management training
37577|NCT03967509|Cluster randomized effectiveness trial|cluster randomized effectiveness trial
37578|NCT03967496|delirium|delirium
37579|NCT03967496|postoperative complications|postoperative complications
37580|NCT03967496|anesthesia recovery period|anesthesia recovery period
37581|NCT03967418|Behavioral addiction|behavioral addiction
37582|NCT03967418|neurocognition|neurocognition
37583|NCT03967418|neuropsychology|neuropsychology
37584|NCT03967418|sexual addiction|sexual addiction
37585|NCT03967418|internet gaming disorder|internet gaming disorder
37586|NCT03967418|eating disorders|eating disorders
37587|NCT03967405|Wound|wound
37588|NCT03967405|Imaging|imaging
37589|NCT03967392|Bupivacaine,dexamethasone,Analgesia,Skin Graft ,Donor|bupivacaine,dexamethasone,analgesia,skin graft ,donor
37590|NCT03967379|Other Cancer|other cancer
37591|NCT03967366|Melatonin|melatonin
37592|NCT03967366|coronary artery calcification|coronary artery calcification
37593|NCT03967366|relation|relation
37594|NCT03967353|Tuberculosis|tuberculosis
37595|NCT03967353|Home Treatment Management|home treatment management
37596|NCT03967353|Infection Control|infection control
37597|NCT03967340|chronic lung allograft dysfunction|chronic lung allograft dysfunction
37598|NCT03967340|lung transplantation|lung transplantation
37599|NCT03967340|biomarkers|biomarkers
37600|NCT03967340|personalized medecine|personalized medecine
37601|NCT03967314|Lumbar spinal surgery|lumbar spinal surgery
37602|NCT03967314|Postoperative pain management|postoperative pain management
37603|NCT03967314|Modified thoracolumbar interfacial plane block|modified thoracolumbar interfacial plane block
37604|NCT03967301|Carbapenemase-producing Enterobacteriaceae|carbapenemase-producing enterobacteriaceae
37605|NCT03967301|probiotics|probiotics
37606|NCT03967288|Chloroprocaine|chloroprocaine
37607|NCT03967288|Bupivacaine|bupivacaine
37608|NCT03967288|Motor Block|motor block
37609|NCT03967288|Anesthesia, Obstetrical|anesthesia, obstetrical
37610|NCT03967275|Bone marrow harvest|bone marrow harvest
37711|NCT03966716|Health Economy|health economy
37611|NCT03967275|Bone Marrow derived Mesenchymal Stem Cells (BM-MSC)|bone marrow derived mesenchymal stem cells (bm-msc)
37612|NCT03967275|Pre-clinical|pre-clinical
37613|NCT03967249|Acromegaly, IONIS-GHR-LRx|acromegaly, ionis-ghr-lrx
37614|NCT03967223|Adoptive T-cell therapy|adoptive t-cell therapy
37615|NCT03967223|Advanced metastatic synovial sarcoma|advanced metastatic synovial sarcoma
37616|NCT03967223|GSK3377794|gsk3377794
37617|NCT03967223|Positive solid tumors|positive solid tumors
37618|NCT03967223|T-cell receptors|t-cell receptors
37619|NCT03967197|manometry|manometry
37620|NCT03967197|pH monitoring|ph monitoring
37621|NCT03967197|lidocaine|lidocaine
37622|NCT03967171|Oxytocin|oxytocin
37623|NCT03967171|cesarean section|cesarean section
37624|NCT03967171|uterine atony|uterine atony
37625|NCT03967171|Postpartum Hemorrhage|postpartum hemorrhage
37626|NCT03967158|Xience Sierra|xience sierra
37627|NCT03967158|Drug Eluting Stent|drug eluting stent
37628|NCT03967158|Percutaneous coronary intervention|percutaneous coronary intervention
37629|NCT03967106|remote ischaemic preconditioning|remote ischaemic preconditioning
37630|NCT03967106|gait analysis|gait analysis
37631|NCT03967106|activity|activity
37632|NCT03967106|fatigue|fatigue
37633|NCT03967093|solid tumor|solid tumor
37634|NCT03967093|brain tumor|brain tumor
37635|NCT03967093|DIPG|dipg
37636|NCT03967093|ependymoma|ependymoma
37637|NCT03967067|Audit|audit
37638|NCT03967067|Liver resection|liver resection
37639|NCT03967067|Surgical complications|surgical complications
37640|NCT03967067|non-Eastern/non-Western|non-eastern/non-western
37641|NCT03967067|Quality improvement|quality improvement
37642|NCT03967054|mosquito|mosquito
37643|NCT03967054|ivermectin|ivermectin
37644|NCT03967054|Anopheles|anopheles
37645|NCT03967054|Plasmodium|plasmodium
37646|NCT03967041|splenic abscess|splenic abscess
37647|NCT03967041|sarcopenia|sarcopenia
37648|NCT03967041|surgical emergency|surgical emergency
37649|NCT03967015|Mobile Health|mobile health
37650|NCT03967015|Kenya|kenya
37651|NCT03967015|Randomized Controlled Trial|randomized controlled trial
37652|NCT03967002|Accelerated orthodontics|accelerated orthodontics
37653|NCT03967002|Alveolar corticotomy|alveolar corticotomy
37654|NCT03967002|Piezoelectric surgery|piezoelectric surgery
37655|NCT03967002|Tooth movement|tooth movement
37656|NCT03967002|Dental crowding|dental crowding
37657|NCT03967002|Guided surgery|guided surgery
37658|NCT03967002|Minimally invasive oral surgery|minimally invasive oral surgery
37659|NCT03967002|Mandibular anterior alignment|mandibular anterior alignment
37660|NCT03967002|Randomized prospective study|randomized prospective study
37661|NCT03966989|Emergency Medicine|emergency medicine
37662|NCT03966989|Behavioral Research|behavioral research
37663|NCT03966963|Eye Movement Desensitization Reprocessing; EMDR|eye movement desensitization reprocessing; emdr
812392|NCT00198328|bleomycin|bleomycin
37664|NCT03966963|childhood sexual abuse|childhood sexual abuse
37665|NCT03966963|posttraumatic stress disorder|posttraumatic stress disorder
37666|NCT03966963|PTSD|ptsd
37667|NCT03966963|adults|adults
37668|NCT03966950|Melatonin|melatonin
37669|NCT03966950|Cognitive Dysfunction|cognitive dysfunction
37670|NCT03966937|Anterior Knee Pain Syndrome|anterior knee pain syndrome
37671|NCT03966937|Patellofemoral Syndrome|patellofemoral syndrome
37672|NCT03966924|submental|submental
37673|NCT03966924|laxity|laxity
37674|NCT03966924|lipodystrophy|lipodystrophy
37675|NCT03966872|integrated health|integrated health
37676|NCT03966872|mental health|mental health
37677|NCT03966872|illness management|illness management
37678|NCT03966872|cardiovascular disease|cardiovascular disease
37679|NCT03966872|physical health|physical health
37680|NCT03966859|Atorvastatin|atorvastatin
37681|NCT03966859|Emotional processing|emotional processing
37682|NCT03966859|Reward processing|reward processing
37683|NCT03966859|Inflammation (C-Reactive Protein)|inflammation (c-reactive protein)
37684|NCT03966846|probiotics|probiotics
37685|NCT03966846|dairy products|dairy products
37686|NCT03966846|kefir|kefir
37687|NCT03966846|gut microbiota|gut microbiota
37688|NCT03966820|Anxiety|anxiety
37689|NCT03966820|Cognitive ageing|cognitive ageing
37690|NCT03966820|Depression|depression
37691|NCT03966820|Fatigue|fatigue
37692|NCT03966820|Fibromyalgia|fibromyalgia
37693|NCT03966820|Quality of life|quality of life
37694|NCT03966820|Sleep|sleep
37695|NCT03966807|lung cancer|lung cancer
37696|NCT03966807|caregiver|caregiver
37697|NCT03966755|Obesity|obesity
37698|NCT03966755|Heart failure with Normal Ejection Fraction|heart failure with normal ejection fraction
37699|NCT03966755|HFpEF|hfpef
37700|NCT03966755|unsaturated fatty acids|unsaturated fatty acids
37701|NCT03966755|cardiorespiratory fitness|cardiorespiratory fitness
37702|NCT03966755|dietary intervention|dietary intervention
37703|NCT03966729|HFmrEF|hfmref
37704|NCT03966729|HFrEF|hfref
37705|NCT03966729|HFpEF|hfpef
37706|NCT03966729|Heart Failure|heart failure
37707|NCT03966716|Internal Fixation|internal fixation
37708|NCT03966716|Hip Arthroplasty|hip arthroplasty
37709|NCT03966716|Reoperation Rate|reoperation rate
37710|NCT03966716|Mortality|mortality
37712|NCT03966716|External validity|external validity
37713|NCT03966716|Adverse events|adverse events
37714|NCT03966703|complete denture|complete denture
37715|NCT03966703|implant-fixed denture|implant-fixed denture
37716|NCT03966703|masticatory efficiency|masticatory efficiency
37717|NCT03966703|mixing ability test|mixing ability test
37718|NCT03966677|Groin hernia repair|groin hernia repair
37719|NCT03966677|Persistent postsurgical pain|persistent postsurgical pain
37720|NCT03966677|Quantitative sensory testing (QST)|quantitative sensory testing (qst)
37721|NCT03966677|Normative data|normative data
37722|NCT03966664|Acid-base equilibrium; pH; septic shock; critical illness|acid-base equilibrium; ph; septic shock; critical illness
37723|NCT03966651|PRRT (Peptide Receptor Radionuclide Therapy)|prrt (peptide receptor radionuclide therapy)
37724|NCT03966651|177Lu-DOTATATE|177lu-dotatate
37725|NCT03966625|screening|screening
37726|NCT03966599|Percutaneous Nephrolithotomy|percutaneous nephrolithotomy
37727|NCT03966599|Analgesic|analgesic
37728|NCT03966599|hemodynamic status|hemodynamic status
37729|NCT03966586|hiv|hiv
37730|NCT03966586|India|india
37731|NCT03966586|retention|retention
37732|NCT03966586|continuum|continuum
37733|NCT03966560|choroidal thickness|choroidal thickness
37734|NCT03966560|multifocal electroretinography|multifocal electroretinography
37735|NCT03966560|optic nerve head|optic nerve head
37736|NCT03966560|optical coherence tomography|optical coherence tomography
37737|NCT03966560|primer open-angle glaucoma|primer open-angle glaucoma
37738|NCT03966521|Endovascular aneurysm repair|endovascular aneurysm repair
37739|NCT03966508|central sensitization|central sensitization
37740|NCT03966508|High-frequency electrical stimulation|high-frequency electrical stimulation
37741|NCT03966482|cleft palate|cleft palate
37742|NCT03966482|velopharyngeal sphincter|velopharyngeal sphincter
37743|NCT03966482|velopharyngeal insufficiency|velopharyngeal insufficiency
37744|NCT03966482|speech therapy|speech therapy
37745|NCT03966482|rehabilitation|rehabilitation
37746|NCT03966469|informed consent|informed consent
37747|NCT03966469|support person|support person
37748|NCT03966430|damage control surgery|damage control surgery
37749|NCT03966430|acute mesenteric ischemia|acute mesenteric ischemia
37750|NCT03966430|complication|complication
37751|NCT03966417|exercise training|exercise training
37752|NCT03966391|school vaccinations|school vaccinations
37753|NCT03966391|pain management|pain management
37754|NCT03966391|knowledge translation|knowledge translation
37755|NCT03966391|cluster trial|cluster trial
37756|NCT03966365|Glaucoma|glaucoma
37757|NCT03966365|Krytantek|krytantek
37758|NCT03966365|Krytantek PF|krytantek pf
37759|NCT03966365|PRO-122|pro-122
37760|NCT03966339|Infertility,Female|infertility,female
37761|NCT03966339|Embryo Development|embryo development
37762|NCT03966326|Mastectomy|mastectomy
37763|NCT03966326|(PECs) pectoral block|(pecs) pectoral block
37764|NCT03966300|school vaccinations|school vaccinations
37765|NCT03966300|pain management|pain management
37766|NCT03966300|vaccination hesitancy|vaccination hesitancy
37767|NCT03966300|knowledge translation|knowledge translation
37768|NCT03966274|Electroencephalography|electroencephalography
37769|NCT03966274|Acute Confusion|acute confusion
37770|NCT03966274|Neurobehavioral Manifestations|neurobehavioral manifestations
37771|NCT03966274|Encephalopathy|encephalopathy
37772|NCT03966274|Neurocognitive Disorders|neurocognitive disorders
37773|NCT03966274|Mental Disorders|mental disorders
37774|NCT03966274|Acute Brain Failure|acute brain failure
37775|NCT03966248|Arthritis|arthritis
37776|NCT03966248|Massage|massage
37777|NCT03966248|Tuina|tuina
37778|NCT03966248|Traditional Chinese medicine|traditional chinese medicine
37779|NCT03966248|Physical therapy|physical therapy
37780|NCT03966248|Joint Diseases|joint diseases
37781|NCT03966248|Musculoskeletal Diseases|musculoskeletal diseases
37782|NCT03966248|Rheumatic Diseases|rheumatic diseases
37783|NCT03966248|manual therapy|manual therapy
37784|NCT03966235|melatonin|melatonin
37785|NCT03966235|coronary artery calcification|coronary artery calcification
37786|NCT03966235|adjuvant therapy|adjuvant therapy
37787|NCT03966222|Vein graft|vein graft
37788|NCT03966209|Checkpoint Inhibitor|checkpoint inhibitor
37789|NCT03966209|Immunotherapy|immunotherapy
37790|NCT03966196|COPD|copd
37791|NCT03966131|Speech|speech
37792|NCT03966131|swallowing|swallowing
37793|NCT03966131|sensors|sensors
37794|NCT03966131|complete denture|complete denture
37795|NCT03966118|2nd line|2nd line
37796|NCT03966118|Ramucirumab|ramucirumab
37797|NCT03966118|Avelumab|avelumab
37798|NCT03966118|Paclitaxel|paclitaxel
37799|NCT03966118|gastric cancer|gastric cancer
37800|NCT03966105|wild-type|wild-type
37801|NCT03966105|carpal tunnel syndrome|carpal tunnel syndrome
37802|NCT03966105|lumbar spinal stenosis|lumbar spinal stenosis
37803|NCT03966105|prevalence|prevalence
37804|NCT03966092|Prospective randomized pilot study|prospective randomized pilot study
37805|NCT03966092|Quadratus lumborum block|quadratus lumborum block
37806|NCT03966092|Quo R 40 score|quo r 40 score
37807|NCT03966092|Post operative pain|post operative pain
38004|NCT03964662|stroke|stroke
37808|NCT03966079|Acute Pulmonary Embolism|acute pulmonary embolism
37809|NCT03966066|Bronchiectasis children|bronchiectasis children
37810|NCT03966053|Diamond Blackfan Anemia|diamond blackfan anemia
37811|NCT03966027|Diabetic Ankle Fractures|diabetic ankle fractures
37812|NCT03966001|Cesarean scar pregnancy|cesarean scar pregnancy
37813|NCT03966001|Isthmocele|isthmocele
37814|NCT03966001|Uterine niche|uterine niche
37815|NCT03966001|Cesarean scar defect|cesarean scar defect
37816|NCT03965936|adipose tissue derived stem cells|adipose tissue derived stem cells
37817|NCT03965936|lipofilling|lipofilling
37818|NCT03965910|stroke|stroke
37819|NCT03965910|rehabilitation|rehabilitation
37820|NCT03965910|diffusion tensor imaging|diffusion tensor imaging
37821|NCT03965845|Tumor Metabolism|tumor metabolism
37822|NCT03965845|Glutaminase Inhibitor|glutaminase inhibitor
37823|NCT03965845|CB-839|cb-839
37824|NCT03965845|Palbociclib|palbociclib
37825|NCT03965845|PALBO|palbo
37826|NCT03965845|Telaglenestat|telaglenestat
37827|NCT03965845|CDK4/6|cdk4/6
37828|NCT03965845|CDK4|cdk4
37829|NCT03965845|CDK6|cdk6
37830|NCT03965832|high-flow nasal therapy|high-flow nasal therapy
37831|NCT03965832|oxygen therapy|oxygen therapy
37832|NCT03965832|Exercise-induced desaturation|exercise-induced desaturation
37833|NCT03965819|Aches|aches
37834|NCT03965819|Discomfort|discomfort
37835|NCT03965819|Healthy|healthy
37836|NCT03965819|Adults|adults
37837|NCT03965819|Body aches|body aches
37838|NCT03965780|Scleroderma|scleroderma
37839|NCT03965780|Systemic Sclerosis|systemic sclerosis
37840|NCT03965780|Peer Support Group|peer support group
37841|NCT03965780|Training|training
37842|NCT03965767|endoscopic sinus surgery- tranexamic acid|endoscopic sinus surgery- tranexamic acid
37843|NCT03965754|Prospect theory|prospect theory
37844|NCT03965715|3D printed technology|3d printed technology
37845|NCT03965715|Ankle-Foot Orthosis (AFO)|ankle-foot orthosis (afo)
37846|NCT03965715|Stroke|stroke
37847|NCT03965715|Gait parameters|gait parameters
37848|NCT03965715|Gait Analysis|gait analysis
37849|NCT03965715|kinetics|kinetics
37850|NCT03965715|kinematics|kinematics
37851|NCT03965676|Gout,Dual-energy computed tomography,Tophus,Erosion|gout,dual-energy computed tomography,tophus,erosion
37852|NCT03965650|axial spondyloarthritis|axial spondyloarthritis
37853|NCT03965650|online video coaching|online video coaching
37854|NCT03965650|physical activity|physical activity
37855|NCT03965637|vitamin c|vitamin c
37856|NCT03965637|Hysterectomy|hysterectomy
37857|NCT03965637|bleeding|bleeding
37858|NCT03965637|wound healing|wound healing
37859|NCT03965637|abdominal surgeries|abdominal surgeries
37860|NCT03965624|MCNS|mcns
37861|NCT03965624|Rituximab|rituximab
37862|NCT03965624|Complete remission|complete remission
37863|NCT03965611|Traumatic brain injury|traumatic brain injury
37864|NCT03965611|Multiple trauma|multiple trauma
37865|NCT03965611|Microbiota|microbiota
37866|NCT03965611|Intensive care unit|intensive care unit
37867|NCT03965598|Schizophrenia; Ultra-high risk for psychosis; Predictors; Pathogenesis|schizophrenia; ultra-high risk for psychosis; predictors; pathogenesis
37868|NCT03965572|cabergoline, lactation, suppression, postpartum care|cabergoline, lactation, suppression, postpartum care
37869|NCT03965533|Japanese, Caucasian, pharmacokinetics, pharmacodynamics, GSK2831781, lymphocyte activation gene-3|japanese, caucasian, pharmacokinetics, pharmacodynamics, gsk2831781, lymphocyte activation gene-3
37870|NCT03965520|peripheral arterial disease|peripheral arterial disease
37871|NCT03965520|exercise training|exercise training
37872|NCT03965520|local aerobic training|local aerobic training
37873|NCT03965507|Disc hernia|disc hernia
37874|NCT03965507|Dysfunction|dysfunction
37875|NCT03965507|Lumbar|lumbar
37876|NCT03965507|Sacroiliac joint|sacroiliac joint
37877|NCT03965494|adult glioblastoma|adult glioblastoma
37878|NCT03965468|NSCLC|nsclc
37879|NCT03965455|labial frenum|labial frenum
37880|NCT03965455|laser therapy|laser therapy
37881|NCT03965455|recurrence|recurrence
37882|NCT03965455|oral hyigiene|oral hyigiene
37883|NCT03965442|Post-mastectomy Pain Syndrome|post-mastectomy pain syndrome
37884|NCT03965442|Esmolol|esmolol
37885|NCT03965442|Perioperative|perioperative
37886|NCT03965429|malignant hemopathy|malignant hemopathy
37887|NCT03965429|allogeneic hematopoietic stem cell transplant|allogeneic hematopoietic stem cell transplant
37888|NCT03965429|blood collection|blood collection
37889|NCT03965416|White Coat|white coat
37890|NCT03965416|Communication|communication
37891|NCT03965416|Physician - Patient Relationship|physician - patient relationship
37892|NCT03965416|Satisfaction|satisfaction
37893|NCT03965416|Trust|trust
37894|NCT03965416|Competence|competence
37895|NCT03965416|Empathy|empathy
37896|NCT03965416|Knowledge|knowledge
37897|NCT03965403|stroke|stroke
37898|NCT03965403|hemiparesis|hemiparesis
37899|NCT03965403|Robotic|robotic
37900|NCT03965390|oral microbiota|oral microbiota
37901|NCT03965390|parkinson|parkinson
37902|NCT03965390|brain stimulation surgery|brain stimulation surgery
37903|NCT03965390|oral therapeutic|oral therapeutic
37904|NCT03965377|effectiveness of gaming technology|effectiveness of gaming technology
38005|NCT03964662|biofeedback|biofeedback
37905|NCT03965377|knowledge of childhood injury prevention|knowledge of childhood injury prevention
37906|NCT03965325|Value-Based Health Care|value-based health care
37907|NCT03965325|VBHC|vbhc
37908|NCT03965325|Patient reported outcomes measure|patient reported outcomes measure
37909|NCT03965325|PROMs|proms
37910|NCT03965325|PROs|pros
37911|NCT03965325|Colorectal Cancer|colorectal cancer
37912|NCT03965325|Patient reported outcomes|patient reported outcomes
37913|NCT03965299|randomized, sham-controlled, double-blind trial|randomized, sham-controlled, double-blind trial
37914|NCT03965299|transcutaneous tibial nerve stimulation|transcutaneous tibial nerve stimulation
37915|NCT03965299|spinal cord injury|spinal cord injury
37916|NCT03965299|neurogenic detrusor overactivity|neurogenic detrusor overactivity
37917|NCT03965299|neuromodulation|neuromodulation
37918|NCT03965299|electrical stimulation|electrical stimulation
37919|NCT03965299|paraplegia; tetraplegia|paraplegia; tetraplegia
37920|NCT03965299|urodynamics|urodynamics
37921|NCT03965273|Child marriage|child marriage
37922|NCT03965273|Tipping Point|tipping point
37923|NCT03965273|CRCT|crct
37924|NCT03965273|Impact|impact
37925|NCT03965273|Bangladesh|bangladesh
37926|NCT03965247|Lithium|lithium
37927|NCT03965247|Reward|reward
37928|NCT03965247|Caudate|caudate
37929|NCT03965247|Reappraisal|reappraisal
37930|NCT03965247|Prefrontal cortex|prefrontal cortex
37931|NCT03965247|Amygdala|amygdala
37932|NCT03965221|PrEP|prep
37933|NCT03965221|HIV Testing|hiv testing
37934|NCT03965221|Sexually Transmitted Infections|sexually transmitted infections
37935|NCT03965221|Mobile app|mobile app
37936|NCT03965221|Young men who have sex with men|young men who have sex with men
37937|NCT03965221|Technology|technology
37938|NCT03965195|Influenza|influenza
37939|NCT03965195|Vaccine|vaccine
37940|NCT03965195|Vaccination|vaccination
37941|NCT03965195|Nursing Home|nursing home
37942|NCT03965195|Respiratory-Related Hospitalizations|respiratory-related hospitalizations
37943|NCT03965195|Cluster Randomized Trial|cluster randomized trial
37944|NCT03965195|MACE (Major Adverse Cardiovascular Event)|mace (major adverse cardiovascular event)
37945|NCT03965195|Cardiorespiratory-Related Hospitalizations|cardiorespiratory-related hospitalizations
37946|NCT03965195|All-Cause Hospitalization|all-cause hospitalization
37947|NCT03965182|colon preparation, ,|colon preparation, ,
37948|NCT03965182|polyethylene glycol|polyethylene glycol
37949|NCT03965182|sodium picosulfate/magnesium citrate|sodium picosulfate/magnesium citrate
37950|NCT03965130|Hepatic Glucose Metabolism|hepatic glucose metabolism
37951|NCT03965130|Hepatic Mitochondrial Oxidation|hepatic mitochondrial oxidation
37952|NCT03965130|PINTA|pinta
37953|NCT03965130|Glucagon|glucagon
37954|NCT03965117|hepatic blood flow|hepatic blood flow
37955|NCT03965117|Norepinephrine|norepinephrine
37956|NCT03965117|hepatic vascular pressure|hepatic vascular pressure
37957|NCT03965078|cataract surgery|cataract surgery
37958|NCT03965065|Aortic Stenosis|aortic stenosis
37959|NCT03965065|Heart Valve Prosthesis|heart valve prosthesis
37960|NCT03965065|Hemodynamics|hemodynamics
37961|NCT03965065|Sutureless|sutureless
37962|NCT03965065|Standard aortic valve prosthesis|standard aortic valve prosthesis
37963|NCT03965052|Travoprost|travoprost
37964|NCT03965052|ophthalmic solution|ophthalmic solution
37965|NCT03965052|Prostaglandin Analogues|prostaglandin analogues
37966|NCT03965052|Antiglaucoma drugs|antiglaucoma drugs
37967|NCT03965052|glaucoma|glaucoma
37968|NCT03965000|SGLT2|sglt2
37969|NCT03965000|SLC5A2|slc5a2
37970|NCT03965000|glucose metabolism|glucose metabolism
37971|NCT03965000|glucagon|glucagon
37972|NCT03965000|incretin|incretin
37973|NCT03964987|PDX-1|pdx-1
37974|NCT03964987|NGN-3|ngn-3
37975|NCT03964987|Glucose|glucose
37976|NCT03964961|functional massage|functional massage
37977|NCT03964961|conventional massage|conventional massage
37978|NCT03964961|neuromuscular response|neuromuscular response
37979|NCT03964870|Malignant Hyperthermia|malignant hyperthermia
37980|NCT03964844|hematologic conditions|hematologic conditions
37981|NCT03964844|recurrence|recurrence
37982|NCT03964818|osteitis|osteitis
37983|NCT03964818|flap surgery|flap surgery
37984|NCT03964818|short-course antibiotics|short-course antibiotics
37985|NCT03964805|Embryo culture|embryo culture
37986|NCT03964805|oxygen tension,|oxygen tension,
37987|NCT03964805|embryo quality,|embryo quality,
37988|NCT03964805|extended culture|extended culture
37989|NCT03964766|rotary files|rotary files
37990|NCT03964766|Primary molar|primary molar
37991|NCT03964766|Pulpectomy|pulpectomy
37992|NCT03964714|Acutely hospitalised|acutely hospitalised
37993|NCT03964714|Elderly|elderly
37994|NCT03964714|Activity monitoring|activity monitoring
37995|NCT03964701|children|children
37996|NCT03964701|renal failure|renal failure
37997|NCT03964701|dialysis|dialysis
37998|NCT03964688|vitamin C|vitamin c
37999|NCT03964688|ascorbate|ascorbate
38000|NCT03964688|ascorbic acid|ascorbic acid
38001|NCT03964688|autologous stem cell transplantation|autologous stem cell transplantation
38002|NCT03964662|home rehabilitation|home rehabilitation
38003|NCT03964662|technology|technology
38006|NCT03964662|games|games
38007|NCT03964636|OCT-A|oct-a
38008|NCT03964636|combined oral contraceptives|combined oral contraceptives
38009|NCT03964623|OCT-A|oct-a
38010|NCT03964623|smokers|smokers
38011|NCT03964623|vapers|vapers
38012|NCT03964623|non-smokers/non-vapers|non-smokers/non-vapers
38013|NCT03964623|nicotine|nicotine
38014|NCT03964623|retinal micro-vascularization|retinal micro-vascularization
38015|NCT03964610|optical coherence tomography (OCT-A)|optical coherence tomography (oct-a)
38016|NCT03964610|color fundus photography (CFP)|color fundus photography (cfp)
38017|NCT03964610|Retinal microvascularization|retinal microvascularization
38018|NCT03964610|Cerebral microangiopathy|cerebral microangiopathy
38019|NCT03964597|Cataract|cataract
38020|NCT03964597|objective scatter index (OSI)|objective scatter index (osi)
38021|NCT03964597|average lens density (ALD)|average lens density (ald)
38022|NCT03964584|dolutegravir|dolutegravir
38023|NCT03964584|dictegravir|dictegravir
38024|NCT03964584|Neurological disorder|neurological disorder
38025|NCT03964584|Psychiatric disorder|psychiatric disorder
38026|NCT03964584|HIV integrase Inhibitors|hiv integrase inhibitors
38027|NCT03964584|Adverse drug event|adverse drug event
38028|NCT03964545|Borderline|borderline
38029|NCT03964545|Post-traumatic stress|post-traumatic stress
38030|NCT03964545|Neurofeedback|neurofeedback
38031|NCT03964545|Amygdala|amygdala
38032|NCT03964545|Emotion regulation|emotion regulation
38033|NCT03964532|Breast Cancer|breast cancer
38034|NCT03964532|Advanced Breast Cancer|advanced breast cancer
38035|NCT03964532|Talazoparib|talazoparib
38036|NCT03964532|Avelumab|avelumab
38037|NCT03964519|velocity loss|velocity loss
38038|NCT03964519|Tensiomiography|tensiomiography
38039|NCT03964519|resistance training|resistance training
38040|NCT03964506|Allogeneic transplant|allogeneic transplant
38041|NCT03964506|Hyperbaric Oxygen|hyperbaric oxygen
38042|NCT03964493|TNP-2092|tnp-2092
38044|NCT03964493|Safety|safety
38046|NCT03964493|Efficacy|efficacy
38047|NCT03964480|Peripheral T-Cell Lymphoma|peripheral t-cell lymphoma
38048|NCT03964480|Prognosis|prognosis
38049|NCT03964480|Outcome|outcome
38050|NCT03964480|Biological Characteristics|biological characteristics
38051|NCT03964480|Heterogeneity|heterogeneity
38052|NCT03964480|Rare Diseases|rare diseases
38053|NCT03964467|stroke|stroke
38054|NCT03964467|upper extremity|upper extremity
38055|NCT03964467|intervention|intervention
38056|NCT03964467|transcranial direct current stimulation|transcranial direct current stimulation
50940|NCT03884140|FNAC|fnac
38057|NCT03964467|actigraph|actigraph
38058|NCT03964467|fMRI|fmri
38059|NCT03964454|Breastfeeding duration|breastfeeding duration
38060|NCT03964454|WIC|wic
38061|NCT03964454|low-income|low-income
38062|NCT03964454|health incentives|health incentives
38063|NCT03964428|periodontitis|periodontitis
38064|NCT03964428|ferritin|ferritin
38065|NCT03964428|hepicidin|hepicidin
38066|NCT03964428|type 2 diabetes mellitus|type 2 diabetes mellitus
38067|NCT03964428|non surgical perioontal therapy|non surgical perioontal therapy
38068|NCT03964402|sample size, survival, randomized clinical trials, statistical test|sample size, survival, randomized clinical trials, statistical test
38069|NCT03964389|Central Nervous System Sensitization|central nervous system sensitization
38070|NCT03964389|kinesiophobia|kinesiophobia
38071|NCT03964376|Sleep Apnea|sleep apnea
38072|NCT03964363|Frailty|frailty
38073|NCT03964363|preoperative period|preoperative period
38074|NCT03964363|surgery|surgery
38075|NCT03964363|breathing exercise|breathing exercise
38076|NCT03964363|postoperative complications|postoperative complications
38077|NCT03964363|resistance training|resistance training
38078|NCT03964363|endurance training|endurance training
38079|NCT03964363|anaesthesia|anaesthesia
38080|NCT03964363|activities of daily living|activities of daily living
38081|NCT03964363|patient reported outcome|patient reported outcome
38082|NCT03964363|prehabilitation|prehabilitation
38083|NCT03964363|perioperative care|perioperative care
38084|NCT03964363|elderly|elderly
38085|NCT03964363|prevention|prevention
38086|NCT03964285|Rumination|rumination
38087|NCT03964285|Fibromyalgia|fibromyalgia
38088|NCT03964285|Chronic Pain|chronic pain
38089|NCT03964285|affectivity|affectivity
38090|NCT03964285|repetitive negative thinking|repetitive negative thinking
38091|NCT03964272|MRgFUS|mrgfus
38092|NCT03964272|ExAblate|exablate
38093|NCT03964272|Parkinsons Disease|parkinsons disease
38094|NCT03964272|Sub-Thalamotomy|sub-thalamotomy
38095|NCT03964259|High Dose Methotrexate|high dose methotrexate
38096|NCT03964259|HDMTX|hdmtx
38097|NCT03964259|Intravenous Fluids|intravenous fluids
38098|NCT03964246|Feasibility Studies|feasibility studies
38099|NCT03964246|Meditation, psychology|meditation, psychology
38100|NCT03964155|Acute Respiratory Distress Syndrome|acute respiratory distress syndrome
38101|NCT03964155|Inhaled Sedation with Sevoflurane|inhaled sedation with sevoflurane
38102|NCT03964155|Biological collection|biological collection
38103|NCT03964142|Chemotherapy|chemotherapy
38104|NCT03964142|Anthracyclines|anthracyclines
38105|NCT03964142|Trastuzumab|trastuzumab
38106|NCT03964142|Pertuzumab|pertuzumab
38107|NCT03964142|Antibodies, Monoclonal, Humanized|antibodies, monoclonal, humanized
38108|NCT03964142|Breast Cancer|breast cancer
38109|NCT03964142|Exercise therapy|exercise therapy
38110|NCT03964090|Tyrosine Kinase Inhibitor|tyrosine kinase inhibitor
38111|NCT03964090|Lymphoma in Brain and CNS|lymphoma in brain and cns
38112|NCT03964090|ABC DLBCL|abc dlbcl
38113|NCT03964090|Diffuse Large B-Cell Lymphomas in CNS|diffuse large b-cell lymphomas in cns
38114|NCT03964077|Neurogenic Bladder|neurogenic bladder
38115|NCT03964077|Quality of life|quality of life
38116|NCT03964077|Spinal Cord Injury|spinal cord injury
38117|NCT03964064|Pancreatic Cancer Non-resectable|pancreatic cancer non-resectable
38118|NCT03964064|I125 seed implantation|i125 seed implantation
38119|NCT03964064|Stereotactic radiotherapy|stereotactic radiotherapy
38120|NCT03964051|Omalizumab|omalizumab
38121|NCT03964051|Xolair|xolair
38122|NCT03964051|Anaphylaxis|anaphylaxis
38123|NCT03964038|gilteritinib|gilteritinib
38124|NCT03964038|ASP2215|asp2215
38125|NCT03964038|Healthy volunteer|healthy volunteer
38126|NCT03964025|Holter Monitor|holter monitor
38127|NCT03964025|ECG Monitor|ecg monitor
38128|NCT03964025|Cardioskin|cardioskin
38129|NCT03964012|Neisseria meningitidis|neisseria meningitidis
38130|NCT03964012|conjugate meningococcal vaccine|conjugate meningococcal vaccine
38131|NCT03964012|Meningococcal serogroup X|meningococcal serogroup x
38132|NCT03963999|Ultrasound Elastography|ultrasound elastography
38133|NCT03963986|Regular physical activity|regular physical activity
38134|NCT03963934|Nurse-led management|nurse-led management
38135|NCT03963934|Home blood pressure|home blood pressure
38136|NCT03963934|Nurse-led telephone follow-up|nurse-led telephone follow-up
38137|NCT03963921|NASH|nash
38138|NCT03963908|chronic pain|chronic pain
38139|NCT03963908|stage of change|stage of change
38140|NCT03963908|pain self management|pain self management
38141|NCT03963908|mobile applications|mobile applications
38142|NCT03963908|Transtheoretical Model|transtheoretical model
38143|NCT03963895|Hemodialysis|hemodialysis
38144|NCT03963843|spinal cord injuries|spinal cord injuries
38145|NCT03963843|anxiety|anxiety
38146|NCT03963843|depression|depression
38147|NCT03963843|internet-delivered cognitive behaviour therapy|internet-delivered cognitive behaviour therapy
38148|NCT03963817|Imaging|imaging
38149|NCT03963817|Autofluorescence imaging|autofluorescence imaging
400502|NCT01866592|Vascular Inflammation|vascular inflammation
38150|NCT03963817|Spectral domain optical coherence tomography|spectral domain optical coherence tomography
38151|NCT03963817|Adaptive optics|adaptive optics
38152|NCT03963817|Soft drusen|soft drusen
38153|NCT03963817|Reticular pseudodrusen|reticular pseudodrusen
38154|NCT03963804|Concussion|concussion
38155|NCT03963804|Mild Traumatic Brain Injury|mild traumatic brain injury
38156|NCT03963804|Sport Related Concussion|sport related concussion
38157|NCT03963804|Non-Sport Related Concussion|non-sport related concussion
38158|NCT03963778|Malnourishment|malnourishment
38159|NCT03963778|Nutritional Deficiency|nutritional deficiency
38160|NCT03963778|Undernutrition|undernutrition
38161|NCT03963752|Idiopathic Precocious Puberty|idiopathic precocious puberty
38162|NCT03963752|Rapid Progressive|rapid progressive
38163|NCT03963752|Integrative Chinese and Western Medicine|integrative chinese and western medicine
38164|NCT03963752|Evidence-based Medicine|evidence-based medicine
38165|NCT03963739|Prostate|prostate
38166|NCT03963739|Adenocarcinoma|adenocarcinoma
38167|NCT03963726|Radiotherapy|radiotherapy
38168|NCT03963726|microwave ablation|microwave ablation
38169|NCT03963726|Liver Metastases|liver metastases
38170|NCT03963726|Colorectal Cancer|colorectal cancer
38171|NCT03963713|Stereotactic radiotherapy|stereotactic radiotherapy
38172|NCT03963713|Intensity modulated radiotherapy|intensity modulated radiotherapy
38173|NCT03963713|spinal metastatic tumors|spinal metastatic tumors
38174|NCT03963687|genomics|genomics
38175|NCT03963687|genetics|genetics
38176|NCT03963687|nursing education|nursing education
38177|NCT03963687|web-based|web-based
38178|NCT03963674|Neuromuscular response|neuromuscular response
38179|NCT03963674|diacutaneous fibrolysis|diacutaneous fibrolysis
38180|NCT03963661|Telerehabilitation|telerehabilitation
38181|NCT03963661|Spatial neglect|spatial neglect
38182|NCT03963661|SIGHT|sight
38183|NCT03963661|Computorized therapy|computorized therapy
38184|NCT03963661|Stroke|stroke
38185|NCT03963661|Innatention|innatention
38186|NCT03963661|Self-admnistered therapy|self-admnistered therapy
38187|NCT03963661|Usability|usability
38188|NCT03963635|Lyme Disease|lyme disease
38189|NCT03963635|Borrelia burgdorferi|borrelia burgdorferi
38190|NCT03963635|Antibody Secreting Cells|antibody secreting cells
38191|NCT03963635|Diagnostics|diagnostics
38192|NCT03963635|Early Diagnosis|early diagnosis
38193|NCT03963635|Treatment Outcome|treatment outcome
38194|NCT03963635|Health Volunteers|health volunteers
38195|NCT03963635|Adult|adult
38196|NCT03963622|Ventilation|ventilation
38197|NCT03963622|ARDS|ards
38198|NCT03963622|Esophageal manometry|esophageal manometry
38199|NCT03963622|Airway closure|airway closure
38200|NCT03963622|Lung recruitment|lung recruitment
38201|NCT03963609|chronic stable angina|chronic stable angina
38202|NCT03963609|multislice CT|multislice ct
38203|NCT03963609|remodeling index|remodeling index
38204|NCT03963596|fundus diseases|fundus diseases
38205|NCT03963596|antiangiogenic therapy|antiangiogenic therapy
38206|NCT03963596|choroidal neovascularization|choroidal neovascularization
38207|NCT03963596|pathologyc myopia|pathologyc myopia
38208|NCT03963596|intravitreal injection|intravitreal injection
38209|NCT03963596|anti-VEGF|anti-vegf
38210|NCT03963583|Heart Failure|heart failure
38211|NCT03963583|Caregivers|caregivers
38212|NCT03963583|Resilience|resilience
38213|NCT03963583|Preventive Health Behaviors|preventive health behaviors
38214|NCT03963570|Accidental Falls|accidental falls
38215|NCT03963570|Prevention and control|prevention and control
38216|NCT03963570|Exercise|exercise
38217|NCT03963570|Exercise therapy/methods*|exercise therapy/methods*
38218|NCT03963570|Aged|aged
38219|NCT03963570|Aged 80 and over|aged 80 and over
38220|NCT03963570|Smartphone|smartphone
38221|NCT03963570|Computers handheld|computers handheld
38222|NCT03963570|Motivation|motivation
38223|NCT03963570|Behaviour change|behaviour change
38224|NCT03963570|Postural balance|postural balance
38225|NCT03963570|Health behaviour|health behaviour
38226|NCT03963570|mHealth|mhealth
38227|NCT03963570|eHealth|ehealth
38228|NCT03963570|Digital health|digital health
38229|NCT03963570|Self-management|self-management
38230|NCT03963518|cancer|cancer
38231|NCT03963518|trial|trial
38232|NCT03963518|immune-checkpoint inhibitors|immune-checkpoint inhibitors
38233|NCT03963518|meta-analysis|meta-analysis
38234|NCT03963492|Walking|walking
38235|NCT03963492|Gait|gait
38236|NCT03963492|Fatigue|fatigue
38237|NCT03963466|Melasma|melasma
38238|NCT03963466|1064-nm Q-Switched Fractional Laser|1064-nm q-switched fractional laser
38239|NCT03963466|Tranexamic acid (TA)|tranexamic acid (ta)
38240|NCT03963466|Treatment|treatment
38241|NCT03963453|Physical Therapy Modalities|physical therapy modalities
38242|NCT03963453|Exercise|exercise
38243|NCT03963453|Physical Activity|physical activity
38244|NCT03963453|Exercise Program|exercise program
38245|NCT03963453|Muscular Dystrophy, Duchenne|muscular dystrophy, duchenne
38246|NCT03963440|Chronic low back pain|chronic low back pain
812393|NCT00198328|cancer|cancer
38247|NCT03963440|Physical activity|physical activity
38248|NCT03963440|Questionnaire|questionnaire
38249|NCT03963440|Adhesion|adhesion
38250|NCT03963427|breast reconstruction|breast reconstruction
38251|NCT03963427|plastic surgery|plastic surgery
38252|NCT03963427|microsurgery|microsurgery
38253|NCT03963414|Extensive stage small cell lung cancer|extensive stage small cell lung cancer
38254|NCT03963401|Spondyloarthritis|spondyloarthritis
38255|NCT03963388|Speech therapy|speech therapy
38256|NCT03963388|Telerehabilitation|telerehabilitation
38257|NCT03963388|Quality of life|quality of life
38258|NCT03963362|GLA5PR|gla5pr
38259|NCT03963362|Renal function|renal function
38260|NCT03963362|Pharmacokinetics|pharmacokinetics
38261|NCT03963362|Pregabalin|pregabalin
38262|NCT03963336|IIH|iih
38263|NCT03963336|D-dimer|d-dimer
38264|NCT03963336|microthrombi|microthrombi
38265|NCT03963336|anticoagulation|anticoagulation
38266|NCT03963271|idiopathic ventricular fibrillation|idiopathic ventricular fibrillation
38267|NCT03963271|polymorphic ventricular tachycardia|polymorphic ventricular tachycardia
38268|NCT03963271|body surface potential mapping|body surface potential mapping
38269|NCT03963271|ECG Imaging|ecg imaging
38270|NCT03963258|Whole-Body vibration|whole-body vibration
38271|NCT03963258|Stroke|stroke
38272|NCT03963258|Hemiplegia|hemiplegia
38273|NCT03963258|upper extremity|upper extremity
38274|NCT03963258|Rehabilitation training|rehabilitation training
38275|NCT03963258|Muscular surface EMG|muscular surface emg
38276|NCT03963258|Vibration training|vibration training
38277|NCT03963245|Psychiatric Disabilities|psychiatric disabilities
38278|NCT03963245|Rehabilitation|rehabilitation
38279|NCT03963245|Recovery|recovery
38280|NCT03963245|Occupational therapy|occupational therapy
38281|NCT03963245|Peer-support|peer-support
38282|NCT03963232|prevention|prevention
38283|NCT03963232|prophylactic|prophylactic
38284|NCT03963219|Type 1 Diabetes Mellitus|type 1 diabetes mellitus
38285|NCT03963206|Hepatocellular carcinoma|hepatocellular carcinoma
38286|NCT03963206|Cabozantinib|cabozantinib
38288|NCT03963167|Adherence|adherence
38289|NCT03963167|HRQoL determinants|hrqol determinants
38290|NCT03963128|Vitamin D|vitamin d
38291|NCT03963128|Royal Marines|royal marines
38292|NCT03963128|Military Training|military training
38293|NCT03963128|Illness|illness
38294|NCT03963115|Large local reaction|large local reaction
38295|NCT03963115|adrenaline, epinephrine|adrenaline, epinephrine
38296|NCT03963102|photodynamic therapy|photodynamic therapy
38297|NCT03963089|Fluid Therapy|fluid therapy
38298|NCT03963089|Hemodynamic Monitoring|hemodynamic monitoring
38299|NCT03963050|Frailty phenotype|frailty phenotype
38300|NCT03963050|Cognitive Impairment|cognitive impairment
38301|NCT03963050|Sarcopenia|sarcopenia
38302|NCT03963050|Exercise|exercise
38303|NCT03963037|Apolipoprotein B|apolipoprotein b
38304|NCT03963037|Cholesterol|cholesterol
38305|NCT03963037|Lipoprotein|lipoprotein
38306|NCT03963037|Metabolism|metabolism
38307|NCT03963037|Steatosis|steatosis
38308|NCT03963037|Cirrhosis|cirrhosis
38309|NCT03963037|Hepatocellular Carcinoma|hepatocellular carcinoma
38310|NCT03963011|NEC|nec
38311|NCT03963011|Necrotizing Enterocolitis|necrotizing enterocolitis
38312|NCT03963011|Premature Infant|premature infant
38313|NCT03963011|Calprotectin|calprotectin
38314|NCT03962998|Gut permeability|gut permeability
38315|NCT03962998|Intestinal permeability|intestinal permeability
38316|NCT03962998|MB-102|mb-102
38317|NCT03962959|Mild Cognitive Impairment|mild cognitive impairment
38318|NCT03962959|Transcranial Magnetic Stimulation|transcranial magnetic stimulation
38319|NCT03962946|Adolfsson-score|adolfsson-score
38320|NCT03962946|Suhm Score|suhm score
38321|NCT03962881|Hepatitis B Vaccine|hepatitis b vaccine
38322|NCT03962881|Randomized Controlled Trial|randomized controlled trial
38323|NCT03962881|Chronic Kidney Disease Population|chronic kidney disease population
38324|NCT03962881|Immunogenicity|immunogenicity
38325|NCT03962881|Long-term Immune Response|long-term immune response
38326|NCT03962868|Colonic Polyp|colonic polyp
38327|NCT03962868|large non pedunculated|large non pedunculated
38328|NCT03962868|colonic adenoma|colonic adenoma
38329|NCT03962868|Endoscopic submucosal dissection|endoscopic submucosal dissection
38330|NCT03962868|Endoscopic Mucosal Resection|endoscopic mucosal resection
38331|NCT03962842|spine|spine
38332|NCT03962842|extensibility|extensibility
38333|NCT03962842|children|children
38334|NCT03962842|pilates|pilates
38335|NCT03962842|exercise|exercise
38336|NCT03962842|health|health
38337|NCT03962842|physical activity|physical activity
38338|NCT03962842|physical education|physical education
38339|NCT03962816|Hepatitis B Vaccine|hepatitis b vaccine
38340|NCT03962816|Randomized Controlled Trial|randomized controlled trial
38341|NCT03962816|Methadone Maintenance Treatment Patients|methadone maintenance treatment patients
38342|NCT03962816|Immunogenicity|immunogenicity
38343|NCT03962816|Long-term Immune Response|long-term immune response
38344|NCT03962803|Hepatitis B Vaccine|hepatitis b vaccine
813491|NCT00190580|CKD|ckd
38345|NCT03962803|Randomized Controlled Trial|randomized controlled trial
38346|NCT03962803|HIV-Infected Patients|hiv-infected patients
38347|NCT03962803|Immunogenicity|immunogenicity
38348|NCT03962803|Long-term Immune Response|long-term immune response
38349|NCT03962777|gingivitis|gingivitis
38350|NCT03962777|oil pulling|oil pulling
38351|NCT03962725|Neuromuscular Blocker Avoidance|neuromuscular blocker avoidance
38352|NCT03962725|Post Operative Pulmonary Complications|post operative pulmonary complications
38353|NCT03962725|General Anesthesia Maintenance|general anesthesia maintenance
38354|NCT03962725|Inhaled Anesthetics|inhaled anesthetics
38355|NCT03962712|obesity|obesity
38356|NCT03962712|overweight|overweight
38357|NCT03962712|food insecurity|food insecurity
38358|NCT03962712|food assistance program|food assistance program
38359|NCT03962712|minimum wage|minimum wage
38360|NCT03962699|sperm|sperm
38361|NCT03962699|Epigenetic|epigenetic
38362|NCT03962699|RNA|rna
38363|NCT03962673|Phototherapy|phototherapy
38364|NCT03962673|Microbiome|microbiome
38365|NCT03962673|Vitamin D|vitamin d
38366|NCT03962634|Cavities|cavities
38367|NCT03962621|Facial rejuvenation, Erbium: YAG Laser, 1064 nm laser, skin aging|facial rejuvenation, erbium: yag laser, 1064 nm laser, skin aging
38368|NCT03962569|Artificial Urinary Sphincter|artificial urinary sphincter
38369|NCT03962556|trigger point,myofacial pain|trigger point,myofacial pain
38370|NCT03962543|Neurofibromatoses|neurofibromatoses
38371|NCT03962543|Neurofibromatosis 1|neurofibromatosis 1
38372|NCT03962543|Plexiform Neurofibroma|plexiform neurofibroma
38373|NCT03962543|PD-0325901|pd-0325901
38374|NCT03962543|MEK Inhibitor|mek inhibitor
38375|NCT03962543|Neurofibroma|neurofibroma
38376|NCT03962504|PTSD|ptsd
38377|NCT03962504|psychosocial treatment|psychosocial treatment
38378|NCT03962504|cognitive behavioral treatment|cognitive behavioral treatment
38379|NCT03962504|veterans|veterans
38380|NCT03962504|quality of life|quality of life
38381|NCT03962452|Rare Diseases|rare diseases
38382|NCT03962452|Genetic Predisposition|genetic predisposition
38383|NCT03962452|Epigenetic variation|epigenetic variation
38384|NCT03962452|Omics|omics
38385|NCT03962452|Genetic variation|genetic variation
38386|NCT03962452|Mitochondrial disease|mitochondrial disease
38387|NCT03962452|Next Generation Sequencing (NGS)|next generation sequencing (ngs)
38388|NCT03962439|Aging|aging
38389|NCT03962439|Cognition|cognition
38390|NCT03962439|Alzheimer's Disease|alzheimer's disease
38391|NCT03962439|Memory|memory
38392|NCT03962439|Engagement|engagement
38393|NCT03962439|Digital Photography|digital photography
38394|NCT03962439|Older Adults|older adults
38395|NCT03962439|Neural Function|neural function
38396|NCT03962439|Neuroimaging|neuroimaging
38397|NCT03962439|Active Learning|active learning
38398|NCT03962413|Endoscopic Approaches To Maxillary Sinus|endoscopic approaches to maxillary sinus
38399|NCT03962400|warfarin|warfarin
38400|NCT03962361|Cardiac Sudden Death|cardiac sudden death
38897|NCT03959475|GP medicine|gp medicine
38401|NCT03962361|Hypoxia Brain|hypoxia brain
38402|NCT03962361|Biomarkers|biomarkers
38403|NCT03962361|Cell-Derived Microparticles|cell-derived microparticles
38404|NCT03962335|Gut microbiota|gut microbiota
38405|NCT03962335|Mediterranean diet|mediterranean diet
38406|NCT03962335|Vegetarian diet|vegetarian diet
38407|NCT03962335|Short chain fatty acids|short chain fatty acids
38408|NCT03962322|Diaphragmatic Tissue Doppler|diaphragmatic tissue doppler
38409|NCT03962322|Weaning|weaning
38410|NCT03962322|Mechanical ventilation|mechanical ventilation
38411|NCT03962309|Screening|screening
38412|NCT03962309|General Practice|general practice
38413|NCT03962309|Self Assessment|self assessment
38414|NCT03962309|Algorithms for risk stratification|algorithms for risk stratification
38415|NCT03962296|Diabetic retinopathy, hard exudates|diabetic retinopathy, hard exudates
38416|NCT03962270|Extracorporeal Shock Wave Therapy|extracorporeal shock wave therapy
38417|NCT03962270|Knee Osteoarthritis|knee osteoarthritis
38418|NCT03962270|Cartilage Injury|cartilage injury
38419|NCT03962257|Patient education|patient education
38420|NCT03962244|Esophagectomy, Esophageal Cancer, Vacuum therapy, Stents|esophagectomy, esophageal cancer, vacuum therapy, stents
38421|NCT03962231|Treatment|treatment
38422|NCT03962231|Physiotherapy|physiotherapy
38423|NCT03962231|Impingement Syndrome|impingement syndrome
38424|NCT03962218|spinal cord injury|spinal cord injury
38425|NCT03962218|Hydrotherapy|hydrotherapy
38426|NCT03962218|Balance|balance
38427|NCT03962218|Gait|gait
38428|NCT03962205|obese patients|obese patients
38429|NCT03962205|psychological well being|psychological well being
38430|NCT03962205|weight loss|weight loss
38431|NCT03962205|depression|depression
38432|NCT03962205|psychological distress|psychological distress
38433|NCT03962205|life-style intervention|life-style intervention
38434|NCT03962205|demoralization|demoralization
38435|NCT03962179|Perforation Esophagus, Esophageal Anastomotic Leak,|perforation esophagus, esophageal anastomotic leak,
38436|NCT03962166|atrial fibrillation|atrial fibrillation
38437|NCT03962166|left ventricular diastolic dysfunction|left ventricular diastolic dysfunction
51483|NCT03880578|QoL|qol
38438|NCT03962166|electrocardiogram|electrocardiogram
38439|NCT03962166|signal processed surface ECG|signal processed surface ecg
38440|NCT03962166|wavECG|wavecg
38441|NCT03962166|transthoracic echocardiography|transthoracic echocardiography
38442|NCT03962153|fetal growth|fetal growth
38443|NCT03962153|ultrasonographic parameters|ultrasonographic parameters
38444|NCT03962140|Endometrial Cancer|endometrial cancer
38445|NCT03962140|CT-scan|ct-scan
38446|NCT03962140|Fat distribution|fat distribution
38447|NCT03962140|Obesity|obesity
38448|NCT03962140|Sarcopenia|sarcopenia
38449|NCT03962127|Cardiovascular risk factors|cardiovascular risk factors
38450|NCT03962127|Risk Assessment|risk assessment
38451|NCT03962127|Severity of Illness Index|severity of illness index
38452|NCT03962127|Mortality|mortality
38453|NCT03962127|Recurrent stroke|recurrent stroke
38454|NCT03962127|Health-related quality of life|health-related quality of life
38455|NCT03962127|modified Rankin scale|modified rankin scale
38456|NCT03962127|NIHSS|nihss
38457|NCT03962127|Fatigue severity score|fatigue severity score
38458|NCT03962127|Hospital anxiety and depression scale|hospital anxiety and depression scale
38459|NCT03962127|Montreal cognitive assessment|montreal cognitive assessment
38460|NCT03962114|Ataxia Telangiectasia|ataxia telangiectasia
38461|NCT03962114|ATM Gene Mutation|atm gene mutation
38462|NCT03962114|ATM protein|atm protein
38463|NCT03962114|Nicotinamide riboside|nicotinamide riboside
38464|NCT03962049|Linzagolix|linzagolix
38465|NCT03962049|OBE2109|obe2109
38466|NCT03962049|Hepatic Impairment|hepatic impairment
38467|NCT03962049|Hepatic Insufficiency|hepatic insufficiency
38468|NCT03962049|Liver Diseases|liver diseases
38469|NCT03962049|Clinical pharmacology study|clinical pharmacology study
38470|NCT03962023|Mitral Valve Insufficiency|mitral valve insufficiency
38471|NCT03962023|Imagery|imagery
38472|NCT03962023|Prognosis|prognosis
38473|NCT03961997|Cytochrome P-450 CYP3A Inhibitors/metabolism|cytochrome p-450 cyp3a inhibitors/metabolism
38474|NCT03961997|Cytochrome P-450 CYP3A Inhibitors/adverse effects|cytochrome p-450 cyp3a inhibitors/adverse effects
38475|NCT03961997|Cytochrome P-450 CYP3A Inhibitors/pharmacokinetics|cytochrome p-450 cyp3a inhibitors/pharmacokinetics
38476|NCT03961997|Cytochrome P-450 CYP3A Inhibitors/pharmacology|cytochrome p-450 cyp3a inhibitors/pharmacology
38477|NCT03961997|Modafinil/adverse effects|modafinil/adverse effects
38478|NCT03961997|Modafinil/pharmacokinetics|modafinil/pharmacokinetics
38479|NCT03961997|Modafinil/pharmacology|modafinil/pharmacology
38480|NCT03961984|anal fistula|anal fistula
38481|NCT03961984|fistula-in-ano|fistula-in-ano
38482|NCT03961984|surgical plug|surgical plug
38483|NCT03961984|collagen plug|collagen plug
38484|NCT03961984|complex anal fistula|complex anal fistula
38485|NCT03961984|transsphincteric anal fistula|transsphincteric anal fistula
38486|NCT03961971|Immunotherapy|immunotherapy
38487|NCT03961958|Hemodynamics|hemodynamics
38488|NCT03961958|Knee-Chest Position|knee-chest position
38489|NCT03961958|Propofol|propofol
38490|NCT03961958|Anesthesia, General|anesthesia, general
38491|NCT03961958|Anesthetics, Intravenous|anesthetics, intravenous
38492|NCT03961958|pharmacokinetics|pharmacokinetics
38493|NCT03961945|Barrett's Esophagus|barrett's esophagus
38494|NCT03961945|Gastroesophageal Reflux|gastroesophageal reflux
38495|NCT03961945|Reflux|reflux
38496|NCT03961945|Esophageal Cancer|esophageal cancer
38497|NCT03961945|Esophageal Adenocarcinoma|esophageal adenocarcinoma
38498|NCT03961932|Linzagolix|linzagolix
38499|NCT03961932|OBE2109|obe2109
38500|NCT03961932|Renal impairment|renal impairment
38501|NCT03961932|Renal Insufficiency|renal insufficiency
38502|NCT03961932|Kidney Diseases|kidney diseases
38503|NCT03961932|Clinical pharmacology study|clinical pharmacology study
38504|NCT03961893|colonoscopy|colonoscopy
38505|NCT03961893|g-eye|g-eye
38506|NCT03961893|adenomas|adenomas
38507|NCT03961854|probiotics|probiotics
38508|NCT03961854|genetics|genetics
38509|NCT03961802|Rehabilitation|rehabilitation
38510|NCT03961802|shoulder dysfunction|shoulder dysfunction
38511|NCT03961802|cervical lymph node dissection|cervical lymph node dissection
38512|NCT03961802|head and neck cancer|head and neck cancer
38513|NCT03961789|Opioid-Related Disorders|opioid-related disorders
38514|NCT03961789|Opiate replacement therapy|opiate replacement therapy
38515|NCT03961789|Community Pharmacy Services|community pharmacy services
38516|NCT03961789|Patient Satisfaction|patient satisfaction
38517|NCT03961776|Diffusion weighted imaging|diffusion weighted imaging
38518|NCT03961776|Radiation therapy|radiation therapy
38519|NCT03961763|omega-3|omega-3
38521|NCT03961763|DHA|dha
38522|NCT03961763|sdLDL|sdldl
38523|NCT03961763|cardiovascular disease|cardiovascular disease
38524|NCT03961763|hyperlipidemia|hyperlipidemia
38525|NCT03961763|dyslipidemia|dyslipidemia
38526|NCT03961750|Older Adult|older adult
38527|NCT03961750|OTAGO|otago
38528|NCT03961750|Student led|student led
38529|NCT03961737|radiotherapy|radiotherapy
38530|NCT03961737|explants|explants
38531|NCT03961737|transcriptomic|transcriptomic
813690|NCT00189800|Solifenacin|solifenacin
38532|NCT03961737|immunohistochemistry|immunohistochemistry
38533|NCT03961698|Phase 2|phase 2
38534|NCT03961698|PI3K|pi3k
38535|NCT03961698|IPI-549|ipi-549
38536|NCT03961698|Advanced Solid Tumor|advanced solid tumor
38537|NCT03961698|Triple Negative Breast Cancer (TNBC)|triple negative breast cancer (tnbc)
38538|NCT03961698|Renal Cell Carcinoma (RCC)|renal cell carcinoma (rcc)
38539|NCT03961698|PD-L1|pd-l1
38540|NCT03961698|Myeloid-Derived Suppressor Cells (MDSCs)|myeloid-derived suppressor cells (mdscs)
38541|NCT03961698|Front-Line Treatment|front-line treatment
38542|NCT03961659|Functional MRI|functional mri
38543|NCT03961659|Olfactory function|olfactory function
38544|NCT03961659|Liraglutid|liraglutid
38545|NCT03961659|Dapagliflozin|dapagliflozin
38546|NCT03961659|Acarbose|acarbose
38547|NCT03961620|perioperative hypothermia|perioperative hypothermia
38548|NCT03961620|core temperature|core temperature
38549|NCT03961620|perioperative normothermia|perioperative normothermia
38550|NCT03961607|Photodynamic Therapy|photodynamic therapy
38551|NCT03961607|Conventional|conventional
38552|NCT03961607|Painless|painless
38553|NCT03961607|Acne|acne
38554|NCT03961568|Idiopathic Generalized Epilepsy|idiopathic generalized epilepsy
38555|NCT03961555|Post-exposure prophylaxis of Rabies|post-exposure prophylaxis of rabies
38556|NCT03961516|continuous glucose monitor|continuous glucose monitor
38557|NCT03961516|cystic fibrosis|cystic fibrosis
38558|NCT03961516|cystic fibrosis related diabetes|cystic fibrosis related diabetes
38559|NCT03961503|Vancomycin|vancomycin
38560|NCT03961503|Daptomycin|daptomycin
38561|NCT03961503|Acute Kidney Injury|acute kidney injury
38562|NCT03961503|Nephrotoxicity|nephrotoxicity
38563|NCT03961503|Infective Endocarditis|infective endocarditis
38564|NCT03961503|Foreign Body Associated Infection|foreign body associated infection
38565|NCT03961503|Cardiovascular surgery|cardiovascular surgery
38566|NCT03961477|Low Back Pain,|low back pain,
38567|NCT03961477|Interferential Therapy|interferential therapy
38568|NCT03961477|Quality of Life|quality of life
38569|NCT03961464|Emotion processing|emotion processing
38570|NCT03961464|Autobiographical memory|autobiographical memory
38571|NCT03961464|Stress|stress
38572|NCT03961451|pedometer|pedometer
38573|NCT03961438|Neutralizing antibody responses|neutralizing antibody responses
38574|NCT03961438|Antibodies|antibodies
38575|NCT03961438|HIV-infection|hiv-infection
38576|NCT03961438|Vaccine|vaccine
38577|NCT03961386|prevention|prevention
38578|NCT03961347|probiotics|probiotics
38579|NCT03961347|genetics|genetics
38580|NCT03961321|SMART|smart
38581|NCT03961321|Prostate cancer|prostate cancer
38582|NCT03961321|SBRT|sbrt
38583|NCT03961321|MRgRT|mrgrt
38584|NCT03961321|Toxicity|toxicity
38585|NCT03961308|Drug therapy|drug therapy
38586|NCT03961295|Drug therapy|drug therapy
38587|NCT03961269|Breast cancer surgery|breast cancer surgery
38588|NCT03961269|Persistent pain|persistent pain
38589|NCT03961256|Kidney Transplant|kidney transplant
38590|NCT03961243|Hemophilia B|hemophilia b
38591|NCT03961243|factor IX|factor ix
38592|NCT03961243|Gene therapylentiviral vector|gene therapylentiviral vector
38593|NCT03961230|Psoriasis Vulgaris|psoriasis vulgaris
38594|NCT03961230|Jueyin granules|jueyin granules
38595|NCT03961230|Blood heat syndrome|blood heat syndrome
38596|NCT03961230|Randomized controlled trial|randomized controlled trial
38597|NCT03961217|Return to work|return to work
38598|NCT03961217|Disability pension|disability pension
38599|NCT03961217|Sickness Absence|sickness absence
38600|NCT03961217|Employability|employability
38601|NCT03961217|Fitness to work|fitness to work
38602|NCT03961217|Wellbeing|wellbeing
38603|NCT03961217|Radiotherapy Side Effect|radiotherapy side effect
38604|NCT03961217|Cancer Survivors|cancer survivors
38605|NCT03961204|Multiple Sclerosis|multiple sclerosis
38606|NCT03961204|Cladribine|cladribine
38607|NCT03961204|High Disease Activity|high disease activity
38608|NCT03961139|Prematurity|prematurity
38609|NCT03961139|Randomised control trial (RCT)|randomised control trial (rct)
38610|NCT03961139|BPD|bpd
38611|NCT03961139|CLD|cld
38612|NCT03961139|continuous feeding|continuous feeding
38613|NCT03961126|Vulvar Lichen Sclerosus|vulvar lichen sclerosus
38614|NCT03961126|Autologous Platelet-rich Plasma (PRP)|autologous platelet-rich plasma (prp)
38615|NCT03961113|Giant Cell Arteritis|giant cell arteritis
38616|NCT03961113|Dependency|dependency
38617|NCT03961113|Elderly|elderly
38618|NCT03961074|Iron Deficiency Anemia|iron deficiency anemia
38619|NCT03961074|iron supplements|iron supplements
38620|NCT03961074|Chinese pregnant women|chinese pregnant women
38621|NCT03961074|adverse maternal outcomes|adverse maternal outcomes
38622|NCT03961074|adverse neonatal outcome|adverse neonatal outcome
38623|NCT03961061|weight management|weight management
38624|NCT03961061|pediatric weight management|pediatric weight management
38625|NCT03961061|mHealth|mhealth
38626|NCT03961061|mobile technology|mobile technology
38627|NCT03961061|parent/child relations|parent/child relations
38628|NCT03961061|dyad|dyad
38629|NCT03961048|Erector Spinae|erector spinae
38630|NCT03961048|Cardiac Surgery|cardiac surgery
38631|NCT03961048|Regional Anesthesia|regional anesthesia
38632|NCT03961022|DOMS|doms
38633|NCT03961022|Fatigue rate|fatigue rate
38634|NCT03961022|Heart rate variability|heart rate variability
38635|NCT03961022|Pain|pain
38636|NCT03961022|Jump performance|jump performance
38637|NCT03961009|Immunoglobulin|immunoglobulin
38638|NCT03961009|Kedrion IVIg10%|kedrion ivig10%
38639|NCT03961009|IgG antibodies|igg antibodies
38640|NCT03961009|Agammaglobulinemia|agammaglobulinemia
38641|NCT03961009|Hypogammaglobulinemia|hypogammaglobulinemia
38642|NCT03960996|lacrimal duct obstruction|lacrimal duct obstruction
38643|NCT03960996|bicanalicular intubation|bicanalicular intubation
38644|NCT03960996|dacryocystorinostomy|dacryocystorinostomy
38645|NCT03960996|silicone stent|silicone stent
38646|NCT03960983|Halitosis|halitosis
38647|NCT03960983|photodynamic therapy|photodynamic therapy
38648|NCT03960983|elderly|elderly
38649|NCT03960983|denture|denture
38650|NCT03960970|Cesarean Delivery|cesarean delivery
38651|NCT03960970|Endometritis|endometritis
38652|NCT03960970|Wound Infection|wound infection
38653|NCT03960970|Azithromycin|azithromycin
38654|NCT03960970|Antibiotic Prophylaxis|antibiotic prophylaxis
38655|NCT03960931|Parkinson's disease|parkinson's disease
38656|NCT03960931|Non motor signs|non motor signs
38657|NCT03960931|Postural control|postural control
38658|NCT03960931|Gait|gait
38659|NCT03960931|Hydrophysiotherapy|hydrophysiotherapy
38660|NCT03960918|stroke|stroke
38661|NCT03960918|physical fitness|physical fitness
38662|NCT03960918|oxygen uptake efficiency slope (OUES)|oxygen uptake efficiency slope (oues)
38663|NCT03960892|Refugees|refugees
38664|NCT03960892|Mental Health|mental health
38665|NCT03960866|Open Angle Glaucoma|open angle glaucoma
38666|NCT03960866|Ocular Hypertension|ocular hypertension
38667|NCT03960853|aged|aged
38668|NCT03960853|mechanical ventilation,|mechanical ventilation,
38669|NCT03960840|CD19 CAR-T cells, CLL, SLL, ibrutinib, DLBCL|cd19 car-t cells, cll, sll, ibrutinib, dlbcl
38670|NCT03960801|Intubation|intubation
38671|NCT03960801|Remifentanil|remifentanil
38672|NCT03960801|neuromuscular blockade|neuromuscular blockade
38673|NCT03960801|succinylcholine|succinylcholine
38674|NCT03960801|Rocuronium|rocuronium
38675|NCT03960801|emergency anesthesia|emergency anesthesia
38676|NCT03960801|rapid sequence induction|rapid sequence induction
38677|NCT03960775|gastric cancer|gastric cancer
38678|NCT03960775|laparoscopic gastrectomy|laparoscopic gastrectomy
38679|NCT03960775|robotic gastrectomy|robotic gastrectomy
38680|NCT03960762|Video assisted thoracic surgery|video assisted thoracic surgery
38681|NCT03960762|Postoperative pain management|postoperative pain management
38682|NCT03960762|Erector spina plane block|erector spina plane block
38683|NCT03960762|Serratus anterior plane block|serratus anterior plane block
38684|NCT03960749|Lumbar puncture|lumbar puncture
38685|NCT03960749|Headache|headache
38686|NCT03960736|Video assisted thoracic surgery|video assisted thoracic surgery
38687|NCT03960736|Postoperative pain management|postoperative pain management
38688|NCT03960736|Erector spina plane block|erector spina plane block
38689|NCT03960736|Thoracic epidural analgesia|thoracic epidural analgesia
38690|NCT03960723|Informed consent|informed consent
38695|NCT03960567|Scoring systems|scoring systems
38696|NCT03960567|Larynx|larynx
38697|NCT03960554|Denosumab|denosumab
38698|NCT03960554|Bone density|bone density
38699|NCT03960554|Kidney transplant|kidney transplant
38700|NCT03960554|Prolia|prolia
38701|NCT03960541|HIV Dyslipidemias|hiv dyslipidemias
38702|NCT03960541|CD24Fc|cd24fc
38703|NCT03960541|HIV Chronic Inflammation|hiv chronic inflammation
38704|NCT03960541|LDL Reduction|ldl reduction
38705|NCT03960528|spine surgery|spine surgery
38706|NCT03960528|postoperative pain|postoperative pain
38707|NCT03960528|perioperative analgesia|perioperative analgesia
38708|NCT03960528|postoperative opioid requirement|postoperative opioid requirement
38709|NCT03960515|Rheumatoid Arthritis|rheumatoid arthritis
38710|NCT03960515|Heart disease|heart disease
38711|NCT03960515|Cardiovascular Risk|cardiovascular risk
38712|NCT03960502|Safety and tolerability|safety and tolerability
38713|NCT03960502|Pharmacokinetic study|pharmacokinetic study
38714|NCT03960489|Pharmacokinetics|pharmacokinetics
38715|NCT03960489|Tolerability|tolerability
38716|NCT03960489|Safety|safety
38717|NCT03960489|ASP1517|asp1517
38718|NCT03960489|Roxadustat|roxadustat
38719|NCT03960463|Infection|infection
38720|NCT03960463|Dehiscence|dehiscence
38721|NCT03960463|Necrotic tissue|necrotic tissue
38722|NCT03960463|Surgical Revision|surgical revision
38723|NCT03960463|Scar tissue|scar tissue
38724|NCT03960463|Wound Closure|wound closure
38725|NCT03960450|Psoriasis|psoriasis
38726|NCT03960450|BOS-475|bos-475
38727|NCT03960437|Kidney disease|kidney disease
38728|NCT03960437|Bone disease|bone disease
38729|NCT03960437|Etelcalcetide|etelcalcetide
38730|NCT03960437|Parsabiv|parsabiv
38731|NCT03960411|Doxycycline|doxycycline
38732|NCT03960411|Cardiac Remodelling|cardiac remodelling
51825|NCT03878303|SLE|sle
38733|NCT03960411|STEMI|stemi
38738|NCT03960385|Dengue|dengue
38739|NCT03960385|Dengvaxia|dengvaxia
38740|NCT03960385|Parana|parana
38741|NCT03960385|Sanofi Pasteur|sanofi pasteur
38742|NCT03960385|Vaccine Effectiveness|vaccine effectiveness
38743|NCT03960385|Maringa|maringa
38744|NCT03960385|Foz de Iguacu|foz de iguacu
38745|NCT03960385|Paranagua|paranagua
38746|NCT03960385|Brazil|brazil
38747|NCT03960372|Family|family
38748|NCT03960359|Asthma|asthma
38749|NCT03960359|wheeze|wheeze
38750|NCT03960359|preschool|preschool
38751|NCT03960359|phenotype|phenotype
38752|NCT03960333|Obesity|obesity
38753|NCT03960333|Type2 Diabetes Mellitus|type2 diabetes mellitus
38754|NCT03960333|Type2 Diabetes|type2 diabetes
38755|NCT03960333|Insulin Resistance|insulin resistance
38756|NCT03960333|Metformin|metformin
38757|NCT03960333|Pediatric Health|pediatric health
38758|NCT03960320|KINDL|kindl
38759|NCT03960320|SDQ|sdq
38760|NCT03960320|SF-36|sf-36
38761|NCT03960307|Glycocalyx|glycocalyx
38762|NCT03960307|PBR|pbr
38763|NCT03960307|microcirculation|microcirculation
38764|NCT03960294|Insomnia|insomnia
38765|NCT03960294|Adolescents|adolescents
38766|NCT03960294|Young Adults|young adults
38767|NCT03960268|Hidradenitis Suppurativa|hidradenitis suppurativa
38768|NCT03960268|Acne Inversa|acne inversa
38769|NCT03960268|Brodalumab|brodalumab
38770|NCT03960255|Adiposity|adiposity
38771|NCT03960255|Diabetic foot ulcer|diabetic foot ulcer
38772|NCT03960255|Anti-microbial resistance|anti-microbial resistance
38773|NCT03960229|microfluid chip|microfluid chip
38774|NCT03960229|gradient-density|gradient-density
38775|NCT03960229|IVF|ivf
38776|NCT03960229|male factor|male factor
38777|NCT03960203|Dascena|dascena
38778|NCT03960203|Patient mortality|patient mortality
38779|NCT03960203|Length of stay|length of stay
38780|NCT03960203|Readmissions|readmissions
38781|NCT03960203|Algorithm|algorithm
38782|NCT03960203|Diagnostic|diagnostic
38783|NCT03960203|Clinical outcomes|clinical outcomes
38784|NCT03960164|Acute skin lesion|acute skin lesion
38785|NCT03960164|Chronic skin ulcer|chronic skin ulcer
38786|NCT03960164|Traumatic skin lesion|traumatic skin lesion
38787|NCT03960164|Photosynthetic matrix|photosynthetic matrix
38788|NCT03960164|Photosynthesis induced regeneration|photosynthesis induced regeneration
38789|NCT03960164|Tissue regeneration|tissue regeneration
38790|NCT03960112|multiparametric MRI|multiparametric mri
38791|NCT03960112|cystoprostatectomy|cystoprostatectomy
38792|NCT03960047|children|children
38793|NCT03960047|crossing streets|crossing streets
38794|NCT03960047|training|training
38795|NCT03960034|Cachexia|cachexia
38796|NCT03960034|Skeletal Muscle Atrophy|skeletal muscle atrophy
38797|NCT03960034|Physical Functional Performance|physical functional performance
38798|NCT03960034|Prognosis|prognosis
38799|NCT03960021|Colo-rectal cancer|colo-rectal cancer
38800|NCT03960021|Lung metastasis|lung metastasis
38801|NCT03960021|Radiofrequency ablation|radiofrequency ablation
38802|NCT03960021|Tumor infiltrating lymphocytes|tumor infiltrating lymphocytes
38803|NCT03960021|Circulating tumor cells|circulating tumor cells
38804|NCT03960021|Circulating DNA|circulating dna
38805|NCT03960008|Hepatocellular Carcinoma (HCC)|hepatocellular carcinoma (hcc)
38806|NCT03960008|Liver transplant|liver transplant
38807|NCT03960008|Bridge to transplant|bridge to transplant
38808|NCT03960008|Stereotactic body radiation therapy (SBRT)|stereotactic body radiation therapy (sbrt)
38809|NCT03960008|Trans-arterial chemoembolization (TACE)|trans-arterial chemoembolization (tace)
38810|NCT03959956|Digital auscultation|digital auscultation
38811|NCT03959956|Pneumonia|pneumonia
38812|NCT03959956|Lung sounds|lung sounds
38813|NCT03959956|IMCI|imci
38814|NCT03959956|LMIC|lmic
38815|NCT03959943|Breast reconstruction|breast reconstruction
38816|NCT03959943|LTP flap|ltp flap
38817|NCT03959943|Sensory recovery|sensory recovery
38818|NCT03959943|Breast sensation|breast sensation
38819|NCT03959943|Nerve coaptation|nerve coaptation
38820|NCT03959917|prostate|prostate
38821|NCT03959917|resection|resection
38822|NCT03959917|incontinence|incontinence
38823|NCT03959917|erectile dysfunction|erectile dysfunction
38824|NCT03959891|Breast Cancer|breast cancer
38825|NCT03959878|Jejunostomy|jejunostomy
38826|NCT03959852|Moderate|moderate
38827|NCT03959852|Severe|severe
38828|NCT03959852|Pain|pain
38829|NCT03959839|Early Rectal Neoplasms|early rectal neoplasms
38830|NCT03959839|ESD|esd
38831|NCT03959839|TAMIS|tamis
38832|NCT03959839|TEO|teo
38833|NCT03959839|Recurrence|recurrence
38834|NCT03959839|R0|r0
38835|NCT03959839|Safety|safety
38836|NCT03959826|contingency management|contingency management
38837|NCT03959800|Hepatoblastoma|hepatoblastoma
38838|NCT03959800|Hepatocellular Carcinoma|hepatocellular carcinoma
38839|NCT03959800|Pediatric Liver Cancer|pediatric liver cancer
38840|NCT03959774|Elderly population|elderly population
38841|NCT03959774|digital monitoring|digital monitoring
38842|NCT03959761|Immunotherapy|immunotherapy
38843|NCT03959761|Debulking surgery|debulking surgery
38844|NCT03959761|Hyperthermic Intraperitoneal Chemotherapy (HIPEC)|hyperthermic intraperitoneal chemotherapy (hipec)
38845|NCT03959748|Pulmonary Hypertension,|pulmonary hypertension,
38846|NCT03959748|CTEPH|cteph
38847|NCT03959748|Pulmonary Arterial Hypertension|pulmonary arterial hypertension
38848|NCT03959748|Registry|registry
38849|NCT03959748|Data Base|data base
38850|NCT03959748|Polish patients|polish patients
38851|NCT03959735|inpatients|inpatients
38852|NCT03959722|Endurance athletes|endurance athletes
38853|NCT03959722|probiotics|probiotics
38854|NCT03959722|endurance exercise|endurance exercise
38855|NCT03959696|Shared Decision Making|shared decision making
38856|NCT03959696|Patient Reported Outcomes|patient reported outcomes
38857|NCT03959696|Continuing Medical Education|continuing medical education
38858|NCT03959696|early detection of cancer|early detection of cancer
38859|NCT03959696|colonoscopy|colonoscopy
38860|NCT03959696|colorectal cancer|colorectal cancer
38861|NCT03959644|unsuccessful spinal anesthesia|unsuccessful spinal anesthesia
38862|NCT03959631|Ischemic Heart Disease Virtual Community of Practice empowerment|ischemic heart disease virtual community of practice empowerment
38863|NCT03959618|dietary supplements|dietary supplements
38864|NCT03959618|Desmodium|desmodium
38865|NCT03959618|chemotherapy|chemotherapy
38866|NCT03959618|breast cancer|breast cancer
38867|NCT03959566|Tuberculosis, Pulmonary|tuberculosis, pulmonary
38868|NCT03959566|Sutezolid|sutezolid
38869|NCT03959566|Randomized Controlled Trial (RCT)|randomized controlled trial (rct)
38870|NCT03959566|PNU-100480|pnu-100480
38871|NCT03959566|Tuberculosis|tuberculosis
38872|NCT03959566|Antitubercular Agents|antitubercular agents
38873|NCT03959566|Gram-positive Bacterial Infections|gram-positive bacterial infections
38874|NCT03959566|Oxazolidinones|oxazolidinones
38875|NCT03959566|Dose-finding|dose-finding
38876|NCT03959566|Combination-evaluation|combination-evaluation
38877|NCT03959566|Safety|safety
38878|NCT03959566|Tolerability|tolerability
38879|NCT03959566|Pharmacokinetics (PK)|pharmacokinetics (pk)
38880|NCT03959566|Exposure-Response Relationship|exposure-response relationship
38881|NCT03959566|Bedaquiline|bedaquiline
38882|NCT03959566|Delamanid|delamanid
38883|NCT03959566|Moxifloxacin|moxifloxacin
38884|NCT03959566|Drug-sensitive TB|drug-sensitive tb
38885|NCT03959553|Alzheimer's Disease|alzheimer's disease
38886|NCT03959553|GV1001|gv1001
38887|NCT03959501|Type 2 diabetes|type 2 diabetes
38888|NCT03959501|Sodium glucose co-transporter 2 inhibitors|sodium glucose co-transporter 2 inhibitors
38889|NCT03959501|Ketones|ketones
38890|NCT03959488|Respiratory Syncytial Virus Infections|respiratory syncytial virus infections
38891|NCT03959488|Preterm Infants|preterm infants
38892|NCT03959488|Lower Respiratory Infection|lower respiratory infection
38893|NCT03959475|Elderly subject|elderly subject
38894|NCT03959475|healthcare|healthcare
38895|NCT03959475|Hotline|hotline
38896|NCT03959475|emergency department|emergency department
38898|NCT03959462|tDCS|tdcs
38899|NCT03959449|Motor imagery|motor imagery
38900|NCT03959449|Action observation|action observation
38901|NCT03959449|Hypoalgesia|hypoalgesia
38902|NCT03959410|hpv|hpv
38903|NCT03959410|cervical cancer|cervical cancer
38904|NCT03959410|microbiome|microbiome
39030|NCT03958435|Adjuvant therapy|adjuvant therapy
38905|NCT03959397|Breast cancer; neoadjuvant therapy; Nab-paclitaxel|breast cancer; neoadjuvant therapy; nab-paclitaxel
38906|NCT03959371|Myelofibrosis|myelofibrosis
38907|NCT03959371|Ruxolitinib|ruxolitinib
38908|NCT03959371|Real world data|real world data
38909|NCT03959319|clinical trial|clinical trial
38910|NCT03959319|rehabilitation|rehabilitation
38911|NCT03959319|joint mobilization|joint mobilization
38912|NCT03959319|movement training|movement training
38913|NCT03959306|Type 2 Diabetes Mellitus|type 2 diabetes mellitus
38914|NCT03959306|Black Seed Oil|black seed oil
38915|NCT03959306|Endothelial Dysfunction|endothelial dysfunction
38916|NCT03959280|obstructive sleep apnea|obstructive sleep apnea
38917|NCT03959280|CPAP therapy|cpap therapy
38918|NCT03959280|exercise|exercise
38919|NCT03959280|diet|diet
38920|NCT03959280|quality of life|quality of life
38921|NCT03959267|Latinas|latinas
38922|NCT03959267|Survivors|survivors
38923|NCT03959241|Acute Leukemia|acute leukemia
38924|NCT03959241|Chronic Myelogenous Leukemia (CML)|chronic myelogenous leukemia (cml)
38925|NCT03959241|Myelodysplasia (MDS)|myelodysplasia (mds)
38926|NCT03959241|Lymphoma|lymphoma
38927|NCT03959241|GVHD prophylaxis|gvhd prophylaxis
38928|NCT03959241|Acute GVHD|acute gvhd
38929|NCT03959215|Knee injuries|knee injuries
38930|NCT03959215|Anterior cruciate ligament injuries|anterior cruciate ligament injuries
38931|NCT03959215|Telemedicine|telemedicine
38932|NCT03959202|older adults|older adults
38933|NCT03959202|exercise intervention|exercise intervention
38934|NCT03959202|cognition|cognition
38935|NCT03959189|Excessive Daytime Sleepiness|excessive daytime sleepiness
38936|NCT03959189|hypersomnia|hypersomnia
38937|NCT03959176|Brimonidine|brimonidine
38938|NCT03959176|Pupil Effects|pupil effects
38939|NCT03959137|Treatment choice|treatment choice
38940|NCT03959124|magnetic resonance image|magnetic resonance image
38941|NCT03959098|Korean Medicine|korean medicine
38942|NCT03959098|Effectiveness|effectiveness
38943|NCT03959098|Neck Pain|neck pain
38944|NCT03959033|PROMs|proms
38945|NCT03959033|EORTC QLQc-30|eortc qlqc-30
38946|NCT03959007|Aesthetic care|aesthetic care
38947|NCT03959007|Transplant|transplant
38948|NCT03959007|Well-being|well-being
38949|NCT03959007|Anxiety|anxiety
38950|NCT03959007|Supportive care|supportive care
38951|NCT03958929|glaucoma surgery|glaucoma surgery
38952|NCT03958929|educational intervention|educational intervention
38953|NCT03958929|satisfaction|satisfaction
38954|NCT03958929|rural|rural
38955|NCT03958903|Responsive neurostimulation|responsive neurostimulation
38956|NCT03958903|Amygdala electrophysiology|amygdala electrophysiology
38957|NCT03958903|Neuropace RNS|neuropace rns
38958|NCT03958903|Temporal lobe epilepsy|temporal lobe epilepsy
38959|NCT03958903|closed-loop brain stimulation|closed-loop brain stimulation
38960|NCT03958864|Healthy Subjects|healthy subjects
38961|NCT03958864|CC-90001|cc-90001
38962|NCT03958864|Japanese|japanese
38963|NCT03958864|Caucasian|caucasian
38964|NCT03958864|Safety|safety
38965|NCT03958864|Pharmacokinetics|pharmacokinetics
38966|NCT03958851|renal resistive index|renal resistive index
38967|NCT03958838|Peer Support|peer support
38968|NCT03958838|Social Support|social support
38969|NCT03958838|Primary Care|primary care
38970|NCT03958838|Integrated Care|integrated care
38971|NCT03958838|Community-Based|community-based
38972|NCT03958838|Self-Management|self-management
38973|NCT03958838|Diabetes Care|diabetes care
38974|NCT03958812|CTCs|ctcs
38975|NCT03958812|VOCs|vocs
38976|NCT03958812|Breast cancer|breast cancer
38977|NCT03958812|Gastric cancer|gastric cancer
38978|NCT03958812|diagnoses|diagnoses
38979|NCT03958773|Mitral valve|mitral valve
38980|NCT03958773|Functional mitral regurgitation|functional mitral regurgitation
38981|NCT03958773|Heart failure|heart failure
38982|NCT03958734|Vascular Dysfunction|vascular dysfunction
38983|NCT03958708|gut microbiota|gut microbiota
38984|NCT03958708|rifaximin|rifaximin
38985|NCT03958695|midurethral sling|midurethral sling
38986|NCT03958695|stress urinary incontinence|stress urinary incontinence
38987|NCT03958695|urinary incontinence|urinary incontinence
38988|NCT03958695|voiding dysfunction|voiding dysfunction
38989|NCT03958682|air medical rescue|air medical rescue
38990|NCT03958682|satellite information transmission|satellite information transmission
38991|NCT03958682|Augmented Reality|augmented reality
38992|NCT03958669|Sorafenib|sorafenib
38993|NCT03958669|Liver Cancer|liver cancer
38994|NCT03958669|Imaging|imaging
38995|NCT03958669|Molecular Charakterization|molecular charakterization
38996|NCT03958656|Chimeric Antigen Receptors|chimeric antigen receptors
38997|NCT03958656|B-cell Maturation Antigen|b-cell maturation antigen
38998|NCT03958656|Immunotherapy|immunotherapy
38999|NCT03958656|Adoptive T Cell Therapy|adoptive t cell therapy
39000|NCT03958643|Sickle Nephropathy|sickle nephropathy
39001|NCT03958643|Iothalamate|iothalamate
39002|NCT03958643|Cystatin-C|cystatin-c
39003|NCT03958630|Fronto Temporal Dementia|fronto temporal dementia
39004|NCT03958630|Amyloid|amyloid
39005|NCT03958630|Neuroinflammation|neuroinflammation
39006|NCT03958552|Palliative Care Consultation|palliative care consultation
39007|NCT03958552|Medicare|medicare
39008|NCT03958552|Skilled Nursing|skilled nursing
39009|NCT03958526|transcranial direct current stimulation|transcranial direct current stimulation
39010|NCT03958526|non-invasive brain stimulation|non-invasive brain stimulation
39011|NCT03958526|neuromodulation|neuromodulation
39012|NCT03958526|chronic pain|chronic pain
39013|NCT03958526|neurogenic claudication|neurogenic claudication
39014|NCT03958487|Activities of Daily Living|activities of daily living
39015|NCT03958487|Brain Injuries/rehabilitation|brain injuries/rehabilitation
39016|NCT03958487|Generalization (Psychology)|generalization (psychology)
39017|NCT03958487|Brain Injuries/psychology|brain injuries/psychology
39018|NCT03958487|Feedback, Psychological/physiology|feedback, psychological/physiology
39019|NCT03958461|periodontitis|periodontitis
39020|NCT03958461|exudative age-related macular degeneration|exudative age-related macular degeneration
39021|NCT03958461|wet age-related macular degeneration|wet age-related macular degeneration
39023|NCT03958461|BAB|bab
39024|NCT03958461|aqueous flare|aqueous flare
39025|NCT03958435|Current status|current status
39026|NCT03958435|Chemotherapy regimen|chemotherapy regimen
39027|NCT03958435|Chemotherapy time|chemotherapy time
39028|NCT03958435|Efficacy|efficacy
39029|NCT03958435|Safety|safety
39031|NCT03958435|Stage II-III colon cancer|stage ii-iii colon cancer
39032|NCT03958435|RWS(Real World Study)|rws(real world study)
39033|NCT03958422|Acute myocardial infarction|acute myocardial infarction
39034|NCT03958422|Nuclear magnetic image|nuclear magnetic image
813691|NCT00189800|tolterodine|tolterodine
39035|NCT03958422|Survival myocardial area|survival myocardial area
39036|NCT03958370|Fitbit|fitbit
39037|NCT03958370|Activity Monitor|activity monitor
39038|NCT03958370|Step Count|step count
39039|NCT03958370|Total Knee Replacement|total knee replacement
39040|NCT03958370|Arthroplasty|arthroplasty
39041|NCT03958357|Cervix|cervix
39042|NCT03958357|Uterus|uterus
39043|NCT03958357|Vagina|vagina
39044|NCT03958357|Cancer|cancer
39045|NCT03958357|Gynecology|gynecology
39046|NCT03958357|Cervical cancer|cervical cancer
39047|NCT03958357|External beam radiation therapy|external beam radiation therapy
39048|NCT03958357|Brachytherapy|brachytherapy
39049|NCT03958331|adolescents, behavioral economics, mHealth|adolescents, behavioral economics, mhealth
39050|NCT03958292|Cataract|cataract
39051|NCT03958292|Endophthalmitis|endophthalmitis
39052|NCT03958292|Microbiological evaluation|microbiological evaluation
39053|NCT03958279|postvoiding residual volume|postvoiding residual volume
39054|NCT03958279|early postpartum period|early postpartum period
39055|NCT03958240|Head and Neck Cancer|head and neck cancer
39056|NCT03958240|Ovarian Cancer|ovarian cancer
39057|NCT03958240|Cervical Cancer|cervical cancer
39058|NCT03958240|Cervical Intraepithelial Neoplasia 3|cervical intraepithelial neoplasia 3
39059|NCT03958240|Glioblastoma Multiforme of Brain Stem|glioblastoma multiforme of brain stem
39060|NCT03958240|Non Small Cell Lung Cancer|non small cell lung cancer
39061|NCT03958240|Anal Cancer|anal cancer
39062|NCT03958227|Glenohumeral Arthritis|glenohumeral arthritis
39063|NCT03958227|Pain|pain
39064|NCT03958227|Mobilisation|mobilisation
39065|NCT03958227|Physiotherapy|physiotherapy
39066|NCT03958227|Rehabilitation|rehabilitation
39067|NCT03958188|Intestinal tumors|intestinal tumors
39068|NCT03958188|Computerized Tomography|computerized tomography
39069|NCT03958162|surgical lung biopsy|surgical lung biopsy
39070|NCT03958162|transbronchial lung cryobiopsy|transbronchial lung cryobiopsy
39071|NCT03958162|interstitial lung disease|interstitial lung disease
39072|NCT03958149|Cervical spine|cervical spine
39073|NCT03958136|Breast cancer|breast cancer
39074|NCT03958136|first metastatic setting|first metastatic setting
39075|NCT03958136|prospective clinico-biological database|prospective clinico-biological database
39076|NCT03958136|multi omic analysis|multi omic analysis
39077|NCT03958136|prediction in silico|prediction in silico
39078|NCT03958136|overall survival|overall survival
39079|NCT03958136|progression free survival|progression free survival
39080|NCT03958136|predictive factors|predictive factors
39081|NCT03958136|treatment response|treatment response
39082|NCT03958136|resistance to cancer therapy|resistance to cancer therapy
39083|NCT03958136|socio demographic profile|socio demographic profile
39084|NCT03958123|QT/QTc Interval|qt/qtc interval
39085|NCT03958110|Retinophotography|retinophotography
39086|NCT03958110|OCT|oct
39087|NCT03958110|Optical nerve|optical nerve
39088|NCT03958084|Lower Extremity|lower extremity
39089|NCT03958084|Musculoskeletal Manipulations|musculoskeletal manipulations
39090|NCT03958084|Range of motion|range of motion
39091|NCT03958084|Hamstring Muscles|hamstring muscles
39092|NCT03958045|rucaparib|rucaparib
39093|NCT03958045|nivolumab|nivolumab
39094|NCT03958045|platinum-sensitive|platinum-sensitive
39095|NCT03958045|maintenance|maintenance
39096|NCT03958045|SCLC|sclc
39097|NCT03958045|immune checkpoint|immune checkpoint
39098|NCT03958045|PARP|parp
39099|NCT03958032|sarcopenia|sarcopenia
39100|NCT03958032|cancer|cancer
39101|NCT03958032|gastrointestinal|gastrointestinal
39102|NCT03958019|Rehabilitation|rehabilitation
39103|NCT03958019|Exercise|exercise
39104|NCT03958019|Diet|diet
39105|NCT03958019|Education|education
39106|NCT03958019|Survivor-ship|survivor-ship
39107|NCT03957915|acute leukemia|acute leukemia
39108|NCT03957915|refractory|refractory
39109|NCT03957915|in relapse|in relapse
39110|NCT03957915|antibody drug conjugate|antibody drug conjugate
39111|NCT03957915|first in human|first in human
39112|NCT03957915|escalating doses|escalating doses
39113|NCT03957915|INA03|ina03
39114|NCT03957850|Emotion Regulation Training|emotion regulation training
39116|NCT03957850|Adolescence|adolescence
39117|NCT03957850|Major Depression|major depression
39118|NCT03957850|Eye-tracking|eye-tracking
39119|NCT03957850|Cognitive Reappraisal|cognitive reappraisal
39120|NCT03957850|Event-related Potentials|event-related potentials
39121|NCT03957824|Risk score|risk score
39122|NCT03957824|Risk prediction|risk prediction
39123|NCT03957824|Prevention|prevention
39124|NCT03957772|upper extremity surgery|upper extremity surgery
39125|NCT03957759|Altitude|altitude
39126|NCT03957759|Hypobaric hypoxia|hypobaric hypoxia
39127|NCT03957759|Altitude-related illness|altitude-related illness
39128|NCT03957759|Prevention|prevention
39129|NCT03957707|basal ganglion hemorrhage|basal ganglion hemorrhage
39130|NCT03957707|stereotactic surgery|stereotactic surgery
39131|NCT03957707|thrombolysis|thrombolysis
39132|NCT03957694|aplastic anemia|aplastic anemia
39133|NCT03957694|romiplostim|romiplostim
39134|NCT03957681|systemic sclerosis|systemic sclerosis
39135|NCT03957681|brodalumab|brodalumab
39136|NCT03957681|KHK4827|khk4827
39137|NCT03957668|PEG 3350|peg 3350
39138|NCT03957668|Constipation|constipation
39139|NCT03957655|Liver Cirrhosis|liver cirrhosis
39140|NCT03957655|stem cell|stem cell
39141|NCT03957655|therapy|therapy
39142|NCT03957629|hepatitis b virus|hepatitis b virus
39143|NCT03957629|liver fibrosis|liver fibrosis
39144|NCT03957629|peg interferon alfa-2a|peg interferon alfa-2a
39145|NCT03957629|tenofovir disoproxil fumarate|tenofovir disoproxil fumarate
39146|NCT03957577|ACOS, AECOPD, AERIS-J, CB, COPD, Exacerbation|acos, aecopd, aeris-j, cb, copd, exacerbation
39147|NCT03957564|Gastric cancer|gastric cancer
39148|NCT03957564|Gastro-oesophageal junction cancer|gastro-oesophageal junction cancer
39149|NCT03957564|Neoadjuvant chemotherapy|neoadjuvant chemotherapy
39150|NCT03957564|Radical gastrectomy|radical gastrectomy
39151|NCT03957564|Circulating tumor cells|circulating tumor cells
39152|NCT03957564|Circulating tumor DNA|circulating tumor dna
39153|NCT03957564|Circulating cell free DNA|circulating cell free dna
39154|NCT03957525|Virtual reality|virtual reality
39155|NCT03957525|Pediatric|pediatric
39156|NCT03957525|Anxiety|anxiety
39157|NCT03957525|Surgery|surgery
39158|NCT03957525|Anesthesia|anesthesia
39159|NCT03957525|Intervention|intervention
39160|NCT03957525|Exposure|exposure
39161|NCT03957525|Randomized controlled trial|randomized controlled trial
39162|NCT03957525|Pediatric urology|pediatric urology
39163|NCT03957525|Orthopedic surgery|orthopedic surgery
39164|NCT03957525|General Pediatric surgery|general pediatric surgery
39165|NCT03957525|Pediatric orthopedics|pediatric orthopedics
39166|NCT03957447|skin wounds|skin wounds
39167|NCT03957447|Ivory Coast community health services|ivory coast community health services
39168|NCT03957447|prevalence study|prevalence study
39169|NCT03957447|thermotherapy|thermotherapy
39170|NCT03957434|Pilot study|pilot study
39171|NCT03957434|Gynecological cancer survivors|gynecological cancer survivors
39172|NCT03957434|Urinary Incontinence|urinary incontinence
39173|NCT03957434|Physiotherapy|physiotherapy
39174|NCT03957395|FBSS|fbss
39175|NCT03957395|CRPS|crps
39176|NCT03957395|SCS|scs
39177|NCT03957395|Burst|burst
39178|NCT03957395|Tonic|tonic
39179|NCT03957395|High-frequency|high-frequency
39180|NCT03957369|HIV infection|hiv infection
39181|NCT03957369|Primary resistance|primary resistance
39182|NCT03957369|Antiretroviral drugs|antiretroviral drugs
39183|NCT03957369|Colombia|colombia
39184|NCT03957369|Cross sectional study|cross sectional study
39185|NCT03957356|Hemostatic|hemostatic
39186|NCT03957356|Blood oozing|blood oozing
39187|NCT03957356|Absorbent hemostatic|absorbent hemostatic
39188|NCT03957356|Liver resection|liver resection
39189|NCT03957356|Intraperitoneal surgery|intraperitoneal surgery
39190|NCT03957343|acquired brain injury|acquired brain injury
39191|NCT03957343|concussion|concussion
39192|NCT03957330|Anxiety|anxiety
39193|NCT03957330|Depression|depression
39194|NCT03957330|Internet-delivered cognitive behaviour therapy|internet-delivered cognitive behaviour therapy
39195|NCT03957330|Randomized controlled trial|randomized controlled trial
39196|NCT03957330|Therapist contact|therapist contact
39198|NCT03957330|Community mental health|community mental health
39200|NCT03957317|Postoperative sleep deprivation|postoperative sleep deprivation
39201|NCT03957278|Mechanical thrombectomy|mechanical thrombectomy
39202|NCT03957278|Acute ischemic stroke|acute ischemic stroke
39203|NCT03957278|neurovascular intervention|neurovascular intervention
39204|NCT03957252|ClarityDX Prostate|claritydx prostate
39205|NCT03957252|Diagnosis|diagnosis
39206|NCT03957252|Reflex Test|reflex test
39207|NCT03957252|Extracellular Vessicle|extracellular vessicle
39208|NCT03957213|Intermittent Hypoxia|intermittent hypoxia
39209|NCT03957213|Cognitive Training|cognitive training
39210|NCT03957200|Ultrasound|ultrasound
39211|NCT03957200|pregnancy|pregnancy
39212|NCT03957200|first trimester|first trimester
39213|NCT03957200|dating|dating
39214|NCT03957187|iron deficiency|iron deficiency
39215|NCT03957187|atrial fibrillation|atrial fibrillation
39216|NCT03957148|Sugar sweetened beverages,|sugar sweetened beverages,
39217|NCT03957148|childhood obesity|childhood obesity
39218|NCT03957148|preschool children|preschool children
39219|NCT03957135|pancreas neoplasms|pancreas neoplasms
39220|NCT03957135|pancreatectomy|pancreatectomy
39221|NCT03957122|tinnitus|tinnitus
39222|NCT03957122|transcranial magnetic stimulation|transcranial magnetic stimulation
39225|NCT03957083|pregnancy|pregnancy
39226|NCT03957083|postpartum hemorrhage|postpartum hemorrhage
39227|NCT03957083|Cesarean delivery|cesarean delivery
39228|NCT03957083|oxytocin|oxytocin
39229|NCT03957083|obesity|obesity
39230|NCT03957070|liver|liver
39231|NCT03957070|ultrasound elastography|ultrasound elastography
39232|NCT03957057|postpartum anemia|postpartum anemia
39233|NCT03957057|iron deficiency|iron deficiency
39234|NCT03957057|ferrous sulphate|ferrous sulphate
39235|NCT03957057|ferric carboxymaltose|ferric carboxymaltose
39236|NCT03957057|ferric isomaltoside|ferric isomaltoside
39237|NCT03957031|Gastric Cancer|gastric cancer
39238|NCT03957031|Personalized medicine|personalized medicine
39239|NCT03957031|Oncology|oncology
39240|NCT03957031|Solid tumor|solid tumor
39241|NCT03957031|Primary Intervention|primary intervention
39242|NCT03957005|Myocardial Infarction|myocardial infarction
39243|NCT03957005|Major cardiovascular events|major cardiovascular events
39244|NCT03957005|Risk assessment|risk assessment
39245|NCT03956966|Quadratus Lumborum Block|quadratus lumborum block
39246|NCT03956966|Laparoscopic Cholecystectomy|laparoscopic cholecystectomy
39247|NCT03956966|dexamethasone|dexamethasone
39248|NCT03956940|Hepatocarcinoma|hepatocarcinoma
39249|NCT03956940|cfDNA|cfdna
39250|NCT03956940|intplex|intplex
39251|NCT03956862|GB001|gb001
39252|NCT03956862|Gossamer Bio|gossamer bio
39253|NCT03956862|Gossamer|gossamer
39254|NCT03956862|Nasal Polyposis|nasal polyposis
39255|NCT03956862|CRSwNP|crswnp
39256|NCT03956862|CRSsNP|crssnp
39257|NCT03956849|overweight|overweight
39258|NCT03956849|obesity|obesity
39259|NCT03956849|pediatric obesity|pediatric obesity
39260|NCT03956823|hypertension|hypertension
39261|NCT03956823|obesity|obesity
39262|NCT03956823|telmisartan|telmisartan
39263|NCT03956823|metabolic abnormalities|metabolic abnormalities
39264|NCT03956823|cardiac remodeling|cardiac remodeling
39265|NCT03956810|transportation; prenatal care|transportation; prenatal care
39266|NCT03956797|Intravitreal Injection|intravitreal injection
39267|NCT03956797|Anesthesia|anesthesia
39268|NCT03956797|Macular Degeneration|macular degeneration
39269|NCT03956797|Diabetic Macular Edema|diabetic macular edema
39270|NCT03956784|Bariatric surgery|bariatric surgery
39271|NCT03956784|Colorectal surgery|colorectal surgery
39272|NCT03956784|Gastric surgery|gastric surgery
39273|NCT03956784|One day surgery|one day surgery
39274|NCT03956784|Post-operative complications|post-operative complications
39275|NCT03956784|Follow-up care via Mobile App|follow-up care via mobile app
39276|NCT03956771|neurofeedback|neurofeedback
39277|NCT03956771|biofeedback|biofeedback
39278|NCT03956771|OCD|ocd
39279|NCT03956771|obsessive-compulsive disorder|obsessive-compulsive disorder
39280|NCT03956771|magnetic resonance imaging|magnetic resonance imaging
39281|NCT03956771|functional magnetic resonance imaging|functional magnetic resonance imaging
39282|NCT03956771|orbitofrontal cortex|orbitofrontal cortex
39283|NCT03956758|MSM|msm
39284|NCT03956758|Chemical sex|chemical sex
39285|NCT03956758|HIV prevention|hiv prevention
39286|NCT03956758|HIV pre-exposure prophylaxis|hiv pre-exposure prophylaxis
39287|NCT03956745|Sleep|sleep
39288|NCT03956745|Aging|aging
39289|NCT03956745|Circadian Rhythms|circadian rhythms
39290|NCT03956745|Circadian Rhythm Disorders|circadian rhythm disorders
39291|NCT03956732|Child Nutrition|child nutrition
39292|NCT03956732|Dietary recommendations|dietary recommendations
39293|NCT03956732|Milk protein|milk protein
39294|NCT03956732|Vitamin D|vitamin d
39295|NCT03956732|Bone mineral density|bone mineral density
39296|NCT03956732|Muscle strength|muscle strength
39297|NCT03956732|Immune defence|immune defence
39298|NCT03956719|Autologous adipose-derived mesenchymal stem cells|autologous adipose-derived mesenchymal stem cells
39299|NCT03956719|Knee Osteoarthritis|knee osteoarthritis
39300|NCT03956706|SRS|srs
39301|NCT03956706|Stereotactic Radiosurgery|stereotactic radiosurgery
39302|NCT03956706|Glioblastoma|glioblastoma
39303|NCT03956706|Astrocytoma|astrocytoma
39304|NCT03956706|Grade III|grade iii
39305|NCT03956706|Grade IV|grade iv
39306|NCT03956706|Glioma|glioma
39307|NCT03956706|Malignant Glioma|malignant glioma
39308|NCT03956706|Gamma Knife|gamma knife
39309|NCT03956693|Stroke|stroke
39310|NCT03956693|CVA (cardiovascular accident)|cva (cardiovascular accident)
39311|NCT03956693|Anxiety|anxiety
39312|NCT03956693|Depression|depression
39313|NCT03956693|Mindfulness|mindfulness
39314|NCT03956693|Mindfulness Based Stress Reduction|mindfulness based stress reduction
39315|NCT03956693|Self-management|self-management
39316|NCT03956667|Paediatric|paediatric
39317|NCT03956667|distress|distress
39318|NCT03956667|Paediatric Emergency Department|paediatric emergency department
39319|NCT03956667|Music|music
39320|NCT03956654|breast cancer|breast cancer
39321|NCT03956654|elderly|elderly
39322|NCT03956654|geriatric assessment|geriatric assessment
39323|NCT03956654|geriatric oncology|geriatric oncology
39324|NCT03956654|translational research|translational research
39325|NCT03956654|biomarkers|biomarkers
39326|NCT03956498|Cervix Cancer|cervix cancer
39327|NCT03956498|Vaginal Cancer|vaginal cancer
39328|NCT03956498|Sexual function|sexual function
39329|NCT03956498|Brachytherapy|brachytherapy
39330|NCT03956498|Radiotherapy|radiotherapy
39331|NCT03956485|intracerebral hemorrhage|intracerebral hemorrhage
39332|NCT03956485|outcome|outcome
39333|NCT03956485|transportation|transportation
39334|NCT03956485|transfer|transfer
39335|NCT03956485|prognosis|prognosis
39336|NCT03956472|Altitude|altitude
39337|NCT03956472|Acute mountain sickness|acute mountain sickness
39338|NCT03956472|Osteopathy|osteopathy
39339|NCT03956472|End expiratory pressure|end expiratory pressure
39340|NCT03956459|FDG-PET|fdg-pet
39341|NCT03956420|Coronary Artery Bypass Surgery/Grafting, ERAS|coronary artery bypass surgery/grafting, eras
39342|NCT03956407|Rehabilitation|rehabilitation
39343|NCT03956407|Neuromodulation|neuromodulation
39344|NCT03956407|Peripheral stimulation|peripheral stimulation
39345|NCT03956407|Motor function|motor function
39346|NCT03956394|Cardiovascular Diseases|cardiovascular diseases
39347|NCT03956394|Vascular Diseases|vascular diseases
39348|NCT03956381|Femoral neck resection, offset, leg lenght, femoral anteversion|femoral neck resection, offset, leg lenght, femoral anteversion
39349|NCT03956368|Chronic subdural haematoma|chronic subdural haematoma
39350|NCT03956368|Medical treatment|medical treatment
39351|NCT03956368|Atorvastatin|atorvastatin
39352|NCT03956368|Clinical outcome|clinical outcome
39353|NCT03956368|Surgical recurrence|surgical recurrence
39354|NCT03956355|Tapinarof|tapinarof
39355|NCT03956355|plaque psoriasis|plaque psoriasis
39356|NCT03956355|adult|adult
39357|NCT03956355|phase 3|phase 3
39358|NCT03956355|topical|topical
39359|NCT03956355|double-blind|double-blind
39360|NCT03956355|efficacy|efficacy
39361|NCT03956355|safety|safety
39362|NCT03956355|psoriasis|psoriasis
39363|NCT03956329|Positive Affect|positive affect
39364|NCT03956329|Influenza Vaccination|influenza vaccination
39365|NCT03956329|Positive Mood|positive mood
39366|NCT03956329|Vaccination|vaccination
39367|NCT03956329|Randomised Control Trial|randomised control trial
39368|NCT03956303|Anesthesia, Spinal|anesthesia, spinal
39369|NCT03956303|Cesarean Section|cesarean section
39370|NCT03956303|Levobupivacaine|levobupivacaine
39371|NCT03956290|Time restricted eating|time restricted eating
39372|NCT03956290|Overweight|overweight
39373|NCT03956290|Obesity|obesity
39374|NCT03956290|Metabolic syndrome|metabolic syndrome
39375|NCT03956290|Diabetes treated with metformin and/or diet and HbA1C< 7%|diabetes treated with metformin and/or diet and hba1c< 7%
39376|NCT03956290|Pre Diabetes|pre diabetes
39377|NCT03956290|Circadian rhythm|circadian rhythm
39378|NCT03956264|Pain|pain
39379|NCT03956264|Anxiety|anxiety
39380|NCT03956264|Mediastinal drain removal|mediastinal drain removal
39381|NCT03956238|Alcohol intoxication|alcohol intoxication
39382|NCT03956238|Alcohol use|alcohol use
39383|NCT03956238|Drinking|drinking
39384|NCT03956238|Sexual assault|sexual assault
39385|NCT03956238|Sexual violence|sexual violence
39386|NCT03956238|Aggression|aggression
39387|NCT03956238|Attention|attention
39388|NCT03956238|Victimization|victimization
39389|NCT03956238|Public health|public health
39390|NCT03956225|Meibomian Gland Dysfunction|meibomian gland dysfunction
39391|NCT03956225|Evaporative Dry Eye Disease|evaporative dry eye disease
39392|NCT03956212|Lyme Borreliosis|lyme borreliosis
39393|NCT03956212|Inflammation|inflammation
39394|NCT03956212|Outcome|outcome
39395|NCT03956160|Caregiver|caregiver
39396|NCT03956160|Support|support
39397|NCT03956147|Cultural adaptation|cultural adaptation
39398|NCT03956147|validation|validation
39399|NCT03956147|responsibility|responsibility
39400|NCT03956147|shoulder|shoulder
39401|NCT03956121|Prematurity|prematurity
39402|NCT03956121|magnesium sulfate|magnesium sulfate
39403|NCT03956121|fetal heart rate|fetal heart rate
39404|NCT03956121|short-term variability|short-term variability
39405|NCT03956121|fetal neuroprotection|fetal neuroprotection
39406|NCT03956108|Active Surveillance|active surveillance
39407|NCT03956095|Nutritional Supplement Shakes|nutritional supplement shakes
39408|NCT03956095|19-108|19-108
39409|NCT03956030|Female Contraception|female contraception
39410|NCT03956030|Education|education
39411|NCT03956004|shared decision making|shared decision making
39412|NCT03956004|osteoarthritis|osteoarthritis
39413|NCT03955991|Breast Cancer|breast cancer
39414|NCT03955991|Flu Vaccine|flu vaccine
39415|NCT03955978|Immune checkpoint inhibition|immune checkpoint inhibition
39416|NCT03955978|Radiation-induced immune response|radiation-induced immune response
39417|NCT03955978|CyTOF|cytof
39418|NCT03955939|aurora kinase A|aurora kinase a
39419|NCT03955939|kinase|kinase
39420|NCT03955939|aurora A|aurora a
39421|NCT03955939|aurora kinase inhibitor|aurora kinase inhibitor
39422|NCT03955939|aurora kinase A inhibitor|aurora kinase a inhibitor
39423|NCT03955939|kinase inhibitor|kinase inhibitor
39424|NCT03955939|AURKA|aurka
39425|NCT03955939|AurA|aura
39426|NCT03955848|AML in Remission|aml in remission
39427|NCT03955848|NK cells|nk cells
39428|NCT03955848|Immunotherapy|immunotherapy
39429|NCT03955822|effectiveness|effectiveness
39430|NCT03955822|security|security
39431|NCT03955822|adverse effects|adverse effects
39432|NCT03955822|permanent birth control|permanent birth control
39433|NCT03955809|Injection|injection
39434|NCT03955809|Intra-Articular|intra-articular
39435|NCT03955809|arthroscopy|arthroscopy
39436|NCT03955809|ketamine|ketamine
39437|NCT03955796|Cataract, cataract surgery, intraocular lens|cataract, cataract surgery, intraocular lens
39438|NCT03955770|Exercise endurance|exercise endurance
39439|NCT03955770|High-flow oxygen therapy|high-flow oxygen therapy
39440|NCT03955770|Low-flow oxygen therapy|low-flow oxygen therapy
39441|NCT03955757|Immunization|immunization
39442|NCT03955757|Boot Camp Translation|boot camp translation
39443|NCT03955757|Adolescent|adolescent
39444|NCT03955679|Spinal Muscular Atrophy|spinal muscular atrophy
39445|NCT03955679|SMA|sma
39446|NCT03955679|Gene replacement therapy|gene replacement therapy
39447|NCT03955679|AVXS-101|avxs-101
39448|NCT03955679|Compassionate Use|compassionate use
39449|NCT03955679|Managed Access Program|managed access program
39450|NCT03955679|MAP|map
39451|NCT03955627|Cancer Treatment Symptoms, Symptom Management|cancer treatment symptoms, symptom management
39452|NCT03955614|Surgery|surgery
39453|NCT03955601|haploidentical|haploidentical
39454|NCT03955601|Aplastic anemia|aplastic anemia
39455|NCT03955601|TBI|tbi
39456|NCT03955588|Cytogenetics|cytogenetics
39457|NCT03955588|aCGH|acgh
39458|NCT03955588|Prenatal Diagnosis|prenatal diagnosis
39459|NCT03955549|Insight Enhancement Program|insight enhancement program
39460|NCT03955549|Insight Enhancement Therapy|insight enhancement therapy
39461|NCT03955549|Metacognitive Training for Psychosis|metacognitive training for psychosis
39462|NCT03955549|Psychotherapeutic Interventions for Schizophrenia|psychotherapeutic interventions for schizophrenia
39463|NCT03955549|Research on Schizophrenia in Egypt|research on schizophrenia in egypt
39464|NCT03955536|Cardiac Rehabilitation|cardiac rehabilitation
39465|NCT03955536|Virtual Reality|virtual reality
39466|NCT03955536|Respiratory Muscle Training|respiratory muscle training
39467|NCT03955536|Open Heart Surgery|open heart surgery
39468|NCT03955523|SCI|sci
39469|NCT03955523|paraplegia|paraplegia
39470|NCT03955523|tetraplegia|tetraplegia
39471|NCT03955523|quadriplegia|quadriplegia
39472|NCT03955523|spinal cord|spinal cord
39473|NCT03955497|Knee Osteoarthritis|knee osteoarthritis
39474|NCT03955497|Stem Cell|stem cell
39475|NCT03955497|Cartilage repair|cartilage repair
39476|NCT03955484|Prostatic Hyperplasia|prostatic hyperplasia
39477|NCT03955484|Lower Urinary Tract Symptoms|lower urinary tract symptoms
39478|NCT03955484|Medical Treatment|medical treatment
39479|NCT03955484|Urine Marker|urine marker
39480|NCT03955484|Glycosaminoglycan|glycosaminoglycan
39481|NCT03955471|Open-label|open-label
39482|NCT03955471|Single-arm|single-arm
39483|NCT03955471|Efficacy and Safety|efficacy and safety
39484|NCT03955458|EXPAREL|exparel
39485|NCT03955458|FICB|ficb
39486|NCT03955458|Fascia Iliaca Compartment Block|fascia iliaca compartment block
39487|NCT03955458|Ropivacaine|ropivacaine
39488|NCT03955445|C3G (C3 glomerulopathy)|c3g (c3 glomerulopathy)
39489|NCT03955445|C3GN (C3 glomerulonephritis)|c3gn (c3 glomerulonephritis)
39490|NCT03955445|DDD (dense deposit disease)|ddd (dense deposit disease)
39491|NCT03955393|LYMPH NODE METASTASES|lymph node metastases
39492|NCT03955393|18F-FAZA PET IMAGING TECHNIQUE|18f-faza pet imaging technique
39493|NCT03955380|anti-prionic|anti-prionic
39494|NCT03955380|anti-Abeta-pionic|anti-abeta-pionic
39495|NCT03955380|treatment of cognition and memory deficits|treatment of cognition and memory deficits
39496|NCT03955380|AD patients|ad patients
39497|NCT03955380|AD stage-independent|ad stage-independent
39498|NCT03955380|NOT anti-amyloid|not anti-amyloid
39499|NCT03955380|neuron specific Ca-ion reduction|neuron specific ca-ion reduction
39500|NCT03955367|Uterine Cervical Neoplasms|uterine cervical neoplasms
39501|NCT03955367|Extended-field irradiation|extended-field irradiation
39502|NCT03955302|Frailty|frailty
39503|NCT03955302|Muscle Architecture|muscle architecture
39504|NCT03955302|Ultrasound|ultrasound
39505|NCT03955302|Exercise Regimen|exercise regimen
39506|NCT03955302|Aqua-Aerobics|aqua-aerobics
39507|NCT03955276|Hodgkin lymphoma|hodgkin lymphoma
39508|NCT03955276|non-Hodgkin lymphoma|non-hodgkin lymphoma
39509|NCT03955276|Acute leukemia|acute leukemia
39510|NCT03955276|Chronic leukemia|chronic leukemia
39511|NCT03955276|rare hematologic tumors|rare hematologic tumors
39512|NCT03955276|Hematopoietic lymphoid/myeloid cancer|hematopoietic lymphoid/myeloid cancer
39513|NCT03955263|asymptomatic|asymptomatic
39514|NCT03955263|Malaria|malaria
39515|NCT03955263|pregnancy|pregnancy
39516|NCT03955263|prevalence|prevalence
39517|NCT03955263|RT-PCR|rt-pcr
39518|NCT03955250|schizophrenia|schizophrenia
39519|NCT03955250|psychosis|psychosis
39520|NCT03955250|mHealth|mhealth
39521|NCT03955250|psychiatric hospitalization|psychiatric hospitalization
39522|NCT03955250|treatment adherence|treatment adherence
39523|NCT03955250|transitions of care|transitions of care
39524|NCT03955250|coping skills|coping skills
39525|NCT03955250|psychosocial intervention|psychosocial intervention
39526|NCT03955224|Upper Aerodigestive Tract Neoplasms|upper aerodigestive tract neoplasms
39527|NCT03955224|Low-Level Laser Therapy (LLLT)|low-level laser therapy (lllt)
39528|NCT03955224|Mucositis|mucositis
39529|NCT03955211|postoperative pain|postoperative pain
39530|NCT03955211|caesarean section|caesarean section
39531|NCT03955211|C-section|c-section
39532|NCT03955198|Brain Metastases|brain metastases
39533|NCT03955198|NSCLC|nsclc
39534|NCT03955198|Anti-PD-L1|anti-pd-l1
39535|NCT03955198|Durvalumab|durvalumab
39536|NCT03955198|Radiation therapy|radiation therapy
39537|NCT03955198|Hypo-fractionated stereotactic irradiation|hypo-fractionated stereotactic irradiation
39538|NCT03955172|Missing self|missing self
39539|NCT03955172|NK cells|nk cells
39540|NCT03955172|Rejection|rejection
39541|NCT03955172|mTOR inhibitors|mtor inhibitors
39542|NCT03955172|Kidney transplanted patients|kidney transplanted patients
39543|NCT03955146|Idiopathic Pulmonary Fibrosis, IPF, Idiopathic Interstitial Pneumonia, Interstitial Lung Disease, Lung Fibrosis|idiopathic pulmonary fibrosis, ipf, idiopathic interstitial pneumonia, interstitial lung disease, lung fibrosis
39544|NCT03955133|medicines management|medicines management
39545|NCT03955133|adverse drug reaction|adverse drug reaction
39546|NCT03955133|care homes|care homes
39547|NCT03955133|nurses|nurses
39548|NCT03955120|sleep disorders|sleep disorders
39549|NCT03955120|cognitive and behavioral treatment|cognitive and behavioral treatment
39550|NCT03955120|digital treatment|digital treatment
39551|NCT03955120|insomnia|insomnia
39552|NCT03955120|sleep apnea|sleep apnea
39553|NCT03955120|sleep|sleep
39554|NCT03955107|gestational diabetes|gestational diabetes
39555|NCT03955107|continuous glucose monitoring|continuous glucose monitoring
39556|NCT03955107|glycemic Control|glycemic control
39557|NCT03955094|AMBU® AURAGAIN™|ambu® auragain™
39558|NCT03955094|intubation in paediatrics|intubation in paediatrics
39559|NCT03955094|flexible scope guided intubation|flexible scope guided intubation
39560|NCT03955094|success rate of intubation|success rate of intubation
39561|NCT03955094|glottic view|glottic view
39562|NCT03955094|supraglottic airway intubation|supraglottic airway intubation
39563|NCT03955094|efficacy safety|efficacy safety
39564|NCT03955055|Gastro Intestinal Bleeding|gastro intestinal bleeding
39565|NCT03955016|pulmonary rehabilitation|pulmonary rehabilitation
39566|NCT03955016|physical activity|physical activity
39567|NCT03954990|Bacterial Vaginoses in pregnancy|bacterial vaginoses in pregnancy
39568|NCT03954977|PICC line|picc line
39569|NCT03954977|Neonate|neonate
39570|NCT03954951|hypertension|hypertension
39571|NCT03954951|blood pressure|blood pressure
39572|NCT03954951|clinical inertia|clinical inertia
39573|NCT03954951|randomized clinical trial|randomized clinical trial
39574|NCT03954951|uncontrolled hypertension|uncontrolled hypertension
39575|NCT03954925|ACL|acl
39576|NCT03954925|short hamstring graft|short hamstring graft
39577|NCT03954925|standard hamstring graft|standard hamstring graft
39578|NCT03954912|MAKO|mako
39579|NCT03954912|NAVIO|navio
39580|NCT03954912|robotic surgery|robotic surgery
39581|NCT03954912|UKA|uka
39582|NCT03954912|surgical time|surgical time
39583|NCT03954912|KSS|kss
39584|NCT03954912|KFS|kfs
39585|NCT03954886|Myopia|myopia
39586|NCT03954886|Choroid|choroid
39587|NCT03954886|Retina|retina
39588|NCT03954886|Blur|blur
39589|NCT03954886|Defocus|defocus
39590|NCT03954886|Eye growth|eye growth
39591|NCT03954873|GLP-2|glp-2
39592|NCT03954873|Glucagon|glucagon
39593|NCT03954847|Lung cancer|lung cancer
39594|NCT03954847|Image|image
39595|NCT03954847|Treatment response|treatment response
39596|NCT03954847|Prognosis|prognosis
39597|NCT03954847|Radiomic|radiomic
39598|NCT03954847|Deep learning|deep learning
39599|NCT03954834|glucose-dependent insulinotropic polypeptide (GIP)|glucose-dependent insulinotropic polypeptide (gip)
39600|NCT03954834|glucagon-like peptide-1 (GLP-1)|glucagon-like peptide-1 (glp-1)
39601|NCT03954834|GIP/GLP-1 dual receptor agonist|gip/glp-1 dual receptor agonist
39602|NCT03954834|T2DM|t2dm
39603|NCT03954821|Foot posture index, foot pronation ,foot orthoses|foot posture index, foot pronation ,foot orthoses
39604|NCT03954808|Unilateral Cerebral Palsy, Motor imagery,|unilateral cerebral palsy, motor imagery,
39605|NCT03954795|TAP OSTAP Postoperative pain|tap ostap postoperative pain
39606|NCT03954782|Hemorrhagic Hereditary Telangiectasia (HHT)|hemorrhagic hereditary telangiectasia (hht)
39607|NCT03954782|antiangiogenic therapy|antiangiogenic therapy
39608|NCT03954782|Tyrosine Kinase Inhibitor|tyrosine kinase inhibitor
39609|NCT03954782|Nintedanib|nintedanib
39610|NCT03954769|Delirium,|delirium,
39611|NCT03954769|Confusion Assessment Method|confusion assessment method
39612|NCT03954769|Proxy Test of Delirium|proxy test of delirium
39613|NCT03954769|DSM-V|dsm-v
39614|NCT03954769|Hyperactive Delirium|hyperactive delirium
39615|NCT03954769|Hypoactive Delirium|hypoactive delirium
39616|NCT03954769|Mixed-type delirium|mixed-type delirium
39617|NCT03954743|HRV|hrv
39618|NCT03954743|Lyophilized formulation|lyophilized formulation
39619|NCT03954743|Liquid formulation|liquid formulation
39620|NCT03954743|Human rotavirus vaccine|human rotavirus vaccine
39621|NCT03954743|Rotarix|rotarix
39622|NCT03954743|Healthy infants|healthy infants
39623|NCT03954743|PCV-free|pcv-free
39624|NCT03954743|Porcine circovirus-free|porcine circovirus-free
39625|NCT03954730|Eccentric training|eccentric training
39626|NCT03954730|Active Release Technique|active release technique
39627|NCT03954678|Exercise|exercise
39628|NCT03954678|Nutrition supplement|nutrition supplement
39629|NCT03954678|Surgery|surgery
39630|NCT03954665|Ketones|ketones
39631|NCT03954665|Supplementation|supplementation
39632|NCT03954665|Exercise Performance|exercise performance
39633|NCT03954652|Rare Diseases|rare diseases
39634|NCT03954652|Genetic Predisposition|genetic predisposition
39635|NCT03954652|Whole-exome sequencing|whole-exome sequencing
39636|NCT03954652|WGS-trio analysis|wgs-trio analysis
39637|NCT03954652|Whole Genome Sequencing (WGS)|whole genome sequencing (wgs)
39638|NCT03954626|AMD, nAMD, wet AMD, RTH258, brolucizumab, ECG, open-label|amd, namd, wet amd, rth258, brolucizumab, ecg, open-label
39639|NCT03954613|Alzheimer Disease|alzheimer disease
39640|NCT03954613|Cognitive Exercises|cognitive exercises
39641|NCT03954613|Internet|internet
39642|NCT03954613|Donepezil|donepezil
39643|NCT03954613|Memantin|memantin
39644|NCT03954613|Combination|combination
39645|NCT03954600|Phase 1|phase 1
39646|NCT03954600|Safety|safety
39647|NCT03954600|Tolerability|tolerability
39648|NCT03954600|Pharmacokinetics|pharmacokinetics
39649|NCT03954600|Parkinson's Disease|parkinson's disease
39650|NCT03954600|Amyotrophic Lateral Sclerosis|amyotrophic lateral sclerosis
39651|NCT03954587|Hormone replacement therapy|hormone replacement therapy
39652|NCT03954587|Frozen thawed embryos|frozen thawed embryos
39653|NCT03954587|Frozen embryo cycle|frozen embryo cycle
39654|NCT03954561|colonoscopy|colonoscopy
39655|NCT03954561|cecal intubation time|cecal intubation time
39656|NCT03954535|sexual minorities|sexual minorities
39657|NCT03954535|prevention|prevention
39658|NCT03954535|web-based intervention|web-based intervention
39659|NCT03954535|substance use|substance use
39660|NCT03954535|longitudinal|longitudinal
39661|NCT03954535|randomized controlled trial|randomized controlled trial
39662|NCT03954535|adolescence|adolescence
39663|NCT03954522|ICU|icu
39664|NCT03954522|acute stress|acute stress
39665|NCT03954522|PTSD|ptsd
39666|NCT03954522|child|child
39667|NCT03954522|parent hospitalized|parent hospitalized
39668|NCT03954509|Complementary and Alternative Medicines|complementary and alternative medicines
39669|NCT03954496|neuroplasticity|neuroplasticity
39670|NCT03954496|rehabilitation|rehabilitation
39671|NCT03954496|transcranial direct current stimulation|transcranial direct current stimulation
39672|NCT03954496|transcranial magnetic stimulation|transcranial magnetic stimulation
39673|NCT03954496|activities of daily living|activities of daily living
39674|NCT03954496|motor training|motor training
39675|NCT03954457|Suicide|suicide
39676|NCT03954457|Aggression|aggression
39677|NCT03954457|Prevention|prevention
39678|NCT03954457|Culturally-Adapted|culturally-adapted
39679|NCT03954457|African American Adolescents|african american adolescents
39680|NCT03954418|Artificial sweeteners|artificial sweeteners
39681|NCT03954418|Non-nutritive sweeteners|non-nutritive sweeteners
39682|NCT03954418|Caesarean section|caesarean section
39683|NCT03954392|Depression|depression
39684|NCT03954392|Adolescents|adolescents
39685|NCT03954392|Treatment|treatment
39686|NCT03954366|rucaparib|rucaparib
39687|NCT03954366|CO-338|co-338
39688|NCT03954366|Clovis|clovis
39689|NCT03954366|Clovis Oncology|clovis oncology
39690|NCT03954366|PARP Inhibitor|parp inhibitor
39691|NCT03954366|Drug-drug Interaction|drug-drug interaction
39692|NCT03954340|MCI|mci
39693|NCT03954340|Early AD|early ad
39694|NCT03954314|Tranexamic Acid|tranexamic acid
39695|NCT03954314|On-pump Cardiac Surgery|on-pump cardiac surgery
39696|NCT03954301|Foot deformities|foot deformities
39697|NCT03954301|Cluster method|cluster method
39698|NCT03954301|Kinematic analysis|kinematic analysis
39699|NCT03954288|otitis media chronic|otitis media chronic
39700|NCT03954288|cholesteatoma|cholesteatoma
39701|NCT03954288|sclerostin|sclerostin
39702|NCT03954249|erector spinae plane block|erector spinae plane block
39703|NCT03954249|multimodal anesthesia|multimodal anesthesia
39704|NCT03954236|Ruxolitinib Cream|ruxolitinib cream
39705|NCT03954236|18-412|18-412
39706|NCT03954210|Cognitive Behavioral Therapy for Insomnia|cognitive behavioral therapy for insomnia
39707|NCT03954210|CBT-I|cbt-i
39708|NCT03954210|Alzheimer's|alzheimer's
39709|NCT03954210|Alzheimer's Disease|alzheimer's disease
39710|NCT03954171|Epithelial Ovarian Cancer|epithelial ovarian cancer
39711|NCT03954171|Platinum based-chemotherapy|platinum based-chemotherapy
39712|NCT03954119|blood pressure|blood pressure
39713|NCT03954119|emergency department|emergency department
39714|NCT03954119|atherosclerotic cardiovascular disease|atherosclerotic cardiovascular disease
39715|NCT03954119|myocardial infarction|myocardial infarction
39716|NCT03954119|stroke|stroke
39717|NCT03954119|long-term prognosis|long-term prognosis
39718|NCT03954067|immunotherapy|immunotherapy
39719|NCT03954067|vaccinia virus|vaccinia virus
39720|NCT03954067|visceral lesions|visceral lesions
39721|NCT03954067|cutaneous lesions|cutaneous lesions
39722|NCT03954067|intratumoral injection|intratumoral injection
39723|NCT03954067|ASP9801|asp9801
39724|NCT03954067|subcutaneous lesions|subcutaneous lesions
39725|NCT03954067|oncolytic virus|oncolytic virus
39726|NCT03954002|Transthoracic Echocardiography (TTE)|transthoracic echocardiography (tte)
39727|NCT03954002|Transoesophageal Echocardiography (TOE)|transoesophageal echocardiography (toe)
39728|NCT03953963|Mesenteric Visceral Fat|mesenteric visceral fat
39729|NCT03953963|Insulin Resistance|insulin resistance
39730|NCT03953963|Diabetes|diabetes
39731|NCT03953963|Type 2 diabetes|type 2 diabetes
39732|NCT03953963|Diabetes Mellitus|diabetes mellitus
39733|NCT03953963|Noninsulin-Dependent Diabetes Mellitus|noninsulin-dependent diabetes mellitus
39734|NCT03953963|Glucose Metabolism Disorder|glucose metabolism disorder
39735|NCT03953963|Obesity|obesity
39736|NCT03953963|Diabesity|diabesity
39737|NCT03953963|HydraSolve T2D|hydrasolve t2d
39738|NCT03953950|Peritoneal Dialysis|peritoneal dialysis
39739|NCT03953950|Peritoneal Membrane|peritoneal membrane
39740|NCT03953950|Spironolactone|spironolactone
39741|NCT03953950|Losartan|losartan
39742|NCT03953950|Renin-Angiotensin-Aldosterone System|renin-angiotensin-aldosterone system
39743|NCT03953924|transtheoretical model|transtheoretical model
39744|NCT03953924|motivational interviewing|motivational interviewing
39745|NCT03953924|depression|depression
39746|NCT03953924|coronary heart disease|coronary heart disease
39747|NCT03953885|Plaque Psoriasis|plaque psoriasis
39748|NCT03953885|Blood stasis syndrome|blood stasis syndrome
39749|NCT03953885|Randomized controlled trial|randomized controlled trial
39750|NCT03953885|Fire Needle Therapy|fire needle therapy
39751|NCT03953833|DLT|dlt
39752|NCT03953833|MTD|mtd
39753|NCT03953833|Safety|safety
39754|NCT03953833|tolerability|tolerability
39755|NCT03953833|HER2-positive|her2-positive
39756|NCT03953833|Recombinant Humanized Anti-HER2 Monoclonal Antibody|recombinant humanized anti-her2 monoclonal antibody
39757|NCT03953781|Epilepsy|epilepsy
39758|NCT03953781|antiepileptic drugs|antiepileptic drugs
39759|NCT03953781|males|males
39760|NCT03953781|reproduction|reproduction
39761|NCT03953768|epilepsy|epilepsy
39762|NCT03953768|vagal|vagal
39763|NCT03953768|autoimmune|autoimmune
39764|NCT03953768|autonomic|autonomic
39765|NCT03953768|inflammatory bowel disease|inflammatory bowel disease
39766|NCT03953768|immune|immune
39767|NCT03953755|tricuspid regurgitation|tricuspid regurgitation
39768|NCT03953755|tricuspid surgery|tricuspid surgery
39769|NCT03953755|moderate tricispid|moderate tricispid
39770|NCT03953742|Intravenous infusion|intravenous infusion
39771|NCT03953742|Phase 1|phase 1
39772|NCT03953742|CPI-200|cpi-200
39773|NCT03953716|Primary Dysmenorrhea|primary dysmenorrhea
39774|NCT03953716|traditional Chinese medicine|traditional chinese medicine
39775|NCT03953716|low-level light therapy|low-level light therapy
39776|NCT03953703|Sjogren's syndrome, dry eye, sicca|sjogren's syndrome, dry eye, sicca
39777|NCT03953625|Common Acute Low Back Pain|common acute low back pain
39778|NCT03953625|Low Back Pain Booklet|low back pain booklet
39779|NCT03953625|Health Insurance|health insurance
39780|NCT03953586|laparoscopy|laparoscopy
39781|NCT03953586|hysteroscopy,|hysteroscopy,
39782|NCT03953586|tubal patency,|tubal patency,
39783|NCT03953586|bubble test,|bubble test,
39784|NCT03953586|peristalsis|peristalsis
39785|NCT03953560|CTEPH|cteph
39786|NCT03953560|Pulmonary Embolism|pulmonary embolism
39787|NCT03953560|Symptoms and Signs|symptoms and signs
39788|NCT03953560|Dyspnea|dyspnea
39789|NCT03953547|antiplatelet resistance|antiplatelet resistance
39790|NCT03953547|peripheral arterial revascularization|peripheral arterial revascularization
39799|NCT03953495|intimate relationships|intimate relationships
39800|NCT03953495|lesbian|lesbian
39801|NCT03953469|passionflower|passionflower
39802|NCT03953469|meditation|meditation
39803|NCT03953469|heart rate|heart rate
39804|NCT03953469|blood pressure|blood pressure
39805|NCT03953456|Hepatic lipid composition|hepatic lipid composition
39806|NCT03953456|Elafibranor|elafibranor
39807|NCT03953456|Hepatic Glucose Production|hepatic glucose production
39808|NCT03953430|Tibialis anterior tendon transfer|tibialis anterior tendon transfer
39809|NCT03953430|Oxford foot model|oxford foot model
39810|NCT03953430|gait analysis|gait analysis
39811|NCT03953417|Bipolar Disorder|bipolar disorder
39812|NCT03953417|Treatment Resistant Depression|treatment resistant depression
39813|NCT03953417|Transcranial Magnetic Stimulation (TMS)|transcranial magnetic stimulation (tms)
39814|NCT03953417|Theta Burst|theta burst
39815|NCT03953365|hyperthermic intraperitoneal chemotherapy|hyperthermic intraperitoneal chemotherapy
39816|NCT03953365|cytoreduction surgery|cytoreduction surgery
39817|NCT03953365|prophylactic mesh|prophylactic mesh
39818|NCT03953352|Adaptive radiotherapy|adaptive radiotherapy
39819|NCT03953300|Asthma|asthma
39820|NCT03953300|Eosinophilic Asthma|eosinophilic asthma
39821|NCT03953300|Lung Diseases|lung diseases
39822|NCT03953300|Inhaled Corticosteroids|inhaled corticosteroids
39823|NCT03953300|ICS|ics
39824|NCT03953300|LABA|laba
39825|NCT03953300|benralizumab|benralizumab
39826|NCT03953300|Fasenra|fasenra
39827|NCT03953300|mechanism of action|mechanism of action
39828|NCT03953300|remodeling|remodeling
39829|NCT03953248|phosphide; poisoning; L-carnitine; oxidative stress|phosphide; poisoning; l-carnitine; oxidative stress
39839|NCT03953222|Parkinson's disease|parkinson's disease
39840|NCT03953222|Real-time feedback|real-time feedback
39841|NCT03953222|Gait|gait
39842|NCT03953222|Posture|posture
39843|NCT03953222|Rehabilitation|rehabilitation
39844|NCT03953209|spironolactone|spironolactone
39845|NCT03953183|Nicotine|nicotine
39846|NCT03953144|Segmentectomy|segmentectomy
39847|NCT03953144|Lung Cancer|lung cancer
39848|NCT03953144|Robotic Surgery|robotic surgery
39849|NCT03953144|3D Modelling|3d modelling
39850|NCT03953144|CT Imaging|ct imaging
39851|NCT03953144|Near-Infrared Fluorescence|near-infrared fluorescence
39852|NCT03953144|IC-GREEN|ic-green
39853|NCT03953144|Surgical Planning|surgical planning
39854|NCT03953144|Indocyanine Green|indocyanine green
39855|NCT03953144|Early-Stage Lung Cancer|early-stage lung cancer
39856|NCT03953144|Surgical Mapping|surgical mapping
39857|NCT03953144|Lung Preservation|lung preservation
39858|NCT03953105|Weight estimation|weight estimation
39859|NCT03953105|Patient safety|patient safety
39860|NCT03953092|Diabetes|diabetes
39861|NCT03953079|Age-related macular degeneration|age-related macular degeneration
39862|NCT03953079|Choroidal neovascularization|choroidal neovascularization
39863|NCT03953066|melatonin,colostral milk,IL-6, delivery, cesarean section|melatonin,colostral milk,il-6, delivery, cesarean section
39864|NCT03953053|Femto Cataract Surgery|femto cataract surgery
39865|NCT03953014|SSRI|ssri
39866|NCT03953014|Depression|depression
39867|NCT03953014|Children|children
39868|NCT03953014|OCD|ocd
39869|NCT03953014|Anxiety|anxiety
39870|NCT03953014|Antidepressants|antidepressants
39871|NCT03952975|Loop electrosurgical excision procedure|loop electrosurgical excision procedure
39872|NCT03952949|Nutrition|nutrition
39873|NCT03952949|Food Insecurity|food insecurity
39874|NCT03952949|Choice Architecture|choice architecture
39875|NCT03952949|Nudge|nudge
39876|NCT03952910|Chronic pain|chronic pain
39877|NCT03952910|Working adults|working adults
39878|NCT03952910|Pain education|pain education
39879|NCT03952910|Internet-delivered|internet-delivered
39880|NCT03952897|knee osteoarthritis|knee osteoarthritis
39881|NCT03952897|rheumatoid arthritis|rheumatoid arthritis
39882|NCT03952897|balneology|balneology
39883|NCT03952897|hip balneology|hip balneology
39884|NCT03952884|Metabolism|metabolism
39885|NCT03952884|Amino Acid Peptides|amino acid peptides
39886|NCT03952884|Muscle Protein Synthesis|muscle protein synthesis
39887|NCT03952884|Muscle Protein Breakdown|muscle protein breakdown
39888|NCT03952871|Shock|shock
39889|NCT03952871|Hemodynamic|hemodynamic
39890|NCT03952858|telerehabilitation|telerehabilitation
39891|NCT03952845|Capsaicin|capsaicin
39892|NCT03952845|Rhinitis|rhinitis
39905|NCT03952715|Experimental pain variability|experimental pain variability
39906|NCT03952715|Placebo effect|placebo effect
39907|NCT03952715|Evoked pain training (EPT)|evoked pain training (ept)
39908|NCT03952702|Intermittent exotropia|intermittent exotropia
39909|NCT03952702|overminus lens therapy|overminus lens therapy
39910|NCT03952702|myopic overcorrection|myopic overcorrection
39911|NCT03952676|Plaque Psoriasis|plaque psoriasis
39912|NCT03952676|Blood stasis syndrome|blood stasis syndrome
39913|NCT03952676|Randomized controlled trial|randomized controlled trial
39914|NCT03952676|Moving cupping|moving cupping
39915|NCT03952663|inferior alveolar nerve lateralization|inferior alveolar nerve lateralization
39916|NCT03952663|platelet rich fibrin|platelet rich fibrin
39917|NCT03952663|posterior atrophic mandible|posterior atrophic mandible
39923|NCT03952637|Lysosomal Diseases|lysosomal diseases
39924|NCT03952624|Symptom Biology|symptom biology
39925|NCT03952624|Symptom Phenotyping|symptom phenotyping
39926|NCT03952624|Fatigue|fatigue
39931|NCT03952559|eczema|eczema
39932|NCT03952559|atopic eczema|atopic eczema
39933|NCT03952546|Total Knee Arthroplasty|total knee arthroplasty
39934|NCT03952546|Surgical Blood Loss|surgical blood loss
39935|NCT03952546|Electrocautery|electrocautery
39936|NCT03952546|Perioperative Blood Conservation|perioperative blood conservation
39937|NCT03952533|alpha-lipoic Acid|alpha-lipoic acid
39938|NCT03952533|vitamin D|vitamin d
39939|NCT03952533|cervical shortening|cervical shortening
39940|NCT03952533|pretermbirth|pretermbirth
39941|NCT03952533|food supplement|food supplement
39942|NCT03952520|Cluster randomized controlled implementation trial|cluster randomized controlled implementation trial
39943|NCT03952520|Intervention mapping|intervention mapping
39944|NCT03952520|People who inject drugs|people who inject drugs
39945|NCT03952520|HIV/AIDS|hiv/aids
39946|NCT03952520|Systems navigation|systems navigation
39947|NCT03952520|Psychosocial counseling|psychosocial counseling
39948|NCT03952520|Vietnam|vietnam
39949|NCT03952481|Dry Eye|dry eye
39950|NCT03952481|Lifitegrast|lifitegrast
39951|NCT03952481|Xiidra|xiidra
39952|NCT03952468|suicide prevention|suicide prevention
39953|NCT03952468|Veterans|veterans
53386|NCT03869073|ICU|icu
39954|NCT03952455|Nucleus Accumbens|nucleus accumbens
39955|NCT03952455|Deep brain stimulation|deep brain stimulation
39956|NCT03952455|Methadone|methadone
39957|NCT03952442|gastric cancer|gastric cancer
39958|NCT03952442|nutrition|nutrition
39959|NCT03952442|health education|health education
39960|NCT03952429|alcohol dependence|alcohol dependence
39961|NCT03952429|alcohol abuse|alcohol abuse
39962|NCT03952429|withdrawal|withdrawal
39963|NCT03952416|Occupational Therapy|occupational therapy
39964|NCT03952416|Spinal Cord Injury|spinal cord injury
39965|NCT03952416|Rehabilitation|rehabilitation
39966|NCT03952390|thrombocytopenia,Renin-Angiotensin System,platelet|thrombocytopenia,renin-angiotensin system,platelet
39971|NCT03952364|Crohn's Disease|crohn's disease
39972|NCT03952364|Ulcerative Colitis|ulcerative colitis
39973|NCT03952364|IBD|ibd
39974|NCT03952364|Inflammatory Bowel Disease|inflammatory bowel disease
39975|NCT03952364|Precious|precious
39976|NCT03952325|Tesetaxel|tesetaxel
39977|NCT03952325|PD-(L)1 inhibitor|pd-(l)1 inhibitor
39978|NCT03952325|Triple-negative breast cancer|triple-negative breast cancer
39979|NCT03952325|Locally advanced or metastatic breast cancer|locally advanced or metastatic breast cancer
39980|NCT03952325|Taxane|taxane
39981|NCT03952325|Metastatic breast cancer|metastatic breast cancer
39982|NCT03952325|Breast cancer|breast cancer
39983|NCT03952325|Combination of tesetaxel and PD-(L)1 inhibitors|combination of tesetaxel and pd-(l)1 inhibitors
39984|NCT03952325|HER2 negative|her2 negative
39985|NCT03952325|Oral chemotherapy|oral chemotherapy
39986|NCT03952325|Central nervous system (CNS) metastases|central nervous system (cns) metastases
39987|NCT03952312|eHealth|ehealth
39988|NCT03952312|Adherence|adherence
39989|NCT03952312|Symptom Burden|symptom burden
39990|NCT03952312|Health Related Quality of Life|health related quality of life
39991|NCT03952299|Transdermal Oxybutynin|transdermal oxybutynin
39992|NCT03952273|Drug eluting stent|drug eluting stent
39993|NCT03952273|Stent|stent
39994|NCT03952260|Clear fluid fasting|clear fluid fasting
39995|NCT03952260|residual gastric volume|residual gastric volume
39996|NCT03952260|paediatric anaesthesia|paediatric anaesthesia
39997|NCT03952247|tracheotomy|tracheotomy
39998|NCT03952247|bronchoscopy|bronchoscopy
39999|NCT03952247|critical care|critical care
40000|NCT03952234|Mitochondrial|mitochondrial
40001|NCT03952234|Encephalomyopathy|encephalomyopathy
40002|NCT03952234|Metabolic strokes|metabolic strokes
40003|NCT03952234|Stroke-like episodes|stroke-like episodes
40004|NCT03952234|Citrulline|citrulline
40005|NCT03952234|Nitric Oxide|nitric oxide
40006|NCT03952221|hip osteoarthritis|hip osteoarthritis
40007|NCT03952221|sonotens|sonotens
40008|NCT03952221|pulsed ultrasound|pulsed ultrasound
40009|NCT03952221|continuous ultrasound|continuous ultrasound
40010|NCT03952195|IPAA|ipaa
40011|NCT03952195|IBD|ibd
40012|NCT03952195|Ulcerative Colitis|ulcerative colitis
40013|NCT03952195|Restorative Proctocolectomy|restorative proctocolectomy
40014|NCT03952195|Ileal Pouch-Anal Anastomosis|ileal pouch-anal anastomosis
40015|NCT03952195|Excisions|excisions
40016|NCT03952195|Salvage|salvage
40017|NCT03952195|Pouch|pouch
40018|NCT03952169|Primary Hypercholesterolemia|primary hypercholesterolemia
40019|NCT03952169|Probiotics|probiotics
40020|NCT03952169|Cardiovascular risk|cardiovascular risk
40021|NCT03952156|PKU|pku
40022|NCT03952156|Phenylketonuria|phenylketonuria
40023|NCT03952156|PAH Deficiency|pah deficiency
40024|NCT03952156|Hyperphenylalaninemia|hyperphenylalaninemia
40025|NCT03952156|Phenylalanine|phenylalanine
40026|NCT03952156|Adeno Associated Virus|adeno associated virus
40027|NCT03952156|AAVHSC15|aavhsc15
40028|NCT03952117|primary motor cortex|primary motor cortex
40029|NCT03952065|Head/Neck tumor|head/neck tumor
40030|NCT03952065|PD1 antibody|pd1 antibody
40031|NCT03952065|Artery infusion|artery infusion
40032|NCT03952052|MRD|mrd
40033|NCT03952052|Mutation|mutation
40034|NCT03952052|Next Generation sequencing|next generation sequencing
40035|NCT03952052|Digital Polymeras Chain Reaction|digital polymeras chain reaction
40036|NCT03952039|MF|mf
40037|NCT03952039|myeloproliferative neoplasms|myeloproliferative neoplasms
40038|NCT03952039|MPN|mpn
40039|NCT03952039|myelofibrosis|myelofibrosis
40040|NCT03952039|PMF|pmf
40041|NCT03952039|post-PV|post-pv
40042|NCT03952039|Post-Polycythemia Vera|post-polycythemia vera
40043|NCT03952039|post-ET MF|post-et mf
40044|NCT03952039|Post-Essential Thrombocythemia Myelofibrosis|post-essential thrombocythemia myelofibrosis
40045|NCT03952026|Pelvic trauma|pelvic trauma
40046|NCT03952026|Pelvic ring fracture|pelvic ring fracture
40047|NCT03952026|Acetabular Fracture|acetabular fracture
40048|NCT03952026|Abdominal Trauma|abdominal trauma
40049|NCT03952026|Polytrauma|polytrauma
40050|NCT03952026|Reduction quality|reduction quality
40051|NCT03951974|emotion regulation|emotion regulation
40052|NCT03951974|social regulation of emotion|social regulation of emotion
40053|NCT03951948|total hip replacement|total hip replacement
40054|NCT03951935|pelvic stability|pelvic stability
40055|NCT03951935|lumbo- pelvic- hip complex|lumbo- pelvic- hip complex
40056|NCT03951935|lumbo-pelvic-hip muscles|lumbo-pelvic-hip muscles
40057|NCT03951870|mesolimbic reward system|mesolimbic reward system
40058|NCT03951870|fMRI Neurofeedback|fmri neurofeedback
40059|NCT03951857|Aging|aging
40060|NCT03951857|Obesity|obesity
40061|NCT03951857|Single muscle fiber contractile properties|single muscle fiber contractile properties
40062|NCT03951857|Intramyocellular lipids|intramyocellular lipids
40063|NCT03951857|Resistance exercise|resistance exercise
40064|NCT03951844|Exoskeleton|exoskeleton
40065|NCT03951844|Upper limb|upper limb
40066|NCT03951844|Assistive device|assistive device
40067|NCT03951831|Cancer|cancer
40068|NCT03951831|Chemoimmunotherapy|chemoimmunotherapy
40069|NCT03951831|Prostate Cancer|prostate cancer
40070|NCT03951766|mHealth|mhealth
40071|NCT03951766|smartphone|smartphone
40072|NCT03951766|smoking cessation|smoking cessation
40073|NCT03951766|app|app
40074|NCT03951766|happiness|happiness
40075|NCT03951766|positive psychology|positive psychology
40076|NCT03951740|Fitbit Charge 2|fitbit charge 2
40077|NCT03951740|Mio Slice|mio slice
40078|NCT03951740|Validation study|validation study
40079|NCT03951740|Energy expenditure|energy expenditure
40080|NCT03951714|Post-market study|post-market study
40081|NCT03951649|headache|headache
40082|NCT03951649|Pregnancy|pregnancy
40083|NCT03951649|Acute treatment|acute treatment
40084|NCT03951649|Emergency department|emergency department
40085|NCT03951649|Occipital nerve block|occipital nerve block
40086|NCT03951636|peri-implant mucositis|peri-implant mucositis
40087|NCT03951636|non surgical therapy|non surgical therapy
40088|NCT03951636|laser|laser
40089|NCT03951636|air powder|air powder
40090|NCT03951636|chlorhexidine|chlorhexidine
40091|NCT03951623|syk inhibitor|syk inhibitor
40092|NCT03951623|ITP|itp
40093|NCT03951597|intrahepatic cholangiocarcinoma|intrahepatic cholangiocarcinoma
40094|NCT03951597|oxaliplatin and gemcitabine chemotherapy|oxaliplatin and gemcitabine chemotherapy
40095|NCT03951597|Lenvatinib|lenvatinib
40096|NCT03951597|programmed cell death protein 1 antibody|programmed cell death protein 1 antibody
40097|NCT03951584|idiopathic sudden sensorineural hearing loss|idiopathic sudden sensorineural hearing loss
40098|NCT03951584|vestibular dysfunction|vestibular dysfunction
40099|NCT03951558|diet|diet
40100|NCT03951558|drinking water|drinking water
40101|NCT03951558|salt|salt
40102|NCT03951558|dietaryprotein|dietaryprotein
40103|NCT03951545|Osteoarthritis Knee|osteoarthritis knee
40104|NCT03951545|Knee prosthesis|knee prosthesis
40105|NCT03951545|Patient satisfaction|patient satisfaction
40106|NCT03951532|Hyperthyroidism|hyperthyroidism
40107|NCT03951532|paediatrics|paediatrics
40108|NCT03951532|health data base|health data base
40109|NCT03951493|Hypo-fractured radiotherapy in stereotactic conditions (RSHF)|hypo-fractured radiotherapy in stereotactic conditions (rshf)
40110|NCT03951493|zoledronic acid|zoledronic acid
40111|NCT03951493|medico-economic|medico-economic
40112|NCT03951493|vertebral compressive fracture|vertebral compressive fracture
40113|NCT03951467|Literacy|literacy
40114|NCT03951467|Cardiovascular Diseases|cardiovascular diseases
40115|NCT03951467|Interventional study|interventional study
40116|NCT03951467|Randomized Controlled Trial|randomized controlled trial
40117|NCT03951467|Tertiary prevention|tertiary prevention
40118|NCT03951467|Health promotion|health promotion
40119|NCT03951454|maternal|maternal
40120|NCT03951454|non-metastatic|non-metastatic
40121|NCT03951454|anxiety|anxiety
40122|NCT03951454|depression|depression
40123|NCT03951441|lower limb|lower limb
40124|NCT03951415|Poly (ADP-ribose) Polymerase Inhibitors|poly (adp-ribose) polymerase inhibitors
40125|NCT03951415|Antibodies, Monoclonal|antibodies, monoclonal
40126|NCT03951415|Checkpoint Inhibitors|checkpoint inhibitors
40127|NCT03951415|olaparib|olaparib
40128|NCT03951415|durvalumab|durvalumab
40129|NCT03951415|Anti-PD-L1|anti-pd-l1
40130|NCT03951402|QT/QTc Interval|qt/qtc interval
40131|NCT03951350|mediterranean lifestyles|mediterranean lifestyles
40132|NCT03951350|depression|depression
40133|NCT03951350|primary health care|primary health care
40134|NCT03951350|adjuvant treatment|adjuvant treatment
40135|NCT03951337|64Cu-ATSM|64cu-atsm
40136|NCT03951337|neoadjuvant treatment|neoadjuvant treatment
40137|NCT03951337|chemoradiotherapy|chemoradiotherapy
40138|NCT03951337|surgery|surgery
40139|NCT03951337|Positron Emission Tomography (PET)/CT scan|positron emission tomography (pet)/ct scan
40140|NCT03951337|Prediction of response to treatment|prediction of response to treatment
40141|NCT03951337|Rodel score|rodel score
40142|NCT03951324|bile duct stricture|bile duct stricture
40143|NCT03951324|bile duct neoplasm|bile duct neoplasm
40144|NCT03951324|bile duct obstruction|bile duct obstruction
40145|NCT03951324|bile duct lesion|bile duct lesion
40146|NCT03951324|cholangiocarcinoma|cholangiocarcinoma
40147|NCT03951324|pancreatic duct stricture|pancreatic duct stricture
40148|NCT03951324|pancreatic duct obstruction|pancreatic duct obstruction
40149|NCT03951324|pancreatic cancer|pancreatic cancer
40150|NCT03951324|primary sclerosing cholangitis|primary sclerosing cholangitis
40151|NCT03951298|Diabetes Mellitus|diabetes mellitus
40152|NCT03951298|Diabetes Insipidus|diabetes insipidus
40153|NCT03951298|Optic Atrophy|optic atrophy
40154|NCT03951298|Deafness|deafness
40155|NCT03951285|Obesity|obesity
40156|NCT03951285|Metabolic syndrome|metabolic syndrome
40157|NCT03951285|Vitamin B3|vitamin b3
40158|NCT03951285|Nicotinamide riboside|nicotinamide riboside
40159|NCT03951285|Mitochondrial dysfunction|mitochondrial dysfunction
40160|NCT03951285|Mitochondria|mitochondria
40161|NCT03951285|Adipose tissue|adipose tissue
40162|NCT03951285|Skeletal muscle|skeletal muscle
40163|NCT03951246|executive functions|executive functions
40164|NCT03951246|motor skills|motor skills
40165|NCT03951246|eye tracking|eye tracking
40166|NCT03951246|pediatric cancer|pediatric cancer
40167|NCT03951246|posterior fossa tumors|posterior fossa tumors
40168|NCT03951168|Diabetes Mellitus|diabetes mellitus
40169|NCT03951168|Health education for diabetes|health education for diabetes
40170|NCT03951155|ADHD|adhd
40171|NCT03951155|behavioral management|behavioral management
40172|NCT03951155|dental management|dental management
40173|NCT03951142|Magnetic Resonance Imaging|magnetic resonance imaging
40174|NCT03951142|Brain Cancer|brain cancer
40175|NCT03951142|Angiotensin II receptor blocker|angiotensin ii receptor blocker
40176|NCT03951142|Losartan|losartan
40177|NCT03951142|Perfusion|perfusion
40178|NCT03951142|Solid stress|solid stress
40179|NCT03951116|solid tumor|solid tumor
40180|NCT03951103|Elocta|elocta
40181|NCT03951103|rFVIIIFc|rfviiifc
40182|NCT03951077|Polycystic Ovary Syndrome|polycystic ovary syndrome
40183|NCT03951077|Hormone|hormone
40184|NCT03951077|Elagolix|elagolix
40185|NCT03951064|Transpulmonary pressure|transpulmonary pressure
40186|NCT03951064|Esophageal balloon|esophageal balloon
40877|NCT03946657|Oximetry|oximetry
40187|NCT03951064|Esophageal pressure monitoring|esophageal pressure monitoring
40188|NCT03951064|Mechanical ventilation|mechanical ventilation
40189|NCT03951051|Olmesartan Medoxomil|olmesartan medoxomil
40190|NCT03951051|Bioequivalence|bioequivalence
40191|NCT03951051|Olmetec|olmetec
40192|NCT03951038|Lumbar disc herniation|lumbar disc herniation
40193|NCT03951038|Postoperative analgesia|postoperative analgesia
40194|NCT03951038|Patient controlled intravenous analgesia|patient controlled intravenous analgesia
40195|NCT03951038|Nerve block|nerve block
40196|NCT03951038|thoracolumbar|thoracolumbar
40197|NCT03951025|melatonin|melatonin
40198|NCT03951025|oral administration|oral administration
40199|NCT03951025|sublingual administration|sublingual administration
40200|NCT03950999|Focus analgesia selection test (FAST)|focus analgesia selection test (fast)
40201|NCT03950999|Placebo effect|placebo effect
40202|NCT03950999|Experimental pain variability|experimental pain variability
40203|NCT03950986|Vaccination|vaccination
40204|NCT03950986|EHR Reminders|ehr reminders
40205|NCT03950986|Nudge|nudge
40206|NCT03950986|Electronic Medical Records|electronic medical records
40207|NCT03950986|Behavioral Economics|behavioral economics
40208|NCT03950973|Diabetes|diabetes
40209|NCT03950973|Self-management|self-management
40210|NCT03950973|Adherence|adherence
40211|NCT03950973|Social determinants of health|social determinants of health
40212|NCT03950973|Social risk factors|social risk factors
40213|NCT03950960|Cytochrome P450 3A4 Inhibition|cytochrome p450 3a4 inhibition
40214|NCT03950947|Circulation, Collateral|circulation, collateral
40215|NCT03950947|Coronary Artery Disease|coronary artery disease
40216|NCT03950947|Internal Mammary-Coronary Artery Anastomosis|internal mammary-coronary artery anastomosis
40217|NCT03950947|Ischemia|ischemia
40218|NCT03950934|Anesthesia|anesthesia
40219|NCT03950934|Airway Management|airway management
40220|NCT03950934|Intubation|intubation
40221|NCT03950934|Bronchoscopes|bronchoscopes
40222|NCT03950934|Risk Assessment|risk assessment
40223|NCT03950934|Surgery|surgery
40224|NCT03950921|Catheter-Related Infections|catheter-related infections
40225|NCT03950921|Pressure Injury|pressure injury
40226|NCT03950921|Patient Safety|patient safety
40227|NCT03950843|Atrial Fibrillation|atrial fibrillation
40228|NCT03950804|Complement hyperactivation|complement hyperactivation
40229|NCT03950804|CD55 deficiency|cd55 deficiency
40230|NCT03950804|Complement C5|complement c5
40231|NCT03950804|Eculizumab|eculizumab
40232|NCT03950804|Multi-OMICs Analyses|multi-omics analyses
40233|NCT03950804|Protein losing enteropathy|protein losing enteropathy
40234|NCT03950765|ecological momentary assessment|ecological momentary assessment
40235|NCT03950765|ecological momentary intervention|ecological momentary intervention
40236|NCT03950765|distress|distress
40237|NCT03950752|postprandial|postprandial
40238|NCT03950752|cardiovascular disease|cardiovascular disease
40239|NCT03950752|saturated fatty acids|saturated fatty acids
40240|NCT03950752|monounsaturated fatty acids|monounsaturated fatty acids
40241|NCT03950752|palm oil|palm oil
40242|NCT03950739|prostacyclin|prostacyclin
40243|NCT03950726|Crohn Disease|crohn disease
40244|NCT03950726|Ileocolic resection|ileocolic resection
40245|NCT03950726|Appendectomy|appendectomy
40246|NCT03950726|Single-port incision|single-port incision
40247|NCT03950726|McBurney|mcburney
40248|NCT03950726|Laparoscopy|laparoscopy
40249|NCT03950713|Mindfulness-based Program|mindfulness-based program
40250|NCT03950713|Relocation stress|relocation stress
40251|NCT03950713|Depression|depression
40252|NCT03950713|Glycemic control|glycemic control
40253|NCT03950700|Analgesia|analgesia
40254|NCT03950700|Bupivacaine|bupivacaine
40255|NCT03950700|Postoperative pain|postoperative pain
40256|NCT03950700|Third molar|third molar
40257|NCT03950700|Extraction|extraction
40258|NCT03950674|Programmed Cell Death-1 (PD1, PD-1)|programmed cell death-1 (pd1, pd-1)
40259|NCT03950674|Programmed Death-Ligand 1 (PDL1, PD-L1)|programmed death-ligand 1 (pdl1, pd-l1)
40260|NCT03950674|Non-Small-Cell Lung Cancer (NSCLC)|non-small-cell lung cancer (nsclc)
40261|NCT03950661|nature|nature
40262|NCT03950661|walk|walk
40263|NCT03950661|stress|stress
40264|NCT03950661|Green Walking|green walking
40265|NCT03950661|Physical Activity|physical activity
40266|NCT03950661|Environment|environment
40267|NCT03950661|anxiety|anxiety
40268|NCT03950661|mood|mood
40269|NCT03950583|interstitial lung disease|interstitial lung disease
40270|NCT03950583|interstitial pneumonia|interstitial pneumonia
40271|NCT03950583|connective tissue disease|connective tissue disease
40272|NCT03950583|clinical course|clinical course
40273|NCT03950557|Infusion pumps|infusion pumps
40274|NCT03950557|Intraoperative brain monitoring|intraoperative brain monitoring
40275|NCT03950531|Bronchiectasis|bronchiectasis
40276|NCT03950531|Chronic Obstructive Pulmonary Disease|chronic obstructive pulmonary disease
40277|NCT03950531|Exacerbation|exacerbation
40278|NCT03950531|Computed Tomography|computed tomography
40279|NCT03950518|treatment|treatment
40280|NCT03950492|Deep Brain Stimulation|deep brain stimulation
40281|NCT03950466|Sleep apnea|sleep apnea
40282|NCT03950466|Children|children
40283|NCT03950466|Neurocognitive|neurocognitive
40284|NCT03950440|Transaortic valve replacement|transaortic valve replacement
40285|NCT03950440|Surgical aortic valve replacement|surgical aortic valve replacement
40286|NCT03950440|TAVR|tavr
40287|NCT03950440|SAVR|savr
40288|NCT03950427|smoking cessation|smoking cessation
40289|NCT03950427|serious mental illness|serious mental illness
40290|NCT03950414|T-cell|t-cell
40291|NCT03950414|immunotherapy|immunotherapy
40292|NCT03950401|skin closure|skin closure
40293|NCT03950375|Sensorineural Hearing Loss|sensorineural hearing loss
40294|NCT03950375|Round Window|round window
40295|NCT03950375|ear surgery|ear surgery
40296|NCT03950375|Cochlear implantation|cochlear implantation
40297|NCT03950362|non-muscle-invasive bladder cancer|non-muscle-invasive bladder cancer
40298|NCT03950362|radiotherapy|radiotherapy
40299|NCT03950362|immunotherapy|immunotherapy
40300|NCT03950362|quality of life|quality of life
40301|NCT03950349|Radiculopathy|radiculopathy
40302|NCT03950349|myelopathy|myelopathy
40303|NCT03950349|anterior cervical fusion|anterior cervical fusion
40304|NCT03950349|stand-alone cage|stand-alone cage
40305|NCT03950349|pseudoarthrosis|pseudoarthrosis
40306|NCT03950349|stabilization|stabilization
40307|NCT03950349|HRCC|hrcc
40308|NCT03950336|intestinal permeability|intestinal permeability
40309|NCT03950336|Crohn's Disease (CD)|crohn's disease (cd)
40310|NCT03950336|oligofructose-enriched inulin|oligofructose-enriched inulin
40311|NCT03950336|prebiotics|prebiotics
40312|NCT03950336|n-3 polyunsaturated fatty acids (n-3 PUFA)|n-3 polyunsaturated fatty acids (n-3 pufa)
40313|NCT03950336|intestinal microbiota|intestinal microbiota
40314|NCT03950323|Parotidetomy|parotidetomy
40315|NCT03950323|Tractography|tractography
40316|NCT03950323|Facial nerve|facial nerve
40317|NCT03950323|Facial palsy|facial palsy
40318|NCT03950323|Tumor of parotid gland|tumor of parotid gland
40319|NCT03950310|ELCA|elca
40320|NCT03950310|STEMI|stemi
40321|NCT03950310|Myocardial Salvage|myocardial salvage
40322|NCT03950245|glucagon-like peptide-1|glucagon-like peptide-1
40323|NCT03950245|glucose-dependent insulinotropic polypeptide|glucose-dependent insulinotropic polypeptide
40324|NCT03950245|Roux-en-Y gastric bypass|roux-en-y gastric bypass
40325|NCT03950245|sleeve gastrectomy|sleeve gastrectomy
40326|NCT03950245|gastric bypass|gastric bypass
40327|NCT03950245|bariatric surgery|bariatric surgery
40328|NCT03950245|glucose|glucose
40329|NCT03950245|diabetes|diabetes
40330|NCT03950245|exendin(9-39)|exendin(9-39)
40331|NCT03950245|GIP(3-30)|gip(3-30)
40332|NCT03950232|Ulcerative Colitis|ulcerative colitis
40333|NCT03950232|Etrasimod|etrasimod
40334|NCT03950232|APD334|apd334
40335|NCT03950219|Diabetes self-management|diabetes self-management
40336|NCT03950219|Diabetes Education|diabetes education
40337|NCT03950219|Ethnic minorities|ethnic minorities
40338|NCT03950219|Patient empowerment|patient empowerment
40339|NCT03950206|Endometriosis|endometriosis
40340|NCT03950206|Ureters|ureters
40341|NCT03950206|Indocyanine green angiography|indocyanine green angiography
40342|NCT03950193|Parental presence|parental presence
40343|NCT03950193|parental involvement|parental involvement
40344|NCT03950193|parental stress|parental stress
40345|NCT03950193|development care|development care
40346|NCT03950193|psychic development|psychic development
40347|NCT03950167|gallbladder functions|gallbladder functions
40348|NCT03950167|cholecystokinin|cholecystokinin
40349|NCT03950167|hyperemesis gravidarum|hyperemesis gravidarum
40350|NCT03950154|effcet|effcet
40351|NCT03950154|safety|safety
40352|NCT03950128|Dating aggression|dating aggression
40353|NCT03950128|Emotion regulation|emotion regulation
40354|NCT03950128|Mindfulness|mindfulness
40355|NCT03950128|Mindfulness-based skills|mindfulness-based skills
40356|NCT03950128|Romantic relationships|romantic relationships
40357|NCT03950128|Dating relationships|dating relationships
40358|NCT03950076|Edoxaban|edoxaban
40359|NCT03950076|Intracranial Hemorrhage|intracranial hemorrhage
40360|NCT03950076|Hemorrhagic Stroke|hemorrhagic stroke
40361|NCT03950063|Cutibacterium acnes Prosthesis|cutibacterium acnes prosthesis
40362|NCT03950063|Bone Infections|bone infections
40363|NCT03950024|arthrogenic muscle inhibition|arthrogenic muscle inhibition
40364|NCT03950024|anterior cruciate ligament|anterior cruciate ligament
40365|NCT03950024|functional brain MRI|functional brain mri
40366|NCT03950024|Central nervous system|central nervous system
40367|NCT03950024|Knee trauma|knee trauma
40368|NCT03950011|Enhanced Recovery After Surgery Program (ERP)|enhanced recovery after surgery program (erp)
40369|NCT03949998|Dry Needling|dry needling
40370|NCT03949972|Focal and Segmental Glomerulosclerosis|focal and segmental glomerulosclerosis
40371|NCT03949972|Focal & Segmental Glomerulosclerosis|focal & segmental glomerulosclerosis
40372|NCT03949972|FSGS|fsgs
40373|NCT03949972|Minimal change disease|minimal change disease
40374|NCT03949972|MCD|mcd
40375|NCT03949972|Nephrotic Syndrome|nephrotic syndrome
40376|NCT03949959|Physiotherapy|physiotherapy
40377|NCT03949946|lipid composition|lipid composition
40378|NCT03949946|MRI|mri
40379|NCT03949933|proton and carbon ion radiotherapy|proton and carbon ion radiotherapy
40380|NCT03949920|Fabry|fabry
40385|NCT03949881|Total bilateral limbal cell deficiency|total bilateral limbal cell deficiency
40386|NCT03949881|Autologous jugal mucosa cell sheet|autologous jugal mucosa cell sheet
40387|NCT03949881|FEMJA graft|femja graft
40388|NCT03949868|mindfulness|mindfulness
40389|NCT03949868|forgetfulness|forgetfulness
40390|NCT03949868|Langerian mindfulness|langerian mindfulness
40391|NCT03949855|Primary Membranous Nephropathy|primary membranous nephropathy
40392|NCT03949855|nephrotic syndrome|nephrotic syndrome
40393|NCT03949855|Pharmacokinetics (PK) Analysis|pharmacokinetics (pk) analysis
40394|NCT03949855|Double-Blind (Masked), Placebo-Controlled Clinical Trial|double-blind (masked), placebo-controlled clinical trial
40395|NCT03949855|Co-administered belimumab and rituximab|co-administered belimumab and rituximab
40396|NCT03949842|Fluticasone furoate|fluticasone furoate
40397|NCT03949842|Umeclidinium bromide|umeclidinium bromide
40398|NCT03949842|Vilanterol|vilanterol
40400|NCT03949842|ELLIPTA|ellipta
40401|NCT03949842|TRELEGY|trelegy
40402|NCT03949842|MITT|mitt
40403|NCT03949842|SITT|sitt
40404|NCT03949829|Pre- eclampsia|pre- eclampsia
40405|NCT03949829|Heart disease in women|heart disease in women
40406|NCT03949816|patient-centered communication|patient-centered communication
40407|NCT03949816|doctor-centered communication|doctor-centered communication
40408|NCT03949816|placebo|placebo
40409|NCT03949816|nocebo|nocebo
40410|NCT03949816|outcome expectation|outcome expectation
40411|NCT03949816|blood pressure|blood pressure
40412|NCT03949816|heart rate|heart rate
40413|NCT03949816|patient-physician communication|patient-physician communication
40414|NCT03949803|Chocolate|chocolate
40415|NCT03949803|Timing|timing
40416|NCT03949803|Menopause|menopause
40417|NCT03949803|Calorimetry|calorimetry
40418|NCT03949777|screening-colonoscopy|screening-colonoscopy
40419|NCT03949777|diagnostic-colonoscopy|diagnostic-colonoscopy
40420|NCT03949777|surveillance-colonoscopy|surveillance-colonoscopy
40421|NCT03949751|gram positive bacteria|gram positive bacteria
40422|NCT03949751|Benzoylperoxid and Miconazolnitrat|benzoylperoxid and miconazolnitrat
40423|NCT03949738|Cerebral Autoregulation|cerebral autoregulation
40424|NCT03949738|Cerebral Hemodynamics|cerebral hemodynamics
40425|NCT03949738|Cognitive Impairment|cognitive impairment
40426|NCT03949738|Near-infrared Spectroscopy|near-infrared spectroscopy
40427|NCT03949686|Postoperative Analgesia|postoperative analgesia
40428|NCT03949686|Ultrasound guided erector spinae plane block|ultrasound guided erector spinae plane block
40429|NCT03949660|bowel|bowel
40430|NCT03949660|spinal cord injury|spinal cord injury
40431|NCT03949660|epidural stimulation|epidural stimulation
40437|NCT03949621|Drug therapy|drug therapy
40438|NCT03949608|e-learning|e-learning
40439|NCT03949608|drug adherence|drug adherence
40440|NCT03949608|health literacy|health literacy
40441|NCT03949595|Obese|obese
40442|NCT03949595|Food behaviour|food behaviour
40443|NCT03949595|Eating rate|eating rate
40444|NCT03949582|Type 2 Diabetes|type 2 diabetes
40445|NCT03949582|South Asian|south asian
40446|NCT03949582|Guar gum|guar gum
40447|NCT03949582|Mycoprotein|mycoprotein
40448|NCT03949582|Caucasian|caucasian
40449|NCT03949582|Glycaemic control|glycaemic control
40450|NCT03949582|Appetite|appetite
40451|NCT03949569|Children|children
40452|NCT03949569|Human-Animal Interaction|human-animal interaction
40453|NCT03949569|Stress|stress
40454|NCT03949569|Cortisol|cortisol
40455|NCT03949517|Prostate Cancer|prostate cancer
40456|NCT03949504|Diabetes|diabetes
40457|NCT03949504|neurological complications|neurological complications
40458|NCT03949504|cardiovascular complications|cardiovascular complications
40459|NCT03949478|Postictal|postictal
40460|NCT03949478|Blood flow|blood flow
40461|NCT03949439|Frailty|frailty
40462|NCT03949439|Cardiac Suregry|cardiac suregry
40463|NCT03949439|Adverse Events|adverse events
40464|NCT03949387|exercise|exercise
40465|NCT03949387|multiple sclerosis|multiple sclerosis
40466|NCT03949387|mobility|mobility
40467|NCT03949361|Glucocorticoids|glucocorticoids
40468|NCT03949361|Brown Adipose tissue|brown adipose tissue
40469|NCT03949361|Cold Induced Thermogenesis|cold induced thermogenesis
40470|NCT03949361|Resting Metabolic Rate|resting metabolic rate
40471|NCT03949348|midurethral sling placement|midurethral sling placement
40472|NCT03949348|synthetic mesh|synthetic mesh
40473|NCT03949348|autologous rectus fascia|autologous rectus fascia
40474|NCT03949348|transobturator approach|transobturator approach
40475|NCT03949322|physical activity|physical activity
40476|NCT03949322|cancer Related Cognitive Impairment|cancer related cognitive impairment
40477|NCT03949283|Ovarian cancer|ovarian cancer
40478|NCT03949283|Platinum resistant|platinum resistant
40479|NCT03949283|ChemoID|chemoid
40482|NCT03949257|transendoscopic enteral tubing|transendoscopic enteral tubing
40483|NCT03949257|gut microbiota|gut microbiota
40484|NCT03949257|ulcerative colitis|ulcerative colitis
40485|NCT03949244|Nailfold capillary imaging|nailfold capillary imaging
40486|NCT03949244|Latanoprost bunod|latanoprost bunod
40488|NCT03949231|Liver Cancer|liver cancer
40489|NCT03949231|PD1 antibody|pd1 antibody
40490|NCT03949231|Artery infusion|artery infusion
40491|NCT03949218|bipolar disorder|bipolar disorder
40492|NCT03949218|machine learning|machine learning
40493|NCT03949179|Low back pain|low back pain
40494|NCT03949179|Pain management|pain management
40495|NCT03949179|Rehabilitation|rehabilitation
40496|NCT03949179|Feasibility outcomes|feasibility outcomes
40500|NCT03949127|non-surgical treatment|non-surgical treatment
40501|NCT03949127|exercise|exercise
40502|NCT03949114|neurosurgery|neurosurgery
40503|NCT03949101|myopia progression|myopia progression
40504|NCT03949101|atropine|atropine
40505|NCT03949101|prospective study|prospective study
40506|NCT03949088|Intradialytic hypotension (IDH)|intradialytic hypotension (idh)
40507|NCT03949088|Ultrafiltration (UF) profiling|ultrafiltration (uf) profiling
40508|NCT03949088|Sodium (Na) profiling|sodium (na) profiling
40509|NCT03949088|Hemodialysis|hemodialysis
40510|NCT03949075|Adaptation, Physiological|adaptation, physiological
40511|NCT03949075|Genotype|genotype
40512|NCT03949075|Polymorphism, Genetic|polymorphism, genetic
40513|NCT03949075|Enalapril|enalapril
40514|NCT03949075|Physiological Effects of Drugs|physiological effects of drugs
40515|NCT03949062|iR2|ir2
40516|NCT03949036|kidney transplantation|kidney transplantation
40517|NCT03949036|preload index|preload index
40518|NCT03949036|stroke volume variation|stroke volume variation
40519|NCT03949036|goad-directed therapy|goad-directed therapy
40520|NCT03949023|Neurovascular Condition|neurovascular condition
40521|NCT03949023|Contrast Injections|contrast injections
40522|NCT03949023|Brain|brain
40523|NCT03949010|Myofascial pain syndrome, kinesiotaping, upper trapezius, home exercise program|myofascial pain syndrome, kinesiotaping, upper trapezius, home exercise program
40524|NCT03948997|port wine stain, PI3K, vascular malformation,PDL|port wine stain, pi3k, vascular malformation,pdl
40525|NCT03948971|cerebral arteriography|cerebral arteriography
40526|NCT03948958|Vascular Access Devices|vascular access devices
40527|NCT03948958|Implantable port|implantable port
40528|NCT03948958|Flush interval|flush interval
40529|NCT03948958|Catheter function|catheter function
40530|NCT03948958|Catheter-related infection|catheter-related infection
40531|NCT03948958|Catheter tip location|catheter tip location
40532|NCT03948958|Catheter tip thrombus|catheter tip thrombus
40533|NCT03948958|Catheter sleeve|catheter sleeve
40534|NCT03948958|Patient-reported outcome measure|patient-reported outcome measure
40535|NCT03948945|Fractional Laser|fractional laser
40536|NCT03948945|Photoaging|photoaging
40537|NCT03948945|Treatment|treatment
40538|NCT03948945|Halo|halo
40539|NCT03948906|Stroke , acute , observational study , rehabilitation|stroke , acute , observational study , rehabilitation
40540|NCT03948867|Sickle Celll Anemia|sickle celll anemia
40541|NCT03948867|Transcranial Doppler|transcranial doppler
40542|NCT03948867|Tanzania|tanzania
40543|NCT03948867|Hydroxyurea|hydroxyurea
40544|NCT03948867|Stroke|stroke
40545|NCT03948841|Neuroendocrine tumor|neuroendocrine tumor
40546|NCT03948828|Endometriosis|endometriosis
40547|NCT03948828|NK cell therapy|nk cell therapy
40548|NCT03948815|Birthing room|birthing room
40549|NCT03948815|labour|labour
40550|NCT03948815|randomised controlled trial|randomised controlled trial
40551|NCT03948802|Ischemic Stroke|ischemic stroke
40552|NCT03948802|Interleukin 33|interleukin 33
40553|NCT03948802|ASTRAL|astral
40554|NCT03948802|DRAGON|dragon
40555|NCT03948802|NIHSS|nihss
40556|NCT03948763|cancer|cancer
40557|NCT03948763|solid tumors|solid tumors
40558|NCT03948763|Pembrolizumab|pembrolizumab
40559|NCT03948763|PD1|pd1
40560|NCT03948763|PD-1|pd-1
40561|NCT03948763|PDL1|pdl1
40562|NCT03948763|PD-L1|pd-l1
40563|NCT03948763|KRAS|kras
40564|NCT03948763|mRNA|mrna
40565|NCT03948737|Haptoglobin|haptoglobin
40566|NCT03948737|Hemopexin|hemopexin
40567|NCT03948737|Hemolysis|hemolysis
40568|NCT03948737|Malondialdehyde|malondialdehyde
40569|NCT03948737|Glutathione|glutathione
40570|NCT03948737|Oxidative stress|oxidative stress
40571|NCT03948737|Alpha-Tocopherol|alpha-tocopherol
40572|NCT03948672|hand hygiene|hand hygiene
40573|NCT03948672|infection|infection
40574|NCT03948672|sensor|sensor
40575|NCT03948633|school vaccinations|school vaccinations
40576|NCT03948633|pain management|pain management
40577|NCT03948633|knowledge translation|knowledge translation
40578|NCT03948607|Electroencephalography|electroencephalography
40579|NCT03948607|Neurocognition|neurocognition
40581|NCT03948607|Attention lapses|attention lapses
40582|NCT03948594|resource|resource
40583|NCT03948594|gastric residual volume|gastric residual volume
40584|NCT03948594|hunger score|hunger score
40585|NCT03948581|Drug therapy|drug therapy
40586|NCT03948568|Radiation Therapy|radiation therapy
40587|NCT03948568|Endocrine Therapy|endocrine therapy
40588|NCT03948542|Intramedullary nailing|intramedullary nailing
40589|NCT03948542|ORIF|orif
40590|NCT03948542|Humeral shaft fracture|humeral shaft fracture
40591|NCT03948529|Poor Graft Function (PGF),|poor graft function (pgf),
40592|NCT03948529|Allogeneic hematopoietic cell transplantation (Allo-HCT)|allogeneic hematopoietic cell transplantation (allo-hct)
40593|NCT03948529|Eltrombopag.|eltrombopag.
40594|NCT03948503|ankle sprain|ankle sprain
40595|NCT03948503|Mulligan|mulligan
40596|NCT03948503|manual therapy|manual therapy
40597|NCT03948490|cognitive impairment|cognitive impairment
40598|NCT03948490|quality of life|quality of life
40599|NCT03948464|slow-release oral morphine|slow-release oral morphine
40600|NCT03948464|methadone|methadone
40601|NCT03948464|opioid use disorder|opioid use disorder
40602|NCT03948464|fentanyl|fentanyl
40603|NCT03948451|Coronary Artery Disease|coronary artery disease
40604|NCT03948399|Ischemic Stroke|ischemic stroke
40605|NCT03948399|TIA|tia
40606|NCT03948399|ABI|abi
40607|NCT03948399|LEAD|lead
40608|NCT03948360|acute burn, thermal injury, wound, phototherapy, wound healing, antimicrobial|acute burn, thermal injury, wound, phototherapy, wound healing, antimicrobial
40609|NCT03948347|ischemic stroke|ischemic stroke
40610|NCT03948347|transient ischemic attack|transient ischemic attack
40611|NCT03948347|glucagon-like peptide-1|glucagon-like peptide-1
40612|NCT03948347|type 2 diabetes mellitus|type 2 diabetes mellitus
40613|NCT03948334|atopic dermatitis, AD, eczema, itch, pruritus, H4R, ZPL389|atopic dermatitis, ad, eczema, itch, pruritus, h4r, zpl389
40614|NCT03948321|Photodynamic Therapy，PDT|photodynamic therapy，pdt
40615|NCT03948321|Conventional|conventional
40616|NCT03948321|Painless|painless
40617|NCT03948321|Genital Warts|genital warts
40618|NCT03948269|menopause|menopause
40619|NCT03948269|group treatment|group treatment
40620|NCT03948269|mood swing|mood swing
40621|NCT03948269|quality of life|quality of life
40622|NCT03948256|External ventricular drain|external ventricular drain
40623|NCT03948256|Weaning|weaning
40624|NCT03948256|Closure|closure
40625|NCT03948243|Licorice|licorice
40626|NCT03948217|artificial lighting|artificial lighting
40627|NCT03948191|99Tc-MDP|99tc-mdp
40628|NCT03948191|TAO|tao
40629|NCT03948191|efficacy|efficacy
40630|NCT03948191|safety|safety
40631|NCT03948165|dTRA|dtra
40632|NCT03948165|transradial access|transradial access
40633|NCT03948165|distal|distal
40634|NCT03948165|coronary|coronary
40635|NCT03948152|Sleep Apnea|sleep apnea
40636|NCT03948139|Pediatric|pediatric
40637|NCT03948139|Fracture|fracture
40638|NCT03948139|Functional Brace|functional brace
40639|NCT03948139|Hip Spica Cast|hip spica cast
40640|NCT03948126|geophagia|geophagia
40641|NCT03948061|cherries|cherries
40642|NCT03948061|inflammatory disease|inflammatory disease
40643|NCT03948061|chronic stress|chronic stress
40644|NCT03948048|septic shock|septic shock
40645|NCT03948048|children|children
40646|NCT03948048|ECMO|ecmo
40647|NCT03948048|timing|timing
40648|NCT03948035|multiple myeloma|multiple myeloma
40649|NCT03948035|autologous stem cell transplant|autologous stem cell transplant
40650|NCT03948035|Elotuzumab|elotuzumab
40651|NCT03948035|Carfilzomib|carfilzomib
40652|NCT03948035|Lenalidomide|lenalidomide
40653|NCT03948022|progesterone|progesterone
40654|NCT03948022|implantation|implantation
40655|NCT03948022|pregnancy|pregnancy
40656|NCT03948022|abortion|abortion
40657|NCT03947983|self-management|self-management
40658|NCT03947983|digital game|digital game
40659|NCT03947983|sensor|sensor
40660|NCT03947970|Hemodialysis|hemodialysis
40661|NCT03947970|Difelikefalin|difelikefalin
40662|NCT03947970|Dialysis|dialysis
40663|NCT03947970|CR845|cr845
40664|NCT03947970|CKD|ckd
40665|NCT03947970|ESRD (end stage renal disease)|esrd (end stage renal disease)
40666|NCT03947944|Small incision lenticule extraction|small incision lenticule extraction
40667|NCT03947944|astigmatism|astigmatism
40668|NCT03947944|vector planning|vector planning
40669|NCT03947931|ulcerative colitis, acute severe ulcerative colitis, predictors of colectomy|ulcerative colitis, acute severe ulcerative colitis, predictors of colectomy
40670|NCT03947905|Vascular|vascular
40671|NCT03947905|Clinic visit|clinic visit
40672|NCT03947905|Tele-health|tele-health
40673|NCT03947840|Colon cancer|colon cancer
40674|NCT03947840|Physical activity|physical activity
40675|NCT03947827|Treatment Resistant Depression|treatment resistant depression
40676|NCT03947827|Minocycline|minocycline
40677|NCT03947827|Neuroinflammation|neuroinflammation
40678|NCT03947827|Microglial Activation|microglial activation
40679|NCT03947827|Biomarker|biomarker
40688|NCT03947775|Men who have sex with men|men who have sex with men
40689|NCT03947775|Human immunodeficiency virus|human immunodeficiency virus
40690|NCT03947775|Human papillomavirus|human papillomavirus
40692|NCT03947775|Gardasil|gardasil
40693|NCT03947775|Anal Intraepithelial Neoplasia|anal intraepithelial neoplasia
40694|NCT03947775|Anal Cancer|anal cancer
40695|NCT03947775|9-valent|9-valent
40696|NCT03947723|trichiasis|trichiasis
40697|NCT03947723|radiofrequency ablation|radiofrequency ablation
40698|NCT03947723|epilation|epilation
40699|NCT03947723|histology|histology
40700|NCT03947697|Obesity|obesity
40701|NCT03947684|Sex Hormones|sex hormones
40702|NCT03947671|temperature regulation|temperature regulation
40703|NCT03947658|surgical|surgical
40704|NCT03947658|prosthetic restoration|prosthetic restoration
40705|NCT03947658|gingiva|gingiva
40706|NCT03947658|surgical flaps|surgical flaps
40707|NCT03947658|stents|stents
40708|NCT03947619|Anterior STEMI|anterior stemi
40709|NCT03947619|ST-Elevated MI|st-elevated mi
40710|NCT03947619|Cardiac Unloading|cardiac unloading
40711|NCT03947606|Decision-making|decision-making
40712|NCT03947606|Decisions|decisions
40713|NCT03947606|Multiphase Optimization Strategy|multiphase optimization strategy
40714|NCT03947606|Factorial design|factorial design
40715|NCT03947593|Early care and education|early care and education
40716|NCT03947593|ECE|ece
40717|NCT03947593|workforce|workforce
40718|NCT03947593|child care|child care
40719|NCT03947593|caregivers|caregivers
40720|NCT03947593|home-based providers|home-based providers
40721|NCT03947593|center-based providers|center-based providers
40722|NCT03947554|Panax ginseng|panax ginseng
40723|NCT03947554|Red ginseng|red ginseng
40724|NCT03947554|Korean ginseng|korean ginseng
40725|NCT03947554|Adaptogen|adaptogen
40726|NCT03947541|Thoracolumbosacral (TLSO) brace|thoracolumbosacral (tlso) brace
40727|NCT03947541|Lumbosacral orthotic (LSO) brace|lumbosacral orthotic (lso) brace
40728|NCT03947541|Adult spinal deformity|adult spinal deformity
40729|NCT03947541|Postoperative Brace|postoperative brace
40730|NCT03947502|Fibromyalgia|fibromyalgia
40731|NCT03947502|pain|pain
40732|NCT03947502|neurobiology|neurobiology
40733|NCT03947502|education|education
40734|NCT03947502|movement|movement
40735|NCT03947463|Pectoral Nerves I & II block, Serratus Plane Block, General Anesthesia, opioid analgesia, breast cancer and modified radical mastectomy|pectoral nerves i & ii block, serratus plane block, general anesthesia, opioid analgesia, breast cancer and modified radical mastectomy
40736|NCT03947450|amputation|amputation
40737|NCT03947450|stem cells|stem cells
40738|NCT03947450|autologous fibroblast|autologous fibroblast
40739|NCT03947450|skin wound|skin wound
40740|NCT03947450|skin breakdown|skin breakdown
40741|NCT03947424|laser|laser
40742|NCT03947424|Er:YAG|er:yag
40743|NCT03947424|NightLase|nightlase
40744|NCT03947424|Fotona SMOOTH|fotona smooth
40745|NCT03947411|severe Influenza|severe influenza
40746|NCT03947372|Open Appendectomy|open appendectomy
40747|NCT03947372|Laparoscopic Appendectomy|laparoscopic appendectomy
40748|NCT03947372|post-operative pain|post-operative pain
40749|NCT03947372|Hospital stay|hospital stay
40750|NCT03947346|Kidney Function|kidney function
40751|NCT03947346|Biomarkers|biomarkers
40752|NCT03947346|19-160|19-160
40753|NCT03947333|Diabetes|diabetes
40754|NCT03947333|Patient Activation|patient activation
40755|NCT03947333|Patient Web Portals|patient web portals
40756|NCT03947333|Health Information Technology|health information technology
40757|NCT03947307|total knee replacement|total knee replacement
40758|NCT03947307|Kinesiotape treatment|kinesiotape treatment
40759|NCT03947307|manual lymphatic drainage|manual lymphatic drainage
40760|NCT03947307|compressive bandages|compressive bandages
40761|NCT03947307|Kinesiotaping|kinesiotaping
40762|NCT03947294|Indirect calorimetry|indirect calorimetry
40763|NCT03947294|Energy expenditure|energy expenditure
40764|NCT03947294|VO2|vo2
40765|NCT03947294|VCO2|vco2
40766|NCT03947281|satiety|satiety
40767|NCT03947281|gastrointestinal hormones|gastrointestinal hormones
40768|NCT03947281|appetite|appetite
40769|NCT03947281|Dietary fiber|dietary fiber
40770|NCT03947281|food cravings|food cravings
40771|NCT03947268|palliative care|palliative care
40772|NCT03947268|pelvic cancer|pelvic cancer
40773|NCT03947268|radiotherapy|radiotherapy
40774|NCT03947268|pain|pain
40775|NCT03947268|Quality of life|quality of life
40776|NCT03947255|CD30-expression|cd30-expression
40777|NCT03947255|sALCL|salcl
40778|NCT03947255|PTCL|ptcl
40779|NCT03947255|cHL|chl
40780|NCT03947242|Trastuzumab-refractory|trastuzumab-refractory
40878|NCT03946644|Safety distance|safety distance
41862|NCT03940625|MRI|mri
40781|NCT03947229|Patients who underwent percutaneous coronary intervention with DES implantation carrying high risks for the recurrent major adverse events.|patients who underwent percutaneous coronary intervention with des implantation carrying high risks for the recurrent major adverse events.
40782|NCT03947229|anti platelet therapy|anti platelet therapy
40783|NCT03947229|bleeding|bleeding
40907|NCT03946475|Adolescent girls|adolescent girls
40784|NCT03947216|impulse control disorders|impulse control disorders
40785|NCT03947216|pimavanserin|pimavanserin
40786|NCT03947216|Serotoninergic 5-HT2A inverse agonist|serotoninergic 5-ht2a inverse agonist
40787|NCT03947216|Dopamine agonist|dopamine agonist
40788|NCT03947216|Behavior|behavior
40789|NCT03947151|Fertility preservation|fertility preservation
40790|NCT03947151|Controlled ovarian stimulation|controlled ovarian stimulation
40791|NCT03947151|Oocyte vitrification|oocyte vitrification
40792|NCT03947151|GnRH antagonist protocol|gnrh antagonist protocol
40793|NCT03947112|Physical activity level|physical activity level
40794|NCT03947099|ketamine|ketamine
40796|NCT03947099|depression|depression
40797|NCT03947099|prehospital|prehospital
40798|NCT03947086|Autistic disorder|autistic disorder
40799|NCT03947086|Neuromodulation|neuromodulation
40800|NCT03947086|Social cognition|social cognition
40801|NCT03947086|Executive functions|executive functions
40802|NCT03947086|Eye tracking|eye tracking
40803|NCT03947073|Media|media
40804|NCT03947073|Education|education
40805|NCT03947073|Gestational diabetes|gestational diabetes
40806|NCT03947073|Pregnancy|pregnancy
40807|NCT03947060|Depth of anesthesia|depth of anesthesia
40808|NCT03947060|SedLine® sensor|sedline® sensor
40809|NCT03947060|Alternative position|alternative position
40810|NCT03947047|Exhaled Women Breath|exhaled women breath
40811|NCT03947047|Placenta Accreta|placenta accreta
40812|NCT03947047|Ultrasound|ultrasound
40813|NCT03947021|Electrocardiography|electrocardiography
40814|NCT03947021|Body Surface Potential Mapping|body surface potential mapping
40815|NCT03947021|Computational Biology|computational biology
40816|NCT03947008|intuitive eating|intuitive eating
40817|NCT03947008|dietary restraint|dietary restraint
40818|NCT03946995|Trigger Area|trigger area
40819|NCT03946995|Myofascial Pain Syndromes|myofascial pain syndromes
40820|NCT03946995|Instrument assisted soft tissue tecnique|instrument assisted soft tissue tecnique
40821|NCT03946982|Patient controlled epidural analgesia ,Cesarean delivery,pain management,epidural opioid|patient controlled epidural analgesia ,cesarean delivery,pain management,epidural opioid
40822|NCT03946969|Neoadjuvant|neoadjuvant
40823|NCT03946969|Esophageal Cancer|esophageal cancer
40824|NCT03946969|PD-1|pd-1
40825|NCT03946956|Screening|screening
40826|NCT03946956|Prevention|prevention
40827|NCT03946956|Cardiovascular|cardiovascular
40828|NCT03946956|Public health|public health
40829|NCT03946943|TKI|tki
40830|NCT03946943|PD-1 inhibitor|pd-1 inhibitor
40831|NCT03946943|Anlotinib|anlotinib
40832|NCT03946917|Regorafenib|regorafenib
40833|NCT03946917|JS001|js001
40834|NCT03946917|Colorectal cancer|colorectal cancer
40835|NCT03946917|Microsatellite stability|microsatellite stability
40836|NCT03946852|abdominal regional perfusion|abdominal regional perfusion
40837|NCT03946852|Donation after Cardiac Death|donation after cardiac death
40838|NCT03946852|Liver Transplantation|liver transplantation
40839|NCT03946852|Ischemia Reperfusion Injury|ischemia reperfusion injury
40840|NCT03946826|nail psoriasis|nail psoriasis
40841|NCT03946826|Pulsed dye laser (PDL)|pulsed dye laser (pdl)
40842|NCT03946826|Halometasone Cream|halometasone cream
40843|NCT03946826|Vaseline|vaseline
40844|NCT03946813|Ovarian Rejuvenation , Infertility|ovarian rejuvenation , infertility
40845|NCT03946800|MEDI1191|medi1191
40846|NCT03946800|Durvalumab|durvalumab
40847|NCT03946800|MEDI4736|medi4736
40848|NCT03946800|Imfinzi|imfinzi
40849|NCT03946774|Atherosclerosis|atherosclerosis
40850|NCT03946774|Macrophage/monocyte|macrophage/monocyte
40851|NCT03946774|mTOR|mtor
40852|NCT03946774|Autophagy|autophagy
40853|NCT03946774|Apoptosis|apoptosis
40854|NCT03946774|Inflammation|inflammation
40855|NCT03946735|Social Anxiety|social anxiety
40856|NCT03946735|Perfectionism|perfectionism
40857|NCT03946735|Rumination|rumination
40858|NCT03946735|Cognitive Behavioural Therapy|cognitive behavioural therapy
40859|NCT03946722|In vitro fertilisation|in vitro fertilisation
40860|NCT03946722|Assisted conception|assisted conception
40861|NCT03946722|Randomised controlled trial|randomised controlled trial
40862|NCT03946722|Down-regulation|down-regulation
40863|NCT03946696|dementia|dementia
40864|NCT03946696|Animal-Assisted Therapy|animal-assisted therapy
40865|NCT03946696|ethnography|ethnography
40866|NCT03946696|qualitative study|qualitative study
40867|NCT03946670|Phase II,|phase ii,
40868|NCT03946670|MBG453|mbg453
40869|NCT03946670|TIM-3|tim-3
40870|NCT03946670|decitabine|decitabine
40871|NCT03946670|azacitidine|azacitidine
40872|NCT03946670|myelodysplastic syndrome (MDS)|myelodysplastic syndrome (mds)
40873|NCT03946657|Bariatric|bariatric
40874|NCT03946657|Surgery|surgery
40875|NCT03946657|Sevoflurane|sevoflurane
40876|NCT03946657|Propofol|propofol
40879|NCT03946644|Laser ablation|laser ablation
40880|NCT03946644|Great saphenous vein|great saphenous vein
40881|NCT03946579|sexual health|sexual health
40882|NCT03946579|quality of life|quality of life
40883|NCT03946579|adjuvant chemotherapy|adjuvant chemotherapy
40884|NCT03946553|intestinal microbiota|intestinal microbiota
40885|NCT03946553|immunological markers|immunological markers
40886|NCT03946527|advanced paraganglioma|advanced paraganglioma
40887|NCT03946527|advanced pheochromocytoma|advanced pheochromocytoma
40888|NCT03946527|metastatic paraganglioma|metastatic paraganglioma
40889|NCT03946527|metastatic pheochromocytoma|metastatic pheochromocytoma
40890|NCT03946527|lanreotide|lanreotide
40891|NCT03946514|Blood pressure|blood pressure
40892|NCT03946514|single-pill fixed combination|single-pill fixed combination
40893|NCT03946514|losartan/hydrochlorothiazide|losartan/hydrochlorothiazide
40894|NCT03946514|amlodipine/hydrochlorothiazide|amlodipine/hydrochlorothiazide
40895|NCT03946501|missing data|missing data
40896|NCT03946501|clinical research|clinical research
40897|NCT03946501|clinical research assistant|clinical research assistant
40898|NCT03946488|Hand function restoration|hand function restoration
40899|NCT03946488|Prehension|prehension
40900|NCT03946488|Closed-loop controlled neuroprosthesis|closed-loop controlled neuroprosthesis
40901|NCT03946475|Anemia|anemia
40902|NCT03946475|Linear programming|linear programming
40903|NCT03946475|Optimized food based recommendations|optimized food based recommendations
40904|NCT03946475|Nutrition knowledge|nutrition knowledge
40905|NCT03946475|Dietary intake|dietary intake
40906|NCT03946475|Dietary practices|dietary practices
40908|NCT03946475|Nutrition education|nutrition education
40909|NCT03946475|Indonesia|indonesia
40910|NCT03946462|Congenital Heart Disease|congenital heart disease
40911|NCT03946462|CHD|chd
40912|NCT03946462|Acute Kidney Injury|acute kidney injury
40913|NCT03946462|AKI|aki
40914|NCT03946462|Cardiopulmonary bypass|cardiopulmonary bypass
40915|NCT03946462|CPB|cpb
40916|NCT03946462|cardiac surgery|cardiac surgery
40917|NCT03946462|neonate|neonate
40918|NCT03946462|infant|infant
40919|NCT03946462|nitric oxide|nitric oxide
40920|NCT03946462|NO|no
40921|NCT03946462|gestational age|gestational age
40922|NCT03946436|stroke technique|stroke technique
40923|NCT03946436|psychophysiological body responses|psychophysiological body responses
40924|NCT03946436|visual perceptual skills|visual perceptual skills
40925|NCT03946436|reaction time.|reaction time.
40926|NCT03946410|screening|screening
40927|NCT03946410|prevention|prevention
40928|NCT03946410|cardiovascular|cardiovascular
40929|NCT03946410|public health|public health
40930|NCT03946410|cost effectiveness|cost effectiveness
40931|NCT03946371|Sub glottic secretions|sub glottic secretions
40932|NCT03946371|Failure Extubation|failure extubation
40933|NCT03946371|endotracheal tube|endotracheal tube
40934|NCT03946358|Human PapillomaVirus (HPV)|human papillomavirus (hpv)
40935|NCT03946358|Atezolizumab|atezolizumab
40936|NCT03946358|Cancer vaccine|cancer vaccine
40937|NCT03946358|Cancer immunotherapy|cancer immunotherapy
40938|NCT03946358|Telomerase|telomerase
40939|NCT03946345|Iohexol|iohexol
40940|NCT03946345|Glomerular Filtration Rate|glomerular filtration rate
40941|NCT03946332|physical activity|physical activity
40942|NCT03946332|multiple myeloma|multiple myeloma
40943|NCT03946332|autologous stem cell transplantation|autologous stem cell transplantation
40944|NCT03946332|quality of life|quality of life
40945|NCT03946332|physical conditioning|physical conditioning
40946|NCT03946319|Internet Interventions|internet interventions
40947|NCT03946319|eMental Health|emental health
40948|NCT03946319|mHealth|mhealth
40949|NCT03946319|Transdiagnostic|transdiagnostic
40950|NCT03946319|Behavioral Health|behavioral health
40951|NCT03946319|Wellness|wellness
40952|NCT03946319|Connected Health|connected health
40953|NCT03946319|Introspect|introspect
40954|NCT03946306|ENDODONTIC IRRIGATION, ENDODONTIC DISINFECTION, EDDY TIPS, APICAL EXTRUSION, ENDODONTIC PAIN|endodontic irrigation, endodontic disinfection, eddy tips, apical extrusion, endodontic pain
40955|NCT03946280|ALARA|alara
40956|NCT03946280|radiation exposure|radiation exposure
40957|NCT03946280|Flutter ablation|flutter ablation
40958|NCT03946267|Large macular hole|large macular hole
40959|NCT03946267|Inverted flap surgery|inverted flap surgery
40960|NCT03946267|Infracyanine green|infracyanine green
40961|NCT03946267|Brilliant blue G|brilliant blue g
40962|NCT03946267|Swept source OCT|swept source oct
40963|NCT03946241|School children|school children
40964|NCT03946241|Physical Activity|physical activity
40965|NCT03946241|Accelerometry|accelerometry
40966|NCT03946241|Body mass index|body mass index
40967|NCT03946241|Implementation|implementation
40968|NCT03946241|Policy|policy
40969|NCT03946228|blood pressure|blood pressure
40970|NCT03946228|sedentary behavior|sedentary behavior
40971|NCT03946228|physical activity|physical activity
40972|NCT03946176|uremic toxins|uremic toxins
40973|NCT03946176|gut microbiota dysbiosis|gut microbiota dysbiosis
40974|NCT03946176|symbiotic|symbiotic
40975|NCT03946176|divinylbenzene cartridge|divinylbenzene cartridge
40976|NCT03946163|chronic prostatitis|chronic prostatitis
40977|NCT03946163|chronic pelvic pain syndrome|chronic pelvic pain syndrome
40978|NCT03946163|cinnamon|cinnamon
40979|NCT03946163|herbal medicine|herbal medicine
40980|NCT03946163|Traditional medicine|traditional medicine
40981|NCT03946150|P/FP Ratio|p/fp ratio
40982|NCT03946150|ARDS Definition|ards definition
40983|NCT03946150|Severity of Oxygenation in ARDS|severity of oxygenation in ards
40984|NCT03946137|Neurological chronic disorder|neurological chronic disorder
40985|NCT03946137|Child|child
40986|NCT03946137|Chest therapy|chest therapy
40987|NCT03946137|Educational intervention|educational intervention
40988|NCT03946137|Postural hygiene|postural hygiene
40989|NCT03946098|Internet intervention|internet intervention
40990|NCT03946098|Gambling Disorder|gambling disorder
40991|NCT03946098|Cognitive-behavioral therapy|cognitive-behavioral therapy
40992|NCT03946098|Psychiatric comorbidity|psychiatric comorbidity
40993|NCT03946098|Regular addiction care|regular addiction care
40994|NCT03946098|Problem gambling|problem gambling
40995|NCT03946085|Lumega-Z|lumega-z
40996|NCT03946085|Carotenoid supplement|carotenoid supplement
40997|NCT03946046|Cervical dystonia|cervical dystonia
40998|NCT03946046|Botulinum toxin|botulinum toxin
40999|NCT03946046|Ultrasound-guided injection|ultrasound-guided injection
41000|NCT03946046|CDIP58|cdip58
41001|NCT03946046|TWSTRS-2|twstrs-2
41002|NCT03946033|Immunoscore Adjuvant Prospective Colon|immunoscore adjuvant prospective colon
41003|NCT03946020|implants; GBR; DBBM; grafts; bone|implants; gbr; dbbm; grafts; bone
41004|NCT03945994|Improve Social Capital|improve social capital
41005|NCT03945994|Improve mental health|improve mental health
41006|NCT03945981|GSK3515864, dolutegravir, Dovato, lamivudine, 3TC, HIV-1, Test and Treat|gsk3515864, dolutegravir, dovato, lamivudine, 3tc, hiv-1, test and treat
41007|NCT03945968|anesthesia|anesthesia
41008|NCT03945968|concomitant diseases|concomitant diseases
41009|NCT03945968|risk stratification|risk stratification
41010|NCT03945955|Melatonin, Sleep quality, DNA Damage, Lipid peroxidation, Nightshift worker|melatonin, sleep quality, dna damage, lipid peroxidation, nightshift worker
41011|NCT03945890|quality improvement|quality improvement
41012|NCT03945890|team resource management|team resource management
41013|NCT03945890|bowel preparation|bowel preparation
41014|NCT03945890|health screening colonoscopy|health screening colonoscopy
41015|NCT03945851|vagal nerve stimulator|vagal nerve stimulator
41016|NCT03945851|MRI|mri
41017|NCT03945851|functional MRI|functional mri
41018|NCT03945838|Lymphedema|lymphedema
41019|NCT03945838|Hand grip strength|hand grip strength
41020|NCT03945838|Breast cancer related lymphedema|breast cancer related lymphedema
41021|NCT03945838|Complete decongestion therapy|complete decongestion therapy
41022|NCT03945825|Immunogenicity|immunogenicity
41023|NCT03945825|Influenza|influenza
41024|NCT03945825|Influenza Vaccine|influenza vaccine
41025|NCT03945825|Phase 1|phase 1
41026|NCT03945825|Quadrivalent|quadrivalent
41027|NCT03945825|Safety|safety
41028|NCT03945812|GCSF|gcsf
41029|NCT03945812|PRP|prp
41030|NCT03945812|Pregnancy|pregnancy
41031|NCT03945786|Hybrid PET/MRI|hybrid pet/mri
41032|NCT03945747|Automated insulin delivery systems|automated insulin delivery systems
41033|NCT03945747|Insulin sensitivity|insulin sensitivity
41034|NCT03945747|Cardiometabolic function|cardiometabolic function
41035|NCT03945747|Renal function|renal function
41036|NCT03945721|Breast Cancer|breast cancer
41037|NCT03945721|Triple Negative|triple negative
41038|NCT03945721|Locally Advanced|locally advanced
41039|NCT03945695|VMT|vmt
41040|NCT03945695|VMA|vma
41041|NCT03945695|Vitreomacular Adhesion|vitreomacular adhesion
41042|NCT03945695|Pneumatic Vitreolysis|pneumatic vitreolysis
41043|NCT03945682|physiotherapy|physiotherapy
41044|NCT03945682|surgical resection|surgical resection
814386|NCT00185770|Screen time|screen time
41045|NCT03945669|External ring fixation|external ring fixation
41046|NCT03945669|Intramedullary nailing|intramedullary nailing
41047|NCT03945669|Tibial shaft fracture|tibial shaft fracture
41048|NCT03945669|patient reported outcome|patient reported outcome
41049|NCT03945630|Quadratus Lumborum Block|quadratus lumborum block
41050|NCT03945617|anxiety|anxiety
41051|NCT03945617|cognitive behavior therapy|cognitive behavior therapy
41052|NCT03945617|transdiagnostic treatment|transdiagnostic treatment
41053|NCT03945617|prediction|prediction
41054|NCT03945591|Cyclophosphamide|cyclophosphamide
41055|NCT03945591|Bortezomib|bortezomib
41056|NCT03945552|Parenting Practices|parenting practices
41057|NCT03945552|Parent-Child Relationships|parent-child relationships
41058|NCT03945552|Child Development|child development
41059|NCT03945526|Astaxanthin|astaxanthin
41060|NCT03945526|Antioxidant|antioxidant
41061|NCT03945526|Plasma Malondialdehyde|plasma malondialdehyde
41062|NCT03945526|NIHSS score|nihss score
41063|NCT03945526|Ischemic Stroke|ischemic stroke
41064|NCT03945513|contraception|contraception
41065|NCT03945513|hormonal oral contraceptive agents|hormonal oral contraceptive agents
41066|NCT03945513|hormonal oral contraceptive|hormonal oral contraceptive
41067|NCT03945513|oral contraceptive|oral contraceptive
41068|NCT03945487|liver cirrhosis|liver cirrhosis
41069|NCT03945487|mesenchymal stem cells|mesenchymal stem cells
41070|NCT03945487|safety|safety
41270|NCT03944421|Metabolites|metabolites
41071|NCT03945487|liver function|liver function
41072|NCT03945435|Exercise|exercise
41073|NCT03945435|Cardiorespiratory Fitness|cardiorespiratory fitness
41074|NCT03945435|Skeletal Muscle|skeletal muscle
41075|NCT03945435|Angiogenesis|angiogenesis
41076|NCT03945409|ARDS|ards
41077|NCT03945409|Respiratory Mechanics|respiratory mechanics
41078|NCT03945409|Transpulmonary pressure|transpulmonary pressure
41079|NCT03945409|Pleural pressure|pleural pressure
41080|NCT03945396|Obesity|obesity
41081|NCT03945396|Overweight|overweight
41082|NCT03945396|Homeopathy|homeopathy
41083|NCT03945396|Calcarea carbonica ostrearum|calcarea carbonica ostrearum
41084|NCT03945396|Mexico|mexico
41085|NCT03945357|Infection|infection
41086|NCT03945357|hernia repair|hernia repair
41087|NCT03945305|Essential Hypertension, Remote Ischemic Conditioning|essential hypertension, remote ischemic conditioning
41088|NCT03945266|gestational weight gain|gestational weight gain
41089|NCT03945266|pregnancy weight regulation|pregnancy weight regulation
41090|NCT03945266|individually tailored intervention|individually tailored intervention
41091|NCT03945253|Pharmacokinetics|pharmacokinetics
41092|NCT03945253|Tumors|tumors
41093|NCT03945253|Oncology|oncology
41094|NCT03945253|Safety and tolerability|safety and tolerability
41095|NCT03945253|Locally advanced or metastatic solid tumor|locally advanced or metastatic solid tumor
41096|NCT03945253|ASP8374|asp8374
41097|NCT03945227|Non small cell lung cancer|non small cell lung cancer
41098|NCT03945227|Unresectable stage III NSCLC|unresectable stage iii nsclc
41099|NCT03945214|Stress|stress
41100|NCT03945214|Health|health
41101|NCT03945214|Meditation|meditation
41102|NCT03945214|Eating|eating
41103|NCT03945214|Mindfulness|mindfulness
41104|NCT03945214|Employees|employees
41105|NCT03945214|Job strain|job strain
41106|NCT03945214|Burnout|burnout
41107|NCT03945214|Work|work
41108|NCT03945214|Mood|mood
41109|NCT03945214|Affect|affect
41110|NCT03945214|Work related stress|work related stress
41111|NCT03945214|Blood pressure|blood pressure
41112|NCT03945214|Inflammation|inflammation
41113|NCT03945201|cardiac rehabilitation|cardiac rehabilitation
41114|NCT03945201|virtual reality|virtual reality
41115|NCT03945201|VR|vr
41116|NCT03945201|treadmill|treadmill
41117|NCT03945201|education retention|education retention
41118|NCT03945201|patient education|patient education
41119|NCT03945188|Ulcerative Colitis|ulcerative colitis
41120|NCT03945188|Etrasimod|etrasimod
41121|NCT03945188|APD334|apd334
41122|NCT03945162|Photodynamic Therapy|photodynamic therapy
41123|NCT03945162|Non-muscle invasive bladder cancer (NMIBC)|non-muscle invasive bladder cancer (nmibc)
41124|NCT03945162|Urothelial carcinoma|urothelial carcinoma
41125|NCT03945162|Ta bladder cancer|ta bladder cancer
41126|NCT03945162|T1 bladder cancer|t1 bladder cancer
41127|NCT03945162|Refractory to BCG|refractory to bcg
41128|NCT03945136|veterans|veterans
41129|NCT03945136|depression|depression
41130|NCT03945136|anxiety|anxiety
41131|NCT03945136|psychodynamic|psychodynamic
41132|NCT03945136|psychotherapy|psychotherapy
41133|NCT03945136|treatment|treatment
41134|NCT03945123|ginseng|ginseng
41135|NCT03945123|Liver|liver
41136|NCT03945045|venous thrombosis|venous thrombosis
41137|NCT03945032|Parent of a childhood cancer survivor|parent of a childhood cancer survivor
41138|NCT03945032|E-platform|e-platform
41139|NCT03945032|TICOP mobile App|ticop mobile app
41140|NCT03945006|Multiple Sclerosis|multiple sclerosis
41141|NCT03945006|Balance|balance
41142|NCT03945006|Trunk impairment|trunk impairment
41143|NCT03945006|Fear of falling|fear of falling
41144|NCT03945006|Incontinence|incontinence
41145|NCT03944993|PEMF|pemf
41146|NCT03944993|Prefrontal cortex|prefrontal cortex
41147|NCT03944993|Exercise mimetic|exercise mimetic
41148|NCT03944993|Pulsed Electromagnetic Fields|pulsed electromagnetic fields
41149|NCT03944980|Effect|effect
41150|NCT03944980|Safety|safety
41151|NCT03944928|Lung ultrasound|lung ultrasound
41152|NCT03944928|B lines|b lines
41153|NCT03944928|Pleural irregularity|pleural irregularity
41154|NCT03944902|BRCA Wild-Type|brca wild-type
41155|NCT03944902|Resistant BRCA|resistant brca
41156|NCT03944902|Poly (ADP-ribose) polymerase (PARP) Inhibitor Therapy|poly (adp-ribose) polymerase (parp) inhibitor therapy
41279|NCT03944369|Drug resistant|drug resistant
41157|NCT03944889|MUAP- Motor Unit Action Potential|muap- motor unit action potential
41158|NCT03944889|RMS- Root Mean Square|rms- root mean square
41159|NCT03944889|US-Ultrasound|us-ultrasound
41160|NCT03944876|Botulinum Toxin Type A|botulinum toxin type a
41161|NCT03944876|Sphenopalatine Ganglion Block|sphenopalatine ganglion block
41162|NCT03944876|Autonomic Nerve Block|autonomic nerve block
41163|NCT03944876|Injections|injections
41164|NCT03944863|antibiotic prophylaxis|antibiotic prophylaxis
41165|NCT03944863|per oral endoscopic myotomy|per oral endoscopic myotomy
41166|NCT03944850|veterans|veterans
41167|NCT03944850|anxiety sensitivity|anxiety sensitivity
41168|NCT03944850|opioid use disorder|opioid use disorder
41169|NCT03944850|intervention|intervention
41170|NCT03944837|Acute maternal hyperoxygenation|acute maternal hyperoxygenation
41171|NCT03944837|Echocardiography|echocardiography
41173|NCT03944824|Intra-Dialytic Exercise|intra-dialytic exercise
41174|NCT03944824|End Stage Renal Disease|end stage renal disease
41175|NCT03944824|Hemodialysis|hemodialysis
41176|NCT03944824|Therabands|therabands
41177|NCT03944824|Exercise Physiologist|exercise physiologist
41178|NCT03944798|Soft Tissue Sarcoma|soft tissue sarcoma
41179|NCT03944798|Lung Metastases|lung metastases
41180|NCT03944798|Overall Survival|overall survival
41181|NCT03944798|Surveillance|surveillance
41182|NCT03944798|Randomized Controlled Trial|randomized controlled trial
41183|NCT03944785|Parkinson's disease|parkinson's disease
41184|NCT03944785|Safinamide|safinamide
41185|NCT03944785|Xadago|xadago
41186|NCT03944785|MAO-B inhibitor|mao-b inhibitor
41187|NCT03944785|off|off
41188|NCT03944785|non-motor symptoms|non-motor symptoms
41189|NCT03944785|motor symptoms|motor symptoms
41190|NCT03944785|levodopa|levodopa
41191|NCT03944785|PD|pd
41192|NCT03944772|Non-small cell lung cancer|non-small cell lung cancer
41193|NCT03944772|Phase II|phase ii
41194|NCT03944772|Platform study|platform study
41195|NCT03944772|Biomarker-directed|biomarker-directed
41196|NCT03944772|Durvalumab|durvalumab
41197|NCT03944772|Osimertinib|osimertinib
41198|NCT03944772|Savolitinib|savolitinib
41199|NCT03944772|Gefitinib|gefitinib
41200|NCT03944772|Necitumumab|necitumumab
41201|NCT03944772|Platinum-containing doublet|platinum-containing doublet
41202|NCT03944772|Pemetrexed|pemetrexed
41203|NCT03944772|Carboplatin|carboplatin
41204|NCT03944772|EGFR positive|egfr positive
41205|NCT03944772|NSCLC|nsclc
41206|NCT03944746|Emergency Department Education|emergency department education
41207|NCT03944733|iron deficiency anemia (IDA)|iron deficiency anemia (ida)
41208|NCT03944733|iron status|iron status
41209|NCT03944733|mother-infant interactions|mother-infant interactions
41210|NCT03944733|intervention study|intervention study
41211|NCT03944733|postpartum depressive symptoms|postpartum depressive symptoms
41212|NCT03944694|delirium|delirium
41213|NCT03944694|stroke|stroke
41214|NCT03944694|neutrophil-to-lymphocyte ratio|neutrophil-to-lymphocyte ratio
41215|NCT03944694|NLR|nlr
41216|NCT03944694|mortality|mortality
41217|NCT03944681|postoperative nausea and vomiting|postoperative nausea and vomiting
41218|NCT03944681|torsadogenic action|torsadogenic action
41219|NCT03944681|transmural dispersion of repolarisation|transmural dispersion of repolarisation
41220|NCT03944681|corrected QT interval|corrected qt interval
41221|NCT03944655|Post operative sore throat|post operative sore throat
41222|NCT03944655|Post operative dysphagia|post operative dysphagia
41223|NCT03944655|Post operative dysphonia|post operative dysphonia
41224|NCT03944642|Complex Intervention|complex intervention
41225|NCT03944642|Pilot Study|pilot study
41226|NCT03944642|Breastfeeding Support|breastfeeding support
41227|NCT03944616|Diet beverages|diet beverages
41228|NCT03944616|diet|diet
41229|NCT03944616|diabetes control|diabetes control
41230|NCT03944616|artificial sweeteners|artificial sweeteners
41231|NCT03944616|continuous glucose monitor|continuous glucose monitor
41232|NCT03944616|gut microbiome|gut microbiome
41233|NCT03944616|metabolomics|metabolomics
41234|NCT03944603|Alzheimer's Disease|alzheimer's disease
41235|NCT03944603|Dementia|dementia
41236|NCT03944603|Older Adult|older adult
41237|NCT03944590|screw osteosynthesis|screw osteosynthesis
41238|NCT03944590|rupture of the interosseous membrane|rupture of the interosseous membrane
41239|NCT03944590|collateral ligaments|collateral ligaments
814387|NCT00185770|Schools|schools
41240|NCT03944577|coronary allograft vasculopathy|coronary allograft vasculopathy
41241|NCT03944577|lipid|lipid
41242|NCT03944577|heart transplant|heart transplant
41243|NCT03944564|cognition|cognition
41244|NCT03944564|brain activity|brain activity
41245|NCT03944564|cognitive reserve|cognitive reserve
41246|NCT03944564|work productivity|work productivity
41247|NCT03944564|musculoskeletal discomfort|musculoskeletal discomfort
41248|NCT03944564|attention|attention
41249|NCT03944538|Exercise|exercise
41250|NCT03944538|Fitness|fitness
41251|NCT03944538|Co-morbidity|co-morbidity
41252|NCT03944512|Pregnancy|pregnancy
41253|NCT03944512|Preeclampsia|preeclampsia
41254|NCT03944486|Cerebrovascular Accident|cerebrovascular accident
41255|NCT03944473|high risk|high risk
41256|NCT03944473|chronic health condition|chronic health condition
41257|NCT03944473|laparoscopic surgery|laparoscopic surgery
41258|NCT03944460|anti-prionic|anti-prionic
41259|NCT03944460|anti-Abeta-pionic|anti-abeta-pionic
41260|NCT03944460|treatment of cognition and memory deficits|treatment of cognition and memory deficits
41261|NCT03944460|AD patients|ad patients
41262|NCT03944460|AD stage-independent|ad stage-independent
41263|NCT03944460|NOT anti-amyloid|not anti-amyloid
41264|NCT03944460|neuron specific Ca-ion reduction|neuron specific ca-ion reduction
41265|NCT03944434|ribociclib|ribociclib
41266|NCT03944434|hormone receptor positive|hormone receptor positive
41267|NCT03944421|Genotoxicity|genotoxicity
41268|NCT03944421|DNA damage|dna damage
41269|NCT03944421|Gut Microbiota|gut microbiota
41271|NCT03944395|Active HIV Case finding|active hiv case finding
41272|NCT03944395|Partner Notification Services|partner notification services
41273|NCT03944369|Microbiome|microbiome
41274|NCT03944369|Antibiotic resistance|antibiotic resistance
41275|NCT03944369|Carbapenem-Resistant Enterobacteriaceae (CRE)|carbapenem-resistant enterobacteriaceae (cre)
41276|NCT03944369|Extended-Spectrum Beta Lactamase-Producing Enterobacteriaceae (ESBLE)|extended-spectrum beta lactamase-producing enterobacteriaceae (esble)
41277|NCT03944369|Vancomycin-resistant Enterococcus (VRE)|vancomycin-resistant enterococcus (vre)
41278|NCT03944369|Multi Drug Resistant Organism (MDRO)|multi drug resistant organism (mdro)
41280|NCT03944369|Kaleido|kaleido
41281|NCT03944369|VITORA|vitora
41282|NCT03944369|KB109|kb109
41283|NCT03944369|Microbiome Metabolic Therapy (MMT)|microbiome metabolic therapy (mmt)
41284|NCT03944369|Oligosaccharide|oligosaccharide
41285|NCT03944369|Glycan|glycan
41286|NCT03944317|IPTip|iptip
41287|NCT03944317|SP|sp
41288|NCT03944317|AZ|az
41289|NCT03944304|Single-center|single-center
41290|NCT03944304|Prospective|prospective
41291|NCT03944304|single-arm|single-arm
41292|NCT03944304|open-label|open-label
41293|NCT03944304|phase II|phase ii
41294|NCT03944226|Beetroot juice|beetroot juice
41295|NCT03944226|Magnetic Resonance Imaging|magnetic resonance imaging
41296|NCT03944226|Breast cancer|breast cancer
41297|NCT03944213|Transcranial Magnetic Stimulation|transcranial magnetic stimulation
41298|NCT03944213|Theta Burst Stimulation|theta burst stimulation
41299|NCT03944213|rTMS|rtms
41300|NCT03944213|TBS|tbs
41301|NCT03944213|resting-state fMRI|resting-state fmri
41302|NCT03944161|nutritional supplement|nutritional supplement
41303|NCT03944161|cost-effectiveness|cost-effectiveness
41304|NCT03944161|cost-utility|cost-utility
41305|NCT03944148|Upper Gastrointestinal Bleeding|upper gastrointestinal bleeding
41306|NCT03944135|Cognition, Cognitive Dissonance, Geriatrics, Technology|cognition, cognitive dissonance, geriatrics, technology
41307|NCT03944122|lateral epicondylitis, therapeutical ultrasound|lateral epicondylitis, therapeutical ultrasound
41308|NCT03944096|fecal microbiota transplantation|fecal microbiota transplantation
41309|NCT03944096|methotrexate|methotrexate
41310|NCT03944096|rheumatoid arthritis|rheumatoid arthritis
41311|NCT03944044|Paracetamol|paracetamol
41312|NCT03944044|Acetaminophen|acetaminophen
41313|NCT03944044|Palliative care|palliative care
41314|NCT03944044|Subcutaneous administration|subcutaneous administration
41315|NCT03944044|intravenous administration|intravenous administration
41316|NCT03944044|pharmacokinetic|pharmacokinetic
41317|NCT03944018|Back pain|back pain
41318|NCT03944005|knee arthroplasty|knee arthroplasty
41319|NCT03944005|discharge readiness|discharge readiness
41320|NCT03944005|analgesia|analgesia
41321|NCT03944005|adductor canal block|adductor canal block
41322|NCT03944005|ipack|ipack
41323|NCT03944005|LIA|lia
41324|NCT03943927|Metoprolol|metoprolol
41325|NCT03943927|Genotype|genotype
41326|NCT03943927|Phenotype|phenotype
41327|NCT03943927|CYP2D6|cyp2d6
41328|NCT03943914|Chest trauma|chest trauma
41329|NCT03943914|Respiratory failure|respiratory failure
41330|NCT03943914|Noninvasive ventilation|noninvasive ventilation
41331|NCT03943914|High-flow nasal oxygen therapy|high-flow nasal oxygen therapy
41332|NCT03943901|chemotherapy|chemotherapy
41333|NCT03943901|cancer|cancer
41334|NCT03943901|elderly|elderly
41335|NCT03943901|lymphoma|lymphoma
41336|NCT03943888|sugammadex|sugammadex
41337|NCT03943888|pharmacokinetics|pharmacokinetics
41338|NCT03943888|pharmacodynamics|pharmacodynamics
41339|NCT03943888|pediatric anesthesia|pediatric anesthesia
41340|NCT03943875|HPV vaccination|hpv vaccination
41341|NCT03943875|Gardasil 9|gardasil 9
41342|NCT03943875|vaccine efficacy|vaccine efficacy
41343|NCT03943862|Stigma|stigma
41344|NCT03943862|Suicide attempt survivor|suicide attempt survivor
41345|NCT03943862|Secrecy|secrecy
41346|NCT03943862|Group intervention|group intervention
41347|NCT03943862|Disclosure|disclosure
41348|NCT03943849|Bone graft|bone graft
41349|NCT03943849|Tooth extraction|tooth extraction
41350|NCT03943849|Dental pulp|dental pulp
41351|NCT03943836|Dental Anxiety|dental anxiety
41352|NCT03943836|Pediatric dentistry|pediatric dentistry
41353|NCT03943823|Pessary|pessary
41354|NCT03943823|Vaginal pH|vaginal ph
41355|NCT03943797|Oral mucosal epithelial cells|oral mucosal epithelial cells
41356|NCT03943797|Cornea|cornea
41357|NCT03943797|Amniotic membrane|amniotic membrane
41358|NCT03943797|Collagenase|collagenase
41359|NCT03943771|Kidney Neoplasms|kidney neoplasms
41360|NCT03943771|Carcinoma, Renal Cell|carcinoma, renal cell
41361|NCT03943771|Nephron-Sparing Surgery|nephron-sparing surgery
41362|NCT03943771|3D Modeling|3d modeling
41363|NCT03943771|3D Printing|3d printing
41364|NCT03943771|Anxiety|anxiety
41365|NCT03943771|Personalized Medicine|personalized medicine
41366|NCT03943758|Bowel preparation|bowel preparation
41367|NCT03943758|Polyp|polyp
41368|NCT03943758|adenoma|adenoma
41369|NCT03943745|EEG|eeg
41370|NCT03943745|Propofol|propofol
41371|NCT03943732|Pneumonia|pneumonia
41372|NCT03943732|Molecular Testing|molecular testing
41373|NCT03943732|Clinical impact|clinical impact
41374|NCT03943732|FilmArray Pneumonia|filmarray pneumonia
41375|NCT03943719|FilmArray|filmarray
41376|NCT03943719|bacteremia|bacteremia
41377|NCT03943719|septicemia|septicemia
41378|NCT03943719|clinical impact|clinical impact
41379|NCT03943719|molecular testing|molecular testing
41380|NCT03943719|identification|identification
41381|NCT03943719|positive blood culture|positive blood culture
41382|NCT03943719|optimal antimicrobial treatment|optimal antimicrobial treatment
41383|NCT03943706|e-cigarettes|e-cigarettes
41384|NCT03943706|JUUL brand e-cigarette|juul brand e-cigarette
41385|NCT03943706|NJOY brand e-cigarette|njoy brand e-cigarette
41386|NCT03943706|EVOLV brand mod e-cigarette|evolv brand mod e-cigarette
41387|NCT03943706|Very Low Nicotine Cigarettes (VLNCs)|very low nicotine cigarettes (vlncs)
41388|NCT03943693|Cardioversion|cardioversion
41389|NCT03943680|Tooth extraction|tooth extraction
41390|NCT03943680|Socket regeneration|socket regeneration
41391|NCT03943680|Dental Implants|dental implants
41392|NCT03943667|Metastatic Pancreas Ductal Adenocarcinoma|metastatic pancreas ductal adenocarcinoma
41393|NCT03943654|Telemedicine|telemedicine
41394|NCT03943654|Diarrhea|diarrhea
41395|NCT03943654|Diarrhoea|diarrhoea
41396|NCT03943654|mHealth|mhealth
41397|NCT03943654|Healthline|healthline
41398|NCT03943628|prevention|prevention
41399|NCT03943628|Hispanic adolescents|hispanic adolescents
41400|NCT03943628|obesity and overweightness|obesity and overweightness
41401|NCT03943628|family functioning|family functioning
41402|NCT03943628|sexual risk behavior|sexual risk behavior
41403|NCT03943537|Psychosis|psychosis
41404|NCT03943537|Insulin|insulin
41405|NCT03943537|Brain Metabolism|brain metabolism
41406|NCT03943537|Cognition|cognition
41407|NCT03943524|Polypharmacy|polypharmacy
41408|NCT03943524|Outpatient|outpatient
41409|NCT03943524|Drug Interaction|drug interaction
41410|NCT03943524|Adverse Drug Reaction|adverse drug reaction
41411|NCT03943524|DrApp|drapp
41412|NCT03943524|Interax-AI|interax-ai
41413|NCT03943485|abdominal hysterectomy|abdominal hysterectomy
41414|NCT03943485|uterine manipulator|uterine manipulator
41415|NCT03943485|vaginal length|vaginal length
41416|NCT03943485|sexual function|sexual function
41417|NCT03943485|surgeons' satisfaction|surgeons' satisfaction
41418|NCT03943472|BCMA|bcma
41419|NCT03943472|CAR-T|car-t
41420|NCT03943472|multiple myeloma|multiple myeloma
41421|NCT03943472|Relapsed /Refractory|relapsed /refractory
41422|NCT03943459|coronary artery disease|coronary artery disease
41423|NCT03943459|sirtuins|sirtuins
41424|NCT03943459|Receptor for Advanced Glycation End Products|receptor for advanced glycation end products
41425|NCT03943459|women|women
41426|NCT03943459|quercetin|quercetin
41427|NCT03943459|atorvastatin|atorvastatin
41428|NCT03943446|Drug Therapy|drug therapy
41429|NCT03943433|Absorption atelectasis|absorption atelectasis
41430|NCT03943433|Lung sono|lung sono
41431|NCT03943433|Oxygen concentration|oxygen concentration
41432|NCT03943420|Safety|safety
41433|NCT03943420|Effectiveness|effectiveness
41434|NCT03943420|Therapy|therapy
41435|NCT03943420|Qianyang Yuyin Granules|qianyang yuyin granules
41436|NCT03943420|Cognitive impairment|cognitive impairment
41437|NCT03943420|Hypertension|hypertension
41438|NCT03943407|Imiquimod|imiquimod
41439|NCT03943407|Doxepin|doxepin
814677|NCT00183716|Women|women
41440|NCT03943407|Trans-cinnamaldehyde (CA)|trans-cinnamaldehyde (ca)
41441|NCT03943407|L-menthol|l-menthol
41442|NCT03943407|Histamine|histamine
41443|NCT03943407|Cowhage|cowhage
41444|NCT03943381|PCS|pcs
41445|NCT03943316|Ovarian Cancer|ovarian cancer
41446|NCT03943316|Ascites|ascites
41447|NCT03943303|monazitc sands|monazitc sands
41448|NCT03943303|radiation|radiation
41449|NCT03943264|inflammation|inflammation
41450|NCT03943264|Biomarker|biomarker
41451|NCT03943264|TNF|tnf
41452|NCT03943238|kidney transplant|kidney transplant
41453|NCT03943238|Immunological Tolerance|immunological tolerance
41454|NCT03943238|Tregs|tregs
41455|NCT03943238|Stem cells|stem cells
41456|NCT03943225|The do-not-resuscitate order, end of life, medical ethics|the do-not-resuscitate order, end of life, medical ethics
41457|NCT03943212|Patient-Reported Outcomes|patient-reported outcomes
41458|NCT03943212|Post-dialysis Fatigue|post-dialysis fatigue
41459|NCT03943212|Dialysis Recovery Time|dialysis recovery time
41460|NCT03943186|non-interventional study|non-interventional study
41461|NCT03943186|Ectoin|ectoin
41462|NCT03943186|Lozenges|lozenges
41463|NCT03943186|Pharyngitis|pharyngitis
41464|NCT03943134|Acute Trauma|acute trauma
41465|NCT03943134|Upper Extremity Trauma|upper extremity trauma
41466|NCT03943134|Acute Upper Extremity Trauma|acute upper extremity trauma
41467|NCT03943134|Avive|avive
41468|NCT03943134|Peripheral Nerve Injury|peripheral nerve injury
41469|NCT03943134|Nerve Repair|nerve repair
41470|NCT03943121|Endoscopic sinus surgery|endoscopic sinus surgery
41471|NCT03943121|Eosinophilic sinusitis with nasal polyps|eosinophilic sinusitis with nasal polyps
41472|NCT03943121|Steroid-eluting stent|steroid-eluting stent
41473|NCT03943121|Randomized Trial|randomized trial
41474|NCT03943030|Pulmonary rehabilitation|pulmonary rehabilitation
41475|NCT03943030|Chronic Obstructive Pulmonary Disease|chronic obstructive pulmonary disease
41476|NCT03943030|Cardiovascular effects|cardiovascular effects
41477|NCT03943030|Endothelial dysfunction|endothelial dysfunction
41478|NCT03943017|safety dysfunctions|safety dysfunctions
41479|NCT03943004|advanced solid tumors|advanced solid tumors
41480|NCT03943004|refractory or relapsed tumors|refractory or relapsed tumors
41481|NCT03942952|Multiple Sclerosis|multiple sclerosis
41482|NCT03942952|NMO|nmo
41483|NCT03942952|anti-MOG|anti-mog
41484|NCT03942952|Acute Disseminated Encephalolmyelitis|acute disseminated encephalolmyelitis
41485|NCT03942926|plastic bronchitis|plastic bronchitis
41486|NCT03942926|sirolimus|sirolimus
41487|NCT03942900|locally advanced SCCA|locally advanced scca
41488|NCT03942900|DCF|dcf
41489|NCT03942900|radiotherapy|radiotherapy
41490|NCT03942900|nivolumab|nivolumab
41491|NCT03942900|biomarkers|biomarkers
41492|NCT03942887|ANCA|anca
41493|NCT03942887|Crescentic glomerulonephritis|crescentic glomerulonephritis
41494|NCT03942887|systemic autoimmune disease|systemic autoimmune disease
41495|NCT03942887|Renal failure|renal failure
41496|NCT03942887|Renal insufficiency|renal insufficiency
41497|NCT03942887|small vessel vasculitis|small vessel vasculitis
41498|NCT03942887|GPA|gpa
41499|NCT03942887|MPA|mpa
41500|NCT03942874|reward|reward
41501|NCT03942874|reward dysfunction|reward dysfunction
41502|NCT03942874|group treatment|group treatment
41503|NCT03942874|binge eating|binge eating
41504|NCT03942861|Ultrasonography|ultrasonography
41505|NCT03942861|Sonography|sonography
41506|NCT03942861|Ulcerative Colitis|ulcerative colitis
41507|NCT03942861|Inflammatory Bowel Disease|inflammatory bowel disease
41508|NCT03942861|Severe Ulcerative colitis|severe ulcerative colitis
41509|NCT03942861|Treatment response|treatment response
41510|NCT03942861|Monitoring treatment|monitoring treatment
41511|NCT03942848|Spinal cord lesion|spinal cord lesion
41512|NCT03942848|intrathecal infusion|intrathecal infusion
41513|NCT03942848|refractory neuropathic pain|refractory neuropathic pain
41514|NCT03942848|ziconotide|ziconotide
41515|NCT03942835|Attention Deficit Hyperactivity Disorder|attention deficit hyperactivity disorder
41516|NCT03942835|attention|attention
41517|NCT03942835|distraction|distraction
41518|NCT03942835|psychometric test|psychometric test
41519|NCT03942835|neuropsychological test validating procedure|neuropsychological test validating procedure
41520|NCT03942835|psychostimulant|psychostimulant
41521|NCT03942822|Non-Alcoholic Fatty Liver Disease|non-alcoholic fatty liver disease
41522|NCT03942822|Milled chia seed suplementation|milled chia seed suplementation
41523|NCT03942809|Airway Morbidity|airway morbidity
41524|NCT03942783|work rehabilitation|work rehabilitation
41525|NCT03942783|vocational rehabilitation|vocational rehabilitation
41526|NCT03942783|occupational therapy|occupational therapy
41527|NCT03942783|rehabilitation|rehabilitation
41528|NCT03942783|presenteeism|presenteeism
41529|NCT03942783|employment|employment
41530|NCT03942757|preterm infant|preterm infant
41531|NCT03942757|jaundice|jaundice
41532|NCT03942757|bilirubin|bilirubin
41533|NCT03942757|phototherapy|phototherapy
41534|NCT03942757|educational program|educational program
41535|NCT03942744|Hemodialysis|hemodialysis
55361|NCT03856931|SDQ|sdq
41536|NCT03942744|Endothelial dysfunction|endothelial dysfunction
41537|NCT03942744|Atherogenesis|atherogenesis
41538|NCT03942718|Exercise|exercise
41539|NCT03942718|Aerobic training|aerobic training
41540|NCT03942718|Anaerobic training|anaerobic training
41541|NCT03942718|Internet-based exercise program|internet-based exercise program
41542|NCT03942705|human papillomavirus (HPV)|human papillomavirus (hpv)
41543|NCT03942705|cervical cancer|cervical cancer
41544|NCT03942705|prevention|prevention
41545|NCT03942705|Kenya|kenya
41546|NCT03942627|mindfulness|mindfulness
41547|NCT03942627|maternal depression|maternal depression
41548|NCT03942614|Nordic Pole Walking|nordic pole walking
41549|NCT03942614|Exercise|exercise
41550|NCT03942614|Rehabilitation|rehabilitation
41551|NCT03942575|Negative pressure wound therapy|negative pressure wound therapy
41552|NCT03942562|DOMS|doms
41553|NCT03942562|Healthy subjects|healthy subjects
41554|NCT03942562|Pressure pain thresholds|pressure pain thresholds
41555|NCT03942562|Active Knee Extension test|active knee extension test
41556|NCT03942562|Maximal strength|maximal strength
41557|NCT03942562|Electromyography|electromyography
41558|NCT03942562|Plantar pressure measurement|plantar pressure measurement
41559|NCT03942562|Gait analysis|gait analysis
41560|NCT03942549|microbiome|microbiome
41561|NCT03942549|cytokine|cytokine
41562|NCT03942510|resistance training|resistance training
41563|NCT03942510|vascular occlusion|vascular occlusion
41564|NCT03942510|hemodynamics, cardiovascular system|hemodynamics, cardiovascular system
41565|NCT03942510|autonomic nervous system|autonomic nervous system
41566|NCT03942510|heart rate|heart rate
41567|NCT03942510|recovery of physiological function|recovery of physiological function
41568|NCT03942497|metastatic|metastatic
41569|NCT03942497|recurrent|recurrent
41570|NCT03942497|urothelial cancers|urothelial cancers
41571|NCT03942497|renal pelvis|renal pelvis
41572|NCT03942497|ureter|ureter
41573|NCT03942497|bladder|bladder
41574|NCT03942497|urethra|urethra
41575|NCT03942445|Muscle ischemia|muscle ischemia
41576|NCT03942445|Satellite cells|satellite cells
41577|NCT03942445|Chronic limb ischemia|chronic limb ischemia
41578|NCT03942445|Endothelial cells|endothelial cells
41579|NCT03942406|pertussis|pertussis
41580|NCT03942406|Bordetella infection|bordetella infection
41581|NCT03942406|Gram-negative bacterial infection|gram-negative bacterial infection
41582|NCT03942406|Respiratory tract infection|respiratory tract infection
41583|NCT03942406|Whooping cough|whooping cough
41584|NCT03942406|Infection|infection
41585|NCT03942406|Respiratory tract disease|respiratory tract disease
41586|NCT03942406|Vaccine|vaccine
41587|NCT03942406|Immunological factors|immunological factors
41588|NCT03942406|Physiological effects of drugs|physiological effects of drugs
41589|NCT03942393|noise|noise
41590|NCT03942393|sleep quality|sleep quality
41591|NCT03942393|polysomnography|polysomnography
41592|NCT03942393|cortical arousals|cortical arousals
41593|NCT03942393|REM sleep|rem sleep
41594|NCT03942393|Intensive Care Unit|intensive care unit
41595|NCT03942367|Premature Ejaculation|premature ejaculation
41596|NCT03942367|Sexual Medicine|sexual medicine
41597|NCT03942367|Urology|urology
41598|NCT03942367|Sexual Dysfunction|sexual dysfunction
41599|NCT03942354|Quality of life, drug-resistant tuberculosis|quality of life, drug-resistant tuberculosis
41600|NCT03942341|Down syndrome|down syndrome
41601|NCT03942341|Alzheimer's disease|alzheimer's disease
41602|NCT03942341|obstructive sleep apnea|obstructive sleep apnea
41603|NCT03942341|Polysomnography|polysomnography
41604|NCT03942289|Human|human
41605|NCT03942289|Aging|aging
41606|NCT03942289|Behavior|behavior
41607|NCT03942289|Noradrenergic system|noradrenergic system
41608|NCT03942289|Positron Emission Tomography|positron emission tomography
41609|NCT03942289|Magnetic Resonance Imaging|magnetic resonance imaging
41610|NCT03942276|Blood pressure|blood pressure
41611|NCT03942276|Menopause|menopause
41612|NCT03942276|Hypertension|hypertension
41613|NCT03942276|Exercise|exercise
41614|NCT03942276|Alternative training|alternative training
41615|NCT03942263|Drug Therapy|drug therapy
41616|NCT03942250|Epidermolysis Bullosa|epidermolysis bullosa
41617|NCT03942250|Amniotic membrane|amniotic membrane
41618|NCT03942237|transmuscular quadratus lumborum block|transmuscular quadratus lumborum block
41619|NCT03942237|adrenalectomy|adrenalectomy
41620|NCT03942211|selexipag, sarcoidosis, pulmonary hypertension|selexipag, sarcoidosis, pulmonary hypertension
41621|NCT03942198|Plaque psoriasis|plaque psoriasis
41622|NCT03942198|Promoting blood circulation for removing blood stasis|promoting blood circulation for removing blood stasis
41623|NCT03942198|Randomized controlled trial|randomized controlled trial
41624|NCT03942198|Taodan Granules|taodan granules
41625|NCT03942185|Psoriasis Vulgaris|psoriasis vulgaris
41626|NCT03942185|Chinese Medicine|chinese medicine
41627|NCT03942185|Real World Study|real world study
41628|NCT03942185|Clearing heat and Cooling blood|clearing heat and cooling blood
814678|NCT00183716|Trauma|trauma
41629|NCT03942185|Promoting blood circulation and Removing blood stasis|promoting blood circulation and removing blood stasis
41630|NCT03942159|Microbiome|microbiome
41631|NCT03942159|stem cell transplantation|stem cell transplantation
41632|NCT03942146|Randomised registry-based trial|randomised registry-based trial
41633|NCT03942146|smoking cessation|smoking cessation
41634|NCT03942146|surgery|surgery
41635|NCT03942146|complications|complications
41636|NCT03942133|adductor canal block|adductor canal block
41637|NCT03942107|Dental posts|dental posts
41638|NCT03942107|postoperative pain|postoperative pain
41639|NCT03942107|single-visit root canal treatment|single-visit root canal treatment
41640|NCT03942107|two-visit root canal treatment|two-visit root canal treatment
41641|NCT03942107|vibration|vibration
41642|NCT03942094|Nilotinib|nilotinib
41643|NCT03942042|Generalized Pustular Psoriasis (GPP)|generalized pustular psoriasis (gpp)
41644|NCT03942042|Erythrodermic Psoriasis (EP)|erythrodermic psoriasis (ep)
41645|NCT03942042|Japan|japan
41646|NCT03941990|Spinal puncture|spinal puncture
41647|NCT03941990|Nitrous oxide|nitrous oxide
41648|NCT03941990|Pain|pain
41649|NCT03941990|Anxiety|anxiety
41650|NCT03941990|Emergency|emergency
41651|NCT03941964|Acute Myeloid Leukemia (AML)|acute myeloid leukemia (aml)
41652|NCT03941964|cancer|cancer
41653|NCT03941964|treatment naive|treatment naive
41654|NCT03941964|venetoclax|venetoclax
41655|NCT03941964|azacitidine|azacitidine
41656|NCT03941964|decitabine|decitabine
41657|NCT03941964|outpatient setting|outpatient setting
41658|NCT03941951|Quasi-experimental study|quasi-experimental study
41659|NCT03941951|Multidrug resistant bacteria|multidrug resistant bacteria
41660|NCT03941951|Antimicrobial stewardship|antimicrobial stewardship
41661|NCT03941951|Ceftaroline|ceftaroline
41662|NCT03941951|Tedizolid|tedizolid
41663|NCT03941951|Dalbavancin|dalbavancin
41664|NCT03941951|Ceftazidime-avibactam|ceftazidime-avibactam
41665|NCT03941951|Ceftolozane-tazobactam|ceftolozane-tazobactam
41666|NCT03941951|Isavuconazole|isavuconazole
41667|NCT03941938|colorectal anastomosis|colorectal anastomosis
41668|NCT03941938|leakage|leakage
41669|NCT03941925|prebiotic|prebiotic
41670|NCT03941899|Pain, radical prostatectomy, QLB II type|pain, radical prostatectomy, qlb ii type
41671|NCT03941886|Pre-Eclampsia|pre-eclampsia
41672|NCT03941886|Aspirin|aspirin
41673|NCT03941873|Carcinoma|carcinoma
41675|NCT03941873|G/GEJ Cancer|g/gej cancer
41676|NCT03941834|Trigeminal Neuralgia, Pain|trigeminal neuralgia, pain
41677|NCT03941795|PD-1 monoclonal antibody|pd-1 monoclonal antibody
41678|NCT03941795|the First Line Therapy|the first line therapy
41679|NCT03941795|Axitinib|axitinib
41680|NCT03941795|Mucosal Melanoma|mucosal melanoma
41681|NCT03941795|Toripalimab|toripalimab
41682|NCT03941795|JS001|js001
41683|NCT03941717|pain management|pain management
41684|NCT03941717|children|children
41685|NCT03941717|parents|parents
41686|NCT03941717|mindfulness|mindfulness
41687|NCT03941691|VSD|vsd
41688|NCT03941691|Ventriculai Septal Defects|ventriculai septal defects
41689|NCT03941691|amplatzer|amplatzer
41690|NCT03941652|Gestational Diabetes|gestational diabetes
41691|NCT03941652|Continuous Glucose Values|continuous glucose values
41692|NCT03941652|Physical Activity|physical activity
41693|NCT03941652|Nutrition|nutrition
41694|NCT03941652|Behaviour Change|behaviour change
41695|NCT03941652|Stress|stress
41696|NCT03941652|Recovery|recovery
41697|NCT03941652|Human-Computer Interaction (HCI)|human-computer interaction (hci)
41698|NCT03941652|Mobile Application|mobile application
41699|NCT03941652|Diet|diet
41700|NCT03941652|Self-tracking|self-tracking
41701|NCT03941639|breast cancer|breast cancer
41702|NCT03941639|metastasis|metastasis
41703|NCT03941639|prediction|prediction
41704|NCT03941613|temporal lobe epilepsy; hippocampus sclerosis (HS); radiofrequency thermocoagulation (RF-TC); cognitive status|temporal lobe epilepsy; hippocampus sclerosis (hs); radiofrequency thermocoagulation (rf-tc); cognitive status
41705|NCT03941600|occupational therapy|occupational therapy
41706|NCT03941600|exercise|exercise
41707|NCT03941561|Gastric Cancer|gastric cancer
41708|NCT03941561|S-1|s-1
41709|NCT03941535|Vitamin K|vitamin k
41710|NCT03941522|loop ileostomy|loop ileostomy
41711|NCT03941522|diversion ileostomy|diversion ileostomy
41712|NCT03941522|ileostomy closure|ileostomy closure
41713|NCT03941496|Tuberculosis|tuberculosis
41714|NCT03941496|TB|tb
41715|NCT03941496|Mycobacterium tuberculosis|mycobacterium tuberculosis
41716|NCT03941496|Mtb|mtb
41717|NCT03941496|anti-TB therapy|anti-tb therapy
41718|NCT03941496|ATT|att
41719|NCT03941496|rifampin (R), isoniazid (H) pyrazinamide (Z) ethambutol (E)|rifampin (r), isoniazid (h) pyrazinamide (z) ethambutol (e)
41720|NCT03941496|RHZE|rhze
41721|NCT03941496|rifampin (R), isoniazid (H)|rifampin (r), isoniazid (h)
41722|NCT03941496|RH|rh
41723|NCT03941470|NK ;natural killer cells|nk ;natural killer cells
41724|NCT03941431|Plaque Psoriasis|plaque psoriasis
41725|NCT03941431|Jueyin granule|jueyin granule
41726|NCT03941431|Moving cupping|moving cupping
41727|NCT03941431|NB-UVB|nb-uvb
41728|NCT03941431|combination of Chinese traditional and Western medicine|combination of chinese traditional and western medicine
41729|NCT03941418|Saccharomyces boulardii|saccharomyces boulardii
41730|NCT03941392|Nutrition|nutrition
41731|NCT03941392|Pediatric age|pediatric age
41732|NCT03941392|Physical activity|physical activity
41733|NCT03941392|Dairy products|dairy products
41734|NCT03941392|Dairy consumption|dairy consumption
41735|NCT03941392|Sedentary habits|sedentary habits
41736|NCT03941392|Diet quality|diet quality
41737|NCT03941392|Children|children
41738|NCT03941379|Choroidal Melanoma|choroidal melanoma
41739|NCT03941379|Indeterminate Lesions of Eye|indeterminate lesions of eye
41740|NCT03941249|Metabolomics|metabolomics
41741|NCT03941249|Tau|tau
41742|NCT03941249|Ischemic stroke|ischemic stroke
41743|NCT03941249|Hemorrhagic stroke|hemorrhagic stroke
41744|NCT03941223|breast cancer, regional anesthesia, cancer recurrence|breast cancer, regional anesthesia, cancer recurrence
41745|NCT03941210|microRNA|microrna
41746|NCT03941210|HIV|hiv
41747|NCT03941210|Tuberculosis|tuberculosis
41748|NCT03941210|IRIS|iris
41749|NCT03941210|Biomarkers|biomarkers
41750|NCT03941197|child development|child development
41751|NCT03941197|family literacy program|family literacy program
41752|NCT03941197|primary care|primary care
41753|NCT03941184|spontaneous coronary artery dissection|spontaneous coronary artery dissection
41754|NCT03941184|autoimmune|autoimmune
41755|NCT03941184|incidence|incidence
41756|NCT03941171|Periacetabular Osteotomy|periacetabular osteotomy
41757|NCT03941171|Progressive resistance training|progressive resistance training
41758|NCT03941171|PAO|pao
41759|NCT03941145|exercise|exercise
41760|NCT03941132|T1D|t1d
41761|NCT03941132|Ustekinumab|ustekinumab
41762|NCT03941132|new-onset|new-onset
41763|NCT03941132|diabetes|diabetes
41764|NCT03941119|Virtual Reality|virtual reality
41765|NCT03941119|Biomedical Technology|biomedical technology
41766|NCT03941119|Non-pharmacological Intervention|non-pharmacological intervention
41767|NCT03941119|Behavioral Symptoms|behavioral symptoms
41768|NCT03941119|Quality of Life|quality of life
41769|NCT03941119|Geriatric Nursing|geriatric nursing
41770|NCT03941119|Health Services for the Aged|health services for the aged
41771|NCT03941119|Hospitals, Community|hospitals, community
41772|NCT03941119|Cognitive Dysfunction|cognitive dysfunction
41773|NCT03941119|Dementia|dementia
41774|NCT03941119|Delirium|delirium
41775|NCT03941106|rTMS, depression, accelerated|rtms, depression, accelerated
41776|NCT03941093|locally advanced pancreatic cancer|locally advanced pancreatic cancer
41777|NCT03941093|unresectable pancreatic cancer|unresectable pancreatic cancer
41778|NCT03941080|colorectal cancer|colorectal cancer
41779|NCT03941080|gut microbiome|gut microbiome
41780|NCT03941067|Neuromuscular response|neuromuscular response
41781|NCT03941067|pre-competition massage|pre-competition massage
41782|NCT03941067|pre-event massage|pre-event massage
41783|NCT03941041|Yoga|yoga
41784|NCT03941041|Caesarean Section|caesarean section
41785|NCT03941041|Delivery Outcome|delivery outcome
41786|NCT03941041|Labour Pain|labour pain
41787|NCT03941015|Near infrared spectroscopy|near infrared spectroscopy
41788|NCT03941015|S100B|s100b
41789|NCT03941015|congenital heart disease|congenital heart disease
41790|NCT03940976|afatinib|afatinib
41791|NCT03940976|EGFR Overexpression|egfr overexpression
41792|NCT03940976|EGFR Amplification|egfr amplification
41793|NCT03940963|Peripheral Nerve Injuries|peripheral nerve injuries
41794|NCT03940963|Peripheral Nervous System Disease|peripheral nervous system disease
41795|NCT03940963|Foot Neuroma|foot neuroma
41796|NCT03940963|Foot Pain|foot pain
41797|NCT03940963|Nerve Foot Pain|nerve foot pain
41798|NCT03940963|Nervous System Diseases|nervous system diseases
41799|NCT03940963|Trauma - Nervous System|trauma - nervous system
41800|NCT03940963|Wounds and Injuries|wounds and injuries
41801|NCT03940963|Nerve Repair|nerve repair
41802|NCT03940963|Surgical Treatment of Pain|surgical treatment of pain
41803|NCT03940924|Interval Training|interval training
41804|NCT03940924|Resistance Training|resistance training
41805|NCT03940924|Overweight|overweight
41806|NCT03940924|Postmenopausal women|postmenopausal women
41807|NCT03940924|Body composition|body composition
41808|NCT03940924|Gut microbiota|gut microbiota
41809|NCT03940911|Axial spondylarthritis|axial spondylarthritis
41810|NCT03940911|tired|tired
41811|NCT03940911|Anti-TNF alpha|anti-tnf alpha
41812|NCT03940911|exercises capacity|exercises capacity
41813|NCT03940911|sacoprnia|sacoprnia
41814|NCT03940898|Repetitive transcranial magnetic stimulation|repetitive transcranial magnetic stimulation
41815|NCT03940898|Schizophrenia|schizophrenia
41816|NCT03940898|Cerebellar vermis|cerebellar vermis
41817|NCT03940898|Negative symptoms|negative symptoms
41818|NCT03940898|Depressive symptoms|depressive symptoms
41819|NCT03940898|Cognitive function|cognitive function
41820|NCT03940898|Follow-up study|follow-up study
41821|NCT03940872|Parkinson Disease|parkinson disease
41822|NCT03940872|Parkinsonian central pain|parkinsonian central pain
41823|NCT03940872|Diagnosis|diagnosis
41824|NCT03940872|Primary Parkinsonian Pain Diagnostic Questionnaire|primary parkinsonian pain diagnostic questionnaire
41825|NCT03940859|contrast-enhanced magnetic resonance imaging|contrast-enhanced magnetic resonance imaging
41826|NCT03940859|intracranial dissecting aneurysm|intracranial dissecting aneurysm
41827|NCT03940859|intramural hematoma|intramural hematoma
41828|NCT03940859|prognosis|prognosis
41829|NCT03940807|Infertility|infertility
41830|NCT03940807|GnRH|gnrh
41831|NCT03940794|Urinary incontinence|urinary incontinence
41832|NCT03940794|Pelvic floor muscle contraction|pelvic floor muscle contraction
41833|NCT03940794|Transabdominal ultrasound|transabdominal ultrasound
41834|NCT03940794|Verbal instructions|verbal instructions
41835|NCT03940781|obstructive sleep apnea|obstructive sleep apnea
41836|NCT03940781|oropharyngeal rehabilitation|oropharyngeal rehabilitation
41837|NCT03940781|cardiopulmonary rehabilitation|cardiopulmonary rehabilitation
41838|NCT03940768|cancer|cancer
41839|NCT03940768|home enteral nutrition|home enteral nutrition
41840|NCT03940768|probiotic|probiotic
41841|NCT03940768|Lactobacillus plantarum 299v|lactobacillus plantarum 299v
41842|NCT03940729|PWID|pwid
41843|NCT03940729|S aureus|s aureus
41844|NCT03940729|colonization|colonization
41845|NCT03940729|infection|infection
41846|NCT03940729|chlorhexidine|chlorhexidine
41847|NCT03940703|Tepotinib|tepotinib
41848|NCT03940703|Osimertinib|osimertinib
41849|NCT03940703|Non-Small Cell Lung Cancer|non-small cell lung cancer
41850|NCT03940703|INSIGHT 2|insight 2
41851|NCT03940690|Retinal Telangiectasis|retinal telangiectasis
41852|NCT03940690|Coats Disease|coats disease
41853|NCT03940690|Anti-VEGF (Vascular Endothelial Growth Factor)|anti-vegf (vascular endothelial growth factor)
41854|NCT03940677|Biomarkers|biomarkers
41855|NCT03940677|Magnetic resonance imaging (MRI)|magnetic resonance imaging (mri)
41856|NCT03940677|Neuropsychology|neuropsychology
41857|NCT03940677|Transcranial magnetic stimulation (TMS)|transcranial magnetic stimulation (tms)
41858|NCT03940625|breast cancer|breast cancer
41859|NCT03940625|antracyclines|antracyclines
41860|NCT03940625|cardiotoxity|cardiotoxity
41861|NCT03940625|myocardial damage|myocardial damage
41863|NCT03940625|T2 mapping|t2 mapping
41864|NCT03940625|diastolic function|diastolic function
41865|NCT03940625|echocardiography|echocardiography
41866|NCT03940625|early detection|early detection
41867|NCT03940625|strain analysis|strain analysis
41868|NCT03940612|candidiasis|candidiasis
41869|NCT03940612|probiotic|probiotic
41870|NCT03940612|STP4|stp4
41871|NCT03940612|pregnant|pregnant
41872|NCT03940560|suture|suture
41873|NCT03940560|suture pull-through|suture pull-through
41874|NCT03940560|suture sinus|suture sinus
41875|NCT03940547|Aflatoxin ingestion|aflatoxin ingestion
41876|NCT03940547|Growth|growth
41877|NCT03940547|Stunting, nutritional|stunting, nutritional
41878|NCT03940508|depression|depression
41879|NCT03940508|treatment engagement|treatment engagement
41880|NCT03940508|adolescents|adolescents
41881|NCT03940508|Black youth|black youth
41882|NCT03940508|Intervention|intervention
41883|NCT03940482|TYPE 2 Diabetes Mellitus|type 2 diabetes mellitus
41884|NCT03940482|Intermittent Fasting|intermittent fasting
41885|NCT03940482|Time Restricted Eating as Treatment (TREAT)|time restricted eating as treatment (treat)
41886|NCT03940469|Dexmedetomidine|dexmedetomidine
41887|NCT03940469|Dexamethasone|dexamethasone
41888|NCT03940469|Interscalene|interscalene
41889|NCT03940456|Cohort|cohort
41890|NCT03940456|Low Back Pain|low back pain
41891|NCT03940456|Illness perception|illness perception
41892|NCT03940456|Life Style|life style
41893|NCT03940391|paradoxical reaction|paradoxical reaction
41894|NCT03940391|midazolam|midazolam
41895|NCT03940365|Labor|labor
41896|NCT03940365|Uterine contraction|uterine contraction
41897|NCT03940352|Phase Ib|phase ib
41898|NCT03940352|BHLRM|bhlrm
41899|NCT03940352|AML|aml
41900|NCT03940352|MDS|mds
41901|NCT03940352|HDM201|hdm201
41902|NCT03940352|TP53|tp53
41903|NCT03940352|MBG453|mbg453
41904|NCT03940352|TIM-3|tim-3
41905|NCT03940352|venetoclax|venetoclax
41906|NCT03940352|Bcl-2|bcl-2
41907|NCT03940339|Hamstring muscles|hamstring muscles
41908|NCT03940339|Pain measurement|pain measurement
41909|NCT03940339|Low back pain|low back pain
41910|NCT03940313|Chronic Low Back Pain|chronic low back pain
41911|NCT03940313|Myofascial pain|myofascial pain
41912|NCT03940313|Tensegrity|tensegrity
41913|NCT03940313|Prolotherapy|prolotherapy
41914|NCT03940313|Platelet-Rich Plasma|platelet-rich plasma
41915|NCT03940300|Diabetes Mellitus, Type 2|diabetes mellitus, type 2
41916|NCT03940300|food insecurity|food insecurity
41917|NCT03940300|food prescriptions|food prescriptions
41918|NCT03940300|minority|minority
41919|NCT03940300|low-income|low-income
41920|NCT03940287|Sacroiliac Joint pain|sacroiliac joint pain
41921|NCT03940287|Low back pain|low back pain
41922|NCT03940287|Pelvic girdle pain|pelvic girdle pain
41923|NCT03940274|Cardiovascular health|cardiovascular health
41924|NCT03940274|Walking training|walking training
41925|NCT03940261|High intensity interval training|high intensity interval training
41926|NCT03940248|Proton Therapy|proton therapy
41927|NCT03940209|Low Income Population|low income population
41928|NCT03940209|Diabetes Mellitus, Type 2|diabetes mellitus, type 2
41929|NCT03940209|Pragmatic clinical trial|pragmatic clinical trial
41930|NCT03940196|Platinum Resistant Ovarian Cancer|platinum resistant ovarian cancer
41931|NCT03940196|PROC|proc
41932|NCT03940196|TTFields|ttfields
41933|NCT03940196|Paclitaxel|paclitaxel
41934|NCT03940196|Minimal toxicity|minimal toxicity
41935|NCT03940196|TTF|ttf
41936|NCT03940196|Tumor Treating Fields|tumor treating fields
41937|NCT03940196|Novocure|novocure
41938|NCT03940183|type 2 diabetes|type 2 diabetes
41939|NCT03940183|monotherapy|monotherapy
41940|NCT03940183|trelagliptin succinate|trelagliptin succinate
41941|NCT03940131|re-challenge|re-challenge
41942|NCT03940131|panitumumab|panitumumab
41943|NCT03940118|respiratory secretion suctioning|respiratory secretion suctioning
41944|NCT03940118|mechanical insufflation exsufflation|mechanical insufflation exsufflation
41945|NCT03940118|hypertonic saline|hypertonic saline
41946|NCT03940118|hyaluronic acid|hyaluronic acid
41947|NCT03940118|critically ill|critically ill
41948|NCT03940118|artificial airway|artificial airway
41949|NCT03940105|intuitive eating|intuitive eating
41950|NCT03940105|package size|package size
41951|NCT03940105|food variety|food variety
41952|NCT03940066|Cardiac Monitor|cardiac monitor
41953|NCT03940027|EUS-guided CPN|eus-guided cpn
41954|NCT03939975|Hepatocellular carcinoma|hepatocellular carcinoma
41955|NCT03939975|Immunotherapy|immunotherapy
41956|NCT03939975|Nivolumab|nivolumab
41957|NCT03939975|Pembrolizumab|pembrolizumab
41958|NCT03939975|Radiofrequency Ablation|radiofrequency ablation
41959|NCT03939975|Microwave ablation|microwave ablation
41960|NCT03939949|pain|pain
41961|NCT03939949|mindfulness|mindfulness
41962|NCT03939949|awareness|awareness
41963|NCT03939949|attention to variability|attention to variability
41964|NCT03939949|quality of life|quality of life
41965|NCT03939949|wellbeing|wellbeing
41966|NCT03939936|Psoriasis|psoriasis
41967|NCT03939923|Coronary Artery Bypass Grafting Surgery|coronary artery bypass grafting surgery
41968|NCT03939923|Sugammadex|sugammadex
41969|NCT03939884|Analgesia|analgesia
41970|NCT03939884|Myofascial Pain|myofascial pain
41971|NCT03939884|MuscleCare|musclecare
41972|NCT03939884|Voltaren|voltaren
41973|NCT03939884|NSAID|nsaid
41974|NCT03939819|weight loss surgery|weight loss surgery
41975|NCT03939819|laparoscopic sleeve gastrectomy|laparoscopic sleeve gastrectomy
41976|NCT03939819|suction calibration system|suction calibration system
41977|NCT03939819|bariatric surgery|bariatric surgery
41978|NCT03939793|Community Health Worker|community health worker
41979|NCT03939793|Financial Incentives|financial incentives
41980|NCT03939741|Chronic kidney disease|chronic kidney disease
41981|NCT03939741|Stromal vascular fraction|stromal vascular fraction
41982|NCT03939741|Adipose derived stem cell|adipose derived stem cell
41983|NCT03939689|bone metastases|bone metastases
41984|NCT03939689|18F-DCFPyL|18f-dcfpyl
41985|NCT03939689|PSMA PET|psma pet
41986|NCT03939689|PSMA-avidity|psma-avidity
41987|NCT03939689|biomarker|biomarker
41988|NCT03939689|radioligand therapy|radioligand therapy
41989|NCT03939689|adjunct radiation therapy|adjunct radiation therapy
41990|NCT03939689|dosimetry|dosimetry
41991|NCT03939689|SPECT/CT|spect/ct
41992|NCT03939689|docetaxel|docetaxel
41993|NCT03939650|differential diagnosis|differential diagnosis
41994|NCT03939650|hospital outpatient clinics|hospital outpatient clinics
41995|NCT03939650|clinical applications software|clinical applications software
41996|NCT03939637|ITP|itp
41997|NCT03939637|Immune Thrombocytopenia|immune thrombocytopenia
41998|NCT03939637|Newly Diagnosed Immune Thrombocytopenia|newly diagnosed immune thrombocytopenia
41999|NCT03939637|Newly Diagnosed ITP|newly diagnosed itp
42000|NCT03939624|Sodium-Glucose Cotransporter 2 Inhibitors|sodium-glucose cotransporter 2 inhibitors
42001|NCT03939624|Type 2 Diabetes|type 2 diabetes
42002|NCT03939624|Myocardial Infarction|myocardial infarction
42003|NCT03939624|Ischemic Stroke|ischemic stroke
42004|NCT03939624|Cardiovascular Death|cardiovascular death
42005|NCT03939611|complementary therapies|complementary therapies
42006|NCT03939611|infantile colic|infantile colic
42007|NCT03939611|nurses|nurses
42008|NCT03939611|reflexology|reflexology
42009|NCT03939572|Psychological mindsets|psychological mindsets
42010|NCT03939572|Physical activity|physical activity
42011|NCT03939572|Wearable fitness trackers|wearable fitness trackers
42012|NCT03939559|dual task|dual task
42013|NCT03939559|balance|balance
42014|NCT03939559|postural control|postural control
42015|NCT03939559|rehabilitation|rehabilitation
42016|NCT03939559|home-based exercise|home-based exercise
42017|NCT03939520|Pneumology|pneumology
42018|NCT03939520|idiopathic pulmonary fibrosis|idiopathic pulmonary fibrosis
42019|NCT03939520|progressive disease|progressive disease
42020|NCT03939520|combined therapy|combined therapy
42021|NCT03939520|pirfenidone|pirfenidone
42022|NCT03939520|nintedanib|nintedanib
42023|NCT03939507|epilepsy,|epilepsy,
42024|NCT03939507|outcome|outcome
42025|NCT03939507|antiepileptic drugs|antiepileptic drugs
42026|NCT03939507|toxicity|toxicity
42027|NCT03939468|Drug Coated Balloons|drug coated balloons
42028|NCT03939468|Drug Eluting Stent|drug eluting stent
42029|NCT03939468|Diffuse Disease|diffuse disease
42157|NCT03938688|incisional hernia|incisional hernia
42030|NCT03939442|obesity, diabetes mellitus, bariatric surgery|obesity, diabetes mellitus, bariatric surgery
42031|NCT03939429|beta-lactam antibiotic|beta-lactam antibiotic
42032|NCT03939416|Fibromyalgia|fibromyalgia
42033|NCT03939416|Chronic pain|chronic pain
42034|NCT03939377|Palliative|palliative
42035|NCT03939377|Osteopathy|osteopathy
42036|NCT03939364|Erythroplakia, oral|erythroplakia, oral
42037|NCT03939364|Erythro-leukoplakia, oral|erythro-leukoplakia, oral
42038|NCT03939312|Migraine|migraine
42039|NCT03939312|Aura|aura
42040|NCT03939299|subintimal stenting|subintimal stenting
42041|NCT03939299|vascular response and healing|vascular response and healing
42042|NCT03939299|optical coherence tomography|optical coherence tomography
42043|NCT03939273|Systemic Inflammation|systemic inflammation
42044|NCT03939273|Microbiome|microbiome
42045|NCT03939273|CABG|cabg
42046|NCT03939273|Coronary Artery Bypass Graft|coronary artery bypass graft
42047|NCT03939273|Innate Immunity|innate immunity
42048|NCT03939273|Gut microbiota|gut microbiota
42049|NCT03939247|elbow|elbow
42050|NCT03939247|tendinopathy|tendinopathy
42051|NCT03939247|physiotherapy|physiotherapy
42052|NCT03939247|exercise|exercise
42053|NCT03939247|electrotherapy|electrotherapy
42054|NCT03939221|skin electric conductance|skin electric conductance
42055|NCT03939221|survival period|survival period
42056|NCT03939221|complementary and alternative medicine|complementary and alternative medicine
42057|NCT03939208|children's mental health|children's mental health
42058|NCT03939208|school mental health|school mental health
42059|NCT03939208|evidence-based practice (EBP)|evidence-based practice (ebp)
42060|NCT03939208|academic success|academic success
42061|NCT03939182|Abexinostat|abexinostat
42062|NCT03939182|Ibrutinib|ibrutinib
42063|NCT03939182|19-080|19-080
42064|NCT03939169|pain|pain
42065|NCT03939169|naso-gastric tube|naso-gastric tube
42066|NCT03939156|adjuvant endocrine therapy|adjuvant endocrine therapy
42067|NCT03939156|patient's preferences|patient's preferences
42068|NCT03939104|Artemether|artemether
42069|NCT03939104|Lumefantrine|lumefantrine
42070|NCT03939104|Amodiaquine|amodiaquine
42071|NCT03939104|Piperaquine|piperaquine
42072|NCT03939104|Artesunate|artesunate
42073|NCT03939104|Mefloquine|mefloquine
42074|NCT03939091|Ultrasonography|ultrasonography
42075|NCT03939091|Pyeloplasty|pyeloplasty
42076|NCT03939091|Renogram|renogram
42077|NCT03939091|Follow up|follow up
42078|NCT03939078|menopause|menopause
42079|NCT03939078|vaginal atrophy|vaginal atrophy
42080|NCT03939078|urinary incontinence|urinary incontinence
42081|NCT03939078|CO2 laser|co2 laser
42082|NCT03939078|fractional laser|fractional laser
42083|NCT03939078|dyspareunia|dyspareunia
42084|NCT03939078|vaginal dryness|vaginal dryness
42085|NCT03939078|vaginal lubrication|vaginal lubrication
42086|NCT03939052|Phenylketonuria|phenylketonuria
42087|NCT03939052|PKU|pku
42088|NCT03939052|Phenylalanine metabolism|phenylalanine metabolism
42089|NCT03939052|Protein requirements|protein requirements
42090|NCT03939052|Indicator Amino acid Oxidation|indicator amino acid oxidation
42091|NCT03939052|Stable isotopes|stable isotopes
42092|NCT03939052|GMP|gmp
42093|NCT03939052|Glycomacropeptide|glycomacropeptide
42094|NCT03939013|hepatitis C|hepatitis c
42095|NCT03939013|Myanmar|myanmar
42096|NCT03939013|primary care|primary care
42097|NCT03939013|direct acting antivirals|direct acting antivirals
42098|NCT03939000|clinical profile|clinical profile
42099|NCT03939000|diabetic foot ulcer|diabetic foot ulcer
42100|NCT03939000|laboratory finding|laboratory finding
42101|NCT03939000|tertiary hospital|tertiary hospital
42102|NCT03938974|self-management|self-management
42103|NCT03938974|social ecology|social ecology
42104|NCT03938974|biopsychosocial|biopsychosocial
42105|NCT03938974|social participation|social participation
42106|NCT03938974|everyday living|everyday living
42107|NCT03938974|person-centered|person-centered
42108|NCT03938974|longitudinal|longitudinal
42109|NCT03938961|Metabolism, Energy,Glucose, Protein, Energy deficit|metabolism, energy,glucose, protein, energy deficit
42110|NCT03938922|PDD|pdd
42111|NCT03938922|parkinson's disease-related dementia|parkinson's disease-related dementia
42112|NCT03938883|Photorefractive Keratectomy, Corneal Defect|photorefractive keratectomy, corneal defect
42113|NCT03938870|Alzheimer's Disease|alzheimer's disease
42114|NCT03938870|Alzheimer's|alzheimer's
42115|NCT03938870|biomarker|biomarker
42116|NCT03938870|dementia|dementia
42117|NCT03938870|Tau|tau
42118|NCT03938870|Tau Kinetics|tau kinetics
42119|NCT03938870|Tauopathies|tauopathies
42120|NCT03938844|hysterectomy|hysterectomy
42121|NCT03938844|anti-incontinence surgery|anti-incontinence surgery
42122|NCT03938844|Burch|burch
42123|NCT03938844|Tot|tot
42124|NCT03938844|stress incontinence|stress incontinence
42125|NCT03938818|Gender-Based Violence|gender-based violence
42126|NCT03938818|PrEP (Pre-exposure Prophylaxis)|prep (pre-exposure prophylaxis)
42127|NCT03938818|AIDS Prevention|aids prevention
42128|NCT03938818|HIV Prevention|hiv prevention
42129|NCT03938792|Factor VIII|factor viii
42130|NCT03938792|Factor IX|factor ix
42131|NCT03938792|Inhibitors|inhibitors
42132|NCT03938792|Anti-Tissue Factor Pathway Inhibitor (TFPI)|anti-tissue factor pathway inhibitor (tfpi)
42133|NCT03938792|Subcutaneous (sc)|subcutaneous (sc)
42134|NCT03938792|Prophylaxis|prophylaxis
42135|NCT03938792|On-Demand|on-demand
42136|NCT03938779|Elite Athletes|elite athletes
42137|NCT03938779|Volleyball|volleyball
42138|NCT03938779|Pelvic Floor Muscle Training|pelvic floor muscle training
42139|NCT03938727|Dementia|dementia
42140|NCT03938727|Aging|aging
42141|NCT03938727|Alzheimer's Disease|alzheimer's disease
42142|NCT03938727|Cognition|cognition
42143|NCT03938727|Frailty|frailty
42144|NCT03938727|Epidemiology|epidemiology
42145|NCT03938727|Lifestyle|lifestyle
42146|NCT03938727|Cardiovascula Risk Factors|cardiovascula risk factors
42147|NCT03938714|VAS pain score|vas pain score
42148|NCT03938714|Harmonic Scalpel Hemorrhoidectomy|harmonic scalpel hemorrhoidectomy
42149|NCT03938714|Conventional Hemorrhoidectomy|conventional hemorrhoidectomy
42150|NCT03938701|Fluorescence|fluorescence
42151|NCT03938701|OTL38|otl38
42152|NCT03938701|Folate receptor|folate receptor
42153|NCT03938701|Disease activity|disease activity
42154|NCT03938688|ventral hernia repair|ventral hernia repair
42155|NCT03938688|mesh|mesh
42156|NCT03938688|pain|pain
42158|NCT03938662|alcoholic liver diseases|alcoholic liver diseases
42159|NCT03938662|S-Adenosyl methionine|s-adenosyl methionine
42160|NCT03938662|choline|choline
42161|NCT03938636|RA|ra
42162|NCT03938636|healthy control|healthy control
42163|NCT03938636|HC|hc
42164|NCT03938636|tilmanocept|tilmanocept
42165|NCT03938623|colorectal cancer|colorectal cancer
42166|NCT03938623|general practitioners|general practitioners
42167|NCT03938623|the patient-centered approach|the patient-centered approach
42168|NCT03938597|yellow fever vaccine|yellow fever vaccine
42169|NCT03938597|genetic factors|genetic factors
42170|NCT03938597|viscerotropic disease|viscerotropic disease
42171|NCT03938597|neurological disease|neurological disease
42172|NCT03938558|multiple sclerosis|multiple sclerosis
42173|NCT03938558|fatigue|fatigue
42174|NCT03938545|IMVT-1401|imvt-1401
42175|NCT03938545|Graves' Orbitopathy|graves' orbitopathy
42176|NCT03938545|Thyroid Eye Disease|thyroid eye disease
42177|NCT03938519|survey|survey
42178|NCT03938519|questionnaire|questionnaire
42179|NCT03938519|radiation protection|radiation protection
42180|NCT03938519|dental|dental
42181|NCT03938506|Adult male patients who require endotracheal intubation using the endotracheal tube size of 6.0 or 8.0|adult male patients who require endotracheal intubation using the endotracheal tube size of 6.0 or 8.0
42182|NCT03938506|endotracheal tube cuff|endotracheal tube cuff
42183|NCT03938493|Adults who require endotracheal intubation for head and neck surgery under general anesthesia|adults who require endotracheal intubation for head and neck surgery under general anesthesia
42184|NCT03938467|Shoulder Arthroplasty|shoulder arthroplasty
42185|NCT03938467|C.acnes|c.acnes
42186|NCT03938467|Cutibacterium acnes|cutibacterium acnes
42187|NCT03938467|Irrisept|irrisept
42188|NCT03938454|Priapism|priapism
42189|NCT03938454|sickle cell disease|sickle cell disease
42190|NCT03938454|crizanlizumab|crizanlizumab
42191|NCT03938454|P-selectin|p-selectin
42192|NCT03938454|SEG101|seg101
42193|NCT03938454|monoclonal antibody|monoclonal antibody
42194|NCT03938454|prolonged erection|prolonged erection
42195|NCT03938454|painful erection|painful erection
42196|NCT03938402|Intraocular pressure|intraocular pressure
42197|NCT03938402|Optic nerve sheath diameter|optic nerve sheath diameter
42198|NCT03938402|Positive end-expiratory pressure|positive end-expiratory pressure
42199|NCT03938389|African American|african american
42200|NCT03938389|Black|black
42201|NCT03938389|Prediabetes|prediabetes
42202|NCT03938389|Impaired Glucose Tolerance|impaired glucose tolerance
42203|NCT03938376|Prostatic Disease|prostatic disease
42204|NCT03938376|Diagnostic Imaging|diagnostic imaging
42205|NCT03938376|Micro-Ultrasound|micro-ultrasound
42206|NCT03938363|cervical dystonia|cervical dystonia
42207|NCT03938363|blepharospasm|blepharospasm
42208|NCT03938363|gait parameters|gait parameters
42209|NCT03938363|botulinum toxin|botulinum toxin
42210|NCT03938350|Toxic stress|toxic stress
42211|NCT03938350|Maternal PTSD|maternal ptsd
42212|NCT03938350|Mindfulness-based intervention|mindfulness-based intervention
42213|NCT03938350|Dialectical Behavior Therapy|dialectical behavior therapy
42214|NCT03938350|Transgenerational transference of health disparities|transgenerational transference of health disparities
42215|NCT03938337|immunotherapy|immunotherapy
42216|NCT03938337|abemaciclib|abemaciclib
42217|NCT03938337|pembrolizumab|pembrolizumab
42218|NCT03938337|Cyclin-Dependent Kinase (CDK): CDK4|cyclin-dependent kinase (cdk): cdk4
42219|NCT03938337|Cyclin-Dependent Kinase (CDK): CDK6|cyclin-dependent kinase (cdk): cdk6
42220|NCT03938311|Ischemic stroke|ischemic stroke
42221|NCT03938311|early rehabilitation|early rehabilitation
42222|NCT03938259|pediatrics|pediatrics
42223|NCT03938259|opioids|opioids
42224|NCT03938259|obstructive sleep apnea|obstructive sleep apnea
42225|NCT03938246|NASH|nash
42226|NCT03938246|Non-Alcoholic Steatohepatitis|non-alcoholic steatohepatitis
42227|NCT03938246|Fatty Liver Disease|fatty liver disease
42228|NCT03938246|Fatty Liver|fatty liver
42229|NCT03938246|Liver Diseases|liver diseases
42230|NCT03938246|FASN|fasn
42231|NCT03938246|Fatty Acid Synthase Inhibitor|fatty acid synthase inhibitor
42232|NCT03938233|Diabetes|diabetes
42233|NCT03938233|Self-management|self-management
42234|NCT03938233|Structured Education|structured education
42235|NCT03938233|Thailand|thailand
42236|NCT03938233|Peer Led|peer led
42237|NCT03938207|Dry eye syndrome|dry eye syndrome
42238|NCT03938207|Sjögren's syndrome|sjögren's syndrome
42239|NCT03938207|Gene modulation|gene modulation
42240|NCT03938207|Xerophthalmia|xerophthalmia
42241|NCT03938207|TCM pattern|tcm pattern
42242|NCT03938181|cardiac surgery patients|cardiac surgery patients
42243|NCT03938181|acute renal failure|acute renal failure
42244|NCT03938181|intensive care|intensive care
42245|NCT03938155|Frailty|frailty
42246|NCT03938155|Women|women
42247|NCT03938155|Early detection|early detection
42248|NCT03938155|Screening Program|screening program
42249|NCT03938116|couple relationship|couple relationship
42250|NCT03938116|heart disease|heart disease
42251|NCT03938103|preschool|preschool
42252|NCT03938103|child care centers|child care centers
42253|NCT03938103|nutrition|nutrition
42254|NCT03938103|physical activity|physical activity
42255|NCT03938103|organizational readiness|organizational readiness
42256|NCT03938103|behavior change|behavior change
42257|NCT03938103|cost-effectiveness|cost-effectiveness
42258|NCT03938103|implementation|implementation
42259|NCT03938090|Cardiac Resynchronization Therapy|cardiac resynchronization therapy
42260|NCT03938090|MultiSite Pacing|multisite pacing
42261|NCT03938077|mHealth|mhealth
42262|NCT03938077|prevention intervention|prevention intervention
42263|NCT03938077|primary health care|primary health care
42268|NCT03938051|Exercise|exercise
42269|NCT03938051|Mild Cognitive Impairment|mild cognitive impairment
42270|NCT03938051|Elderly Population|elderly population
42271|NCT03938025|Sleeve gastrectomy|sleeve gastrectomy
42272|NCT03938025|Morbid obesity|morbid obesity
42273|NCT03938025|Resected gastric volume|resected gastric volume
42274|NCT03938012|mutations in MET and TP53|mutations in met and tp53
42275|NCT03937999|clostridium difficile|clostridium difficile
42276|NCT03937999|diarrhea|diarrhea
42278|NCT03937973|heart|heart
42279|NCT03937973|stress|stress
42280|NCT03937960|Dietary intervention|dietary intervention
42281|NCT03937960|Anthropometric measure|anthropometric measure
42282|NCT03937960|Lipid profile|lipid profile
42283|NCT03937960|Augmentation Index|augmentation index
42284|NCT03937960|Flow mediated dilation|flow mediated dilation
42285|NCT03937960|DXA scan|dxa scan
42286|NCT03937960|Nuclear magnetic resonance lipid profile|nuclear magnetic resonance lipid profile
42287|NCT03937921|Signal intensity enhancement|signal intensity enhancement
42288|NCT03937921|Relaxation rate enhancement|relaxation rate enhancement
42289|NCT03937895|Biliary Tract Cancer|biliary tract cancer
42290|NCT03937895|BTC|btc
42291|NCT03937895|Cholangiocarcinoma|cholangiocarcinoma
42292|NCT03937882|Dry Eye|dry eye
42293|NCT03937882|Dry Eye Syndrome|dry eye syndrome
42294|NCT03937882|DES|des
42295|NCT03937869|Adolescents|adolescents
42296|NCT03937869|Vaginal fishy smell|vaginal fishy smell
42297|NCT03937869|Vaginal itching|vaginal itching
42298|NCT03937869|off-white milky vaginal discharge|off-white milky vaginal discharge
42299|NCT03937843|Seminoma|seminoma
42300|NCT03937843|Stage IIA/B seminoma|stage iia/b seminoma
42301|NCT03937843|Radio-chemotherapy|radio-chemotherapy
42302|NCT03937843|Phase II trial|phase ii trial
42303|NCT03937843|Testicular Cancer|testicular cancer
42308|NCT03937817|Assay Development|assay development
42309|NCT03937817|Malaria|malaria
42310|NCT03937817|Sickle Cell Disease|sickle cell disease
42311|NCT03937817|Alpha Thalassemia|alpha thalassemia
42312|NCT03937804|Trans-omics|trans-omics
42313|NCT03937791|Human Papilloma Virus (HPV) Type 16|human papilloma virus (hpv) type 16
42314|NCT03937791|Retroviral Vector Supernatant|retroviral vector supernatant
42315|NCT03937791|Leukapheresis|leukapheresis
42316|NCT03937791|T Cell Receptor|t cell receptor
42317|NCT03937791|Premalignant Epithelial Lesion|premalignant epithelial lesion
42318|NCT03937778|Somatosensory|somatosensory
42319|NCT03937752|anal fistula|anal fistula
42320|NCT03937752|fistula in ano|fistula in ano
42321|NCT03937752|endoanal ultrasound|endoanal ultrasound
42322|NCT03937752|3D ultrasound|3d ultrasound
42323|NCT03937752|3D ultrasonography|3d ultrasonography
42324|NCT03937752|endoanal ultrasonography|endoanal ultrasonography
42325|NCT03937752|diagnostics|diagnostics
42326|NCT03937739|Nutrition|nutrition
42327|NCT03937739|Constipation|constipation
42328|NCT03937739|Hernia|hernia
42329|NCT03937726|Peanut allergy|peanut allergy
42330|NCT03937726|Desensitisation|desensitisation
42331|NCT03937726|Safety|safety
42332|NCT03937713|post traumatic stress disorder|post traumatic stress disorder
42333|NCT03937713|complex insomnia|complex insomnia
42334|NCT03937713|cognitive behavioral therapy|cognitive behavioral therapy
42335|NCT03937713|eszopiclone|eszopiclone
42336|NCT03937674|Physical Activity|physical activity
42337|NCT03937674|Mobile Health|mobile health
42338|NCT03937674|Self Monitoring|self monitoring
42339|NCT03937674|Wearable Sensors|wearable sensors
42340|NCT03937674|Tailored Health Communication|tailored health communication
42341|NCT03937674|Implementation Intentions|implementation intentions
42342|NCT03937674|Mobile Apps|mobile apps
42343|NCT03937674|Anti-Sedentary Behavior|anti-sedentary behavior
42344|NCT03937674|Opportunistic Physical Activity|opportunistic physical activity
42345|NCT03937674|Health Belief Model|health belief model
42346|NCT03937609|infliximab|infliximab
42347|NCT03937583|Venous Thromboembolic Disease|venous thromboembolic disease
42348|NCT03937583|Pulmonary Embolism|pulmonary embolism
42349|NCT03937583|Extended screening|extended screening
42350|NCT03937570|left ventricular assist device|left ventricular assist device
42351|NCT03937570|echo-optimization|echo-optimization
42352|NCT03937570|functional capacity|functional capacity
42353|NCT03937570|cardiopulmonary exercise test|cardiopulmonary exercise test
42354|NCT03937531|Postoperative voiding dysfunction|postoperative voiding dysfunction
42355|NCT03937531|Postoperative void trial|postoperative void trial
42356|NCT03937531|Retrograde fill void trial|retrograde fill void trial
42357|NCT03937531|Spontaneous void trial|spontaneous void trial
42358|NCT03937531|Midurethral sling|midurethral sling
43936|NCT03927534|Overweight|overweight
42363|NCT03937492|Distal radius fracture|distal radius fracture
42364|NCT03937466|hot flashes|hot flashes
42365|NCT03937466|menopause|menopause
42366|NCT03937466|cooling mattress pad|cooling mattress pad
42367|NCT03937453|Pancreas|pancreas
42368|NCT03937453|Cancer|cancer
42369|NCT03937453|Diabetes Mellitus|diabetes mellitus
42370|NCT03937453|MRI|mri
42371|NCT03937453|Early Detection|early detection
42372|NCT03937440|deep neuromuscular block|deep neuromuscular block
42373|NCT03937440|robot-assisted surgery|robot-assisted surgery
42374|NCT03937440|stress response|stress response
42375|NCT03937440|stomach cancer|stomach cancer
42376|NCT03937414|Breast neoplasm; Molecular Diagnostic Techniques|breast neoplasm; molecular diagnostic techniques
42377|NCT03937401|oxytocin|oxytocin
42378|NCT03937401|MRI-HIFU|mri-hifu
42379|NCT03937401|fibroid|fibroid
42380|NCT03937401|adenomyosis|adenomyosis
42381|NCT03937388|cochlear implants|cochlear implants
42382|NCT03937388|electrical stimulation|electrical stimulation
42383|NCT03937388|processing strategy|processing strategy
42384|NCT03937388|hearing quality|hearing quality
42385|NCT03937388|speech recognition|speech recognition
42386|NCT03937388|energy consumption|energy consumption
42387|NCT03937375|Surgery|surgery
42388|NCT03937375|Mechanical ventilation|mechanical ventilation
42389|NCT03937375|PEEP|peep
42390|NCT03937375|Postoperative pulmonary complications|postoperative pulmonary complications
42391|NCT03937375|Individual patient data meta-analysis|individual patient data meta-analysis
42392|NCT03937362|Esophagectomy|esophagectomy
42393|NCT03937362|Neoadjuvant chemoradiotherapy|neoadjuvant chemoradiotherapy
42394|NCT03937362|Esophageal cancer|esophageal cancer
42395|NCT03937362|Esophageal squamous cell carcinoma|esophageal squamous cell carcinoma
42396|NCT03937362|Active surveillance|active surveillance
42397|NCT03937336|Active Commuting|active commuting
42398|NCT03937336|Health behaviour|health behaviour
42399|NCT03937336|Design|design
42400|NCT03937336|Intervention|intervention
42401|NCT03937336|Technology|technology
42402|NCT03937336|Children|children
42403|NCT03937336|Adolescents|adolescents
42404|NCT03937336|Parents|parents
42405|NCT03937336|Mobility|mobility
42406|NCT03937323|Pancreatitis|pancreatitis
42407|NCT03937323|Lymphocyte subtypes|lymphocyte subtypes
42408|NCT03937323|Cytokine|cytokine
42409|NCT03937297|non-pharmacological|non-pharmacological
42410|NCT03937297|intervention|intervention
42411|NCT03937297|culturally appropriate|culturally appropriate
42412|NCT03937297|Chinese|chinese
42413|NCT03937297|cognitive stimulation therapy|cognitive stimulation therapy
42414|NCT03937297|Six Arts|six arts
42415|NCT03937297|dementia|dementia
42416|NCT03937297|CST|cst
42417|NCT03937284|Lipoproteins|lipoproteins
42418|NCT03937284|Lipopolysaccharide|lipopolysaccharide
42419|NCT03937284|Lipopolysaccharide binding protein|lipopolysaccharide binding protein
42420|NCT03937284|Inflammation|inflammation
42421|NCT03937271|Sjögren's syndrome|sjögren's syndrome
814885|NCT00183079|Depression|depression
56522|NCT03849820|RAS|ras
42422|NCT03937271|Systemic lupus erythematosus|systemic lupus erythematosus
42423|NCT03937271|Rheumatoid Arthritis|rheumatoid arthritis
42424|NCT03937271|Systemic Sclerosis|systemic sclerosis
42425|NCT03937271|Ankylosing spondylitis|ankylosing spondylitis
42426|NCT03937271|Dry eye syndrome|dry eye syndrome
42427|NCT03937258|healthy volunteers|healthy volunteers
42432|NCT03937219|renal|renal
42433|NCT03937219|cancer|cancer
42434|NCT03937219|carcinoma|carcinoma
42435|NCT03937193|aortomesenteric angle|aortomesenteric angle
42436|NCT03937193|aortomesenteric distance|aortomesenteric distance
42437|NCT03937193|retroperitoneal adipose tissue|retroperitoneal adipose tissue
42438|NCT03937193|computerized tomography|computerized tomography
42439|NCT03937193|young Chinese population|young chinese population
42440|NCT03937180|benzodiazepines|benzodiazepines
42441|NCT03937180|blended care|blended care
42442|NCT03937167|obesity|obesity
42443|NCT03937167|Psychotherapy|psychotherapy
42444|NCT03937167|Psychotherapy Group|psychotherapy group
42445|NCT03937154|Chemotherapy-induced thrombocytopenia|chemotherapy-induced thrombocytopenia
42446|NCT03937154|Non-small Cell Lung Cancer|non-small cell lung cancer
42447|NCT03937154|Ovarian Cancer|ovarian cancer
42448|NCT03937154|Breast Cancer|breast cancer
42449|NCT03937115|tDCS|tdcs
42450|NCT03937115|Noninvasive brain stimulation|noninvasive brain stimulation
42451|NCT03937115|Endurance performance|endurance performance
42452|NCT03937115|Cognitive performance|cognitive performance
42453|NCT03937102|cardiac output|cardiac output
42454|NCT03937102|trans thoracic echocardiography|trans thoracic echocardiography
42455|NCT03937102|passive leg raising|passive leg raising
42456|NCT03937102|volume expansion|volume expansion
42457|NCT03937076|Intercostal block|intercostal block
42458|NCT03937076|Pectoral nerve block II|pectoral nerve block ii
42459|NCT03937050|pregnancy|pregnancy
42460|NCT03937050|gestational diabetes|gestational diabetes
42461|NCT03937050|India|india
42462|NCT03937050|Uganda|uganda
42463|NCT03937050|cluster randomized trial|cluster randomized trial
42464|NCT03937037|ERCP|ercp
42465|NCT03937037|Common bile duct stone|common bile duct stone
42466|NCT03937037|Cholangitis|cholangitis
42467|NCT03937037|Residual stone|residual stone
42468|NCT03937037|Irrigation|irrigation
42469|NCT03937037|Recurrence|recurrence
42470|NCT03937011|STRATAFIX SPIRAL PDS PLUS, ROBOTIC SUTURING,|stratafix spiral pds plus, robotic suturing,
42471|NCT03936972|tibia fracture; ilizarov; open fracture; external fixator|tibia fracture; ilizarov; open fracture; external fixator
42472|NCT03936959|PD-1|pd-1
42473|NCT03936959|PD-L1|pd-l1
42474|NCT03936894|Canakinumab|canakinumab
42475|NCT03936894|Biomarker|biomarker
42476|NCT03936829|panniculitis associated acquired generalised lipodystrophy|panniculitis associated acquired generalised lipodystrophy
42477|NCT03936829|cyclophosphamide|cyclophosphamide
42478|NCT03936790|cesarean section|cesarean section
42479|NCT03936790|combined spinal epidural anaesthesia|combined spinal epidural anaesthesia
42480|NCT03936790|tall parturients|tall parturients
42481|NCT03936790|ropivacaine ED50 and MLAD|ropivacaine ed50 and mlad
42482|NCT03936764|NSCLC|nsclc
42483|NCT03936764|Preoperative pulmonary rehabilitation|preoperative pulmonary rehabilitation
42484|NCT03936764|Preoperative training|preoperative training
42485|NCT03936764|Prehabilitation|prehabilitation
42486|NCT03936764|Lung resection|lung resection
42487|NCT03936725|Rehabilitation program|rehabilitation program
42488|NCT03936725|Non specific chronic low back pain|non specific chronic low back pain
42489|NCT03936725|Return to work|return to work
42490|NCT03936712|Energy drinks|energy drinks
42491|NCT03936712|Exercise|exercise
42492|NCT03936712|Physiological response|physiological response
42493|NCT03936712|Mood State|mood state
42494|NCT03936712|Fatigue|fatigue
42495|NCT03936686|Education|education
42496|NCT03936686|Knowledge level|knowledge level
42497|NCT03936673|obstructive uropathy|obstructive uropathy
42498|NCT03936673|relative renal function|relative renal function
42499|NCT03936673|DMSA|dmsa
42500|NCT03936660|COORDINATE-DIABETES|coordinate-diabetes
42501|NCT03936660|COORDINATE|coordinate
42502|NCT03936660|T2DM|t2dm
42503|NCT03936660|Diabetes Mellitus, Type 2|diabetes mellitus, type 2
42504|NCT03936660|Cardiovascular Disease|cardiovascular disease
42505|NCT03936660|Prevention|prevention
42506|NCT03936647|intracranial aneurysm|intracranial aneurysm
42507|NCT03936647|cerebral aneurysm|cerebral aneurysm
42508|NCT03936647|brain aneurysm|brain aneurysm
42509|NCT03936647|unruptured cerebral aneurysm|unruptured cerebral aneurysm
42510|NCT03936647|ruptured cerebral aneurysm|ruptured cerebral aneurysm
42511|NCT03936647|WEB embolization device|web embolization device
42512|NCT03936647|embolization|embolization
42513|NCT03936634|Observation study|observation study
42514|NCT03936634|First degree relatives|first degree relatives
42515|NCT03936634|Beta cell|beta cell
42516|NCT03936634|C-Peptide|c-peptide
42517|NCT03936634|Immune cells|immune cells
42518|NCT03936634|Disease progression|disease progression
42519|NCT03936621|Omega 3|omega 3
42521|NCT03936608|CRT Programming|crt programming
42522|NCT03936530|colon adenocarcinoma|colon adenocarcinoma
42523|NCT03936530|lymph node metastasis|lymph node metastasis
42524|NCT03936530|right hemi-colectomy|right hemi-colectomy
42525|NCT03936517|Glucocorticoids|glucocorticoids
42526|NCT03936517|Hydrocortisone|hydrocortisone
42527|NCT03936517|Prednisolone|prednisolone
42528|NCT03936517|Cortisol|cortisol
42529|NCT03936504|Tai Chi|tai chi
42530|NCT03936504|cardiac rehabilitation|cardiac rehabilitation
42531|NCT03936504|coronary heart disease|coronary heart disease
42532|NCT03936504|major adverse cardiac and cerebrovascular events|major adverse cardiac and cerebrovascular events
42533|NCT03936491|biomarker|biomarker
42534|NCT03936491|ADHD|adhd
42535|NCT03936478|cosmesis|cosmesis
42536|NCT03936478|cosmetic|cosmetic
42537|NCT03936478|breast-conserving therapy|breast-conserving therapy
42538|NCT03936465|Solid Tumor|solid tumor
42539|NCT03936465|Lymphoma|lymphoma
42540|NCT03936465|Neuroblastoma|neuroblastoma
42541|NCT03936465|Sarcoma|sarcoma
42542|NCT03936465|Medulloblastoma|medulloblastoma
42543|NCT03936465|MYC|myc
42544|NCT03936465|MYCN|mycn
42545|NCT03936465|BRD4|brd4
42546|NCT03936465|BET inhibitor|bet inhibitor
42547|NCT03936465|Bromodomain|bromodomain
42548|NCT03936439|stroke|stroke
42549|NCT03936413|imaging|imaging
42550|NCT03936413|echocardiography|echocardiography
42551|NCT03936413|artificial intelligence|artificial intelligence
42552|NCT03936400|cancer|cancer
42553|NCT03936400|females|females
42554|NCT03936400|partners|partners
42555|NCT03936387|erector spinae block|erector spinae block
42556|NCT03936387|regional anesthesia|regional anesthesia
42557|NCT03936387|sternotomy|sternotomy
42558|NCT03936387|ropivacaine|ropivacaine
42559|NCT03936348|Pulmonary rehabilitation|pulmonary rehabilitation
42560|NCT03936348|Medical device|medical device
42561|NCT03936348|FeelBreathe|feelbreathe
42562|NCT03936348|Exercise intervention|exercise intervention
42563|NCT03936348|Equipment and Supplies|equipment and supplies
42564|NCT03936296|multiparametric prostate magnetic resonance imaging|multiparametric prostate magnetic resonance imaging
42565|NCT03936296|MR-US fusion|mr-us fusion
42566|NCT03936296|MR guided prostate biopsy|mr guided prostate biopsy
42567|NCT03936296|prostate cancer|prostate cancer
42568|NCT03936283|lifestyle|lifestyle
42569|NCT03936283|intervention|intervention
42570|NCT03936283|body weight|body weight
42571|NCT03936283|pregnancy|pregnancy
42572|NCT03936283|Overweight|overweight
42574|NCT03936283|Signs and Symptoms|signs and symptoms
42575|NCT03936283|Body weight changes|body weight changes
42576|NCT03936270|Palbociclib|palbociclib
42577|NCT03936270|Letrozole|letrozole
42578|NCT03936270|Ovarian Cancer|ovarian cancer
42579|NCT03936231|VILI|vili
42580|NCT03936231|Mechanical Power|mechanical power
42581|NCT03936231|Driving Pressure|driving pressure
42582|NCT03936231|Strain|strain
42583|NCT03936231|Stress|stress
42584|NCT03936127|Transperineal|transperineal
42585|NCT03936127|Transrectal|transrectal
42586|NCT03936127|Fusion Biopsy|fusion biopsy
42587|NCT03936075|receptive music therapy|receptive music therapy
42588|NCT03936075|Guided Imagery & Music (GIM)|guided imagery & music (gim)
42589|NCT03936075|chemotherapy|chemotherapy
42590|NCT03936075|radiotherapy|radiotherapy
42591|NCT03936075|breast cancer|breast cancer
42592|NCT03936075|gynecologic cancer|gynecologic cancer
42593|NCT03935997|Palliative care|palliative care
42594|NCT03935997|End of life care|end of life care
42595|NCT03935997|Long-term care|long-term care
42596|NCT03935997|Nursing home|nursing home
42597|NCT03935958|kidney transplantation|kidney transplantation
42598|NCT03935958|inflammation|inflammation
42599|NCT03935958|vascular dysfunction|vascular dysfunction
42600|NCT03935958|cognitive impairment|cognitive impairment
42601|NCT03935958|oxidative stress|oxidative stress
42602|NCT03935958|graft function|graft function
42603|NCT03935945|Drinking|drinking
42604|NCT03935945|Alcohol|alcohol
42605|NCT03935945|HIV+|hiv+
42606|NCT03935932|COPD|copd
42607|NCT03935932|Chronic bronchitis|chronic bronchitis
42608|NCT03935919|perioperative glucose management|perioperative glucose management
42609|NCT03935919|continuous glucose monitoring|continuous glucose monitoring
42610|NCT03935919|diabetes|diabetes
42611|NCT03935906|Point of Care|point of care
42612|NCT03935906|Direct Acting Antivirals|direct acting antivirals
42613|NCT03935906|Community Pharmacy|community pharmacy
42614|NCT03935906|Opiate Substitution Therapy|opiate substitution therapy
42615|NCT03935828|chronic rhinosinusitis|chronic rhinosinusitis
42616|NCT03935828|topical sinonasal antibiotics|topical sinonasal antibiotics
42617|NCT03935828|randomized controlled trial|randomized controlled trial
42618|NCT03935802|Radiotherapy|radiotherapy
42619|NCT03935802|CETC|cetc
42620|NCT03935802|CTC|ctc
42621|NCT03935802|breast cancer|breast cancer
42622|NCT03935789|stroke|stroke
42623|NCT03935789|occupational therapy|occupational therapy
42624|NCT03935789|participation|participation
42625|NCT03935776|Peripheral arterial disease|peripheral arterial disease
42626|NCT03935776|Risk factor modifications|risk factor modifications
42627|NCT03935776|Cardiovascular risk factors|cardiovascular risk factors
42628|NCT03935763|Real Worl Evidence|real worl evidence
42629|NCT03935750|Lateral extra-articular tenodesis|lateral extra-articular tenodesis
42630|NCT03935750|Autografting|autografting
42631|NCT03935750|Allografting|allografting
42632|NCT03935750|Bone-Patellar Tendon-Bone Grafting|bone-patellar tendon-bone grafting
42633|NCT03935711|cbct|cbct
42634|NCT03935711|cbct dental|cbct dental
42635|NCT03935711|mandibular anterior teeth|mandibular anterior teeth
42636|NCT03935711|canal morphology|canal morphology
42637|NCT03935698|Pilot study|pilot study
42638|NCT03935698|Feasibility study|feasibility study
42639|NCT03935698|Dyspareunia|dyspareunia
42640|NCT03935698|Gynecological cancer survivors|gynecological cancer survivors
42641|NCT03935698|Physiotherapy|physiotherapy
42642|NCT03935672|Oropharyngeal Cancer|oropharyngeal cancer
42643|NCT03935672|Radiotherapy|radiotherapy
42644|NCT03935672|HPV positive|hpv positive
42645|NCT03935672|Automated segmentation|automated segmentation
42646|NCT03935672|Radiotherapy re-planning|radiotherapy re-planning
42647|NCT03935659|Negative Pressure Wound Therapy|negative pressure wound therapy
42648|NCT03935646|Attention Deficit Hyperactivity Disorder|attention deficit hyperactivity disorder
42649|NCT03935646|Stimulant Use|stimulant use
42650|NCT03935646|Working Memory|working memory
42651|NCT03935646|Change in Sustained Attention|change in sustained attention
42652|NCT03935646|Mood|mood
42653|NCT03935594|platelet rich plasma (PRP)|platelet rich plasma (prp)
42654|NCT03935594|hypertrophic scar|hypertrophic scar
42655|NCT03935594|burn scar|burn scar
42656|NCT03935594|tissue repair|tissue repair
42658|NCT03935594|patient and observer scar assessment scale (POSAS)|patient and observer scar assessment scale (posas)
42660|NCT03935581|ExAblate|exablate
42661|NCT03935581|Essential Tremor|essential tremor
42662|NCT03935581|Auto-Focusing Echo Imaging|auto-focusing echo imaging
42663|NCT03935568|PU-AD|pu-ad
42664|NCT03935555|Primary Myelofibrosis (PMF)|primary myelofibrosis (pmf)
42665|NCT03935555|Post-Polycythemia Vera Myelofibrosis (Post-PV MF)|post-polycythemia vera myelofibrosis (post-pv mf)
42666|NCT03935555|Post-Essential Thrombocythemia Myelofibrosis (Post-ET MF)|post-essential thrombocythemia myelofibrosis (post-et mf)
42667|NCT03935542|Bifurcation|bifurcation
42668|NCT03935542|Side branch|side branch
42669|NCT03935542|Ischemia|ischemia
42670|NCT03935542|Myocardium|myocardium
42671|NCT03935542|Revascularization|revascularization
42672|NCT03935516|cast|cast
42673|NCT03935516|open growth plate|open growth plate
42674|NCT03935516|pediatric|pediatric
42675|NCT03935516|both bone|both bone
42676|NCT03935503|Quality of life|quality of life
42677|NCT03935503|Inguinal Hernia|inguinal hernia
42678|NCT03935503|Lichtenstein repair|lichtenstein repair
42679|NCT03935503|Sexual Function|sexual function
42680|NCT03935503|Total Extraperitoneal Repair|total extraperitoneal repair
42681|NCT03935490|Inguinal hernia|inguinal hernia
42682|NCT03935490|Strangulated|strangulated
42683|NCT03935490|TREPP|trepp
42684|NCT03935490|Transrectus sheath pre-peritoneal|transrectus sheath pre-peritoneal
42685|NCT03935464|PrEP, women, Kenya, adherence, POC monitoring, urine test, immunoassay, tenofovir|prep, women, kenya, adherence, poc monitoring, urine test, immunoassay, tenofovir
42686|NCT03935438|cardiac rehabilitation|cardiac rehabilitation
42687|NCT03935438|acute coronary syndrome|acute coronary syndrome
42688|NCT03935438|anthropometric parameters|anthropometric parameters
42689|NCT03935438|physical efficiency|physical efficiency
42690|NCT03935438|cardiovascular function|cardiovascular function
42691|NCT03935412|Erector spinae plane block|erector spinae plane block
42692|NCT03935412|morphine|morphine
42693|NCT03935412|cesarean section|cesarean section
42694|NCT03935412|postoperative analgesia|postoperative analgesia
42695|NCT03935412|spinal anesthesia|spinal anesthesia
42696|NCT03935373|Immune regulation|immune regulation
42697|NCT03935373|Sjögren's syndrome|sjögren's syndrome
42698|NCT03935373|Gene modulation|gene modulation
42699|NCT03935373|Traditional Chinese Medicine pattern|traditional chinese medicine pattern
42700|NCT03935373|Traditional Chinese Medicine tongue diagnosis|traditional chinese medicine tongue diagnosis
42701|NCT03935373|Traditional Chinese Medicine pulse diagnosis|traditional chinese medicine pulse diagnosis
42702|NCT03935373|Proteomics|proteomics
42703|NCT03935373|Oral microbiome|oral microbiome
42704|NCT03935360|lower gastrointestinal bleeding|lower gastrointestinal bleeding
42705|NCT03935360|external validation|external validation
42706|NCT03935360|prognostic risk score|prognostic risk score
42707|NCT03935360|safe discharge|safe discharge
42708|NCT03935360|multi-centre cohort study|multi-centre cohort study
42709|NCT03935360|obscure gastrointestinal bleeding|obscure gastrointestinal bleeding
42710|NCT03935360|hospital presentation|hospital presentation
42711|NCT03935321|Tetraplegia|tetraplegia
42712|NCT03935321|Trauma|trauma
42713|NCT03935321|Upper limbs function|upper limbs function
814886|NCT00183079|Alcohol Use|alcohol use
42714|NCT03935308|prostate cancer, MRI, intraprostatic lesions|prostate cancer, mri, intraprostatic lesions
42715|NCT03935295|AIS|ais
42716|NCT03935295|adolescent idiopathic scoliosis|adolescent idiopathic scoliosis
42717|NCT03935282|Cardiovascular risk|cardiovascular risk
42718|NCT03935282|Cardiovascular disease|cardiovascular disease
42719|NCT03935282|Cancer|cancer
42720|NCT03935282|Survivor|survivor
42721|NCT03935282|Health Behaviors|health behaviors
42722|NCT03935282|Oncology Providers|oncology providers
42723|NCT03935282|EHR|ehr
42724|NCT03935282|Informatics|informatics
42725|NCT03935269|High-grade glioma|high-grade glioma
42726|NCT03935269|Stress|stress
42727|NCT03935269|Caregivers|caregivers
42730|NCT03935230|unexpected cardiopulmonary arrest|unexpected cardiopulmonary arrest
42731|NCT03935230|potential organ donors|potential organ donors
42732|NCT03935217|Vaginal Itching|vaginal itching
42733|NCT03935217|Vaginal Discharge|vaginal discharge
42734|NCT03935204|human papillomavirus vaccine|human papillomavirus vaccine
42735|NCT03935165|indocyanine Green|indocyanine green
42736|NCT03935165|deep Infiltrating Endometriosis|deep infiltrating endometriosis
42737|NCT03935165|near-Infrared Vision|near-infrared vision
42738|NCT03935165|occult endometriosis|occult endometriosis
42739|NCT03935165|invisible endometriosis|invisible endometriosis
42740|NCT03935139|microdialysis|microdialysis
42741|NCT03935139|bone free flap|bone free flap
42742|NCT03935139|fibula|fibula
42743|NCT03935139|iliac crest|iliac crest
42744|NCT03935074|enucleation|enucleation
42745|NCT03935074|globe salvage|globe salvage
42746|NCT03935074|superselective intra-arterial chemotherapy|superselective intra-arterial chemotherapy
42747|NCT03935061|Anthocyanin|anthocyanin
42748|NCT03935061|Anxiety Disorders|anxiety disorders
42749|NCT03935061|Inflammation|inflammation
42750|NCT03935061|interleukin-17A|interleukin-17a
42751|NCT03935035|adolescents|adolescents
42752|NCT03935035|internet-delivered|internet-delivered
42753|NCT03935035|online|online
42754|NCT03935035|young people|young people
42755|NCT03935035|trauma|trauma
42756|NCT03935035|cognitive therapy|cognitive therapy
42757|NCT03935009|Oral hygiene|oral hygiene
42758|NCT03935009|Dental Plaque|dental plaque
42759|NCT03935009|Brushing|brushing
42760|NCT03935009|Flossing|flossing
42761|NCT03935009|Gamification|gamification
42762|NCT03935009|Game elements|game elements
42763|NCT03935009|Motivation|motivation
42764|NCT03935009|Education|education
42765|NCT03935009|Children|children
42766|NCT03935009|Parents|parents
42767|NCT03934996|pelvic floor|pelvic floor
42768|NCT03934996|athletes|athletes
42769|NCT03934983|Viscoelastic testing|viscoelastic testing
42770|NCT03934983|Coagulation|coagulation
42771|NCT03934983|Quantra|quantra
42772|NCT03934983|Hemostasis|hemostasis
42773|NCT03934970|Diabetic Polyneuropathy|diabetic polyneuropathy
42774|NCT03934970|Diffusion tensor imaging|diffusion tensor imaging
42775|NCT03934970|Neuropathy scores|neuropathy scores
42776|NCT03934957|Epidemiology|epidemiology
42777|NCT03934957|prospective cohort study|prospective cohort study
42778|NCT03934957|Nutrition|nutrition
42779|NCT03934957|prevention|prevention
42780|NCT03934957|psychiatric and psychosomatic disorders|psychiatric and psychosomatic disorders
42781|NCT03934944|Patient education|patient education
42782|NCT03934944|Prevention|prevention
42783|NCT03934944|Smart phone application|smart phone application
42784|NCT03934931|latent tuberculosis|latent tuberculosis
42785|NCT03934931|tuberculosis|tuberculosis
42786|NCT03934931|HIV/AIDS|hiv/aids
42787|NCT03934931|implementation science|implementation science
42788|NCT03934931|Uganda|uganda
42789|NCT03934931|3HP|3hp
42790|NCT03934931|shared decision making|shared decision making
42791|NCT03934931|rifapentine|rifapentine
42792|NCT03934918|cervical preparation|cervical preparation
42793|NCT03934918|cervical ripening|cervical ripening
42794|NCT03934918|NTSV|ntsv
42795|NCT03934918|induction of labor|induction of labor
42796|NCT03934905|doxorubicin|doxorubicin
42797|NCT03934905|sulforaphane|sulforaphane
42798|NCT03934905|cardiotoxicity|cardiotoxicity
42799|NCT03934905|nrf2|nrf2
42800|NCT03934905|heart|heart
42801|NCT03934827|Cancer|cancer
42802|NCT03934827|Solid Tumour|solid tumour
42803|NCT03934788|contact lens material|contact lens material
42804|NCT03934788|silicon hydrogel|silicon hydrogel
42805|NCT03934775|emergency department|emergency department
42806|NCT03934775|risk prediction|risk prediction
42807|NCT03934775|non-invasive hemodynamic|non-invasive hemodynamic
42808|NCT03934775|Heart rate variability|heart rate variability
42809|NCT03934762|aseptic inflammation|aseptic inflammation
42810|NCT03934762|muscle trauma|muscle trauma
42811|NCT03934762|muscle strength|muscle strength
42812|NCT03934762|aloe vera|aloe vera
42813|NCT03934736|ESRD|esrd
42814|NCT03934736|Hemodialysis|hemodialysis
42815|NCT03934736|End Stage Renal Disease|end stage renal disease
42816|NCT03934736|Hepatitis B|hepatitis b
42817|NCT03934736|HEPLISAV-B|heplisav-b
42818|NCT03934736|Prevention and Control|prevention and control
42819|NCT03934736|HBV Vaccine|hbv vaccine
42820|NCT03934736|Hepatitis B Vaccine|hepatitis b vaccine
42821|NCT03934723|Exercise|exercise
42822|NCT03934723|Antidepressants|antidepressants
42823|NCT03934723|Visceral fat|visceral fat
42824|NCT03934697|Eating Disorder|eating disorder
42825|NCT03934697|Anorexia Nervosa|anorexia nervosa
42826|NCT03934697|Bulimia Nervosa|bulimia nervosa
42827|NCT03934697|Imaginal Exposure Therapy|imaginal exposure therapy
42828|NCT03934671|Chronic wound|chronic wound
42829|NCT03934671|Wound healing|wound healing
42830|NCT03934671|Hard-to-heal wounds|hard-to-heal wounds
42831|NCT03934671|Antioxidant dressing|antioxidant dressing
42832|NCT03934671|Oxidative stress|oxidative stress
42833|NCT03934658|PTSD|ptsd
42834|NCT03934658|Nightmare Disorder|nightmare disorder
42835|NCT03934658|Post-traumatic stress disorder|post-traumatic stress disorder
42836|NCT03934658|Veteran|veteran
42837|NCT03934658|Digital therapeutic|digital therapeutic
42838|NCT03934658|Digital medicine|digital medicine
42839|NCT03934658|Nightmares|nightmares
42840|NCT03934645|delirium|delirium
42841|NCT03934645|Intensive Care Delirium Screening Checklist (ICDSC)|intensive care delirium screening checklist (icdsc)
42842|NCT03934645|intensive care unit (ICU)|intensive care unit (icu)
42843|NCT03934645|Delirium prediction model for ICU patients version 1|delirium prediction model for icu patients version 1
42844|NCT03934645|Delirium prediction model for ICU patients version 2|delirium prediction model for icu patients version 2
42845|NCT03934645|Early prediction model for delirium in ICU patients|early prediction model for delirium in icu patients
42846|NCT03934645|sensitivity|sensitivity
42847|NCT03934645|specificity|specificity
42848|NCT03934593|diabetes|diabetes
42849|NCT03934593|Hispanics|hispanics
42850|NCT03934593|HbA1c|hba1c
42851|NCT03934593|Self-Management Support Program|self-management support program
42852|NCT03934567|refractory|refractory
42853|NCT03934567|relapsed|relapsed
42854|NCT03934567|lymph nodes|lymph nodes
42855|NCT03934554|Nephrology|nephrology
42856|NCT03934554|Kidney transplant|kidney transplant
42857|NCT03934554|Registration|registration
42858|NCT03934554|Transplant waiting list|transplant waiting list
42859|NCT03934528|Phantom Limb Pain|phantom limb pain
42860|NCT03934528|Virtual Reality|virtual reality
42861|NCT03934528|Virtual Environment|virtual environment
42862|NCT03934515|Gastric tube, capnometry, pHmetry|gastric tube, capnometry, phmetry
42863|NCT03934502|Evobrutinib|evobrutinib
42864|NCT03934502|Pharmacokinetics|pharmacokinetics
42865|NCT03934476|ketogenic diet|ketogenic diet
42866|NCT03934476|carbohydrates|carbohydrates
42867|NCT03934476|chronic diseases|chronic diseases
42868|NCT03934476|physical activity|physical activity
42869|NCT03934476|fatigue|fatigue
42870|NCT03934476|mood|mood
42871|NCT03934476|wellbeing|wellbeing
42872|NCT03934450|Hemolysis|hemolysis
42873|NCT03934450|Primaquine|primaquine
42874|NCT03934450|Pharmacokinetics|pharmacokinetics
42875|NCT03934424|appetite|appetite
42876|NCT03934424|fMRI|fmri
42877|NCT03934424|overweight|overweight
42878|NCT03934424|obese|obese
42879|NCT03934424|weight stigma|weight stigma
42880|NCT03934385|anxiety|anxiety
42881|NCT03934385|consolidation|consolidation
42882|NCT03934385|extinction|extinction
42883|NCT03934385|mental rehearsal|mental rehearsal
42884|NCT03934372|Leukemia|leukemia
42885|NCT03934372|Solid tumors|solid tumors
42886|NCT03934372|Pediatric|pediatric
42887|NCT03934372|Tyrosine kinase inhibitor|tyrosine kinase inhibitor
42888|NCT03934346|zinc|zinc
42889|NCT03934346|absorption|absorption
42890|NCT03934346|kinetics|kinetics
42891|NCT03934346|amino acid chelate|amino acid chelate
42892|NCT03934333|Pharmacokinetics|pharmacokinetics
42893|NCT03934333|Inhaled corticosteroid|inhaled corticosteroid
42894|NCT03934294|Critically ill|critically ill
42895|NCT03934294|Intensive care|intensive care
42896|NCT03934294|Oral cancer|oral cancer
42897|NCT03934294|Hypo-pharyngeal cancer|hypo-pharyngeal cancer
42898|NCT03934294|Acupuncture|acupuncture
42899|NCT03934294|Digestion|digestion
42900|NCT03934294|ICU|icu
42901|NCT03934229|Overweight|overweight
42902|NCT03934229|Obesity|obesity
42903|NCT03934190|macular edema|macular edema
42904|NCT03934190|pseudophakic cystoid macular edema|pseudophakic cystoid macular edema
42905|NCT03934190|macular pucker|macular pucker
43029|NCT03933410|Elevated Ammonia|elevated ammonia
42906|NCT03934190|internal limiting membrane peeling|internal limiting membrane peeling
42907|NCT03934190|pars plana vitrectomy|pars plana vitrectomy
42908|NCT03934177|Blueberry|blueberry
42909|NCT03934177|Microbiota|microbiota
42910|NCT03934177|Intestinal permeability|intestinal permeability
42911|NCT03934164|prostate|prostate
42912|NCT03934164|molecular stratification|molecular stratification
42913|NCT03934151|laparoscopy|laparoscopy
42914|NCT03934151|ileocolic anastomosis|ileocolic anastomosis
42915|NCT03934151|right hemicolectomy|right hemicolectomy
42916|NCT03934138|Placebo|placebo
42917|NCT03934138|Experimental pain|experimental pain
42918|NCT03934086|Migraine prevention, phonophobia, photophobia, nausea|migraine prevention, phonophobia, photophobia, nausea
42919|NCT03934060|exercise|exercise
42920|NCT03934060|strength training|strength training
42921|NCT03934060|activities of daily living|activities of daily living
42922|NCT03934060|childhood cancer|childhood cancer
42923|NCT03934060|leukemia|leukemia
42924|NCT03934060|Non-Hodgkin lymphoma|non-hodgkin lymphoma
42925|NCT03934034|NTM|ntm
42926|NCT03934034|Registry|registry
42927|NCT03934034|Pulmonary infection|pulmonary infection
42928|NCT03934021|Stroke|stroke
42929|NCT03934021|Ischemic stroke|ischemic stroke
42930|NCT03934021|microbiome|microbiome
42931|NCT03934021|atherosclerotic|atherosclerotic
42932|NCT03934008|Motivational Interviewing|motivational interviewing
42933|NCT03934008|Pediatrics|pediatrics
42934|NCT03933982|Breast cancer, Brain metastases, Pyrotinib, Vinorelbine, HER2|breast cancer, brain metastases, pyrotinib, vinorelbine, her2
42935|NCT03933956|Diabetic nephropathy|diabetic nephropathy
42936|NCT03933956|Sodium-glucose Cotransporter 2 Inhibitors|sodium-glucose cotransporter 2 inhibitors
42937|NCT03933904|Castleman|castleman
42938|NCT03933904|iMCD|imcd
42939|NCT03933904|Castleman's Disease|castleman's disease
42940|NCT03933904|multicentric Castleman's disease|multicentric castleman's disease
42941|NCT03933904|multicentric Castleman disease|multicentric castleman disease
42942|NCT03933904|idiopathic Castleman disease|idiopathic castleman disease
42943|NCT03933904|idiopathic Castleman's disease|idiopathic castleman's disease
42944|NCT03933904|CD|cd
42945|NCT03933904|MCD|mcd
42946|NCT03933904|Castleman Disease|castleman disease
42947|NCT03933891|TIPS|tips
42948|NCT03933891|functional MRI|functional mri
42949|NCT03933891|liver corrhosis|liver corrhosis
42950|NCT03933891|portal hypertension|portal hypertension
42951|NCT03933891|HVPG|hvpg
42952|NCT03933865|buprenorphine|buprenorphine
42953|NCT03933865|quantitative sensory testing|quantitative sensory testing
42954|NCT03933865|cold pressor|cold pressor
42955|NCT03933865|abuse liability|abuse liability
42956|NCT03933865|ketamine|ketamine
42957|NCT03933865|hydromorphone|hydromorphone
42958|NCT03933839|Lupus|lupus
42959|NCT03933839|Systemic Lupus Erythematosus|systemic lupus erythematosus
42960|NCT03933826|pragmatic trial|pragmatic trial
42961|NCT03933826|Bacillus Calmette-Guerin (BCG)|bacillus calmette-guerin (bcg)
42962|NCT03933826|urinary bladder neoplasms|urinary bladder neoplasms
42963|NCT03933826|urogenital neoplasms|urogenital neoplasms
42964|NCT03933826|radical cystectomy|radical cystectomy
42965|NCT03933826|neoplasms by site|neoplasms by site
42966|NCT03933826|neoplasms|neoplasms
42967|NCT03933826|urinary bladder disease|urinary bladder disease
42968|NCT03933826|immunologic factors|immunologic factors
42969|NCT03933826|caregivers|caregivers
42970|NCT03933826|physiological effects of drugs|physiological effects of drugs
42971|NCT03933826|immunologic adjuvants|immunologic adjuvants
42972|NCT03933826|urologic diseases|urologic diseases
42973|NCT03933813|ovarian cancer|ovarian cancer
42974|NCT03933813|anemia|anemia
42975|NCT03933813|iron deficiency|iron deficiency
42976|NCT03933813|blood transfusion|blood transfusion
42977|NCT03933800|Therapy|therapy
42978|NCT03933800|High flow nasal cannula|high flow nasal cannula
42979|NCT03933800|Children|children
42980|NCT03933800|Adolescents|adolescents
42981|NCT03933787|neuropeptide Y,catecholamine, exercise|neuropeptide y,catecholamine, exercise
42982|NCT03933761|High grade serous|high grade serous
42983|NCT03933761|ABCB1 fusion|abcb1 fusion
42984|NCT03933761|BRCA 1/2 reversion|brca 1/2 reversion
42985|NCT03933683|fecal incontinence|fecal incontinence
42986|NCT03933683|pudendal neuropthy|pudendal neuropthy
42987|NCT03933683|pudendal nerve terminal motor latency|pudendal nerve terminal motor latency
42988|NCT03933657|Chronic Total Occlusion|chronic total occlusion
42989|NCT03933657|CTO|cto
42990|NCT03933657|Crossing Device|crossing device
42991|NCT03933657|Peripheral|peripheral
42992|NCT03933657|SoundBite Crossing System|soundbite crossing system
42993|NCT03933631|Cataract|cataract
42994|NCT03933631|Glaucoma Surgery|glaucoma surgery
42995|NCT03933631|Vision|vision
42996|NCT03933631|Cataract Surgery|cataract surgery
42997|NCT03933631|Eye surgery|eye surgery
42998|NCT03933605|postoperative nausea and vomiting|postoperative nausea and vomiting
42999|NCT03933605|midazolam|midazolam
43000|NCT03933605|palonosetron|palonosetron
43001|NCT03933566|Ultrasound-Guided Superficial Cervical Plexus Block|ultrasound-guided superficial cervical plexus block
43002|NCT03933566|Landmark-Based Superficial Cervical Plexus Block|landmark-based superficial cervical plexus block
43003|NCT03933553|aromatherapy essential oil|aromatherapy essential oil
43004|NCT03933553|Easy Sleep complex essential oil|easy sleep complex essential oil
43005|NCT03933553|Lavender essential oil|lavender essential oil
43006|NCT03933553|sleep disorders|sleep disorders
43007|NCT03933540|Patient Reported Outcome Measures|patient reported outcome measures
43008|NCT03933540|Activity Monitors|activity monitors
43009|NCT03933540|Pedometry|pedometry
43010|NCT03933540|PROMIS|promis
43011|NCT03933540|Health Measurement|health measurement
43012|NCT03933527|tooth bleaching|tooth bleaching
43013|NCT03933527|staining beverage|staining beverage
43014|NCT03933514|Family|family
43015|NCT03933514|Microbiome|microbiome
43016|NCT03933514|Cytokines|cytokines
43017|NCT03933514|Aggressive Periodontitis|aggressive periodontitis
43018|NCT03933501|Aggressive periodontitis|aggressive periodontitis
43019|NCT03933501|anti-infective agents|anti-infective agents
43020|NCT03933501|debridement|debridement
43021|NCT03933501|randomized clinical trial|randomized clinical trial
43022|NCT03933501|ultrasonic|ultrasonic
43023|NCT03933488|Drug therapy|drug therapy
43024|NCT03933449|PD1|pd1
43025|NCT03933449|PD-L1|pd-l1
43026|NCT03933449|PDL1|pdl1
43027|NCT03933449|Gene expression profiling (GEP)|gene expression profiling (gep)
43028|NCT03933410|Microbiome|microbiome
43030|NCT03933410|Disorder of the Urea Cycle Metabolism|disorder of the urea cycle metabolism
43031|NCT03933410|Urea Cycle Disorder|urea cycle disorder
43032|NCT03933410|KB195|kb195
43033|NCT03933410|Kaleido|kaleido
43034|NCT03933410|UNLOCKED|unlocked
43035|NCT03933410|Ornithine Transcarbamylase Deficiency (OTC)|ornithine transcarbamylase deficiency (otc)
43036|NCT03933410|Carbamoyl Phosphatase Synthetase 1 (CPS1)|carbamoyl phosphatase synthetase 1 (cps1)
43037|NCT03933410|Argininosuccinic Acid Synthetase (ASS1)|argininosuccinic acid synthetase (ass1)
43038|NCT03933410|Argininosuccinic Acid Lyase (ASL)|argininosuccinic acid lyase (asl)
43039|NCT03933410|Arginase (ARG 1)|arginase (arg 1)
43040|NCT03933410|N-acetyl Glutamate Synthetase (NAGS)|n-acetyl glutamate synthetase (nags)
43041|NCT03933410|Ornithine Translocase (ORNT1)|ornithine translocase (ornt1)
43042|NCT03933410|Microbiome Metabolic Therapy (MMT)|microbiome metabolic therapy (mmt)
43043|NCT03933410|Glycan|glycan
43044|NCT03933410|Nitrogen Binding Therapy (NBT)|nitrogen binding therapy (nbt)
43045|NCT03933410|Quality of Life|quality of life
43046|NCT03933410|Oligosaccharide|oligosaccharide
43047|NCT03933384|Hepatitis B|hepatitis b
43056|NCT03933345|Naloxone|naloxone
43057|NCT03933345|Overdose|overdose
43058|NCT03933306|blood pressure management|blood pressure management
43059|NCT03933306|dexmedetomidine|dexmedetomidine
43060|NCT03933306|high-risk patients|high-risk patients
43061|NCT03933306|abdominal surgery|abdominal surgery
43062|NCT03933306|postoperative organ injury|postoperative organ injury
43063|NCT03933293|HoFH|hofh
43064|NCT03933293|LDL-C|ldl-c
43065|NCT03933267|Cervical Pain|cervical pain
43066|NCT03933267|Kinesthesis|kinesthesis
43067|NCT03933254|Intraocular pressure|intraocular pressure
43068|NCT03933254|Optic nerve sheath diameter|optic nerve sheath diameter
43069|NCT03933254|Pneumoperitoneum|pneumoperitoneum
43070|NCT03933254|Laparoscopy|laparoscopy
43071|NCT03933254|Laparoscopic surgery|laparoscopic surgery
43072|NCT03933241|nasal irrigation|nasal irrigation
43073|NCT03933228|Combined Interscalene-Cervical Plexus Block|combined interscalene-cervical plexus block
43074|NCT03933228|Combined Supraclavicular-Cervical Plexus Block|combined supraclavicular-cervical plexus block
43075|NCT03933215|Multiple Sclerosis|multiple sclerosis
43076|NCT03933215|Cladribine Tablets|cladribine tablets
43077|NCT03933215|Observational|observational
43078|NCT03933215|Mavenclad|mavenclad
43083|NCT03933189|chronic pain|chronic pain
43084|NCT03933189|refugees|refugees
43085|NCT03933189|torture|torture
43086|NCT03933189|trauma|trauma
43087|NCT03933189|rehabilitiation|rehabilitiation
43088|NCT03933189|physical therapy|physical therapy
43089|NCT03933189|musculoskeletal pain|musculoskeletal pain
43090|NCT03933176|Glass ionomer|glass ionomer
43091|NCT03933176|Bulk-Fill Composite|bulk-fill composite
43092|NCT03933163|Resveratrol|resveratrol
43093|NCT03933163|Frataxin|frataxin
43094|NCT03933137|mortality|mortality
43095|NCT03933137|morbidity|morbidity
43096|NCT03933137|length of stay|length of stay
43097|NCT03933137|kidney|kidney
43098|NCT03933137|transplant|transplant
43099|NCT03933124|Post-surgical pain|post-surgical pain
43100|NCT03933124|Virtual Reality|virtual reality
43101|NCT03933124|Distraction|distraction
43102|NCT03933111|Endoscopic Ultrasound|endoscopic ultrasound
43103|NCT03933111|Zone Sonography Technology|zone sonography technology
43108|NCT03933085|Spanish-Speaking|spanish-speaking
43109|NCT03933085|Hispanic|hispanic
43110|NCT03933085|ages ≥50|ages ≥50
43111|NCT03933072|complete spinal cord injury, spinal cord transection, olfactory ensheathing cells, olfactory fibroblasts, Glial Neuropatch, nerve grafts|complete spinal cord injury, spinal cord transection, olfactory ensheathing cells, olfactory fibroblasts, glial neuropatch, nerve grafts
43112|NCT03933046|osa|osa
43113|NCT03933046|proteinuria|proteinuria
43114|NCT03933046|periodic limb movement disorder|periodic limb movement disorder
43115|NCT03933046|children|children
43116|NCT03933033|Acne scars|acne scars
43117|NCT03933033|Erbium-YAG laser|erbium-yag laser
43118|NCT03933033|platelet-rich plasma|platelet-rich plasma
43119|NCT03933020|Multiple Sclerosis|multiple sclerosis
43120|NCT03933020|Cognitive Impairment|cognitive impairment
815163|NCT00182078|injuries|injuries
43121|NCT03933020|Physical activity|physical activity
43122|NCT03932981|Brainstem|brainstem
43123|NCT03932981|Adult Glioma|adult glioma
43124|NCT03932981|Chemotherapy|chemotherapy
43125|NCT03932981|Temozolomide|temozolomide
43126|NCT03932968|sleeve gastrectomy|sleeve gastrectomy
43127|NCT03932968|clip ascent|clip ascent
43128|NCT03932968|oesogastric reflux|oesogastric reflux
43129|NCT03932968|sleeve gastrectomy follow-up|sleeve gastrectomy follow-up
43130|NCT03932942|Anti-bacterial agents|anti-bacterial agents
43131|NCT03932942|Emergency room|emergency room
43132|NCT03932942|Respiratory pathogen|respiratory pathogen
43133|NCT03932942|Point-of-care testing|point-of-care testing
43134|NCT03932942|Patient admission|patient admission
43135|NCT03932942|Pediatrics|pediatrics
43136|NCT03932942|Pediatric emergency medicine|pediatric emergency medicine
43137|NCT03932942|Cost-benefit analysis|cost-benefit analysis
43138|NCT03932942|Antimicrobial stewardship|antimicrobial stewardship
43139|NCT03932929|Non-Carious Cervical Lesions|non-carious cervical lesions
43140|NCT03932929|Universal adhesive|universal adhesive
43141|NCT03932903|Adherence|adherence
43142|NCT03932903|Adolescent|adolescent
43143|NCT03932903|Young Adult|young adult
43144|NCT03932903|Mobile Health|mobile health
43145|NCT03932903|Oncology|oncology
43146|NCT03932825|Nitrous Oxide|nitrous oxide
43147|NCT03932825|Laughing Gas|laughing gas
43148|NCT03932812|Alzheimer's disease|alzheimer's disease
43149|NCT03932812|Dementia|dementia
43150|NCT03932812|Caregiver|caregiver
43151|NCT03932812|Bridging community|bridging community
43152|NCT03932812|Bridging medical settings|bridging medical settings
43153|NCT03932799|Workers' Compensation|workers' compensation
43154|NCT03932799|Occupational Injuries|occupational injuries
43155|NCT03932799|Drug Utilization Review|drug utilization review
43156|NCT03932799|Humans|humans
43157|NCT03932799|Adult|adult
43158|NCT03932799|Cohort Studies|cohort studies
43159|NCT03932799|Qualitative Research|qualitative research
43160|NCT03932773|PTSD|ptsd
43161|NCT03932773|post-traumatic stress disorder|post-traumatic stress disorder
43162|NCT03932773|military-related PTSD|military-related ptsd
43164|NCT03932773|cognitive processing therapy|cognitive processing therapy
43165|NCT03932773|rTMS|rtms
43166|NCT03932773|repetitive transcranial magnetic stimulation|repetitive transcranial magnetic stimulation
43167|NCT03932773|combat|combat
43168|NCT03932773|combat-related PTSD|combat-related ptsd
43169|NCT03932747|Hydration|hydration
43170|NCT03932747|UREA|urea
43171|NCT03932734|Satisfaction|satisfaction
43172|NCT03932734|Jawline augmentation|jawline augmentation
43173|NCT03932734|Transgender|transgender
43174|NCT03932734|Cosmetic jaw angle|cosmetic jaw angle
43175|NCT03932721|Dyslipidemia|dyslipidemia
43176|NCT03932721|Diabetes Mellitus, Type 2|diabetes mellitus, type 2
43177|NCT03932721|Hypertension Arterial|hypertension arterial
43178|NCT03932708|Antibiotic Stewardship|antibiotic stewardship
43179|NCT03932708|Outpatient Antibiotic Stewardship|outpatient antibiotic stewardship
43180|NCT03932708|Urgent Care|urgent care
43181|NCT03932682|Influenza Vaccine|influenza vaccine
43182|NCT03932669|spinocerebellar ataxia, treatment, nilotinib, bcr-abl inhibitor|spinocerebellar ataxia, treatment, nilotinib, bcr-abl inhibitor
43183|NCT03932656|borderline personality disorder|borderline personality disorder
43184|NCT03932656|latent toxoplasmosis|latent toxoplasmosis
43185|NCT03932656|Toxoplasma gondii|toxoplasma gondii
43186|NCT03932656|pharmacotherapy|pharmacotherapy
43187|NCT03932656|psychotherapy|psychotherapy
43188|NCT03932656|clinical features|clinical features
43189|NCT03932630|artificial pancreas|artificial pancreas
43190|NCT03932630|hybrid closed-loop|hybrid closed-loop
43191|NCT03932630|low carbohydrate diet|low carbohydrate diet
43192|NCT03932630|glucose control|glucose control
43193|NCT03932591|Spasticity|spasticity
43194|NCT03932591|kinesio tape|kinesio tape
43195|NCT03932591|stretch reflex|stretch reflex
43196|NCT03932591|H-reflex|h-reflex
43197|NCT03932591|T-reflex|t-reflex
43198|NCT03932578|Cesarean section|cesarean section
43199|NCT03932578|Nausea and vomiting|nausea and vomiting
43200|NCT03932578|Spinal Anesthesia|spinal anesthesia
43201|NCT03932539|Immunosuppressive therapy|immunosuppressive therapy
43202|NCT03932539|Tacrolimus|tacrolimus
43203|NCT03932539|Heart transplantation|heart transplantation
43204|NCT03932539|Pharmacokinetics|pharmacokinetics
43205|NCT03932539|Pharmacogenetics|pharmacogenetics
43206|NCT03932539|Acute rejection|acute rejection
43207|NCT03932500|Validation|validation
43208|NCT03932500|Prognostic score|prognostic score
43209|NCT03932487|iodine|iodine
43210|NCT03932487|bisphenol A|bisphenol a
43211|NCT03932487|autoimmune thyroid disease|autoimmune thyroid disease
43212|NCT03932474|depression|depression
43213|NCT03932474|probiotic|probiotic
43214|NCT03932474|SAMe|same
43215|NCT03932474|Lactobacillus plantarum 299v|lactobacillus plantarum 299v
43216|NCT03932474|anxiety|anxiety
43217|NCT03932474|insomnia|insomnia
43218|NCT03932474|irritable bowel syndrome|irritable bowel syndrome
57473|NCT03844282|racing|racing
43219|NCT03932474|randomized controlled study|randomized controlled study
43220|NCT03932422|hypertension|hypertension
43221|NCT03932422|resistant hypertension|resistant hypertension
43222|NCT03932422|arterial stiffness|arterial stiffness
43223|NCT03932422|sodium urine test|sodium urine test
43224|NCT03932409|pembrolizumab|pembrolizumab
43225|NCT03932409|radiation therapy|radiation therapy
43226|NCT03932396|hepatitis C virus|hepatitis c virus
43227|NCT03932396|non-custodial sentences|non-custodial sentences
43228|NCT03932396|addictive behaviours|addictive behaviours
43229|NCT03932396|Mental disease|mental disease
43230|NCT03932396|Navigator|navigator
43231|NCT03932396|screening|screening
43232|NCT03932396|POCT|poct
43233|NCT03932344|SJIA|sjia
43234|NCT03932344|Kineret|kineret
43235|NCT03932344|Anakinra|anakinra
43236|NCT03932344|Long term safety|long term safety
43237|NCT03932318|Lintuzumab-Ac225|lintuzumab-ac225
43238|NCT03932318|Venetoclax|venetoclax
43239|NCT03932318|Azacitidine|azacitidine
43240|NCT03932318|Lintuzumab|lintuzumab
43241|NCT03932318|Refractory AML|refractory aml
43242|NCT03932292|Ectoin|ectoin
43243|NCT03932292|Oral mucositis|oral mucositis
43244|NCT03932292|Radiotherapy|radiotherapy
43245|NCT03932292|Medical Device|medical device
43246|NCT03932292|Non interventional study|non interventional study
43247|NCT03932292|Mouth Wash|mouth wash
43248|NCT03932292|§23b Medical Device Act|§23b medical device act
43249|NCT03932266|Endostar|endostar
43250|NCT03932266|Nasopharyngeal Carcinoma|nasopharyngeal carcinoma
43251|NCT03932266|Chemoradiotherapy|chemoradiotherapy
43252|NCT03932266|Endostatin|endostatin
43253|NCT03932240|Fibrinogen Concentrate|fibrinogen concentrate
43254|NCT03932240|FC|fc
43255|NCT03932240|Cryoprecipitate|cryoprecipitate
43256|NCT03932240|Transfusion|transfusion
43257|NCT03932240|in vivo|in vivo
43258|NCT03932240|Open-heart surgery|open-heart surgery
43259|NCT03932240|Cardiopulmonary Bypass|cardiopulmonary bypass
43260|NCT03932240|Fibrin Network Structure|fibrin network structure
43261|NCT03932214|venous access|venous access
43262|NCT03932214|illumination, infrared|illumination, infrared
43263|NCT03932214|critically-ill|critically-ill
43264|NCT03932214|catheterization|catheterization
43265|NCT03932188|early psychosis|early psychosis
43266|NCT03932188|prodrome|prodrome
43267|NCT03932188|schizophrenia|schizophrenia
43268|NCT03932188|psychosis|psychosis
43269|NCT03932149|Alcohol Use Disorder|alcohol use disorder
43270|NCT03932149|Intermittent Theta Burst Stimulation|intermittent theta burst stimulation
43271|NCT03932149|Alcohol Dependence|alcohol dependence
43272|NCT03932110|psoriasis vulgaris|psoriasis vulgaris
43273|NCT03932110|psoriatic arthritis|psoriatic arthritis
43274|NCT03932110|metabolic syndrome|metabolic syndrome
43275|NCT03932110|omentin|omentin
43276|NCT03932110|visfatin|visfatin
43277|NCT03932084|Type 2 diabetes|type 2 diabetes
43278|NCT03932084|Cerebral infarction|cerebral infarction
43279|NCT03932084|Glucose fluctuation targeted intervention|glucose fluctuation targeted intervention
43280|NCT03932019|Jitongning Tablet, Spondyloarthritis|jitongning tablet, spondyloarthritis
43281|NCT03932006|ankylosing spondylitis|ankylosing spondylitis
43282|NCT03932006|Fengshigutong Capsule|fengshigutong capsule
43283|NCT03932006|imrecoxib|imrecoxib
43284|NCT03931993|Grass MATA MPL|grass mata mpl
43285|NCT03931993|Safety|safety
43286|NCT03931980|rectal cancer|rectal cancer
43287|NCT03931980|robotic surgery|robotic surgery
43288|NCT03931980|laparoscopic surgery|laparoscopic surgery
43289|NCT03931967|Sepsis|sepsis
43290|NCT03931967|Septic shock|septic shock
43291|NCT03931967|Microcirculation|microcirculation
43292|NCT03931967|Glycocalix|glycocalix
43293|NCT03931967|Proadrenomedullin|proadrenomedullin
43294|NCT03931967|Organ dysfunction|organ dysfunction
43295|NCT03931967|Critical Care|critical care
43296|NCT03931967|Intensive Care|intensive care
43297|NCT03931954|eosinophilic asthma|eosinophilic asthma
43298|NCT03931954|severe asthma|severe asthma
43299|NCT03931954|prevalence|prevalence
43300|NCT03931954|phenotype|phenotype
43301|NCT03931954|atopic phenotype|atopic phenotype
43302|NCT03931954|eosinophilic phenotype|eosinophilic phenotype
43303|NCT03931941|C. Difficile Diarrhea|c. difficile diarrhea
43304|NCT03931941|Clostridium Difficile|clostridium difficile
43306|NCT03931941|FMT|fmt
43307|NCT03931941|Fecal Microbiota Transplant|fecal microbiota transplant
43308|NCT03931941|Microbiota Restoration Therapy|microbiota restoration therapy
43309|NCT03931941|Diarrhea|diarrhea
43310|NCT03931941|Microbial Suspension|microbial suspension
43311|NCT03931941|Fecal Transplant|fecal transplant
43312|NCT03931941|C Difficile Colitis|c difficile colitis
43313|NCT03931941|Clostridium Difficile Associated Diarrhea|clostridium difficile associated diarrhea
43314|NCT03931941|C diff diarrhea|c diff diarrhea
43315|NCT03931941|C Difficile|c difficile
43316|NCT03931941|C diff|c diff
43317|NCT03931928|tamoxifen|tamoxifen
43318|NCT03931928|endoxifen|endoxifen
43319|NCT03931928|endocrine receptor positive breast cancer|endocrine receptor positive breast cancer
43320|NCT03931928|adjuvant therapy|adjuvant therapy
43321|NCT03931902|pediatric airway management|pediatric airway management
43322|NCT03931863|ondansetron|ondansetron
43323|NCT03931850|Pudendal nerve|pudendal nerve
43324|NCT03931850|circumcision|circumcision
43325|NCT03931850|pediatric|pediatric
43326|NCT03931837|Tourniquet|tourniquet
43327|NCT03931837|Total knee arthroplasty|total knee arthroplasty
43328|NCT03931837|Postoperative pain|postoperative pain
43329|NCT03931837|Range of motion|range of motion
43330|NCT03931837|Wound complication|wound complication
43331|NCT03931824|Shoulder Pain|shoulder pain
43332|NCT03931824|Hemiplegia|hemiplegia
43333|NCT03931824|Shoulder Subluxation|shoulder subluxation
43334|NCT03931824|Spasticity|spasticity
43335|NCT03931824|Stroke|stroke
43336|NCT03931811|Knee Osteoarthritis|knee osteoarthritis
43337|NCT03931811|Prolotherapy|prolotherapy
43338|NCT03931811|Hypertonic dextrose solution injections|hypertonic dextrose solution injections
43339|NCT03931811|Short-wave diathermy|short-wave diathermy
43340|NCT03931798|Unilateral spatial neglect|unilateral spatial neglect
43341|NCT03931798|Extrapersonal space|extrapersonal space
43342|NCT03931798|Neuropsychology|neuropsychology
43343|NCT03931785|Abdominal pain|abdominal pain
43344|NCT03931785|Diarrhea|diarrhea
43345|NCT03931785|Irritable Bowel Syndrome|irritable bowel syndrome
43346|NCT03931759|diabetes mellitus|diabetes mellitus
43347|NCT03931759|cardiac autonomic neuropathy|cardiac autonomic neuropathy
43348|NCT03931759|laparoscopic surgery|laparoscopic surgery
43350|NCT03931707|Hereditary Disease|hereditary disease
43351|NCT03931707|Genetic Predisposition to Disease|genetic predisposition to disease
43352|NCT03931707|Defect, Congenital|defect, congenital
43353|NCT03931707|Genome Sequencing|genome sequencing
43354|NCT03931707|Exome Sequencing|exome sequencing
43355|NCT03931707|Newborn Screening|newborn screening
43356|NCT03931707|Genetic Diseases, Inborn|genetic diseases, inborn
43357|NCT03931694|Chronic pain|chronic pain
43358|NCT03931694|e-Health|e-health
43359|NCT03931668|tolerance|tolerance
43360|NCT03931668|pharmacokinetics|pharmacokinetics
43361|NCT03931668|pharmacodynamics|pharmacodynamics
43362|NCT03931668|TPN-672|tpn-672
43363|NCT03931655|Photoacoustic imaging|photoacoustic imaging
43364|NCT03931655|Lymph nodes|lymph nodes
43365|NCT03931655|micrometastases|micrometastases
43366|NCT03931629|FEMTOSECOND LASER|femtosecond laser
43367|NCT03931629|Femtosecond Laser-Assisted Cataract Surgery|femtosecond laser-assisted cataract surgery
43368|NCT03931629|CATARACT SURGERY|cataract surgery
43369|NCT03931629|phacoemulsification|phacoemulsification
43370|NCT03931629|operation room workflow|operation room workflow
43371|NCT03931629|public setting|public setting
43372|NCT03931616|stroke|stroke
43373|NCT03931616|prehospital|prehospital
43374|NCT03931616|telemedicine|telemedicine
43375|NCT03931616|thrombolysis|thrombolysis
43376|NCT03931616|endovascular treatment|endovascular treatment
43377|NCT03931616|functional outcome|functional outcome
43378|NCT03931590|RTA 408|rta 408
43379|NCT03931590|RTA 408 capsules|rta 408 capsules
43380|NCT03931590|omaveloxolone|omaveloxolone
43381|NCT03931590|omaveloxolone capsules|omaveloxolone capsules
43382|NCT03931590|AME|ame
43383|NCT03931590|mass balance|mass balance
43384|NCT03931590|metabolite identification|metabolite identification
43385|NCT03931577|Antimicrobial Stewardship|antimicrobial stewardship
43386|NCT03931577|Cost-Benefit Analysis|cost-benefit analysis
43387|NCT03931577|Anti-Bacterial Agents|anti-bacterial agents
43388|NCT03931577|Primary Health Care|primary health care
43389|NCT03931564|Glaucoma, Open-Angle|glaucoma, open-angle
43390|NCT03931564|Trabeculectomy|trabeculectomy
43391|NCT03931564|Intraocular Pressure|intraocular pressure
43392|NCT03931564|Minimally invasive glaucoma surgery|minimally invasive glaucoma surgery
43393|NCT03931564|InnFocus Microshunt|innfocus microshunt
43394|NCT03931564|PRESERFLO Microshunt|preserflo microshunt
43395|NCT03931538|UTI|uti
43396|NCT03931538|IC|ic
43397|NCT03931525|Stretch Marks|stretch marks
43398|NCT03931525|Skin Disease|skin disease
43399|NCT03931525|Diathermy|diathermy
43400|NCT03931525|Drug Delivery Systems|drug delivery systems
43401|NCT03931512|transcranial direct current stimulation|transcranial direct current stimulation
43402|NCT03931512|motor learning|motor learning
43403|NCT03931434|coronary artery disease|coronary artery disease
43404|NCT03931434|Endothelium|endothelium
43405|NCT03931408|bladder|bladder
43406|NCT03931408|spinal cord injury|spinal cord injury
43407|NCT03931408|urinary tract infection|urinary tract infection
43408|NCT03931395|Honey|honey
43409|NCT03931395|Pediatrics|pediatrics
43410|NCT03931395|Post-Operative|post-operative
43411|NCT03931343|Thoracolumbar interfascial block, Erector spinae plane block|thoracolumbar interfascial block, erector spinae plane block
43412|NCT03931330|FGID|fgid
43413|NCT03931330|Neural Stimulation|neural stimulation
43414|NCT03931330|Functional Abdominal Pain|functional abdominal pain
43415|NCT03931330|Dysautonomia|dysautonomia
43416|NCT03931226|drug consumption|drug consumption
43417|NCT03931187|cognitive psychotherapy|cognitive psychotherapy
43418|NCT03931187|progressive muscular relaxation|progressive muscular relaxation
43419|NCT03931187|in vitro fertilization and embryo transfer(IVF-ET)|in vitro fertilization and embryo transfer(ivf-et)
43420|NCT03931187|Couples Therapy|couples therapy
43421|NCT03931174|implementation|implementation
43422|NCT03931174|opioid use|opioid use
43423|NCT03931161|carotid plaque morphology|carotid plaque morphology
43424|NCT03931161|carotid plaque composition|carotid plaque composition
43425|NCT03931161|evolocumab|evolocumab
43426|NCT03931148|Neuroimaging|neuroimaging
43427|NCT03931148|Dementia|dementia
43428|NCT03931148|Decision making|decision making
43429|NCT03931148|Neuropsychology|neuropsychology
43430|NCT03931148|Aging|aging
43431|NCT03931122|Ear Size|ear size
43432|NCT03931109|Osteoporosis|osteoporosis
43433|NCT03931109|primary hyperparathyroidism|primary hyperparathyroidism
43434|NCT03931109|miRNA|mirna
43435|NCT03931109|Bone remodeling|bone remodeling
43436|NCT03931109|parathyroidectomy|parathyroidectomy
43437|NCT03931109|Osteopenia|osteopenia
43438|NCT03931109|postmenopausal|postmenopausal
43439|NCT03931096|health related quality of life|health related quality of life
43440|NCT03931096|congenital heart disease|congenital heart disease
43441|NCT03931096|pediatrics|pediatrics
43442|NCT03931096|cardiology|cardiology
43443|NCT03931096|PedsQL 4.0|pedsql 4.0
43444|NCT03931096|psychometric properties|psychometric properties
43445|NCT03931044|Robotic surgery|robotic surgery
43446|NCT03931044|fluorescence|fluorescence
43447|NCT03931044|indocyanine green|indocyanine green
43448|NCT03931044|lymphadenectomy|lymphadenectomy
43449|NCT03931031|Viscoelastic testing|viscoelastic testing
43450|NCT03931031|Coagulation|coagulation
43451|NCT03931031|Quantra|quantra
43452|NCT03931031|Hemostasis|hemostasis
43453|NCT03931018|"binge drinking"|"binge drinking"
43454|NCT03931018|"alcohol"|"alcohol"
43455|NCT03931018|"pharmacokinetics"|"pharmacokinetics"
43456|NCT03931018|"biomarkers"|"biomarkers"
43457|NCT03930992|4 mg zoledronic acid|4 mg zoledronic acid
43458|NCT03930992|Colaren|colaren
43459|NCT03930992|HIV|hiv
43460|NCT03930992|Secondary Osteoporosis|secondary osteoporosis
43461|NCT03930992|Man|man
43462|NCT03930979|Procedural sedation|procedural sedation
43463|NCT03930979|Cardiac output measurements non-invasive|cardiac output measurements non-invasive
43464|NCT03930979|Emergency department|emergency department
43465|NCT03930966|Severe trauma|severe trauma
43466|NCT03930966|General anaesthesia|general anaesthesia
43467|NCT03930966|Peri-traumatic dissociation state|peri-traumatic dissociation state
43468|NCT03930966|Post-traumatic stress disorder|post-traumatic stress disorder
43469|NCT03930953|Non-Hodgkin Lymphomas|non-hodgkin lymphomas
43470|NCT03930953|Safety|safety
43471|NCT03930953|Efficacy|efficacy
43472|NCT03930953|CC-99282|cc-99282
43473|NCT03930953|Rituximab|rituximab
43474|NCT03930953|Relapsed|relapsed
43475|NCT03930953|Refractory|refractory
43476|NCT03930940|Spontenous intracerebral hemorrhage|spontenous intracerebral hemorrhage
43477|NCT03930940|Hemorrhage resolution|hemorrhage resolution
43478|NCT03930940|Remote ischemic conditioning|remote ischemic conditioning
43479|NCT03930940|Neuroprotection|neuroprotection
43480|NCT03930901|Intestinal Parasitic Infections|intestinal parasitic infections
43481|NCT03930901|Soil-transmitted helminth infections|soil-transmitted helminth infections
43482|NCT03930901|Health education|health education
43483|NCT03930888|nutritional support|nutritional support
43484|NCT03930888|colorectal cancer|colorectal cancer
43485|NCT03930888|muscle strength|muscle strength
43486|NCT03930888|muscle mass|muscle mass
43487|NCT03930888|self-sufficiency|self-sufficiency
43488|NCT03930849|Depression|depression
43489|NCT03930849|Patient Participation|patient participation
43490|NCT03930849|Text messaging|text messaging
43491|NCT03930849|Patient Portals|patient portals
43492|NCT03930836|motor function|motor function
43493|NCT03930836|motor skill learning|motor skill learning
43494|NCT03930784|physical function|physical function
43495|NCT03930784|recovery|recovery
43496|NCT03930784|abdominal|abdominal
43497|NCT03930745|Bacterial vaginosis|bacterial vaginosis
43498|NCT03930745|Candida albicans|candida albicans
43499|NCT03930745|Double-Blind|double-blind
43500|NCT03930745|Gardnerella vaginalis|gardnerella vaginalis
43501|NCT03930745|Phase II|phase ii
43502|NCT03930745|Placebo|placebo
43503|NCT03930745|Randomized|randomized
43504|NCT03930745|Suppression|suppression
43505|NCT03930745|TOL-463 insert|tol-463 insert
43506|NCT03930719|stroke|stroke
43507|NCT03930719|delirium|delirium
43508|NCT03930719|screening tool|screening tool
43509|NCT03930693|Pregnancy|pregnancy
43510|NCT03930693|hypertension|hypertension
43511|NCT03930693|nitrate|nitrate
43512|NCT03930693|beetroot juice|beetroot juice
43513|NCT03930667|Appendicitis; Laparoscopic Surgery; Cost Effectiveness|appendicitis; laparoscopic surgery; cost effectiveness
400503|NCT01866592|Lipid Biomarkers|lipid biomarkers
43514|NCT03930654|African American women, HIV risk, substance use, sexual risk|african american women, hiv risk, substance use, sexual risk
43515|NCT03930641|brolucizumab 6 mg prefilled syringe PFS|brolucizumab 6 mg prefilled syringe pfs
43516|NCT03930641|open label study|open label study
43517|NCT03930641|neovascular age related macular degeneration intravitreal injection IVT|neovascular age related macular degeneration intravitreal injection ivt
43518|NCT03930641|observation|observation
43519|NCT03930563|inorganic nitrate|inorganic nitrate
43520|NCT03930563|blood flow|blood flow
43521|NCT03930563|Peripheral chemoreflex|peripheral chemoreflex
43522|NCT03930563|Common carotid artery|common carotid artery
43523|NCT03930511|Telemonitoring|telemonitoring
43524|NCT03930511|Physical activity|physical activity
43525|NCT03930511|Pulmonary Rehabilitation|pulmonary rehabilitation
43526|NCT03930498|PD-1 antibody|pd-1 antibody
43527|NCT03930498|Intensity-modulated Radiation Therapy|intensity-modulated radiation therapy
43528|NCT03930498|Chemotherapy|chemotherapy
43529|NCT03930498|Efficacy|efficacy
43530|NCT03930498|Adverse effects|adverse effects
43531|NCT03930472|Farmers Markets|farmers markets
43532|NCT03930472|Vouchers|vouchers
43533|NCT03930433|Nebivolol|nebivolol
43534|NCT03930420|evidence-based practice|evidence-based practice
43535|NCT03930420|implementation science|implementation science
43536|NCT03930420|public health practice|public health practice
43537|NCT03930407|Cesarean section|cesarean section
43538|NCT03930407|Uterine atony|uterine atony
43539|NCT03930407|Hayman uterine compression suture|hayman uterine compression suture
43540|NCT03930407|Follicle-stimulating hormone|follicle-stimulating hormone
43541|NCT03930407|Luteinizing hormone|luteinizing hormone
44143|NCT03926117|CRP|crp
43548|NCT03930303|dilatation and curettage|dilatation and curettage
43549|NCT03930303|multimedia based education|multimedia based education
43551|NCT03930251|Cognitive Remediation|cognitive remediation
43552|NCT03930238|Veterans|veterans
43553|NCT03930225|Stigma|stigma
43554|NCT03930225|Intervention program|intervention program
43555|NCT03930225|Schizophrenia|schizophrenia
43556|NCT03930199|Prosthesis|prosthesis
43557|NCT03930199|Amputation|amputation
43558|NCT03930199|Prosthetic|prosthetic
43559|NCT03930199|Amputee|amputee
43560|NCT03930199|Smartphone|smartphone
43561|NCT03930199|Sensors|sensors
43562|NCT03930199|Mobility|mobility
43563|NCT03930160|Intensive care unit|intensive care unit
43564|NCT03930160|Logistic Organ Dysfunction System|logistic organ dysfunction system
43565|NCT03930160|30-day Mortality|30-day mortality
43566|NCT03930160|Sepsis|sepsis
43567|NCT03930160|Mortality prediction|mortality prediction
43568|NCT03930147|Children|children
43569|NCT03930147|Ventilation|ventilation
43570|NCT03930147|Closed-loop mechanical ventilation|closed-loop mechanical ventilation
43571|NCT03930147|Adaptive support ventilation|adaptive support ventilation
43572|NCT03930134|caesarean|caesarean
43573|NCT03930134|scar defect|scar defect
43574|NCT03930134|sparse uterine suture|sparse uterine suture
43575|NCT03930134|one layer uterine suture|one layer uterine suture
43576|NCT03930134|blood loss|blood loss
43577|NCT03930134|ultrasound|ultrasound
43578|NCT03930121|Rehabilitation|rehabilitation
43579|NCT03930121|Intensive speech-language therapy|intensive speech-language therapy
43580|NCT03930121|Transcranial direct current stimulation|transcranial direct current stimulation
43581|NCT03930108|Burn injury|burn injury
43582|NCT03930108|Mortality prediction|mortality prediction
43583|NCT03930108|SOFA score|sofa score
43584|NCT03930108|Organ failure|organ failure
43585|NCT03930082|Gastrointestinal surgery|gastrointestinal surgery
43586|NCT03930082|Frailty|frailty
43587|NCT03930082|Elder patient|elder patient
43588|NCT03930082|Complication|complication
43589|NCT03930056|Orthotic|orthotic
43590|NCT03930056|C-Brace|c-brace
43591|NCT03930017|Observational|observational
43592|NCT03930017|Influenza|influenza
43593|NCT03930017|Vaccine immunogenicity|vaccine immunogenicity
43594|NCT03930017|Arsenic|arsenic
43595|NCT03930017|Immunology|immunology
43596|NCT03929991|Site infection|site infection
43597|NCT03929991|Sierra Leone|sierra leone
43598|NCT03929991|Africa|africa
43599|NCT03929991|Cesarean Infection|cesarean infection
43600|NCT03929991|Maternal Mortality|maternal mortality
43601|NCT03929965|Anlotinib|anlotinib
43602|NCT03929965|FGFR|fgfr
43603|NCT03929965|solid tumors|solid tumors
43609|NCT03929900|Renal progression|renal progression
43610|NCT03929900|Mortality|mortality
43611|NCT03929900|Complications|complications
43612|NCT03929900|Risk factors|risk factors
43613|NCT03929887|Glomerular disease|glomerular disease
43614|NCT03929887|sample repository|sample repository
43615|NCT03929887|clinical data|clinical data
43616|NCT03929887|digital pathology repository|digital pathology repository
43617|NCT03929887|web-based database|web-based database
43618|NCT03929861|Fluconazole|fluconazole
43619|NCT03929861|bioequivalence|bioequivalence
43620|NCT03929861|capsule|capsule
43621|NCT03929848|cuff pressure, laryngomicrosurgery|cuff pressure, laryngomicrosurgery
43622|NCT03929835|Cannabis|cannabis
43623|NCT03929822|Mammography|mammography
43624|NCT03929822|Contrast-Enhanced Spectral Mammography|contrast-enhanced spectral mammography
43625|NCT03929822|19-116|19-116
43626|NCT03929770|Swan-Ganz catheter|swan-ganz catheter
43627|NCT03929705|TB|tb
43628|NCT03929666|HER2|her2
43629|NCT03929666|Bispecific antibody|bispecific antibody
43630|NCT03929666|Biparatopic antibody|biparatopic antibody
43631|NCT03929666|Immunotherapy|immunotherapy
43632|NCT03929666|Gastric cancers|gastric cancers
43633|NCT03929666|Esophageal cancers|esophageal cancers
43634|NCT03929666|Gastroesophageal junction (GEJ) cancers|gastroesophageal junction (gej) cancers
43635|NCT03929666|Chemotherapy|chemotherapy
43636|NCT03929666|XP|xp
43637|NCT03929666|FP|fp
43638|NCT03929666|mFOLFOX6|mfolfox6
43639|NCT03929666|Capecitabine|capecitabine
43640|NCT03929666|Cisplatin|cisplatin
43641|NCT03929666|5-FU|5-fu
43642|NCT03929666|Leucovorin (folinic acid)|leucovorin (folinic acid)
43643|NCT03929666|Oxaliplatin|oxaliplatin
43644|NCT03929666|XELOX|xelox
43645|NCT03929653|Next Generation Sequencing|next generation sequencing
44343|NCT03924791|Sciatica|sciatica
43649|NCT03929614|Health-related quality of life (HRQOL)|health-related quality of life (hrqol)
43650|NCT03929614|Questionnaire development|questionnaire development
43652|NCT03929588|hyperopia|hyperopia
43653|NCT03929562|Elective Surgery|elective surgery
43654|NCT03929536|hip joint replacement|hip joint replacement
43655|NCT03929536|hip joint preserving surgery|hip joint preserving surgery
43656|NCT03929523|Liver Transplantation|liver transplantation
43657|NCT03929523|Liver machine perfusion|liver machine perfusion
43658|NCT03929523|extended criteria donor|extended criteria donor
43659|NCT03929510|Phase 1|phase 1
43660|NCT03929510|Male|male
43661|NCT03929510|healthy|healthy
43662|NCT03929484|Pneumonia|pneumonia
43663|NCT03929484|Hypoxemia|hypoxemia
43664|NCT03929484|Oxygen therapy|oxygen therapy
43665|NCT03929484|Oxygen mask|oxygen mask
43666|NCT03929458|oxidative stress|oxidative stress
43667|NCT03929458|Sarcopenia|sarcopenia
43668|NCT03929458|copy number of mitochondrial DNA (mtDNA)|copy number of mitochondrial dna (mtdna)
43669|NCT03929445|Bougie|bougie
43670|NCT03929445|Air Q|air q
43671|NCT03929445|Fastrach|fastrach
43672|NCT03929406|Deep Brain Stimulation|deep brain stimulation
43673|NCT03929406|Tissue harvesting|tissue harvesting
43674|NCT03929406|Molecular analysis - Proteomics|molecular analysis - proteomics
43675|NCT03929393|Randomized controlled trial|randomized controlled trial
43676|NCT03929393|Exercise|exercise
43677|NCT03929393|Physical Activity|physical activity
43678|NCT03929393|Behavior Change|behavior change
43679|NCT03929393|Mindfulness|mindfulness
43680|NCT03929393|Aging|aging
43681|NCT03929380|Squat|squat
43682|NCT03929380|Acute effect|acute effect
43683|NCT03929380|Tendon thickness|tendon thickness
43684|NCT03929380|Counter movement jump test|counter movement jump test
43685|NCT03929380|Postural sway|postural sway
43686|NCT03929380|Muscular power|muscular power
43687|NCT03929354|Asymptomatic Carotid Artery Stenosis|asymptomatic carotid artery stenosis
43688|NCT03929354|Cardiovascular risk factors|cardiovascular risk factors
43689|NCT03929354|Risk factor modification|risk factor modification
43690|NCT03929341|angina|angina
43691|NCT03929315|one lung ventilation|one lung ventilation
43692|NCT03929289|Functional Magnetic Resonance Imaging (fMRI)|functional magnetic resonance imaging (fmri)
43693|NCT03929289|Healthy Subjects|healthy subjects
43694|NCT03929276|adhesive capsulitis|adhesive capsulitis
43695|NCT03929276|high-intensity laser therapy|high-intensity laser therapy
43696|NCT03929211|Relapsed/refractory myelodysplastic syndrome|relapsed/refractory myelodysplastic syndrome
43697|NCT03929211|Failed hypomethylating therapy|failed hypomethylating therapy
43698|NCT03929198|metabolic syndrome|metabolic syndrome
43699|NCT03929198|obesity|obesity
43700|NCT03929185|Volatile organic compounds|volatile organic compounds
43701|NCT03929185|colorectal cancer|colorectal cancer
43702|NCT03929185|non invasive diagnostic tests|non invasive diagnostic tests
43703|NCT03929185|medical device|medical device
43704|NCT03929172|HPV-L2|hpv-l2
43705|NCT03929133|fetal heart sounds|fetal heart sounds
43706|NCT03929133|big data|big data
43707|NCT03929133|cloud computing|cloud computing
43708|NCT03929133|congenital heart disease|congenital heart disease
43709|NCT03929133|data base|data base
43710|NCT03929133|Acoustic structure design|acoustic structure design
43711|NCT03929107|interleukin 7, Chemokine (C-C Motif) Ligand 19, CAR-T|interleukin 7, chemokine (c-c motif) ligand 19, car-t
43712|NCT03929081|Obsessive-Compulsive Disorder|obsessive-compulsive disorder
43713|NCT03929081|Inference Based Approach (IBA)|inference based approach (iba)
43714|NCT03929081|Cognitive Behavioral Therapy (CBT)|cognitive behavioral therapy (cbt)
43715|NCT03929081|Personalized care|personalized care
43716|NCT03929081|Neurocognitive working mechanisms of treatment|neurocognitive working mechanisms of treatment
43717|NCT03929081|Non-inferiority|non-inferiority
43718|NCT03929081|Prediction of treatment efficiency|prediction of treatment efficiency
58124|NCT03840525|HIV|hiv
43719|NCT03929068|ALS|als
43720|NCT03929068|PLS|pls
43721|NCT03929068|Primary Lateral Sclerosis|primary lateral sclerosis
43722|NCT03929042|AIS|ais
43723|NCT03929029|Melanoma|melanoma
43724|NCT03929016|First-in-human|first-in-human
43725|NCT03929016|single ascending dose|single ascending dose
43726|NCT03929016|healthy volunteer|healthy volunteer
43727|NCT03928977|Transient Ischemic Attack|transient ischemic attack
43728|NCT03928977|Stroke|stroke
43729|NCT03928977|functional Magnetic Resonance Imaging|functional magnetic resonance imaging
43734|NCT03928925|Intubation|intubation
43735|NCT03928925|Bougie|bougie
43736|NCT03928912|nonunion|nonunion
43737|NCT03928912|tibial shaft fracture|tibial shaft fracture
43738|NCT03928912|path analysis model|path analysis model
43739|NCT03928899|induction|induction
43740|NCT03928899|caesarean section|caesarean section
43746|NCT03928886|screening|screening
43747|NCT03928886|mammography|mammography
43748|NCT03928886|Senographe Pristina|senographe pristina
43749|NCT03928873|shock wave|shock wave
43750|NCT03928873|trigger finger|trigger finger
43751|NCT03928860|Peripheral arterial disease|peripheral arterial disease
43752|NCT03928860|Osteopathic manual treatment|osteopathic manual treatment
43753|NCT03928834|adolescence, HIV drug resistance mutations, genotyping, dried blood spots|adolescence, hiv drug resistance mutations, genotyping, dried blood spots
43754|NCT03928808|Fecal Microbiota Transplantation|fecal microbiota transplantation
43755|NCT03928795|neonatal ph|neonatal ph
43756|NCT03928795|neonatal eucapnic ph|neonatal eucapnic ph
43757|NCT03928795|fetal extraction|fetal extraction
43758|NCT03928795|elective caesarean|elective caesarean
43759|NCT03928795|apgar score|apgar score
43760|NCT03928782|Radiation Injuries|radiation injuries
43761|NCT03928782|microRNA|microrna
43762|NCT03928769|Telomere length|telomere length
43763|NCT03928769|Endothelial progenitor cell|endothelial progenitor cell
43764|NCT03928769|Smooth muscle cell|smooth muscle cell
43765|NCT03928769|Senescence|senescence
43766|NCT03928756|substance use|substance use
43767|NCT03928756|mobile health|mobile health
43768|NCT03928743|Ankylosing spondylitis|ankylosing spondylitis
43769|NCT03928743|AS|as
43770|NCT03928743|Bimekizumab|bimekizumab
43771|NCT03928743|Axial spondyloarthritis|axial spondyloarthritis
43772|NCT03928717|adherence|adherence
43773|NCT03928717|young adult|young adult
43774|NCT03928717|Africa|africa
43775|NCT03928717|mhealth|mhealth
43776|NCT03928717|adolescent|adolescent
43777|NCT03928717|viral load|viral load
43778|NCT03928704|Nonradiographic axial spondyloarthritis|nonradiographic axial spondyloarthritis
43779|NCT03928704|Axial spondyloarthritis|axial spondyloarthritis
43780|NCT03928704|Nr-axSpA|nr-axspa
43781|NCT03928704|Bimekizumab|bimekizumab
43786|NCT03928626|Binge Drinking|binge drinking
43787|NCT03928626|Heavy Drinking|heavy drinking
43788|NCT03928626|Young Adult|young adult
43789|NCT03928626|Heavy Drinker|heavy drinker
43790|NCT03928626|Regulation of craving|regulation of craving
43791|NCT03928626|Cognitive behavioral therapy|cognitive behavioral therapy
43792|NCT03928626|Neurocognitive training|neurocognitive training
43793|NCT03928626|Emotion regulation|emotion regulation
43794|NCT03928626|Alcohol|alcohol
43795|NCT03928613|Cognitive training|cognitive training
43796|NCT03928613|Cognitive intervention|cognitive intervention
43797|NCT03928613|Cognitive rehabilitation|cognitive rehabilitation
43798|NCT03928600|induction of labor|induction of labor
43799|NCT03928600|cervical ripening|cervical ripening
43800|NCT03928600|combined methods|combined methods
43801|NCT03928574|Ultrasound-Guided Plane Block|ultrasound-guided plane block
43802|NCT03928574|Conventional Block|conventional block
43803|NCT03928561|Asthma|asthma
43804|NCT03928561|Cat allergy|cat allergy
43805|NCT03928561|Environmental Exposure Chamber|environmental exposure chamber
43806|NCT03928561|Air cleaner|air cleaner
43807|NCT03928457|preterm neonate|preterm neonate
43808|NCT03928457|radiofrequency exposure|radiofrequency exposure
43809|NCT03928457|neurophysiological functions|neurophysiological functions
43810|NCT03928444|Adipose tissue derived stem cells|adipose tissue derived stem cells
43811|NCT03928444|Facial rejuvenation|facial rejuvenation
43812|NCT03928431|microbiota|microbiota
43813|NCT03928431|cesarean section|cesarean section
43814|NCT03928431|vaginal delivery|vaginal delivery
43815|NCT03928431|allergy|allergy
43816|NCT03928431|immunological programming|immunological programming
43817|NCT03928405|Alzheimer's Dementia|alzheimer's dementia
43818|NCT03928405|Balance|balance
43819|NCT03928405|Gait Speed|gait speed
43820|NCT03928405|Virtual Reality|virtual reality
43821|NCT03928392|Post Traumatic Stress Disorder, Depression, Anxiety, Stress, SCUBA, Occupational therapy|post traumatic stress disorder, depression, anxiety, stress, scuba, occupational therapy
43822|NCT03928366|Propofol, remifentanil, hypnosis, EEG, fMRI,|propofol, remifentanil, hypnosis, eeg, fmri,
43823|NCT03928327|Drug Therapy|drug therapy
43824|NCT03928314|GR antagonist|gr antagonist
43825|NCT03928314|Glucocorticoid receptor antagonist|glucocorticoid receptor antagonist
43826|NCT03928275|Interleukin-2|interleukin-2
43827|NCT03928275|Bacillus Calmette Guerin|bacillus calmette guerin
43828|NCT03928262|Pharmacokinetics|pharmacokinetics
43829|NCT03928262|Safety|safety
43830|NCT03928262|Tolerability|tolerability
43831|NCT03928262|Benralizumab|benralizumab
43832|NCT03928262|Healthy Chinese subjects|healthy chinese subjects
43833|NCT03928249|Eriocitrin|eriocitrin
43834|NCT03928249|Citrus bioflavonoids|citrus bioflavonoids
43835|NCT03928249|Flavanone|flavanone
43836|NCT03928249|Pre-diabetes|pre-diabetes
43837|NCT03928249|Blood glucose|blood glucose
43838|NCT03928223|contagious itch|contagious itch
43839|NCT03928223|Manchester Color Wheel|manchester color wheel
43840|NCT03928210|cluster of circulating tumor cells (CTCs)|cluster of circulating tumor cells (ctcs)
43841|NCT03928210|cardiac glycosides|cardiac glycosides
43842|NCT03928210|digoxin|digoxin
43843|NCT03928184|SM04690|sm04690
43844|NCT03928184|Wnt pathway inhibitor|wnt pathway inhibitor
43845|NCT03928184|osteoarthritis|osteoarthritis
43846|NCT03928184|Samumed|samumed
43847|NCT03928184|lorecivivint|lorecivivint
43848|NCT03928171|Laparoscopic surgery|laparoscopic surgery
43849|NCT03928171|Pneumoperitoneum|pneumoperitoneum
43850|NCT03928171|Peritoneal perfusion|peritoneal perfusion
43851|NCT03928171|Intra-abdominal pressure|intra-abdominal pressure
43852|NCT03928158|left ventricular hypertrophy|left ventricular hypertrophy
43853|NCT03928158|diastolic dysfunction|diastolic dysfunction
43854|NCT03928158|LCZ696|lcz696
43855|NCT03928158|HFpEF|hfpef
43856|NCT03928158|HF|hf
43857|NCT03928158|LV filling pressures|lv filling pressures
43858|NCT03928145|Hypertension|hypertension
43859|NCT03928145|Treatment|treatment
43860|NCT03928145|Chlorthalidone|chlorthalidone
43861|NCT03928145|Hydrochlorothiazide|hydrochlorothiazide
43862|NCT03928145|Amiloride|amiloride
43863|NCT03928132|Diabetes and depression|diabetes and depression
43864|NCT03928132|Continuing professional development|continuing professional development
43865|NCT03928132|Continuing medical education|continuing medical education
43866|NCT03928132|Sex and gender|sex and gender
43867|NCT03928132|Minority languages|minority languages
43868|NCT03928132|Knowledge translation|knowledge translation
43869|NCT03928119|Acute myocardial infarction|acute myocardial infarction
43870|NCT03928119|STEMI|stemi
43871|NCT03928119|regional network|regional network
43872|NCT03928106|Medication Reconciliation|medication reconciliation
43873|NCT03928080|diagnostic accuracy|diagnostic accuracy
43874|NCT03928080|early detection|early detection
43875|NCT03928080|self-assessment|self-assessment
43876|NCT03928080|periodontitis|periodontitis
43877|NCT03928067|alcohol|alcohol
43878|NCT03928067|sexual violence|sexual violence
43879|NCT03928067|risky sex|risky sex
43880|NCT03928067|college students|college students
43881|NCT03928041|Lumbar Degenerative Disc Disease|lumbar degenerative disc disease
43882|NCT03928041|Spondylolisthesis|spondylolisthesis
43883|NCT03928015|marijuana|marijuana
43884|NCT03928015|dronabinol|dronabinol
43885|NCT03928015|morphine milligram equivalents|morphine milligram equivalents
43886|NCT03928002|Eisenmenger|eisenmenger
43887|NCT03928002|Pulmonary arterial hypertension|pulmonary arterial hypertension
43888|NCT03928002|Magnetic resonance imaging|magnetic resonance imaging
43889|NCT03928002|4Dflow imagery|4dflow imagery
43890|NCT03928002|cardiac catheterization|cardiac catheterization
43891|NCT03927950|Treatment efficacy|treatment efficacy
43892|NCT03927950|Safety|safety
43893|NCT03927924|Prostate Cancer|prostate cancer
43894|NCT03927924|Focal Therapy|focal therapy
43895|NCT03927924|High-intensity focused ultrasound|high-intensity focused ultrasound
43896|NCT03927833|Infant, Newborn, Diseases|infant, newborn, diseases
43897|NCT03927833|Phototherapy|phototherapy
43898|NCT03927820|inhaler|inhaler
43899|NCT03927820|pharmacy|pharmacy
43900|NCT03927807|misoprostol|misoprostol
43901|NCT03927794|Self-Assembling Peptide P11-4|self-assembling peptide p11-4
43902|NCT03927794|Biomimetic Remineralization|biomimetic remineralization
43903|NCT03927794|White spot lesions|white spot lesions
43904|NCT03927794|Primary Anterior Teeth|primary anterior teeth
43905|NCT03927794|Biomimetic Mineralization|biomimetic mineralization
43906|NCT03927781|Pregabalin|pregabalin
43907|NCT03927781|Perioperative medicine|perioperative medicine
43908|NCT03927781|Opioid sparing|opioid sparing
43909|NCT03927781|Urolithiasis|urolithiasis
43910|NCT03927781|Ureteroscopy|ureteroscopy
43911|NCT03927755|Bedside Ultrasound|bedside ultrasound
43912|NCT03927742|sun protection|sun protection
43913|NCT03927742|sunburn|sunburn
43914|NCT03927729|Methoxyflurane|methoxyflurane
43915|NCT03927729|Penthrox|penthrox
43916|NCT03927729|non opioid analgesia|non opioid analgesia
43917|NCT03927729|traumatic pain|traumatic pain
43918|NCT03927729|pain|pain
43919|NCT03927729|antalgic protocol|antalgic protocol
43920|NCT03927729|emergency department|emergency department
43921|NCT03927612|virtual reality|virtual reality
43922|NCT03927612|perspective taking|perspective taking
43923|NCT03927612|conduct disorder|conduct disorder
58374|NCT03839043|SMS|sms
43924|NCT03927612|oppositional defiant disorder|oppositional defiant disorder
43925|NCT03927612|functional magnetic resonance imaging|functional magnetic resonance imaging
43926|NCT03927612|child|child
43927|NCT03927612|adolescent|adolescent
43928|NCT03927599|TP53|tp53
43929|NCT03927599|PARP|parp
43930|NCT03927599|VEGFR|vegfr
43931|NCT03927599|Solid tumor|solid tumor
43932|NCT03927586|Mild Cognitive Impairment|mild cognitive impairment
43933|NCT03927586|exercise|exercise
43934|NCT03927586|Cognitive training|cognitive training
43935|NCT03927534|Obesity|obesity
43937|NCT03927534|Mindful Eating|mindful eating
43938|NCT03927534|Primary Care|primary care
43939|NCT03927534|Randomized controlled trial (RCT)|randomized controlled trial (rct)
43940|NCT03927521|Prostate cancer|prostate cancer
43941|NCT03927521|Post-Radiotherapy|post-radiotherapy
43942|NCT03927521|Focal HIFU|focal hifu
43944|NCT03927521|PET-MRI|pet-mri
43945|NCT03927521|Local recurrence|local recurrence
43946|NCT03927508|Pulmonary Embolism|pulmonary embolism
43947|NCT03927417|oocyte yield|oocyte yield
43948|NCT03927417|ethnicity|ethnicity
43949|NCT03927417|ovarian stimulation|ovarian stimulation
43950|NCT03927404|Transfemoral Amputees|transfemoral amputees
43951|NCT03927404|Transtibial Amputees|transtibial amputees
43952|NCT03927404|Prosthesis|prosthesis
43953|NCT03927391|enzalutamide|enzalutamide
43954|NCT03927391|cognitive side effects|cognitive side effects
43955|NCT03927378|Perinatal Depression|perinatal depression
43956|NCT03927378|Ketamine|ketamine
43957|NCT03927378|Postpartum Depression|postpartum depression
43958|NCT03927339|Osteoarthritis- Obesity- single aerobic exercise session|osteoarthritis- obesity- single aerobic exercise session
43959|NCT03927313|TB meningitis, HIV|tb meningitis, hiv
43960|NCT03927300|Home Peritoneal Dialysis|home peritoneal dialysis
43961|NCT03927274|Glioma|glioma
43962|NCT03927274|Brain Tumor|brain tumor
43963|NCT03927274|High Grade Glioma|high grade glioma
43964|NCT03927261|MDS|mds
43965|NCT03927261|AML|aml
43966|NCT03927235|Transbronchial Cryobiopsy|transbronchial cryobiopsy
43967|NCT03927235|freezing time|freezing time
43968|NCT03927235|Diagnostic Yield|diagnostic yield
43969|NCT03927235|Safety|safety
43970|NCT03927235|Diffuse Parenchymal Lung Disease|diffuse parenchymal lung disease
43971|NCT03927222|Glioblastoma|glioblastoma
43972|NCT03927222|Dendritic cells|dendritic cells
43973|NCT03927222|Temozolomide|temozolomide
43974|NCT03927222|Tetanus|tetanus
43975|NCT03927222|David Ashley|david ashley
43976|NCT03927222|Immunotherapy|immunotherapy
43977|NCT03927222|Vaccine|vaccine
43978|NCT03927196|primary prevention|primary prevention
43979|NCT03927196|cardiovascular risk|cardiovascular risk
43980|NCT03927196|hyperlipidaemia|hyperlipidaemia
43981|NCT03927196|adherence|adherence
43982|NCT03927183|Person-centred care|person-centred care
43983|NCT03927183|Clinical pathway|clinical pathway
43984|NCT03927183|Intervention|intervention
43985|NCT03927183|Quasi-experimental|quasi-experimental
43986|NCT03927157|Asthma|asthma
43987|NCT03927157|Uncontrolled Asthma|uncontrolled asthma
43988|NCT03927157|Severe Uncontrolled Asthma|severe uncontrolled asthma
43989|NCT03927144|Erenumab|erenumab
43990|NCT03927144|AMG334|amg334
43991|NCT03927144|Migraine|migraine
43992|NCT03927144|Episodic|episodic
43993|NCT03927144|Headache|headache
43994|NCT03927144|CGRP|cgrp
43995|NCT03927131|Vaccine|vaccine
43996|NCT03927118|Diabetic maculopathy|diabetic maculopathy
43997|NCT03927118|dexamethasone implant|dexamethasone implant
43998|NCT03927118|optic disc|optic disc
43999|NCT03927118|vascular endothelial growth factor|vascular endothelial growth factor
44000|NCT03927092|multiple sclerosis|multiple sclerosis
44001|NCT03927092|surveys and questionnaires|surveys and questionnaires
44002|NCT03927092|diagnostic self evaluation|diagnostic self evaluation
44003|NCT03927079|Antibiotics|antibiotics
44004|NCT03927079|Pneumonia|pneumonia
44005|NCT03927079|broncho-alveolar lavage|broncho-alveolar lavage
44006|NCT03927053|substance use|substance use
44007|NCT03927040|Alzheimer's Disease|alzheimer's disease
44008|NCT03927040|Transcranial Electromagnetic Treatment|transcranial electromagnetic treatment
44009|NCT03927040|Cognitive Assessment|cognitive assessment
44010|NCT03927040|Alzheimer's markers in blood and CSF|alzheimer's markers in blood and csf
44011|NCT03927014|oxidative stress|oxidative stress
44012|NCT03927014|mercaptan|mercaptan
44013|NCT03927014|severity|severity
44014|NCT03926936|fulvestrant|fulvestrant
44015|NCT03926936|low-grade gynecological cancer|low-grade gynecological cancer
44016|NCT03926936|efficacy|efficacy
44017|NCT03926923|stress response|stress response
44018|NCT03926923|neurodevelopment|neurodevelopment
44019|NCT03926923|newborn|newborn
44020|NCT03926910|Preload-dependency|preload-dependency
44021|NCT03926910|hypotension|hypotension
44022|NCT03926910|cardiac surgery|cardiac surgery
44023|NCT03926910|delta PP|delta pp
44024|NCT03926910|PLR|plr
44025|NCT03926910|Fluid responsiveness|fluid responsiveness
44026|NCT03926858|post-surgical pain|post-surgical pain
44027|NCT03926858|health-related quality of life|health-related quality of life
44028|NCT03926845|Isobutylamido-thiazolyl-resorcinol|isobutylamido-thiazolyl-resorcinol
44029|NCT03926832|CPAP|cpap
44030|NCT03926819|Anemia, Sickle Cell|anemia, sickle cell
44031|NCT03926819|Anemia, Hemolytic, Congenital|anemia, hemolytic, congenital
44032|NCT03926819|Anemia, Hemolytic|anemia, hemolytic
44033|NCT03926819|Anemia|anemia
44034|NCT03926819|Hematologic Diseases|hematologic diseases
44035|NCT03926819|Hemoglobinopathies|hemoglobinopathies
44036|NCT03926819|Genetic Diseases, Inborn|genetic diseases, inborn
44044|NCT03926806|glycemic control|glycemic control
44046|NCT03926780|rivaroxaban|rivaroxaban
44047|NCT03926780|left ventricular thrombus|left ventricular thrombus
44048|NCT03926767|Pain Neuroscience Education|pain neuroscience education
44049|NCT03926767|Chronic Pain|chronic pain
44050|NCT03926767|Orofacial Manual Therapy|orofacial manual therapy
44051|NCT03926767|Orofacial exercises|orofacial exercises
44052|NCT03926767|Neck Motor Control Exercises|neck motor control exercises
44053|NCT03926728|CTH522|cth522
44054|NCT03926728|Chlamydia|chlamydia
44055|NCT03926728|C. Trachomatis|c. trachomatis
44056|NCT03926715|Malnutrition|malnutrition
44057|NCT03926715|Post-operative complication|post-operative complication
44058|NCT03926689|egg consumption|egg consumption
44059|NCT03926689|dietary diversity|dietary diversity
44060|NCT03926689|complementary feeding|complementary feeding
44061|NCT03926689|South Asia|south asia
44062|NCT03926689|SMS|sms
44063|NCT03926637|Clinically Isolated Syndrome|clinically isolated syndrome
44064|NCT03926611|BTK inhibitor|btk inhibitor
44065|NCT03926611|Urticaria Activity Score|urticaria activity score
44066|NCT03926611|Angioedema Activity Score|angioedema activity score
44067|NCT03926598|Observational|observational
44068|NCT03926598|Mobile Applications|mobile applications
44069|NCT03926533|Post-Intensive Care Syndrome|post-intensive care syndrome
44070|NCT03926520|ECT|ect
44071|NCT03926520|Agitation|agitation
44072|NCT03926520|Alzheimer's|alzheimer's
44073|NCT03926520|Dementia|dementia
44078|NCT03926481|weight loss|weight loss
44079|NCT03926481|cognition|cognition
44080|NCT03926481|sarcopenia|sarcopenia
44081|NCT03926481|obesity|obesity
44082|NCT03926481|lifestyle|lifestyle
44083|NCT03926468|Liquid biopsy|liquid biopsy
44084|NCT03926468|FDG PET-CT|fdg pet-ct
44085|NCT03926442|Spices|spices
44086|NCT03926442|Herbs|herbs
44087|NCT03926442|Metabolic responses|metabolic responses
44088|NCT03926442|Endothelial function|endothelial function
44089|NCT03926442|Inflammatory markers|inflammatory markers
44090|NCT03926416|vaccines|vaccines
44091|NCT03926416|live-attenuated vaccine|live-attenuated vaccine
44092|NCT03926416|influenza vaccine|influenza vaccine
44093|NCT03926403|hypnosis|hypnosis
44094|NCT03926403|local anaesthesia|local anaesthesia
44095|NCT03926403|outpatient surgery|outpatient surgery
44096|NCT03926403|face surgery|face surgery
44097|NCT03926377|osteoporosis|osteoporosis
44098|NCT03926377|dermocortocoids|dermocortocoids
44099|NCT03926377|bullous pemphigoid|bullous pemphigoid
44100|NCT03926377|pharmacoepidemiology|pharmacoepidemiology
44101|NCT03926364|Pain drawings|pain drawings
44102|NCT03926364|referred pain|referred pain
44103|NCT03926364|somatic pain|somatic pain
44104|NCT03926364|neuropathic pain|neuropathic pain
44105|NCT03926364|e-health|e-health
44106|NCT03926364|pain location|pain location
44107|NCT03926364|biopsychosocial factors|biopsychosocial factors
44108|NCT03926364|back pain|back pain
44109|NCT03926364|neck pain|neck pain
44110|NCT03926364|pain extent|pain extent
44111|NCT03926364|function|function
44112|NCT03926312|myocardial infarction|myocardial infarction
44113|NCT03926312|cardiac rehabilitation|cardiac rehabilitation
44114|NCT03926312|smart device|smart device
44115|NCT03926312|remote monitoring|remote monitoring
44116|NCT03926312|telemonitoring|telemonitoring
44117|NCT03926312|low physical activity|low physical activity
44118|NCT03926312|risk factors control|risk factors control
44119|NCT03926286|Dry Eye|dry eye
44120|NCT03926286|Auto-Immune Disorder|auto-immune disorder
44121|NCT03926273|epilepsy|epilepsy
44122|NCT03926273|serum ghrelin|serum ghrelin
44123|NCT03926273|urine ghrelin|urine ghrelin
44124|NCT03926247|pilot study|pilot study
44125|NCT03926247|mental health|mental health
44126|NCT03926247|immigrant|immigrant
44127|NCT03926247|within-group longitudinal design|within-group longitudinal design
44128|NCT03926208|Betadine|betadine
44129|NCT03926208|Foot|foot
44130|NCT03926208|Ankle|ankle
44131|NCT03926208|Nail fold|nail fold
44132|NCT03926208|Scrub|scrub
44133|NCT03926208|Infection|infection
44134|NCT03926208|Prevention|prevention
44135|NCT03926208|Postoperative|postoperative
44136|NCT03926169|Hidradenitis Suppurativa|hidradenitis suppurativa
44137|NCT03926169|Risankizumab|risankizumab
44138|NCT03926169|Placebo|placebo
44142|NCT03926117|IL-6|il-6
44144|NCT03926117|Chronic Kidney Disease|chronic kidney disease
44145|NCT03926117|Cardiovascular Disease|cardiovascular disease
44146|NCT03926117|Inflammation|inflammation
44147|NCT03926091|docetaxel|docetaxel
44148|NCT03926091|cyclophosphamide|cyclophosphamide
44149|NCT03926091|adjuvant chemotherapy|adjuvant chemotherapy
44150|NCT03926078|Haller Index|haller index
44151|NCT03926078|Optical Imaging|optical imaging
44152|NCT03926078|Torso Topography|torso topography
44153|NCT03926078|Three-dimensional Surface Scan|three-dimensional surface scan
44154|NCT03926078|Diagnostic accuracy|diagnostic accuracy
44155|NCT03926039|Hepatocarcinoma|hepatocarcinoma
44156|NCT03926039|sharing decision-making|sharing decision-making
44157|NCT03926039|Health Literacy|health literacy
44158|NCT03926039|decisional conflicts|decisional conflicts
44159|NCT03925948|Type 2 diabetes|type 2 diabetes
44160|NCT03925948|African American|african american
44161|NCT03925948|numeracy|numeracy
44162|NCT03925948|self-management|self-management
44163|NCT03925948|glucose control|glucose control
44164|NCT03925909|Eriocitrin|eriocitrin
44165|NCT03925909|Citrus bioflavonoids|citrus bioflavonoids
44166|NCT03925909|Flavanone|flavanone
44167|NCT03925909|Pre-diabetes|pre-diabetes
44168|NCT03925909|Blood glucose|blood glucose
44169|NCT03925909|Microbiome|microbiome
44170|NCT03925896|EBV TCR-T cells|ebv tcr-t cells
44171|NCT03925896|recurrent|recurrent
44172|NCT03925896|metastatic|metastatic
44173|NCT03925883|Colorectal cancer screening|colorectal cancer screening
44174|NCT03925883|Cancer screening|cancer screening
44175|NCT03925883|Risk prediction model|risk prediction model
44176|NCT03925883|Patient navigation|patient navigation
44177|NCT03925883|Colonoscopy|colonoscopy
44178|NCT03925857|Allocetra-OTS|allocetra-ots
44179|NCT03925857|Cell based therapy|cell based therapy
44180|NCT03925857|Apoptotic cells|apoptotic cells
44181|NCT03925844|Cardiovascular risk prediction models|cardiovascular risk prediction models
44182|NCT03925844|Framingham risk function|framingham risk function
44183|NCT03925844|FRESCO risk function|fresco risk function
44184|NCT03925844|risk function|risk function
44185|NCT03925844|cognitive aging|cognitive aging
44186|NCT03925844|prevention|prevention
44187|NCT03925818|Lactobacillus reuteri; Bismuth; Helicobacter pylori;|lactobacillus reuteri; bismuth; helicobacter pylori;
44188|NCT03925792|lifestyle Medicine|lifestyle medicine
44190|NCT03925792|mood|mood
44191|NCT03925792|psychological being|psychological being
44192|NCT03925792|mental health|mental health
44193|NCT03925792|body-mind|body-mind
44194|NCT03925792|resilience|resilience
44195|NCT03925766|biliary disease|biliary disease
44196|NCT03925766|gallstones|gallstones
44197|NCT03925766|obesity|obesity
44198|NCT03925753|autophagy|autophagy
44199|NCT03925753|inflammatory markers|inflammatory markers
44200|NCT03925740|caries|caries
44201|NCT03925740|interproximal caries|interproximal caries
44202|NCT03925740|MI varnish|mi varnish
44203|NCT03925740|PreviDent varnish|prevident varnish
44204|NCT03925740|Fluoride|fluoride
44205|NCT03925740|1.23% ACP Fluoride|1.23% acp fluoride
44206|NCT03925688|heterotopic ossification|heterotopic ossification
44207|NCT03925688|serum uric acid，|serum uric acid，
44208|NCT03925688|elbow joint|elbow joint
44209|NCT03925649|SCI|sci
44210|NCT03925649|stem cells|stem cells
44211|NCT03925649|quadriplegia|quadriplegia
44212|NCT03925649|spinal cord injury|spinal cord injury
44213|NCT03925649|paralysis|paralysis
44214|NCT03925649|MSCs|mscs
44215|NCT03925636|Specific Carbohydrate Diet|specific carbohydrate diet
44216|NCT03925636|Clostridium Difficile Infection|clostridium difficile infection
44217|NCT03925636|Clostridium Difficile|clostridium difficile
44218|NCT03925636|cDiff|cdiff
44219|NCT03925636|Diet|diet
44220|NCT03925610|Morbid obesity|morbid obesity
44221|NCT03925610|Opioid-induced ventilatory depression|opioid-induced ventilatory depression
44222|NCT03925610|Bariatric surgery|bariatric surgery
44223|NCT03925610|Sleep apnea|sleep apnea
44224|NCT03925493|Graded exercise testing|graded exercise testing
44225|NCT03925493|Cardiac rehab|cardiac rehab
44226|NCT03925493|Exercise Prescription|exercise prescription
44227|NCT03925493|Target heart rate range|target heart rate range
44228|NCT03925493|RPE|rpe
44229|NCT03925467|knee osteoarthritis|knee osteoarthritis
44230|NCT03925467|acupuncture|acupuncture
44231|NCT03925467|radial pressure pulse-wave|radial pressure pulse-wave
44232|NCT03925467|spectral energy|spectral energy
44233|NCT03925441|Post-marketing|post-marketing
44234|NCT03925441|Adalimumab|adalimumab
44235|NCT03925441|Humira|humira
44236|NCT03925441|Pediatric|pediatric
44237|NCT03925441|Chronic severe plaque psoriasis|chronic severe plaque psoriasis
44238|NCT03925441|Psoriasis|psoriasis
44239|NCT03925415|Severe Asthma|severe asthma
44240|NCT03925415|Eosinophilic Asthma|eosinophilic asthma
44241|NCT03925415|Eosinophilic Phenotype|eosinophilic phenotype
44242|NCT03925389|Nasal function|nasal function
44243|NCT03925389|Septorhinoplasty|septorhinoplasty
44244|NCT03925389|Patient-reported outcome|patient-reported outcome
44245|NCT03925389|Rhinomanometry|rhinomanometry
44246|NCT03925389|Acoustic Rhinometry|acoustic rhinometry
44247|NCT03925389|Peak Nasal Inspiratory Flow|peak nasal inspiratory flow
44248|NCT03925389|Esthetics|esthetics
44249|NCT03925376|Redo cardiac surgery|redo cardiac surgery
44250|NCT03925376|Outcome|outcome
44251|NCT03925350|Homologous recombination (HR)|homologous recombination (hr)
44252|NCT03925350|Mutation|mutation
44253|NCT03925350|Niraparib|niraparib
44254|NCT03925350|PARP inhibitor|parp inhibitor
44255|NCT03925311|Transcriptome|transcriptome
44256|NCT03925311|endometrial receptivity|endometrial receptivity
44257|NCT03925298|acute ischemic stroke|acute ischemic stroke
44258|NCT03925298|troponin-I|troponin-i
44259|NCT03925298|outcome|outcome
44260|NCT03925298|intravenous thrombolytic therapy|intravenous thrombolytic therapy
44261|NCT03925272|immune system|immune system
44262|NCT03925272|environmental interactions|environmental interactions
44263|NCT03925272|genetic component|genetic component
44264|NCT03925259|ACT|act
44265|NCT03925259|dismantling|dismantling
44266|NCT03925259|long term conditions|long term conditions
44267|NCT03925246|Recurrent high grade gliomas|recurrent high grade gliomas
44268|NCT03925246|IDH mutation|idh mutation
44269|NCT03925246|Immune Checkpoint inhibitor|immune checkpoint inhibitor
44270|NCT03925246|Nivolumab|nivolumab
44271|NCT03925233|Drug sensitivity experiment|drug sensitivity experiment
44272|NCT03925233|Resistance mechanism research|resistance mechanism research
44273|NCT03925220|Primary Prevention|primary prevention
44274|NCT03925220|Adolescent Behavior|adolescent behavior
44275|NCT03925220|Family|family
44276|NCT03925220|Personal Communication|personal communication
44277|NCT03925207|retrobulbar block|retrobulbar block
44278|NCT03925207|general anesthesia|general anesthesia
44279|NCT03925168|end stage kidney disease|end stage kidney disease
44280|NCT03925168|depression|depression
44281|NCT03925168|major depressive disorder|major depressive disorder
44282|NCT03925168|anxiety|anxiety
44283|NCT03925168|generalized anxiety disorder|generalized anxiety disorder
44284|NCT03925168|music therapy|music therapy
44285|NCT03925168|dialysis|dialysis
44286|NCT03925168|quality of life|quality of life
44287|NCT03925168|blood pressure|blood pressure
44288|NCT03925168|heart rate|heart rate
44289|NCT03925168|pain|pain
44290|NCT03925168|energy|energy
44291|NCT03925168|mood|mood
44292|NCT03925168|medication compliance|medication compliance
44293|NCT03925168|music|music
44294|NCT03925155|vaginal prep|vaginal prep
44295|NCT03925155|randomization|randomization
44296|NCT03925155|chlorhexidine|chlorhexidine
44297|NCT03925155|povidone iodine|povidone iodine
44298|NCT03925142|beef|beef
44299|NCT03925142|cardio-metabolic disease|cardio-metabolic disease
44300|NCT03925116|contraceptive pathway|contraceptive pathway
44301|NCT03925116|continuation|continuation
44302|NCT03925103|VATS|vats
44303|NCT03925103|Lobectomy|lobectomy
44304|NCT03925103|3D VATS|3d vats
44305|NCT03925103|VATS Ergonomics|vats ergonomics
44306|NCT03925103|Non small cell lung cancer|non small cell lung cancer
44307|NCT03925103|Three-dimensional thoracoscopy|three-dimensional thoracoscopy
44308|NCT03924999|Lipedema|lipedema
44309|NCT03924999|Combined decongestive treatment|combined decongestive treatment
44310|NCT03924999|Intermittent pneumatic compression|intermittent pneumatic compression
44311|NCT03924960|fibromyalgia|fibromyalgia
44312|NCT03924960|functional capacity|functional capacity
44313|NCT03924960|aerobic exercise|aerobic exercise
44314|NCT03924947|Cystic Fibrosis|cystic fibrosis
44315|NCT03924947|Creon|creon
44316|NCT03924947|Pancrelipase|pancrelipase
44317|NCT03924947|ABT-SLV-245|abt-slv-245
44318|NCT03924947|Exocrine Pancreatic Insufficiency (EPI)|exocrine pancreatic insufficiency (epi)
44319|NCT03924947|Modernized Process (MP)|modernized process (mp)
44320|NCT03924934|Infection|infection
44321|NCT03924934|Bacterial Infection|bacterial infection
44322|NCT03924921|relaxation|relaxation
44323|NCT03924921|quality of life|quality of life
44324|NCT03924921|symptoms|symptoms
44325|NCT03924921|pain|pain
44326|NCT03924921|depression|depression
44327|NCT03924921|anxiety|anxiety
44328|NCT03924921|sleep problems|sleep problems
44329|NCT03924921|fatigue|fatigue
44330|NCT03924895|Programmed Cell Death-1 (PD1, PD-1)|programmed cell death-1 (pd1, pd-1)
44331|NCT03924895|Programmed Death-Ligand 1 (PDL1, PD-L1)|programmed death-ligand 1 (pdl1, pd-l1)
44332|NCT03924895|Pembrolizumab (MK-3475)|pembrolizumab (mk-3475)
44333|NCT03924882|Anlotinib; Ovarian cancer|anlotinib; ovarian cancer
44334|NCT03924869|Programmed Cell Death-1 (PD1, PD-1)|programmed cell death-1 (pd1, pd-1)
44335|NCT03924869|Programmed Death-Ligand 1 (PDL1, PD-L1)|programmed death-ligand 1 (pdl1, pd-l1)
44336|NCT03924856|Programmed Cell Death-1 (PD1, PD-1)|programmed cell death-1 (pd1, pd-1)
44337|NCT03924856|Programmed Death-Ligand 1 (PDL1, PD-L1)|programmed death-ligand 1 (pdl1, pd-l1)
44338|NCT03924856|Pembrolizumab (MK-3475)|pembrolizumab (mk-3475)
44339|NCT03924856|Chemotherapy|chemotherapy
815273|NCT00181688|Anastrozole|anastrozole
44340|NCT03924830|dentin bonding agents|dentin bonding agents
44341|NCT03924830|tooth sensitivity|tooth sensitivity
44342|NCT03924830|composite resin restoration|composite resin restoration
44344|NCT03924791|Acute sciatica|acute sciatica
44345|NCT03924791|Transforaminal epidural injection|transforaminal epidural injection
44346|NCT03924791|Leg pain|leg pain
44347|NCT03924791|Lumbar spine|lumbar spine
44348|NCT03924791|Back pain|back pain
44349|NCT03924791|Lumbar surgery|lumbar surgery
44350|NCT03924791|Herniated intervertebral lumbar disk|herniated intervertebral lumbar disk
44351|NCT03924791|Cost-effectiveness|cost-effectiveness
44352|NCT03924765|Exoskeleton|exoskeleton
44353|NCT03924752|Exoskeleton|exoskeleton
44354|NCT03924739|Atrial fibrillation|atrial fibrillation
44355|NCT03924739|Self-care|self-care
44356|NCT03924739|Model of care|model of care
44357|NCT03924739|Nurse-led|nurse-led
44358|NCT03924739|Disease management|disease management
44359|NCT03924739|Empowerment|empowerment
44360|NCT03924713|Community health worker|community health worker
44361|NCT03924713|health care utilization|health care utilization
44362|NCT03924700|Herniated intervertebral disc|herniated intervertebral disc
44363|NCT03924700|Discectomy|discectomy
44364|NCT03924700|Microscope|microscope
44365|NCT03924700|Biportal endoscopy|biportal endoscopy
44366|NCT03924687|chronic pain|chronic pain
44367|NCT03924687|Acceptance or Commitment Therapy (ACT)|acceptance or commitment therapy (act)
44368|NCT03924687|self-help|self-help
44369|NCT03924687|pain-related disability|pain-related disability
44370|NCT03924687|psychological inflexibility|psychological inflexibility
44371|NCT03924687|depression|depression
44372|NCT03924687|pain acceptance|pain acceptance
44373|NCT03924687|bibliotherapy|bibliotherapy
44374|NCT03924648|Premature menopause|premature menopause
44375|NCT03924648|Premature ovarian insufficiency|premature ovarian insufficiency
44376|NCT03924635|Airway inflammation|airway inflammation
44377|NCT03924635|Anti-inflammatory reliever|anti-inflammatory reliever
44378|NCT03924635|Symbicort|symbicort
44379|NCT03924635|Maintenance anti-inflammatory therapy|maintenance anti-inflammatory therapy
44380|NCT03924635|Reliever medication|reliever medication
44381|NCT03924635|Salbutamol|salbutamol
44382|NCT03924622|Pressure injury/prevention|pressure injury/prevention
44383|NCT03924622|Military Nursing|military nursing
44384|NCT03924622|Risk Reduction|risk reduction
44385|NCT03924596|Renal Stones|renal stones
44386|NCT03924596|Kidney Stones|kidney stones
44387|NCT03924596|Renal Calculi|renal calculi
44388|NCT03924596|Kidney Calculi|kidney calculi
44389|NCT03924596|Urinary Calculi|urinary calculi
44390|NCT03924596|Urolithiasis|urolithiasis
44391|NCT03924596|Frankincense|frankincense
44392|NCT03924596|Olibanum|olibanum
44393|NCT03924596|Boswellia|boswellia
44394|NCT03924596|Boswellic acid|boswellic acid
44395|NCT03924596|Clinical Trial|clinical trial
44396|NCT03924531|Hypertension|hypertension
44397|NCT03924531|Health Behavior|health behavior
44398|NCT03924531|Mindfulness|mindfulness
44399|NCT03924531|Meditation|meditation
44400|NCT03924518|sepsis|sepsis
44401|NCT03924518|septic shock|septic shock
44402|NCT03924518|granisetron|granisetron
44403|NCT03924505|Opioid Overdose Prevention|opioid overdose prevention
44404|NCT03924505|Naloxone Implementation|naloxone implementation
44405|NCT03924505|Implementation Science|implementation science
44406|NCT03924492|Expanded Access|expanded access
44407|NCT03924479|heart failure preserved ejection fraction|heart failure preserved ejection fraction
44408|NCT03924479|exercise|exercise
44409|NCT03924479|respiratory muscle|respiratory muscle
44410|NCT03924466|HER2|her2
44411|NCT03924414|Parkinson Disease|parkinson disease
44412|NCT03924414|Parkinson's Disease|parkinson's disease
44413|NCT03924414|Osteoporosis|osteoporosis
44414|NCT03924414|Zoledronic acid|zoledronic acid
44415|NCT03924414|Neurology|neurology
44416|NCT03924414|Bone|bone
44417|NCT03924414|Fracture|fracture
44418|NCT03924401|Pediatrics|pediatrics
44419|NCT03924401|Non-malignant hematologic diseases|non-malignant hematologic diseases
44420|NCT03924401|Severe aplastic anemia|severe aplastic anemia
44421|NCT03924401|Fanconi anemia|fanconi anemia
44422|NCT03924401|Sickle cell disease|sickle cell disease
44423|NCT03924401|Hematopoietic stem cell transplantation|hematopoietic stem cell transplantation
44424|NCT03924401|Thalassemia|thalassemia
44425|NCT03924401|Mismatched unrelated donor|mismatched unrelated donor
44426|NCT03924388|Transcutaneous Spinal Cord Stimulation|transcutaneous spinal cord stimulation
44427|NCT03924388|Epidural Spinal Cord Stimulation|epidural spinal cord stimulation
44428|NCT03924388|Orthostatic Hypotension|orthostatic hypotension
44429|NCT03924388|Autonomic Dysreflexia|autonomic dysreflexia
44430|NCT03924388|Spinal Cord Stimulation|spinal cord stimulation
44431|NCT03924336|stage 3 periodontitis|stage 3 periodontitis
44432|NCT03924336|A-PRF|a-prf
44433|NCT03924336|Advanced platelet rich fibrin|advanced platelet rich fibrin
44434|NCT03924336|open flap debridement|open flap debridement
44435|NCT03924336|OFD|ofd
44436|NCT03924336|2-wall intraosseous defect|2-wall intraosseous defect
44437|NCT03924336|3-wall intraosseous defect|3-wall intraosseous defect
44438|NCT03924310|myoelectric prostheses|myoelectric prostheses
44439|NCT03924310|closed-loop control|closed-loop control
44440|NCT03924310|vibrotactile feedback|vibrotactile feedback
44749|NCT03922503|DFDBA|dfdba
44441|NCT03924310|feedback display|feedback display
44442|NCT03924297|chilipad|chilipad
44443|NCT03924219|cmv|cmv
44444|NCT03924206|Smoke|smoke
44445|NCT03924206|Plume|plume
44446|NCT03924206|Electrocautery|electrocautery
44447|NCT03924206|Mass spectrometer|mass spectrometer
44448|NCT03924180|Amino acid|amino acid
44449|NCT03924180|GMP|gmp
44450|NCT03924180|PKU|pku
44451|NCT03924154|Pulmonary arterial hypertension (PAH)|pulmonary arterial hypertension (pah)
44452|NCT03924154|Pulmonary hypertension (PH)|pulmonary hypertension (ph)
44453|NCT03924154|RVT-1201|rvt-1201
44454|NCT03924154|Rodatristat ethyl|rodatristat ethyl
44455|NCT03924154|Tryptophan hydroxylase (TPH)|tryptophan hydroxylase (tph)
44456|NCT03924154|Serotonin reduction|serotonin reduction
44457|NCT03924154|ELEVATE 1|elevate 1
44458|NCT03924154|KAR5417|kar5417
44459|NCT03924141|De-escalation|de-escalation
44460|NCT03924141|Aggression|aggression
44461|NCT03924141|Violence prevention|violence prevention
44462|NCT03924115|Adherence, Hypertension, Mobil App, video|adherence, hypertension, mobil app, video
44463|NCT03924063|total shoulder|total shoulder
44464|NCT03924063|failure|failure
44465|NCT03924063|salvage|salvage
44466|NCT03924024|Depression|depression
44467|NCT03924024|Transcranial Magnetic Stimulation (TMS)|transcranial magnetic stimulation (tms)
44468|NCT03924024|Theta Burst|theta burst
44469|NCT03924024|Orthopaedic Trauma|orthopaedic trauma
44470|NCT03924024|Pain|pain
44471|NCT03924011|Radiodermatitis|radiodermatitis
44472|NCT03924011|Breast cancer|breast cancer
44473|NCT03924011|Radiotherapy|radiotherapy
44474|NCT03924011|Photobiomodulation therapy|photobiomodulation therapy
44475|NCT03924011|Low-level light therapy|low-level light therapy
44476|NCT03924011|Skin diseases|skin diseases
44477|NCT03924011|Radiation injuries|radiation injuries
44478|NCT03924011|Wounds and injuries|wounds and injuries
44479|NCT03924011|Oncology|oncology
44480|NCT03923998|Oral neoplasms|oral neoplasms
44481|NCT03923998|Mouth neoplasms|mouth neoplasms
44482|NCT03923985|Vaginal Flora|vaginal flora
44483|NCT03923985|Oral Probiotics|oral probiotics
44484|NCT03923972|physical activity|physical activity
44485|NCT03923972|exercise training|exercise training
44486|NCT03923972|surveys and questionnaires|surveys and questionnaires
44487|NCT03923972|chronic kidney disease|chronic kidney disease
44488|NCT03923972|dialysis|dialysis
44489|NCT03923972|kidney transplantation|kidney transplantation
44490|NCT03923972|health care facilities|health care facilities
44491|NCT03923959|Blood|blood
44492|NCT03923959|Transfusion|transfusion
44493|NCT03923959|Hip|hip
44494|NCT03923959|Fracture|fracture
44495|NCT03923959|Surgery|surgery
44496|NCT03923959|Replacement|replacement
44497|NCT03923959|Trauma|trauma
44498|NCT03923946|Stroke|stroke
44499|NCT03923946|Compassion Focused Therapy|compassion focused therapy
44500|NCT03923946|CFT|cft
44501|NCT03923946|Distress|distress
44502|NCT03923946|Feasibility RCT|feasibility rct
44503|NCT03923933|Diuretics|diuretics
44504|NCT03923933|Bumetanide|bumetanide
44505|NCT03923933|Chlorthalidone|chlorthalidone
44506|NCT03923933|Chronic Kidney Disease|chronic kidney disease
44507|NCT03923933|Volume Overload|volume overload
44508|NCT03923920|Biopsy|biopsy
44509|NCT03923920|Surgery|surgery
44510|NCT03923920|Screening|screening
44511|NCT03923881|Multispectral Optoacoustic Tomography|multispectral optoacoustic tomography
44512|NCT03923881|Molecular Imaging|molecular imaging
44513|NCT03923881|Cetuximab-800CW|cetuximab-800cw
44514|NCT03923842|NPC|npc
44515|NCT03923842|EBV|ebv
44516|NCT03923829|zinc|zinc
44517|NCT03923829|Non-surgical Periodontal Therapy|non-surgical periodontal therapy
44518|NCT03923829|stage II periodontitis|stage ii periodontitis
44519|NCT03923829|stage III periodontitis|stage iii periodontitis
44520|NCT03923829|gingival crevicular fluid|gingival crevicular fluid
44521|NCT03923829|total oxidant capacity|total oxidant capacity
44522|NCT03923829|Type 2 diabetic patients|type 2 diabetic patients
44523|NCT03923777|Active Surveillance|active surveillance
44524|NCT03923725|Artemether|artemether
44525|NCT03923725|Lumefantrine|lumefantrine
44526|NCT03923725|Amodiaquine|amodiaquine
44527|NCT03923725|Artesunate|artesunate
44528|NCT03923725|Piperaquine|piperaquine
44529|NCT03923725|Mefloquine|mefloquine
44530|NCT03923712|Physical exercise|physical exercise
44531|NCT03923712|ageing|ageing
44532|NCT03923712|dementia|dementia
44533|NCT03923712|Alzheimer|alzheimer
44534|NCT03923712|magnetic resonance image|magnetic resonance image
44535|NCT03923712|cerebral|cerebral
44536|NCT03923712|cognition|cognition
44537|NCT03923712|metabolomic|metabolomic
44538|NCT03923712|older people|older people
44539|NCT03923712|mild cognitive impairment|mild cognitive impairment
44540|NCT03923699|Telemedicine|telemedicine
44541|NCT03923699|Anesthesia Control Tower|anesthesia control tower
44542|NCT03923699|Machine Learning|machine learning
44543|NCT03923699|Forecasting Algoritms|forecasting algoritms
44544|NCT03923699|Decision Support|decision support
44545|NCT03923699|Randomized Controlled Trial|randomized controlled trial
44548|NCT03923686|Necrotizing pancreatitis|necrotizing pancreatitis
44550|NCT03923686|Lumen apposing metal stents|lumen apposing metal stents
44551|NCT03923686|Double pigtail plastic stent|double pigtail plastic stent
44553|NCT03923660|breathing pattern|breathing pattern
44554|NCT03923660|exercise|exercise
44555|NCT03923660|concentric|concentric
44556|NCT03923660|eccentric|eccentric
44557|NCT03923621|Endoscopic Pilonidal Sinus Treatment (EPSiT)|endoscopic pilonidal sinus treatment (epsit)
44558|NCT03923569|Alzheimer's disease|alzheimer's disease
44559|NCT03923569|Rapid eye movement (REM) sleep|rapid eye movement (rem) sleep
44560|NCT03923569|Memory consolidation|memory consolidation
44561|NCT03923569|Epilepsy|epilepsy
44562|NCT03923569|MRI|mri
44563|NCT03923517|Young onset dementia|young onset dementia
44564|NCT03923517|caregiver|caregiver
44565|NCT03923517|online intervention|online intervention
44566|NCT03923517|online communication technology|online communication technology
44567|NCT03923504|Physical Activity Intervention|physical activity intervention
44568|NCT03923504|Healthy Living Intervention|healthy living intervention
44569|NCT03923504|Health-related Quality of Life|health-related quality of life
44573|NCT03923452|mindfulness|mindfulness
44574|NCT03923452|immigrant|immigrant
44575|NCT03923452|stress|stress
44576|NCT03923452|wellbeing|wellbeing
44577|NCT03923439|Stroke|stroke
44578|NCT03923439|High b-value diffusion MRI|high b-value diffusion mri
44579|NCT03923439|Rescued penumbra|rescued penumbra
44580|NCT03923439|Selective neuronal loss.|selective neuronal loss.
44581|NCT03923426|ceftazidime-avibactam|ceftazidime-avibactam
44582|NCT03923426|Zavicefta|zavicefta
44583|NCT03923413|circulating MP|circulating mp
44584|NCT03923413|FMD|fmd
44585|NCT03923413|LVAD|lvad
44586|NCT03923413|endothelial function|endothelial function
44587|NCT03923413|endothelial integrity|endothelial integrity
44588|NCT03923400|GIST|gist
44589|NCT03923400|small bowel|small bowel
44590|NCT03923400|jejunum|jejunum
44591|NCT03923400|ileum|ileum
44592|NCT03923387|Vascular closure|vascular closure
44593|NCT03923374|Pregnant with Opioid Use Disorder|pregnant with opioid use disorder
44594|NCT03923374|Opioid Use Disorder ( OUD)|opioid use disorder ( oud)
44595|NCT03923374|Subutex|subutex
44596|NCT03923374|Buprenorphine|buprenorphine
44597|NCT03923374|Pregnant taking buprenorphine/subutex|pregnant taking buprenorphine/subutex
44598|NCT03923348|female urinary incontinence|female urinary incontinence
44599|NCT03923348|urge urinary incontinence|urge urinary incontinence
44600|NCT03923348|urgency|urgency
44601|NCT03923348|frequency|frequency
44602|NCT03923348|overactive bladder|overactive bladder
44603|NCT03923348|pelvic floor muscle training|pelvic floor muscle training
44604|NCT03923348|biofeedback|biofeedback
44605|NCT03923335|colorectal cancer|colorectal cancer
44606|NCT03923335|prognostic biomarkers|prognostic biomarkers
44607|NCT03923335|DNA Methylation|dna methylation
44608|NCT03923335|gene panel|gene panel
44609|NCT03923335|recurrence|recurrence
44610|NCT03923335|disease free survival|disease free survival
44611|NCT03923309|Organ preservation|organ preservation
44612|NCT03923309|Oncologic outcome|oncologic outcome
44613|NCT03923296|point of care|point of care
44614|NCT03923296|home monitoring|home monitoring
44615|NCT03923296|device|device
44616|NCT03923296|blood|blood
44617|NCT03923283|End-tidal carbondioxide|end-tidal carbondioxide
44618|NCT03923283|surgery drapes|surgery drapes
44619|NCT03923283|carbondioxide accumulation|carbondioxide accumulation
44620|NCT03923283|eye surgery|eye surgery
44621|NCT03923270|lung cancer|lung cancer
44622|NCT03923244|Dry Eye Syndrome|dry eye syndrome
44623|NCT03923244|tear film analysis|tear film analysis
44624|NCT03923244|ocular surface|ocular surface
44625|NCT03923244|cataract surgery|cataract surgery
44626|NCT03923218|Gingival crevicular fluid|gingival crevicular fluid
44627|NCT03923218|Vitamin D|vitamin d
44628|NCT03923218|LL-37|ll-37
44629|NCT03923218|Serum|serum
44630|NCT03923218|periodontitis|periodontitis
44631|NCT03923205|buckwheat|buckwheat
44632|NCT03923205|postprandial glycemia|postprandial glycemia
44633|NCT03923205|Type 2 diabetes|type 2 diabetes
44634|NCT03923153|inspiratory muscle trainig|inspiratory muscle trainig
44635|NCT03923153|quality of life|quality of life
44636|NCT03923153|aerobic capacity|aerobic capacity
44637|NCT03923153|depression|depression
44638|NCT03923153|fatique|fatique
44639|NCT03923140|Cryopyrin-Associated Periodic Syndromes|cryopyrin-associated periodic syndromes
44640|NCT03923140|Tranilast|tranilast
44641|NCT03923140|Efficacy|efficacy
44642|NCT03923140|Safety|safety
44643|NCT03923114|exendin|exendin
44644|NCT03923114|GLP-1 receptor agonist|glp-1 receptor agonist
44645|NCT03923114|HPA-axis|hpa-axis
44646|NCT03923114|Imaging|imaging
44647|NCT03923101|Keratoconus|keratoconus
44648|NCT03923101|Crosslinking|crosslinking
44649|NCT03923101|Intracorneal ring segments|intracorneal ring segments
44650|NCT03923101|Gas-permeable rigid contact-lenses|gas-permeable rigid contact-lenses
44651|NCT03923101|Penetrating Keratoplasty|penetrating keratoplasty
44652|NCT03923101|Deep anterior lamellar Keratoplasty|deep anterior lamellar keratoplasty
44653|NCT03923101|ABCD Grading System|abcd grading system
44654|NCT03923075|dexmedetomidine|dexmedetomidine
44655|NCT03923075|propofol|propofol
44656|NCT03923075|rocuronium|rocuronium
44657|NCT03923075|TOF|tof
44658|NCT03923075|children|children
44659|NCT03923023|Facility delivery|facility delivery
44660|NCT03923023|Neonatal mortality|neonatal mortality
44661|NCT03923023|Preterm delivery|preterm delivery
44662|NCT03923023|Preterm birth|preterm birth
44663|NCT03923023|Perinatal mortality|perinatal mortality
44664|NCT03922984|magnetic resonance imaging, arterial spin labeling|magnetic resonance imaging, arterial spin labeling
44665|NCT03922971|colonoscopy|colonoscopy
44666|NCT03922971|EGD|egd
44667|NCT03922971|endoscopy|endoscopy
44668|NCT03922971|ASC|asc
44669|NCT03922971|outpatient|outpatient
44670|NCT03922971|infection|infection
44671|NCT03922971|Endoscopic procedures|endoscopic procedures
44672|NCT03922945|weight loss|weight loss
44673|NCT03922945|obesity|obesity
44674|NCT03922945|weight control|weight control
44675|NCT03922932|Diabetes|diabetes
44676|NCT03922932|OCT|oct
44677|NCT03922932|Angiography|angiography
44678|NCT03922932|Diabetic retinopathy|diabetic retinopathy
44679|NCT03922893|Genetic evaluation|genetic evaluation
44680|NCT03922893|Germline genetic variant|germline genetic variant
44681|NCT03922893|Genetic cancer|genetic cancer
44682|NCT03922893|Memorial Sloan Kettering Cancer Center|memorial sloan kettering cancer center
44683|NCT03922893|19-133|19-133
44684|NCT03922880|ADI-PEG 20|adi-peg 20
44685|NCT03922880|nivolumab|nivolumab
44686|NCT03922880|ipilimumab|ipilimumab
44687|NCT03922880|19-010|19-010
44688|NCT03922880|Memorial Sloan Kettering Cancer Center|memorial sloan kettering cancer center
44689|NCT03922867|insomnia|insomnia
44690|NCT03922867|fibromyalgia|fibromyalgia
44691|NCT03922815|Surgical Pleth Index (SPI)|surgical pleth index (spi)
44692|NCT03922815|Adequacy of Anaesthesia (AoA)|adequacy of anaesthesia (aoa)
44693|NCT03922815|State Entropy (SE)|state entropy (se)
44694|NCT03922815|Postoperative nausea and vomitting (PONV)|postoperative nausea and vomitting (ponv)
44695|NCT03922815|Colonoscopy|colonoscopy
44696|NCT03922802|Spinal Cord Injury|spinal cord injury
44697|NCT03922802|Stimulation|stimulation
44698|NCT03922802|Spinal Stimulation|spinal stimulation
44699|NCT03922802|Noninvasive stimulation|noninvasive stimulation
44700|NCT03922776|Ovarian cancer|ovarian cancer
44701|NCT03922776|Tubal Cancer|tubal cancer
44702|NCT03922776|Immunological profile|immunological profile
44703|NCT03922776|PBMc|pbmc
44704|NCT03922776|TILs|tils
44705|NCT03922776|Carcinomatosis|carcinomatosis
44706|NCT03922776|HGSOC|hgsoc
44707|NCT03922724|Autoimmunity|autoimmunity
44708|NCT03922724|Immune Dysregulation|immune dysregulation
44709|NCT03922724|Congenital|congenital
44710|NCT03922724|Opportunistic Infection|opportunistic infection
44711|NCT03922711|Levodopa|levodopa
44712|NCT03922711|Dyskinesia|dyskinesia
44713|NCT03922698|atherosclerotic plaque|atherosclerotic plaque
44714|NCT03922698|autonomic nervous system|autonomic nervous system
44715|NCT03922698|immune system|immune system
44716|NCT03922698|autophagy|autophagy
44717|NCT03922672|caregiver|caregiver
44718|NCT03922672|Parkinson's disease|parkinson's disease
44719|NCT03922672|group piano training|group piano training
44720|NCT03922659|Heroin dependence, transcranial magnetic stimulation, cognitive behavioral therapy|heroin dependence, transcranial magnetic stimulation, cognitive behavioral therapy
44721|NCT03922646|Cognitive Rehabilitation|cognitive rehabilitation
44722|NCT03922646|Brain Rehabilitation|brain rehabilitation
44723|NCT03922646|Treatment|treatment
44724|NCT03922646|Addiction|addiction
44725|NCT03922646|Heroin|heroin
44726|NCT03922646|Opiates|opiates
44727|NCT03922646|Meth|meth
44728|NCT03922646|Methamphetamine|methamphetamine
44729|NCT03922633|E3112|e3112
44730|NCT03922633|Phase 1|phase 1
44731|NCT03922633|Pharmacokinetics|pharmacokinetics
44732|NCT03922633|Japanese|japanese
44733|NCT03922607|Psoriasis|psoriasis
44734|NCT03922607|Chronic Plaque Psoriasis|chronic plaque psoriasis
44735|NCT03922607|ABBV-157|abbv-157
44736|NCT03922607|Healthy Volunteers|healthy volunteers
44737|NCT03922581|Anxiety disorders|anxiety disorders
44738|NCT03922581|Behavioral intervention|behavioral intervention
44739|NCT03922581|Psychology|psychology
44740|NCT03922568|Gender Ratio|gender ratio
44741|NCT03922568|PICSI|picsi
44742|NCT03922568|MACS|macs
44743|NCT03922568|Sperm Selection|sperm selection
44744|NCT03922555|Neurological Cancer|neurological cancer
44745|NCT03922503|Stage III periodontitis|stage iii periodontitis
44746|NCT03922503|APRF|aprf
44747|NCT03922503|Advanced Platelet Rich Fibrin|advanced platelet rich fibrin
44748|NCT03922503|Demineralized freeze-dried bone allograft|demineralized freeze-dried bone allograft
44753|NCT03922503|combined 1- to 2-wall intraosseous defect|combined 1- to 2-wall intraosseous defect
44760|NCT03922412|Anesthesia|anesthesia
44761|NCT03922412|plantar Block|plantar block
44762|NCT03922399|burn scar|burn scar
44763|NCT03922399|laser|laser
44764|NCT03922399|ultrapulse|ultrapulse
44765|NCT03922360|Nicotine Dependence|nicotine dependence
44766|NCT03922360|Financial Incentives|financial incentives
44767|NCT03922360|Pregnant Women|pregnant women
44768|NCT03922360|Smoking Cessation|smoking cessation
44769|NCT03922360|mHealth|mhealth
44770|NCT03922360|Smartphone|smartphone
44771|NCT03922321|IMVT-1401|imvt-1401
44772|NCT03922321|Graves' Orbitopathy|graves' orbitopathy
44773|NCT03922321|Thyroid Eye Disease|thyroid eye disease
44774|NCT03922282|Gasless|gasless
44775|NCT03922282|Bilateral axillo-breast approach|bilateral axillo-breast approach
44776|NCT03922282|Da Vinci|da vinci
44777|NCT03922282|Robot-assisted thyroid surgery|robot-assisted thyroid surgery
44778|NCT03922243|students|students
44779|NCT03922243|dental treatment|dental treatment
44780|NCT03922243|gender|gender
44781|NCT03922243|age|age
44782|NCT03922230|esophageal squamous cancer|esophageal squamous cancer
44783|NCT03922230|DNA methylolation|dna methylolation
44784|NCT03922230|early screening|early screening
44785|NCT03922204|First-in-human|first-in-human
44786|NCT03922204|MCLA-145|mcla-145
44787|NCT03922204|Antibodies|antibodies
44788|NCT03922204|Bispecific|bispecific
44789|NCT03922165|Pediatrics|pediatrics
44790|NCT03922165|Adenotonsillectomy|adenotonsillectomy
44791|NCT03922152|palliative care|palliative care
44792|NCT03922152|radiotherapy|radiotherapy
44793|NCT03922152|pain|pain
44794|NCT03922152|quality of life|quality of life
44795|NCT03922152|esophageal cancer|esophageal cancer
44796|NCT03922074|ADR with Non-Anesthesiologist administered propofol (NAAP)|adr with non-anesthesiologist administered propofol (naap)
44797|NCT03922061|inactivated polio vaccine (IPV)|inactivated polio vaccine (ipv)
44798|NCT03922061|fractional-dose inactivated polio vaccine (fIPV)|fractional-dose inactivated polio vaccine (fipv)
44799|NCT03922061|double mutant [LT(R192G/L211A)] Enterotoxigenic E coli heat toxin (dmLT)|double mutant [lt(r192g/l211a)] enterotoxigenic e coli heat toxin (dmlt)
44800|NCT03922048|inguinal hernia|inguinal hernia
44801|NCT03922048|postoperative pain|postoperative pain
44802|NCT03922048|herniorrhaphy|herniorrhaphy
44803|NCT03922048|pediatric|pediatric
44804|NCT03922048|local anesthetic|local anesthetic
44805|NCT03922009|Virtual Reality；Anxiety|virtual reality；anxiety
44806|NCT03921996|Extended pelvic lymph node dissection|extended pelvic lymph node dissection
44807|NCT03921996|Pelvic lymph node dissection|pelvic lymph node dissection
44808|NCT03921996|ePLND|eplnd
44809|NCT03921996|Prostate Cancer|prostate cancer
44810|NCT03921996|intermediate prostate cancer|intermediate prostate cancer
44811|NCT03921996|High-risk prostate cancer|high-risk prostate cancer
44812|NCT03921983|muscle oxygenation|muscle oxygenation
44813|NCT03921983|hypoxia|hypoxia
44814|NCT03921983|mitochondrial function|mitochondrial function
44815|NCT03921983|non invasive|non invasive
44816|NCT03921970|Laparoscopic sleeve gastrectomy|laparoscopic sleeve gastrectomy
44817|NCT03921970|Postoperative pain management|postoperative pain management
44818|NCT03921970|Erector spina plane block|erector spina plane block
44819|NCT03921944|shoulder surgery|shoulder surgery
44820|NCT03921944|arthritis|arthritis
44821|NCT03921944|rotator cuff|rotator cuff
44822|NCT03921931|light stimulation|light stimulation
44823|NCT03921931|retinal photoreceptors|retinal photoreceptors
44824|NCT03921931|light adaptation|light adaptation
44825|NCT03921931|functional optical coherence tomography|functional optical coherence tomography
44826|NCT03921931|optophysiology|optophysiology
44827|NCT03921931|intrinsic optical signals|intrinsic optical signals
44828|NCT03921905|Peripheral Artery Disease|peripheral artery disease
44829|NCT03921905|Coronary Artery Disease|coronary artery disease
44830|NCT03921905|General Practice|general practice
44831|NCT03921905|Ankle-brachial index (ABI)|ankle-brachial index (abi)
44832|NCT03921827|MCA; ICA; vasodilatory reserve; EECP; intracranial stenosis|mca; ica; vasodilatory reserve; eecp; intracranial stenosis
44833|NCT03921801|Osteoarthritis|osteoarthritis
44834|NCT03921801|Knee|knee
44835|NCT03921801|Achilles tendon|achilles tendon
44836|NCT03921801|Triceps surae|triceps surae
44837|NCT03921801|Balance|balance
44838|NCT03921801|Electromyography|electromyography
44839|NCT03921801|Biofeedback|biofeedback
44840|NCT03921801|Strength training|strength training
44841|NCT03921801|Gait|gait
44842|NCT03921801|Walking|walking
44843|NCT03921788|venous pelvic pain|venous pelvic pain
45241|NCT03919201|exercise|exercise
44848|NCT03921762|Enhanced depth of focus (EDOF)|enhanced depth of focus (edof)
44849|NCT03921762|Intraocular lens|intraocular lens
44850|NCT03921736|estrogen-progestin therapy|estrogen-progestin therapy
44852|NCT03921736|uric acid|uric acid
44853|NCT03921736|xanthine|xanthine
44854|NCT03921736|hypoxanthine|hypoxanthine
44855|NCT03921736|menopause|menopause
44856|NCT03921736|thiazide diuretic|thiazide diuretic
44857|NCT03921736|angiotensin-converting enzyme inhibitor|angiotensin-converting enzyme inhibitor
44858|NCT03921723|Dolutegravir|dolutegravir
44859|NCT03921723|Human immunodeficiency virus|human immunodeficiency virus
44860|NCT03921723|Sequential study|sequential study
44861|NCT03921723|Dispersible tablet|dispersible tablet
44862|NCT03921723|Suspension|suspension
44863|NCT03921723|Liquid solution|liquid solution
44864|NCT03921697|Technological Rehabilitation; Digital Inclusion|technological rehabilitation; digital inclusion
44865|NCT03921684|Nivolumab|nivolumab
44866|NCT03921684|Chemoradiation|chemoradiation
44867|NCT03921684|mFOLFOX6|mfolfox6
44868|NCT03921684|rectal cancer|rectal cancer
44869|NCT03921684|Anti-PD-1 antibody|anti-pd-1 antibody
44870|NCT03921671|metastatic or relapsed non-pre-treated disease|metastatic or relapsed non-pre-treated disease
44871|NCT03921632|Anorexia nervosa|anorexia nervosa
44872|NCT03921632|Bulimia|bulimia
44873|NCT03921593|quality of life|quality of life
44874|NCT03921593|pancreas transplant|pancreas transplant
44875|NCT03921580|Satiety|satiety
44876|NCT03921580|Polyphenols|polyphenols
44877|NCT03921580|Fibre|fibre
44878|NCT03921580|Visual Analogue Scale|visual analogue scale
44879|NCT03921580|Cross-over|cross-over
44880|NCT03921580|Tuna|tuna
44881|NCT03921567|Analgesia|analgesia
44882|NCT03921567|Perioperative periode|perioperative periode
44883|NCT03921567|Postoperative periode|postoperative periode
44884|NCT03921567|VAS scale|vas scale
44885|NCT03921554|AGS|ags
44886|NCT03921541|ARG1-D|arg1-d
44891|NCT03921502|Choledocholithiasis|choledocholithiasis
44892|NCT03921502|Gall Bladder drainage|gall bladder drainage
44893|NCT03921502|LAMS|lams
44894|NCT03921489|bone marrow edema|bone marrow edema
44895|NCT03921489|subchondroplasty|subchondroplasty
44896|NCT03921489|foot and ankle|foot and ankle
44897|NCT03921450|motor behavior|motor behavior
44898|NCT03921450|psychomotor slowing|psychomotor slowing
44899|NCT03921450|psychosis|psychosis
44900|NCT03921437|Chronic Renal Diseases|chronic renal diseases
44901|NCT03921437|Decision-making|decision-making
44902|NCT03921424|Pneumococcal conjugate vaccine (PCV), 15-valent, 22F, 33F|pneumococcal conjugate vaccine (pcv), 15-valent, 22f, 33f
44903|NCT03921398|Lupus nephritis|lupus nephritis
44904|NCT03921398|haemodialysis|haemodialysis
44905|NCT03921372|Normal tension glaucoma|normal tension glaucoma
44906|NCT03921359|Parkinson Disease|parkinson disease
44907|NCT03921359|Exercise Training|exercise training
44908|NCT03921359|Cognitive function|cognitive function
44909|NCT03921346|Medication errors|medication errors
44910|NCT03921346|Drugs|drugs
44911|NCT03921346|Pediatrics|pediatrics
44912|NCT03921346|Biomedical Technology|biomedical technology
44913|NCT03921346|Mobile applications|mobile applications
44914|NCT03921346|Emergency Medical Services|emergency medical services
44915|NCT03921320|Hyperhidrosis|hyperhidrosis
44916|NCT03921320|Sympathectomy|sympathectomy
44917|NCT03921320|Sweating|sweating
44918|NCT03921307|Computer-Aided Design|computer-aided design
44919|NCT03921307|dental crowns|dental crowns
44920|NCT03921307|survival|survival
44921|NCT03921281|Cerebral palsy|cerebral palsy
44922|NCT03921281|Motor dysfunction|motor dysfunction
44923|NCT03921281|Scalp acupuncture treatment|scalp acupuncture treatment
44924|NCT03921281|Safety/Efficacy assessment|safety/efficacy assessment
44925|NCT03921255|Thought-Action Fusion|thought-action fusion
44926|NCT03921255|Cognitive Bias Modification|cognitive bias modification
44927|NCT03921255|Interpretation Training|interpretation training
44928|NCT03921255|Stress Management Psychoeducation|stress management psychoeducation
44929|NCT03921229|Patient Care|patient care
44930|NCT03921229|Tele-health|tele-health
44931|NCT03921229|Behavioral intervention|behavioral intervention
44932|NCT03921190|Buccal infiltration anesthesia|buccal infiltration anesthesia
44933|NCT03921190|Discomfort|discomfort
44934|NCT03921177|preconceptional multiple micronutrient supplementation|preconceptional multiple micronutrient supplementation
44935|NCT03921177|periconceptional multiple micronutrient supplementation|periconceptional multiple micronutrient supplementation
44936|NCT03921177|pregnancy outcomes|pregnancy outcomes
44937|NCT03921177|adolescent pregnancy|adolescent pregnancy
44938|NCT03921177|Bangladesh|bangladesh
44939|NCT03921164|Cardiac after-load|cardiac after-load
44940|NCT03921164|Pressure volume loop|pressure volume loop
44941|NCT03921164|Perioperative risk|perioperative risk
44942|NCT03921125|Living donors|living donors
44943|NCT03921125|PVI|pvi
44944|NCT03921125|PPV|ppv
44945|NCT03921125|Fluids|fluids
44946|NCT03921125|Response|response
44947|NCT03921073|Cutaneous|cutaneous
44948|NCT03921073|Angiosarcoma|angiosarcoma
44949|NCT03921073|Skin|skin
44950|NCT03920982|acute kidney injury|acute kidney injury
44951|NCT03920982|septic shock|septic shock
44952|NCT03920982|uremic toxins|uremic toxins
44953|NCT03920982|indoxyl sulfate|indoxyl sulfate
44954|NCT03920982|mortality|mortality
44955|NCT03920969|Sport|sport
44956|NCT03920969|HIV|hiv
44957|NCT03920969|Self Esteem|self esteem
44958|NCT03920943|patient transfer|patient transfer
44959|NCT03920930|ERAS|eras
44960|NCT03920930|pain|pain
44961|NCT03920930|knee arthroplasty|knee arthroplasty
44962|NCT03920930|joint pain|joint pain
44963|NCT03920930|regional anaesthesia|regional anaesthesia
44964|NCT03920917|Atrial fibrillation|atrial fibrillation
44965|NCT03920917|Radiofrequency Pulmonary vein isolation|radiofrequency pulmonary vein isolation
44966|NCT03920917|Cryoballoon Pulmonary Vein isolation|cryoballoon pulmonary vein isolation
44967|NCT03920891|Valvular Atrial fibrillation|valvular atrial fibrillation
44968|NCT03920891|Radiofrequency Pulmonary vein isolation|radiofrequency pulmonary vein isolation
44969|NCT03920891|Cryoballoon Pulmonary Vein isolation|cryoballoon pulmonary vein isolation
44970|NCT03920878|anti-VEGF injections|anti-vegf injections
44971|NCT03920878|pre-existing DME|pre-existing dme
44972|NCT03920878|cataract surgery|cataract surgery
44973|NCT03920852|Atopic dermatitis|atopic dermatitis
44974|NCT03920852|ruxolitinib cream|ruxolitinib cream
44975|NCT03920852|maximum use|maximum use
44976|NCT03920839|solid tumors|solid tumors
44977|NCT03920839|non-small cell lung cancer|non-small cell lung cancer
44978|NCT03920839|malignant pleural mesothelioma|malignant pleural mesothelioma
44979|NCT03920839|chemotherapy|chemotherapy
44980|NCT03920839|programmed cell death protein 1 (PD-1) inhibitor|programmed cell death protein 1 (pd-1) inhibitor
44981|NCT03920787|inositol|inositol
44982|NCT03920787|insulin resistance|insulin resistance
44983|NCT03920787|overweight|overweight
44984|NCT03920787|children|children
44985|NCT03920748|Difficult laryngoscopy, airway measurements, newborn, infant|difficult laryngoscopy, airway measurements, newborn, infant
44986|NCT03920722|MPA|mpa
44987|NCT03920722|Rituximab|rituximab
44988|NCT03920722|ANCA-associated vasculitis|anca-associated vasculitis
44989|NCT03920696|Pityriasis Lichenoides;|pityriasis lichenoides;
44990|NCT03920696|cutaneous lymphoma|cutaneous lymphoma
44991|NCT03920696|lymphoproliferation|lymphoproliferation
44992|NCT03920683|Prediction of coronary artery calcification score|prediction of coronary artery calcification score
44993|NCT03920683|Diabetes mellitus|diabetes mellitus
44994|NCT03920683|Toe-brachial index|toe-brachial index
44995|NCT03920670|Neuromuscular Blockade|neuromuscular blockade
44996|NCT03920670|ToFscan|tofscan
44997|NCT03920670|Tetragraph|tetragraph
44998|NCT03920670|AMG|amg
44999|NCT03920670|EMG|emg
45000|NCT03920657|MDS|mds
45001|NCT03920644|Motion Sickness, INSCOP, Scopolamine, Defender, NAMRU|motion sickness, inscop, scopolamine, defender, namru
45002|NCT03920631|B Cell Lymphomas|b cell lymphomas
45003|NCT03920631|Microtransplantation|microtransplantation
45004|NCT03920631|Nivolumab|nivolumab
45005|NCT03920618|hepatitis b virus|hepatitis b virus
45006|NCT03920618|acute-on-chronic liver failure|acute-on-chronic liver failure
45007|NCT03920618|nucleotide|nucleotide
45008|NCT03920618|nucleoside|nucleoside
45009|NCT03920605|hepatitis b virus|hepatitis b virus
45010|NCT03920605|peginterferon alfa|peginterferon alfa
45011|NCT03920605|liver fibrosis|liver fibrosis
45012|NCT03920592|Virtual reality|virtual reality
45013|NCT03920592|Psychophysiology|psychophysiology
45014|NCT03920592|Empathy|empathy
45015|NCT03920579|CKD-386|ckd-386
45016|NCT03920579|Pharmacokinetics|pharmacokinetics
45017|NCT03920579|D326|d326
45018|NCT03920579|D337|d337
45019|NCT03920579|D013|d013
45020|NCT03920566|Enzalutamide|enzalutamide
45021|NCT03920566|Anticoagulant Drugs|anticoagulant drugs
45022|NCT03920566|P-glycoprotein|p-glycoprotein
45023|NCT03920540|GC1111|gc1111
45024|NCT03920540|Mucopolysaccharidosis II|mucopolysaccharidosis ii
45025|NCT03920540|MPS II|mps ii
45026|NCT03920540|idursulfase-beta|idursulfase-beta
45027|NCT03920540|IDS|ids
45028|NCT03920527|CPA|cpa
45029|NCT03920527|Aspergillosis|aspergillosis
45030|NCT03920527|CCPA|ccpa
45031|NCT03920527|CFPA|cfpa
45032|NCT03920514|infertility|infertility
45033|NCT03920501|Critical care|critical care
45034|NCT03920501|Quality improvement|quality improvement
45035|NCT03920501|Tele-critical care|tele-critical care
45036|NCT03920501|Telemedicine|telemedicine
45037|NCT03920488|genetic testing|genetic testing
45038|NCT03920488|breast cancer|breast cancer
45039|NCT03920462|Physical Activity|physical activity
45040|NCT03920462|Connected bike|connected bike
45041|NCT03920462|Connected vest|connected vest
45042|NCT03920462|Rehabilitation|rehabilitation
45043|NCT03920449|Chronic anal fissure|chronic anal fissure
45044|NCT03920449|Botulinum toxin|botulinum toxin
45045|NCT03920449|Sphincterotomy|sphincterotomy
45046|NCT03920397|type 1 diabetes|type 1 diabetes
45047|NCT03920397|pancreatic function|pancreatic function
45048|NCT03920397|adipose tissue-derived stromal/stem cells|adipose tissue-derived stromal/stem cells
45049|NCT03920371|small field of view|small field of view
45050|NCT03920371|hybrid compact gamma camera|hybrid compact gamma camera
45051|NCT03920371|handheld gamma camera|handheld gamma camera
45052|NCT03920332|Pregnancy|pregnancy
59749|NCT03830801|EGD|egd
45053|NCT03920332|obstetric|obstetric
45054|NCT03920332|miscarriage|miscarriage
45055|NCT03920332|haemorrhage|haemorrhage
45056|NCT03920332|fibrinogen|fibrinogen
45057|NCT03920254|TD-1473|td-1473
45058|NCT03920254|Janus kinase inhibitor|janus kinase inhibitor
45059|NCT03920254|JAK inhibitor|jak inhibitor
45060|NCT03920254|Inflammatory Bowel Disease|inflammatory bowel disease
45061|NCT03920254|IBD|ibd
45062|NCT03920254|Ulcerative colitis|ulcerative colitis
45063|NCT03920254|UC|uc
45064|NCT03920254|Intestinal restriction|intestinal restriction
45065|NCT03920254|Gut-selective|gut-selective
45066|NCT03920241|Mindfulness|mindfulness
45067|NCT03920241|Compassion|compassion
45068|NCT03920241|Well-being|well-being
45069|NCT03920241|Network analysis|network analysis
45070|NCT03920241|MBSR|mbsr
45071|NCT03920241|CCT|cct
45072|NCT03920241|Attentional blink|attentional blink
45073|NCT03920241|Cognition|cognition
45074|NCT03920228|PC|pc
45075|NCT03920202|Rectal cancer|rectal cancer
45076|NCT03920202|Bowel dysfunction|bowel dysfunction
45077|NCT03920202|Low anterior resection syndrome|low anterior resection syndrome
45078|NCT03920202|Low anterior resection syndrome score|low anterior resection syndrome score
45079|NCT03920202|Quality of life|quality of life
45080|NCT03920176|Cardiology|cardiology
45081|NCT03920176|Computed tomography coronary angiography|computed tomography coronary angiography
45082|NCT03920150|optimal vitamin D value|optimal vitamin d value
45083|NCT03920098|Breast densities|breast densities
45084|NCT03920098|Breast neoplasms|breast neoplasms
45085|NCT03920098|Glucose metabolism disorders|glucose metabolism disorders
45086|NCT03920098|Diabetes, gestational|diabetes, gestational
45087|NCT03920098|Glycated Hemoglobin A|glycated hemoglobin a
45088|NCT03920098|Insulin-Like Growth Factor I|insulin-like growth factor i
45089|NCT03920098|Pregnancy|pregnancy
45090|NCT03920098|Gestation|gestation
45091|NCT03920098|Primary Health Care|primary health care
45092|NCT03920098|Dual-energy X-ray Absorptiometry|dual-energy x-ray absorptiometry
45093|NCT03920098|Latin America|latin america
45094|NCT03920098|Chile|chile
45095|NCT03920046|esophagogastroduodenoscopy|esophagogastroduodenoscopy
45096|NCT03920046|laryngospasm|laryngospasm
45097|NCT03920046|passive smoking|passive smoking
45098|NCT03920046|sedation|sedation
45099|NCT03920020|Concentric|concentric
45100|NCT03920020|Eccentric|eccentric
45101|NCT03920020|Muscle Architecture|muscle architecture
45102|NCT03920020|Proprioception|proprioception
45103|NCT03919994|Alkermes|alkermes
45104|NCT03919994|Schizophrenia|schizophrenia
45105|NCT03919994|ARISTADA|aristada
45106|NCT03919994|Abilify Maintena|abilify maintena
45107|NCT03919994|Invega Sustenna|invega sustenna
45108|NCT03919994|Risperdal Consta|risperdal consta
45109|NCT03919994|Cohort Study|cohort study
45110|NCT03919994|Observational|observational
45111|NCT03919994|Phase 4|phase 4
45112|NCT03919968|Elderly|elderly
45113|NCT03919968|Martial Arts|martial arts
45114|NCT03919968|Functional Training|functional training
45115|NCT03919968|Cardiovascular|cardiovascular
45116|NCT03919968|Health|health
45117|NCT03919942|Quality of life|quality of life
45118|NCT03919942|Pericoronitis|pericoronitis
45119|NCT03919942|Phytotherapy|phytotherapy
45120|NCT03919929|Insulin Resistance|insulin resistance
45121|NCT03919864|Lung cancer caregivers|lung cancer caregivers
45122|NCT03919851|Prehospital recognition and treatment|prehospital recognition and treatment
45123|NCT03919838|probiotic|probiotic
45124|NCT03919838|oral health|oral health
45125|NCT03919838|children|children
45126|NCT03919786|postoperative atrial fibrillation|postoperative atrial fibrillation
45127|NCT03919786|POAF|poaf
45128|NCT03919786|thoracic surgery|thoracic surgery
45129|NCT03919786|vagus nerve block|vagus nerve block
45130|NCT03919786|pulmonary vein|pulmonary vein
45131|NCT03919760|Implementation Science|implementation science
45132|NCT03919760|Youth and Emerging Adults|youth and emerging adults
45133|NCT03919760|First Episode Psychosis|first episode psychosis
45134|NCT03919760|Schizophrenia|schizophrenia
45135|NCT03919760|Mental Health|mental health
45136|NCT03919760|Psychiatric Services|psychiatric services
45137|NCT03919760|NAVIGATE|navigate
45138|NCT03919747|oral contraceptives|oral contraceptives
45139|NCT03919747|knowledge|knowledge
45140|NCT03919721|applied behavioral analysis|applied behavioral analysis
45141|NCT03919721|data collection software|data collection software
45142|NCT03919682|early detection, Rwanda|early detection, rwanda
45143|NCT03919656|Metabolomics|metabolomics
45144|NCT03919656|Dapagliflozin|dapagliflozin
45145|NCT03919604|cystic fibrosis|cystic fibrosis
45146|NCT03919604|lung transplantation|lung transplantation
45147|NCT03919604|extracorporeal membrane oxygenation|extracorporeal membrane oxygenation
45148|NCT03919565|hepatitis b virus|hepatitis b virus
45149|NCT03919565|peginterferon alfa|peginterferon alfa
45150|NCT03919565|liver fibrosis|liver fibrosis
815274|NCT00181688|Arimidex|arimidex
59868|NCT03829956|snoring|snoring
45151|NCT03919552|Nasopharyngeal Carcinoma|nasopharyngeal carcinoma
45152|NCT03919552|cisplatin|cisplatin
45153|NCT03919552|carboplatin|carboplatin
45154|NCT03919539|osteosarcoma|osteosarcoma
45155|NCT03919539|5hmc|5hmc
45156|NCT03919539|drug resistance|drug resistance
45157|NCT03919539|famitinib|famitinib
45158|NCT03919539|camrelizumab|camrelizumab
45159|NCT03919526|CD19/CD22|cd19/cd22
45160|NCT03919526|Bispecific CAR-T|bispecific car-t
45161|NCT03919526|leukemia|leukemia
45162|NCT03919526|MRD-positive|mrd-positive
45163|NCT03919526|B-ALL|b-all
45164|NCT03919513|IMT,NPPV,Pulmonary rehabilitation|imt,nppv,pulmonary rehabilitation
45165|NCT03919500|Preterm infant|preterm infant
45166|NCT03919500|Necrotizing enterocolitis|necrotizing enterocolitis
45167|NCT03919500|Erythropoietin|erythropoietin
45168|NCT03919500|Neurodevelopment|neurodevelopment
45169|NCT03919474|sudden hearing loss,|sudden hearing loss,
45170|NCT03919474|SSNHL|ssnhl
45171|NCT03919474|serotonin|serotonin
45172|NCT03919474|homocystein|homocystein
45173|NCT03919474|antiphospholipid syndrom|antiphospholipid syndrom
45174|NCT03919474|thrombophilia|thrombophilia
45175|NCT03919461|Beta-blocker|beta-blocker
45176|NCT03919461|Propranolol|propranolol
45177|NCT03919461|COX-2 inhibitor|cox-2 inhibitor
45178|NCT03919461|Etodolac|etodolac
45179|NCT03919448|Bevacizumab|bevacizumab
45180|NCT03919448|Biosimilar|biosimilar
45181|NCT03919448|Antineoplasic Agents|antineoplasic agents
45182|NCT03919448|Bioequivalence|bioequivalence
45183|NCT03919448|Inmunogenicity|inmunogenicity
45184|NCT03919448|safety|safety
45185|NCT03919448|healthy male volunteers|healthy male volunteers
45186|NCT03919422|thoracic paravertebral block|thoracic paravertebral block
45187|NCT03919422|regional anesthesia|regional anesthesia
45188|NCT03919422|elderly|elderly
45189|NCT03919422|proximal humeral fracture|proximal humeral fracture
45190|NCT03919422|brachial plexus block|brachial plexus block
45191|NCT03919422|cervical plexus block|cervical plexus block
45192|NCT03919422|intercostobrachial nerve|intercostobrachial nerve
45193|NCT03919409|TS-161|ts-161
45194|NCT03919409|CSF|csf
45195|NCT03919409|first-in-human|first-in-human
45196|NCT03919396|Myopia|myopia
45197|NCT03919396|Myopia Control|myopia control
45198|NCT03919396|Orthokeratology|orthokeratology
45199|NCT03919396|Electroretinogram|electroretinogram
45200|NCT03919396|Multifocal Electroretinogram|multifocal electroretinogram
45201|NCT03919383|Hepatocellular Carcinoma|hepatocellular carcinoma
45202|NCT03919383|Lenvatinib|lenvatinib
45203|NCT03919383|Toripalimab|toripalimab
45204|NCT03919331|High flow nasal canula / P-SILI/ AHRF / EIT|high flow nasal canula / p-sili/ ahrf / eit
45205|NCT03919318|postoperative pain|postoperative pain
45206|NCT03919318|Endoseal MTA|endoseal mta
45207|NCT03919318|Endosequence BC|endosequence bc
45208|NCT03919318|AH Plus|ah plus
45209|NCT03919318|Root canal filling|root canal filling
45210|NCT03919318|endodontic treatment|endodontic treatment
45211|NCT03919305|Cerebral venous sinus thrombosis|cerebral venous sinus thrombosis
45212|NCT03919305|Deep cerebral vein thrombosis|deep cerebral vein thrombosis
45213|NCT03919305|Cortical vein thrombosis|cortical vein thrombosis
45214|NCT03919305|Cohort study|cohort study
45215|NCT03919305|Real world evidence|real world evidence
45216|NCT03919305|Observational study|observational study
45217|NCT03919305|China mainland|china mainland
45218|NCT03919305|Cerebral venous system thrombosis|cerebral venous system thrombosis
45219|NCT03919292|Colon Cancer|colon cancer
45220|NCT03919292|Pancreatic Cancer|pancreatic cancer
45221|NCT03919292|Other solid tumor|other solid tumor
45222|NCT03919292|Advanced solid tumor|advanced solid tumor
45223|NCT03919292|Tumor progression|tumor progression
45224|NCT03919279|Erosive hand osteoarthritis|erosive hand osteoarthritis
45225|NCT03919279|pain|pain
45226|NCT03919279|inflammation|inflammation
45227|NCT03919279|vagus nerve stimulation|vagus nerve stimulation
45228|NCT03919266|Acute chest syndrome|acute chest syndrome
45229|NCT03919266|SCD|scd
45230|NCT03919266|PCR multiplex|pcr multiplex
45231|NCT03919266|antibiotic treatment|antibiotic treatment
45232|NCT03919240|Acute Lymphoblastic Leukemia|acute lymphoblastic leukemia
45233|NCT03919240|Refractory and relapsed|refractory and relapsed
45234|NCT03919240|Chimeric antigen receptor T-cell therapy|chimeric antigen receptor t-cell therapy
45235|NCT03919227|RIRS|rirs
45236|NCT03919227|Upper urinary calculi|upper urinary calculi
45237|NCT03919227|Ureteral access sheath|ureteral access sheath
45238|NCT03919227|Bladder filling degree|bladder filling degree
45239|NCT03919227|Ureteral injury|ureteral injury
45240|NCT03919201|postmenopausal|postmenopausal
45242|NCT03919188|preterm neonates|preterm neonates
45243|NCT03919188|incubator management|incubator management
45244|NCT03919188|body temperature|body temperature
45245|NCT03919188|relative air humidity|relative air humidity
45246|NCT03919188|thermoneutrality|thermoneutrality
45247|NCT03919175|Lymphoma|lymphoma
59991|NCT03829072|Cooking|cooking
45248|NCT03919175|Follicular Lymphoma|follicular lymphoma
45249|NCT03919175|Marginal Zone Lymphoma|marginal zone lymphoma
45250|NCT03919136|Heart Failure|heart failure
45251|NCT03919136|Advanced Heart Failure|advanced heart failure
45252|NCT03919136|Blood Pressure|blood pressure
45253|NCT03919136|High Blood Pressure|high blood pressure
45254|NCT03919136|Low Blood Pressure|low blood pressure
45255|NCT03919123|Pelvic Organ Prolapse|pelvic organ prolapse
45256|NCT03919123|laparoscopic promontofixation|laparoscopic promontofixation
45257|NCT03919123|symptoms|symptoms
45258|NCT03919123|Satisfaction|satisfaction
45259|NCT03919123|Quality of Life|quality of life
45260|NCT03919110|Inflammation|inflammation
45261|NCT03919110|Rheumatology|rheumatology
45262|NCT03919084|THRIVE|thrive
45263|NCT03919084|Patient navigation|patient navigation
45264|NCT03919084|Accountable Care Organization|accountable care organization
45265|NCT03919084|Pharmacy liaison|pharmacy liaison
45266|NCT03919084|Pharmacy services|pharmacy services
45267|NCT03919084|Social determinants of health|social determinants of health
45268|NCT03919084|health-related social needs|health-related social needs
45269|NCT03919084|screening and referral|screening and referral
45270|NCT03919084|Medicaid ACO|medicaid aco
45272|NCT03919058|Multiple Sclerosis|multiple sclerosis
45273|NCT03919058|Non-exercise physical activity|non-exercise physical activity
45274|NCT03919058|NEPA|nepa
45275|NCT03919058|Cardiometabolic health|cardiometabolic health
45276|NCT03919058|Comorbidities|comorbidities
45277|NCT03919045|Chronic migraine|chronic migraine
45278|NCT03919045|Saline injection|saline injection
45279|NCT03919019|oral supplementation|oral supplementation
45280|NCT03919019|mfERG|mferg
45281|NCT03919019|OCT|oct
45282|NCT03919006|periodontal diseases|periodontal diseases
45283|NCT03919006|cytokines|cytokines
45284|NCT03919006|gingival crevicular fluid|gingival crevicular fluid
45285|NCT03919006|saliva|saliva
45286|NCT03919006|serum|serum
45287|NCT03918993|Erectile Dysfunction|erectile dysfunction
45288|NCT03918993|lymphocyte to monocyte ratio|lymphocyte to monocyte ratio
45289|NCT03918993|monocyte to HDL ratio|monocyte to hdl ratio
45290|NCT03918941|patients satisfaction|patients satisfaction
45291|NCT03918941|Mobile application|mobile application
45292|NCT03918941|orthognathic surgery|orthognathic surgery
45293|NCT03918915|Children|children
45294|NCT03918915|Myopia|myopia
45295|NCT03918902|mortality|mortality
45296|NCT03918902|oral hygiene|oral hygiene
45297|NCT03918902|periodontitis|periodontitis
45298|NCT03918902|smokeless tobacco|smokeless tobacco
45299|NCT03918902|tobacco|tobacco
45300|NCT03918889|dexmedetomidine|dexmedetomidine
45301|NCT03918889|midazolam|midazolam
45302|NCT03918889|cough|cough
45303|NCT03918889|sedation|sedation
45304|NCT03918889|pain|pain
45305|NCT03918876|dance|dance
45306|NCT03918876|health|health
45307|NCT03918876|ballet|ballet
45308|NCT03918876|musculoskeletal injury|musculoskeletal injury
45309|NCT03918876|SF-36|sf-36
45310|NCT03918876|wellness|wellness
45311|NCT03918876|dance medicine|dance medicine
45312|NCT03918863|electromyography|electromyography
45313|NCT03918863|physiotherapy|physiotherapy
45314|NCT03918863|knee|knee
45315|NCT03918863|quadriceps muscle|quadriceps muscle
45316|NCT03918850|CTN-0080|ctn-0080
45317|NCT03918850|clinical trials network|clinical trials network
45318|NCT03918850|medication assisted treatment|medication assisted treatment
45319|NCT03918837|Arterial Spin Labeling|arterial spin labeling
45320|NCT03918837|Obsessive Compulsive Disorder|obsessive compulsive disorder
45321|NCT03918837|Magnetic Resonance Imaging|magnetic resonance imaging
45322|NCT03918837|Repetitive Transcranial Magnetic Stimulation|repetitive transcranial magnetic stimulation
45323|NCT03918837|Double blinded|double blinded
45324|NCT03918837|Sham|sham
45325|NCT03918811|airway extubation|airway extubation
45326|NCT03918811|extubation methods|extubation methods
45327|NCT03918811|positive pressure|positive pressure
45328|NCT03918811|positive-pressure extubation|positive-pressure extubation
45329|NCT03918811|tracheal extubation|tracheal extubation
45330|NCT03918811|positive-pressure ventilation|positive-pressure ventilation
45331|NCT03918811|extubation complications|extubation complications
45332|NCT03918798|Surgery|surgery
45333|NCT03918798|Hernia, Inguinal|hernia, inguinal
45334|NCT03918798|Flat Foot|flat foot
45335|NCT03918798|Pediatric population|pediatric population
45336|NCT03918798|Peripheral nerve block|peripheral nerve block
45337|NCT03918785|rice germ|rice germ
45338|NCT03918785|swimmers|swimmers
45339|NCT03918785|nutritional supplement|nutritional supplement
45340|NCT03918785|lactic acid|lactic acid
45341|NCT03918785|fat free mass|fat free mass
45344|NCT03918772|Hypersensitivity, Immediate|hypersensitivity, immediate
45345|NCT03918772|Morbidity|morbidity
45346|NCT03918772|Mortality|mortality
45347|NCT03918772|Perioperative Period|perioperative period
45348|NCT03918772|Skin Tests|skin tests
45349|NCT03918772|Tryptases|tryptases
45350|NCT03918759|Lymph node metastases|lymph node metastases
45351|NCT03918759|Diagnostic accuracy|diagnostic accuracy
45352|NCT03918746|compassion|compassion
45353|NCT03918746|internet-based Interventions|internet-based interventions
45354|NCT03918746|feasibility|feasibility
45355|NCT03918746|meditation|meditation
45356|NCT03918746|attachment|attachment
45357|NCT03918733|retreatment|retreatment
45358|NCT03918733|endodontic surgery|endodontic surgery
45359|NCT03918733|nonsurgical endodontic retreatment|nonsurgical endodontic retreatment
45360|NCT03918720|Quality of Life|quality of life
45361|NCT03918720|Empowerment|empowerment
45362|NCT03918720|Low-income Families|low-income families
45363|NCT03918720|Parent-child health relationship|parent-child health relationship
45364|NCT03918681|Running|running
45365|NCT03918681|Gait Retraining|gait retraining
45366|NCT03918681|Return to Run|return to run
45367|NCT03918681|ACLR|aclr
45368|NCT03918681|Loading|loading
45369|NCT03918668|breast neoplasm|breast neoplasm
45370|NCT03918668|cancer|cancer
45371|NCT03918668|risk factor|risk factor
45372|NCT03918668|nutrition|nutrition
45373|NCT03918655|Acute Myeloid Leukemia.|acute myeloid leukemia.
45374|NCT03918655|Macrophage migration inhibitory factor|macrophage migration inhibitory factor
45375|NCT03918655|Hematopoietic stem cell|hematopoietic stem cell
45376|NCT03918642|Chronic Pain|chronic pain
45377|NCT03918642|Psychotherapy|psychotherapy
45378|NCT03918642|Musculoskeletal Disease|musculoskeletal disease
45379|NCT03918629|Clostridium Difficile|clostridium difficile
45380|NCT03918629|vaccine|vaccine
45381|NCT03918616|Alzheimer disease|alzheimer disease
45382|NCT03918616|Parkinson disease|parkinson disease
45383|NCT03918616|P2X7 receptor|p2x7 receptor
45384|NCT03918577|Caloric Vestibular Stimulation|caloric vestibular stimulation
45385|NCT03918577|Insight|insight
45386|NCT03918564|Weightloss|weightloss
45387|NCT03918551|bioequivalence|bioequivalence
45388|NCT03918551|febuxostat|febuxostat
45389|NCT03918551|Adenuric|adenuric
45390|NCT03918538|lung cancer|lung cancer
45391|NCT03918538|early physical rehabilitation|early physical rehabilitation
45392|NCT03918538|muscle endurance|muscle endurance
45393|NCT03918538|aerobic capacity|aerobic capacity
45394|NCT03918538|quality of life|quality of life
45395|NCT03918512|Lumbar spinal stenosis|lumbar spinal stenosis
45396|NCT03918512|LSS specific activity limitation|lss specific activity limitation
45397|NCT03918512|development and validation of new questionaire|development and validation of new questionaire
45398|NCT03918473|Functional Performance|functional performance
45399|NCT03918473|Manual Therapy|manual therapy
45400|NCT03918447|Bardoxolone Methyl|bardoxolone methyl
45401|NCT03918447|RTA 402|rta 402
45402|NCT03918447|Autosomal Dominant Polycystic Kidney Disease|autosomal dominant polycystic kidney disease
45403|NCT03918447|ADPKD|adpkd
45404|NCT03918434|tibial nerve block|tibial nerve block
45405|NCT03918382|Patient-Reported Outcome|patient-reported outcome
45406|NCT03918382|Quality of life|quality of life
45407|NCT03918382|Electronic reporting of symptoms|electronic reporting of symptoms
45408|NCT03918382|Radiotherapy|radiotherapy
45409|NCT03918369|Right Colon Cancer,|right colon cancer,
45410|NCT03918369|Right hemicolectomy|right hemicolectomy
45411|NCT03918369|Laparoscopic right hemicolectomy|laparoscopic right hemicolectomy
45412|NCT03918369|Intracorporeal anastomosis|intracorporeal anastomosis
45413|NCT03918291|Muscle strength|muscle strength
45414|NCT03918291|Squat|squat
45415|NCT03918291|Brain derived neurotrophic factor|brain derived neurotrophic factor
45416|NCT03918291|Osteoarthritis of knee|osteoarthritis of knee
45417|NCT03918291|Whole-body vibration|whole-body vibration
45418|NCT03918291|Elderly|elderly
45419|NCT03918265|Tacrolimus|tacrolimus
45420|NCT03918265|Refractory autoimmune cytopenia|refractory autoimmune cytopenia
45421|NCT03918265|Prospective study|prospective study
45422|NCT03918252|malignant|malignant
45423|NCT03918252|resectable|resectable
45424|NCT03918213|high-resolution anorectal manometry|high-resolution anorectal manometry
45425|NCT03918213|solid-state catheter|solid-state catheter
45426|NCT03918213|healthy population|healthy population
45427|NCT03918213|Russian population|russian population
45430|NCT03918161|Interstitial fibrosis|interstitial fibrosis
45431|NCT03918161|Tubular atrophy Renal transplantation|tubular atrophy renal transplantation
45432|NCT03918161|Renal allograft|renal allograft
45433|NCT03918161|Magnetic Resonance Imaging|magnetic resonance imaging
45434|NCT03918161|Elastography|elastography
45435|NCT03918161|non-invasive diagnosis|non-invasive diagnosis
45436|NCT03918135|fever, emergency department, paracetamol, ibuprofen, upper respiratory infection|fever, emergency department, paracetamol, ibuprofen, upper respiratory infection
45437|NCT03918122|Preceptor|preceptor
45441|NCT03918096|vaccin|vaccin
45442|NCT03918044|Obesity|obesity
45443|NCT03918044|Cesarean Section|cesarean section
45444|NCT03918044|Vaginal Delivery|vaginal delivery
45445|NCT03918044|Elective Cesarean Section|elective cesarean section
45446|NCT03918044|Non-elective Cesarean Section|non-elective cesarean section
45447|NCT03918031|Psychological Distress|psychological distress
45448|NCT03918031|Tobacco|tobacco
45449|NCT03918031|Smoking|smoking
45450|NCT03918031|Feedback|feedback
45451|NCT03918031|Stress|stress
45452|NCT03918031|Anxiety Disorders|anxiety disorders
45453|NCT03918031|Depression|depression
45454|NCT03918018|Pulse oximetry|pulse oximetry
45455|NCT03917992|Atrial fibrillation|atrial fibrillation
45456|NCT03917979|Music Therapy|music therapy
45457|NCT03917979|Guided Imagery|guided imagery
45458|NCT03917979|Randomized Controlled Trial|randomized controlled trial
45459|NCT03917940|Irisin|irisin
45460|NCT03917940|sirtuin-1|sirtuin-1
45461|NCT03917940|Omega 3 fatty acids|omega 3 fatty acids
45462|NCT03917914|COPD|copd
45463|NCT03917901|Anxiety Disorders|anxiety disorders
45464|NCT03917901|Depression|depression
45465|NCT03917901|Anxiety Sensitivity|anxiety sensitivity
45466|NCT03917901|Obesity|obesity
45467|NCT03917901|Eating|eating
45468|NCT03917901|Physical Activity|physical activity
45469|NCT03917901|Exercise|exercise
45470|NCT03917888|ventilator associated pneumonia|ventilator associated pneumonia
45471|NCT03917888|lung ultrasound|lung ultrasound
45472|NCT03917862|Ascending Aortic Surgery|ascending aortic surgery
45473|NCT03917862|Hemostasis|hemostasis
45474|NCT03917862|Ascending Aortic Dissection|ascending aortic dissection
45475|NCT03917862|Ascending Aorta Aneurysm|ascending aorta aneurysm
45476|NCT03917862|Bleeding|bleeding
45477|NCT03917810|Nutrition|nutrition
45478|NCT03917810|Carbohydrates|carbohydrates
45479|NCT03917810|Ketogenic|ketogenic
45480|NCT03917810|Metabolism|metabolism
45481|NCT03917797|Systemic Lupus Erythematosus|systemic lupus erythematosus
45482|NCT03917797|Mesenchymal Stromal Cells|mesenchymal stromal cells
45483|NCT03917797|Lupus nephritis|lupus nephritis
45484|NCT03917784|Curcumin|curcumin
45485|NCT03917784|Insulin sensitivity|insulin sensitivity
45486|NCT03917784|HOMA|homa
45487|NCT03917771|physiotherapy|physiotherapy
45488|NCT03917758|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors
45489|NCT03917758|Renin-Angiotensin System|renin-angiotensin system
45490|NCT03917758|Vasopressin|vasopressin
45491|NCT03917758|Natriuretic Peptide, Brain|natriuretic peptide, brain
45492|NCT03917758|Blood Pressure|blood pressure
45493|NCT03917758|Body Composition|body composition
45494|NCT03917758|Diabetes Mellitus, Type 2|diabetes mellitus, type 2
45495|NCT03917745|anxiety|anxiety
45496|NCT03917745|depression|depression
45497|NCT03917745|eHealth|ehealth
45498|NCT03917745|mindfulness|mindfulness
45499|NCT03917745|pregnancy distress|pregnancy distress
45500|NCT03917719|Muscular Dystrophies|muscular dystrophies
45501|NCT03917719|Musculoskeletal Diseases|musculoskeletal diseases
45502|NCT03917719|Neuromuscular Diseases|neuromuscular diseases
45503|NCT03917719|DMD|dmd
45504|NCT03917719|dystrophin|dystrophin
45505|NCT03917719|dystrophy|dystrophy
45506|NCT03917719|Duchenne|duchenne
45507|NCT03917667|Sarcopenia|sarcopenia
45513|NCT03917641|Oculoplastic Surgery|oculoplastic surgery
45514|NCT03917641|Khat leaves|khat leaves
45515|NCT03917641|Post operative care|post operative care
45516|NCT03917641|Edema|edema
45517|NCT03917641|Hematoma|hematoma
45518|NCT03917615|pelvic diaphragm, Physiotherapy students, education|pelvic diaphragm, physiotherapy students, education
45519|NCT03917602|Human amniotic membrane; large macular holes|human amniotic membrane; large macular holes
45520|NCT03917589|post-partum|post-partum
45521|NCT03917589|corticosteroids|corticosteroids
45522|NCT03917589|relapse|relapse
45523|NCT03917589|disease modifying drugs (DMD)|disease modifying drugs (dmd)
45524|NCT03917563|atrial fibrillation|atrial fibrillation
45525|NCT03917550|Transdiagnostic|transdiagnostic
45526|NCT03917550|Cognitive behavioural therapy (CBT)|cognitive behavioural therapy (cbt)
45527|NCT03917550|Depression|depression
45528|NCT03917550|Anxiety|anxiety
45529|NCT03917537|programmed death 1 (PD-1)|programmed death 1 (pd-1)
45530|NCT03917537|programmed death ligand 1 (PD-1)|programmed death ligand 1 (pd-1)
45531|NCT03917537|Nivolumab|nivolumab
45532|NCT03917537|Pembrolizumab|pembrolizumab
45533|NCT03917537|immune-related adverse events (irAEs)|immune-related adverse events (iraes)
45534|NCT03917537|whole-genome sequencing (WGS)|whole-genome sequencing (wgs)
45535|NCT03917537|Circulating tumor cells (CTCs)|circulating tumor cells (ctcs)
45536|NCT03917537|Platinum-refractory|platinum-refractory
45537|NCT03917524|Oral Cavity Cancer|oral cavity cancer
45538|NCT03917524|Circulating Tumor Cells|circulating tumor cells
45539|NCT03917524|Whole-genome analysis|whole-genome analysis
45540|NCT03917524|transcriptomes|transcriptomes
45541|NCT03917524|distant metastasis|distant metastasis
45542|NCT03917524|locoregional recurrence|locoregional recurrence
45543|NCT03917524|second primary tumor|second primary tumor
45544|NCT03917511|Stroke|stroke
45545|NCT03917511|Mirror therapy|mirror therapy
45546|NCT03917511|Robotic Training|robotic training
45547|NCT03917511|Neurorehabilitation|neurorehabilitation
45548|NCT03917498|radiation therapy|radiation therapy
45549|NCT03917472|Diabetic Macular Edema|diabetic macular edema
45550|NCT03917472|intravitreal injection|intravitreal injection
45551|NCT03917472|brolucizumab|brolucizumab
45552|NCT03917472|aflibercept|aflibercept
45553|NCT03917472|double-masked|double-masked
45554|NCT03917459|heart failure|heart failure
45555|NCT03917459|systolic heart failure|systolic heart failure
45556|NCT03917459|heart failure with reduced ejection fraction|heart failure with reduced ejection fraction
45557|NCT03917459|erectile dysfunction|erectile dysfunction
45558|NCT03917459|Enalapril|enalapril
45559|NCT03917459|Enalaprilat|enalaprilat
45560|NCT03917459|LCZ696|lcz696
45561|NCT03917459|Sacubitril/valsartan|sacubitril/valsartan
45562|NCT03917433|exposure therapy|exposure therapy
45563|NCT03917433|virtual reality|virtual reality
45564|NCT03917433|acrophobia|acrophobia
45565|NCT03917433|fear of heights|fear of heights
45566|NCT03917407|Alcoholic Hepatitis|alcoholic hepatitis
45567|NCT03917407|Alcoholic Liver Disease|alcoholic liver disease
45568|NCT03917394|THA/TKA|tha/tka
45569|NCT03917394|Perioperative anemia|perioperative anemia
45570|NCT03917394|rHuEPO|rhuepo
45571|NCT03917394|iron sucrose|iron sucrose
45572|NCT03917368|Jugular Venous Pulse|jugular venous pulse
45573|NCT03917368|Central Venous Pressure|central venous pressure
45574|NCT03917368|Ultrasounds|ultrasounds
45575|NCT03917368|Validation Studies|validation studies
45576|NCT03917368|Software Validation|software validation
45577|NCT03917329|Parents|parents
45578|NCT03917329|Education staff|education staff
45579|NCT03917329|Teachers|teachers
45580|NCT03917329|Intellectual Disability|intellectual disability
45581|NCT03917329|Learning Disability|learning disability
45582|NCT03917329|Positive Behaviour Support|positive behaviour support
45583|NCT03917329|Acceptance and Commitment Therapy|acceptance and commitment therapy
45584|NCT03917329|Group Therapy|group therapy
45585|NCT03917329|Children|children
45586|NCT03917329|Psychological Distress|psychological distress
45587|NCT03917277|Erysipelas-like erythema|erysipelas-like erythema
45588|NCT03917277|Familial Mediterranean Fever|familial mediterranean fever
45589|NCT03917277|Musculoskeletal ultrasound|musculoskeletal ultrasound
45590|NCT03917264|implant|implant
45591|NCT03917264|titanium|titanium
45592|NCT03917264|dental|dental
45593|NCT03917251|coronary microvascular dysfunction|coronary microvascular dysfunction
45594|NCT03917212|Organic acidemias|organic acidemias
45595|NCT03917212|Mitochondria|mitochondria
45596|NCT03917212|Oxidative stress|oxidative stress
45597|NCT03917212|Fatty liver|fatty liver
45598|NCT03917212|Dyslipidemia|dyslipidemia
45599|NCT03917199|myocardial perfusion imaging|myocardial perfusion imaging
45600|NCT03917199|computed tomography perfusion|computed tomography perfusion
45601|NCT03917199|regadenoson|regadenoson
45602|NCT03917199|dynamic perfusion|dynamic perfusion
45603|NCT03917199|coronary artery disease|coronary artery disease
45604|NCT03917186|Desflurane, Sevoflurane, Endovascular aortic repair|desflurane, sevoflurane, endovascular aortic repair
45605|NCT03917173|gastric cancer|gastric cancer
45606|NCT03917173|HIPEC CO2|hipec co2
45607|NCT03917173|Prophylactic surgery|prophylactic surgery
45608|NCT03917173|hyperthermic intraperitoneal chemotherapy|hyperthermic intraperitoneal chemotherapy
45609|NCT03917147|Endometrial Hyperplasia|endometrial hyperplasia
45610|NCT03917147|Office Hysteroscopy|office hysteroscopy
45611|NCT03917147|Predictive values|predictive values
45612|NCT03917147|Sensitivity|sensitivity
45613|NCT03917121|Jet anesthesia|jet anesthesia
45614|NCT03917121|Pressure anesthesia|pressure anesthesia
45615|NCT03917121|Needle-free anesthesia|needle-free anesthesia
45616|NCT03917121|Needle-less anesthesia|needle-less anesthesia
45617|NCT03917121|Needle-free injection|needle-free injection
45618|NCT03917121|Jet injection|jet injection
45619|NCT03917121|Needle-less local anesthesia|needle-less local anesthesia
45620|NCT03917121|Needle-less syringe|needle-less syringe
45621|NCT03917121|Needle infiltration anesthesia|needle infiltration anesthesia
45622|NCT03917121|Needle injection|needle injection
45623|NCT03917121|Local infiltration anesthesia|local infiltration anesthesia
45624|NCT03917121|Local anesthesia|local anesthesia
45625|NCT03917121|Pulpotomy|pulpotomy
45626|NCT03917121|Vital pulp therapy|vital pulp therapy
45627|NCT03917121|Primary molars|primary molars
45628|NCT03917121|Child patients|child patients
45629|NCT03917121|Pediatric patients|pediatric patients
45630|NCT03917121|Children|children
45631|NCT03917095|Inflammatory Bowel Disease|inflammatory bowel disease
45632|NCT03917095|Transendoscopic Enteral Tubing|transendoscopic enteral tubing
45633|NCT03917095|Mesalazine|mesalazine
45634|NCT03917095|Compound Glutamine|compound glutamine
45635|NCT03917082|endocrine therapy|endocrine therapy
45636|NCT03917069|nab-paclitaxel|nab-paclitaxel
45637|NCT03917069|carboplatin|carboplatin
45638|NCT03917069|endostatin|endostatin
45639|NCT03917069|melanoma|melanoma
45640|NCT03917056|Cap-assisted endoscopic sclerotherapy|cap-assisted endoscopic sclerotherapy
45641|NCT03917056|Internal Hemorrhoid|internal hemorrhoid
45642|NCT03917056|Rectal Prolapse|rectal prolapse
45643|NCT03917017|radiomics|radiomics
45644|NCT03917017|Watson artificial intelligence|watson artificial intelligence
45645|NCT03917017|hepatocellular carcinoma|hepatocellular carcinoma
45646|NCT03917017|surgical decisions|surgical decisions
45647|NCT03917017|prognosis|prognosis
45648|NCT03917004|controlled hypotension|controlled hypotension
45649|NCT03917004|cardiac output on|cardiac output on
45650|NCT03917004|blood loss|blood loss
45651|NCT03917004|surgical field|surgical field
45652|NCT03917004|oxygen supply|oxygen supply
45653|NCT03917004|oxygen consumption|oxygen consumption
45654|NCT03916978|Ovarian rejuvenation|ovarian rejuvenation
45655|NCT03916978|Ovarian reactivation; ovulation|ovarian reactivation; ovulation
45656|NCT03916965|dissection of the superior mesenteric artery|dissection of the superior mesenteric artery
45657|NCT03916965|patency of stents|patency of stents
45658|NCT03916965|remodeling|remodeling
45659|NCT03916926|Dental Caries|dental caries
45660|NCT03916926|Oral Health Quality of Life|oral health quality of life
45661|NCT03916913|Non small cell lung cancer|non small cell lung cancer
45662|NCT03916913|Oligo-metastasis|oligo-metastasis
45663|NCT03916913|EGFR activating mutation|egfr activating mutation
45664|NCT03916913|Radiotherapy|radiotherapy
45665|NCT03916900|Pulpotomy|pulpotomy
45666|NCT03916900|Root canal treatment|root canal treatment
45667|NCT03916900|Mature|mature
45668|NCT03916900|Cariously exposed|cariously exposed
45669|NCT03916900|Permanent molars|permanent molars
45670|NCT03916900|Irreversible pulpitis|irreversible pulpitis
45671|NCT03916887|aging, exercise golf senior intervention|aging, exercise golf senior intervention
45672|NCT03916861|Hemodialysis|hemodialysis
45673|NCT03916861|BIA|bia
45674|NCT03916861|Acute Kidney Injury|acute kidney injury
45675|NCT03916848|Stereoelectroencephalography|stereoelectroencephalography
45676|NCT03916848|Single unit recording|single unit recording
45677|NCT03916848|Single neuron recording|single neuron recording
45678|NCT03916848|SEEG|seeg
45679|NCT03916848|Epilepsy surgery|epilepsy surgery
45680|NCT03916835|Pediatric Critical ill care or intensive care|pediatric critical ill care or intensive care
45681|NCT03916835|anxiety|anxiety
45682|NCT03916835|pain|pain
45683|NCT03916822|Antibody mediated Rejection|antibody mediated rejection
45684|NCT03916822|Renal Transplantation|renal transplantation
45685|NCT03916822|Adults|adults
45686|NCT03916822|CD154|cd154
45687|NCT03916822|B-cells|b-cells
45688|NCT03916822|B-cell subsets|b-cell subsets
45689|NCT03916822|alloantigen-specific|alloantigen-specific
45690|NCT03916809|oropharyngeal cancer|oropharyngeal cancer
45691|NCT03916809|laryngeal cancer|laryngeal cancer
45692|NCT03916809|swallow|swallow
45693|NCT03916809|chemoradiation|chemoradiation
45694|NCT03916809|expiratory muscle strength training|expiratory muscle strength training
45695|NCT03916783|Suubi|suubi
45696|NCT03916783|Youth|youth
45697|NCT03916783|Poverty|poverty
45698|NCT03916783|Economic Empowerment Interventions|economic empowerment interventions
45699|NCT03916783|Epidemiology|epidemiology
45700|NCT03916783|Access to Treatment Services|access to treatment services
45701|NCT03916783|Treatment Adherence|treatment adherence
45702|NCT03916783|Uganda|uganda
45703|NCT03916770|muscle|muscle
45704|NCT03916770|vibration|vibration
45705|NCT03916770|H reflex|h reflex
45706|NCT03916770|H/M ratio|h/m ratio
45707|NCT03916770|spasticity|spasticity
45708|NCT03916757|Brain cancer|brain cancer
45709|NCT03916731|Hemodialysis|hemodialysis
45710|NCT03916731|Vascular Access|vascular access
45711|NCT03916731|Arterio-Venous Grafts (AVG)|arterio-venous grafts (avg)
45712|NCT03916705|Back Pain|back pain
45713|NCT03916705|Ultrasound|ultrasound
45714|NCT03916705|Fascia|fascia
45715|NCT03916679|Ovarian Cancer|ovarian cancer
45716|NCT03916679|CAR-T|car-t
45717|NCT03916679|MESO|meso
45718|NCT03916679|Relapsed and Refractory|relapsed and refractory
45719|NCT03916627|NSCLC|nsclc
45720|NCT03916627|HCC|hcc
45721|NCT03916627|HNSCC|hnscc
45722|NCT03916627|Resectable|resectable
45723|NCT03916562|Walking|walking
45724|NCT03916562|Gait|gait
45725|NCT03916562|Stability|stability
45726|NCT03916562|Energetic cost|energetic cost
45727|NCT03916536|Holmium Laser|holmium laser
45728|NCT03916536|Thulium Laser|thulium laser
45729|NCT03916536|Bipolar diathermy|bipolar diathermy
45730|NCT03916536|prostate enucleation|prostate enucleation
45731|NCT03916523|Sustained lung inflation|sustained lung inflation
45732|NCT03916523|Lung injury|lung injury
45733|NCT03916523|Delivery room management|delivery room management
45734|NCT03916523|CPAP|cpap
45735|NCT03916510|locally advanced|locally advanced
45736|NCT03916510|rectal cancer|rectal cancer
45737|NCT03916510|Enadenotucirev|enadenotucirev
45738|NCT03916510|oncolytic virus|oncolytic virus
45739|NCT03916510|adenovirus|adenovirus
45740|NCT03916510|dose escalation|dose escalation
45741|NCT03916510|Time To Event Continual Reassessment Method|time to event continual reassessment method
45742|NCT03916510|chemoradiotherapy|chemoradiotherapy
45743|NCT03916510|phase 1|phase 1
45744|NCT03916471|Stress Urinary Incontinence|stress urinary incontinence
45745|NCT03916458|Carcinoma, Renal Cell|carcinoma, renal cell
45746|NCT03916458|Disease-Free Survival|disease-free survival
45747|NCT03916458|Sunitinib|sunitinib
45748|NCT03916458|Protein Kinase Inhibitors|protein kinase inhibitors
45749|NCT03916458|Angiogenesis Inhibitors|angiogenesis inhibitors
45750|NCT03916458|Prognosis|prognosis
45751|NCT03916393|PF-06651600|pf-06651600
45752|NCT03916393|Palatability|palatability
45753|NCT03916393|Bitrex|bitrex
45754|NCT03916393|Taste Study|taste study
45755|NCT03916380|Tacrolimus|tacrolimus
45756|NCT03916380|Grapefruit Juice|grapefruit juice
45757|NCT03916380|CYP3A4|cyp3a4
45758|NCT03916380|Midazolam|midazolam
45759|NCT03916380|Kidney Transplant|kidney transplant
45760|NCT03916367|radioactive iodine-125 seeds implantation|radioactive iodine-125 seeds implantation
45761|NCT03916367|non-small cell lung cancer|non-small cell lung cancer
45762|NCT03916367|early stage|early stage
45763|NCT03916341|e-cigarettes|e-cigarettes
45764|NCT03916341|tobacco cigarettes|tobacco cigarettes
45765|NCT03916341|nicotine|nicotine
45766|NCT03916341|ventricular repolarization|ventricular repolarization
45767|NCT03916315|General Anxiety Disorder|general anxiety disorder
45768|NCT03916315|Social Anxiety Disorder|social anxiety disorder
45769|NCT03916315|Specific Phobia|specific phobia
45770|NCT03916315|Obsessive Compulsive Disorder|obsessive compulsive disorder
45771|NCT03916315|posttraumatic stress disorder|posttraumatic stress disorder
45772|NCT03916302|acute pulmonary embolism|acute pulmonary embolism
45773|NCT03916276|Chronic Pain|chronic pain
45774|NCT03916276|Opioid|opioid
45775|NCT03916276|Heterogeneous Pain|heterogeneous pain
45776|NCT03916276|Musculoskeletal Pain|musculoskeletal pain
45777|NCT03916276|Mindfulness Meditation|mindfulness meditation
45778|NCT03916276|Behavioral Activation|behavioral activation
45779|NCT03916276|Cognitive Therapy|cognitive therapy
45780|NCT03916276|Telehealth|telehealth
45781|NCT03916276|Opioid Misuse|opioid misuse
45782|NCT03916276|Mechanisms|mechanisms
45783|NCT03916263|PCOS|pcos
45784|NCT03916263|Diet|diet
45785|NCT03916263|Video Instruction|video instruction
45786|NCT03916237|medical legal partnership|medical legal partnership
45787|NCT03916237|urban health services|urban health services
45788|NCT03916237|urban health|urban health
45789|NCT03916224|Intubation|intubation
45790|NCT03916224|Airway management|airway management
45791|NCT03916211|stem cells|stem cells
45792|NCT03916198|healing|healing
45793|NCT03916198|fatty degeneration|fatty degeneration
45794|NCT03916198|retear|retear
45795|NCT03916172|Adolescence|adolescence
45796|NCT03916172|Stress|stress
45797|NCT03916172|Parent-adolescent relationship|parent-adolescent relationship
45798|NCT03916159|extrauterine placental transfusion|extrauterine placental transfusion
45799|NCT03916159|delayed cord clamping|delayed cord clamping
45800|NCT03916159|neonatal resuscitation|neonatal resuscitation
45801|NCT03916107|Ptosis|ptosis
45802|NCT03916107|Frontalis flap|frontalis flap
45803|NCT03916094|overexpressing HER2|overexpressing her2
45804|NCT03916055|Tourette syndrome|tourette syndrome
45805|NCT03916055|Tourette|tourette
45806|NCT03916055|Tics|tics
45807|NCT03916055|Behavior therapy|behavior therapy
45808|NCT03916055|ERP|erp
45809|NCT03916055|Internet|internet
45810|NCT03916055|Self-help|self-help
45811|NCT03916029|primary health care|primary health care
45812|NCT03916029|workforce|workforce
45813|NCT03916029|Aboriginal or Torres Strait Islander|aboriginal or torres strait islander
45814|NCT03916029|facilitator|facilitator
45815|NCT03916029|education|education
45816|NCT03916016|Integrated Behavioral Health|integrated behavioral health
45817|NCT03916016|Integrated Care|integrated care
45818|NCT03916016|Volunteer Clinic|volunteer clinic
45819|NCT03915990|diabetes|diabetes
45820|NCT03915990|umbilical artery|umbilical artery
45821|NCT03915990|middle cerebral artery|middle cerebral artery
45822|NCT03915951|lung cancer|lung cancer
45823|NCT03915951|cancer|cancer
45824|NCT03915951|non-small cell lung cancer|non-small cell lung cancer
45825|NCT03915938|Ketamine|ketamine
45826|NCT03915938|ERP|erp
45827|NCT03915938|Oddball|oddball
45828|NCT03915925|right ventricle dysfunction|right ventricle dysfunction
45829|NCT03915925|prediction model|prediction model
45830|NCT03915925|functional outcomes|functional outcomes
45831|NCT03915912|Malignant Glioma|malignant glioma
45832|NCT03915912|Mindfulness|mindfulness
45833|NCT03915912|Dina Randazzo|dina randazzo
45834|NCT03915912|Meditation|meditation
45835|NCT03915873|von willebrand|von willebrand
45836|NCT03915873|egyptian|egyptian
45837|NCT03915873|questionnaire|questionnaire
45838|NCT03915834|Biomarker|biomarker
45839|NCT03915834|Mechanical thrombectomy|mechanical thrombectomy
45840|NCT03915834|Intracerebral Hemorrhage|intracerebral hemorrhage
45841|NCT03915834|Acute Ischemic stroke|acute ischemic stroke
45842|NCT03915795|Kawasaki Disease|kawasaki disease
45843|NCT03915795|coronary artery abnormalities|coronary artery abnormalities
45844|NCT03915795|statins|statins
60775|NCT03824470|TOF|tof
45845|NCT03915782|Ischemic stroke|ischemic stroke
45846|NCT03915782|Mechanical Thrombectomy|mechanical thrombectomy
45847|NCT03915782|Ischemia/Reperfusion|ischemia/reperfusion
45848|NCT03915782|Remote Ischemic Conditioning|remote ischemic conditioning
45849|NCT03915782|Magnetic Resonance Imaging|magnetic resonance imaging
45850|NCT03915769|Ulcerative colitis|ulcerative colitis
45851|NCT03915769|Ozanimod|ozanimod
45852|NCT03915769|colitis|colitis
45853|NCT03915769|Ulcerative|ulcerative
45854|NCT03915756|Knee replacement|knee replacement
45855|NCT03915756|Blood loss|blood loss
45856|NCT03915756|Wound drainage|wound drainage
45857|NCT03915743|Palliative care|palliative care
45858|NCT03915743|Out-patient clinic|out-patient clinic
45859|NCT03915743|COPD symptom burden|copd symptom burden
45860|NCT03915730|Chronic periodontitis|chronic periodontitis
45861|NCT03915730|gingival crevicular fluid|gingival crevicular fluid
45862|NCT03915730|initial periodontal therapy|initial periodontal therapy
45863|NCT03915730|peptidoglycan recognition proteins|peptidoglycan recognition proteins
45864|NCT03915730|smoking|smoking
45865|NCT03915704|pain management|pain management
45866|NCT03915704|intramuscular injection|intramuscular injection
45867|NCT03915704|non-pharmacological method|non-pharmacological method
45868|NCT03915691|Atrial Tachycardia|atrial tachycardia
45869|NCT03915691|Atrial Fibrillation|atrial fibrillation
45870|NCT03915691|Mapping|mapping
45871|NCT03915691|Ablation|ablation
45872|NCT03915678|Immunotherapy|immunotherapy
45873|NCT03915678|Radiotherapy|radiotherapy
45874|NCT03915678|Oncology|oncology
45875|NCT03915678|Metastatic|metastatic
45876|NCT03915652|minority health|minority health
45877|NCT03915652|prevention|prevention
45878|NCT03915652|vaccine|vaccine
45879|NCT03915652|behavior|behavior
45880|NCT03915652|women's health|women's health
45881|NCT03915652|autoimmune|autoimmune
45882|NCT03915652|intervention|intervention
45883|NCT03915652|survey|survey
45884|NCT03915652|QI/QA|qi/qa
45885|NCT03915652|outcomes (health services/delivery)|outcomes (health services/delivery)
45886|NCT03915639|Post-Craniotomy Headache|post-craniotomy headache
45887|NCT03915639|Postoperative Pain|postoperative pain
45888|NCT03915639|Cocktail|cocktail
45889|NCT03915639|Analgesia|analgesia
45890|NCT03915600|Metabolic Syndrome|metabolic syndrome
45891|NCT03915600|Micronuceli|micronuceli
45892|NCT03915600|Quinoa|quinoa
45893|NCT03915600|Flaxseed|flaxseed
45894|NCT03915600|Diet|diet
45895|NCT03915561|postoperative sore throat|postoperative sore throat
45896|NCT03915522|total kee arthroplasty|total kee arthroplasty
45897|NCT03915522|adductor canal block|adductor canal block
45898|NCT03915522|multimodal analgesia|multimodal analgesia
45899|NCT03915509|nanotopography|nanotopography
45900|NCT03915509|osseointegration|osseointegration
45901|NCT03915509|resonance frequency analysis.|resonance frequency analysis.
45902|NCT03915496|atopic dermatitis|atopic dermatitis
45903|NCT03915496|atopic eczema|atopic eczema
45904|NCT03915496|eczema|eczema
45905|NCT03915496|JAK|jak
45906|NCT03915496|janus kinase|janus kinase
45907|NCT03915470|Post-operative|post-operative
45908|NCT03915470|Post-surgical|post-surgical
45909|NCT03915470|Infection prevention|infection prevention
45910|NCT03915470|Staphylococcus aureus|staphylococcus aureus
45911|NCT03915470|MSSA|mssa
45912|NCT03915470|MRSA|mrsa
45913|NCT03915457|Simulated Microgravity|simulated microgravity
45914|NCT03915457|Weightlessness|weightlessness
45915|NCT03915457|Countermeasure|countermeasure
45916|NCT03915457|Dry immersion|dry immersion
45917|NCT03915457|Supportlessness|supportlessness
45918|NCT03915418|Screening|screening
45919|NCT03915418|sleep disorders|sleep disorders
45920|NCT03915418|children|children
45921|NCT03915418|cerebral palsy|cerebral palsy
45922|NCT03915418|connected tools|connected tools
45923|NCT03915392|Diffusion weighted MRI|diffusion weighted mri
45924|NCT03915392|Cholesteatoma|cholesteatoma
45925|NCT03915392|Localization|localization
45926|NCT03915353|Noise|noise
45927|NCT03915353|Balance|balance
45928|NCT03915353|Quality of Life|quality of life
45929|NCT03915340|propafenone|propafenone
45930|NCT03915340|bioequivalence|bioequivalence
45931|NCT03915340|Rytmonorm|rytmonorm
45932|NCT03915327|Iron-deficiency anemia|iron-deficiency anemia
45933|NCT03915327|Intravenous iron dextran|intravenous iron dextran
45934|NCT03915327|Preoperative|preoperative
45935|NCT03915314|delirium|delirium
45936|NCT03915314|blood biomakers|blood biomakers
45937|NCT03915314|endothelial dysfunction|endothelial dysfunction
45938|NCT03915314|blood brain barrier (BBB)|blood brain barrier (bbb)
45939|NCT03915288|Cancer|cancer
45940|NCT03915288|Aerobic exercise|aerobic exercise
45941|NCT03915288|High intensity training|high intensity training
45942|NCT03915288|Force|force
45943|NCT03915249|Energy metabolism|energy metabolism
45944|NCT03915249|Exercise test|exercise test
45945|NCT03915249|Leisure activities|leisure activities
45946|NCT03915249|Hematopoietic stem cell transplantation|hematopoietic stem cell transplantation
45947|NCT03915249|Muscle strength|muscle strength
45948|NCT03915249|Respiratory function test|respiratory function test
45949|NCT03915249|Exercise|exercise
45950|NCT03915236|MON4STRAT|mon4strat
45951|NCT03915236|Treatment Drug Monitoring|treatment drug monitoring
45952|NCT03915236|Antibiotic Resistance|antibiotic resistance
45953|NCT03915236|Beta-Lactams Resistance|beta-lactams resistance
45954|NCT03915236|Meropenem|meropenem
45955|NCT03915236|Health Care-Asociated Infection|health care-asociated infection
45956|NCT03915223|preoperative procedure|preoperative procedure
45957|NCT03915223|leg fractures|leg fractures
45958|NCT03915223|osteosynthesis|osteosynthesis
45959|NCT03915223|corticosteroids|corticosteroids
45960|NCT03915210|Energy metabolism|energy metabolism
45961|NCT03915210|Exercise|exercise
45962|NCT03915210|respiratory function test|respiratory function test
45963|NCT03915210|quality of life|quality of life
45964|NCT03915210|leisure activities|leisure activities
45965|NCT03915210|hematopoietic stem cell transplantation|hematopoietic stem cell transplantation
45966|NCT03915197|allergic asthma|allergic asthma
45967|NCT03915197|acute bronchiolitis|acute bronchiolitis
45968|NCT03915197|allergic sensitization|allergic sensitization
45969|NCT03915197|-risk factor|-risk factor
45970|NCT03915184|CAR-T|car-t
45971|NCT03915184|Carcinoma|carcinoma
45972|NCT03915184|Carcinoma, Multiple Myeloma|carcinoma, multiple myeloma
45973|NCT03915171|NGS bMSI Gastrointestinal|ngs bmsi gastrointestinal
45974|NCT03915132|VMAT|vmat
45975|NCT03915132|Nimotuzumab|nimotuzumab
45976|NCT03915132|Elderly Patients|elderly patients
45977|NCT03915132|efficacy|efficacy
45978|NCT03915132|toxicity|toxicity
45979|NCT03915106|scoliosis|scoliosis
45980|NCT03915106|adolescent idiopathic scoliosis|adolescent idiopathic scoliosis
45981|NCT03915106|bracing|bracing
45982|NCT03915106|surgery|surgery
45983|NCT03915106|quality of life|quality of life
45984|NCT03915106|questionnaire|questionnaire
45985|NCT03915093|Thoracoscopy|thoracoscopy
45986|NCT03915093|Educational nursing protocol|educational nursing protocol
45987|NCT03915093|Quality of life|quality of life
45988|NCT03915041|virtual reality|virtual reality
45989|NCT03915041|brain stimulation|brain stimulation
45990|NCT03915041|tDCS|tdcs
45991|NCT03915041|phenomenology|phenomenology
45992|NCT03915028|Multiple sclerosis|multiple sclerosis
45993|NCT03915028|Spa treatment|spa treatment
45994|NCT03915028|Crenotherapy|crenotherapy
45995|NCT03915028|Balneotherapy|balneotherapy
45996|NCT03915028|Physical exercise|physical exercise
45997|NCT03914989|Memory preservation|memory preservation
45998|NCT03914989|Age-related memory disorders|age-related memory disorders
45999|NCT03914989|Intervention|intervention
46000|NCT03914989|Life quality|life quality
46001|NCT03914989|Olfaction|olfaction
46002|NCT03914976|high-risk digestive surgery|high-risk digestive surgery
46003|NCT03914976|intensive care unit|intensive care unit
46004|NCT03914963|Fibrin Tissue Adhesive|fibrin tissue adhesive
46005|NCT03914963|Lymph node dissection|lymph node dissection
46006|NCT03914950|TOF-18F-FDG PET/CT|tof-18f-fdg pet/ct
46007|NCT03914950|pancreatic lesions|pancreatic lesions
46008|NCT03914924|Diabetes Mellitus|diabetes mellitus
46009|NCT03914924|Exercise|exercise
46010|NCT03914924|Health Education|health education
46011|NCT03914924|Patient Education|patient education
46012|NCT03914924|Randomized Controlled Trial|randomized controlled trial
46013|NCT03914898|burnout|burnout
46014|NCT03914898|compassion fatigue|compassion fatigue
46015|NCT03914898|nursing|nursing
46016|NCT03914898|psychological distress|psychological distress
46017|NCT03914820|colorectal cancer, HIPEC CO2, prophylactic surgery , mitomycin|colorectal cancer, hipec co2, prophylactic surgery , mitomycin
46018|NCT03914807|milk|milk
46019|NCT03914807|fat|fat
46020|NCT03914807|cohort-embedded|cohort-embedded
46021|NCT03914794|Bladder Cancer|bladder cancer
46022|NCT03914794|Non Muscle Invasive Bladder Cancer|non muscle invasive bladder cancer
46023|NCT03914794|Non-Muscle Invasive Bladder Cancer (NMIBC)|non-muscle invasive bladder cancer (nmibc)
46024|NCT03914794|NMIBC|nmibc
46025|NCT03914794|Urothelial Carcinoma|urothelial carcinoma
46026|NCT03914794|Urothelial Cancer|urothelial cancer
46027|NCT03914794|Urinary Bladder Neoplasm|urinary bladder neoplasm
46028|NCT03914794|Bladder Neoplasm|bladder neoplasm
46029|NCT03914794|Fibroblast inhibitors|fibroblast inhibitors
46030|NCT03914794|Pemigatinib|pemigatinib
46031|NCT03914794|FGFR inhibitor|fgfr inhibitor
46032|NCT03914781|Scleroderma|scleroderma
46033|NCT03914781|Systemic Sclerosis|systemic sclerosis
46034|NCT03914781|Self-management|self-management
46035|NCT03914781|E-health|e-health
46036|NCT03914781|Intervention|intervention
46037|NCT03914768|DC vaccine therapy|dc vaccine therapy
46038|NCT03914768|DIPG|dipg
46039|NCT03914768|GBM|gbm
46046|NCT03914716|Radiogenomics|radiogenomics
46047|NCT03914716|Arthropathy|arthropathy
46048|NCT03914677|Spinal Cord Injuries|spinal cord injuries
46049|NCT03914677|autonomic dysreflexia|autonomic dysreflexia
46050|NCT03914677|mecamylamine|mecamylamine
46051|NCT03914586|Sepsis|sepsis
46052|NCT03914586|Acute Renal Failure|acute renal failure
46053|NCT03914586|Extra Corporeal Therapy|extra corporeal therapy
46054|NCT03914573|health|health
46055|NCT03914573|football|football
46056|NCT03914573|pain|pain
46057|NCT03914573|obesity|obesity
46058|NCT03914521|hip surgery|hip surgery
46059|NCT03914521|bone mineral density|bone mineral density
46060|NCT03914521|femoral head|femoral head
46061|NCT03914521|Pre-surgical prognostic|pre-surgical prognostic
46062|NCT03914508|Overweight|overweight
46063|NCT03914508|Obesity|obesity
46064|NCT03914508|Overeating|overeating
46065|NCT03914508|Body Mass Index|body mass index
46066|NCT03914508|Weight|weight
46067|NCT03914508|Treatment|treatment
46068|NCT03914508|Cravings|cravings
46069|NCT03914508|Intervention|intervention
46070|NCT03914508|Behavioral Treatment|behavioral treatment
46071|NCT03914495|inulin|inulin
46072|NCT03914495|microbiome|microbiome
46073|NCT03914495|hepatic steatosis|hepatic steatosis
46074|NCT03914495|obesity|obesity
46075|NCT03914456|Spinal Cord Injury|spinal cord injury
46076|NCT03914456|Motor rehabilitation|motor rehabilitation
46077|NCT03914456|Sensorimotor reorganization|sensorimotor reorganization
46078|NCT03914456|Robotic|robotic
46079|NCT03914456|Functional magnetic resonance imaging|functional magnetic resonance imaging
46080|NCT03914443|Esophageal squamous cell carcinoma|esophageal squamous cell carcinoma
46081|NCT03914443|Neoadjuvant chemotherapy|neoadjuvant chemotherapy
46082|NCT03914443|Nivolumab|nivolumab
46083|NCT03914443|JCOG|jcog
46084|NCT03914430|Breakfast|breakfast
46085|NCT03914430|Blood glucose|blood glucose
46086|NCT03914430|Food intake|food intake
46087|NCT03914430|Satiety|satiety
46088|NCT03914417|Actinic Keratosis|actinic keratosis
46089|NCT03914378|Radiotherapy|radiotherapy
46090|NCT03914365|Circumcision|circumcision
46091|NCT03914365|Penile block|penile block
46092|NCT03914365|Pudendal block|pudendal block
46093|NCT03914365|Pediatric|pediatric
46094|NCT03914352|Hepatocellular carcinoma|hepatocellular carcinoma
46095|NCT03914352|Portal vein tumor thrombus|portal vein tumor thrombus
46096|NCT03914352|Hepatic resection|hepatic resection
46097|NCT03914352|Recurrence|recurrence
46098|NCT03914352|PD-1 antibody|pd-1 antibody
46099|NCT03914313|Lokomat|lokomat
46100|NCT03914313|Robotic rehab|robotic rehab
46101|NCT03914313|Executive function|executive function
46102|NCT03914313|VR|vr
46103|NCT03914274|Sport Injury; Technical socks; Temperature; Hiking|sport injury; technical socks; temperature; hiking
46104|NCT03914261|Expanded Access|expanded access
46105|NCT03914261|Pre-approval Access|pre-approval access
46106|NCT03914261|Compassionate Use|compassionate use
46107|NCT03914261|Special Access Program|special access program
46108|NCT03914261|Named Patient Basis|named patient basis
46109|NCT03914261|Special Access Scheme|special access scheme
46110|NCT03914235|Tumescent anesthesia|tumescent anesthesia
46111|NCT03914235|tenosynovitis|tenosynovitis
46112|NCT03914235|Visual Analog Scale|visual analog scale
46113|NCT03914235|Tourniquets|tourniquets
46114|NCT03914235|Epinephrine|epinephrine
46115|NCT03914170|colorectal cancer|colorectal cancer
46116|NCT03914170|first line|first line
46117|NCT03914170|folfirinox + cetuximab|folfirinox + cetuximab
46118|NCT03914144|catether|catether
46119|NCT03914144|pregnancy|pregnancy
46120|NCT03914144|postnatal infection|postnatal infection
46127|NCT03914066|overweight|overweight
46128|NCT03914066|obesity|obesity
46129|NCT03914066|group treatment|group treatment
46130|NCT03914066|primary care|primary care
46131|NCT03914014|connective tissue massage|connective tissue massage
46132|NCT03914014|massage|massage
46133|NCT03914014|menstrual pain|menstrual pain
46134|NCT03914014|treatment|treatment
46135|NCT03914001|Non muscle invasive bladder cancer|non muscle invasive bladder cancer
46136|NCT03914001|multiparametric magnetic resonance imaging|multiparametric magnetic resonance imaging
46137|NCT03914001|second resection|second resection
46138|NCT03913988|Dreaming|dreaming
46139|NCT03913988|Sleep|sleep
46140|NCT03913988|Dream|dream
46141|NCT03913962|Paediatric|paediatric
46142|NCT03913962|Auto-immunity|auto-immunity
46143|NCT03913962|Treatment|treatment
46144|NCT03913962|Physical Activity|physical activity
46145|NCT03913949|APG-2575|apg-2575
46146|NCT03913949|B-cell lymphoma 2 (BCL-2)|b-cell lymphoma 2 (bcl-2)
46147|NCT03913949|Chronic lymphocytic leukemia|chronic lymphocytic leukemia
46148|NCT03913949|non-hodgkin's lymphoma|non-hodgkin's lymphoma
46149|NCT03913936|Breast Cancer|breast cancer
46150|NCT03913910|Autologous micro-fragmented adipose tissue|autologous micro-fragmented adipose tissue
46151|NCT03913910|Perianal fistula|perianal fistula
46152|NCT03913910|Lipogems|lipogems
46153|NCT03913910|Mesenchymal Stem Cells|mesenchymal stem cells
46154|NCT03913897|acute pain|acute pain
46155|NCT03913897|blood collection|blood collection
46156|NCT03913897|nursing|nursing
46157|NCT03913897|children|children
46158|NCT03913897|distraction|distraction
46159|NCT03913884|Impacted third molar surgery|impacted third molar surgery
46160|NCT03913884|Clinical outcomes|clinical outcomes
46161|NCT03913884|Concentrated growth factor|concentrated growth factor
46162|NCT03913871|mHealth|mhealth
46163|NCT03913871|African American|african american
46164|NCT03913871|Women's Health|women's health
46165|NCT03913871|Minority Health|minority health
46166|NCT03913858|Morbid Obesity|morbid obesity
46167|NCT03913858|Sleeve Gastrectomy|sleeve gastrectomy
46168|NCT03913858|Low Flow Anesthesia|low flow anesthesia
46169|NCT03913780|Exercise|exercise
46170|NCT03913780|Force|force
46171|NCT03913780|Cardiac Rehabilitation|cardiac rehabilitation
46172|NCT03913780|Rehabilitation|rehabilitation
46173|NCT03913780|Heart Failure|heart failure
46174|NCT03913767|Chest pain|chest pain
46175|NCT03913767|Acute coronary syndrom|acute coronary syndrom
46176|NCT03913767|ED triage|ed triage
46177|NCT03913741|tisotumab vedotin|tisotumab vedotin
46178|NCT03913741|cervical cancer|cervical cancer
46179|NCT03913702|Ketorolac|ketorolac
46180|NCT03913702|Methylprednisolone|methylprednisolone
46181|NCT03913702|Subacromial impingement syndrome|subacromial impingement syndrome
46182|NCT03913650|peripheral nerve block|peripheral nerve block
46183|NCT03913650|IL-6|il-6
46184|NCT03913650|post-operative pain|post-operative pain
46185|NCT03913650|limb surgery|limb surgery
46186|NCT03913637|Mild Cognitive Impairment|mild cognitive impairment
46187|NCT03913637|Cognition|cognition
46188|NCT03913637|Disability|disability
46189|NCT03913637|Non-pharmacological Intervention|non-pharmacological intervention
46190|NCT03913637|Behavioral Intervention|behavioral intervention
46191|NCT03913637|Amyloid deposition|amyloid deposition
46192|NCT03913624|Rehabilitation|rehabilitation
46193|NCT03913624|Electric stimulation|electric stimulation
46194|NCT03913624|Upper limb|upper limb
46195|NCT03913624|Aging|aging
46196|NCT03913611|Shoulder arthroscopy|shoulder arthroscopy
46197|NCT03913611|Rotator cuff repair|rotator cuff repair
46198|NCT03913598|social media use|social media use
46199|NCT03913598|online medical services|online medical services
46200|NCT03913598|internet use|internet use
46201|NCT03913585|Tailored lifestyle intervention|tailored lifestyle intervention
46202|NCT03913585|Selective prevention|selective prevention
46203|NCT03913585|Primary care|primary care
46204|NCT03913585|Web based health risk assessment|web based health risk assessment
46205|NCT03913585|Patient-centered health information system|patient-centered health information system
46206|NCT03913559|B-cell Acute Lymphoblastic Leukemia|b-cell acute lymphoblastic leukemia
46207|NCT03913546|neuromuscular properties|neuromuscular properties
46208|NCT03913546|strength|strength
46209|NCT03913546|power|power
46210|NCT03913546|performance|performance
46211|NCT03913533|Newborn|newborn
46212|NCT03913533|Heart rate assessment|heart rate assessment
46213|NCT03913533|Delivery Room|delivery room
46214|NCT03913507|Cystic Fibrosis Children|cystic fibrosis children
46215|NCT03913494|Upper Airway Conditioning|upper airway conditioning
46216|NCT03913494|Snoring|snoring
46217|NCT03913494|Snore|snore
46218|NCT03913494|Sleep|sleep
46219|NCT03913494|OSA|osa
46220|NCT03913494|Sleep Apnea|sleep apnea
46221|NCT03913494|Neurostimulation|neurostimulation
46222|NCT03913481|tissue|tissue
46223|NCT03913481|organ and systemic injury responses to surgery|organ and systemic injury responses to surgery
46224|NCT03913481|trauma|trauma
46225|NCT03913481|burn|burn
46226|NCT03913481|sepsis|sepsis
46227|NCT03913481|hemorrhage|hemorrhage
46228|NCT03913481|ischemia- reperfusion|ischemia- reperfusion
46229|NCT03913481|resuscitation|resuscitation
46230|NCT03913481|including integrating pathways and signals|including integrating pathways and signals
46231|NCT03913481|cardiac surgery|cardiac surgery
46232|NCT03913481|transfusion|transfusion
46233|NCT03913468|ascorbic acid|ascorbic acid
46234|NCT03913468|septic shock|septic shock
46235|NCT03913468|severe sepsis|severe sepsis
46236|NCT03913429|Orthognathic Surgery|orthognathic surgery
46237|NCT03913429|Maxillary nerve blockade|maxillary nerve blockade
46238|NCT03913416|pulmonary malformation|pulmonary malformation
46239|NCT03913416|3D printed models|3d printed models
46240|NCT03913416|thoracotomy|thoracotomy
46241|NCT03913416|thoracoscopy children|thoracoscopy children
46242|NCT03913403|Fluid Management|fluid management
46243|NCT03913403|Sepsis-Induced Hypotension|sepsis-induced hypotension
46244|NCT03913403|Vasopressors|vasopressors
46245|NCT03913403|Cardiac Contractility|cardiac contractility
46246|NCT03913390|guidelines|guidelines
46247|NCT03913390|decision making|decision making
46248|NCT03913390|bioethics|bioethics
46249|NCT03913390|palliative care|palliative care
46250|NCT03913390|end of life|end of life
46251|NCT03913364|obesity|obesity
46252|NCT03913364|breast milk|breast milk
46253|NCT03913364|probiotic|probiotic
46254|NCT03913364|IL-6|il-6
46255|NCT03913364|CRP|crp
46256|NCT03913364|Insulin|insulin
46257|NCT03913364|Adiponectin|adiponectin
46258|NCT03913364|Resistin|resistin
46259|NCT03913364|breastmilk microbiota|breastmilk microbiota
46260|NCT03913364|Bifidobacterium|bifidobacterium
46261|NCT03913312|AML,Elderly patients,Decitabine,Unrelated cord blood|aml,elderly patients,decitabine,unrelated cord blood
46262|NCT03913299|Frailty|frailty
46263|NCT03913299|Cardiac surgery|cardiac surgery
46264|NCT03913299|Vascular surgery|vascular surgery
46265|NCT03913286|neuroprosthetic|neuroprosthetic
46266|NCT03913286|neuroprosthesis|neuroprosthesis
46267|NCT03913286|brain-computer|brain-computer
46268|NCT03913286|brain-machine|brain-machine
46269|NCT03913286|microelectrode|microelectrode
46270|NCT03913286|Utah array|utah array
46271|NCT03913286|orthosis|orthosis
46272|NCT03913286|brain computer interface|brain computer interface
46273|NCT03913286|assistive device|assistive device
46274|NCT03913286|Neurorehabilitation|neurorehabilitation
46275|NCT03913286|neurotechnology|neurotechnology
46276|NCT03913273|Proprioception|proprioception
46277|NCT03913273|Movement|movement
46278|NCT03913273|Joint Prosthesis|joint prosthesis
46279|NCT03913273|Feedback|feedback
46280|NCT03913273|Rehabilitation|rehabilitation
46281|NCT03913234|HR-positive|hr-positive
46282|NCT03913234|HER2-positive|her2-positive
46283|NCT03913234|Breast Cancer|breast cancer
46284|NCT03913234|Hormone-positive|hormone-positive
46285|NCT03913234|CDK4/6 inhibitor|cdk4/6 inhibitor
46286|NCT03913195|HIV|hiv
46287|NCT03913195|ibalizumab|ibalizumab
46288|NCT03913195|MDR HIV|mdr hiv
46289|NCT03913182|Esophageal squamous cell carcinoma|esophageal squamous cell carcinoma
46290|NCT03913182|apatinib|apatinib
46291|NCT03913182|recurrence|recurrence
46292|NCT03913182|metastasis|metastasis
46293|NCT03913169|Interprofessional Education|interprofessional education
46294|NCT03913169|Medical Education|medical education
46295|NCT03913169|Interprofessional Practice|interprofessional practice
46296|NCT03913169|Doctor of Osteopathic Medicine|doctor of osteopathic medicine
46297|NCT03913169|Physician Assistant|physician assistant
46298|NCT03913143|LCA10|lca10
46299|NCT03913143|CEP290|cep290
46300|NCT03913143|p.Cys998X|p.cys998x
46301|NCT03913143|c.2991+1655A>G|c.2991+1655a>g
46302|NCT03913143|Leber's Congenital Amaurosis|leber's congenital amaurosis
46303|NCT03913143|Antisense oligonucleotide|antisense oligonucleotide
46304|NCT03913143|RNA therapy|rna therapy
46305|NCT03913130|LCA10|lca10
46306|NCT03913130|CEP290|cep290
46307|NCT03913130|p.Cys998X|p.cys998x
46308|NCT03913130|c.2991+1655A>G|c.2991+1655a>g
46309|NCT03913130|Leber's Congenital Amaurosis|leber's congenital amaurosis
46310|NCT03913130|Antisense oligonucleotide|antisense oligonucleotide
46311|NCT03913130|RNA therapy|rna therapy
46312|NCT03913117|HPV16|hpv16
46313|NCT03913091|Total Shoulder Arthroplasty (TSA)|total shoulder arthroplasty (tsa)
46314|NCT03913091|Interscalene Nerve Block (ISB)|interscalene nerve block (isb)
46315|NCT03913078|fitness|fitness
46316|NCT03913078|exercise|exercise
46317|NCT03913078|physical activity|physical activity
46318|NCT03913065|Cardiac arrest|cardiac arrest
46319|NCT03913065|Hypothermia|hypothermia
46320|NCT03913065|Neurological function|neurological function
46321|NCT03913065|Cardiovascular disease|cardiovascular disease
46322|NCT03913065|Cerebral oedema|cerebral oedema
46323|NCT03913065|Cerebral edema|cerebral edema
46324|NCT03913065|Cerebral ischaemia|cerebral ischaemia
46325|NCT03913065|Cerebral ischemia|cerebral ischemia
46326|NCT03913065|Gray-white-matter differentiation|gray-white-matter differentiation
46327|NCT03913065|Grey-white-matter differentiation|grey-white-matter differentiation
46328|NCT03913065|ROI|roi
46329|NCT03913065|Regions of interest|regions of interest
46330|NCT03913065|CT|ct
46331|NCT03913065|GWR|gwr
46332|NCT03913065|Neurological prognostication|neurological prognostication
46333|NCT03913026|UM171|um171
46334|NCT03913026|Stem Cell Expansion|stem cell expansion
46335|NCT03913013|Family Therapy|family therapy
46336|NCT03912948|regional analgesia techniques|regional analgesia techniques
46337|NCT03912948|breast cancer surgery|breast cancer surgery
46338|NCT03912948|conservative surgery|conservative surgery
46339|NCT03912935|Rapid sequence induction|rapid sequence induction
46340|NCT03912935|Bed up head elevation|bed up head elevation
46341|NCT03912935|sniffing position|sniffing position
46342|NCT03912935|cricoid pressure|cricoid pressure
46343|NCT03912935|time taken for intubation in seconds|time taken for intubation in seconds
46443|NCT03912207|Tuberculosis|tuberculosis
46348|NCT03912909|Central sympathetic nervous system|central sympathetic nervous system
46349|NCT03912909|Sodium-glucose co-transporter-2 (SGLT2)|sodium-glucose co-transporter-2 (sglt2)
46351|NCT03912896|taekwondo|taekwondo
46352|NCT03912896|Autism Spectrum Disorder|autism spectrum disorder
46353|NCT03912896|occupational therapy|occupational therapy
46354|NCT03912896|Social interaction skills|social interaction skills
46355|NCT03912896|child participants|child participants
46356|NCT03912883|biomarkers|biomarkers
46357|NCT03912883|pathology|pathology
46358|NCT03912883|tissue|tissue
46359|NCT03912883|watchful waiting|watchful waiting
46360|NCT03912883|active surveillance|active surveillance
46361|NCT03912857|mCRC MSI-H|mcrc msi-h
46362|NCT03912844|SIRT|sirt
46363|NCT03912844|liver resection|liver resection
46364|NCT03912844|hypertrophy|hypertrophy
46365|NCT03912844|liver metastases|liver metastases
46366|NCT03912844|liver transplantation|liver transplantation
46367|NCT03912792|Natural History Study|natural history study
46368|NCT03912792|X-Linked Hypohidrotic Ectodermal Dysplasia|x-linked hypohidrotic ectodermal dysplasia
46369|NCT03912779|First time hearing aid user|first time hearing aid user
46370|NCT03912766|transurethral prostatectomy|transurethral prostatectomy
46371|NCT03912766|copeptin|copeptin
46372|NCT03912766|hyponatremia|hyponatremia
46373|NCT03912766|risk prediction|risk prediction
46374|NCT03912727|alpha-lipoic acid|alpha-lipoic acid
46375|NCT03912727|Cardiovascular events|cardiovascular events
46376|NCT03912727|Hemodialysis|hemodialysis
46377|NCT03912714|Appendectomy, Ulcerative Colitis|appendectomy, ulcerative colitis
46378|NCT03912675|Cell transplants|cell transplants
46379|NCT03912675|Autografting|autografting
46380|NCT03912636|cardiac vagal tone|cardiac vagal tone
46381|NCT03912636|deep breathing|deep breathing
46382|NCT03912636|diaphragmatic breathing|diaphragmatic breathing
46383|NCT03912636|vagal nerve|vagal nerve
46384|NCT03912636|vagal tone|vagal tone
46385|NCT03912636|cognitive behavioral therapy|cognitive behavioral therapy
46386|NCT03912636|visceral hypersensitivity|visceral hypersensitivity
46387|NCT03912623|HbA1c|hba1c
46388|NCT03912623|Diabetes|diabetes
46389|NCT03912623|Type 2|type 2
46390|NCT03912610|Osteoarthritis of knee|osteoarthritis of knee
46391|NCT03912610|Depressive Symptoms|depressive symptoms
46392|NCT03912610|Anxiety State|anxiety state
46393|NCT03912610|Brain Structure and Function|brain structure and function
46394|NCT03912610|Multi-mode Magnetic Resonance Imaging|multi-mode magnetic resonance imaging
46395|NCT03912597|virtual reality|virtual reality
46396|NCT03912597|stigma reduction|stigma reduction
46397|NCT03912597|depression|depression
46398|NCT03912597|mental health campaigns|mental health campaigns
46399|NCT03912597|user experience|user experience
46400|NCT03912597|enjoyment|enjoyment
46401|NCT03912597|presence|presence
46402|NCT03912558|BPH|bph
46403|NCT03912558|BOO|boo
46404|NCT03912558|Enlarged prostate|enlarged prostate
46405|NCT03912558|LUTS|luts
46406|NCT03912558|Urinary obstruction|urinary obstruction
46407|NCT03912558|Retrograde ejaculation|retrograde ejaculation
46408|NCT03912545|Viscoelastic testing|viscoelastic testing
46409|NCT03912545|Coagulation|coagulation
46410|NCT03912545|Quantra|quantra
46411|NCT03912545|Hemostasis|hemostasis
46412|NCT03912493|Subacromial Impingement Syndrome|subacromial impingement syndrome
46413|NCT03912493|Physiotherapy and Rehabilitation|physiotherapy and rehabilitation
46414|NCT03912493|Virtual Reality|virtual reality
46415|NCT03912493|Technologic Rehabilitation|technologic rehabilitation
46416|NCT03912428|Myositis|myositis
46417|NCT03912428|PET Imaging|pet imaging
46418|NCT03912376|Blood Flow|blood flow
46419|NCT03912376|Healthy Participant|healthy participant
46420|NCT03912376|Memorial Sloan Kettering Cancer Center|memorial sloan kettering cancer center
46421|NCT03912376|19-098|19-098
46422|NCT03912363|intrapartum|intrapartum
46423|NCT03912363|glycemic control|glycemic control
46424|NCT03912363|diabetes|diabetes
46425|NCT03912363|insulin|insulin
46432|NCT03912324|Atrial fibrillation|atrial fibrillation
46433|NCT03912324|Pulmonary vein isolation|pulmonary vein isolation
46434|NCT03912272|Long-Term Low-Frequency High-Intensity Interval Training|long-term low-frequency high-intensity interval training
46435|NCT03912272|Non-Alcoholic Fatty Liver Disease|non-alcoholic fatty liver disease
46436|NCT03912272|Central Obesity|central obesity
46437|NCT03912272|Body Adiposity|body adiposity
46438|NCT03912272|Liver Fat|liver fat
46439|NCT03912246|sample|sample
46440|NCT03912246|diagnostic|diagnostic
46441|NCT03912207|BCG|bcg
46442|NCT03912207|Aerosol|aerosol
46446|NCT03912129|genetic causes|genetic causes
46447|NCT03912129|immunophenotyping immunologic explorations|immunophenotyping immunologic explorations
46448|NCT03912103|Deprescibing|deprescibing
46449|NCT03912103|Multimorbidity/comorbidity|multimorbidity/comorbidity
46451|NCT03912103|Interdiciplinary intervention|interdiciplinary intervention
46452|NCT03912103|Medication information|medication information
46453|NCT03912103|Motivation|motivation
46454|NCT03912090|pediatric|pediatric
46455|NCT03912090|fentanyl|fentanyl
46456|NCT03912090|intranasal|intranasal
46457|NCT03912090|emergency|emergency
46458|NCT03912077|Refugees|refugees
46459|NCT03912077|Psychological distress|psychological distress
46460|NCT03912077|Psychological trauma|psychological trauma
46461|NCT03912077|Anxiety|anxiety
46462|NCT03912077|CA-CBT|ca-cbt
46463|NCT03912077|Depression|depression
46464|NCT03912077|Post-traumatic stress disorder|post-traumatic stress disorder
46465|NCT03912077|Intervention|intervention
46466|NCT03912077|Turkey|turkey
46467|NCT03912077|Migration|migration
46468|NCT03912064|Myelofibrosis|myelofibrosis
46469|NCT03912064|Chronic Myelomonocytic Leukemia|chronic myelomonocytic leukemia
46470|NCT03912064|Myeloproliferative Neoplasms|myeloproliferative neoplasms
46471|NCT03912064|Myelodysplastic Syndromes|myelodysplastic syndromes
46472|NCT03912064|Acute Myeloid Leukemia|acute myeloid leukemia
46473|NCT03912038|Non-caloric sweeteners|non-caloric sweeteners
46474|NCT03912038|microbiota|microbiota
46475|NCT03912038|breast milk|breast milk
46476|NCT03912038|umbilical cord|umbilical cord
46477|NCT03912012|Diabetes mellitus type 1|diabetes mellitus type 1
46478|NCT03912012|Type 1 diabetes|type 1 diabetes
46479|NCT03912012|diabetes|diabetes
46480|NCT03912012|pediatrics|pediatrics
46481|NCT03912012|Glomerular hyperfiltration|glomerular hyperfiltration
46482|NCT03912012|endothelial dysfunction|endothelial dysfunction
46483|NCT03912012|children|children
46484|NCT03912012|adolescent|adolescent
46485|NCT03911960|tobacco smoking|tobacco smoking
46486|NCT03911960|psychiatric disorder|psychiatric disorder
46487|NCT03911960|psychiatric hospitalization|psychiatric hospitalization
46488|NCT03911960|acceptance and commitment therapy|acceptance and commitment therapy
46489|NCT03911947|Vibroacoustic therapy, acute respiratory failure, pneumonia|vibroacoustic therapy, acute respiratory failure, pneumonia
46490|NCT03911934|Polypharmacy|polypharmacy
46491|NCT03911934|Medication review|medication review
46492|NCT03911934|Randomized|randomized
46493|NCT03911934|Deprescribing|deprescribing
46494|NCT03911921|Fatigue, Cancer|fatigue, cancer
46495|NCT03911908|near-infrared spectroscopy|near-infrared spectroscopy
46496|NCT03911908|cardiopulmonary resuscitation|cardiopulmonary resuscitation
46497|NCT03911908|cardiac arrest|cardiac arrest
46498|NCT03911908|cerebral oximetry|cerebral oximetry
46499|NCT03911882|Fibromyalgia|fibromyalgia
46500|NCT03911882|Cytokines|cytokines
46501|NCT03911882|TNF|tnf
46502|NCT03911882|Substance P|substance p
46503|NCT03911882|Spermine|spermine
46504|NCT03911882|Pain|pain
46505|NCT03911882|Fatigue|fatigue
46509|NCT03911843|omega3|omega3
46510|NCT03911843|T1D remission period|t1d remission period
46511|NCT03911843|honeymoon period|honeymoon period
46512|NCT03911843|AA/EPA ratio|aa/epa ratio
46513|NCT03911830|Rheumatoid Arthritis|rheumatoid arthritis
46514|NCT03911830|Physical exercise|physical exercise
46515|NCT03911830|Cryotherapy|cryotherapy
46516|NCT03911830|Pulse Wave Velocity|pulse wave velocity
46517|NCT03911817|Midodrine|midodrine
46518|NCT03911817|Septic shock|septic shock
46519|NCT03911817|Norepinephrine|norepinephrine
46520|NCT03911817|Weaning|weaning
46521|NCT03911752|Occupational Therapy|occupational therapy
46522|NCT03911752|Sexuality|sexuality
46523|NCT03911752|Acquired Bain Injury|acquired bain injury
46524|NCT03911752|Subacute Stage|subacute stage
46525|NCT03911752|Qualitative Study|qualitative study
46526|NCT03911739|CTN-0080|ctn-0080
46527|NCT03911739|clinical trials network|clinical trials network
46528|NCT03911739|medication assisted treatment|medication assisted treatment
46529|NCT03911739|pharmacokinetics|pharmacokinetics
46530|NCT03911726|PET/MR|pet/mr
46531|NCT03911726|Dopaminergic supersensitivity|dopaminergic supersensitivity
46532|NCT03911726|D2/3 receptor availability|d2/3 receptor availability
46533|NCT03911687|Early warning system|early warning system
46534|NCT03911687|Clinical decision support|clinical decision support
46535|NCT03911687|Predictive analysis|predictive analysis
46536|NCT03911687|Failure to rescue|failure to rescue
46537|NCT03911687|Inter-professional situational awareness|inter-professional situational awareness
46538|NCT03911687|Nursing surveillance|nursing surveillance
46539|NCT03911687|Healthcare process models of clinical concern (HPM-CC)|healthcare process models of clinical concern (hpm-cc)
46540|NCT03911648|Bupivacaine|bupivacaine
46541|NCT03911648|Lidocaine|lidocaine
46542|NCT03911648|Caudal block|caudal block
46543|NCT03911648|Pediatric urologic surgery|pediatric urologic surgery
46544|NCT03911596|Presbyopia, accommodation, smart eyeglasses|presbyopia, accommodation, smart eyeglasses
46545|NCT03911557|mutational burden|mutational burden
46546|NCT03911557|TMB|tmb
46547|NCT03911557|PD-1|pd-1
46548|NCT03911557|CTLA-4|ctla-4
46549|NCT03911557|MEDI4736|medi4736
46550|NCT03911557|durvalumab|durvalumab
46551|NCT03911557|tremelimumab|tremelimumab
46552|NCT03911557|immune therapy|immune therapy
46553|NCT03911557|refractory|refractory
46554|NCT03911544|Neuromuscular Agents|neuromuscular agents
46555|NCT03911544|Bispectral Index|bispectral index
46556|NCT03911531|hydrops|hydrops
46557|NCT03911531|prenatal diagnosis|prenatal diagnosis
46558|NCT03911531|amniocentesis|amniocentesis
46559|NCT03911531|whole genome sequencing|whole genome sequencing
46560|NCT03911518|incision and drainage|incision and drainage
46561|NCT03911518|loop drainage|loop drainage
46562|NCT03911518|soft tissue infection|soft tissue infection
46563|NCT03911518|abscess|abscess
46564|NCT03911505|Pompe|pompe
46565|NCT03911505|rhGAA|rhgaa
46566|NCT03911492|SCI|sci
46567|NCT03911492|Spinal Cord Injury|spinal cord injury
46568|NCT03911492|CSF|csf
46569|NCT03911492|Biomarker|biomarker
46570|NCT03911492|CSF pressure|csf pressure
46571|NCT03911492|Traumatic SCI|traumatic sci
46572|NCT03911492|Perfusion pressure|perfusion pressure
46573|NCT03911466|CTN-0080|ctn-0080
46574|NCT03911466|clinical trials network|clinical trials network
46575|NCT03911466|medication assisted treatment|medication assisted treatment
46576|NCT03911466|pharmacokinetics|pharmacokinetics
46577|NCT03911453|Breast Cancer|breast cancer
46578|NCT03911453|Triple Negative|triple negative
46579|NCT03911453|Breast Tumors|breast tumors
46580|NCT03911453|PD-L1|pd-l1
46581|NCT03911453|PARP|parp
46582|NCT03911453|PARPi|parpi
46583|NCT03911453|Rucaparib|rucaparib
46584|NCT03911440|Mycoplasma pneumoniae, Macrolide-resistance, Children|mycoplasma pneumoniae, macrolide-resistance, children
46585|NCT03911427|Beverage|beverage
46586|NCT03911427|Beta glucan|beta glucan
46587|NCT03911427|Fiber|fiber
46588|NCT03911427|Oat|oat
46589|NCT03911427|Hypercholesterolemia|hypercholesterolemia
46590|NCT03911427|LDL|ldl
46591|NCT03911427|Cholesterol|cholesterol
46592|NCT03911388|Brain Tumor, Recurrent|brain tumor, recurrent
46593|NCT03911388|Glioma|glioma
46594|NCT03911388|Glioblastoma Multiforme|glioblastoma multiforme
46595|NCT03911388|Gliosarcoma|gliosarcoma
46596|NCT03911388|Medulloblastoma|medulloblastoma
46597|NCT03911388|Anaplastic Astrocytoma|anaplastic astrocytoma
46598|NCT03911388|Oligodendroglioma|oligodendroglioma
46599|NCT03911388|Rhabdoid Tumor|rhabdoid tumor
46600|NCT03911388|Ependymoma|ependymoma
46601|NCT03911388|Germ Cell Tumor|germ cell tumor
46602|NCT03911388|Choroid Plexus Carcinoma|choroid plexus carcinoma
46603|NCT03911388|Cerebral Primitive Neuroectodermal Tumor|cerebral primitive neuroectodermal tumor
46604|NCT03911388|Giant Cell Glioblastoma|giant cell glioblastoma
46605|NCT03911388|Atypical teratoid/rhabdoid tumor|atypical teratoid/rhabdoid tumor
46606|NCT03911388|Secondary Malignant Cerebellar Tumor|secondary malignant cerebellar tumor
46607|NCT03911388|Embryonal Tumor|embryonal tumor
46608|NCT03911388|Neoplasms|neoplasms
46609|NCT03911388|Oncolytic Virus Therapy|oncolytic virus therapy
46610|NCT03911388|Virotherapy, Oncolytic|virotherapy, oncolytic
46611|NCT03911388|Immunotherapy|immunotherapy
46612|NCT03911388|Central Nervous System Agents|central nervous system agents
46613|NCT03911388|Antineoplastic Agents|antineoplastic agents
46614|NCT03911388|Pediatric|pediatric
46615|NCT03911388|Pediatrics|pediatrics
46616|NCT03911388|Oncolytic|oncolytic
46617|NCT03911388|Virus|virus
46618|NCT03911388|HSV|hsv
46619|NCT03911388|Herpes Virus|herpes virus
46620|NCT03911388|G207|g207
46621|NCT03911388|Oncolytic Herpes Virus|oncolytic herpes virus
46622|NCT03911362|Lumbopelvic Stabilisation Exercises|lumbopelvic stabilisation exercises
46623|NCT03911362|Pelvic Floor Exercises|pelvic floor exercises
46624|NCT03911362|Stress Urinary Incontinence|stress urinary incontinence
46625|NCT03911336|Chronotherapy|chronotherapy
46626|NCT03911336|Chronomodulation|chronomodulation
46627|NCT03911336|Osteogenesis|osteogenesis
46628|NCT03911336|NSAID|nsaid
46629|NCT03911310|prostate cancer|prostate cancer
46630|NCT03911310|biochemical recurrence|biochemical recurrence
46631|NCT03911310|18F-PSMA PET imaging|18f-psma pet imaging
46632|NCT03911297|polycystic ovary syndrome|polycystic ovary syndrome
46633|NCT03911297|androgens|androgens
46634|NCT03911297|steroids|steroids
46635|NCT03911297|metabolic risk|metabolic risk
46636|NCT03911297|prediction|prediction
46637|NCT03911297|stratified medicine|stratified medicine
46638|NCT03911284|ASCVD|ascvd
46639|NCT03911232|intraoperative neural monitoring|intraoperative neural monitoring
46640|NCT03911206|Asthma|asthma
46641|NCT03911180|Pertrochanteric fracture|pertrochanteric fracture
46642|NCT03911180|Intertrochanteric fracture|intertrochanteric fracture
46643|NCT03911180|subtrochanteric extension|subtrochanteric extension
46647|NCT03911154|Sleep|sleep
46648|NCT03911154|Sleep restriction|sleep restriction
46649|NCT03911154|Cognitive performance|cognitive performance
46650|NCT03911128|Leukemia|leukemia
46651|NCT03911128|Acute Lymphoblastic|acute lymphoblastic
46652|NCT03911128|ALL|all
46653|NCT03911128|ALLTogether|alltogether
46654|NCT03911128|Leukaemia|leukaemia
46655|NCT03911102|Lateral canthal wrinkle|lateral canthal wrinkle
46656|NCT03911102|Crow's feet lines|crow's feet lines
46657|NCT03911102|LCL|lcl
46658|NCT03911063|Telemedicine|telemedicine
46659|NCT03911050|endogenous reactive carbonyl species|endogenous reactive carbonyl species
46660|NCT03911050|apple consumption|apple consumption
46661|NCT03911050|formation of carbonyl species adducts of apple polyphenols|formation of carbonyl species adducts of apple polyphenols
46662|NCT03911050|pharmacokinetics of adducts in human|pharmacokinetics of adducts in human
46663|NCT03911050|intervention|intervention
46664|NCT03911037|Regenerative medicine|regenerative medicine
46665|NCT03911024|HIV prevention|hiv prevention
46666|NCT03911024|homeless|homeless
46667|NCT03911011|avalanche, survival, physiology|avalanche, survival, physiology
46668|NCT03910998|neuromuscular blockade|neuromuscular blockade
46669|NCT03910998|NOL monitoring|nol monitoring
46670|NCT03910998|opioid consumption|opioid consumption
46671|NCT03910998|intraoperative|intraoperative
46672|NCT03910998|anesthesia|anesthesia
46673|NCT03910985|COPD|copd
46674|NCT03910933|Warfarin|warfarin
46675|NCT03910933|Child|child
46680|NCT03910855|Mindfulness|mindfulness
46681|NCT03910855|Stroke Survivors|stroke survivors
46682|NCT03910855|Caregivers|caregivers
46683|NCT03910842|Non-Hodgkin Lymphoma|non-hodgkin lymphoma
46684|NCT03910842|Leukemia|leukemia
46685|NCT03910842|children|children
46686|NCT03910842|CD19|cd19
46687|NCT03910842|CAR-T|car-t
46688|NCT03910842|TriCAR-T|tricar-t
46689|NCT03910842|TriCAR-SILK|tricar-silk
46690|NCT03910829|Motor Imagery|motor imagery
46691|NCT03910829|Action observation|action observation
46692|NCT03910816|Surgery|surgery
46693|NCT03910816|Eighteen|eighteen
46694|NCT03910790|livery biopsy|livery biopsy
46695|NCT03910790|fine needle biopsy|fine needle biopsy
46696|NCT03910790|19-gauge needle|19-gauge needle
46697|NCT03910751|TAVI|tavi
46698|NCT03910751|TAVR|tavr
46699|NCT03910751|Early discharge|early discharge
46700|NCT03910751|ACURATE Neo|acurate neo
46701|NCT03910738|Neuroprotection|neuroprotection
46702|NCT03910738|Remyelination|remyelination
46703|NCT03910738|Relapsing Remitting Multiple sclerosis|relapsing remitting multiple sclerosis
46704|NCT03910738|Testosterone undecanoate|testosterone undecanoate
46705|NCT03910738|Diffusion tensor Imaging|diffusion tensor imaging
46706|NCT03910712|MBC, Pyrotinib, Trastuzumab, First line, HER2|mbc, pyrotinib, trastuzumab, first line, her2
46707|NCT03910699|Anastomosis|anastomosis
46708|NCT03910699|Anastomotic leakage|anastomotic leakage
46709|NCT03910699|Rectal cancer|rectal cancer
46710|NCT03910699|Total mesorectal excision|total mesorectal excision
46711|NCT03910699|Low anterior resection|low anterior resection
46712|NCT03910699|Anastomotic leak|anastomotic leak
46713|NCT03910699|Colorectal anastomosis|colorectal anastomosis
46714|NCT03910699|Three-row stapler|three-row stapler
46715|NCT03910686|Alcohol Dependence, transcranial magnetic stimulation, cognitive behavioral therapy|alcohol dependence, transcranial magnetic stimulation, cognitive behavioral therapy
46716|NCT03910673|Adults|adults
46717|NCT03910673|Fosfomycin Disodium|fosfomycin disodium
46718|NCT03910673|Healthy|healthy
46719|NCT03910673|Intrapulmonary|intrapulmonary
46720|NCT03910673|Intravenous|intravenous
46721|NCT03910673|Pharmacokinetics|pharmacokinetics
46722|NCT03910673|Phase 1|phase 1
46723|NCT03910673|ZTI-01|zti-01
46724|NCT03910634|Esophageal Cancer|esophageal cancer
46725|NCT03910634|radiotherapy|radiotherapy
46726|NCT03910634|chemotherapy|chemotherapy
46727|NCT03910634|Carboplatin|carboplatin
46728|NCT03910608|Paired Associative Stimulation|paired associative stimulation
46729|NCT03910608|Frontoparietal Pathway|frontoparietal pathway
46730|NCT03910608|Transcranial Magnetic Stimulation|transcranial magnetic stimulation
46731|NCT03910608|Cognitive Function|cognitive function
46732|NCT03910595|Barrier Film|barrier film
46733|NCT03910595|Mepitel|mepitel
46734|NCT03910595|Quality of Life|quality of life
46735|NCT03910595|Radiation Dermatitis|radiation dermatitis
46736|NCT03910595|Skin toxicity|skin toxicity
46737|NCT03910569|Takotsubo|takotsubo
46738|NCT03910556|re-craniotomy|re-craniotomy
46739|NCT03910556|major non-neurological complications|major non-neurological complications
46740|NCT03910556|neurosurgery|neurosurgery
46741|NCT03910556|brain tumors|brain tumors
46742|NCT03910530|Advanced solid tumors|advanced solid tumors
46943|NCT03909178|iHOT-33|ihot-33
46756|NCT03910478|Dried Blood Spot|dried blood spot
46757|NCT03910478|Hematopoietic cell transplantation|hematopoietic cell transplantation
46759|NCT03910465|Comprehensive Evaluation and Recommendations|comprehensive evaluation and recommendations
46760|NCT03910465|Collecting Clinical, Epidemiologic and Biological Data|collecting clinical, epidemiologic and biological data
46761|NCT03910452|Haploidentical|haploidentical
46762|NCT03910452|Allogeneic Stem Cell Transplant|allogeneic stem cell transplant
46763|NCT03910452|Peripheral Blood Stem Cell Transplant|peripheral blood stem cell transplant
46764|NCT03910452|Graft-Versus-Host Disease|graft-versus-host disease
46765|NCT03910452|Non-Myeloablative Conditioning Regimen|non-myeloablative conditioning regimen
46766|NCT03910439|Monoclonal Antibody|monoclonal antibody
46767|NCT03910439|Radiotherapy|radiotherapy
46768|NCT03910400|STEMI|stemi
46769|NCT03910400|Cardiac magnetic resonance|cardiac magnetic resonance
46770|NCT03910400|balloon catheter|balloon catheter
46771|NCT03910374|L-PRF|l-prf
46772|NCT03910374|fibrin sealants|fibrin sealants
46773|NCT03910374|endoscopic endonasal skull base reconstruction|endoscopic endonasal skull base reconstruction
46774|NCT03910309|degenerative disc disease, spondylolisthesis|degenerative disc disease, spondylolisthesis
46775|NCT03910296|Cancer|cancer
46776|NCT03910244|Epistaxis|epistaxis
46777|NCT03910244|pomalidomide|pomalidomide
46778|NCT03910244|blood transfusion|blood transfusion
46779|NCT03910231|vasopressin receptor|vasopressin receptor
46780|NCT03910231|renal sodium excretion|renal sodium excretion
46781|NCT03910218|HIV prevention|hiv prevention
46782|NCT03910218|homeless|homeless
46786|NCT03910166|drug eluting balloon catheter|drug eluting balloon catheter
46787|NCT03910166|stenting|stenting
46788|NCT03910153|Prebiotic|prebiotic
46789|NCT03910153|Potato Starch|potato starch
46790|NCT03910153|Resistant Starch|resistant starch
46791|NCT03910153|MSPrebiotic|msprebiotic
46792|NCT03910153|Gut Health|gut health
46793|NCT03910153|Microbiome|microbiome
46794|NCT03910153|Glucose|glucose
46795|NCT03910088|spinal|spinal
46796|NCT03910088|cesarean|cesarean
46797|NCT03910088|pregabalin|pregabalin
46808|NCT03910062|VA-ECMO|va-ecmo
46809|NCT03910062|VA-ECLS|va-ecls
46810|NCT03910062|Near-Infrared Spectroscopy (NIRS)|near-infrared spectroscopy (nirs)
46811|NCT03910049|Indocyanine Green|indocyanine green
46812|NCT03910049|Near Infrared Imaging|near infrared imaging
46813|NCT03910049|Total Thyroidectomy|total thyroidectomy
46814|NCT03910036|PRP|prp
46815|NCT03910036|regeneration|regeneration
46816|NCT03910036|ultrasound|ultrasound
46817|NCT03910023|Low back pain|low back pain
46818|NCT03910023|Crenobalneotherapy|crenobalneotherapy
46819|NCT03910023|Spa therapy|spa therapy
46820|NCT03910023|Mud application|mud application
46821|NCT03910023|Water exercises|water exercises
46822|NCT03910023|Underwater massages|underwater massages
46823|NCT03909997|Stomach neoplasms|stomach neoplasms
46824|NCT03909997|gastrectomy|gastrectomy
46825|NCT03909997|Risk factors|risk factors
46826|NCT03909997|morbidity|morbidity
46827|NCT03909997|adenocarcinoma|adenocarcinoma
46828|NCT03909971|ALK positive|alk positive
46829|NCT03909971|ALK inhibitor-treated|alk inhibitor-treated
46830|NCT03909971|NSCLC|nsclc
46831|NCT03909958|spinal cord injury|spinal cord injury
46832|NCT03909958|electroacupuncture|electroacupuncture
46833|NCT03909958|Brain Structure and Function|brain structure and function
46834|NCT03909958|Multi-mode Magnetic Resonance Imaging|multi-mode magnetic resonance imaging
46835|NCT03909945|Annona muricata|annona muricata
46836|NCT03909945|Hypertension|hypertension
46837|NCT03909945|Sub saharan Africa|sub saharan africa
46838|NCT03909932|Physician attire|physician attire
46839|NCT03909932|neuro-urology|neuro-urology
46840|NCT03909932|urodynamic|urodynamic
46841|NCT03909932|patient satisfaction|patient satisfaction
46847|NCT03909906|anxiety|anxiety
46848|NCT03909906|herbal supplements|herbal supplements
46851|NCT03909880|kinesio taping, sensorimotor control|kinesio taping, sensorimotor control
46852|NCT03909815|total hip arthroplasty|total hip arthroplasty
46853|NCT03909815|dual mobility cup|dual mobility cup
46854|NCT03909815|dislocation|dislocation
46855|NCT03909815|mortality|mortality
46856|NCT03909815|periprosthetic joint infection|periprosthetic joint infection
46857|NCT03909815|health economy|health economy
46858|NCT03909789|Endothelium|endothelium
46859|NCT03909776|osteosarcoma|osteosarcoma
46860|NCT03909776|Intra-arterial chemotherapy|intra-arterial chemotherapy
46861|NCT03909776|survival|survival
46862|NCT03909776|Tumor neovascularity|tumor neovascularity
46863|NCT03909776|telangiectatic subtype|telangiectatic subtype
46864|NCT03909776|complications|complications
46865|NCT03909763|corticosteroid-resistant or relapsed ITP|corticosteroid-resistant or relapsed itp
46866|NCT03909763|Danazole|danazole
46867|NCT03909763|berberine|berberine
46868|NCT03909724|colorectal cancer|colorectal cancer
46869|NCT03909724|TAS-102|tas-102
46870|NCT03909724|Sunitinib|sunitinib
46871|NCT03909711|Temperature|temperature
46872|NCT03909711|Bleeding|bleeding
46873|NCT03909711|Anemia|anemia
46874|NCT03909711|Spine|spine
46875|NCT03909672|low back pain|low back pain
46876|NCT03909672|cupping therapy|cupping therapy
46877|NCT03909620|lung cancer|lung cancer
46878|NCT03909620|ldct|ldct
46879|NCT03909620|low-dose CT|low-dose ct
46880|NCT03909620|screening|screening
46881|NCT03909620|lung nodule|lung nodule
46882|NCT03909581|CABG|cabg
46883|NCT03909581|EndoCAB|endocab
46884|NCT03909581|PCI|pci
46885|NCT03909555|Type 2 diabetes mellitus|type 2 diabetes mellitus
46886|NCT03909555|Continuous subcutaneous insulin infusion|continuous subcutaneous insulin infusion
46887|NCT03909555|chronic complications|chronic complications
46888|NCT03909542|inflammatory bowel disease|inflammatory bowel disease
46889|NCT03909542|ileostomy|ileostomy
46890|NCT03909542|ileostomy reversal|ileostomy reversal
46891|NCT03909542|stoma reversal|stoma reversal
46895|NCT03909425|nAMD|namd
46896|NCT03909425|Treat and Extend|treat and extend
46897|NCT03909425|Aflibercept|aflibercept
46898|NCT03909425|OCTA|octa
46899|NCT03909425|Neovascular age-related macular degeneration|neovascular age-related macular degeneration
46900|NCT03909347|Korean American elders|korean american elders
46901|NCT03909347|Caregivers|caregivers
46902|NCT03909347|dementia Literacy education And Navigation|dementia literacy education and navigation
46903|NCT03909347|Community health workers|community health workers
46904|NCT03909347|successful aging|successful aging
46905|NCT03909347|PLAN|plan
46906|NCT03909321|Exercise|exercise
46907|NCT03909321|Beach Tennis|beach tennis
46908|NCT03909321|Sport training|sport training
46909|NCT03909321|Ambulatory blood pressure monitoring|ambulatory blood pressure monitoring
46910|NCT03909308|Exercise|exercise
46911|NCT03909308|Beach Tennis|beach tennis
46912|NCT03909308|Sport training|sport training
46913|NCT03909308|Post exercise hypotension|post exercise hypotension
46914|NCT03909308|Ambulatory blood pressure monitoring|ambulatory blood pressure monitoring
46915|NCT03909282|Ductal Breast Carcinoma|ductal breast carcinoma
46916|NCT03909269|HbA1c|hba1c
46917|NCT03909269|Glycated albumin|glycated albumin
46918|NCT03909269|Fructosamine|fructosamine
46919|NCT03909269|Continuous glucose monitoring|continuous glucose monitoring
46920|NCT03909256|Rehabilitation|rehabilitation
46921|NCT03909256|Nutrition impact symptoms|nutrition impact symptoms
46922|NCT03909256|Quality of life|quality of life
46923|NCT03909243|psychological attributes|psychological attributes
46924|NCT03909243|child mental disorders|child mental disorders
46925|NCT03909243|strength and difficulties questionnaire|strength and difficulties questionnaire
46926|NCT03909243|child behavior|child behavior
46927|NCT03909204|Laparoscopic-Assisted Percutaneous Endoscopic Cecostomy|laparoscopic-assisted percutaneous endoscopic cecostomy
46928|NCT03909191|HBV RNA|hbv rna
46929|NCT03909191|HBsAg|hbsag
46930|NCT03909191|cccDNA|cccdna
46931|NCT03909191|Nucleos(t)ide analogue|nucleos(t)ide analogue
46932|NCT03909191|virological relapse|virological relapse
46933|NCT03909178|Acetabular Labrum Tear|acetabular labrum tear
46934|NCT03909178|Femoro Acetabular Impingement|femoro acetabular impingement
46935|NCT03909178|Osteoarthritis|osteoarthritis
46936|NCT03909178|Hip Arthroscopy|hip arthroscopy
46937|NCT03909178|Prospective|prospective
46938|NCT03909178|PROMs|proms
46939|NCT03909178|mHHS|mhhs
46940|NCT03909178|HOS|hos
46941|NCT03909178|NAHS|nahs
46942|NCT03909178|LEFS|lefs
46944|NCT03909178|RCT, Randomized Control Trial|rct, randomized control trial
46945|NCT03909178|Physical Therapy, PT|physical therapy, pt
46946|NCT03909178|Osteoarthritis, Hip|osteoarthritis, hip
46948|NCT03909178|Outerbridge|outerbridge
46949|NCT03909178|Older than 40 years old|older than 40 years old
46950|NCT03909152|Onapristone ER (Apristor)|onapristone er (apristor)
46951|NCT03909152|Oral Progesterone|oral progesterone
46952|NCT03909152|Progesterone Receptor Positive (PR+)|progesterone receptor positive (pr+)
46953|NCT03909152|19-061|19-061
46954|NCT03909139|Acetabular Labrum Tear|acetabular labrum tear
46955|NCT03909139|Pincer Lesion|pincer lesion
46956|NCT03909139|Femoro Acetabular Impingement|femoro acetabular impingement
46957|NCT03909139|Chondral Defect|chondral defect
46958|NCT03909139|Bone Marrow Aspirate Concentrate|bone marrow aspirate concentrate
46959|NCT03909139|Mesenchymal Stem Cell|mesenchymal stem cell
46960|NCT03909139|Chondrolabral Junction|chondrolabral junction
46961|NCT03909139|Osteoarthritis|osteoarthritis
46962|NCT03909139|Acetabuloplasty|acetabuloplasty
46963|NCT03909139|Hip Arthroscopy|hip arthroscopy
46964|NCT03909139|BMAC|bmac
46965|NCT03909139|Bone Marrow Cell Analysis|bone marrow cell analysis
46966|NCT03909126|pertussis|pertussis
46967|NCT03909126|immunization coverage|immunization coverage
46968|NCT03909126|vaccination|vaccination
46969|NCT03909126|pregnant women|pregnant women
46970|NCT03909126|Quebec|quebec
46971|NCT03909061|Wheelchair|wheelchair
46972|NCT03909061|Participation|participation
46973|NCT03909061|Training|training
46974|NCT03909061|Maintenance|maintenance
46975|NCT03909061|Breakdown|breakdown
46976|NCT03909048|Chronic Pain|chronic pain
46977|NCT03909048|Low Back Pain|low back pain
46978|NCT03909035|Medication review polypharmacy|medication review polypharmacy
46979|NCT03909035|clinical pharmacy|clinical pharmacy
46980|NCT03909035|older people|older people
46981|NCT03909035|inappropriate prescribing|inappropriate prescribing
46982|NCT03909035|collaboration|collaboration
46983|NCT03909009|Fibromyalgia, transcranial magnetic stimulation, pain|fibromyalgia, transcranial magnetic stimulation, pain
46984|NCT03908983|Mitral Regurgitation|mitral regurgitation
46985|NCT03908983|Mitral valve repair|mitral valve repair
46986|NCT03908983|Mitral annuloplasty|mitral annuloplasty
46987|NCT03908983|Adjustable annuloplasty|adjustable annuloplasty
46988|NCT03908905|Pain|pain
46989|NCT03908905|Sleep|sleep
46990|NCT03908905|Neuropsychology|neuropsychology
46991|NCT03908905|Fatigue|fatigue
46992|NCT03908905|Activity level|activity level
46993|NCT03908905|Attention|attention
46994|NCT03908905|Executive function|executive function
46995|NCT03908905|Memory|memory
46996|NCT03908892|Paronychia|paronychia
46997|NCT03908892|Zanthoxylum nitidum tincture|zanthoxylum nitidum tincture
46998|NCT03908892|Afatinib|afatinib
46999|NCT03908879|Intraosseous catheter|intraosseous catheter
47000|NCT03908879|Intraosseous access|intraosseous access
47001|NCT03908879|Resuscitation|resuscitation
47002|NCT03908879|Diagnostic accuracy|diagnostic accuracy
47003|NCT03908840|Hepatocellular|hepatocellular
47004|NCT03908840|Carcinoma|carcinoma
47005|NCT03908840|Liver|liver
47006|NCT03908840|Cancer|cancer
47007|NCT03908827|Randomized Clinical Trial|randomized clinical trial
47008|NCT03908827|Osteoarthritis|osteoarthritis
47009|NCT03908827|Hip|hip
47010|NCT03908827|Knee|knee
47011|NCT03908827|Bone Mineral Aspirate Concentrate|bone mineral aspirate concentrate
47012|NCT03908788|Metastatic Colorectal Cancer|metastatic colorectal cancer
47013|NCT03908788|Detection of the emergence of RAS mutations|detection of the emergence of ras mutations
47014|NCT03908788|Circulating DNA in patients|circulating dna in patients
47015|NCT03908788|Treatment with anti-EGFR therapy|treatment with anti-egfr therapy
47016|NCT03908775|Intubation|intubation
47017|NCT03908775|Children|children
47018|NCT03908775|Hemodynamics|hemodynamics
47019|NCT03908749|Pyrotinib Maleate Tablets|pyrotinib maleate tablets
47020|NCT03908749|HER-2|her-2
47021|NCT03908749|Real word study|real word study
47022|NCT03908749|Efficacy|efficacy
47023|NCT03908749|Safety|safety
47024|NCT03908710|Home blood pressure monitor|home blood pressure monitor
47025|NCT03908710|Telemedicine|telemedicine
47026|NCT03908710|mHealth|mhealth
47027|NCT03908710|eHealth|ehealth
47028|NCT03908684|Ultrasound|ultrasound
47029|NCT03908684|Spectroscopy|spectroscopy
47030|NCT03908671|mRNA cancer vaccine|mrna cancer vaccine
47031|NCT03908671|cancer vaccine|cancer vaccine
47032|NCT03908671|tumor vaccine|tumor vaccine
47033|NCT03908671|NSCLC|nsclc
47034|NCT03908671|Esophageal Cancer|esophageal cancer
47035|NCT03908658|inspiratory muscle training|inspiratory muscle training
47036|NCT03908658|Nasal High Flow|nasal high flow
47037|NCT03908645|Bowel Preparation, Deep Learning, Central Neural Networks|bowel preparation, deep learning, central neural networks
47038|NCT03908632|Community Acquired Pneumonia|community acquired pneumonia
47039|NCT03908632|Endemic Areas|endemic areas
47040|NCT03908632|Observational Study|observational study
47041|NCT03908632|Primary Pulmonary Coccidioidomycosis|primary pulmonary coccidioidomycosis
47043|NCT03908619|Triple therapy|triple therapy
47044|NCT03908619|Proton pump inhibitor|proton pump inhibitor
47046|NCT03908593|Gastrointestinal|gastrointestinal
47047|NCT03908593|Mucosal injury|mucosal injury
47048|NCT03908593|Antiplatelet|antiplatelet
47049|NCT03908593|Coronary artery bypass grafting|coronary artery bypass grafting
47050|NCT03908593|Prevention|prevention
47051|NCT03908567|Vertigo|vertigo
47052|NCT03908567|Balance|balance
47053|NCT03908554|coping skill|coping skill
47054|NCT03908554|quality of life|quality of life
47055|NCT03908554|pain|pain
47056|NCT03908554|fatigue|fatigue
47057|NCT03908554|Workplace Health Promotion Program|workplace health promotion program
47058|NCT03908541|Inflammatory markers|inflammatory markers
47059|NCT03908541|Magnetic resonance imaging|magnetic resonance imaging
47060|NCT03908541|disorder of consciousness|disorder of consciousness
47061|NCT03908528|alpha-lipoic acid|alpha-lipoic acid
47062|NCT03908528|taxol|taxol
47063|NCT03908528|Adriamycin|adriamycin
47064|NCT03908528|cyclophosphamide|cyclophosphamide
47065|NCT03908528|breast cancer|breast cancer
47066|NCT03908528|Brain Natriuretic Peptide (BNP).|brain natriuretic peptide (bnp).
47067|NCT03908528|Neurotensin|neurotensin
47068|NCT03908528|TNF-alpha|tnf-alpha
47069|NCT03908515|Foldable Capsular Vitreous Body|foldable capsular vitreous body
47070|NCT03908515|Retina detachment|retina detachment
47071|NCT03908515|eye atrophy|eye atrophy
47072|NCT03908502|Radiotherapy|radiotherapy
47073|NCT03908502|Nervous System Complications|nervous system complications
47074|NCT03908437|opiate use disorder|opiate use disorder
47075|NCT03908437|overdose|overdose
47076|NCT03908437|medication assisted treatment|medication assisted treatment
47077|NCT03908424|PDPH - Post Dural Puncture Headache|pdph - post dural puncture headache
47078|NCT03908424|chronic headache|chronic headache
47079|NCT03908424|chronic backache|chronic backache
47080|NCT03908411|Paratracheal pressure|paratracheal pressure
47081|NCT03908398|ATP bioluminescence|atp bioluminescence
47082|NCT03908398|Visual assessment|visual assessment
47083|NCT03908359|Congenital Cataract|congenital cataract
47084|NCT03908359|minimal invasive surgery|minimal invasive surgery
47085|NCT03908359|secondary intraocular lens implantation|secondary intraocular lens implantation
47086|NCT03908346|Neurologic Prognosis|neurologic prognosis
47087|NCT03908346|Guideline Concordance|guideline concordance
47088|NCT03908346|Surrogate Decision Makers|surrogate decision makers
47089|NCT03908333|metastatic pancreatic cancer|metastatic pancreatic cancer
47090|NCT03908333|cancer|cancer
47091|NCT03908333|pancreatic|pancreatic
47092|NCT03908333|Vitamin C|vitamin c
47093|NCT03908333|Ascorbic Acid|ascorbic acid
47094|NCT03908333|Nanoparticle Paclitaxel Protein Bound|nanoparticle paclitaxel protein bound
47095|NCT03908333|cisplatin|cisplatin
47096|NCT03908333|gemcitabine|gemcitabine
47097|NCT03908333|pancreas|pancreas
47098|NCT03908281|Exercise|exercise
47099|NCT03908281|Glycated hemoglobin|glycated hemoglobin
47100|NCT03908281|Liver fat|liver fat
47101|NCT03908281|Continuous glucose monitoring|continuous glucose monitoring
47102|NCT03908268|Co-regulation|co-regulation
47103|NCT03908268|Emotional Connection|emotional connection
47104|NCT03908268|Family Nurture Intervention|family nurture intervention
47105|NCT03908268|Preschool Intervention|preschool intervention
47106|NCT03908268|Martha G. Welch MD|martha g. welch md
47107|NCT03908268|Multiple Family Group Intervention|multiple family group intervention
47108|NCT03908268|Randomized Controlled Trial|randomized controlled trial
47109|NCT03908255|branch chain amino acid|branch chain amino acid
47110|NCT03908255|nutritional supplement|nutritional supplement
47111|NCT03908255|malnutrition|malnutrition
47112|NCT03908255|decompensated liver failure|decompensated liver failure
47113|NCT03908216|overweight,obesity,patients' survey,drug&non-drug treatment|overweight,obesity,patients' survey,drug&non-drug treatment
47114|NCT03908190|Peer Support|peer support
47115|NCT03908190|Patient Navigators|patient navigators
47116|NCT03908164|Pregnancy|pregnancy
47117|NCT03908164|Immunisation|immunisation
47118|NCT03908164|Pertussis|pertussis
47119|NCT03908151|hip prosthesis|hip prosthesis
47122|NCT03908112|convergence insufficiency|convergence insufficiency
47123|NCT03908112|concussion|concussion
47124|NCT03908112|vision therapy|vision therapy
47125|NCT03908112|vision rehabilitation|vision rehabilitation
47126|NCT03908099|Lifestyle intervention|lifestyle intervention
47127|NCT03908099|Weight loss|weight loss
47128|NCT03908099|Obesity|obesity
47129|NCT03908099|Infertility|infertility
47130|NCT03908099|Interdisciplinary program|interdisciplinary program
47131|NCT03908073|Ulcerative Colitis|ulcerative colitis
47132|NCT03908073|Vagal Nerve Stimulation|vagal nerve stimulation
47133|NCT03908073|Transcutaneous Vagal Nerve Stimulation|transcutaneous vagal nerve stimulation
47134|NCT03908073|Cytokines|cytokines
47135|NCT03908073|LPS stimulated cytokine production|lps stimulated cytokine production
47136|NCT03908021|diabetes mellitus|diabetes mellitus
47137|NCT03908021|children|children
47138|NCT03908021|microbiome|microbiome
47139|NCT03908008|Glabella line|glabella line
47140|NCT03908008|Glabella lines|glabella lines
47141|NCT03908008|Botulinum Toxin|botulinum toxin
47142|NCT03907982|Cardiac ablation|cardiac ablation
47143|NCT03907982|Cardioversion|cardioversion
47144|NCT03907982|pacemaker|pacemaker
47145|NCT03907982|implantable cardioverter-defibrillator|implantable cardioverter-defibrillator
47146|NCT03907969|Safety,|safety,
47147|NCT03907969|Pharmacokinetics,|pharmacokinetics,
47148|NCT03907969|Pegylated liposomal doxorubicin,|pegylated liposomal doxorubicin,
47149|NCT03907969|Olaparib,|olaparib,
47150|NCT03907969|Dose finding|dose finding
47151|NCT03907956|physiotherapy|physiotherapy
47152|NCT03907956|carpal tunnel syndrome|carpal tunnel syndrome
47153|NCT03907956|myofascial pain syndrome|myofascial pain syndrome
47154|NCT03907956|dry needling|dry needling
47155|NCT03907904|Intraoperative/methods* Oximetry/methods* Oxygen/metabolism|intraoperative/methods* oximetry/methods* oxygen/metabolism
47156|NCT03907904|brain/metabolism|brain/metabolism
47157|NCT03907904|brain chemistry|brain chemistry
47158|NCT03907904|cerebrovascular circulation|cerebrovascular circulation
47159|NCT03907904|humans|humans
47160|NCT03907904|monitoring, intraoperative/methods|monitoring, intraoperative/methods
47161|NCT03907904|oximetry/methods|oximetry/methods
47162|NCT03907904|oxygen/metabolism|oxygen/metabolism
47163|NCT03907878|CSU (chronic spontaneous urticaria)|csu (chronic spontaneous urticaria)
47164|NCT03907878|Japanese|japanese
47165|NCT03907878|QGE031|qge031
47166|NCT03907878|Anti-IgE|anti-ige
47167|NCT03907878|Ligelizumab|ligelizumab
47168|NCT03907839|COPD|copd
47169|NCT03907839|cognitive training|cognitive training
47170|NCT03907839|cognitive impairment|cognitive impairment
47171|NCT03907839|P300 test|p300 test
47172|NCT03907839|MOCA|moca
47173|NCT03907826|PD-1 antibody|pd-1 antibody
47174|NCT03907826|Intensity-modulated Radiation Therapy|intensity-modulated radiation therapy
47175|NCT03907826|Efficacy|efficacy
47176|NCT03907826|Adverse effect|adverse effect
47177|NCT03907761|thyroidectomy|thyroidectomy
47178|NCT03907761|recurrent laryngeal nerve|recurrent laryngeal nerve
47179|NCT03907761|hydrodissection|hydrodissection
47180|NCT03907748|music therapy|music therapy
47181|NCT03907748|music interventions|music interventions
47182|NCT03907748|home-based interventions|home-based interventions
47183|NCT03907748|Reading|reading
47184|NCT03907748|dementia|dementia
47185|NCT03907748|care giver|care giver
47186|NCT03907735|Post-abortion hemorrhage|post-abortion hemorrhage
47187|NCT03907735|Obstetric hemorrhage|obstetric hemorrhage
47188|NCT03907735|Preterm labor|preterm labor
47189|NCT03907735|Abnormal labor|abnormal labor
47190|NCT03907735|Oxytocin|oxytocin
47191|NCT03907735|Oxytocin receptor|oxytocin receptor
47192|NCT03907670|chronic myeloid leukemia|chronic myeloid leukemia
47193|NCT03907670|Tyrosine kinase inhibitors|tyrosine kinase inhibitors
47194|NCT03907631|Rescue|rescue
47195|NCT03907631|Infliximab|infliximab
47196|NCT03907631|Outcomes|outcomes
47197|NCT03907631|Risk Stratification|risk stratification
47198|NCT03907618|Antral follicle count|antral follicle count
47199|NCT03907618|Anti müllerian hormone|anti müllerian hormone
47200|NCT03907618|Ovarian reserve|ovarian reserve
47201|NCT03907618|HbA1c|hba1c
47202|NCT03907618|type 1 diabetes mellitus|type 1 diabetes mellitus
47203|NCT03907592|L-Carnitine|l-carnitine
47204|NCT03907592|Resistance training|resistance training
47205|NCT03907592|Magnetic resonance imaging|magnetic resonance imaging
47206|NCT03907592|Muscle function|muscle function
47207|NCT03907592|Aging|aging
47208|NCT03907592|Leucine|leucine
47209|NCT03907579|Knowledge|knowledge
47210|NCT03907540|absorption|absorption
47211|NCT03907540|metabolism|metabolism
47212|NCT03907540|excretion|excretion
47213|NCT03907527|Platinum resistant|platinum resistant
47214|NCT03907527|Ovarian Cancer|ovarian cancer
47215|NCT03907514|Technology Assessment, Health|technology assessment, health
47216|NCT03907514|Dental anxiety|dental anxiety
47217|NCT03907514|Adolescent|adolescent
47218|NCT03907514|Clinical Trial|clinical trial
47219|NCT03907501|Gastrointestinal System|gastrointestinal system
47220|NCT03907501|Inflammatory Biomarkers|inflammatory biomarkers
47221|NCT03907501|Psychological Health|psychological health
47222|NCT03907462|young adult|young adult
47223|NCT03907462|overweight|overweight
47224|NCT03907462|obesity|obesity
47225|NCT03907462|college|college
47226|NCT03907462|university|university
47227|NCT03907462|technology|technology
47228|NCT03907462|social media|social media
47229|NCT03907462|text message|text message
47230|NCT03907462|health coach|health coach
47231|NCT03907462|intervention|intervention
47232|NCT03907462|weight loss|weight loss
47233|NCT03907462|wellness|wellness
47234|NCT03907462|physical activity|physical activity
47235|NCT03907462|diet|diet
47236|NCT03907462|sleep|sleep
47237|NCT03907462|resilience|resilience
47238|NCT03907462|wearable|wearable
47239|NCT03907462|mobile application|mobile application
47240|NCT03907462|behavior mechanism|behavior mechanism
47241|NCT03907462|behavior|behavior
47242|NCT03907436|nutrition|nutrition
47243|NCT03907436|diet|diet
47244|NCT03907436|inflammation|inflammation
47245|NCT03907436|myeloproliferative neoplasm|myeloproliferative neoplasm
47246|NCT03907397|allergy|allergy
47247|NCT03907397|food|food
47248|NCT03907397|peanut|peanut
47249|NCT03907397|threshold|threshold
47250|NCT03907397|immunotherapy|immunotherapy
47251|NCT03907345|Exposure Therapy|exposure therapy
47252|NCT03907345|Fear of Spiders|fear of spiders
47253|NCT03907345|Fear of Heights|fear of heights
47254|NCT03907345|Anxiety Disorders|anxiety disorders
47255|NCT03907345|Generalization|generalization
47256|NCT03907345|Extinction|extinction
47257|NCT03907345|Specific Phobias|specific phobias
47258|NCT03907332|Home visits|home visits
47259|NCT03907332|Community Health Nurse|community health nurse
47260|NCT03907332|Community Health Workers|community health workers
47261|NCT03907332|Pregnant women|pregnant women
47262|NCT03907332|Effectiveness|effectiveness
47263|NCT03907319|STN|stn
47264|NCT03907319|Parkinson's Disease|parkinson's disease
47265|NCT03907319|Subthalamic Nucleus|subthalamic nucleus
47266|NCT03907306|Cold argon plasma|cold argon plasma
47267|NCT03907306|hemorrhoidectomy|hemorrhoidectomy
47268|NCT03907306|wound healing|wound healing
47269|NCT03907306|hemorrhoids|hemorrhoids
47270|NCT03907293|Cardiac Rehabilitation|cardiac rehabilitation
47271|NCT03907293|Exercise|exercise
47272|NCT03907293|Coronary Artery Disease|coronary artery disease
47273|NCT03907202|Sub-cutaneous injection|sub-cutaneous injection
47274|NCT03907202|Metformin|metformin
47275|NCT03907202|KBP-089|kbp-089
47276|NCT03907202|randomised|randomised
47277|NCT03907202|placebo-controlled|placebo-controlled
47278|NCT03907202|multiple-ascending dose|multiple-ascending dose
47279|NCT03907176|inguinal hernia|inguinal hernia
47280|NCT03907176|hernia|hernia
47281|NCT03907176|hernia surgery|hernia surgery
47282|NCT03907176|postoperative pain|postoperative pain
47283|NCT03907176|herniorrhaphy|herniorrhaphy
47284|NCT03907176|multimodal analgesia|multimodal analgesia
47285|NCT03907150|Pont-of-Care Ultrasound|pont-of-care ultrasound
47286|NCT03907124|Utility|utility
47287|NCT03907124|Pharmacogenomics|pharmacogenomics
47288|NCT03907124|Psychotropic|psychotropic
47289|NCT03907124|Medications|medications
47290|NCT03907111|bleeding wounds, hemostasis, open wounds, infection, antimicrobial|bleeding wounds, hemostasis, open wounds, infection, antimicrobial
47291|NCT03907098|breast cancer|breast cancer
47292|NCT03907098|endostar|endostar
47293|NCT03907085|HILT|hilt
47294|NCT03907085|calcaneal spur|calcaneal spur
47295|NCT03907085|placebo|placebo
47296|NCT03907059|protein source|protein source
47297|NCT03907059|hypertrophy|hypertrophy
47298|NCT03907059|resistance training|resistance training
47299|NCT03907059|plant-based protein|plant-based protein
47300|NCT03907059|omnivorous|omnivorous
47301|NCT03907007|Neurostimulator|neurostimulator
47302|NCT03906955|leisure-time physical activity|leisure-time physical activity
47303|NCT03906955|adherence|adherence
47304|NCT03906955|working adults|working adults
47305|NCT03906955|motivation|motivation
47306|NCT03906955|social cognitive theory|social cognitive theory
47307|NCT03906955|telemedicine|telemedicine
47308|NCT03906955|teleconference|teleconference
47309|NCT03906955|self-perceptions|self-perceptions
47310|NCT03906955|self-confidence|self-confidence
47311|NCT03906903|Mild Cognitive Impairment|mild cognitive impairment
47312|NCT03906864|Critical pathway, length of stay, recovery of function, subacute care|critical pathway, length of stay, recovery of function, subacute care
47313|NCT03906851|School|school
47314|NCT03906851|Health|health
47315|NCT03906851|Academic performance|academic performance
47316|NCT03906851|Physical activity|physical activity
47317|NCT03906825|Endothelium|endothelium
47318|NCT03906799|Atrial Fibrillation|atrial fibrillation
47319|NCT03906799|Electrical Cardioversion|electrical cardioversion
47320|NCT03906799|Dose-finding|dose-finding
47321|NCT03906786|self-care|self-care
47322|NCT03906786|motivational interviewing|motivational interviewing
47323|NCT03906786|doctor-pacient relationship|doctor-pacient relationship
47324|NCT03906734|septal myectomy|septal myectomy
47325|NCT03906734|hypertrophic cardiomyopathy|hypertrophic cardiomyopathy
47326|NCT03906682|prevention|prevention
47327|NCT03906682|urban youth|urban youth
47328|NCT03906682|mindfulness|mindfulness
47329|NCT03906669|early stage breast cancer|early stage breast cancer
47330|NCT03906669|prometrium|prometrium
47331|NCT03906669|progesterone|progesterone
47332|NCT03906669|post-menopausal|post-menopausal
47333|NCT03906669|endocrine therapy|endocrine therapy
47334|NCT03906643|tumor|tumor
47335|NCT03906643|verteporfin|verteporfin
47336|NCT03906643|HSP90 inhibitor|hsp90 inhibitor
47337|NCT03906552|acupressure|acupressure
47338|NCT03906552|massage|massage
47339|NCT03906552|pain|pain
47340|NCT03906552|neonate|neonate
47341|NCT03906552|heel lancing|heel lancing
47342|NCT03906539|Cardiometabolic parameters|cardiometabolic parameters
47343|NCT03906539|Virgin coconut oil|virgin coconut oil
47344|NCT03906539|Serum lipoprotein|serum lipoprotein
47345|NCT03906539|Lipid peroxidation|lipid peroxidation
47346|NCT03906539|Atorvastatin|atorvastatin
47347|NCT03906526|Motolimod|motolimod
47348|NCT03906526|Nivolumab|nivolumab
47349|NCT03906526|Head and Neck Cancer|head and neck cancer
47350|NCT03906526|Squamous Cell Carcinoma|squamous cell carcinoma
47351|NCT03906526|Checkpoint inhibitor|checkpoint inhibitor
47352|NCT03906526|anti-PD1 inhibitor|anti-pd1 inhibitor
47353|NCT03906526|TLR 8 agonist|tlr 8 agonist
47354|NCT03906513|Cornea|cornea
47355|NCT03906513|Diabetes|diabetes
47356|NCT03906513|Neural damage|neural damage
47357|NCT03906500|Adolescence|adolescence
47358|NCT03906500|Alcohol use|alcohol use
47359|NCT03906500|High school|high school
47360|NCT03906487|Intimate partner violence|intimate partner violence
47361|NCT03906487|Self defining memories|self defining memories
47362|NCT03906435|Vulnerable Child Syndrome|vulnerable child syndrome
47363|NCT03906435|Neonatal Intensive Care Unit|neonatal intensive care unit
47364|NCT03906435|Cognitive Behavioral Therapy|cognitive behavioral therapy
47365|NCT03906435|Parental Perception of Child Vulnerability|parental perception of child vulnerability
47366|NCT03906435|Child Developmental Outcomes|child developmental outcomes
47367|NCT03906435|Parent Mental Health|parent mental health
47368|NCT03906422|Orthodontic|orthodontic
47369|NCT03906422|Pain|pain
47370|NCT03906409|Feeding Patterns|feeding patterns
47371|NCT03906409|Skeletal Muscle|skeletal muscle
47372|NCT03906409|Metabolism|metabolism
47373|NCT03906409|Circadian Rhythms|circadian rhythms
47374|NCT03906409|Diurnal Rhythms|diurnal rhythms
47375|NCT03906396|xbox kinect|xbox kinect
47376|NCT03906396|gaming technology|gaming technology
47377|NCT03906396|stress|stress
47378|NCT03906396|anxiety|anxiety
47379|NCT03906396|depression|depression
47380|NCT03906396|randomised control trial|randomised control trial
47381|NCT03906396|sleep quality|sleep quality
47382|NCT03906396|intervention|intervention
47383|NCT03906305|Muscle Spasticity|muscle spasticity
47384|NCT03906305|Dry Needling|dry needling
47385|NCT03906305|Stroke|stroke
47386|NCT03906240|Web-Based Intervention|web-based intervention
47387|NCT03906240|Pilot Study|pilot study
47388|NCT03906240|Moral Elevation|moral elevation
47389|NCT03906240|Veterans|veterans
47390|NCT03906240|PTSD|ptsd
47391|NCT03906240|Moral Injury|moral injury
47392|NCT03906214|Porphyrias|porphyrias
47393|NCT03906214|Variegate Porphyria|variegate porphyria
47394|NCT03906214|Hereditary Coproporphyria|hereditary coproporphyria
47395|NCT03906214|Acute Intermittent Porphyria|acute intermittent porphyria
47396|NCT03906201|PreDiabetes|prediabetes
47397|NCT03906201|Ecdysterone|ecdysterone
47398|NCT03906201|Genotoxicity|genotoxicity
47399|NCT03906201|Citotoxicity|citotoxicity
47400|NCT03906201|Micronuclei|micronuclei
47401|NCT03906201|Glycemic Control|glycemic control
47402|NCT03906188|serious game|serious game
47403|NCT03906188|videogame|videogame
47404|NCT03906175|Depression|depression
47405|NCT03906175|Hyperthermia|hyperthermia
47406|NCT03906175|Randomized Controlled Trial|randomized controlled trial
47407|NCT03906162|physical activity monitors|physical activity monitors
47408|NCT03906162|motivational interviewing|motivational interviewing
47409|NCT03906162|walking|walking
47410|NCT03906162|fitness-tracker|fitness-tracker
47411|NCT03906162|social cognitive theory|social cognitive theory
47412|NCT03906162|older age|older age
47413|NCT03906149|Depression|depression
47414|NCT03906149|Hyperthermia|hyperthermia
47415|NCT03906149|Randomized Controlled Trial|randomized controlled trial
47416|NCT03906136|axial spondyloarthritis (axSpA)|axial spondyloarthritis (axspa)
47417|NCT03906136|treat-to-target (T2T)|treat-to-target (t2t)
47418|NCT03906136|secukinumab|secukinumab
47419|NCT03906136|AIN457|ain457
47420|NCT03906136|Non-Radiographic Axial Spondyloarthritis (nr-axSpA)|non-radiographic axial spondyloarthritis (nr-axspa)
47421|NCT03906136|Radiographic Axial Spondyloarthritis (r-axSpA)|radiographic axial spondyloarthritis (r-axspa)
47422|NCT03906123|DL-3-n-butylphthalide|dl-3-n-butylphthalide
47423|NCT03906123|vascular dementia|vascular dementia
47424|NCT03906123|cerebral small vessel disease|cerebral small vessel disease
47425|NCT03906123|cognitive function|cognitive function
47426|NCT03906123|cerebral blood flow|cerebral blood flow
47427|NCT03906110|Colorectal Cancer Screening|colorectal cancer screening
47428|NCT03906110|FIT test|fit test
47429|NCT03906110|Fecal Immunochemical Test|fecal immunochemical test
47430|NCT03906097|Dyslexia|dyslexia
47431|NCT03906097|Executive function|executive function
47432|NCT03906097|Cognitive control|cognitive control
47433|NCT03906097|Inhibition|inhibition
47434|NCT03906097|Working memory|working memory
47435|NCT03906097|Prefrontal Cortex|prefrontal cortex
47436|NCT03906071|Sitravatinib|sitravatinib
47437|NCT03906071|Nivolumab|nivolumab
47438|NCT03906071|Docetaxel|docetaxel
47439|NCT03906071|Checkpoint inhibitor|checkpoint inhibitor
47440|NCT03906071|MGCD516|mgcd516
47441|NCT03906071|NSCLC|nsclc
47442|NCT03906045|COPD|copd
47443|NCT03906045|scintigraphy|scintigraphy
47444|NCT03906045|budesonide|budesonide
47445|NCT03906045|glycopyrronium|glycopyrronium
47446|NCT03906045|formoterol|formoterol
47447|NCT03906032|Timed up and go|timed up and go
47448|NCT03906032|mobility|mobility
47449|NCT03906032|functional outcome|functional outcome
47450|NCT03906019|erector spinae plane block|erector spinae plane block
47451|NCT03906019|postoperative pain|postoperative pain
47452|NCT03906019|pediatric patients|pediatric patients
47453|NCT03906006|gout|gout
47454|NCT03905993|Immune response|immune response
47455|NCT03905993|Immune System|immune system
47456|NCT03905993|genotype-to-phenotype association|genotype-to-phenotype association
47457|NCT03905993|genetic variability|genetic variability
47458|NCT03905993|reference-based population|reference-based population
47459|NCT03905967|Lenvatinib|lenvatinib
47460|NCT03905967|Transarterial chemoembolisation|transarterial chemoembolisation
47461|NCT03905954|employment|employment
47462|NCT03905954|work|work
47463|NCT03905954|diagnosis|diagnosis
47464|NCT03905954|early support|early support
47465|NCT03905941|Polycystic Ovary Syndrome|polycystic ovary syndrome
47466|NCT03905928|smoking|smoking
47467|NCT03905928|electronic cigarettes|electronic cigarettes
47468|NCT03905928|flavor|flavor
47469|NCT03905928|cue-reactivity|cue-reactivity
47470|NCT03905902|active cellular immunotherapy|active cellular immunotherapy
47471|NCT03905902|dendritic cells|dendritic cells
47472|NCT03905902|platinum-sensitive|platinum-sensitive
47473|NCT03905902|relapsed ovarian cancer|relapsed ovarian cancer
47474|NCT03905902|biologic|biologic
47475|NCT03905889|Renal cell carcinoma|renal cell carcinoma
47476|NCT03905889|Abemaciclib|abemaciclib
47477|NCT03905889|Sunitinib|sunitinib
47478|NCT03905876|Psychological experience|psychological experience
47479|NCT03905876|early clinical trial|early clinical trial
47480|NCT03905876|initial predisposition|initial predisposition
47481|NCT03905863|topical oxygen|topical oxygen
47482|NCT03905863|topical oxygen treatment|topical oxygen treatment
47483|NCT03905863|diabetic foot ulcer|diabetic foot ulcer
47484|NCT03905863|non-healing wound|non-healing wound
47485|NCT03905863|surgical site|surgical site
47486|NCT03905863|pain|pain
47487|NCT03905863|wound size|wound size
47488|NCT03905863|healing|healing
47489|NCT03905863|infection|infection
47490|NCT03905837|lidocaine|lidocaine
47491|NCT03905837|postoperative complications|postoperative complications
47492|NCT03905837|thoracic surgery|thoracic surgery
47493|NCT03905811|terazosin|terazosin
47494|NCT03905798|Status Epilepticus;|status epilepticus;
47495|NCT03905798|Lorazepam;|lorazepam;
47496|NCT03905798|LORA-PITA;|lora-pita;
47497|NCT03905798|Ativan|ativan
47498|NCT03905772|Electrical stimulation|electrical stimulation
47499|NCT03905772|M wave|m wave
47500|NCT03905772|H reflex|h reflex
47501|NCT03905772|Wide pulse|wide pulse
47502|NCT03905720|cancer|cancer
47503|NCT03905720|inpatient|inpatient
47504|NCT03905720|non-pharmacologic approaches|non-pharmacologic approaches
62741|NCT03812120|L-PRF|l-prf
47505|NCT03905720|pain management|pain management
47506|NCT03905720|acupuncture|acupuncture
47507|NCT03905720|pain counseling|pain counseling
47508|NCT03905694|PH1|ph1
47509|NCT03905694|Primary Hyperoxaluria|primary hyperoxaluria
47510|NCT03905694|Hyperoxaluria|hyperoxaluria
47511|NCT03905694|RNAi Therapeutic|rnai therapeutic
47512|NCT03905694|siRNA|sirna
47513|NCT03905694|AGT|agt
47514|NCT03905681|Transcutaneous Electrical Nerve Stimulation, Acute back pain|transcutaneous electrical nerve stimulation, acute back pain
47515|NCT03905642|Cystic Fibrosis|cystic fibrosis
47516|NCT03905642|Respiratory Infections|respiratory infections
47517|NCT03905642|Pulmonary Cystic Fibrosis|pulmonary cystic fibrosis
47518|NCT03905642|CFTR|cftr
47519|NCT03905616|Vision|vision
47520|NCT03905616|perception|perception
47521|NCT03905616|BOLD activity|bold activity
47522|NCT03905603|Polycystic Ovary Syndrome|polycystic ovary syndrome
47523|NCT03905577|Motor Imagery|motor imagery
47524|NCT03905577|Action observation|action observation
47525|NCT03905577|Pain perception|pain perception
47526|NCT03905551|cold dialysis|cold dialysis
47527|NCT03905551|intradialytic exercise|intradialytic exercise
47528|NCT03905551|insulin resistance|insulin resistance
47529|NCT03905551|thermoregulation|thermoregulation
47530|NCT03905551|muscle architecture|muscle architecture
47531|NCT03905551|quality of life|quality of life
47532|NCT03905551|fitness|fitness
47533|NCT03905551|fatigue|fatigue
47534|NCT03905551|physical activity|physical activity
47535|NCT03905525|Sjögren|sjögren
47536|NCT03905525|fatigue|fatigue
47537|NCT03905525|dryness|dryness
47538|NCT03905525|anti-CD40|anti-cd40
47539|NCT03905525|CFZ533|cfz533
47540|NCT03905525|iscalimab|iscalimab
47541|NCT03905525|TWINSS|twinss
47542|NCT03905525|autoimmune|autoimmune
47543|NCT03905499|Massive rotator cuff tear|massive rotator cuff tear
47544|NCT03905499|Pseudoparalysis|pseudoparalysis
47545|NCT03905499|Robotic mediated therapy|robotic mediated therapy
47546|NCT03905473|Survey|survey
47842|NCT03903484|Frailty|frailty
47557|NCT03905395|mindfulness|mindfulness
47558|NCT03905395|pregnancy loss|pregnancy loss
47559|NCT03905395|stress|stress
47560|NCT03905382|Technology|technology
47561|NCT03905382|Modems|modems
47562|NCT03905382|Qualitative Research|qualitative research
47563|NCT03905369|shared decision making|shared decision making
47564|NCT03905369|quality of life|quality of life
47565|NCT03905369|patient-doctor communication|patient-doctor communication
47566|NCT03905369|patient treatment preferences|patient treatment preferences
47567|NCT03905343|breast cancer|breast cancer
47568|NCT03905343|Visceral metastatic breast cancer|visceral metastatic breast cancer
47569|NCT03905343|Ribociclib|ribociclib
47570|NCT03905343|Ribociclib-endocrine|ribociclib-endocrine
47581|NCT03905317|bevacizumab|bevacizumab
47582|NCT03905317|chemoradiotherapy|chemoradiotherapy
47583|NCT03905317|Oligometastasis of lung adenocarcinoma|oligometastasis of lung adenocarcinoma
47584|NCT03905304|CD phase III|cd phase iii
47585|NCT03905278|parental cancer|parental cancer
47586|NCT03905278|parental guidance|parental guidance
47587|NCT03905278|parent-child communication|parent-child communication
47588|NCT03905265|moxidectin|moxidectin
47589|NCT03905265|acaricide|acaricide
47590|NCT03905265|oral|oral
47591|NCT03905239|algorithm|algorithm
47592|NCT03905239|procalcitonin|procalcitonin
47593|NCT03905239|small bowel obstruction|small bowel obstruction
47594|NCT03905174|revision surgery|revision surgery
47595|NCT03905161|Fatigue|fatigue
47596|NCT03905161|6-minute walk test|6-minute walk test
47597|NCT03905161|Rhythmic Auditory Stimulation|rhythmic auditory stimulation
47598|NCT03905135|T-cell Lymphoproliferative Disorder|t-cell lymphoproliferative disorder
47599|NCT03905135|Cutaneous T Cell Lymphoma|cutaneous t cell lymphoma
47600|NCT03905135|Anti-PD-L1 monoclonal antibody|anti-pd-l1 monoclonal antibody
47601|NCT03905135|Antibody Dependent Cellular Cytotoxicity|antibody dependent cellular cytotoxicity
47602|NCT03905109|Inflammatory Bowel Disorders|inflammatory bowel disorders
47603|NCT03905109|ABX464|abx464
47604|NCT03905070|bariatric surgery|bariatric surgery
47605|NCT03905070|body awareness|body awareness
47606|NCT03905070|physical therapy|physical therapy
47607|NCT03905070|metabolic surgery|metabolic surgery
47608|NCT03905031|Trauma|trauma
47609|NCT03905031|Traumatic Brain Injury|traumatic brain injury
47610|NCT03905031|Infrascanner|infrascanner
47611|NCT03905031|Near-Infrared Spectroscopy|near-infrared spectroscopy
47612|NCT03905031|Pediatric|pediatric
47613|NCT03904992|Nutrtition|nutrtition
47614|NCT03904992|Physical activity|physical activity
47615|NCT03904992|Preescholer|preescholer
47616|NCT03904992|Informatics|informatics
47617|NCT03904953|Ankylosing Spondylitis|ankylosing spondylitis
47618|NCT03904953|Pilates|pilates
47619|NCT03904953|Respiratory muscle strenght|respiratory muscle strenght
47620|NCT03904940|Orthotic Devices|orthotic devices
47621|NCT03904940|Insoles|insoles
47622|NCT03904940|Quality of life|quality of life
47623|NCT03904940|Function|function
47624|NCT03904914|TOCI|toci
47625|NCT03904914|scoliosis|scoliosis
47626|NCT03904875|pollution|pollution
47627|NCT03904875|Chronic Obstructive Pulmonary Disease|chronic obstructive pulmonary disease
47628|NCT03904875|ultrathin particles|ultrathin particles
47629|NCT03904862|Medulloblastoma|medulloblastoma
47630|NCT03904862|Sonic Hedgehog (SHH) positive|sonic hedgehog (shh) positive
47631|NCT03904836|Chronic Renal Diseases|chronic renal diseases
47632|NCT03904836|Kidney Failure, Chronic|kidney failure, chronic
47633|NCT03904836|Renal Failure, Chronic|renal failure, chronic
47634|NCT03904836|Tobramycin|tobramycin
47635|NCT03904836|Aminoglycosides|aminoglycosides
47636|NCT03904836|Pharmacokinetics|pharmacokinetics
47637|NCT03904836|Infection|infection
47638|NCT03904836|Anti-Bacterial Agents|anti-bacterial agents
47639|NCT03904836|Antibiotics|antibiotics
47640|NCT03904836|Renal Insufficiency, Chronic|renal insufficiency, chronic
47641|NCT03904810|HIIT|hiit
47642|NCT03904810|Exercise frequency|exercise frequency
47643|NCT03904810|Exercise intensity|exercise intensity
47644|NCT03904797|patient-reported outcome|patient-reported outcome
47645|NCT03904797|electronic|electronic
47646|NCT03904797|participation|participation
47647|NCT03904797|early intervention|early intervention
47648|NCT03904758|extraesophageal reflux|extraesophageal reflux
47649|NCT03904758|laryngopharyngeal reflux|laryngopharyngeal reflux
47650|NCT03904758|pepsin|pepsin
47651|NCT03904758|saliva|saliva
47652|NCT03904758|oropharyngeal pH monitoring|oropharyngeal ph monitoring
47653|NCT03904758|esophageal impedance|esophageal impedance
47654|NCT03904745|in vitro fertilization|in vitro fertilization
47655|NCT03904745|atosiban|atosiban
47656|NCT03904745|embryo transfer|embryo transfer
47657|NCT03904745|oxytocin antagonist|oxytocin antagonist
47658|NCT03904706|Facility-based|facility-based
47659|NCT03904706|Mortality|mortality
47660|NCT03904706|Audits|audits
47661|NCT03904706|Community engagement|community engagement
47662|NCT03904706|Gilgit-Baltistan|gilgit-baltistan
47663|NCT03904706|Pakistan|pakistan
47664|NCT03904693|Pulmonary Arterial Hypertension|pulmonary arterial hypertension
47665|NCT03904693|PAH|pah
47666|NCT03904693|macitentan|macitentan
47667|NCT03904693|tadalafil|tadalafil
47668|NCT03904693|fixed dose combination therapy|fixed dose combination therapy
47669|NCT03904680|Psoriasis|psoriasis
47670|NCT03904680|Cardiovascular risk|cardiovascular risk
47671|NCT03904680|Methotrexate|methotrexate
47672|NCT03904680|Vitamin D|vitamin d
47673|NCT03904667|Watson artificial intelligence|watson artificial intelligence
47674|NCT03904667|hepatocellular carcinoma|hepatocellular carcinoma
47675|NCT03904667|surgical decisions|surgical decisions
47676|NCT03904654|Parkinson's disease|parkinson's disease
47677|NCT03904654|Mindfulness-based intervention|mindfulness-based intervention
47678|NCT03904654|Mindfulness-based cognitive therapy (MBCT)|mindfulness-based cognitive therapy (mbct)
47679|NCT03904602|Chronic Venous Insufficiency|chronic venous insufficiency
47680|NCT03904602|CVI|cvi
47681|NCT03904563|bevacizumab|bevacizumab
47682|NCT03904563|Split-course Chemoradiotherapy|split-course chemoradiotherapy
47683|NCT03904537|Colorectal Cancer|colorectal cancer
47684|NCT03904537|TIL|til
47685|NCT03904537|immunotherapy|immunotherapy
47686|NCT03904524|Intensive Care Unit|intensive care unit
47687|NCT03904524|Serious Illness Communication|serious illness communication
47688|NCT03904524|Clinician-Family Communication|clinician-family communication
47689|NCT03904524|Family Support|family support
47690|NCT03904485|SPK ,DCM,CMR|spk ,dcm,cmr
47691|NCT03904472|cognitive behavioral therapy|cognitive behavioral therapy
47692|NCT03904472|GERD|gerd
47693|NCT03904459|Temporomandibular Joint|temporomandibular joint
47694|NCT03904459|Oral Health|oral health
47695|NCT03904459|Bone & Bones|bone & bones
47696|NCT03904459|Bone Density|bone density
47697|NCT03904459|Quality of Life|quality of life
47698|NCT03904446|Methergine|methergine
47699|NCT03904446|Uterine Atony|uterine atony
47700|NCT03904407|overactive bladder|overactive bladder
47701|NCT03904407|probiotic|probiotic
47702|NCT03904407|anticholinergic|anticholinergic
47703|NCT03904407|beta-3 agonist|beta-3 agonist
47704|NCT03904342|Cognitive behavioral therapy (CBT)|cognitive behavioral therapy (cbt)
47705|NCT03904342|Sophie CBT|sophie cbt
47706|NCT03904342|iHope CBT|ihope cbt
47707|NCT03904342|Consolidated Framework for Implementation Research (CFIR)|consolidated framework for implementation research (cfir)
47708|NCT03904264|tinnitus|tinnitus
47709|NCT03904264|hearing aids|hearing aids
47710|NCT03904264|normal hearing|normal hearing
47711|NCT03904251|AML, Leukemia|aml, leukemia
47712|NCT03904238|Hypersomnia|hypersomnia
47713|NCT03904238|narcolepsy|narcolepsy
47714|NCT03904238|idiopathic hypersomnia|idiopathic hypersomnia
47715|NCT03904238|psychosocial|psychosocial
47716|NCT03904238|cognitive-behavior therapy|cognitive-behavior therapy
47717|NCT03904225|adjuvant chemotherapy|adjuvant chemotherapy
47718|NCT03904225|Tegio|tegio
47719|NCT03904199|High Blood Sugar|high blood sugar
47720|NCT03904199|High Blood Glucose|high blood glucose
47721|NCT03904186|Tobacco Use|tobacco use
47722|NCT03904186|Tobacco Use Disorder|tobacco use disorder
47723|NCT03904186|Substance-Related Disorders|substance-related disorders
47724|NCT03904186|Nicotine|nicotine
47725|NCT03904186|Ganglionic Stimulants|ganglionic stimulants
47726|NCT03904186|Autonomic Agents|autonomic agents
47727|NCT03904186|Peripheral Nervous System Agents|peripheral nervous system agents
47728|NCT03904186|Physiological Effects of Drugs|physiological effects of drugs
47729|NCT03904186|Nicotinic Agonists|nicotinic agonists
47730|NCT03904186|Cholinergic Agonists|cholinergic agonists
47731|NCT03904186|Cholinergic Agents|cholinergic agents
47732|NCT03904186|Neurotransmitter Agents|neurotransmitter agents
47733|NCT03904186|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action
47734|NCT03904186|HIV|hiv
47735|NCT03904186|Anxious|anxious
47736|NCT03904186|Anxiety Symptoms|anxiety symptoms
47737|NCT03904186|Depressive Symptoms|depressive symptoms
47738|NCT03904186|Quitting|quitting
47739|NCT03904186|Cognitive Behavioral Therapy|cognitive behavioral therapy
47740|NCT03904186|Anxiety Sensitivity|anxiety sensitivity
47741|NCT03904186|Distress Intolerance|distress intolerance
47742|NCT03904186|Anhedonia|anhedonia
47841|NCT03903497|Diminutive colorectal polyps|diminutive colorectal polyps
47744|NCT03904173|human epidermal growth factor receptor 2 negative|human epidermal growth factor receptor 2 negative
47745|NCT03904121|Colon cancer surgery octogenarian postoperative outcome|colon cancer surgery octogenarian postoperative outcome
47746|NCT03904108|NSCLC|nsclc
47747|NCT03904108|Immunotherapy|immunotherapy
47748|NCT03904108|Ramucirumab|ramucirumab
47749|NCT03904108|anti-PD-1|anti-pd-1
47750|NCT03904095|Erector spinae block|erector spinae block
47751|NCT03904095|hip arthroplasty|hip arthroplasty
47752|NCT03904095|postoperative analgesia|postoperative analgesia
47753|NCT03904095|psoas compartment block|psoas compartment block
47754|NCT03904095|ultrasound|ultrasound
47755|NCT03904082|dispne, pain|dispne, pain
47756|NCT03904069|Relapsed/refractory acute myeloid leukemia|relapsed/refractory acute myeloid leukemia
47757|NCT03904069|Acute myeloid leukemia|acute myeloid leukemia
47758|NCT03904069|Oncology/hematology|oncology/hematology
47759|NCT03904069|CAR T cell therapy|car t cell therapy
47760|NCT03904056|Diabetic Retinopathy|diabetic retinopathy
47761|NCT03904056|Macular Edema|macular edema
47762|NCT03904030|knee arthroplasty|knee arthroplasty
47763|NCT03904030|rehabilitation|rehabilitation
47764|NCT03904030|anti-gravity treadmill|anti-gravity treadmill
47765|NCT03904030|Randomized study|randomized study
47766|NCT03904004|esophageal motility disorders|esophageal motility disorders
47767|NCT03904004|laparoscopic Heller myotomy|laparoscopic heller myotomy
47768|NCT03904004|peroral endoscopic myotomy|peroral endoscopic myotomy
47769|NCT03904004|neumatic cilatation|neumatic cilatation
47770|NCT03904004|botulinic toxin injection|botulinic toxin injection
47771|NCT03904004|gastro esophageal reflux|gastro esophageal reflux
47772|NCT03903991|Thoracic surgery|thoracic surgery
47773|NCT03903991|Body temperature|body temperature
47774|NCT03903978|Resilience|resilience
47775|NCT03903978|University students|university students
47776|NCT03903978|Prevention|prevention
47777|NCT03903978|Online intervention|online intervention
47778|NCT03903965|diabetes|diabetes
47779|NCT03903965|OCT Angiography|oct angiography
47780|NCT03903965|cataract surgery|cataract surgery
47781|NCT03903952|ASCUS|ascus
47782|NCT03903952|HPV|hpv
47783|NCT03903952|Vitamine B12|vitamine b12
47784|NCT03903952|Folate|folate
47785|NCT03903939|Trauma patients|trauma patients
47786|NCT03903939|Shock-induced endotheliopathy|shock-induced endotheliopathy
47787|NCT03903926|EV71 vaccine; Efficacy; Seroprotective correlates|ev71 vaccine; efficacy; seroprotective correlates
47788|NCT03903913|Asthma|asthma
47789|NCT03903913|Carbon dioxide|carbon dioxide
47790|NCT03903913|Perfluorocarbon|perfluorocarbon
47791|NCT03903913|Mucolytic|mucolytic
47792|NCT03903900|Activities of daily living|activities of daily living
47793|NCT03903900|Occupational performance|occupational performance
47794|NCT03903900|Quality of life|quality of life
47795|NCT03903900|Health behaviour change|health behaviour change
47796|NCT03903900|Healthy eating|healthy eating
47797|NCT03903900|Physical activity|physical activity
47798|NCT03903900|Occupational Therapy|occupational therapy
47799|NCT03903887|Lung Cancer|lung cancer
47800|NCT03903887|TIL|til
47801|NCT03903887|immunotherapy|immunotherapy
47804|NCT03903796|HBeAg-positive or negative|hbeag-positive or negative
47805|NCT03903757|Epigenetics|epigenetics
47806|NCT03903757|Network medicine|network medicine
47807|NCT03903757|Personalized therapy|personalized therapy
47808|NCT03903744|syncope|syncope
47809|NCT03903744|cardioneuroablation|cardioneuroablation
47810|NCT03903744|cardioneuromodulation|cardioneuromodulation
47811|NCT03903718|Influenza|influenza
47812|NCT03903718|Influenza A|influenza a
47813|NCT03903718|Flu|flu
47814|NCT03903718|Flu A|flu a
47815|NCT03903705|Fruquintinib|fruquintinib
47816|NCT03903705|Sintilimab|sintilimab
47817|NCT03903705|VEGFR|vegfr
47818|NCT03903705|PD-1|pd-1
47819|NCT03903705|Solid Tumor|solid tumor
47820|NCT03903679|Airway management|airway management
47821|NCT03903679|Septal surgery|septal surgery
47822|NCT03903679|Laryngeal mask airway|laryngeal mask airway
47823|NCT03903679|Endotracheal tube|endotracheal tube
47824|NCT03903679|Presence of tracheal blood|presence of tracheal blood
47825|NCT03903666|Sleep Apnoa|sleep apnoa
47826|NCT03903666|Down Syndrome|down syndrome
47827|NCT03903666|Children|children
47828|NCT03903666|OSA|osa
47829|NCT03903627|verbal cue, pelvic diaphragm, stroke|verbal cue, pelvic diaphragm, stroke
47830|NCT03903614|Developmental Dysgraphia|developmental dysgraphia
47831|NCT03903614|Ambidexterity|ambidexterity
47832|NCT03903614|Outcome study|outcome study
47833|NCT03903601|trimethylamine-N-oxide|trimethylamine-n-oxide
47834|NCT03903601|magnetic resonance imaging|magnetic resonance imaging
47835|NCT03903601|cognitive functions|cognitive functions
47836|NCT03903510|Virtual Reality|virtual reality
47837|NCT03903510|Cast removal|cast removal
47838|NCT03903510|Fracture|fracture
47839|NCT03903497|Narrow band imaging|narrow band imaging
47840|NCT03903497|WASP classification|wasp classification
47843|NCT03903484|Deprescribing|deprescribing
47845|NCT03903471|Mediastinal and Hilar Lymphadenopathy|mediastinal and hilar lymphadenopathy
47846|NCT03903471|EBUS-TBNA|ebus-tbna
47847|NCT03903471|Diagnostic Yield|diagnostic yield
47848|NCT03903471|Quality of Specimen|quality of specimen
47849|NCT03903458|systemic anticancer treatment|systemic anticancer treatment
47850|NCT03903458|immunotherapy|immunotherapy
47851|NCT03903458|epigenetic treatment|epigenetic treatment
47852|NCT03903445|Parenting Program|parenting program
47853|NCT03903432|MRI|mri
47854|NCT03903432|CT|ct
47855|NCT03903432|Chronic Sinusitis|chronic sinusitis
47856|NCT03903432|ESS|ess
47857|NCT03903406|quality of life|quality of life
47858|NCT03903380|Virtual reality|virtual reality
47859|NCT03903380|Therapeuthic exercise|therapeuthic exercise
47860|NCT03903380|Quantitative sensory testing|quantitative sensory testing
47861|NCT03903341|Superior colliculus|superior colliculus
47862|NCT03903341|fMRI|fmri
47863|NCT03903328|muscle strength|muscle strength
47864|NCT03903328|physical performance|physical performance
47865|NCT03903328|Sarcopenia|sarcopenia
47866|NCT03903302|tissue-plasminogen activator (t-PA)|tissue-plasminogen activator (t-pa)
47867|NCT03903302|plasminogen-activator inhibitor 1 (PAI-1)|plasminogen-activator inhibitor 1 (pai-1)
47868|NCT03903302|fibrinolysis|fibrinolysis
47869|NCT03903302|thrombosis|thrombosis
47870|NCT03903263|dermatologic disease|dermatologic disease
47871|NCT03903250|A-GPC|a-gpc
47872|NCT03903250|focus|focus
47873|NCT03903250|non-resistance trained|non-resistance trained
47874|NCT03903237|post-zoster neuralgia|post-zoster neuralgia
47875|NCT03903237|Herpes Zoster-related complications|herpes zoster-related complications
47876|NCT03903224|Breast Cancer|breast cancer
47877|NCT03903224|Regional Anaesthesia|regional anaesthesia
47878|NCT03903224|Morphine Consumption|morphine consumption
47879|NCT03903211|[18F]PI-2620|[18f]pi-2620
47880|NCT03903211|tauopathy|tauopathy
47881|NCT03903211|positron emission computed tomography|positron emission computed tomography
47882|NCT03903185|Hepatitis C virus|hepatitis c virus
47883|NCT03903185|Pharmacokinetic Modeling|pharmacokinetic modeling
47884|NCT03903185|Pharmacokinetics|pharmacokinetics
47885|NCT03903185|Pediatrics|pediatrics
47886|NCT03903185|Leukemia|leukemia
47887|NCT03903185|Ledipasvir|ledipasvir
47888|NCT03903185|Sofosbuvir|sofosbuvir
47889|NCT03903185|Antiviral Drugs|antiviral drugs
47890|NCT03903172|pain management|pain management
47891|NCT03903172|vaginal delivery|vaginal delivery
47892|NCT03903172|nonpharmacologic|nonpharmacologic
47893|NCT03903172|abdominal binder|abdominal binder
47894|NCT03903146|Breastfeeding|breastfeeding
47895|NCT03903146|Exclusive breastfeeding|exclusive breastfeeding
47896|NCT03903146|Hispanic Women|hispanic women
47897|NCT03903146|Kentucky|kentucky
47898|NCT03903094|anticholinergic burden|anticholinergic burden
47899|NCT03903094|anticholinergic|anticholinergic
47900|NCT03903094|overactive bladder|overactive bladder
47901|NCT03903068|transcranial alternating current stimulation|transcranial alternating current stimulation
47902|NCT03903055|MDS|mds
47903|NCT03903055|RNA-seq|rna-seq
47904|NCT03903042|Aurora fundus camera|aurora fundus camera
47905|NCT03903042|Artificial intelligence|artificial intelligence
47906|NCT03903042|Diabetic retinopathy|diabetic retinopathy
47907|NCT03903029|Cholesterol, LDL|cholesterol, ldl
47908|NCT03903029|Asian|asian
47909|NCT03903029|Rosuvastatin|rosuvastatin
47910|NCT03903029|Low-dose|low-dose
47911|NCT03903003|high flow nasal oxygen (POİNT)|high flow nasal oxygen (point)
47912|NCT03902990|dual task, treadmill, cognitive rehabilitation|dual task, treadmill, cognitive rehabilitation
47913|NCT03902925|vitrectomy|vitrectomy
47914|NCT03902925|anesthesia|anesthesia
47915|NCT03902925|retinal disease|retinal disease
47916|NCT03902925|Pain|pain
815275|NCT00181675|Adult|adult
47917|NCT03902925|diabetic retinopathy|diabetic retinopathy
47918|NCT03902925|maculopathy|maculopathy
47919|NCT03902912|recurrent miscarriage|recurrent miscarriage
47920|NCT03902912|prednisolone treatment|prednisolone treatment
47921|NCT03902886|toddlers, gait|toddlers, gait
47922|NCT03902847|motor imagery|motor imagery
47923|NCT03902847|action observation|action observation
47924|NCT03902847|motor learning|motor learning
47925|NCT03902795|Rhegmatogenous retinal detachment|rhegmatogenous retinal detachment
47926|NCT03902795|Vitrectomy|vitrectomy
47927|NCT03902795|Metamorphopsia|metamorphopsia
47928|NCT03902795|M-charts|m-charts
47929|NCT03902795|Microperimetry|microperimetry
47930|NCT03902730|Electromyography|electromyography
47931|NCT03902730|Resistance trained|resistance trained
47932|NCT03902717|Minimally invasive cardiac surgery|minimally invasive cardiac surgery
47933|NCT03902717|Endoscopic coronary artery bypass grafting|endoscopic coronary artery bypass grafting
47934|NCT03902704|videolaryngoscopy|videolaryngoscopy
47935|NCT03902704|tracheal intubation|tracheal intubation
47936|NCT03902678|EUS|eus
47937|NCT03902678|FNA|fna
47938|NCT03902678|PVT|pvt
47939|NCT03902652|Chest Compression|chest compression
47940|NCT03902652|Newborn|newborn
47941|NCT03902652|Infant|infant
47942|NCT03902652|Sustained Inflation|sustained inflation
47943|NCT03902639|High flow nasal cannual|high flow nasal cannual
47944|NCT03902639|Airway pressure|airway pressure
47945|NCT03902639|Lung volume|lung volume
47946|NCT03902639|Non-invasive ventilation|non-invasive ventilation
47947|NCT03902626|attitudes|attitudes
47948|NCT03902626|chronic low back pain|chronic low back pain
47949|NCT03902626|functionality|functionality
47950|NCT03902626|healthcare professional students|healthcare professional students
47951|NCT03902509|pirfenidone|pirfenidone
47952|NCT03902418|Prevention in Pregnant and Breastfeeding Women|prevention in pregnant and breastfeeding women
47953|NCT03902418|HIV Pre-Exposure Prophylaxis (PrEP)|hiv pre-exposure prophylaxis (prep)
47954|NCT03902392|Allergic contact dermatitis|allergic contact dermatitis
47955|NCT03902392|Cytokines|cytokines
47956|NCT03902392|Cellular and molecular rehabilitation|cellular and molecular rehabilitation
47957|NCT03902392|Immune response|immune response
47958|NCT03902392|Nickel|nickel
47959|NCT03902392|Polyphenols|polyphenols
47960|NCT03902366|Hepatitis C|hepatitis c
47961|NCT03902366|Direct-acting antiviral therapies|direct-acting antiviral therapies
47962|NCT03902366|DAA|daa
47963|NCT03902366|Chronic HCV infection|chronic hcv infection
47964|NCT03902366|Alcohol Use Disorder|alcohol use disorder
47965|NCT03902353|Pulmonary veino occlusive disease, pulmonary hypertension|pulmonary veino occlusive disease, pulmonary hypertension
47966|NCT03902340|Pain|pain
47967|NCT03902340|Knee osteoarthritis (KOA)|knee osteoarthritis (koa)
47968|NCT03902340|Nociceptive pain|nociceptive pain
47969|NCT03902340|TENS|tens
47970|NCT03902340|Step 2 analgesics|step 2 analgesics
47971|NCT03902327|N - acetylocysteine|n - acetylocysteine
47972|NCT03902327|Obesity|obesity
47973|NCT03902327|Insulin resistance|insulin resistance
47974|NCT03902327|Nutrition intervention|nutrition intervention
47975|NCT03902327|Carbohydrate Metabolism|carbohydrate metabolism
47976|NCT03902314|Lidocaine|lidocaine
47977|NCT03902314|Tonsillectomy and Adenoidectomy|tonsillectomy and adenoidectomy
47978|NCT03902314|Pain|pain
47979|NCT03902301|Lactobacillus rhamnosus|lactobacillus rhamnosus
47980|NCT03902301|Polycystic Ovary Syndrome|polycystic ovary syndrome
47981|NCT03902301|insulin resistance|insulin resistance
47982|NCT03902301|nutrition intervention|nutrition intervention
47983|NCT03902301|probiotic|probiotic
47984|NCT03902288|Patients with type 2 diabetes|patients with type 2 diabetes
47985|NCT03902288|Fresh pomegranate juice|fresh pomegranate juice
47986|NCT03902288|Fasting serum glucose|fasting serum glucose
47987|NCT03902275|cardiac surgery|cardiac surgery
47988|NCT03902275|bleeding|bleeding
47989|NCT03902275|point of care testing|point of care testing
47990|NCT03902275|POCT|poct
47991|NCT03902275|algorithm based therapy|algorithm based therapy
47992|NCT03902249|Intravenous Dexamethasone|intravenous dexamethasone
47993|NCT03902249|Pudendal nerve block|pudendal nerve block
47994|NCT03902249|Analgesia|analgesia
47995|NCT03902249|Postoperative pain|postoperative pain
47996|NCT03902249|Children|children
47997|NCT03902249|Hypospadias|hypospadias
47998|NCT03902236|postural control|postural control
47999|NCT03902236|reaction time|reaction time
48000|NCT03902236|cystic fibrosis|cystic fibrosis
48001|NCT03902236|Bronchiectasis|bronchiectasis
48002|NCT03902223|sarcoidosis|sarcoidosis
48003|NCT03902223|cardiac sarcoidosis|cardiac sarcoidosis
48004|NCT03902223|cardiac sarcoidosis screening|cardiac sarcoidosis screening
48005|NCT03902197|CD19 hsCAR-T|cd19 hscar-t
48006|NCT03902197|B-ALL|b-all
48007|NCT03902197|Humanized selective CAR|humanized selective car
48008|NCT03902145|Complementary Feeding|complementary feeding
48009|NCT03902145|Animal Source Foods|animal source foods
48010|NCT03902145|Bone Age|bone age
48011|NCT03902145|Stunting|stunting
48012|NCT03902145|Ecuador|ecuador
48013|NCT03902145|Follow Up Cohort|follow up cohort
48014|NCT03902132|Backache|backache
48015|NCT03902132|Core Stability exercises|core stability exercises
48016|NCT03902132|Post menopausal|post menopausal
48017|NCT03902119|neck pain|neck pain
48018|NCT03902119|randomized control trial|randomized control trial
48019|NCT03902119|manual therapy|manual therapy
48020|NCT03902119|physical therapy|physical therapy
48021|NCT03902119|suboccipital inhibition|suboccipital inhibition
48022|NCT03902093|hearing loss, hearing aid|hearing loss, hearing aid
48023|NCT03902080|Overactive Bladder|overactive bladder
48024|NCT03902080|Benign Prostatic Hyperplasia|benign prostatic hyperplasia
48025|NCT03902080|Vibegron|vibegron
48026|NCT03902080|Beta-3 adrenergic receptor (β3-AR)|beta-3 adrenergic receptor (β3-ar)
48027|NCT03902080|β3-AR agonist|β3-ar agonist
48028|NCT03902067|AMI|ami
48029|NCT03902028|Heart failure|heart failure
48030|NCT03902028|pharmacist|pharmacist
48031|NCT03902028|multidisciplinary team|multidisciplinary team
48032|NCT03902028|readmission|readmission
48033|NCT03902015|Attention Deficit/Hyperactivity Disorder|attention deficit/hyperactivity disorder
48034|NCT03902002|RTA 408|rta 408
48035|NCT03902002|RTA 408 capsules|rta 408 capsules
48036|NCT03902002|Omaveloxolone|omaveloxolone
48037|NCT03902002|Omaveloxolone capsules|omaveloxolone capsules
48038|NCT03902002|Hepatic impairment|hepatic impairment
48039|NCT03901937|postoperative complications|postoperative complications
48040|NCT03901924|Diaphragm Atrophy|diaphragm atrophy
48041|NCT03901924|Ventilator Induced Diaphragm Dysfunction|ventilator induced diaphragm dysfunction
48042|NCT03901924|Mechanical Ventilation|mechanical ventilation
48043|NCT03901924|Volume Support Mode|volume support mode
48044|NCT03901924|Assist Control Mode|assist control mode
48045|NCT03901924|Diaphragm Thickening Fraction|diaphragm thickening fraction
48046|NCT03901924|Intubation|intubation
48047|NCT03901924|Delirium|delirium
48048|NCT03901924|Ventilator-Free Days|ventilator-free days
48049|NCT03901898|screening|screening
48050|NCT03901898|primary care|primary care
48051|NCT03901898|general practice|general practice
48052|NCT03901898|feasibility|feasibility
48054|NCT03901859|tryptophan|tryptophan
48055|NCT03901859|executive function|executive function
48056|NCT03901820|Electronic Record|electronic record
48057|NCT03901820|Drug interaction|drug interaction
48058|NCT03901820|Polypharmacy|polypharmacy
48060|NCT03901820|Adverse Drug reaction|adverse drug reaction
48061|NCT03901807|sepsis|sepsis
48062|NCT03901807|septic shock|septic shock
48063|NCT03901807|severe sepsis|severe sepsis
48064|NCT03901807|endotoxemia|endotoxemia
48065|NCT03901807|endotoxemic|endotoxemic
48066|NCT03901807|TIGRIS|tigris
48067|NCT03901807|PMX|pmx
48068|NCT03901807|Toraymyxin|toraymyxin
48069|NCT03901807|EAA|eaa
48070|NCT03901755|Blood Coagulation Disorder|blood coagulation disorder
48071|NCT03901755|Hematologic Diseases|hematologic diseases
48072|NCT03901755|Coagulation Protein Disorder|coagulation protein disorder
48073|NCT03901755|Hemorrhagic Disorder|hemorrhagic disorder
48074|NCT03901755|Genetic Diseases, Inborn|genetic diseases, inborn
48075|NCT03901742|Children|children
48076|NCT03901742|Intensive Care|intensive care
48077|NCT03901742|Nutrition|nutrition
48078|NCT03901742|Enteral feeding|enteral feeding
48079|NCT03901742|Protein intake|protein intake
48080|NCT03901742|Protein balance.|protein balance.
48081|NCT03901742|Lean Body Mass|lean body mass
48082|NCT03901729|Chronic heart failure (CHF)|chronic heart failure (chf)
48083|NCT03901729|Heart failure with reduced ejection fraction (HFrEF)|heart failure with reduced ejection fraction (hfref)
48084|NCT03901729|Heart failure with preserved ejection fraction (HFpEF)|heart failure with preserved ejection fraction (hfpef)
48085|NCT03901729|Heart failure with mid-range ejection fraction (HFmrEF)|heart failure with mid-range ejection fraction (hfmref)
48086|NCT03901690|Betaglucin soluble gel|betaglucin soluble gel
48087|NCT03901690|Ano-genital warts|ano-genital warts
48088|NCT03901690|Clearance|clearance
48089|NCT03901690|Human papillomavirus|human papillomavirus
48090|NCT03901677|exercise|exercise
48091|NCT03901677|Awareness|awareness
48092|NCT03901677|posture|posture
48093|NCT03901651|colonic polyps|colonic polyps
48094|NCT03901638|multiple system atrophy, cerebellar ataxia, NMDA, microbiota|multiple system atrophy, cerebellar ataxia, nmda, microbiota
48095|NCT03901547|documentation|documentation
48096|NCT03901547|serious illness|serious illness
48097|NCT03901534|Interstitial Lung Disease (ILD)|interstitial lung disease (ild)
48098|NCT03901534|Idiopathic Pulmonary Fibrosis (IPF)|idiopathic pulmonary fibrosis (ipf)
48099|NCT03901534|Obstructive Sleep Apnea (OSA)|obstructive sleep apnea (osa)
48100|NCT03901534|CPAP|cpap
48101|NCT03901508|tDCS|tdcs
48102|NCT03901508|Athlete|athlete
48103|NCT03901508|Isokinetic|isokinetic
48104|NCT03901508|Strength|strength
48105|NCT03901508|Endurance|endurance
48106|NCT03901495|differential diagnosis|differential diagnosis
48107|NCT03901495|hospital outpatient clinics|hospital outpatient clinics
48108|NCT03901495|clinical applications software|clinical applications software
63491|NCT03807609|obesity|obesity
48109|NCT03901482|dihydroergotamine|dihydroergotamine
48110|NCT03901482|dihydroergotamine mesylate|dihydroergotamine mesylate
48111|NCT03901482|migraine|migraine
48112|NCT03901469|TNBC|tnbc
48113|NCT03901469|ZEN003694|zen003694
48114|NCT03901469|ZEN-3694|zen-3694
48115|NCT03901469|Talazoparib|talazoparib
48116|NCT03901469|Breast Cancer|breast cancer
48117|NCT03901469|PARPi|parpi
48118|NCT03901469|poly ADP ribose polymerase|poly adp ribose polymerase
48119|NCT03901469|bromodomain|bromodomain
48120|NCT03901469|BETi|beti
48121|NCT03901456|Caregiving|caregiving
48122|NCT03901443|itchy skin diseases|itchy skin diseases
48123|NCT03901443|itch treatments|itch treatments
48124|NCT03901443|pruriception|pruriception
48125|NCT03901404|Myomectomy|myomectomy
48126|NCT03901404|Fundus Incision|fundus incision
48127|NCT03901404|Energy Modalities|energy modalities
48128|NCT03901404|Methods of Extraction|methods of extraction
48129|NCT03901378|Neuroendocrine carcinoma|neuroendocrine carcinoma
48130|NCT03901378|Gastroenteropancreatic|gastroenteropancreatic
48131|NCT03901378|Large cell neuroendocrine|large cell neuroendocrine
48132|NCT03901365|Manual Therapy|manual therapy
48133|NCT03901365|Neuroscience pain education|neuroscience pain education
48134|NCT03901365|Quality of life|quality of life
48135|NCT03901365|Chronic low back pain|chronic low back pain
48136|NCT03901352|Central neuropathic pain|central neuropathic pain
48142|NCT03901339|progesterone receptor|progesterone receptor
48143|NCT03901339|hormonal receptor|hormonal receptor
48145|NCT03901339|Unresectable or Metastatic Breast Cancer|unresectable or metastatic breast cancer
48146|NCT03901339|Human epidermal growth factor receptor 2 (HER2) Negative|human epidermal growth factor receptor 2 (her2) negative
48147|NCT03901339|ADC|adc
48148|NCT03901339|Antibody Drug Conjugate|antibody drug conjugate
48149|NCT03901326|Coronary artery disease|coronary artery disease
48150|NCT03901326|Coronary computed tomographic angiography|coronary computed tomographic angiography
48151|NCT03901326|Fractional flow reserve|fractional flow reserve
48152|NCT03901313|Pharmacokinetics|pharmacokinetics
48153|NCT03901287|pulmonary hypertension|pulmonary hypertension
48154|NCT03901287|dual energy CT|dual energy ct
48155|NCT03901287|quantification|quantification
48156|NCT03901287|lung perfusion|lung perfusion
48157|NCT03901287|prediction|prediction
48158|NCT03901274|School-based services|school-based services
48159|NCT03901274|Stakeholder Engagement|stakeholder engagement
48160|NCT03901274|Middle School|middle school
48161|NCT03901261|Down Syndrome|down syndrome
48162|NCT03901261|Alzheimer Disease|alzheimer disease
48163|NCT03901261|Marker|marker
48164|NCT03901261|Neuropsychological|neuropsychological
48165|NCT03901261|Prodromal|prodromal
48166|NCT03901261|Risk factors|risk factors
48167|NCT03901222|tDCS|tdcs
48168|NCT03901222|Athlete|athlete
48169|NCT03901222|Endurance|endurance
48170|NCT03901222|Fatigue|fatigue
48171|NCT03901222|3D|3d
48172|NCT03901196|Laser Induced Breakdown Spectroscopy|laser induced breakdown spectroscopy
48173|NCT03901196|Multi elemental imaging|multi elemental imaging
48174|NCT03901183|Metabolic Syndrom|metabolic syndrom
48175|NCT03901183|Plant-based Diet|plant-based diet
48176|NCT03901183|Nutrition|nutrition
48177|NCT03901170|In Vitro Fertilization|in vitro fertilization
48178|NCT03901170|letrozole|letrozole
48179|NCT03901170|endometrial receptivity|endometrial receptivity
48180|NCT03901157|satiety|satiety
48181|NCT03901157|lipids in alginate gel|lipids in alginate gel
48182|NCT03901157|food intake|food intake
48183|NCT03901144|atopic dermatitis|atopic dermatitis
48184|NCT03901144|skin barrier|skin barrier
48185|NCT03901144|moisturiser|moisturiser
48186|NCT03901144|emollient|emollient
48187|NCT03901118|ovarian cancer, relapsed or refractory|ovarian cancer, relapsed or refractory
48188|NCT03901118|chiauranib, chemotherapy|chiauranib, chemotherapy
48189|NCT03901092|flortaucipir F 18|flortaucipir f 18
48190|NCT03901092|Positron Emission Tomography|positron emission tomography
48191|NCT03901092|18F-AV-1451|18f-av-1451
48192|NCT03901092|Diagnostic imaging|diagnostic imaging
48193|NCT03901092|Tau imaging|tau imaging
48194|NCT03901053|Ankle Foot Orthoses|ankle foot orthoses
48195|NCT03901053|Carbon Fiber|carbon fiber
48196|NCT03901053|Gait|gait
48197|NCT03901053|Adult|adult
48198|NCT03901053|Biomechanics|biomechanics
48199|NCT03901053|Materials Testing|materials testing
48200|NCT03901053|Physical Performance|physical performance
48201|NCT03901027|Parents|parents
48202|NCT03901027|Children|children
48203|NCT03901027|Chronic Illnesses|chronic illnesses
48204|NCT03901014|ketogenic diet|ketogenic diet
48205|NCT03901014|LDL cholesterol|ldl cholesterol
48206|NCT03901014|carbohydrate|carbohydrate
48207|NCT03901001|respiratory|respiratory
48208|NCT03901001|Mortality|mortality
48209|NCT03901001|cytokines|cytokines
48210|NCT03901001|chemokines|chemokines
400504|NCT01866592|Metabolic biomarkers|metabolic biomarkers
400505|NCT01866592|FDG-PET/CT|fdg-pet/ct
48211|NCT03900988|respiratory, mortality, cytokines, chemokines, N-acetylcysteine (NAC)|respiratory, mortality, cytokines, chemokines, n-acetylcysteine (nac)
48218|NCT03900949|Acute Myeloid Leukemia|acute myeloid leukemia
48219|NCT03900949|FLT3|flt3
48220|NCT03900949|FLT-3|flt-3
48221|NCT03900923|cannabidiol (CBD)|cannabidiol (cbd)
48222|NCT03900910|Cancer prevention; Antibiotics; Inequality|cancer prevention; antibiotics; inequality
48223|NCT03900858|rifapentine|rifapentine
48224|NCT03900858|isoniazid|isoniazid
48225|NCT03900858|preventive|preventive
48226|NCT03900845|lower limb prosthesis|lower limb prosthesis
48227|NCT03900845|transtibial amputation|transtibial amputation
48228|NCT03900845|below knee amputation|below knee amputation
48229|NCT03900845|adherence|adherence
48230|NCT03900845|perspiration|perspiration
48231|NCT03900832|exercise|exercise
48232|NCT03900832|blood pressure response|blood pressure response
48233|NCT03900832|heating|heating
48234|NCT03900806|Cancer, Cognitive rehabilitation, eHealth|cancer, cognitive rehabilitation, ehealth
48235|NCT03900793|Pediatrics|pediatrics
48236|NCT03900793|Adults|adults
48237|NCT03900793|Phase 1|phase 1
48238|NCT03900793|Losartan|losartan
48239|NCT03900793|Sunitinib|sunitinib
48240|NCT03900793|Maximum Tolerated Dose|maximum tolerated dose
48241|NCT03900793|Recommended Phase 2 Dose|recommended phase 2 dose
48242|NCT03900754|Oxytocin|oxytocin
48243|NCT03900741|Peri-Implantitis|peri-implantitis
48244|NCT03900741|Peri-Implant Diseases|peri-implant diseases
48245|NCT03900741|Bone Regeneration|bone regeneration
48246|NCT03900741|Submerged Healing|submerged healing
48247|NCT03900741|Non-Submerged Healing|non-submerged healing
48248|NCT03900741|Dental Implants|dental implants
48249|NCT03900715|Myelodysplastic Syndromes|myelodysplastic syndromes
48250|NCT03900715|MDS|mds
48251|NCT03900715|ACE-536|ace-536
48252|NCT03900715|Anemia|anemia
48253|NCT03900650|Condom use resistance|condom use resistance
48254|NCT03900650|Emotion dysregulation|emotion dysregulation
48255|NCT03900572|Human Papilloma Virus|human papilloma virus
48256|NCT03900572|Papillomavirus vaccines|papillomavirus vaccines
48257|NCT03900572|Cervical Cancer|cervical cancer
48258|NCT03900572|Genital Warts|genital warts
48259|NCT03900559|Specific Phobia|specific phobia
48260|NCT03900559|Computer-Assisted Exposure|computer-assisted exposure
48261|NCT03900559|Self-help|self-help
48262|NCT03900559|Internet-based Therapy|internet-based therapy
48263|NCT03900559|Sense of presence|sense of presence
48264|NCT03900533|child psychiatry|child psychiatry
48265|NCT03900533|emotion regulation skills training|emotion regulation skills training
48266|NCT03900520|pneumococcal conjugate vaccine|pneumococcal conjugate vaccine
48267|NCT03900520|vaccine impact|vaccine impact
48268|NCT03900520|radiographic pneumonia|radiographic pneumonia
48269|NCT03900520|hospitalization|hospitalization
48270|NCT03900520|nasopharyngeal swab|nasopharyngeal swab
48271|NCT03900520|India|india
48272|NCT03900520|cost of illness|cost of illness
48273|NCT03900520|pneumococcal carriage|pneumococcal carriage
48274|NCT03900520|pneumococcal serotypes|pneumococcal serotypes
48275|NCT03900520|pneumonia|pneumonia
48276|NCT03900520|meningitis|meningitis
48277|NCT03900520|sepsis|sepsis
48278|NCT03900520|invasive pneumococcal disease|invasive pneumococcal disease
48279|NCT03900507|incisional endometriosis|incisional endometriosis
48280|NCT03900507|scar endometriosis|scar endometriosis
48281|NCT03900494|salbutamol|salbutamol
48282|NCT03900494|valved holding chamber|valved holding chamber
48283|NCT03900494|pMDI|pmdi
48284|NCT03900494|inhalation therapy|inhalation therapy
48285|NCT03900494|children|children
48286|NCT03900494|toddlers|toddlers
48287|NCT03900494|emergency room|emergency room
48288|NCT03900468|Epilepsy|epilepsy
48289|NCT03900468|Deep Brain Stimulation|deep brain stimulation
48290|NCT03900468|DBS|dbs
48291|NCT03900468|EPAS|epas
48292|NCT03900455|Patients at risk|patients at risk
48293|NCT03900455|polyurethane foam|polyurethane foam
48294|NCT03900455|pressure ulcer|pressure ulcer
48295|NCT03900416|Mindfulness|mindfulness
48296|NCT03900416|Mobile Intervention|mobile intervention
48297|NCT03900416|Brief Intervention|brief intervention
48298|NCT03900416|Adolescence|adolescence
48299|NCT03900390|heart transplantation|heart transplantation
48300|NCT03900390|ischemia-reperfusion injury|ischemia-reperfusion injury
48301|NCT03900377|Lymphoma, B-cell, Diffuse, SyB L-0501RI|lymphoma, b-cell, diffuse, syb l-0501ri
48302|NCT03900364|partial nephrectomy|partial nephrectomy
48303|NCT03900364|robot-assisted partial nephrectomy|robot-assisted partial nephrectomy
48304|NCT03900364|laparoscopic partial nephrectomy|laparoscopic partial nephrectomy
48305|NCT03900338|pulse wave velocity|pulse wave velocity
48306|NCT03900338|intestinal microbiota|intestinal microbiota
48307|NCT03900338|cardiovascular disease|cardiovascular disease
48308|NCT03900338|short chain fatty acids|short chain fatty acids
48309|NCT03900338|multicentric study|multicentric study
48310|NCT03900312|Native American|native american
48311|NCT03900312|Youth|youth
48312|NCT03900312|Young Adult|young adult
815276|NCT00181675|ADHD|adhd
48313|NCT03900299|breast conservative surgery|breast conservative surgery
48314|NCT03900299|oncoplastic breast surgery|oncoplastic breast surgery
48315|NCT03900286|Familial Partial Lipodystrophy|familial partial lipodystrophy
48316|NCT03900286|FPLD|fpld
48317|NCT03900286|Diet|diet
48318|NCT03900286|Total Diet Replacement|total diet replacement
48319|NCT03900286|Diabetes|diabetes
48320|NCT03900273|Alzheimer's disease|alzheimer's disease
48321|NCT03900273|Neuropsychological Testing|neuropsychological testing
48322|NCT03900273|Healthy Older Individuals|healthy older individuals
48323|NCT03900273|Psychometrics|psychometrics
48324|NCT03900273|Prevention|prevention
48325|NCT03900273|Clinical Trial|clinical trial
48326|NCT03900247|brain computer interface|brain computer interface
48327|NCT03900234|chronic venous disease|chronic venous disease
48328|NCT03900234|prevalence|prevalence
48329|NCT03900234|risk factors|risk factors
48330|NCT03900221|Multiple sclerosis|multiple sclerosis
48331|NCT03900221|pregnancy|pregnancy
48332|NCT03900221|disease modifying drugs|disease modifying drugs
48333|NCT03900221|breastfeeding|breastfeeding
48334|NCT03900221|loco-regional analgesia|loco-regional analgesia
48443|NCT03899792|C611S|c611s
48335|NCT03900182|Traumatic brain injury|traumatic brain injury
48336|NCT03900182|hyperbaric oxygen therapy|hyperbaric oxygen therapy
48337|NCT03900182|neuropsychological treatment|neuropsychological treatment
48338|NCT03900182|cognitive function|cognitive function
48339|NCT03900182|biomarkers.|biomarkers.
48340|NCT03900130|hunger, satiety, satiety cascade, satiating capacity|hunger, satiety, satiety cascade, satiating capacity
48341|NCT03900117|Non-small Cell Lung Cancer|non-small cell lung cancer
48342|NCT03900117|Split-course Chemoradiotherapy|split-course chemoradiotherapy
48343|NCT03900117|Severe Impairment of Baseline Pulmonary Function|severe impairment of baseline pulmonary function
48344|NCT03900104|Endometrial Cancer|endometrial cancer
48345|NCT03900104|Sentinel Lymph Node|sentinel lymph node
48346|NCT03900104|Paraaortic nodes involvement|paraaortic nodes involvement
48347|NCT03900091|Point of care|point of care
48348|NCT03900091|Diagnostics|diagnostics
48349|NCT03900091|Low-income countries|low-income countries
48350|NCT03900091|Meningitis|meningitis
48351|NCT03900091|Pediatrics|pediatrics
48352|NCT03900091|MxA|mxa
48353|NCT03900091|FilmArray|filmarray
48354|NCT03900091|Low-cost diagnostics|low-cost diagnostics
48355|NCT03900065|flap preconditioning|flap preconditioning
48356|NCT03900052|Knee Osteoarthritis|knee osteoarthritis
48357|NCT03900052|Knee adduction moment|knee adduction moment
48358|NCT03900052|Knee loading|knee loading
48359|NCT03900052|Walking cane|walking cane
48360|NCT03900039|Hip arthroplasty|hip arthroplasty
48361|NCT03900039|Tribology|tribology
48362|NCT03900039|wear|wear
48363|NCT03900026|Coronary Artery Bypass Surgery|coronary artery bypass surgery
48364|NCT03900026|CABG|cabg
48365|NCT03900026|Saphenous Vein Graft|saphenous vein graft
48366|NCT03900026|Evolocumab|evolocumab
48367|NCT03900026|Repatha|repatha
48368|NCT03900013|injectable platelet rich fibrin|injectable platelet rich fibrin
48369|NCT03900013|Demineralized Freeze-Dried Bone Allograft|demineralized freeze-dried bone allograft
48370|NCT03900013|Stage 3 periodontitis|stage 3 periodontitis
48371|NCT03899961|cesarean delivery|cesarean delivery
48372|NCT03899961|blood loss|blood loss
48373|NCT03899961|troponin|troponin
48374|NCT03899948|Excessive Anxiety|excessive anxiety
48375|NCT03899948|Teacher Training|teacher training
48376|NCT03899948|Elementary School|elementary school
48377|NCT03899948|School-based|school-based
48378|NCT03899948|Effectiveness Research|effectiveness research
48379|NCT03899948|Randomized Controlled Trial|randomized controlled trial
48380|NCT03899935|Endometriosis|endometriosis
48381|NCT03899935|Obesity|obesity
48382|NCT03899935|Laparoscopy|laparoscopy
48383|NCT03899922|Uvea toxicity|uvea toxicity
48384|NCT03899922|chemotherapies|chemotherapies
48385|NCT03899922|drugs|drugs
48386|NCT03899870|rectal adenocarcinoma|rectal adenocarcinoma
48387|NCT03899870|recurrence|recurrence
48388|NCT03899870|prognosis|prognosis
48389|NCT03899831|Elopement|elopement
48390|NCT03899818|small vessels|small vessels
48391|NCT03899818|drug coated balloon|drug coated balloon
48392|NCT03899805|Sarcoma|sarcoma
48393|NCT03899792|Loxo|loxo
48394|NCT03899792|LOXO-292|loxo-292
48395|NCT03899792|KIF5B-RET|kif5b-ret
48396|NCT03899792|M918T|m918t
48397|NCT03899792|CCDC6-RET|ccdc6-ret
48398|NCT03899792|RET-PTC1|ret-ptc1
48399|NCT03899792|NCOA4-RET|ncoa4-ret
48400|NCT03899792|RET-PTC|ret-ptc
48401|NCT03899792|RET-PTC3|ret-ptc3
48402|NCT03899792|RET-PTC4|ret-ptc4
48403|NCT03899792|PRKAR1A-RET|prkar1a-ret
48404|NCT03899792|RET-PTC2|ret-ptc2
48405|NCT03899792|GOLGA5-RET|golga5-ret
48406|NCT03899792|RET-PTC5|ret-ptc5
48407|NCT03899792|ERC1-RET|erc1-ret
48408|NCT03899792|KTN1-RET|ktn1-ret
48409|NCT03899792|RET-PTC8|ret-ptc8
48410|NCT03899792|HOOK3-RET|hook3-ret
48411|NCT03899792|PCM1-RET|pcm1-ret
48412|NCT03899792|TRIM24-RET|trim24-ret
48413|NCT03899792|RET-PTC6|ret-ptc6
48414|NCT03899792|TRIM27-RET|trim27-ret
48415|NCT03899792|TRIM33-RET|trim33-ret
48416|NCT03899792|RET-PTC7|ret-ptc7
48417|NCT03899792|AKAP13-RET|akap13-ret
48418|NCT03899792|FKBP15-RET|fkbp15-ret
48419|NCT03899792|SPECC1L-RET|specc1l-ret
48420|NCT03899792|TBL1XR1-RET|tbl1xr1-ret
48421|NCT03899792|BCR-RET|bcr-ret
48422|NCT03899792|FGRF1OP-RET|fgrf1op-ret
48423|NCT03899792|RFG8-RET|rfg8-ret
48424|NCT03899792|RET-PTC9|ret-ptc9
48425|NCT03899792|ACBD5-RET|acbd5-ret
48426|NCT03899792|MYH13-RET|myh13-ret
48427|NCT03899792|CUX1-RET|cux1-ret
48428|NCT03899792|KIAA1468-RET|kiaa1468-ret
48429|NCT03899792|FRMD4A-RET|frmd4a-ret
48430|NCT03899792|SQSTM1-RET|sqstm1-ret
48431|NCT03899792|AFAP1L2-RET|afap1l2-ret
48432|NCT03899792|PPFIBP2-RET|ppfibp2-ret
48433|NCT03899792|EML4-RET|eml4-ret
48434|NCT03899792|PARD3-RET|pard3-ret
48435|NCT03899792|G533C|g533c
48436|NCT03899792|C609F|c609f
48437|NCT03899792|C609G|c609g
48438|NCT03899792|C609R|c609r
48439|NCT03899792|C609S|c609s
48440|NCT03899792|C609Y|c609y
48441|NCT03899792|C611F|c611f
48442|NCT03899792|C611G|c611g
48444|NCT03899792|C611Y|c611y
48445|NCT03899792|C611W|c611w
48446|NCT03899792|C618F|c618f
48447|NCT03899792|C618R|c618r
48448|NCT03899792|C618S|c618s
48449|NCT03899792|C620F|c620f
48450|NCT03899792|C620R|c620r
48451|NCT03899792|C620S|c620s
48452|NCT03899792|C630R|c630r
48453|NCT03899792|C630Y|c630y
48454|NCT03899792|D631Y|d631y
48455|NCT03899792|C634F|c634f
48456|NCT03899792|C634G|c634g
48457|NCT03899792|C634R|c634r
48458|NCT03899792|C634S|c634s
48459|NCT03899792|C634W|c634w
48460|NCT03899792|C634Y|c634y
48461|NCT03899792|K666E|k666e
48462|NCT03899792|E768D|e768d
48463|NCT03899792|L790F|l790f
48464|NCT03899792|V804L|v804l
48465|NCT03899792|V804M|v804m
48466|NCT03899792|A883F|a883f
48467|NCT03899792|S891A|s891a
48468|NCT03899792|R912P|r912p
48469|NCT03899792|CLIP1-RET|clip1-ret
48470|NCT03899792|Y806C|y806c
48471|NCT03899792|RET fusion|ret fusion
48472|NCT03899792|RET alteration|ret alteration
48473|NCT03899792|RET mutation|ret mutation
48474|NCT03899792|RET rearrangement|ret rearrangement
48475|NCT03899792|RET translocation|ret translocation
48476|NCT03899792|Neoplasms by Site|neoplasms by site
48477|NCT03899792|Neoplasms|neoplasms
48478|NCT03899792|Non-Small Cell Lung Cancer|non-small cell lung cancer
48479|NCT03899792|Lung Neoplasms|lung neoplasms
48480|NCT03899792|Carcinoma, Non-Small-Cell Lung|carcinoma, non-small-cell lung
48481|NCT03899792|Cancer of Lung|cancer of lung
48482|NCT03899792|Cancer of the Lung|cancer of the lung
48483|NCT03899792|Lung Cancer|lung cancer
48484|NCT03899792|Neoplasms, Lung|neoplasms, lung
48485|NCT03899792|Neoplasms, Pulmonary|neoplasms, pulmonary
48486|NCT03899792|Pulmonary Cancer|pulmonary cancer
48487|NCT03899792|Pulmonary Neoplasms|pulmonary neoplasms
48488|NCT03899792|Respiratory Tract Neoplasms|respiratory tract neoplasms
48489|NCT03899792|Lung Diseases|lung diseases
48490|NCT03899792|Respiratory Tract Diseases|respiratory tract diseases
48491|NCT03899792|Carcinoma, Bronchogenic|carcinoma, bronchogenic
48492|NCT03899792|Bronchial Neoplasms|bronchial neoplasms
48493|NCT03899792|Medullary Thyroid Cancer|medullary thyroid cancer
48494|NCT03899792|Papillary Thyroid Cancer|papillary thyroid cancer
48495|NCT03899792|Thyroid Diseases|thyroid diseases
48496|NCT03899792|Thyroid Neoplasms|thyroid neoplasms
48497|NCT03899792|Cancer of the Thyroid|cancer of the thyroid
48498|NCT03899792|Cancer of Thyroid|cancer of thyroid
48499|NCT03899792|Neoplasms, Thyroid|neoplasms, thyroid
48500|NCT03899792|Thyroid Adenoma|thyroid adenoma
48501|NCT03899792|Thyroid Cancer|thyroid cancer
48502|NCT03899792|Thyroid Carcinoma|thyroid carcinoma
48503|NCT03899792|Endocrine System Diseases|endocrine system diseases
48504|NCT03899792|Endocrine Gland Neoplasms|endocrine gland neoplasms
48505|NCT03899792|Head and Neck Neoplasms|head and neck neoplasms
48506|NCT03899792|Thoracic Neoplasms|thoracic neoplasms
48507|NCT03899792|CNS tumor|cns tumor
48508|NCT03899792|Primary CNS tumor|primary cns tumor
48509|NCT03899792|Colonic Neoplasms|colonic neoplasms
48510|NCT03899792|Cancer of Colon|cancer of colon
48511|NCT03899792|Cancer of the Colon|cancer of the colon
48512|NCT03899792|Colon Cancer|colon cancer
48513|NCT03899792|Colon Neoplasms|colon neoplasms
48514|NCT03899792|Colonic Cancer|colonic cancer
48515|NCT03899792|Neoplasms, Colonic|neoplasms, colonic
48516|NCT03899792|Malignant tumor of Breast|malignant tumor of breast
48517|NCT03899792|Mammary Cancer|mammary cancer
48518|NCT03899792|Mammary Carcinoma, Human|mammary carcinoma, human
48519|NCT03899792|Mammary Neoplasm, Human|mammary neoplasm, human
48520|NCT03899792|Neoplasms, Breast|neoplasms, breast
48521|NCT03899792|Tumors, Breast|tumors, breast
48522|NCT03899792|Human Mammary Carcinoma|human mammary carcinoma
48523|NCT03899792|Malignant Neoplasm of Breast|malignant neoplasm of breast
48524|NCT03899792|Breast Carcinoma|breast carcinoma
48525|NCT03899792|Breast Tumors|breast tumors
48526|NCT03899792|Cancer of the Breast|cancer of the breast
48527|NCT03899792|Breast Neoplasms|breast neoplasms
48528|NCT03899792|Breast Cancer|breast cancer
48529|NCT03899792|RET Inhibitor|ret inhibitor
48530|NCT03899792|MTC|mtc
48531|NCT03899792|NSCLC|nsclc
48532|NCT03899792|Soft tissue sarcoma|soft tissue sarcoma
48533|NCT03899792|Infantile Myofibromatosis|infantile myofibromatosis
48534|NCT03899792|Infantile Fibrosarcoma|infantile fibrosarcoma
48535|NCT03899766|pain, procedural|pain, procedural
48536|NCT03899766|child|child
48537|NCT03899766|anxiety|anxiety
48538|NCT03899753|prino|prino
48539|NCT03899753|total shoulder arthroplasty|total shoulder arthroplasty
48540|NCT03899753|wound closure|wound closure
48541|NCT03899714|Postural Stability|postural stability
48542|NCT03899714|Public Health|public health
48543|NCT03899714|Balance|balance
48544|NCT03899688|antrostomy|antrostomy
48545|NCT03899688|Maxillary sinus augmentation|maxillary sinus augmentation
48546|NCT03899688|collagen membrane|collagen membrane
48547|NCT03899688|biomaterial|biomaterial
48548|NCT03899675|Caffeine|caffeine
48549|NCT03899675|Exercise|exercise
48550|NCT03899675|Heart Rate Variability|heart rate variability
48551|NCT03899675|Autonomic Nervous System|autonomic nervous system
48552|NCT03899675|Cardiovascular Risk Factor|cardiovascular risk factor
48553|NCT03899662|Electroencephalography|electroencephalography
48554|NCT03899662|Cognitive training|cognitive training
48555|NCT03899662|Physical training|physical training
48556|NCT03899662|Resting state networks|resting state networks
48557|NCT03899623|Diabete Mellitus|diabete mellitus
48558|NCT03899623|Diabetic Retinopathy|diabetic retinopathy
48559|NCT03899623|Artificial Intelligence|artificial intelligence
48560|NCT03899610|TRU-D|tru-d
48561|NCT03899584|4-Aminopyridine|4-aminopyridine
48562|NCT03899584|erectile function|erectile function
48563|NCT03899584|tetraplegia|tetraplegia
48564|NCT03899584|rehabilitation|rehabilitation
48565|NCT03899584|questionnaires|questionnaires
48566|NCT03899584|paraplegia|paraplegia
48567|NCT03899558|Neural respiratory drive|neural respiratory drive
48568|NCT03899558|Physiology|physiology
48569|NCT03899558|Respiratory muscles|respiratory muscles
48570|NCT03899558|COPD exacerbation|copd exacerbation
48571|NCT03899558|Ventilation|ventilation
48572|NCT03899558|Nasal high-flow|nasal high-flow
48573|NCT03899558|High-flow nasal cannula|high-flow nasal cannula
48574|NCT03899545|serratus plane block|serratus plane block
48575|NCT03899545|pectoral I block|pectoral i block
48576|NCT03899545|breast cancer surgery|breast cancer surgery
48577|NCT03899545|perioperative analgesia|perioperative analgesia
48578|NCT03899532|Remote Ischemic Conditioning|remote ischemic conditioning
48579|NCT03899532|Traumatic Brain Injury|traumatic brain injury
48580|NCT03899519|OSA|osa
48581|NCT03899519|ultrasound|ultrasound
48582|NCT03899519|airway|airway
48583|NCT03899519|difficult intubation|difficult intubation
48584|NCT03899493|Electroencephalography|electroencephalography
48585|NCT03899493|Electromyography|electromyography
48586|NCT03899493|Pelvic Floor|pelvic floor
48587|NCT03899493|Labor curve|labor curve
48588|NCT03899493|Intrauterine infection|intrauterine infection
48589|NCT03899493|Hypertensive Disorders of Pregnancy|hypertensive disorders of pregnancy
48590|NCT03899480|Suppressive Antiretroviral Therapy (ART)|suppressive antiretroviral therapy (art)
48591|NCT03899454|exercise-induced oxidative-stress|exercise-induced oxidative-stress
48592|NCT03899454|Garcinia mangostana L rind|garcinia mangostana l rind
48593|NCT03899441|multimedia, video teaching|multimedia, video teaching
48594|NCT03899389|trimethylamine-N-oxide|trimethylamine-n-oxide
48595|NCT03899376|Gynecological Cancer|gynecological cancer
48596|NCT03899376|Radiotherapy|radiotherapy
48597|NCT03899376|VMAT|vmat
48598|NCT03899376|Toxicity|toxicity
48599|NCT03899350|Treatment Efficacy|treatment efficacy
48600|NCT03899350|Intracerebral Hemorrhage|intracerebral hemorrhage
48601|NCT03899350|Surgery|surgery
48602|NCT03899350|Outcome|outcome
48603|NCT03899350|Prediction Model|prediction model
48604|NCT03899337|Chronic Lymphocytic Leukaemia|chronic lymphocytic leukaemia
48605|NCT03899337|Richter's Transformation|richter's transformation
48606|NCT03899337|Richter's Syndrome|richter's syndrome
48607|NCT03899337|CHOP-R|chop-r
48608|NCT03899337|Acalabrutinib|acalabrutinib
48609|NCT03899337|Diffuse Large B Cell Lymphoma|diffuse large b cell lymphoma
48610|NCT03899337|non-Hodgkin Lymphoma|non-hodgkin lymphoma
48611|NCT03899298|stem cell therapy|stem cell therapy
48612|NCT03899298|umbilical stem cells|umbilical stem cells
48613|NCT03899298|amniotic stem cells|amniotic stem cells
48614|NCT03899298|stem cells|stem cells
48615|NCT03899298|regenerative medicine|regenerative medicine
48616|NCT03899298|r3 stem cell|r3 stem cell
48617|NCT03899298|perinatal tissue|perinatal tissue
48618|NCT03899298|placenta stem cell|placenta stem cell
48619|NCT03899285|citalopram|citalopram
48620|NCT03899285|major depressive disorder|major depressive disorder
48621|NCT03899285|non responder|non responder
48622|NCT03899285|MADRS|madrs
48623|NCT03899272|osteoarthritis|osteoarthritis
48624|NCT03899272|psychology|psychology
48625|NCT03899246|Capsaicin|capsaicin
48626|NCT03899246|Topical Analgesia|topical analgesia
48627|NCT03899246|Quantitative Sensory Testing|quantitative sensory testing
48628|NCT03899246|Pain|pain
48629|NCT03899233|Melasma|melasma
48630|NCT03899233|Tranexamic acid|tranexamic acid
48631|NCT03899233|Fractional CO2 laser|fractional co2 laser
48632|NCT03899194|major depressive disorder|major depressive disorder
48633|NCT03899194|neuroimmunology|neuroimmunology
48634|NCT03899194|PRKCB1 gene|prkcb1 gene
48635|NCT03899194|modulation|modulation
48636|NCT03899194|biomarker|biomarker
48637|NCT03899168|Depression|depression
48638|NCT03899168|Mood Disorder|mood disorder
48639|NCT03899168|Information Search|information search
48640|NCT03899168|Attitudes|attitudes
48641|NCT03899168|Psychotherapy|psychotherapy
48642|NCT03899168|Antidepressants|antidepressants
48643|NCT03899051|interdental papilla reconstruction|interdental papilla reconstruction
48644|NCT03899025|HRpQCT|hrpqct
48645|NCT03899025|high resolution quantitative peripheral CT|high resolution quantitative peripheral ct
48646|NCT03899025|Xtreme CT scan|xtreme ct scan
48647|NCT03899025|CT scan|ct scan
48648|NCT03899025|Diagnoses Disease|diagnoses disease
48649|NCT03899025|Fracture healing|fracture healing
48650|NCT03898999|Ankle|ankle
48651|NCT03898999|Balance|balance
48652|NCT03898999|Falls|falls
48653|NCT03898999|Older Adult|older adult
48654|NCT03898947|Tamoxifen|tamoxifen
48655|NCT03898947|Aromatase inhibitors|aromatase inhibitors
48656|NCT03898947|Breast cancer|breast cancer
48657|NCT03898947|Endometrial cancer|endometrial cancer
48658|NCT03898947|Endometrial pathologies|endometrial pathologies
48659|NCT03898934|Lean PCOS|lean pcos
48660|NCT03898934|Vitamin D|vitamin d
48661|NCT03898934|Supplementation|supplementation
48662|NCT03898934|Ovulation|ovulation
48663|NCT03898934|Pregnancy|pregnancy
48664|NCT03898921|Small Hepatocellular Carcinoma|small hepatocellular carcinoma
48665|NCT03898921|Radiofrequency Ablation|radiofrequency ablation
48666|NCT03898921|Stereotactic Body Radiotherapy|stereotactic body radiotherapy
48667|NCT03898908|metastases|metastases
48668|NCT03898908|melanoma|melanoma
48669|NCT03898908|encorafenib|encorafenib
48670|NCT03898908|binimetinib|binimetinib
48671|NCT03898856|diarrhea|diarrhea
48672|NCT03898856|diagnosis|diagnosis
48673|NCT03898856|crofelemer|crofelemer
48674|NCT03898856|treatment|treatment
48675|NCT03898843|Animal assisted therapy|animal assisted therapy
48676|NCT03898843|Intensive Care Unit|intensive care unit
48677|NCT03898843|Anxiety|anxiety
48678|NCT03898817|helicase|helicase
48679|NCT03898817|induced pluripotent stem cells|induced pluripotent stem cells
48680|NCT03898791|aurora kinase A|aurora kinase a
48681|NCT03898791|kinase|kinase
48682|NCT03898791|aurora A|aurora a
48683|NCT03898791|aurora kinase inhibitor|aurora kinase inhibitor
48684|NCT03898791|aurora kinase A inhibitor|aurora kinase a inhibitor
48685|NCT03898791|kinase inhibitor|kinase inhibitor
48686|NCT03898791|AURKA|aurka
48687|NCT03898791|AurA|aura
48688|NCT03898765|Dry blood spot test|dry blood spot test
48689|NCT03898765|Biliary Atresia|biliary atresia
48690|NCT03898739|Traction|traction
48691|NCT03898739|Decompression angles|decompression angles
48692|NCT03898713|IQ|iq
48693|NCT03898713|Speech|speech
48694|NCT03898713|VPI|vpi
48695|NCT03898687|melanoma|melanoma
48696|NCT03898687|Sentinel node|sentinel node
48697|NCT03898687|SPIO-MRI|spio-mri
48698|NCT03898661|Xiapex|xiapex
48699|NCT03898661|esophageal stricture|esophageal stricture
48700|NCT03898661|stricture|stricture
48701|NCT03898661|collagenase|collagenase
48702|NCT03898661|refractory|refractory
48703|NCT03898661|anastomotic|anastomotic
48704|NCT03898648|Depression|depression
48705|NCT03898648|Suicide attempt|suicide attempt
48706|NCT03898648|Neuropsychology|neuropsychology
48707|NCT03898648|Decision- making|decision- making
48708|NCT03898648|Social interaction|social interaction
48709|NCT03898648|Implicit Emotional processing|implicit emotional processing
48710|NCT03898635|linezolid|linezolid
48711|NCT03898596|Neonates|neonates
48712|NCT03898596|Electrocardiogram|electrocardiogram
48713|NCT03898596|Umbilical Vein Catheterization|umbilical vein catheterization
48714|NCT03898544|gait kinematics|gait kinematics
48715|NCT03898544|TKA|tka
48716|NCT03898531|hip arthroplasty|hip arthroplasty
48717|NCT03898531|hip prosthesis resection|hip prosthesis resection
48718|NCT03898531|first implantation|first implantation
48719|NCT03898531|wear particles|wear particles
48720|NCT03898518|adolescence|adolescence
48721|NCT03898518|exercise|exercise
48722|NCT03898518|body composition|body composition
48723|NCT03898518|insulin sensitivity|insulin sensitivity
48724|NCT03898518|obesity|obesity
815277|NCT00181675|galantamine|galantamine
48725|NCT03898518|academic self-efficacy|academic self-efficacy
48726|NCT03898505|Avocado|avocado
48727|NCT03898505|Polyhydroxylated Fatty Alcohols|polyhydroxylated fatty alcohols
48728|NCT03898505|Avocatin B|avocatin b
48729|NCT03898453|Breast Cancer|breast cancer
48730|NCT03898453|support psychotherapy|support psychotherapy
48731|NCT03898453|EMDR therapy|emdr therapy
48732|NCT03898453|anxiety disorders|anxiety disorders
48733|NCT03898440|anogenital distance|anogenital distance
48734|NCT03898440|prenatal|prenatal
48735|NCT03898440|sex determination|sex determination
48736|NCT03898440|androgen|androgen
48737|NCT03898427|Wearable devices|wearable devices
48738|NCT03898427|Scratch|scratch
48739|NCT03898427|Sleep|sleep
48740|NCT03898375|Virtual reality|virtual reality
48741|NCT03898375|optic flow|optic flow
48742|NCT03898375|gait|gait
48743|NCT03898362|wheelchair|wheelchair
48744|NCT03898362|scooter|scooter
48745|NCT03898349|Automated Text Messaging System|automated text messaging system
48746|NCT03898349|Implementation science|implementation science
48747|NCT03898349|Hepatitis C|hepatitis c
48748|NCT03898323|human laboratory|human laboratory
48749|NCT03898323|alcohol approach bias modification|alcohol approach bias modification
48750|NCT03898323|alcohol use disorder|alcohol use disorder
48751|NCT03898323|non-treatment seeking|non-treatment seeking
48752|NCT03898297|Depression|depression
48753|NCT03898297|Bipolar|bipolar
48854|NCT03897582|cefotaxime|cefotaxime
48755|NCT03898297|PET|pet
48756|NCT03898297|mGluR5|mglur5
48757|NCT03898297|glutamate system|glutamate system
48758|NCT03898297|MRI|mri
48759|NCT03898284|Idiopathic Pulmonary Fibrosis|idiopathic pulmonary fibrosis
48760|NCT03898284|Impulse Oscillometry|impulse oscillometry
48761|NCT03898284|Forced Vital Capacity|forced vital capacity
48762|NCT03898271|PTSD|ptsd
48763|NCT03898271|Motivational Interviewing|motivational interviewing
48764|NCT03898271|veterans|veterans
48765|NCT03898271|military|military
48766|NCT03898271|virtual world|virtual world
48767|NCT03898271|virtual reality|virtual reality
48768|NCT03898271|education|education
48769|NCT03898271|training|training
48770|NCT03898271|primary care|primary care
48771|NCT03898271|mental health|mental health
48772|NCT03898219|Hematogenous osteomyelitis|hematogenous osteomyelitis
48773|NCT03898219|relapse|relapse
48774|NCT03898219|adulthood|adulthood
48775|NCT03898193|Bioequivalence|bioequivalence
48776|NCT03898193|Montelukast|montelukast
48777|NCT03898193|Singulair|singulair
48778|NCT03898180|Advanced or metastatic urothelial cancer|advanced or metastatic urothelial cancer
48779|NCT03898180|Lenvatinib|lenvatinib
48780|NCT03898180|Pembrolizumab|pembrolizumab
48781|NCT03898180|Programmed Cell Death-1 (PD1, PD-1)|programmed cell death-1 (pd1, pd-1)
48782|NCT03898180|Programmed Death-Ligand 1 (PDL1, PD-L1)|programmed death-ligand 1 (pdl1, pd-l1)
48783|NCT03898167|Screening|screening
48784|NCT03898167|Human Papillomavirus Infection|human papillomavirus infection
48785|NCT03898167|Self-Testing|self-testing
48786|NCT03898115|implementation science|implementation science
48787|NCT03898115|chlorhexidine gluconate bathing|chlorhexidine gluconate bathing
48788|NCT03898089|Myofascial Release Technique|myofascial release technique
48789|NCT03898089|Core Stabilization Exercise|core stabilization exercise
48790|NCT03898050|transcutaneous pacer pad|transcutaneous pacer pad
48791|NCT03898050|transcutaneous cardiac pacing|transcutaneous cardiac pacing
48792|NCT03898011|Bioequivalence|bioequivalence
48793|NCT03898011|Lamotrigine|lamotrigine
48794|NCT03897998|Naloxone|naloxone
48795|NCT03897998|fMRI|fmri
48796|NCT03897998|EEG|eeg
48797|NCT03897998|Observation|observation
48798|NCT03897998|Healthy Volunteers|healthy volunteers
48800|NCT03897959|suprapubic, urinary catheter|suprapubic, urinary catheter
48801|NCT03897933|Erector spinae block|erector spinae block
48802|NCT03897933|percutaneous|percutaneous
48803|NCT03897933|nephrolithotomy|nephrolithotomy
48804|NCT03897933|stone|stone
48805|NCT03897933|ultrasound|ultrasound
48806|NCT03897894|resilience|resilience
48807|NCT03897894|child protection|child protection
48808|NCT03897894|child development|child development
48809|NCT03897881|mRNA-4157|mrna-4157
48810|NCT03897881|Personalized cancer vaccine|personalized cancer vaccine
48811|NCT03897881|PCV|pcv
48812|NCT03897881|Pembrolizumab|pembrolizumab
48813|NCT03897881|Moderna|moderna
48814|NCT03897829|enthesitis|enthesitis
48815|NCT03897829|osteoarthritis|osteoarthritis
48816|NCT03897829|ultrasound|ultrasound
48817|NCT03897816|personality disorders|personality disorders
48818|NCT03897816|anxiety disorders|anxiety disorders
48819|NCT03897816|mood disorders|mood disorders
48820|NCT03897790|cerebral vasoreactivity|cerebral vasoreactivity
48821|NCT03897790|transcranial doppler|transcranial doppler
48822|NCT03897790|hypertensive disease|hypertensive disease
48823|NCT03897790|elderly|elderly
48824|NCT03897790|vasopressors|vasopressors
48825|NCT03897790|general anesthesia|general anesthesia
48826|NCT03897777|Blood pressure|blood pressure
48827|NCT03897777|Gut dysbiosis|gut dysbiosis
48828|NCT03897777|Exercise training|exercise training
48829|NCT03897764|cesarean section|cesarean section
48830|NCT03897764|postoperative pain|postoperative pain
48831|NCT03897764|superior hypogastric block|superior hypogastric block
48832|NCT03897738|succinate|succinate
48833|NCT03897738|B complex vitamins|b complex vitamins
48834|NCT03897738|perimenopause|perimenopause
48835|NCT03897686|intra-articular|intra-articular
48836|NCT03897686|polyacrylamide hydrogel|polyacrylamide hydrogel
48837|NCT03897660|Omega-3 fatty acids|omega-3 fatty acids
48838|NCT03897660|Vitamin K2|vitamin k2
48839|NCT03897660|Bioavailability|bioavailability
48840|NCT03897660|Side effects|side effects
48841|NCT03897660|Monoacylglyderols|monoacylglyderols
48842|NCT03897647|echocardiography|echocardiography
48843|NCT03897647|pulmonary artery catheter|pulmonary artery catheter
48844|NCT03897647|point of care ultrasound|point of care ultrasound
48845|NCT03897634|Assistive Listening Device (ALD)|assistive listening device (ald)
48846|NCT03897634|Hearing in Noise|hearing in noise
48847|NCT03897621|tranexamic acid|tranexamic acid
48848|NCT03897621|Rotational thromboelastometry|rotational thromboelastometry
48849|NCT03897621|Fibrinolysis|fibrinolysis
48850|NCT03897621|viscoelastic essay|viscoelastic essay
48851|NCT03897582|amoxicillin|amoxicillin
48852|NCT03897582|amoxicillin-clavulanic acid|amoxicillin-clavulanic acid
48853|NCT03897582|piperacillin-tazobactam|piperacillin-tazobactam
48858|NCT03897582|imipenem|imipenem
48859|NCT03897582|multifiltrate|multifiltrate
48860|NCT03897582|citrate|citrate
48861|NCT03897582|CVVHD|cvvhd
48862|NCT03897582|extended and continuous infusion|extended and continuous infusion
48863|NCT03897582|TDM|tdm
48864|NCT03897582|Therapeutic Drug Monitoring|therapeutic drug monitoring
48865|NCT03897569|Patellofemoral Pain Syndrome|patellofemoral pain syndrome
48866|NCT03897569|knee kinematics|knee kinematics
48867|NCT03897569|frontal projection angle|frontal projection angle
48868|NCT03897569|ankle motion|ankle motion
48869|NCT03897543|HCC|hcc
48870|NCT03897543|Nivolumab|nivolumab
48871|NCT03897543|ABX196|abx196
48872|NCT03897517|Glycemia|glycemia
48873|NCT03897517|Carbohydrate blocker|carbohydrate blocker
48874|NCT03897504|congenital adrenal hyperplasia|congenital adrenal hyperplasia
48875|NCT03897504|Feminizing genitoplasty|feminizing genitoplasty
48876|NCT03897504|Vaginal stenosis|vaginal stenosis
48877|NCT03897478|Ischemic stroke|ischemic stroke
48878|NCT03897478|Atrial fibrillation|atrial fibrillation
48879|NCT03897478|Transient neurological event|transient neurological event
48880|NCT03897478|Cryptogenic stroke|cryptogenic stroke
48881|NCT03897478|Gene expression|gene expression
48882|NCT03897478|RNA|rna
48883|NCT03897478|Anticoagulant|anticoagulant
48884|NCT03897478|NOAC|noac
48885|NCT03897478|Implantable cardiac monitor|implantable cardiac monitor
48886|NCT03897478|Point of care|point of care
48887|NCT03897478|tPA|tpa
48888|NCT03897478|Thrombectomy|thrombectomy
48889|NCT03897478|Cardiac monitoring|cardiac monitoring
48890|NCT03897452|analgesia|analgesia
48891|NCT03897452|neonates|neonates
48892|NCT03897452|procedural pain|procedural pain
48893|NCT03897452|pain assessment|pain assessment
48894|NCT03897452|physiological response|physiological response
48895|NCT03897452|pharmacogenetics|pharmacogenetics
48896|NCT03897348|alcohol craving|alcohol craving
48897|NCT03897348|human laboratory|human laboratory
48898|NCT03897348|lacosamide|lacosamide
48899|NCT03897348|non-treatment seeking|non-treatment seeking
48900|NCT03897296|high-resolution anorectal manometry|high-resolution anorectal manometry
48901|NCT03897296|healthy|healthy
48902|NCT03897296|Russian population|russian population
48903|NCT03897244|Helicobacter pylori|helicobacter pylori
48904|NCT03897244|high dose dual therapy|high dose dual therapy
48905|NCT03897244|bismuth high-dose dual therapy|bismuth high-dose dual therapy
48906|NCT03897244|bismuth quadruple therapy|bismuth quadruple therapy
48907|NCT03897218|Liver health|liver health
48908|NCT03897218|Diet|diet
48909|NCT03897218|Microbiom|microbiom
48910|NCT03897192|punctate inner choroidopathy|punctate inner choroidopathy
48911|NCT03897192|multifocal choroiditis|multifocal choroiditis
48912|NCT03897192|zonal outer retinopathy|zonal outer retinopathy
48913|NCT03897192|long-term outcome|long-term outcome
48914|NCT03897153|Stroke, Acute|stroke, acute
48915|NCT03897127|CPX-351|cpx-351
48916|NCT03897127|Acute Myeloid Leukemia|acute myeloid leukemia
48917|NCT03897114|Nutritional Supplement|nutritional supplement
48918|NCT03897114|Cocoa|cocoa
48919|NCT03897114|Prebiotic|prebiotic
48920|NCT03897114|Physical Exercise|physical exercise
48921|NCT03897114|Gut Microbiota|gut microbiota
48922|NCT03897101|mild neonatal encephalopathy|mild neonatal encephalopathy
48923|NCT03897101|birth asphyxia|birth asphyxia
48924|NCT03897101|metabolic acidosis|metabolic acidosis
48925|NCT03897101|Autophagy|autophagy
48926|NCT03897101|Mitophagy|mitophagy
48927|NCT03897101|inflammation|inflammation
48928|NCT03897062|suvorexant|suvorexant
48929|NCT03897062|insomnia|insomnia
48930|NCT03897062|alcohol use disorder|alcohol use disorder
48931|NCT03897062|craving|craving
48932|NCT03897062|withdrawal|withdrawal
48933|NCT03897049|Transgender Women|transgender women
48934|NCT03897049|STI|sti
48935|NCT03897049|Sexual Health|sexual health
48936|NCT03897049|HIV/AIDS|hiv/aids
48937|NCT03897036|Advanced Basal Cell Carcinoma|advanced basal cell carcinoma
48938|NCT03897036|laBCC|labcc
48939|NCT03897036|Locally Advanced Basal Cell Carcinoma|locally advanced basal cell carcinoma
48940|NCT03897036|mBCC|mbcc
48941|NCT03897036|Metastatic Basal Cell Carcinoma|metastatic basal cell carcinoma
48942|NCT03897010|Silica-calcium phosphate composite|silica-calcium phosphate composite
48943|NCT03897010|Socket augmentation|socket augmentation
48944|NCT03896971|thrombopoietin mimetic|thrombopoietin mimetic
48945|NCT03896971|Egyptian|egyptian
48946|NCT03896971|Aplastic|aplastic
48950|NCT03896906|preoxygenation|preoxygenation
48951|NCT03896906|high-flow nasal cannula|high-flow nasal cannula
48952|NCT03896867|Temperature management|temperature management
48953|NCT03896867|Perioperative temperature management|perioperative temperature management
48954|NCT03896867|Pediatric temperature management|pediatric temperature management
49054|NCT03896126|Healthy Control|healthy control
48966|NCT03896737|diagnosis|diagnosis
48967|NCT03896737|elderly|elderly
48968|NCT03896737|autologous stem cell transplantation|autologous stem cell transplantation
48969|NCT03896711|dementia care|dementia care
48970|NCT03896711|community-based|community-based
48971|NCT03896711|companion care|companion care
48972|NCT03896711|activity|activity
48973|NCT03896711|caregiver wellbeing|caregiver wellbeing
48974|NCT03896711|caregiver respite|caregiver respite
48975|NCT03896711|caregiver support|caregiver support
48976|NCT03896711|home-based|home-based
48977|NCT03896711|volunteer|volunteer
48978|NCT03896698|Alzheimer's Disease|alzheimer's disease
48979|NCT03896698|Transcranial Ultrasound Stimulation|transcranial ultrasound stimulation
48980|NCT03896685|bedaquiline|bedaquiline
48981|NCT03896685|delamanid|delamanid
48982|NCT03896685|linezolid|linezolid
48983|NCT03896685|clofazimine|clofazimine
48984|NCT03896685|tuberculosis|tuberculosis
48985|NCT03896685|MDR-TB|mdr-tb
48986|NCT03896685|XDR-TB|xdr-tb
48987|NCT03896672|Clinical Practice Based on Scientific Evidence|clinical practice based on scientific evidence
48988|NCT03896672|Non-Invasive Positive Airway Pressure|non-invasive positive airway pressure
48989|NCT03896672|Pleural effusion|pleural effusion
48990|NCT03896672|Chest drain|chest drain
48991|NCT03896672|Physical therapy|physical therapy
48992|NCT03896620|Sarcoma|sarcoma
48993|NCT03896620|ctDNA|ctdna
48994|NCT03896607|shear wave elastography|shear wave elastography
48995|NCT03896581|Psoriatic Arthritis|psoriatic arthritis
48997|NCT03896581|Bimekizumab|bimekizumab
48998|NCT03896529|Aging|aging
48999|NCT03896529|Spatial Memory|spatial memory
49000|NCT03896529|Stress|stress
49001|NCT03896529|fMRI|fmri
49012|NCT03896464|Autograft|autograft
49013|NCT03896464|Soft-tissue hamstring|soft-tissue hamstring
49014|NCT03896464|Quadriceps Tendon|quadriceps tendon
49015|NCT03896438|tDCS|tdcs
49016|NCT03896438|cognitive training|cognitive training
49017|NCT03896438|functional connectivity|functional connectivity
49018|NCT03896425|tDCS|tdcs
49019|NCT03896425|cognitive training|cognitive training
49020|NCT03896425|functional connectivity|functional connectivity
49021|NCT03896425|non-invasive brain stimulation|non-invasive brain stimulation
49022|NCT03896412|circulating tumor DNA|circulating tumor dna
49023|NCT03896412|Next Generation Sequencing|next generation sequencing
49024|NCT03896412|Digital PCR|digital pcr
49025|NCT03896399|Esophageal Cancer|esophageal cancer
49026|NCT03896399|Esophagectomy|esophagectomy
49027|NCT03896399|Ischemic conditioning|ischemic conditioning
49028|NCT03896386|Epilepsy|epilepsy
49029|NCT03896386|Seizures|seizures
49030|NCT03896386|Seizure alert dogs|seizure alert dogs
49031|NCT03896386|Seizure diary|seizure diary
49032|NCT03896347|OLIF|olif
49033|NCT03896347|ViBone|vibone
49034|NCT03896347|DBM|dbm
49035|NCT03896347|BMP|bmp
49036|NCT03896347|DDD|ddd
49037|NCT03896295|M281|m281
49038|NCT03896295|Generalized Myasthenia Gravis|generalized myasthenia gravis
49039|NCT03896243|Uterine atony|uterine atony
49040|NCT03896243|amh|amh
49041|NCT03896230|moderate to severe pain|moderate to severe pain
49042|NCT03896230|emergency department patient|emergency department patient
49043|NCT03896230|ketamine|ketamine
49044|NCT03896217|Multiple sclerosis|multiple sclerosis
49045|NCT03896191|Total knee replacement|total knee replacement
49046|NCT03896191|Revision knee surgery|revision knee surgery
49047|NCT03896191|Knee instability|knee instability
49048|NCT03896191|Gait analysis|gait analysis
49049|NCT03896191|Patient reported outcome|patient reported outcome
49050|NCT03896165|Complementary Health Approach|complementary health approach
49051|NCT03896165|Parent|parent
49052|NCT03896165|Adolescent|adolescent
49053|NCT03896152|Complement, alternative pathway, paroxysmal nocturnal hemoglobinuria, hemolysis|complement, alternative pathway, paroxysmal nocturnal hemoglobinuria, hemolysis
49059|NCT03896048|diaphragm ultrasound|diaphragm ultrasound
49060|NCT03896048|mechanical ventilation|mechanical ventilation
49061|NCT03896048|diaphragm function|diaphragm function
49062|NCT03896035|Chronic Back Pain|chronic back pain
49063|NCT03896035|Depression|depression
49064|NCT03896035|Veterans|veterans
49065|NCT03896035|Aging|aging
49066|NCT03896022|auriculotherapy|auriculotherapy
49067|NCT03896022|abortion|abortion
49068|NCT03896022|pain management|pain management
49069|NCT03896009|Migraine|migraine
49070|NCT03896009|AXS-07|axs-07
49071|NCT03896009|Meloxicam|meloxicam
49072|NCT03896009|Rizatriptan|rizatriptan
49073|NCT03896009|Axsome|axsome
49074|NCT03896009|Axsome Therapeutics|axsome therapeutics
49075|NCT03896009|MoSEIC meloxicam|moseic meloxicam
49076|NCT03895970|Hepatobiliary Cancer|hepatobiliary cancer
49077|NCT03895970|Pembrolizumab|pembrolizumab
49078|NCT03895970|Lenvatinib|lenvatinib
49079|NCT03895970|Biomarker|biomarker
49080|NCT03895957|virtual reality|virtual reality
49081|NCT03895957|social phobia|social phobia
49082|NCT03895957|vret|vret
49083|NCT03895957|virtual reality exposure therapy|virtual reality exposure therapy
49084|NCT03895931|Frailty|frailty
49085|NCT03895931|Lung transplant candidates|lung transplant candidates
49086|NCT03895931|Rehabilitation|rehabilitation
49087|NCT03895905|colposcopy|colposcopy
49088|NCT03895905|High Risk HPV|high risk hpv
49089|NCT03895879|Rheumatoid Arthritis|rheumatoid arthritis
49090|NCT03895879|Tocilizumab|tocilizumab
49091|NCT03895879|Therapeutic Drug Monitoring|therapeutic drug monitoring
49092|NCT03895879|Drug level|drug level
49093|NCT03895879|Dose reduction|dose reduction
49094|NCT03895827|Opioid Overdose|opioid overdose
49095|NCT03895827|First responders|first responders
49096|NCT03895827|Medication Assisted Treatment|medication assisted treatment
49097|NCT03895827|Treatment linkage|treatment linkage
49098|NCT03895814|Balance|balance
49099|NCT03895814|Falls|falls
49100|NCT03895814|Posture|posture
49101|NCT03895814|Cognition|cognition
49102|NCT03895814|Training|training
49103|NCT03895801|granulomatosis|granulomatosis
49104|NCT03895801|polyangiitis|polyangiitis
49105|NCT03895801|corticosteroid|corticosteroid
49106|NCT03895801|replacement|replacement
49107|NCT03895801|glucocorticoid|glucocorticoid
49108|NCT03895775|obstructive sleep apnea|obstructive sleep apnea
49109|NCT03895775|adolescents|adolescents
49110|NCT03895775|prevalence|prevalence
49111|NCT03895736|Transcriptome|transcriptome
49112|NCT03895736|messenger ribonucleic acid (mRNA)|messenger ribonucleic acid (mrna)
49113|NCT03895736|sequencing|sequencing
49114|NCT03895736|biomarker|biomarker
49115|NCT03895736|cardiac arrest|cardiac arrest
49116|NCT03895736|prognostication|prognostication
49117|NCT03895736|successful resuscitation|successful resuscitation
49118|NCT03895723|Colorectal liver metastasis|colorectal liver metastasis
49119|NCT03895723|Minimally invasive surgery|minimally invasive surgery
49120|NCT03895723|Robotic surgery|robotic surgery
49121|NCT03895723|Laparoscopic surgery|laparoscopic surgery
49122|NCT03895710|sleep duration|sleep duration
49123|NCT03895710|blood pressure|blood pressure
49124|NCT03895710|adolescents|adolescents
49125|NCT03895710|holiday|holiday
49126|NCT03895697|glucagon|glucagon
49131|NCT03895632|Extraocular muscle|extraocular muscle
49132|NCT03895632|Electromyogram|electromyogram
49133|NCT03895632|Monopolar|monopolar
49134|NCT03895632|Needle guidance|needle guidance
49135|NCT03895632|Botulinum toxin|botulinum toxin
49136|NCT03895632|Strabismus|strabismus
49137|NCT03895593|fecal microbiota transplantation|fecal microbiota transplantation
49138|NCT03895593|intestinal infection|intestinal infection
49139|NCT03895593|Clostridium Difficile Infection|clostridium difficile infection
49140|NCT03895593|Antibiotic-associated Diarrhea|antibiotic-associated diarrhea
49141|NCT03895541|heart failure|heart failure
49142|NCT03895541|myocardial rigidity|myocardial rigidity
49143|NCT03895541|new diagnosis|new diagnosis
49144|NCT03895541|ultrasound imaging|ultrasound imaging
49145|NCT03895502|Venous Thrombosis|venous thrombosis
49146|NCT03895502|Neoplasms|neoplasms
49147|NCT03895502|Anticoagulant|anticoagulant
49148|NCT03895437|Type 1 Diabetes|type 1 diabetes
49149|NCT03895437|Diabetes|diabetes
49150|NCT03895437|Diabetes Mellitus|diabetes mellitus
49151|NCT03895424|Iron|iron
49152|NCT03895424|Isotope study|isotope study
49153|NCT03895424|Fatty Acid|fatty acid
49154|NCT03895398|underfive children|underfive children
49155|NCT03895398|post-disaster recovery|post-disaster recovery
49156|NCT03895398|optimized food based recommendation|optimized food based recommendation
49157|NCT03895398|growth|growth
49158|NCT03895398|development|development
49159|NCT03895398|psycho-social stimulation|psycho-social stimulation
49160|NCT03895385|BKZ|bkz
49161|NCT03895385|UCB4940|ucb4940
49162|NCT03895385|Healthy Subjects|healthy subjects
49163|NCT03895346|Mindfulness|mindfulness
49164|NCT03895346|Meditation|meditation
49165|NCT03895346|Imaging|imaging
49166|NCT03895346|MRI|mri
49167|NCT03895333|Bone mineral density|bone mineral density
49168|NCT03895333|Postmenopause|postmenopause
49169|NCT03895320|Native American|native american
49170|NCT03895320|Youth|youth
49171|NCT03895320|Young Adults|young adults
49172|NCT03895320|STI Screening|sti screening
49173|NCT03895320|Self Administered Sample Collection|self administered sample collection
49174|NCT03895307|chronic low back pain|chronic low back pain
49175|NCT03895307|kinesio taping|kinesio taping
49176|NCT03895307|injection|injection
49177|NCT03895307|local anesthetic|local anesthetic
49178|NCT03895294|Direct-Acting Antivirals|direct-acting antivirals
49179|NCT03895294|Health Services Accessibility|health services accessibility
49180|NCT03895255|lymph node dissection|lymph node dissection
49181|NCT03895255|high tie|high tie
49182|NCT03895255|low tie|low tie
49183|NCT03895255|splenic flexure mobilization|splenic flexure mobilization
49184|NCT03895255|anastomotic leak|anastomotic leak
49185|NCT03895242|Preterm infant|preterm infant
49186|NCT03895242|Mechanical ventilation|mechanical ventilation
49187|NCT03895242|Position|position
49188|NCT03895229|Diabetes|diabetes
49189|NCT03895229|Empagliflozin|empagliflozin
49190|NCT03895229|Circadian rythm|circadian rythm
49191|NCT03895216|MicroRNAs|micrornas
49192|NCT03895216|Bone Metastases|bone metastases
49193|NCT03895216|Exosomes|exosomes
49194|NCT03895203|Psoriatic Arthritis|psoriatic arthritis
49195|NCT03895203|PsA|psa
49196|NCT03895203|Bimekizumab|bimekizumab
49197|NCT03895190|well-being|well-being
49198|NCT03895190|stress|stress
49199|NCT03895190|positive psychology|positive psychology
49200|NCT03895190|meditation|meditation
49201|NCT03895190|mobile application (app)|mobile application (app)
49202|NCT03895190|medical students|medical students
49203|NCT03895125|dual-task training|dual-task training
49204|NCT03895125|attention|attention
49205|NCT03895125|Parkinson's disease|parkinson's disease
49206|NCT03895125|walking|walking
49208|NCT03895112|Therapeutic|therapeutic
49209|NCT03895112|Fibrosis|fibrosis
49210|NCT03895112|Splenomegaly|splenomegaly
49211|NCT03895112|Myeloproliferative neoplasms research consortium|myeloproliferative neoplasms research consortium
49212|NCT03895112|Intravenous Infusion|intravenous infusion
49213|NCT03895112|Phase 1|phase 1
49214|NCT03895021|falls prevention|falls prevention
49215|NCT03895021|Latino|latino
49216|NCT03895021|Hispanic|hispanic
49217|NCT03895021|Stepping On|stepping on
49218|NCT03895008|Cardia gastric cancer|cardia gastric cancer
49219|NCT03895008|Non-cardia gastric cancer|non-cardia gastric cancer
49220|NCT03895008|Resection|resection
49221|NCT03895008|Prognosis|prognosis
49222|NCT03894995|Ventilation|ventilation
49223|NCT03894969|Immunogenicity|immunogenicity
49224|NCT03894969|Chronic obstructive pulmonary disease (COPD)|chronic obstructive pulmonary disease (copd)
49225|NCT03894969|Non-typeable Haemophilus influenza|non-typeable haemophilus influenza
49226|NCT03894969|Moraxella catarrhalis|moraxella catarrhalis
49227|NCT03894969|Shingrix|shingrix
49228|NCT03894969|Herpes Zoster|herpes zoster
49229|NCT03894969|Adjuvanted vaccines|adjuvanted vaccines
49230|NCT03894969|Safety|safety
49231|NCT03894956|Hidradenitis Suppurativa (HS)|hidradenitis suppurativa (hs)
49232|NCT03894956|Humira|humira
49233|NCT03894956|Adalimumab|adalimumab
49234|NCT03894943|PET/CT|pet/ct
49235|NCT03894930|healthy subjects|healthy subjects
49236|NCT03894930|prosocial|prosocial
49237|NCT03894930|metta meditation|metta meditation
49238|NCT03894930|fMRI|fmri
49239|NCT03894904|Heparin|heparin
49240|NCT03894904|Papaverine|papaverine
49241|NCT03894891|Head and Neck Cancer|head and neck cancer
49242|NCT03894878|Warfarin|warfarin
49243|NCT03894878|Coumadin|coumadin
49244|NCT03894878|Pharmacogenomics|pharmacogenomics
49245|NCT03894878|Pharmacogenetics|pharmacogenetics
49246|NCT03894878|Adverse Drug Reactions|adverse drug reactions
49247|NCT03894878|Bleeding/hemorrhaging|bleeding/hemorrhaging
49248|NCT03894865|scoliosis, prevalence|scoliosis, prevalence
49249|NCT03894865|screening, Egypt|screening, egypt
49250|NCT03894839|Prothesis stomatitis, disinfection methods|prothesis stomatitis, disinfection methods
49251|NCT03894826|PEDIATRIC|pediatric
49252|NCT03894800|metoxyflurane|metoxyflurane
49253|NCT03894800|pain|pain
49254|NCT03894800|fentanyl|fentanyl
49255|NCT03894800|cold pressor test|cold pressor test
49256|NCT03894787|Ross procedure|ross procedure
49257|NCT03894787|Conventional aortic valve replacement|conventional aortic valve replacement
49258|NCT03894774|Chronic Post-Traumatic Stress Disorder|chronic post-traumatic stress disorder
49259|NCT03894774|Neuroses, Posttraumatic|neuroses, posttraumatic
49260|NCT03894774|PTSD|ptsd
49261|NCT03894761|Pain|pain
49262|NCT03894761|Shoulder|shoulder
49263|NCT03894761|Rotator Cuff|rotator cuff
49264|NCT03894748|Glabella line|glabella line
49265|NCT03894748|Glabella lines|glabella lines
49266|NCT03894748|Botulinum Toxin|botulinum toxin
49267|NCT03894735|Calcium|calcium
49268|NCT03894735|Magnesium|magnesium
49269|NCT03894735|Inflammation|inflammation
49270|NCT03894722|third molar surgery|third molar surgery
49271|NCT03894722|povidone iodine|povidone iodine
49272|NCT03894709|older persons|older persons
49273|NCT03894709|family-centered care model|family-centered care model
49274|NCT03894709|family caregiver's competence|family caregiver's competence
49275|NCT03894709|intervention protocol|intervention protocol
49276|NCT03894683|Heart failure|heart failure
49277|NCT03894683|Melatonin|melatonin
49278|NCT03894683|Muscle wasting|muscle wasting
49279|NCT03894670|Gastric emptying|gastric emptying
49280|NCT03894670|Gastrointestinal transit|gastrointestinal transit
49281|NCT03894670|Food reward|food reward
49282|NCT03894670|Food preferences|food preferences
49283|NCT03894657|CYSTIC FIBROSIS|cystic fibrosis
49284|NCT03894657|ORKAMBI|orkambi
49285|NCT03894631|Kahook dual blade|kahook dual blade
49286|NCT03894631|Trabectome|trabectome
49287|NCT03894631|Intraocular Pressure|intraocular pressure
49288|NCT03894579|natural killer cells|natural killer cells
49289|NCT03894579|autologous|autologous
49290|NCT03894566|Clinical Trial Protocol [Publication Type];|clinical trial protocol [publication type];
49291|NCT03894566|Cohort Studies|cohort studies
49292|NCT03894566|Infant, Newborn|infant, newborn
49293|NCT03894566|Child|child
49294|NCT03894566|Infant|infant
49295|NCT03894566|Health|health
49296|NCT03894566|Public Health|public health
49297|NCT03894566|Predictors|predictors
49298|NCT03894527|Acute Exercise|acute exercise
49299|NCT03894527|Endothelial Function|endothelial function
49300|NCT03894527|Simple Obesity|simple obesity
49301|NCT03894527|Metabolic Syndrome|metabolic syndrome
49302|NCT03894501|opioid|opioid
49303|NCT03894501|chronic pain|chronic pain
49304|NCT03894501|methadone|methadone
49305|NCT03894501|mindfulness|mindfulness
49306|NCT03894475|Asthma|asthma
49307|NCT03894475|COPD|copd
49308|NCT03894475|Mobile Spirometry|mobile spirometry
49309|NCT03894462|Zero Suicide|zero suicide
49310|NCT03894462|Effectiveness|effectiveness
49311|NCT03894462|Brief Treatment|brief treatment
49312|NCT03894462|Interpersonal Theory|interpersonal theory
49313|NCT03894462|Cost-Effectiveness|cost-effectiveness
49314|NCT03894410|HER2|her2
49315|NCT03894410|Lapatinib|lapatinib
49316|NCT03894397|(Unilateral) Deep brain stimulation|(unilateral) deep brain stimulation
49317|NCT03894397|Anxiety|anxiety
49318|NCT03894397|Mood|mood
49319|NCT03894384|TFF3|tff3
49321|NCT03894293|functional performance|functional performance
49322|NCT03894293|respiratory failure|respiratory failure
49323|NCT03894293|weaning|weaning
49324|NCT03894293|mechanical ventilator|mechanical ventilator
49325|NCT03894293|physical therapy|physical therapy
49326|NCT03894293|cardiopulmonary physical therapy|cardiopulmonary physical therapy
49327|NCT03894280|bioequivalence|bioequivalence
49328|NCT03894280|fluticasone propionate|fluticasone propionate
49329|NCT03894280|salmeterol xinafoate|salmeterol xinafoate
49330|NCT03894280|SERETIDE|seretide
49331|NCT03894280|charcoal blockade|charcoal blockade
49332|NCT03894241|Sedentary lifestyle|sedentary lifestyle
49333|NCT03894241|academic performance|academic performance
49334|NCT03894241|aerobic fitness|aerobic fitness
49335|NCT03894241|electroencephalogram|electroencephalogram
49336|NCT03894137|Grains of Paradise|grains of paradise
49337|NCT03894137|energy metabolism|energy metabolism
49338|NCT03894137|substrate oxidation|substrate oxidation
49339|NCT03894111|trauma, mortality|trauma, mortality
49340|NCT03894098|nerve block|nerve block
49341|NCT03894085|anxiety disorder|anxiety disorder
49342|NCT03894085|obsessive-compulsive disorder|obsessive-compulsive disorder
49343|NCT03894085|neuroimaging|neuroimaging
49344|NCT03894085|biomarkers|biomarkers
49345|NCT03894085|treatment response|treatment response
49346|NCT03894072|High flow oxygen device, HFHO, CPAP, One-lung ventilation|high flow oxygen device, hfho, cpap, one-lung ventilation
49347|NCT03894059|cardiac arrest|cardiac arrest
49348|NCT03894059|bystander cardiopulmonary resuscitation CPR|bystander cardiopulmonary resuscitation cpr
49349|NCT03894059|dispatch-assisted CPR instructions|dispatch-assisted cpr instructions
49350|NCT03894059|agonal breathing|agonal breathing
49351|NCT03894007|Neoadjuvant therapy|neoadjuvant therapy
49352|NCT03894007|PD-L1 positive breast cancer|pd-l1 positive breast cancer
49353|NCT03893981|Rehabilitation|rehabilitation
49354|NCT03893981|Pain|pain
49355|NCT03893981|Functionality|functionality
49356|NCT03893981|Proprioception|proprioception
49357|NCT03893955|Cancer|cancer
49358|NCT03893955|Advanced Solid Tumors|advanced solid tumors
49359|NCT03893955|Triple-Negative Breast Cancer (TNBC)|triple-negative breast cancer (tnbc)
49360|NCT03893955|Non-small-cell-lung-cancer (NSCLC)|non-small-cell-lung-cancer (nsclc)
49459|NCT03893136|cohort|cohort
49361|NCT03893955|Head and neck squamous cell carcinoma (HNSCC)|head and neck squamous cell carcinoma (hnscc)
49362|NCT03893955|ABBV-927|abbv-927
49363|NCT03893955|ABBV-368|abbv-368
49364|NCT03893955|ABBV-181|abbv-181
49365|NCT03893955|metastatic solid tumors|metastatic solid tumors
49366|NCT03893955|dose-escalation|dose-escalation
49367|NCT03893955|recommended phase 2 dose|recommended phase 2 dose
49368|NCT03893942|Inflammatory Bowel Diseases|inflammatory bowel diseases
49369|NCT03893942|Mindfulness|mindfulness
49370|NCT03893942|Psychological predictors|psychological predictors
49371|NCT03893942|Colorectal surgery|colorectal surgery
49372|NCT03893890|Edematous Fibrosclerotic Panniculopathy|edematous fibrosclerotic panniculopathy
49373|NCT03893890|EFP|efp
49374|NCT03893890|Cellulite|cellulite
49375|NCT03893864|Coenzyme Q10|coenzyme q10
49376|NCT03893864|Ubiquinone|ubiquinone
49377|NCT03893864|Ubiquinol|ubiquinol
49378|NCT03893864|Oxidative pattern|oxidative pattern
49379|NCT03893864|Exercise|exercise
49380|NCT03893851|violence|violence
49381|NCT03893760|heart Failure|heart failure
49382|NCT03893760|ventricular elastance|ventricular elastance
49383|NCT03893760|dilated cardiomyopathy|dilated cardiomyopathy
49384|NCT03893760|right heart systolic function|right heart systolic function
49385|NCT03893760|right ventriculo-arterial coupling|right ventriculo-arterial coupling
49386|NCT03893708|pregnancy|pregnancy
49387|NCT03893708|prenatal yoga|prenatal yoga
49388|NCT03893708|excessive gestational weight gain|excessive gestational weight gain
49389|NCT03893695|Phase Ib/II|phase ib/ii
49390|NCT03893695|HCC|hcc
49391|NCT03893695|Metastatic Hepatocellular Carcinoma|metastatic hepatocellular carcinoma
49392|NCT03893656|Living donor nephrectomy|living donor nephrectomy
49393|NCT03893656|Kindey transplantation|kindey transplantation
49394|NCT03893656|Retroperitoneoscopic donor nephrectomy|retroperitoneoscopic donor nephrectomy
49395|NCT03893656|Hernia|hernia
49396|NCT03893630|aspirin|aspirin
49397|NCT03893630|pulsatility index|pulsatility index
49398|NCT03893630|doppler|doppler
49399|NCT03893630|uterine|uterine
49400|NCT03893630|acetylsalicylic acid|acetylsalicylic acid
49401|NCT03893630|preeclampsia|preeclampsia
49402|NCT03893630|blood pressure|blood pressure
49403|NCT03893604|tDCS|tdcs
49404|NCT03893604|Athlete|athlete
49405|NCT03893604|Isokinetic|isokinetic
49406|NCT03893604|Endurance|endurance
49407|NCT03893604|Fatigue|fatigue
49408|NCT03893578|Conveyor System|conveyor system
49409|NCT03893578|Sapien 3|sapien 3
49410|NCT03893578|cardiovascular disease|cardiovascular disease
49411|NCT03893578|TMVR|tmvr
49412|NCT03893578|failing valve|failing valve
49413|NCT03893578|failing bioprosthetic valve|failing bioprosthetic valve
49414|NCT03893565|GSK2831781, ulcerative colitis, anti-LAG3 cell|gsk2831781, ulcerative colitis, anti-lag3 cell
49415|NCT03893565|depleting monoclonal antibody, dose-response|depleting monoclonal antibody, dose-response
49416|NCT03893552|Negative expiratory pressure, sleep apnea, Snoring, Sleep-disordered breathing|negative expiratory pressure, sleep apnea, snoring, sleep-disordered breathing
49417|NCT03893526|GLP-1|glp-1
49418|NCT03893526|Neprilysin|neprilysin
49419|NCT03893526|Diabetes|diabetes
49420|NCT03893513|Bio-impedance|bio-impedance
49421|NCT03893513|Haemodynamic monitoring|haemodynamic monitoring
49422|NCT03893513|Pulse contour analysis|pulse contour analysis
49423|NCT03893513|kidney transplantation|kidney transplantation
49424|NCT03893500|Six minute walk test|six minute walk test
49425|NCT03893500|Six minute walk distance|six minute walk distance
49426|NCT03893500|Heart rate recovery|heart rate recovery
49427|NCT03893500|Mobile health|mobile health
49428|NCT03893474|AMD|amd
49429|NCT03893474|nAMD|namd
49430|NCT03893422|glucose control|glucose control
49431|NCT03893422|inflammation|inflammation
49432|NCT03893422|safety|safety
49433|NCT03893422|microbiome|microbiome
49434|NCT03893396|drug eluting stent|drug eluting stent
49435|NCT03893396|Drug-coated balloon|drug-coated balloon
49436|NCT03893396|Bare-Metal Stent|bare-metal stent
49437|NCT03893396|Revascularization|revascularization
49438|NCT03893383|knowledge attitude practice questionnaire post exposure prophylaxis|knowledge attitude practice questionnaire post exposure prophylaxis
49439|NCT03893331|Arrhythmia's|arrhythmia's
49440|NCT03893214|virtual reality exposure therapy|virtual reality exposure therapy
49441|NCT03893214|waitlist control design|waitlist control design
49442|NCT03893214|single session exposure|single session exposure
49443|NCT03893214|emotion-driven behavior|emotion-driven behavior
49444|NCT03893214|respiration|respiration
49445|NCT03893201|Endovenous Ablation|endovenous ablation
49446|NCT03893175|Non-steroidal anti-inflammatory drugs|non-steroidal anti-inflammatory drugs
49447|NCT03893162|probiotic|probiotic
49448|NCT03893162|depression|depression
49449|NCT03893162|microbiome|microbiome
49450|NCT03893162|bacteria|bacteria
49451|NCT03893149|Exercise|exercise
49452|NCT03893149|Prevention|prevention
49453|NCT03893149|Attention capacity|attention capacity
49454|NCT03893136|Takayasu arteritis|takayasu arteritis
49455|NCT03893136|follow-up|follow-up
49456|NCT03893136|treatment|treatment
49457|NCT03893136|outcome|outcome
49458|NCT03893136|pregnancy|pregnancy
49460|NCT03893097|Schistosoma|schistosoma
49461|NCT03893097|Schistosomiasis|schistosomiasis
49462|NCT03893097|Senegal|senegal
49463|NCT03893097|Praziquantel|praziquantel
49464|NCT03893097|Artesunate|artesunate
49465|NCT03893097|Mefloquine|mefloquine
49466|NCT03893084|preconception|preconception
49467|NCT03893084|period|period
49468|NCT03893084|education|education
49469|NCT03893084|midwfiery|midwfiery
49470|NCT03893058|Train-Of-Four|train-of-four
49471|NCT03893058|Single Fiber Electromyography|single fiber electromyography
49472|NCT03893058|NeuroMuscular Junction|neuromuscular junction
49473|NCT03893058|Critical Illness|critical illness
49474|NCT03893045|IDA|ida
49475|NCT03893045|anemia|anemia
49476|NCT03893045|pediatrics|pediatrics
49477|NCT03893045|ferumoxytol|ferumoxytol
49478|NCT03893045|iron sucrose|iron sucrose
49479|NCT03892980|breast cancer|breast cancer
49480|NCT03892980|BRCA|brca
49481|NCT03892980|NSM|nsm
49482|NCT03892967|SPADE|spade
49483|NCT03892967|Cancer Control|cancer control
49484|NCT03892967|Sleep Disturbance|sleep disturbance
49485|NCT03892967|Electronic Health Record|electronic health record
49486|NCT03892967|Pain|pain
49487|NCT03892967|Anxiety|anxiety
49488|NCT03892967|Depression|depression
49489|NCT03892967|Fatigue|fatigue
49490|NCT03892954|MicroRNAs|micrornas
49491|NCT03892954|Chronic fatigue syndrome|chronic fatigue syndrome
49492|NCT03892954|Pain intensity|pain intensity
49493|NCT03892863|Amyotrophic Lateral Sclerosis|amyotrophic lateral sclerosis
49494|NCT03892863|depression|depression
49495|NCT03892863|rTMS|rtms
49496|NCT03892850|Prescriptions|prescriptions
49497|NCT03892850|Nurses|nurses
49498|NCT03892850|Primary Health Care|primary health care
49499|NCT03892850|Acute Disease|acute disease
49500|NCT03892837|Platelet-rich plasma|platelet-rich plasma
49501|NCT03892837|Refractory benign stenosis|refractory benign stenosis
49502|NCT03892824|AF|af
49503|NCT03892824|Stroke|stroke
49504|NCT03892824|Filter|filter
49505|NCT03892824|Emboli|emboli
49506|NCT03892824|Carotid|carotid
49507|NCT03892824|OAC|oac
49508|NCT03892798|IRF2BPL|irf2bpl
49509|NCT03892798|NEDAMSS|nedamss
49510|NCT03892798|dystonia|dystonia
49511|NCT03892798|movement disorder|movement disorder
49512|NCT03892798|seizures|seizures
49513|NCT03892759|Osteopathic Manipulative Treatment|osteopathic manipulative treatment
49514|NCT03892746|Cervical Spinal Cord Injury|cervical spinal cord injury
49515|NCT03892746|tDCS|tdcs
49516|NCT03892746|Transcranial Direct Current Stimulation|transcranial direct current stimulation
49517|NCT03892746|Upper limb|upper limb
49518|NCT03892746|Rehabilitation|rehabilitation
49519|NCT03892746|Brain Stimulation|brain stimulation
49520|NCT03892707|Low back pain|low back pain
49521|NCT03892707|Milgamma|milgamma
49522|NCT03892707|NSAIDs|nsaids
49523|NCT03892681|HBsAg(+) with chronic hepatitis or cirrhosis|hbsag(+) with chronic hepatitis or cirrhosis
49524|NCT03892681|anti-HCV(+) with cirrhosis|anti-hcv(+) with cirrhosis
49525|NCT03892681|cirrhosis of any etiology|cirrhosis of any etiology
49526|NCT03892655|breast carcinoma|breast carcinoma
49527|NCT03892655|receptors 2 (HER2)|receptors 2 (her2)
49528|NCT03892655|biosimilar|biosimilar
49529|NCT03892655|trastuzumab|trastuzumab
49530|NCT03892655|Zedora|zedora
49531|NCT03892642|Intravesical BCG|intravesical bcg
49532|NCT03892642|Bacille Calmette-Guerin|bacille calmette-guerin
49533|NCT03892642|avelumab|avelumab
49534|NCT03892551|risk prediction|risk prediction
49535|NCT03892551|Electronic triage systems (ETS)|electronic triage systems (ets)
49536|NCT03892551|undertriage|undertriage
49537|NCT03892551|overtriage|overtriage
49538|NCT03892538|Stress|stress
49539|NCT03892538|Blood pressure|blood pressure
49540|NCT03892538|Heart rate|heart rate
49541|NCT03892538|Corticotropin|corticotropin
49542|NCT03892538|Cortisol|cortisol
49543|NCT03892486|metabolomics, proteomics, PUFA, nutrition|metabolomics, proteomics, pufa, nutrition
49544|NCT03892486|healthy people aged 18-50|healthy people aged 18-50
49545|NCT03892473|Community mental health teams|community mental health teams
49546|NCT03892447|AKI|aki
49547|NCT03892447|Child|child
49548|NCT03892447|Alprostadil|alprostadil
49549|NCT03892447|Sodium Ferulate|sodium ferulate
49550|NCT03892447|Dopamine|dopamine
49551|NCT03892395|Healthy ageing|healthy ageing
49552|NCT03892395|B-vitamins|b-vitamins
49553|NCT03892395|Bone health|bone health
49554|NCT03892382|Amyotrophic Lateral Sclerosis|amyotrophic lateral sclerosis
49555|NCT03892382|rTMS|rtms
49556|NCT03892382|apathy|apathy
49557|NCT03892382|depression|depression
49558|NCT03892369|Alcohol|alcohol
49559|NCT03892369|FGF21|fgf21
49560|NCT03892369|Alcohol dependence|alcohol dependence
49561|NCT03892356|Concussion, Oculomotor function|concussion, oculomotor function
49562|NCT03892330|Nephroblastoma|nephroblastoma
49563|NCT03892330|Anthracycline|anthracycline
49564|NCT03892330|Liposome doxorubicin|liposome doxorubicin
49565|NCT03892330|Doxorubicin|doxorubicin
49566|NCT03892330|Pharmorubicin|pharmorubicin
49567|NCT03892330|Pirarubicin|pirarubicin
49568|NCT03892291|mild traumatic brain injury|mild traumatic brain injury
49569|NCT03892291|dual-task|dual-task
49570|NCT03892291|veterans|veterans
49571|NCT03892291|mobility|mobility
49572|NCT03892278|combined training|combined training
49573|NCT03892278|aerobic training|aerobic training
49574|NCT03892278|aquatic exercises|aquatic exercises
49576|NCT03892226|stroke|stroke
49577|NCT03892226|stroke-heart syndrome|stroke-heart syndrome
49578|NCT03892226|troponin|troponin
49579|NCT03892226|myocardial stunning|myocardial stunning
49580|NCT03892226|acute coronary syndrome|acute coronary syndrome
49581|NCT03892226|periodic repolarization dynamics|periodic repolarization dynamics
49582|NCT03892226|cardiac complications|cardiac complications
49583|NCT03892213|Chagas Disease|chagas disease
49584|NCT03892213|drug-drug interaction|drug-drug interaction
49585|NCT03892213|benznidazole|benznidazole
49586|NCT03892213|E1224|e1224
49587|NCT03892213|pharmacokinetics|pharmacokinetics
49588|NCT03892200|Mouth Care|mouth care
49589|NCT03892187|prehabilitation|prehabilitation
49590|NCT03892187|perioperative outcomes|perioperative outcomes
49591|NCT03892148|Heart Failure|heart failure
49592|NCT03892148|Diuretics|diuretics
49593|NCT03892148|Diuretic resistance|diuretic resistance
49594|NCT03892148|Loop diuretics|loop diuretics
49595|NCT03892148|Furosemide|furosemide
49596|NCT03892135|Role of parents, children and physician|role of parents, children and physician
49597|NCT03892135|Qualitative|qualitative
49598|NCT03892135|Interview|interview
49599|NCT03892135|Juvenile idiopathic arthritis|juvenile idiopathic arthritis
49600|NCT03892135|Adherence|adherence
49601|NCT03892135|mechanisms of adherence in juvenile idiopathic arthritis|mechanisms of adherence in juvenile idiopathic arthritis
49602|NCT03892122|Drug-induced sleep endoscopy|drug-induced sleep endoscopy
49603|NCT03892122|Dexmedetomidine|dexmedetomidine
49604|NCT03892122|Airway collapsibility|airway collapsibility
49605|NCT03892122|Propofol|propofol
49606|NCT03892083|Developmental coordination disorder|developmental coordination disorder
49607|NCT03892083|Postural balance|postural balance
49608|NCT03892083|Transcranial Direct Current Stimulation|transcranial direct current stimulation
49609|NCT03892083|Children|children
49610|NCT03892083|Child Development|child development
49611|NCT03892070|HMB|hmb
49612|NCT03892070|Physical exercise|physical exercise
49613|NCT03892057|Hispanics/Latinos|hispanics/latinos
49614|NCT03892057|Underserved Population|underserved population
49615|NCT03892057|Internet-based|internet-based
49616|NCT03892031|brain natriuretic peptide|brain natriuretic peptide
49617|NCT03892031|pneumoperitoneum|pneumoperitoneum
49618|NCT03892031|Trendelenburg|trendelenburg
49619|NCT03892031|circulatory function|circulatory function
49620|NCT03892031|laparoscopic radical cystectomy for bladder cancer|laparoscopic radical cystectomy for bladder cancer
49621|NCT03892031|central venous pressure|central venous pressure
49622|NCT03892031|stroke volume variation|stroke volume variation
49623|NCT03892031|transthoracic echocardiography|transthoracic echocardiography
49624|NCT03891966|Upper Extremity Fracture|upper extremity fracture
49625|NCT03891953|Non-small Cell Lung Cancer, melanoma, Nasopharyngeal Carcinoma, Microsatellite Stable Colorectal Cancer, Triple Negative Breast Cancer|non-small cell lung cancer, melanoma, nasopharyngeal carcinoma, microsatellite stable colorectal cancer, triple negative breast cancer
49626|NCT03891927|olive oil|olive oil
49627|NCT03891927|glycemic control|glycemic control
49628|NCT03891914|Multiple Myeloma|multiple myeloma
49629|NCT03891914|PET/CT|pet/ct
49630|NCT03891914|18F-FDG|18f-fdg
49631|NCT03891914|18F-FCH|18f-fch
49632|NCT03891888|Tibial diaphyseal fracture|tibial diaphyseal fracture
49633|NCT03891888|Nonunion|nonunion
49634|NCT03891888|Delayed union|delayed union
49635|NCT03891875|AMD|amd
49636|NCT03891875|Macular degeneration|macular degeneration
49637|NCT03891875|non-central geographic atrophy|non-central geographic atrophy
49638|NCT03891875|MTP-131|mtp-131
49639|NCT03891875|elamipretide|elamipretide
49640|NCT03891849|microcirculation|microcirculation
49641|NCT03891849|octreotide|octreotide
49642|NCT03891849|norepinephrine|norepinephrine
49643|NCT03891849|Variceal Hemorrhage|variceal hemorrhage
49644|NCT03891849|Haemorrhagic Shock|haemorrhagic shock
49645|NCT03891771|Elderly|elderly
49646|NCT03891771|Activities of daily living|activities of daily living
49647|NCT03891771|Telemonitoring|telemonitoring
49648|NCT03891758|Haemophilus influenza type b|haemophilus influenza type b
49649|NCT03891758|Adsorbed Diphtheria-purified Pertussis-Tetanus- Inactivate poliovirus combined vaccine|adsorbed diphtheria-purified pertussis-tetanus- inactivate poliovirus combined vaccine
49650|NCT03891758|Hib|hib
49651|NCT03891758|DPT-IPV|dpt-ipv
49652|NCT03891732|Prostate cancer|prostate cancer
49653|NCT03891732|PSA|psa
49654|NCT03891732|MRI|mri
49655|NCT03891732|Biopsy|biopsy
49656|NCT03891719|rhinoplasty|rhinoplasty
49657|NCT03891719|cleft lip nose|cleft lip nose
49658|NCT03891719|autologous cartilage graft|autologous cartilage graft
49659|NCT03891719|asian nose|asian nose
49660|NCT03891706|TCR-T|tcr-t
49661|NCT03891693|Stenosis|stenosis
49662|NCT03891693|Angioplasty|angioplasty
49663|NCT03891693|Vascular Disease|vascular disease
49664|NCT03891667|Lyme Disease|lyme disease
49665|NCT03891667|Post-treatment Lyme Disease Syndrome|post-treatment lyme disease syndrome
49666|NCT03891667|Disulfiram|disulfiram
49667|NCT03891667|Chronic Lyme Disease|chronic lyme disease
49668|NCT03891654|Radiation|radiation
49669|NCT03891654|Metastases|metastases
49670|NCT03891654|Dynamic Contrast Enhanced Computed Tomography|dynamic contrast enhanced computed tomography
49671|NCT03891654|Pilot|pilot
49672|NCT03891615|Lung Cancer|lung cancer
49673|NCT03891602|Smoker|smoker
49674|NCT03891602|Memorial Sloan Kettering Cancer Center|memorial sloan kettering cancer center
49675|NCT03891589|Complementary feeding|complementary feeding
49676|NCT03891589|Linear Programming|linear programming
49677|NCT03891589|Nutritional status|nutritional status
49678|NCT03891589|Micronutrient|micronutrient
49679|NCT03891589|Growth|growth
49680|NCT03891576|Ovarian Cancer|ovarian cancer
49681|NCT03891576|Fallopian Tube Cancer|fallopian tube cancer
49682|NCT03891576|Primary Peritoneal Cancer|primary peritoneal cancer
49683|NCT03891576|Platinum Senitive|platinum senitive
49684|NCT03891576|Recurrent Cancer|recurrent cancer
49685|NCT03891576|Niraparib|niraparib
49686|NCT03891576|Thrombocytopenia|thrombocytopenia
49687|NCT03891576|Neutropenia|neutropenia
49688|NCT03891576|Anemia|anemia
49689|NCT03891576|RADAR dosing|radar dosing
49690|NCT03891576|Maintenance Therapy|maintenance therapy
49691|NCT03891576|PARP-inhibitor|parp-inhibitor
49692|NCT03891550|HCV, micro-elimination, DAA|hcv, micro-elimination, daa
49693|NCT03891537|Bilateral Tubal Ligation|bilateral tubal ligation
49694|NCT03891537|Postoperative Discomforts|postoperative discomforts
49695|NCT03891485|Nivolumab|nivolumab
49696|NCT03891485|CXCR4 antagonist|cxcr4 antagonist
49697|NCT03891485|mRCC|mrcc
49698|NCT03891485|Tregs-NKs|tregs-nks
49699|NCT03891472|mFOLFIRINOX|mfolfirinox
49700|NCT03891472|SBRT|sbrt
49701|NCT03891472|Unresectable Pancreatic Cancer|unresectable pancreatic cancer
49702|NCT03891459|social placebo effect|social placebo effect
49703|NCT03891459|fMRI|fmri
49704|NCT03891459|neural account|neural account
49705|NCT03891433|adult|adult
49706|NCT03891433|Equivalence Trial|equivalence trial
49707|NCT03891433|Randomized Controlled Trial|randomized controlled trial
49708|NCT03891433|Comparative Study|comparative study
49709|NCT03891433|Anti-Bacterial Agents/therapeutic use*|anti-bacterial agents/therapeutic use*
49710|NCT03891433|Meropenem|meropenem
49711|NCT03891433|Ertapenem|ertapenem
49712|NCT03891433|Piperacillin, Tazobactam Drug Combination|piperacillin, tazobactam drug combination
49713|NCT03891433|Escherichia coli Infections/drug therapy|escherichia coli infections/drug therapy
49714|NCT03891433|Klebsiella Infections/drug therapy|klebsiella infections/drug therapy
49715|NCT03891368|Learning collaborative|learning collaborative
49716|NCT03891368|Technical assistance|technical assistance
49717|NCT03891368|Serious mental illness|serious mental illness
49718|NCT03891368|Organizational change|organizational change
49719|NCT03891368|InSHAPE|inshape
49720|NCT03891355|Carfilzomib|carfilzomib
49721|NCT03891355|Lenalidomide|lenalidomide
49722|NCT03891355|Dexamethasone|dexamethasone
49723|NCT03891355|relapsed-refractory or intolerant mantle cell lymphomas|relapsed-refractory or intolerant mantle cell lymphomas
49724|NCT03891303|Aorta, abdominal|aorta, abdominal
49725|NCT03891303|Intraoperative blood salvage|intraoperative blood salvage
49726|NCT03891303|Elective surgical procedures|elective surgical procedures
49727|NCT03891303|Patient outcomes assessment|patient outcomes assessment
49728|NCT03891277|Vascular Cognitive Impairment|vascular cognitive impairment
49729|NCT03891277|dementia|dementia
49730|NCT03891277|iron deficiency|iron deficiency
49731|NCT03891277|cerebral infarction|cerebral infarction
49733|NCT03891277|biological markers|biological markers
49734|NCT03891277|Clinical Trial|clinical trial
49735|NCT03891238|unfit for cisplatin|unfit for cisplatin
49736|NCT03891238|PD-L1|pd-l1
49737|NCT03891238|urotelian metastatic cancer|urotelian metastatic cancer
49738|NCT03891212|Prone Position|prone position
49739|NCT03891212|Treatment Outcome|treatment outcome
49740|NCT03891212|Respiration, Artificial|respiration, artificial
49741|NCT03891199|clinical trial|clinical trial
49742|NCT03891199|randomization|randomization
49743|NCT03891199|hip arthroplasty|hip arthroplasty
49744|NCT03891186|schizophrenia|schizophrenia
49745|NCT03891186|metacognitive training|metacognitive training
49746|NCT03891186|insight|insight
49747|NCT03891186|positive symptoms|positive symptoms
49748|NCT03891186|functioning|functioning
49749|NCT03891173|lung adenocarcinoma|lung adenocarcinoma
49750|NCT03891173|immunoconjugate|immunoconjugate
49751|NCT03891173|tumor microenvironment alkalinization|tumor microenvironment alkalinization
49752|NCT03891147|symptomatic gallstone diseases|symptomatic gallstone diseases
49753|NCT03891147|electro-acupuncture|electro-acupuncture
49754|NCT03891121|Myofascial Pain|myofascial pain
49755|NCT03891121|Botulinum Toxin|botulinum toxin
65497|NCT03795012|ER|er
49756|NCT03891095|intranasal oxytocin|intranasal oxytocin
49757|NCT03891095|L-DOPA|l-dopa
49758|NCT03891095|Vicarious optimism|vicarious optimism
49759|NCT03891069|Parkinson's disease|parkinson's disease
49760|NCT03891069|Exergames|exergames
49761|NCT03891069|Virtual reality|virtual reality
49762|NCT03891069|Exercise|exercise
49763|NCT03891069|Feasibility study|feasibility study
49764|NCT03891056|Diabetes Mellitus|diabetes mellitus
49765|NCT03891056|Metabolic Surgery|metabolic surgery
49766|NCT03891056|BMI 30-35|bmi 30-35
49767|NCT03891056|BPGY|bpgy
49768|NCT03891056|Vertical Gastrectomy|vertical gastrectomy
49769|NCT03890991|Intervention|intervention
49770|NCT03890991|Self-efficacy|self-efficacy
49771|NCT03890991|Diabetes Self-care Activities|diabetes self-care activities
49772|NCT03890991|Self-Monitoring of Blood Glucose|self-monitoring of blood glucose
49773|NCT03890991|Diabetes|diabetes
49774|NCT03890991|Community|community
49775|NCT03890991|Older people with diabetes|older people with diabetes
49776|NCT03890978|exclusive, breastfeeding, text messages, Jordan|exclusive, breastfeeding, text messages, jordan
49777|NCT03890965|stroke|stroke
49778|NCT03890965|Physical therapy|physical therapy
49779|NCT03890965|neurological hand|neurological hand
49780|NCT03890965|Vojta therapy|vojta therapy
49781|NCT03890939|Sleep Apnea, Mixed|sleep apnea, mixed
49782|NCT03890939|Sleep Apnea Device|sleep apnea device
49783|NCT03890939|BiPap device|bipap device
49784|NCT03890939|Sleep Study|sleep study
49785|NCT03890926|Three-Dimensional Printing|three-dimensional printing
49786|NCT03890926|Rectum Cancer, Recurrent|rectum cancer, recurrent
49787|NCT03890926|Radioactive Iodine-125 seed implantation|radioactive iodine-125 seed implantation
49788|NCT03890874|Cardiopulmonary Resuscitation|cardiopulmonary resuscitation
49789|NCT03890874|Teaching techniques|teaching techniques
49790|NCT03890874|Basic Life Support training|basic life support training
49791|NCT03890874|Simulation|simulation
49792|NCT03890861|African American|african american
49793|NCT03890861|Aging|aging
49794|NCT03890861|Physical activity|physical activity
49795|NCT03890861|Cognition|cognition
49796|NCT03890861|Prevention|prevention
49797|NCT03890848|functional exercise|functional exercise
49798|NCT03890848|health belief model|health belief model
49799|NCT03890835|Pulpotomy|pulpotomy
49800|NCT03890835|Mineral Trioxide Aggregate (MTA)|mineral trioxide aggregate (mta)
49801|NCT03890835|Biodentine|biodentine
49802|NCT03890835|Vital pulp therapy|vital pulp therapy
49803|NCT03890835|Postoperative pain|postoperative pain
49804|NCT03890835|Overall success|overall success
49805|NCT03890731|Metastatic colorectal cancer (mCRC)|metastatic colorectal cancer (mcrc)
49806|NCT03890731|Renal cell cancer|renal cell cancer
49807|NCT03890731|Gastro-intestinal stromal tumor|gastro-intestinal stromal tumor
49808|NCT03890731|Hepatocellular carcinoma|hepatocellular carcinoma
49809|NCT03890640|Ultrasound|ultrasound
49810|NCT03890640|Thoracic epidural catheter insertion|thoracic epidural catheter insertion
49811|NCT03890640|Fluoroscopy|fluoroscopy
49812|NCT03890614|3D organoid technique|3d organoid technique
49813|NCT03890588|Chronic Kidney Disease|chronic kidney disease
49814|NCT03890588|CKD|ckd
49815|NCT03890588|Clinical Decision Support|clinical decision support
49816|NCT03890588|Diabetes|diabetes
49817|NCT03890588|Hypertension|hypertension
49818|NCT03890575|3D printed|3d printed
49819|NCT03890575|airway stent|airway stent
49820|NCT03890575|carina|carina
49821|NCT03890575|distal bronchi|distal bronchi
49822|NCT03890562|acupressure|acupressure
49823|NCT03890549|obstructive sleep apnea|obstructive sleep apnea
49824|NCT03890549|polysomnography|polysomnography
49825|NCT03890549|smart phone application|smart phone application
49826|NCT03890536|Microbiome|microbiome
49827|NCT03890523|3D printed|3d printed
49828|NCT03890523|retrievable stent|retrievable stent
49829|NCT03890523|carina|carina
49830|NCT03890523|distal bronchi|distal bronchi
49831|NCT03890510|pulse pressure variation|pulse pressure variation
49832|NCT03890510|intraocular pressure|intraocular pressure
49833|NCT03890510|optic sheath diameter|optic sheath diameter
49834|NCT03890510|spine surgery|spine surgery
49835|NCT03890510|prone position|prone position
49836|NCT03890484|Alcohol use|alcohol use
49837|NCT03890484|Risk-taking|risk-taking
49838|NCT03890484|Anxiety|anxiety
49839|NCT03890484|Motives|motives
49840|NCT03890484|Multimethod|multimethod
49841|NCT03890458|vitamin D|vitamin d
49842|NCT03890458|vitamin D supplementation|vitamin d supplementation
49843|NCT03890458|infertility|infertility
49844|NCT03890458|D vitamin deficiency|d vitamin deficiency
49845|NCT03890458|infertile women|infertile women
49846|NCT03890458|embryo transfer|embryo transfer
49847|NCT03890458|pregnancy rate|pregnancy rate
49848|NCT03890445|Crohn´s Disease|crohn´s disease
49849|NCT03890445|Inflammatory Bowel Disease|inflammatory bowel disease
49850|NCT03890445|Adalimumab|adalimumab
49851|NCT03890445|Infliximab|infliximab
49852|NCT03890445|Biosimilar|biosimilar
49853|NCT03890445|IBD-Index|ibd-index
49854|NCT03890432|Nutrition management|nutrition management
49855|NCT03890432|Glycaemia control|glycaemia control
49856|NCT03890432|ICU|icu
49857|NCT03890432|Software|software
49858|NCT03890432|Critical illness|critical illness
49859|NCT03890432|Insulin-therapy|insulin-therapy
49860|NCT03890432|Critically ill patients|critically ill patients
49861|NCT03890432|Blood glucose control|blood glucose control
49862|NCT03890419|Acute Pain|acute pain
49863|NCT03890419|Chronic Pain|chronic pain
49864|NCT03890419|Opioid Use|opioid use
49865|NCT03890419|Pain|pain
49866|NCT03890406|Deep neuromuscular blockade|deep neuromuscular blockade
49867|NCT03890289|Idelalisib|idelalisib
49868|NCT03890289|Obinutuzumab|obinutuzumab
49869|NCT03890289|Relapsed/Refractory Follicular Lymphoma|relapsed/refractory follicular lymphoma
49870|NCT03890276|labor|labor
49871|NCT03890276|birth|birth
49872|NCT03890276|routine care|routine care
49873|NCT03890276|midwifery|midwifery
49874|NCT03890276|Zanzibar|zanzibar
49875|NCT03890276|Sub-Saharan Africa|sub-saharan africa
49876|NCT03890276|training|training
49877|NCT03890276|skilled birth attendant|skilled birth attendant
49878|NCT03890276|competency|competency
49879|NCT03890276|simulation|simulation
49880|NCT03890276|video|video
49881|NCT03890250|pulmonary rehabilitation|pulmonary rehabilitation
49882|NCT03890250|neuromuscular electrical stimulation|neuromuscular electrical stimulation
49883|NCT03890224|Respiratory Support|respiratory support
49884|NCT03890211|Hypothermia|hypothermia
49885|NCT03890211|Infant Warmer|infant warmer
49886|NCT03890198|Gastric cancer|gastric cancer
49887|NCT03890198|Pancreatic Ductal Adenocarcinoma|pancreatic ductal adenocarcinoma
49888|NCT03890172|platelets rich plasma|platelets rich plasma
49889|NCT03890146|intensive care|intensive care
49890|NCT03890146|capillary sampling|capillary sampling
49891|NCT03890146|veinous sampling|veinous sampling
49892|NCT03890146|natremia|natremia
49893|NCT03890146|kalaemia|kalaemia
49894|NCT03890146|Chloremia|chloremia
49895|NCT03890133|Fibromyalgia|fibromyalgia
49896|NCT03890133|Ba-Duan-Jin|ba-duan-jin
49897|NCT03890133|Gut microbiota|gut microbiota
49898|NCT03890133|Mechanism|mechanism
49899|NCT03890107|Ear Infection|ear infection
49900|NCT03890107|Ear tubes|ear tubes
49901|NCT03890107|Myringotomy|myringotomy
49902|NCT03890107|Otitis Media|otitis media
49903|NCT03890107|Tympanostomy|tympanostomy
49904|NCT03890094|Sufentanil|sufentanil
49905|NCT03890094|Bronchoscopy|bronchoscopy
49906|NCT03890094|Conscious sedation|conscious sedation
49907|NCT03890094|midazolam|midazolam
49908|NCT03890081|Coping Strategies Questionnaire|coping strategies questionnaire
49909|NCT03890081|Cross-cultural adaptation|cross-cultural adaptation
49910|NCT03890081|Reliability|reliability
49911|NCT03890081|Validity|validity
49912|NCT03890029|PTSD|ptsd
49913|NCT03890029|Elevated Cardiovascular Disease risk|elevated cardiovascular disease risk
49914|NCT03890029|Resilience|resilience
49915|NCT03890016|Modified Lee and White Method|modified lee and white method
49916|NCT03890016|20'WBCT|20'wbct
49917|NCT03890016|Whole Blood Clotting Test|whole blood clotting test
49918|NCT03889990|pulmonary function|pulmonary function
49919|NCT03889990|IQOS|iqos
49920|NCT03889990|heated tobacco|heated tobacco
49921|NCT03889964|cardiopulmonary exercise testing|cardiopulmonary exercise testing
49922|NCT03889964|cardiovascular comorbidities|cardiovascular comorbidities
49923|NCT03889964|cardiopulmonary interaction|cardiopulmonary interaction
49924|NCT03889912|Recurrent|recurrent
49925|NCT03889912|CSCC|cscc
49926|NCT03889899|Squamous Cell Carcinoma|squamous cell carcinoma
49927|NCT03889899|SCC|scc
49928|NCT03889899|Skin Cancer|skin cancer
49929|NCT03889899|Skin metastasis|skin metastasis
49930|NCT03889899|HNSCC|hnscc
49931|NCT03889899|Carcinoma, Squamous|carcinoma, squamous
49932|NCT03889899|CMN|cmn
49933|NCT03889899|Basal cell carcinoma|basal cell carcinoma
49934|NCT03889899|Superficial sarcoma|superficial sarcoma
49935|NCT03889899|Kaposi sarcoma|kaposi sarcoma
49936|NCT03889899|Alpha radiation|alpha radiation
49937|NCT03889899|Cutaneous lesion|cutaneous lesion
49938|NCT03889899|Tongue cancer|tongue cancer
49939|NCT03889899|Lip cancer|lip cancer
49940|NCT03889873|Drinking identity|drinking identity
49941|NCT03889873|Hazardous drinking|hazardous drinking
49942|NCT03889873|Social networks|social networks
49943|NCT03889873|Self-efficacy|self-efficacy
49944|NCT03889873|Alcohol craving|alcohol craving
49945|NCT03889873|Cognitive control|cognitive control
49946|NCT03889873|Narrative writing|narrative writing
49947|NCT03889847|Fiberoptic intubation|fiberoptic intubation
49948|NCT03889847|double lumen tube|double lumen tube
49949|NCT03889834|autologous transfusion|autologous transfusion
49950|NCT03889834|doping|doping
49951|NCT03889834|blood markers|blood markers
49952|NCT03889834|detection|detection
49953|NCT03889795|Pancreatic|pancreatic
49954|NCT03889795|Solid Tumor|solid tumor
815786|NCT00178880|imaging|imaging
65776|NCT03793049|ECG|ecg
49955|NCT03889795|Advanced Pancreatic Cancer|advanced pancreatic cancer
49956|NCT03889795|Dose Escalation|dose escalation
49957|NCT03889795|Maximum Tolerated Dose|maximum tolerated dose
49958|NCT03889756|depression, ketamine|depression, ketamine
49959|NCT03889743|Respiratory Sounds|respiratory sounds
49960|NCT03889743|Steroids|steroids
49961|NCT03889743|Rhinovirus|rhinovirus
49962|NCT03889730|Coronary Artery Bypass, Off-Pump|coronary artery bypass, off-pump
49963|NCT03889730|Intraoperative Hypotension|intraoperative hypotension
49964|NCT03889730|Acute Kidney Injury|acute kidney injury
49965|NCT03889678|Color flow Doppler|color flow doppler
49966|NCT03889678|infiltration|infiltration
49967|NCT03889678|extravasation|extravasation
49968|NCT03889678|peripheral intravenous catheters|peripheral intravenous catheters
49969|NCT03889678|general anesthesia|general anesthesia
49970|NCT03889652|Retinal nerve fiber layer (RNFL)|retinal nerve fiber layer (rnfl)
49971|NCT03889652|Ganglion cell complex (GCC)|ganglion cell complex (gcc)
49972|NCT03889652|Optical coherence tomography (OCT)|optical coherence tomography (oct)
49973|NCT03889652|Primary open angle glaucoma (POAG)|primary open angle glaucoma (poag)
49974|NCT03889652|Cataract|cataract
49975|NCT03889626|Capecitabine|capecitabine
49976|NCT03889626|Apatinib|apatinib
49977|NCT03889626|Maintenance Treatment|maintenance treatment
49978|NCT03889626|Advance Gastric Cancer|advance gastric cancer
49979|NCT03889600|Diabetes Mellitus, Type 2|diabetes mellitus, type 2
49980|NCT03889600|Social determinants|social determinants
49981|NCT03889600|Readmission|readmission
49982|NCT03889587|Jaw reconstruction|jaw reconstruction
49983|NCT03889587|Innervation|innervation
49984|NCT03889587|Bone resorption|bone resorption
49985|NCT03889574|ICD10 for ACS, STEMI or NSTEMI, with triple therapy agents of aspirin, P2Y12 inhibitorand OAC status post-stent|icd10 for acs, stemi or nstemi, with triple therapy agents of aspirin, p2y12 inhibitorand oac status post-stent
49986|NCT03889561|Water|water
49987|NCT03889561|Parks|parks
49988|NCT03889561|Public spaces|public spaces
49989|NCT03889561|Sugar-sweetened beverages|sugar-sweetened beverages
49990|NCT03889535|primary maxillary incisors|primary maxillary incisors
49991|NCT03889535|crowns|crowns
49992|NCT03889535|bonded composite resin strip crowns|bonded composite resin strip crowns
49993|NCT03889535|zirconia crowns|zirconia crowns
49994|NCT03889535|one-year survival|one-year survival
49995|NCT03889509|systemic sclerosis|systemic sclerosis
49996|NCT03889509|scleroderma|scleroderma
49997|NCT03889509|pulmonary hypertension|pulmonary hypertension
49998|NCT03889509|pulmonary arterial hypertension|pulmonary arterial hypertension
49999|NCT03889496|exendin-4|exendin-4
50000|NCT03889496|GLP-1 receptor imaging|glp-1 receptor imaging
50001|NCT03889496|SPECT|spect
50002|NCT03889496|pancreas|pancreas
50003|NCT03889496|surgery|surgery
50004|NCT03889496|quantification|quantification
50005|NCT03889470|transradial catheterisation|transradial catheterisation
50006|NCT03889470|radial artery spasm|radial artery spasm
50007|NCT03889457|Deep Vein Thrombosis|deep vein thrombosis
50008|NCT03889457|Superficial Vein Thrombosis|superficial vein thrombosis
50009|NCT03889457|Anticoagulant|anticoagulant
50010|NCT03889457|Patient Compliance|patient compliance
50011|NCT03889457|Preference|preference
50012|NCT03889457|Venous Thrombosis|venous thrombosis
50013|NCT03889457|pulmonary embolism|pulmonary embolism
50014|NCT03889379|albuterol|albuterol
50015|NCT03889379|immune cells|immune cells
50016|NCT03889379|immune cell composition|immune cell composition
50017|NCT03889340|resuscitation|resuscitation
50018|NCT03889340|cardiac arrest|cardiac arrest
50019|NCT03889340|coma|coma
50020|NCT03889327|Perceived Cognitive Impairment|perceived cognitive impairment
50021|NCT03889327|Neuropsychology|neuropsychology
50022|NCT03889314|Statin Therapy|statin therapy
50023|NCT03889314|Prevention|prevention
50024|NCT03889314|High ASCVD Risk|high ascvd risk
50025|NCT03889288|pain treatment|pain treatment
50026|NCT03889288|intensive care|intensive care
50027|NCT03889288|cardiology|cardiology
50028|NCT03889288|medical device|medical device
50029|NCT03889275|solid tumors|solid tumors
50030|NCT03889275|immunotherapy|immunotherapy
50031|NCT03889275|oncolytic virus|oncolytic virus
50032|NCT03889275|NDV-GMCSF|ndv-gmcsf
50033|NCT03889262|Cerebral Palsy|cerebral palsy
50034|NCT03889262|Physiotherapy and Rehabilitation|physiotherapy and rehabilitation
50035|NCT03889262|Hippotherapy|hippotherapy
50036|NCT03889262|Balance|balance
50037|NCT03889223|neuraxial anesthesia positioning technique|neuraxial anesthesia positioning technique
50038|NCT03889223|sitting cross-legged fetal position|sitting cross-legged fetal position
50039|NCT03889223|lateral decubitus fetal position|lateral decubitus fetal position
50040|NCT03889223|ultrasonography|ultrasonography
50041|NCT03889210|Ketones|ketones
50042|NCT03889210|Prediabetes|prediabetes
50043|NCT03889197|Postnatal Growth Disorder|postnatal growth disorder
50044|NCT03889197|Growth and development|growth and development
50045|NCT03889184|meals-on-wheels|meals-on-wheels
50046|NCT03889184|home-dwelling older people|home-dwelling older people
50047|NCT03889171|genetic testing|genetic testing
50048|NCT03889171|genes BRCA1|genes brca1
50049|NCT03889171|genes BRCA2|genes brca2
50050|NCT03889171|mutation|mutation
50051|NCT03889171|family|family
50052|NCT03889171|disclosure|disclosure
50053|NCT03889171|psychology|psychology
50054|NCT03889171|DNA mismatch repair|dna mismatch repair
50055|NCT03889171|genetic predisposition to disease|genetic predisposition to disease
50056|NCT03889171|cancer|cancer
50057|NCT03889171|oncology|oncology
50058|NCT03889158|Cardiorespiratory Fitness|cardiorespiratory fitness
50059|NCT03889158|Endothelial Function|endothelial function
50060|NCT03889158|Oxidative Stress|oxidative stress
50061|NCT03889132|Obesity|obesity
50062|NCT03889132|Continous Glucose Monitoring|continous glucose monitoring
50063|NCT03889132|Cognition|cognition
50064|NCT03889132|Brain Iron content|brain iron content
50065|NCT03889093|peripheral blood monocytes|peripheral blood monocytes
50066|NCT03889093|cytokine|cytokine
50067|NCT03889080|functional MRI|functional mri
50068|NCT03889080|fMRI|fmri
50069|NCT03889080|pain|pain
50070|NCT03889067|Enteric fever|enteric fever
50071|NCT03889067|Typhoid|typhoid
50072|NCT03889067|Salmonella Typhi|salmonella typhi
50073|NCT03889067|Typhoid fever|typhoid fever
50074|NCT03889067|Salmonella infections|salmonella infections
50075|NCT03889067|Gram-negative bacterial infections|gram-negative bacterial infections
50076|NCT03889067|Human model of infection|human model of infection
50077|NCT03889002|Intellectual disabilities|intellectual disabilities
50078|NCT03889002|Health indicators|health indicators
50079|NCT03889002|Functioning|functioning
50080|NCT03889002|Health care services|health care services
50081|NCT03888989|Influenza|influenza
50082|NCT03888989|Pregnancy|pregnancy
50083|NCT03888989|Quadrivalent inactivated influenza vaccine (IIV).|quadrivalent inactivated influenza vaccine (iiv).
50084|NCT03888976|Cholecystoduodenal fistula|cholecystoduodenal fistula
50085|NCT03888976|Gallbladder|gallbladder
50086|NCT03888924|BCG Vaccine|bcg vaccine
50087|NCT03888924|Radiologically Isolated Syndrome|radiologically isolated syndrome
50088|NCT03888911|Flaxseed mucilage|flaxseed mucilage
50089|NCT03888911|Weight loss|weight loss
50090|NCT03888911|Satiety|satiety
50091|NCT03888898|N95 filtering facepiece respirators|n95 filtering facepiece respirators
50092|NCT03888898|elastomeric respirators|elastomeric respirators
50093|NCT03888898|public health emergency|public health emergency
50094|NCT03888898|healthcare workers|healthcare workers
50095|NCT03888898|occupational health|occupational health
50096|NCT03888898|respiratory protection program|respiratory protection program
50097|NCT03888898|personal protective equipment|personal protective equipment
50098|NCT03888898|airborne transmissible pathogens|airborne transmissible pathogens
50099|NCT03888898|reusable respirator|reusable respirator
50100|NCT03888885|Physical Education|physical education
50101|NCT03888885|Sport Education|sport education
50102|NCT03888885|Physical Literacy|physical literacy
50103|NCT03888885|Physical Activity|physical activity
50104|NCT03888885|University Students|university students
50105|NCT03888807|Knee Osteoarthritis|knee osteoarthritis
50106|NCT03888807|Topical Analgesic|topical analgesic
50107|NCT03888768|intravenous iron isomaltoside(monofer)|intravenous iron isomaltoside(monofer)
50108|NCT03888768|iron deficiency|iron deficiency
50109|NCT03888768|anaemia|anaemia
50110|NCT03888768|patient blood management|patient blood management
50111|NCT03888729|Hepatitis C|hepatitis c
50112|NCT03888729|direct-acting antiviral|direct-acting antiviral
50113|NCT03888729|Rwanda|rwanda
50114|NCT03888716|Mitochondrial Diseases|mitochondrial diseases
50115|NCT03888716|Mitochondrial Respiratory Chain Deficiencies|mitochondrial respiratory chain deficiencies
50116|NCT03888716|MELAS Syndrome|melas syndrome
50117|NCT03888716|Mitochondrial Myopathies|mitochondrial myopathies
50118|NCT03888716|Kearns-Sayre Syndrome|kearns-sayre syndrome
50119|NCT03888716|Ophthalmoplegia, Chronic Progressive External|ophthalmoplegia, chronic progressive external
50120|NCT03888703|early laser intervention|early laser intervention
50121|NCT03888703|scar prevention|scar prevention
50122|NCT03888703|laser resurfacing|laser resurfacing
50123|NCT03888703|wound healing|wound healing
50124|NCT03888690|Children|children
50125|NCT03888690|Adolescent|adolescent
50126|NCT03888690|non pharmacological interventions|non pharmacological interventions
50127|NCT03888690|onco-hematologic|onco-hematologic
50128|NCT03888677|Breast Cancer|breast cancer
50129|NCT03888625|macular holes|macular holes
50130|NCT03888612|Metastatic Prostate Cancer|metastatic prostate cancer
50131|NCT03888612|Castrate-Resistant|castrate-resistant
50132|NCT03888612|Prostate Cancer|prostate cancer
50133|NCT03888612|mCRPC|mcrpc
50134|NCT03888612|adenocarcinoma of the prostate|adenocarcinoma of the prostate
50135|NCT03888586|Dry needling, subacromial joint, night pain|dry needling, subacromial joint, night pain
50136|NCT03888573|Stretching, Traction Decompression|stretching, traction decompression
50137|NCT03888560|micro-osteperforation|micro-osteperforation
50138|NCT03888560|orthodontic tooth movement|orthodontic tooth movement
50139|NCT03888560|treatment duration|treatment duration
50140|NCT03888547|occupational therapy|occupational therapy
50141|NCT03888547|health|health
50142|NCT03888547|wellness|wellness
50143|NCT03888534|Drug Therapy|drug therapy
50144|NCT03888521|Relief|relief
50145|NCT03888482|Visual acuity|visual acuity
50146|NCT03888482|VA|va
50147|NCT03888482|Daily disposable contact lenses|daily disposable contact lenses
50148|NCT03888469|Visual acuity|visual acuity
50149|NCT03888469|VA|va
50150|NCT03888469|Daily disposable contact lenses|daily disposable contact lenses
50151|NCT03888443|Unilateral cerebral palsy|unilateral cerebral palsy
50152|NCT03888443|three-dimensional movement analysis|three-dimensional movement analysis
50153|NCT03888443|upper limb|upper limb
50154|NCT03888443|bimanual task|bimanual task
50155|NCT03888443|bimanual performance|bimanual performance
50156|NCT03888430|Transcutaneous PCO2|transcutaneous pco2
50157|NCT03888430|Preoxygenation|preoxygenation
50158|NCT03888430|Post-intubation hypotension|post-intubation hypotension
50160|NCT03888417|TPE|tpe
50161|NCT03888417|therapeutic plasma exchange|therapeutic plasma exchange
50162|NCT03888417|Side Effects|side effects
50163|NCT03888404|Unintended Pregnancy|unintended pregnancy
50164|NCT03888404|Unintended Birth|unintended birth
50165|NCT03888404|Pregnancy Preferences|pregnancy preferences
50166|NCT03888404|Pregnancy Desires|pregnancy desires
50167|NCT03888404|Prenatal Care|prenatal care
50168|NCT03888404|Abortion|abortion
50169|NCT03888404|Adoption|adoption
50170|NCT03888404|Pregnancy Decision-Making|pregnancy decision-making
50171|NCT03888404|Mental Health|mental health
50172|NCT03888404|Stress|stress
50173|NCT03888404|Socioeconomic Status|socioeconomic status
50174|NCT03888404|Education|education
50175|NCT03888391|ADHD|adhd
50176|NCT03888391|neuromodulation|neuromodulation
50177|NCT03888391|trigeminal nerve stimulation|trigeminal nerve stimulation
50178|NCT03888378|Minocycline Topical|minocycline topical
50179|NCT03888378|Tetracycline|tetracycline
50180|NCT03888378|Doxycycline|doxycycline
50181|NCT03888378|MGD|mgd
50182|NCT03888378|Meibomian Gland Disorder|meibomian gland disorder
50183|NCT03888378|Anti-Bacterial Agent|anti-bacterial agent
50184|NCT03888378|Anti-imflammatory Agent|anti-imflammatory agent
50185|NCT03888378|Minocycline|minocycline
50186|NCT03888365|Hypertension|hypertension
50187|NCT03888365|Treprostinil|treprostinil
50188|NCT03888365|Pulmonary Hypertension|pulmonary hypertension
50189|NCT03888365|Lung Diseases|lung diseases
50190|NCT03888326|Robotic Rehabilitation|robotic rehabilitation
50191|NCT03888326|Proprioception|proprioception
50192|NCT03888326|Transcranial Direct Current Stimulation|transcranial direct current stimulation
50193|NCT03888326|Non-invasive Brain Stimulation|non-invasive brain stimulation
50194|NCT03888326|Chronic Stroke|chronic stroke
50195|NCT03888326|tDCS|tdcs
50196|NCT03888326|Sensory Recovery|sensory recovery
50197|NCT03888287|PICK study|pick study
50198|NCT03888287|Impact of Watch Rx|impact of watch rx
50199|NCT03888248|Neurofibromatosis Type 1|neurofibromatosis type 1
50200|NCT03888248|Whole-body vibration|whole-body vibration
50201|NCT03888248|Muscle weakness|muscle weakness
50202|NCT03888235|Sacroiliac Instability|sacroiliac instability
50203|NCT03888235|Sacroiliac Strain|sacroiliac strain
50204|NCT03888235|Hypermobility|hypermobility
50205|NCT03888235|sacroiliac sprain|sacroiliac sprain
50206|NCT03888209|tDCS|tdcs
50207|NCT03888209|WMFT|wmft
50208|NCT03888209|Semmes Weinstein|semmes weinstein
50209|NCT03888209|Acute stroke|acute stroke
50210|NCT03888196|Panax|panax
50211|NCT03888196|Lipid Metabolism|lipid metabolism
50212|NCT03888196|Sport Performance|sport performance
50213|NCT03888196|Running|running
50214|NCT03888196|Ginseng|ginseng
50215|NCT03888183|hyaluronic acid|hyaluronic acid
50216|NCT03888183|salt solution|salt solution
50217|NCT03888183|dry eye disease|dry eye disease
50218|NCT03888183|ocular surface disease|ocular surface disease
50219|NCT03888170|Myogenic Tone|myogenic tone
50220|NCT03888170|Vascular Reactivity|vascular reactivity
50221|NCT03888170|Vascular Remodeling|vascular remodeling
50222|NCT03888131|Lung functions|lung functions
50223|NCT03888131|COPD|copd
50224|NCT03888118|Luna EMG|luna emg
50225|NCT03888118|drop foot|drop foot
50226|NCT03888118|chronic stroke|chronic stroke
50227|NCT03888105|Relapsed|relapsed
50228|NCT03888105|Refractory|refractory
50229|NCT03888079|Otosclerosis|otosclerosis
50230|NCT03888079|otosclerosis surgery|otosclerosis surgery
50231|NCT03888079|local anesthesia|local anesthesia
50232|NCT03888079|general anesthesia|general anesthesia
50233|NCT03888079|comfort assessment|comfort assessment
50234|NCT03888079|Glasgow Benefit Inventory questionnaire|glasgow benefit inventory questionnaire
50235|NCT03888079|hearing results|hearing results
50236|NCT03888066|treatment of hyperkalemia|treatment of hyperkalemia
50237|NCT03888066|chronic kidney disease|chronic kidney disease
50238|NCT03888066|hypertension|hypertension
50239|NCT03888066|hyperkalemia|hyperkalemia
50240|NCT03888066|potassium|potassium
815893|NCT00178516|infertility|infertility
50241|NCT03888066|spironolactone|spironolactone
50242|NCT03888066|heart failure|heart failure
50243|NCT03888066|Renin Angiotensin-Aldosterone System Inhibitor (RAASi)|renin angiotensin-aldosterone system inhibitor (raasi)
50244|NCT03888066|RAASi|raasi
50245|NCT03888066|high potassium|high potassium
50246|NCT03888066|eplerenone|eplerenone
50247|NCT03888066|reduced ejection fraction|reduced ejection fraction
50248|NCT03888040|Aging|aging
50249|NCT03888040|Fatigue|fatigue
50250|NCT03888040|Resistance training|resistance training
50251|NCT03888040|Skeletal Muscle|skeletal muscle
50252|NCT03888040|Knee extensor muscles|knee extensor muscles
50255|NCT03887988|Orbital implant|orbital implant
50256|NCT03887988|Midface fracture|midface fracture
50257|NCT03887988|Diplopia|diplopia
50258|NCT03887962|Motor Neglect|motor neglect
50259|NCT03887936|diabetes mellitus|diabetes mellitus
50260|NCT03887936|hypogonadism|hypogonadism
50261|NCT03887936|testosterone|testosterone
50262|NCT03887936|bone quality|bone quality
50263|NCT03887910|Postpartum Nurse Home Visitation|postpartum nurse home visitation
50264|NCT03887910|Infant Emergency Medical Care Presentations|infant emergency medical care presentations
50265|NCT03887910|Mother Emergency Medical Care Presentations|mother emergency medical care presentations
50266|NCT03887910|Parent-Child Relationship Quality|parent-child relationship quality
50267|NCT03887910|Family Connections to Community Resources|family connections to community resources
50268|NCT03887910|Child Development and Milestone Achievement|child development and milestone achievement
50269|NCT03887910|Maternal Mental Health|maternal mental health
50270|NCT03887910|Child Abuse|child abuse
50271|NCT03887910|Child Neglect|child neglect
50272|NCT03887910|Child Well-Care Compliance|child well-care compliance
50273|NCT03887910|Mother Well-Care Compliance|mother well-care compliance
50274|NCT03887897|First-pass; first attempt;intubation success|first-pass; first attempt;intubation success
50275|NCT03887845|postoperative ileus|postoperative ileus
50276|NCT03887845|prospective study|prospective study
50277|NCT03887845|case-control|case-control
50278|NCT03887845|open surgery|open surgery
50279|NCT03887845|laparoscopic surgery|laparoscopic surgery
50280|NCT03887845|bowel recovery|bowel recovery
50281|NCT03887845|intestinal recovery|intestinal recovery
50282|NCT03887845|gut recovery|gut recovery
50283|NCT03887832|child development|child development
50284|NCT03887832|maternal empathy|maternal empathy
50285|NCT03887832|digital media-based pediatric intervention|digital media-based pediatric intervention
50286|NCT03887832|small moments, big impact (SMBI)|small moments, big impact (smbi)
50287|NCT03887806|Venous|venous
50288|NCT03887806|Thromboembolic|thromboembolic
50289|NCT03887806|Direct Oral Anticoagulants|direct oral anticoagulants
50290|NCT03887806|AOD|aod
50291|NCT03887806|Cost analysis|cost analysis
50292|NCT03887806|REMOTEV|remotev
50293|NCT03887806|AVK|avk
50294|NCT03887806|Pulmonary embolism|pulmonary embolism
50295|NCT03887793|quality improvement|quality improvement
50296|NCT03887793|HPV vaccine|hpv vaccine
50297|NCT03887793|integrated healthcare delivery systems|integrated healthcare delivery systems
50298|NCT03887780|Stroke;|stroke;
50299|NCT03887780|Systemic embolism|systemic embolism
50300|NCT03887754|Autism|autism
50301|NCT03887754|Childhood Autism Rating Scale|childhood autism rating scale
50302|NCT03887754|Hyperbaric oxygen|hyperbaric oxygen
50303|NCT03887754|Risperidone|risperidone
50304|NCT03887728|progesterone|progesterone
50305|NCT03887728|endometrium|endometrium
50306|NCT03887728|blood flow|blood flow
50307|NCT03887728|estradiol|estradiol
50308|NCT03887715|VNS|vns
50309|NCT03887715|Depression|depression
50310|NCT03887715|TRD|trd
50311|NCT03887676|ASD|asd
50312|NCT03887676|Autism|autism
50313|NCT03887663|Motor symptoms|motor symptoms
50314|NCT03887663|Nonmotor symptoms|nonmotor symptoms
50315|NCT03887663|Chinese longitudinal cohort|chinese longitudinal cohort
50316|NCT03887663|Natural history|natural history
50317|NCT03887650|Brachial Plexus|brachial plexus
50318|NCT03887650|Liposomal Bupivacaine|liposomal bupivacaine
50319|NCT03887650|Dexamethasone|dexamethasone
50320|NCT03887650|Interscalene|interscalene
50321|NCT03887650|Bupivacaine|bupivacaine
50322|NCT03887650|Shoulder Arthroplasty|shoulder arthroplasty
50323|NCT03887650|Regional anesthesia|regional anesthesia
50324|NCT03887650|Exparel|exparel
50325|NCT03887624|Depressive Disorder, Treatment-Resistant|depressive disorder, treatment-resistant
50326|NCT03887624|ethosuximide|ethosuximide
50327|NCT03887611|Artificial Intelligence; Ultrasound;Thyroid nodule; ECI|artificial intelligence; ultrasound;thyroid nodule; eci
50328|NCT03887598|Artificial Intelligence; Ultrasound; Breast nodule; ECI|artificial intelligence; ultrasound; breast nodule; eci
50329|NCT03887559|Psychotherapy|psychotherapy
50330|NCT03887546|Multiple sclerosis|multiple sclerosis
50331|NCT03887546|Rehabilitation|rehabilitation
50332|NCT03887546|Respiration|respiration
50333|NCT03887546|Breathing exercise|breathing exercise
50334|NCT03887546|Fatigue|fatigue
50336|NCT03887520|CVD, Lipoprotein (a),|cvd, lipoprotein (a),
50337|NCT03887507|Vojta therapy|vojta therapy
815994|NCT00177879|comparison|comparison
50338|NCT03887507|core stability|core stability
50339|NCT03887507|postural balance|postural balance
50340|NCT03887494|Implantable device, Hip fractures|implantable device, hip fractures
50341|NCT03887481|transcranial direct current stimulation (tDCS)|transcranial direct current stimulation (tdcs)
50342|NCT03887481|neurodegeneration|neurodegeneration
50343|NCT03887481|verbal short-term memory|verbal short-term memory
50344|NCT03887481|working memory|working memory
50345|NCT03887481|semantic short-term memory|semantic short-term memory
50346|NCT03887481|non-fluent variant|non-fluent variant
50347|NCT03887481|logopenic variant|logopenic variant
50348|NCT03887481|semantic variant|semantic variant
50349|NCT03887481|primary progressive aphasia|primary progressive aphasia
50350|NCT03887468|dialysis adequacy|dialysis adequacy
50351|NCT03887468|clotting|clotting
50352|NCT03887455|BAN2401|ban2401
50353|NCT03887455|Clinical Dementia Rating-Sum of Boxes|clinical dementia rating-sum of boxes
50354|NCT03887455|Mild cognitive impairment|mild cognitive impairment
50355|NCT03887455|Alzheimer's disease/prodromal Alzheimer's disease|alzheimer's disease/prodromal alzheimer's disease
50356|NCT03887455|Mild Alzheimer's disease dementia|mild alzheimer's disease dementia
50357|NCT03887455|Clarity AD|clarity ad
50358|NCT03887442|Head and Neck Cancer|head and neck cancer
50359|NCT03887442|Cetuximab|cetuximab
50360|NCT03887442|Erbitux|erbitux
50361|NCT03887442|Paclitaxel|paclitaxel
50362|NCT03887442|Extreme|extreme
50363|NCT03887442|Metastatic|metastatic
50364|NCT03887442|Recurrent|recurrent
50365|NCT03887429|Promentis Pharmaceuticals|promentis pharmaceuticals
50366|NCT03887429|SXC-2023|sxc-2023
50367|NCT03887416|Nighttime blood pressure|nighttime blood pressure
50368|NCT03887416|Dapagliflozin|dapagliflozin
50369|NCT03887390|Depression|depression
50370|NCT03887390|Decision Aid|decision aid
50371|NCT03887390|Shared Decision Making|shared decision making
50372|NCT03887390|Primary Care|primary care
50373|NCT03887390|Comparative Effectiveness Research|comparative effectiveness research
50374|NCT03887377|macromastia|macromastia
50375|NCT03887377|botulinum toxin|botulinum toxin
50376|NCT03887377|scar prevention|scar prevention
50377|NCT03887377|scar formation|scar formation
50378|NCT03887364|Breathing Exercises|breathing exercises
50379|NCT03887364|Icing and Airflow Stimulation|icing and airflow stimulation
50380|NCT03887364|Chronic Obstructive Lung Diseases.|chronic obstructive lung diseases.
50381|NCT03887351|frailty, heart failure, mortality, quality of life|frailty, heart failure, mortality, quality of life
50382|NCT03887338|Noninvasive Ventilation|noninvasive ventilation
50383|NCT03887338|Laryngoscopy|laryngoscopy
50384|NCT03887312|Phone-delivered therapy|phone-delivered therapy
50385|NCT03887312|Cognitive behavioral therapy (CBT)|cognitive behavioral therapy (cbt)
50386|NCT03887312|Telephone-delivered therapy|telephone-delivered therapy
50387|NCT03887312|Children|children
50388|NCT03887312|Adolescents|adolescents
50389|NCT03887312|Syrian refugees|syrian refugees
50390|NCT03887299|Cesarean|cesarean
50391|NCT03887299|Wound care|wound care
50392|NCT03887299|Wound complication|wound complication
50393|NCT03887299|Surgical site infection|surgical site infection
50394|NCT03887247|Care coordination|care coordination
50395|NCT03887247|Opioid|opioid
50396|NCT03887247|Benzodiazepine|benzodiazepine
50397|NCT03887247|Behavioral science|behavioral science
50398|NCT03887247|Behavioral economics|behavioral economics
50399|NCT03887247|Nudge|nudge
50400|NCT03887247|Fragmentation of care|fragmentation of care
50401|NCT03887247|Concurrent prescribing|concurrent prescribing
50402|NCT03887221|Pharmacokinetic|pharmacokinetic
50403|NCT03887221|Safety|safety
50404|NCT03887221|Tolerability|tolerability
50405|NCT03887221|Healthy Chinese subjects|healthy chinese subjects
50406|NCT03887208|scar treatment|scar treatment
50407|NCT03887208|cutis laxa treatment|cutis laxa treatment
50408|NCT03887208|stromal vascular fraction|stromal vascular fraction
50409|NCT03887208|adipose-derived mesenchymal stem cells|adipose-derived mesenchymal stem cells
50410|NCT03887195|empathy|empathy
50411|NCT03887195|emotional intelligence|emotional intelligence
50412|NCT03887195|Medical student|medical student
50413|NCT03887195|Educational program|educational program
50414|NCT03887195|Physician-Patient Relations|physician-patient relations
50415|NCT03887182|auditory processing disorders|auditory processing disorders
50416|NCT03887182|functional MRI|functional mri
50417|NCT03887169|Pulmonary alveolar proteinosis|pulmonary alveolar proteinosis
50418|NCT03887169|MARS gene|mars gene
50419|NCT03887169|methionine|methionine
50420|NCT03887143|Ischemic stroke|ischemic stroke
50421|NCT03887143|children|children
50422|NCT03887143|recanalization treatment|recanalization treatment
50423|NCT03887143|thrombolysis|thrombolysis
50424|NCT03887143|thrombectomy|thrombectomy
50425|NCT03887130|Breast cancer|breast cancer
50426|NCT03887117|IQOS|iqos
50427|NCT03887117|Heated Tobacco|heated tobacco
50428|NCT03887091|Web Based Tools|web based tools
50429|NCT03887091|Video Communication|video communication
50430|NCT03887091|Web-based communication|web-based communication
50431|NCT03887078|Obesity|obesity
66382|NCT03789461|FMT|fmt
50432|NCT03887078|Bariatric Surgery|bariatric surgery
50433|NCT03887078|mHealth|mhealth
50434|NCT03887039|oral findings|oral findings
50435|NCT03887039|oral characteristics|oral characteristics
50436|NCT03887039|oral health|oral health
50437|NCT03887039|caries|caries
50438|NCT03887039|oral habits|oral habits
50439|NCT03887039|dental trauma|dental trauma
50440|NCT03887039|ADHD|adhd
50441|NCT03887039|children|children
50442|NCT03887000|Fibromyalgia|fibromyalgia
50443|NCT03887000|Stress|stress
50444|NCT03887000|Magnesium|magnesium
50445|NCT03887000|Sleep disorders|sleep disorders
50446|NCT03886987|Modified Draize-95 Test|modified draize-95 test
50447|NCT03886987|Skin Sensitisation|skin sensitisation
50448|NCT03886987|Repeat Insult Patch Test|repeat insult patch test
50449|NCT03886974|Transition of care|transition of care
50450|NCT03886974|Support networks|support networks
50451|NCT03886974|Adults with Type 1 diabetes|adults with type 1 diabetes
50452|NCT03886909|Exercise|exercise
50453|NCT03886909|Hematopoietic Stem Cell Transplant|hematopoietic stem cell transplant
50454|NCT03886909|Physical function|physical function
50455|NCT03886909|Quality of Life|quality of life
50456|NCT03886896|systemic lidocaine|systemic lidocaine
50457|NCT03886896|nalbuphine|nalbuphine
50458|NCT03886896|postoperative pain|postoperative pain
50459|NCT03886896|multimodal analgesia|multimodal analgesia
50460|NCT03886896|laparoscopic appendectomy|laparoscopic appendectomy
50461|NCT03886896|laparoscopy|laparoscopy
50462|NCT03886896|recovery|recovery
50463|NCT03886883|Stretch tolerance|stretch tolerance
50464|NCT03886883|Stretching Exercises|stretching exercises
50465|NCT03886883|Exercise induced hypoalgesia|exercise induced hypoalgesia
50466|NCT03886870|Obesity|obesity
50467|NCT03886870|Work Focus|work focus
50468|NCT03886870|Workability|workability
50469|NCT03886870|Life-style treatment|life-style treatment
50470|NCT03886844|Infant weight gain|infant weight gain
50471|NCT03886844|Human milk fortifier|human milk fortifier
50472|NCT03886844|Preterm infants|preterm infants
50473|NCT03886844|ELBW infants|elbw infants
50474|NCT03886779|Post-Ocular Inflammation|post-ocular inflammation
50475|NCT03886779|Cataract Surgery|cataract surgery
50476|NCT03886766|amorphous solid dispersion|amorphous solid dispersion
50477|NCT03886766|Plasma concentration-time profile|plasma concentration-time profile
50478|NCT03886766|Hot-Melt Extrusion|hot-melt extrusion
50479|NCT03886740|Eustachian Tube Dysfunction|eustachian tube dysfunction
50480|NCT03886740|Eustachian Tube balloon dilation|eustachian tube balloon dilation
50481|NCT03886740|Eustachian Tube dilation|eustachian tube dilation
50482|NCT03886740|Tympanostomy|tympanostomy
50483|NCT03886714|Fabry disease|fabry disease
50484|NCT03886714|Renal transplantation|renal transplantation
50485|NCT03886714|Diabetic nephropathy|diabetic nephropathy
50486|NCT03886714|Focal Segmental Hyalinosis (FSH)|focal segmental hyalinosis (fsh)
50487|NCT03886714|Undetermined nephropathy|undetermined nephropathy
50488|NCT03886701|Drug-drug interaction|drug-drug interaction
50489|NCT03886701|Pharmacokinetics|pharmacokinetics
50490|NCT03886701|Non-nucleoside reverse transcriptase inhibitor|non-nucleoside reverse transcriptase inhibitor
50491|NCT03886701|NNRTI|nnrti
50492|NCT03886701|LTBI|ltbi
50493|NCT03886701|Antimycobacterial|antimycobacterial
50494|NCT03886675|Stroke|stroke
50495|NCT03886675|Silent cerebral infarction|silent cerebral infarction
50496|NCT03886675|Carbon dioxide|carbon dioxide
50497|NCT03886675|Thoracic endovascular aortic repair|thoracic endovascular aortic repair
50498|NCT03886675|TEVAR|tevar
50499|NCT03886675|DW-MRI|dw-mri
50500|NCT03886675|Vascular brain infarction|vascular brain infarction
50501|NCT03886649|Relapsed or refractory B-cell non-Hodgkin lymphoma|relapsed or refractory b-cell non-hodgkin lymphoma
50502|NCT03886649|Copanlisib|copanlisib
50503|NCT03886649|Venetoclax|venetoclax
50504|NCT03886649|Non-Hodgkin lymphoma|non-hodgkin lymphoma
50505|NCT03886649|Splenic marginal zone lymphoma|splenic marginal zone lymphoma
50506|NCT03886649|Extranodal marginal zone lymphoma of mucosa-associated lymphoid tissue (MALT lymphoma)|extranodal marginal zone lymphoma of mucosa-associated lymphoid tissue (malt lymphoma)
50507|NCT03886649|Nodal marginal zone lymphoma|nodal marginal zone lymphoma
50508|NCT03886649|Follicular lymphoma|follicular lymphoma
50509|NCT03886649|Diffuse large B-cell lymphoma (DLBCL), NOS|diffuse large b-cell lymphoma (dlbcl), nos
50510|NCT03886597|Polyphenols|polyphenols
50511|NCT03886597|Triterpenes|triterpenes
50512|NCT03886597|Olea europaea|olea europaea
50513|NCT03886597|Table Olives|table olives
50514|NCT03886597|Pharmacokinetics|pharmacokinetics
50515|NCT03886597|Functional Food|functional food
50516|NCT03886597|Antioxidant|antioxidant
50517|NCT03886597|Cardiovascular Disease|cardiovascular disease
50518|NCT03886597|Anti-inflammatory|anti-inflammatory
50519|NCT03886584|Bipolar Disorder|bipolar disorder
50520|NCT03886584|Source-monitoring|source-monitoring
50521|NCT03886558|exercise|exercise
50522|NCT03886558|longevity|longevity
400571|NCT01866228|Neuroendocrine Cancer|neuroendocrine cancer
50523|NCT03886545|Assessment ; work-related musculoskeletal disorders of the shoulder|assessment ; work-related musculoskeletal disorders of the shoulder
50524|NCT03886493|high-risk prostate cancer|high-risk prostate cancer
50525|NCT03886493|localized prostate cancer|localized prostate cancer
50526|NCT03886493|prior to prostatectomy|prior to prostatectomy
50527|NCT03886493|neoadjuvant|neoadjuvant
50528|NCT03886480|rehabilitation, upper extremity, virtual reality, SaeboVR|rehabilitation, upper extremity, virtual reality, saebovr
50529|NCT03886467|Nepal|nepal
50530|NCT03886467|ASF consumption|asf consumption
50531|NCT03886454|Central apnea|central apnea
50532|NCT03886454|Obstructive apnea|obstructive apnea
50533|NCT03886454|Oxygen desaturation|oxygen desaturation
50534|NCT03886454|Escalation of Care|escalation of care
50535|NCT03886454|conscious sedation|conscious sedation
50536|NCT03886454|Bronchoscopy|bronchoscopy
50537|NCT03886454|Respiratory impairment|respiratory impairment
50538|NCT03886441|beclomethasone propionate|beclomethasone propionate
50539|NCT03886441|radiation pneumonitis|radiation pneumonitis
50540|NCT03886441|NSCLC|nsclc
50541|NCT03886441|radical radiotherapy|radical radiotherapy
50542|NCT03886441|Preventive effect|preventive effect
50543|NCT03886389|Breast Cancer|breast cancer
50544|NCT03886389|Estrogen receptor positive|estrogen receptor positive
50545|NCT03886389|Proliferation|proliferation
50546|NCT03886389|Insulin resistance|insulin resistance
50547|NCT03886389|PROMs|proms
50548|NCT03886389|NMRI|nmri
50549|NCT03886389|RFS|rfs
50550|NCT03886389|BCSS|bcss
50551|NCT03886376|Athletes|athletes
50552|NCT03886376|Swimming|swimming
50553|NCT03886376|Performance|performance
50554|NCT03886376|Massage|massage
50555|NCT03886350|Unconventional T cells|unconventional t cells
50556|NCT03886350|Cystic fibrosis|cystic fibrosis
50557|NCT03886350|gamma delta T cell|gamma delta t cell
50558|NCT03886350|Mucosal Associated Invariant T cell|mucosal associated invariant t cell
50559|NCT03886350|Natural Killer T cell|natural killer t cell
50560|NCT03886337|Germicidal lights|germicidal lights
50561|NCT03886337|S. aureus|s. aureus
50562|NCT03886337|Transmission|transmission
50563|NCT03886337|Operating room S. aureus exposure|operating room s. aureus exposure
50564|NCT03886311|marine derived alkaloid|marine derived alkaloid
50565|NCT03886311|PD1 inhibitor|pd1 inhibitor
50566|NCT03886311|CTLA4 inhibitor|ctla4 inhibitor
50567|NCT03886285|Multimorbidity|multimorbidity
50568|NCT03886285|Exercise coordinated groups (GECO)|exercise coordinated groups (geco)
50569|NCT03886285|Caregivers|caregivers
50570|NCT03886259|Chronic Pain|chronic pain
50571|NCT03886259|Total Knee Arthroplasty|total knee arthroplasty
50572|NCT03886259|Pain Neuroscience Education|pain neuroscience education
50573|NCT03886259|Neuromuscular exercise (NEMEX-TJR)|neuromuscular exercise (nemex-tjr)
50574|NCT03886220|Elagolix|elagolix
50575|NCT03886220|ABT-620|abt-620
50576|NCT03886220|Uterine Fibroids|uterine fibroids
50577|NCT03886220|Heavy Menstrual Bleeding (HMB)|heavy menstrual bleeding (hmb)
50578|NCT03886207|Anorexia|anorexia
50579|NCT03886207|Footbath|footbath
50580|NCT03886207|Ginger powder|ginger powder
50581|NCT03886207|Thermogenic substances|thermogenic substances
50582|NCT03886207|Thermoregulation|thermoregulation
50583|NCT03886207|External applications|external applications
50584|NCT03886207|Anthroposophic medicine|anthroposophic medicine
50585|NCT03886207|Eating disorders|eating disorders
50586|NCT03886181|Squamous Cell Carcinoma|squamous cell carcinoma
50587|NCT03886181|SCC|scc
50588|NCT03886181|Skin Cancer|skin cancer
50589|NCT03886181|Skin metastasis|skin metastasis
50590|NCT03886181|HNSCC|hnscc
50591|NCT03886181|Carcinoma, Squamous|carcinoma, squamous
50592|NCT03886181|CMN|cmn
50593|NCT03886181|Basal cell carcinoma|basal cell carcinoma
50594|NCT03886181|Superficial sarcoma|superficial sarcoma
50595|NCT03886181|Kaposi sarcoma|kaposi sarcoma
50596|NCT03886181|Alpha radiation|alpha radiation
50597|NCT03886181|Cutaneous lesion|cutaneous lesion
50598|NCT03886181|Tongue cancer|tongue cancer
50599|NCT03886181|Lip cancer|lip cancer
50600|NCT03886168|Pediatric Hearing Loss|pediatric hearing loss
50601|NCT03886155|Surgery|surgery
50602|NCT03886155|Surgical release|surgical release
50603|NCT03886155|Biopsy|biopsy
50604|NCT03886116|Arteriovenous Fistula|arteriovenous fistula
50605|NCT03886116|AVF Maturation|avf maturation
50606|NCT03886116|Pre Operative exercise|pre operative exercise
50607|NCT03886090|Parkinson's Disease|parkinson's disease
50608|NCT03886090|motor learning|motor learning
50609|NCT03886090|neuroplasticity|neuroplasticity
50610|NCT03886090|aerobic exercise|aerobic exercise
50611|NCT03886090|cardiovascular exercise|cardiovascular exercise
50612|NCT03886090|balance|balance
50613|NCT03886090|postural instability|postural instability
50614|NCT03886090|motor memory|motor memory
50615|NCT03886090|consolidation|consolidation
50616|NCT03886025|transcranial Direct Current Stimulation (tDCS)|transcranial direct current stimulation (tdcs)
50617|NCT03886025|Decision-making|decision-making
50618|NCT03886025|Implusivity|implusivity
50619|NCT03886025|Brain stimulation|brain stimulation
50620|NCT03886012|Migraine Associated Vertigo|migraine associated vertigo
50621|NCT03885973|SCFA|scfa
50622|NCT03885973|Probiotic|probiotic
50623|NCT03885973|Lactobacillus plantarum|lactobacillus plantarum
50624|NCT03885973|Functional constipation|functional constipation
50625|NCT03885960|Hip|hip
50626|NCT03885960|function|function
50627|NCT03885960|quality of life|quality of life
50628|NCT03885960|osteoarthritis|osteoarthritis
50629|NCT03885960|Perthes|perthes
50630|NCT03885960|LCPD|lcpd
50631|NCT03885947|Hematological Malignancies|hematological malignancies
50632|NCT03885947|Expanded Umbilical Cord|expanded umbilical cord
50633|NCT03885947|Allogeneic Stem Cell Transplant|allogeneic stem cell transplant
50634|NCT03885947|Leukemia|leukemia
50635|NCT03885947|Lymphoma|lymphoma
50636|NCT03885908|Automated Geriatric Co-Management Program|automated geriatric co-management program
50637|NCT03885908|Perioperative Care|perioperative care
50638|NCT03885908|19-066|19-066
50639|NCT03885882|E0302|e0302
50640|NCT03885882|Healthy Subjects|healthy subjects
50641|NCT03885882|E0302 SR Tablet|e0302 sr tablet
50642|NCT03885882|E0302 IR Tablet|e0302 ir tablet
50643|NCT03885869|Type 2 Diabetes Mellitus|type 2 diabetes mellitus
50644|NCT03885869|Joint Position Sense|joint position sense
50645|NCT03885869|Plantar Sensation|plantar sensation
50646|NCT03885869|Balance|balance
50647|NCT03885869|Dual Task Performance|dual task performance
50648|NCT03885856|rotator cuff repair|rotator cuff repair
50649|NCT03885856|rotator cuff tear|rotator cuff tear
50650|NCT03885856|single row repair technique|single row repair technique
50651|NCT03885856|double row repair technique|double row repair technique
50652|NCT03885830|Observational|observational
50653|NCT03885830|Bosutinib|bosutinib
50654|NCT03885830|Dasatinib|dasatinib
50655|NCT03885830|Nilotinib|nilotinib
50656|NCT03885830|Imatinib|imatinib
50657|NCT03885830|Chronic Myeloid Leukemia|chronic myeloid leukemia
50659|NCT03885830|Pharmacokinetics|pharmacokinetics
50660|NCT03885817|Exercise therapy|exercise therapy
50661|NCT03885817|Fatigue|fatigue
50662|NCT03885817|Adjuvant chemotherapy|adjuvant chemotherapy
50663|NCT03885817|Peripheral neuropathy, chemotherapy induced|peripheral neuropathy, chemotherapy induced
50664|NCT03885817|Nutritional guide|nutritional guide
50665|NCT03885804|quadratus - dexmedetomidine- bupivavaine- perineural|quadratus - dexmedetomidine- bupivavaine- perineural
50666|NCT03885713|inflammatory bowel diseases|inflammatory bowel diseases
50667|NCT03885713|Crohn Disease|crohn disease
50668|NCT03885713|Ulcerative Colitis|ulcerative colitis
50669|NCT03885713|Infliximab|infliximab
50670|NCT03885713|Adalimumab|adalimumab
50671|NCT03885713|Golimumab|golimumab
50672|NCT03885713|Vedolizumab|vedolizumab
50673|NCT03885713|Ustekinumab|ustekinumab
50674|NCT03885713|Anti-TNF|anti-tnf
50675|NCT03885687|Rehabilitation|rehabilitation
50676|NCT03885687|Exercise|exercise
50677|NCT03885687|Music Intervention|music intervention
50678|NCT03885648|Breast cancer|breast cancer
50679|NCT03885648|Microbiota|microbiota
50680|NCT03885648|Endocrine disruptors|endocrine disruptors
50681|NCT03885648|Estrogens|estrogens
50682|NCT03885622|NIDJD|nidjd
50683|NCT03885622|ANTHEM™ CR Total Knee System|anthem™ cr total knee system
50684|NCT03885583|thoracotomy|thoracotomy
50685|NCT03885583|thoracic epidural block|thoracic epidural block
50686|NCT03885583|paravertebral block|paravertebral block
50687|NCT03885570|mitral valve replacement|mitral valve replacement
50688|NCT03885570|Predictive Model|predictive model
50689|NCT03885570|Blood Transfusion|blood transfusion
50690|NCT03885570|Perioperative period|perioperative period
50691|NCT03885557|Flexibility|flexibility
50692|NCT03885557|Extensibility|extensibility
50693|NCT03885557|Static stretching|static stretching
50694|NCT03885544|beef|beef
50695|NCT03885544|pork|pork
50696|NCT03885544|red meat|red meat
50697|NCT03885544|gut microbiota|gut microbiota
50698|NCT03885531|Journey II CR Total Knee System|journey ii cr total knee system
50699|NCT03885479|Inflammatory bowel disease|inflammatory bowel disease
50700|NCT03885479|Food specific IgGs|food specific iggs
50701|NCT03885466|Nordic walking|nordic walking
50702|NCT03885466|Osteoporosis|osteoporosis
50703|NCT03885466|Hyperkyphosis|hyperkyphosis
50704|NCT03885466|Vertebral Fracture|vertebral fracture
50705|NCT03885427|sedation|sedation
50706|NCT03885427|ketamine|ketamine
50707|NCT03885427|analgesia|analgesia
50708|NCT03885427|pre-schoolers|pre-schoolers
50709|NCT03885388|GTN|gtn
50710|NCT03885388|MTX|mtx
50711|NCT03885388|ACTD|actd
50712|NCT03885362|Type 1 Diabetes Mellitus|type 1 diabetes mellitus
50713|NCT03885362|Chronic Kidney Diseases|chronic kidney diseases
50714|NCT03885349|Intimate partner violence|intimate partner violence
50715|NCT03885349|Alcohol|alcohol
50716|NCT03885349|Drug|drug
50717|NCT03885349|Batterer intervention programs|batterer intervention programs
50718|NCT03885297|obesity|obesity
50719|NCT03885297|metabolism|metabolism
50720|NCT03885297|liraglutide|liraglutide
50721|NCT03885297|saxenda|saxenda
66735|NCT03787056|dd|dd
50722|NCT03885297|metabolomics|metabolomics
50723|NCT03885297|miRNA|mirna
50724|NCT03885297|weight loss|weight loss
50725|NCT03885284|Pancreas|pancreas
50726|NCT03885284|Radiation|radiation
50727|NCT03885284|mFOLFIRINOX|mfolfirinox
50728|NCT03885258|melatonin|melatonin
50729|NCT03885258|pinealectomy|pinealectomy
50730|NCT03885258|Cardiac Autonomic System|cardiac autonomic system
50731|NCT03885258|heart rate variability|heart rate variability
50732|NCT03885232|Communication|communication
50733|NCT03885232|Immunization|immunization
50734|NCT03885193|anticoagulation|anticoagulation
50735|NCT03885193|cardiopulmonary bypass|cardiopulmonary bypass
50736|NCT03885193|heparin|heparin
50737|NCT03885193|protamine|protamine
50738|NCT03885193|postoperatively bleeding|postoperatively bleeding
50739|NCT03885180|bioprosthetic heart valves|bioprosthetic heart valves
50740|NCT03885180|oral anticoagulation|oral anticoagulation
50741|NCT03885180|thrombotic events|thrombotic events
50742|NCT03885154|Migraine|migraine
50743|NCT03885154|Headache|headache
50744|NCT03885154|Valproic acid|valproic acid
50745|NCT03885154|Dihydroergotamine|dihydroergotamine
50746|NCT03885154|Pediatric|pediatric
50747|NCT03885141|Insomnia|insomnia
50748|NCT03885141|Zolpidem|zolpidem
50749|NCT03885102|chronic kidney disease|chronic kidney disease
50750|NCT03885102|hemodialysis|hemodialysis
50751|NCT03885102|intradialytic exercise|intradialytic exercise
50752|NCT03885102|physical activity|physical activity
50753|NCT03885102|safety|safety
50754|NCT03885102|health economics|health economics
50755|NCT03885102|health literacy|health literacy
50756|NCT03885102|training therapy|training therapy
50757|NCT03885089|Infliximab|infliximab
50758|NCT03885089|biosimilar|biosimilar
50759|NCT03885037|Rheumatoid Arthritis|rheumatoid arthritis
50760|NCT03885037|Infliximab|infliximab
50761|NCT03885037|biosimilar|biosimilar
50762|NCT03884959|Urea Cycle Disorder|urea cycle disorder
50763|NCT03884959|Hyperammonemia|hyperammonemia
50764|NCT03884959|Metabolic Decompensation|metabolic decompensation
50765|NCT03884946|MSM|msm
50766|NCT03884946|mHealth|mhealth
50767|NCT03884946|App|app
50768|NCT03884920|Impaired Fasting Glucose|impaired fasting glucose
50769|NCT03884920|Impaired Glucose Tolerance|impaired glucose tolerance
50770|NCT03884920|2hr -75gm Oral Glucose Tolerance Test|2hr -75gm oral glucose tolerance test
50771|NCT03884920|Diabetes Mellitus Prevention|diabetes mellitus prevention
50772|NCT03884907|human bone graft screw|human bone graft screw
50773|NCT03884907|foot and ankle surgery|foot and ankle surgery
50774|NCT03884907|hallux valgus deformity|hallux valgus deformity
50775|NCT03884894|neonatal sepsis|neonatal sepsis
50776|NCT03884894|Blood culture|blood culture
50777|NCT03884894|molecular assay|molecular assay
50778|NCT03884868|Colorectal cancer screening|colorectal cancer screening
50779|NCT03884868|Iconographies|iconographies
50780|NCT03884868|Risk communication|risk communication
50781|NCT03884868|Patient medical knowledge|patient medical knowledge
50782|NCT03884842|Airway hyperresponsivness|airway hyperresponsivness
50783|NCT03884842|Ventilation heterogeneity|ventilation heterogeneity
50784|NCT03884842|Hyperpolarized Xenon-129|hyperpolarized xenon-129
50785|NCT03884842|Sputum eosinophils|sputum eosinophils
50786|NCT03884829|AML, ALL, CLL, CML, MDS, advanced leukemias, leukemia|aml, all, cll, cml, mds, advanced leukemias, leukemia
50787|NCT03884816|HIV|hiv
50788|NCT03884816|Pre-exposure prophylaxis|pre-exposure prophylaxis
50789|NCT03884816|Sexually Transmitted Diseases|sexually transmitted diseases
50790|NCT03884790|Bone substitute|bone substitute
50791|NCT03884790|Bone regeneration|bone regeneration
50792|NCT03884777|Influenza A virus|influenza a virus
50793|NCT03884777|myasthenia gravis|myasthenia gravis
50794|NCT03884777|neurocritical care clinical|neurocritical care clinical
50795|NCT03884777|neuromuscular disease|neuromuscular disease
50796|NCT03884751|Hepatocellular Carcinoma|hepatocellular carcinoma
50797|NCT03884751|CAR-T|car-t
50798|NCT03884738|Muscle Tonus|muscle tonus
50799|NCT03884738|Elasticity|elasticity
50800|NCT03884738|Electric Stimulation Therapy|electric stimulation therapy
50801|NCT03884738|Physical Conditioning, Human|physical conditioning, human
50802|NCT03884725|Cardiac surgical procedures|cardiac surgical procedures
50803|NCT03884725|Fibrinogen|fibrinogen
50804|NCT03884725|Bleeding|bleeding
50805|NCT03884712|anxiety symptoms|anxiety symptoms
50806|NCT03884712|panic attack symptoms|panic attack symptoms
50807|NCT03884712|emergency department|emergency department
50808|NCT03884712|CalmiGo|calmigo
50809|NCT03884699|Orthognathic Surgery|orthognathic surgery
50810|NCT03884673|DTG + 3TC Simplified Therapy|dtg + 3tc simplified therapy
50811|NCT03884673|Simplified Therapy Regimen|simplified therapy regimen
50812|NCT03884673|Real World Study|real world study
50813|NCT03884673|HIV-1-infected patients|hiv-1-infected patients
50814|NCT03884621|continuity of patient care|continuity of patient care
50815|NCT03884595|sepsis|sepsis
50816|NCT03884595|septic shock|septic shock
66863|NCT03786367|Dyspnea|dyspnea
50817|NCT03884595|severe sepsis|severe sepsis
50818|NCT03884595|SIRS|sirs
50819|NCT03884595|children|children
50820|NCT03884595|immature platelet fraction (IPF)|immature platelet fraction (ipf)
50821|NCT03884595|immature granulocytes (IG)|immature granulocytes (ig)
50822|NCT03884595|nucleated red blood cells (NRBC)|nucleated red blood cells (nrbc)
50823|NCT03884582|Healthy volunteers|healthy volunteers
50824|NCT03884569|limbal stem cell deficiency|limbal stem cell deficiency
50825|NCT03884569|corneal failure|corneal failure
50826|NCT03884569|limbal epithelial stem cells|limbal epithelial stem cells
50827|NCT03884569|ocular surface|ocular surface
50828|NCT03884569|corneal blindness|corneal blindness
50829|NCT03884556|Cancer|cancer
50830|NCT03884556|Metastatic Solid Tumors|metastatic solid tumors
50831|NCT03884556|Advanced Solid Tumors|advanced solid tumors
50832|NCT03884556|Relapsed/Refractory Lymphoma|relapsed/refractory lymphoma
50833|NCT03884556|Prostrate Cancer|prostrate cancer
50834|NCT03884556|Pancreatic Cancer|pancreatic cancer
50835|NCT03884556|Monotherapy|monotherapy
50836|NCT03884556|Combination Therapy|combination therapy
50837|NCT03884556|CD39|cd39
50838|NCT03884556|Adenosine Pathway|adenosine pathway
50839|NCT03884556|Immunotherapy|immunotherapy
50840|NCT03884556|Immuno-oncology|immuno-oncology
50841|NCT03884556|PD-1|pd-1
50842|NCT03884556|Checkpoint Inhibitor|checkpoint inhibitor
50843|NCT03884556|Nab-paclitaxel|nab-paclitaxel
50844|NCT03884556|Gemcitabine|gemcitabine
50845|NCT03884556|Pembrolizumab|pembrolizumab
50846|NCT03884556|Docetaxel|docetaxel
50847|NCT03884556|Bladder Cancer|bladder cancer
50848|NCT03884556|Lung Cancer|lung cancer
50849|NCT03884543|Mechanical ventilation|mechanical ventilation
50850|NCT03884543|Positive end-expiratory pressure|positive end-expiratory pressure
50851|NCT03884543|Driving pressure|driving pressure
50852|NCT03884543|Post-operative postoperative complications|post-operative postoperative complications
50853|NCT03884543|Open abdominal surgery|open abdominal surgery
50854|NCT03884543|Recruitment maneuver|recruitment maneuver
50855|NCT03884543|PEEP|peep
50856|NCT03884530|ticagrelol|ticagrelol
50857|NCT03884530|aspirin|aspirin
50858|NCT03884504|Advanced Heart Failure|advanced heart failure
50859|NCT03884504|Ventricular Assist Device System|ventricular assist device system
50860|NCT03884504|Destination Therapy|destination therapy
50861|NCT03884478|Social Norms|social norms
50862|NCT03884478|Personalized Normative Feedback|personalized normative feedback
50863|NCT03884478|Sexual Minority Women|sexual minority women
50864|NCT03884465|Pulmonary arterial hypertension|pulmonary arterial hypertension
50865|NCT03884465|Pulmonary hypertension|pulmonary hypertension
50866|NCT03884465|PAH|pah
50867|NCT03884465|PH|ph
50868|NCT03884465|WHO Group 1 pulmonary arterial hypertension|who group 1 pulmonary arterial hypertension
50869|NCT03884465|WHO Group 1 pulmonary hypertension|who group 1 pulmonary hypertension
50870|NCT03884465|WHO Group 1 PAH|who group 1 pah
50871|NCT03884465|WHO Group 1 PH|who group 1 ph
50872|NCT03884465|WHO Group 1|who group 1
50873|NCT03884465|Group 1 PAH|group 1 pah
50874|NCT03884465|Group 1 PH|group 1 ph
50875|NCT03884465|Idiopathic PAH|idiopathic pah
50876|NCT03884465|Heritable PAH|heritable pah
50877|NCT03884465|Drug induced PAH|drug induced pah
50878|NCT03884465|Toxin induced PAH|toxin induced pah
50879|NCT03884465|Pulmonary shunt|pulmonary shunt
50880|NCT03884465|Idiopathic pulmonary arterial hypertension|idiopathic pulmonary arterial hypertension
50881|NCT03884465|Heritable pulmonary arterial hypertension|heritable pulmonary arterial hypertension
50882|NCT03884465|Drug induced pulmonary arterial hypertension|drug induced pulmonary arterial hypertension
50883|NCT03884465|Toxin induced pulmonary arterial hypertension|toxin induced pulmonary arterial hypertension
50884|NCT03884465|Connective tissue disease|connective tissue disease
50885|NCT03884439|Crohn's Disease|crohn's disease
50886|NCT03884439|Ulcerative Colitis|ulcerative colitis
50887|NCT03884439|Infliximab|infliximab
50888|NCT03884439|biosimilar|biosimilar
50889|NCT03884426|Mitral valve prolapse|mitral valve prolapse
50890|NCT03884426|genetic|genetic
50891|NCT03884426|echocardiography|echocardiography
50892|NCT03884413|breast cancer survivors,|breast cancer survivors,
50893|NCT03884413|spontaneous fertility rates,|spontaneous fertility rates,
50894|NCT03884413|pregnancy,|pregnancy,
50895|NCT03884413|birth rate,|birth rate,
50896|NCT03884413|chemotherapy-induced infertility|chemotherapy-induced infertility
50897|NCT03884387|Shared Decision Making, Lumbar Herniated Disk|shared decision making, lumbar herniated disk
50898|NCT03884335|Epidural analgesia|epidural analgesia
50899|NCT03884335|Transversus abdominis plane blockade|transversus abdominis plane blockade
50900|NCT03884335|Laparoscopic prostatectomy|laparoscopic prostatectomy
50901|NCT03884322|physical activity|physical activity
50902|NCT03884322|prematurity|prematurity
50903|NCT03884322|bone density|bone density
50904|NCT03884322|length of stay|length of stay
50905|NCT03884296|Obstructive sleep apnea|obstructive sleep apnea
400572|NCT01866228|Quality of Life|quality of life
50906|NCT03884296|Quadrivalent live, attenuated influenza vaccine|quadrivalent live, attenuated influenza vaccine
50907|NCT03884296|Flumist|flumist
50908|NCT03884270|functional dyspepsia|functional dyspepsia
50909|NCT03884270|hypnotherapy|hypnotherapy
50910|NCT03884270|functional gastrointestinal disorders|functional gastrointestinal disorders
50911|NCT03884244|Laparoscopic Surgery|laparoscopic surgery
50912|NCT03884244|Postoperative Bowel Function|postoperative bowel function
50913|NCT03884218|Thermal Comfort|thermal comfort
50914|NCT03884192|Locally advanced|locally advanced
50915|NCT03884192|Stage III Non-Small Cell Lung Cancer|stage iii non-small cell lung cancer
50916|NCT03884192|Unresectable Non-Small Cell Lung Cancer|unresectable non-small cell lung cancer
50917|NCT03884192|Concurrent Chemoradiation|concurrent chemoradiation
50918|NCT03884192|Immune-mediated cancer therapy|immune-mediated cancer therapy
50919|NCT03884192|PD-1|pd-1
50920|NCT03884192|Sintilimab|sintilimab
50921|NCT03884192|IBI308|ibi308
50922|NCT03884179|Endoscopic ultrasound|endoscopic ultrasound
50923|NCT03884179|Radiology|radiology
50924|NCT03884179|Accuracy|accuracy
50925|NCT03884179|Pancreatic Cyst|pancreatic cyst
50926|NCT03884179|Pancreatic Cystadenocarcinoma|pancreatic cystadenocarcinoma
50927|NCT03884179|Pancreatic Mucinous Cystadenoma|pancreatic mucinous cystadenoma
51027|NCT03883464|Quality of live|quality of live
50928|NCT03884179|Pancreatic Intraductal Papillary-Mucinous Neoplasm|pancreatic intraductal papillary-mucinous neoplasm
50929|NCT03884179|Pancreatic Serous Cystadenoma|pancreatic serous cystadenoma
50930|NCT03884179|Pancreatic Pseudocyst|pancreatic pseudocyst
50931|NCT03884179|Pancreatic Neuroendocrine Tumor|pancreatic neuroendocrine tumor
50932|NCT03884179|Solid Pseudopapillary Tumor of the Pancreas|solid pseudopapillary tumor of the pancreas
50933|NCT03884166|Acute Ischemic Stroke|acute ischemic stroke
50934|NCT03884166|Bronchoscopy|bronchoscopy
50935|NCT03884153|Ischemic Stroke|ischemic stroke
50936|NCT03884153|CRP apheresis|crp apheresis
50937|NCT03884140|Thyroid nodules|thyroid nodules
50938|NCT03884140|T.S.H|t.s.h
50939|NCT03884140|Thyroid US|thyroid us
50941|NCT03884127|orlistat|orlistat
50942|NCT03884127|Ezetimibe|ezetimibe
50943|NCT03884127|Gastrointestinal Microbiome|gastrointestinal microbiome
50944|NCT03884114|technology-enhanced simulation|technology-enhanced simulation
50945|NCT03884114|serious games|serious games
50946|NCT03884114|multiple choice questionnaires|multiple choice questionnaires
50947|NCT03884114|medical education|medical education
50948|NCT03884088|Balance|balance
50949|NCT03884088|Limits of Stability|limits of stability
50950|NCT03884088|Postural Sway|postural sway
50951|NCT03884075|Non-Alcoholic Steatohepatitis (NASH)|non-alcoholic steatohepatitis (nash)
50952|NCT03884075|Steatosis|steatosis
50953|NCT03884075|Caloric Load|caloric load
50954|NCT03884062|HCC, chronic hepatitis C, hepatitis C, liver fibrosis|hcc, chronic hepatitis c, hepatitis c, liver fibrosis
50955|NCT03884049|ranscatheter|ranscatheter
50956|NCT03884049|embolization|embolization
50957|NCT03884049|osteoarthritis|osteoarthritis
50958|NCT03884049|arterial|arterial
50959|NCT03884023|Plasma REST|plasma rest
50960|NCT03884023|REST gene polymorphism|rest gene polymorphism
50961|NCT03884023|AD|ad
50962|NCT03884010|DXA|dxa
50963|NCT03884010|Soccer players|soccer players
50964|NCT03884010|Skeletal muscle mass|skeletal muscle mass
50965|NCT03883997|Body fat|body fat
50966|NCT03883997|Soccer players|soccer players
50967|NCT03883997|DXA|dxa
50968|NCT03883945|rosacea|rosacea
50969|NCT03883893|Tonsillectomy|tonsillectomy
50970|NCT03883893|Intravenous Acetaminophen|intravenous acetaminophen
50971|NCT03883893|Pediatric|pediatric
50972|NCT03883880|diet|diet
50973|NCT03883880|food choice|food choice
50974|NCT03883880|taste|taste
50975|NCT03883867|Pelvic Floor, Perineal Rapture, Obstetric Trauma|pelvic floor, perineal rapture, obstetric trauma
50976|NCT03883815|cerebral palsy|cerebral palsy
50977|NCT03883815|neurodevelopmental therapy|neurodevelopmental therapy
50978|NCT03883815|active video games|active video games
50979|NCT03883815|treatment intensity|treatment intensity
50980|NCT03883815|energy consumption|energy consumption
50981|NCT03883789|Fibrosis, FibroScan, Pregnancy, Trimesters, Liver disease|fibrosis, fibroscan, pregnancy, trimesters, liver disease
50982|NCT03883776|PET/CT|pet/ct
50983|NCT03883776|Somatostatin receptor imaging|somatostatin receptor imaging
50984|NCT03883776|Al18F-NOTA-octreotide|al18f-nota-octreotide
50985|NCT03883724|Nocturia|nocturia
50986|NCT03883724|Poor sleep|poor sleep
50987|NCT03883711|Acute coronary syndrome|acute coronary syndrome
50988|NCT03883711|Myocardial injury|myocardial injury
50989|NCT03883711|ACS|acs
50990|NCT03883711|MINOCA|minoca
50991|NCT03883659|frozen shoulder|frozen shoulder
50992|NCT03883659|smartphone|smartphone
50993|NCT03883659|home exercise program|home exercise program
50994|NCT03883659|range of motion|range of motion
50995|NCT03883633|Dementia|dementia
50996|NCT03883633|Alzheimer's Disease|alzheimer's disease
50997|NCT03883633|Cognitive Decline|cognitive decline
50998|NCT03883633|MCI|mci
50999|NCT03883620|Dengue|dengue
51000|NCT03883607|Pediatric|pediatric
51001|NCT03883607|Pharmacokinetics|pharmacokinetics
51002|NCT03883581|bulbar dysfunction|bulbar dysfunction
51003|NCT03883568|phenotypes|phenotypes
51004|NCT03883568|(bio)markers|(bio)markers
51005|NCT03883555|Acute cardiogenic pulmonary|acute cardiogenic pulmonary
51006|NCT03883555|Respiratory failure|respiratory failure
51007|NCT03883555|Hypercapnia|hypercapnia
51008|NCT03883555|High flow nasal oxygen|high flow nasal oxygen
51009|NCT03883555|Non invasive ventilation|non invasive ventilation
51010|NCT03883555|Emergency department|emergency department
51011|NCT03883542|low malignant potential|low malignant potential
51012|NCT03883542|serous|serous
51013|NCT03883529|Birth experience|birth experience
51014|NCT03883529|Midwifery|midwifery
51015|NCT03883529|Feasibilty|feasibilty
51016|NCT03883529|Intervention|intervention
51017|NCT03883516|guideline for the treatment of Status Epilepticus|guideline for the treatment of status epilepticus
51018|NCT03883516|antiseizure drugs (ASDs)|antiseizure drugs (asds)
51019|NCT03883503|Copeptin|copeptin
51020|NCT03883503|Salt-water homeostasis|salt-water homeostasis
51021|NCT03883490|Magnetic Resonance Imaging|magnetic resonance imaging
51022|NCT03883490|Elastin Metabolites|elastin metabolites
51023|NCT03883490|Aorta Stiffness|aorta stiffness
51024|NCT03883490|Bicuspid aortic valve|bicuspid aortic valve
51025|NCT03883477|Tendinopathy|tendinopathy
51026|NCT03883477|Trigger Finger|trigger finger
51030|NCT03883464|Postoperative|postoperative
51031|NCT03883438|Gingival recession|gingival recession
51032|NCT03883438|Therapy|therapy
51033|NCT03883438|Surgery|surgery
51034|NCT03883438|Tooth root|tooth root
51035|NCT03883438|Surgical flaps|surgical flaps
51036|NCT03883438|Acellular dermis|acellular dermis
51037|NCT03883425|Home Care Services|home care services
51038|NCT03883425|Geriatric Assessment|geriatric assessment
51039|NCT03883425|Aging|aging
51040|NCT03883425|Frailty|frailty
51041|NCT03883425|Complexity|complexity
51042|NCT03883425|Nursing|nursing
51043|NCT03883399|Surgical Site Infection|surgical site infection
51044|NCT03883399|Prevention|prevention
51045|NCT03883399|Survey|survey
51046|NCT03883399|Colorectal surgery|colorectal surgery
51047|NCT03883399|Guidelines|guidelines
51049|NCT03883373|alveolar graft|alveolar graft
51050|NCT03883373|cancellous bone|cancellous bone
51051|NCT03883373|cortical block|cortical block
51052|NCT03883373|nasal floor|nasal floor
51053|NCT03883360|schizophrenia|schizophrenia
51054|NCT03883360|cannabis|cannabis
51055|NCT03883360|cannabidiol|cannabidiol
51056|NCT03883360|psychosis|psychosis
51057|NCT03883321|stress management|stress management
51058|NCT03883321|CBSM|cbsm
51059|NCT03883321|Chronic Pain|chronic pain
51060|NCT03883321|Cancer|cancer
51061|NCT03883282|patient adherence, randomized clinical trials|patient adherence, randomized clinical trials
51062|NCT03883256|High flow nasal cannula oxygen|high flow nasal cannula oxygen
51063|NCT03883256|exercise performance|exercise performance
51064|NCT03883256|COPD|copd
51065|NCT03883243|Telecoaching|telecoaching
51066|NCT03883243|Physical activity|physical activity
51067|NCT03883243|Lung cancer|lung cancer
51068|NCT03883217|Gait|gait
51069|NCT03883217|Balance|balance
51070|NCT03883204|Cognition|cognition
51071|NCT03883204|Antipsychotic Agents|antipsychotic agents
51072|NCT03883204|Treatment|treatment
51073|NCT03883204|Effectiveness|effectiveness
51074|NCT03883204|Aripiprazole|aripiprazole
51075|NCT03883204|Risperidone|risperidone
51076|NCT03883191|Probiotics|probiotics
51077|NCT03883191|Overweight|overweight
51078|NCT03883191|Obese|obese
51079|NCT03883191|Children|children
51080|NCT03883191|Weight reduction|weight reduction
51081|NCT03883165|Concussion|concussion
51082|NCT03883165|Contact sport|contact sport
51083|NCT03883165|Collision sport|collision sport
51084|NCT03883165|Neck strengthening|neck strengthening
51085|NCT03883165|Soccer|soccer
51086|NCT03883165|Head Acceleration|head acceleration
51087|NCT03883152|Eating Difficulties|eating difficulties
51088|NCT03883152|Chewing|chewing
51089|NCT03883152|Swallowing|swallowing
51090|NCT03883152|Head and neck cancer|head and neck cancer
51091|NCT03883152|Depression|depression
51092|NCT03883152|Physical function|physical function
51093|NCT03883152|Nutrition|nutrition
51094|NCT03883139|autism|autism
51095|NCT03883139|JASPER|jasper
51096|NCT03883139|DTT|dtt
51097|NCT03883139|ASD|asd
51098|NCT03883139|Autism Spectrum Disorder|autism spectrum disorder
51099|NCT03883139|social and communication deficits|social and communication deficits
51100|NCT03883100|Chronic Myeloid Leukemia,CML|chronic myeloid leukemia,cml
51101|NCT03883100|T315I mutation|t315i mutation
51102|NCT03883100|CML-AP|cml-ap
51103|NCT03883100|HQP1351|hqp1351
51104|NCT03883087|Chronic Myeloid Leukemia,CML|chronic myeloid leukemia,cml
51105|NCT03883087|T315I mutation|t315i mutation
51106|NCT03883087|TKI|tki
51107|NCT03883087|CML-CP|cml-cp
51108|NCT03883087|HQP1351|hqp1351
816096|NCT00177255|esophagus|esophagus
51109|NCT03883022|Deep surgical site infection|deep surgical site infection
51110|NCT03883022|Vancomycin-impregnated bone graft|vancomycin-impregnated bone graft
51111|NCT03883022|Spine surgery|spine surgery
51112|NCT03883022|Degenerative lumbar disorder|degenerative lumbar disorder
51113|NCT03883009|Epidemiology|epidemiology
51114|NCT03883009|Modeling|modeling
51115|NCT03883009|Risk factors|risk factors
51116|NCT03883009|Surgical site infections|surgical site infections
51117|NCT03882983|Autologous Adult Stem Cell|autologous adult stem cell
51118|NCT03882983|Lipoaspirate|lipoaspirate
51119|NCT03882983|Non-healing Wounds|non-healing wounds
51120|NCT03882983|Stomal Vasular Fraction|stomal vasular fraction
51121|NCT03882970|T2DM|t2dm
51122|NCT03882957|Attention|attention
51123|NCT03882957|Food cues|food cues
51124|NCT03882957|Media multi-tasking|media multi-tasking
51125|NCT03882931|Dorsolateral Prefrontal Cortex|dorsolateral prefrontal cortex
51126|NCT03882931|Neuromodulation|neuromodulation
51127|NCT03882931|Transcranial Magnetic Stimulation|transcranial magnetic stimulation
51128|NCT03882931|Transcranial Ultrasound Stimulation|transcranial ultrasound stimulation
51129|NCT03882879|karate|karate
51130|NCT03882879|exercise|exercise
51131|NCT03882879|martial arts|martial arts
51132|NCT03882879|Parkinson's Disease|parkinson's disease
51133|NCT03882879|non-pharmacologic|non-pharmacologic
51134|NCT03882879|randomized trial|randomized trial
51135|NCT03882879|camaraderie|camaraderie
51136|NCT03882879|depression|depression
51137|NCT03882879|anxiety|anxiety
51138|NCT03882879|quality of life|quality of life
51139|NCT03882866|Iodine-125|iodine-125
51140|NCT03882866|Three-Dimensional Printing|three-dimensional printing
51141|NCT03882866|Brachytherapy|brachytherapy
51142|NCT03882866|template|template
51143|NCT03882853|yoga|yoga
51144|NCT03882853|osteoporosis|osteoporosis
51145|NCT03882853|balance|balance
51146|NCT03882853|tree pose|tree pose
51147|NCT03882853|asana|asana
51148|NCT03882814|Analgesia|analgesia
51149|NCT03882814|labor|labor
51150|NCT03882814|pethidine|pethidine
51151|NCT03882814|Active Phase|active phase
51152|NCT03882775|Major adverse cardiac events (MACEs)|major adverse cardiac events (maces)
51153|NCT03882775|bivalirudin|bivalirudin
51154|NCT03882749|Pain, WOMAC|pain, womac
51155|NCT03882736|plastic and reconstructive surgery|plastic and reconstructive surgery
51156|NCT03882736|gluteal ptosis|gluteal ptosis
51157|NCT03882736|platipygia|platipygia
51158|NCT03882710|heart failure, metoprolol, diastolic dysfunction|heart failure, metoprolol, diastolic dysfunction
51159|NCT03882697|Robotic surgery|robotic surgery
51160|NCT03882697|Position|position
51161|NCT03882697|Cardio Q|cardio q
51162|NCT03882697|hypotension|hypotension
51163|NCT03882645|China Heart Diet|china heart diet
51164|NCT03882645|Randomized Controlled Trial|randomized controlled trial
51165|NCT03882645|Feeding Study|feeding study
51166|NCT03882645|Blood Pressure|blood pressure
51167|NCT03882645|Cholesterol|cholesterol
51168|NCT03882645|Fasting Blood Glucose|fasting blood glucose
51169|NCT03882645|Diet Modification|diet modification
51170|NCT03882580|anticancer drugs|anticancer drugs
51171|NCT03882580|cardiac toxicities|cardiac toxicities
51172|NCT03882580|cardiovascular prevention|cardiovascular prevention
51173|NCT03882580|vascular toxicities|vascular toxicities
51174|NCT03882580|metabolic toxicities|metabolic toxicities
51175|NCT03882580|adverse drug reactions|adverse drug reactions
51176|NCT03882567|visual analogue scale|visual analogue scale
51177|NCT03882567|conditioned pain modulation|conditioned pain modulation
51178|NCT03882567|disability|disability
51179|NCT03882567|pressure pain threshold|pressure pain threshold
51180|NCT03882567|temporal summation|temporal summation
51181|NCT03882541|Anxiety|anxiety
51182|NCT03882541|Pain|pain
51183|NCT03882541|perioperative|perioperative
51184|NCT03882541|Surgery|surgery
51185|NCT03882541|Music Therapy|music therapy
51186|NCT03882541|Drugs|drugs
51187|NCT03882515|Neck Pain|neck pain
51188|NCT03882515|Fascia|fascia
51189|NCT03882515|Modalities of Physiotherapy|modalities of physiotherapy
51190|NCT03882515|Oxygenation|oxygenation
51191|NCT03882489|spinal anesthesia|spinal anesthesia
51192|NCT03882489|Knee Arthroscopy|knee arthroscopy
51193|NCT03882489|Chloroprocaine|chloroprocaine
51194|NCT03882489|Height|height
51195|NCT03882489|Effective Dose (ED95)|effective dose (ed95)
51196|NCT03882489|Continual Reassessment Method (CRM)|continual reassessment method (crm)
51197|NCT03882476|Dascena|dascena
51198|NCT03882476|patient mortality|patient mortality
51199|NCT03882476|machine learning|machine learning
51200|NCT03882476|algorithm|algorithm
51201|NCT03882476|diagnostic|diagnostic
51202|NCT03882437|hypertrophic cardiomyopathy|hypertrophic cardiomyopathy
51203|NCT03882437|HCM|hcm
51204|NCT03882411|Implementation science|implementation science
51205|NCT03882411|Stepped wedge design|stepped wedge design
51206|NCT03882398|Neurodegenerative disorders|neurodegenerative disorders
51207|NCT03882398|physical activity|physical activity
51208|NCT03882398|balance|balance
51209|NCT03882398|endurance|endurance
51210|NCT03882372|Chronic obstructive pulmonary disease|chronic obstructive pulmonary disease
51211|NCT03882372|Pulmonary rehabilitation|pulmonary rehabilitation
51212|NCT03882372|Nasal high flow|nasal high flow
51213|NCT03882359|echo|echo
51214|NCT03882359|echocardiogram|echocardiogram
51215|NCT03882359|Healthy Volunteers|healthy volunteers
51216|NCT03882359|Definity|definity
51217|NCT03882346|Acute Liver Failure|acute liver failure
51218|NCT03882346|Acute-On-Chronic Liver Failure|acute-on-chronic liver failure
51219|NCT03882346|Artificial Liver|artificial liver
51220|NCT03882346|Liver Transplantation|liver transplantation
51221|NCT03882333|Chronic musculoskeletal pain|chronic musculoskeletal pain
51222|NCT03882333|Acute exercise|acute exercise
51223|NCT03882333|Movement control|movement control
51224|NCT03882333|Muscle activity|muscle activity
51225|NCT03882320|Sublingual Patient Controlled Analgesia (PCA)|sublingual patient controlled analgesia (pca)
51226|NCT03882320|Intravenous Patient Controlled Analgesia (PCA)|intravenous patient controlled analgesia (pca)
51227|NCT03882320|Patient Controlled Analgesia (PCA)|patient controlled analgesia (pca)
51228|NCT03882307|hepatitis C virus therapy|hepatitis c virus therapy
51229|NCT03882307|interleukin-6|interleukin-6
51230|NCT03882307|transforming growth factor -beta|transforming growth factor -beta
51231|NCT03882307|sustained virological response|sustained virological response
51239|NCT03882268|Maternal Nutrition|maternal nutrition
51240|NCT03882268|Nutrition Counseling|nutrition counseling
51241|NCT03882268|Behavior change|behavior change
51242|NCT03882268|Infant and young child feeding|infant and young child feeding
51243|NCT03882229|Registry|registry
51244|NCT03882229|Observational Study|observational study
51245|NCT03882164|Liver transplant;|liver transplant;
51246|NCT03882164|Immunosuppression;|immunosuppression;
51247|NCT03882164|Transplant rejection;|transplant rejection;
51248|NCT03882151|epilepsy|epilepsy
51249|NCT03882151|drug resistant epilepsy|drug resistant epilepsy
51250|NCT03882151|electrical source imaging|electrical source imaging
51251|NCT03882151|surgery|surgery
51252|NCT03882125|mindfulness|mindfulness
51253|NCT03882125|methadone maintenance|methadone maintenance
51254|NCT03882125|relapse prevention|relapse prevention
51255|NCT03882086|Foot reflexology|foot reflexology
51256|NCT03882086|nursing|nursing
51257|NCT03882086|postpartum period|postpartum period
51258|NCT03882086|postpartum sleep quality|postpartum sleep quality
51259|NCT03882034|Pediatric|pediatric
51260|NCT03882034|Gigantism|gigantism
51261|NCT03882034|Growth Hormone|growth hormone
51262|NCT03881969|Trial Recruitment|trial recruitment
51263|NCT03881969|Incentive Payment|incentive payment
51264|NCT03881969|Patient Demographics|patient demographics
51265|NCT03881956|gestational diabetes|gestational diabetes
51266|NCT03881956|health-promoting lifestyle|health-promoting lifestyle
51267|NCT03881956|maternal and neonatal health|maternal and neonatal health
51268|NCT03881956|education|education
51269|NCT03881930|Peripheral neuropathy|peripheral neuropathy
51270|NCT03881930|Balance|balance
51271|NCT03881930|Proprioceptive Disorders|proprioceptive disorders
51272|NCT03881930|Visual dependence|visual dependence
51273|NCT03881930|Rehabilitation|rehabilitation
51274|NCT03881930|Physical Therapy|physical therapy
51275|NCT03881917|renal impairment|renal impairment
51276|NCT03881904|PCOS|pcos
51277|NCT03881904|Anatgonist protocol|anatgonist protocol
51278|NCT03881904|OCP pretreatment|ocp pretreatment
51279|NCT03881865|Somatosensory Evoked Potential|somatosensory evoked potential
51280|NCT03881865|cardiac arrest|cardiac arrest
51281|NCT03881865|prognosis|prognosis
51282|NCT03881865|P25/30|p25/30
51283|NCT03881852|CONCERT|concert
51284|NCT03881852|AXS-12|axs-12
51285|NCT03881852|EDS|eds
51286|NCT03881852|Cataplexy|cataplexy
51287|NCT03881852|Narcolepsy|narcolepsy
51288|NCT03881852|Axsome|axsome
51289|NCT03881852|Reboxetine|reboxetine
51290|NCT03881813|fixed retainers|fixed retainers
51291|NCT03881813|alignment|alignment
51292|NCT03881800|Ceftazidime|ceftazidime
51293|NCT03881800|Burned Children|burned children
51294|NCT03881800|Intensive care|intensive care
51295|NCT03881800|Pharmacokinetic|pharmacokinetic
51296|NCT03881748|Acupuncture|acupuncture
51297|NCT03881709|prostate biopsy|prostate biopsy
51298|NCT03881709|E-Book|e-book
51299|NCT03881709|decision support intervention|decision support intervention
51300|NCT03881709|decision self-efficacy|decision self-efficacy
51301|NCT03881709|decision conflict|decision conflict
51308|NCT03881683|BRCA 1/2 genes|brca 1/2 genes
51309|NCT03881683|Circulating Tumor DNA/blood*|circulating tumor dna/blood*
51310|NCT03881683|somatic tumor mutations|somatic tumor mutations
51311|NCT03881683|HRD genes|hrd genes
51312|NCT03881657|Integrated Behavioral Health|integrated behavioral health
51313|NCT03881657|Reverse Colocation|reverse colocation
51314|NCT03881657|Integrated Care|integrated care
51315|NCT03881605|MRI|mri
51316|NCT03881605|Screening|screening
51317|NCT03881605|Quality of life|quality of life
51318|NCT03881605|Surveillance|surveillance
67496|NCT03782584|pilates|pilates
51319|NCT03881553|Prematurity|prematurity
51320|NCT03881553|Neonatal Abstinence Syndrome|neonatal abstinence syndrome
51321|NCT03881553|Autonomic Function|autonomic function
51322|NCT03881553|Sleep|sleep
51323|NCT03881553|Stochastic Resonance|stochastic resonance
51324|NCT03881553|Newborn/Infant|newborn/infant
51325|NCT03881514|Newborn Hearing Screening|newborn hearing screening
51326|NCT03881514|Automated Auditory Brainstem Response|automated auditory brainstem response
51327|NCT03881514|Mode Of Delivery|mode of delivery
51328|NCT03881501|Hepatocellular Carcinoma|hepatocellular carcinoma
51329|NCT03881501|Sintilimab Injection|sintilimab injection
51330|NCT03881501|Endostar|endostar
51331|NCT03881462|muscle function|muscle function
51340|NCT03881397|social media|social media
51341|NCT03881397|family rules|family rules
51342|NCT03881384|ctDNA|ctdna
51343|NCT03881358|Myopia control|myopia control
51344|NCT03881358|Orthokeratology|orthokeratology
51345|NCT03881358|Children|children
51346|NCT03881319|Acupuncture|acupuncture
51347|NCT03881319|Premenstrual Syndrome|premenstrual syndrome
51348|NCT03881319|Dysmenorrhea|dysmenorrhea
51349|NCT03881319|Autonomic nervous activity|autonomic nervous activity
51350|NCT03881319|TCM syndrome|tcm syndrome
51351|NCT03881319|Meridian|meridian
51352|NCT03881306|TACE|tace
51353|NCT03881306|Oxaliplatin|oxaliplatin
51354|NCT03881293|urodynamics|urodynamics
51355|NCT03881293|women|women
51356|NCT03881293|lidocaine gel|lidocaine gel
51357|NCT03881280|Childhood Obesity|childhood obesity
51358|NCT03881280|Nutrition|nutrition
51359|NCT03881280|mHealth|mhealth
51360|NCT03881280|Parenting|parenting
51361|NCT03881267|VLU|vlu
51362|NCT03881267|Ulcer|ulcer
51363|NCT03881267|SkinTE™|skinte™
51364|NCT03881254|DFU|dfu
51365|NCT03881254|Ulcer|ulcer
51366|NCT03881254|Skin TE|skin te
51377|NCT03881150|Cardiac rehabilitation|cardiac rehabilitation
51378|NCT03881150|Exercise|exercise
51379|NCT03881150|Coronary Artery Disease|coronary artery disease
51380|NCT03881150|Mobile technology|mobile technology
51381|NCT03881137|older|older
51382|NCT03881137|cancer|cancer
51383|NCT03881137|radiotherapy|radiotherapy
51384|NCT03881137|geriatric assessment|geriatric assessment
51385|NCT03881137|quality of life|quality of life
51386|NCT03881137|physical function|physical function
51387|NCT03881124|Inguinal Herniorrhaphy|inguinal herniorrhaphy
51388|NCT03881124|Hernia|hernia
51389|NCT03881124|Persistent postsurgical pain|persistent postsurgical pain
51390|NCT03881124|Long term follow up|long term follow up
51391|NCT03881124|Quantitative sensory testing (QST)|quantitative sensory testing (qst)
51392|NCT03881124|Pain trajectory|pain trajectory
51393|NCT03881124|Explanatory variables|explanatory variables
51394|NCT03881111|Programmed Cell Death-1 (PD-1)|programmed cell death-1 (pd-1)
51395|NCT03881111|Programmed Cell Death 1 (PD1)|programmed cell death 1 (pd1)
51396|NCT03881111|Programmed Cell Death-Ligand 1 (PD-L1, PDL1)|programmed cell death-ligand 1 (pd-l1, pdl1)
51397|NCT03881111|Programmed Cell Death-Ligand 2 (PD-L2, PDL2)|programmed cell death-ligand 2 (pd-l2, pdl2)
51398|NCT03881098|Bronchoscopy|bronchoscopy
51399|NCT03881098|Squamous Cell Carcinoma|squamous cell carcinoma
51400|NCT03881098|Pre-Malignant Lesions|pre-malignant lesions
51401|NCT03881098|Smoking|smoking
51402|NCT03881098|Multi-site|multi-site
51403|NCT03881085|minorities|minorities
51404|NCT03881085|stress reactivity|stress reactivity
51405|NCT03881085|allostatic load|allostatic load
51406|NCT03881085|disparities|disparities
51407|NCT03881072|Ultrasounicelastography|ultrasounicelastography
51408|NCT03881072|Frozen embryo transplantation|frozen embryo transplantation
51409|NCT03881072|Endometrial Receptivity|endometrial receptivity
51410|NCT03881072|pregnancy outcome|pregnancy outcome
51411|NCT03881007|Gonorrhea|gonorrhea
51412|NCT03881007|Syphilis|syphilis
51413|NCT03881007|Chlamydia|chlamydia
51414|NCT03881007|Listerine|listerine
51415|NCT03881007|STI|sti
51416|NCT03880994|Sexual Health|sexual health
51417|NCT03880994|Fatigue|fatigue
51418|NCT03880994|Quality of Life|quality of life
51419|NCT03880994|Depression|depression
51420|NCT03880994|Anxiety|anxiety
51421|NCT03880994|Fertility concerns|fertility concerns
51422|NCT03880994|Sleep Quality|sleep quality
51423|NCT03880994|Erectile Function|erectile function
51424|NCT03880994|Cognitive Impairment|cognitive impairment
51425|NCT03880994|Testis Cancer|testis cancer
51426|NCT03880981|fracture|fracture
51427|NCT03880981|tendon rupture|tendon rupture
51428|NCT03880981|NSAID|nsaid
51429|NCT03880981|healing|healing
51430|NCT03880929|kawasaki disease|kawasaki disease
51431|NCT03880929|coronary artery lesion|coronary artery lesion
51432|NCT03880929|epidemiology|epidemiology
51433|NCT03880916|Duloxetine|duloxetine
51434|NCT03880890|sphenoid nasalization|sphenoid nasalization
51435|NCT03880877|metastatic colorectal cancer|metastatic colorectal cancer
51436|NCT03880877|FOLFIRI|folfiri
51438|NCT03880864|Lung ulrasound, weaning, mechanical ventilation|lung ulrasound, weaning, mechanical ventilation
51439|NCT03880851|hypofractionation|hypofractionation
51440|NCT03880851|MR-based IGRT|mr-based igrt
51441|NCT03880851|Mbase HyPro|mbase hypro
51442|NCT03880838|Plant-based diet|plant-based diet
51443|NCT03880838|Behavioral nudge|behavioral nudge
51444|NCT03880838|Mail distribution|mail distribution
51445|NCT03880838|Randomized controlled trial|randomized controlled trial
51446|NCT03880838|Insurance claims|insurance claims
51447|NCT03880838|Chronic disease|chronic disease
51448|NCT03880838|Letter-based intervention|letter-based intervention
51449|NCT03880838|Health behaviors|health behaviors
51450|NCT03880838|Prevention focus|prevention focus
51451|NCT03880838|Loss framing|loss framing
51452|NCT03880838|Commitment|commitment
51453|NCT03880838|Provider testimonial|provider testimonial
51454|NCT03880799|Mindfulness|mindfulness
51455|NCT03880799|Surgical Decision Making|surgical decision making
51456|NCT03880760|T1DM|t1dm
51457|NCT03880760|Autoimmune diseases|autoimmune diseases
51458|NCT03880760|Microbiota|microbiota
51459|NCT03880760|Probiotics|probiotics
51460|NCT03880721|radiomics|radiomics
51461|NCT03880721|prognosis|prognosis
51462|NCT03880708|brugada syndrome|brugada syndrome
51463|NCT03880708|long QT syndrome|long qt syndrome
51464|NCT03880708|short QT syndrome|short qt syndrome
51465|NCT03880708|early repolarization syndrome|early repolarization syndrome
51466|NCT03880708|catecholaminergic polymorphic ventricular tachycardia|catecholaminergic polymorphic ventricular tachycardia
51467|NCT03880682|kidney transplant recipients|kidney transplant recipients
51468|NCT03880682|chronic hepatitis c virus infection|chronic hepatitis c virus infection
51469|NCT03880682|direct acting antivirals|direct acting antivirals
51470|NCT03880682|sofosbuvir/ledipasvir|sofosbuvir/ledipasvir
51472|NCT03880643|membranous nephropathy|membranous nephropathy
51473|NCT03880643|rituximab|rituximab
51474|NCT03880617|Chronic myeloid leukemia|chronic myeloid leukemia
51475|NCT03880617|Gastrointestinal stromal tumor|gastrointestinal stromal tumor
51476|NCT03880617|Targeted therapy|targeted therapy
51477|NCT03880617|Care needs|care needs
51478|NCT03880617|Medication adherence|medication adherence
51479|NCT03880604|Haemostatic tourniquets|haemostatic tourniquets
51480|NCT03880604|tranexamic acid|tranexamic acid
51481|NCT03880604|myomectomy|myomectomy
51482|NCT03880578|LT4 treatment|lt4 treatment
51484|NCT03880565|advanced reperfusion|advanced reperfusion
51485|NCT03880565|mechanical cardiopulmonary resuscitation|mechanical cardiopulmonary resuscitation
51486|NCT03880552|perineal laceration|perineal laceration
51487|NCT03880552|obstetric trauma|obstetric trauma
51488|NCT03880539|C.diff|c.diff
51489|NCT03880539|Clostridium Difficile|clostridium difficile
51490|NCT03880539|recurrence|recurrence
51491|NCT03880539|Bezlotoxumab|bezlotoxumab
51492|NCT03880539|CDI|cdi
51493|NCT03880526|Cancer prevention control|cancer prevention control
51494|NCT03880526|Cancer navigation|cancer navigation
51495|NCT03880513|Endogenous Cushing's Syndrome|endogenous cushing's syndrome
51496|NCT03880513|Cardiovascular status|cardiovascular status
51497|NCT03880513|Metabolic profile|metabolic profile
51498|NCT03880513|Endothelial function|endothelial function
51499|NCT03880513|Quality of life|quality of life
51500|NCT03880487|Phase I, Healthy Adult Participants|phase i, healthy adult participants
51501|NCT03880461|Gestational weight gain|gestational weight gain
51502|NCT03880461|Lifestyle|lifestyle
51503|NCT03880461|Intervention|intervention
51504|NCT03880461|Body weight|body weight
51505|NCT03880461|Overweight|overweight
51506|NCT03880461|Obesity|obesity
51507|NCT03880461|Signs and Symptoms|signs and symptoms
51508|NCT03880461|Body weight changes|body weight changes
51509|NCT03880448|Disease Progression|disease progression
51510|NCT03880448|Microbiota|microbiota
51511|NCT03880448|Periodontitis/surgery|periodontitis/surgery
51512|NCT03880448|Periodontitis/therapy|periodontitis/therapy
51513|NCT03880448|Periodontitis/drug effect|periodontitis/drug effect
51514|NCT03880448|Periodontitis/drug therapy|periodontitis/drug therapy
51515|NCT03880448|Periodontal diseases/surgery|periodontal diseases/surgery
51516|NCT03880448|Periodontal diseases/therapy|periodontal diseases/therapy
51517|NCT03880448|Periodontal pocket/drug therapy|periodontal pocket/drug therapy
51518|NCT03880448|Metronidazole/therapeutic use|metronidazole/therapeutic use
51519|NCT03880448|Metronidazole|metronidazole
51520|NCT03880448|Porphyromonas gingivalis|porphyromonas gingivalis
51521|NCT03880448|Systemic antimicrobial/periodontal surgery|systemic antimicrobial/periodontal surgery
51522|NCT03880435|Infertility|infertility
51523|NCT03880435|Reproductive outcome|reproductive outcome
51524|NCT03880435|Hysteroscopy|hysteroscopy
51525|NCT03880435|Adhesion prophylaxis|adhesion prophylaxis
51526|NCT03880383|brain-based developmental disorders|brain-based developmental disorders
51527|NCT03880383|child development|child development
51528|NCT03880383|preschool skills and development|preschool skills and development
51529|NCT03880383|parenting stress|parenting stress
51530|NCT03880383|parenting mental health|parenting mental health
51531|NCT03880383|coaching intervention|coaching intervention
51532|NCT03880383|online education|online education
51533|NCT03880383|parent peer support|parent peer support
51534|NCT03880383|developmental delay|developmental delay
51535|NCT03880370|ultrasound|ultrasound
51536|NCT03880370|functional test|functional test
51537|NCT03880370|herniated lumbar disk|herniated lumbar disk
51538|NCT03880370|low back pain|low back pain
51539|NCT03880344|vibration therapy|vibration therapy
51540|NCT03880344|Knee Osteoarthritis|knee osteoarthritis
51541|NCT03880344|Knee Arthropathy|knee arthropathy
51542|NCT03880331|Secondary intention|secondary intention
51543|NCT03880331|Wound care methods|wound care methods
51544|NCT03880305|neonatal sepsis|neonatal sepsis
51545|NCT03880305|white blood cells|white blood cells
51546|NCT03880305|platelets|platelets
51547|NCT03880240|Alzheimer Disease|alzheimer disease
51548|NCT03880240|Mild Cognitive Impairment|mild cognitive impairment
51549|NCT03880214|oral GVHD|oral gvhd
51550|NCT03880214|Pediatric|pediatric
51551|NCT03880201|perfusion index.ulnar nerve sparing. supraclavicular blocK|perfusion index.ulnar nerve sparing. supraclavicular block
51552|NCT03880188|Autologous Transplantation|autologous transplantation
51553|NCT03880188|Free Tissue Flaps|free tissue flaps
51554|NCT03880188|Graft Survival|graft survival
51555|NCT03880188|Reconstructive Surgical Procedures|reconstructive surgical procedures
51556|NCT03880188|Patient Selection|patient selection
51557|NCT03880188|Debridement|debridement
51558|NCT03880188|Subcutaneous Fat|subcutaneous fat
51559|NCT03880188|Surgical Flaps|surgical flaps
51560|NCT03880188|Treatment Outcome|treatment outcome
51561|NCT03880162|Prediabetes|prediabetes
51562|NCT03880162|Bariatric Surgery|bariatric surgery
51563|NCT03880162|Low-carb diet|low-carb diet
51564|NCT03880149|Omega-3|omega-3
51565|NCT03880149|Athletes|athletes
51566|NCT03880149|Sports injuries|sports injuries
51567|NCT03880149|Inflammatory markers|inflammatory markers
51568|NCT03880149|Isokinetic muscle force|isokinetic muscle force
51569|NCT03880136|Safety|safety
51570|NCT03880136|Bioavailability|bioavailability
51571|NCT03880136|Pharmacokinetics|pharmacokinetics
51572|NCT03880123|Liposarcoma|liposarcoma
51573|NCT03880123|Malignant Peripheral Nerve Sheath Tumors|malignant peripheral nerve sheath tumors
51574|NCT03880123|Alveolar Soft Part Sarcoma|alveolar soft part sarcoma
51575|NCT03880123|Ewing Sarcoma|ewing sarcoma
51576|NCT03880123|Selinexor|selinexor
51577|NCT03880123|ixazomib|ixazomib
51578|NCT03880123|sarcoma|sarcoma
51579|NCT03880123|kpt-330|kpt-330
51580|NCT03880110|Acute Kidney Injury|acute kidney injury
51581|NCT03880110|Early prediction|early prediction
51582|NCT03880110|Non cardiac surgery|non cardiac surgery
51583|NCT03880110|Biomarker|biomarker
51584|NCT03880110|Urine sedimentation|urine sedimentation
51585|NCT03880110|Renal resistive index|renal resistive index
51586|NCT03880071|Psychiatry|psychiatry
51587|NCT03880071|Suicidal Behavior|suicidal behavior
51588|NCT03880071|Borderline Personality Disorder|borderline personality disorder
51589|NCT03880071|Prevention|prevention
51590|NCT03880071|Dialectic Behavioral Therapy|dialectic behavioral therapy
51591|NCT03880071|Acceptance Commitment Therapy|acceptance commitment therapy
51592|NCT03880045|abdominal myomectomy|abdominal myomectomy
51593|NCT03880045|tranexamic acid|tranexamic acid
51594|NCT03880045|vasopressin|vasopressin
51595|NCT03880032|anxiety|anxiety
51596|NCT03880032|depression|depression
51597|NCT03880032|birth outcomes|birth outcomes
51598|NCT03879993|Exercise|exercise
51599|NCT03879993|Cognition|cognition
51600|NCT03879993|Body composition|body composition
51601|NCT03879993|Inflammatory biomarkers|inflammatory biomarkers
51602|NCT03879993|CD4|cd4
51603|NCT03879980|quadratus lumborum block|quadratus lumborum block
51604|NCT03879980|pre-emptive analgesia|pre-emptive analgesia
51605|NCT03879980|laparoscopic nephrectomy|laparoscopic nephrectomy
51606|NCT03879967|Allograft block|allograft block
51607|NCT03879967|guided bone regeneration|guided bone regeneration
51608|NCT03879967|implants|implants
51609|NCT03879941|Amputation|amputation
51610|NCT03879941|thumb reconstruction|thumb reconstruction
51611|NCT03879941|toe transfer|toe transfer
51612|NCT03879941|foot morbidity|foot morbidity
51613|NCT03879941|biomechanics|biomechanics
51614|NCT03879915|hypophosphatemia|hypophosphatemia
51615|NCT03879915|hypophosphatemic rickets|hypophosphatemic rickets
51616|NCT03879915|dental implants|dental implants
51617|NCT03879915|osseointegration|osseointegration
51618|NCT03879902|fall|fall
51619|NCT03879902|elderly|elderly
51620|NCT03879889|Smoking reduction|smoking reduction
51621|NCT03879889|Randomised controlled trial|randomised controlled trial
51622|NCT03879889|Motivational interview|motivational interview
51623|NCT03879889|Nicotine replacement therapy|nicotine replacement therapy
51624|NCT03879889|Environmental tobacco smoke exposure|environmental tobacco smoke exposure
51625|NCT03879889|Paediatrics|paediatrics
51626|NCT03879889|Children|children
51627|NCT03879876|SCID|scid
400573|NCT01866228|Patient Satisfaction|patient satisfaction
51628|NCT03879876|hematopoietic stem cell transplantation|hematopoietic stem cell transplantation
51832|NCT03878212|app|app
51629|NCT03879876|Human T Lymphoid Progenitor|human t lymphoid progenitor
51630|NCT03879837|Bioequivalence|bioequivalence
51631|NCT03879811|MMR-Proficient Colorectal Cancer|mmr-proficient colorectal cancer
51632|NCT03879811|Temozolomide|temozolomide
51633|NCT03879811|Nivolumab|nivolumab
51634|NCT03879811|Memorial Sloan Kettering Cancer Center|memorial sloan kettering cancer center
51636|NCT03879798|DS-3201b|ds-3201b
51637|NCT03879798|Irinotecan|irinotecan
51638|NCT03879798|18-553|18-553
51639|NCT03879785|Tobacco|tobacco
51640|NCT03879785|Alcohol|alcohol
51641|NCT03879785|Prescription Drug|prescription drug
51642|NCT03879785|Illicit Substance Use|illicit substance use
51643|NCT03879785|Screening|screening
51644|NCT03879785|Spanish|spanish
51645|NCT03879785|Hispanic|hispanic
51646|NCT03879733|childcare|childcare
51647|NCT03879733|quality|quality
51648|NCT03879733|universal prevention|universal prevention
51649|NCT03879733|mental health|mental health
51650|NCT03879733|well-being|well-being
51651|NCT03879720|ERCP|ercp
51652|NCT03879720|Endoscopic Procedures|endoscopic procedures
51653|NCT03879720|Anesthesia|anesthesia
51654|NCT03879668|Advanced disease|advanced disease
51655|NCT03879668|Specialised outpatient palliative care|specialised outpatient palliative care
51656|NCT03879668|IPOS|ipos
51657|NCT03879668|Electronical monitoring|electronical monitoring
51658|NCT03879655|Niemann-Pick|niemann-pick
51659|NCT03879655|NPC|npc
51660|NCT03879603|Alphavirus|alphavirus
51661|NCT03879603|VEE|vee
51662|NCT03879603|WEE|wee
51663|NCT03879603|EEE|eee
51664|NCT03879603|Vaccine|vaccine
51665|NCT03879603|Virus-like particles|virus-like particles
51666|NCT03879590|doxophylline|doxophylline
51667|NCT03879590|asthma|asthma
51668|NCT03879590|steroid sparing|steroid sparing
51669|NCT03879577|breast cancer|breast cancer
51670|NCT03879577|breast cancer stage II|breast cancer stage ii
51671|NCT03879577|Breast Cancer Stage III|breast cancer stage iii
51672|NCT03879577|Docetaxel|docetaxel
51673|NCT03879577|Herceptin|herceptin
51674|NCT03879577|neoadjuvant treatment|neoadjuvant treatment
51675|NCT03879577|nigeria|nigeria
51676|NCT03879525|Electronic medical record|electronic medical record
51677|NCT03879525|EMR|emr
51678|NCT03879525|Patient Outcomes|patient outcomes
51679|NCT03879512|cancer vaccine|cancer vaccine
51680|NCT03879512|high-grade glioma|high-grade glioma
51681|NCT03879512|immunomodulation|immunomodulation
51682|NCT03879499|cuff hematoma|cuff hematoma
51683|NCT03879499|CRP levels|crp levels
51684|NCT03879447|Korean Medicine|korean medicine
51685|NCT03879447|Effectiveness|effectiveness
51686|NCT03879447|Numeric Rating Scale|numeric rating scale
51687|NCT03879447|Safety|safety
51688|NCT03879447|Walking ability|walking ability
51689|NCT03879447|Disability|disability
51690|NCT03879408|Analgesics|analgesics
51691|NCT03879408|Dental Pain|dental pain
51692|NCT03879408|Naproxen|naproxen
51693|NCT03879408|Acetaminophen|acetaminophen
51694|NCT03879408|Pain|pain
51695|NCT03879395|melanoma|melanoma
51696|NCT03879395|abdominal metastasis|abdominal metastasis
51697|NCT03879395|metastasectomy|metastasectomy
51698|NCT03879395|tumor resection|tumor resection
51699|NCT03879395|M1c|m1c
51700|NCT03879382|CD19/BCMA|cd19/bcma
51701|NCT03879382|Bispecific CAR-T Cell|bispecific car-t cell
51702|NCT03879382|POMES Syndrome|pomes syndrome
51703|NCT03879382|Relapsed and Refractory|relapsed and refractory
51704|NCT03879356|Aluminum phosphide|aluminum phosphide
51705|NCT03879356|N-acetylcystein|n-acetylcystein
51706|NCT03879356|Assiut|assiut
51707|NCT03879356|prognostic factors|prognostic factors
51708|NCT03879304|Virtual Reality [L01.224.160.875], [L01.296.555]|virtual reality [l01.224.160.875], [l01.296.555]
51709|NCT03879304|Physical Therapy Modalities [E02.779], [E02.831.535]|physical therapy modalities [e02.779], [e02.831.535]
51710|NCT03879304|Respiratory Therapy [E02.880]|respiratory therapy [e02.880]
51711|NCT03879304|Dystrophin [D12.776.210.500.250]|dystrophin [d12.776.210.500.250]
51712|NCT03879304|Becker Muscular Dystrophy [C10.668.491.175.500.300]|becker muscular dystrophy [c10.668.491.175.500.300]
51713|NCT03879304|Resistance training [E02.831.535.483.875]|resistance training [e02.831.535.483.875]
51714|NCT03879304|Muscular Stretching Therapy [E02.831.535.483.750]|muscular stretching therapy [e02.831.535.483.750]
51715|NCT03879265|Diagnosis|diagnosis
51716|NCT03879265|Reproduction|reproduction
51717|NCT03879265|Chromosomal Endowment|chromosomal endowment
51718|NCT03879226|Photobiomodulation Therapy|photobiomodulation therapy
51719|NCT03879226|Low-level Laser Therapy|low-level laser therapy
51720|NCT03879226|Aerobic Endurance|aerobic endurance
51721|NCT03879213|Raspberry|raspberry
51722|NCT03879213|Metabolic responses|metabolic responses
51723|NCT03879213|Endothelial function|endothelial function
51724|NCT03879213|Cognitive function|cognitive function
51725|NCT03879187|High-fat diet|high-fat diet
51726|NCT03879187|Insulin|insulin
51727|NCT03879187|Glucose|glucose
67992|NCT03779529|lipids|lipids
51728|NCT03879187|Muscle|muscle
51729|NCT03879187|eNOS|enos
51730|NCT03879187|Isotopes|isotopes
51731|NCT03879174|HR Positive Breast Cancer|hr positive breast cancer
51732|NCT03879161|Ultrasound|ultrasound
51733|NCT03879161|Femoral Artery|femoral artery
51734|NCT03879161|Intra-arterial|intra-arterial
51735|NCT03879161|Catheterization|catheterization
51736|NCT03879161|Liver Neoplasms|liver neoplasms
51737|NCT03879148|Erector spinae plane block|erector spinae plane block
51738|NCT03879148|Video assisted thoracic surgery|video assisted thoracic surgery
51739|NCT03879148|Postoperative analgesia|postoperative analgesia
51740|NCT03879122|prostate cancer|prostate cancer
51741|NCT03879122|immunotherapy|immunotherapy
51742|NCT03879109|Locally recurrent rectal cancer|locally recurrent rectal cancer
51743|NCT03879109|Pelvic reirradiation|pelvic reirradiation
51744|NCT03879109|Oncological surgery|oncological surgery
51745|NCT03879096|cancer|cancer
51746|NCT03879096|oncology|oncology
51747|NCT03879096|Metastasis|metastasis
51748|NCT03879096|survivors|survivors
51749|NCT03879096|Exercise Therapy|exercise therapy
51750|NCT03879096|Therapeutics|therapeutics
51751|NCT03879096|Complementary Therapies|complementary therapies
51752|NCT03879096|fatigue|fatigue
51753|NCT03879096|assesment|assesment
51754|NCT03879044|Transcranial Direct Current Stimulation|transcranial direct current stimulation
51755|NCT03879031|lumbar|lumbar
51756|NCT03879031|physical endurance|physical endurance
51757|NCT03879031|pain|pain
51758|NCT03879031|disability|disability
51759|NCT03879031|assessment|assessment
51760|NCT03879018|Cerebellar Ataxia|cerebellar ataxia
51761|NCT03878992|Growth hormone|growth hormone
51762|NCT03878992|Satellite cells|satellite cells
51763|NCT03878992|Metabolism|metabolism
51764|NCT03878992|insulin-like effects|insulin-like effects
51765|NCT03878927|AML|aml
51766|NCT03878927|De novo AML|de novo aml
51767|NCT03878927|Secondary AML|secondary aml
51768|NCT03878927|Therapy-related AML|therapy-related aml
51769|NCT03878914|Nephrotic sydrome|nephrotic sydrome
51770|NCT03878914|Steroid sensitive nephrotic syndrome|steroid sensitive nephrotic syndrome
51771|NCT03878901|hypothermia|hypothermia
51772|NCT03878888|liposomal bupivacaine|liposomal bupivacaine
51773|NCT03878888|TAP block|tap block
51774|NCT03878888|pain control|pain control
51775|NCT03878823|metastatic castration-resistant prostate cancer|metastatic castration-resistant prostate cancer
51776|NCT03878823|advanced hormone receptor positive breast cancer|advanced hormone receptor positive breast cancer
51777|NCT03878797|Endotracheal tube|endotracheal tube
51778|NCT03878797|Endobronchial intubation|endobronchial intubation
51779|NCT03878797|Vocal cords|vocal cords
51780|NCT03878797|Bronchoscopy|bronchoscopy
51781|NCT03878771|Platelet rich fibrin, Oral Ulcer, Pain, Mucositis|platelet rich fibrin, oral ulcer, pain, mucositis
51782|NCT03878719|Adolescent|adolescent
51783|NCT03878719|BRAF V600K|braf v600k
51784|NCT03878719|BRAF V600E|braf v600e
51785|NCT03878706|Endothelial glycocalyx integrity|endothelial glycocalyx integrity
51786|NCT03878706|Oxidative stress biomarkers|oxidative stress biomarkers
51787|NCT03878706|Arterial stiffness|arterial stiffness
51788|NCT03878706|GLS|gls
51789|NCT03878667|Calcium Supplementation|calcium supplementation
51790|NCT03878667|Exercise Intervention|exercise intervention
51791|NCT03878615|liver surgery|liver surgery
51792|NCT03878615|hepatic resection|hepatic resection
51793|NCT03878615|inflammation|inflammation
51794|NCT03878615|organ dysfunction|organ dysfunction
51795|NCT03878615|blood loss|blood loss
51796|NCT03878615|IFABP|ifabp
51797|NCT03878602|Newborn|newborn
51798|NCT03878602|Elective Caesaren Section|elective caesaren section
51799|NCT03878602|Cord Clamping|cord clamping
51800|NCT03878576|Glycemic Index|glycemic index
51801|NCT03878576|glycemic response|glycemic response
51802|NCT03878576|bread|bread
51803|NCT03878576|barley|barley
51804|NCT03878576|beta-glucans|beta-glucans
51805|NCT03878576|glucose level|glucose level
51806|NCT03878576|continous glucose monitoring|continous glucose monitoring
51807|NCT03878498|Crohn disease|crohn disease
51808|NCT03878498|anal fistula|anal fistula
51809|NCT03878498|anal surgery|anal surgery
51810|NCT03878459|T1DM,ketoacidosis, dapagliflozin, pioglitazone|t1dm,ketoacidosis, dapagliflozin, pioglitazone
51811|NCT03878420|Dry AMD|dry amd
51812|NCT03878420|Photobiomodulation|photobiomodulation
51813|NCT03878420|Visual Acuity|visual acuity
51814|NCT03878420|Contrast Sensitivity|contrast sensitivity
51815|NCT03878420|Optical Coherence Tomography|optical coherence tomography
51816|NCT03878420|Drusen|drusen
51817|NCT03878407|ARCH|arch
51818|NCT03878394|balance|balance
51819|NCT03878394|cognitive function|cognitive function
51820|NCT03878394|healthy individuals|healthy individuals
51821|NCT03878394|quality of life|quality of life
51822|NCT03878394|cognitive exercises|cognitive exercises
51823|NCT03878394|depression|depression
51824|NCT03878368|Sulforaphane|sulforaphane
816097|NCT00177255|esophageal|esophageal
51826|NCT03878251|Intellectual disability|intellectual disability
51827|NCT03878251|Attention evaluation criteria|attention evaluation criteria
51828|NCT03878251|Games on touchscreen|games on touchscreen
51829|NCT03878251|Eye tracking|eye tracking
51830|NCT03878238|Probiotic|probiotic
51831|NCT03878212|mHealth|mhealth
51833|NCT03878186|HIV|hiv
51834|NCT03878186|Threat appraisal|threat appraisal
51835|NCT03878186|Cognitive behavioral therapy|cognitive behavioral therapy
51836|NCT03878186|Antiretroviral-naïve|antiretroviral-naïve
51837|NCT03878186|Challenge appraisal|challenge appraisal
51838|NCT03878186|Affect|affect
51839|NCT03878186|Adherence|adherence
51840|NCT03878186|Quality of life|quality of life
51841|NCT03878186|Anxiety|anxiety
51842|NCT03878186|Depression|depression
51843|NCT03878186|Viral load|viral load
51844|NCT03878186|Loss to follow-up|loss to follow-up
51845|NCT03878173|temporary tooth|temporary tooth
51846|NCT03878173|pain|pain
51847|NCT03878173|analgesic|analgesic
51848|NCT03878173|paracetamol|paracetamol
51849|NCT03878173|acetaminophen|acetaminophen
51850|NCT03878160|Mindfulness|mindfulness
51851|NCT03878160|Acute Coronary Syndrome|acute coronary syndrome
51852|NCT03878160|Videoconferencing|videoconferencing
51853|NCT03878160|Depression|depression
51854|NCT03878134|Photon Counting CT|photon counting ct
51855|NCT03878134|Computed Tomography|computed tomography
51856|NCT03878134|Photon Counting Detectors|photon counting detectors
51857|NCT03878121|Ad4-Env150KN|ad4-env150kn
51858|NCT03878121|Ad4-Env145NFL|ad4-env145nfl
51859|NCT03878121|VRC-HIVRGP096-00-VP (Trimer 4571) with alum|vrc-hivrgp096-00-vp (trimer 4571) with alum
51860|NCT03878121|Adenovirus|adenovirus
51861|NCT03878121|HIV Vaccine|hiv vaccine
51862|NCT03878108|Accelerometry|accelerometry
51863|NCT03878108|Body Composition|body composition
51864|NCT03878108|Body Weight Regulation|body weight regulation
51865|NCT03878108|Calories|calories
51866|NCT03878108|Energy Expenditure|energy expenditure
51867|NCT03878082|cesarean section|cesarean section
51868|NCT03878082|uterine contraction pain|uterine contraction pain
51869|NCT03878082|propacetamol|propacetamol
51870|NCT03878043|subdural hematoma|subdural hematoma
51871|NCT03878043|readmission|readmission
51872|NCT03878043|risk factors|risk factors
51873|NCT03878004|Tuberculosis|tuberculosis
51874|NCT03878004|Mycobacterium tuberculosis|mycobacterium tuberculosis
51875|NCT03878004|Recombinant vaccine|recombinant vaccine
51876|NCT03878004|Mycobacterium Infections|mycobacterium infections
51877|NCT03878004|Vaccines|vaccines
51878|NCT03877991|Bioavailability|bioavailability
51879|NCT03877991|Pharmacokinetics|pharmacokinetics
51880|NCT03877939|Ectopic pregnancy|ectopic pregnancy
51881|NCT03877939|non-viable pregnancy|non-viable pregnancy
51882|NCT03877939|miRNA|mirna
51883|NCT03877939|Kisspeptin|kisspeptin
51884|NCT03877939|β-HCG|β-hcg
51885|NCT03877939|biomarkers|biomarkers
51886|NCT03877926|Anthrax|anthrax
51887|NCT03877926|AV7909|av7909
51888|NCT03877926|BioThrax|biothrax
51889|NCT03877926|Bacillus anthracis|bacillus anthracis
51890|NCT03877926|Anthrax Vaccine Adsorbed|anthrax vaccine adsorbed
51891|NCT03877926|Post-exposure Prophylaxis|post-exposure prophylaxis
51892|NCT03877926|Vaccine|vaccine
51893|NCT03877926|CPG 7909|cpg 7909
51894|NCT03877926|Adjuvant|adjuvant
51895|NCT03877913|atrial fibrillation|atrial fibrillation
51896|NCT03877913|ablation|ablation
51897|NCT03877913|electrocardiographic monitoring|electrocardiographic monitoring
51898|NCT03877900|post mortem Magnetic Resonance Imaging|post mortem magnetic resonance imaging
51899|NCT03877900|stillbirth|stillbirth
51900|NCT03877900|fetal death|fetal death
51901|NCT03877900|neonatal death|neonatal death
51902|NCT03877900|Minimally Invasive Autopsy|minimally invasive autopsy
51903|NCT03877900|Tissue samplings|tissue samplings
51904|NCT03877848|bleeding|bleeding
51905|NCT03877848|PCI|pci
51906|NCT03877809|Fetal hemoglobin|fetal hemoglobin
51907|NCT03877809|Sirolimus|sirolimus
51908|NCT03877809|Red Blood Cells|red blood cells
51909|NCT03877783|mediterranean diet|mediterranean diet
51910|NCT03877783|physical fitness|physical fitness
51911|NCT03877757|Family Planning|family planning
51912|NCT03877757|Implementation science|implementation science
51913|NCT03877757|Evaluation|evaluation
51914|NCT03877757|Contraceptive initiative|contraceptive initiative
51915|NCT03877731|hypertrophic cardiomyopathy, mitral valve, echocardiography|hypertrophic cardiomyopathy, mitral valve, echocardiography
51916|NCT03877718|Acute Migraine Pain|acute migraine pain
51917|NCT03877718|Acute Migraine Pain, With or Without Aura|acute migraine pain, with or without aura
51918|NCT03877718|Prevention of Migraine Associated Nausea and Vomiting (MANV)|prevention of migraine associated nausea and vomiting (manv)
51919|NCT03877705|Dental Plaque , salivary pH|dental plaque , salivary ph
51920|NCT03877692|Hypertension|hypertension
51921|NCT03877692|Labetalol|labetalol
51922|NCT03877679|oral lichen planus|oral lichen planus
51923|NCT03877679|curcumin|curcumin
51924|NCT03877679|IL-33|il-33
51925|NCT03877679|corticosteroids|corticosteroids
51926|NCT03877653|PNS|pns
51927|NCT03877653|Chronic|chronic
51928|NCT03877653|Pain|pain
51929|NCT03877653|Wireless|wireless
51930|NCT03877653|Neuromodulation|neuromodulation
51931|NCT03877640|incontinence|incontinence
51932|NCT03877640|stress urgency incontinence|stress urgency incontinence
51933|NCT03877640|urge incontinence|urge incontinence
51934|NCT03877640|EMSELLA|emsella
51935|NCT03877601|Fluorescence|fluorescence
51936|NCT03877601|Endoscopy|endoscopy
51937|NCT03877601|Bevacizumab-800CW|bevacizumab-800cw
51938|NCT03877523|Cocarnit|cocarnit
51939|NCT03877523|Diabetes Mellitus|diabetes mellitus
51940|NCT03877523|Macrophages polarization|macrophages polarization
51941|NCT03877510|motor fluctuations|motor fluctuations
51942|NCT03877510|IPX203|ipx203
51943|NCT03877484|chronic and acute wounds|chronic and acute wounds
51944|NCT03877484|full-thickness|full-thickness
51945|NCT03877484|partial thickness|partial thickness
51946|NCT03877484|shadow granulating|shadow granulating
51947|NCT03877484|exuding wounds|exuding wounds
51948|NCT03877484|including pressure ulcers|including pressure ulcers
51949|NCT03877484|leg ulcers|leg ulcers
51950|NCT03877484|diabetic foot ulcers|diabetic foot ulcers
51951|NCT03877484|dehisced surgical wounds|dehisced surgical wounds
51952|NCT03877471|Mesenchymal stem cell|mesenchymal stem cell
51953|NCT03877471|Transplantation|transplantation
51954|NCT03877471|Human embryonic stem cell|human embryonic stem cell
51955|NCT03877471|Premature ovarian failure|premature ovarian failure
51956|NCT03877458|Infantile Colic|infantile colic
51957|NCT03877458|Bifidobacteria and Lactobacilli|bifidobacteria and lactobacilli
51958|NCT03877458|Intestinal Microbiome|intestinal microbiome
51959|NCT03877458|Probiotics|probiotics
51960|NCT03877419|dental implant|dental implant
51961|NCT03877419|bone quality|bone quality
51962|NCT03877419|tactile sensation|tactile sensation
51963|NCT03877419|drilling speed|drilling speed
51964|NCT03877406|Sodium-glucose transporter 2 inhibitor|sodium-glucose transporter 2 inhibitor
51965|NCT03877393|Probiotics; dietary supplements|probiotics; dietary supplements
51966|NCT03877393|Diet, Gluten-Free|diet, gluten-free
51967|NCT03877393|Inflammation|inflammation
51968|NCT03877393|Gastrointestinal Microbiome|gastrointestinal microbiome
51969|NCT03877393|Intestinal mucosal permeability|intestinal mucosal permeability
51970|NCT03877393|Gut-brain axis|gut-brain axis
51971|NCT03877393|Gut permeability|gut permeability
51972|NCT03877393|EEG functional connectivity|eeg functional connectivity
51973|NCT03877393|Cortisol|cortisol
51974|NCT03877393|Hypothalamic-pituitary-adrenal axis|hypothalamic-pituitary-adrenal axis
51975|NCT03877393|Cognitive function|cognitive function
51976|NCT03877380|personalised autonomy allowance|personalised autonomy allowance
51977|NCT03877380|difficulties|difficulties
51978|NCT03877380|physician's role|physician's role
51979|NCT03877367|Chiropractic manipulation|chiropractic manipulation
51980|NCT03877367|Extremity manipulation|extremity manipulation
51981|NCT03877367|Balance task|balance task
51982|NCT03877354|ventilation|ventilation
51983|NCT03877354|paediatric patient|paediatric patient
51984|NCT03877354|mechanical ventilation|mechanical ventilation
51985|NCT03877328|heart failure|heart failure
51986|NCT03877328|exercise|exercise
51987|NCT03877328|life coach|life coach
51988|NCT03877302|Birth|birth
51989|NCT03877302|Reflexology|reflexology
51990|NCT03877302|Pain|pain
51991|NCT03877289|pediatrics|pediatrics
51992|NCT03877289|cystitis|cystitis
51993|NCT03877289|UTI|uti
51994|NCT03877289|oxybutynin|oxybutynin
51995|NCT03877276|dietary oxalate|dietary oxalate
51996|NCT03877276|diet therapy|diet therapy
51997|NCT03877263|Chlamydia Trachomatis|chlamydia trachomatis
51998|NCT03877263|Neisseria gonorrhoeae|neisseria gonorrhoeae
51999|NCT03877250|PD-L1 High|pd-l1 high
52000|NCT03877250|19-030|19-030
52001|NCT03877250|Memorial Sloan Kettering Cancer Center|memorial sloan kettering cancer center
52002|NCT03877211|speech audiometry|speech audiometry
52003|NCT03877211|psychophysical tuning curve|psychophysical tuning curve
52004|NCT03877211|electrophysiology|electrophysiology
52005|NCT03877211|auditory brainstem response|auditory brainstem response
52006|NCT03877185|IVF|ivf
52007|NCT03877185|infertility|infertility
52008|NCT03877185|long antagonist|long antagonist
52009|NCT03877185|long acting gonadotropin|long acting gonadotropin
52010|NCT03877185|corifollitropin alfa|corifollitropin alfa
52011|NCT03877185|ovarian stimulation|ovarian stimulation
52012|NCT03877146|Controlled Breathing|controlled breathing
52013|NCT03877146|MRI-Guided Breast Biopsy|mri-guided breast biopsy
52014|NCT03877146|Breast Pain|breast pain
52015|NCT03877146|Body Pain|body pain
52016|NCT03877146|Anticipatory Pain|anticipatory pain
52017|NCT03877146|Anxiety|anxiety
52018|NCT03877146|Coping Skills|coping skills
52019|NCT03877146|Self Efficacy|self efficacy
52020|NCT03877133|Near-infrared spectroscopy|near-infrared spectroscopy
52021|NCT03877133|Renal regional oxygen saturation|renal regional oxygen saturation
52022|NCT03877133|Living donor liver transplantation|living donor liver transplantation
52023|NCT03877133|Acute kidney injury|acute kidney injury
52024|NCT03877120|Dexmedetomidine|dexmedetomidine
52025|NCT03877120|Diazepam|diazepam
52026|NCT03877120|Alcohol dependence|alcohol dependence
52027|NCT03877120|Alcohol withdrawal syndrome|alcohol withdrawal syndrome
52028|NCT03877120|Benzodiacepines|benzodiacepines
52029|NCT03877107|lower urinary tract dysfunction|lower urinary tract dysfunction
52030|NCT03877107|urinary incontinence|urinary incontinence
52039|NCT03877094|Nurse care|nurse care
52040|NCT03877081|Acute kidney injury|acute kidney injury
52041|NCT03877081|Probiotics|probiotics
52043|NCT03877081|Shock|shock
52044|NCT03877068|Glycemic control|glycemic control
52045|NCT03877068|Bedside point-of-care capillary glucose monitoring|bedside point-of-care capillary glucose monitoring
52046|NCT03877068|POC|poc
52047|NCT03877068|Dexcom|dexcom
52048|NCT03877068|Continuous glucose monitoring|continuous glucose monitoring
52049|NCT03877068|Hyperglycemia|hyperglycemia
52050|NCT03877068|Inpatient|inpatient
52051|NCT03877055|Copanlisib|copanlisib
52052|NCT03877055|Ibrutinib|ibrutinib
52053|NCT03877055|18-450|18-450
52054|NCT03877042|Total Knee Arthroplasty|total knee arthroplasty
52055|NCT03877042|CR|cr
52056|NCT03877042|PS|ps
52057|NCT03877029|Mammography|mammography
52058|NCT03877029|Breast cancer screening|breast cancer screening
52059|NCT03877029|Health related quality of life|health related quality of life
52060|NCT03877029|Long-term effects of breast cancer treatment|long-term effects of breast cancer treatment
52061|NCT03877029|Screen-detected breast cancer|screen-detected breast cancer
52062|NCT03877029|Symptomatic breast cancer|symptomatic breast cancer
52063|NCT03877029|Tumor characteristics|tumor characteristics
52064|NCT03877029|Interval breast cancer|interval breast cancer
52065|NCT03877016|neuropathic pain|neuropathic pain
52066|NCT03877016|electrical nerve stimulation therapy|electrical nerve stimulation therapy
52067|NCT03877016|patient report outcomes|patient report outcomes
52068|NCT03877016|non-pharmalogical treatment|non-pharmalogical treatment
52069|NCT03877003|eggs,|eggs,
52070|NCT03877003|choline|choline
52071|NCT03877003|metabolic syndrome|metabolic syndrome
52072|NCT03877003|TMAO|tmao
52073|NCT03876990|multiplex PCR|multiplex pcr
52074|NCT03876990|blood culture|blood culture
52075|NCT03876990|rapid diagnosis|rapid diagnosis
52076|NCT03876951|breast cancer|breast cancer
52077|NCT03876951|neoadjuvant chemotherapy|neoadjuvant chemotherapy
52078|NCT03876951|vacuum-assisted biopsy|vacuum-assisted biopsy
52079|NCT03876951|pathological complete response|pathological complete response
52080|NCT03876925|RCC|rcc
52081|NCT03876912|Prostate Specific Membrane Antigen|prostate specific membrane antigen
52082|NCT03876912|GnRH antagonist|gnrh antagonist
52083|NCT03876912|Positron Emission Tomography|positron emission tomography
52084|NCT03876912|PSMA-PET/CT|psma-pet/ct
52085|NCT03876886|homologous recombination deficiency;adjuvant chemotherapy;anthracycline;taxanes;platinum|homologous recombination deficiency;adjuvant chemotherapy;anthracycline;taxanes;platinum
52086|NCT03876873|Face Mask|face mask
52087|NCT03876873|Obesity|obesity
52088|NCT03876873|Anesthetized Adult|anesthetized adult
52089|NCT03876873|Ventilation|ventilation
52090|NCT03876873|Head Rotation|head rotation
52091|NCT03876860|Vaginal dilator|vaginal dilator
52092|NCT03876860|Vaginal stenosis|vaginal stenosis
52093|NCT03876834|leukemia|leukemia
52094|NCT03876834|chemotherapy|chemotherapy
52095|NCT03876834|respiratory training|respiratory training
52096|NCT03876808|temperature|temperature
52097|NCT03876808|prewarming|prewarming
52098|NCT03876808|convective warming|convective warming
52099|NCT03876808|thermoregulation|thermoregulation
52100|NCT03876808|gastrointestinal surgery|gastrointestinal surgery
52101|NCT03876808|genitourinary surgery|genitourinary surgery
52102|NCT03876795|Bone Marrow Comcentrate|bone marrow comcentrate
52103|NCT03876795|intra-articular|intra-articular
52104|NCT03876795|intra-osseus|intra-osseus
52105|NCT03876782|cataract surgery|cataract surgery
52106|NCT03876782|Verion Image-Guided System|verion image-guided system
52107|NCT03876782|IOLMaster|iolmaster
52108|NCT03876782|IOL calculation|iol calculation
52109|NCT03876782|keratometry|keratometry
52110|NCT03876782|corneal power|corneal power
52111|NCT03876782|toric IOL|toric iol
52120|NCT03876730|Cerebral Palsy|cerebral palsy
52121|NCT03876730|Lower Extremity Orthosis|lower extremity orthosis
52122|NCT03876730|ICF Core Set|icf core set
52123|NCT03876678|Hyperbilirubinemia|hyperbilirubinemia
52124|NCT03876678|Jaundice|jaundice
52125|NCT03876678|Probiotics|probiotics
52126|NCT03876678|Intestinal microbial flora|intestinal microbial flora
52127|NCT03876665|Polycystic Ovary Syndrome|polycystic ovary syndrome
52129|NCT03876665|Service Women|service women
52130|NCT03876665|Active Duty|active duty
52131|NCT03876652|Syncope|syncope
52132|NCT03876652|Presyncope|presyncope
52133|NCT03876652|Time|time
52134|NCT03876652|Vasovagal|vasovagal
52135|NCT03876652|Unconsciousness|unconsciousness
52136|NCT03876639|Water-in-oil emulsion|water-in-oil emulsion
52137|NCT03876639|Confocal Raman spectroscopy|confocal raman spectroscopy
52138|NCT03876639|Skin parameters|skin parameters
52139|NCT03876639|Tape stripping|tape stripping
52140|NCT03876600|pacemaker|pacemaker
52141|NCT03876600|replace for elective wear|replace for elective wear
52142|NCT03876600|french context|french context
52143|NCT03876600|cost-utility analysis|cost-utility analysis
52144|NCT03876600|prospective|prospective
52145|NCT03876600|multicentric|multicentric
52146|NCT03876600|randomized study|randomized study
52147|NCT03876587|Metastatic Breast Cancer|metastatic breast cancer
52148|NCT03876587|Pyrotinib Maleate|pyrotinib maleate
52149|NCT03876587|HER2 Targeted Therapy|her2 targeted therapy
52150|NCT03876574|Hepatic artery infusion pump|hepatic artery infusion pump
52151|NCT03876574|Gemcitabine|gemcitabine
52152|NCT03876574|Floxuridine|floxuridine
52153|NCT03876548|keloid|keloid
52154|NCT03876522|Lafora Disease|lafora disease
52155|NCT03876522|EPM2A|epm2a
52156|NCT03876522|EPM2B|epm2b
52157|NCT03876522|Myoclonus epilepsy|myoclonus epilepsy
52158|NCT03876522|Myoclonic seizures|myoclonic seizures
52159|NCT03876522|Glycogen storage disease|glycogen storage disease
52160|NCT03876509|impedance cardiography|impedance cardiography
52161|NCT03876496|fall prevention|fall prevention
52162|NCT03876496|bed fall|bed fall
52163|NCT03876496|acute care|acute care
52164|NCT03876496|patient safety|patient safety
52165|NCT03876496|patient monitoring|patient monitoring
52166|NCT03876496|health technology assessment|health technology assessment
52167|NCT03876496|sensor devices and platforms|sensor devices and platforms
52168|NCT03876496|nursing|nursing
52169|NCT03876483|HIV|hiv
52170|NCT03876483|Adolescents|adolescents
52171|NCT03876483|ART|art
52172|NCT03876470|Hepatitis C|hepatitis c
52173|NCT03876470|Telehealth|telehealth
52174|NCT03876470|Injection Drug Use|injection drug use
52175|NCT03876457|Ischemic stroke|ischemic stroke
52176|NCT03876457|Large vessel occlusion|large vessel occlusion
52177|NCT03876457|Endovascular thrombectomy|endovascular thrombectomy
52178|NCT03876444|Hypsarrythmia|hypsarrythmia
52179|NCT03876444|Methylprednisolone|methylprednisolone
52180|NCT03876444|Prednisolone|prednisolone
52181|NCT03876431|Knee prosthesis|knee prosthesis
52182|NCT03876431|Physiotherapy|physiotherapy
52183|NCT03876431|Range of motion|range of motion
52184|NCT03876405|hand prosthesis|hand prosthesis
52185|NCT03876405|sensory feedback|sensory feedback
52186|NCT03876405|amputation|amputation
52187|NCT03876405|upper limb|upper limb
52188|NCT03876379|Depth of anesthesia|depth of anesthesia
52189|NCT03876379|brain fragility|brain fragility
52190|NCT03876379|electrographic suppression|electrographic suppression
52191|NCT03876379|postoperative cognitive dysfunction|postoperative cognitive dysfunction
52192|NCT03876366|cancer patients|cancer patients
52193|NCT03876366|male cancer patients|male cancer patients
52194|NCT03876366|Decision Aid (DA)|decision aid (da)
52195|NCT03876366|online Decision Aid tool|online decision aid tool
52196|NCT03876340|Burns|burns
52197|NCT03876340|Cost-effectiveness|cost-effectiveness
52198|NCT03876340|Clinical decision rule|clinical decision rule
52199|NCT03876340|Length of stay|length of stay
52200|NCT03876340|Cost of treatment|cost of treatment
52201|NCT03876301|Factor VIII|factor viii
52202|NCT03876301|Factor VIII Protein|factor viii protein
52203|NCT03876301|Recombinant|recombinant
52204|NCT03876236|Magnetic Resonance Imaging|magnetic resonance imaging
52205|NCT03876236|Diffusion Tensor Imaging|diffusion tensor imaging
52206|NCT03876236|Reproducibility of Results|reproducibility of results
52207|NCT03876236|Feasibility Study|feasibility study
52208|NCT03876236|Healthy Volunteers|healthy volunteers
52209|NCT03876223|Microvascular Coronary Dysfunction (MCD)|microvascular coronary dysfunction (mcd)
52210|NCT03876223|Coronary Vascular Dysfunction (CVD)|coronary vascular dysfunction (cvd)
52211|NCT03876223|Coronary angiography|coronary angiography
52212|NCT03876223|Magnetic resonance imaging (MRI)|magnetic resonance imaging (mri)
52213|NCT03876197|Xerostomia Due to Radiotherapy|xerostomia due to radiotherapy
52214|NCT03876184|tooth alignment|tooth alignment
52215|NCT03876184|coating loss|coating loss
52216|NCT03876184|color change|color change
52217|NCT03876184|patient perception|patient perception
52218|NCT03876184|aesthetic archwire|aesthetic archwire
52219|NCT03876132|regular consumption of alcohol|regular consumption of alcohol
52220|NCT03876132|young adults|young adults
52221|NCT03876132|Moderate or severe alcohol use disorders|moderate or severe alcohol use disorders
52222|NCT03876119|Mechanical Thrombectomy|mechanical thrombectomy
52223|NCT03876119|Recanalization|recanalization
52224|NCT03876119|Reperfusion|reperfusion
52225|NCT03876054|spinal cord stimulation|spinal cord stimulation
52227|NCT03876041|SIRS|sirs
52228|NCT03876041|MiRNA-155|mirna-155
52229|NCT03876041|Treg|treg
52230|NCT03876028|Lymphoma|lymphoma
52231|NCT03876028|Diffuse Large B-cell lymphoma|diffuse large b-cell lymphoma
52232|NCT03876028|DLBCL|dlbcl
52233|NCT03876028|r/r Diffuse Large B-cell Lymphoma|r/r diffuse large b-cell lymphoma
52234|NCT03876028|relapsed/refractory DLBCL|relapsed/refractory dlbcl
52235|NCT03876028|CTL019|ctl019
52236|NCT03876028|Tisagenlecleucel|tisagenlecleucel
52237|NCT03876028|Ibrutinib|ibrutinib
52238|NCT03876002|HV|hv
52239|NCT03876002|ALS|als
52240|NCT03875989|Prolapse|prolapse
52241|NCT03875989|Vaginal native tissues repair|vaginal native tissues repair
52242|NCT03875989|Pelvic organ|pelvic organ
52243|NCT03875976|fast track care|fast track care
52244|NCT03875976|total hip arthroplasty|total hip arthroplasty
52245|NCT03875963|Infection|infection
52246|NCT03875963|Antibiotic bone cement|antibiotic bone cement
52247|NCT03875963|Tibia nonunion|tibia nonunion
52248|NCT03875950|Adolescents|adolescents
52249|NCT03875950|Young women|young women
52250|NCT03875950|HIV care and treatment|hiv care and treatment
52251|NCT03875950|Clinical training|clinical training
52252|NCT03875950|Africa|africa
52253|NCT03875950|Kenya|kenya
52254|NCT03875937|tranexamic acid|tranexamic acid
52255|NCT03875937|pharmacokinetic|pharmacokinetic
52256|NCT03875937|intramuscular|intramuscular
52257|NCT03875911|Trabeculectomy|trabeculectomy
52258|NCT03875911|Mitomycin-C|mitomycin-c
52259|NCT03875911|Glaucoma|glaucoma
52260|NCT03875885|Head and Neck Cancer Caregivers|head and neck cancer caregivers
52261|NCT03875872|propofol, inhalation anaesthetics, postoperative outcomes, regression control|propofol, inhalation anaesthetics, postoperative outcomes, regression control
52262|NCT03875846|Intraoperative Decision Making|intraoperative decision making
52263|NCT03875846|Revascularization|revascularization
52264|NCT03875846|Physiologic Monitoring Feedback|physiologic monitoring feedback
52265|NCT03875820|KRAS|kras
52266|NCT03875820|RAS mutant|ras mutant
52267|NCT03875807|ACL|acl
52268|NCT03875807|ACL reconstruction|acl reconstruction
52269|NCT03875807|Knee Flexion Angle|knee flexion angle
52270|NCT03875807|Bone Patellar Tendon Bone|bone patellar tendon bone
52271|NCT03875794|Lactation; Insufficient, Partial|lactation; insufficient, partial
52272|NCT03875794|Lactating Female|lactating female
52273|NCT03875781|Rectal cancer|rectal cancer
52274|NCT03875781|FOLFIRINOX,|folfirinox,
52275|NCT03875781|chemotherapy|chemotherapy
52276|NCT03875781|radiochemotherapy|radiochemotherapy
52277|NCT03875781|surgery|surgery
52278|NCT03875768|Digital Health|digital health
52279|NCT03875768|Dash Diet|dash diet
52280|NCT03875755|Diabetes|diabetes
52281|NCT03875755|Pregnancy|pregnancy
52282|NCT03875755|MYO-INOSITOL|myo-inositol
52283|NCT03875755|Oral supplementation|oral supplementation
52284|NCT03875742|simulation|simulation
52285|NCT03875742|interfascial blocks|interfascial blocks
52286|NCT03875742|TAP block|tap block
52287|NCT03875742|needles|needles
52288|NCT03875729|T1D, type 1 diabetes, recent-onset T1D|t1d, type 1 diabetes, recent-onset t1d
52289|NCT03875703|Biological Collection|biological collection
52290|NCT03875703|Vaccination|vaccination
52291|NCT03875703|Active Immune Response|active immune response
52292|NCT03875664|liposomal bupivacaine|liposomal bupivacaine
52293|NCT03875664|posterior repair|posterior repair
52294|NCT03875651|Drug-Eluting Stents|drug-eluting stents
52295|NCT03875625|MRI|mri
52296|NCT03875625|Dietitian Lifestyle intervention|dietitian lifestyle intervention
52297|NCT03875625|Bariatric surgery|bariatric surgery
52298|NCT03875625|Brown adipose tissue|brown adipose tissue
52299|NCT03875625|White adipose tissue|white adipose tissue
52300|NCT03875625|no alcoholic fatty liver disease|no alcoholic fatty liver disease
52301|NCT03875625|diabetes mellitus type 2|diabetes mellitus type 2
52302|NCT03875625|Pancreatic fat|pancreatic fat
52303|NCT03875612|Inferior Mesenteric Artery|inferior mesenteric artery
52304|NCT03875612|Computerized Tomography|computerized tomography
52305|NCT03875599|self-efficacy|self-efficacy
52306|NCT03875599|instrument validity|instrument validity
52307|NCT03875599|PRAISE|praise
52308|NCT03875586|Reasons for consultation|reasons for consultation
52309|NCT03875586|Family Medicine|family medicine
52310|NCT03875573|Breast Cancer|breast cancer
52311|NCT03875534|Achondroplasia|achondroplasia
52312|NCT03875534|Dwarfism|dwarfism
52313|NCT03875521|Work Schedule Tolerance|work schedule tolerance
52314|NCT03875521|Observational Study|observational study
52315|NCT03875521|Intensive Care Units/manpower|intensive care units/manpower
52316|NCT03875521|Job Satisfaction|job satisfaction
52317|NCT03875508|Psoriasis|psoriasis
52318|NCT03875508|Risankizumab|risankizumab
52319|NCT03875508|Plaque Psoriasis|plaque psoriasis
52320|NCT03875495|Temferon|temferon
52321|NCT03875495|Gene Therapy|gene therapy
52322|NCT03875495|Immunotherapy|immunotherapy
52323|NCT03875495|Hematological malignancy|hematological malignancy
52332|NCT03875456|Plagiocephaly|plagiocephaly
52333|NCT03875456|Nonsynostotic|nonsynostotic
52334|NCT03875456|Skull/pathology|skull/pathology
52335|NCT03875443|implant positioning|implant positioning
52336|NCT03875443|reduction|reduction
52337|NCT03875443|intraoperative fluoroscopy|intraoperative fluoroscopy
52338|NCT03875443|reduction algorithm|reduction algorithm
52340|NCT03875417|HCC in elderly|hcc in elderly
52341|NCT03875417|recurrent HCC|recurrent hcc
52342|NCT03875417|Liver resection|liver resection
52343|NCT03875417|Quality of Life|quality of life
52344|NCT03875417|intervention radiology|intervention radiology
52345|NCT03875417|RF|rf
52346|NCT03875417|TACE|tace
52347|NCT03875404|Deep Brain Stimulation|deep brain stimulation
52348|NCT03875378|Bone mineral density|bone mineral density
52349|NCT03875378|Estrogen|estrogen
52350|NCT03875365|POPE|pope
52351|NCT03875352|central venous catheter|central venous catheter
52352|NCT03875352|reddening|reddening
52353|NCT03875352|dressing|dressing
52354|NCT03875352|hydrophilic methacrylate gel|hydrophilic methacrylate gel
52355|NCT03875352|chlorhexidine gluconate|chlorhexidine gluconate
52356|NCT03875339|Infant Hearing Screening|infant hearing screening
52357|NCT03875339|Patient Navigator|patient navigator
52358|NCT03875326|Dementia|dementia
52359|NCT03875326|Memory|memory
52360|NCT03875326|Cognitive Rehabilitation|cognitive rehabilitation
52361|NCT03875326|PET scan|pet scan
52362|NCT03875326|fMRI|fmri
52363|NCT03875326|Brain Stimulation|brain stimulation
52364|NCT03875313|Tumor Metabolism|tumor metabolism
52365|NCT03875313|Glutaminase Inhibitor|glutaminase inhibitor
52366|NCT03875313|CB-839|cb-839
52367|NCT03875313|telaglenastat|telaglenastat
52368|NCT03875313|talazoparib|talazoparib
52369|NCT03875313|PARP Inhibitor|parp inhibitor
52370|NCT03875313|DNA Damage|dna damage
52371|NCT03875313|DNA Repair|dna repair
52372|NCT03875313|Homologous recombination deficiency|homologous recombination deficiency
52373|NCT03875313|HRD|hrd
52374|NCT03875313|BRCA 1|brca 1
52375|NCT03875313|BRCA 2|brca 2
52376|NCT03875235|First-Line Advanced Biliary Tract Cancers (BTC)|first-line advanced biliary tract cancers (btc)
52377|NCT03875235|Durvalumab|durvalumab
52378|NCT03875235|Gemcitabine/Cisplatin|gemcitabine/cisplatin
52379|NCT03875235|Placebo|placebo
52380|NCT03875196|Stress urinary incontinence|stress urinary incontinence
52381|NCT03875196|quality of life|quality of life
52382|NCT03875196|sexual function|sexual function
52383|NCT03875183|Heart failure|heart failure
52384|NCT03875170|Proprioceptive Neuromuscular Facilitation|proprioceptive neuromuscular facilitation
52385|NCT03875170|Range of motion|range of motion
52386|NCT03875170|Stretching|stretching
52387|NCT03875170|Muscle strength|muscle strength
52388|NCT03875170|Randomized clinical trial|randomized clinical trial
52389|NCT03875144|Peritoneal mesothelioma|peritoneal mesothelioma
52390|NCT03875144|PIPAC|pipac
52391|NCT03875144|Surgical oncology|surgical oncology
52392|NCT03875144|Peritoneal Carcinomatosis|peritoneal carcinomatosis
52393|NCT03875118|Oral cancer|oral cancer
52394|NCT03875118|Trismus|trismus
52395|NCT03875118|Mouth-opening training|mouth-opening training
52396|NCT03875118|Jaw exercise|jaw exercise
52397|NCT03875105|exercise capacity|exercise capacity
52398|NCT03875105|activities of daily living|activities of daily living
52399|NCT03875092|Programmed Cell Death-1 (PD1, PD-1)|programmed cell death-1 (pd1, pd-1)
52400|NCT03875092|Programmed Death-Ligand 1 (PDL1, PD-L1)|programmed death-ligand 1 (pdl1, pd-l1)
52401|NCT03875066|Rehabilitation|rehabilitation
52402|NCT03875066|Neurological condition|neurological condition
52403|NCT03875066|Walking ability|walking ability
52404|NCT03875066|Feedback|feedback
52405|NCT03875066|External information|external information
52406|NCT03875040|kinesiophobia|kinesiophobia
52407|NCT03875040|osteoarthritis|osteoarthritis
52408|NCT03875040|fear of movement|fear of movement
52409|NCT03875040|tampa|tampa
52410|NCT03875040|physical inactivity|physical inactivity
52411|NCT03875027|proximal femur|proximal femur
52412|NCT03875027|functional outcome|functional outcome
52413|NCT03875027|fracture|fracture
52414|NCT03875027|failed hip surgery|failed hip surgery
52415|NCT03875014|dual mobility cup|dual mobility cup
52416|NCT03875014|total hip repcament|total hip repcament
52417|NCT03875014|bipolar hemiarthroplasty|bipolar hemiarthroplasty
52418|NCT03875014|dislocation|dislocation
52419|NCT03874962|Oral care intervention|oral care intervention
52420|NCT03874962|Nursing home residents|nursing home residents
52421|NCT03874936|postoperative pain|postoperative pain
52422|NCT03874936|dexamethasone|dexamethasone
52423|NCT03874936|pain management|pain management
52424|NCT03874923|fluid expansion|fluid expansion
52425|NCT03874923|oxygen delivery|oxygen delivery
52821|NCT03872453|photophobia|photophobia
52426|NCT03874923|tissue perfusion|tissue perfusion
52427|NCT03874923|cardiac output|cardiac output
52428|NCT03874897|Advanced solid tumor|advanced solid tumor
52429|NCT03874897|claudin18.2|claudin18.2
52430|NCT03874897|CAR-T cell therapy|car-t cell therapy
52431|NCT03874871|gastric cancer|gastric cancer
52432|NCT03874871|function preserving gastrectomy|function preserving gastrectomy
52433|NCT03874858|CML|cml
52434|NCT03874858|CML-CP|cml-cp
52435|NCT03874858|TFR|tfr
52436|NCT03874858|nilotinib|nilotinib
52437|NCT03874858|AMN107|amn107
52438|NCT03874858|Tasigna|tasigna
52439|NCT03874858|DMR|dmr
52440|NCT03874858|sustained deep molecular response|sustained deep molecular response
52441|NCT03874858|full treatment-free remission|full treatment-free remission
52442|NCT03874858|TKI|tki
52443|NCT03874858|qPCR|qpcr
52444|NCT03874858|adult|adult
52445|NCT03874845|Mindfulness-Based Cognitive Therapy|mindfulness-based cognitive therapy
52446|NCT03874845|Muscle Relaxation|muscle relaxation
52447|NCT03874845|fMRI|fmri
52448|NCT03874845|Group Psychotherapy|group psychotherapy
52449|NCT03874832|dihydroergotamine|dihydroergotamine
52450|NCT03874832|dihydroergotamine mesylate|dihydroergotamine mesylate
52451|NCT03874832|migraine|migraine
52452|NCT03874793|Mindfulness-Based Cognitive Therapy|mindfulness-based cognitive therapy
52453|NCT03874793|Muscle Relaxation|muscle relaxation
52454|NCT03874793|fMRI|fmri
52455|NCT03874793|Group Psychotherapy|group psychotherapy
52456|NCT03874767|patient mobility|patient mobility
52457|NCT03874767|ambulation|ambulation
52458|NCT03874754|Multiple chronic conditions|multiple chronic conditions
52459|NCT03874741|Head and Neck Cancer|head and neck cancer
52460|NCT03874741|Epidermal growth factor receptor|epidermal growth factor receptor
52461|NCT03874741|SCT200|sct200
52462|NCT03874728|Falls|falls
52463|NCT03874728|Gait|gait
52464|NCT03874728|Stability|stability
52465|NCT03874728|Muscle activity|muscle activity
52466|NCT03874728|Footwear|footwear
52467|NCT03874728|Minimal shoes|minimal shoes
52468|NCT03874728|Smart shoe insoles|smart shoe insoles
52469|NCT03874702|stroke|stroke
52470|NCT03874702|artificial intelligence|artificial intelligence
52471|NCT03874702|ischemic stroke|ischemic stroke
52472|NCT03874689|Neurocysticercosis|neurocysticercosis
52473|NCT03874663|HIV|hiv
52474|NCT03874663|HIV self-testing|hiv self-testing
52475|NCT03874663|young people|young people
52476|NCT03874663|Nigeria|nigeria
52477|NCT03874650|acquired brain injury|acquired brain injury
52478|NCT03874650|traumatic brain injury|traumatic brain injury
52479|NCT03874650|depression|depression
52480|NCT03874650|rehabilitation|rehabilitation
52481|NCT03874650|executive function|executive function
52482|NCT03874637|Overactive Bladder|overactive bladder
52483|NCT03874637|Women|women
52484|NCT03874637|Neuromodulation|neuromodulation
52485|NCT03874637|Bioelectronic Medicine|bioelectronic medicine
52486|NCT03874637|Non-significant Risk|non-significant risk
52487|NCT03874598|Sleep Initiation and Maintenance Disorders|sleep initiation and maintenance disorders
52488|NCT03874598|Acupuncture, Ear|acupuncture, ear
52489|NCT03874598|Cytokines|cytokines
52490|NCT03874598|Breast Neoplasm|breast neoplasm
52491|NCT03874572|Xerostomia Due to Radiotherapy|xerostomia due to radiotherapy
52492|NCT03874559|neoadjuvant chemoradiation therapy|neoadjuvant chemoradiation therapy
52493|NCT03874559|Low anterior resection|low anterior resection
52494|NCT03874559|abdominoperineal resection|abdominoperineal resection
52495|NCT03874559|exosomes|exosomes
52496|NCT03874559|biomarkers|biomarkers
52497|NCT03874559|external beam radiation|external beam radiation
52498|NCT03874546|Severe and moderate traumatic brain injury|severe and moderate traumatic brain injury
52499|NCT03874546|Prognosis|prognosis
52500|NCT03874546|IMPACT score|impact score
52501|NCT03874533|Cochlear Implantation|cochlear implantation
52502|NCT03874533|telemonitoring|telemonitoring
52503|NCT03874533|training workshop|training workshop
52504|NCT03874520|Telemedicine|telemedicine
52505|NCT03874520|Triage|triage
52506|NCT03874520|Call Centers|call centers
52507|NCT03874520|Respiratory Tract Diseases|respiratory tract diseases
52508|NCT03874520|Pediatrics|pediatrics
52509|NCT03874507|virtual reality|virtual reality
52510|NCT03874507|augmented reality|augmented reality
52511|NCT03874507|physical therapy|physical therapy
52512|NCT03874507|deconditioning|deconditioning
52513|NCT03874494|Schizophrenia|schizophrenia
52514|NCT03874494|Brexpiprazole|brexpiprazole
52515|NCT03874494|Non-inferiority|non-inferiority
52516|NCT03874481|sleep duration|sleep duration
52517|NCT03874481|sleep quality|sleep quality
52518|NCT03874481|coronary artery disease|coronary artery disease
52519|NCT03874481|in stent restenosis|in stent restenosis
52520|NCT03874442|postoperative pain in children|postoperative pain in children
52521|NCT03874442|preoperative anxiety in children|preoperative anxiety in children
52522|NCT03874416|moderate to severe traumatic brain injury|moderate to severe traumatic brain injury
52523|NCT03874416|cognitive rehabilitation|cognitive rehabilitation
52524|NCT03874416|working memory|working memory
52525|NCT03874416|daily life function|daily life function
52526|NCT03874416|Working Memory Questionnaire, WMQ|working memory questionnaire, wmq
52527|NCT03874416|Brown-Peterson test|brown-peterson test
52528|NCT03874351|Migraine;|migraine;
52529|NCT03874351|transcranial direct current stimulation (tDCS)|transcranial direct current stimulation (tdcs)
52530|NCT03874351|tDCS-Telehealth intervention|tdcs-telehealth intervention
52531|NCT03874325|HR+|hr+
52532|NCT03874312|right heart catheterization|right heart catheterization
52533|NCT03874312|Peripheral congestion|peripheral congestion
52534|NCT03874312|Right atrial pressure|right atrial pressure
52535|NCT03874312|Internal jugular vein distention ratio|internal jugular vein distention ratio
52536|NCT03874312|ultrasound of jugular vein|ultrasound of jugular vein
52537|NCT03874312|chronic heart failure|chronic heart failure
52538|NCT03874286|Liver Transplant|liver transplant
52539|NCT03874273|inflammatory myofibroblastic tumor|inflammatory myofibroblastic tumor
52540|NCT03874273|crizotinib|crizotinib
52541|NCT03874273|Paediatric oncology|paediatric oncology
52542|NCT03874234|Dose escalation phase|dose escalation phase
52543|NCT03874234|First time in human|first time in human
52544|NCT03874234|Single ascending dose|single ascending dose
52545|NCT03874234|Multiple ascending dose|multiple ascending dose
52546|NCT03874234|GSK3186899|gsk3186899
52547|NCT03874208|Outcome prediction|outcome prediction
52548|NCT03874208|Disorders of Consciousness|disorders of consciousness
52549|NCT03874208|Coma,|coma,
52550|NCT03874208|MRI|mri
52551|NCT03874208|Brain injury|brain injury
52552|NCT03874182|Prevalence|prevalence
52553|NCT03874182|Dental trauma|dental trauma
52554|NCT03874182|Special health care needs children|special health care needs children
52555|NCT03874169|Biosensor watch|biosensor watch
52556|NCT03874169|E4 Wristband|e4 wristband
52557|NCT03874169|Intensive Care Unit|intensive care unit
52558|NCT03874169|GI bleeding|gi bleeding
52559|NCT03874091|Erector Spinae Plane block|erector spinae plane block
52560|NCT03874091|ESP block|esp block
52561|NCT03874091|Laparoscopic Nephrectomy|laparoscopic nephrectomy
52562|NCT03874078|school children|school children
52563|NCT03874078|balance|balance
52564|NCT03874000|Sintilimab|sintilimab
52565|NCT03874000|Metformin Hydrochloride|metformin hydrochloride
52566|NCT03874000|second line|second line
52567|NCT03874000|cancer|cancer
52568|NCT03874000|NSCLC|nsclc
52569|NCT03873974|Lyme Borreliosis|lyme borreliosis
52570|NCT03873974|Lyme disease|lyme disease
52571|NCT03873974|In Vitro Diagnostics System|in vitro diagnostics system
52572|NCT03873974|Dark Field Microscopy|dark field microscopy
52573|NCT03873961|High-Intensity Laser Therapy|high-intensity laser therapy
52574|NCT03873961|Low-level Laser Therapy|low-level laser therapy
52575|NCT03873922|Ketogenic diet|ketogenic diet
52576|NCT03873922|Intervention|intervention
52577|NCT03873922|Ketosis|ketosis
52578|NCT03873922|Feasibility|feasibility
52579|NCT03873922|Psychosis|psychosis
52580|NCT03873922|Psychotic symptoms|psychotic symptoms
52581|NCT03873922|Schizophrenia|schizophrenia
52582|NCT03873922|Dietary intervention|dietary intervention
52583|NCT03873909|Ketocarotenoids|ketocarotenoids
52584|NCT03873909|Mamey sapote|mamey sapote
52585|NCT03873909|Sapotexanthin|sapotexanthin
52586|NCT03873909|Cryptocapsin|cryptocapsin
52587|NCT03873909|Vitamin A|vitamin a
52588|NCT03873870|PET scans|pet scans
52589|NCT03873857|Chronic Lymphocytic Leukemia (CLL)|chronic lymphocytic leukemia (cll)
52590|NCT03873857|Cancer|cancer
52591|NCT03873857|Observational Study|observational study
52592|NCT03873857|Venetoclax|venetoclax
52593|NCT03873857|Relapsed Chronic Lymphocytic Leukemia|relapsed chronic lymphocytic leukemia
52594|NCT03873857|Refractory Chronic Lymphocytic Leukemia|refractory chronic lymphocytic leukemia
52595|NCT03873844|cognitive processing, transfer package|cognitive processing, transfer package
52596|NCT03873831|Therapy dog|therapy dog
52597|NCT03873831|Autism Spectrum Disorder|autism spectrum disorder
52598|NCT03873831|Social skills|social skills
52599|NCT03873831|Group therapy|group therapy
52600|NCT03873792|Allergic diseases|allergic diseases
52601|NCT03873792|Probiotics|probiotics
52602|NCT03873792|Immunoglobulin E|immunoglobulin e
52603|NCT03873792|Intestinal microbiota|intestinal microbiota
52604|NCT03873753|Pediatric dentistry|pediatric dentistry
52605|NCT03873753|Mouth, Edentulous|mouth, edentulous
52606|NCT03873740|Inactivated Enterovirus Type 71 (EV71) Vaccine|inactivated enterovirus type 71 (ev71) vaccine
52607|NCT03873740|Sequential vaccination|sequential vaccination
52608|NCT03873740|Immunity|immunity
52609|NCT03873740|Safety|safety
52610|NCT03873727|Vaccination / Re-vaccination|vaccination / re-vaccination
52611|NCT03873727|Asplenic patient|asplenic patient
52612|NCT03873727|Splenectomy|splenectomy
52613|NCT03873727|Pneumococcal infections|pneumococcal infections
52614|NCT03873727|immunological response|immunological response
52615|NCT03873727|Pneumovax|pneumovax
52616|NCT03873727|Prevenar13|prevenar13
52617|NCT03873701|bedside ultrasonography|bedside ultrasonography
52618|NCT03873701|emergency department|emergency department
52619|NCT03873688|expiratory muscle training|expiratory muscle training
52620|NCT03873688|cough|cough
52621|NCT03873688|respiratory muscle strength|respiratory muscle strength
52622|NCT03873688|exercise capacity|exercise capacity
52623|NCT03873675|acute kidney injury|acute kidney injury
52624|NCT03873675|parathyroid hormone|parathyroid hormone
52625|NCT03873675|continuous renal replacement therapy|continuous renal replacement therapy
52626|NCT03873675|citrate anticoagulation|citrate anticoagulation
52627|NCT03873675|intensive care|intensive care
52628|NCT03873662|Out-Of-Hospital Cardiac Arrest|out-of-hospital cardiac arrest
52629|NCT03873662|Pediatric patient|pediatric patient
52630|NCT03873662|Outcome|outcome
52631|NCT03873662|Prognostication|prognostication
52632|NCT03873662|Neurologic outcome|neurologic outcome
52633|NCT03873623|Kidney transplant|kidney transplant
52634|NCT03873597|tele-coaching|tele-coaching
52635|NCT03873597|physical activity|physical activity
52636|NCT03873597|lung transplant|lung transplant
52637|NCT03873545|Cartilage|cartilage
52638|NCT03873545|Cartilage Injury|cartilage injury
52639|NCT03873545|Cartilage Repair|cartilage repair
52640|NCT03873545|Cartilage Damage|cartilage damage
52641|NCT03873545|Cartilage Lesion|cartilage lesion
52642|NCT03873545|Cartilage Defect|cartilage defect
52643|NCT03873519|chemotherapy|chemotherapy
52644|NCT03873519|vital signs|vital signs
52645|NCT03873519|stress|stress
52646|NCT03873519|health status|health status
52647|NCT03873519|healing environment|healing environment
52648|NCT03873506|Bronchopulmonary Dysplasia|bronchopulmonary dysplasia
52649|NCT03873506|human umbilical cord -derived mesenchymal stem cells|human umbilical cord -derived mesenchymal stem cells
52650|NCT03873493|T-cell Prolymphocytic Leukemia (T-PLL)|t-cell prolymphocytic leukemia (t-pll)
52651|NCT03873493|Cancer|cancer
52652|NCT03873493|venetoclax|venetoclax
52653|NCT03873493|ibrutinib|ibrutinib
52654|NCT03873493|Relapsed or Refractory T-lymphoid malignancy|relapsed or refractory t-lymphoid malignancy
52655|NCT03873467|Group Lifestyle Balance|group lifestyle balance
52656|NCT03873467|Physical Activity|physical activity
52657|NCT03873467|Stroke|stroke
52658|NCT03873467|Weight-loss|weight-loss
52659|NCT03873467|Dietary Behaviors|dietary behaviors
52660|NCT03873454|cataract surgery|cataract surgery
52661|NCT03873454|music|music
52662|NCT03873454|salivary cortisol|salivary cortisol
52663|NCT03873441|Cerebral Palsy|cerebral palsy
52664|NCT03873441|Balance|balance
52665|NCT03873441|Rehabilitation|rehabilitation
52666|NCT03873428|breast cancer|breast cancer
52667|NCT03873428|first metastatic relapse|first metastatic relapse
52668|NCT03873428|PET|pet
52669|NCT03873376|mass screening|mass screening
52670|NCT03873376|non-attendance|non-attendance
52671|NCT03873376|self-sampling|self-sampling
52672|NCT03873376|HPV|hpv
52673|NCT03873363|Total Knee Arthroplasty|total knee arthroplasty
52674|NCT03873363|Total Knee Replacement|total knee replacement
52675|NCT03873363|Outcome|outcome
52676|NCT03873363|Implant Design|implant design
52677|NCT03873350|Microbiota colonization kombucha bacteria yeast|microbiota colonization kombucha bacteria yeast
52678|NCT03873337|tobacco|tobacco
52679|NCT03873337|cigarette|cigarette
52680|NCT03873337|schizophrenia|schizophrenia
52681|NCT03873337|schizoaffective disorders|schizoaffective disorders
52682|NCT03873337|smoking cessation|smoking cessation
52683|NCT03873311|Azacytidine; HAG regimen|azacytidine; hag regimen
52684|NCT03873285|Genodermatosis|genodermatosis
52685|NCT03873285|genetic|genetic
52686|NCT03873285|children|children
52687|NCT03873272|Neuropathy|neuropathy
52688|NCT03873272|CIPN|cipn
52689|NCT03873272|Cryotherapy|cryotherapy
52690|NCT03873272|Compression therapy|compression therapy
52691|NCT03873220|Wearable devices|wearable devices
52692|NCT03873220|Scratch|scratch
52693|NCT03873220|Sleep|sleep
52694|NCT03873194|systemic arterial hypertension|systemic arterial hypertension
52695|NCT03873194|hypertension|hypertension
52696|NCT03873194|hypertension, pregnancy-induced|hypertension, pregnancy-induced
52697|NCT03873194|pre-eclampsia|pre-eclampsia
52698|NCT03873194|meditation|meditation
52699|NCT03873194|randomized clinical Trial|randomized clinical trial
52700|NCT03873129|antiretroviral therapy|antiretroviral therapy
52701|NCT03873129|HIV transmission|hiv transmission
52702|NCT03873116|BCX7353|bcx7353
52703|NCT03873077|local infiltration analgesia|local infiltration analgesia
52704|NCT03873077|postoperative analgesia|postoperative analgesia
52705|NCT03873064|BMI|bmi
52706|NCT03873064|EORTC QLQ-C30|eortc qlq-c30
52707|NCT03873064|metastatic cancer|metastatic cancer
52708|NCT03873064|localized cancer|localized cancer
52709|NCT03873051|Community-based intervention|community-based intervention
52710|NCT03873051|Motivation|motivation
52711|NCT03873025|Relapsed|relapsed
52712|NCT03873025|Refractory|refractory
52713|NCT03873012|Dual antiplatelet therapy duration|dual antiplatelet therapy duration
52714|NCT03873012|Optical coherence tomography|optical coherence tomography
52715|NCT03872999|Attention|attention
52716|NCT03872999|Control|control
52717|NCT03872999|Functional Magnetic Resonance Imaging (fMRI)|functional magnetic resonance imaging (fmri)
52718|NCT03872999|Parietal|parietal
52719|NCT03872999|Space|space
52720|NCT03872986|primary teeth|primary teeth
52822|NCT03872453|nausea|nausea
52721|NCT03872986|silver diamine fluoride|silver diamine fluoride
52722|NCT03872986|caries sealing|caries sealing
52723|NCT03872973|balance|balance
52724|NCT03872973|chronic ankle instability|chronic ankle instability
52725|NCT03872973|function|function
52726|NCT03872973|running|running
52727|NCT03872960|cardiac arrest|cardiac arrest
52728|NCT03872960|pre-hospital care|pre-hospital care
52729|NCT03872960|strategy trial|strategy trial
52730|NCT03872908|Breast cancer|breast cancer
52731|NCT03872908|Colorectal cancer|colorectal cancer
816098|NCT00177242|pancreas|pancreas
52732|NCT03872882|Newborn hearing screening|newborn hearing screening
52733|NCT03872882|Hearing loss|hearing loss
52734|NCT03872882|Hearing screening equipment|hearing screening equipment
52735|NCT03872869|osteoarthritis|osteoarthritis
52736|NCT03872869|patient education|patient education
52737|NCT03872869|Tai Chi|tai chi
52738|NCT03872869|physical function|physical function
52739|NCT03872856|High Blood Pressure|high blood pressure
52740|NCT03872856|Alaska Native and American Indian|alaska native and american indian
52741|NCT03872856|Home Blood Pressure Monitoring|home blood pressure monitoring
52742|NCT03872856|Self-efficacy|self-efficacy
52743|NCT03872856|Primary Care|primary care
52744|NCT03872843|Ureteroscopy|ureteroscopy
52745|NCT03872843|Opioid|opioid
52746|NCT03872843|Non-Opioid|non-opioid
52747|NCT03872843|Stent Placement|stent placement
52748|NCT03872843|Nephrolithiasis|nephrolithiasis
52749|NCT03872817|Mental Health|mental health
52750|NCT03872817|Health Literacy|health literacy
52751|NCT03872817|Adolescent|adolescent
52752|NCT03872817|Schools|schools
52753|NCT03872804|Vitiligo|vitiligo
52754|NCT03872804|Punch graft|punch graft
52755|NCT03872804|Oral pulse steroid|oral pulse steroid
52756|NCT03872804|Transverse needling|transverse needling
52757|NCT03872739|CIN|cin
52758|NCT03872739|Hydration|hydration
52759|NCT03872739|enhanced computed tomography|enhanced computed tomography
52760|NCT03872726|disability|disability
52761|NCT03872726|Inflammatory Bowel Diseases|inflammatory bowel diseases
52762|NCT03872726|Ulcerative Colitis|ulcerative colitis
52763|NCT03872726|Crohn Disease|crohn disease
52764|NCT03872687|dental implants, tufted brush, IDB, mucositis, gingivitis|dental implants, tufted brush, idb, mucositis, gingivitis
52765|NCT03872596|Seroquel|seroquel
52766|NCT03872596|Digital Medicine Quetiapine|digital medicine quetiapine
52767|NCT03872596|Pharmacokinetics|pharmacokinetics
52768|NCT03872596|Bioavailability|bioavailability
52769|NCT03872583|Patient education|patient education
52770|NCT03872583|Disease-specific knowledge|disease-specific knowledge
52771|NCT03872583|Shared decision making|shared decision making
52772|NCT03872570|cardiac output|cardiac output
52773|NCT03872570|pulse pressure variation|pulse pressure variation
52774|NCT03872570|fluid responsiveness|fluid responsiveness
52775|NCT03872570|hemodynamic monitoring|hemodynamic monitoring
52776|NCT03872557|Glucose tolerance|glucose tolerance
52777|NCT03872557|Tyrosine|tyrosine
52778|NCT03872544|Autologous Transplantation|autologous transplantation
52779|NCT03872544|Free Tissue Flaps|free tissue flaps
52780|NCT03872544|Graft Survival|graft survival
52781|NCT03872544|Reconstructive Surgical Procedures|reconstructive surgical procedures
52782|NCT03872544|Patient Selection|patient selection
52783|NCT03872544|Debridement|debridement
52784|NCT03872544|Subcutaneous Fat|subcutaneous fat
52785|NCT03872544|Surgical Flaps|surgical flaps
52786|NCT03872544|Treatment Outcome|treatment outcome
52787|NCT03872505|breast cancer|breast cancer
52788|NCT03872505|durvalumab|durvalumab
52789|NCT03872505|immunotherapy|immunotherapy
52790|NCT03872505|triple negative|triple negative
52791|NCT03872505|HER2 negative|her2 negative
52792|NCT03872505|ER/PR negative|er/pr negative
52793|NCT03872505|carboplatin|carboplatin
52794|NCT03872505|radiation therapy|radiation therapy
52795|NCT03872505|paclitaxel|paclitaxel
52796|NCT03872505|neoadjuvant|neoadjuvant
52797|NCT03872505|stage II breast cancer|stage ii breast cancer
52798|NCT03872505|stage III breast cancer|stage iii breast cancer
52799|NCT03872492|REDRESS|redress
52800|NCT03872492|Depression|depression
52801|NCT03872492|Application|application
52802|NCT03872492|Mobile|mobile
52803|NCT03872479|CEP290|cep290
52804|NCT03872479|LCA10|lca10
52805|NCT03872479|Retinal degenerative diseases (RDD)|retinal degenerative diseases (rdd)
52806|NCT03872479|Leber congenital amaurosis (LCA)|leber congenital amaurosis (lca)
52807|NCT03872479|Congenital Retinal Blindness|congenital retinal blindness
52808|NCT03872479|p.Cys998X|p.cys998x
52809|NCT03872479|c.2991+1655A>G|c.2991+1655a>g
52810|NCT03872479|CRISPR Treatment|crispr treatment
52811|NCT03872479|Cas9 Protein|cas9 protein
52812|NCT03872479|Eye Diseases Signs and Symptoms|eye diseases signs and symptoms
52813|NCT03872479|Genetic Diseases, Inborn|genetic diseases, inborn
52814|NCT03872479|Congenital Abnormalities|congenital abnormalities
52815|NCT03872479|Eye Abnormalities|eye abnormalities
52816|NCT03872479|CRISPR-Cas9|crispr-cas9
52817|NCT03872479|CRISPR Associated Protein 9|crispr associated protein 9
52818|NCT03872479|Cas9 Enzyme|cas9 enzyme
52819|NCT03872453|Acute Migraine|acute migraine
52820|NCT03872453|phonophobia|phonophobia
52823|NCT03872440|EGFR mutant cancer|egfr mutant cancer
52824|NCT03872414|Emotional Aging|emotional aging
52825|NCT03872414|Neurofeedback|neurofeedback
52826|NCT03872401|High Cardiovascular Risk|high cardiovascular risk
52827|NCT03872401|No prior Myocardial Infarction stroke|no prior myocardial infarction stroke
52828|NCT03872401|>= 50 years of age (men)|>= 50 years of age (men)
52829|NCT03872401|>= 55 years of age (women)|>= 55 years of age (women)
816099|NCT00177242|pancreatic|pancreatic
52830|NCT03872401|lipid-lowering therapy|lipid-lowering therapy
52831|NCT03872375|Executive function|executive function
52832|NCT03872375|MRI|mri
52833|NCT03872375|Memory|memory
52834|NCT03872375|5-2 CR|5-2 cr
52835|NCT03872362|Lung cancer|lung cancer
52836|NCT03872362|CT|ct
52837|NCT03872362|Frozen sections|frozen sections
52838|NCT03872362|Radiomics|radiomics
52839|NCT03872362|Lung adenocarcinoma|lung adenocarcinoma
52840|NCT03872336|Hypertension|hypertension
52841|NCT03872336|Labetalol|labetalol
52842|NCT03872336|Obesity|obesity
52843|NCT03872323|Artery Injury|artery injury
52844|NCT03872323|Surgery|surgery
52845|NCT03872323|Endovascular Repair|endovascular repair
52846|NCT03872323|Peripheral Arteries|peripheral arteries
52847|NCT03872310|Schizephrenia|schizephrenia
52848|NCT03872310|Cognitive enhancement|cognitive enhancement
52849|NCT03872310|Transcranial direct current stimulation|transcranial direct current stimulation
52850|NCT03872310|Non-invasive brain stimulation|non-invasive brain stimulation
52851|NCT03872310|Working memory|working memory
52852|NCT03872258|Physical activity|physical activity
52853|NCT03872258|Postmenopause|postmenopause
52854|NCT03872258|Body composition|body composition
52855|NCT03872258|Health education|health education
52856|NCT03872258|Information and Communication Technologies|information and communication technologies
52857|NCT03872219|biodiversity intervention|biodiversity intervention
52858|NCT03872219|IgE|ige
52859|NCT03872219|atopy|atopy
52860|NCT03872193|Amputation|amputation
52861|NCT03872193|Virtual Reality|virtual reality
52862|NCT03872193|Rehabilitation|rehabilitation
52863|NCT03872167|NIV|niv
52864|NCT03872167|hypoxemia|hypoxemia
52865|NCT03872167|hypercapnia|hypercapnia
52866|NCT03872154|code status discussion|code status discussion
52867|NCT03872154|resuscitation|resuscitation
52868|NCT03872154|hospitalized patient|hospitalized patient
52869|NCT03872154|cardiac arrest|cardiac arrest
52870|NCT03872141|neuropathy|neuropathy
52871|NCT03872141|taxane|taxane
52872|NCT03872141|docetaxel|docetaxel
52873|NCT03872115|Gait|gait
52874|NCT03872115|Balance|balance
52875|NCT03872089|Infrared Thermography|infrared thermography
52876|NCT03872089|Diabetic foot|diabetic foot
52877|NCT03872089|Six minutes walking test|six minutes walking test
52878|NCT03872089|Microcirculation|microcirculation
52879|NCT03872076|Strengthening|strengthening
52880|NCT03872076|Stability|stability
52881|NCT03872076|Muscle Volume|muscle volume
52882|NCT03872076|Physical Effort|physical effort
52883|NCT03872076|Randomized clinical trial|randomized clinical trial
52884|NCT03872063|Volleyball|volleyball
52885|NCT03872063|Range of motion|range of motion
52886|NCT03872063|Myofascial|myofascial
52887|NCT03872063|Eccentric|eccentric
52888|NCT03872063|Pain|pain
52889|NCT03872037|minimally invasive dentistry|minimally invasive dentistry
52890|NCT03872037|dental caries|dental caries
52891|NCT03872037|dentine|dentine
52892|NCT03872011|septic shock|septic shock
52893|NCT03872011|vitamin C|vitamin c
52894|NCT03872011|thiamine|thiamine
52895|NCT03872011|hydrocortisone|hydrocortisone
52896|NCT03872011|mortality|mortality
52897|NCT03871998|Eczema|eczema
52898|NCT03871998|Atopic dermatitis|atopic dermatitis
52899|NCT03871998|Food allergy|food allergy
52900|NCT03871998|Skin barrier|skin barrier
52901|NCT03871998|Filaggrin|filaggrin
52902|NCT03871998|Natural moisturizing factor|natural moisturizing factor
52903|NCT03871998|TEWL|tewl
52904|NCT03871998|Skin microbiome|skin microbiome
52905|NCT03871998|Prevention|prevention
52906|NCT03871998|Moisturizer|moisturizer
52907|NCT03871985|ventilator-associated pneumonia|ventilator-associated pneumonia
52908|NCT03871985|subglottic secretion drainage|subglottic secretion drainage
52909|NCT03871985|endotracheal tube|endotracheal tube
52910|NCT03871985|length of mechanical ventilation|length of mechanical ventilation
52911|NCT03871959|PD1 Monoclonal Antibody|pd1 monoclonal antibody
52912|NCT03871959|IAP Antagonist|iap antagonist
52913|NCT03871959|phase I|phase i
52914|NCT03871959|MSI|msi
52915|NCT03871933|atrial fibrillation|atrial fibrillation
52916|NCT03871933|autonomic function|autonomic function
52917|NCT03871933|cardiopulmonary interaction|cardiopulmonary interaction
52918|NCT03871920|Physiotherapy|physiotherapy
52919|NCT03871920|outcomes|outcomes
52920|NCT03871920|therapy quality|therapy quality
52921|NCT03871894|Indirect calorimeter|indirect calorimeter
52922|NCT03871894|Resting energy expenditure|resting energy expenditure
52923|NCT03871894|substrate utilization|substrate utilization
52924|NCT03871894|nitrogen balance|nitrogen balance
52925|NCT03871881|Magnetic resonance imaging|magnetic resonance imaging
52926|NCT03871881|Brain|brain
52927|NCT03871881|Neuropsychology|neuropsychology
52928|NCT03871881|Heart Defects, Congenital|heart defects, congenital
52929|NCT03871881|Follow-Up Studies|follow-up studies
52930|NCT03871868|25-hydroxyvitamin D|25-hydroxyvitamin d
52931|NCT03871803|Heart failure with preserved ejection fraction|heart failure with preserved ejection fraction
52932|NCT03871803|Chronotropic incompetence|chronotropic incompetence
52933|NCT03871803|Functional capacity|functional capacity
52934|NCT03871803|Quality of life|quality of life
52935|NCT03871790|Neoepitopes|neoepitopes
52936|NCT03871790|Vaccination|vaccination
52937|NCT03871790|Tumor-specific antigens|tumor-specific antigens
52938|NCT03871790|Personalized medicine|personalized medicine
52939|NCT03871777|nitrate|nitrate
52940|NCT03871777|vegetarian|vegetarian
52941|NCT03871777|nitrite|nitrite
52942|NCT03871777|oral microbiome|oral microbiome
52943|NCT03871751|Polyvagal Theory|polyvagal theory
52944|NCT03871751|Social Behavior|social behavior
52945|NCT03871751|Hyperacusis|hyperacusis
52946|NCT03871751|Prosody|prosody
52947|NCT03871751|Auditory intervention|auditory intervention
52948|NCT03871738|Proprioception|proprioception
52949|NCT03871738|Sports performance|sports performance
52950|NCT03871738|Long jump|long jump
52951|NCT03871738|Physiotherapy|physiotherapy
52952|NCT03871738|Randomized clinical trial.|randomized clinical trial.
52953|NCT03871699|Heart|heart
52954|NCT03871699|Failure|failure
52955|NCT03871699|Iron|iron
52956|NCT03871699|Deficiency|deficiency
52957|NCT03871699|Systolic|systolic
52958|NCT03871699|Reduced|reduced
52959|NCT03871699|Ejection|ejection
52960|NCT03871673|Hepatic Glycogen Storage Diseases|hepatic glycogen storage diseases
52961|NCT03871673|Treatment|treatment
52962|NCT03871673|Clinical trial|clinical trial
52963|NCT03871673|Cornstarch|cornstarch
52964|NCT03871673|Sweet polvilho|sweet polvilho
52965|NCT03871660|Total Parenteral Nutrition|total parenteral nutrition
52966|NCT03871608|temporomandibular joint disorders|temporomandibular joint disorders
52967|NCT03871608|rehabilitation|rehabilitation
52968|NCT03871608|assessment|assessment
52969|NCT03871582|Protein intake|protein intake
52970|NCT03871582|Older adults|older adults
52971|NCT03871582|Mexican adults|mexican adults
52972|NCT03871582|Functionality|functionality
52973|NCT03871569|Telemedicine|telemedicine
52974|NCT03871569|dentistry|dentistry
52975|NCT03871569|long-term-care-home|long-term-care-home
52976|NCT03871530|Analgesia|analgesia
52977|NCT03871530|Epidural|epidural
52978|NCT03871530|Labor|labor
52979|NCT03871530|Obstetric Analgesia|obstetric analgesia
52980|NCT03871530|Obstetrical|obstetrical
52981|NCT03871504|exercise|exercise
52982|NCT03871504|hypoalgesia|hypoalgesia
52983|NCT03871504|pain|pain
52984|NCT03871504|expectation|expectation
52985|NCT03871491|maternal sepsis|maternal sepsis
52986|NCT03871491|maternal death|maternal death
52987|NCT03871491|neonatal sepsis|neonatal sepsis
52988|NCT03871491|neonatal death|neonatal death
52989|NCT03871491|azithromycin|azithromycin
52990|NCT03871491|Democratic Republic of Congo|democratic republic of congo
52991|NCT03871491|Zambia|zambia
52992|NCT03871491|Guatemala|guatemala
52993|NCT03871491|Bangladesh|bangladesh
52994|NCT03871491|India|india
52995|NCT03871491|Pakistan|pakistan
52996|NCT03871491|Kenya|kenya
52997|NCT03871465|subacromial bursitis|subacromial bursitis
52998|NCT03871465|subacromial impingement syndrome|subacromial impingement syndrome
52999|NCT03871465|corticosteroid|corticosteroid
53000|NCT03871465|physical therapy|physical therapy
53001|NCT03871465|therapeutic exercise|therapeutic exercise
53002|NCT03871465|rehabilitation|rehabilitation
53003|NCT03871452|Ankaferd BloodStopper, laceration, bleeding|ankaferd bloodstopper, laceration, bleeding
53004|NCT03871426|High resolution manometry|high resolution manometry
53005|NCT03871426|globus pharyngeus|globus pharyngeus
53006|NCT03871426|gastroesophageal reflux disease|gastroesophageal reflux disease
53007|NCT03871426|manual cervical traction|manual cervical traction
53008|NCT03871426|trunk stabilization maneuver|trunk stabilization maneuver
53009|NCT03871413|Benign Paroxysmal Positional Vertigo|benign paroxysmal positional vertigo
53010|NCT03871413|Vertigo|vertigo
53011|NCT03871413|Dizziness|dizziness
53012|NCT03871413|Vestibular Diseases|vestibular diseases
53013|NCT03871413|Epley Maneuver|epley maneuver
53014|NCT03871413|TRV-chair|trv-chair
53015|NCT03871413|Repositioning chair|repositioning chair
53016|NCT03871361|Birdshot Uveitis|birdshot uveitis
53017|NCT03871361|HLA A29|hla a29
53018|NCT03871361|Abatacept|abatacept
53019|NCT03871335|work-related musculoskeletal disorders|work-related musculoskeletal disorders
53020|NCT03871335|hazelnut factory|hazelnut factory
53021|NCT03871335|low back pain|low back pain
53022|NCT03871335|neck pain|neck pain
53023|NCT03871322|vitamin D|vitamin d
53024|NCT03871322|vitamin K2|vitamin k2
53025|NCT03871322|low-energy fractures|low-energy fractures
53026|NCT03871322|fracture healing|fracture healing
53027|NCT03871322|children|children
53028|NCT03871296|DNA-methylation|dna-methylation
53029|NCT03871296|Allogeneic stem cell transplantation|allogeneic stem cell transplantation
53030|NCT03871270|healing|healing
53031|NCT03871270|spiritual|spiritual
53032|NCT03871270|psycho-social-spiritual|psycho-social-spiritual
53033|NCT03871270|growth|growth
816193|NCT00176657|transfusion|transfusion
53034|NCT03871270|chronic illness|chronic illness
53035|NCT03871270|patient care|patient care
53036|NCT03871244|hemoglobin threshold|hemoglobin threshold
53037|NCT03871244|critically ill children|critically ill children
53038|NCT03871244|randomized controlled trial|randomized controlled trial
53039|NCT03871244|red blood cell tranfusions|red blood cell tranfusions
53040|NCT03871231|Termination|termination
53041|NCT03871231|Unpinning|unpinning
53042|NCT03871231|Therapy|therapy
53043|NCT03871205|Neoantigen|neoantigen
53044|NCT03871205|Dentritic cell vaccine|dentritic cell vaccine
53045|NCT03871205|Immunotherapy|immunotherapy
53046|NCT03871205|Refractory lung cancer|refractory lung cancer
53047|NCT03871192|FACET JOINTS|facet joints
53048|NCT03871192|FACET INJECTIONS|facet injections
53049|NCT03871192|NERVE BLOCK|nerve block
53050|NCT03871127|PCI|pci
53051|NCT03871127|CABG|cabg
53052|NCT03871127|Left main|left main
53053|NCT03871101|Dental Anxiety|dental anxiety
53054|NCT03871101|STAI|stai
53055|NCT03871101|Er,Cr:YSGG|er,cr:ysgg
53056|NCT03871101|oral surgery|oral surgery
53057|NCT03871088|Depression, omega-3 fatty acids, nutritional intervention|depression, omega-3 fatty acids, nutritional intervention
53058|NCT03871075|peripheral arterial disease|peripheral arterial disease
53059|NCT03871075|Peripheral Artery Disease|peripheral artery disease
53060|NCT03871075|PAD|pad
53061|NCT03871075|exercise|exercise
53062|NCT03871075|Intermittent claudication|intermittent claudication
53063|NCT03871062|intravitreal injection|intravitreal injection
53064|NCT03871062|pain|pain
53065|NCT03871062|anesthesia|anesthesia
53066|NCT03871036|Advanced urothelial carcinoma|advanced urothelial carcinoma
53067|NCT03871036|Checkpoint inhibition|checkpoint inhibition
53068|NCT03871036|Tremelimumab|tremelimumab
53069|NCT03871036|Durvalumab|durvalumab
53070|NCT03871036|Paclitaxel|paclitaxel
53071|NCT03871010|Midline catheter|midline catheter
53072|NCT03871010|Vascular nursing team|vascular nursing team
53073|NCT03870984|obesity, children, nuts,|obesity, children, nuts,
53074|NCT03870932|Fibromyalgia|fibromyalgia
53075|NCT03870932|Pain|pain
53076|NCT03870932|Imagery|imagery
53077|NCT03870919|therapies combination|therapies combination
53078|NCT03870893|cerebral palsy|cerebral palsy
53079|NCT03870893|hippotherapy|hippotherapy
53080|NCT03870893|cardiopulmonary fitness|cardiopulmonary fitness
53081|NCT03870893|physical activity|physical activity
53082|NCT03870893|attention|attention
53083|NCT03870867|seniors|seniors
53084|NCT03870867|falls|falls
53085|NCT03870867|imaging|imaging
53086|NCT03870867|emergency department|emergency department
53087|NCT03870867|CT head|ct head
53088|NCT03870867|intracranial hemorrhages|intracranial hemorrhages
53089|NCT03870828|IPAF|ipaf
53090|NCT03870828|CTD-ILD|ctd-ild
53091|NCT03870828|ILD|ild
53092|NCT03870828|diagnostic markers|diagnostic markers
53093|NCT03870828|progression markers|progression markers
53094|NCT03870815|Ischemic heart disease|ischemic heart disease
53095|NCT03870815|Coronary artery bypass grafting|coronary artery bypass grafting
53096|NCT03870815|Percutaneous coronary intervention|percutaneous coronary intervention
53097|NCT03870802|Breast cancer|breast cancer
53098|NCT03870802|Stem cells|stem cells
53099|NCT03870802|Immune cells|immune cells
53100|NCT03870789|sepsis, septic shock, early warning scores, infecion|sepsis, septic shock, early warning scores, infecion
53101|NCT03870776|Depression|depression
53102|NCT03870776|Resistant depression|resistant depression
53103|NCT03870763|Pediatric, Multiple Sclerosis|pediatric, multiple sclerosis
53104|NCT03870737|ADHD|adhd
53105|NCT03870737|neuromodulation|neuromodulation
53106|NCT03870737|trigeminal nerve stimulation|trigeminal nerve stimulation
53107|NCT03870724|Prevention|prevention
53108|NCT03870724|Cardiovascular diseases|cardiovascular diseases
53109|NCT03870724|Physical activity|physical activity
53110|NCT03870724|Ethnic differences in health|ethnic differences in health
53111|NCT03870724|Risk factors|risk factors
53112|NCT03870711|Intrauterine device|intrauterine device
53113|NCT03870711|lidocaine spray|lidocaine spray
53114|NCT03870672|Upper limb|upper limb
53115|NCT03870672|Stroke|stroke
53116|NCT03870672|CVA|cva
53117|NCT03870672|Rehabilitation|rehabilitation
53118|NCT03870672|Brain Stimulation|brain stimulation
53119|NCT03870672|CCFES|ccfes
53120|NCT03870672|Motor Cortex|motor cortex
53121|NCT03870672|TMS|tms
53122|NCT03870672|Motor Recovery|motor recovery
53123|NCT03870646|Critical Illness|critical illness
53124|NCT03870646|Tracheostomy|tracheostomy
53125|NCT03870646|Mechanical Ventilation|mechanical ventilation
53126|NCT03870646|Complication|complication
53127|NCT03870646|Plug|plug
53128|NCT03870646|Mucus|mucus
53129|NCT03870607|probiotics|probiotics
53130|NCT03870607|prebiotics|prebiotics
53131|NCT03870607|microbiome|microbiome
53132|NCT03870581|Artificial intelligence|artificial intelligence
53133|NCT03870581|social software|social software
53134|NCT03870581|warfarin|warfarin
53135|NCT03870581|anticoagulation therapy|anticoagulation therapy
53136|NCT03870581|INR|inr
53137|NCT03870568|frailty|frailty
53138|NCT03870568|liver transplantation|liver transplantation
53139|NCT03870568|functional status|functional status
53140|NCT03870555|Drug Therapy|drug therapy
53141|NCT03870516|mitral|mitral
53142|NCT03870516|regurgitation|regurgitation
53143|NCT03870516|speckle|speckle
53144|NCT03870516|echocardiography|echocardiography
53145|NCT03870516|replacement|replacement
53146|NCT03870503|Postpartum Hemorrhage|postpartum hemorrhage
53147|NCT03870503|vaginal delivery|vaginal delivery
53148|NCT03870503|carbetocin|carbetocin
53149|NCT03870503|misoprostol|misoprostol
53150|NCT03870503|oxytocin|oxytocin
53151|NCT03870477|Cannulated Screws|cannulated screws
53152|NCT03870477|Lag Screws|lag screws
53153|NCT03870477|Compression Screws|compression screws
53154|NCT03870477|Telescoping Lag Screws|telescoping lag screws
53155|NCT03870477|Cortical Screws|cortical screws
53156|NCT03870477|Hip Fracture Plate|hip fracture plate
53157|NCT03870464|non-small cell lung cancer|non-small cell lung cancer
53158|NCT03870464|immunotherapy|immunotherapy
53159|NCT03870464|checkpoint inhibition|checkpoint inhibition
53160|NCT03870464|biomarkers|biomarkers
53161|NCT03870464|quality of life|quality of life
53162|NCT03870464|real life patients|real life patients
53163|NCT03870438|HIV-1|hiv-1
53164|NCT03870438|PMTCT|pmtct
53165|NCT03870438|Point of Care|point of care
53166|NCT03870438|PrEP|prep
53167|NCT03870438|Zambia|zambia
53168|NCT03870438|Burkina Faso|burkina faso
53169|NCT03870438|Expanded Program of Immunization (EPI)|expanded program of immunization (epi)
53170|NCT03870425|Dietary protein|dietary protein
53171|NCT03870425|Sarcopenia|sarcopenia
53172|NCT03870425|Protein turnover|protein turnover
53173|NCT03870425|Muscle protein|muscle protein
53174|NCT03870412|PEG-rhG-CSF|peg-rhg-csf
53175|NCT03870399|neuroendocrine tumor|neuroendocrine tumor
53176|NCT03870399|tamoxifen|tamoxifen
53177|NCT03870399|Progesterone Receptor|progesterone receptor
53178|NCT03870399|Estrogen Receptor|estrogen receptor
53179|NCT03870386|EUS|eus
53180|NCT03870386|ERCP|ercp
53181|NCT03870386|Lumen apposing metal stent|lumen apposing metal stent
53182|NCT03870386|Biliary drainage|biliary drainage
53183|NCT03870386|Biliary obstruction|biliary obstruction
53184|NCT03870386|Pancreatic adenocarcinoma|pancreatic adenocarcinoma
53185|NCT03870321|Core|core
53186|NCT03870321|Strength|strength
53187|NCT03870321|Proprioception|proprioception
53188|NCT03870321|Ankle|ankle
53189|NCT03870321|Basketball|basketball
53190|NCT03870308|Deep Brain Stimulation|deep brain stimulation
53191|NCT03870295|Type C nerve fibres|type c nerve fibres
53192|NCT03870295|Conduction velocity|conduction velocity
53193|NCT03870295|Polyneuropathy|polyneuropathy
53194|NCT03870282|Childhood sleep promotion|childhood sleep promotion
53195|NCT03870282|Sleep promotion|sleep promotion
53196|NCT03870282|Sleep|sleep
53197|NCT03870256|Postpartum Hemorrhage|postpartum hemorrhage
53198|NCT03870256|vaginal delivery|vaginal delivery
53199|NCT03870256|tranexamic acid|tranexamic acid
53200|NCT03870256|misoprostol|misoprostol
53201|NCT03870243|Bubble CPAP|bubble cpap
53202|NCT03870243|Young Children|young children
53203|NCT03870243|Severe Pneumonia|severe pneumonia
53204|NCT03870204|Schistosoma japonicum|schistosoma japonicum
53205|NCT03870126|cognitive|cognitive
53206|NCT03870126|phytochemicals|phytochemicals
53207|NCT03870126|caffeine|caffeine
53208|NCT03870126|polyphenol|polyphenol
53209|NCT03870126|beverage|beverage
53210|NCT03870126|exercise|exercise
53211|NCT03870126|mental performance|mental performance
53212|NCT03870126|physical performance|physical performance
53213|NCT03870126|vigilance|vigilance
53214|NCT03870126|vigor|vigor
53215|NCT03870126|energy|energy
53216|NCT03870126|vitality|vitality
53217|NCT03870126|fatigue|fatigue
53218|NCT03870126|sports performance|sports performance
53219|NCT03870126|high-intensity intermittent exercise|high-intensity intermittent exercise
53220|NCT03870113|Cervical Intraepithelial Neoplasia|cervical intraepithelial neoplasia
53221|NCT03870113|Human Papillomavirus|human papillomavirus
53222|NCT03870113|Dentritic Vaccine|dentritic vaccine
53223|NCT03870113|E6/E7 protein|e6/e7 protein
53224|NCT03870074|heart failure|heart failure
53225|NCT03870074|cardiac resynchronization therapy|cardiac resynchronization therapy
53226|NCT03870074|cardiopulmonary exercise test|cardiopulmonary exercise test
53227|NCT03870074|responders to CRT|responders to crt
53228|NCT03870074|non-responders to CRT|non-responders to crt
53229|NCT03870074|survival prognosis after CRT|survival prognosis after crt
53230|NCT03870061|Randomized Controlled Trial|randomized controlled trial
53231|NCT03870061|Vaccinations|vaccinations
53232|NCT03870061|Nigeria|nigeria
53233|NCT03870061|Conditional Cash Transfers|conditional cash transfers
53234|NCT03870061|Cash Incentives|cash incentives
53236|NCT03870061|Impact Evaluation|impact evaluation
53237|NCT03870061|Immunization|immunization
53238|NCT03870009|ARDS|ards
53239|NCT03870009|computed tomography|computed tomography
53240|NCT03870009|cyclic hyperinflation|cyclic hyperinflation
53241|NCT03870009|mechanical ventilation|mechanical ventilation
53242|NCT03869996|fast track care|fast track care
53243|NCT03869996|total knee arthroplasty|total knee arthroplasty
53244|NCT03869983|Iohexol|iohexol
53245|NCT03869983|Captisol®|captisol®
53246|NCT03869983|cyclodextrin|cyclodextrin
53247|NCT03869983|radiographic|radiographic
53248|NCT03869983|iodinated contrast medium|iodinated contrast medium
53249|NCT03869983|Omnipaque™|omnipaque™
53250|NCT03869970|Concussion|concussion
53251|NCT03869957|omega 3 polyunsaturated fatty acids|omega 3 polyunsaturated fatty acids
53252|NCT03869957|intestinal failure|intestinal failure
53253|NCT03869957|oxidative stress|oxidative stress
53254|NCT03869944|HIV-1|hiv-1
53255|NCT03869944|PMTCT|pmtct
53256|NCT03869944|Point of Care|point of care
53257|NCT03869944|PrEP|prep
53258|NCT03869944|Burkina Faso|burkina faso
53259|NCT03869944|Expanded Program of Immunization (EPI)|expanded program of immunization (epi)
53260|NCT03869931|Fenofibrate|fenofibrate
53261|NCT03869931|Diabetic Nephropathy|diabetic nephropathy
53262|NCT03869931|Metabolomics|metabolomics
53263|NCT03869905|Remission|remission
53264|NCT03869892|Metastatic|metastatic
53265|NCT03869892|Cancer|cancer
53266|NCT03869892|Colorectal|colorectal
53267|NCT03869892|Colorectal Cancer|colorectal cancer
53268|NCT03869892|Colon|colon
53269|NCT03869892|Rectum|rectum
53270|NCT03869892|Metastasis|metastasis
53271|NCT03869879|gait|gait
53272|NCT03869879|balance|balance
53273|NCT03869879|falls|falls
53274|NCT03869879|mobility|mobility
53275|NCT03869879|feedback|feedback
53276|NCT03869853|nutritional status|nutritional status
53277|NCT03869853|agripreneurs|agripreneurs
53278|NCT03869853|women farmers|women farmers
53279|NCT03869762|Castration-resistant|castration-resistant
53280|NCT03869762|Progressive|progressive
53281|NCT03869762|Metastatic|metastatic
53282|NCT03869762|Prostate Cancer|prostate cancer
53283|NCT03869762|Bone Metastases|bone metastases
53284|NCT03869736|Depression|depression
53285|NCT03869736|Depressive Disorder, Major|depressive disorder, major
53286|NCT03869736|Mood Disorders|mood disorders
53287|NCT03869736|Mental Disorders|mental disorders
53288|NCT03869736|Nitrous Oxide|nitrous oxide
53289|NCT03869736|Anesthetics, Inhalational|anesthetics, inhalational
53290|NCT03869736|Anesthetics|anesthetics
53291|NCT03869736|Anesthetics, General|anesthetics, general
53292|NCT03869736|Physiologic Effects of Drugs|physiologic effects of drugs
53293|NCT03869736|Analgesics, Non-Narcotic|analgesics, non-narcotic
53294|NCT03869736|Analgesics|analgesics
53295|NCT03869710|Pain|pain
53296|NCT03869684|Exudative|exudative
53297|NCT03869684|Wet|wet
53298|NCT03869684|AMD|amd
53299|NCT03869684|Age-related macular degeneration|age-related macular degeneration
53300|NCT03869684|Age related macular degeneration|age related macular degeneration
53301|NCT03869671|Antiretroviral pre-exposure prophylaxis (PrEP)|antiretroviral pre-exposure prophylaxis (prep)
53302|NCT03869671|Syringe exchange program (SEP)|syringe exchange program (sep)
53303|NCT03869671|HIV-related risk behaviors|hiv-related risk behaviors
53304|NCT03869671|Adherence intervention|adherence intervention
53305|NCT03869671|People who inject drugs (PWID)|people who inject drugs (pwid)
53306|NCT03869658|Voice recognition|voice recognition
53307|NCT03869658|24-hr diet recall|24-hr diet recall
53308|NCT03869658|Mobile application|mobile application
53309|NCT03869658|Self-report|self-report
53310|NCT03869632|YL-13027|yl-13027
53311|NCT03869632|Advanced Solid Tumors|advanced solid tumors
53312|NCT03869619|lymphoma|lymphoma
53313|NCT03869619|real life|real life
53314|NCT03869619|cohort|cohort
53315|NCT03869619|epidemiology|epidemiology
53316|NCT03869619|PRO|pro
53317|NCT03869567|thrombectomy|thrombectomy
53318|NCT03869567|flat panel Computed tomography|flat panel computed tomography
53319|NCT03869567|cone beam computed tomography|cone beam computed tomography
53320|NCT03869567|hemorrhage|hemorrhage
53321|NCT03869567|stroke|stroke
53322|NCT03869567|dual energy computed tomography|dual energy computed tomography
53323|NCT03869541|Critical Illness|critical illness
53324|NCT03869541|Physical rehabilitation|physical rehabilitation
53325|NCT03869528|bronchoscopy|bronchoscopy
53326|NCT03869528|lignocaine|lignocaine
53327|NCT03869515|chILD|child
53328|NCT03869515|clinic features|clinic features
53329|NCT03869515|genetic backgrounds|genetic backgrounds
53330|NCT03869515|outcomes|outcomes
53331|NCT03869489|approach motivation|approach motivation
53332|NCT03869489|avoidance motivation|avoidance motivation
53333|NCT03869489|transcranial direct current stimulation|transcranial direct current stimulation
53334|NCT03869411|diabetes|diabetes
53335|NCT03869411|muscle quality|muscle quality
53336|NCT03869411|aerobic exercise|aerobic exercise
53337|NCT03869411|FTO gene|fto gene
53338|NCT03869385|Human albumin|human albumin
53339|NCT03869385|Sepsis|sepsis
53340|NCT03869359|gluten-free diet|gluten-free diet
53341|NCT03869359|gluten-containing diet|gluten-containing diet
53342|NCT03869359|microbiota|microbiota
53343|NCT03869359|metabolomics|metabolomics
53344|NCT03869359|healthy volunteers|healthy volunteers
53345|NCT03869333|Shigella flexneri 2a|shigella flexneri 2a
53346|NCT03869333|Enteric|enteric
53347|NCT03869333|Shigella|shigella
53348|NCT03869307|Joint instability|joint instability
53349|NCT03869307|Hypermobility|hypermobility
53350|NCT03869307|Shoulder|shoulder
53351|NCT03869307|Strength training|strength training
53352|NCT03869242|Glioblastoma|glioblastoma
53353|NCT03869242|NovoTTF-200A|novottf-200a
53354|NCT03869242|Radiation Therapy|radiation therapy
53355|NCT03869242|Temozolomide|temozolomide
53356|NCT03869229|osteoarthritis|osteoarthritis
53357|NCT03869229|Adipose-derived Mesenchymal Stem Cells|adipose-derived mesenchymal stem cells
53358|NCT03869216|Prostate cancer|prostate cancer
53359|NCT03869216|Primary Care|primary care
53360|NCT03869216|PSA-screening|psa-screening
53361|NCT03869216|African American males|african american males
53362|NCT03869177|Family psychoeducation|family psychoeducation
53363|NCT03869177|Schizophrenia|schizophrenia
53364|NCT03869177|Implementation science|implementation science
53365|NCT03869177|Mental health care services|mental health care services
53366|NCT03869177|Clinical ethics|clinical ethics
53367|NCT03869177|Family involvement|family involvement
53368|NCT03869177|Family intervention|family intervention
53369|NCT03869112|COPD|copd
53370|NCT03869112|Physical activity|physical activity
53371|NCT03869112|pulmonary rehabilitation|pulmonary rehabilitation
53372|NCT03869112|COPD physical activity level|copd physical activity level
53373|NCT03869112|COPD comorbidities|copd comorbidities
53374|NCT03869099|Childhood pneumonia|childhood pneumonia
53375|NCT03869099|acute respiratory illness|acute respiratory illness
53376|NCT03869099|Pakistan|pakistan
53377|NCT03869086|Blueberry|blueberry
53378|NCT03869086|Metabolism|metabolism
53379|NCT03869086|Anthocyanins|anthocyanins
53380|NCT03869086|Inter-individual variation|inter-individual variation
53381|NCT03869086|Cardiometabolic health|cardiometabolic health
53382|NCT03869073|Bacterial|bacterial
53383|NCT03869073|Infection|infection
53384|NCT03869073|Blood|blood
53385|NCT03869073|Systemic|systemic
53387|NCT03869060|Dengue|dengue
53388|NCT03869060|Flavivirus Infections|flavivirus infections
53389|NCT03869060|Virus Diseases|virus diseases
53390|NCT03869034|Transarterial Infusion Chemotherapy|transarterial infusion chemotherapy
53391|NCT03869034|PD-1 Inhibitor|pd-1 inhibitor
53392|NCT03869034|Hepatocellular Carcinoma|hepatocellular carcinoma
53393|NCT03869021|Computer guided surgery|computer guided surgery
53394|NCT03869021|Hemifacial Microsomia|hemifacial microsomia
53395|NCT03868982|acute respiratory distress syndrome|acute respiratory distress syndrome
53396|NCT03868982|neurally adjusted ventilatory assist|neurally adjusted ventilatory assist
53397|NCT03868982|lung protective strategy|lung protective strategy
53398|NCT03868956|Deep vein thrombosis|deep vein thrombosis
53399|NCT03868956|Recurrence|recurrence
53400|NCT03868956|Diagnostic strategy|diagnostic strategy
53401|NCT03868956|Colour doppler ultrasound|colour doppler ultrasound
53402|NCT03868956|D-dimer|d-dimer
53403|NCT03868930|Mental health|mental health
53404|NCT03868930|Veterans health|veterans health
53405|NCT03868891|Otitis media|otitis media
53406|NCT03868891|Eustachian tube|eustachian tube
53407|NCT03868891|Eustachian tube dysfunction|eustachian tube dysfunction
53408|NCT03868891|Eustachian tube function testing|eustachian tube function testing
53409|NCT03868891|Middle ear ventilation|middle ear ventilation
53410|NCT03868878|Capoeira Training (martial arts)|capoeira training (martial arts)
53411|NCT03868878|Triglycerides|triglycerides
53412|NCT03868878|Aging|aging
53413|NCT03868852|Radiation Therapy|radiation therapy
53414|NCT03868852|Rhabdomyosarcoma in Children|rhabdomyosarcoma in children
53415|NCT03868774|treatment|treatment
53416|NCT03868761|Mobile app|mobile app
53417|NCT03868761|Disaster|disaster
53418|NCT03868761|Digital Medicine|digital medicine
53419|NCT03868761|Teens|teens
53420|NCT03868709|Postoperative pulmonary complications|postoperative pulmonary complications
53421|NCT03868709|Penehyclidine Hydrochloride|penehyclidine hydrochloride
53422|NCT03868709|High risk patients|high risk patients
53423|NCT03868709|Postoperative period|postoperative period
53424|NCT03868709|Long-term outcome|long-term outcome
53425|NCT03868696|Ultrasound|ultrasound
53426|NCT03868696|Manipulation under anaesthesia|manipulation under anaesthesia
53427|NCT03868696|Emergency Department|emergency department
53428|NCT03868644|Youth|youth
53429|NCT03868644|Kenya|kenya
53430|NCT03868644|Voluntary Counseling and Testing for HIV|voluntary counseling and testing for hiv
53431|NCT03868644|Condoms|condoms
53432|NCT03868644|HIV prevention|hiv prevention
53433|NCT03868644|HSV-2|hsv-2
53434|NCT03868514|breast reconstruction|breast reconstruction
53435|NCT03868514|surgical mesh|surgical mesh
816466|NCT00175682|Ejaculation|ejaculation
53436|NCT03868475|High-risk breast lesions|high-risk breast lesions
53437|NCT03868475|Vacuum-assisted excision|vacuum-assisted excision
53438|NCT03868475|Vacuum-assisted biopsy|vacuum-assisted biopsy
53439|NCT03868475|Surgical excisional biopsy|surgical excisional biopsy
53440|NCT03868475|Complete removal|complete removal
53441|NCT03868475|Patient satisfaction|patient satisfaction
53442|NCT03868475|Cosmesis|cosmesis
53443|NCT03868410|stroke|stroke
53444|NCT03868410|brain stimulation|brain stimulation
53445|NCT03868410|TMS|tms
53446|NCT03868410|Upper Limb|upper limb
53447|NCT03868410|MRI|mri
53448|NCT03868410|CVA|cva
53449|NCT03868410|Rehabilitation|rehabilitation
53450|NCT03868397|MRI|mri
53451|NCT03868397|cirrhosis|cirrhosis
53452|NCT03868345|ALS|als
53453|NCT03868345|Cognitive dysfunction|cognitive dysfunction
53454|NCT03868345|Speech|speech
53455|NCT03868319|lung-protective ventilation strategy|lung-protective ventilation strategy
53456|NCT03868319|low tidal volume|low tidal volume
53457|NCT03868319|positive end-expiratory pressure|positive end-expiratory pressure
53458|NCT03868319|Lung ultrasound|lung ultrasound
53459|NCT03868319|postoperative pulmonary complications|postoperative pulmonary complications
53460|NCT03868267|Quality of Life|quality of life
53461|NCT03868267|Anxiety|anxiety
53462|NCT03868267|Microbiome|microbiome
53463|NCT03868267|Upper GI|upper gi
53464|NCT03868267|Dyspepsia|dyspepsia
53465|NCT03868267|Nitrates|nitrates
53466|NCT03868267|Gastrointestinal symptoms|gastrointestinal symptoms
53467|NCT03868241|sepsis|sepsis
53468|NCT03868241|ventilator-associated pneumonia|ventilator-associated pneumonia
53469|NCT03868241|catheter related bloodstream infection|catheter related bloodstream infection
53470|NCT03868241|urinary catheter-related infection|urinary catheter-related infection
53471|NCT03868228|intraperitoneal chemotherapy|intraperitoneal chemotherapy
53472|NCT03868228|PIPAC|pipac
53473|NCT03868228|pressurised|pressurised
53474|NCT03868228|colorectal cancer|colorectal cancer
53475|NCT03868228|peritoneal metastases|peritoneal metastases
53476|NCT03868215|Colorectal Cancer|colorectal cancer
53477|NCT03868215|Lymph Node Metastases|lymph node metastases
53478|NCT03868215|Local Residual|local residual
53479|NCT03868176|surveillance|surveillance
53480|NCT03868176|compliance|compliance
53481|NCT03868176|germ cell tumors|germ cell tumors
53482|NCT03868176|short message service|short message service
53483|NCT03868163|Chronic Hepatitis C|chronic hepatitis c
53484|NCT03868163|Hepatitis C|hepatitis c
53485|NCT03868163|Hepatitis|hepatitis
53486|NCT03868163|glecaprevir|glecaprevir
53487|NCT03868163|pibrentasvir|pibrentasvir
53488|NCT03868163|real world setting|real world setting
53489|NCT03868163|Observational Study|observational study
53490|NCT03868137|NSAID|nsaid
53491|NCT03868137|Intrauterine Devices|intrauterine devices
53492|NCT03868137|Ibuprofen|ibuprofen
53493|NCT03868137|Pelvic pain|pelvic pain
53494|NCT03868046|Immune-related Adverse Events|immune-related adverse events
53495|NCT03868046|Immune Checkpoint Inhibitors|immune checkpoint inhibitors
53496|NCT03868046|Biomarkers|biomarkers
53497|NCT03868046|Autoantibodies|autoantibodies
53498|NCT03868033|Osteoporosis|osteoporosis
53499|NCT03868033|Denosumab|denosumab
53500|NCT03868033|Zoledronate|zoledronate
53501|NCT03868033|Bone mineral density|bone mineral density
53502|NCT03868007|remote ischemic conditioning|remote ischemic conditioning
53503|NCT03868007|elderly|elderly
53504|NCT03868007|acute ischemic stroke|acute ischemic stroke
53505|NCT03868007|Acute Coronary Syndrome|acute coronary syndrome
53506|NCT03867994|Cardiac catheterization, carvedilol, atorvastatin.|cardiac catheterization, carvedilol, atorvastatin.
53507|NCT03867981|Obesity|obesity
53508|NCT03867981|weight loss|weight loss
53509|NCT03867981|exercise|exercise
53510|NCT03867981|diet|diet
53511|NCT03867981|phone coaching|phone coaching
53512|NCT03867955|photomotor reflex|photomotor reflex
53513|NCT03867955|depth of anesthesia|depth of anesthesia
53514|NCT03867955|AlgiScan™|algiscan™
53515|NCT03867955|pupil diameter|pupil diameter
53516|NCT03867929|Erectile dysfunction|erectile dysfunction
53517|NCT03867929|Vitamin-D|vitamin-d
53518|NCT03867929|Hypogonadism|hypogonadism
53519|NCT03867929|Endothelial Dysfunction|endothelial dysfunction
53520|NCT03867929|Nitric Oxide|nitric oxide
53521|NCT03867864|Headache|headache
53522|NCT03867864|Migraine|migraine
53523|NCT03867864|Disability|disability
53524|NCT03867864|Quality of life|quality of life
53525|NCT03867864|Nurse|nurse
53526|NCT03867864|Aromatherapy|aromatherapy
53527|NCT03867864|Essential oils|essential oils
53528|NCT03867864|Missed care|missed care
53529|NCT03867786|Resistance Exercise Neurobiological Mechanisms|resistance exercise neurobiological mechanisms
53530|NCT03867747|Ventricular Tachycardia|ventricular tachycardia
53531|NCT03867747|Stereotactic Body Radiation Therapy|stereotactic body radiation therapy
53532|NCT03867747|Radiosurgery|radiosurgery
53533|NCT03867734|aztreonam|aztreonam
53534|NCT03867734|treatment study|treatment study
816665|NCT00174837|Cisplatin|cisplatin
53535|NCT03867721|noninvasive ventilation|noninvasive ventilation
53733|NCT03866603|Biomarker|biomarker
53548|NCT03867656|Type 2 Diabetes Mellitus|type 2 diabetes mellitus
53549|NCT03867656|Bone resorption|bone resorption
53550|NCT03867656|Bone formation|bone formation
53551|NCT03867656|CTX|ctx
53552|NCT03867656|P1NP|p1np
53553|NCT03867656|GLP-2|glp-2
53554|NCT03867656|GIP|gip
53555|NCT03867656|Bone turnover|bone turnover
53556|NCT03867656|Bone remodeling|bone remodeling
53557|NCT03867643|Hepatitis B Vaccine|hepatitis b vaccine
53558|NCT03867643|booster|booster
53559|NCT03867643|Immune response|immune response
53560|NCT03867565|Minor burns|minor burns
53561|NCT03867565|Nutrition|nutrition
53562|NCT03867552|post-operative pain|post-operative pain
53563|NCT03867552|recovery|recovery
53564|NCT03867552|laparoscopy|laparoscopy
53565|NCT03867552|nitrous oxide|nitrous oxide
53566|NCT03867539|hand|hand
53567|NCT03867539|exparel|exparel
53568|NCT03867539|opioid crisis|opioid crisis
53569|NCT03867513|Magnetoencephalography|magnetoencephalography
53570|NCT03867513|Magnetic Resonance Imaging|magnetic resonance imaging
53571|NCT03867513|Mild traumatic brain injury|mild traumatic brain injury
53572|NCT03867474|Mindfulness, Primary Care, MBSR, Cognitive Impairment|mindfulness, primary care, mbsr, cognitive impairment
53573|NCT03867461|End-Tidal Carbon Dioxide|end-tidal carbon dioxide
53574|NCT03867461|Venous Sinus Stenting|venous sinus stenting
53575|NCT03867461|Venous Sinus Caliber and Pressures|venous sinus caliber and pressures
53576|NCT03867448|Adrenal Gland|adrenal gland
53577|NCT03867448|Pituitary|pituitary
53582|NCT03867396|Cochlear Implant|cochlear implant
53583|NCT03867396|Hearing Loss|hearing loss
53584|NCT03867396|Hearing Aids|hearing aids
53585|NCT03867396|Hearing Tests|hearing tests
53586|NCT03867357|Androgen deprivation therapy|androgen deprivation therapy
53587|NCT03867357|Prostate cancer|prostate cancer
53588|NCT03867357|Sarcopenia|sarcopenia
53592|NCT03867292|Paddle-tennis|paddle-tennis
53593|NCT03867292|Myofascial release|myofascial release
53594|NCT03867292|Electrotherapy|electrotherapy
53595|NCT03867292|Physiotherapy|physiotherapy
53596|NCT03867292|Low back|low back
53597|NCT03867292|Randomized clinical trial|randomized clinical trial
53598|NCT03867279|Weightlifters|weightlifters
53599|NCT03867279|Flossbands|flossbands
53600|NCT03867279|Clinical Trial|clinical trial
53601|NCT03867279|Physical Therapy|physical therapy
53602|NCT03867279|Squat|squat
53603|NCT03867266|Ablation index|ablation index
53604|NCT03867266|Interlesion distance|interlesion distance
53605|NCT03867253|Alzheimer's Disease, ORY-2001|alzheimer's disease, ory-2001
53606|NCT03867240|Gabapentin|gabapentin
53607|NCT03867240|Pain medication|pain medication
53608|NCT03867240|Chronic postsurgical pain|chronic postsurgical pain
53609|NCT03867240|Pediatric|pediatric
53610|NCT03867240|Idiopathic scoliosis surgery|idiopathic scoliosis surgery
53611|NCT03867227|left atrial appendage|left atrial appendage
53612|NCT03867227|LAA occluder|laa occluder
53613|NCT03867227|thromboembolic prophylaxis|thromboembolic prophylaxis
53614|NCT03867227|atrial fibrillation|atrial fibrillation
53615|NCT03867201|AMG334|amg334
53616|NCT03867201|erenumab|erenumab
53617|NCT03867201|migraine|migraine
53618|NCT03867201|chronic|chronic
53619|NCT03867201|headache|headache
53620|NCT03867201|Chinese|chinese
53621|NCT03867188|Exparel|exparel
53622|NCT03867188|Liposomal Bupivacaine|liposomal bupivacaine
53623|NCT03867188|Removal by Surgery|removal by surgery
53624|NCT03867188|Pain Reduction|pain reduction
53625|NCT03867149|Mediodorsal nucleus|mediodorsal nucleus
53626|NCT03867149|higher order cognition|higher order cognition
53627|NCT03867136|Multidrug resistant tuberculosis|multidrug resistant tuberculosis
53628|NCT03867136|shorter treatment|shorter treatment
53629|NCT03867136|all-oral regimen|all-oral regimen
53630|NCT03867110|Hypercholesterolemia|hypercholesterolemia
53631|NCT03867110|Ezetimibe|ezetimibe
53632|NCT03867110|Atorvastatin|atorvastatin
53633|NCT03867110|Low density lipoprotein-cholesterol|low density lipoprotein-cholesterol
53634|NCT03867097|systemic sclerosis|systemic sclerosis
53635|NCT03867097|raynaud phenomenon|raynaud phenomenon
53734|NCT03866590|Pyruvate Kinase Deficiency|pyruvate kinase deficiency
53636|NCT03867084|Programmed Cell Death 1 (PD-1, PD1)|programmed cell death 1 (pd-1, pd1)
53637|NCT03867084|Programmed Cell Death Ligand 1 (PD-L1, PDL1)|programmed cell death ligand 1 (pd-l1, pdl1)
53638|NCT03867084|Checkpoint Inhibitor|checkpoint inhibitor
53639|NCT03867084|Immunotherapy|immunotherapy
53640|NCT03867084|Adjuvant|adjuvant
53641|NCT03867019|Benign Paroxysmal Positional Vertigo|benign paroxysmal positional vertigo
53642|NCT03867019|BPPV|bppv
53643|NCT03867019|Vertigo|vertigo
53644|NCT03867019|Autonomic Nervous System|autonomic nervous system
53645|NCT03867019|Heart Rate Variability|heart rate variability
53646|NCT03867019|Vestibulo Sympathetic Response|vestibulo sympathetic response
53647|NCT03867019|Vestibulo Sympathetic Reflex|vestibulo sympathetic reflex
53648|NCT03867006|Malnutrition|malnutrition
816666|NCT00174837|Radiation|radiation
53649|NCT03867006|Undernutrition|undernutrition
53650|NCT03867006|Elderly|elderly
53651|NCT03867006|Protein|protein
53652|NCT03867006|Carbohydrate|carbohydrate
53653|NCT03866993|immuno-oncology|immuno-oncology
53654|NCT03866993|NSCLC|nsclc
53655|NCT03866993|Anti-PD-1 Antibody|anti-pd-1 antibody
53656|NCT03866993|immunotherapy|immunotherapy
53657|NCT03866980|immunotherapy,immuno-oncology, non-small cell lung cancer|immunotherapy,immuno-oncology, non-small cell lung cancer
53658|NCT03866980|Anti-PD-1 antibody|anti-pd-1 antibody
53659|NCT03866967|immunotherapy|immunotherapy
53660|NCT03866967|Anti-PD-1 antibody|anti-pd-1 antibody
53661|NCT03866967|Nasopharyngeal Carcinoma|nasopharyngeal carcinoma
53662|NCT03866967|immuno-oncology|immuno-oncology
53663|NCT03866954|neuropathy|neuropathy
53664|NCT03866954|gastrointestinal disease|gastrointestinal disease
53665|NCT03866954|thymidine phosphorylase|thymidine phosphorylase
53666|NCT03866954|enyme replacement|enyme replacement
53667|NCT03866941|synthetic cannabinoids, Assiut, violence,acute,chronic|synthetic cannabinoids, assiut, violence,acute,chronic
53668|NCT03866902|overweight|overweight
53669|NCT03866902|obesity|obesity
53670|NCT03866902|adiposity|adiposity
53671|NCT03866902|nutrition|nutrition
53672|NCT03866902|physical activity|physical activity
53673|NCT03866902|Hispanic|hispanic
53674|NCT03866889|Strength|strength
53675|NCT03866889|Military|military
53676|NCT03866889|Functionality|functionality
53677|NCT03866889|Physiotherapy|physiotherapy
53678|NCT03866889|Randomized clinical trial|randomized clinical trial
53679|NCT03866837|Iron-deficiency|iron-deficiency
53680|NCT03866837|Iron supplementation|iron supplementation
53681|NCT03866837|Galacto-oligosaccharides|galacto-oligosaccharides
53682|NCT03866837|Lactoferrin|lactoferrin
53683|NCT03866837|Ferrous fumarate|ferrous fumarate
53684|NCT03866837|Clinical trial|clinical trial
53685|NCT03866837|Microbiome|microbiome
53686|NCT03866837|PolyFermS|polyferms
53687|NCT03866837|Polyfermenter intestinal model|polyfermenter intestinal model
53688|NCT03866811|emergency medicine|emergency medicine
53689|NCT03866811|reproductive health|reproductive health
53690|NCT03866811|sexual health|sexual health
53691|NCT03866811|adolescent health|adolescent health
53692|NCT03866811|emergency department|emergency department
53693|NCT03866811|text messaging|text messaging
53694|NCT03866811|mobile health|mobile health
53695|NCT03866811|digital health|digital health
53696|NCT03866785|Prostate cancer|prostate cancer
53697|NCT03866785|Physical activity|physical activity
53698|NCT03866785|Activity actigraph|activity actigraph
53699|NCT03866785|Peer|peer
53700|NCT03866785|Program|program
53701|NCT03866785|Sports medicine|sports medicine
53702|NCT03866772|induction of labor|induction of labor
53703|NCT03866772|unfavorable cervix|unfavorable cervix
53704|NCT03866772|misoprostol|misoprostol
53705|NCT03866772|cytotec|cytotec
53706|NCT03866772|double balloon device|double balloon device
53707|NCT03866772|cervical ripening|cervical ripening
53708|NCT03866759|Sexually Transmitted Infection|sexually transmitted infection
53709|NCT03866759|HIV Vaccine Trials Network|hiv vaccine trials network
53710|NCT03866759|Pre-exposure prophylaxis|pre-exposure prophylaxis
53711|NCT03866746|Aflibercept|aflibercept
53712|NCT03866746|Anti-VEGFs|anti-vegfs
53713|NCT03866746|micropulsed diode laser|micropulsed diode laser
53714|NCT03866746|subthreshold|subthreshold
53715|NCT03866733|erector spinea block, open heart surgeries,analgesia|erector spinea block, open heart surgeries,analgesia
53716|NCT03866694|maternal opioid use|maternal opioid use
53717|NCT03866694|substance use|substance use
53718|NCT03866694|parent-child relationship|parent-child relationship
53719|NCT03866694|parenting|parenting
53720|NCT03866694|social and emotional development|social and emotional development
53721|NCT03866694|mental health and well-being|mental health and well-being
53722|NCT03866694|perinatal|perinatal
53723|NCT03866694|postpartum|postpartum
53724|NCT03866694|health disparities|health disparities
53725|NCT03866668|Esomeprazole|esomeprazole
53726|NCT03866655|Breast Cancer|breast cancer
53727|NCT03866655|Digital|digital
53728|NCT03866655|eHealth|ehealth
53729|NCT03866655|Supportive Care|supportive care
53730|NCT03866655|Patient Activation|patient activation
53731|NCT03866655|Resource Utilisation|resource utilisation
53732|NCT03866603|Parkinson disease|parkinson disease
53737|NCT03866577|Immune thrombocytopenic purpura|immune thrombocytopenic purpura
53738|NCT03866577|Healthy subjects|healthy subjects
53739|NCT03866577|M254|m254
53740|NCT03866577|Intravenous immunoglobulin (IVIg)|intravenous immunoglobulin (ivig)
53741|NCT03866551|Acute Heart Failure|acute heart failure
53742|NCT03866551|Decompensated Heart Failure|decompensated heart failure
53743|NCT03866551|Heart Failure Treatment|heart failure treatment
53744|NCT03866551|Heart Failure Management Fluid Overload|heart failure management fluid overload
53745|NCT03866551|Diuresis|diuresis
53746|NCT03866525|Oncolytic Virus|oncolytic virus
53747|NCT03866499|EGFR|egfr
53748|NCT03866499|T790M|t790m
53749|NCT03866499|NSCLC|nsclc
816667|NCT00174824|Diabetes|diabetes
53750|NCT03866486|Clinical outcome; IVUS; Stent|clinical outcome; ivus; stent
53751|NCT03866460|Hearing Status|hearing status
53752|NCT03866460|18-529|18-529
53753|NCT03866408|adipose tissue|adipose tissue
53754|NCT03866395|Stable angina|stable angina
53755|NCT03866395|coronary artery diseases|coronary artery diseases
53756|NCT03866395|heart rate|heart rate
53757|NCT03866395|exercise tolerability|exercise tolerability
53758|NCT03866395|diastolic function|diastolic function
53759|NCT03866395|ivabradine|ivabradine
53760|NCT03866369|healthy male volunteers|healthy male volunteers
53761|NCT03866369|multiple ascending dose|multiple ascending dose
53762|NCT03866369|supra-therapeutic dose|supra-therapeutic dose
53763|NCT03866356|Nursing|nursing
53764|NCT03866356|evidence-based practice|evidence-based practice
53765|NCT03866356|Star model|star model
53766|NCT03866356|stress incontinence|stress incontinence
53767|NCT03866356|nursing care protocol|nursing care protocol
53768|NCT03866356|female|female
53769|NCT03866330|Osteoarthritis|osteoarthritis
53770|NCT03866330|Wharton Jelly derived Mesenchymal Stem Cells|wharton jelly derived mesenchymal stem cells
53771|NCT03866278|Opiate|opiate
53772|NCT03866265|Platelet Sensitivity|platelet sensitivity
53773|NCT03866265|PAF|paf
53774|NCT03866265|Thrombin|thrombin
53775|NCT03866265|Salmon Polar Lipids|salmon polar lipids
53776|NCT03866265|anti-inflammatory|anti-inflammatory
53777|NCT03866265|anti-coagulant|anti-coagulant
53778|NCT03866265|platelet aggregation|platelet aggregation
53779|NCT03866226|ambulatory blood pressure monitoring|ambulatory blood pressure monitoring
53780|NCT03866226|sleep|sleep
53781|NCT03866213|Diagnostic|diagnostic
53782|NCT03866213|Point-of-Care|point-of-care
53783|NCT03866213|Low-Resource Setting|low-resource setting
53784|NCT03866200|resveratrol|resveratrol
53785|NCT03866200|joint pain|joint pain
53787|NCT03866148|Atrial Fibrillation|atrial fibrillation
53788|NCT03866148|Obstructive Sleep Apnea|obstructive sleep apnea
53789|NCT03866148|Implantable Loop Recorder|implantable loop recorder
53790|NCT03866148|Extended Cardiac Monitoring|extended cardiac monitoring
53791|NCT03866148|Matrix Metalloproteinase-9|matrix metalloproteinase-9
53792|NCT03866148|Interleukin-6|interleukin-6
53793|NCT03866148|Tumour Necrosis Factor-Alpha|tumour necrosis factor-alpha
53794|NCT03866148|High sensitivity C-Reactive Protein|high sensitivity c-reactive protein
53795|NCT03866148|High sensitivity Troponin-T|high sensitivity troponin-t
53796|NCT03866148|Fibroblast Growth Factor-23|fibroblast growth factor-23
53797|NCT03866148|Heart Rate Variability|heart rate variability
53798|NCT03866148|N-Terminal pro B-type Natriuretic Peptide|n-terminal pro b-type natriuretic peptide
53799|NCT03866109|Temferon|temferon
53800|NCT03866109|Gene Therapy|gene therapy
53801|NCT03866109|Immunotherapy|immunotherapy
53802|NCT03866109|Solid tumor|solid tumor
53803|NCT03866070|Handball|handball
53804|NCT03866070|Physiotherapy|physiotherapy
53805|NCT03866070|Shoulder instability|shoulder instability
53806|NCT03866070|Scapular dyskinesia|scapular dyskinesia
53807|NCT03866070|Female|female
53808|NCT03866057|Stroke|stroke
53809|NCT03866057|Predictors of recovery|predictors of recovery
53810|NCT03866057|Neurological Rehabilitation|neurological rehabilitation
53811|NCT03866057|Genetic|genetic
53812|NCT03866057|Epigenetic|epigenetic
53813|NCT03866057|Mirror Therapy|mirror therapy
53814|NCT03866057|Neurophysiopathology|neurophysiopathology
53815|NCT03866031|Implant, overdenture, Immediate loading|implant, overdenture, immediate loading
53816|NCT03866005|diabetes, retina, diabetic retinopathy, diabetic macular edema, anti-VEGF therapy|diabetes, retina, diabetic retinopathy, diabetic macular edema, anti-vegf therapy
53817|NCT03865992|Breast cancer|breast cancer
53818|NCT03865992|curcumin|curcumin
53819|NCT03865992|aromatase inhibitor|aromatase inhibitor
53820|NCT03865992|joint pain|joint pain
53821|NCT03865992|arthropathy|arthropathy
53822|NCT03865979|Artificial Intelligence|artificial intelligence
53823|NCT03865979|ICH|ich
53824|NCT03865927|Reactive oxygen species (ROS)|reactive oxygen species (ros)
53825|NCT03865927|nicotinamide adenine dinucleotide phosphate (NADPH) oxidase|nicotinamide adenine dinucleotide phosphate (nadph) oxidase
53826|NCT03865914|Diabetic kidney disease (DKD)|diabetic kidney disease (dkd)
53827|NCT03865914|Diabetic nephropathy（DN)|diabetic nephropathy（dn)
53828|NCT03865914|non-diabetic renal diseases（ NDRD)|non-diabetic renal diseases（ ndrd)
53831|NCT03865901|in vitro diagnostic|in vitro diagnostic
53833|NCT03865901|gestational diabetes mellitus|gestational diabetes mellitus
53834|NCT03865901|screening|screening
53835|NCT03865901|pregnancy|pregnancy
53836|NCT03865901|prenatal care|prenatal care
53837|NCT03865901|women's health|women's health
53838|NCT03865888|Sjogren Syndrome|sjogren syndrome
53839|NCT03865888|Dry eye|dry eye
53840|NCT03865888|Cyclosporine|cyclosporine
53841|NCT03865888|Tacrolimus|tacrolimus
53842|NCT03865875|Pancreatic Ductal Adenocarcinoma|pancreatic ductal adenocarcinoma
53843|NCT03865875|Total Neoadjuvant Therapy|total neoadjuvant therapy
53844|NCT03865875|Prehabilitation|prehabilitation
53845|NCT03865875|Exercise|exercise
53846|NCT03865875|Nutrition|nutrition
53847|NCT03865875|Optimization|optimization
53848|NCT03865875|Surgery|surgery
53849|NCT03865862|Eccentric|eccentric
53850|NCT03865862|Load control|load control
53851|NCT03865862|Volleyball|volleyball
53852|NCT03865862|Physiotherapy|physiotherapy
53853|NCT03865862|Patellar tendon|patellar tendon
53854|NCT03865862|Randomized clinical trial|randomized clinical trial
53855|NCT03865836|expanded access|expanded access
53856|NCT03865836|compassionate use|compassionate use
53857|NCT03865823|anal fistula|anal fistula
53858|NCT03865823|anal infection|anal infection
53859|NCT03865784|Boxing|boxing
53860|NCT03865784|Injuries|injuries
53861|NCT03865784|Physiotherapy|physiotherapy
53862|NCT03865784|Kinesiotape|kinesiotape
53863|NCT03865784|Core|core
53864|NCT03865784|Low back pain|low back pain
53865|NCT03865771|Memory consolidation|memory consolidation
53866|NCT03865771|Epilepsy|epilepsy
53867|NCT03865771|Childhood|childhood
53868|NCT03865771|Benign epilepsy with centro temporal spikes (BECTS)|benign epilepsy with centro temporal spikes (bects)
53869|NCT03865771|Epileptic encephalopathy with continuous spike and waves during sleep (ECSWS)|epileptic encephalopathy with continuous spike and waves during sleep (ecsws)
53870|NCT03865758|Dementia|dementia
53871|NCT03865758|Rehabilitation|rehabilitation
53875|NCT03865719|Second Generation Antipsychotics|second generation antipsychotics
53876|NCT03865719|Weight Management|weight management
53877|NCT03865706|Microbiome|microbiome
53878|NCT03865706|Antibiotic resistance|antibiotic resistance
53879|NCT03865706|Intensive care unit|intensive care unit
53880|NCT03865706|Sepsis|sepsis
53881|NCT03865706|Nutrition|nutrition
53882|NCT03865706|Pathogen colonization|pathogen colonization
53883|NCT03865693|Burn|burn
53884|NCT03865693|pain scrambler|pain scrambler
53885|NCT03865680|Fluoride varnish|fluoride varnish
53886|NCT03865680|Casein|casein
53887|NCT03865680|MI varnish|mi varnish
53888|NCT03865654|Breast Cancer|breast cancer
53889|NCT03865641|burn|burn
53890|NCT03865641|virtual reality|virtual reality
53891|NCT03865628|Doppler|doppler
53892|NCT03865628|Ombilical artery|ombilical artery
53893|NCT03865628|Middel cerebral artery|middel cerebral artery
53894|NCT03865628|Ductus venous|ductus venous
53895|NCT03865628|Aortic isthmus|aortic isthmus
53896|NCT03865628|Amniotic fluid|amniotic fluid
53897|NCT03865628|Intrauterine Growth Restriction|intrauterine growth restriction
53898|NCT03865628|Small-for-gestational Age|small-for-gestational age
53899|NCT03865628|Prognosis|prognosis
53900|NCT03865602|evidence based medicine|evidence based medicine
53901|NCT03865602|continuity of patient care|continuity of patient care
53902|NCT03865602|patient navigator|patient navigator
53903|NCT03865602|health services|health services
53904|NCT03865602|pragmatic clinical trial|pragmatic clinical trial
53905|NCT03865589|Ultrasound Elastography|ultrasound elastography
53906|NCT03865576|ICP|icp
53907|NCT03865576|Papilledema|papilledema
53908|NCT03865576|Neurological Intensive Care|neurological intensive care
53909|NCT03865563|retrograde venous infusion|retrograde venous infusion
53910|NCT03865563|chemotherapy|chemotherapy
53911|NCT03865563|gemcitabine|gemcitabine
53912|NCT03865563|lipiodol|lipiodol
53913|NCT03865524|Osteoarthritis, Knee|osteoarthritis, knee
53914|NCT03865524|Obesity|obesity
53915|NCT03865524|Knee replacement|knee replacement
53916|NCT03865524|Arthroplasty|arthroplasty
53917|NCT03865498|Family Caregivers|family caregivers
53918|NCT03865498|Dementia|dementia
53919|NCT03865485|Parenting Program|parenting program
53920|NCT03865459|anxiety|anxiety
53921|NCT03865459|cystoscopy|cystoscopy
53922|NCT03865459|female|female
53923|NCT03865459|nursing|nursing
53924|NCT03865459|pain|pain
53925|NCT03865459|video|video
53926|NCT03865446|Pharmacokinetics|pharmacokinetics
53927|NCT03865446|Dacomitinib|dacomitinib
53928|NCT03865446|Hepatic Impairment|hepatic impairment
53929|NCT03865420|Pre-symptomatic|pre-symptomatic
53930|NCT03865420|Familial|familial
53931|NCT03865420|FALS|fals
53935|NCT03865420|TARDBP|tardbp
53936|NCT03865420|FUS|fus
53937|NCT03865420|VCP|vcp
53938|NCT03865420|PFN1|pfn1
53939|NCT03865394|stromal vascular fraction|stromal vascular fraction
53940|NCT03865394|adipose-derived mesenchymal stem cells|adipose-derived mesenchymal stem cells
53941|NCT03865394|chronic wounds|chronic wounds
53942|NCT03865394|diabetes|diabetes
53943|NCT03865394|foot ulcer|foot ulcer
53944|NCT03865355|Metabolomic profile|metabolomic profile
53945|NCT03865355|Biomarkers|biomarkers
53946|NCT03865342|mHealth|mhealth
53947|NCT03865342|Diabetes Prevention Program|diabetes prevention program
53948|NCT03865342|weight loss|weight loss
53949|NCT03865342|body weight|body weight
53950|NCT03865342|behavioral interventions|behavioral interventions
53951|NCT03865303|Critical Illness|critical illness
53952|NCT03865303|Patient Safety|patient safety
53953|NCT03865303|Delivery of Health Care|delivery of health care
53954|NCT03865303|Electronic Health Records|electronic health records
816761|NCT00173758|IL-15|il-15
53955|NCT03865277|Head and neck cancer|head and neck cancer
53956|NCT03865277|radiochemotherapy|radiochemotherapy
53957|NCT03865277|HPV|hpv
53958|NCT03865251|H-reflex modulation|h-reflex modulation
53959|NCT03865251|motoneuronal excitability|motoneuronal excitability
53960|NCT03865251|Ia afferent inputs|ia afferent inputs
53961|NCT03865251|posture|posture
53962|NCT03865251|Kinesiology tape|kinesiology tape
53963|NCT03865225|Ischaemic Stroke|ischaemic stroke
53964|NCT03865225|Heart Rate Variability|heart rate variability
53965|NCT03865225|Autonomic Nervous System|autonomic nervous system
53966|NCT03865225|cardiac autonomic dysfunction|cardiac autonomic dysfunction
53967|NCT03865225|sudomotor function|sudomotor function
53968|NCT03865225|vasomotor function|vasomotor function
53969|NCT03865186|Cognition|cognition
53970|NCT03865186|facial expression|facial expression
53971|NCT03865186|facial recognition|facial recognition
53972|NCT03865186|psychiatric nursing|psychiatric nursing
53973|NCT03865186|psychoeducation|psychoeducation
53974|NCT03865186|schizophrenia|schizophrenia
53975|NCT03865173|Stroke|stroke
53976|NCT03865173|Pathways|pathways
53977|NCT03865173|Sequelae|sequelae
53978|NCT03865173|Health services research|health services research
53979|NCT03865160|Myopia|myopia
53980|NCT03865160|Children|children
53981|NCT03865160|Atropine|atropine
53982|NCT03865160|Low-dose|low-dose
53983|NCT03865160|0.01|0.01
53984|NCT03865121|Parkinson Disease|parkinson disease
53985|NCT03865121|Nicotine|nicotine
53986|NCT03865121|Transnasal|transnasal
53987|NCT03865108|Pessary|pessary
53988|NCT03865108|Cervix|cervix
53989|NCT03865108|Biomechanical environment|biomechanical environment
53990|NCT03865108|Aspiration|aspiration
53991|NCT03865108|Computer simulation models|computer simulation models
53992|NCT03865095|Critical Care|critical care
53993|NCT03865095|Muscle loss|muscle loss
53994|NCT03865095|Rectus femoris cross sectional area|rectus femoris cross sectional area
53995|NCT03865095|Muscle ultrasound|muscle ultrasound
53996|NCT03865069|automated oxygen control|automated oxygen control
53997|NCT03865069|automated pressure control|automated pressure control
53998|NCT03865069|CLIO|clio
53999|NCT03865069|Volume guarantee|volume guarantee
54000|NCT03865069|preterm|preterm
54001|NCT03865069|ventilated infants|ventilated infants
54002|NCT03865043|TAVI|tavi
54003|NCT03865043|preclosing|preclosing
54004|NCT03865017|Regulatory T cell|regulatory t cell
54005|NCT03865017|Treg|treg
54006|NCT03865017|cell therapy|cell therapy
54007|NCT03865017|autologous|autologous
54008|NCT03864991|Log book|log book
54009|NCT03864991|Step count|step count
54010|NCT03864991|Diet|diet
54011|NCT03864991|Physical activity|physical activity
54012|NCT03864991|HbA1c|hba1c
54013|NCT03864991|Blood sugar|blood sugar
54014|NCT03864965|Alzheimer's disease|alzheimer's disease
54015|NCT03864965|Dementia|dementia
54016|NCT03864952|Infection|infection
54017|NCT03864952|genomic|genomic
54018|NCT03864952|dental calculus|dental calculus
54019|NCT03864926|Kidney Transplant|kidney transplant
54020|NCT03864913|Gender affirming care|gender affirming care
54021|NCT03864900|Anticoagulants|anticoagulants
54022|NCT03864900|Atrial fibrillation|atrial fibrillation
54023|NCT03864900|Adherence|adherence
54024|NCT03864900|Health belief model|health belief model
54025|NCT03864887|Brain death|brain death
54026|NCT03864887|Oxygen metabolism|oxygen metabolism
54027|NCT03864887|Near infrared spectroscopy|near infrared spectroscopy
54028|NCT03864874|Pulmonary metastases|pulmonary metastases
54029|NCT03864874|Intraoperative ultrasonography|intraoperative ultrasonography
54030|NCT03864874|Thoracoscopy|thoracoscopy
54031|NCT03864874|Lung|lung
54035|NCT03864770|myofascial trigger points|myofascial trigger points
54036|NCT03864770|nocturnal leg cramps|nocturnal leg cramps
54037|NCT03864770|extracorporeal shock wave therapy|extracorporeal shock wave therapy
54038|NCT03864757|unilateral vocal fold paralysis|unilateral vocal fold paralysis
54039|NCT03864757|type I thyroplasty|type i thyroplasty
54040|NCT03864744|liver biopsy|liver biopsy
54041|NCT03864744|Lipid metabolism|lipid metabolism
54042|NCT03864744|Glucose metabolism|glucose metabolism
54043|NCT03864744|Postoperative complications|postoperative complications
54044|NCT03864744|Pancreatic surgery|pancreatic surgery
54045|NCT03864679|exercise|exercise
54046|NCT03864679|fed|fed
54047|NCT03864679|fasted|fasted
54048|NCT03864679|fat|fat
54049|NCT03864679|carbohydrate|carbohydrate
54050|NCT03864666|Peripheral Artery Disease|peripheral artery disease
54051|NCT03864666|Cilostazol|cilostazol
54052|NCT03864666|PMR|pmr
54053|NCT03864666|Extended-Release Tablet of Cilostazol|extended-release tablet of cilostazol
54054|NCT03864653|MSM|msm
54055|NCT03864653|PrEP|prep
54056|NCT03864653|ART|art
54057|NCT03864653|Sexual Risk Behavior|sexual risk behavior
54058|NCT03864575|Nivolumab|nivolumab
54059|NCT03864575|Celecoxib|celecoxib
54060|NCT03864562|gastric emptying|gastric emptying
54061|NCT03864562|oral glucose tolerance test|oral glucose tolerance test
54062|NCT03864562|Ethnicity|ethnicity
54063|NCT03864562|Diabetes risk|diabetes risk
54064|NCT03864523|AMN|amn
54065|NCT03864523|pioglitazone|pioglitazone
54066|NCT03864458|Tenapanor|tenapanor
54067|NCT03864458|Hyperphosphatemia|hyperphosphatemia
54068|NCT03864458|Hemodialysis|hemodialysis
54069|NCT03864445|Tenapanor|tenapanor
54070|NCT03864445|Hyperphosphatemia|hyperphosphatemia
54071|NCT03864445|Hemodialysis|hemodialysis
54072|NCT03864406|Antiretroviral Therapy|antiretroviral therapy
54073|NCT03864406|Human Immunodeficiency Disease|human immunodeficiency disease
54074|NCT03864406|Drug-Drug Interactions|drug-drug interactions
54075|NCT03864406|Thrombosis|thrombosis
54076|NCT03864406|Bleeding|bleeding
54077|NCT03864393|walking economy|walking economy
54078|NCT03864393|fatigability|fatigability
54079|NCT03864393|propulsion|propulsion
54080|NCT03864380|Retinal Vascularization|retinal vascularization
54081|NCT03864380|Intense effort|intense effort
54082|NCT03864380|OCT-A|oct-a
54083|NCT03864354|osteopathic manipulative medicine|osteopathic manipulative medicine
54084|NCT03864354|Spirometry|spirometry
54085|NCT03864354|Respiratory|respiratory
54086|NCT03864354|OMM|omm
54087|NCT03864354|OMT|omt
54088|NCT03864354|osteopathic manual medicine|osteopathic manual medicine
54089|NCT03864354|osteopathic manipulative treatment|osteopathic manipulative treatment
54090|NCT03864354|osteopathic manual treatment|osteopathic manual treatment
54091|NCT03864328|Cough|cough
54092|NCT03864328|Chronic Cough|chronic cough
54093|NCT03864328|IPF|ipf
54094|NCT03864328|IPF Cough|ipf cough
54095|NCT03864315|Vitiligo|vitiligo
54096|NCT03864315|Harmonic Generation Microscopy|harmonic generation microscopy
54097|NCT03864315|In Vivo|in vivo
54098|NCT03864237|alcohol abuse|alcohol abuse
54099|NCT03864237|college students|college students
54100|NCT03864237|preventive programs|preventive programs
54101|NCT03864237|text messages|text messages
54102|NCT03864224|Low Back Pain|low back pain
54103|NCT03864211|Hepatocellular Carcinoma|hepatocellular carcinoma
54104|NCT03864211|Immunotherapy|immunotherapy
54105|NCT03864211|Thermal ablation|thermal ablation
54106|NCT03864198|Male infertility|male infertility
54107|NCT03864198|Reveratrol|reveratrol
54108|NCT03864198|Vitamin B12|vitamin b12
54109|NCT03864198|Vitamin B6|vitamin b6
54110|NCT03864198|Folic acid|folic acid
54111|NCT03864185|IgG4 autoantibody|igg4 autoantibody
54112|NCT03864185|Neurofascin-155|neurofascin-155
54113|NCT03864185|Contactin-1|contactin-1
54114|NCT03864185|Rituximab|rituximab
54115|NCT03864159|Cupping therapy|cupping therapy
54116|NCT03864159|Foam roller|foam roller
54117|NCT03864159|Basketball|basketball
54118|NCT03864159|Flexibility|flexibility
54119|NCT03864159|Hamstring|hamstring
54120|NCT03864146|Alcohol Use Disorder|alcohol use disorder
54121|NCT03864146|Alcohol dependence|alcohol dependence
54122|NCT03864146|Craving|craving
54123|NCT03864107|Glycaemic Control|glycaemic control
54124|NCT03864107|Gut Permeability|gut permeability
54125|NCT03864107|Gut Microbiota|gut microbiota
54126|NCT03864107|Metabolic Endotoxemia|metabolic endotoxemia
54127|NCT03864107|Metabolic Health|metabolic health
54128|NCT03864094|Cardiac Output (CO)|cardiac output (co)
54129|NCT03864094|Systolic Blood Pressure (SBP)|systolic blood pressure (sbp)
54130|NCT03864094|Systemic Vascular Resistance (SVR)|systemic vascular resistance (svr)
54131|NCT03864094|Heart Rate (HR)|heart rate (hr)
54132|NCT03864094|Stroke Volume (SV)|stroke volume (sv)
54133|NCT03864094|Lithium Dilutional Cardiac Output (LiDCO)|lithium dilutional cardiac output (lidco)
54134|NCT03864094|Minimal Invasive Hemodynamic Monitor|minimal invasive hemodynamic monitor
54135|NCT03864094|Propofol|propofol
54136|NCT03864094|Remifentanil|remifentanil
54137|NCT03864094|Ephedrine|ephedrine
54138|NCT03864094|Phenylephrine|phenylephrine
54139|NCT03864094|Norepinephrine|norepinephrine
54140|NCT03864068|Polycystic Ovary Syndrome|polycystic ovary syndrome
54141|NCT03864068|Anovulation|anovulation
54142|NCT03864068|Hyperandrogenism|hyperandrogenism
54143|NCT03864068|Insulin Resistance|insulin resistance
54144|NCT03864068|Glucose Intolerance|glucose intolerance
54145|NCT03864068|Metabolic Complication|metabolic complication
54146|NCT03864055|otitis media|otitis media
54147|NCT03864055|mastoiditis|mastoiditis
54148|NCT03864055|Lateral Sinus Thrombosis|lateral sinus thrombosis
54149|NCT03864055|subperiosteal abscess|subperiosteal abscess
54150|NCT03864055|sigmoid sinus|sigmoid sinus
54151|NCT03864055|mastoid|mastoid
54152|NCT03864055|mastoidectomy|mastoidectomy
54153|NCT03864055|ventilation tube|ventilation tube
54154|NCT03864042|solid tumor|solid tumor
54155|NCT03864042|melanoma|melanoma
54156|NCT03863990|PAH prognosis|pah prognosis
54157|NCT03863990|PAH outcomes|pah outcomes
54158|NCT03863990|PAH survival|pah survival
54159|NCT03863990|PAH risk status|pah risk status
54160|NCT03863977|TAP block|tap block
54161|NCT03863977|inguinal hernia|inguinal hernia
54162|NCT03863964|tranexamic acid|tranexamic acid
54163|NCT03863964|pharmacodynamics|pharmacodynamics
54164|NCT03863964|pharmacokinetics|pharmacokinetics
54165|NCT03863964|pregnancy|pregnancy
54166|NCT03863964|thromboelastometry|thromboelastometry
54167|NCT03863951|ischemic stroke|ischemic stroke
54168|NCT03863951|depression|depression
54169|NCT03863951|intestinal microbiota|intestinal microbiota
54170|NCT03863925|Electroconvulsive therapy|electroconvulsive therapy
54171|NCT03863925|Propofol|propofol
54172|NCT03863925|Target controlled infusion|target controlled infusion
54173|NCT03863899|Ilioinguinal Iliohypogastric nerve block|ilioinguinal iliohypogastric nerve block
54174|NCT03863899|local anaesthesia infiltration|local anaesthesia infiltration
54175|NCT03863899|ultrasound-guided|ultrasound-guided
54176|NCT03863899|pain control|pain control
54177|NCT03863886|crohn's disease|crohn's disease
54178|NCT03863886|ulcerative colitis|ulcerative colitis
54179|NCT03863886|endoscopic ultrasound|endoscopic ultrasound
54180|NCT03863886|inflammatory bowel disease|inflammatory bowel disease
54181|NCT03863873|Carpal Tunnel Syndrome|carpal tunnel syndrome
54182|NCT03863873|Platelet-rich plasma|platelet-rich plasma
54183|NCT03863847|Pain|pain
54184|NCT03863847|Chronic Pain|chronic pain
54185|NCT03863847|Musculoskeletal Pain|musculoskeletal pain
54186|NCT03863847|Treatment|treatment
54187|NCT03863847|Neurofeedback|neurofeedback
54188|NCT03863847|Brain Activity|brain activity
54189|NCT03863847|Brain Oscillation|brain oscillation
54190|NCT03863847|Brain Computer Interface|brain computer interface
54191|NCT03863821|chronic obstructive pulmonary disease|chronic obstructive pulmonary disease
54192|NCT03863821|heated humidified high-flow nasal cannula|heated humidified high-flow nasal cannula
54193|NCT03863821|pulmonary rehabilitation|pulmonary rehabilitation
54194|NCT03863821|six-minute walking test|six-minute walking test
54195|NCT03863808|Cognitive Behavioural Therapy|cognitive behavioural therapy
54196|NCT03863808|Flexion Relaxation Phenomenon|flexion relaxation phenomenon
54197|NCT03863808|Electromyography|electromyography
54198|NCT03863808|Biofeedback|biofeedback
54199|NCT03863808|Functional Training|functional training
54200|NCT03863769|Chiropractic manipulation|chiropractic manipulation
54201|NCT03863769|postural sway|postural sway
54202|NCT03863769|distraction manipulation|distraction manipulation
54203|NCT03863769|performance-based mobility|performance-based mobility
54204|NCT03863756|spondyloarthritis|spondyloarthritis
54205|NCT03863756|spine|spine
54206|NCT03863756|syndesmophyte|syndesmophyte
54207|NCT03863756|radiography|radiography
54208|NCT03863756|EOS|eos
54209|NCT03863730|Food for special medical purposes|food for special medical purposes
54210|NCT03863730|Gut and liver axis|gut and liver axis
54211|NCT03863691|dopamine antagonists|dopamine antagonists
54212|NCT03863691|dopamine blockade|dopamine blockade
54213|NCT03863691|psychophysiological stress response|psychophysiological stress response
54214|NCT03863691|Maastricht acute stress test (MAST)|maastricht acute stress test (mast)
54215|NCT03863691|effort based paradigms|effort based paradigms
54216|NCT03863691|positivity offset theory|positivity offset theory
54217|NCT03863691|international affective picture system (IAPS)|international affective picture system (iaps)
54218|NCT03863678|dry needling|dry needling
54219|NCT03863678|neurodevelopmental therapy|neurodevelopmental therapy
54220|NCT03863678|spasticity|spasticity
54221|NCT03863678|balance|balance
54222|NCT03863678|functions|functions
54223|NCT03863678|independence|independence
54224|NCT03863652|snuffbox approach|snuffbox approach
54225|NCT03863652|distal radial approach|distal radial approach
54226|NCT03863652|hemostasis|hemostasis
54227|NCT03863639|Pre-Eclampsia|pre-eclampsia
54228|NCT03863639|Functional Magnetic Resonance Imaging|functional magnetic resonance imaging
54229|NCT03863639|Neurocognitive Function|neurocognitive function
54230|NCT03863613|Pessary, Cerclage, Progesterone, Twins, Preterm birth|pessary, cerclage, progesterone, twins, preterm birth
54231|NCT03863600|Satisfaction with care|satisfaction with care
54232|NCT03863600|Low-middle income country|low-middle income country
54233|NCT03863600|Continuity of care|continuity of care
54234|NCT03863600|Maternal care|maternal care
54235|NCT03863574|NASH|nash
54236|NCT03863561|self-management|self-management
54237|NCT03863561|questionnaire|questionnaire
54238|NCT03863561|diabetes education|diabetes education
54239|NCT03863535|Conbercept|conbercept
54240|NCT03863535|Panretinal photocoagulation|panretinal photocoagulation
54241|NCT03863535|non-proliferative diabetic retinopathy|non-proliferative diabetic retinopathy
54242|NCT03863535|diabetic macular edema|diabetic macular edema
54243|NCT03863522|Breast Cancer Diagnosis|breast cancer diagnosis
54244|NCT03863522|Ultrasound-guided core needle biopsy|ultrasound-guided core needle biopsy
54245|NCT03863522|Fine needle aspiration|fine needle aspiration
54246|NCT03863522|FNA|fna
54247|NCT03863522|Diagnostic Cartridge|diagnostic cartridge
54248|NCT03863509|vape|vape
54249|NCT03863509|E-Cigarette|e-cigarette
54250|NCT03863509|E-cig|e-cig
54251|NCT03863470|Early ICU mobility|early icu mobility
54252|NCT03863457|breast cancer|breast cancer
54253|NCT03863444|First-time Parents|first-time parents
54254|NCT03863444|Prenatal Preparation Education|prenatal preparation education
54255|NCT03863444|Partner Support|partner support
54256|NCT03863431|High-fat diets|high-fat diets
54257|NCT03863431|High-carbohydrate diets|high-carbohydrate diets
54258|NCT03863431|Glycaemic control|glycaemic control
54259|NCT03863379|Sarcopenia|sarcopenia
54260|NCT03863379|sarcopenic obesity|sarcopenic obesity
54261|NCT03863379|stroke|stroke
54262|NCT03863379|sci|sci
54263|NCT03863379|TBI|tbi
54264|NCT03863379|MS|ms
54265|NCT03863366|5-HT4|5-ht4
54266|NCT03863366|Prucalopride|prucalopride
54267|NCT03863366|Resolor|resolor
54268|NCT03863366|Emotional Processing|emotional processing
54269|NCT03863366|Healthy Volunteers|healthy volunteers
54270|NCT03863340|muscle fatigue|muscle fatigue
54271|NCT03863340|work-related disorders|work-related disorders
54272|NCT03863340|trapezius myalgia|trapezius myalgia
54273|NCT03863340|sustained working task|sustained working task
54274|NCT03863340|high-density EMG|high-density emg
54275|NCT03863327|Acute Coronary Occlusion|acute coronary occlusion
54276|NCT03863327|ACO|aco
54277|NCT03863327|Occlusive Myocardial Infarction|occlusive myocardial infarction
54278|NCT03863327|OMI|omi
54279|NCT03863327|Non-occlusive Myocardial Infarction|non-occlusive myocardial infarction
54280|NCT03863327|NOMI|nomi
54281|NCT03863314|Virtual Reality|virtual reality
54282|NCT03863314|Augmented Reality|augmented reality
54283|NCT03863314|Simulation|simulation
54284|NCT03863314|Workplace|workplace
54285|NCT03863301|Radiotherapy|radiotherapy
54286|NCT03863288|oxytocin|oxytocin
54287|NCT03863288|neuroimaging|neuroimaging
54288|NCT03863288|irritability|irritability
54289|NCT03863288|fMRI|fmri
54290|NCT03863288|pharmacokinetics|pharmacokinetics
54291|NCT03863262|cardiovascular|cardiovascular
54292|NCT03863249|Periodontitis|periodontitis
54293|NCT03863249|Microbiome|microbiome
54294|NCT03863249|Dysbiosis|dysbiosis
54295|NCT03863249|Homeostasis|homeostasis
54296|NCT03863249|Dental plaque|dental plaque
54297|NCT03863249|Antibiotics|antibiotics
54298|NCT03863236|colon cancer, nutritional support, complications, mortality,|colon cancer, nutritional support, complications, mortality,
54299|NCT03863210|cardiovascular risk|cardiovascular risk
54300|NCT03863210|patient education|patient education
54301|NCT03863210|hope|hope
54302|NCT03863210|decisional conflict|decisional conflict
54303|NCT03863210|women|women
54304|NCT03863197|Cerebral Palsy|cerebral palsy
54305|NCT03863197|Spastic Cerebral Palsy|spastic cerebral palsy
54306|NCT03863197|Progressive Strength Training|progressive strength training
54307|NCT03863197|Muscle morphology|muscle morphology
54308|NCT03863184|MRD|mrd
54309|NCT03863184|Minimal-residual-disease|minimal-residual-disease
54310|NCT03863184|Treatment naive|treatment naive
54311|NCT03863184|Untreated|untreated
54312|NCT03863184|Frontline|frontline
54313|NCT03863184|Acalabrutinib|acalabrutinib
54314|NCT03863184|Lenalidomide|lenalidomide
54315|NCT03863184|Rituximab|rituximab
54316|NCT03863132|Aortic stenosis|aortic stenosis
54317|NCT03863132|Low flow|low flow
54318|NCT03863132|Low gradient|low gradient
54319|NCT03863132|Transcatheter aortic valve replacement|transcatheter aortic valve replacement
54320|NCT03863119|Duchenne Muscular Dystrophy|duchenne muscular dystrophy
54321|NCT03863119|Vamorolone|vamorolone
54322|NCT03863119|VBP-15|vbp-15
54323|NCT03863119|DMD|dmd
54324|NCT03863080|IMVT-1401|imvt-1401
54325|NCT03863067|Lumbosacral epiduroscopy|lumbosacral epiduroscopy
54326|NCT03863067|spinal stenosis|spinal stenosis
54327|NCT03863067|magnetic resonance imaging|magnetic resonance imaging
54328|NCT03863067|intraoperative neurophysiological monitoring|intraoperative neurophysiological monitoring
54329|NCT03863067|neurogenic claudication|neurogenic claudication
54330|NCT03863054|Topical Oxygen|topical oxygen
54331|NCT03863054|Wound Management|wound management
54332|NCT03863028|Validity-evidence|validity-evidence
54333|NCT03863028|TURB|turb
54334|NCT03863028|Mastery Learning|mastery learning
54335|NCT03863028|Bladder Cancer|bladder cancer
54336|NCT03863015|OHCA|ohca
54337|NCT03863015|PCAS|pcas
54338|NCT03863015|SIRS|sirs
54339|NCT03863015|Inflammation|inflammation
54340|NCT03863015|RoActemra|roactemra
54341|NCT03863015|Tociluzumab|tociluzumab
54342|NCT03863002|mesenchymal stem cell|mesenchymal stem cell
54343|NCT03862950|Congenital Abnormalities|congenital abnormalities
54344|NCT03862950|Metformin|metformin
54345|NCT03862950|Nervous System Diseases|nervous system diseases
54346|NCT03862950|Chromosome Disorders|chromosome disorders
54347|NCT03862937|Protein Supplementation|protein supplementation
54348|NCT03862937|Body Composition|body composition
54349|NCT03862937|Resistance Training|resistance training
54350|NCT03862937|Functional Capacity|functional capacity
54351|NCT03862937|Muscle Strength|muscle strength
54353|NCT03862924|smoking|smoking
54354|NCT03862872|Inflammation|inflammation
54355|NCT03862872|Skin|skin
54356|NCT03862872|UV-light|uv-light
54357|NCT03862872|Inflammatory markers|inflammatory markers
54358|NCT03862872|Eicosapentaenoic acid (EPA)|eicosapentaenoic acid (epa)
54359|NCT03862872|Docosahexaenoic acid (DHA)|docosahexaenoic acid (dha)
54360|NCT03862872|Fish Oil|fish oil
54361|NCT03862872|Gamma-linolenic acid (GLA)|gamma-linolenic acid (gla)
54362|NCT03862872|Borage oil|borage oil
54363|NCT03862872|Vitamin D|vitamin d
54364|NCT03862872|Zeaxanthin|zeaxanthin
54365|NCT03862872|Lutein|lutein
54366|NCT03862872|Omega-3 Index|omega-3 index
54367|NCT03862872|Chronic Inflammation Test|chronic inflammation test
54368|NCT03862872|11-dehydrothromboxane B2|11-dehydrothromboxane b2
54369|NCT03862872|8-hydroxy-2' -deoxyguanosine (8- OHdG)|8-hydroxy-2' -deoxyguanosine (8- ohdg)
54370|NCT03862872|8-isoprostane|8-isoprostane
54371|NCT03862833|Haplo-SCT|haplo-sct
54372|NCT03862833|Phase 1|phase 1
54373|NCT03862833|Zoledronic acid|zoledronic acid
54374|NCT03862833|IL-2|il-2
54375|NCT03862833|g/d T cells|g/d t cells
54376|NCT03862768|Gastrointestinal Stromal Tumors|gastrointestinal stromal tumors
54377|NCT03862768|imatinib-resistant|imatinib-resistant
54378|NCT03862768|focal progression|focal progression
54379|NCT03862755|Pulmonary embolism|pulmonary embolism
54380|NCT03862755|Thoracic surgery|thoracic surgery
54381|NCT03862755|Thromboprophylaxis|thromboprophylaxis
54382|NCT03862729|Risk stratification|risk stratification
54383|NCT03862729|minimally invasive surgery|minimally invasive surgery
54384|NCT03862729|early-stage ICH patient|early-stage ich patient
54385|NCT03862729|prospective cohort study|prospective cohort study
54386|NCT03862716|Diabetes|diabetes
54387|NCT03862716|IDegLira|ideglira
54388|NCT03862716|Metformin|metformin
54389|NCT03862716|Insulin|insulin
54390|NCT03862716|Diet|diet
54391|NCT03862716|Excercise|excercise
54392|NCT03862716|Lifestyle|lifestyle
54393|NCT03862677|Epithelial ovarian cancer|epithelial ovarian cancer
54394|NCT03862677|Fallopian tube cancer|fallopian tube cancer
54395|NCT03862677|Primary peritoneal cancer|primary peritoneal cancer
54396|NCT03862677|EOC|eoc
54397|NCT03862677|Immunity|immunity
54398|NCT03862677|IMPrOVE|improve
54399|NCT03862677|Prognostic|prognostic
54400|NCT03862677|Immune markers|immune markers
54401|NCT03862651|aNtiplatElet Therapy|antiplatelet therapy
54402|NCT03862651|cangrelor|cangrelor
54403|NCT03862651|randomized|randomized
54404|NCT03862651|DAPT|dapt
54405|NCT03862625|cerebral palsy|cerebral palsy
54406|NCT03862625|scoliosis|scoliosis
54407|NCT03862625|adaptive seating system|adaptive seating system
54408|NCT03862625|sagittal balance|sagittal balance
54409|NCT03862625|pelvic obliquity|pelvic obliquity
54410|NCT03862625|coronal balance|coronal balance
54411|NCT03862599|erectile dysfunction|erectile dysfunction
54412|NCT03862599|shockwave|shockwave
54413|NCT03862599|treatment|treatment
54414|NCT03862599|prostatectomy|prostatectomy
54415|NCT03862586|Implantation|implantation
54416|NCT03862586|Recurrent implantation failure|recurrent implantation failure
54417|NCT03862586|N-acetyl cysteine|n-acetyl cysteine
54418|NCT03862586|HOXA cluster genes|hoxa cluster genes
54419|NCT03862586|Window of implantation|window of implantation
54420|NCT03862573|Virtual Reality|virtual reality
54421|NCT03862573|Pain|pain
54422|NCT03862573|Anxiety|anxiety
54423|NCT03862560|Soccer|soccer
54424|NCT03862560|Female|female
54425|NCT03862560|Lower limb asymmetries|lower limb asymmetries
54426|NCT03862560|Strength|strength
54427|NCT03862547|Erectile Dysfunction|erectile dysfunction
54428|NCT03862547|NGF|ngf
54429|NCT03862547|TrKA|trka
54430|NCT03862547|p75NTR|p75ntr
54431|NCT03862534|Gingival recession|gingival recession
54432|NCT03862534|Non-carious cervical lesion|non-carious cervical lesion
54433|NCT03862534|Connective tissue graft|connective tissue graft
54434|NCT03862521|type 1 diabetes|type 1 diabetes
54435|NCT03862521|low carbohydrate diets|low carbohydrate diets
54436|NCT03862521|insulin pump therapy|insulin pump therapy
54437|NCT03862521|continuous glucose monitoring|continuous glucose monitoring
54438|NCT03862508|Jump|jump
54439|NCT03862508|Plyometrics|plyometrics
54440|NCT03862508|Training|training
54441|NCT03862508|Performance|performance
54442|NCT03862508|Powerinstep|powerinstep
54443|NCT03862508|Non-randomized clinical trial|non-randomized clinical trial
54444|NCT03862482|Dental implant|dental implant
54445|NCT03862456|Disease Progression|disease progression
54446|NCT03862456|Microbiota|microbiota
54447|NCT03862456|Periodontitis/surgery|periodontitis/surgery
54448|NCT03862456|Periodontitis/therapy|periodontitis/therapy
54449|NCT03862456|Periodontitis/drug effect|periodontitis/drug effect
54450|NCT03862456|Periodontitis/drug therapy|periodontitis/drug therapy
54451|NCT03862456|Periodontal diseases/surgery|periodontal diseases/surgery
54452|NCT03862456|Periodontal diseases/therapy|periodontal diseases/therapy
54453|NCT03862456|Periodontal pocket/surgery|periodontal pocket/surgery
54454|NCT03862456|Periodontal pocket/therapy|periodontal pocket/therapy
54455|NCT03862456|Periodontal pocket/drug therapy|periodontal pocket/drug therapy
816858|NCT00173225|asthma|asthma
54456|NCT03862456|Azithromycin/therapeutic use|azithromycin/therapeutic use
54457|NCT03862456|Metronidazole/therapeutic use|metronidazole/therapeutic use
54458|NCT03862456|Azithromycin|azithromycin
54459|NCT03862456|Metronidazole|metronidazole
54460|NCT03862456|Porphyromonas gingivalis|porphyromonas gingivalis
54461|NCT03862443|Preventive Dentistry|preventive dentistry
54462|NCT03862443|Health Disparities|health disparities
54463|NCT03862443|Health Behavior|health behavior
54464|NCT03862443|Behavioral Economics|behavioral economics
54465|NCT03862443|Monetary Incentives|monetary incentives
54466|NCT03862417|Scoliosis|scoliosis
54467|NCT03862417|Exercise|exercise
54468|NCT03862417|Pain|pain
54469|NCT03862417|Posture|posture
54470|NCT03862417|Quality of life|quality of life
54471|NCT03862417|Disability|disability
54472|NCT03862391|postanesthesia agitation|postanesthesia agitation
54473|NCT03862391|general anesthesia|general anesthesia
54474|NCT03862391|low-flow anesthesia|low-flow anesthesia
54475|NCT03862365|reliability|reliability
54476|NCT03862365|validity|validity
54477|NCT03862352|Coronary artery perforation|coronary artery perforation
54478|NCT03862352|Covered coronary stent|covered coronary stent
54479|NCT03862352|Calcific coronary disease|calcific coronary disease
54480|NCT03862339|Catheter Ablation|catheter ablation
54481|NCT03862313|optic neuritis|optic neuritis
54482|NCT03862313|multiple sclerosis|multiple sclerosis
54483|NCT03862313|repetitive transorbital alternating current stimulation|repetitive transorbital alternating current stimulation
54484|NCT03862313|optical coherence tomography|optical coherence tomography
54485|NCT03862313|low-contrast visual acuity|low-contrast visual acuity
54486|NCT03862235|anabolic steroid|anabolic steroid
54487|NCT03862235|T1-mapping|t1-mapping
54488|NCT03862235|cardiac structure|cardiac structure
54489|NCT03862222|retina|retina
54490|NCT03862222|Alzheimer|alzheimer
54491|NCT03862222|cognitive aging|cognitive aging
54492|NCT03862222|biomarker|biomarker
54493|NCT03862222|preclinical Alzheimer's disease|preclinical alzheimer's disease
54494|NCT03862222|ophthalmology|ophthalmology
54495|NCT03862222|neurology|neurology
54496|NCT03862209|Community implementation|community implementation
54497|NCT03862209|Community engagement|community engagement
54498|NCT03862209|patient centerednessP|patient centerednessp
54499|NCT03862209|Implementation science|implementation science
54500|NCT03862209|Co-creation|co-creation
54501|NCT03862209|Iterative learning processes|iterative learning processes
54502|NCT03862196|prevention|prevention
54503|NCT03862196|retention|retention
54504|NCT03862196|mHealth|mhealth
54505|NCT03862170|HDR Brachytherapy|hdr brachytherapy
54506|NCT03862170|prophylactic antibiotics|prophylactic antibiotics
54507|NCT03862170|ciprofloxacin|ciprofloxacin
54508|NCT03862170|ancef|ancef
54510|NCT03862144|nausea|nausea
54511|NCT03862144|vomiting|vomiting
54512|NCT03862144|breast cancer|breast cancer
54513|NCT03862144|AC-based chemotherapy|ac-based chemotherapy
54514|NCT03862092|Enteric zoster|enteric zoster
54515|NCT03862092|Salivary VZV DNA PCR|salivary vzv dna pcr
54516|NCT03862066|head and neck cancer|head and neck cancer
54517|NCT03862053|ocular allergy|ocular allergy
54518|NCT03862053|allergy|allergy
54519|NCT03862053|manuka honey|manuka honey
54520|NCT03862053|anti-inflammatory|anti-inflammatory
54521|NCT03862014|molar incisor hypomineralization|molar incisor hypomineralization
54522|NCT03862014|silver diamine flouride|silver diamine flouride
54523|NCT03862001|randomized control trial|randomized control trial
54524|NCT03862001|lung cancer risk assessment|lung cancer risk assessment
54525|NCT03862001|shared decision making|shared decision making
54526|NCT03861988|depression|depression
54527|NCT03861988|ketamine|ketamine
54528|NCT03861988|anesthesia|anesthesia
54529|NCT03861988|total joint arthroplasty|total joint arthroplasty
54530|NCT03861975|Breast Cancer|breast cancer
54531|NCT03861962|serum-specific donor antibodies (DSA)|serum-specific donor antibodies (dsa)
54532|NCT03861962|human leukocyte antigens (HLA)|human leukocyte antigens (hla)
54533|NCT03861962|organ allocation|organ allocation
54534|NCT03861962|epitope level|epitope level
54535|NCT03861949|apnea|apnea
54544|NCT03861858|borderline personality disorder|borderline personality disorder
54546|NCT03861858|suicide|suicide
54547|NCT03861858|substance use|substance use
54548|NCT03861845|Assistive Technology|assistive technology
54549|NCT03861793|Alkermes|alkermes
54550|NCT03861793|IL-2|il-2
54551|NCT03861793|Interleukin-2|interleukin-2
54552|NCT03861793|Oncology|oncology
54553|NCT03861793|Immuno-oncology|immuno-oncology
54554|NCT03861793|Cytokine|cytokine
54555|NCT03861793|ALKS 4230|alks 4230
54556|NCT03861793|Pembrolizumab|pembrolizumab
54557|NCT03861793|Keytruda|keytruda
54558|NCT03861793|PD-L1|pd-l1
54559|NCT03861793|Solid tumors|solid tumors
54560|NCT03861793|Immunotherapy|immunotherapy
54561|NCT03861767|Prehabilitation|prehabilitation
54562|NCT03861754|Obesity|obesity
54563|NCT03861754|Weight loss|weight loss
71494|NCT03757013|France|france
54564|NCT03861754|Weight maintenance|weight maintenance
54565|NCT03861754|Physical activity|physical activity
54566|NCT03861754|Fitness|fitness
54567|NCT03861741|screening, aortic disease, mortality, genetic testing, imaging|screening, aortic disease, mortality, genetic testing, imaging
54568|NCT03861715|antagonist protocol|antagonist protocol
54569|NCT03861715|degarelix antagonist protocol|degarelix antagonist protocol
54570|NCT03861715|degarelix|degarelix
54571|NCT03861715|IVF|ivf
54572|NCT03861689|Perianal Crohn's disease|perianal crohn's disease
54573|NCT03861689|MRI|mri
54578|NCT03861650|bone marrow aspirate concentrate|bone marrow aspirate concentrate
54579|NCT03861650|Hemifacial Microsomia|hemifacial microsomia
54580|NCT03861650|Distraction osteogenesis|distraction osteogenesis
54581|NCT03861624|Tibia|tibia
54582|NCT03861624|Intramedullary nailing|intramedullary nailing
54583|NCT03861624|External fixation|external fixation
54584|NCT03861624|Trauma|trauma
54585|NCT03861611|ketorolac|ketorolac
54586|NCT03861611|diclofenac|diclofenac
54587|NCT03861611|ibuprofen|ibuprofen
54588|NCT03861611|low back pain|low back pain
54589|NCT03861611|back pain|back pain
54590|NCT03861572|Achilles tendon|achilles tendon
54591|NCT03861572|physical therapy|physical therapy
54592|NCT03861572|eccentric training|eccentric training
54593|NCT03861572|Achilles tendon rupture|achilles tendon rupture
54594|NCT03861572|rehabilitation|rehabilitation
54595|NCT03861546|South Asian adults|south asian adults
54596|NCT03861546|Patient-centered approach|patient-centered approach
54597|NCT03861546|Intensive lifestyle interventions|intensive lifestyle interventions
54598|NCT03861546|Diabetes|diabetes
54599|NCT03861520|Anomaly scan|anomaly scan
54600|NCT03861520|Anuploidy|anuploidy
54601|NCT03861481|Chronic inflammatory demyelinating polyradiculoneuropathy|chronic inflammatory demyelinating polyradiculoneuropathy
54602|NCT03861481|CIDP|cidp
54603|NCT03861481|UCB7665|ucb7665
54604|NCT03861481|rozanolixizumab|rozanolixizumab
54605|NCT03861468|obesity hypoventilation syndrome|obesity hypoventilation syndrome
54606|NCT03861468|obstructive sleep apnea|obstructive sleep apnea
54607|NCT03861468|bicarbonates|bicarbonates
54608|NCT03861468|STOP-BANG|stop-bang
54609|NCT03861455|Chronic Hand Eczema|chronic hand eczema
54610|NCT03861442|front-end features|front-end features
54611|NCT03861442|speech perception|speech perception
54612|NCT03861442|patient reported outcome|patient reported outcome
54613|NCT03861416|Peripheral Arterial Disease|peripheral arterial disease
54614|NCT03861416|Arterial Occlusive Disease|arterial occlusive disease
54615|NCT03861416|intermittent claudication|intermittent claudication
54616|NCT03861403|Metastatic|metastatic
54617|NCT03861403|Stage III or IV|stage iii or iv
54618|NCT03861403|Recurrent|recurrent
54619|NCT03861403|Refractory|refractory
54620|NCT03861403|Solid tumors|solid tumors
54621|NCT03861403|Breast cancer|breast cancer
54622|NCT03861403|Prostate cancer|prostate cancer
54623|NCT03861403|Ovarian cancer|ovarian cancer
54624|NCT03861377|Cardiac Output (CO)|cardiac output (co)
54625|NCT03861377|Systolic Blood Pressure (SBP)|systolic blood pressure (sbp)
54626|NCT03861377|Systemic Vascular Resistance (SVR)|systemic vascular resistance (svr)
54627|NCT03861377|Heart Rate (HR)|heart rate (hr)
54628|NCT03861377|Stroke Volume (SV)|stroke volume (sv)
54629|NCT03861377|Lithium Dilutional Cardiac Output (LiDCO)|lithium dilutional cardiac output (lidco)
54630|NCT03861377|Minimal Invasive Hemodynamic Monitor|minimal invasive hemodynamic monitor
54631|NCT03861377|Remifentanil|remifentanil
54632|NCT03861364|Cardiac Output (CO)|cardiac output (co)
54633|NCT03861364|Systolic Blood Pressure (SBP)|systolic blood pressure (sbp)
54735|NCT03860766|Electromyography|electromyography
54634|NCT03861364|Systemic Vascular Resistance (SVR)|systemic vascular resistance (svr)
54635|NCT03861364|Heart Rate (HR)|heart rate (hr)
54636|NCT03861364|Stroke Volume (SV)|stroke volume (sv)
54637|NCT03861364|Lithium Dilutional Cardiac Output (LiDCO)|lithium dilutional cardiac output (lidco)
54638|NCT03861364|Minimal Invasive Hemodynamic Monitor|minimal invasive hemodynamic monitor
54639|NCT03861364|Propofol|propofol
54640|NCT03861364|Propolipid|propolipid
54641|NCT03861351|Cataract|cataract
54642|NCT03861351|Astigmatism|astigmatism
54643|NCT03861338|opioid use disorder, sublocade, buprenorphine|opioid use disorder, sublocade, buprenorphine
54644|NCT03861325|acute gut failure|acute gut failure
54645|NCT03861312|Laterality task, neck pain|laterality task, neck pain
54646|NCT03861299|Glioblastoma|glioblastoma
54647|NCT03861299|Neurological morbidity|neurological morbidity
54648|NCT03861299|Postoperative complications|postoperative complications
54649|NCT03861299|Extent of resection|extent of resection
54650|NCT03861299|Gross-total resection|gross-total resection
54651|NCT03861299|Health-related quality of life|health-related quality of life
54652|NCT03861299|Progression-free survival|progression-free survival
54653|NCT03861299|Overall survival|overall survival
54654|NCT03861286|Cardiopulmonary Bypass Surgery|cardiopulmonary bypass surgery
54655|NCT03861286|Unfractionated Heparin|unfractionated heparin
54656|NCT03861273|PF 06838435|pf 06838435
54657|NCT03861273|Hemophilia|hemophilia
54658|NCT03861273|Factor IX|factor ix
54659|NCT03861273|FIX|fix
54660|NCT03861273|Gene Therapy|gene therapy
54661|NCT03861273|Infusion|infusion
54662|NCT03861273|rAAV Spark100 hFIX Padua|raav spark100 hfix padua
54663|NCT03861273|BeneGene 2|benegene 2
54664|NCT03861273|Hematological Diseases|hematological diseases
54665|NCT03861273|Annualized bleeding rate (ABR)|annualized bleeding rate (abr)
54666|NCT03861130|Kawasaki Disease|kawasaki disease
54667|NCT03861117|Critical care|critical care
54668|NCT03861117|spontaneous breathing trial|spontaneous breathing trial
54669|NCT03861117|T-piece|t-piece
54670|NCT03861117|positive end-expiratory pressure|positive end-expiratory pressure
54671|NCT03861117|difficult weaning|difficult weaning
54672|NCT03861104|septoplasty; nasal packing; anxiety; medical video|septoplasty; nasal packing; anxiety; medical video
54673|NCT03861013|Stress management|stress management
54674|NCT03861013|Intervention program|intervention program
54675|NCT03861013|University students|university students
54676|NCT03861013|Perceived stress|perceived stress
54677|NCT03861013|Mental health|mental health
54678|NCT03861013|Anxiety|anxiety
54679|NCT03861013|Depression|depression
54680|NCT03861013|Quality of life|quality of life
54681|NCT03861013|Sense of coherence|sense of coherence
54682|NCT03861013|Self-efficacy|self-efficacy
54683|NCT03861013|Social support|social support
54684|NCT03861013|Resilience|resilience
54685|NCT03861013|Psychological resources|psychological resources
54686|NCT03861013|Reward|reward
54687|NCT03861013|Cortisol|cortisol
54688|NCT03861013|Ambulatory assessment|ambulatory assessment
54689|NCT03861000|Healthy Control Subjects|healthy control subjects
54690|NCT03861000|PET Imaging|pet imaging
54691|NCT03861000|Receptor Occupancy|receptor occupancy
54692|NCT03861000|Depression|depression
54693|NCT03860987|Imaging|imaging
54694|NCT03860987|Prostatectomy|prostatectomy
54695|NCT03860987|Anti-androgen Therapy|anti-androgen therapy
54696|NCT03860987|18F-DCFPyL-PSMA|18f-dcfpyl-psma
54697|NCT03860974|regional anesthesia|regional anesthesia
54698|NCT03860974|paravertebral|paravertebral
54699|NCT03860974|erector spinae|erector spinae
54700|NCT03860974|nerve block|nerve block
54701|NCT03860935|Amyloidosis|amyloidosis
54702|NCT03860935|ATTR-CM|attr-cm
54703|NCT03860935|Transthyretin|transthyretin
54704|NCT03860935|Amyloid|amyloid
54705|NCT03860935|TTR|ttr
54706|NCT03860896|Inflammatory Bowel Disease|inflammatory bowel disease
54707|NCT03860896|Ulcerative Colitis|ulcerative colitis
54708|NCT03860883|Malignant|malignant
54709|NCT03860883|Melanoma|melanoma
54710|NCT03860883|Cancer|cancer
54711|NCT03860883|Surgery|surgery
54712|NCT03860870|dried blood spots|dried blood spots
54713|NCT03860870|skeletal muscle biopsies|skeletal muscle biopsies
54714|NCT03860870|muscle strength|muscle strength
54715|NCT03860870|muscle signaling|muscle signaling
54716|NCT03860857|Alzheimer disease|alzheimer disease
54717|NCT03860857|cognitive impairment|cognitive impairment
54718|NCT03860857|mild cognitive impairment|mild cognitive impairment
54719|NCT03860857|biomarker|biomarker
54720|NCT03860857|MRI|mri
54721|NCT03860857|PET|pet
54722|NCT03860831|nasal|nasal
54723|NCT03860831|sedation|sedation
54724|NCT03860831|developmental delay|developmental delay
54725|NCT03860818|medication safety|medication safety
54726|NCT03860805|Sterilization Tubal|sterilization tubal
54727|NCT03860805|Salpingectomy|salpingectomy
54728|NCT03860805|Laparoscopy|laparoscopy
54729|NCT03860805|Ovarian Reserve|ovarian reserve
54730|NCT03860779|colonoscopy|colonoscopy
54731|NCT03860779|biosignals|biosignals
54732|NCT03860779|pain|pain
54733|NCT03860779|sedation|sedation
54734|NCT03860766|Isokinetic|isokinetic
54736|NCT03860766|Physiotherapy|physiotherapy
54737|NCT03860766|Handball|handball
54738|NCT03860753|Alcohol|alcohol
54739|NCT03860753|Pioglitazone|pioglitazone
54740|NCT03860753|Stress|stress
54741|NCT03860753|Anxiety|anxiety
54742|NCT03860740|Physical exercise|physical exercise
54743|NCT03860740|Breast Cancer|breast cancer
54744|NCT03860714|Postoperative Cognitive Dysfunction|postoperative cognitive dysfunction
54745|NCT03860714|Delirium|delirium
54746|NCT03860714|UACR|uacr
54747|NCT03860688|Intestinal lipoprotein|intestinal lipoprotein
54748|NCT03860688|Gut peptide|gut peptide
54749|NCT03860688|Chylomicrons|chylomicrons
54750|NCT03860688|Glucose|glucose
54751|NCT03860662|Antispastic drugs|antispastic drugs
54752|NCT03860662|Nociceptive flexor reflex|nociceptive flexor reflex
54753|NCT03860662|Baclofen|baclofen
54754|NCT03860662|Botulinum toxin|botulinum toxin
54755|NCT03860649|Mobility|mobility
54756|NCT03860649|Functionality|functionality
54757|NCT03860649|Movement disorders|movement disorders
54758|NCT03860649|Rehabilitation|rehabilitation
54759|NCT03860649|Locomotion|locomotion
54760|NCT03860636|In Vitro Fertilisation (IVF)|in vitro fertilisation (ivf)
54761|NCT03860636|Intra Cytoplasmic Injection (ICSI)|intra cytoplasmic injection (icsi)
71742|NCT03755284|anxiety|anxiety
54762|NCT03860636|Endometrial Pattern|endometrial pattern
54763|NCT03860636|Ultrasound|ultrasound
54764|NCT03860623|satiety|satiety
54765|NCT03860623|gut blood flow|gut blood flow
54766|NCT03860623|gastric emptying|gastric emptying
54767|NCT03860623|obesity|obesity
54768|NCT03860623|incretin hormones|incretin hormones
54769|NCT03860610|Total Hip Arthroplasty|total hip arthroplasty
54770|NCT03860610|Total Knee Arthroplasty|total knee arthroplasty
54771|NCT03860610|Osteoarthritis|osteoarthritis
54772|NCT03860610|Muscle strength deficits|muscle strength deficits
54773|NCT03860610|Dynamic stability|dynamic stability
54774|NCT03860584|metabolic endotoxemia|metabolic endotoxemia
54775|NCT03860584|milk fat globule membrane|milk fat globule membrane
54776|NCT03860584|gut health|gut health
54777|NCT03860584|endotoxin|endotoxin
54778|NCT03860584|inflammation|inflammation
54779|NCT03860584|obesity|obesity
54780|NCT03860545|Acute Kidney Injury, cardiopulmonary bypass|acute kidney injury, cardiopulmonary bypass
54781|NCT03860545|brush-border enzymes of the proximal renal tubules|brush-border enzymes of the proximal renal tubules
54782|NCT03860545|ischemia modified albumin|ischemia modified albumin
54783|NCT03860519|asthma|asthma
54784|NCT03860519|uncontrolled asthma|uncontrolled asthma
54785|NCT03860519|asthma medication adherence|asthma medication adherence
54786|NCT03860519|Propeller Health|propeller health
54787|NCT03860519|Connected Inhaler System|connected inhaler system
54788|NCT03860506|healthy subjects who smoke|healthy subjects who smoke
54789|NCT03860506|healthy subjects|healthy subjects
54790|NCT03860493|organ perfusion|organ perfusion
54791|NCT03860493|Fluorescence|fluorescence
54792|NCT03860493|icg|icg
54793|NCT03860480|Post-operative analgesia|post-operative analgesia
54794|NCT03860480|VATS|vats
54795|NCT03860480|Thoracoscopic surgery|thoracoscopic surgery
54796|NCT03860480|Erector spinae plane block|erector spinae plane block
54797|NCT03860480|Regional anesthesia|regional anesthesia
54798|NCT03860467|Status epilepticus|status epilepticus
54799|NCT03860467|Electroencephalogram|electroencephalogram
54800|NCT03860467|Intensive Care Unit|intensive care unit
54801|NCT03860454|Dilated Cardiomyopathy|dilated cardiomyopathy
54802|NCT03860454|Lamin A/C Cardiomyopathy|lamin a/c cardiomyopathy
54803|NCT03860454|Heart failure|heart failure
54804|NCT03860441|cognition|cognition
54805|NCT03860441|mobility|mobility
54806|NCT03860441|cognitive reserve|cognitive reserve
54807|NCT03860441|EEG/ERP|eeg/erp
54808|NCT03860428|PDA|pda
54809|NCT03860428|Ibuprofen|ibuprofen
54810|NCT03860428|Paracetamol|paracetamol
54811|NCT03860428|Expectant management|expectant management
54812|NCT03860402|pre-warmed epiural anesthetics|pre-warmed epiural anesthetics
54813|NCT03860402|epidural anesthesia|epidural anesthesia
54814|NCT03860389|Autism|autism
54815|NCT03860389|Anxiety|anxiety
54816|NCT03860389|Exercise|exercise
54817|NCT03860389|Behaviour|behaviour
54818|NCT03860376|ex vivo drug sensitivity assay|ex vivo drug sensitivity assay
54819|NCT03860376|genomic profiling|genomic profiling
54820|NCT03860350|garlic|garlic
54821|NCT03860337|fat digestion|fat digestion
54822|NCT03860337|alginate|alginate
54823|NCT03860337|sausages|sausages
54824|NCT03860324|Hip Arthroplasty|hip arthroplasty
54825|NCT03860324|Erector Spinae Plane Block|erector spinae plane block
54826|NCT03860311|Ovarian Torsion|ovarian torsion
54827|NCT03860311|Point-of-Care|point-of-care
54828|NCT03860311|Pelvic pain|pelvic pain
54829|NCT03860311|Bedside Ultrasound|bedside ultrasound
54830|NCT03860298|NaviFUS System|navifus system
54831|NCT03860298|Focused Ultrasound|focused ultrasound
54832|NCT03860298|Drug Resistant Epilepsy|drug resistant epilepsy
54833|NCT03860298|Intracranial Electroencephalography|intracranial electroencephalography
54834|NCT03860285|inguinal hernia|inguinal hernia
54835|NCT03860285|quality of life|quality of life
54836|NCT03860285|survey|survey
54837|NCT03860285|surgery|surgery
54838|NCT03860285|pamplona|pamplona
54839|NCT03860285|prospective|prospective
54840|NCT03860285|observational|observational
54841|NCT03860285|cohorts|cohorts
54842|NCT03860233|Continuous Positive Airway Pressure|continuous positive airway pressure
54843|NCT03860233|CPAP|cpap
54844|NCT03860233|Oxytocin|oxytocin
54845|NCT03860207|Humanized 3F8 Bispecific Antibody (Hu3F8-BsAb)|humanized 3f8 bispecific antibody (hu3f8-bsab)
54846|NCT03860207|18-034|18-034
54847|NCT03860168|sleep|sleep
54848|NCT03860168|sedation|sedation
54849|NCT03860168|early mobilization|early mobilization
54850|NCT03860168|acute rehabilitation|acute rehabilitation
54851|NCT03860168|delirium|delirium
54852|NCT03860155|Acute-on-Chronic Liver Failure|acute-on-chronic liver failure
54853|NCT03860155|ACLF|aclf
54854|NCT03860155|ABCB5|abcb5
54855|NCT03860155|ATP Binding Cassette Subfamily B Member 5|atp binding cassette subfamily b member 5
54856|NCT03860155|allogeneic|allogeneic
54857|NCT03860155|mesenchymal stem cells|mesenchymal stem cells
54858|NCT03860155|advanced therapy medicinal product|advanced therapy medicinal product
54859|NCT03860155|somatic cell therapy|somatic cell therapy
54860|NCT03860155|phase I/IIa|phase i/iia
54861|NCT03860129|inhalational Sedation|inhalational sedation
54862|NCT03860116|case management|case management
54863|NCT03860116|men who have sex with men|men who have sex with men
54864|NCT03860116|mhealth|mhealth
54865|NCT03860103|microDoppler|microdoppler
54866|NCT03860103|placenta|placenta
54867|NCT03860103|preeclampsia|preeclampsia
54868|NCT03860103|intrauterine growth restriction|intrauterine growth restriction
54869|NCT03860090|Cephalic Vein|cephalic vein
54870|NCT03860090|Axillary Vein|axillary vein
54871|NCT03860012|methotrexate|methotrexate
54872|NCT03860012|folic|folic
54873|NCT03860012|acid|acid
54874|NCT03859999|Colles' Fracture|colles' fracture
54875|NCT03859999|Distal radial fracture|distal radial fracture
54876|NCT03859999|Manipulation under anaesthesia (MUA)|manipulation under anaesthesia (mua)
54877|NCT03859999|Emergency Department|emergency department
54878|NCT03859960|Body composition|body composition
54879|NCT03859960|glucose|glucose
54880|NCT03859960|spasticity|spasticity
54881|NCT03859960|spinal cord injury|spinal cord injury
54882|NCT03859947|Bronchiolitis|bronchiolitis
54883|NCT03859947|Emergency department|emergency department
54884|NCT03859947|High‑flow nasal cannula|high‑flow nasal cannula
54885|NCT03859947|Flow rate|flow rate
54886|NCT03859908|surgery|surgery
54887|NCT03859908|infection|infection
54888|NCT03859908|antisepsis|antisepsis
54889|NCT03859882|sleep deprivation|sleep deprivation
54890|NCT03859882|cognition|cognition
54891|NCT03859882|attention|attention
54892|NCT03859869|Exocrine Pancreatic Insufficiency (EPI)|exocrine pancreatic insufficiency (epi)
54893|NCT03859869|Pancreatic Cancer|pancreatic cancer
54894|NCT03859869|Creon|creon
54895|NCT03859869|Pancrelipase|pancrelipase
54896|NCT03859804|fusion|fusion
54897|NCT03859804|prostate|prostate
54898|NCT03859804|biopsy|biopsy
54899|NCT03859804|pain|pain
54900|NCT03859778|Opioid-Related Disorders|opioid-related disorders
54901|NCT03859778|student|student
54902|NCT03859778|Community Pharmacy Services|community pharmacy services
54903|NCT03859765|physical disability|physical disability
54904|NCT03859765|pain|pain
54905|NCT03859765|fatigue|fatigue
54906|NCT03859765|distress|distress
54907|NCT03859765|physical activity|physical activity
54908|NCT03859765|coping|coping
54909|NCT03859765|mHealth|mhealth
54910|NCT03859765|cancer|cancer
54911|NCT03859765|symptom management|symptom management
54912|NCT03859752|antibody-drug conjugate|antibody-drug conjugate
54913|NCT03859752|c-Met|c-met
54914|NCT03859752|solid tumors|solid tumors
54915|NCT03859752|Phase 1|phase 1
54916|NCT03859726|Sepsis, NIRS, sublingual microcirculation|sepsis, nirs, sublingual microcirculation
54917|NCT03859713|Physical Therapy|physical therapy
54918|NCT03859713|Cognitive Behavioral Therapy|cognitive behavioral therapy
54919|NCT03859713|Mindfulness|mindfulness
54920|NCT03859713|Adaptive Treatment Regimens|adaptive treatment regimens
54921|NCT03859700|EPIT|epit
54922|NCT03859700|Epicutaneous|epicutaneous
54923|NCT03859700|Immunotherapy|immunotherapy
54924|NCT03859700|Viaskin|viaskin
54925|NCT03859687|Children|children
54926|NCT03859687|Vitamin Supplements|vitamin supplements
54927|NCT03859687|PCV13|pcv13
54928|NCT03859687|Hepatitis A vaccine|hepatitis a vaccine
54929|NCT03859635|acute pain|acute pain
54930|NCT03859635|VATS|vats
54931|NCT03859622|Cytochrome P 450 CYP2D6 Variants|cytochrome p 450 cyp2d6 variants
54932|NCT03859622|Genetic polymorphism|genetic polymorphism
54933|NCT03859622|Practice, Family|practice, family
54934|NCT03859622|Drug metabolism|drug metabolism
54935|NCT03859609|GAP-score|gap-score
54936|NCT03859609|Schwab score|schwab score
54937|NCT03859609|Proximal Junctional Failure|proximal junctional failure
54938|NCT03859609|Spinal Fusion|spinal fusion
54939|NCT03859583|capsaicin|capsaicin
55037|NCT03858972|Tesetaxel|tesetaxel
54940|NCT03859583|resting metabolic rate|resting metabolic rate
54941|NCT03859583|glucose|glucose
54942|NCT03859505|Low Back Pain|low back pain
54943|NCT03859505|Photobiomodulation Therapy|photobiomodulation therapy
54944|NCT03859505|PBMT|pbmt
54945|NCT03859505|Low-Level Laser Therapy|low-level laser therapy
54946|NCT03859505|LLLT|lllt
54947|NCT03859479|Cold snare polypectomy|cold snare polypectomy
54948|NCT03859479|Hot snare polypectomy|hot snare polypectomy
54949|NCT03859479|Сolorectal polyps|сolorectal polyps
54950|NCT03859479|Endoscopic treatment|endoscopic treatment
54951|NCT03859427|Bone Marrow Cancer|bone marrow cancer
54952|NCT03859401|Artificial Pancreas|artificial pancreas
54953|NCT03859401|Continuous Glucose Monitor|continuous glucose monitor
54954|NCT03859401|Exercise|exercise
54955|NCT03859401|Exercise-Induced Hypoglycemia|exercise-induced hypoglycemia
54956|NCT03859375|Colony forming units|colony forming units
54957|NCT03859375|preoperative skin disinfection|preoperative skin disinfection
54958|NCT03859375|microbial skin counts|microbial skin counts
71994|NCT03753581|Aged|aged
54959|NCT03859362|pharmacokinetic, pharmacodynamic, ertapenem, urosepsis|pharmacokinetic, pharmacodynamic, ertapenem, urosepsis
54960|NCT03859349|Endobronchial Ultrasound|endobronchial ultrasound
54961|NCT03859349|Diagnostic Imaging|diagnostic imaging
54962|NCT03859349|Feasibility|feasibility
54963|NCT03859349|Randomized Controlled Trial|randomized controlled trial
54964|NCT03859349|Clinical N0 Disease|clinical n0 disease
54965|NCT03859336|Anxiety|anxiety
54966|NCT03859336|Sleep Issues|sleep issues
54967|NCT03859297|rumination|rumination
54968|NCT03859297|depression|depression
54969|NCT03859297|brain imaging|brain imaging
54970|NCT03859297|cognitive behavioral therapy|cognitive behavioral therapy
54971|NCT03859297|rumination focused cognitive behavioral therapy|rumination focused cognitive behavioral therapy
54972|NCT03859297|default mode network|default mode network
54973|NCT03859297|rumination induction|rumination induction
54974|NCT03859271|Physical activity|physical activity
54975|NCT03859245|Photobiomodulation|photobiomodulation
54976|NCT03859245|Diabetic Retinopathy (DR)|diabetic retinopathy (dr)
54977|NCT03859245|Age-related Macular Degeneration (AMD)|age-related macular degeneration (amd)
54978|NCT03859245|Mid-peripheral Drusen|mid-peripheral drusen
54979|NCT03859245|Alzheimer's disease (AD)|alzheimer's disease (ad)
54980|NCT03859245|Ketogenic Diet (KD)|ketogenic diet (kd)
54981|NCT03859219|Rozanolixizumab|rozanolixizumab
54982|NCT03859219|Caucasian healthy-volunteers|caucasian healthy-volunteers
54983|NCT03859219|Japanese healthy-volunteers|japanese healthy-volunteers
54984|NCT03859219|Phase 1|phase 1
54985|NCT03859219|UCB7665|ucb7665
54986|NCT03859219|Chinese healthy-volunteers|chinese healthy-volunteers
54987|NCT03859206|medical|medical
54988|NCT03859206|Thoracoscopy|thoracoscopy
54989|NCT03859206|loculated|loculated
54990|NCT03859206|empyema|empyema
54991|NCT03859180|Anxiety|anxiety
54992|NCT03859180|Self-managed Intervention|self-managed intervention
54993|NCT03859180|Focused Breathing|focused breathing
54994|NCT03859141|Influenza Vaccine|influenza vaccine
54995|NCT03859141|Quadrivalent|quadrivalent
54996|NCT03859141|Trivalent|trivalent
54997|NCT03859141|Children|children
54998|NCT03859115|transcutaneous electrical nerve stimulation|transcutaneous electrical nerve stimulation
54999|NCT03859115|sevoflurane|sevoflurane
55000|NCT03859115|propofol|propofol
55001|NCT03859115|anesthesia|anesthesia
55002|NCT03859115|myocardial protection|myocardial protection
55003|NCT03859102|Enhanced recovery after Surgery|enhanced recovery after surgery
55004|NCT03859102|ERAS|eras
55005|NCT03859102|Enhanced Recovery after Cardiac Surgery|enhanced recovery after cardiac surgery
55006|NCT03859102|Cardiac Surgery|cardiac surgery
55007|NCT03859102|Coronary Artery Bypass graft|coronary artery bypass graft
55008|NCT03859102|Aortic Valve Surgery|aortic valve surgery
55009|NCT03859102|Mitral Valve Surgery|mitral valve surgery
55010|NCT03859102|Aortic Root Surgery|aortic root surgery
55011|NCT03859089|medical cannabis|medical cannabis
55012|NCT03859089|opioids|opioids
55013|NCT03859089|pain|pain
55014|NCT03859089|substitution|substitution
55015|NCT03859089|alternative|alternative
55016|NCT03859076|mindfulness|mindfulness
55017|NCT03859076|blood pressure|blood pressure
55018|NCT03859076|hypertension|hypertension
55019|NCT03859076|prehypertension|prehypertension
55020|NCT03859076|self regulation|self regulation
55021|NCT03859076|Science of Behavior Change|science of behavior change
55022|NCT03859076|attention control|attention control
55023|NCT03859076|self awareness|self awareness
55024|NCT03859076|emotion regulation|emotion regulation
55025|NCT03859063|Rehabilitation|rehabilitation
55026|NCT03859063|Cognition|cognition
55027|NCT03859063|Physical Fitness|physical fitness
55028|NCT03859063|Case Managers|case managers
55029|NCT03859063|Secondary prevention|secondary prevention
55030|NCT03859024|anterior urethroplasty|anterior urethroplasty
55031|NCT03859024|pain management|pain management
55032|NCT03859024|postoperative pain|postoperative pain
55033|NCT03859024|opioid use|opioid use
55034|NCT03859011|acupuncture|acupuncture
55035|NCT03859011|pain|pain
55036|NCT03859011|disability|disability
55038|NCT03858972|Capecitabine|capecitabine
55039|NCT03858972|HER2 negative|her2 negative
55040|NCT03858972|Combination of tesetaxel and capecitabine|combination of tesetaxel and capecitabine
55041|NCT03858972|Taxane-naive|taxane-naive
55042|NCT03858972|Locally advanced or metastatic breast cancer|locally advanced or metastatic breast cancer
55043|NCT03858972|Hormone receptor positive|hormone receptor positive
55044|NCT03858972|Metastatic breast cancer (MBC)|metastatic breast cancer (mbc)
55045|NCT03858972|Breast cancer|breast cancer
55046|NCT03858972|Central nervous system (CNS) metastases|central nervous system (cns) metastases
55047|NCT03858972|de novo metastatic breast cancer|de novo metastatic breast cancer
55048|NCT03858972|Oral chemotherapy|oral chemotherapy
55049|NCT03858972|Taxane|taxane
55050|NCT03858933|PTSD|ptsd
55051|NCT03858933|Post-Traumatic Stress Disorder|post-traumatic stress disorder
55052|NCT03858933|Acute Stress Syndrome|acute stress syndrome
55053|NCT03858933|Emotion Regulation|emotion regulation
55054|NCT03858933|Depression|depression
55055|NCT03858933|Anxiety|anxiety
55056|NCT03858933|Sexual Assault|sexual assault
55057|NCT03858933|Combat PTSD|combat ptsd
55058|NCT03858868|physical activity|physical activity
55059|NCT03858868|community-based health promotion|community-based health promotion
55060|NCT03858868|built environment|built environment
55061|NCT03858868|faith-based organizations|faith-based organizations
55062|NCT03858855|aromatherapy|aromatherapy
55063|NCT03858855|essential oils|essential oils
55064|NCT03858855|Gastrointestinal Cancer|gastrointestinal cancer
55065|NCT03858855|Neuroendocrine Cancer|neuroendocrine cancer
55066|NCT03858855|Melanoma|melanoma
55067|NCT03858842|Progressive fibrosing interstitial lung disease|progressive fibrosing interstitial lung disease
55068|NCT03858842|Systemic Sclerosis-Associated Interstitial Lung Disease|systemic sclerosis-associated interstitial lung disease
55069|NCT03858829|coronary artery disease|coronary artery disease
55070|NCT03858829|physical activity|physical activity
55071|NCT03858829|cardiac rehabilitation|cardiac rehabilitation
55072|NCT03858829|validation studies|validation studies
55073|NCT03858829|psychometrics|psychometrics
55074|NCT03858816|probiotics|probiotics
55075|NCT03858816|neuropsychiatric disorder|neuropsychiatric disorder
55076|NCT03858816|very low birth weight infants|very low birth weight infants
55077|NCT03858816|attention deficit and hyperactivity disorder (ADHD)|attention deficit and hyperactivity disorder (adhd)
55078|NCT03858816|autism spectrum disorder (ASD)|autism spectrum disorder (asd)
55079|NCT03858803|HIV|hiv
55080|NCT03858803|STI|sti
55081|NCT03858803|Unplanned pregnancy|unplanned pregnancy
55082|NCT03858803|Reproductive health of families|reproductive health of families
55083|NCT03858803|Adolescents|adolescents
55084|NCT03858790|Pain|pain
55085|NCT03858777|sarcoidosis|sarcoidosis
55086|NCT03858764|Paclitaxel|paclitaxel
55087|NCT03858764|Peripheral arterial disease|peripheral arterial disease
55088|NCT03858764|restenosis|restenosis
55089|NCT03858738|breast cancer|breast cancer
55090|NCT03858738|breast pathology|breast pathology
55091|NCT03858738|malignancy|malignancy
55092|NCT03858738|artificial intelligence|artificial intelligence
55093|NCT03858738|liquid crystal contact thermography|liquid crystal contact thermography
55094|NCT03858738|automatic algorithms|automatic algorithms
55095|NCT03858738|efficacy|efficacy
55096|NCT03858738|sensitivity|sensitivity
55097|NCT03858738|specificity|specificity
55098|NCT03858712|Oral Cancer Directed Therapy|oral cancer directed therapy
55099|NCT03858712|Breast Cancer|breast cancer
55100|NCT03858712|Gastrointestinal Cancer|gastrointestinal cancer
55101|NCT03858712|oral chemotherapy|oral chemotherapy
55102|NCT03858673|Vault prolapse|vault prolapse
55103|NCT03858673|Vaginal total hysterectomy|vaginal total hysterectomy
55104|NCT03858621|pain|pain
55105|NCT03858621|Postoperative Pain|postoperative pain
55106|NCT03858621|fentanyl|fentanyl
55107|NCT03858621|Nociceptive monitoring index|nociceptive monitoring index
55108|NCT03858608|Weight loss|weight loss
55109|NCT03858608|Counterweight Plus|counterweight plus
55110|NCT03858595|Eclampsia,|eclampsia,
55111|NCT03858595|Pre-Eclampsia|pre-eclampsia
55112|NCT03858595|Low birthweight|low birthweight
55113|NCT03858595|Wearable|wearable
55114|NCT03858595|continuous monitoring|continuous monitoring
55115|NCT03858556|gait|gait
55116|NCT03858556|effectiveness|effectiveness
55117|NCT03858556|treatment|treatment
55118|NCT03858556|Lumbar intervertebral disc herniation|lumbar intervertebral disc herniation
55119|NCT03858556|Chuna|chuna
55120|NCT03858543|Stretch marks|stretch marks
55121|NCT03858543|Fractional laser therapy|fractional laser therapy
55122|NCT03858543|Poly-L lactic acid|poly-l lactic acid
55123|NCT03858543|Sculptra|sculptra
55124|NCT03858530|Ultrasound elastography|ultrasound elastography
55125|NCT03858504|yoga, home exercises, juvenile idiopathic arthritis|yoga, home exercises, juvenile idiopathic arthritis
55126|NCT03858491|Osimertinib|osimertinib
55127|NCT03858491|Cobicistat|cobicistat
55128|NCT03858491|Pharmacokinetic boosting|pharmacokinetic boosting
55129|NCT03858465|Hypotension|hypotension
55130|NCT03858465|Phenylephrine|phenylephrine
55131|NCT03858465|Ephedryne|ephedryne
55132|NCT03858452|Prostatectomy|prostatectomy
55133|NCT03858452|Rehabilitation|rehabilitation
55134|NCT03858452|Incontinence|incontinence
55135|NCT03858426|Eosinophilic Esophagitis; PPIs, children, elimination diet, topical steroids|eosinophilic esophagitis; ppis, children, elimination diet, topical steroids
55136|NCT03858400|Unconscious patient|unconscious patient
55137|NCT03858400|critical care unit|critical care unit
55138|NCT03858400|electrophysiological test|electrophysiological test
55139|NCT03858387|pharmacokinetic, betalactams, ICU|pharmacokinetic, betalactams, icu
55140|NCT03858335|constraint-induced movement therapy|constraint-induced movement therapy
55141|NCT03858335|hemiplegia|hemiplegia
55142|NCT03858335|hand function|hand function
55143|NCT03858335|gross motor|gross motor
55144|NCT03858322|Breast Cancer|breast cancer
55145|NCT03858309|Cerebrospinal Fluid|cerebrospinal fluid
816859|NCT00173225|COPD|copd
55146|NCT03858309|Cerebrospinal Fluid Flow|cerebrospinal fluid flow
55147|NCT03858309|Cerebrospinal Fluid Circulation|cerebrospinal fluid circulation
55148|NCT03858309|Yoga|yoga
55149|NCT03858309|Yogic Breathwork|yogic breathwork
55150|NCT03858309|Magnetic Resonance Imaging|magnetic resonance imaging
55151|NCT03858309|Breathing|breathing
55152|NCT03858309|Sleep|sleep
55153|NCT03858309|RT-PCMRI|rt-pcmri
55154|NCT03858309|CSF Flow|csf flow
55155|NCT03858309|Slow Breathing|slow breathing
55156|NCT03858309|Respiration|respiration
55157|NCT03858283|Mindfulness|mindfulness
55158|NCT03858283|Anxiety and depression symptoms|anxiety and depression symptoms
55159|NCT03858283|Caregivers|caregivers
55160|NCT03858283|Alzheimer|alzheimer
55161|NCT03858283|neuropsychiatric disorders|neuropsychiatric disorders
55162|NCT03858257|Oxygen|oxygen
55163|NCT03858257|Ventilation|ventilation
55164|NCT03858257|High-flow nasal oxygen|high-flow nasal oxygen
55165|NCT03858257|Hypercapnia|hypercapnia
55166|NCT03858257|Respiratory depression|respiratory depression
55167|NCT03858257|Respiratory compromise|respiratory compromise
55168|NCT03858257|Carbon dioxide|carbon dioxide
55169|NCT03858257|Transcutaneous carbon dioxide|transcutaneous carbon dioxide
55170|NCT03858218|Psychometric properties|psychometric properties
55171|NCT03858218|Sleep disturbance|sleep disturbance
55172|NCT03858218|Childhood cancer survivors|childhood cancer survivors
55173|NCT03858218|Quality of life,|quality of life,
55174|NCT03858218|Confirmatory factor analysis|confirmatory factor analysis
55175|NCT03858192|Acute sarcopenia, muscle, physical function, older adults|acute sarcopenia, muscle, physical function, older adults
55176|NCT03858179|Photobiomodulation Therapy|photobiomodulation therapy
55177|NCT03858179|Low-level Laser Therapy|low-level laser therapy
55178|NCT03858179|Skeletal Muscle Strenght|skeletal muscle strenght
55179|NCT03858179|Strength Training|strength training
55180|NCT03858166|PEG-rhG-CSF|peg-rhg-csf
55181|NCT03858166|secondary prophylaxis|secondary prophylaxis
55182|NCT03858153|chemotherapy|chemotherapy
55183|NCT03858088|liver transplant|liver transplant
55184|NCT03858088|allograft failure|allograft failure
55185|NCT03858088|primary dysfunction|primary dysfunction
55186|NCT03858088|early outcome|early outcome
55187|NCT03858088|survival analysis|survival analysis
55188|NCT03858088|primary non-function|primary non-function
55189|NCT03858088|retransplant|retransplant
55190|NCT03858062|Artificial pancreas|artificial pancreas
55191|NCT03858062|Glucose control|glucose control
55192|NCT03858049|Frozen-thawed embryo transfer|frozen-thawed embryo transfer
55193|NCT03858049|Infertility|infertility
55194|NCT03858049|Crinone|crinone
55195|NCT03858049|Duphaston|duphaston
55196|NCT03858049|Chinese population|chinese population
55197|NCT03858023|hippotherapy|hippotherapy
55198|NCT03858023|gross motor|gross motor
55199|NCT03858023|balance|balance
55200|NCT03858023|behavior|behavior
55201|NCT03858010|asthma|asthma
55202|NCT03857971|Vulnerable plaque|vulnerable plaque
55203|NCT03857971|Optical coherence Tomography|optical coherence tomography
55204|NCT03857971|OCT|oct
55205|NCT03857945|preoperative mobility device training|preoperative mobility device training
55206|NCT03857906|intra-aortic balloon pump|intra-aortic balloon pump
55207|NCT03857906|coronary artery bypass graft|coronary artery bypass graft
55208|NCT03857906|preoperative|preoperative
55209|NCT03857893|Vulvo-vaginal atrophy|vulvo-vaginal atrophy
55210|NCT03857893|Dynamic Quadripolar Radio-Frequency|dynamic quadripolar radio-frequency
55211|NCT03857893|Menopause|menopause
55212|NCT03857893|Genitourinary syndrome of menopause|genitourinary syndrome of menopause
55213|NCT03857802|diabetes mellitus type 2|diabetes mellitus type 2
55214|NCT03857802|prediabetic state|prediabetic state
55215|NCT03857802|sleep hygiene|sleep hygiene
55216|NCT03857802|haemoglobin A glycosylated|haemoglobin a glycosylated
55217|NCT03857802|clinical nursing research|clinical nursing research
55218|NCT03857776|Randomized controlled trial|randomized controlled trial
55219|NCT03857776|Neoplasm|neoplasm
55220|NCT03857776|Communication|communication
55221|NCT03857776|Complementary medicine|complementary medicine
55222|NCT03857776|Integrative care|integrative care
55223|NCT03857776|Integrative medicine|integrative medicine
55224|NCT03857737|early gastric cancer|early gastric cancer
55225|NCT03857737|endoscopic submucosal dissection|endoscopic submucosal dissection
55226|NCT03857737|surgery|surgery
55227|NCT03857711|Bipolar radiofrequency ablation|bipolar radiofrequency ablation
55228|NCT03857711|Atrial Fibrillation New Onset|atrial fibrillation new onset
55229|NCT03857711|Cardiac Heart Diseases|cardiac heart diseases
55230|NCT03857711|CABG|cabg
55231|NCT03857711|Coronary artery disease|coronary artery disease
55232|NCT03857698|Total Knee Prosthesis|total knee prosthesis
55233|NCT03857698|Stabilization Exercise|stabilization exercise
55234|NCT03857698|Balance|balance
55235|NCT03857698|Functional Performance|functional performance
55236|NCT03857698|Lumbar Lordosis Angle|lumbar lordosis angle
55237|NCT03857685|Lens capsule|lens capsule
55238|NCT03857685|Proliferation|proliferation
55239|NCT03857672|Behavioral|behavioral
55240|NCT03857672|Cognitive Therapy|cognitive therapy
55241|NCT03857672|Self-Hypnosis|self-hypnosis
55242|NCT03857659|Pregnancy|pregnancy
55243|NCT03857659|Ultrasound|ultrasound
55244|NCT03857659|neonatal morbidity|neonatal morbidity
55245|NCT03857646|parenteral nutrition|parenteral nutrition
55246|NCT03857646|lipid emulsion|lipid emulsion
55247|NCT03857646|free bilirubin|free bilirubin
55248|NCT03857646|free fatty acids|free fatty acids
55249|NCT03857633|Cardiac MRI|cardiac mri
55250|NCT03857633|Myocardial Fibrosis|myocardial fibrosis
55251|NCT03857633|End Stage Renal Failure|end stage renal failure
55252|NCT03857633|Monocyte Subsets|monocyte subsets
55253|NCT03857633|Renal Replacement Therapy|renal replacement therapy
55254|NCT03857594|Hereditary Cancer Syndrome|hereditary cancer syndrome
55255|NCT03857594|High-Risk|high-risk
55256|NCT03857594|Mutation|mutation
55257|NCT03857594|Germline Mutation|germline mutation
55258|NCT03857594|Rare Cancer Histology|rare cancer histology
55259|NCT03857594|Whole Genome Sequencing (WGS)|whole genome sequencing (wgs)
55260|NCT03857594|Whole Exome Sequencing (WES)|whole exome sequencing (wes)
55261|NCT03857581|Schizophrenia|schizophrenia
55262|NCT03857581|Schizoaffective disorder|schizoaffective disorder
55263|NCT03857581|Bipolar disorder|bipolar disorder
55264|NCT03857581|Major depressive disorder|major depressive disorder
55265|NCT03857581|Psychosis|psychosis
55266|NCT03857581|Substance abuse|substance abuse
55267|NCT03857581|Clozapine|clozapine
55268|NCT03857581|Olanzapine|olanzapine
55269|NCT03857490|Ambulatory Blood Pressure Monitoring|ambulatory blood pressure monitoring
55270|NCT03857490|Sympathetic Neural Control|sympathetic neural control
55271|NCT03857490|Vascular Function|vascular function
55272|NCT03857477|Prostate Cancer|prostate cancer
55273|NCT03857464|Near-Patient Testing|near-patient testing
55274|NCT03857464|Clostridioides difficile|clostridioides difficile
55275|NCT03857464|nosocomial infections|nosocomial infections
55276|NCT03857464|Clostridium difficile Infection|clostridium difficile infection
55277|NCT03857451|Dravet syndrome|dravet syndrome
55278|NCT03857451|severe myoclonic epilepsy of infancy|severe myoclonic epilepsy of infancy
55279|NCT03857451|intellectual disabilities|intellectual disabilities
55280|NCT03857451|movement disorders|movement disorders
55281|NCT03857451|gait|gait
55282|NCT03857451|biomechanics|biomechanics
55283|NCT03857438|Bipolar and Related Disorders|bipolar and related disorders
55284|NCT03857438|Mood Disorders|mood disorders
55285|NCT03857438|Mental Disorders|mental disorders
55286|NCT03857438|Behavioral Symptoms|behavioral symptoms
55287|NCT03857438|Cognitive functions|cognitive functions
55288|NCT03857438|Simulation|simulation
55289|NCT03857425|Gastritis|gastritis
55290|NCT03857425|H Pylori Infection|h pylori infection
55291|NCT03857412|Polishing|polishing
55292|NCT03857412|Cataract surgery|cataract surgery
55293|NCT03857386|pectoral nerve block (PECS block)|pectoral nerve block (pecs block)
55294|NCT03857386|breast reduction surgery|breast reduction surgery
55295|NCT03857386|ultrasonography|ultrasonography
55296|NCT03857386|postoperative pain|postoperative pain
55297|NCT03857386|VAS score|vas score
55298|NCT03857373|Renal Cancer|renal cancer
55299|NCT03857373|Machine Learning|machine learning
55300|NCT03857360|Gluten|gluten
55301|NCT03857360|Probiotic|probiotic
55302|NCT03857360|Microbiota|microbiota
55303|NCT03857360|Dysbiosis|dysbiosis
55304|NCT03857347|FND|fnd
55305|NCT03857347|Functional Neurological Disorder|functional neurological disorder
55306|NCT03857347|Psychoeducation|psychoeducation
55307|NCT03857321|Intranasal Delivery of Insulin|intranasal delivery of insulin
55308|NCT03857321|Cognitive Testing|cognitive testing
55309|NCT03857321|Nasal Insulin|nasal insulin
55310|NCT03857308|well-being|well-being
55311|NCT03857308|sleep|sleep
55312|NCT03857308|caregiver|caregiver
55313|NCT03857295|infections|infections
55314|NCT03857295|neurosurgery|neurosurgery
55315|NCT03857295|multi drug resistance|multi drug resistance
55316|NCT03857295|spondylodiscitis|spondylodiscitis
55317|NCT03857295|sepsis|sepsis
55318|NCT03857282|Bicycling|bicycling
55319|NCT03857282|Coronary Artery Disease|coronary artery disease
55320|NCT03857282|Pulmonary Function|pulmonary function
55321|NCT03857282|Tai Chi|tai chi
55322|NCT03857269|acupressure|acupressure
55323|NCT03857269|Aromatherapy|aromatherapy
55324|NCT03857269|Nursing Homes|nursing homes
55325|NCT03857269|china|china
55326|NCT03857230|follitropin alfa|follitropin alfa
55327|NCT03857230|follicle stimulating hormone|follicle stimulating hormone
55328|NCT03857230|hormones, hormone substitutes, and hormone antagonists|hormones, hormone substitutes, and hormone antagonists
55329|NCT03857230|physiological effects of drugs|physiological effects of drugs
55330|NCT03857230|biosimilar|biosimilar
55331|NCT03857230|bioequivalence|bioequivalence
55332|NCT03857191|obesity|obesity
55333|NCT03857191|sleep apnea|sleep apnea
55334|NCT03857191|hypertension|hypertension
55335|NCT03857191|type 2 diabetes|type 2 diabetes
55336|NCT03857191|CPAP|cpap
816860|NCT00173225|cough|cough
55337|NCT03857126|Signal Database|signal database
55338|NCT03857126|Pregnancy|pregnancy
55339|NCT03857126|Electrocardiogram|electrocardiogram
55340|NCT03857126|Phonocardiogram|phonocardiogram
55341|NCT03857126|Cardiotocography|cardiotocography
55342|NCT03857126|Usability|usability
55343|NCT03857074|Refractory Epilepsy|refractory epilepsy
55344|NCT03857074|Green Light Exposure|green light exposure
55345|NCT03857074|Epileptic Spikes|epileptic spikes
55346|NCT03857061|wearables|wearables
55347|NCT03857061|self-monitoring|self-monitoring
55348|NCT03857035|Trismus|trismus
55349|NCT03857035|piezosurgery|piezosurgery
55350|NCT03857035|pain|pain
55351|NCT03857035|swelling|swelling
55352|NCT03857022|EECP, Heart Failure, NT-proBNP, Inotropic Agents|eecp, heart failure, nt-probnp, inotropic agents
55353|NCT03856957|Serrated Lesion|serrated lesion
55354|NCT03856957|Endocuff|endocuff
55355|NCT03856957|Detection|detection
55356|NCT03856944|Astigmatism|astigmatism
55357|NCT03856944|intraocular lens|intraocular lens
55358|NCT03856944|multifocal|multifocal
55359|NCT03856931|mental health|mental health
55360|NCT03856931|preschool|preschool
55362|NCT03856931|parental depression|parental depression
55363|NCT03856918|Protective ventilation|protective ventilation
55364|NCT03856918|One-lung ventilation|one-lung ventilation
55365|NCT03856905|Cerebral palsy|cerebral palsy
55366|NCT03856905|Extracorporeal Shock Wave Therapy|extracorporeal shock wave therapy
55367|NCT03856905|Functional Electrical Stimulation|functional electrical stimulation
55368|NCT03856905|Function|function
55369|NCT03856905|Gait|gait
55370|NCT03856905|Spasticity|spasticity
55371|NCT03856892|Yoga|yoga
55372|NCT03856892|Breath-based yoga|breath-based yoga
55373|NCT03856892|Stress management|stress management
55374|NCT03856892|Meditation|meditation
55375|NCT03856892|Hatha yoga|hatha yoga
55376|NCT03856879|Chronic obstructive pulmonary disease|chronic obstructive pulmonary disease
55377|NCT03856879|intervention studies|intervention studies
55378|NCT03856879|randomized controlled trial|randomized controlled trial
55379|NCT03856879|provider satisfaction|provider satisfaction
55380|NCT03856879|patient satisfaction|patient satisfaction
55381|NCT03856879|E-consult|e-consult
55382|NCT03856866|PBD, Zellweger spectrum, PBD-ZSD|pbd, zellweger spectrum, pbd-zsd
55383|NCT03856840|Pemphigoid, Bullous|pemphigoid, bullous
55384|NCT03856840|Bullous Pemphigoid|bullous pemphigoid
55385|NCT03856840|Blister Fluid|blister fluid
55386|NCT03856840|Eosinophil Cationic Protein|eosinophil cationic protein
55387|NCT03856840|Tumor Necrosis Factor-alpha|tumor necrosis factor-alpha
55388|NCT03856840|Anti-BP180|anti-bp180
55389|NCT03856840|Disease activity|disease activity
55390|NCT03856840|Disease severity|disease severity
55391|NCT03856801|neuromuscular disease|neuromuscular disease
55392|NCT03856801|whole-body vibration|whole-body vibration
55393|NCT03856801|hypoxia|hypoxia
55394|NCT03856801|strength|strength
55395|NCT03856788|Randomized control trial|randomized control trial
55396|NCT03856788|Subcostal transversus abdominis plane block|subcostal transversus abdominis plane block
55397|NCT03856788|Laparoscopic sleeve gastrectomy|laparoscopic sleeve gastrectomy
55398|NCT03856788|Regional anesthesia|regional anesthesia
55399|NCT03856788|Opioid consumption|opioid consumption
55400|NCT03856788|Bariatrics|bariatrics
55401|NCT03856736|Heart Failure|heart failure
55402|NCT03856736|Telomere Length|telomere length
55403|NCT03856736|Aerobic Exercise|aerobic exercise
55404|NCT03856723|Acute Kidney Injury|acute kidney injury
55405|NCT03856723|Renal Replacement Treatment|renal replacement treatment
55406|NCT03856723|Biomarker|biomarker
55407|NCT03856710|Inguinal hernia|inguinal hernia
55408|NCT03856710|Groin hernia|groin hernia
55409|NCT03856710|Laparoscopy|laparoscopy
55410|NCT03856710|Mesh|mesh
55411|NCT03856684|vaginal|vaginal
55412|NCT03856684|self-sampling|self-sampling
55413|NCT03856684|cervical cancer screening|cervical cancer screening
55414|NCT03856684|Papillomavirus|papillomavirus
55415|NCT03856684|HPV|hpv
55416|NCT03856684|High Risk Human papillomavirus Infection|high risk human papillomavirus infection
55417|NCT03856684|pap smear|pap smear
55418|NCT03856671|Surgical Site Infection|surgical site infection
55419|NCT03856671|oral antibiotics|oral antibiotics
55420|NCT03856671|mechanical bowel preparation|mechanical bowel preparation
55421|NCT03856671|laparoscopic surgery|laparoscopic surgery
55422|NCT03856658|pancreatic cancer, liver metastases, HAI, hepatic artery infusion pump|pancreatic cancer, liver metastases, hai, hepatic artery infusion pump
55423|NCT03856593|Opioids|opioids
55424|NCT03856593|Safe prescribing|safe prescribing
55425|NCT03856567|Anxiety|anxiety
55427|NCT03856567|Obsessive Compulsive Disorder|obsessive compulsive disorder
55428|NCT03856567|Generalized Anxiety Disorder|generalized anxiety disorder
55429|NCT03856567|Social Phobia|social phobia
55430|NCT03856567|Separation Anxiety|separation anxiety
55431|NCT03856567|GAD|gad
55432|NCT03856567|Youth|youth
55433|NCT03856567|Teen|teen
55434|NCT03856567|Therapy|therapy
55435|NCT03856567|Specific Phobia|specific phobia
55436|NCT03856567|Children|children
55437|NCT03856541|advanced solid tumor|advanced solid tumor
55438|NCT03856541|C-Met antibody drug conjugate|c-met antibody drug conjugate
55439|NCT03856541|Safety|safety
55440|NCT03856541|Pharmacokinetics|pharmacokinetics
55441|NCT03856528|meningitis|meningitis
55442|NCT03856528|encephalitis|encephalitis
55443|NCT03856515|Cigarette|cigarette
55444|NCT03856515|Smoker|smoker
55445|NCT03856502|spinal anesthesia|spinal anesthesia
55446|NCT03856502|femoral fracture|femoral fracture
55447|NCT03856502|dexamethasone|dexamethasone
55448|NCT03856489|sleep|sleep
55449|NCT03856489|intensive care unit|intensive care unit
55450|NCT03856489|patient|patient
55451|NCT03856489|nurse|nurse
55452|NCT03856489|inter-rater reliability|inter-rater reliability
55453|NCT03856489|Richards-Campbell sleeping questionnaire|richards-campbell sleeping questionnaire
55454|NCT03856463|end of life|end of life
55455|NCT03856463|quality of care|quality of care
55456|NCT03856463|cancer care delivery|cancer care delivery
55457|NCT03856424|Ventilation|ventilation
55458|NCT03856424|Tracheotomy|tracheotomy
55459|NCT03856424|Difficult weaning|difficult weaning
55460|NCT03856424|Spontaneous Breathing Test|spontaneous breathing test
55461|NCT03856424|Esophageal pressure|esophageal pressure
55462|NCT03856424|Work of breathing|work of breathing
55463|NCT03856424|Esophageal pressure time-product|esophageal pressure time-product
55464|NCT03856424|Difficult weaning from mechanical ventilation|difficult weaning from mechanical ventilation
55465|NCT03856424|Ventilation weaning|ventilation weaning
55466|NCT03856372|Postmastectomy Hypofractionated Adjuvant Radiotherapy|postmastectomy hypofractionated adjuvant radiotherapy
55467|NCT03856346|Vitrectomy|vitrectomy
55468|NCT03856346|Phacoemulsification|phacoemulsification
55469|NCT03856346|Biometry|biometry
55470|NCT03856346|IOL calculation|iol calculation
55471|NCT03856346|Cataract|cataract
55472|NCT03856333|Cognitive Exercise Therapy Approach Scale|cognitive exercise therapy approach scale
55473|NCT03856333|validity|validity
55474|NCT03856333|reliability|reliability
55475|NCT03856333|responsiveness|responsiveness
55476|NCT03856333|neck pain|neck pain
55477|NCT03856320|Obesity|obesity
55478|NCT03856320|Patient Education|patient education
55479|NCT03856320|Weight Loss|weight loss
55480|NCT03856294|gastric motility|gastric motility
55481|NCT03856294|functional dyspepsia|functional dyspepsia
55482|NCT03856294|functional dyspepsia symptoms|functional dyspepsia symptoms
55483|NCT03856229|HIV/AIDS|hiv/aids
55484|NCT03856229|PCP treatment|pcp treatment
55485|NCT03856229|Steroids for PCP|steroids for pcp
55486|NCT03856190|Fasting|fasting
55487|NCT03856190|Vegan|vegan
55488|NCT03856190|Plant based|plant based
55489|NCT03856190|Randomized Trial|randomized trial
55490|NCT03856164|Tranexamic acid|tranexamic acid
55491|NCT03856164|TXA|txa
55492|NCT03856164|Anti-fibrinolytics|anti-fibrinolytics
55493|NCT03856164|Postpartum hemorrhage|postpartum hemorrhage
55494|NCT03856164|Obstetric hemorrhage|obstetric hemorrhage
55495|NCT03856164|Fibrinolysis|fibrinolysis
55496|NCT03856151|hemodialysis|hemodialysis
55497|NCT03856151|Intra-dialytic Hypotension|intra-dialytic hypotension
55498|NCT03856151|heating device|heating device
55499|NCT03856125|Tennis elbow|tennis elbow
55500|NCT03856125|Lateral epicondylalgia|lateral epicondylalgia
55501|NCT03856125|Lateral elbow tendinopathy|lateral elbow tendinopathy
55502|NCT03856125|Lateral elbow pain|lateral elbow pain
55503|NCT03856125|Percutaneous electrical stimulation|percutaneous electrical stimulation
55504|NCT03856086|Comparing Distress Screening|comparing distress screening
55505|NCT03856086|Consultation With Enhanced Usual Care|consultation with enhanced usual care
55506|NCT03856086|Supportive care|supportive care
55507|NCT03856086|18-539|18-539
55508|NCT03856034|spina bifida|spina bifida
55509|NCT03856034|myelomeningocele|myelomeningocele
55510|NCT03856034|neural tube defect|neural tube defect
55511|NCT03856034|chiari malformation|chiari malformation
55512|NCT03856034|fetoscopy|fetoscopy
55513|NCT03856034|percutaneous|percutaneous
55514|NCT03856034|fetus|fetus
55515|NCT03856008|cervical spinal stabilisation exercises|cervical spinal stabilisation exercises
55516|NCT03856008|muscle cross sectional area|muscle cross sectional area
55517|NCT03856008|muscle t2 relaxation time|muscle t2 relaxation time
55518|NCT03855995|Malaria|malaria
55519|NCT03855995|Plasmodium falciparum|plasmodium falciparum
55520|NCT03855995|Vaccine effectiveness|vaccine effectiveness
55521|NCT03855995|Sub-Saharan Africa|sub-saharan africa
55522|NCT03855995|Active surveillance|active surveillance
55523|NCT03855982|myocardial toxicity|myocardial toxicity
55524|NCT03855982|chemotherapies|chemotherapies
55525|NCT03855982|drugs|drugs
55526|NCT03855969|PAC infections|pac infections
55527|NCT03855969|oncology|oncology
55528|NCT03855904|GI bleeding|gi bleeding
55529|NCT03855904|Hemospray|hemospray
55530|NCT03855904|TC-325|tc-325
55531|NCT03855904|malignancy|malignancy
55532|NCT03855904|tumor|tumor
55533|NCT03855891|Ischemic Heart Disease|ischemic heart disease
55534|NCT03855891|Atherosclerosis|atherosclerosis
55535|NCT03855891|micro-RNA|micro-rna
55536|NCT03855891|multislice spiral computed tomography|multislice spiral computed tomography
55537|NCT03855891|coronary angiography|coronary angiography
55538|NCT03855852|vertical bone defect|vertical bone defect
55539|NCT03855852|Ridge augmentation|ridge augmentation
55540|NCT03855852|One stage|one stage
55541|NCT03855852|Xenograft|xenograft
55542|NCT03855852|Collagen membrane|collagen membrane
55543|NCT03855852|Advanced platelet rich fibrin|advanced platelet rich fibrin
55544|NCT03855852|Guided bone regeneration|guided bone regeneration
55545|NCT03855852|Surgical template|surgical template
55546|NCT03855852|Implant|implant
55547|NCT03855852|horizontal bone defect|horizontal bone defect
55548|NCT03855839|Posture|posture
55549|NCT03855839|Muscle activity|muscle activity
55550|NCT03855839|Posture corrective shirts|posture corrective shirts
55551|NCT03855813|30 seconds chair stand test|30 seconds chair stand test
55552|NCT03855813|Performance test|performance test
55553|NCT03855813|Reliability|reliability
55554|NCT03855774|healthy subject|healthy subject
55555|NCT03855774|epidemiological|epidemiological
55556|NCT03855735|Preventable adverse events|preventable adverse events
55557|NCT03855735|Patient safety|patient safety
55558|NCT03855735|Core communication competences|core communication competences
55559|NCT03855735|Different communication models|different communication models
55560|NCT03855735|HAPA|hapa
55561|NCT03855735|Participatory intervention development|participatory intervention development
55562|NCT03855735|Digitization|digitization
55563|NCT03855735|App|app
55564|NCT03855735|eHealth|ehealth
55565|NCT03855735|Health services research|health services research
55566|NCT03855696|MG1113|mg1113
55567|NCT03855696|Hemophilia|hemophilia
55568|NCT03855683|depression|depression
55569|NCT03855683|anxiety|anxiety
55570|NCT03855657|Biobank|biobank
55571|NCT03855644|Pelvic Fracture|pelvic fracture
55572|NCT03855644|Predictive Model|predictive model
55573|NCT03855644|Blood Transfusion|blood transfusion
55574|NCT03855644|Perioperative period|perioperative period
55575|NCT03855631|Kabuki syndrome CRIPSR/Cas9 KMT2D|kabuki syndrome cripsr/cas9 kmt2d
55576|NCT03855618|Translation.|translation.
55577|NCT03855618|Transcultural validation.|transcultural validation.
55578|NCT03855618|Post-Stroke.|post-stroke.
55579|NCT03855579|Levosimendan|levosimendan
55580|NCT03855579|Milrinone|milrinone
55581|NCT03855579|Off-pump|off-pump
55582|NCT03855579|Coronary|coronary
55583|NCT03855553|Anorexia Nervosa|anorexia nervosa
55584|NCT03855553|Bulimia Nervosa|bulimia nervosa
55585|NCT03855553|Eating Disorders|eating disorders
55586|NCT03855553|Adolescence|adolescence
55587|NCT03855553|Clinical Training|clinical training
55588|NCT03855553|Community Outreach|community outreach
55589|NCT03855553|Family Based Treatment|family based treatment
55590|NCT03855553|Enhanced Cognitive Behavioral Therapy|enhanced cognitive behavioral therapy
55591|NCT03855540|Atrial fibrillation|atrial fibrillation
55592|NCT03855540|ECG monitoring|ecg monitoring
55593|NCT03855540|quality of sleep|quality of sleep
55594|NCT03855540|plasmatic biomarkers|plasmatic biomarkers
55595|NCT03855527|Atraumatic Restorative Treatment|atraumatic restorative treatment
55596|NCT03855527|Chlorhexidine|chlorhexidine
55597|NCT03855527|Silver Diamine Fluoride|silver diamine fluoride
55598|NCT03855527|Primary Teeth|primary teeth
55599|NCT03855514|DFU|dfu
55600|NCT03855514|Chronic Diabetic Foot Ulcer|chronic diabetic foot ulcer
55601|NCT03855514|Non-healing DFU|non-healing dfu
55602|NCT03855501|apexification treatment|apexification treatment
55603|NCT03855501|calcium hydroxide|calcium hydroxide
55604|NCT03855501|mineral trioxide aggregate|mineral trioxide aggregate
55605|NCT03855488|Worry|worry
55606|NCT03855488|Anxiety|anxiety
55607|NCT03855488|Imagery|imagery
55608|NCT03855488|Cognitive bias modification|cognitive bias modification
55609|NCT03855475|Exercise|exercise
55610|NCT03855475|Memory|memory
55611|NCT03855475|Brain|brain
55612|NCT03855462|endotamponade|endotamponade
55613|NCT03855462|retinal detachment|retinal detachment
55614|NCT03855462|vitreoretinal proliferation|vitreoretinal proliferation
55615|NCT03855449|Problem solving|problem solving
55616|NCT03855449|Self-management|self-management
55617|NCT03855449|Education|education
55618|NCT03855436|coronary intermediate lesions|coronary intermediate lesions
55619|NCT03855436|quantitative flow reserve|quantitative flow reserve
55620|NCT03855436|serum biomarker|serum biomarker
55621|NCT03855436|risk score|risk score
55622|NCT03855423|MTD|mtd
55623|NCT03855423|TRF|trf
55624|NCT03855423|Pharmacology|pharmacology
55625|NCT03855410|mHealth|mhealth
55626|NCT03855410|preventive intervention|preventive intervention
55627|NCT03855410|substance use|substance use
55628|NCT03855410|youth|youth
55629|NCT03855410|eHealth|ehealth
55630|NCT03855410|technology-based|technology-based
55631|NCT03855410|HIV/STI|hiv/sti
55632|NCT03855397|Microneedles|microneedles
55633|NCT03855397|Buccal mucosa|buccal mucosa
55634|NCT03855397|Transbuccal administration|transbuccal administration
55635|NCT03855371|p53 mutation|p53 mutation
55636|NCT03855371|personalized treatment|personalized treatment
55637|NCT03855371|Decitabine|decitabine
55638|NCT03855371|Arsenic Trioxide|arsenic trioxide
55639|NCT03855371|AML|aml
55640|NCT03855371|MDS|mds
55641|NCT03855319|Neurofeedback|neurofeedback
55642|NCT03855319|Electroencephalography|electroencephalography
55643|NCT03855319|MCI|mci
55644|NCT03855319|Alzheimer|alzheimer
55645|NCT03855267|propofol|propofol
55646|NCT03855267|etomidate|etomidate
55647|NCT03855267|General anesthesia|general anesthesia
55648|NCT03855267|mixture|mixture
55649|NCT03855254|Contextual effects|contextual effects
55650|NCT03855241|Leftover opioids|leftover opioids
55651|NCT03855241|Unused opioids|unused opioids
55652|NCT03855241|Safe prescription opioid disposal|safe prescription opioid disposal
55653|NCT03855241|Drug disposal|drug disposal
55654|NCT03855215|acute respiratory infection|acute respiratory infection
55655|NCT03855215|ARI|ari
55656|NCT03855215|antibiotic|antibiotic
55657|NCT03855215|Antimicrobial resistance|antimicrobial resistance
55658|NCT03855215|AMR|amr
55659|NCT03855215|primary health care|primary health care
55660|NCT03855215|CRP|crp
55661|NCT03855202|PS|ps
55662|NCT03855202|cord blood mononuclaer Cells|cord blood mononuclaer cells
55663|NCT03855202|preterm|preterm
55664|NCT03855163|Mental Distress|mental distress
55665|NCT03855163|Musculoskeletal Pain|musculoskeletal pain
55666|NCT03855163|Work-related|work-related
55667|NCT03855163|Cluster Randomized Trial|cluster randomized trial
55668|NCT03855163|Effect Evaluation|effect evaluation
55669|NCT03855124|Electromyography|electromyography
55670|NCT03855124|Musculoskeletal|musculoskeletal
55671|NCT03855111|Neuropathic pain|neuropathic pain
55672|NCT03855111|HIV Neuropathy|hiv neuropathy
55673|NCT03855111|HIV/AIDS|hiv/aids
55674|NCT03855111|Symptom Management|symptom management
55675|NCT03855111|Acupuncture|acupuncture
55676|NCT03855111|Pain|pain
55677|NCT03855111|Pain Syndrome|pain syndrome
55678|NCT03855098|Metabolomics|metabolomics
55679|NCT03855098|dietary biomarkers|dietary biomarkers
55680|NCT03855098|personalized nutrition|personalized nutrition
55681|NCT03855085|Kidney transplant|kidney transplant
55682|NCT03855085|volumetry|volumetry
55683|NCT03855085|ultrasound|ultrasound
55684|NCT03855072|Mandibular Prognanthism,customized plate|mandibular prognanthism,customized plate
55685|NCT03855046|Internal sphincterotomy|internal sphincterotomy
55686|NCT03855046|Anal fissure|anal fissure
55687|NCT03855046|Chronic anal fissure|chronic anal fissure
55688|NCT03855046|botulinum toxin A|botulinum toxin a
55689|NCT03855046|proctologic diseases|proctologic diseases
55690|NCT03855046|surgical treatment|surgical treatment
55691|NCT03855046|Chronic anal pain|chronic anal pain
55692|NCT03855046|Fecal incontinence|fecal incontinence
55693|NCT03855046|Spasm of the internal sphincter|spasm of the internal sphincter
55694|NCT03855046|Anal sphincter insufficiency|anal sphincter insufficiency
55695|NCT03855046|randomized|randomized
55696|NCT03855020|plasma EBV DNA|plasma ebv dna
55697|NCT03855020|nasopharyngeal carcinoma|nasopharyngeal carcinoma
55698|NCT03855020|longitudinal surveillance|longitudinal surveillance
55699|NCT03855007|Iguratimod|iguratimod
55700|NCT03854981|Insulin Resistance|insulin resistance
55701|NCT03854981|Cardiovascular Risk|cardiovascular risk
55702|NCT03854981|Inflammation|inflammation
55703|NCT03854981|Exercise|exercise
55704|NCT03854981|Diet|diet
55705|NCT03854968|Mechanical ventilation|mechanical ventilation
55706|NCT03854968|Performance|performance
55707|NCT03854955|iScribes|iscribes
55708|NCT03854955|patient satisfaction|patient satisfaction
55709|NCT03854955|device based scribe|device based scribe
55710|NCT03854929|Azithromycin|azithromycin
55711|NCT03854929|Ciprofloxacin|ciprofloxacin
55712|NCT03854929|Children|children
55713|NCT03854929|Dysentery|dysentery
55714|NCT03854929|Vietnam|vietnam
55715|NCT03854916|Physical Activity|physical activity
55716|NCT03854916|Latina|latina
55717|NCT03854916|Hispanic|hispanic
55718|NCT03854916|Women|women
55719|NCT03854916|Minority Health|minority health
55720|NCT03854916|Mobile Technology|mobile technology
55721|NCT03854916|Social Support|social support
55722|NCT03854916|mHealth|mhealth
55723|NCT03854916|Location-based Services|location-based services
55724|NCT03854916|Walking|walking
55725|NCT03854903|breast cancer|breast cancer
55726|NCT03854903|HR+|hr+
55727|NCT03854903|HER2-|her2-
55728|NCT03854903|HR positive|hr positive
55729|NCT03854903|HER2 negative|her2 negative
55730|NCT03854903|metastatic|metastatic
55731|NCT03854903|aromatase inhibitor|aromatase inhibitor
55732|NCT03854903|CDK4/6 inhibitor|cdk4/6 inhibitor
55733|NCT03854903|palbociclib|palbociclib
55734|NCT03854903|bosutinib|bosutinib
55735|NCT03854903|fulvestrant|fulvestrant
55736|NCT03854903|Faslodex|faslodex
55737|NCT03854877|Health behaviour|health behaviour
55738|NCT03854877|Work place intervention|work place intervention
55739|NCT03854877|Stress|stress
55740|NCT03854877|Physical activity|physical activity
55741|NCT03854877|Nutrition|nutrition
55742|NCT03854877|e-health|e-health
55743|NCT03854877|Mindfulness|mindfulness
55744|NCT03854864|Peripheral Nervous System Diseases|peripheral nervous system diseases
55745|NCT03854864|Oncologists|oncologists
55746|NCT03854851|Naldebain|naldebain
55747|NCT03854851|long-term analgesia|long-term analgesia
55748|NCT03854851|take down of anastomosis|take down of anastomosis
55749|NCT03854838|toripalimab|toripalimab
55750|NCT03854838|IMRT|imrt
55751|NCT03854838|Intensity-Modulated Radiation Therapy|intensity-modulated radiation therapy
55752|NCT03854838|PD-1|pd-1
55753|NCT03854812|magnesium sulphate|magnesium sulphate
55754|NCT03854812|fentanyl|fentanyl
55755|NCT03854812|propofol|propofol
55756|NCT03854812|monitored anesthesia care|monitored anesthesia care
55757|NCT03854812|burr-hole evacuation|burr-hole evacuation
55758|NCT03854812|chronic subdural hematoma|chronic subdural hematoma
55759|NCT03854773|Erector spinae plane block|erector spinae plane block
55760|NCT03854773|Video assisted thoracic surgery,|video assisted thoracic surgery,
55761|NCT03854773|Postoperative analgesia|postoperative analgesia
55762|NCT03854734|Vaccinations|vaccinations
55763|NCT03854734|Vaccine hesitancy|vaccine hesitancy
55764|NCT03854734|School-based research|school-based research
55765|NCT03854721|Non-Muscle Invasive Bladder Cancer|non-muscle invasive bladder cancer
55766|NCT03854708|gastric accommodation|gastric accommodation
55767|NCT03854708|gastric emptying|gastric emptying
55768|NCT03854708|hunger|hunger
55769|NCT03854708|satiety|satiety
55770|NCT03854708|nutrient tolerance|nutrient tolerance
55771|NCT03854669|Acute post-operative pain|acute post-operative pain
55772|NCT03854669|Clinical pain variability|clinical pain variability
55773|NCT03854669|Experimental pain variability|experimental pain variability
55774|NCT03854669|FAST|fast
55775|NCT03854669|pain reporting accuracy|pain reporting accuracy
55776|NCT03854656|Overweight|overweight
55777|NCT03854656|Obesity|obesity
55778|NCT03854656|Time-restricted eating|time-restricted eating
55779|NCT03854656|Prediabetes|prediabetes
55780|NCT03854643|pilates method|pilates method
55781|NCT03854617|oral Navelbine|oral navelbine
55782|NCT03854617|Metastasis Breast Cancer|metastasis breast cancer
55783|NCT03854617|metronomic chemotherapy|metronomic chemotherapy
55784|NCT03854591|GLOBAL SURGERY|global surgery
55785|NCT03854591|COLLABORATIVE RESEARCH|collaborative research
55786|NCT03854591|GUNSHOT IN JURY|gunshot in jury
55787|NCT03854591|EPIDEMIOLOGY|epidemiology
55788|NCT03854565|ARDS|ards
55789|NCT03854565|Endothelial Dysfunction|endothelial dysfunction
55790|NCT03854565|mechanical ventilation|mechanical ventilation
55791|NCT03854565|Glycocalyx|glycocalyx
55792|NCT03854565|pulmonary fibrosis|pulmonary fibrosis
55793|NCT03854565|mortality|mortality
55794|NCT03854500|Tenecteplase|tenecteplase
55795|NCT03854500|Thrombolysis|thrombolysis
55796|NCT03854500|Alteplase|alteplase
55797|NCT03854487|stroke; unilateral neglect; mirror therapy; mirror visual feedback|stroke; unilateral neglect; mirror therapy; mirror visual feedback
55798|NCT03854461|individualised dietary advice|individualised dietary advice
55799|NCT03854461|biomarkers|biomarkers
55800|NCT03854461|diet quality|diet quality
55801|NCT03854461|cardiometabolic health|cardiometabolic health
55802|NCT03854448|inferior STEMI|inferior stemi
55803|NCT03854422|Colonoscopy|colonoscopy
55804|NCT03854422|Insertıon tecnique|insertıon tecnique
55805|NCT03854422|Prone|prone
55806|NCT03854422|Left Supine|left supine
55807|NCT03854422|Dynamic|dynamic
55808|NCT03854396|recurrent urinary tract infection|recurrent urinary tract infection
55809|NCT03854396|genitourinary syndrome of menopause|genitourinary syndrome of menopause
55810|NCT03854396|prasterone|prasterone
55811|NCT03854370|surgical prep|surgical prep
55812|NCT03854370|vaginal prep|vaginal prep
55813|NCT03854370|baby shampoo|baby shampoo
55814|NCT03854357|Subscapularis|subscapularis
55815|NCT03854357|Total Shoulder Arthroplasty|total shoulder arthroplasty
55816|NCT03854357|Subscapularis Rehabilitation|subscapularis rehabilitation
55817|NCT03854357|Subscapularis strength|subscapularis strength
55818|NCT03854331|Resilience|resilience
55819|NCT03854331|Cortisol|cortisol
55820|NCT03854331|Feasibility|feasibility
55821|NCT03854331|Healthy lifestyle|healthy lifestyle
55822|NCT03854331|Sleep|sleep
55823|NCT03854318|inherited hematological diseases|inherited hematological diseases
55824|NCT03854318|Rare Diseases|rare diseases
55825|NCT03854318|Hematological Malignancies|hematological malignancies
55826|NCT03854318|Cancer|cancer
55827|NCT03854318|Acute Myeloid Leukemia|acute myeloid leukemia
55828|NCT03854305|Crohn's Disease|crohn's disease
56031|NCT03852797|ketamine|ketamine
55847|NCT03854110|Disease progression on Folfirinox|disease progression on folfirinox
55849|NCT03854045|telepsychiatry|telepsychiatry
55850|NCT03854045|telemedicine|telemedicine
55851|NCT03854045|home-based care|home-based care
55852|NCT03854019|Irritability|irritability
55853|NCT03854006|Atrial Fibrillation|atrial fibrillation
55854|NCT03853993|Influenza Vaccine|influenza vaccine
55855|NCT03853993|Quadrivalent|quadrivalent
55856|NCT03853993|Trivalent|trivalent
55857|NCT03853980|submental|submental
55858|NCT03853980|laxity|laxity
55859|NCT03853980|lipodystrophy|lipodystrophy
55860|NCT03853967|low dose CT scan|low dose ct scan
55861|NCT03853941|Motivation|motivation
55862|NCT03853941|Communication|communication
55863|NCT03853941|Healthcare Professional|healthcare professional
55864|NCT03853941|Training|training
55865|NCT03853941|Adherence|adherence
55866|NCT03853941|Diabetes|diabetes
55867|NCT03853941|Foot Ulcer|foot ulcer
55868|NCT03853928|Hepatocellular carcinoma|hepatocellular carcinoma
55869|NCT03853928|prevention|prevention
55870|NCT03853928|microbiome|microbiome
55874|NCT03853902|prostate cancer|prostate cancer
55875|NCT03853902|mindfulness|mindfulness
55876|NCT03853902|MBSR|mbsr
55877|NCT03853902|online course|online course
55878|NCT03853889|optic nerve sheath pressure|optic nerve sheath pressure
55879|NCT03853889|noninvasive intracranial pressure measurement|noninvasive intracranial pressure measurement
55880|NCT03853889|epidural anesthesia|epidural anesthesia
55881|NCT03853889|cesarean|cesarean
55882|NCT03853863|foot muscle strength|foot muscle strength
55883|NCT03853863|foot muscle size|foot muscle size
55884|NCT03853863|minimal footwear|minimal footwear
55885|NCT03853863|preschool child|preschool child
55886|NCT03853863|ultrasonography|ultrasonography
55887|NCT03853759|Gait Parameters, Heart Failure,Balance,Gait,Cognition,Functional Capacity,Muscle Strength|gait parameters, heart failure,balance,gait,cognition,functional capacity,muscle strength
55888|NCT03853733|palliative radiotherapy|palliative radiotherapy
55889|NCT03853733|rectal bleeding|rectal bleeding
55890|NCT03853733|hypofractionated radiotherapy|hypofractionated radiotherapy
55899|NCT03853668|sleep quality|sleep quality
55900|NCT03853668|aerobic and resisted exercises|aerobic and resisted exercises
55901|NCT03853668|CABG|cabg
55902|NCT03853655|Cancer of the Mouth|cancer of the mouth
55903|NCT03853655|Tongue cancer|tongue cancer
55904|NCT03853655|Buccal Mucosa cancer|buccal mucosa cancer
55905|NCT03853655|Head and Neck|head and neck
55906|NCT03853655|Oral Cancer|oral cancer
55907|NCT03853655|Adjuvant Radiotherapy|adjuvant radiotherapy
55908|NCT03853655|Depth of Invasion|depth of invasion
55909|NCT03853603|lipid profile|lipid profile
55910|NCT03853603|12,13-diHOME|12,13-dihome
55911|NCT03853564|DNA methylation|dna methylation
55912|NCT03853564|Epigenetic regulation|epigenetic regulation
55913|NCT03853564|Video-feedback intervention|video-feedback intervention
55914|NCT03853564|Developmental disability|developmental disability
55915|NCT03853564|Cerebral palsy|cerebral palsy
55916|NCT03853564|Genetic syndromes|genetic syndromes
55917|NCT03853564|Parent-infant interaction|parent-infant interaction
55918|NCT03853564|Early intervention|early intervention
55919|NCT03853564|Neuroendocrine regulation|neuroendocrine regulation
55920|NCT03853551|Non small cell lung cancer (NSCLC)|non small cell lung cancer (nsclc)
55921|NCT03853538|Dermal spray|dermal spray
55922|NCT03853538|Ablative lasering|ablative lasering
55923|NCT03853538|Skin hydration|skin hydration
55924|NCT03853538|Consumer satisfaction|consumer satisfaction
55925|NCT03853538|Sensorial perception|sensorial perception
55926|NCT03853525|Dermal spray|dermal spray
56032|NCT03852797|propofol|propofol
55927|NCT03853525|Laser depilation|laser depilation
55928|NCT03853525|Skin hydration|skin hydration
55929|NCT03853525|Consumer satisfaction|consumer satisfaction
55930|NCT03853525|Sensorial perception|sensorial perception
55931|NCT03853512|Dermal spray|dermal spray
55932|NCT03853512|Peeling|peeling
55933|NCT03853512|Skin hydration|skin hydration
55934|NCT03853512|Consumer satisfaction|consumer satisfaction
55935|NCT03853512|Sensorial perception|sensorial perception
55936|NCT03853499|Failure|failure
55937|NCT03853499|Forceps Delivery|forceps delivery
55938|NCT03853499|Cesarean Section|cesarean section
55939|NCT03853499|Affecting Fetus or Newborn|affecting fetus or newborn
55940|NCT03853499|Vacuum Extraction|vacuum extraction
55941|NCT03853486|VWF|vwf
55942|NCT03853486|von Willebrand Disease|von willebrand disease
55943|NCT03853486|VWD|vwd
55944|NCT03853486|Factor|factor
55945|NCT03853486|ATHN 9|athn 9
55946|NCT03853434|embolization|embolization
55947|NCT03853434|blood loss|blood loss
55948|NCT03853434|Early Goal Directed Therapy|early goal directed therapy
55949|NCT03853434|spine metastasis|spine metastasis
55950|NCT03853408|Acute cholecystitis|acute cholecystitis
55951|NCT03853408|Cholecystectomy|cholecystectomy
55952|NCT03853408|overweight|overweight
55953|NCT03853408|BMI|bmi
55954|NCT03853408|early|early
55955|NCT03853408|delayed|delayed
55956|NCT03853369|ventricular tachycardia|ventricular tachycardia
55957|NCT03853369|ventricular fibrillation|ventricular fibrillation
55958|NCT03853278|Colorectal Neoplasms|colorectal neoplasms
55959|NCT03853278|self-management support|self-management support
55960|NCT03853278|cancer survivor|cancer survivor
55961|NCT03853278|healthy life styles|healthy life styles
55962|NCT03853239|face mask|face mask
55963|NCT03853239|nasal ventilation|nasal ventilation
55964|NCT03853226|After-load cardiac performance|after-load cardiac performance
55965|NCT03853226|high cardiovascular risk|high cardiovascular risk
55966|NCT03853226|surgical patient|surgical patient
55967|NCT03853213|Fear of Recurrence|fear of recurrence
55968|NCT03853213|Acute Coronary Syndrome|acute coronary syndrome
55969|NCT03853213|Intervention|intervention
55970|NCT03853213|Cognitive Bias Modification Training|cognitive bias modification training
55971|NCT03853213|Attentional Bias|attentional bias
55972|NCT03853213|Interpretation Bias|interpretation bias
55973|NCT03853213|Medication Adherence|medication adherence
55974|NCT03853200|Final irrigation|final irrigation
55975|NCT03853200|Irrigation in Endodontics|irrigation in endodontics
55976|NCT03853200|QMix|qmix
55977|NCT03853200|CFU|cfu
55978|NCT03853200|Colony forming unit|colony forming unit
55979|NCT03853200|MRS|mrs
55980|NCT03853200|Microbiological root canal sampling|microbiological root canal sampling
55981|NCT03853174|COPD|copd
55982|NCT03853174|Inflammation|inflammation
55983|NCT03853174|exercise training|exercise training
55984|NCT03853135|Behçet disease|behçet disease
55985|NCT03853135|endocan|endocan
55986|NCT03853122|tendinopathy|tendinopathy
55987|NCT03853122|exercise|exercise
55988|NCT03853122|dosage|dosage
55989|NCT03853122|physiotherapy|physiotherapy
55990|NCT03853057|volumetric capnography|volumetric capnography
55991|NCT03853057|gravity|gravity
55992|NCT03853057|mechanical ventilation|mechanical ventilation
55993|NCT03853057|EIT|eit
55994|NCT03853031|TEE|tee
55995|NCT03853031|LVEDA|lveda
55996|NCT03853031|CVP|cvp
55997|NCT03853031|GDFT|gdft
55998|NCT03852992|Male Pattern Hair Loss|male pattern hair loss
55999|NCT03852992|Androgenetic Alopecia|androgenetic alopecia
56000|NCT03852992|Male Baldness|male baldness
56001|NCT03852992|Bald|bald
56002|NCT03852992|Baldness|baldness
56003|NCT03852953|Screening|screening
56004|NCT03852953|Mammography|mammography
56005|NCT03852953|Overdiagnosis|overdiagnosis
56006|NCT03852953|Womens' perspectives|womens' perspectives
56007|NCT03852953|Harms and benefits|harms and benefits
56008|NCT03852953|False negative|false negative
56009|NCT03852953|Quantitative methods|quantitative methods
56010|NCT03852953|Survival|survival
56011|NCT03852940|vasoactive drug|vasoactive drug
56012|NCT03852940|mechanical ventilation|mechanical ventilation
56013|NCT03852940|early enteral nutrition|early enteral nutrition
56014|NCT03852940|intensive care unit|intensive care unit
56015|NCT03852940|early parenteral nutrition|early parenteral nutrition
56016|NCT03852940|critical care medicine|critical care medicine
56017|NCT03852940|nosocomial infection|nosocomial infection
56018|NCT03852940|mortality|mortality
56019|NCT03852940|shock|shock
56020|NCT03852901|Ketones|ketones
56021|NCT03852901|Metabolism|metabolism
56022|NCT03852901|Hormones|hormones
56023|NCT03852901|Alzheimer's Disease|alzheimer's disease
56024|NCT03852875|Cardiac Rehabilitation|cardiac rehabilitation
56025|NCT03852875|Stress Testing|stress testing
56026|NCT03852875|Education|education
56027|NCT03852836|Cholangiopancreatography by MRI|cholangiopancreatography by mri
56028|NCT03852836|Compressed Sensing|compressed sensing
56029|NCT03852797|uterine contraction|uterine contraction
56030|NCT03852797|oxytocin|oxytocin
56037|NCT03852745|cognitive behavioral therapy, online intervention|cognitive behavioral therapy, online intervention
56039|NCT03852680|wide necked intracranial aneurysms|wide necked intracranial aneurysms
56040|NCT03852667|low back pain|low back pain
56041|NCT03852667|recurrent|recurrent
56042|NCT03852667|non-specific|non-specific
56043|NCT03852667|secondary prevention|secondary prevention
56044|NCT03852667|pain neuroscience education|pain neuroscience education
56045|NCT03852667|exercise therapy|exercise therapy
56046|NCT03852654|Prostate Cancer, PET CT scan, 18F-DCFPyL|prostate cancer, pet ct scan, 18f-dcfpyl
56047|NCT03852628|Alcohol Use Disorder (AUD)|alcohol use disorder (aud)
56048|NCT03852628|Alcoholism|alcoholism
56049|NCT03852628|Alcohol Abuse|alcohol abuse
56050|NCT03852628|Post Traumatic Stress Disorder (PTSD)|post traumatic stress disorder (ptsd)
56051|NCT03852628|Military|military
56052|NCT03852628|Veteran|veteran
56053|NCT03852615|Ovarian Torsion|ovarian torsion
56054|NCT03852615|Laparoscopy|laparoscopy
56055|NCT03852615|Anti Mullarian Hormone (AMH)|anti mullarian hormone (amh)
56056|NCT03852589|Airway management|airway management
56057|NCT03852589|Videolaryngoscopy|videolaryngoscopy
56058|NCT03852589|General anesthesia|general anesthesia
56059|NCT03852563|Skin cream|skin cream
56060|NCT03852563|Ablative lasering|ablative lasering
56061|NCT03852563|Skin hydration|skin hydration
56062|NCT03852563|Consumer satisfaction|consumer satisfaction
56063|NCT03852563|Sensorial perception|sensorial perception
56064|NCT03852550|Health Care Transition|health care transition
56065|NCT03852550|Brain-Based Disabilities|brain-based disabilities
56066|NCT03852550|CHILD-BRIGHT|child-bright
56067|NCT03852550|e-health application|e-health application
56068|NCT03852550|randomized controlled trial|randomized controlled trial
56069|NCT03852537|Pneumonia, steroid|pneumonia, steroid
56070|NCT03852524|Spinal Arthrodesis|spinal arthrodesis
56071|NCT03852524|Ileus|ileus
56072|NCT03852524|Postoperative Ileus|postoperative ileus
56073|NCT03852524|Adult Spinal Deformity|adult spinal deformity
56074|NCT03852511|metastatic; epithelial; virus; advanced|metastatic; epithelial; virus; advanced
56075|NCT03852498|Adrenoleukodystrophy|adrenoleukodystrophy
56076|NCT03852498|X-linked adrenoleukodystrophy|x-linked adrenoleukodystrophy
56077|NCT03852498|Gene therapy|gene therapy
56078|NCT03852498|Hematopoietic stem cell|hematopoietic stem cell
56079|NCT03852472|Avacopan|avacopan
56080|NCT03852472|ChemoCentryx|chemocentryx
56081|NCT03852472|Skin Disease|skin disease
56082|NCT03852472|Inflammatory nodule|inflammatory nodule
56083|NCT03852472|Abscess|abscess
56084|NCT03852472|Sinus formation|sinus formation
56085|NCT03852472|Fistula formation|fistula formation
56086|NCT03852446|Indoximod|indoximod
56087|NCT03852407|hematological malignancies|hematological malignancies
56088|NCT03852407|Graft versus host disease|graft versus host disease
56089|NCT03852407|GVHD|gvhd
56090|NCT03852407|Progression free survival|progression free survival
56091|NCT03852407|Allogeneic hematopoeitic cell transplantation|allogeneic hematopoeitic cell transplantation
56092|NCT03852407|HLA-matched donor|hla-matched donor
56093|NCT03852407|reduced intensity conditioning|reduced intensity conditioning
56094|NCT03852407|Overall survival|overall survival
56095|NCT03852407|ATG PK|atg pk
56096|NCT03852407|Immunosuppressive regimen|immunosuppressive regimen
56097|NCT03852407|Prophylaxis|prophylaxis
56098|NCT03852381|Spinal Cord Stimulation|spinal cord stimulation
56099|NCT03852381|Burst Stimulation|burst stimulation
56100|NCT03852381|High Frequency Stimulation|high frequency stimulation
56101|NCT03852381|High Density Stimulation|high density stimulation
56102|NCT03852381|fMRI|fmri
56103|NCT03852381|MEG|meg
56104|NCT03852381|QST|qst
56105|NCT03852342|Anaphylaxis|anaphylaxis
56106|NCT03852342|Oral Food Challenge|oral food challenge
56107|NCT03852342|Hypersensitivity|hypersensitivity
56108|NCT03852342|Food Allergy|food allergy
56109|NCT03852342|Peanut|peanut
56110|NCT03852329|Image-guidance|image-guidance
56111|NCT03852329|Lateral skull base surgery|lateral skull base surgery
56117|NCT03852290|Colon cancer|colon cancer
56118|NCT03852290|Fluoropyrimidine|fluoropyrimidine
56119|NCT03852264|Oxytocin|oxytocin
56120|NCT03852264|Vasopressin|vasopressin
56121|NCT03852264|Cortisol|cortisol
56122|NCT03852264|Human-animal interaction|human-animal interaction
56123|NCT03852251|immuno-oncology|immuno-oncology
56124|NCT03852251|PD-1/CTLA-4 Bispecific|pd-1/ctla-4 bispecific
56125|NCT03852251|gastric or GEJ adenocarcinoma|gastric or gej adenocarcinoma
56126|NCT03852251|PD-1|pd-1
56127|NCT03852251|CTLA-4|ctla-4
56128|NCT03852238|hepatocellular carcinoma|hepatocellular carcinoma
56129|NCT03852238|Non-cirrhotic liver|non-cirrhotic liver
56130|NCT03852238|Risk factors|risk factors
56131|NCT03852212|Thrust technique|thrust technique
56132|NCT03852212|Blood levels|blood levels
56133|NCT03852212|Pancreas|pancreas
56134|NCT03852212|Ninth vertebra|ninth vertebra
56135|NCT03852212|Manipulation|manipulation
56136|NCT03852199|force sense|force sense
56137|NCT03852199|knee joint|knee joint
56138|NCT03852199|proprioception|proprioception
56139|NCT03852199|sphygmomanometer|sphygmomanometer
56140|NCT03852199|surface EMG|surface emg
56141|NCT03852173|Child|child
56142|NCT03852173|Health promotion|health promotion
56143|NCT03852173|longitudinal studies|longitudinal studies
56144|NCT03852173|Surveys and Questionnaires|surveys and questionnaires
56145|NCT03852173|beverages|beverages
56146|NCT03852173|Water/administration & dosage|water/administration & dosage
56147|NCT03852173|Austria|austria
56148|NCT03852173|Program evaluation|program evaluation
56149|NCT03852173|Students/statistics & numerical data|students/statistics & numerical data
56150|NCT03852173|Food Preferences|food preferences
56151|NCT03852173|Follow-Up Studies|follow-up studies
56152|NCT03852173|school setting|school setting
56153|NCT03852173|behavioural change|behavioural change
56154|NCT03852147|respiratory quotient, post operative complications, anaerobic metabolism.|respiratory quotient, post operative complications, anaerobic metabolism.
56155|NCT03852134|preterm infant|preterm infant
56156|NCT03852134|delayed cord clamping|delayed cord clamping
56157|NCT03852134|cord milking|cord milking
56158|NCT03852134|resuscitation|resuscitation
56159|NCT03852121|caregiving appraisal|caregiving appraisal
56160|NCT03852121|bibliotherapy|bibliotherapy
56161|NCT03852121|psychological wellbeing|psychological wellbeing
56162|NCT03852121|informal caregiver|informal caregiver
56163|NCT03852095|Pediatric, traumatology, hemarthrosis, ankle, knee,|pediatric, traumatology, hemarthrosis, ankle, knee,
56164|NCT03852095|buckle fracture, clavicle, sprains|buckle fracture, clavicle, sprains
56165|NCT03852030|prostate cancer|prostate cancer
56166|NCT03852030|mindfulness|mindfulness
56167|NCT03852030|eHealth|ehealth
56168|NCT03852030|kidney cancer|kidney cancer
56169|NCT03852030|bladder cancer|bladder cancer
56170|NCT03852030|caregiver|caregiver
56171|NCT03852017|prostate cancer|prostate cancer
56172|NCT03852017|mindfulness|mindfulness
56173|NCT03852017|music|music
56174|NCT03852004|osteopathy|osteopathy
56175|NCT03852004|hypotonia|hypotonia
56176|NCT03852004|children|children
56177|NCT03851991|AECOPD|aecopd
56178|NCT03851991|Arbidol|arbidol
56179|NCT03851978|vaccination|vaccination
56180|NCT03851965|Soluble urokinase plasminogen activator receptor|soluble urokinase plasminogen activator receptor
56181|NCT03851965|Major non-cardiac surgery|major non-cardiac surgery
56182|NCT03851965|Outcome|outcome
56183|NCT03851965|Perioperative|perioperative
56184|NCT03851926|HYPOFRACTIONED|hypofractioned
56185|NCT03851900|Dentin hypersensitivity|dentin hypersensitivity
56186|NCT03851900|Randomized clinical trial|randomized clinical trial
56187|NCT03851900|Calcium phosphate desensitizer|calcium phosphate desensitizer
56188|NCT03851900|Adhesive resin|adhesive resin
56189|NCT03851900|VAS|vas
56190|NCT03851874|Bariatric surgery, gut peptides, weight loss, glycemia|bariatric surgery, gut peptides, weight loss, glycemia
56191|NCT03851861|Intestinal Permeability|intestinal permeability
56192|NCT03851861|Mediterranean Diet|mediterranean diet
56193|NCT03851861|Leaky Gut|leaky gut
56194|NCT03851861|Intestinal Barrier Function|intestinal barrier function
56195|NCT03851848|Myofascial release|myofascial release
56196|NCT03851848|Ankle and foot mobilization|ankle and foot mobilization
56197|NCT03851848|Diabetic patients|diabetic patients
56198|NCT03851848|plantar heel pain|plantar heel pain
56199|NCT03851835|Vomiting|vomiting
56200|NCT03851835|Zofran|zofran
56201|NCT03851835|Ondansetron|ondansetron
56202|NCT03851835|Gastroenteritis|gastroenteritis
56203|NCT03851835|Pediatrics|pediatrics
56204|NCT03851835|DOSE-AGE|dose-age
56205|NCT03851809|traditional chinese medicine combination treatment|traditional chinese medicine combination treatment
56206|NCT03851796|Pediatric Obesity|pediatric obesity
56207|NCT03851796|Lifestyle Intervention|lifestyle intervention
56208|NCT03851796|Family-based Intervention|family-based intervention
56209|NCT03851796|Motivational Interviewing|motivational interviewing
56210|NCT03851783|solar|solar
56211|NCT03851783|oxygen|oxygen
56212|NCT03851770|Epilepsy|epilepsy
56213|NCT03851757|biofilm|biofilm
56214|NCT03851757|interdental brushes|interdental brushes
56215|NCT03851757|interproximal|interproximal
56216|NCT03851757|oral hygiene|oral hygiene
56217|NCT03851757|periodontal disease(s)/periodontitis|periodontal disease(s)/periodontitis
56218|NCT03851718|Acupuncture|acupuncture
56219|NCT03851718|Hypogalactia|hypogalactia
56220|NCT03851718|Power Pumping|power pumping
56221|NCT03851718|Brest Milk Production|brest milk production
56222|NCT03851692|Sevoflurane|sevoflurane
56223|NCT03851692|Intravenous Cannulation|intravenous cannulation
56224|NCT03851692|anesthesia|anesthesia
56225|NCT03851692|child|child
56226|NCT03851679|pulmonary echography|pulmonary echography
56227|NCT03851679|B-Type natriuretic peptide|b-type natriuretic peptide
56228|NCT03851679|Spinal anesthesia|spinal anesthesia
56229|NCT03851653|obstructive sleep apnea|obstructive sleep apnea
56230|NCT03851653|weight loss|weight loss
56231|NCT03851653|lifestyle intervention|lifestyle intervention
56232|NCT03851653|continuous positive airway pressure|continuous positive airway pressure
56234|NCT03851653|CPAP|cpap
56235|NCT03851588|Antiretroviral therapy|antiretroviral therapy
56236|NCT03851588|Dolutegravir|dolutegravir
56237|NCT03851588|Rifampicin|rifampicin
56238|NCT03851588|Tuberculosis|tuberculosis
56239|NCT03851588|Drug-drug interaction|drug-drug interaction
56240|NCT03851536|Embryo Transfer|embryo transfer
56241|NCT03851536|ICSI|icsi
56242|NCT03851536|Transvaginal Ultrasound|transvaginal ultrasound
56243|NCT03851484|Tourette syndrome|tourette syndrome
56244|NCT03851484|premonitory urge|premonitory urge
56245|NCT03851484|sensory dysregulation|sensory dysregulation
56246|NCT03851484|hypersensitivity|hypersensitivity
56247|NCT03851458|Focus Groups|focus groups
56248|NCT03851458|15-088|15-088
56249|NCT03851393|Cough|cough
56250|NCT03851393|Reflux|reflux
56251|NCT03851393|Pepsin|pepsin
56252|NCT03851393|Peptest|peptest
56253|NCT03851380|Transcranial Magnetic Stimulation|transcranial magnetic stimulation
56254|NCT03851380|Magnetic Resonance Imaging|magnetic resonance imaging
56255|NCT03851380|Functional Magnetic Resonance Imaging|functional magnetic resonance imaging
56256|NCT03851380|fMRI|fmri
56257|NCT03851380|TMS|tms
56258|NCT03851380|Neuronavigation|neuronavigation
56259|NCT03851380|MRI|mri
56260|NCT03851367|back pain|back pain
56261|NCT03851367|suspension therapy|suspension therapy
56262|NCT03851367|Gymball|gymball
56263|NCT03851367|standing posture|standing posture
56264|NCT03851367|muscle endurance|muscle endurance
56265|NCT03851354|enteral feeding|enteral feeding
56266|NCT03851354|gastric ultrasound|gastric ultrasound
816861|NCT00173212|adenomyosis|adenomyosis
56267|NCT03851328|Adverse Drug Events (ADEs)|adverse drug events (ades)
56268|NCT03851328|Medication Accuracy|medication accuracy
56269|NCT03851328|Medication Discrepancy|medication discrepancy
56270|NCT03851315|Atrioventricular Block|atrioventricular block
56271|NCT03851315|left bundle branch area pacing|left bundle branch area pacing
56272|NCT03851302|Remote ischemic conditioning|remote ischemic conditioning
56273|NCT03851302|Neuroplasticity|neuroplasticity
56274|NCT03851302|transcranial magnetic stimulation|transcranial magnetic stimulation
56275|NCT03851289|socket augmentation|socket augmentation
56276|NCT03851289|platelet-rich fibrin|platelet-rich fibrin
56277|NCT03851289|calcium sulfate|calcium sulfate
56278|NCT03851289|xenograft|xenograft
56279|NCT03851250|MRx-4DP0004|mrx-4dp0004
56280|NCT03851250|Asthma|asthma
56281|NCT03851250|Live Biotherapeutic Product|live biotherapeutic product
56282|NCT03851198|Mild Cognitive Impairment|mild cognitive impairment
56283|NCT03851198|Diagnosis|diagnosis
56284|NCT03851198|Functional tests|functional tests
56285|NCT03851198|Kinematics|kinematics
56286|NCT03851198|Validation|validation
56287|NCT03851198|Reliability|reliability
56288|NCT03851172|Cataract surgery|cataract surgery
56289|NCT03851172|Intraoperative Miosis|intraoperative miosis
56290|NCT03851172|Ketorolac eye drops|ketorolac eye drops
56291|NCT03851172|Nepafenac eye drops|nepafenac eye drops
56292|NCT03851159|Microbiome|microbiome
56293|NCT03851133|pancreas|pancreas
56294|NCT03851133|biobank|biobank
56295|NCT03851133|quantitative imaging|quantitative imaging
56296|NCT03851133|biomarkers|biomarkers
56297|NCT03851133|health disparities|health disparities
56298|NCT03851107|participation|participation
56299|NCT03851107|environmental barriers|environmental barriers
56300|NCT03851107|youth|youth
56301|NCT03851107|disabilities|disabilities
56302|NCT03851107|body functions|body functions
56303|NCT03851055|Zinc|zinc
56304|NCT03851055|blood glucose|blood glucose
56305|NCT03851055|diabetes|diabetes
56306|NCT03851055|beta thalassemia|beta thalassemia
56307|NCT03851029|Aerobic Exercise|aerobic exercise
56308|NCT03851029|Smoking|smoking
56309|NCT03851029|Tai Chi Exercise|tai chi exercise
56310|NCT03851029|University Student|university student
56311|NCT03851003|cesarean section|cesarean section
56312|NCT03851003|niche|niche
56313|NCT03851003|uterine scar defect|uterine scar defect
56314|NCT03850964|Osler-Weber-Rendu|osler-weber-rendu
56315|NCT03850964|Hereditary Hemorrhagic Telangiectasia|hereditary hemorrhagic telangiectasia
56316|NCT03850964|Patient Reported Outcome|patient reported outcome
56317|NCT03850951|Fixed appliances|fixed appliances
56318|NCT03850951|labial appliances|labial appliances
56319|NCT03850951|lingual appliances|lingual appliances
56320|NCT03850938|fractures, compression|fractures, compression
56321|NCT03850938|back pain|back pain
56322|NCT03850938|bone cements|bone cements
56323|NCT03850938|kyphoplasty|kyphoplasty
56324|NCT03850912|Other Cancer|other cancer
56325|NCT03850912|Digital health|digital health
56326|NCT03850912|Patient reported outcomes|patient reported outcomes
56327|NCT03850912|Symptom management|symptom management
56328|NCT03850860|prosthetic joint infection|prosthetic joint infection
56329|NCT03850860|empirical antibiotherapy|empirical antibiotherapy
56330|NCT03850847|Neurological Determination of Death|neurological determination of death
56331|NCT03850847|Organ Donation|organ donation
56332|NCT03850847|Determination of Death|determination of death
56333|NCT03850847|Understanding Decision Making|understanding decision making
56334|NCT03850847|Substitute Decision Maker|substitute decision maker
56335|NCT03850821|Physical Activity|physical activity
56336|NCT03850821|Community-based Intervention|community-based intervention
56337|NCT03850821|Social Motivational Theories|social motivational theories
56338|NCT03850821|Behavioral Change|behavioral change
56339|NCT03850821|Social Mechanisms|social mechanisms
56340|NCT03850808|heart failure|heart failure
56341|NCT03850808|permanent pacemaker|permanent pacemaker
56342|NCT03850808|AV node dysfunction|av node dysfunction
56343|NCT03850795|HC-1119|hc-1119
56344|NCT03850795|enzalutamide|enzalutamide
56345|NCT03850756|Biomarker|biomarker
56346|NCT03850756|Tobacco|tobacco
56347|NCT03850756|Nephrotoxicity|nephrotoxicity
56348|NCT03850756|Prevention|prevention
56349|NCT03850756|Diagnosis|diagnosis
56350|NCT03850730|osler-weber-rendu|osler-weber-rendu
56351|NCT03850730|nose bleeds|nose bleeds
56352|NCT03850730|open label|open label
56353|NCT03850730|HHT|hht
56354|NCT03850730|Pazopanib|pazopanib
56355|NCT03850704|MM|mm
56356|NCT03850691|MM|mm
56357|NCT03850665|total|total
56358|NCT03850665|hip|hip
56359|NCT03850665|arthroplasty|arthroplasty
56360|NCT03850665|surgical|surgical
56361|NCT03850665|approach|approach
56362|NCT03850652|Iron Supplementation|iron supplementation
56363|NCT03850652|Prebiotics|prebiotics
56364|NCT03850652|Microbiota|microbiota
56365|NCT03850626|Allergy|allergy
56366|NCT03850626|Rhinoconjuctivitis|rhinoconjuctivitis
73766|NCT03742973|JAK|jak
56367|NCT03850626|Combined Symptom and Medication Score|combined symptom and medication score
56368|NCT03850626|Allergic Asthma|allergic asthma
56369|NCT03850626|Pollen|pollen
56370|NCT03850626|Mites|mites
56371|NCT03850613|caregivers, stress, anxiety|caregivers, stress, anxiety
56372|NCT03850600|Microbiota|microbiota
56373|NCT03850600|Diet|diet
56374|NCT03850600|Immune System|immune system
56375|NCT03850561|Male infertility|male infertility
56376|NCT03850561|Coenzyme Q10|coenzyme q10
56377|NCT03850561|Antioxidants|antioxidants
56378|NCT03850548|bone and joint infection|bone and joint infection
56379|NCT03850548|Propionibacterium acnes|propionibacterium acnes
56380|NCT03850548|Cutibacterium acnes|cutibacterium acnes
56381|NCT03850535|AML|aml
56382|NCT03850522|smoldering|smoldering
56383|NCT03850522|myeloma|myeloma
56384|NCT03850522|vaccination|vaccination
56385|NCT03850522|PD-L1|pd-l1
56386|NCT03850522|high-risk|high-risk
56387|NCT03850509|Crohn's Disease|crohn's disease
56388|NCT03850509|inflammatory bowel disease|inflammatory bowel disease
56389|NCT03850509|fluoroquinolones|fluoroquinolones
56390|NCT03850509|inflammation|inflammation
56391|NCT03850509|intestine|intestine
56392|NCT03850509|digestive tract|digestive tract
56393|NCT03850509|abdominal pain|abdominal pain
56394|NCT03850509|diarrhea|diarrhea
56395|NCT03850496|Venous|venous
56396|NCT03850483|psoriasis|psoriasis
56397|NCT03850483|topical|topical
56398|NCT03850470|Diagnostic accuracy|diagnostic accuracy
56399|NCT03850470|Clinical examination|clinical examination
56400|NCT03850470|neck|neck
56401|NCT03850470|back|back
56402|NCT03850470|shoulder|shoulder
56403|NCT03850470|hip|hip
56404|NCT03850470|knee|knee
56405|NCT03850470|foot|foot
56406|NCT03850470|ankle|ankle
56407|NCT03850470|stress fracture|stress fracture
56408|NCT03850457|bronchopulmonary dysplasia|bronchopulmonary dysplasia
56409|NCT03850457|preterm infants|preterm infants
56410|NCT03850457|epidemiologic characteristics|epidemiologic characteristics
56411|NCT03850457|risk factors|risk factors
56412|NCT03850457|mortality|mortality
56413|NCT03850444|Programmed Cell Death-1 (PD-1)|programmed cell death-1 (pd-1)
56414|NCT03850444|Programmed Cell Death 1|programmed cell death 1
56415|NCT03850444|PD1|pd1
56416|NCT03850444|Programmed Cell Death Ligand 1 (PD-L1)|programmed cell death ligand 1 (pd-l1)
56417|NCT03850444|PDL1|pdl1
56418|NCT03850431|Behavioral Economics|behavioral economics
56419|NCT03850431|Mental Health|mental health
56420|NCT03850431|Veterans|veterans
56421|NCT03850431|Veterans Health|veterans health
56422|NCT03850431|Primary Care|primary care
56423|NCT03850431|Appointments and Schedules|appointments and schedules
56424|NCT03850392|cryotherapy|cryotherapy
56425|NCT03850392|knee arthritis|knee arthritis
56426|NCT03850392|cytokines|cytokines
56427|NCT03850340|Ventilator Associated Conditions|ventilator associated conditions
56428|NCT03850340|Infection Related Ventilator Associated Conditions|infection related ventilator associated conditions
56429|NCT03850340|Probable Ventilator Associated Pneumonia|probable ventilator associated pneumonia
56430|NCT03850327|Implantable Cardiac Monitor|implantable cardiac monitor
56431|NCT03850249|Radioscapholunate|radioscapholunate
56432|NCT03850249|Fusion|fusion
56433|NCT03850249|Arthrodesis|arthrodesis
56434|NCT03850249|Radiocarpal osteoarthritis|radiocarpal osteoarthritis
56435|NCT03850249|Partial radiocarpal fusion|partial radiocarpal fusion
56436|NCT03850236|pancreatic fistula|pancreatic fistula
56437|NCT03850236|morbidity|morbidity
56438|NCT03850236|risk factors|risk factors
56439|NCT03850236|Benign or malign pathology|benign or malign pathology
56440|NCT03850197|Tubomanometry|tubomanometry
56441|NCT03850197|EarPopper|earpopper
56442|NCT03850197|Eustachian tube function test|eustachian tube function test
56443|NCT03850171|Breast Cancer|breast cancer
56444|NCT03850171|Exercise Training Therapy|exercise training therapy
56445|NCT03850171|Global longitudinal strain|global longitudinal strain
56446|NCT03850171|Barriers|barriers
56447|NCT03850171|Left ventricular dysfunction|left ventricular dysfunction
56448|NCT03850171|Heart failure|heart failure
56449|NCT03850171|Breast disease|breast disease
56450|NCT03850171|Exercise rehabilitation|exercise rehabilitation
56451|NCT03850145|inhaled therapy|inhaled therapy
56452|NCT03850145|physiotherapist|physiotherapist
56453|NCT03850145|educational program|educational program
56454|NCT03850132|Caregivers|caregivers
56455|NCT03850132|Cancer|cancer
56456|NCT03850132|Palliative care|palliative care
56457|NCT03850119|adipose derived stem cells|adipose derived stem cells
56458|NCT03850119|stromal vascular fraction|stromal vascular fraction
56459|NCT03850119|wound healing|wound healing
56460|NCT03850119|scar formation|scar formation
56461|NCT03850119|donor site morbidity|donor site morbidity
56462|NCT03850119|nanofat|nanofat
56463|NCT03850093|gabapentin|gabapentin
56464|NCT03850093|bisoprolol|bisoprolol
56465|NCT03850093|hemodynamic|hemodynamic
817353|NCT00171015|VALSARTAN|valsartan
56466|NCT03850093|surgical field|surgical field
56467|NCT03850080|Knee|knee
56468|NCT03850080|Osteoarthritis|osteoarthritis
56469|NCT03850080|Inflammation|inflammation
56470|NCT03850080|Joint|joint
56471|NCT03850080|Autologous Conditioned Serum|autologous conditioned serum
56472|NCT03850067|Safety|safety
56473|NCT03850067|CC-90011|cc-90011
56474|NCT03850067|Extensive stage small cell lung cancer|extensive stage small cell lung cancer
56475|NCT03850054|AADI; glaucoma tube shunt|aadi; glaucoma tube shunt
56476|NCT03850028|high risk DLBCL|high risk dlbcl
56477|NCT03850028|molecular imaging|molecular imaging
56478|NCT03850028|89Zr-atezolizumab-PET|89zr-atezolizumab-pet
56479|NCT03850028|PDL1 imaging|pdl1 imaging
56480|NCT03850015|echocardiography|echocardiography
56481|NCT03849976|Therapeutic communication|therapeutic communication
56482|NCT03849976|Anxiety|anxiety
56483|NCT03849976|Endoscopic examination under general anesthesia|endoscopic examination under general anesthesia
56484|NCT03849976|Operating room|operating room
56485|NCT03849976|Stretcher bearer|stretcher bearer
56486|NCT03849950|self-management support|self-management support
56487|NCT03849950|health coaching|health coaching
56488|NCT03849950|patient education|patient education
56489|NCT03849950|treatment-related toxicities|treatment-related toxicities
56490|NCT03849937|Behavioral and Psychological Symptoms of Dementia|behavioral and psychological symptoms of dementia
56491|NCT03849937|Psychotropic Medication|psychotropic medication
56492|NCT03849937|Elderspeak|elderspeak
56493|NCT03849937|Staff Training|staff training
56494|NCT03849937|Staff Communication|staff communication
56495|NCT03849937|Nonpharmacological treatment for Dementia|nonpharmacological treatment for dementia
56496|NCT03849924|well-being|well-being
56497|NCT03849924|randomised controlled trial|randomised controlled trial
56498|NCT03849924|intervention|intervention
56499|NCT03849898|Fracture fixation|fracture fixation
56500|NCT03849898|Surgical treatment|surgical treatment
56501|NCT03849898|Non-Surgical treatment|non-surgical treatment
56502|NCT03849859|Plastic stent|plastic stent
56503|NCT03849859|Endoscopic Retrograde Cholangiopancreatography|endoscopic retrograde cholangiopancreatography
56504|NCT03849846|Low socioeconomic status population|low socioeconomic status population
56505|NCT03849846|Web-based prospective cohort study|web-based prospective cohort study
56506|NCT03849846|Focus groups|focus groups
56507|NCT03849846|Recruitment|recruitment
56508|NCT03849846|Behavioural beliefs|behavioural beliefs
56509|NCT03849846|Normative beliefs|normative beliefs
56510|NCT03849846|Control beliefs|control beliefs
56511|NCT03849846|Security of data|security of data
56512|NCT03849846|Use of data|use of data
56513|NCT03849846|Share of data|share of data
56514|NCT03849833|Vitamin D|vitamin d
56515|NCT03849833|25(OH)D|25(oh)d
56516|NCT03849833|vitamin D3 supplementation|vitamin d3 supplementation
56517|NCT03849833|pigment genes|pigment genes
56518|NCT03849820|Robotic-assisted Surgery|robotic-assisted surgery
56519|NCT03849820|Open Surgery|open surgery
56520|NCT03849820|Partial Nephrectomy|partial nephrectomy
56521|NCT03849820|minimal invasive surgery|minimal invasive surgery
56523|NCT03849820|MIS|mis
56524|NCT03849807|Attention Deficit Disorder with Hyperactivity|attention deficit disorder with hyperactivity
56525|NCT03849807|Children|children
56526|NCT03849807|Chiropractic|chiropractic
56527|NCT03849807|Neurological function|neurological function
56528|NCT03849807|Quality of life|quality of life
56529|NCT03849794|Chronic Stroke|chronic stroke
56530|NCT03849794|Chiropractic Care|chiropractic care
56531|NCT03849794|Physiotherapy|physiotherapy
56532|NCT03849755|bolus advisor|bolus advisor
56533|NCT03849729|Obesity|obesity
56534|NCT03849729|Obesity treatment|obesity treatment
56535|NCT03849729|Non-alcoholic Fatty Liver|non-alcoholic fatty liver
56536|NCT03849729|Weight Loss|weight loss
56537|NCT03849703|Adolescent parents|adolescent parents
56538|NCT03849703|coparenting|coparenting
56539|NCT03849703|romantic relationships|romantic relationships
56540|NCT03849690|Drug Therapy|drug therapy
56541|NCT03849677|uric acid|uric acid
56542|NCT03849677|hemodynamic parameters|hemodynamic parameters
56543|NCT03849677|endothelial function|endothelial function
56544|NCT03849677|oxidative stress and inflammation|oxidative stress and inflammation
56545|NCT03849677|vegan|vegan
56546|NCT03849677|omnivore|omnivore
56547|NCT03849664|postoperative cognitive decline|postoperative cognitive decline
56548|NCT03849638|gait analysis|gait analysis
56549|NCT03849638|gait training|gait training
56550|NCT03849638|biofeedback|biofeedback
56551|NCT03849599|Ulcerative Colitis|ulcerative colitis
56552|NCT03849586|penile prosthesis implant|penile prosthesis implant
56553|NCT03849573|eHealth|ehealth
56554|NCT03849573|Adherence|adherence
56555|NCT03849573|Health Related Quality of Life|health related quality of life
56556|NCT03849573|Symptom Burden|symptom burden
56557|NCT03849573|Breast Cancer|breast cancer
56558|NCT03849547|Chronic ankle instability|chronic ankle instability
56559|NCT03849547|Smartphone|smartphone
56560|NCT03849534|Children|children
56561|NCT03849534|Mixed dentition|mixed dentition
56562|NCT03849534|Primary dentition|primary dentition
56563|NCT03849534|Adolescents|adolescents
56564|NCT03849534|Myalgia|myalgia
56565|NCT03849534|Arthralgia of TMJ|arthralgia of tmj
56566|NCT03849534|Treatment|treatment
56567|NCT03849534|Side-effects|side-effects
56568|NCT03849521|Atherosclerosis|atherosclerosis
56569|NCT03849521|Calcium|calcium
56571|NCT03849508|cesarean section complications|cesarean section complications
56572|NCT03849508|spinal anesthesia|spinal anesthesia
56573|NCT03849508|norepinephrine|norepinephrine
56574|NCT03849508|maternal hemodynamic and cardiac output|maternal hemodynamic and cardiac output
56575|NCT03849482|Fine Needle Aspiration Cytology|fine needle aspiration cytology
56576|NCT03849482|Multiparametric Magnetic Resonance Imaging|multiparametric magnetic resonance imaging
56577|NCT03849482|Diffusion-Weighted Magnetic Resonance Imaging|diffusion-weighted magnetic resonance imaging
56578|NCT03849482|Dynamic Contrast-Enhanced Magnetic Resonance Imaging|dynamic contrast-enhanced magnetic resonance imaging
56579|NCT03849469|DUET-4|duet-4
56580|NCT03849469|Advanced solid tumors|advanced solid tumors
56581|NCT03849469|Metastatic solid tumors|metastatic solid tumors
56582|NCT03849469|Melanoma|melanoma
56583|NCT03849469|Cervical Cancer|cervical cancer
56584|NCT03849469|Pancreatic Cancer|pancreatic cancer
56585|NCT03849469|Triple Negative Breast Cancer|triple negative breast cancer
56586|NCT03849469|Hepatocellular/Liver Cancer|hepatocellular/liver cancer
56587|NCT03849469|Urothelial Cancer|urothelial cancer
56588|NCT03849469|Renal Cell Cancer|renal cell cancer
56589|NCT03849469|Squamous Cell Carcinoma of the Head and Neck|squamous cell carcinoma of the head and neck
56590|NCT03849469|Non-small Cell Lung Cancer|non-small cell lung cancer
56591|NCT03849469|Small Cell Lung Cancer|small cell lung cancer
56592|NCT03849469|Gastric Cancer|gastric cancer
56593|NCT03849469|Gastroesophageal Junction Cancer|gastroesophageal junction cancer
56594|NCT03849469|Lymphocyte-activation gene 3 (LAG3)|lymphocyte-activation gene 3 (lag3)
56595|NCT03849469|Cytotoxic T-lymphocyte-associated protein 4 (CTLA4)|cytotoxic t-lymphocyte-associated protein 4 (ctla4)
56596|NCT03849469|Prostate Cancer|prostate cancer
56597|NCT03849469|MSI (microsatellite instability)-high tumors|msi (microsatellite instability)-high tumors
56598|NCT03849469|MMR (mismatch repair)-deficient tumors|mmr (mismatch repair)-deficient tumors
56599|NCT03849469|Nasopharyngeal carcinoma|nasopharyngeal carcinoma
56600|NCT03849469|Epithelial ovarian cancer|epithelial ovarian cancer
56601|NCT03849469|Fallopian tube cancer|fallopian tube cancer
56602|NCT03849469|Primary peritoneal carcinoma|primary peritoneal carcinoma
56603|NCT03849469|Intrahepatic cholangiocarcinoma|intrahepatic cholangiocarcinoma
56604|NCT03849456|Cannabidivarin|cannabidivarin
56605|NCT03849456|CBDV|cbdv
56606|NCT03849456|GWP42006|gwp42006
56607|NCT03849430|Low grade glioma|low grade glioma
56608|NCT03849430|High grade glioma|high grade glioma
56609|NCT03849430|HRQOL|hrqol
56610|NCT03849417|Late-life depression|late-life depression
56611|NCT03849417|Electroconvulsive therapy|electroconvulsive therapy
56612|NCT03849417|Neuroimaging|neuroimaging
56613|NCT03849417|Aging|aging
56614|NCT03849326|Neuromuscular function|neuromuscular function
56615|NCT03849300|arterial stiffness|arterial stiffness
56616|NCT03849300|cardiorespiratory capacity|cardiorespiratory capacity
56617|NCT03849300|exercise tolerance|exercise tolerance
56618|NCT03849300|VO2max|vo2max
56619|NCT03849274|Knee Arthropathy|knee arthropathy
56620|NCT03849274|Hip Arthopathy|hip arthopathy
56621|NCT03849274|Hypertrophic Scar|hypertrophic scar
56622|NCT03849274|Smart Scar Care Pad|smart scar care pad
56623|NCT03849274|Pressure Garment|pressure garment
56624|NCT03849248|maternal scent|maternal scent
56625|NCT03849248|infant behavior|infant behavior
56626|NCT03849248|feeding patterns|feeding patterns
56627|NCT03849248|stress levels|stress levels
56628|NCT03849222|Open apex|open apex
56629|NCT03849222|Immature teeth|immature teeth
56630|NCT03849222|Non vital pulp|non vital pulp
56631|NCT03849222|Apical plug|apical plug
56632|NCT03849222|Internal matrix|internal matrix
56633|NCT03849209|Pancreatic Solid Lesions|pancreatic solid lesions
56634|NCT03849209|Fine-Needle Biopsy|fine-needle biopsy
56635|NCT03849209|Stylet Slow-Pull Technique|stylet slow-pull technique
56636|NCT03849209|Standard Suction|standard suction
56637|NCT03849209|Endoscopic Ultrasound|endoscopic ultrasound
56638|NCT03849183|Radial Artery|radial artery
56639|NCT03849183|Vascular Catheters|vascular catheters
56640|NCT03849170|cheerleading|cheerleading
56641|NCT03849170|stress management|stress management
56642|NCT03849170|injury prevention|injury prevention
56643|NCT03849170|psychosocial factors|psychosocial factors
56644|NCT03849170|stress-injury|stress-injury
56645|NCT03849170|performance|performance
56646|NCT03849170|coping skills|coping skills
56647|NCT03849170|stress inoculation technique|stress inoculation technique
56648|NCT03849170|competitive anxiety|competitive anxiety
56649|NCT03849170|psychological intervention|psychological intervention
56650|NCT03849131|monoclonal anti-PD-1 immunotherapy|monoclonal anti-pd-1 immunotherapy
56651|NCT03849131|monoclonal anti-CTLA-4 immunotherapy|monoclonal anti-ctla-4 immunotherapy
56652|NCT03849131|checkpoint inhibitors|checkpoint inhibitors
56653|NCT03849131|autoimmune manifestations|autoimmune manifestations
56654|NCT03849131|patient reported outcome|patient reported outcome
56655|NCT03849131|oncology|oncology
56656|NCT03849118|clear cell renal cell carcinoma|clear cell renal cell carcinoma
56657|NCT03849118|PET/CT imaging|pet/ct imaging
56658|NCT03849118|89Zr-girentuximab|89zr-girentuximab
56659|NCT03849105|glioblastoma multiforme (GBM),|glioblastoma multiforme (gbm),
56660|NCT03849105|External Radiotherapy|external radiotherapy
56661|NCT03849105|131I-IPA|131i-ipa
56662|NCT03849079|Peanut Allergy|peanut allergy
56663|NCT03849079|Skin Prick Test|skin prick test
56664|NCT03849079|Oral Food Challenge|oral food challenge
56665|NCT03849079|Hyponut|hyponut
56666|NCT03849066|Neurological Impairment|neurological impairment
56667|NCT03849066|Pediatric Complex Chronic Condition|pediatric complex chronic condition
56668|NCT03849066|Children with Medical Complexity|children with medical complexity
56669|NCT03849066|Pediatric Polypharmacy|pediatric polypharmacy
56670|NCT03849053|Low back pain|low back pain
56671|NCT03849053|Mézières method|mézières method
56672|NCT03849053|Postural treatment|postural treatment
56673|NCT03849053|Athletes|athletes
56674|NCT03849040|endobronchial ultrasound|endobronchial ultrasound
56675|NCT03849040|ultrasonographic features|ultrasonographic features
56676|NCT03849040|artificial intelligence|artificial intelligence
56677|NCT03849040|deep neural network|deep neural network
56678|NCT03849040|segmentation|segmentation
56679|NCT03849027|altitude|altitude
56680|NCT03849027|analgesia|analgesia
56681|NCT03849027|methoxyflurane|methoxyflurane
56682|NCT03849027|wilderness medicine|wilderness medicine
56683|NCT03849014|Hip fractures|hip fractures
56684|NCT03849014|Inflammatory response|inflammatory response
56685|NCT03849014|Interleukin-6|interleukin-6
56686|NCT03849014|Comparative study|comparative study
56687|NCT03849001|Exercise|exercise
56688|NCT03848988|Chiropractic|chiropractic
56689|NCT03848988|Screening tool|screening tool
56690|NCT03848988|Teaching|teaching
56691|NCT03848975|Simulation training|simulation training
56692|NCT03848975|Obstetrics|obstetrics
56693|NCT03848975|External cephalic version|external cephalic version
56694|NCT03848975|Vacuum assisted delivery|vacuum assisted delivery
56695|NCT03848936|adult cerebral palsy|adult cerebral palsy
56696|NCT03848936|cerebral palsy|cerebral palsy
56697|NCT03848936|functional status|functional status
56698|NCT03848936|mental function|mental function
56699|NCT03848923|Thrombocytopenia|thrombocytopenia
56700|NCT03848923|Neonates|neonates
56701|NCT03848923|Platelets|platelets
56702|NCT03848923|NET Formation|net formation
56703|NCT03848897|Virtual reality|virtual reality
56704|NCT03848897|Human metrology|human metrology
56705|NCT03848897|Motor behavior|motor behavior
56706|NCT03848897|Modeling|modeling
56707|NCT03848897|Ageing|ageing
56708|NCT03848897|Parkinson's disease|parkinson's disease
56709|NCT03848858|HIV|hiv
56710|NCT03848858|Psychological Trauma|psychological trauma
56711|NCT03848858|Eye Movement Desensitization and Reprocessing Therapy|eye movement desensitization and reprocessing therapy
56712|NCT03848845|GSK2857916, Pembrolizumab, Multiple Myeloma, RP2D|gsk2857916, pembrolizumab, multiple myeloma, rp2d
56713|NCT03848832|Cannabidiol|cannabidiol
56714|NCT03848832|CBD|cbd
56715|NCT03848832|Epidiolex|epidiolex
56716|NCT03848832|GWP42003-P|gwp42003-p
56717|NCT03848819|Chronic Obstructive Pulmonary Disease|chronic obstructive pulmonary disease
57223|NCT03845751|HIFU|hifu
56718|NCT03848819|Dynamic Hyperinflation|dynamic hyperinflation
56719|NCT03848806|Psoriasis|psoriasis
56720|NCT03848780|preconditioning|preconditioning
56721|NCT03848780|hepatectomy|hepatectomy
56722|NCT03848780|ischemia reperfusion injury|ischemia reperfusion injury
56723|NCT03848728|HIV|hiv
56724|NCT03848728|Adolescent|adolescent
56725|NCT03848728|Young Adult|young adult
56726|NCT03848728|Viral Load|viral load
56727|NCT03848728|Counseling|counseling
56728|NCT03848728|Costs and Cost Analysis|costs and cost analysis
56729|NCT03848676|Multiple Myeloma|multiple myeloma
56730|NCT03848676|Immunotherapies|immunotherapies
56731|NCT03848676|Genomic|genomic
56732|NCT03848676|Resistance|resistance
56733|NCT03848663|Scotoma|scotoma
56734|NCT03848663|Remapping|remapping
56735|NCT03848663|Reading|reading
56736|NCT03848663|Low vision|low vision
56737|NCT03848663|Visual aid|visual aid
56738|NCT03848650|FFR OCT LAD|ffr oct lad
56739|NCT03848598|patellar|patellar
56740|NCT03848598|ultrasound|ultrasound
56741|NCT03848598|speckle|speckle
56742|NCT03848598|isometric|isometric
56743|NCT03848585|Immunosuppressants|immunosuppressants
56744|NCT03848585|Treatment adherence|treatment adherence
56745|NCT03848572|Dual Anti-platelet Therapy|dual anti-platelet therapy
56746|NCT03848572|Bleeding|bleeding
56747|NCT03848546|fiber intake|fiber intake
56748|NCT03848546|personalized dietary advice|personalized dietary advice
56749|NCT03848546|stool pattern|stool pattern
56750|NCT03848546|perceived wellbeing|perceived wellbeing
56751|NCT03848533|Melatonin|melatonin
56752|NCT03848533|Metformin|metformin
56753|NCT03848533|Pre Diabetes|pre diabetes
56754|NCT03848533|PreDiabetes|prediabetes
56755|NCT03848533|Micronuclei|micronuclei
56756|NCT03848533|Genotoxicity Markers|genotoxicity markers
56757|NCT03848533|Cytotoxicity Markers|cytotoxicity markers
56758|NCT03848507|hyperoncotic albumin, blood loss, fluid replacement, cystectomy|hyperoncotic albumin, blood loss, fluid replacement, cystectomy
56759|NCT03848494|gastroesophageal reflux disease|gastroesophageal reflux disease
56760|NCT03848494|hiatus hernia|hiatus hernia
56761|NCT03848481|PWS|pws
56762|NCT03848481|Prader- Willi Syndrome|prader- willi syndrome
56763|NCT03848481|Irritability|irritability
56764|NCT03848481|CBDV|cbdv
56765|NCT03848481|Cannabinoids|cannabinoids
56766|NCT03848468|Visual Analogue pain score|visual analogue pain score
56767|NCT03848468|conventional Hemorrhoidectomy|conventional hemorrhoidectomy
56768|NCT03848468|Ligasure Hemorrhoidectomy|ligasure hemorrhoidectomy
56769|NCT03848455|Parkinson's disease|parkinson's disease
56770|NCT03848455|synaptic correlation function|synaptic correlation function
56771|NCT03848455|key gene|key gene
56772|NCT03848377|Spine surgery|spine surgery
56773|NCT03848377|Neuromonitoring|neuromonitoring
56774|NCT03848377|Evoked potential|evoked potential
56775|NCT03848377|electromyography|electromyography
56776|NCT03848377|neurological injury|neurological injury
56777|NCT03848364|Stroke|stroke
56778|NCT03848364|Education|education
56779|NCT03848364|Hip Hop Stroke|hip hop stroke
56780|NCT03848364|Community|community
56781|NCT03848364|Nutrition|nutrition
56782|NCT03848364|Schools|schools
56783|NCT03848364|Stroke Centers|stroke centers
56784|NCT03848338|Cochlear Implant|cochlear implant
56785|NCT03848338|Electrocochleography|electrocochleography
56786|NCT03848325|adenosine|adenosine
56787|NCT03848299|Glycemic responses|glycemic responses
56788|NCT03848299|Microbiota|microbiota
56789|NCT03848299|Personalized nutrition|personalized nutrition
56790|NCT03848299|Digital cohort|digital cohort
56791|NCT03848299|Citizen Science|citizen science
56792|NCT03848286|Nasopharyngeal Carcinoma|nasopharyngeal carcinoma
56793|NCT03848273|stroke|stroke
56794|NCT03848273|epilepsy|epilepsy
56795|NCT03848273|seizure|seizure
56796|NCT03848273|EEG|eeg
56797|NCT03848260|Lagophthalmos|lagophthalmos
56798|NCT03848260|Incomplete eye closure|incomplete eye closure
56799|NCT03848260|Magnetic device|magnetic device
56800|NCT03848260|Blink restoration|blink restoration
56801|NCT03848260|Facial nerve palsy|facial nerve palsy
56802|NCT03848221|Systane Complete|systane complete
56803|NCT03848221|Dry Eye|dry eye
56804|NCT03848221|Contact Lens Discomfort|contact lens discomfort
56805|NCT03848221|Artificial Tears|artificial tears
56806|NCT03848221|Rewetting Drops|rewetting drops
56807|NCT03848195|hip fractures|hip fractures
56808|NCT03848195|adult|adult
56809|NCT03848195|middle-aged|middle-aged
56810|NCT03848195|DXA-scan|dxa-scan
56811|NCT03848195|osteoporosis|osteoporosis
56812|NCT03848182|T-cell responses|t-cell responses
56813|NCT03848182|Pancreatic cancer|pancreatic cancer
56814|NCT03848182|Gemcitabine|gemcitabine
56815|NCT03848182|Perforin|perforin
56816|NCT03848182|Granzyme-B|granzyme-b
56817|NCT03848182|Myeloid-derived suppressor cells|myeloid-derived suppressor cells
56818|NCT03848130|Knee osteoarthritis|knee osteoarthritis
56819|NCT03848130|Knee injury and Osteoarthritis Outcome Score|knee injury and osteoarthritis outcome score
56820|NCT03848130|Rapid assessment of physical activity|rapid assessment of physical activity
57522|NCT03843957|Mortality|mortality
56821|NCT03848130|Quality of life|quality of life
56822|NCT03848130|Traditional physiotherapy|traditional physiotherapy
56823|NCT03848117|Patient Rated Tennis Elbow Evaluation (PRTEE)|patient rated tennis elbow evaluation (prtee)
56824|NCT03848117|Mobilization with movement|mobilization with movement
56825|NCT03848117|Deep Transverse friction massage|deep transverse friction massage
56826|NCT03848104|cefoxitin|cefoxitin
56827|NCT03848104|Bone and Joint Infection|bone and joint infection
56828|NCT03848091|bone and joint infection|bone and joint infection
56829|NCT03848091|Antibiotic pretreatment|antibiotic pretreatment
56830|NCT03848078|Basal Cell Carcinoma|basal cell carcinoma
56831|NCT03848078|Optical Coherence Tomography|optical coherence tomography
56832|NCT03848078|Punch biopsy|punch biopsy
56833|NCT03848065|Pneumococcal Vaccines|pneumococcal vaccines
56834|NCT03848052|lung cancer|lung cancer
56835|NCT03848052|observational study|observational study
56836|NCT03848052|survival|survival
56837|NCT03848052|real world data|real world data
56838|NCT03848052|real life setting|real life setting
56839|NCT03848039|Cervical Cancer|cervical cancer
56840|NCT03848039|cervical intraepithelial neoplasia|cervical intraepithelial neoplasia
56841|NCT03848039|Papillomavirus Vaccines|papillomavirus vaccines
56842|NCT03848026|Otitis media|otitis media
56843|NCT03848026|tympanostomy tube|tympanostomy tube
56844|NCT03848026|viscosity|viscosity
56845|NCT03848026|middle ear fluid|middle ear fluid
56846|NCT03848000|Alcohol abuse|alcohol abuse
56847|NCT03848000|Exercise|exercise
56848|NCT03848000|Alcohol consumption|alcohol consumption
56849|NCT03848000|Depression|depression
56851|NCT03847961|sepsis|sepsis
56852|NCT03847961|IL-6|il-6
56853|NCT03847961|hemoperfusion|hemoperfusion
56854|NCT03847935|treatment outcome|treatment outcome
56855|NCT03847935|hand therapy|hand therapy
56856|NCT03847935|physical therapy|physical therapy
56857|NCT03847935|occupational therapy|occupational therapy
56858|NCT03847909|PH1|ph1
56859|NCT03847909|PH2|ph2
56860|NCT03847909|Primary Hyperoxaluria|primary hyperoxaluria
56861|NCT03847909|RNAi|rnai
56862|NCT03847909|RNAi therapeutic|rnai therapeutic
56863|NCT03847909|GalNAc|galnac
56864|NCT03847909|LDHA gene|ldha gene
56865|NCT03847909|LDH|ldh
56866|NCT03847909|siRNA|sirna
56867|NCT03847883|Ateplase|ateplase
56868|NCT03847883|Intravenous recombinant tissue plasminogen activator|intravenous recombinant tissue plasminogen activator
56869|NCT03847883|Acute is hemic stroke|acute is hemic stroke
56870|NCT03847883|Low-dose Ateplase|low-dose ateplase
56871|NCT03847883|rtPa|rtpa
56872|NCT03847883|Modified Rankin 's Scale|modified rankin 's scale
56873|NCT03847870|rickettsiae|rickettsiae
56874|NCT03847870|seroprevalence|seroprevalence
56875|NCT03847857|Esophageal Cancer|esophageal cancer
56876|NCT03847857|Anastomotic Leak|anastomotic leak
56877|NCT03847831|whole-school|whole-school
56878|NCT03847831|health promotion|health promotion
56879|NCT03847805|Bouldering|bouldering
56880|NCT03847805|Exercise|exercise
56881|NCT03847805|Shoulder|shoulder
56882|NCT03847805|Stability|stability
56883|NCT03847805|Performance|performance
56884|NCT03847779|vasomotion|vasomotion
56885|NCT03847766|PRO-based follow-up, TelePRO|pro-based follow-up, telepro
56886|NCT03847766|Outpatients, Chronic Kidney Disease|outpatients, chronic kidney disease
56887|NCT03847753|Comorbidity|comorbidity
56888|NCT03847727|Chronic Lymphocytic Leukemia|chronic lymphocytic leukemia
56889|NCT03847727|Bendamustine Hydrochloride|bendamustine hydrochloride
56890|NCT03847727|Rituximab|rituximab
56891|NCT03847727|Maintenance|maintenance
56892|NCT03847701|Slowly Digestible Starch|slowly digestible starch
56893|NCT03847701|SDS|sds
56894|NCT03847701|Type 2 diabetes|type 2 diabetes
56895|NCT03847701|T2D|t2d
56896|NCT03847701|Glycemic response|glycemic response
56897|NCT03847701|Continuous Glucose Monitoring System|continuous glucose monitoring system
56898|NCT03847701|CGMS|cgms
56899|NCT03847701|Diet|diet
56900|NCT03847701|MAGE|mage
56901|NCT03847701|Mean Amplitude of Glucose Excursion|mean amplitude of glucose excursion
56902|NCT03847688|Transcranial Magnetic Stimulation|transcranial magnetic stimulation
56903|NCT03847688|Electroencephalography|electroencephalography
56904|NCT03847688|Machine Learning|machine learning
56905|NCT03847675|Reach out and Read|reach out and read
56906|NCT03847675|Arabic literacy|arabic literacy
56907|NCT03847675|Child development|child development
56908|NCT03847662|Food Insecurity|food insecurity
56909|NCT03847662|Stunting|stunting
56910|NCT03847662|Wasting|wasting
56911|NCT03847662|Underweight|underweight
56912|NCT03847662|Anemia|anemia
56913|NCT03847662|Complimentary Foods|complimentary foods
56914|NCT03847662|Food Fortification|food fortification
56915|NCT03847662|Complimentary Feeding|complimentary feeding
56916|NCT03847610|Pharmacokinetics|pharmacokinetics
56917|NCT03847610|Penicillin V|penicillin v
56918|NCT03847610|Penicillins|penicillins
56919|NCT03847610|Proof of Concept Study|proof of concept study
56920|NCT03847610|Clinical Trial, Phase I|clinical trial, phase i
56926|NCT03847584|Attitude|attitude
56927|NCT03847584|Subjective norms|subjective norms
56928|NCT03847584|Perceived behavioural control|perceived behavioural control
56929|NCT03847584|Intention|intention
56930|NCT03847571|Acetazolamide|acetazolamide
56931|NCT03847571|Hypokalemic metabolic alkalosis|hypokalemic metabolic alkalosis
56932|NCT03847571|Bartter syndrome|bartter syndrome
56933|NCT03847545|Speckle tracking ultrasonography|speckle tracking ultrasonography
56934|NCT03847545|Muscle strain|muscle strain
56935|NCT03847545|Fampridine|fampridine
56936|NCT03847545|Multiple Sclerosis|multiple sclerosis
56937|NCT03847545|Neurological diseases|neurological diseases
56938|NCT03847545|Biomarkers|biomarkers
56939|NCT03847545|muscle contractility|muscle contractility
56940|NCT03847532|MutYH-associated polyposis|mutyh-associated polyposis
56941|NCT03847532|familial adenomatous polyposis|familial adenomatous polyposis
56942|NCT03847532|biallelic mutation|biallelic mutation
56943|NCT03847532|monoallelic mutation|monoallelic mutation
56944|NCT03847532|colproctectomy|colproctectomy
56945|NCT03847519|NSCLC Lung Cancer|nsclc lung cancer
56946|NCT03847519|Metastatic Squamous Non-Small Cell Lung Cancer|metastatic squamous non-small cell lung cancer
56947|NCT03847519|Metastatic Non-Squamous Cell Lung Cancer|metastatic non-squamous cell lung cancer
56948|NCT03847493|perfused boundary region|perfused boundary region
56949|NCT03847493|PBR|pbr
56950|NCT03847493|Sepsis|sepsis
56951|NCT03847493|endothelial glycocalyx|endothelial glycocalyx
74498|NCT03738592|child|child
56952|NCT03847493|ICU|icu
56953|NCT03847480|Dose painting|dose painting
56954|NCT03847480|18F-FDG|18f-fdg
56955|NCT03847480|Positron emission tomography|positron emission tomography
56956|NCT03847480|Radiotherapy|radiotherapy
56957|NCT03847441|Alopecia Areata|alopecia areata
56958|NCT03847441|Calcipotriol|calcipotriol
56959|NCT03847441|Narrow Band-UVB|narrow band-uvb
56960|NCT03847441|Vitamin D3|vitamin d3
56961|NCT03847428|Early stage HCC|early stage hcc
56962|NCT03847428|Durvalumab|durvalumab
56963|NCT03847428|Bevacizumab|bevacizumab
56964|NCT03847428|Liver Cancer|liver cancer
56965|NCT03847376|Rilpivirine|rilpivirine
56966|NCT03847376|Long Acting Rilpivirine Injection|long acting rilpivirine injection
56967|NCT03847376|HIV|hiv
56968|NCT03847376|Rilpivirine Expanded Access|rilpivirine expanded access
56969|NCT03847376|Rilpivirine Single Patient Request|rilpivirine single patient request
56970|NCT03847337|telemedicine|telemedicine
56971|NCT03847298|pediatric|pediatric
56972|NCT03847298|pacemaker|pacemaker
56973|NCT03847298|physical activity|physical activity
56974|NCT03847298|physical fitness|physical fitness
56975|NCT03847285|Transplant|transplant
56976|NCT03847285|Infection|infection
56977|NCT03847285|rejection|rejection
56978|NCT03847285|immunology|immunology
56979|NCT03847233|Superficial Femoral Artery|superficial femoral artery
56980|NCT03847233|Proximal Popliteal Artery|proximal popliteal artery
56981|NCT03847233|Endovascular therapy|endovascular therapy
56982|NCT03847233|Atherectomy|atherectomy
56983|NCT03847220|metastatic breast cancer|metastatic breast cancer
56984|NCT03847220|bone metastasis|bone metastasis
56985|NCT03847220|quality of life|quality of life
56986|NCT03847220|psychometric|psychometric
56987|NCT03847220|treatment|treatment
56988|NCT03847220|assessments|assessments
56989|NCT03847207|First in Human|first in human
56990|NCT03847207|Single Ascending Dose|single ascending dose
56996|NCT03847155|nicotine patch|nicotine patch
56997|NCT03847155|placebo|placebo
56998|NCT03847155|critically ill patients|critically ill patients
56999|NCT03847155|delirium|delirium
57000|NCT03847155|prevention|prevention
57001|NCT03847142|informatics|informatics
57002|NCT03847142|asthma|asthma
57003|NCT03847103|Stroke|stroke
57004|NCT03847103|Robotic-Assisted Therapy|robotic-assisted therapy
57005|NCT03847103|Bilateral Practice|bilateral practice
57006|NCT03847103|Task-specific Training|task-specific training
57007|NCT03847103|Rehabilitation|rehabilitation
57008|NCT03847090|kidney stone|kidney stone
57009|NCT03847090|hyperoxaluria|hyperoxaluria
57010|NCT03847090|enteric hyperoxaluria|enteric hyperoxaluria
57011|NCT03847090|oxalate|oxalate
57012|NCT03847090|kidney calcification|kidney calcification
57013|NCT03847051|MRI (magnetic resonance imaging)|mri (magnetic resonance imaging)
57014|NCT03847051|Neuroradiology|neuroradiology
57015|NCT03847051|EPIMix (Echo planar imaging mix)|epimix (echo planar imaging mix)
57016|NCT03847051|Multicontrast EPI (echo planar imaging)|multicontrast epi (echo planar imaging)
57017|NCT03847051|Clinical validation|clinical validation
57018|NCT03847025|Pacemaker|pacemaker
57019|NCT03847025|Implantable cardioverter defibrillator|implantable cardioverter defibrillator
57020|NCT03847025|Lead extraction|lead extraction
57021|NCT03847012|coronary artery disease|coronary artery disease
57022|NCT03847012|blood pressure|blood pressure
57023|NCT03847012|rehabilitation|rehabilitation
57024|NCT03847012|exercise mode|exercise mode
57025|NCT03846999|breast cancer|breast cancer
57026|NCT03846999|comorbidities|comorbidities
57027|NCT03846999|healthcare services research|healthcare services research
57028|NCT03846999|survival|survival
57029|NCT03846986|Apple pomace fiber|apple pomace fiber
57030|NCT03846986|Glycemic response|glycemic response
57031|NCT03846986|Apple|apple
57032|NCT03846973|Trauma, Mortality, Tranexamic , Prehospital|trauma, mortality, tranexamic , prehospital
57033|NCT03846960|video laryngoscope|video laryngoscope
57034|NCT03846960|minimally invasive surfactant administration|minimally invasive surfactant administration
57035|NCT03846934|Pleural Effusion|pleural effusion
57036|NCT03846934|Ultrasonography|ultrasonography
57037|NCT03846934|Thoracic|thoracic
57038|NCT03846934|Acute Respiratory Failure|acute respiratory failure
57039|NCT03846934|Emergencies|emergencies
57040|NCT03846882|PET/MR|pet/mr
57041|NCT03846882|PET/CT|pet/ct
57042|NCT03846882|FDG|fdg
57043|NCT03846882|Staging|staging
57044|NCT03846869|Fluid Therapy|fluid therapy
57045|NCT03846869|Anesthesia|anesthesia
57046|NCT03846869|Renal Transplantation|renal transplantation
57047|NCT03846843|Cirrhosis|cirrhosis
57048|NCT03846843|Ornithine phenylacetate|ornithine phenylacetate
57049|NCT03846843|OCR-002|ocr-002
57050|NCT03846830|gaze stability|gaze stability
57051|NCT03846830|balance|balance
57052|NCT03846830|vestibulo-ocular reflex (VOR) gain|vestibulo-ocular reflex (vor) gain
57053|NCT03846830|dizzy|dizzy
57054|NCT03846804|infection|infection
400574|NCT01866215|gluconeogenesis|gluconeogenesis
57055|NCT03846804|plasma based next generation sequencing|plasma based next generation sequencing
57056|NCT03846804|blood culture|blood culture
57057|NCT03846804|tissue culture|tissue culture
57058|NCT03846804|joint fluid culture|joint fluid culture
57059|NCT03846804|pathogen identification|pathogen identification
57060|NCT03846778|Postoperative outcomes|postoperative outcomes
57061|NCT03846778|Laparoscopy|laparoscopy
57062|NCT03846778|Comprehensive complication index|comprehensive complication index
57063|NCT03846778|Postoperative complications|postoperative complications
57064|NCT03846765|spinal oxygenation|spinal oxygenation
57065|NCT03846765|NIRS|nirs
57066|NCT03846752|Transradial Intervention|transradial intervention
57067|NCT03846752|transfemoral intervention|transfemoral intervention
57068|NCT03846752|PCI for complex coronary lesions|pci for complex coronary lesions
57069|NCT03846739|amygdala|amygdala
57070|NCT03846739|reward|reward
57071|NCT03846739|oxytocin|oxytocin
57072|NCT03846739|dose|dose
57073|NCT03846739|emotion processing|emotion processing
57074|NCT03846739|sex differences|sex differences
57075|NCT03846726|Rectal Cancer|rectal cancer
57076|NCT03846726|clinical complete response|clinical complete response
57077|NCT03846713|double-lumen tube|double-lumen tube
57078|NCT03846713|intubation|intubation
57079|NCT03846713|airway exchange catheter|airway exchange catheter
57080|NCT03846713|thermosoftening|thermosoftening
57081|NCT03846635|Cellulitis|cellulitis
57082|NCT03846635|Temperature|temperature
57083|NCT03846635|Venous Stasis|venous stasis
57084|NCT03846635|Lymphedema|lymphedema
57085|NCT03846609|Endoscopic Submucosal Dissection|endoscopic submucosal dissection
57086|NCT03846596|Sepsis|sepsis
57087|NCT03846596|reactive oxygen species|reactive oxygen species
57088|NCT03846596|immature neutrophils|immature neutrophils
57089|NCT03846583|Breast Cancer|breast cancer
57090|NCT03846570|Randomized Controlled Trial|randomized controlled trial
57091|NCT03846570|Inhaled corticosteroids|inhaled corticosteroids
57092|NCT03846570|Placebo|placebo
57093|NCT03846570|Cough|cough
57094|NCT03846557|TAVI|tavi
57095|NCT03846557|Valve|valve
57096|NCT03846531|Nano-Pulse Stimulation|nano-pulse stimulation
57097|NCT03846531|Seborrheic Keratosis|seborrheic keratosis
57098|NCT03846518|palatal expansion technique|palatal expansion technique
57099|NCT03846518|adolescent|adolescent
57100|NCT03846518|quality of life|quality of life
57101|NCT03846505|Couple|couple
57102|NCT03846505|Alcohol|alcohol
57103|NCT03846505|Therapy|therapy
57104|NCT03846492|Dementia|dementia
57105|NCT03846492|Transcranial Magnetic Stimulation|transcranial magnetic stimulation
57106|NCT03846492|Transcranial Direct Current Stimulation|transcranial direct current stimulation
57107|NCT03846492|tDCS|tdcs
57108|NCT03846492|TMS|tms
57109|NCT03846492|TMS-EEG|tms-eeg
57110|NCT03846492|MRI|mri
57111|NCT03846492|Agitation|agitation
57112|NCT03846492|Alzheimer's disease|alzheimer's disease
57113|NCT03846492|Neuropsychiatric symptoms|neuropsychiatric symptoms
57114|NCT03846492|Agitation in dementia|agitation in dementia
57115|NCT03846492|Mixed dementia|mixed dementia
57116|NCT03846492|Non-invasive brain stimulation|non-invasive brain stimulation
57117|NCT03846479|Graft-versus-host disease|graft-versus-host disease
57118|NCT03846479|Itacitinib|itacitinib
57119|NCT03846440|Protein intake|protein intake
57120|NCT03846440|Older adults|older adults
57121|NCT03846440|Mexican adults|mexican adults
57122|NCT03846440|Functionality|functionality
57123|NCT03846427|BGB-3111|bgb-3111
57124|NCT03846427|Zanubrutinib|zanubrutinib
57125|NCT03846414|PEG-rhG-CSF|peg-rhg-csf
57126|NCT03846414|Pegfilgrastim|pegfilgrastim
57127|NCT03846375|Emotional Dysregulation|emotional dysregulation
57128|NCT03846375|Emotional regulation|emotional regulation
57129|NCT03846375|Dialectical Behavioral Therapy|dialectical behavioral therapy
57130|NCT03846375|para-suicidal behavior|para-suicidal behavior
57131|NCT03846362|AML|aml
57132|NCT03846362|MRD|mrd
57133|NCT03846362|stem cell transplantation|stem cell transplantation
57134|NCT03846362|pediatric|pediatric
57135|NCT03846362|leukemia|leukemia
57136|NCT03846362|haploidentical|haploidentical
57137|NCT03846362|TcRab-depletion|tcrab-depletion
57138|NCT03846362|young adult|young adult
57139|NCT03846336|Multiple Sclerosis|multiple sclerosis
57140|NCT03846336|Upper Extremity Function|upper extremity function
57141|NCT03846336|Position Sense|position sense
57142|NCT03846323|Posttraumatic stress disorder (PTSD)|posttraumatic stress disorder (ptsd)
57143|NCT03846323|ICU|icu
57144|NCT03846323|visiting hours policies|visiting hours policies
57145|NCT03846297|hypertrophic cardiomyopathy|hypertrophic cardiomyopathy
57146|NCT03846297|implantable cardioverter defibrillator|implantable cardioverter defibrillator
57147|NCT03846284|Sevoflurane-|sevoflurane-
57148|NCT03846284|Emergence agitation|emergence agitation
57149|NCT03846284|Magnesium sulfate|magnesium sulfate
57150|NCT03846284|Children|children
57151|NCT03846271|Oxytocin|oxytocin
57152|NCT03846271|performance monitoring|performance monitoring
57153|NCT03846271|reinforcement learning|reinforcement learning
57154|NCT03846219|RRMS|rrms
57155|NCT03846219|Multiple Sclerosis (MS)|multiple sclerosis (ms)
57156|NCT03846206|Microbiota.|microbiota.
57157|NCT03846206|Mediterranean Diet|mediterranean diet
57158|NCT03846206|Bacterial Traslocation|bacterial traslocation
57159|NCT03846193|Dry AMD|dry amd
57160|NCT03846193|AMD|amd
57161|NCT03846193|Atrophic AMD|atrophic amd
57162|NCT03846193|Geographic Atrophy (GA)|geographic atrophy (ga)
57163|NCT03846102|Fascia Iliaca Compartment Block|fascia iliaca compartment block
57164|NCT03846102|Peripheral Nerve Block|peripheral nerve block
57165|NCT03846102|Elderly|elderly
57166|NCT03846102|Hip fracture|hip fracture
57167|NCT03846102|Levobupivacaïne|levobupivacaïne
57168|NCT03846102|Morphine|morphine
57169|NCT03846102|Emergency Physician|emergency physician
57170|NCT03846102|Emergency department|emergency department
57171|NCT03846102|Ultrasound|ultrasound
57172|NCT03846102|Pain score|pain score
57173|NCT03846102|Numerical Rating scale|numerical rating scale
57174|NCT03846063|Total hip arthroplasty|total hip arthroplasty
57175|NCT03846063|Physiotherapy|physiotherapy
57176|NCT03846063|Osteoarthritis|osteoarthritis
57177|NCT03846063|Usual care|usual care
57178|NCT03846063|Home-based rehabilitation program|home-based rehabilitation program
57179|NCT03846050|alcohol impaired driving|alcohol impaired driving
57180|NCT03846050|decision making|decision making
57181|NCT03846050|drunk driving|drunk driving
57182|NCT03846050|ambulatory assessment|ambulatory assessment
57183|NCT03846037|Proprioception|proprioception
57184|NCT03846037|Balance|balance
57185|NCT03846037|Whole-body Vibation|whole-body vibation
57186|NCT03846037|One-foot Stance|one-foot stance
57187|NCT03846024|RibFx|ribfx
57188|NCT03846024|PelvicBinder|pelvicbinder
57189|NCT03846024|Rib Fractures|rib fractures
57190|NCT03846024|Trauma|trauma
57191|NCT03846024|Pulmonary toilet|pulmonary toilet
57192|NCT03846024|Incentive Spirometry|incentive spirometry
57193|NCT03846011|urolithiasis|urolithiasis
57194|NCT03846011|24-h urine composition|24-h urine composition
57195|NCT03845998|airway|airway
57196|NCT03845998|anaesthesia|anaesthesia
57197|NCT03845998|laryngeal mask airway|laryngeal mask airway
57198|NCT03845998|paediatric|paediatric
57199|NCT03845985|psychotherapy|psychotherapy
57200|NCT03845985|trauma|trauma
57201|NCT03845985|addiction|addiction
57202|NCT03845985|Deaf|deaf
57203|NCT03845894|Shoulder Surgery|shoulder surgery
57204|NCT03845894|Interscalene Nerve Block|interscalene nerve block
57205|NCT03845894|Liposomal Bupivacaine|liposomal bupivacaine
57206|NCT03845894|Shoulder pain|shoulder pain
57207|NCT03845894|Regional anesthesia|regional anesthesia
57208|NCT03845894|Brachial plexus blockade|brachial plexus blockade
57209|NCT03845855|virtual reality|virtual reality
57210|NCT03845855|stroke|stroke
57211|NCT03845855|dual task|dual task
57212|NCT03845842|Cannabis|cannabis
57213|NCT03845842|Risk reduction|risk reduction
57214|NCT03845803|Sit/stand workstation|sit/stand workstation
57215|NCT03845803|Office workers|office workers
57216|NCT03845803|Sedentary behaviour|sedentary behaviour
57217|NCT03845803|Sitting time|sitting time
57218|NCT03845803|Musculoskeletal disorder|musculoskeletal disorder
57219|NCT03845777|Iodine|iodine
57220|NCT03845777|Surgical|surgical
57221|NCT03845777|Staff|staff
57222|NCT03845777|Antiseptic|antiseptic
57224|NCT03845751|hemi ablation|hemi ablation
57225|NCT03845751|focal therapy|focal therapy
57226|NCT03845738|OsseoSpeed|osseospeed
57227|NCT03845738|EV|ev
57228|NCT03845699|Opioid Overdose|opioid overdose
57229|NCT03845699|Diagnostic Algorithm|diagnostic algorithm
57230|NCT03845699|Wearable Trachea Sound Sensor|wearable trachea sound sensor
57231|NCT03845699|Respiratory Depression|respiratory depression
57232|NCT03845699|Hypoventilation|hypoventilation
57233|NCT03845686|stroke|stroke
57234|NCT03845686|reading|reading
57235|NCT03845686|fMRI|fmri
57236|NCT03845686|perfusion|perfusion
57237|NCT03845686|activation|activation
57238|NCT03845686|BOLD|bold
57239|NCT03845686|recovery|recovery
57240|NCT03845686|subacute|subacute
57241|NCT03845686|chronic|chronic
57242|NCT03845673|Bowel recipe|bowel recipe
57243|NCT03845673|Bristol stool form scale|bristol stool form scale
57244|NCT03845673|Konsyl|konsyl
57245|NCT03845673|psyllium|psyllium
57246|NCT03845673|wheat bran|wheat bran
57247|NCT03845660|Heart Failure|heart failure
57248|NCT03845660|Prognosis|prognosis
57249|NCT03845660|Electronic Alerts|electronic alerts
57250|NCT03845647|lymph node dissection|lymph node dissection
57251|NCT03845647|differentiated thyroid carcinoma|differentiated thyroid carcinoma
57252|NCT03845634|Non-motor fluctuation|non-motor fluctuation
57253|NCT03845595|Cortical excitability sequential change|cortical excitability sequential change
57254|NCT03845595|Transcranial Magnetic stimulation|transcranial magnetic stimulation
57255|NCT03845595|Recommended number of sessions|recommended number of sessions
57256|NCT03845595|Upper limb motor performance|upper limb motor performance
57257|NCT03845569|Amino acids|amino acids
57258|NCT03845569|Protein|protein
57259|NCT03845569|metabolism|metabolism
57260|NCT03845569|IAAO|iaao
57261|NCT03845569|Tracer|tracer
57262|NCT03845569|Indicator amino acid|indicator amino acid
57263|NCT03845569|Resistance trained|resistance trained
57264|NCT03845504|depression|depression
57265|NCT03845504|transcranial magnetic stimulation|transcranial magnetic stimulation
57266|NCT03845504|adolescent|adolescent
57267|NCT03845504|treatment refractory|treatment refractory
57268|NCT03845478|Obesity|obesity
57269|NCT03845478|Physical Activity|physical activity
57270|NCT03845478|Fat mass|fat mass
57271|NCT03845478|Fat free mass|fat free mass
57272|NCT03845478|Pedometer|pedometer
57273|NCT03845478|mHealth|mhealth
57274|NCT03845452|chronic kidney disease|chronic kidney disease
57275|NCT03845452|muscle strength|muscle strength
57276|NCT03845452|muscle mass|muscle mass
57277|NCT03845452|lean body mass|lean body mass
57278|NCT03845452|physical activity|physical activity
57279|NCT03845439|tau|tau
57280|NCT03845439|post mortem interval|post mortem interval
57281|NCT03845439|cerebrospinal fluid|cerebrospinal fluid
57282|NCT03845439|immunoassay|immunoassay
57283|NCT03845439|biomarker|biomarker
57284|NCT03845439|forensic medicine|forensic medicine
57285|NCT03845413|tobacco cessation|tobacco cessation
57286|NCT03845413|women|women
57287|NCT03845413|capacity building|capacity building
57288|NCT03845361|Perfusion index|perfusion index
57289|NCT03845361|Cardiac Surgery|cardiac surgery
57290|NCT03845361|Radial artery cannulation|radial artery cannulation
57291|NCT03845322|curcumin|curcumin
57292|NCT03845322|chronic|chronic
57293|NCT03845322|recurrence|recurrence
57294|NCT03845322|hematoma|hematoma
57295|NCT03845322|subdural|subdural
57296|NCT03845322|turmeric|turmeric
57297|NCT03845309|Heart failure|heart failure
57298|NCT03845309|Nutritional intervention|nutritional intervention
57299|NCT03845309|Quality of Life|quality of life
57300|NCT03845309|Self-Care Behavior|self-care behavior
57301|NCT03845283|Cardiovascular Diseases|cardiovascular diseases
57302|NCT03845283|Obesity|obesity
57303|NCT03845283|Multiphase Optimization Strategy|multiphase optimization strategy
57304|NCT03845283|Technology|technology
57305|NCT03845283|Weight Loss|weight loss
57306|NCT03845283|Cardiac Rehabilitation|cardiac rehabilitation
57307|NCT03845270|IFCT|ifct
57308|NCT03845270|NSCLC|nsclc
57309|NCT03845270|HER2|her2
57310|NCT03845244|high flow nasal cannula|high flow nasal cannula
57311|NCT03845244|weaning|weaning
57312|NCT03845244|adult|adult
57313|NCT03845231|Intranasal Vaccination|intranasal vaccination
57314|NCT03845231|Influenza Vaccination|influenza vaccination
57315|NCT03845231|Human Challenge|human challenge
57316|NCT03845231|Vaccine|vaccine
57317|NCT03845231|Mucosal IgA|mucosal iga
57318|NCT03845231|Antibody|antibody
57319|NCT03845231|Systemic IgG|systemic igg
57320|NCT03845231|Challenge Study|challenge study
57321|NCT03845231|Healthy Volunteer|healthy volunteer
57322|NCT03845231|Immune Response|immune response
57323|NCT03845218|Retina|retina
57324|NCT03845218|Imaging|imaging
57325|NCT03845218|Psychophysics|psychophysics
57326|NCT03845218|Functional Outcome Measures|functional outcome measures
57327|NCT03845205|Alcohol treatment|alcohol treatment
57328|NCT03845205|Liver transplant|liver transplant
57719|NCT03842787|ficolin-3|ficolin-3
57329|NCT03845205|Motivational intervention|motivational intervention
57330|NCT03845205|Cognitive-behavioral therapy|cognitive-behavioral therapy
57331|NCT03845153|Bone Fracture|bone fracture
57332|NCT03845153|Post-Menopausal Women|post-menopausal women
57333|NCT03845153|Metformin|metformin
57334|NCT03845153|Irisin|irisin
57335|NCT03845140|Schistosomiasis|schistosomiasis
57336|NCT03845140|Children|children
57337|NCT03845140|L-praziquantel|l-praziquantel
57338|NCT03845140|Biltricide®|biltricide®
57339|NCT03845127|Ischemic Cardiomyopathy, Heart Failure, Revivent TC System|ischemic cardiomyopathy, heart failure, revivent tc system
57340|NCT03845114|Type 1 diabetes|type 1 diabetes
57341|NCT03845114|Exercise|exercise
57342|NCT03845114|Hypoglycemia|hypoglycemia
57343|NCT03845101|Social anxiety|social anxiety
57344|NCT03845101|Virtual Reality|virtual reality
57345|NCT03845101|Virtual Reality Exposure Therapy|virtual reality exposure therapy
57346|NCT03845101|RCT|rct
57347|NCT03845101|Social Phobia|social phobia
57348|NCT03845088|Virtual mandibular position; temporomandibular joint reconstruction; Jaw deformity;Costochondral graft|virtual mandibular position; temporomandibular joint reconstruction; jaw deformity;costochondral graft
57349|NCT03845062|drug-induced sleep endoscopy|drug-induced sleep endoscopy
57350|NCT03845062|pediatric obstructive sleep apnea hypopnea syndrome|pediatric obstructive sleep apnea hypopnea syndrome
57351|NCT03845062|tongue base|tongue base
57352|NCT03845062|epiglottis|epiglottis
57353|NCT03845062|occult laryngomalacia|occult laryngomalacia
57354|NCT03845062|lingual tonsillectomy|lingual tonsillectomy
57355|NCT03845062|epiglottopexy|epiglottopexy
817622|NCT00169572|Nausea|nausea
57356|NCT03845062|aryepiglottic folds division|aryepiglottic folds division
57357|NCT03844971|Arthrocentesis|arthrocentesis
57358|NCT03844971|Computer assisted surgery|computer assisted surgery
57359|NCT03844971|Anterior disc displacement with reduction|anterior disc displacement with reduction
57360|NCT03844958|Red furu|red furu
57361|NCT03844958|Metabolism|metabolism
57362|NCT03844958|Randomized|randomized
57363|NCT03844945|Glaucoma|glaucoma
57364|NCT03844945|Ocular Hypertension|ocular hypertension
57365|NCT03844945|Open-Angle Glaucoma|open-angle glaucoma
57366|NCT03844919|Children|children
57367|NCT03844919|Adolescent|adolescent
57368|NCT03844919|CBIT|cbit
57369|NCT03844919|Transcranial magnetic stimulation|transcranial magnetic stimulation
57370|NCT03844919|Comprehensive Behavioral Intervention for Tics|comprehensive behavioral intervention for tics
57371|NCT03844919|rTMS|rtms
57372|NCT03844919|TMS|tms
57373|NCT03844919|MRI|mri
57374|NCT03844919|Tourette's Syndrome|tourette's syndrome
57375|NCT03844880|Chronic Pain|chronic pain
57376|NCT03844880|Psychotherapy|psychotherapy
57377|NCT03844880|Musculoskeletal Disease|musculoskeletal disease
57378|NCT03844854|Sonoelastography|sonoelastography
57379|NCT03844854|Elastography|elastography
57380|NCT03844854|Shear-wave|shear-wave
57381|NCT03844854|Masseter muscle|masseter muscle
57382|NCT03844854|Temporomandibular disorders|temporomandibular disorders
57383|NCT03844841|Atrial Fibrillation|atrial fibrillation
57384|NCT03844841|Ablation|ablation
57385|NCT03844841|Sedation|sedation
57386|NCT03844841|Anesthesia|anesthesia
57387|NCT03844841|Propofol|propofol
57388|NCT03844841|Dexmedetomidine|dexmedetomidine
57389|NCT03844828|Intraocular Lens|intraocular lens
57390|NCT03844828|Trifocal|trifocal
57391|NCT03844828|Toric Lens|toric lens
57392|NCT03844802|neck pain|neck pain
57393|NCT03844802|randomized control trial|randomized control trial
57394|NCT03844802|trigger points|trigger points
57395|NCT03844802|dry needling|dry needling
57396|NCT03844802|physical therapy|physical therapy
57397|NCT03844789|Artificial Pancreas (AP)|artificial pancreas (ap)
57398|NCT03844789|Control-IQ System|control-iq system
57399|NCT03844789|Insulin Pump|insulin pump
57400|NCT03844789|Closed Loop Control (CLC)|closed loop control (clc)
57401|NCT03844789|Continuous Glucose Monitor (CGM)|continuous glucose monitor (cgm)
57402|NCT03844789|Standard of Care (SC)|standard of care (sc)
57403|NCT03844789|Multiple Daily Injections (MDI)|multiple daily injections (mdi)
57404|NCT03844776|dry socket|dry socket
57405|NCT03844776|bleeding|bleeding
57406|NCT03844776|swelling|swelling
57407|NCT03844763|Immunotherapy|immunotherapy
57408|NCT03844763|Avelumab|avelumab
57409|NCT03844763|Head and neck cancer|head and neck cancer
57410|NCT03844763|Radiotherapy|radiotherapy
57411|NCT03844763|Cyclophosphamide|cyclophosphamide
57412|NCT03844724|Peripheral Arterial Disease|peripheral arterial disease
57413|NCT03844724|Drug-eluting PTA Balloon Dilatation Catheter|drug-eluting pta balloon dilatation catheter
57414|NCT03844724|Late Lumen Loss（6 months）|late lumen loss（6 months）
57415|NCT03844711|Chronic Obstructive Pulmonary Disease|chronic obstructive pulmonary disease
57416|NCT03844711|Electrical Stimulation|electrical stimulation
57417|NCT03844711|Respiratory Muscle Training|respiratory muscle training
57418|NCT03844698|sarcoidosis, cancer, paraneoplastic, treatment, outcome|sarcoidosis, cancer, paraneoplastic, treatment, outcome
57419|NCT03844633|lactation|lactation
57420|NCT03844633|Depo Provera|depo provera
57421|NCT03844633|contraception|contraception
57422|NCT03844594|Acute Ischemic Stroke|acute ischemic stroke
57423|NCT03844594|Eptifibatide|eptifibatide
57424|NCT03844594|Endovascular Treatment|endovascular treatment
57425|NCT03844594|Recovery of Dysfunction|recovery of dysfunction
57426|NCT03844568|aspiration pneumonia|aspiration pneumonia
57427|NCT03844568|continuous positive airway pressure, CPAP|continuous positive airway pressure, cpap
57428|NCT03844516|Chronotropic incompetence|chronotropic incompetence
57429|NCT03844516|pacing|pacing
57430|NCT03844516|heart rate|heart rate
57431|NCT03844516|exercise|exercise
57432|NCT03844516|peak oxygen uptake|peak oxygen uptake
57433|NCT03844503|Cereal bar|cereal bar
57434|NCT03844503|Fiber|fiber
57435|NCT03844503|Resistant Starch|resistant starch
57436|NCT03844503|Glycemic Response|glycemic response
57437|NCT03844503|Insulin Response|insulin response
57438|NCT03844490|Postpartum Hemorrhage|postpartum hemorrhage
57439|NCT03844490|Neonatal jaundice|neonatal jaundice
57440|NCT03844490|Umbilical cord|umbilical cord
57441|NCT03844451|Exparel, liposomal bupivacaine, postoperative, pain control|exparel, liposomal bupivacaine, postoperative, pain control
57442|NCT03844425|Orthodontic Retainers|orthodontic retainers
57443|NCT03844425|Printing, Three-Dimensional|printing, three-dimensional
57444|NCT03844425|Colony Count, Microbial|colony count, microbial
57445|NCT03844412|Pelvic pain|pelvic pain
57446|NCT03844412|Lidocaine|lidocaine
57447|NCT03844412|Estradiol|estradiol
57448|NCT03844412|Nortriptyline|nortriptyline
57449|NCT03844412|Chronic pain|chronic pain
57450|NCT03844399|Diagnostic|diagnostic
57451|NCT03844399|Intervention|intervention
57452|NCT03844399|3D Ultrasound|3d ultrasound
57453|NCT03844386|HIV-1|hiv-1
57454|NCT03844386|Infection|infection
57455|NCT03844386|Suppressed|suppressed
57456|NCT03844386|ART|art
57457|NCT03844386|Vaccines|vaccines
57458|NCT03844386|Alone|alone
57459|NCT03844386|Combination|combination
57460|NCT03844386|Immunogenicity|immunogenicity
57461|NCT03844347|Colorectal cancer|colorectal cancer
57462|NCT03844347|Well-being|well-being
57463|NCT03844347|Stress|stress
57464|NCT03844347|Recovery|recovery
57465|NCT03844295|stimulation|stimulation
57466|NCT03844295|hypoglossal nerve|hypoglossal nerve
57467|NCT03844295|Upper-airway|upper-airway
57468|NCT03844282|Concussion|concussion
57469|NCT03844282|mTBI|mtbi
57470|NCT03844282|mild traumatic brain injury|mild traumatic brain injury
57471|NCT03844282|motorsport|motorsport
57472|NCT03844282|motor sport|motor sport
57474|NCT03844269|ADHD|adhd
57475|NCT03844269|Inattention|inattention
57476|NCT03844256|Immunotherapy|immunotherapy
57477|NCT03844256|Chemoradiotherapy|chemoradiotherapy
57478|NCT03844256|Nivolumab|nivolumab
57479|NCT03844256|Ipilimumab|ipilimumab
57480|NCT03844256|bladder sparing treatment|bladder sparing treatment
57481|NCT03844243|NGF-induced hyperalgesia|ngf-induced hyperalgesia
57482|NCT03844243|Exercise-induced ischemic pain|exercise-induced ischemic pain
57483|NCT03844243|Pain modulation|pain modulation
57484|NCT03844243|NGF pain model|ngf pain model
57485|NCT03844230|sweeteners|sweeteners
57486|NCT03844230|glucose metabolism|glucose metabolism
57487|NCT03844230|taste receptors|taste receptors
57488|NCT03844230|sucralose|sucralose
57489|NCT03844217|Copeptin|copeptin
57490|NCT03844217|Macimorelin|macimorelin
57491|NCT03844217|Ghrelin receptor agonist|ghrelin receptor agonist
57492|NCT03844217|posterior pituitary gland|posterior pituitary gland
57493|NCT03844217|polyuria-polydipsia syndrome|polyuria-polydipsia syndrome
57494|NCT03844217|hypothalamo-pituitary-adrenal axis|hypothalamo-pituitary-adrenal axis
57495|NCT03844152|fermented whey|fermented whey
57496|NCT03844152|microbiota|microbiota
57497|NCT03844152|gut health|gut health
57498|NCT03844152|butyrate|butyrate
57499|NCT03844113|carnosine|carnosine
57500|NCT03844113|peripheral arterial disease|peripheral arterial disease
57501|NCT03844100|Refractory Functional Dyspepsia|refractory functional dyspepsia
57502|NCT03844087|multiplanar, plyometric, neck strength|multiplanar, plyometric, neck strength
57503|NCT03844074|Subfoveal Choroidal Neovascularization|subfoveal choroidal neovascularization
57504|NCT03844061|Systemic Sclerosis|systemic sclerosis
57505|NCT03844048|Chronic Lymphocytic Leukemia (CLL)|chronic lymphocytic leukemia (cll)
57506|NCT03844048|Acute Myeloid Leukemia (AML)|acute myeloid leukemia (aml)
57507|NCT03844048|Multiple Myeloma (MM)|multiple myeloma (mm)
57508|NCT03844048|Non-Hodgkin's Lymphoma (NHL)|non-hodgkin's lymphoma (nhl)
57509|NCT03844048|Acute Lymphoblastic Leukemia (ALL)|acute lymphoblastic leukemia (all)
57510|NCT03844048|Cancer|cancer
57511|NCT03844048|Venetoclax|venetoclax
57512|NCT03844035|periimplant mucositis|periimplant mucositis
57513|NCT03843996|Stratamed|stratamed
57514|NCT03843996|wound healing|wound healing
57515|NCT03843996|follicular unit extraction hair transplantation|follicular unit extraction hair transplantation
57516|NCT03843983|Meibomian gland dysfunction|meibomian gland dysfunction
57517|NCT03843983|Lipiflow|lipiflow
57518|NCT03843983|Meibum composition|meibum composition
57519|NCT03843983|Adverse environmental conditions|adverse environmental conditions
57520|NCT03843983|Dry eye disease|dry eye disease
57521|NCT03843970|Hip fracture, Subarachnoid block|hip fracture, subarachnoid block
57523|NCT03843957|Cancer Screening|cancer screening
57524|NCT03843957|Cancer Intervention|cancer intervention
57525|NCT03843957|Mobile Health|mobile health
57526|NCT03843957|Implementation Science|implementation science
57527|NCT03843944|IMAO-B|imao-b
57528|NCT03843944|Safinamide|safinamide
57529|NCT03843944|Rasagiline|rasagiline
57530|NCT03843931|Exercise|exercise
57531|NCT03843931|Placebo|placebo
57532|NCT03843931|Injection|injection
57533|NCT03843918|Prostate Cancer|prostate cancer
57534|NCT03843905|Gut microbiota|gut microbiota
57535|NCT03843905|Colorectal cancer|colorectal cancer
57536|NCT03843905|Sarcopenia|sarcopenia
57537|NCT03843905|Metabolic syndrome|metabolic syndrome
57538|NCT03843905|Prognostic factors|prognostic factors
57539|NCT03843905|Pathogenic E.coli|pathogenic e.coli
57540|NCT03843814|MRI (Magnetic Resonance Imaging) of the brain|mri (magnetic resonance imaging) of the brain
57541|NCT03843814|Amide Proton Transfer (APT)|amide proton transfer (apt)
57542|NCT03843814|Diffuse Weighted Imaging (DWI)|diffuse weighted imaging (dwi)
57543|NCT03843801|Endoscopy|endoscopy
57544|NCT03843801|Mini invasive|mini invasive
57545|NCT03843788|Post-cesarean pain|post-cesarean pain
57546|NCT03843788|Transcutaneous Electrical Nerve Stimulation|transcutaneous electrical nerve stimulation
57547|NCT03843775|Binimetinib|binimetinib
57548|NCT03843775|Encorafenib|encorafenib
57549|NCT03843775|18-547|18-547
57550|NCT03843762|Adolescents|adolescents
57551|NCT03843762|Sleep|sleep
57552|NCT03843762|Actigraphy|actigraphy
57553|NCT03843762|Psychiatric Health|psychiatric health
57554|NCT03843749|HER2|her2
57555|NCT03843749|Pyrotinib|pyrotinib
57556|NCT03843749|Trastuzumab|trastuzumab
57557|NCT03843749|Metastatic Colorectal Cancar|metastatic colorectal cancar
57558|NCT03843736|Polycystic Ovary Syndrome|polycystic ovary syndrome
57559|NCT03843736|Metagenomics|metagenomics
57560|NCT03843736|Metabonomics|metabonomics
57561|NCT03843723|Pre-flight evaluation|pre-flight evaluation
57562|NCT03843723|Air travel|air travel
57563|NCT03843723|Pulseoximetry|pulseoximetry
57564|NCT03843723|Exercise desaturation|exercise desaturation
57565|NCT03843723|Hypobaria|hypobaria
57566|NCT03843723|Hypoxemia|hypoxemia
57567|NCT03843710|Neurodegeneration|neurodegeneration
57568|NCT03843710|gold|gold
57569|NCT03843710|nanocrystal|nanocrystal
57570|NCT03843710|NAD+|nad+
57571|NCT03843710|NADH|nadh
57572|NCT03843710|Redox|redox
57573|NCT03843710|Redox Ratio|redox ratio
57575|NCT03843710|Amyotrophic Lateral Sclerosis|amyotrophic lateral sclerosis
57576|NCT03843710|31P-MRS|31p-mrs
57577|NCT03843710|MRS|mrs
57578|NCT03843710|magnetic resonance spectroscopy|magnetic resonance spectroscopy
57579|NCT03843710|nanoparticle|nanoparticle
57580|NCT03843710|nanomedicine|nanomedicine
57581|NCT03843671|Hyperbaric oxygen; HNSCC; Radiotherapy; Chemotherapy|hyperbaric oxygen; hnscc; radiotherapy; chemotherapy
57582|NCT03843645|anesthesia, general|anesthesia, general
57583|NCT03843645|anesthesia, regional|anesthesia, regional
57584|NCT03843645|sleep disorder|sleep disorder
57585|NCT03843645|REM stage|rem stage
57586|NCT03843593|Decline Adjuvant Immunotherapy|decline adjuvant immunotherapy
57587|NCT03843593|Agree To Adjuvant Immunotherapy|agree to adjuvant immunotherapy
57588|NCT03843593|19-012|19-012
57589|NCT03843580|Time of apnea|time of apnea
57590|NCT03843580|Optiflow|optiflow
57591|NCT03843580|Thrive|thrive
57592|NCT03843580|Apnea oxygenation|apnea oxygenation
57593|NCT03843580|Suspension laryngoscopy|suspension laryngoscopy
57594|NCT03843580|General Anesthesia|general anesthesia
57595|NCT03843580|Oxygenation apnea|oxygenation apnea
57596|NCT03843567|Colonic polyps|colonic polyps
57597|NCT03843567|Virtual chromoendoscopy|virtual chromoendoscopy
57598|NCT03843567|Training|training
57599|NCT03843567|Polyp characterisation|polyp characterisation
57600|NCT03843554|Head Cancer|head cancer
57601|NCT03843554|Neck Cancer|neck cancer
57602|NCT03843554|Oral Mucositis|oral mucositis
57603|NCT03843554|Oral Health|oral health
57604|NCT03843554|Radiation|radiation
57605|NCT03843554|Chemoradiation|chemoradiation
57606|NCT03843541|N-acetylcysteine (NAC)|n-acetylcysteine (nac)
57607|NCT03843541|ambroxol hydrochloride|ambroxol hydrochloride
57608|NCT03843541|bronchitis|bronchitis
57609|NCT03843541|cystic fibrosis|cystic fibrosis
57610|NCT03843541|fibrosis bronchiectasis|fibrosis bronchiectasis
57611|NCT03843541|increased sputum viscosity|increased sputum viscosity
57612|NCT03843541|cough|cough
57613|NCT03843541|Chronic Obstructive Pulmonary Disease (COPD)|chronic obstructive pulmonary disease (copd)
57614|NCT03843515|head and neck squamous cell carcinoma|head and neck squamous cell carcinoma
57615|NCT03843515|nivolumab|nivolumab
57616|NCT03843515|PD-L1|pd-l1
57617|NCT03843515|PET/CT|pet/ct
57618|NCT03843515|neoadjuvant|neoadjuvant
57619|NCT03843502|kava|kava
57620|NCT03843502|dietary supplement|dietary supplement
57621|NCT03843502|anxiety|anxiety
57622|NCT03843502|generalized anxiety disorder (GAD)|generalized anxiety disorder (gad)
57623|NCT03843450|circulating tumor cells,WBCs adhesion, biomedical materials|circulating tumor cells,wbcs adhesion, biomedical materials
57624|NCT03843437|Atopic Dermatitis|atopic dermatitis
57625|NCT03843437|Tencel fabric|tencel fabric
57626|NCT03843437|cotton fabric|cotton fabric
57627|NCT03843411|mini-fluid challenge|mini-fluid challenge
57628|NCT03843398|Colorectal Cancer|colorectal cancer
57629|NCT03843398|Minilaparotomy|minilaparotomy
57630|NCT03843398|Survival|survival
57631|NCT03843385|fecal transplantation|fecal transplantation
57632|NCT03843385|multidonor fecal transplantation|multidonor fecal transplantation
57633|NCT03843372|Continuous Positive Airway pressure|continuous positive airway pressure
57634|NCT03843372|Transnasal High Flow|transnasal high flow
57635|NCT03843359|GSK3745417, pembrolizumab, solid tumor, first time in human, Stimulator of Interferon Genes, STING|gsk3745417, pembrolizumab, solid tumor, first time in human, stimulator of interferon genes, sting
57636|NCT03843333|Functional decline|functional decline
57637|NCT03843333|Older adult|older adult
57638|NCT03843333|Community health workers|community health workers
57639|NCT03843333|Cognitive impairment|cognitive impairment
57640|NCT03843333|Mobility limitation|mobility limitation
57641|NCT03843333|Depressive symptoms|depressive symptoms
57642|NCT03843333|Rural|rural
57643|NCT03843333|Primary care|primary care
57644|NCT03843320|SAVR|savr
57645|NCT03843320|TAVR|tavr
57646|NCT03843320|Physical function|physical function
57647|NCT03843320|Aortic valve replacement|aortic valve replacement
817623|NCT00169572|Vomiting|vomiting
57648|NCT03843320|Wearable devices|wearable devices
57649|NCT03843320|Smart watch|smart watch
57650|NCT03843320|Activity tracker|activity tracker
57651|NCT03843307|Electrical stimulation|electrical stimulation
57652|NCT03843307|Perfusion|perfusion
57653|NCT03843307|Foot wound|foot wound
57654|NCT03843307|Foot pain|foot pain
57655|NCT03843281|Paracetamol|paracetamol
57656|NCT03843281|Morphine|morphine
57657|NCT03843268|Automated Mechanical Peripheral Stimulation (AMPS)|automated mechanical peripheral stimulation (amps)
57658|NCT03843268|Gait Disorders|gait disorders
57659|NCT03843229|Cinobufacini|cinobufacini
57660|NCT03843203|Pain|pain
57661|NCT03843203|Brain derived neurotrophic factor|brain derived neurotrophic factor
57662|NCT03843203|functional capacity|functional capacity
57663|NCT03843190|weight loss|weight loss
57664|NCT03843190|african american women|african american women
57665|NCT03843190|physical function|physical function
57666|NCT03843164|Solitary Pulmonary Nodule|solitary pulmonary nodule
57667|NCT03843164|Multidetector Computed Tomography|multidetector computed tomography
57668|NCT03843164|Artificial Intelligence|artificial intelligence
57669|NCT03843138|3D virtual planning software|3d virtual planning software
57670|NCT03843138|Individual Patient Solutions Case Designer (IPSCD)|individual patient solutions case designer (ipscd)
57671|NCT03843138|timing|timing
57672|NCT03843138|international|international
57673|NCT03843138|multicenter|multicenter
57674|NCT03843125|SLE|sle
57675|NCT03843112|Infertility, female|infertility, female
57676|NCT03843112|Vaginal microbiome|vaginal microbiome
57677|NCT03843073|Spinal Cord Injury (SCI),|spinal cord injury (sci),
57678|NCT03843073|Neurogenic Lower Urinary Tract Dysfunction (NLUTD)|neurogenic lower urinary tract dysfunction (nlutd)
57679|NCT03843073|Catheter associated Urinary Tract Infection (CAUTI)|catheter associated urinary tract infection (cauti)
57680|NCT03843073|Urinary Catheters|urinary catheters
57681|NCT03843073|Urinary Retention|urinary retention
57682|NCT03843073|Enlarged Prostate|enlarged prostate
57683|NCT03843073|Prostate cancer|prostate cancer
57684|NCT03843060|Congestive heart failure|congestive heart failure
57685|NCT03843060|Healthy volunteers|healthy volunteers
57686|NCT03843060|Itraconazole|itraconazole
57687|NCT03843060|Drug-drug interaction|drug-drug interaction
57688|NCT03843060|Pharmacokinetics|pharmacokinetics
57689|NCT03843060|Open-label non-randomized|open-label non-randomized
57690|NCT03842995|Genetic Counseling|genetic counseling
57691|NCT03842995|NICU|nicu
57692|NCT03842982|Ovarian cancer|ovarian cancer
57693|NCT03842982|Hyperthermic intraperitoneal chemotherapy|hyperthermic intraperitoneal chemotherapy
57694|NCT03842982|HIPEC|hipec
57695|NCT03842982|Primary Debulking Surgery|primary debulking surgery
57696|NCT03842982|Interval Debulking Surgery|interval debulking surgery
57697|NCT03842956|Fixator extern|fixator extern
57698|NCT03842956|Fixateur externe|fixateur externe
57699|NCT03842956|External fixator|external fixator
57700|NCT03842956|Wound healing|wound healing
57701|NCT03842956|Fix-Ex|fix-ex
57702|NCT03842956|Pin Side|pin side
57703|NCT03842956|Trauma|trauma
57704|NCT03842956|Infection|infection
57705|NCT03842917|Cancer|cancer
57706|NCT03842917|bevacizumab|bevacizumab
57707|NCT03842917|blood pressure|blood pressure
57708|NCT03842917|proteinuria|proteinuria
57709|NCT03842865|Immunotherapy|immunotherapy
57710|NCT03842852|inguinal hernia|inguinal hernia
57711|NCT03842852|laparoscopy reapir|laparoscopy reapir
57712|NCT03842852|open repair|open repair
57713|NCT03842826|Clinical examination|clinical examination
57714|NCT03842826|Groin|groin
57715|NCT03842826|Reproducibility|reproducibility
57716|NCT03842787|systemic lupus erythematosus|systemic lupus erythematosus
57717|NCT03842787|lupus nephritis|lupus nephritis
57718|NCT03842787|complement|complement
57720|NCT03842787|anti-ficolin-3 autoantibodies|anti-ficolin-3 autoantibodies
57721|NCT03842748|Nonalcoholic|nonalcoholic
57722|NCT03842748|fatty liver|fatty liver
57723|NCT03842748|hepatitis|hepatitis
57724|NCT03842748|liver fibrosis|liver fibrosis
57725|NCT03842735|Physiotherapy|physiotherapy
57726|NCT03842735|Rehabilitation|rehabilitation
57727|NCT03842735|Exercise|exercise
57728|NCT03842696|GVHD|gvhd
57729|NCT03842670|Alcohol Use Disorder|alcohol use disorder
57730|NCT03842670|Behavioral Treatment|behavioral treatment
57731|NCT03842670|Mechanisms of behavior change|mechanisms of behavior change
57732|NCT03842670|Neuroimaging|neuroimaging
57733|NCT03842657|citrate, dialysate|citrate, dialysate
57734|NCT03842657|hemodialysis|hemodialysis
57735|NCT03842657|coagulation|coagulation
57736|NCT03842644|Tension Reduction|tension reduction
57737|NCT03842631|Timolol Maleate|timolol maleate
57738|NCT03842631|Doppler Ultrasound Examination|doppler ultrasound examination
57739|NCT03842618|asthma- obstructive sleep apnea-adenotonsillectomy|asthma- obstructive sleep apnea-adenotonsillectomy
57740|NCT03842579|Frailty|frailty
57741|NCT03842579|Ageing|ageing
57742|NCT03842579|High-Protein diet|high-protein diet
57743|NCT03842579|Protein Supplementation|protein supplementation
57744|NCT03842579|Resistance Training|resistance training
57745|NCT03842579|Strength Training|strength training
57746|NCT03842579|Muscle Power|muscle power
57747|NCT03842579|Muscle Strength|muscle strength
57748|NCT03842579|Muscle Mass|muscle mass
57749|NCT03842579|Functional Performance|functional performance
57750|NCT03842579|Nutritional Status|nutritional status
57751|NCT03842553|PTSD|ptsd
57752|NCT03842553|Trauma|trauma
57753|NCT03842553|Coping|coping
57754|NCT03842553|Self Efficacy|self efficacy
57755|NCT03842540|LARC|larc
57756|NCT03842540|Contraceptive decision-making|contraceptive decision-making
57757|NCT03842540|Diffusion of Innovations|diffusion of innovations
57758|NCT03842527|Gastric Ultrasound|gastric ultrasound
57759|NCT03842527|Carbohydrate Loading|carbohydrate loading
57760|NCT03842462|Preterm Infant|preterm infant
57761|NCT03842462|Respiratory distress syndrome|respiratory distress syndrome
57762|NCT03842462|nasal continuous positive airway pressure|nasal continuous positive airway pressure
57763|NCT03842462|noninvasive intermittent positive airway pressure|noninvasive intermittent positive airway pressure
57764|NCT03842462|noninvasive high-frequency oscillatory ventilation|noninvasive high-frequency oscillatory ventilation
57765|NCT03842449|Tobacco|tobacco
57766|NCT03842449|Pregnancy Addictive|pregnancy addictive
57767|NCT03842449|Pregnant Women|pregnant women
57768|NCT03842449|Stop smoking|stop smoking
57769|NCT03842436|PrEP|prep
57770|NCT03842436|Substance Use Disorder|substance use disorder
57771|NCT03842436|Digital Pills|digital pills
57772|NCT03842436|Medication Adherence|medication adherence
57773|NCT03842397|Mitral regurgitation|mitral regurgitation
57774|NCT03842397|Mitral valve repair|mitral valve repair
57775|NCT03842397|Mitral annuloplasty|mitral annuloplasty
57776|NCT03842397|Adjustable annuloplasty|adjustable annuloplasty
57777|NCT03842319|Atherosclerosis|atherosclerosis
57778|NCT03842319|Mediterranean diet|mediterranean diet
57779|NCT03842319|microbiota|microbiota
57780|NCT03842319|immune system|immune system
57781|NCT03842319|metabolome|metabolome
57782|NCT03842319|proteome|proteome
57783|NCT03842306|End tidal oxygen|end tidal oxygen
57784|NCT03842306|Preoxygenation|preoxygenation
57785|NCT03842306|Arterial oxygen|arterial oxygen
57786|NCT03842280|Prolonged mechanical ventilation|prolonged mechanical ventilation
57787|NCT03842280|Esophageal pressure|esophageal pressure
57788|NCT03842280|Pleural pressure|pleural pressure
57789|NCT03842215|smart physical examination system|smart physical examination system
57790|NCT03842215|health management|health management
57791|NCT03842215|elderly|elderly
57792|NCT03842189|M281|m281
57793|NCT03842189|Hemolytic Disease of the Fetus and Newborn|hemolytic disease of the fetus and newborn
57794|NCT03842189|HDFN|hdfn
57795|NCT03842189|Rhesus Disease|rhesus disease
57796|NCT03842189|Hemolytic disease due to fetomaternal alloimmunization|hemolytic disease due to fetomaternal alloimmunization
57797|NCT03842189|Hemolytic disease of the newborn with Kell alloimmunization|hemolytic disease of the newborn with kell alloimmunization
57798|NCT03842189|Rhesus (Rh) isoimmunization of foetus or newborn|rhesus (rh) isoimmunization of foetus or newborn
57799|NCT03842189|Isoimmunization due to other red cell factors|isoimmunization due to other red cell factors
57800|NCT03842189|ABO isoimmunization of foetus or newborn|abo isoimmunization of foetus or newborn
57801|NCT03842189|Haemolytic anaemia due to other unclassified antibodies|haemolytic anaemia due to other unclassified antibodies
57802|NCT03842189|Isoimmune|isoimmune
57803|NCT03842189|Isoimmunized|isoimmunized
57804|NCT03842189|Isoimmunization|isoimmunization
57805|NCT03842189|Alloimmune|alloimmune
57806|NCT03842189|Alloimmunized|alloimmunized
57807|NCT03842189|Alloimmunization|alloimmunization
57808|NCT03842189|Pregnant women|pregnant women
57809|NCT03842176|Breast Cancer|breast cancer
57811|NCT03842176|Neoadjuvant chemotherapy|neoadjuvant chemotherapy
57812|NCT03842176|Adjuvant chemotherapy|adjuvant chemotherapy
57825|NCT03842111|child development|child development
57826|NCT03842111|child health|child health
57827|NCT03842111|child rearing|child rearing
57828|NCT03842111|children|children
57829|NCT03842111|curriculum|curriculum
57830|NCT03842111|early childhood education|early childhood education
57831|NCT03842111|families|families
57832|NCT03842111|Head Start|head start
57833|NCT03842111|Native Americans|native americans
57834|NCT03842111|parenting skills|parenting skills
57835|NCT03842111|parents|parents
57836|NCT03842111|programs|programs
57837|NCT03842111|school readiness|school readiness
57838|NCT03842111|teachers|teachers
57839|NCT03842098|Korean Medicine Patient Registry|korean medicine patient registry
57840|NCT03842098|Post-operative Therapy|post-operative therapy
57841|NCT03842098|Musculoskeletal Disorders|musculoskeletal disorders
57842|NCT03842085|HER2-positive|her2-positive
57843|NCT03842085|solid tumor|solid tumor
57844|NCT03842085|MBS301|mbs301
57845|NCT03842046|hypotension|hypotension
57846|NCT03842046|phenylephrine|phenylephrine
57847|NCT03842046|noradrenaline|noradrenaline
57848|NCT03842046|cardiac output|cardiac output
57849|NCT03842046|fetal|fetal
57850|NCT03842046|maternal hemodynamics|maternal hemodynamics
57851|NCT03842046|cesarean section|cesarean section
57852|NCT03842033|Asthma Action Plan|asthma action plan
57853|NCT03842033|Smartphone App|smartphone app
57854|NCT03842020|heart rhythm disorder|heart rhythm disorder
57855|NCT03842020|Amiodarone|amiodarone
57856|NCT03842020|Cardiac arrhythmias|cardiac arrhythmias
57857|NCT03842020|Pediatric|pediatric
57858|NCT03842020|Population pharmacokinetic (Pop PK)|population pharmacokinetic (pop pk)
57859|NCT03842020|Modeling|modeling
57860|NCT03841994|microbiome|microbiome
57861|NCT03841981|Exercise|exercise
57862|NCT03841981|Sex steroids|sex steroids
57863|NCT03841981|Hyperandrogenism|hyperandrogenism
57864|NCT03841981|Adipose tissue|adipose tissue
57865|NCT03841981|Muscle|muscle
57866|NCT03841981|Proteome|proteome
57867|NCT03841981|Gene expression|gene expression
57868|NCT03841981|Adipokine|adipokine
57869|NCT03841981|Cardiovascular risk|cardiovascular risk
57870|NCT03841981|Microbiome|microbiome
57871|NCT03841929|Multimodal hemodynamic assessment|multimodal hemodynamic assessment
57872|NCT03841903|Spinal cord|spinal cord
57873|NCT03841903|Spinal cord atrophy|spinal cord atrophy
57874|NCT03841903|Cerebrospinal Fluid|cerebrospinal fluid
57875|NCT03841903|Swiss Multiple Sclerosis Cohort|swiss multiple sclerosis cohort
57876|NCT03841838|Energy drink|energy drink
57877|NCT03841838|Heart rhythm|heart rhythm
57878|NCT03841838|QT prolongation|qt prolongation
57879|NCT03841838|Blood pressure|blood pressure
57880|NCT03841799|Microbiota|microbiota
57881|NCT03841799|Microenvironment colorectal tissue|microenvironment colorectal tissue
57882|NCT03841799|Immune infiltrate|immune infiltrate
57883|NCT03841786|Metabolome|metabolome
57884|NCT03841786|Phosphorus|phosphorus
57885|NCT03841786|Nutrition|nutrition
57886|NCT03841773|PTSD|ptsd
57887|NCT03841747|ER-positive|er-positive
57888|NCT03841747|Metastatic|metastatic
57889|NCT03841747|Locally Advanced|locally advanced
57890|NCT03841747|Ki67|ki67
57891|NCT03841747|PAM50|pam50
57892|NCT03841747|Pembrolizumab|pembrolizumab
57893|NCT03841747|Paclitaxel|paclitaxel
57894|NCT03841747|HER2-negative|her2-negative
57895|NCT03841721|pharmacokinetic|pharmacokinetic
57896|NCT03841721|linezolid|linezolid
57897|NCT03841721|healthy volunteers|healthy volunteers
57898|NCT03841708|Cardiac arrest|cardiac arrest
57899|NCT03841708|Hemodynamic monitoring|hemodynamic monitoring
57900|NCT03841708|Non invasive monitoring|non invasive monitoring
57901|NCT03841708|Pleth Variability Index|pleth variability index
57902|NCT03841708|Adult cardiac arrest|adult cardiac arrest
57903|NCT03841669|Brain|brain
57904|NCT03841669|Cardiovascular Disease|cardiovascular disease
57905|NCT03841669|Exercise|exercise
57906|NCT03841669|Brain Health|brain health
57907|NCT03841643|cranial reconstruction|cranial reconstruction
57908|NCT03841643|cement|cement
57909|NCT03841643|patient-specific implant|patient-specific implant
57910|NCT03841643|preprothetic surgery|preprothetic surgery
57911|NCT03841643|atrophic jaw|atrophic jaw
57912|NCT03841617|Thyroid Cancer|thyroid cancer
57913|NCT03841617|PET/CT|pet/ct
57914|NCT03841617|124-I|124-i
57915|NCT03841617|Radioiodine|radioiodine
57916|NCT03841617|Metastases|metastases
57917|NCT03841578|Dark chocolate, gastrointestinal motility|dark chocolate, gastrointestinal motility
57918|NCT03841552|Low Back Pain|low back pain
57919|NCT03841539|Cognitive Impairment|cognitive impairment
57920|NCT03841539|Dementia|dementia
57921|NCT03841539|Alzheimer Disease|alzheimer disease
57922|NCT03841539|Mediterranean Diet|mediterranean diet
57923|NCT03841539|Low Fat Diet|low fat diet
57924|NCT03841526|Exercise|exercise
57925|NCT03841526|Glucagon|glucagon
57926|NCT03841526|Insulin|insulin
57927|NCT03841513|Burch Colposuspension|burch colposuspension
57928|NCT03841513|Sacrocolpopexy|sacrocolpopexy
57929|NCT03841513|Laparoscopy|laparoscopy
57930|NCT03841513|Robotic Surgery|robotic surgery
57931|NCT03841487|ST-elevation myocardial infarction|st-elevation myocardial infarction
57932|NCT03841487|Thrombectomy|thrombectomy
57933|NCT03841487|Mortality|mortality
57934|NCT03841487|Stroke|stroke
57935|NCT03841487|Physician volume|physician volume
57936|NCT03841474|Brain derived neurotrophic factor|brain derived neurotrophic factor
57937|NCT03841474|BDNF|bdnf
57938|NCT03841474|Psychosocial indicators|psychosocial indicators
57939|NCT03841474|Depression|depression
57940|NCT03841474|Cardiovascular disease|cardiovascular disease
57941|NCT03841461|Academician|academician
57942|NCT03841461|Physical Activity Level|physical activity level
57943|NCT03841461|Sleep Quality|sleep quality
57944|NCT03841461|Fatigue|fatigue
57945|NCT03841422|hereditary hemorrhagic telangiectasia|hereditary hemorrhagic telangiectasia
57946|NCT03841422|video-assisted teaching|video-assisted teaching
57947|NCT03841422|nasal self-packing|nasal self-packing
57948|NCT03841357|Polyarthritis|polyarthritis
57949|NCT03841357|abatacept|abatacept
57950|NCT03841357|uveitis|uveitis
57951|NCT03841357|prevention|prevention
57952|NCT03841331|Pruritus|pruritus
817624|NCT00169572|Emesis|emesis
57953|NCT03841318|lymphoid cells|lymphoid cells
57954|NCT03841318|gut-derived lymphocytes|gut-derived lymphocytes
57955|NCT03841305|Liver|liver
57956|NCT03841305|Interventional radiology|interventional radiology
57957|NCT03841305|Portal vein embolization|portal vein embolization
57958|NCT03841305|Portal and hepatic vein embolization|portal and hepatic vein embolization
57959|NCT03841305|Future liver remnant|future liver remnant
57960|NCT03841305|Surgery|surgery
57961|NCT03841305|Non-cirrhotic liver|non-cirrhotic liver
57962|NCT03841305|Liver metastases|liver metastases
57963|NCT03841305|Colorectal cancer|colorectal cancer
57964|NCT03841305|Liver Regeneration|liver regeneration
57965|NCT03841305|Liver resection|liver resection
57966|NCT03841292|Smoking Cessation Medication|smoking cessation medication
57967|NCT03841292|Smoking Treatment|smoking treatment
57968|NCT03841292|Tobacco Treatment|tobacco treatment
57969|NCT03841292|Quitting Smoking|quitting smoking
57970|NCT03841292|Varenicline|varenicline
57971|NCT03841292|Transcranial Direct Current Stimulation|transcranial direct current stimulation
57972|NCT03841292|Neuroimaging|neuroimaging
57973|NCT03841292|fMRI|fmri
57974|NCT03841292|Attentional Bias|attentional bias
57975|NCT03841292|Eye-tracking|eye-tracking
57976|NCT03841292|Dependence|dependence
57977|NCT03841292|Addiction|addiction
57978|NCT03841292|Cigarettes|cigarettes
57979|NCT03841292|Biochemical Confirmation|biochemical confirmation
57980|NCT03841292|Cue reactivity|cue reactivity
57981|NCT03841292|Reward Anticipation|reward anticipation
57982|NCT03841292|Diffusion Tensor Imaging|diffusion tensor imaging
57983|NCT03841292|Resting State Functional Connectivity|resting state functional connectivity
57984|NCT03841292|BOLD fMRI|bold fmri
57985|NCT03841292|Quantitative T1|quantitative t1
57986|NCT03841253|Trans-epithelial phototherapeutic keratectomy|trans-epithelial phototherapeutic keratectomy
57987|NCT03841253|PTK|ptk
57988|NCT03841253|TE-PTK|te-ptk
57989|NCT03841253|Corneal epithelium|corneal epithelium
57990|NCT03841253|Excimer laser|excimer laser
57991|NCT03841240|catheter|catheter
57992|NCT03841240|thrombosis|thrombosis
57993|NCT03841240|infection|infection
57994|NCT03841240|ultrasound|ultrasound
57995|NCT03841240|risk factor|risk factor
57996|NCT03841227|fibromyalgia|fibromyalgia
57997|NCT03841227|tDCS|tdcs
57998|NCT03841227|fMRI|fmri
57999|NCT03841227|rs-fMRI|rs-fmri
58000|NCT03841201|hepatocellular carcinoma|hepatocellular carcinoma
58001|NCT03841188|osteogenesis imperfecta|osteogenesis imperfecta
58002|NCT03841188|Nutritional intervention|nutritional intervention
58003|NCT03841188|calcium intake|calcium intake
58004|NCT03841175|Squamous cell carcinoma|squamous cell carcinoma
58005|NCT03841175|FDG PET/CT|fdg pet/ct
58006|NCT03841175|Initial staging|initial staging
58007|NCT03841175|Clinical management|clinical management
58008|NCT03841175|Prognosis|prognosis
58009|NCT03841162|Blood Cultures|blood cultures
58010|NCT03841149|3D Ultrasound volume measurements|3d ultrasound volume measurements
58011|NCT03841149|Renal volume|renal volume
58012|NCT03841149|Tumour Volume|tumour volume
58013|NCT03841123|complementary feeding|complementary feeding
58014|NCT03841123|added sugar|added sugar
58015|NCT03841123|ultra-processed foods|ultra-processed foods
58016|NCT03841123|intervention|intervention
58017|NCT03841123|infants|infants
58018|NCT03841110|Advanced Solid Tumor|advanced solid tumor
58019|NCT03841110|Lymphoma|lymphoma
58020|NCT03841110|Breast Cancer|breast cancer
58021|NCT03841110|Head and Neck Cancer|head and neck cancer
58022|NCT03841110|Head and Neck|head and neck
58023|NCT03841110|Squamous Cell Carcinoma|squamous cell carcinoma
58024|NCT03841110|Gastric Cancer|gastric cancer
58025|NCT03841110|Colorectal Cancer|colorectal cancer
58026|NCT03841110|Immunotherapy|immunotherapy
58027|NCT03841110|NK cell therapy|nk cell therapy
58028|NCT03841110|Melanoma|melanoma
58029|NCT03841110|Checkpoint Inhibitor|checkpoint inhibitor
58030|NCT03841110|Immune Checkpoint Inhibitor|immune checkpoint inhibitor
58031|NCT03841110|Monoclonal Antibody|monoclonal antibody
58032|NCT03841110|Cell therapy|cell therapy
58033|NCT03841110|Cellular therapy|cellular therapy
58034|NCT03841110|nivolumab|nivolumab
58035|NCT03841110|pembrolizumab|pembrolizumab
58036|NCT03841110|atezolizumab|atezolizumab
58037|NCT03841097|Renal|renal
58038|NCT03841097|Transplant|transplant
58039|NCT03841097|Pulse wave velocity|pulse wave velocity
58040|NCT03841084|ECMO|ecmo
58041|NCT03841084|V-A ECMO|v-a ecmo
58042|NCT03841084|Oxygen|oxygen
58043|NCT03841084|Hyperoxia|hyperoxia
58044|NCT03841058|abalopartide|abalopartide
58045|NCT03841058|pain|pain
58046|NCT03841058|surgical outcome|surgical outcome
58047|NCT03841032|Facial redness|facial redness
58048|NCT03841032|Skin sensitivity|skin sensitivity
58049|NCT03840993|Endometriosis|endometriosis
58050|NCT03840941|COPD|copd
58051|NCT03840941|Frailty|frailty
58052|NCT03840941|Balance|balance
58053|NCT03840941|Cognition|cognition
817731|NCT00169104|Her-2/neu|her-2/neu
58054|NCT03840941|Activities of Daily Living|activities of daily living
58055|NCT03840915|Non-small Cell Lung Cancer|non-small cell lung cancer
58056|NCT03840915|Bintrafusp alfa (proposed INN)|bintrafusp alfa (proposed inn)
58057|NCT03840915|M7824|m7824
58058|NCT03840915|Stage IV|stage iv
58059|NCT03840915|INTR@PID LUNG 024|intr@pid lung 024
58060|NCT03840902|Non-small Cell Lung Cancer|non-small cell lung cancer
58061|NCT03840902|Bintrafusp alfa (proposed INN)|bintrafusp alfa (proposed inn)
58062|NCT03840902|M7824|m7824
58063|NCT03840902|Durvalumab|durvalumab
58064|NCT03840902|Stage III|stage iii
58065|NCT03840902|INTR@PID LUNG 005|intr@pid lung 005
58066|NCT03840889|Prospective cohort|prospective cohort
58067|NCT03840889|Population-based study|population-based study
58068|NCT03840889|Multicenter study|multicenter study
58069|NCT03840889|Maternity|maternity
58070|NCT03840876|Jet Ventilation|jet ventilation
58071|NCT03840876|Supraglottic|supraglottic
58072|NCT03840876|Intranasal|intranasal
58073|NCT03840876|Microlaryngeal Surgery|microlaryngeal surgery
58074|NCT03840863|Energy Drink|energy drink
58075|NCT03840863|Blood Pressure|blood pressure
58076|NCT03840863|Arrhythmia|arrhythmia
58077|NCT03840850|Type 2 diabetes mellitus|type 2 diabetes mellitus
58078|NCT03840837|cognitive impairment|cognitive impairment
58079|NCT03840837|Parkinson disease dementia|parkinson disease dementia
58080|NCT03840837|wearable sensor|wearable sensor
58081|NCT03840837|gait analysis|gait analysis
58082|NCT03840837|rivastigmine|rivastigmine
58083|NCT03840837|cholinesterase inhibitor|cholinesterase inhibitor
58084|NCT03840824|healthy|healthy
58085|NCT03840824|premenopausal|premenopausal
58086|NCT03840824|postmenarchal|postmenarchal
58087|NCT03840824|chemotherapy|chemotherapy
58088|NCT03840824|alkylating agent|alkylating agent
58089|NCT03840824|alkylator|alkylator
58090|NCT03840824|high dose cancer therapy|high dose cancer therapy
58091|NCT03840824|low dose cancer therapy|low dose cancer therapy
58092|NCT03840811|ceftriaxone|ceftriaxone
58093|NCT03840811|challenge|challenge
58094|NCT03840811|ciprofloxacin|ciprofloxacin
58095|NCT03840811|males|males
58096|NCT03840811|Neisseria gonorrhoeae|neisseria gonorrhoeae
58097|NCT03840785|Chronic inflammatory arthritis|chronic inflammatory arthritis
58098|NCT03840785|argentine tango|argentine tango
58099|NCT03840785|physical activity|physical activity
58100|NCT03840772|Solitary Fibrous Tumor|solitary fibrous tumor
58101|NCT03840772|soft tissue sarcoma|soft tissue sarcoma
58102|NCT03840772|rare sarcoma|rare sarcoma
58103|NCT03840746|self-reported healthy adults|self-reported healthy adults
58104|NCT03840746|age 40-70|age 40-70
58105|NCT03840746|BMI > 25|bmi > 25
58106|NCT03840733|physical activity|physical activity
58107|NCT03840733|sleep|sleep
58108|NCT03840733|eating patterns|eating patterns
58109|NCT03840733|energy expenditure|energy expenditure
58110|NCT03840668|USB eyemask|usb eyemask
58111|NCT03840603|Respiratory Tract Infections|respiratory tract infections
58112|NCT03840603|Emergency Department|emergency department
58113|NCT03840603|Procalcitonin|procalcitonin
58114|NCT03840590|adenoma detection rate|adenoma detection rate
58115|NCT03840577|Deep Sedation|deep sedation
58116|NCT03840577|Bispectral index|bispectral index
58117|NCT03840577|critical care patients|critical care patients
58118|NCT03840577|delirium|delirium
58119|NCT03840577|sedatives|sedatives
58120|NCT03840551|injury prevention|injury prevention
58121|NCT03840551|biomechanical indices|biomechanical indices
58219|NCT03839927|Geriatrics|geriatrics
58122|NCT03840551|inertial sensors|inertial sensors
58123|NCT03840525|qigong|qigong
58125|NCT03840473|Neck pain|neck pain
58126|NCT03840473|Upper trapezius muscle|upper trapezius muscle
58127|NCT03840473|Myofascial trigger points|myofascial trigger points
58128|NCT03840473|Muscle tenderness|muscle tenderness
58129|NCT03840473|Pain pressure threshold|pain pressure threshold
58130|NCT03840447|Chronic Disease|chronic disease
58131|NCT03840447|Prevention and control|prevention and control
58132|NCT03840447|Patient Education as Topic|patient education as topic
58133|NCT03840447|Health Services/utilization|health services/utilization
58134|NCT03840447|Program Evaluation|program evaluation
58135|NCT03840447|Cost-Benefit Analysis|cost-benefit analysis
58136|NCT03840447|Self-Efficacy|self-efficacy
58137|NCT03840447|Disease Management|disease management
58138|NCT03840447|Health Status|health status
58139|NCT03840447|Outcome Assessment (Health Care)|outcome assessment (health care)
58140|NCT03840447|Self Care|self care
58141|NCT03840447|Socioeconomic Factors|socioeconomic factors
58142|NCT03840447|Poverty Areas|poverty areas
58143|NCT03840447|Chronic Disease Self-Management Programme|chronic disease self-management programme
58144|NCT03840434|compartment syndrome|compartment syndrome
58145|NCT03840434|intramuscular punction Versus non invasive assessment|intramuscular punction versus non invasive assessment
58146|NCT03840421|gemcitabine|gemcitabine
58147|NCT03840421|cisplatin|cisplatin
58148|NCT03840421|fluorouracil|fluorouracil
58149|NCT03840395|Dysphagia|dysphagia
58150|NCT03840395|Extubation|extubation
58151|NCT03840395|Intensive Care Unit|intensive care unit
58152|NCT03840395|Pharyngeal Electrical Stimulation|pharyngeal electrical stimulation
58153|NCT03840395|Oropharyngeal Dysphagia|oropharyngeal dysphagia
58154|NCT03840395|Mechanical Ventilation|mechanical ventilation
58155|NCT03840395|Critically ill patients|critically ill patients
58156|NCT03840395|Post-Extubation Dysphagia|post-extubation dysphagia
58157|NCT03840343|Mesenchymal Stem Cell|mesenchymal stem cell
58158|NCT03840343|Mesencymal Stromal Cell|mesencymal stromal cell
58159|NCT03840343|Stem Cell|stem cell
58160|NCT03840343|Regenerative Medicine|regenerative medicine
58161|NCT03840343|Cell therapy|cell therapy
58162|NCT03840343|Rejuvenation|rejuvenation
58163|NCT03840330|High-intensity interval training|high-intensity interval training
58164|NCT03840330|Circuit training|circuit training
58165|NCT03840330|Elderly|elderly
58166|NCT03840330|Functional capacity|functional capacity
58167|NCT03840330|VO2 max|vo2 max
58168|NCT03840330|Cardiovascular parameters|cardiovascular parameters
58169|NCT03840278|bionic pancreas|bionic pancreas
58170|NCT03840278|closed loop|closed loop
58171|NCT03840278|glucagon|glucagon
58172|NCT03840278|insulin|insulin
58173|NCT03840252|3D-gait analysis|3d-gait analysis
58174|NCT03840252|Magnetic Resonance Imaging|magnetic resonance imaging
58175|NCT03840239|rectal cancer|rectal cancer
58176|NCT03840239|chemoradiation|chemoradiation
58177|NCT03840239|total neoadjuvant treatment|total neoadjuvant treatment
58178|NCT03840226|magnesium|magnesium
58179|NCT03840226|heart failure|heart failure
58180|NCT03840213|Chemotherapy|chemotherapy
58181|NCT03840213|nutrition|nutrition
58182|NCT03840213|self-care|self-care
58183|NCT03840213|care/caregiver relationship|care/caregiver relationship
58184|NCT03840213|fasting|fasting
58185|NCT03840187|digital cervicography|digital cervicography
58186|NCT03840187|Gynescope system|gynescope system
58187|NCT03840161|Diabetes mellitus Type 1|diabetes mellitus type 1
58188|NCT03840161|Diabetes mellitus Type 2|diabetes mellitus type 2
58189|NCT03840161|blood glucose self-testing|blood glucose self-testing
58190|NCT03840161|non-invasive tissue glucose prediction|non-invasive tissue glucose prediction
58191|NCT03840161|optical pain-free glucose testing|optical pain-free glucose testing
58192|NCT03840148|Bacterial Infections|bacterial infections
58193|NCT03840148|Cefepime|cefepime
58194|NCT03840148|Meropenem|meropenem
58195|NCT03840148|Complicated Urinary Tract Infections|complicated urinary tract infections
58196|NCT03840148|Anti-Infective Agents|anti-infective agents
58197|NCT03840148|β-Lactamase Inhibitors|β-lactamase inhibitors
58198|NCT03840135|ARI, acute respiratory infection|ari, acute respiratory infection
58199|NCT03840109|emotional support|emotional support
58200|NCT03840109|cancer|cancer
58201|NCT03840057|GIB|gib
58202|NCT03840057|UGIB|ugib
58203|NCT03840044|Asthma|asthma
58204|NCT03840044|Exercise|exercise
58205|NCT03840044|Cold air exposure|cold air exposure
58206|NCT03840031|Biofortification|biofortification
58207|NCT03840031|Orange fleshed sweet potato|orange fleshed sweet potato
58208|NCT03840031|Stable isotope studies|stable isotope studies
58209|NCT03839992|abnormal FEF75|abnormal fef75
58210|NCT03839992|bronchiectasis|bronchiectasis
58211|NCT03839992|lung CT|lung ct
58212|NCT03839953|Rehabilitation|rehabilitation
58213|NCT03839953|Exercise|exercise
58214|NCT03839953|Revascularization|revascularization
58215|NCT03839953|Endovascular|endovascular
58216|NCT03839953|Vascular Surgery|vascular surgery
58217|NCT03839927|Life Space Assesment|life space assesment
58218|NCT03839927|Daily Life Activity|daily life activity
58220|NCT03839927|Physical Activity|physical activity
58221|NCT03839914|vancomycin powder|vancomycin powder
58222|NCT03839914|surgical site infection|surgical site infection
58223|NCT03839914|open posterior spinal surgery|open posterior spinal surgery
58224|NCT03839901|Scaphoid-Lunate|scaphoid-lunate
58225|NCT03839901|instability|instability
58226|NCT03839901|wrist|wrist
58227|NCT03839888|atropine|atropine
58228|NCT03839888|cycloplegia|cycloplegia
58229|NCT03839888|refraction|refraction
58230|NCT03839888|axial length|axial length
58231|NCT03839888|anterior chamber depth|anterior chamber depth
58232|NCT03839849|periodontal pockets|periodontal pockets
58233|NCT03839849|injectable platelet-rich fibrin|injectable platelet-rich fibrin
58234|NCT03839849|saline|saline
58235|NCT03839823|HR-positive|hr-positive
58236|NCT03839823|HER2-negative|her2-negative
58237|NCT03839823|advanced breast cancer|advanced breast cancer
58238|NCT03839823|Ribociclib|ribociclib
58239|NCT03839823|NSAI|nsai
58240|NCT03839823|Goserelin|goserelin
58241|NCT03839823|Docetaxel / capecitabine|docetaxel / capecitabine
58242|NCT03839823|Paclitaxel/gemcitabine|paclitaxel/gemcitabine
58243|NCT03839823|Capecitabine/vinorelbine|capecitabine/vinorelbine
58244|NCT03839823|CDK4/6|cdk4/6
58245|NCT03839823|Phase II|phase ii
58246|NCT03839823|ER-positive|er-positive
58247|NCT03839823|PR-positive|pr-positive
58248|NCT03839823|Premenopausal|premenopausal
76192|NCT03727906|ECG|ecg
58249|NCT03839823|Perimenopausal.|perimenopausal.
58250|NCT03839810|stochastic resonance|stochastic resonance
58251|NCT03839810|proprioception|proprioception
58252|NCT03839810|motor control|motor control
58253|NCT03839810|motor recovery|motor recovery
58254|NCT03839758|Prothesis|prothesis
58255|NCT03839758|Glenoid implantation|glenoid implantation
58256|NCT03839745|E-Cigarettes|e-cigarettes
58257|NCT03839745|Vaping|vaping
58258|NCT03839745|E-Cig Mods|e-cig mods
58259|NCT03839732|observer variability|observer variability
58260|NCT03839732|kauppila score|kauppila score
58261|NCT03839732|quantitative vertebral morphometry|quantitative vertebral morphometry
58262|NCT03839732|computer assisted procedure|computer assisted procedure
58263|NCT03839732|abdominal aorta|abdominal aorta
58264|NCT03839732|lumbar spine|lumbar spine
58265|NCT03839719|Gingivitis|gingivitis
58266|NCT03839719|Aerosol|aerosol
58267|NCT03839719|Ocimum sanctum|ocimum sanctum
58268|NCT03839719|Mouth rinse|mouth rinse
58269|NCT03839719|SRP|srp
58270|NCT03839719|Chlorhexidine mouthrinse|chlorhexidine mouthrinse
58271|NCT03839719|Periodontitis|periodontitis
58272|NCT03839680|ulcerative colitis, endoscopic activity, mucosal healing, vedolizumab|ulcerative colitis, endoscopic activity, mucosal healing, vedolizumab
58273|NCT03839654|Obstructive Sleep Apnea|obstructive sleep apnea
58274|NCT03839654|heart valve replacement|heart valve replacement
58275|NCT03839654|CPAP treatment|cpap treatment
58276|NCT03839654|loop gain|loop gain
58277|NCT03839602|Locoregional Failure Pattern|locoregional failure pattern
58278|NCT03839602|Toxicity|toxicity
58279|NCT03839589|Hispanics|hispanics
58280|NCT03839589|Mindfulness|mindfulness
58281|NCT03839589|Emotional well-being|emotional well-being
58282|NCT03839576|gait|gait
58283|NCT03839576|computerized cognitive training|computerized cognitive training
58284|NCT03839576|falls|falls
58285|NCT03839576|mild cognitive impairment|mild cognitive impairment
58286|NCT03839576|mobility|mobility
58287|NCT03839576|physical exercise|physical exercise
58288|NCT03839576|tai chi chuan|tai chi chuan
58289|NCT03839563|Biomarker|biomarker
58290|NCT03839563|Cognitive impairment|cognitive impairment
58291|NCT03839563|Gait abnormality|gait abnormality
58292|NCT03839563|Older Adults|older adults
58293|NCT03839563|Exercise|exercise
58294|NCT03839537|Ultrafine particles|ultrafine particles
58295|NCT03839537|black carbon|black carbon
58296|NCT03839537|taxi drivers|taxi drivers
58297|NCT03839537|respiratory function test|respiratory function test
58298|NCT03839537|occupational exposure|occupational exposure
58299|NCT03839498|Axitinib|axitinib
58300|NCT03839485|pulpectomy|pulpectomy
58301|NCT03839485|primary teeth|primary teeth
58302|NCT03839485|root canal filling materials|root canal filling materials
58303|NCT03839459|Smoldering Multiple Myeloma|smoldering multiple myeloma
58304|NCT03839459|Denosumab|denosumab
58305|NCT03839446|cytogenetic status|cytogenetic status
58306|NCT03839446|mitoxantrone|mitoxantrone
58307|NCT03839446|etoposide|etoposide
58308|NCT03839446|gemtuzumab ozogamicin|gemtuzumab ozogamicin
58309|NCT03839446|bone marrow|bone marrow
58310|NCT03839433|Asthma|asthma
58311|NCT03839381|mini BESTest|mini bestest
58312|NCT03839381|balance defisit|balance defisit
58313|NCT03839381|postural control|postural control
58314|NCT03839381|Sensoriomotor impairment|sensoriomotor impairment
58315|NCT03839368|angle fracture|angle fracture
58316|NCT03839355|Apixaban|apixaban
58317|NCT03839355|Warfarin|warfarin
58318|NCT03839342|Advanced Cancer|advanced cancer
58319|NCT03839342|Advanced Solid Tumors|advanced solid tumors
58320|NCT03839342|Non-V600 BRAF Mutations|non-v600 braf mutations
58321|NCT03839329|Older Adult|older adult
58322|NCT03839329|Psychological Well-being|psychological well-being
58323|NCT03839329|Acceptance and Commitment Therapy|acceptance and commitment therapy
58324|NCT03839329|Brief interventions|brief interventions
58325|NCT03839329|Psychological flexibility|psychological flexibility
58326|NCT03839316|Cortical stimulation|cortical stimulation
58327|NCT03839316|Motor function|motor function
58328|NCT03839316|Rehabilitation|rehabilitation
58329|NCT03839316|Stroke|stroke
58330|NCT03839290|bilateral cleft lip and palate|bilateral cleft lip and palate
58331|NCT03839290|unilateral cleft lip and palate|unilateral cleft lip and palate
58332|NCT03839290|3D geometric morphometrics|3d geometric morphometrics
58333|NCT03839290|upper dental arch|upper dental arch
58334|NCT03839290|classical morphometrics|classical morphometrics
58335|NCT03839290|early neonatal cheiloplasty|early neonatal cheiloplasty
58336|NCT03839277|adenoma detection rate|adenoma detection rate
58337|NCT03839264|diagnostic accuracy|diagnostic accuracy
58338|NCT03839264|screening|screening
58339|NCT03839251|aripiprazole|aripiprazole
58340|NCT03839251|long-acting injection|long-acting injection
58341|NCT03839186|personalized medicine|personalized medicine
58342|NCT03839186|genetic polymorphism|genetic polymorphism
58343|NCT03839186|pharmacogenetics|pharmacogenetics
817837|NCT00168597|Morbidity|morbidity
58344|NCT03839186|hemodynamic change|hemodynamic change
58345|NCT03839173|premature infant|premature infant
58346|NCT03839173|breast milk|breast milk
58347|NCT03839173|breastmilk|breastmilk
58348|NCT03839173|human milk|human milk
58349|NCT03839173|human milk fortifier|human milk fortifier
58350|NCT03839147|hysterosalpingography|hysterosalpingography
58351|NCT03839147|anxiety|anxiety
58352|NCT03839147|pain|pain
58353|NCT03839147|education|education
58354|NCT03839147|counseling|counseling
58355|NCT03839121|Heart Diseases|heart diseases
58356|NCT03839121|CRT-D|crt-d
58357|NCT03839108|paraffin|paraffin
58358|NCT03839108|prolotherapy|prolotherapy
58359|NCT03839108|hand osteoarthritis|hand osteoarthritis
58360|NCT03839095|Nonmetastatic Osteosarcoma|nonmetastatic osteosarcoma
58361|NCT03839095|Pediatric Cancer|pediatric cancer
58362|NCT03839095|Limb Salvage|limb salvage
58363|NCT03839095|Prediction Model|prediction model
58364|NCT03839082|Mobile Technology|mobile technology
58365|NCT03839082|Weight|weight
58366|NCT03839082|Nutrition|nutrition
58367|NCT03839056|epidural local anesthetic|epidural local anesthetic
58368|NCT03839056|epidural analgesia|epidural analgesia
58369|NCT03839056|analgesia labor|analgesia labor
58370|NCT03839043|Tobacco|tobacco
58371|NCT03839043|Cigarettes|cigarettes
58372|NCT03839043|Surgery|surgery
58373|NCT03839043|Text Message|text message
58375|NCT03839017|War Injury Combat Casualty Care Cognitive Aid|war injury combat casualty care cognitive aid
58376|NCT03838952|Chinese Herbal Medicine|chinese herbal medicine
58377|NCT03838952|Herbal treatment|herbal treatment
58378|NCT03838939|chronic inflammatory rheumatism|chronic inflammatory rheumatism
58379|NCT03838939|biotherapies|biotherapies
58380|NCT03838939|therapeutic education|therapeutic education
58381|NCT03838939|safety skills|safety skills
58382|NCT03838926|Hematologic|hematologic
58383|NCT03838926|Malignancies|malignancies
58384|NCT03838926|Cancer|cancer
58385|NCT03838926|Blood|blood
58386|NCT03838913|Whole-exome Sequencing|whole-exome sequencing
58387|NCT03838913|intraductal papillary neoplasms of the bile duct|intraductal papillary neoplasms of the bile duct
58388|NCT03838913|mutation characteristics|mutation characteristics
58389|NCT03838900|Loop|loop
58390|NCT03838900|RileyLink|rileylink
58391|NCT03838900|Type 1 Diabetes|type 1 diabetes
58392|NCT03838822|nicotinamid riboside|nicotinamid riboside
58393|NCT03838822|L-carnitine|l-carnitine
58394|NCT03838822|L-serine|l-serine
58395|NCT03838822|N-acetylcystein|n-acetylcystein
58396|NCT03838783|Exercise|exercise
58397|NCT03838783|Insulin Degludec|insulin degludec
58398|NCT03838783|Continuous glucose monitoring (CGM)|continuous glucose monitoring (cgm)
58399|NCT03838783|Continuous Subcutaneous Insulin Infusion (CSII)|continuous subcutaneous insulin infusion (csii)
58400|NCT03838757|Lung cancer|lung cancer
58401|NCT03838757|Exercise capacity|exercise capacity
58402|NCT03838757|Cardiopulmonary exercise test|cardiopulmonary exercise test
58403|NCT03838757|Respiratory muscle strength|respiratory muscle strength
58404|NCT03838757|Physical activity|physical activity
58405|NCT03838757|Pulmonary functions|pulmonary functions
58406|NCT03838757|Peripheral Muscle Strength|peripheral muscle strength
58407|NCT03838757|Quality of life|quality of life
58408|NCT03838757|Sleep of quality|sleep of quality
58409|NCT03838757|Dyspnea|dyspnea
58410|NCT03838757|Depression|depression
58411|NCT03838757|Fatigue|fatigue
58412|NCT03838757|Cough|cough
58413|NCT03838744|Soft tissue sarcoma|soft tissue sarcoma
58414|NCT03838718|Sarcoma|sarcoma
58415|NCT03838718|Surgery|surgery
58416|NCT03838718|Multivisceral resection|multivisceral resection
58417|NCT03838718|Chemotherapy|chemotherapy
58418|NCT03838718|Radiation Therapy|radiation therapy
58419|NCT03838718|Patients' Registry|patients' registry
58420|NCT03838705|stop-bang, bariatric surgery, obesity, hypoxia|stop-bang, bariatric surgery, obesity, hypoxia
58421|NCT03838692|Ponatinib|ponatinib
58422|NCT03838692|Metastatic Medullary|metastatic medullary
58423|NCT03838692|Advanced Medullary|advanced medullary
58424|NCT03838653|Double-lumen endotracheal tube|double-lumen endotracheal tube
58425|NCT03838653|Multidetector Computed Tomography|multidetector computed tomography
58426|NCT03838575|SSI|ssi
58427|NCT03838575|Surgical Site Infection|surgical site infection
58428|NCT03838575|Infection Prevention|infection prevention
58429|NCT03838575|MAMS|mams
58430|NCT03838575|Multi-arm, Multi-stage|multi-arm, multi-stage
58431|NCT03838575|Pragmatic|pragmatic
58432|NCT03838575|Abdominal Surgery|abdominal surgery
58433|NCT03838575|Multicentre|multicentre
58434|NCT03838575|RCT|rct
58435|NCT03838575|Pilot|pilot
58436|NCT03838575|Chlorhexidine|chlorhexidine
58437|NCT03838575|Skin Prep|skin prep
58438|NCT03838575|Iodophor|iodophor
58439|NCT03838575|Drape|drape
58440|NCT03838575|Gentamicin|gentamicin
58441|NCT03838575|Sponge|sponge
58442|NCT03838562|virtual reality|virtual reality
58443|NCT03838562|vestibular|vestibular
58444|NCT03838562|balance|balance
58445|NCT03838562|rehabilitation|rehabilitation
58446|NCT03838549|Prophylactic Surgical Procedure|prophylactic surgical procedure
58447|NCT03838549|Subcutaneous Mastectomy|subcutaneous mastectomy
58448|NCT03838549|Endoscopy|endoscopy
58449|NCT03838549|Breast Reconstruction|breast reconstruction
58450|NCT03838549|Breast Implants|breast implants
58451|NCT03838536|Breastfeeding|breastfeeding
58452|NCT03838536|Eggs|eggs
58453|NCT03838536|Baby|baby
58454|NCT03838484|Nicotine|nicotine
58455|NCT03838484|Nicotinic acetylcholine receptors|nicotinic acetylcholine receptors
58456|NCT03838484|Schizophrenia|schizophrenia
58457|NCT03838484|Schizoaffective disorder|schizoaffective disorder
58458|NCT03838484|Healthy control|healthy control
58459|NCT03838484|Impulsive behavior|impulsive behavior
58460|NCT03838484|Aggression|aggression
58461|NCT03838484|Urgency|urgency
58462|NCT03838471|CSI|csi
58463|NCT03838471|kinesiophobia|kinesiophobia
58464|NCT03838471|Central Nervous System Sensitization|central nervous system sensitization
58465|NCT03838471|Catastrophizing|catastrophizing
58466|NCT03838471|Illness Behavior|illness behavior
58467|NCT03838458|hypospadias|hypospadias
58468|NCT03838458|prepuce|prepuce
58469|NCT03838458|HOXA13|hoxa13
58470|NCT03838458|FGFR2|fgfr2
58471|NCT03838458|TGF beta|tgf beta
58472|NCT03838445|Pulmonary Arterial Hypertension|pulmonary arterial hypertension
58473|NCT03838445|PAH|pah
58474|NCT03838445|Interatrial Shunt|interatrial shunt
58475|NCT03838445|Interatrial Shunting|interatrial shunting
58476|NCT03838445|Atrial Septostomy|atrial septostomy
58477|NCT03838432|focal therapy|focal therapy
58478|NCT03838432|IRE|ire
58479|NCT03838432|Composite Steep-pulse Treatment Apparatus|composite steep-pulse treatment apparatus
58480|NCT03838432|prostate cancer|prostate cancer
58481|NCT03838432|Multi-center|multi-center
58482|NCT03838406|Stomach cancer|stomach cancer
58483|NCT03838406|Chemotherapy|chemotherapy
58484|NCT03838406|FOLFOX|folfox
58485|NCT03838406|Capecitabine plus Oxalipatin (CAPOX)|capecitabine plus oxalipatin (capox)
58486|NCT03838393|multidisciplinary management|multidisciplinary management
58487|NCT03838393|real-life study|real-life study
58488|NCT03838367|TNBC|tnbc
58489|NCT03838367|PRO 140|pro 140
58490|NCT03838354|ITP|itp
58491|NCT03838354|Chidamide|chidamide
58492|NCT03838341|Stroke prevention|stroke prevention
58493|NCT03838341|Atrial fibrillation|atrial fibrillation
58494|NCT03838341|Totally thoracoscopic|totally thoracoscopic
58495|NCT03838341|LAAO|laao
58496|NCT03838341|AtriClip®|atriclip®
58497|NCT03838328|dose effect|dose effect
58498|NCT03838328|tranexamic acid|tranexamic acid
58499|NCT03838328|deep vein thromboses|deep vein thromboses
58500|NCT03838315|Cervical Radiculopathy,|cervical radiculopathy,
58501|NCT03838315|Neural Mobilizations,|neural mobilizations,
58502|NCT03838315|Soft Tissue Mobilization|soft tissue mobilization
58503|NCT03838302|Sexual functioning|sexual functioning
58504|NCT03838302|Laparoscopy|laparoscopy
58505|NCT03838302|Colpotomy|colpotomy
58506|NCT03838302|Specimen retrieval|specimen retrieval
58507|NCT03838302|Transvaginal extraction|transvaginal extraction
58508|NCT03838263|Nivolumab|nivolumab
58509|NCT03838263|High-risk|high-risk
58510|NCT03838263|HPV-driven oropharynx cancer|hpv-driven oropharynx cancer
58511|NCT03838250|Alcoholic|alcoholic
58512|NCT03838250|Liver|liver
58513|NCT03838250|Cirrhosis|cirrhosis
58514|NCT03838250|Liver Disease|liver disease
58515|NCT03838237|Fabry Disease|fabry disease
58516|NCT03838237|Migalastat|migalastat
58517|NCT03838237|Cardiomyopathy|cardiomyopathy
58518|NCT03838237|Cardiac Magnetic Resonance|cardiac magnetic resonance
58519|NCT03838237|T1 mapping|t1 mapping
58520|NCT03838211|memory|memory
58521|NCT03838211|brain stimulation|brain stimulation
58522|NCT03838198|Adaptive Intervention|adaptive intervention
58523|NCT03838198|Sequential, Multiple Assignment, Randomized Trial (SMART)|sequential, multiple assignment, randomized trial (smart)
58524|NCT03838198|Adolescent|adolescent
58525|NCT03838198|Motivational Interviewing|motivational interviewing
58526|NCT03838198|Suicide attempt|suicide attempt
58527|NCT03838198|Safety planning|safety planning
58528|NCT03838198|mobile technology|mobile technology
58529|NCT03838185|Dementia|dementia
58530|NCT03838185|Neurodegenerative Disease|neurodegenerative disease
58531|NCT03838172|Burn Injury|burn injury
58532|NCT03838172|quality of life|quality of life
58534|NCT03838120|Ultrasound|ultrasound
58535|NCT03838120|Minimum|minimum
58536|NCT03838120|Infraclavicular block|infraclavicular block
58537|NCT03838107|pediatric complex regional pain syndrome|pediatric complex regional pain syndrome
58538|NCT03838107|fMRI|fmri
58539|NCT03838107|psychosocial|psychosocial
58540|NCT03838107|quantitative sensory testing|quantitative sensory testing
58541|NCT03838107|markers|markers
58542|NCT03838094|pulp exposure|pulp exposure
58543|NCT03838094|vital immature|vital immature
58544|NCT03838094|MTA|mta
58545|NCT03838094|Biodentine|biodentine
58546|NCT03838081|third molar extraction|third molar extraction
58547|NCT03838081|Preoperative anxiety|preoperative anxiety
58548|NCT03838081|Dental Anxiety|dental anxiety
58549|NCT03838068|trauma|trauma
58550|NCT03838068|vital immature|vital immature
58551|NCT03838068|MTA|mta
58552|NCT03838068|Biodentine|biodentine
58553|NCT03838042|high-risk solid tumors|high-risk solid tumors
58554|NCT03838042|high-risk CNS tumors|high-risk cns tumors
58555|NCT03838029|Beta-blocker|beta-blocker
58556|NCT03838029|Propranolol|propranolol
58557|NCT03838029|COX-2 inhibitor|cox-2 inhibitor
58558|NCT03838029|Etodolac|etodolac
58559|NCT03838003|Exercise|exercise
58560|NCT03838003|Rehabilitation Nursing|rehabilitation nursing
58561|NCT03838003|Functional capacity|functional capacity
58562|NCT03838003|Heart failure|heart failure
58563|NCT03837990|Whole genome sequencing|whole genome sequencing
58564|NCT03837990|Polymorphism|polymorphism
58565|NCT03837951|reliability|reliability
58566|NCT03837951|edema|edema
58567|NCT03837951|physical therapy|physical therapy
58568|NCT03837951|occupational therapy|occupational therapy
58569|NCT03837951|figure-of-eight|figure-of-eight
58570|NCT03837925|Statins|statins
58571|NCT03837925|cardiovascular risk|cardiovascular risk
58572|NCT03837925|primary prevention microbiota|primary prevention microbiota
58573|NCT03837925|metabolomics|metabolomics
58574|NCT03837912|cluster randomized controlled trial|cluster randomized controlled trial
58575|NCT03837912|primary health care|primary health care
58576|NCT03837912|patient safety|patient safety
58577|NCT03837912|patient-centred care|patient-centred care
58578|NCT03837912|patient-reported experiences and outcomes measures|patient-reported experiences and outcomes measures
58579|NCT03837912|audit and feedback interventions.|audit and feedback interventions.
58580|NCT03837899|Pediatric, solid tumors, hematological malignancies, durvalumab, tremelimumab, immunotherapy|pediatric, solid tumors, hematological malignancies, durvalumab, tremelimumab, immunotherapy
58581|NCT03837847|Health coaching|health coaching
58582|NCT03837834|HIGH INTENSITY INTERVAL TRAINING|high intensity interval training
58583|NCT03837834|INCOMPLETE SPINAL CORD INJURY|incomplete spinal cord injury
58584|NCT03837834|MUSCLE STRENGTH|muscle strength
58585|NCT03837834|CARDIO-RESPIRATORY FITNESS|cardio-respiratory fitness
58586|NCT03837808|nimotuzumab|nimotuzumab
58587|NCT03837795|Neurofeedback|neurofeedback
58588|NCT03837795|Sensory Modulation Disorder|sensory modulation disorder
58589|NCT03837795|Sensory Over-Responsivity|sensory over-responsivity
58590|NCT03837782|laparoscopy,laparotomy,colorectal cancer|laparoscopy,laparotomy,colorectal cancer
58591|NCT03837769|Blood Pressure|blood pressure
58592|NCT03837769|OBPM|obpm
58593|NCT03837769|Cuffless|cuffless
58594|NCT03837730|ICU, sepsis, septic shok, arginase, citrulline|icu, sepsis, septic shok, arginase, citrulline
58595|NCT03837717|Saliva|saliva
58596|NCT03837717|Neonatal Encephalopathy|neonatal encephalopathy
58597|NCT03837717|Hypoxic-Ischemic Encephalopathy|hypoxic-ischemic encephalopathy
58598|NCT03837717|Bonding|bonding
58599|NCT03837717|Oxytocin|oxytocin
58600|NCT03837717|Stress|stress
58601|NCT03837717|Cortisol|cortisol
58602|NCT03837665|Platelet Rich Plasma|platelet rich plasma
58603|NCT03837665|TM perforations|tm perforations
58604|NCT03837665|Hearing loss|hearing loss
58605|NCT03837665|Hole in the eardrum|hole in the eardrum
58606|NCT03837652|Cleft palate|cleft palate
58607|NCT03837652|transverse discrepancy|transverse discrepancy
58608|NCT03837652|palatal expansion|palatal expansion
58609|NCT03837652|bone-borne|bone-borne
58610|NCT03837639|arm-crank|arm-crank
58611|NCT03837639|exercise training|exercise training
58612|NCT03837639|cardiovascular function|cardiovascular function
58613|NCT03837613|cancer|cancer
58614|NCT03837613|squamous cell carcinoma|squamous cell carcinoma
58615|NCT03837613|ultrasound|ultrasound
58616|NCT03837613|tumor thickness|tumor thickness
58617|NCT03837600|LDCT|ldct
58618|NCT03837600|Sputum|sputum
58619|NCT03837600|High-risk Smoker|high-risk smoker
58620|NCT03837600|Porphyrin|porphyrin
58621|NCT03837600|Early detection|early detection
58622|NCT03837587|Validity|validity
58623|NCT03837587|Reliability|reliability
58624|NCT03837587|Temporomandibular Joint Disorders|temporomandibular joint disorders
58625|NCT03837574|tretalogy of fallot|tretalogy of fallot
58626|NCT03837574|implantable cardioverter defibrillator|implantable cardioverter defibrillator
58627|NCT03837574|congenital heart disease|congenital heart disease
58628|NCT03837574|sudden cardiac death|sudden cardiac death
58629|NCT03837574|ventricular arrhythmia|ventricular arrhythmia
58630|NCT03837548|Parkinson's Disease|parkinson's disease
58631|NCT03837548|Magnetoencephalography|magnetoencephalography
58632|NCT03837548|Neurofeedback|neurofeedback
58633|NCT03837522|Biopsy|biopsy
58634|NCT03837522|Deceased kidney donation|deceased kidney donation
58635|NCT03837522|Kidney transplantation|kidney transplantation
58636|NCT03837509|Arginase inhibitor|arginase inhibitor
58637|NCT03837509|multiple myeloma|multiple myeloma
58638|NCT03837509|recombinant human immunoglobulin G monoclonal antibody|recombinant human immunoglobulin g monoclonal antibody
58639|NCT03837496|Breast Cancer|breast cancer
58640|NCT03837496|Endocrine Therapy|endocrine therapy
58641|NCT03837496|Hormonal Therapy|hormonal therapy
58642|NCT03837496|Symptoms|symptoms
58643|NCT03837496|Distress|distress
58644|NCT03837496|Survivors|survivors
58645|NCT03837457|PRISM|prism
58646|NCT03837457|Cutaneous T-cell Lymphoma|cutaneous t-cell lymphoma
58647|NCT03837457|CTCL|ctcl
58648|NCT03837457|Mycosis Fungoides|mycosis fungoides
58649|NCT03837457|Lymphoma|lymphoma
58650|NCT03837457|Lymphoma, T-cell|lymphoma, t-cell
58651|NCT03837457|Lymphoma, T-cell, cutaneous|lymphoma, t-cell, cutaneous
58652|NCT03837457|Lymphoma, Non-Hodgkin|lymphoma, non-hodgkin
58653|NCT03837457|Lymphoproliferative Disorders|lymphoproliferative disorders
58654|NCT03837457|Lymphatic Diseases|lymphatic diseases
58655|NCT03837457|Immunoproliferative Disorders|immunoproliferative disorders
58656|NCT03837457|Immune System Diseases|immune system diseases
58657|NCT03837457|Neoplasms|neoplasms
58658|NCT03837457|MicroRNAs|micrornas
58659|NCT03837444|Cirrhosis|cirrhosis
58660|NCT03837444|Outcome prognostication|outcome prognostication
58661|NCT03837444|Microvesicle|microvesicle
58662|NCT03837444|Monocyte|monocyte
58663|NCT03837431|Cutaneous|cutaneous
58664|NCT03837431|Leishmaniasis|leishmaniasis
58665|NCT03837431|Ethiopia|ethiopia
58666|NCT03837431|RDT|rdt
58667|NCT03837418|Patient-Oriented|patient-oriented
58668|NCT03837418|Designing|designing
58669|NCT03837418|Prescriptions|prescriptions
58670|NCT03837392|Pregnancy|pregnancy
58671|NCT03837392|Mental Health|mental health
58672|NCT03837366|Activity tracker|activity tracker
58673|NCT03837366|Physical Activity|physical activity
58674|NCT03837366|mHealth|mhealth
58675|NCT03837366|habit|habit
58676|NCT03837366|Motivational Interviewing|motivational interviewing
58677|NCT03837340|Community mental health teams|community mental health teams
58678|NCT03837327|InterVenn|intervenn
58679|NCT03837327|Ovarian Cancer|ovarian cancer
58680|NCT03837327|Liquid Biopsy|liquid biopsy
58681|NCT03837327|Mass Spectrometry|mass spectrometry
58682|NCT03837327|Adnexal Mass/ Pelvic Mass|adnexal mass/ pelvic mass
58683|NCT03837327|Venn Biosciences|venn biosciences
58684|NCT03837327|VOCAL Study|vocal study
58685|NCT03837314|Parkinson's disease|parkinson's disease
58686|NCT03837314|Deep Brain Stimulation|deep brain stimulation
58687|NCT03837314|Neuromodulation|neuromodulation
58688|NCT03837288|preterm labor|preterm labor
58689|NCT03837288|cerclage|cerclage
58690|NCT03837275|intralift|intralift
58691|NCT03837275|maxillery sinus lift|maxillery sinus lift
58692|NCT03837275|hydrodynamic ultrasonic|hydrodynamic ultrasonic
58693|NCT03837262|Flash Glucose Monitoring|flash glucose monitoring
58694|NCT03837249|Older People|older people
58695|NCT03837249|Sleep Disturbance|sleep disturbance
58696|NCT03837249|Self-Monitoring|self-monitoring
58697|NCT03837249|Self-Management|self-management
58698|NCT03837249|Social Support|social support
58699|NCT03837249|Wrist-worn Actigraphy|wrist-worn actigraphy
58700|NCT03837236|Behçet disease|behçet disease
58701|NCT03837236|Physical activity level|physical activity level
58702|NCT03837236|Exercise barriers|exercise barriers
58703|NCT03837197|donors and donation|donors and donation
58704|NCT03837197|Extended criteria donor|extended criteria donor
58705|NCT03837197|Organ perfusion and preservation|organ perfusion and preservation
58706|NCT03837197|Liver transplantation|liver transplantation
58707|NCT03837197|Kidney transplantation|kidney transplantation
58708|NCT03837197|Preservation injury|preservation injury
58709|NCT03837197|Ischemia reperfusion injury|ischemia reperfusion injury
58710|NCT03837184|Spinal Muscular Atrophy|spinal muscular atrophy
58711|NCT03837184|SMN2|smn2
58712|NCT03837184|Onasemnogene Abeparvovec-xioi|onasemnogene abeparvovec-xioi
58713|NCT03837184|Gene replacement therapy|gene replacement therapy
58714|NCT03837171|Septic Shock|septic shock
58715|NCT03837171|Anemia|anemia
58716|NCT03837171|cancer|cancer
58717|NCT03837171|erythrocyte transfusion|erythrocyte transfusion
58718|NCT03837132|Advanced Pancreatic Cancer|advanced pancreatic cancer
58719|NCT03837132|Early Palliative Care|early palliative care
59423|NCT03832816|Heart rate|heart rate
58720|NCT03837132|Quality of Life|quality of life
58721|NCT03837119|pregnancy|pregnancy
58722|NCT03837119|gestational diabetes|gestational diabetes
58723|NCT03837119|cholestasis in pregnancy|cholestasis in pregnancy
58724|NCT03837119|urinary tract infection in pregnancy|urinary tract infection in pregnancy
58725|NCT03837093|Low dose of IL-2|low dose of il-2
58726|NCT03837093|Healthy volunteers|healthy volunteers
58727|NCT03837093|Kinetic study|kinetic study
58728|NCT03837080|chronic pain|chronic pain
58729|NCT03837080|nutrition education|nutrition education
58730|NCT03837080|inflammatory biomarkers|inflammatory biomarkers
58731|NCT03837067|Domperidone|domperidone
58732|NCT03837041|total knee arthroplasty|total knee arthroplasty
58733|NCT03837041|Proprioception|proprioception
58734|NCT03837041|osteoarthritis|osteoarthritis
58735|NCT03837002|Foot Disease|foot disease
58736|NCT03837002|Foot Care Protocol|foot care protocol
58737|NCT03837002|Nursing Care|nursing care
58738|NCT03836989|Facial Paralysis|facial paralysis
58739|NCT03836989|Bell Palsy|bell palsy
58740|NCT03836989|Electrical Stimulation|electrical stimulation
58741|NCT03836976|mild traumatic brain injury|mild traumatic brain injury
58742|NCT03836976|EEG|eeg
58743|NCT03836976|neuroplasticity|neuroplasticity
58744|NCT03836976|gamma oscillation|gamma oscillation
58745|NCT03836963|Parkinson's disease|parkinson's disease
58746|NCT03836963|cognition|cognition
58747|NCT03836963|cognitive training|cognitive training
58748|NCT03836963|prospective memory|prospective memory
58749|NCT03836963|executive function|executive function
58750|NCT03836950|rTMS|rtms
58751|NCT03836950|Parkinson's disease|parkinson's disease
58752|NCT03836950|mild cognitive impairment|mild cognitive impairment
58753|NCT03836950|executive function|executive function
58754|NCT03836950|neuromodulation|neuromodulation
58755|NCT03836950|functional connectivity|functional connectivity
58756|NCT03836924|E2007|e2007
58757|NCT03836924|Fycompa|fycompa
58758|NCT03836924|Perampanel|perampanel
58759|NCT03836924|Prospective|prospective
58760|NCT03836924|Partial onset seizures|partial onset seizures
58761|NCT03836924|Epilepsy|epilepsy
58762|NCT03836924|Seizures|seizures
58763|NCT03836911|Institutionalized olders adults|institutionalized olders adults
58764|NCT03836911|SERIOUS GAME|serious game
58765|NCT03836820|Rheumatoid Arhritis|rheumatoid arhritis
58766|NCT03836820|Pilates exercises|pilates exercises
58767|NCT03836820|Fatigue|fatigue
58768|NCT03836755|osseointegration|osseointegration
58769|NCT03836755|implant migration|implant migration
58770|NCT03836755|amputee|amputee
58771|NCT03836729|Human immunodeficiency virus|human immunodeficiency virus
58772|NCT03836729|Sequential|sequential
58773|NCT03836729|Tenofovir alafenamide|tenofovir alafenamide
58774|NCT03836729|Emtricitabine|emtricitabine
58775|NCT03836729|GSK3640254|gsk3640254
58776|NCT03836716|Arimoclomol|arimoclomol
58777|NCT03836716|ALS|als
58778|NCT03836703|Pregnancy, Twins , Iron Deficiency Anaemia|pregnancy, twins , iron deficiency anaemia
58779|NCT03836677|COPD|copd
58780|NCT03836664|Headache|headache
58781|NCT03836664|Acute migraine headache|acute migraine headache
58782|NCT03836651|oxidative stress|oxidative stress
58783|NCT03836651|metabolic syndrome|metabolic syndrome
58784|NCT03836651|inflammation|inflammation
58785|NCT03836638|Botulinum Toxin|botulinum toxin
58786|NCT03836638|Rejuvenation|rejuvenation
58787|NCT03836638|Age|age
58788|NCT03836638|Wrinkles|wrinkles
58789|NCT03836638|Rhytidis|rhytidis
58790|NCT03836599|Uric acid transporter 1 (URAT1) Inhibitor|uric acid transporter 1 (urat1) inhibitor
58791|NCT03836599|Xantine oxidoreductase inhibitor|xantine oxidoreductase inhibitor
58792|NCT03836599|Pharmacokinetics|pharmacokinetics
58793|NCT03836599|Verinurad|verinurad
58794|NCT03836599|Allopurinol|allopurinol
58795|NCT03836586|catastrophizing|catastrophizing
58796|NCT03836586|cognitive-behavior therapy|cognitive-behavior therapy
58797|NCT03836573|E-cigarettes|e-cigarettes
58798|NCT03836573|Nicotine Replacement Therapy|nicotine replacement therapy
58799|NCT03836560|nicotine replacement therapy|nicotine replacement therapy
58800|NCT03836560|smoking cessation|smoking cessation
58801|NCT03836560|quit rates|quit rates
58802|NCT03836482|Awaiting Left ventricular assist device implantation|awaiting left ventricular assist device implantation
58803|NCT03836482|Hospitalized|hospitalized
58804|NCT03836469|Lung cancer|lung cancer
58805|NCT03836469|Non-small cell|non-small cell
58806|NCT03836443|NAFLD, toxic lipids, postprandial lipotoxicity|nafld, toxic lipids, postprandial lipotoxicity
58807|NCT03836430|newborn behavioral observation|newborn behavioral observation
58808|NCT03836430|late preterm|late preterm
58809|NCT03836430|postpartum depression|postpartum depression
58810|NCT03836404|Bone substitute|bone substitute
58811|NCT03836404|Bone regeneration|bone regeneration
58812|NCT03836391|Mobile health|mobile health
58813|NCT03836391|Physical activity|physical activity
58814|NCT03836391|Nutrition|nutrition
58815|NCT03836391|Self-monitoring|self-monitoring
58816|NCT03836391|Smartphone app|smartphone app
58817|NCT03836391|Digital health tools|digital health tools
58818|NCT03836365|Pelvic organ prolapse|pelvic organ prolapse
58827|NCT03836352|Microsatellite Instability-High|microsatellite instability-high
58829|NCT03836352|Anti-PD-1|anti-pd-1
58830|NCT03836352|MK-3475|mk-3475
58831|NCT03836339|emergency department|emergency department
58832|NCT03836339|pathway of care|pathway of care
58833|NCT03836339|assessment|assessment
58834|NCT03836339|anticoagulants|anticoagulants
58835|NCT03836326|Prematurity|prematurity
58836|NCT03836326|Development|development
58837|NCT03836326|Parental engagement|parental engagement
58838|NCT03836326|Parental satisfaction|parental satisfaction
58839|NCT03836300|Early intervention|early intervention
58840|NCT03836300|Fragile X Syndrome|fragile x syndrome
58841|NCT03836300|Parent-Child interaction|parent-child interaction
58842|NCT03836261|CLL|cll
58843|NCT03836261|Chronic Leukemia Lymphocytic|chronic leukemia lymphocytic
58844|NCT03836261|Leukemia|leukemia
58845|NCT03836248|Osteopathic treatment|osteopathic treatment
58846|NCT03836248|Sham osteopathic treatment|sham osteopathic treatment
58847|NCT03836248|Low back pain|low back pain
58848|NCT03836235|older adults|older adults
58849|NCT03836235|quality of life|quality of life
58850|NCT03836235|adverse events|adverse events
58851|NCT03836209|Gilteritinib|gilteritinib
58852|NCT03836209|Midostaurin|midostaurin
58853|NCT03836209|Daunorubicin|daunorubicin
58854|NCT03836209|Cytarabine|cytarabine
58855|NCT03836209|FLT3|flt3
58856|NCT03836209|FLT3 Mutation|flt3 mutation
58857|NCT03836209|FLT3 Internal Tandem Duplication (ITD)|flt3 internal tandem duplication (itd)
58858|NCT03836209|FLT3 ITD|flt3 itd
58859|NCT03836209|FLT3 Tyrosine Kinase Domain (TKD)|flt3 tyrosine kinase domain (tkd)
58860|NCT03836209|FLT3 TKD|flt3 tkd
58861|NCT03836196|Prostate Cancer|prostate cancer
58862|NCT03836196|PSMA PET/CT|psma pet/ct
58863|NCT03836196|multi-parametric MRI|multi-parametric mri
58864|NCT03836196|multi-parametric TRUS|multi-parametric trus
58865|NCT03836196|Transperineal mapping biopsy|transperineal mapping biopsy
58866|NCT03836196|LDR Brachytherapy|ldr brachytherapy
58867|NCT03836196|External Beam Radiation Treatment|external beam radiation treatment
58868|NCT03836183|bronchoscopy|bronchoscopy
58869|NCT03836183|ultrasound|ultrasound
58870|NCT03836183|thorax|thorax
58871|NCT03836170|laparoscopic cholecystectomy|laparoscopic cholecystectomy
58872|NCT03836170|gut microbiota|gut microbiota
58873|NCT03836157|Mirvetuximab soravtansine|mirvetuximab soravtansine
58874|NCT03836157|gynecologic cancer|gynecologic cancer
58875|NCT03836144|Mass spectrometry|mass spectrometry
58876|NCT03836144|Cystinuria|cystinuria
58877|NCT03836144|Inflammation|inflammation
58878|NCT03836144|Nephrolithiasis|nephrolithiasis
58879|NCT03836066|NSCLC, Atezolizumab, Bevacizumab|nsclc, atezolizumab, bevacizumab
58890|NCT03835988|Embolization|embolization
58891|NCT03835936|Physical Therapy|physical therapy
58892|NCT03835936|Respiratory|respiratory
58893|NCT03835936|Pediatric|pediatric
58894|NCT03835923|lifestyle intervention|lifestyle intervention
58895|NCT03835923|chronic ischemic heart disease|chronic ischemic heart disease
58896|NCT03835923|diabetes mellitus type 2|diabetes mellitus type 2
58897|NCT03835923|cardiovascular risk factors|cardiovascular risk factors
58898|NCT03835923|health literacy|health literacy
58899|NCT03835923|telemedicine|telemedicine
58900|NCT03835923|cross-sectoral care|cross-sectoral care
58901|NCT03835923|HbA1c|hba1c
58902|NCT03835923|individual exercise training|individual exercise training
58903|NCT03835923|dietary change|dietary change
58904|NCT03835923|sustainability|sustainability
58905|NCT03835923|heart disease|heart disease
58906|NCT03835923|nutrition|nutrition
58907|NCT03835923|exercise|exercise
58908|NCT03835923|physical activity|physical activity
58909|NCT03835923|coronary artery disease|coronary artery disease
58910|NCT03835923|coronary heart disease|coronary heart disease
58911|NCT03835910|corticosteroid injection|corticosteroid injection
58912|NCT03835910|physical activity|physical activity
58913|NCT03835910|pain|pain
58914|NCT03835910|disability|disability
58915|NCT03835910|behavioral incentives|behavioral incentives
58916|NCT03835884|Neovascular AMD|neovascular amd
58917|NCT03835884|Diabetic macular edema|diabetic macular edema
58918|NCT03835884|Diabetic retinopathy|diabetic retinopathy
58920|NCT03835884|Intravitreal injection|intravitreal injection
58922|NCT03835858|Respiratory|respiratory
58923|NCT03835858|Pediatric|pediatric
58924|NCT03835832|Tuberculin skin test|tuberculin skin test
58925|NCT03835832|latent TB infection|latent tb infection
58926|NCT03835832|HIV/TB co-infected participants|hiv/tb co-infected participants
58927|NCT03835832|Sensitivity|sensitivity
58928|NCT03835832|Specificity|specificity
58929|NCT03835832|positive predictive value (PPV)|positive predictive value (ppv)
58930|NCT03835832|negative predictive value (NPV)|negative predictive value (npv)
58931|NCT03835819|Endometrial Cancer|endometrial cancer
58932|NCT03835793|long-term|long-term
58933|NCT03835793|premature ovarian insufficiency|premature ovarian insufficiency
58934|NCT03835767|Oral Food Challenge|oral food challenge
58935|NCT03835767|Atopic Dermatitis|atopic dermatitis
58936|NCT03835767|Milk|milk
58937|NCT03835767|Peanut|peanut
58938|NCT03835767|Food Allergy|food allergy
58941|NCT03835702|PAP|pap
58942|NCT03835702|Group|group
58943|NCT03835702|PAP adherence|pap adherence
58944|NCT03835689|Behavioural intervention|behavioural intervention
58945|NCT03835689|E-health intervention|e-health intervention
58946|NCT03835689|Parenting intervention|parenting intervention
58947|NCT03835676|Pulmonary hypertension|pulmonary hypertension
58948|NCT03835676|Right ventricular function|right ventricular function
58949|NCT03835624|Juvenile Idiopathic Arthritis|juvenile idiopathic arthritis
58950|NCT03835624|Interleukin 33|interleukin 33
58951|NCT03835611|Parkinson Disease,|parkinson disease,
58952|NCT03835611|Balance|balance
58953|NCT03835611|Gait|gait
58954|NCT03835611|Dual Task walking|dual task walking
58955|NCT03835611|Feasibility|feasibility
58956|NCT03835572|Circadian Rhythm|circadian rhythm
58957|NCT03835572|Education|education
58958|NCT03835572|Student burnout|student burnout
58959|NCT03835572|Sleep Hygiene|sleep hygiene
58960|NCT03835559|varicose vein|varicose vein
58961|NCT03835559|stripping|stripping
58962|NCT03835559|endovenous|endovenous
58963|NCT03835559|ablation|ablation
58964|NCT03835559|Occlusion|occlusion
58965|NCT03835559|quality of life|quality of life
58966|NCT03835546|Brain|brain
58967|NCT03835546|HIV-1 Infection|hiv-1 infection
58968|NCT03835533|Metastatic Castration-resistant Prostate Cancer|metastatic castration-resistant prostate cancer
58969|NCT03835533|Immunotherapy|immunotherapy
58970|NCT03835533|Platform study|platform study
58971|NCT03835533|NKTR-214|nktr-214
58972|NCT03835533|Nivolumab|nivolumab
58973|NCT03835533|CDX-301|cdx-301
58974|NCT03835533|Poly-ICLC|poly-iclc
58975|NCT03835533|INO-5151|ino-5151
58976|NCT03835520|Immunotherapy|immunotherapy
58977|NCT03835520|Molecular Targeted Therapies|molecular targeted therapies
58978|NCT03835520|Tumor Biopsy|tumor biopsy
58979|NCT03835520|Plasma Samples|plasma samples
58980|NCT03835494|Tetralogy of Fallot|tetralogy of fallot
58981|NCT03835494|Tissue Doppler Imaging|tissue doppler imaging
58982|NCT03835494|Exercise testing|exercise testing
58983|NCT03835455|Finger food|finger food
58984|NCT03835429|oral appliance|oral appliance
58985|NCT03835429|atrial fibrillation|atrial fibrillation
58986|NCT03835429|sleep apnea|sleep apnea
58987|NCT03835429|mouth shield|mouth shield
58988|NCT03835429|snoring|snoring
58989|NCT03835416|obesity|obesity
58990|NCT03835416|prediabetic state|prediabetic state
58991|NCT03835416|older person|older person
58992|NCT03835416|diet, reducing|diet, reducing
58993|NCT03835416|protein|protein
58994|NCT03835416|muscle function|muscle function
58995|NCT03835390|Anxiety|anxiety
58996|NCT03835390|Preparedness|preparedness
58997|NCT03835390|Spinal Fusion|spinal fusion
58998|NCT03835377|Iron|iron
58999|NCT03835377|Biofortification|biofortification
59000|NCT03835377|Iron deficiency|iron deficiency
59001|NCT03835377|Anemia|anemia
59002|NCT03835377|Children|children
59003|NCT03835377|Mexico|mexico
59004|NCT03835351|Urinary catheter|urinary catheter
59005|NCT03835351|Urinary retention|urinary retention
59006|NCT03835351|Laparoscopic inguinal hernia repair|laparoscopic inguinal hernia repair
59007|NCT03835325|Postmenopausal Symptoms, Memory Disorders|postmenopausal symptoms, memory disorders
59008|NCT03835312|Islets of Langerhans Transplantation|islets of langerhans transplantation
59009|NCT03835312|Cord Blood Stem Cell Transplantation|cord blood stem cell transplantation
59010|NCT03835299|blood donor, fear, vasovagal reaction|blood donor, fear, vasovagal reaction
59011|NCT03835286|critical care|critical care
59012|NCT03835286|vitamin C|vitamin c
59013|NCT03835286|vasopressor|vasopressor
59014|NCT03835286|intensive care unit|intensive care unit
59015|NCT03835273|Esophagectomy|esophagectomy
59016|NCT03835273|Motion capture|motion capture
59017|NCT03835273|Respiratory|respiratory
59018|NCT03835273|Oesophageal cancer|oesophageal cancer
59019|NCT03835247|physician-nurse collaboration|physician-nurse collaboration
59025|NCT03835208|MAGE|mage
59026|NCT03835208|continuous glucose monitoring|continuous glucose monitoring
59027|NCT03835208|Pregnancy in Diabetics|pregnancy in diabetics
59028|NCT03835182|lumbar vertebrae|lumbar vertebrae
59029|NCT03835182|herniated disc|herniated disc
59030|NCT03835182|radiculopathy|radiculopathy
59031|NCT03835182|low back pain|low back pain
59032|NCT03835182|short wave therapy|short wave therapy
59033|NCT03835182|diathermy|diathermy
59034|NCT03835182|ultrasonic waves|ultrasonic waves
59035|NCT03835169|Cardiac intensive care unit|cardiac intensive care unit
59036|NCT03835169|Organization|organization
59037|NCT03835169|Prognostic score|prognostic score
59038|NCT03835117|Mitochondrial Dysfunction|mitochondrial dysfunction
59039|NCT03835104|diagnosis|diagnosis
59040|NCT03835104|sensitivity and specificity|sensitivity and specificity
59041|NCT03835104|serious infections|serious infections
59042|NCT03835065|Displaced distal third forearm|displaced distal third forearm
59043|NCT03835065|Pediatric Patients|pediatric patients
59044|NCT03835065|Closed reduction|closed reduction
59045|NCT03835065|Cast|cast
59046|NCT03835065|Patient centered outcome data|patient centered outcome data
59047|NCT03835065|RCT|rct
59048|NCT03835052|Survivorship|survivorship
59049|NCT03835000|virtual patient|virtual patient
59050|NCT03835000|joint modeling|joint modeling
59051|NCT03835000|biomechanical simulation|biomechanical simulation
59052|NCT03835000|surgery mechanical results|surgery mechanical results
59053|NCT03834987|NGLY1 Deficiency|ngly1 deficiency
59054|NCT03834948|CD47|cd47
59055|NCT03834948|AO-176|ao-176
59056|NCT03834948|Immunotherapy|immunotherapy
59057|NCT03834935|pityriasis alba|pityriasis alba
59058|NCT03834935|treatment|treatment
59059|NCT03834935|topical calcineurin inhibitor|topical calcineurin inhibitor
59060|NCT03834922|Acute pain|acute pain
59061|NCT03834922|Chronification of pain|chronification of pain
77133|NCT03721978|CIN 2|cin 2
59062|NCT03834922|Pain treatment|pain treatment
59063|NCT03834922|Pain management|pain management
59064|NCT03834922|Postoperative pain|postoperative pain
59065|NCT03834909|HIV Prevention|hiv prevention
59066|NCT03834909|Healthy Volunteer|healthy volunteer
59067|NCT03834844|Symptom Management|symptom management
59068|NCT03834844|Quality of Life|quality of life
59069|NCT03834844|Anxiety|anxiety
59070|NCT03834831|Male infertility|male infertility
59071|NCT03834831|Coenzyme Q10|coenzyme q10
59072|NCT03834831|Selenium|selenium
59073|NCT03834831|Antioxidants|antioxidants
59074|NCT03834818|opioid use|opioid use
59075|NCT03834818|pain|pain
59076|NCT03834818|surgery|surgery
59077|NCT03834818|orthopedic surgery|orthopedic surgery
59078|NCT03834818|orthopedic|orthopedic
59079|NCT03834792|Sleep disorders|sleep disorders
59080|NCT03834792|Health outcomes|health outcomes
59081|NCT03834792|Predictive model|predictive model
59082|NCT03834792|Health care utilization|health care utilization
59083|NCT03834792|Validation|validation
59084|NCT03834779|HIV|hiv
59085|NCT03834779|AIDS|aids
59086|NCT03834779|Substance Use|substance use
59087|NCT03834753|Subfoveal Choroidal Neovascularization|subfoveal choroidal neovascularization
59095|NCT03834688|Venetoclax|venetoclax
59096|NCT03834688|Bendamustine|bendamustine
59097|NCT03834688|Rituximab|rituximab
59098|NCT03834688|Bcl-2 Family Protein Inhibitor|bcl-2 family protein inhibitor
59099|NCT03834675|PICC|picc
59100|NCT03834675|shock|shock
59101|NCT03834675|cardiac output|cardiac output
59102|NCT03834662|Solid tumors|solid tumors
59103|NCT03834623|melanoma|melanoma
59104|NCT03834623|skin|skin
59105|NCT03834610|Erectile dysfunction|erectile dysfunction
59106|NCT03834610|Diabetes|diabetes
59107|NCT03834610|Tadaladil|tadaladil
59108|NCT03834610|L-arginine|l-arginine
59109|NCT03834584|Lymphoma|lymphoma
59110|NCT03834584|DHODH|dhodh
59111|NCT03834584|Hodgkins Lymphoma|hodgkins lymphoma
59112|NCT03834584|Non-Hodgkins Lymphoma|non-hodgkins lymphoma
59113|NCT03834584|T-Cell Lymphoma|t-cell lymphoma
59114|NCT03834571|Cervical Cancer|cervical cancer
59115|NCT03834571|HIV Infection|hiv infection
59116|NCT03834558|Sarcopenia|sarcopenia
59117|NCT03834558|Frailty|frailty
59118|NCT03834558|Strength|strength
59119|NCT03834558|myofascial self conditioning|myofascial self conditioning
59120|NCT03834558|image biomarkers|image biomarkers
59121|NCT03834519|Programmed Cell Death-1 (PD1, PD-1)|programmed cell death-1 (pd1, pd-1)
59220|NCT03833804|artificial intelligence|artificial intelligence
59124|NCT03834506|Programmed Death-Ligand 1 (PDL1, PD-L1)|programmed death-ligand 1 (pdl1, pd-l1)
59125|NCT03834493|Programmed Cell Death-1 (PD1, PD-1)|programmed cell death-1 (pd1, pd-1)
59126|NCT03834493|Programmed Death-Ligand 1 (PDL1, PD-L1)|programmed death-ligand 1 (pdl1, pd-l1)
59127|NCT03834480|Platelet reach plasma|platelet reach plasma
59129|NCT03834480|Ultrasound|ultrasound
59130|NCT03834480|Steroid|steroid
59131|NCT03834480|Chronic low back Pain|chronic low back pain
59132|NCT03834467|psychopathic traits|psychopathic traits
59133|NCT03834467|moral elevation|moral elevation
59134|NCT03834467|prosocial behavior|prosocial behavior
59135|NCT03834454|pregnancy|pregnancy
59136|NCT03834454|caesarean section|caesarean section
59137|NCT03834454|spinal anesthesia|spinal anesthesia
59138|NCT03834454|bupivacaine|bupivacaine
59139|NCT03834454|opioid|opioid
59140|NCT03834454|hypotension|hypotension
59141|NCT03834454|intraoperative|intraoperative
59142|NCT03834454|postoperative|postoperative
59143|NCT03834441|social needs|social needs
59144|NCT03834428|Text message reminder|text message reminder
59145|NCT03834428|ICOUGH protocol|icough protocol
59146|NCT03834428|IText|itext
59147|NCT03834428|Safety net hospital|safety net hospital
59148|NCT03834428|Inpatient|inpatient
59149|NCT03834402|Mild Cognitive Impairment|mild cognitive impairment
59150|NCT03834402|Alzheimer Disease|alzheimer disease
59151|NCT03834389|case- based learning|case- based learning
59152|NCT03834389|critical thinking|critical thinking
59153|NCT03834389|self-efficacy|self-efficacy
59154|NCT03834389|nursing education|nursing education
59155|NCT03834389|nursing|nursing
59156|NCT03834363|COPD|copd
59157|NCT03834363|Refractory Dyspnea|refractory dyspnea
59158|NCT03834363|Morphine|morphine
59159|NCT03834363|Fentanyl|fentanyl
59160|NCT03834324|Functional Electrical Stimulation|functional electrical stimulation
59161|NCT03834324|Cycling|cycling
59162|NCT03834324|Virtual Reality|virtual reality
59163|NCT03834272|Gastrointestinal Cancer|gastrointestinal cancer
59164|NCT03834272|Ovarian Cancer|ovarian cancer
59165|NCT03834272|Mesothelioma|mesothelioma
59166|NCT03834272|Peritoneal surface malignancies|peritoneal surface malignancies
59167|NCT03834259|spinal anaesthesia|spinal anaesthesia
59168|NCT03834259|ephedrine|ephedrine
59169|NCT03834246|Prognostic Factors|prognostic factors
59170|NCT03834246|intensive care unit|intensive care unit
59171|NCT03834207|C3-Cloud|c3-cloud
59172|NCT03834207|Multimorbidity|multimorbidity
59173|NCT03834207|Diabetes Type 2|diabetes type 2
59174|NCT03834207|Heart Failure|heart failure
59175|NCT03834207|Cardiac Failure|cardiac failure
59176|NCT03834207|Depression|depression
59177|NCT03834207|Renal Failure|renal failure
59178|NCT03834207|Kidney Failure|kidney failure
59179|NCT03834207|Ageing|ageing
59180|NCT03834207|Computer System|computer system
59181|NCT03834207|Information Technology|information technology
59182|NCT03834207|Patient Empowerment|patient empowerment
59183|NCT03834207|Guideline Reconciliation|guideline reconciliation
59184|NCT03834207|Polypharmacy|polypharmacy
59185|NCT03834207|Integrated Care|integrated care
59186|NCT03834207|Clinical Decision Support|clinical decision support
59189|NCT03834181|Connected devices|connected devices
59190|NCT03834181|Telemetry|telemetry
59191|NCT03834181|Obesity surgery|obesity surgery
59192|NCT03834168|Diurnal Rhythm|diurnal rhythm
59193|NCT03834168|Race|race
59194|NCT03834142|Auriculotherapy|auriculotherapy
59195|NCT03834142|Pain Therapy|pain therapy
59196|NCT03834077|physiotherapy|physiotherapy
59197|NCT03834025|Opioid Abuse Disorder|opioid abuse disorder
59200|NCT03833973|Training|training
59201|NCT03833973|Cell free plasma DNA|cell free plasma dna
59202|NCT03833973|Oxidative stress|oxidative stress
59203|NCT03833973|Performance|performance
59204|NCT03833960|breast cancer|breast cancer
59205|NCT03833960|Sentinel Lymph Node Biopsy|sentinel lymph node biopsy
59206|NCT03833960|Neoadjuvant Chemotherapy|neoadjuvant chemotherapy
59207|NCT03833960|locoregional recurrence|locoregional recurrence
59208|NCT03833960|distant recurrence|distant recurrence
59209|NCT03833947|Intracuff Dexamethasone|intracuff dexamethasone
59210|NCT03833947|Intracuff Alkalinized lignocaine|intracuff alkalinized lignocaine
59211|NCT03833947|General anesthesia|general anesthesia
59212|NCT03833934|ALK positive|alk positive
59213|NCT03833921|Abiraterone acetate|abiraterone acetate
59214|NCT03833921|hormone naive prostate cancer|hormone naive prostate cancer
59215|NCT03833817|advance care planning|advance care planning
59216|NCT03833817|prognostic understanding|prognostic understanding
59217|NCT03833817|communication|communication
59218|NCT03833804|natural language processing|natural language processing
59219|NCT03833804|machine learning|machine learning
59421|NCT03832816|cortisol|cortisol
59221|NCT03833804|clinical decision support|clinical decision support
59222|NCT03833804|unhealthy alcohol use|unhealthy alcohol use
59223|NCT03833804|opioid use disorder|opioid use disorder
59224|NCT03833804|illicit drug use|illicit drug use
59225|NCT03833791|obesity|obesity
59226|NCT03833791|Physical Activity|physical activity
59227|NCT03833791|fat mass|fat mass
59228|NCT03833791|fat free mass|fat free mass
59229|NCT03833765|gingival recession|gingival recession
59230|NCT03833752|rigid cystoscopy|rigid cystoscopy
59231|NCT03833752|flexible cystosocpy|flexible cystosocpy
59232|NCT03833752|UTI|uti
59233|NCT03833752|BPH|bph
59234|NCT03833739|Class II division 2|class ii division 2
59235|NCT03833739|Alignment|alignment
59236|NCT03833739|Leveling|leveling
59237|NCT03833726|Vaginal Atrophy|vaginal atrophy
59238|NCT03833726|Breast Cancer|breast cancer
59239|NCT03833726|Hormonal Therapy|hormonal therapy
59240|NCT03833726|Photodynamic Therapy|photodynamic therapy
59241|NCT03833726|Light Emitting Diode|light emitting diode
59242|NCT03833713|text message|text message
59243|NCT03833713|behavioral intervention|behavioral intervention
59244|NCT03833713|motor vehicle|motor vehicle
59245|NCT03833700|Solid Tumor|solid tumor
59246|NCT03833700|Colorectal Cancer|colorectal cancer
59247|NCT03833700|E7386|e7386
59248|NCT03833674|acute intermittent hypoxia (AIH)|acute intermittent hypoxia (aih)
59249|NCT03833674|spinal neuroplasticity|spinal neuroplasticity
59250|NCT03833674|motor function|motor function
59251|NCT03833674|respiratory strength training|respiratory strength training
59252|NCT03833674|respiration|respiration
59253|NCT03833674|breathing|breathing
59254|NCT03833674|plasticity|plasticity
59255|NCT03833661|M7824|m7824
59256|NCT03833661|Bintrafusp alfa (proposed INN)|bintrafusp alfa (proposed inn)
59257|NCT03833661|Transforming growth factor-beta|transforming growth factor-beta
59258|NCT03833661|First-line Platinum-Based Chemotherapy|first-line platinum-based chemotherapy
59259|NCT03833661|Programmed death-ligand 1|programmed death-ligand 1
59260|NCT03833661|Metastatic Biliary Tract Cancer|metastatic biliary tract cancer
59261|NCT03833661|Cholangiocarcinoma|cholangiocarcinoma
59262|NCT03833661|Gallbladder cancer|gallbladder cancer
59263|NCT03833661|INTR@PID BTC 047|intr@pid btc 047
59264|NCT03833596|Corticosteroids|corticosteroids
59265|NCT03833596|Exclusive Enteral Nutrition|exclusive enteral nutrition
59266|NCT03833583|Transcranial Direct Current Stimulation|transcranial direct current stimulation
59267|NCT03833583|tDCS|tdcs
59268|NCT03833583|Brain Stimulation|brain stimulation
59269|NCT03833583|Cocaine Addiction|cocaine addiction
59270|NCT03833583|Drug Craving|drug craving
59271|NCT03833570|Melatonin|melatonin
59272|NCT03833557|Formocresol|formocresol
59273|NCT03833557|MTA|mta
59274|NCT03833557|Nanohydroxyapatite|nanohydroxyapatite
59275|NCT03833557|Pulpotomy|pulpotomy
59276|NCT03833531|PTSD|ptsd
59277|NCT03833531|CPD|cpd
59278|NCT03833531|Imagination and rescripting therapy (ImRs)|imagination and rescripting therapy (imrs)
59279|NCT03833531|Schema-Focused Therapy (SFT)|schema-focused therapy (sft)
59280|NCT03833531|Integrated treatment|integrated treatment
59281|NCT03833531|Prediction|prediction
59282|NCT03833518|hand|hand
59283|NCT03833518|rehabilitation|rehabilitation
59284|NCT03833518|motor cortex|motor cortex
59285|NCT03833479|TSR-042|tsr-042
59286|NCT03833479|Anti-PD1|anti-pd1
59287|NCT03833479|advanced cervical cancer|advanced cervical cancer
59288|NCT03833466|Advanced Esophageal Squamous Cell Carcinoma|advanced esophageal squamous cell carcinoma
59289|NCT03833466|Neoadjuvant Therapy|neoadjuvant therapy
59290|NCT03833466|Metformin|metformin
59291|NCT03833466|Cisplatin|cisplatin
59292|NCT03833466|Paclitaxel|paclitaxel
59293|NCT03833453|PTSD|ptsd
59294|NCT03833453|BPD|bpd
59295|NCT03833453|Eye Movement Desensitisation and Reprocessing (EMDR)|eye movement desensitisation and reprocessing (emdr)
59296|NCT03833453|Dialectical Behavior Therapy (DBT)|dialectical behavior therapy (dbt)
59297|NCT03833453|Integrated treatment|integrated treatment
59298|NCT03833453|Prediction|prediction
59299|NCT03833427|programmed cell death 1 (PD-1, PD1)|programmed cell death 1 (pd-1, pd1)
59300|NCT03833427|programmed cell death ligand 1 (PD-L1, PDL1)|programmed cell death ligand 1 (pd-l1, pdl1)
59301|NCT03833414|intra-articular fractures; distal humerus; osteotomy; elbow joint|intra-articular fractures; distal humerus; osteotomy; elbow joint
59302|NCT03833375|TBI|tbi
59303|NCT03833375|stroke|stroke
59304|NCT03833375|ICH|ich
59305|NCT03833375|AIS|ais
59306|NCT03833375|decision aid|decision aid
59307|NCT03833375|shared decision making|shared decision making
59308|NCT03833375|neurocritical care|neurocritical care
59309|NCT03833375|SABI|sabi
59310|NCT03833375|surrogate|surrogate
59311|NCT03833349|Parkinson's disease|parkinson's disease
59312|NCT03833349|fatigue|fatigue
59313|NCT03833349|anxiety|anxiety
59314|NCT03833349|depression|depression
59315|NCT03833349|exercise|exercise
59316|NCT03833336|heart failure|heart failure
59317|NCT03833336|preserved ejection fraction|preserved ejection fraction
59318|NCT03833336|ferropenic anemia|ferropenic anemia
59319|NCT03833323|PAH|pah
59422|NCT03832816|ACTH|acth
59324|NCT03833323|DelIVery for PAH|delivery for pah
59325|NCT03833323|Implantable Pump|implantable pump
59326|NCT03833323|Drug Pump|drug pump
59327|NCT03833323|Intrathecal Catheter|intrathecal catheter
59328|NCT03833323|Targeted Drug Delivery|targeted drug delivery
59329|NCT03833323|Programmable Pump|programmable pump
59330|NCT03833297|hepatological disease|hepatological disease
59331|NCT03833297|hepatotoxicity|hepatotoxicity
59332|NCT03833297|chemotherapies|chemotherapies
59333|NCT03833297|drugs|drugs
59334|NCT03833284|Transvaginal Ultrasound|transvaginal ultrasound
59335|NCT03833284|Telemedicine|telemedicine
59336|NCT03833258|THR|thr
59337|NCT03833258|THA|tha
59338|NCT03833258|Total Hip Arthroplasty|total hip arthroplasty
59339|NCT03833258|Total Hip Replacement|total hip replacement
59340|NCT03833219|distracted driving automobile|distracted driving automobile
59341|NCT03833219|behavioral economics|behavioral economics
59342|NCT03833219|usage-based insurance|usage-based insurance
59343|NCT03833219|auto insurance|auto insurance
59344|NCT03833219|automobile|automobile
59345|NCT03833219|smartphone application|smartphone application
59346|NCT03833193|Hypofractionated radiotherapy;|hypofractionated radiotherapy;
59347|NCT03833193|Radiation-reduced esophagitis;|radiation-reduced esophagitis;
59348|NCT03833193|Radiation-reduced pneumonitis;Predictor|radiation-reduced pneumonitis;predictor
59349|NCT03833180|Lymphoma|lymphoma
59350|NCT03833180|Lymphoma, Non-Hodgkin|lymphoma, non-hodgkin
59351|NCT03833180|Leukemia, B-Cell|leukemia, b-cell
59352|NCT03833180|Leukemia, Lymphoid|leukemia, lymphoid
59353|NCT03833180|Leukemia|leukemia
59354|NCT03833180|Leukemia, Lymphocytic, Chronic, B-Cell|leukemia, lymphocytic, chronic, b-cell
59355|NCT03833180|Lymphoma, Follicular|lymphoma, follicular
59356|NCT03833180|Lymphoma, Mantle-Cell|lymphoma, mantle-cell
59357|NCT03833167|Programmed Cell Death-1 (PD-1)|programmed cell death-1 (pd-1)
59358|NCT03833167|Programmed Cell Death 1|programmed cell death 1
59359|NCT03833167|PD1|pd1
59360|NCT03833167|Programmed Cell Death Ligand 1 (PD-L1)|programmed cell death ligand 1 (pd-l1)
59361|NCT03833167|Programmed Cell Death Ligand 2 (PD-L2)|programmed cell death ligand 2 (pd-l2)
59362|NCT03833167|PDL1|pdl1
59363|NCT03833167|PDL2|pdl2
59364|NCT03833154|NSCLC|nsclc
59365|NCT03833154|Double- Blind|double- blind
59366|NCT03833154|PD-L1|pd-l1
59367|NCT03833154|MEDI4736|medi4736
59368|NCT03833154|Durvalumab|durvalumab
59369|NCT03833154|PFS|pfs
59370|NCT03833154|OS|os
59371|NCT03833102|Staphylococcus aureus|staphylococcus aureus
59372|NCT03833063|botulinumtoxin|botulinumtoxin
59373|NCT03833063|botox|botox
59374|NCT03833063|depression|depression
59375|NCT03833063|geriatric depression|geriatric depression
59376|NCT03833063|depression in older adults|depression in older adults
59377|NCT03833063|depression in the elderly|depression in the elderly
59378|NCT03833063|old age depression|old age depression
59379|NCT03833050|heart transplant|heart transplant
59380|NCT03833037|Synovial sarcoma|synovial sarcoma
59381|NCT03833024|deep vein thrombosis|deep vein thrombosis
59382|NCT03833024|chronic venous insufficiency|chronic venous insufficiency
59383|NCT03833024|venoactive drug|venoactive drug
59384|NCT03833024|Micronized Purified Flavonoid Fraction|micronized purified flavonoid fraction
59385|NCT03833024|DVT|dvt
59386|NCT03833024|post thrombotic syndrome|post thrombotic syndrome
59392|NCT03832985|adult-onset|adult-onset
59393|NCT03832985|pediatric|pediatric
59394|NCT03832985|genomic|genomic
59395|NCT03832985|genetic|genetic
59396|NCT03832972|menstrual cycle|menstrual cycle
59397|NCT03832972|Estrogen|estrogen
59398|NCT03832972|performance|performance
59399|NCT03832972|variation|variation
59400|NCT03832946|TD139|td139
59401|NCT03832946|Idiopathic pulmonary fibrosis|idiopathic pulmonary fibrosis
59402|NCT03832946|Galectin-3 inhibitor|galectin-3 inhibitor
59403|NCT03832933|weight loss|weight loss
59404|NCT03832933|dietary protein|dietary protein
59405|NCT03832920|general anesthesia|general anesthesia
59406|NCT03832920|paravertebral Block|paravertebral block
59407|NCT03832920|analgesia nociception index|analgesia nociception index
59408|NCT03832907|Glucose monitoring|glucose monitoring
59409|NCT03832907|POC BG|poc bg
59410|NCT03832907|DexcomG6 CGM|dexcomg6 cgm
59411|NCT03832894|IVF|ivf
59412|NCT03832894|ICSI|icsi
59413|NCT03832894|oestradiol|oestradiol
59414|NCT03832894|long protocol|long protocol
59415|NCT03832868|Decision aid|decision aid
59416|NCT03832842|ECMO|ecmo
59417|NCT03832842|thrombin generation test|thrombin generation test
59418|NCT03832842|hemostasis|hemostasis
59419|NCT03832842|bleeding events|bleeding events
59420|NCT03832842|thrombotic events|thrombotic events
59424|NCT03832816|delta9-Tetrahydrocannabinol|delta9-tetrahydrocannabinol
59425|NCT03832816|cannabidiol|cannabidiol
59426|NCT03832777|Borderline Personality Disorder|borderline personality disorder
59427|NCT03832777|Personality Disorders|personality disorders
59428|NCT03832764|skin impedance|skin impedance
59429|NCT03832764|pain monitoring|pain monitoring
59430|NCT03832764|observational study|observational study
59431|NCT03832764|PACU/ICU|pacu/icu
59432|NCT03832738|JTE-451|jte-451
59433|NCT03832738|Psoriasis|psoriasis
59434|NCT03832738|Plaque psoriasis|plaque psoriasis
59435|NCT03832738|IMPACT-PS|impact-ps
59436|NCT03832725|Type 2 Diabetes|type 2 diabetes
59437|NCT03832725|obesity|obesity
59438|NCT03832725|pathobiology|pathobiology
59439|NCT03832712|Deep Brain Stimulation|deep brain stimulation
59440|NCT03832712|Randomized Controlled Trial|randomized controlled trial
59441|NCT03832673|bladder|bladder
59442|NCT03832673|cancer|cancer
59443|NCT03832660|Lifestyle|lifestyle
59444|NCT03832660|ARNI|arni
59445|NCT03832660|Exercise tolerance|exercise tolerance
59446|NCT03832621|nivolumab|nivolumab
59447|NCT03832621|ipilimumab|ipilimumab
59448|NCT03832621|temozolomide|temozolomide
59449|NCT03832621|microsatellite stable|microsatellite stable
59450|NCT03832621|MSS|mss
59451|NCT03832621|MGMT|mgmt
59452|NCT03832608|Older adult|older adult
59453|NCT03832608|Sarcopenia|sarcopenia
59454|NCT03832608|Frailty|frailty
59455|NCT03832608|Functionality|functionality
59456|NCT03832608|Muscle strength|muscle strength
59457|NCT03832608|Muscle mass|muscle mass
59458|NCT03832608|Walk speed|walk speed
59459|NCT03832595|electronic health record|electronic health record
59460|NCT03832595|population health management|population health management
59461|NCT03832595|patient education|patient education
59462|NCT03832595|medication therapy management|medication therapy management
59463|NCT03832595|electronic consultation|electronic consultation
59464|NCT03832595|randomized controlled trial|randomized controlled trial
59465|NCT03832595|pragmatic trial|pragmatic trial
59466|NCT03832582|Aorta|aorta
59467|NCT03832582|Type B dissection|type b dissection
59468|NCT03832582|Descending aorta dissection|descending aorta dissection
59469|NCT03832582|Annexin|annexin
59470|NCT03832569|Pembrolizumab|pembrolizumab
59471|NCT03832569|18-399|18-399
59472|NCT03832556|neurogenic myositis ossificans|neurogenic myositis ossificans
59473|NCT03832556|para-osteo-arthropathy|para-osteo-arthropathy
59474|NCT03832556|preoperative evaluation|preoperative evaluation
59475|NCT03832556|CT scan|ct scan
59476|NCT03832556|MRI|mri
59477|NCT03832543|Vaginal Hysterectomy|vaginal hysterectomy
59478|NCT03832530|PrEP|prep
59479|NCT03832530|conception|conception
59480|NCT03832530|prevention|prevention
59481|NCT03832491|Primary Ciliary Dyskinesia|primary ciliary dyskinesia
59482|NCT03832491|Kartegener Syndrome|kartegener syndrome
59483|NCT03832491|Immotile Cilia Syndrome|immotile cilia syndrome
59484|NCT03832491|Pulmonary Rehabilitation|pulmonary rehabilitation
59485|NCT03832491|Airway Clearance Techniques|airway clearance techniques
59486|NCT03832491|Exergame|exergame
59487|NCT03832478|Virtual Reality|virtual reality
59488|NCT03832478|Meditation|meditation
59489|NCT03832478|Mindfulness Meditation|mindfulness meditation
59490|NCT03832478|Guided Mindfulness Meditation|guided mindfulness meditation
59491|NCT03832478|Anxiety|anxiety
59492|NCT03832478|Pain|pain
59493|NCT03832478|Postoperative pain|postoperative pain
59494|NCT03832465|Levofloxacin|levofloxacin
59495|NCT03832465|Amoxicillin|amoxicillin
59496|NCT03832465|Proton pump inhibitor|proton pump inhibitor
59497|NCT03832465|Helicobacter Pylori|helicobacter pylori
59498|NCT03832439|Probiotic|probiotic
59499|NCT03832439|Microbiome|microbiome
59500|NCT03832387|Non-invasive mechanical ventilation|non-invasive mechanical ventilation
59501|NCT03832387|Oxygen therapy|oxygen therapy
59502|NCT03832387|Extubation failure|extubation failure
59503|NCT03832348|PET scan imaging, pembrolizumab, response, parametric imaging|pet scan imaging, pembrolizumab, response, parametric imaging
59504|NCT03832322|Adenoma miss rate|adenoma miss rate
59505|NCT03832322|Adenoma detection rate|adenoma detection rate
59506|NCT03832296|Arthritis|arthritis
59507|NCT03832296|Knee|knee
59508|NCT03832296|weight loss|weight loss
59509|NCT03832270|Parenting support|parenting support
59510|NCT03832244|sub-mental ultrasonography|sub-mental ultrasonography
59511|NCT03832244|obstructive sleep apnea|obstructive sleep apnea
59512|NCT03832231|Shear wave elastography|shear wave elastography
59513|NCT03832231|Ultrasonography|ultrasonography
59514|NCT03832231|Transdiaphragmatic pressure|transdiaphragmatic pressure
59515|NCT03832231|Diaphragmatic function|diaphragmatic function
59516|NCT03832231|Mechanical ventilation|mechanical ventilation
59517|NCT03832192|patient satisfaction|patient satisfaction
59518|NCT03832192|HCAHPS|hcahps
59519|NCT03832192|loneliness|loneliness
59520|NCT03832192|delirium|delirium
59521|NCT03832192|falls|falls
59522|NCT03832192|HELP|help
59523|NCT03832192|hospitals|hospitals
59524|NCT03832192|geriatrics|geriatrics
59525|NCT03832192|elder care|elder care
59526|NCT03832166|CKD|ckd
59527|NCT03832166|Low Income|low income
59528|NCT03832166|Diet|diet
59529|NCT03832166|Fruits and Vegetables|fruits and vegetables
59530|NCT03832153|Bioprinting|bioprinting
59531|NCT03832153|thrombus aspiration|thrombus aspiration
59532|NCT03832153|micro-CT|micro-ct
59533|NCT03832088|osteoporosis|osteoporosis
59534|NCT03832088|sarcopenia|sarcopenia
59535|NCT03832088|balance disorder|balance disorder
59536|NCT03832075|osteoporosis|osteoporosis
59537|NCT03832075|balance|balance
59538|NCT03832075|berg balance scale|berg balance scale
59539|NCT03832075|korebalance balance system|korebalance balance system
59540|NCT03832049|HPV vaccination in healthy females|hpv vaccination in healthy females
59541|NCT03832036|Electromyography|electromyography
59542|NCT03832036|Paraspinal Mapping|paraspinal mapping
59543|NCT03832036|Quantitative clinical tests|quantitative clinical tests
59544|NCT03832036|Conditioned pain modulation|conditioned pain modulation
59545|NCT03832036|Temporal pain summation|temporal pain summation
59546|NCT03832036|Pain threshold|pain threshold
59547|NCT03832036|Pain tolerance|pain tolerance
59548|NCT03832023|Children|children
59549|NCT03832023|Contact tracing|contact tracing
59550|NCT03832023|Preventive therapy|preventive therapy
59551|NCT03832023|Prophylaxis|prophylaxis
59552|NCT03832023|Community health workers|community health workers
59553|NCT03832023|Community-based distribution|community-based distribution
59554|NCT03832023|Standard of care|standard of care
59555|NCT03832023|Screening|screening
59556|NCT03832023|Randomized controlled trial|randomized controlled trial
59557|NCT03832023|Cameroon|cameroon
59558|NCT03832023|Uganda|uganda
59559|NCT03832023|Patient outcome assessment|patient outcome assessment
59560|NCT03832010|Topical steroid|topical steroid
59561|NCT03832010|Crisaborole|crisaborole
59562|NCT03832010|Topical calcineurin inhibitor|topical calcineurin inhibitor
59563|NCT03831984|Phacoemulsification|phacoemulsification
59564|NCT03831984|femtosecond laser|femtosecond laser
59565|NCT03831984|bromfenac|bromfenac
59566|NCT03831984|NSAID|nsaid
59567|NCT03831984|pupil|pupil
59568|NCT03831971|Reward Pathway|reward pathway
59569|NCT03831971|Pharmacokinetics|pharmacokinetics
59570|NCT03831971|Dopamine|dopamine
59571|NCT03831971|Opioid Use|opioid use
59572|NCT03831971|Addiction|addiction
59573|NCT03831958|Body Mass Index Z Score|body mass index z score
59574|NCT03831958|Adult Height|adult height
59575|NCT03831958|Endocrine Function|endocrine function
59576|NCT03831958|Neuropsychological Outcome|neuropsychological outcome
59577|NCT03831958|Metabolic Syndrome|metabolic syndrome
59578|NCT03831945|HIV Therapy|hiv therapy
59579|NCT03831945|HIV Neutralizing Antibodies|hiv neutralizing antibodies
59580|NCT03831919|ocular accommodation|ocular accommodation
59581|NCT03831867|spine|spine
59582|NCT03831867|extensibility|extensibility
59583|NCT03831867|children|children
59584|NCT03831867|health|health
59585|NCT03831867|pilates|pilates
59586|NCT03831867|exercise|exercise
59587|NCT03831867|physical activity|physical activity
59588|NCT03831867|physical education|physical education
59589|NCT03831841|elderly|elderly
59590|NCT03831841|multicomponent exercise|multicomponent exercise
59591|NCT03831841|body composition|body composition
59592|NCT03831841|vitamin D|vitamin d
59593|NCT03831841|fitness|fitness
59594|NCT03831802|epilepsy|epilepsy
59595|NCT03831802|mhealth|mhealth
59596|NCT03831802|quality of life|quality of life
59597|NCT03831776|Bosupeg|bosupeg
59598|NCT03831776|Ropeginterferon|ropeginterferon
59599|NCT03831750|ulcerative colitis|ulcerative colitis
59600|NCT03831750|remission|remission
59601|NCT03831750|perceived stress|perceived stress
59602|NCT03831750|fecal calprotectin|fecal calprotectin
59603|NCT03831750|salivary stress biomarker|salivary stress biomarker
59604|NCT03831750|psychological stress|psychological stress
59605|NCT03831750|stress reduction|stress reduction
59606|NCT03831750|Crohn's disease|crohn's disease
59607|NCT03831750|Inflammatory bowel diseases|inflammatory bowel diseases
59608|NCT03831698|Omega 3|omega 3
59609|NCT03831685|sepsis|sepsis
59610|NCT03831685|lactate|lactate
59611|NCT03831685|prehospital|prehospital
59612|NCT03831685|prediction|prediction
59613|NCT03831685|mortality|mortality
59614|NCT03831672|intracranial aneurysm|intracranial aneurysm
59615|NCT03831672|outcome|outcome
59616|NCT03831672|occlusion|occlusion
59617|NCT03831672|Pipeline embolization device|pipeline embolization device
59618|NCT03831672|endovascular treatment|endovascular treatment
59619|NCT03831672|flow diversion|flow diversion
59620|NCT03831659|migraine|migraine
59621|NCT03831659|in vitro fertilization|in vitro fertilization
59622|NCT03831659|infertility|infertility
59623|NCT03831646|atopic dermatitis|atopic dermatitis
59624|NCT03831646|psoriasis|psoriasis
59625|NCT03831646|brain-derived neurotrophic factor|brain-derived neurotrophic factor
59626|NCT03831646|depression|depression
59627|NCT03831646|gender|gender
59628|NCT03831646|immunoglobulin E|immunoglobulin e
59629|NCT03831646|cortisol|cortisol
59630|NCT03831646|testosterone|testosterone
59631|NCT03831607|Tenapanor|tenapanor
59632|NCT03831607|Hyperphosphatemia|hyperphosphatemia
59633|NCT03831607|Hemodialysis|hemodialysis
59634|NCT03831594|stroke|stroke
59635|NCT03831594|galvanic vestibular stimulation|galvanic vestibular stimulation
59636|NCT03831581|Erector Spinae Plane|erector spinae plane
59637|NCT03831581|Erector Spinae Plane Block|erector spinae plane block
59638|NCT03831568|Airway management|airway management
59639|NCT03831568|Cough|cough
59640|NCT03831568|Neuromuscular diseases|neuromuscular diseases
59641|NCT03831568|Pediatrics|pediatrics
59642|NCT03831568|Mechanical insufflation-exsufflation|mechanical insufflation-exsufflation
59643|NCT03831555|Psychosocial Readiness Evaluation and Preparation for Hepatitis C Treatment tool|psychosocial readiness evaluation and preparation for hepatitis c treatment tool
59644|NCT03831542|follicular flushing|follicular flushing
59645|NCT03831542|double lumen needle|double lumen needle
59646|NCT03831529|critically ill|critically ill
59647|NCT03831529|mortality|mortality
59648|NCT03831529|outcome|outcome
59649|NCT03831529|treatment intensity level|treatment intensity level
59650|NCT03831516|Ablation|ablation
59651|NCT03831516|Ventricular Tachycardia|ventricular tachycardia
59652|NCT03831516|Mapping|mapping
59653|NCT03831490|screening|screening
59654|NCT03831490|biomarkers|biomarkers
59655|NCT03831490|prediction|prediction
59656|NCT03831477|fractional radiofrequency|fractional radiofrequency
59657|NCT03831477|fractional RF|fractional rf
59658|NCT03831477|wrinkles|wrinkles
59659|NCT03831477|facial wrinkles|facial wrinkles
59660|NCT03831451|stroke preparedness|stroke preparedness
59661|NCT03831451|behavioral intervention|behavioral intervention
59662|NCT03831425|CoQ10|coq10
59663|NCT03831425|muscle function|muscle function
59664|NCT03831425|attention span|attention span
59665|NCT03831425|quality of life|quality of life
59666|NCT03831399|Frailty|frailty
59667|NCT03831399|Aged|aged
59668|NCT03831399|Leucine|leucine
59669|NCT03831399|Sarcopenia|sarcopenia
59670|NCT03831373|Exercise|exercise
59671|NCT03831308|Breast cancer|breast cancer
59672|NCT03831308|Physical exercise and Breast Cancer|physical exercise and breast cancer
59673|NCT03831308|Cognitive status and Breast Cancer|cognitive status and breast cancer
59674|NCT03831308|Physical activity and quality of life of cancer patients|physical activity and quality of life of cancer patients
59675|NCT03831308|New tools for evaluating breast Cancer patients|new tools for evaluating breast cancer patients
59676|NCT03831256|Real life comparative effectiveness|real life comparative effectiveness
59677|NCT03831256|Non-invasive prenatal screening|non-invasive prenatal screening
59678|NCT03831256|Fetal aneuploidy|fetal aneuploidy
59679|NCT03831256|Randomized controlled trial|randomized controlled trial
59680|NCT03831243|Stereotactic Body Radiotherapy|stereotactic body radiotherapy
59681|NCT03831243|Spinal metastases|spinal metastases
59682|NCT03831243|Bone metastases|bone metastases
59683|NCT03831230|ex vivo|ex vivo
59684|NCT03831230|predictive tests|predictive tests
59685|NCT03831230|tumor models|tumor models
59686|NCT03831217|Trans-Obturator Tape|trans-obturator tape
59687|NCT03831217|Tension-Free Vaginal Tape|tension-free vaginal tape
59688|NCT03831217|trans-labial ultrasound|trans-labial ultrasound
59689|NCT03831204|impedance|impedance
59690|NCT03831204|dyspnea|dyspnea
59691|NCT03831204|AHF|ahf
59692|NCT03831204|BNP|bnp
59693|NCT03831204|EFFECT|effect
59694|NCT03831204|GWTG-HF|gwtg-hf
59695|NCT03831191|eczema|eczema
59696|NCT03831191|atopic eczema|atopic eczema
59697|NCT03831165|acyclovir|acyclovir
59698|NCT03831165|melatonin|melatonin
59699|NCT03831113|Buprenorphine|buprenorphine
59700|NCT03831113|medication-assisted treatment (MAT) programs|medication-assisted treatment (mat) programs
59701|NCT03831061|Mild Cognitive Impairment|mild cognitive impairment
59702|NCT03831061|Elderly|elderly
59703|NCT03831061|Randomized Controlled Trial|randomized controlled trial
59704|NCT03831061|Cognitive Stimulation|cognitive stimulation
59705|NCT03831061|Cognitive Intervention|cognitive intervention
59706|NCT03831048|Heart preservation|heart preservation
59707|NCT03831048|Beating heart transplant|beating heart transplant
59708|NCT03831035|Fast trio exome|fast trio exome
59709|NCT03831035|Multiple congenital malformation|multiple congenital malformation
59710|NCT03831035|Intensive care unit|intensive care unit
59711|NCT03831035|Neurological distress|neurological distress
59712|NCT03831022|shock|shock
59713|NCT03831022|sepsis|sepsis
59714|NCT03831022|haemoragy|haemoragy
59715|NCT03831022|intensive care unit|intensive care unit
59716|NCT03831022|prediction|prediction
59717|NCT03830983|Cardioembolic stroke|cardioembolic stroke
59718|NCT03830983|Cardiac MRI|cardiac mri
59719|NCT03830983|Heart disease|heart disease
59720|NCT03830983|Vascular disease|vascular disease
59721|NCT03830970|Mixed Beans|mixed beans
59722|NCT03830944|ST elevation myocardial infarction|st elevation myocardial infarction
59723|NCT03830944|Inflammatory Response|inflammatory response
59724|NCT03830944|Coronary plaque vulnerability|coronary plaque vulnerability
59725|NCT03830944|myocardial viability|myocardial viability
59726|NCT03830931|Hyperglycemia, arthroplasty , complication|hyperglycemia, arthroplasty , complication
59727|NCT03830918|Small Cell Lung Cancer|small cell lung cancer
59729|NCT03830918|PARP Inhibitor|parp inhibitor
59730|NCT03830918|Maintenance Therapy|maintenance therapy
59731|NCT03830866|Durvalumab|durvalumab
59732|NCT03830866|Chemoradiotherapy|chemoradiotherapy
59733|NCT03830866|Locally Advanced Cervical Cancer|locally advanced cervical cancer
59734|NCT03830853|CTO - chronic total occlusion|cto - chronic total occlusion
59735|NCT03830853|OCT - optical coherence tomography|oct - optical coherence tomography
59736|NCT03830853|coronary physiology|coronary physiology
59737|NCT03830853|absolute flow|absolute flow
59738|NCT03830840|Type 2 diabetes|type 2 diabetes
59739|NCT03830840|Cardio-metabolic disease|cardio-metabolic disease
59740|NCT03830840|Latino/Hispanic|latino/hispanic
59741|NCT03830840|Especialista|especialista
59742|NCT03830840|Community health worker|community health worker
59743|NCT03830840|Social determinants of health|social determinants of health
59744|NCT03830840|LatinX|latinx
59745|NCT03830814|Sacubitril/Valsartan|sacubitril/valsartan
59746|NCT03830814|Heart Failure|heart failure
59747|NCT03830814|Ejection Fraction|ejection fraction
59748|NCT03830801|Barrett's Esophagus|barrett's esophagus
59750|NCT03830801|Endoscopy|endoscopy
59751|NCT03830801|Biopsy|biopsy
59752|NCT03830801|Tethered Capulse Endomicroscopy|tethered capulse endomicroscopy
59753|NCT03830801|OCT|oct
59754|NCT03830788|SBRT|sbrt
59755|NCT03830788|brachytherapy|brachytherapy
59756|NCT03830788|localized low-risk and favorable intermediate risk prostate cancer|localized low-risk and favorable intermediate risk prostate cancer
59757|NCT03830775|TFCC|tfcc
59758|NCT03830775|PRP|prp
59759|NCT03830762|Actinogen|actinogen
59760|NCT03830762|Xanamem|xanamem
59761|NCT03830762|UE2343|ue2343
59762|NCT03830762|Cortisol|cortisol
59763|NCT03830762|11β-HSD1|11β-hsd1
59764|NCT03830762|11-beta-Hydroxysteroid Dehydrogenase Type 1|11-beta-hydroxysteroid dehydrogenase type 1
59765|NCT03830762|Healthy Ageing|healthy ageing
59766|NCT03830762|Peripheral Neuropathy|peripheral neuropathy
59767|NCT03830762|Safety|safety
59768|NCT03830762|Dose Escalation|dose escalation
59769|NCT03830762|Elderly|elderly
59770|NCT03830762|XanaHES|xanahes
59771|NCT03830710|Squamous cell carcinoma|squamous cell carcinoma
59772|NCT03830710|8-hydroxy-2- deoxyguanosine|8-hydroxy-2- deoxyguanosine
59773|NCT03830710|Antioxidant|antioxidant
59774|NCT03830619|exosomes；lncRNA； lung cancer；|exosomes；lncrna； lung cancer；
59775|NCT03830606|Nab-paclitaxel, S-1, Advanced Biliary Tract Adenocarcinoma|nab-paclitaxel, s-1, advanced biliary tract adenocarcinoma
59776|NCT03830593|endocrine surgery; laparoscopic adrenalectomy;|endocrine surgery; laparoscopic adrenalectomy;
59777|NCT03830567|Hormonal Contraception|hormonal contraception
59778|NCT03830567|Birth Control|birth control
59779|NCT03830567|Pharmacists|pharmacists
59780|NCT03830554|sleep disturbances|sleep disturbances
59781|NCT03830554|Aromatherapy|aromatherapy
59782|NCT03830554|sleep quality|sleep quality
59783|NCT03830554|Atlas cedar wood essential oil|atlas cedar wood essential oil
59784|NCT03830541|oral health|oral health
59785|NCT03830541|dental care|dental care
59786|NCT03830541|general anaesthesia|general anaesthesia
59787|NCT03830541|tooth loss|tooth loss
59788|NCT03830515|Lacerations|lacerations
59789|NCT03830515|Wounds|wounds
59790|NCT03830502|Prophylactic salpingectomy|prophylactic salpingectomy
59791|NCT03830502|Opportunistic salpingectomy|opportunistic salpingectomy
59792|NCT03830502|Risk-reducing|risk-reducing
59793|NCT03830489|Cleansing quality score|cleansing quality score
59794|NCT03830489|Colonoscopy|colonoscopy
59795|NCT03830476|Acceptance- and Commitment Therapy, Parenting stress, depression, anxiety, parenting, children with disabilities|acceptance- and commitment therapy, parenting stress, depression, anxiety, parenting, children with disabilities
59796|NCT03830450|Acute kidney injury|acute kidney injury
59797|NCT03830450|Cardiac surgery|cardiac surgery
59798|NCT03830450|NGAL|ngal
59799|NCT03830450|GDF-15|gdf-15
59800|NCT03830437|Newborn|newborn
59801|NCT03830437|Salivary Cortisol Level|salivary cortisol level
59802|NCT03830437|Double Weghing|double weghing
59803|NCT03830437|Physiological weight loss|physiological weight loss
59804|NCT03830437|Breastfeeding|breastfeeding
59805|NCT03830437|Stress marker|stress marker
59806|NCT03830411|Sintilimab|sintilimab
59807|NCT03830411|docetaxel|docetaxel
59808|NCT03830411|pemetrexed|pemetrexed
59809|NCT03830411|nonsquamous non-small-cell lung cancer|nonsquamous non-small-cell lung cancer
59810|NCT03830411|wild-type EGFR|wild-type egfr
59811|NCT03830411|second-line treatment|second-line treatment
59812|NCT03830372|stroke|stroke
59813|NCT03830372|post-stroke rehabilitation|post-stroke rehabilitation
59814|NCT03830372|virtual reality|virtual reality
59815|NCT03830372|depression|depression
59816|NCT03830372|mental health|mental health
59817|NCT03830346|Instrument Assisted Soft Tissue Mobilization|instrument assisted soft tissue mobilization
59818|NCT03830346|Manual Therapy|manual therapy
59819|NCT03830346|Muscle Stretching Exercises|muscle stretching exercises
59820|NCT03830346|Range of motion|range of motion
59821|NCT03830346|Shoulder Joint|shoulder joint
59822|NCT03830346|CrossFit|crossfit
59823|NCT03830320|PET-MRI|pet-mri
59824|NCT03830307|Pain Therapy|pain therapy
59825|NCT03830307|Auriculotherapy|auriculotherapy
59826|NCT03830307|Cesarean Delivery|cesarean delivery
59827|NCT03830294|breast prostheses, physical, psychological, breast cancer,|breast prostheses, physical, psychological, breast cancer,
59828|NCT03830268|Ketones|ketones
59829|NCT03830268|Medium Chain Triglycerides|medium chain triglycerides
59830|NCT03830268|Glucose|glucose
59831|NCT03830268|Insulin|insulin
59832|NCT03830268|Free fatty acids|free fatty acids
59833|NCT03830255|Renal Transplantation|renal transplantation
59834|NCT03830255|Genetic Polymorphism|genetic polymorphism
59835|NCT03830255|CP3A5|cp3a5
59836|NCT03830255|CYP3A4|cyp3a4
59837|NCT03830229|DNA Repair Genes|dna repair genes
59838|NCT03830190|Parkinson's disease|parkinson's disease
59839|NCT03830190|Parkinson's disease nurse specialist|parkinson's disease nurse specialist
59840|NCT03830190|Nursing|nursing
59841|NCT03830190|Quality of life|quality of life
59842|NCT03830190|Cost-effectiveness|cost-effectiveness
59843|NCT03830190|Multidisciplinary care|multidisciplinary care
59844|NCT03830138|Oxidized-LDL|oxidized-ldl
59845|NCT03830138|OLR1 gene|olr1 gene
59846|NCT03830138|Single nucleotide polymorphism|single nucleotide polymorphism
59847|NCT03830138|Oxygen therapy|oxygen therapy
59848|NCT03830125|Autotaxin|autotaxin
59849|NCT03830086|postoperative pain|postoperative pain
59850|NCT03830086|regional anesthesia|regional anesthesia
59851|NCT03830086|general anesthesia|general anesthesia
59852|NCT03830086|gynecological laparoscopy|gynecological laparoscopy
59853|NCT03830073|Cytomegalovirus|cytomegalovirus
59854|NCT03830073|Coxsackie- virus|coxsackie- virus
59855|NCT03830073|Vitamin D receptor gene|vitamin d receptor gene
59856|NCT03830073|IG4|ig4
59857|NCT03830073|Autoimmune pancreatitis|autoimmune pancreatitis
59858|NCT03830060|Marker of inflammation|marker of inflammation
59859|NCT03830060|high-sensitivity CRP|high-sensitivity crp
59860|NCT03830060|Antinuclear antibodies|antinuclear antibodies
59861|NCT03830060|Cortisol|cortisol
59862|NCT03830008|Problem Management Plus|problem management plus
59863|NCT03830008|Distress|distress
59864|NCT03830008|Mental Health Care|mental health care
59865|NCT03830008|Low-intensity|low-intensity
59866|NCT03830008|Refugees|refugees
59867|NCT03829982|Circadian Rhythm|circadian rhythm
59869|NCT03829956|obstructive sleep apnoea|obstructive sleep apnoea
59870|NCT03829956|hypopnoea|hypopnoea
59871|NCT03829930|Castration resistant prostate cancer|castration resistant prostate cancer
59872|NCT03829904|Benign Prostatic Hyperplasia|benign prostatic hyperplasia
59873|NCT03829904|Traditional Chinese medicine|traditional chinese medicine
59874|NCT03829891|Type 2 Diabetes Mellitus|type 2 diabetes mellitus
59875|NCT03829891|Beinaglutide|beinaglutide
59876|NCT03829891|glycemic variability|glycemic variability
59877|NCT03829839|Amygdala, anxiety, benzodiazepines, fear, fMRI, lorazepam, oxytocin, 7 Tesla|amygdala, anxiety, benzodiazepines, fear, fmri, lorazepam, oxytocin, 7 tesla
59878|NCT03829800|Glycemic Index|glycemic index
59879|NCT03829800|Insulin|insulin
59880|NCT03829800|Incretins|incretins
59881|NCT03829800|Diabetes Mellitus type 2|diabetes mellitus type 2
59882|NCT03829800|Subjective appetite|subjective appetite
59883|NCT03829800|Nutritional formula|nutritional formula
59884|NCT03829761|rTMS|rtms
59885|NCT03829748|Pancreatic adenocarcinoma|pancreatic adenocarcinoma
59886|NCT03829748|Endoscopic ultrasound|endoscopic ultrasound
59887|NCT03829748|Fine-needle aspiration|fine-needle aspiration
59888|NCT03829657|Symptomatic Neurogenic Orthostatic Hypotension|symptomatic neurogenic orthostatic hypotension
59889|NCT03829657|snOH|snoh
59890|NCT03829657|multiple symptom atrophy|multiple symptom atrophy
59891|NCT03829657|MSA|msa
59892|NCT03829657|Parkinson's disease|parkinson's disease
59893|NCT03829657|PD|pd
59894|NCT03829657|pure autonomic failure|pure autonomic failure
59895|NCT03829657|PAF|paf
59896|NCT03829657|orthostatic hypotension|orthostatic hypotension
59897|NCT03829657|OH|oh
59898|NCT03829657|REDWOOD|redwood
59899|NCT03829657|ampreloxetine|ampreloxetine
59900|NCT03829657|170|170
59901|NCT03829657|low blood pressure|low blood pressure
59902|NCT03829657|dizziness|dizziness
59903|NCT03829657|fainting|fainting
59904|NCT03829657|blacking out|blacking out
59905|NCT03829657|lightheadedness|lightheadedness
59906|NCT03829657|norepinephrine|norepinephrine
59907|NCT03829657|hypotension|hypotension
59908|NCT03829605|Hydrogen sulfide|hydrogen sulfide
59909|NCT03829605|Nitric oxide|nitric oxide
59910|NCT03829605|Stress hyperglycemia|stress hyperglycemia
59911|NCT03829605|Acute coronary syndrome|acute coronary syndrome
59912|NCT03829566|Autologous Stem Cell Transplantation|autologous stem cell transplantation
59913|NCT03829566|Hematopoietic Stem Cell Transplant|hematopoietic stem cell transplant
59914|NCT03829553|regional nodal irradiation|regional nodal irradiation
59915|NCT03829553|IMRT|imrt
59916|NCT03829553|Hypofractionated radiotherapy|hypofractionated radiotherapy
59917|NCT03829540|CD4; T-cell; lymphoma; leukemia; chimeric antigen; CAR-T|cd4; t-cell; lymphoma; leukemia; chimeric antigen; car-t
59918|NCT03829475|Crohn's DIsease|crohn's disease
59919|NCT03829475|Ulcerative Colitis|ulcerative colitis
59920|NCT03829462|REGIRI|regiri
59921|NCT03829462|regorafenib|regorafenib
59922|NCT03829462|irinotecan|irinotecan
59923|NCT03829423|artificial intelligence|artificial intelligence
59924|NCT03829423|magnetic resonance imaging|magnetic resonance imaging
59925|NCT03829423|breast cancer|breast cancer
59926|NCT03829410|Kras mutation|kras mutation
59928|NCT03829410|Onvansertib|onvansertib
59929|NCT03829410|FOLFIRI|folfiri
59930|NCT03829410|Irinotecan|irinotecan
59931|NCT03829410|5-Fluorouracil|5-fluorouracil
59932|NCT03829410|Leucovorin|leucovorin
59933|NCT03829410|Avastin|avastin
59934|NCT03829410|Bevacizumab|bevacizumab
59935|NCT03829397|Demoralization Scale-Mandarin Version|demoralization scale-mandarin version
59936|NCT03829397|Demoralization syndrome|demoralization syndrome
59937|NCT03829384|Chikungunya fever|chikungunya fever
59938|NCT03829384|Alphavirus infections|alphavirus infections
59939|NCT03829384|Togavirus|togavirus
59940|NCT03829384|Viral diseases|viral diseases
59941|NCT03829371|TRANSPLANT INELIGIBLE|transplant ineligible
59942|NCT03829371|STANDARD TREATMENTS|standard treatments
59943|NCT03829358|Constipation|constipation
59944|NCT03829358|Quality of Life|quality of life
59945|NCT03829358|Probiotic|probiotic
59946|NCT03829358|PAC-QOL|pac-qol
59947|NCT03829332|programmed cell death 1 (PD-1, PD1)|programmed cell death 1 (pd-1, pd1)
59948|NCT03829332|programmed cell death-ligand 1 (PD-L1, PDL1)|programmed cell death-ligand 1 (pd-l1, pdl1)
59949|NCT03829332|programmed cell death-ligand 2 (PD-L2, PDL2)|programmed cell death-ligand 2 (pd-l2, pdl2)
59950|NCT03829319|programmed cell death 1 (PD-1, PD1)|programmed cell death 1 (pd-1, pd1)
59951|NCT03829319|programmed cell death-ligand 1 (PD-L1, PDL1)|programmed cell death-ligand 1 (pd-l1, pdl1)
59952|NCT03829319|programmed cell death-ligand 2 (PD-L2, PDL2)|programmed cell death-ligand 2 (pd-l2, pdl2)
59953|NCT03829306|HER2-positive|her2-positive
59954|NCT03829293|High-flow nasal cannula oxygenation|high-flow nasal cannula oxygenation
59955|NCT03829293|gastrointestinal endoscopy|gastrointestinal endoscopy
59956|NCT03829293|upper gasatrointestinal endoscopy|upper gasatrointestinal endoscopy
59957|NCT03829293|colonoscopy|colonoscopy
59958|NCT03829293|sedation|sedation
59959|NCT03829293|hypoxia|hypoxia
59960|NCT03829280|Schizophrenia|schizophrenia
59961|NCT03829280|Cognitive Adaptation Training|cognitive adaptation training
59962|NCT03829280|Functional Outcome|functional outcome
59963|NCT03829267|exercise|exercise
59964|NCT03829267|physical activity|physical activity
59965|NCT03829254|Solid tumors|solid tumors
59966|NCT03829254|Lymphoma|lymphoma
59967|NCT03829254|Cordycepin|cordycepin
59968|NCT03829241|Generalized Anxiety Disorder (GAD)|generalized anxiety disorder (gad)
59969|NCT03829228|Protective Qi|protective qi
59970|NCT03829228|Immunity|immunity
817939|NCT00168116|prevention|prevention
78247|NCT03714776|AGT|agt
59971|NCT03829215|targeted temperature management|targeted temperature management
59972|NCT03829215|prehospital cooling|prehospital cooling
59973|NCT03829215|cardiac arrest|cardiac arrest
59974|NCT03829215|postresuscitation encephalopathy|postresuscitation encephalopathy
59975|NCT03829215|resuscitation|resuscitation
59976|NCT03829215|heart arrest|heart arrest
59977|NCT03829189|microbiome|microbiome
59978|NCT03829189|food wanting|food wanting
59979|NCT03829189|memory|memory
59980|NCT03829189|fiber|fiber
59981|NCT03829176|Whole Genome Sequencing|whole genome sequencing
59982|NCT03829150|non-bismuth containing quadruple therapy|non-bismuth containing quadruple therapy
59983|NCT03829124|Electroconvulsive therapy|electroconvulsive therapy
59984|NCT03829124|ketamine|ketamine
59985|NCT03829098|Anastomotic leakage|anastomotic leakage
59986|NCT03829085|Acute Pancreatitis|acute pancreatitis
59987|NCT03829085|Oral refeeding|oral refeeding
59988|NCT03829085|Nutrition|nutrition
59989|NCT03829085|Length hospitalization|length hospitalization
59990|NCT03829072|Allo Stem Cell Transplantation|allo stem cell transplantation
59992|NCT03829072|Physical activity|physical activity
59993|NCT03829046|PCSK9 inhibition|pcsk9 inhibition
59994|NCT03829046|Evolocumab|evolocumab
59995|NCT03829046|Inflammatory Signals|inflammatory signals
59996|NCT03829046|Circulating monocyte subsets|circulating monocyte subsets
59997|NCT03829033|Tonsil Cancer|tonsil cancer
59998|NCT03829033|Early Tonsil Cancer|early tonsil cancer
59999|NCT03829033|Radiotherapy|radiotherapy
60000|NCT03829033|Photons|photons
60001|NCT03829033|Protons|protons
60002|NCT03829033|Acute Side Effects|acute side effects
60003|NCT03829033|Late Side Effects|late side effects
60004|NCT03829033|Locoregional Control|locoregional control
60005|NCT03829033|Disease Free Survival|disease free survival
60006|NCT03829033|Quality of Life|quality of life
60007|NCT03829033|Health Economic|health economic
60008|NCT03829007|durvalumab|durvalumab
60009|NCT03829007|PD-L1 imaging|pd-l1 imaging
60010|NCT03828994|Pelvic Inflammatory Disease(PID)|pelvic inflammatory disease(pid)
60011|NCT03828994|Community Health Nursing|community health nursing
60012|NCT03828994|Adolescents|adolescents
60013|NCT03828994|Text Messaging|text messaging
60014|NCT03828994|mobile health (mhealth)|mobile health (mhealth)
60015|NCT03828968|urinary retention|urinary retention
60016|NCT03828968|chronic disease|chronic disease
60017|NCT03828968|aged|aged
60018|NCT03828968|homes for the aged|homes for the aged
60019|NCT03828955|soybean peptides|soybean peptides
60020|NCT03828955|clinical trial|clinical trial
60021|NCT03828955|blood preesure|blood preesure
60022|NCT03828955|SBP|sbp
60023|NCT03828955|DBP|dbp
60024|NCT03828942|advrese event|advrese event
60025|NCT03828942|hematotoxicity|hematotoxicity
60026|NCT03828942|drugs|drugs
60027|NCT03828942|chemotherapies|chemotherapies
60028|NCT03828916|Tendon Surgery|tendon surgery
60029|NCT03828916|NuShield|nushield
60030|NCT03828903|Cryobiopsy|cryobiopsy
60031|NCT03828877|Acupuncture, Pain , IL 17, IL 23 and Vessel|acupuncture, pain , il 17, il 23 and vessel
60032|NCT03828799|Metastatic colorectal cancer|metastatic colorectal cancer
60033|NCT03828799|Colorectal cancer|colorectal cancer
60034|NCT03828799|Folfirinox|folfirinox
60035|NCT03828799|Regorafenib|regorafenib
60036|NCT03828799|RAS mutated|ras mutated
60037|NCT03828786|intra-uterine insemination|intra-uterine insemination
60038|NCT03828786|endometrial injury|endometrial injury
60039|NCT03828786|scratching|scratching
60040|NCT03828760|Intrauterine Device|intrauterine device
60041|NCT03828760|IUD|iud
60042|NCT03828760|Anxiety|anxiety
60043|NCT03828760|Pain|pain
60044|NCT03828760|Music|music
60045|NCT03828760|Contraception|contraception
60046|NCT03828760|Visual analog scale|visual analog scale
60047|NCT03828760|VAS|vas
60048|NCT03828682|tacrolimus|tacrolimus
60049|NCT03828682|extended release|extended release
60050|NCT03828682|kidney transplantation|kidney transplantation
60051|NCT03828682|steroid withdrawal|steroid withdrawal
60052|NCT03828682|once daily|once daily
60053|NCT03828669|behavioral medicine|behavioral medicine
60054|NCT03828669|pain|pain
60055|NCT03828669|perioperative|perioperative
60056|NCT03828669|enhanced recovery after surgery|enhanced recovery after surgery
60057|NCT03828669|surgery|surgery
60058|NCT03828669|intervention|intervention
60059|NCT03828669|post-operative pain|post-operative pain
60060|NCT03828669|opioid|opioid
60061|NCT03828669|digital|digital
60062|NCT03828656|PTSD|ptsd
60063|NCT03828656|Nightmare Disorder|nightmare disorder
60064|NCT03828656|Post-traumatic stress disorder|post-traumatic stress disorder
60065|NCT03828656|Veteran|veteran
60066|NCT03828656|Digital therapeutic|digital therapeutic
60067|NCT03828656|Digital medicine|digital medicine
60068|NCT03828656|Nightmares|nightmares
60069|NCT03828643|Secukinumab|secukinumab
60070|NCT03828643|loading dose|loading dose
60071|NCT03828643|chronic plaque psoriasis|chronic plaque psoriasis
60072|NCT03828643|no loading dose|no loading dose
60073|NCT03828604|reward processing|reward processing
60074|NCT03828591|Endometriosis|endometriosis
60075|NCT03828591|Psychological support|psychological support
60076|NCT03828539|migraine|migraine
60077|NCT03828539|erenumab|erenumab
60078|NCT03828539|topiramate|topiramate
60079|NCT03828539|CAMG 334|camg 334
60080|NCT03828539|headache|headache
60081|NCT03828539|CGRP receptor agonist|cgrp receptor agonist
60082|NCT03828526|Patient Safety|patient safety
60083|NCT03828526|Medication Errors|medication errors
60084|NCT03828526|Critical Care|critical care
60085|NCT03828526|Nursing Education|nursing education
60086|NCT03828526|High Fidelity Simulation Training|high fidelity simulation training
60087|NCT03828500|Cataract|cataract
60088|NCT03828500|Cataract Extraction|cataract extraction
60089|NCT03828500|Fasting|fasting
60090|NCT03828500|Preoperative Period|preoperative period
60091|NCT03828500|Interrupted Time Series Analysis|interrupted time series analysis
60092|NCT03828500|Guideline|guideline
60093|NCT03828500|Patient Care|patient care
60094|NCT03828474|acetazolamide|acetazolamide
60095|NCT03828474|chemoprophylaxis|chemoprophylaxis
60096|NCT03828474|altitude|altitude
60097|NCT03828461|hoarding disorder|hoarding disorder
60098|NCT03828461|hoarding|hoarding
60099|NCT03828461|clutter|clutter
60100|NCT03828448|Treatment naïve|treatment naïve
60101|NCT03828435|patient|patient
60102|NCT03828422|essential thrombocythaemia|essential thrombocythaemia
60103|NCT03828422|JAK2 V617F mutation burden|jak2 v617f mutation burden
60104|NCT03828422|preclinical atherosclerosis|preclinical atherosclerosis
60105|NCT03828422|arterial stiffness|arterial stiffness
60106|NCT03828422|endothelial function|endothelial function
60107|NCT03828422|coronary artery calcium score|coronary artery calcium score
60108|NCT03828409|short stitch|short stitch
60109|NCT03828409|post-operative pain|post-operative pain
60110|NCT03828409|PCA morphine usage|pca morphine usage
60111|NCT03828409|elective midline laparotomy|elective midline laparotomy
60112|NCT03828396|DNA methylation|dna methylation
60113|NCT03828396|Next generation sequencing|next generation sequencing
60114|NCT03828383|Caregivers|caregivers
60115|NCT03828383|Dementia|dementia
60116|NCT03828383|In-Home Assistive Technology|in-home assistive technology
60117|NCT03828344|rheumatoid arthritis|rheumatoid arthritis
60118|NCT03828344|mesenchymal stem cell|mesenchymal stem cell
60119|NCT03828344|autoimmune|autoimmune
60120|NCT03828331|Rehabilitation|rehabilitation
61607|NCT03819621|Prosthetic|prosthetic
60124|NCT03828305|emergency medical system services|emergency medical system services
60125|NCT03828305|mobile phone|mobile phone
60126|NCT03828305|Primary healt-care|primary healt-care
60127|NCT03828305|Technology|technology
60128|NCT03828292|Japanese|japanese
60129|NCT03828292|GSK2857916|gsk2857916
60130|NCT03828292|Relapsed/Refractory Multiple Myeloma|relapsed/refractory multiple myeloma
60131|NCT03828292|dose-escalation|dose-escalation
60132|NCT03828292|antibody drug conjugate|antibody drug conjugate
60133|NCT03828279|angioedema|angioedema
60134|NCT03828279|disease registry|disease registry
60135|NCT03828279|C1 inhibitor|c1 inhibitor
60136|NCT03828279|anti bradykinin treatments|anti bradykinin treatments
60137|NCT03828227|chemotherapy|chemotherapy
60138|NCT03828214|exoskeleton, gait, kinematics, electromyography, stair climbing|exoskeleton, gait, kinematics, electromyography, stair climbing
60139|NCT03828201|WHO 9-11-month regimen for MDR-TB|who 9-11-month regimen for mdr-tb
60140|NCT03828201|bedaquiline (BDQ)|bedaquiline (bdq)
60141|NCT03828201|delamanid (DLM)|delamanid (dlm)
60142|NCT03828201|linezolid (LZD)|linezolid (lzd)
60143|NCT03828201|levofloxacin (LFX)|levofloxacin (lfx)
60144|NCT03828201|clofazimine (CF)|clofazimine (cf)
60145|NCT03828188|Red Ginseng Concentrated Powder|red ginseng concentrated powder
60146|NCT03828188|Hyperlipidemias|hyperlipidemias
60147|NCT03828188|Clinical Trial|clinical trial
60148|NCT03828175|Cardiac output, Hemodynamic, Monitoring, Percutaneous.|cardiac output, hemodynamic, monitoring, percutaneous.
60149|NCT03828136|Cervical Disc Disease|cervical disc disease
60150|NCT03828136|ACDF|acdf
60151|NCT03828136|Single-level|single-level
60152|NCT03828110|Robotic-Assisted Gait Training|robotic-assisted gait training
60153|NCT03828110|Gait Rehabilitation|gait rehabilitation
60154|NCT03828045|Psoriatic Arthritis|psoriatic arthritis
60155|NCT03828045|Apremilast|apremilast
60156|NCT03828045|CC-10004|cc-10004
60157|NCT03828045|Biologic Treatments|biologic treatments
60158|NCT03828032|Brain edema|brain edema
60159|NCT03828032|dehydration|dehydration
60160|NCT03828032|Noninvasive optical method|noninvasive optical method
60161|NCT03827980|Acute Haematogenous Osteomyelitis|acute haematogenous osteomyelitis
60162|NCT03827980|Septic Arthritis|septic arthritis
60163|NCT03827980|Outcome|outcome
60164|NCT03827980|Osteoarticular Infections|osteoarticular infections
60165|NCT03827980|Follow-up|follow-up
60170|NCT03827928|Multiple Sclerosis|multiple sclerosis
60171|NCT03827928|Fatigue|fatigue
60172|NCT03827928|Anxiety|anxiety
60173|NCT03827928|Depression|depression
60174|NCT03827915|Atrial fibrillation|atrial fibrillation
60175|NCT03827915|Refractory atrial fibrillation|refractory atrial fibrillation
60176|NCT03827915|Double sequential external defibrillation|double sequential external defibrillation
60177|NCT03827889|dental caries|dental caries
60178|NCT03827889|Tooth, Deciduous|tooth, deciduous
60179|NCT03827889|Fluorides, Topical|fluorides, topical
60180|NCT03827850|sqNSCLC|sqnsclc
60181|NCT03827850|FGFR Mutations|fgfr mutations
60182|NCT03827824|Virtual Reality|virtual reality
60183|NCT03827824|Hysteroscopy|hysteroscopy
60184|NCT03827824|Pain|pain
60185|NCT03827824|Anxiety|anxiety
60186|NCT03827811|MDR|mdr
60187|NCT03827798|Hidradenitis suppurativa|hidradenitis suppurativa
60188|NCT03827785|repetitive transcranial magnetic stimulation (rTMS)|repetitive transcranial magnetic stimulation (rtms)
60189|NCT03827785|randomized clinical trials|randomized clinical trials
60190|NCT03827785|treatment|treatment
60191|NCT03827785|craving|craving
60192|NCT03827785|cognitive function|cognitive function
60193|NCT03827759|idiopathic juvenile arthritis, septic arthritis, biomarkers|idiopathic juvenile arthritis, septic arthritis, biomarkers
60194|NCT03827746|Parkinson's Disease, Kinesiophobia, Physical Activity, Balance, Falling|parkinson's disease, kinesiophobia, physical activity, balance, falling
60195|NCT03827733|Gut Microbiota|gut microbiota
60196|NCT03827733|Alzheimer's Diseases|alzheimer's diseases
60197|NCT03827707|meal ingestion|meal ingestion
60198|NCT03827707|postprandial responses|postprandial responses
60199|NCT03827707|hedonic sensations|hedonic sensations
60200|NCT03827707|homeostatic sensations|homeostatic sensations
60201|NCT03827707|ambient noise|ambient noise
60202|NCT03827668|Drug-Drug Interaction|drug-drug interaction
60203|NCT03827655|Drug Therapy|drug therapy
60204|NCT03827616|Prostate cancer|prostate cancer
60205|NCT03827616|Radiation therapy|radiation therapy
60206|NCT03827616|Hypofractionated radiotherapy|hypofractionated radiotherapy
60207|NCT03827564|Dry Eye Disease|dry eye disease
60208|NCT03827551|Oral Health|oral health
60209|NCT03827551|Parkinson Disease|parkinson disease
60210|NCT03827551|Tooth cavities|tooth cavities
60211|NCT03827551|Saliva|saliva
60212|NCT03827551|Mucosa|mucosa
60213|NCT03827525|Williams Syndrome|williams syndrome
60214|NCT03827525|Anxiety|anxiety
60219|NCT03827512|classification|classification
60220|NCT03827512|doppler waveforms|doppler waveforms
60221|NCT03827512|Saint-Bonnet|saint-bonnet
60222|NCT03827460|Alcohol|alcohol
60223|NCT03827460|Alcoholism|alcoholism
60224|NCT03827460|Sex Differences|sex differences
60225|NCT03827460|Abstinence|abstinence
60226|NCT03827460|Alcohol Deprivation Effect|alcohol deprivation effect
60227|NCT03827447|Clostridium Difficile|clostridium difficile
60228|NCT03827447|Metabolomics|metabolomics
60229|NCT03827447|Vancomycin|vancomycin
60230|NCT03827447|Microbiome|microbiome
60231|NCT03827421|transcranial doppler|transcranial doppler
60232|NCT03827421|learning curve|learning curve
60233|NCT03827421|emergency|emergency
60234|NCT03827421|traumatic brain injury|traumatic brain injury
60235|NCT03827408|Nebulized Dexmedetomidine|nebulized dexmedetomidine
60236|NCT03827408|Nebulized Midazolam|nebulized midazolam
60237|NCT03827408|Moderate sedation|moderate sedation
60238|NCT03827408|Dental procedural sedation|dental procedural sedation
60239|NCT03827408|Pediatric dentistry|pediatric dentistry
60240|NCT03827395|Adult|adult
60241|NCT03827395|Healthy|healthy
60242|NCT03827395|Hecolin|hecolin
60243|NCT03827395|Hepatitis E|hepatitis e
60244|NCT03827395|HEV239|hev239
60245|NCT03827395|Immunogenicity|immunogenicity
60246|NCT03827395|Placebo|placebo
60247|NCT03827395|Population|population
60248|NCT03827395|Reactogenicity|reactogenicity
60249|NCT03827395|Route|route
60250|NCT03827395|Safety|safety
60251|NCT03827395|Vaccine|vaccine
60252|NCT03827382|Life Style Intervention|life style intervention
60253|NCT03827382|Type 2 Diabetes mellitus|type 2 diabetes mellitus
60254|NCT03827369|Blood pressure|blood pressure
60255|NCT03827369|Arterial pulse|arterial pulse
60256|NCT03827369|Coefficient of variation of harmonic magnitude|coefficient of variation of harmonic magnitude
60257|NCT03827356|REHABILITATION|rehabilitation
60258|NCT03827356|RESPIRATION|respiration
60259|NCT03827356|BREATHING EXERCISE|breathing exercise
60260|NCT03827356|FATIGUE|fatigue
60261|NCT03827356|PHYSICAL CAPACITY|physical capacity
60262|NCT03827343|CAR-T Cell Therapy|car-t cell therapy
60263|NCT03827343|Macrophage Activation Syndrome (MAS)|macrophage activation syndrome (mas)
60264|NCT03827343|Hemophagocytic Lymphohistiocytosis (HLH)|hemophagocytic lymphohistiocytosis (hlh)
60270|NCT03827317|HER2|her2
60271|NCT03827317|imaging|imaging
60272|NCT03827317|PET|pet
60273|NCT03827317|positron emission tomography|positron emission tomography
60274|NCT03827304|Burns|burns
60275|NCT03827304|Virtual Reality|virtual reality
60276|NCT03827304|Qualitative|qualitative
60277|NCT03827278|Talaromyces|talaromyces
60278|NCT03827278|voriconazole|voriconazole
60279|NCT03827278|Amphotericin Sequential Itraconazole therapy|amphotericin sequential itraconazole therapy
60280|NCT03827278|anti-Interferon-γ autoantibodies|anti-interferon-γ autoantibodies
818043|NCT00167778|Locomotion|locomotion
60281|NCT03827213|shoulder surgery, post operative pain|shoulder surgery, post operative pain
60282|NCT03827200|Cirrhosis|cirrhosis
60283|NCT03827200|Portal Hypertension|portal hypertension
60284|NCT03827200|Ambrisentan|ambrisentan
60285|NCT03827200|N-003|n-003
60286|NCT03827200|Hepatic Vein Pressure Gradient|hepatic vein pressure gradient
60287|NCT03827200|HVPG|hvpg
60288|NCT03827200|Refractory Ascites|refractory ascites
60289|NCT03827200|Varices, Esophageal|varices, esophageal
60290|NCT03827200|Variceal Hemorrhage|variceal hemorrhage
60291|NCT03827200|Hepatitis B|hepatitis b
60292|NCT03827200|Hepatitis C|hepatitis c
60293|NCT03827200|Non-Alcoholic Fatty Liver Disease|non-alcoholic fatty liver disease
60294|NCT03827200|Non-alcoholic Steatohepatitis|non-alcoholic steatohepatitis
60295|NCT03827200|Ascites|ascites
60296|NCT03827174|Chronic pain|chronic pain
60297|NCT03827174|Endometriosis|endometriosis
60298|NCT03827174|Opioid therapy|opioid therapy
60299|NCT03827174|Return to work|return to work
60300|NCT03827174|Vocational rehabilitation|vocational rehabilitation
60301|NCT03827174|Behavioural medicine|behavioural medicine
60302|NCT03827148|Pharmacist intervention|pharmacist intervention
60303|NCT03827148|Disease knowledge|disease knowledge
60304|NCT03827148|Medication adherence|medication adherence
60305|NCT03827148|Rehabilitation|rehabilitation
60306|NCT03827148|Physical therapy|physical therapy
60307|NCT03827148|Health related quality of life|health related quality of life
60308|NCT03827148|Direct cost of treatment|direct cost of treatment
60309|NCT03827148|Rheumatoid arthritis|rheumatoid arthritis
60310|NCT03827148|Pakistan|pakistan
60311|NCT03827148|Out-patients|out-patients
60312|NCT03827135|Cervical Discogenic pain|cervical discogenic pain
60313|NCT03827135|Cyriax manipulation|cyriax manipulation
60314|NCT03827135|Neck Pain Disability index|neck pain disability index
60316|NCT03827083|spinal and general anesthesia|spinal and general anesthesia
60317|NCT03827083|cerebral pulse oxymetry|cerebral pulse oxymetry
60318|NCT03827083|cognitive dysfunction|cognitive dysfunction
60319|NCT03827070|Afatinib|afatinib
60320|NCT03827070|Talcum powder|talcum powder
60321|NCT03827070|Thoracoscopy|thoracoscopy
60322|NCT03827070|Pleurodesis|pleurodesis
60323|NCT03827070|BIBW2992|bibw2992
60324|NCT03827057|posttraumatic stress disorder|posttraumatic stress disorder
60325|NCT03827057|traumatic brain injury|traumatic brain injury
60326|NCT03827057|cognitive behavioral therapy|cognitive behavioral therapy
60327|NCT03827057|exposure therapy|exposure therapy
60328|NCT03827057|reconsolidation|reconsolidation
60329|NCT03827044|colon cancer|colon cancer
60330|NCT03827044|dMMR|dmmr
60331|NCT03827044|POLE exonuclease domain mutant|pole exonuclease domain mutant
60332|NCT03827018|GCA|gca
60333|NCT03827018|temporal arteritis|temporal arteritis
60334|NCT03827018|Horton's disease|horton's disease
60335|NCT03827005|L-arginine|l-arginine
60336|NCT03827005|flow mediated dilation|flow mediated dilation
60337|NCT03827005|resistance exercise|resistance exercise
60338|NCT03826992|relapsed|relapsed
60339|NCT03826992|refractory|refractory
60340|NCT03826992|Vyxeos|vyxeos
60341|NCT03826992|Venetoclax|venetoclax
60342|NCT03826992|acute myeloid leukemia|acute myeloid leukemia
60343|NCT03826992|acute myeloid leukemia, childhood|acute myeloid leukemia, childhood
60344|NCT03826992|mixed-lineage leukemia (MLL)|mixed-lineage leukemia (mll)
60345|NCT03826992|AML|aml
60346|NCT03826992|CPX-351|cpx-351
60347|NCT03826992|Venclexta|venclexta
60348|NCT03826992|Histone-lysine N-methyltransferase 2A (KmT2A)|histone-lysine n-methyltransferase 2a (kmt2a)
60349|NCT03826979|Breast cancer.|breast cancer.
60350|NCT03826979|Exercise Therapy|exercise therapy
60351|NCT03826979|Modified Radical Mastectomy|modified radical mastectomy
60352|NCT03826953|nurse led allergy clinic|nurse led allergy clinic
60353|NCT03826940|Inhibition|inhibition
60354|NCT03826940|GABA|gaba
60355|NCT03826940|molecular imaging|molecular imaging
60356|NCT03826940|functional magnetic resonance imaging|functional magnetic resonance imaging
60357|NCT03826940|Autism Spectrum Disorder|autism spectrum disorder
60358|NCT03826940|Neurofibromatosis 1|neurofibromatosis 1
60359|NCT03826927|New oral Anticoagulants (NOAC)|new oral anticoagulants (noac)
60360|NCT03826927|vitamin K antagonists (VKA)|vitamin k antagonists (vka)
60361|NCT03826927|cerebrovascular disease|cerebrovascular disease
60362|NCT03826914|dietary supplements|dietary supplements
60363|NCT03826914|cardiovascular diseases|cardiovascular diseases
60364|NCT03826914|heart attack|heart attack
60365|NCT03826914|stroke|stroke
60366|NCT03826914|hypertension|hypertension
60367|NCT03826914|amino acids|amino acids
60368|NCT03826914|electrolytes|electrolytes
60369|NCT03826914|antioxidants|antioxidants
60370|NCT03826901|adults, pediatric|adults, pediatric
60371|NCT03826888|IVF|ivf
60372|NCT03826888|AMH isoforms|amh isoforms
60373|NCT03826888|ovarian reserve test|ovarian reserve test
60374|NCT03826888|poor response|poor response
60375|NCT03826875|stroke|stroke
60376|NCT03826875|hemorrhagic stroke|hemorrhagic stroke
60377|NCT03826875|subarachnoid hemorrhage|subarachnoid hemorrhage
60378|NCT03826875|depression|depression
60379|NCT03826862|lateral lymph node dissection|lateral lymph node dissection
60380|NCT03826862|node-by-node|node-by-node
60381|NCT03826862|rectal cancer|rectal cancer
60382|NCT03826862|CT three-dimensional reconstruction|ct three-dimensional reconstruction
60383|NCT03826862|internal iliac vessels dissection|internal iliac vessels dissection
60384|NCT03826849|mobile app|mobile app
60385|NCT03826849|Veteran|veteran
60386|NCT03826849|cognitive behavioral therapy for insomnia|cognitive behavioral therapy for insomnia
60387|NCT03826823|hysterosalpingography, catheter, pain, visual analogue scale|hysterosalpingography, catheter, pain, visual analogue scale
60388|NCT03826797|Non invasive ventilation|non invasive ventilation
60389|NCT03826797|Esophageal pressure|esophageal pressure
60390|NCT03826797|Transpulmonary pressure|transpulmonary pressure
60391|NCT03826771|stroke|stroke
60392|NCT03826771|rehabilitation|rehabilitation
60393|NCT03826771|depression|depression
60394|NCT03826771|exercise|exercise
60395|NCT03826758|chronic kidney disease|chronic kidney disease
60396|NCT03826758|clinical decision support|clinical decision support
60397|NCT03826758|health informatics|health informatics
60398|NCT03826758|pragmatic clinical trial|pragmatic clinical trial
60399|NCT03826706|Videolaryngoscopy|videolaryngoscopy
60400|NCT03826706|Double lumen tube|double lumen tube
60401|NCT03826706|One-lung ventilation|one-lung ventilation
60402|NCT03826693|OCD|ocd
60403|NCT03826693|nitrous oxide|nitrous oxide
60404|NCT03826654|vitamin D|vitamin d
60405|NCT03826654|fortified oil|fortified oil
60406|NCT03826589|Cervical cancer|cervical cancer
60407|NCT03826589|Avelumab|avelumab
60408|NCT03826589|Axitinib|axitinib
60409|NCT03826576|mediterranean diet|mediterranean diet
60410|NCT03826576|Food allergen|food allergen
60414|NCT03826524|epinephrine|epinephrine
60415|NCT03826524|randomized controlled trial|randomized controlled trial
60416|NCT03826511|mud-pack therapy|mud-pack therapy
60417|NCT03826511|osteoarthritis of the knee|osteoarthritis of the knee
60418|NCT03826511|hot-pack therapy|hot-pack therapy
60419|NCT03826511|non-inferiority study|non-inferiority study
60420|NCT03826498|Cerebral palsy|cerebral palsy
60421|NCT03826498|CP|cp
60422|NCT03826498|Cord Blood|cord blood
60423|NCT03826498|Stem cells|stem cells
60424|NCT03826485|Pranlukast hydrate|pranlukast hydrate
60425|NCT03826446|Right colon cancer|right colon cancer
60426|NCT03826446|Mesocolic excision|mesocolic excision
60427|NCT03826433|Hepatitis B Cirrhosis, mesenchymal stem cell|hepatitis b cirrhosis, mesenchymal stem cell
60428|NCT03826407|Coma|coma
60429|NCT03826407|Machine Learning|machine learning
60430|NCT03826407|Prognosis|prognosis
60431|NCT03826407|Electrophysiology|electrophysiology
60432|NCT03826407|Event-related potentials|event-related potentials
60433|NCT03826407|Electroencephalography|electroencephalography
60434|NCT03826407|Mismatch Negativity|mismatch negativity
60435|NCT03826407|Auditory Brainstem Response|auditory brainstem response
60436|NCT03826407|Disorders of Consciousness|disorders of consciousness
60437|NCT03826394|Postpartum, Overweight, Obesity, Exercise, Diet, Lifestyle|postpartum, overweight, obesity, exercise, diet, lifestyle
60438|NCT03826368|Cannabinoid|cannabinoid
60439|NCT03826368|CBD|cbd
60440|NCT03826329|Adjacent segment disease (ASD)|adjacent segment disease (asd)
60441|NCT03826329|Second surgery|second surgery
60442|NCT03826329|Anterior cervical discectomy and fusion (ACDF)|anterior cervical discectomy and fusion (acdf)
60443|NCT03826329|Risk factors|risk factors
60444|NCT03826329|Cohort study|cohort study
60445|NCT03826316|Pharmacokinetic|pharmacokinetic
60446|NCT03826290|Decision Support Systems, Clinical|decision support systems, clinical
60447|NCT03826290|Machine Learning|machine learning
60448|NCT03826290|Data Visualization|data visualization
60449|NCT03826264|TAVR|tavr
60450|NCT03826264|TAVI|tavi
60451|NCT03826264|real-world|real-world
60452|NCT03826238|alcohol-related brain damage|alcohol-related brain damage
60453|NCT03826238|depression|depression
60454|NCT03826238|attention|attention
60455|NCT03826238|eeg|eeg
60456|NCT03826199|pre-exposure prophylaxis|pre-exposure prophylaxis
60457|NCT03826199|PrEP|prep
60458|NCT03826199|pregnancy|pregnancy
60459|NCT03826199|prevention of mother to child transmission|prevention of mother to child transmission
60460|NCT03826199|PMTCT|pmtct
60461|NCT03826186|CompuFlo; dynamic pressure sensing|compuflo; dynamic pressure sensing
60462|NCT03826173|Positive Psychology|positive psychology
60463|NCT03826173|Affect|affect
60464|NCT03826121|Cognitive Function|cognitive function
60465|NCT03826121|Sesam Esamesame Oil Cake|sesam esamesame oil cake
60466|NCT03826095|Multiple Sclerosis|multiple sclerosis
60467|NCT03826095|Respiratory function|respiratory function
60468|NCT03826095|Respiratory muscle strength|respiratory muscle strength
60469|NCT03826095|Trunk control|trunk control
60470|NCT03826095|Functional mobility|functional mobility
60471|NCT03826069|Augmented reality|augmented reality
60472|NCT03826069|Endoscopy|endoscopy
60473|NCT03826069|Polypectomy|polypectomy
60474|NCT03826069|Simulation training|simulation training
60475|NCT03826056|clinical education|clinical education
60476|NCT03826043|Neoplasms, Thrombosis, hypocoagulability|neoplasms, thrombosis, hypocoagulability
60481|NCT03826017|Catechin high contain greentea extract|catechin high contain greentea extract
60482|NCT03826017|Cognitive Function|cognitive function
60483|NCT03826004|Cardiovascular Surgery|cardiovascular surgery
60484|NCT03826004|Histamine H1 Receptor Antagonist|histamine h1 receptor antagonist
60485|NCT03826004|Anaphylaxis|anaphylaxis
60486|NCT03825991|Pharmacoepidemiology|pharmacoepidemiology
60487|NCT03825991|Back pain|back pain
60488|NCT03825991|Psychiatric disorder|psychiatric disorder
60489|NCT03825991|Psychiatric comorbidity|psychiatric comorbidity
60490|NCT03825991|Comorbidity|comorbidity
60491|NCT03825978|prenatal genetic screening|prenatal genetic screening
60492|NCT03825978|prenatal diagnosis|prenatal diagnosis
60493|NCT03825978|counseling|counseling
60494|NCT03825978|decision|decision
60495|NCT03825978|anxiety|anxiety
60496|NCT03825978|nursing|nursing
60497|NCT03825965|Total knee arthroplasty|total knee arthroplasty
60498|NCT03825965|Cannabis|cannabis
60499|NCT03825965|Pilot trial|pilot trial
60500|NCT03825965|Persistent post-surgical pain|persistent post-surgical pain
60501|NCT03825952|adherence|adherence
60502|NCT03825939|Total hip arthroplasty|total hip arthroplasty
60503|NCT03825939|Total knee arthroplasty|total knee arthroplasty
60504|NCT03825913|Melanoma|melanoma
60505|NCT03825861|Gastric Cancer|gastric cancer
60506|NCT03825861|FOLFIRINOX|folfirinox
60507|NCT03825835|Delivery Room|delivery room
60508|NCT03825835|Resuscitation|resuscitation
60509|NCT03825835|Premature Infant|premature infant
60510|NCT03825835|Oxygen|oxygen
60511|NCT03825822|Pain|pain
60512|NCT03825822|Procedures|procedures
60513|NCT03825822|Infants|infants
60514|NCT03825822|Assessment|assessment
60515|NCT03825822|Management|management
60516|NCT03825822|Knowledge translation|knowledge translation
60517|NCT03825822|Context|context
60518|NCT03825822|Implementation|implementation
60519|NCT03825783|Leukocyte Adhesion Deficiency- Type I|leukocyte adhesion deficiency- type i
60520|NCT03825783|LAD-I|lad-i
60521|NCT03825770|Fatigue|fatigue
60522|NCT03825770|Energy conservation|energy conservation
60523|NCT03825770|Rehabilitation|rehabilitation
60524|NCT03825770|Occupational therapy|occupational therapy
60525|NCT03825770|End-stage renal disease|end-stage renal disease
60526|NCT03825770|Chronic kidney disease|chronic kidney disease
60527|NCT03825770|Hemodialysis|hemodialysis
60528|NCT03825770|Disability|disability
60529|NCT03825770|Quality of life|quality of life
60530|NCT03825757|chronic rhinosinusitis with nasal polyps|chronic rhinosinusitis with nasal polyps
60531|NCT03825757|Acetyl salicylic acid exacerbated respiratory disease|acetyl salicylic acid exacerbated respiratory disease
60533|NCT03825692|Functional Dyspepsia|functional dyspepsia
60534|NCT03825692|Postprandial Distress Syndrome|postprandial distress syndrome
60535|NCT03825692|Traditional Chinese Medicine|traditional chinese medicine
60536|NCT03825692|efficacy|efficacy
60537|NCT03825692|safety|safety
60538|NCT03825692|clinical evaluation|clinical evaluation
60539|NCT03825666|quality of recovery|quality of recovery
60540|NCT03825666|PONV|ponv
60541|NCT03825666|PDNV|pdnv
60542|NCT03825653|stress urinary incontinence|stress urinary incontinence
60543|NCT03825653|pelvic tilt|pelvic tilt
60544|NCT03825653|ankle position|ankle position
60545|NCT03825601|Patients,|patients,
60546|NCT03825601|Multiple Sclerosis,|multiple sclerosis,
60547|NCT03825601|Relapsing-Remitting|relapsing-remitting
60548|NCT03825575|Fecal Incontinence|fecal incontinence
60549|NCT03825575|Anorectal manometry|anorectal manometry
60550|NCT03825562|type 1 diabetes|type 1 diabetes
60551|NCT03825562|ACT|act
60552|NCT03825562|adolescents|adolescents
60553|NCT03825562|value based methods|value based methods
60554|NCT03825562|acceptance|acceptance
60555|NCT03825549|Opioids|opioids
60556|NCT03825549|Nudges|nudges
60557|NCT03825549|Emergency Medicine|emergency medicine
60558|NCT03825549|Urgent Care|urgent care
60559|NCT03825549|Feedback|feedback
60560|NCT03825536|HIV|hiv
60561|NCT03825536|methamphetamine|methamphetamine
60562|NCT03825536|viral transcription|viral transcription
60563|NCT03825536|inflammation|inflammation
60564|NCT03825523|HIV/AIDS|hiv/aids
60565|NCT03825523|ART|art
60566|NCT03825510|Opdivo, Keytruda, Cyberknife|opdivo, keytruda, cyberknife
60567|NCT03825497|older medical patient|older medical patient
60568|NCT03825497|mobility|mobility
60569|NCT03825497|hospitalization|hospitalization
60570|NCT03825497|activity monitoring|activity monitoring
60571|NCT03825497|cross sectoral|cross sectoral
60572|NCT03825471|Cranial electrotherapy stimulation (CES)|cranial electrotherapy stimulation (ces)
60573|NCT03825471|Autonomic nervous system|autonomic nervous system
60574|NCT03825471|acute postoperative pain|acute postoperative pain
60575|NCT03825471|colon cancer surgery|colon cancer surgery
60576|NCT03825471|patient-controlled analgesia (PCA)|patient-controlled analgesia (pca)
60577|NCT03825445|GnRH agonist trigger|gnrh agonist trigger
60578|NCT03825445|hCG trigger|hcg trigger
60579|NCT03825445|ovulation induction|ovulation induction
60580|NCT03825432|Physical activity|physical activity
60581|NCT03825432|Prosthesis|prosthesis
60582|NCT03825419|Stroke, Acute, Neurocritical Care, Nutrition, Sarcopenia|stroke, acute, neurocritical care, nutrition, sarcopenia
60583|NCT03825393|Fibromyalgia Syndrome, Ferritin, Sleep|fibromyalgia syndrome, ferritin, sleep
60584|NCT03825367|Relapse|relapse
60585|NCT03825367|Refractory|refractory
60586|NCT03825367|Leukemia|leukemia
60587|NCT03825367|Acute|acute
60588|NCT03825367|Pediatric|pediatric
60589|NCT03825367|nivolumab|nivolumab
60590|NCT03825367|azacytidine|azacytidine
60591|NCT03825354|suicide|suicide
60592|NCT03825354|thoughts|thoughts
60593|NCT03825354|attempts|attempts
60594|NCT03825354|death|death
60595|NCT03825354|brief intervention|brief intervention
60596|NCT03825354|contact|contact
60597|NCT03825315|DAXI for injection,|daxi for injection,
60598|NCT03825315|Plantar Fasciitis,|plantar fasciitis,
60599|NCT03825315|Heel Pain,|heel pain,
60600|NCT03825315|BotulinumtoxinA|botulinumtoxina
60601|NCT03825276|Mango|mango
60602|NCT03825276|Polyphenols|polyphenols
60603|NCT03825276|Inflammation|inflammation
60604|NCT03825276|Insulin resistance|insulin resistance
60605|NCT03825276|Transcriptomic|transcriptomic
60606|NCT03825276|Metabolomic|metabolomic
60607|NCT03825276|Metagenomic|metagenomic
60608|NCT03825250|Sodium Valproate|sodium valproate
60609|NCT03825250|Cardiac Surgery|cardiac surgery
60610|NCT03825250|Organ Injury Prevention|organ injury prevention
60611|NCT03825237|diagnostic|diagnostic
60612|NCT03825237|polysomnography|polysomnography
60613|NCT03825237|sleep architecture|sleep architecture
60614|NCT03825237|sleep bruxism|sleep bruxism
60615|NCT03825224|MRI|mri
60616|NCT03825224|SENC MyoStrain|senc myostrain
60617|NCT03825172|Caudal block|caudal block
60618|NCT03825172|Ultrasound|ultrasound
60619|NCT03825172|Children|children
60620|NCT03825172|Regional block anatomy|regional block anatomy
60621|NCT03825146|relapse/refractory acute myeloid leukaemia|relapse/refractory acute myeloid leukaemia
60622|NCT03825146|autologous progenitor cells|autologous progenitor cells
60623|NCT03825120|reproductive health|reproductive health
60624|NCT03825120|fertility|fertility
60625|NCT03825120|infertility|infertility
60626|NCT03825120|aging|aging
60627|NCT03825120|health|health
60628|NCT03825120|cardiovascular disease|cardiovascular disease
60629|NCT03825120|cardiovascular disease risk|cardiovascular disease risk
60630|NCT03825055|disease-specific variables|disease-specific variables
60631|NCT03825055|biopsychosocial characteristics|biopsychosocial characteristics
60632|NCT03825055|resilience|resilience
60633|NCT03825055|adjustment|adjustment
60634|NCT03825055|quality of life|quality of life
60635|NCT03825055|well-being|well-being
60636|NCT03825055|young adults|young adults
60637|NCT03825003|Basketball|basketball
60638|NCT03825003|Sedentary|sedentary
60639|NCT03825003|Joint Mobility|joint mobility
60640|NCT03825003|Performance|performance
60641|NCT03824990|Quality improvement|quality improvement
60642|NCT03824990|Hyperbilirubinemia|hyperbilirubinemia
60643|NCT03824990|screening|screening
60644|NCT03824990|follow-up|follow-up
60645|NCT03824977|lung resection|lung resection
60646|NCT03824977|low technology|low technology
60647|NCT03824977|six minutes stepper test|six minutes stepper test
60648|NCT03824977|sit to stand test|sit to stand test
60649|NCT03824977|physiotherapy|physiotherapy
60650|NCT03824977|lung surgery|lung surgery
60651|NCT03824938|exercise|exercise
60652|NCT03824938|aspirin|aspirin
60653|NCT03824938|cooling|cooling
60654|NCT03824938|antipyretic|antipyretic
60655|NCT03824925|Taste alterations|taste alterations
60656|NCT03824925|zinc sulfate|zinc sulfate
60657|NCT03824925|oral cancer|oral cancer
60658|NCT03824925|taste acuity|taste acuity
60659|NCT03824899|neoadjuvant chemoradiotherapy|neoadjuvant chemoradiotherapy
60660|NCT03824899|irinotecan|irinotecan
60661|NCT03824899|SN-38|sn-38
60662|NCT03824886|Skin Integrity|skin integrity
60663|NCT03824886|Aged Care Receivers|aged care receivers
60664|NCT03824886|Care Dependent|care dependent
60665|NCT03824886|Geriatric Patients|geriatric patients
60666|NCT03824886|Prevention|prevention
60667|NCT03824886|Skin Protection|skin protection
60668|NCT03824873|Internal iliac artery|internal iliac artery
60669|NCT03824873|Internal iliac artery ligation|internal iliac artery ligation
60670|NCT03824873|Placenta previa|placenta previa
60671|NCT03824873|Placenta accreta|placenta accreta
60672|NCT03824873|cesarean hysterectomy|cesarean hysterectomy
60673|NCT03824860|Chemotherapy-induced Peripheral Neuropathy|chemotherapy-induced peripheral neuropathy
60674|NCT03824860|Yoga|yoga
60675|NCT03824860|Chronic Pain|chronic pain
60676|NCT03824860|Neuropathic Pain|neuropathic pain
60677|NCT03824847|Macrolides|macrolides
60678|NCT03824847|Immunomodulation|immunomodulation
60679|NCT03824834|Breathlessness|breathlessness
60680|NCT03824834|Dyspnea|dyspnea
60681|NCT03824834|Exercise|exercise
79124|NCT03709654|zit|zit
60682|NCT03824834|Opioids|opioids
60683|NCT03824834|Morphine|morphine
60684|NCT03824834|Exercise tolerance|exercise tolerance
60685|NCT03824821|Nutrition|nutrition
60686|NCT03824821|Irritable Bowel Syndrome|irritable bowel syndrome
60687|NCT03824821|Quality of Life|quality of life
60688|NCT03824808|prostatectomy|prostatectomy
60689|NCT03824808|partial nephrectomy|partial nephrectomy
60690|NCT03824808|robotic surgery|robotic surgery
60691|NCT03824808|intravenous lidocaine|intravenous lidocaine
60692|NCT03824808|lidocaine hydrochloride|lidocaine hydrochloride
60693|NCT03824795|Clostridium difficile|clostridium difficile
60694|NCT03824795|CDAD|cdad
60695|NCT03824795|MGB-BP-3|mgb-bp-3
60696|NCT03824795|Novel anti-infective|novel anti-infective
60697|NCT03824795|Efficacy|efficacy
60698|NCT03824795|Tolerability|tolerability
60699|NCT03824795|Safety|safety
60700|NCT03824795|Phase IIa|phase iia
60701|NCT03824782|Retinopathy of Prematurity|retinopathy of prematurity
60702|NCT03824782|ROP|rop
60703|NCT03824782|Screening|screening
60704|NCT03824782|Stress|stress
60705|NCT03824782|Pain|pain
60706|NCT03824782|Photophobia|photophobia
60707|NCT03824782|Neonate|neonate
60708|NCT03824782|Light Sensitivity|light sensitivity
60709|NCT03824782|Desaturation|desaturation
60710|NCT03824782|Bradycardia|bradycardia
60711|NCT03824782|Apnea|apnea
60712|NCT03824769|Weight Loss Maintenance|weight loss maintenance
60713|NCT03824756|Growth monitoring and promotion|growth monitoring and promotion
60714|NCT03824756|child growth|child growth
60715|NCT03824756|Infant and young child feeding practices|infant and young child feeding practices
60716|NCT03824756|program|program
60717|NCT03824756|Bangladesh|bangladesh
60718|NCT03824730|endovascular|endovascular
60719|NCT03824730|stent|stent
60720|NCT03824730|aorto-iliac|aorto-iliac
60721|NCT03824730|occlusions|occlusions
60722|NCT03824730|iliac|iliac
60723|NCT03824717|Ropivacaine|ropivacaine
60724|NCT03824717|Brachial plexus block|brachial plexus block
60725|NCT03824717|Infraclavicular block|infraclavicular block
60726|NCT03824704|PARP|parp
60727|NCT03824704|PARPi|parpi
60728|NCT03824704|PARP inhibitor|parp inhibitor
60729|NCT03824704|ARIES|aries
60730|NCT03824704|Opdivo|opdivo
60731|NCT03824704|Rucaparib|rucaparib
60732|NCT03824704|Nivolumab|nivolumab
60733|NCT03824704|PD-1|pd-1
60734|NCT03824704|BRCA|brca
60735|NCT03824704|LOH|loh
60736|NCT03824704|CO-338|co-338
60737|NCT03824704|Immunotherapy|immunotherapy
60738|NCT03824704|BMS-936558|bms-936558
60739|NCT03824704|Clovis|clovis
60740|NCT03824704|Clovis Oncology|clovis oncology
60741|NCT03824704|Rubraca|rubraca
60742|NCT03824678|Hepatic impairment|hepatic impairment
60743|NCT03824678|Healthy Subjects|healthy subjects
60744|NCT03824678|CC-220|cc-220
60745|NCT03824678|Pharmacokinetics|pharmacokinetics
60746|NCT03824652|prostate cancer|prostate cancer
60747|NCT03824652|prostate adenocarcinoma|prostate adenocarcinoma
60748|NCT03824652|diet|diet
60749|NCT03824652|walnuts|walnuts
60750|NCT03824652|radical prostatectomy|radical prostatectomy
60751|NCT03824652|omega-3 fatty acids|omega-3 fatty acids
60752|NCT03824652|polyphenols|polyphenols
60753|NCT03824639|Mild cognitive impairment|mild cognitive impairment
60754|NCT03824639|exercise therapy|exercise therapy
60755|NCT03824639|patient adherence|patient adherence
60756|NCT03824626|thoracic endovascular aortic repair|thoracic endovascular aortic repair
60757|NCT03824626|computational fluid dynamics|computational fluid dynamics
60758|NCT03824626|preoperative planning|preoperative planning
60759|NCT03824574|Functional appliance|functional appliance
60760|NCT03824574|skeletal class II|skeletal class ii
60761|NCT03824574|mandibular deficiency|mandibular deficiency
60762|NCT03824574|twin-block|twin-block
60763|NCT03824574|Growing patients|growing patients
60764|NCT03824574|Clear appliance|clear appliance
60765|NCT03824574|Aligner|aligner
60766|NCT03824509|risk|risk
60767|NCT03824509|CHA2DS-VASc score|cha2ds-vasc score
60768|NCT03824483|Zanubrutinib|zanubrutinib
60769|NCT03824483|Obinutuzumab|obinutuzumab
60770|NCT03824483|Venetoclax|venetoclax
60771|NCT03824483|18-427|18-427
60772|NCT03824470|stop bang|stop bang
60773|NCT03824470|Intubation Without Muscle Relaxation|intubation without muscle relaxation
60774|NCT03824470|Post Operative Recovery|post operative recovery
60776|NCT03824457|Intoxication|intoxication
60777|NCT03824444|humerus|humerus
60778|NCT03824444|amputee|amputee
60779|NCT03824444|Amputation|amputation
60780|NCT03824431|Gastroesophageal reflux disease|gastroesophageal reflux disease
60781|NCT03824431|Narrow Band Imaging|narrow band imaging
60782|NCT03824431|High definition endoscopy|high definition endoscopy
60783|NCT03824431|Microerosions|microerosions
60784|NCT03824431|Esophageal biopsy|esophageal biopsy
60785|NCT03824431|Immunohistochemistry.|immunohistochemistry.
60786|NCT03824418|Surveillance|surveillance
60787|NCT03824418|Chromoendoscopy|chromoendoscopy
60788|NCT03824418|Dysplasia|dysplasia
60789|NCT03824418|Ulcerative Colitis|ulcerative colitis
60790|NCT03824405|CBD|cbd
60791|NCT03824405|Synthetic CBD|synthetic cbd
60792|NCT03824405|Cannabidiol|cannabidiol
60793|NCT03824392|Pulmonary Sarcoidosis|pulmonary sarcoidosis
60794|NCT03824392|Resokine|resokine
60795|NCT03824392|Sarcoidosis|sarcoidosis
60796|NCT03824392|Granulomas|granulomas
60797|NCT03824392|Inflammation|inflammation
60798|NCT03824392|Lymphoproliferative Disorders|lymphoproliferative disorders
60799|NCT03824392|Interstitial Lung Disease|interstitial lung disease
60800|NCT03824392|Neuropilin-2|neuropilin-2
60801|NCT03824392|Steroids|steroids
60802|NCT03824392|Oral corticosteroids|oral corticosteroids
60803|NCT03824392|Immunomodulatory|immunomodulatory
60804|NCT03824392|tRNA Synthetase|trna synthetase
60805|NCT03824392|ATYR1923|atyr1923
60806|NCT03824379|magnesium|magnesium
60807|NCT03824379|diabetic nephropathy|diabetic nephropathy
60808|NCT03824379|osteocalcin|osteocalcin
60809|NCT03824301|cardiopulmonary bypass|cardiopulmonary bypass
60810|NCT03824301|pressure-controlled ventilation|pressure-controlled ventilation
60811|NCT03824301|volume-controlled ventilation|volume-controlled ventilation
60812|NCT03824301|atelectasis|atelectasis
60813|NCT03824301|pleural effusion|pleural effusion
60814|NCT03824301|lung compliance|lung compliance
60815|NCT03824249|Energy Expenditure|energy expenditure
60816|NCT03824249|Ventilator Weaning|ventilator weaning
60817|NCT03824249|Calorimetry, indirect|calorimetry, indirect
60818|NCT03824236|Malaria|malaria
60819|NCT03824236|RTS,S/AS01E vaccine|rts,s/as01e vaccine
60820|NCT03824236|Fractional dose|fractional dose
60821|NCT03824236|Sporozoite challenge|sporozoite challenge
60822|NCT03824158|cancer, advance care planning|cancer, advance care planning
60823|NCT03824093|Adolescent Vaccines|adolescent vaccines
60824|NCT03824067|HIV/AIDS|hiv/aids
60825|NCT03824067|Point of Care|point of care
60826|NCT03824067|Early infant diagnosis|early infant diagnosis
60827|NCT03824067|Health systems|health systems
60828|NCT03824067|Diagnostic tools|diagnostic tools
60829|NCT03824067|LMIC|lmic
60830|NCT03824054|deep infiltrating endometriosis|deep infiltrating endometriosis
60831|NCT03824054|colorectal resection|colorectal resection
60832|NCT03824054|quality of life|quality of life
60833|NCT03824041|Polyphenols|polyphenols
60834|NCT03824041|Anthocyanins|anthocyanins
60835|NCT03824041|Vascular function|vascular function
60836|NCT03824041|Gut microbiome|gut microbiome
60837|NCT03824041|Gut health|gut health
60838|NCT03824041|Berries|berries
60839|NCT03824028|Cataract surgery|cataract surgery
60840|NCT03824028|Intraocular lens|intraocular lens
60841|NCT03824028|IOL|iol
60842|NCT03824028|Clareon|clareon
60843|NCT03824028|AutonoMe|autonome
60844|NCT03824015|Physical Activity|physical activity
60845|NCT03824015|Older Adults|older adults
60846|NCT03824015|Behaviour maintenance|behaviour maintenance
60847|NCT03824015|feasibility study|feasibility study
60848|NCT03824015|falls prevention|falls prevention
60849|NCT03824002|diabetes mellitus|diabetes mellitus
60850|NCT03824002|dulaglutide|dulaglutide
60851|NCT03824002|endothelial function|endothelial function
60852|NCT03823976|dental care|dental care
60853|NCT03823976|oral rehabilitation|oral rehabilitation
60854|NCT03823976|general anaesthesia|general anaesthesia
60855|NCT03823976|tooth loss|tooth loss
60856|NCT03823937|fibromyalgia|fibromyalgia
60857|NCT03823937|smell|smell
60858|NCT03823937|taste|taste
60859|NCT03823924|Psoriatic arthritis|psoriatic arthritis
60860|NCT03823924|ustekinumab|ustekinumab
60861|NCT03823924|body composition|body composition
60862|NCT03823924|bone mineral density|bone mineral density
60863|NCT03823924|adiposity|adiposity
60864|NCT03823911|Cardiovascular Disease|cardiovascular disease
60865|NCT03823898|obesity|obesity
60866|NCT03823898|body composition|body composition
60867|NCT03823898|weight management|weight management
60868|NCT03823898|cardiovascular and metabolic markers|cardiovascular and metabolic markers
60869|NCT03823898|Behavioral change|behavioral change
60870|NCT03823898|Exercise|exercise
60871|NCT03823859|Hypothyroidism|hypothyroidism
60872|NCT03823859|Metabolomics|metabolomics
60873|NCT03823859|Thyroid Hormones|thyroid hormones
60874|NCT03823859|Hyperthyroidism|hyperthyroidism
60875|NCT03823846|movement evoked pain|movement evoked pain
60876|NCT03823846|analgesia|analgesia
60877|NCT03823846|general surgery|general surgery
60878|NCT03823846|hepatobiliary and pancreatic disease|hepatobiliary and pancreatic disease
60879|NCT03823833|Oocyte freezing|oocyte freezing
60880|NCT03823833|fertility preservation|fertility preservation
60881|NCT03823833|ovarian cysts|ovarian cysts
60882|NCT03823833|benign ovarian tumor|benign ovarian tumor
60883|NCT03823833|endometrioma|endometrioma
60884|NCT03823703|Nonalcoholic Steatohepatitis|nonalcoholic steatohepatitis
60885|NCT03823703|NASH|nash
60886|NCT03823703|Nonalcoholic Fatty Liver Disease|nonalcoholic fatty liver disease
60887|NCT03823664|prediabetes|prediabetes
60888|NCT03823664|type 2 diabetes|type 2 diabetes
60889|NCT03823664|cardiorespiratory fitness|cardiorespiratory fitness
60890|NCT03823664|pulmonary functions|pulmonary functions
60891|NCT03823664|functional capacity|functional capacity
60892|NCT03823664|exercise capacity|exercise capacity
60893|NCT03823625|SqLC|sqlc
60894|NCT03823599|chat-based intervention|chat-based intervention
60895|NCT03823599|alcohol brief intervention|alcohol brief intervention
60896|NCT03823599|Alcohol misuse|alcohol misuse
60897|NCT03823599|Accident & Emergency Department|accident & emergency department
60898|NCT03823599|AUDIT|audit
60899|NCT03823599|instant messaging|instant messaging
60900|NCT03823573|fast track|fast track
60901|NCT03823573|total knee arthroplasty|total knee arthroplasty
60902|NCT03823573|tranexamic acid|tranexamic acid
60903|NCT03823573|drain|drain
60904|NCT03823547|DAPT|dapt
60905|NCT03823547|Dual Antiplatelet Therapy|dual antiplatelet therapy
60906|NCT03823547|Myocardial infarction|myocardial infarction
60907|NCT03823547|Acute Coronary Syndrome|acute coronary syndrome
60908|NCT03823547|Ticagrelor|ticagrelor
60909|NCT03823547|Prasugrel|prasugrel
60910|NCT03823547|Clopidogrel|clopidogrel
60911|NCT03823547|Thrombosis|thrombosis
60912|NCT03823547|Myocardial Ischemia|myocardial ischemia
60913|NCT03823547|Platelet aggregation inhibitors|platelet aggregation inhibitors
60914|NCT03823547|Risk scores|risk scores
60915|NCT03823547|Cardiovascular diseases|cardiovascular diseases
60916|NCT03823534|Toradol|toradol
60917|NCT03823534|Ketorolac|ketorolac
60918|NCT03823534|Prophylactic intramedullary nail|prophylactic intramedullary nail
60919|NCT03823534|bone metastases|bone metastases
60920|NCT03823534|Opioid use|opioid use
60921|NCT03823534|post-operative pain|post-operative pain
60926|NCT03823508|Transcranial direct current stimulation|transcranial direct current stimulation
60927|NCT03823508|Non invasive brain stimulation|non invasive brain stimulation
60929|NCT03823508|High density electroencephalography|high density electroencephalography
60930|NCT03823495|pain management|pain management
60931|NCT03823495|nursing home|nursing home
60932|NCT03823495|elderly|elderly
60933|NCT03823495|non-drug|non-drug
60934|NCT03823482|aneurysm, cerebral|aneurysm, cerebral
60935|NCT03823482|inflammation mediators|inflammation mediators
60936|NCT03823482|lidocaine, hydrochloride|lidocaine, hydrochloride
60937|NCT03823469|Home cooking|home cooking
60938|NCT03823469|Telemedicine|telemedicine
60939|NCT03823469|Nutrition|nutrition
60940|NCT03823469|Health coaching|health coaching
60941|NCT03823456|acupressure|acupressure
60942|NCT03823456|insomnia|insomnia
60943|NCT03823456|anxiety|anxiety
60944|NCT03823456|depression|depression
60945|NCT03823456|symptom cluster|symptom cluster
60946|NCT03823443|exacerbation|exacerbation
60947|NCT03823443|cough|cough
60948|NCT03823443|sputum|sputum
60949|NCT03823417|Tranexamic Acid|tranexamic acid
60950|NCT03823417|Periacetabular Osteotomy|periacetabular osteotomy
60951|NCT03823417|Bleeding|bleeding
60952|NCT03823391|Rheumatoid Arthritis (RA)|rheumatoid arthritis (ra)
60953|NCT03823391|ABBV-3373|abbv-3373
60954|NCT03823391|Adalimumab|adalimumab
60955|NCT03823378|ABBV-105|abbv-105
60956|NCT03823378|Upadacitinib|upadacitinib
60957|NCT03823378|ABBV-599|abbv-599
60958|NCT03823378|Rheumatoid Arthritis (RA)|rheumatoid arthritis (ra)
60959|NCT03823378|Long-term extension (LTE)|long-term extension (lte)
60960|NCT03823313|Spiritual Care|spiritual care
60961|NCT03823313|Religion|religion
60962|NCT03823313|Spirituality|spirituality
60963|NCT03823313|Caregiver|caregiver
60968|NCT03823287|AMD|amd
60969|NCT03823287|nAMD|namd
60970|NCT03823287|neovascular age-related macular degeneration|neovascular age-related macular degeneration
60971|NCT03823287|choroidal neovascularization secondary to age-related macular degeneration|choroidal neovascularization secondary to age-related macular degeneration
60972|NCT03823222|Duckweed protein|duckweed protein
60973|NCT03823222|protein|protein
60974|NCT03823222|degree of digestibility|degree of digestibility
60975|NCT03823222|whey protein|whey protein
60976|NCT03823209|Pre-exposure prophylaxis (PrEP)|pre-exposure prophylaxis (prep)
60977|NCT03823183|Aging, geriatrics & gerontology|aging, geriatrics & gerontology
60978|NCT03823183|Video-game cognitive training|video-game cognitive training
60979|NCT03823183|Dance|dance
60980|NCT03823183|Physical exercise|physical exercise
60981|NCT03823183|Multi-domain training|multi-domain training
60982|NCT03823183|Executive functions|executive functions
60983|NCT03823183|Memory functions|memory functions
60984|NCT03823183|Plasticity|plasticity
60985|NCT03823183|Transfer|transfer
60986|NCT03823183|Follow-up intervention|follow-up intervention
60987|NCT03823183|Randomized controlled trial|randomized controlled trial
60988|NCT03823170|hypomineralization molar incisor|hypomineralization molar incisor
60989|NCT03823170|Child|child
60990|NCT03823170|Laser Therapy|laser therapy
60991|NCT03823170|Tooth Sensitivity|tooth sensitivity
60992|NCT03823105|Sleep apnea|sleep apnea
60993|NCT03823105|Hypersomnia|hypersomnia
60994|NCT03823105|Parasomnia|parasomnia
60995|NCT03823092|macular function|macular function
60996|NCT03823092|polarization perception|polarization perception
60997|NCT03823092|Haidinger's brush|haidinger's brush
60998|NCT03823092|vision testing|vision testing
60999|NCT03823092|cataract|cataract
61000|NCT03823092|age related macular degeneration|age related macular degeneration
61001|NCT03823092|pseudophakia|pseudophakia
61002|NCT03823092|macular disease|macular disease
61003|NCT03823092|retinal disease|retinal disease
61004|NCT03823079|Recombinant human interleukin-11|recombinant human interleukin-11
61005|NCT03823079|Recombinant human thrombopoietin|recombinant human thrombopoietin
61006|NCT03823066|acceptance|acceptance
61007|NCT03823066|usability|usability
61008|NCT03823066|home care|home care
61009|NCT03823066|socially assistive robot|socially assistive robot
61010|NCT03823066|humanoid robot|humanoid robot
61011|NCT03823066|caregivers|caregivers
61012|NCT03823066|dementia trainers|dementia trainers
61013|NCT03823066|cognitive training|cognitive training
61014|NCT03823066|physical training|physical training
61015|NCT03823053|Adolescent idiopathic scoliosis|adolescent idiopathic scoliosis
61016|NCT03823053|Scoliosis|scoliosis
61017|NCT03823053|Core Stabilization Training|core stabilization training
61018|NCT03823053|Exercise Training|exercise training
61019|NCT03823053|Pulmonary Function Test|pulmonary function test
61020|NCT03823053|6 - Minute Walk Test|6 - minute walk test
61021|NCT03823053|Peripheral Muscle Strength|peripheral muscle strength
61022|NCT03823053|Balance with Biodex|balance with biodex
61023|NCT03823053|Quality of Life|quality of life
61024|NCT03823027|Medical Device|medical device
61025|NCT03823027|Prediabetes|prediabetes
61026|NCT03823027|Type2 Diabetes|type2 diabetes
61027|NCT03823027|Silica|silica
61028|NCT03823027|Metabolic risk factors|metabolic risk factors
61029|NCT03823014|transgender|transgender
61030|NCT03823014|transmasculine|transmasculine
61031|NCT03823014|ftm|ftm
61032|NCT03823014|phalloplasty|phalloplasty
61033|NCT03823014|penile prosthesis|penile prosthesis
61034|NCT03823001|Magnetic Resonance Imaging (MRI)|magnetic resonance imaging (mri)
61035|NCT03822988|advance directives|advance directives
61036|NCT03822988|Advance care planning|advance care planning
61037|NCT03822988|Patient's informed|patient's informed
61038|NCT03822988|treatment preferences|treatment preferences
61039|NCT03822988|skin cancer|skin cancer
61040|NCT03822988|dermatology|dermatology
61041|NCT03822975|Primary percutaneous coronary intervention|primary percutaneous coronary intervention
61042|NCT03822975|anticoagulant agents|anticoagulant agents
61043|NCT03822975|bivalirudin|bivalirudin
61044|NCT03822975|heparin|heparin
61045|NCT03822962|NSAIDs|nsaids
61046|NCT03822962|post-operative pain|post-operative pain
61047|NCT03822962|post-operative hemorrhage|post-operative hemorrhage
61048|NCT03822962|Functional endoscopic sinus surgery|functional endoscopic sinus surgery
61049|NCT03822936|carbon ion radiation therapy|carbon ion radiation therapy
61050|NCT03822936|exocrine pancreas|exocrine pancreas
61051|NCT03822936|pancreas tumour|pancreas tumour
61052|NCT03822923|Neurodynamics|neurodynamics
61053|NCT03822923|Spasticity|spasticity
61054|NCT03822923|Stroke|stroke
61055|NCT03822871|prostate cancer|prostate cancer
61056|NCT03822871|metastatic castration resistant prostate cancer|metastatic castration resistant prostate cancer
61057|NCT03822871|prostate specific membrane antigen|prostate specific membrane antigen
61058|NCT03822871|mCRPC|mcrpc
61059|NCT03822871|PSMA|psma
61060|NCT03822871|positron emission tomography|positron emission tomography
61061|NCT03822871|PET|pet
61062|NCT03822871|radiotherapy|radiotherapy
61063|NCT03822871|targeted therapy|targeted therapy
61064|NCT03822871|lutetium|lutetium
61065|NCT03822871|177Lu|177lu
61066|NCT03822858|Mesenchymal Stem Cells|mesenchymal stem cells
61067|NCT03822858|Neural Progenitors|neural progenitors
61068|NCT03822858|Autologous|autologous
61069|NCT03822858|Bone Marrow|bone marrow
61070|NCT03822858|Multiple Sclerosis|multiple sclerosis
61071|NCT03822845|Nuclear scans|nuclear scans
61072|NCT03822845|PET imaging|pet imaging
61073|NCT03822845|prostate cancer|prostate cancer
61074|NCT03822793|tranexamic acid (TXA)|tranexamic acid (txa)
61075|NCT03822793|arthroplasty|arthroplasty
61076|NCT03822793|hip|hip
61077|NCT03822793|Exacyl|exacyl
61078|NCT03822780|Interstitial lung disease|interstitial lung disease
61079|NCT03822780|Hydroxychloroquine|hydroxychloroquine
61080|NCT03822767|Sabin strain|sabin strain
61081|NCT03822767|Inactivated poliovirus vaccine|inactivated poliovirus vaccine
61082|NCT03822767|poliomyelitis|poliomyelitis
61083|NCT03822767|safety|safety
61084|NCT03822767|immunogenicity|immunogenicity
61085|NCT03822767|infant|infant
61086|NCT03822767|sequential schedule|sequential schedule
61087|NCT03822754|Sabin strain|sabin strain
61088|NCT03822754|Inactivated poliovirus vaccine|inactivated poliovirus vaccine
61089|NCT03822754|poliomyelitis|poliomyelitis
61090|NCT03822754|safety|safety
61091|NCT03822754|immunogenicity|immunogenicity
61092|NCT03822754|infant|infant
61093|NCT03822754|sequential schedule|sequential schedule
61094|NCT03822741|seizure|seizure
61095|NCT03822715|aromatase inhibitor|aromatase inhibitor
61096|NCT03822715|carbohydrate restricted diet|carbohydrate restricted diet
61097|NCT03822702|handwriting|handwriting
61098|NCT03822702|kinetics|kinetics
61099|NCT03822702|kinematics|kinematics
61100|NCT03822702|handwriting difficulty|handwriting difficulty
61101|NCT03822689|pediatric|pediatric
61102|NCT03822689|Ventilation breathing tube|ventilation breathing tube
61103|NCT03822689|End-Tidal Carbon Dioxide|end-tidal carbon dioxide
61104|NCT03822689|Heart rate|heart rate
61105|NCT03822689|tidal volume|tidal volume
61106|NCT03822689|blood temperature|blood temperature
61107|NCT03822663|Sports nutrition|sports nutrition
61108|NCT03822663|Caffeine|caffeine
61109|NCT03822663|Physical capacity|physical capacity
61110|NCT03822663|Exercise performance|exercise performance
61111|NCT03822624|Probiotic|probiotic
61112|NCT03822598|Teaching Recovery Techniques|teaching recovery techniques
61113|NCT03822598|Asylum-seeking children|asylum-seeking children
61114|NCT03822598|Refugee children|refugee children
61115|NCT03822598|Low-threshold intervention|low-threshold intervention
61116|NCT03822585|HbA2, HPLC|hba2, hplc
61117|NCT03822572|endurance exercise|endurance exercise
61118|NCT03822559|Glaucoma|glaucoma
61119|NCT03822533|Primary assessor|primary assessor
61120|NCT03822533|cost efficiency|cost efficiency
61121|NCT03822533|physiotherapist|physiotherapist
61122|NCT03822533|quality of life|quality of life
61123|NCT03822494|radiation therapy|radiation therapy
61124|NCT03822494|Cyberknife|cyberknife
61125|NCT03822494|SBRT|sbrt
61126|NCT03822494|Protons|protons
61127|NCT03822481|Post-Bariatric Surgery Weight-loss Diary|post-bariatric surgery weight-loss diary
61128|NCT03822468|Breast Cancer|breast cancer
61129|NCT03822468|HR-positive|hr-positive
61130|NCT03822468|HER2-negative|her2-negative
61131|NCT03822468|ER-positive|er-positive
61132|NCT03822468|advanced breast cancer|advanced breast cancer
61133|NCT03822468|ribociclib|ribociclib
61134|NCT03822468|LEE011|lee011
61135|NCT03822468|premenopausal|premenopausal
61136|NCT03822468|postmenopausal|postmenopausal
61137|NCT03822455|cystic fibrosis|cystic fibrosis
61138|NCT03822442|Cardiomyopathy, cardiomegaly|cardiomyopathy, cardiomegaly
61139|NCT03822442|cardiac transplant|cardiac transplant
61140|NCT03822429|CLBR|clbr
61141|NCT03822416|mental illness|mental illness
61142|NCT03822416|tobacco treatment|tobacco treatment
61143|NCT03822403|glass ionomer|glass ionomer
61144|NCT03822403|composite resin|composite resin
61145|NCT03822390|Artificial Intelligence|artificial intelligence
61146|NCT03822390|Computer aided diagnosis|computer aided diagnosis
61147|NCT03822390|Diminutive colorectal polyps|diminutive colorectal polyps
61148|NCT03822390|Optical diagnosis|optical diagnosis
61149|NCT03822364|apomorphine|apomorphine
61150|NCT03822364|aerosol|aerosol
61151|NCT03822351|Locally Advanced NSCLC|locally advanced nsclc
61152|NCT03822351|Non-small Cell Lung Cancer|non-small cell lung cancer
61153|NCT03822351|Cancer|cancer
61154|NCT03822351|Lung|lung
61155|NCT03822351|Unresectable|unresectable
61156|NCT03822351|Stage III|stage iii
61157|NCT03822338|Renal ischemia reperfusion injury|renal ischemia reperfusion injury
61158|NCT03822338|Pneumoperitoneum preconditioning|pneumoperitoneum preconditioning
61159|NCT03822338|Laparoscopic partial nephrectomy|laparoscopic partial nephrectomy
61160|NCT03822312|Breast Cancer|breast cancer
61161|NCT03822312|Optical imaging|optical imaging
61162|NCT03822312|neoadjuvant therapy|neoadjuvant therapy
61163|NCT03822286|home-care worker|home-care worker
61164|NCT03822286|e-training|e-training
61165|NCT03822286|mentoring support|mentoring support
61166|NCT03822273|Traumatic rib fractures|traumatic rib fractures
61167|NCT03822273|Acupuncture|acupuncture
61168|NCT03822273|Analgesia|analgesia
61169|NCT03822247|Recovery|recovery
61170|NCT03822247|Patient reported outcome measures|patient reported outcome measures
61171|NCT03822247|Hip fracture|hip fracture
61172|NCT03822247|Hip arthritis|hip arthritis
61173|NCT03822247|Knee fracture|knee fracture
61174|NCT03822247|Knee arthritis|knee arthritis
61175|NCT03822221|Quadriceps muscle|quadriceps muscle
61176|NCT03822221|Electrical Stimulation|electrical stimulation
61177|NCT03822221|Patellar Tendon|patellar tendon
61178|NCT03822221|Ultrasonography|ultrasonography
61179|NCT03822221|Electromyography|electromyography
61180|NCT03822195|carotid artery atherosclerosis|carotid artery atherosclerosis
61181|NCT03822195|alternative complement pathway|alternative complement pathway
61182|NCT03822182|liposomal bupivicaine|liposomal bupivicaine
61183|NCT03822182|interscalene block|interscalene block
61184|NCT03822156|Cavitary Pulmonary Tuberculosis|cavitary pulmonary tuberculosis
61185|NCT03822156|Acid fast bacilli (AFB)|acid fast bacilli (afb)
61186|NCT03822156|Isolation|isolation
61187|NCT03822156|Endobronchial Tuberculosis|endobronchial tuberculosis
61188|NCT03822156|Transmission|transmission
61189|NCT03822156|Drug susceptible test (DST)|drug susceptible test (dst)
61190|NCT03822156|Ant-tuberculous agent|ant-tuberculous agent
61191|NCT03822117|Fibroblast growth factor receptor (FGFR) inhibitor|fibroblast growth factor receptor (fgfr) inhibitor
61192|NCT03822117|FGFR mutations|fgfr mutations
61193|NCT03822117|FGFR translocations|fgfr translocations
61194|NCT03822117|solid tumor malignancy|solid tumor malignancy
61195|NCT03822104|Very Preterm Infants|very preterm infants
61196|NCT03822104|Human Milk Fortifier|human milk fortifier
61197|NCT03822104|Bovine Colostrum|bovine colostrum
61198|NCT03822104|Enteral Feeding|enteral feeding
61199|NCT03822104|Nutrition|nutrition
61200|NCT03822104|Human milk|human milk
61201|NCT03822078|Postmenopausal|postmenopausal
61202|NCT03822078|Denosumab|denosumab
61203|NCT03822065|Depressive Disorder, Major|depressive disorder, major
61204|NCT03822065|Depressive Disorder|depressive disorder
61205|NCT03822065|Mood Disorders|mood disorders
61206|NCT03822065|Mental Disorders|mental disorders
61207|NCT03822065|Desvenlafaxine Succinate|desvenlafaxine succinate
61208|NCT03822065|Serotonin and Noradrenaline Reuptake Inhibitors|serotonin and noradrenaline reuptake inhibitors
61209|NCT03822065|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors
61210|NCT03822065|Membrane Transport Modulators|membrane transport modulators
61211|NCT03822065|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action
61212|NCT03822065|Neurotransmitter Agents|neurotransmitter agents
61213|NCT03822065|Physiological Effects of Drugs|physiological effects of drugs
61214|NCT03822065|Antidepressive Agents|antidepressive agents
61215|NCT03822065|Psychotropic Drugs|psychotropic drugs
61216|NCT03822026|intracranial pressure|intracranial pressure
61217|NCT03822026|cerebral metabolism|cerebral metabolism
61218|NCT03822026|cerebral oxygenation|cerebral oxygenation
61219|NCT03822013|Sandhoff Disease|sandhoff disease
61220|NCT03822013|Tay-Sachs Disease|tay-sachs disease
61221|NCT03822013|Miglustat|miglustat
61222|NCT03822000|femur fracture|femur fracture
61223|NCT03822000|trauma|trauma
61224|NCT03822000|fall|fall
61225|NCT03822000|elderly|elderly
61226|NCT03822000|mortality|mortality
61227|NCT03822000|respiratory complication|respiratory complication
61228|NCT03821987|haploidentical transplantation|haploidentical transplantation
61229|NCT03821987|aplastic anemia|aplastic anemia
61230|NCT03821974|Pancreatic solid lesions|pancreatic solid lesions
61231|NCT03821974|wet suction technique|wet suction technique
61232|NCT03821974|dry suction technique|dry suction technique
61233|NCT03821961|Diabetes Mellitus, Type 2|diabetes mellitus, type 2
61234|NCT03821961|PreDiabetes|prediabetes
61235|NCT03821961|Obesity|obesity
61236|NCT03821948|Blood Draw|blood draw
61237|NCT03821948|Sample Collection|sample collection
61238|NCT03821948|Stool DNA|stool dna
61239|NCT03821935|Advanced Solid Tumors Cancer|advanced solid tumors cancer
61240|NCT03821935|cancer|cancer
61241|NCT03821935|Solid Tumors|solid tumors
61242|NCT03821935|metastatic|metastatic
61243|NCT03821935|monotherapy|monotherapy
61244|NCT03821935|combination therapy|combination therapy
61245|NCT03821935|triple negative breast cancer (TNBC)|triple negative breast cancer (tnbc)
61246|NCT03821935|pancreatic adenocarcinoma|pancreatic adenocarcinoma
61247|NCT03821935|urothelial cancer|urothelial cancer
61248|NCT03821935|hepatocellular carcinoma (HCC)|hepatocellular carcinoma (hcc)
61249|NCT03821935|head and neck squamous cell carcinoma (HNSCC)|head and neck squamous cell carcinoma (hnscc)
61250|NCT03821922|Hypertension, Pregnancy-Induced|hypertension, pregnancy-induced
61251|NCT03821922|FGF23|fgf23
61252|NCT03821909|Pancreatic cancer|pancreatic cancer
61253|NCT03821909|Portal venous blood|portal venous blood
61254|NCT03821909|Circulating tumor cells|circulating tumor cells
61255|NCT03821909|Exosome|exosome
61256|NCT03821896|Adolescents; Obesity; Lifestyle; Goals; Communication|adolescents; obesity; lifestyle; goals; communication
61257|NCT03821883|atrial fibrillation|atrial fibrillation
61258|NCT03821883|stroke|stroke
61259|NCT03821883|left atrial appendage closure|left atrial appendage closure
61260|NCT03821883|aspirin|aspirin
61261|NCT03821831|Obstructive sleep apnea|obstructive sleep apnea
61262|NCT03821831|Children|children
61263|NCT03821831|Orthodontic intervention|orthodontic intervention
61264|NCT03821831|Nutrition|nutrition
61265|NCT03821831|Metabolomic markers|metabolomic markers
61266|NCT03821818|Food Hypersensitivity|food hypersensitivity
61267|NCT03821818|Exercise|exercise
61268|NCT03821805|Heart rate variability|heart rate variability
61269|NCT03821805|Arterial pulse waveform|arterial pulse waveform
61270|NCT03821766|Intracavitary pressure|intracavitary pressure
61271|NCT03821766|Ballistocardiography|ballistocardiography
61272|NCT03821766|Seismocardiography|seismocardiography
61273|NCT03821766|Microaccelerations|microaccelerations
61274|NCT03821766|Kinetic energy|kinetic energy
61275|NCT03821753|Diabetic retinopathy|diabetic retinopathy
61276|NCT03821753|Glycemic variability|glycemic variability
61277|NCT03821753|Diabetes|diabetes
61278|NCT03821753|Macular retinal microcirculation|macular retinal microcirculation
61279|NCT03821753|Microangiopathy|microangiopathy
61280|NCT03821753|Cognitive dysfunction|cognitive dysfunction
61281|NCT03821714|septic shock|septic shock
61282|NCT03821714|glucocorticoid|glucocorticoid
61283|NCT03821714|vitamin C|vitamin c
61284|NCT03821714|microcirculation|microcirculation
61285|NCT03821701|Shakurba valsartan|shakurba valsartan
61286|NCT03821701|Heart failure|heart failure
61287|NCT03821701|ACEI/ARB|acei/arb
61288|NCT03821675|electrical stimulation|electrical stimulation
61289|NCT03821675|wound healing|wound healing
61290|NCT03821675|skin perfusion|skin perfusion
61291|NCT03821675|home based therapy|home based therapy
61292|NCT03821675|diabetic foot|diabetic foot
61293|NCT03821675|Foot ulcer|foot ulcer
61294|NCT03821662|Diabetes|diabetes
61295|NCT03821662|Occupational Therapy|occupational therapy
61296|NCT03821662|Interdisciplinary Teams|interdisciplinary teams
61297|NCT03821662|Diabetes Self-Management Education (DSME)|diabetes self-management education (dsme)
61298|NCT03821662|Diabetes Self-Management|diabetes self-management
61299|NCT03821649|Education|education
61300|NCT03821649|Naloxone|naloxone
61301|NCT03821649|Opioid|opioid
61302|NCT03821649|Overdose|overdose
61303|NCT03821649|Resusitation|resusitation
61304|NCT03821636|Obesity|obesity
61305|NCT03821636|Diabetes Mellitus Type 2|diabetes mellitus type 2
61306|NCT03821636|Bariatric Surgery|bariatric surgery
61307|NCT03821636|Roux-en-Y|roux-en-y
61308|NCT03821636|gastric bypass|gastric bypass
61309|NCT03821597|Fibrinolysis, sequential compression devices|fibrinolysis, sequential compression devices
61310|NCT03821584|migraine|migraine
61311|NCT03821584|perfusion arterial|perfusion arterial
61312|NCT03821584|aura brain|aura brain
61313|NCT03821571|Hypertension,primary aldosteronism|hypertension,primary aldosteronism
61314|NCT03821558|exercise|exercise
61315|NCT03821558|interval training|interval training
61316|NCT03821558|continuous training|continuous training
61317|NCT03821558|endothelial dysfunction|endothelial dysfunction
61318|NCT03821545|Anti-Inflammatory Effect|anti-inflammatory effect
61319|NCT03821545|Surgical Stress|surgical stress
61320|NCT03821545|Lidocaine|lidocaine
61321|NCT03821545|Ketamine|ketamine
61322|NCT03821545|Abdominal Surgery|abdominal surgery
61323|NCT03821532|Action Plan|action plan
61324|NCT03821532|Adherence|adherence
61325|NCT03821532|Pediatrics|pediatrics
61326|NCT03821493|PF-06651600|pf-06651600
61327|NCT03821493|Itraconazole|itraconazole
61328|NCT03821493|CYP3A4|cyp3a4
61329|NCT03821493|Drug-Drug Interaction|drug-drug interaction
61330|NCT03821480|Fluconazole|fluconazole
61331|NCT03821467|doppler optical coherence tomography|doppler optical coherence tomography
61332|NCT03821467|dynamic vessel analyzer|dynamic vessel analyzer
61333|NCT03821441|bOPV|bopv
61334|NCT03821441|IPV|ipv
61335|NCT03821441|Sequential immunization|sequential immunization
61336|NCT03821441|Immunity Duration|immunity duration
61337|NCT03821441|Booster Immunization|booster immunization
61338|NCT03821415|Keratoconjunctivitis sicca|keratoconjunctivitis sicca
61339|NCT03821415|Dry Eye Disease|dry eye disease
61340|NCT03821415|Slow-release|slow-release
61341|NCT03821415|Ophthalmology|ophthalmology
61342|NCT03821415|Topical Eye Disease|topical eye disease
61343|NCT03821402|ULS|uls
61344|NCT03821402|JUNIPER|juniper
61345|NCT03821402|DAXI for injection|daxi for injection
61346|NCT03821402|Botulinum toxin|botulinum toxin
61347|NCT03821389|Chest Physiotherapy|chest physiotherapy
61348|NCT03821389|Non-invasive|non-invasive
61349|NCT03821389|Oscillation|oscillation
61350|NCT03821389|Secretion|secretion
61351|NCT03821363|Neoplasms|neoplasms
61352|NCT03821363|Solid Tumors|solid tumors
61353|NCT03821363|Lymphoma|lymphoma
61354|NCT03821363|PD-1|pd-1
61355|NCT03821363|SCT-I10A|sct-i10a
61356|NCT03821350|Transforaminal epidural steroid injection|transforaminal epidural steroid injection
61357|NCT03821350|Radicular pain|radicular pain
61358|NCT03821337|Opioid use disorder|opioid use disorder
61359|NCT03821324|acne scarring|acne scarring
61360|NCT03821324|acne scar|acne scar
61361|NCT03821324|fractional radiofrequency|fractional radiofrequency
61362|NCT03821324|fractional RF|fractional rf
61363|NCT03821298|pain|pain
61364|NCT03821298|osteoarthritis|osteoarthritis
61365|NCT03821298|function|function
61366|NCT03821285|TB|tb
61367|NCT03821285|Pulmonary rehabilitation|pulmonary rehabilitation
61368|NCT03821285|Lung function|lung function
61369|NCT03821272|Squamous cell carcinoma|squamous cell carcinoma
61370|NCT03821233|HER2|her2
61371|NCT03821233|Bispecific antibody|bispecific antibody
61372|NCT03821233|Biparatopic antibody|biparatopic antibody
61373|NCT03821233|Immunotherapy|immunotherapy
61374|NCT03821233|Gastric cancers|gastric cancers
61375|NCT03821233|Esophageal cancers|esophageal cancers
61376|NCT03821233|Gastroesophageal junction (GEJ) cancers|gastroesophageal junction (gej) cancers
61377|NCT03821233|Breast cancer|breast cancer
61378|NCT03821233|Ovarian cancer|ovarian cancer
61379|NCT03821233|Non-small cell lung cancer|non-small cell lung cancer
61380|NCT03821233|Colorectal cancer|colorectal cancer
61381|NCT03821233|Cholangiocarcinoma|cholangiocarcinoma
61382|NCT03821220|Activity tracker; Arab population; Physical Activity|activity tracker; arab population; physical activity
61383|NCT03821207|Abdominal massage|abdominal massage
61384|NCT03821207|Exercise|exercise
61385|NCT03821207|Primary Dysmenorrhea|primary dysmenorrhea
61386|NCT03821194|pain relief|pain relief
61387|NCT03821194|complementary and alternative therapy|complementary and alternative therapy
61388|NCT03821181|pediatric moyamoya disease|pediatric moyamoya disease
61389|NCT03821181|TIA|tia
61390|NCT03821181|Stroke|stroke
61391|NCT03821181|Remote ischemic conditioning|remote ischemic conditioning
61392|NCT03821155|Vestibular Neuritis|vestibular neuritis
61393|NCT03821155|SHIMP (suppressing head impulse paradigm)|shimp (suppressing head impulse paradigm)
61394|NCT03821155|SVV (subjective visual vertical)|svv (subjective visual vertical)
61395|NCT03821155|Vestibular rehabilitation|vestibular rehabilitation
61396|NCT03821155|Prednisolone|prednisolone
61397|NCT03821155|v-HIT (video head impulse test)|v-hit (video head impulse test)
61398|NCT03821155|Vestibular Neuronitis|vestibular neuronitis
61399|NCT03821142|pelvic organ prolapse|pelvic organ prolapse
61400|NCT03821142|mesh|mesh
61401|NCT03821142|Calistar|calistar
61402|NCT03821129|Occluder|occluder
61403|NCT03821129|Patent Foramen Ovale|patent foramen ovale
61404|NCT03821129|PFO|pfo
61405|NCT03821129|Stroke|stroke
61406|NCT03821129|Gore Septal Occluder|gore septal occluder
61407|NCT03821077|Allergen immunotherapy (AIT)|allergen immunotherapy (ait)
61408|NCT03821077|Rhinitis|rhinitis
61409|NCT03821077|Rhinoconjunctivitis|rhinoconjunctivitis
61608|NCT03819621|Eye|eye
61413|NCT03821064|Patient Navigation|patient navigation
61414|NCT03821051|structural ventricular arrythmia|structural ventricular arrythmia
61415|NCT03821051|ischemic cardiomyopathy|ischemic cardiomyopathy
61416|NCT03821051|arrhythmogenic right ventricular cardiomyopathy|arrhythmogenic right ventricular cardiomyopathy
61417|NCT03821051|dilated cardiomyopathy|dilated cardiomyopathy
61418|NCT03821051|hypertrophic cardiomyopathy|hypertrophic cardiomyopathy
61419|NCT03821051|risk stratification|risk stratification
61420|NCT03821038|Sepsis|sepsis
61421|NCT03821038|IL-7|il-7
61422|NCT03821038|lymphocytopenia|lymphocytopenia
61423|NCT03820999|treatment delay|treatment delay
61424|NCT03820999|primary health care|primary health care
61425|NCT03820986|programmed cell death 1 (PD-1, PD1)|programmed cell death 1 (pd-1, pd1)
61426|NCT03820986|programmed cell death-ligand 1 (PD-L1, PDL1)|programmed cell death-ligand 1 (pd-l1, pdl1)
61427|NCT03820986|programmed cell death-ligand 2 (PD-L2, PDL2)|programmed cell death-ligand 2 (pd-l2, pdl2)
61428|NCT03820973|brief Cognitive Behavioral Therapy|brief cognitive behavioral therapy
61429|NCT03820973|VA Video Connect to home|va video connect to home
61430|NCT03820960|Thrombosis|thrombosis
61431|NCT03820947|VenaSeal|venaseal
61432|NCT03820947|Venous leg ulcer|venous leg ulcer
61433|NCT03820947|Venous reflux|venous reflux
61434|NCT03820947|Great Saphenous Vein|great saphenous vein
61435|NCT03820947|Small Sapheonus Vein|small sapheonus vein
61436|NCT03820947|Anterior Accessory Saphehnous Vein|anterior accessory saphehnous vein
61437|NCT03820934|Methotrexate|methotrexate
61438|NCT03820934|FibroScan|fibroscan
61439|NCT03820934|FibroSure|fibrosure
61440|NCT03820934|Cirrhosis|cirrhosis
61441|NCT03820934|Fibrosis|fibrosis
61442|NCT03820921|EUS-FNB, PDL1, MMR|eus-fnb, pdl1, mmr
61443|NCT03820908|relapsed AML|relapsed aml
61444|NCT03820908|refractory AML|refractory aml
61445|NCT03820895|vitamin D|vitamin d
61446|NCT03820895|Cobb angle|cobb angle
61447|NCT03820895|alkaline phosphatase|alkaline phosphatase
61448|NCT03820856|Lateral Epicondylitis|lateral epicondylitis
61449|NCT03820856|Tennis Elbow|tennis elbow
61450|NCT03820856|Acupuncture|acupuncture
61451|NCT03820856|Fire needle|fire needle
61452|NCT03820843|brain connectivity|brain connectivity
61453|NCT03820843|aphasia|aphasia
61454|NCT03820843|art therapy|art therapy
61455|NCT03820843|rehabilitation|rehabilitation
61459|NCT03820765|Hemodialyis, Peritonealdialysis, Qualitiy assurance dialysis|hemodialyis, peritonealdialysis, qualitiy assurance dialysis
61460|NCT03820700|Virtual Reality|virtual reality
61461|NCT03820700|Hypnosis|hypnosis
61462|NCT03820700|Intensive care units|intensive care units
61463|NCT03820700|Cardiac surgery|cardiac surgery
61464|NCT03820700|Anxiety|anxiety
61465|NCT03820700|Pain|pain
61466|NCT03820700|Cognition and perception|cognition and perception
61467|NCT03820700|Recovery|recovery
61468|NCT03820674|Heart Failure|heart failure
61469|NCT03820674|Fatigue|fatigue
61470|NCT03820674|Rehabilitation|rehabilitation
61471|NCT03820674|Occupational Therapy|occupational therapy
61472|NCT03820622|coronary artery stenosis|coronary artery stenosis
61473|NCT03820622|drug eluting balloon|drug eluting balloon
61474|NCT03820622|bifurcation|bifurcation
61475|NCT03820609|Sexual Assault|sexual assault
61476|NCT03820609|Digital Intervention|digital intervention
61477|NCT03820596|Sintilimab|sintilimab
61478|NCT03820596|Chidamide|chidamide
61479|NCT03820596|refractory and relapsed|refractory and relapsed
400575|NCT01866215|de novo lipogenesis|de novo lipogenesis
61480|NCT03820596|Extranodal natural killer cell/T-cell lymphoma|extranodal natural killer cell/t-cell lymphoma
61481|NCT03820583|Whipple procedure, pancreatic carcinoma, biliary stenting,|whipple procedure, pancreatic carcinoma, biliary stenting,
61482|NCT03820531|DNA Mutational Analysis|dna mutational analysis
61483|NCT03820531|Cyst Fluid|cyst fluid
61484|NCT03820531|Pancreas|pancreas
61485|NCT03820505|obstetrics|obstetrics
61486|NCT03820505|pre-hospital emergencies unannounced delivery outside maternity,|pre-hospital emergencies unannounced delivery outside maternity,
61487|NCT03820505|mortality-morbidity|mortality-morbidity
61488|NCT03820505|reinforcement midwife in pre-hospital|reinforcement midwife in pre-hospital
61489|NCT03820492|Coronary artery disease|coronary artery disease
61490|NCT03820492|Fractional flow reserve|fractional flow reserve
61491|NCT03820492|Optical coherence tomography|optical coherence tomography
61492|NCT03820492|Computed tomography angiography|computed tomography angiography
61493|NCT03820479|Quality of recovery|quality of recovery
61494|NCT03820479|PONV|ponv
61495|NCT03820479|PDNV|pdnv
61496|NCT03820466|Aspirin|aspirin
61497|NCT03820466|Atorvastatin|atorvastatin
61498|NCT03820466|Troponin|troponin
61499|NCT03820440|End-expiratory occlusion test|end-expiratory occlusion test
61500|NCT03820440|Lung Recruitment Manovre|lung recruitment manovre
61501|NCT03820440|Fluid responsiveness|fluid responsiveness
61502|NCT03820440|Functional Hemodynamic Test|functional hemodynamic test
61503|NCT03820414|VZV, Vaccine, Shingles|vzv, vaccine, shingles
61504|NCT03820401|hemodialyzer|hemodialyzer
61505|NCT03820401|fibre clotting|fibre clotting
61506|NCT03820388|Etomidate|etomidate
61507|NCT03820388|Propofol|propofol
61508|NCT03820375|Stroke|stroke
61509|NCT03820375|ESUS|esus
61510|NCT03820375|PFO|pfo
61511|NCT03820375|PFO closure|pfo closure
61512|NCT03820375|ICM|icm
61513|NCT03820362|personal identity|personal identity
61514|NCT03820362|personal constructs|personal constructs
61515|NCT03820349|CFRD|cfrd
61516|NCT03820349|Cystic fibrosis|cystic fibrosis
61517|NCT03820310|malignancy|malignancy
61518|NCT03820310|intrahepatic cholangiocarcinoma|intrahepatic cholangiocarcinoma
61519|NCT03820271|Liver transplantation|liver transplantation
61520|NCT03820271|Predictive prognostic models|predictive prognostic models
61521|NCT03820271|Decompensated cirrhosis|decompensated cirrhosis
61522|NCT03820245|Carotenoid|carotenoid
61523|NCT03820245|LDL oxidation|ldl oxidation
61524|NCT03820245|Cardiovascular disease|cardiovascular disease
61525|NCT03820245|Antioxidant|antioxidant
61526|NCT03820232|Intraoperative, Hypothermia|intraoperative, hypothermia
61527|NCT03820219|spine|spine
61528|NCT03820219|surgical dressing|surgical dressing
61529|NCT03820219|negative pressure therapy|negative pressure therapy
61530|NCT03820219|surgical infection|surgical infection
61531|NCT03820180|bioequivalence|bioequivalence
61532|NCT03820180|fluticasone propionate|fluticasone propionate
61533|NCT03820180|salmeterol xinafoate|salmeterol xinafoate
61534|NCT03820180|ADVAIR|advair
61535|NCT03820063|neo adjuvant|neo adjuvant
61536|NCT03820063|HER2 positive|her2 positive
61537|NCT03820063|de-escalation|de-escalation
61538|NCT03820011|participation|participation
61539|NCT03820011|environment|environment
61540|NCT03820011|goal setting|goal setting
61541|NCT03819959|Pilot Trial|pilot trial
61542|NCT03819959|Muscle Biopsy|muscle biopsy
61543|NCT03819959|Blood Metabolome|blood metabolome
61544|NCT03819946|Oesophageal protection|oesophageal protection
61545|NCT03819946|Ablation-related thermal injury|ablation-related thermal injury
61546|NCT03819946|Catheter ablation for AF|catheter ablation for af
61547|NCT03819946|Persistent AF ablation|persistent af ablation
61548|NCT03819933|Counseling|counseling
61549|NCT03819933|Extreme Prematurity|extreme prematurity
61550|NCT03819920|cancer screening beliefs|cancer screening beliefs
61551|NCT03819920|colorectal cancer screening|colorectal cancer screening
61552|NCT03819894|myocardial infarction|myocardial infarction
61553|NCT03819894|sex differences|sex differences
61554|NCT03819894|high-sensitivity cardiac troponin|high-sensitivity cardiac troponin
61555|NCT03819894|biomarkers|biomarkers
61556|NCT03819894|heart attack|heart attack
61557|NCT03819894|emergency department|emergency department
61558|NCT03819894|acute coronary syndrome|acute coronary syndrome
61559|NCT03819868|dental caries|dental caries
61560|NCT03819868|molars|molars
61561|NCT03819868|Pit and Fissure Sealants|pit and fissure sealants
61562|NCT03819842|cataract surgery|cataract surgery
61563|NCT03819842|cataract|cataract
61564|NCT03819842|toric IOL|toric iol
61565|NCT03819816|informal caregivers|informal caregivers
61566|NCT03819816|person with dementia|person with dementia
61567|NCT03819816|e-health solution|e-health solution
61568|NCT03819790|Diabetes, type 2|diabetes, type 2
61569|NCT03819790|GLP-1 RA|glp-1 ra
61570|NCT03819790|Insulin glargine|insulin glargine
61571|NCT03819790|Glucose variability|glucose variability
61572|NCT03819790|Insulin Titration|insulin titration
61573|NCT03819790|South Asians|south asians
61574|NCT03819764|stroke|stroke
61575|NCT03819764|aerobic exercise|aerobic exercise
61576|NCT03819764|forced exercise|forced exercise
61577|NCT03819764|repetitive task practice|repetitive task practice
61578|NCT03819764|arm function|arm function
61579|NCT03819764|upper extremity|upper extremity
61580|NCT03819751|prostatic neoplasms|prostatic neoplasms
61581|NCT03819751|biopsy|biopsy
61582|NCT03819751|Multimodal Imaging|multimodal imaging
61583|NCT03819751|prostate|prostate
61584|NCT03819738|fMRI|fmri
61585|NCT03819738|epilepsy|epilepsy
61586|NCT03819738|pain|pain
61587|NCT03819738|electrode|electrode
61588|NCT03819738|brain|brain
61589|NCT03819738|neuromodulation|neuromodulation
61590|NCT03819738|DBS|dbs
61591|NCT03819725|Glucose variation|glucose variation
61592|NCT03819725|Infant|infant
61593|NCT03819725|Nutrition|nutrition
61594|NCT03819725|interstitial glucose variation|interstitial glucose variation
61595|NCT03819686|end stage renal disease|end stage renal disease
61596|NCT03819686|ESRD|esrd
61597|NCT03819686|living donor kidney transplantation|living donor kidney transplantation
61598|NCT03819686|LDKT|ldkt
61599|NCT03819686|African American|african american
61600|NCT03819673|Personalised|personalised
61601|NCT03819673|Nutrition|nutrition
61602|NCT03819673|Intervention|intervention
61603|NCT03819673|Children|children
61604|NCT03819673|Obesity|obesity
61605|NCT03819673|Health professionals|health professionals
61606|NCT03819660|Type 3|type 3
61609|NCT03819621|Enucleation|enucleation
61610|NCT03819608|mTBI|mtbi
61611|NCT03819608|PTSD|ptsd
61612|NCT03819608|intermittent theta burst stimulation|intermittent theta burst stimulation
61613|NCT03819608|cognitive training|cognitive training
61614|NCT03819608|neuroimaging|neuroimaging
61615|NCT03819569|genomic risk assessment|genomic risk assessment
61616|NCT03819569|small renal mass|small renal mass
61617|NCT03819556|Cow milk allergy|cow milk allergy
61618|NCT03819556|Oral immune therapy|oral immune therapy
61619|NCT03819556|Basophil activation test|basophil activation test
61620|NCT03819556|IgE|ige
61621|NCT03819556|Microbiome|microbiome
61622|NCT03819556|Quality of life|quality of life
61623|NCT03819517|COPD|copd
61624|NCT03819504|Structural Heart Disease|structural heart disease
61625|NCT03819504|Ventricular Tachycardia|ventricular tachycardia
61626|NCT03819504|Substrate Ablation|substrate ablation
61627|NCT03819504|Stereotactic Radiosurgery|stereotactic radiosurgery
61628|NCT03819504|Functional Radiosurgery|functional radiosurgery
61629|NCT03819504|4D navigation|4d navigation
61630|NCT03819491|COQUN|coqun
61631|NCT03819491|antioxidant|antioxidant
61632|NCT03819491|Bioavailability|bioavailability
61633|NCT03819491|CoQ10|coq10
61634|NCT03819491|Healthy|healthy
61635|NCT03819465|First-Line Stage IV Metastatic Non-Small Cell Lung Cancer|first-line stage iv metastatic non-small cell lung cancer
61636|NCT03819465|Stage IV Metastatic Non-Small Cell Lung Cancer|stage iv metastatic non-small cell lung cancer
61637|NCT03819465|Metastatic Non-Small Cell Lung Cancer|metastatic non-small cell lung cancer
61638|NCT03819465|Non-Small Cell Lung Cancer|non-small cell lung cancer
61639|NCT03819465|Non-Small Cell Lung|non-small cell lung
61640|NCT03819465|Non-Small Cell|non-small cell
61641|NCT03819465|NSCLC|nsclc
61642|NCT03819465|Non-Small Cell Lung Carcinoma|non-small cell lung carcinoma
61643|NCT03819452|vitamin D|vitamin d
61644|NCT03819452|Ischemic Stroke|ischemic stroke
61645|NCT03819439|autism|autism
61646|NCT03819439|microbiome|microbiome
61647|NCT03819439|mycobiome|mycobiome
61648|NCT03819439|bacteria|bacteria
61649|NCT03819439|fungi|fungi
61650|NCT03819413|Neuromyelitis Optica Spectrum Disorder|neuromyelitis optica spectrum disorder
61651|NCT03819413|prevalence|prevalence
61652|NCT03819413|anti-AQP4|anti-aqp4
61653|NCT03819413|anti-MOG|anti-mog
61654|NCT03819400|kidney graft|kidney graft
61655|NCT03819400|fibrosis|fibrosis
61656|NCT03819400|elastography|elastography
61657|NCT03819361|Night-to-night variability|night-to-night variability
61658|NCT03819361|Apnoea-Hypopnoea Index|apnoea-hypopnoea index
61659|NCT03819361|Oxygen Desaturation Index|oxygen desaturation index
61660|NCT03819361|Pulse-oximetry|pulse-oximetry
61661|NCT03819335|Diabetes Mellitus, Type 1|diabetes mellitus, type 1
61662|NCT03819335|Mobile Applications|mobile applications
61663|NCT03819335|Telemedicine|telemedicine
61664|NCT03819309|tubo ovarian abscess|tubo ovarian abscess
61665|NCT03819309|transvaginal aspiration|transvaginal aspiration
61666|NCT03819309|laparoscopy|laparoscopy
61667|NCT03819283|fatty liver, coronary artery disease, atherosclerosis|fatty liver, coronary artery disease, atherosclerosis
61668|NCT03819244|Diode Laser|diode laser
61669|NCT03819244|Erbium Laser|erbium laser
61670|NCT03819244|Second-stage Implant Surgery|second-stage implant surgery
61671|NCT03819231|Mindfulness|mindfulness
61672|NCT03819231|Oxytocin|oxytocin
61673|NCT03819205|cerebral palsy|cerebral palsy
61674|NCT03819205|upper extremity kinesiotaping|upper extremity kinesiotaping
61675|NCT03819205|modified house|modified house
61676|NCT03819140|Hyperandrogenism|hyperandrogenism
61677|NCT03819140|Oral Contraceptive Pills|oral contraceptive pills
61678|NCT03819114|Levonorgestrel|levonorgestrel
61679|NCT03819114|Pharmacokinetics|pharmacokinetics
61680|NCT03819114|Efavirenz|efavirenz
61681|NCT03819114|Dolutegravir|dolutegravir
61682|NCT03819114|Rifampin|rifampin
61683|NCT03819075|laser|laser
61684|NCT03819075|Er:YAG|er:yag
61685|NCT03819075|Nd:YAG|nd:yag
61686|NCT03819075|periimplantitis|periimplantitis
61687|NCT03819075|randomized controlled trial|randomized controlled trial
61688|NCT03819062|Constipation|constipation
61689|NCT03819062|spinal cord injury|spinal cord injury
61690|NCT03819062|back pain|back pain
61691|NCT03819062|High-Resolution Colonic Manometry|high-resolution colonic manometry
61692|NCT03819062|Anorectal Manometry|anorectal manometry
61693|NCT03819036|Dental emergency|dental emergency
61694|NCT03819036|Toothache|toothache
61695|NCT03819036|Tooth pain|tooth pain
61696|NCT03818971|retina AND electroretinogram|retina and electroretinogram
61697|NCT03818906|Photochemotherapy|photochemotherapy
61698|NCT03818893|Cancer immunotherapy|cancer immunotherapy
61699|NCT03818880|Myopia|myopia
61700|NCT03818880|Myopia control|myopia control
61701|NCT03818867|cervical cerclage|cervical cerclage
61702|NCT03818867|Preterm Birth|preterm birth
61703|NCT03818867|Twin pregnancy|twin pregnancy
61704|NCT03818867|Twin to Twin Transfusion Syndrome|twin to twin transfusion syndrome
61705|NCT03818854|Human Mesenchymal Stromal Cells|human mesenchymal stromal cells
61706|NCT03818854|Acute Respiratory Distress Syndrome|acute respiratory distress syndrome
61711|NCT03818802|NAD precursors|nad precursors
61712|NCT03818802|Aging|aging
61713|NCT03818776|Durvalumab|durvalumab
61714|NCT03818776|PARTICLE-D|particle-d
61715|NCT03818737|mesenchymal stem cells|mesenchymal stem cells
61716|NCT03818737|corticosteroids|corticosteroids
61717|NCT03818737|bone marrow aspiration|bone marrow aspiration
61718|NCT03818737|adipose-derived stromal vascular fraction|adipose-derived stromal vascular fraction
61719|NCT03818724|Atrial Fibrillation|atrial fibrillation
61720|NCT03818724|Paroxysmal Atrial Fibrillation|paroxysmal atrial fibrillation
61721|NCT03818724|Persistent Atrial Fibrillation|persistent atrial fibrillation
61722|NCT03818724|Cryoablation|cryoablation
61723|NCT03818724|Cryosurgery|cryosurgery
61724|NCT03818685|Residual disease with RCB of Class III|residual disease with rcb of class iii
61725|NCT03818646|Exacerbation|exacerbation
61726|NCT03818646|Functional respiratory imaging|functional respiratory imaging
61729|NCT03818568|chronic kidney disease|chronic kidney disease
61730|NCT03818568|ketoanalogue|ketoanalogue
61731|NCT03818568|diabetes|diabetes
61732|NCT03818542|Head and Neck Squamous Cell Carcinoma|head and neck squamous cell carcinoma
61733|NCT03818542|Cancer|cancer
61734|NCT03818542|ABBV-927|abbv-927
61735|NCT03818542|ABBV-368|abbv-368
61736|NCT03818542|ABBV-181|abbv-181
61737|NCT03818542|tumor resection|tumor resection
61738|NCT03818542|immunotherapeutic drug|immunotherapeutic drug
61739|NCT03818529|Hemophilia|hemophilia
61740|NCT03818529|Previously Untreated Patients (PUPs)|previously untreated patients (pups)
61741|NCT03818529|Clotting Factor Replacement Products|clotting factor replacement products
61742|NCT03818529|Haemophilia|haemophilia
61743|NCT03818516|Inflammation|inflammation
61744|NCT03818516|Magnetic Resonance Imaging (MRI)|magnetic resonance imaging (mri)
61745|NCT03818516|Negative Symptoms|negative symptoms
61746|NCT03818490|Aromatherapy|aromatherapy
61747|NCT03818490|Essential Oils|essential oils
61748|NCT03818490|Children|children
61749|NCT03818464|pre-operative assessment|pre-operative assessment
61750|NCT03818464|postoperative pain|postoperative pain
61751|NCT03818464|biological complications|biological complications
61752|NCT03818451|Moderate brain trauma|moderate brain trauma
61753|NCT03818451|Glialia|glialia
61754|NCT03818451|Neuroinflammation|neuroinflammation
61755|NCT03818451|Neuroprotection|neuroprotection
61756|NCT03818438|Chronic instability|chronic instability
61757|NCT03818438|Strength|strength
61758|NCT03818438|Proprioception|proprioception
61759|NCT03818438|Rehabilitation|rehabilitation
61760|NCT03818438|Ankle|ankle
61761|NCT03818438|Balance|balance
61762|NCT03818425|Anxiety|anxiety
61763|NCT03818425|Posttraumatic Stress Disorder|posttraumatic stress disorder
61764|NCT03818412|Circulating tumor DNA|circulating tumor dna
61765|NCT03818386|gadolinium nanoparticles|gadolinium nanoparticles
61766|NCT03818386|AGuIX|aguix
61767|NCT03818373|Univentricular congenital heart|univentricular congenital heart
61768|NCT03818373|Sleep apnea|sleep apnea
61769|NCT03818373|Polysomnography|polysomnography
61770|NCT03818373|Respiratory drive|respiratory drive
61771|NCT03818373|VE/VCO2 slope|ve/vco2 slope
61772|NCT03818360|Smoking cessation intervention|smoking cessation intervention
61773|NCT03818360|Evidence-based|evidence-based
61774|NCT03818360|Brief advice|brief advice
61775|NCT03818360|Active referrals|active referrals
61776|NCT03818360|Emergency departments|emergency departments
61777|NCT03818347|Solid tumor|solid tumor
61778|NCT03818347|Hydrogen gas|hydrogen gas
61779|NCT03818334|Bone Marrow Transplantation|bone marrow transplantation
61780|NCT03818334|Hematological Malignancies|hematological malignancies
61781|NCT03818334|Post-Cy|post-cy
61783|NCT03818256|Antipsychotic-induced weight gain (AIWG)|antipsychotic-induced weight gain (aiwg)
61784|NCT03818256|Obesity|obesity
61785|NCT03818256|Weight Gain|weight gain
61786|NCT03818256|Mental disorders|mental disorders
61787|NCT03818256|Schizophrenia|schizophrenia
61788|NCT03818256|Risperidone|risperidone
61789|NCT03818256|Quetiapine|quetiapine
61790|NCT03818256|Olanzapine|olanzapine
61791|NCT03818243|Parkinson disease|parkinson disease
61792|NCT03818243|Restless Leg Syndrome|restless leg syndrome
61793|NCT03818243|Impulse control disorders|impulse control disorders
61794|NCT03818243|circadian rhythm|circadian rhythm
61795|NCT03818230|Clinical trials|clinical trials
61796|NCT03818230|Early phase clinical trials|early phase clinical trials
61797|NCT03818230|Experimental cancer medicine|experimental cancer medicine
61798|NCT03818217|socially assistive robot|socially assistive robot
61799|NCT03818217|humanoid robot|humanoid robot
61800|NCT03818217|motivation|motivation
61801|NCT03818217|home care|home care
61802|NCT03818217|cognitive training|cognitive training
62491|NCT03813797|Laparoscopy|laparoscopy
61803|NCT03818217|physical training|physical training
61804|NCT03818217|caregivers|caregivers
61805|NCT03818217|dementia trainers|dementia trainers
61806|NCT03818217|Computers, handheld|computers, handheld
61807|NCT03818165|pancreatic carcinoma|pancreatic carcinoma
61808|NCT03818165|Cacinomaembryonic antigen postive (CEA +)|cacinomaembryonic antigen postive (cea +)
61809|NCT03818165|liver metastases|liver metastases
61810|NCT03818165|pancreatic cancer|pancreatic cancer
61811|NCT03818165|CEA|cea
61812|NCT03818165|metastatic pancreatic carcinoma|metastatic pancreatic carcinoma
61813|NCT03818165|metastatic pancreatic cancer|metastatic pancreatic cancer
61814|NCT03818165|phase 1|phase 1
61815|NCT03818152|Cerebral palsy|cerebral palsy
61816|NCT03818152|Children|children
61817|NCT03818152|Functional strength measurement|functional strength measurement
61818|NCT03818152|Lower limbs|lower limbs
61819|NCT03818152|Reproducability|reproducability
61820|NCT03818139|diagnostic imaging, Newborn, Intubation, Ultrasonography methods|diagnostic imaging, newborn, intubation, ultrasonography methods
61821|NCT03818126|del Nido|del nido
61822|NCT03818126|cardioplegia|cardioplegia
61823|NCT03818126|aortic valve|aortic valve
61824|NCT03818113|mitral valve insufficiency|mitral valve insufficiency
61825|NCT03818113|cardioplegia|cardioplegia
61826|NCT03818113|cardioplegia Solution|cardioplegia solution
61827|NCT03818113|HTK-Bretschneider (Custidiol®) solution|htk-bretschneider (custidiol®) solution
61828|NCT03818113|St. Thomas solution|st. thomas solution
61829|NCT03818113|cardiac biomarker|cardiac biomarker
61830|NCT03818087|Breast Cancer|breast cancer
61831|NCT03818074|High Frequency spinal cord stimulation|high frequency spinal cord stimulation
61832|NCT03818061|Atezolizumab|atezolizumab
61833|NCT03818061|Bevacizumab|bevacizumab
61834|NCT03818048|sedation|sedation
61835|NCT03818048|colonoscopy|colonoscopy
61836|NCT03818022|knee|knee
61837|NCT03818022|joint replacement|joint replacement
61838|NCT03818022|total knee|total knee
61839|NCT03818022|cryoneurolysis|cryoneurolysis
61840|NCT03818022|Iovera|iovera
61841|NCT03818022|TKA|tka
61842|NCT03818022|pain|pain
61843|NCT03818009|Cognitive function postoperative|cognitive function postoperative
61844|NCT03817996|High flow nasal cannula|high flow nasal cannula
61845|NCT03817996|Nasal high flow|nasal high flow
61846|NCT03817996|Plethysmographic variation index|plethysmographic variation index
61847|NCT03817996|Fluid responsiveness|fluid responsiveness
61848|NCT03817970|Nephrotoxicity|nephrotoxicity
61849|NCT03817970|Cisplatin|cisplatin
61850|NCT03817970|Kidney Injury|kidney injury
61851|NCT03817970|anti-emetics|anti-emetics
61852|NCT03817957|post surgery anemia treatment,|post surgery anemia treatment,
61853|NCT03817944|potato consumption|potato consumption
61854|NCT03817944|CHNS|chns
61855|NCT03817944|mortality|mortality
61856|NCT03817944|fried potato|fried potato
61857|NCT03817944|sweet potato|sweet potato
61858|NCT03817905|Colonoscopy|colonoscopy
61859|NCT03817905|Fecal Immunochemical Testing|fecal immunochemical testing
61860|NCT03817892|No-Flow|no-flow
61861|NCT03817892|Chest Compression Fraction|chest compression fraction
61862|NCT03817892|Out Hospital|out hospital
61863|NCT03817892|External Chest Compression Relay|external chest compression relay
61864|NCT03817892|External Chest Compression Guidance|external chest compression guidance
61865|NCT03817892|External Chest Compression Quality|external chest compression quality
61866|NCT03817892|Correct Compression Score|correct compression score
61867|NCT03817866|Endocrine tumors|endocrine tumors
61868|NCT03817866|Carcinoids|carcinoids
61869|NCT03817866|Functional NETs|functional nets
61870|NCT03817866|Non-functional NETs|non-functional nets
61871|NCT03817866|Immunoassay|immunoassay
61872|NCT03817840|Glucocorticoids|glucocorticoids
61873|NCT03817827|sports injury|sports injury
818044|NCT00167778|Walking|walking
61874|NCT03817827|female athlete triad|female athlete triad
61875|NCT03817827|acupuncture|acupuncture
61876|NCT03817814|Quality of Life|quality of life
61877|NCT03817814|Web-based questionnaire|web-based questionnaire
61878|NCT03817814|18-461|18-461
61879|NCT03817775|Music therapy|music therapy
61880|NCT03817775|sedation|sedation
61881|NCT03817775|coronary angioplasty|coronary angioplasty
61882|NCT03817762|pediatric obstructive sleep apnea hypopnea syndrome|pediatric obstructive sleep apnea hypopnea syndrome
61883|NCT03817762|pediatric respiratory polygraphy|pediatric respiratory polygraphy
61884|NCT03817762|device acceptance|device acceptance
61885|NCT03817762|signal quality|signal quality
61886|NCT03817762|automatic detection of respiratory events|automatic detection of respiratory events
61887|NCT03817749|Flow mediated dilation|flow mediated dilation
61888|NCT03817749|Glucose control|glucose control
61889|NCT03817749|Inflammation|inflammation
61890|NCT03817749|Immune cell function|immune cell function
61891|NCT03817749|Cognition|cognition
61892|NCT03817749|Oxidative stress|oxidative stress
61893|NCT03817749|Cardiovascular function|cardiovascular function
61894|NCT03817736|HCC|hcc
61895|NCT03817736|START-FIT|start-fit
61896|NCT03817736|TACE|tace
61897|NCT03817736|SBRT|sbrt
61898|NCT03817736|immunotherapy|immunotherapy
61899|NCT03817736|hepatectomy|hepatectomy
61900|NCT03817736|hepatocellular carcinoma|hepatocellular carcinoma
61901|NCT03817736|liver cancer|liver cancer
61902|NCT03817723|Radiation dose|radiation dose
61903|NCT03817723|cholangiography|cholangiography
61904|NCT03817723|Cholecystectomy|cholecystectomy
61905|NCT03817710|tics disorder in childern with acute deficit hyper activity syndrom|tics disorder in childern with acute deficit hyper activity syndrom
61906|NCT03817671|Thawed blastocyst|thawed blastocyst
61907|NCT03817671|ultra low oxygen tension|ultra low oxygen tension
61908|NCT03817671|2%O2|2%o2
61909|NCT03817671|Degree of expansion|degree of expansion
61910|NCT03817645|Zeolite|zeolite
61911|NCT03817632|Navigation|navigation
61912|NCT03817632|Computer Assisted Orthopedic Surgery|computer assisted orthopedic surgery
61913|NCT03817632|OrthoPilot®|orthopilot®
61914|NCT03817632|Total Knee Arthroplasty|total knee arthroplasty
61915|NCT03817593|meditation|meditation
61916|NCT03817593|heart rate variability|heart rate variability
61917|NCT03817593|ADD|add
61918|NCT03817593|ADHD|adhd
61919|NCT03817593|children|children
61920|NCT03817567|Carcinoma|carcinoma
61921|NCT03817567|Carcinoma, Squamous Cell|carcinoma, squamous cell
61922|NCT03817567|Esophageal Neoplasms|esophageal neoplasms
61923|NCT03817567|Neoplasms, Squamous Cell|neoplasms, squamous cell
61924|NCT03817567|Esophageal Diseases|esophageal diseases
61925|NCT03817567|Epidermal growth factor receptor|epidermal growth factor receptor
61926|NCT03817567|EGFR|egfr
61927|NCT03817567|SCT200|sct200
61928|NCT03817554|Pramipexole,|pramipexole,
61929|NCT03817554|Restless Leg Syndrome|restless leg syndrome
61930|NCT03817554|Peritoneal Dialysis|peritoneal dialysis
61931|NCT03817489|Colorectal Cancer Survivors|colorectal cancer survivors
61932|NCT03817489|Qigong|qigong
61933|NCT03817489|Mindfulness meditation|mindfulness meditation
61934|NCT03817489|Randomized controlled trial|randomized controlled trial
61935|NCT03817489|Cortisol|cortisol
61936|NCT03817450|Mouth Care|mouth care
61937|NCT03817437|Oral health|oral health
61938|NCT03817437|Odontology|odontology
61939|NCT03817437|Epidemiology|epidemiology
61940|NCT03817437|Public health|public health
61941|NCT03817437|Deprivation|deprivation
61942|NCT03817385|Transcranial magnetic stimulation|transcranial magnetic stimulation
61943|NCT03817385|Robotic gait training|robotic gait training
61944|NCT03817385|Gait|gait
61945|NCT03817385|Spasticity|spasticity
61946|NCT03817372|Cardioversion|cardioversion
61947|NCT03817372|Electrode position|electrode position
61948|NCT03817359|propofol|propofol
61949|NCT03817359|remifentanil|remifentanil
61950|NCT03817359|total intravenous anesthesia|total intravenous anesthesia
61951|NCT03817359|breast surgery|breast surgery
61952|NCT03817346|Safety|safety
61953|NCT03817346|Tolerability|tolerability
61954|NCT03817346|Pharmacokinetics|pharmacokinetics
61955|NCT03817333|phenotype|phenotype
61956|NCT03817333|inflammation|inflammation
61957|NCT03817333|pulmonary function|pulmonary function
61958|NCT03817333|comorbidities|comorbidities
61959|NCT03817242|Cartilage|cartilage
61960|NCT03817242|Hearing loss|hearing loss
61961|NCT03817242|Tympanoplasty|tympanoplasty
61962|NCT03817229|adherence|adherence
61963|NCT03817229|mHealth|mhealth
61964|NCT03817229|eHealth|ehealth
61965|NCT03817229|children|children
61966|NCT03817229|caregivers|caregivers
61967|NCT03817229|compliance|compliance
61968|NCT03817216|Prostatic Urethral Lift (PUL)|prostatic urethral lift (pul)
61969|NCT03817138|Primary Care|primary care
61970|NCT03817138|Disease Progression|disease progression
61971|NCT03817138|Electronic Health Records|electronic health records
61972|NCT03817138|Medical Records|medical records
61973|NCT03817138|Prognosis|prognosis
61974|NCT03817125|Metastatic Melanoma|metastatic melanoma
61975|NCT03817125|anti-PD1|anti-pd1
61976|NCT03817125|Nivolumab|nivolumab
61977|NCT03817125|Microbiome|microbiome
61978|NCT03817125|SER-401|ser-401
61979|NCT03817112|cerebral oxygen saturation|cerebral oxygen saturation
61980|NCT03817112|cardiopulmonary bypass|cardiopulmonary bypass
61981|NCT03817112|dexmedetomidine|dexmedetomidine
61982|NCT03817112|propofol|propofol
61983|NCT03817060|OHSS|ohss
61984|NCT03817060|Agonist trigger|agonist trigger
61985|NCT03817060|freeze-all|freeze-all
61986|NCT03817060|blastocyst|blastocyst
61987|NCT03817060|cleavage|cleavage
61988|NCT03817047|Adolescents|adolescents
61989|NCT03817047|Physical activity|physical activity
61990|NCT03817047|Physical fitness|physical fitness
61991|NCT03817047|Academic performance|academic performance
61992|NCT03817047|Cluster RCT|cluster rct
61993|NCT03817047|Mental health|mental health
61994|NCT03817047|Secondary school|secondary school
61995|NCT03817047|Physical education|physical education
61996|NCT03817047|Physical active educational lessons|physical active educational lessons
61997|NCT03817047|Accelerometer|accelerometer
61998|NCT03817034|multimodal|multimodal
61999|NCT03817034|dexmedetomidine|dexmedetomidine
62000|NCT03817034|ropivacaine|ropivacaine
62001|NCT03817034|ketorolac|ketorolac
62002|NCT03817034|pain management|pain management
62003|NCT03817034|opioid sparing|opioid sparing
62004|NCT03817034|analgesia|analgesia
62005|NCT03817021|Responsive parenting|responsive parenting
62006|NCT03817021|Children's Appetite Self-Regulation|children's appetite self-regulation
62007|NCT03817021|Early Childhood Education|early childhood education
62008|NCT03816995|wound irrigation|wound irrigation
62009|NCT03816995|cleancision|cleancision
62010|NCT03816995|colorectal surgery|colorectal surgery
62011|NCT03816969|Self-pressurized Air Q|self-pressurized air q
62012|NCT03816956|Staphylococcus aureus|staphylococcus aureus
62013|NCT03816956|S. aureus|s. aureus
62014|NCT03816956|monoclonal antibody|monoclonal antibody
62015|NCT03816956|Aridis|aridis
62016|NCT03816956|VAP|vap
62017|NCT03816956|ventilator acquired pneumonia|ventilator acquired pneumonia
62018|NCT03816956|infection|infection
62019|NCT03816956|pneumonia|pneumonia
62020|NCT03816956|AR301|ar301
62021|NCT03816943|fixed appliances|fixed appliances
62022|NCT03816943|orthodontics|orthodontics
62023|NCT03816943|quality of life|quality of life
62024|NCT03816943|anxiety|anxiety
62025|NCT03816943|pain|pain
62026|NCT03816943|instant messaging|instant messaging
62027|NCT03816943|telephone call|telephone call
62028|NCT03816930|CAD/CAM|cad/cam
62029|NCT03816930|Gingival retraction|gingival retraction
62030|NCT03816917|Screening|screening
62031|NCT03816917|Prediction Model|prediction model
62032|NCT03816852|Premature Ovarian Failure|premature ovarian failure
62033|NCT03816852|Premature Ovarian Insufficiency|premature ovarian insufficiency
62034|NCT03816852|mesenchymal stem cell|mesenchymal stem cell
62035|NCT03816800|Allergy|allergy
62036|NCT03816800|iron-deficiency|iron-deficiency
62037|NCT03816800|birch|birch
62038|NCT03816800|grass|grass
62039|NCT03816787|Cupping Therapy|cupping therapy
62040|NCT03816787|Near Infrared Spectroscopy|near infrared spectroscopy
62041|NCT03816774|screening colonoscopy|screening colonoscopy
62042|NCT03816774|colo-rectal cancer|colo-rectal cancer
62043|NCT03816774|simethicone|simethicone
62044|NCT03816774|split-dose polyethylene glycol|split-dose polyethylene glycol
62045|NCT03816774|adequate bowel preparation|adequate bowel preparation
62046|NCT03816748|Minimally invasive surgery, High flow nasal cannula|minimally invasive surgery, high flow nasal cannula
62047|NCT03816709|heating rates|heating rates
62048|NCT03816709|therapeutic ultrasound|therapeutic ultrasound
62049|NCT03816696|GSK3640254, dolutegravir, healthy subjects, two-way interaction, HIV|gsk3640254, dolutegravir, healthy subjects, two-way interaction, hiv
62050|NCT03816683|Mantle Cell Lymphoma|mantle cell lymphoma
62051|NCT03816683|Registry|registry
62052|NCT03816644|Cognitive screening|cognitive screening
62053|NCT03816644|Primary care|primary care
62054|NCT03816644|Dementia|dementia
62055|NCT03816644|Cognitive Impairment|cognitive impairment
62056|NCT03816644|Mild Cognitive Impairment|mild cognitive impairment
62057|NCT03816618|purilon gel|purilon gel
62058|NCT03816618|medihoney|medihoney
62059|NCT03816618|fucidine|fucidine
62060|NCT03816605|GDM|gdm
62061|NCT03816605|IRS-1|irs-1
62062|NCT03816605|GLUT-1|glut-1
62063|NCT03816501|postoperative anxiety|postoperative anxiety
62064|NCT03816501|State - Trait Anxiety Inventory|state - trait anxiety inventory
62065|NCT03816488|Metformin|metformin
62066|NCT03816488|Salsalate|salsalate
62067|NCT03816475|Dose Hypofractionation|dose hypofractionation
62068|NCT03816475|Neoadjuvant Therapy|neoadjuvant therapy
62069|NCT03816475|Sarcoma|sarcoma
62070|NCT03816475|Dose Fractionation|dose fractionation
62071|NCT03816475|Dose-Response Relationship|dose-response relationship
62072|NCT03816436|clavicle non-unions|clavicle non-unions
62073|NCT03816436|plate treatment of clavicular fractures|plate treatment of clavicular fractures
62074|NCT03816436|cortical bone grafting of clavicular fractures|cortical bone grafting of clavicular fractures
62075|NCT03816436|clavicular midshaft non- union|clavicular midshaft non- union
62076|NCT03816436|clavicular lateral non- union|clavicular lateral non- union
62077|NCT03816436|clavicular shortening|clavicular shortening
62078|NCT03816423|patient education|patient education
62079|NCT03816423|genetic counseling|genetic counseling
62080|NCT03816384|urinary catheter|urinary catheter
62081|NCT03816371|thyroidectomy|thyroidectomy
62082|NCT03816371|head-of-bed elevation|head-of-bed elevation
62083|NCT03816371|supine position|supine position
62084|NCT03816371|respiratory pattern|respiratory pattern
62085|NCT03816371|amount of drainage|amount of drainage
62086|NCT03816371|peripheral oxygen saturation|peripheral oxygen saturation
62087|NCT03816293|colon surgery|colon surgery
62088|NCT03816293|abdominal hysterectomy|abdominal hysterectomy
62089|NCT03816280|Spectroscopy, Near-Infrared|spectroscopy, near-infrared
62090|NCT03816228|Dementia|dementia
62091|NCT03816228|Taupathies|taupathies
62092|NCT03816228|Brain Disease|brain disease
62093|NCT03816228|Mild Cognitive Impairment|mild cognitive impairment
62094|NCT03816228|Neurodegenerative Disease|neurodegenerative disease
62095|NCT03816215|Adolescents|adolescents
62096|NCT03816215|FMRI|fmri
62097|NCT03816215|volunteerism|volunteerism
62098|NCT03816189|Eosinophil|eosinophil
62099|NCT03816189|Fibrosis|fibrosis
62492|NCT03813797|Colectomy|colectomy
62115|NCT03816137|Neuralizing antibody responses|neuralizing antibody responses
62117|NCT03816124|radiofrequency ablation|radiofrequency ablation
62118|NCT03816111|Training|training
62119|NCT03816098|elderly|elderly
62120|NCT03816098|screening|screening
62121|NCT03816085|women|women
62122|NCT03816085|shoes|shoes
62123|NCT03816085|balance|balance
62124|NCT03816085|muscles|muscles
62125|NCT03816059|Respiratory virus infection|respiratory virus infection
62126|NCT03816059|Extrapulmonary complications|extrapulmonary complications
62127|NCT03816059|Myocardial infarction|myocardial infarction
62128|NCT03816059|Asthma|asthma
62129|NCT03816059|Bronchiectasis|bronchiectasis
62130|NCT03816059|Chronic obstructive pulmonary disease|chronic obstructive pulmonary disease
62131|NCT03816059|Cerebrovascular disease|cerebrovascular disease
62132|NCT03816046|botulinum toxim|botulinum toxim
62133|NCT03816046|abobotulinum|abobotulinum
62134|NCT03816046|hyperhydrosis|hyperhydrosis
62135|NCT03816046|injection|injection
62136|NCT03816033|catheter ablation techniques|catheter ablation techniques
62137|NCT03816020|clinical pilot, Nicotamide Riboside, Parkinson's Disease|clinical pilot, nicotamide riboside, parkinson's disease
62138|NCT03816007|PTSD|ptsd
62139|NCT03816007|chronic pain|chronic pain
62140|NCT03816007|yoga|yoga
62141|NCT03816007|mantram repetition|mantram repetition
62142|NCT03816007|mind-body interventions|mind-body interventions
62143|NCT03816007|complementary and integrative medicine|complementary and integrative medicine
62144|NCT03815994|Physical therapy modalities,|physical therapy modalities,
62145|NCT03815994|Electric stimulation therapy|electric stimulation therapy
62146|NCT03815994|Indirect calorimetry|indirect calorimetry
62147|NCT03815981|iron|iron
62148|NCT03815981|siderophores|siderophores
62149|NCT03815981|allergy|allergy
62150|NCT03815981|allergic sensitisation|allergic sensitisation
62151|NCT03815981|trace elements|trace elements
62152|NCT03815968|oligohydroamnios|oligohydroamnios
62153|NCT03815968|low salt diet|low salt diet
62154|NCT03815929|Hormone therapy|hormone therapy
62155|NCT03815929|Pre-menopausal Oophorectomy|pre-menopausal oophorectomy
62156|NCT03815929|Cardiovascular Disease|cardiovascular disease
62157|NCT03815916|neurodegeneration|neurodegeneration
62158|NCT03815916|gold|gold
62159|NCT03815916|nanocrystal|nanocrystal
62160|NCT03815916|NAD+|nad+
62161|NCT03815916|redox|redox
62162|NCT03815916|31P-MRS|31p-mrs
62163|NCT03815916|Parkinson's Disease|parkinson's disease
62164|NCT03815916|magnetic resonance spectroscopy|magnetic resonance spectroscopy
62165|NCT03815916|nanoparticle|nanoparticle
62166|NCT03815916|nanomedicine|nanomedicine
62167|NCT03815916|NADH|nadh
62168|NCT03815890|pre-operative|pre-operative
62169|NCT03815890|triple negative and Luminal B|triple negative and luminal b
62170|NCT03815890|resectable, stage I-III|resectable, stage i-iii
62171|NCT03815877|Caffeine|caffeine
62172|NCT03815877|Postoperative Ileus|postoperative ileus
62173|NCT03815877|Caesarean Section|caesarean section
62174|NCT03815864|donor specific antibody|donor specific antibody
62175|NCT03815864|autoantibody|autoantibody
62176|NCT03815864|human leucocyte antigen|human leucocyte antigen
62177|NCT03815799|Erector Spinae Block|erector spinae block
62178|NCT03815799|Laparoscopy|laparoscopy
62179|NCT03815799|Respiratory Function|respiratory function
62180|NCT03815786|gut microbiota dysbiosis|gut microbiota dysbiosis
62181|NCT03815786|uremic toxins|uremic toxins
62182|NCT03815786|symbiotic|symbiotic
62183|NCT03815773|ECMO|ecmo
62184|NCT03815773|PRBC|prbc
62185|NCT03815773|Fresh frozen Plasma|fresh frozen plasma
62186|NCT03815773|Fibrinogen|fibrinogen
62187|NCT03815773|Antithrombin III|antithrombin iii
62188|NCT03815773|Bleeding|bleeding
62189|NCT03815773|Anticoagulation|anticoagulation
62190|NCT03815760|infraspinatus, external rotators, blood flow restriction|infraspinatus, external rotators, blood flow restriction
62191|NCT03815734|Mental practice|mental practice
62192|NCT03815734|motor imagery|motor imagery
62193|NCT03815734|trapeziometacarpal osteoarthritis|trapeziometacarpal osteoarthritis
62194|NCT03815669|arthroscopic subacromial decompression|arthroscopic subacromial decompression
62195|NCT03815669|shoulder impingement syndrome|shoulder impingement syndrome
62196|NCT03815669|effect|effect
62197|NCT03815669|surgery|surgery
62198|NCT03815656|Deep Brain Stimulation|deep brain stimulation
62199|NCT03815643|Avelumab|avelumab
62200|NCT03815643|Non-small cell lung cancer (NSCLC)|non-small cell lung cancer (nsclc)
62201|NCT03815643|Renal cell carcinoma (RCC)|renal cell carcinoma (rcc)
62202|NCT03815643|Urothelial carcinoma (UC)|urothelial carcinoma (uc)
62203|NCT03815643|Ovarian cancer|ovarian cancer
62204|NCT03815617|IBS|ibs
62205|NCT03815604|Psychiatric Rehabilitation|psychiatric rehabilitation
62206|NCT03815604|Supported Housing|supported housing
62207|NCT03815604|Residential Care|residential care
62208|NCT03815591|smoking|smoking
62209|NCT03815591|tobacco|tobacco
62210|NCT03815591|e-cigarettes|e-cigarettes
62211|NCT03815591|flavored tobacco|flavored tobacco
62212|NCT03815578|pain sensitization|pain sensitization
62213|NCT03815578|Tofacitinib|tofacitinib
62214|NCT03815578|miRNA|mirna
62215|NCT03815565|analgesia|analgesia
62216|NCT03815565|continuous|continuous
62217|NCT03815565|femoral block|femoral block
62218|NCT03815552|type 1 diabetes|type 1 diabetes
62219|NCT03815552|pediatrics|pediatrics
62220|NCT03815552|blood sugar devices|blood sugar devices
62221|NCT03815539|dry eye|dry eye
62222|NCT03815539|noninvasive tear breakup time|noninvasive tear breakup time
62223|NCT03815539|tear film related optical quality|tear film related optical quality
62224|NCT03815539|correlation analysis|correlation analysis
62225|NCT03815526|DynamicTape|dynamictape
62226|NCT03815526|Sport Tape|sport tape
62227|NCT03815526|Kinesio Tape|kinesio tape
62228|NCT03815513|Intracerebral hemorrhage|intracerebral hemorrhage
62229|NCT03815513|MRI|mri
62230|NCT03815513|human|human
62231|NCT03815487|pediatrics|pediatrics
62232|NCT03815487|type 1 diabetes|type 1 diabetes
62233|NCT03815487|insulin pump|insulin pump
62234|NCT03815487|closed loop|closed loop
62235|NCT03815448|Methotrexate|methotrexate
62236|NCT03815448|knee osteoarthritis|knee osteoarthritis
62237|NCT03815448|Magnetic Resonance imaging|magnetic resonance imaging
62238|NCT03815448|pain|pain
62239|NCT03815448|synovitis|synovitis
62240|NCT03815435|Surgical field clarity|surgical field clarity
62241|NCT03815435|Endonasal surgery|endonasal surgery
62242|NCT03815435|Intraoperative bleeding|intraoperative bleeding
62243|NCT03815422|Early ambulation|early ambulation
62244|NCT03815422|Plantar block|plantar block
62245|NCT03815396|Alpha-1 antitrypsin deficiency|alpha-1 antitrypsin deficiency
62246|NCT03815396|AATD|aatd
62247|NCT03815396|alpha-1 disease|alpha-1 disease
62248|NCT03815396|AAT|aat
62249|NCT03815370|Abdominal trauma/injury|abdominal trauma/injury
62250|NCT03815370|Abdominal sepsis/infection|abdominal sepsis/infection
62251|NCT03815370|Open Abdomen|open abdomen
62252|NCT03815370|Abdominal binder|abdominal binder
62253|NCT03815370|Abthera|abthera
62254|NCT03815370|VAC|vac
62255|NCT03815370|ABRO|abro
62256|NCT03815357|streptococcus pneumoniae|streptococcus pneumoniae
62257|NCT03815357|invasive pneumococcal disease|invasive pneumococcal disease
62258|NCT03815357|primary immunodeficiency|primary immunodeficiency
62259|NCT03815344|Robot-assisted|robot-assisted
62260|NCT03815344|Laparoscopic|laparoscopic
62261|NCT03815344|vasopressin|vasopressin
62262|NCT03815344|misoprostol|misoprostol
62263|NCT03815344|blood loss|blood loss
62264|NCT03815331|Peyronie's disease|peyronie's disease
62265|NCT03815331|Hypogonadism|hypogonadism
62266|NCT03815305|dry skin|dry skin
62267|NCT03815305|dm type 2|dm type 2
62268|NCT03815305|centella asiatica|centella asiatica
62269|NCT03815305|superoxide dismutase|superoxide dismutase
62270|NCT03815305|AGEs CML|ages cml
62271|NCT03815305|IL-1α|il-1α
62272|NCT03815279|Multiple Myeloma|multiple myeloma
62273|NCT03815279|Smoldering Multiple Myeloma|smoldering multiple myeloma
62274|NCT03815279|Carfilzomib|carfilzomib
62275|NCT03815279|Lenalidomide|lenalidomide
62276|NCT03815279|Screening|screening
62277|NCT03815266|transcranial Direct Current Stimulation (tDCS)|transcranial direct current stimulation (tdcs)
62278|NCT03815266|Computerized Mirror Therapy (CMT)|computerized mirror therapy (cmt)
62279|NCT03815266|hemiparetic|hemiparetic
62280|NCT03815266|Ischemic|ischemic
62281|NCT03815266|stroke|stroke
62282|NCT03815266|Intensive Visual Simulation3 (IVS3)|intensive visual simulation3 (ivs3)
818341|NCT00166595|Risperidone|risperidone
62283|NCT03815240|Pressure Ulcer Prevention|pressure ulcer prevention
62284|NCT03815240|Preventive Dressings|preventive dressings
62285|NCT03815201|muscle mass|muscle mass
62286|NCT03815201|protein supplementation|protein supplementation
62287|NCT03815201|leucine|leucine
62288|NCT03815201|elderly|elderly
62289|NCT03815201|exercise training|exercise training
62290|NCT03815175|High Bleeding Risk (HBR)|high bleeding risk (hbr)
62291|NCT03815175|Dual antiplatelet therapy (DAPT)|dual antiplatelet therapy (dapt)
62292|NCT03815175|Drug eluting stent (DES)|drug eluting stent (des)
62293|NCT03815175|XIENCE|xience
62294|NCT03815175|Percutaneous coronary intervention (PCI)|percutaneous coronary intervention (pci)
62295|NCT03815175|Coronary Artery Disease|coronary artery disease
62296|NCT03815162|cocoa flavanols|cocoa flavanols
62297|NCT03815149|Interventional Neuroradiology|interventional neuroradiology
62696|NCT03812458|resilience|resilience
62298|NCT03815149|Diagnostic neuroradiology|diagnostic neuroradiology
62299|NCT03815149|Neurosurgery|neurosurgery
62300|NCT03815149|Neurovascular Devices|neurovascular devices
62301|NCT03815149|Flow Diversion Device|flow diversion device
62302|NCT03815019|Gastrostomy Tube|gastrostomy tube
62303|NCT03815019|G-Tube|g-tube
62304|NCT03815019|Oral Food Refusal|oral food refusal
62305|NCT03815019|Behavioral Intervention|behavioral intervention
62306|NCT03815019|Megestrol|megestrol
62307|NCT03815019|Transition to Oral Feedings|transition to oral feedings
62308|NCT03815019|Weaning|weaning
62309|NCT03814967|schizophrenia|schizophrenia
62310|NCT03814967|EEG|eeg
62311|NCT03814967|tDCS|tdcs
62312|NCT03814967|dorsolateral prefrontal cortex|dorsolateral prefrontal cortex
62313|NCT03814967|cognitive control|cognitive control
62314|NCT03814967|language|language
62315|NCT03814967|transcranial direct current stimulation|transcranial direct current stimulation
62316|NCT03814941|Artifacts|artifacts
62317|NCT03814941|anesthesia information management system|anesthesia information management system
62318|NCT03814928|education|education
62319|NCT03814928|online|online
62320|NCT03814928|skill development|skill development
62321|NCT03814928|e-learning|e-learning
62322|NCT03814928|caregivers|caregivers
62323|NCT03814915|Gene-environment interaction|gene-environment interaction
62324|NCT03814915|Genome|genome
62325|NCT03814915|Glycaemic control|glycaemic control
62326|NCT03814915|Lifestyle|lifestyle
62327|NCT03814915|Microbiome|microbiome
62328|NCT03814915|Prediabetes|prediabetes
62329|NCT03814915|Proteome|proteome
62330|NCT03814915|Type 2 diabetes|type 2 diabetes
62331|NCT03814889|spasticity|spasticity
62332|NCT03814889|tone|tone
62333|NCT03814889|hemiplegia|hemiplegia
62334|NCT03814889|hemiparesis|hemiparesis
62335|NCT03814889|arm|arm
62336|NCT03814889|hand|hand
62337|NCT03814889|vibration|vibration
62338|NCT03814863|red eye|red eye
62339|NCT03814863|conjunctival congestion|conjunctival congestion
62340|NCT03814863|ophthalmology clinic|ophthalmology clinic
62341|NCT03814850|brain aneurysm|brain aneurysm
62342|NCT03814850|endovascular repair|endovascular repair
62343|NCT03814850|ischemic stroke|ischemic stroke
62344|NCT03814824|VLE|vle
62345|NCT03814824|Volumetric laser endomicroscopy|volumetric laser endomicroscopy
62346|NCT03814824|IRIS|iris
62347|NCT03814824|Intelligent real-time image segmentation|intelligent real-time image segmentation
62348|NCT03814824|Barrett's Esophagus|barrett's esophagus
62349|NCT03814811|Breast Cancer|breast cancer
62350|NCT03814811|Bone|bone
62351|NCT03814811|Metastasis|metastasis
62352|NCT03814811|Osteoblast|osteoblast
62353|NCT03814772|liver transplantation|liver transplantation
62354|NCT03814772|blood transfusion|blood transfusion
62355|NCT03814772|Patient blood management|patient blood management
62356|NCT03814746|Sickle Cell Disease|sickle cell disease
62357|NCT03814746|SEG101|seg101
62358|NCT03814746|Crizanlizumab|crizanlizumab
62359|NCT03814746|Hydroxyurea/ Hydroxycarbamide Therapy|hydroxyurea/ hydroxycarbamide therapy
62360|NCT03814746|Vaso-Occlusive Crises|vaso-occlusive crises
62361|NCT03814746|SCA|sca
62362|NCT03814746|blood disorders|blood disorders
62363|NCT03814746|hemoglobin|hemoglobin
62364|NCT03814746|red blood cells|red blood cells
62365|NCT03814746|sickle-like shape|sickle-like shape
62366|NCT03814746|mutation in hemoglobin gene|mutation in hemoglobin gene
62367|NCT03814746|sickle-cell trait|sickle-cell trait
62368|NCT03814746|sickle-cell crisis|sickle-cell crisis
62369|NCT03814720|Flu|flu
62370|NCT03814720|Seasonal Allergy|seasonal allergy
62371|NCT03814720|Respiratory Illness|respiratory illness
62372|NCT03814720|Flu Virus|flu virus
62373|NCT03814720|Viral Infection|viral infection
62374|NCT03814707|gingival recession|gingival recession
62375|NCT03814707|gingival augmentation|gingival augmentation
62376|NCT03814707|free gingival graft|free gingival graft
62377|NCT03814707|platelet rich fibrin in wound healing|platelet rich fibrin in wound healing
62378|NCT03814707|2 steps free gingival graft|2 steps free gingival graft
62379|NCT03814707|hyaluronic acid in wound healing|hyaluronic acid in wound healing
62380|NCT03814694|Weight Loss|weight loss
81280|NCT03695588|QLB|qlb
62381|NCT03814694|Diet, Carbohydrate-Restricted|diet, carbohydrate-restricted
62382|NCT03814694|Diet, High-Protein|diet, high-protein
62383|NCT03814694|Insulin Resistance|insulin resistance
62384|NCT03814694|Non-alcoholic Fatty Liver Disease|non-alcoholic fatty liver disease
62385|NCT03814694|Metabolic Syndrome|metabolic syndrome
62386|NCT03814655|Dental implants|dental implants
62387|NCT03814655|digital workflow|digital workflow
62388|NCT03814655|guided surgery|guided surgery
62389|NCT03814629|chronic atrophic gastritis|chronic atrophic gastritis
62390|NCT03814629|precancerous lesions of gastric cancer|precancerous lesions of gastric cancer
62391|NCT03814629|Weifuchun|weifuchun
62392|NCT03814629|randomized clinical trial|randomized clinical trial
62393|NCT03814629|mechanism|mechanism
62394|NCT03814616|Asymptomatic malaria|asymptomatic malaria
62395|NCT03814590|Respiratory syncytial virus (RSV)|respiratory syncytial virus (rsv)
62396|NCT03814590|Vaccine|vaccine
62397|NCT03814590|Safety|safety
62398|NCT03814590|Reactogenicity|reactogenicity
62399|NCT03814590|Immunogenicity|immunogenicity
62400|NCT03814577|General anesthesia|general anesthesia
62401|NCT03814577|Inhalation anesthetics|inhalation anesthetics
62402|NCT03814577|Total Intravenous anesthesia|total intravenous anesthesia
62403|NCT03814577|Oxidative Stress|oxidative stress
62404|NCT03814577|Morbid Obesity|morbid obesity
62405|NCT03814538|Postoperative pulmonary complications|postoperative pulmonary complications
62406|NCT03814538|Incidence of EFL|incidence of efl
62407|NCT03814486|platelet transfusion|platelet transfusion
62408|NCT03814486|palliative care|palliative care
62409|NCT03814460|Topographical mapping|topographical mapping
62410|NCT03814460|Muscle state of tension|muscle state of tension
62411|NCT03814460|Myotonometer|myotonometer
62412|NCT03814460|Pressure Pain Threshold|pressure pain threshold
62413|NCT03814460|Muscle Thickness|muscle thickness
62414|NCT03814447|MESO|meso
62415|NCT03814447|CAR-T|car-t
62416|NCT03814447|Ovarian cancer|ovarian cancer
62417|NCT03814447|Refractory-Relapsed|refractory-relapsed
62418|NCT03814434|peri-implantitis|peri-implantitis
62419|NCT03814434|inflammation|inflammation
62420|NCT03814434|Therapy|therapy
62421|NCT03814408|FANCA, FA-A, Fanconi Anemia Subtype A|fanca, fa-a, fanconi anemia subtype a
62422|NCT03814369|colonoscopy|colonoscopy
62423|NCT03814369|adenoma detection rate|adenoma detection rate
62424|NCT03814369|colorectal cancer screening|colorectal cancer screening
62425|NCT03814369|new technology|new technology
62426|NCT03814343|fungal infection|fungal infection
62427|NCT03814343|onychomycosis|onychomycosis
62428|NCT03814343|amphotericin B|amphotericin b
62429|NCT03814343|Dimethylsulphoxide|dimethylsulphoxide
62430|NCT03814343|non-dermatophyte|non-dermatophyte
62431|NCT03814343|randomized double blind controlled trial|randomized double blind controlled trial
62432|NCT03814330|Anesthesia management|anesthesia management
62433|NCT03814330|In-vitro Fertilization|in-vitro fertilization
62434|NCT03814330|Sedation-Analgesia|sedation-analgesia
62435|NCT03814317|right heart catheterization (RHC)|right heart catheterization (rhc)
62436|NCT03814317|pulmonary vascular resistance (PVR)|pulmonary vascular resistance (pvr)
62437|NCT03814317|mean pulmonary arterial pressure (mPAP)|mean pulmonary arterial pressure (mpap)
62438|NCT03814317|pulmonary hypertension (PH)|pulmonary hypertension (ph)
62439|NCT03814317|Inhaled treprostinil|inhaled treprostinil
62440|NCT03814317|Sarcoidosis|sarcoidosis
62441|NCT03814265|Cortisol|cortisol
62442|NCT03814265|Laughter Yoga|laughter yoga
62443|NCT03814265|Mental Symptom|mental symptom
62444|NCT03814265|Nursing|nursing
62445|NCT03814265|Student|student
62446|NCT03814252|Localized prostate cancer|localized prostate cancer
62447|NCT03814252|Transurethral ultrasound ablation|transurethral ultrasound ablation
62448|NCT03814252|Image guided|image guided
62449|NCT03814252|Magnetic resonance imaging guided|magnetic resonance imaging guided
62450|NCT03814252|Lesion-targeted|lesion-targeted
62451|NCT03814252|Focal therapy|focal therapy
62452|NCT03814239|transfusion|transfusion
62453|NCT03814239|goal directed fluid therapy|goal directed fluid therapy
62454|NCT03814213|Comprehensive geriatric assessment|comprehensive geriatric assessment
62455|NCT03814213|Cancer|cancer
62456|NCT03814213|Short time mortality|short time mortality
62457|NCT03814187|Inclisiran sodium|inclisiran sodium
62458|NCT03814187|ASCVD|ascvd
62459|NCT03814187|LDL-C|ldl-c
62460|NCT03814187|HeFH|hefh
62461|NCT03814187|HoFH|hofh
62462|NCT03814174|Childhood Epilepsy|childhood epilepsy
62463|NCT03814174|Physical Fitness|physical fitness
62464|NCT03814174|Physical Activity|physical activity
62465|NCT03814174|Use of Pedometer|use of pedometer
62466|NCT03814135|insomnia|insomnia
62467|NCT03814109|Hypertension|hypertension
62468|NCT03814096|Syphilis, prenatal screening, SHC, point-of-care test|syphilis, prenatal screening, shc, point-of-care test
62469|NCT03814057|Anthropometric measurements,|anthropometric measurements,
62470|NCT03814057|creatinine height index|creatinine height index
62471|NCT03814057|lean body mass|lean body mass
818342|NCT00166595|Autism|autism
62472|NCT03814057|Mini- nutritional assessment|mini- nutritional assessment
62473|NCT03814057|Hand Grip strength|hand grip strength
62474|NCT03814031|TEE|tee
62475|NCT03814031|orthotopic liver transplant|orthotopic liver transplant
62476|NCT03814031|postoperative graft function|postoperative graft function
62477|NCT03814018|Bronchodilation test|bronchodilation test
62478|NCT03814018|GINA|gina
62479|NCT03814018|Reversibility criteria|reversibility criteria
62480|NCT03814005|Drug therapy|drug therapy
62481|NCT03813979|pharmacokinetics|pharmacokinetics
62482|NCT03813979|dolutegravir|dolutegravir
62483|NCT03813940|human papillomavirus vaccine|human papillomavirus vaccine
62484|NCT03813914|insulin resistance, blood pressure,|insulin resistance, blood pressure,
62485|NCT03813849|remnants of conception|remnants of conception
62486|NCT03813836|Head and Neck Cancer|head and neck cancer
62487|NCT03813836|Metastatic Head and Neck Squamous Cell Carcinoma|metastatic head and neck squamous cell carcinoma
62488|NCT03813836|Recurrent Head and Neck Squamous Cell Carcinoma|recurrent head and neck squamous cell carcinoma
62489|NCT03813836|Pembrolizumab|pembrolizumab
62490|NCT03813797|Low Pressure|low pressure
62493|NCT03813797|Pneumoperitoneum|pneumoperitoneum
62494|NCT03813797|AirSeal|airseal
62495|NCT03813784|PD-1|pd-1
62496|NCT03813784|SHR-1210|shr-1210
62497|NCT03813771|T-cells|t-cells
62498|NCT03813771|Treat to Target|treat to target
62499|NCT03813771|DMARD-naive|dmard-naive
62500|NCT03813771|Benepali|benepali
62501|NCT03813745|embryo quality|embryo quality
62502|NCT03813745|denudation|denudation
62503|NCT03813745|IVF|ivf
62504|NCT03813745|ICSI|icsi
62505|NCT03813732|trans-conjunctival approach|trans-conjunctival approach
62506|NCT03813719|endometrial cancer|endometrial cancer
62507|NCT03813719|cancer|cancer
62508|NCT03813719|uterine cancer|uterine cancer
62509|NCT03813719|anxiety|anxiety
62510|NCT03813719|stress|stress
62511|NCT03813719|psychological|psychological
62512|NCT03813719|survey|survey
62513|NCT03813719|point-of-care|point-of-care
62514|NCT03813680|Mechanical Neck Pain|mechanical neck pain
62515|NCT03813680|Passive Vertebral Mobilization|passive vertebral mobilization
62516|NCT03813680|Proprioceptive Neuromuscular Techniques (PNF)|proprioceptive neuromuscular techniques (pnf)
62517|NCT03813680|Quality of Life|quality of life
62518|NCT03813680|Disability|disability
62519|NCT03813680|Pain|pain
62520|NCT03813667|advanced lung diseases|advanced lung diseases
62521|NCT03813667|Palliative Care|palliative care
62522|NCT03813667|Dyspnea|dyspnea
62523|NCT03813667|pilot projects|pilot projects
62524|NCT03813667|Terminal Care|terminal care
62525|NCT03813654|sleep|sleep
62526|NCT03813654|attention|attention
62527|NCT03813654|vigilance|vigilance
62528|NCT03813654|aging|aging
62529|NCT03813654|shift work|shift work
62530|NCT03813641|Raltitrexed|raltitrexed
62531|NCT03813641|First-line therapy|first-line therapy
62532|NCT03813641|Bevacizumab|bevacizumab
62533|NCT03813641|Colorectal Cancer|colorectal cancer
62534|NCT03813628|celtra press|celtra press
62535|NCT03813615|Aerobic Training|aerobic training
62536|NCT03813615|18-534|18-534
62537|NCT03813576|screening|screening
62538|NCT03813576|cervical cancer|cervical cancer
62539|NCT03813576|primary prevention|primary prevention
62540|NCT03813576|human papillomavirus infection|human papillomavirus infection
62541|NCT03813576|acceptability|acceptability
62542|NCT03813576|feasibility|feasibility
62543|NCT03813550|PXE|pxe
62544|NCT03813550|calcification|calcification
62545|NCT03813550|Gla proteins|gla proteins
62546|NCT03813550|gut microbiota|gut microbiota
62547|NCT03813550|vitamin K2|vitamin k2
62548|NCT03813550|menaquinones|menaquinones
62549|NCT03813550|taxonomic meta-sequencing|taxonomic meta-sequencing
62550|NCT03813511|Minimally invasive surgery|minimally invasive surgery
62551|NCT03813511|Clip procedure|clip procedure
62552|NCT03813485|surface electromyographic|surface electromyographic
62553|NCT03813485|dry needling|dry needling
62554|NCT03813459|Delirium|delirium
62555|NCT03813459|Subsyndromal delirium|subsyndromal delirium
62556|NCT03813459|Intensive Care Unit|intensive care unit
62557|NCT03813420|Sleep quality|sleep quality
62558|NCT03813420|Body mass index|body mass index
62559|NCT03813420|Active life|active life
62560|NCT03813420|Academic performance|academic performance
62561|NCT03813407|sodium zirconium cyclosilicate|sodium zirconium cyclosilicate
62562|NCT03813407|Hyperkalaemia in children|hyperkalaemia in children
62563|NCT03813394|Immunotherapy|immunotherapy
62564|NCT03813394|Epstein Barr virus|epstein barr virus
62565|NCT03813394|Nasopharyngeal cancer|nasopharyngeal cancer
62566|NCT03813394|Anti-PD1|anti-pd1
62567|NCT03813394|Tumor neoantigens|tumor neoantigens
62568|NCT03813381|Esophageal adenocarcinoma|esophageal adenocarcinoma
62569|NCT03813381|Diet|diet
62570|NCT03813381|Physical activity|physical activity
62571|NCT03813381|Microbiota|microbiota
62572|NCT03813355|brain stimulation|brain stimulation
62573|NCT03813355|Body Mass Index|body mass index
62574|NCT03813342|stroke|stroke
62575|NCT03813342|gait training|gait training
62576|NCT03813342|visual feedback|visual feedback
62577|NCT03813316|Diabetes|diabetes
62578|NCT03813316|Type 2|type 2
62579|NCT03813316|T2D|t2d
62580|NCT03813303|Colonoscopy|colonoscopy
62581|NCT03813303|Anesthesia|anesthesia
62582|NCT03813303|Fentanyl|fentanyl
62583|NCT03813303|Midazolam|midazolam
62584|NCT03813303|Propofol|propofol
62585|NCT03813290|Brain Computer Interface|brain computer interface
62586|NCT03813290|Neuro technological intervention|neuro technological intervention
62587|NCT03813290|Neurofeedback|neurofeedback
62588|NCT03813264|MATRIX|matrix
62589|NCT03813264|ROM (Routine Outcome Measures)|rom (routine outcome measures)
62590|NCT03813264|mobile-assisted PROMS|mobile-assisted proms
62591|NCT03813264|managed care|managed care
62592|NCT03813238|DCP|dcp
62593|NCT03813225|Analgesia, patient- controlled, Block , Pain Postoperative|analgesia, patient- controlled, block , pain postoperative
62594|NCT03813186|MDS|mds
62595|NCT03813186|CMML|cmml
62596|NCT03813186|ASTX727|astx727
62597|NCT03813186|decitabine|decitabine
62598|NCT03813186|AML|aml
62599|NCT03813160|dermatomyositis|dermatomyositis
62600|NCT03813160|cannabinoid receptor type 2 agonist|cannabinoid receptor type 2 agonist
62601|NCT03813160|JBT-101|jbt-101
62602|NCT03813160|lenabasum|lenabasum
62603|NCT03813134|Cardiogenic Shock|cardiogenic shock
62604|NCT03813134|Acute Myocardial Infarction|acute myocardial infarction
62605|NCT03813134|Acute Coronary Syndrome|acute coronary syndrome
62606|NCT03813108|Mosquito bites|mosquito bites
62607|NCT03813108|Sporozoite|sporozoite
62608|NCT03813108|Immunization|immunization
62609|NCT03813108|Malaria|malaria
62610|NCT03813108|Falciparum|falciparum
62611|NCT03813095|Addiction|addiction
62612|NCT03813095|Cannabis|cannabis
62613|NCT03813095|Substance Use|substance use
62614|NCT03813095|Opioids: Harmful Use|opioids: harmful use
62615|NCT03813095|Cocaine|cocaine
62616|NCT03813095|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors
62617|NCT03813095|Analgesics|analgesics
62618|NCT03813095|Mental Disorders|mental disorders
62619|NCT03813095|Narcotics|narcotics
62620|NCT03813095|Cannabidiol|cannabidiol
62621|NCT03813082|Positron emission tomography|positron emission tomography
62622|NCT03813082|Magnetic resonance spectroscopy|magnetic resonance spectroscopy
62623|NCT03813082|Aging|aging
62624|NCT03813030|Dermal open flow microperfusion|dermal open flow microperfusion
62625|NCT03813030|Dermal microdialysis|dermal microdialysis
62626|NCT03813004|motek grail|motek grail
62627|NCT03813004|balance|balance
62628|NCT03813004|gait perturbation|gait perturbation
62629|NCT03812978|"Flexor tendon rehabilitation"|"flexor tendon rehabilitation"
62630|NCT03812978|"Smart-phone application"|"smart-phone application"
62631|NCT03812978|"adherence"|"adherence"
62632|NCT03812965|Botulinum Toxin|botulinum toxin
62633|NCT03812965|Gingival Smile|gingival smile
62634|NCT03812952|misdiagnose|misdiagnose
62635|NCT03812952|mistreatment|mistreatment
62636|NCT03812952|antibiotics|antibiotics
62637|NCT03812913|Turner syndrome|turner syndrome
62638|NCT03812913|Cognitive Functions|cognitive functions
62639|NCT03812913|Social Cognition|social cognition
62640|NCT03812913|Pediatrics|pediatrics
62641|NCT03812861|failure to rescue|failure to rescue
62642|NCT03812861|postoperative complications|postoperative complications
62643|NCT03812861|adherence to best practice|adherence to best practice
62644|NCT03812848|anticoagulation|anticoagulation
62645|NCT03812848|stewardship program|stewardship program
62646|NCT03812848|anticoagulants|anticoagulants
62647|NCT03812848|clinical pharmacist|clinical pharmacist
62648|NCT03812848|heparin|heparin
62649|NCT03812848|warfarin|warfarin
62650|NCT03812822|Femoral anteversion, flat foot, insole, gait|femoral anteversion, flat foot, insole, gait
62651|NCT03812809|EGFR|egfr
62652|NCT03812809|T790M|t790m
62653|NCT03812809|NSCLC|nsclc
62654|NCT03812783|Hepatocellular Carcinoma|hepatocellular carcinoma
62655|NCT03812783|Hepatic artery infusion chemotherapy|hepatic artery infusion chemotherapy
62656|NCT03812783|Oxaliplatin, 5-Fluorouracil and Leucovorin (FOLFOX)|oxaliplatin, 5-fluorouracil and leucovorin (folfox)
62657|NCT03812783|Irinotecan, Oxaliplatin, 5-Fluorouracil and Leucovorin (FOLFIRINOX)|irinotecan, oxaliplatin, 5-fluorouracil and leucovorin (folfirinox)
62658|NCT03812783|sorafenib|sorafenib
62659|NCT03812770|Hepatocellular Carcinoma|hepatocellular carcinoma
62660|NCT03812770|Sorafenib|sorafenib
62661|NCT03812770|Hepatic artery infusion chemotherapy|hepatic artery infusion chemotherapy
62662|NCT03812770|Oxaliplatin, 5-Fluorouracil and Leucovorin|oxaliplatin, 5-fluorouracil and leucovorin
62663|NCT03812770|Oxaliplatin|oxaliplatin
62664|NCT03812757|Central venous catheter|central venous catheter
62665|NCT03812757|Subclavian vein|subclavian vein
62666|NCT03812757|Supraclavicular fossa ultrasound view|supraclavicular fossa ultrasound view
62667|NCT03812705|allogeneic hematopoeitic stem cell transplantation|allogeneic hematopoeitic stem cell transplantation
62668|NCT03812705|acute gastrointestinal graft versus host disease|acute gastrointestinal graft versus host disease
818442|NCT00165984|cardiac|cardiac
62669|NCT03812705|fecal microbiome transplantation|fecal microbiome transplantation
62670|NCT03812692|Oral appliance therapy|oral appliance therapy
62671|NCT03812666|Stroke|stroke
62672|NCT03812666|Pneumonia|pneumonia
62673|NCT03812666|Biomarkers|biomarkers
62674|NCT03812666|Infection|infection
62675|NCT03812640|pediatric|pediatric
62676|NCT03812640|cataract|cataract
62677|NCT03812640|suture|suture
62678|NCT03812640|poliglactin|poliglactin
62679|NCT03812640|nylon|nylon
62680|NCT03812627|Implantable medical devices|implantable medical devices
62681|NCT03812627|Biomarker|biomarker
62682|NCT03812627|Systemic inflammation|systemic inflammation
62683|NCT03812614|Diabetes|diabetes
62684|NCT03812614|Patient Activation|patient activation
62685|NCT03812614|Self Management Education|self management education
62686|NCT03812614|Self Management Behavior|self management behavior
62687|NCT03812614|Autonomy Support|autonomy support
62688|NCT03812614|Social Support|social support
62689|NCT03812614|Caregiver|caregiver
62690|NCT03812614|Family Support|family support
62691|NCT03812614|Glycemic Control|glycemic control
62692|NCT03812549|Immunotherapy;SBRT; PD-L1 positive; LDRT|immunotherapy;sbrt; pd-l1 positive; ldrt
62693|NCT03812510|common warts|common warts
62694|NCT03812497|Microbiome|microbiome
62695|NCT03812497|Metabolome|metabolome
62697|NCT03812458|anxiety|anxiety
62698|NCT03812458|acute stress|acute stress
62699|NCT03812458|relatives|relatives
62700|NCT03812458|critical ill patients|critical ill patients
62701|NCT03812445|Probiotics|probiotics
62702|NCT03812445|Gut microbiota|gut microbiota
62703|NCT03812445|ischemic stroke|ischemic stroke
62704|NCT03812419|Allograft rejection|allograft rejection
62705|NCT03812419|cyclosporine|cyclosporine
62706|NCT03812419|kidney transplantation|kidney transplantation
62707|NCT03812419|proton pump inhibitors|proton pump inhibitors
62708|NCT03812419|gastric complications.|gastric complications.
62709|NCT03812406|cesarean|cesarean
62710|NCT03812380|Bone mineral density|bone mineral density
62711|NCT03812354|infant|infant
62712|NCT03812354|airway management|airway management
62713|NCT03812354|apneic oxygenation|apneic oxygenation
62714|NCT03812328|venous thromboembolism|venous thromboembolism
62715|NCT03812328|adhesion molecule|adhesion molecule
62716|NCT03812328|P-selectin glycoprotein ligand 1|p-selectin glycoprotein ligand 1
62717|NCT03812328|P-selectin|p-selectin
62718|NCT03812328|venous thrombosis|venous thrombosis
62719|NCT03812315|Propoplis|propoplis
62720|NCT03812315|chewing gum|chewing gum
62721|NCT03812315|mouthwash|mouthwash
62722|NCT03812315|high caries risk children|high caries risk children
62723|NCT03812315|antimicrobial|antimicrobial
62724|NCT03812276|Dental Implants|dental implants
62725|NCT03812263|Leukocyte Adhesion Deficiency- Type I|leukocyte adhesion deficiency- type i
62726|NCT03812263|LAD-I|lad-i
62727|NCT03812237|Lapidus Arthrodesis|lapidus arthrodesis
62728|NCT03812237|Early Weight Bearing|early weight bearing
62729|NCT03812237|First Tarsometatarsal Arthrodesis|first tarsometatarsal arthrodesis
62730|NCT03812198|healthy|healthy
62731|NCT03812172|Heart Failure|heart failure
62732|NCT03812172|Cardiac Amyloidosis|cardiac amyloidosis
62733|NCT03812172|TTR mutation|ttr mutation
62734|NCT03812172|Blacks|blacks
62735|NCT03812172|Hispanics|hispanics
62736|NCT03812172|Aging|aging
62737|NCT03812159|Shape analysis|shape analysis
62738|NCT03812159|Computer-assited surgical plan|computer-assited surgical plan
62739|NCT03812159|Surgical planning|surgical planning
62740|NCT03812159|Computational anatomy|computational anatomy
62742|NCT03812120|CSF leakage|csf leakage
62743|NCT03812120|fibrin sealants|fibrin sealants
62744|NCT03812107|Opioid-use Disorder (OUD)|opioid-use disorder (oud)
62745|NCT03812107|Medication for OUD (MOUD)|medication for oud (moud)
62746|NCT03812107|Co-occurring opioid use disorder and mental disorders|co-occurring opioid use disorder and mental disorders
62747|NCT03812107|Office-based Addiction Treatment|office-based addiction treatment
62748|NCT03812094|paediatric, children, treatment, intervention|paediatric, children, treatment, intervention
62749|NCT03812068|ASD|asd
62750|NCT03812068|Early intervention|early intervention
62751|NCT03812068|Development|development
62752|NCT03812042|Gaucher disease|gaucher disease
62753|NCT03812042|Fabry disease|fabry disease
62754|NCT03812042|Pompe disease|pompe disease
62755|NCT03812042|Gangliosidoses|gangliosidoses
62756|NCT03812029|EYP001|eyp001
62757|NCT03812029|Liver Diseases|liver diseases
62758|NCT03812029|Non-alcoholic Fatty Liver Disease|non-alcoholic fatty liver disease
62759|NCT03812029|Non-alcoholic Steatohepatitis|non-alcoholic steatohepatitis
62760|NCT03812029|NASH|nash
62761|NCT03812016|Blepharoptosis|blepharoptosis
62762|NCT03812016|Blink restoration|blink restoration
62763|NCT03812016|Magnetic device|magnetic device
62764|NCT03812016|Oculomotor nerve palsy|oculomotor nerve palsy
62765|NCT03812016|Ptosis|ptosis
62766|NCT03812003|opioid-induced hyperalgesia, remifentanil|opioid-induced hyperalgesia, remifentanil
62767|NCT03811951|Tobacco|tobacco
62768|NCT03811951|Cigarettes|cigarettes
62769|NCT03811951|Nicotine|nicotine
62770|NCT03811951|Insulin|insulin
62771|NCT03811951|Electroencephalogram|electroencephalogram
62772|NCT03811951|EEG|eeg
62773|NCT03811951|Event-Related Potential|event-related potential
62774|NCT03811951|ERP (Event-Related Potential)|erp (event-related potential)
62775|NCT03811938|Radiofrequency Catheter Ablation|radiofrequency catheter ablation
62776|NCT03811886|Natalizumab|natalizumab
62777|NCT03811873|transplant related disorders|transplant related disorders
62778|NCT03811873|liver transplant|liver transplant
62779|NCT03811873|transplant related bone disease|transplant related bone disease
62780|NCT03811860|lithium|lithium
62781|NCT03811860|pharmacokinetics|pharmacokinetics
62782|NCT03811860|renal|renal
62783|NCT03811860|kidney|kidney
62784|NCT03811834|Drug Therapy|drug therapy
62785|NCT03811821|Accidental Bowel Leakage|accidental bowel leakage
62786|NCT03811821|Fecal Incontinence|fecal incontinence
62787|NCT03811821|Biofeedback|biofeedback
62788|NCT03811821|Sacral Nerve Stimulation|sacral nerve stimulation
62789|NCT03811821|Injectable Bulking Agents|injectable bulking agents
62790|NCT03811821|Enhanced Medical Management|enhanced medical management
62791|NCT03811782|conscious motor processing|conscious motor processing
62792|NCT03811782|single-task training|single-task training
62793|NCT03811782|dual-task training|dual-task training
62794|NCT03811782|analogy training|analogy training
62893|NCT03811197|Weight Loss|weight loss
62795|NCT03811782|gait rehabilitation|gait rehabilitation
62796|NCT03811782|reinvestment propensity|reinvestment propensity
62797|NCT03811782|balance|balance
62798|NCT03811782|fear of falling|fear of falling
62799|NCT03811782|older adults|older adults
62800|NCT03811782|Hong Kong|hong kong
62801|NCT03811769|Mechanical thrombectomy|mechanical thrombectomy
62802|NCT03811769|Stroke|stroke
62803|NCT03811769|Proximal intracranial arterial occlusions|proximal intracranial arterial occlusions
62804|NCT03811769|Large vessel occlusion|large vessel occlusion
62805|NCT03811743|Youth|youth
62806|NCT03811743|Parents|parents
62807|NCT03811743|Overweight|overweight
62808|NCT03811743|Families|families
62809|NCT03811730|transesophageal echocardiography|transesophageal echocardiography
62810|NCT03811730|intensive care unit|intensive care unit
62811|NCT03811704|three-dimensional reconstruction|three-dimensional reconstruction
62812|NCT03811704|fluorescence|fluorescence
62813|NCT03811704|indocyanine green|indocyanine green
62814|NCT03811704|liver resection|liver resection
62815|NCT03811704|navigation surgery|navigation surgery
62816|NCT03811652|Medi7247|medi7247
62817|NCT03811652|non small cell lung cancer|non small cell lung cancer
62818|NCT03811652|head and neck cancer|head and neck cancer
62819|NCT03811652|small cell lung cancer|small cell lung cancer
62820|NCT03811652|colorectal cancer|colorectal cancer
62821|NCT03811652|prostate cancer|prostate cancer
62822|NCT03811652|pancreatic adenocarcinoma|pancreatic adenocarcinoma
62823|NCT03811639|ablation, atrial fibrillation, autonomic nervous system|ablation, atrial fibrillation, autonomic nervous system
62824|NCT03811626|Mild TBI|mild tbi
62825|NCT03811626|quality of life|quality of life
62826|NCT03811626|coping strategies|coping strategies
62827|NCT03811626|symptoms|symptoms
62828|NCT03811626|neuropsychological tests|neuropsychological tests
62829|NCT03811626|pain|pain
62830|NCT03811626|memory reactive|memory reactive
62831|NCT03811626|Cognitive dimension|cognitive dimension
62832|NCT03811613|movement disorders|movement disorders
62833|NCT03811613|light therapy|light therapy
62834|NCT03811613|motor aspects|motor aspects
62835|NCT03811587|Diet|diet
62836|NCT03811587|Fasting|fasting
62837|NCT03811509|osteoporosis|osteoporosis
62838|NCT03811509|aromatase inhibitors|aromatase inhibitors
62839|NCT03811509|breast cancer|breast cancer
62840|NCT03811509|microindentation|microindentation
62841|NCT03811509|arthralgia|arthralgia
62842|NCT03811509|musculoskeletal pain|musculoskeletal pain
62843|NCT03811496|Parkinson disease|parkinson disease
62844|NCT03811496|Gaucher disease|gaucher disease
62845|NCT03811496|GBA gene|gba gene
62846|NCT03811496|alpha-synuclein|alpha-synuclein
62847|NCT03811483|Fluid Therapy|fluid therapy
62848|NCT03811483|Gender difference|gender difference
62849|NCT03811457|CAR-T cell, CD19, Lymphoma, Leukemia|car-t cell, cd19, lymphoma, leukemia
62850|NCT03811444|needlestick|needlestick
62851|NCT03811444|needlestick injury|needlestick injury
62852|NCT03811444|safety lancet|safety lancet
62853|NCT03811444|sharps injury prevention|sharps injury prevention
62854|NCT03811444|capillary blood sampling|capillary blood sampling
62855|NCT03811431|contrast enhanced ultrasound guided liver biopsy|contrast enhanced ultrasound guided liver biopsy
62856|NCT03811431|ultrasound guided liver biopsy|ultrasound guided liver biopsy
62857|NCT03811431|focal liver lesions|focal liver lesions
62858|NCT03811431|hepatocellular carcinoma|hepatocellular carcinoma
62859|NCT03811431|advanced chronic liver disease|advanced chronic liver disease
62860|NCT03811418|advanced breast cancer|advanced breast cancer
62861|NCT03811418|HER2-positive|her2-positive
62862|NCT03811418|metastatic|metastatic
62863|NCT03811418|inoperable|inoperable
62864|NCT03811418|female|female
62865|NCT03811418|quality of life|quality of life
62866|NCT03811405|Deep Brain Stimulation (DBS)|deep brain stimulation (dbs)
62867|NCT03811405|ventralis intermedius nucleus (VIN)|ventralis intermedius nucleus (vin)
62868|NCT03811405|implantable pulse generator (IPG)|implantable pulse generator (ipg)
62869|NCT03811405|Diffusion Tensor Imaging (DTI)|diffusion tensor imaging (dti)
62870|NCT03811379|Immunotherapy|immunotherapy
62871|NCT03811327|Zero-time Exercise|zero-time exercise
62872|NCT03811327|Depression|depression
62873|NCT03811327|Lifestyle|lifestyle
62874|NCT03811327|Behavioural Activation|behavioural activation
62875|NCT03811314|Dementia|dementia
62876|NCT03811275|upper extremity recovery of function|upper extremity recovery of function
62877|NCT03811275|action observation|action observation
62878|NCT03811275|virtual reality|virtual reality
62879|NCT03811275|task-based intervention|task-based intervention
62880|NCT03811262|PECS|pecs
62881|NCT03811262|ESP|esp
62882|NCT03811262|RCT|rct
62883|NCT03811249|Near Vision|near vision
62884|NCT03811249|Reading Vision|reading vision
62885|NCT03811249|Reading Glasses|reading glasses
62886|NCT03811249|Reading|reading
62887|NCT03811249|Readers|readers
62888|NCT03811249|Presbyopic|presbyopic
62889|NCT03811223|Postprandial hyperlipidemia|postprandial hyperlipidemia
62890|NCT03811223|Evolocumab|evolocumab
62891|NCT03811223|PCSK9 monoclonal antibody|pcsk9 monoclonal antibody
62892|NCT03811197|Obesity|obesity
62894|NCT03811197|Telemedicine|telemedicine
62895|NCT03811197|Hypnotic Suggestions|hypnotic suggestions
62896|NCT03811171|Stone|stone
62897|NCT03811171|Lithotripsy|lithotripsy
62898|NCT03811171|Calculi|calculi
62899|NCT03811145|Topical|topical
62900|NCT03811145|Gel|gel
62901|NCT03811145|Platelet|platelet
62902|NCT03811145|Growth factor|growth factor
62903|NCT03811145|Regenerative|regenerative
62904|NCT03811119|Vascular Closure Devices|vascular closure devices
62905|NCT03811119|Transcatheter Aortic Valve Implantation|transcatheter aortic valve implantation
62906|NCT03811106|Electrotherapy, Neuromuscular Electrical Stimulation, Stroke|electrotherapy, neuromuscular electrical stimulation, stroke
62907|NCT03811093|Adipose, Fat, Aesthetics, Skin, Weight Reduction,|adipose, fat, aesthetics, skin, weight reduction,
62908|NCT03811067|Postoperative pain|postoperative pain
62909|NCT03811067|Transversus abdominis plane block|transversus abdominis plane block
62910|NCT03811067|Rectus sheath block|rectus sheath block
62911|NCT03811067|Cesarean delivery|cesarean delivery
62912|NCT03811054|Apatinib|apatinib
62913|NCT03811054|Non Small Cell Lung Cancer|non small cell lung cancer
62914|NCT03811054|EGFR TKI|egfr tki
62915|NCT03811054|slowly progress|slowly progress
62916|NCT03810989|dermodialysis|dermodialysis
62917|NCT03810963|High intensity interval training|high intensity interval training
62918|NCT03810963|functional electrical stimulation cycling|functional electrical stimulation cycling
62919|NCT03810963|chronic spinal cord injury|chronic spinal cord injury
62920|NCT03810963|cardiometabolic disease risk|cardiometabolic disease risk
62921|NCT03810963|body composition|body composition
62922|NCT03810963|body fat percentage|body fat percentage
62923|NCT03810963|nutritional counseling|nutritional counseling
62924|NCT03810911|Forearm blood flow|forearm blood flow
62925|NCT03810911|Flow mediated dilatation|flow mediated dilatation
62926|NCT03810898|Huntington Disease|huntington disease
62927|NCT03810898|Huntington's Disease|huntington's disease
62928|NCT03810898|HD|hd
62929|NCT03810898|HDGEC|hdgec
62930|NCT03810898|Gene Expansion Carrier|gene expansion carrier
62931|NCT03810898|PET|pet
62932|NCT03810898|Tracer|tracer
62933|NCT03810898|Positron Emission Tomography|positron emission tomography
62934|NCT03810898|radioligand|radioligand
62935|NCT03810898|imaging|imaging
62936|NCT03810898|mHTT|mhtt
62937|NCT03810898|huntingtin|huntingtin
62938|NCT03810898|iMagemHTT|imagemhtt
62939|NCT03810885|24hr urine collection|24hr urine collection
62940|NCT03810859|Amelogenesis imperfecta|amelogenesis imperfecta
62941|NCT03810859|Dentinogenesis imperfecta|dentinogenesis imperfecta
62942|NCT03810859|Dentin anomalies|dentin anomalies
62943|NCT03810859|Whole Exome Study|whole exome study
62944|NCT03810846|Exercise|exercise
62945|NCT03810846|Physical Activity|physical activity
62946|NCT03810846|Football|football
62947|NCT03810846|Walking Football|walking football
62948|NCT03810846|Type 2 Diabetes|type 2 diabetes
62949|NCT03810846|Primary Health Care|primary health care
62950|NCT03810846|Feasibility|feasibility
62951|NCT03810846|Safety|safety
62952|NCT03810833|Glomerular Filtration Rate|glomerular filtration rate
62953|NCT03810820|TAVR|tavr
62954|NCT03810820|TAVI|tavi
62955|NCT03810820|Heart block|heart block
62956|NCT03810820|Atrial fibrillation|atrial fibrillation
62957|NCT03810820|Cardiac arrhythmias|cardiac arrhythmias
62958|NCT03810820|Permanent pacemaker|permanent pacemaker
62959|NCT03810820|Remote cardiac monitoring|remote cardiac monitoring
62960|NCT03810820|Loop monitor|loop monitor
62961|NCT03810807|Dacomitinib|dacomitinib
62962|NCT03810807|Osimertinib|osimertinib
62963|NCT03810807|EGFR Mutant Lung Cancers|egfr mutant lung cancers
62964|NCT03810807|18-411|18-411
62965|NCT03810794|Acupuncture Treatment|acupuncture treatment
62966|NCT03810794|Alzheimer's Disease|alzheimer's disease
62967|NCT03810781|Posturography|posturography
62968|NCT03810781|Spinal Cord Injury|spinal cord injury
62969|NCT03810768|pilot trial|pilot trial
62970|NCT03810768|muscle biopsy|muscle biopsy
62971|NCT03810768|blood metabolome|blood metabolome
62972|NCT03810729|Smartphone|smartphone
62973|NCT03810729|Coronary artery bypass grafting|coronary artery bypass grafting
62974|NCT03810729|Modified Allen's Test|modified allen's test
62975|NCT03810716|interactive platform|interactive platform
62976|NCT03810716|family planning|family planning
62977|NCT03810716|contraception|contraception
62978|NCT03810638|Heart Failure|heart failure
62979|NCT03810638|Heart Transplant|heart transplant
62980|NCT03810638|Left Ventricular Assist Device|left ventricular assist device
62981|NCT03810612|Adherence to treatment|adherence to treatment
62982|NCT03810612|Continuity of care|continuity of care
62983|NCT03810612|Health literacy|health literacy
62984|NCT03810612|Patient involvement|patient involvement
62985|NCT03810612|Patient preferences|patient preferences
62986|NCT03810612|Percutaneous coronary intervention|percutaneous coronary intervention
62987|NCT03810612|Rehabilitation|rehabilitation
62988|NCT03810599|Cardiac rehabilitation adherence|cardiac rehabilitation adherence
62989|NCT03810599|Patient-reported outcomes|patient-reported outcomes
62990|NCT03810599|Post-traumatic growth|post-traumatic growth
62992|NCT03810599|Depression|depression
62993|NCT03810599|Adherence|adherence
62994|NCT03810599|Lifestyle|lifestyle
62995|NCT03810599|Self-reported health|self-reported health
62996|NCT03810586|Hypertension|hypertension
62997|NCT03810586|Continuous Monitoring|continuous monitoring
62998|NCT03810586|Non-invasive Blood Pressure|non-invasive blood pressure
62999|NCT03810586|Non-invasive Monitoring|non-invasive monitoring
63000|NCT03810547|Abdominoplasty|abdominoplasty
63001|NCT03810547|spinal anesthesia|spinal anesthesia
63002|NCT03810547|general anesthesia|general anesthesia
63003|NCT03810547|postoperative pain|postoperative pain
63004|NCT03810534|Transitional Care|transitional care
63005|NCT03810534|Skilled Nursing Facilities|skilled nursing facilities
63006|NCT03810521|mesenchymal stromal cells|mesenchymal stromal cells
63007|NCT03810508|CMT4J|cmt4j
63008|NCT03810495|naltrexone|naltrexone
63009|NCT03810495|opioids|opioids
63010|NCT03810495|opioid use disorder|opioid use disorder
63011|NCT03810495|OLANI implant|olani implant
63012|NCT03810482|health related quality of life|health related quality of life
63013|NCT03810482|anxiety|anxiety
63014|NCT03810482|depression|depression
63015|NCT03810482|coping|coping
63016|NCT03810482|fatigue|fatigue
63017|NCT03810469|limb salvage|limb salvage
63018|NCT03810469|foot perfusion|foot perfusion
63019|NCT03810469|hybrid room|hybrid room
63020|NCT03810456|Cognitive Behavior Therapy|cognitive behavior therapy
63021|NCT03810443|Hyperventilation|hyperventilation
63022|NCT03810417|coronary artery bypass surgery|coronary artery bypass surgery
63023|NCT03810417|ouabain|ouabain
63024|NCT03810417|acute kidney injury|acute kidney injury
63025|NCT03810404|Sports nutrition|sports nutrition
63026|NCT03810404|Sodium bicarbonate|sodium bicarbonate
63027|NCT03810404|Physical capacity|physical capacity
63028|NCT03810404|Exercise performance|exercise performance
63029|NCT03810404|Buffering potential|buffering potential
63030|NCT03810404|Biochemical markers|biochemical markers
63031|NCT03810391|Butorphanol|butorphanol
63032|NCT03810391|preoperative anxiety|preoperative anxiety
63033|NCT03810391|sedation|sedation
63034|NCT03810391|recommend dose|recommend dose
63035|NCT03810378|Ketogenic diet|ketogenic diet
63036|NCT03810378|Mediterranean diet|mediterranean diet
63037|NCT03810378|Diabetes|diabetes
63038|NCT03810378|Prediabetes|prediabetes
63039|NCT03810352|ITP|itp
63040|NCT03810352|platelet function|platelet function
63041|NCT03810352|Sysmex|sysmex
63042|NCT03810339|Immune checkpoint inhibitor|immune checkpoint inhibitor
63043|NCT03810339|POLE/POLD mutation|pole/pold mutation
63044|NCT03810339|non-MSI-H|non-msi-h
63045|NCT03810313|Visual impairment|visual impairment
63046|NCT03810313|Macular edema|macular edema
63047|NCT03810313|Central retinal vein occlusion|central retinal vein occlusion
63048|NCT03810313|CRVO|crvo
63049|NCT03810313|Brolucizumab|brolucizumab
63050|NCT03810313|Aflibercept|aflibercept
63051|NCT03810313|Vascular endothelial growth factor|vascular endothelial growth factor
63052|NCT03810313|VEGF|vegf
63053|NCT03810313|anti-VEGF|anti-vegf
63054|NCT03810300|Cash transfers|cash transfers
63055|NCT03810300|Food transfers|food transfers
63056|NCT03810300|Behavior change communication|behavior change communication
63057|NCT03810300|Sustainability|sustainability
63058|NCT03810300|Social protection|social protection
63059|NCT03810300|Nutrition|nutrition
63060|NCT03810300|Gender|gender
63061|NCT03810248|sleep bruxism|sleep bruxism
63062|NCT03810248|polisomnography|polisomnography
63063|NCT03810235|lidocaine|lidocaine
63064|NCT03810235|patch|patch
63065|NCT03810222|TBI moderate, TBI severe, GOSE|tbi moderate, tbi severe, gose
63066|NCT03810183|QAW039,|qaw039,
63067|NCT03810183|Chronic obstructive pulmonary disease,|chronic obstructive pulmonary disease,
63068|NCT03810183|COPD, sputum,|copd, sputum,
63069|NCT03810183|eosinophillic,|eosinophillic,
63070|NCT03810183|eosinophilia,|eosinophilia,
63071|NCT03810183|prostaglandin D2 receptor,|prostaglandin d2 receptor,
63072|NCT03810183|DP2,|dp2,
63073|NCT03810183|CRTh2,|crth2,
63074|NCT03810183|fevipiprant|fevipiprant
63075|NCT03810157|laser-assisted hatching (LAH)|laser-assisted hatching (lah)
63076|NCT03810157|zona pellucida|zona pellucida
63077|NCT03810157|cryopreservation|cryopreservation
63078|NCT03810157|pregnancy outcomes|pregnancy outcomes
63079|NCT03810131|Acceptance and Commitment Therapy|acceptance and commitment therapy
63080|NCT03810105|radical prostatectomy|radical prostatectomy
63081|NCT03810105|Olaparib|olaparib
63082|NCT03810105|Durvalumab|durvalumab
63083|NCT03810105|Castration Sensitive Biochemically Recurrent Non-Metastatic Prostate Cancer|castration sensitive biochemically recurrent non-metastatic prostate cancer
63084|NCT03810105|18-480|18-480
63085|NCT03810105|Memorial Sloan Kettering Cancer Center|memorial sloan kettering cancer center
63086|NCT03810079|transcranial direct current stimulation|transcranial direct current stimulation
63087|NCT03810079|minimally conscious state|minimally conscious state
63088|NCT03810079|disorders of consciousness|disorders of consciousness
63089|NCT03810079|non invasive brain stimulation|non invasive brain stimulation
63090|NCT03810079|neuromodulation|neuromodulation
63091|NCT03810040|Embryos quality|embryos quality
63092|NCT03810040|In vitro fertilization|in vitro fertilization
63093|NCT03810040|Denuding pipette|denuding pipette
63094|NCT03810027|Nocturnal polyuria|nocturnal polyuria
63095|NCT03810027|Overactive bladder|overactive bladder
63096|NCT03810014|rapid diagnostic test (RDT)|rapid diagnostic test (rdt)
63097|NCT03810014|Artemisinin combination therapy (ACT)|artemisinin combination therapy (act)
63098|NCT03810014|Conditional subsidy|conditional subsidy
63099|NCT03810014|Private retail sector|private retail sector
63100|NCT03810001|oocyte activation|oocyte activation
63101|NCT03810001|intracytoplasmic sperm injection(ICSI)|intracytoplasmic sperm injection(icsi)
63102|NCT03810001|mechanical stimulation|mechanical stimulation
63103|NCT03810001|2PN rate|2pn rate
63104|NCT03809988|HR|hr
63105|NCT03809988|breast cancer|breast cancer
63106|NCT03809988|ABC|abc
63107|NCT03809988|progesterone receptor|progesterone receptor
63108|NCT03809988|HER2|her2
63109|NCT03809988|advanced|advanced
63110|NCT03809988|estrogen receptor|estrogen receptor
63111|NCT03809975|Knee|knee
63112|NCT03809975|Osteoarthritis|osteoarthritis
63113|NCT03809975|Model of care|model of care
63114|NCT03809975|Multi-disciplinary|multi-disciplinary
63115|NCT03809936|tDCS|tdcs
63116|NCT03809936|EEG|eeg
63117|NCT03809923|Lidocaine|lidocaine
63118|NCT03809923|Dexmedetomidine|dexmedetomidine
63119|NCT03809923|Postoperative nausea and vomiting|postoperative nausea and vomiting
63120|NCT03809923|laparoscopic hysterectomy|laparoscopic hysterectomy
63121|NCT03809910|Oral Health, Dental care, Lifestyle|oral health, dental care, lifestyle
63122|NCT03809884|High blood pressure|high blood pressure
63123|NCT03809884|Potassium|potassium
63124|NCT03809884|Potassium Citrate|potassium citrate
63125|NCT03809884|Dietary Counselling|dietary counselling
63126|NCT03809884|Hypertension|hypertension
63127|NCT03809871|exercise training|exercise training
63128|NCT03809871|weight management|weight management
63129|NCT03809871|biomarkers|biomarkers
63130|NCT03809858|Klue|klue
63131|NCT03809858|Meal bolus|meal bolus
63132|NCT03809858|Bolus reminder|bolus reminder
63133|NCT03809819|Laparoscopic Vecchietti vaginoplasty|laparoscopic vecchietti vaginoplasty
63134|NCT03809819|sexual function|sexual function
63135|NCT03809819|urinary incontinence|urinary incontinence
63136|NCT03809806|vaginal stump prolapse|vaginal stump prolapse
63137|NCT03809806|sexual function|sexual function
63138|NCT03809806|quality of life|quality of life
63139|NCT03809741|Infection prevention and control|infection prevention and control
63140|NCT03809741|Alcoholic hand rubs|alcoholic hand rubs
63141|NCT03809741|Intrapartum care|intrapartum care
63142|NCT03809741|Postpartum care|postpartum care
63143|NCT03809741|Infection Control Assessment Tool (ICAT)|infection control assessment tool (icat)
63144|NCT03809741|Rural Zambia|rural zambia
63145|NCT03809702|Herpes Zoster|herpes zoster
63146|NCT03809702|Herpetic neuralgia|herpetic neuralgia
63147|NCT03809702|Pregabalin|pregabalin
63148|NCT03809689|Acute myocardial infarction|acute myocardial infarction
63149|NCT03809689|Myocardial reperfusion treatment|myocardial reperfusion treatment
63150|NCT03809689|Chronic ischemic occlusion|chronic ischemic occlusion
63151|NCT03809689|68Ga-NODAGA-RGD|68ga-nodaga-rgd
63152|NCT03809663|Atopic Dermatitis|atopic dermatitis
63153|NCT03809663|eczema|eczema
63154|NCT03809663|tezepelumab|tezepelumab
63155|NCT03809663|dermatology|dermatology
63156|NCT03809663|dermatitis|dermatitis
63157|NCT03809663|inflammation|inflammation
63158|NCT03809663|skin|skin
63159|NCT03809663|moderate dermatitis|moderate dermatitis
63160|NCT03809663|severe dermatitis|severe dermatitis
63161|NCT03809650|CTEPH|cteph
63162|NCT03809650|chronic thromboembolic pulmonary hypertension|chronic thromboembolic pulmonary hypertension
63163|NCT03809650|macitentan|macitentan
63164|NCT03809624|Phase 1|phase 1
63165|NCT03809624|Phase 1 Clinical Trial|phase 1 clinical trial
63166|NCT03809624|Solid Tumors|solid tumors
63167|NCT03809624|Hodgkin Lymphoma|hodgkin lymphoma
63168|NCT03809624|Non Hodgkin Lymphoma|non hodgkin lymphoma
63169|NCT03809624|Lung Cancer|lung cancer
63170|NCT03809624|Melanoma|melanoma
63171|NCT03809624|Head and Neck Cancer|head and neck cancer
63172|NCT03809624|Stomach Cancer|stomach cancer
63173|NCT03809624|Gastric Cancer|gastric cancer
63174|NCT03809624|Kidney Cancer|kidney cancer
63175|NCT03809624|Renal cell carcinoma|renal cell carcinoma
63176|NCT03809624|Renal Cancer|renal cancer
63177|NCT03809624|Urothelial Carcinoma|urothelial carcinoma
63178|NCT03809624|PDL1|pdl1
63179|NCT03809624|41BB|41bb
63180|NCT03809624|PD-L1|pd-l1
63181|NCT03809624|4-1BB|4-1bb
63182|NCT03809611|Presbyopia, adults, randomized study, placebo|presbyopia, adults, randomized study, placebo
63183|NCT03809598|Infant MRI|infant mri
63184|NCT03809598|Brain Development|brain development
63185|NCT03809598|MBCT|mbct
63186|NCT03809598|Mindfulness|mindfulness
63187|NCT03809585|Iris|iris
63188|NCT03809585|Tumor|tumor
63189|NCT03809585|Melanoma|melanoma
63287|NCT03808961|Niacin|niacin
63192|NCT03809572|fMRI|fmri
63193|NCT03809572|pregnancy|pregnancy
63194|NCT03809572|postpartum|postpartum
63195|NCT03809572|MBCT|mbct
63196|NCT03809572|Mindfulness Based Cognitive Therapy|mindfulness based cognitive therapy
63197|NCT03809572|emotion regulation|emotion regulation
63198|NCT03809559|Magnetic Resonance Cholangiopancreatography (MRCP)|magnetic resonance cholangiopancreatography (mrcp)
63199|NCT03809507|opioids|opioids
63200|NCT03809494|lower extremity|lower extremity
63201|NCT03809494|Peripheral Arterial Disease|peripheral arterial disease
63202|NCT03809494|Ischemia|ischemia
63203|NCT03809494|Peripheral Blood Stem Cell Transplantation|peripheral blood stem cell transplantation
63204|NCT03809494|Leukocytes, Mononuclear|leukocytes, mononuclear
63205|NCT03809494|Transplantation, Autologous|transplantation, autologous
63206|NCT03809468|patient satisfaction, hysterectomy, follow up|patient satisfaction, hysterectomy, follow up
63207|NCT03809455|Breakthrough Pain|breakthrough pain
63211|NCT03809403|Colorectal cancer|colorectal cancer
63212|NCT03809403|Surgical Technic|surgical technic
63213|NCT03809403|No touch technic|no touch technic
63214|NCT03809403|Circulating Tumor DNA|circulating tumor dna
63215|NCT03809403|Circulating Tumor Cells|circulating tumor cells
63216|NCT03809390|Body mass index|body mass index
63217|NCT03809390|Allergic risk|allergic risk
63218|NCT03809390|Vaginal seeding|vaginal seeding
63219|NCT03809390|Randomized controlled study|randomized controlled study
63220|NCT03809390|Caesarean delivery|caesarean delivery
63221|NCT03809390|Overweight and obesity|overweight and obesity
63222|NCT03809364|Couple-based intervention|couple-based intervention
63223|NCT03809364|Antiretroviral therapy|antiretroviral therapy
63224|NCT03809364|South Africa|south africa
63225|NCT03809312|ESS|ess
63226|NCT03809312|Prophylactic antibiotics|prophylactic antibiotics
63227|NCT03809312|Chronic sinus infection|chronic sinus infection
63228|NCT03809299|Caloric restriction|caloric restriction
63229|NCT03809299|Fasting|fasting
63230|NCT03809299|intermittent fasting|intermittent fasting
63231|NCT03809299|isocaloric ad lib meal timing|isocaloric ad lib meal timing
63232|NCT03809299|Twice-a-day feeding|twice-a-day feeding
63233|NCT03809299|insulin|insulin
63234|NCT03809299|glucose metabolism|glucose metabolism
63235|NCT03809299|normoglycemia|normoglycemia
63236|NCT03809299|hyperglycemia|hyperglycemia
63237|NCT03809286|rTMS|rtms
63238|NCT03809286|alcohol use disorder|alcohol use disorder
63239|NCT03809273|Cardiopulmonary Exercise Test|cardiopulmonary exercise test
63240|NCT03809221|down-regulation|down-regulation
63241|NCT03809221|controlled ovarian hyperstimulation|controlled ovarian hyperstimulation
63242|NCT03809221|IVF/ICSI|ivf/icsi
63243|NCT03809195|hypnosis|hypnosis
63244|NCT03809195|inflammatory bowel disease|inflammatory bowel disease
63245|NCT03809195|mind-body|mind-body
63246|NCT03809195|brain-gut|brain-gut
63247|NCT03809195|hypnotherapy|hypnotherapy
63248|NCT03809195|quality of life|quality of life
63249|NCT03809195|psychosocial|psychosocial
63250|NCT03809182|Impaired Glucose Tolerance|impaired glucose tolerance
63251|NCT03809182|Obese patients|obese patients
63252|NCT03809182|Dexmedetomidine|dexmedetomidine
63253|NCT03809169|peripheral endobronchial ultrasound|peripheral endobronchial ultrasound
63254|NCT03809169|radial endobronchial ultrasound|radial endobronchial ultrasound
63255|NCT03809169|guide sheath|guide sheath
63256|NCT03809169|ultrathin bronchoscope|ultrathin bronchoscope
63257|NCT03809169|peripheral pulmonary lesion|peripheral pulmonary lesion
63258|NCT03809156|Pulmonary Hypertension|pulmonary hypertension
63259|NCT03809104|virtual reality|virtual reality
63260|NCT03809104|sarcopenia|sarcopenia
63261|NCT03809104|elderly|elderly
63262|NCT03809078|Prostate Cancer|prostate cancer
63263|NCT03809065|Deliberate hypotension|deliberate hypotension
63264|NCT03809065|Nitroglycerin|nitroglycerin
63265|NCT03809065|Labetalol|labetalol
63266|NCT03809065|Peripheral perfusion|peripheral perfusion
63267|NCT03809052|GB1211|gb1211
63268|NCT03809052|Phase 1|phase 1
63269|NCT03809052|First Time in Human|first time in human
63270|NCT03809052|Safety|safety
63271|NCT03809052|Tolerability|tolerability
63272|NCT03809052|Pharmacokinetics|pharmacokinetics
63273|NCT03809052|Single Ascending Dose (SAD)|single ascending dose (sad)
63274|NCT03809052|Multiple Ascending Dose (MAD)|multiple ascending dose (mad)
63275|NCT03809052|Healthy Volunteers|healthy volunteers
63276|NCT03809052|Nonalcoholic Steatohepatitis (NASH)|nonalcoholic steatohepatitis (nash)
63277|NCT03809052|Liver Fibrosis|liver fibrosis
63278|NCT03809026|Azoospermia|azoospermia
63279|NCT03809026|micro-TESE|micro-tese
63280|NCT03809026|Klinefelter's syndrome|klinefelter's syndrome
63281|NCT03809026|Cryptorchidism|cryptorchidism
63282|NCT03809026|Vitrified oocytes|vitrified oocytes
63283|NCT03809000|Post-prostatectomy|post-prostatectomy
63284|NCT03809000|Enzalutamide|enzalutamide
63285|NCT03809000|STEEL|steel
63286|NCT03808961|Parkinson's disease, Niacin, Niacinamide|parkinson's disease, niacin, niacinamide
63288|NCT03808961|Niacinamide|niacinamide
63289|NCT03808948|congestive heart failure|congestive heart failure
63290|NCT03808948|glomerular filtration rate|glomerular filtration rate
63291|NCT03808948|plasma volume|plasma volume
63292|NCT03808935|epilepsy|epilepsy
63293|NCT03808935|drug resistant|drug resistant
63294|NCT03808935|refractory|refractory
63295|NCT03808935|seizures|seizures
63296|NCT03808935|cannabidiol|cannabidiol
63298|NCT03808935|cannabis|cannabis
63299|NCT03808922|Parainfluenza|parainfluenza
63300|NCT03808922|PIV|piv
63301|NCT03808922|Immunocompromised|immunocompromised
63302|NCT03808922|Lower Respiratory Tract Infection|lower respiratory tract infection
63303|NCT03808922|LRTI|lrti
63304|NCT03808883|Barriers to Healthcare Access|barriers to healthcare access
63305|NCT03808883|Participatory Action Research|participatory action research
63306|NCT03808883|Cultural Competency|cultural competency
63307|NCT03808857|recurrent Metastatic Cervical Cancer|recurrent metastatic cervical cancer
63308|NCT03808857|platinum|platinum
63309|NCT03808831|Fall detection|fall detection
63310|NCT03808831|Fall prevention|fall prevention
63311|NCT03808831|Accelerometer|accelerometer
63312|NCT03808831|Elderly|elderly
63313|NCT03808792|Ovarian cancer|ovarian cancer
63314|NCT03808792|Ultrasound|ultrasound
63315|NCT03808792|CT|ct
63316|NCT03808792|WB-DW/MRI|wb-dw/mri
63317|NCT03808792|Imaging|imaging
63318|NCT03808779|Papillary Thyroid Microcarcinoma|papillary thyroid microcarcinoma
63319|NCT03808779|Radiofrequency Ablation|radiofrequency ablation
63320|NCT03808779|Surgery|surgery
63321|NCT03808753|Mini Fluid Challenge|mini fluid challenge
63322|NCT03808753|End-expiratory occlusion test|end-expiratory occlusion test
63323|NCT03808753|Fluid responsiveness|fluid responsiveness
63324|NCT03808753|Functional Hemodynamic Test|functional hemodynamic test
63325|NCT03808727|cognitive processing therapy|cognitive processing therapy
63326|NCT03808727|CPT|cpt
63327|NCT03808727|PTSD|ptsd
63328|NCT03808727|military|military
63329|NCT03808714|african american, smoking cessation, rural, young adults|african american, smoking cessation, rural, young adults
63330|NCT03808701|SCT200|sct200
63331|NCT03808701|Squamous non-small cell Lung cancer|squamous non-small cell lung cancer
63332|NCT03808701|NSCLC|nsclc
63333|NCT03808675|Parkinson's disease|parkinson's disease
63334|NCT03808675|Exercise|exercise
63335|NCT03808675|Aerobic exercise|aerobic exercise
63336|NCT03808675|Cognition|cognition
63337|NCT03808675|Driving|driving
63338|NCT03808675|Diffusion tensor imaging|diffusion tensor imaging
63339|NCT03808675|DTI|dti
63340|NCT03808675|MRI|mri
63341|NCT03808675|Depression|depression
63342|NCT03808675|Cardiorespiratory Fitness|cardiorespiratory fitness
63343|NCT03808675|Quality of life|quality of life
63344|NCT03808675|Health education|health education
63345|NCT03808675|Executive functions|executive functions
63346|NCT03808662|SBRT|sbrt
63347|NCT03808662|Stereotactic Body Radiotherapy|stereotactic body radiotherapy
63348|NCT03808662|Non-hematology metatstatic cancer|non-hematology metatstatic cancer
63349|NCT03808662|non-CNS oligo-progressive disease|non-cns oligo-progressive disease
63350|NCT03808662|intracranial metastatic disease|intracranial metastatic disease
63351|NCT03808662|Memorial Sloan Kettering Cancer Center|memorial sloan kettering cancer center
63352|NCT03808662|18-431|18-431
63353|NCT03808623|cartilage defect|cartilage defect
63354|NCT03808623|knee|knee
63355|NCT03808623|AMIC|amic
63356|NCT03808597|digital health|digital health
818443|NCT00165984|hypoplastic|hypoplastic
63357|NCT03808597|digital health promotion|digital health promotion
63358|NCT03808597|health promotion|health promotion
63359|NCT03808597|disease prevention|disease prevention
63360|NCT03808597|HIV|hiv
63361|NCT03808597|Tuberculosis|tuberculosis
63362|NCT03808597|Cysticercosis|cysticercosis
63363|NCT03808584|Core muscle exercise|core muscle exercise
63364|NCT03808584|rehabilitation|rehabilitation
63365|NCT03808584|Incisional hernia|incisional hernia
63366|NCT03808519|n3 PUFA|n3 pufa
63367|NCT03808506|Ulcerative colitis|ulcerative colitis
63368|NCT03808506|Therapeutic drug monitoring|therapeutic drug monitoring
63369|NCT03808506|fecal calprotectin|fecal calprotectin
63370|NCT03808506|adalimumab|adalimumab
63371|NCT03808506|bowel ultrasound|bowel ultrasound
63372|NCT03808467|Cognitive Remediation|cognitive remediation
63373|NCT03808467|Neuropsychology|neuropsychology
63374|NCT03808467|Neuropsychological Tests|neuropsychological tests
63375|NCT03808454|Platelet rich plasma, proprioception, ankle sprain|platelet rich plasma, proprioception, ankle sprain
63376|NCT03808441|Circulating tumour DNA|circulating tumour dna
63377|NCT03808441|targeted therapy|targeted therapy
63378|NCT03808441|immune therapy|immune therapy
63379|NCT03808441|dabrafenib|dabrafenib
63380|NCT03808441|trametinib|trametinib
63381|NCT03808441|ipilimumab|ipilimumab
63382|NCT03808441|nivolumab|nivolumab
63383|NCT03808402|Surfactant|surfactant
63384|NCT03808402|Less Invasive Surfactant Administration|less invasive surfactant administration
63385|NCT03808402|Mechanical Ventilation|mechanical ventilation
63386|NCT03808389|Parkinson's disease|parkinson's disease
63387|NCT03808389|Fecal microbiota transplantation|fecal microbiota transplantation
63389|NCT03808389|Gut-brain axis|gut-brain axis
63390|NCT03808363|Metabolic Syndrome|metabolic syndrome
63391|NCT03808363|Spinal Cord Injury|spinal cord injury
63392|NCT03808363|Cardiovascular Disease|cardiovascular disease
63393|NCT03808363|High Intensity Interval Training|high intensity interval training
63394|NCT03808337|Stereotactic body radiotherapy|stereotactic body radiotherapy
63395|NCT03808337|SBRT|sbrt
63396|NCT03808337|18-486|18-486
63397|NCT03808337|Memorial Sloan Kettering Cancer Center|memorial sloan kettering cancer center
63398|NCT03808285|bone and joint infection|bone and joint infection
63399|NCT03808285|osteomyelitis|osteomyelitis
63400|NCT03808285|mandibular|mandibular
63401|NCT03808285|denosumab|denosumab
63402|NCT03808207|Docosahexaenoic acid|docosahexaenoic acid
63403|NCT03808207|LcPufas|lcpufas
63404|NCT03808207|Diet|diet
63405|NCT03808207|Human milk|human milk
63406|NCT03808207|gas chromatography|gas chromatography
63407|NCT03808155|Urinary retention|urinary retention
63408|NCT03808155|Tamsulosin|tamsulosin
63409|NCT03808129|erector spinae plane block|erector spinae plane block
63410|NCT03808129|postoperative analgesia|postoperative analgesia
63411|NCT03808129|RSO2|rso2
63412|NCT03808116|breast biopsy|breast biopsy
63413|NCT03808103|Phage|phage
63414|NCT03808103|Bacteriophage|bacteriophage
63415|NCT03808103|AIEC|aiec
63416|NCT03808090|oxalate|oxalate
63417|NCT03808090|obesity|obesity
63418|NCT03808090|kidney stones|kidney stones
63419|NCT03808090|diabetes|diabetes
63420|NCT03808077|prostate cancer|prostate cancer
63421|NCT03808077|robotic surgery|robotic surgery
63422|NCT03808077|muscle relaxants|muscle relaxants
63423|NCT03808077|neuromuscular blockade|neuromuscular blockade
63424|NCT03808077|18-408|18-408
63425|NCT03808077|Memorial Sloan Kettering Cancer Center|memorial sloan kettering cancer center
63426|NCT03808051|Preterm infant|preterm infant
63427|NCT03808051|Cord clamping|cord clamping
63428|NCT03808051|Resuscitation|resuscitation
63429|NCT03808038|Lower Urinary Tract Symptoms|lower urinary tract symptoms
63430|NCT03808038|Bladder Symptoms|bladder symptoms
63431|NCT03808038|Recall|recall
63432|NCT03808038|Lower Urinary Tract Dysfunction|lower urinary tract dysfunction
63433|NCT03807986|Striae Distensae|striae distensae
63434|NCT03807986|Platelet-Rich Plasma (PRP)|platelet-rich plasma (prp)
63435|NCT03807986|Nanofat Graft|nanofat graft
63436|NCT03807986|Microfat Graft|microfat graft
63437|NCT03807986|Combination Therapy|combination therapy
63438|NCT03807947|embolisation, therapeutic|embolisation, therapeutic
63439|NCT03807947|Embolization, Therapeutic|embolization, therapeutic
63440|NCT03807947|Hepatocellular Carcinoma|hepatocellular carcinoma
63441|NCT03807947|HCC|hcc
63442|NCT03807947|TAE|tae
63443|NCT03807934|transcranial direct current stimulation|transcranial direct current stimulation
63444|NCT03807934|cognitive psychology|cognitive psychology
63445|NCT03807934|noninvasive brain stimulation|noninvasive brain stimulation
63446|NCT03807934|electrical brain stimulation|electrical brain stimulation
63447|NCT03807921|aortic valve replacement|aortic valve replacement
63448|NCT03807921|bioprosthesis|bioprosthesis
63449|NCT03807921|anticoagulation|anticoagulation
63450|NCT03807908|Pregnancy|pregnancy
63451|NCT03807908|Low back pain|low back pain
63452|NCT03807908|Pelvic girdle pain|pelvic girdle pain
63453|NCT03807908|Kinesiotape|kinesiotape
63454|NCT03807895|career indecision|career indecision
63455|NCT03807895|career decision-making difficulties|career decision-making difficulties
63456|NCT03807895|worry|worry
63457|NCT03807895|psychological distress|psychological distress
63458|NCT03807882|M-ECT|m-ect
63459|NCT03807882|Clozapine|clozapine
63460|NCT03807882|Psychopathology|psychopathology
63461|NCT03807882|Cerebral hemodynamics|cerebral hemodynamics
63462|NCT03807869|I-stent|i-stent
63463|NCT03807869|glaucoma surgery|glaucoma surgery
63464|NCT03807869|minimally invasive glaucoma surgery|minimally invasive glaucoma surgery
63465|NCT03807791|Vitamine C deficiency|vitamine c deficiency
63466|NCT03807791|skin rash|skin rash
63467|NCT03807791|scurvy|scurvy
63468|NCT03807791|food texture|food texture
63469|NCT03807791|geriatric institution|geriatric institution
63470|NCT03807791|Unit Of Long Term Care|unit of long term care
63471|NCT03807765|breast cancer|breast cancer
63472|NCT03807765|brain metastases|brain metastases
63473|NCT03807752|Dietary Supplements|dietary supplements
63474|NCT03807752|Fish Proteins|fish proteins
63475|NCT03807752|Protein Hydrolysates|protein hydrolysates
63476|NCT03807726|Breastfeeding, self-efficacy, education, intervention|breastfeeding, self-efficacy, education, intervention
63477|NCT03807700|Denture, Adhesive, Gum-Health, Lifestyle|denture, adhesive, gum-health, lifestyle
63478|NCT03807674|Calcium-silicate, coronal pulpotomy, MMP-9, symptomatic pulpitis.|calcium-silicate, coronal pulpotomy, mmp-9, symptomatic pulpitis.
63479|NCT03807661|Desert foot|desert foot
63480|NCT03807661|No-option patients|no-option patients
63481|NCT03807661|Venous arterialization|venous arterialization
63482|NCT03807635|needlestick|needlestick
63483|NCT03807635|needlestick injury|needlestick injury
63484|NCT03807635|safety lancet|safety lancet
63485|NCT03807635|sharps injury prevention|sharps injury prevention
63486|NCT03807635|capillary blood sampling|capillary blood sampling
63487|NCT03807622|Elective Major Cardiothoracic|elective major cardiothoracic
63488|NCT03807622|Mitral Valve Surgery|mitral valve surgery
63489|NCT03807622|Coronary Artery Bypass Grafting|coronary artery bypass grafting
63490|NCT03807609|appetite control|appetite control
63492|NCT03807609|Adolescents|adolescents
63493|NCT03807609|exercise timing|exercise timing
63494|NCT03807570|Morus Alba L. Extract|morus alba l. extract
63495|NCT03807570|Clinical Trial|clinical trial
63496|NCT03807557|Stroke rehabilitation|stroke rehabilitation
63497|NCT03807557|Botulinum toxin type A injection|botulinum toxin type a injection
63498|NCT03807557|robot-assisted therapy|robot-assisted therapy
63499|NCT03807557|Constraint-induced movement therapy|constraint-induced movement therapy
63500|NCT03807557|spasticity|spasticity
63501|NCT03807544|AUD|aud
63502|NCT03807544|TENS|tens
63503|NCT03807518|Oesophageal Cancer|oesophageal cancer
63504|NCT03807518|Gastric Cancer|gastric cancer
63505|NCT03807518|Physical Fitness|physical fitness
63506|NCT03807479|CP-CML|cp-cml
63507|NCT03807479|CML in chronic phase|cml in chronic phase
63508|NCT03807479|Chronic Myelogenous Leukemia|chronic myelogenous leukemia
63509|NCT03807479|Leukemia, Myelogenous, Chronic, BCR-ABL Positive|leukemia, myelogenous, chronic, bcr-abl positive
63510|NCT03807453|Psoriasis Vulgaris|psoriasis vulgaris
63511|NCT03807453|Seborrheic Dermatitis|seborrheic dermatitis
63512|NCT03807453|Scalp|scalp
63513|NCT03807453|Microbiome|microbiome
63514|NCT03807427|Adolescents|adolescents
63515|NCT03807427|Mental Health|mental health
63516|NCT03807427|Prevention|prevention
63517|NCT03807427|Emotion Regulation|emotion regulation
63518|NCT03807427|Global Mental Health|global mental health
63519|NCT03807414|intensive care unit|intensive care unit
63520|NCT03807414|regisrty|regisrty
63521|NCT03807414|endotoxin|endotoxin
63522|NCT03807414|heparin|heparin
63523|NCT03807401|Virtual Reality|virtual reality
63524|NCT03807401|prismatic adaptation|prismatic adaptation
63525|NCT03807401|motor imagery|motor imagery
63526|NCT03807388|eHealth|ehealth
63527|NCT03807388|mHealth|mhealth
63528|NCT03807388|smartphone|smartphone
63529|NCT03807388|app|app
63530|NCT03807388|psychosis|psychosis
63531|NCT03807388|adherence|adherence
63532|NCT03807388|early intervention|early intervention
63533|NCT03807375|CPAP(Continuous Positive Airway Pressure)|cpap(continuous positive airway pressure)
63534|NCT03807375|Standard preoxygenation|standard preoxygenation
63535|NCT03807349|Cannulated Screws|cannulated screws
63536|NCT03807349|Augmentation|augmentation
63537|NCT03807323|Primary intervention|primary intervention
63538|NCT03807310|COPD|copd
63539|NCT03807310|nutrient supplementation|nutrient supplementation
63540|NCT03807310|Physical activity|physical activity
63541|NCT03807310|Health related quality of life|health related quality of life
63542|NCT03807297|total intravenous anesthesia|total intravenous anesthesia
63543|NCT03807284|Feasibility|feasibility
63544|NCT03807284|Confidence|confidence
63545|NCT03807284|group intervention|group intervention
63546|NCT03807284|Psycho-social intervention|psycho-social intervention
63547|NCT03807284|Stroke recovery|stroke recovery
63548|NCT03807271|Anesthesia, Methods|anesthesia, methods
63549|NCT03807271|Anesthesia, Analysis|anesthesia, analysis
82756|NCT03685591|HR+|hr+
63550|NCT03807271|Patient Safety|patient safety
63551|NCT03807271|Anesthetics/administration and dosage|anesthetics/administration and dosage
63552|NCT03807258|COPD|copd
63553|NCT03807258|Transcranial magnetic stimulation|transcranial magnetic stimulation
63554|NCT03807258|Motor-evoked potentials|motor-evoked potentials
63555|NCT03807258|Muscle weakness|muscle weakness
63556|NCT03807258|Interhemispheric|interhemispheric
63557|NCT03807258|Inhibition|inhibition
63558|NCT03807232|ARDS, Human|ards, human
63559|NCT03807232|Burns|burns
63560|NCT03807232|Lung Diseases|lung diseases
63561|NCT03807232|Risk Factors|risk factors
63562|NCT03807232|Retrospective Studies|retrospective studies
63563|NCT03807232|Decision Support Techniques|decision support techniques
63564|NCT03807219|nocturnal legs cramps|nocturnal legs cramps
63565|NCT03807219|legs cramps|legs cramps
63566|NCT03807219|NLC|nlc
63567|NCT03807193|Worry|worry
63568|NCT03807180|Tai Chi|tai chi
63569|NCT03807180|ankylosing spondylitis|ankylosing spondylitis
63570|NCT03807180|functionality|functionality
63571|NCT03807154|Loneliness|loneliness
63572|NCT03807154|ICBT|icbt
63573|NCT03807154|Internet-based psychotherapy|internet-based psychotherapy
63574|NCT03807154|Cognitive behavioral therapy|cognitive behavioral therapy
63575|NCT03807154|Interpersonal psychotherapy|interpersonal psychotherapy
63576|NCT03807128|Myeloma|myeloma
63577|NCT03807128|Cohort|cohort
63578|NCT03807128|Resistance|resistance
63579|NCT03807128|Quality of life|quality of life
63580|NCT03807115|Stroke|stroke
63581|NCT03807115|Rehabilitation|rehabilitation
63582|NCT03807115|Knowledge translation intervention|knowledge translation intervention
63583|NCT03807115|Walking capacity|walking capacity
63584|NCT03807102|Lung Cancer|lung cancer
63585|NCT03807089|Colonoscopy|colonoscopy
63586|NCT03807089|colon cancer screening|colon cancer screening
63587|NCT03807050|Pharmacokinetics|pharmacokinetics
63588|NCT03807037|atrial fibrillation,tocotrienol,coronary artery bypass grafting|atrial fibrillation,tocotrienol,coronary artery bypass grafting
63589|NCT03807024|Overactive bladder|overactive bladder
63590|NCT03807024|Bladder diary|bladder diary
63591|NCT03807011|Emergence Agitation|emergence agitation
63592|NCT03807011|fentanyl|fentanyl
63593|NCT03807011|remifentanil|remifentanil
63594|NCT03807011|children|children
63595|NCT03806985|psilocybin|psilocybin
63596|NCT03806972|acute heart failure prognosis|acute heart failure prognosis
63597|NCT03806920|Isomaltulose|isomaltulose
63598|NCT03806920|Palatinose|palatinose
63599|NCT03806920|second meal effect|second meal effect
63600|NCT03806920|incretin|incretin
63602|NCT03806920|GLP-1|glp-1
63603|NCT03806920|postprandial inflammation|postprandial inflammation
63604|NCT03806907|INSITIGATE|insitigate
63605|NCT03806907|Pulmonary Hypertension|pulmonary hypertension
63606|NCT03806907|Pulmonary embolism|pulmonary embolism
63607|NCT03806907|Chronic Thromboembolism|chronic thromboembolism
63608|NCT03806907|Iodine Subtraction|iodine subtraction
63609|NCT03806868|COPD|copd
63610|NCT03806855|Health Related Quality of Life|health related quality of life
63611|NCT03806855|Overactive Bladder|overactive bladder
63612|NCT03806855|Bladder Diary|bladder diary
63613|NCT03806842|shoulder arthroplasty|shoulder arthroplasty
63614|NCT03806842|reverse shoulder replacement|reverse shoulder replacement
63615|NCT03806829|antioxidants|antioxidants
63616|NCT03806829|polyphenols|polyphenols
63617|NCT03806829|flow-mediated dilatation|flow-mediated dilatation
63618|NCT03806816|autophagy|autophagy
63619|NCT03806816|neuroprotection|neuroprotection
63620|NCT03806816|melatonin|melatonin
63621|NCT03806816|Hypoxic-Ischemic Encephalopathy|hypoxic-ischemic encephalopathy
63622|NCT03806816|hypothermia|hypothermia
63623|NCT03806816|newborn|newborn
63624|NCT03806816|neurological outcome|neurological outcome
63625|NCT03806816|perinatal asphyxia|perinatal asphyxia
63626|NCT03806777|dexmedetomidine|dexmedetomidine
63627|NCT03806764|Cytomegalovirus|cytomegalovirus
63628|NCT03806764|CMV|cmv
63629|NCT03806764|Reactivation|reactivation
63630|NCT03806764|HSCT|hsct
63631|NCT03806764|Stem cell transplant|stem cell transplant
63632|NCT03806764|allogeneic|allogeneic
63633|NCT03806764|immunosuppression|immunosuppression
63634|NCT03806764|viral infection|viral infection
63635|NCT03806738|Metastatic Breast Cancer|metastatic breast cancer
63636|NCT03806738|Treatment Decision Making|treatment decision making
63637|NCT03806738|Shared Decision Making|shared decision making
63638|NCT03806725|Contrast-induced Nephropathy|contrast-induced nephropathy
63639|NCT03806725|Contrast-induced acute kidney injury|contrast-induced acute kidney injury
63640|NCT03806725|Coronary computed tomography angiography|coronary computed tomography angiography
63641|NCT03806712|social representation|social representation
63642|NCT03806699|Tuberculosis, TB, vaccine, adjuvant|tuberculosis, tb, vaccine, adjuvant
63643|NCT03806686|Tuberculosis, TB, vaccine, adjuvant|tuberculosis, tb, vaccine, adjuvant
63644|NCT03806673|unilateral, ,|unilateral, ,
63645|NCT03806673|epidural block|epidural block
63646|NCT03806673|repeated epidural|repeated epidural
63647|NCT03806660|Cardiac Arrest|cardiac arrest
63648|NCT03806660|Coma|coma
63649|NCT03806660|hypoxic brain damage|hypoxic brain damage
63650|NCT03806660|prognosis|prognosis
63651|NCT03806660|neurological examination|neurological examination
63652|NCT03806660|pupillary reflex|pupillary reflex
63653|NCT03806660|electroencephalography|electroencephalography
63654|NCT03806660|targeted temperature management|targeted temperature management
63655|NCT03806660|biomarkers|biomarkers
63656|NCT03806660|clinical score|clinical score
63657|NCT03806660|evoked potentials|evoked potentials
63658|NCT03806647|Amyotrophic lateral sclerosis, ALS, communication, needs|amyotrophic lateral sclerosis, als, communication, needs
63659|NCT03806634|Amyotrophic lateral sclerosis, ALS, communication, needs|amyotrophic lateral sclerosis, als, communication, needs
63660|NCT03806621|coronary artery disease|coronary artery disease
63661|NCT03806621|percutaneous coronary intervention|percutaneous coronary intervention
63662|NCT03806621|rotational atherectomy|rotational atherectomy
63663|NCT03806608|Marginal Bone Loss|marginal bone loss
63664|NCT03806608|Implant depth|implant depth
63665|NCT03806608|Crestal or Subcrestal|crestal or subcrestal
63666|NCT03806569|cognitive behavioral therapy|cognitive behavioral therapy
63667|NCT03806569|mindfulness|mindfulness
63668|NCT03806569|acceptance|acceptance
63669|NCT03806569|commitment|commitment
63670|NCT03806569|adult ADHD|adult adhd
63671|NCT03806556|tranexamic acid|tranexamic acid
63672|NCT03806556|anti-fibrinolytic agents|anti-fibrinolytic agents
63673|NCT03806556|chemotherapy-induced thrombocytopenia|chemotherapy-induced thrombocytopenia
63674|NCT03806517|bone mineral density|bone mineral density
63675|NCT03806517|Parkinson's disease|parkinson's disease
63676|NCT03806517|tremor|tremor
63679|NCT03806504|Chronic thromboembolic pulmonary hypertension|chronic thromboembolic pulmonary hypertension
63681|NCT03806504|reperfusion injury|reperfusion injury
63687|NCT03806478|Alzheimer's Disease|alzheimer's disease
63688|NCT03806478|Dementia|dementia
63689|NCT03806465|Vaccine|vaccine
63690|NCT03806465|Malaria|malaria
63691|NCT03806465|Africa|africa
63692|NCT03806465|Child|child
63693|NCT03806452|albuminuria|albuminuria
63694|NCT03806452|hydroxycarbamide|hydroxycarbamide
63695|NCT03806426|Eicosapentaenoic Acid|eicosapentaenoic acid
63697|NCT03806426|EPA 99%|epa 99%
63698|NCT03806426|Fatty Acid|fatty acid
63699|NCT03806426|omega-3|omega-3
63700|NCT03806426|polyp|polyp
63701|NCT03806426|Familial Adenomatous Polyposis|familial adenomatous polyposis
63702|NCT03806426|FAP|fap
63703|NCT03806426|IRA (Ileo-rectal anastomosis)|ira (ileo-rectal anastomosis)
63704|NCT03806426|PUFA (polyunsaturated fatty acid)|pufa (polyunsaturated fatty acid)
63705|NCT03806426|Endoscopy|endoscopy
63706|NCT03806400|Postoperative nausea and vomiting|postoperative nausea and vomiting
63707|NCT03806400|strabismus surgery|strabismus surgery
63708|NCT03806400|oculocardiac reflex|oculocardiac reflex
63709|NCT03806374|fentanyl|fentanyl
63710|NCT03806374|lidocaine|lidocaine
63711|NCT03806374|ketamine|ketamine
63712|NCT03806374|induction of anesthesia|induction of anesthesia
63713|NCT03806374|intubation|intubation
63714|NCT03806309|Immunotherapy|immunotherapy
63715|NCT03806309|Chemotherapy|chemotherapy
63716|NCT03806296|sleep|sleep
63717|NCT03806296|circadian|circadian
63718|NCT03806296|adolescence|adolescence
63719|NCT03806296|substance use|substance use
63720|NCT03806296|reward|reward
63721|NCT03806296|impulse control|impulse control
63722|NCT03806270|Strabismus surgery|strabismus surgery
63723|NCT03806270|Oculocardiac reflex|oculocardiac reflex
63724|NCT03806270|Hydroxyzine dihydrochloride|hydroxyzine dihydrochloride
63725|NCT03806270|Midazolam|midazolam
63726|NCT03806270|Premedication|premedication
63727|NCT03806270|The Ramsay Scale|the ramsay scale
63728|NCT03806244|stereotactic navigation|stereotactic navigation
63729|NCT03806244|colorectal cancer|colorectal cancer
63730|NCT03806244|laparoscopy|laparoscopy
63731|NCT03806244|transanal surgery|transanal surgery
63732|NCT03806231|Cervical Ripening|cervical ripening
63733|NCT03806218|RFA|rfa
63734|NCT03806205|Knee osteoarthritis pain; Adherence; Diclofenac; Follow up|knee osteoarthritis pain; adherence; diclofenac; follow up
63735|NCT03806179|Radioimmunotherapy|radioimmunotherapy
63736|NCT03806179|Lu-177|lu-177
63737|NCT03806179|Betalutin|betalutin
63738|NCT03806179|Phase 1b|phase 1b
63739|NCT03806179|Combination|combination
63740|NCT03806179|Rituximab|rituximab
63741|NCT03806140|Texting|texting
63742|NCT03806140|mHealth|mhealth
63743|NCT03806140|Adolescents and young adults transitioning of treatment|adolescents and young adults transitioning of treatment
63744|NCT03806127|Irritable Bowel Syndrome|irritable bowel syndrome
63745|NCT03806127|Irritable Bowel Syndrome with predominantly diarrhea (IBS-D)|irritable bowel syndrome with predominantly diarrhea (ibs-d)
63746|NCT03806127|Irritable Bowel Syndrome with mixed episodes of diarrhea and constipation (IBS-M)|irritable bowel syndrome with mixed episodes of diarrhea and constipation (ibs-m)
63747|NCT03806127|Vibegron|vibegron
63748|NCT03806127|Beta-3 adrenergic receptor (β3-AR)|beta-3 adrenergic receptor (β3-ar)
82995|NCT03684070|Chinese|chinese
63749|NCT03806088|CKD|ckd
63750|NCT03806075|Second generation gene sequencing, gut microbiota, Gastrointestinal polyp syndrome|second generation gene sequencing, gut microbiota, gastrointestinal polyp syndrome
63751|NCT03806049|chemotherapy-free regimen|chemotherapy-free regimen
63752|NCT03806049|niraparib|niraparib
63753|NCT03806049|bevacizumab|bevacizumab
63754|NCT03806049|TSR042|tsr042
63755|NCT03806049|recurrent ovarian cancer|recurrent ovarian cancer
63756|NCT03806023|transcutaneous electric nerve stimulation|transcutaneous electric nerve stimulation
63757|NCT03806023|transcranial magnetic stimulation|transcranial magnetic stimulation
63758|NCT03806010|Quantitative sensory testing|quantitative sensory testing
63759|NCT03805984|Healthy volunteer|healthy volunteer
63760|NCT03805971|pCLE|pcle
63761|NCT03805971|confocal laser endomicroscopy|confocal laser endomicroscopy
63762|NCT03805971|pleural carcinomatosis|pleural carcinomatosis
63763|NCT03805971|mesothelioma|mesothelioma
63764|NCT03805971|optical biopsies|optical biopsies
63765|NCT03805945|Cesarean Section|cesarean section
63766|NCT03805945|Dexmedetomidine|dexmedetomidine
63767|NCT03805945|Breast Feeding|breast feeding
63768|NCT03805945|Recovery quality|recovery quality
63769|NCT03805932|HCL Variant|hcl variant
63770|NCT03805932|Recombinant Immunotoxin|recombinant immunotoxin
63771|NCT03805932|Monoclonal Antibody|monoclonal antibody
63772|NCT03805932|Targeted Therapy|targeted therapy
63773|NCT03805932|Biologic Therapy|biologic therapy
63782|NCT03805854|neural oscillations|neural oscillations
63783|NCT03805854|brain|brain
63784|NCT03805828|Autism spectrum disorder|autism spectrum disorder
63785|NCT03805828|parenting stress|parenting stress
63786|NCT03805828|coping mechanism|coping mechanism
63787|NCT03805828|coping strategies|coping strategies
63788|NCT03805828|education program|education program
63789|NCT03805828|educational intervention|educational intervention
63790|NCT03805815|blood pressure|blood pressure
63791|NCT03805815|crack sensor|crack sensor
63792|NCT03805802|fiber|fiber
63793|NCT03805802|type 2 diabetes|type 2 diabetes
63794|NCT03805802|dietary intervention|dietary intervention
63795|NCT03805802|weight loss|weight loss
63796|NCT03805802|glucose control|glucose control
63797|NCT03805802|obesity|obesity
63798|NCT03805802|overweight|overweight
63799|NCT03805802|metabolic syndrome|metabolic syndrome
63800|NCT03805802|oats|oats
63801|NCT03805776|Intermittent fasting|intermittent fasting
63802|NCT03805776|Fasting|fasting
63803|NCT03805776|Cholesterol|cholesterol
63804|NCT03805711|Aortic Stenosis|aortic stenosis
63805|NCT03805711|Transcatheter Aortic Valve Replacement|transcatheter aortic valve replacement
63806|NCT03805711|TAVR|tavr
63807|NCT03805711|TAVI|tavi
63808|NCT03805711|Aortic Valve|aortic valve
63809|NCT03805698|Platelet-rich Plasma|platelet-rich plasma
63810|NCT03805672|Lovenox|lovenox
63811|NCT03805672|enoxaparin|enoxaparin
63812|NCT03805672|DVT|dvt
63813|NCT03805659|Adult|adult
63814|NCT03805659|Primary Progressive Aphasia|primary progressive aphasia
63815|NCT03805659|High-definition Transcranial Direct Current Stimulation|high-definition transcranial direct current stimulation
63816|NCT03805659|HD-tDCS|hd-tdcs
63817|NCT03805659|Language|language
63818|NCT03805659|Logopenic|logopenic
63819|NCT03805659|Magnetic Resonance Imaging|magnetic resonance imaging
63820|NCT03805659|MRI|mri
63821|NCT03805659|Magnetoencephalography|magnetoencephalography
63822|NCT03805659|MEG|meg
63823|NCT03805659|Brain|brain
63824|NCT03805659|Aphasia|aphasia
63825|NCT03805646|Aftercare|aftercare
63826|NCT03805646|Telemedicine|telemedicine
63827|NCT03805646|Africa South of the Sahara|africa south of the sahara
63828|NCT03805620|mild cognitive impairment|mild cognitive impairment
63829|NCT03805620|combined physical-cognitive training|combined physical-cognitive training
63830|NCT03805620|BDNF|bdnf
63831|NCT03805620|mitochondrial function|mitochondrial function
63832|NCT03805620|cognitive function|cognitive function
63833|NCT03805607|Cesarean Section Complications|cesarean section complications
63834|NCT03805607|Postoperative Pain|postoperative pain
63835|NCT03805607|Coagulation Defect; Postpartum|coagulation defect; postpartum
63836|NCT03805607|Nonsteroidals (NSAIDs)Toxicity|nonsteroidals (nsaids)toxicity
63837|NCT03805607|Postpartum Hemorrhage|postpartum hemorrhage
63838|NCT03805607|Ketorolac|ketorolac
63839|NCT03805607|Cesarean Delivery|cesarean delivery
63840|NCT03805607|Platelet Function|platelet function
63841|NCT03805568|postoperative sore throat|postoperative sore throat
63842|NCT03805568|dexmedetomidine|dexmedetomidine
63843|NCT03805568|remifentanil|remifentanil
63844|NCT03805568|thyroidectomy|thyroidectomy
63845|NCT03805555|ablation|ablation
63846|NCT03805542|calculous pyonephrosis|calculous pyonephrosis
63847|NCT03805542|I-stage PCNL|i-stage pcnl
63848|NCT03805542|iodophors|iodophors
63849|NCT03805503|Chloroprocaine|chloroprocaine
63850|NCT03805503|spinal anesthesia|spinal anesthesia
63851|NCT03805503|one-day clinic|one-day clinic
818444|NCT00165984|pediatric|pediatric
63852|NCT03805477|allogeneic hematopoietic cell transplantation.|allogeneic hematopoietic cell transplantation.
63853|NCT03805477|chronic graft-versus-host disease (cGvHD)|chronic graft-versus-host disease (cgvhd)
63854|NCT03805477|Nintedanib|nintedanib
63855|NCT03805477|fibrotic lung disease|fibrotic lung disease
63856|NCT03805464|biomechanics|biomechanics
63857|NCT03805464|inertial measurement unit|inertial measurement unit
63858|NCT03805425|Hypeorpia|hypeorpia
63859|NCT03805425|Crosslinking|crosslinking
63860|NCT03805425|PiXL|pixl
63861|NCT03805399|TNBC|tnbc
63862|NCT03805399|Molecular Subtype|molecular subtype
63863|NCT03805399|Precision Treatment|precision treatment
63864|NCT03805399|Umbrella|umbrella
63865|NCT03805386|patient directed postoperative opioid prescribing|patient directed postoperative opioid prescribing
63866|NCT03805347|Ankle fracture|ankle fracture
63867|NCT03805347|Helminthostachys zeylanica(L.)Hook|helminthostachys zeylanica(l.)hook
63868|NCT03805347|Clinical trials|clinical trials
63869|NCT03805347|Functional recovery|functional recovery
63870|NCT03805334|sleep|sleep
63871|NCT03805334|sensory over-responsiveness|sensory over-responsiveness
63872|NCT03805334|hypersensitivity|hypersensitivity
63873|NCT03805308|Stroke|stroke
63874|NCT03805308|Ischemic Stroke|ischemic stroke
63875|NCT03805308|Thrombectomy|thrombectomy
63879|NCT03805282|lidocaine|lidocaine
63880|NCT03805230|anaesthesia|anaesthesia
63881|NCT03805230|Intensive Care|intensive care
63882|NCT03805230|vasopressor|vasopressor
63883|NCT03805191|Glycemic excursions|glycemic excursions
63884|NCT03805191|Acarbose|acarbose
63885|NCT03805191|Continuous glucose monitoring|continuous glucose monitoring
63886|NCT03805139|Ajwa (Pheonix Dactylfera) Derived polyphenol|ajwa (pheonix dactylfera) derived polyphenol
63887|NCT03805139|Dyslipidemia|dyslipidemia
63888|NCT03805139|Cardioprotection|cardioprotection
63890|NCT03805139|Transferulic Acid|transferulic acid
63891|NCT03805139|Gallic Acid|gallic acid
63892|NCT03805113|Erosive arthritis|erosive arthritis
63893|NCT03805113|Hands arthritis|hands arthritis
63894|NCT03805113|Magnetotherapy|magnetotherapy
63895|NCT03805087|Hemorrhoids|hemorrhoids
63896|NCT03805087|Embolization, Therapeutic|embolization, therapeutic
63897|NCT03805061|Multiple sclerosis|multiple sclerosis
63898|NCT03805061|aerobic|aerobic
63899|NCT03805061|isokinetic|isokinetic
63900|NCT03805061|exercise|exercise
63901|NCT03805048|Percutaneous Coronary Intervention|percutaneous coronary intervention
63902|NCT03805048|Dysfunctional venous bypass graft|dysfunctional venous bypass graft
63903|NCT03805048|Second generation DES|second generation des
63904|NCT03805048|CABG|cabg
63905|NCT03805035|Electroacupuncture (EA)|electroacupuncture (ea)
63906|NCT03805035|Antihistamine|antihistamine
63907|NCT03805035|Pain|pain
63908|NCT03805022|Solid tumor|solid tumor
63909|NCT03805022|Phase III trial|phase iii trial
63910|NCT03805022|Soft-tissue sarcoma|soft-tissue sarcoma
63911|NCT03805022|Resectable|resectable
63912|NCT03805022|Non-metastatic|non-metastatic
63913|NCT03805009|Stroke|stroke
63914|NCT03805009|Robot|robot
63915|NCT03805009|Hemiparesis|hemiparesis
63916|NCT03805009|Gait Training|gait training
63917|NCT03805009|Rehabilitation|rehabilitation
63918|NCT03805009|Functional Recovery|functional recovery
63919|NCT03805009|Robot-Assisted Gait Training|robot-assisted gait training
63920|NCT03804996|relapsed or refractory|relapsed or refractory
63921|NCT03804983|Artificial Pancreas (AP)|artificial pancreas (ap)
63922|NCT03804983|Insulin Pump|insulin pump
63923|NCT03804983|Continuous Glucose Monitor (CGM)|continuous glucose monitor (cgm)
63924|NCT03804983|MyTDI|mytdi
63925|NCT03804983|Hybrid Closed Loop (HCL)|hybrid closed loop (hcl)
63926|NCT03804983|Total Daily Insulin (TDI)|total daily insulin (tdi)
63927|NCT03804970|Diabetes|diabetes
63928|NCT03804970|follow-up|follow-up
63929|NCT03804970|Diabetic retinopathy|diabetic retinopathy
63930|NCT03804970|Diabetic teaching|diabetic teaching
63931|NCT03804970|SMS|sms
63932|NCT03804970|rewards|rewards
63933|NCT03804957|biopsy|biopsy
63934|NCT03804957|pneumothorax|pneumothorax
63935|NCT03804918|Healthcare education|healthcare education
63936|NCT03804918|Breaking bad news|breaking bad news
63937|NCT03804918|Digital learning|digital learning
63938|NCT03804905|Type 2 Diabetes Mellitus|type 2 diabetes mellitus
63939|NCT03804905|Medication Compliance|medication compliance
63940|NCT03804905|Medication Insurance|medication insurance
63941|NCT03804866|NGR-hTNF|ngr-htnf
63942|NCT03804866|Pegylated liposomal doxorubicin|pegylated liposomal doxorubicin
63943|NCT03804866|Doxorubicin|doxorubicin
63944|NCT03804866|Platinum-resistant|platinum-resistant
63945|NCT03804866|Progression or recurrence Ovarian Cancer|progression or recurrence ovarian cancer
63946|NCT03804866|Ovarian Cancer|ovarian cancer
63947|NCT03804866|Advanced or metastatic|advanced or metastatic
63948|NCT03804853|Rehabilitiation|rehabilitiation
63949|NCT03804853|Reverse total shoulder|reverse total shoulder
63950|NCT03804827|Sleep|sleep
63951|NCT03804827|OSA|osa
63952|NCT03804827|CSA|csa
63953|NCT03804827|CHF|chf
63954|NCT03804827|Heart Failure|heart failure
63955|NCT03804827|Troponin|troponin
63956|NCT03804814|Motivational Interviewing|motivational interviewing
63957|NCT03804814|Healthcare delivery|healthcare delivery
63963|NCT03804749|suramin sodium|suramin sodium
63964|NCT03804710|Skin care, Moisturizing Cream|skin care, moisturizing cream
63965|NCT03804684|open angle glaucoma|open angle glaucoma
63966|NCT03804684|visual field|visual field
63967|NCT03804684|Standard Automatic Perimetry|standard automatic perimetry
63968|NCT03804658|Brain-derived neurotrophic factor|brain-derived neurotrophic factor
63969|NCT03804658|Vascular cell adhesion molecule 1|vascular cell adhesion molecule 1
63970|NCT03804658|Renalase|renalase
63971|NCT03804658|Orexin|orexin
63972|NCT03804658|Continue glucose monitor|continue glucose monitor
63973|NCT03804645|Mineralocorticoid receptor|mineralocorticoid receptor
63974|NCT03804645|Heart failure with preserved ejection fraction|heart failure with preserved ejection fraction
63975|NCT03804645|Safety|safety
64177|NCT03803423|Education|education
63976|NCT03804645|Pharmacokinetics|pharmacokinetics
63977|NCT03804645|Influence of Food|influence of food
63978|NCT03804645|Bioavailability|bioavailability
63979|NCT03804606|Heart Failure|heart failure
63980|NCT03804606|Machine Learning|machine learning
63981|NCT03804606|Medication Therapy Management|medication therapy management
63982|NCT03804606|Supervised Machine Learning|supervised machine learning
63983|NCT03804606|Population Health Management|population health management
63984|NCT03804580|Targeted therapy|targeted therapy
63985|NCT03804580|EGFR|egfr
63986|NCT03804567|Oldpain2go®|oldpain2go®
63987|NCT03804567|Feasibility|feasibility
63988|NCT03804515|EGFR|egfr
63989|NCT03804515|HER2 mutations|her2 mutations
63990|NCT03804515|EGFR/HER2 overexpression/amplification|egfr/her2 overexpression/amplification
63991|NCT03804489|Decision Aids; Shared decision making; Rotavirus Vaccines|decision aids; shared decision making; rotavirus vaccines
63992|NCT03804476|stroke|stroke
63993|NCT03804476|acute ischemic stroke|acute ischemic stroke
63994|NCT03804476|cerebral edema|cerebral edema
63995|NCT03804463|Preservation of fertility surger|preservation of fertility surger
63996|NCT03804463|ovarian preservation|ovarian preservation
63997|NCT03804463|endometrial cancer|endometrial cancer
63998|NCT03804450|Mature teeth|mature teeth
63999|NCT03804450|Necrotic teeth|necrotic teeth
64000|NCT03804450|REPs|reps
64001|NCT03804450|Biodentine|biodentine
64002|NCT03804450|MRI|mri
64003|NCT03804450|CBCT|cbct
64004|NCT03804437|Mandibular canals|mandibular canals
64005|NCT03804437|bifid canal|bifid canal
64006|NCT03804437|cbct|cbct
64007|NCT03804437|cbct dental.|cbct dental.
64008|NCT03804372|diffuse Large B‑Cell Lymphoma|diffuse large b‑cell lymphoma
64009|NCT03804372|chronic Lymphoid Leukemia HBsAg-positive|chronic lymphoid leukemia hbsag-positive
64010|NCT03804372|Rituximab|rituximab
64011|NCT03804372|chemotherapy|chemotherapy
64012|NCT03804372|alafenamide|alafenamide
64013|NCT03804372|hepatitis B virus reactivation|hepatitis b virus reactivation
64014|NCT03804359|Nephrotic Syndrome|nephrotic syndrome
64015|NCT03804359|PLA2R1-antibodies|pla2r1-antibodies
64016|NCT03804359|Epitope spreading|epitope spreading
64017|NCT03804359|Rituximab|rituximab
64018|NCT03804333|short course radiotherapy|short course radiotherapy
64019|NCT03804333|symptomatic pelvic lesions|symptomatic pelvic lesions
64020|NCT03804320|Kidney cancer|kidney cancer
64021|NCT03804320|Active surveillance|active surveillance
64022|NCT03804320|Small renal masses|small renal masses
64023|NCT03804320|Partial nephrectomy|partial nephrectomy
64024|NCT03804307|Short Course Radiotherapy|short course radiotherapy
64025|NCT03804307|Symptomatic thoracic lesions|symptomatic thoracic lesions
64026|NCT03804242|positive youth development|positive youth development
64027|NCT03804242|school-to-prison pipeline|school-to-prison pipeline
64028|NCT03804242|mental health stigma|mental health stigma
64029|NCT03804242|help-seeking|help-seeking
64030|NCT03804242|identity|identity
64031|NCT03804229|Vascular Dementia|vascular dementia
64032|NCT03804229|cognition|cognition
64033|NCT03804203|Short Course Radiotherapy|short course radiotherapy
64034|NCT03804203|Symptomatic esophageal lesions|symptomatic esophageal lesions
64035|NCT03804177|immediate implant|immediate implant
64036|NCT03804177|hyaluronic acid|hyaluronic acid
64037|NCT03804177|melatonin|melatonin
64038|NCT03804177|vitamin C|vitamin c
64039|NCT03804151|Exercise|exercise
64040|NCT03804073|Short Course Radiotherapy|short course radiotherapy
64041|NCT03804073|Symptomatic head and neck lesions|symptomatic head and neck lesions
64042|NCT03804060|Therapeutic Hypothermia|therapeutic hypothermia
64043|NCT03804060|Cooling|cooling
64044|NCT03804060|Stroke|stroke
64045|NCT03804060|Neurological Acute Care|neurological acute care
64046|NCT03804047|Kinesio Tape|kinesio tape
64047|NCT03804047|Physical functioning|physical functioning
64048|NCT03804047|Disability|disability
64049|NCT03804034|Neurogenic inflammation|neurogenic inflammation
64050|NCT03804034|Dental Pulp|dental pulp
64051|NCT03804034|Occlusal trauma|occlusal trauma
64052|NCT03804034|Orthodontics forces|orthodontics forces
64053|NCT03804034|SP|sp
64054|NCT03804034|CGRP|cgrp
64055|NCT03804034|VEGF|vegf
64056|NCT03804021|alpha1-antitrypsin deficiency|alpha1-antitrypsin deficiency
64057|NCT03804021|alpha 1-antitrypsin deficiency|alpha 1-antitrypsin deficiency
64058|NCT03804021|alpha1AT|alpha1at
64059|NCT03804021|A1AT|a1at
64060|NCT03804021|ADVM-043|advm-043
64061|NCT03804021|AAVrh.10halpha1AT|aavrh.10halpha1at
64062|NCT03804021|AAVrh.10hA1AT|aavrh.10ha1at
64063|NCT03804021|Gene transfer vector|gene transfer vector
64064|NCT03804021|Gene therapy|gene therapy
64065|NCT03804021|Lung disease|lung disease
64066|NCT03804021|Emphysema|emphysema
64067|NCT03804021|COPD|copd
64068|NCT03804021|ADVANCE study|advance study
64069|NCT03804021|Long Term Follow Up|long term follow up
64070|NCT03803969|Syncope|syncope
64071|NCT03803969|Cryptogenic Stroke|cryptogenic stroke
64072|NCT03803969|Physical activity|physical activity
64073|NCT03803969|Posture|posture
64074|NCT03803956|Photobiomodulation therapy|photobiomodulation therapy
64075|NCT03803956|Low-level laser therapy|low-level laser therapy
64076|NCT03803956|Performance|performance
64077|NCT03803956|Skeletal muscle recovery|skeletal muscle recovery
64078|NCT03803956|High-level soccer players|high-level soccer players
64079|NCT03803956|Intense progressive running test|intense progressive running test
64080|NCT03803943|Hearing Loss|hearing loss
64081|NCT03803943|Toddlers|toddlers
64082|NCT03803943|Early Intervention|early intervention
64083|NCT03803943|Parent-mediated intervention|parent-mediated intervention
64084|NCT03803930|EUS-FNB|eus-fnb
64085|NCT03803930|slow pull|slow pull
64086|NCT03803930|modified wet suction technique|modified wet suction technique
64087|NCT03803904|exercise|exercise
64088|NCT03803904|brain health|brain health
64089|NCT03803891|Endoscopic resection|endoscopic resection
64090|NCT03803891|Colonoscopy|colonoscopy
64091|NCT03803891|Full-thickness resection|full-thickness resection
64092|NCT03803865|Job Stress|job stress
64093|NCT03803865|Mindfulness|mindfulness
64094|NCT03803865|Inflammation|inflammation
64095|NCT03803865|Neuroimaging|neuroimaging
64096|NCT03803839|RSA|rsa
64097|NCT03803839|DXA|dxa
64098|NCT03803839|Bisphosphonates|bisphosphonates
64099|NCT03803839|Migration of stem|migration of stem
64100|NCT03803839|Aseptic loosening of prosthesis|aseptic loosening of prosthesis
64101|NCT03803826|cardiac resynchronization therapy|cardiac resynchronization therapy
64102|NCT03803826|non-responders|non-responders
64103|NCT03803813|sepsis|sepsis
64104|NCT03803813|septic shock|septic shock
64105|NCT03803813|infection|infection
64106|NCT03803813|craniotomy|craniotomy
64107|NCT03803813|outcome|outcome
64108|NCT03803800|Rehabilitation|rehabilitation
64109|NCT03803800|Periodized exercise therapy|periodized exercise therapy
64110|NCT03803800|Ergogenic supplementation|ergogenic supplementation
64111|NCT03803787|Non-Small Cell Lung Cancer|non-small cell lung cancer
64112|NCT03803787|Radiation Pneumonia|radiation pneumonia
64113|NCT03803787|Lung cancer treatment|lung cancer treatment
64114|NCT03803787|Respiratory Tract Neoplasms|respiratory tract neoplasms
64115|NCT03803787|Radiation fibrosis|radiation fibrosis
64116|NCT03803787|Thoracic Neoplasms|thoracic neoplasms
64117|NCT03803787|Lung Diseases|lung diseases
64118|NCT03803787|Radiation Injury with Fibrosis|radiation injury with fibrosis
64119|NCT03803787|Radiation Fibrosis of Lung|radiation fibrosis of lung
64120|NCT03803787|Lung Injury|lung injury
64121|NCT03803709|dietary fibers|dietary fibers
64122|NCT03803709|alcohol-dependent|alcohol-dependent
64123|NCT03803696|Hematopoietic Stem Cell Transplantation|hematopoietic stem cell transplantation
64124|NCT03803696|Hematologic Diseases|hematologic diseases
64125|NCT03803696|Sexual Dysfunction|sexual dysfunction
64126|NCT03803683|mLab|mlab
64127|NCT03803683|HIV prevention|hiv prevention
64128|NCT03803670|acute lymphoblastic leukemia|acute lymphoblastic leukemia
64129|NCT03803670|flow cytometry|flow cytometry
64130|NCT03803644|Healthy Subjects|healthy subjects
64131|NCT03803644|CC-92480|cc-92480
64132|NCT03803644|Food Effect|food effect
64133|NCT03803605|VRC07-523LS|vrc07-523ls
64134|NCT03803605|Vorinostat|vorinostat
64135|NCT03803605|HIV-1|hiv-1
64136|NCT03803605|Suppressed|suppressed
64137|NCT03803605|Latency|latency
64138|NCT03803605|Reversal|reversal
64139|NCT03803605|Novel|novel
64140|NCT03803605|Monoclonal|monoclonal
64141|NCT03803605|Agent|agent
64142|NCT03803605|Antibody|antibody
64143|NCT03803605|Frequency|frequency
64144|NCT03803605|T Cell|t cell
64145|NCT03803605|Infection|infection
64146|NCT03803605|ART|art
64147|NCT03803605|Resting|resting
64148|NCT03803579|Atrial Fibrillation|atrial fibrillation
64149|NCT03803579|Bleeding event|bleeding event
64150|NCT03803579|Thromboembolic event|thromboembolic event
64151|NCT03803579|Plasma concentration of drug|plasma concentration of drug
64152|NCT03803566|Manual dexterity|manual dexterity
64153|NCT03803553|Metastatic colorectal cancer|metastatic colorectal cancer
64154|NCT03803553|Stage III Colorectal Cancer|stage iii colorectal cancer
64155|NCT03803540|Non-Alcoholic Fatty Liver Disease|non-alcoholic fatty liver disease
64156|NCT03803540|Non Alcoholic Steatohepatitis|non alcoholic steatohepatitis
64157|NCT03803540|NAFLD|nafld
64158|NCT03803540|NASH|nash
64159|NCT03803540|Fecal Microbiota Transplantation|fecal microbiota transplantation
64160|NCT03803540|FMT|fmt
64161|NCT03803488|needlestick|needlestick
64162|NCT03803488|needlestick injury|needlestick injury
64163|NCT03803488|pen needle|pen needle
64164|NCT03803488|sharps injury prevention|sharps injury prevention
64165|NCT03803462|Damage|damage
64166|NCT03803462|Outcome measure|outcome measure
64167|NCT03803449|propofol|propofol
64168|NCT03803449|fentanyl|fentanyl
64169|NCT03803449|gastrointestinal endoscopy|gastrointestinal endoscopy
64170|NCT03803436|Liver Transplant|liver transplant
64171|NCT03803436|Colorectal Cancer|colorectal cancer
64172|NCT03803436|Chemotherapy|chemotherapy
64173|NCT03803436|Metastasis|metastasis
64174|NCT03803423|Live Donor Transplant|live donor transplant
64175|NCT03803423|Social Media|social media
64176|NCT03803423|Advocacy|advocacy
64181|NCT03803358|CHRF|chrf
64182|NCT03803358|NIV|niv
64183|NCT03803358|exercise training|exercise training
64184|NCT03803345|Food timing|food timing
64185|NCT03803345|Gestational diabetes mellitus|gestational diabetes mellitus
64186|NCT03803345|Glucose tolerance|glucose tolerance
64187|NCT03803345|Night-eating|night-eating
64188|NCT03803345|Pregnancy outcomes|pregnancy outcomes
64189|NCT03803345|Snacking|snacking
64190|NCT03803332|PTSD|ptsd
64191|NCT03803332|Military Sexual Trauma|military sexual trauma
64192|NCT03803332|exposure therapy|exposure therapy
64193|NCT03803332|interpersonal psychotherapy|interpersonal psychotherapy
64194|NCT03803332|treatment|treatment
64195|NCT03803319|dietary fibre|dietary fibre
64196|NCT03803293|Pharmacogenomics|pharmacogenomics
64197|NCT03803293|Personalized Medicine|personalized medicine
64198|NCT03803293|Pharmacogenomic Varients|pharmacogenomic varients
64199|NCT03803254|Hepatocellular Carcinoma|hepatocellular carcinoma
64200|NCT03803254|Lenvatinib|lenvatinib
64201|NCT03803254|PD-1 Antibody|pd-1 antibody
64202|NCT03803254|Oxaliplatin, 5-Fluorouracil and Leucovorin|oxaliplatin, 5-fluorouracil and leucovorin
64203|NCT03803254|Hepatic arterial infusion chemotherapy|hepatic arterial infusion chemotherapy
64204|NCT03803215|theophylline|theophylline
64205|NCT03803215|asystole|asystole
64206|NCT03803215|implantable loop recorder|implantable loop recorder
64207|NCT03803202|Pneumococcal vaccine|pneumococcal vaccine
64208|NCT03803202|Vaccine|vaccine
64209|NCT03803202|Pneumococccal Disease|pneumococccal disease
64210|NCT03803202|ASP3772|asp3772
64211|NCT03803124|CYSTS, KIDNEYS|cysts, kidneys
64212|NCT03803111|Heart Failure with Reduced Ejection Fraction|heart failure with reduced ejection fraction
64213|NCT03803111|Exercise Training Program|exercise training program
64214|NCT03803111|Iron Deficiency|iron deficiency
64215|NCT03803072|Exercise therapy|exercise therapy
64216|NCT03803072|Diet|diet
64217|NCT03803072|Prevention and control|prevention and control
64218|NCT03803046|Benzodiazepin|benzodiazepin
64219|NCT03803046|Children|children
64220|NCT03803046|Epilepsy|epilepsy
64221|NCT03803033|Treatment-related problems|treatment-related problems
64222|NCT03803033|Cost saving|cost saving
64223|NCT03803033|Clinical pharmacy|clinical pharmacy
64224|NCT03803020|coronary artery disease|coronary artery disease
64225|NCT03803020|chronic total occlusion|chronic total occlusion
64226|NCT03803020|fractional flow reserve|fractional flow reserve
64227|NCT03803020|single-photon emission computed tomography|single-photon emission computed tomography
64228|NCT03803007|Haemorrhages|haemorrhages
64229|NCT03803007|Thrombolysis|thrombolysis
64230|NCT03803007|Thrombectomy|thrombectomy
64231|NCT03803007|Anti-platelet|anti-platelet
64232|NCT03803007|Dose-escalation|dose-escalation
64233|NCT03802994|Prevnar|prevnar
64234|NCT03802994|pneumococcal conjugate vaccine|pneumococcal conjugate vaccine
64235|NCT03802994|aging|aging
64236|NCT03802994|renal transplant recipient|renal transplant recipient
64237|NCT03802955|Solid Tumor|solid tumor
64238|NCT03802955|Non-Hodgkin Lymphoma|non-hodgkin lymphoma
64239|NCT03802942|hypoglycemia|hypoglycemia
64240|NCT03802942|diabetes mellitus|diabetes mellitus
64241|NCT03802942|malnutrition|malnutrition
64242|NCT03802916|iron overload|iron overload
64243|NCT03802916|chelation|chelation
64244|NCT03802916|deferiprone|deferiprone
64245|NCT03802916|Ferriprox|ferriprox
64246|NCT03802890|microbial dysbiosis|microbial dysbiosis
64247|NCT03802890|rheumatoid arthritis|rheumatoid arthritis
64248|NCT03802890|dietary factors|dietary factors
64249|NCT03802877|gestational weight gain|gestational weight gain
64250|NCT03802877|large for gestational age status|large for gestational age status
64251|NCT03802877|step counts|step counts
64252|NCT03802877|physical activity|physical activity
64253|NCT03802877|health coaching|health coaching
64254|NCT03802877|ePlatform|eplatform
64255|NCT03802877|pedometer|pedometer
64256|NCT03802838|Schizophrenia ，acupuncture，Amisulpride|schizophrenia ，acupuncture，amisulpride
64257|NCT03802786|pharmacokinetics|pharmacokinetics
64258|NCT03802747|Liver Metastases|liver metastases
64259|NCT03802747|Phase 1|phase 1
64260|NCT03802747|Durvalumab|durvalumab
64261|NCT03802747|Tremelimumab|tremelimumab
64262|NCT03802747|Yttrium-90|yttrium-90
64263|NCT03802747|Radioembolization|radioembolization
64264|NCT03802747|Stereotactic Body Radiation Therapy|stereotactic body radiation therapy
64265|NCT03802721|Benzo[a]pyrene|benzo[a]pyrene
64266|NCT03802721|Accelerator Mass Spectrometry|accelerator mass spectrometry
64267|NCT03802721|Polycyclic Aromatic Hydrocarbons|polycyclic aromatic hydrocarbons
64268|NCT03802721|cruciferous vegetable|cruciferous vegetable
64269|NCT03802721|Brussels sprouts|brussels sprouts
64270|NCT03802721|3,3'-diindolylmethane|3,3'-diindolylmethane
64271|NCT03802721|DIM|dim
64272|NCT03802721|indole-3-carbinol|indole-3-carbinol
64273|NCT03802721|I3C|i3c
64274|NCT03802721|PAH|pah
64275|NCT03802669|human saliva|human saliva
64276|NCT03802669|mutans streptococcus|mutans streptococcus
64277|NCT03802669|PCR|pcr
64278|NCT03802669|caries activity|caries activity
64279|NCT03802656|Scoliosis|scoliosis
64280|NCT03802656|Idiopathic Scoliosis|idiopathic scoliosis
64281|NCT03802656|Adolescent Idiopathic Scoliosis|adolescent idiopathic scoliosis
64282|NCT03802656|Vertebral Body Tethering|vertebral body tethering
64283|NCT03802656|growth modulation spine|growth modulation spine
64284|NCT03802656|spine|spine
64285|NCT03802656|juvenile scoliosis|juvenile scoliosis
64286|NCT03802643|Oximetry|oximetry
64287|NCT03802643|Desaturation of Blood|desaturation of blood
64288|NCT03802643|Postoperative pulmonary complications|postoperative pulmonary complications
64289|NCT03802630|Visual impairment|visual impairment
64290|NCT03802630|Macular edema|macular edema
64291|NCT03802630|Branch retinal vein occlusion|branch retinal vein occlusion
64292|NCT03802630|BRVO|brvo
64293|NCT03802630|Brolucizumab|brolucizumab
64294|NCT03802630|Aflibercept|aflibercept
64295|NCT03802630|Vascular endothelial growth factor|vascular endothelial growth factor
64296|NCT03802630|VEGF|vegf
64297|NCT03802630|anti-VEGF|anti-vegf
64298|NCT03802604|atezolizumab|atezolizumab
64299|NCT03802604|T-vec|t-vec
64300|NCT03802604|talimogene laherparepvec|talimogene laherparepvec
64301|NCT03802578|Exercise|exercise
64302|NCT03802578|Hand function|hand function
64303|NCT03802578|Quality of Life|quality of life
64304|NCT03802539|Root caries|root caries
64305|NCT03802539|Cavity lining|cavity lining
64306|NCT03802539|Composite resin restorations|composite resin restorations
64307|NCT03802539|Self-etch adhesive|self-etch adhesive
64308|NCT03802513|tinnitus|tinnitus
64309|NCT03802461|Fecal Microbiota Transplantation|fecal microbiota transplantation
64310|NCT03802461|Gut Microbiome|gut microbiome
64311|NCT03802461|Carbapenemase-producing Enterobacteriaceae (CPE)|carbapenemase-producing enterobacteriaceae (cpe)
64312|NCT03802435|perineural injection therapy|perineural injection therapy
64313|NCT03802435|nerve hydrodissection|nerve hydrodissection
64314|NCT03802422|Hydrodissection|hydrodissection
64315|NCT03802422|Vitamin B12|vitamin b12
64316|NCT03802409|Albumin-binding taxol|albumin-binding taxol
64317|NCT03802396|Delirium|delirium
64318|NCT03802396|Aging|aging
64319|NCT03802396|Elderly|elderly
64320|NCT03802396|Postoperative|postoperative
64321|NCT03802396|Cognitive Dysfunction|cognitive dysfunction
64322|NCT03802357|Pulmonary rehabilitation|pulmonary rehabilitation
64323|NCT03802357|Exercise training|exercise training
64324|NCT03802357|Alpha-1 Antitrypsin deficiency|alpha-1 antitrypsin deficiency
64325|NCT03802318|Helicobacter pylori|helicobacter pylori
64326|NCT03802318|Proton pump inhibitor|proton pump inhibitor
64327|NCT03802318|Amoxicillin|amoxicillin
64328|NCT03802318|Urea breath test|urea breath test
64329|NCT03802318|Levofloxacin|levofloxacin
64330|NCT03802318|Clarithromycin|clarithromycin
64331|NCT03802279|Rhabdomyolysis linked to a hereditary disease of metabolism|rhabdomyolysis linked to a hereditary disease of metabolism
64332|NCT03802279|Correlation between the effort test and the severity of the disease and biochemical flux on myoblasts|correlation between the effort test and the severity of the disease and biochemical flux on myoblasts
64333|NCT03802201|chronic anemia|chronic anemia
64334|NCT03802201|β-thalassemia|β-thalassemia
64335|NCT03802188|Retinal toxicity|retinal toxicity
64336|NCT03802162|Alzheimer's disease|alzheimer's disease
64337|NCT03802162|CKD-355|ckd-355
64338|NCT03802149|Ulipristal Acetate|ulipristal acetate
64339|NCT03802149|Abortion|abortion
64340|NCT03802149|Cervical Preparation|cervical preparation
64341|NCT03802149|Dilation and Evacuation|dilation and evacuation
64342|NCT03802136|AKI|aki
64343|NCT03802136|Sepsis|sepsis
64344|NCT03802136|Biomarker|biomarker
64345|NCT03802136|renal function|renal function
64346|NCT03802136|oxidative stress|oxidative stress
64347|NCT03802123|PET/CT|pet/ct
64348|NCT03802123|⁸⁹Zr-Df-IAB22M2C|⁸⁹zr-df-iab22m2c
64349|NCT03802123|CD8|cd8
64350|NCT03802123|Imaging|imaging
64351|NCT03802097|Gastric cancer|gastric cancer
64352|NCT03802097|Laparoscopic gastrectomy|laparoscopic gastrectomy
64353|NCT03802097|Prophylactic antibiotics|prophylactic antibiotics
64354|NCT03802097|Infectious complications|infectious complications
64355|NCT03802045|Acupuncture|acupuncture
64356|NCT03802045|Electroacupuncture|electroacupuncture
64357|NCT03802045|Low back pain|low back pain
64358|NCT03802045|Aged|aged
64359|NCT03802045|Clinical trial|clinical trial
64360|NCT03802032|infertility|infertility
64361|NCT03802032|hysterosalpingography|hysterosalpingography
64362|NCT03802032|pain|pain
64363|NCT03802019|Smoking Behavior|smoking behavior
64364|NCT03801993|Cystic Fibrosis|cystic fibrosis
64365|NCT03801993|CF|cf
64366|NCT03801993|GI|gi
64367|NCT03801993|nutrition|nutrition
64368|NCT03801993|quality of life|quality of life
64369|NCT03801993|bowel|bowel
64370|NCT03801993|constipation|constipation
64371|NCT03801993|gastrointestinal|gastrointestinal
64372|NCT03801967|Mineralocorticoid receptor|mineralocorticoid receptor
64373|NCT03801967|Heart failure with preserved ejection fraction|heart failure with preserved ejection fraction
64374|NCT03801967|Safety|safety
64375|NCT03801967|Pharmacokinetics|pharmacokinetics
64376|NCT03801967|Single Ascending Dose|single ascending dose
64377|NCT03801967|Multiple Ascending Dose|multiple ascending dose
64378|NCT03801954|Nutrition|nutrition
64379|NCT03801954|Diet|diet
64380|NCT03801954|Radical cystectomy|radical cystectomy
64381|NCT03801941|Low back pain|low back pain
64382|NCT03801941|Medical device|medical device
64383|NCT03801941|Spine|spine
64384|NCT03801941|Rehabilitation|rehabilitation
64385|NCT03801941|Traction|traction
64386|NCT03801928|Inflectra|inflectra
64387|NCT03801928|Remicade|remicade
64388|NCT03801915|Well Tolerated Agent|well tolerated agent
64389|NCT03801915|Pancreas and Liver Resections|pancreas and liver resections
64390|NCT03801915|Recurrence Free Survival|recurrence free survival
64391|NCT03801889|chelator|chelator
64392|NCT03801863|Erector Spinae Plane Block|erector spinae plane block
64393|NCT03801863|Ropivacaine|ropivacaine
64394|NCT03801863|Ultrasound guided nerve block|ultrasound guided nerve block
64395|NCT03801850|volume variation|volume variation
64396|NCT03801850|deformation|deformation
64397|NCT03801850|repositioning|repositioning
64398|NCT03801850|dosimetric quality|dosimetric quality
64399|NCT03801850|3D scan|3d scan
64400|NCT03801837|Macadamia Nuts|macadamia nuts
64401|NCT03801837|Cardiovascular Disease|cardiovascular disease
64402|NCT03801837|Inflammation|inflammation
64403|NCT03801824|Gestational Diabetes Mellitus|gestational diabetes mellitus
64404|NCT03801824|Glycemic index|glycemic index
64405|NCT03801824|Metabolic Response|metabolic response
64406|NCT03801824|Pregnancy Outcomes|pregnancy outcomes
64407|NCT03801824|Glycemic control|glycemic control
64408|NCT03801811|Port|port
64409|NCT03801811|Glue|glue
64410|NCT03801811|CVC|cvc
64411|NCT03801798|GC1102|gc1102
64412|NCT03801798|GC1102B|gc1102b
64413|NCT03801798|Chronic Hepatitis B virus|chronic hepatitis b virus
64414|NCT03801798|CHB|chb
64415|NCT03801798|NAs|nas
64416|NCT03801798|NUC|nuc
64417|NCT03801785|Proprioceptive and exteroceptive development|proprioceptive and exteroceptive development
64418|NCT03801785|Non-nutritive habit benefits|non-nutritive habit benefits
64419|NCT03801785|Thumb sucking|thumb sucking
64420|NCT03801785|Pacifiers|pacifiers
64421|NCT03801785|Appropriate age to stop non-nutritive sucking|appropriate age to stop non-nutritive sucking
64422|NCT03801785|Dental problems|dental problems
64423|NCT03801785|Theta Rhythm|theta rhythm
64424|NCT03801772|Aquatic Therapy|aquatic therapy
64425|NCT03801772|Hydrotherapy|hydrotherapy
64426|NCT03801772|Pool Therapy|pool therapy
64427|NCT03801759|vadadustat|vadadustat
64428|NCT03801759|drug interactions|drug interactions
64429|NCT03801759|healthy volunteers|healthy volunteers
64430|NCT03801746|Healthy volunteers|healthy volunteers
64431|NCT03801746|vadadustat|vadadustat
64432|NCT03801746|drug interactions|drug interactions
64433|NCT03801733|Vadadustat|vadadustat
64434|NCT03801733|Normal Healthy volunteers|normal healthy volunteers
64435|NCT03801733|Pharmacokinetics|pharmacokinetics
64436|NCT03801733|Rosuvastatin|rosuvastatin
64437|NCT03801733|Sulfasalazine|sulfasalazine
64438|NCT03801733|Pravastatin|pravastatin
64439|NCT03801733|Atrovastatin|atrovastatin
64440|NCT03801733|Simvastatin|simvastatin
64441|NCT03801720|Clean Catch Urine (CCU)|clean catch urine (ccu)
64442|NCT03801720|Catherterization|catherterization
64443|NCT03801720|Ultrasound|ultrasound
64444|NCT03801720|Micturition|micturition
64445|NCT03801720|Urine Collection|urine collection
64446|NCT03801720|Pre-Continent Children|pre-continent children
64447|NCT03801720|Pediatrics|pediatrics
64448|NCT03801681|myocarditis|myocarditis
64449|NCT03801681|heart failure|heart failure
64450|NCT03801681|endomyocardial biopsy|endomyocardial biopsy
64451|NCT03801681|arrythmia|arrythmia
64452|NCT03801681|sudden cardiac death|sudden cardiac death
64453|NCT03801681|biomarker|biomarker
64454|NCT03801681|cardiomyopathy|cardiomyopathy
64455|NCT03801681|high-sensitive troponin|high-sensitive troponin
64456|NCT03801681|galectin-3|galectin-3
64457|NCT03801681|st-2|st-2
64458|NCT03801681|NT-proBNP|nt-probnp
64459|NCT03801668|Gastric Cancer|gastric cancer
64460|NCT03801668|Albumin-bound Paclitaxel|albumin-bound paclitaxel
64461|NCT03801629|Neuroinflammation|neuroinflammation
64462|NCT03801629|Morphine|morphine
64463|NCT03801629|PET Imaging|pet imaging
64464|NCT03801629|TSPO|tspo
64465|NCT03801577|omega-3|omega-3
64466|NCT03801577|nafld|nafld
64467|NCT03801577|nafl|nafl
64468|NCT03801577|nash|nash
64469|NCT03801577|medical food|medical food
64470|NCT03801564|Knee Osteoarthritis|knee osteoarthritis
64471|NCT03801564|Hyaluronic Acid|hyaluronic acid
64472|NCT03801564|Platelet Rich Plasma|platelet rich plasma
64473|NCT03801551|apathy|apathy
64474|NCT03801551|schizophrenia|schizophrenia
64475|NCT03801525|CLL|cll
64476|NCT03801499|Intrahepatic Cholangiocarcinoma|intrahepatic cholangiocarcinoma
64477|NCT03801499|Lenvatinib|lenvatinib
64478|NCT03801473|rehabilitation|rehabilitation
64479|NCT03801473|robot assisted gait training|robot assisted gait training
64480|NCT03801421|Surgical Wound|surgical wound
64481|NCT03801421|Suture, Complication|suture, complication
64482|NCT03801382|cognitive model|cognitive model
64483|NCT03801382|cognitive assessment|cognitive assessment
64484|NCT03801382|digital cognitive tests|digital cognitive tests
64485|NCT03801382|automated scoring|automated scoring
64486|NCT03801382|algorithms|algorithms
64487|NCT03801356|back pain|back pain
64488|NCT03801356|lumbar spine pain|lumbar spine pain
64489|NCT03801356|nerve root block|nerve root block
64490|NCT03801356|foraminotomy|foraminotomy
64491|NCT03801356|radiculopathy|radiculopathy
64492|NCT03801356|lumbar|lumbar
64493|NCT03801356|foraminal stenosis|foraminal stenosis
64494|NCT03801330|pulmonary rehabilitation|pulmonary rehabilitation
64495|NCT03801330|digital|digital
64496|NCT03801330|telehealth|telehealth
64497|NCT03801330|software|software
64498|NCT03801330|electronic health|electronic health
64499|NCT03801304|immunotherapy|immunotherapy
64500|NCT03801304|second line of chemotherapy|second line of chemotherapy
64501|NCT03801278|Single patient|single patient
64502|NCT03801265|lumbar plexus block|lumbar plexus block
64503|NCT03801265|quadratus lumborum block|quadratus lumborum block
64504|NCT03801265|total hip arthroplasty|total hip arthroplasty
64505|NCT03801226|Peritoneal dialysis|peritoneal dialysis
64506|NCT03801213|Urine Specimen Collection/methods|urine specimen collection/methods
64507|NCT03801213|Infant|infant
64508|NCT03801213|Newborn|newborn
64509|NCT03801213|Feasibility Studies|feasibility studies
64510|NCT03801213|Bladder stimulation|bladder stimulation
64511|NCT03801200|Brain metastasis|brain metastasis
64512|NCT03801200|Apatinib|apatinib
64513|NCT03801200|Radiotherapy|radiotherapy
64514|NCT03801200|NSCLC|nsclc
64515|NCT03801200|Drive gene negative|drive gene negative
64516|NCT03801187|peri-implantitis|peri-implantitis
64517|NCT03801187|surgical treatment|surgical treatment
64518|NCT03801187|Er:Yag laser|er:yag laser
64519|NCT03801187|Air-flow|air-flow
64520|NCT03801187|chlorhexidine|chlorhexidine
64521|NCT03801161|vitamin A|vitamin a
64522|NCT03801161|vitamin A isotope|vitamin a isotope
64523|NCT03801161|vitamin D|vitamin d
64524|NCT03801161|ferritin|ferritin
64525|NCT03801161|transferrin receptor|transferrin receptor
64526|NCT03801161|folate|folate
64527|NCT03801161|cobalamin|cobalamin
64528|NCT03801161|beta-carotene|beta-carotene
64529|NCT03801161|Inflammation|inflammation
64530|NCT03801148|Drug therapy|drug therapy
64531|NCT03801135|Fibrinogen concentrate|fibrinogen concentrate
64532|NCT03801135|Fresh frozen plasma|fresh frozen plasma
64533|NCT03801135|ROTEM|rotem
64534|NCT03801135|Fibrinogen|fibrinogen
64535|NCT03801135|Overall coagulation potential|overall coagulation potential
64536|NCT03801122|Tranexamic acid|tranexamic acid
64537|NCT03801122|bleeding|bleeding
64538|NCT03801122|hematological malignancies|hematological malignancies
64539|NCT03801122|thrombocytopenia|thrombocytopenia
64540|NCT03801109|transcranial magnetic stimulation|transcranial magnetic stimulation
64541|NCT03801109|hyperbaric chamber|hyperbaric chamber
64542|NCT03801109|pain|pain
64543|NCT03801109|endorphins|endorphins
64544|NCT03801083|Biliary Tract Cancer|biliary tract cancer
64545|NCT03801083|Cholangiocarcinoma|cholangiocarcinoma
64546|NCT03801057|Dietary Supplements|dietary supplements
64547|NCT03801057|Fish Proteins|fish proteins
64548|NCT03801057|Protein Hydrolysates|protein hydrolysates
64549|NCT03800992|SPIKES - a Six-Step Protocol for Delivering Bad News|spikes - a six-step protocol for delivering bad news
64550|NCT03800992|advisory skills|advisory skills
64551|NCT03800979|Alopecia areata|alopecia areata
64552|NCT03800979|Alopecia universalis|alopecia universalis
64553|NCT03800979|Alopecia totalis|alopecia totalis
64554|NCT03800979|Tofacitinib|tofacitinib
84050|NCT03677791|CT|ct
64555|NCT03800979|JAK inhibitor|jak inhibitor
64556|NCT03800888|Real-time|real-time
64557|NCT03800888|Medication Adherence|medication adherence
64558|NCT03800888|Tuberculosis|tuberculosis
64559|NCT03800875|Diabetes Mellitus, Type 1|diabetes mellitus, type 1
64560|NCT03800875|Pramlintide|pramlintide
64561|NCT03800875|Glucagon|glucagon
64562|NCT03800875|Insulin|insulin
64563|NCT03800875|Triple-Hormone|triple-hormone
64564|NCT03800875|Closed-Loop|closed-loop
64565|NCT03800875|Artificial Pancreas|artificial pancreas
64566|NCT03800862|Stenoses|stenoses
64567|NCT03800862|Chest pain|chest pain
64568|NCT03800862|Myocardial Infarction|myocardial infarction
64569|NCT03800862|Heart Attack|heart attack
64570|NCT03800862|Radiology|radiology
64571|NCT03800862|Cardiac Imaging|cardiac imaging
64572|NCT03800862|Coronary artery disease|coronary artery disease
64573|NCT03800823|Children|children
64574|NCT03800823|Obesity|obesity
64575|NCT03800823|Treatment|treatment
64576|NCT03800823|Family|family
64577|NCT03800823|mHealth|mhealth
64578|NCT03800810|Osteoarthritis|osteoarthritis
64579|NCT03800810|Mesenchymal Stem Cells|mesenchymal stem cells
64580|NCT03800810|Umbilical Cord|umbilical cord
64783|NCT03799406|Vitamin D|vitamin d
64581|NCT03800797|ankylosing spondylitis|ankylosing spondylitis
64582|NCT03800797|loxoprofen|loxoprofen
64583|NCT03800797|patch|patch
64584|NCT03800784|18F-DCFPyL PET/CT PyL|18f-dcfpyl pet/ct pyl
64585|NCT03800784|PSMA|psma
64586|NCT03800771|geriatric|geriatric
64587|NCT03800771|dual-task|dual-task
64588|NCT03800771|ergometer|ergometer
64589|NCT03800719|smoking cessation|smoking cessation
64590|NCT03800719|active referral|active referral
64592|NCT03800680|Diabetes|diabetes
64593|NCT03800680|Smartphone application|smartphone application
64594|NCT03800680|Behavior change|behavior change
64595|NCT03800680|Weight monitoring|weight monitoring
64596|NCT03800680|Physical activity|physical activity
64597|NCT03800680|Blood glucose monitoring|blood glucose monitoring
64598|NCT03800680|Medication adherence|medication adherence
64599|NCT03800680|Financial incentive|financial incentive
64600|NCT03800680|Cost-effectiveness analysis|cost-effectiveness analysis
64601|NCT03800667|Vitamin C, CAUTI|vitamin c, cauti
64602|NCT03800654|Chronic Pain|chronic pain
64603|NCT03800654|Psychological Flexibility|psychological flexibility
64604|NCT03800654|Mindfulness Meditation|mindfulness meditation
64605|NCT03800641|Dexmedetomidine|dexmedetomidine
64606|NCT03800628|survivor|survivor
64607|NCT03800628|QOL|qol
64608|NCT03800628|resources|resources
64609|NCT03800576|tacrolimus|tacrolimus
64610|NCT03800576|liver transplant|liver transplant
64611|NCT03800576|gene polymorphism|gene polymorphism
64612|NCT03800576|immunosuppressant|immunosuppressant
64613|NCT03800511|sliding test , ceaserean section|sliding test , ceaserean section
64614|NCT03800485|stroke|stroke
64615|NCT03800485|respiratory muscles|respiratory muscles
64616|NCT03800485|lung|lung
64617|NCT03800485|stroke rehabilitation|stroke rehabilitation
64618|NCT03800459|Children with Cystic Fibrosis|children with cystic fibrosis
64619|NCT03800459|Parents|parents
64620|NCT03800459|Quality of Life|quality of life
64621|NCT03800459|Coping with Stress|coping with stress
64622|NCT03800459|Problem Solving|problem solving
64623|NCT03800459|family empowerment program|family empowerment program
64624|NCT03800459|Nursing|nursing
64625|NCT03800433|pentoxifylline|pentoxifylline
64626|NCT03800420|Pellino-1|pellino-1
64627|NCT03800407|Pharmacokinetic|pharmacokinetic
64628|NCT03800407|Concurrent antituberculosis therapy|concurrent antituberculosis therapy
64629|NCT03800407|Efavirenz|efavirenz
64630|NCT03800407|Virologic response|virologic response
64631|NCT03800407|Children|children
64632|NCT03800394|Pharmacokinetic|pharmacokinetic
64633|NCT03800394|Pharmacogenomic|pharmacogenomic
64634|NCT03800394|Tenofovir diphosphate|tenofovir diphosphate
64635|NCT03800394|Emtricitabine triphosphate|emtricitabine triphosphate
64636|NCT03800394|Adolescents|adolescents
64637|NCT03800381|Pharmacokinetic|pharmacokinetic
64638|NCT03800381|Pharmacogenomic|pharmacogenomic
64639|NCT03800381|Antituberculosis drugs|antituberculosis drugs
64640|NCT03800381|Children|children
64641|NCT03800381|Tuberculosis|tuberculosis
64642|NCT03800381|TB/HIV coinfection|tb/hiv coinfection
64643|NCT03800368|Exercise|exercise
64644|NCT03800368|Sleep-dependent memory consolidation|sleep-dependent memory consolidation
64645|NCT03800368|Aerobic|aerobic
64646|NCT03800368|Anaerobic|anaerobic
64647|NCT03800355|Breast Cancer in males|breast cancer in males
64648|NCT03800355|Observational|observational
64649|NCT03800355|Gene Sequencing|gene sequencing
64650|NCT03800342|recovery|recovery
64651|NCT03800342|proteomics|proteomics
64652|NCT03800342|cardiorespiratory fitness|cardiorespiratory fitness
64653|NCT03800342|exercise|exercise
64654|NCT03800342|aerobic exercise training|aerobic exercise training
64655|NCT03800303|depression|depression
64656|NCT03800303|bipolar|bipolar
64657|NCT03800303|caregivers|caregivers
64658|NCT03800303|children|children
64659|NCT03800303|adolescents|adolescents
64660|NCT03800303|treatment|treatment
64661|NCT03800303|parents|parents
64662|NCT03800290|Beta-2 adrenergic agonist|beta-2 adrenergic agonist
64663|NCT03800290|Glucose homeostasis|glucose homeostasis
64664|NCT03800290|Skeletal muscle|skeletal muscle
64665|NCT03800290|Human|human
64666|NCT03800264|Bisoprolol,|bisoprolol,
64667|NCT03800264|corticosteroid,|corticosteroid,
64668|NCT03800264|atrial fibrillation|atrial fibrillation
64669|NCT03800264|cardiac surgery|cardiac surgery
64670|NCT03800251|Gastric Emptying|gastric emptying
64671|NCT03800251|Pregnancy|pregnancy
64672|NCT03800251|Elective Cesarean section|elective cesarean section
64673|NCT03800251|Fasting|fasting
64674|NCT03800238|caregiver|caregiver
64675|NCT03800238|wellness|wellness
64676|NCT03800238|telehealth|telehealth
64677|NCT03800199|health statues|health statues
64678|NCT03800199|observational study|observational study
64679|NCT03800199|questionnaire|questionnaire
64680|NCT03800160|metabolic surgery|metabolic surgery
64681|NCT03800160|metabolic disease|metabolic disease
64682|NCT03800160|multicenter|multicenter
64784|NCT03799406|Modified Tal score|modified tal score
64785|NCT03799406|Randomized|randomized
64683|NCT03800134|Resectable Non-small Cell Lung Cancer, NSCLC, Carcinoma, Non-small Cell Lung Cancer|resectable non-small cell lung cancer, nsclc, carcinoma, non-small cell lung cancer
64684|NCT03800121|exosomes|exosomes
64685|NCT03800095|Supportive care|supportive care
64686|NCT03800095|Early palliative care|early palliative care
64687|NCT03800095|Quality of life|quality of life
64688|NCT03800095|Symptoms management|symptoms management
64689|NCT03800095|Haematological malignancy|haematological malignancy
64690|NCT03800082|Women, Self-Management, Cardiac Pain|women, self-management, cardiac pain
64691|NCT03800056|APECED syndrome|apeced syndrome
64692|NCT03800056|autoimmune polyendocrinopathy|autoimmune polyendocrinopathy
64693|NCT03800056|chronic mucocutaneous candidiasis|chronic mucocutaneous candidiasis
64694|NCT03800043|Early Childhood Caries|early childhood caries
64695|NCT03800043|children|children
64696|NCT03800043|dentistry|dentistry
64697|NCT03800043|face perception|face perception
64698|NCT03800043|dental appearance|dental appearance
64699|NCT03800030|tACS|tacs
64700|NCT03800030|Cognitive Control|cognitive control
64701|NCT03800030|Executive Function|executive function
64702|NCT03800004|Bone Health|bone health
64703|NCT03799952|Older adult|older adult
64704|NCT03799952|Peer-led exercise program|peer-led exercise program
64705|NCT03799952|Risk of falling|risk of falling
64706|NCT03799913|CAR-T|car-t
64707|NCT03799913|MESO|meso
64708|NCT03799913|Ovarian Cancer|ovarian cancer
64709|NCT03799913|Relapsed and Refractory|relapsed and refractory
64710|NCT03799887|Parkinson's disease|parkinson's disease
64711|NCT03799887|gait|gait
64712|NCT03799887|balance|balance
64713|NCT03799887|treadmill training|treadmill training
64714|NCT03799887|fatigue|fatigue
64715|NCT03799861|Neonatal Resuscitation|neonatal resuscitation
64716|NCT03799861|Stillbirth|stillbirth
64717|NCT03799861|Neonatal Respiratory Depression|neonatal respiratory depression
64718|NCT03799861|Neonatal Bradycardia|neonatal bradycardia
64719|NCT03799848|Hepatic impairment|hepatic impairment
64720|NCT03799848|Healthy subjects|healthy subjects
64721|NCT03799848|Child-pugh|child-pugh
64722|NCT03799848|Vadadustat|vadadustat
64723|NCT03799822|hemodialysis|hemodialysis
64724|NCT03799822|rivaroxaban|rivaroxaban
64725|NCT03799822|vitamin K2|vitamin k2
64726|NCT03799796|flash glucose monitoring|flash glucose monitoring
64727|NCT03799796|online peer support|online peer support
64728|NCT03799796|Hispanic|hispanic
64729|NCT03799796|Spanish-Speaking|spanish-speaking
64730|NCT03799783|dexmedetomidine|dexmedetomidine
64731|NCT03799783|sedation|sedation
64732|NCT03799757|bupivacaine|bupivacaine
64733|NCT03799757|Post-mastectomy acute pain|post-mastectomy acute pain
64734|NCT03799757|Wound instillation|wound instillation
64735|NCT03799692|Neoadjuvant Chemotherapy|neoadjuvant chemotherapy
64736|NCT03799679|Neoadjuvant Chemotherapy|neoadjuvant chemotherapy
64737|NCT03799666|Pulmonary rehabilitation|pulmonary rehabilitation
64738|NCT03799666|Community-based|community-based
64739|NCT03799666|Chronic Respiratory Diseases|chronic respiratory diseases
64740|NCT03799666|Cost-benefit analysis|cost-benefit analysis
64741|NCT03799627|Vadadustat|vadadustat
64742|NCT03799627|AKB-6548|akb-6548
64743|NCT03799627|Anemia|anemia
64744|NCT03799627|Chronic kidney disease (CKD)|chronic kidney disease (ckd)
64745|NCT03799627|erythropoietin|erythropoietin
64746|NCT03799601|Anlotinib|anlotinib
64747|NCT03799601|Docetaxel|docetaxel
64748|NCT03799601|Carboplatin|carboplatin
64749|NCT03799601|NSCLC|nsclc
64750|NCT03799588|Pediatrics|pediatrics
64751|NCT03799588|biphasic chest cuirass|biphasic chest cuirass
64752|NCT03799588|transpulmonary pressure|transpulmonary pressure
64753|NCT03799562|Depression|depression
64754|NCT03799562|Pain|pain
64755|NCT03799562|Clinical Trial|clinical trial
64756|NCT03799562|Veteran|veteran
64757|NCT03799562|Supplement|supplement
64758|NCT03799536|Bioequivalence|bioequivalence
64759|NCT03799536|Sotalol|sotalol
64760|NCT03799536|Sotalex|sotalex
64761|NCT03799510|Schistosomiasis|schistosomiasis
64762|NCT03799510|Recombinant vaccine|recombinant vaccine
64763|NCT03799510|rSm14|rsm14
64764|NCT03799510|GLA-SE|gla-se
64765|NCT03799510|Fatty acid-binding protein (FABP)|fatty acid-binding protein (fabp)
64766|NCT03799510|Phase II Clinical Trial|phase ii clinical trial
64767|NCT03799510|Senegal|senegal
64768|NCT03799497|Anorexia nervosa|anorexia nervosa
64769|NCT03799497|functional MRI (fMRI)|functional mri (fmri)
64770|NCT03799497|self body-shape recognition|self body-shape recognition
64771|NCT03799484|Rhytides|rhytides
64772|NCT03799484|Forehead Wrinkles|forehead wrinkles
64773|NCT03799471|chronic musculoskeletal pain|chronic musculoskeletal pain
64774|NCT03799471|central hypersensitivity|central hypersensitivity
64775|NCT03799432|Implementation Science|implementation science
64776|NCT03799432|Cognitive Behavioral Therapy|cognitive behavioral therapy
64777|NCT03799432|Children|children
64778|NCT03799432|Youth|youth
64779|NCT03799419|cognitive bias modification|cognitive bias modification
64780|NCT03799419|interpretation bias|interpretation bias
64781|NCT03799419|approach avoidance|approach avoidance
64782|NCT03799406|Acute bronchiolitis|acute bronchiolitis
64786|NCT03799406|Controlled trial|controlled trial
64787|NCT03799393|injury prevention|injury prevention
64788|NCT03799393|car safety|car safety
64789|NCT03799393|car seats|car seats
64790|NCT03799393|booster seats|booster seats
64791|NCT03799393|car restraints|car restraints
64792|NCT03799354|rehabilitation|rehabilitation
64793|NCT03799354|resistive training|resistive training
64794|NCT03799354|exercise|exercise
64795|NCT03799341|Cocaine-Related Disorders|cocaine-related disorders
64796|NCT03799341|Contingency Management|contingency management
64797|NCT03799341|Reward|reward
64798|NCT03799341|Choice Behavior|choice behavior
64799|NCT03799341|Executive Function|executive function
64800|NCT03799341|Precision Medicine|precision medicine
64801|NCT03799341|Evidence-Based Practice|evidence-based practice
64802|NCT03799341|Prospective Thinking|prospective thinking
64803|NCT03799341|Electroencephalography|electroencephalography
64804|NCT03799341|Event-Related Potentials|event-related potentials
64805|NCT03799341|Functional Connectivity|functional connectivity
64806|NCT03799315|Incarceration|incarceration
64807|NCT03799315|Smoking|smoking
64808|NCT03799315|Counseling|counseling
64809|NCT03799315|Nicotine Replacement|nicotine replacement
64810|NCT03799315|Disparities|disparities
64811|NCT03799289|Obesity|obesity
64812|NCT03799289|Weight loss|weight loss
64813|NCT03799289|physical activity|physical activity
64814|NCT03799289|yoga|yoga
64815|NCT03799289|exercise|exercise
64816|NCT03799237|Dengue|dengue
64817|NCT03799237|Adult Aedes|adult aedes
64818|NCT03799237|GOS trap|gos trap
64819|NCT03799237|Dengue NS1 antigen test|dengue ns1 antigen test
64820|NCT03799237|Early dengue detection and surveillance|early dengue detection and surveillance
64821|NCT03799224|recurrent acute leukemia|recurrent acute leukemia
64822|NCT03799224|refractory acute leukemia|refractory acute leukemia
64823|NCT03799224|preconditioning regimen|preconditioning regimen
64824|NCT03799224|allogeneic stem cell transplantation|allogeneic stem cell transplantation
64825|NCT03799185|Coronary Heart Disease|coronary heart disease
64826|NCT03799185|Hypercholesterolemia|hypercholesterolemia
64827|NCT03799185|Triglycerides High|triglycerides high
64828|NCT03799185|LDL Hyperlipoproteinemia|ldl hyperlipoproteinemia
64829|NCT03799185|HDL Low|hdl low
64830|NCT03799185|Diabetes|diabetes
64831|NCT03799185|Cardiovascular Diseases|cardiovascular diseases
64832|NCT03799185|Hypertension|hypertension
64833|NCT03799185|Risk Factor, Cardiovascular|risk factor, cardiovascular
64834|NCT03799185|Diet Habit|diet habit
64835|NCT03799185|Smoking|smoking
64836|NCT03799159|Sepsis|sepsis
64837|NCT03799159|Acute Kidney Injury|acute kidney injury
64838|NCT03799159|Ultrasound|ultrasound
64839|NCT03799159|Resistive Index|resistive index
64840|NCT03799159|Biomarkers|biomarkers
64841|NCT03799146|physical activity|physical activity
64842|NCT03799146|sedentary behaviour|sedentary behaviour
64843|NCT03799146|eHealth|ehealth
64844|NCT03799146|mHealth|mhealth
64845|NCT03799146|self-regulation|self-regulation
64846|NCT03799146|behaviour change techniques|behaviour change techniques
64847|NCT03799133|gastric reactance|gastric reactance
64848|NCT03799133|elective cardiac surgery|elective cardiac surgery
64849|NCT03799133|morbimortality|morbimortality
64850|NCT03799133|APACHE II|apache ii
64851|NCT03799133|STS|sts
64852|NCT03799133|SOFA|sofa
64853|NCT03799133|EUROSCORE II|euroscore ii
64854|NCT03799094|tyrosine kinase inhibitor|tyrosine kinase inhibitor
64855|NCT03799094|Vitamin C|vitamin c
64856|NCT03799094|non-small cell lung cancer|non-small cell lung cancer
64857|NCT03799094|progression-free survival|progression-free survival
64858|NCT03799094|overall survival|overall survival
64859|NCT03799068|bupivacaine|bupivacaine
64860|NCT03799068|suprazygomatic nerve block|suprazygomatic nerve block
64861|NCT03799029|Cognitive training|cognitive training
64862|NCT03799029|treatment|treatment
64863|NCT03799029|ADHD|adhd
64864|NCT03799003|ASP1951|asp1951
64865|NCT03799003|cervical cancer|cervical cancer
64866|NCT03799003|Oncology|oncology
64867|NCT03799003|squamous cell carcinoma of the head and neck (SCCHN)|squamous cell carcinoma of the head and neck (scchn)
64868|NCT03799003|metastatic castration-resistant prostate cancer (mCRPC)|metastatic castration-resistant prostate cancer (mcrpc)
64869|NCT03799003|melanoma|melanoma
64870|NCT03799003|Tumors|tumors
64871|NCT03799003|pembrolizumab|pembrolizumab
64872|NCT03799003|colorectal cancer|colorectal cancer
64873|NCT03799003|Advanced (unresectable) or metastatic solid tumor malignancies|advanced (unresectable) or metastatic solid tumor malignancies
64874|NCT03799003|Advanced solid tumors|advanced solid tumors
64875|NCT03798990|Speed|speed
64876|NCT03798990|Road safety|road safety
64877|NCT03798977|Skin metastasis|skin metastasis
64878|NCT03798977|Resistance|resistance
64879|NCT03798977|Endoplasmic reticulum stress|endoplasmic reticulum stress
64880|NCT03798977|Metastasis|metastasis
64881|NCT03798951|Esophageal cancer surgery|esophageal cancer surgery
64882|NCT03798951|Prehabilitation|prehabilitation
64883|NCT03798951|Enhanced recovery after surgery|enhanced recovery after surgery
64984|NCT03798275|caffeine|caffeine
64985|NCT03798275|coffee|coffee
64884|NCT03798912|RaniPill capsule, drug delivery, octreotide, pharmacokinetic|ranipill capsule, drug delivery, octreotide, pharmacokinetic
64885|NCT03798886|Frozen embryo replacement, IVF success, ovarian stimulation|frozen embryo replacement, ivf success, ovarian stimulation
64886|NCT03798873|Compression garment|compression garment
64887|NCT03798873|Physical therapy|physical therapy
64889|NCT03798873|Movement|movement
64890|NCT03798873|Abdominal binder|abdominal binder
64891|NCT03798847|Journey II XR Total Knee System|journey ii xr total knee system
64892|NCT03798808|vegetables, fruits, dairy, children, habits|vegetables, fruits, dairy, children, habits
64893|NCT03798782|Cardiac surgery|cardiac surgery
64894|NCT03798782|Aortic valve replacement|aortic valve replacement
64895|NCT03798782|Ross procedure|ross procedure
64896|NCT03798769|Pancreas Cancer|pancreas cancer
64897|NCT03798743|Non-small Cell Lung Cancer|non-small cell lung cancer
64898|NCT03798743|Sintilimab|sintilimab
64899|NCT03798743|Docetaxel|docetaxel
64900|NCT03798730|Older Adults|older adults
64901|NCT03798730|Oral Nutritional Supplements|oral nutritional supplements
64902|NCT03798730|Saliva Flow|saliva flow
64903|NCT03798730|Mucoadhesion|mucoadhesion
64904|NCT03798730|Mouthdrying|mouthdrying
64905|NCT03798704|Lyme disease|lyme disease
64906|NCT03798704|IFA|ifa
64907|NCT03798704|LIAISON|liaison
64908|NCT03798704|children|children
64909|NCT03798704|Slovenia|slovenia
64910|NCT03798652|Perfusion|perfusion
64911|NCT03798652|Viability|viability
64912|NCT03798626|colorectal cancer|colorectal cancer
64913|NCT03798626|gastroesophageal cancer|gastroesophageal cancer
64914|NCT03798626|renal cell carcinoma|renal cell carcinoma
64915|NCT03798626|gevokizumab|gevokizumab
64916|NCT03798626|bevacizumab|bevacizumab
64917|NCT03798626|modified FOLFOX6|modified folfox6
64918|NCT03798626|FOLFIRI|folfiri
64919|NCT03798626|ramucirumab|ramucirumab
64920|NCT03798626|paclitaxel|paclitaxel
64921|NCT03798626|cabozantinib|cabozantinib
64922|NCT03798626|CRC|crc
64923|NCT03798626|GEC|gec
64924|NCT03798626|RCC|rcc
64925|NCT03798626|VPM087|vpm087
64926|NCT03798613|Post-op Atrial Fibrillation|post-op atrial fibrillation
64927|NCT03798613|Heart Rhythm|heart rhythm
64928|NCT03798613|Accuracy|accuracy
64929|NCT03798613|Apple Watch|apple watch
64930|NCT03798600|Caspofungin|caspofungin
64931|NCT03798600|pharmacokinetic|pharmacokinetic
64932|NCT03798600|pharmacodynamic|pharmacodynamic
64933|NCT03798548|CBT|cbt
64934|NCT03798548|Brief Therapy|brief therapy
64935|NCT03798548|Bedside Intervention|bedside intervention
64936|NCT03798522|ultrasound guided regional blocks|ultrasound guided regional blocks
64937|NCT03798522|laparoscopic surgery|laparoscopic surgery
64938|NCT03798522|erector spinae plane block|erector spinae plane block
64939|NCT03798509|CD19|cd19
64940|NCT03798509|CAR-T|car-t
64941|NCT03798509|leukemia|leukemia
64942|NCT03798509|Relapsed /Refractory|relapsed /refractory
64943|NCT03798509|B-ALL|b-all
64944|NCT03798470|opioid|opioid
64945|NCT03798470|overdose|overdose
64946|NCT03798457|Community-acquired pneumonia (CAP)|community-acquired pneumonia (cap)
64947|NCT03798444|Height loss, Kyphosis|height loss, kyphosis
64948|NCT03798444|Osteoporosis, Vertebral fracture|osteoporosis, vertebral fracture
64949|NCT03798444|Postmenopausal women|postmenopausal women
64950|NCT03798418|Sarcopenia|sarcopenia
64951|NCT03798418|stroke|stroke
64952|NCT03798418|osteoporosis|osteoporosis
64953|NCT03798418|chronic kidney disease|chronic kidney disease
64954|NCT03798418|cancer|cancer
64955|NCT03798418|balance and gait|balance and gait
64956|NCT03798418|fall|fall
64957|NCT03798405|Pain|pain
64958|NCT03798405|Inflammatory Bowel Disease|inflammatory bowel disease
64959|NCT03798405|Opioids|opioids
64960|NCT03798379|cancer|cancer
64961|NCT03798379|chemotherapy|chemotherapy
64962|NCT03798379|peripheral neuropathy|peripheral neuropathy
64963|NCT03798379|exercise|exercise
64964|NCT03798353|Cardiac repair|cardiac repair
64965|NCT03798353|Wharton jelly mesenchymal stem cells|wharton jelly mesenchymal stem cells
64966|NCT03798353|Chronic myocardial infarction|chronic myocardial infarction
64967|NCT03798353|Tissue engineering|tissue engineering
64968|NCT03798353|Cell therapy|cell therapy
64969|NCT03798353|Clinical trial|clinical trial
64970|NCT03798340|stroke|stroke
64971|NCT03798340|perturbation-based training|perturbation-based training
64972|NCT03798340|task-specific motor training|task-specific motor training
64973|NCT03798340|recovery of function|recovery of function
64974|NCT03798327|Palliative Care|palliative care
64975|NCT03798327|Home-Based Care|home-based care
64976|NCT03798301|Immunocompromised|immunocompromised
64977|NCT03798301|Allogeneic Stem Cell Transplantation|allogeneic stem cell transplantation
64978|NCT03798301|Hematopoietic stem cell transplantation (HSCT)|hematopoietic stem cell transplantation (hsct)
64979|NCT03798301|T-cell|t-cell
64980|NCT03798288|Digital Decision Support System|digital decision support system
64981|NCT03798288|App|app
64982|NCT03798288|Self-management|self-management
64983|NCT03798275|amniotic fluid index|amniotic fluid index
64986|NCT03798275|oligohydramnios|oligohydramnios
64987|NCT03798236|Adenosine A3 receptor antagonist|adenosine a3 receptor antagonist
64988|NCT03798236|autoimmune diseases|autoimmune diseases
64989|NCT03798236|Immune modulator|immune modulator
64990|NCT03798223|Selective Laser Trabeculoplasty|selective laser trabeculoplasty
64991|NCT03798210|ulcerative colitis|ulcerative colitis
64992|NCT03798210|prevention|prevention
64993|NCT03798210|microbiota|microbiota
64994|NCT03798210|Lactobacillus|lactobacillus
64995|NCT03798197|Estetrol|estetrol
64996|NCT03798197|Menopausal hormone therapy|menopausal hormone therapy
64997|NCT03798184|Prime&Bond Active|prime&bond active
64998|NCT03798184|Bioactive glass|bioactive glass
64999|NCT03798184|non-carious cervical lesion|non-carious cervical lesion
65000|NCT03798184|direct resin composite|direct resin composite
65001|NCT03798171|peritoneal dialysis|peritoneal dialysis
65002|NCT03798171|exit site|exit site
65003|NCT03798171|infection|infection
65004|NCT03798171|peritonitis|peritonitis
65005|NCT03798132|Ovarian Neoplasms, Laparoscopy, Cytoreduction Surgical Procedures.|ovarian neoplasms, laparoscopy, cytoreduction surgical procedures.
65006|NCT03798119|Hepatitis B|hepatitis b
65007|NCT03798119|advanced fibrosis|advanced fibrosis
65008|NCT03798119|Cirrhosis|cirrhosis
65009|NCT03798119|Switch|switch
65010|NCT03798119|Tenofovir alafenamide|tenofovir alafenamide
65011|NCT03798093|Umbilical Cord Milking|umbilical cord milking
65012|NCT03798093|Immediate Cord Clamping|immediate cord clamping
65013|NCT03798093|Resuscitation|resuscitation
65014|NCT03798041|Surgical Wound|surgical wound
65015|NCT03798041|Suture, Complication|suture, complication
65016|NCT03798028|anemia|anemia
65017|NCT03798028|Interstitial pulmonary disease|interstitial pulmonary disease
65018|NCT03798015|mitral valve surgery|mitral valve surgery
65019|NCT03798015|mitral valve stenosis|mitral valve stenosis
65020|NCT03798015|mitral valve insufficiency|mitral valve insufficiency
65021|NCT03798015|minimal invasive mitral valve surgery|minimal invasive mitral valve surgery
65022|NCT03798015|neurological outcome|neurological outcome
65023|NCT03798002|isolated quadriceps training|isolated quadriceps training
65024|NCT03798002|Neuro-muscular exercise training|neuro-muscular exercise training
65025|NCT03798002|knee Osteoarthritis|knee osteoarthritis
65026|NCT03797963|Maxillary sinus augmentation|maxillary sinus augmentation
65027|NCT03797963|Sinus lift|sinus lift
65028|NCT03797963|Biomaterial|biomaterial
65029|NCT03797963|Anorganic bovine bone|anorganic bovine bone
65030|NCT03797963|Porcine bone mineral|porcine bone mineral
65031|NCT03797963|Implant dentistry|implant dentistry
65032|NCT03797950|OPV|opv
65033|NCT03797950|BCG|bcg
65034|NCT03797950|vaccine delivery|vaccine delivery
65035|NCT03797950|mhealth|mhealth
65036|NCT03797950|incentives|incentives
65037|NCT03797924|Intercostobrachial Nerve Block|intercostobrachial nerve block
65038|NCT03797924|Tourniquet Pain|tourniquet pain
65039|NCT03797924|Upper Limb Surgeries|upper limb surgeries
65040|NCT03797846|ptosis|ptosis
65041|NCT03797846|combined procedures|combined procedures
65042|NCT03797846|glaucoma|glaucoma
65043|NCT03797846|post-surgery complication|post-surgery complication
65044|NCT03797833|breech presentation, external version, spinal anaesthesia|breech presentation, external version, spinal anaesthesia
65045|NCT03797755|survival|survival
65046|NCT03797755|cancer|cancer
65047|NCT03797755|palliative|palliative
65048|NCT03797755|radiotherapy|radiotherapy
65049|NCT03797755|prognosis|prognosis
65050|NCT03797729|ST Elevation Myocardial Infarction|st elevation myocardial infarction
65051|NCT03797729|Tirofiban|tirofiban
400576|NCT01866215|intramyocellular lipids|intramyocellular lipids
65052|NCT03797729|Percutaneous Coronary Intervention|percutaneous coronary intervention
65053|NCT03797716|Anxiety, peri-operative, preparation, app|anxiety, peri-operative, preparation, app
65054|NCT03797690|Dupuytren's disease|dupuytren's disease
65055|NCT03797690|Percutaneous needle aponeurotomy|percutaneous needle aponeurotomy
65056|NCT03797690|Limited aponeurectomy|limited aponeurectomy
65057|NCT03797690|Randomized trial|randomized trial
65058|NCT03797677|Airway Clearance|airway clearance
65059|NCT03797677|Cystic Fibrosis|cystic fibrosis
65060|NCT03797677|Motor Neuron Disease|motor neuron disease
65061|NCT03797677|Home care|home care
65062|NCT03797638|Dystonic Disorder|dystonic disorder
65063|NCT03797638|Focal Dystonia|focal dystonia
65064|NCT03797638|Writer's Cramp|writer's cramp
65065|NCT03797612|Knee replacement|knee replacement
65066|NCT03797612|TKA|tka
65067|NCT03797612|Total Knee Arthroplasty|total knee arthroplasty
65068|NCT03797586|electroacupuncture；opioid-induced constipation ,cancer|electroacupuncture；opioid-induced constipation ,cancer
65069|NCT03797573|transcranial direct current stimulation|transcranial direct current stimulation
65070|NCT03797573|disorder of consciousness|disorder of consciousness
65071|NCT03797573|muscle hypertonia|muscle hypertonia
65072|NCT03797573|spasticity|spasticity
65073|NCT03797573|vegetative state|vegetative state
65074|NCT03797573|minimally conscious state|minimally conscious state
65075|NCT03797560|Eight Brocades; Ba-Duan-Jin; Baduanjin; Qigong; Pain|eight brocades; ba-duan-jin; baduanjin; qigong; pain
65076|NCT03797534|warfarin|warfarin
65077|NCT03797534|gene|gene
65078|NCT03797521|Promentis Pharmaceuticals|promentis pharmaceuticals
65079|NCT03797521|TTM|ttm
65080|NCT03797521|SXC-2023|sxc-2023
65081|NCT03797469|Perimetry|perimetry
65082|NCT03797469|Vitamins|vitamins
65083|NCT03797469|Glaucoma|glaucoma
65084|NCT03797469|Supplements|supplements
65085|NCT03797469|Vitamin B3|vitamin b3
65086|NCT03797469|Nicotinamide|nicotinamide
65087|NCT03797443|Metastatic Pancreatic Cancer|metastatic pancreatic cancer
65088|NCT03797443|Cancer|cancer
65089|NCT03797443|Pancreatic|pancreatic
65090|NCT03797443|Vitamin C|vitamin c
65091|NCT03797443|Ascorbic Acid|ascorbic acid
65092|NCT03797443|Paclitaxel Protein Bound|paclitaxel protein bound
65093|NCT03797443|Cisplatin|cisplatin
65094|NCT03797443|Gemcitabine|gemcitabine
65095|NCT03797430|hand ball|hand ball
65096|NCT03797430|evaluation|evaluation
65097|NCT03797430|risk of injury|risk of injury
65098|NCT03797430|women|women
65099|NCT03797417|Gut Microbiome|gut microbiome
65100|NCT03797417|Vitiligo|vitiligo
65101|NCT03797417|Metabolic Pathways|metabolic pathways
65102|NCT03797404|Eosinophil|eosinophil
65103|NCT03797404|Bronchial biopsies|bronchial biopsies
65104|NCT03797404|Mepolizumab|mepolizumab
65105|NCT03797404|Severe|severe
65106|NCT03797391|Human Bispecific antibody,|human bispecific antibody,
65107|NCT03797391|Epidermal Growth Factor Receptor (EGFR),|epidermal growth factor receptor (egfr),
65108|NCT03797391|c-Mesenchymal-Epithelial Transition (cMet),|c-mesenchymal-epithelial transition (cmet),
65109|NCT03797391|Neoplasms, Neoplasm Metastasis,|neoplasms, neoplasm metastasis,
65110|NCT03797391|Non-Small-Cell Lung Cancer (NSCLC), First-in-human,|non-small-cell lung cancer (nsclc), first-in-human,
65111|NCT03797391|EMB-01, Tyrosine Kinase Inhibitor (TKI) Resistant|emb-01, tyrosine kinase inhibitor (tki) resistant
65112|NCT03797352|Bone Health|bone health
65113|NCT03797352|Cognitive Decline|cognitive decline
65114|NCT03797352|Health Education|health education
65115|NCT03797352|Mobility Decline|mobility decline
65116|NCT03797339|epigenome|epigenome
65117|NCT03797339|metabolome|metabolome
65118|NCT03797339|microbiome|microbiome
65119|NCT03797339|genome|genome
65120|NCT03797339|multi-omics targets|multi-omics targets
65121|NCT03797339|individual drug use|individual drug use
65122|NCT03797326|programmed cell death 1 (PD-1, PD1)|programmed cell death 1 (pd-1, pd1)
65123|NCT03797326|programmed cell death ligand 1 (PD-L1, PDL1)|programmed cell death ligand 1 (pd-l1, pdl1)
65124|NCT03797326|programmed cell death ligand 2 (PD-L2, PDL2)|programmed cell death ligand 2 (pd-l2, pdl2)
65125|NCT03797326|tyrosine kinase inhibitor (TKI)|tyrosine kinase inhibitor (tki)
65126|NCT03797326|multiple TKI|multiple tki
65127|NCT03797326|Vascular Endothelial Growth Factor Receptor (VEFG)|vascular endothelial growth factor receptor (vefg)
65128|NCT03797326|Fibroblast Growth Factor (FGF)|fibroblast growth factor (fgf)
65129|NCT03797326|Platelet-Derived Growth Factor (PDGF)|platelet-derived growth factor (pdgf)
65130|NCT03797261|Acute Myeloid Leukemia|acute myeloid leukemia
65131|NCT03797261|Non-Hodgkin's Lymphoma|non-hodgkin's lymphoma
65132|NCT03797261|Cancer|cancer
65133|NCT03797261|Venetoclax|venetoclax
65134|NCT03797261|AMG 176|amg 176
65135|NCT03797261|diffuse large B-cell lymphoma (DLBCL)|diffuse large b-cell lymphoma (dlbcl)
65136|NCT03797248|traditional Chinese medicine|traditional chinese medicine
65137|NCT03797248|quality of life|quality of life
65138|NCT03797248|disease-free survival|disease-free survival
65139|NCT03797248|adjuvant chemotherapy|adjuvant chemotherapy
65140|NCT03797248|breast cancer|breast cancer
65141|NCT03797235|Ultrasound-guided regional anesthesia|ultrasound-guided regional anesthesia
65142|NCT03797222|hyperinsulinism|hyperinsulinism
65143|NCT03797222|hyperammonemia|hyperammonemia
65144|NCT03797222|hypoglycemia|hypoglycemia
65145|NCT03797222|vitamin e|vitamin e
65146|NCT03797209|PPC|ppc
65147|NCT03797209|WON|won
65148|NCT03797170|RCHOP|rchop
65149|NCT03797170|first line|first line
65150|NCT03797170|microbiota|microbiota
65151|NCT03797170|response|response
65152|NCT03797170|disease control|disease control
65153|NCT03797170|therapy toxicity|therapy toxicity
65154|NCT03797131|KB195|kb195
65155|NCT03797131|Urea Cycle Disorders|urea cycle disorders
65156|NCT03797131|UCD|ucd
65157|NCT03797131|microbiome|microbiome
65158|NCT03797131|Kaleido|kaleido
65159|NCT03797131|ammonia|ammonia
65160|NCT03797118|noninvasive assessment of the fractional flow reserve|noninvasive assessment of the fractional flow reserve
65161|NCT03797118|coronary computed tomography angiography|coronary computed tomography angiography
65162|NCT03797092|Stem cell therapy|stem cell therapy
65163|NCT03797092|Heart failure|heart failure
65164|NCT03797092|Clinical trial|clinical trial
65165|NCT03797092|Allogeneic|allogeneic
65166|NCT03797079|Erector spinae plane block|erector spinae plane block
65167|NCT03797066|hepatitis C virus|hepatitis c virus
65168|NCT03797066|homeless|homeless
65169|NCT03797027|Percutaneous nephrolithotomy|percutaneous nephrolithotomy
65170|NCT03797027|cushion|cushion
65171|NCT03797014|HIV-1|hiv-1
65172|NCT03797014|Hepatitis B|hepatitis b
65173|NCT03797014|HIV-HBV coinfection|hiv-hbv coinfection
65174|NCT03797014|Bictegravir|bictegravir
65175|NCT03797014|B/F/TAF|b/f/taf
65176|NCT03797014|Tenofovir alafenamide|tenofovir alafenamide
65177|NCT03797014|Biktarvy|biktarvy
65178|NCT03797001|heart failure|heart failure
65179|NCT03797001|inflammation|inflammation
65180|NCT03797001|anakinra|anakinra
65181|NCT03797001|exercise capacity|exercise capacity
65182|NCT03796962|Epilepsy|epilepsy
65183|NCT03796936|posttraumatic stress disorder|posttraumatic stress disorder
65184|NCT03796936|traumatic brain injury|traumatic brain injury
65185|NCT03796936|virtual reality|virtual reality
65186|NCT03796936|eye movement desensitization and reprocessing|eye movement desensitization and reprocessing
65187|NCT03796923|Elderly|elderly
65188|NCT03796923|Hospital at home|hospital at home
65189|NCT03796923|Readmission|readmission
65190|NCT03796923|Transitional care|transitional care
65191|NCT03796923|Frailty|frailty
65192|NCT03796923|Patient Related Outcome Measures|patient related outcome measures
65193|NCT03796910|safety|safety
65194|NCT03796910|tolerability|tolerability
65195|NCT03796910|pharmacokinetics|pharmacokinetics
65196|NCT03796910|SPR720|spr720
65197|NCT03796845|Exercise|exercise
65198|NCT03796832|Knee Osteoarthritis|knee osteoarthritis
65199|NCT03796832|Exercise Therapy|exercise therapy
65200|NCT03796832|Shoes|shoes
65201|NCT03796832|Pain|pain
65202|NCT03796819|intrahepatic cholangiocarcinoma|intrahepatic cholangiocarcinoma
65203|NCT03796819|surgery|surgery
65204|NCT03796819|lymphadenectomy|lymphadenectomy
65205|NCT03796819|lymph node metastasis|lymph node metastasis
65206|NCT03796819|prognosis|prognosis
65207|NCT03796806|lichen planus|lichen planus
65208|NCT03796806|proteomics|proteomics
65209|NCT03796806|xenograft model for lichen planus|xenograft model for lichen planus
65210|NCT03796715|sepsis|sepsis
65211|NCT03796715|presepsin|presepsin
65212|NCT03796715|red cell distribution width|red cell distribution width
65213|NCT03796676|Atopic Dermatitis, JAK1 inhibitor|atopic dermatitis, jak1 inhibitor
65214|NCT03796663|Disruptive Behavioral Problems|disruptive behavioral problems
65215|NCT03796663|ADHD|adhd
65216|NCT03796663|Oppositional Defiant Disorder|oppositional defiant disorder
65217|NCT03796663|Conduct Disorder|conduct disorder
65218|NCT03796663|Mindfulness|mindfulness
65219|NCT03796663|Mindful Parenting|mindful parenting
65220|NCT03796663|Behavioral Parent Training|behavioral parent training
65221|NCT03796650|Clostridium difficile|clostridium difficile
65222|NCT03796650|Intestinal microbiota therapy|intestinal microbiota therapy
65223|NCT03796650|Fecal microbiota transplantation|fecal microbiota transplantation
65224|NCT03796650|Investigator-initiated|investigator-initiated
65225|NCT03796650|Antibiotics|antibiotics
65226|NCT03796650|Diarrhea|diarrhea
65227|NCT03796624|Intraocular lens|intraocular lens
65228|NCT03796624|Monofocal|monofocal
65229|NCT03796624|Hydrophobic|hydrophobic
65230|NCT03796611|immunology|immunology
65231|NCT03796611|B cells|b cells
65232|NCT03796598|fecal microbial transplant|fecal microbial transplant
65233|NCT03796598|cirrhosis|cirrhosis
65234|NCT03796598|hepatic encephalopathy|hepatic encephalopathy
65235|NCT03796572|lateral condyle|lateral condyle
65236|NCT03796572|infraclavicular|infraclavicular
65237|NCT03796572|regional block|regional block
65238|NCT03796559|Neo-adjuvant chemotherapy|neo-adjuvant chemotherapy
65239|NCT03796546|Pediatric|pediatric
65240|NCT03796533|AML-PCZ-UGT1A4 gene|aml-pcz-ugt1a4 gene
65241|NCT03796494|dental implant|dental implant
65242|NCT03796494|periimplant tissues|periimplant tissues
65243|NCT03796468|Mechanical thrombectomy|mechanical thrombectomy
65244|NCT03796468|stroke|stroke
65245|NCT03796468|Proximal intracranial arterial occlusions|proximal intracranial arterial occlusions
65246|NCT03796468|Large vessel occlusion|large vessel occlusion
65247|NCT03796455|Fish Oil supplement|fish oil supplement
65248|NCT03796455|HMB supplement|hmb supplement
65249|NCT03796442|aortic valve replacement|aortic valve replacement
65250|NCT03796442|bioprosthesis|bioprosthesis
65251|NCT03796429|Advanced Biliary Tract Cancer|advanced biliary tract cancer
65252|NCT03796429|PD-1 antibody(Toripalimab)|pd-1 antibody(toripalimab)
65253|NCT03796429|first-line chemotherapy|first-line chemotherapy
65254|NCT03796390|AML，CD123|aml，cd123
65255|NCT03796364|endostatin|endostatin
65256|NCT03796364|Radiotherapy|radiotherapy
65257|NCT03796364|Radiation pneumonitis|radiation pneumonitis
65258|NCT03796364|Radiation fibrosis|radiation fibrosis
65259|NCT03796338|intensive care unit|intensive care unit
65260|NCT03796338|Sleep interruption|sleep interruption
65261|NCT03796338|Sleep phases|sleep phases
65262|NCT03796312|Bathing|bathing
65263|NCT03796312|Comfort|comfort
65264|NCT03796312|Neonatal intensive care unit|neonatal intensive care unit
65265|NCT03796312|Nursing care|nursing care
65266|NCT03796312|Premature infant|premature infant
65267|NCT03796312|Skin care|skin care
65268|NCT03796299|bladder cancer|bladder cancer
65269|NCT03796299|biomarker|biomarker
65270|NCT03796299|urothelial cancer|urothelial cancer
65271|NCT03796299|cystoscopy|cystoscopy
65272|NCT03796286|Postprandial glucose|postprandial glucose
65273|NCT03796286|Meal tolerance test|meal tolerance test
65274|NCT03796247|cognition|cognition
65275|NCT03796247|alexithymia|alexithymia
65276|NCT03796221|Childhood obesity|childhood obesity
65277|NCT03796221|Parenting intervention|parenting intervention
65278|NCT03796221|Video intervention|video intervention
65279|NCT03796221|Healthcare delivery|healthcare delivery
65280|NCT03796208|Opioid Use Disorder|opioid use disorder
65281|NCT03796208|Pregnancy|pregnancy
65282|NCT03796208|tobacco|tobacco
65283|NCT03796195|Stelate Ganglion Block|stelate ganglion block
65284|NCT03796182|Phase 1|phase 1
65285|NCT03796182|Metformin|metformin
65286|NCT03796182|Atopic dermatitis|atopic dermatitis
65287|NCT03796117|Muscle Strength|muscle strength
65288|NCT03796117|Fatigue|fatigue
65289|NCT03796117|Neuromuscular efficiency|neuromuscular efficiency
65290|NCT03796117|Discomfort level|discomfort level
65291|NCT03796117|Electric Stimulation|electric stimulation
65292|NCT03796104|Bone and Joint Infection|bone and joint infection
65293|NCT03796104|Staphylococcus Aureus|staphylococcus aureus
65294|NCT03796104|chronic infection|chronic infection
65295|NCT03796078|OSA|osa
65296|NCT03796078|orthognathic surgery|orthognathic surgery
65297|NCT03796065|refugees|refugees
65298|NCT03796065|parental self-efficacy|parental self-efficacy
65299|NCT03796065|family communication|family communication
65300|NCT03796065|family connectedness|family connectedness
65301|NCT03796065|refugee youth|refugee youth
65302|NCT03796065|youth functioning|youth functioning
65303|NCT03796065|integration|integration
65304|NCT03796052|Pruritis|pruritis
65305|NCT03796052|Itching|itching
65306|NCT03796052|Dryness|dryness
65307|NCT03796052|Xerosis|xerosis
65308|NCT03796039|Long Term Care Residents|long term care residents
65309|NCT03796039|Sedentary|sedentary
65310|NCT03795987|PTSD|ptsd
65311|NCT03795987|Nightmare|nightmare
65312|NCT03795987|Nightmare Disorder|nightmare disorder
65313|NCT03795987|Post-traumatic stress disorder|post-traumatic stress disorder
65314|NCT03795987|Veteran|veteran
65315|NCT03795987|Digital therapeutic|digital therapeutic
65316|NCT03795987|Digital medicine|digital medicine
65317|NCT03795974|Quadriparetic CP, Diparetic CP, Spastic|quadriparetic cp, diparetic cp, spastic
65318|NCT03795948|Stoke|stoke
65319|NCT03795948|Patient-reported outcomes (PROs)|patient-reported outcomes (pros)
65320|NCT03795948|Quality of life|quality of life
65321|NCT03795948|Morbidity|morbidity
65322|NCT03795948|Mortality|mortality
65323|NCT03795948|Functional status|functional status
65324|NCT03795948|Patient-centered care|patient-centered care
65325|NCT03795948|ICHOM|ichom
65326|NCT03795948|Treatment quality|treatment quality
65327|NCT03795935|Deep Brain Stimulation|deep brain stimulation
65328|NCT03795935|Directional Lead|directional lead
65329|NCT03795935|Essential Tremor|essential tremor
65330|NCT03795883|Thrombin generation|thrombin generation
65331|NCT03795883|Calibrated automated thrombogram|calibrated automated thrombogram
65332|NCT03795883|Atrial fibrillation|atrial fibrillation
65333|NCT03795870|Home Enteral Nutrition|home enteral nutrition
65334|NCT03795870|Gut Microbiome|gut microbiome
65335|NCT03795870|Blenderized Tube Feeds|blenderized tube feeds
65336|NCT03795779|CLL1|cll1
65337|NCT03795779|CD33|cd33
65338|NCT03795779|CLL1-CD33 cCAR|cll1-cd33 ccar
65339|NCT03795779|Leukemia|leukemia
65340|NCT03795779|Hematologic Malignancies|hematologic malignancies
65341|NCT03795753|Emphysema|emphysema
85017|NCT03671876|Stroke|stroke
65342|NCT03795753|Chronic obstructive pulmonary disease|chronic obstructive pulmonary disease
65343|NCT03795753|Obstructive sleep apnea|obstructive sleep apnea
65344|NCT03795740|computed tomography|computed tomography
65345|NCT03795740|chronic thromboembolic pulmonary hypertension|chronic thromboembolic pulmonary hypertension
65346|NCT03795740|pulmonary endarterectomy|pulmonary endarterectomy
65347|NCT03795740|result|result
65348|NCT03795740|randomized controlled trial|randomized controlled trial
65349|NCT03795714|Intravascular Ultrasound|intravascular ultrasound
65350|NCT03795714|Optical Coherence Tomography|optical coherence tomography
65351|NCT03795714|Fractional Flow Reserve|fractional flow reserve
65352|NCT03795714|Diastolic Pressure Ratio|diastolic pressure ratio
65353|NCT03795714|Resting Full-Cycle Ratio|resting full-cycle ratio
65354|NCT03795714|Ischemic Heart Disease|ischemic heart disease
65355|NCT03795714|Instantaneous Wave-free Ratio|instantaneous wave-free ratio
65356|NCT03795701|Neuroimaging|neuroimaging
65357|NCT03795701|Hormones|hormones
65358|NCT03795675|Cochlear implants|cochlear implants
65359|NCT03795662|Community-acquired pneumonia|community-acquired pneumonia
65360|NCT03795662|Diabetes|diabetes
65361|NCT03795662|Immune status|immune status
65362|NCT03795662|Nutritional status|nutritional status
65363|NCT03795662|Physical inactivity|physical inactivity
65364|NCT03795662|Risk factors|risk factors
65365|NCT03795636|Primary molars|primary molars
65366|NCT03795636|Garlic extract|garlic extract
65367|NCT03795636|Sodium hypochlorite|sodium hypochlorite
65368|NCT03795636|Pulpectomy|pulpectomy
65369|NCT03795623|Critical Illness|critical illness
65370|NCT03795623|Respiration Disorder|respiration disorder
65371|NCT03795623|Neurology|neurology
65372|NCT03795610|HPV positive|hpv positive
65373|NCT03795610|HPV negative|hpv negative
65374|NCT03795610|HPV-|hpv-
65375|NCT03795610|HPV+|hpv+
65376|NCT03795610|PI3K-γ|pi3k-γ
65377|NCT03795610|microenvironment|microenvironment
65378|NCT03795610|immunotherapy|immunotherapy
65379|NCT03795610|tumor|tumor
65380|NCT03795610|resection|resection
65381|NCT03795610|PI3K|pi3k
65382|NCT03795610|cancer|cancer
65383|NCT03795610|carcinoma|carcinoma
65384|NCT03795610|malignancy|malignancy
65385|NCT03795610|head|head
65386|NCT03795610|neck|neck
65387|NCT03795610|throat|throat
65388|NCT03795610|esophageal|esophageal
65389|NCT03795610|nasopharyngeal|nasopharyngeal
65390|NCT03795610|nasopharynx|nasopharynx
65391|NCT03795597|Multiple Myeloma|multiple myeloma
65392|NCT03795597|Autologous|autologous
65393|NCT03795597|Stem Cell Transplantation|stem cell transplantation
65394|NCT03795597|Bone Marrow Transplant|bone marrow transplant
65395|NCT03795597|Carfilzomib|carfilzomib
65396|NCT03795571|lenalidomide|lenalidomide
65397|NCT03795571|R-GOD|r-god
65398|NCT03795571|DLBCL|dlbcl
65399|NCT03795545|ureteric stone|ureteric stone
65400|NCT03795545|SWL|swl
65401|NCT03795545|High density stones|high density stones
65402|NCT03795545|Ultraslow SWL|ultraslow swl
65403|NCT03795545|Slow SWL|slow swl
65404|NCT03795545|Ramping|ramping
65405|NCT03795545|Pause|pause
65406|NCT03795532|renal stones|renal stones
65407|NCT03795532|SWL|swl
65408|NCT03795532|High density stones|high density stones
65409|NCT03795532|Ultraslow SWL|ultraslow swl
65410|NCT03795532|Slow SWL|slow swl
65411|NCT03795532|Ramping|ramping
65412|NCT03795532|Pause|pause
65413|NCT03795506|Atopic Dermatitis Eczema|atopic dermatitis eczema
65414|NCT03795493|Exercise|exercise
65415|NCT03795493|Nutrition|nutrition
65416|NCT03795493|Caloric Restriction|caloric restriction
65417|NCT03795493|Chemotherapy|chemotherapy
65418|NCT03795454|Kangaroo care|kangaroo care
65419|NCT03795454|MEG|meg
65420|NCT03795454|AERP|aerp
65421|NCT03795454|preterm infant|preterm infant
65422|NCT03795415|WLHIV|wlhiv
65423|NCT03795415|empowerment|empowerment
65424|NCT03795415|disclosure|disclosure
65425|NCT03795415|Mali|mali
65426|NCT03795389|Diabetes|diabetes
65427|NCT03795389|Chronic Kidney Disease|chronic kidney disease
65428|NCT03795363|CF|cf
65429|NCT03795363|CFTR|cftr
65430|NCT03795363|Cystic Fibrosis|cystic fibrosis
65431|NCT03795350|Lung deposition|lung deposition
65432|NCT03795350|Gamma scintigraphy|gamma scintigraphy
65433|NCT03795337|Hypofractionation|hypofractionation
65434|NCT03795337|Prostate Cancer|prostate cancer
65435|NCT03795337|Radiotherapy|radiotherapy
65436|NCT03795337|long-term toxicity|long-term toxicity
65437|NCT03795324|Anthocyanins|anthocyanins
65438|NCT03795324|apple|apple
65439|NCT03795324|biofortification|biofortification
65440|NCT03795324|cardiometabolic|cardiometabolic
65441|NCT03795324|LDL cholesterol|ldl cholesterol
65442|NCT03795324|polyphenols|polyphenols
65443|NCT03795311|FOLFIRINOX3 Bevacizumab|folfirinox3 bevacizumab
65444|NCT03795298|Non-valvular atrial fibrillation|non-valvular atrial fibrillation
818749|NCT00164385|HIV/AIDS|hiv/aids
65445|NCT03795298|Left atrial appendage|left atrial appendage
65446|NCT03795298|Ablation|ablation
65447|NCT03795285|Early onset sepsis|early onset sepsis
65448|NCT03795285|sTREM-1|strem-1
65449|NCT03795285|Neutrophil CD64|neutrophil cd64
65450|NCT03795272|Cervical cancer|cervical cancer
65451|NCT03795272|rucaparib|rucaparib
65452|NCT03795272|maintenance therapy|maintenance therapy
65453|NCT03795272|placebo-controlled|placebo-controlled
65454|NCT03795259|Sugammadex|sugammadex
65455|NCT03795259|Sevoflurane|sevoflurane
65456|NCT03795259|Desflurane|desflurane
65457|NCT03795259|Rocuronium|rocuronium
65458|NCT03795259|TOF|tof
65459|NCT03795259|Child|child
65460|NCT03795259|Train-of-four|train-of-four
65461|NCT03795233|Fecal Microbiota Transplant (FMT)|fecal microbiota transplant (fmt)
65462|NCT03795233|Vancomycin|vancomycin
65463|NCT03795233|Dysbiosis|dysbiosis
65464|NCT03795233|fecal microbiome|fecal microbiome
65465|NCT03795233|C difficile infection|c difficile infection
65466|NCT03795207|Node; Prostate|node; prostate
65467|NCT03795207|Bone Metastases|bone metastases
65468|NCT03795207|Prostate cancer patients|prostate cancer patients
65469|NCT03795207|SBRT (Stereotactic body radiation therapy)|sbrt (stereotactic body radiation therapy)
65470|NCT03795207|Durvalumab|durvalumab
65471|NCT03795207|TEP-FCH|tep-fch
65472|NCT03795207|TEP-PSMA|tep-psma
65473|NCT03795181|multiple pulmonary nodules; predictive model|multiple pulmonary nodules; predictive model
65474|NCT03795168|Vestibular physical therapy|vestibular physical therapy
65475|NCT03795168|Positional vertigo|positional vertigo
65476|NCT03795168|Ménière's disease|ménière's disease
65477|NCT03795129|Early awakening|early awakening
65478|NCT03795116|Light emitting diode|light emitting diode
65479|NCT03795116|Light emitting diode-red light|light emitting diode-red light
65480|NCT03795116|Visible red light|visible red light
65481|NCT03795116|Skin fibrosis|skin fibrosis
65482|NCT03795116|Wound healing|wound healing
65483|NCT03795116|Scarring|scarring
65584|NCT03794635|Caregiver|caregiver
65487|NCT03795064|Venous Insufficiency of Leg|venous insufficiency of leg
65488|NCT03795064|Varicose Veins|varicose veins
65489|NCT03795051|Transcranial Magnetic Stimulation|transcranial magnetic stimulation
65490|NCT03795051|Navigated Transcranial Magnetic Stimulation|navigated transcranial magnetic stimulation
65491|NCT03795038|Lipoprotein apheresis|lipoprotein apheresis
65492|NCT03795025|Contralateral|contralateral
65493|NCT03795025|Strength training|strength training
65495|NCT03795012|breast cancer|breast cancer
65496|NCT03795012|Unresectable|unresectable
65498|NCT03795012|PR|pr
65499|NCT03795012|Her2|her2
65500|NCT03795012|recurrent|recurrent
65501|NCT03795012|metastatic|metastatic
65502|NCT03794999|asthma|asthma
65503|NCT03794999|pregnancy|pregnancy
65504|NCT03794999|benralizumab|benralizumab
65505|NCT03794999|infant|infant
65506|NCT03794999|teratogenic|teratogenic
65507|NCT03794973|Type 1 Diabetes|type 1 diabetes
65508|NCT03794973|Diabetes|diabetes
65509|NCT03794973|Diabetes Mellitus|diabetes mellitus
65510|NCT03794960|Diabetes|diabetes
65511|NCT03794960|Type 1 Diabetes|type 1 diabetes
65512|NCT03794960|Diabetes Mellitus|diabetes mellitus
65513|NCT03794947|remote ischaemic conditioning|remote ischaemic conditioning
65514|NCT03794934|Type 1 Diabetes Mellitus|type 1 diabetes mellitus
65515|NCT03794934|Continuous Glucose Monitoring|continuous glucose monitoring
65516|NCT03794934|Insulin pump|insulin pump
65517|NCT03794934|Structured Education|structured education
65518|NCT03794921|Pulmonary Rehabilitation|pulmonary rehabilitation
65519|NCT03794921|Technology-Mediated|technology-mediated
65520|NCT03794921|Web-Based Intervention|web-based intervention
65521|NCT03794921|Physical Activity|physical activity
65522|NCT03794908|Circadian timing|circadian timing
65523|NCT03794908|Pain|pain
65524|NCT03794908|Light|light
65525|NCT03794882|Hernia, Ventral|hernia, ventral
65526|NCT03794882|Pain, Postoperative|pain, postoperative
65527|NCT03794882|Opioid Use|opioid use
65528|NCT03794882|Pain|pain
65529|NCT03794869|chronic low back pain|chronic low back pain
65530|NCT03794869|physical therapy|physical therapy
65531|NCT03794869|randomized clinical trial|randomized clinical trial
65532|NCT03794869|exercise program|exercise program
65533|NCT03794856|Healthy participants|healthy participants
65534|NCT03794856|Asthma|asthma
65535|NCT03794856|Cognitive functioning|cognitive functioning
65536|NCT03794856|MRI|mri
65537|NCT03794843|Nimodipine|nimodipine
65538|NCT03794843|bioavailability|bioavailability
65539|NCT03794843|Safety|safety
65540|NCT03794843|ischemic cerebrovascular disease|ischemic cerebrovascular disease
65541|NCT03794830|sacroiliac joint|sacroiliac joint
65542|NCT03794830|low back pain|low back pain
65543|NCT03794830|Osteopathic manipulation|osteopathic manipulation
65544|NCT03794817|Kidney transplant recipient|kidney transplant recipient
65545|NCT03794791|HBV|hbv
65546|NCT03794791|HCV|hcv
65547|NCT03794791|Co-infection|co-infection
400577|NCT01866215|muscle glycogen|muscle glycogen
65548|NCT03794778|PEGylated Doxorubicin Hydrochloride Liposome Injection|pegylated doxorubicin hydrochloride liposome injection
65549|NCT03794778|Duomeisu|duomeisu
65550|NCT03794778|First-line treatment|first-line treatment
65551|NCT03794778|Epithelial Ovarian Cancer|epithelial ovarian cancer
65552|NCT03794765|Antibiotics|antibiotics
65553|NCT03794765|Ceftriaxone|ceftriaxone
65554|NCT03794765|Metronidazole|metronidazole
65555|NCT03794739|Diabetes mellitus|diabetes mellitus
65556|NCT03794739|Beta cell loss|beta cell loss
65557|NCT03794739|Beta cell apoptosis|beta cell apoptosis
65562|NCT03794713|beta-blocker|beta-blocker
65563|NCT03794713|Stable Angina Pectoris|stable angina pectoris
65564|NCT03794713|Patient support tool|patient support tool
65565|NCT03794713|Adherence|adherence
65566|NCT03794700|Hospice|hospice
65567|NCT03794700|End-of-life|end-of-life
65568|NCT03794700|Patient decision aid|patient decision aid
65569|NCT03794700|Shared decision making|shared decision making
65570|NCT03794687|Left heart catheterizations|left heart catheterizations
65571|NCT03794674|Multidimensional Prognostic Index|multidimensional prognostic index
65572|NCT03794674|Frailty|frailty
65573|NCT03794674|Geriatric|geriatric
65574|NCT03794674|Elderly|elderly
65575|NCT03794674|Aged|aged
65576|NCT03794674|+75|+75
65577|NCT03794674|Comprehensive Geriatric Assessment|comprehensive geriatric assessment
65578|NCT03794648|mobile app|mobile app
65579|NCT03794648|HIV-infections|hiv-infections
65580|NCT03794648|medication adherence|medication adherence
65581|NCT03794635|Latina|latina
65582|NCT03794635|Latino|latino
65583|NCT03794635|Spanish|spanish
65586|NCT03794635|Memorial Sloan Kettering Cancer Center|memorial sloan kettering cancer center
65587|NCT03794622|Bone Marrow|bone marrow
65588|NCT03794622|Mesenchymal Stromal Cells|mesenchymal stromal cells
65589|NCT03794622|Femoral Shaft Fracture|femoral shaft fracture
65590|NCT03794583|Treprostinil|treprostinil
65591|NCT03794583|Lung Diseases|lung diseases
65592|NCT03794583|Hypertension|hypertension
65593|NCT03794583|Vascular Diseases|vascular diseases
65594|NCT03794544|Neoadjuvant|neoadjuvant
65595|NCT03794544|Non-small Cell Lung Cancer|non-small cell lung cancer
65596|NCT03794544|Cancer|cancer
65597|NCT03794544|Lung|lung
65598|NCT03794544|Resectable|resectable
65599|NCT03794544|Early-stage|early-stage
65600|NCT03794544|Stage I|stage i
65601|NCT03794544|Stage II|stage ii
65602|NCT03794544|Stage IIIA|stage iiia
65603|NCT03794544|Durvalumab|durvalumab
65604|NCT03794531|Hispanics/Latinos|hispanics/latinos
65605|NCT03794531|Minority health|minority health
65606|NCT03794531|Puerto Rico|puerto rico
65607|NCT03794531|Cardiovascular disease|cardiovascular disease
65608|NCT03794531|Cardiometabolic health|cardiometabolic health
65609|NCT03794531|Chronic disease risk factors|chronic disease risk factors
65610|NCT03794531|Disaster research|disaster research
65611|NCT03794531|Caribbean and Latin America|caribbean and latin america
65612|NCT03794531|Population health|population health
65613|NCT03794531|Prospective study|prospective study
65614|NCT03794531|Allostatic load|allostatic load
65615|NCT03794479|Intestinal microbiota|intestinal microbiota
65616|NCT03794479|Antimicrobial resistance|antimicrobial resistance
65617|NCT03794466|gonadal vein embolization|gonadal vein embolization
65618|NCT03794453|Stroke|stroke
65619|NCT03794453|Intestinal microbiota|intestinal microbiota
65620|NCT03794453|Antimicrobial resistance|antimicrobial resistance
65621|NCT03794401|body composition|body composition
65622|NCT03794401|chronic kidney disease|chronic kidney disease
65623|NCT03794401|dietary pattern|dietary pattern
65624|NCT03794401|gut microbiot|gut microbiot
65625|NCT03794388|Breast cancer patient|breast cancer patient
65626|NCT03794388|Surgery|surgery
65627|NCT03794388|Inter Costobrachial Neuralgia|inter costobrachial neuralgia
65628|NCT03794375|Follow-up|follow-up
65629|NCT03794375|Telehealth|telehealth
65630|NCT03794375|Recurrence|recurrence
65631|NCT03794362|analgesia|analgesia
65632|NCT03794362|pain|pain
65633|NCT03794362|nociception|nociception
65634|NCT03794362|pupillometry|pupillometry
65635|NCT03794362|analgesic|analgesic
65636|NCT03794245|Prevention|prevention
65637|NCT03794245|Testing and Diagnosis|testing and diagnosis
65638|NCT03794245|Treatment|treatment
65639|NCT03794232|Inulin|inulin
65640|NCT03794232|Soluble dietary fiber|soluble dietary fiber
65641|NCT03794232|Prediabetes|prediabetes
65642|NCT03794180|Anti-GM-CSF agents|anti-gm-csf agents
65643|NCT03794180|GM-CSF/GM-CSFR (GM-CSF receptor) antibody|gm-csf/gm-csfr (gm-csf receptor) antibody
65644|NCT03794180|colony-stimulating factor 2|colony-stimulating factor 2
65645|NCT03794180|monoclonal antibody|monoclonal antibody
65646|NCT03794128|neoantigen cancer vaccine|neoantigen cancer vaccine
65647|NCT03794128|personalized neoantigen cancer vaccine|personalized neoantigen cancer vaccine
65648|NCT03794089|anxiety|anxiety
65649|NCT03794089|primary health care|primary health care
65650|NCT03794089|Veterans|veterans
65651|NCT03794076|schizophrenia|schizophrenia
65652|NCT03794076|schizoaffective disorder|schizoaffective disorder
65653|NCT03794076|cromoglicate|cromoglicate
65654|NCT03794063|Robson classification|robson classification
65655|NCT03794037|ovarian hyperstimulation syndrome|ovarian hyperstimulation syndrome
65656|NCT03794037|Montelukast|montelukast
65657|NCT03794011|myelomeningocele|myelomeningocele
65658|NCT03794011|MMC|mmc
65659|NCT03794011|NTD|ntd
65660|NCT03794011|neural|neural
65661|NCT03794011|defect|defect
65662|NCT03794011|Spinal Bifida|spinal bifida
65663|NCT03794011|Neural Tube Defect|neural tube defect
65664|NCT03793998|Cardiac Catheter Ablation|cardiac catheter ablation
65665|NCT03793998|Cardiac Arrhythmias|cardiac arrhythmias
65666|NCT03793998|Mapping System|mapping system
65667|NCT03793972|Triage|triage
65668|NCT03793972|Primary Health Care|primary health care
65669|NCT03793972|Emergency Service, Hospital|emergency service, hospital
65670|NCT03793959|female athletes|female athletes
65671|NCT03793959|iron supplementation|iron supplementation
65672|NCT03793959|prebiotic|prebiotic
65673|NCT03793959|probiotic|probiotic
65674|NCT03793959|synbiotic|synbiotic
65675|NCT03793959|serum ferritin|serum ferritin
65676|NCT03793946|Drug Resistance, Microbial|drug resistance, microbial
65677|NCT03793946|Multicenter Study|multicenter study
65678|NCT03793946|Decision Support Systems, Clinical|decision support systems, clinical
65679|NCT03793920|Prenatal alcohol exposure|prenatal alcohol exposure
65680|NCT03793920|Emotional|emotional
65681|NCT03793920|Cognition|cognition
65682|NCT03793920|Addiction|addiction
65683|NCT03793920|Fetal Alcohol Syndrome|fetal alcohol syndrome
65684|NCT03793894|Community health worker (CHW)|community health worker (chw)
65685|NCT03793894|Shared decision making (SDM)|shared decision making (sdm)
65686|NCT03793894|Low-dose computed tomography (LDCT)|low-dose computed tomography (ldct)
65687|NCT03793842|Electrical Impedance Tomography|electrical impedance tomography
65688|NCT03793842|Ventilator|ventilator
65689|NCT03793842|Lung|lung
65690|NCT03793842|Respiration|respiration
65691|NCT03793829|HER2-expressing ductal carcinoma in situ (DCIS).|her2-expressing ductal carcinoma in situ (dcis).
65692|NCT03793803|Palliative Care|palliative care
65693|NCT03793803|Home-Based Care|home-based care
65694|NCT03793790|Nocebo|nocebo
65695|NCT03793790|Pain|pain
65696|NCT03793790|Conditioning|conditioning
65697|NCT03793790|Counterconditioning|counterconditioning
65698|NCT03793790|Partial reinforcement|partial reinforcement
65699|NCT03793790|Learning|learning
65700|NCT03793738|anterior component separation, posterior component separation, transversus abdominis muscle release|anterior component separation, posterior component separation, transversus abdominis muscle release
65701|NCT03793699|Suicide|suicide
65702|NCT03793699|Suicidal ideation|suicidal ideation
65703|NCT03793699|Sleep disorder|sleep disorder
65704|NCT03793673|Adolescents and Young Adults(AYA)|adolescents and young adults(aya)
65705|NCT03793660|Biologic|biologic
65706|NCT03793660|Safety|safety
65707|NCT03793660|LITAR|litar
65708|NCT03793660|DACIMA|dacima
65709|NCT03793660|Tunisia|tunisia
65710|NCT03793582|OSA|osa
65711|NCT03793582|ACS (Acute Coronary Syndrome)|acs (acute coronary syndrome)
65712|NCT03793582|MACE (Major Adverse Cardiac Events)|mace (major adverse cardiac events)
65713|NCT03793543|J18127 PSMA PyL 18F-DCFPyL PET/CT|j18127 psma pyl 18f-dcfpyl pet/ct
65714|NCT03793530|Bone Marrow|bone marrow
65715|NCT03793530|Mesenchymal Stromal Cells|mesenchymal stromal cells
65716|NCT03793530|spine fusion surgery|spine fusion surgery
65717|NCT03793517|high risk acute myeloid leukemia|high risk acute myeloid leukemia
65718|NCT03793517|hematopoietic stem cell transplantation|hematopoietic stem cell transplantation
65719|NCT03793517|leukemia relapse|leukemia relapse
65720|NCT03793517|preparation regimen|preparation regimen
65721|NCT03793517|decitabine|decitabine
65722|NCT03793504|pulmonary rehabilitation|pulmonary rehabilitation
65723|NCT03793504|exercise|exercise
65724|NCT03793504|physical activity|physical activity
65725|NCT03793491|continuous infusion|continuous infusion
65726|NCT03793491|personality|personality
65727|NCT03793478|Acute myeloid leukemia recurrent|acute myeloid leukemia recurrent
65728|NCT03793478|Relapsed or refractory|relapsed or refractory
65729|NCT03793478|FMS-like tyrosine kinase 3 positive|fms-like tyrosine kinase 3 positive
65730|NCT03793478|Cancer of the blood|cancer of the blood
65731|NCT03793478|AML|aml
65732|NCT03793478|FLT3-ITD mutation|flt3-itd mutation
65733|NCT03793452|COPD, pulmonary rehabilitation, fear of falling, evaluation|copd, pulmonary rehabilitation, fear of falling, evaluation
65734|NCT03793439|Sarcoidosis|sarcoidosis
65735|NCT03793439|Corticosteroid dependent sarcoidosis|corticosteroid dependent sarcoidosis
65736|NCT03793413|tongue tie|tongue tie
65737|NCT03793413|ankyloglossia|ankyloglossia
65738|NCT03793413|infant feeding|infant feeding
65739|NCT03793413|bottle feeding|bottle feeding
65740|NCT03793400|punctate inner choroidopathy|punctate inner choroidopathy
65741|NCT03793400|multifocal choroidits|multifocal choroidits
65742|NCT03793400|choroidal neovascularization|choroidal neovascularization
65743|NCT03793400|anti-VEGF|anti-vegf
65744|NCT03793400|long-term outcome|long-term outcome
65745|NCT03793374|Axillary osmidrosis|axillary osmidrosis
65746|NCT03793374|Surgery|surgery
65747|NCT03793374|Cartilage shaver|cartilage shaver
65748|NCT03793348|facial wrinkles|facial wrinkles
65749|NCT03793348|skin laxity|skin laxity
65750|NCT03793348|sagging skin|sagging skin
65751|NCT03793322|Hepatocellular Carcinoma|hepatocellular carcinoma
65752|NCT03793322|Indocyanine-Green(ICG)|indocyanine-green(icg)
65753|NCT03793296|Paravalvular leak|paravalvular leak
65754|NCT03793270|Rheumatoid arthritis RA - B cells (B Lymphocyte).|rheumatoid arthritis ra - b cells (b lymphocyte).
65755|NCT03793257|Intensive Care|intensive care
65756|NCT03793257|Critical Care|critical care
65757|NCT03793257|Extracorporeal Membrane Oxygenation|extracorporeal membrane oxygenation
65758|NCT03793257|Extracorporeal Life Support|extracorporeal life support
65759|NCT03793231|Fungal infections|fungal infections
65760|NCT03793231|Deep learning|deep learning
65761|NCT03793231|Electronic surveillance|electronic surveillance
65762|NCT03793231|Antifungal stewardship|antifungal stewardship
65763|NCT03793231|Image classification|image classification
65764|NCT03793140|Burkitt Lymphoma/Leukemia|burkitt lymphoma/leukemia
65765|NCT03793140|high-grade B-cell lymphoma|high-grade b-cell lymphoma
65766|NCT03793140|CPI-613|cpi-613
65767|NCT03793101|BiMICS, biaxial cataract surgery, SIA,diabetes mellitus,|bimics, biaxial cataract surgery, sia,diabetes mellitus,
65768|NCT03793088|Glioblastoma|glioblastoma
65769|NCT03793088|Glioma|glioma
65770|NCT03793088|Pancreatic Adenocarcinoma|pancreatic adenocarcinoma
65771|NCT03793062|genome|genome
65772|NCT03793062|epigenome|epigenome
65773|NCT03793062|chronic wounds|chronic wounds
65774|NCT03793062|genetics|genetics
65775|NCT03793049|acoustic|acoustic
65777|NCT03793036|fasting|fasting
65778|NCT03793036|carbohydrate|carbohydrate
65779|NCT03793036|insulin resistance|insulin resistance
65780|NCT03793010|Osteoarthritis|osteoarthritis
65781|NCT03793010|Hip|hip
65782|NCT03793010|Pain|pain
65783|NCT03793010|Intra-articular|intra-articular
65784|NCT03793010|Injection|injection
65785|NCT03792984|Polycystic Ovary Syndrome|polycystic ovary syndrome
65786|NCT03792984|Calcium|calcium
65787|NCT03792984|Vitamin D|vitamin d
65788|NCT03792984|Metformin|metformin
65789|NCT03792945|extracorporeal shock wave therapy|extracorporeal shock wave therapy
65790|NCT03792945|corticosteroid injection|corticosteroid injection
65791|NCT03792893|Cardiovascular parameters|cardiovascular parameters
65792|NCT03792893|Blood Pressure|blood pressure
65793|NCT03792893|Pulse Wave|pulse wave
65794|NCT03792893|Ergometry|ergometry
65795|NCT03792893|Somnotouch|somnotouch
65796|NCT03792893|BOSO-TM-2430|boso-tm-2430
65797|NCT03792880|CPAP treatment|cpap treatment
65798|NCT03792880|Self-management|self-management
65799|NCT03792854|anal cancer|anal cancer
65800|NCT03792854|quality of life|quality of life
65801|NCT03792854|chemoradiation|chemoradiation
65802|NCT03792841|AMG 160|amg 160
65803|NCT03792841|HLE-BiTE®|hle-bite®
65804|NCT03792841|mCRPC|mcrpc
65805|NCT03792841|Metastatic Castration-resistant Prostate Cancer|metastatic castration-resistant prostate cancer
65806|NCT03792841|Prostate cancer|prostate cancer
65807|NCT03792841|PSMA|psma
65808|NCT03792841|BiTE®|bite®
65809|NCT03792841|Bispecific T-Cell engager®|bispecific t-cell engager®
65810|NCT03792841|Immunotherapy|immunotherapy
65811|NCT03792841|Immuno-oncology|immuno-oncology
65812|NCT03792841|Immunooncology|immunooncology
65813|NCT03792841|Solid tumor|solid tumor
65814|NCT03792841|PSMA Targeted Therapy|psma targeted therapy
65815|NCT03792828|total knee replacement arthroplasty|total knee replacement arthroplasty
65816|NCT03792828|total knee arthroplasty|total knee arthroplasty
65817|NCT03792828|central censitization|central censitization
65818|NCT03792828|duloxetine|duloxetine
65819|NCT03792828|serotonin-norepinephrine reuptake inhibitors|serotonin-norepinephrine reuptake inhibitors
65820|NCT03792828|pre-emptive effect|pre-emptive effect
65821|NCT03792815|Transplantation Conditioning|transplantation conditioning
65822|NCT03792802|dermatome|dermatome
65823|NCT03792802|laparoscopic appendectomy|laparoscopic appendectomy
65824|NCT03792789|Transcranial Magnetic Stimulation (TMS)|transcranial magnetic stimulation (tms)
65825|NCT03792789|modified Constraint Induced Movement Therapy (mCIMT)|modified constraint induced movement therapy (mcimt)
65826|NCT03792776|Lidocaine 1%|lidocaine 1%
65827|NCT03792776|Lidocaine 2%|lidocaine 2%
65828|NCT03792776|Endotracheal tube cuff|endotracheal tube cuff
65829|NCT03792776|Cuff inflation|cuff inflation
65830|NCT03792776|Postoperative sore throat|postoperative sore throat
65831|NCT03792776|Postoperative cough|postoperative cough
65832|NCT03792776|General anesthesia|general anesthesia
65833|NCT03792776|Endotracheal intubation|endotracheal intubation
65834|NCT03792763|early multiple myeloma|early multiple myeloma
65835|NCT03792763|smoldering multiple myeloma|smoldering multiple myeloma
65836|NCT03792763|SLiM CRAB|slim crab
65837|NCT03792763|denosumab|denosumab
65838|NCT03792763|Austrian Study Group of Medical Tumour Therapy (AGMT)|austrian study group of medical tumour therapy (agmt)
65839|NCT03792763|high risk smoldering myeloma|high risk smoldering myeloma
65840|NCT03792698|Lung Transplantation|lung transplantation
85650|NCT03667989|CZT|czt
65841|NCT03792698|Frailty|frailty
65842|NCT03792698|Readmisson|readmisson
65843|NCT03792698|Physical Therapy|physical therapy
65844|NCT03792698|Personalized|personalized
65845|NCT03792672|Drug Therapy|drug therapy
65846|NCT03792646|Supplementary Feeding|supplementary feeding
65847|NCT03792646|Protein|protein
65848|NCT03792646|Muscle strenght|muscle strenght
65849|NCT03792646|Exercise|exercise
65850|NCT03792646|Aged|aged
65851|NCT03792620|multiple myeloma|multiple myeloma
65852|NCT03792607|Network medicine|network medicine
65853|NCT03792607|Epigenetics|epigenetics
65854|NCT03792607|Diabetes|diabetes
65855|NCT03792607|Cardiovascular risk|cardiovascular risk
65856|NCT03792594|Bone Marrow|bone marrow
65857|NCT03792594|Mesenchymal Stromal Cells|mesenchymal stromal cells
65858|NCT03792594|Rotator Cuff Tear|rotator cuff tear
65859|NCT03792568|ALK mutation|alk mutation
65860|NCT03792568|ALK inhibitor|alk inhibitor
65861|NCT03792568|Metastatic Colorectal Cancer|metastatic colorectal cancer
65862|NCT03792555|Acromegaly|acromegaly
65863|NCT03792555|ACROBAT|acrobat
65864|NCT03792555|EVOLVE|evolve
65865|NCT03792529|Targeted Therapy|targeted therapy
65866|NCT03792529|Molecular Screening|molecular screening
65867|NCT03792516|artesunate|artesunate
65868|NCT03792516|pre-invasive disease|pre-invasive disease
65869|NCT03792516|treatment|treatment
65870|NCT03792516|alternative|alternative
65871|NCT03792516|non-surgical|non-surgical
65872|NCT03792516|cancer prevention|cancer prevention
65873|NCT03792490|Motor neuron disease|motor neuron disease
65874|NCT03792490|Neurodegenerative disease|neurodegenerative disease
65875|NCT03792412|bariatric surgery|bariatric surgery
65876|NCT03792412|lifelong follow-up|lifelong follow-up
65877|NCT03792412|primary care|primary care
65878|NCT03792412|obesity|obesity
65879|NCT03792412|health care study|health care study
65880|NCT03792399|continuous glucose monitoring|continuous glucose monitoring
65881|NCT03792399|immediate feedback counseling|immediate feedback counseling
65882|NCT03792399|delayed feedback counseling|delayed feedback counseling
65883|NCT03792347|esophageal squamous cell carcinoma|esophageal squamous cell carcinoma
65884|NCT03792347|neoadjuvant chemoradiotherapy|neoadjuvant chemoradiotherapy
65885|NCT03792347|pembrolizumab|pembrolizumab
65886|NCT03792347|immune therapy|immune therapy
65887|NCT03792347|checkpoint inhibitor|checkpoint inhibitor
65888|NCT03792321|testosterone|testosterone
65889|NCT03792321|hypogonadism|hypogonadism
65890|NCT03792321|diabetes mellitus|diabetes mellitus
65891|NCT03792321|visceral obesity|visceral obesity
65892|NCT03792321|insulin resistance|insulin resistance
65893|NCT03792321|metabolic syndrome|metabolic syndrome
65894|NCT03792321|NAFLD|nafld
65895|NCT03792321|endothelial function|endothelial function
65896|NCT03792308|Safety|safety
65897|NCT03792308|Tolerability|tolerability
65898|NCT03792308|Pharmacokinetics|pharmacokinetics
65899|NCT03792308|SPR206|spr206
65900|NCT03792282|Polycystic Ovary Syndrome|polycystic ovary syndrome
65901|NCT03792282|Overweight and Obesity|overweight and obesity
65902|NCT03792282|Time-Restricted Feeding|time-restricted feeding
65903|NCT03792282|Intermittent fasting regimens|intermittent fasting regimens
65904|NCT03792230|Lumbar disc hernia surgery|lumbar disc hernia surgery
65905|NCT03792230|Body mechanics|body mechanics
65906|NCT03792230|Patient education|patient education
65907|NCT03792230|Quality of life|quality of life
65908|NCT03792230|Disability|disability
65909|NCT03792230|Pain|pain
65910|NCT03792230|Nursing|nursing
65911|NCT03792204|wearing off|wearing off
65912|NCT03792204|wearing-off 9 questionnaire|wearing-off 9 questionnaire
65913|NCT03792204|prevalence|prevalence
65914|NCT03792204|sensitivity|sensitivity
65915|NCT03792204|specificity|specificity
65916|NCT03792178|Post operative sensitivity|post operative sensitivity
65917|NCT03792152|Atrial Fibrillation|atrial fibrillation
65918|NCT03792152|Left Atrial Appendage Thrombosis|left atrial appendage thrombosis
65919|NCT03792152|rivaroxaban|rivaroxaban
65920|NCT03792100|SmofKabiven|smofkabiven
65921|NCT03792100|Abdominal surgery|abdominal surgery
65922|NCT03792100|Parenteral|parenteral
65923|NCT03792100|Nutrition|nutrition
65924|NCT03792087|SmofKabiven|smofkabiven
65925|NCT03792087|Nutrition|nutrition
65926|NCT03792087|Parenteral|parenteral
65927|NCT03792087|Abdominal surgery|abdominal surgery
65928|NCT03792048|bilioenteric anastomosis|bilioenteric anastomosis
65929|NCT03792048|pancreaticojejunostomy|pancreaticojejunostomy
65930|NCT03792048|Magnetic Compressive|magnetic compressive
65931|NCT03791996|Cranioplasty|cranioplasty
65932|NCT03791996|Craniectomy|craniectomy
65933|NCT03791996|Cognitive impairment|cognitive impairment
65934|NCT03791996|Syndrome of the trephined|syndrome of the trephined
65935|NCT03791944|nasopharynx cancer|nasopharynx cancer
65936|NCT03791944|Radiotherapy|radiotherapy
65937|NCT03791918|Hepatocellular Carcinoma|hepatocellular carcinoma
65938|NCT03791918|Lenvatinib|lenvatinib
400578|NCT01866215|fructose|fructose
65939|NCT03791918|PD-1 Antibody|pd-1 antibody
65940|NCT03791918|TACE|tace
65941|NCT03791905|Esophageal squamous cell carcinoma|esophageal squamous cell carcinoma
65942|NCT03791905|PET|pet
65943|NCT03791905|Definitive chemoradiotherapy|definitive chemoradiotherapy
65944|NCT03791905|Induction chemotherapy|induction chemotherapy
65945|NCT03791892|Adhesive capsulitis|adhesive capsulitis
65946|NCT03791892|suprascapular nerve|suprascapular nerve
65947|NCT03791892|shoulder mobilization|shoulder mobilization
65948|NCT03791879|Caudal|caudal
65949|NCT03791879|Dexmedetomidine|dexmedetomidine
65950|NCT03791879|Levobupivacaine|levobupivacaine
65951|NCT03791879|hypospadias|hypospadias
65952|NCT03791853|Breast Neoplasms|breast neoplasms
65953|NCT03791853|Optical Coherence Tomogram|optical coherence tomogram
65954|NCT03791853|Sentinel lymph node|sentinel lymph node
65955|NCT03791853|Dynamic cell imaging|dynamic cell imaging
65956|NCT03791840|breast neoplasms|breast neoplasms
65957|NCT03791840|Ultrasonography, Interventional|ultrasonography, interventional
65958|NCT03791840|Biopsy, Large-Core Needle|biopsy, large-core needle
65959|NCT03791840|Biopsy, Fine-Needle|biopsy, fine-needle
65960|NCT03791814|HCV treatment|hcv treatment
65961|NCT03791814|Zepatier|zepatier
65962|NCT03791814|Dialysis patients|dialysis patients
65963|NCT03791801|sugammadex|sugammadex
65964|NCT03791801|rocuronium|rocuronium
65965|NCT03791801|critically ill|critically ill
65966|NCT03791788|Stable angina|stable angina
65967|NCT03791788|Acute Myocardial Infarction|acute myocardial infarction
65968|NCT03791788|Fractional Flow Reserve|fractional flow reserve
65969|NCT03791788|Quantitative Flow Ratio|quantitative flow ratio
65970|NCT03791775|Hemorrhoids|hemorrhoids
65971|NCT03791775|Sclerotherapy|sclerotherapy
65972|NCT03791775|Polidocanol 3%|polidocanol 3%
65973|NCT03791775|Non-surgical treatments|non-surgical treatments
65974|NCT03791762|postoperative pain|postoperative pain
65975|NCT03791762|WaveOne Gold|waveone gold
65976|NCT03791762|Reciproc Blue|reciproc blue
65977|NCT03791762|ProTaper Next|protaper next
65978|NCT03791749|breastfeeding|breastfeeding
65979|NCT03791749|postnatal mental health|postnatal mental health
65980|NCT03791749|breastfeeding support|breastfeeding support
65982|NCT03791749|late preterm infant|late preterm infant
65983|NCT03791749|breast milk|breast milk
65984|NCT03791736|breast cancer|breast cancer
65985|NCT03791736|axillary clearance|axillary clearance
65986|NCT03791736|lymphocele|lymphocele
65987|NCT03791723|Atrial Fibrillation|atrial fibrillation
65988|NCT03791723|Cardiac Remodeling|cardiac remodeling
65989|NCT03791723|Sacubitril/Valsartan|sacubitril/valsartan
65990|NCT03791697|Postoperative patient satisfaction|postoperative patient satisfaction
65991|NCT03791671|Balance training|balance training
65992|NCT03791671|Gait Speed|gait speed
65993|NCT03791658|TAI|tai
65994|NCT03791658|Test for the Adherence to Inhalers|test for the adherence to inhalers
65995|NCT03791580|Polypharmacy|polypharmacy
65996|NCT03791580|Primary Health Care|primary health care
65997|NCT03791580|Economics, Behavioral|economics, behavioral
65998|NCT03791580|Deprescriptions|deprescriptions
65999|NCT03791580|Decision Support Systems, Clinical|decision support systems, clinical
66000|NCT03791580|Electronic Health Records|electronic health records
66001|NCT03791580|Geriatrics|geriatrics
66002|NCT03791567|Type 1|type 1
66003|NCT03791567|Type 1 Diabetes Mellitus|type 1 diabetes mellitus
66004|NCT03791567|Islets of Langerhans Transplantation|islets of langerhans transplantation
66005|NCT03791567|Allogeneic Islet transplantation|allogeneic islet transplantation
66006|NCT03791554|tunneling|tunneling
66007|NCT03791554|laterally closed tunnel|laterally closed tunnel
66008|NCT03791554|gingival recession|gingival recession
66009|NCT03791554|recession type 2|recession type 2
66010|NCT03791541|Readmissions|readmissions
66011|NCT03791541|Survey|survey
66012|NCT03791528|Sacroiliac Joint Dysfunction|sacroiliac joint dysfunction
66013|NCT03791528|Kinesio Taping Treatment|kinesio taping treatment
66014|NCT03791502|Exercise Movement Techniques|exercise movement techniques
66015|NCT03791502|Elderly|elderly
66016|NCT03791502|Muscular Strength|muscular strength
66017|NCT03791502|Postural Balance|postural balance
66018|NCT03791502|Flexibility|flexibility
66019|NCT03791502|Pilates|pilates
66020|NCT03791476|Delayed graft function|delayed graft function
66021|NCT03791437|digital chest tube system, shorten hospital stay|digital chest tube system, shorten hospital stay
66022|NCT03791424|sedation|sedation
66023|NCT03791424|midazolam|midazolam
66024|NCT03791424|skin resistance|skin resistance
66025|NCT03791424|measurements|measurements
66026|NCT03791411|Clinical Narratives|clinical narratives
66027|NCT03791411|Respect|respect
66028|NCT03791411|Intentional presence|intentional presence
66029|NCT03791411|knowing the person|knowing the person
66030|NCT03791411|Professional development|professional development
66031|NCT03791398|Metastatic|metastatic
66032|NCT03791398|colorectal cancer|colorectal cancer
66033|NCT03791398|colon cancer|colon cancer
66034|NCT03791398|microsatellite stable|microsatellite stable
66035|NCT03791385|Autism Spectrum Disorder|autism spectrum disorder
66036|NCT03791385|Picture Exchange Communication System (PECS)|picture exchange communication system (pecs)
66037|NCT03791385|Tooth-brushing program|tooth-brushing program
66038|NCT03791385|Gingival index|gingival index
66039|NCT03791385|Plaque index|plaque index
66040|NCT03791372|Cerebral palsy|cerebral palsy
66041|NCT03791372|Autologous Umbilical Cord Blood|autologous umbilical cord blood
66042|NCT03791372|safety|safety
66043|NCT03791372|effect|effect
66044|NCT03791359|Out- of- Hospital Cardiac Arrest|out- of- hospital cardiac arrest
66045|NCT03791346|neuroendocrine tumor|neuroendocrine tumor
66046|NCT03791346|Survival|survival
66047|NCT03791346|WHO 2017 grading system|who 2017 grading system
66048|NCT03791346|pancreatectomy|pancreatectomy
66049|NCT03791346|Laparoscopy|laparoscopy
66050|NCT03791346|Postoperative outcomes|postoperative outcomes
66051|NCT03791320|Fractional Flow Reserve|fractional flow reserve
66052|NCT03791320|Coronary Physiology|coronary physiology
66053|NCT03791320|3D-QCA|3d-qca
66054|NCT03791320|Percutaneous coronary intervention|percutaneous coronary intervention
66055|NCT03791307|Pilates method|pilates method
66056|NCT03791307|Blood pressure|blood pressure
66057|NCT03791307|Autonomic heart rate modulation|autonomic heart rate modulation
66058|NCT03791281|pre-implementation intervention|pre-implementation intervention
66059|NCT03791281|implementation strategy|implementation strategy
66060|NCT03791281|individual-level barriers|individual-level barriers
66061|NCT03791268|Stomach Adenocarcinoma|stomach adenocarcinoma
66062|NCT03791268|neoadjuvant chemotherapy|neoadjuvant chemotherapy
66063|NCT03791255|resin modified calcium silicate|resin modified calcium silicate
66064|NCT03791255|indirect pulp treatment|indirect pulp treatment
66065|NCT03791255|primary molars|primary molars
66066|NCT03791229|Appendectomy|appendectomy
66067|NCT03791229|Chronic abdominal pain|chronic abdominal pain
66068|NCT03791229|Discomfort|discomfort
66069|NCT03791229|Numerical rating scale|numerical rating scale
66070|NCT03791229|Pediatric quality of life inventory|pediatric quality of life inventory
66071|NCT03791203|Non-alcoholic fatty liver disease|non-alcoholic fatty liver disease
66072|NCT03791190|CRRT|crrt
66073|NCT03791190|liver failure|liver failure
66074|NCT03791190|filter lifespan|filter lifespan
66075|NCT03791190|bleeding|bleeding
66076|NCT03791177|Music|music
66077|NCT03791151|Pharmacogenetics|pharmacogenetics
66078|NCT03791151|Lung cancer|lung cancer
66079|NCT03791151|Cisplatin|cisplatin
66080|NCT03791138|breast reconstruction|breast reconstruction
66081|NCT03791138|patient decision aid|patient decision aid
66082|NCT03791138|decisional conflict|decisional conflict
66083|NCT03791138|randomized controlled trial|randomized controlled trial
66084|NCT03791099|Periodontitis treatment|periodontitis treatment
66085|NCT03791099|Periodonal pockets|periodonal pockets
66086|NCT03791099|local delivery drugs|local delivery drugs
66087|NCT03791073|Biomarker discovery|biomarker discovery
66088|NCT03791073|Pancreatic adenocarcinoma|pancreatic adenocarcinoma
66089|NCT03791073|Bioinformatics|bioinformatics
66090|NCT03791073|pancreatic cancer|pancreatic cancer
66091|NCT03791073|microenvironment|microenvironment
66092|NCT03791073|proteomics|proteomics
66093|NCT03791073|transcriptomics|transcriptomics
66094|NCT03791073|metabolomics|metabolomics
66095|NCT03791073|diagnosis|diagnosis
66096|NCT03791073|Prognosis|prognosis
66097|NCT03791060|Necrobiosis lipoidica|necrobiosis lipoidica
66098|NCT03791060|NLD|nld
66099|NCT03791047|Balance|balance
66100|NCT03791047|Postural control|postural control
66101|NCT03791047|Muscle|muscle
66102|NCT03791047|Older adults|older adults
66103|NCT03791034|Non-small cell lung cancer|non-small cell lung cancer
66104|NCT03791034|Recurrence|recurrence
66105|NCT03791034|cfDNA|cfdna
66106|NCT03791021|postpartum, depression, self portraits|postpartum, depression, self portraits
66107|NCT03791008|Personalized|personalized
66108|NCT03791008|Early detection|early detection
66109|NCT03791008|Screening|screening
66110|NCT03791008|Feasibility|feasibility
66111|NCT03791008|Acceptability|acceptability
66112|NCT03790995|Prostate cancer|prostate cancer
66113|NCT03790995|Robot assisted radical prostatectomy|robot assisted radical prostatectomy
66114|NCT03790995|RALP|ralp
66115|NCT03790995|RARP|rarp
66116|NCT03790995|High risk|high risk
66117|NCT03790995|Intermediate risk|intermediate risk
66118|NCT03790995|Low risk|low risk
66119|NCT03790995|Urinary|urinary
66120|NCT03790995|Erectile|erectile
66121|NCT03790995|Quality of life|quality of life
66122|NCT03790995|QoL|qol
66123|NCT03790995|Post operation|post operation
66124|NCT03790995|functional outcomes|functional outcomes
66125|NCT03790995|follow-up|follow-up
66126|NCT03790982|AD-35 tablet|ad-35 tablet
66127|NCT03790982|Alzheimer's Disease|alzheimer's disease
66128|NCT03790982|Phase II study|phase ii study
66129|NCT03790969|steroid injection|steroid injection
66130|NCT03790969|pain|pain
66131|NCT03790969|needle gauge|needle gauge
66132|NCT03790969|trigger finger|trigger finger
66133|NCT03790956|vocal fold paralysis|vocal fold paralysis
818954|NCT00163449|Pediatric|pediatric
66134|NCT03790956|glottal insufficiency|glottal insufficiency
66135|NCT03790956|vocal fold injection|vocal fold injection
66136|NCT03790956|augmentation|augmentation
66137|NCT03790956|medialization|medialization
66138|NCT03790956|laryngoplasty|laryngoplasty
66139|NCT03790956|silk|silk
66140|NCT03790943|Childhood cancer survivors|childhood cancer survivors
66141|NCT03790943|Late effects|late effects
66142|NCT03790943|Cardiotoxicity|cardiotoxicity
66143|NCT03790943|Chemotherapy|chemotherapy
66144|NCT03790943|Anthracyclines|anthracyclines
66145|NCT03790943|Radiation|radiation
66146|NCT03790917|adherence|adherence
66147|NCT03790917|new oral anticoagulants (NOACs)|new oral anticoagulants (noacs)
66148|NCT03790917|AF|af
66149|NCT03790904|Dental plaque,|dental plaque,
66150|NCT03790904|Tea|tea
66151|NCT03790904|Salvadora|salvadora
66152|NCT03790904|Mouthwash|mouthwash
66153|NCT03790904|Clinical trial|clinical trial
66154|NCT03790891|CAR-T|car-t
66155|NCT03790891|TriCAR-T|tricar-t
66156|NCT03790891|CD19-TriCAR-T|cd19-tricar-t
66157|NCT03790891|CD19-TriCAR-SILK|cd19-tricar-silk
66158|NCT03790891|Non-Hodgkin Lymphoma|non-hodgkin lymphoma
66159|NCT03790878|Emotion Dysregulation|emotion dysregulation
66160|NCT03790878|Empathy|empathy
66161|NCT03790878|Emotion Perception|emotion perception
66162|NCT03790865|Prader-Willi Syndrome|prader-willi syndrome
66163|NCT03790865|PWS|pws
66164|NCT03790852|DME|dme
66165|NCT03790852|wAMD|wamd
66166|NCT03790852|RVO|rvo
66167|NCT03790852|KSI-301|ksi-301
66168|NCT03790852|Kodiak|kodiak
66169|NCT03790826|bladder mucosal trauma|bladder mucosal trauma
66170|NCT03790800|stroke|stroke
66171|NCT03790800|blood pressure control|blood pressure control
66172|NCT03790800|hypertension|hypertension
66173|NCT03790800|clinical trial|clinical trial
66174|NCT03790800|ambulances|ambulances
66175|NCT03790761|Guam|guam
66176|NCT03790761|healthy relationships|healthy relationships
66177|NCT03790761|non-profit organization|non-profit organization
66178|NCT03790761|PREP 8.0 curriculum|prep 8.0 curriculum
66179|NCT03790735|pulmonary nodule|pulmonary nodule
66180|NCT03790722|Cardiovascular parameters|cardiovascular parameters
66181|NCT03790722|Blood Pressure|blood pressure
66182|NCT03790722|Pulse Wave|pulse wave
66183|NCT03790722|Ergometry|ergometry
66184|NCT03790722|MobiloGraph|mobilograph
66185|NCT03790722|Somnotouch|somnotouch
66186|NCT03790683|intraoperative hypothermia|intraoperative hypothermia
66187|NCT03790683|inadvertent hypothermia|inadvertent hypothermia
66188|NCT03790683|perioperative hypothermia|perioperative hypothermia
66189|NCT03790657|aging|aging
66190|NCT03790657|walking|walking
66191|NCT03790657|brain|brain
66192|NCT03790657|electrical stimulation|electrical stimulation
66193|NCT03790644|Walking|walking
66194|NCT03790644|Exoskeleton Device|exoskeleton device
66195|NCT03790605|periodontitis, 1% curcumin chips, host modulation therapy, anti inflammatory effect, interleukin 1 beta|periodontitis, 1% curcumin chips, host modulation therapy, anti inflammatory effect, interleukin 1 beta
66196|NCT03790579|Gestational diabetes mellitus|gestational diabetes mellitus
66197|NCT03790579|Dietary acid load|dietary acid load
66198|NCT03790579|Pregnancy|pregnancy
66199|NCT03790566|ESP block|esp block
66200|NCT03790566|TAP block|tap block
66201|NCT03790566|pyeloplasty|pyeloplasty
66202|NCT03790566|erector spina plane block|erector spina plane block
66203|NCT03790566|transversus abdominus plane block|transversus abdominus plane block
66204|NCT03790566|flank incision|flank incision
66205|NCT03790566|post-op analgesia|post-op analgesia
66206|NCT03790566|peri-op analgesia|peri-op analgesia
66207|NCT03790553|chemoradiotherapy|chemoradiotherapy
66208|NCT03790553|esophageal cancer|esophageal cancer
66209|NCT03790553|PET/CT|pet/ct
66210|NCT03790540|DentalVibe|dentalvibe
66211|NCT03790540|Mandibular nerve block injection|mandibular nerve block injection
66212|NCT03790540|Consolability Scale|consolability scale
66213|NCT03790514|Heat wrap|heat wrap
66214|NCT03790488|Solid Tumor Malignancies|solid tumor malignancies
66215|NCT03790488|JTX-4014|jtx-4014
66216|NCT03790488|Monoclonal Antibody (mAb)|monoclonal antibody (mab)
66217|NCT03790488|Programmed Cell Death Receptor-1 (PD-1)|programmed cell death receptor-1 (pd-1)
66218|NCT03790488|Immunotherapy|immunotherapy
66219|NCT03790488|Immuno-oncology|immuno-oncology
66220|NCT03790488|Dose Escalation|dose escalation
66221|NCT03790475|Colorectal Cancer Screening|colorectal cancer screening
66222|NCT03790462|Stress, Electroencephalogram,Indian Music, Electrocardiogram|stress, electroencephalogram,indian music, electrocardiogram
66223|NCT03790449|Infertility|infertility
66224|NCT03790449|Lifestyle|lifestyle
66225|NCT03790449|mobile health|mobile health
66226|NCT03790449|Diet|diet
66227|NCT03790449|Physical Activity|physical activity
66228|NCT03790449|Mindfulness|mindfulness
66229|NCT03790410|COPD Postural Control IMT|copd postural control imt
66230|NCT03790397|Lung Cancer, EGFR positive, NSCLC, Osimertinib|lung cancer, egfr positive, nsclc, osimertinib
66231|NCT03790345|Schizophrenia|schizophrenia
66232|NCT03790345|Cobalamin|cobalamin
66233|NCT03790345|Pyridoxine|pyridoxine
66234|NCT03790345|Drug-induced movement disorder|drug-induced movement disorder
66235|NCT03790332|cGVHD|cgvhd
66236|NCT03790332|chronic graft versus host disease|chronic graft versus host disease
66237|NCT03790332|PCYC1146IM|pcyc1146im
66238|NCT03790332|Pediatric|pediatric
66239|NCT03790332|GVHD|gvhd
66240|NCT03790332|chronic|chronic
66241|NCT03790332|1146|1146
66242|NCT03790332|Pharmacyclics|pharmacyclics
66243|NCT03790332|PCYC|pcyc
66244|NCT03790332|Imbruvica|imbruvica
66245|NCT03790332|Ibrutinib|ibrutinib
66246|NCT03790332|Immunology|immunology
66247|NCT03790332|graft versus host disease|graft versus host disease
66248|NCT03790332|corticosteroids|corticosteroids
66249|NCT03790332|prednisone|prednisone
66250|NCT03790332|PCI32765|pci32765
66251|NCT03790332|PCYC1146|pcyc1146
66252|NCT03790332|refractory|refractory
66253|NCT03790332|new onset graft versus host disease|new onset graft versus host disease
66254|NCT03790332|refractory graft versus host disease|refractory graft versus host disease
66255|NCT03790332|moderate cGVHD|moderate cgvhd
66256|NCT03790332|severe cGVHD|severe cgvhd
66257|NCT03790332|moderate chronic graft versus host disease|moderate chronic graft versus host disease
66258|NCT03790332|severe chronic graft versus host disease|severe chronic graft versus host disease
66259|NCT03790319|Stress|stress
66260|NCT03790319|Emotion|emotion
66261|NCT03790254|recurrent urinary tract infections|recurrent urinary tract infections
66262|NCT03790254|d mannose prophylaxis|d mannose prophylaxis
66263|NCT03790254|antibiotic prophylaxis|antibiotic prophylaxis
66264|NCT03790241|catheter insertion|catheter insertion
66265|NCT03790241|puncture|puncture
66266|NCT03790241|skin|skin
66267|NCT03790241|vein|vein
66268|NCT03790241|palpation|palpation
66269|NCT03790241|motion tracking|motion tracking
66270|NCT03790228|Advanced nonsquamous Non-Small Cell Lung Cancer|advanced nonsquamous non-small cell lung cancer
66271|NCT03790228|Anlotinib Combined With Pemetrexed and Carboplatin as the First-line|anlotinib combined with pemetrexed and carboplatin as the first-line
66272|NCT03790202|wound|wound
66273|NCT03790202|VistaCare|vistacare
66274|NCT03790202|wound healing|wound healing
66275|NCT03790202|controlled atmosphere|controlled atmosphere
66276|NCT03790189|knee|knee
66277|NCT03790189|unicompartmental osteoarthritis|unicompartmental osteoarthritis
66278|NCT03790189|injection|injection
66279|NCT03790189|subchondroplasty|subchondroplasty
66280|NCT03790189|bone marrow concentrate|bone marrow concentrate
66281|NCT03790189|mesenchymal stem cells|mesenchymal stem cells
66282|NCT03790163|levobupivacaine,spinal anesthesia ,temperature|levobupivacaine,spinal anesthesia ,temperature
66283|NCT03790150|Ventilator-associated pneumonia|ventilator-associated pneumonia
66284|NCT03790150|Mechanical Ventilation|mechanical ventilation
66285|NCT03790150|Ventilator-associated events|ventilator-associated events
66286|NCT03790150|Intensive care unit|intensive care unit
66287|NCT03790150|Quality improvement project|quality improvement project
66288|NCT03790137|Sunflower Syndrome|sunflower syndrome
66289|NCT03790137|Epilepsy|epilepsy
66290|NCT03790085|Precision medicine|precision medicine
66291|NCT03790085|Bio-marker|bio-marker
66292|NCT03790085|Neuroimaging|neuroimaging
66293|NCT03790085|Molecular genetics|molecular genetics
66294|NCT03790085|Neurobiochemical|neurobiochemical
66295|NCT03790085|Early diagnosis|early diagnosis
66296|NCT03790085|Early prediction|early prediction
66297|NCT03790072|Gamma Delta T Lymphocytes|gamma delta t lymphocytes
66298|NCT03790059|radiofrequency ablation|radiofrequency ablation
66299|NCT03790059|hepatocellular carcinoma|hepatocellular carcinoma
66300|NCT03790059|recombinant human adenovirus type 5 injection|recombinant human adenovirus type 5 injection
66301|NCT03790033|Cold Hypersensitivity|cold hypersensitivity
66302|NCT03790033|Korean medicine|korean medicine
66303|NCT03790033|Ucha-Shinki-Hwan|ucha-shinki-hwan
66304|NCT03790020|acute appendicitis|acute appendicitis
66305|NCT03790020|postoperative pain relief|postoperative pain relief
66306|NCT03790020|local anesthetic|local anesthetic
66307|NCT03790020|laparoscopic appendectomy|laparoscopic appendectomy
66308|NCT03790007|laparoscopic cholecystectomy|laparoscopic cholecystectomy
66309|NCT03790007|postoperative pain relief|postoperative pain relief
66310|NCT03790007|local anesthetic|local anesthetic
66311|NCT03789994|Family caregiver|family caregiver
66312|NCT03789994|attachment security|attachment security
66313|NCT03789994|affective touch|affective touch
66314|NCT03789994|self-esteem|self-esteem
66315|NCT03789994|family harmony|family harmony
66316|NCT03789981|AML|aml
66317|NCT03789981|Acute Myeloid Leukemia|acute myeloid leukemia
66318|NCT03789981|Immunogenic profile|immunogenic profile
66319|NCT03789981|transcriptome analysis|transcriptome analysis
66320|NCT03789955|Fluoroscopy|fluoroscopy
66321|NCT03789955|Contralateral Oblique View|contralateral oblique view
66322|NCT03789955|Thoracic epidural block|thoracic epidural block
66323|NCT03789955|Mid thoracic epidural space|mid thoracic epidural space
66324|NCT03789929|Stress|stress
66325|NCT03789929|Emotion|emotion
818955|NCT00163436|Asthma|asthma
86290|NCT03664024|PD1|pd1
66326|NCT03789916|coronary artery bypass grafting|coronary artery bypass grafting
66327|NCT03789916|incomplete revascularization|incomplete revascularization
66328|NCT03789916|coronary artery disease|coronary artery disease
66329|NCT03789916|dual antiplatelet therapy|dual antiplatelet therapy
66330|NCT03789890|Drug-drug interaction|drug-drug interaction
66331|NCT03789890|Itraconazole (ITZ)|itraconazole (itz)
66332|NCT03789890|Cytochrom P450 3A4 (CYP3A4) metabolism|cytochrom p450 3a4 (cyp3a4) metabolism
66333|NCT03789890|P2X3-inhibitor|p2x3-inhibitor
66334|NCT03789864|Lymphoma|lymphoma
66335|NCT03789786|Selective Dorsal Rhizotomy|selective dorsal rhizotomy
66336|NCT03789786|Outcomes|outcomes
66337|NCT03789760|Vascular Dementia|vascular dementia
66338|NCT03789760|cognitive|cognitive
66339|NCT03789747|incidence|incidence
66340|NCT03789747|outcome|outcome
66341|NCT03789747|acute kidney injury|acute kidney injury
66342|NCT03789747|risk factor|risk factor
66343|NCT03789656|Acromegaly|acromegaly
66344|NCT03789656|ACROBAT|acrobat
66345|NCT03789656|EDGE|edge
66346|NCT03789643|JTT-251|jtt-251
66347|NCT03789643|Pulmonary arterial hypertension|pulmonary arterial hypertension
66348|NCT03789643|RELIEF-PAH|relief-pah
66349|NCT03789643|Six-minute walk distance (6MWD)|six-minute walk distance (6mwd)
66350|NCT03789630|Knee Replacement|knee replacement
66351|NCT03789630|Wearable|wearable
66352|NCT03789630|Pain Score Quantification|pain score quantification
66353|NCT03789617|Cytotoxic T cell|cytotoxic t cell
66354|NCT03789617|Lymphoma|lymphoma
66355|NCT03789617|Immuno-oncology|immuno-oncology
66356|NCT03789617|ENKTL|enktl
66357|NCT03789617|EBViNT|ebvint
66358|NCT03789591|Hydroxyurea|hydroxyurea
66359|NCT03789591|HbSS|hbss
66360|NCT03789591|HbSD|hbsd
66361|NCT03789591|TREAT|treat
66362|NCT03789565|periodontal diseases|periodontal diseases
66363|NCT03789565|hepcidin|hepcidin
66364|NCT03789565|elisa|elisa
66365|NCT03789565|interleukin 6|interleukin 6
66366|NCT03789565|interleukin 10|interleukin 10
66367|NCT03789552|angina pectoris|angina pectoris
66368|NCT03789539|Safety|safety
66369|NCT03789539|Reactogenicity|reactogenicity
66370|NCT03789539|Universal Influenza Vaccine|universal influenza vaccine
66371|NCT03789526|Tenosynovitis|tenosynovitis
66375|NCT03789487|Cardiac Resynchronization Therapy|cardiac resynchronization therapy
66376|NCT03789487|Non-responders|non-responders
66377|NCT03789487|Pacing vector optimization|pacing vector optimization
66378|NCT03789487|Atrioventricular delay optimization|atrioventricular delay optimization
66379|NCT03789487|Non invasive hemodynamic optimization|non invasive hemodynamic optimization
66380|NCT03789487|Heart Failure|heart failure
66381|NCT03789461|Fecal Microbiota Transplantation|fecal microbiota transplantation
66383|NCT03789448|Antiretroviral Treatment|antiretroviral treatment
66384|NCT03789396|Oxygenation|oxygenation
66385|NCT03789396|Hypoxia|hypoxia
66386|NCT03789396|Normoxia|normoxia
66387|NCT03789396|Hyperoxia|hyperoxia
66388|NCT03789396|Trauma|trauma
66389|NCT03789396|Critical Illness|critical illness
66390|NCT03789357|Hypertension|hypertension
66391|NCT03789357|Arrhythmia|arrhythmia
66392|NCT03789357|Adrenal vein sampling|adrenal vein sampling
66393|NCT03789357|Mineralocorticoid-receptor Antagonists|mineralocorticoid-receptor antagonists
66394|NCT03789344|acupuncture, PCI|acupuncture, pci
66395|NCT03789331|transgender males|transgender males
66396|NCT03789331|anogenital distance|anogenital distance
66397|NCT03789305|Early Mobilization|early mobilization
66398|NCT03789305|Early Rehabilitation|early rehabilitation
66399|NCT03789305|Functional Status|functional status
66400|NCT03789305|Functional Outcome|functional outcome
66401|NCT03789305|Patient Outcome|patient outcome
66402|NCT03789305|Intensive Care|intensive care
66403|NCT03789305|Critical Care Outcomes|critical care outcomes
66404|NCT03789279|Invasive coronary angiography|invasive coronary angiography
66405|NCT03789279|Distal transradial arterial access|distal transradial arterial access
66406|NCT03789279|Anatomical snuffbox|anatomical snuffbox
66407|NCT03789279|dTRA|dtra
66408|NCT03789279|dRA|dra
66409|NCT03789279|Distal radial|distal radial
66410|NCT03789279|Radial artery occlusion|radial artery occlusion
66411|NCT03789253|active surveillance, microarray, latent, GSEA, latent|active surveillance, microarray, latent, gsea, latent
66412|NCT03789240|BAY 80-6946|bay 80-6946
66413|NCT03789240|PI3K Target|pi3k target
66414|NCT03789240|Aliqopa|aliqopa
66415|NCT03789240|Monoclonal Antibody|monoclonal antibody
66416|NCT03789201|TMS-Evoked Potential|tms-evoked potential
66417|NCT03789201|TMS|tms
66418|NCT03789201|fMRI|fmri
66419|NCT03789201|Behavior|behavior
66420|NCT03789201|Electroencephalogram (EEG)|electroencephalogram (eeg)
66426|NCT03789175|Oxidative Phosphorylation Capacity|oxidative phosphorylation capacity
66427|NCT03789175|Increased Oxidative Metabolism|increased oxidative metabolism
66428|NCT03789175|Regeneration of Phosphocreatine( PCr)|regeneration of phosphocreatine( pcr)
66429|NCT03789175|Inherited Mutation of TP53 Tumor Supressor Gene|inherited mutation of tp53 tumor supressor gene
66430|NCT03789162|Blood Draw|blood draw
66431|NCT03789162|Sample Collection|sample collection
66432|NCT03789162|Stool DNA|stool dna
66433|NCT03789149|Intraoperative Radiotherapy|intraoperative radiotherapy
66434|NCT03789123|Endometrioma|endometrioma
66435|NCT03789123|Estradiol valerate + dienogest|estradiol valerate + dienogest
66436|NCT03789123|Dienogest|dienogest
66437|NCT03789123|Ovarian reserve|ovarian reserve
66438|NCT03789110|Breast Cancer|breast cancer
66439|NCT03789097|Radiation|radiation
66440|NCT03789097|Poly-ICLC|poly-iclc
66441|NCT03789097|Pembrolizumab|pembrolizumab
66442|NCT03789097|Lymphoma|lymphoma
66443|NCT03789097|Breast Cancer|breast cancer
66444|NCT03789097|Carcinoma|carcinoma
66445|NCT03789045|Exercise|exercise
66446|NCT03789045|Metabolic thresholds|metabolic thresholds
66447|NCT03789045|Fat oxidation|fat oxidation
66448|NCT03789032|Vadadustat|vadadustat
66449|NCT03789032|Rabeprazole|rabeprazole
66450|NCT03789032|Pharmacokinetics|pharmacokinetics
66451|NCT03789019|BP-C1|bp-c1
66452|NCT03789019|Cis-coordinated complexes of platinum(II) with polymer of benzene polycarboxylic acids derived from lignin|cis-coordinated complexes of platinum(ii) with polymer of benzene polycarboxylic acids derived from lignin
66453|NCT03789019|Benzene polycarboxylic acids complex with cis-diammineplatinum( II)|benzene polycarboxylic acids complex with cis-diammineplatinum( ii)
66454|NCT03789019|Metastatic Breast Cancer|metastatic breast cancer
66455|NCT03789019|Platinum analogue|platinum analogue
66456|NCT03789019|Metronomic chemotherapy|metronomic chemotherapy
66457|NCT03789019|Breast cancer|breast cancer
66458|NCT03789019|Cisplatin|cisplatin
66459|NCT03789019|cis-diammineplatinum(II) complexed with a polymer containing benzene polycarboxylic acids derived from lignin|cis-diammineplatinum(ii) complexed with a polymer containing benzene polycarboxylic acids derived from lignin
66460|NCT03788993|Phototherapy|phototherapy
66461|NCT03788993|Hospitals, psychiatric|hospitals, psychiatric
66462|NCT03788993|Emergency Services, Psychiatric|emergency services, psychiatric
66463|NCT03788980|Endarterectomy|endarterectomy
66464|NCT03788967|Complicated Urinary Tract Infection|complicated urinary tract infection
66465|NCT03788967|Acute Pyelonephritis|acute pyelonephritis
66466|NCT03788954|Range of motion|range of motion
66467|NCT03788954|Hand injuries|hand injuries
66468|NCT03788954|Biomechanics|biomechanics
66469|NCT03788954|Rehabilitation|rehabilitation
66470|NCT03788915|obesity|obesity
66471|NCT03788915|internet community|internet community
66472|NCT03788915|treatment; preventive medicine|treatment; preventive medicine
66473|NCT03788915|risk perception|risk perception
66474|NCT03788915|lifestyle counseling|lifestyle counseling
66475|NCT03788889|Lorazepam|lorazepam
66476|NCT03788889|Ketamine|ketamine
66477|NCT03788889|Phenobarbital|phenobarbital
66478|NCT03788850|residual disease|residual disease
66479|NCT03788850|central cone|central cone
66480|NCT03788850|predictive model|predictive model
66481|NCT03788837|Microcirculatory defects|microcirculatory defects
66482|NCT03788837|hemodynamic macroparameters|hemodynamic macroparameters
66483|NCT03788837|mottling|mottling
66484|NCT03788837|Septic shock|septic shock
66485|NCT03788837|SOFA score|sofa score
66486|NCT03788824|Ulcerative Colitis|ulcerative colitis
66487|NCT03788824|probe-based Confocal Laser Endoscopy|probe-based confocal laser endoscopy
66488|NCT03788824|Inflammation Activity|inflammation activity
66489|NCT03788824|Histology|histology
66490|NCT03788811|Retinal Signal|retinal signal
66491|NCT03788811|Schizophrenia|schizophrenia
66492|NCT03788811|Bipolar I Disorder|bipolar i disorder
66493|NCT03788811|Support to diagnostic|support to diagnostic
66495|NCT03788811|Mental Disorder|mental disorder
66496|NCT03788772|dendritic cell|dendritic cell
66497|NCT03788772|sepsis|sepsis
66498|NCT03788759|Schizophrenia|schizophrenia
66499|NCT03788759|Drug repurposing|drug repurposing
66500|NCT03788759|Alpha-lipoic acid|alpha-lipoic acid
66501|NCT03788759|Adjuvant treatment|adjuvant treatment
66502|NCT03788746|Urothelial Carcinoma|urothelial carcinoma
66503|NCT03788746|Registry|registry
66504|NCT03788733|Burning mouth syndrome,|burning mouth syndrome,
66505|NCT03788733|melatonin|melatonin
66506|NCT03788733|pain|pain
66507|NCT03788733|sleep|sleep
66508|NCT03788720|Endometrioma|endometrioma
66509|NCT03788720|Laparoscopy|laparoscopy
66510|NCT03788720|Suture|suture
66511|NCT03788720|Ovary|ovary
66512|NCT03788694|Ketamine|ketamine
66513|NCT03788694|Veteran|veteran
66514|NCT03788694|Suicide|suicide
66515|NCT03788694|Suicidal Ideation|suicidal ideation
66516|NCT03788668|Hyoid suspension|hyoid suspension
66517|NCT03788668|Barbed reposition pharyngoplasty|barbed reposition pharyngoplasty
66518|NCT03788655|metal stent|metal stent
66519|NCT03788655|biliary stricture|biliary stricture
66520|NCT03788655|stenting|stenting
66521|NCT03788642|Diabetic Foot Ulcer|diabetic foot ulcer
66522|NCT03788642|Low Level Laser Therapy|low level laser therapy
66523|NCT03788629|hemiplegia|hemiplegia
66524|NCT03788629|foot|foot
66525|NCT03788629|mobilization|mobilization
818956|NCT00163436|Ciclesonide|ciclesonide
66526|NCT03788616|Bioactive Restorative Material , ART|bioactive restorative material , art
66527|NCT03788525|Screen time|screen time
66528|NCT03788512|acute ischemic cerebrovascular disease|acute ischemic cerebrovascular disease
66529|NCT03788512|cerebral atherosclerosis|cerebral atherosclerosis
66530|NCT03788512|coronary atherosclerosis|coronary atherosclerosis
66531|NCT03788512|coexistence|coexistence
66532|NCT03788499|Massage|massage
66533|NCT03788499|Maxillofacial and Oral Cavity|maxillofacial and oral cavity
66534|NCT03788499|Radioactive Oral Mucositis|radioactive oral mucositis
66535|NCT03788499|Nasopharyngeal Carcinoma|nasopharyngeal carcinoma
66536|NCT03788486|dry eye|dry eye
66537|NCT03788434|Clostridium Difficile Infection Recurrence|clostridium difficile infection recurrence
66538|NCT03788434|Clostridium Difficile Infection|clostridium difficile infection
66539|NCT03788434|Clostridium Difficile|clostridium difficile
66540|NCT03788434|VE303|ve303
66541|NCT03788434|Consortium|consortium
66542|NCT03788434|Vedanta|vedanta
66543|NCT03788434|CDI|cdi
66544|NCT03788434|C. Diff|c. diff
66545|NCT03788434|CDiff|cdiff
66546|NCT03788434|Clostridiodes Difficile Infection|clostridiodes difficile infection
66547|NCT03788434|Clostridiodes Difficile|clostridiodes difficile
66548|NCT03788382|Failure Adjuvant Therapy|failure adjuvant therapy
66549|NCT03788369|Hybrid coronary revascularization|hybrid coronary revascularization
66550|NCT03788343|Phenylketonuria|phenylketonuria
66551|NCT03788343|PKU|pku
66552|NCT03788343|Phenylalanine|phenylalanine
66553|NCT03788343|Diet|diet
66554|NCT03788343|Neuropsychology|neuropsychology
66555|NCT03788343|Working Memory|working memory
66556|NCT03788343|Neuroimaging|neuroimaging
66557|NCT03788330|exhaled nitric oxide|exhaled nitric oxide
66558|NCT03788330|Sick building syndrome|sick building syndrome
66559|NCT03788330|indoor air|indoor air
66560|NCT03788317|Cerebral Palsy, Botulinum Toxin A, Participation|cerebral palsy, botulinum toxin a, participation
66561|NCT03788291|Chronic Lymphocytic Leukemia (CLL)|chronic lymphocytic leukemia (cll)
66562|NCT03788291|Small Lymphocytic Lymphoma (SLL)|small lymphocytic lymphoma (sll)
66564|NCT03788291|Acalabrutinib|acalabrutinib
66565|NCT03788291|Rituximab|rituximab
66566|NCT03788278|Digital psychiatry|digital psychiatry
66567|NCT03788252|Sarcopenia|sarcopenia
66568|NCT03788252|AST-120|ast-120
66569|NCT03788252|Indoxyl sulfate|indoxyl sulfate
66570|NCT03788213|Hypo-fractionated Radiotherapy,|hypo-fractionated radiotherapy,
66571|NCT03788213|One week Radiotherapy|one week radiotherapy
66572|NCT03788213|Simultaneous integrated boost|simultaneous integrated boost
66573|NCT03788213|Breast Cancer|breast cancer
66574|NCT03788161|trigger points|trigger points
66575|NCT03788161|virtual reality|virtual reality
66576|NCT03788161|Dry needling|dry needling
66577|NCT03788148|transfusion, PCI, DES, BMS|transfusion, pci, des, bms
66578|NCT03788122|Acceptability|acceptability
66579|NCT03788122|Qualitative research|qualitative research
66580|NCT03788122|Patient Perspectives|patient perspectives
66581|NCT03788096|Post-Intensive Care Syndrome (PICS)|post-intensive care syndrome (pics)
66582|NCT03788096|Chronic Critical Illness|chronic critical illness
66583|NCT03788083|immune therapy|immune therapy
66584|NCT03788083|dendritic cells|dendritic cells
66585|NCT03788083|immune priming|immune priming
66586|NCT03788044|Education|education
66587|NCT03788044|Application|application
66588|NCT03788044|Adherence|adherence
66589|NCT03788018|Lidocaine|lidocaine
66590|NCT03788018|Dexmedetomidine|dexmedetomidine
66591|NCT03788018|Postoperative nausea and vomiting|postoperative nausea and vomiting
66592|NCT03788018|laparoscopic hysterectomy|laparoscopic hysterectomy
66593|NCT03788005|Chronic Subdural Hematoma|chronic subdural hematoma
66594|NCT03788005|Bed rest|bed rest
66595|NCT03788005|Early mobilization|early mobilization
66596|NCT03787979|History of low back pain|history of low back pain
66597|NCT03787979|Clinical lumbar instability|clinical lumbar instability
66598|NCT03787979|Stretching exercise|stretching exercise
66599|NCT03787966|Breast neoplasm|breast neoplasm
66600|NCT03787966|Breast cancer|breast cancer
66601|NCT03787966|therapeutic exercise|therapeutic exercise
66602|NCT03787966|cardiotoxicity|cardiotoxicity
66603|NCT03787966|muscle toxicity|muscle toxicity
66604|NCT03787953|anti-PD-1/PD-L1 antibodies|anti-pd-1/pd-l1 antibodies
66605|NCT03787953|Efficacy|efficacy
66606|NCT03787953|Safety|safety
66607|NCT03787953|Real world study|real world study
66608|NCT03787940|N-Acetyltransferase Type 2 Genotype|n-acetyltransferase type 2 genotype
66609|NCT03787940|treatment|treatment
66610|NCT03787940|Tuberculous Meningitis|tuberculous meningitis
66611|NCT03787875|RANKL|rankl
66612|NCT03787875|OPG|opg
66613|NCT03787875|periodontal biomarkers|periodontal biomarkers
66614|NCT03787875|alveolar bone loss|alveolar bone loss
66615|NCT03787875|chronic periodontitis|chronic periodontitis
66616|NCT03787862|Foot ulcers|foot ulcers
66617|NCT03787862|Foot Surgery|foot surgery
66618|NCT03787862|Hyperspectral imaging|hyperspectral imaging
66619|NCT03787849|Emergence delirium|emergence delirium
66620|NCT03787849|Child|child
818957|NCT00163423|Asthma|asthma
86656|NCT03661463|Aspirin|aspirin
66621|NCT03787849|Postoperative complications|postoperative complications
66622|NCT03787849|DNA methylation|dna methylation
66623|NCT03787849|Epigenetic|epigenetic
66624|NCT03787836|Exercise Response|exercise response
66625|NCT03787836|Interindividual Variability|interindividual variability
66626|NCT03787797|Epicardial adipose tissue|epicardial adipose tissue
66627|NCT03787797|Chest pain|chest pain
66628|NCT03787797|Echocardiography|echocardiography
66629|NCT03787797|Coronary artery disease|coronary artery disease
66630|NCT03787771|Fecal Microbiota Transplantation|fecal microbiota transplantation
66631|NCT03787745|Primary PCI|primary pci
66632|NCT03787745|Ischemic postconditioning|ischemic postconditioning
66633|NCT03787745|Clinical outcome|clinical outcome
66635|NCT03787719|Twice weekly dialysis|twice weekly dialysis
66636|NCT03787719|Thrice weekly dialysis|thrice weekly dialysis
66637|NCT03787719|End Stage Renal Disease|end stage renal disease
66638|NCT03787706|Neck Pain|neck pain
66639|NCT03787706|Trigger points|trigger points
66640|NCT03787706|Dry needling|dry needling
66641|NCT03787706|Cranio-cervical flexion test|cranio-cervical flexion test
66642|NCT03787693|hemiparesis|hemiparesis
66643|NCT03787693|gait|gait
66644|NCT03787693|perception|perception
66645|NCT03787693|sensory|sensory
66646|NCT03787693|vision|vision
66647|NCT03787693|coordination|coordination
66648|NCT03787641|cardiopulmonary bypass|cardiopulmonary bypass
66649|NCT03787641|heparin|heparin
66650|NCT03787641|protamine|protamine
66651|NCT03787641|anti-IIa assay|anti-iia assay
66652|NCT03787641|anti-Xa assay|anti-xa assay
66653|NCT03787641|activated clotting time|activated clotting time
66654|NCT03787628|Buprenorphine|buprenorphine
66655|NCT03787628|Cannabidiol|cannabidiol
66656|NCT03787628|Opioid Use disorder|opioid use disorder
66657|NCT03787615|kidney|kidney
66658|NCT03787589|Renal Failure|renal failure
66659|NCT03787589|Hemodialysis|hemodialysis
66660|NCT03787589|Peritoneal Dialysis|peritoneal dialysis
66661|NCT03787589|Exercise|exercise
66662|NCT03787576|Multifocal intraocular lens|multifocal intraocular lens
66663|NCT03787576|Trifocal intraocular lens|trifocal intraocular lens
66664|NCT03787576|Extended Depth of Focus Lens|extended depth of focus lens
66665|NCT03787563|Herbal Tea|herbal tea
66666|NCT03787563|Diabetes|diabetes
66667|NCT03787550|ECMO|ecmo
66668|NCT03787550|Sedatives|sedatives
66669|NCT03787550|Analgesics|analgesics
66670|NCT03787550|Antibiotics|antibiotics
66671|NCT03787537|Nutrition|nutrition
66672|NCT03787537|Surgery|surgery
66673|NCT03787511|cough|cough
66674|NCT03787511|diabetes|diabetes
66675|NCT03787511|small fiber neuropathy|small fiber neuropathy
66676|NCT03787498|PLX2853|plx2853
66677|NCT03787498|Acute Myeloid Leukemia|acute myeloid leukemia
66678|NCT03787498|AML|aml
66679|NCT03787498|Myelodysplastic Syndrome|myelodysplastic syndrome
66680|NCT03787498|MDS|mds
66681|NCT03787498|Hematologic Malignancy|hematologic malignancy
66682|NCT03787498|Blood Cancer|blood cancer
66683|NCT03787485|Community Health Worker|community health worker
66684|NCT03787485|Community Clinical Linkage|community clinical linkage
66685|NCT03787459|severe influenza, arbidol, oseltamivir, ordinal scale|severe influenza, arbidol, oseltamivir, ordinal scale
66686|NCT03787433|Rehabilitation|rehabilitation
66687|NCT03787433|Accelerometers|accelerometers
66688|NCT03787433|Wearable sensors|wearable sensors
66689|NCT03787433|Artificial Intelligence|artificial intelligence
66690|NCT03787433|Stroke|stroke
66691|NCT03787433|Home-based Rehabilitation|home-based rehabilitation
66692|NCT03787433|Activities of Daily Living|activities of daily living
66693|NCT03787433|Post-stroke rehabilitation|post-stroke rehabilitation
66694|NCT03787407|resilience|resilience
66695|NCT03787407|emotional labor|emotional labor
66696|NCT03787407|mindfulness|mindfulness
66697|NCT03787407|neurofeedback|neurofeedback
66698|NCT03787394|taste enhancers|taste enhancers
66699|NCT03787381|cesarean section, niche, uterine scar defect|cesarean section, niche, uterine scar defect
66700|NCT03787368|End-stage renal disease patients undergoing hemodialysis|end-stage renal disease patients undergoing hemodialysis
66701|NCT03787342|Periosteal Releasing Incision, Modified Periosteal Releasing Incision, Coronally Advanced Lingual Flap, Double Flap Incision, Titanium mesh, GBR|periosteal releasing incision, modified periosteal releasing incision, coronally advanced lingual flap, double flap incision, titanium mesh, gbr
66702|NCT03787329|Femur Head Necrosis|femur head necrosis
66703|NCT03787329|Mesenchymal Stromal Cells|mesenchymal stromal cells
66704|NCT03787329|Bone Marrow|bone marrow
66705|NCT03787316|gait|gait
66706|NCT03787316|sever's|sever's
66707|NCT03787277|Aortic Dissection Type A|aortic dissection type a
66708|NCT03787277|Post operative residual aortic dissection|post operative residual aortic dissection
66709|NCT03787277|Aneurysmal progression of the dissected aorta|aneurysmal progression of the dissected aorta
66710|NCT03787277|Intimal flap mobility|intimal flap mobility
66711|NCT03787199|Andago|andago
66712|NCT03787199|Feasibility|feasibility
66713|NCT03787199|Pediatric Neurorehabilitation|pediatric neurorehabilitation
66714|NCT03787173|non invasive ventilation|non invasive ventilation
66715|NCT03787173|patient ventilator synchrony|patient ventilator synchrony
66716|NCT03787173|acute respiratory failure|acute respiratory failure
66717|NCT03787173|closed loop ventilation|closed loop ventilation
66718|NCT03787160|congenital diaphragmatic hernia|congenital diaphragmatic hernia
66719|NCT03787160|volatile organic compounds|volatile organic compounds
66720|NCT03787160|microbiome|microbiome
66721|NCT03787160|pulmonary function|pulmonary function
66722|NCT03787160|multiple breath washout|multiple breath washout
66723|NCT03787147|Virtual Reality|virtual reality
66724|NCT03787147|Spinal Injection|spinal injection
66725|NCT03787147|Adult|adult
66726|NCT03787147|Analgesia|analgesia
66727|NCT03787147|Google cardboard|google cardboard
66728|NCT03787147|Oculus|oculus
66729|NCT03787121|health economics|health economics
66730|NCT03787121|care management pathways|care management pathways
66731|NCT03787121|overtreatment|overtreatment
66732|NCT03787108|Non-Alcoholic Fatty Liver Disease|non-alcoholic fatty liver disease
66733|NCT03787108|Magnetic Resonance Spectroscopy|magnetic resonance spectroscopy
66734|NCT03787108|Ultrasonographic hepatorenal index|ultrasonographic hepatorenal index
66736|NCT03787056|TUMOR MARKER|tumor marker
66737|NCT03787056|PROGASTRIN|progastrin
66738|NCT03787043|Food Effect|food effect
66739|NCT03787004|Chronic Pain|chronic pain
66740|NCT03787004|Nociceptive Pain|nociceptive pain
66741|NCT03787004|Mixed Pain|mixed pain
66742|NCT03786978|Diabetes mellitus|diabetes mellitus
66743|NCT03786978|Pharmaceutical care|pharmaceutical care
66744|NCT03786978|Educational intervention|educational intervention
66745|NCT03786978|Pharmacoeconomic evaluation|pharmacoeconomic evaluation
66746|NCT03786965|Ischemic Heart Disease|ischemic heart disease
66747|NCT03786965|Valve Disease|valve disease
66748|NCT03786965|Septal Defect|septal defect
66749|NCT03786965|Myeloperoxidase|myeloperoxidase
66750|NCT03786965|Molecular biology|molecular biology
66751|NCT03786965|Gene analysis|gene analysis
66752|NCT03786952|stress|stress
66753|NCT03786952|sex|sex
66754|NCT03786952|fear|fear
66755|NCT03786952|generalization|generalization
66756|NCT03786952|cortisol|cortisol
66757|NCT03786952|alpha-amylase|alpha-amylase
66758|NCT03786952|estradiol|estradiol
66759|NCT03786952|progesterone|progesterone
66760|NCT03786939|Ischemic Heart Disease|ischemic heart disease
66761|NCT03786939|coronary artery bypass grafting|coronary artery bypass grafting
66762|NCT03786939|on-pump CABG|on-pump cabg
66763|NCT03786939|off-pump CABG|off-pump cabg
66764|NCT03786939|pump - assisted CABG|pump - assisted cabg
66765|NCT03786939|myeloperoxidase after CABG|myeloperoxidase after cabg
66766|NCT03786926|CLL|cll
66767|NCT03786926|SLL|sll
66768|NCT03786926|FL|fl
66769|NCT03786926|MZL|mzl
66770|NCT03786926|LPL|lpl
66771|NCT03786926|WM|wm
66772|NCT03786926|MCL|mcl
66773|NCT03786913|Inflammatory myositis|inflammatory myositis
66774|NCT03786913|Duchenne Muscular Dystrophy|duchenne muscular dystrophy
66775|NCT03786913|Musculoskeletal ultrasound|musculoskeletal ultrasound
66776|NCT03786887|mechanical ventilation|mechanical ventilation
66777|NCT03786887|nalbuphine|nalbuphine
66778|NCT03786874|Risk management|risk management
66779|NCT03786874|health & safety|health & safety
66780|NCT03786874|task interruptions|task interruptions
66781|NCT03786874|teamwork|teamwork
66782|NCT03786861|aberration free|aberration free
66783|NCT03786861|corneal wavefront guided|corneal wavefront guided
66784|NCT03786861|higher order aberrations|higher order aberrations
66785|NCT03786861|photorefractive keratectomy.|photorefractive keratectomy.
66786|NCT03786848|Prostate Cancer|prostate cancer
66787|NCT03786848|Patient Derived Xenograft|patient derived xenograft
66788|NCT03786848|CRPC|crpc
66789|NCT03786822|cryoballoon|cryoballoon
66790|NCT03786822|Atrial fibrillation|atrial fibrillation
66791|NCT03786822|pulmonary vein isolation|pulmonary vein isolation
66792|NCT03786809|postmenopause|postmenopause
66793|NCT03786809|vascular effects|vascular effects
66794|NCT03786809|CIMICIFUGA RACEMOSA|cimicifuga racemosa
66795|NCT03786796|Olaparib|olaparib
66796|NCT03786770|Forehead Lines|forehead lines
66797|NCT03786770|Glabellar Lines|glabellar lines
66798|NCT03786770|Frown Lines|frown lines
66799|NCT03786757|STEMI|stemi
66800|NCT03786757|left ventricular thrombus|left ventricular thrombus
66801|NCT03786757|rivaroxaban|rivaroxaban
66802|NCT03786744|Autism, ASD, Cord blood|autism, asd, cord blood
66803|NCT03786731|Major Depressive Disorder|major depressive disorder
66804|NCT03786731|Sleep|sleep
66805|NCT03786731|Transdiagnostic Sleep and Circadian Treatment|transdiagnostic sleep and circadian treatment
66806|NCT03786718|Diabetes|diabetes
66807|NCT03786718|Patient Web Portals|patient web portals
66808|NCT03786718|Usability|usability
66809|NCT03786718|Health Information Technology|health information technology
66810|NCT03786679|Non-operative treatment, orthosis, healing, rehabilitation|non-operative treatment, orthosis, healing, rehabilitation
66811|NCT03786666|Stroke|stroke
66812|NCT03786666|Ischemia|ischemia
66813|NCT03786666|Carotid artery Stenosis|carotid artery stenosis
66814|NCT03786666|CEA|cea
66815|NCT03786666|Stenting|stenting
66816|NCT03786666|Ultrasound|ultrasound
66817|NCT03786666|Vulnerable plaque|vulnerable plaque
66818|NCT03786653|Immunotherapy, bronchial cancer, home-based hospitalization|immunotherapy, bronchial cancer, home-based hospitalization
66819|NCT03786640|3 Tesla MRI|3 tesla mri
66820|NCT03786627|Clinical lumbar instability|clinical lumbar instability
66821|NCT03786627|History of low back pain|history of low back pain
66822|NCT03786627|Arthrogenic muscle inhibition|arthrogenic muscle inhibition
66823|NCT03786627|Neuromuscular electrical stimulation|neuromuscular electrical stimulation
66824|NCT03786627|Motor control training|motor control training
66825|NCT03786614|treatment resistant depression|treatment resistant depression
66826|NCT03786614|serotonergic antidepressants|serotonergic antidepressants
66827|NCT03786614|short form of serotonin transporter|short form of serotonin transporter
66828|NCT03786575|Breast Neoplasm|breast neoplasm
66829|NCT03786575|Next Generation Sequencing|next generation sequencing
66830|NCT03786575|Endocrine Therapy|endocrine therapy
66831|NCT03786549|sickle cell disease (SDC)|sickle cell disease (sdc)
66832|NCT03786549|Pediatric-adult care transition|pediatric-adult care transition
66833|NCT03786523|Nonalcoholic Fatty Liver Disease|nonalcoholic fatty liver disease
66834|NCT03786523|Obesity|obesity
66835|NCT03786523|Time restricted feeding|time restricted feeding
66836|NCT03786523|Calorie restriction|calorie restriction
66837|NCT03786510|Risk reduction|risk reduction
66838|NCT03786510|Community|community
66839|NCT03786510|Older adults|older adults
66840|NCT03786510|Lifestyle modification|lifestyle modification
66841|NCT03786484|solid tumors|solid tumors
66842|NCT03786484|PDE10 inhibitors|pde10 inhibitors
66843|NCT03786484|Immunoncology|immunoncology
66844|NCT03786471|dementia|dementia
66845|NCT03786471|pragmatic clinical trial|pragmatic clinical trial
66846|NCT03786471|effectiveness|effectiveness
66847|NCT03786471|cost-effectiveness|cost-effectiveness
66848|NCT03786471|Alzheimer's disease|alzheimer's disease
66849|NCT03786458|Infertility|infertility
66850|NCT03786458|young female cancer patients|young female cancer patients
66851|NCT03786458|decision aids|decision aids
66852|NCT03786458|fertility concerns|fertility concerns
66853|NCT03786419|Malignant Pleural Mesothelioma|malignant pleural mesothelioma
66854|NCT03786419|Atezolizumab|atezolizumab
66855|NCT03786419|Thoracic neoplasms|thoracic neoplasms
66856|NCT03786419|Antibodies, monoclonal|antibodies, monoclonal
66857|NCT03786419|Antineoplasic, agents|antineoplasic, agents
66858|NCT03786393|Fibromyalgia|fibromyalgia
66859|NCT03786393|Migraine|migraine
66860|NCT03786393|estrogen receptor alpha|estrogen receptor alpha
66861|NCT03786393|polymorphism|polymorphism
66862|NCT03786380|Diabetic Gastroparesis|diabetic gastroparesis
66864|NCT03786367|Exertional Dyspnea|exertional dyspnea
66865|NCT03786367|Pulmonary Hypertension|pulmonary hypertension
66866|NCT03786367|Exercise|exercise
66867|NCT03786341|Gait|gait
66868|NCT03786341|Stroke|stroke
66869|NCT03786341|Walking assist device|walking assist device
66870|NCT03786341|Auxiliary illuminator|auxiliary illuminator
66871|NCT03786341|visual feedback|visual feedback
66872|NCT03786328|Early detection and treatment|early detection and treatment
66873|NCT03786315|Primary care|primary care
66874|NCT03786315|Elderly|elderly
66875|NCT03786315|Older age|older age
66876|NCT03786315|Multimorbidity|multimorbidity
66877|NCT03786315|Shared decision-making|shared decision-making
66878|NCT03786315|Patient involvement|patient involvement
66879|NCT03786302|TAMP BG|tamp bg
66880|NCT03786302|Biodentine|biodentine
66881|NCT03786302|Regenerative materials|regenerative materials
66882|NCT03786302|pulp therapy|pulp therapy
66883|NCT03786289|Recombinant human erythropoietin|recombinant human erythropoietin
66884|NCT03786276|Alcohol Use Disorder|alcohol use disorder
66885|NCT03786276|Traumatic Brain Injury|traumatic brain injury
66886|NCT03786276|Working Memory Training|working memory training
66887|NCT03786276|Virtual Reality|virtual reality
66888|NCT03786276|Physical Exercise|physical exercise
66889|NCT03786250|Emergency department|emergency department
66890|NCT03786250|Older|older
66891|NCT03786250|Frailty|frailty
66892|NCT03786211|Mandible|mandible
66893|NCT03786211|Anesthesia|anesthesia
66894|NCT03786198|early breast cancer|early breast cancer
66895|NCT03786198|aromatase inhibitor therapy|aromatase inhibitor therapy
66896|NCT03786198|activity program|activity program
66897|NCT03786198|physical activity|physical activity
66898|NCT03786198|activity tracker|activity tracker
66899|NCT03786198|pedometer|pedometer
66900|NCT03786198|stepcounter|stepcounter
66901|NCT03786185|Neuroplasticity|neuroplasticity
66902|NCT03786185|Computerized training|computerized training
66903|NCT03786185|Music reading|music reading
66904|NCT03786185|Multisensory training|multisensory training
66905|NCT03786172|Smoking cessation|smoking cessation
66906|NCT03786172|Intervention|intervention
66907|NCT03786172|Head and Neck neoplasms|head and neck neoplasms
66908|NCT03786172|Cognitive therapy|cognitive therapy
66909|NCT03786133|Subgingival analysis|subgingival analysis
66910|NCT03786133|Real-time PCR|real-time pcr
66911|NCT03786133|Comparative study|comparative study
66912|NCT03786133|Chronic Periodontitis|chronic periodontitis
66913|NCT03786133|Type 2 Diabetes Mellitus|type 2 diabetes mellitus
66914|NCT03786107|Circulating Tumor DNA|circulating tumor dna
66915|NCT03786107|HER2|her2
66916|NCT03786107|Genomic Screening|genomic screening
66917|NCT03786107|Metastatic|metastatic
66918|NCT03786107|Breast|breast
66919|NCT03786107|Cervical|cervical
66920|NCT03786107|ERBB2|erbb2
66921|NCT03786107|Mutation|mutation
66922|NCT03786081|cervical carcinoma|cervical carcinoma
66923|NCT03786068|Emergency Medical Services|emergency medical services
66924|NCT03786068|Prehospital|prehospital
66925|NCT03786068|Time to admission|time to admission
66926|NCT03786068|Time to neurosurgery|time to neurosurgery
66927|NCT03786068|Treatment delay|treatment delay
66928|NCT03786055|cancer survivor|cancer survivor
66929|NCT03786055|pain|pain
66930|NCT03786055|chemotherapy induced peripheral neuropathy|chemotherapy induced peripheral neuropathy
66931|NCT03786055|fall risk|fall risk
66932|NCT03786055|quality of life|quality of life
66933|NCT03786055|somatic yoga|somatic yoga
66934|NCT03786055|meditation|meditation
66935|NCT03786042|Positive Smoking expectancies|positive smoking expectancies
66936|NCT03786042|e-cigarette advertising|e-cigarette advertising
66937|NCT03786042|adolescents|adolescents
66938|NCT03786029|Pre-emptive administration|pre-emptive administration
66939|NCT03786029|Analgesic|analgesic
66940|NCT03786029|Tooth extraction|tooth extraction
66941|NCT03786003|Video-Assisted Thoracic Surgery|video-assisted thoracic surgery
66942|NCT03786003|Thoracotomy|thoracotomy
66943|NCT03786003|Early-stage NSCLC|early-stage nsclc
66944|NCT03786003|Consolidation-predominant|consolidation-predominant
66945|NCT03785990|preterm|preterm
66946|NCT03785990|fatty acid|fatty acid
66947|NCT03785990|docosahexaenoic acid|docosahexaenoic acid
66948|NCT03785990|arachidonic acid|arachidonic acid
66949|NCT03785990|infant|infant
66950|NCT03785990|adipose tissue|adipose tissue
66951|NCT03785990|subcutaneous adipose tissue|subcutaneous adipose tissue
66952|NCT03785977|Ventilation|ventilation
66953|NCT03785977|pediatrics|pediatrics
66954|NCT03785977|airway management|airway management
66955|NCT03785977|respiration|respiration
66975|NCT03785938|infection|infection
66976|NCT03785938|supportive care|supportive care
66996|NCT03785886|hypertension|hypertension
66997|NCT03785886|hypertension complicated with type diabetes|hypertension complicated with type diabetes
66998|NCT03785886|walking|walking
66999|NCT03785886|Chinese square dancing|chinese square dancing
67000|NCT03785821|Bitter melon seed oil|bitter melon seed oil
67001|NCT03785821|Olive oil|olive oil
67002|NCT03785821|Weight control|weight control
67003|NCT03785821|UCP1 polymorphism|ucp1 polymorphism
67004|NCT03785808|ketogenic diet|ketogenic diet
67005|NCT03785808|low-fat diet|low-fat diet
67006|NCT03785795|Preterm labor detection|preterm labor detection
67007|NCT03785795|Labor detection|labor detection
67008|NCT03785795|False labor|false labor
67009|NCT03785782|Screening|screening
67010|NCT03785743|Pancreatic Carcinoma|pancreatic carcinoma
67011|NCT03785743|Laparoscopic|laparoscopic
67012|NCT03785743|Pancreaticoduodenectomy|pancreaticoduodenectomy
67013|NCT03785743|Survival|survival
67014|NCT03785717|shock wave therapy (SWT or ESWT)|shock wave therapy (swt or eswt)
67015|NCT03785717|Guided bone regeneration (GBR)|guided bone regeneration (gbr)
67016|NCT03785717|horizontal ridge augmentation|horizontal ridge augmentation
67017|NCT03785704|Xinmailong injection|xinmailong injection
67018|NCT03785704|anthracycline induced cardiac toxicity|anthracycline induced cardiac toxicity
67019|NCT03785691|Hyperemesis Gravidarum (HG)|hyperemesis gravidarum (hg)
67020|NCT03785691|Mirtazapine|mirtazapine
67021|NCT03785691|Ondansetron|ondansetron
67022|NCT03785691|Pregnancy|pregnancy
67023|NCT03785691|Nausea and Vomiting of Pregnancy (NVP)|nausea and vomiting of pregnancy (nvp)
67024|NCT03785691|Randomized Controlled Trial (RCT)|randomized controlled trial (rct)
67025|NCT03785639|balance|balance
67026|NCT03785639|dual task|dual task
67027|NCT03785639|Four Square Step Test|four square step test
67028|NCT03785626|Ultrasound|ultrasound
67029|NCT03785626|Carotid Endarterectomy|carotid endarterectomy
67030|NCT03785626|Risk Prediction Model|risk prediction model
67031|NCT03785600|traumatic brain injury|traumatic brain injury
67032|NCT03785600|sleep-wake disturbances|sleep-wake disturbances
67033|NCT03785600|Veterans|veterans
67034|NCT03785600|chronic pain|chronic pain
67035|NCT03785574|Pulmonary Nodule|pulmonary nodule
67036|NCT03785574|Chemotherapy|chemotherapy
67037|NCT03785574|Chorionic Gonadotrophin|chorionic gonadotrophin
67038|NCT03785561|Musculoskeletal Diseases|musculoskeletal diseases
67039|NCT03785561|Osteoarthritis, Knee|osteoarthritis, knee
67040|NCT03785561|cohort study|cohort study
67041|NCT03785561|illness perceptions|illness perceptions
400579|NCT01866189|ischemic stroke|ischemic stroke
67042|NCT03785509|DAPT, Statin, Compliance, Persistence, Adherence, PCI|dapt, statin, compliance, persistence, adherence, pci
67043|NCT03785483|Physical activity|physical activity
67044|NCT03785483|Multiple sclerosis|multiple sclerosis
67045|NCT03785483|Motivation|motivation
67046|NCT03785483|Intention|intention
67047|NCT03785483|Mindfulness|mindfulness
67048|NCT03785470|arterial stiffness|arterial stiffness
67049|NCT03785470|endothelial dysfunction|endothelial dysfunction
67050|NCT03785470|fructose|fructose
67051|NCT03785470|physical inactivity|physical inactivity
67052|NCT03785457|Low Back Pain|low back pain
67053|NCT03785457|Extension|extension
67054|NCT03785457|Posture|posture
67055|NCT03785457|Physical Therapy|physical therapy
67056|NCT03785444|Assessment by others|assessment by others
67057|NCT03785444|Self-Assessment|self-assessment
67058|NCT03785444|Critically ill|critically ill
67059|NCT03785444|Intensive care|intensive care
67060|NCT03785444|standardized questionnaire|standardized questionnaire
67061|NCT03785444|functional status|functional status
67062|NCT03785444|WHODAS|whodas
67063|NCT03785444|EQ5D|eq5d
67064|NCT03785444|IADL|iadl
67065|NCT03785444|Barthel Score|barthel score
67066|NCT03785444|SF-36|sf-36
67067|NCT03785444|MoCA Blind|moca blind
67068|NCT03785431|STEMI|stemi
67069|NCT03785431|cardiovascular disease|cardiovascular disease
67070|NCT03785431|bioresorbable scaffold|bioresorbable scaffold
67071|NCT03785418|Atrial Fibrillation|atrial fibrillation
67072|NCT03785405|heart failure|heart failure
67073|NCT03785405|pediatric|pediatric
67074|NCT03785405|LCZ696|lcz696
67075|NCT03785405|sacubitril/valsartan|sacubitril/valsartan
67076|NCT03785405|open-label study|open-label study
67077|NCT03785405|angiotensin receptor neprilysin inhibitor|angiotensin receptor neprilysin inhibitor
67078|NCT03785379|Obesity|obesity
67079|NCT03785379|Lifestyle intervention|lifestyle intervention
67080|NCT03785353|Pain Neuroscience Education|pain neuroscience education
67081|NCT03785353|Spanish-speaking|spanish-speaking
67082|NCT03785340|Dry Eye Disease|dry eye disease
67083|NCT03785314|Optic Nerve Sheath Diameter Different Position|optic nerve sheath diameter different position
67084|NCT03785275|Glycemic control|glycemic control
67085|NCT03785249|KRAS|kras
67086|NCT03785249|NSCLC|nsclc
67087|NCT03785249|Colorectal Cancer|colorectal cancer
67088|NCT03785249|Colon Cancer|colon cancer
67089|NCT03785249|Metastatic Cancer|metastatic cancer
67090|NCT03785223|ADHD|adhd
67091|NCT03785223|Anxiety Disorders|anxiety disorders
67092|NCT03785223|Stimulants|stimulants
67093|NCT03785223|Methylphenidate|methylphenidate
67094|NCT03785210|Anticancer Activities|anticancer activities
67095|NCT03785210|Altering Gut Commensual Bacteria|altering gut commensual bacteria
67096|NCT03785210|Immunodulatory Effect|immunodulatory effect
67097|NCT03785210|Checkpoint Inhibition|checkpoint inhibition
67098|NCT03785197|fasting|fasting
67099|NCT03785197|natural therapies|natural therapies
67100|NCT03785197|prolonged fasting|prolonged fasting
67101|NCT03785184|Multiple Myeloma|multiple myeloma
67102|NCT03785184|Cancer|cancer
67103|NCT03785184|t(11;14)-Positive Multiple Myeloma|t(11;14)-positive multiple myeloma
67104|NCT03785184|Venetoclax|venetoclax
67105|NCT03785184|Lenalidomide|lenalidomide
67106|NCT03785158|Delirium|delirium
67235|NCT03784196|pain sensitivity|pain sensitivity
67107|NCT03785158|Elderly patients having non-cardiac surgery|elderly patients having non-cardiac surgery
67108|NCT03785158|Melatonin|melatonin
67109|NCT03785158|sleep quality|sleep quality
67110|NCT03785158|sleep deprivation|sleep deprivation
67111|NCT03785158|sleep-wake cycle|sleep-wake cycle
67112|NCT03785132|blood pressure|blood pressure
67113|NCT03785132|performance measurement|performance measurement
67114|NCT03785132|cardiac surgery|cardiac surgery
67115|NCT03785132|mortality|mortality
67116|NCT03785106|people living with HIV (PLHIV)|people living with hiv (plhiv)
67117|NCT03785093|Microbiota, Allergy, Growth, Development, offspring|microbiota, allergy, growth, development, offspring
67118|NCT03785080|gastrointestinal bleeding|gastrointestinal bleeding
67119|NCT03785080|stroke|stroke
67120|NCT03785080|thromboembolism|thromboembolism
67121|NCT03785080|atrial fibrillation|atrial fibrillation
67122|NCT03785080|NOAC|noac
67123|NCT03785067|TRIDENT|trident
67124|NCT03785041|Tramadol|tramadol
67125|NCT03785041|Intra-articular injection|intra-articular injection
67126|NCT03785041|Preemptive|preemptive
67127|NCT03785041|post-arthroscopy pain|post-arthroscopy pain
67128|NCT03785041|Levobupivacaine|levobupivacaine
67129|NCT03784963|Angiogenesis|angiogenesis
67130|NCT03784963|Inflammation|inflammation
67131|NCT03784963|Microbiome|microbiome
67132|NCT03784937|Wells Clinical score|wells clinical score
67133|NCT03784937|Thromboprophylaxis|thromboprophylaxis
67134|NCT03784924|Prostate cancer|prostate cancer
67135|NCT03784924|psa|psa
67136|NCT03784924|early detection|early detection
67137|NCT03784924|MRI|mri
67138|NCT03784911|Body Composition|body composition
67139|NCT03784911|SOZO|sozo
67140|NCT03784911|Cancer|cancer
67141|NCT03784911|Cancer Treatment|cancer treatment
67142|NCT03784911|Impedimed|impedimed
67143|NCT03784885|adjuvant|adjuvant
67144|NCT03784885|vaccine|vaccine
67145|NCT03784885|mucosa|mucosa
67146|NCT03784885|IgA|iga
67147|NCT03784885|Escherichia coli Enterotoxin|escherichia coli enterotoxin
67148|NCT03784833|heart failure|heart failure
67149|NCT03784820|Binge-Eating Disorder|binge-eating disorder
67150|NCT03784820|Eating disorders|eating disorders
67151|NCT03784820|Couple therapy|couple therapy
67152|NCT03784820|CBT|cbt
67153|NCT03784807|synovial fluid analysis|synovial fluid analysis
67154|NCT03784794|Post Partum Hemorrhage|post partum hemorrhage
67155|NCT03784794|Massive tranfusion|massive tranfusion
67156|NCT03784794|Thromboelastometry|thromboelastometry
67157|NCT03784781|Severe asthma in children|severe asthma in children
67158|NCT03784781|Type 2 innate lymphoid cells (ILC2)|type 2 innate lymphoid cells (ilc2)
67159|NCT03784781|bronchial mucosa|bronchial mucosa
67160|NCT03784781|bronchoalveolar lavages|bronchoalveolar lavages
67161|NCT03784768|Static balanced|static balanced
67162|NCT03784768|Dynamic balanced|dynamic balanced
67163|NCT03784768|Stroke|stroke
67164|NCT03784768|Rehabilitation|rehabilitation
67165|NCT03784768|Vibration|vibration
67166|NCT03784755|Oligometastatic Hormone|oligometastatic hormone
67167|NCT03784716|Fatty Liver|fatty liver
67168|NCT03784716|Liver Disease|liver disease
67169|NCT03784716|Ketogenic diet|ketogenic diet
67170|NCT03784716|Keto diet|keto diet
67171|NCT03784703|Adiponectin|adiponectin
67172|NCT03784703|Sortilin|sortilin
67173|NCT03784703|Leptin|leptin
67174|NCT03784703|Atherosclerosis|atherosclerosis
67175|NCT03784703|Diabetes type II|diabetes type ii
67176|NCT03784703|Rosuvastatin|rosuvastatin
67177|NCT03784703|Atorvastatin|atorvastatin
67178|NCT03784690|Hypotension|hypotension
67179|NCT03784690|Intraoperative blood pressure|intraoperative blood pressure
67180|NCT03784690|Cardiopulmonary bypass|cardiopulmonary bypass
67181|NCT03784690|Myocardial infarction|myocardial infarction
67182|NCT03784690|Acute kidney injury|acute kidney injury
67183|NCT03784638|trismus|trismus
67184|NCT03784638|pain|pain
67185|NCT03784638|edema|edema
67186|NCT03784638|flap design|flap design
67187|NCT03784625|metastatic melanoma|metastatic melanoma
67188|NCT03784625|targeted radionuclide therapy|targeted radionuclide therapy
67189|NCT03784612|Smartphone application|smartphone application
67190|NCT03784612|HbA1c|hba1c
67191|NCT03784612|Blood lipids|blood lipids
67192|NCT03784612|Dietary intake|dietary intake
67193|NCT03784586|Arrhythmias|arrhythmias
67194|NCT03784586|electrophisiological study|electrophisiological study
67195|NCT03784586|primary prevention|primary prevention
67196|NCT03784547|multiple sclerosis|multiple sclerosis
67197|NCT03784547|Latin america|latin america
67198|NCT03784534|EEG|eeg
67199|NCT03784534|Recovery|recovery
67200|NCT03784534|Motor|motor
67201|NCT03784521|SIRS|sirs
67202|NCT03784521|In-line filtration|in-line filtration
67203|NCT03784521|Cardiac surgery|cardiac surgery
67204|NCT03784508|morbid obesity|morbid obesity
67205|NCT03784508|bariatric surgery|bariatric surgery
67206|NCT03784508|psychological profile|psychological profile
67207|NCT03784482|Multiple Drug Hypersensitivity|multiple drug hypersensitivity
67208|NCT03784482|drug hypersensitivity|drug hypersensitivity
67209|NCT03784482|antibiotics|antibiotics
67210|NCT03784482|drug provocation tests|drug provocation tests
67211|NCT03784482|skin tests|skin tests
67212|NCT03784469|Transcatheter Arterial Chemoembolization|transcatheter arterial chemoembolization
67213|NCT03784469|position change|position change
67214|NCT03784469|back pain|back pain
67215|NCT03784443|Diabetes|diabetes
67216|NCT03784443|Eye|eye
67217|NCT03784443|Macular Oedema|macular oedema
67218|NCT03784443|Intravitreal Injection|intravitreal injection
67219|NCT03784443|Ranibizumab|ranibizumab
67220|NCT03784443|Fluocinolone Acetonide|fluocinolone acetonide
67221|NCT03784378|RXDX-105|rxdx-105
67222|NCT03784378|Memorial Sloan Kettering Cancer Center|memorial sloan kettering cancer center
67223|NCT03784378|18-487|18-487
67224|NCT03784365|oesophageal aperistalsis|oesophageal aperistalsis
67225|NCT03784339|Patellofemoral|patellofemoral
67226|NCT03784339|Knee|knee
67227|NCT03784313|Axillary Hidradenitis Suppurativa|axillary hidradenitis suppurativa
67228|NCT03784313|Perforator flaps|perforator flaps
67229|NCT03784313|Secondary intention wound healing|secondary intention wound healing
67230|NCT03784287|Sanfilippo Syndrome Type B|sanfilippo syndrome type b
67231|NCT03784196|WAD|wad
67232|NCT03784196|rehabilitation|rehabilitation
67233|NCT03784196|whiplash|whiplash
67234|NCT03784196|neck pain|neck pain
67236|NCT03784183|Alzheimer's Disease|alzheimer's disease
67237|NCT03784183|Mild Cognitive Stimulation|mild cognitive stimulation
67238|NCT03784183|Non Pharmacological Intervention|non pharmacological intervention
67239|NCT03784183|Cognitive Stimulation|cognitive stimulation
67240|NCT03784183|Transcranial Magnetic Stimulation|transcranial magnetic stimulation
67241|NCT03784183|Blink Reflex|blink reflex
87481|NCT03656133|HPV|hpv
67242|NCT03784183|Neuropsychological Evaluation|neuropsychological evaluation
67243|NCT03784183|Randomized Controlled Trial|randomized controlled trial
67244|NCT03784170|Overactive Bladder|overactive bladder
67245|NCT03784170|OAB|oab
67246|NCT03784170|Women|women
67247|NCT03784170|Neuromodulation|neuromodulation
67248|NCT03784170|Bioelectronic Medicine|bioelectronic medicine
67249|NCT03784157|Hysterotomy|hysterotomy
67250|NCT03784157|UTERINE MUSCLE CELLS|uterine muscle cells
67251|NCT03784157|ISCHEMIA|ischemia
67252|NCT03784157|COLD ISCHEMIA|cold ischemia
67253|NCT03784144|Muscle endurance|muscle endurance
67254|NCT03784144|Biering-Sorensen Test|biering-sorensen test
67255|NCT03784144|Prone Plank Test.|prone plank test.
67256|NCT03784144|Dual task|dual task
67257|NCT03784144|time to failure|time to failure
67258|NCT03784131|CVI|cvi
67259|NCT03784131|Leg Ulcer|leg ulcer
67260|NCT03784131|Tissue Engineering|tissue engineering
67261|NCT03784131|Personalized Vascular Graft|personalized vascular graft
67262|NCT03784131|Chronic Venous Insufficiency|chronic venous insufficiency
67263|NCT03784131|ATMP|atmp
67264|NCT03784105|codeine|codeine
67265|NCT03784105|Esophageal motility|esophageal motility
67266|NCT03784105|Pharyngeal motility|pharyngeal motility
67267|NCT03784079|HIV-1, Antiviral Effect, GSK3640254, Proof of Concept|hiv-1, antiviral effect, gsk3640254, proof of concept
67268|NCT03784066|squamous cell carcinoma|squamous cell carcinoma
67269|NCT03784053|Older adults|older adults
67270|NCT03784053|Virtual reality|virtual reality
67271|NCT03784053|Quality of life|quality of life
67272|NCT03784053|Occupation|occupation
67273|NCT03784040|Nivolumab|nivolumab
67274|NCT03784040|Ipilimumab|ipilimumab
67275|NCT03784040|OTSGC-A24|otsgc-a24
67276|NCT03784014|advanced disease|advanced disease
67277|NCT03784014|metastatic disease|metastatic disease
67278|NCT03784014|Next generation sequencing exome|next generation sequencing exome
67279|NCT03784001|Gratitude, Expectations|gratitude, expectations
67280|NCT03783975|Cascade|cascade
67281|NCT03783975|Screening|screening
67282|NCT03783975|Ethical|ethical
67283|NCT03783975|Legal|legal
67284|NCT03783975|Social|social
67285|NCT03783962|behavioral weight loss intervention, obesity|behavioral weight loss intervention, obesity
67286|NCT03783949|Ganetespib|ganetespib
67287|NCT03783949|Niraparib|niraparib
67288|NCT03783910|Chronic pain|chronic pain
67289|NCT03783897|OC DDI, drug-drug interaction, oral contraceptive|oc ddi, drug-drug interaction, oral contraceptive
67290|NCT03783884|VIDD|vidd
67291|NCT03783884|Diaphragm Atrophy|diaphragm atrophy
67292|NCT03783884|Weaning Failure|weaning failure
67293|NCT03783884|VLT|vlt
67294|NCT03783884|SBT|sbt
67295|NCT03783884|VILI|vili
67296|NCT03783884|Phrenic nerve stimulation|phrenic nerve stimulation
67297|NCT03783884|Maximal Inspiratory Pressure|maximal inspiratory pressure
67298|NCT03783871|HCC|hcc
67299|NCT03783819|Hypericum perforatum|hypericum perforatum
67300|NCT03783819|Saint John's Wort|saint john's wort
67301|NCT03783819|St. John's Wort|st. john's wort
67302|NCT03783806|hip, postural control, degenerative, inflammation|hip, postural control, degenerative, inflammation
67303|NCT03783793|mindfulness|mindfulness
67304|NCT03783793|attention|attention
67305|NCT03783793|mobile health|mobile health
67306|NCT03783793|interoception|interoception
67307|NCT03783793|mood|mood
67308|NCT03783767|school|school
67309|NCT03783767|intervention|intervention
67310|NCT03783767|physical literacy|physical literacy
67311|NCT03783767|peer mentor|peer mentor
67312|NCT03783767|leadership|leadership
67313|NCT03783767|motor skills|motor skills
67314|NCT03783767|physical activity|physical activity
67315|NCT03783741|Prostate cancer|prostate cancer
67316|NCT03783741|Biopsy|biopsy
67317|NCT03783676|extubation|extubation
67318|NCT03783624|hypnosis|hypnosis
67319|NCT03783624|open label placebo|open label placebo
67320|NCT03783624|neurocognitive measures|neurocognitive measures
67321|NCT03783624|stress|stress
67322|NCT03783624|induced pain|induced pain
67323|NCT03783624|HRV|hrv
67324|NCT03783598|Diabetes Mellitus|diabetes mellitus
67325|NCT03783598|Problem Solving|problem solving
67326|NCT03783598|Occupational Therapy|occupational therapy
67327|NCT03783598|Healthy Lifestyle|healthy lifestyle
67328|NCT03783598|Occupational Performance|occupational performance
67329|NCT03783598|Person-Centered|person-centered
67330|NCT03783598|Occupation Based|occupation based
67331|NCT03783572|Botulinum toxin|botulinum toxin
67332|NCT03783572|Cerebrovascular Accident|cerebrovascular accident
67333|NCT03783572|upper-limb movement|upper-limb movement
67334|NCT03783572|spastic cocontraction|spastic cocontraction
67335|NCT03783572|electromyography|electromyography
67336|NCT03783572|electroencephalography|electroencephalography
67337|NCT03783559|colorectal cancer liver metastasis|colorectal cancer liver metastasis
67338|NCT03783559|Transarterial chemoembolization|transarterial chemoembolization
67339|NCT03783559|conversion resection rates|conversion resection rates
67340|NCT03783559|chemotherapy|chemotherapy
67341|NCT03783546|Breast Cancer|breast cancer
67342|NCT03783520|root canal treatment|root canal treatment
67343|NCT03783520|intracanal irrigation|intracanal irrigation
67344|NCT03783520|Laser|laser
67345|NCT03783507|Energy Density|energy density
67346|NCT03783494|ED|ed
67347|NCT03783494|dislocation reduction|dislocation reduction
67348|NCT03783494|emergency department|emergency department
67349|NCT03783494|TCI|tci
67350|NCT03783494|Target-controlled infusion|target-controlled infusion
67351|NCT03783494|sedation|sedation
67352|NCT03783494|fracture reduction|fracture reduction
67353|NCT03783481|Breast cancer survivors|breast cancer survivors
67354|NCT03783481|mobile community|mobile community
67355|NCT03783481|distress|distress
67356|NCT03783455|Corticosteroid|corticosteroid
67357|NCT03783455|Hyaluronic acid|hyaluronic acid
67358|NCT03783455|Joint Lavage|joint lavage
67359|NCT03783429|Heart Failure|heart failure
67367|NCT03783338|Aerobic exercises|aerobic exercises
67369|NCT03783338|Cognition|cognition
67370|NCT03783338|Down syndrome|down syndrome
67371|NCT03783338|Physical performance|physical performance
67372|NCT03783338|Vitamin D|vitamin d
67378|NCT03783312|Electroconvulsive therapy|electroconvulsive therapy
67379|NCT03783312|Intravenous paracetamol|intravenous paracetamol
67380|NCT03783312|Intravenous ibuprofen|intravenous ibuprofen
67381|NCT03783312|Postoperative pain|postoperative pain
67382|NCT03783286|CF transmembrane conductance regulator|cf transmembrane conductance regulator
67383|NCT03783286|CFTR|cftr
67384|NCT03783286|Gating Mutations|gating mutations
67385|NCT03783273|Vitamin D Insufficiency|vitamin d insufficiency
67386|NCT03783273|Vitamin D Supplementation|vitamin d supplementation
67387|NCT03783273|Food Fortification|food fortification
67388|NCT03783260|Gut Microbiome|gut microbiome
67389|NCT03783260|Metabolites|metabolites
67390|NCT03783260|Endocannabinoid|endocannabinoid
67391|NCT03783260|Mediterranean diet|mediterranean diet
67392|NCT03783234|Emergency triage|emergency triage
67393|NCT03783221|meal ingestion|meal ingestion
67394|NCT03783221|diet|diet
67395|NCT03783221|postprandial responses|postprandial responses
67396|NCT03783221|hedonic sensations|hedonic sensations
67397|NCT03783221|homeostatic sensations|homeostatic sensations
67398|NCT03783221|intestinal gas production|intestinal gas production
67399|NCT03783208|Endometrium|endometrium
67400|NCT03783208|G-CSF|g-csf
67401|NCT03783208|Recurrent implantation failure|recurrent implantation failure
67402|NCT03783195|Glucose|glucose
67403|NCT03783195|Fructose|fructose
67404|NCT03783195|Fatty-liver|fatty-liver
67405|NCT03783195|Polymorphisms|polymorphisms
67406|NCT03783195|Imaging|imaging
67407|NCT03783195|Fibroscan|fibroscan
67408|NCT03783156|polypectomy snare|polypectomy snare
67409|NCT03783156|polypectomy complications|polypectomy complications
67414|NCT03783130|Human Immunodeficiency Virus|human immunodeficiency virus
67415|NCT03783130|Immune Response|immune response
67416|NCT03783130|Neutralizing Antibodies|neutralizing antibodies
67417|NCT03783130|HIV Prevention|hiv prevention
67418|NCT03783130|Cellular Immunogenicity|cellular immunogenicity
67419|NCT03783117|Hypertension|hypertension
67420|NCT03783104|Vitamin B12|vitamin b12
67421|NCT03783104|Maternal nutrition|maternal nutrition
67422|NCT03783104|Neurodevelopment|neurodevelopment
67423|NCT03783104|Supplementation|supplementation
67424|NCT03783078|programmed cell death receptor 1 (PD-1)|programmed cell death receptor 1 (pd-1)
67425|NCT03783078|programmed cell death ligand 1 (PD-L1)|programmed cell death ligand 1 (pd-l1)
67426|NCT03783078|anti-PD-1|anti-pd-1
67427|NCT03783078|anti-PD-L1|anti-pd-l1
67428|NCT03783078|Merkel cell carcinoma|merkel cell carcinoma
67429|NCT03783065|Variceal Rebleeding|variceal rebleeding
67430|NCT03783065|Hepatic venous pressure gradient|hepatic venous pressure gradient
67431|NCT03783065|Laparoscopic Therapy|laparoscopic therapy
67432|NCT03783065|Endoscopic Therapy|endoscopic therapy
67433|NCT03783039|bleeding|bleeding
67434|NCT03783039|broad area oozing bleeding|broad area oozing bleeding
67435|NCT03783039|hemostat|hemostat
67436|NCT03783039|topical hemostatic agents|topical hemostatic agents
67437|NCT03783039|adjunctive hemostats|adjunctive hemostats
67438|NCT03783026|Psoriatic Arthritis|psoriatic arthritis
67439|NCT03783026|CC-10004|cc-10004
67440|NCT03783026|MRI|mri
67441|NCT03783026|apremilast|apremilast
67442|NCT03782974|Protective Qi|protective qi
67443|NCT03782974|Immunity|immunity
67444|NCT03782948|gait training|gait training
67445|NCT03782948|dynamic balance|dynamic balance
67446|NCT03782948|gait symmetry|gait symmetry
67447|NCT03782948|rehabilitation robotics|rehabilitation robotics
67448|NCT03782935|alcohol|alcohol
67449|NCT03782935|pregnancy|pregnancy
67450|NCT03782935|infant|infant
67451|NCT03782922|exercise|exercise
67452|NCT03782922|anatomical|anatomical
67453|NCT03782922|mental|mental
67454|NCT03782922|training program|training program
67455|NCT03782909|Nutrition|nutrition
67456|NCT03782909|Weight|weight
87651|NCT03654924|LMA|lma
67457|NCT03782909|BMI|bmi
67458|NCT03782909|Behaviour change|behaviour change
67459|NCT03782870|granulomatosis with polyangitis, cardiac involvement|granulomatosis with polyangitis, cardiac involvement
67460|NCT03782831|Hepatocellular carcinoma|hepatocellular carcinoma
67561|NCT03782220|kinesio taping|kinesio taping
67461|NCT03782831|Programmed cell death protein-1 antibody|programmed cell death protein-1 antibody
67462|NCT03782831|Transarterial chemoembolization|transarterial chemoembolization
67463|NCT03782818|Pulmonary Arterial Hypertension|pulmonary arterial hypertension
67464|NCT03782818|PAH|pah
67465|NCT03782818|poly (ADP-ribose) polymerases inhibition|poly (adp-ribose) polymerases inhibition
67466|NCT03782818|PARP-1 inhibition|parp-1 inhibition
67467|NCT03782818|DNA damage|dna damage
67468|NCT03782818|Multicenter study|multicenter study
67469|NCT03782818|Olaparib|olaparib
67470|NCT03782818|Safety and efficacy|safety and efficacy
67471|NCT03782805|vitamin D, type 2 diabetes, inflammation|vitamin d, type 2 diabetes, inflammation
67472|NCT03782779|Respiratory physical therapy|respiratory physical therapy
67473|NCT03782766|Piezocision|piezocision
67474|NCT03782766|Temporary anchorage device|temporary anchorage device
67475|NCT03782766|molar protraction|molar protraction
67476|NCT03782753|Parkinson Disease|parkinson disease
67477|NCT03782753|LRRK2|lrrk2
67478|NCT03782727|skin cancer|skin cancer
67479|NCT03782727|surgery|surgery
67480|NCT03782727|ulcerated|ulcerated
67481|NCT03782727|infection|infection
67482|NCT03782714|Low-level laser therapy, pulpotomy, formocresol|low-level laser therapy, pulpotomy, formocresol
67483|NCT03782675|Total shoulder replacement|total shoulder replacement
67484|NCT03782675|operating room air|operating room air
67485|NCT03782675|surgical site infection|surgical site infection
67486|NCT03782675|airborne CFU|airborne cfu
67487|NCT03782649|Non-invasive glucose monitoring|non-invasive glucose monitoring
67488|NCT03782649|Raman spectroscopy|raman spectroscopy
67489|NCT03782610|Patent Ductus Arteriosus|patent ductus arteriosus
67490|NCT03782610|Preterm Infant|preterm infant
67491|NCT03782610|Echocardiogram|echocardiogram
67492|NCT03782610|Prospective Cohort|prospective cohort
67493|NCT03782610|Prediction Modeling|prediction modeling
67494|NCT03782597|Radicalization|radicalization
67495|NCT03782584|exercise|exercise
67497|NCT03782584|modified pilates|modified pilates
67498|NCT03782584|chronic neck pain|chronic neck pain
67499|NCT03782558|carpal tunnel syndrome|carpal tunnel syndrome
67500|NCT03782558|pBCTQ|pbctq
67501|NCT03782558|validation|validation
67502|NCT03782558|nerve conduction study|nerve conduction study
67503|NCT03782519|Incremental Hemodialysis|incremental hemodialysis
67504|NCT03782519|Nephrology|nephrology
67505|NCT03782506|music therapy|music therapy
67506|NCT03782506|pain management|pain management
67507|NCT03782506|opioid use|opioid use
67508|NCT03782506|cancer survivors|cancer survivors
67509|NCT03782454|Bacterial DNA clearance|bacterial dna clearance
67510|NCT03782454|Droplet digital PCR|droplet digital pcr
67511|NCT03782454|Betalactam antibiotics|betalactam antibiotics
67512|NCT03782454|Acute gastrointestinal index|acute gastrointestinal index
67513|NCT03782454|Cytokines|cytokines
67514|NCT03782441|Non-invasive glucose monitoring|non-invasive glucose monitoring
67515|NCT03782441|Raman spectroscopy|raman spectroscopy
67516|NCT03782415|ibudilast|ibudilast
67517|NCT03782415|MN-166|mn-166
67518|NCT03782415|GBM|gbm
67519|NCT03782415|glioblastoma|glioblastoma
67520|NCT03782415|recurrent GBM|recurrent gbm
67521|NCT03782415|temozolomide|temozolomide
67522|NCT03782389|Athlete|athlete
67523|NCT03782389|injury prevention|injury prevention
67524|NCT03782389|muscle strain|muscle strain
67525|NCT03782389|prediction|prediction
67526|NCT03782389|prognosis|prognosis
67527|NCT03782389|screening|screening
67528|NCT03782389|sport|sport
67529|NCT03782363|advanced sarcoma|advanced sarcoma
67530|NCT03782363|osteosarcoma|osteosarcoma
67531|NCT03782363|soft tissue sarcoma|soft tissue sarcoma
67532|NCT03782350|Tranexamic Acid|tranexamic acid
67533|NCT03782350|Antifibrinolytics|antifibrinolytics
67534|NCT03782350|Mortality and Morbidity|mortality and morbidity
67535|NCT03782350|Cardiac Surgery|cardiac surgery
67536|NCT03782350|Cardiopulmonary Bypass|cardiopulmonary bypass
67537|NCT03782337|Heart failure,|heart failure,
67538|NCT03782337|Cardiac biomarker|cardiac biomarker
67539|NCT03782337|Cardiopulmonary exercise test|cardiopulmonary exercise test
67540|NCT03782337|Multi-discipline disease management program|multi-discipline disease management program
67541|NCT03782337|Reverse remodeling|reverse remodeling
67542|NCT03782298|Dynomite|dynomite
67543|NCT03782298|Spyromite|spyromite
67544|NCT03782298|Raptormite|raptormite
67545|NCT03782298|Foot|foot
67546|NCT03782298|Ankle|ankle
67547|NCT03782298|Wrist|wrist
67548|NCT03782298|Hand|hand
67549|NCT03782298|Elbow|elbow
67550|NCT03782285|apical prolapse|apical prolapse
67551|NCT03782285|sacrospinous Ligament Fixation|sacrospinous ligament fixation
67552|NCT03782246|chronic pain|chronic pain
67553|NCT03782246|multiple sclerosis|multiple sclerosis
67554|NCT03782246|pain|pain
67555|NCT03782246|mindfulness|mindfulness
67556|NCT03782246|cognitive behavioral therapy|cognitive behavioral therapy
67557|NCT03782233|Neuromuscular Blockade|neuromuscular blockade
67558|NCT03782233|Gastrointestinal Barrier Function|gastrointestinal barrier function
67559|NCT03782220|somatosensory tinnitus|somatosensory tinnitus
67560|NCT03782220|neck pain|neck pain
67562|NCT03782194|Ultrasound|ultrasound
67563|NCT03782194|MRI|mri
67564|NCT03782194|Emotion|emotion
67565|NCT03782194|Reactivity|reactivity
67566|NCT03782194|Reappraisal|reappraisal
67567|NCT03782194|Cognitive Neural Prosthetic|cognitive neural prosthetic
67568|NCT03782155|wound healing, diabetes wound healing|wound healing, diabetes wound healing
67569|NCT03782129|diabetes mellitus|diabetes mellitus
67570|NCT03782129|diabetic foot|diabetic foot
67571|NCT03782129|mortality rate|mortality rate
67572|NCT03782129|diabetes complications|diabetes complications
67573|NCT03782064|Multiple Myeloma|multiple myeloma
67574|NCT03782051|Viscocanalostomy|viscocanalostomy
67575|NCT03782051|Ologen|ologen
67576|NCT03782051|glaucoma|glaucoma
67577|NCT03782051|phacoemulsification|phacoemulsification
67578|NCT03782038|Acne Scars|acne scars
67579|NCT03782038|Stretchmarks|stretchmarks
67580|NCT03782038|Surgical Scars|surgical scars
67581|NCT03782012|Reading Comprehension|reading comprehension
67582|NCT03782012|Adolescents|adolescents
67583|NCT03782012|Knowledge Availability and Accessibility|knowledge availability and accessibility
67584|NCT03782012|Inference Making|inference making
67585|NCT03781999|Performance|performance
67586|NCT03781999|Polyphenols|polyphenols
67587|NCT03781999|Nutrition|nutrition
67588|NCT03781999|Sports|sports
67589|NCT03781973|Transition to adult care|transition to adult care
67590|NCT03781973|Glycemic control|glycemic control
67591|NCT03781921|eating disorder|eating disorder
67592|NCT03781921|Electroencephalography|electroencephalography
67593|NCT03781921|emotion regulation|emotion regulation
67594|NCT03781921|emotion processing|emotion processing
67595|NCT03781921|negative urgency|negative urgency
67596|NCT03781895|COPD|copd
67597|NCT03781895|VitaminD3|vitamind3
67598|NCT03781895|6 Minute Walk Distance|6 minute walk distance
67599|NCT03781895|Modified BORG scale|modified borg scale
67600|NCT03781882|Platelet rich plasma|platelet rich plasma
67601|NCT03781882|disrupted wounds|disrupted wounds
67602|NCT03781882|Obstetrics and Gynecology|obstetrics and gynecology
67603|NCT03781869|Small Cell Lung Cancer; Anlotinib; Maintenance therapy|small cell lung cancer; anlotinib; maintenance therapy
67604|NCT03781856|childhood obesity|childhood obesity
67605|NCT03781856|intervention|intervention
67606|NCT03781856|community health workers|community health workers
67607|NCT03781856|community-based|community-based
67608|NCT03781843|Neuropathic Pain|neuropathic pain
67609|NCT03781843|Nerve block|nerve block
67610|NCT03781843|Knee osteoarthritis|knee osteoarthritis
67611|NCT03781830|mHealth|mhealth
67612|NCT03781830|liver transplantation|liver transplantation
67613|NCT03781830|medication adherence|medication adherence
67614|NCT03781830|video directly observed therapy|video directly observed therapy
67615|NCT03781817|procedural sedation|procedural sedation
67616|NCT03781817|ketamine|ketamine
67617|NCT03781817|pediatric|pediatric
67618|NCT03781817|fracture|fracture
67619|NCT03781817|intranasal|intranasal
67620|NCT03781817|intravenous|intravenous
67621|NCT03781817|emergency department|emergency department
67622|NCT03781778|Resistant Starch|resistant starch
67623|NCT03781778|Colorectal Cancer|colorectal cancer
67624|NCT03781778|Recurrence|recurrence
67625|NCT03781765|fMRI Study|fmri study
67626|NCT03781765|MPH|mph
67627|NCT03781765|Methylphenidate|methylphenidate
67628|NCT03781765|ATX|atx
67629|NCT03781765|Atomoxetine|atomoxetine
67630|NCT03781765|Reward System|reward system
67631|NCT03781765|Substance Abuse Risk|substance abuse risk
67632|NCT03781752|PK Study|pk study
67633|NCT03781752|PD Study|pd study
67634|NCT03781752|Pharmacokinetics|pharmacokinetics
67635|NCT03781752|Pharmacodynamics|pharmacodynamics
67636|NCT03781752|Methylphenidate|methylphenidate
67637|NCT03781752|MPH|mph
67638|NCT03781726|hemodialysis|hemodialysis
67639|NCT03781726|renal failure|renal failure
67640|NCT03781726|kidney transplant|kidney transplant
67641|NCT03781713|prospective|prospective
67642|NCT03781713|surveillance|surveillance
67643|NCT03781713|trigger|trigger
67644|NCT03781713|stabilization|stabilization
67645|NCT03781700|Children|children
67646|NCT03781700|Paediatric|paediatric
67647|NCT03781687|erector spinae plane block|erector spinae plane block
67648|NCT03781687|postoperative pain|postoperative pain
67649|NCT03781687|laparoscopic cholecystectomy|laparoscopic cholecystectomy
67650|NCT03781674|Preterm birth|preterm birth
67651|NCT03781674|Twin gestation|twin gestation
67652|NCT03781674|Vaginal progesterone|vaginal progesterone
67653|NCT03781661|Non coronary Chest Pain|non coronary chest pain
67654|NCT03781661|Extended Information|extended information
67655|NCT03781661|Normal Examination Result|normal examination result
67656|NCT03781661|Coronar Computed Tomography Angiography|coronar computed tomography angiography
67657|NCT03781661|CCTA|ccta
67658|NCT03781661|Calcium score|calcium score
67659|NCT03781661|Diagnostic Examination|diagnostic examination
67660|NCT03781661|Patient Satisfaction|patient satisfaction
67661|NCT03781661|Normal Coronary Arteries|normal coronary arteries
67662|NCT03781635|Ketamine|ketamine
67663|NCT03781635|anesthesia|anesthesia
67664|NCT03781635|BIS monitoring|bis monitoring
67665|NCT03781635|epidural|epidural
67666|NCT03781635|intraoperative|intraoperative
67667|NCT03781609|manual wheelchair|manual wheelchair
67668|NCT03781609|wheelchair propulsion|wheelchair propulsion
67669|NCT03781609|occupational therapy|occupational therapy
67670|NCT03781609|motor learning|motor learning
67671|NCT03781557|Omega-3|omega-3
67672|NCT03781557|DHA fatty acids|dha fatty acids
67673|NCT03781557|EPA fatty acids|epa fatty acids
67674|NCT03781557|Cognition|cognition
67675|NCT03781557|Brain|brain
67676|NCT03781557|Healthy Adult|healthy adult
67677|NCT03781557|Fish Oil|fish oil
67678|NCT03781557|Human|human
67679|NCT03781531|Occult cancer|occult cancer
67680|NCT03781531|Venous thromboembolism|venous thromboembolism
67681|NCT03781531|Biomarkers|biomarkers
67682|NCT03781531|Early diagnosis|early diagnosis
67683|NCT03781531|Neutrophil extracellular traps|neutrophil extracellular traps
67684|NCT03781479|Type 3|type 3
67685|NCT03781466|Preterm birth|preterm birth
67686|NCT03781466|Twin gestation|twin gestation
67687|NCT03781466|Vaginal progesterone|vaginal progesterone
67688|NCT03781466|cervical cerclage|cervical cerclage
67689|NCT03781427|Pacemaker|pacemaker
67690|NCT03781427|Cardiac resynchronization therapy|cardiac resynchronization therapy
67691|NCT03781414|Liver transplantation|liver transplantation
67692|NCT03781414|de novo recipients|de novo recipients
67693|NCT03781414|deceased donor|deceased donor
67694|NCT03781414|CFZ533|cfz533
67695|NCT03781414|CNI-free immunosuppression|cni-free immunosuppression
67696|NCT03781414|Transplant rejection|transplant rejection
67697|NCT03781388|Bupivacaine ED90|bupivacaine ed90
67698|NCT03781388|Cesarean Delivery|cesarean delivery
67699|NCT03781388|Obesity|obesity
67700|NCT03781388|Spinal Anesthesia|spinal anesthesia
67701|NCT03781362|Intravenous infusion|intravenous infusion
67702|NCT03781336|mindfulness|mindfulness
67703|NCT03781336|stress|stress
67704|NCT03781336|resilience building|resilience building
67705|NCT03781336|meditation|meditation
67706|NCT03781336|healthcare professionals|healthcare professionals
67707|NCT03781336|trainees|trainees
67708|NCT03781336|physicians|physicians
67709|NCT03781336|nurses|nurses
67710|NCT03781323|Advanced rectal cancer|advanced rectal cancer
67711|NCT03781323|FOLFOX (fluorouracil, leucovorin, oxaliplatin)|folfox (fluorouracil, leucovorin, oxaliplatin)
67712|NCT03781297|Homeless Populations|homeless populations
67713|NCT03781297|PTSD|ptsd
67714|NCT03781297|Narrative Exposure Therapy|narrative exposure therapy
67715|NCT03781297|Individual Therapy|individual therapy
67716|NCT03781297|Genealogy|genealogy
67717|NCT03781284|[18F]-FDG PET/MR enterography|[18f]-fdg pet/mr enterography
67718|NCT03781284|Diagnosis|diagnosis
67719|NCT03781271|Interstitial Brachytherapy|interstitial brachytherapy
67720|NCT03781271|Electromagnetic tracking|electromagnetic tracking
67721|NCT03781271|Implant quality|implant quality
67722|NCT03781271|Image guidance|image guidance
67723|NCT03781258|Mechanical circulatory support|mechanical circulatory support
67724|NCT03781258|Anti-thrombotic monotherapy|anti-thrombotic monotherapy
67725|NCT03781232|Non-invasive glucose monitoring|non-invasive glucose monitoring
67726|NCT03781232|Raman spectroscopy|raman spectroscopy
67727|NCT03781206|Stoma|stoma
67728|NCT03781206|Surgical Site Infection|surgical site infection
67729|NCT03781206|Negative Pressure Wound Therapy|negative pressure wound therapy
67730|NCT03781193|mindfulness|mindfulness
67731|NCT03781193|Psychological predictors|psychological predictors
67732|NCT03781193|Colorectal surgery|colorectal surgery
67733|NCT03781193|ERAS|eras
67734|NCT03781180|SIPT|sipt
67735|NCT03781180|Motor Accuracy|motor accuracy
67736|NCT03781180|Validity|validity
67737|NCT03781180|Reliability|reliability
67738|NCT03781154|Physical activity|physical activity
67739|NCT03781154|Survivors|survivors
67740|NCT03781154|Maintenance|maintenance
67741|NCT03781154|Personal Training|personal training
67742|NCT03781154|Group Mediated Cognitive Behavior|group mediated cognitive behavior
67743|NCT03781154|Randomized|randomized
67744|NCT03781128|lysergic acid diethylamide (LSD)|lysergic acid diethylamide (lsd)
67745|NCT03781128|serotonin|serotonin
67746|NCT03781128|hallucinogen|hallucinogen
67747|NCT03781128|cluster headache|cluster headache
67748|NCT03781115|schizophrenia, psychosis, ziprasidone, olanzapine|schizophrenia, psychosis, ziprasidone, olanzapine
67749|NCT03781102|Type 2 Diabetes|type 2 diabetes
67750|NCT03781102|Diabetes Prevention|diabetes prevention
67751|NCT03781102|Prediabetes Intervention|prediabetes intervention
67752|NCT03781102|Mothers|mothers
67753|NCT03781102|Children|children
67754|NCT03781102|Federally Qualified Health Center (FQHC) Program|federally qualified health center (fqhc) program
67755|NCT03781089|Hemodialysis|hemodialysis
67756|NCT03781076|Adolescence, Sleep|adolescence, sleep
67757|NCT03781063|Locally Advanced Breast Cancer|locally advanced breast cancer
67758|NCT03781063|Metastatic Breast Cancer|metastatic breast cancer
67759|NCT03781063|Lasofoxifene|lasofoxifene
67760|NCT03781063|Fulvestrant|fulvestrant
67761|NCT03781063|ER+/HER2|er+/her2
67762|NCT03781063|ESR1 mutation|esr1 mutation
67763|NCT03781050|Peutz-Jeghers Syndrome (PJS)|peutz-jeghers syndrome (pjs)
67764|NCT03781050|Rapamycin (sirolimus)|rapamycin (sirolimus)
67765|NCT03781050|Mammalian target of rapamycin (mTOR) inhibitor|mammalian target of rapamycin (mtor) inhibitor
67766|NCT03781050|Treatment|treatment
67767|NCT03781011|Gut microbiota|gut microbiota
67768|NCT03781011|Trimethylamine N-oxide|trimethylamine n-oxide
67769|NCT03781011|Oral carnitine challenge test|oral carnitine challenge test
67770|NCT03781011|Cardiovascular disease|cardiovascular disease
67771|NCT03780946|magnamosis; magnetic anastomosis; pancreaticojejunostomy|magnamosis; magnetic anastomosis; pancreaticojejunostomy
67772|NCT03780907|Epilepsy|epilepsy
67773|NCT03780907|E2007|e2007
67774|NCT03780907|partial seizures|partial seizures
67775|NCT03780907|generalized seizures|generalized seizures
67776|NCT03780894|Polytrauma|polytrauma
67777|NCT03780894|Red blood cells transfusion|red blood cells transfusion
67778|NCT03780894|Acute traumatic hemorrhage|acute traumatic hemorrhage
67779|NCT03780868|External DCR, canalicular silicone intubation, Mitomycin C|external dcr, canalicular silicone intubation, mitomycin c
67780|NCT03780855|scaffold|scaffold
67781|NCT03780855|Peripheral nerve injures|peripheral nerve injures
67782|NCT03780855|repair|repair
67783|NCT03780855|safety|safety
67784|NCT03780855|effectiveness|effectiveness
67785|NCT03780829|spinal cord injury|spinal cord injury
67786|NCT03780829|hypoxia|hypoxia
67787|NCT03780829|plasticity|plasticity
67788|NCT03780803|cardiac rehabilitation|cardiac rehabilitation
67789|NCT03780803|pulmonary rehabilitation|pulmonary rehabilitation
67790|NCT03780790|quadratus lumborum block|quadratus lumborum block
67791|NCT03780790|transversus abdominis plane block|transversus abdominis plane block
67792|NCT03780790|caudal block|caudal block
67793|NCT03780790|ultrasound-guided|ultrasound-guided
67794|NCT03780777|older adult falls|older adult falls
67795|NCT03780777|home hazards|home hazards
67796|NCT03780777|home barriers|home barriers
67797|NCT03780764|Pulpal blood flow|pulpal blood flow
67798|NCT03780764|self ligating brackets|self ligating brackets
67799|NCT03780764|orthodontics|orthodontics
67800|NCT03780751|Sexual dysfunction|sexual dysfunction
67801|NCT03780751|Female Sexual Interest/Arousal Disorder|female sexual interest/arousal disorder
67802|NCT03780751|Internet-based intervention|internet-based intervention
67803|NCT03780751|Mindfulness|mindfulness
67804|NCT03780751|Cognitive-behavioral therapy|cognitive-behavioral therapy
67805|NCT03780738|Aortic dissection|aortic dissection
67806|NCT03780738|Aldehyde dehydrogenase 2 polymorphism|aldehyde dehydrogenase 2 polymorphism
67807|NCT03780686|Restrictive hydration,|restrictive hydration,
67808|NCT03780686|Dopamine,|dopamine,
67809|NCT03780686|Norepinephrine,|norepinephrine,
67810|NCT03780686|Serum lactate,|serum lactate,
67811|NCT03780686|Standard hydration|standard hydration
67812|NCT03780660|Volume expansion|volume expansion
67813|NCT03780660|fluid responsiveness|fluid responsiveness
67814|NCT03780660|critically ill patient|critically ill patient
67815|NCT03780660|spontaneously breathing patient|spontaneously breathing patient
67816|NCT03780660|central venous pressure variation|central venous pressure variation
67817|NCT03780647|Thoracic outlet syndrome|thoracic outlet syndrome
67818|NCT03780647|Performance at work|performance at work
67819|NCT03780634|Hepatocellular Carcinoma|hepatocellular carcinoma
67820|NCT03780634|Hepatic arterial infusion chemotherapy|hepatic arterial infusion chemotherapy
67821|NCT03780634|Programmed cell death protein-1 antibody|programmed cell death protein-1 antibody
67822|NCT03780634|Oxaliplatin, 5-Fluorouracil and Leucovorin|oxaliplatin, 5-fluorouracil and leucovorin
67823|NCT03780621|Electroencephalography|electroencephalography
67824|NCT03780621|Andrographis|andrographis
67825|NCT03780621|Ashwagandha|ashwagandha
67826|NCT03780595|Benzodiazepine|benzodiazepine
67827|NCT03780595|Withdrawal|withdrawal
67828|NCT03780595|passiflora|passiflora
67830|NCT03780569|TTFields|ttfields
67831|NCT03780569|Tumor Treating Fields|tumor treating fields
67832|NCT03780569|Glioblastoma|glioblastoma
67833|NCT03780569|Glioblastoma Multiforme|glioblastoma multiforme
67834|NCT03780556|Renal pain|renal pain
67835|NCT03780556|lornoxicam|lornoxicam
67836|NCT03780556|pethidine|pethidine
67837|NCT03780556|emergency room|emergency room
67838|NCT03780556|ketamine|ketamine
67839|NCT03780543|CHB|chb
67840|NCT03780543|HBV|hbv
67841|NCT03780543|HBeAg positive|hbeag positive
67842|NCT03780543|HBeAg negative|hbeag negative
67843|NCT03780543|hepatitis B|hepatitis b
67844|NCT03780543|hepatitis B virus|hepatitis b virus
67845|NCT03780543|SVR|svr
67846|NCT03780517|BOS172738|bos172738
67847|NCT03780517|RET gene|ret gene
67848|NCT03780517|Medullary Thyroid Cancer|medullary thyroid cancer
67849|NCT03780517|Non-Small Cell Lung Cancer|non-small cell lung cancer
67850|NCT03780452|intramedullary nail|intramedullary nail
67851|NCT03780452|arthrodesis|arthrodesis
67852|NCT03780452|subtalar|subtalar
67853|NCT03780452|tibiotalar|tibiotalar
67854|NCT03780439|procalcitonin|procalcitonin
67855|NCT03780439|infection|infection
67856|NCT03780439|gastric cancer|gastric cancer
67857|NCT03780439|gastrectomy|gastrectomy
67858|NCT03780400|Osteoarthritis|osteoarthritis
67859|NCT03780400|Knee Osteoarthritis|knee osteoarthritis
67860|NCT03780400|Hip Osteoarthritis|hip osteoarthritis
67861|NCT03780387|Felis Catus (cat)|felis catus (cat)
67862|NCT03780361|soluble CD14|soluble cd14
67863|NCT03780361|MCP-1|mcp-1
67864|NCT03780361|IL-6|il-6
67865|NCT03780361|ICAM-1|icam-1
67866|NCT03780361|cytokine|cytokine
67867|NCT03780361|visual acuity|visual acuity
67868|NCT03780361|optical coherence tomography|optical coherence tomography
67869|NCT03780361|macular thickness|macular thickness
67870|NCT03780361|hyperreflective foci|hyperreflective foci
67871|NCT03780348|Weigh-for-Height/Length|weigh-for-height/length
67872|NCT03780348|Assessment|assessment
67873|NCT03780335|STEMI|stemi
67874|NCT03780335|Cardiac magnetic resonance|cardiac magnetic resonance
67875|NCT03780322|brachial plexus birth palsy|brachial plexus birth palsy
67876|NCT03780322|Armeo®Spring Pediatric|armeo®spring pediatric
67877|NCT03780322|physical therapy|physical therapy
67878|NCT03780309|antihypertensive lifestyle therapy|antihypertensive lifestyle therapy
67879|NCT03780309|positive outcome expectations|positive outcome expectations
67880|NCT03780309|postexercise hypotension|postexercise hypotension
67881|NCT03780309|self-efficacy|self-efficacy
67882|NCT03780309|self-management|self-management
67883|NCT03780296|Kinect|kinect
67884|NCT03780296|Rehabilitation|rehabilitation
67885|NCT03780296|Virtual reality|virtual reality
67886|NCT03780296|Mirror therapy|mirror therapy
67887|NCT03780283|SCLC|sclc
67888|NCT03780283|maintenance|maintenance
67889|NCT03780283|Anlotinib|anlotinib
67890|NCT03780257|Retinitis Pigmentosa|retinitis pigmentosa
67891|NCT03780257|USH2A|ush2a
67892|NCT03780257|RP|rp
67893|NCT03780257|exon 13|exon 13
67894|NCT03780257|RNA therapies|rna therapies
67895|NCT03780257|antisense oligonucleotide|antisense oligonucleotide
67896|NCT03780257|exon skipping|exon skipping
67897|NCT03780257|STELLAR|stellar
67898|NCT03780257|IVT|ivt
67899|NCT03780257|mutations in exon 13 of the USH2A gene|mutations in exon 13 of the ush2a gene
67900|NCT03780257|NSRP|nsrp
67901|NCT03780231|Athletes|athletes
67902|NCT03780231|Late gadolinium enhancement|late gadolinium enhancement
67903|NCT03780231|fibrosis|fibrosis
67904|NCT03780218|Burn Injury|burn injury
67905|NCT03780218|Pulmonary function|pulmonary function
67906|NCT03780218|Respiratory muscle|respiratory muscle
67907|NCT03780218|Peripheral muscle|peripheral muscle
67908|NCT03780205|Amblyopia|amblyopia
67909|NCT03780179|measles-mumps-rubella vaccine|measles-mumps-rubella vaccine
67910|NCT03780166|Pemphigus vulgaris|pemphigus vulgaris
67911|NCT03780166|phosphatidylinositol 3-kinase delta|phosphatidylinositol 3-kinase delta
67912|NCT03780166|immunoglobulin G autoantibodies|immunoglobulin g autoantibodies
67913|NCT03780140|S-649266|s-649266
67914|NCT03780140|cefiderocol|cefiderocol
67915|NCT03780140|Gram-negative|gram-negative
67916|NCT03780062|S100B protein|s100b protein
67917|NCT03780062|minor traumatic brain injuries|minor traumatic brain injuries
67918|NCT03780062|antiplatelet therapy|antiplatelet therapy
67919|NCT03780049|Hepatocellular Carcinoma|hepatocellular carcinoma
67920|NCT03780049|Hepatic artery infusion chemotherapy|hepatic artery infusion chemotherapy
67921|NCT03780049|Oxaliplatin, 5-fluorouracil and leucovorin|oxaliplatin, 5-fluorouracil and leucovorin
67922|NCT03780049|Recombinant Human Type-5 Adenovirus|recombinant human type-5 adenovirus
67923|NCT03779997|Buprenorphine|buprenorphine
67924|NCT03779997|Directly Observed Therapy|directly observed therapy
67925|NCT03779997|mHealth|mhealth
67926|NCT03779997|Opioid Abuse|opioid abuse
67927|NCT03779945|PRP|prp
67928|NCT03779906|hypothyroidism|hypothyroidism
67929|NCT03779906|ISOVUE|isovue
67930|NCT03779906|Iodinated Contrast Agent|iodinated contrast agent
67931|NCT03779880|Parkinson Disease, Early Retirement,|parkinson disease, early retirement,
67932|NCT03779828|CIDP|cidp
67933|NCT03779828|telemonitoring|telemonitoring
67934|NCT03779828|telemedicine|telemedicine
67935|NCT03779815|multiple myeloma|multiple myeloma
67936|NCT03779815|amyloidosis|amyloidosis
67937|NCT03779815|Florbetaben|florbetaben
67938|NCT03779802|Cardiac Resynchronization Therapy|cardiac resynchronization therapy
67939|NCT03779802|Atrioventricular delay optimization|atrioventricular delay optimization
67940|NCT03779802|Multipoint pacing|multipoint pacing
818958|NCT00163423|Ciclesonide|ciclesonide
67941|NCT03779802|Negative atrioventricular hysteresis|negative atrioventricular hysteresis
67942|NCT03779802|Non invasive hemodynamic optimization|non invasive hemodynamic optimization
67943|NCT03779802|Heart Failure|heart failure
67944|NCT03779789|vortioxetine|vortioxetine
67945|NCT03779789|SSRI|ssri
67946|NCT03779789|depression|depression
67947|NCT03779789|elderly|elderly
67948|NCT03779724|multiple sclerosis|multiple sclerosis
67949|NCT03779724|isokinetic|isokinetic
67950|NCT03779724|exercises|exercises
67951|NCT03779724|joint position sense|joint position sense
67952|NCT03779724|kinesiophobia|kinesiophobia
67953|NCT03779711|Hypoplastic Left Heart Syndrome|hypoplastic left heart syndrome
67954|NCT03779711|HLHS|hlhs
67955|NCT03779711|Congenital Heart Disease|congenital heart disease
67956|NCT03779711|Umbilical Cord Blood|umbilical cord blood
67957|NCT03779711|UCB|ucb
67958|NCT03779711|Cord blood|cord blood
67959|NCT03779711|Stem cells|stem cells
67960|NCT03779711|Regenerative therapy|regenerative therapy
67961|NCT03779711|Stage II Glenn|stage ii glenn
67962|NCT03779711|Glenn Surgery|glenn surgery
67963|NCT03779711|single ventricle|single ventricle
67964|NCT03779698|BiodentineTM|biodentinetm
67965|NCT03779698|Formocresol|formocresol
67966|NCT03779698|Primary molars|primary molars
67967|NCT03779698|Pulpotomy|pulpotomy
67968|NCT03779672|Memantine|memantine
67969|NCT03779672|N-methyl-D-aspartate receptor|n-methyl-d-aspartate receptor
67970|NCT03779672|Serum inflammatory|serum inflammatory
67971|NCT03779672|Seizure|seizure
67972|NCT03779659|Electronic dental anesthesia|electronic dental anesthesia
67973|NCT03779659|Transcutaneous Electronic Nerve Stimulation (TENS)|transcutaneous electronic nerve stimulation (tens)
67974|NCT03779659|Topical anesthesia|topical anesthesia
67975|NCT03779659|Analgesia|analgesia
67976|NCT03779646|Duchenne muscular dystrophy|duchenne muscular dystrophy
67977|NCT03779646|Early cardiomyopathy|early cardiomyopathy
67978|NCT03779646|bisoprolol|bisoprolol
67979|NCT03779633|Local Oestrogen|local oestrogen
67980|NCT03779620|symptomatic|symptomatic
67981|NCT03779620|aortic valve|aortic valve
67982|NCT03779620|stenosis|stenosis
67983|NCT03779620|ultrasound|ultrasound
67984|NCT03779620|non-invasive|non-invasive
67985|NCT03779594|NPH|nph
67986|NCT03779594|Acetazolamide|acetazolamide
67987|NCT03779542|anterior chamber parameters|anterior chamber parameters
67988|NCT03779542|phacoemulsification|phacoemulsification
67989|NCT03779542|anterior segment swept-source optical coherence tomography|anterior segment swept-source optical coherence tomography
67990|NCT03779529|olive oil|olive oil
67991|NCT03779529|hemodialysis|hemodialysis
67993|NCT03779490|Edwards Cardioband TR|edwards cardioband tr
67994|NCT03779490|Annuloplasty|annuloplasty
67995|NCT03779490|Tricuspid Repair|tricuspid repair
67996|NCT03779490|Tricuspid Valve|tricuspid valve
67997|NCT03779477|Depression|depression
67998|NCT03779477|High-Risk|high-risk
67999|NCT03779477|Adolescent|adolescent
68000|NCT03779477|fMRI|fmri
68001|NCT03779464|pancreatic cancer|pancreatic cancer
68002|NCT03779464|nab-paclitaxel|nab-paclitaxel
68003|NCT03779464|gemcitabine|gemcitabine
68004|NCT03779464|S1|s1
68005|NCT03779451|cesarean section|cesarean section
68006|NCT03779451|placenta previa|placenta previa
68007|NCT03779451|antepartum hemorrhage|antepartum hemorrhage
68008|NCT03779451|vaginal progesterone|vaginal progesterone
68009|NCT03779451|17-Alpha-Hydroxyprogesterone Caproate|17-alpha-hydroxyprogesterone caproate
68010|NCT03779438|cesarean section|cesarean section
68011|NCT03779438|placenta previa|placenta previa
68012|NCT03779438|antepartum hemorrhage|antepartum hemorrhage
68013|NCT03779438|17-alpha-Hydroxyprogesterone caproate|17-alpha-hydroxyprogesterone caproate
68014|NCT03779399|Ovarian Cancer|ovarian cancer
68015|NCT03779399|Borderline Ovarian Tumor|borderline ovarian tumor
68016|NCT03779399|Benign Ovarian Tumor|benign ovarian tumor
68017|NCT03779399|lymphocyte T regulatory|lymphocyte t regulatory
68018|NCT03779399|Natural Killer T cell|natural killer t cell
68019|NCT03779399|ROMA|roma
68020|NCT03779399|HE4|he4
68021|NCT03779347|pregnancy, UPC-LF CAA, Schistosomiasis, children|pregnancy, upc-lf caa, schistosomiasis, children
68022|NCT03779321|food, acceptability, appetite, hormones, ghrelin, GLP-1|food, acceptability, appetite, hormones, ghrelin, glp-1
68023|NCT03779308|whole body vibration therapy|whole body vibration therapy
68024|NCT03779308|cerebral palsy|cerebral palsy
68025|NCT03779308|dystonia|dystonia
68026|NCT03779308|functional abilities|functional abilities
68027|NCT03779308|tone abnormalities|tone abnormalities
68028|NCT03779295|perioral dermatitis|perioral dermatitis
68029|NCT03779295|laser therapy|laser therapy
68030|NCT03779256|Deep infiltrating endometriosis|deep infiltrating endometriosis
68031|NCT03779256|Transvaginal ultrasound|transvaginal ultrasound
68032|NCT03779256|Endometriosis rectum|endometriosis rectum
68033|NCT03779256|Conservative surgery|conservative surgery
68034|NCT03779256|Radical surgery|radical surgery
68035|NCT03779256|Quality of life|quality of life
68036|NCT03779204|Social Isolation|social isolation
68037|NCT03779204|Self-Esteem|self-esteem
88404|NCT03650920|HCV|hcv
68038|NCT03779204|Hope|hope
68039|NCT03779204|Psychiatric Problem|psychiatric problem
68040|NCT03779204|Education|education
68041|NCT03779204|Employment|employment
68042|NCT03779204|Income|income
68043|NCT03779204|Housing Problems|housing problems
68044|NCT03779204|Identity, Social|identity, social
68045|NCT03779204|Youth|youth
68046|NCT03779204|Rent Subsidy|rent subsidy
68047|NCT03779204|Mentorship|mentorship
68048|NCT03779178|landiolol|landiolol
68049|NCT03779178|microcirculation|microcirculation
68050|NCT03779178|cardiac surgery|cardiac surgery
68051|NCT03779178|atrial fibrillation|atrial fibrillation
68052|NCT03779165|ventricular tachycardia|ventricular tachycardia
68053|NCT03779165|R wave; sensing|r wave; sensing
68054|NCT03779165|radiofrequency ablation|radiofrequency ablation
68055|NCT03779165|follow-up|follow-up
68056|NCT03779139|total pancreatectomy with islet autotransplant|total pancreatectomy with islet autotransplant
68057|NCT03779126|Chronic Kidney Disease|chronic kidney disease
68058|NCT03779126|Electrical stimulation|electrical stimulation
68059|NCT03779113|lymphoma|lymphoma
68060|NCT03779113|mantle cell|mantle cell
68061|NCT03779113|marginal zone|marginal zone
68062|NCT03779113|waldenstrom|waldenstrom
68063|NCT03779113|chronic lymphocytic leukemia|chronic lymphocytic leukemia
68064|NCT03779113|follicular|follicular
68065|NCT03779100|intrahepatic cholangiocarcinoma|intrahepatic cholangiocarcinoma
68066|NCT03779100|Lenvatinib|lenvatinib
68067|NCT03779100|PD-1 Antibody|pd-1 antibody
68068|NCT03779087|Helicobacter pylori|helicobacter pylori
68069|NCT03779087|Eradication rate|eradication rate
68070|NCT03779087|Rescue treatment|rescue treatment
68071|NCT03779074|Helicobacter pylori|helicobacter pylori
68072|NCT03779074|Eradication rate|eradication rate
68073|NCT03779048|phentermine|phentermine
68074|NCT03779048|Hypoglycemic agents|hypoglycemic agents
68075|NCT03779048|Incretins|incretins
68076|NCT03779048|Hormones|hormones
68077|NCT03779048|Appetitive Behavior|appetitive behavior
68078|NCT03779048|Appetite Depressants|appetite depressants
68079|NCT03779048|Anti-Obesity Agents|anti-obesity agents
68080|NCT03779048|Weight Loss|weight loss
68081|NCT03779048|Body Weight|body weight
68082|NCT03779048|Body Weight Changes|body weight changes
68083|NCT03779048|Signs and Symptoms|signs and symptoms
68084|NCT03779035|adjuvant chemotherapy|adjuvant chemotherapy
68085|NCT03779035|cholangiocarcinoma|cholangiocarcinoma
68086|NCT03779035|invasive gall bladder carcinoma|invasive gall bladder carcinoma
68087|NCT03779035|overall survival|overall survival
68088|NCT03779035|disease free survival|disease free survival
68089|NCT03779035|Gemcitabine|gemcitabine
68090|NCT03779035|Capecitabine|capecitabine
68091|NCT03779022|breast cancer|breast cancer
68092|NCT03779022|biomarker|biomarker
68093|NCT03779022|neoadjuvant treatment|neoadjuvant treatment
68094|NCT03779022|microRNA|microrna
68095|NCT03779022|response|response
68096|NCT03778996|Ewing's Sarcoma|ewing's sarcoma
68097|NCT03778996|Locally advanced sarcoma|locally advanced sarcoma
68098|NCT03778996|Metastatic sarcoma|metastatic sarcoma
68099|NCT03778996|SM-88|sm-88
68100|NCT03778996|D.L-alpha-metyrosine|d.l-alpha-metyrosine
68101|NCT03778983|Cognitive Development|cognitive development
68102|NCT03778983|Pediatric Live Transplantation|pediatric live transplantation
68103|NCT03778957|Hepatocellular Carcinoma|hepatocellular carcinoma
68104|NCT03778957|TACE|tace
68105|NCT03778957|Durvalumab|durvalumab
68106|NCT03778957|Bevacizumab|bevacizumab
68107|NCT03778957|Liver Cancer|liver cancer
68108|NCT03778944|Mannitol|mannitol
68109|NCT03778944|Dopamine|dopamine
68110|NCT03778944|Perfusion|perfusion
68111|NCT03778944|Renal graft donor|renal graft donor
68112|NCT03778944|Anesthesia|anesthesia
68113|NCT03778918|REG3 alpha|reg3 alpha
68114|NCT03778918|IBD|ibd
68115|NCT03778918|biomarker|biomarker
68116|NCT03778918|ulcerative colitis|ulcerative colitis
68117|NCT03778918|serum calprotectin|serum calprotectin
68118|NCT03778892|PrEP adherence|prep adherence
68119|NCT03778892|Youth|youth
68120|NCT03778892|Adolescents|adolescents
68121|NCT03778892|MSM|msm
68122|NCT03778892|HIV Prevention|hiv prevention
68123|NCT03778892|Mobile Health|mobile health
68124|NCT03778879|Adenocarcinoma|adenocarcinoma
68125|NCT03778879|Pancreas|pancreas
68126|NCT03778879|Radiation Therapy|radiation therapy
68127|NCT03778879|CCX872-B|ccx872-b
68128|NCT03778853|Non-squamous NSCLC|non-squamous nsclc
68129|NCT03778840|Infections|infections
68130|NCT03778840|immunoglobulins|immunoglobulins
68131|NCT03778840|secondary immunodeficiency|secondary immunodeficiency
68132|NCT03778840|rituximab|rituximab
68133|NCT03778827|Pivotal Response Treatment|pivotal response treatment
68134|NCT03778814|Lung Cancer; Solid Tumor|lung cancer; solid tumor
68135|NCT03778814|Immunotherapy|immunotherapy
68136|NCT03778814|TCR-T Cell Therapy|tcr-t cell therapy
68137|NCT03778801|kinesiophobia|kinesiophobia
68138|NCT03778801|physical activity|physical activity
68139|NCT03778801|disability|disability
68140|NCT03778788|life style modification program|life style modification program
68141|NCT03778788|mobile application|mobile application
68142|NCT03778788|booklet|booklet
68143|NCT03778788|exercise|exercise
68144|NCT03778788|body weight|body weight
68145|NCT03778788|randomized control trial|randomized control trial
68146|NCT03778788|metabolic syndrome|metabolic syndrome
68147|NCT03778788|adult|adult
68148|NCT03778775|Transient elastography|transient elastography
68149|NCT03778775|Gastroesophageal varices bleeding|gastroesophageal varices bleeding
68150|NCT03778775|Varices needing treatment|varices needing treatment
68151|NCT03778762|air-Q, blind intubation, correction maneuvers, fiberoptic guided intubation|air-q, blind intubation, correction maneuvers, fiberoptic guided intubation
68152|NCT03778749|train-of-four monitoring|train-of-four monitoring
68153|NCT03778749|acceleromyography|acceleromyography
68154|NCT03778749|electromyography|electromyography
68155|NCT03778749|intensive care unit|intensive care unit
68163|NCT03778658|Psychosocial Health|psychosocial health
68164|NCT03778645|Adrenal venous sampling|adrenal venous sampling
68165|NCT03778645|Hyperaldosteronism|hyperaldosteronism
68167|NCT03778645|Antecubital approach|antecubital approach
68168|NCT03778632|Stuttering|stuttering
68169|NCT03778632|School-age|school-age
68170|NCT03778632|Emotional reactivity|emotional reactivity
68171|NCT03778632|Wearable technology|wearable technology
68172|NCT03778606|Clostridium difficile|clostridium difficile
68173|NCT03778606|Asymptomatic carrier|asymptomatic carrier
68174|NCT03778606|Potato starch|potato starch
68175|NCT03778606|Non digestable oligosaccharide|non digestable oligosaccharide
68176|NCT03778593|biliary tract carcinoma|biliary tract carcinoma
68177|NCT03778593|5-FU|5-fu
68178|NCT03778593|Irinotecan|irinotecan
68179|NCT03778593|oxaliplatin|oxaliplatin
68180|NCT03778580|Vitamin B6|vitamin b6
68181|NCT03778580|Diabetes|diabetes
68182|NCT03778567|chronic hepatitis B infection|chronic hepatitis b infection
68183|NCT03778567|telbivudine|telbivudine
68184|NCT03778567|chronic kidney disease|chronic kidney disease
68185|NCT03778567|nucleotide analogue|nucleotide analogue
68186|NCT03778515|Axial|axial
68187|NCT03778515|Spondyloarthritis|spondyloarthritis
68188|NCT03778515|MRI|mri
68189|NCT03778515|Ankylosing Spondylitis|ankylosing spondylitis
68190|NCT03778489|Pannexin-1 channel|pannexin-1 channel
68191|NCT03778476|Exercise|exercise
68192|NCT03778476|pain sensitivity|pain sensitivity
68193|NCT03778476|fibromyalgia|fibromyalgia
68194|NCT03778424|Central Nervous System|central nervous system
68195|NCT03778424|E2080|e2080
68196|NCT03778424|Rufinamide|rufinamide
68197|NCT03778424|Epilepsy|epilepsy
68198|NCT03778424|Seizures|seizures
68199|NCT03778424|Brain Diseases|brain diseases
68200|NCT03778398|music therapy|music therapy
68201|NCT03778398|cerebral palsy|cerebral palsy
68202|NCT03778398|piano training|piano training
68203|NCT03778385|Fibromyalgia|fibromyalgia
68204|NCT03778385|Exercise|exercise
68205|NCT03778385|Pain|pain
68206|NCT03778385|Physical Activity|physical activity
68207|NCT03778385|Body Composition|body composition
68208|NCT03778333|Mesenchymal Stem Cells|mesenchymal stem cells
68209|NCT03778333|Multiple Sclerosis|multiple sclerosis
68210|NCT03778307|Trauma|trauma
68211|NCT03778307|PTSD|ptsd
68212|NCT03778307|Endothelial Dysfunction|endothelial dysfunction
68213|NCT03778281|Baclofen|baclofen
68214|NCT03778281|Chemotheropy|chemotheropy
68215|NCT03778268|Sentinel Lymph Node Biopsy|sentinel lymph node biopsy
68216|NCT03778255|Sentinel Lymph Node Biopsy|sentinel lymph node biopsy
68217|NCT03778242|cesarean section|cesarean section
68218|NCT03778242|tranexamic acid|tranexamic acid
68219|NCT03778242|postpartum hemorrhage|postpartum hemorrhage
68220|NCT03778242|oxytocin|oxytocin
68229|NCT03778203|Immunology|immunology
68230|NCT03778203|Inactivated influenza vaccine|inactivated influenza vaccine
68231|NCT03778203|Influenza infection|influenza infection
68232|NCT03778203|Host response|host response
68233|NCT03778203|Pediatrics|pediatrics
68234|NCT03778177|transcranial electrical stimulation (tES)|transcranial electrical stimulation (tes)
68235|NCT03778138|Advanced nonsquamous Non-Small Cell Lung Cancer|advanced nonsquamous non-small cell lung cancer
68236|NCT03778138|Anlotinib Combined With Pemetrexed|anlotinib combined with pemetrexed
68237|NCT03778125|multidrug resistant|multidrug resistant
68238|NCT03778112|Prostate Cancer|prostate cancer
68239|NCT03778112|Radiotherapy|radiotherapy
68240|NCT03778112|SBRT|sbrt
68241|NCT03778112|Stereotactic Body Radiotherapy|stereotactic body radiotherapy
68242|NCT03778112|MRI|mri
68243|NCT03778099|PCOS|pcos
68244|NCT03778099|Ovulation|ovulation
68245|NCT03778099|Cinnamon|cinnamon
68246|NCT03778073|relapsed or refractory|relapsed or refractory
68247|NCT03778060|Transcutaneous Nerve Stimulation|transcutaneous nerve stimulation
68248|NCT03778060|Positron-Emission Tomography|positron-emission tomography
68249|NCT03778008|Radiation therapy|radiation therapy
68250|NCT03778008|Nasopharyngeal carcinoma|nasopharyngeal carcinoma
68251|NCT03777995|Balance|balance
68252|NCT03777982|Prostate Cancer|prostate cancer
68253|NCT03777969|Chronic Hepatitis B|chronic hepatitis b
68254|NCT03777969|Liver fibrosis/cirrhosis|liver fibrosis/cirrhosis
68255|NCT03777969|HBV-related endpoint events|hbv-related endpoint events
68256|NCT03777969|Precise prediction model|precise prediction model
68257|NCT03777930|thalidomide|thalidomide
68258|NCT03777930|megestrol acetate|megestrol acetate
68259|NCT03777930|tumor|tumor
68260|NCT03777930|lymphocyte|lymphocyte
68261|NCT03777930|inflammatory cytokines|inflammatory cytokines
68262|NCT03777930|nutritional|nutritional
68263|NCT03777878|cesarean section|cesarean section
68264|NCT03777878|tranexamic acid|tranexamic acid
68265|NCT03777878|oxytocin|oxytocin
68266|NCT03777878|carbetocin|carbetocin
68267|NCT03777852|breast cancer, breast surgery, breast reconstruction,|breast cancer, breast surgery, breast reconstruction,
68268|NCT03777813|oesophagus|oesophagus
68269|NCT03777813|localised unresectable|localised unresectable
68270|NCT03777813|adenocarcinoma or squamous cell carcinoma|adenocarcinoma or squamous cell carcinoma
68271|NCT03777813|durvalumab|durvalumab
68272|NCT03777813|FOLFOX 4 simplified|folfox 4 simplified
68273|NCT03777813|Definitive modulated-intensity radiotherapy|definitive modulated-intensity radiotherapy
68274|NCT03777800|Veterans|veterans
68275|NCT03777800|Nervous System Diseases|nervous system diseases
68276|NCT03777800|Body Therapy|body therapy
68277|NCT03777800|Mind-Body Therapies|mind-body therapies
68278|NCT03777800|Coping Skills|coping skills
68279|NCT03777800|Breathing techniques|breathing techniques
68280|NCT03777800|Body awareness|body awareness
68281|NCT03777800|Emotional regulation|emotional regulation
68282|NCT03777800|Randomized Controlled Trial|randomized controlled trial
68283|NCT03777800|Qualitative study|qualitative study
68284|NCT03777800|Mixed-methods|mixed-methods
68285|NCT03777787|Bitter|bitter
68286|NCT03777787|TLESRs|tlesrs
68287|NCT03777787|Gastric tone|gastric tone
68288|NCT03777774|Decompressive craniectomy|decompressive craniectomy
68289|NCT03777774|subgaleal drain|subgaleal drain
68290|NCT03777774|subgaleal hematoma|subgaleal hematoma
68291|NCT03777774|Post craniectomy hydrocephalus|post craniectomy hydrocephalus
68292|NCT03777774|surgical site infection|surgical site infection
68293|NCT03777774|Bradycardia|bradycardia
68294|NCT03777774|Hypotension|hypotension
68295|NCT03777774|Wound breakdown|wound breakdown
68296|NCT03777748|Oral Health Impact Factor|oral health impact factor
68297|NCT03777748|Survival rate|survival rate
68298|NCT03777748|Maxillary overdenture|maxillary overdenture
68299|NCT03777748|Implant-Supported|implant-supported
68300|NCT03777748|Bone Resorption|bone resorption
68301|NCT03777748|Titanium-Zirconium|titanium-zirconium
68302|NCT03777748|Anchor System|anchor system
68303|NCT03777735|human bone graft screw|human bone graft screw
68304|NCT03777735|osteochondral defect|osteochondral defect
68305|NCT03777735|knee|knee
68306|NCT03777696|cesarean section|cesarean section
68307|NCT03777696|tranexamic acid|tranexamic acid
68308|NCT03777696|postpartum hemorrhage|postpartum hemorrhage
68309|NCT03777696|misoprostol|misoprostol
68310|NCT03777670|Newborn|newborn
68311|NCT03777631|anticoagulation treatment|anticoagulation treatment
68312|NCT03777631|catheter ablation|catheter ablation
68313|NCT03777618|plastic and reconstructive surgery|plastic and reconstructive surgery
68314|NCT03777618|gluteal ptosis|gluteal ptosis
68315|NCT03777618|platipygia|platipygia
68316|NCT03777553|posttraumatic stress disorder|posttraumatic stress disorder
68317|NCT03777553|criminal justice|criminal justice
68318|NCT03777553|Veterans|veterans
68319|NCT03777501|proprioception|proprioception
68320|NCT03777501|vibration|vibration
68321|NCT03777501|balance|balance
68322|NCT03777488|pharmacokinetics, tranexamic acid|pharmacokinetics, tranexamic acid
68323|NCT03777462|pancreatic cancer|pancreatic cancer
68324|NCT03777462|neoadjuvant chemotherapy|neoadjuvant chemotherapy
68325|NCT03777462|SBRT|sbrt
68326|NCT03777436|Genital Psoriasis|genital psoriasis
68327|NCT03777436|CC-10004|cc-10004
68328|NCT03777436|Apremilast|apremilast
68329|NCT03777436|Plaque Psoriasis|plaque psoriasis
68330|NCT03777410|functional|functional
68331|NCT03777410|biomarker|biomarker
68332|NCT03777410|multiple myeloma|multiple myeloma
68333|NCT03777410|phenotypic|phenotypic
68334|NCT03777410|biophysical|biophysical
68335|NCT03777384|oropharynx|oropharynx
68336|NCT03777384|head and neck cancer|head and neck cancer
68337|NCT03777306|Educational intervention|educational intervention
68338|NCT03777267|Stress|stress
68339|NCT03777267|Neurotechnology|neurotechnology
68340|NCT03777267|Autonomic Dysregulation|autonomic dysregulation
68341|NCT03777267|Hyperarousal|hyperarousal
68342|NCT03777267|Brain electrical activity|brain electrical activity
68343|NCT03777267|Allostasis|allostasis
68344|NCT03777267|HIRREM|hirrem
68345|NCT03777267|Cereset Research|cereset research
68346|NCT03777267|Insomnia|insomnia
68347|NCT03777267|Anxiety|anxiety
400580|NCT01866189|hypoxic tissues|hypoxic tissues
68348|NCT03777228|Traumatic brain injury, concussion, eye tracking, EEG, fMRI, DTI, Neurocognition|traumatic brain injury, concussion, eye tracking, eeg, fmri, dti, neurocognition
68349|NCT03777163|Vaccine|vaccine
68350|NCT03777163|Immunization|immunization
68351|NCT03777163|Safety|safety
68352|NCT03777163|Immunogenicity|immunogenicity
68353|NCT03777150|Intensive care|intensive care
68355|NCT03777150|elective surgery|elective surgery
68356|NCT03777137|Brain network for pain|brain network for pain
68357|NCT03777111|Aging|aging
68358|NCT03777111|gait|gait
68359|NCT03777111|balance|balance
68360|NCT03777111|functional mobility|functional mobility
68361|NCT03777111|dual task training|dual task training
68362|NCT03777072|Total Ankle Replacement|total ankle replacement
68363|NCT03777072|Pain Measurement|pain measurement
68366|NCT03777046|PPD|ppd
68367|NCT03777046|Post Partum|post partum
68368|NCT03777046|Post Partum Depression|post partum depression
68369|NCT03777020|human-animal interaction|human-animal interaction
68370|NCT03777020|service dog|service dog
68371|NCT03777020|stress|stress
68372|NCT03776994|Venezuelan Equine Encephalitis, vaccine|venezuelan equine encephalitis, vaccine
68373|NCT03776994|Intramuscular|intramuscular
68374|NCT03776994|Phase 1 clinical study|phase 1 clinical study
68375|NCT03776929|Dialectical Behavioral Therapy|dialectical behavioral therapy
68376|NCT03776929|Orthopaedic|orthopaedic
68377|NCT03776929|Trauma|trauma
68378|NCT03776929|Pain Catastrophizing Scale|pain catastrophizing scale
68379|NCT03776890|stress reduction|stress reduction
68380|NCT03776890|rural|rural
68381|NCT03776890|health behaviors|health behaviors
68382|NCT03776890|north carolina|north carolina
68383|NCT03776851|Hemolytic-Uremic Syndrome|hemolytic-uremic syndrome
68384|NCT03776851|erythropoietin|erythropoietin
68385|NCT03776851|RBC transfusion|rbc transfusion
68386|NCT03776838|NOL monitoring|nol monitoring
68387|NCT03776838|anesthesia|anesthesia
68388|NCT03776838|fentanyl consumption|fentanyl consumption
68389|NCT03776838|intraoperative|intraoperative
68390|NCT03776812|Glucocorticoid Receptor|glucocorticoid receptor
68391|NCT03776812|Ovarian Cancer|ovarian cancer
68392|NCT03776812|Fallopian Tube Cancer|fallopian tube cancer
68393|NCT03776812|Primary Peritoneal Cancer|primary peritoneal cancer
68394|NCT03776812|Nab-paclitaxel|nab-paclitaxel
68395|NCT03776812|GR Antagonist|gr antagonist
68396|NCT03776812|Relacorilant|relacorilant
68397|NCT03776734|precooling|precooling
68398|NCT03776734|exercise|exercise
68399|NCT03776734|pulmonary function|pulmonary function
68400|NCT03776734|isokinetic|isokinetic
68401|NCT03776734|lactate|lactate
68402|NCT03776708|pressure pain threshold|pressure pain threshold
68403|NCT03776708|asymptomatic subjects|asymptomatic subjects
68404|NCT03776708|duration|duration
68405|NCT03776669|Morbid obesity|morbid obesity
68406|NCT03776669|Hiatal hernia|hiatal hernia
68407|NCT03776669|Gastroesophageal reflux disease|gastroesophageal reflux disease
68408|NCT03776669|High resolution impedance manometry|high resolution impedance manometry
68409|NCT03776656|Adenylosuccinate lyase|adenylosuccinate lyase
68410|NCT03776656|Deficit|deficit
68411|NCT03776656|Allopurinol|allopurinol
68412|NCT03776656|Autism|autism
68413|NCT03776656|Epilepsy|epilepsy
68414|NCT03776630|Ovarian cancer|ovarian cancer
68415|NCT03776630|endometrial cancer|endometrial cancer
68416|NCT03776630|miR|mir
68417|NCT03776630|diagnostic|diagnostic
68418|NCT03776617|scalp block|scalp block
68419|NCT03776617|craniotomy|craniotomy
68420|NCT03776617|dexmedetomidine|dexmedetomidine
68421|NCT03776617|ropivacaine|ropivacaine
68422|NCT03776591|D3 lymphadenectomy|d3 lymphadenectomy
68423|NCT03776591|Right-sided|right-sided
68424|NCT03776591|Colon cancer|colon cancer
68425|NCT03776591|Complications|complications
68426|NCT03776591|Circulating tumor cells|circulating tumor cells
68427|NCT03776591|Circulating DNA (cDNA)|circulating dna (cdna)
68428|NCT03776591|Laparoscopy|laparoscopy
68429|NCT03776591|Complete mesocolic excision|complete mesocolic excision
68430|NCT03776539|Impaired Renal Function|impaired renal function
68431|NCT03776539|PK|pk
68432|NCT03776526|Hip fractures|hip fractures
68433|NCT03776513|obesity, teenagers, emotional memory, brain networks|obesity, teenagers, emotional memory, brain networks
68434|NCT03776474|Food allergy in children|food allergy in children
68435|NCT03776474|Immunoglobulin E|immunoglobulin e
68436|NCT03776474|Immunoglobulin G4|immunoglobulin g4
68437|NCT03776474|Oral food challenge|oral food challenge
68438|NCT03776461|fractional radiofrequency|fractional radiofrequency
68439|NCT03776461|fractional RF|fractional rf
68440|NCT03776461|facial wrinkles|facial wrinkles
68441|NCT03776461|wrinkles|wrinkles
68442|NCT03776396|Perioperative Goal Directed Therapy|perioperative goal directed therapy
68443|NCT03776396|Minimally invasive hemodynamic monitoring|minimally invasive hemodynamic monitoring
68444|NCT03776396|Kidney transplantation|kidney transplantation
68445|NCT03776383|Antibiotic use|antibiotic use
68446|NCT03776383|Audit and feedback|audit and feedback
68447|NCT03776383|implementation science|implementation science
88973|NCT03647605|vr|vr
68448|NCT03776383|Antimicrobial stewardship|antimicrobial stewardship
68449|NCT03776370|rectal cancer|rectal cancer
68450|NCT03776370|Postoperative Complications|postoperative complications
68451|NCT03776370|Preserve the left colonic artery|preserve the left colonic artery
68452|NCT03776331|Myeloma|myeloma
68453|NCT03776331|Flow mediated dilation|flow mediated dilation
68454|NCT03776331|Endothelial Dysfunction|endothelial dysfunction
68455|NCT03776331|Proteasome inhibitors|proteasome inhibitors
68456|NCT03776305|pharmacokinetic|pharmacokinetic
68457|NCT03776305|imipenem|imipenem
68458|NCT03776305|extracorporeal membrane oxygenation|extracorporeal membrane oxygenation
68459|NCT03776292|cardiac, output, pulmonary, compliance, bladder, Retractor.|cardiac, output, pulmonary, compliance, bladder, retractor.
68460|NCT03776266|Transfusion|transfusion
68461|NCT03776266|PCI|pci
68462|NCT03776266|Percutaneous Coronary Intervention|percutaneous coronary intervention
68463|NCT03776240|randomized|randomized
68464|NCT03776240|double-blind|double-blind
68465|NCT03776214|No pitting edema|no pitting edema
68466|NCT03776214|After medical and surgical evaluation|after medical and surgical evaluation
68467|NCT03776214|Microlipoaspiration|microlipoaspiration
68468|NCT03776214|surgery|surgery
68469|NCT03776214|lymphedema|lymphedema
68470|NCT03776188|Endoscopic Suturing|endoscopic suturing
68471|NCT03776188|Bariatric Revision|bariatric revision
68472|NCT03776188|Stent Fixation|stent fixation
68473|NCT03776188|Bariatric Surgery|bariatric surgery
68474|NCT03776162|Anterior Cruciate Ligament Tear|anterior cruciate ligament tear
68475|NCT03776162|Anterior Cruciate Ligament Reconstruction|anterior cruciate ligament reconstruction
68476|NCT03776162|Anterior Cruciate Ligament Repair|anterior cruciate ligament repair
68477|NCT03776162|Knee Surgery|knee surgery
68478|NCT03776136|programmed cell death 1 (PD-1, PD1)|programmed cell death 1 (pd-1, pd1)
68479|NCT03776136|programmed cell death ligand 1 (PD-L1, PDL1)|programmed cell death ligand 1 (pd-l1, pdl1)
68480|NCT03776136|programmed cell death ligand 2 (PD-L2, PDL2)|programmed cell death ligand 2 (pd-l2, pdl2)
68481|NCT03776110|Dose escalation|dose escalation
68482|NCT03776084|treatment adherence and compliance|treatment adherence and compliance
68483|NCT03776084|attitudes|attitudes
68484|NCT03776084|Continuous Positive Airway Pressure|continuous positive airway pressure
68485|NCT03776084|cross-cultural validation|cross-cultural validation
68486|NCT03776045|Prostate Cancer|prostate cancer
68487|NCT03776045|Androgen deprivation therapy|androgen deprivation therapy
68488|NCT03776045|Exercise|exercise
68489|NCT03776032|Lung cancer|lung cancer
68490|NCT03776019|Pain|pain
68491|NCT03776019|Stress|stress
68492|NCT03776019|AVWF|avwf
68493|NCT03776019|Audio-Visual-Perception-Enhancement|audio-visual-perception-enhancement
68494|NCT03776006|Transperineal laser ablation|transperineal laser ablation
68495|NCT03776006|LUTS|luts
68496|NCT03775993|Growth Hormone|growth hormone
68497|NCT03775993|Placebo|placebo
68498|NCT03775993|Exercise capacity|exercise capacity
68499|NCT03775993|Vascular reactivity|vascular reactivity
68500|NCT03775993|LV function|lv function
68501|NCT03775993|Prognosis|prognosis
68502|NCT03775967|sialic acid|sialic acid
68503|NCT03775967|IL10|il10
68504|NCT03775967|stage 1 periodontal disease|stage 1 periodontal disease
68505|NCT03775967|stage 2 periodontal disease|stage 2 periodontal disease
68506|NCT03775954|Fetal Magnetocardiography|fetal magnetocardiography
68507|NCT03775954|Stillbirth|stillbirth
68508|NCT03775954|Intrauterine Fetal Demise|intrauterine fetal demise
68509|NCT03775954|Mobile Medical Technologies|mobile medical technologies
68510|NCT03775954|Fetal Heart Rate Variability|fetal heart rate variability
68511|NCT03775954|Fetal Arrhythmias|fetal arrhythmias
68512|NCT03775954|High Risk Pregnancy|high risk pregnancy
68513|NCT03775954|Pregnancy|pregnancy
68514|NCT03775954|Fetal Anomaly|fetal anomaly
68515|NCT03775954|Fetal Echocardiography|fetal echocardiography
68516|NCT03775954|Non-Stress Testing|non-stress testing
68517|NCT03775954|New Technology|new technology
68518|NCT03775954|Birth Defects|birth defects
68519|NCT03775954|Fetal Research|fetal research
68520|NCT03775941|Neuroimaging|neuroimaging
68521|NCT03775941|White matter|white matter
68522|NCT03775941|Cardiorespiratory fitness|cardiorespiratory fitness
68523|NCT03775941|Physical activity|physical activity
68524|NCT03775941|Cognitive aging|cognitive aging
68525|NCT03775941|Executive function|executive function
68526|NCT03775941|Cognitive reserve|cognitive reserve
68527|NCT03775915|Motor function|motor function
68528|NCT03775915|Brain activity|brain activity
68529|NCT03775876|Propofol|propofol
68530|NCT03775876|Dexmedetomidine|dexmedetomidine
68531|NCT03775876|Regional anesthesia|regional anesthesia
68532|NCT03775876|Satisfaction|satisfaction
68533|NCT03775876|Shoulder arthroscopy|shoulder arthroscopy
68534|NCT03775863|Hepatocellular carcinoma|hepatocellular carcinoma
68535|NCT03775863|models|models
68536|NCT03775863|allocation|allocation
68537|NCT03775863|selection|selection
68538|NCT03775824|microbiome|microbiome
68539|NCT03775824|methotrexate|methotrexate
68540|NCT03775824|tnf-inhibitor|tnf-inhibitor
68541|NCT03775824|dysbiosis|dysbiosis
68542|NCT03775798|direct acting antivirals|direct acting antivirals
68543|NCT03775798|hepatitis c|hepatitis c
68544|NCT03775798|hepatocellular carcinoma|hepatocellular carcinoma
68545|NCT03775785|enteral nutrition|enteral nutrition
68546|NCT03775785|fortification|fortification
68547|NCT03775785|tailored enteral nutrition|tailored enteral nutrition
68548|NCT03775772|oral health|oral health
68549|NCT03775772|bite force|bite force
68556|NCT03775759|Right heart failure|right heart failure
68557|NCT03775733|Hydrolysed red ginseng extract|hydrolysed red ginseng extract
68558|NCT03775733|Glucose|glucose
68559|NCT03775733|Clinical Trial|clinical trial
68560|NCT03775707|Hepatocellular Carcinoma|hepatocellular carcinoma
68561|NCT03775707|Lenvatinib|lenvatinib
68562|NCT03775707|PD-1 Antibody|pd-1 antibody
68563|NCT03775707|BCLC B stage|bclc b stage
68564|NCT03775707|Beyond up-to-seven criteria|beyond up-to-seven criteria
68565|NCT03775655|Cesarean Section|cesarean section
68566|NCT03775655|Intrathecal Dexmedetomidine|intrathecal dexmedetomidine
68567|NCT03775590|Atopic Dermatitis|atopic dermatitis
68568|NCT03775590|Eczema|eczema
68569|NCT03775577|Heart Failure with Preserved Ejection Fraction|heart failure with preserved ejection fraction
68570|NCT03775577|HFpEF|hfpef
68571|NCT03775551|quality improvement|quality improvement
68572|NCT03775551|collaborative|collaborative
68573|NCT03775551|counter reference|counter reference
68574|NCT03775538|Parkinson|parkinson
68575|NCT03775538|CDNF|cdnf
68576|NCT03775538|Drug Delivery System|drug delivery system
68577|NCT03775538|Intracerebral|intracerebral
68578|NCT03775486|NSCLC|nsclc
68579|NCT03775486|Durvalumab|durvalumab
68580|NCT03775486|Olaparib|olaparib
68581|NCT03775486|Maintenance|maintenance
68582|NCT03775486|Homologous Recombination Repair (HRR)|homologous recombination repair (hrr)
68583|NCT03775473|progastrin|progastrin
68584|NCT03775473|screening|screening
68585|NCT03775473|bio-marker|bio-marker
68586|NCT03775473|healthy person|healthy person
68587|NCT03775473|early stage|early stage
68588|NCT03775460|Erythema Nodosum Leprosum|erythema nodosum leprosum
68589|NCT03775460|ENL|enl
68590|NCT03775460|corticosteroids|corticosteroids
68591|NCT03775460|Methotrexate|methotrexate
68592|NCT03775460|ENL severity scale|enl severity scale
68593|NCT03775460|quality of life|quality of life
68594|NCT03775460|Leprosy|leprosy
68595|NCT03775447|Parkinson's Disease|parkinson's disease
68596|NCT03775447|Biomarker|biomarker
68597|NCT03775447|LRRK2|lrrk2
68598|NCT03775447|CSF|csf
68604|NCT03775395|Hepatocellular carcinoma|hepatocellular carcinoma
68605|NCT03775395|Hepatic artery infusion chemotherapy|hepatic artery infusion chemotherapy
68606|NCT03775395|Sorafenib|sorafenib
68607|NCT03775395|Lenvatinib|lenvatinib
68608|NCT03775369|interventions of physical activity and exercising (PAE)|interventions of physical activity and exercising (pae)
68609|NCT03775369|resistance training|resistance training
68610|NCT03775369|endurance training|endurance training
68611|NCT03775356|Intraoperative EEG based monitoring|intraoperative eeg based monitoring
68612|NCT03775356|Level of hypnosis|level of hypnosis
68613|NCT03775356|Burst suppression|burst suppression
68614|NCT03775356|Postoperative delirium|postoperative delirium
68615|NCT03775356|EEG-signal characteristics|eeg-signal characteristics
68616|NCT03775356|Entropy|entropy
68617|NCT03775343|Anesthesia|anesthesia
68618|NCT03775343|Postoperative cognitive decline|postoperative cognitive decline
68619|NCT03775317|Video laryngoscopy|video laryngoscopy
68620|NCT03775317|Nasal intubation|nasal intubation
68621|NCT03775252|Ketogenic Diet|ketogenic diet
68622|NCT03775239|Desire dysfunction|desire dysfunction
68623|NCT03775239|Erectile dysfunction|erectile dysfunction
68624|NCT03775239|Orgasm dysfunction|orgasm dysfunction
68625|NCT03775239|Sexual pain|sexual pain
68626|NCT03775239|Hyper sexuality|hyper sexuality
68627|NCT03775239|Mindfulness|mindfulness
68628|NCT03775213|Ductal carcinoma in situ|ductal carcinoma in situ
68629|NCT03775213|Decision support tool|decision support tool
68630|NCT03775213|Informed decision-making|informed decision-making
68631|NCT03775213|Overtreatment|overtreatment
68632|NCT03775213|Active surveillance|active surveillance
68633|NCT03775187|Expanded Access|expanded access
68634|NCT03775187|Compassionate Use|compassionate use
68635|NCT03775187|XLH|xlh
68636|NCT03775187|TIO|tio
68637|NCT03775174|Expanded Access|expanded access
68638|NCT03775174|Compassionate Use|compassionate use
68639|NCT03775148|Depression|depression
68640|NCT03775148|Insomnia|insomnia
68641|NCT03775148|Transdiagnostic Sleep and Circadian Treatment|transdiagnostic sleep and circadian treatment
68642|NCT03775135|Identity|identity
68643|NCT03775109|Canakinumab|canakinumab
68644|NCT03775109|Alcoholic Hepatitis|alcoholic hepatitis
68645|NCT03775109|Alcohol Use Disorder|alcohol use disorder
68646|NCT03775109|Interleukin|interleukin
68647|NCT03775109|Treatment|treatment
68648|NCT03775109|Ilaris|ilaris
68649|NCT03775109|Liver disease|liver disease
820230|NCT00157651|bleeding|bleeding
68650|NCT03775096|Early Parkinson Disease|early parkinson disease
68651|NCT03775096|REM Sleep Behaviour Disorder (RBD)|rem sleep behaviour disorder (rbd)
68652|NCT03775096|carvedilol|carvedilol
68653|NCT03775096|Autonomic dysfunction|autonomic dysfunction
68654|NCT03775096|Neurodegeneration|neurodegeneration
68655|NCT03775083|PEP|pep
68656|NCT03775083|nPEP|npep
68657|NCT03775083|Post Exposure Prophylaxis|post exposure prophylaxis
68658|NCT03775083|non occupational exposure to HIV|non occupational exposure to hiv
68659|NCT03775044|Telemedicine|telemedicine
68660|NCT03775044|Medication Adherence|medication adherence
68661|NCT03775044|Mental Health Issue|mental health issue
68662|NCT03775005|Short Course Radiotherapy|short course radiotherapy
68663|NCT03775005|Symptomatic abdomen lesions|symptomatic abdomen lesions
68664|NCT03774992|Orthokeratology lenses|orthokeratology lenses
68665|NCT03774992|Myopia|myopia
68666|NCT03774992|Children|children
68667|NCT03774979|SHR-1701|shr-1701
68668|NCT03774979|Solid tumor|solid tumor
68669|NCT03774979|Metastatic or locally advanced solid tumors|metastatic or locally advanced solid tumors
68670|NCT03774966|total knee arthroplasty|total knee arthroplasty
68671|NCT03774966|regional block|regional block
68672|NCT03774953|pneumonia|pneumonia
68673|NCT03774953|community acquired pneumonia|community acquired pneumonia
68674|NCT03774953|protein|protein
68675|NCT03774953|lean body mass|lean body mass
68676|NCT03774953|weight loss|weight loss
68677|NCT03774953|readmission|readmission
68678|NCT03774953|infection|infection
68679|NCT03774940|fever|fever
68680|NCT03774940|bacteremia|bacteremia
68681|NCT03774940|lymphocytes|lymphocytes
68682|NCT03774940|percutaneous nephrolithotomy|percutaneous nephrolithotomy
68683|NCT03774940|neutrophil-lymphocyte ratio|neutrophil-lymphocyte ratio
68684|NCT03774927|schizophrenia|schizophrenia
68685|NCT03774927|rTMS|rtms
68686|NCT03774901|Immunotherapy|immunotherapy
68687|NCT03774901|Penile Cancer|penile cancer
68688|NCT03774901|Penile Squamous Cell Carcinoma|penile squamous cell carcinoma
68689|NCT03774901|Avelumab|avelumab
68690|NCT03774901|maintenance|maintenance
68691|NCT03774888|Keratinized Tissue|keratinized tissue
68692|NCT03774888|Keratinized mucosa|keratinized mucosa
68693|NCT03774888|attached mucosa|attached mucosa
68694|NCT03774888|dental implants|dental implants
68695|NCT03774888|ridge augmentation|ridge augmentation
68696|NCT03774888|guided bone regeneration|guided bone regeneration
68697|NCT03774888|connective tissue graft|connective tissue graft
68698|NCT03774888|acellular demral matrix|acellular demral matrix
68699|NCT03774875|Apremilast|apremilast
68700|NCT03774875|CC-10004|cc-10004
68701|NCT03774875|Quality of life|quality of life
68702|NCT03774875|Safety|safety
68703|NCT03774875|Efficacy|efficacy
68704|NCT03774875|Psoriasis manifestations|psoriasis manifestations
68705|NCT03774862|Medullary carcinoma|medullary carcinoma
68706|NCT03774862|Colorectal cancer|colorectal cancer
68707|NCT03774862|Microsatellite instability|microsatellite instability
68708|NCT03774823|RF/PEMF|rf/pemf
68709|NCT03774823|Ultrasound|ultrasound
68710|NCT03774810|insomnia|insomnia
68711|NCT03774810|sleep|sleep
68712|NCT03774810|chronic insomnia|chronic insomnia
68713|NCT03774810|zolpidem|zolpidem
68714|NCT03774810|ambien|ambien
68715|NCT03774797|contraception|contraception
68716|NCT03774797|long-acting reversible contraception|long-acting reversible contraception
68717|NCT03774797|postpartum|postpartum
68718|NCT03774797|toolkit|toolkit
68719|NCT03774797|implementation|implementation
68720|NCT03774797|feasibility|feasibility
68721|NCT03774758|Lung cancer screening|lung cancer screening
68722|NCT03774758|Biomarkers of lung cancer|biomarkers of lung cancer
68723|NCT03774758|Circulating tumor DNA|circulating tumor dna
68724|NCT03774758|Low dose computed tomography of lung|low dose computed tomography of lung
68725|NCT03774758|Pulmonary nodule|pulmonary nodule
68726|NCT03774745|mifepristone|mifepristone
68727|NCT03774745|progesterone|progesterone
68728|NCT03774745|abortion|abortion
68729|NCT03774732|NSCLC|nsclc
68730|NCT03774732|radiotherapy|radiotherapy
68731|NCT03774732|immunotherapy|immunotherapy
68732|NCT03774732|PD(L)-1blockage|pd(l)-1blockage
68733|NCT03774706|cesarean section|cesarean section
68734|NCT03774706|tranexamic acid|tranexamic acid
68735|NCT03774706|misoprostol|misoprostol
68736|NCT03774667|Placenta Previa|placenta previa
68737|NCT03774667|Risk Factors|risk factors
68738|NCT03774667|Perinatal Complications|perinatal complications
68739|NCT03774667|Perinatal Outcomes|perinatal outcomes
68740|NCT03774654|Gene Therapy|gene therapy
68741|NCT03774654|CAR T-cells|car t-cells
68742|NCT03774654|chimeric antigen receptor|chimeric antigen receptor
68743|NCT03774654|B-Cell Malignancies|b-cell malignancies
68744|NCT03774654|CD19|cd19
68745|NCT03774641|Lamotrigine|lamotrigine
68746|NCT03774641|Bipolar Disorder|bipolar disorder
68747|NCT03774641|Major Depressive Disorder|major depressive disorder
68748|NCT03774641|Schizo Affective Disorder|schizo affective disorder
68749|NCT03774615|Iron Deficiency|iron deficiency
68750|NCT03774589|bilioenteric anastomosis|bilioenteric anastomosis
68753|NCT03774563|weight loss|weight loss
68754|NCT03774563|sleep|sleep
68755|NCT03774550|Atrial Fibrillation|atrial fibrillation
68756|NCT03774550|Catheter ablation|catheter ablation
68757|NCT03774550|Radiofrequency|radiofrequency
68758|NCT03774550|Contact-force|contact-force
68759|NCT03774550|Cryoablation|cryoablation
68760|NCT03774537|high risk； Bronchopulmonary Dysplasia；hUC-MSCs|high risk； bronchopulmonary dysplasia；huc-mscs
68761|NCT03774524|cesarean section|cesarean section
68762|NCT03774524|tranexamic acid|tranexamic acid
68763|NCT03774524|postpartum hemorrhage|postpartum hemorrhage
68764|NCT03774524|misoprostol|misoprostol
68768|NCT03774433|self-regulation|self-regulation
68769|NCT03774433|binge eating|binge eating
68770|NCT03774433|smoking|smoking
68771|NCT03774433|ecological momentary assessment|ecological momentary assessment
68772|NCT03774433|mobile sensing|mobile sensing
68773|NCT03774433|mHealth|mhealth
68774|NCT03774420|Infusion pumps|infusion pumps
68775|NCT03774420|Intraoperative brain monitoring|intraoperative brain monitoring
68776|NCT03774407|remyelination|remyelination
68777|NCT03774407|urogenital health|urogenital health
68778|NCT03774407|multiple sclerosis|multiple sclerosis
68779|NCT03774394|pharmacodynamics (PD)|pharmacodynamics (pd)
68780|NCT03774394|pharmacokinetic (PK)|pharmacokinetic (pk)
68781|NCT03774394|clopidogrel|clopidogrel
68782|NCT03774342|Coronary artery bypass grafting|coronary artery bypass grafting
68783|NCT03774342|Quality of life|quality of life
68784|NCT03774342|Cognitive dysfunction|cognitive dysfunction
68785|NCT03774342|Sarcopenia|sarcopenia
68786|NCT03774329|inflammatory bowel disease|inflammatory bowel disease
68787|NCT03774329|physical activity|physical activity
68788|NCT03774329|bone mineral density|bone mineral density
68789|NCT03774329|pediatric|pediatric
68790|NCT03774316|De-escalation|de-escalation
68791|NCT03774316|Antifungal treatment|antifungal treatment
68792|NCT03774316|Mortality|mortality
68793|NCT03774316|Immunocompromised|immunocompromised
68794|NCT03774316|Intensive care|intensive care
68795|NCT03774277|Hypertension|hypertension
68796|NCT03774277|Blood Pressure|blood pressure
68797|NCT03774277|DASH-Diet|dash-diet
68798|NCT03774277|BMI|bmi
68799|NCT03774277|American Indian|american indian
68800|NCT03774277|Food Environment|food environment
68801|NCT03774277|CBPR|cbpr
68802|NCT03774277|CHEERS|cheers
68803|NCT03774277|Native American|native american
68804|NCT03774238|Flow-mediated dilatation|flow-mediated dilatation
68805|NCT03774238|COPD|copd
68806|NCT03774238|Pulmonary Rehabilitation|pulmonary rehabilitation
68807|NCT03774238|Comorbidities|comorbidities
68808|NCT03774238|endothelial cell|endothelial cell
68809|NCT03774238|oxidative stress|oxidative stress
68810|NCT03774225|Virtual Reality|virtual reality
68811|NCT03774225|International Classification of Functioning|international classification of functioning
68812|NCT03774225|Disability and Health|disability and health
68813|NCT03774225|Rehabilitation|rehabilitation
68814|NCT03774225|Gait|gait
68815|NCT03774225|Balance|balance
68816|NCT03774212|Critical care patients|critical care patients
68817|NCT03774212|High dependency unit|high dependency unit
68818|NCT03774212|Intensive care unit|intensive care unit
68819|NCT03774186|type 1 diabetes mellitus|type 1 diabetes mellitus
68820|NCT03774186|pregnancy|pregnancy
68821|NCT03774186|hybrid closed-loop therapy|hybrid closed-loop therapy
68822|NCT03774186|artificial pancreas therapy|artificial pancreas therapy
68823|NCT03774186|sensor-augmented pump therapy|sensor-augmented pump therapy
68824|NCT03774134|Colon cancer|colon cancer
68825|NCT03774134|Surgery|surgery
68826|NCT03774134|Oncological outcome|oncological outcome
68827|NCT03774134|Survival|survival
68828|NCT03774121|Cryoneurolysis|cryoneurolysis
68829|NCT03774121|Exercise|exercise
68830|NCT03774121|Pain|pain
68831|NCT03774121|Physical capacity|physical capacity
68832|NCT03774095|incretins|incretins
68833|NCT03774095|Fat metabolites|fat metabolites
68834|NCT03774095|Free fatty acid receptors|free fatty acid receptors
68835|NCT03774095|G-protein-coupled receptors|g-protein-coupled receptors
68836|NCT03774082|INC424|inc424
68837|NCT03774082|pediatric|pediatric
68838|NCT03774082|Chronic Graft versus Host Disease|chronic graft versus host disease
68839|NCT03774082|moderate and severe chronic graft vs. host disease|moderate and severe chronic graft vs. host disease
68840|NCT03774082|allogeneic stem cell transplant|allogeneic stem cell transplant
68841|NCT03774082|ruxolitinib|ruxolitinib
68842|NCT03774082|corticosteroids|corticosteroids
68843|NCT03774069|Insulin pump treatment|insulin pump treatment
68844|NCT03774069|Type 1 diabetes|type 1 diabetes
68845|NCT03774069|Pump setting advisor|pump setting advisor
68846|NCT03774017|brain arteriovenous malformations|brain arteriovenous malformations
68847|NCT03774017|one-staged hybrid operation|one-staged hybrid operation
68848|NCT03773991|Dyspnea|dyspnea
68849|NCT03773991|Hemodialysis|hemodialysis
68850|NCT03773991|End Stage Renal Disease|end stage renal disease
68851|NCT03773978|Polyarticular JIA|polyarticular jia
68852|NCT03773978|Oligoarthritis|oligoarthritis
68853|NCT03773978|Juvenile psoriatic arthritis (JPsA)|juvenile psoriatic arthritis (jpsa)
68854|NCT03773978|Enthesitis‑related juvenile idiopathic arthritis (ERA)|enthesitis‑related juvenile idiopathic arthritis (era)
68855|NCT03773965|Polyarticular JIA|polyarticular jia
68856|NCT03773965|Oligoarthritis|oligoarthritis
68857|NCT03773965|Juvenile psoriatic arthritis (JPsA)|juvenile psoriatic arthritis (jpsa)
68980|NCT03773289|rational drug use|rational drug use
68858|NCT03773965|Enthesitis‑related juvenile idiopathic arthritis (ERA)|enthesitis‑related juvenile idiopathic arthritis (era)
68859|NCT03773965|Systemic JIA with and without systemic features|systemic jia with and without systemic features
68860|NCT03773926|Tinnitus|tinnitus
68861|NCT03773926|Neuro-feedback|neuro-feedback
68862|NCT03773926|Male|male
68863|NCT03773926|Female|female
68864|NCT03773926|Tinnitus Handicap Inventory|tinnitus handicap inventory
68865|NCT03773913|Child Mortality|child mortality
68866|NCT03773913|Reproductive, Maternal, Newborn, and Child Health|reproductive, maternal, newborn, and child health
68867|NCT03773913|Community Health Workers|community health workers
68868|NCT03773913|Implementation Research|implementation research
68869|NCT03773913|Preliminary Research|preliminary research
68870|NCT03773913|Health Systems Strengthening|health systems strengthening
68871|NCT03773900|chitin-glucan|chitin-glucan
68872|NCT03773900|gut microbiota|gut microbiota
68873|NCT03773900|Fecal Short Chain Fatty Acid (SCFA)|fecal short chain fatty acid (scfa)
68874|NCT03773900|cardiometabolic risk|cardiometabolic risk
68875|NCT03773900|nutritional challenge test|nutritional challenge test
68876|NCT03773900|biomarkers|biomarkers
68877|NCT03773822|Cardiogenic Shock|cardiogenic shock
68878|NCT03773822|Steroids|steroids
68879|NCT03773822|Hydrocortisone|hydrocortisone
68880|NCT03773822|Fludrocortisone|fludrocortisone
68881|NCT03773822|Reversal of shock|reversal of shock
68882|NCT03773822|Mortality|mortality
68883|NCT03773822|Adrenal insufficiency|adrenal insufficiency
68884|NCT03773809|ACO|aco
68885|NCT03773809|HRV|hrv
68886|NCT03773809|Vitamin D deficiency|vitamin d deficiency
68887|NCT03773796|Parkinson´s Disease|parkinson´s disease
68888|NCT03773796|cannabinoids|cannabinoids
68889|NCT03773796|non-motor symptoms|non-motor symptoms
68890|NCT03773783|Myofunctional appliance|myofunctional appliance
68891|NCT03773770|Expanded Access|expanded access
68892|NCT03773770|Compassionate Use|compassionate use
68893|NCT03773718|metabolic syndrome|metabolic syndrome
68894|NCT03773718|children|children
68895|NCT03773718|cancer|cancer
68896|NCT03773718|survivors|survivors
68897|NCT03773718|genetic|genetic
68898|NCT03773692|Spinal Cord Injuries|spinal cord injuries
68899|NCT03773692|Physical Activity|physical activity
68900|NCT03773692|Mobile-health|mobile-health
68901|NCT03773692|Just-in-time-adaptive intervention|just-in-time-adaptive intervention
68902|NCT03773692|Real-time feedback|real-time feedback
68903|NCT03773679|Preterm infants with very low birth weight (VLBW)|preterm infants with very low birth weight (vlbw)
68904|NCT03773679|bone mineral density|bone mineral density
68905|NCT03773679|cortisol|cortisol
68906|NCT03773679|exercise|exercise
68907|NCT03773666|Bladder Cancer|bladder cancer
68908|NCT03773653|stroke, robot-assisted therapy, mirror therapy|stroke, robot-assisted therapy, mirror therapy
68909|NCT03773640|temporomandibular joint dysfunction,|temporomandibular joint dysfunction,
68910|NCT03773640|supportive treatment,|supportive treatment,
68911|NCT03773640|occlusal splint,|occlusal splint,
68912|NCT03773640|radiofreqency,|radiofreqency,
68913|NCT03773640|physiotherapy|physiotherapy
68914|NCT03773601|Sleep|sleep
68915|NCT03773601|Athlete|athlete
68916|NCT03773601|Sleep Profiler|sleep profiler
68917|NCT03773588|Closed loop|closed loop
68918|NCT03773588|Entropy|entropy
68919|NCT03773588|Surgical pleth index|surgical pleth index
68920|NCT03773588|Adequacy of Anesthesia|adequacy of anesthesia
68921|NCT03773588|Target controlled infusion|target controlled infusion
68922|NCT03773562|Migraine|migraine
68923|NCT03773562|Magnetic Resonance Imaging|magnetic resonance imaging
68924|NCT03773562|Brain Structure|brain structure
68925|NCT03773562|Brain Function|brain function
68926|NCT03773536|Artesunate-amodiaquine|artesunate-amodiaquine
68927|NCT03773536|Single Low Dose Primaquine|single low dose primaquine
68928|NCT03773536|Zanzibar|zanzibar
68929|NCT03773523|tDCS|tdcs
68930|NCT03773523|Transcranial Direct Current Stimulation|transcranial direct current stimulation
68931|NCT03773523|MRI|mri
68932|NCT03773523|Opioid dependence|opioid dependence
68933|NCT03773523|Opioids|opioids
68934|NCT03773523|Buprenorphine|buprenorphine
68935|NCT03773523|Suboxone|suboxone
68936|NCT03773523|Lodging Plus|lodging plus
68937|NCT03773523|Fairview Lodging Plus|fairview lodging plus
68938|NCT03773510|trabectedin|trabectedin
68939|NCT03773510|soft tissue sarcoma|soft tissue sarcoma
68940|NCT03773484|Opioids|opioids
68941|NCT03773484|Behavioral Research|behavioral research
68942|NCT03773458|Orthopedic Disorder of Spine|orthopedic disorder of spine
68943|NCT03773445|ulcerative colitis|ulcerative colitis
68944|NCT03773445|golimumab|golimumab
68945|NCT03773445|simponi|simponi
68946|NCT03773445|therapeutic drug monitoring|therapeutic drug monitoring
68947|NCT03773445|endoscopic healing|endoscopic healing
68948|NCT03773445|histologic remission|histologic remission
68949|NCT03773432|meal ingestion|meal ingestion
68950|NCT03773432|meal schedule|meal schedule
68951|NCT03773432|postprandial responses|postprandial responses
68952|NCT03773432|hedonic sensations|hedonic sensations
68953|NCT03773432|homeostatic sensations|homeostatic sensations
68954|NCT03773419|Stroke-related aphasia|stroke-related aphasia
68955|NCT03773419|Rehabilitation|rehabilitation
68956|NCT03773419|Writing|writing
68957|NCT03773419|Texting|texting
68958|NCT03773406|Aphasia, tDCS, Script training, Functional language, Naming|aphasia, tdcs, script training, functional language, naming
68959|NCT03773367|Gastric adenocarcinoma|gastric adenocarcinoma
68960|NCT03773367|Gastroesophageal junction adenocarcinoma|gastroesophageal junction adenocarcinoma
68961|NCT03773367|Chemotherapy|chemotherapy
68962|NCT03773367|Fluorouracil|fluorouracil
68963|NCT03773367|Oxaliplatin|oxaliplatin
68964|NCT03773367|Irinotecan|irinotecan
68965|NCT03773367|Preoperative chemotherapy|preoperative chemotherapy
68966|NCT03773367|Postoperative chemotherapy|postoperative chemotherapy
68967|NCT03773367|Histopathological response|histopathological response
68968|NCT03773367|Rate of R0-resection|rate of r0-resection
68969|NCT03773341|ACL injury|acl injury
68970|NCT03773341|non sport causes|non sport causes
68971|NCT03773341|Egyptians|egyptians
68972|NCT03773302|cholangiocarcinoma|cholangiocarcinoma
68973|NCT03773302|unresectable cholangiocarcinoma|unresectable cholangiocarcinoma
68974|NCT03773302|metastatic cholangiocarcinoma|metastatic cholangiocarcinoma
68975|NCT03773302|fibroblast growth factor receptor inhibitor|fibroblast growth factor receptor inhibitor
68976|NCT03773302|FGFR2|fgfr2
68977|NCT03773302|FGFR2 gene fusions/translocations|fgfr2 gene fusions/translocations
68978|NCT03773302|BGJ398|bgj398
68979|NCT03773289|Infants, neonates|infants, neonates
68981|NCT03773263|sequential IVM system|sequential ivm system
68982|NCT03773263|PCOS|pcos
68983|NCT03773263|infertility|infertility
68984|NCT03773237|SMOF|smof
68985|NCT03773237|Intralipid|intralipid
68986|NCT03773237|Mixed oil emulsion|mixed oil emulsion
68987|NCT03773237|Intestinal failure|intestinal failure
68988|NCT03773237|HPN|hpn
68989|NCT03773172|Lipid and Lipoprotein Metabolism|lipid and lipoprotein metabolism
68990|NCT03773146|mobile phone surveys|mobile phone surveys
68991|NCT03773146|interactive voice response|interactive voice response
68992|NCT03773146|incentive|incentive
68993|NCT03773120|superior laryngeal nerve|superior laryngeal nerve
68994|NCT03773081|Acute Coronary Syndrome|acute coronary syndrome
68995|NCT03773081|STE-ACS|ste-acs
68996|NCT03773081|NSTE-ACS|nste-acs
68997|NCT03773081|Magmaris|magmaris
68998|NCT03773068|Endometriosis|endometriosis
68999|NCT03773068|Refractory chronic cough|refractory chronic cough
69000|NCT03773016|care home|care home
69001|NCT03773016|visual art|visual art
69002|NCT03773016|app|app
69003|NCT03773016|touchscreen technology|touchscreen technology
69004|NCT03773016|dementia|dementia
69005|NCT03773003|Cancer Fatigue, Chronic Fatigue|cancer fatigue, chronic fatigue
69006|NCT03772990|inotropic support|inotropic support
69007|NCT03772990|calcium chloride|calcium chloride
69008|NCT03772990|cardiopulmonary bypass|cardiopulmonary bypass
69009|NCT03772990|cardiac surgery|cardiac surgery
69010|NCT03772977|mild cognitive impairment|mild cognitive impairment
69011|NCT03772977|dementia risk reduction|dementia risk reduction
69012|NCT03772964|prefrail|prefrail
69013|NCT03772964|non-diabetic|non-diabetic
69014|NCT03772964|metformin|metformin
69015|NCT03772964|thrombosis|thrombosis
69016|NCT03772964|microbiome|microbiome
69017|NCT03772964|cellular respiration|cellular respiration
69018|NCT03772964|short physical performance batter|short physical performance batter
69019|NCT03772938|stem cells|stem cells
69020|NCT03772938|Retinitis Pigmentosa|retinitis pigmentosa
69021|NCT03772938|Age Related Macular Degeneration|age related macular degeneration
69022|NCT03772938|Stargardt Disease|stargardt disease
69023|NCT03772938|electroretinography|electroretinography
69024|NCT03772912|Hemostatics|hemostatics
69025|NCT03772912|Coagulants|coagulants
69026|NCT03772886|Peanut Ball|peanut ball
69027|NCT03772795|Pulpal blood flow|pulpal blood flow
69028|NCT03772795|clear aligners|clear aligners
69029|NCT03772795|orthodontics|orthodontics
69030|NCT03772756|pancreatic adenocarcinoma|pancreatic adenocarcinoma
69031|NCT03772756|radiofrequency ablation|radiofrequency ablation
69032|NCT03772756|Endoscopic ultrasound|endoscopic ultrasound
69033|NCT03772743|older adults|older adults
69034|NCT03772743|multivessel coronary disease|multivessel coronary disease
69035|NCT03772743|intracoronary physiology|intracoronary physiology
69036|NCT03772743|functional assessment|functional assessment
69037|NCT03772717|Pediatrics|pediatrics
69038|NCT03772717|Vagus nerve stimulation|vagus nerve stimulation
69039|NCT03772665|Stargardt Disease|stargardt disease
69040|NCT03772665|STGD|stgd
69041|NCT03772665|ABCA4|abca4
69042|NCT03772626|COPD|copd
69043|NCT03772626|Heated humidified high-flow nasal cannula|heated humidified high-flow nasal cannula
69044|NCT03772626|Exacerbation of COPD|exacerbation of copd
69045|NCT03772613|activated clotting time|activated clotting time
69046|NCT03772613|outcomes|outcomes
69047|NCT03772613|bleeding|bleeding
69048|NCT03772600|Dexcom G6|dexcom g6
69049|NCT03772600|FreeStyle Libre|freestyle libre
69050|NCT03772600|time in range|time in range
69051|NCT03772600|continuous glucose monitoring|continuous glucose monitoring
69052|NCT03772600|flash glucose monitoring|flash glucose monitoring
69053|NCT03772587|M281|m281
69054|NCT03772587|Generalized Myasthenia Gravis|generalized myasthenia gravis
69055|NCT03772561|AZD5363|azd5363
69056|NCT03772561|Olaparib|olaparib
69057|NCT03772561|Durvalumab|durvalumab
69058|NCT03772561|Solid Tumor|solid tumor
69059|NCT03772522|Hopelessness|hopelessness
69060|NCT03772522|Self Esteem|self esteem
69061|NCT03772522|Social Isolation|social isolation
69062|NCT03772522|Employment Status|employment status
69063|NCT03772522|Education|education
69064|NCT03772522|Housing Problems|housing problems
69065|NCT03772522|Identity, Social|identity, social
69066|NCT03772522|Self Efficacy|self efficacy
69067|NCT03772522|Control Locus|control locus
69068|NCT03772522|Poverty|poverty
69069|NCT03772522|Youth|youth
69070|NCT03772522|Homelessness|homelessness
69071|NCT03772522|Homeless Youth|homeless youth
69072|NCT03772509|mobile phone surveys|mobile phone surveys
69073|NCT03772509|interactive voice response|interactive voice response
69074|NCT03772509|computer-assisted telephone interviews|computer-assisted telephone interviews
69075|NCT03772509|introduction mode|introduction mode
69076|NCT03772496|fine needle aspiration biopsy|fine needle aspiration biopsy
69077|NCT03772496|Circulating tumor cells|circulating tumor cells
69078|NCT03772496|benign|benign
69079|NCT03772496|malignant|malignant
69080|NCT03772483|virtual reality|virtual reality
69081|NCT03772483|pain control|pain control
69082|NCT03772483|pediatric dental patients|pediatric dental patients
69083|NCT03772483|pediatric pain management|pediatric pain management
69084|NCT03772483|local anesthesia children|local anesthesia children
69085|NCT03772470|mobile phone surveys|mobile phone surveys
69086|NCT03772470|interactive voice response|interactive voice response
69087|NCT03772470|incentive|incentive
69088|NCT03772431|mobile phone surveys|mobile phone surveys
69089|NCT03772431|interactive voice response|interactive voice response
69090|NCT03772431|narration|narration
69091|NCT03772288|Drug Therapy|drug therapy
69092|NCT03772262|Pharmacokinetics|pharmacokinetics
69093|NCT03772262|Goldenseal|goldenseal
69094|NCT03772262|Metformin|metformin
69095|NCT03772262|Furosemide|furosemide
69096|NCT03772262|Rosuvastatin|rosuvastatin
69097|NCT03772262|Midazolam|midazolam
69098|NCT03772262|Natural product|natural product
69099|NCT03772249|Chronic Hepatitis B|chronic hepatitis b
69100|NCT03772249|DNA Virus Infections|dna virus infections
69101|NCT03772249|CHB|chb
69102|NCT03772249|HBsAg|hbsag
69103|NCT03772249|Liver Disease|liver disease
69104|NCT03772249|RNAi|rnai
69105|NCT03772236|Total Ankle Replacement; Pain Measurement|total ankle replacement; pain measurement
69106|NCT03772223|Pharmacokinectics|pharmacokinectics
69107|NCT03772223|Inhaled corticosteroid|inhaled corticosteroid
69108|NCT03772210|fMRI|fmri
69109|NCT03772210|mechanism|mechanism
69110|NCT03772210|tDCS|tdcs
69111|NCT03772210|neuromodulation|neuromodulation
69112|NCT03772197|Breast cancer|breast cancer
69113|NCT03772197|Distant recurrence|distant recurrence
69114|NCT03772197|NanoString|nanostring
69115|NCT03772197|Gene-expression profiling|gene-expression profiling
69116|NCT03772197|Prognosis|prognosis
69117|NCT03772197|Locoreginal recurrence|locoreginal recurrence
69118|NCT03772158|Bioequivalence study|bioequivalence study
69119|NCT03772158|Healthy volunteers|healthy volunteers
69120|NCT03772158|Cetirizine|cetirizine
69121|NCT03772158|Tablet|tablet
69122|NCT03772145|Ulcerative colitis|ulcerative colitis
69123|NCT03772145|Inflammatory bowel diseases|inflammatory bowel diseases
69124|NCT03772145|Tofacitinib|tofacitinib
69125|NCT03772119|Vertebral Malformation|vertebral malformation
69126|NCT03772119|Hemivertebra|hemivertebra
69127|NCT03772119|Surgical resection|surgical resection
69128|NCT03772119|SOFOP|sofop
69129|NCT03772106|hepato-splanchnic blood flow|hepato-splanchnic blood flow
69130|NCT03772093|massage|massage
69131|NCT03772093|low back pain|low back pain
69132|NCT03772093|Trabert current|trabert current
69133|NCT03772093|Ultra-Reiz current|ultra-reiz current
69134|NCT03772080|Antenatal Counseling|antenatal counseling
69135|NCT03772080|Education|education
69136|NCT03772054|Syndecan-1|syndecan-1
69137|NCT03772054|Heparan sulfate|heparan sulfate
69138|NCT03772054|Thrombomodulin|thrombomodulin
69139|NCT03772054|Ischemia Reperfusion|ischemia reperfusion
69140|NCT03772054|Anesthesia|anesthesia
820231|NCT00157638|pharmacist|pharmacist
69141|NCT03772028|ovarian cancer|ovarian cancer
69142|NCT03772028|HIPEC|hipec
69143|NCT03772028|OVHIPEC|ovhipec
69144|NCT03772028|primary debulking|primary debulking
69145|NCT03772015|laparoscopic lateral mesh suspension|laparoscopic lateral mesh suspension
69146|NCT03772015|lateral abdominocervicopexy|lateral abdominocervicopexy
69147|NCT03772015|apical prolapse|apical prolapse
69148|NCT03772015|anterior prolapse|anterior prolapse
69149|NCT03772015|vaginal axis|vaginal axis
69150|NCT03772015|magnetic resonance imaging|magnetic resonance imaging
69151|NCT03771976|Older women (>35 years of age)|older women (>35 years of age)
69152|NCT03771976|Primipara|primipara
69153|NCT03771976|Cesarean section|cesarean section
69154|NCT03771963|Vaccine|vaccine
69155|NCT03771950|rehabilitation|rehabilitation
69156|NCT03771937|lifestyle change|lifestyle change
69157|NCT03771937|telephone follow-up|telephone follow-up
69158|NCT03771937|Roy Adaptation Model|roy adaptation model
69159|NCT03771924|inorganic phosphate|inorganic phosphate
69160|NCT03771924|postprandial response|postprandial response
69161|NCT03771924|fibroblast growth factor-23|fibroblast growth factor-23
69162|NCT03771924|health individuals|health individuals
69163|NCT03771846|intrahepatic cholangiocarcinoma|intrahepatic cholangiocarcinoma
69164|NCT03771846|systemic chemotherapy|systemic chemotherapy
69165|NCT03771846|hepatic artery infusion chemotherapy|hepatic artery infusion chemotherapy
69166|NCT03771833|breast|breast
69167|NCT03771833|cancer|cancer
69168|NCT03771833|breast cancer|breast cancer
69169|NCT03771833|imaging|imaging
69170|NCT03771794|HRV|hrv
69171|NCT03771794|Peripheral neuromodulation|peripheral neuromodulation
69172|NCT03771794|Autonomic balance|autonomic balance
69173|NCT03771768|Oral ulcers|oral ulcers
69174|NCT03771755|ibuprofen|ibuprofen
69175|NCT03771755|acetaminophen|acetaminophen
69176|NCT03771755|orthopedic|orthopedic
69177|NCT03771755|VAS|vas
69178|NCT03771755|morphine|morphine
69179|NCT03771755|opioid|opioid
69180|NCT03771729|Sacubitril/Valsartan|sacubitril/valsartan
69181|NCT03771729|Advanced CKD Patients|advanced ckd patients
69182|NCT03771729|Heart Failure|heart failure
69183|NCT03771690|Appetite|appetite
69184|NCT03771690|FTO|fto
69185|NCT03771690|Ghrelin|ghrelin
69186|NCT03771690|Individual variability|individual variability
69187|NCT03771690|Meal intake|meal intake
69188|NCT03771690|Peptide YY|peptide yy
69189|NCT03771677|Chronic Hepatitis B|chronic hepatitis b
69190|NCT03771677|IFNA2p.Ala120Thr /ISGs|ifna2p.ala120thr /isgs
69191|NCT03771638|Adherence|adherence
69192|NCT03771638|PrEP|prep
69193|NCT03771638|HIV Prevention|hiv prevention
69194|NCT03771638|Truvada|truvada
69195|NCT03771638|HIV Risk Reduction|hiv risk reduction
69196|NCT03771638|Mobile App|mobile app
69197|NCT03771625|fMRI|fmri
69198|NCT03771625|DTI|dti
69199|NCT03771625|Intracranial Germ cell tumor|intracranial germ cell tumor
69200|NCT03771625|Basal ganglia|basal ganglia
69201|NCT03771612|Immune system|immune system
69202|NCT03771612|Social psychology|social psychology
69203|NCT03771612|Health psychology|health psychology
69204|NCT03771599|cerebral palsy, traditional massage, spasticity, children|cerebral palsy, traditional massage, spasticity, children
69205|NCT03771573|REHABILITATION|rehabilitation
69206|NCT03771573|PHYSICAL THERAPY|physical therapy
69207|NCT03771573|CARDIOVASCULAR DISEASE|cardiovascular disease
69208|NCT03771547|ERCP|ercp
69209|NCT03771547|Elderly|elderly
69210|NCT03771547|Difficult cannulation|difficult cannulation
69211|NCT03771534|maternal hyperoxygenation|maternal hyperoxygenation
69212|NCT03771534|fetal echocardiography|fetal echocardiography
69213|NCT03771534|fetal MRI|fetal mri
69214|NCT03771495|mobilization|mobilization
69215|NCT03771495|muscle strength|muscle strength
69216|NCT03771495|hip abductors|hip abductors
69217|NCT03771495|hip external rotators|hip external rotators
69218|NCT03771469|OSA|osa
69219|NCT03771469|obstructive sleep apnea|obstructive sleep apnea
69220|NCT03771469|Down syndrome|down syndrome
69221|NCT03771469|sleep questionnaires|sleep questionnaires
69222|NCT03771469|sleep study|sleep study
69223|NCT03771443|Gluten-free toothpaste,celiac disease, GFD, children|gluten-free toothpaste,celiac disease, gfd, children
69224|NCT03771430|Total knee arthroplasty|total knee arthroplasty
69225|NCT03771430|Physiotherapy|physiotherapy
69226|NCT03771430|Cognitive behavioral therapy|cognitive behavioral therapy
69227|NCT03771430|e-therapy|e-therapy
69228|NCT03771404|NSCLC|nsclc
69229|NCT03771404|Tumor heterogeneity|tumor heterogeneity
69230|NCT03771404|liquid biopsy|liquid biopsy
69231|NCT03771404|CTCs|ctcs
69232|NCT03771404|ctDNA|ctdna
69233|NCT03771404|NGS|ngs
69234|NCT03771391|Phenylketonuria|phenylketonuria
69235|NCT03771391|PKU|pku
69236|NCT03771391|Child|child
69237|NCT03771391|Children|children
69238|NCT03771391|Adult|adult
69239|NCT03771391|Adults|adults
69240|NCT03771391|GMP|gmp
69241|NCT03771391|Glycomacropeptide|glycomacropeptide
69242|NCT03771391|Amino acid mixture|amino acid mixture
69243|NCT03771391|Amino acid|amino acid
69244|NCT03771391|Protein supplement|protein supplement
69245|NCT03771391|Protein substitute|protein substitute
69246|NCT03771378|ITP|itp
69247|NCT03771378|rhTPO|rhtpo
69248|NCT03771378|Eltrombopag|eltrombopag
69249|NCT03771378|platelets|platelets
69250|NCT03771365|percutaneous nephrostolithotomy|percutaneous nephrostolithotomy
69251|NCT03771365|renal stone|renal stone
69252|NCT03771365|safety|safety
69253|NCT03771365|efficacy|efficacy
69254|NCT03771339|quadratus lumborum block|quadratus lumborum block
69255|NCT03771339|continuous epidural|continuous epidural
69256|NCT03771339|postoperative analgesia|postoperative analgesia
69257|NCT03771339|kidney transplant|kidney transplant
69258|NCT03771300|Wellness|wellness
69259|NCT03771300|University students|university students
69260|NCT03771300|Mindfulness|mindfulness
69261|NCT03771300|Virtual Reality (VR)|virtual reality (vr)
69262|NCT03771261|Egg|egg
69263|NCT03771261|Protein|protein
69264|NCT03771261|Aging|aging
69265|NCT03771261|Health Disparities|health disparities
69266|NCT03771261|Weight Loss|weight loss
69267|NCT03771235|Tourette Syndrome|tourette syndrome
69268|NCT03771235|Tic Disorder|tic disorder
69269|NCT03771235|Online|online
69270|NCT03771235|Adults|adults
69271|NCT03771235|Mindfulness|mindfulness
69272|NCT03771235|Therapy|therapy
69273|NCT03771209|ultrasound assessment|ultrasound assessment
69274|NCT03771209|ankle brachial index|ankle brachial index
69275|NCT03771209|lung ultrasound|lung ultrasound
69276|NCT03771209|carotid intima media thickness|carotid intima media thickness
69277|NCT03771209|vascular ultrasound (abdominal aorta and cave vein)|vascular ultrasound (abdominal aorta and cave vein)
69278|NCT03771209|echocardiographic ejection fraction|echocardiographic ejection fraction
69279|NCT03771196|Bioactive Restorative Material|bioactive restorative material
69280|NCT03771196|ACTIVA Restorative|activa restorative
69281|NCT03771196|Resin Modified Glass Ionomer (RMGI)|resin modified glass ionomer (rmgi)
69282|NCT03771196|class V|class v
69283|NCT03771196|Clinical perfomance|clinical perfomance
69284|NCT03771157|shingles vaccine (Shingrix)|shingles vaccine (shingrix)
69285|NCT03771157|Chronic lymphocytic leukemia (CLL)|chronic lymphocytic leukemia (cll)
69286|NCT03771157|Waldenstrom macroglobulinemia (WM)|waldenstrom macroglobulinemia (wm)
69287|NCT03771157|Pilot Study|pilot study
69288|NCT03771144|Brachial obstetrical palsy|brachial obstetrical palsy
69289|NCT03771131|healthy cognitive ageing|healthy cognitive ageing
69290|NCT03771131|multi-domain cognitive training|multi-domain cognitive training
69291|NCT03771118|Drug Hypersensitivity Reaction|drug hypersensitivity reaction
69292|NCT03771118|Drug Provocation Test|drug provocation test
69293|NCT03771118|Paracetamol|paracetamol
69294|NCT03771118|Reactive Doses|reactive doses
69295|NCT03771118|Reactive Times|reactive times
69296|NCT03771118|Acetaminophen|acetaminophen
69297|NCT03771092|Iron|iron
69298|NCT03771092|Iron Deficiency Anemia|iron deficiency anemia
69299|NCT03771092|Anemia|anemia
69300|NCT03771079|Hematological Malignancy|hematological malignancy
69301|NCT03771079|mutations|mutations
69302|NCT03771079|NGS sequencing|ngs sequencing
69303|NCT03771079|mass spectrometry|mass spectrometry
69304|NCT03771066|bisphenol A|bisphenol a
69305|NCT03771066|diet|diet
69306|NCT03771053|Coronary heart disease|coronary heart disease
69307|NCT03771053|Atherosclerosis|atherosclerosis
69308|NCT03771053|Acute myocardial infarction|acute myocardial infarction
69309|NCT03771053|Coronary intervention|coronary intervention
69310|NCT03771040|Severe persistent asthma|severe persistent asthma
69311|NCT03771040|Eosinophil|eosinophil
69312|NCT03771040|Tyrosine kinase inhibitor|tyrosine kinase inhibitor
69313|NCT03771027|low FODMAP diet|low fodmap diet
69314|NCT03771027|functional abdominal pain|functional abdominal pain
69315|NCT03771027|children|children
69316|NCT03771014|intensive care|intensive care
69317|NCT03771014|physiotherapy|physiotherapy
69318|NCT03771014|rehabilitation|rehabilitation
69319|NCT03771001|Wellness|wellness
69320|NCT03771001|Caregivers|caregivers
69321|NCT03771001|Lifestyle|lifestyle
69322|NCT03771001|Stressor|stressor
69323|NCT03770988|esophageal squamous carcinoma|esophageal squamous carcinoma
69324|NCT03770988|poziotinib|poziotinib
69325|NCT03770988|pan-HER inhibitor|pan-her inhibitor
69326|NCT03770962|Midwifery intervention|midwifery intervention
69327|NCT03770962|Birth experience|birth experience
69328|NCT03770962|Obstetric anal sphincter injuries|obstetric anal sphincter injuries
69329|NCT03770962|Perineal tears|perineal tears
69330|NCT03770949|3-D printing|3-d printing
69331|NCT03770949|Children|children
69332|NCT03770949|Adolescents|adolescents
69333|NCT03770910|GIP|gip
69334|NCT03770910|Insulin secretin|insulin secretin
69335|NCT03770910|Incretin hormone|incretin hormone
69336|NCT03770897|3d Laparoscopy|3d laparoscopy
69337|NCT03770884|rheumatoid arthritis|rheumatoid arthritis
69338|NCT03770884|Axial spondyloarthritis|axial spondyloarthritis
69339|NCT03770884|hand osteoarthritis|hand osteoarthritis
69340|NCT03770884|diet|diet
69341|NCT03770884|beliefs|beliefs
69342|NCT03770871|indirect pulp|indirect pulp
69343|NCT03770871|primary|primary
69344|NCT03770871|calcium hydroxide|calcium hydroxide
69345|NCT03770871|resin modified glass ionomer|resin modified glass ionomer
69346|NCT03770871|Children|children
69347|NCT03770858|Wearables|wearables
70145|NCT03765905|SCUBE|scube
69348|NCT03770858|Atopic Dermatitis|atopic dermatitis
69349|NCT03770858|Scratch sensor|scratch sensor
69350|NCT03770845|nutritional status|nutritional status
69351|NCT03770845|vitamin D|vitamin d
69352|NCT03770793|One lung ventilation|one lung ventilation
69353|NCT03770793|Lung ultrasound|lung ultrasound
69354|NCT03770793|Alveolar recruitment|alveolar recruitment
69355|NCT03770754|clean|clean
69356|NCT03770754|Primary Root canal|primary root canal
69357|NCT03770754|rotary instrumentation|rotary instrumentation
69358|NCT03770741|Near-infrared spectroscopy|near-infrared spectroscopy
69359|NCT03770741|NIRS|nirs
69360|NCT03770741|Cerebral oximetry|cerebral oximetry
69361|NCT03770741|Extremely preterm|extremely preterm
69362|NCT03770741|Brain injury|brain injury
69363|NCT03770741|Mortality|mortality
69364|NCT03770741|Treatment guideline|treatment guideline
69365|NCT03770715|Sleep Apnea|sleep apnea
69366|NCT03770715|Respiratory polygraphy|respiratory polygraphy
69367|NCT03770715|Extubation|extubation
69368|NCT03770689|DNA-PK inhibitor|dna-pk inhibitor
69369|NCT03770689|M3814|m3814
69370|NCT03770689|capecitabine|capecitabine
69371|NCT03770676|Food sensory perception|food sensory perception
69372|NCT03770676|Selenium|selenium
69373|NCT03770637|glucagon|glucagon
69374|NCT03770637|post-bariatric hypoglycemia|post-bariatric hypoglycemia
69375|NCT03770611|dialysis|dialysis
69376|NCT03770611|uremic toxin|uremic toxin
69377|NCT03770611|inflammation|inflammation
69378|NCT03770611|prebiotics|prebiotics
69379|NCT03770611|probiotics|probiotics
69380|NCT03770598|Psychosocial Care|psychosocial care
69381|NCT03770598|Wellness|wellness
69382|NCT03770572|CLN3|cln3
69383|NCT03770572|Neuronal ceroid lipofuscinosis|neuronal ceroid lipofuscinosis
69384|NCT03770572|NCL|ncl
69385|NCT03770572|Gene Transfer|gene transfer
69386|NCT03770559|Radical Antegrade Modular Pancreatosplenectomy|radical antegrade modular pancreatosplenectomy
69387|NCT03770559|Pancreatic cancer|pancreatic cancer
69388|NCT03770559|Laparoscopy|laparoscopy
69389|NCT03770559|Open|open
69390|NCT03770520|Quantitative Flow Ratio|quantitative flow ratio
69391|NCT03770520|Coronary Artery Bypass Grafting|coronary artery bypass grafting
69392|NCT03770520|Graft patency|graft patency
69393|NCT03770481|communication|communication
69394|NCT03770481|end-of-life|end-of-life
69395|NCT03770481|intensive care unit|intensive care unit
69396|NCT03770442|ICU acquired weakness (ICU-AW)|icu acquired weakness (icu-aw)
69397|NCT03770442|FES|fes
69398|NCT03770442|Functional Electrical Stimulation|functional electrical stimulation
69399|NCT03770442|Rehabilitation|rehabilitation
69400|NCT03770429|Leukemia|leukemia
69401|NCT03770429|Myelodysplastic Syndrome|myelodysplastic syndrome
69402|NCT03770377|speech|speech
69403|NCT03770377|swallowing|swallowing
69404|NCT03770377|rehabilitation|rehabilitation
69405|NCT03770377|stroke|stroke
69406|NCT03770377|deglutition|deglutition
69407|NCT03770377|dysphagia|dysphagia
69408|NCT03770377|dysarthria|dysarthria
69409|NCT03770377|laryngeal|laryngeal
69410|NCT03770377|ataxia|ataxia
69411|NCT03770351|genomics|genomics
69412|NCT03770351|racial disparities|racial disparities
69413|NCT03770351|patient reported outcomes|patient reported outcomes
69414|NCT03770338|osteoporosis, teriparatide, insertional torque|osteoporosis, teriparatide, insertional torque
69415|NCT03770273|Cytokine|cytokine
69416|NCT03770273|Monoclonal Therapy|monoclonal therapy
69417|NCT03770273|Interleukin-6|interleukin-6
69418|NCT03770273|Mast Cell|mast cell
69419|NCT03770273|Bone Marrow|bone marrow
69420|NCT03770208|Lidocaine Infusions|lidocaine infusions
69421|NCT03770208|Thoracic trauma|thoracic trauma
69422|NCT03770208|Analgesic Management|analgesic management
69423|NCT03770208|Rib Fractures|rib fractures
69424|NCT03770208|Pain|pain
69425|NCT03770195|Hemostatics|hemostatics
69426|NCT03770195|Coagulants|coagulants
69427|NCT03770156|Terrorist attack|terrorist attack
69428|NCT03770156|Post-Traumatic Stress Disorder|post-traumatic stress disorder
69429|NCT03770156|Depression|depression
69430|NCT03770156|Psychotherapy|psychotherapy
69431|NCT03770156|Mental health|mental health
69432|NCT03770156|Victimology|victimology
69433|NCT03770156|Mourning|mourning
69434|NCT03770117|Pancreas|pancreas
69435|NCT03770117|Cancer|cancer
69436|NCT03770117|Sarcopenia|sarcopenia
69437|NCT03770117|Cachexia|cachexia
69438|NCT03770117|Prehabilitation|prehabilitation
69439|NCT03770117|Pancreatoduodenectomy|pancreatoduodenectomy
69440|NCT03770104|Intubation|intubation
69441|NCT03770104|Newborn|newborn
69442|NCT03770104|Delivery room|delivery room
69443|NCT03770104|Complications|complications
69444|NCT03770039|PF-06700841|pf-06700841
69445|NCT03770039|mass balance|mass balance
69446|NCT03770039|metabolites|metabolites
69447|NCT03770039|absolute bioavailability|absolute bioavailability
69448|NCT03770013|Bupivacaine|bupivacaine
69449|NCT03770013|Dexmedetomidine|dexmedetomidine
69450|NCT03770013|Clonidine|clonidine
69451|NCT03770013|Transversus Abdominis Plane Block|transversus abdominis plane block
70536|NCT03762902|Prediction|prediction
69463|NCT03769909|Osteoarthritis|osteoarthritis
69464|NCT03769909|Intra-Articular Fractures|intra-articular fractures
69465|NCT03769909|Ankle Fractures|ankle fractures
69467|NCT03769909|Biomarkers|biomarkers
69468|NCT03769909|Inflammation|inflammation
69469|NCT03769909|Pro-inflammatory|pro-inflammatory
69470|NCT03769909|Cartilage|cartilage
69471|NCT03769909|Fracture|fracture
69472|NCT03769909|Joint Injury|joint injury
69473|NCT03769896|Parkinson´s Disease|parkinson´s disease
69474|NCT03769896|cannabinoids|cannabinoids
69475|NCT03769896|non-motor symptoms|non-motor symptoms
69476|NCT03769883|Exercise|exercise
69477|NCT03769883|Physical Activity|physical activity
69478|NCT03769883|Type 2 diabetes|type 2 diabetes
69479|NCT03769883|Pancreatic beta-cell function|pancreatic beta-cell function
69480|NCT03769883|Insulin sensitivity|insulin sensitivity
69481|NCT03769883|Dose finding|dose finding
69482|NCT03769883|lifestyle|lifestyle
69483|NCT03769857|exercise-induced|exercise-induced
69484|NCT03769857|joint pain|joint pain
69485|NCT03769857|joint stiffness|joint stiffness
69486|NCT03769857|cartilage turnover|cartilage turnover
69487|NCT03769857|CTX-II|ctx-ii
69488|NCT03769844|sepsis|sepsis
69489|NCT03769844|MODS|mods
69490|NCT03769844|pediatric|pediatric
69491|NCT03769844|immunoparalysis|immunoparalysis
69492|NCT03769844|GM-CSF|gm-csf
69493|NCT03769818|erector spinae plane block|erector spinae plane block
69494|NCT03769818|total abdominal hysterectomy|total abdominal hysterectomy
69495|NCT03769818|dexamethasone|dexamethasone
69496|NCT03769805|anlotinib|anlotinib
69497|NCT03769805|Maintenance treatment|maintenance treatment
69498|NCT03769792|Obstetrical anal sphincter injury|obstetrical anal sphincter injury
69499|NCT03769792|Impedance spectroscopy|impedance spectroscopy
69500|NCT03769766|prostate cancer|prostate cancer
69501|NCT03769766|active surveillance|active surveillance
69502|NCT03769766|curcumin|curcumin
69503|NCT03769753|intraoperative use of IRE|intraoperative use of ire
69504|NCT03769753|18-489|18-489
69505|NCT03769740|cardiac arrest, cardiac death, CPR, neurologic prognostication, emergency medicine,|cardiac arrest, cardiac death, cpr, neurologic prognostication, emergency medicine,
69506|NCT03769714|laparoscopy|laparoscopy
69507|NCT03769714|supracervical hysterectomy|supracervical hysterectomy
69508|NCT03769714|Multimodal pain management|multimodal pain management
69509|NCT03769714|bupivacaine liposome|bupivacaine liposome
69510|NCT03769714|Exparel|exparel
69511|NCT03769688|bacterial vaginosis|bacterial vaginosis
69512|NCT03769688|cervicovaginal secretions|cervicovaginal secretions
69513|NCT03769688|vaginal microbiota|vaginal microbiota
69514|NCT03769675|spinal cord stimulation|spinal cord stimulation
69515|NCT03769675|type 2 diabetes|type 2 diabetes
69516|NCT03769662|Cytokines|cytokines
69517|NCT03769662|Anti-inflammatory|anti-inflammatory
69518|NCT03769662|Pain|pain
69519|NCT03769662|Inflammation|inflammation
69520|NCT03769636|Multiple Sclerosis|multiple sclerosis
69521|NCT03769636|In-patient rehabilitation|in-patient rehabilitation
69522|NCT03769636|All day life activities|all day life activities
69523|NCT03769636|Walking capacity|walking capacity
69524|NCT03769636|Fatigue|fatigue
69525|NCT03769636|Quality of life|quality of life
69526|NCT03769610|Foley|foley
69527|NCT03769610|Transcervical|transcervical
69528|NCT03769597|Cirrhosis Renal|cirrhosis renal
69529|NCT03769597|GFR|gfr
69530|NCT03769597|renal function|renal function
69531|NCT03769597|Bayesian model|bayesian model
69532|NCT03769597|plasma clearance|plasma clearance
69533|NCT03769597|iohexol|iohexol
69534|NCT03769584|quality of life|quality of life
69535|NCT03769584|treatment outcome|treatment outcome
69536|NCT03769584|sexuality|sexuality
69537|NCT03769584|partnership|partnership
69538|NCT03769584|surgery of endometriosis|surgery of endometriosis
69539|NCT03769532|AML|aml
69540|NCT03769532|NPM1mut|npm1mut
69541|NCT03769532|molecular relapse|molecular relapse
69542|NCT03769532|pembrolizumab|pembrolizumab
69543|NCT03769532|azacitidine|azacitidine
69544|NCT03769519|health disparities|health disparities
69545|NCT03769519|african american|african american
69546|NCT03769519|adult|adult
69554|NCT03769493|Medication adherence|medication adherence
69555|NCT03769493|Treatment adherence|treatment adherence
69556|NCT03769493|Ecological momentary assessment|ecological momentary assessment
69557|NCT03769493|Ecological momentary intervention|ecological momentary intervention
69558|NCT03769493|Coping skills|coping skills
69559|NCT03769493|Psychiatric Hospitalization|psychiatric hospitalization
69560|NCT03769480|Athletes|athletes
69561|NCT03769480|Disability|disability
69562|NCT03769480|Respiratory Function|respiratory function
69563|NCT03769480|Core Muscles|core muscles
69564|NCT03769480|Sport|sport
69565|NCT03769467|Nasopharyngeal Carcinoma (NPC)|nasopharyngeal carcinoma (npc)
69566|NCT03769467|NPC|npc
69567|NCT03769467|Nasopharyngeal Cancer|nasopharyngeal cancer
69568|NCT03769467|Nose Cancer|nose cancer
69569|NCT03769467|Epstein-Barr Virus (EBV)|epstein-barr virus (ebv)
69570|NCT03769467|Epstein-Barr Virus Viremia|epstein-barr virus viremia
69571|NCT03769467|EBV-associated NPC|ebv-associated npc
69572|NCT03769467|Allogeneic, off-the-shelf T-cell|allogeneic, off-the-shelf t-cell
69573|NCT03769467|immunotherapy|immunotherapy
69574|NCT03769467|Head and Neck Cancer|head and neck cancer
69575|NCT03769467|Carcinoma|carcinoma
69576|NCT03769467|Nasopharyngeal Neoplasms|nasopharyngeal neoplasms
69577|NCT03769467|Neoplasms, Glandular and Epithelial|neoplasms, glandular and epithelial
69578|NCT03769467|Neoplasms by Histologic Type|neoplasms by histologic type
69579|NCT03769467|Neoplasms|neoplasms
69580|NCT03769467|Pharyngeal Neoplasms|pharyngeal neoplasms
69581|NCT03769467|Otorhinolaryngologic Neoplasms|otorhinolaryngologic neoplasms
69582|NCT03769467|Head and Neck Neoplasms|head and neck neoplasms
69583|NCT03769467|Neoplasms by Site|neoplasms by site
69584|NCT03769467|Nasopharyngeal Diseases|nasopharyngeal diseases
69585|NCT03769467|Pharyngeal Diseases|pharyngeal diseases
69586|NCT03769467|Stomatognathic Diseases|stomatognathic diseases
69587|NCT03769467|Otorhinolaryngologic Diseases|otorhinolaryngologic diseases
69588|NCT03769467|Pembrolizumab|pembrolizumab
69589|NCT03769467|Programmed death-1 (PD-1)|programmed death-1 (pd-1)
69590|NCT03769467|Programmed death-ligand 1(PD-L1)|programmed death-ligand 1(pd-l1)
69591|NCT03769441|Renal Transplantation|renal transplantation
69592|NCT03769441|Kidney Transplantation|kidney transplantation
69593|NCT03769441|Iron Deficiency|iron deficiency
69594|NCT03769428|opioid consumption|opioid consumption
69595|NCT03769428|erector spinae plane block|erector spinae plane block
69596|NCT03769428|breast surgery|breast surgery
69597|NCT03769428|analgesia|analgesia
69598|NCT03769428|PCA morphine|pca morphine
69599|NCT03769428|Locoregional anesthesia|locoregional anesthesia
69600|NCT03769428|breast cancer surgery|breast cancer surgery
69601|NCT03769376|toothlessness|toothlessness
69602|NCT03769337|serum markers of infections|serum markers of infections
69603|NCT03769298|Tremors|tremors
69604|NCT03769259|suicide|suicide
69605|NCT03769259|suicidal ideation|suicidal ideation
69606|NCT03769259|ambivalence|ambivalence
69607|NCT03769259|suicide ambivalence|suicide ambivalence
69608|NCT03769259|reasons for living|reasons for living
69609|NCT03769259|reasons for dying|reasons for dying
69610|NCT03769259|military|military
69611|NCT03769259|clinical trial|clinical trial
69612|NCT03769259|cognitive behavioral therapy|cognitive behavioral therapy
69613|NCT03769259|psychotherapy|psychotherapy
69614|NCT03769259|crisis|crisis
69615|NCT03769259|Crisis Response Plan (CRP)|crisis response plan (crp)
69616|NCT03769259|Present Centered Therapy (PCT)|present centered therapy (pct)
69617|NCT03769259|Brief Cognitive-Behavioral Therapy (BCBT)|brief cognitive-behavioral therapy (bcbt)
69618|NCT03769246|Upright|upright
69619|NCT03769246|Back|back
69620|NCT03769246|Posture|posture
69621|NCT03769246|Back pain|back pain
69622|NCT03769233|Mindfulness|mindfulness
69623|NCT03769233|Well-being|well-being
69624|NCT03769233|Emotion Regulation|emotion regulation
69625|NCT03769233|Perceived Stress|perceived stress
69626|NCT03769233|Self-Compassion|self-compassion
69627|NCT03769220|Time up and Go Test|time up and go test
69628|NCT03769194|VLA15, Lyme Borreliosis, Vaccine|vla15, lyme borreliosis, vaccine
69629|NCT03769168|JIA|jia
69630|NCT03769168|JPsA|jpsa
69631|NCT03769168|ERA|era
69632|NCT03769168|Secukinumab|secukinumab
69633|NCT03769168|ILAR|ilar
69634|NCT03769168|Juvenile Psoriatic Arthritis|juvenile psoriatic arthritis
69635|NCT03769168|Enthesitis Related Arthritis|enthesitis related arthritis
69636|NCT03769168|cain457|cain457
69637|NCT03769168|cain457f|cain457f
69638|NCT03769142|cerebral perfusion|cerebral perfusion
69639|NCT03769142|hypotension|hypotension
69640|NCT03769142|transcranial Doppler|transcranial doppler
69641|NCT03769142|general anesthesia|general anesthesia
69642|NCT03769142|Bispectral Index|bispectral index
69643|NCT03769142|Near-infrared spectroscopy (NIRS)|near-infrared spectroscopy (nirs)
69644|NCT03769129|Microwave ablation|microwave ablation
69645|NCT03769129|Pembrolizumab|pembrolizumab
69646|NCT03769129|NSCLC|nsclc
69647|NCT03769116|Duchenne Muscular Dystrophy|duchenne muscular dystrophy
69648|NCT03769116|Gene-Delivery|gene-delivery
69649|NCT03769116|DMD|dmd
69650|NCT03769116|Ambulatory|ambulatory
69651|NCT03769116|Pediatric|pediatric
70537|NCT03762902|Forecast|forecast
69652|NCT03769116|North Star Ambulatory Assessment (NSAA)|north star ambulatory assessment (nsaa)
69653|NCT03769116|Percent Dystrophin Positive Fibers (PDPF)|percent dystrophin positive fibers (pdpf)
69654|NCT03769103|EGFR positive|egfr positive
69655|NCT03769103|Osimertinib|osimertinib
69656|NCT03769103|SRS|srs
69657|NCT03769077|Cerebral Palsy|cerebral palsy
820232|NCT00157638|physician|physician
69658|NCT03769077|Orthopedic Surgery|orthopedic surgery
69659|NCT03769077|Exergames|exergames
69660|NCT03769077|Motor Function|motor function
69661|NCT03769077|Rehabilitation|rehabilitation
69662|NCT03769077|GMFCS|gmfcs
69663|NCT03769077|Pain Reduction|pain reduction
69664|NCT03769077|Cycling|cycling
69665|NCT03769064|ADHD|adhd
69666|NCT03769064|attention deficit hyperactivity disorder|attention deficit hyperactivity disorder
69667|NCT03769064|stimulant|stimulant
69668|NCT03769051|Cow's Milk Protein allergy|cow's milk protein allergy
69669|NCT03769051|Open Food Challenge test|open food challenge test
69670|NCT03769051|Immune Tolerance|immune tolerance
69671|NCT03769051|Amino Acid Formula|amino acid formula
69672|NCT03769025|remote observed dosing|remote observed dosing
69673|NCT03768947|Chronic Pain|chronic pain
69674|NCT03768934|mobile phone surveys|mobile phone surveys
69675|NCT03768934|short message service|short message service
69676|NCT03768934|incentive|incentive
69677|NCT03768921|Dyspnea|dyspnea
69678|NCT03768921|Respiration, Artificial|respiration, artificial
69679|NCT03768921|Intensive Care Units|intensive care units
69680|NCT03768908|Artemether-Lumefantrine|artemether-lumefantrine
69681|NCT03768908|Coartem|coartem
69682|NCT03768908|Artesunate|artesunate
69683|NCT03768908|Amodiaquine|amodiaquine
69684|NCT03768908|Zanzibar|zanzibar
69685|NCT03768882|paracetamol,dexketoprofen,emergency department,sore throat|paracetamol,dexketoprofen,emergency department,sore throat
69686|NCT03768869|Pediatrics|pediatrics
69687|NCT03768869|Oncology|oncology
69688|NCT03768869|Outpatient therapy|outpatient therapy
69689|NCT03768856|Radiation|radiation
69690|NCT03768830|Quality of life|quality of life
69691|NCT03768830|Multiple Sclerosis|multiple sclerosis
69692|NCT03768830|Pain|pain
69693|NCT03768830|Headache|headache
69694|NCT03768830|Anxiety Disorders|anxiety disorders
69695|NCT03768830|Depressive Disorder|depressive disorder
69696|NCT03768830|Sleep Disorder|sleep disorder
69697|NCT03768830|Fatigue|fatigue
69698|NCT03768817|Long-chain Fatty Acid Oxidation Disorders (LC-FAOD)|long-chain fatty acid oxidation disorders (lc-faod)
69699|NCT03768817|Triheptanoin|triheptanoin
69700|NCT03768804|Cardiac resynchronisation therapy|cardiac resynchronisation therapy
69701|NCT03768804|Fusion pacing|fusion pacing
69702|NCT03768804|SyncAV|syncav
69703|NCT03768791|Spinal Cord Stimulation|spinal cord stimulation
69704|NCT03768791|Heart rate variability|heart rate variability
69705|NCT03768778|Penetrating brain trauma (PBT),Traumatic brain injury (TBI), Intensive care unit, non missile.|penetrating brain trauma (pbt),traumatic brain injury (tbi), intensive care unit, non missile.
69706|NCT03768752|intensive care unit|intensive care unit
69707|NCT03768752|echocardiography|echocardiography
69708|NCT03768739|Dysphagia|dysphagia
69709|NCT03768739|Extubation|extubation
69710|NCT03768739|Cardiac Intensive Care Unit (CICU)|cardiac intensive care unit (cicu)
69711|NCT03768739|Forced Expiratory Volume in One second (FEV1)|forced expiratory volume in one second (fev1)
69712|NCT03768739|Peak Expiratory Flow (PEF)|peak expiratory flow (pef)
69713|NCT03768687|pancreatic cancer|pancreatic cancer
69714|NCT03768687|albumin-bound paclitaxel|albumin-bound paclitaxel
69715|NCT03768674|Selfharming behaviors|selfharming behaviors
69716|NCT03768661|cholecystectomy|cholecystectomy
69717|NCT03768661|laparoscopy|laparoscopy
69718|NCT03768661|single-incision laparoscopic surgery|single-incision laparoscopic surgery
69719|NCT03768661|incisional hernia|incisional hernia
69720|NCT03768661|trocar-site hernia|trocar-site hernia
69721|NCT03768648|Autoimmune Diseases of the Nervous System|autoimmune diseases of the nervous system
69722|NCT03768648|Demyelinating Autoimmune Diseases, CNS|demyelinating autoimmune diseases, cns
69723|NCT03768648|Demyelinating Diseases|demyelinating diseases
69724|NCT03768648|Immune System Diseases|immune system diseases
69725|NCT03768648|Nervous System Diseases|nervous system diseases
69726|NCT03768648|Pathologic Processes|pathologic processes
69727|NCT03768648|cognitive impairment|cognitive impairment
69728|NCT03768648|ecological assessment|ecological assessment
69729|NCT03768648|brain MRI|brain mri
69730|NCT03768635|otitis|otitis
69731|NCT03768622|femoral neck fracture|femoral neck fracture
69732|NCT03768622|pertrochanteric femoral fracture|pertrochanteric femoral fracture
69733|NCT03768622|risk factor for proximal femoral fracture|risk factor for proximal femoral fracture
69734|NCT03768596|Nudge|nudge
69735|NCT03768596|acceptability|acceptability
69736|NCT03768583|Postural Balace|postural balace
69737|NCT03768583|Physioteraphy|physioteraphy
69738|NCT03768583|Ankle Injuries|ankle injuries
69739|NCT03768583|Electromyography|electromyography
69740|NCT03768544|generalized anxiety disorder|generalized anxiety disorder
69741|NCT03768544|older adult|older adult
69742|NCT03768544|psychological treatment|psychological treatment
69743|NCT03768544|randomized controlled trial|randomized controlled trial
69744|NCT03768531|Nivolumab|nivolumab
69751|NCT03768531|Adjuvant chemotherapy|adjuvant chemotherapy
69752|NCT03768531|Tumor microenvironment|tumor microenvironment
69754|NCT03768518|GLP-1|glp-1
69755|NCT03768518|PET/CT|pet/ct
69756|NCT03768492|Masectomy|masectomy
69757|NCT03768440|ropivacaine infusion|ropivacaine infusion
69758|NCT03768440|regional anesthesia|regional anesthesia
69759|NCT03768440|paravertebral block|paravertebral block
69760|NCT03768440|erector spinae block|erector spinae block
69761|NCT03768349|Prostate Cancer|prostate cancer
69762|NCT03768349|PET/CT|pet/ct
69763|NCT03768349|PSMA|psma
69764|NCT03768349|C-11 Choline|c-11 choline
69765|NCT03768336|Cancer|cancer
69766|NCT03768336|Behavioral Intervention|behavioral intervention
69767|NCT03768336|Adolescent|adolescent
69768|NCT03768336|Young Adult|young adult
69769|NCT03768323|mobile phone surveys|mobile phone surveys
69770|NCT03768323|interactive voice response|interactive voice response
69771|NCT03768323|incentive|incentive
69772|NCT03768310|ALL|all
69773|NCT03768310|NHL|nhl
69774|NCT03768310|hematopoietic stem cell transplantation (HSCT)|hematopoietic stem cell transplantation (hsct)
69775|NCT03768245|Body Mass Index|body mass index
69776|NCT03768245|Glucose|glucose
69777|NCT03768245|Haemoglobin glycosylated|haemoglobin glycosylated
69778|NCT03768245|Blood Lipids|blood lipids
69779|NCT03768245|Liver Function|liver function
69780|NCT03768245|Kidney Function|kidney function
69781|NCT03768245|Exercise|exercise
69782|NCT03768245|Physical activity|physical activity
69783|NCT03768232|ultrasound assessment|ultrasound assessment
69784|NCT03768232|diaphragm disfuncion|diaphragm disfuncion
69785|NCT03768206|knee arthroplasty|knee arthroplasty
69786|NCT03768206|behavioral intervention|behavioral intervention
69787|NCT03768206|physical activity|physical activity
69788|NCT03768167|Corpectomy|corpectomy
69789|NCT03768167|Pyramesh|pyramesh
69790|NCT03768167|Posterolateral|posterolateral
69791|NCT03768167|Pediculectomy|pediculectomy
69792|NCT03768167|Facetectomies|facetectomies
69793|NCT03768154|spontaneous breathing|spontaneous breathing
69794|NCT03768154|prone position|prone position
69795|NCT03768154|muscle paralysis|muscle paralysis
69796|NCT03768141|Liver|liver
69797|NCT03768141|Surgery|surgery
69798|NCT03768141|Outcomes|outcomes
69799|NCT03768141|Snapshot|snapshot
69800|NCT03768141|Collaborative|collaborative
69801|NCT03768141|International|international
69802|NCT03768050|integrated care|integrated care
69803|NCT03767998|Respiratory muscle training|respiratory muscle training
69804|NCT03767998|Spirometry|spirometry
69805|NCT03767998|Maximal Inspiratory Pressure|maximal inspiratory pressure
69806|NCT03767998|Maximal Expiratory pressure|maximal expiratory pressure
69807|NCT03767998|Surface electromyography|surface electromyography
69808|NCT03767946|Tuberculosis|tuberculosis
69809|NCT03767946|Quantiferon Gold Plus test|quantiferon gold plus test
69810|NCT03767946|Tuberculosis in children|tuberculosis in children
69811|NCT03767946|SENEGAL|senegal
69812|NCT03767946|MTBVAC|mtbvac
69821|NCT03767920|dexamethasone|dexamethasone
69822|NCT03767920|transversus abdominis plane block|transversus abdominis plane block
69823|NCT03767920|cesarean section|cesarean section
69824|NCT03767907|cognitive behavioural therapy|cognitive behavioural therapy
69825|NCT03767907|online treatment|online treatment
69826|NCT03767894|Hand orthosis|hand orthosis
69827|NCT03767894|Stroke|stroke
69828|NCT03767881|AXIOS|axios
69829|NCT03767881|Acute Cholecystitis|acute cholecystitis
69830|NCT03767881|Percutaneous Gallbladder Drainage|percutaneous gallbladder drainage
69831|NCT03767881|Cholecystitis|cholecystitis
69832|NCT03767881|Gallbladder Drainage|gallbladder drainage
69833|NCT03767855|CK-3773274|ck-3773274
69834|NCT03767855|CK-274|ck-274
69835|NCT03767855|obstructive hypertrophic cardiomyopathy|obstructive hypertrophic cardiomyopathy
69836|NCT03767855|oHCM|ohcm
69837|NCT03767816|laparoscopic cholecystectomy|laparoscopic cholecystectomy
69838|NCT03767816|erector spinae plane block|erector spinae plane block
69839|NCT03767816|visceral pain|visceral pain
69840|NCT03767803|Hypertension|hypertension
69841|NCT03767803|Proteinuria|proteinuria
69842|NCT03767803|Thrombocytopenia|thrombocytopenia
69843|NCT03767803|Renal Insufficiency|renal insufficiency
69844|NCT03767803|Impaired Liver Function|impaired liver function
69845|NCT03767803|Pulmonary Edema|pulmonary edema
69846|NCT03767803|Cerebral Symptoms|cerebral symptoms
69852|NCT03767777|Aortic arch|aortic arch
69853|NCT03767777|Aortic disease|aortic disease
69854|NCT03767777|Aortic Dissection|aortic dissection
69855|NCT03767777|Stent Graft|stent graft
69856|NCT03767764|Hepatocellular carcinoma|hepatocellular carcinoma
69857|NCT03767764|Tumor associated antigen|tumor associated antigen
69858|NCT03767764|Early diagnosis|early diagnosis
69859|NCT03767764|Autoantibodies|autoantibodies
69860|NCT03767764|Alpha fetoprotein|alpha fetoprotein
69861|NCT03767725|Anti-BCMA, Anti-CD19, CART cell, treatment, Multiple Myeloma|anti-bcma, anti-cd19, cart cell, treatment, multiple myeloma
69862|NCT03767712|trauma|trauma
69863|NCT03767712|immunological reaction to trauma|immunological reaction to trauma
69988|NCT03767088|rehabilitation|rehabilitation
69864|NCT03767712|pertrochanteric femoral fracture|pertrochanteric femoral fracture
69865|NCT03767712|antinuclear antibodies|antinuclear antibodies
69866|NCT03767712|activation of innate immunity|activation of innate immunity
69867|NCT03767712|adaptive immunity|adaptive immunity
69868|NCT03767699|Medical nutrition therapy|medical nutrition therapy
69869|NCT03767699|Eating behavior|eating behavior
69870|NCT03767699|Type 2 diabetes mellitus|type 2 diabetes mellitus
69871|NCT03767699|Gestational Diabetes|gestational diabetes
69872|NCT03767660|Blue Rubber Bleb Nevus Syndrome|blue rubber bleb nevus syndrome
69873|NCT03767660|Venous Malformation|venous malformation
69874|NCT03767660|Rapamycin (sirolimus)|rapamycin (sirolimus)
69875|NCT03767660|Mammalian target of rapamycin (mTOR) inhibitor|mammalian target of rapamycin (mtor) inhibitor
69876|NCT03767660|Treatment|treatment
69877|NCT03767647|emotional intelligence|emotional intelligence
69878|NCT03767647|students|students
69879|NCT03767647|randomized clinical trial|randomized clinical trial
69880|NCT03767647|schools|schools
69881|NCT03767634|Preterm neonate|preterm neonate
69882|NCT03767634|Parenteral nutrition|parenteral nutrition
69888|NCT03767582|GVAX|gvax
69889|NCT03767582|Nivolumab|nivolumab
69890|NCT03767582|CCR2/CCR5 dual antagonist|ccr2/ccr5 dual antagonist
69891|NCT03767582|Anti-PD-1|anti-pd-1
69892|NCT03767582|Cancer vaccine|cancer vaccine
69893|NCT03767582|Monoclonal antibody|monoclonal antibody
69894|NCT03767582|Checkpoint inhibitor|checkpoint inhibitor
69895|NCT03767582|Myeloid modulating agent|myeloid modulating agent
69896|NCT03767582|Immunotherapy|immunotherapy
69897|NCT03767582|Neoadjuvant chemotherapy|neoadjuvant chemotherapy
69898|NCT03767582|Stereotactic body radiation therapy|stereotactic body radiation therapy
69899|NCT03767582|SBRT|sbrt
69900|NCT03767582|Pancreatic cancer|pancreatic cancer
69901|NCT03767582|Pancreatic Ductal Adenocarcinoma|pancreatic ductal adenocarcinoma
69902|NCT03767582|PDAC|pdac
69903|NCT03767582|Locally advanced pancreatic ductal adenocarcinoma|locally advanced pancreatic ductal adenocarcinoma
69904|NCT03767582|LAPC|lapc
69905|NCT03767556|physical tests|physical tests
69906|NCT03767556|functional capacity|functional capacity
69907|NCT03767556|spirometry|spirometry
69908|NCT03767556|travelled distance|travelled distance
69909|NCT03767556|cardiorespiratory fitness|cardiorespiratory fitness
69910|NCT03767556|flexibility|flexibility
69911|NCT03767556|respiratory pressures|respiratory pressures
69912|NCT03767556|dyspnea|dyspnea
69913|NCT03767530|Meibomian gland dysfunction|meibomian gland dysfunction
69914|NCT03767530|Mibo|mibo
69915|NCT03767530|MGD|mgd
69916|NCT03767530|Dry eye disease|dry eye disease
69917|NCT03767530|Thermic devices|thermic devices
69918|NCT03767478|neuromuscular stimulation|neuromuscular stimulation
69919|NCT03767465|HIV|hiv
69920|NCT03767465|Cancer|cancer
69921|NCT03767465|Checkpoint inhibitors|checkpoint inhibitors
69922|NCT03767465|HIV reservoir|hiv reservoir
69923|NCT03767465|Immunity|immunity
69924|NCT03767452|Recurrence|recurrence
69925|NCT03767452|Incomplete Response|incomplete response
69926|NCT03767452|Worsening|worsening
69927|NCT03767452|Curvature|curvature
69928|NCT03767439|Nivolumab|nivolumab
69929|NCT03767439|Vismodegib|vismodegib
69930|NCT03767439|Basal Cell|basal cell
69931|NCT03767439|Basal Cell Nevus Syndrome (BCNS)|basal cell nevus syndrome (bcns)
69932|NCT03767426|Emotion|emotion
69933|NCT03767426|Memory|memory
69934|NCT03767426|Sleep|sleep
69935|NCT03767426|Sleep Deprivation|sleep deprivation
69936|NCT03767387|Prehabilitation|prehabilitation
69937|NCT03767387|Physical Activity|physical activity
69938|NCT03767387|Integrated Care|integrated care
69939|NCT03767387|Collaborative Self-management|collaborative self-management
69940|NCT03767374|MDR, XDR, ESBL, ESBL, MRSA, CRE|mdr, xdr, esbl, esbl, mrsa, cre
69941|NCT03767374|HIV, PrEP, CeGIDD, STI, bacteria colonization|hiv, prep, cegidd, sti, bacteria colonization
69942|NCT03767335|Advanced Breast Cancer|advanced breast cancer
69943|NCT03767335|Metastatic Breast Cancer|metastatic breast cancer
69944|NCT03767335|PI3K inhibitor|pi3k inhibitor
69945|NCT03767335|HER2-positive|her2-positive
69946|NCT03767322|contrast induced acute kidney injury|contrast induced acute kidney injury
69947|NCT03767322|contrast induced nephropathy|contrast induced nephropathy
69948|NCT03767322|allopurinol|allopurinol
69949|NCT03767322|febuxostat|febuxostat
69950|NCT03767296|spinal oxygenation|spinal oxygenation
69951|NCT03767296|NIRS|nirs
69952|NCT03767270|OTC|otc
69953|NCT03767270|Urea Cycle Disorder|urea cycle disorder
69954|NCT03767270|UCD|ucd
69955|NCT03767257|Lenalidomide Associated Diarrhea|lenalidomide associated diarrhea
69956|NCT03767257|Colesevelam|colesevelam
69957|NCT03767257|18-421|18-421
69958|NCT03767257|Memorial Sloan Kettering Cancer Center|memorial sloan kettering cancer center
69959|NCT03767231|viral load testing|viral load testing
69960|NCT03767231|point of care|point of care
69961|NCT03767218|Oocyte donor|oocyte donor
69962|NCT03767218|Ovarian stimulation|ovarian stimulation
69963|NCT03767205|gait function|gait function
69964|NCT03767205|Metabolic energy expenditure|metabolic energy expenditure
69965|NCT03767205|ankle assist robot|ankle assist robot
69966|NCT03767192|acute ischemic stroke|acute ischemic stroke
69967|NCT03767192|randomized clinical trial|randomized clinical trial
69968|NCT03767192|effectiveness|effectiveness
69969|NCT03767192|safety|safety
69970|NCT03767179|Missed abortion|missed abortion
69971|NCT03767179|Procalcitonin|procalcitonin
69972|NCT03767179|Erythrocyte sedimentation rate (ESR)|erythrocyte sedimentation rate (esr)
69973|NCT03767179|C-reactive protein (CRP)|c-reactive protein (crp)
69974|NCT03767179|Leukocyte (WBC)|leukocyte (wbc)
69975|NCT03767153|acne scarring|acne scarring
69976|NCT03767153|acne scar|acne scar
69977|NCT03767153|fractional radiofrequency|fractional radiofrequency
69978|NCT03767153|fractional RF|fractional rf
69979|NCT03767127|transfusion|transfusion
69980|NCT03767127|intensive care medicine|intensive care medicine
69981|NCT03767127|90-day mortality|90-day mortality
69982|NCT03767101|Positive Affect|positive affect
69983|NCT03767101|Mental Imagery|mental imagery
69984|NCT03767101|Cognitive Behavioral Therapy|cognitive behavioral therapy
69985|NCT03767101|Psychotherapy process|psychotherapy process
69986|NCT03767101|Micro-Intervention|micro-intervention
69987|NCT03767088|WB-EMS|wb-ems
69989|NCT03767088|sarcopenia|sarcopenia
69990|NCT03767075|Advanced Solid Tumor|advanced solid tumor
69991|NCT03767075|Cancer|cancer
69992|NCT03767075|Atezolizumab|atezolizumab
69993|NCT03767075|Immunotherapy|immunotherapy
69994|NCT03767062|Medication overuse headache; Greater occipital nerve block; supratrochlear nerve block; topiramate.|medication overuse headache; greater occipital nerve block; supratrochlear nerve block; topiramate.
69995|NCT03767036|tramadol|tramadol
69996|NCT03767036|ketorolac|ketorolac
69997|NCT03767036|interaction|interaction
69998|NCT03766997|Granulomatous Mastitis|granulomatous mastitis
69999|NCT03766997|local injection|local injection
70000|NCT03766997|topical steroids|topical steroids
70001|NCT03766984|fixed-dose combination|fixed-dose combination
70002|NCT03766984|diclofenac|diclofenac
70003|NCT03766984|tramadol|tramadol
70004|NCT03766984|interaction|interaction
70005|NCT03766945|Gastric Cancer|gastric cancer
70006|NCT03766945|Surgery|surgery
70007|NCT03766945|Fatigue|fatigue
70008|NCT03766945|Quality of Life|quality of life
70009|NCT03766919|INVICTA|invicta
70010|NCT03766919|Lead|lead
70011|NCT03766919|ICD|icd
70012|NCT03766919|CRT-D|crt-d
70013|NCT03766919|MicroPort|microport
70014|NCT03766880|clinically significant portal hypertension, hepatic venous pressure gradient, MR imaging|clinically significant portal hypertension, hepatic venous pressure gradient, mr imaging
70015|NCT03766841|consumer informatics|consumer informatics
70016|NCT03766841|communication|communication
70017|NCT03766841|patient engagement|patient engagement
70018|NCT03766828|thoracic central venous occlusion|thoracic central venous occlusion
70019|NCT03766828|Dialysis access|dialysis access
70020|NCT03766802|Diabetes Mellitus, Type 2|diabetes mellitus, type 2
70021|NCT03766802|Physical activity|physical activity
70022|NCT03766802|exercise behavior|exercise behavior
70023|NCT03766802|exercise|exercise
70024|NCT03766802|smart phone|smart phone
70025|NCT03766802|wearable technology|wearable technology
70026|NCT03766802|self-management|self-management
70027|NCT03766802|glycated hemoglobin (HbA1c)|glycated hemoglobin (hba1c)
70028|NCT03766789|Adherence, Medication, Therapy|adherence, medication, therapy
70029|NCT03766737|Vision Disorders|vision disorders
70030|NCT03766711|Bimanual Task|bimanual task
70031|NCT03766711|Motor Adaptation|motor adaptation
70032|NCT03766698|Multiple Sclerosis|multiple sclerosis
70033|NCT03766698|Muscle Architecture|muscle architecture
70034|NCT03766698|Lower extremity|lower extremity
70035|NCT03766685|Bimekizumab|bimekizumab
70036|NCT03766685|PSO|pso
70037|NCT03766685|Psoriasis|psoriasis
70038|NCT03766685|Auto-Injector|auto-injector
70039|NCT03766672|Endometrial carcinoma|endometrial carcinoma
70040|NCT03766646|Optiflow|optiflow
70041|NCT03766646|High Flow Nasal Oxygen|high flow nasal oxygen
70043|NCT03766646|Speech|speech
70044|NCT03766633|LiverVision|livervision
70045|NCT03766633|Liver|liver
70046|NCT03766633|Volumetry|volumetry
70047|NCT03766633|Semi-automated|semi-automated
70048|NCT03766633|Living donor liver transplantation|living donor liver transplantation
70049|NCT03766633|Surgery|surgery
70050|NCT03766568|Rhinosinusitis|rhinosinusitis
70051|NCT03766568|upper respiratory tract infection|upper respiratory tract infection
70052|NCT03766568|antibiotic|antibiotic
70053|NCT03766568|endoscopy|endoscopy
70054|NCT03766568|Otolaryngology|otolaryngology
70055|NCT03766568|primary care|primary care
70056|NCT03766555|Hepatocellular carcinoma|hepatocellular carcinoma
70057|NCT03766555|Hepatectomy|hepatectomy
70058|NCT03766555|Microwave Ablation|microwave ablation
70059|NCT03766555|Local Ablation|local ablation
70060|NCT03766503|Medication adherence|medication adherence
70061|NCT03766503|Severe and persistent mental illness|severe and persistent mental illness
70062|NCT03766477|Sleep bruxism|sleep bruxism
70063|NCT03766477|Sleep|sleep
70064|NCT03766477|Sleep hygiene|sleep hygiene
70065|NCT03766464|sleep bruxism|sleep bruxism
70066|NCT03766464|polisomnography|polisomnography
70067|NCT03766464|sleep wake disorders|sleep wake disorders
70068|NCT03766425|aflibercept|aflibercept
70069|NCT03766425|glaucoma|glaucoma
70070|NCT03766425|mitomycin|mitomycin
70071|NCT03766425|trabeculectomy|trabeculectomy
70073|NCT03766347|Pediatric|pediatric
70074|NCT03766347|Aquaporin-4|aquaporin-4
70075|NCT03766347|AQP4|aqp4
70076|NCT03766347|NMOSD|nmosd
70077|NCT03766347|NMO|nmo
70078|NCT03766347|Neuromyelitis Optica|neuromyelitis optica
70079|NCT03766334|Highland Barley Diet|highland barley diet
70080|NCT03766334|Glucose variability|glucose variability
70081|NCT03766321|microbiota|microbiota
70082|NCT03766321|fecal transplantation|fecal transplantation
70083|NCT03766321|adaptive immunity|adaptive immunity
70084|NCT03766321|T regulatory lymphocytes|t regulatory lymphocytes
70085|NCT03766308|highland barley diet|highland barley diet
70086|NCT03766295|Pancreatic cancer|pancreatic cancer
70087|NCT03766295|tyrosine kinase inhibitor|tyrosine kinase inhibitor
70088|NCT03766282|Pharmacokinetics|pharmacokinetics
70089|NCT03766282|extracorporeal membrane oxygenation|extracorporeal membrane oxygenation
70090|NCT03766243|Microstomia|microstomia
70091|NCT03766243|Rehabilitation|rehabilitation
70092|NCT03766243|Self-Management|self-management
70093|NCT03766204|circRNAs|circrnas
70094|NCT03766204|microRNAs|micrornas
70095|NCT03766191|Obesity|obesity
70096|NCT03766191|Cue Reactivity|cue reactivity
70097|NCT03766191|Genetics|genetics
70098|NCT03766191|Self Regulation|self regulation
70099|NCT03766191|fMRI|fmri
70100|NCT03766191|Children|children
70101|NCT03766191|Eating in the Absence of Hunger|eating in the absence of hunger
70102|NCT03766152|Hearing aid|hearing aid
70103|NCT03766126|refractory|refractory
70104|NCT03766126|relapsed|relapsed
70105|NCT03766126|Acute|acute
70106|NCT03766126|Myeloid|myeloid
70107|NCT03766126|leukemia|leukemia
70108|NCT03766126|AML|aml
70109|NCT03766113|Neurofeedback ; fMRI ; EEG ; BCI ; Motor imagery|neurofeedback ; fmri ; eeg ; bci ; motor imagery
70110|NCT03766100|Rheumatoid Arthritis|rheumatoid arthritis
70111|NCT03766100|Insomnia|insomnia
70112|NCT03766100|Sleep|sleep
70113|NCT03766100|Cognitive Behavioural Therapy for Insomnia|cognitive behavioural therapy for insomnia
70114|NCT03766100|CBT-I|cbt-i
70115|NCT03766100|Non-pharmacological treatment|non-pharmacological treatment
70116|NCT03766100|Polysomnography|polysomnography
70117|NCT03766100|Actigraphy|actigraphy
70118|NCT03766100|Patient reported outcomes|patient reported outcomes
70119|NCT03766074|vitamin D- Depression- Cholecalciferol-|vitamin d- depression- cholecalciferol-
70120|NCT03766048|Urogenital prolapse|urogenital prolapse
70121|NCT03766048|laparoscopic sacropexy|laparoscopic sacropexy
70122|NCT03766048|mesh|mesh
70123|NCT03766048|medico-economic study|medico-economic study
70124|NCT03766035|per oral cholangioscopy|per oral cholangioscopy
70125|NCT03766035|PSC|psc
70126|NCT03766035|cholangiocarcinoma|cholangiocarcinoma
70127|NCT03766035|primary sclerosing cholangitis|primary sclerosing cholangitis
70128|NCT03766035|ERCP|ercp
70129|NCT03765983|Breast Cancer|breast cancer
70130|NCT03765970|Tumor resection|tumor resection
70131|NCT03765970|MSTS|msts
70132|NCT03765970|TESS|tess
70133|NCT03765970|Soft tissue and bone|soft tissue and bone
70134|NCT03765970|Questionnaires|questionnaires
70135|NCT03765957|Mesenchymal Stem Cells|mesenchymal stem cells
70136|NCT03765918|PD-1|pd-1
70137|NCT03765918|PD1|pd1
70138|NCT03765918|Programmed Cell Death-1|programmed cell death-1
70139|NCT03765918|Programmed Cell Death 1|programmed cell death 1
70140|NCT03765918|Programmed Cell Death-Ligand 1 (PD-L1)|programmed cell death-ligand 1 (pd-l1)
70141|NCT03765918|Programmed Cell Death-Ligand 2 (PD-L2)|programmed cell death-ligand 2 (pd-l2)
70142|NCT03765918|PDL1|pdl1
70143|NCT03765918|PDL2|pdl2
70144|NCT03765905|PCOS|pcos
70153|NCT03765814|serious brain-injured patient|serious brain-injured patient
70154|NCT03765814|anticipated approach|anticipated approach
70155|NCT03765788|Giant Cell Arteritis|giant cell arteritis
70156|NCT03765788|Secukinumab|secukinumab
70157|NCT03765788|Subcutaneous|subcutaneous
70158|NCT03765788|Vessel Inflammation|vessel inflammation
70159|NCT03765775|Non-small Cell Lung Cancer|non-small cell lung cancer
70160|NCT03765775|Anlotinib|anlotinib
70161|NCT03765775|Sintilimab|sintilimab
70162|NCT03765762|Brain Diseases|brain diseases
70163|NCT03765762|Nervous System Diseases|nervous system diseases
70164|NCT03765762|Central Nervous System Diseases|central nervous system diseases
70165|NCT03765762|Neurodegenerative Diseases|neurodegenerative diseases
70166|NCT03765762|Neurocognitive Disorders|neurocognitive disorders
70167|NCT03765762|Mental Disorders|mental disorders
70168|NCT03765762|Dementia|dementia
70169|NCT03765762|Tauopathy|tauopathy
70170|NCT03765723|TKRA|tkra
70171|NCT03765723|Postoperative pain|postoperative pain
70172|NCT03765697|post-herpetic neuralgia|post-herpetic neuralgia
70173|NCT03765697|lidocaine|lidocaine
70174|NCT03765645|Liver Transplant|liver transplant
70175|NCT03765645|Donor Hepatectomy|donor hepatectomy
70176|NCT03765645|Antibiotic prophylaxis|antibiotic prophylaxis
70177|NCT03765606|Cocoa Flavan-3-ols|cocoa flavan-3-ols
70178|NCT03765606|methylaxanthin|methylaxanthin
70179|NCT03765606|theobromine|theobromine
70180|NCT03765606|Ileostomists|ileostomists
70181|NCT03765606|bioavailability|bioavailability
70182|NCT03765606|randomised controlled trial|randomised controlled trial
70183|NCT03765593|Primary Sjogren Syndrome|primary sjogren syndrome
70184|NCT03765593|Lymphoma|lymphoma
70185|NCT03765593|Biomarker|biomarker
70186|NCT03765580|Polyunsaturated fatty acids (PUFA)|polyunsaturated fatty acids (pufa)
70187|NCT03765580|fish|fish
70188|NCT03765580|fish consumption|fish consumption
70189|NCT03765580|women|women
70190|NCT03765580|childbearing age|childbearing age
70191|NCT03765567|infection|infection
70192|NCT03765567|vancomycin|vancomycin
70193|NCT03765567|topical antibiotic|topical antibiotic
70194|NCT03765567|antibiotic prophylaxis|antibiotic prophylaxis
70203|NCT03765528|Clostridium difficile|clostridium difficile
70204|NCT03765528|Extended-Spectrum β-Lactamase producing Enterobacteriaceae|extended-spectrum β-lactamase producing enterobacteriaceae
70205|NCT03765528|Vancomycin-resistant enterococci|vancomycin-resistant enterococci
70206|NCT03765528|Antimicrobial resistance|antimicrobial resistance
70207|NCT03765528|Microbiome|microbiome
70208|NCT03765528|Nosocomial infection|nosocomial infection
70209|NCT03765528|Antimicrobial Stewardship|antimicrobial stewardship
70210|NCT03765528|Infection Control|infection control
70211|NCT03765489|polyneuropathies|polyneuropathies
70212|NCT03765489|muscle weakness|muscle weakness
70213|NCT03765489|sepsis|sepsis
70214|NCT03765489|septic shock|septic shock
70215|NCT03765489|electrical stimulation|electrical stimulation
70216|NCT03765489|intensive care unit|intensive care unit
70217|NCT03765463|Extinction learning|extinction learning
70218|NCT03765463|Behavior Therapy|behavior therapy
70219|NCT03765463|Tourette's Disorder|tourette's disorder
70220|NCT03765463|Habit Reversal Training|habit reversal training
70221|NCT03765463|Comprehensive Behavioral Intervention for Tics|comprehensive behavioral intervention for tics
70222|NCT03765450|ASUC|asuc
70223|NCT03765450|Infliximab|infliximab
70224|NCT03765450|Optimal Dose|optimal dose
70225|NCT03765450|Optimal Frequency|optimal frequency
70226|NCT03765450|Theraputic Drug Monitoring|theraputic drug monitoring
70227|NCT03765398|Dual-task training|dual-task training
70228|NCT03765398|Virtual-reality exergaming|virtual-reality exergaming
70229|NCT03765398|Cognitive-motor-balance training|cognitive-motor-balance training
70230|NCT03765398|Mild cognitive impairment|mild cognitive impairment
70231|NCT03765398|Older adults|older adults
70232|NCT03765385|Aged|aged
70233|NCT03765385|Aged, 80 and over|aged, 80 and over
70234|NCT03765385|Exercise|exercise
70235|NCT03765372|perioperative outcome|perioperative outcome
70236|NCT03765372|clavien-dindo classification|clavien-dindo classification
70237|NCT03765372|IPF|ipf
70238|NCT03765372|hsTnT|hstnt
70239|NCT03765372|proBNP|probnp
70240|NCT03765359|insulin need|insulin need
70241|NCT03765359|diabetic pregnancy|diabetic pregnancy
70242|NCT03765359|insulin resistance|insulin resistance
70243|NCT03765359|metformin|metformin
70244|NCT03765346|intranasal abuse|intranasal abuse
70245|NCT03765346|abuse-deterrent|abuse-deterrent
70246|NCT03765307|Asthma|asthma
70247|NCT03765307|Bronchial Ablation|bronchial ablation
70248|NCT03765307|Bronchial Thermoplasty|bronchial thermoplasty
70249|NCT03765255|youth|youth
70250|NCT03765255|adolescent|adolescent
70251|NCT03765229|PD-1|pd-1
70252|NCT03765177|Chimeric Antigen Receptor T cells|chimeric antigen receptor t cells
70253|NCT03765177|CLIC-1901|clic-1901
70254|NCT03765177|anti-CD19 CAR-T cells|anti-cd19 car-t cells
70255|NCT03765151|low-level laser therapy|low-level laser therapy
70256|NCT03765151|orthodontic retention|orthodontic retention
70257|NCT03765151|periodontal disease|periodontal disease
70258|NCT03765125|gingivitis|gingivitis
70259|NCT03765125|collagen peptide|collagen peptide
70260|NCT03765125|plaque|plaque
70261|NCT03765047|Standardized Test Score|standardized test score
70262|NCT03765047|Academic Achievement|academic achievement
70263|NCT03765008|water|water
70264|NCT03765008|vasopressin|vasopressin
70265|NCT03764995|massage|massage
70266|NCT03764995|abdominal massage|abdominal massage
70267|NCT03764995|chronic constipation|chronic constipation
70268|NCT03764995|primary constipation|primary constipation
70269|NCT03764995|functional constipation|functional constipation
70270|NCT03764995|defecation|defecation
70271|NCT03764982|Rehabilitation|rehabilitation
70272|NCT03764982|Multidisciplinary|multidisciplinary
70273|NCT03764982|Health care|health care
70274|NCT03764969|Addiction|addiction
70275|NCT03764969|Nicotine|nicotine
70276|NCT03764969|Smoking Cessation|smoking cessation
70277|NCT03764969|Relapse|relapse
70278|NCT03764969|Craving|craving
70279|NCT03764969|habitual behavior|habitual behavior
70280|NCT03764969|cognitive remediation|cognitive remediation
70281|NCT03764969|implicit priming|implicit priming
91176|NCT03633773|ICC|icc
70282|NCT03764969|pavlovian instrumental transfer|pavlovian instrumental transfer
70283|NCT03764956|MAD|mad
70284|NCT03764956|LGIT|lgit
70285|NCT03764917|NGS|ngs
70286|NCT03764917|RNAseq|rnaseq
70287|NCT03764865|cleavage embryo|cleavage embryo
70288|NCT03764865|blastocyst|blastocyst
70289|NCT03764865|embryo transfer|embryo transfer
70290|NCT03764865|in vitro fertilization|in vitro fertilization
70291|NCT03764852|outpatient|outpatient
70292|NCT03764839|pain|pain
70293|NCT03764839|treatment|treatment
70294|NCT03764839|opioid cessation|opioid cessation
70295|NCT03764748|Tic Disorders|tic disorders
70296|NCT03764748|Gut microbiota|gut microbiota
70297|NCT03764748|Brain-gut axis|brain-gut axis
70298|NCT03764748|Microbiota Transplantation|microbiota transplantation
70299|NCT03764748|Tourette syndrome|tourette syndrome
70300|NCT03764735|Dry Eye|dry eye
70301|NCT03764735|Dry Eye Syndrome|dry eye syndrome
70302|NCT03764735|SkQ1|skq1
70303|NCT03764735|KCS|kcs
70304|NCT03764735|Keratoconjunctivitis|keratoconjunctivitis
70305|NCT03764722|Levosimendan|levosimendan
70306|NCT03764722|Rehospitalisation|rehospitalisation
70307|NCT03764722|Heart failure|heart failure
70308|NCT03764709|Wireless monitoring, hospital-territory integration|wireless monitoring, hospital-territory integration
70309|NCT03764670|tacrolimus|tacrolimus
70310|NCT03764670|clinical outcomes|clinical outcomes
70311|NCT03764670|genetic polymorphism|genetic polymorphism
70312|NCT03764670|clinical factors|clinical factors
70313|NCT03764657|Pilonidal sinus disease|pilonidal sinus disease
70314|NCT03764657|wound deiscence|wound deiscence
70315|NCT03764618|wAIHA|waiha
70316|NCT03764618|Warm Antibody Autoimmune Hemolytic Anemia|warm antibody autoimmune hemolytic anemia
70317|NCT03764618|Warm Autoimmune Hemolytic Anemia|warm autoimmune hemolytic anemia
70318|NCT03764566|childhood adversities|childhood adversities
70319|NCT03764566|childhood neglect|childhood neglect
70320|NCT03764566|childhood abuse|childhood abuse
70321|NCT03764566|rejection sensitivity|rejection sensitivity
70322|NCT03764566|justice sensitivity|justice sensitivity
70323|NCT03764566|loneliness|loneliness
70324|NCT03764553|palliative chemotherapy|palliative chemotherapy
70325|NCT03764553|metastatic esophagogastric cancer|metastatic esophagogastric cancer
70326|NCT03764553|Efficacy|efficacy
70327|NCT03764553|toxicity|toxicity
70328|NCT03764527|Artemether-Lumefantrine|artemether-lumefantrine
70329|NCT03764527|Coartem|coartem
70330|NCT03764527|Artesunate|artesunate
70331|NCT03764527|Amodiaquine|amodiaquine
70332|NCT03764527|Zanzibar|zanzibar
70333|NCT03764436|Early Child Development|early child development
70334|NCT03764436|School Readiness|school readiness
70335|NCT03764436|Early Childhood Education|early childhood education
70336|NCT03764436|Youth Development|youth development
70337|NCT03764410|Diabetes mellitus, periodontal diseases, periodontal index|diabetes mellitus, periodontal diseases, periodontal index
70338|NCT03764397|Lifestyle|lifestyle
70339|NCT03764397|Education|education
70340|NCT03764397|Self-management|self-management
70341|NCT03764397|Physical Activity|physical activity
70342|NCT03764397|Proof-of-concept study|proof-of-concept study
70343|NCT03764384|PaCO2|paco2
70344|NCT03764384|N-Tidal C Device|n-tidal c device
70345|NCT03764384|Self-monitoring|self-monitoring
70347|NCT03764332|Footwear|footwear
70348|NCT03764332|Barefoot|barefoot
70349|NCT03764319|ARDS, ECMO, Ventilation|ards, ecmo, ventilation
70350|NCT03764306|carotid angioplaty|carotid angioplaty
70351|NCT03764306|MRI DWI|mri dwi
70352|NCT03764280|Multiple Daily Injections|multiple daily injections
70353|NCT03764280|type 1 diabetes|type 1 diabetes
70354|NCT03764280|pediatrics|pediatrics
70355|NCT03764280|optimization algorithm|optimization algorithm
70356|NCT03764241|STEMI|stemi
70357|NCT03764241|left ventricular thrombus|left ventricular thrombus
70358|NCT03764241|rivaroxaban|rivaroxaban
70359|NCT03764228|human amniotic epithelial cells(hAECs)|human amniotic epithelial cells(haecs)
70360|NCT03764228|Acute-graft-versus-host disease（aGVHD）|acute-graft-versus-host disease（agvhd）
70361|NCT03764189|Accelerated tooth movement AND anterior segment retraction AND miniscrews AND microosteoperforation|accelerated tooth movement and anterior segment retraction and miniscrews and microosteoperforation
70362|NCT03764150|Sleep Apnea Syndrome|sleep apnea syndrome
70363|NCT03764150|Muscular Diseases|muscular diseases
70364|NCT03764150|non invasive ventilation|non invasive ventilation
70365|NCT03764150|Diaphragmatic Disorder|diaphragmatic disorder
70366|NCT03764124|Allograft survival|allograft survival
70367|NCT03764124|PET/CT imaging|pet/ct imaging
70368|NCT03764124|Corticoids withdrawal|corticoids withdrawal
70369|NCT03764124|Bone mineral Density|bone mineral density
70370|NCT03764059|Universal restorative|universal restorative
70371|NCT03764059|Composite posterior restorative|composite posterior restorative
70372|NCT03764046|Pain Measurement|pain measurement
70373|NCT03764046|Acute Postoperative Pain|acute postoperative pain
70374|NCT03764033|Stress Disorders, Post-Traumatic|stress disorders, post-traumatic
70375|NCT03764033|Moral Injury|moral injury
91311|NCT03632980|MRI|mri
70376|NCT03764033|Treatment|treatment
70377|NCT03764020|melatonin|melatonin
70378|NCT03764020|inflammatory biomarkers|inflammatory biomarkers
70379|NCT03764007|Positron emission tomography|positron emission tomography
70380|NCT03763942|Human Immunodeficiency Virus (HIV)|human immunodeficiency virus (hiv)
70381|NCT03763942|Men who have sex with men (MSM)|men who have sex with men (msm)
70382|NCT03763942|Pre-Exposure Prophylaxis (PrEP)|pre-exposure prophylaxis (prep)
70383|NCT03763942|HealthMindr|healthmindr
70384|NCT03763903|skills training|skills training
70385|NCT03763903|laparoscopic surgery|laparoscopic surgery
70386|NCT03763890|ARDS（Acute respiratory syndrome）;|ards（acute respiratory syndrome）;
70387|NCT03763890|stress;|stress;
70388|NCT03763890|strain;|strain;
70389|NCT03763890|Trans-pulmonary pressure;|trans-pulmonary pressure;
70390|NCT03763890|FRC(functional residual capacity )|frc(functional residual capacity )
70391|NCT03763890|PEEP（post end-expiratory pressure）;|peep（post end-expiratory pressure）;
70392|NCT03763890|EIT（Electronic impedance tomography）;|eit（electronic impedance tomography）;
70393|NCT03763890|RVD(region ventilation delay)|rvd(region ventilation delay)
70395|NCT03763825|fear of recurrence|fear of recurrence
70396|NCT03763825|cancer|cancer
70397|NCT03763825|brief intervention|brief intervention
70398|NCT03763825|telephone counselling|telephone counselling
70399|NCT03763825|following primary cancer treatment|following primary cancer treatment
70400|NCT03763812|EVAR|evar
70401|NCT03763812|EVAS|evas
70402|NCT03763812|Post implant syndrome|post implant syndrome
70403|NCT03763812|Abdominal Aortic Aneurysm|abdominal aortic aneurysm
70404|NCT03763799|Aspiration pneumonia|aspiration pneumonia
70405|NCT03763799|Invasive ventilation|invasive ventilation
70406|NCT03763799|PCR|pcr
70407|NCT03763799|Antibiotics|antibiotics
70408|NCT03763799|Tracheal aspirate|tracheal aspirate
70409|NCT03763773|respiratory variations,|respiratory variations,
70410|NCT03763773|superior vena cava|superior vena cava
70411|NCT03763773|prognosis.|prognosis.
70412|NCT03763760|Hip Arthroplasty|hip arthroplasty
70413|NCT03763760|Hip Replacement|hip replacement
70414|NCT03763760|Perioperative Medicine|perioperative medicine
70415|NCT03763747|Coronary Artery Disease|coronary artery disease
70416|NCT03763747|Coronary Disease|coronary disease
70417|NCT03763747|Myocardial Ischemia|myocardial ischemia
70418|NCT03763747|Heart Diseases|heart diseases
70419|NCT03763747|Arteriosclerosis|arteriosclerosis
70420|NCT03763747|Cardiovascular Diseases|cardiovascular diseases
70421|NCT03763734|Knee Arthroplasty|knee arthroplasty
70422|NCT03763734|Knee Replacement|knee replacement
70423|NCT03763734|Perioperative Medicine|perioperative medicine
70424|NCT03763695|Pediatric intensive care unit|pediatric intensive care unit
70425|NCT03763695|Oral Hygiene Care|oral hygiene care
70426|NCT03763695|Chlorhexidine|chlorhexidine
70427|NCT03763695|Broncho-alveolar lavage|broncho-alveolar lavage
70428|NCT03763695|Pharyngeal swab|pharyngeal swab
70429|NCT03763669|Insulin resistance|insulin resistance
70430|NCT03763669|Fetal sonographic parameter|fetal sonographic parameter
70431|NCT03763669|Myoinositol|myoinositol
70432|NCT03763656|Hydroxyurea|hydroxyurea
70433|NCT03763656|Hydroxycarbomide|hydroxycarbomide
70434|NCT03763656|Xromi|xromi
70435|NCT03763630|Atopy|atopy
70436|NCT03763630|Early childhood|early childhood
70437|NCT03763630|House Dust-mite|house dust-mite
70438|NCT03763630|Sublingual immunotherapy|sublingual immunotherapy
70439|NCT03763617|Socket preservation|socket preservation
70440|NCT03763552|arthroscopy|arthroscopy
70441|NCT03763552|wrist osteoarthrosis|wrist osteoarthrosis
70442|NCT03763539|renal stones|renal stones
70443|NCT03763539|SWL|swl
70444|NCT03763539|High density stones|high density stones
70445|NCT03763539|Ultraslow SWL|ultraslow swl
70446|NCT03763539|Slow SWL|slow swl
70447|NCT03763539|Ramping|ramping
70448|NCT03763539|Pause|pause
70449|NCT03763526|Perioperative Nutritional Status|perioperative nutritional status
70450|NCT03763526|Surgical Outcome in Digestive System Cancer|surgical outcome in digestive system cancer
70451|NCT03763513|Tennis Elbow|tennis elbow
70452|NCT03763513|Taping|taping
70453|NCT03763513|Grip Strength|grip strength
70454|NCT03763513|Pain|pain
70455|NCT03763500|Atrial fibrillation|atrial fibrillation
70456|NCT03763500|Symptom burden|symptom burden
70457|NCT03763500|Health-related quality of life|health-related quality of life
70458|NCT03763500|Health economy|health economy
70459|NCT03763487|celiac sprue, celiac, hyposplenism, IgM memory, B lymphocytes|celiac sprue, celiac, hyposplenism, igm memory, b lymphocytes
70460|NCT03763474|Diabetes|diabetes
70461|NCT03763461|Awake Craniotomy|awake craniotomy
70462|NCT03763461|HFNC|hfnc
70463|NCT03763461|Oxygen Therapy|oxygen therapy
70464|NCT03763461|Atelectasis|atelectasis
70465|NCT03763461|Ultrasound|ultrasound
70466|NCT03763461|Patient Comfort|patient comfort
70467|NCT03763448|Infrapatellar Fat Pad|infrapatellar fat pad
70468|NCT03763448|Knee Osteoarthritis|knee osteoarthritis
70469|NCT03763448|Total Knee Arthroplasty|total knee arthroplasty
820521|NCT00156039|Oncologist|oncologist
70470|NCT03763448|Randomized Clinical Trial|randomized clinical trial
70471|NCT03763435|postpartum depression|postpartum depression
70472|NCT03763435|sleep disorder|sleep disorder
70473|NCT03763435|genital self-image|genital self-image
70474|NCT03763435|breast-feeding|breast-feeding
70475|NCT03763435|prevalence|prevalence
70476|NCT03763409|anxiety|anxiety
70477|NCT03763409|losartan|losartan
70478|NCT03763409|appetitive learning|appetitive learning
70479|NCT03763409|aversive learning|aversive learning
70480|NCT03763396|recurrent high grade glioma, posaconazole, ketoconazole, hexokinase 2 (HK2)|recurrent high grade glioma, posaconazole, ketoconazole, hexokinase 2 (hk2)
70481|NCT03763344|memory|memory
70482|NCT03763344|visual spatial training|visual spatial training
70483|NCT03763344|multiple object tracking|multiple object tracking
70484|NCT03763344|Elderly|elderly
70485|NCT03763305|skin sympathetic nerve activity, anesthetics|skin sympathetic nerve activity, anesthetics
70486|NCT03763292|Parents|parents
70487|NCT03763292|Patient Education as Topic|patient education as topic
70488|NCT03763292|Preoperative Care|preoperative care
70489|NCT03763292|Pamphlets|pamphlets
70490|NCT03763266|bowel preparation|bowel preparation
70491|NCT03763266|low residue diet|low residue diet
70492|NCT03763266|colonoscopy|colonoscopy
70493|NCT03763214|metal stent|metal stent
70494|NCT03763214|biliary stricture|biliary stricture
70495|NCT03763214|stenting|stenting
70496|NCT03763201|Rheumatoid arthritis|rheumatoid arthritis
70497|NCT03763201|glucocorticoid-induced tumour necrosis factor receptor related protein|glucocorticoid-induced tumour necrosis factor receptor related protein
70498|NCT03763175|Irritable Bowel Syndrome with Constipation|irritable bowel syndrome with constipation
70499|NCT03763175|Lovastatin|lovastatin
70500|NCT03763175|SYN-010|syn-010
70501|NCT03763097|pelvic floor ultrasonography|pelvic floor ultrasonography
70502|NCT03763097|transperineal ultrasound|transperineal ultrasound
70503|NCT03763097|introital ultrasound|introital ultrasound
70504|NCT03763097|mini-sling|mini-sling
70505|NCT03763097|needleless|needleless
70506|NCT03763097|Urinary Incontinence,Stress|urinary incontinence,stress
70507|NCT03763084|acetaminophen|acetaminophen
70508|NCT03763084|analgesia|analgesia
70509|NCT03763084|delirium|delirium
70510|NCT03763058|Migraine|migraine
70511|NCT03763058|Headache|headache
70512|NCT03763058|Music intervention|music intervention
70513|NCT03763058|Pain|pain
70514|NCT03763058|Smartphone application|smartphone application
70515|NCT03763032|Palliative Care|palliative care
70516|NCT03763032|Latino|latino
70517|NCT03763032|Psychosocial Intervention|psychosocial intervention
70518|NCT03763032|Patient Navigation|patient navigation
70519|NCT03763019|hemiplegia|hemiplegia
70520|NCT03763019|respiratory function tests|respiratory function tests
70521|NCT03763019|respiratory exercises|respiratory exercises
70522|NCT03763019|diaphragm ultrasonography|diaphragm ultrasonography
70523|NCT03762967|Autologous Stem Cell|autologous stem cell
70524|NCT03762967|Male infertility|male infertility
70525|NCT03762967|Adipose-Derived stem cell|adipose-derived stem cell
70526|NCT03762967|Azoospermia|azoospermia
70527|NCT03762967|Oligospermia|oligospermia
70528|NCT03762941|Elderly patients|elderly patients
70529|NCT03762941|Emergency Department|emergency department
70530|NCT03762941|Homecare|homecare
70531|NCT03762928|PK|pk
70532|NCT03762928|Phase 1|phase 1
70533|NCT03762902|Migraine|migraine
70534|NCT03762902|Smartphone|smartphone
70535|NCT03762902|App|app
70541|NCT03762902|Data Science|data science
70542|NCT03762902|Algorithm|algorithm
70543|NCT03762902|Behavior|behavior
70544|NCT03762902|Henry Ford Health System|henry ford health system
70545|NCT03762902|HFHS|hfhs
70546|NCT03762902|Lifegraph|lifegraph
70547|NCT03762876|Hepatectomy|hepatectomy
70548|NCT03762876|Trans-hepatic flow|trans-hepatic flow
70549|NCT03762876|Post-hepatectomy liver failure|post-hepatectomy liver failure
70550|NCT03762876|Mortality|mortality
70551|NCT03762837|Gallbladder cancer|gallbladder cancer
70552|NCT03762824|Pneumococcal Conjugate Vaccine|pneumococcal conjugate vaccine
70553|NCT03762824|Pneumococcal Disease|pneumococcal disease
70554|NCT03762824|Immune Response|immune response
70555|NCT03762824|Inflammatory Rheumatic Disease|inflammatory rheumatic disease
70556|NCT03762824|Pneumococcal Polysaccharide Vaccine|pneumococcal polysaccharide vaccine
70557|NCT03762824|Immunosuppression|immunosuppression
70558|NCT03762811|Demineralized Bone Matrix|demineralized bone matrix
70559|NCT03762811|Bone Graft|bone graft
70560|NCT03762811|Fusion|fusion
70561|NCT03762798|substance abuse|substance abuse
70562|NCT03762798|the bridge|the bridge
70563|NCT03762785|pharmacokinitics|pharmacokinitics
70564|NCT03762785|nebulized|nebulized
70565|NCT03762785|dexmedetomidine|dexmedetomidine
70566|NCT03762785|preschool children|preschool children
70568|NCT03762772|TAF|taf
70569|NCT03762772|EVG|evg
70570|NCT03762772|Prevention|prevention
70571|NCT03762772|Vaginal Insert|vaginal insert
70575|NCT03762720|Manual Therapy|manual therapy
70576|NCT03762720|Massage|massage
91637|NCT03631030|MRI|mri
70577|NCT03762720|physium|physium
70578|NCT03762720|pain|pain
70579|NCT03762720|range of motion|range of motion
70580|NCT03762720|quality of life|quality of life
70581|NCT03762720|muscle injuries|muscle injuries
70582|NCT03762707|Platelet Function Analyser-100 (PFA-100)|platelet function analyser-100 (pfa-100)
70583|NCT03762707|Kidney biopsy|kidney biopsy
70584|NCT03762707|Bleeding Complications|bleeding complications
70585|NCT03762694|Acupuncture|acupuncture
70586|NCT03762694|Insomnia|insomnia
70587|NCT03762694|Breast cancer|breast cancer
70588|NCT03762694|Chemotherapy|chemotherapy
70589|NCT03762668|Contact lens|contact lens
70590|NCT03762668|Vision correction|vision correction
70591|NCT03762668|Visual acuity|visual acuity
70592|NCT03762642|Breast Cancer Surgery|breast cancer surgery
70593|NCT03762642|Lumpectomy|lumpectomy
70594|NCT03762642|Surgery Choice|surgery choice
70595|NCT03762642|Procedure Choice|procedure choice
70596|NCT03762642|Surgical Outcome|surgical outcome
70597|NCT03762616|multiparametric MRI|multiparametric mri
70598|NCT03762616|micro-ultrasound|micro-ultrasound
70599|NCT03762616|prostate biopsy|prostate biopsy
70600|NCT03762603|Pneumatic|pneumatic
70601|NCT03762603|exoskeleton|exoskeleton
70602|NCT03762590|Candidates for Hereditary Pancreatic Cancer Testing|candidates for hereditary pancreatic cancer testing
70603|NCT03762577|Pulmonary Hypertension|pulmonary hypertension
70604|NCT03762577|Walking Training|walking training
70605|NCT03762577|Exercise|exercise
70606|NCT03762577|Balance|balance
70607|NCT03762577|Quality of Life|quality of life
70608|NCT03762564|Squamous Cell Carcinoma of the Esophagus|squamous cell carcinoma of the esophagus
70609|NCT03762564|Ramucirumab|ramucirumab
70610|NCT03762564|Paclitaxel|paclitaxel
70611|NCT03762538|propofol|propofol
70612|NCT03762538|ALDH2|aldh2
70613|NCT03762538|potency|potency
70614|NCT03762499|Young adults|young adults
70615|NCT03762499|Echocardiography|echocardiography
70616|NCT03762486|Postoperative pain|postoperative pain
70617|NCT03762486|Alternative therapy|alternative therapy
70618|NCT03762486|Acupuncture|acupuncture
70619|NCT03762486|TENS|tens
70620|NCT03762486|Surgical nursing|surgical nursing
70621|NCT03762486|Randomised controlled trial|randomised controlled trial
70622|NCT03762473|Envarsus|envarsus
70623|NCT03762460|Measurement-Based Care|measurement-based care
70624|NCT03762460|e-Mental Health|e-mental health
70625|NCT03762460|Functional Outcomes|functional outcomes
70626|NCT03762460|Occupational Functioning|occupational functioning
70627|NCT03762460|Cognition|cognition
70628|NCT03762460|Mobile Technology|mobile technology
70629|NCT03762447|solid tumors|solid tumors
70630|NCT03762434|life style modification program|life style modification program
70631|NCT03762434|mobile application|mobile application
70632|NCT03762434|metabolic sydrome|metabolic sydrome
70633|NCT03762434|booklet|booklet
70634|NCT03762434|RCT|rct
70635|NCT03762408|Osteoarthritis|osteoarthritis
70636|NCT03762408|Knee|knee
70637|NCT03762408|Chondroitin Sulfate|chondroitin sulfate
70638|NCT03762408|Hyaluronic Acid|hyaluronic acid
70639|NCT03762408|Intra-articular Injection|intra-articular injection
70640|NCT03762408|Viscosupplementation|viscosupplementation
70641|NCT03762408|Pain Relief|pain relief
70642|NCT03762408|Biomarkers|biomarkers
70643|NCT03762382|Intravaginal Ring|intravaginal ring
70644|NCT03762382|HIV Prevention|hiv prevention
70645|NCT03762382|Tenofovir|tenofovir
70646|NCT03762382|Levonorgestrel|levonorgestrel
70647|NCT03762382|Pregnancy Prevention|pregnancy prevention
70648|NCT03762369|Primary Open-angle Glaucoma|primary open-angle glaucoma
70649|NCT03762369|Ocular Hypertension|ocular hypertension
70650|NCT03762369|CKD-351|ckd-351
70651|NCT03762356|Insight|insight
70652|NCT03762356|Awareness|awareness
70653|NCT03762356|Violence|violence
70654|NCT03762356|Professional views|professional views
70655|NCT03762356|Risk to others|risk to others
70656|NCT03762343|greater occipital nerve block|greater occipital nerve block
70657|NCT03762343|posterior fossa|posterior fossa
70658|NCT03762343|ultrasound|ultrasound
70659|NCT03762343|pain|pain
70660|NCT03762343|craniotomy|craniotomy
70661|NCT03762330|quality of life|quality of life
70662|NCT03762330|self-management,|self-management,
70663|NCT03762330|structured plan|structured plan
70664|NCT03762330|COPD|copd
70665|NCT03762304|Causal inference|causal inference
70666|NCT03762304|Regression discontinuity|regression discontinuity
70667|NCT03762291|hematologic malignancy|hematologic malignancy
70668|NCT03762291|malignant proliferation of plasma cells|malignant proliferation of plasma cells
70669|NCT03762291|MM|mm
70670|NCT03762278|Unilateral Immobilisation|unilateral immobilisation
70671|NCT03762278|Leucine|leucine
70672|NCT03762278|Muscle Wasting|muscle wasting
70673|NCT03762278|Nutritional Intervention|nutritional intervention
70674|NCT03762265|Pemphigus Vulgaris (PV)|pemphigus vulgaris (pv)
70675|NCT03762265|Pemphigus Foliaceus (PF)|pemphigus foliaceus (pf)
70676|NCT03762239|Attention|attention
70677|NCT03762239|Air pollution|air pollution
70678|NCT03762239|Black carbon|black carbon
70679|NCT03762239|Particulate matter|particulate matter
70680|NCT03762239|Risk behavior|risk behavior
70681|NCT03762239|Social preferences|social preferences
70682|NCT03762239|Decision making|decision making
70683|NCT03762239|Air purifier|air purifier
70684|NCT03762239|Air cleaner|air cleaner
70685|NCT03762200|bleeding|bleeding
70686|NCT03762200|broad area oozing bleeding|broad area oozing bleeding
70687|NCT03762200|hemostat|hemostat
70688|NCT03762200|topical hemostatic agents|topical hemostatic agents
70689|NCT03762200|adjunctive hemostats|adjunctive hemostats
70690|NCT03762174|Emergency Medical Services|emergency medical services
70691|NCT03762174|Emergency Department|emergency department
70692|NCT03762174|Back Pain|back pain
70693|NCT03762148|iron-deficiency|iron-deficiency
70694|NCT03762148|prebiotics|prebiotics
70695|NCT03762148|galacto-oligosaccharides|galacto-oligosaccharides
70696|NCT03762122|Fibroblast growth factor receptor (FGFR)|fibroblast growth factor receptor (fgfr)
70697|NCT03762122|Rogaratinib|rogaratinib
70698|NCT03762122|Advanced pretreated squamous-cell non-small cell lung cancer|advanced pretreated squamous-cell non-small cell lung cancer
70699|NCT03762122|SQCLC|sqclc
70700|NCT03762122|FGFR mRNA|fgfr mrna
70701|NCT03762109|Surgery|surgery
70702|NCT03762109|Dantrolene|dantrolene
70703|NCT03762109|Anesthesia|anesthesia
70704|NCT03762083|vaginitis|vaginitis
70705|NCT03762083|vaginal disease|vaginal disease
70706|NCT03762083|vulvovaginitis|vulvovaginitis
70707|NCT03762083|genital disease, female|genital disease, female
70708|NCT03762083|vaginitis, bacterial|vaginitis, bacterial
70709|NCT03762057|Intraabdominal Hypertension|intraabdominal hypertension
70710|NCT03762057|Abdominal Compartment Syndrome|abdominal compartment syndrome
70711|NCT03762057|Prevalence|prevalence
70712|NCT03762057|Risk factors|risk factors
70713|NCT03762057|ICU|icu
70714|NCT03762057|Surgical|surgical
70715|NCT03762044|Breast Cancer|breast cancer
70716|NCT03762044|Breast Cancer Lymphedema|breast cancer lymphedema
70717|NCT03762044|Post-Mastectomy Secondary Lymphedema|post-mastectomy secondary lymphedema
70718|NCT03762044|Occupational Therapy|occupational therapy
70719|NCT03762044|Proprioceptive Neuromuscular Facilitation|proprioceptive neuromuscular facilitation
70720|NCT03762044|Neural Mobilization|neural mobilization
70722|NCT03762005|Septic Shock|septic shock
70723|NCT03762005|Lactate|lactate
70724|NCT03762005|Capillary refill time|capillary refill time
70725|NCT03762005|Fluid Responsiveness|fluid responsiveness
70726|NCT03762005|Mortality|mortality
70727|NCT03761979|Bone density|bone density
70728|NCT03761979|Osteopenia|osteopenia
70729|NCT03761979|Osteoporosis|osteoporosis
70730|NCT03761979|Bone health|bone health
70731|NCT03761979|Pharmacokinetics|pharmacokinetics
70732|NCT03761966|IL-10|il-10
70733|NCT03761966|IL-4|il-4
70734|NCT03761966|IFN-γ|ifn-γ
70735|NCT03761966|TNF-α|tnf-α
70736|NCT03761966|Pregnancy|pregnancy
70737|NCT03761914|peptide vaccine|peptide vaccine
70738|NCT03761914|immuno-oncology|immuno-oncology
70739|NCT03761914|WT1-expressing tumors|wt1-expressing tumors
70740|NCT03761914|galinpepimut-S|galinpepimut-s
70741|NCT03761914|pembrolizumab|pembrolizumab
70939|NCT03760796|readmission|readmission
70742|NCT03761914|PD1 inhibitor|pd1 inhibitor
70743|NCT03761914|checkpoint inhibitor|checkpoint inhibitor
70744|NCT03761914|combination immunotherapy|combination immunotherapy
70745|NCT03761914|heteroclitic|heteroclitic
70746|NCT03761914|multivalent|multivalent
70747|NCT03761914|off-the-shelf vaccine|off-the-shelf vaccine
70748|NCT03761914|HLA allele|hla allele
70749|NCT03761914|WT1 vaccine|wt1 vaccine
70750|NCT03761914|SLS-001|sls-001
70751|NCT03761914|WT1 analog peptide vaccine|wt1 analog peptide vaccine
70752|NCT03761901|EGFRm|egfrm
70753|NCT03761901|NSCLC|nsclc
70754|NCT03761901|locally advanced|locally advanced
70755|NCT03761901|metastatic|metastatic
70756|NCT03761901|lung cancer|lung cancer
70757|NCT03761875|Hepatitis B Virus - Natural Killer|hepatitis b virus - natural killer
70758|NCT03761849|HD, RG6042, intrathecal, ASO, antisense oligonucleotide|hd, rg6042, intrathecal, aso, antisense oligonucleotide
70759|NCT03761823|Flexible endoscopic evaluation of swallowing|flexible endoscopic evaluation of swallowing
70760|NCT03761823|High resolution impedance manometry|high resolution impedance manometry
70761|NCT03761823|Electromyography|electromyography
70762|NCT03761823|Intensive Care Unit|intensive care unit
70763|NCT03761784|Acne Vulgaris|acne vulgaris
70764|NCT03761745|Rotation|rotation
70765|NCT03761745|Postoperative Care|postoperative care
70766|NCT03761706|breast cancer|breast cancer
70767|NCT03761706|exercise|exercise
70768|NCT03761706|chemotherapy and aging|chemotherapy and aging
70769|NCT03761693|Mcad deficiency|mcad deficiency
70770|NCT03761693|Phenotypic Variation|phenotypic variation
70771|NCT03761693|Biomarkers|biomarkers
70772|NCT03761693|Diet Therapy|diet therapy
70773|NCT03761680|Malnutrition|malnutrition
70774|NCT03761654|Subarachnoid Hemorrhage (SAH)|subarachnoid hemorrhage (sah)
70775|NCT03761654|Left Ventricular Dysfunction|left ventricular dysfunction
70776|NCT03761654|Intensive Care Unit|intensive care unit
70777|NCT03761654|Speckle-tracking|speckle-tracking
70778|NCT03761654|STRAIN|strain
70779|NCT03761628|Vaginal Yeast Infection|vaginal yeast infection
70780|NCT03761628|Candidiasis, vulvovaginal|candidiasis, vulvovaginal
70781|NCT03761628|Genital diseases, female|genital diseases, female
70782|NCT03761628|Vaginitis|vaginitis
70783|NCT03761628|Vulvovaginitis|vulvovaginitis
70784|NCT03761628|Vaginal diseases|vaginal diseases
70785|NCT03761615|type 1 diabetes|type 1 diabetes
70786|NCT03761615|pregnancy|pregnancy
70787|NCT03761615|continues glucose monitoring|continues glucose monitoring
70788|NCT03761615|artificial pancreas|artificial pancreas
70789|NCT03761589|Cardiovascular fitness|cardiovascular fitness
70790|NCT03761589|Physical Activity|physical activity
70791|NCT03761589|Obesity|obesity
70792|NCT03761589|Children|children
70793|NCT03761589|Adults|adults
70794|NCT03761550|pMDT|pmdt
70795|NCT03761550|Pain|pain
70796|NCT03761550|Thoracic surgery|thoracic surgery
70797|NCT03761524|Angle fracture|angle fracture
70798|NCT03761524|superior-inferior plate fixation|superior-inferior plate fixation
70799|NCT03761524|custom made plate fixation|custom made plate fixation
70800|NCT03761524|postoperative complications|postoperative complications
70801|NCT03761511|Friedreich Ataxia|friedreich ataxia
70802|NCT03761511|Nicotinamide|nicotinamide
70803|NCT03761511|Rare disease|rare disease
70804|NCT03761511|ZSEA|zsea
70805|NCT03761511|SARA|sara
70806|NCT03761472|Osteoarthritis|osteoarthritis
70807|NCT03761472|Hyaluronic acid|hyaluronic acid
70808|NCT03761472|Platelet-rich plasma|platelet-rich plasma
70809|NCT03761472|Injection|injection
70810|NCT03761459|Surgical site infection|surgical site infection
70811|NCT03761459|low and middle income country|low and middle income country
70812|NCT03761459|low resource setting|low resource setting
70813|NCT03761459|Africa|africa
70814|NCT03761459|Ethiopia|ethiopia
70815|NCT03761420|Medication Adherence|medication adherence
70816|NCT03761420|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal
70817|NCT03761420|Chemotherapy, Adjuvant|chemotherapy, adjuvant
70818|NCT03761420|Treatment Outcome|treatment outcome
70819|NCT03761394|Cardiac Arrhythmias|cardiac arrhythmias
70820|NCT03761381|MCI|mci
70821|NCT03761381|OCT|oct
70822|NCT03761381|Angiography|angiography
70823|NCT03761381|Alzheimer's|alzheimer's
70824|NCT03761381|Dementia|dementia
70825|NCT03761368|remote ischemic preconditioning|remote ischemic preconditioning
70826|NCT03761368|contrast induced-acute kidney injury|contrast induced-acute kidney injury
70827|NCT03761368|neutrophil gelatinase-associated lipocalin|neutrophil gelatinase-associated lipocalin
70828|NCT03761368|percutaneous coronary intervention|percutaneous coronary intervention
70829|NCT03761355|mindfulness|mindfulness
70830|NCT03761355|executive functions|executive functions
70831|NCT03761355|medical simulation|medical simulation
70832|NCT03761355|medical students|medical students
70833|NCT03761355|pediatrics|pediatrics
70834|NCT03761342|Front-of-pack label|front-of-pack label
70835|NCT03761342|Nutrition label|nutrition label
70836|NCT03761342|Diet Quality|diet quality
70837|NCT03761342|Online grocery store|online grocery store
70838|NCT03761342|Diet|diet
70839|NCT03761329|Anesthesia|anesthesia
70840|NCT03761329|Bier's block|bier's block
70841|NCT03761329|Mini-Bier's block|mini-bier's block
70842|NCT03761329|Hand surgery|hand surgery
70843|NCT03761316|Spinal cord stimulation|spinal cord stimulation
70844|NCT03761316|interview|interview
70845|NCT03761303|rTMS|rtms
70846|NCT03761303|Escitalopram|escitalopram
70847|NCT03761303|add-on therapy|add-on therapy
70848|NCT03761277|Pain|pain
70849|NCT03761277|Intrathecal|intrathecal
70850|NCT03761277|Targeted Drug Delivery (TDD)|targeted drug delivery (tdd)
70851|NCT03761277|Non-Malignant Pain|non-malignant pain
70852|NCT03761277|Systemic Opioids|systemic opioids
70853|NCT03761277|Opioid Weaning|opioid weaning
70854|NCT03761277|Pain Pump|pain pump
70855|NCT03761277|Drug Pump|drug pump
70856|NCT03761277|Medtronic Pump|medtronic pump
70857|NCT03761264|Odontogenic Infections|odontogenic infections
70858|NCT03761264|Paediatric Patients|paediatric patients
70859|NCT03761264|Local Antimicrobials|local antimicrobials
70860|NCT03761264|Systemic Antimicrobials|systemic antimicrobials
70861|NCT03761264|Dentoalveolar Abscess|dentoalveolar abscess
70862|NCT03761264|Apical Dentoalveolar Abscess|apical dentoalveolar abscess
70863|NCT03761264|Periapical Abscess|periapical abscess
70864|NCT03761264|Suppurative Periapical Periodontitis|suppurative periapical periodontitis
70865|NCT03761238|Molecular Adsorbent Recirculating System|molecular adsorbent recirculating system
70866|NCT03761238|post-hepatectomy liver failure|post-hepatectomy liver failure
70867|NCT03761238|liver dialysis|liver dialysis
70868|NCT03761238|post-hepatectomy liver dysfunction|post-hepatectomy liver dysfunction
70869|NCT03761225|metastatic castration-resistant prostate cancer|metastatic castration-resistant prostate cancer
820522|NCT00156026|CIN 1|cin 1
70870|NCT03761225|metastatic hormone-resistant prostate cancer|metastatic hormone-resistant prostate cancer
70871|NCT03761225|tyrosine kinase inhibitor|tyrosine kinase inhibitor
70872|NCT03761225|mCRPC|mcrpc
70873|NCT03761225|mHRPC|mhrpc
70874|NCT03761212|Ankylosing spondylitis|ankylosing spondylitis
70875|NCT03761212|Gait|gait
70876|NCT03761212|BASFI|basfi
70877|NCT03761212|BASDAI|basdai
70878|NCT03761212|6MWT|6mwt
70879|NCT03761199|AD patients|ad patients
70880|NCT03761199|whole body cryostimulation|whole body cryostimulation
70881|NCT03761186|type 1 diabetes|type 1 diabetes
70882|NCT03761186|low carbohydrate diet|low carbohydrate diet
70883|NCT03761186|randomized trial|randomized trial
70884|NCT03761186|adults|adults
70885|NCT03761186|insulin|insulin
70886|NCT03761186|metabolic control|metabolic control
70887|NCT03761173|PE|pe
70888|NCT03761173|pulmonary embolism|pulmonary embolism
70889|NCT03761173|thromboembolism|thromboembolism
70890|NCT03761173|thrombectomy|thrombectomy
70891|NCT03761173|FlowTriever|flowtriever
70892|NCT03761160|Prostate Cancer|prostate cancer
70893|NCT03761121|Neuro Oncology|neuro oncology
70894|NCT03761108|Relapsed, Refractory|relapsed, refractory
70895|NCT03761069|Leukemia, Myeloid|leukemia, myeloid
70896|NCT03761069|Neoplasms by Histologic Type|neoplasms by histologic type
70897|NCT03761069|Neoplasms|neoplasms
70898|NCT03761069|Dihydroorotate dehydrogenase (DHODH) inhibitor|dihydroorotate dehydrogenase (dhodh) inhibitor
70899|NCT03761043|Nurse|nurse
70900|NCT03761043|Antibiotic step-down|antibiotic step-down
70901|NCT03761030|Depressive symptoms|depressive symptoms
70902|NCT03761030|Cognitive problems|cognitive problems
70903|NCT03761030|Antidepressant non-response|antidepressant non-response
70904|NCT03761030|Dopamine system|dopamine system
70905|NCT03761030|Older Adults|older adults
70906|NCT03761030|Motor slowing|motor slowing
70907|NCT03761017|Checkpoint blockade|checkpoint blockade
70908|NCT03760978|sedation|sedation
70909|NCT03760978|dexmedetomidine|dexmedetomidine
70910|NCT03760952|T-cell therapy|t-cell therapy
70911|NCT03760952|Immunotherapy|immunotherapy
70912|NCT03760952|Screening|screening
70913|NCT03760952|Metastatic|metastatic
70914|NCT03760952|Previously Treated|previously treated
70915|NCT03760939|Colorectal surgery|colorectal surgery
70916|NCT03760939|Ambulatory care|ambulatory care
70917|NCT03760939|Medical and economic evaluation|medical and economic evaluation
70918|NCT03760926|Anovulatory infertility|anovulatory infertility
70919|NCT03760913|Pain|pain
70920|NCT03760913|Pain Injection|pain injection
70921|NCT03760900|Autologous Umbilical Cord Blood Stem Cells|autologous umbilical cord blood stem cells
70922|NCT03760900|Safety|safety
70923|NCT03760900|Effect|effect
70924|NCT03760900|neonates|neonates
70925|NCT03760900|Mechanism|mechanism
70926|NCT03760887|Low back pain|low back pain
70927|NCT03760887|Sensory|sensory
70928|NCT03760887|Tactile|tactile
70929|NCT03760887|Education|education
70930|NCT03760835|congenital adrenal hyperplasia|congenital adrenal hyperplasia
70931|NCT03760835|glucocorticoid treatment|glucocorticoid treatment
70932|NCT03760835|dual release hydrocortisone|dual release hydrocortisone
70933|NCT03760822|ramucirumab|ramucirumab
70934|NCT03760822|elderly patient|elderly patient
70935|NCT03760822|second line therapy|second line therapy
70936|NCT03760809|dexmedetomidine|dexmedetomidine
70937|NCT03760809|hydromophine|hydromophine
70938|NCT03760809|tonsillectomy and adenoidectomy|tonsillectomy and adenoidectomy
70940|NCT03760796|cardiovascular disease prevention|cardiovascular disease prevention
70941|NCT03760796|cardiovascular disease risk factors|cardiovascular disease risk factors
70942|NCT03760796|cost-effectiveness|cost-effectiveness
70943|NCT03760796|heart attack|heart attack
70944|NCT03760796|acute myocardial infarction|acute myocardial infarction
70945|NCT03760796|secondary prevention|secondary prevention
70946|NCT03760796|digital health|digital health
70947|NCT03760796|smartphone app|smartphone app
70948|NCT03760796|self-management|self-management
70949|NCT03760796|guideline adherence|guideline adherence
70950|NCT03760796|behavior modification|behavior modification
70951|NCT03760770|Crosslinking|crosslinking
70952|NCT03760770|Keratoconus|keratoconus
70953|NCT03760770|Cold|cold
70954|NCT03760770|Pain|pain
70955|NCT03760757|krill oil|krill oil
70956|NCT03760757|DOMS|doms
70957|NCT03760757|EIMD (exercise induced muscle damage)|eimd (exercise induced muscle damage)
70958|NCT03760744|lymphedema|lymphedema
70959|NCT03760744|therapy|therapy
70960|NCT03760744|swelling|swelling
70961|NCT03760744|graded negative pressure|graded negative pressure
70962|NCT03760744|complete decongestive therapy|complete decongestive therapy
70963|NCT03760731|Psychosocial Rehabilitation|psychosocial rehabilitation
70964|NCT03760731|Acceptance and Commitment Therapy|acceptance and commitment therapy
70965|NCT03760718|chloroprocaine|chloroprocaine
70966|NCT03760718|cesarean delivery|cesarean delivery
70967|NCT03760718|lavage|lavage
70968|NCT03760705|CAD|cad
70969|NCT03760705|CHF|chf
70970|NCT03760705|AF|af
70971|NCT03760705|SingCLOUD|singcloud
70972|NCT03760705|Cardiovascular|cardiovascular
70973|NCT03760705|Retrospective|retrospective
70974|NCT03760705|BRAIN|brain
70975|NCT03760705|HDG|hdg
70976|NCT03760705|Database|database
70977|NCT03760692|supraglottic airway device|supraglottic airway device
70978|NCT03760692|laparoscopic gynecological surgery|laparoscopic gynecological surgery
70979|NCT03760679|laryngeal mask|laryngeal mask
70980|NCT03760679|geriatric|geriatric
70981|NCT03760679|patient|patient
70982|NCT03760666|DHODH|dhodh
70983|NCT03760666|Brequinar|brequinar
70984|NCT03760666|Differentiation|differentiation
70985|NCT03760653|Breast Cancer Survivor|breast cancer survivor
70986|NCT03760653|Probiotic|probiotic
70987|NCT03760653|Immune System|immune system
70988|NCT03760653|Physical Exercise|physical exercise
70989|NCT03760653|Quality of Life|quality of life
70990|NCT03760653|Gut Microbiota|gut microbiota
70991|NCT03760588|LCZ696|lcz696
70992|NCT03760588|CMR|cmr
70993|NCT03760588|Echocardiography|echocardiography
70994|NCT03760588|Cardio-oncology|cardio-oncology
70995|NCT03760588|Circulating biomarkers|circulating biomarkers
70996|NCT03760588|Breast Cancer|breast cancer
70997|NCT03760588|Anthracyclines|anthracyclines
70998|NCT03760523|leukemia|leukemia
70999|NCT03760523|myeloid leukemia|myeloid leukemia
71000|NCT03760510|endotracheal tube|endotracheal tube
71001|NCT03760510|tube fastener|tube fastener
71002|NCT03760510|facial skin tear|facial skin tear
71003|NCT03760510|lip ulcer|lip ulcer
71004|NCT03760510|endotracheal tube dislodgement|endotracheal tube dislodgement
71005|NCT03760497|Lasers|lasers
71006|NCT03760497|Hipomineralization of dental enamel|hipomineralization of dental enamel
71007|NCT03760497|Preventive dentistry|preventive dentistry
71008|NCT03760497|Glass ionomer cement|glass ionomer cement
71009|NCT03760484|Fecal microbiota transplantation|fecal microbiota transplantation
71010|NCT03760484|Fidaxomicin|fidaxomicin
71011|NCT03760445|HDM201|hdm201
71012|NCT03760445|midostaurin|midostaurin
71013|NCT03760445|cytarabine|cytarabine
71014|NCT03760445|daunorubicin|daunorubicin
71015|NCT03760445|idarubicin|idarubicin
71016|NCT03760445|liposomal cytarabine/daunorubicin|liposomal cytarabine/daunorubicin
71017|NCT03760445|acute myeloid leukemia (AML)|acute myeloid leukemia (aml)
71018|NCT03760445|1L newly diagnosed AML|1l newly diagnosed aml
71019|NCT03760445|relapsed/refractory AML|relapsed/refractory aml
71020|NCT03760445|FLT3-mutation|flt3-mutation
71021|NCT03760445|combination treatment|combination treatment
71022|NCT03760445|dose escalation|dose escalation
71023|NCT03760445|CR/CRi|cr/cri
71024|NCT03760445|minimal residual disease|minimal residual disease
71025|NCT03760445|DDI with CYP3A4 inhibitors|ddi with cyp3a4 inhibitors
71026|NCT03760445|DDI with sensitive CYP3A4 substrate|ddi with sensitive cyp3a4 substrate
71027|NCT03760432|Keratoconus (KCN)|keratoconus (kcn)
71028|NCT03760432|Optical Coherence Tomography (OCT)|optical coherence tomography (oct)
71029|NCT03760432|Collagen Cross-linking (CXL)|collagen cross-linking (cxl)
71030|NCT03760406|Essential Tremor|essential tremor
71031|NCT03760406|Deep brain stimulation|deep brain stimulation
71032|NCT03760406|Ventro-intermediate nucleus of the thalamus|ventro-intermediate nucleus of the thalamus
71033|NCT03760406|Targeting|targeting
71034|NCT03760406|Asleep surgery|asleep surgery
71035|NCT03760393|Sedentary Behaviour|sedentary behaviour
71036|NCT03760393|Health Behaviour Change|health behaviour change
71037|NCT03760393|Health Action Process Approach|health action process approach
71038|NCT03760393|mHealth|mhealth
71137|NCT03759652|laminectomy|laminectomy
71039|NCT03760393|Intervention|intervention
71040|NCT03760393|Non-Sedentary Behaviours|non-sedentary behaviours
71041|NCT03760393|Break Frequency|break frequency
71042|NCT03760393|Break Duration|break duration
71043|NCT03760393|Action Planning|action planning
71044|NCT03760393|Coping Planning|coping planning
71045|NCT03760393|Work Performance|work performance
71046|NCT03760393|Health Outcomes|health outcomes
71047|NCT03760380|osteoarthritis (OA)|osteoarthritis (oa)
71048|NCT03760380|gait modifying shoe|gait modifying shoe
71049|NCT03760367|blue covarine|blue covarine
71050|NCT03760367|numeric analogue scale|numeric analogue scale
71051|NCT03760367|spectrophotometry|spectrophotometry
71052|NCT03760367|tooth bleaching|tooth bleaching
71053|NCT03760354|Caustic|caustic
71054|NCT03760354|Esophageal Stenosis|esophageal stenosis
71055|NCT03760354|Pharyngeal Stenosis|pharyngeal stenosis
71056|NCT03760354|Corticosteroid treatment|corticosteroid treatment
71057|NCT03760315|next- generation sequencing； microbe|next- generation sequencing； microbe
71058|NCT03760224|Intervention|intervention
71059|NCT03760224|WhatsApp|whatsapp
71060|NCT03760224|Smoking Cessation|smoking cessation
71061|NCT03760224|Relapse Prevention|relapse prevention
71062|NCT03760224|Group Disscussion|group disscussion
71063|NCT03760133|Gut microbiota|gut microbiota
71064|NCT03760133|Colonoscopy|colonoscopy
71065|NCT03760133|Bowel preparation|bowel preparation
71066|NCT03760133|Probiotics|probiotics
71067|NCT03760120|physiotherapy|physiotherapy
71068|NCT03760120|pulmonary function|pulmonary function
71069|NCT03760081|Incurable Platinum Refractory Germ Cell Tumors|incurable platinum refractory germ cell tumors
71070|NCT03760081|ASP1650|asp1650
71071|NCT03760016|Rehabilitation|rehabilitation
71072|NCT03760016|Locomotion|locomotion
71073|NCT03760016|Aerobic|aerobic
71074|NCT03760016|Intensity|intensity
71075|NCT03760016|Dosing|dosing
71076|NCT03760003|ABX464|abx464
71077|NCT03760003|Refractory patients|refractory patients
71078|NCT03760003|Phase 2b|phase 2b
71079|NCT03760003|Dose Ranging|dose ranging
71080|NCT03759990|videolaryngoscope|videolaryngoscope
71081|NCT03759990|Airtraq|airtraq
71082|NCT03759990|McGrath MAC|mcgrath mac
71083|NCT03759990|Morbid obesity|morbid obesity
71084|NCT03759990|intubation|intubation
71085|NCT03759977|adapted physical activity|adapted physical activity
71086|NCT03759977|nursing home|nursing home
71087|NCT03759977|elderly|elderly
71088|NCT03759977|postural control|postural control
71089|NCT03759964|cardiac surgery|cardiac surgery
71090|NCT03759964|ferric carboxymaltose|ferric carboxymaltose
71091|NCT03759964|anemia|anemia
71092|NCT03759964|transfusion|transfusion
71093|NCT03759951|functional fitness|functional fitness
71094|NCT03759951|circuit training|circuit training
71095|NCT03759951|bodyweight training|bodyweight training
71096|NCT03759938|ischaemic stroke, atrial fibrilation|ischaemic stroke, atrial fibrilation
71097|NCT03759912|Atrial fibrillation ablation|atrial fibrillation ablation
71098|NCT03759912|Pulmonary vein|pulmonary vein
71099|NCT03759912|Ultra high resolution mapping|ultra high resolution mapping
71100|NCT03759873|Incentives|incentives
71101|NCT03759873|Case management|case management
71102|NCT03759873|Socioeconomic status|socioeconomic status
71103|NCT03759847|hemodialysis|hemodialysis
71104|NCT03759847|fluid intake|fluid intake
71105|NCT03759847|Interdialytic weight gain|interdialytic weight gain
71106|NCT03759821|Infant and young child feeding|infant and young child feeding
71107|NCT03759821|nutrition|nutrition
71108|NCT03759821|Stimulation|stimulation
71109|NCT03759821|Parenting|parenting
71110|NCT03759821|Early childhood development|early childhood development
71111|NCT03759821|Social and behavior change|social and behavior change
71112|NCT03759821|Father involvement|father involvement
71113|NCT03759821|Male engagement|male engagement
71114|NCT03759821|Household decision-making|household decision-making
71115|NCT03759821|Community health workers|community health workers
71116|NCT03759821|Peer groups|peer groups
71117|NCT03759821|Integrated interventions|integrated interventions
71118|NCT03759808|post-concussion syndrome|post-concussion syndrome
71119|NCT03759808|mild traumatic brain injury|mild traumatic brain injury
71120|NCT03759808|autonomic dysfunction|autonomic dysfunction
71121|NCT03759808|concussion|concussion
71122|NCT03759808|capnometry-assisted respiratory training|capnometry-assisted respiratory training
71123|NCT03759808|cognitive behavioral therapy|cognitive behavioral therapy
71124|NCT03759795|Resilience|resilience
71125|NCT03759795|Psychological flexibility|psychological flexibility
71126|NCT03759795|Acceptance and Commitment Training|acceptance and commitment training
71127|NCT03759769|power wheelchair|power wheelchair
71128|NCT03759769|virtual reality|virtual reality
71129|NCT03759769|skills|skills
71130|NCT03759704|Musculoskeletal Sarcoma|musculoskeletal sarcoma
71131|NCT03759691|prehospital delay|prehospital delay
71132|NCT03759691|help-seeking behaviour|help-seeking behaviour
71133|NCT03759652|neurosurgery|neurosurgery
71134|NCT03759652|surgical site infections|surgical site infections
71135|NCT03759652|spinal surgery|spinal surgery
71136|NCT03759652|craniotomy|craniotomy
71138|NCT03759626|alcohol|alcohol
71139|NCT03759626|youth|youth
71140|NCT03759626|prevention|prevention
71141|NCT03759626|comparative study|comparative study
71142|NCT03759626|reflexive model|reflexive model
71143|NCT03759626|impulsive model|impulsive model
71144|NCT03759626|para-social connection|para-social connection
71145|NCT03759613|Burn Injury|burn injury
71146|NCT03759613|Gait Symmetry|gait symmetry
71147|NCT03759613|Arm Swing|arm swing
71148|NCT03759574|Orthostatic Intolerance|orthostatic intolerance
71149|NCT03759574|Orthostatic Hypotension|orthostatic hypotension
71150|NCT03759548|Nutritional Status|nutritional status
71151|NCT03759548|Colorectal Cancer|colorectal cancer
71152|NCT03759548|Breast Cancer|breast cancer
71153|NCT03759548|Pharmacological Treatment|pharmacological treatment
71154|NCT03759548|Toxicity|toxicity
71155|NCT03759548|Quality of Life|quality of life
71156|NCT03759535|DNA acute rejection kidney transplantation|dna acute rejection kidney transplantation
71157|NCT03759496|bladder|bladder
71158|NCT03759496|durvalumab|durvalumab
71159|NCT03759496|cancer|cancer
71160|NCT03759483|Deep convolutional neural network|deep convolutional neural network
71161|NCT03759483|Visual field|visual field
71162|NCT03759483|Glaucoma|glaucoma
71163|NCT03759444|Perception of time|perception of time
71164|NCT03759444|Eating disorders|eating disorders
71165|NCT03759444|Ego-syntonicity|ego-syntonicity
821097|NCT00153491|Tanzania|tanzania
71166|NCT03759444|Existential suffering|existential suffering
71167|NCT03759444|Psychotherapy|psychotherapy
71168|NCT03759418|Left Atrial Appendage Ligation|left atrial appendage ligation
71169|NCT03759418|Atriclip|atriclip
71170|NCT03759418|atrial fibrillation|atrial fibrillation
71171|NCT03759366|Myasthenia Gravis|myasthenia gravis
71172|NCT03759366|Myasthenia Gravis, Generalized|myasthenia gravis, generalized
71173|NCT03759314|EMS, elderly, inadequate nutrition, falling, cognitive functioning|ems, elderly, inadequate nutrition, falling, cognitive functioning
71174|NCT03759301|Growth Hormone|growth hormone
71175|NCT03759301|IVF/ICSI|ivf/icsi
71176|NCT03759301|Poor Responders|poor responders
71177|NCT03759275|pMDT|pmdt
71178|NCT03759275|Pain|pain
71179|NCT03759275|Thoracic surgery|thoracic surgery
71180|NCT03759262|vitamin D|vitamin d
71181|NCT03759262|cytokines|cytokines
71182|NCT03759249|multiple sclerosis|multiple sclerosis
71183|NCT03759249|polysomnography|polysomnography
71184|NCT03759236|Health Messaging|health messaging
71185|NCT03759236|Health Education|health education
71186|NCT03759236|Human Papilloma Virus|human papilloma virus
71187|NCT03759236|HPV Vaccination|hpv vaccination
71188|NCT03759223|Mild Traumatic Brain Injury|mild traumatic brain injury
71189|NCT03759223|Concussion, Mild|concussion, mild
71190|NCT03759223|Veterans|veterans
71191|NCT03759223|Stress Disorders, Post-Traumatic|stress disorders, post-traumatic
71192|NCT03759184|Monoclonal Antibody Treatment|monoclonal antibody treatment
71193|NCT03759184|Recombinant Human Interleukin-15|recombinant human interleukin-15
71194|NCT03759184|Lymphoid Malignancy|lymphoid malignancy
71195|NCT03759184|Antibody-Dependent Cell-Mediated Cytotoxicity (ADCC)|antibody-dependent cell-mediated cytotoxicity (adcc)
71196|NCT03759145|virtual reality|virtual reality
71197|NCT03759145|exergame|exergame
71198|NCT03759145|stroke rehabilitation|stroke rehabilitation
71199|NCT03759106|Virtual reality|virtual reality
71200|NCT03759106|telerehabilitation|telerehabilitation
71201|NCT03759106|Stroke rehabilitation|stroke rehabilitation
71202|NCT03759067|clopidogrel loading|clopidogrel loading
71203|NCT03759067|maintenance dose|maintenance dose
71204|NCT03759067|periprocedural MI|periprocedural mi
71205|NCT03759041|microbiome|microbiome
71206|NCT03759028|closed reduction percutaneous pinning|closed reduction percutaneous pinning
71207|NCT03759028|post-operative pain control|post-operative pain control
71208|NCT03759028|opiod|opiod
71209|NCT03759028|pediatric|pediatric
71210|NCT03759028|elbow fracture|elbow fracture
71211|NCT03758976|Metastatic breast cancer|metastatic breast cancer
71212|NCT03758976|Molecular profiling|molecular profiling
71213|NCT03758976|Circulating tumor DNA|circulating tumor dna
71214|NCT03758976|Circulating tumor cells|circulating tumor cells
71215|NCT03758950|Sickle Cell|sickle cell
71216|NCT03758950|Inhaled Steroids|inhaled steroids
71217|NCT03758937|bariatric surgery|bariatric surgery
71218|NCT03758937|volume-controlled ventilation|volume-controlled ventilation
71219|NCT03758937|pressure-controlled ventilation|pressure-controlled ventilation
71220|NCT03758911|bone marrow|bone marrow
71221|NCT03758911|stem cell|stem cell
71222|NCT03758911|donor|donor
71223|NCT03758911|interview|interview
71224|NCT03758898|Bariatric surgery|bariatric surgery
71225|NCT03758898|Chest physiotherapy|chest physiotherapy
71226|NCT03758898|Pulmonary functions|pulmonary functions
71227|NCT03758898|Quality of life|quality of life
71228|NCT03758885|IVF|ivf
71229|NCT03758885|ICSI|icsi
71230|NCT03758885|ART|art
71231|NCT03758885|ET|et
71232|NCT03758859|Glaucoma|glaucoma
71233|NCT03758846|Dual-task training|dual-task training
71234|NCT03758846|Cognitive-motor training|cognitive-motor training
71235|NCT03758846|Conventional training|conventional training
71236|NCT03758846|Virtual-reality exergaming|virtual-reality exergaming
71237|NCT03758846|Dance Therapy|dance therapy
71238|NCT03758833|in vitro fertilization|in vitro fertilization
71239|NCT03758833|single embryo transfer|single embryo transfer
71240|NCT03758833|preimplantation genetic diagnosis|preimplantation genetic diagnosis
71241|NCT03758833|clinical pregnancy|clinical pregnancy
71242|NCT03758807|Low back pain|low back pain
71243|NCT03758807|Manual Therapy|manual therapy
71244|NCT03758807|Education|education
71245|NCT03758807|Neuroplasticiy|neuroplasticiy
71246|NCT03758768|Circadian rhythm|circadian rhythm
71247|NCT03758768|Sleep|sleep
71248|NCT03758768|evening-type individuals|evening-type individuals
71249|NCT03758768|morningness-eveningness|morningness-eveningness
71250|NCT03758768|blue light|blue light
71251|NCT03758768|monochromatic light|monochromatic light
71252|NCT03758768|randomized controlled trial|randomized controlled trial
71253|NCT03758755|BFR|bfr
71254|NCT03758755|ACL|acl
71255|NCT03758755|rehabilitation|rehabilitation
71256|NCT03758742|diabetes|diabetes
71257|NCT03758742|whole fruit|whole fruit
71258|NCT03758742|diabetes remission|diabetes remission
71259|NCT03758742|glycemic control|glycemic control
71260|NCT03758742|liver fat|liver fat
71261|NCT03758742|intrahepatic lipid|intrahepatic lipid
821098|NCT00153491|adherence|adherence
71262|NCT03758742|controlled feeding trial|controlled feeding trial
71263|NCT03758651|Williams Syndrome|williams syndrome
71264|NCT03758651|Lipedema|lipedema
71265|NCT03758651|Body Composition|body composition
71266|NCT03758651|Glucose|glucose
71267|NCT03758651|Bone Density|bone density
71268|NCT03758625|dendritic cell|dendritic cell
71269|NCT03758625|vaccine|vaccine
71270|NCT03758625|immunogenicity|immunogenicity
71271|NCT03758625|HIV|hiv
71272|NCT03758625|vaccination|vaccination
71273|NCT03758625|immune system|immune system
71274|NCT03758612|TB|tb
71275|NCT03758612|Tuberculosis|tuberculosis
71276|NCT03758612|TBI-223|tbi-223
71277|NCT03758612|Pulmonary Tuberculosis|pulmonary tuberculosis
71278|NCT03758599|Anxiety Disorder|anxiety disorder
71279|NCT03758599|Posttraumatic Stress Disorder|posttraumatic stress disorder
71280|NCT03758599|Sports intervention|sports intervention
71281|NCT03758573|Breathing Exercises|breathing exercises
71282|NCT03758573|Respiratory Muscles|respiratory muscles
71283|NCT03758573|Respiration Artificial|respiration artificial
71284|NCT03758573|Weaning|weaning
71285|NCT03758521|SSADHD|ssadhd
71286|NCT03758521|SSADH deficiency|ssadh deficiency
71287|NCT03758508|Noninvasive ventilation|noninvasive ventilation
71288|NCT03758508|High flow oxygen nasal cannula|high flow oxygen nasal cannula
71289|NCT03758508|Pneumonia|pneumonia
71290|NCT03758508|Acute hypoxemic respiratory failure|acute hypoxemic respiratory failure
71291|NCT03758482|meal ingestion|meal ingestion
71292|NCT03758482|metabolomic responses|metabolomic responses
71293|NCT03758482|hedonic sensations|hedonic sensations
71294|NCT03758482|homeostatic sensations|homeostatic sensations
71295|NCT03758456|Subcutaneous immunotherapy|subcutaneous immunotherapy
71296|NCT03758456|Ragweed pollen|ragweed pollen
71297|NCT03758456|Allergic rhinitis/rhinoconjunctivitis|allergic rhinitis/rhinoconjunctivitis
71298|NCT03758456|Safety|safety
71299|NCT03758456|Tolerability|tolerability
71300|NCT03758443|TD-1473|td-1473
71301|NCT03758443|Janus kinase inhibitor|janus kinase inhibitor
71302|NCT03758443|JAK inhibitor|jak inhibitor
71303|NCT03758443|Inflammatory Bowel Disease|inflammatory bowel disease
71304|NCT03758443|IBD|ibd
71305|NCT03758443|Ulcerative colitis|ulcerative colitis
71306|NCT03758443|UC|uc
71307|NCT03758443|Gut selective|gut selective
71308|NCT03758391|Neonatal-Perinatal Medicine|neonatal-perinatal medicine
71309|NCT03758391|Andragogy|andragogy
71310|NCT03758391|Flipped Classroom|flipped classroom
71311|NCT03758378|dietary modification|dietary modification
71312|NCT03758352|ischemia reperfusion injury|ischemia reperfusion injury
71313|NCT03758352|remote ischemic preconditioning|remote ischemic preconditioning
71314|NCT03758352|liver transplantation|liver transplantation
71315|NCT03758326|Body image|body image
71316|NCT03758261|VATS|vats
71317|NCT03758261|Regional Anesthesia|regional anesthesia
71318|NCT03758261|Paravertebral nerve block|paravertebral nerve block
71319|NCT03758261|Erector Spinae nerve block|erector spinae nerve block
71320|NCT03758261|Video assisted thoracoscopic surgery|video assisted thoracoscopic surgery
71321|NCT03758248|Genotype-guided therapy|genotype-guided therapy
71322|NCT03758248|CYP2C19 Polymorphism|cyp2c19 polymorphism
71323|NCT03758235|overactive bladder syndrome|overactive bladder syndrome
71324|NCT03758235|botulinum toxin type A|botulinum toxin type a
71325|NCT03758235|onabotulinumtoxin/A|onabotulinumtoxin/a
71326|NCT03758235|incobotulinumtoxin/A|incobotulinumtoxin/a
71327|NCT03758235|treatment|treatment
71328|NCT03758209|Morbidity, Mortality, Complication, Prehabilitation, ERAS|morbidity, mortality, complication, prehabilitation, eras
71329|NCT03758196|renal sympathetic denervation|renal sympathetic denervation
71330|NCT03758196|resistant hypertension|resistant hypertension
71331|NCT03758183|Arthroplasty|arthroplasty
71332|NCT03758183|Prolotherapy|prolotherapy
71333|NCT03758183|Osteoarthritis|osteoarthritis
71334|NCT03758170|Knee Arthroplasty|knee arthroplasty
71335|NCT03758170|Knee Replacement|knee replacement
71336|NCT03758170|Perioperative Medicine|perioperative medicine
71337|NCT03758144|gut dysbiosis|gut dysbiosis
71338|NCT03758144|rifaximin|rifaximin
71339|NCT03758144|insulin resistance|insulin resistance
71340|NCT03758131|Motivational Interviewing|motivational interviewing
71341|NCT03758118|Citicoline|citicoline
71342|NCT03758118|Non-arteritic ischemic optic neuropathy|non-arteritic ischemic optic neuropathy
71343|NCT03758118|Neuroprotection|neuroprotection
71344|NCT03758118|Neuroenhancement|neuroenhancement
71345|NCT03758105|Depression|depression
71346|NCT03758105|psychiatry|psychiatry
71347|NCT03758105|health economics|health economics
71348|NCT03758105|Neurostimulation|neurostimulation
71349|NCT03758105|tDCS|tdcs
71350|NCT03758066|youth|youth
71351|NCT03758066|young adults|young adults
71352|NCT03758066|digital health|digital health
71353|NCT03758066|mobile application|mobile application
71354|NCT03758066|case management|case management
71355|NCT03758027|emotional regulation|emotional regulation
71356|NCT03758027|drug taking refusal skills|drug taking refusal skills
71357|NCT03758027|physiological responses|physiological responses
71358|NCT03757988|Walking|walking
71359|NCT03757988|Exercise|exercise
71360|NCT03757988|Physical Health|physical health
71361|NCT03757975|quality of life|quality of life
71362|NCT03757975|urethral length|urethral length
71363|NCT03757975|sexual function|sexual function
71364|NCT03757962|dietary modification|dietary modification
71365|NCT03757923|PCO|pco
71366|NCT03757923|Metformin|metformin
71367|NCT03757910|Metformin|metformin
71368|NCT03757910|Pre-diabetes|pre-diabetes
71369|NCT03757910|Type 2 diabetes|type 2 diabetes
71370|NCT03757910|DPPOS|dppos
71371|NCT03757897|dexmedetomidine|dexmedetomidine
71372|NCT03757884|Diagnostic Errors|diagnostic errors
71373|NCT03757884|Hospital Medicine|hospital medicine
71374|NCT03757819|Multiple Scerosis|multiple scerosis
71375|NCT03757806|Dementia|dementia
71376|NCT03757806|Physical activity|physical activity
71377|NCT03757806|Home-based|home-based
71378|NCT03757806|Lifestyle|lifestyle
71379|NCT03757793|Near infrared spectroscopy|near infrared spectroscopy
71380|NCT03757767|Physiology|physiology
71381|NCT03757767|Humans|humans
71382|NCT03757754|PHHP|phhp
71383|NCT03757754|Esophageal cancer|esophageal cancer
71384|NCT03757754|Phase I study|phase i study
71385|NCT03757741|atrial fibrillation recurrence|atrial fibrillation recurrence
71386|NCT03757741|atrial volume|atrial volume
71387|NCT03757741|atrial fibrosis|atrial fibrosis
71388|NCT03757741|epicardial adipose tissue|epicardial adipose tissue
71389|NCT03757741|inflammatory biomarkers|inflammatory biomarkers
71390|NCT03757741|late gadolinium-enhancement cardiac magnetic resonance|late gadolinium-enhancement cardiac magnetic resonance
71391|NCT03757741|pulmonary vein isolation|pulmonary vein isolation
71392|NCT03757689|Stage IIB/C|stage iib/c
71393|NCT03757676|Physical Activity|physical activity
71394|NCT03757676|Mobile Games|mobile games
71395|NCT03757663|UV Dosimetry|uv dosimetry
71396|NCT03757663|UV Exposure|uv exposure
71397|NCT03757663|Behavioral|behavioral
71398|NCT03757663|Social Cognitive Theory|social cognitive theory
71399|NCT03757663|Self-Regulation|self-regulation
71400|NCT03757663|Self-Efficacy|self-efficacy
71401|NCT03757650|obesity|obesity
71402|NCT03757650|laparoscopic sleeve gastrectomy|laparoscopic sleeve gastrectomy
71403|NCT03757650|helicobacter pylori|helicobacter pylori
71404|NCT03757650|gastric wall thickness|gastric wall thickness
71405|NCT03757637|Thyroid cancer|thyroid cancer
71406|NCT03757637|Survivorship Care|survivorship care
71407|NCT03757637|Mobile applications|mobile applications
71408|NCT03757637|Mobile phone|mobile phone
71409|NCT03757624|shrinkage|shrinkage
71410|NCT03757624|formol|formol
71411|NCT03757624|stomach|stomach
71412|NCT03757624|gastric wall|gastric wall
71413|NCT03757598|partograph, labor, birth, complications, newborn, Kenya|partograph, labor, birth, complications, newborn, kenya
71414|NCT03757585|autism|autism
71415|NCT03757585|learning disorder|learning disorder
71416|NCT03757585|natural supplements|natural supplements
71417|NCT03757585|NAC|nac
71418|NCT03757585|omega-3|omega-3
71419|NCT03757572|Pilonidal|pilonidal
71420|NCT03757572|Fistula|fistula
71421|NCT03757572|Cyst|cyst
71422|NCT03757572|Alginate|alginate
71423|NCT03757572|Gauze|gauze
71424|NCT03757572|Dressings|dressings
71425|NCT03757572|Prospective|prospective
71426|NCT03757572|Randomized Controlled Trial|randomized controlled trial
71427|NCT03757559|Cebranopadol|cebranopadol
71428|NCT03757559|Hydromorphone|hydromorphone
71429|NCT03757559|Drug liking|drug liking
71430|NCT03757416|recurrent|recurrent
71431|NCT03757416|carpal tunnel release|carpal tunnel release
71432|NCT03757416|flexor tenosynovectomy|flexor tenosynovectomy
71433|NCT03757364|Distal Interphalangeal Joint Extensor Tendon Enthesopathy|distal interphalangeal joint extensor tendon enthesopathy
71434|NCT03757364|Nail Psoriasis|nail psoriasis
71435|NCT03757312|cardiopulmonary bypass|cardiopulmonary bypass
71438|NCT03757286|osteotomy, cutting guide|osteotomy, cutting guide
71440|NCT03757286|operation time|operation time
71441|NCT03757286|free scapular flap|free scapular flap
71442|NCT03757273|Mandibular tumors resection/reconstruction|mandibular tumors resection/reconstruction
71443|NCT03757273|CAD/CAM|cad/cam
71444|NCT03757273|Osteotomy, Cutting guide|osteotomy, cutting guide
71445|NCT03757273|Aesthetic|aesthetic
71446|NCT03757273|Operation time|operation time
71447|NCT03757273|Free fibular flap|free fibular flap
71448|NCT03757221|Multiple Myeloma|multiple myeloma
71449|NCT03757208|Carbohydrate loading, oral carbohydrate beverage|carbohydrate loading, oral carbohydrate beverage
71450|NCT03757195|Mineralized plasmatic matrix|mineralized plasmatic matrix
71451|NCT03757195|sticky bone|sticky bone
71452|NCT03757195|plasma|plasma
71453|NCT03757195|autogeous fibrin glue|autogeous fibrin glue
71454|NCT03757182|Wearable device|wearable device
71455|NCT03757182|Fitness tracker|fitness tracker
71456|NCT03757182|Wearable activity monitor|wearable activity monitor
71457|NCT03757182|Biosensor|biosensor
71458|NCT03757182|Performance Status|performance status
71459|NCT03757182|Activity Monitoring|activity monitoring
71460|NCT03757169|training|training
71461|NCT03757169|hand grip|hand grip
71462|NCT03757169|exercise|exercise
71463|NCT03757143|Skin antisepsis|skin antisepsis
71464|NCT03757143|Chlorhexidine|chlorhexidine
71465|NCT03757143|Povidone Iodine|povidone iodine
71466|NCT03757143|Intravascular-catheter colonization|intravascular-catheter colonization
71467|NCT03757143|Catheter failure|catheter failure
71468|NCT03757143|Bundle of new devices|bundle of new devices
71469|NCT03757117|Peru|peru
71470|NCT03757117|Health services|health services
71471|NCT03757117|Transgender women|transgender women
71472|NCT03757117|Patient navigation|patient navigation
71473|NCT03757117|Implementation science|implementation science
71474|NCT03757117|Gender affirming care|gender affirming care
71475|NCT03757117|HIV prevention|hiv prevention
71476|NCT03757117|HIV treatment|hiv treatment
71477|NCT03757117|HIV care cascade|hiv care cascade
71478|NCT03757039|contact lenses|contact lenses
71479|NCT03757039|multifocal|multifocal
71480|NCT03757039|spectacles|spectacles
71481|NCT03757039|glasses|glasses
71482|NCT03757039|progressive|progressive
71483|NCT03757039|vision|vision
71484|NCT03757039|eyes|eyes
71485|NCT03757026|Balance Training|balance training
71486|NCT03757026|Multidirectional harness|multidirectional harness
71487|NCT03757026|Conventional balance training|conventional balance training
71488|NCT03757026|Reactive Slip Training|reactive slip training
71489|NCT03757026|Stroke|stroke
71490|NCT03757026|Independent ambulation|independent ambulation
71491|NCT03757026|Physical therapy|physical therapy
71492|NCT03757013|Plaque Psoriasis|plaque psoriasis
71493|NCT03757013|Apremilast|apremilast
71495|NCT03757013|CC-10004|cc-10004
71496|NCT03757000|YY-20394|yy-20394
71497|NCT03757000|B-cell Lymphoma Recurrent|b-cell lymphoma recurrent
71498|NCT03756987|ultrasound-guided|ultrasound-guided
71499|NCT03756987|erector spinae plane block|erector spinae plane block
71500|NCT03756987|quality of recovery|quality of recovery
71501|NCT03756974|cannabinoid|cannabinoid
71502|NCT03756974|dronabinol|dronabinol
71503|NCT03756961|opioids|opioids
71504|NCT03756961|bariatric surgery|bariatric surgery
71505|NCT03756961|anesthesia|anesthesia
71506|NCT03756961|opioid-free|opioid-free
71507|NCT03756961|person-centred care|person-centred care
71508|NCT03756961|recovery|recovery
71509|NCT03756961|TENS|tens
71510|NCT03756961|pain|pain
71511|NCT03756948|Liver Transplantation|liver transplantation
71512|NCT03756948|Blood Coagulation Disorders|blood coagulation disorders
71513|NCT03756948|Blood Transfusion|blood transfusion
71514|NCT03756948|Hemostasis|hemostasis
71515|NCT03756948|Thromboelastometry|thromboelastometry
71516|NCT03756922|Cystic Fibrosis|cystic fibrosis
71517|NCT03756870|Chronic total coronary occlusion|chronic total coronary occlusion
71518|NCT03756870|Percutaneous coronary intervention|percutaneous coronary intervention
71519|NCT03756870|Optimal medical therapy|optimal medical therapy
71520|NCT03756870|Myocardial ischemia|myocardial ischemia
71521|NCT03756844|Avoidant Restrictive Food Intake Disorder|avoidant restrictive food intake disorder
71522|NCT03756831|BMI, Core Stability, Healthy Adult|bmi, core stability, healthy adult
71523|NCT03756805|obstructive sleep apnea|obstructive sleep apnea
71524|NCT03756805|hypoglossal nerve stimulation|hypoglossal nerve stimulation
71525|NCT03756805|upper airway stimulation|upper airway stimulation
71526|NCT03756805|surgical treatment sleep apnea|surgical treatment sleep apnea
71530|NCT03756779|Diet study|diet study
71531|NCT03756740|telerehabilitation, exercises, video, physical therapy|telerehabilitation, exercises, video, physical therapy
71532|NCT03756675|allogeneic stem cell transplantation|allogeneic stem cell transplantation
71533|NCT03756675|G-CSF-mobilized peripheral blood stem cell|g-csf-mobilized peripheral blood stem cell
71534|NCT03756675|haplotype|haplotype
71535|NCT03756662|Non-penetrating glaucoma surgery|non-penetrating glaucoma surgery
71536|NCT03756662|Open angle glaucoma|open angle glaucoma
71537|NCT03756662|Intraocular pressure measurements|intraocular pressure measurements
71538|NCT03756662|Suprachoroidal pressure sensor|suprachoroidal pressure sensor
71539|NCT03756662|ARGOS-SC|argos-sc
71540|NCT03756649|IBD|ibd
71541|NCT03756649|Ulcerative colitis|ulcerative colitis
71542|NCT03756649|Crohn's|crohn's
71543|NCT03756610|tACS|tacs
71544|NCT03756610|schizophrenia|schizophrenia
71545|NCT03756610|cognition|cognition
71546|NCT03756610|fMRI|fmri
71547|NCT03756519|acute|acute
71548|NCT03756519|exercise|exercise
71549|NCT03756519|emergency department|emergency department
71550|NCT03756493|Platlet rich fibrin|platlet rich fibrin
71551|NCT03756493|Bone graft|bone graft
71552|NCT03756493|Furcation defects|furcation defects
71553|NCT03756480|Endometriosis|endometriosis
71554|NCT03756467|Adolescent Behavior|adolescent behavior
71555|NCT03756467|Sexual Violence|sexual violence
71556|NCT03756402|Acute Kidney Injury|acute kidney injury
71557|NCT03756402|ColorDoppler|colordoppler
71558|NCT03756402|IRRIV test|irriv test
71559|NCT03756402|Renal functional reserve|renal functional reserve
71560|NCT03756402|Renal resistive index|renal resistive index
71561|NCT03756402|Ultrasound|ultrasound
71562|NCT03756363|Postoperative pain|postoperative pain
71563|NCT03756363|Debris extrusion|debris extrusion
71564|NCT03756363|Filling removal|filling removal
71565|NCT03756363|solvent|solvent
71566|NCT03756350|abdomen|abdomen
71567|NCT03756350|adipose|adipose
71568|NCT03756350|fat|fat
71569|NCT03756337|cochlear implant|cochlear implant
71570|NCT03756337|sound processor|sound processor
71571|NCT03756337|upgrade|upgrade
71572|NCT03756324|Pugongying|pugongying
71573|NCT03756324|Herba Taraxaci|herba taraxaci
71574|NCT03756324|Acute Mastitis|acute mastitis
71575|NCT03756324|Cefdinir|cefdinir
71576|NCT03756324|Randomized controlled trial|randomized controlled trial
71577|NCT03756324|Postpartum|postpartum
71578|NCT03756324|Breastfeeding|breastfeeding
71579|NCT03756324|Lactation|lactation
71580|NCT03756324|multicenter|multicenter
71581|NCT03756324|Chinese herb|chinese herb
71582|NCT03756324|Traditional Chinese medicine|traditional chinese medicine
71583|NCT03756324|Cephalosporin|cephalosporin
71584|NCT03756324|Antibiotics|antibiotics
71585|NCT03756285|Heart Failure with Ejection Fraction|heart failure with ejection fraction
71586|NCT03756246|depression|depression
71587|NCT03756246|Major Depressive Disorder|major depressive disorder
71588|NCT03756246|depressive|depressive
71589|NCT03756220|Septic shock|septic shock
71590|NCT03756220|Sepsis|sepsis
71591|NCT03756220|Vitamin C|vitamin c
71592|NCT03756220|Thiamine|thiamine
71593|NCT03756207|multidisciplinary; bladder cancer; bladder-preservation|multidisciplinary; bladder cancer; bladder-preservation
71594|NCT03756194|Aged|aged
71595|NCT03756194|Elders|elders
71596|NCT03756194|Robotics|robotics
71597|NCT03756194|Cultural competence|cultural competence
71598|NCT03756194|Quality of life|quality of life
71599|NCT03756194|Loneliness|loneliness
71600|NCT03756194|Technology acceptance|technology acceptance
71601|NCT03756194|Social robotics|social robotics
71602|NCT03756194|Informal caregiver|informal caregiver
71603|NCT03756194|Homes for the aged|homes for the aged
71604|NCT03756142|3D analysis|3d analysis
71605|NCT03756142|Biomarkers|biomarkers
71606|NCT03756142|Rehabilition|rehabilition
71607|NCT03756142|Locomotion|locomotion
71608|NCT03756129|Refractory Depression; Therapy-Resistant Depression; Treatment Resistant Depression; MDE; MDD|refractory depression; therapy-resistant depression; treatment resistant depression; mde; mdd
71609|NCT03756103|mild-moderate essential hypertension|mild-moderate essential hypertension
71610|NCT03756103|SPH3127 tablet|sph3127 tablet
71611|NCT03756103|renin inhibitor|renin inhibitor
71612|NCT03756103|efficacy|efficacy
71613|NCT03756103|safety|safety
71614|NCT03756051|Physical Harms|physical harms
71615|NCT03756051|Financial Harms|financial harms
71616|NCT03756051|Overdiagnosis|overdiagnosis
71617|NCT03756051|Psychosocial Harms|psychosocial harms
71618|NCT03756025|Early Childhood Caries|early childhood caries
71619|NCT03756025|Atraumatic Restorative Treatment|atraumatic restorative treatment
71620|NCT03756025|Glass Ionomer Cement|glass ionomer cement
71621|NCT03756025|Deciduous Tooth|deciduous tooth
71622|NCT03756025|Odontopediatrics|odontopediatrics
71623|NCT03755999|preterm infants|preterm infants
71624|NCT03755999|transitional feeding period|transitional feeding period
71625|NCT03755999|cue-based care|cue-based care
71626|NCT03755999|clinical guidelines|clinical guidelines
71627|NCT03755960|acupuncture|acupuncture
71628|NCT03755960|peripheral neuropathy|peripheral neuropathy
71629|NCT03755960|diabetes mellitus type II|diabetes mellitus type ii
71630|NCT03755960|neurophysiology|neurophysiology
71631|NCT03755960|nerve conduction velocity|nerve conduction velocity
71632|NCT03755908|Forced oscillation technique|forced oscillation technique
71633|NCT03755908|Airway obstruction|airway obstruction
71634|NCT03755908|Asthma|asthma
71635|NCT03755895|Cancer|cancer
71636|NCT03755895|hypnosis|hypnosis
71637|NCT03755895|care management|care management
71638|NCT03755869|Non-squamous NSCLC|non-squamous nsclc
71639|NCT03755869|Anlotinib|anlotinib
71640|NCT03755843|passive leg risging|passive leg risging
71641|NCT03755843|Fluid challenge|fluid challenge
71642|NCT03755843|Preeclampsia|preeclampsia
71643|NCT03755817|Spinal pain|spinal pain
71644|NCT03755804|Hodgkin Lymphoma|hodgkin lymphoma
71645|NCT03755804|Pediatric Cancer|pediatric cancer
71646|NCT03755804|Frontline Therapy|frontline therapy
71647|NCT03755804|Response Adapted Therapy|response adapted therapy
71648|NCT03755804|Risk Adapted Therapy|risk adapted therapy
71649|NCT03755791|liver|liver
71650|NCT03755791|cancer|cancer
71651|NCT03755791|hepatocellular|hepatocellular
71652|NCT03755791|carcinoma|carcinoma
71653|NCT03755778|drug-drug interaction|drug-drug interaction
71654|NCT03755739|Hepatocarcinoma|hepatocarcinoma
71655|NCT03755739|Immunotherapy|immunotherapy
71657|NCT03755713|ASP0892|asp0892
71658|NCT03755713|Peanut Allergy|peanut allergy
71659|NCT03755687|Art Therapy|art therapy
71660|NCT03755687|Pain Management|pain management
71661|NCT03755687|Pediatrics|pediatrics
71662|NCT03755687|Emergency Medicine|emergency medicine
71663|NCT03755674|Obesity|obesity
71664|NCT03755674|Appetite regulation|appetite regulation
71665|NCT03755674|Chronotype|chronotype
71666|NCT03755674|Diet|diet
71667|NCT03755648|Delorme resistance exercises|delorme resistance exercises
71668|NCT03755648|treadmill training|treadmill training
71669|NCT03755648|locomotor abilities|locomotor abilities
71670|NCT03755648|tendon of achilles lengthening|tendon of achilles lengthening
71671|NCT03755635|Neonatal sepsis|neonatal sepsis
71672|NCT03755635|Infection control|infection control
71673|NCT03755635|Hand hygiene|hand hygiene
71674|NCT03755635|WHO multi modal|who multi modal
71675|NCT03755609|Endoscopic Retrograde Choledochopancreatography|endoscopic retrograde choledochopancreatography
71676|NCT03755609|sedation|sedation
71677|NCT03755609|fentanyl|fentanyl
71678|NCT03755609|oxycodonel|oxycodonel
71679|NCT03755596|Zingiber officinale|zingiber officinale
71680|NCT03755596|Motion sickness|motion sickness
71681|NCT03755596|Motion sickness assessment questionnaire|motion sickness assessment questionnaire
71682|NCT03755583|Exclusive enteral nutrition|exclusive enteral nutrition
71683|NCT03755570|Cognitive Impairment|cognitive impairment
71684|NCT03755570|Left Ventricular Systolic Dysfunction|left ventricular systolic dysfunction
71685|NCT03755570|Heart Failure|heart failure
71686|NCT03755570|Cardiac Resynchronisation Therapy|cardiac resynchronisation therapy
71687|NCT03755570|Implantable Cardioverter-Defibrillator|implantable cardioverter-defibrillator
71688|NCT03755570|Pacemaker|pacemaker
71689|NCT03755570|CRT|crt
71690|NCT03755570|ICD|icd
71691|NCT03755570|PPM|ppm
71692|NCT03755557|budesonide|budesonide
71693|NCT03755557|allergic rhinitis|allergic rhinitis
71694|NCT03755557|allergic rhinoconjuntivitis|allergic rhinoconjuntivitis
71695|NCT03755557|allergen exposure chamber|allergen exposure chamber
71696|NCT03755557|onset of action|onset of action
71697|NCT03755557|therapeutic equivalence|therapeutic equivalence
71698|NCT03755557|total nasal symptom score|total nasal symptom score
71699|NCT03755557|hayfever|hayfever
71700|NCT03755557|glucocorticosteroids|glucocorticosteroids
71701|NCT03755557|nasal congestion|nasal congestion
71702|NCT03755557|Vienna Challenge Chamber|vienna challenge chamber
71703|NCT03755531|Oxytocin|oxytocin
71704|NCT03755531|Carbetocin|carbetocin
71705|NCT03755531|Emergency Caesarean Section|emergency caesarean section
71706|NCT03755518|Myelofibrosis (MF)|myelofibrosis (mf)
71707|NCT03755518|Primary Myelofibrosis (PMF)|primary myelofibrosis (pmf)
71708|NCT03755518|Post-Polycythemia vera (Post-PV)|post-polycythemia vera (post-pv)
71709|NCT03755518|Post-essential thrombocythemia (Post-ET)|post-essential thrombocythemia (post-et)
71710|NCT03755518|Myeloproliferative neoplasms (MPN)|myeloproliferative neoplasms (mpn)
71711|NCT03755505|Emphysema|emphysema
71712|NCT03755505|Microbiome|microbiome
71713|NCT03755479|Diabetes Mellitus Type 1|diabetes mellitus type 1
71714|NCT03755479|Insulin Pump|insulin pump
71715|NCT03755479|Hybrid closed Loop System|hybrid closed loop system
71716|NCT03755479|Minimed 670G|minimed 670g
71717|NCT03755440|EBV|ebv
71718|NCT03755440|Gatric cancer|gatric cancer
71719|NCT03755440|Check point inhibitor|check point inhibitor
71720|NCT03755427|H7N9|h7n9
71721|NCT03755401|psychotherapy|psychotherapy
71722|NCT03755401|psychodynamic psychotherapy|psychodynamic psychotherapy
71723|NCT03755375|Chronic Pelvic Pain Syndrome|chronic pelvic pain syndrome
71724|NCT03755375|Physiotherapy|physiotherapy
71725|NCT03755375|Biofeedback|biofeedback
71726|NCT03755375|Interventions|interventions
71727|NCT03755362|carotid stenosis cognitive function periodontitis|carotid stenosis cognitive function periodontitis
71728|NCT03755349|Burr hole cover|burr hole cover
71729|NCT03755349|Chronic subdural hematoma|chronic subdural hematoma
71730|NCT03755349|Trepanation|trepanation
71731|NCT03755349|Aesthetic outcome|aesthetic outcome
71732|NCT03755349|Complications|complications
71733|NCT03755349|Patient satisfaction|patient satisfaction
71734|NCT03755349|Burr hole plate|burr hole plate
71735|NCT03755349|Scar|scar
71736|NCT03755349|Skin depression|skin depression
71737|NCT03755323|Obesity|obesity
71738|NCT03755323|Nutrition Disorders|nutrition disorders
71739|NCT03755297|Rheumatoid arthritis|rheumatoid arthritis
71740|NCT03755297|Regulatory B cells|regulatory b cells
71741|NCT03755297|JAK/STAT inhibitors|jak/stat inhibitors
71743|NCT03755284|labor pain|labor pain
71744|NCT03755284|massage|massage
71745|NCT03755284|surveys and questionnaires|surveys and questionnaires
71746|NCT03755284|visual analog scale|visual analog scale
71747|NCT03755271|Intraoperative hypotension|intraoperative hypotension
71748|NCT03755271|Caesarean section|caesarean section
71749|NCT03755271|Spinal anesthesia|spinal anesthesia
71750|NCT03755258|Ginsenoside compound K tablet|ginsenoside compound k tablet
71751|NCT03755258|Rheumatoid Arthritis|rheumatoid arthritis
71752|NCT03755258|Phase Ib study|phase ib study
71753|NCT03755232|dietary fibre|dietary fibre
71754|NCT03755232|fructo-oligosaccharide|fructo-oligosaccharide
71755|NCT03755232|prebiotic|prebiotic
71756|NCT03755232|glucose metabolism|glucose metabolism
71757|NCT03755232|insulin metabolism|insulin metabolism
71758|NCT03755219|Totally extraperitoneal|totally extraperitoneal
71759|NCT03755219|Transabdominal preperitoneal|transabdominal preperitoneal
71760|NCT03755219|Fibrin glue|fibrin glue
71761|NCT03755219|Fibrin sealant|fibrin sealant
71762|NCT03755219|Mesh fixation|mesh fixation
71763|NCT03755219|Fixation devices|fixation devices
71764|NCT03755180|Venous Insufficiency|venous insufficiency
71765|NCT03755180|Exercise|exercise
71766|NCT03755180|Compression Bandages|compression bandages
71767|NCT03755180|Duplex Doppler Ultrasonography|duplex doppler ultrasonography
71768|NCT03755154|Leukemia|leukemia
71769|NCT03755154|Lymphoma|lymphoma
71770|NCT03755154|Myeloma|myeloma
71771|NCT03755154|Dose-escalation|dose-escalation
71772|NCT03755128|Hemolytic disease of the fetus and newborn (HDFN)|hemolytic disease of the fetus and newborn (hdfn)
71773|NCT03755128|Erythroblastosis, Fetal|erythroblastosis, fetal
71774|NCT03755128|Early onset severe hemolytic disease of the fetus and newborn (EOS-HDFN)|early onset severe hemolytic disease of the fetus and newborn (eos-hdfn)
71775|NCT03755128|M281|m281
71776|NCT03755128|Pregnant Women|pregnant women
71777|NCT03755115|ICD|icd
71778|NCT03755115|PD1|pd1
71779|NCT03755115|ED-SCLC|ed-sclc
71780|NCT03755102|EGFR C797S|egfr c797s
71781|NCT03755102|EGFR mutant lung cancer|egfr mutant lung cancer
71782|NCT03755102|dacomitinib|dacomitinib
71783|NCT03755102|osimertinib|osimertinib
71784|NCT03755102|18-341|18-341
71785|NCT03755102|Memorial Sloan Kettering Cancer Center|memorial sloan kettering cancer center
71786|NCT03754946|cardiopulmonary resuscitation|cardiopulmonary resuscitation
71787|NCT03754946|pulse oximetry plethysmographic waveform|pulse oximetry plethysmographic waveform
71788|NCT03754946|quality monitor|quality monitor
71789|NCT03754946|partial pressure of end-tidal carbon dioxide|partial pressure of end-tidal carbon dioxide
71790|NCT03754933|Fludarabine|fludarabine
71791|NCT03754933|Adenovirus|adenovirus
71792|NCT03754933|Head & neck squamous cell carcinoma|head & neck squamous cell carcinoma
71793|NCT03754920|prolonged fasting|prolonged fasting
71794|NCT03754920|meditation|meditation
71795|NCT03754920|physical exercise|physical exercise
71796|NCT03754907|stapled anastomosis|stapled anastomosis
71797|NCT03754907|hand-sewn anastomosis|hand-sewn anastomosis
71798|NCT03754907|intestinal atresia|intestinal atresia
71799|NCT03754907|neonate|neonate
71800|NCT03754894|dental implants|dental implants
71801|NCT03754868|ECMO|ecmo
71802|NCT03754868|Coagulation monitoring|coagulation monitoring
71803|NCT03754868|point-of-care|point-of-care
71804|NCT03754855|Rheumatoid arthritis|rheumatoid arthritis
71805|NCT03754855|medication adherence|medication adherence
71806|NCT03754855|vaccination coverage|vaccination coverage
71807|NCT03754855|electronic health tools|electronic health tools
71808|NCT03754855|diet|diet
71809|NCT03754829|Randomized Controlled trial|randomized controlled trial
71810|NCT03754829|Mobile Application|mobile application
71811|NCT03754829|Problem-Solving Therapy|problem-solving therapy
71812|NCT03754829|Online Guided Intervention|online guided intervention
71813|NCT03754816|PECS II block, parasternal block, analgesia|pecs ii block, parasternal block, analgesia
71814|NCT03754803|Dolutegravir|dolutegravir
71815|NCT03754803|Two-drug regimen|two-drug regimen
71816|NCT03754803|Human Immunodeficiency Virus|human immunodeficiency virus
71817|NCT03754803|HIV Symptom Distress Module|hiv symptom distress module
71818|NCT03754803|Lamivudine|lamivudine
71819|NCT03754803|HIV treatment satisfaction questionnaire|hiv treatment satisfaction questionnaire
71820|NCT03754777|enhanced recovery|enhanced recovery
71821|NCT03754777|fast-track|fast-track
71822|NCT03754777|appendectomy|appendectomy
71823|NCT03754777|intraperitoneal anesthesia|intraperitoneal anesthesia
71824|NCT03754777|low pressure pneumoperitoneum|low pressure pneumoperitoneum
71825|NCT03754751|enhanced recovery|enhanced recovery
72221|NCT03752346|Depression|depression
71829|NCT03754751|in-hospital stay|in-hospital stay
71830|NCT03754751|laparoscopic cholecystectomy|laparoscopic cholecystectomy
71831|NCT03754725|Deferiprone|deferiprone
71833|NCT03754699|Surgery|surgery
71834|NCT03754699|Preoperative Education|preoperative education
71835|NCT03754699|Outpatient|outpatient
71836|NCT03754660|PAH|pah
71837|NCT03754660|CTEPH|cteph
71838|NCT03754660|pulmonary arterial hypertension|pulmonary arterial hypertension
71839|NCT03754660|chronic thromboembolic pulmonary hypertension|chronic thromboembolic pulmonary hypertension
71840|NCT03754647|Vitamin C|vitamin c
71841|NCT03754647|OCD|ocd
71842|NCT03754647|MDA|mda
71843|NCT03754647|RBC Glutathione|rbc glutathione
71844|NCT03754634|ITP|itp
71845|NCT03754634|Eltrombopag|eltrombopag
71846|NCT03754634|Diacerein|diacerein
71847|NCT03754621|TSH|tsh
71848|NCT03754595|2D and 3D Laparoscopic pancreatoduodenectomy|2d and 3d laparoscopic pancreatoduodenectomy
71852|NCT03754569|ovarian|ovarian
71853|NCT03754569|peritoneal|peritoneal
71854|NCT03754569|recurrences|recurrences
71855|NCT03754569|surgery|surgery
71856|NCT03754569|cancer|cancer
71857|NCT03754569|metastases|metastases
71858|NCT03754556|Contraception|contraception
71859|NCT03754556|Breast-feeding|breast-feeding
71860|NCT03754556|Electronic medical records|electronic medical records
71861|NCT03754556|Uterine perforation|uterine perforation
71862|NCT03754556|Expulsion of intrauterine device|expulsion of intrauterine device
71863|NCT03754530|NSCLC brain metastases|nsclc brain metastases
71864|NCT03754517|syphilis|syphilis
71865|NCT03754517|serofast|serofast
71866|NCT03754491|Acute cholangitis|acute cholangitis
71867|NCT03754491|choledocholithiasis|choledocholithiasis
71868|NCT03754491|ERCP|ercp
71869|NCT03754491|One-stage treatment|one-stage treatment
71870|NCT03754387|children|children
71871|NCT03754387|antibiotic therapy|antibiotic therapy
71872|NCT03754387|laparoscopic appendectomy|laparoscopic appendectomy
71873|NCT03754387|randomized clinical trial(RCT)|randomized clinical trial(rct)
71874|NCT03754387|Chronic appendicitis|chronic appendicitis
71875|NCT03754374|Primary health|primary health
71876|NCT03754374|migrants|migrants
71877|NCT03754374|health care utilization|health care utilization
71878|NCT03754374|access to healthcare|access to healthcare
71879|NCT03754361|urgent start dialysis|urgent start dialysis
71880|NCT03754361|automated PD|automated pd
71881|NCT03754348|narcolepsy type 1|narcolepsy type 1
71882|NCT03754348|orexin|orexin
71883|NCT03754348|hypocretin|hypocretin
71884|NCT03754348|[18F] DPA-714|[18f] dpa-714
71885|NCT03754348|biomarker|biomarker
71886|NCT03754348|auto immunity|auto immunity
71887|NCT03754335|Aneurysmal subarachnoid hemorrhage|aneurysmal subarachnoid hemorrhage
71888|NCT03754335|lumbar puncture|lumbar puncture
71889|NCT03754335|headache|headache
71890|NCT03754283|Indirect bonding|indirect bonding
71891|NCT03754283|Accuracy|accuracy
71892|NCT03754270|Apnea/hypopnea index|apnea/hypopnea index
71893|NCT03754257|sepsis|sepsis
71894|NCT03754257|septic shock|septic shock
71895|NCT03754257|electrical stimulation|electrical stimulation
71896|NCT03754231|Vital sign monitoring|vital sign monitoring
71897|NCT03754231|Heart rate|heart rate
71898|NCT03754231|Respiratory rate|respiratory rate
71899|NCT03754218|Human amnion membrane|human amnion membrane
71900|NCT03754218|Autologous skin graft|autologous skin graft
71901|NCT03754218|Scar Formation|scar formation
71902|NCT03754192|Perfusion computer tomography|perfusion computer tomography
71903|NCT03754192|dual-energy computer tomography|dual-energy computer tomography
71904|NCT03754179|autophagy|autophagy
71905|NCT03754179|dabrafenib|dabrafenib
71906|NCT03754179|hydroxychloroquine|hydroxychloroquine
71907|NCT03754179|trametinib|trametinib
71908|NCT03754179|melanoma|melanoma
71909|NCT03754179|rechallenge|rechallenge
71910|NCT03754140|Sclerosant|sclerosant
71911|NCT03754140|Polidocanol|polidocanol
71912|NCT03754127|tinnitus|tinnitus
71913|NCT03754127|tdcs|tdcs
71914|NCT03754127|neuromodulation|neuromodulation
71915|NCT03754127|RCT|rct
71916|NCT03754114|intracranial pressure|intracranial pressure
71917|NCT03754114|hypoxia, brain|hypoxia, brain
71918|NCT03754114|critical care|critical care
71919|NCT03754114|emergency treatment|emergency treatment
71920|NCT03754114|monitoring, physiologic|monitoring, physiologic
71921|NCT03754075|Colon cancer|colon cancer
71922|NCT03754075|Surgery|surgery
71923|NCT03754075|Oncological outcome|oncological outcome
71924|NCT03754075|Survival|survival
71925|NCT03754023|AKI|aki
71926|NCT03754023|Biomarkers|biomarkers
71927|NCT03754023|Urine TIMP-IGFBP7|urine timp-igfbp7
72419|NCT03751137|Satiety|satiety
71928|NCT03754023|Emergency Department|emergency department
71929|NCT03754010|periodontitis|periodontitis
71930|NCT03754010|hyaluronic acid|hyaluronic acid
71931|NCT03754010|scaling and root planning|scaling and root planning
71932|NCT03754010|adenosione deaminase|adenosione deaminase
71933|NCT03754010|catalase|catalase
71934|NCT03754010|glutathione|glutathione
71935|NCT03753984|Fatigue|fatigue
71936|NCT03753984|Low-level Laser Therapy|low-level laser therapy
71937|NCT03753984|Stroke|stroke
71938|NCT03753984|Infrared thermograpy|infrared thermograpy
71939|NCT03753945|deep brain stimulation|deep brain stimulation
71940|NCT03753880|Liver resection|liver resection
71941|NCT03753880|Bile leaks|bile leaks
71942|NCT03753880|Outcome|outcome
71943|NCT03753854|sickle cell disease|sickle cell disease
71944|NCT03753854|obstructive sleep apnoea|obstructive sleep apnoea
71945|NCT03753854|vaso-occlusive crisis|vaso-occlusive crisis
71946|NCT03753841|Dysphagia|dysphagia
71947|NCT03753841|Aspiration|aspiration
71948|NCT03753841|Management of Dysphagia|management of dysphagia
71949|NCT03753841|Deglutition Disorders|deglutition disorders
71950|NCT03753841|Deglutition|deglutition
71951|NCT03753841|FEES|fees
71952|NCT03753841|Intensive Care Neurological Disorder|intensive care neurological disorder
71953|NCT03753802|Bronchiolitis|bronchiolitis
71954|NCT03753802|Chest physiotherapy|chest physiotherapy
71955|NCT03753802|Infants|infants
71956|NCT03753776|Homeopathy|homeopathy
71957|NCT03753776|Radium bromatum|radium bromatum
71958|NCT03753776|Apis mellifica|apis mellifica
71959|NCT03753776|Belladonna|belladonna
71960|NCT03753776|Radiodermatitis|radiodermatitis
71961|NCT03753776|Radiotherapy|radiotherapy
71962|NCT03753776|Prevention|prevention
71963|NCT03753776|Treatment|treatment
71964|NCT03753776|Breast cancer|breast cancer
71965|NCT03753724|pulmonary nodules|pulmonary nodules
71966|NCT03753724|lung cancer|lung cancer
71967|NCT03753724|artificial intelligence|artificial intelligence
71968|NCT03753724|CAP model|cap model
71969|NCT03753711|lumbar disc herniation|lumbar disc herniation
71970|NCT03753711|hernia|hernia
71971|NCT03753698|Multiple Sclerosis|multiple sclerosis
71972|NCT03753698|Lower Urinary Tract Symptoms|lower urinary tract symptoms
71973|NCT03753698|Posterior tibial nerve stimulation|posterior tibial nerve stimulation
71974|NCT03753698|Neuromodulation|neuromodulation
71975|NCT03753685|NSCLC|nsclc
71976|NCT03753685|Brain metastases|brain metastases
71977|NCT03753685|ALK mutations|alk mutations
71978|NCT03753685|X-396 (Ensartinib)|x-396 (ensartinib)
71979|NCT03753659|Hepatocellular carcinoma (HCC)|hepatocellular carcinoma (hcc)
71980|NCT03753646|Bangladesh|bangladesh
71981|NCT03753646|Cognitive development|cognitive development
71982|NCT03753646|behavior|behavior
71983|NCT03753646|quality of life|quality of life
71984|NCT03753646|psycho social stimulation|psycho social stimulation
71985|NCT03753646|lactating allowance|lactating allowance
71986|NCT03753633|speech therapy|speech therapy
71987|NCT03753633|sleep apnea|sleep apnea
71988|NCT03753633|resistant hypertension|resistant hypertension
71989|NCT03753633|quality of life|quality of life
71990|NCT03753633|quality of sleep|quality of sleep
71991|NCT03753594|Peripheral nerve block|peripheral nerve block
71992|NCT03753581|Electric Stimulation Therapy|electric stimulation therapy
71993|NCT03753581|Pressure Ulcer|pressure ulcer
71995|NCT03753568|medicine reminder|medicine reminder
71996|NCT03753568|diabetes mellitus, type 2|diabetes mellitus, type 2
71997|NCT03753568|direct oral anticoagulants|direct oral anticoagulants
71998|NCT03753542|chemotherapy, side effects, parents, anxiety, depression|chemotherapy, side effects, parents, anxiety, depression
71999|NCT03753503|Parkinson's disease|parkinson's disease
72000|NCT03753503|intensive interval training|intensive interval training
72001|NCT03753503|motor function|motor function
72002|NCT03753503|executive function|executive function
72003|NCT03753503|neuroplasticity|neuroplasticity
72004|NCT03753451|periodontal diseases|periodontal diseases
72005|NCT03753451|atherosclerosis|atherosclerosis
72006|NCT03753451|mannose binding protein|mannose binding protein
72007|NCT03753451|sirtuins|sirtuins
72008|NCT03753451|inflammation|inflammation
72009|NCT03753425|Inflammatory bowel disease|inflammatory bowel disease
72010|NCT03753425|colonoscopy|colonoscopy
72011|NCT03753425|bowel preparations|bowel preparations
72012|NCT03753412|Extra Corporeal Membrane Oxygenation (ECMO)|extra corporeal membrane oxygenation (ecmo)
72013|NCT03753412|Intensive Care Unit Acquired Weakness (ICUAW)|intensive care unit acquired weakness (icuaw)
72014|NCT03753412|Critical Illness Polyneuromyopathy (CIPM)|critical illness polyneuromyopathy (cipm)
72015|NCT03753412|Ultrasound (US)|ultrasound (us)
72016|NCT03753412|Health Related Quality of Life (HRQoL)|health related quality of life (hrqol)
72017|NCT03753399|Gastric cancer|gastric cancer
72018|NCT03753399|Acupuncture|acupuncture
72019|NCT03753399|Quality of life|quality of life
72020|NCT03753399|Adjuvant chemotherapy|adjuvant chemotherapy
72021|NCT03753373|acupuncture|acupuncture
72022|NCT03753373|Medial Tibial Stress Syndrome|medial tibial stress syndrome
72023|NCT03753360|Stress|stress
72024|NCT03753360|Mindfulness|mindfulness
72025|NCT03753360|Meditation|meditation
72026|NCT03753360|Gene expression|gene expression
72027|NCT03753360|Immune|immune
72028|NCT03753360|Online|online
72029|NCT03753360|Healthcare workers|healthcare workers
72030|NCT03753360|Burnout|burnout
72031|NCT03753360|Cytokines|cytokines
72032|NCT03753360|Cortisol|cortisol
72033|NCT03753334|Biochemical recurrence (BCR)|biochemical recurrence (bcr)
72034|NCT03753334|Androgen-deprivation therapy (ADT)|androgen-deprivation therapy (adt)
72035|NCT03753334|PSA doubling time|psa doubling time
72036|NCT03753334|Quality of life|quality of life
72037|NCT03753334|Omega-3 fatty acids|omega-3 fatty acids
72038|NCT03753334|Biomarkers|biomarkers
72039|NCT03753334|Prostate cancer progression|prostate cancer progression
72040|NCT03753334|PSA kinetics|psa kinetics
72041|NCT03753308|Dendritic cells|dendritic cells
72042|NCT03753308|C-type lectins (CLR)|c-type lectins (clr)
72043|NCT03753308|mDCs BDCA1+ and BDCA3+ circulating and hepatic|mdcs bdca1+ and bdca3+ circulating and hepatic
72044|NCT03753295|BMI, Hand Grip, Healthy Adults|bmi, hand grip, healthy adults
72045|NCT03753282|Total hip arthroplasty|total hip arthroplasty
72046|NCT03753282|Total hip replacement|total hip replacement
72047|NCT03753269|myocardial infarction|myocardial infarction
72048|NCT03753269|reperfusion therapy|reperfusion therapy
72049|NCT03753269|microvascular dysfunction|microvascular dysfunction
72050|NCT03753269|Fasudil Hydrochloride|fasudil hydrochloride
72051|NCT03753269|myocardial perfusion|myocardial perfusion
72052|NCT03753243|Neoadjuvant|neoadjuvant
72053|NCT03753243|Programmed cell death protein 1 (PD-1)|programmed cell death protein 1 (pd-1)
72054|NCT03753217|Anesthesia Monitoring|anesthesia monitoring
72055|NCT03753178|ultrasonography|ultrasonography
72056|NCT03753178|Common peroneal electrophysiological evaluations|common peroneal electrophysiological evaluations
72057|NCT03753178|Common peroneal neuropathy|common peroneal neuropathy
72058|NCT03753165|Chronic low back pain, Heart rate variability|chronic low back pain, heart rate variability
72059|NCT03753139|Atrial fibrillation; detection; portable device; algorithms|atrial fibrillation; detection; portable device; algorithms
72060|NCT03753113|Androgenic Alopecia|androgenic alopecia
72061|NCT03753113|Hair Diseases|hair diseases
72062|NCT03753113|Skin Diseases|skin diseases
72063|NCT03753113|Baldness|baldness
72064|NCT03753113|Alopecia|alopecia
72065|NCT03753113|Hair Loss|hair loss
72067|NCT03753087|HFpEF|hfpef
72068|NCT03753087|DM|dm
72069|NCT03753087|Empagliflozin|empagliflozin
72070|NCT03753087|Jardiance|jardiance
72071|NCT03753061|Large vessel occlusion|large vessel occlusion
72072|NCT03753061|Acute ischemic stroke|acute ischemic stroke
72073|NCT03753061|Endovascular treatment|endovascular treatment
72074|NCT03753061|Mechanical thrombectomy|mechanical thrombectomy
72075|NCT03753061|Aspiration Catheter|aspiration catheter
72076|NCT03753048|Total Arterial Revascularization|total arterial revascularization
72077|NCT03753048|Y-Graft|y-graft
72078|NCT03753048|In-Situ|in-situ
72079|NCT03753048|Coronary Artery Bypass Grafting|coronary artery bypass grafting
72080|NCT03753035|epilepsy|epilepsy
72081|NCT03753035|children|children
72082|NCT03753035|seizures|seizures
72083|NCT03753035|patient compliance|patient compliance
72084|NCT03753035|quality of life|quality of life
72085|NCT03753022|Acute Lung Injury|acute lung injury
72086|NCT03753022|postoperative of cardiac surgery|postoperative of cardiac surgery
72087|NCT03752957|Wide-Awake Local Anesthesia|wide-awake local anesthesia
72088|NCT03752931|Pneumonectomy Thoracic surgery Celiprolol Diltiazem|pneumonectomy thoracic surgery celiprolol diltiazem
72089|NCT03752918|MDMA|mdma
72090|NCT03752905|RDEB|rdeb
72091|NCT03752892|pulmonary rehabilitation|pulmonary rehabilitation
72092|NCT03752892|exercise training|exercise training
72093|NCT03752879|Kristeller maneuver,LAM avulsion,3D transperineal ultrasoun|kristeller maneuver,lam avulsion,3d transperineal ultrasoun
72094|NCT03752866|Portico™ valve|portico™ valve
72095|NCT03752866|Portico™ valve delivery system|portico™ valve delivery system
72096|NCT03752866|Portico™ valve loading system|portico™ valve loading system
72097|NCT03752866|Transcatheter Aortic Valve Replacement|transcatheter aortic valve replacement
72098|NCT03752866|Aortic Stenosis|aortic stenosis
72099|NCT03752866|Heart Valve Prosthesis|heart valve prosthesis
72100|NCT03752866|TAVR|tavr
72101|NCT03752866|TAVR Registry|tavr registry
72102|NCT03752866|Transcatheter Aortic Valve Implant|transcatheter aortic valve implant
72103|NCT03752866|TAVI|tavi
72104|NCT03752866|TAVI Registry|tavi registry
72105|NCT03752853|major depressive episode|major depressive episode
72106|NCT03752853|cortisol|cortisol
72107|NCT03752853|alpha-amylase|alpha-amylase
72108|NCT03752853|psychotherapy|psychotherapy
72109|NCT03752827|rotator cuff tear|rotator cuff tear
72110|NCT03752827|adipose-derived regenerative cells|adipose-derived regenerative cells
72111|NCT03752827|adipose-derived stem cells|adipose-derived stem cells
72112|NCT03752827|partial rotator cuff tears|partial rotator cuff tears
72113|NCT03752827|corticosteroid|corticosteroid
72114|NCT03752814|distraction osteogenesis|distraction osteogenesis
72115|NCT03752814|bone lengthening|bone lengthening
72116|NCT03752814|leg length discrepancy|leg length discrepancy
72117|NCT03752814|callotasis|callotasis
72118|NCT03752814|Intramedullary distraction nail|intramedullary distraction nail
72119|NCT03752801|education|education
72120|NCT03752801|pediatric|pediatric
72121|NCT03752801|family|family
72122|NCT03752788|Stroke|stroke
72123|NCT03752788|Gait velocity|gait velocity
72124|NCT03752788|Stride length|stride length
72125|NCT03752788|Step length|step length
72126|NCT03752788|Balance training|balance training
72127|NCT03752788|Dual task|dual task
72128|NCT03752788|Institutional priority sets|institutional priority sets
72129|NCT03752775|stroke|stroke
72130|NCT03752775|upper limb|upper limb
72131|NCT03752775|Joint coordination|joint coordination
72132|NCT03752762|Stunting|stunting
72133|NCT03752762|Obesity|obesity
72134|NCT03752762|Lipid-based Nutrient Supplements (LNS)|lipid-based nutrient supplements (lns)
72135|NCT03752762|Latin America|latin america
72136|NCT03752762|Child nutrition|child nutrition
72137|NCT03752762|Feeding practices|feeding practices
72138|NCT03752736|Sunscreen|sunscreen
72139|NCT03752736|Sun protection|sun protection
72140|NCT03752736|Education|education
72141|NCT03752736|skin cancer|skin cancer
72142|NCT03752736|school-aged children|school-aged children
72143|NCT03752736|prevention|prevention
72144|NCT03752697|metacognition|metacognition
72145|NCT03752697|self-assessment|self-assessment
72146|NCT03752684|Oxalobacter formigenes|oxalobacter formigenes
72147|NCT03752684|oxalate|oxalate
72148|NCT03752684|kidney stones|kidney stones
72149|NCT03752645|acoustic rhinometry|acoustic rhinometry
72150|NCT03752645|active anterior rhinomanometry|active anterior rhinomanometry
72151|NCT03752645|allergic rhinitis|allergic rhinitis
72152|NCT03752645|red light rhinophototherapy|red light rhinophototherapy
72153|NCT03752632|intravenous|intravenous
72154|NCT03752632|peripheral vein|peripheral vein
72155|NCT03752632|cannulation|cannulation
72156|NCT03752632|IV access|iv access
72157|NCT03752619|peripheral nerve stimulation|peripheral nerve stimulation
72158|NCT03752619|Sprint|sprint
72159|NCT03752619|stimulation|stimulation
72160|NCT03752606|lymphadenectomy|lymphadenectomy
72161|NCT03752606|lymphocele|lymphocele
72162|NCT03752606|endometrial cancer|endometrial cancer
72163|NCT03752606|cervical cancer|cervical cancer
72164|NCT03752567|adherence|adherence
72165|NCT03752567|terapy|terapy
72166|NCT03752567|follow up|follow up
72167|NCT03752567|community pharmacy|community pharmacy
72168|NCT03752567|pharmacist|pharmacist
72169|NCT03752567|case manager|case manager
72170|NCT03752567|telemedicine|telemedicine
72171|NCT03752567|pharmacy of service|pharmacy of service
72172|NCT03752567|fundus camera|fundus camera
72173|NCT03752567|ecg|ecg
72174|NCT03752567|local pharmacist|local pharmacist
72175|NCT03752567|general physician|general physician
72176|NCT03752554|segmental mandibular resection-IAN|segmental mandibular resection-ian
72177|NCT03752489|Dascena|dascena
72178|NCT03752489|machine learning|machine learning
72179|NCT03752489|fluid administration|fluid administration
72180|NCT03752489|clustering algorithm|clustering algorithm
72181|NCT03752489|mortality|mortality
72182|NCT03752489|diagnostic|diagnostic
72183|NCT03752476|antibiotic resistant|antibiotic resistant
72184|NCT03752476|multidrug resistant|multidrug resistant
72185|NCT03752476|Beta lactam|beta lactam
72186|NCT03752450|Water-electrolyte imbalance|water-electrolyte imbalance
72187|NCT03752398|DUET-3|duet-3
72188|NCT03752398|Advanced solid tumors|advanced solid tumors
72189|NCT03752398|Melanoma|melanoma
72190|NCT03752398|Cervical Cancer|cervical cancer
72191|NCT03752398|Pancreatic Cancer|pancreatic cancer
72192|NCT03752398|Triple Negative Breast Cancer|triple negative breast cancer
72193|NCT03752398|Hepatocellular/Liver Cancer|hepatocellular/liver cancer
72194|NCT03752398|Urothelial Cancer|urothelial cancer
72195|NCT03752398|Bladder Cancer|bladder cancer
72196|NCT03752398|Renal Cell Cancer|renal cell cancer
72197|NCT03752398|Head and Neck Cancer|head and neck cancer
72198|NCT03752398|Colorectal Cancer|colorectal cancer
72199|NCT03752398|Endometrial Cancer|endometrial cancer
72200|NCT03752398|Non-small Cell Lung Cancer|non-small cell lung cancer
72201|NCT03752398|Small Cell Lung Cancer|small cell lung cancer
72202|NCT03752398|Gastric Cancer|gastric cancer
72203|NCT03752398|Gastroesophageal Junction Cancer|gastroesophageal junction cancer
72204|NCT03752385|smartphone|smartphone
72205|NCT03752385|screen time|screen time
72206|NCT03752385|sedentary behaviour|sedentary behaviour
72207|NCT03752385|physical activity|physical activity
72208|NCT03752385|mental health|mental health
72209|NCT03752385|sleep|sleep
72210|NCT03752385|adolescents|adolescents
72211|NCT03752385|young adults|young adults
72212|NCT03752372|interleukin 10 receptor alpha gene|interleukin 10 receptor alpha gene
72213|NCT03752359|sarcopenia|sarcopenia
72214|NCT03752359|obesity|obesity
72215|NCT03752359|protein intake|protein intake
72216|NCT03752359|IL-6|il-6
72217|NCT03752359|lean tissue|lean tissue
72218|NCT03752346|Parkinson's Disease|parkinson's disease
72219|NCT03752346|A Multimodal Exercise Program|a multimodal exercise program
72220|NCT03752346|Aerobic Exercise|aerobic exercise
72225|NCT03752320|Multiplex PCR|multiplex pcr
72226|NCT03752320|Bacterial and pulmonary colonization|bacterial and pulmonary colonization
72227|NCT03752320|Diagnosis|diagnosis
72228|NCT03752320|Mortality|mortality
72229|NCT03752294|MCI|mci
72230|NCT03752294|Mild AD|mild ad
72231|NCT03752294|Dabigatran|dabigatran
72232|NCT03752281|Health, activity, function and long-term social assistance|health, activity, function and long-term social assistance
72233|NCT03752268|Other Cancer|other cancer
72234|NCT03752255|Video|video
72235|NCT03752255|Anxiety|anxiety
72236|NCT03752229|safety lancets|safety lancets
72237|NCT03752229|lancet|lancet
72238|NCT03752229|capillary blood|capillary blood
72239|NCT03752229|capillary blood sampling|capillary blood sampling
72240|NCT03752229|blood volume|blood volume
72241|NCT03752229|pain|pain
72245|NCT03752203|Sodium Fluorescein|sodium fluorescein
72246|NCT03752203|Surgical Microscope|surgical microscope
72247|NCT03752203|Central Nervous System|central nervous system
72248|NCT03752203|Tumors|tumors
72249|NCT03752177|TIM-3|tim-3
72250|NCT03752177|PD-L1|pd-l1
72251|NCT03752125|energy expenditure|energy expenditure
72252|NCT03752125|caffeine|caffeine
72253|NCT03752125|flavonoids|flavonoids
72254|NCT03752125|fat metabolism|fat metabolism
72255|NCT03752112|Syphilis|syphilis
72256|NCT03752112|Women|women
72257|NCT03752112|Cefixime|cefixime
72258|NCT03752112|Brazil|brazil
72259|NCT03752112|Sexually Transmitted Infection|sexually transmitted infection
72260|NCT03752112|STI|sti
72261|NCT03752060|post-menopause|post-menopause
72262|NCT03752060|women|women
72263|NCT03752060|post-prandial|post-prandial
72264|NCT03752060|metabolic function|metabolic function
72265|NCT03752060|cardiovascular function|cardiovascular function
72266|NCT03752060|muscle|muscle
72267|NCT03752060|body composition|body composition
72268|NCT03752060|angiogenesis|angiogenesis
72269|NCT03752034|Muscle Fiber Fragments|muscle fiber fragments
72270|NCT03752034|Rotator Cuff Musculature|rotator cuff musculature
72271|NCT03752034|Rotator Cuff Repair|rotator cuff repair
72272|NCT03752021|Endocannabinoid System|endocannabinoid system
72273|NCT03752021|Human Gestational Tissues|human gestational tissues
72274|NCT03752021|Labor|labor
72275|NCT03752021|Cesarean Section|cesarean section
72276|NCT03751982|transcranial electrical stimulation|transcranial electrical stimulation
72277|NCT03751943|Demineralized Bone Matrix|demineralized bone matrix
72278|NCT03751943|Primary Lumbar Fusion|primary lumbar fusion
72279|NCT03751943|Autograft Lumbar Fusion|autograft lumbar fusion
72280|NCT03751930|Autism Spectrum Disorder|autism spectrum disorder
72281|NCT03751930|Tryptophan metabolism|tryptophan metabolism
72282|NCT03751930|Gut microbiota|gut microbiota
72283|NCT03751917|Acute promyelocytic leukemia|acute promyelocytic leukemia
72284|NCT03751917|Adults|adults
72285|NCT03751917|Arsenic trioxide|arsenic trioxide
72286|NCT03751878|Reporting guidelines|reporting guidelines
72287|NCT03751878|CONSORT|consort
72288|NCT03751878|Adherence|adherence
72289|NCT03751878|Completeness of reporting|completeness of reporting
72290|NCT03751878|Quality of reporting|quality of reporting
72291|NCT03751878|Peer review|peer review
72292|NCT03751800|Heavy Menstrual Bleeding|heavy menstrual bleeding
72293|NCT03751787|osteopathy|osteopathy
72294|NCT03751787|cranial|cranial
72295|NCT03751735|Diabetes|diabetes
72296|NCT03751735|Wharton jelly mesenchymal stem cells|wharton jelly mesenchymal stem cells
72297|NCT03751735|efficacy|efficacy
72298|NCT03751722|Crohn disease|crohn disease
72299|NCT03751722|Ulcerative colitis|ulcerative colitis
72300|NCT03751722|genetic makers|genetic makers
72301|NCT03751722|cytokines|cytokines
72302|NCT03751709|Haplo-Mismatched Cellular Therapy|haplo-mismatched cellular therapy
72303|NCT03751709|Acute Lymphoblastic Leukemia|acute lymphoblastic leukemia
72304|NCT03751709|ALL|all
72305|NCT03751709|B-ALL|b-all
72306|NCT03751709|donor lymphocyte|donor lymphocyte
72307|NCT03751709|DLI|dli
72308|NCT03751709|blinatumomab|blinatumomab
72309|NCT03751709|bispecific|bispecific
72310|NCT03751709|microtransplantation|microtransplantation
72311|NCT03751709|microtransplant|microtransplant
72312|NCT03751670|Acute exacerbation of chronic obstructive pulmonary disease|acute exacerbation of chronic obstructive pulmonary disease
72313|NCT03751670|Pulmonary rehabilitation|pulmonary rehabilitation
72314|NCT03751670|Community|community
72315|NCT03751670|Inpatient|inpatient
72316|NCT03751644|systemic autoimmune myopathies|systemic autoimmune myopathies
72317|NCT03751644|Peripherical neuromuscular electrical stimulation|peripherical neuromuscular electrical stimulation
72318|NCT03751644|myositis|myositis
72319|NCT03751618|Hip arthroscopy|hip arthroscopy
72320|NCT03751618|capsular suture|capsular suture
72321|NCT03751618|Femoral Acetabular Impingement|femoral acetabular impingement
72322|NCT03751605|unipulmonary ventilation, complications, respiratory quotient.|unipulmonary ventilation, complications, respiratory quotient.
72323|NCT03751579|coelioscopic|coelioscopic
72324|NCT03751579|surgery complications|surgery complications
72325|NCT03751579|respiratory quotient|respiratory quotient
72326|NCT03751514|Bordetella Pertussis|bordetella pertussis
72327|NCT03751488|Schizophrenia|schizophrenia
72328|NCT03751475|Acute Malnutrition|acute malnutrition
72329|NCT03751475|Severe Acute Malnutrition|severe acute malnutrition
72330|NCT03751475|Moderate Acute Malnutrition|moderate acute malnutrition
72331|NCT03751475|Child Malnutrition|child malnutrition
72332|NCT03751475|Congo, The Democratic Republic of the|congo, the democratic republic of the
72333|NCT03751475|Randomized Clinical Trial|randomized clinical trial
72334|NCT03751475|Africa|africa
72335|NCT03751462|Cataract|cataract
72336|NCT03751462|Pseudoexfoliation|pseudoexfoliation
72337|NCT03751462|Traumatic cataract|traumatic cataract
72338|NCT03751423|procedural sedation|procedural sedation
72339|NCT03751423|ketamine|ketamine
72340|NCT03751423|fentanyl|fentanyl
72341|NCT03751423|morphine|morphine
72342|NCT03751410|ibrutinib|ibrutinib
72343|NCT03751410|echocardiography|echocardiography
72344|NCT03751410|left atrium|left atrium
72345|NCT03751410|function|function
72346|NCT03751410|long-term|long-term
72347|NCT03751397|Creatinine|creatinine
72348|NCT03751397|Albumin|albumin
72349|NCT03751397|Cystatin C|cystatin c
72350|NCT03751397|Neutrophil gelatinase-associated lipocalin (NGAL)|neutrophil gelatinase-associated lipocalin (ngal)
72351|NCT03751397|beta-trace Protein|beta-trace protein
72352|NCT03751397|beta-2 Microglobulin|beta-2 microglobulin
72353|NCT03751397|Uromodulin|uromodulin
72354|NCT03751371|Parkinson|parkinson
72355|NCT03751371|Exoskeleton|exoskeleton
72356|NCT03751371|Honda|honda
72357|NCT03751371|Walking Assist|walking assist
72358|NCT03751371|Walking|walking
72359|NCT03751371|Gait|gait
72360|NCT03751371|Mobility|mobility
72361|NCT03751371|Rehabilitation|rehabilitation
72362|NCT03751371|Physical Therapy|physical therapy
72363|NCT03751358|ESP Thoracic|esp thoracic
72364|NCT03751358|Spread Local anesthetic|spread local anesthetic
72365|NCT03751358|Volunteer|volunteer
72366|NCT03751358|Magnetic résonance imaging|magnetic résonance imaging
72367|NCT03751345|Parenting skills|parenting skills
72368|NCT03751345|Computer-based parenting program|computer-based parenting program
72369|NCT03751345|Parenting Wisely|parenting wisely
72370|NCT03751345|Adolescent disruptive behavior disorders|adolescent disruptive behavior disorders
72371|NCT03751332|Calcineurin inhibitors|calcineurin inhibitors
72372|NCT03751332|Tacrolimus modified release|tacrolimus modified release
72373|NCT03751332|Conversion|conversion
72374|NCT03751332|Trough levels|trough levels
72375|NCT03751332|MDR-1|mdr-1
72376|NCT03751306|Neurological Diseases|neurological diseases
72377|NCT03751306|Cardiorespiratory Rehabilitation|cardiorespiratory rehabilitation
72378|NCT03751306|Aerobic exercise|aerobic exercise
72379|NCT03751306|Fotobiomodulação Transcraniana|fotobiomodulação transcraniana
72380|NCT03751280|Schizophrenia|schizophrenia
72381|NCT03751280|Digital Therapeutic|digital therapeutic
72382|NCT03751280|CBT|cbt
72383|NCT03751280|smartphone app|smartphone app
72384|NCT03751267|Paediatric Massage, Constipation, Pre-school Children|paediatric massage, constipation, pre-school children
72385|NCT03751254|Cataract|cataract
72386|NCT03751254|Cataract surgery|cataract surgery
72387|NCT03751254|Phacoemulsification platform|phacoemulsification platform
72388|NCT03751241|Pseudophakia|pseudophakia
72389|NCT03751241|Reading speed|reading speed
72390|NCT03751215|Cataract|cataract
72391|NCT03751215|Cataract surgery|cataract surgery
72392|NCT03751215|Intraocular lens|intraocular lens
72393|NCT03751202|inhaler|inhaler
72394|NCT03751202|fluticasone proprionate|fluticasone proprionate
72395|NCT03751202|salmeterol xinafoate|salmeterol xinafoate
72396|NCT03751202|ADVAIR DISKUS|advair diskus
72397|NCT03751189|trauma|trauma
72398|NCT03751189|overjet|overjet
72399|NCT03751189|libya|libya
72400|NCT03751189|schoolchildren|schoolchildren
72401|NCT03751176|Clinical trial, phase II|clinical trial, phase ii
72402|NCT03751176|Aged (at least 18 years old)|aged (at least 18 years old)
72403|NCT03751176|Progression -Free - Survival|progression -free - survival
72404|NCT03751176|Safety|safety
72405|NCT03751176|Conversion rate of RAS/BRAF status in liquid biopsy|conversion rate of ras/braf status in liquid biopsy
72406|NCT03751176|Chemotherapy regimen|chemotherapy regimen
72407|NCT03751176|Monoclonal antibody|monoclonal antibody
72408|NCT03751176|FOLFIRI|folfiri
72409|NCT03751176|Panitumumab|panitumumab
72410|NCT03751176|RAS/BRAF Wild-type|ras/braf wild-type
72411|NCT03751163|melasma|melasma
72412|NCT03751163|tranexamic acid|tranexamic acid
72413|NCT03751163|hydroquinone|hydroquinone
72414|NCT03751163|mMASI|mmasi
72415|NCT03751163|mexameter|mexameter
72416|NCT03751150|Running-related injury|running-related injury
72417|NCT03751137|Microbiome|microbiome
72418|NCT03751137|Gut-brain axis|gut-brain axis
72420|NCT03751137|Hormone|hormone
72421|NCT03751137|Obesity|obesity
72422|NCT03751137|Metabolome|metabolome
72423|NCT03751124|Heavy menstrual bleeding|heavy menstrual bleeding
72424|NCT03751124|Menorrhagia|menorrhagia
72425|NCT03751124|Uterine Fibroids|uterine fibroids
72426|NCT03751124|Uterine Leiomyoma|uterine leiomyoma
72427|NCT03751111|arsenic exposure|arsenic exposure
72428|NCT03751111|naloxone|naloxone
72429|NCT03751111|placebo|placebo
72430|NCT03751111|single-blind randomized trial|single-blind randomized trial
72431|NCT03751085|AW frame|aw frame
72432|NCT03751085|biopsy|biopsy
72433|NCT03751085|stereotactic|stereotactic
72434|NCT03751085|accuracy|accuracy
72435|NCT03751085|safety|safety
72437|NCT03751046|Cognitive therapy|cognitive therapy
72438|NCT03751046|Treatment|treatment
72439|NCT03751046|HAART|haart
72440|NCT03751046|Treatment adherence and compliance|treatment adherence and compliance
72441|NCT03751033|Cataract Extraction|cataract extraction
72442|NCT03751020|Expressive Writing|expressive writing
72443|NCT03751020|Minority Stress|minority stress
72444|NCT03751020|Lesbian Gay Bisexual|lesbian gay bisexual
72445|NCT03750929|Takayasus's arteritis|takayasus's arteritis
72446|NCT03750929|Physical exercises|physical exercises
72447|NCT03750929|Rheumatic diseases|rheumatic diseases
72448|NCT03750929|Systemic vasculitis|systemic vasculitis
72449|NCT03750916|NSCLC Anlotinib Docetaxel|nsclc anlotinib docetaxel
72450|NCT03750903|aging|aging
72451|NCT03750877|median approach|median approach
72452|NCT03750877|paramedian approach|paramedian approach
72453|NCT03750877|geriatric patient|geriatric patient
821198|NCT00152750|Children|children
72454|NCT03750877|spinal anesthesia|spinal anesthesia
72455|NCT03750864|Lung cancer|lung cancer
72456|NCT03750864|Stigma|stigma
72457|NCT03750864|Lung cancer stigma|lung cancer stigma
72458|NCT03750864|Acceptance and commitment therapy|acceptance and commitment therapy
72459|NCT03750851|desensitizing treatment|desensitizing treatment
72460|NCT03750851|dental hypersensitivity|dental hypersensitivity
72461|NCT03750851|CPPACPF|cppacpf
72462|NCT03750851|Low level laser therapy|low level laser therapy
72463|NCT03750825|Electronic Nicotine Delivery System|electronic nicotine delivery system
72464|NCT03750747|IMCI services|imci services
72465|NCT03750747|Pulse Oximeter|pulse oximeter
72466|NCT03750747|Acute respiratory infections|acute respiratory infections
72467|NCT03750747|Implementation research|implementation research
72468|NCT03750747|Hypoxaemia|hypoxaemia
72469|NCT03750747|Childhood Pneumonia|childhood pneumonia
72470|NCT03750747|Resource poor settings|resource poor settings
72471|NCT03750708|Alveolar bone graft complications, oral hygiene, cleft lip and palate, connected health|alveolar bone graft complications, oral hygiene, cleft lip and palate, connected health
72472|NCT03750695|exercise|exercise
72473|NCT03750695|glucose|glucose
72474|NCT03750695|vascular|vascular
72475|NCT03750669|Pancreatic Cancer|pancreatic cancer
72476|NCT03750669|Pancreatic Adenocarcinoma|pancreatic adenocarcinoma
72477|NCT03750669|Gemcitabine|gemcitabine
72478|NCT03750669|Nab-paclitaxel|nab-paclitaxel
72479|NCT03750669|Modified Folfirinox|modified folfirinox
72480|NCT03750669|Sequential treatment|sequential treatment
72481|NCT03750630|vision, children, adolescent|vision, children, adolescent
72482|NCT03750617|Colorectal Polyp|colorectal polyp
72483|NCT03750617|Screening|screening
72484|NCT03750617|Risk assessment|risk assessment
72485|NCT03750604|abdominal obesity|abdominal obesity
72486|NCT03750604|OAB|oab
72487|NCT03750591|Integrative Korean medicine|integrative korean medicine
72488|NCT03750591|treatment|treatment
72489|NCT03750591|effectiveness|effectiveness
72490|NCT03750591|safety|safety
72491|NCT03750591|Lumbar intervertebral disc herniation|lumbar intervertebral disc herniation
72492|NCT03750578|virtual reality|virtual reality
72493|NCT03750578|procedural pain|procedural pain
72494|NCT03750578|pediatric emergency department|pediatric emergency department
72495|NCT03750578|procedural anxiety|procedural anxiety
72496|NCT03750565|Healthy Japanese Subjects|healthy japanese subjects
72497|NCT03750565|Healthy Caucasian Subjects|healthy caucasian subjects
72498|NCT03750565|Ethnobridging|ethnobridging
72499|NCT03750552|Symptomatic Neurogenic Orthostatic Hypotension|symptomatic neurogenic orthostatic hypotension
72500|NCT03750552|snOH|snoh
72501|NCT03750552|multiple system atrophy|multiple system atrophy
72502|NCT03750552|MSA|msa
72503|NCT03750552|Parkinson's disease|parkinson's disease
72504|NCT03750552|PD|pd
72505|NCT03750552|pure autonomic failure|pure autonomic failure
72506|NCT03750552|PAF|paf
72507|NCT03750552|primary autonomic failure|primary autonomic failure
72508|NCT03750552|SEQUOIA|sequoia
72509|NCT03750552|ampreloxetine|ampreloxetine
72510|NCT03750552|169|169
72511|NCT03750552|low blood pressure|low blood pressure
72512|NCT03750552|dizziness|dizziness
72513|NCT03750552|fainting|fainting
72514|NCT03750552|blacking out|blacking out
72515|NCT03750552|lightheadedness|lightheadedness
72516|NCT03750552|norepinephrine|norepinephrine
72517|NCT03750552|hypotension|hypotension
72518|NCT03750552|orthostatic hypotension|orthostatic hypotension
72519|NCT03750552|OH|oh
72520|NCT03750526|Repetitive transcranial magnetic stimulation (rTMS)|repetitive transcranial magnetic stimulation (rtms)
72521|NCT03750526|Augmented reality (AR)|augmented reality (ar)
72522|NCT03750526|stroke|stroke
72523|NCT03750474|elastography; magnetic resonance imaging|elastography; magnetic resonance imaging
72524|NCT03750461|ileostomy|ileostomy
72525|NCT03750461|hernia|hernia
72526|NCT03750461|rectal cancer|rectal cancer
72527|NCT03750461|colon cancer|colon cancer
72528|NCT03750448|Total knee arthroplasty|total knee arthroplasty
72529|NCT03750448|Total hip arthroplasty|total hip arthroplasty
72530|NCT03750448|Randomized controlled trial|randomized controlled trial
72531|NCT03750448|No intervention|no intervention
72532|NCT03750448|Telerehabilitation|telerehabilitation
72533|NCT03750409|dementia|dementia
72534|NCT03750396|Oligometastasis|oligometastasis
72535|NCT03750396|Local treatments|local treatments
72536|NCT03750383|drug drug interaction study|drug drug interaction study
72537|NCT03750357|Cardiac surgery pain reduction|cardiac surgery pain reduction
72538|NCT03750357|Post operative pain|post operative pain
72539|NCT03750357|PENS|pens
72540|NCT03750357|Neurostimulation|neurostimulation
72541|NCT03750344|Respiratory Rate|respiratory rate
72542|NCT03750331|telemedicine|telemedicine
72543|NCT03750318|Vital sign monitoring|vital sign monitoring
72544|NCT03750318|Heart rate|heart rate
72545|NCT03750318|Respiratory rate|respiratory rate
72546|NCT03750279|Knee osteoarthritis|knee osteoarthritis
72547|NCT03750279|Inflammation|inflammation
72548|NCT03750279|Photobiomodulation|photobiomodulation
72549|NCT03750279|Low-level laser therapy|low-level laser therapy
72550|NCT03750279|Double-blind|double-blind
72551|NCT03750279|Randomized clinical trial|randomized clinical trial
72552|NCT03750279|RCT|rct
72553|NCT03750253|Extracorporeal Shock Wave Therapy|extracorporeal shock wave therapy
72554|NCT03750253|Osteochondral Lesions of Talus|osteochondral lesions of talus
72555|NCT03750253|Arthroscopy|arthroscopy
72556|NCT03750253|Pain-relief|pain-relief
72557|NCT03750188|CNS|cns
72558|NCT03750188|MRI|mri
72559|NCT03750188|ProHance|prohance
72560|NCT03750188|Gadoteridol|gadoteridol
72561|NCT03750162|photodynamic therapy|photodynamic therapy
72562|NCT03750162|diode laser|diode laser
72563|NCT03750149|Diabetic Maculopathy|diabetic maculopathy
72564|NCT03750149|Age Related Macular Degeneration|age related macular degeneration
72565|NCT03750149|Glaucoma|glaucoma
72566|NCT03750149|Epiretinal membrane|epiretinal membrane
72567|NCT03750149|Reading analysis|reading analysis
72568|NCT03750136|diuretics|diuretics
72569|NCT03750123|kawasaki|kawasaki
72570|NCT03750123|arterial stiffness|arterial stiffness
72571|NCT03750123|PWV|pwv
72572|NCT03750123|cIMT|cimt
72573|NCT03750097|Multiple Sclerosis|multiple sclerosis
72574|NCT03750097|Motion sensors|motion sensors
72575|NCT03750097|Smartwatch|smartwatch
72576|NCT03750097|Steps|steps
72577|NCT03750097|Walking|walking
72578|NCT03750097|Validation|validation
72579|NCT03750084|Anesthesia|anesthesia
72580|NCT03750084|Cell Phone|cell phone
72581|NCT03750084|Mobile Applications|mobile applications
72582|NCT03750058|quadripolar LV leads|quadripolar lv leads
72583|NCT03750032|acute appendicitis|acute appendicitis
72584|NCT03750032|laparoscopy|laparoscopy
72585|NCT03750032|closure of appendicular stump|closure of appendicular stump
72586|NCT03750032|economical and medical outcomes|economical and medical outcomes
72587|NCT03750019|food intake|food intake
72588|NCT03750019|memory|memory
72589|NCT03750019|remembered satisfaction|remembered satisfaction
72590|NCT03750019|memory for recent eating|memory for recent eating
72591|NCT03750019|satiety|satiety
72592|NCT03750019|eating behavior|eating behavior
72593|NCT03750006|frailty|frailty
72594|NCT03750006|sarcopenia|sarcopenia
72595|NCT03750006|exercise|exercise
72596|NCT03750006|high intensity|high intensity
72597|NCT03750006|older adults|older adults
72598|NCT03750006|microRNA|microrna
72599|NCT03749980|VHL|vhl
72600|NCT03749980|BHD|bhd
72601|NCT03749980|HLRCC|hlrcc
72602|NCT03749980|SDHB|sdhb
72603|NCT03749980|MyVHL|myvhl
72604|NCT03749967|Depression|depression
72605|NCT03749954|Magnetically controlled capsule endoscopy|magnetically controlled capsule endoscopy
72606|NCT03749954|Gastroesophageal varices bleeding|gastroesophageal varices bleeding
72607|NCT03749954|Varices needing treatment|varices needing treatment
72608|NCT03749941|EUS-FNA|eus-fna
72609|NCT03749928|night guard|night guard
72610|NCT03749928|biofeedback|biofeedback
72611|NCT03749928|biosensor|biosensor
72612|NCT03749915|Pain Ease|pain ease
72613|NCT03749915|Ametop Gel|ametop gel
72614|NCT03749902|preeclampsia|preeclampsia
72615|NCT03749902|misoprostol|misoprostol
72616|NCT03749902|oxytocin|oxytocin
72617|NCT03749876|Cigarette filters|cigarette filters
72618|NCT03749876|Cigarette smoking|cigarette smoking
72619|NCT03749876|Unfiltered cigarettes|unfiltered cigarettes
72620|NCT03749863|presbyphonia|presbyphonia
72621|NCT03749863|presbylarynx|presbylarynx
72622|NCT03749863|vocal fold atrophy|vocal fold atrophy
72623|NCT03749863|dysphonia|dysphonia
72624|NCT03749863|platelet rich plasma|platelet rich plasma
72625|NCT03749863|PRP|prp
72626|NCT03749850|High Intensity Focused Ultrasound|high intensity focused ultrasound
72627|NCT03749850|lyso-thermosensitive liposomal doxorubicin|lyso-thermosensitive liposomal doxorubicin
72628|NCT03749850|ThermoDox|thermodox
72629|NCT03749850|MR-HIFU|mr-hifu
72630|NCT03749850|mild local hyperthermia|mild local hyperthermia
72631|NCT03749850|local drug delivery|local drug delivery
72632|NCT03749850|image-guided therapy|image-guided therapy
72633|NCT03749850|nanomedicine|nanomedicine
72634|NCT03749850|liposome|liposome
72635|NCT03749850|doxorubicin|doxorubicin
72636|NCT03749850|adriamycin|adriamycin
72637|NCT03749850|cyclophosphamide|cyclophosphamide
72638|NCT03749850|HIFU|hifu
72639|NCT03749850|LTLD|ltld
72640|NCT03749850|hyperthermia|hyperthermia
72641|NCT03749850|de novo stage IV|de novo stage iv
72642|NCT03749850|metastatic breast cancer|metastatic breast cancer
72643|NCT03749811|Pupil dilatory reflex|pupil dilatory reflex
72644|NCT03749811|Remifentanil|remifentanil
72645|NCT03749811|Analgesia|analgesia
72646|NCT03749798|Cataract|cataract
72647|NCT03749798|Wavefront measurement|wavefront measurement
72648|NCT03749772|obesity, cognitive therapy, executive function|obesity, cognitive therapy, executive function
72649|NCT03749759|Cataract|cataract
72650|NCT03749759|Cataract surgery|cataract surgery
72651|NCT03749759|Biofeedback|biofeedback
72652|NCT03749733|Bioequivalence|bioequivalence
72653|NCT03749733|Estradiol|estradiol
72654|NCT03749733|Nomegestrol acetate|nomegestrol acetate
72655|NCT03749720|Cervical Cancer|cervical cancer
72656|NCT03749720|HPV|hpv
72657|NCT03749720|Pathology|pathology
72658|NCT03749720|ddPCR|ddpcr
72659|NCT03749707|HPV|hpv
72660|NCT03749707|Cervical cancer|cervical cancer
72661|NCT03749707|SLN|sln
72662|NCT03749694|Acute Myocardial Infarction|acute myocardial infarction
72663|NCT03749694|mortality|mortality
72664|NCT03749694|evidence-based care|evidence-based care
72665|NCT03749694|Myocardial Ischaemia National Audit Project|myocardial ischaemia national audit project
72666|NCT03749694|ST-elevation myocardial infarction|st-elevation myocardial infarction
72667|NCT03749681|Neuroendocrine Tumors|neuroendocrine tumors
72668|NCT03749681|75 y and over patients|75 y and over patients
72669|NCT03749681|Oncogeriatric follow-up|oncogeriatric follow-up
72670|NCT03749681|Oncologic care|oncologic care
72671|NCT03749668|surgery: colorectal|surgery: colorectal
72672|NCT03749668|enhanced recovery|enhanced recovery
72673|NCT03749668|caloric intake|caloric intake
72674|NCT03749668|protein intake|protein intake
72675|NCT03749655|Pulmonary Rehabilitation|pulmonary rehabilitation
72676|NCT03749655|Physical activity|physical activity
72677|NCT03749655|Anxiety and depression|anxiety and depression
72678|NCT03749642|Trazodone|trazodone
72679|NCT03749642|Gabapentin|gabapentin
72680|NCT03749642|Neuropathic pain|neuropathic pain
72681|NCT03749642|Placebo|placebo
72682|NCT03749629|Depression|depression
72683|NCT03749629|Major Depressive Disorder|major depressive disorder
72684|NCT03749629|Pharmacogenomic testing|pharmacogenomic testing
72685|NCT03749590|MagPEP, post-ERCP pancreatitis, Magnesium Sulfate|magpep, post-ercp pancreatitis, magnesium sulfate
72686|NCT03749577|l-citrullin|l-citrullin
72687|NCT03749577|beetroot juice|beetroot juice
72688|NCT03749577|Raynaud's phenomenon|raynaud's phenomenon
72689|NCT03749564|Spinal Manipulative Therapy|spinal manipulative therapy
72690|NCT03749564|Optimization|optimization
72691|NCT03749512|NLCR, The neutrophil-lymphocyte count ratio, Lung Neoplasm|nlcr, the neutrophil-lymphocyte count ratio, lung neoplasm
72692|NCT03749499|Emergency Department|emergency department
72693|NCT03749499|Minorities|minorities
72694|NCT03749486|Cataract surgery|cataract surgery
72695|NCT03749486|High resolution immersion ultrasound|high resolution immersion ultrasound
72696|NCT03749473|Physical Activity|physical activity
72697|NCT03749473|Goal-Setting|goal-setting
72698|NCT03749473|Gamification|gamification
72699|NCT03749460|Metastatic Malignant Neoplasm in the Bone|metastatic malignant neoplasm in the bone
72700|NCT03749460|Metastatic Malignant Neoplasm in the Lung|metastatic malignant neoplasm in the lung
72701|NCT03749460|Salivary Gland Carcinoma|salivary gland carcinoma
72702|NCT03749460|Stage IV Major Salivary Gland Cancer AJCC v8|stage iv major salivary gland cancer ajcc v8
72703|NCT03749460|Stage IVA Major Salivary Gland Cancer AJCC v8|stage iva major salivary gland cancer ajcc v8
72704|NCT03749460|Stage IVB Major Salivary Gland Cancer AJCC v8|stage ivb major salivary gland cancer ajcc v8
72705|NCT03749460|Stage IVC Major Salivary Gland Cancer AJCC v8|stage ivc major salivary gland cancer ajcc v8
72706|NCT03749447|Bardoxolone methyl|bardoxolone methyl
72707|NCT03749447|CDDO-ME|cddo-me
72708|NCT03749447|RTA 402|rta 402
72709|NCT03749447|Alport Syndrome|alport syndrome
72710|NCT03749434|Infections|infections
72711|NCT03749434|Ventricular Assist Device Therapy|ventricular assist device therapy
72712|NCT03749421|Breast Cancer|breast cancer
72713|NCT03749408|inferior alveolar nerve block|inferior alveolar nerve block
72714|NCT03749408|long-acting local anesthesia|long-acting local anesthesia
72715|NCT03749408|bupivacaine|bupivacaine
72716|NCT03749408|mannitol|mannitol
72912|NCT03748121|Safety|safety
72717|NCT03749408|symptomatic irreversible pulpitits|symptomatic irreversible pulpitits
72718|NCT03749382|Smoking|smoking
72719|NCT03749382|Tobacco|tobacco
72720|NCT03749382|Cessation|cessation
72721|NCT03749382|Intervention|intervention
72722|NCT03749343|T1 mapping|t1 mapping
72723|NCT03749343|native T1|native t1
72724|NCT03749343|native T2|native t2
72725|NCT03749343|accuracy|accuracy
72726|NCT03749343|prognosis|prognosis
72727|NCT03749330|cardiac intensive care unit|cardiac intensive care unit
72728|NCT03749330|pediatrics|pediatrics
72729|NCT03749330|medical communication|medical communication
72730|NCT03749317|IVIEW-1201|iview-1201
72731|NCT03749317|Adenoviral Conjunctivitis|adenoviral conjunctivitis
72732|NCT03749291|Childhood Obesity|childhood obesity
72733|NCT03749291|Motivational therapy|motivational therapy
72734|NCT03749291|Dietary Patterns|dietary patterns
72735|NCT03749291|Cardiovascular disease risk|cardiovascular disease risk
72736|NCT03749278|Mental Health|mental health
72737|NCT03749278|Minority Health|minority health
72738|NCT03749278|Latina|latina
72739|NCT03749265|Peroneus Tertius Muscle|peroneus tertius muscle
72740|NCT03749226|Nebulized antibiotic|nebulized antibiotic
72741|NCT03749226|Ventilator associated pneumonia|ventilator associated pneumonia
72742|NCT03749226|Ventilated associated tracheobronchitis|ventilated associated tracheobronchitis
72743|NCT03749226|Aztreonam lysine|aztreonam lysine
72744|NCT03749200|Childhood Obesity|childhood obesity
72745|NCT03749200|Motivational therapy|motivational therapy
72746|NCT03749174|Radial fracture|radial fracture
72747|NCT03749174|Anesthetic|anesthetic
72748|NCT03749174|Plaster|plaster
72749|NCT03749174|Ortotic|ortotic
72750|NCT03749161|Cataract Surgery|cataract surgery
72751|NCT03749161|Low-add intraocular lens|low-add intraocular lens
72752|NCT03749148|hives|hives
72753|NCT03749148|itch|itch
72754|NCT03749148|exercise|exercise
72755|NCT03749135|hives|hives
72756|NCT03749135|itch|itch
72757|NCT03749109|Endometrioma|endometrioma
72758|NCT03749109|Adenomyosis|adenomyosis
72759|NCT03749109|Deep infiltrating endometriosis|deep infiltrating endometriosis
72760|NCT03749096|IVIG|ivig
72761|NCT03749096|stiff-person syndrome|stiff-person syndrome
72762|NCT03749096|SPS|sps
72763|NCT03749096|glycine receptor antibody|glycine receptor antibody
72764|NCT03749096|intravenous immunoglobulin|intravenous immunoglobulin
72765|NCT03749096|GlyRα1|glyrα1
72766|NCT03749083|Gastrointestinal Malignancies|gastrointestinal malignancies
72767|NCT03749070|Non-Alcoholic Fatty Liver Disease|non-alcoholic fatty liver disease
72768|NCT03749070|sylimarin|sylimarin
72769|NCT03749057|rivaroxaban|rivaroxaban
72770|NCT03749044|Adverse Pregnancy Outcomes|adverse pregnancy outcomes
72771|NCT03749044|SLE|sle
72772|NCT03749044|Aspirin Adherence|aspirin adherence
72773|NCT03749005|Pancreatic Cancer|pancreatic cancer
72774|NCT03749005|Three-dimensional Visualization|three-dimensional visualization
72775|NCT03748966|XLH|xlh
72776|NCT03748966|calcitriol|calcitriol
72777|NCT03748966|x-linked hypophosphatemia|x-linked hypophosphatemia
72778|NCT03748966|rickets|rickets
72779|NCT03748966|1,25 dihydroxyvitamin D|1,25 dihydroxyvitamin d
72780|NCT03748966|bone disorder|bone disorder
72781|NCT03748966|rare bone disease|rare bone disease
72782|NCT03748966|vitamin D|vitamin d
72783|NCT03748966|hypophosphatemic rickets|hypophosphatemic rickets
72784|NCT03748953|Drug Therapy|drug therapy
72785|NCT03748927|Clinical Outcome|clinical outcome
72786|NCT03748927|Advice in the Management of Cancer|advice in the management of cancer
72787|NCT03748927|Patterns of Disease Progression|patterns of disease progression
72788|NCT03748927|Response or Lack of Response to Therapeutic Interventions|response or lack of response to therapeutic interventions
72789|NCT03748888|Cardiovascular system|cardiovascular system
72790|NCT03748888|Antenatal physical activity|antenatal physical activity
72791|NCT03748888|Maternal heart rate|maternal heart rate
72792|NCT03748888|Foetal heart rate|foetal heart rate
72793|NCT03748875|Mindfulness-based relapse prevention|mindfulness-based relapse prevention
72794|NCT03748875|methamphetamine|methamphetamine
72795|NCT03748875|Prefrontal-striatal circuit|prefrontal-striatal circuit
72796|NCT03748875|impulsive|impulsive
72797|NCT03748875|mechanism|mechanism
72798|NCT03748862|Opioids|opioids
72799|NCT03748862|Chronic Pain|chronic pain
72800|NCT03748862|Opioid Therapy|opioid therapy
72801|NCT03748862|Opioid Taper|opioid taper
72802|NCT03748836|Healthy Volunteers|healthy volunteers
72803|NCT03748810|Empagliflozin|empagliflozin
72804|NCT03748810|Dapagliflozin|dapagliflozin
72805|NCT03748810|Sodium-glucose cotransporter 2 inhibitors|sodium-glucose cotransporter 2 inhibitors
72806|NCT03748810|Quadruple combination antidiabetic drugs|quadruple combination antidiabetic drugs
72807|NCT03748797|HIV, exercise, aging, physical health, quality of life|hiv, exercise, aging, physical health, quality of life
72808|NCT03748784|Choroidal Neovascularizatio|choroidal neovascularizatio
72809|NCT03748784|ADVM-022|advm-022
72810|NCT03748784|CNV|cnv
72811|NCT03748784|ADVM-022-01|advm-022-01
72812|NCT03748784|AAV.7m8|aav.7m8
72813|NCT03748784|Anti-VEGF therapy|anti-vegf therapy
72814|NCT03748784|Blindness|blindness
72815|NCT03748784|Gene therapy|gene therapy
72816|NCT03748784|Aflibercept (Eylea)|aflibercept (eylea)
72817|NCT03748784|Age-Related Macular Degeneration|age-related macular degeneration
72818|NCT03748784|Wet Macular Degeneration|wet macular degeneration
72819|NCT03748784|Retinal Degeneration|retinal degeneration
72820|NCT03748784|Retinal Diseases|retinal diseases
72821|NCT03748784|Eye Diseases|eye diseases
72822|NCT03748784|AAV Vector|aav vector
72823|NCT03748784|Adverum|adverum
72824|NCT03748784|wAMD|wamd
72825|NCT03748784|AMD|amd
72826|NCT03748784|wet AMD|wet amd
72827|NCT03748745|HCV|hcv
72828|NCT03748745|SH229|sh229
72829|NCT03748732|uveal effusion|uveal effusion
72830|NCT03748719|High Risk Prostate Cancer|high risk prostate cancer
72831|NCT03748719|prostate|prostate
72832|NCT03748719|radiation therapy|radiation therapy
72833|NCT03748667|Endoscopy|endoscopy
72834|NCT03748667|Colonoscopy|colonoscopy
72835|NCT03748667|Invasive pattern|invasive pattern
72836|NCT03748667|Polypectomy|polypectomy
72837|NCT03748667|NBI|nbi
72838|NCT03748667|BLI|bli
72839|NCT03748667|Deep submucosal invasion|deep submucosal invasion
72840|NCT03748667|JNET|jnet
72841|NCT03748667|Kudo pit pattern|kudo pit pattern
72842|NCT03748628|AME Study|ame study
72843|NCT03748602|thoracic outlet decompression (TOD)|thoracic outlet decompression (tod)
72844|NCT03748589|i-gel|i-gel
72845|NCT03748589|pediatric|pediatric
72846|NCT03748589|laryngeal mask airway|laryngeal mask airway
72847|NCT03748589|children|children
72848|NCT03748563|Capsule Endoscopy|capsule endoscopy
72849|NCT03748563|Portal Hypertension|portal hypertension
72850|NCT03748563|Cirrhosis|cirrhosis
72851|NCT03748550|Anthracyclines|anthracyclines
72852|NCT03748550|Cardiotoxic|cardiotoxic
72853|NCT03748550|Breast cancer|breast cancer
72854|NCT03748550|Aerobic exercise|aerobic exercise
72855|NCT03748550|Cardiac structure|cardiac structure
72856|NCT03748550|Cardiac function|cardiac function
72857|NCT03748550|CVD risk|cvd risk
72858|NCT03748524|Influenza, B cells, Antibodies, Vaccination|influenza, b cells, antibodies, vaccination
72859|NCT03748498|laser|laser
72860|NCT03748498|pulpitis|pulpitis
72861|NCT03748498|pain|pain
72862|NCT03748485|local advanced colorectal cancer|local advanced colorectal cancer
72863|NCT03748485|adjuvant chemotherapy|adjuvant chemotherapy
72864|NCT03748433|Real time continuous glucose monitoring|real time continuous glucose monitoring
72865|NCT03748433|continuous subcutaneous insulin infusion|continuous subcutaneous insulin infusion
72866|NCT03748433|self monitoring blood glucose|self monitoring blood glucose
72867|NCT03748433|sensor augmented pump|sensor augmented pump
72868|NCT03748433|severe hypoglycaemia|severe hypoglycaemia
72869|NCT03748433|hypounaware|hypounaware
72870|NCT03748420|Decision Support Systems, Clinical|decision support systems, clinical
72871|NCT03748420|Cardiovascular Diseases|cardiovascular diseases
72872|NCT03748420|Cardiovascular Risk Factor|cardiovascular risk factor
72873|NCT03748420|Medication Non-adherence|medication non-adherence
72874|NCT03748394|Work capacity evaluation|work capacity evaluation
72875|NCT03748394|Common mental disorders|common mental disorders
72876|NCT03748394|Occupational therapy|occupational therapy
72877|NCT03748394|Physical Therapy Modalities|physical therapy modalities
72878|NCT03748381|Cataract surgery|cataract surgery
72879|NCT03748381|Trifocal IOL|trifocal iol
72880|NCT03748368|Cataract surgery|cataract surgery
72881|NCT03748368|Informed Consent Process|informed consent process
72882|NCT03748355|Polypharmacy|polypharmacy
72883|NCT03748303|Alzheimer's disease|alzheimer's disease
72884|NCT03748303|Mild cognitive impairment|mild cognitive impairment
72885|NCT03748303|Dementia|dementia
72886|NCT03748303|Regenerative therapeutic|regenerative therapeutic
72887|NCT03748303|Drug development|drug development
72888|NCT03748277|intraoperative procedures|intraoperative procedures
72889|NCT03748251|Continuous Subcutaneous Insulin Infusion|continuous subcutaneous insulin infusion
72890|NCT03748251|diet|diet
72891|NCT03748251|postprandial glucose|postprandial glucose
72892|NCT03748251|postprandial hypoglycemia|postprandial hypoglycemia
72893|NCT03748251|postprandial hyperglycemia|postprandial hyperglycemia
72894|NCT03748238|Recurrent implantation failure|recurrent implantation failure
72895|NCT03748238|Endometrial injury|endometrial injury
72896|NCT03748238|Implantation|implantation
72897|NCT03748238|Hysteroscopy|hysteroscopy
72898|NCT03748212|Hypertension|hypertension
72899|NCT03748212|Chronic stable angina|chronic stable angina
72900|NCT03748212|Congestive Heart Failure|congestive heart failure
72901|NCT03748199|CF|cf
72902|NCT03748199|cystic fibrosis|cystic fibrosis
72903|NCT03748199|POL6014|pol6014
72904|NCT03748199|neutrophil elastase inhibitor|neutrophil elastase inhibitor
72905|NCT03748199|anti-inflammatory|anti-inflammatory
72906|NCT03748121|Posttraumatic Stress Disorder|posttraumatic stress disorder
72907|NCT03748121|Cognitive-Behavioral Therapy|cognitive-behavioral therapy
72908|NCT03748121|Complementary Therapies|complementary therapies
72909|NCT03748121|Yoga|yoga
72910|NCT03748121|Pranayama|pranayama
72911|NCT03748121|Effectiveness|effectiveness
72913|NCT03748121|Randomized Controlled Trial|randomized controlled trial
72914|NCT03748108|lidocaine|lidocaine
72915|NCT03748108|Postoperative Pain|postoperative pain
72916|NCT03748108|hysterectomy|hysterectomy
72917|NCT03748082|Cardiac Surgery|cardiac surgery
72918|NCT03748082|Cardiopulmonary Bypass|cardiopulmonary bypass
72919|NCT03748082|Reactive Hyperemia Index|reactive hyperemia index
72920|NCT03748082|Nitric Oxide|nitric oxide
72921|NCT03748069|Influenza|influenza
72922|NCT03748069|IPA|ipa
72923|NCT03748069|ICU|icu
72924|NCT03748069|Immunology|immunology
72925|NCT03748004|Homeless|homeless
72926|NCT03748004|Employment|employment
72927|NCT03747991|Infant GERD|infant gerd
72928|NCT03747991|H2RA medication|h2ra medication
72929|NCT03747978|diabetes|diabetes
72930|NCT03747978|hypertension|hypertension
72931|NCT03747978|blacks|blacks
72932|NCT03747978|Africa|africa
72933|NCT03747978|ACE inhibitor|ace inhibitor
72934|NCT03747978|Calcium channel blocker|calcium channel blocker
72935|NCT03747978|Diuretic|diuretic
72936|NCT03747952|Tibiotalocalcaneal arthrodesis|tibiotalocalcaneal arthrodesis
72937|NCT03747952|Intramedullary Nail|intramedullary nail
72938|NCT03747952|Sustained Compression|sustained compression
72939|NCT03747939|Oligoarthritis|oligoarthritis
72940|NCT03747939|PsA|psa
72941|NCT03747939|Apremilast|apremilast
72942|NCT03747939|Oral tablet|oral tablet
72943|NCT03747939|Background therapy|background therapy
72944|NCT03747939|Standard of care|standard of care
72945|NCT03747900|Needling, botulinum, toxin, spasticity, stroke|needling, botulinum, toxin, spasticity, stroke
72946|NCT03747861|R-R intervals|r-r intervals
72947|NCT03747861|Heart rate|heart rate
72948|NCT03747861|HRV|hrv
72949|NCT03747848|fatigue|fatigue
72950|NCT03747848|cognitive behavioral therapy|cognitive behavioral therapy
72951|NCT03747809|Remote Monitoring|remote monitoring
72952|NCT03747783|Survival|survival
72953|NCT03747783|Nomograms|nomograms
72954|NCT03747783|Laryngeal cancer|laryngeal cancer
72955|NCT03747770|CERVARIX|cervarix
72956|NCT03747770|Urine|urine
72957|NCT03747770|DNA PCR|dna pcr
72958|NCT03747770|HPV infection|hpv infection
72959|NCT03747770|HPV genotyping|hpv genotyping
72960|NCT03747770|Effectiveness|effectiveness
72961|NCT03747731|Renal blood perfusion|renal blood perfusion
72962|NCT03747731|Mechanical ventilation|mechanical ventilation
72963|NCT03747718|Crohn's|crohn's
72964|NCT03747718|Pediatric|pediatric
72965|NCT03747718|IBD|ibd
72966|NCT03747718|Fecal|fecal
72967|NCT03747692|intracervical anasthesia , outpatient hystroscopy ,|intracervical anasthesia , outpatient hystroscopy ,
72968|NCT03747679|CML; palatability; taste; pediatric formulation|cml; palatability; taste; pediatric formulation
72969|NCT03747653|Hemophilia A|hemophilia a
72970|NCT03747653|Pharmacokinetics|pharmacokinetics
72971|NCT03747653|Factor VIII-Fc Fusion Protein|factor viii-fc fusion protein
72972|NCT03747653|Adolescent and Adult Patients|adolescent and adult patients
72973|NCT03747653|Phase I|phase i
72974|NCT03747653|Safety and Tolerability|safety and tolerability
72975|NCT03747627|Interstitial Lung Disease (ILD)|interstitial lung disease (ild)
72976|NCT03747627|Hypersensitivity Pneumonitis|hypersensitivity pneumonitis
72977|NCT03747627|Idiopathic Pulmonary Fibrosis (IPF)|idiopathic pulmonary fibrosis (ipf)
72978|NCT03747627|Extrinsic Allergic Alveolitis (EAA)|extrinsic allergic alveolitis (eaa)
72979|NCT03747627|Bird Fancier's Lung|bird fancier's lung
72980|NCT03747627|Genetics|genetics
72981|NCT03747588|laparoscopic pancreaticoduodenectomy|laparoscopic pancreaticoduodenectomy
72982|NCT03747588|open pancreaticoduodenectomy|open pancreaticoduodenectomy
72983|NCT03747588|pancreatic cancer|pancreatic cancer
72984|NCT03747562|Gabapentin|gabapentin
72985|NCT03747536|Ipratropium bromide|ipratropium bromide
72986|NCT03747536|Sialorrhea|sialorrhea
72987|NCT03747536|Pediatric|pediatric
72988|NCT03747523|Vitamin D Deficiency|vitamin d deficiency
72989|NCT03747523|Drisdol|drisdol
72990|NCT03747523|Rickets|rickets
72991|NCT03747523|Plasma|plasma
72992|NCT03747523|Healthy Subjects|healthy subjects
72993|NCT03747523|Autosomal Dominant Tubulo Interstitial Kidney Disease|autosomal dominant tubulo interstitial kidney disease
72994|NCT03747497|ABSSI|abssi
72995|NCT03747497|Acute bacterial skin and skin structure infection|acute bacterial skin and skin structure infection
72996|NCT03747484|Clinical Stage III Merkel Cell Carcinoma AJCC v8|clinical stage iii merkel cell carcinoma ajcc v8
72997|NCT03747484|Clinical Stage IV Merkel Cell Carcinoma AJCC v8|clinical stage iv merkel cell carcinoma ajcc v8
72998|NCT03747484|HLA-A*0201 Positive Cells Present|hla-a*0201 positive cells present
72999|NCT03747484|Merkel Cell Polyomavirus T Antigen Positive|merkel cell polyomavirus t antigen positive
73000|NCT03747484|Pathologic Stage III Merkel Cell Carcinoma AJCC v8|pathologic stage iii merkel cell carcinoma ajcc v8
73001|NCT03747484|Pathologic Stage IIIA Merkel Cell Carcinoma AJCC v8|pathologic stage iiia merkel cell carcinoma ajcc v8
73002|NCT03747484|Pathologic Stage IIIB Merkel Cell Carcinoma AJCC v8|pathologic stage iiib merkel cell carcinoma ajcc v8
73003|NCT03747484|Pathologic Stage IV Merkel Cell Carcinoma AJCC v8|pathologic stage iv merkel cell carcinoma ajcc v8
73004|NCT03747484|Merkel cell carcinoma, metastatic|merkel cell carcinoma, metastatic
73005|NCT03747484|Merkel cell carcinoma, unresectable|merkel cell carcinoma, unresectable
73010|NCT03747471|Health Education|health education
73011|NCT03747471|Conversation Map|conversation map
73012|NCT03747471|Developing countries|developing countries
73013|NCT03747432|Transcatheter Aortic Valve Replacement|transcatheter aortic valve replacement
73014|NCT03747432|Conscious Sedation|conscious sedation
73015|NCT03747432|Propofol|propofol
73016|NCT03747432|Dexmedetomidine|dexmedetomidine
73017|NCT03747419|Bladder Cancer|bladder cancer
73018|NCT03747419|Bladder Carcinoma|bladder carcinoma
73019|NCT03747419|Carcinoma of Bladder|carcinoma of bladder
73020|NCT03747419|Carcinoma of the Bladder|carcinoma of the bladder
73021|NCT03747419|MIBC|mibc
73022|NCT03747419|Muscle Invasive Bladder Cancer|muscle invasive bladder cancer
73023|NCT03747419|Muscle-Invasive Urothelial Carcinoma of the Bladder|muscle-invasive urothelial carcinoma of the bladder
73024|NCT03747419|Immunotherapy|immunotherapy
73025|NCT03747419|Avelumab|avelumab
73026|NCT03747419|Radiation and Immunotherapy|radiation and immunotherapy
73027|NCT03747419|No cisplatin|no cisplatin
73028|NCT03747419|Cisplatin Ineligible|cisplatin ineligible
73029|NCT03747419|Cisplatin-Ineligible|cisplatin-ineligible
73030|NCT03747419|T2 Disease|t2 disease
73031|NCT03747419|T3 Disease|t3 disease
73032|NCT03747419|T4 Disease|t4 disease
73033|NCT03747419|squamous bladder cancer|squamous bladder cancer
73034|NCT03747419|adenocarcinoma bladder cancer|adenocarcinoma bladder cancer
73035|NCT03747419|micropapillary bladder cancer|micropapillary bladder cancer
73036|NCT03747419|Inability to receive cisplatin-based chemotherapy|inability to receive cisplatin-based chemotherapy
73037|NCT03747393|knee osteoarthritis|knee osteoarthritis
73038|NCT03747393|physical therapy|physical therapy
73039|NCT03747393|clinical practice guidelines|clinical practice guidelines
73040|NCT03747393|military service members|military service members
73041|NCT03747393|self-management|self-management
73042|NCT03747367|Microbiome|microbiome
73043|NCT03747367|Stress|stress
73044|NCT03747367|Sleep|sleep
73045|NCT03747367|Circadian|circadian
73046|NCT03747302|Adolescence|adolescence
73047|NCT03747302|Attitudes|attitudes
73048|NCT03747302|Parents|parents
73049|NCT03747302|Vaccination|vaccination
73050|NCT03747276|clinical trial|clinical trial
73051|NCT03747276|accrual|accrual
73052|NCT03747250|Videolaryngoscopy|videolaryngoscopy
73053|NCT03747250|Laryngoscopy|laryngoscopy
73054|NCT03747250|Tracheal intubation|tracheal intubation
73055|NCT03747250|Success rate|success rate
73056|NCT03747237|edema|edema
73057|NCT03747237|third molar|third molar
73058|NCT03747185|Clinical lumbar instability|clinical lumbar instability
73059|NCT03747185|History of low back pain|history of low back pain
73060|NCT03747185|Corticospinal excitability|corticospinal excitability
73061|NCT03747185|Stretching exercise|stretching exercise
73062|NCT03747185|Movement system impairment|movement system impairment
73063|NCT03747172|complementary alternative medicine|complementary alternative medicine
73064|NCT03747172|cancer|cancer
73065|NCT03747172|complementary alternative therapy|complementary alternative therapy
73066|NCT03747172|hospice care|hospice care
73067|NCT03747172|palliative care|palliative care
73068|NCT03747159|systemic lupus erythematosus|systemic lupus erythematosus
73069|NCT03747159|lupus nephritis|lupus nephritis
73070|NCT03747159|systemic autoimmune disease|systemic autoimmune disease
73071|NCT03747159|glomerulonephritis|glomerulonephritis
73072|NCT03747159|autoimmune glomerulonephritis|autoimmune glomerulonephritis
73073|NCT03747159|membranoproliferative glomerulonephritis|membranoproliferative glomerulonephritis
73074|NCT03747159|renal insufficiency|renal insufficiency
73075|NCT03747159|renal failure|renal failure
73081|NCT03747120|her2-positive breast cancer|her2-positive breast cancer
73082|NCT03747120|Breast Cancer|breast cancer
73083|NCT03747120|Pembrolizumab|pembrolizumab
73084|NCT03747120|Immunotherapy|immunotherapy
73085|NCT03747120|Neoadjuvant her2 targeted therapy|neoadjuvant her2 targeted therapy
73086|NCT03747120|Trastuzumab|trastuzumab
73087|NCT03747120|Pertuzumab|pertuzumab
73088|NCT03747120|Paclitaxel|paclitaxel
73089|NCT03747107|primary care|primary care
73090|NCT03747107|prescribing safety|prescribing safety
73091|NCT03747107|adverse drug event|adverse drug event
73092|NCT03747107|drug therapy risk|drug therapy risk
73093|NCT03747107|pharmacist|pharmacist
73094|NCT03747107|general practice|general practice
73095|NCT03747055|Nepal|nepal
73096|NCT03747055|Psychological treatment|psychological treatment
73097|NCT03747055|Task shifting|task shifting
73098|NCT03747055|Humanitarian crisis|humanitarian crisis
73099|NCT03747042|ER-positive|er-positive
73100|NCT03747042|HER2-negative|her2-negative
73706|NCT03743363|movement|movement
73101|NCT03747042|invasive mammary carcinoma|invasive mammary carcinoma
73102|NCT03746990|fluoride|fluoride
73103|NCT03746990|mottling|mottling
73104|NCT03746990|libya|libya
73105|NCT03746990|fluorosis|fluorosis
73106|NCT03746977|exercise|exercise
73107|NCT03746977|electromyostimulation|electromyostimulation
73108|NCT03746977|protein|protein
73109|NCT03746977|weight reduction|weight reduction
73110|NCT03746925|DAA|daa
73111|NCT03746925|SuperPATH|superpath
73112|NCT03746925|Direct Anterior Approach|direct anterior approach
73113|NCT03746925|THA|tha
73114|NCT03746912|Refractory or Relapsed|refractory or relapsed
73115|NCT03746912|FLT3- internal tandem duplication (ITD) positive|flt3- internal tandem duplication (itd) positive
73116|NCT03746912|FLT3-ITD positive refractory or relapsed acute myeloid leukemia|flt3-itd positive refractory or relapsed acute myeloid leukemia
73117|NCT03746899|Critical Limb Ischemia (CLI)|critical limb ischemia (cli)
73118|NCT03746886|breast milk|breast milk
73119|NCT03746886|lipids|lipids
73120|NCT03746886|bioactive compounds|bioactive compounds
73121|NCT03746886|infant formula|infant formula
73122|NCT03746873|Pulmonary Disease, Chronic Obstructive|pulmonary disease, chronic obstructive
73123|NCT03746873|Health promotion tool|health promotion tool
73124|NCT03746873|Self management|self management
73125|NCT03746873|Evidence based care|evidence based care
73126|NCT03746873|Implementation|implementation
73127|NCT03746860|Allergy|allergy
73128|NCT03746860|Allergic Rhinitis|allergic rhinitis
73129|NCT03746860|Allergic Asthma|allergic asthma
73130|NCT03746860|House Dust Mite|house dust mite
821477|NCT00151021|Diabetes|diabetes
73131|NCT03746860|Immunotherapy|immunotherapy
73132|NCT03746834|Fecal incontinence|fecal incontinence
73133|NCT03746834|Anorectal malformation|anorectal malformation
73134|NCT03746795|electrical impedance tomography|electrical impedance tomography
73135|NCT03746795|spirometric examination|spirometric examination
73136|NCT03746795|bioimpedance|bioimpedance
73137|NCT03746795|FVC|fvc
73138|NCT03746795|FEV1|fev1
73139|NCT03746795|Tiffeneau index|tiffeneau index
73140|NCT03746782|Dual Anti-Platelet Therapy|dual anti-platelet therapy
73141|NCT03746769|islet|islet
73142|NCT03746769|islet cell|islet cell
73143|NCT03746769|transplant|transplant
73144|NCT03746769|gastrin|gastrin
73145|NCT03746769|hypoglycemia|hypoglycemia
73146|NCT03746769|labile diabetes|labile diabetes
73147|NCT03746678|Cesarean delivery|cesarean delivery
73148|NCT03746678|Perioperative medicine|perioperative medicine
73149|NCT03746678|Mobile health|mobile health
73150|NCT03746665|Men A|men a
73151|NCT03746665|Maternal|maternal
73152|NCT03746665|Systems Immunology|systems immunology
73153|NCT03746665|Vaccination|vaccination
73154|NCT03746652|Second line treatment; Daratumumab; Ixazomib; Dexamethasone;|second line treatment; daratumumab; ixazomib; dexamethasone;
73155|NCT03746639|Chronic Pain|chronic pain
73156|NCT03746639|physiotherapy|physiotherapy
73157|NCT03746639|renal function|renal function
73158|NCT03746626|Spiritual care|spiritual care
73159|NCT03746626|Palliative care|palliative care
73160|NCT03746626|Chaplain|chaplain
73161|NCT03746626|Day care|day care
73162|NCT03746613|robot|robot
73163|NCT03746613|Image guidance|image guidance
73164|NCT03746613|Cochlear implantation|cochlear implantation
73165|NCT03746613|navigation|navigation
73166|NCT03746613|HEARO procedure|hearo procedure
73167|NCT03746613|sensorineural hearing loss|sensorineural hearing loss
73168|NCT03746613|inner ear access|inner ear access
73169|NCT03746600|HIV/AIDS|hiv/aids
73170|NCT03746600|Alcohol Drinking|alcohol drinking
73171|NCT03746600|Medication Adherence|medication adherence
73172|NCT03746587|Gaucher Disease|gaucher disease
73173|NCT03746522|MC4R Pathway|mc4r pathway
73174|NCT03746522|Obesity|obesity
73175|NCT03746522|BBS|bbs
73176|NCT03746522|AS|as
73177|NCT03746509|Dystonia|dystonia
73178|NCT03746509|Spasmodic dysphonia|spasmodic dysphonia
73179|NCT03746509|Laryngeal dystonia|laryngeal dystonia
73180|NCT03746496|intraosseous|intraosseous
73181|NCT03746496|blood gas analysis|blood gas analysis
73182|NCT03746496|emergency medicine|emergency medicine
73183|NCT03746496|critically ill|critically ill
73184|NCT03746496|point-of-care|point-of-care
73185|NCT03746483|Exocrine pancreatic insufficiency|exocrine pancreatic insufficiency
73186|NCT03746483|EPI|epi
73187|NCT03746483|Cystic Fibrosis|cystic fibrosis
73188|NCT03746483|CF|cf
73189|NCT03746483|Pancreatic enzyme replacement therapy|pancreatic enzyme replacement therapy
73190|NCT03746483|Lipase|lipase
73191|NCT03746470|arthroscopy|arthroscopy
73192|NCT03746444|total knee arthroplasty|total knee arthroplasty
73193|NCT03746444|general anesthesia|general anesthesia
73194|NCT03746444|neuraxial anesthesia|neuraxial anesthesia
73195|NCT03746444|complications|complications
73196|NCT03746418|erector spinae|erector spinae
73197|NCT03746418|dexmedetomidine|dexmedetomidine
73198|NCT03746418|ultrasound|ultrasound
73199|NCT03746418|lumbar interbody fusion|lumbar interbody fusion
73200|NCT03746418|spondylolisthesis|spondylolisthesis
73201|NCT03746379|kinezyhophobia|kinezyhophobia
73202|NCT03746379|sensory processing|sensory processing
73203|NCT03746379|fybromyalgia|fybromyalgia
73204|NCT03746340|sevoflurane|sevoflurane
73205|NCT03746340|propofol|propofol
73206|NCT03746340|Folic Acid|folic acid
73207|NCT03746314|Caregivers|caregivers
73208|NCT03746314|Oncology|oncology
73209|NCT03746314|Cancer|cancer
73210|NCT03746301|Non-valvular Atrial fibrillation (NVAF), Stroke; Non-Central Nervous Systemic (CNS) embolism|non-valvular atrial fibrillation (nvaf), stroke; non-central nervous systemic (cns) embolism
73211|NCT03746275|Coronary artery disease (CAD)|coronary artery disease (cad)
73212|NCT03746275|Peripheral artery disease (PAD)|peripheral artery disease (pad)
73213|NCT03746275|Major adverse limb events (MALE)|major adverse limb events (male)
73214|NCT03746275|Major adverse cardiac events (MACE)|major adverse cardiac events (mace)
73215|NCT03746275|Atherosclerosis|atherosclerosis
73216|NCT03746275|Atherothrombosis|atherothrombosis
73217|NCT03746275|Thrombosis|thrombosis
73218|NCT03746275|Embolism|embolism
73219|NCT03746275|Thromboembolism|thromboembolism
73220|NCT03746262|Non-Metastatic Non-Small Cell Lung Cancer|non-metastatic non-small cell lung cancer
73221|NCT03746262|Cancer|cancer
73222|NCT03746262|Lung Cancer|lung cancer
73223|NCT03746262|circulating tumor-specific DNA (ctDNA)|circulating tumor-specific dna (ctdna)
73224|NCT03746262|non-invasive diagnostic|non-invasive diagnostic
73225|NCT03746249|Hepatocellular Carcinoma|hepatocellular carcinoma
73226|NCT03746249|Lenvatinib|lenvatinib
73227|NCT03746249|PD-1 Antibody|pd-1 antibody
73228|NCT03746223|intravitreal methotrexate injection|intravitreal methotrexate injection
94948|NCT03610516|CFZ533|cfz533
73229|NCT03746223|rituximab|rituximab
73230|NCT03746223|lenalidomide|lenalidomide
73231|NCT03746223|Primary vitreoretinal lymphoma|primary vitreoretinal lymphoma
73232|NCT03746197|Lupus|lupus
73233|NCT03746197|SLE|sle
73234|NCT03746197|Cognition|cognition
73235|NCT03746197|Cognitive Assessment|cognitive assessment
73236|NCT03746197|Videogames|videogames
73237|NCT03746184|precision medicine|precision medicine
73238|NCT03746184|Patient-Specific Modeling|patient-specific modeling
73239|NCT03746145|probiotics|probiotics
73240|NCT03746145|microbiota|microbiota
73241|NCT03746145|gastrointestinal|gastrointestinal
73242|NCT03746145|immune system|immune system
73243|NCT03746145|immunology|immunology
73244|NCT03746145|stress|stress
73245|NCT03746145|Bifidobacterium|bifidobacterium
73246|NCT03746145|hypoxia|hypoxia
73247|NCT03746145|confinement|confinement
73248|NCT03746145|isolation|isolation
73249|NCT03746132|Vascular|vascular
73250|NCT03746132|Surgery|surgery
73251|NCT03746132|groin|groin
73252|NCT03746132|incision|incision
73253|NCT03746132|oxygen|oxygen
73254|NCT03746132|infection|infection
73255|NCT03746132|wound healing|wound healing
73256|NCT03746132|Transdermal Continuos|transdermal continuos
73257|NCT03746119|Nicotine|nicotine
73258|NCT03746119|Electronic cigarette|electronic cigarette
73259|NCT03746119|E-cigarrette|e-cigarrette
73260|NCT03746119|Forearm Plethysmography|forearm plethysmography
73261|NCT03746106|Drug-induced vitamin deficiency|drug-induced vitamin deficiency
73262|NCT03746067|TS-134, CSF|ts-134, csf
73263|NCT03746054|Blood|blood
73264|NCT03746054|Chronic Myeloid Leukemia|chronic myeloid leukemia
73265|NCT03746054|Vascular medicine|vascular medicine
73266|NCT03746041|Myelodysplastic syndromes|myelodysplastic syndromes
73267|NCT03746041|MDS|mds
73268|NCT03746041|Chronic myelomonocytic leukemia|chronic myelomonocytic leukemia
73269|NCT03746041|CMML|cmml
73270|NCT03746041|abaloparatide|abaloparatide
73271|NCT03746041|bevacizumab|bevacizumab
73272|NCT03746041|phase 1|phase 1
73273|NCT03746028|Adverse Pregnancy Outcomes|adverse pregnancy outcomes
73274|NCT03746028|SLE|sle
73275|NCT03746015|Vaccine|vaccine
73276|NCT03746002|diuretic|diuretic
73277|NCT03746002|metolazone|metolazone
73278|NCT03746002|furosemide|furosemide
73279|NCT03745989|advanced/metastatic|advanced/metastatic
73280|NCT03745989|solid tumors|solid tumors
73281|NCT03745989|Selumetinib|selumetinib
73282|NCT03745976|follow-up|follow-up
73283|NCT03745976|total knee arthroplasty|total knee arthroplasty
73284|NCT03745976|total hip arthroplasty|total hip arthroplasty
73285|NCT03745963|Neonate|neonate
73286|NCT03745963|Pain|pain
73287|NCT03745963|Sucrose|sucrose
73288|NCT03745963|Skin-to-skin contact|skin-to-skin contact
73289|NCT03745963|EEG|eeg
73290|NCT03745963|Assessment|assessment
73291|NCT03745963|RCT|rct
73292|NCT03745963|Bio behavioural|bio behavioural
73293|NCT03745950|Maintenance therapy|maintenance therapy
73294|NCT03745950|Olaparib|olaparib
73295|NCT03745950|Randomized, double blinded|randomized, double blinded
73296|NCT03745950|P53 and MMR Immunohistochemistry|p53 and mmr immunohistochemistry
73297|NCT03745950|Phase II|phase ii
73298|NCT03745950|progression-free survival|progression-free survival
73299|NCT03745937|MEDI0382, diabetes, obesity, overweight, type 2 diabetes mellitus|medi0382, diabetes, obesity, overweight, type 2 diabetes mellitus
73300|NCT03745911|Urothelial carcinoma|urothelial carcinoma
73301|NCT03745872|Sunscreen|sunscreen
73302|NCT03745872|Sun Exposure|sun exposure
73303|NCT03745872|Behaviors|behaviors
73707|NCT03743363|exergaming|exergaming
73310|NCT03745768|depression|depression
73311|NCT03745768|executive dysfunction|executive dysfunction
73312|NCT03745768|transcranial magnetic stimulation|transcranial magnetic stimulation
73313|NCT03745768|intermittent theta burst stimulation|intermittent theta burst stimulation
73314|NCT03745768|neuromodulation|neuromodulation
73315|NCT03745768|older adults|older adults
73316|NCT03745768|geriatrics|geriatrics
73317|NCT03745755|elderly|elderly
73318|NCT03745755|clinical decision rule|clinical decision rule
73319|NCT03745755|emergency department|emergency department
73320|NCT03745755|CT scan|ct scan
73321|NCT03745755|bleeding|bleeding
73322|NCT03745742|Cardiac rehabilitation|cardiac rehabilitation
73323|NCT03745742|myocardial infarction|myocardial infarction
73324|NCT03745742|heart rate variability|heart rate variability
73325|NCT03745742|physical fitness|physical fitness
73326|NCT03745664|corticosteroids|corticosteroids
73327|NCT03745651|Atopic dermatitis|atopic dermatitis
73328|NCT03745651|pruritus|pruritus
73329|NCT03745651|eczema|eczema
73330|NCT03745651|topical therapy|topical therapy
73331|NCT03745651|JAK inhibitor|jak inhibitor
73332|NCT03745638|Atopic dermatitis|atopic dermatitis
73333|NCT03745638|pruritus|pruritus
73334|NCT03745638|eczema|eczema
73335|NCT03745638|topical therapy|topical therapy
821478|NCT00151021|Pedometer|pedometer
73336|NCT03745638|JAK inhibitor|jak inhibitor
73337|NCT03745599|Pericoronitis|pericoronitis
73338|NCT03745599|Analgesics|analgesics
73339|NCT03745599|Non steroid anti-inflammatory drugs|non steroid anti-inflammatory drugs
73340|NCT03745599|Benzydamine|benzydamine
73341|NCT03745599|Quality of life|quality of life
73342|NCT03745573|corporal punishment, teacher violence, school violence, sexual violence|corporal punishment, teacher violence, school violence, sexual violence
73343|NCT03745560|Cochlear implant|cochlear implant
73344|NCT03745521|XLH|xlh
73345|NCT03745469|Smartphone|smartphone
73346|NCT03745469|Age|age
73347|NCT03745469|proprioception|proprioception
73348|NCT03745469|Deep cervical fatigue|deep cervical fatigue
73349|NCT03745469|neck pain|neck pain
73350|NCT03745456|Rotational Thromboelstrometry|rotational thromboelstrometry
73351|NCT03745417|Psoriasis|psoriasis
73352|NCT03745417|Umbilical cord Mesenchymal Stem Cells|umbilical cord mesenchymal stem cells
73353|NCT03745404|Post herpetic neuralgia|post herpetic neuralgia
73354|NCT03745404|Lidocaine|lidocaine
73355|NCT03745404|Herpes zoster|herpes zoster
73356|NCT03745378|Myeloproliferative neoplasms|myeloproliferative neoplasms
73357|NCT03745378|Secondary cancer|secondary cancer
73358|NCT03745378|JAK2V617F mutation|jak2v617f mutation
73359|NCT03745339|Addiction|addiction
73360|NCT03745339|Orbitofrontal Cortex|orbitofrontal cortex
73361|NCT03745339|Associative Learning|associative learning
73362|NCT03745339|Implicit Learning|implicit learning
73363|NCT03745326|Immunotherapy|immunotherapy
73364|NCT03745326|Cell Therapy|cell therapy
73365|NCT03745326|KRAS|kras
73366|NCT03745326|HRAS|hras
73367|NCT03745326|NRAS|nras
73368|NCT03745313|Functional|functional
73369|NCT03745313|TR|tr
73370|NCT03745313|FTR|ftr
73371|NCT03745313|Transcatheter|transcatheter
73372|NCT03745313|Repair|repair
73373|NCT03745313|Regurgitation|regurgitation
73374|NCT03745313|Degenerative|degenerative
73375|NCT03745261|Pulmonary Disease, Chronic Obstructive|pulmonary disease, chronic obstructive
73376|NCT03745261|mild, moderate, severe|mild, moderate, severe
73377|NCT03745261|Medicine, Chinese Traditional|medicine, chinese traditional
73378|NCT03745261|Cordyceps sinensis|cordyceps sinensis
73379|NCT03745248|Degenerative cerebellar disease|degenerative cerebellar disease
73380|NCT03745248|Ataxia|ataxia
73381|NCT03745248|Aerobic Exercise|aerobic exercise
73382|NCT03745222|Locally Advanced, Unresectable Non-Small Cell Lung Cancer|locally advanced, unresectable non-small cell lung cancer
73383|NCT03745222|Non-Small Cell Lung Cancer|non-small cell lung cancer
73384|NCT03745222|NSCLC|nsclc
73385|NCT03745222|Randomized|randomized
73386|NCT03745222|BGB-A317|bgb-a317
73387|NCT03745222|Tislelizumab|tislelizumab
73388|NCT03745222|PD-1|pd-1
73389|NCT03745209|Peripheral IV|peripheral iv
73390|NCT03745209|Difficult|difficult
73391|NCT03745209|Ultrasound-guided|ultrasound-guided
73392|NCT03745183|tinea imbricata|tinea imbricata
73393|NCT03745183|Senna alata|senna alata
73394|NCT03745144|Multiple Sclerosis|multiple sclerosis
73395|NCT03745144|Cladribine|cladribine
73396|NCT03745144|Microgynon®|microgynon®
73397|NCT03745131|Immunisation|immunisation
73398|NCT03745131|Modified Vaccinia Ankara|modified vaccinia ankara
73399|NCT03745131|Imvanex|imvanex
73400|NCT03745131|Imvamune|imvamune
73401|NCT03745131|Vaccine|vaccine
73402|NCT03745118|Seizure|seizure
73403|NCT03745092|normobaric oxygen|normobaric oxygen
73404|NCT03745092|chronic cerebral ischemia|chronic cerebral ischemia
73405|NCT03745066|coronary artery disease|coronary artery disease
73406|NCT03745027|in vitro fertilization|in vitro fertilization
73407|NCT03745027|sialic acid|sialic acid
73408|NCT03744949|Tracheal intubation|tracheal intubation
73409|NCT03744949|Remifentanil|remifentanil
73410|NCT03744949|Pain|pain
73411|NCT03744949|NOL index|nol index
73412|NCT03744949|Anesthesia|anesthesia
73413|NCT03744949|Analgesia|analgesia
73414|NCT03744910|Chronic Active|chronic active
73415|NCT03744910|Antibody-mediated Rejection (AMR)|antibody-mediated rejection (amr)
73416|NCT03744897|pain perception|pain perception
73417|NCT03744897|tDCS|tdcs
73418|NCT03744897|Hypnosis|hypnosis
73419|NCT03744897|cortical activity|cortical activity
73420|NCT03744884|Virtual reality|virtual reality
73421|NCT03744884|Haptic feedback|haptic feedback
73422|NCT03744884|Robotic|robotic
73423|NCT03744858|chronic vein disease|chronic vein disease
73424|NCT03744858|inflammation|inflammation
73425|NCT03744858|pyroptosis|pyroptosis
73426|NCT03744845|Pain|pain
73427|NCT03744845|Anxiety|anxiety
73428|NCT03744845|Intraoperative Care|intraoperative care
73429|NCT03744832|Pediatrics|pediatrics
73430|NCT03744832|Emergency Department|emergency department
73431|NCT03744832|Point of Care Testing|point of care testing
73432|NCT03744832|Group A Strep|group a strep
73433|NCT03744754|Fertility Preservation|fertility preservation
73434|NCT03744754|Endometriosis|endometriosis
73435|NCT03744754|Endometriomas|endometriomas
73436|NCT03744754|Ovarian stimulation|ovarian stimulation
73437|NCT03744754|Oocyte vitrification|oocyte vitrification
73438|NCT03744741|Acute Infections|acute infections
73439|NCT03744741|Host response|host response
73440|NCT03744741|mRNA|mrna
73441|NCT03744741|diagnosis|diagnosis
73442|NCT03744741|prognosis|prognosis
73443|NCT03744741|procalcitonin|procalcitonin
73444|NCT03744741|c-reactive protein|c-reactive protein
73445|NCT03744741|molecular respiratory panel|molecular respiratory panel
73446|NCT03744741|adults|adults
73447|NCT03744715|EGFR|egfr
73448|NCT03744715|HER2|her2
73449|NCT03744715|Exon 20 insertion mutation|exon 20 insertion mutation
73450|NCT03744715|Poziotinib|poziotinib
73451|NCT03744702|vasoplegia|vasoplegia
73452|NCT03744702|cardiac surgery|cardiac surgery
73453|NCT03744702|ascorbic acid|ascorbic acid
73454|NCT03744689|Lomber disc hernia|lomber disc hernia
73455|NCT03744689|Erector spinae plane block|erector spinae plane block
73456|NCT03744689|Postoperative pain|postoperative pain
73457|NCT03744676|Lisocabtagene maraleucel|lisocabtagene maraleucel
73458|NCT03744676|liso-cel|liso-cel
73459|NCT03744676|JCAR017|jcar017
73460|NCT03744676|relapse|relapse
73461|NCT03744676|refractory|refractory
73462|NCT03744676|B-Cell Non-Hodgkin Lymphoma|b-cell non-hodgkin lymphoma
73463|NCT03744676|NHL|nhl
73464|NCT03744676|chimeric antigen receptor|chimeric antigen receptor
73465|NCT03744676|CAR|car
73466|NCT03744676|CAR T cell|car t cell
73467|NCT03744676|autologous T cell therapy|autologous t cell therapy
73468|NCT03744676|immunotherapy|immunotherapy
73469|NCT03744676|cell therapy|cell therapy
73470|NCT03744676|B-cell malignancies|b-cell malignancies
73471|NCT03744663|opioid|opioid
73472|NCT03744663|Opioid Agonist Treatment|opioid agonist treatment
73473|NCT03744663|buprenorphine|buprenorphine
73474|NCT03744663|substance abuse|substance abuse
73475|NCT03744663|drug|drug
73476|NCT03744663|abstinence|abstinence
73477|NCT03744650|Pirmary prevention|pirmary prevention
73478|NCT03744650|Coronary Heart Disease|coronary heart disease
73479|NCT03744650|mHealth|mhealth
73480|NCT03744624|3D printing|3d printing
73481|NCT03744624|Liver cancer|liver cancer
73482|NCT03744624|Laparoscopic surgery|laparoscopic surgery
73483|NCT03744611|Cortex Eucommiae (CE: Eucommia ulmoides Oliver extract), mild OA|cortex eucommiae (ce: eucommia ulmoides oliver extract), mild oa
73484|NCT03744572|atherectomy|atherectomy
73485|NCT03744572|Drug coated balloon|drug coated balloon
73486|NCT03744546|Expanded Access, Pre-approval Access, Compassionate Use, Special Access Program, Named Patient Basis, Special Access Scheme.|expanded access, pre-approval access, compassionate use, special access program, named patient basis, special access scheme.
73487|NCT03744533|head-down position|head-down position
73488|NCT03744533|Large Artery Atherosclerosis|large artery atherosclerosis
73489|NCT03744520|regional anesthesia|regional anesthesia
73490|NCT03744507|Uterine leiomyoma|uterine leiomyoma
73491|NCT03744507|Uterine fibroids|uterine fibroids
73492|NCT03744507|Heavy menstrual bleeding|heavy menstrual bleeding
73493|NCT03744507|Menorrhagia|menorrhagia
73494|NCT03744507|Endometriosis|endometriosis
73495|NCT03744494|orchidectomy|orchidectomy
73496|NCT03744494|pseudotesticle|pseudotesticle
73497|NCT03744442|CALM Therapy|calm therapy
73498|NCT03744442|Dignity Therapy|dignity therapy
73499|NCT03744442|Mindfulness-based intervention|mindfulness-based intervention
73500|NCT03744442|Personalized Modular Intervention|personalized modular intervention
73501|NCT03744429|Breast Milk|breast milk
73502|NCT03744429|Mediterranean Diet|mediterranean diet
73503|NCT03744416|birth plan|birth plan
73504|NCT03744416|share decision making|share decision making
73510|NCT03744351|Follicular helper T cells|follicular helper t cells
73511|NCT03744351|B cells|b cells
73512|NCT03744351|Differentiation|differentiation
73513|NCT03744325|Food allergy|food allergy
73514|NCT03744325|Hen's egg allergy|hen's egg allergy
73515|NCT03744325|Desensitization|desensitization
73516|NCT03744325|Oral immunotherapy (OIT)|oral immunotherapy (oit)
73517|NCT03744325|Systems biology|systems biology
73518|NCT03744312|Inflammation|inflammation
73519|NCT03744312|PET scans|pet scans
73520|NCT03744299|acupuncture|acupuncture
73521|NCT03744299|surveys and questionnaires|surveys and questionnaires
73522|NCT03744299|patient|patient
73523|NCT03744299|caregiver|caregiver
73524|NCT03744260|Lower back pain|lower back pain
73525|NCT03744260|Radiofrequency ablation|radiofrequency ablation
73526|NCT03744260|Spine|spine
73527|NCT03744247|Hepatocellular Carcinoma|hepatocellular carcinoma
73528|NCT03744247|Lenvatinib|lenvatinib
73529|NCT03744247|PD-1 Antibody|pd-1 antibody
73530|NCT03744234|PRP|prp
73531|NCT03744234|Platelet-Rich Plasma|platelet-rich plasma
73532|NCT03744234|Sacroiliac Joint Pain|sacroiliac joint pain
73533|NCT03744234|SIJ Pain|sij pain
73534|NCT03744234|Osteoarthritis|osteoarthritis
73535|NCT03744208|Head and Neck Cancer|head and neck cancer
73536|NCT03744208|Epidermal growth factor receptor|epidermal growth factor receptor
73537|NCT03744208|EGFR|egfr
73538|NCT03744208|SCT200|sct200
73539|NCT03744195|Supraspinatus|supraspinatus
73540|NCT03744195|Tendinitis|tendinitis
73541|NCT03744195|Kinesotaping|kinesotaping
73542|NCT03744143|Vaginal endometriosis|vaginal endometriosis
73543|NCT03744143|Deep infiltrating endometriosis|deep infiltrating endometriosis
73544|NCT03744130|Contrast-enhanced Ultrasound|contrast-enhanced ultrasound
73545|NCT03744130|Inflammatory Bowel Disease|inflammatory bowel disease
73546|NCT03744130|CD|cd
73547|NCT03744130|UC|uc
73548|NCT03744130|SonoVue|sonovue
73549|NCT03744130|Endoscopic activity|endoscopic activity
73550|NCT03744117|dialysis|dialysis
73551|NCT03744117|end-stage kidney disease|end-stage kidney disease
73552|NCT03744117|supportive care|supportive care
73553|NCT03744117|palliative care|palliative care
73554|NCT03744117|rural health|rural health
73555|NCT03744091|cannabis|cannabis
73556|NCT03744065|nerve block|nerve block
73557|NCT03744065|fascia iliaca|fascia iliaca
73558|NCT03744065|hip replacement|hip replacement
73559|NCT03744065|lumbar plexus|lumbar plexus
73560|NCT03744026|Recurrent Glioblastoma|recurrent glioblastoma
73561|NCT03744026|Carboplatin|carboplatin
73562|NCT03744026|Ultrasound|ultrasound
73563|NCT03744026|Blood-brain barrier|blood-brain barrier
73564|NCT03744026|Glioblastoma|glioblastoma
73565|NCT03744026|SonoCloud|sonocloud
73566|NCT03744026|Low Intensity Pulsed Ultrasound (LIPU)|low intensity pulsed ultrasound (lipu)
73567|NCT03744000|STEMI|stemi
73568|NCT03744000|Deferred stenting|deferred stenting
73569|NCT03744000|Anterior wall myocardial infarction|anterior wall myocardial infarction
73570|NCT03743974|arthroscopic shoulder surgery|arthroscopic shoulder surgery
73571|NCT03743974|interscalene block analgesia|interscalene block analgesia
73572|NCT03743974|supraclavicular block analgesia|supraclavicular block analgesia
73573|NCT03743974|Ambulatory surgery for rotator cuff|ambulatory surgery for rotator cuff
73574|NCT03743961|quality of life|quality of life
73575|NCT03743961|elderly|elderly
73576|NCT03743961|metastatic neoplasia|metastatic neoplasia
73577|NCT03743961|systemic therapies|systemic therapies
73578|NCT03743948|Non Invasive Prenatal Diagnosis|non invasive prenatal diagnosis
73579|NCT03743948|Circulating Fetal Trophoblastic Cells|circulating fetal trophoblastic cells
73580|NCT03743948|monogenic disease|monogenic disease
73581|NCT03743935|STEMI|stemi
73582|NCT03743935|MRI|mri
73583|NCT03743935|ICD|icd
73584|NCT03743935|Sudden death|sudden death
73585|NCT03743896|Transdermal Delivery|transdermal delivery
73586|NCT03743896|Glucosamine|glucosamine
73587|NCT03743896|Synovial Fluid|synovial fluid
73588|NCT03743896|Osteoarthritis|osteoarthritis
73589|NCT03743896|Knee|knee
73590|NCT03743896|Human|human
73591|NCT03743896|Arthrocentesis|arthrocentesis
73592|NCT03743870|intraoperative hypotension|intraoperative hypotension
73593|NCT03743870|bupivacaine|bupivacaine
73594|NCT03743870|levobupivacaine|levobupivacaine
73595|NCT03743870|cesarean section|cesarean section
73596|NCT03743870|spinal anaesthesia|spinal anaesthesia
73597|NCT03743870|intraoperative bradycardia|intraoperative bradycardia
73598|NCT03743857|Ankle|ankle
73599|NCT03743857|Balance|balance
73600|NCT03743857|Manual Therapy|manual therapy
73601|NCT03743857|Older Adult|older adult
73606|NCT03743831|Laryngoscopy direct|laryngoscopy direct
73607|NCT03743831|Laryngoscopy indirect by Airtraq|laryngoscopy indirect by airtraq
73608|NCT03743831|hemodynamic changes|hemodynamic changes
73609|NCT03743831|side effects|side effects
73610|NCT03743805|brain|brain
73611|NCT03743805|death|death
73612|NCT03743805|sedative|sedative
73613|NCT03743805|narcotic|narcotic
73614|NCT03743792|Raspberry|raspberry
73615|NCT03743792|Cognition|cognition
73616|NCT03743792|Vascular function|vascular function
73617|NCT03743779|diabetes|diabetes
73618|NCT03743779|lifestyle|lifestyle
73619|NCT03743779|plant-based, whole food|plant-based, whole food
73620|NCT03743779|vegetarian|vegetarian
73621|NCT03743779|vegan|vegan
73622|NCT03743779|exercise|exercise
73623|NCT03743766|Stage IIIB|stage iiib
73624|NCT03743766|Stage IIIC|stage iiic
73625|NCT03743766|Stage IIID|stage iiid
73626|NCT03743766|Stage IV|stage iv
73627|NCT03743766|immune checkpoint blockade (ICB)|immune checkpoint blockade (icb)
73628|NCT03743766|Lymphocyte activation gene-3 (LAG3; CD223)|lymphocyte activation gene-3 (lag3; cd223)
73629|NCT03743766|immunotherapy|immunotherapy
73630|NCT03743753|Patient education|patient education
73631|NCT03743753|Satisfaction|satisfaction
73632|NCT03743753|Anxiety|anxiety
73633|NCT03743753|Quality of life|quality of life
73634|NCT03743753|Implant|implant
73635|NCT03743753|Autologous|autologous
73636|NCT03743753|Breast reconstruction|breast reconstruction
73637|NCT03743753|Alloplastic|alloplastic
73638|NCT03743688|Influenza Vaccine|influenza vaccine
73639|NCT03743688|Influenza|influenza
73640|NCT03743675|Overweight|overweight
73641|NCT03743675|Exercise Training|exercise training
73642|NCT03743675|Older Adults|older adults
73643|NCT03743675|Weight Loss|weight loss
73644|NCT03743662|WHO grade IV|who grade iv
73645|NCT03743662|IDH wildtype|idh wildtype
95547|NCT03606655|NNK|nnk
73646|NCT03743662|MGMT hypermethylation|mgmt hypermethylation
73647|NCT03743662|18-400|18-400
73648|NCT03743662|nivolumab|nivolumab
73649|NCT03743662|recurrent glioblastoma|recurrent glioblastoma
73650|NCT03743662|Memorial Sloan Kettering Cancer Center|memorial sloan kettering cancer center
73651|NCT03743636|Peripheral Artery Disease|peripheral artery disease
73652|NCT03743636|PAD|pad
73653|NCT03743636|Resveratrol|resveratrol
73654|NCT03743636|Nicotinamide riboside (NR)|nicotinamide riboside (nr)
73655|NCT03743636|Six-minute walk|six-minute walk
73656|NCT03743636|Functional performance|functional performance
73657|NCT03743584|cardiac arrest|cardiac arrest
73658|NCT03743584|hypothermia, therapeutic|hypothermia, therapeutic
73659|NCT03743584|ischemia reperfusion injury|ischemia reperfusion injury
73660|NCT03743584|Innate Immune system|innate immune system
73661|NCT03743571|social anxiety|social anxiety
73662|NCT03743571|transcranial direct current stimulation|transcranial direct current stimulation
73663|NCT03743571|exposure therapy|exposure therapy
73664|NCT03743558|Obstructive sleep apnea syndrome|obstructive sleep apnea syndrome
73665|NCT03743558|Adeno-amygdala hypertrophy|adeno-amygdala hypertrophy
73666|NCT03743558|Tonsillectomy|tonsillectomy
73667|NCT03743558|Video|video
73668|NCT03743558|Smartphone|smartphone
73669|NCT03743558|Ventilatory polygraphy|ventilatory polygraphy
73670|NCT03743532|smoking cessation|smoking cessation
73671|NCT03743532|contingency management|contingency management
73672|NCT03743532|financial incentives|financial incentives
73673|NCT03743532|JUUL|juul
73674|NCT03743506|Wobble board|wobble board
73675|NCT03743506|center of pressure|center of pressure
73676|NCT03743506|dynamic balance|dynamic balance
73677|NCT03743506|force platform|force platform
73678|NCT03743480|palliative care|palliative care
73679|NCT03743480|cancer|cancer
73680|NCT03743480|hematologic malignancies|hematologic malignancies
73681|NCT03743467|Parkinson's disease|parkinson's disease
73682|NCT03743467|vision|vision
73683|NCT03743467|quality of life|quality of life
73684|NCT03743454|physical activity level|physical activity level
73685|NCT03743454|physical activity awareness|physical activity awareness
73686|NCT03743441|Chronic tendinopathy|chronic tendinopathy
73687|NCT03743441|Low-level Laser Therapy|low-level laser therapy
73688|NCT03743441|LLLT|lllt
73689|NCT03743441|Photobiomodulation|photobiomodulation
73690|NCT03743441|Cryotherapy|cryotherapy
73691|NCT03743441|Exercise therapy|exercise therapy
73692|NCT03743441|Randomized Clinical Trial|randomized clinical trial
73693|NCT03743441|RCT|rct
73694|NCT03743441|Placebo-controlled|placebo-controlled
73695|NCT03743428|apatinib,bevacizumab,FOLFIRI,colorectal cancer|apatinib,bevacizumab,folfiri,colorectal cancer
73696|NCT03743415|psychosocial oncology|psychosocial oncology
73697|NCT03743415|symptom management|symptom management
73698|NCT03743402|long-term opioid therapy|long-term opioid therapy
73699|NCT03743402|chronic pain self-management|chronic pain self-management
73700|NCT03743402|primary care prescribing guidance|primary care prescribing guidance
73701|NCT03743389|uniportal video-assisted thoracoscopic surgery|uniportal video-assisted thoracoscopic surgery
73702|NCT03743389|mediastinal nodes|mediastinal nodes
73703|NCT03743389|chest drainage|chest drainage
73704|NCT03743389|pigtail catheter|pigtail catheter
73705|NCT03743363|balance|balance
73709|NCT03743337|Infant-toddler care|infant-toddler care
73710|NCT03743337|Early child development|early child development
73711|NCT03743337|Professional development|professional development
73712|NCT03743324|breast reconstruction|breast reconstruction
73714|NCT03743324|radiation|radiation
73715|NCT03743324|timing|timing
73716|NCT03743272|Multiparametric MRI|multiparametric mri
73717|NCT03743272|LiverMultiScan|livermultiscan
73718|NCT03743272|Repeatability|repeatability
73719|NCT03743272|Reproducibility|reproducibility
73720|NCT03743272|Liver MRI|liver mri
73721|NCT03743259|Nonpalpable Breast Lesions|nonpalpable breast lesions
73722|NCT03743246|Pediatric|pediatric
73723|NCT03743246|JCAR017|jcar017
73724|NCT03743246|CAR-T|car-t
73725|NCT03743246|CART|cart
73726|NCT03743246|CD19|cd19
73727|NCT03743246|ALL|all
73728|NCT03743246|NHL|nhl
73729|NCT03743246|DLBCL|dlbcl
73730|NCT03743246|BL|bl
73731|NCT03743246|PMBCL|pmbcl
73732|NCT03743246|Cell Therapy|cell therapy
73733|NCT03743246|LisoCell|lisocell
73734|NCT03743246|Young Adults|young adults
73735|NCT03743246|Lymphoproliferative disorders|lymphoproliferative disorders
73736|NCT03743246|Immune system diseases|immune system diseases
73737|NCT03743246|Leukemia|leukemia
73738|NCT03743246|Lymphoma|lymphoma
73739|NCT03743246|lymphatic diseases|lymphatic diseases
73740|NCT03743220|Drug Hypersensitivity Reaction|drug hypersensitivity reaction
73741|NCT03743220|Drug Provocation Test|drug provocation test
73742|NCT03743220|Non steroidal Anti Inflammatory drugs|non steroidal anti inflammatory drugs
73743|NCT03743220|Reactive Doses|reactive doses
73744|NCT03743220|Reactive Times|reactive times
73745|NCT03743207|Prematurity|prematurity
95678|NCT03605927|HCT|hct
73746|NCT03743207|Enteral nutrition|enteral nutrition
73747|NCT03743207|Feeding tolerance|feeding tolerance
73748|NCT03743207|Temperature|temperature
73749|NCT03743116|Orthostatic Intolerance|orthostatic intolerance
73750|NCT03743116|Orthostatic Hypotension|orthostatic hypotension
73751|NCT03743116|Knee arthroplasty|knee arthroplasty
73752|NCT03743090|coronary artery disease|coronary artery disease
73753|NCT03743090|obstructive sleep apnea|obstructive sleep apnea
73754|NCT03743077|Exercise|exercise
73755|NCT03743077|Respiratory training|respiratory training
73756|NCT03743025|Coronary Artery Bypass Surgery (CABG)|coronary artery bypass surgery (cabg)
73757|NCT03743025|Post Operative|post operative
73758|NCT03743025|Obesity|obesity
73761|NCT03742999|Biofeedback|biofeedback
73762|NCT03742999|eye-hand coordination|eye-hand coordination
73763|NCT03742999|Peabody|peabody
73764|NCT03742986|Nivolumab|nivolumab
73765|NCT03742973|Janus kinase inhibitor|janus kinase inhibitor
73767|NCT03742947|ancillary biologic study|ancillary biologic study
73768|NCT03742947|fibrinolysis|fibrinolysis
73769|NCT03742947|tranexamic acid|tranexamic acid
73770|NCT03742947|post-partum haemorrhage|post-partum haemorrhage
73771|NCT03742934|Bowel preparation|bowel preparation
73772|NCT03742921|Istodax|istodax
73773|NCT03742921|Survey|survey
73774|NCT03742921|Relapsed or refractory|relapsed or refractory
73775|NCT03742921|Peripheral T-Cell Lymphoma|peripheral t-cell lymphoma
73776|NCT03742908|Implant-based breast reconstruction|implant-based breast reconstruction
73777|NCT03742908|intraoperative antibiotics/antiseptics|intraoperative antibiotics/antiseptics
73778|NCT03742908|Chinese|chinese
73779|NCT03742882|CC-90001|cc-90001
73780|NCT03742882|Pharmacokinetics|pharmacokinetics
73781|NCT03742882|Hepatic Impairment|hepatic impairment
73782|NCT03742882|Healthy subjects|healthy subjects
73783|NCT03742791|TS-134, multiple dose, titration|ts-134, multiple dose, titration
73784|NCT03742778|exercise|exercise
73785|NCT03742778|Incentives|incentives
73786|NCT03742778|reflection|reflection
73787|NCT03742778|output|output
73788|NCT03742765|Exercise|exercise
73789|NCT03742765|Incentives|incentives
73790|NCT03742765|Planning|planning
73791|NCT03742752|enteral nutrition|enteral nutrition
73792|NCT03742752|parenteral nutrition|parenteral nutrition
73793|NCT03742752|gastrointestinal fistula|gastrointestinal fistula
73794|NCT03742700|e-cigarette|e-cigarette
73795|NCT03742700|health effects|health effects
73796|NCT03742700|cigarette smoking|cigarette smoking
73797|NCT03742700|exhaled nitric oxide|exhaled nitric oxide
73798|NCT03742700|pulmonary function tests|pulmonary function tests
73799|NCT03742687|Locally advanced NSCLC|locally advanced nsclc
73800|NCT03742687|Radiotherapy|radiotherapy
73801|NCT03742687|Hypofractionation|hypofractionation
73802|NCT03742648|pO2|po2
73803|NCT03742648|pCO2|pco2
73804|NCT03742648|pH|ph
73805|NCT03742648|Rhonchi|rhonchi
73806|NCT03742648|Wheeze|wheeze
73807|NCT03742648|Crackles|crackles
73808|NCT03742648|ISM|ism
73809|NCT03742648|DBE|dbe
73810|NCT03742622|appetite control|appetite control
73811|NCT03742622|obesity|obesity
73812|NCT03742622|Adolescents|adolescents
73813|NCT03742622|exercise|exercise
73814|NCT03742622|Energy replacement|energy replacement
73815|NCT03742596|Colorectal cancer|colorectal cancer
73816|NCT03742596|Radiotherapy|radiotherapy
73817|NCT03742596|immune system|immune system
73818|NCT03742596|Inflammatory markers|inflammatory markers
73819|NCT03742596|Life quality|life quality
73820|NCT03742570|Childhood Bladder and Bowel Dysfunction Questionnaire|childhood bladder and bowel dysfunction questionnaire
73821|NCT03742570|Reliability|reliability
73822|NCT03742570|Turkish|turkish
73823|NCT03742557|Depression|depression
73824|NCT03742557|Ketamine|ketamine
73825|NCT03742557|Treatment-Resistant|treatment-resistant
73826|NCT03742557|Magnetic Resonance Spectroscopy|magnetic resonance spectroscopy
73827|NCT03742518|male pattern baldness|male pattern baldness
73828|NCT03742518|SM04554|sm04554
73829|NCT03742518|AGA|aga
73830|NCT03742492|Omega-3 fatty acids|omega-3 fatty acids
73831|NCT03742492|Eicosapentaenoic acid (EPA)|eicosapentaenoic acid (epa)
73832|NCT03742492|Docosahexaenoic acid (DHA)|docosahexaenoic acid (dha)
73833|NCT03742492|Bioavailability|bioavailability
73834|NCT03742492|Blood pressure|blood pressure
73835|NCT03742492|Lipid absorption|lipid absorption
73836|NCT03742492|Canned tuna|canned tuna
73837|NCT03742453|CEUS|ceus
73838|NCT03742453|gadoxetic acid|gadoxetic acid
73839|NCT03742453|MRI|mri
73840|NCT03742427|ultrasonography|ultrasonography
73841|NCT03742427|optic nerve sheath|optic nerve sheath
73842|NCT03742427|head trauma|head trauma
73843|NCT03742414|Dermatitis|dermatitis
73844|NCT03742401|Breast Fibroadenoma|breast fibroadenoma
73845|NCT03742375|Human Papilloma Virus|human papilloma virus
73846|NCT03742375|Anal Intraepithelial Neoplasia|anal intraepithelial neoplasia
73847|NCT03742362|Osteoporosis|osteoporosis
73848|NCT03742362|MRI|mri
73849|NCT03742362|distal radius|distal radius
73850|NCT03742362|postmenopausal|postmenopausal
73851|NCT03742349|Phase Ib, TNBC, advanced, metastatic, immunotherapy, PDR001,|phase ib, tnbc, advanced, metastatic, immunotherapy, pdr001,
73852|NCT03742349|LAG525, NIR178, INC280, MCS110, ACZ885|lag525, nir178, inc280, mcs110, acz885
73853|NCT03742310|Vitamin D Receptor gene|vitamin d receptor gene
73854|NCT03742310|physical development|physical development
73855|NCT03742310|intelligent development|intelligent development
73856|NCT03742245|breast cancer|breast cancer
73857|NCT03742245|relapsed|relapsed
73858|NCT03742245|refractory|refractory
73859|NCT03742245|metastatic|metastatic
73860|NCT03742167|Prehospital emergency care|prehospital emergency care
73861|NCT03742167|Paramedic performance|paramedic performance
73862|NCT03742167|Telemedicine|telemedicine
73863|NCT03742167|Medical control physician|medical control physician
73864|NCT03742167|Infant mannequin smulation|infant mannequin smulation
73865|NCT03742167|Pediatric life threatening illness|pediatric life threatening illness
73866|NCT03742141|Thyroidectomy|thyroidectomy
73867|NCT03742141|Neck Procedures|neck procedures
73868|NCT03742141|Nerve Monitoring|nerve monitoring
73869|NCT03742102|Breast Cancer|breast cancer
73870|NCT03742102|TNBC|tnbc
73871|NCT03742102|Triple Negative|triple negative
73872|NCT03742102|Triple Negative Breast Cancer|triple negative breast cancer
73873|NCT03742102|Triple-Negative Breast Cancer|triple-negative breast cancer
73874|NCT03742102|Triple-Negative Breast Neoplasm|triple-negative breast neoplasm
73875|NCT03742102|ER-Negative PR-Negative HER2-Negative Breast Cancer|er-negative pr-negative her2-negative breast cancer
73876|NCT03742102|ER-Negative PR-Negative HER2-Negative Breast Neoplasms|er-negative pr-negative her2-negative breast neoplasms
73877|NCT03742063|osteosarcoma|osteosarcoma
73878|NCT03742063|Ewing sarcoma|ewing sarcoma
73879|NCT03742063|clinical evaluation|clinical evaluation
73880|NCT03742063|pathological evaluation|pathological evaluation
73881|NCT03742063|chemotherapy|chemotherapy
73882|NCT03742063|targeted therapy|targeted therapy
73883|NCT03742037|Musculoskeletal and connective tissue disorders|musculoskeletal and connective tissue disorders
73884|NCT03742011|PCOS|pcos
73885|NCT03742011|Hyperandrogenism|hyperandrogenism
73886|NCT03742011|Epigenetics|epigenetics
73887|NCT03742011|Glucolipid metabolism disorder|glucolipid metabolism disorder
73888|NCT03741972|Heart failure|heart failure
73889|NCT03741972|Diabetes|diabetes
73890|NCT03741972|iSGLT2|isglt2
73891|NCT03741959|postural defect|postural defect
73892|NCT03741946|carotid arteries|carotid arteries
73893|NCT03741946|central venous catheterization|central venous catheterization
73894|NCT03741946|jugular veins|jugular veins
73895|NCT03741946|Malay race|malay race
73896|NCT03741946|ultrasonography|ultrasonography
73897|NCT03741920|Personal KinetiGraph (PKG) Movement Recording System|personal kinetigraph (pkg) movement recording system
73898|NCT03741907|Cesarean|cesarean
73899|NCT03741907|Surgery|surgery
73900|NCT03741907|Birth|birth
73901|NCT03741907|Recovery|recovery
73902|NCT03741907|Outcomes|outcomes
73903|NCT03741894|alveolitis|alveolitis
73904|NCT03741894|iodoform|iodoform
73905|NCT03741894|chlorhexidine|chlorhexidine
73906|NCT03741894|minor complications|minor complications
73907|NCT03741868|Lung Cancer|lung cancer
73908|NCT03741868|Immunotherapy|immunotherapy
73909|NCT03741868|Stage IV cancer|stage iv cancer
73910|NCT03741855|COPD|copd
73911|NCT03741855|Chronic Obstructive Pulmonary Disease|chronic obstructive pulmonary disease
73912|NCT03741855|Self-Management|self-management
73913|NCT03741829|Thymidylate Synthase|thymidylate synthase
73914|NCT03741829|Cancer|cancer
73915|NCT03741829|Cancer Treatments|cancer treatments
73916|NCT03741816|permanent molars|permanent molars
73917|NCT03741816|indirect pulp capping|indirect pulp capping
73918|NCT03741816|reversible pulpitis|reversible pulpitis
73919|NCT03741816|deep carious lesions|deep carious lesions
73920|NCT03741816|Biodentine|biodentine
73921|NCT03741816|TheraCal LC|theracal lc
73922|NCT03741790|airway|airway
73923|NCT03741790|intubation|intubation
73924|NCT03741777|NPO time|npo time
73925|NCT03741777|Gastric content|gastric content
73926|NCT03741751|cognition|cognition
73927|NCT03741751|schizophrenia|schizophrenia
73928|NCT03741751|schizoaffective disorder|schizoaffective disorder
73929|NCT03741712|Castration-resistant Prostate Cancer|castration-resistant prostate cancer
73930|NCT03741712|SHR2554|shr2554
73931|NCT03741712|SHR3680|shr3680
73932|NCT03741699|Poor ovarian response|poor ovarian response
73933|NCT03741699|Recombinant LH|recombinant lh
73934|NCT03741699|Advanced maternal age|advanced maternal age
73935|NCT03741699|Oocyte retrieved|oocyte retrieved
73936|NCT03741686|insulin resistance syndrome|insulin resistance syndrome
73937|NCT03741686|fiber|fiber
73938|NCT03741686|konjac|konjac
73939|NCT03741660|konjac|konjac
73940|NCT03741660|type2 diabetes|type2 diabetes
73941|NCT03741660|fiber|fiber
73942|NCT03741660|coronary heart disease|coronary heart disease
73943|NCT03741634|adolescent health|adolescent health
73944|NCT03741634|sexual health|sexual health
73945|NCT03741634|reproductive health|reproductive health
73946|NCT03741634|food security|food security
73947|NCT03741621|dietary fibre|dietary fibre
73948|NCT03741621|Viscosity|viscosity
73949|NCT03741621|lipids|lipids
73950|NCT03741621|Healthy|healthy
73951|NCT03741582|Transportation|transportation
73952|NCT03741582|Urban Health|urban health
73953|NCT03741582|Quality of Life|quality of life
73954|NCT03741582|Social Capital|social capital
73955|NCT03741582|Crime|crime
73956|NCT03741582|Respiratory Diseases|respiratory diseases
73957|NCT03741569|Fetal heart rate|fetal heart rate
73958|NCT03741569|Multiple sensors|multiple sensors
73959|NCT03741543|health promotion|health promotion
73960|NCT03741543|early-stage dementia|early-stage dementia
73961|NCT03741543|psychosocial|psychosocial
73962|NCT03741530|Intracerebral hemorrhage|intracerebral hemorrhage
73963|NCT03741530|Perihematomal edema|perihematomal edema
73964|NCT03741530|Disability|disability
73965|NCT03741530|Clinical trial|clinical trial
73966|NCT03741465|neuraxial anesthesia positioning technique|neuraxial anesthesia positioning technique
73967|NCT03741465|Anatolian sitting position|anatolian sitting position
73968|NCT03741465|sitting cross-legged position|sitting cross-legged position
73969|NCT03741465|sitting fetal position|sitting fetal position
73970|NCT03741465|ultrasonography|ultrasonography
73971|NCT03741465|numerical rating scale|numerical rating scale
73972|NCT03741426|Olaparib|olaparib
73973|NCT03741426|Cediranib|cediranib
73974|NCT03741426|Durvalumab|durvalumab
73975|NCT03741400|motor weakness|motor weakness
73976|NCT03741400|rehabilitation|rehabilitation
73977|NCT03741361|Female|female
73978|NCT03741361|Prospective Studies|prospective studies
73979|NCT03741361|Anesthetics, Intravenous|anesthetics, intravenous
73980|NCT03741361|Propofol|propofol
73981|NCT03741361|Anxiety/*psychology|anxiety/*psychology
73982|NCT03741361|Depression/*psychology|depression/*psychology
73983|NCT03741348|Erector Spinae Plane Block|erector spinae plane block
73984|NCT03741348|Postoperative Analgesia|postoperative analgesia
73985|NCT03741348|Total Abdominal Hysterectomy|total abdominal hysterectomy
73986|NCT03741348|fentanyl consumption|fentanyl consumption
73987|NCT03741309|dentinal hypersensitivity|dentinal hypersensitivity
73988|NCT03741309|visual analog scale|visual analog scale
73989|NCT03741296|Hip replacement|hip replacement
73990|NCT03741296|periprosthetic hip infection|periprosthetic hip infection
73991|NCT03741296|single stage revision|single stage revision
73992|NCT03741296|two-stage revision|two-stage revision
73993|NCT03741283|Medicines optimisation|medicines optimisation
73994|NCT03741283|Multimodal interventions|multimodal interventions
73995|NCT03741283|Inflammation|inflammation
73996|NCT03741283|Emergency Service, Hospital|emergency service, hospital
73997|NCT03741283|Pharmacogenetics|pharmacogenetics
73998|NCT03741283|Renal function|renal function
73999|NCT03741283|Food intake|food intake
74000|NCT03741283|Quality of life|quality of life
74001|NCT03741283|Polypharmacy|polypharmacy
74002|NCT03741244|glioma|glioma
74003|NCT03741244|Apatinib|apatinib
74004|NCT03741244|VEGFR-2|vegfr-2
74005|NCT03741244|temozolomide|temozolomide
74006|NCT03741231|melanoma|melanoma
74007|NCT03741231|NSCLC|nsclc
74008|NCT03741231|FDG|fdg
74009|NCT03741231|PET|pet
74010|NCT03741231|immunotherapy|immunotherapy
74011|NCT03741218|Polyphenols|polyphenols
74012|NCT03741218|Obesity|obesity
74013|NCT03741218|Grape|grape
74014|NCT03741218|Postprandial|postprandial
74015|NCT03741218|Insulin resistance|insulin resistance
74016|NCT03741218|Second meal effect|second meal effect
74017|NCT03741179|pre-eclampsia|pre-eclampsia
74018|NCT03741179|pregnant|pregnant
74019|NCT03741179|sFlt-1/PlGF ratio|sflt-1/plgf ratio
74020|NCT03741179|ASA treatment|asa treatment
74021|NCT03741166|Blood Draw|blood draw
74022|NCT03741127|CAR-T cells|car-t cells
74023|NCT03741114|placenta previa|placenta previa
74024|NCT03741114|tranexamic acid|tranexamic acid
74025|NCT03741114|cesarean section|cesarean section
74026|NCT03741114|Foley's Catheter Balloon|foley's catheter balloon
74027|NCT03741075|placenta previa|placenta previa
74028|NCT03741075|tranexamic acid|tranexamic acid
74029|NCT03741075|uterine artery ligation|uterine artery ligation
74030|NCT03741062|Laser Therapy|laser therapy
74031|NCT03741062|Low-Level Light Therapy|low-level light therapy
74032|NCT03741062|Periodontics|periodontics
74033|NCT03741062|Oral Surgery|oral surgery
74034|NCT03741062|Palate|palate
74035|NCT03741062|Palate, Hard|palate, hard
74036|NCT03741049|CVCI|cvci
74037|NCT03741049|Emergency medicine|emergency medicine
74038|NCT03741049|Airway management|airway management
74039|NCT03741049|Cricothyroidotomy|cricothyroidotomy
74040|NCT03741036|immidiate|immidiate
74041|NCT03741036|dental implant|dental implant
74042|NCT03741036|immidiate provisionalization|immidiate provisionalization
74043|NCT03741036|bone graft|bone graft
400581|NCT01866189|F-MISO uptake|f-miso uptake
74044|NCT03740997|Contrast-enhanced echocardiography (CE-ECHO)|contrast-enhanced echocardiography (ce-echo)
74045|NCT03740997|Transthoracic echocardiogram|transthoracic echocardiogram
74046|NCT03740997|Child|child
74047|NCT03740997|Left ventricular opacification (LVO)|left ventricular opacification (lvo)
74048|NCT03740997|Left ventricular ejection fraction (LVEF)|left ventricular ejection fraction (lvef)
74049|NCT03740997|Left ventricular endocardial border delineation (LV EBD)|left ventricular endocardial border delineation (lv ebd)
74050|NCT03740984|Chemotherapy|chemotherapy
74051|NCT03740984|Side effects of chemotherapy|side effects of chemotherapy
74052|NCT03740945|Vulvovaginal atrophy (VVA)|vulvovaginal atrophy (vva)
74053|NCT03740945|Vaginal atrophy|vaginal atrophy
74054|NCT03740945|Atrophic vaginitis|atrophic vaginitis
74055|NCT03740945|Prasterone|prasterone
74056|NCT03740945|DHEA|dhea
74057|NCT03740945|Intrarosa|intrarosa
74058|NCT03740945|Breast cancer|breast cancer
74059|NCT03740945|Aromatase inhibitor|aromatase inhibitor
74060|NCT03740919|prandial insulin|prandial insulin
74061|NCT03740919|multiple daily injections|multiple daily injections
74062|NCT03740919|pediatric patients|pediatric patients
74063|NCT03740919|postmeal dosing|postmeal dosing
74064|NCT03740893|AZD6738|azd6738
74065|NCT03740893|Olaparib|olaparib
74066|NCT03740893|Durvalumab|durvalumab
74067|NCT03740893|Window of opportunity|window of opportunity
74068|NCT03740893|Triple negative breast cancer|triple negative breast cancer
74069|NCT03740893|Breast cancer|breast cancer
74070|NCT03740880|ICSI|icsi
74071|NCT03740880|early trigger|early trigger
74072|NCT03740880|poor ovarian responders|poor ovarian responders
74073|NCT03740880|low AMH|low amh
74074|NCT03740867|Cognitive Impairment|cognitive impairment
74075|NCT03740867|pulmonary rehabilitation|pulmonary rehabilitation
74076|NCT03740867|exercise|exercise
74077|NCT03740867|MOCA|moca
74078|NCT03740867|aerobic training|aerobic training
74079|NCT03740854|lung ultrasonography|lung ultrasonography
74080|NCT03740854|mechanical ventilation|mechanical ventilation
74081|NCT03740854|pressure controlled ventilation|pressure controlled ventilation
74082|NCT03740854|volume controlled ventilation|volume controlled ventilation
74083|NCT03740841|Per-operative stress|per-operative stress
74084|NCT03740841|per-operative anxiety|per-operative anxiety
74085|NCT03740841|pediatric surgery|pediatric surgery
74086|NCT03740828|In vitro fertilization|in vitro fertilization
74087|NCT03740828|Time-lapse|time-lapse
74088|NCT03740828|Assisted Reproduction|assisted reproduction
74089|NCT03740789|Hepatitis B|hepatitis b
74090|NCT03740789|ALT|alt
74091|NCT03740763|Pain|pain
74092|NCT03740763|Quality of Life|quality of life
74093|NCT03740763|Electric Stimulation Therapy|electric stimulation therapy
74094|NCT03740763|Physiotherapy|physiotherapy
74095|NCT03740750|heat|heat
74096|NCT03740750|hot temperature|hot temperature
74097|NCT03740750|cutaneous electrostimulation|cutaneous electrostimulation
74098|NCT03740724|Morphea|morphea
74099|NCT03740711|Cardiogenic shock|cardiogenic shock
74100|NCT03740711|Extracorporeal Membrane Oxygenation Support|extracorporeal membrane oxygenation support
74101|NCT03740711|Left atrial venting|left atrial venting
74102|NCT03740646|Bronchiolitis|bronchiolitis
74103|NCT03740646|Nasopharyngeal aspirates|nasopharyngeal aspirates
74104|NCT03740620|epistaxis|epistaxis
74105|NCT03740607|Adult|adult
74106|NCT03740607|Peripheral IV|peripheral iv
74107|NCT03740607|procedural pain|procedural pain
74108|NCT03740607|procedural anxiety|procedural anxiety
74109|NCT03740607|virtual reality|virtual reality
74110|NCT03740607|peripheral intravenous catheter|peripheral intravenous catheter
74111|NCT03740581|Diabetic foot ulcer|diabetic foot ulcer
74112|NCT03740581|Intensive glycemic control|intensive glycemic control
74113|NCT03740529|Loxo|loxo
74114|NCT03740529|LOXO-305|loxo-305
74116|NCT03740529|Bruton's tyrosine kinase|bruton's tyrosine kinase
74117|NCT03740529|CLL|cll
74118|NCT03740529|SLL|sll
74119|NCT03740529|NHL|nhl
74120|NCT03740529|Chronic Lymphocytic Leukemia|chronic lymphocytic leukemia
74121|NCT03740529|C481S|c481s
74122|NCT03740529|C481|c481
74123|NCT03740529|Ibrutinib|ibrutinib
74124|NCT03740529|Acalabrutinib|acalabrutinib
74125|NCT03740529|Zanubrutinib|zanubrutinib
74126|NCT03740529|BGB-3111|bgb-3111
74127|NCT03740529|GS-4059|gs-4059
74128|NCT03740529|ONO-4059|ono-4059
74129|NCT03740529|Tirabrutinib|tirabrutinib
74130|NCT03740529|Small Lymphocytic Lymphoma|small lymphocytic lymphoma
74131|NCT03740529|Mantle Cell Lymphoma|mantle cell lymphoma
74132|NCT03740529|Waldenstrom macroglobulinemia|waldenstrom macroglobulinemia
74133|NCT03740529|Non-Hodgkin Lymphoma|non-hodgkin lymphoma
74134|NCT03740529|BTK Intolerant|btk intolerant
74135|NCT03740529|C481S Mutation|c481s mutation
74136|NCT03740529|Marginal zone lymphoma|marginal zone lymphoma
74137|NCT03740529|DLBCL (Diffuse Large B-cell lymphoma)|dlbcl (diffuse large b-cell lymphoma)
74138|NCT03740529|Follicular Lymphoma|follicular lymphoma
74139|NCT03740516|Expanded Access|expanded access
74140|NCT03740516|Compassionate Use|compassionate use
74141|NCT03740503|Cancer|cancer
74142|NCT03740503|Breast Cancer|breast cancer
74143|NCT03740503|Non- small Cell Lung Cancer|non- small cell lung cancer
74144|NCT03740503|Colorectal Cancer|colorectal cancer
74145|NCT03740503|Genitourinary Cancer|genitourinary cancer
74146|NCT03740503|Gynecological Cancer|gynecological cancer
74147|NCT03740503|Upper Aerodigestive Tract Cancer|upper aerodigestive tract cancer
74148|NCT03740503|Pancreatobiliary Gastrointestinal Cancer|pancreatobiliary gastrointestinal cancer
74149|NCT03740503|Melanoma Cancer|melanoma cancer
74150|NCT03740503|Rare Cancer|rare cancer
74151|NCT03740503|Unknown Primary Cancer|unknown primary cancer
74152|NCT03740490|Smoking Cessation|smoking cessation
74153|NCT03740490|Smartphone Based Smoking Cessation|smartphone based smoking cessation
74154|NCT03740451|Fibromyalgia, Manual Therapy, Autonomic Nervous System, Pain, Psychological well-being|fibromyalgia, manual therapy, autonomic nervous system, pain, psychological well-being
74155|NCT03740438|Hemoglobin|hemoglobin
74156|NCT03740438|Hemoglobin drop|hemoglobin drop
74157|NCT03740438|Surgical Blood loss|surgical blood loss
74158|NCT03740412|sedentary|sedentary
74159|NCT03740412|arthroplasty|arthroplasty
74160|NCT03740412|osteoarthritis|osteoarthritis
74161|NCT03740412|older adults|older adults
74162|NCT03740412|elderly|elderly
74163|NCT03740412|old|old
74164|NCT03740412|elders|elders
74165|NCT03740412|sitting|sitting
74166|NCT03740412|intervention|intervention
74167|NCT03740399|sitting position|sitting position
74168|NCT03740399|lateral decubitus position|lateral decubitus position
74169|NCT03740399|spinal block|spinal block
74170|NCT03740386|phentolamine mesylate|phentolamine mesylate
74171|NCT03740386|reverse local anesthesia|reverse local anesthesia
74172|NCT03740360|Pancreatic cystic neoplasm|pancreatic cystic neoplasm
74173|NCT03740360|Molecular analysis|molecular analysis
74174|NCT03740360|Mucinous cystic neoplasm|mucinous cystic neoplasm
74175|NCT03740360|Serous cystic neoplasm|serous cystic neoplasm
74176|NCT03740360|Intraductal papillary neoplasm|intraductal papillary neoplasm
74177|NCT03740347|Juvenile idiopathic arthritis|juvenile idiopathic arthritis
74178|NCT03740347|chronic pain|chronic pain
74179|NCT03740347|anxiety|anxiety
74180|NCT03740347|depression|depression
74181|NCT03740347|sleepiness|sleepiness
74182|NCT03740347|quality of life|quality of life
74183|NCT03740334|ALL|all
74184|NCT03740321|Hemorrhoids|hemorrhoids
74185|NCT03740321|Superior rectal artery|superior rectal artery
74186|NCT03740321|embolization|embolization
74187|NCT03740321|microspheric particles|microspheric particles
74188|NCT03740308|Primary posterior teeth|primary posterior teeth
74189|NCT03740308|zirconia crown|zirconia crown
74190|NCT03740282|arthrodesis|arthrodesis
74191|NCT03740282|bunion|bunion
74192|NCT03740282|early weight-bearing|early weight-bearing
74193|NCT03740282|lapidus|lapidus
74194|NCT03740282|hallux valgus|hallux valgus
74195|NCT03740269|oral health education|oral health education
74196|NCT03740269|oral health promotion|oral health promotion
74197|NCT03740269|oral health education program|oral health education program
74198|NCT03740269|oral hygiene status|oral hygiene status
74199|NCT03740269|knowledge,attitude,practice|knowledge,attitude,practice
74200|NCT03740269|oral health knowledge,attitude,practice|oral health knowledge,attitude,practice
74201|NCT03740269|oral hygiene knowledge,attitude,practice|oral hygiene knowledge,attitude,practice
74202|NCT03740269|knowledge,attitude,practice oral health|knowledge,attitude,practice oral health
74203|NCT03740269|knowledge,attitude,practice oral hygiene|knowledge,attitude,practice oral hygiene
74204|NCT03740269|KAP|kap
74205|NCT03740256|HER2|her2
74206|NCT03740256|Human Epidermal Growth Factor Receptor 2|human epidermal growth factor receptor 2
74211|NCT03740256|Breast|breast
74212|NCT03740256|Gastric|gastric
74213|NCT03740256|Esophageal|esophageal
74214|NCT03740256|Colorectal|colorectal
74215|NCT03740256|Pancreatic|pancreatic
74216|NCT03740243|opioid use disorder|opioid use disorder
74217|NCT03740243|Buprenorphine/naloxone|buprenorphine/naloxone
74218|NCT03740243|Buprenorphine|buprenorphine
74219|NCT03740230|Hepatitis C|hepatitis c
74220|NCT03740230|Chronic Hepatitis C|chronic hepatitis c
74221|NCT03740230|Genotypes|genotypes
74222|NCT03740230|Genotypes 1 to 6|genotypes 1 to 6
74223|NCT03740230|Maviret|maviret
74224|NCT03740230|Glecaprevir|glecaprevir
74225|NCT03740230|Pibrentasvir|pibrentasvir
74226|NCT03740204|Adolescent|adolescent
74227|NCT03740204|Amenorrhea|amenorrhea
74228|NCT03740204|Anorexia Nervosa|anorexia nervosa
74229|NCT03740204|Cognitive Flexibility|cognitive flexibility
74230|NCT03740204|Dietary Restriction|dietary restriction
74231|NCT03740204|Eating Disorders|eating disorders
74232|NCT03740204|Estrogen|estrogen
74233|NCT03740204|Excessive Exercise|excessive exercise
74234|NCT03740204|Females|females
74235|NCT03740204|Hypoestrogenemia|hypoestrogenemia
74236|NCT03740204|Reward|reward
74237|NCT03740139|Serious mental illnesses|serious mental illnesses
74238|NCT03740139|Pre-arrest jail diversion|pre-arrest jail diversion
74239|NCT03740139|Police|police
821479|NCT00151021|Behavioral|behavioral
74240|NCT03740126|Positron Emission Tomography Computed Tomography|positron emission tomography computed tomography
74241|NCT03740126|X-Ray Computed Tomography|x-ray computed tomography
74242|NCT03740126|Liquid Biopsy|liquid biopsy
74243|NCT03740126|Quality of Life|quality of life
74244|NCT03740126|Medical Oncology|medical oncology
74245|NCT03740126|Radiation Oncology|radiation oncology
74246|NCT03740126|Follow-up|follow-up
74247|NCT03740113|Sugar sweetened beverages|sugar sweetened beverages
74248|NCT03740113|health disparities|health disparities
74249|NCT03740113|Appalachia|appalachia
74250|NCT03740100|Head and Neck Squamous Cell Carcinoma|head and neck squamous cell carcinoma
74251|NCT03740100|Notch 1 loss of function mutation|notch 1 loss of function mutation
74252|NCT03740100|PI3K/mTOR Inhibitor|pi3k/mtor inhibitor
74253|NCT03740100|Refractory metastatic|refractory metastatic
74254|NCT03740087|miRNA|mirna
74255|NCT03740087|Xenomirs|xenomirs
74256|NCT03740087|Diet|diet
74257|NCT03740087|Vegan|vegan
74258|NCT03740061|Ultrasound|ultrasound
74259|NCT03740061|Assessment|assessment
74260|NCT03740061|Acute sarcopenia|acute sarcopenia
74261|NCT03740061|Hospitalized older people|hospitalized older people
74262|NCT03740048|Hemodialysis|hemodialysis
74263|NCT03740048|Kidney Disease|kidney disease
74264|NCT03740048|Kidney Function|kidney function
74265|NCT03740035|Prostate Cancer|prostate cancer
74266|NCT03740035|eHealth|ehealth
74267|NCT03740035|movement|movement
74268|NCT03740009|Hormone Replacement Therapy|hormone replacement therapy
74269|NCT03740009|Estrogen|estrogen
74270|NCT03740009|Depression|depression
74271|NCT03740009|Mood Disorders|mood disorders
74272|NCT03740009|Estrogen Replacement Therapy|estrogen replacement therapy
74273|NCT03740009|Depressive Disorder|depressive disorder
74274|NCT03740009|Mental Disorders|mental disorders
74275|NCT03740009|Hormones|hormones
74276|NCT03740009|Physiological effects of drugs|physiological effects of drugs
74277|NCT03740009|Reproductive Control Agents|reproductive control agents
74278|NCT03740009|Tissue Selective Estrogen Complex|tissue selective estrogen complex
74279|NCT03739957|COPD|copd
74280|NCT03739957|Telemonitoring systems|telemonitoring systems
74281|NCT03739931|mRNA-2752|mrna-2752
74282|NCT03739931|OX40L|ox40l
74283|NCT03739931|IL-23|il-23
74284|NCT03739931|IL-36γ|il-36γ
74285|NCT03739931|Intratumoral injection|intratumoral injection
74286|NCT03739918|Cystic|cystic
74287|NCT03739918|Adrenal|adrenal
74288|NCT03739918|Incidentaloma|incidentaloma
74289|NCT03739918|Vascular|vascular
74290|NCT03739918|Benign|benign
74291|NCT03739905|Magnetic Resonance guided Focal Ultrasound (MRgFUS)|magnetic resonance guided focal ultrasound (mrgfus)
74292|NCT03739905|Alzheimer's Disease|alzheimer's disease
74293|NCT03739905|ExAblate|exablate
74294|NCT03739905|Blood Brain Barrier|blood brain barrier
74295|NCT03739879|Inspiratory muscle trainer|inspiratory muscle trainer
74296|NCT03739879|Pulmonary rehabilitation|pulmonary rehabilitation
74297|NCT03739879|COPD|copd
74298|NCT03739879|St George Respiratory Questionnaire|st george respiratory questionnaire
74299|NCT03739879|6-minute Walking Test|6-minute walking test
74300|NCT03739840|Epilepsy|epilepsy
74301|NCT03739840|Padsevonil|padsevonil
74305|NCT03739775|HPV positive pelvic cancer|hpv positive pelvic cancer
74306|NCT03739775|Circulating tumor biomarker|circulating tumor biomarker
74408|NCT03739242|Lipids|lipids
74307|NCT03739749|Arthroscopic Superior Capsular Reconstruction|arthroscopic superior capsular reconstruction
74308|NCT03739749|Irreparable rotator cuff tear|irreparable rotator cuff tear
74309|NCT03739749|Allograft|allograft
74310|NCT03739749|Autograft|autograft
74311|NCT03739749|Xenograft|xenograft
74312|NCT03739736|Combination TB/HIV prevention interventions|combination tb/hiv prevention interventions
74313|NCT03739736|Incidence of Tuberculosis|incidence of tuberculosis
74314|NCT03739736|Prevalence of Tuberculosis|prevalence of tuberculosis
74315|NCT03739736|Africa|africa
74316|NCT03739736|Community-based|community-based
74317|NCT03739710|Non-small cell lung cancer|non-small cell lung cancer
74318|NCT03739710|Inducible t-cell co-stimulator (ICOS)|inducible t-cell co-stimulator (icos)
74319|NCT03739710|docetaxel|docetaxel
74320|NCT03739710|Standard of care|standard of care
74321|NCT03739710|Immuno-oncology agents|immuno-oncology agents
74322|NCT03739684|Positron emission tomography|positron emission tomography
74323|NCT03739684|biochemical recurrence|biochemical recurrence
74324|NCT03739684|rising PSA|rising psa
74325|NCT03739684|PET/CT|pet/ct
74326|NCT03739684|Diagnostic|diagnostic
74327|NCT03739684|Imaging|imaging
74328|NCT03739684|PSMA|psma
74329|NCT03739684|radical prostatectomy|radical prostatectomy
74330|NCT03739684|BCR|bcr
74331|NCT03739658|Sports|sports
74332|NCT03739658|Athletic Injuries|athletic injuries
74333|NCT03739658|Exercise|exercise
74334|NCT03739645|fear|fear
74335|NCT03739645|pain|pain
74336|NCT03739645|conditioning|conditioning
74337|NCT03739645|skin conductance response|skin conductance response
74338|NCT03739645|Ratings of Pain and Conditioning|ratings of pain and conditioning
74339|NCT03739645|Intracranial Electrophysiology|intracranial electrophysiology
74340|NCT03739593|Macular Edema|macular edema
74341|NCT03739593|Retinal Vein Occlusion|retinal vein occlusion
74342|NCT03739593|Dexamethasone Intravitreal Implant|dexamethasone intravitreal implant
74343|NCT03739580|drug-coating balloon|drug-coating balloon
74344|NCT03739580|stent|stent
74345|NCT03739580|popliteal artery|popliteal artery
74346|NCT03739580|atherosclerotic occlusion|atherosclerotic occlusion
74347|NCT03739567|General anesthesia, clinical manifestations. .|general anesthesia, clinical manifestations. .
74348|NCT03739554|CYC065|cyc065
74349|NCT03739554|CDK2/9|cdk2/9
74350|NCT03739554|venetoclax|venetoclax
74351|NCT03739554|BCL-2|bcl-2
74352|NCT03739554|MCL-1|mcl-1
74353|NCT03739554|Relapsed|relapsed
74354|NCT03739554|Refractory|refractory
74355|NCT03739554|chronic lymphocytic leukemia|chronic lymphocytic leukemia
74356|NCT03739554|small lymphocytic lymphoma|small lymphocytic lymphoma
74357|NCT03739515|Emergency department|emergency department
74358|NCT03739515|Health and Social Care Professional|health and social care professional
74359|NCT03739515|Team care|team care
74360|NCT03739515|Older patients|older patients
74361|NCT03739515|Effectiveness|effectiveness
74362|NCT03739489|healthy subjects|healthy subjects
74363|NCT03739489|repetitive transcranial magnetic stimulation|repetitive transcranial magnetic stimulation
74364|NCT03739489|heart rate variability|heart rate variability
74365|NCT03739476|Postoperative|postoperative
74366|NCT03739476|Delirium|delirium
74367|NCT03739476|Quetiapine|quetiapine
74368|NCT03739476|Prophylaxis|prophylaxis
74369|NCT03739463|Pro-omega-3|pro-omega-3
74370|NCT03739463|Inflammation|inflammation
74371|NCT03739463|Prematurity|prematurity
74372|NCT03739437|automated|automated
74373|NCT03739437|smoking cessation|smoking cessation
74374|NCT03739437|socioeconomic disadvantage|socioeconomic disadvantage
74375|NCT03739437|contingency management|contingency management
74376|NCT03739437|financial incentives|financial incentives
74377|NCT03739437|mobile health|mobile health
74378|NCT03739437|biochemical verification|biochemical verification
74379|NCT03739424|Bone|bone
74380|NCT03739424|Cognition|cognition
74381|NCT03739424|Egg|egg
74382|NCT03739424|Protein|protein
74383|NCT03739385|Intergenerational|intergenerational
74384|NCT03739385|Exercise|exercise
74385|NCT03739385|Health|health
74386|NCT03739372|High-grade glioma|high-grade glioma
74387|NCT03739372|whole exome sequencing|whole exome sequencing
74388|NCT03739372|WES|wes
74389|NCT03739372|genomics|genomics
74390|NCT03739372|RNA sequencing|rna sequencing
74391|NCT03739359|Nasal cannula|nasal cannula
74392|NCT03739359|Aerosol therapy|aerosol therapy
74393|NCT03739359|Gas flow|gas flow
74394|NCT03739346|Dental anxiety|dental anxiety
74395|NCT03739346|Pain|pain
74396|NCT03739346|Child|child
74397|NCT03739346|Pediatric dentistry|pediatric dentistry
74398|NCT03739346|Hypnosis|hypnosis
74399|NCT03739333|glioblastoma|glioblastoma
74400|NCT03739333|11C-Methionine PET-MRI|11c-methionine pet-mri
74401|NCT03739333|sensitivity|sensitivity
74402|NCT03739333|temozolomide|temozolomide
74403|NCT03739333|radiotherapy|radiotherapy
74404|NCT03739320|severe asthma|severe asthma
74405|NCT03739320|biologic therapy|biologic therapy
74406|NCT03739320|physical activity monitoring|physical activity monitoring
74407|NCT03739268|bile acid|bile acid
74409|NCT03739242|Cholesterol|cholesterol
74410|NCT03739242|Triglycerides|triglycerides
74411|NCT03739242|Dyslipidemia|dyslipidemia
74412|NCT03739242|Low density lipoprotein cholesterol|low density lipoprotein cholesterol
74413|NCT03739242|Dietary Fats|dietary fats
74414|NCT03739242|Hyperlipidemias|hyperlipidemias
74415|NCT03739242|Dietary Supplements|dietary supplements
74416|NCT03739242|Food Supplements|food supplements
74417|NCT03739242|Nutraceuticals|nutraceuticals
74418|NCT03739242|Nutriceuticals|nutriceuticals
74419|NCT03739229|pandemic|pandemic
74420|NCT03739229|influenza|influenza
74421|NCT03739229|vaccine|vaccine
74422|NCT03739229|H7N9|h7n9
74423|NCT03739203|MDD|mdd
74424|NCT03739177|Neoadjuvant Chemotherapy, Muscle Invasive Bladder Cancer|neoadjuvant chemotherapy, muscle invasive bladder cancer
74425|NCT03739151|overweight and obesity|overweight and obesity
74426|NCT03739151|eating behavior|eating behavior
74427|NCT03739151|nonadherence, patient|nonadherence, patient
74428|NCT03739151|ecological momentary assessment|ecological momentary assessment
74429|NCT03739151|passive sensing|passive sensing
74430|NCT03739151|dietary assessment|dietary assessment
74431|NCT03739138|Programmed Death-1 (PD-1, PD1),|programmed death-1 (pd-1, pd1),
74432|NCT03739138|Programmed Death-Ligand 1 (PD-L1, PDL1)|programmed death-ligand 1 (pd-l1, pdl1)
74433|NCT03739099|Type 1 diabetes|type 1 diabetes
74434|NCT03739099|Prepubertal children|prepubertal children
74435|NCT03739099|Closed-loop insulin infusion|closed-loop insulin infusion
74436|NCT03739060|Inguinal hernia|inguinal hernia
74437|NCT03739060|Transcutaneous electric nerve stimulation|transcutaneous electric nerve stimulation
74438|NCT03739060|Postoperative pain|postoperative pain
74439|NCT03739060|Quality of life|quality of life
74440|NCT03739060|Pain threshold|pain threshold
74441|NCT03739060|Algometry|algometry
74442|NCT03739047|Children with feeding disorders|children with feeding disorders
74443|NCT03739021|replacement|replacement
74444|NCT03739021|shoulder|shoulder
74445|NCT03739008|Thunderclap headache|thunderclap headache
74446|NCT03738995|Red cell transfusion|red cell transfusion
74447|NCT03738995|Obstetric transfusion|obstetric transfusion
74448|NCT03738995|anaemia in pregnancy|anaemia in pregnancy
74449|NCT03738956|Axial spondyloarthritis|axial spondyloarthritis
74450|NCT03738943|Adenosine Triphosphate|adenosine triphosphate
74451|NCT03738943|Pyridoxine|pyridoxine
74452|NCT03738943|Cardiovascular|cardiovascular
74453|NCT03738943|PLP|plp
74454|NCT03738943|P5P|p5p
74455|NCT03738930|Acute Coronary Syndrome|acute coronary syndrome
74456|NCT03738930|Percutaneous coronary intervention|percutaneous coronary intervention
74457|NCT03738930|Bleeding|bleeding
74458|NCT03738917|Cough; Dextromethorphan; Ipratropium; Honey.|cough; dextromethorphan; ipratropium; honey.
74459|NCT03738865|glucagon|glucagon
74460|NCT03738865|hypoglycemia|hypoglycemia
74461|NCT03738839|White Spot Lesions|white spot lesions
74462|NCT03738839|Direct Bonding|direct bonding
74463|NCT03738839|Indirect Bonding|indirect bonding
74464|NCT03738839|Quantitative Light-Induced Fluorescence|quantitative light-induced fluorescence
74465|NCT03738826|medication adherence|medication adherence
74466|NCT03738774|Post intensive care syndrome|post intensive care syndrome
74467|NCT03738761|Hypertension|hypertension
74468|NCT03738761|Blood pressure control|blood pressure control
74469|NCT03738761|Fixed-dose combination antihypertensives|fixed-dose combination antihypertensives
74470|NCT03738761|Ambulatory blood pressure monitoring|ambulatory blood pressure monitoring
74471|NCT03738748|Neuromodulation|neuromodulation
74472|NCT03738748|Low back pain|low back pain
74473|NCT03738748|Ultrasound-guied percutaneous|ultrasound-guied percutaneous
74474|NCT03738748|TENS|tens
74475|NCT03738748|Randomized Controlled Trial|randomized controlled trial
74476|NCT03738748|Percutaneous stimulation|percutaneous stimulation
74477|NCT03738709|Prevention|prevention
74478|NCT03738709|Group|group
74479|NCT03738709|Technical assistance|technical assistance
74480|NCT03738709|Fall|fall
74481|NCT03738709|Occupational therapy|occupational therapy
74482|NCT03738709|Hospitalization discharge|hospitalization discharge
74483|NCT03738683|Pharmacokinetics|pharmacokinetics
74484|NCT03738683|Piperacillin-tazobactam|piperacillin-tazobactam
74485|NCT03738683|Renal function|renal function
74486|NCT03738683|Intensive Care Unit|intensive care unit
74487|NCT03738683|Cystatin C|cystatin c
74488|NCT03738670|Pain|pain
74489|NCT03738670|Extra-spinal|extra-spinal
74490|NCT03738670|RFA|rfa
74491|NCT03738670|Radiofrequency ablation|radiofrequency ablation
74492|NCT03738670|Bone metastases|bone metastases
74493|NCT03738644|Endovascular treatment|endovascular treatment
74494|NCT03738644|Near-infrared spectroscopy|near-infrared spectroscopy
74495|NCT03738644|Intra-operational monitoring|intra-operational monitoring
74496|NCT03738592|spatial hearing perception|spatial hearing perception
74497|NCT03738592|cochlear implant|cochlear implant
74499|NCT03738592|virtual reality|virtual reality
74500|NCT03738579|biofilm|biofilm
74501|NCT03738579|EPS matrix|eps matrix
74502|NCT03738579|antimicrobial|antimicrobial
74503|NCT03738540|Weight loss|weight loss
74504|NCT03738540|Nutrition|nutrition
74505|NCT03738540|Exercise|exercise
74512|NCT03738514|Visual Analogue Score|visual analogue score
74514|NCT03738501|Chest physiotherapy|chest physiotherapy
74515|NCT03738501|Sleep|sleep
74516|NCT03738501|Respiratory Distress|respiratory distress
74517|NCT03738436|Visual feedback|visual feedback
74518|NCT03738436|Proprioception|proprioception
74519|NCT03738423|Moderate|moderate
74520|NCT03738423|Severe|severe
74521|NCT03738410|mHealth|mhealth
74522|NCT03738410|mobile applications|mobile applications
74523|NCT03738410|culturally-competent|culturally-competent
74524|NCT03738410|HIV stigma|hiv stigma
74525|NCT03738410|Resilience|resilience
74526|NCT03738397|Upadacitinib|upadacitinib
74527|NCT03738397|ABT-494|abt-494
74528|NCT03738397|Dupilumab|dupilumab
74529|NCT03738397|Atopic Dermatitis|atopic dermatitis
74530|NCT03738384|Rehabilitation, Visual, Feedback|rehabilitation, visual, feedback
74531|NCT03738345|High flow nasal cannula|high flow nasal cannula
74532|NCT03738345|Hypoxemia|hypoxemia
74533|NCT03738345|Flow setting|flow setting
74534|NCT03738293|Steroid|steroid
74535|NCT03738293|Corticosteroid|corticosteroid
74536|NCT03738293|Betamethasone|betamethasone
74537|NCT03738293|Preterm Birth|preterm birth
74546|NCT03738215|MDD|mdd
74547|NCT03738202|Randomized controlled trial|randomized controlled trial
74548|NCT03738202|Textile industry|textile industry
74549|NCT03738202|Cotton fiber|cotton fiber
74550|NCT03738202|Byssinosis|byssinosis
74551|NCT03738189|Dental Prosthesis Designs|dental prosthesis designs
74552|NCT03738189|Dentures|dentures
74553|NCT03738189|Denture Design|denture design
74554|NCT03738189|Denture, Complete, Upper|denture, complete, upper
74555|NCT03738189|Technology, Dental|technology, dental
74556|NCT03738189|Aesthetics, Dental|aesthetics, dental
74557|NCT03738176|Oral lichen planus|oral lichen planus
74558|NCT03738176|sesame oil|sesame oil
74559|NCT03738176|corticosteroid|corticosteroid
74560|NCT03738176|MDA|mda
74561|NCT03738150|PAH|pah
74562|NCT03738137|Narcotrend|narcotrend
74563|NCT03738137|Bispectral index|bispectral index
74564|NCT03738137|Bronchoscopy|bronchoscopy
74565|NCT03738137|Conscious Sedation|conscious sedation
74566|NCT03738124|stent graft|stent graft
74567|NCT03738124|branch stent graft|branch stent graft
74568|NCT03738124|thoracic aneurysm|thoracic aneurysm
74569|NCT03738124|endovascular aortic repair|endovascular aortic repair
74570|NCT03738124|aortic dissection|aortic dissection
74571|NCT03738124|Valiant Mona LSA Thoracic Stent Graft System|valiant mona lsa thoracic stent graft system
74572|NCT03738098|Whole Genome Sequencing|whole genome sequencing
74573|NCT03738098|Genetic Counseling|genetic counseling
74574|NCT03738098|Hereditary Childhood Disease|hereditary childhood disease
74575|NCT03738098|Genomic Medicine|genomic medicine
74576|NCT03738085|Complication|complication
74577|NCT03738085|Previous surgery|previous surgery
74578|NCT03738085|Total laparoscopic hysterectomy|total laparoscopic hysterectomy
74579|NCT03738085|Obesity|obesity
74580|NCT03738072|Epilepsy|epilepsy
74581|NCT03738072|Electrical Brain stimulation|electrical brain stimulation
74582|NCT03738072|Neurosurgery|neurosurgery
74583|NCT03738072|stereo-electro-encephalography (SEEG)|stereo-electro-encephalography (seeg)
74584|NCT03738059|Skull Pin Insertion|skull pin insertion
74585|NCT03738059|Dexmedetomidine|dexmedetomidine
74586|NCT03738059|Hemodynamic Responses|hemodynamic responses
74587|NCT03738033|emergency medicine ,emergency ultrasound|emergency medicine ,emergency ultrasound
74588|NCT03737968|oral cavity|oral cavity
74589|NCT03737968|hypopharynx|hypopharynx
74590|NCT03737968|oropharynx|oropharynx
74591|NCT03737968|larynx|larynx
74592|NCT03737968|medi4736|medi4736
74593|NCT03737968|tremelimumab|tremelimumab
74594|NCT03737942|diabetes mellitus|diabetes mellitus
74595|NCT03737942|Neuromuscular Transmission|neuromuscular transmission
74596|NCT03737929|Epicardial surgical ablation|epicardial surgical ablation
74597|NCT03737929|Percutaneous endocardial catheter ablation|percutaneous endocardial catheter ablation
74598|NCT03737903|Frail elderly|frail elderly
74599|NCT03737903|Accelerometer|accelerometer
74600|NCT03737903|Preoperative assessment|preoperative assessment
74601|NCT03737877|ADHD|adhd
74602|NCT03737877|Diet Modification|diet modification
74603|NCT03737864|transition to substance abuse treatment|transition to substance abuse treatment
74604|NCT03737864|readmission|readmission
74605|NCT03737864|recidivism|recidivism
74606|NCT03737864|patient navigation|patient navigation
74712|NCT03737331|Fractals|fractals
74607|NCT03737851|Relapsing multiple sclerosis|relapsing multiple sclerosis
74608|NCT03737838|Paroxysmal|paroxysmal
74609|NCT03737838|Atrial|atrial
74610|NCT03737838|Fibrillation|fibrillation
74611|NCT03737838|Ventricular|ventricular
74612|NCT03737838|Tachycardia|tachycardia
74614|NCT03737825|Multiple Sclerosis|multiple sclerosis
74615|NCT03737825|Cognitive remediation|cognitive remediation
74616|NCT03737825|Brain training|brain training
74617|NCT03737825|Physical Therapy|physical therapy
74618|NCT03737812|Progressive multiple sclerosis|progressive multiple sclerosis
74619|NCT03737799|Diabetes|diabetes
74620|NCT03737799|C-peptide|c-peptide
74621|NCT03737799|Insulin|insulin
74622|NCT03737799|Classification|classification
74623|NCT03737786|large vessel occlusion|large vessel occlusion
74624|NCT03737786|anesthesia|anesthesia
74625|NCT03737786|thrombectomy|thrombectomy
74626|NCT03737786|acute ischemic stroke|acute ischemic stroke
74627|NCT03737760|walking|walking
74628|NCT03737760|aging|aging
74629|NCT03737760|brain|brain
74630|NCT03737747|Synek score|synek score
74631|NCT03737747|electroencephalography|electroencephalography
74632|NCT03737747|cardiac arrest|cardiac arrest
74633|NCT03737734|Squamous Cell Carcinoma|squamous cell carcinoma
74634|NCT03737734|SCC|scc
74635|NCT03737734|Skin Cancer|skin cancer
74636|NCT03737734|Skin metastasis|skin metastasis
74637|NCT03737734|HNSCC|hnscc
74638|NCT03737734|Carcinoma, Squamous|carcinoma, squamous
74639|NCT03737734|CMN|cmn
74640|NCT03737734|Basal cell carcinoma|basal cell carcinoma
74641|NCT03737734|Superficial sarcoma|superficial sarcoma
74642|NCT03737734|Kaposi sarcoma|kaposi sarcoma
74643|NCT03737734|Alpha radiation|alpha radiation
74644|NCT03737734|Cutaneous lesion|cutaneous lesion
74645|NCT03737734|Tongue cancer|tongue cancer
74646|NCT03737734|Lip cancer|lip cancer
74647|NCT03737708|tacrolimus|tacrolimus
74648|NCT03737708|abatacept|abatacept
74649|NCT03737708|Prograf|prograf
74650|NCT03737708|adalimumab|adalimumab
74651|NCT03737708|methotrexate|methotrexate
74652|NCT03737708|tocilizumab|tocilizumab
74653|NCT03737708|FK506|fk506
74654|NCT03737669|transfusion|transfusion
74655|NCT03737669|pathogen reduction technology|pathogen reduction technology
74656|NCT03737669|Uganda|uganda
74657|NCT03737669|tranfusion transmitted infections|tranfusion transmitted infections
74658|NCT03737669|Mirasol|mirasol
74659|NCT03737669|blood|blood
74660|NCT03737656|Progesterone|progesterone
74661|NCT03737656|Vaginal ring|vaginal ring
74662|NCT03737643|Advanced Ovarian Cancer|advanced ovarian cancer
74663|NCT03737643|Ovarian neoplasms|ovarian neoplasms
74664|NCT03737630|cystic fibrosis|cystic fibrosis
74665|NCT03737630|quality of life|quality of life
74666|NCT03737630|posture|posture
74667|NCT03737617|Replacement therapy|replacement therapy
74668|NCT03737617|Microbiology|microbiology
74669|NCT03737617|Exacerbations|exacerbations
74670|NCT03737617|Bronchiectasis|bronchiectasis
74671|NCT03737617|Immunoglobulin G subclass 2|immunoglobulin g subclass 2
74672|NCT03737604|Transversus Abdominis Plane Block|transversus abdominis plane block
74673|NCT03737604|Ropivacaine|ropivacaine
74674|NCT03737604|Liposomal bupivacaine|liposomal bupivacaine
74675|NCT03737591|Colorectal Cancer|colorectal cancer
74676|NCT03737591|Adenomas|adenomas
74677|NCT03737591|ctDNA Methylation Haplotypes|ctdna methylation haplotypes
74678|NCT03737578|Home hemodialysis|home hemodialysis
74679|NCT03737578|Daily hemodialysis|daily hemodialysis
74680|NCT03737578|Frequent hemodialysis|frequent hemodialysis
74681|NCT03737565|Cobalt-chromium|cobalt-chromium
74682|NCT03737552|Sleep|sleep
74683|NCT03737552|ADHD|adhd
74684|NCT03737552|Children|children
74685|NCT03737552|Cognition|cognition
74686|NCT03737539|Colorectal Cancer|colorectal cancer
74687|NCT03737539|Circulating tumor DNA|circulating tumor dna
74688|NCT03737539|Surveillance|surveillance
74689|NCT03737539|ctDNA Methylation|ctdna methylation
74690|NCT03737526|loop electrosurgical excision procedure|loop electrosurgical excision procedure
74691|NCT03737513|Rhabdomyolysis|rhabdomyolysis
74692|NCT03737513|Military Training|military training
74693|NCT03737487|geriatric assessment|geriatric assessment
74694|NCT03737487|fear of falling|fear of falling
74695|NCT03737487|injuries|injuries
74696|NCT03737461|BM-MSCs|bm-mscs
74697|NCT03737461|Low back pain|low back pain
74698|NCT03737461|Lumbar degenerative disc disease (DDD)|lumbar degenerative disc disease (ddd)
74699|NCT03737396|Preanaesthesia health assessment|preanaesthesia health assessment
74700|NCT03737396|Computerized health assessment|computerized health assessment
74701|NCT03737370|Prostate Cancer|prostate cancer
74702|NCT03737357|dental implants|dental implants
74703|NCT03737357|SLActive® surface|slactive® surface
74704|NCT03737357|biomarkers|biomarkers
74705|NCT03737357|BLT implant|blt implant
74706|NCT03737344|haemorrhage|haemorrhage
74707|NCT03737344|Stroke|stroke
74708|NCT03737344|Bleeding|bleeding
74709|NCT03737331|Visual|visual
74710|NCT03737331|Variability|variability
74711|NCT03737331|Gait|gait
74713|NCT03737331|Rehabilitation|rehabilitation
74714|NCT03737331|Brain|brain
74715|NCT03737318|speech, articulation, motor development|speech, articulation, motor development
74716|NCT03737305|TMJ|tmj
74717|NCT03737305|Disc Displacement|disc displacement
74718|NCT03737305|Temporomandibular Disorders|temporomandibular disorders
74719|NCT03737305|TMJ Distraction Device|tmj distraction device
74720|NCT03737305|TMJ Pain|tmj pain
74721|NCT03737279|Pregnancy|pregnancy
74722|NCT03737279|Meditation|meditation
74723|NCT03737253|gonadotropin|gonadotropin
74724|NCT03737253|receptor|receptor
74725|NCT03737253|assisted reproduction|assisted reproduction
74726|NCT03737240|Type 2 Diabetes|type 2 diabetes
74727|NCT03737227|Lumbar intervertebral motion|lumbar intervertebral motion
74728|NCT03737227|Flexion|flexion
74729|NCT03737227|Extension|extension
74730|NCT03737227|Cinematographic recording|cinematographic recording
74731|NCT03737227|Segmental rotations|segmental rotations
74732|NCT03737227|Segmental translation|segmental translation
74733|NCT03737227|lumbar spine|lumbar spine
74734|NCT03737227|asymptomatic participants|asymptomatic participants
74735|NCT03737201|ozone|ozone
74736|NCT03737201|Deep Carious Lesion|deep carious lesion
74737|NCT03737201|Primary Molars|primary molars
74738|NCT03737149|Knee Replacement|knee replacement
74739|NCT03737149|Knee Arthroplasty|knee arthroplasty
74740|NCT03737149|Hip Replacement|hip replacement
74741|NCT03737149|Hip Arthroplasty|hip arthroplasty
74742|NCT03737149|Joint Replacement|joint replacement
74743|NCT03737149|Physical Therapy|physical therapy
74744|NCT03737149|Partial Knee Replacement|partial knee replacement
74745|NCT03737149|Hip Pain, Chronic|hip pain, chronic
74746|NCT03737149|Knee Pain, Chronic|knee pain, chronic
74747|NCT03737136|transplantation|transplantation
74748|NCT03737136|plasmapheresis|plasmapheresis
74749|NCT03737097|Fall|fall
74750|NCT03737097|Multiple Sclerosis|multiple sclerosis
74751|NCT03737084|hematopoietic stem cell transplant|hematopoietic stem cell transplant
74752|NCT03737084|cancer|cancer
74753|NCT03737084|compassion|compassion
74754|NCT03737084|meditation|meditation
74755|NCT03737084|depression|depression
74756|NCT03737084|anxiety|anxiety
74757|NCT03737084|heart rate variability|heart rate variability
74758|NCT03737084|resilience|resilience
74759|NCT03737045|Decision Aid|decision aid
74760|NCT03737045|Shared Decision-Making|shared decision-making
74761|NCT03736967|Moderate|moderate
74762|NCT03736967|Severe|severe
74763|NCT03736915|hand; injections; pain; syringes; anesthesia, local|hand; injections; pain; syringes; anesthesia, local
74764|NCT03736902|Physical activity|physical activity
74765|NCT03736902|Exercise|exercise
74766|NCT03736902|Relapse|relapse
74767|NCT03736902|Exacerbation|exacerbation
74768|NCT03736902|Attack|attack
74769|NCT03736889|MSI-H/dMMR|msi-h/dmmr
74770|NCT03736889|Solid tumors|solid tumors
74771|NCT03736889|PD-1|pd-1
74772|NCT03736876|Youth|youth
74773|NCT03736876|Adolescents|adolescents
74774|NCT03736876|Teens|teens
74775|NCT03736876|Healthy Relationships|healthy relationships
74776|NCT03736876|Unintended Pregnancy|unintended pregnancy
74777|NCT03736876|Teen Pregnancy|teen pregnancy
74778|NCT03736876|Sexually Transmitted Infections|sexually transmitted infections
74779|NCT03736876|Sexually Transmitted Diseases|sexually transmitted diseases
74780|NCT03736876|Sexual Health Education|sexual health education
74781|NCT03736876|School-Based Health Center|school-based health center
74782|NCT03736876|Randomized Controlled Trial|randomized controlled trial
74783|NCT03736837|sensitive EGFR mutations|sensitive egfr mutations
74784|NCT03736837|anlotinib|anlotinib
74785|NCT03736837|icotinib|icotinib
74786|NCT03736837|first line|first line
74787|NCT03736837|cancer|cancer
74788|NCT03736837|non-squamous NSCLC|non-squamous nsclc
74789|NCT03736759|exercise|exercise
74790|NCT03736759|vaccine|vaccine
74791|NCT03736759|older adults|older adults
74792|NCT03736746|Other Cancer|other cancer
74793|NCT03736733|sedentary time|sedentary time
74794|NCT03736694|Insomnia|insomnia
74795|NCT03736694|Cognitive behavioural therapy for insomnia|cognitive behavioural therapy for insomnia
74796|NCT03736694|Sleep hygiene education|sleep hygiene education
74797|NCT03736642|stool|stool
74798|NCT03736642|constitutional thinness|constitutional thinness
74799|NCT03736629|Asthma|asthma
74800|NCT03736629|Azithromycin|azithromycin
74801|NCT03736629|Microbiome|microbiome
74802|NCT03736629|Sputum|sputum
74803|NCT03736564|FGF 23|fgf 23
74804|NCT03736564|oncogenic|oncogenic
74805|NCT03736564|tumor induced|tumor induced
74806|NCT03736551|intermittent fasting|intermittent fasting
74807|NCT03736551|weight loss|weight loss
74808|NCT03736538|Nitrous Oxide|nitrous oxide
74809|NCT03736538|Anesthetics|anesthetics
74810|NCT03736525|Wellness|wellness
74811|NCT03736525|Home environment|home environment
74812|NCT03736525|Design|design
74813|NCT03736525|Online intervention|online intervention
74814|NCT03736525|Randomized Controlled Trail (RCT)|randomized controlled trail (rct)
74815|NCT03736525|Nudge theory|nudge theory
74816|NCT03736525|Mothers|mothers
74817|NCT03736486|Type 2 diabetes|type 2 diabetes
74818|NCT03736486|Cardio-metabolic disease|cardio-metabolic disease
74819|NCT03736486|Latino|latino
74820|NCT03736486|Hispanic|hispanic
74821|NCT03736486|Especialista|especialista
74822|NCT03736447|CODIT™ (characterized oral desensitization immunotherapy™)|codit™ (characterized oral desensitization immunotherapy™)
74823|NCT03736447|Peanut-Allergic Children|peanut-allergic children
74824|NCT03736447|CPNA (Characterized Peanut Allergen)|cpna (characterized peanut allergen)
74825|NCT03736447|Desensitization|desensitization
74826|NCT03736447|AR101|ar101
74827|NCT03736447|Allergy|allergy
74828|NCT03736447|Peanut Allergy|peanut allergy
74829|NCT03736447|Characterized Peanut Allergen|characterized peanut allergen
74830|NCT03736447|Oral Immunotherapy|oral immunotherapy
74831|NCT03736434|Mindfulness|mindfulness
74832|NCT03736434|Blood pressure|blood pressure
74833|NCT03736434|Hypertension|hypertension
74834|NCT03736434|Mild Cognitive impairment (MCI)|mild cognitive impairment (mci)
74835|NCT03736434|functional Magnetic resonance Imaging (fMRI)|functional magnetic resonance imaging (fmri)
74836|NCT03736434|Hair cortisol|hair cortisol
74837|NCT03736408|temporomandibular joint dysfunction|temporomandibular joint dysfunction
74838|NCT03736408|pain form|pain form
74839|NCT03736408|treatment|treatment
74840|NCT03736408|epidemiologcal assessment|epidemiologcal assessment
74841|NCT03736395|Behavioral Symptoms|behavioral symptoms
74842|NCT03736395|Disruptive Behavior|disruptive behavior
74843|NCT03736395|Schools|schools
74844|NCT03736395|School Teachers|school teachers
74845|NCT03736382|Mild Intermittent hypoxia|mild intermittent hypoxia
74846|NCT03736382|Continuous positive airway pressure therapy|continuous positive airway pressure therapy
74847|NCT03736356|Aeromedical Evacuation|aeromedical evacuation
74848|NCT03736356|Combat Injury|combat injury
74849|NCT03736343|impulsivity|impulsivity
74850|NCT03736343|family history|family history
74851|NCT03736343|heavy drinking|heavy drinking
74852|NCT03736343|blood alcohol content (BAC)|blood alcohol content (bac)
74853|NCT03736343|breath alcohol content (BrAC)|breath alcohol content (brac)
74854|NCT03736330|Ranal Carcinoma|ranal carcinoma
74855|NCT03736330|Immunotherapy|immunotherapy
74856|NCT03736330|Axitinib|axitinib
74857|NCT03736317|Amphetamine-type stimulants|amphetamine-type stimulants
74858|NCT03736317|prefrontal-striatal circuits|prefrontal-striatal circuits
74859|NCT03736317|rTMS|rtms
74860|NCT03736317|individualized therapy|individualized therapy
74861|NCT03736317|craving|craving
74862|NCT03736317|relapse|relapse
74863|NCT03736265|Portal Hypertension|portal hypertension
74864|NCT03736265|Esophageal varices|esophageal varices
74865|NCT03736265|Carvedilol|carvedilol
74866|NCT03736252|Orthosis|orthosis
74867|NCT03736252|Pain|pain
74868|NCT03736252|Function|function
74869|NCT03736239|ECMO|ecmo
74870|NCT03736239|Intensive Care Units|intensive care units
74871|NCT03736239|Shock, Cardiogenic|shock, cardiogenic
74872|NCT03736239|Ventilator Weaning|ventilator weaning
74873|NCT03736239|Diaphragm|diaphragm
74874|NCT03736239|Ultrasonography|ultrasonography
74875|NCT03736213|speech|speech
74876|NCT03736213|articulation|articulation
74877|NCT03736213|motor development|motor development
74878|NCT03736200|balance|balance
74879|NCT03736200|movement|movement
74880|NCT03736200|exergaming|exergaming
74881|NCT03736200|posture|posture
74882|NCT03736200|quality of life|quality of life
74883|NCT03736200|gait|gait
74884|NCT03736174|CECS|cecs
74885|NCT03736161|PsA|psa
74886|NCT03736148|manipulation|manipulation
74887|NCT03736148|electromyography|electromyography
74888|NCT03736148|sympathetic nervous system|sympathetic nervous system
74889|NCT03736135|Cortisol|cortisol
74890|NCT03736135|Post-ICU syndrome|post-icu syndrome
74891|NCT03736135|Cognitive impairment|cognitive impairment
74892|NCT03736135|Anxiety and depressive symptoms|anxiety and depressive symptoms
74893|NCT03736135|Mechanical ventilated patients|mechanical ventilated patients
74894|NCT03736109|Copper-Albumin Complex|copper-albumin complex
74895|NCT03736109|Osteoarthritis|osteoarthritis
74896|NCT03736109|Syndecan 4|syndecan 4
74897|NCT03736109|Substance P|substance p
74898|NCT03736109|hyaluronic acid|hyaluronic acid
74899|NCT03736109|Insulin like growth factor|insulin like growth factor
74900|NCT03736109|Nitric oxide|nitric oxide
74901|NCT03736096|cystic fibrosis|cystic fibrosis
74902|NCT03736096|sputum|sputum
74903|NCT03736096|nasopharyngeal swab|nasopharyngeal swab
74904|NCT03736096|viral molecular diagnosis|viral molecular diagnosis
74905|NCT03736096|respiratory infection|respiratory infection
74906|NCT03736096|expectoration|expectoration
74907|NCT03736083|glucose monitoring|glucose monitoring
74908|NCT03736083|glycemic control|glycemic control
74909|NCT03736044|Rheumatoid arthritis|rheumatoid arthritis
74910|NCT03736044|Remission|remission
74911|NCT03736044|T regulatory lymphocytes|t regulatory lymphocytes
74912|NCT03736044|Tumor Necrosis Factor-blocker therapy|tumor necrosis factor-blocker therapy
74913|NCT03736031|cancer|cancer
74914|NCT03736018|Coronary Artery Bypass Grafts|coronary artery bypass grafts
74915|NCT03736018|Computed Tomography Cardiac Angiography|computed tomography cardiac angiography
74916|NCT03736018|Invasive Coronary Angiogram|invasive coronary angiogram
74917|NCT03735992|Hematologic Neoplasms|hematologic neoplasms
74918|NCT03735992|Supportive Therapy|supportive therapy
74919|NCT03735992|Fatigue|fatigue
74920|NCT03735992|Mind-body medicine|mind-body medicine
74921|NCT03735992|Complementary and alternative medicine|complementary and alternative medicine
74922|NCT03735940|Electroencephalography|electroencephalography
74923|NCT03735940|Intensive Care|intensive care
74924|NCT03735940|Brain disease|brain disease
74925|NCT03735940|Confusion|confusion
74926|NCT03735940|Neurobehavioral Manifestations|neurobehavioral manifestations
74927|NCT03735940|Nervous System Diseases|nervous system diseases
74928|NCT03735940|Signs and Symptoms|signs and symptoms
74929|NCT03735940|Neurocognitive Disorders|neurocognitive disorders
74930|NCT03735940|Mental Disorders|mental disorders
74931|NCT03735927|Electroencephalography|electroencephalography
74932|NCT03735927|Brain diseases|brain diseases
74933|NCT03735927|Confusion|confusion
74934|NCT03735927|Neurobehavioral Manifestations|neurobehavioral manifestations
74935|NCT03735927|Nervous System Diseases|nervous system diseases
74936|NCT03735927|Signs and Symptoms|signs and symptoms
74937|NCT03735927|Neurocognitive Disorders|neurocognitive disorders
74938|NCT03735927|Mental Disorders|mental disorders
74939|NCT03735901|Levodopa/ Carbidopa|levodopa/ carbidopa
74940|NCT03735901|Fugl-Meyer-Motor-Assessment (FMMA)|fugl-meyer-motor-assessment (fmma)
74941|NCT03735823|IL-11 T cell migration|il-11 t cell migration
74942|NCT03735771|Epidural|epidural
74943|NCT03735771|Labor analgesia|labor analgesia
74944|NCT03735771|Programmed intermittent epidural bolus|programmed intermittent epidural bolus
74945|NCT03735758|in-label prescription|in-label prescription
74946|NCT03735758|Quality of Life|quality of life
74947|NCT03735758|pazopanib|pazopanib
74948|NCT03735758|chemotherapy|chemotherapy
74949|NCT03735719|soluble ST2|soluble st2
74950|NCT03735719|galectin-3|galectin-3
74951|NCT03735719|prognosis|prognosis
74952|NCT03735719|STEMI|stemi
74953|NCT03735719|primary PCI|primary pci
74954|NCT03735706|Radiation|radiation
74955|NCT03735706|Contrast media|contrast media
74956|NCT03735706|Liver|liver
74957|NCT03735706|Body Weight|body weight
74958|NCT03735693|ultrasound|ultrasound
74959|NCT03735693|intensive care|intensive care
74960|NCT03735641|Expanded Pedicled Deltopectoral Flap|expanded pedicled deltopectoral flap
74961|NCT03735641|skin color|skin color
74962|NCT03735641|Sensory recovery|sensory recovery
74963|NCT03735615|Exercise therapy|exercise therapy
74964|NCT03735615|High-Intensity Interval Training|high-intensity interval training
74965|NCT03735576|Late-life depression|late-life depression
74966|NCT03735576|Psychotherapy|psychotherapy
74967|NCT03735576|Major depression|major depression
74968|NCT03735576|Randomized controlled trial|randomized controlled trial
74969|NCT03735576|Treatment|treatment
74970|NCT03735563|less invasive surfactant administration|less invasive surfactant administration
74971|NCT03735563|premedication|premedication
74972|NCT03735550|breast cancer|breast cancer
74973|NCT03735550|contact thermography|contact thermography
74974|NCT03735550|thermography|thermography
74975|NCT03735550|liquid crystal contact thermography|liquid crystal contact thermography
74976|NCT03735550|efficacy|efficacy
74977|NCT03735550|breast neoplasm|breast neoplasm
74978|NCT03735537|Fracture|fracture
74979|NCT03735537|Teriparatide|teriparatide
74980|NCT03735524|exercise, synaptopathy, inflammation|exercise, synaptopathy, inflammation
74981|NCT03735498|Malignant Gliomas|malignant gliomas
74982|NCT03735485|proprioceptive neuromuscular facilitation|proprioceptive neuromuscular facilitation
74983|NCT03735485|functionality|functionality
74984|NCT03735485|mobilization|mobilization
74985|NCT03735485|pnf|pnf
74986|NCT03735459|Treatment adherence and compliance|treatment adherence and compliance
74987|NCT03735446|Acute Myeloid Leukemia|acute myeloid leukemia
74988|NCT03735446|Myelodysplastic Syndromes|myelodysplastic syndromes
74989|NCT03735446|AML|aml
74990|NCT03735446|MDS|mds
74991|NCT03735446|CHK1|chk1
74992|NCT03735446|MEC|mec
74993|NCT03735446|Prexasertib|prexasertib
74994|NCT03735433|aspirin|aspirin
74995|NCT03735433|obesity|obesity
74996|NCT03735420|xanthohumol|xanthohumol
74997|NCT03735420|gut microbiome|gut microbiome
74998|NCT03735420|inflammation|inflammation
74999|NCT03735394|Gingival thickness|gingival thickness
75000|NCT03735394|gingival biotype|gingival biotype
75001|NCT03735394|gingival recession|gingival recession
75002|NCT03735394|maxilla|maxilla
75003|NCT03735394|mandible|mandible
75004|NCT03735381|Pedometer watch, walking, pregnancy, insomnia|pedometer watch, walking, pregnancy, insomnia
75005|NCT03735342|Hospital discharge|hospital discharge
75006|NCT03735342|Audio-recording|audio-recording
75007|NCT03735342|Cardiology|cardiology
75008|NCT03735342|Provider-patient communication|provider-patient communication
75009|NCT03735316|Vitamin B12a|vitamin b12a
75010|NCT03735316|Hypotension|hypotension
75011|NCT03735316|Cardiopulmonary Bypass|cardiopulmonary bypass
75012|NCT03735303|vitamin D3|vitamin d3
75028|NCT03735251|Left Ventricular Diastoic Dysfunction Cohort study|left ventricular diastoic dysfunction cohort study
75029|NCT03735238|lupus|lupus
75030|NCT03735238|decision making|decision making
75031|NCT03735238|implementation|implementation
75032|NCT03735238|SLE|sle
75033|NCT03735238|decision-aid|decision-aid
75034|NCT03735238|decision conflict|decision conflict
75035|NCT03735199|3D Printed Scaffold Device|3d printed scaffold device
75036|NCT03735186|Coronary heart disease|coronary heart disease
75037|NCT03735186|Exercise|exercise
75038|NCT03735186|Inflammation|inflammation
75039|NCT03735186|Postprandial lipaemia|postprandial lipaemia
75040|NCT03735186|Smoking|smoking
75041|NCT03735160|Nasotracheal intubation|nasotracheal intubation
75042|NCT03735160|nasal alar injury|nasal alar injury
75043|NCT03735069|Vital pulp therapy|vital pulp therapy
75044|NCT03735069|Indirect pulp treatment|indirect pulp treatment
75045|NCT03735069|Partial (Cvek) pulpotomy|partial (cvek) pulpotomy
75046|NCT03735069|Complete (cervical) pulpotomy|complete (cervical) pulpotomy
75047|NCT03735069|Enamel hypomineralization defects|enamel hypomineralization defects
75048|NCT03735069|Molar incisor hypomineralization|molar incisor hypomineralization
75049|NCT03735069|Children|children
75050|NCT03735056|Diagnosis|diagnosis
75051|NCT03735056|Emotional support|emotional support
75052|NCT03735056|Peer support|peer support
75053|NCT03735043|Pregnancy|pregnancy
75054|NCT03735043|ccNexfin©|ccnexfin©
75055|NCT03735043|cardiac output|cardiac output
75056|NCT03735043|hemodynamic|hemodynamic
75057|NCT03735043|non-invasive monitoring|non-invasive monitoring
75058|NCT03735017|Virtual Reality|virtual reality
75059|NCT03735004|electrical stimulation|electrical stimulation
75060|NCT03735004|electric anesthesia|electric anesthesia
75061|NCT03734978|Blood group|blood group
75062|NCT03734978|sepsis|sepsis
75063|NCT03734978|preterms|preterms
75064|NCT03734965|aweken intubation|aweken intubation
75065|NCT03734965|fiberoptic|fiberoptic
75066|NCT03734965|videolaryngoscopy|videolaryngoscopy
75067|NCT03734939|cardiovascular risk factor|cardiovascular risk factor
75068|NCT03734939|Slums|slums
75069|NCT03734939|survey|survey
75070|NCT03734939|cardiovascular disease|cardiovascular disease
75071|NCT03734861|Asthma|asthma
75072|NCT03734848|Pectoralis block|pectoralis block
75073|NCT03734848|Opioids Consumption|opioids consumption
75074|NCT03734848|off-pump|off-pump
75075|NCT03734796|High-sensitive cardiac troponin|high-sensitive cardiac troponin
75076|NCT03734796|Non-ST-elevation Myocardial Infarction (NSTEMI)|non-st-elevation myocardial infarction (nstemi)
75077|NCT03734796|Chinese|chinese
75078|NCT03734796|Acute chest pain|acute chest pain
75079|NCT03734783|chronic hepatitis B|chronic hepatitis b
75080|NCT03734783|regulating B cells|regulating b cells
75081|NCT03734783|T help 17 cells|t help 17 cells
75082|NCT03734783|Interleukin 35|interleukin 35
75083|NCT03734770|progesterone|progesterone
75084|NCT03734770|subcutaneous|subcutaneous
75085|NCT03734770|vaginal|vaginal
75086|NCT03734770|luteal phase support|luteal phase support
75087|NCT03734770|in vitro fertilization|in vitro fertilization
75088|NCT03734757|prostate cancer|prostate cancer
75089|NCT03734757|Imaging|imaging
75090|NCT03734757|trimodality|trimodality
75091|NCT03734744|Pharmacokinetics|pharmacokinetics
75092|NCT03734744|Pharmacodynamics|pharmacodynamics
75093|NCT03734718|Gastric Inhibitory Polypeptide|gastric inhibitory polypeptide
75094|NCT03734718|Diabetes Mellitus, Type 1|diabetes mellitus, type 1
75095|NCT03734718|Hypoglycemia|hypoglycemia
75096|NCT03734718|Glucose Metabolism Disorders|glucose metabolism disorders
75097|NCT03734718|Metabolic Diseases|metabolic diseases
75098|NCT03734718|Endocrine System Diseases|endocrine system diseases
75099|NCT03734718|Glucagon|glucagon
75100|NCT03734718|Incretin|incretin
75101|NCT03734705|hoarding disorder|hoarding disorder
75102|NCT03734705|intolerance of uncertainty|intolerance of uncertainty
75103|NCT03734705|experiential avoidance|experiential avoidance
75104|NCT03734705|imaginal exposure|imaginal exposure
75105|NCT03734705|clutter|clutter
75106|NCT03734705|attachment|attachment
75107|NCT03734666|alcohol drinking|alcohol drinking
75108|NCT03734666|quit smoking|quit smoking
75109|NCT03734653|Square Wave Testosterone Therapy|square wave testosterone therapy
75110|NCT03734653|Androgen Deprivation Therapy|androgen deprivation therapy
75210|NCT03734016|SLL|sll
75111|NCT03734653|Transdermal Testosterone|transdermal testosterone
75112|NCT03734653|Feasibility Study|feasibility study
75113|NCT03734627|Gut hormones|gut hormones
75114|NCT03734627|GLP-1|glp-1
75115|NCT03734627|Enteroendocrine L-cell|enteroendocrine l-cell
75116|NCT03734627|Early satiety|early satiety
75117|NCT03734627|Dumping syndrome|dumping syndrome
75118|NCT03734627|Gastrointestinal transit|gastrointestinal transit
75119|NCT03734627|Insulin|insulin
75120|NCT03734627|Octreotide|octreotide
75121|NCT03734627|Somatostatin|somatostatin
75122|NCT03734627|Esophagectomy|esophagectomy
75123|NCT03734614|asprin|asprin
75124|NCT03734614|locally advanced|locally advanced
75125|NCT03734614|renal cell carcinoma|renal cell carcinoma
75126|NCT03734614|adjuvant therapy|adjuvant therapy
75127|NCT03734562|Ventricular tachycardia|ventricular tachycardia
75128|NCT03734562|Ischemic cardiomyopathy|ischemic cardiomyopathy
75129|NCT03734562|Catheter Ablation|catheter ablation
75130|NCT03734562|Antiarrhythmic drug therapy|antiarrhythmic drug therapy
75131|NCT03734562|ICD|icd
75132|NCT03734536|REGENETEN|regeneten
75133|NCT03734536|REGENETEN Bioinductive Implant|regeneten bioinductive implant
75134|NCT03734536|highgrade partial thickness tear|highgrade partial thickness tear
75135|NCT03734536|rotator cuff tear|rotator cuff tear
75136|NCT03734536|rotator cuff repair|rotator cuff repair
75137|NCT03734484|Dascena|dascena
75138|NCT03734484|Gram infection|gram infection
75139|NCT03734484|antibiotic administration|antibiotic administration
75140|NCT03734484|machine learning|machine learning
75141|NCT03734484|algorithm|algorithm
75142|NCT03734484|diagnostic|diagnostic
75143|NCT03734445|Diabetes Mellitus type 2|diabetes mellitus type 2
75144|NCT03734445|Vitamin C|vitamin c
75145|NCT03734445|Vitamin D|vitamin d
75146|NCT03734445|Cinc|cinc
75147|NCT03734432|Diagnostic, Imaging, MRI|diagnostic, imaging, mri
75148|NCT03734419|epiaging|epiaging
75149|NCT03734419|biological age|biological age
75150|NCT03734419|chronological age|chronological age
75151|NCT03734419|DNA methylation|dna methylation
75152|NCT03734419|ELOVL2-AS1|elovl2-as1
75153|NCT03734419|ELOVL2|elovl2
75154|NCT03734380|Gait retraining|gait retraining
75155|NCT03734380|Knee adduction moment|knee adduction moment
75156|NCT03734380|Wearable technology|wearable technology
75157|NCT03734380|Knee osteoarthritis|knee osteoarthritis
75158|NCT03734367|Emotional Intelligence|emotional intelligence
75159|NCT03734367|HbA1c|hba1c
75160|NCT03734367|Healthy habits|healthy habits
821480|NCT00151008|psoriasis|psoriasis
75161|NCT03734367|Type 1 Diabetes Mellitus|type 1 diabetes mellitus
75162|NCT03734341|CPAP|cpap
75163|NCT03734341|Titration|titration
75164|NCT03734341|Obstructive Sleep Apnea|obstructive sleep apnea
75165|NCT03734341|Telemonitoring|telemonitoring
75166|NCT03734341|Telemedicine|telemedicine
75167|NCT03734328|connective tissue graft|connective tissue graft
75168|NCT03734328|platelet rich fibrin|platelet rich fibrin
75169|NCT03734328|patient perceptions|patient perceptions
75170|NCT03734328|VAS|vas
75171|NCT03734250|Sugammadex|sugammadex
75172|NCT03734250|Neostigmine|neostigmine
75173|NCT03734250|Anesthesia|anesthesia
75174|NCT03734250|Neuromuscular blockers|neuromuscular blockers
75175|NCT03734250|Reverse time|reverse time
75176|NCT03734250|Vitamin D|vitamin d
75177|NCT03734237|Influenza vaccine|influenza vaccine
75178|NCT03734211|Evolocumab|evolocumab
75179|NCT03734211|Heart Transplantation|heart transplantation
75180|NCT03734211|Vasculopathy|vasculopathy
75181|NCT03734198|p53 dysfunction|p53 dysfunction
75182|NCT03734185|Cardiac Rehabilitation|cardiac rehabilitation
75183|NCT03734172|Tuberculosis|tuberculosis
75184|NCT03734172|Paediatrics|paediatrics
75185|NCT03734172|Diagnostics|diagnostics
75186|NCT03734159|Regional Anesthesia|regional anesthesia
75187|NCT03734159|Sternotomy|sternotomy
75188|NCT03734120|Cryo preservation|cryo preservation
75189|NCT03734120|Spermatic nuclear quality|spermatic nuclear quality
75190|NCT03734107|transition to adult medical care|transition to adult medical care
75191|NCT03734107|adolescents and young adults|adolescents and young adults
75192|NCT03734107|health communication|health communication
75193|NCT03734107|adherence|adherence
75194|NCT03734107|type 1 diabetes|type 1 diabetes
75195|NCT03734068|Hepatocellular carcinoma|hepatocellular carcinoma
75196|NCT03734068|Transarterial chemoembolization|transarterial chemoembolization
75197|NCT03734068|Tumor response|tumor response
75198|NCT03734068|Lifepearls|lifepearls
75199|NCT03734042|Platelet rich plasma|platelet rich plasma
75200|NCT03734042|Intrauterine infusion|intrauterine infusion
75201|NCT03734042|Thawed embryos|thawed embryos
75202|NCT03734042|IVF/ICSI cycles|ivf/icsi cycles
75203|NCT03734029|Anti-HER2-Antibody Drug Conjugate (ADC)|anti-her2-antibody drug conjugate (adc)
75204|NCT03734029|Unresectable or Metastatic|unresectable or metastatic
75205|NCT03734029|Human epidermal growth factor receptor 2 (HER2)-low|human epidermal growth factor receptor 2 (her2)-low
75206|NCT03734029|DESTINY - Breast 04|destiny - breast 04
75207|NCT03734016|Chronic Lymphocytic Leukemia|chronic lymphocytic leukemia
75208|NCT03734016|Small Lymphocytic Lymphoma|small lymphocytic lymphoma
75209|NCT03734016|CLL|cll
75211|NCT03734016|relapsed|relapsed
75212|NCT03734016|refractory|refractory
75213|NCT03734003|hyperthermia|hyperthermia
75214|NCT03734003|human papilloma virus|human papilloma virus
75215|NCT03734003|cutaneous warts|cutaneous warts
75216|NCT03733977|Family|family
75217|NCT03733977|Intensive Care Unit|intensive care unit
75218|NCT03733977|Quality Of Care|quality of care
75219|NCT03733977|Satisfaction|satisfaction
75220|NCT03733964|manual therapy|manual therapy
75221|NCT03733964|kinesiotherapy|kinesiotherapy
75222|NCT03733964|pnf|pnf
75223|NCT03733964|back pain|back pain
75224|NCT03733938|rarifaction|rarifaction
75225|NCT03733938|root end filling|root end filling
75226|NCT03733938|bioceramic|bioceramic
75227|NCT03733938|outcome|outcome
75228|NCT03733873|nocturnal enuresischildren|nocturnal enuresischildren
75229|NCT03733873|Chinsese medicine|chinsese medicine
75230|NCT03733873|children|children
75231|NCT03733873|relapse rate|relapse rate
75232|NCT03733860|erectile dysfunction|erectile dysfunction
75233|NCT03733860|penile tumescence|penile tumescence
75234|NCT03733860|cavernous tissue|cavernous tissue
75235|NCT03733821|rTMS|rtms
75236|NCT03733808|rTMS|rtms
75237|NCT03733743|Circadian Rhythm|circadian rhythm
75238|NCT03733691|Multiple Myeloma|multiple myeloma
75239|NCT03733691|Front-line|front-line
75240|NCT03733691|Maintenance therapy|maintenance therapy
75241|NCT03733678|adolescent sexual and reproductive health, maternal mortality, teen pregnancy, LARCs, family planning counseling|adolescent sexual and reproductive health, maternal mortality, teen pregnancy, larcs, family planning counseling
75242|NCT03733665|Hospital Episode Statistics|hospital episode statistics
75243|NCT03733665|HES|hes
75244|NCT03733665|National Institute for Cardiovascular Outcomes Research|national institute for cardiovascular outcomes research
75245|NCT03733665|NICOR|nicor
75246|NCT03733665|National Heart Failure Audit|national heart failure audit
75247|NCT03733652|Chronic Hepatitis B|chronic hepatitis b
75248|NCT03733652|entecavir|entecavir
75249|NCT03733613|Kinect|kinect
75250|NCT03733613|somatosensory detector|somatosensory detector
75251|NCT03733613|physical fitness|physical fitness
75252|NCT03733613|gait analysis|gait analysis
75253|NCT03733574|Depressive Disorder, Major|depressive disorder, major
75254|NCT03733574|Depressive Disorder|depressive disorder
75255|NCT03733574|Mood Disorders|mood disorders
75256|NCT03733574|Mental Disorders|mental disorders
75257|NCT03733574|Desvenlafaxine Succinate|desvenlafaxine succinate
75258|NCT03733574|Serotonin and Noradrenaline Reuptake Inhibitors|serotonin and noradrenaline reuptake inhibitors
75259|NCT03733574|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors
75260|NCT03733574|Membrane Transport Modulators|membrane transport modulators
75261|NCT03733574|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action
75262|NCT03733574|Neurotransmitter Agents|neurotransmitter agents
75263|NCT03733574|Physiological Effects of Drugs|physiological effects of drugs
75264|NCT03733574|Antidepressive Agents|antidepressive agents
75265|NCT03733574|Psychotropic Drugs|psychotropic drugs
75266|NCT03733535|Benralizumab|benralizumab
75267|NCT03733535|Xenon|xenon
75268|NCT03733496|PD|pd
75269|NCT03733496|Parkinson's Disease|parkinson's disease
75270|NCT03733496|Aromatic L-Amino Acid Decarboxylase|aromatic l-amino acid decarboxylase
75271|NCT03733496|AADC|aadc
75272|NCT03733496|AAV2|aav2
75273|NCT03733496|AAV2-AADC|aav2-aadc
75274|NCT03733496|VY-AADC|vy-aadc
75275|NCT03733483|Bone|bone
75276|NCT03733483|Sleep Restriction|sleep restriction
75277|NCT03733431|vagal nerve stimulation|vagal nerve stimulation
75278|NCT03733418|vitamin D|vitamin d
75279|NCT03733418|cognitive decline|cognitive decline
75280|NCT03733418|dementia|dementia
75281|NCT03733418|critical care|critical care
75282|NCT03733405|Breastfeeding|breastfeeding
75283|NCT03733405|Contraception|contraception
75284|NCT03733405|Emergency|emergency
75285|NCT03733405|Department|department
75286|NCT03733379|Periodontitis|periodontitis
75287|NCT03733379|Probiotic|probiotic
75288|NCT03733379|Metronidazole|metronidazole
75289|NCT03733379|Amoxicillin|amoxicillin
75290|NCT03733379|Scaling and root planing|scaling and root planing
75291|NCT03733379|Periodontal treatment|periodontal treatment
75292|NCT03733366|desk surface|desk surface
75293|NCT03733366|thermal comfort|thermal comfort
75294|NCT03733366|ergonomics|ergonomics
75295|NCT03733366|attention|attention
75296|NCT03733314|Crohn's Disease|crohn's disease
75297|NCT03733314|E6011|e6011
75298|NCT03733314|Inflammatory Bowel Diseases|inflammatory bowel diseases
75299|NCT03733314|Gastroenteritis|gastroenteritis
75300|NCT03733314|Gastrointestinal tract|gastrointestinal tract
75301|NCT03733301|eczema|eczema
75302|NCT03733301|atopic eczema|atopic eczema
75303|NCT03733288|Intervention|intervention
75304|NCT03733288|Workplace|workplace
75305|NCT03733288|Sedentary behaviour|sedentary behaviour
75306|NCT03733288|Physical activity|physical activity
75307|NCT03733288|Adults|adults
75308|NCT03733288|Economic|economic
75309|NCT03733288|Evaluation|evaluation
75310|NCT03733262|deprescribing|deprescribing
75320|NCT03733249|Long term follow up|long term follow up
75321|NCT03733249|Gene-modified cells|gene-modified cells
75323|NCT03733249|AML|aml
75324|NCT03733249|hematologic neoplasms|hematologic neoplasms
75325|NCT03733249|hematologic malignancies|hematologic malignancies
75326|NCT03733249|anemia|anemia
75327|NCT03733249|congenital cytopenia|congenital cytopenia
75328|NCT03733249|primary immune deficiencies|primary immune deficiencies
75329|NCT03733249|hemoglobinopathy|hemoglobinopathy
75330|NCT03733236|Ischemic Stroke|ischemic stroke
75331|NCT03733236|Treatment|treatment
75332|NCT03733236|ISS|iss
75333|NCT03733236|ImpACT|impact
75334|NCT03733236|clinical trial|clinical trial
75335|NCT03733223|t-PA/PAI-1|t-pa/pai-1
75336|NCT03733223|MMP-9|mmp-9
75337|NCT03733223|FVIII|fviii
75338|NCT03733223|Alteplase|alteplase
75339|NCT03733223|intracranial haemorrhage|intracranial haemorrhage
75340|NCT03733223|Ischemic stroke|ischemic stroke
75341|NCT03733210|Head and Neck Cancer|head and neck cancer
75342|NCT03733184|Colorectal|colorectal
75343|NCT03733184|Cancer|cancer
75344|NCT03733184|Peritoneal Metastasis|peritoneal metastasis
75345|NCT03733184|IDEAL|ideal
75346|NCT03733184|PCI|pci
75347|NCT03733184|CRPM|crpm
75348|NCT03733184|Colorectal Peritoneal Metastasis|colorectal peritoneal metastasis
75349|NCT03733171|platelet rich plasma|platelet rich plasma
75350|NCT03733158|endotracheal intubation|endotracheal intubation
75351|NCT03733158|emergency medicine|emergency medicine
75352|NCT03733158|cardiopulmonary resuscitation|cardiopulmonary resuscitation
75353|NCT03733158|physician|physician
75354|NCT03733145|Angiotensin II|angiotensin ii
75355|NCT03733145|Angiotensin Converting Enzyme Inhibitors|angiotensin converting enzyme inhibitors
75356|NCT03733145|Angiotensin Receptor Blockers|angiotensin receptor blockers
75357|NCT03733145|Anesthesia-Mediated Hypotension|anesthesia-mediated hypotension
75358|NCT03733132|Insulin Resistance|insulin resistance
75359|NCT03733132|Cognition|cognition
75360|NCT03733132|Cognitive Impairment|cognitive impairment
75361|NCT03733132|Brain Function|brain function
75362|NCT03733106|screening|screening
75363|NCT03733106|tomosynthesis|tomosynthesis
75369|NCT03733080|Motor Behavior|motor behavior
75370|NCT03733080|Healthy Volunteers|healthy volunteers
75376|NCT03733054|female|female
75377|NCT03733054|Veterans|veterans
75378|NCT03733054|Quality of life|quality of life
97607|NCT03593629|HIV|hiv
75379|NCT03733054|Prostheses|prostheses
75380|NCT03733054|Lower extremity amputation|lower extremity amputation
75381|NCT03733054|Surveys and questionnaires|surveys and questionnaires
75382|NCT03733054|electronic health records|electronic health records
75383|NCT03733041|exercise adherence|exercise adherence
75384|NCT03733041|Older veterans|older veterans
75385|NCT03733041|home based exercise|home based exercise
75386|NCT03733028|anger|anger
75387|NCT03733028|posttraumatic stress disorder|posttraumatic stress disorder
75388|NCT03733028|hostile interpretation bias|hostile interpretation bias
75389|NCT03733028|mHealth|mhealth
75390|NCT03733015|repetitive transcranial magnetic stimulation|repetitive transcranial magnetic stimulation
75391|NCT03733015|dorsolateral prefrontal cortex|dorsolateral prefrontal cortex
75392|NCT03733015|pain thresholds|pain thresholds
75393|NCT03733002|acute ischemic stroke|acute ischemic stroke
75394|NCT03733002|AngongNiuhuang pill|angongniuhuang pill
75395|NCT03732963|Oral Melatonin Premedication|oral melatonin premedication
75396|NCT03732911|Child Development|child development
75397|NCT03732911|Cognitive Home Environment|cognitive home environment
75398|NCT03732911|Literacy promotion|literacy promotion
75399|NCT03732911|Text Messages|text messages
75400|NCT03732885|Sinus|sinus
75401|NCT03732885|Stability|stability
75402|NCT03732885|Bone gain|bone gain
75403|NCT03732885|Osseodensification|osseodensification
75404|NCT03732872|OSMF|osmf
75405|NCT03732872|EMT|emt
75406|NCT03732872|miRNA 21|mirna 21
75407|NCT03732872|vimentin|vimentin
75408|NCT03732872|e-cadherin|e-cadherin
75409|NCT03732859|IPF|ipf
75512|NCT03732144|Physical Activity|physical activity
75410|NCT03732820|metastatic castration-resistant prostate cancer (mCRPC)|metastatic castration-resistant prostate cancer (mcrpc)
75411|NCT03732807|Alopecia|alopecia
75412|NCT03732807|Alopecia totalis|alopecia totalis
75413|NCT03732807|Alopecia universalis|alopecia universalis
75414|NCT03732807|Patchy hair loss|patchy hair loss
75415|NCT03732807|Diffuse hair loss|diffuse hair loss
75416|NCT03732807|Hair loss|hair loss
75417|NCT03732807|Hair disease|hair disease
75418|NCT03732807|PF-06651600|pf-06651600
75419|NCT03732716|blood pressure|blood pressure
75420|NCT03732716|elderly|elderly
75421|NCT03732716|sarcopenia|sarcopenia
75422|NCT03732716|fall|fall
75423|NCT03732703|Multiple Myeloma|multiple myeloma
75424|NCT03732703|Relapsed Refractory|relapsed refractory
75425|NCT03732703|Multiple Myeloma Research Consortium (MMRC)|multiple myeloma research consortium (mmrc)
75426|NCT03732703|Genomic Profile|genomic profile
75427|NCT03732703|My Drug|my drug
75428|NCT03732703|Multiple Myeloma Research Foundation|multiple myeloma research foundation
75429|NCT03732690|Type 2 diabetes|type 2 diabetes
75430|NCT03732690|Diet|diet
75431|NCT03732690|Protein|protein
75432|NCT03732690|Gut microbiota|gut microbiota
75433|NCT03732690|Metabolites|metabolites
75434|NCT03732677|Bladder Cancer|bladder cancer
75435|NCT03732677|Immunotherapy|immunotherapy
75436|NCT03732677|PD-L1|pd-l1
75437|NCT03732677|Durvalumab (MEDI4736)|durvalumab (medi4736)
75438|NCT03732638|Migraine Prevention|migraine prevention
75439|NCT03732638|phonophobia|phonophobia
75440|NCT03732638|photophobia|photophobia
75441|NCT03732638|nausea|nausea
75442|NCT03732625|HIV infection|hiv infection
75443|NCT03732625|neuropsychological adverse effects|neuropsychological adverse effects
75444|NCT03732625|Raltegravir|raltegravir
75445|NCT03732586|Severe Alcoholic Hepatitis treatment|severe alcoholic hepatitis treatment
75446|NCT03732573|Physical Activity|physical activity
75447|NCT03732573|Cycling|cycling
75448|NCT03732573|Behaviour Change Techniques|behaviour change techniques
75449|NCT03732547|Hepatocellular carcinoma|hepatocellular carcinoma
75450|NCT03732547|Polyinosinic-polycytidylic acid|polyinosinic-polycytidylic acid
75451|NCT03732547|PD-1 mAb|pd-1 mab
75452|NCT03732521|Dementia|dementia
75453|NCT03732521|family caregiver|family caregiver
75454|NCT03732521|Zarit scale|zarit scale
75455|NCT03732521|NPI-10|npi-10
75456|NCT03732521|psychological and behavioral symptoms|psychological and behavioral symptoms
75457|NCT03732469|egg retrieval|egg retrieval
75458|NCT03732469|oocyte retrieval|oocyte retrieval
75459|NCT03732469|opioid dependence|opioid dependence
75460|NCT03732469|rectal acetaminophen|rectal acetaminophen
75461|NCT03732469|rectal tylenol|rectal tylenol
75462|NCT03732469|pain|pain
75463|NCT03732469|opioid use|opioid use
75464|NCT03732469|opioid abuse|opioid abuse
75465|NCT03732443|Delirium|delirium
75466|NCT03732443|Family Members|family members
75467|NCT03732443|Critical Illness|critical illness
75468|NCT03732443|ABCDEF|abcdef
75469|NCT03732443|Validation|validation
75470|NCT03732443|Translation|translation
75471|NCT03732443|FAMCAM|famcam
75472|NCT03732443|CAM-ICU|cam-icu
75473|NCT03732417|Nurse's Role|nurse's role
75474|NCT03732417|quality of life|quality of life
75475|NCT03732417|adherence|adherence
75476|NCT03732417|risk factors|risk factors
97716|NCT03593044|pupil|pupil
75477|NCT03732417|stroke|stroke
75478|NCT03732417|secondary prevention|secondary prevention
75479|NCT03732404|Enhanced recovery after surgery|enhanced recovery after surgery
75480|NCT03732404|Preoperative carbohydrate drink|preoperative carbohydrate drink
75481|NCT03732404|cesarean section|cesarean section
75482|NCT03732326|Cardiac and Vascular Structure and Function|cardiac and vascular structure and function
75483|NCT03732313|Ingrown toenail|ingrown toenail
75484|NCT03732313|Biomechanic|biomechanic
75485|NCT03732313|Central resection|central resection
75486|NCT03732313|Recurrence|recurrence
75487|NCT03732287|intravitreal injection|intravitreal injection
75488|NCT03732287|anesthesia|anesthesia
75489|NCT03732287|macular degeneration|macular degeneration
75490|NCT03732287|diabetic macular edema|diabetic macular edema
75491|NCT03732261|postpartum, lactation, bone density, exercise, yogurt|postpartum, lactation, bone density, exercise, yogurt
75492|NCT03732235|Liver Metastases|liver metastases
75493|NCT03732235|Transarterial chemoembolization|transarterial chemoembolization
75494|NCT03732235|Bevacizumab|bevacizumab
75495|NCT03732235|Anti-angiogenesis|anti-angiogenesis
75496|NCT03732235|Irinotecan|irinotecan
75497|NCT03732235|Embolics|embolics
75498|NCT03732235|FOLFIRI|folfiri
75499|NCT03732222|Diaphragm|diaphragm
75500|NCT03732222|Neck|neck
75501|NCT03732222|Frenic Nerve|frenic nerve
75502|NCT03732183|Stress|stress
75503|NCT03732183|Military Caregiver|military caregiver
75504|NCT03732183|Caregiver|caregiver
75505|NCT03732183|Online|online
75506|NCT03732183|Podcast|podcast
75507|NCT03732183|Mind-Body|mind-body
75508|NCT03732183|Wellness|wellness
75509|NCT03732157|Primary Hyperparathyroidism|primary hyperparathyroidism
75510|NCT03732157|Parathyroidectomy|parathyroidectomy
75511|NCT03732157|Outpatient management|outpatient management
75515|NCT03732144|Behavioral Change|behavioral change
75516|NCT03732144|Agents of Change|agents of change
75517|NCT03732144|Social Mechanisms|social mechanisms
75518|NCT03732092|disorders of consciousness|disorders of consciousness
75519|NCT03732092|prognosis prediction|prognosis prediction
75520|NCT03732092|minimally conscious state|minimally conscious state
75521|NCT03732092|vegetative state|vegetative state
75522|NCT03732092|olfactory stimulation|olfactory stimulation
75523|NCT03732079|Inferior Vena Cava Diameter|inferior vena cava diameter
75524|NCT03732066|Dual antiplatelet therapy|dual antiplatelet therapy
75525|NCT03732066|Mobile health|mobile health
75526|NCT03732066|Discontinuation rate|discontinuation rate
75527|NCT03732066|Drug-eluting stent implantation|drug-eluting stent implantation
75528|NCT03732066|Randomized controlled trial|randomized controlled trial
75529|NCT03732014|Bronchial wash|bronchial wash
75530|NCT03732014|Xpert MTB/RIF|xpert mtb/rif
75531|NCT03732014|AFB Culture|afb culture
75532|NCT03732014|AFB microscopy|afb microscopy
75533|NCT03732014|Bronchoscopy|bronchoscopy
75534|NCT03731988|actinic keratosis|actinic keratosis
75535|NCT03731988|ablative fractional laser|ablative fractional laser
75536|NCT03731988|photodynamic therapy|photodynamic therapy
75537|NCT03731988|ablative density|ablative density
75538|NCT03731988|protoporphyrin IX|protoporphyrin ix
75539|NCT03731975|Tooth, deciduous|tooth, deciduous
75540|NCT03731975|Pulp Capping and Pulpectomy Agents|pulp capping and pulpectomy agents
75541|NCT03731975|Pulpectomy|pulpectomy
75542|NCT03731962|Urine Metabolomics|urine metabolomics
75543|NCT03731962|Contrast Induced Nephropathy|contrast induced nephropathy
75544|NCT03731936|artificial intelligence|artificial intelligence
75545|NCT03731936|facial characteristics|facial characteristics
75546|NCT03731923|MRI|mri
75547|NCT03731923|ultrasonography|ultrasonography
75548|NCT03731910|MRI|mri
75549|NCT03731884|Coronary thrombus|coronary thrombus
75550|NCT03731884|Proteomics|proteomics
75551|NCT03731884|Lipidomics|lipidomics
75552|NCT03731884|Thrombus aspiration|thrombus aspiration
75553|NCT03731845|Breast Cancer|breast cancer
75554|NCT03731845|ovarian reserve|ovarian reserve
75555|NCT03731845|primary ovarian insufficiency|primary ovarian insufficiency
75556|NCT03731845|chemotherapy|chemotherapy
75557|NCT03731845|single nucleotide polymorphism|single nucleotide polymorphism
75558|NCT03731819|MRI|mri
75559|NCT03731806|celiac disease|celiac disease
75560|NCT03731806|capsule endoscopy|capsule endoscopy
75561|NCT03731793|non-animal chondroitin sulphate|non-animal chondroitin sulphate
75562|NCT03731793|knee osteoarthritis|knee osteoarthritis
75563|NCT03731793|overweight|overweight
75564|NCT03731780|caries, prevention, personalized medicine|caries, prevention, personalized medicine
75565|NCT03731767|Manipulation|manipulation
75566|NCT03731767|Thrust|thrust
75567|NCT03731767|Ankle|ankle
75568|NCT03731767|Ligaments|ligaments
75569|NCT03731754|Traditional closure|traditional closure
75570|NCT03731754|"Cross closure"|"cross closure"
75571|NCT03731754|Rectal cancer|rectal cancer
75572|NCT03731754|Anal canal cancer|anal canal cancer
75573|NCT03731754|Abdominoperineal resection|abdominoperineal resection
75574|NCT03731715|LGS|lgs
75578|NCT03731689|intrauterine lavage therapy|intrauterine lavage therapy
75579|NCT03731689|hysteroscopy|hysteroscopy
75580|NCT03731689|microbiome|microbiome
75581|NCT03731689|uterine endometrial repair|uterine endometrial repair
75582|NCT03731689|intrauterine gel-injection therapy|intrauterine gel-injection therapy
75583|NCT03731663|foodporn|foodporn
75584|NCT03731663|food craving|food craving
75585|NCT03731663|external eating|external eating
75586|NCT03731663|disordered eating|disordered eating
75587|NCT03731663|social networks|social networks
75588|NCT03731637|New Onset Diabetes|new onset diabetes
75589|NCT03731637|Diabetes|diabetes
75590|NCT03731637|Type 2 Diabetes|type 2 diabetes
75591|NCT03731611|Umbilical cord milking|umbilical cord milking
75592|NCT03731572|Falls|falls
75593|NCT03731572|Balance|balance
75594|NCT03731572|Protective Stepping|protective stepping
75595|NCT03731572|Lateral Balance|lateral balance
75596|NCT03731572|Elderly|elderly
75597|NCT03731572|Power training|power training
75598|NCT03731559|Efficacy|efficacy
75599|NCT03731559|safety|safety
75600|NCT03731559|pharmacokinetics|pharmacokinetics
75601|NCT03731559|Dolutegravir|dolutegravir
75602|NCT03731559|HIV/TB co-infected patients|hiv/tb co-infected patients
75603|NCT03731559|rifampin-based antituberculosis therapy|rifampin-based antituberculosis therapy
75604|NCT03731546|Delayed cord clamping|delayed cord clamping
75605|NCT03731546|Preterm Infant|preterm infant
75606|NCT03731546|Placental Insufficiency|placental insufficiency
75607|NCT03731546|Intrauterine growth restriction|intrauterine growth restriction
75608|NCT03731533|diabetes|diabetes
75609|NCT03731533|lifestyle|lifestyle
75610|NCT03731533|nutrition|nutrition
75611|NCT03731533|exercise|exercise
75612|NCT03731520|Juvenile Idiopathic Arthritis|juvenile idiopathic arthritis
75613|NCT03731520|exercise|exercise
75614|NCT03731520|behavior|behavior
75615|NCT03731507|range of motion|range of motion
75616|NCT03731507|upper extremity|upper extremity
75617|NCT03731507|lower extremity|lower extremity
75618|NCT03731494|Nickel allergy|nickel allergy
75619|NCT03731494|Systemic nickel allergy syndrome|systemic nickel allergy syndrome
75620|NCT03731494|Health-related quality of life|health-related quality of life
75621|NCT03731494|Nickel oral hyposensitizing treatment|nickel oral hyposensitizing treatment
75622|NCT03731494|Diet|diet
75623|NCT03731494|Short-Form 36-Item Health Survey|short-form 36-item health survey
75624|NCT03731494|Psychological General Well Being Index|psychological general well being index
75625|NCT03731494|Minnesota Multiphasic Personality Inventory|minnesota multiphasic personality inventory
75626|NCT03731455|Cortical strip|cortical strip
75627|NCT03731455|Electrode|electrode
75628|NCT03731442|Salvage therapy|salvage therapy
75629|NCT03731442|Recurrence|recurrence
75630|NCT03731442|Chemoradiation|chemoradiation
75631|NCT03731429|Cough|cough
75632|NCT03731429|Sore throat|sore throat
75633|NCT03731429|Hemodynamic changes|hemodynamic changes
75634|NCT03731429|Extubation|extubation
75635|NCT03731429|Lidocaine|lidocaine
75636|NCT03731429|Double blind|double blind
75637|NCT03731416|GBR, autogenous bone, xenograft|gbr, autogenous bone, xenograft
75638|NCT03731403|Early childhood caries|early childhood caries
75639|NCT03731403|Casein phosphopeptides‑amorphous calcium phosphate|casein phosphopeptides‑amorphous calcium phosphate
75640|NCT03731403|fluoride|fluoride
75641|NCT03731403|remineralization potential|remineralization potential
75642|NCT03731403|varnish|varnish
75643|NCT03731390|programmed death ligand-1 (PD-L1)|programmed death ligand-1 (pd-l1)
75644|NCT03731351|Large Vessel Occlusion|large vessel occlusion
75645|NCT03731351|mechanical thrombectomy|mechanical thrombectomy
75646|NCT03731351|acute ischemic stroke|acute ischemic stroke
75647|NCT03731312|Iodine|iodine
75648|NCT03731312|Urinary iodine concentration|urinary iodine concentration
75649|NCT03731299|muscle synergies|muscle synergies
75650|NCT03731299|gait|gait
75651|NCT03731299|functional ability|functional ability
75652|NCT03731247|Optical biopsy|optical biopsy
75653|NCT03731247|Skin cancer|skin cancer
75654|NCT03731247|Diagnostic performance|diagnostic performance
75655|NCT03731234|DLBCL|dlbcl
75656|NCT03731234|Activated-B-Cell DLBCL|activated-b-cell dlbcl
75657|NCT03731234|Ibrutinib|ibrutinib
75658|NCT03731234|Phase II|phase ii
75659|NCT03731208|Quality of life|quality of life
75660|NCT03731208|Telerehabilitation|telerehabilitation
75661|NCT03731208|Knee rehabilitation|knee rehabilitation
75662|NCT03731208|Knee Osteoarthritis|knee osteoarthritis
75663|NCT03731208|Total Knee Replacement|total knee replacement
75664|NCT03731195|Baby Massage|baby massage
75665|NCT03731195|SSEP|ssep
75666|NCT03731156|Granulomatous Pneumocystis Pneumonia|granulomatous pneumocystis pneumonia
75667|NCT03731156|PCR Pneumocystis jirovecii|pcr pneumocystis jirovecii
75668|NCT03731143|pigtail|pigtail
75669|NCT03731143|punctal stenosis|punctal stenosis
75670|NCT03731143|bicanalicular|bicanalicular
75671|NCT03731130|rectal cancer|rectal cancer
75672|NCT03731130|quality of life|quality of life
75673|NCT03731130|neoadjuvant|neoadjuvant
75674|NCT03731130|radiation therapy|radiation therapy
75675|NCT03731130|chemoradiation|chemoradiation
75676|NCT03731117|Ischemic Acute Kidney Injury|ischemic acute kidney injury
75677|NCT03731117|Intensive care units|intensive care units
75678|NCT03731117|AKI|aki
75679|NCT03731117|ICU|icu
75680|NCT03731117|FST|fst
75681|NCT03731117|FUROSEMIDE STRESS TEST|furosemide stress test
75682|NCT03731117|RRT|rrt
75683|NCT03731117|Renal Replacement Therapy|renal replacement therapy
75684|NCT03731117|sepsis|sepsis
75685|NCT03731117|Cardio-pulmonary bypass|cardio-pulmonary bypass
75686|NCT03731104|Near InfraRed Spectroscopy|near infrared spectroscopy
75687|NCT03731104|Brain perfusion|brain perfusion
75688|NCT03731104|Pediatric shock|pediatric shock
75689|NCT03731104|Catecholamines|catecholamines
75690|NCT03731078|Conversion Disorder|conversion disorder
75691|NCT03731078|Functional Limb Weakness|functional limb weakness
75692|NCT03731078|Functional Movement Disorder|functional movement disorder
75693|NCT03731039|Postoperative pain|postoperative pain
75694|NCT03731039|Anxiety|anxiety
75695|NCT03731039|Depression|depression
75696|NCT03731039|Adult|adult
75697|NCT03731000|Pediatric|pediatric
75698|NCT03730987|Family Violence|family violence
75699|NCT03730987|Hispanic/Latino|hispanic/latino
75700|NCT03730987|Health Disparities|health disparities
75701|NCT03730987|Migrant farmworkers|migrant farmworkers
75702|NCT03730948|colorectal cancer|colorectal cancer
75703|NCT03730948|cancer vaccine|cancer vaccine
75704|NCT03730948|dendritic cell vaccine|dendritic cell vaccine
75705|NCT03730922|Breast cancer|breast cancer
75706|NCT03730922|Reconstruction|reconstruction
75707|NCT03730922|Post mastectomy radiotherapy|post mastectomy radiotherapy
75708|NCT03730896|Dry needling|dry needling
75807|NCT03730324|Biomarkers|biomarkers
75709|NCT03730896|Cervicogenic headache|cervicogenic headache
75710|NCT03730896|Manual therapy|manual therapy
75711|NCT03730870|Attention Deficit Disorders with Hyperactivity|attention deficit disorders with hyperactivity
75712|NCT03730870|ADHD|adhd
75713|NCT03730870|Pharmacogenomics|pharmacogenomics
75714|NCT03730870|Pediatric ADHD|pediatric adhd
75715|NCT03730870|ADHD medications|adhd medications
75716|NCT03730857|schizophrenia|schizophrenia
75717|NCT03730857|PANSS|panss
75718|NCT03730857|positive predictive value|positive predictive value
75719|NCT03730857|negative predictive value|negative predictive value
75720|NCT03730844|Functional outcomes|functional outcomes
75721|NCT03730844|Skeletal muscle|skeletal muscle
75722|NCT03730831|Course|course
75723|NCT03730831|Schizophrenia spectrum disorder|schizophrenia spectrum disorder
75724|NCT03730831|Posttraumatic Stress Disorder|posttraumatic stress disorder
75725|NCT03730831|Narrative Exposure Therapy|narrative exposure therapy
75726|NCT03730818|Exercise Therapy|exercise therapy
75727|NCT03730818|Aquatic Therapy|aquatic therapy
75728|NCT03730818|Health-Related Quality of Life|health-related quality of life
75729|NCT03730818|Cancer-related Fatigue|cancer-related fatigue
75730|NCT03730818|Exercise Tolerance|exercise tolerance
75731|NCT03730818|Physical Activity|physical activity
75732|NCT03730805|Catha Edulis|catha edulis
75733|NCT03730805|Khat|khat
75734|NCT03730805|Qat|qat
75735|NCT03730805|Khat Use Disorder|khat use disorder
75736|NCT03730805|Screening and Brief Intervention|screening and brief intervention
75737|NCT03730805|ASSIST|assist
75738|NCT03730792|Body Weight|body weight
75739|NCT03730792|Nutrition|nutrition
75740|NCT03730792|Physical Activity|physical activity
75741|NCT03730792|Sleep|sleep
75742|NCT03730792|Stress|stress
75743|NCT03730792|Occupational Health|occupational health
75744|NCT03730792|Working Conditions|working conditions
75745|NCT03730766|helicobacter pylori, saliva microbiota|helicobacter pylori, saliva microbiota
75746|NCT03730727|Exercise|exercise
75747|NCT03730727|Type 2 diabetes|type 2 diabetes
75748|NCT03730727|Walking|walking
75749|NCT03730727|Standing|standing
75750|NCT03730727|Circuit exercises|circuit exercises
75751|NCT03730727|Inactivity|inactivity
75752|NCT03730727|Blood glucose control|blood glucose control
75753|NCT03730727|Continuous glucose monitoring|continuous glucose monitoring
75754|NCT03730701|Life style|life style
75755|NCT03730701|Primary prevention|primary prevention
75756|NCT03730701|Modifiable risk factors|modifiable risk factors
75757|NCT03730688|compartment syndrome|compartment syndrome
75758|NCT03730688|compartment pressure|compartment pressure
75759|NCT03730688|polytrauma|polytrauma
75760|NCT03730688|burn injury|burn injury
75761|NCT03730688|limb ischemia|limb ischemia
75762|NCT03730688|fasciotomy|fasciotomy
75763|NCT03730662|GIP|gip
75764|NCT03730662|GLP-1|glp-1
75765|NCT03730662|glucose metabolism disorders|glucose metabolism disorders
75766|NCT03730662|metabolic diseases|metabolic diseases
75767|NCT03730662|endocrine system diseases|endocrine system diseases
75768|NCT03730662|cardiovascular risk|cardiovascular risk
75769|NCT03730636|Late Onset Sepsis (LOS)|late onset sepsis (los)
75770|NCT03730636|antibiotic therapy duration|antibiotic therapy duration
75771|NCT03730636|procalcitonin (PCTR)|procalcitonin (pctr)
821481|NCT00151008|bexarotene|bexarotene
75772|NCT03730623|Supervised exercise training|supervised exercise training
75773|NCT03730623|community based intervention|community based intervention
75774|NCT03730623|Rehabilitation Program|rehabilitation program
75775|NCT03730623|Cross-sectoral intervention|cross-sectoral intervention
75776|NCT03730623|Interdisciplinary|interdisciplinary
75777|NCT03730623|Mixed Methods Research|mixed methods research
75778|NCT03730584|Hereditary Epidermolysis Bullosa|hereditary epidermolysis bullosa
75779|NCT03730584|pain|pain
75780|NCT03730584|bath|bath
75781|NCT03730584|dressing change|dressing change
75782|NCT03730584|Ropivacaine|ropivacaine
75783|NCT03730584|topical application|topical application
75784|NCT03730558|metastatic|metastatic
75785|NCT03730558|colon cancer|colon cancer
75786|NCT03730545|gastric cancer|gastric cancer
75787|NCT03730545|enteral nutrition|enteral nutrition
75788|NCT03730545|enteral immunonutrition|enteral immunonutrition
75789|NCT03730545|immune function|immune function
75790|NCT03730545|inflammation response|inflammation response
75791|NCT03730532|Guided self help|guided self help
75792|NCT03730532|Cognitive Analytic Therapy|cognitive analytic therapy
75793|NCT03730532|Cognitive Behavioral Therapy|cognitive behavioral therapy
75794|NCT03730519|Refractory Hypertension|refractory hypertension
75795|NCT03730467|Breast feeding|breast feeding
75796|NCT03730467|breast abscess|breast abscess
75797|NCT03730467|ultrasound-guide|ultrasound-guide
75798|NCT03730467|puncture|puncture
75799|NCT03730467|health|health
75800|NCT03730402|post-operative analgesia|post-operative analgesia
75801|NCT03730389|Ureteral Calculi|ureteral calculi
75802|NCT03730389|External Physical Vibration Lithecbole (EPVL)|external physical vibration lithecbole (epvl)
75803|NCT03730389|Efficacy|efficacy
75804|NCT03730389|Safety|safety
75805|NCT03730363|Pentamidine|pentamidine
75806|NCT03730363|Salvage Chemotherapy|salvage chemotherapy
75808|NCT03730324|Magnetic Resonance Imaging|magnetic resonance imaging
75809|NCT03730324|Diagnostic|diagnostic
75810|NCT03730298|American Ginseng|american ginseng
75811|NCT03730298|Cancer related fatigue|cancer related fatigue
75812|NCT03730298|Breast Cancer Female|breast cancer female
75813|NCT03730285|telemedicine, patient satisfaction, randomization|telemedicine, patient satisfaction, randomization
75814|NCT03730259|Pediatric|pediatric
75815|NCT03730259|Pain|pain
75816|NCT03730259|Postoperative|postoperative
75817|NCT03730259|General Anesthesia|general anesthesia
75818|NCT03730259|Anesthesia Recovery Period|anesthesia recovery period
75819|NCT03730259|Patient Satisfaction|patient satisfaction
75820|NCT03730259|mobile health|mobile health
75821|NCT03730194|Autism Spectrum Disorder|autism spectrum disorder
75822|NCT03730194|Attention Deficit Hyperactivity Disorder|attention deficit hyperactivity disorder
75823|NCT03730194|Sleep Disturbance|sleep disturbance
75824|NCT03730194|Melatonin|melatonin
75826|NCT03730194|ADHD|adhd
75827|NCT03730168|Diabetes mellitus.|diabetes mellitus.
75828|NCT03730168|Inflammatory markers|inflammatory markers
75829|NCT03730168|Circuit weight training|circuit weight training
75830|NCT03730142|phosphoinositide-3 kinase (PI3K)|phosphoinositide-3 kinase (pi3k)
75831|NCT03730142|mammalian target of rapamycin (mTOR)|mammalian target of rapamycin (mtor)
75832|NCT03730129|chronic lymphocytic leukemia|chronic lymphocytic leukemia
75833|NCT03730064|Inflammation|inflammation
75834|NCT03730064|NAC|nac
75835|NCT03730064|N-acetyl cysteine|n-acetyl cysteine
75836|NCT03730051|Breast MRI|breast mri
75837|NCT03730051|Mammography|mammography
75838|NCT03730051|Dotarem contrast|dotarem contrast
75839|NCT03730051|Gadobutrol contrast|gadobutrol contrast
75840|NCT03730051|wash-in/wash-out contrast curve|wash-in/wash-out contrast curve
75841|NCT03730051|Contrast enhanced MRI|contrast enhanced mri
75842|NCT03730038|Dyslipidemia|dyslipidemia
75843|NCT03730025|Heart rate|heart rate
75844|NCT03730025|Assessment|assessment
75845|NCT03730025|Time|time
75846|NCT03730025|Resuscitation intervention|resuscitation intervention
75847|NCT03730012|AML|aml
75848|NCT03730012|gilteritinib|gilteritinib
75849|NCT03730012|ASP2215|asp2215
75850|NCT03730012|Acute Myeloid Leukemia|acute myeloid leukemia
75851|NCT03730012|FLT3|flt3
75852|NCT03729895|Orthodontic Appliances|orthodontic appliances
75853|NCT03729895|Cone-Beam Computed Tomography|cone-beam computed tomography
75854|NCT03729882|endoscopic ultrasound|endoscopic ultrasound
75855|NCT03729882|acute cholecystitis|acute cholecystitis
75856|NCT03729882|cholangiocarcinoma|cholangiocarcinoma
75857|NCT03729882|gallbladder drainage|gallbladder drainage
75858|NCT03729882|metallic stents|metallic stents
75859|NCT03729817|Vertebrobasilar stenosis|vertebrobasilar stenosis
75860|NCT03729817|Stenosis|stenosis
75861|NCT03729817|Angioplasty|angioplasty
75862|NCT03729817|Blood Flow|blood flow
75863|NCT03729791|Schizophrenia|schizophrenia
75864|NCT03729791|tDCS|tdcs
75865|NCT03729791|negative symptoms|negative symptoms
75866|NCT03729778|HIV|hiv
75867|NCT03729778|Streptococcus pneumoniae infection|streptococcus pneumoniae infection
75868|NCT03729778|Prevnar-13|prevnar-13
75869|NCT03729778|PCV-13|pcv-13
75870|NCT03729778|Pneumococcal vaccine|pneumococcal vaccine
75871|NCT03729778|Pneumococcal vaccines|pneumococcal vaccines
75872|NCT03729778|Streptococcus pneumoniae colonization|streptococcus pneumoniae colonization
75873|NCT03729765|veno-arterial extracorporeal membrane oxygenation (VA-ECMO)|veno-arterial extracorporeal membrane oxygenation (va-ecmo)
75874|NCT03729765|hemoperfusion|hemoperfusion
75875|NCT03729765|inflammatory factor|inflammatory factor
75876|NCT03729752|HIV-1-infection|hiv-1-infection
75877|NCT03729752|PET scan|pet scan
75878|NCT03729752|MRI|mri
75879|NCT03729752|Viremia|viremia
75880|NCT03729752|Antiretroviral therapy|antiretroviral therapy
75881|NCT03729739|Fractional Flow Reserve (FFR)|fractional flow reserve (ffr)
75882|NCT03729739|Quantitative Flow Ratio (QFR)|quantitative flow ratio (qfr)
75883|NCT03729739|Stable coronary artery disease|stable coronary artery disease
75884|NCT03729739|Angina pectoris|angina pectoris
75885|NCT03729739|Angiography derived fractional flow reserve|angiography derived fractional flow reserve
75886|NCT03729687|rectal cancer|rectal cancer
75887|NCT03729687|high risk|high risk
75888|NCT03729687|total neoadjuvant treatment|total neoadjuvant treatment
75889|NCT03729674|Inflammatory rheumatic diseases Inflammatory Bowel Diseases|inflammatory rheumatic diseases inflammatory bowel diseases
75890|NCT03729648|Younger Stroke survivors|younger stroke survivors
75891|NCT03729648|Expressive Arts Therapy|expressive arts therapy
75892|NCT03729648|Rehabilitation|rehabilitation
75893|NCT03729648|Randomized Controlled Trial|randomized controlled trial
75894|NCT03729648|Salivary Cortisol|salivary cortisol
75895|NCT03729622|FODMAPs|fodmaps
75896|NCT03729622|Low FODMAP Diet|low fodmap diet
75897|NCT03729596|antibody-drug conjugate (ADC)|antibody-drug conjugate (adc)
75898|NCT03729596|B7-H3|b7-h3
75899|NCT03729596|anti-PD-1|anti-pd-1
75900|NCT03729570|PrEP|prep
75901|NCT03729570|MSM|msm
75902|NCT03729570|HIV|hiv
75903|NCT03729570|telemedicine|telemedicine
75906|NCT03729544|echocardiography|echocardiography
75907|NCT03729544|pulmonary embolism|pulmonary embolism
75908|NCT03729544|pulmonary hypertension|pulmonary hypertension
75910|NCT03729531|Coronary Artery Disease|coronary artery disease
75911|NCT03729531|Coronary Artery Bypass Grafting|coronary artery bypass grafting
75912|NCT03729531|Vein Graft Failure|vein graft failure
75913|NCT03729531|Endothelial dysfunction|endothelial dysfunction
75914|NCT03729479|dietary intervention|dietary intervention
75915|NCT03729466|clinical pilates|clinical pilates
75916|NCT03729453|IPMN|ipmn
75917|NCT03729453|SpyGlass|spyglass
75918|NCT03729453|Pancreatoscopy|pancreatoscopy
75919|NCT03729453|Intraductal Papillary Mucinous Neoplasm|intraductal papillary mucinous neoplasm
75920|NCT03729453|Intraoperative|intraoperative
75921|NCT03729453|Surgical|surgical
75922|NCT03729427|Erector Spinae Plane|erector spinae plane
75923|NCT03729427|Erector Spiane Plane Block|erector spiane plane block
75924|NCT03729427|Rib Cartilage|rib cartilage
75925|NCT03729414|Hemorrhoid|hemorrhoid
75926|NCT03729414|Doppler|doppler
75927|NCT03729414|Mucopexy|mucopexy
75928|NCT03729401|1-year post myocardial infarction|1-year post myocardial infarction
75929|NCT03729401|P2Y12 inhibitor|p2y12 inhibitor
75930|NCT03729401|antiplatelet regimen|antiplatelet regimen
75931|NCT03729388|Opiate substitution treatment|opiate substitution treatment
75932|NCT03729388|Opioid-related disorder|opioid-related disorder
75933|NCT03729388|Behavior|behavior
75934|NCT03729388|Addictive|addictive
75935|NCT03729388|Substance-related disorder|substance-related disorder
75936|NCT03729388|Methadone|methadone
75937|NCT03729388|Buprenorphine|buprenorphine
75938|NCT03729388|Prognosis|prognosis
75939|NCT03729362|Pompe|pompe
75940|NCT03729362|rhGAA|rhgaa
75941|NCT03729336|urine specimen|urine specimen
75942|NCT03729336|contamination|contamination
75943|NCT03729323|Motivational Interviewing|motivational interviewing
75944|NCT03729323|Type 2 Diabetes Mellitus|type 2 diabetes mellitus
75945|NCT03729323|Systemic Arterial Hypertension|systemic arterial hypertension
75946|NCT03729323|Chronic Diseases|chronic diseases
75947|NCT03729323|Self-care|self-care
75951|NCT03729297|salivary gland cancer|salivary gland cancer
75952|NCT03729297|adenoid cystic carcinoma|adenoid cystic carcinoma
75953|NCT03729297|salivary duct carcinoma|salivary duct carcinoma
75954|NCT03729297|cabozantinib|cabozantinib
75955|NCT03729297|progression free survival|progression free survival
75956|NCT03729297|overall survival|overall survival
75957|NCT03729297|phase 2 clinical trial|phase 2 clinical trial
75958|NCT03729271|IBS|ibs
75959|NCT03729271|Irritable Bowel Syndrome|irritable bowel syndrome
75960|NCT03729245|Kidney Cancer|kidney cancer
75961|NCT03729245|Kidney Neoplasms|kidney neoplasms
75962|NCT03729245|Renal Cancer|renal cancer
75963|NCT03729245|Renal Neoplasms|renal neoplasms
75964|NCT03729245|CD122|cd122
75965|NCT03729245|CD122-Biased Agonist|cd122-biased agonist
75966|NCT03729245|CD122-Biased Cytokine|cd122-biased cytokine
75967|NCT03729245|IL-2 Receptor Agonist|il-2 receptor agonist
75968|NCT03729245|Immuno-oncology therapy|immuno-oncology therapy
98375|NCT03589092|GDM|gdm
75969|NCT03729245|NKTR-214|nktr-214
75970|NCT03729245|Nivolumab|nivolumab
75971|NCT03729245|Opdivo®|opdivo®
75972|NCT03729245|PD-L1|pd-l1
75973|NCT03729245|PD-1|pd-1
75974|NCT03729245|Bempegaldesleukin|bempegaldesleukin
75975|NCT03729245|IL-2|il-2
75976|NCT03729232|Catheter Ablation|catheter ablation
75977|NCT03729232|Cardiac Arrhythmias|cardiac arrhythmias
75978|NCT03729232|Registry|registry
75979|NCT03729232|Complication|complication
75980|NCT03729232|REDCap|redcap
75981|NCT03729193|musculoskeletal system pain|musculoskeletal system pain
75982|NCT03729193|athlete|athlete
75983|NCT03729193|psychosocial problems|psychosocial problems
75984|NCT03729193|algometer|algometer
75985|NCT03729167|periodontal debridement|periodontal debridement
75986|NCT03729167|non-surgical therapy|non-surgical therapy
75987|NCT03729167|periodontal disease|periodontal disease
75988|NCT03729167|dental scaling|dental scaling
75989|NCT03729141|Cholesterol|cholesterol
75990|NCT03729141|Adipocyte|adipocyte
75991|NCT03729141|Macrophage|macrophage
75992|NCT03729128|amphetamine-type stimulants use disorder|amphetamine-type stimulants use disorder
75993|NCT03729128|dextromethorphan|dextromethorphan
75994|NCT03729128|memantine|memantine
75995|NCT03729128|inflammation|inflammation
75996|NCT03729128|neurodegeneration|neurodegeneration
75997|NCT03729102|rabies vaccination|rabies vaccination
75998|NCT03729050|Mental Disorder|mental disorder
75999|NCT03729050|Rehabilitation|rehabilitation
76000|NCT03729037|Virtual learning|virtual learning
76001|NCT03729037|Educational technology|educational technology
76002|NCT03729037|Medical education|medical education
76003|NCT03729011|delirium|delirium
76004|NCT03729011|Cardiac surgery|cardiac surgery
76005|NCT03729011|Cardiopulmonary bypass|cardiopulmonary bypass
76006|NCT03729011|Cognitive dysfunction|cognitive dysfunction
76007|NCT03728998|Passive leg raise|passive leg raise
76008|NCT03728998|Fluid responsiveness|fluid responsiveness
76009|NCT03728998|Cardiac output, non-invasive|cardiac output, non-invasive
76010|NCT03728998|Emergency Department|emergency department
76011|NCT03728972|Pembrolizumab|pembrolizumab
76012|NCT03728972|Early stage NK/T-Cell Lymphoma|early stage nk/t-cell lymphoma
76013|NCT03728972|18-393|18-393
76014|NCT03728972|Memorial Sloan kettering Cancer Center|memorial sloan kettering cancer center
76015|NCT03728959|hypoparathyroidism|hypoparathyroidism
76016|NCT03728959|Glucose-dependent insulinotropic polypeptide (GIP)|glucose-dependent insulinotropic polypeptide (gip)
76017|NCT03728959|Glucagon-like peptide-2 (GLP-2)|glucagon-like peptide-2 (glp-2)
76018|NCT03728959|Bone remodeling|bone remodeling
76019|NCT03728959|Bone resorption|bone resorption
76020|NCT03728959|Bone formation|bone formation
76021|NCT03728959|C-terminal telopeptide (CTX)|c-terminal telopeptide (ctx)
76022|NCT03728959|N-terminal propeptide of type 1 procollagen (P1NP)|n-terminal propeptide of type 1 procollagen (p1np)
76024|NCT03728933|Rotigotine|rotigotine
76025|NCT03728933|Neupro|neupro
76026|NCT03728907|hearing aid|hearing aid
76027|NCT03728907|self-fitting|self-fitting
76028|NCT03728894|Midazolam|midazolam
76029|NCT03728894|hydroxyzine|hydroxyzine
76030|NCT03728894|oxygen|oxygen
76031|NCT03728894|behavior|behavior
76032|NCT03728894|child|child
76033|NCT03728894|tooth|tooth
76034|NCT03728881|Fewer Doses|fewer doses
76035|NCT03728881|Human Papillomavirus|human papillomavirus
76036|NCT03728881|Cervical Cancer|cervical cancer
76037|NCT03728881|Costa Rica|costa rica
76038|NCT03728881|HPV-Associated Cancers|hpv-associated cancers
76039|NCT03728868|Faecalibacterium prausnitzii|faecalibacterium prausnitzii
76040|NCT03728868|Desulfovibrio piger|desulfovibrio piger
76041|NCT03728868|tolerability|tolerability
76042|NCT03728868|blood glucose levels|blood glucose levels
76043|NCT03728855|Self-administration of medication|self-administration of medication
76044|NCT03728855|SAM|sam
76045|NCT03728855|Medication Safety|medication safety
76046|NCT03728855|Patient Empowerment|patient empowerment
76047|NCT03728855|Patient Satisfaction|patient satisfaction
76048|NCT03728855|Staff Satisfaction|staff satisfaction
76049|NCT03728842|metastatic disease|metastatic disease
76050|NCT03728842|spontaneous regression|spontaneous regression
76051|NCT03728829|breast cancer|breast cancer
76052|NCT03728829|HER2 positive|her2 positive
76053|NCT03728829|next generation sequencing|next generation sequencing
76054|NCT03728829|trastuzumab|trastuzumab
76055|NCT03728829|neoadjuvant chemotherapy|neoadjuvant chemotherapy
76056|NCT03728816|Community Acquired Pneumonia|community acquired pneumonia
76057|NCT03728816|Epidemiology|epidemiology
76058|NCT03728816|Multicenter study|multicenter study
76059|NCT03728790|hypertensive disorders of pregnancy|hypertensive disorders of pregnancy
76060|NCT03728790|preeclampsia|preeclampsia
76061|NCT03728790|gestational hypertension|gestational hypertension
76062|NCT03728790|HELLP|hellp
76063|NCT03728751|Dry needling|dry needling
76064|NCT03728751|Autonomic nervous system|autonomic nervous system
821482|NCT00151008|narrow band|narrow band
76065|NCT03728751|pupillometry|pupillometry
76066|NCT03728699|AML|aml
76067|NCT03728686|Intubation, Intratracheal|intubation, intratracheal
76068|NCT03728673|serotonin selective reuptake inhibitor|serotonin selective reuptake inhibitor
76069|NCT03728673|cognition|cognition
76070|NCT03728673|escitalopram|escitalopram
76071|NCT03728660|age related macular degeneration|age related macular degeneration
76072|NCT03728660|visual impairment|visual impairment
76073|NCT03728660|virtual reality|virtual reality
76074|NCT03728621|obesity|obesity
76075|NCT03728621|child|child
76076|NCT03728621|AIP|aip
76077|NCT03728621|lifestyle intervention|lifestyle intervention
76078|NCT03728608|neonatal intensive care unit (NICU)|neonatal intensive care unit (nicu)
76079|NCT03728608|feeding tube contamination|feeding tube contamination
76080|NCT03728595|gas exchange|gas exchange
76081|NCT03728595|in-flight hypoxia|in-flight hypoxia
76082|NCT03728595|hypoxic altitude simulation test|hypoxic altitude simulation test
76083|NCT03728595|blood gas response|blood gas response
76084|NCT03728582|Aphasia|aphasia
76085|NCT03728582|Language therapy|language therapy
76086|NCT03728582|Neurocognitive Disorders|neurocognitive disorders
76087|NCT03728582|Frontotemporal Dementia|frontotemporal dementia
76088|NCT03728582|Dementia|dementia
76089|NCT03728582|Anomia|anomia
76090|NCT03728543|Anesthesia|anesthesia
76091|NCT03728543|Pediatrics|pediatrics
76092|NCT03728543|Pediatric oncology|pediatric oncology
76093|NCT03728543|MRI anesthesia|mri anesthesia
76094|NCT03728530|Deep breathing exercises, smokers, lung function|deep breathing exercises, smokers, lung function
76095|NCT03728517|Narcotic|narcotic
76096|NCT03728517|Inpatient|inpatient
76097|NCT03728517|Outpatient|outpatient
76098|NCT03728517|Comparison|comparison
76099|NCT03728504|eczema|eczema
76100|NCT03728504|hand eczema|hand eczema
76101|NCT03728504|hand dermatitis|hand dermatitis
76102|NCT03728491|Medical Education|medical education
76103|NCT03728491|Simulation-based training|simulation-based training
76104|NCT03728491|Ultrasonography|ultrasonography
76105|NCT03728491|Thoracic imaging|thoracic imaging
76106|NCT03728478|juvenile idiopathic arthritis|juvenile idiopathic arthritis
76107|NCT03728478|treatment|treatment
76108|NCT03728478|treat to target|treat to target
76109|NCT03728452|Trophic nutrition|trophic nutrition
76110|NCT03728452|high flow ventilation|high flow ventilation
76111|NCT03728452|noninvasive ventilation|noninvasive ventilation
76112|NCT03728452|mortality|mortality
76113|NCT03728452|complications|complications
76114|NCT03728439|Recovery|recovery
76115|NCT03728439|Rugby|rugby
76116|NCT03728439|Phototherapy|phototherapy
76117|NCT03728426|Cytomegalovirus Infections|cytomegalovirus infections
76118|NCT03728426|CMV|cmv
76119|NCT03728413|Elderly|elderly
76120|NCT03728413|Human|human
76121|NCT03728413|Respiratory Syncytial Infections|respiratory syncytial infections
76122|NCT03728413|RNA Virus Infections|rna virus infections
76123|NCT03728387|osteoarthritis|osteoarthritis
76124|NCT03728387|exercise|exercise
76125|NCT03728387|balance|balance
76126|NCT03728348|Sample Collection|sample collection
76127|NCT03728348|Stool DNA|stool dna
76128|NCT03728348|Colonoscopy|colonoscopy
76129|NCT03728283|connective tissue graft|connective tissue graft
76130|NCT03728283|implant surgery|implant surgery
76131|NCT03728283|two-stage implants|two-stage implants
76132|NCT03728283|mucosa thickness|mucosa thickness
76133|NCT03728283|crestal bone|crestal bone
76134|NCT03728244|mucoginival defects|mucoginival defects
76135|NCT03728244|Free gingival graft|free gingival graft
76136|NCT03728244|palatal donor site|palatal donor site
76137|NCT03728244|pain|pain
76138|NCT03728166|venous thromboembolism|venous thromboembolism
76139|NCT03728166|prevention|prevention
76140|NCT03728166|medical patients|medical patients
76141|NCT03728166|hospital discharge|hospital discharge
76142|NCT03728153|Motor recovery|motor recovery
76143|NCT03728140|Embryo Transfer|embryo transfer
76144|NCT03728114|adult|adult
76145|NCT03728114|remote ischemic conditioning|remote ischemic conditioning
76146|NCT03728114|high altitude condition|high altitude condition
76147|NCT03728114|cognitive function|cognitive function
76148|NCT03728114|blood oxygen levels|blood oxygen levels
76149|NCT03728088|Non-technical attributes|non-technical attributes
76150|NCT03728088|Surgical training|surgical training
76151|NCT03728088|Communication style|communication style
76152|NCT03728088|Risk aversion|risk aversion
76153|NCT03728088|Reaction to uncertainty|reaction to uncertainty
76154|NCT03728088|Self-assessment|self-assessment
76155|NCT03728075|NMES|nmes
76156|NCT03728075|IL-6|il-6
76157|NCT03728075|IL-15|il-15
76158|NCT03728075|Chronic Heart Failure|chronic heart failure
76159|NCT03728062|Mindfulness|mindfulness
76160|NCT03728062|Physical exercise|physical exercise
76161|NCT03728062|Salivary Immunoglobulin A|salivary immunoglobulin a
76162|NCT03728062|Recovery strategy from stress|recovery strategy from stress
76163|NCT03728049|Transcatheter Aortic Valve Replacement|transcatheter aortic valve replacement
76164|NCT03728049|Paravalvular regurgitation|paravalvular regurgitation
76165|NCT03728049|Point-of-care test|point-of-care test
76166|NCT03728049|Biomarker|biomarker
76167|NCT03728049|Aortic stenosis|aortic stenosis
76168|NCT03728049|Von willebrand Factor|von willebrand factor
76169|NCT03728036|walking|walking
76170|NCT03728036|recovery|recovery
76171|NCT03728036|compensation|compensation
76172|NCT03728010|Electrical impedance tomography|electrical impedance tomography
76173|NCT03728010|One-lung ventilation|one-lung ventilation
76174|NCT03728010|Protective ventilation|protective ventilation
76175|NCT03728010|Ventilator- Induce Lung injury|ventilator- induce lung injury
76176|NCT03727997|Acute kidney injury|acute kidney injury
76177|NCT03727997|Renal replacement therapy|renal replacement therapy
76178|NCT03727997|Intensive Care Unit|intensive care unit
76179|NCT03727984|Myocardial infarction|myocardial infarction
76180|NCT03727984|Hospitalization|hospitalization
76181|NCT03727984|Coronary artery disease|coronary artery disease
76182|NCT03727984|Retrospective|retrospective
76183|NCT03727984|Cohort study|cohort study
76184|NCT03727945|stress urinary incontinence|stress urinary incontinence
76185|NCT03727945|abdominopelvic exercise|abdominopelvic exercise
76186|NCT03727945|quality of life|quality of life
76187|NCT03727919|stroke|stroke
76188|NCT03727919|rehabilitation|rehabilitation
76189|NCT03727919|robotics|robotics
76190|NCT03727906|Cardiovascular|cardiovascular
76191|NCT03727906|Blood Pressure|blood pressure
76193|NCT03727906|EEG|eeg
76194|NCT03727893|manual wheelchairs|manual wheelchairs
76195|NCT03727893|wheelchair propulsion|wheelchair propulsion
76196|NCT03727893|high intensity exercise training|high intensity exercise training
76197|NCT03727880|Pembrolizumab|pembrolizumab
76198|NCT03727880|Defactinib|defactinib
76199|NCT03727880|Immunotherapy|immunotherapy
76200|NCT03727880|Anti-PD-1|anti-pd-1
76201|NCT03727880|Antibody|antibody
76207|NCT03727880|FAK (focal adhesion kinase) inhibitor|fak (focal adhesion kinase) inhibitor
76208|NCT03727880|Resectable Pancreatic Adenocarcinoma|resectable pancreatic adenocarcinoma
76209|NCT03727880|High Risk Resectable Pancreatic Cancer|high risk resectable pancreatic cancer
76210|NCT03727880|Tumor microenvironment|tumor microenvironment
76211|NCT03727880|CA 19-9|ca 19-9
76212|NCT03727880|Surgery|surgery
76213|NCT03727880|Pancreatectomy|pancreatectomy
76214|NCT03727854|protein-enriched bar|protein-enriched bar
76215|NCT03727854|glycemic control|glycemic control
76216|NCT03727854|type 2 diabetes|type 2 diabetes
76217|NCT03727854|long term|long term
76223|NCT03727815|mindfulness|mindfulness
76224|NCT03727815|meditation|meditation
76225|NCT03727815|patient satisfaction|patient satisfaction
76226|NCT03727815|rhinoplasty|rhinoplasty
76227|NCT03727815|pain control|pain control
76228|NCT03727815|quality of life|quality of life
76229|NCT03727802|TRK-250|trk-250
76230|NCT03727802|Idiopathic Pulmonary Fibrosis|idiopathic pulmonary fibrosis
76231|NCT03727776|Post-operative Intraocular Inflammation|post-operative intraocular inflammation
76232|NCT03727763|FLOFIRI|flofiri
76233|NCT03727763|vemurafenib|vemurafenib
76234|NCT03727763|cetuximab|cetuximab
76235|NCT03727763|BRAF V600E mutation|braf v600e mutation
76236|NCT03727763|Advanced Colorectal Cancer|advanced colorectal cancer
76237|NCT03727750|gemtuzumab ozogamicin|gemtuzumab ozogamicin
76238|NCT03727750|Mylotarg|mylotarg
76239|NCT03727750|QT interval prolongation|qt interval prolongation
76240|NCT03727750|Pharmacokinetics|pharmacokinetics
76241|NCT03727750|Safety|safety
76242|NCT03727750|Veno-occlusive disease|veno-occlusive disease
76243|NCT03727750|Anti-drug antibody|anti-drug antibody
76244|NCT03727737|repetitive Transcranial Magnetic Stimulation|repetitive transcranial magnetic stimulation
76245|NCT03727737|Brain Injuries, Traumatic|brain injuries, traumatic
76246|NCT03727711|transcutaneous posterior tibial nerve stimulation|transcutaneous posterior tibial nerve stimulation
76247|NCT03727685|Advance care planning|advance care planning
76248|NCT03727672|Primary headaches|primary headaches
76249|NCT03727672|CRP|crp
76250|NCT03727672|Interleukin1β|interleukin1β
76251|NCT03727672|Interleukin6|interleukin6
76252|NCT03727672|markers|markers
76253|NCT03727659|Cannabis|cannabis
76254|NCT03727659|CONNECT|connect
76255|NCT03727659|Depression|depression
76256|NCT03727659|FaceBook|facebook
76257|NCT03727620|aggressive periodontitis|aggressive periodontitis
76258|NCT03727620|systemic antibiotics|systemic antibiotics
76259|NCT03727620|doxycycline|doxycycline
76260|NCT03727581|hemodialysis|hemodialysis
76261|NCT03727581|vascular access|vascular access
76262|NCT03727581|dialysis catheter|dialysis catheter
76263|NCT03727555|X-linked adrenoleukodystrophy|x-linked adrenoleukodystrophy
76264|NCT03727555|Lentiviral vector|lentiviral vector
76265|NCT03727529|Parkinson's Disease|parkinson's disease
76266|NCT03727529|Virtual reality|virtual reality
76267|NCT03727529|Long range autocorrelations|long range autocorrelations
76268|NCT03727477|lorlatinib|lorlatinib
76269|NCT03727477|Non-small Cell Lung Cancer|non-small cell lung cancer
76270|NCT03727464|Memory priming|memory priming
76271|NCT03727464|Anesthesia|anesthesia
76272|NCT03727464|Language processing|language processing
76273|NCT03727464|Abstract and Concrete words|abstract and concrete words
76274|NCT03727464|Neural correlates|neural correlates
76275|NCT03727451|Pulmonary Hypertension|pulmonary hypertension
76276|NCT03727451|Pulmonary Fibrosis|pulmonary fibrosis
76277|NCT03727451|Sarcoidosis|sarcoidosis
76278|NCT03727438|Cognitive Behavioral Therapy for Insomnia|cognitive behavioral therapy for insomnia
76279|NCT03727438|Self-Management|self-management
76280|NCT03727438|Telehealth|telehealth
76281|NCT03727425|Bronchoscopy|bronchoscopy
76282|NCT03727425|Robotic bronchoscopy|robotic bronchoscopy
76283|NCT03727425|Lung cancer|lung cancer
76284|NCT03727425|Peripheral lesions|peripheral lesions
76285|NCT03727412|post implantation syndrome|post implantation syndrome
76286|NCT03727412|EVAR|evar
76287|NCT03727412|cardiovascular outcome|cardiovascular outcome
76288|NCT03727412|NSAIDs|nsaids
76289|NCT03727373|Pain measurement|pain measurement
76290|NCT03727373|Pain, Chronic or acute|pain, chronic or acute
76291|NCT03727373|Pain, Cancer|pain, cancer
76292|NCT03727373|Health technology|health technology
76293|NCT03727360|Walking Exercise|walking exercise
76294|NCT03727360|Flexibility Exercise|flexibility exercise
76295|NCT03727360|Cognition|cognition
76296|NCT03727360|Memory|memory
76297|NCT03727360|Magnetic Resonance Imaging|magnetic resonance imaging
76298|NCT03727321|Fecal microbial transplant|fecal microbial transplant
76299|NCT03727321|obesity|obesity
76300|NCT03727321|metabolic syndrome|metabolic syndrome
76301|NCT03727308|medical abortion|medical abortion
76302|NCT03727308|self-use|self-use
76303|NCT03727269|Wii Fit|wii fit
76304|NCT03727269|Urinary Incontinence|urinary incontinence
76305|NCT03727269|Females|females
76306|NCT03727269|Abdomino-Pelvic Training|abdomino-pelvic training
76307|NCT03727256|knee osteoarthritis|knee osteoarthritis
76308|NCT03727256|neuromuscular electrical stimulation|neuromuscular electrical stimulation
76309|NCT03727256|ultrasound therapy|ultrasound therapy
76310|NCT03727243|Pneumonia|pneumonia
76311|NCT03727243|Infection|infection
76312|NCT03727243|Tropical Infection|tropical infection
76313|NCT03727243|Endotypes|endotypes
76314|NCT03727243|Biomarkers|biomarkers
76315|NCT03727243|Immunephenotyping|immunephenotyping
76316|NCT03727243|Lower middle-income countries (LMIC)|lower middle-income countries (lmic)
76317|NCT03727243|Microbiome|microbiome
76318|NCT03727243|Post-sepsis survival|post-sepsis survival
76319|NCT03727243|Multi-omics|multi-omics
76320|NCT03727217|Thyroidectomy|thyroidectomy
76321|NCT03727217|Paralysis of Vocal Cords|paralysis of vocal cords
76322|NCT03727217|Ultrasound|ultrasound
76323|NCT03727204|Ultrasound|ultrasound
76324|NCT03727204|Ultrasonographic flow measures|ultrasonographic flow measures
76325|NCT03727204|Fluid treatment|fluid treatment
76326|NCT03727191|Deglutition disorders|deglutition disorders
76327|NCT03727191|Nutritional deficiency|nutritional deficiency
76328|NCT03727191|Chew problems|chew problems
76329|NCT03727191|Swallowing disorder|swallowing disorder
76330|NCT03727191|Nutritional formula|nutritional formula
76331|NCT03727191|Nutritional oral supplement|nutritional oral supplement
76332|NCT03727178|Acromioclavicular Joint Dislocation|acromioclavicular joint dislocation
76333|NCT03727178|AC joint dislocation|ac joint dislocation
76334|NCT03727178|Treatment|treatment
76335|NCT03727178|Conservative treatment|conservative treatment
76336|NCT03727178|Type III AC dislocation|type iii ac dislocation
76337|NCT03727178|Grade III AC dislocation|grade iii ac dislocation
76338|NCT03727178|AC joint|ac joint
76339|NCT03727178|Rockwood|rockwood
76340|NCT03727178|Rockwood type III|rockwood type iii
76341|NCT03727178|Rockwood grade III|rockwood grade iii
76342|NCT03727165|enteral nutrition|enteral nutrition
76343|NCT03727165|critically ill|critically ill
76344|NCT03727165|continous infusion|continous infusion
76345|NCT03727165|cyclic infusion|cyclic infusion
76346|NCT03727152|generic TAF/E/D|generic taf/e/d
76347|NCT03727152|virologically suppressed HIV-infected adults|virologically suppressed hiv-infected adults
76348|NCT03727152|pharmacokinetics (PK) parameters of DTG|pharmacokinetics (pk) parameters of dtg
76349|NCT03727152|psychiatric symptoms|psychiatric symptoms
76350|NCT03727152|metabolic syndrome|metabolic syndrome
76351|NCT03727152|ASCVD risk|ascvd risk
76352|NCT03727152|liver fibrosis|liver fibrosis
76353|NCT03727126|Esophagectomy|esophagectomy
76354|NCT03727126|Robotic esophagectomy|robotic esophagectomy
76355|NCT03727126|Laparoscopic esophagectomy|laparoscopic esophagectomy
76356|NCT03727126|Minimally invasive esophagectomy|minimally invasive esophagectomy
76357|NCT03727126|Ivor Lewis esophagectomy|ivor lewis esophagectomy
76358|NCT03727126|McKeown's esophagectomy|mckeown's esophagectomy
76359|NCT03727113|microbiota|microbiota
76360|NCT03727113|microbiome|microbiome
76361|NCT03727113|graft versus host disease|graft versus host disease
76362|NCT03727113|infection|infection
76363|NCT03727113|antibiotics|antibiotics
76364|NCT03727074|Actinic Keratosis ,AK|actinic keratosis ,ak
76365|NCT03727035|CD163, Chronic periodontitis|cd163, chronic periodontitis
98907|NCT03585335|BMI|bmi
76366|NCT03727022|SM04690|sm04690
76367|NCT03727022|Wnt pathway inhibitor|wnt pathway inhibitor
76368|NCT03727022|osteoarthritis|osteoarthritis
76369|NCT03727022|Samumed|samumed
76370|NCT03727009|blood draw|blood draw
76371|NCT03727009|sample collections|sample collections
76372|NCT03726996|Pediatric genetic disorder|pediatric genetic disorder
76373|NCT03726996|cognitive function|cognitive function
76374|NCT03726996|neuro-muscular disorder|neuro-muscular disorder
76375|NCT03726996|PLA2G6|pla2g6
76376|NCT03726983|gestational diabetes mellitus|gestational diabetes mellitus
76377|NCT03726983|pregnant women|pregnant women
76378|NCT03726983|e-health management|e-health management
76379|NCT03726983|metabolic syndrome|metabolic syndrome
76380|NCT03726905|CHF|chf
76381|NCT03726905|exercise|exercise
76382|NCT03726905|aerobic|aerobic
76383|NCT03726905|respiratory muscle training|respiratory muscle training
76384|NCT03726866|dyslipidemias|dyslipidemias
76385|NCT03726866|hypertension|hypertension
76386|NCT03726866|Drug-Drug interaction|drug-drug interaction
76387|NCT03726853|Acute upper respiratory infection|acute upper respiratory infection
76388|NCT03726853|Acute bronchitis|acute bronchitis
76389|NCT03726827|NAFLD|nafld
76390|NCT03726827|NASH|nash
76391|NCT03726827|cirrhosis|cirrhosis
76392|NCT03726827|fatty liver|fatty liver
76393|NCT03726827|incidence|incidence
76394|NCT03726827|fibroscan|fibroscan
76395|NCT03726801|Body image|body image
76396|NCT03726801|Conservative surgery|conservative surgery
76397|NCT03726801|Quality of life|quality of life
76398|NCT03726801|Breast cancer|breast cancer
76399|NCT03726801|Mastectomy|mastectomy
76400|NCT03726801|Ostomy|ostomy
76401|NCT03726801|Colon cancer|colon cancer
76402|NCT03726801|Self esteem|self esteem
76403|NCT03726788|knee|knee
76404|NCT03726788|Arthrosis|arthrosis
76405|NCT03726788|Botulinum toxin|botulinum toxin
76406|NCT03726788|Magnetic Resonance Imaging|magnetic resonance imaging
76407|NCT03726775|durvalumab|durvalumab
76408|NCT03726775|without prophylactic|without prophylactic
76409|NCT03726762|diet beverages|diet beverages
76410|NCT03726762|water|water
76411|NCT03726762|diabetes|diabetes
76412|NCT03726762|weight loss|weight loss
76413|NCT03726762|insulin sensitivity|insulin sensitivity
76414|NCT03726749|GCA|gca
76415|NCT03726749|Tocilizumab|tocilizumab
76416|NCT03726749|Prednisone|prednisone
76417|NCT03726697|Tahneek|tahneek
76418|NCT03726697|Neonatal; Hypoglycemia, Diabetes, Maternal|neonatal; hypoglycemia, diabetes, maternal
76419|NCT03726697|Neonatal Hypoglycemia|neonatal hypoglycemia
76420|NCT03726697|late preterm infants|late preterm infants
76421|NCT03726697|Prevention|prevention
76422|NCT03726697|IUGR|iugr
76423|NCT03726684|cochlear implant|cochlear implant
76424|NCT03726684|coding strategy|coding strategy
76425|NCT03726684|objective measures|objective measures
76426|NCT03726645|ankylosing spondylitis|ankylosing spondylitis
76427|NCT03726645|fecal microbiota transplantation|fecal microbiota transplantation
76428|NCT03726645|intestinal mucosal immunity|intestinal mucosal immunity
76429|NCT03726645|dysbiosis|dysbiosis
76430|NCT03726645|microbiome|microbiome
76431|NCT03726632|Elderly|elderly
76432|NCT03726632|Intoxication|intoxication
76433|NCT03726632|Poison Control centre|poison control centre
76434|NCT03726632|Poisoning|poisoning
76435|NCT03726632|Accidental exposure|accidental exposure
76436|NCT03726632|Prevention|prevention
76437|NCT03726606|Cataract|cataract
76438|NCT03726606|Intraocular lenses|intraocular lenses
76439|NCT03726606|Trifocal intraocular lenses|trifocal intraocular lenses
76440|NCT03726606|Extended depth of focus intraocular lenses|extended depth of focus intraocular lenses
76441|NCT03726606|Presbyopia|presbyopia
76442|NCT03726593|malaria|malaria
76443|NCT03726593|plasmodium falciparum|plasmodium falciparum
76444|NCT03726593|malarone|malarone
76445|NCT03726593|atovaquone|atovaquone
76446|NCT03726593|mefloquine|mefloquine
76447|NCT03726593|pyramax|pyramax
76448|NCT03726593|pyronaridine|pyronaridine
76449|NCT03726593|combination treatment|combination treatment
76450|NCT03726593|triple therapy|triple therapy
76451|NCT03726593|multidrug resistant malaria|multidrug resistant malaria
76452|NCT03726580|General anesthesia.|general anesthesia.
76453|NCT03726580|neurotoxicity,|neurotoxicity,
76454|NCT03726580|olfaction,|olfaction,
76455|NCT03726580|olfactory identification.|olfactory identification.
76456|NCT03726580|sevoflurane.|sevoflurane.
76457|NCT03726554|Reverse Shoulder Arthroplasty|reverse shoulder arthroplasty
76458|NCT03726554|Medical Device|medical device
76459|NCT03726554|Performance|performance
76460|NCT03726554|Safety|safety
76461|NCT03726554|Shoulder Prosthesis|shoulder prosthesis
76462|NCT03726554|Glenoid Erosion|glenoid erosion
76463|NCT03726502|Ureteral Calculi|ureteral calculi
76464|NCT03726502|safety guide-wire|safety guide-wire
76465|NCT03726502|ureteroscopy|ureteroscopy
76466|NCT03726450|myo-inositol|myo-inositol
76467|NCT03726450|N-acetyl-cysteine|n-acetyl-cysteine
76468|NCT03726450|semen hyperviscosity|semen hyperviscosity
76469|NCT03726450|idiopathic male infertility|idiopathic male infertility
76470|NCT03726424|pathogenic mutations|pathogenic mutations
76471|NCT03726424|clinical phenotype|clinical phenotype
76472|NCT03726424|prognosis|prognosis
76473|NCT03726411|periodontitis|periodontitis
76474|NCT03726411|Prolactin|prolactin
76475|NCT03726411|GCF|gcf
76476|NCT03726411|non-surgical periodontal treatment|non-surgical periodontal treatment
76477|NCT03726385|cerebral palsy|cerebral palsy
76478|NCT03726385|upper extremity rehabilitation|upper extremity rehabilitation
76479|NCT03726385|neurodevelopmental therapy|neurodevelopmental therapy
76480|NCT03726385|physiotherapy and rehabilitation|physiotherapy and rehabilitation
76481|NCT03726385|visual feedback device|visual feedback device
76482|NCT03726372|robotic surgery|robotic surgery
76483|NCT03726372|laparoscopic surgery|laparoscopic surgery
76484|NCT03726372|neuromuscular blockade|neuromuscular blockade
76485|NCT03726372|postoperative complication|postoperative complication
76486|NCT03726333|hepatic impairment|hepatic impairment
76487|NCT03726333|lorlatinib|lorlatinib
76488|NCT03726333|cancer|cancer
76489|NCT03726333|pharmacokinetic|pharmacokinetic
76490|NCT03726307|allogeneic regulatory dendritic cell therapy (DCreg)|allogeneic regulatory dendritic cell therapy (dcreg)
76491|NCT03726307|DCreg therapy|dcreg therapy
76492|NCT03726307|de novo live-donor renal transplant recipients|de novo live-donor renal transplant recipients
76493|NCT03726255|Perianal fistula|perianal fistula
76494|NCT03726255|compassionate use|compassionate use
76792|NCT03724331|Lung Cancer|lung cancer
76495|NCT03726255|mesenchymal stem cells|mesenchymal stem cells
76496|NCT03726229|liver disease|liver disease
76497|NCT03726203|Laparoscopy|laparoscopy
76498|NCT03726203|Trocar|trocar
76499|NCT03726203|MiniLap|minilap
76500|NCT03726203|surgery|surgery
76501|NCT03726203|gynecology|gynecology
76502|NCT03726203|pain, scars|pain, scars
76503|NCT03726203|scars|scars
76504|NCT03726190|Degenerative Disk Disease|degenerative disk disease
76505|NCT03726190|Lumbar Fusion|lumbar fusion
76506|NCT03726190|Minimally Invasive Surgery|minimally invasive surgery
76507|NCT03726190|Lumbar Disk Disease|lumbar disk disease
76508|NCT03726177|preeclampsia|preeclampsia
76509|NCT03726177|low dose aspirin|low dose aspirin
76510|NCT03726177|high risk pregnancy|high risk pregnancy
76511|NCT03726151|Human Papillomavirus|human papillomavirus
76512|NCT03726151|Immunization|immunization
76513|NCT03726151|Oncogenic viruses|oncogenic viruses
76514|NCT03726151|Cervical Cancer|cervical cancer
76515|NCT03726151|Health Disparities|health disparities
76516|NCT03726151|Comparative effectiveness|comparative effectiveness
76517|NCT03726151|System-level Intervention|system-level intervention
76518|NCT03726151|Federally Qualified Health Centers|federally qualified health centers
76519|NCT03726099|Concomitant Therapy|concomitant therapy
76520|NCT03726099|Rescue treatment|rescue treatment
76521|NCT03726086|larynx|larynx
76522|NCT03726086|injury|injury
76523|NCT03726086|voice|voice
76524|NCT03726086|trachea|trachea
76525|NCT03726073|cognitive function|cognitive function
76526|NCT03726073|elderly patients|elderly patients
76527|NCT03726073|acupoint stimulation|acupoint stimulation
76528|NCT03726034|Caregiver relationship|caregiver relationship
76529|NCT03726034|Life story book|life story book
76530|NCT03726034|migrant caregivers|migrant caregivers
76531|NCT03726034|older adults|older adults
76532|NCT03726034|randomized controlled trial|randomized controlled trial
76533|NCT03726021|overall survival; Irinotecan; Oxaliplatin; S1; Chemotherapy|overall survival; irinotecan; oxaliplatin; s1; chemotherapy
76534|NCT03725995|midazolam|midazolam
76535|NCT03725995|Lidocaine|lidocaine
76536|NCT03725995|Intranasal|intranasal
76537|NCT03725995|Burning|burning
76538|NCT03725995|Children|children
76539|NCT03725982|passive exoskeleton|passive exoskeleton
76540|NCT03725982|forward trunk flexion|forward trunk flexion
76541|NCT03725982|trunk rotation|trunk rotation
76542|NCT03725982|muscle activity|muscle activity
76543|NCT03725982|inverse dynamics|inverse dynamics
76544|NCT03725982|modelling|modelling
76545|NCT03725956|Nasal polyposis|nasal polyposis
76546|NCT03725956|sleep|sleep
76547|NCT03725956|sinus surgery|sinus surgery
76548|NCT03725956|polysomnography|polysomnography
76549|NCT03725956|quality of life|quality of life
76550|NCT03725943|Automated Sleep Staging|automated sleep staging
76551|NCT03725930|paediatric|paediatric
76552|NCT03725930|premedication|premedication
76553|NCT03725930|clonidine|clonidine
76554|NCT03725930|intranasal|intranasal
76555|NCT03725917|Prevention|prevention
76556|NCT03725917|Physiotherapy|physiotherapy
76557|NCT03725917|Diabetic Foot Ulcer|diabetic foot ulcer
76558|NCT03725917|Exercise Therapy|exercise therapy
76559|NCT03725917|Manual Therapy|manual therapy
76560|NCT03725904|Progesterone|progesterone
76561|NCT03725904|Saliva|saliva
76563|NCT03725904|Frozen embryo transfer|frozen embryo transfer
76564|NCT03725891|preeclampsia|preeclampsia
76565|NCT03725891|low dose aspirin|low dose aspirin
76566|NCT03725891|high risk pregnancy|high risk pregnancy
76567|NCT03725878|Birth Defects|birth defects
76568|NCT03725878|periconception|periconception
76569|NCT03725878|randomized controlled trial|randomized controlled trial
76570|NCT03725878|folate|folate
76571|NCT03725826|Sudden Cardiac Death|sudden cardiac death
76572|NCT03725826|Acute Myocardial Infarction|acute myocardial infarction
76573|NCT03725826|Implantable Cardioverter Defibrillator|implantable cardioverter defibrillator
76574|NCT03725826|Cardiac Magnetic Resonance|cardiac magnetic resonance
76575|NCT03725813|Person-centred care|person-centred care
76576|NCT03725813|Intervention|intervention
76577|NCT03725813|Inpatient care|inpatient care
76578|NCT03725813|Satisfaction of care|satisfaction of care
76579|NCT03725813|quasi-experimental|quasi-experimental
76580|NCT03725813|internal medicine|internal medicine
76581|NCT03725800|coronary heart disease|coronary heart disease
76582|NCT03725800|mono-antiplatelet drug|mono-antiplatelet drug
76583|NCT03725800|antiplatelet-induced gastrointestinal injury symptom|antiplatelet-induced gastrointestinal injury symptom
76584|NCT03725800|medication adherence|medication adherence
76585|NCT03725800|prospective observational study|prospective observational study
76586|NCT03725787|Static air support surface|static air support surface
76587|NCT03725787|Support device|support device
76588|NCT03725787|Elderly|elderly
76589|NCT03725787|Prevention|prevention
76590|NCT03725774|pain|pain
76591|NCT03725774|accidental falls|accidental falls
76592|NCT03725774|urinary incontinence|urinary incontinence
76593|NCT03725774|clinical audit|clinical audit
76594|NCT03725761|Prostate|prostate
76595|NCT03725748|saline, betadine, cesarean scar infection|saline, betadine, cesarean scar infection
76596|NCT03725735|Gambling disorder|gambling disorder
76597|NCT03725735|psychiatric comorbidities|psychiatric comorbidities
76598|NCT03725735|emotion regulation|emotion regulation
76599|NCT03725670|Metachromatic leukodystrophy (MLD)|metachromatic leukodystrophy (mld)
76600|NCT03725670|lentiviral vector|lentiviral vector
76601|NCT03725631|Magnetic resonance imager(MRI)|magnetic resonance imager(mri)
76602|NCT03725631|Nonalcoholic fatty liver disease(NAFLD)|nonalcoholic fatty liver disease(nafld)
76603|NCT03725631|Biomarker|biomarker
76604|NCT03725592|arsenic|arsenic
76605|NCT03725592|drinking water|drinking water
76606|NCT03725579|Anesthetic efficacy|anesthetic efficacy
76607|NCT03725579|Inferior alveolar nerve blocks|inferior alveolar nerve blocks
76608|NCT03725566|New vascular macular degeneration|new vascular macular degeneration
76609|NCT03725553|vasopressin|vasopressin
76610|NCT03725553|placenta previa|placenta previa
76611|NCT03725553|postpartum hemorrhage|postpartum hemorrhage
76612|NCT03725540|Laryngeal Masks|laryngeal masks
76613|NCT03725540|Oropharyngeal leak pressure|oropharyngeal leak pressure
76614|NCT03725540|I-gel laryngeal mask airway|i-gel laryngeal mask airway
76615|NCT03725488|Dental labs|dental labs
76616|NCT03725488|genre|genre
76617|NCT03725488|music|music
76618|NCT03725488|perceived stress scale|perceived stress scale
76619|NCT03725488|stress|stress
76620|NCT03725475|Lung Cancer|lung cancer
76621|NCT03725384|Anemia|anemia
76622|NCT03725384|Iron deficiency|iron deficiency
76623|NCT03725384|hemoglobin|hemoglobin
76624|NCT03725384|oral iron|oral iron
76625|NCT03725384|Ferrous sulfate|ferrous sulfate
76626|NCT03725358|adolescent sexual and reproductive health, maternal mortality, teen pregnancy, LARCs|adolescent sexual and reproductive health, maternal mortality, teen pregnancy, larcs
76627|NCT03725319|Endoscopic Biliary Sphincterotomy|endoscopic biliary sphincterotomy
76628|NCT03725319|Endoscopic Retrograde Cholangiopancreatography|endoscopic retrograde cholangiopancreatography
76629|NCT03725319|Bleeding|bleeding
76630|NCT03725319|Epinephrine|epinephrine
76631|NCT03725319|Stent|stent
76632|NCT03725306|Heavy Menstrual Bleeding|heavy menstrual bleeding
76633|NCT03725306|Endometrial Ablation|endometrial ablation
76634|NCT03725293|thrombosis|thrombosis
76635|NCT03725293|superficial venous thrombosis|superficial venous thrombosis
76636|NCT03725293|deep venous thrombosis|deep venous thrombosis
76637|NCT03725293|line related infection|line related infection
76638|NCT03725293|catheter survival|catheter survival
76639|NCT03725280|Micro RNA|micro rna
76640|NCT03725280|Ovarian Follicular fluid|ovarian follicular fluid
76641|NCT03725280|Transgender men|transgender men
76642|NCT03725280|Testosterone|testosterone
76643|NCT03725267|Melatonin|melatonin
76644|NCT03725267|Polymixin B|polymixin b
76645|NCT03725267|RIFLE|rifle
76646|NCT03725267|Nephrotoxicity|nephrotoxicity
76647|NCT03725254|Chemoradiotherapy|chemoradiotherapy
76648|NCT03725254|retroperitoneal lymphadenectomy|retroperitoneal lymphadenectomy
76649|NCT03725254|IMRT|imrt
76650|NCT03725254|SBRT|sbrt
76651|NCT03725215|Split-Belt Treadmill|split-belt treadmill
76652|NCT03725215|Training|training
76653|NCT03725202|Giant Cell Arteritis (GCA)|giant cell arteritis (gca)
76654|NCT03725202|ABT-494|abt-494
76655|NCT03725202|Upadacitinib|upadacitinib
76656|NCT03725189|Photophlethysmograph|photophlethysmograph
76657|NCT03725189|device|device
76658|NCT03725189|pulse waveform|pulse waveform
76659|NCT03725163|Trichotillomania|trichotillomania
76660|NCT03725163|Adolescents|adolescents
76661|NCT03725163|Telepsychotherapy|telepsychotherapy
76662|NCT03725163|AEBT|aebt
76663|NCT03725163|ACT|act
76664|NCT03725072|[14C]-evobrutinib|[14c]-evobrutinib
76665|NCT03725072|Healthy|healthy
76666|NCT03725072|Pharmacokinetics|pharmacokinetics
76667|NCT03725072|Metabolism|metabolism
76668|NCT03725072|Excretion|excretion
76669|NCT03725059|PD1|pd1
76670|NCT03725059|PD-1|pd-1
76671|NCT03725059|PDL1|pdl1
76672|NCT03725059|PD-L1|pd-l1
76673|NCT03725020|Orthodontics|orthodontics
76674|NCT03725020|Fixed appliance|fixed appliance
76675|NCT03725020|White Spot Lesions|white spot lesions
76676|NCT03725020|Fluoride varnish|fluoride varnish
76677|NCT03725007|Upadacitinib|upadacitinib
76678|NCT03725007|ABT-494|abt-494
76679|NCT03725007|Polyarticular Course Juvenile Idiopathic Arthritis (pcJIA)|polyarticular course juvenile idiopathic arthritis (pcjia)
76680|NCT03724994|chemotherapy|chemotherapy
76681|NCT03724994|adjuvant|adjuvant
76682|NCT03724994|palliative|palliative
76683|NCT03724994|prognostic|prognostic
76684|NCT03724994|predictive|predictive
76685|NCT03724994|immune response|immune response
76686|NCT03724994|biomarkers|biomarkers
76687|NCT03724994|mutations|mutations
76688|NCT03724994|cytokines|cytokines
76689|NCT03724994|immune cell signatures|immune cell signatures
76690|NCT03724955|Hypogonadism|hypogonadism
76691|NCT03724955|Estrogen Supplement|estrogen supplement
76692|NCT03724929|Ulcerative Colitis|ulcerative colitis
76693|NCT03724929|Vedolizumab|vedolizumab
76694|NCT03724929|anti-vedolizumab|anti-vedolizumab
76703|NCT03724825|Adropin|adropin
76704|NCT03724825|adiponectin|adiponectin
76705|NCT03724825|testosterone|testosterone
76706|NCT03724825|obese men|obese men
76707|NCT03724812|Aortic Stenosis|aortic stenosis
76708|NCT03724812|FlexNav™ Delivery System|flexnav™ delivery system
76709|NCT03724812|Portico Delivery System|portico delivery system
76710|NCT03724812|Transcatheter Aortic Valve Replacement|transcatheter aortic valve replacement
76711|NCT03724812|Heart Valve Disease|heart valve disease
76712|NCT03724812|High surgical risk|high surgical risk
76713|NCT03724773|Closed Reduction|closed reduction
76714|NCT03724773|Sugar-Tong Splint|sugar-tong splint
76715|NCT03724773|Long-Arm Cast|long-arm cast
76716|NCT03724747|Metastatic castration resistant prostate cancer, thorium-227, targeted alpha therapy,PSMA|metastatic castration resistant prostate cancer, thorium-227, targeted alpha therapy,psma
76717|NCT03724734|subthalamic nucleus|subthalamic nucleus
76718|NCT03724734|deep brain stimulation|deep brain stimulation
76719|NCT03724734|closed-loop|closed-loop
76720|NCT03724721|Pneumothorax,Vacuum bottle|pneumothorax,vacuum bottle
76721|NCT03724708|IUD expulsion|iud expulsion
76722|NCT03724708|hang up technique|hang up technique
76723|NCT03724708|postpartum insertion|postpartum insertion
76724|NCT03724656|Transcutaneous Acupoint Electrical Stimulation|transcutaneous acupoint electrical stimulation
76725|NCT03724656|non-gastrointestinal abdominal surgery|non-gastrointestinal abdominal surgery
76726|NCT03724656|gastrointestinal motility|gastrointestinal motility
76727|NCT03724643|Mechanical ventilation|mechanical ventilation
76728|NCT03724643|Ventilator weaning|ventilator weaning
76729|NCT03724643|Extubation|extubation
76730|NCT03724617|thin endometrium|thin endometrium
76731|NCT03724617|Intrauterine Adhesion|intrauterine adhesion
76732|NCT03724617|stem cell|stem cell
76733|NCT03724617|Collagen scaffold|collagen scaffold
76734|NCT03724604|Neuron-Specific Enolase|neuron-specific enolase
76735|NCT03724604|Albumin|albumin
76736|NCT03724604|Prognostic Biomarker|prognostic biomarker
76737|NCT03724591|left colic artery|left colic artery
76738|NCT03724591|rectal cancer|rectal cancer
76739|NCT03724565|endoscopy, gastrointestinal|endoscopy, gastrointestinal
76740|NCT03724565|air pollution, indoor|air pollution, indoor
76741|NCT03724565|Respiratory Protective Devices|respiratory protective devices
76742|NCT03724552|photobiomodulation|photobiomodulation
76743|NCT03724539|Drug utilization review|drug utilization review
76744|NCT03724539|Old age|old age
76745|NCT03724526|Diabetes Mellitus|diabetes mellitus
76746|NCT03724526|cardiovascular disease|cardiovascular disease
76747|NCT03724526|text message|text message
76748|NCT03724513|High Altitude|high altitude
76749|NCT03724513|Gastric Antrum Perforation|gastric antrum perforation
76750|NCT03724513|Mucosal Atrophy|mucosal atrophy
76751|NCT03724513|Intra Luminal Pressure|intra luminal pressure
76752|NCT03724500|Non small cell lung cancer|non small cell lung cancer
76753|NCT03724500|Circulating tumor cell|circulating tumor cell
76754|NCT03724474|Physical Activity|physical activity
76755|NCT03724474|Sleep|sleep
76756|NCT03724474|Smartphones|smartphones
76757|NCT03724474|Wearable Activity Monitors|wearable activity monitors
76758|NCT03724474|Smart Coaches|smart coaches
76759|NCT03724461|resistance training|resistance training
76760|NCT03724461|sarcopenia|sarcopenia
76761|NCT03724461|hypertrophy|hypertrophy
76762|NCT03724461|tendon|tendon
76763|NCT03724461|frailty|frailty
76764|NCT03724461|ageing|ageing
76765|NCT03724435|pancreatic cancer|pancreatic cancer
76766|NCT03724435|focused ultrasound|focused ultrasound
76767|NCT03724422|Herteropic Ossification|herteropic ossification
76768|NCT03724409|PRRT|prrt
76769|NCT03724409|Radionuclide|radionuclide
76770|NCT03724409|DOTATOC|dotatoc
76771|NCT03724409|intra-arterial|intra-arterial
76772|NCT03724409|peptide receptor radiotherapy|peptide receptor radiotherapy
76773|NCT03724396|weight loss|weight loss
76774|NCT03724396|executive function|executive function
76775|NCT03724383|Non-permanent atrial fibrillation|non-permanent atrial fibrillation
76776|NCT03724383|Non-valvular atrial fibrillation|non-valvular atrial fibrillation
76777|NCT03724383|Nutrition|nutrition
76778|NCT03724383|Diet|diet
76779|NCT03724383|Exercise|exercise
76780|NCT03724383|Physical Activity|physical activity
76781|NCT03724383|Sleep Apnea|sleep apnea
76782|NCT03724383|Cardiovascular Risk|cardiovascular risk
76783|NCT03724383|Obesity|obesity
76784|NCT03724383|Hypertension|hypertension
76785|NCT03724383|Diabetes|diabetes
76786|NCT03724383|Risk Factor Management|risk factor management
76787|NCT03724331|Cancer-Related Fatigue|cancer-related fatigue
76788|NCT03724331|Fatigue|fatigue
76789|NCT03724331|Symptoms|symptoms
76790|NCT03724331|Functional Status|functional status
76791|NCT03724331|Quality of Life|quality of life
76793|NCT03724331|Rehabilitation|rehabilitation
76794|NCT03724331|Exercise|exercise
76795|NCT03724331|Physical Activity|physical activity
76796|NCT03724331|Self-Efficacy|self-efficacy
76797|NCT03724331|Self-Management|self-management
76798|NCT03724318|Left Atrium Appendage|left atrium appendage
76799|NCT03724318|Atrial Fibrillation|atrial fibrillation
76800|NCT03724318|Stroke|stroke
76801|NCT03724318|Heart Surgery|heart surgery
76802|NCT03724305|insomnia|insomnia
76803|NCT03724305|nocturnal rumination|nocturnal rumination
76804|NCT03724305|telemedicine CBTI|telemedicine cbti
76805|NCT03724305|digital CBTI|digital cbti
76806|NCT03724292|Moderate to severe chronic plaque-type psoriasis|moderate to severe chronic plaque-type psoriasis
76807|NCT03724227|Expanded Access|expanded access
76808|NCT03724227|Compassionate Use|compassionate use
76809|NCT03724214|Gastroschisis|gastroschisis
76810|NCT03724214|Sub-Saharan Africa|sub-saharan africa
76811|NCT03724214|Low-resource settings|low-resource settings
76812|NCT03724214|Low- and middle-income countries|low- and middle-income countries
76813|NCT03724214|Mortality|mortality
76814|NCT03724214|Outcomes|outcomes
76815|NCT03724214|Implementation science|implementation science
76816|NCT03724214|Intervention|intervention
76817|NCT03724201|Delirium|delirium
76818|NCT03724201|Confusion|confusion
76819|NCT03724201|Neurobehavioral Manifestations|neurobehavioral manifestations
76820|NCT03724201|Neurologic Manifestations|neurologic manifestations
76821|NCT03724201|Nervous System Diseases|nervous system diseases
76822|NCT03724201|Signs and Symptoms|signs and symptoms
76823|NCT03724201|Neurocognitive Disorders|neurocognitive disorders
76824|NCT03724201|Mental Disorders|mental disorders
76825|NCT03724201|Biomarkers|biomarkers
76826|NCT03724201|Pathophysiology|pathophysiology
76827|NCT03724175|Ulcerative Colitis|ulcerative colitis
76828|NCT03724175|Pouchitis|pouchitis
76829|NCT03724162|cancer oesophagus|cancer oesophagus
76830|NCT03724149|Lung Disease|lung disease
76831|NCT03724136|Dementia|dementia
76832|NCT03724136|Alzheimer's Disease|alzheimer's disease
76833|NCT03724136|CADASIL|cadasil
76834|NCT03724136|Autism Spectrum Disorder|autism spectrum disorder
76835|NCT03724136|Adult Autism|adult autism
76836|NCT03724136|High Functioning Autism|high functioning autism
76837|NCT03724136|Asperger's Syndrome|asperger's syndrome
76838|NCT03724136|CTE Chronic Traumatic Encephalopathy|cte chronic traumatic encephalopathy
76839|NCT03724136|TBI Traumatic Brain Injury|tbi traumatic brain injury
76840|NCT03724136|LATE Limbic-predominant Age-related TDP-43 Encephalopathy|late limbic-predominant age-related tdp-43 encephalopathy
76841|NCT03724123|random forests|random forests
76842|NCT03724123|heart valve surgery|heart valve surgery
76843|NCT03724123|support vector machines|support vector machines
76844|NCT03724123|artificial neural networks|artificial neural networks
76845|NCT03724110|Telestroke|telestroke
76846|NCT03724110|Telemedicine|telemedicine
76847|NCT03724110|Secondary stroke prevention|secondary stroke prevention
76848|NCT03724097|biomarkers|biomarkers
76849|NCT03724097|target therapy|target therapy
76850|NCT03724097|NGS|ngs
76851|NCT03724097|RNAseq|rnaseq
76852|NCT03724097|mRNA|mrna
76853|NCT03724097|transcriptome analysis|transcriptome analysis
76854|NCT03724097|signaling pathway|signaling pathway
76855|NCT03724097|intracellular molecular pathway|intracellular molecular pathway
76856|NCT03724097|Oncobox|oncobox
76857|NCT03724097|Next generation sequencing|next generation sequencing
76858|NCT03724097|RNA sequencing|rna sequencing
76859|NCT03724019|Ketamine|ketamine
76860|NCT03724019|QoR-15|qor-15
76861|NCT03724019|Laparoscopic surgery|laparoscopic surgery
76862|NCT03724006|Congenital Heart Defects|congenital heart defects
76863|NCT03724006|Diagnosis|diagnosis
76864|NCT03724006|Parents|parents
76865|NCT03724006|Quality of Life|quality of life
76866|NCT03724006|Education|education
76867|NCT03723993|Ischemic preconditioning|ischemic preconditioning
76868|NCT03723993|Lactate level|lactate level
76869|NCT03723993|Cardiopulmonary bypass|cardiopulmonary bypass
76870|NCT03723980|Flare up|flare up
76994|NCT03723096|Expanded Access|expanded access
76871|NCT03723967|Squamous Cell Carcinoma of the Head and Neck|squamous cell carcinoma of the head and neck
76872|NCT03723967|Recurrent / metastatic SCCHN|recurrent / metastatic scchn
76873|NCT03723967|Frail patients|frail patients
76874|NCT03723967|GORTEC|gortec
76875|NCT03723941|Adrenocortical Carcinoma|adrenocortical carcinoma
76876|NCT03723941|Adjuvant Chemotherapy|adjuvant chemotherapy
76877|NCT03723902|Strength training|strength training
76878|NCT03723902|Pre-frail|pre-frail
76879|NCT03723889|Near Infrared Spectroscopy|near infrared spectroscopy
76880|NCT03723889|preterm infants|preterm infants
76881|NCT03723889|intestinal complications|intestinal complications
76882|NCT03723876|Autism|autism
76883|NCT03723876|Movement|movement
76884|NCT03723876|Body-mind therapy|body-mind therapy
76885|NCT03723876|Physiotherapy|physiotherapy
76886|NCT03723850|Transcranial Direct Current Stimulation|transcranial direct current stimulation
76887|NCT03723850|Memory|memory
76888|NCT03723850|Prefrontal Cortex|prefrontal cortex
76889|NCT03723837|IPV|ipv
76890|NCT03723837|Routine immunization|routine immunization
76891|NCT03723837|Single dose|single dose
76892|NCT03723837|Persistence of immunity|persistence of immunity
76893|NCT03723733|amygdala|amygdala
76894|NCT03723733|mirror neuron system|mirror neuron system
76895|NCT03723733|brain network|brain network
76896|NCT03723668|kidney transplantation|kidney transplantation
76897|NCT03723668|allograft survival|allograft survival
76898|NCT03723655|Symptomatic, left ventricular outflow tract gradient|symptomatic, left ventricular outflow tract gradient
76899|NCT03723642|acute appendicitis|acute appendicitis
76900|NCT03723642|volatile organic compounds|volatile organic compounds
76901|NCT03723642|oxidative stress|oxidative stress
76902|NCT03723642|laparoscopic appendectomy|laparoscopic appendectomy
76903|NCT03723642|open appendectomy|open appendectomy
76904|NCT03723629|Ground glass opacity|ground glass opacity
76905|NCT03723616|Hookah|hookah
76906|NCT03723616|Shisha|shisha
76907|NCT03723616|Tobacco|tobacco
76908|NCT03723616|Narghile|narghile
76909|NCT03723564|bilateral renal agenesis|bilateral renal agenesis
76910|NCT03723564|lower urinary tract obstruction|lower urinary tract obstruction
76911|NCT03723564|congenital renal anomalies|congenital renal anomalies
76912|NCT03723564|fetal surgery|fetal surgery
76913|NCT03723564|amnioinfusion|amnioinfusion
76914|NCT03723564|fetus|fetus
76915|NCT03723525|Package of care|package of care
76916|NCT03723525|Rapid Initiation of antiretroviral therapy|rapid initiation of antiretroviral therapy
76917|NCT03723525|Advanced HIV disease|advanced hiv disease
76918|NCT03723525|mHealth|mhealth
76919|NCT03723525|Acquired Immunodeficiency Syndrome|acquired immunodeficiency syndrome
76920|NCT03723525|Management of advance HIV disease|management of advance hiv disease
76921|NCT03723512|Non-contrast enhanced MRI|non-contrast enhanced mri
76922|NCT03723512|Diffusivity|diffusivity
76923|NCT03723512|Renal microstructure|renal microstructure
76924|NCT03723512|Renal function|renal function
76925|NCT03723512|C3G|c3g
76926|NCT03723512|IC-MPGN|ic-mpgn
76927|NCT03723499|Carcinoid tumors|carcinoid tumors
76928|NCT03723499|Endoscopic treatment|endoscopic treatment
76929|NCT03723499|Recurrence|recurrence
76930|NCT03723486|Morbidly obese|morbidly obese
76931|NCT03723486|Insulin resistance|insulin resistance
76932|NCT03723486|Metabolic syndrome|metabolic syndrome
76933|NCT03723486|Intestinal microbiome|intestinal microbiome
76934|NCT03723486|Gastric bypass|gastric bypass
76935|NCT03723486|Oral microbiome|oral microbiome
76936|NCT03723473|Peripheral Arterial Occlusive Disease (PAOD)|peripheral arterial occlusive disease (paod)
76937|NCT03723473|Phosphorus-31|phosphorus-31
76938|NCT03723473|Magnetic Resonance Imaging (MRI)|magnetic resonance imaging (mri)
76939|NCT03723473|Spectroscopy|spectroscopy
76940|NCT03723473|Revascularization|revascularization
76941|NCT03723473|Claudication with surgical planning|claudication with surgical planning
76942|NCT03723460|Dietary Intake Assessment|dietary intake assessment
76943|NCT03723460|Malnutrition|malnutrition
76944|NCT03723447|transversus abdominis plane block|transversus abdominis plane block
76945|NCT03723447|tap block|tap block
76946|NCT03723447|liposomal bupivacaine|liposomal bupivacaine
76947|NCT03723447|exparel|exparel
76948|NCT03723447|dexamethasone|dexamethasone
76949|NCT03723447|colorectal surgery|colorectal surgery
76950|NCT03723447|regional anesthesia|regional anesthesia
76951|NCT03723447|bupivacaine|bupivacaine
76952|NCT03723447|surgery|surgery
76953|NCT03723447|postoperative pain|postoperative pain
76954|NCT03723447|pain|pain
76955|NCT03723434|Human|human
76956|NCT03723434|Brain|brain
76957|NCT03723434|Connectivity|connectivity
76958|NCT03723434|Stroke|stroke
76959|NCT03723434|Traumatic brain injury|traumatic brain injury
76960|NCT03723434|Multiple sclerosis|multiple sclerosis
76961|NCT03723434|Transcranial magnetic stimulation|transcranial magnetic stimulation
76962|NCT03723434|Paired associative stimulation|paired associative stimulation
76963|NCT03723434|Electroencephalography|electroencephalography
76964|NCT03723434|Magnetic resonance imaging|magnetic resonance imaging
76965|NCT03723421|pain management|pain management
76966|NCT03723421|Vaccination|vaccination
76967|NCT03723421|Aspiration|aspiration
76968|NCT03723330|Endothelial function|endothelial function
76969|NCT03723330|Blood pressure|blood pressure
76970|NCT03723330|healthy diet|healthy diet
76971|NCT03723291|Head and Neck|head and neck
76972|NCT03723278|nitric oxide|nitric oxide
76973|NCT03723252|Nonalcoholic Steatohepatitis|nonalcoholic steatohepatitis
76974|NCT03723252|SGLT-2 inhibitor|sglt-2 inhibitor
76975|NCT03723239|Tricuspid Valve Insufficiency|tricuspid valve insufficiency
76976|NCT03723239|Heart Valve Diseases|heart valve diseases
76977|NCT03723239|Heart Diseases|heart diseases
76978|NCT03723239|Cardiovascular Diseases|cardiovascular diseases
76979|NCT03723213|stroke|stroke
76980|NCT03723213|occupational therapy|occupational therapy
76981|NCT03723213|activity daily living|activity daily living
76982|NCT03723200|Hemorrhagic|hemorrhagic
76983|NCT03723200|Obstetric|obstetric
76984|NCT03723200|Fibrinogen|fibrinogen
76985|NCT03723187|intravenous port|intravenous port
77280|NCT03720938|obesity|obesity
76986|NCT03723187|port maintenancem|port maintenancem
76987|NCT03723148|Expanded Access|expanded access
76988|NCT03723148|Compassionate Use|compassionate use
76989|NCT03723135|Expanded Access|expanded access
76990|NCT03723135|Compassionate Use|compassionate use
76991|NCT03723122|Psychological intervention|psychological intervention
76992|NCT03723122|Dyadic communication|dyadic communication
76993|NCT03723122|Dyadic adaptation to cancer|dyadic adaptation to cancer
76995|NCT03723096|Compassionate Use|compassionate use
76996|NCT03723083|Expanded Access|expanded access
76997|NCT03723083|Compassionate Use|compassionate use
76998|NCT03723057|Expanded Access|expanded access
76999|NCT03723057|Compassionate Use|compassionate use
77000|NCT03723044|Multistable Perception|multistable perception
77001|NCT03723044|Micro eye movement|micro eye movement
77002|NCT03723044|Electroencephalography|electroencephalography
77003|NCT03723031|hemorrhage|hemorrhage
77004|NCT03723031|misopristol|misopristol
77005|NCT03723031|Cesarean section|cesarean section
77006|NCT03722966|smoking cessation|smoking cessation
77007|NCT03722966|varenicline|varenicline
77008|NCT03722966|nicotine gum|nicotine gum
77009|NCT03722966|nicotine lozenges|nicotine lozenges
77010|NCT03722966|nicotine replacement therapy|nicotine replacement therapy
77011|NCT03722966|adherence|adherence
77012|NCT03722966|mHealth|mhealth
77013|NCT03722953|Exercise|exercise
77014|NCT03722953|Treadmill|treadmill
77015|NCT03722953|Vascular Function|vascular function
77016|NCT03722953|Intensity|intensity
77017|NCT03722927|Bupivacaine|bupivacaine
77018|NCT03722927|Liposomal Bupivacaine|liposomal bupivacaine
77019|NCT03722927|Mastectomy|mastectomy
77020|NCT03722927|Breast Reconstruction|breast reconstruction
77021|NCT03722927|Pain Control|pain control
77022|NCT03722849|functional brain imaging|functional brain imaging
77023|NCT03722849|ATP|atp
77024|NCT03722849|Capsaicin|capsaicin
77025|NCT03722849|Refractory cough|refractory cough
77026|NCT03722810|Medical Professionalism|medical professionalism
77027|NCT03722810|Professionalism Education|professionalism education
77028|NCT03722797|energy metabolism|energy metabolism
77029|NCT03722797|walking|walking
77030|NCT03722797|exercise|exercise
77031|NCT03722771|Lavandula|lavandula
77032|NCT03722771|phytotherapy|phytotherapy
77033|NCT03722771|aromatherapy|aromatherapy
77034|NCT03722771|dental anxiety|dental anxiety
77035|NCT03722771|anaesthesia|anaesthesia
77036|NCT03722758|micro hybrid resin composite|micro hybrid resin composite
77037|NCT03722758|resin-modified glass ionomer|resin-modified glass ionomer
77038|NCT03722758|split-mouth randomized clinical trial|split-mouth randomized clinical trial
77039|NCT03722719|Urinary Incontinence, Stress|urinary incontinence, stress
77040|NCT03722719|Physical Therapy Modalities|physical therapy modalities
77041|NCT03722680|Riluzole|riluzole
77042|NCT03722680|oxaliplatin|oxaliplatin
77043|NCT03722680|colorectal cancer|colorectal cancer
77044|NCT03722680|neuropathy|neuropathy
77045|NCT03722654|Adolescents|adolescents
77046|NCT03722654|Conduct problems|conduct problems
77047|NCT03722654|Delinquency|delinquency
77048|NCT03722654|Substance misuse|substance misuse
77049|NCT03722602|stroke|stroke
77050|NCT03722602|BMI|bmi
77051|NCT03722602|body composition|body composition
77052|NCT03722602|functional scales|functional scales
77053|NCT03722563|lateral suspension|lateral suspension
77054|NCT03722563|laparoscopic hysterectomy|laparoscopic hysterectomy
77055|NCT03722563|pelvic organ prolapse|pelvic organ prolapse
99730|NCT03580174|ICF|icf
77056|NCT03722563|sacrocolpopexy|sacrocolpopexy
77057|NCT03722537|Allograft|allograft
77058|NCT03722537|Osteochondral Allograft|osteochondral allograft
77059|NCT03722537|Arthritis|arthritis
77060|NCT03722511|Enterade|enterade
77061|NCT03722511|Medical Food/Drink|medical food/drink
77062|NCT03722498|Hepatic arterial infusion chemotherapy|hepatic arterial infusion chemotherapy
77063|NCT03722498|Sorafenib|sorafenib
77064|NCT03722472|Vaccine, recombinant, adjuvant, GLA-SE, ID93|vaccine, recombinant, adjuvant, gla-se, id93
77065|NCT03722407|CMML|cmml
77066|NCT03722355|Glioma|glioma
77067|NCT03722355|Glioblastoma|glioblastoma
77068|NCT03722355|Glioblastoma multiforme|glioblastoma multiforme
77069|NCT03722355|Astrocytoma|astrocytoma
77070|NCT03722303|carpal|carpal
77071|NCT03722303|tunnel|tunnel
77072|NCT03722303|injection|injection
77073|NCT03722303|steroid|steroid
77074|NCT03722303|lipografting|lipografting
77075|NCT03722303|numbness|numbness
77076|NCT03722303|tingling|tingling
77077|NCT03722303|median nerve|median nerve
77078|NCT03722290|Metformin|metformin
77079|NCT03722290|Insulin signalisation|insulin signalisation
77080|NCT03722251|appetite, food intake, active gaming|appetite, food intake, active gaming
77081|NCT03722199|flavanols|flavanols
77082|NCT03722199|diabetes type 2|diabetes type 2
77083|NCT03722199|essential hypertension|essential hypertension
77084|NCT03722199|vascular function (peripheral and cerebral)|vascular function (peripheral and cerebral)
77085|NCT03722186|advanced solid tumor|advanced solid tumor
77086|NCT03722186|R/R lymphoma|r/r lymphoma
77087|NCT03722147|immunotherapy|immunotherapy
77088|NCT03722147|immuno-oncology|immuno-oncology
77089|NCT03722147|Classic Hodgkin Lymphoma|classic hodgkin lymphoma
77090|NCT03722134|Great saphenous vein|great saphenous vein
77091|NCT03722134|Thermal ablation|thermal ablation
77092|NCT03722134|Mechanochemical ablation|mechanochemical ablation
77093|NCT03722134|Randomized controlled trial|randomized controlled trial
77094|NCT03722121|distance|distance
77095|NCT03722108|adenocarcinoma|adenocarcinoma
77096|NCT03722108|gastro-oesophageal|gastro-oesophageal
77097|NCT03722108|regorafenib|regorafenib
77098|NCT03722095|Non-invasive Brain Stimulation|non-invasive brain stimulation
77099|NCT03722095|intermittent Theta Burst Stimulation (iTBS)|intermittent theta burst stimulation (itbs)
77100|NCT03722095|Transcranial Direct Current Stimulation (tDCS)|transcranial direct current stimulation (tdcs)
77101|NCT03722095|Dorsolateral Prefrontal Cortex|dorsolateral prefrontal cortex
77102|NCT03722095|Stress reactivity|stress reactivity
77103|NCT03722095|Stress-related Disorders|stress-related disorders
77104|NCT03722095|Major Depressive Disorder|major depressive disorder
77105|NCT03722082|bipolar disorder|bipolar disorder
77106|NCT03722082|schizophrenia|schizophrenia
77107|NCT03722082|offsprings|offsprings
77108|NCT03722069|Hyponatremia|hyponatremia
77109|NCT03722069|Sodium Intake|sodium intake
77110|NCT03722069|Blood Pressure|blood pressure
77111|NCT03722069|Sodium Chloride|sodium chloride
77112|NCT03722056|Gastric GISTs|gastric gists
77113|NCT03722056|Submucosal tumours|submucosal tumours
77114|NCT03722056|Benign gastric lesions|benign gastric lesions
77115|NCT03722056|Laparoscopic wedge resection|laparoscopic wedge resection
77116|NCT03722030|Strength Training|strength training
77117|NCT03722030|Resistance Training|resistance training
77119|NCT03722030|Sedentary|sedentary
77120|NCT03722017|deprescriptions|deprescriptions
77121|NCT03722017|polypharmacy|polypharmacy
77122|NCT03722017|potentially inappropriate medication|potentially inappropriate medication
77123|NCT03722017|medication adherence|medication adherence
77124|NCT03722004|monovalent oral poliovirus vaccine type 1|monovalent oral poliovirus vaccine type 1
77125|NCT03722004|bivalent oral poliovirus vaccine|bivalent oral poliovirus vaccine
77126|NCT03722004|inactivated poliovirus vaccine|inactivated poliovirus vaccine
77127|NCT03722004|fractional inactivated poliovirus vaccine|fractional inactivated poliovirus vaccine
77128|NCT03722004|humoral immunity|humoral immunity
77129|NCT03722004|intestinal immunity|intestinal immunity
77130|NCT03722004|Bangladesh|bangladesh
77131|NCT03721991|beta cell|beta cell
77132|NCT03721978|Cervical intraepithelial neoplasia (CIN)|cervical intraepithelial neoplasia (cin)
77134|NCT03721978|CIN 3|cin 3
77135|NCT03721978|Human papillomavirus (HPV)|human papillomavirus (hpv)
77136|NCT03721978|HPV-16|hpv-16
77137|NCT03721978|HPV-18|hpv-18
77138|NCT03721978|High Grade Squamous Intraepithelial Lesion (HSIL)|high grade squamous intraepithelial lesion (hsil)
77139|NCT03721978|papillomavirus|papillomavirus
77140|NCT03721965|Acute graft-versus-host disease|acute graft-versus-host disease
77141|NCT03721965|GVHD|gvhd
77142|NCT03721965|pediatric|pediatric
77143|NCT03721965|JAK1 inhibitor|jak1 inhibitor
77144|NCT03721965|corticosteroids|corticosteroids
77145|NCT03721926|Other Cancer|other cancer
77146|NCT03721913|Autism|autism
77147|NCT03721913|participation-based intervention|participation-based intervention
77148|NCT03721913|community participation|community participation
821483|NCT00151008|UVB|uvb
77149|NCT03721913|family empowerment|family empowerment
77150|NCT03721913|randomized controlled trial|randomized controlled trial
77151|NCT03721900|Depression|depression
77152|NCT03721887|Parkinson's disease|parkinson's disease
77153|NCT03721887|Multiple system atrophy|multiple system atrophy
77154|NCT03721887|Freezing of gait|freezing of gait
77155|NCT03721887|Transcranial direct current stimulation|transcranial direct current stimulation
77156|NCT03721874|Dapagliflozin|dapagliflozin
77157|NCT03721874|Disrupted glucose homeostasis|disrupted glucose homeostasis
77158|NCT03721874|Nocturnal substrate oxidation|nocturnal substrate oxidation
77159|NCT03721874|Glucose metabolism|glucose metabolism
77160|NCT03721861|neural stimulation|neural stimulation
77161|NCT03721861|quadriplegia|quadriplegia
77162|NCT03721861|grasping|grasping
77163|NCT03721835|Femoral Neck Fracture|femoral neck fracture
77164|NCT03721835|Hip|hip
77165|NCT03721835|Broken hip|broken hip
77166|NCT03721835|CONQUEST FN|conquest fn
77167|NCT03721835|Hip Fracture|hip fracture
77168|NCT03721783|cryoablation|cryoablation
77169|NCT03721783|pediatric|pediatric
77170|NCT03721783|registry|registry
77171|NCT03721770|organ donation|organ donation
77172|NCT03721770|family|family
77173|NCT03721770|Post Traumatic Stress Disorder|post traumatic stress disorder
77174|NCT03721770|Bereavement|bereavement
77175|NCT03721757|Head and Neck cancer|head and neck cancer
77176|NCT03721757|Squamous cell carcinoma|squamous cell carcinoma
77177|NCT03721744|Pancreatic Cancer|pancreatic cancer
77178|NCT03721718|MERS CoV|mers cov
77179|NCT03721718|MERS-CoV|mers-cov
77180|NCT03721718|Middle East Respiratory Syndrome|middle east respiratory syndrome
77181|NCT03721718|MERS|mers
77182|NCT03721718|DNA Vaccine|dna vaccine
77183|NCT03721679|Immunotherapy|immunotherapy
77184|NCT03721679|Vaccine Therapy|vaccine therapy
77185|NCT03721666|Dispatcher-assisted cardiopulmonary resuscitation|dispatcher-assisted cardiopulmonary resuscitation
77186|NCT03721666|Out-Of-Hospital Cardiac Arrest|out-of-hospital cardiac arrest
77187|NCT03721666|Emergency Medical dispatcher|emergency medical dispatcher
77188|NCT03721653|FOLFOXIRI|folfoxiri
77189|NCT03721653|Bevacizumab|bevacizumab
77190|NCT03721653|Atezolizumab|atezolizumab
77191|NCT03721640|INSURE (Intubation / surfactant / extubation)|insure (intubation / surfactant / extubation)
77192|NCT03721640|LISA (Less-invasive surfactant administration)|lisa (less-invasive surfactant administration)
77193|NCT03721640|surfactant|surfactant
77194|NCT03721640|propofol|propofol
77195|NCT03721627|Ledipasvir/Sofosbuvir|ledipasvir/sofosbuvir
77196|NCT03721627|Gaucher disease|gaucher disease
77197|NCT03721627|HCV|hcv
77198|NCT03721601|atrial fibrillation|atrial fibrillation
77199|NCT03721601|stroke|stroke
77200|NCT03721601|atrial fibrillation screening|atrial fibrillation screening
77201|NCT03721601|heart rate monitoring|heart rate monitoring
77202|NCT03721562|Antibiotic Resistance|antibiotic resistance
77203|NCT03721562|Gram Negative Bacteria|gram negative bacteria
77204|NCT03721562|Pediatric Patients|pediatric patients
77205|NCT03721536|Morbidly obese patients|morbidly obese patients
77206|NCT03721536|Bariatric surgery|bariatric surgery
77207|NCT03721536|Arterial blood analysis|arterial blood analysis
77208|NCT03721510|HIV|hiv
77209|NCT03721510|AIDS|aids
77210|NCT03721510|Monoclonal antibodies|monoclonal antibodies
77211|NCT03721510|Neutralizing antibodies|neutralizing antibodies
77212|NCT03721510|Analytical treatment interruption|analytical treatment interruption
77213|NCT03721406|ropivacaine|ropivacaine
77214|NCT03721406|undergoing ultrasound guided thoracic paravertebral block|undergoing ultrasound guided thoracic paravertebral block
77215|NCT03721393|tilt table test, valsalva|tilt table test, valsalva
77216|NCT03721380|Behavior drug and risk reduction counseling|behavior drug and risk reduction counseling
77217|NCT03721380|Heroin|heroin
77218|NCT03721380|Addiction treatment|addiction treatment
77219|NCT03721380|Randomization|randomization
77220|NCT03721380|Treatment effect|treatment effect
77221|NCT03721328|Hip|hip
77222|NCT03721328|Knee|knee
77223|NCT03721328|Biofilm|biofilm
77224|NCT03721328|Minimum-biofilm-eradication-concentration|minimum-biofilm-eradication-concentration
77225|NCT03721263|Allergic disorder|allergic disorder
77226|NCT03721237|Esophageal catheter calibration|esophageal catheter calibration
77227|NCT03721237|Assisted mechanical ventilation|assisted mechanical ventilation
77228|NCT03721224|psychiatry, children, habit cough|psychiatry, children, habit cough
77229|NCT03721211|Breast Cancer|breast cancer
77230|NCT03721185|obesity|obesity
77231|NCT03721185|overweight|overweight
77232|NCT03721185|fat percentage|fat percentage
77233|NCT03721185|body fat|body fat
77234|NCT03721185|lipolytic cream|lipolytic cream
77235|NCT03721172|Phase 3|phase 3
77236|NCT03721172|Double-Blind|double-blind
77237|NCT03721172|Efficacy|efficacy
77238|NCT03721172|Safety|safety
77239|NCT03721172|Apremilast|apremilast
77240|NCT03721172|Otezla|otezla
77241|NCT03721172|CC-10004|cc-10004
77242|NCT03721172|Plaque Psoriasis|plaque psoriasis
77243|NCT03721172|Mild|mild
77244|NCT03721172|Moderate|moderate
77245|NCT03721172|Scalp|scalp
77246|NCT03721172|Nail|nail
77247|NCT03721172|Itch|itch
77248|NCT03721159|Micro-RNA|micro-rna
77249|NCT03721159|Chronic periodontitis|chronic periodontitis
77250|NCT03721146|Encapsulated bacterial Infection|encapsulated bacterial infection
77251|NCT03721146|Primary immune deficiency|primary immune deficiency
77252|NCT03721146|Secondary immune deficiency|secondary immune deficiency
77253|NCT03721146|Adult|adult
77254|NCT03721107|constipation|constipation
77255|NCT03721107|diarrhea|diarrhea
77256|NCT03721068|Autologous Chimeric Antigen Receptor (CAR) T Cells|autologous chimeric antigen receptor (car) t cells
77257|NCT03721068|Interleukin (IL)-15|interleukin (il)-15
77258|NCT03721068|Disialoganglioside (GD2)|disialoganglioside (gd2)
77259|NCT03721068|Caspase 9|caspase 9
77260|NCT03721068|Pediatric|pediatric
77261|NCT03721068|Rimiducid|rimiducid
77262|NCT03721068|AP1903|ap1903
77263|NCT03721068|modified T cells|modified t cells
77264|NCT03721068|CAR T|car t
77265|NCT03721029|Urinary incontinence|urinary incontinence
77266|NCT03721029|Prostate cancer|prostate cancer
77267|NCT03721029|Erectile dysfunction|erectile dysfunction
77268|NCT03721029|Functional outcome|functional outcome
77269|NCT03721029|Robotic prostatectomy|robotic prostatectomy
77270|NCT03721029|Prostatectomy|prostatectomy
77271|NCT03721029|Urethral sphincter|urethral sphincter
77272|NCT03720990|7-Dehydrocholesterol reductase deficiency|7-dehydrocholesterol reductase deficiency
77273|NCT03720951|Pulsed Radiofrequency|pulsed radiofrequency
77274|NCT03720951|chronic Prostatitis|chronic prostatitis
77275|NCT03720938|inactive children|inactive children
77276|NCT03720938|active video games|active video games
77277|NCT03720938|physical fitness|physical fitness
77278|NCT03720938|self-perception|self-perception
77279|NCT03720938|enjoyment|enjoyment
77281|NCT03720925|oral heath|oral heath
77282|NCT03720925|quality of life|quality of life
77283|NCT03720925|tooth injuries|tooth injuries
77284|NCT03720925|children|children
77285|NCT03720925|family|family
77286|NCT03720847|Steroid hormones|steroid hormones
77287|NCT03720847|Estradiol|estradiol
77288|NCT03720847|Progesterone|progesterone
77289|NCT03720847|Depression|depression
77290|NCT03720847|Suicide|suicide
77291|NCT03720808|pain management|pain management
77292|NCT03720808|pain in children|pain in children
77293|NCT03720808|venous blood sample|venous blood sample
77294|NCT03720808|non-pharmacological method|non-pharmacological method
77295|NCT03720782|Legion|legion
77296|NCT03720756|nickel-free|nickel-free
77297|NCT03720756|diet|diet
77298|NCT03720756|GERD|gerd
77299|NCT03720756|Gastroesophageal Reflux|gastroesophageal reflux
77300|NCT03720743|Biodanza|biodanza
77301|NCT03720743|libido|libido
77302|NCT03720743|sexual excitement|sexual excitement
77303|NCT03720743|sexual inhibition|sexual inhibition
77304|NCT03720743|young adults|young adults
77305|NCT03720743|dance therapy|dance therapy
77306|NCT03720743|complementary therapies|complementary therapies
77307|NCT03720730|Suicidal crisis|suicidal crisis
77308|NCT03720730|Suicidal behaviour|suicidal behaviour
77309|NCT03720730|Prevention|prevention
77310|NCT03720730|Smartphone application|smartphone application
77311|NCT03720730|Ecological momentary assessment|ecological momentary assessment
77312|NCT03720730|Psychiatry|psychiatry
77313|NCT03720730|Follow-up|follow-up
77314|NCT03720704|Lesion-exclusion|lesion-exclusion
77315|NCT03720704|Visceral Perfusion|visceral perfusion
77316|NCT03720704|Luminal Reconstruction|luminal reconstruction
77317|NCT03720704|Occlusive Disease|occlusive disease
77318|NCT03720691|parkinsonism|parkinsonism
77319|NCT03720691|vascular parkinsonism|vascular parkinsonism
77320|NCT03720691|repetitive transcranial magnetic stimulation|repetitive transcranial magnetic stimulation
77321|NCT03720691|brain stimulation|brain stimulation
77322|NCT03720652|Stress Reduction|stress reduction
77323|NCT03720652|Certified Nursing Assistants|certified nursing assistants
77324|NCT03720652|Long-Term Care|long-term care
77325|NCT03720652|Staff Turnover|staff turnover
77326|NCT03720652|Mindful Self-Compassion|mindful self-compassion
77327|NCT03720639|Implantable Loop Recorder|implantable loop recorder
77328|NCT03720639|Implantable Cardiac Monitor|implantable cardiac monitor
77329|NCT03720639|Cryptogenic Stroke|cryptogenic stroke
77330|NCT03720626|Sickle cell disease|sickle cell disease
77331|NCT03720626|sickle cell anemia|sickle cell anemia
77332|NCT03720626|vaso-occlusive crisis|vaso-occlusive crisis
77333|NCT03720626|P-selectin|p-selectin
77334|NCT03720626|SEG101|seg101
77335|NCT03720626|crizanlizumab|crizanlizumab
77336|NCT03720626|monoclonal antibody|monoclonal antibody
77337|NCT03720626|Anemia, Sickle Cell|anemia, sickle cell
77338|NCT03720626|HbS Disease|hbs disease
77339|NCT03720626|Hemoglobin SC Disease|hemoglobin sc disease
77340|NCT03720626|Sickle Cell Disorders|sickle cell disorders
77341|NCT03720626|Sickling Disorder Due to Hemoglobin S|sickling disorder due to hemoglobin s
77342|NCT03720626|Adult|adult
77343|NCT03720626|Hb SS|hb ss
77344|NCT03720626|Hb SC|hb sc
77345|NCT03720626|Hb Sβ+-thalassemia|hb sβ+-thalassemia
77346|NCT03720626|Hb Sβ0-thalassemia|hb sβ0-thalassemia
77347|NCT03720626|Expanded Access Use|expanded access use
77348|NCT03720626|Pain Crisis|pain crisis
77349|NCT03720626|Compassionate Use|compassionate use
77350|NCT03720613|naloxegol|naloxegol
77351|NCT03720613|major adverse cardiovascular event (MACE)|major adverse cardiovascular event (mace)
77352|NCT03720613|opioid induced constipation (OIC)|opioid induced constipation (oic)
77353|NCT03720613|lubiprostone|lubiprostone
77354|NCT03720613|naldemedine|naldemedine
77355|NCT03720600|mindfulness|mindfulness
77356|NCT03720600|acceptance|acceptance
77357|NCT03720600|racism|racism
77358|NCT03720587|GTPS|gtps
77359|NCT03720587|Gluteal tendinopathy|gluteal tendinopathy
77360|NCT03720587|Lateral hip pain|lateral hip pain
77361|NCT03720587|Trochanteric bursitis|trochanteric bursitis
77362|NCT03720574|Overweight or Obesity Management|overweight or obesity management
77363|NCT03720574|Behavioral Modification|behavioral modification
77364|NCT03720496|CAR-T|car-t
77365|NCT03720496|TriCAR-T|tricar-t
77366|NCT03720496|CD19-TriCAR-T|cd19-tricar-t
77367|NCT03720496|Non-hodgkin Lymphoma|non-hodgkin lymphoma
77368|NCT03720496|NHL|nhl
77369|NCT03720496|CD19-CAR-T|cd19-car-t
77370|NCT03720470|atopic dermatitis|atopic dermatitis
77371|NCT03720470|atopic eczema|atopic eczema
77372|NCT03720470|eczema|eczema
77373|NCT03720470|JAK|jak
77374|NCT03720470|janus kinase|janus kinase
77375|NCT03720457|CD19|cd19
77376|NCT03720457|CAR-T|car-t
77377|NCT03720457|Diffuse Large B-cell Lymphoma|diffuse large b-cell lymphoma
77378|NCT03720457|Follicular Lymphoma|follicular lymphoma
77379|NCT03720457|Relapsed /Refractory|relapsed /refractory
77380|NCT03720418|Parkinson's disease|parkinson's disease
77381|NCT03720418|Gene therapy|gene therapy
77382|NCT03720418|OXB-102|oxb-102
77383|NCT03720418|AXO-Lenti-PD|axo-lenti-pd
77384|NCT03720405|pulmonary resection|pulmonary resection
77385|NCT03720405|Esophageal segmentation|esophageal segmentation
77386|NCT03720405|Regression equation|regression equation
77387|NCT03720392|Allogeneic Hematopoietic Cell Transplantation (HCT)|allogeneic hematopoietic cell transplantation (hct)
77388|NCT03720379|fluoride varnish|fluoride varnish
77389|NCT03720379|dental caries|dental caries
77390|NCT03720379|ADOLESCENTS|adolescents
77391|NCT03720366|Enasidenib|enasidenib
77392|NCT03720366|CC-90007|cc-90007
77393|NCT03720366|Acute Myeloid Leukemia|acute myeloid leukemia
77394|NCT03720340|Nasopharyngeal Carcinoma|nasopharyngeal carcinoma
77395|NCT03720340|Acute Radiation Oral Mucositis|acute radiation oral mucositis
77396|NCT03720340|Recombinant human interleukin-11|recombinant human interleukin-11
77397|NCT03720340|oral microflora|oral microflora
77398|NCT03720301|Sore Throat|sore throat
77399|NCT03720301|Osteopathic Manipulation|osteopathic manipulation
77400|NCT03720301|Post operative sore throat|post operative sore throat
77401|NCT03720301|Endotracheal tube|endotracheal tube
77402|NCT03720275|proportion, TTR-FAP, study, neuropathy|proportion, ttr-fap, study, neuropathy
77403|NCT03720236|dental implant|dental implant
77404|NCT03720236|immediate loading|immediate loading
77405|NCT03720236|periimplant tissues|periimplant tissues
77406|NCT03720223|Buccal mucosal graft|buccal mucosal graft
77407|NCT03720210|Hyperthyroidism|hyperthyroidism
77408|NCT03720210|RFA|rfa
77409|NCT03720184|Retrograde autologous priming|retrograde autologous priming
77410|NCT03720184|RAP|rap
77411|NCT03720184|HAR|har
77412|NCT03720184|cardiopulmonary bypass|cardiopulmonary bypass
77413|NCT03720184|Extracorporeal circulation|extracorporeal circulation
77414|NCT03720184|Gaseous microemboli|gaseous microemboli
77415|NCT03720184|perfusion|perfusion
77416|NCT03720171|Osseointegration|osseointegration
77417|NCT03720171|Bone-anchored prosthesis|bone-anchored prosthesis
77418|NCT03720171|Neuro-prosthesis|neuro-prosthesis
77419|NCT03720158|Head and Neck Neoplasms|head and neck neoplasms
77420|NCT03720158|Omega 3 PolyUnsaturated Fatty Acid (PUFA)|omega 3 polyunsaturated fatty acid (pufa)
77421|NCT03720158|Quality of Life|quality of life
77422|NCT03720158|Radiotherapy|radiotherapy
77423|NCT03720158|Cancer Cachexia|cancer cachexia
77424|NCT03720145|Depression|depression
77425|NCT03720145|Lifestyle Medicine|lifestyle medicine
77426|NCT03720132|Vancomycin|vancomycin
77427|NCT03720132|Therapeutic drug monitoring|therapeutic drug monitoring
77428|NCT03720132|Catheter related blood stream infections|catheter related blood stream infections
77429|NCT03720119|wound healing|wound healing
77430|NCT03720119|pain|pain
77431|NCT03720119|lidocaine|lidocaine
77432|NCT03720106|interdisciplinarity|interdisciplinarity
77433|NCT03720106|therapy planning|therapy planning
77434|NCT03720106|assessment|assessment
77435|NCT03720106|stroke|stroke
77436|NCT03720106|neurorehabilitation|neurorehabilitation
77437|NCT03720106|physical therapy|physical therapy
77438|NCT03720106|occupational therapy|occupational therapy
77439|NCT03720106|neuropsychology|neuropsychology
77440|NCT03720106|logopedia|logopedia
77441|NCT03720093|ventilation|ventilation
77442|NCT03720093|intubation|intubation
100230|NCT03577119|Diet|diet
77443|NCT03720093|pulmonary microbiome|pulmonary microbiome
77444|NCT03720080|Type 1 Diabetes|type 1 diabetes
77445|NCT03720080|Artificial Pancreas|artificial pancreas
77446|NCT03720080|Medtronic 670G|medtronic 670g
77447|NCT03720080|OpenAPS|openaps
77448|NCT03720041|Multiple Myeloma|multiple myeloma
77449|NCT03720041|Lenalidomide|lenalidomide
77450|NCT03720041|Ixazomib|ixazomib
77451|NCT03720041|Dexamethasone|dexamethasone
77452|NCT03720041|Revlimid|revlimid
77453|NCT03720041|Ninlaro|ninlaro
77454|NCT03720041|Non-transplant eligible myeloma patients|non-transplant eligible myeloma patients
77455|NCT03720041|Newly diagnosed myeloma|newly diagnosed myeloma
77456|NCT03720041|Double blind|double blind
77457|NCT03720041|Placebo|placebo
77458|NCT03720041|Frailty scoring|frailty scoring
77459|NCT03720041|Frailty score-adjusted dosing|frailty score-adjusted dosing
77460|NCT03719976|Refugee Health|refugee health
77461|NCT03719976|Immigrant Health|immigrant health
77462|NCT03719976|Health care navigation|health care navigation
77463|NCT03719937|prone positioning|prone positioning
77464|NCT03719937|chest wall mechanics|chest wall mechanics
77465|NCT03719937|alveolar recruitment|alveolar recruitment
77466|NCT03719937|acute respiratory distress syndrome|acute respiratory distress syndrome
77467|NCT03719924|ESCC NAL-IRI|escc nal-iri
77468|NCT03719872|laparoscopic surgery|laparoscopic surgery
77469|NCT03719872|transabdominal ultrasound|transabdominal ultrasound
77470|NCT03719872|Free air|free air
77471|NCT03719859|reverse total shoulder arthroplasty|reverse total shoulder arthroplasty
77472|NCT03719859|physical therapy|physical therapy
77473|NCT03719833|Breast Cancer|breast cancer
77474|NCT03719833|Sentinel Lymph Node Biopsy|sentinel lymph node biopsy
77475|NCT03719833|Neoadjuvant Chemotherapy|neoadjuvant chemotherapy
77476|NCT03719820|Acute Ischemic Stroke|acute ischemic stroke
77477|NCT03719820|Intracranial Atherosclerosis ICAS|intracranial atherosclerosis icas
77478|NCT03719820|HRMRI|hrmri
77483|NCT03719768|meningeal|meningeal
77484|NCT03719768|LMDz|lmdz
77485|NCT03719768|brain metastases|brain metastases
77486|NCT03719768|Immunotherapy|immunotherapy
77487|NCT03719716|Oncology|oncology
77488|NCT03719716|Palliative Care|palliative care
77489|NCT03719716|Primary care|primary care
77490|NCT03719716|Care planning|care planning
77491|NCT03719703|Frozen embryo transfer; cardiovascular; metabolic; IVF|frozen embryo transfer; cardiovascular; metabolic; ivf
77492|NCT03719690|TIPIFARNIB|tipifarnib
77493|NCT03719690|HEAD AND NECK CANCER|head and neck cancer
77494|NCT03719664|HIV-1|hiv-1
77495|NCT03719664|3BNC117|3bnc117
77496|NCT03719664|Albuvirtide|albuvirtide
77497|NCT03719664|Broadly neutralizing antibody|broadly neutralizing antibody
77498|NCT03719664|Long-Acting HIV-1 Fusion Inhibitor|long-acting hiv-1 fusion inhibitor
77499|NCT03719651|Implementation|implementation
77500|NCT03719651|Implementation strategy|implementation strategy
77501|NCT03719651|Leadership|leadership
77502|NCT03719651|Organizational climate|organizational climate
77503|NCT03719651|Fidelity|fidelity
77504|NCT03719651|PTSD treatment|ptsd treatment
77505|NCT03719638|D-Blade|d-blade
77506|NCT03719638|Macintosh videolaryngoscope blade|macintosh videolaryngoscope blade
77507|NCT03719638|Simulated difficult intubation|simulated difficult intubation
77508|NCT03719612|Left Ventricular Ejection Fraction|left ventricular ejection fraction
77509|NCT03719612|DEFINITY®|definity®
77510|NCT03719612|Enhanced Echocardiogram|enhanced echocardiogram
77511|NCT03719612|Cardiac Magnetic Resonance|cardiac magnetic resonance
77517|NCT03719586|EBOV|ebov
77518|NCT03719586|Viral Hemorrhagic Fever|viral hemorrhagic fever
77519|NCT03719586|Ebola Treatment Center|ebola treatment center
77520|NCT03719586|Filovirus|filovirus
77521|NCT03719586|Zaire Ebola Virus|zaire ebola virus
77522|NCT03719573|Colon Cancer|colon cancer
77523|NCT03719573|Frailty|frailty
77524|NCT03719573|Geriatric assessment|geriatric assessment
77525|NCT03719573|perioperative care|perioperative care
77526|NCT03719573|exercise|exercise
77527|NCT03719573|quality of recovery|quality of recovery
77528|NCT03719547|Cervical cancer|cervical cancer
77529|NCT03719547|Robot-assisted surgery|robot-assisted surgery
77530|NCT03719547|Sentinel node biopsy|sentinel node biopsy
77531|NCT03719547|Laparotomy|laparotomy
77532|NCT03719547|Recurrence|recurrence
77533|NCT03719547|Survival|survival
77534|NCT03719521|Adolescents|adolescents
77535|NCT03719521|Youth|youth
77536|NCT03719521|Sexual and reproductive health|sexual and reproductive health
77537|NCT03719521|Africa|africa
77538|NCT03719521|community-based|community-based
77539|NCT03719508|Nutritional assesment|nutritional assesment
77540|NCT03719508|Nutritional screening tools|nutritional screening tools
77541|NCT03719508|Abdominal Surgery|abdominal surgery
77542|NCT03719508|Stomach Neoplasms|stomach neoplasms
77543|NCT03719508|Colorectal Surgery|colorectal surgery
77544|NCT03719482|HV|hv
77545|NCT03719456|Renal stone|renal stone
77546|NCT03719456|Calculi|calculi
400582|NCT01866189|Magnetic Resonance Imaging|magnetic resonance imaging
77547|NCT03719456|Retrograde Intrarenal Surgery|retrograde intrarenal surgery
77548|NCT03719456|Flexible ureteroscope|flexible ureteroscope
77549|NCT03719443|chronic glomerular disease|chronic glomerular disease
77550|NCT03719443|autoimmune glomerulonephritis|autoimmune glomerulonephritis
77551|NCT03719430|Leiomyosarcoma|leiomyosarcoma
77552|NCT03719430|Liposarcoma|liposarcoma
77553|NCT03719430|Pleomorphic sarcoma|pleomorphic sarcoma
77554|NCT03719430|Synovial sarcoma|synovial sarcoma
77555|NCT03719430|Malignant peripheral nerve sheath tumor|malignant peripheral nerve sheath tumor
77556|NCT03719430|Spindle cell sarcoma|spindle cell sarcoma
77557|NCT03719417|Knee Pain|knee pain
77558|NCT03719404|Retreatment|retreatment
77559|NCT03719404|Irrigants|irrigants
77560|NCT03719404|chlorhexidine|chlorhexidine
77561|NCT03719391|Electronic Nicotine Delivery System|electronic nicotine delivery system
77562|NCT03719391|Combustible Cigarettes|combustible cigarettes
77563|NCT03719391|Nicotine|nicotine
77564|NCT03719378|Fluid Management|fluid management
77565|NCT03719365|PSV|psv
77566|NCT03719365|NAVA|nava
77567|NCT03719365|Driving Pressure|driving pressure
77568|NCT03719365|Mechanical Assisted Ventilation|mechanical assisted ventilation
77569|NCT03719339|Kidney disease|kidney disease
77570|NCT03719339|Kidney allograph|kidney allograph
77571|NCT03719300|BCG-unresponsive|bcg-unresponsive
77572|NCT03719248|Epidural.|epidural.
77573|NCT03719248|ventricular mass|ventricular mass
77574|NCT03719248|Aortic valve|aortic valve
77575|NCT03719248|coronary bypass|coronary bypass
77576|NCT03719222|Genomic profiling assay|genomic profiling assay
77577|NCT03719209|Crohns disease|crohns disease
77578|NCT03719209|Patient Education|patient education
77583|NCT03719209|Gastrointestinal bleeding|gastrointestinal bleeding
77584|NCT03719209|Inflammatory Bowel Disease|inflammatory bowel disease
77586|NCT03719196|Presbyopia|presbyopia
77587|NCT03719196|Quality of life|quality of life
77588|NCT03719196|Reading glass|reading glass
77589|NCT03719196|Productivity|productivity
77590|NCT03719170|proton pump inhibitors|proton pump inhibitors
77591|NCT03719170|program evaluation|program evaluation
77592|NCT03719170|low-value care|low-value care
77593|NCT03719170|de-implementation|de-implementation
77594|NCT03719170|patient safety|patient safety
77595|NCT03719079|Fluid decompensation|fluid decompensation
77596|NCT03719079|Non-invasive Multi-parameter monitoring|non-invasive multi-parameter monitoring
77597|NCT03719079|Multi-parameter algorithm|multi-parameter algorithm
77598|NCT03719079|Heart Rate Variability|heart rate variability
77599|NCT03719079|Thoracic impedance|thoracic impedance
77600|NCT03719079|Heart Sounds|heart sounds
77601|NCT03719079|Respiration|respiration
77602|NCT03719079|Posture|posture
77603|NCT03719079|Activity|activity
77604|NCT03719079|Tidal Volume|tidal volume
77605|NCT03719079|Stroke Volume|stroke volume
77606|NCT03719066|cholera|cholera
77607|NCT03719066|oral cholera vaccine|oral cholera vaccine
77608|NCT03719066|vibriocidal titer|vibriocidal titer
77609|NCT03719066|ELISA antibodies|elisa antibodies
77610|NCT03719066|Adverse event following immunization|adverse event following immunization
77611|NCT03719027|Prevalence and incidence of CTEPH after pulmonary embolism|prevalence and incidence of cteph after pulmonary embolism
77612|NCT03719027|history of diagnosis|history of diagnosis
77613|NCT03718949|pre-operative fasting|pre-operative fasting
77614|NCT03718949|general anesthesia|general anesthesia
77615|NCT03718949|cardiac output,Ultrasonography|cardiac output,ultrasonography
77616|NCT03718949|Ultrasonography|ultrasonography
77617|NCT03718936|ADNP|adnp
77618|NCT03718936|Intellectual Disability|intellectual disability
77619|NCT03718936|Autism Spectrum Disorder|autism spectrum disorder
77620|NCT03718936|Global Developmental Delay|global developmental delay
77621|NCT03718936|Neurodevelopmental Deficits|neurodevelopmental deficits
77622|NCT03718936|Developmental Disability|developmental disability
77623|NCT03718923|FOXP1|foxp1
77624|NCT03718923|Intellectual Disability|intellectual disability
77625|NCT03718923|Autism Spectrum Disorder|autism spectrum disorder
77626|NCT03718923|Global Developmental Delay|global developmental delay
77627|NCT03718923|Neurodevelopmental Deficits|neurodevelopmental deficits
77628|NCT03718923|Developmental Disability|developmental disability
77629|NCT03718910|DDX3X|ddx3x
77630|NCT03718910|Intellectual Disability|intellectual disability
77631|NCT03718910|Global Developmental Delay|global developmental delay
77632|NCT03718910|Neurodevelopmental Deficits|neurodevelopmental deficits
77633|NCT03718910|Developmental Disability|developmental disability
77634|NCT03718845|Empathy|empathy
77635|NCT03718845|Hope|hope
77636|NCT03718832|Diabetes|diabetes
77637|NCT03718819|multiple sclerosis|multiple sclerosis
77638|NCT03718819|pilates|pilates
77639|NCT03718819|aquatherapy|aquatherapy
77640|NCT03718819|postural control|postural control
77641|NCT03718819|dual task|dual task
77642|NCT03718780|transcutaneous PtCO2|transcutaneous ptco2
77643|NCT03718780|dead space|dead space
77644|NCT03718780|exercise test|exercise test
77649|NCT03718728|Overweight|overweight
77650|NCT03718728|Obesity|obesity
77651|NCT03718728|Adults|adults
77652|NCT03718728|Mindfulness|mindfulness
77653|NCT03718728|Acceptance|acceptance
77654|NCT03718728|Emotional eating|emotional eating
77655|NCT03718715|Metformin|metformin
77656|NCT03718715|Gastrointestinal side effects|gastrointestinal side effects
77657|NCT03718715|Microbiota|microbiota
77658|NCT03718702|Chronic pain|chronic pain
77659|NCT03718702|Working population|working population
77660|NCT03718702|Online learning|online learning
77661|NCT03718676|pulpotomy|pulpotomy
77662|NCT03718637|Tennis Elbow|tennis elbow
77663|NCT03718637|Tendinopathy|tendinopathy
77664|NCT03718637|Lateral Epicondylitis|lateral epicondylitis
77665|NCT03718637|Bioinductive|bioinductive
77666|NCT03718611|Generic|generic
77667|NCT03718598|Carpal tunnel syndrome|carpal tunnel syndrome
77668|NCT03718598|home exercise|home exercise
77669|NCT03718598|pregnant women|pregnant women
77670|NCT03718585|Nocturnal Hypertension|nocturnal hypertension
77671|NCT03718585|Chronic Kidney Disease|chronic kidney disease
77672|NCT03718585|Whole Exome Sequencing|whole exome sequencing
77673|NCT03718559|Edoxaban|edoxaban
77674|NCT03718559|antiplatelet|antiplatelet
77675|NCT03718559|anticoagulant|anticoagulant
77774|NCT03717935|hepatic de novo lipogenesis|hepatic de novo lipogenesis
77775|NCT03717922|Ultrasound|ultrasound
77676|NCT03718533|Eltrombopag, hematological response; poor graft function, stem cell transplantation. CETB115EES03, adult, ELTION, phase II|eltrombopag, hematological response; poor graft function, stem cell transplantation. cetb115ees03, adult, eltion, phase ii
77677|NCT03718520|cannabis|cannabis
77678|NCT03718520|fetal programming|fetal programming
77679|NCT03718520|pregnancy|pregnancy
77680|NCT03718520|infant neuroimaging|infant neuroimaging
77681|NCT03718481|ARCP|arcp
77682|NCT03718481|Surgical Training|surgical training
77683|NCT03718481|Assessment|assessment
77684|NCT03718481|Qualitative|qualitative
77685|NCT03718429|aspirin|aspirin
77686|NCT03718429|clopidogrel|clopidogrel
77687|NCT03718429|ticagrelor|ticagrelor
77688|NCT03718429|rivaroxaban|rivaroxaban
77689|NCT03718429|pharmacodynamic (PD)|pharmacodynamic (pd)
77690|NCT03718416|observational|observational
77691|NCT03718416|non-interventional|non-interventional
77692|NCT03718416|Prader-Willi syndrome|prader-willi syndrome
77694|NCT03718403|PHP|php
77695|NCT03718364|atrial fibrillation|atrial fibrillation
77696|NCT03718364|pulmonary vein isolation|pulmonary vein isolation
77697|NCT03718351|Transanal endoscopic microsurgery|transanal endoscopic microsurgery
77698|NCT03718351|Endoscopic submucosal dissection|endoscopic submucosal dissection
77699|NCT03718351|Minimally invasive surgery|minimally invasive surgery
77700|NCT03718325|Burst-SCS|burst-scs
77701|NCT03718325|Chronic pain|chronic pain
77702|NCT03718325|Spinal cord stimulation|spinal cord stimulation
77703|NCT03718312|Clamping|clamping
77704|NCT03718312|pre-conditioning|pre-conditioning
77705|NCT03718273|Ivabradine|ivabradine
77706|NCT03718273|Digoxin|digoxin
77707|NCT03718273|Atrial Fibrillation|atrial fibrillation
77708|NCT03718273|Heart rate control|heart rate control
77709|NCT03718260|Prostate Cancer|prostate cancer
77710|NCT03718260|Biochemical Failure|biochemical failure
77711|NCT03718260|Node positive|node positive
77712|NCT03718260|PSMA-PET|psma-pet
77713|NCT03718260|[18F]DCFPyL PET/CT imaging|[18f]dcfpyl pet/ct imaging
77714|NCT03718260|Radical Prostatectomy|radical prostatectomy
77715|NCT03718260|Radiation Therapy|radiation therapy
77716|NCT03718247|Ketogenic diet|ketogenic diet
77717|NCT03718234|adrenal gland diseases|adrenal gland diseases
77718|NCT03718234|cortisol succinate|cortisol succinate
77719|NCT03718234|hydrocortisone|hydrocortisone
77720|NCT03718234|hyperplasia|hyperplasia
77721|NCT03718182|vitamin D supplementation|vitamin d supplementation
77722|NCT03718182|quality of life|quality of life
77723|NCT03718182|Inflammatory Bowel Disease Questionnaire IBDQ|inflammatory bowel disease questionnaire ibdq
77724|NCT03718182|Hepcidin|hepcidin
77725|NCT03718169|women|women
77726|NCT03718156|delirium|delirium
77727|NCT03718156|dementia|dementia
77728|NCT03718156|long-term care|long-term care
77729|NCT03718156|cluster randomized trial|cluster randomized trial
77730|NCT03718156|nursing|nursing
77731|NCT03718156|geriatrics|geriatrics
77732|NCT03718117|Non-Small Cell Lung Cancer (NSCLC)|non-small cell lung cancer (nsclc)
77733|NCT03718117|crizotinib|crizotinib
77734|NCT03718117|ALK gene rearrangement or ROS1 gene rearrangement|alk gene rearrangement or ros1 gene rearrangement
77735|NCT03718104|naltrexone|naltrexone
77736|NCT03718104|buprenorphine/naloxone|buprenorphine/naloxone
77737|NCT03718104|maternal relapse|maternal relapse
77738|NCT03718104|retention in care|retention in care
77739|NCT03718104|pharmacokinetics|pharmacokinetics
77740|NCT03718104|pharmacogenetics|pharmacogenetics
77741|NCT03718091|Solid Tumor|solid tumor
77742|NCT03718091|leiomyosarcoma|leiomyosarcoma
77743|NCT03718091|Osteosarcoma|osteosarcoma
77744|NCT03718039|bunion|bunion
77745|NCT03718039|bunionectomy|bunionectomy
77746|NCT03718039|bunion surgery|bunion surgery
77747|NCT03718039|postoperative pain|postoperative pain
77748|NCT03718026|The timed 360° turn test|the timed 360° turn test
77749|NCT03718026|Multiple sclerosis|multiple sclerosis
77750|NCT03718026|reliability|reliability
77751|NCT03718026|validity|validity
77752|NCT03718000|Holiday weight gain|holiday weight gain
77753|NCT03718000|Daily self-weighing|daily self-weighing
77754|NCT03718000|Weight maintenance|weight maintenance
77755|NCT03718000|Caloric titration method|caloric titration method
77756|NCT03718000|Obesity|obesity
77757|NCT03718000|Overweight|overweight
77758|NCT03718000|Holiday season|holiday season
77759|NCT03717987|gummy smile|gummy smile
77760|NCT03717987|Botulinum toxin type A|botulinum toxin type a
77761|NCT03717987|excessive gingival display|excessive gingival display
77762|NCT03717974|telemedecine|telemedecine
77763|NCT03717974|medico-economic|medico-economic
77764|NCT03717974|neurological disability|neurological disability
77765|NCT03717961|Raynaud Phenomenon|raynaud phenomenon
77766|NCT03717961|Systemic Sclerosis|systemic sclerosis
77767|NCT03717961|Botulinum toxin A|botulinum toxin a
77768|NCT03717948|Acute Exercise|acute exercise
77769|NCT03717948|Mitochondria|mitochondria
77770|NCT03717948|Skeletal Muscle|skeletal muscle
77771|NCT03717948|PGC1α|pgc1α
77772|NCT03717948|Mitochondrial Biogenesis|mitochondrial biogenesis
77773|NCT03717948|Intracellular Signalling|intracellular signalling
77776|NCT03717922|MRI|mri
77777|NCT03717922|Learning|learning
77778|NCT03717922|Memory|memory
77779|NCT03717922|Cognitive Neural Prosthetic|cognitive neural prosthetic
77780|NCT03717909|Wolfram Syndrome|wolfram syndrome
77781|NCT03717909|Treat Wolfram|treat wolfram
77782|NCT03717909|Sodium valproate|sodium valproate
77783|NCT03717896|diabetic ketoacidosis|diabetic ketoacidosis
77784|NCT03717896|DKA|dka
77785|NCT03717896|thiamine|thiamine
77786|NCT03717896|acidosis|acidosis
77787|NCT03717896|oxygen consumption|oxygen consumption
77788|NCT03717896|lactate|lactate
77789|NCT03717883|hepatic transporters|hepatic transporters
77790|NCT03717870|Endometrioma|endometrioma
77791|NCT03717870|Infertility|infertility
77792|NCT03717870|Laparoscopy|laparoscopy
77793|NCT03717870|GnRH-a|gnrh-a
77794|NCT03717870|Assisted Reproduction Technology|assisted reproduction technology
77795|NCT03717870|Reproductive outcomes|reproductive outcomes
77796|NCT03717857|Latino children|latino children
77797|NCT03717857|middles school|middles school
77798|NCT03717857|sleep hygiene|sleep hygiene
77799|NCT03717857|educational intervention|educational intervention
77800|NCT03717831|muscle ultrasound|muscle ultrasound
77801|NCT03717831|post-intensive care syndrome|post-intensive care syndrome
77802|NCT03717831|physical function|physical function
77803|NCT03717831|muscle tissue analysis|muscle tissue analysis
77804|NCT03717805|Patient-centered care|patient-centered care
77805|NCT03717805|Patient information|patient information
77806|NCT03717779|Lung ultrasound,|lung ultrasound,
77807|NCT03717779|heart failure|heart failure
77808|NCT03717779|diagnosis|diagnosis
77809|NCT03717779|accuracy|accuracy
77810|NCT03717740|preeclampsia|preeclampsia
77811|NCT03717740|esomeprazole|esomeprazole
77812|NCT03717740|Soluble Fms Like Tyrosine Kinase -1|soluble fms like tyrosine kinase -1
77813|NCT03717727|Total knee replacement|total knee replacement
77814|NCT03717727|Exergame|exergame
77815|NCT03717727|Total knee arthroplasty|total knee arthroplasty
77816|NCT03717727|Exercise|exercise
77817|NCT03717727|Physiotherapy|physiotherapy
77818|NCT03717727|Physical functioning|physical functioning
77819|NCT03717701|preeclampsia|preeclampsia
77820|NCT03717701|esomeprazole|esomeprazole
77821|NCT03717701|metformin|metformin
77822|NCT03717688|GLP-1|glp-1
77823|NCT03717688|Neprilysin|neprilysin
77824|NCT03717688|DPP-4|dpp-4
77825|NCT03717662|women|women
77826|NCT03717584|microbiota|microbiota
77827|NCT03717584|metabolome|metabolome
77828|NCT03717584|lipidome|lipidome
77829|NCT03717519|platelets|platelets
77830|NCT03717519|thrombocytosis|thrombocytosis
77831|NCT03717519|prognosis|prognosis
77832|NCT03717506|zits|zits
77833|NCT03717506|pimples|pimples
77834|NCT03717506|blackheads|blackheads
77835|NCT03717493|Binge-Eating Disorder|binge-eating disorder
77836|NCT03717493|Affect Regulation Training|affect regulation training
77837|NCT03717493|Emotion Regulation|emotion regulation
77838|NCT03717493|Transdiagnostic|transdiagnostic
77839|NCT03717480|Graft vs. Host Disease|graft vs. host disease
77840|NCT03717480|Hematologic Malignancy|hematologic malignancy
77841|NCT03717467|Magnesium sulfate|magnesium sulfate
77842|NCT03717467|Morphine requirement|morphine requirement
77843|NCT03717467|Hepatotomy|hepatotomy
77844|NCT03717467|Orthotopic liver transplantation|orthotopic liver transplantation
77845|NCT03717454|Dopamine agonist|dopamine agonist
77846|NCT03717454|Dopamine D2 receptors|dopamine d2 receptors
77847|NCT03717454|PET-MR|pet-mr
77848|NCT03717415|rebastinib|rebastinib
77849|NCT03717415|breast cancer|breast cancer
77850|NCT03717415|ovarian cancer|ovarian cancer
77851|NCT03717415|mesothelioma|mesothelioma
77852|NCT03717402|Cancer|cancer
77853|NCT03717402|Pain management|pain management
77854|NCT03717402|Opioid use|opioid use
77855|NCT03717402|Health app|health app
77856|NCT03717402|Gastrointestinal cancer|gastrointestinal cancer
77857|NCT03717402|Breast cancer|breast cancer
77858|NCT03717402|Lung cancer|lung cancer
77859|NCT03717389|prevalence|prevalence
77860|NCT03717389|soft tissue calcification in head and neck|soft tissue calcification in head and neck
77861|NCT03717376|Functional Movement Disorder|functional movement disorder
77862|NCT03717376|Functional Neurological Disorder|functional neurological disorder
77863|NCT03717376|Early Maladaptive Scheme|early maladaptive scheme
77864|NCT03717376|Parkinson|parkinson
77865|NCT03717376|Dystonia|dystonia
77866|NCT03717363|Training Programme|training programme
77867|NCT03717363|Physical Activity|physical activity
77868|NCT03717363|cardiovascular primary prevention|cardiovascular primary prevention
77869|NCT03717350|biomarkers|biomarkers
77870|NCT03717350|suPAR|supar
77871|NCT03717350|outcome|outcome
77872|NCT03717350|antibiotics|antibiotics
77873|NCT03717337|Regeneration, mature teeth, regenerative procedures|regeneration, mature teeth, regenerative procedures
77874|NCT03717324|Emergency Department|emergency department
77875|NCT03717324|Geriatrics|geriatrics
77876|NCT03717324|Frailty|frailty
77877|NCT03717311|biomarkers|biomarkers
77878|NCT03717311|fermentation|fermentation
77887|NCT03717285|ureteral access sheath|ureteral access sheath
77888|NCT03717285|ureteral injury|ureteral injury
77889|NCT03717272|AEF0117|aef0117
77890|NCT03717272|Cannabis-related Use Disorder|cannabis-related use disorder
77891|NCT03717272|Cannabis subjective effects|cannabis subjective effects
77892|NCT03717272|Cannabis self-administration|cannabis self-administration
77893|NCT03717272|cannabis-induced analgesia|cannabis-induced analgesia
77894|NCT03717272|cannabis-related cognitive disorder|cannabis-related cognitive disorder
77895|NCT03717259|Renal Donation|renal donation
77896|NCT03717259|Renal Transplant|renal transplant
77897|NCT03717259|Open Nephrectomy|open nephrectomy
77898|NCT03717259|Laparoscopic Nephrectomy|laparoscopic nephrectomy
77899|NCT03717259|Hand Assisted|hand assisted
77900|NCT03717259|Surgical Morbidity|surgical morbidity
77901|NCT03717246|sleep hygiene|sleep hygiene
77902|NCT03717246|Latino Children|latino children
77903|NCT03717246|middle school|middle school
77904|NCT03717246|educational intervention|educational intervention
77905|NCT03717220|soft-tissue defects|soft-tissue defects
77906|NCT03717220|dorsal branch of the digital artery|dorsal branch of the digital artery
77907|NCT03717220|regional flap|regional flap
77908|NCT03717194|type 2 diabetes|type 2 diabetes
77909|NCT03717194|heart failure|heart failure
77910|NCT03717194|ertugliflozin|ertugliflozin
77911|NCT03717194|Global longitudinal strain (GLS)|global longitudinal strain (gls)
77912|NCT03717168|recombinant growth hormone|recombinant growth hormone
77913|NCT03717168|Difficult ventilator weaning|difficult ventilator weaning
77914|NCT03717168|postoperative complications|postoperative complications
77920|NCT03717142|Fluorescence|fluorescence
77921|NCT03717142|Brain|brain
77922|NCT03717142|Cancer detection|cancer detection
77923|NCT03717116|hypocalcemia, parathormone, bone density|hypocalcemia, parathormone, bone density
77924|NCT03717090|mass spectrometry, diagnosis, prosthetic joint infection, matrix-assisted laser desorption ionization|mass spectrometry, diagnosis, prosthetic joint infection, matrix-assisted laser desorption ionization
77929|NCT03717038|Metastatic Colorectal Cancer|metastatic colorectal cancer
77930|NCT03717038|Colorectal Cancer Metastatic|colorectal cancer metastatic
77931|NCT03717038|Carcinoma|carcinoma
77932|NCT03717038|Sym004|sym004
77933|NCT03717038|futuximab|futuximab
77934|NCT03717038|modotuximab|modotuximab
77935|NCT03717038|TAS-102|tas-102
77936|NCT03717038|Trifluridine|trifluridine
77937|NCT03717038|Tipiracil|tipiracil
77938|NCT03717038|Lonsurf|lonsurf
77939|NCT03717025|ACRAL|acral
77940|NCT03716999|palliative|palliative
77941|NCT03716999|starlight|starlight
77942|NCT03716999|end-of-life symptoms|end-of-life symptoms
77943|NCT03716999|non-pharmacological|non-pharmacological
77944|NCT03716986|MRI|mri
77945|NCT03716986|Hypoxia|hypoxia
77946|NCT03716986|O2 saturation|o2 saturation
77947|NCT03716986|FMISO PET|fmiso pet
77948|NCT03716986|Glioma|glioma
77949|NCT03716973|spinal cord stimulation|spinal cord stimulation
77950|NCT03716973|paraesthesia-free|paraesthesia-free
77951|NCT03716947|Clinical outcome|clinical outcome
77952|NCT03716947|Mobility|mobility
77953|NCT03716947|Facet-joints|facet-joints
77954|NCT03716921|Septic Arthritis of native joint|septic arthritis of native joint
77955|NCT03716921|short antibiotic treatment|short antibiotic treatment
77956|NCT03716921|native joint|native joint
77957|NCT03716921|septic arthritis|septic arthritis
77958|NCT03716895|Severe Septic Shock|severe septic shock
77959|NCT03716895|Lactate clearance|lactate clearance
77960|NCT03716895|Acute Kidney Injury|acute kidney injury
821484|NCT00150982|psoriasis|psoriasis
77961|NCT03716895|Days alive and free|days alive and free
77962|NCT03716895|Ventilation-free days|ventilation-free days
77963|NCT03716895|Vasopressor-free days|vasopressor-free days
77964|NCT03716882|Infants|infants
77965|NCT03716882|Principal Component 1 (PC1)|principal component 1 (pc1)
77966|NCT03716882|Principal Component 2 (PC2)|principal component 2 (pc2)
77967|NCT03716882|Song Meter 4|song meter 4
77968|NCT03716882|Acoustic structures crying|acoustic structures crying
77969|NCT03716882|PRAAT software|praat software
77970|NCT03716869|adolescent; mental health; depression; suicide|adolescent; mental health; depression; suicide
77971|NCT03716843|Dynamic Pressure Monitoring|dynamic pressure monitoring
77972|NCT03716817|Crown|crown
77973|NCT03716817|Ceramic|ceramic
77974|NCT03716817|CAD/CAM|cad/cam
77984|NCT03716752|recession defects with infrabony defects|recession defects with infrabony defects
77989|NCT03716687|negative pressure wound closure|negative pressure wound closure
77990|NCT03716687|surgical site infection|surgical site infection
77991|NCT03716687|cost effectiveness|cost effectiveness
77992|NCT03716674|Parkinson's Disease|parkinson's disease
77993|NCT03716674|rhythmic auditory stimulation|rhythmic auditory stimulation
77994|NCT03716674|cueing|cueing
77995|NCT03716674|Long-Range Autocorrelations|long-range autocorrelations
77996|NCT03716622|Helicobacter Pylori|helicobacter pylori
77997|NCT03716622|furazolidone|furazolidone
77998|NCT03716622|clarithromycin|clarithromycin
77999|NCT03716622|bismuth-containing quadruple regimen|bismuth-containing quadruple regimen
78000|NCT03716596|pancreatic cancer|pancreatic cancer
78001|NCT03716596|Second-line Chemotherapy resistant|second-line chemotherapy resistant
78002|NCT03716596|immune therapy|immune therapy
78003|NCT03716596|Stereotactic Body Radiotherapy|stereotactic body radiotherapy
78004|NCT03716583|melatonin|melatonin
78005|NCT03716557|spinal cord stimulation|spinal cord stimulation
78006|NCT03716557|high frequency stimulation|high frequency stimulation
78007|NCT03716557|paraesthesia-free|paraesthesia-free
78008|NCT03716544|Tinnitus|tinnitus
78009|NCT03716544|Hearing Loss|hearing loss
78010|NCT03716544|Amplification|amplification
78011|NCT03716544|Sound Therapy|sound therapy
78012|NCT03716531|Pancreatic Cancer|pancreatic cancer
78020|NCT03716414|Sentinel lymph node|sentinel lymph node
78021|NCT03716401|Magnetic Resonance Imaging|magnetic resonance imaging
78022|NCT03716401|Ultrasound Imaging|ultrasound imaging
78023|NCT03716401|Biomarkers|biomarkers
78024|NCT03716401|Prognosis|prognosis
78025|NCT03716388|Fecal Microbiota Transplantation|fecal microbiota transplantation
78026|NCT03716388|Ulcerative Colitis|ulcerative colitis
78027|NCT03716388|Induction of Remission|induction of remission
78028|NCT03716375|Pleural empyema, urokinase|pleural empyema, urokinase
78029|NCT03716336|resistive exercises|resistive exercises
78030|NCT03716336|aerobic exercises|aerobic exercises
78031|NCT03716336|diet|diet
78032|NCT03716336|insulin resistance|insulin resistance
78033|NCT03716336|premenopausal|premenopausal
78034|NCT03716284|electromagnetic navigation bronchoscopy(ENB)|electromagnetic navigation bronchoscopy(enb)
78035|NCT03716284|peripheral pulmonary nodules|peripheral pulmonary nodules
78036|NCT03716284|diagnostic yield|diagnostic yield
78037|NCT03716271|presbyopia compensation|presbyopia compensation
78038|NCT03716271|EDF|edf
78039|NCT03716271|Light Sword Lens|light sword lens
78040|NCT03716258|Parkinson Disease|parkinson disease
78041|NCT03716258|Biomarkers|biomarkers
78042|NCT03716258|Inflammation|inflammation
78043|NCT03716245|breast cancer|breast cancer
78044|NCT03716245|supraclavicular lymph node|supraclavicular lymph node
78045|NCT03716245|dissection|dissection
78046|NCT03716245|radiotherpy|radiotherpy
78047|NCT03716245|prognosis|prognosis
78048|NCT03716206|Shoulder Pain|shoulder pain
78049|NCT03716206|Stroke|stroke
78050|NCT03716206|Motor function|motor function
78051|NCT03716180|Breast Cancer|breast cancer
78052|NCT03716167|laser|laser
78053|NCT03716167|ulcer|ulcer
78054|NCT03716167|wound|wound
78055|NCT03716089|GIST|gist
78056|NCT03716089|laparoscopic resection|laparoscopic resection
78057|NCT03716089|early complication|early complication
78058|NCT03716089|mortality|mortality
78059|NCT03716089|tumor sites|tumor sites
78060|NCT03716076|Carbetocin|carbetocin
78061|NCT03716076|Myocardial repolarization|myocardial repolarization
78062|NCT03716063|colorectal cancer|colorectal cancer
78063|NCT03716063|traditional Chinese medicine|traditional chinese medicine
78064|NCT03716050|breast reconstruction|breast reconstruction
78065|NCT03716050|Breast Cancer|breast cancer
78066|NCT03716050|Implant Complication|implant complication
78067|NCT03716037|physical activity|physical activity
78068|NCT03716037|exercise|exercise
78069|NCT03716037|depression|depression
78070|NCT03716037|anxiety|anxiety
78071|NCT03716037|stress|stress
78072|NCT03716024|CSSSI|csssi
78073|NCT03715972|cerebrovascular reserve|cerebrovascular reserve
78074|NCT03715972|white matter disease in patients with chronic anemia|white matter disease in patients with chronic anemia
78075|NCT03715946|Phase II|phase ii
78076|NCT03715946|Oropharynx Cancer|oropharynx cancer
78077|NCT03715946|OPSCC|opscc
78078|NCT03715946|Nivolumab|nivolumab
78079|NCT03715946|Adjuvant therapy|adjuvant therapy
78080|NCT03715946|De-Escalated Radiation|de-escalated radiation
78081|NCT03715946|Squamous cell carcinoma|squamous cell carcinoma
78082|NCT03715946|P16+|p16+
78083|NCT03715946|Head and Neck cancer|head and neck cancer
78084|NCT03715946|Oropharynx Squamous Cell Carcinoma|oropharynx squamous cell carcinoma
78085|NCT03715946|Carcinoma, Squamous Cell of Head and Neck|carcinoma, squamous cell of head and neck
78086|NCT03715946|Transoral surgery|transoral surgery
78087|NCT03715946|Radiotherapy|radiotherapy
78088|NCT03715933|Phase 1|phase 1
78089|NCT03715933|Phase 1 Clinical Trial|phase 1 clinical trial
78090|NCT03715933|Solid Tumors|solid tumors
78091|NCT03715933|Sarcoma|sarcoma
78092|NCT03715933|Pleural Mesothelioma|pleural mesothelioma
78093|NCT03715933|Stomach Cancer|stomach cancer
78094|NCT03715933|Colorectal Cancer|colorectal cancer
78095|NCT03715933|Colon Cancer|colon cancer
78096|NCT03715933|Rectal Cancer|rectal cancer
78097|NCT03715933|DR5|dr5
78098|NCT03715933|Gastric Adenocarcinoma|gastric adenocarcinoma
78099|NCT03715933|Colorectal Adenocarcinoma|colorectal adenocarcinoma
78100|NCT03715920|Quadriceps femoris|quadriceps femoris
78101|NCT03715920|isometric form|isometric form
78102|NCT03715920|exercise|exercise
78103|NCT03715907|Professional Practice Gaps|professional practice gaps
78104|NCT03715894|Transcatheter aortic valve implantation|transcatheter aortic valve implantation
78105|NCT03715894|Pacemaker|pacemaker
78106|NCT03715894|Aortic valve calcification|aortic valve calcification
78107|NCT03715894|PPI|ppi
78108|NCT03715868|Acute kidney injury|acute kidney injury
78109|NCT03715868|Acute renal failure|acute renal failure
78110|NCT03715868|Diet|diet
78111|NCT03715868|Cardiothoracic surgery|cardiothoracic surgery
78112|NCT03715868|Change of protein source|change of protein source
78113|NCT03715816|endoscopy|endoscopy
78114|NCT03715816|minimally invasive surgery|minimally invasive surgery
78115|NCT03715816|passive breaks|passive breaks
78116|NCT03715816|active breaks|active breaks
78117|NCT03715816|muscle activity|muscle activity
78118|NCT03715816|back curvature|back curvature
78119|NCT03715777|BoNTA|bonta
78120|NCT03715777|Electromyography|electromyography
78121|NCT03715777|EMG|emg
78122|NCT03715777|Pelvic Pain|pelvic pain
78123|NCT03715777|Pelvic Pain Syndrome|pelvic pain syndrome
78124|NCT03715764|Knee osteoarthritis|knee osteoarthritis
78125|NCT03715764|Physical Therapist|physical therapist
78126|NCT03715764|Primary assessor|primary assessor
78127|NCT03715764|Primary care|primary care
78128|NCT03715751|Adaptive Support Ventilation|adaptive support ventilation
78129|NCT03715751|ARDS|ards
78130|NCT03715751|Esophageal Pressure|esophageal pressure
78131|NCT03715751|Mechanical Ventilation|mechanical ventilation
78132|NCT03715751|Transpulmonary Pressure|transpulmonary pressure
78133|NCT03715686|Neoplasm, Breast|neoplasm, breast
78134|NCT03715686|neoadjuvant chemotherapy|neoadjuvant chemotherapy
78135|NCT03715686|Lymph Node Metastases|lymph node metastases
78136|NCT03715686|response|response
78137|NCT03715660|Non muscle invasive bladder cancer, recurrence, progression|non muscle invasive bladder cancer, recurrence, progression
78138|NCT03715621|Acute Myeloid Leukemia|acute myeloid leukemia
78139|NCT03715621|next generation sequencing|next generation sequencing
78140|NCT03715621|Hematopoietic Stem Cell Transplantation|hematopoietic stem cell transplantation
78141|NCT03715595|treat-to-target|treat-to-target
78142|NCT03715595|smart system of disease management|smart system of disease management
78143|NCT03715595|drug use|drug use
78144|NCT03715517|Injections, Spinal|injections, spinal
78145|NCT03715517|Analgesia, Epidural|analgesia, epidural
78146|NCT03715517|Anesthesia, Spinal|anesthesia, spinal
78147|NCT03715517|Patient Reported Outcome Measures|patient reported outcome measures
78148|NCT03715517|Postoperative Period|postoperative period
78149|NCT03715504|Tolero|tolero
78150|NCT03715504|Solid Tumor|solid tumor
78151|NCT03715504|Advanced Malignancy|advanced malignancy
78152|NCT03715504|First in Human|first in human
78153|NCT03715504|Phase 1|phase 1
78154|NCT03715504|Cancer|cancer
78155|NCT03715413|pulsed radiofrequency, non-cyclic mastalgia|pulsed radiofrequency, non-cyclic mastalgia
78156|NCT03715374|Platelet rich fibrin|platelet rich fibrin
78157|NCT03715374|bone graft|bone graft
78158|NCT03715374|non inferiority trial|non inferiority trial
78159|NCT03715361|ECG measurement|ecg measurement
78160|NCT03715361|AF-Stroke|af-stroke
78161|NCT03715361|Germany|germany
78162|NCT03715361|Electrocardiogram|electrocardiogram
78163|NCT03715348|fresh frozen plasma|fresh frozen plasma
78164|NCT03715348|prothrombin complex concentrate|prothrombin complex concentrate
78165|NCT03715348|cardiac surgery|cardiac surgery
78166|NCT03715335|Screening|screening
78167|NCT03715335|Emergency Department|emergency department
78168|NCT03715335|Adolescents|adolescents
78172|NCT03715335|Pragmatic Trial|pragmatic trial
78173|NCT03715322|bronchiectasis|bronchiectasis
78174|NCT03715322|Pseudomonas aeruginosa|pseudomonas aeruginosa
78175|NCT03715322|tobramycin|tobramycin
78176|NCT03715322|nebulization|nebulization
78177|NCT03715322|bacterial load|bacterial load
78178|NCT03715322|quality of life|quality of life
78179|NCT03715283|MUNIX|munix
78180|NCT03715257|Advanced extubation|advanced extubation
78181|NCT03715205|programmed cell death 1 (PD-1, PD1 )|programmed cell death 1 (pd-1, pd1 )
78182|NCT03715205|programmed cell death ligand 1 (PD-L1, PDL1)|programmed cell death ligand 1 (pd-l1, pdl1)
78183|NCT03715205|programmed cell death ligand 2 (PD-L2, PDL2)|programmed cell death ligand 2 (pd-l2, pdl2)
78184|NCT03715140|Osteoarthritis, Crucumin, Flowcytometry|osteoarthritis, crucumin, flowcytometry
78185|NCT03715127|Depression|depression
78186|NCT03715127|5HT-2A|5ht-2a
78187|NCT03715127|Psilocybin|psilocybin
78188|NCT03715127|clinical efficacy|clinical efficacy
78189|NCT03715127|self|self
78190|NCT03715127|emotion regulation|emotion regulation
78191|NCT03715127|placebo-controlled|placebo-controlled
78192|NCT03715127|proof-of-concept|proof-of-concept
78193|NCT03715088|Irisin|irisin
78194|NCT03715088|Obesity|obesity
78195|NCT03715088|Resistance Training|resistance training
78196|NCT03715088|Older Adults|older adults
78197|NCT03715088|Younger Adults|younger adults
78198|NCT03715088|Myokines|myokines
78199|NCT03715075|Intra-epidermal|intra-epidermal
78200|NCT03715075|nerve fibre density|nerve fibre density
78201|NCT03715062|Long-term care facility|long-term care facility
78202|NCT03715062|ISBAR|isbar
78203|NCT03715062|Communication|communication
78204|NCT03715062|Antibiotics|antibiotics
78205|NCT03715062|Antibiotic stewardship|antibiotic stewardship
78206|NCT03715049|upper lip wrinkles|upper lip wrinkles
78207|NCT03715023|RSV infection|rsv infection
78208|NCT03715023|Hematopoeitic stem cell transplant|hematopoeitic stem cell transplant
78209|NCT03714984|Prostatectomy|prostatectomy
78210|NCT03714984|Pelvic Floor Disorders|pelvic floor disorders
78211|NCT03714984|Robotic Surgical Procedures|robotic surgical procedures
78212|NCT03714984|rehabilitation|rehabilitation
78213|NCT03714971|Whatsapp|whatsapp
78214|NCT03714971|smoking cessation|smoking cessation
78215|NCT03714971|cessation service|cessation service
78216|NCT03714945|Allergic Rhinitis|allergic rhinitis
78217|NCT03714945|Children|children
78218|NCT03714945|Cognitive Ability|cognitive ability
78219|NCT03714932|Arch analysis, Mixed dentition,Tanaka & Johnston|arch analysis, mixed dentition,tanaka & johnston
78220|NCT03714906|head and neck cancer|head and neck cancer
78221|NCT03714906|pain|pain
78222|NCT03714906|analgesia|analgesia
78223|NCT03714867|head and neck cancer|head and neck cancer
78224|NCT03714867|analgesia|analgesia
78225|NCT03714867|pregabalin|pregabalin
78226|NCT03714841|C reactive protein|c reactive protein
78227|NCT03714841|randomized controlled trial|randomized controlled trial
78228|NCT03714841|Blood culture|blood culture
78229|NCT03714828|Skin cancer|skin cancer
78230|NCT03714828|Squamous cell|squamous cell
78231|NCT03714828|Squamous Cell Carcinoma|squamous cell carcinoma
78232|NCT03714828|Skin lesion|skin lesion
78233|NCT03714828|Keratoacanthoma|keratoacanthoma
78234|NCT03714828|talimogene laherparepvec|talimogene laherparepvec
78238|NCT03714802|bifurcation lesion|bifurcation lesion
78239|NCT03714802|percutaneous coronary intervention|percutaneous coronary intervention
78240|NCT03714802|Szabo|szabo
78241|NCT03714802|T-stenting|t-stenting
78242|NCT03714789|Kidney Failure|kidney failure
78243|NCT03714789|Pharmacokinetics|pharmacokinetics
78244|NCT03714789|Antibiotics|antibiotics
78245|NCT03714776|Hypertension|hypertension
78246|NCT03714776|Hypertensive|hypertensive
78248|NCT03714776|Angiotensinogen|angiotensinogen
78249|NCT03714776|Blood Pressure|blood pressure
78250|NCT03714776|High Blood Pressure|high blood pressure
78251|NCT03714763|Nonfunctioning Pituitary Adenoma|nonfunctioning pituitary adenoma
78252|NCT03714763|Dopamine Agonist|dopamine agonist
78253|NCT03714763|Dopamine D2 Receptors|dopamine d2 receptors
78254|NCT03714763|PET-MR|pet-mr
78255|NCT03714750|bifurcation coronary lesions|bifurcation coronary lesions
78256|NCT03714750|interventional technique of coronary lesions|interventional technique of coronary lesions
78257|NCT03714750|Double kissing and crush|double kissing and crush
78258|NCT03714750|DK crush|dk crush
78259|NCT03714750|Reverse TAP|reverse tap
78260|NCT03714750|reverse T-and-protrusion|reverse t-and-protrusion
78261|NCT03714724|Critically ill patients|critically ill patients
78262|NCT03714724|intraabdominal pressure|intraabdominal pressure
78263|NCT03714724|hemodynamics|hemodynamics
78264|NCT03714724|positive end-expiratory pressure|positive end-expiratory pressure
78265|NCT03714711|total hip replacement|total hip replacement
78267|NCT03714698|Pilates exercise|pilates exercise
78268|NCT03714672|Wisdom tooth removal|wisdom tooth removal
78269|NCT03714672|Dental pain|dental pain
78270|NCT03714633|cognitive development|cognitive development
78271|NCT03714633|motor development|motor development
78272|NCT03714633|parent-child interaction|parent-child interaction
78273|NCT03714633|parental mental health|parental mental health
78274|NCT03714633|strength-based intervention|strength-based intervention
78275|NCT03714633|prematurity|prematurity
101240|NCT03570931|INAD|inad
78276|NCT03714490|rectal cancer|rectal cancer
78277|NCT03714490|short-term radiotherapy|short-term radiotherapy
78278|NCT03714490|neoadjuvant chemotherapy|neoadjuvant chemotherapy
78279|NCT03714490|total mesorectal excision|total mesorectal excision
78280|NCT03714490|MRI-simulation|mri-simulation
78281|NCT03714490|boost|boost
78282|NCT03714477|Worsening hypertension|worsening hypertension
78283|NCT03714477|Renal stone|renal stone
78284|NCT03714464|Gastrointestinal physiology|gastrointestinal physiology
78285|NCT03714464|Gastrointestinal response to sugars|gastrointestinal response to sugars
78286|NCT03714464|gastrointestinal|gastrointestinal
78288|NCT03714464|stomach|stomach
78289|NCT03714464|small bowel|small bowel
78290|NCT03714464|sorbitol|sorbitol
78291|NCT03714464|excess fructose|excess fructose
78292|NCT03714464|FODMAPs|fodmaps
78293|NCT03714464|colon|colon
78294|NCT03714438|Medicago sativa|medicago sativa
78295|NCT03714438|Insulin secretion|insulin secretion
78296|NCT03714438|Insulin Sensitivity|insulin sensitivity
78297|NCT03714399|Intensive Care Unit Acquired Weakness (ICUAW)|intensive care unit acquired weakness (icuaw)
78298|NCT03714399|Critical Illness Polyneuromyopathy (CIPM)|critical illness polyneuromyopathy (cipm)
78299|NCT03714399|Health Related Quality of Life (HRQoL)|health related quality of life (hrqol)
78300|NCT03714399|Ultrasound (US)|ultrasound (us)
78301|NCT03714399|Cardiac Surgery|cardiac surgery
78302|NCT03714399|Rectus Femoris Cross Sectional Area (RFcsa)|rectus femoris cross sectional area (rfcsa)
78303|NCT03714373|PWS|pws
78304|NCT03714373|Prader-Willi Syndrome|prader-willi syndrome
78305|NCT03714360|TXA;decompression; discectomy; operative time; blood loss|txa;decompression; discectomy; operative time; blood loss
78306|NCT03714347|cerebral oxygen monitoring|cerebral oxygen monitoring
78307|NCT03714347|intracranial surgery|intracranial surgery
78308|NCT03714347|general anesthesia|general anesthesia
78309|NCT03714334|Recurrent Glioblastoma|recurrent glioblastoma
78310|NCT03714334|oncolytic virus|oncolytic virus
78311|NCT03714334|immunotherapy|immunotherapy
78312|NCT03714321|mechanical insufflation-exsufflation|mechanical insufflation-exsufflation
78314|NCT03714282|Spinal cord stimulation|spinal cord stimulation
78315|NCT03714282|electrical stimulation|electrical stimulation
78316|NCT03714282|locomotion|locomotion
78317|NCT03714269|children|children
78318|NCT03714269|medial gastrocnemius muscle|medial gastrocnemius muscle
78319|NCT03714256|Pediatric|pediatric
78320|NCT03714230|Functional status, Symptoms, Cognitive functioning, QOL|functional status, symptoms, cognitive functioning, qol
78321|NCT03714217|Spinal Cord Injury|spinal cord injury
78322|NCT03714217|Obesity|obesity
78323|NCT03714217|Telenutrition|telenutrition
78324|NCT03714204|academic physician burnout|academic physician burnout
78325|NCT03714204|physician burnout|physician burnout
78326|NCT03714204|Intervention to reduce physician burnout|intervention to reduce physician burnout
78327|NCT03714204|physician depression|physician depression
78328|NCT03714204|physician insomnia|physician insomnia
78329|NCT03714204|physician stress|physician stress
78330|NCT03714204|Transcendental Meditation|transcendental meditation
78331|NCT03714204|TM|tm
78332|NCT03714165|Alpha defensin|alpha defensin
78333|NCT03714165|16S rRNA gene|16s rrna gene
78334|NCT03714152|CHB|chb
78335|NCT03714152|HBV|hbv
78336|NCT03714152|hepatitis B|hepatitis b
78337|NCT03714152|HBeAg positive|hbeag positive
78338|NCT03714139|Dental Implants|dental implants
78339|NCT03714139|bone healing|bone healing
78340|NCT03714139|clinical trial|clinical trial
78341|NCT03714139|histology|histology
78342|NCT03714113|Donor-specific antibodies|donor-specific antibodies
78343|NCT03714087|Finishing protocol|finishing protocol
78344|NCT03714087|Aligner|aligner
78345|NCT03714048|Extracorporeal Membrane Oxygenation|extracorporeal membrane oxygenation
78346|NCT03714048|ECMO|ecmo
78347|NCT03714048|VA-ECMO|va-ecmo
78348|NCT03714009|Infertility|infertility
78349|NCT03714009|Poor ovarian reserve|poor ovarian reserve
78350|NCT03714009|Intracytoplasmic sperm injection|intracytoplasmic sperm injection
78351|NCT03714009|fasting|fasting
78352|NCT03713996|Cognitive Behavioral Therapy for Insomnia|cognitive behavioral therapy for insomnia
78353|NCT03713996|Self-Care|self-care
78354|NCT03713996|Fatigue|fatigue
78355|NCT03713996|Diabetes|diabetes
78356|NCT03713996|Glycemic Control|glycemic control
78357|NCT03713983|behavior, addictive|behavior, addictive
78358|NCT03713983|addiction medicine|addiction medicine
78359|NCT03713983|substance-related disorders|substance-related disorders
78360|NCT03713983|abuse, narcotic|abuse, narcotic
78361|NCT03713983|addiction, narcotic|addiction, narcotic
78362|NCT03713983|analgesics, narcotic|analgesics, narcotic
78363|NCT03713983|opioid-related disorders|opioid-related disorders
78364|NCT03713983|benzodiazepines|benzodiazepines
78365|NCT03713983|prescription drugs|prescription drugs
78366|NCT03713970|cetra duo press,e.max press,clinical performance|cetra duo press,e.max press,clinical performance
78367|NCT03713957|Brain Diseases|brain diseases
78368|NCT03713957|Central Nervous System Diseases|central nervous system diseases
78369|NCT03713957|Nervous System Diseases|nervous system diseases
78370|NCT03713957|Neurodegenerative Diseases|neurodegenerative diseases
78371|NCT03713957|Neurocognitive Disorders|neurocognitive disorders
78372|NCT03713957|Mental Disorders|mental disorders
78373|NCT03713957|Parkinson's Disease|parkinson's disease
78374|NCT03713957|Dementia|dementia
78375|NCT03713879|post ERCP panceatitis|post ercp panceatitis
78376|NCT03713879|rectal indomethacin|rectal indomethacin
78377|NCT03713879|pancreatic stents|pancreatic stents
78378|NCT03713853|Total hip replacement|total hip replacement
78379|NCT03713853|Total hip arthroplasty|total hip arthroplasty
78380|NCT03713853|Open Reduction internal Fixation|open reduction internal fixation
78381|NCT03713853|Hip fixation|hip fixation
78382|NCT03713840|nutrition|nutrition
78383|NCT03713840|child care|child care
78384|NCT03713840|obesity|obesity
78385|NCT03713827|glass hybrids|glass hybrids
78386|NCT03713827|bruxism|bruxism
78387|NCT03713827|Non carious cervical lesions|non carious cervical lesions
78388|NCT03713814|Electromyography|electromyography
78389|NCT03713814|Exercise therapy|exercise therapy
78390|NCT03713814|Muscle Strength Dynamometer|muscle strength dynamometer
78391|NCT03713814|Pilots|pilots
78392|NCT03713814|Back Pain|back pain
78393|NCT03713788|Stretch tolerance|stretch tolerance
78394|NCT03713788|Range of Motion|range of motion
78395|NCT03713762|Peribulbar block|peribulbar block
78396|NCT03713749|Robotic esophagectomy|robotic esophagectomy
78397|NCT03713749|Video-assisted thoracoscopic esophagectomy|video-assisted thoracoscopic esophagectomy
78398|NCT03713749|Recurrent laryngeal nerve lymh node|recurrent laryngeal nerve lymh node
78399|NCT03713749|Esophageal squamous cell carcinoma|esophageal squamous cell carcinoma
78400|NCT03713736|HPV infection|hpv infection
78401|NCT03713736|Spondyloarthritis|spondyloarthritis
78402|NCT03713736|Rhumatoid Arthritis|rhumatoid arthritis
78403|NCT03713736|Cervical smear|cervical smear
78404|NCT03713736|cervical cancer screening|cervical cancer screening
78405|NCT03713710|self-sampling for HPV testing|self-sampling for hpv testing
78406|NCT03713697|self-collection for HPV testing|self-collection for hpv testing
78407|NCT03713671|Primary Hyperparathyroidism|primary hyperparathyroidism
78408|NCT03713671|Spatio-Temporal Parameters of Gait|spatio-temporal parameters of gait
78409|NCT03713671|Gait Symmetry|gait symmetry
78410|NCT03713671|Balance|balance
78411|NCT03713632|acne inversa|acne inversa
78412|NCT03713632|Hidradenitis suppurativa|hidradenitis suppurativa
78413|NCT03713632|maladie de Verneuil|maladie de verneuil
78414|NCT03713632|inflammatory disease|inflammatory disease
78415|NCT03713632|AIN457|ain457
78416|NCT03713632|AIN457M|ain457m
78417|NCT03713619|acne inversa|acne inversa
78418|NCT03713619|Hidradenitis suppurativa|hidradenitis suppurativa
78419|NCT03713619|maladie de Verneuil|maladie de verneuil
78420|NCT03713619|inflammatory disease|inflammatory disease
78421|NCT03713619|AIN457|ain457
78422|NCT03713619|AIN457M|ain457m
78423|NCT03713606|Portal hypertension|portal hypertension
78424|NCT03713606|serum biomarker|serum biomarker
78425|NCT03713606|diagnosis|diagnosis
78426|NCT03713593|receptor tyrosine kinase inhibitor|receptor tyrosine kinase inhibitor
78427|NCT03713593|programmed cell death 1 (PD-1, PD1)|programmed cell death 1 (pd-1, pd1)
78428|NCT03713593|programmed cell death ligand 1 (PD-L1, PDL1)|programmed cell death ligand 1 (pd-l1, pdl1)
78429|NCT03713593|programmed cell death ligand 2 (PD-L2, PDL2)|programmed cell death ligand 2 (pd-l2, pdl2)
78430|NCT03713580|Autologous stem cell transplant (ASCT)|autologous stem cell transplant (asct)
78431|NCT03713580|Venetoclax|venetoclax
78432|NCT03713567|Aggressive Periodontitis|aggressive periodontitis
78433|NCT03713567|Biomarkers|biomarkers
78434|NCT03713567|Microbiota|microbiota
78435|NCT03713567|Dental Implants|dental implants
78436|NCT03713554|SSD, unilateral hearing loss|ssd, unilateral hearing loss
78437|NCT03713541|Anorexia nervosa [MeSH]|anorexia nervosa [mesh]
78438|NCT03713541|Feeding and Eating Disorders [MeSH]|feeding and eating disorders [mesh]
78439|NCT03713541|women|women
78440|NCT03713541|youth|youth
78441|NCT03713541|adolescent|adolescent
78442|NCT03713541|duration of untreated illness (DUI)|duration of untreated illness (dui)
78443|NCT03713541|time-to-treatment [MeSH]|time-to-treatment [mesh]
78444|NCT03713541|facilitators|facilitators
78445|NCT03713541|barriers|barriers
78446|NCT03713541|factors|factors
78447|NCT03713541|treatment|treatment
78448|NCT03713541|first treatment initiation|first treatment initiation
78449|NCT03713502|Pre-diabetes|pre-diabetes
78450|NCT03713502|Diabetes|diabetes
78451|NCT03713502|HIV|hiv
78452|NCT03713502|Enteropathy|enteropathy
78453|NCT03713502|Inflammation|inflammation
78454|NCT03713502|Microbial translocation|microbial translocation
78455|NCT03713502|Endotoxin translocation|endotoxin translocation
78456|NCT03713502|Insulin resistance|insulin resistance
78457|NCT03713502|Visceral obesity|visceral obesity
78458|NCT03713502|Incretin hormones|incretin hormones
78459|NCT03713502|GLP-1|glp-1
78460|NCT03713502|GLP-2|glp-2
78462|NCT03713489|acute-on-chronic liver failure|acute-on-chronic liver failure
78463|NCT03713489|platelet|platelet
78464|NCT03713489|Hepatitis B|hepatitis b
78465|NCT03713450|Radiation|radiation
78466|NCT03713450|Contrast|contrast
78467|NCT03713450|Endovascular|endovascular
78468|NCT03713450|Fusion imaging guidance|fusion imaging guidance
78469|NCT03713450|Iliac|iliac
78470|NCT03713372|Head and Neck Cancer|head and neck cancer
78471|NCT03713372|Epidermal growth factor receptor|epidermal growth factor receptor
78472|NCT03713372|EGFR|egfr
78473|NCT03713372|SCT200|sct200
78474|NCT03713359|MRVAC vaccine, fever, rash|mrvac vaccine, fever, rash
78475|NCT03713346|lactose intolerance, dairy intolerance|lactose intolerance, dairy intolerance
78476|NCT03713333|digital health|digital health
78477|NCT03713333|handheld ultrasound|handheld ultrasound
78478|NCT03713333|smartphone ECG|smartphone ecg
78479|NCT03713333|mobile health|mobile health
78480|NCT03713333|point of care genomics|point of care genomics
78481|NCT03713333|big data|big data
78482|NCT03713333|artificial intelligence|artificial intelligence
78483|NCT03713333|learning health system|learning health system
78484|NCT03713320|SOLAR|solar
78485|NCT03713320|Cutaneous T-cell Lymphoma|cutaneous t-cell lymphoma
78486|NCT03713320|CTCL|ctcl
78487|NCT03713320|Mycosis Fungoides|mycosis fungoides
78488|NCT03713320|Lymphoma|lymphoma
78489|NCT03713320|Lymphoma, T-cell|lymphoma, t-cell
78490|NCT03713320|Lymphoma, T-cell, cutaneous|lymphoma, t-cell, cutaneous
78491|NCT03713320|Lymphoma, Non-Hodgkin|lymphoma, non-hodgkin
78492|NCT03713320|Lymphoproliferative Disorders|lymphoproliferative disorders
78493|NCT03713320|Lymphatic Diseases|lymphatic diseases
78494|NCT03713320|Immunoproliferative Disorders|immunoproliferative disorders
78495|NCT03713320|Immune System Diseases|immune system diseases
78496|NCT03713320|Neoplasms|neoplasms
78497|NCT03713320|MicroRNAs|micrornas
78498|NCT03713320|Vorinostat|vorinostat
78499|NCT03713320|Histone Deacetylase Inhibitors|histone deacetylase inhibitors
78500|NCT03713307|Septic shock|septic shock
78501|NCT03713307|acute kidney injury|acute kidney injury
78502|NCT03713307|haemodynamic monitoring|haemodynamic monitoring
78503|NCT03713307|microcirculation|microcirculation
78504|NCT03713294|multiple myeloma|multiple myeloma
78505|NCT03713268|Microscope Integrated optical coherence tomography|microscope integrated optical coherence tomography
78506|NCT03713268|MIOCT|mioct
78507|NCT03713268|OCT Angiography|oct angiography
78508|NCT03713268|OCTA|octa
78509|NCT03713255|Regional Anesthesia|regional anesthesia
78510|NCT03713255|Paravertebral Block|paravertebral block
78511|NCT03713255|Breast Cancer Surgery|breast cancer surgery
78512|NCT03713255|MTP block|mtp block
78513|NCT03713229|anal squamous intraepithelial lesions|anal squamous intraepithelial lesions
78514|NCT03713229|anal squamous cell carcinoma|anal squamous cell carcinoma
78515|NCT03713229|high-resolution anoscopy|high-resolution anoscopy
78516|NCT03713229|liquid-based cytology|liquid-based cytology
78517|NCT03713229|human papillomavirus|human papillomavirus
78518|NCT03713229|men who have sex with men|men who have sex with men
78519|NCT03713229|HIV infection|hiv infection
78520|NCT03713229|diagnostic performance|diagnostic performance
78521|NCT03713203|Photodynamic Therapy (PDT)|photodynamic therapy (pdt)
78522|NCT03713203|Medical Device|medical device
78523|NCT03713203|Paget Disease|paget disease
78524|NCT03713203|Metvixia®|metvixia®
78525|NCT03713151|Telemedicine, Feasibility, Exercise|telemedicine, feasibility, exercise
78526|NCT03713138|Follicle stimulating hormone|follicle stimulating hormone
78527|NCT03713138|Leutinizing hormone|leutinizing hormone
78528|NCT03713138|Sex hormone binding globulin|sex hormone binding globulin
78529|NCT03713138|Serum Prolactin|serum prolactin
78530|NCT03713138|Flaxseed sachets|flaxseed sachets
78531|NCT03713138|Lipid profile|lipid profile
78532|NCT03713112|deprescribe|deprescribe
78533|NCT03713112|multi-disciplinary|multi-disciplinary
78534|NCT03713112|open label|open label
78535|NCT03713112|rounds|rounds
78536|NCT03713112|randomised controlled trial|randomised controlled trial
78537|NCT03713099|Microwave Ablation|microwave ablation
78538|NCT03713086|Rabies|rabies
78539|NCT03713086|Vaccine|vaccine
78540|NCT03713086|Safety|safety
78541|NCT03713086|Ractogenicity|ractogenicity
78542|NCT03713086|Immunogenicity|immunogenicity
78543|NCT03713060|Pregnancy|pregnancy
78544|NCT03713060|Gastric bypass|gastric bypass
78545|NCT03713060|Hypoglycemia|hypoglycemia
78546|NCT03713060|Gestational weight gain|gestational weight gain
78547|NCT03713060|Fetal growth|fetal growth
78548|NCT03713047|Questionnaire|questionnaire
78549|NCT03713047|Long term follow up|long term follow up
78550|NCT03713047|Surgical Procedure|surgical procedure
78551|NCT03713047|Groin hernia repair|groin hernia repair
78552|NCT03713047|Neuropathy|neuropathy
78553|NCT03713047|Inflammation|inflammation
78554|NCT03713047|Chronic pain|chronic pain
78555|NCT03713047|ADL-functions|adl-functions
78556|NCT03713047|Psychometrics|psychometrics
78557|NCT03713047|Quantitative sensory testing (QST)|quantitative sensory testing (qst)
78558|NCT03713034|HIV testing and counseling (HTC)|hiv testing and counseling (htc)
78559|NCT03713008|Fluid Responsiveness, Anesthesia, Surgery, Stroke Volume Variation, Fluid status,|fluid responsiveness, anesthesia, surgery, stroke volume variation, fluid status,
78560|NCT03712995|Cutler-Beard|cutler-beard
78561|NCT03712995|tarsoconjunctival graft|tarsoconjunctival graft
78562|NCT03712995|upper eyelid|upper eyelid
78563|NCT03712982|Infertility|infertility
78564|NCT03712982|Fertility|fertility
78565|NCT03712982|Mindfulness|mindfulness
78566|NCT03712982|Ellen Langer|ellen langer
78567|NCT03712982|Wellbeing|wellbeing
78568|NCT03712982|Attention to Variability|attention to variability
78569|NCT03712956|early breast cancer|early breast cancer
78570|NCT03712956|luminal B|luminal b
78571|NCT03712956|adjuvant chemotherapy|adjuvant chemotherapy
78572|NCT03712943|colon cancer|colon cancer
78573|NCT03712943|colorectal|colorectal
78574|NCT03712943|MMR|mmr
78575|NCT03712943|Mismatch Repair|mismatch repair
78576|NCT03712917|Migraine|migraine
78577|NCT03712917|Greater Occipital Nerve Block|greater occipital nerve block
78578|NCT03712917|Topiramate|topiramate
78579|NCT03712917|Flunarizine|flunarizine
78580|NCT03712891|PACU length of stay|pacu length of stay
78581|NCT03712891|coffee|coffee
78582|NCT03712865|embolic stroke|embolic stroke
78583|NCT03712865|cryptogenic|cryptogenic
78584|NCT03712865|atrial fibrillation|atrial fibrillation
78585|NCT03712865|long term cardiac rhythm monitoring|long term cardiac rhythm monitoring
78586|NCT03712852|Platelet rich fibrin|platelet rich fibrin
78587|NCT03712852|sub-epithelial connective tissue|sub-epithelial connective tissue
78588|NCT03712852|coronally advanced flap|coronally advanced flap
78589|NCT03712839|Activities of Daily Living (ADL)|activities of daily living (adl)
78590|NCT03712839|Executive Deficit|executive deficit
78591|NCT03712839|Monitoring|monitoring
78592|NCT03712839|Self Awareness|self awareness
78593|NCT03712826|Crohn|crohn
78594|NCT03712826|immunological profile|immunological profile
78595|NCT03712826|ustekinumab|ustekinumab
78596|NCT03712826|anti-TNF|anti-tnf
78597|NCT03712813|aromatase inhibitors|aromatase inhibitors
78598|NCT03712813|low intensity vibration|low intensity vibration
78599|NCT03712800|Dysmenorrhea|dysmenorrhea
78600|NCT03712800|Women Health|women health
78601|NCT03712800|Rhythmical Massage|rhythmical massage
78602|NCT03712800|Anthroposophic Medicine|anthroposophic medicine
78603|NCT03712800|HRV Biofeedback|hrv biofeedback
78604|NCT03712774|quality of life|quality of life
78605|NCT03712774|neoadjuvant|neoadjuvant
78606|NCT03712774|definitive|definitive
78607|NCT03712774|chemoradiation|chemoradiation
78608|NCT03712774|esophageal cancer|esophageal cancer
78609|NCT03712761|Dietary Protein Supplementation|dietary protein supplementation
78610|NCT03712735|Labor analgesia|labor analgesia
78611|NCT03712735|Programmed intermittent epidural bolus|programmed intermittent epidural bolus
78612|NCT03712683|Unexplained Infertility, pregnancy rate,hypothyroidism|unexplained infertility, pregnancy rate,hypothyroidism
78613|NCT03712657|ERAS|eras
78614|NCT03712657|Pediatric surgery|pediatric surgery
78615|NCT03712657|Emergency|emergency
78616|NCT03712657|Both of systolic and diastolic will be measured|both of systolic and diastolic will be measured
78617|NCT03712644|Critical limb ischemia|critical limb ischemia
78618|NCT03712644|Coronary artery disease|coronary artery disease
78619|NCT03712644|Fractional flow reserve-guided coronary revascularization|fractional flow reserve-guided coronary revascularization
78620|NCT03712631|tunneling technique|tunneling technique
78621|NCT03712631|collagen membrane|collagen membrane
78622|NCT03712631|tunnel|tunnel
78623|NCT03712631|augmentation|augmentation
78624|NCT03712631|horizontal ridge augmentation|horizontal ridge augmentation
78625|NCT03712631|bone graft|bone graft
78626|NCT03712631|ridge augmentation|ridge augmentation
78627|NCT03712631|posterior mandible|posterior mandible
78628|NCT03712618|Platelet Transfusion Refractoriness|platelet transfusion refractoriness
78629|NCT03712618|Continuous Platelet Transfusion|continuous platelet transfusion
78630|NCT03712566|Liquid Biopsy|liquid biopsy
78631|NCT03712566|Circulating Tumor DNA|circulating tumor dna
78632|NCT03712566|Molecular Profiling|molecular profiling
78633|NCT03712566|Immune Analysis|immune analysis
78634|NCT03712566|Epigenetics|epigenetics
78635|NCT03712566|Radiomics|radiomics
78636|NCT03712553|Behavioral Economics|behavioral economics
78637|NCT03712553|Screening|screening
78638|NCT03712553|Outreach|outreach
78639|NCT03712527|Active discopathy|active discopathy
78640|NCT03712488|chronic lymphoproliferative disorders|chronic lymphoproliferative disorders
78641|NCT03712475|Pharmacokinetic|pharmacokinetic
78642|NCT03712462|Eating Disorder|eating disorder
78643|NCT03712462|Binge Eating|binge eating
78644|NCT03712462|Binge Eating Disorder|binge eating disorder
78645|NCT03712462|Weight Loss|weight loss
78646|NCT03712436|Palliative Care|palliative care
78647|NCT03712436|Supportive Care|supportive care
78648|NCT03712436|Low Income Setting|low income setting
78649|NCT03712436|LMIC|lmic
78650|NCT03712436|Africa|africa
78651|NCT03712423|Nanoparticles|nanoparticles
78652|NCT03712423|Positron-Emission Tomography|positron-emission tomography
78653|NCT03712423|Docetaxel|docetaxel
78654|NCT03712423|Neoplasms|neoplasms
78655|NCT03712423|Quantification|quantification
78656|NCT03712384|Recovery|recovery
78657|NCT03712384|Qualitative research|qualitative research
78658|NCT03712384|Personal narratives|personal narratives
78659|NCT03712345|Granulomatosis with Polyangiitis (GPA)|granulomatosis with polyangiitis (gpa)
78660|NCT03712345|Microscopic Polyangiitis (MPA)|microscopic polyangiitis (mpa)
78661|NCT03712345|IFS-1|ifs-1
78662|NCT03712345|ANCA|anca
78663|NCT03712345|AAV|aav
78664|NCT03712332|Distress tolerance|distress tolerance
78665|NCT03712332|transdiagnostic|transdiagnostic
78666|NCT03712319|mindfulness|mindfulness
78667|NCT03712319|mobile application|mobile application
78668|NCT03712319|students|students
78669|NCT03712319|anxiety|anxiety
78670|NCT03712319|depression|depression
78671|NCT03712319|self-compassion|self-compassion
78672|NCT03712319|empathy|empathy
78673|NCT03712319|burnout|burnout
78674|NCT03712254|acute pain, fosphenytoin|acute pain, fosphenytoin
78675|NCT03712215|Mechanical Ventilation|mechanical ventilation
78676|NCT03712215|Electrical Stimulation|electrical stimulation
78677|NCT03712215|Diaphragm|diaphragm
78678|NCT03712215|Ventilometry|ventilometry
78679|NCT03712215|Physiotherapy|physiotherapy
78680|NCT03712085|Functional magnetic resonance imaging（fMRI）|functional magnetic resonance imaging（fmri）
78681|NCT03712085|Surface electromyography （sEMG）|surface electromyography （semg）
78682|NCT03712085|Abdominal acupuncture|abdominal acupuncture
78683|NCT03712085|Brain Plasticity|brain plasticity
78684|NCT03712085|Effects and mechanism|effects and mechanism
78685|NCT03712059|Colorectal cancer sreening|colorectal cancer sreening
78686|NCT03712059|Polypectomy|polypectomy
78687|NCT03712059|Artificial intelligence|artificial intelligence
78688|NCT03712033|Hypertension management|hypertension management
78689|NCT03712033|Stroke|stroke
78690|NCT03712033|Secondary Prevention|secondary prevention
78691|NCT03712033|Modifiable stroke risk factor|modifiable stroke risk factor
78692|NCT03712033|Home blood pressure monitoring system|home blood pressure monitoring system
78693|NCT03712033|Telehealth|telehealth
78694|NCT03712033|Telus Health|telus health
78695|NCT03712033|Telemonitoring|telemonitoring
78696|NCT03712033|Systolic hypertension|systolic hypertension
78697|NCT03712033|Cerebrovascular Accident|cerebrovascular accident
78698|NCT03712033|TIA|tia
78699|NCT03712007|Orthodontic Anchorage Procedures|orthodontic anchorage procedures
78700|NCT03712007|Malocclusion, Angle Class III|malocclusion, angle class iii
78701|NCT03712007|Palatal Expansion Technique.|palatal expansion technique.
78702|NCT03712007|Cone-Beam Computed Tomography|cone-beam computed tomography
78703|NCT03712007|Dental Models|dental models
78704|NCT03711981|laparascopic, surgery, anesthesia|laparascopic, surgery, anesthesia
78705|NCT03711968|Interoception|interoception
78706|NCT03711968|Sense of movement|sense of movement
78707|NCT03711968|Posture|posture
78708|NCT03711968|body scheme|body scheme
78709|NCT03711942|Root canal treatment, intraorifice barrier.|root canal treatment, intraorifice barrier.
78710|NCT03711916|Breast cancer|breast cancer
78711|NCT03711916|Mastectomy|mastectomy
78712|NCT03711916|Perfusion|perfusion
78713|NCT03711916|Hemostasis|hemostasis
78714|NCT03711877|alopecia|alopecia
78715|NCT03711877|scalp cooling system|scalp cooling system
78716|NCT03711877|cold cap|cold cap
78717|NCT03711851|Chronic pain|chronic pain
78718|NCT03711851|Self-help|self-help
78719|NCT03711851|Bibliotherapy|bibliotherapy
78720|NCT03711851|Web-based interventions|web-based interventions
78721|NCT03711851|Acceptance and commitment therapy|acceptance and commitment therapy
78722|NCT03711851|Psychological flexibility|psychological flexibility
78723|NCT03711838|Pax7|pax7
78724|NCT03711838|MyoD|myod
78725|NCT03711838|Antioxidants|antioxidants
78726|NCT03711838|Myogenic potential|myogenic potential
78727|NCT03711838|Skeletal muscle healing|skeletal muscle healing
78728|NCT03711812|regional anaesthesia|regional anaesthesia
78729|NCT03711812|rib fractures|rib fractures
78730|NCT03711799|Autism Services|autism services
78731|NCT03711799|Mind the Gap|mind the gap
78732|NCT03711799|Peer Coach|peer coach
78733|NCT03711773|joint pain|joint pain
78734|NCT03711773|osteoarthritis|osteoarthritis
78735|NCT03711773|hip pain|hip pain
78736|NCT03711773|knee pain|knee pain
78737|NCT03711773|ankle pain|ankle pain
78738|NCT03711760|telepsychology|telepsychology
78739|NCT03711760|spinal cord injuries|spinal cord injuries
78740|NCT03711760|depression|depression
78741|NCT03711760|cognitive behavioral therapy|cognitive behavioral therapy
78742|NCT03711747|Ankle|ankle
78743|NCT03711747|Ankle Pain|ankle pain
78744|NCT03711747|Joint Pain|joint pain
78745|NCT03711747|Ankle Osteoarthritis|ankle osteoarthritis
78746|NCT03711734|Acupuncture|acupuncture
78747|NCT03711695|ibeat|ibeat
78748|NCT03711695|wrist watch|wrist watch
78749|NCT03711695|digital health|digital health
78750|NCT03711695|Arrythmia|arrythmia
78751|NCT03711682|Type 2 diabetes mellitus|type 2 diabetes mellitus
78752|NCT03711682|Glucose|glucose
78753|NCT03711682|Cinnamomum verum|cinnamomum verum
78754|NCT03711682|Cinnamomum zeylanicum|cinnamomum zeylanicum
78755|NCT03711682|Cinnamon|cinnamon
78756|NCT03711682|HbA1c|hba1c
78757|NCT03711682|Blood Pressure|blood pressure
78758|NCT03711682|Glycated Hemoglobin|glycated hemoglobin
78759|NCT03711682|Diastolic Pressure|diastolic pressure
78760|NCT03711682|Systolic Pressure|systolic pressure
78761|NCT03711682|Body Mass Index|body mass index
78762|NCT03711682|BMI|bmi
78763|NCT03711682|Metformin|metformin
78764|NCT03711682|Waist Circumference|waist circumference
78765|NCT03711669|autoimmune hepatitis|autoimmune hepatitis
78766|NCT03711669|disease flare|disease flare
78767|NCT03711669|treatment withdrawal|treatment withdrawal
78768|NCT03711656|Type 1 diabetes|type 1 diabetes
78769|NCT03711656|intermittent continuous glucose monitoring|intermittent continuous glucose monitoring
78770|NCT03711656|hypoglycemia|hypoglycemia
78771|NCT03711656|machine learning|machine learning
78772|NCT03711643|prostatic biopsies echo-guided|prostatic biopsies echo-guided
78773|NCT03711643|Pain measurement|pain measurement
78774|NCT03711643|Anxiety assessment|anxiety assessment
78775|NCT03711617|chronic kidney disease|chronic kidney disease
78776|NCT03711617|uremic toxin|uremic toxin
78777|NCT03711617|prognosis|prognosis
78778|NCT03711604|Hematological Malignancies|hematological malignancies
78779|NCT03711604|Tenalisib|tenalisib
78780|NCT03711604|RP6530|rp6530
78781|NCT03711604|Compassionate Use|compassionate use
78782|NCT03711591|Proximal humerus fracture fixation|proximal humerus fracture fixation
78783|NCT03711591|Trauma|trauma
78784|NCT03711591|Proximal Humerus|proximal humerus
78785|NCT03711591|Fixation|fixation
78786|NCT03711578|Non-Hodgkin lymphoma,|non-hodgkin lymphoma,
78787|NCT03711578|Tenalisib|tenalisib
78788|NCT03711578|RP6530|rp6530
78789|NCT03711565|Nasal CPAP|nasal cpap
78790|NCT03711565|High Frequency NCPAP|high frequency ncpap
78791|NCT03711552|Caesarean|caesarean
78792|NCT03711552|cesarean|cesarean
78793|NCT03711552|ObsQoR-11|obsqor-11
78794|NCT03711552|QoR-15|qor-15
78795|NCT03711552|MCID|mcid
78796|NCT03711552|minimal clinically important difference|minimal clinically important difference
78797|NCT03711552|quality of recovery|quality of recovery
78798|NCT03711539|Endurance Exercise|endurance exercise
78799|NCT03711539|Coronary Artery Disease|coronary artery disease
78800|NCT03711539|Atrial Fibrillation|atrial fibrillation
78801|NCT03711539|Myocardial Fibrosis|myocardial fibrosis
78802|NCT03711539|Coronary CT|coronary ct
78803|NCT03711500|plasticity|plasticity
78804|NCT03711487|Colorectal surgery|colorectal surgery
78805|NCT03711487|Foeniculum|foeniculum
78806|NCT03711487|Ileus|ileus
78807|NCT03711435|Idiopathic Pulmonary Fibrosis|idiopathic pulmonary fibrosis
78808|NCT03711435|Metabolomics|metabolomics
78809|NCT03711435|Chinese medicine|chinese medicine
78810|NCT03711409|Frozen Shoulder|frozen shoulder
78811|NCT03711409|Manual therapy|manual therapy
78812|NCT03711409|Soft tissue mobilization|soft tissue mobilization
78813|NCT03711396|Advance Care Planning|advance care planning
78814|NCT03711370|infant feeding|infant feeding
78815|NCT03711370|feeding interactions|feeding interactions
78816|NCT03711370|maternal feeding practices|maternal feeding practices
78817|NCT03711370|bottle-feeding|bottle-feeding
78818|NCT03711370|opaque bottles|opaque bottles
78819|NCT03711344|Cognitive Behavioral Therapy|cognitive behavioral therapy
78820|NCT03711344|Cultural Adaptation|cultural adaptation
78821|NCT03711344|East Asian Youth|east asian youth
78822|NCT03711331|Ventilator-associated pneumonia|ventilator-associated pneumonia
78823|NCT03711331|Hospital-acquired pneumonia|hospital-acquired pneumonia
78824|NCT03711331|Antimicrobial therapy|antimicrobial therapy
78825|NCT03711331|Ventilator-associated pneumonia Hospital-acquired pneumonia Antimicrobial therapy Polymerase chain reaction Antibiotics stewardship|ventilator-associated pneumonia hospital-acquired pneumonia antimicrobial therapy polymerase chain reaction antibiotics stewardship
78826|NCT03711331|Polymerase chain reaction|polymerase chain reaction
78827|NCT03711331|Antibiotics stewardship|antibiotics stewardship
78828|NCT03711292|Emergency Department|emergency department
78829|NCT03711292|Urgent Care Center|urgent care center
78830|NCT03711292|Behavioral Sciences|behavioral sciences
78831|NCT03711279|Sarcoma|sarcoma
78832|NCT03711279|SHR-1210|shr-1210
78833|NCT03711279|Apatinib|apatinib
78834|NCT03711253|acute hiv infection|acute hiv infection
78835|NCT03711253|emergency department|emergency department
78836|NCT03711253|antiretroviral therapy|antiretroviral therapy
78837|NCT03711240|colorectal liver metastases|colorectal liver metastases
78838|NCT03711240|FOLFOXIRI|folfoxiri
78839|NCT03711240|bevacizumab|bevacizumab
78840|NCT03711227|Serial Procalcitonin, Admitted Pneumonia, qSOFA, Sepsis|serial procalcitonin, admitted pneumonia, qsofa, sepsis
78841|NCT03711201|Hypertensive patients|hypertensive patients
78842|NCT03711201|Introduction of operating room|introduction of operating room
78843|NCT03711201|Anxiety|anxiety
78844|NCT03711201|Blood pressure|blood pressure
78845|NCT03711175|Sub-scapularis repair|sub-scapularis repair
78846|NCT03711149|Ambulation|ambulation
78847|NCT03711149|Length of stay|length of stay
78848|NCT03711149|Patient Satisfaction|patient satisfaction
78849|NCT03711149|Activity Monitor|activity monitor
78850|NCT03711149|Digital Health|digital health
78851|NCT03711123|metacognitive therapy, psychotherapy|metacognitive therapy, psychotherapy
78852|NCT03711110|Cardiotoxicity|cardiotoxicity
78853|NCT03711110|Elderly|elderly
78854|NCT03711110|Antineoplastic agents|antineoplastic agents
78855|NCT03711110|Cardiovascular monitoring|cardiovascular monitoring
78856|NCT03711110|Cardioprotection|cardioprotection
78857|NCT03711110|Cardio-oncology|cardio-oncology
78858|NCT03711110|Chemically-Induced Disorders|chemically-induced disorders
78859|NCT03711110|Radiation Injuries|radiation injuries
78860|NCT03711110|Drug-Related Side Effects and Adverse Reactions.|drug-related side effects and adverse reactions.
78861|NCT03711110|Primary prevention|primary prevention
78862|NCT03711110|Secondary prevention.|secondary prevention.
78863|NCT03711110|Mortality|mortality
78864|NCT03711084|non-nutritive sweeteners|non-nutritive sweeteners
78865|NCT03711084|sucrose|sucrose
78866|NCT03711084|food-cue responses|food-cue responses
78867|NCT03711084|appetite|appetite
78868|NCT03711084|blood glucose|blood glucose
78869|NCT03711084|energy intake|energy intake
78870|NCT03711071|patient-centered-communication|patient-centered-communication
78871|NCT03711071|Primary Care|primary care
78872|NCT03711071|over investigation|over investigation
78873|NCT03711071|communication|communication
78874|NCT03711071|consultation|consultation
78875|NCT03711071|shared-decision making|shared-decision making
78876|NCT03711071|medical education|medical education
78877|NCT03711071|low back pain|low back pain
78878|NCT03711058|Immunotherapy|immunotherapy
78879|NCT03711058|Nivolumab|nivolumab
78880|NCT03711058|Copanlisib|copanlisib
78881|NCT03711058|Unresectable|unresectable
78882|NCT03711058|Metastatic|metastatic
78883|NCT03711058|PD-1|pd-1
78884|NCT03711058|P13K|p13k
78885|NCT03711058|Antibody|antibody
78886|NCT03711058|Solid Tumors|solid tumors
78887|NCT03711058|Colon Cancer|colon cancer
78888|NCT03711058|MSS|mss
78889|NCT03711058|Mismatch-repair proficient|mismatch-repair proficient
78890|NCT03711058|Microsatellite stable|microsatellite stable
78891|NCT03711045|eye-tracking|eye-tracking
78892|NCT03711045|eye movement|eye movement
78893|NCT03711045|saccade|saccade
78894|NCT03711032|programmed cell death receptor 1 (PD-1)|programmed cell death receptor 1 (pd-1)
78895|NCT03711032|programmed cell death ligand 1 (PD-L1)|programmed cell death ligand 1 (pd-l1)
78896|NCT03711032|anti-PD-1|anti-pd-1
78897|NCT03711032|anti-PD-L1|anti-pd-l1
78898|NCT03711032|BCG|bcg
78899|NCT03711032|HR NMIBC|hr nmibc
78900|NCT03711032|Patient Reported Outcome (PRO)|patient reported outcome (pro)
78901|NCT03711019|Magnetic Seizure Therapy|magnetic seizure therapy
78902|NCT03711019|Electroconvulsive Therapy|electroconvulsive therapy
78903|NCT03711006|Fecal Microbiota Transplantation|fecal microbiota transplantation
78904|NCT03710954|Evaluation of pain|evaluation of pain
78905|NCT03710954|Fuzzy systems theory|fuzzy systems theory
78906|NCT03710928|very low carbohydrate diet|very low carbohydrate diet
78907|NCT03710928|nutrition|nutrition
78908|NCT03710928|ketogenic diet|ketogenic diet
78909|NCT03710928|ketosis|ketosis
78910|NCT03710928|nutritional ketosis|nutritional ketosis
78911|NCT03710928|metabolism|metabolism
78912|NCT03710928|metabolic health|metabolic health
78913|NCT03710915|HDAC inhibitor|hdac inhibitor
78914|NCT03710915|Dose escalation|dose escalation
78915|NCT03710915|HG146|hg146
78916|NCT03710889|BA058|ba058
78917|NCT03710889|abaloparatide|abaloparatide
78918|NCT03710889|TYMLOS®|tymlos®
78919|NCT03710889|Bone metabolism|bone metabolism
78920|NCT03710889|Osteoporosis|osteoporosis
78921|NCT03710889|Fracture|fracture
78922|NCT03710889|Bone loss|bone loss
78923|NCT03710850|Insulin resistance|insulin resistance
78924|NCT03710850|Diabetes|diabetes
78925|NCT03710850|Inulin|inulin
78926|NCT03710850|Microbiome|microbiome
78927|NCT03710837|Education|education
78928|NCT03710837|Healthcare professional students|healthcare professional students
78929|NCT03710811|insulin|insulin
78930|NCT03710811|drug naive|drug naive
78931|NCT03710798|Diet, ketogenic|diet, ketogenic
78932|NCT03710798|Pain|pain
78933|NCT03710798|Quality of Life|quality of life
78934|NCT03710798|Body Composition|body composition
78935|NCT03710798|Body Fat Distribution|body fat distribution
78936|NCT03710785|8 Channel Surface Electromyography|8 channel surface electromyography
78937|NCT03710785|Forward Neck Posture Syndrome|forward neck posture syndrome
78938|NCT03710759|Pneumonia|pneumonia
78939|NCT03710759|Drainage|drainage
78940|NCT03710759|Autogenic Drainage|autogenic drainage
78941|NCT03710746|obesity|obesity
78942|NCT03710746|overweight|overweight
78943|NCT03710746|prevention|prevention
78944|NCT03710746|adolescence|adolescence
78945|NCT03710746|dissonance|dissonance
78946|NCT03710720|Traumatic stress|traumatic stress
78947|NCT03710720|substance use prevention|substance use prevention
78948|NCT03710720|HIV prevention|hiv prevention
78949|NCT03710720|adolescents|adolescents
78950|NCT03710707|LRRK2|lrrk2
78951|NCT03710707|Parkinson's Disease|parkinson's disease
78952|NCT03710707|Movement Disorders|movement disorders
78953|NCT03710681|SHR-1314 Phase 1|shr-1314 phase 1
78954|NCT03710655|QOL and pain|qol and pain
78955|NCT03710642|Dementia|dementia
78956|NCT03710642|Agitation|agitation
78957|NCT03710642|PEACE-AD|peace-ad
78958|NCT03710629|Non-small cell lung cancer, gene mutations|non-small cell lung cancer, gene mutations
78959|NCT03710616|early-stage NSCLC, real-world evidences, patient survivals|early-stage nsclc, real-world evidences, patient survivals
78960|NCT03710564|neovascular age-related macular degeneration|neovascular age-related macular degeneration
78961|NCT03710564|nAMD|namd
78962|NCT03710564|intravitreal injection|intravitreal injection
78963|NCT03710564|IVT|ivt
78964|NCT03710564|anti-VEGF|anti-vegf
78965|NCT03710564|brolucizumab|brolucizumab
78966|NCT03710564|aflibercept|aflibercept
78967|NCT03710564|EYLEA|eylea
78968|NCT03710564|double-masked|double-masked
78969|NCT03710564|MERLIN|merlin
78970|NCT03710564|BEOVU|beovu
78971|NCT03710538|glycemia|glycemia
78972|NCT03710512|hydroset|hydroset
78973|NCT03710499|Acromegaly|acromegaly
78974|NCT03710499|Rehabilitation|rehabilitation
78975|NCT03710499|Physiotherapy|physiotherapy
78976|NCT03710486|Drug Therapy|drug therapy
78977|NCT03710473|Hypertension|hypertension
78978|NCT03710473|Non-invasive blood pressure Monitoring|non-invasive blood pressure monitoring
78979|NCT03710473|Photoplethysmography|photoplethysmography
78980|NCT03710460|Obesity|obesity
78981|NCT03710460|Dapagliflozin|dapagliflozin
78982|NCT03710460|Metformin XR|metformin xr
78983|NCT03710460|Visceral adiposity|visceral adiposity
78984|NCT03710447|Cardiometabolic Health|cardiometabolic health
78985|NCT03710447|Cardiorespiratory Fitness|cardiorespiratory fitness
78986|NCT03710447|Muscular Strength|muscular strength
78987|NCT03710447|Body Composition|body composition
78988|NCT03710447|Inflammation|inflammation
78989|NCT03710447|Aerobic Exercise|aerobic exercise
78990|NCT03710447|Resistance Exercise|resistance exercise
78991|NCT03710434|Phase 1, healthy, bioavailability, pharmacokinetics|phase 1, healthy, bioavailability, pharmacokinetics
78992|NCT03710408|Hypodermoclysis|hypodermoclysis
78993|NCT03710408|Older adults|older adults
78994|NCT03710408|Geriatric patient|geriatric patient
78995|NCT03710408|Hydration therapy|hydration therapy
78996|NCT03710408|Adverse effects|adverse effects
78997|NCT03710408|Subcutaneous hydration|subcutaneous hydration
78998|NCT03710343|Cerebral Palsy|cerebral palsy
78999|NCT03710343|Spastic|spastic
79000|NCT03710343|Pediatric|pediatric
79001|NCT03710343|Motor Function|motor function
79002|NCT03710343|GMFCS|gmfcs
79003|NCT03710343|Cognitive Function|cognitive function
79004|NCT03710343|Glucophage|glucophage
79005|NCT03710343|Metformin|metformin
79006|NCT03710330|cesarean section|cesarean section
79007|NCT03710330|tranexamic acid|tranexamic acid
79008|NCT03710330|postpartum hemorrhage|postpartum hemorrhage
79009|NCT03710317|cesarean section|cesarean section
79010|NCT03710317|tranexamic acid|tranexamic acid
79011|NCT03710317|postpartum hemorrhage|postpartum hemorrhage
79012|NCT03710317|buccal misoprostol|buccal misoprostol
79013|NCT03710317|carbetocin|carbetocin
79014|NCT03710304|cesarean section|cesarean section
79015|NCT03710304|tranexamic acid|tranexamic acid
79016|NCT03710304|postpartum hemorrhage|postpartum hemorrhage
79017|NCT03710304|buccal misoprostol|buccal misoprostol
79018|NCT03710291|serum bicarbonate|serum bicarbonate
79019|NCT03710291|renal outcomes|renal outcomes
79020|NCT03710291|TRC101|trc101
79021|NCT03710291|eGFR|egfr
79022|NCT03710265|SHR-1701|shr-1701
79023|NCT03710265|Solid tumor|solid tumor
79024|NCT03710265|Metastatic or locally advanced solid tumors|metastatic or locally advanced solid tumors
79025|NCT03710226|mean platelet volume|mean platelet volume
79026|NCT03710226|plateletcrit|plateletcrit
79027|NCT03710226|platelet distribution width|platelet distribution width
79028|NCT03710161|dialysis|dialysis
79029|NCT03710161|end stage renal disease|end stage renal disease
79030|NCT03710148|Iodine|iodine
79031|NCT03710148|Estimated Average Requirement|estimated average requirement
79032|NCT03710148|Recommended Nutritent Intake|recommended nutritent intake
79033|NCT03710148|Tolerable Upper Intake Level|tolerable upper intake level
79034|NCT03710148|Pregnant Women|pregnant women
79035|NCT03710148|Pregnancy|pregnancy
79036|NCT03710148|EAR|ear
79037|NCT03710148|RNI|rni
79038|NCT03710148|UL|ul
79039|NCT03710109|Concussion|concussion
79040|NCT03710109|Sports Concussion|sports concussion
79041|NCT03710109|Sports Medicine|sports medicine
79042|NCT03710109|Electroencephalography|electroencephalography
79043|NCT03710109|Steady state visual evoked potential|steady state visual evoked potential
79044|NCT03710109|Evoked Potential|evoked potential
79045|NCT03710096|Mac Grath|mac grath
79142|NCT03709498|Diet|diet
79046|NCT03710096|Double lumen tube|double lumen tube
79047|NCT03710083|Diabetes Type I Type II|diabetes type i type ii
79048|NCT03710070|Collateral Flow Index|collateral flow index
79049|NCT03710070|Permanent Internal Mammary Artery Occlusion|permanent internal mammary artery occlusion
79050|NCT03710057|Ivabradine|ivabradine
79051|NCT03710057|Heart Rate|heart rate
79052|NCT03710057|Health Related Quality of Life|health related quality of life
79053|NCT03710057|Safety|safety
79054|NCT03710057|Chronic Heart Failure Patient|chronic heart failure patient
79055|NCT03710044|atopic dermatitis|atopic dermatitis
79056|NCT03710044|cyclosporine A|cyclosporine a
79057|NCT03710044|atopic dermatitis pathophysiology|atopic dermatitis pathophysiology
79058|NCT03710031|psychoneurological symptoms (PNS)|psychoneurological symptoms (pns)
79059|NCT03710031|quality of life (QOL)|quality of life (qol)
79060|NCT03710031|hematopoietic stem cell transplant (HSCT)|hematopoietic stem cell transplant (hsct)
79061|NCT03710031|microbiota gut-brain axis|microbiota gut-brain axis
79062|NCT03710031|inflammation|inflammation
79063|NCT03710018|Breast conservative surgery, tumor bed irradiation|breast conservative surgery, tumor bed irradiation
79064|NCT03709992|ureteral stent|ureteral stent
79065|NCT03709992|USSQ|ussq
79066|NCT03709992|Tamsulosin|tamsulosin
79067|NCT03709992|Trospium Chloride|trospium chloride
79068|NCT03709979|video laryngoscopy|video laryngoscopy
79069|NCT03709979|Pediatric patient|pediatric patient
79070|NCT03709979|Position|position
79071|NCT03709966|Portable monitoring device|portable monitoring device
79072|NCT03709953|apatinib|apatinib
79073|NCT03709953|pulmonary lymphoepithelioid carcinoma|pulmonary lymphoepithelioid carcinoma
79074|NCT03709940|longitudinal study|longitudinal study
79075|NCT03709940|magnetic resonance imaging (MRI)|magnetic resonance imaging (mri)
79076|NCT03709940|brain connectivity|brain connectivity
79077|NCT03709940|biomarker|biomarker
79078|NCT03709940|treatment response|treatment response
79079|NCT03709940|methylphenidate|methylphenidate
79080|NCT03709940|stimulant medication|stimulant medication
79081|NCT03709914|Pediatric PK|pediatric pk
79082|NCT03709901|Chronic Lumbar Back Pain|chronic lumbar back pain
79083|NCT03709901|Low Back Pain|low back pain
79084|NCT03709901|Back Pain|back pain
79085|NCT03709901|Degenerative Disc Disease|degenerative disc disease
79086|NCT03709901|Intervertebral Disc Degeneration|intervertebral disc degeneration
79087|NCT03709875|Telerehabilitation|telerehabilitation
79088|NCT03709875|Motor outcomes|motor outcomes
79089|NCT03709875|Cognitive dysfunction|cognitive dysfunction
79090|NCT03709849|Anovulatory Infertility|anovulatory infertility
79091|NCT03709849|Bushen Culuan Decoction|bushen culuan decoction
79092|NCT03709836|Coronary artery disease|coronary artery disease
79093|NCT03709836|Coronary bifurcation lesion|coronary bifurcation lesion
79094|NCT03709836|Coronary angiography|coronary angiography
79095|NCT03709836|Coronary computed tomography angiography|coronary computed tomography angiography
79096|NCT03709836|Percutaneous coronary intervention|percutaneous coronary intervention
79097|NCT03709797|Spinal Cord Injury|spinal cord injury
79098|NCT03709797|Shoulder Pain|shoulder pain
79099|NCT03709797|Myofascial Pain Syndrome|myofascial pain syndrome
79100|NCT03709797|Dry Needling|dry needling
79101|NCT03709758|Acute Myeloid Leukemia|acute myeloid leukemia
79102|NCT03709732|Quality of Life|quality of life
79103|NCT03709732|Registries|registries
79104|NCT03709732|Norway|norway
79105|NCT03709732|Caregivers|caregivers
79106|NCT03709732|Employment|employment
79107|NCT03709706|GSK3377794|gsk3377794
79108|NCT03709706|Pembrolizumab|pembrolizumab
79109|NCT03709706|T Cell Receptors|t cell receptors
79110|NCT03709706|Adoptive T-cell therapy|adoptive t-cell therapy
79111|NCT03709706|Non-Small Cell Lung Cancer|non-small cell lung cancer
79112|NCT03709693|sternotomy|sternotomy
79113|NCT03709693|rigid fixation|rigid fixation
79114|NCT03709693|sternal fixation|sternal fixation
79115|NCT03709693|sternal plating|sternal plating
79116|NCT03709680|Solid tumor, Ewing and Rhabdomyosarcoma, Neuroblastoma, brain|solid tumor, ewing and rhabdomyosarcoma, neuroblastoma, brain
79117|NCT03709680|tumor|tumor
79118|NCT03709667|exercise|exercise
79119|NCT03709667|methamphetamine|methamphetamine
79120|NCT03709654|acne|acne
79121|NCT03709654|pimple|pimple
79122|NCT03709654|black head|black head
79123|NCT03709654|white head|white head
79125|NCT03709654|probiotic|probiotic
79126|NCT03709641|Dry Eye Disease|dry eye disease
79127|NCT03709641|Restyalne Defyne|restyalne defyne
79128|NCT03709615|Social anxiety disorder|social anxiety disorder
79129|NCT03709615|iCBT|icbt
79130|NCT03709615|Therapeutic processes|therapeutic processes
79131|NCT03709602|HPV|hpv
79132|NCT03709602|adolescents|adolescents
79133|NCT03709602|HPV Vaccine|hpv vaccine
79134|NCT03709602|social determinants|social determinants
79135|NCT03709589|Mortality|mortality
79136|NCT03709589|High Dependency Unit|high dependency unit
79137|NCT03709589|Modified Early Warning Score|modified early warning score
79138|NCT03709511|Heart valve surgery|heart valve surgery
79139|NCT03709511|Rehabilitation|rehabilitation
79140|NCT03709511|Physical exercise|physical exercise
79141|NCT03709511|Psycho-education|psycho-education
79149|NCT03709459|Syphilis, Gonorrhea, Chlamydia, Doxycycline, PrEP, Syphilaxis|syphilis, gonorrhea, chlamydia, doxycycline, prep, syphilaxis
79150|NCT03709446|Breast Neoplasms|breast neoplasms
79151|NCT03709446|Breast Diseases|breast diseases
79152|NCT03709446|Leflunomide|leflunomide
79153|NCT03709446|Teriflunomide|teriflunomide
79154|NCT03709446|Phosphatase and tensin homolog|phosphatase and tensin homolog
79155|NCT03709420|Hydroxysteroid (17B) dehydrogenase|hydroxysteroid (17b) dehydrogenase
79156|NCT03709420|HSD17B1|hsd17b1
79157|NCT03709394|ultrasound|ultrasound
79158|NCT03709394|peripheral venous catheter|peripheral venous catheter
79159|NCT03709381|steroid-induced adrenal suppression|steroid-induced adrenal suppression
79160|NCT03709381|vascular endothelial growth factor|vascular endothelial growth factor
79161|NCT03709381|adrenocorticotropic hormone|adrenocorticotropic hormone
79162|NCT03709381|osteopenia|osteopenia
79163|NCT03709368|Hand washing|hand washing
79164|NCT03709368|WASH|wash
79165|NCT03709368|RANAS|ranas
79166|NCT03709368|Behavior change|behavior change
79167|NCT03709355|HIV-1|hiv-1
79168|NCT03709329|End-effector|end-effector
79169|NCT03709329|Robot Assisted Gait Therapy|robot assisted gait therapy
79170|NCT03709329|Gait Pattern|gait pattern
79171|NCT03709329|Energy Consumption|energy consumption
79172|NCT03709329|Chronic stroke|chronic stroke
79173|NCT03709329|Hemiplegia|hemiplegia
79179|NCT03709277|Specialty|specialty
79180|NCT03709277|Pharmacist Intervention|pharmacist intervention
79181|NCT03709264|kidney protection|kidney protection
79182|NCT03709264|acute kidney injury|acute kidney injury
79183|NCT03709264|cardiac surgery|cardiac surgery
79184|NCT03709264|amino acids|amino acids
79185|NCT03709264|mortality|mortality
79186|NCT03709264|ICU|icu
79187|NCT03709238|Pain|pain
79188|NCT03709238|Alzheimers disease|alzheimers disease
79189|NCT03709225|Anxiety|anxiety
79190|NCT03709225|Music Therapy|music therapy
79191|NCT03709225|Oncology|oncology
79192|NCT03709225|Adolescent and Young Adults|adolescent and young adults
79193|NCT03709212|Chronic Kidney Disease|chronic kidney disease
79194|NCT03709212|Physical Activity|physical activity
79195|NCT03709212|Cultural influences|cultural influences
79196|NCT03709212|Exercise|exercise
79197|NCT03709147|LKB1-inactive adenocarcinoma|lkb1-inactive adenocarcinoma
79198|NCT03709147|Cisplatin-pemetrexed|cisplatin-pemetrexed
79199|NCT03709147|Metformin|metformin
79200|NCT03709147|Fasting-mimicking diet (FMD)|fasting-mimicking diet (fmd)
79201|NCT03709147|Progression-free survival|progression-free survival
79202|NCT03709134|Circulating tumor cells|circulating tumor cells
79203|NCT03709134|CTC|ctc
79204|NCT03709121|reproxalap|reproxalap
79205|NCT03709121|ADX-102|adx-102
79206|NCT03709121|allergic conjunctivitis|allergic conjunctivitis
79207|NCT03709108|Continuous Glucose Monitor|continuous glucose monitor
79208|NCT03709108|Insulin Sensitivity|insulin sensitivity
79209|NCT03709108|Exercise|exercise
79210|NCT03709095|Inpatient Rehabilitation|inpatient rehabilitation
79211|NCT03709095|Sprint interval training|sprint interval training
79212|NCT03709095|Exercise|exercise
79213|NCT03709095|Spinal Cord Injury|spinal cord injury
79214|NCT03709082|palbociclib|palbociclib
79215|NCT03709004|Pacifier|pacifier
79216|NCT03708991|IVF|ivf
79217|NCT03708991|ICSI|icsi
79218|NCT03708952|Dietary factors|dietary factors
79219|NCT03708952|Precursor lesions of colorectal cancer|precursor lesions of colorectal cancer
79220|NCT03708952|Lifestyle|lifestyle
79221|NCT03708952|Polyps|polyps
79222|NCT03708926|degenerative disc disease|degenerative disc disease
79223|NCT03708926|low back pain|low back pain
79224|NCT03708926|PTH|pth
79225|NCT03708926|abaloparatide|abaloparatide
79226|NCT03708900|Cushing's disease (CD)|cushing's disease (cd)
79227|NCT03708900|LCI699|lci699
79228|NCT03708900|osilodrostat|osilodrostat
79229|NCT03708900|Pituitary Gland|pituitary gland
79230|NCT03708900|Adrenocorticotropic Hormone (ACTH)|adrenocorticotropic hormone (acth)
79231|NCT03708900|Urinary Free Cortisol (UFC)|urinary free cortisol (ufc)
79232|NCT03708900|mean Urinary Free Cortisol (mUFC)|mean urinary free cortisol (mufc)
79233|NCT03708887|Type 2 diabetes|type 2 diabetes
79234|NCT03708887|Obesity|obesity
79235|NCT03708887|Omega-3 fatty acids|omega-3 fatty acids
79236|NCT03708861|maraviroc, atazanavir/ritonavir|maraviroc, atazanavir/ritonavir
79237|NCT03708848|Helicobacter pylori|helicobacter pylori
79238|NCT03708848|Tailored therapy|tailored therapy
79239|NCT03708848|Penicillin allergy|penicillin allergy
79240|NCT03708848|Antimicrobial susceptibility testing|antimicrobial susceptibility testing
79241|NCT03708835|Stroke patient|stroke patient
79242|NCT03708835|home care|home care
79243|NCT03708835|family caregiver|family caregiver
79244|NCT03708835|transitional care model|transitional care model
79245|NCT03708835|caregiving competence|caregiving competence
79246|NCT03708835|health literacy|health literacy
79247|NCT03708835|burnout|burnout
79248|NCT03708809|IUD, contraception, levonogestral|iud, contraception, levonogestral
79250|NCT03708796|ER|er
79251|NCT03708796|qSOFA|qsofa
79252|NCT03708796|SOFA|sofa
79253|NCT03708796|RETTS|retts
79254|NCT03708796|NEWS|news
79255|NCT03708796|SIRS|sirs
79256|NCT03708796|triage|triage
79257|NCT03708757|Cerebral palsy|cerebral palsy
79258|NCT03708757|Post Isometric Relaxation|post isometric relaxation
79259|NCT03708757|Hamstring Spasticity|hamstring spasticity
79260|NCT03708744|Healthy|healthy
79261|NCT03708744|Volunteer|volunteer
79262|NCT03708744|Pharmacokinetics|pharmacokinetics
79263|NCT03708731|Sickle Cell Disease|sickle cell disease
79264|NCT03708731|Youth|youth
79265|NCT03708731|Hydroxyurea|hydroxyurea
79266|NCT03708731|Non-Adherence|non-adherence
79267|NCT03708731|Electronic Adherence Monitoring|electronic adherence monitoring
79268|NCT03708731|AdhereTech smart bottle|adheretech smart bottle
79269|NCT03708718|Diffuse cutaneous systemic sclerosis (dcSSc)|diffuse cutaneous systemic sclerosis (dcssc)
79270|NCT03708718|Prednisolone|prednisolone
79271|NCT03708718|Randomised Controlled Trial|randomised controlled trial
79272|NCT03708718|Disability|disability
79273|NCT03708718|Pain|pain
79274|NCT03708718|Fatigue|fatigue
79275|NCT03708692|General Anesthesia|general anesthesia
79276|NCT03708692|Recovery|recovery
79277|NCT03708692|Cognitive Function|cognitive function
79278|NCT03708692|Menstrual Cycle phase|menstrual cycle phase
79279|NCT03708640|Frailty|frailty
79280|NCT03708640|Physical Activity|physical activity
79281|NCT03708640|HIV|hiv
79282|NCT03708640|Aging|aging
79283|NCT03708640|Exercise|exercise
79284|NCT03708640|mHealth|mhealth
79285|NCT03708640|smartphone|smartphone
79286|NCT03708640|activity tracker|activity tracker
79287|NCT03708640|pedometer|pedometer
79288|NCT03708640|text messaging|text messaging
79289|NCT03708640|Short Message Service (SMS)|short message service (sms)
79290|NCT03708614|Autism Spectrum Disorder|autism spectrum disorder
79291|NCT03708614|Atypical antipsychotic medication|atypical antipsychotic medication
79292|NCT03708614|Psychotropic medication|psychotropic medication
79293|NCT03708614|Psychotropic-induced weight gain|psychotropic-induced weight gain
79294|NCT03708614|Controlled energy intake with elevated protein|controlled energy intake with elevated protein
79295|NCT03708614|Dietary intervention|dietary intervention
79296|NCT03708614|Acceptability|acceptability
79297|NCT03708614|Feasibility|feasibility
79298|NCT03708588|Ticagrelor|ticagrelor
79299|NCT03708588|Stent|stent
79300|NCT03708549|Berberine|berberine
79301|NCT03708549|Metformin|metformin
79302|NCT03708549|Metabolic syndrome|metabolic syndrome
79303|NCT03708549|Schizophrenia|schizophrenia
79304|NCT03708536|bevacizumab|bevacizumab
79305|NCT03708536|s-1|s-1
79306|NCT03708536|capecitabin|capecitabin
79307|NCT03708536|maintenance|maintenance
79308|NCT03708523|Hypopituitarism,Pituitary function|hypopituitarism,pituitary function
79309|NCT03708497|carbetocin|carbetocin
79310|NCT03708497|tranexamic acid|tranexamic acid
79311|NCT03708497|postpartum hemorrhage|postpartum hemorrhage
79312|NCT03708497|buccal misoprostol|buccal misoprostol
79313|NCT03708484|Aerobic Interval training|aerobic interval training
79314|NCT03708484|Ejection Fraction|ejection fraction
79315|NCT03708484|Myocardial Infarction|myocardial infarction
79316|NCT03708484|Resistive Interval Training|resistive interval training
79317|NCT03708471|Atrial fibrillation|atrial fibrillation
79318|NCT03708471|Hybrid ablation|hybrid ablation
79319|NCT03708471|Surgical ablation|surgical ablation
79320|NCT03708458|endoscopic retrograde cholangiopancreatography (ERCP)|endoscopic retrograde cholangiopancreatography (ercp)
79321|NCT03708458|post-ERCP pancreatitis (PEP)|post-ercp pancreatitis (pep)
79322|NCT03708458|Nonsteroidal anti-inflammatory drugs (NSAID's)|nonsteroidal anti-inflammatory drugs (nsaid's)
79323|NCT03708458|acetylcysteine (ACC)|acetylcysteine (acc)
79324|NCT03708445|bile duct obstruction, extrahepatic|bile duct obstruction, extrahepatic
79325|NCT03708445|cytology|cytology
79326|NCT03708445|aminoacyl-tRNA synthetases|aminoacyl-trna synthetases
79327|NCT03708419|Insulin resistance|insulin resistance
79328|NCT03708419|Personalized nutrition|personalized nutrition
79329|NCT03708406|cleft palate|cleft palate
79330|NCT03708406|Eustachian dysfunction|eustachian dysfunction
79331|NCT03708406|Obstructive ventilation|obstructive ventilation
79332|NCT03708354|skeletal muscle strength|skeletal muscle strength
79333|NCT03708341|melatonin|melatonin
79334|NCT03708341|Sleep Deprivation|sleep deprivation
79335|NCT03708341|Intensive Care Psychosis|intensive care psychosis
79336|NCT03708302|breast reduction surgery|breast reduction surgery
79337|NCT03708302|serratus plane block|serratus plane block
79338|NCT03708302|parasternal infrapectoral block|parasternal infrapectoral block
79339|NCT03708276|Self-management|self-management
79344|NCT03708263|telangiectasis score|telangiectasis score
79346|NCT03708250|button battery|button battery
79347|NCT03708250|intoxication|intoxication
79348|NCT03708250|oesophageal necrosis|oesophageal necrosis
79349|NCT03708250|Poison Control Centre|poison control centre
79350|NCT03708250|Poisoning|poisoning
79351|NCT03708224|Cancer|cancer
821485|NCT00150982|alefacept|alefacept
79352|NCT03708224|Non-Virally Associated Squamous Cell Carcinoma|non-virally associated squamous cell carcinoma
79353|NCT03708224|Head and Neck|head and neck
79354|NCT03708211|Drug therapy|drug therapy
79355|NCT03708172|rTMS|rtms
79356|NCT03708172|Depression|depression
79357|NCT03708172|Youth|youth
79358|NCT03708172|TBS|tbs
79359|NCT03708172|Brain Stimulation|brain stimulation
79360|NCT03708172|Electrophysiology|electrophysiology
79361|NCT03708172|Imaging|imaging
79362|NCT03708159|tDCS|tdcs
79363|NCT03708159|Mindfulness meditation|mindfulness meditation
79364|NCT03708159|Home-based tDCS|home-based tdcs
79365|NCT03708159|rTMS|rtms
79366|NCT03708133|New formulation|new formulation
79367|NCT03708107|galvanic current|galvanic current
79368|NCT03708107|electrolysis|electrolysis
79369|NCT03708107|myofascial trigger point|myofascial trigger point
79370|NCT03708107|percutaneous microelectrolysis|percutaneous microelectrolysis
79371|NCT03708107|dry needling|dry needling
79372|NCT03708107|ischemic compression|ischemic compression
79373|NCT03708094|prognosis|prognosis
79374|NCT03708094|pathogenic gene|pathogenic gene
79375|NCT03708094|decision tree study|decision tree study
79376|NCT03708068|Exclusive|exclusive
79377|NCT03708068|Enteral Nutrition|enteral nutrition
79378|NCT03708068|Preterm Infant|preterm infant
79379|NCT03708042|Neoadjuvant Chemoradiation|neoadjuvant chemoradiation
79380|NCT03708042|Definitive Chemoradiation|definitive chemoradiation
79381|NCT03708042|Clinical complete response|clinical complete response
79382|NCT03708003|lymphocytic leukemia|lymphocytic leukemia
79383|NCT03708003|relapsed/refractory chronic lymphocytic leukemia|relapsed/refractory chronic lymphocytic leukemia
79384|NCT03708003|Ibrutinib|ibrutinib
79385|NCT03708003|venetoclax|venetoclax
79386|NCT03707977|broadly neutralizing antibodies|broadly neutralizing antibodies
79387|NCT03707977|HIV suppression|hiv suppression
79388|NCT03707964|Medical Education|medical education
79389|NCT03707964|Simulation|simulation
79390|NCT03707964|Crisis Resource Management|crisis resource management
79391|NCT03707951|alcohol|alcohol
79392|NCT03707951|youth|youth
79393|NCT03707951|adolescent|adolescent
79394|NCT03707951|pharmacotherapy|pharmacotherapy
79395|NCT03707951|medication|medication
79396|NCT03707951|N-acetylcysteine|n-acetylcysteine
79397|NCT03707886|chronic pain|chronic pain
79398|NCT03707886|shared medical appointment|shared medical appointment
79399|NCT03707886|veterans|veterans
79400|NCT03707873|Education|education
79401|NCT03707847|crizotinib|crizotinib
79402|NCT03707847|etoposide|etoposide
79403|NCT03707847|autologous hematopoietic stem cell transplantation|autologous hematopoietic stem cell transplantation
79404|NCT03707847|ORR|orr
79405|NCT03707847|OS|os
79406|NCT03707847|PFS|pfs
79407|NCT03707847|adverse events|adverse events
79408|NCT03707808|solid tumors|solid tumors
79409|NCT03707756|DFNA9|dfna9
79410|NCT03707756|COCh|coch
79411|NCT03707756|Mutation|mutation
79412|NCT03707756|Genotype-phenotype|genotype-phenotype
79413|NCT03707717|BKZ|bkz
79414|NCT03707717|UCB4940|ucb4940
79415|NCT03707717|Auto-Injector|auto-injector
79416|NCT03707717|Healthy Participants|healthy participants
79417|NCT03707704|Exercise|exercise
79418|NCT03707704|Rehabilitation|rehabilitation
79419|NCT03707691|Hearing|hearing
79420|NCT03707691|Cochlear Implants|cochlear implants
79421|NCT03707691|Congenital Amusia|congenital amusia
79422|NCT03707691|Pitch|pitch
79423|NCT03707691|Audio-visual interactions|audio-visual interactions
79424|NCT03707678|GSK2245035|gsk2245035
79425|NCT03707678|Allergic asthma|allergic asthma
79426|NCT03707678|Inhaled corticosteroids|inhaled corticosteroids
79427|NCT03707678|Toll-like receptors|toll-like receptors
79428|NCT03707665|Compression Ultrasound testing|compression ultrasound testing
79429|NCT03707665|Nurse|nurse
79430|NCT03707626|wellens sign|wellens sign
79431|NCT03707626|coronary collateral circulation|coronary collateral circulation
79432|NCT03707626|acute myocardial infarction|acute myocardial infarction
79433|NCT03707626|left anterior descending artery|left anterior descending artery
79434|NCT03707613|ERCP|ercp
79435|NCT03707613|double guidewire technique|double guidewire technique
79436|NCT03707613|learning curve|learning curve
79538|NCT03706924|HIV -1|hiv -1
79443|NCT03707587|Monoclonal Antibody|monoclonal antibody
79444|NCT03707587|PD-L1 Expression|pd-l1 expression
79445|NCT03707548|body psychotherapy|body psychotherapy
79446|NCT03707548|smartphone-triggered interventions|smartphone-triggered interventions
79447|NCT03707548|psychosocial impairments related to cancer|psychosocial impairments related to cancer
79448|NCT03707548|cancer-related disturbances in bodily wellbeing|cancer-related disturbances in bodily wellbeing
79449|NCT03707548|Body Image Scale|body image scale
79450|NCT03707548|group psychotherapy|group psychotherapy
79451|NCT03707548|bodily disturbances in post-treatment cancer patients|bodily disturbances in post-treatment cancer patients
79452|NCT03707509|Nasopharyngeal Carcinoma|nasopharyngeal carcinoma
79453|NCT03707509|PD-1 Antibody|pd-1 antibody
79454|NCT03707509|Cisplatin|cisplatin
79455|NCT03707509|Gemcitabine|gemcitabine
79456|NCT03707496|De Winter Syndrome|de winter syndrome
79457|NCT03707470|exercise induced muscle damage|exercise induced muscle damage
79458|NCT03707470|recovery|recovery
79460|NCT03707431|Adolescent|adolescent
79461|NCT03707431|Pancreatitis|pancreatitis
79462|NCT03707431|Pain|pain
79463|NCT03707431|Internet Intervention|internet intervention
79464|NCT03707431|Behavioral Intervention|behavioral intervention
79465|NCT03707392|stoma education|stoma education
79466|NCT03707379|Diabetes mellitus|diabetes mellitus
79467|NCT03707379|Diabetic management|diabetic management
79468|NCT03707379|Share care|share care
79469|NCT03707366|Mentoring|mentoring
79470|NCT03707366|Positive Youth Development|positive youth development
79471|NCT03707366|Skills training|skills training
79472|NCT03707366|Relationships|relationships
79473|NCT03707366|Child Welfare|child welfare
79474|NCT03707340|tamoxifen|tamoxifen
79475|NCT03707340|Flibanserin|flibanserin
79476|NCT03707340|hyposexual desire disorder|hyposexual desire disorder
79477|NCT03707327|pain|pain
79478|NCT03707327|knee|knee
79479|NCT03707327|cryotherapy|cryotherapy
79480|NCT03707314|NSTEMI|nstemi
79481|NCT03707301|Cancer|cancer
79482|NCT03707301|Sophrology|sophrology
79483|NCT03707301|Anxiety|anxiety
79484|NCT03707301|Hospital Anxiety and Depression scale|hospital anxiety and depression scale
79485|NCT03707275|Clinical trial|clinical trial
79486|NCT03707275|Patient-centered outcomes|patient-centered outcomes
79487|NCT03707275|Treatment of heart failure|treatment of heart failure
79488|NCT03707275|Technology in heart failure|technology in heart failure
79489|NCT03707262|Tolerance|tolerance
79490|NCT03707262|Kidney Transplant|kidney transplant
79491|NCT03707236|Isotretinoin|isotretinoin
79492|NCT03707223|career development, people with disabilities|career development, people with disabilities
79493|NCT03707210|virtual reality|virtual reality
79494|NCT03707210|chemotherapy|chemotherapy
79495|NCT03707171|Type 2 diabetes mellitus|type 2 diabetes mellitus
79496|NCT03707171|Cognitive function|cognitive function
79497|NCT03707171|Liraglutide|liraglutide
79498|NCT03707158|Cognitive Behavioral Therapy (CBT)|cognitive behavioral therapy (cbt)
79499|NCT03707158|Face to face CBT|face to face cbt
79500|NCT03707158|Online CBT|online cbt
79501|NCT03707158|Telehealth|telehealth
79502|NCT03707158|Anxiety|anxiety
79503|NCT03707158|Child|child
79504|NCT03707145|well-being|well-being
79505|NCT03707145|exercise|exercise
79506|NCT03707145|physical activity|physical activity
79507|NCT03707145|nutrition|nutrition
79508|NCT03707145|gait|gait
79509|NCT03707132|Tourniquet|tourniquet
79510|NCT03707132|low uterus segment|low uterus segment
79511|NCT03707132|placenta accreta|placenta accreta
79512|NCT03707132|hysterectomy|hysterectomy
79513|NCT03707132|massive blood loss management|massive blood loss management
79514|NCT03707119|educational programme; EBP competencies; training;|educational programme; ebp competencies; training;
79515|NCT03707106|virtual reality|virtual reality
79516|NCT03707106|cue exposure|cue exposure
79517|NCT03707106|progressive muscle relaxation|progressive muscle relaxation
79518|NCT03707093|Solid tumor|solid tumor
79519|NCT03707093|Non-Hodgkin Lymphoma|non-hodgkin lymphoma
79520|NCT03707067|exercise induced muscle damage|exercise induced muscle damage
79521|NCT03707067|elite athlete|elite athlete
79522|NCT03707067|recovery|recovery
79523|NCT03707041|malaria|malaria
79524|NCT03707041|PfSPZ Challenge|pfspz challenge
79525|NCT03707041|chemoprotection|chemoprotection
79526|NCT03707015|Retinal Detachment; internal limiting membrane flap; retinal paracentral breaks|retinal detachment; internal limiting membrane flap; retinal paracentral breaks
79527|NCT03706989|EEG|eeg
79528|NCT03706989|Cognitive reserve|cognitive reserve
79529|NCT03706989|Neuroinflammation|neuroinflammation
79530|NCT03706950|HIV-1|hiv-1
79531|NCT03706937|Addiction|addiction
79532|NCT03706937|Tobacco|tobacco
79533|NCT03706937|Oncology|oncology
79534|NCT03706937|Care pathways|care pathways
79535|NCT03706937|Motivational attitude|motivational attitude
79536|NCT03706937|Motivational interviewing|motivational interviewing
79537|NCT03706937|Nursing|nursing
79539|NCT03706924|elsulfavirine fixed-dose combination|elsulfavirine fixed-dose combination
79540|NCT03706911|HIV-1|hiv-1
79541|NCT03706872|pregnant women|pregnant women
79542|NCT03706872|obesity|obesity
79543|NCT03706872|Mobile Applications|mobile applications
79544|NCT03706872|weight gain|weight gain
79545|NCT03706872|physical activity|physical activity
79546|NCT03706846|Cirrhosis|cirrhosis
79547|NCT03706846|Upper digestive endoscopy|upper digestive endoscopy
79548|NCT03706846|fasting|fasting
79549|NCT03706846|esophageal cancer|esophageal cancer
79550|NCT03706846|Superficial neoplastic lesions|superficial neoplastic lesions
79551|NCT03706846|Esophageal mucosa|esophageal mucosa
79552|NCT03706846|Gastric mucosa|gastric mucosa
79553|NCT03706807|Mindfulness|mindfulness
79554|NCT03706807|Older people|older people
79555|NCT03706807|Quality of Life|quality of life
821486|NCT00150969|vitamin K|vitamin k
79556|NCT03706807|Cognitive Function|cognitive function
79557|NCT03706781|Phase I|phase i
79558|NCT03706781|Local tolerability|local tolerability
79559|NCT03706781|Systemic Availability|systemic availability
79560|NCT03706781|Cetylpyridinium chloride 0.05%|cetylpyridinium chloride 0.05%
79561|NCT03706781|Benzydamine hydrochloride 0.15%|benzydamine hydrochloride 0.15%
79562|NCT03706781|Mucoadhesive polymer|mucoadhesive polymer
79563|NCT03706781|Tantum Verde Bocca|tantum verde bocca
79564|NCT03706755|spinal anesthesia|spinal anesthesia
79565|NCT03706755|blood pressure|blood pressure
79566|NCT03706755|norepinephrine|norepinephrine
79567|NCT03706755|Cesarean Section|cesarean section
79568|NCT03706729|Ankle injury|ankle injury
79569|NCT03706729|Joint instability|joint instability
79570|NCT03706729|Prevention and control|prevention and control
79571|NCT03706729|Elite athletes|elite athletes
79572|NCT03706729|Indoor Sports|indoor sports
79573|NCT03706729|Ligamentous sprain|ligamentous sprain
79574|NCT03706729|Fear of re-injury|fear of re-injury
79575|NCT03706716|shared decision making|shared decision making
79576|NCT03706690|NSCLC|nsclc
79577|NCT03706690|Double-Blind|double-blind
79578|NCT03706690|PD-L1|pd-l1
79579|NCT03706690|MEDI4736|medi4736
79580|NCT03706690|Durvalumab|durvalumab
79581|NCT03706690|PFS|pfs
79582|NCT03706690|OS|os
79583|NCT03706677|Ablation|ablation
79584|NCT03706677|Cryoballoon|cryoballoon
79585|NCT03706677|Radiofrequency|radiofrequency
79586|NCT03706638|Iron Deficiency Anemia|iron deficiency anemia
79587|NCT03706638|Pregnancy|pregnancy
79588|NCT03706638|Side Effects|side effects
79589|NCT03706625|Non Hodgkin Lymphoma|non hodgkin lymphoma
79590|NCT03706625|glioma|glioma
79591|NCT03706625|lung cancer|lung cancer
79592|NCT03706625|HIV|hiv
79593|NCT03706625|transplantation|transplantation
79594|NCT03706625|brain|brain
79595|NCT03706586|Delivery Room|delivery room
79596|NCT03706586|Resuscitation|resuscitation
79597|NCT03706573|byl719,adult,breast cancer,HR+ advanced cancer, HR+ metastic cancer, resistant, refractory|byl719,adult,breast cancer,hr+ advanced cancer, hr+ metastic cancer, resistant, refractory
79598|NCT03706560|workers|workers
79599|NCT03706560|eye injuries|eye injuries
79600|NCT03706560|work abilities|work abilities
79601|NCT03706534|Breast cancer|breast cancer
79602|NCT03706534|Breast Imaging|breast imaging
79603|NCT03706521|SM04690|sm04690
79604|NCT03706521|Wnt pathway inhibitor|wnt pathway inhibitor
79605|NCT03706521|osteoarthritis|osteoarthritis
79606|NCT03706521|Samumed|samumed
79607|NCT03706508|Robot-assisted prostatectomy|robot-assisted prostatectomy
79608|NCT03706508|Pentafecta|pentafecta
79609|NCT03706508|Biochemical failure|biochemical failure
79610|NCT03706508|Surgical margin|surgical margin
79611|NCT03706495|Postural Kyphosis|postural kyphosis
79612|NCT03706495|Exercises|exercises
79613|NCT03706495|Balance|balance
79614|NCT03706495|Respiratory Functions|respiratory functions
79615|NCT03706469|Drug Therapy|drug therapy
79616|NCT03706417|Hypothermia, Induced|hypothermia, induced
79617|NCT03706417|Telemedicine|telemedicine
79618|NCT03706417|Hospitals, Community|hospitals, community
79619|NCT03706404|Renal Colic|renal colic
79620|NCT03706404|Point-of-Care ultrasound|point-of-care ultrasound
79621|NCT03706404|Point-of-Care testing|point-of-care testing
79622|NCT03706391|amyotrophic lateral sclerosis|amyotrophic lateral sclerosis
79623|NCT03706391|progressive muscular atrophy|progressive muscular atrophy
79624|NCT03706391|motor neuron disease|motor neuron disease
79625|NCT03706391|ALS Reversal|als reversal
79626|NCT03706391|PMA Reversal|pma reversal
79627|NCT03706365|Metastatic Castration Resistant Prostate Cancer|metastatic castration resistant prostate cancer
79628|NCT03706365|mCRPC|mcrpc
79629|NCT03706352|Cancer patients, Epidural analgesia, Postoperative pain, tunneling|cancer patients, epidural analgesia, postoperative pain, tunneling
79630|NCT03706339|cesarean section|cesarean section
79631|NCT03706339|tranexamic acid|tranexamic acid
79632|NCT03706339|postpartum hemorrhage|postpartum hemorrhage
79633|NCT03706326|Esophageal cancer|esophageal cancer
79634|NCT03706326|Neoplasms, Esophageal|neoplasms, esophageal
79635|NCT03706326|Cancer of Esophagus|cancer of esophagus
79636|NCT03706326|Solid tumor|solid tumor
79637|NCT03706313|Total knee replacement|total knee replacement
79646|NCT03706261|Racial/Ethnic Minority|racial/ethnic minority
79647|NCT03706261|Alzheimer's disease|alzheimer's disease
79648|NCT03706209|moderate to severe|moderate to severe
79649|NCT03706209|chronic|chronic
79650|NCT03706209|plaque psoriasis|plaque psoriasis
79651|NCT03706196|dental exposome|dental exposome
79652|NCT03706170|Persistent Vegetative State|persistent vegetative state
79653|NCT03706170|minimally conscious state|minimally conscious state
79654|NCT03706170|Emotions|emotions
79655|NCT03706170|Awareness|awareness
79656|NCT03706170|electrodermal activity|electrodermal activity
79657|NCT03706170|Electroencephalography|electroencephalography
79658|NCT03706157|Conventional transarterial chemoembolization (c-TACE)|conventional transarterial chemoembolization (c-tace)
79659|NCT03706157|Doxorubicin|doxorubicin
79660|NCT03706157|Kinetics of distribution|kinetics of distribution
79661|NCT03706131|multiple sclerosis|multiple sclerosis
79662|NCT03706131|cervical region|cervical region
79663|NCT03706131|balance|balance
79664|NCT03706131|spasticity|spasticity
79665|NCT03706131|mobilisation|mobilisation
79666|NCT03706118|Multiple Sclerosis|multiple sclerosis
79667|NCT03706118|Spinal Cord Atrophy|spinal cord atrophy
79668|NCT03706092|iatrogenic|iatrogenic
79669|NCT03706092|surgery ICU|surgery icu
79670|NCT03706092|quality of life|quality of life
79671|NCT03706092|disability|disability
79672|NCT03706092|inappropriate medications|inappropriate medications
79673|NCT03706079|Asthma, Uncontrolled Asthma, Severe Uncontrolled Asthma|asthma, uncontrolled asthma, severe uncontrolled asthma
79674|NCT03706040|Atopic dermatitis|atopic dermatitis
79675|NCT03706040|Atopic dermatitis (atopic eczema)|atopic dermatitis (atopic eczema)
79676|NCT03706014|siblings|siblings
79677|NCT03706014|family|family
79678|NCT03706014|Latinos|latinos
79679|NCT03706014|social emotional competencies|social emotional competencies
79680|NCT03706014|parenting|parenting
79681|NCT03706014|middle childhood|middle childhood
79682|NCT03706014|late childhood|late childhood
79683|NCT03705988|Tic disorders|tic disorders
79684|NCT03705988|Tourette Syndrome|tourette syndrome
79685|NCT03705988|Cranial Electrotherapy Stimulation|cranial electrotherapy stimulation
79686|NCT03705988|CES|ces
79687|NCT03705936|Non-invasive brain stimulation|non-invasive brain stimulation
79688|NCT03705936|Swallowing|swallowing
79689|NCT03705936|Metaplasticity|metaplasticity
79698|NCT03705871|Palatal Expansion Technique|palatal expansion technique
79699|NCT03705871|Cone-Beam Computed Tomography|cone-beam computed tomography
79700|NCT03705871|Dental Models|dental models
79701|NCT03705858|Acute Myeloid Leukemia|acute myeloid leukemia
79702|NCT03705858|Actinium-225|actinium-225
79703|NCT03705858|Lintuzumab|lintuzumab
79704|NCT03705858|Columbia|columbia
79705|NCT03705858|Post-remission|post-remission
79706|NCT03705858|Phase I|phase i
79707|NCT03705832|Ginger|ginger
79708|NCT03705832|Dietary supplement|dietary supplement
79710|NCT03705793|mometasone irrigation, mometasone spray, chronic rhinosinusitis|mometasone irrigation, mometasone spray, chronic rhinosinusitis
79711|NCT03705780|fentanyl|fentanyl
79712|NCT03705780|OSAS screening scale|osas screening scale
79713|NCT03705780|adenotonsillectomy|adenotonsillectomy
79714|NCT03705780|diagnose|diagnose
79715|NCT03705741|pregnancy|pregnancy
79716|NCT03705741|exercise|exercise
79717|NCT03705741|public health|public health
79718|NCT03705741|randomized controlled trial|randomized controlled trial
79719|NCT03705728|anesthesia, general|anesthesia, general
79720|NCT03705728|postoperative delirium|postoperative delirium
79721|NCT03705728|postoperative nausea and vomiting|postoperative nausea and vomiting
79722|NCT03705728|elderly|elderly
79723|NCT03705728|total intravenous anesthesia|total intravenous anesthesia
79724|NCT03705728|closed-loop anesthesia|closed-loop anesthesia
79725|NCT03705728|EEG monitoring|eeg monitoring
79726|NCT03705728|propofol|propofol
79727|NCT03705728|remifentanil|remifentanil
79728|NCT03705728|sevoflurane|sevoflurane
79729|NCT03705715|Microglial activation|microglial activation
79730|NCT03705715|Immune activation|immune activation
79731|NCT03705715|PET neuroimaging|pet neuroimaging
79732|NCT03705702|Physical activity|physical activity
79733|NCT03705702|Behavioral intervention|behavioral intervention
79734|NCT03705702|Asthma clinical control|asthma clinical control
79735|NCT03705676|Sensorimotor control|sensorimotor control
79736|NCT03705676|Event-related potentials|event-related potentials
79935|NCT03704649|Girl|girl
79747|NCT03705624|anopheles|anopheles
79748|NCT03705624|transmission|transmission
79749|NCT03705624|diagnostic|diagnostic
79750|NCT03705611|Secondary distribution|secondary distribution
79751|NCT03705611|HIV self-testing|hiv self-testing
79752|NCT03705611|Malawi|malawi
79753|NCT03705572|Milk|milk
79754|NCT03705572|Lacprodan PL20|lacprodan pl20
79755|NCT03705572|Glycerophospholipids|glycerophospholipids
79756|NCT03705572|Cognition|cognition
79757|NCT03705559|marijuana|marijuana
79758|NCT03705559|opioid|opioid
79759|NCT03705559|opiate|opiate
79760|NCT03705559|cannabis|cannabis
79761|NCT03705533|telmisartan|telmisartan
79762|NCT03705533|bioequivalence|bioequivalence
79763|NCT03705533|Micardis|micardis
79764|NCT03705520|PD|pd
79765|NCT03705520|Parkinson's|parkinson's
79766|NCT03705520|Parkinson's Disease|parkinson's disease
79767|NCT03705520|Microbiome|microbiome
79768|NCT03705494|Breastfeeding|breastfeeding
79769|NCT03705494|Peer counsellor|peer counsellor
79770|NCT03705468|Less Invasive Surfactant Administration (LISA)|less invasive surfactant administration (lisa)
79771|NCT03705468|Sedation|sedation
79772|NCT03705468|RDS treated by CPAP requiring surfactant|rds treated by cpap requiring surfactant
79773|NCT03705468|Sedation during intra tracheal surfactant administration by the LISA method|sedation during intra tracheal surfactant administration by the lisa method
79774|NCT03705468|Available intravenous line|available intravenous line
79775|NCT03705416|GERD|gerd
79776|NCT03705416|Bariatric surgery|bariatric surgery
79777|NCT03705416|Endoscopic sleeve gastroplasty|endoscopic sleeve gastroplasty
79778|NCT03705416|Sleeve gastrectomy|sleeve gastrectomy
79779|NCT03705416|Roux-en-Y gastric bypass|roux-en-y gastric bypass
79780|NCT03705390|ILB|ilb
79781|NCT03705390|Amyotrophic Lateral Sclerosis|amyotrophic lateral sclerosis
79782|NCT03705390|Motor Neuron Disease|motor neuron disease
79783|NCT03705390|ALS|als
79784|NCT03705377|child care|child care
79785|NCT03705377|child development|child development
79786|NCT03705377|child health|child health
79787|NCT03705377|child nutrition|child nutrition
79788|NCT03705377|child rearing|child rearing
79789|NCT03705377|children|children
79790|NCT03705377|curriculum|curriculum
79791|NCT03705377|early childhood education|early childhood education
79792|NCT03705377|families|families
79793|NCT03705377|Head Start|head start
79794|NCT03705377|parenting skills|parenting skills
79795|NCT03705377|parents|parents
79796|NCT03705377|school readiness|school readiness
79797|NCT03705364|wheelchair|wheelchair
79798|NCT03705364|non-ambulatory|non-ambulatory
79805|NCT03705338|Anesthesia|anesthesia
79806|NCT03705338|Children|children
79807|NCT03705338|Electroencephalography|electroencephalography
79808|NCT03705338|Propofol|propofol
79809|NCT03705312|mitral regurgitation|mitral regurgitation
79810|NCT03705312|transcatheter mitral valve repair|transcatheter mitral valve repair
79811|NCT03705286|Pneumonia|pneumonia
79812|NCT03705286|Endotracheal intubation|endotracheal intubation
79813|NCT03705247|Dental Implants|dental implants
79821|NCT03705182|fluorescence|fluorescence
79822|NCT03705182|dermal assessment|dermal assessment
79823|NCT03705182|skin exposure|skin exposure
79824|NCT03705169|HIV|hiv
79825|NCT03705169|pharmacokinetics|pharmacokinetics
79826|NCT03705169|pharmacodynamics|pharmacodynamics
79827|NCT03705169|broadly neutralizing antibody|broadly neutralizing antibody
79828|NCT03705169|antiretroviral|antiretroviral
79829|NCT03705169|Phase 1|phase 1
79830|NCT03705143|Disease|disease
79831|NCT03705143|Depressive Disorder|depressive disorder
79832|NCT03705143|Depression|depression
79833|NCT03705143|Mood Disorders|mood disorders
79834|NCT03705143|Mental Disorders|mental disorders
79835|NCT03705143|Substance use Disorders|substance use disorders
79836|NCT03705143|Chinese heroin user|chinese heroin user
79837|NCT03705143|Culture|culture
79838|NCT03705130|Multifocal Contact Lens|multifocal contact lens
79839|NCT03705130|Myopia|myopia
79840|NCT03705130|Visual Performance|visual performance
79841|NCT03705104|Pain|pain
79842|NCT03705104|Chronic Pain|chronic pain
79843|NCT03705104|Self-management|self-management
79844|NCT03705104|E-health|e-health
79845|NCT03705104|Appication|appication
79846|NCT03705104|App|app
79847|NCT03705104|Intervention|intervention
79848|NCT03705104|Cognitive Behavioral Therapy|cognitive behavioral therapy
79849|NCT03705104|CBT|cbt
79850|NCT03705104|Acceptance and Commitment Therapy|acceptance and commitment therapy
79851|NCT03705104|ACT|act
79852|NCT03705104|Psychological well-being|psychological well-being
79853|NCT03705091|Magnetic resonance imaging|magnetic resonance imaging
79854|NCT03705091|Biomarkers|biomarkers
79855|NCT03705091|Arterial spin labelling|arterial spin labelling
79856|NCT03705091|Diffusion weighted imaging|diffusion weighted imaging
79857|NCT03705091|Renal transplantation|renal transplantation
79858|NCT03705078|Bleeding gastric varices|bleeding gastric varices
79859|NCT03705078|cirrhosis|cirrhosis
79860|NCT03705078|type 2 gastro-esophageal varices|type 2 gastro-esophageal varices
79861|NCT03705078|isolated gastric varices|isolated gastric varices
79862|NCT03705078|transjugular intra-hepatic porto systemic shunt (TIPS)|transjugular intra-hepatic porto systemic shunt (tips)
79863|NCT03705078|portal hypertension|portal hypertension
79864|NCT03705078|glue obliteration|glue obliteration
79865|NCT03705078|tissue adhesive|tissue adhesive
79866|NCT03705065|augmentation mammoplasty|augmentation mammoplasty
79867|NCT03705052|Art therapy|art therapy
79868|NCT03705052|surveys and questionnaires|surveys and questionnaires
79869|NCT03705052|patient|patient
79870|NCT03705052|caregiver|caregiver
79871|NCT03705039|knee osteoarthritis|knee osteoarthritis
79872|NCT03705039|ultrasonography|ultrasonography
79873|NCT03705039|ultrasound treatment|ultrasound treatment
79874|NCT03705026|postoperative nausea and vomiting|postoperative nausea and vomiting
79875|NCT03705026|general anesthesia|general anesthesia
79876|NCT03705026|breast surgery|breast surgery
79877|NCT03705026|single nucleotide polymorphism|single nucleotide polymorphism
79878|NCT03705013|Cologuard|cologuard
79879|NCT03704987|Klinefelter|klinefelter
79880|NCT03704987|Osteoporosis|osteoporosis
79881|NCT03704987|dual-energy X-ray absorptiometry|dual-energy x-ray absorptiometry
79882|NCT03704974|Child Health Services|child health services
79883|NCT03704974|Pediatric Health Service Utilization|pediatric health service utilization
79884|NCT03704974|Incredible Years|incredible years
79885|NCT03704948|Depression|depression
79886|NCT03704948|Listening Visits|listening visits
79887|NCT03704948|Nurses|nurses
79888|NCT03704948|Hospitalized newborns|hospitalized newborns
79889|NCT03704935|Pulmonary rehabilitation|pulmonary rehabilitation
79890|NCT03704935|Maintenance program|maintenance program
79891|NCT03704935|Cohort|cohort
79892|NCT03704935|Microenvironment|microenvironment
79893|NCT03704935|Long-term benefits|long-term benefits
79894|NCT03704922|Transfusion|transfusion
79895|NCT03704909|Epinephrine, Ephedrine, cesarean section, spinal anesthesia|epinephrine, ephedrine, cesarean section, spinal anesthesia
79896|NCT03704883|Cycling|cycling
79897|NCT03704883|Endurance|endurance
79898|NCT03704883|Pain|pain
79899|NCT03704883|Injury|injury
79900|NCT03704857|Root canal Preparation|root canal preparation
79901|NCT03704857|Postoperative symptoms|postoperative symptoms
79902|NCT03704857|Apical repair|apical repair
79903|NCT03704857|Oral health-related quality of life|oral health-related quality of life
79904|NCT03704857|PDT|pdt
79905|NCT03704857|Passive ultrassonic irrigation|passive ultrassonic irrigation
79906|NCT03704857|Irrigating solutions|irrigating solutions
79907|NCT03704857|Filling materials|filling materials
79908|NCT03704857|Foraminal enlargement|foraminal enlargement
79909|NCT03704831|Locoregional anesthesia|locoregional anesthesia
79910|NCT03704831|IPACK block|ipack block
79911|NCT03704831|surgical infiltration|surgical infiltration
79912|NCT03704831|Total knee arthroplasty|total knee arthroplasty
79913|NCT03704779|Mindfulness|mindfulness
79914|NCT03704779|Student|student
79915|NCT03704766|synovial biomarkers|synovial biomarkers
79916|NCT03704766|alpha-defensin|alpha-defensin
79917|NCT03704766|diagnostics|diagnostics
79918|NCT03704766|pediatric|pediatric
79919|NCT03704753|Cardiac Surgery|cardiac surgery
79920|NCT03704753|Thoracic Surgery|thoracic surgery
79921|NCT03704753|Nerve block|nerve block
79922|NCT03704688|trametinib|trametinib
79923|NCT03704688|Ponatinib|ponatinib
79924|NCT03704688|KRAS Mutant Advanced Non-Small Cell Lung Cancer|kras mutant advanced non-small cell lung cancer
79925|NCT03704688|17-297|17-297
79926|NCT03704688|Memorial Sloan Kettering Cancer Center|memorial sloan kettering cancer center
79927|NCT03704662|resectable pancreatic adenocarcinoma|resectable pancreatic adenocarcinoma
79928|NCT03704662|borderline resectable pancreatic adenocarcinoma|borderline resectable pancreatic adenocarcinoma
79929|NCT03704662|Stereotactic Body Radiation Therapy|stereotactic body radiation therapy
79930|NCT03704662|Preoperative Fractionated Radiation Therapy|preoperative fractionated radiation therapy
79931|NCT03704649|Nutrition|nutrition
79932|NCT03704649|Literacy|literacy
79933|NCT03704649|Education|education
79934|NCT03704649|Adolescent|adolescent
79936|NCT03704649|Participatory|participatory
79937|NCT03704649|Video|video
79938|NCT03704649|Ghana|ghana
79939|NCT03704623|Acute renal colic|acute renal colic
79940|NCT03704623|Ureteric stone|ureteric stone
79941|NCT03704623|Selective COX2 inhibitor|selective cox2 inhibitor
79942|NCT03704623|Parecoxib|parecoxib
79943|NCT03704623|Paracetamol|paracetamol
79944|NCT03704610|sarcoidosis|sarcoidosis
79945|NCT03704610|extra-thoracic|extra-thoracic
79946|NCT03704610|infliximab|infliximab
79947|NCT03704584|orthopedic disorders|orthopedic disorders
79948|NCT03704584|corticosteroids(CS)|corticosteroids(cs)
79949|NCT03704584|Lidocaine|lidocaine
79950|NCT03704584|Injections|injections
79951|NCT03704571|adenoma|adenoma
79952|NCT03704571|bowel preparation|bowel preparation
79953|NCT03704571|colonoscopy|colonoscopy
79954|NCT03704571|predictive model|predictive model
79955|NCT03704571|randomized controlled trial|randomized controlled trial
79956|NCT03704532|achilles tendon rupture|achilles tendon rupture
79957|NCT03704532|nonoperative treatment|nonoperative treatment
79958|NCT03704532|functional rehabilitation|functional rehabilitation
79959|NCT03704532|operative treatment|operative treatment
79960|NCT03704532|biomechanical measurements|biomechanical measurements
79961|NCT03704519|Healthy volunteers|healthy volunteers
79962|NCT03704519|Magnetic Resonance Imaging (MRI)|magnetic resonance imaging (mri)
79963|NCT03704506|Reyanning mixture|reyanning mixture
79964|NCT03704506|efficacy|efficacy
79965|NCT03704506|safety|safety
79966|NCT03704506|randomized|randomized
79967|NCT03704506|double-blind|double-blind
79968|NCT03704506|placebo-controlled|placebo-controlled
79969|NCT03704506|multicenter|multicenter
79970|NCT03704506|antibiotics|antibiotics
79971|NCT03704493|Exercise testing|exercise testing
79972|NCT03704493|coronary artery disease|coronary artery disease
79973|NCT03704493|virtual group motivation|virtual group motivation
79974|NCT03704480|Immunotherapy|immunotherapy
79975|NCT03704467|Avelumab|avelumab
79976|NCT03704467|Carboplatin|carboplatin
79977|NCT03704467|Primary Peritoneal Cancer|primary peritoneal cancer
79978|NCT03704467|Fallopian Tube Cancer|fallopian tube cancer
79979|NCT03704467|Platinum sensitive ovarian cancer|platinum sensitive ovarian cancer
79980|NCT03704467|Deoxy ribonucleic acid (DNA)-damage response inhibition|deoxy ribonucleic acid (dna)-damage response inhibition
79981|NCT03704441|Spinal anesthesia in old age|spinal anesthesia in old age
79982|NCT03704428|SHR1314|shr1314
79983|NCT03704389|Geriatrics|geriatrics
79984|NCT03704389|Clinical decision support|clinical decision support
79985|NCT03704389|Behavioral Economics|behavioral economics
79986|NCT03704376|Femoral Nerve Block|femoral nerve block
79987|NCT03704376|Adductor Canal Block|adductor canal block
79988|NCT03704363|Modic changes|modic changes
79989|NCT03704363|biomarkers|biomarkers
79990|NCT03704363|treatment|treatment
79991|NCT03704363|infliximab|infliximab
79992|NCT03704363|chronic low back pain|chronic low back pain
79993|NCT03704324|Incidence and profile|incidence and profile
79994|NCT03704324|Risk factors|risk factors
79995|NCT03704324|Prediction model|prediction model
79996|NCT03704285|anesthesia|anesthesia
79997|NCT03704285|burned|burned
79998|NCT03704285|TIVA|tiva
79999|NCT03704285|propofol|propofol
80000|NCT03704233|Transbrochial cryobiopsy|transbrochial cryobiopsy
80001|NCT03704233|Diffuse parenchymal lung diseases|diffuse parenchymal lung diseases
80002|NCT03704233|Diagnosis|diagnosis
80003|NCT03704220|Single anti-thrombotic therapy|single anti-thrombotic therapy
80004|NCT03704220|Mechanical circulatory support|mechanical circulatory support
80005|NCT03704194|falls|falls
80006|NCT03704194|exercise program|exercise program
80007|NCT03704194|medically underserved|medically underserved
80008|NCT03704181|fibrosis|fibrosis
80009|NCT03704181|Inflammation|inflammation
80010|NCT03704129|Diaphragm Ultrasound|diaphragm ultrasound
80011|NCT03704129|Educational Programme|educational programme
80012|NCT03704116|chronic traumatic brain injury|chronic traumatic brain injury
80013|NCT03704116|cognition|cognition
80014|NCT03704116|executive function|executive function
80015|NCT03704090|Postoperative Delirium|postoperative delirium
80016|NCT03704090|Prevention Measure|prevention measure
80017|NCT03704090|Non-pharmacological|non-pharmacological
80018|NCT03704090|Subsyndromal Delirium|subsyndromal delirium
80019|NCT03704064|Weight Loss|weight loss
80020|NCT03704064|Weight Stigma|weight stigma
80021|NCT03704064|Physical Activity|physical activity
80022|NCT03704064|Cardiovascular Risk Factor|cardiovascular risk factor
80023|NCT03704051|infant feeding|infant feeding
80024|NCT03704051|feeding interactions|feeding interactions
80025|NCT03704051|maternal feeding practices|maternal feeding practices
80026|NCT03704051|breastfeeding|breastfeeding
80027|NCT03704051|bottle-feeding|bottle-feeding
80028|NCT03704038|PEEP|peep
80029|NCT03704038|Electrical impedance tomography|electrical impedance tomography
80030|NCT03704038|Mechanical ventialtion|mechanical ventialtion
80031|NCT03704025|Exercise tolerance|exercise tolerance
80032|NCT03704025|Heart rate variability|heart rate variability
80033|NCT03704025|Baroreflex sensitivity|baroreflex sensitivity
80034|NCT03704012|Premature Infant|premature infant
80035|NCT03704012|Massage|massage
80036|NCT03704012|Tactile Kinesthetic Stimulation|tactile kinesthetic stimulation
80037|NCT03703999|flash glucose monitoring|flash glucose monitoring
80038|NCT03703999|HbA1c|hba1c
80039|NCT03703986|deterioration|deterioration
80040|NCT03703986|risk factors|risk factors
80041|NCT03703986|predictors|predictors
80042|NCT03703973|Postoperative Cognitive Dysfunction|postoperative cognitive dysfunction
80043|NCT03703973|Leukocyte Telomere Length|leukocyte telomere length
80044|NCT03703947|Abdominal Aortic Aneurysm|abdominal aortic aneurysm
80045|NCT03703947|Biomarkers|biomarkers
80046|NCT03703934|Pain phenotyping|pain phenotyping
80047|NCT03703934|Quantitative sensory testing|quantitative sensory testing
80048|NCT03703921|Intensive interdisciplinary pain treatment|intensive interdisciplinary pain treatment
80049|NCT03703921|fMRI|fmri
80050|NCT03703921|fear of pain|fear of pain
80051|NCT03703908|FSGS|fsgs
80052|NCT03703908|Glomerulosclerosis|glomerulosclerosis
80053|NCT03703908|Proteinuria|proteinuria
80054|NCT03703882|Muscular Dystrophies|muscular dystrophies
80055|NCT03703882|Musculoskeletal Diseases|musculoskeletal diseases
80056|NCT03703882|Neuromuscular Diseases|neuromuscular diseases
80057|NCT03703882|Duchenne muscular dystrophy|duchenne muscular dystrophy
80059|NCT03703882|dystrophin|dystrophin
80060|NCT03703882|dystrophy|dystrophy
80061|NCT03703882|Duchenne|duchenne
80062|NCT03703856|Alzheimer's Disease|alzheimer's disease
80063|NCT03703856|Alzheimer Disease|alzheimer disease
80064|NCT03703856|Alzheimer|alzheimer
80065|NCT03703856|AD|ad
80066|NCT03703856|Alzheimer's|alzheimer's
80067|NCT03703843|AUS|aus
80068|NCT03703843|Artificial Urinary Sphincter|artificial urinary sphincter
80069|NCT03703830|Cerebellum|cerebellum
80070|NCT03703830|Transcranial direct current stimulation|transcranial direct current stimulation
80071|NCT03703830|Gait ataxia|gait ataxia
80072|NCT03703791|AR101|ar101
80073|NCT03703791|Characterized Peanut Allergen CPNA|characterized peanut allergen cpna
80074|NCT03703791|(Characterized Peanut Allergen) OIT|(characterized peanut allergen) oit
80075|NCT03703791|Peanut Allergy|peanut allergy
80076|NCT03703791|Allergy|allergy
80077|NCT03703791|Peanut-Allergic Children|peanut-allergic children
80078|NCT03703791|Peanut-Allergic Adolescents|peanut-allergic adolescents
80079|NCT03703791|Desensitization|desensitization
80080|NCT03703791|Quality of Life|quality of life
80081|NCT03703791|OIT (oral immunotherapy)|oit (oral immunotherapy)
80082|NCT03703791|CODIT (TM) Characterized Oral Desensitization Immunotherapy (TM)|codit (tm) characterized oral desensitization immunotherapy (tm)
80083|NCT03703778|Prostate Cancer|prostate cancer
80084|NCT03703778|Androgen deprivation therapy|androgen deprivation therapy
80085|NCT03703765|Volume|volume
80086|NCT03703765|veins|veins
80087|NCT03703765|lower limb|lower limb
80088|NCT03703765|imaging|imaging
80089|NCT03703739|Iron deficiency|iron deficiency
80090|NCT03703739|iron fortified rice|iron fortified rice
80091|NCT03703739|extruded rice|extruded rice
80092|NCT03703726|Iron deficiency|iron deficiency
80093|NCT03703726|iron fortified rice|iron fortified rice
80094|NCT03703726|extruded rice|extruded rice
80095|NCT03703700|IVF-ET|ivf-et
80096|NCT03703700|infertility|infertility
80097|NCT03703700|aged|aged
80098|NCT03703700|women|women
80099|NCT03703687|palliative care|palliative care
80100|NCT03703687|gratitude|gratitude
80101|NCT03703687|positive psychology|positive psychology
80102|NCT03703661|negative pressure wound therapy|negative pressure wound therapy
80103|NCT03703648|Dental caries|dental caries
80104|NCT03703648|Periodontal disease|periodontal disease
80105|NCT03703648|Head and neck cancer|head and neck cancer
80106|NCT03703648|Radiotherapy|radiotherapy
80107|NCT03703648|Micro-costings study|micro-costings study
80108|NCT03703648|Dental health|dental health
80109|NCT03703635|ICAD|icad
80110|NCT03703635|Intracranial Artery Stenosis|intracranial artery stenosis
80111|NCT03703635|Ischemic Stroke|ischemic stroke
80112|NCT03703635|TIA|tia
80113|NCT03703635|Angioplasty|angioplasty
80114|NCT03703635|Aggressive Medical Care|aggressive medical care
80115|NCT03703622|HBB knowledge and skills attainment and retention|hbb knowledge and skills attainment and retention
80116|NCT03703622|Video-debriefing|video-debriefing
80117|NCT03703622|Skills, knowledge, Birth attendants|skills, knowledge, birth attendants
80118|NCT03703609|yoga|yoga
80119|NCT03703609|rehabilitation|rehabilitation
80120|NCT03703609|physical activity|physical activity
80121|NCT03703609|quality of life|quality of life
80122|NCT03703609|anxiety|anxiety
80123|NCT03703609|depression|depression
80124|NCT03703557|Breast|breast
80125|NCT03703557|Volatile organic compounds|volatile organic compounds
80126|NCT03703518|Mixed reality|mixed reality
80127|NCT03703518|Exercise|exercise
80128|NCT03703440|Transition care|transition care
80129|NCT03703440|Pediatric|pediatric
80130|NCT03703440|Adolescent|adolescent
80131|NCT03703440|Education|education
80132|NCT03703440|Hemaglobin A1c|hemaglobin a1c
80133|NCT03703440|Health Services|health services
80134|NCT03703440|Randomized Controlled Trial|randomized controlled trial
80135|NCT03703375|CC-486|cc-486
80136|NCT03703375|Azacitidine|azacitidine
80137|NCT03703375|Angioimmunoblastic|angioimmunoblastic
80138|NCT03703375|T Cell Lymphoma|t cell lymphoma
80139|NCT03703375|Lymphoma|lymphoma
80140|NCT03703362|Resistance training|resistance training
80141|NCT03703362|Feasibility|feasibility
80142|NCT03703349|Coronary artery surgery|coronary artery surgery
80143|NCT03703349|oral magnesium|oral magnesium
80144|NCT03703349|atrial fibrillation|atrial fibrillation
80145|NCT03703349|Randomized controlled trial|randomized controlled trial
80146|NCT03703336|ROTAVIN|rotavin
80147|NCT03703336|Rotavirus vaccine|rotavirus vaccine
80148|NCT03703336|Rotavirus|rotavirus
80149|NCT03703336|Diarrhea|diarrhea
80150|NCT03703310|Gorlin syndrome|gorlin syndrome
80151|NCT03703310|Basal cell nevus syndrome BCNS|basal cell nevus syndrome bcns
80152|NCT03703310|Nevoid basal cell carcinoma syndrome|nevoid basal cell carcinoma syndrome
80153|NCT03703310|Basal cell carcinoma|basal cell carcinoma
80154|NCT03703310|Hedgehog|hedgehog
80155|NCT03703310|Surgically eligible basal cell carcinomas|surgically eligible basal cell carcinomas
80156|NCT03703310|Patidegib|patidegib
80157|NCT03703297|Small Cell Lung Cancer|small cell lung cancer
80158|NCT03703297|SCLC|sclc
80159|NCT03703297|LS-SCLC|ls-sclc
80160|NCT03703297|Limited Stage|limited stage
80161|NCT03703297|Carcinoma|carcinoma
80162|NCT03703297|Lung Cancer|lung cancer
80163|NCT03703284|mechanism,|mechanism,
80164|NCT03703284|cerebral edema,|cerebral edema,
80165|NCT03703284|large hemispheric infarction|large hemispheric infarction
80166|NCT03703271|postmolar|postmolar
80167|NCT03703271|Gestational Trophoblastic Neoplasia|gestational trophoblastic neoplasia
80168|NCT03703271|hysteroscopic|hysteroscopic
80169|NCT03703271|repeat curettage|repeat curettage
80170|NCT03703271|methotrexate|methotrexate
80171|NCT03703245|Plaque Accumulation|plaque accumulation
80172|NCT03703232|prosthesis|prosthesis
80173|NCT03703232|prosthetic|prosthetic
80174|NCT03703232|foot|foot
80175|NCT03703232|ankle|ankle
80176|NCT03703232|mobility|mobility
80177|NCT03703232|amputee|amputee
80178|NCT03703167|Ibrutinib|ibrutinib
80179|NCT03703167|Rituximab|rituximab
80180|NCT03703167|Lenalidomide|lenalidomide
103644|NCT03556124|MRI|mri
80181|NCT03703167|relapsed/refractory PCNSL|relapsed/refractory pcnsl
80182|NCT03703167|relapsed/refractory SCNSL|relapsed/refractory scnsl
80183|NCT03703167|18-432|18-432
80184|NCT03703154|End Stage Renal Disease|end stage renal disease
80185|NCT03703141|sucralose|sucralose
80186|NCT03703141|insulin|insulin
80187|NCT03703141|AUC|auc
80188|NCT03703141|young|young
80189|NCT03703141|inflammatory markers|inflammatory markers
80190|NCT03703141|intolerance|intolerance
80191|NCT03703128|psychological autopsy|psychological autopsy
80192|NCT03703128|prevention|prevention
80193|NCT03703115|ICSI|icsi
80194|NCT03703115|Polycystic ovary syndrome|polycystic ovary syndrome
80195|NCT03703115|Infertility|infertility
80196|NCT03703115|Fasting|fasting
80197|NCT03703102|AD|ad
80198|NCT03703102|eczema|eczema
80199|NCT03703102|skin diseases|skin diseases
80200|NCT03703102|biologics|biologics
80201|NCT03703089|Positive Peritoneal Cytology|positive peritoneal cytology
80202|NCT03703063|Pancreatic cancer|pancreatic cancer
80203|NCT03703063|nal-IRI|nal-iri
80204|NCT03703063|NAPOLI|napoli
80205|NCT03703037|Late term pregnancy|late term pregnancy
80206|NCT03703037|Doppler|doppler
80207|NCT03703011|geriatrics|geriatrics
80208|NCT03703011|discharge|discharge
80209|NCT03703011|Accelerometers|accelerometers
80210|NCT03702985|Neoadjuvant Chemoradiotherapy|neoadjuvant chemoradiotherapy
80211|NCT03702985|amifostine|amifostine
80212|NCT03702985|irinotecan|irinotecan
80213|NCT03702985|capecitabine|capecitabine
80214|NCT03702972|Burn|burn
80215|NCT03702972|Pediatry|pediatry
80216|NCT03702972|Flir One Thermal Imager|flir one thermal imager
80217|NCT03702972|Depth determination|depth determination
80218|NCT03702907|Frontotemporal Dementia|frontotemporal dementia
80219|NCT03702907|Lewy Body Dementia|lewy body dementia
80220|NCT03702907|Aging|aging
80221|NCT03702907|Vascular Dementia|vascular dementia
80222|NCT03702894|bioequivalence|bioequivalence
80223|NCT03702894|amoxicillin|amoxicillin
80224|NCT03702894|clavulanic acid|clavulanic acid
80225|NCT03702894|Augmentin|augmentin
80226|NCT03702881|Open Bite|open bite
80227|NCT03702881|Orthodontic appliance|orthodontic appliance
80228|NCT03702881|Cephalometry|cephalometry
80229|NCT03702881|Dental models|dental models
80230|NCT03702842|walking|walking
80231|NCT03702842|locomotor training|locomotor training
80232|NCT03702842|rehabilitation|rehabilitation
80233|NCT03702829|wild-type transthyretin amyloidosis|wild-type transthyretin amyloidosis
80234|NCT03702829|TTR amyloidosis|ttr amyloidosis
80235|NCT03702829|familial amyloid cardiomyopathy|familial amyloid cardiomyopathy
80236|NCT03702829|mutant transthyretin amyloidosis|mutant transthyretin amyloidosis
80237|NCT03702816|neuroinflammation|neuroinflammation
80238|NCT03702803|Phytopharmaceutical|phytopharmaceutical
80239|NCT03702803|Anxiety|anxiety
80240|NCT03702803|Outpatients|outpatients
80241|NCT03702777|Underactive Bladder|underactive bladder
80242|NCT03702777|ASP8302|asp8302
80243|NCT03702764|coronary plaque eccentricity|coronary plaque eccentricity
80244|NCT03702764|vulnerable coronary plaque|vulnerable coronary plaque
80245|NCT03702764|coronary artery disease|coronary artery disease
80246|NCT03702764|myocardial infarction|myocardial infarction
80247|NCT03702764|coronary computed tomography angiography|coronary computed tomography angiography
80248|NCT03702764|major adverse cardiac events|major adverse cardiac events
80249|NCT03702738|Host-directed therapy|host-directed therapy
80250|NCT03702738|N-acetylcysteine|n-acetylcysteine
80251|NCT03702738|Glutathione|glutathione
80252|NCT03702725|Myeloma|myeloma
80253|NCT03702725|Multiple Myeloma|multiple myeloma
80254|NCT03702725|Refractory Multiple Myeloma|refractory multiple myeloma
80255|NCT03702725|Ibrutinib|ibrutinib
80256|NCT03702712|Survivorship|survivorship
80257|NCT03702712|Fatigue|fatigue
80258|NCT03702712|Relax|relax
80259|NCT03702712|Cognition|cognition
80260|NCT03702712|Exercise|exercise
80261|NCT03702699|auricular point detection|auricular point detection
80262|NCT03702699|knee osteoarthritis|knee osteoarthritis
80263|NCT03702699|pain|pain
80264|NCT03702686|breastfeeding, pre-term infant, NICU|breastfeeding, pre-term infant, nicu
80265|NCT03702647|Peroral Endoscopic Myotomy|peroral endoscopic myotomy
80266|NCT03702647|Ropivacaine|ropivacaine
80267|NCT03702647|Post-procedure pain control|post-procedure pain control
80268|NCT03702595|Hip Osteoarthritis|hip osteoarthritis
80269|NCT03702595|Manual therapy|manual therapy
80270|NCT03702595|physiotherapy|physiotherapy
80271|NCT03702582|Atrial Fibrillation|atrial fibrillation
80272|NCT03702582|Rivaroxaban|rivaroxaban
80273|NCT03702582|Warfarin|warfarin
80274|NCT03702582|Stroke|stroke
80275|NCT03702582|Anticoagulation|anticoagulation
80276|NCT03702582|Bleeding|bleeding
80277|NCT03702569|Volume Expansion|volume expansion
80278|NCT03702569|Intensive Care Unit|intensive care unit
80279|NCT03702569|Left Ventricular Contractility|left ventricular contractility
80280|NCT03702569|Speckle Tracking|speckle tracking
80281|NCT03702569|STRAIN|strain
80282|NCT03702517|lateral stair walking|lateral stair walking
80283|NCT03702517|range of motion|range of motion
80284|NCT03702517|muscle strength|muscle strength
80285|NCT03702478|Quality of life|quality of life
80286|NCT03702478|hernia|hernia
80287|NCT03702478|parastomal bulging|parastomal bulging
80288|NCT03702478|stoma|stoma
80289|NCT03702478|cross-sectional|cross-sectional
80290|NCT03702465|Type 2 Diabetes|type 2 diabetes
80291|NCT03702465|DNA-based diet|dna-based diet
80292|NCT03702465|App|app
80293|NCT03702413|Acute cerebral infarction due to large vessel occlusion|acute cerebral infarction due to large vessel occlusion
80294|NCT03702413|Mechanical thrombectomy|mechanical thrombectomy
80295|NCT03702413|Ischemic stroke|ischemic stroke
80296|NCT03702400|phenylephrine|phenylephrine
80297|NCT03702400|norepinephrine|norepinephrine
80298|NCT03702400|cesarean delivery under spinal anesthesia|cesarean delivery under spinal anesthesia
80299|NCT03702387|IVRA|ivra
80300|NCT03702387|Bier Block|bier block
80301|NCT03702387|Esmarch Bandage|esmarch bandage
80302|NCT03702374|diabetic retinopathy|diabetic retinopathy
80303|NCT03702374|oxidative stress|oxidative stress
80304|NCT03702374|mitochondrial dysfunction|mitochondrial dysfunction
80305|NCT03702374|oxidative markers|oxidative markers
80306|NCT03702374|diabetes|diabetes
80307|NCT03702374|antioxidant therapy|antioxidant therapy
80308|NCT03702335|Older adults|older adults
80309|NCT03702335|Dietary consultation|dietary consultation
80310|NCT03702335|Mental health|mental health
80311|NCT03702335|Sleep quality|sleep quality
80312|NCT03702335|Dietary quality|dietary quality
80313|NCT03702335|Cardio-metabolic health|cardio-metabolic health
80314|NCT03702309|High Risk|high risk
80315|NCT03702309|Liquid Biopsy|liquid biopsy
80316|NCT03702309|Circulating Tumor DNA|circulating tumor dna
80317|NCT03702309|Blood|blood
80318|NCT03702309|Molecular Profiling|molecular profiling
80319|NCT03702309|Next Generation Sequencing|next generation sequencing
80320|NCT03702309|Solid Tumors|solid tumors
80321|NCT03702309|Hematological|hematological
80322|NCT03702244|suspected coronary artery disease|suspected coronary artery disease
80323|NCT03702231|Ibrutinib|ibrutinib
80324|NCT03702231|Acalabrutinib|acalabrutinib
80325|NCT03702231|Shingles|shingles
80326|NCT03702231|Herpes|herpes
80327|NCT03702218|Transplantation|transplantation
80328|NCT03702218|Hepatitis C|hepatitis c
80329|NCT03702192|heart failure|heart failure
80330|NCT03702179|localized muscle invasive bladder cancer|localized muscle invasive bladder cancer
80331|NCT03702179|bladder preservation|bladder preservation
80332|NCT03702179|durvalumab|durvalumab
80333|NCT03702179|tremelimumab|tremelimumab
80334|NCT03702179|radiotherapy|radiotherapy
80335|NCT03702153|ventral hernia|ventral hernia
80336|NCT03702153|mesh infection|mesh infection
80337|NCT03702153|enteric fistula|enteric fistula
80338|NCT03702153|polypropylene mesh|polypropylene mesh
80339|NCT03702153|synthetic mesh|synthetic mesh
80340|NCT03702153|abdominal wall reconstruction|abdominal wall reconstruction
80341|NCT03702153|complex hernia|complex hernia
80342|NCT03702114|menstrual migraine|menstrual migraine
80343|NCT03702114|auricular point|auricular point
80344|NCT03702114|diagnostic accuracy|diagnostic accuracy
80345|NCT03702114|Auricular Point Detection device|auricular point detection device
80346|NCT03702101|orofacial pain|orofacial pain
80347|NCT03702101|auricular point|auricular point
80348|NCT03702101|electrical impedance|electrical impedance
80349|NCT03702088|Minimal residual disease|minimal residual disease
80350|NCT03702088|Multi-parametric flow cytometry|multi-parametric flow cytometry
80351|NCT03702088|Hevylite®|hevylite®
80352|NCT03702075|chronic neck pain|chronic neck pain
80353|NCT03702036|Nuclear protein in testis (NUT)|nuclear protein in testis (nut)
80354|NCT03702036|NUT Midline Carcinoma (NMC)|nut midline carcinoma (nmc)
80355|NCT03702010|Spinal cord stimulation|spinal cord stimulation
80356|NCT03702010|Back surgery|back surgery
80357|NCT03702010|Chronic pain|chronic pain
80358|NCT03701945|microbiota|microbiota
80359|NCT03701945|pulmonary rehabilitation|pulmonary rehabilitation
80360|NCT03701932|Depression, Transcranial Magnetic Stimulation (TMS)|depression, transcranial magnetic stimulation (tms)
80361|NCT03701880|Decompensated Heart Failure|decompensated heart failure
80362|NCT03701880|Ivabradine|ivabradine
80363|NCT03701880|ST2 Biomarker|st2 biomarker
80364|NCT03701854|heart failure|heart failure
80365|NCT03701854|pacemaker|pacemaker
80366|NCT03701854|exercise test|exercise test
80367|NCT03701854|muscle strength|muscle strength
80368|NCT03701854|dyspnea|dyspnea
80369|NCT03701854|fatigue|fatigue
80370|NCT03701815|brain-derived neurotrophic factor|brain-derived neurotrophic factor
80371|NCT03701815|exercise|exercise
80372|NCT03701815|BDNF|bdnf
80373|NCT03701815|lifestyle medicine|lifestyle medicine
80374|NCT03701802|HIV prevention|hiv prevention
80375|NCT03701802|Tenofovir Disoproxil Fumarate (TDF)/Emtricitabine (FTC)|tenofovir disoproxil fumarate (tdf)/emtricitabine (ftc)
80376|NCT03701802|PrEP|prep
821973|NCT00148681|navelbine|navelbine
80377|NCT03701776|Ataxia, exercise, spinocerebellar disease, neuroimaging|ataxia, exercise, spinocerebellar disease, neuroimaging
80378|NCT03701763|Pediatric|pediatric
80379|NCT03701763|6 through 17 years|6 through 17 years
80380|NCT03701763|Plaque Psoriasis|plaque psoriasis
80381|NCT03701763|Psoriasis|psoriasis
80382|NCT03701763|CC-10004|cc-10004
80383|NCT03701763|Apremilast|apremilast
80384|NCT03701763|Otezla|otezla
80385|NCT03701763|Children|children
80386|NCT03701763|Adolescents|adolescents
80387|NCT03701763|SPROUT|sprout
80388|NCT03701750|IVF|ivf
80389|NCT03701750|pregnancy|pregnancy
80390|NCT03701750|LMWH|lmwh
80391|NCT03701750|Low Molecular Weight Heparin|low molecular weight heparin
80392|NCT03701750|Assisted Reproductive Technology|assisted reproductive technology
80393|NCT03701750|Implantation|implantation
80394|NCT03701724|Major Depressive Disorder|major depressive disorder
80395|NCT03701724|Unipolar depression|unipolar depression
80396|NCT03701724|Chronic depression|chronic depression
80397|NCT03701724|Recurrent depression|recurrent depression
80398|NCT03701724|Depressive disorder|depressive disorder
80399|NCT03701724|Magnetic stimulation|magnetic stimulation
80400|NCT03701724|Non-invasive brain stimulation|non-invasive brain stimulation
80401|NCT03701724|1 Hertz (Hz) rTMS|1 hertz (hz) rtms
80402|NCT03701724|Maintenance rTMS|maintenance rtms
80403|NCT03701724|Cost-utility|cost-utility
80404|NCT03701724|Efficiency|efficiency
80405|NCT03701724|Medico-economic|medico-economic
80406|NCT03701724|Antidepressants|antidepressants
80407|NCT03701711|Lenalidomide|lenalidomide
80408|NCT03701685|nerve flap|nerve flap
80409|NCT03701685|sensory reconstruction|sensory reconstruction
80410|NCT03701685|nerve repair|nerve repair
80411|NCT03701568|myopathy, muscle weakness, hypotonia, dysphagia, ptosis|myopathy, muscle weakness, hypotonia, dysphagia, ptosis
80412|NCT03701542|macular hole|macular hole
80413|NCT03701542|microperymetry|microperymetry
80414|NCT03701542|vitrectomy|vitrectomy
80415|NCT03701542|m-charts|m-charts
80416|NCT03701542|metamorphopsia|metamorphopsia
80417|NCT03701477|Migraine|migraine
80418|NCT03701477|trans-diagnostic approach|trans-diagnostic approach
80419|NCT03701477|headache|headache
80420|NCT03701464|ERCP|ercp
80421|NCT03701464|PTGBD|ptgbd
80422|NCT03701464|ENGBD|engbd
80423|NCT03701464|Gallbladder drainage|gallbladder drainage
80424|NCT03701464|Cholecystitis|cholecystitis
80425|NCT03701451|Nasopharyngeal Carcinoma|nasopharyngeal carcinoma
80426|NCT03701451|Decitabine|decitabine
80427|NCT03701451|Concurrent chemoradiotherapy|concurrent chemoradiotherapy
80428|NCT03701451|Induced chemotherapy|induced chemotherapy
80429|NCT03701399|Ataxia, SCA, Spinocerebellar Ataxia|ataxia, sca, spinocerebellar ataxia
80430|NCT03701386|cesarean section|cesarean section
80431|NCT03701386|placenta accreta spectrum|placenta accreta spectrum
80432|NCT03701386|N&H sandwich technique|n&h sandwich technique
80433|NCT03701373|Advanced Gastric Cancer|advanced gastric cancer
80434|NCT03701373|Maintenance|maintenance
80435|NCT03701373|S-1|s-1
81332|NCT03695315|Hypoxia|hypoxia
80447|NCT03701269|Fracture|fracture
80448|NCT03701256|TAP block|tap block
80449|NCT03701256|curare|curare
80450|NCT03701256|laparoscopy|laparoscopy
80451|NCT03701256|gynecology surgery|gynecology surgery
80452|NCT03701256|abdominal compliance|abdominal compliance
80453|NCT03701230|low temperature|low temperature
80454|NCT03701230|rota-flush solution|rota-flush solution
80455|NCT03701230|RA-related myocardial injury|ra-related myocardial injury
80456|NCT03701230|severe calcified lesion|severe calcified lesion
80457|NCT03701191|gingival recession, periosteum, autogenous graft|gingival recession, periosteum, autogenous graft
80458|NCT03701139|phacoemulsification|phacoemulsification
80459|NCT03701139|cataract|cataract
80460|NCT03701139|primary posterior capsule opacification|primary posterior capsule opacification
80461|NCT03701139|posterior capsulotomy|posterior capsulotomy
80462|NCT03701139|randomized controlled trial|randomized controlled trial
80463|NCT03701139|Nd:YAG laser capsulotomy|nd:yag laser capsulotomy
80464|NCT03701113|Osteoporosis|osteoporosis
80465|NCT03701113|Postmenopausal|postmenopausal
80466|NCT03701113|Bone Turnover Markers|bone turnover markers
80467|NCT03701113|Dairy Products|dairy products
80468|NCT03701074|patent ductus arteriosus|patent ductus arteriosus
80469|NCT03701074|acetaminophen|acetaminophen
80470|NCT03701074|ibuprofen|ibuprofen
80471|NCT03701074|bronchopulmonary dysplasia|bronchopulmonary dysplasia
80472|NCT03701074|mechanical ventilation|mechanical ventilation
80473|NCT03701061|immune response|immune response
80474|NCT03701009|ERCP|ercp
80475|NCT03701009|Common bile duct stone|common bile duct stone
80476|NCT03701009|Cholangitis|cholangitis
80477|NCT03701009|Residual stone|residual stone
80478|NCT03701009|Irrigation|irrigation
80479|NCT03700996|ACL|acl
80480|NCT03700944|Allergic Rhinitis|allergic rhinitis
80481|NCT03700944|Yoga|yoga
80482|NCT03700944|Cytokines|cytokines
80483|NCT03700944|Rhinitis symptoms|rhinitis symptoms
80484|NCT03700931|Episodic memory|episodic memory
80485|NCT03700931|Eating episodes|eating episodes
80486|NCT03700931|Fruit and vegetable intake|fruit and vegetable intake
80487|NCT03700892|e-cig|e-cig
80488|NCT03700892|E-cigarette|e-cigarette
80489|NCT03700892|Electronic cigarette|electronic cigarette
80490|NCT03700892|Vaping|vaping
80491|NCT03700866|luxation injury|luxation injury
80492|NCT03700866|splinting time|splinting time
80493|NCT03700866|crown-root fracture|crown-root fracture
80494|NCT03700866|surgical extrusion|surgical extrusion
80495|NCT03700840|Oral biofilm|oral biofilm
80496|NCT03700840|Microbiota|microbiota
80497|NCT03700840|Adolescent|adolescent
80498|NCT03700840|Dental carie|dental carie
80499|NCT03700827|Abdominal Fat|abdominal fat
80500|NCT03700827|Visceral Adipose Tissue|visceral adipose tissue
80501|NCT03700827|Subcutaneous Adipose Tissue|subcutaneous adipose tissue
80502|NCT03700827|Exercise|exercise
80503|NCT03700827|Intervention|intervention
80504|NCT03700801|Triple Combination Therapy|triple combination therapy
80505|NCT03700801|Premixed Insulin|premixed insulin
80506|NCT03700801|Hypoglycemic efficacy|hypoglycemic efficacy
80507|NCT03700801|Weight control|weight control
80508|NCT03700801|Safety|safety
80509|NCT03700775|Hypertension|hypertension
80510|NCT03700775|Telemedicine|telemedicine
80511|NCT03700762|Thyroid Nodule|thyroid nodule
80512|NCT03700762|differential diagnosis|differential diagnosis
80513|NCT03700736|post-partum women|post-partum women
80514|NCT03700736|social media|social media
80515|NCT03700736|Facebook|facebook
80516|NCT03700736|digital health|digital health
80517|NCT03700710|lifestyle modification|lifestyle modification
80518|NCT03700710|DASH diet|dash diet
80519|NCT03700710|weight loss|weight loss
80520|NCT03700710|exercise|exercise
80521|NCT03700645|Diabetes Mellitus|diabetes mellitus
80522|NCT03700645|Uric asid|uric asid
80523|NCT03700645|Multi Vessel Coronary Artery Disease|multi vessel coronary artery disease
80524|NCT03700606|high flow nasal cannula|high flow nasal cannula
80525|NCT03700606|nasal cpap|nasal cpap
80526|NCT03700593|Single port robotic surgery|single port robotic surgery
80527|NCT03700593|Minimally invasive colectomy|minimally invasive colectomy
80528|NCT03700593|Single port robotic colectomy|single port robotic colectomy
80529|NCT03700593|Single port robotic TEM|single port robotic tem
80530|NCT03700580|diabetes type 2|diabetes type 2
80531|NCT03700580|wound healing|wound healing
80532|NCT03700580|peripheral neuropathy|peripheral neuropathy
80533|NCT03700580|P1G10|p1g10
80534|NCT03700567|low temperature|low temperature
80535|NCT03700567|contrast|contrast
81433|NCT03694730|Tendinitis|tendinitis
80540|NCT03700554|Pleuralvent|pleuralvent
80541|NCT03700541|Perioperative analgesia|perioperative analgesia
80542|NCT03700541|Colorectal Cancer|colorectal cancer
80543|NCT03700541|Circulating Tumor Cell|circulating tumor cell
80544|NCT03700515|EPO|epo
80545|NCT03700502|resting state functional MRI|resting state functional mri
80546|NCT03700502|painful diabetic neuropathy|painful diabetic neuropathy
80547|NCT03700450|Without detection of deletion 17p or translocation 4;14;|without detection of deletion 17p or translocation 4;14;
80548|NCT03700450|Post Cyclophosphamide|post cyclophosphamide
80549|NCT03700450|GvHD Prophylaxis|gvhd prophylaxis
80550|NCT03700450|Allogeneic SCT|allogeneic sct
80551|NCT03700437|fasting|fasting
80552|NCT03700437|diet|diet
80553|NCT03700437|chemo-immunotherapy|chemo-immunotherapy
80554|NCT03700437|lung cancer|lung cancer
80555|NCT03700437|circulating tumor cells|circulating tumor cells
80556|NCT03700424|Acute Coronary Syndrome|acute coronary syndrome
80557|NCT03700424|Trehalose|trehalose
80558|NCT03700424|Arterial inflammation|arterial inflammation
80559|NCT03700424|Autophagy|autophagy
80560|NCT03700411|Perioperative analgesia|perioperative analgesia
80561|NCT03700411|Colorectal Cancer|colorectal cancer
80562|NCT03700411|Circulating Tumor Cell|circulating tumor cell
80566|NCT03700333|Carcinoma, Non-Small-Cell Lung|carcinoma, non-small-cell lung
80567|NCT03700333|S-1|s-1
80568|NCT03700333|Pemetrexed|pemetrexed
80569|NCT03700333|maintenance therapy|maintenance therapy
80570|NCT03700268|Deafness|deafness
80571|NCT03700268|cochlear implant|cochlear implant
80572|NCT03700268|Artificial Intelligence|artificial intelligence
80573|NCT03700216|limb Fracture|limb fracture
80574|NCT03700216|limb blood circulation|limb blood circulation
80575|NCT03700216|early-warning model|early-warning model
80576|NCT03700216|Children|children
80577|NCT03700203|Cardiac Arrest|cardiac arrest
80578|NCT03700190|autism|autism
80579|NCT03700190|activity and participation|activity and participation
80580|NCT03700190|sensory perception|sensory perception
80581|NCT03700190|facial expression|facial expression
80582|NCT03700190|developmental functions|developmental functions
80583|NCT03700190|predictors|predictors
80584|NCT03700190|follow-up study|follow-up study
80585|NCT03700164|Cold Exposure|cold exposure
80586|NCT03700164|Glucose Tolerance|glucose tolerance
80587|NCT03700125|Advanced life support (ALS)|advanced life support (als)
400583|NCT01866189|F-MISO Positon Emission Tomography|f-miso positon emission tomography
80588|NCT03700125|Extra-corporeal Membrane Oxygenation Resuscitation (ECMO)|extra-corporeal membrane oxygenation resuscitation (ecmo)
80589|NCT03700112|Electronic Nicotine Delivery System|electronic nicotine delivery system
80590|NCT03700112|Combustible Cigarettes|combustible cigarettes
80591|NCT03700112|Nicotine|nicotine
80592|NCT03700086|negative pressure wound therapy|negative pressure wound therapy
80593|NCT03700086|wound infection|wound infection
80594|NCT03700086|pancreaticoduodenectomy|pancreaticoduodenectomy
80595|NCT03700086|total pancreatectomy|total pancreatectomy
80596|NCT03700086|surgical palliation of pancreatic cancer|surgical palliation of pancreatic cancer
80597|NCT03700073|physiological cost index|physiological cost index
80598|NCT03700073|health-related quality of life|health-related quality of life
80599|NCT03700073|gait deviation index|gait deviation index
80600|NCT03700073|gait analysis|gait analysis
80601|NCT03700073|cerebral palsy|cerebral palsy
80602|NCT03700008|Mental Disorder|mental disorder
80603|NCT03700008|Treatment planning|treatment planning
80604|NCT03700008|Technical measurements of mental state|technical measurements of mental state
80605|NCT03700008|Course-prediction of Mental Illness|course-prediction of mental illness
80606|NCT03699982|Cystic Fibrosis|cystic fibrosis
80607|NCT03699969|Hypofractionation|hypofractionation
80608|NCT03699969|VMAT|vmat
80609|NCT03699969|head and neck cancer|head and neck cancer
80610|NCT03699956|RRx-001|rrx-001
80611|NCT03699956|Lung Cancer|lung cancer
80612|NCT03699956|Lung Neoplasms|lung neoplasms
80613|NCT03699956|Phase 3|phase 3
80614|NCT03699956|Immunotherapy|immunotherapy
80615|NCT03699956|Small Cell Carcinoma|small cell carcinoma
80616|NCT03699930|transcranial direct current stimulation|transcranial direct current stimulation
80617|NCT03699917|Fluid therapy|fluid therapy
80618|NCT03699917|gastric emptying|gastric emptying
80619|NCT03699917|pancreatic leak|pancreatic leak
80620|NCT03699917|pancreaticoduodenectomy|pancreaticoduodenectomy
80621|NCT03699917|stroke volume variation|stroke volume variation
80622|NCT03699904|COPD|copd
80623|NCT03699904|EBV|ebv
80624|NCT03699865|low nicotine|low nicotine
80625|NCT03699865|smoking behaviors|smoking behaviors
80626|NCT03699865|risk perceptions|risk perceptions
80627|NCT03699839|Vaccination|vaccination
80628|NCT03699839|Adjuvanted vaccine|adjuvanted vaccine
80629|NCT03699839|High-dose vaccine|high-dose vaccine
80728|NCT03699345|Transcatheter Heart Valve|transcatheter heart valve
80630|NCT03699826|transcranial magnetic stimulation|transcranial magnetic stimulation
80631|NCT03699826|neuromodulation|neuromodulation
80632|NCT03699813|ROTEM, PT, aPTT|rotem, pt, aptt
80633|NCT03699800|Graphomotor intervention program|graphomotor intervention program
80634|NCT03699800|Second grade children|second grade children
80635|NCT03699800|Prevention and early identification|prevention and early identification
80636|NCT03699800|Process and product of handwriting|process and product of handwriting
80637|NCT03699800|Quality and speed of handwriting|quality and speed of handwriting
80638|NCT03699787|Graphomotor intervention program|graphomotor intervention program
80639|NCT03699787|Preschool children|preschool children
80640|NCT03699787|Graphomotor competences|graphomotor competences
80641|NCT03699787|Prevention|prevention
80642|NCT03699761|Anastomotic leakage|anastomotic leakage
80643|NCT03699761|Sexual Dysfunction|sexual dysfunction
80644|NCT03699761|low anterior resection syndrome|low anterior resection syndrome
80645|NCT03699761|Pelvic Peritonization|pelvic peritonization
80647|NCT03699748|end of life|end of life
80648|NCT03699748|patient-centered|patient-centered
80649|NCT03699722|women|women
80650|NCT03699722|HIV|hiv
80651|NCT03699722|PrEP|prep
80652|NCT03699722|intervention|intervention
80653|NCT03699709|diet|diet
80654|NCT03699709|cooking skills|cooking skills
80655|NCT03699696|acute kidney injury|acute kidney injury
80656|NCT03699696|hypotension|hypotension
80657|NCT03699696|anesthetic dosing|anesthetic dosing
80658|NCT03699696|induction|induction
80659|NCT03699696|elderly|elderly
80660|NCT03699670|Resuscitation|resuscitation
80661|NCT03699670|Wounds and Injuries|wounds and injuries
80662|NCT03699670|Ultrasonography|ultrasonography
80663|NCT03699670|Radiography|radiography
80664|NCT03699670|Diagnostic Imaging|diagnostic imaging
80665|NCT03699657|RFA|rfa
80666|NCT03699644|FTD|ftd
80667|NCT03699644|Dementia|dementia
80668|NCT03699644|Retina|retina
80669|NCT03699618|NVAMD|nvamd
80670|NCT03699618|Anti-VEGF|anti-vegf
80671|NCT03699605|Stroke|stroke
80672|NCT03699605|Aphasia|aphasia
80673|NCT03699605|Broca Aphasia|broca aphasia
80674|NCT03699605|communication skills|communication skills
80675|NCT03699605|Verbal expressive skill management programme|verbal expressive skill management programme
80676|NCT03699579|advanced or metastatic renal cell carcinoma (RCC)|advanced or metastatic renal cell carcinoma (rcc)
80677|NCT03699566|Trunk muscle endurance|trunk muscle endurance
80678|NCT03699566|respiratory muscle strength|respiratory muscle strength
80679|NCT03699566|respiratory functions|respiratory functions
80680|NCT03699553|online intervention|online intervention
80681|NCT03699553|chronic pain|chronic pain
80682|NCT03699553|positive emotion|positive emotion
80683|NCT03699553|affective science|affective science
80684|NCT03699540|simulated driving, outpatient|simulated driving, outpatient
80685|NCT03699527|medical cannabis|medical cannabis
80686|NCT03699514|Brain Network Activation (BNA™)|brain network activation (bna™)
80687|NCT03699514|EEG|eeg
80688|NCT03699514|Cognitive Tasks|cognitive tasks
80689|NCT03699488|technology|technology
80690|NCT03699488|messaging psychotherapy|messaging psychotherapy
80691|NCT03699488|depression|depression
80692|NCT03699488|anxiety|anxiety
80693|NCT03699488|telehealth|telehealth
80694|NCT03699462|Endothelial Glycocalyx (EG)|endothelial glycocalyx (eg)
80695|NCT03699462|5% albumin|5% albumin
80696|NCT03699462|off-pump coronary artery bypass surgery (OPCAB)|off-pump coronary artery bypass surgery (opcab)
80697|NCT03699436|Vascular alterations|vascular alterations
80698|NCT03699436|Galvanic current|galvanic current
80699|NCT03699436|Pain|pain
80700|NCT03699436|Peripheral blow flow|peripheral blow flow
80701|NCT03699436|Temperature|temperature
80702|NCT03699436|Upper limb functionality|upper limb functionality
80703|NCT03699436|Central Sensitization|central sensitization
80704|NCT03699436|Pain catastrophizing.|pain catastrophizing.
80705|NCT03699436|Number of attacks|number of attacks
80706|NCT03699423|myopia control|myopia control
80707|NCT03699423|low concentration atropine eye drops|low concentration atropine eye drops
80708|NCT03699423|anti-muscarinic receptors|anti-muscarinic receptors
80709|NCT03699423|pupil size|pupil size
80710|NCT03699423|accommodative amplitude|accommodative amplitude
80711|NCT03699384|Azacitidine|azacitidine
80712|NCT03699384|Avelumab|avelumab
80713|NCT03699384|18-012|18-012
80714|NCT03699371|early parenteral nutrition|early parenteral nutrition
80715|NCT03699371|supplemental nutrition|supplemental nutrition
80716|NCT03699371|quality of life|quality of life
80717|NCT03699371|oncological surgery|oncological surgery
80718|NCT03699371|critical care|critical care
80719|NCT03699358|hematopoietic stem cell transplantation|hematopoietic stem cell transplantation
80720|NCT03699358|respiratory function test|respiratory function test
80721|NCT03699358|respiratory muscles|respiratory muscles
80722|NCT03699358|muscle strength|muscle strength
80723|NCT03699358|exercise|exercise
80724|NCT03699358|walk test|walk test
80725|NCT03699358|quality of life|quality of life
80726|NCT03699345|CENTERA|centera
80727|NCT03699345|THV|thv
80730|NCT03699332|CRS|crs
80731|NCT03699332|HIPEC|hipec
80732|NCT03699332|Fluorescence|fluorescence
80733|NCT03699332|Antibodies, monoclonal|antibodies, monoclonal
80734|NCT03699319|FOLFIRINOX|folfirinox
80735|NCT03699319|CPI-613|cpi-613
80736|NCT03699280|virtual reality, hysteroscopy, acute pain, distraction technique|virtual reality, hysteroscopy, acute pain, distraction technique
80737|NCT03699254|Lung transplantation|lung transplantation
80738|NCT03699254|Cytomegalovirus infection|cytomegalovirus infection
80739|NCT03699254|Specific immunity|specific immunity
80740|NCT03699228|Bone mineral density, quantitative computed tomography, Osteoporosis, obesity, liver steatosis|bone mineral density, quantitative computed tomography, osteoporosis, obesity, liver steatosis
80742|NCT03699189|type 1 diabetes|type 1 diabetes
80743|NCT03699189|education programme|education programme
80744|NCT03699189|quality of life|quality of life
80745|NCT03699189|dietary freedom|dietary freedom
80746|NCT03699189|patient empowerment|patient empowerment
80747|NCT03699163|Volatile organic compounds|volatile organic compounds
80748|NCT03699163|Mass spectrometry|mass spectrometry
80749|NCT03699163|Early detection|early detection
80750|NCT03699137|Acute coronary syndrome|acute coronary syndrome
80751|NCT03699137|Emergency Medical Services|emergency medical services
80752|NCT03699137|Electrocardiogram|electrocardiogram
80753|NCT03699137|Outcomes|outcomes
80754|NCT03699098|hypothyroidism|hypothyroidism
80755|NCT03699098|radiotherapy|radiotherapy
80756|NCT03699098|head and neck cancer|head and neck cancer
80757|NCT03699085|Opioid Use|opioid use
80758|NCT03699085|Emergency Department|emergency department
80759|NCT03699085|Collaborative Care|collaborative care
80760|NCT03699059|Kidney transplant|kidney transplant
80761|NCT03699059|Weight gain|weight gain
80762|NCT03699059|Physical activity|physical activity
80763|NCT03699059|Weight management|weight management
80764|NCT03699046|Bone Marrow Lesion|bone marrow lesion
80765|NCT03699046|Subchondroplasty|subchondroplasty
80766|NCT03699046|Knee Function|knee function
80767|NCT03699046|Knee Pain|knee pain
80768|NCT03699046|Bone Quality|bone quality
80769|NCT03699046|Bone Micro-architecture|bone micro-architecture
80770|NCT03699033|Radiation|radiation
80771|NCT03699033|NSCLC|nsclc
80772|NCT03699033|Hypofractionated|hypofractionated
80773|NCT03699033|Carboplatin|carboplatin
80774|NCT03699033|Paclitaxel|paclitaxel
80775|NCT03699033|IMRT|imrt
80776|NCT03699033|Fraction|fraction
80777|NCT03699033|Stage III|stage iii
80778|NCT03699033|4D PET/CT|4d pet/ct
80779|NCT03699020|HIV|hiv
80780|NCT03699020|Chronic Pain|chronic pain
400584|NCT01866137|Copeptin|copeptin
80781|NCT03699020|Acceptance and Commitment Therapy|acceptance and commitment therapy
80782|NCT03699020|Behavioral Intervention|behavioral intervention
80783|NCT03699020|Older Adults|older adults
80784|NCT03698981|HIV|hiv
80785|NCT03698981|Stigma|stigma
80786|NCT03698968|surgical complication|surgical complication
80787|NCT03698968|NPWT|npwt
80788|NCT03698968|negative pressure|negative pressure
80789|NCT03698968|knee arthroplasty|knee arthroplasty
80790|NCT03698968|abdominal incision|abdominal incision
80791|NCT03698968|skin graft|skin graft
80792|NCT03698968|infection|infection
80793|NCT03698968|dehisced|dehisced
80794|NCT03698955|Plant-based diet|plant-based diet
80795|NCT03698955|Mediterranean diet|mediterranean diet
80796|NCT03698955|Vegan diet|vegan diet
80797|NCT03698955|Metabolism|metabolism
80798|NCT03698955|Insulin sensitivity|insulin sensitivity
80799|NCT03698955|Cholesterol|cholesterol
80800|NCT03698955|Advanced glycation end-products|advanced glycation end-products
80801|NCT03698942|Breast Screening|breast screening
80802|NCT03698942|Breast Imaging|breast imaging
80803|NCT03698942|SoftVue|softvue
80804|NCT03698942|Mammography|mammography
80805|NCT03698942|Ultrasound|ultrasound
80806|NCT03698942|Reader Study|reader study
80807|NCT03698942|ROC AUC|roc auc
80808|NCT03698942|Breast Cancer Detection|breast cancer detection
80809|NCT03698942|Dense Breasts|dense breasts
80810|NCT03698942|Breast Density|breast density
80811|NCT03698942|Dense Breast Tissue|dense breast tissue
80812|NCT03698942|Dense Breast Parenchyma|dense breast parenchyma
80813|NCT03698929|dietary cholesterol|dietary cholesterol
80814|NCT03698929|cholesterol|cholesterol
80815|NCT03698929|nutrition|nutrition
80816|NCT03698929|egg yolks|egg yolks
80817|NCT03698929|eggs|eggs
80818|NCT03698903|Intervention|intervention
80819|NCT03698903|Sedentary Behavior|sedentary behavior
80820|NCT03698903|Overweight or obese adults|overweight or obese adults
80821|NCT03698890|Hypertension|hypertension
80822|NCT03698890|Telehealth|telehealth
80823|NCT03698890|Primary care|primary care
80824|NCT03698890|Teamlet|teamlet
80825|NCT03698851|Peri-Implantitis lesion|peri-implantitis lesion
80826|NCT03698851|Dental Implants|dental implants
80827|NCT03698812|Ulcerative Colitis|ulcerative colitis
80828|NCT03698812|Mucosal Healing|mucosal healing
80829|NCT03698812|Histological Remission|histological remission
81034|NCT03697421|couples|couples
80830|NCT03698812|Prospective Study|prospective study
80831|NCT03698799|Adherence|adherence
80832|NCT03698799|Intensive Care Unit|intensive care unit
80833|NCT03698799|Lung Protective Strategy|lung protective strategy
80834|NCT03698799|Mechanical Ventilation|mechanical ventilation
80835|NCT03698799|Perioperative Critical Care|perioperative critical care
80836|NCT03698799|Surgical|surgical
80837|NCT03698721|Tissue engineering|tissue engineering
80838|NCT03698721|Collagen scaffold|collagen scaffold
80839|NCT03698721|Alginate scaffold|alginate scaffold
80840|NCT03698721|Urothelial cells|urothelial cells
80841|NCT03698669|Depression|depression
80842|NCT03698669|Pain|pain
80843|NCT03698669|Cognitive behavioral therapy (CBT)|cognitive behavioral therapy (cbt)
80844|NCT03698669|Buprenorphine|buprenorphine
80845|NCT03698669|Behavioral health specialist (BHS)|behavioral health specialist (bhs)
80846|NCT03698669|Primary care provider (PCP)|primary care provider (pcp)
80847|NCT03698656|Spiritual dimension|spiritual dimension
80848|NCT03698656|Hematologic cancer|hematologic cancer
80849|NCT03698656|Acute leukemia|acute leukemia
80850|NCT03698656|Lymphoma|lymphoma
80851|NCT03698656|Nurse interview|nurse interview
80852|NCT03698656|Quality of life|quality of life
80853|NCT03698630|Asthma|asthma
80854|NCT03698630|Pediatric|pediatric
80855|NCT03698630|Corticosteroid|corticosteroid
80856|NCT03698630|Emergency department|emergency department
80857|NCT03698565|Pain Postoperative|pain postoperative
80858|NCT03698565|Tonsillectomy|tonsillectomy
80859|NCT03698565|Analgesia Nociception Index|analgesia nociception index
80860|NCT03698565|Pupillary Index Pain|pupillary index pain
80861|NCT03698539|Stuttering|stuttering
80862|NCT03698539|Down syndrome|down syndrome
80863|NCT03698539|Gestures|gestures
80864|NCT03698500|Ulcerative Colitis|ulcerative colitis
80865|NCT03698500|Crohn`s disease|crohn`s disease
80866|NCT03698500|miRNA|mirna
80867|NCT03698448|Oligosaccharide|oligosaccharide
80868|NCT03698435|ganciclovir|ganciclovir
80869|NCT03698435|valganciclovir|valganciclovir
80870|NCT03698435|therapeutic drug monitoring|therapeutic drug monitoring
80871|NCT03698435|pharmacokinetics|pharmacokinetics
80872|NCT03698409|Migraine|migraine
80873|NCT03698409|Onabotulinumtoxin A|onabotulinumtoxin a
80874|NCT03698409|Botox|botox
80875|NCT03698409|Reconstitution|reconstitution
80876|NCT03698409|Saline|saline
80877|NCT03698383|Herzuma|herzuma
80878|NCT03698383|Gedatolisib|gedatolisib
80879|NCT03698357|interactive video balance-based exercise|interactive video balance-based exercise
80880|NCT03698357|conventional physiotherapy|conventional physiotherapy
80881|NCT03698344|air pollution|air pollution
80882|NCT03698344|microneurography|microneurography
80883|NCT03698344|MNSA|mnsa
80884|NCT03698344|Biodiesel|biodiesel
80885|NCT03698344|RME|rme
80886|NCT03698318|Ginger|ginger
80887|NCT03698318|Pharmacokinetics|pharmacokinetics
80888|NCT03698318|Shogaols|shogaols
80889|NCT03698318|Gingerols|gingerols
80890|NCT03698318|Bioavailability|bioavailability
80891|NCT03698305|Tolerability|tolerability
80892|NCT03698305|Pharmacokinetics|pharmacokinetics
80893|NCT03698305|Safety|safety
80894|NCT03698305|ASP5354|asp5354
80895|NCT03698266|Needle Knife Fistulotomy|needle knife fistulotomy
80896|NCT03698266|Sphincterotomy|sphincterotomy
80897|NCT03698266|Post-ERCP pancreatitis|post-ercp pancreatitis
80898|NCT03698253|EGFR|egfr
80899|NCT03698253|KRAS|kras
80900|NCT03698253|tumor sideness|tumor sideness
80901|NCT03698253|FOLFIRI|folfiri
80902|NCT03698253|regorafenib|regorafenib
80903|NCT03698253|metastatic colorectal cancer|metastatic colorectal cancer
80904|NCT03698240|Mindfulness|mindfulness
80905|NCT03698240|ADHD|adhd
80906|NCT03698240|Oppositional Defiant Disorder|oppositional defiant disorder
80907|NCT03698227|Soft tissue sarcoma|soft tissue sarcoma
80908|NCT03698214|systolic blood pressure|systolic blood pressure
80909|NCT03698214|reversed shock index|reversed shock index
80910|NCT03698214|traumatic brain injury|traumatic brain injury
80911|NCT03698214|mortality|mortality
80912|NCT03698175|Emotion|emotion
80913|NCT03698175|Cognition|cognition
80914|NCT03698175|Positive psychology|positive psychology
80915|NCT03698136|tetraplegia|tetraplegia
80916|NCT03698136|denervated muscles|denervated muscles
80917|NCT03698136|electrical stimulation|electrical stimulation
80918|NCT03698123|Nutrition|nutrition
80919|NCT03698123|Physician well-being|physician well-being
80920|NCT03698123|Cognitive performance|cognitive performance
80921|NCT03698123|Sleepiness|sleepiness
80922|NCT03698123|Shift-work|shift-work
80923|NCT03698097|quality management|quality management
80924|NCT03698097|paper questionnaires|paper questionnaires
80925|NCT03698097|satisfaction surveys|satisfaction surveys
80926|NCT03698097|survey technique|survey technique
80927|NCT03698097|online questionnaires|online questionnaires
80928|NCT03698071|ANCA associated vasculitis|anca associated vasculitis
80929|NCT03698071|Granulomatosis with polyangiitis|granulomatosis with polyangiitis
80930|NCT03698071|microscopic polyangiitis|microscopic polyangiitis
81035|NCT03697421|marriage|marriage
80931|NCT03698071|eosinophilic granulomatosis with polyangiitis|eosinophilic granulomatosis with polyangiitis
80932|NCT03698071|soluble-CD95-Ligand|soluble-cd95-ligand
80933|NCT03698058|Nutrition|nutrition
80934|NCT03698058|Toddlers|toddlers
80935|NCT03698058|A2|a2
80936|NCT03698058|B-casein|b-casein
80937|NCT03698058|Gut comfort|gut comfort
80938|NCT03698058|Growing up milk|growing up milk
80939|NCT03698045|PRO-143|pro-143
80940|NCT03698045|Topical antibiotic|topical antibiotic
80941|NCT03698045|Ophthalmic antibiotic|ophthalmic antibiotic
80942|NCT03698045|External bacterial infections|external bacterial infections
80943|NCT03697993|Fosfomycin|fosfomycin
80944|NCT03697993|levofloxacin|levofloxacin
80945|NCT03697993|Open-label|open-label
80946|NCT03697993|Phase IV|phase iv
80947|NCT03697993|UTI|uti
80948|NCT03697967|Delayed cord clamping|delayed cord clamping
80949|NCT03697928|Acetylcarnitine kinetic|acetylcarnitine kinetic
80950|NCT03697928|Phosphocreatine (PCr) kinetic|phosphocreatine (pcr) kinetic
80951|NCT03697915|Lift system|lift system
80952|NCT03697915|Early mobilization|early mobilization
80953|NCT03697915|Immobilization|immobilization
80954|NCT03697902|Cisterna magna length|cisterna magna length
80955|NCT03697902|ultrasound|ultrasound
80956|NCT03697889|Bioequivalence|bioequivalence
80957|NCT03697876|PRO-165|pro-165
80958|NCT03697876|sodium hyaluronate|sodium hyaluronate
80959|NCT03697876|Chondroitin sulfate 0.18%|chondroitin sulfate 0.18%
80960|NCT03697863|Neurally Adjusted Ventilatory Assist|neurally adjusted ventilatory assist
80961|NCT03697824|HLA-A2+|hla-a2+
80962|NCT03697824|Synovial Sarcoma|synovial sarcoma
80963|NCT03697824|pembrolizumab|pembrolizumab
80964|NCT03697824|NY-ESO-1|ny-eso-1
80965|NCT03697824|GSK3377794|gsk3377794
80966|NCT03697824|LAGE-1a|lage-1a
80967|NCT03697785|weaning|weaning
80968|NCT03697785|cardiothoracic|cardiothoracic
80969|NCT03697785|mechanical ventilation|mechanical ventilation
80970|NCT03697785|intensive care|intensive care
80971|NCT03697785|critical care|critical care
80972|NCT03697785|beacon caresystem|beacon caresystem
80973|NCT03697772|continuity of care|continuity of care
80974|NCT03697772|primary care|primary care
80975|NCT03697772|multimorbidity|multimorbidity
80976|NCT03697772|quality of life|quality of life
80977|NCT03697759|Digital Decision Support System|digital decision support system
80978|NCT03697759|App|app
80979|NCT03697759|Self-management|self-management
80980|NCT03697720|cross-organ sensitivity|cross-organ sensitivity
80981|NCT03697720|bladder pain|bladder pain
80982|NCT03697720|NSAID|nsaid
80983|NCT03697720|visceral pain|visceral pain
80984|NCT03697707|AML in CR1 or CRi|aml in cr1 or cri
80985|NCT03697707|DCOne|dcone
80986|NCT03697707|DCP-001|dcp-001
80987|NCT03697707|Minimal Residual Disease|minimal residual disease
80988|NCT03697668|Imatinib Mesylate|imatinib mesylate
80989|NCT03697668|piperaquine phosphate|piperaquine phosphate
80990|NCT03697668|dihydroartemisinin|dihydroartemisinin
80991|NCT03697629|Multiple Myeloma|multiple myeloma
80992|NCT03697629|Relapse|relapse
80993|NCT03697629|Refractory|refractory
80994|NCT03697629|Daratumumab|daratumumab
80995|NCT03697629|Accelerated Infusion|accelerated infusion
80996|NCT03697577|cyclin-dependent kinase (CDK) 4/6 inhibitors|cyclin-dependent kinase (cdk) 4/6 inhibitors
80997|NCT03697577|Body composition|body composition
80998|NCT03697577|body fat mass|body fat mass
80999|NCT03697577|metastatic ER+/HER2- breast cancer|metastatic er+/her2- breast cancer
81000|NCT03697564|Pancreating Cancer|pancreating cancer
81001|NCT03697564|Cancer|cancer
81002|NCT03697564|Stage IV|stage iv
81003|NCT03697564|gemcitabine|gemcitabine
81004|NCT03697564|nivolumab|nivolumab
81005|NCT03697564|cabiralizumab|cabiralizumab
81006|NCT03697564|BMS-986227|bms-986227
81007|NCT03697564|FPA008|fpa008
81008|NCT03697564|GemCaN|gemcan
81009|NCT03697564|Stand Up to Cancer|stand up to cancer
81010|NCT03697525|repetitive muscle vibration (rMV)|repetitive muscle vibration (rmv)
81011|NCT03697525|acute stroke|acute stroke
81012|NCT03697525|motor recovery|motor recovery
81013|NCT03697525|nonpharmacological therapy|nonpharmacological therapy
81014|NCT03697525|bedside intervention|bedside intervention
81015|NCT03697499|ozone exposure|ozone exposure
81016|NCT03697499|fish oil|fish oil
81017|NCT03697499|2*2 factorial design|2*2 factorial design
81018|NCT03697486|PYY|pyy
81019|NCT03697486|ghrelin|ghrelin
81020|NCT03697486|ad libitum intake|ad libitum intake
81021|NCT03697486|high protein diet|high protein diet
81022|NCT03697486|moderately protein diet|moderately protein diet
81023|NCT03697486|low protein diet|low protein diet
81024|NCT03697486|breakfast|breakfast
81025|NCT03697486|obesity|obesity
81026|NCT03697473|Hamstring strength|hamstring strength
81027|NCT03697473|Isokinetics|isokinetics
81028|NCT03697473|Nordic hamstring exercise|nordic hamstring exercise
81029|NCT03697473|Eccentric strength|eccentric strength
81030|NCT03697473|Hip extension exercise|hip extension exercise
81031|NCT03697421|parenting|parenting
81032|NCT03697421|relationships|relationships
81033|NCT03697421|relationship education|relationship education
81036|NCT03697330|liberal, restrictive, fluid, RIFLE|liberal, restrictive, fluid, rifle
81037|NCT03697291|Self invented iECG wire|self invented iecg wire
81038|NCT03697291|PS wire|ps wire
81039|NCT03697291|Certodyn|certodyn
81040|NCT03697291|intracavitary ECG|intracavitary ecg
81041|NCT03697291|PICC line|picc line
81042|NCT03697291|giant P wave|giant p wave
81043|NCT03697278|pain|pain
81044|NCT03697278|postoperative|postoperative
81045|NCT03697252|Schizophrenia|schizophrenia
81046|NCT03697239|metastatic pancreatic cancer|metastatic pancreatic cancer
81047|NCT03697239|cancer|cancer
81048|NCT03697239|pancreatic|pancreatic
81049|NCT03697239|Vitamin C|vitamin c
81050|NCT03697239|Ascorbic Acid|ascorbic acid
81051|NCT03697239|Nanoparticle Paclitaxel Protein Bound|nanoparticle paclitaxel protein bound
81052|NCT03697239|cisplatin|cisplatin
81053|NCT03697239|gemcitabine|gemcitabine
81054|NCT03697239|pancreas|pancreas
81055|NCT03697213|Surprise Question|surprise question
81056|NCT03697213|Prognostication|prognostication
81057|NCT03697200|Breast Cancer Survivors|breast cancer survivors
81058|NCT03697200|Aromatase Inhibitor|aromatase inhibitor
81059|NCT03697200|Ecological Momentary Assessment|ecological momentary assessment
81060|NCT03697200|Musculoskeletal Symptoms|musculoskeletal symptoms
81061|NCT03697187|Hereditary Angioedema|hereditary angioedema
81062|NCT03697187|HAE|hae
81063|NCT03697187|Ruconest|ruconest
81064|NCT03697187|rhC1INH|rhc1inh
81065|NCT03697187|Registry|registry
81066|NCT03697187|Pharming|pharming
81067|NCT03697122|Cardiopulmonary bypass|cardiopulmonary bypass
81068|NCT03697122|Afterdrop|afterdrop
81069|NCT03697122|Deep Hypothermic Circulatory Arrest|deep hypothermic circulatory arrest
81070|NCT03697122|Heated Humidified Breathing Circuit|heated humidified breathing circuit
81071|NCT03697109|Cushing syndrome|cushing syndrome
81072|NCT03697109|Cushing disease|cushing disease
81073|NCT03697109|Hypercortisolemia|hypercortisolemia
81074|NCT03697109|Cushingoid|cushingoid
81075|NCT03697109|Type 2 Diabetes|type 2 diabetes
81076|NCT03697109|Impaired Glucose Intolerance|impaired glucose intolerance
81077|NCT03697109|Hypertension|hypertension
81078|NCT03697109|Adrenocorticotropic hormone|adrenocorticotropic hormone
81079|NCT03697109|Primary Pigmented Nodular Adrenal Disease|primary pigmented nodular adrenal disease
81080|NCT03697109|Moon Facies|moon facies
81081|NCT03697109|Dorsocervical Fat Pad|dorsocervical fat pad
81082|NCT03697109|Adrenal Adenoma|adrenal adenoma
81083|NCT03697109|Adrenal Autonomy|adrenal autonomy
81084|NCT03697109|Cortisol|cortisol
81085|NCT03697109|Cushing|cushing
81086|NCT03697096|UTI|uti
81087|NCT03697096|CPOE|cpoe
81088|NCT03697096|Empiric Therapy|empiric therapy
81089|NCT03697070|PNA|pna
81090|NCT03697070|CPOE|cpoe
81091|NCT03697070|Empiric Therapy|empiric therapy
81092|NCT03697057|postoperative recovery|postoperative recovery
81093|NCT03697057|psychomotor function|psychomotor function
81094|NCT03697057|measurement|measurement
81095|NCT03696992|colonoscopy|colonoscopy
81096|NCT03696966|weight management|weight management
81097|NCT03696966|obesity|obesity
81098|NCT03696966|very-low calorie diet|very-low calorie diet
81099|NCT03696966|intermittent diet|intermittent diet
81100|NCT03696953|Probiotics|probiotics
81101|NCT03696953|Pregnancy|pregnancy
81102|NCT03696953|Group B Streptococcus|group b streptococcus
81103|NCT03696953|Gastrointestinal symptoms|gastrointestinal symptoms
81104|NCT03696914|eosinophil|eosinophil
81105|NCT03696914|phenotype|phenotype
81106|NCT03696914|cluster|cluster
81107|NCT03696914|asthma severity|asthma severity
81108|NCT03696901|Dalbavancine|dalbavancine
81109|NCT03696901|Xydalba|xydalba
81110|NCT03696888|Randomized Controlled Trial|randomized controlled trial
81111|NCT03696888|Internet|internet
81112|NCT03696888|Mobile phone|mobile phone
81113|NCT03696888|Smartphone|smartphone
81114|NCT03696888|App|app
81115|NCT03696888|Alcohol|alcohol
81116|NCT03696888|Substance use|substance use
81117|NCT03696875|Discharge Planning|discharge planning
81118|NCT03696875|Emergency Department|emergency department
81119|NCT03696875|Heart failure|heart failure
81120|NCT03696875|Older|older
81121|NCT03696875|Frail|frail
81122|NCT03696797|Iron Reduction|iron reduction
81123|NCT03696797|Phlebotomy|phlebotomy
81124|NCT03696784|CAR T cells|car t cells
81125|NCT03696784|CD19|cd19
81126|NCT03696784|Lymphoma|lymphoma
81127|NCT03696784|AP1903|ap1903
81128|NCT03696784|Cytokine Release Syndrome|cytokine release syndrome
81129|NCT03696784|Neurotoxicity|neurotoxicity
81130|NCT03696771|Phase I, NJH395, HER2+, ISAC, TLR7|phase i, njh395, her2+, isac, tlr7
81131|NCT03696758|premature adults|premature adults
81132|NCT03696758|premature|premature
81133|NCT03696758|premature cardiac function|premature cardiac function
81134|NCT03696758|MRI|mri
81135|NCT03696758|sildenafil|sildenafil
81136|NCT03696758|metoprolol|metoprolol
81137|NCT03696758|CMR|cmr
81138|NCT03696745|Autologous Umbilical Cord Blood Stem Cells|autologous umbilical cord blood stem cells
81139|NCT03696745|Safety|safety
81140|NCT03696745|Effect|effect
81143|NCT03696680|brain metastases|brain metastases
81144|NCT03696680|FSRT|fsrt
81145|NCT03696680|Stereotactic radiation therapy|stereotactic radiation therapy
81146|NCT03696628|Cardiomyocytes|cardiomyocytes
81147|NCT03696628|Induced pluripotent stem cells|induced pluripotent stem cells
81148|NCT03696628|Genetic cardiomyopathy|genetic cardiomyopathy
81149|NCT03696615|high-intensity|high-intensity
81150|NCT03696602|airway smooth muscle, asthma, bronchial test, lung function|airway smooth muscle, asthma, bronchial test, lung function
81151|NCT03696563|prehospital|prehospital
81152|NCT03696563|oxygen therapy|oxygen therapy
81153|NCT03696563|automation|automation
81154|NCT03696563|trauma|trauma
81155|NCT03696563|COPD|copd
81156|NCT03696537|Radiation|radiation
81157|NCT03696537|Total Marrow Irradiation|total marrow irradiation
81158|NCT03696537|Fludarabine|fludarabine
81159|NCT03696537|Human Leukocyte Antigen donor|human leukocyte antigen donor
81160|NCT03696524|congestive heart failure|congestive heart failure
81161|NCT03696524|pleural effusion|pleural effusion
81162|NCT03696524|shortness of breath|shortness of breath
81163|NCT03696524|tunneled pleural catheter|tunneled pleural catheter
81164|NCT03696524|thoracentesis|thoracentesis
81165|NCT03696511|Miniscrew|miniscrew
81166|NCT03696498|Partial excavation|partial excavation
81167|NCT03696498|Deep dentin caries|deep dentin caries
81169|NCT03696485|Secondary Progressive Multiple Sclerosis (SPMS), safety|secondary progressive multiple sclerosis (spms), safety
81170|NCT03696446|Cardiac Rehabilitation|cardiac rehabilitation
81171|NCT03696446|Patient Activation|patient activation
81172|NCT03696433|salt sensitive, blood pressure, obesity, magnetic resonance imaging|salt sensitive, blood pressure, obesity, magnetic resonance imaging
81173|NCT03696420|Probabilistic targeting|probabilistic targeting
81174|NCT03696420|VIM-DBS|vim-dbs
81175|NCT03696420|Machine-learning|machine-learning
81176|NCT03696420|Essential Tremor|essential tremor
81177|NCT03696381|computerized cognitive rehabilitation|computerized cognitive rehabilitation
81178|NCT03696381|trns|trns
81179|NCT03696381|traumatic brain injury|traumatic brain injury
81180|NCT03696381|tbi|tbi
81181|NCT03696381|cognitive impairment|cognitive impairment
81182|NCT03696355|Anaplastic Astrocytoma|anaplastic astrocytoma
81183|NCT03696355|Atypical Brainstem Glioma|atypical brainstem glioma
81184|NCT03696355|Brain Cancer|brain cancer
81185|NCT03696355|Brain Stem Glioma|brain stem glioma
81186|NCT03696355|Brain Tumors in Children|brain tumors in children
81187|NCT03696355|Diffuse Intrinsic Pontine Glioma|diffuse intrinsic pontine glioma
81188|NCT03696355|Diffuse Midline Glioma|diffuse midline glioma
81189|NCT03696355|Glioblastoma|glioblastoma
81190|NCT03696355|H3 K27M mutant|h3 k27m mutant
81191|NCT03696355|Newly Diagnosed|newly diagnosed
81192|NCT03696355|Non-brainstem Midline Glioma|non-brainstem midline glioma
81193|NCT03696355|Pediatric Brain Tumor|pediatric brain tumor
81194|NCT03696355|Radiation Therapy|radiation therapy
81195|NCT03696355|St. Jude Brain Tumor Studies|st. jude brain tumor studies
81196|NCT03696355|St. Jude Studies|st. jude studies
81197|NCT03696355|St. Jude Treatment|st. jude treatment
81198|NCT03696342|pazufloxacin|pazufloxacin
81199|NCT03696342|PRO-157|pro-157
81200|NCT03696342|Fluoroquinolones|fluoroquinolones
81201|NCT03696303|Streptococcus pneumoniae|streptococcus pneumoniae
81202|NCT03696303|Pneumonia|pneumonia
81203|NCT03696303|Community-acquired|community-acquired
81204|NCT03696303|Pediatric|pediatric
81205|NCT03696303|Urine antigen|urine antigen
81206|NCT03696290|Bronchiectasis|bronchiectasis
81207|NCT03696277|Stereotactic, Radiotherapy,|stereotactic, radiotherapy,
81208|NCT03696264|Protein Requirements|protein requirements
81209|NCT03696225|PTSD|ptsd
81210|NCT03696225|Cognitive Function|cognitive function
81211|NCT03696186|Metastatic Castration-resistant Prostate Cancer|metastatic castration-resistant prostate cancer
81212|NCT03696186|Cancer Subtype|cancer subtype
81213|NCT03696186|Chemotherapy|chemotherapy
81214|NCT03696186|Target Therapy|target therapy
81215|NCT03696121|intracerebral haemorrhage|intracerebral haemorrhage
81216|NCT03696095|total knee arthroplasty|total knee arthroplasty
81217|NCT03696095|postoperative pain|postoperative pain
81218|NCT03696095|programmed intermittent bolus|programmed intermittent bolus
81219|NCT03696095|Continuous femoral nerve block|continuous femoral nerve block
81220|NCT03696043|intracranial pressure|intracranial pressure
81221|NCT03696043|external ventricular drain|external ventricular drain
81222|NCT03696043|cerebrospinal fluid|cerebrospinal fluid
81225|NCT03695939|xenograft, allograft, burns, severe burns, temporary coverage, porcine.|xenograft, allograft, burns, severe burns, temporary coverage, porcine.
81226|NCT03695926|HV|hv
81227|NCT03695913|Pre-diabetes, low carbohydrate diet|pre-diabetes, low carbohydrate diet
81228|NCT03695887|burns, pain, dressing change, nitrous oxide|burns, pain, dressing change, nitrous oxide
81229|NCT03695861|Endocarditis Infectious|endocarditis infectious
81230|NCT03695861|Native valve|native valve
81231|NCT03695861|ESC 2015 modified diagnostic criteria|esc 2015 modified diagnostic criteria
81232|NCT03695861|18F-FDG PET-CT|18f-fdg pet-ct
81233|NCT03695861|Detection of peripheral emboli|detection of peripheral emboli
81234|NCT03695848|Cervical Myelopathy，Prognostication，Diffusion Tensor Imaging, fMRI|cervical myelopathy，prognostication，diffusion tensor imaging, fmri
81235|NCT03695835|prostate cancer|prostate cancer
81236|NCT03695835|lung cancer|lung cancer
81237|NCT03695835|pancreatic cancer|pancreatic cancer
81238|NCT03695835|colorectal cancer|colorectal cancer
81239|NCT03695835|bladder cancer|bladder cancer
81240|NCT03695796|patients with a NAFLD proven by liver biopsy|patients with a nafld proven by liver biopsy
81241|NCT03695757|Immunoglobulin G|immunoglobulin g
81242|NCT03695757|Treatment|treatment
81243|NCT03695757|Immunostimulatory effect|immunostimulatory effect
81244|NCT03695757|Tumor|tumor
81245|NCT03695757|Solid tumor|solid tumor
81246|NCT03695744|Myeloma|myeloma
81247|NCT03695744|Daratumumab|daratumumab
81248|NCT03695744|Non-Transplant Eligible|non-transplant eligible
81249|NCT03695731|diabetes|diabetes
81250|NCT03695731|brown adipose tissue|brown adipose tissue
81251|NCT03695731|energy expenditure|energy expenditure
81252|NCT03695731|glycemic control|glycemic control
81253|NCT03695731|neuropathy|neuropathy
81254|NCT03695731|18F-FDG PET-RMI|18f-fdg pet-rmi
81255|NCT03695705|Norfloxacin,Rifaximin,Prophylaxis|norfloxacin,rifaximin,prophylaxis
81256|NCT03695679|computer-assisted instruction/methods|computer-assisted instruction/methods
81257|NCT03695679|safe sex|safe sex
81258|NCT03695679|students|students
81259|NCT03695679|universities|universities
81260|NCT03695653|Drinking|drinking
81261|NCT03695653|Alcohol Problems|alcohol problems
81262|NCT03695653|Moderation-Oriented Treatment|moderation-oriented treatment
81263|NCT03695653|Controlled Drinking|controlled drinking
81264|NCT03695653|Reduced Drinking|reduced drinking
81265|NCT03695653|Problem Drinking|problem drinking
81266|NCT03695653|Text Message|text message
81267|NCT03695653|Mobile Phone|mobile phone
81268|NCT03695653|Technology|technology
81269|NCT03695640|total knee arthroplasty|total knee arthroplasty
81270|NCT03695640|postoperative pain|postoperative pain
81271|NCT03695640|continuous femoral nerve block|continuous femoral nerve block
81272|NCT03695640|magnesium sulphate|magnesium sulphate
81273|NCT03695627|Stress, health, meditation, mindfulness, employees, job strain, burnout, work, help, mood, affect|stress, health, meditation, mindfulness, employees, job strain, burnout, work, help, mood, affect
81274|NCT03695588|pain relief|pain relief
81275|NCT03695588|Caesarean|caesarean
81276|NCT03695588|Cesarean|cesarean
81277|NCT03695588|c-section|c-section
81278|NCT03695588|intrathecal morphine|intrathecal morphine
81279|NCT03695588|analgesia|analgesia
81281|NCT03695588|QL|ql
81282|NCT03695588|QLB2|qlb2
81283|NCT03695588|QL2|ql2
81284|NCT03695575|Bone Conduction|bone conduction
81285|NCT03695575|Assistive Listening Devices|assistive listening devices
81286|NCT03695575|Listening Effort|listening effort
81287|NCT03695575|Speech in Noise|speech in noise
81288|NCT03695562|vitamin D|vitamin d
81289|NCT03695562|implant stability|implant stability
81290|NCT03695562|sequential drilling|sequential drilling
81291|NCT03695562|single drilling|single drilling
81292|NCT03695549|advanced platelet rich fibrin,A-PRF|advanced platelet rich fibrin,a-prf
81293|NCT03695523|Physical activity|physical activity
81294|NCT03695523|Children|children
81295|NCT03695523|Child care|child care
81296|NCT03695523|Policy|policy
81297|NCT03695523|Accelerometer|accelerometer
81298|NCT03695510|head and neck cancer,Immunotherapy|head and neck cancer,immunotherapy
81299|NCT03695497|Arthroplasty, Replacement, Hip|arthroplasty, replacement, hip
81300|NCT03695497|Orthopedic procedures|orthopedic procedures
81301|NCT03695484|Paroxysmal Atrial Fibrillation|paroxysmal atrial fibrillation
81302|NCT03695484|Catheter Ablation|catheter ablation
81303|NCT03695484|Cryoballoon|cryoballoon
81304|NCT03695484|Radiofrequency ablation|radiofrequency ablation
81305|NCT03695484|Remote Magnetic Navigation|remote magnetic navigation
81306|NCT03695458|phototherapy|phototherapy
81307|NCT03695458|systemic effect|systemic effect
81308|NCT03695458|recovery|recovery
81309|NCT03695458|performance|performance
81310|NCT03695458|photobiomodulation|photobiomodulation
81311|NCT03695432|Influenza|influenza
81312|NCT03695432|Vaccine|vaccine
81313|NCT03695432|Probiotic|probiotic
81314|NCT03695432|Influenza-like Illness|influenza-like illness
81315|NCT03695393|Injection drug use|injection drug use
81316|NCT03695393|Stigma|stigma
81317|NCT03695393|HIV|hiv
81318|NCT03695367|inguinal hernia|inguinal hernia
81319|NCT03695367|hernia|hernia
81320|NCT03695367|hernia surgery|hernia surgery
81321|NCT03695367|postoperative pain|postoperative pain
81322|NCT03695367|herniorrhaphy|herniorrhaphy
81323|NCT03695354|sarcopenia|sarcopenia
81324|NCT03695354|vibration|vibration
81325|NCT03695354|gait|gait
81326|NCT03695354|muscle|muscle
81327|NCT03695354|rehabilitation|rehabilitation
81328|NCT03695341|Endocrine Therapy|endocrine therapy
81329|NCT03695341|Fulvestrant|fulvestrant
81330|NCT03695341|Everolimus|everolimus
81331|NCT03695315|Obstructive Sleep Apnea|obstructive sleep apnea
81333|NCT03695315|Insulin Resistance|insulin resistance
81334|NCT03695302|knowledge/attitude/practice/questionnaire/post-exposure|knowledge/attitude/practice/questionnaire/post-exposure
81335|NCT03695289|Antipsychotics|antipsychotics
81336|NCT03695276|Health coaching|health coaching
81337|NCT03695276|COPD|copd
81338|NCT03695276|Asthma|asthma
81339|NCT03695276|Access to specialty care|access to specialty care
81340|NCT03695237|Central Precocious Puberty (CPP)|central precocious puberty (cpp)
81341|NCT03695237|Leuprolide Acetate (LA)|leuprolide acetate (la)
81342|NCT03695224|Topological perception|topological perception
81343|NCT03695224|Glaucoma|glaucoma
81344|NCT03695211|great auricular nerve|great auricular nerve
81345|NCT03695211|sternocleidomastoid muscle|sternocleidomastoid muscle
81346|NCT03695211|ultrasound guidance|ultrasound guidance
81347|NCT03695185|Ulcerative Colitis (UC)|ulcerative colitis (uc)
81348|NCT03695185|ABBV-323|abbv-323
81349|NCT03695159|anti-thrombotic drugs|anti-thrombotic drugs
81350|NCT03695159|cardiac intervention|cardiac intervention
81351|NCT03695159|Non-cardiac intervention|non-cardiac intervention
81352|NCT03695146|High blood pressure|high blood pressure
81354|NCT03695133|loneliness|loneliness
81355|NCT03695133|elderly|elderly
81356|NCT03695133|integrative nursing|integrative nursing
81357|NCT03695133|omaha system|omaha system
81358|NCT03695120|ACEI (Angiotensin-Converting-Enzyme Inhibitor)|acei (angiotensin-converting-enzyme inhibitor)
81359|NCT03695120|ARB (Angiotensin II Receptor Blocker)|arb (angiotensin ii receptor blocker)
81360|NCT03695120|CHF (Congestive Heart Failure)|chf (congestive heart failure)
81361|NCT03695120|RAAS (Renin Angiotensin Aldosterone System)|raas (renin angiotensin aldosterone system)
81362|NCT03695094|Epilepsy|epilepsy
81363|NCT03695094|Phase 1|phase 1
81364|NCT03695094|padsevonil|padsevonil
81365|NCT03695081|Medicine review|medicine review
81366|NCT03695081|Patient handoff|patient handoff
81367|NCT03695081|Patient hand over|patient hand over
81368|NCT03695081|Intertrochanteric fractures|intertrochanteric fractures
81369|NCT03695081|Trochanteric fractures|trochanteric fractures
81370|NCT03695081|Subtrochanteric fractures|subtrochanteric fractures
81371|NCT03695081|Hospital readmission|hospital readmission
81372|NCT03695081|Hospital readmissions|hospital readmissions
81373|NCT03695081|Injuries, Hip|injuries, hip
81374|NCT03695081|Hospitalization|hospitalization
81375|NCT03695081|Hospitalisation|hospitalisation
81376|NCT03695081|Hip|hip
81377|NCT03695081|Fracture|fracture
81378|NCT03695081|Femoral fractures|femoral fractures
81379|NCT03695081|Femoral neck fractures|femoral neck fractures
81380|NCT03695081|Medication errors|medication errors
81381|NCT03695081|Medication review|medication review
81382|NCT03695081|Medication reconciliation|medication reconciliation
81383|NCT03695068|Learning Disabilities|learning disabilities
81384|NCT03695068|Dyslexia|dyslexia
81385|NCT03695068|Reading|reading
81386|NCT03695003|Sage|sage
81387|NCT03695003|Terpene|terpene
81388|NCT03695003|Polyphenol|polyphenol
81389|NCT03695003|Cognition|cognition
81390|NCT03695003|Mood|mood
81391|NCT03694977|Gastric Cancer|gastric cancer
81392|NCT03694964|Pulmonary Disease, Chronic Obstructive|pulmonary disease, chronic obstructive
81393|NCT03694964|Sarcopenia|sarcopenia
81394|NCT03694964|Citrulline|citrulline
81395|NCT03694964|Body composition|body composition
81396|NCT03694964|Denutrition|denutrition
81397|NCT03694951|Sedentary Behaviour|sedentary behaviour
81398|NCT03694951|Subjective Well-Being|subjective well-being
81399|NCT03694951|University Students|university students
81400|NCT03694938|Brain metastasis|brain metastasis
81401|NCT03694938|Magnetic resonance imaging|magnetic resonance imaging
81402|NCT03694912|renal cell cancer|renal cell cancer
81403|NCT03694912|high risk group|high risk group
81404|NCT03694912|bio-marker|bio-marker
81405|NCT03694860|crush induction, RSI|crush induction, rsi
81406|NCT03694847|asthma|asthma
81407|NCT03694847|chronic rhinosinusitis|chronic rhinosinusitis
81408|NCT03694847|nasal polyposis|nasal polyposis
81409|NCT03694834|Endometrial Cancer|endometrial cancer
81410|NCT03694834|Uterus|uterus
81411|NCT03694834|Endometrioid|endometrioid
81412|NCT03694821|Osteoarthritis|osteoarthritis
81413|NCT03694821|Knee|knee
81414|NCT03694821|Injection|injection
81415|NCT03694821|Ketorolac|ketorolac
81416|NCT03694808|Flu|flu
81417|NCT03694808|Vaccine|vaccine
81418|NCT03694782|diet|diet
81419|NCT03694782|food prices|food prices
81420|NCT03694782|environment|environment
81421|NCT03694782|physical activity|physical activity
81422|NCT03694782|nature|nature
81423|NCT03694782|well being|well being
81424|NCT03694782|natural experiment|natural experiment
81425|NCT03694782|loneliness|loneliness
81426|NCT03694782|accelerometry|accelerometry
81427|NCT03694769|functional neurological symptoms|functional neurological symptoms
81428|NCT03694756|TMEM;|tmem;
81429|NCT03694756|Magnetic resonance imaging (MRI);|magnetic resonance imaging (mri);
81430|NCT03694756|breast cancer.|breast cancer.
81431|NCT03694743|mandibular molars|mandibular molars
81432|NCT03694730|Tendinopathy|tendinopathy
81434|NCT03694730|Tendinosis|tendinosis
81435|NCT03694730|Rehabilitation|rehabilitation
81436|NCT03694730|Exercise Treatment|exercise treatment
81437|NCT03694730|Activity Modification|activity modification
81438|NCT03694717|shock|shock
81439|NCT03694717|fluid expansion|fluid expansion
81440|NCT03694717|fluid responsiveness|fluid responsiveness
81441|NCT03694704|cochlear implant|cochlear implant
81442|NCT03694704|stimulation strategy|stimulation strategy
81443|NCT03694704|sound coding strategy|sound coding strategy
81444|NCT03694678|Psychiatry|psychiatry
81445|NCT03694678|Dyads|dyads
81446|NCT03694678|Patients|patients
81447|NCT03694678|Caregivers|caregivers
81448|NCT03694678|Psychosocial|psychosocial
81449|NCT03694665|airways pressure|airways pressure
81450|NCT03694665|mechanical ventilation|mechanical ventilation
81451|NCT03694665|Atelectasis|atelectasis
81452|NCT03694652|Text messaging|text messaging
81453|NCT03694652|PAD|pad
81454|NCT03694613|Preterm Infant|preterm infant
81455|NCT03694613|Early-Onset Neonatal Sepsis|early-onset neonatal sepsis
81456|NCT03694613|Umbilical Cord|umbilical cord
81457|NCT03694613|Complete Cell Count|complete cell count
81458|NCT03694613|Placenta|placenta
81459|NCT03694613|Blood Culture|blood culture
81460|NCT03694561|Pompe disease|pompe disease
81461|NCT03694561|Glycogen Storage Disease Type II|glycogen storage disease type ii
81462|NCT03694561|Acid Maltase Deficiency|acid maltase deficiency
81463|NCT03694561|Acid Alpha-Glucosidase Deficiency|acid alpha-glucosidase deficiency
81464|NCT03694561|Alglucosidase alfa|alglucosidase alfa
81465|NCT03694561|Newborn Screening|newborn screening
81466|NCT03694548|Yoga|yoga
81467|NCT03694548|Behavioral/Social|behavioral/social
81468|NCT03694548|Pediatrics|pediatrics
81469|NCT03694535|Thermochemotherapy|thermochemotherapy
81470|NCT03694535|bladder|bladder
81471|NCT03694535|cancer|cancer
81472|NCT03694509|Gastric emptying|gastric emptying
81473|NCT03694509|tea|tea
81474|NCT03694509|milk|milk
81475|NCT03694509|pregnancy|pregnancy
81476|NCT03694509|gastric ultrasound|gastric ultrasound
81477|NCT03694509|ultrasound|ultrasound
81478|NCT03694509|gastric antrum|gastric antrum
81479|NCT03694483|prostasomes,|prostasomes,
81480|NCT03694483|prostate cancer,|prostate cancer,
81481|NCT03694483|biomarkers|biomarkers
81482|NCT03694457|Prospective|prospective
81483|NCT03694457|Randomized study|randomized study
822078|NCT00148239|Paralysis|paralysis
81484|NCT03694457|Proximal humerus fracture|proximal humerus fracture
81485|NCT03694457|Surgical treatment|surgical treatment
81486|NCT03694405|MenACWY|menacwy
81487|NCT03694405|Neisseria meningitidis|neisseria meningitidis
81488|NCT03694405|adolescents|adolescents
81489|NCT03694392|influenza|influenza
81490|NCT03694392|vaccine effectiveness|vaccine effectiveness
81491|NCT03694379|Apneic Oxygenation|apneic oxygenation
81492|NCT03694379|Endotracheal intubation|endotracheal intubation
81493|NCT03694379|Airway Management|airway management
81494|NCT03694379|Emergency Department|emergency department
81495|NCT03694366|Child Mortality|child mortality
81496|NCT03694366|Reproductive, Maternal, Newborn, and Child Health|reproductive, maternal, newborn, and child health
81497|NCT03694366|Community Health Workers|community health workers
81498|NCT03694366|Implementation Research|implementation research
81499|NCT03694366|Health Systems Strengthening|health systems strengthening
81500|NCT03694314|Omega-3 fatty acids|omega-3 fatty acids
81501|NCT03694314|Sleep|sleep
81502|NCT03694314|Behavior|behavior
81503|NCT03694314|Parenting|parenting
81504|NCT03694301|Monitoring, Intraoperative|monitoring, intraoperative
81505|NCT03694301|Pulse Wave Analysis|pulse wave analysis
81506|NCT03694288|Lisfranc|lisfranc
81507|NCT03694275|Drug Therapy|drug therapy
81508|NCT03694275|15q Duplication Syndrome|15q duplication syndrome
81509|NCT03694275|CDKL5 Deficiency Disease|cdkl5 deficiency disease
81510|NCT03694275|Brain Diseases|brain diseases
81511|NCT03694275|Epilepsy|epilepsy
81512|NCT03694275|Central Nervous System Diseases|central nervous system diseases
81513|NCT03694275|Autism|autism
81514|NCT03694275|Infantile spams|infantile spams
81515|NCT03694275|Cholesterol 24S-hydroxylase inhibitor|cholesterol 24s-hydroxylase inhibitor
81516|NCT03694275|Anti-epilepsy drug|anti-epilepsy drug
81517|NCT03694275|Anticonvulsants|anticonvulsants
81518|NCT03694275|Cyclin-dependent kinase-like 5 deficiency disorder|cyclin-dependent kinase-like 5 deficiency disorder
81519|NCT03694275|RETT syndrome|rett syndrome
81520|NCT03694275|Chromosome 15q|chromosome 15q
81521|NCT03694262|recurrent endometrial cancer|recurrent endometrial cancer
81522|NCT03694262|Bevacizumab|bevacizumab
81523|NCT03694262|Atezolizumab|atezolizumab
81524|NCT03694262|Rucaparib|rucaparib
81525|NCT03694236|NSCLC|nsclc
81526|NCT03694236|Durvalumab|durvalumab
81527|NCT03694236|medi4736|medi4736
81528|NCT03694223|FODMAP|fodmap
81529|NCT03694223|DIET|diet
81530|NCT03694223|BLOATING|bloating
81531|NCT03694210|Direct Endoscopic Necrosectomy|direct endoscopic necrosectomy
81532|NCT03694210|Walled Off Necrosis|walled off necrosis
81533|NCT03694210|Walled Off Pancreatic Necrosis|walled off pancreatic necrosis
81534|NCT03694171|Elderly|elderly
81535|NCT03694171|Cancer|cancer
81536|NCT03694171|Cohort study|cohort study
81537|NCT03694171|Cancer registry|cancer registry
81538|NCT03694171|Access to care|access to care
81539|NCT03694171|Cancer stage|cancer stage
81540|NCT03694171|Cancer treatment|cancer treatment
81541|NCT03694171|Prognosis|prognosis
81542|NCT03694171|Functional decline|functional decline
81543|NCT03694171|Survival|survival
81544|NCT03694132|Brain excitability|brain excitability
81545|NCT03694132|Brain connectivity|brain connectivity
81546|NCT03694132|Motor cortex|motor cortex
81547|NCT03694132|Somatosensory cortex|somatosensory cortex
81548|NCT03694119|Healthy Volunteer|healthy volunteer
81549|NCT03694119|Ozanimod|ozanimod
81550|NCT03694119|Oral Tyramine|oral tyramine
81551|NCT03694067|Androgenetic|androgenetic
81552|NCT03694067|Alopecia|alopecia
81553|NCT03694067|JAK|jak
81554|NCT03694067|STAT|stat
81555|NCT03694054|Care Coordination|care coordination
81556|NCT03694054|Oncology Care|oncology care
81557|NCT03694054|Lung Cancer|lung cancer
81558|NCT03694028|biomechanical|biomechanical
81559|NCT03694028|kinematic|kinematic
81560|NCT03694028|muscle coactivation|muscle coactivation
81561|NCT03694028|torque|torque
81562|NCT03693989|corticosteroid|corticosteroid
81563|NCT03693989|anti-inflammatory steroid|anti-inflammatory steroid
81564|NCT03693989|phacoemulsification|phacoemulsification
81565|NCT03693911|gamification|gamification
81566|NCT03693911|Acceptance and Commitment Therapy|acceptance and commitment therapy
81567|NCT03693911|digitalized intervention|digitalized intervention
81568|NCT03693885|caesarean section|caesarean section
81569|NCT03693885|Oxytocin challenge test|oxytocin challenge test
81570|NCT03693872|Parkinson|parkinson
81571|NCT03693872|Nonmotor symptomatology|nonmotor symptomatology
81572|NCT03693833|Cannabidiol|cannabidiol
81573|NCT03693833|Cannabis|cannabis
81574|NCT03693833|Osteoarthritis|osteoarthritis
81575|NCT03693833|Psoriatic arthritis|psoriatic arthritis
81576|NCT03693820|cholecystectomy;|cholecystectomy;
81577|NCT03693820|analgesia;|analgesia;
81578|NCT03693820|gallbladder;|gallbladder;
81579|NCT03693820|infiltration;|infiltration;
81580|NCT03693820|visceral pain|visceral pain
81581|NCT03693807|Medtronic Pump|medtronic pump
81582|NCT03693807|Codman Catheter|codman catheter
105391|NCT03545139|NeoMTA|neomta
81583|NCT03693807|Hepatic Arterial Infusion (HAI)|hepatic arterial infusion (hai)
81584|NCT03693807|Floxuridine (FUDR)|floxuridine (fudr)
81585|NCT03693807|Gemcitabine|gemcitabine
81586|NCT03693807|Oxaliplatin|oxaliplatin
81587|NCT03693807|Irinotecan (CPT-11)|irinotecan (cpt-11)
81588|NCT03693807|Fluorouracil|fluorouracil
81589|NCT03693807|Leucovorin Calcium (Folinic Acid)|leucovorin calcium (folinic acid)
81590|NCT03693807|Dexamethasone|dexamethasone
81591|NCT03693807|18-343|18-343
81592|NCT03693794|psychosocial/rehabilitative interventions|psychosocial/rehabilitative interventions
81593|NCT03693794|Schizophrenia|schizophrenia
81594|NCT03693794|evidence based interventions|evidence based interventions
81595|NCT03693794|long acting injection antipsychotic|long acting injection antipsychotic
81596|NCT03693794|functional outcome|functional outcome
81597|NCT03693781|amyotrophic lateral sclerosis|amyotrophic lateral sclerosis
81598|NCT03693781|stress granules|stress granules
81599|NCT03693781|HSPB8|hspb8
81600|NCT03693781|protein quality control|protein quality control
81601|NCT03693781|colchicine|colchicine
81602|NCT03693781|ALSFRS-r|alsfrs-r
81603|NCT03693781|survival|survival
81604|NCT03693781|safety|safety
81605|NCT03693729|memory|memory
81606|NCT03693729|metacognition|metacognition
81607|NCT03693729|metamemory|metamemory
81608|NCT03693729|transcranial direct current stimulation|transcranial direct current stimulation
81609|NCT03693716|Transsubscapular|transsubscapular
81610|NCT03693716|Long head of the biceps tendon|long head of the biceps tendon
81611|NCT03693716|LHBT|lhbt
81612|NCT03693716|Anterior Shoulder Dislocation|anterior shoulder dislocation
81613|NCT03693716|Bankart|bankart
81614|NCT03693716|HillSachs|hillsachs
81860|NCT03692000|Health Behavior|health behavior
81615|NCT03693716|Arthroscopic Anterior Dynamic Stabilization|arthroscopic anterior dynamic stabilization
81616|NCT03693703|magnetic resonance imaging|magnetic resonance imaging
81617|NCT03693703|prostate biopsy|prostate biopsy
81618|NCT03693703|microRNA|microrna
81619|NCT03693664|Asthma|asthma
81620|NCT03693664|Daily Living Activities|daily living activities
81621|NCT03693664|6 Minute Pegboard and Ring Test|6 minute pegboard and ring test
81622|NCT03693638|spinal anesthesia|spinal anesthesia
81623|NCT03693638|pregnancy-induced hypertension|pregnancy-induced hypertension
81624|NCT03693638|Cesarean section|cesarean section
81625|NCT03693612|advanced solid tumor|advanced solid tumor
81626|NCT03693612|Head and Neck Squamous Cell Carcinoma|head and neck squamous cell carcinoma
81627|NCT03693612|standard of care|standard of care
81628|NCT03693612|GSK3359609|gsk3359609
81629|NCT03693612|urothelial carcinoma of the upper and lower urinary tract|urothelial carcinoma of the upper and lower urinary tract
81630|NCT03693612|non-small cell lung cancer|non-small cell lung cancer
81631|NCT03693612|cutaneous melanoma|cutaneous melanoma
81927|NCT03691545|telehealth|telehealth
81632|NCT03693612|Tremelimumab|tremelimumab
81633|NCT03693612|clear cell renal carcinoma|clear cell renal carcinoma
81634|NCT03693612|castrate resistant prostate adenocarcinoma|castrate resistant prostate adenocarcinoma
81635|NCT03693586|seroprevalence|seroprevalence
81636|NCT03693586|viral load|viral load
81637|NCT03693586|chronic hepatitis c|chronic hepatitis c
81638|NCT03693586|vasculitis|vasculitis
81639|NCT03693534|Long Antagonist|long antagonist
81640|NCT03693534|Long agonist|long agonist
81641|NCT03693534|clinical pregnancy rate|clinical pregnancy rate
81642|NCT03693534|live birth rate|live birth rate
81643|NCT03693534|ovarian stimulation|ovarian stimulation
81644|NCT03693534|IVF|ivf
81645|NCT03693469|Virtual Reality|virtual reality
81646|NCT03693469|Pain|pain
81647|NCT03693469|Anxiety|anxiety
81648|NCT03693443|knowledge|knowledge
81649|NCT03693443|behaviors|behaviors
81650|NCT03693443|Early childhood caries|early childhood caries
81651|NCT03693417|pharyngitis|pharyngitis
81652|NCT03693417|intubation|intubation
81653|NCT03693417|heat|heat
81654|NCT03693378|high-risk familial|high-risk familial
81655|NCT03693378|screening program|screening program
81656|NCT03693378|pancreatic cancer|pancreatic cancer
81657|NCT03693365|Carbon dioxide|carbon dioxide
81658|NCT03693365|Pulmonary blood flow|pulmonary blood flow
81659|NCT03693365|Ventilation|ventilation
81660|NCT03693313|ASD, Autism Spectrum Disorder|asd, autism spectrum disorder
81661|NCT03693300|Stage III Non-Small Cell Lung Cancer|stage iii non-small cell lung cancer
81662|NCT03693300|Durvalumab|durvalumab
81663|NCT03693300|IV infusion immunoglobulin G (IgG)|iv infusion immunoglobulin g (igg)
81664|NCT03693300|Antibody-dependent cellular cytotoxicity|antibody-dependent cellular cytotoxicity
81665|NCT03693300|Complement-dependent cytotoxicity|complement-dependent cytotoxicity
81666|NCT03693300|Monotherapy|monotherapy
81667|NCT03693287|Preterm|preterm
81668|NCT03693287|Infant|infant
81669|NCT03693287|Parenteral Nutrition|parenteral nutrition
81670|NCT03693287|Growth|growth
81671|NCT03693261|epicardial fat|epicardial fat
81672|NCT03693248|advanced ovarian cancer|advanced ovarian cancer
81673|NCT03693248|advanced fallopian cancer|advanced fallopian cancer
81674|NCT03693248|advanced peritoneal cancer|advanced peritoneal cancer
81675|NCT03693248|neoadjuvant chemotherapy|neoadjuvant chemotherapy
81676|NCT03693248|cycles of chemotherapy|cycles of chemotherapy
81677|NCT03693248|survival|survival
81678|NCT03693235|Tracheal Intubation|tracheal intubation
81679|NCT03693235|Lightwand|lightwand
81680|NCT03693222|Quadratus lumborum block, abdominal trunk block|quadratus lumborum block, abdominal trunk block
81681|NCT03693209|Implementation intentions|implementation intentions
81682|NCT03693209|Volitional Help Sheet|volitional help sheet
81683|NCT03693209|Adolescent|adolescent
81684|NCT03693196|Dental implant|dental implant
81685|NCT03693196|Immunology|immunology
81686|NCT03693196|Microbiology|microbiology
81687|NCT03693196|Surface characteristic|surface characteristic
81688|NCT03693183|Dry Eye|dry eye
81689|NCT03693170|Metastatic Colorectal Cancer|metastatic colorectal cancer
81690|NCT03693118|manual therapy; multiple sclerosis; rehabilitation; motor cortex; neuroplasticity|manual therapy; multiple sclerosis; rehabilitation; motor cortex; neuroplasticity
81691|NCT03693079|heavy metal|heavy metal
81692|NCT03693079|wet cupping therapy|wet cupping therapy
81693|NCT03693079|steel industry worker|steel industry worker
81694|NCT03693066|stepwise excavation|stepwise excavation
81695|NCT03693066|indirect pulp capping|indirect pulp capping
81696|NCT03693066|ozone|ozone
81697|NCT03693066|deep caries|deep caries
81698|NCT03693027|Older adults|older adults
81699|NCT03693027|microbiome|microbiome
81700|NCT03693027|gum health|gum health
81701|NCT03693027|gingivitis|gingivitis
81702|NCT03693027|gum disease|gum disease
81703|NCT03693014|Radiation|radiation
81704|NCT03693014|Immunotherapy/Checkpoint Inhibitors|immunotherapy/checkpoint inhibitors
81705|NCT03693014|18-359|18-359
81706|NCT03692988|Psychotherapy|psychotherapy
81707|NCT03692988|Dignity|dignity
81708|NCT03692988|Family|family
81709|NCT03692975|Clinically Isolated Syndrome|clinically isolated syndrome
81710|NCT03692975|NODDI|noddi
81711|NCT03692975|Hippocampus|hippocampus
81712|NCT03692975|episodic memory function|episodic memory function
81713|NCT03692975|dentate gyrus|dentate gyrus
81714|NCT03692975|MRI|mri
81715|NCT03692884|diabetes mellitus|diabetes mellitus
81716|NCT03692884|risk factors|risk factors
81717|NCT03692884|biomarkers|biomarkers
81718|NCT03692884|chronic diabetes complications|chronic diabetes complications
81719|NCT03692858|arthroplasty|arthroplasty
81720|NCT03692858|replacement|replacement
81721|NCT03692858|knee|knee
81722|NCT03692845|spine fusion|spine fusion
81723|NCT03692845|minimally invasive surgery|minimally invasive surgery
81724|NCT03692819|Chronic Periodontitis|chronic periodontitis
81725|NCT03692819|Periodontal Debridement|periodontal debridement
81726|NCT03692819|Antibiotics|antibiotics
81727|NCT03692819|Probiotics|probiotics
81728|NCT03692793|Pulmonary Disease, Chronic Obstructive|pulmonary disease, chronic obstructive
81729|NCT03692793|Minimal Clinically Important Difference|minimal clinically important difference
81730|NCT03692793|Exercise Test|exercise test
81731|NCT03692793|Rehabilitation|rehabilitation
81732|NCT03692793|Disability Evaluation|disability evaluation
81733|NCT03692793|Activities of Daily Living|activities of daily living
81734|NCT03692793|Motivation|motivation
81735|NCT03692793|Self-efficacy|self-efficacy
81736|NCT03692754|Immune Thrombocytopenia|immune thrombocytopenia
81737|NCT03692728|congenital cataract|congenital cataract
81738|NCT03692728|attention deficit hyperactivity disorder|attention deficit hyperactivity disorder
81739|NCT03692728|Conners'Parent Rating Scale-48|conners'parent rating scale-48
81740|NCT03692715|ureteral stones; ureteral calculi; shockwave lithotripsy|ureteral stones; ureteral calculi; shockwave lithotripsy
81741|NCT03692689|Triple Negative Breast Neoplasms|triple negative breast neoplasms
81742|NCT03692689|Breast Neoplasms|breast neoplasms
81743|NCT03692689|Neoplasms by Site|neoplasms by site
81744|NCT03692689|Neoplasms|neoplasms
81745|NCT03692689|Epidermal growth factor receptor|epidermal growth factor receptor
81746|NCT03692689|EGFR|egfr
81747|NCT03692689|SCT200|sct200
81748|NCT03692624|cancer survivors|cancer survivors
81749|NCT03692624|heart rate variability|heart rate variability
81750|NCT03692624|biofeedback|biofeedback
81751|NCT03692611|chronic pain|chronic pain
81753|NCT03692611|opioid prescribing|opioid prescribing
81754|NCT03692611|behavioral clinical trial|behavioral clinical trial
81755|NCT03692585|Ethnography|ethnography
81756|NCT03692585|Health Informatics|health informatics
81757|NCT03692585|Healthy Lifestyle|healthy lifestyle
81758|NCT03692585|Patient Involvement|patient involvement
81759|NCT03692585|eHealth Literacy|ehealth literacy
81760|NCT03692572|Neural control|neural control
81761|NCT03692572|Cardiovascular function|cardiovascular function
81762|NCT03692572|Inorganic nitrate supplementation|inorganic nitrate supplementation
81763|NCT03692559|CRBSI|crbsi
81764|NCT03692559|CLABSI|clabsi
81765|NCT03692533|Geminin, prognosis|geminin, prognosis
81766|NCT03692520|Neoplasms|neoplasms
81767|NCT03692520|Solid Tumors|solid tumors
81768|NCT03692520|Epidermal growth factor receptor|epidermal growth factor receptor
81769|NCT03692520|EGFR|egfr
81770|NCT03692520|SCT200|sct200
81771|NCT03692507|HMB: β-hydroxy β-methylbutyrate|hmb: β-hydroxy β-methylbutyrate
81772|NCT03692507|MNA: Mini Nutrition Assessment|mna: mini nutrition assessment
81773|NCT03692507|GMS: Graz Malnutrition Screening|gms: graz malnutrition screening
81774|NCT03692507|MUST: Malnutrition Universal Screening Tool|must: malnutrition universal screening tool
81775|NCT03692507|MST: Malnutrition Screening Tool|mst: malnutrition screening tool
81776|NCT03692507|SGA: Subjective Global Assessment|sga: subjective global assessment
81777|NCT03692507|REE: Resting Energy Expenditure|ree: resting energy expenditure
81778|NCT03692507|IC: Indirect calorimetry|ic: indirect calorimetry
81779|NCT03692481|Idiopathic Pulmonary Fibrosis (IPF)|idiopathic pulmonary fibrosis (ipf)
81780|NCT03692481|18FDG uptake|18fdg uptake
81781|NCT03692481|prognosis|prognosis
81782|NCT03692455|GERD|gerd
81783|NCT03692455|Roux-en-Y Gastric Bypass|roux-en-y gastric bypass
81784|NCT03692455|Vertical Sleeve Gastrectomy|vertical sleeve gastrectomy
81785|NCT03692442|NGS|ngs
81786|NCT03692442|cytokine|cytokine
81787|NCT03692442|efficacy|efficacy
81788|NCT03692442|side effect|side effect
81789|NCT03692429|unresectable metastatic colorectal cancer|unresectable metastatic colorectal cancer
81790|NCT03692416|C3,C4, C5a & ANCA|c3,c4, c5a & anca
81791|NCT03692390|Virtual Reality|virtual reality
81792|NCT03692390|Heart Rate|heart rate
81793|NCT03692390|Blood Pressure|blood pressure
81794|NCT03692377|Virtual Reality|virtual reality
81795|NCT03692364|biomaterials|biomaterials
81796|NCT03692364|Implant wear|implant wear
81797|NCT03692364|hip arthroplasty|hip arthroplasty
81798|NCT03692364|osteolysis|osteolysis
81799|NCT03692364|aseptic loosening|aseptic loosening
81800|NCT03692351|uncemented hip arthroplasty|uncemented hip arthroplasty
81801|NCT03692351|osteolysis|osteolysis
81802|NCT03692351|polyethylene wear|polyethylene wear
81803|NCT03692351|implant design|implant design
81804|NCT03692338|metastatic renal cell carcinoma|metastatic renal cell carcinoma
81805|NCT03692338|ipilimumab|ipilimumab
81806|NCT03692338|nivolumab|nivolumab
81807|NCT03692338|exercise|exercise
81808|NCT03692312|Tideglusib|tideglusib
81809|NCT03692312|AMO-02-MD-2-003|amo-02-md-2-003
81810|NCT03692312|Congenital Myotonic Dystrophy|congenital myotonic dystrophy
81811|NCT03692312|Myotonic Dystrophy|myotonic dystrophy
81812|NCT03692312|Dystrophia Myotonica|dystrophia myotonica
81813|NCT03692312|Myotonia Atrophica|myotonia atrophica
81814|NCT03692312|Myotonia Dystrophica|myotonia dystrophica
81815|NCT03692312|Myotonic Dystrophy, Congenital|myotonic dystrophy, congenital
81816|NCT03692312|Steinert Disease|steinert disease
81817|NCT03692312|Steinert Myotonic Dystrophy|steinert myotonic dystrophy
81818|NCT03692312|Steinert's Disease|steinert's disease
81819|NCT03692299|Systemic Sclerosis|systemic sclerosis
81820|NCT03692299|Small Intestinal Bacterial Overgrowth|small intestinal bacterial overgrowth
81821|NCT03692299|Saccaromyces boulardii|saccaromyces boulardii
81822|NCT03692247|pain|pain
81823|NCT03692247|music|music
81824|NCT03692234|homoarginine|homoarginine
81825|NCT03692221|Back pain|back pain
81826|NCT03692208|Geriatrics|geriatrics
81827|NCT03692195|sleep|sleep
81828|NCT03692195|healthy volunteers|healthy volunteers
81829|NCT03692195|sleep study|sleep study
81830|NCT03692182|Antipsychotic|antipsychotic
81831|NCT03692182|Dementia|dementia
81832|NCT03692169|Central serous chorioretinopathy|central serous chorioretinopathy
81833|NCT03692156|sternocleidomastoid muscle|sternocleidomastoid muscle
81834|NCT03692156|Superficial Cervical Plexus block|superficial cervical plexus block
81835|NCT03692156|ultrasound|ultrasound
81836|NCT03692130|Acceptance|acceptance
81837|NCT03692130|Mindfulness|mindfulness
81838|NCT03692130|Commitment|commitment
81839|NCT03692130|Group-Psychotherapy|group-psychotherapy
81840|NCT03692117|COPD Exacerbation|copd exacerbation
81841|NCT03692117|Severe|severe
81842|NCT03692117|ECCO2R|ecco2r
81843|NCT03692117|invasive mechanical ventilation|invasive mechanical ventilation
81844|NCT03692104|prostate cancer|prostate cancer
81845|NCT03692104|brachytherapy|brachytherapy
81846|NCT03692104|Quality assurance|quality assurance
81847|NCT03692065|Cancer|cancer
81848|NCT03692065|VTE|vte
81849|NCT03692065|Apixaban|apixaban
81850|NCT03692065|Thrombosis|thrombosis
81851|NCT03692026|post-extraction implant, dental implant|post-extraction implant, dental implant
81852|NCT03692026|melatonin|melatonin
81853|NCT03692026|Hyaluronic acid|hyaluronic acid
81854|NCT03692013|Nocturnal hypertension,Peritoneal dialysis,Losartan|nocturnal hypertension,peritoneal dialysis,losartan
81855|NCT03692000|eHealth Literacy|ehealth literacy
81856|NCT03692000|Health Literacy|health literacy
81857|NCT03692000|Computer Literacy|computer literacy
81858|NCT03692000|Software Design|software design
81859|NCT03692000|Healthy Lifestyle|healthy lifestyle
81861|NCT03691987|fecal transplantation|fecal transplantation
81862|NCT03691987|bacterio therapy|bacterio therapy
81863|NCT03691987|fatigue|fatigue
81864|NCT03691987|fecal microbiota transplantation|fecal microbiota transplantation
81865|NCT03691935|kidney|kidney
81866|NCT03691935|surgery|surgery
81867|NCT03691935|analgesia|analgesia
81868|NCT03691935|surgical incision|surgical incision
81869|NCT03691935|opioid sparing|opioid sparing
81870|NCT03691935|flank pain|flank pain
81871|NCT03691935|local anesthesia|local anesthesia
81872|NCT03691922|Shoulder|shoulder
81873|NCT03691922|Pain|pain
81874|NCT03691922|Erector Spinae Plane block|erector spinae plane block
81875|NCT03691922|Surgery|surgery
81876|NCT03691922|Arthroscopy|arthroscopy
81877|NCT03691922|Periarticular infiltration|periarticular infiltration
81878|NCT03691922|Post-Anesthesia Care Unit|post-anesthesia care unit
81879|NCT03691922|Day Surgery Unit|day surgery unit
81880|NCT03691922|Regional anesthesia|regional anesthesia
81881|NCT03691922|Analgesia|analgesia
81882|NCT03691909|arthritis|arthritis
81883|NCT03691909|stem cells|stem cells
81884|NCT03691909|MSCs|mscs
81885|NCT03691909|adipose MSCs|adipose mscs
81886|NCT03691896|premature|premature
81887|NCT03691896|osteopenia|osteopenia
81888|NCT03691896|Vit. D|vit. d
81889|NCT03691896|LBW (low birth weight)|lbw (low birth weight)
81890|NCT03691896|25OHD|25ohd
81891|NCT03691883|tuberculosis, infectious diseases|tuberculosis, infectious diseases
81892|NCT03691870|brain arteriovenous malformation|brain arteriovenous malformation
81893|NCT03691870|Arteriovenous malformations|arteriovenous malformations
81894|NCT03691870|AVM|avm
81895|NCT03691870|BAVM|bavm
81896|NCT03691870|stroke|stroke
81897|NCT03691870|intracranial hemorrhage|intracranial hemorrhage
81898|NCT03691870|congenital abnormalities|congenital abnormalities
81899|NCT03691870|aneurysm|aneurysm
81900|NCT03691870|vascular malformations|vascular malformations
81901|NCT03691870|cardiovascular abnormalities|cardiovascular abnormalities
81902|NCT03691870|cardiovascular diseases|cardiovascular diseases
81903|NCT03691870|vascular diseases|vascular diseases
81904|NCT03691844|AMZ001|amz001
81905|NCT03691805|Transcranial Direct Current Stimulation|transcranial direct current stimulation
81906|NCT03691792|cognitive-behavioral therapy|cognitive-behavioral therapy
81907|NCT03691792|light therapy|light therapy
81908|NCT03691792|biomarkers|biomarkers
81909|NCT03691792|treatment mechanisms|treatment mechanisms
81910|NCT03691753|Fitaya|fitaya
81911|NCT03691753|Vena cava filter|vena cava filter
81912|NCT03691740|circadian, melatonin, preterm labor|circadian, melatonin, preterm labor
81913|NCT03691688|aspirin; coronary artery disease, uric acid|aspirin; coronary artery disease, uric acid
81914|NCT03691675|Drug-coated balloon|drug-coated balloon
81915|NCT03691675|restenosis|restenosis
81916|NCT03691675|dissection|dissection
81917|NCT03691623|challenge study|challenge study
81918|NCT03691623|RSV|rsv
81919|NCT03691623|antiviral|antiviral
81920|NCT03691623|RSV-A Memphis 37b|rsv-a memphis 37b
81921|NCT03691558|ketogenic diet|ketogenic diet
81922|NCT03691558|triathlon|triathlon
81923|NCT03691558|VO2max|vo2max
81924|NCT03691558|PPO|ppo
81925|NCT03691545|physical activity|physical activity
81926|NCT03691545|fruit and vegetable consumption|fruit and vegetable consumption
81928|NCT03691545|young adult cancer survivors|young adult cancer survivors
81929|NCT03691545|rural-dwelling|rural-dwelling
81930|NCT03691532|lipemia|lipemia
81931|NCT03691532|feeding|feeding
81932|NCT03691532|paraplegia|paraplegia
81933|NCT03691532|tetraplegia|tetraplegia
81934|NCT03691532|physical activity|physical activity
81935|NCT03691532|macronutrient metabolism|macronutrient metabolism
81936|NCT03691519|Low OMega 3|low omega 3
81937|NCT03691519|Preventive trial|preventive trial
81938|NCT03691519|low RBC DHA/EPA index|low rbc dha/epa index
81939|NCT03691506|Cerebral Palsy|cerebral palsy
81940|NCT03691506|Constraint-Induced Movement Therapy|constraint-induced movement therapy
81941|NCT03691467|immediate dental implant|immediate dental implant
81942|NCT03691467|immediate implant|immediate implant
81943|NCT03691467|hyaluronic acid|hyaluronic acid
81944|NCT03691467|gengigel|gengigel
81945|NCT03691454|gastric adenocarcinoma|gastric adenocarcinoma
81946|NCT03691454|neoadjuvant chemotherapy|neoadjuvant chemotherapy
81947|NCT03691454|locally advanced|locally advanced
81948|NCT03691454|Oxaliplatin|oxaliplatin
81950|NCT03691454|Docetaxel|docetaxel
81951|NCT03691441|locally advanced|locally advanced
81952|NCT03691441|transorally resectable|transorally resectable
81953|NCT03691415|Double Chin Fat Reduction|double chin fat reduction
81954|NCT03691363|child|child
81955|NCT03691363|Adolescent|adolescent
81956|NCT03691363|exercise|exercise
81957|NCT03691363|rehabilitation|rehabilitation
81958|NCT03691363|physical activity|physical activity
81959|NCT03691363|virtual|virtual
81960|NCT03691363|mobile health|mobile health
81961|NCT03691311|rank|rank
81962|NCT03691311|rankl|rankl
81963|NCT03691311|denosumab|denosumab
81964|NCT03691298|Suturefix|suturefix
81965|NCT03691298|hip instability|hip instability
81966|NCT03691298|shoulder instability|shoulder instability
81967|NCT03691285|Overdenture|overdenture
81968|NCT03691285|Dental implant|dental implant
81969|NCT03691285|Cost analysis|cost analysis
105889|NCT03541707|TMS|tms
81970|NCT03691259|Dance|dance
81971|NCT03691259|Postural stability|postural stability
81972|NCT03691259|Ballet|ballet
81973|NCT03691246|Myocardial Infarction|myocardial infarction
81974|NCT03691246|Dyslipidemia|dyslipidemia
81975|NCT03691220|Intervention|intervention
81976|NCT03691220|Adherence|adherence
81977|NCT03691181|Outpatient ventilator support|outpatient ventilator support
81978|NCT03691168|Inherited retinal dystrophies, Gene screen|inherited retinal dystrophies, gene screen
81979|NCT03691116|Mental Health|mental health
81980|NCT03691116|Digital Intervention|digital intervention
81981|NCT03691116|Alcohol|alcohol
81982|NCT03691116|Tobacco|tobacco
81983|NCT03691116|Diet|diet
81984|NCT03691116|Physical Activity|physical activity
81985|NCT03691116|Primary Health Care|primary health care
81986|NCT03691090|PD-1Antibody|pd-1antibody
81987|NCT03691090|advanced esophageal cancer|advanced esophageal cancer
81988|NCT03691090|paclitaxel|paclitaxel
81989|NCT03691090|cisplatin|cisplatin
81990|NCT03691077|Multiple Sclerosis|multiple sclerosis
81991|NCT03691077|Ocrelizumab|ocrelizumab
81992|NCT03691077|Microglial cells Activation|microglial cells activation
81993|NCT03691077|PET-IRM|pet-irm
81994|NCT03691077|18F-DPA714|18f-dpa714
81995|NCT03691064|Gastroenteropancreatic neuroendocrine tumours|gastroenteropancreatic neuroendocrine tumours
81996|NCT03691025|robot assisted laparoscopic prostatectomy|robot assisted laparoscopic prostatectomy
81997|NCT03691025|optic nerve sheath diameter|optic nerve sheath diameter
81998|NCT03690973|Bone graft|bone graft
81999|NCT03690973|Immediate dental implant|immediate dental implant
82000|NCT03690973|Flap|flap
82001|NCT03690973|Flapless|flapless
82002|NCT03690960|immature teeth|immature teeth
82003|NCT03690869|Newly Diagnosed|newly diagnosed
82004|NCT03690869|Recurrent|recurrent
82005|NCT03690869|Refractory|refractory
82006|NCT03690843|motor development|motor development
82007|NCT03690843|toddler|toddler
82008|NCT03690843|prediction|prediction
82009|NCT03690830|Metabolomic|metabolomic
82010|NCT03690830|Endometrial biomarkers|endometrial biomarkers
82011|NCT03690830|Infertility|infertility
82012|NCT03690804|kangaroo care|kangaroo care
82013|NCT03690804|neonatal intensive care units|neonatal intensive care units
82014|NCT03690804|autonomic co-regulation|autonomic co-regulation
82015|NCT03690765|endometriosis|endometriosis
82016|NCT03690765|dydrogesterone|dydrogesterone
82017|NCT03690765|Duphaston®|duphaston®
82018|NCT03690765|progestogens|progestogens
82019|NCT03690765|pelvic pain|pelvic pain
82020|NCT03690752|Obesity|obesity
82021|NCT03690752|Alter-G Anti-Gravity Treadmill|alter-g anti-gravity treadmill
82022|NCT03690752|6-minute walk test|6-minute walk test
82023|NCT03690752|timed up and go test|timed up and go test
82024|NCT03690752|physical activity enjoyment|physical activity enjoyment
82025|NCT03690752|pain|pain
82026|NCT03690739|Symptom Benefit|symptom benefit
82027|NCT03690713|fractional flow reserve|fractional flow reserve
82028|NCT03690713|myocardial ischemia|myocardial ischemia
82029|NCT03690713|coronary artery disease|coronary artery disease
82030|NCT03690713|coronary flow reserve|coronary flow reserve
82031|NCT03690713|index of microcirculatory resistance|index of microcirculatory resistance
82032|NCT03690713|prognosis|prognosis
82033|NCT03690713|percutaneous coronary intervention|percutaneous coronary intervention
82034|NCT03690700|BFR Exercise|bfr exercise
82035|NCT03690700|Spinal Cord Injury|spinal cord injury
82036|NCT03690700|Tetraplegia|tetraplegia
82037|NCT03690700|Neuromuscular Recovery|neuromuscular recovery
82038|NCT03690700|Randomized controlled study|randomized controlled study
82039|NCT03690700|Physical Function|physical function
82040|NCT03690700|Quality of Life|quality of life
82041|NCT03690687|Surgical Anastomosis|surgical anastomosis
82042|NCT03690687|Enterostomy|enterostomy
82043|NCT03690687|Mortality|mortality
82044|NCT03690687|Morbidity|morbidity
82045|NCT03690687|Abdominal Closure Techniques|abdominal closure techniques
82046|NCT03690687|APACHE II|apache ii
82047|NCT03690687|Secondary Peritonitis|secondary peritonitis
82048|NCT03690687|Delayed Anastomosis|delayed anastomosis
82049|NCT03690687|Primary Anastomosis|primary anastomosis
82050|NCT03690687|Mannheim Peritonitis Index|mannheim peritonitis index
82051|NCT03690674|ADHD|adhd
82052|NCT03690674|Physical Activity|physical activity
82053|NCT03690674|Behavioral Management Training|behavioral management training
82054|NCT03690674|Mobile Health|mobile health
82055|NCT03690661|adolescent|adolescent
82056|NCT03690661|face|face
82057|NCT03690661|social skills|social skills
82058|NCT03690661|video game|video game
82059|NCT03690635|treatment of gingival recession|treatment of gingival recession
82060|NCT03690635|root coverage|root coverage
82061|NCT03690635|tunneling technique|tunneling technique
82062|NCT03690635|VISTA technique|vista technique
82063|NCT03690635|sub epithelial connective tissue graft|sub epithelial connective tissue graft
82064|NCT03690635|recession treatment|recession treatment
82065|NCT03690583|Pneumonia|pneumonia
822181|NCT00147836|metformin|metformin
82066|NCT03690583|Zinc supplementation|zinc supplementation
82067|NCT03690583|Cytokines|cytokines
82068|NCT03690583|Lymphoproliferation|lymphoproliferation
82069|NCT03690583|Viruses|viruses
82070|NCT03690583|Respiratory bacteria|respiratory bacteria
82071|NCT03690570|Glioma|glioma
82072|NCT03690570|Children|children
82073|NCT03690570|Chemotherapy|chemotherapy
82074|NCT03690570|treatment toxicitT|treatment toxicitt
82075|NCT03690570|Survival|survival
82076|NCT03690557|Delivery of Health Care|delivery of health care
82077|NCT03690557|Rural Health|rural health
82078|NCT03690557|Primary Health Care|primary health care
82079|NCT03690557|Outcomes and Process Assessment (Health Care)|outcomes and process assessment (health care)
82080|NCT03690518|cardiac rehabilitation|cardiac rehabilitation
82081|NCT03690518|Congenital heart diseases|congenital heart diseases
82082|NCT03690518|Heart defects, congenital|heart defects, congenital
82083|NCT03690518|Adolescent|adolescent
82084|NCT03690518|Young adult|young adult
82085|NCT03690518|Physical activity|physical activity
82086|NCT03690518|Cardio-pulmonary exercice test|cardio-pulmonary exercice test
82087|NCT03690518|Oxygen uptake|oxygen uptake
82088|NCT03690518|Muscular deconditioning|muscular deconditioning
82089|NCT03690518|Patient education as topic|patient education as topic
82090|NCT03690518|Quality of life|quality of life
82091|NCT03690518|Health Knowledge, Attitudes, Practice|health knowledge, attitudes, practice
82092|NCT03690440|Borderline Ovarian Tumor (BOT)|borderline ovarian tumor (bot)
82093|NCT03690440|Fertility-sparing surgery|fertility-sparing surgery
82094|NCT03690440|Gynecology|gynecology
82095|NCT03690440|Oncology|oncology
82096|NCT03690414|Myopia control|myopia control
82097|NCT03690414|Atropine eye drops|atropine eye drops
82098|NCT03690414|Caffeine eye drops|caffeine eye drops
82099|NCT03690414|Pupillary diameter|pupillary diameter
82100|NCT03690414|Accommodative responses|accommodative responses
82101|NCT03690401|Cancer|cancer
82102|NCT03690401|Post-Treatment|post-treatment
82103|NCT03690401|Body Composition|body composition
82104|NCT03690401|SOZO|sozo
82105|NCT03690401|Impedimed|impedimed
82106|NCT03690388|Thyroid cancer, papillary|thyroid cancer, papillary
82107|NCT03690388|Papillary thyroid carcinoma|papillary thyroid carcinoma
82108|NCT03690388|Nonmedullary thyroid carcinoma|nonmedullary thyroid carcinoma
82109|NCT03690388|Cancer of the thyroid|cancer of the thyroid
82110|NCT03690388|Thyroid cancer|thyroid cancer
82111|NCT03690388|Follicular thyroid cancer|follicular thyroid cancer
82238|NCT03689426|Response to Therapy|response to therapy
82112|NCT03690388|Thyroid cancer, follicular|thyroid cancer, follicular
82113|NCT03690388|Hürthle cell cancer|hürthle cell cancer
82114|NCT03690375|skin atrophy|skin atrophy
82115|NCT03690375|broad band bight|broad band bight
82116|NCT03690375|ecchymosis|ecchymosis
82117|NCT03690375|collagen|collagen
82118|NCT03690375|elastin|elastin
82120|NCT03690349|severe asthma exacerbation|severe asthma exacerbation
82121|NCT03690349|Mold sensitization|mold sensitization
82122|NCT03690323|Pancreatic cancer|pancreatic cancer
82123|NCT03690323|Pancreatic neoplasms|pancreatic neoplasms
82124|NCT03690323|Locally advanced pancreatic cancer|locally advanced pancreatic cancer
82125|NCT03690323|Radiofrequency ablation|radiofrequency ablation
82126|NCT03690323|Chemotherapy|chemotherapy
82127|NCT03690297|adenoma detection rate|adenoma detection rate
82128|NCT03690297|Linked Color Imaging|linked color imaging
82129|NCT03690297|colonoscopy|colonoscopy
82130|NCT03690258|muscle function; muscle fibers; systolic blood pressure|muscle function; muscle fibers; systolic blood pressure
82131|NCT03690245|Congenital Heart Defect|congenital heart defect
82132|NCT03690245|Newborn|newborn
82133|NCT03690193|Ketogenic Diet|ketogenic diet
82134|NCT03690193|Alzheimer's disease|alzheimer's disease
82135|NCT03690141|Prostate Cancer|prostate cancer
82136|NCT03690141|Castrate-resistant Prostate Cancer|castrate-resistant prostate cancer
82137|NCT03690141|CRPC|crpc
82138|NCT03690141|eFT508|eft508
82139|NCT03690141|eFT508-0009|eft508-0009
82140|NCT03690141|tomivosertib|tomivosertib
82141|NCT03690128|Clinical deterioration|clinical deterioration
82142|NCT03690128|Risk stratification|risk stratification
82143|NCT03690128|Patient Safety|patient safety
82144|NCT03690128|Early Warning Score|early warning score
82145|NCT03690128|Monitoring|monitoring
82146|NCT03690128|Clinical assessment|clinical assessment
82147|NCT03690076|Heart|heart
82148|NCT03690076|Mitochondria|mitochondria
82149|NCT03690076|Obesity|obesity
82150|NCT03690076|Endocarditis|endocarditis
82151|NCT03690050|Diabetic macular oedema|diabetic macular oedema
82152|NCT03690050|Diabetic retinopathy|diabetic retinopathy
82153|NCT03690037|Tranexamic Acid|tranexamic acid
82154|NCT03690011|Autologouse CAR T cells|autologouse car t cells
82155|NCT03690011|T-cell Acute Lymphoblastic Leukemia|t-cell acute lymphoblastic leukemia
82156|NCT03690011|T-cell acute lymphoblastic lymphoma|t-cell acute lymphoblastic lymphoma
82157|NCT03690011|T-non-Hodgkin lymphoma|t-non-hodgkin lymphoma
82158|NCT03689998|immediate implant|immediate implant
82159|NCT03689998|melatonin|melatonin
822182|NCT00147836|insulin|insulin
82160|NCT03689998|atrumatic extraction|atrumatic extraction
82161|NCT03689959|knee|knee
82162|NCT03689959|flexion deformity|flexion deformity
82163|NCT03689959|hemiepiphysiodesis|hemiepiphysiodesis
82164|NCT03689959|eight plate|eight plate
82165|NCT03689959|children|children
82166|NCT03689881|Sacroiliitis|sacroiliitis
82167|NCT03689881|SI joint|si joint
82168|NCT03689881|tomosynthesis|tomosynthesis
82169|NCT03689881|CT|ct
82170|NCT03689881|Xray|xray
82171|NCT03689868|virtual reality|virtual reality
82172|NCT03689751|multimedia|multimedia
82173|NCT03689738|Resistant Starch|resistant starch
82174|NCT03689738|Free Fatty Acids|free fatty acids
82175|NCT03689738|Potato|potato
82176|NCT03689738|Insulin sensitivity|insulin sensitivity
82177|NCT03689738|Lipid Metabolism|lipid metabolism
82178|NCT03689712|Oral Mucositis|oral mucositis
82179|NCT03689712|Superoxide Dismutase Mimetic|superoxide dismutase mimetic
82180|NCT03689712|Cisplatin|cisplatin
82181|NCT03689712|Intensity-Modulated Radiation Therapy|intensity-modulated radiation therapy
82182|NCT03689712|Chemoradiation|chemoradiation
82183|NCT03689712|OM|om
82184|NCT03689712|IMRT|imrt
82185|NCT03689712|Head and Neck Cancer|head and neck cancer
82186|NCT03689712|Squamous Cell Carcinoma|squamous cell carcinoma
82187|NCT03689712|SCC|scc
82188|NCT03689712|Oral Cavity|oral cavity
82189|NCT03689712|Oropharnyx|oropharnyx
82190|NCT03689712|Mouth Sores|mouth sores
82191|NCT03689699|Immunotherapy|immunotherapy
82192|NCT03689699|Nivolumab|nivolumab
82193|NCT03689699|BMS-986253|bms-986253
82194|NCT03689699|Degarelix|degarelix
82195|NCT03689699|HuMax IL-8|humax il-8
82196|NCT03689686|Noninvasive ventilation|noninvasive ventilation
82197|NCT03689660|motivation|motivation
82198|NCT03689660|neuromuscular disease|neuromuscular disease
82199|NCT03689660|duchenne muscular dystrophy|duchenne muscular dystrophy
82200|NCT03689660|spinal Muscular Atrophy|spinal muscular atrophy
82201|NCT03689660|virtual reality|virtual reality
82202|NCT03689660|biofeedback training|biofeedback training
82203|NCT03689608|intermittent fasting|intermittent fasting
82204|NCT03689608|calorie restriction|calorie restriction
82205|NCT03689608|prediabetes|prediabetes
82206|NCT03689595|Multiple Myeloma|multiple myeloma
82207|NCT03689569|microbiome|microbiome
82208|NCT03689569|inflammation|inflammation
82209|NCT03689569|resistant starch|resistant starch
82210|NCT03689569|exercise training|exercise training
82211|NCT03689556|FLT PET/CT|flt pet/ct
82212|NCT03689556|carbon ion radiation therapy|carbon ion radiation therapy
82213|NCT03689556|re-irradiation|re-irradiation
82214|NCT03689543|Perimenopause-related depression|perimenopause-related depression
82215|NCT03689530|peer support|peer support
82216|NCT03689504|Guatemala|guatemala
82217|NCT03689504|indigenous|indigenous
82218|NCT03689504|dietary diversity|dietary diversity
82219|NCT03689504|chronic malnutrition|chronic malnutrition
82220|NCT03689504|Maya|maya
82221|NCT03689504|agriculture|agriculture
82222|NCT03689504|behavior change|behavior change
82223|NCT03689504|food insecurity|food insecurity
82224|NCT03689491|rTMS|rtms
82225|NCT03689491|visual feedback|visual feedback
82226|NCT03689491|gait|gait
82724|NCT03685721|Trait|trait
82228|NCT03689478|Bladder cancer|bladder cancer
82229|NCT03689465|Hematopoietic Stem Cell Transplantation|hematopoietic stem cell transplantation
82230|NCT03689465|posttransplantation cyclophosphamide|posttransplantation cyclophosphamide
82231|NCT03689465|antithymocyte globulin|antithymocyte globulin
82232|NCT03689465|viral infection|viral infection
82233|NCT03689465|graft-versus-host disease|graft-versus-host disease
82234|NCT03689426|Cardiovascular Magnetic Resonance Imaging|cardiovascular magnetic resonance imaging
82235|NCT03689426|Tissue Characterisation|tissue characterisation
82236|NCT03689426|Wearable Technology|wearable technology
82237|NCT03689426|Prognosis|prognosis
82239|NCT03689413|neuromonitoring|neuromonitoring
82240|NCT03689413|thyroid surgery|thyroid surgery
82241|NCT03689387|cerebral vascular stroke|cerebral vascular stroke
82242|NCT03689387|activity practice|activity practice
82243|NCT03689361|migraine aura|migraine aura
82244|NCT03689322|aging|aging
82245|NCT03689322|whole body vibration|whole body vibration
82246|NCT03689322|respiratory muscle training|respiratory muscle training
82247|NCT03689309|Spontaneous breathing Trial|spontaneous breathing trial
82248|NCT03689309|High Flow Oxygen|high flow oxygen
82249|NCT03689270|subluxation|subluxation
82250|NCT03689270|Divide and conquer|divide and conquer
82251|NCT03689257|inflammatory bowel disease|inflammatory bowel disease
82252|NCT03689257|Ulcerative colitis|ulcerative colitis
82253|NCT03689257|Crohn´s disease|crohn´s disease
82254|NCT03689257|epidemiology|epidemiology
82255|NCT03689257|incidence|incidence
82256|NCT03689257|omics|omics
82259|NCT03689192|Arginase 1|arginase 1
82260|NCT03689166|Probiotics|probiotics
82261|NCT03689166|Preterm birth|preterm birth
82262|NCT03689166|Threatened preterm labour|threatened preterm labour
82263|NCT03689140|mHealth|mhealth
82264|NCT03689140|Mobile health|mobile health
82265|NCT03689140|Telehealth|telehealth
82266|NCT03689140|Pregnancy|pregnancy
82267|NCT03689140|Tobacco|tobacco
82268|NCT03689140|Cessation|cessation
82269|NCT03689127|intubation|intubation
82270|NCT03689127|pharyngitis|pharyngitis
82271|NCT03689114|epilepsy|epilepsy
82272|NCT03689114|antiepileptic drugs|antiepileptic drugs
82273|NCT03689114|low dose|low dose
82274|NCT03689114|standard dose|standard dose
82275|NCT03689114|new diagnosis|new diagnosis
82276|NCT03689049|Polypharmacy|polypharmacy
82277|NCT03689049|Deprescribing|deprescribing
82278|NCT03689049|Aged Adult|aged adult
82279|NCT03689049|Elderly Patient|elderly patient
82280|NCT03689049|Primary Health Care|primary health care
82281|NCT03689049|Quality Improvement|quality improvement
82282|NCT03689049|Practice Facilitation|practice facilitation
82283|NCT03689049|Learning Collaborative|learning collaborative
82284|NCT03689049|Electronic Medical Records (EMR)|electronic medical records (emr)
82285|NCT03689036|malaria|malaria
82286|NCT03689036|transmission|transmission
82287|NCT03689036|Asymptomatic infeccion|asymptomatic infeccion
82288|NCT03689036|malaria elimination|malaria elimination
82289|NCT03689036|residual malaria|residual malaria
82290|NCT03689036|Amazon|amazon
82291|NCT03689023|Cardiovascular Diseases|cardiovascular diseases
82292|NCT03689023|Health Promotion|health promotion
82293|NCT03688997|simulator|simulator
82294|NCT03688997|knot tying|knot tying
82295|NCT03688997|vessel ligation|vessel ligation
82296|NCT03688997|surgical training|surgical training
82297|NCT03688932|aging|aging
82298|NCT03688932|functional capacity|functional capacity
82299|NCT03688932|muscle metabolism|muscle metabolism
82300|NCT03688919|adolescents|adolescents
82301|NCT03688919|Type 1 Diabetes|type 1 diabetes
82302|NCT03688906|Liquid biopsy|liquid biopsy
82303|NCT03688906|Blood test cancer|blood test cancer
82304|NCT03688906|Cancer diagnostic|cancer diagnostic
82305|NCT03688906|Genomics|genomics
82306|NCT03688906|Genomic test|genomic test
82307|NCT03688906|AI genomics|ai genomics
82308|NCT03688906|CRC|crc
82309|NCT03688906|Cancer screening|cancer screening
82310|NCT03688893|Bleaching|bleaching
82311|NCT03688893|Laser|laser
82312|NCT03688893|CIELCH|cielch
82313|NCT03688880|Wounds|wounds
82314|NCT03688880|Injuries|injuries
82315|NCT03688880|Surgery|surgery
82316|NCT03688880|Lacerations|lacerations
82317|NCT03688880|Wound healing|wound healing
82318|NCT03688880|Surgical Wounds|surgical wounds
82319|NCT03688841|Varicose ulcer|varicose ulcer
82320|NCT03688841|Compression Therapy|compression therapy
82321|NCT03688841|Negative Pressure|negative pressure
82322|NCT03688841|Vacuum Assisted Closure|vacuum assisted closure
82323|NCT03688828|Saccharomyces Boulardii|saccharomyces boulardii
82324|NCT03688828|Standard Quadruple Therapy|standard quadruple therapy
82325|NCT03688763|insomnia|insomnia
82326|NCT03688763|anxiety|anxiety
82327|NCT03688763|PTSD|ptsd
82328|NCT03688750|heel height|heel height
82329|NCT03688750|spinal configuration|spinal configuration
82330|NCT03688750|phases of menstrual cycle|phases of menstrual cycle
82331|NCT03688737|low level laser , cleft palate , healing|low level laser , cleft palate , healing
82332|NCT03688711|glucagon|glucagon
82333|NCT03688685|ET|et
82334|NCT03688685|Essential Tremor|essential tremor
82335|NCT03688672|contact lens|contact lens
82336|NCT03688672|soft contact lens|soft contact lens
82337|NCT03688672|feasibility|feasibility
82338|NCT03688620|Pilot study|pilot study
82339|NCT03688620|Safety surveillance|safety surveillance
82340|NCT03688620|Quadrivalent seasonal influenza vaccine|quadrivalent seasonal influenza vaccine
82341|NCT03688620|Influenza|influenza
82342|NCT03688607|NICU|nicu
82343|NCT03688607|POKE|poke
82344|NCT03688607|Length of Stay|length of stay
82345|NCT03688607|Infection|infection
82346|NCT03688607|Neonates|neonates
82347|NCT03688581|Abortion|abortion
82348|NCT03688581|Emergency contraception|emergency contraception
82349|NCT03688581|Emergency pill|emergency pill
82350|NCT03688581|Perception of pregnancy risk|perception of pregnancy risk
82351|NCT03688581|Contraceptive failure|contraceptive failure
82352|NCT03688542|Deprescribing|deprescribing
82353|NCT03688542|Inappropriate Medication|inappropriate medication
82354|NCT03688542|Nursing Homes|nursing homes
82355|NCT03688516|emotion|emotion
82356|NCT03688516|memory|memory
82357|NCT03688516|Williams-Beuren syndrome|williams-beuren syndrome
82358|NCT03688490|aquagenic pruritus|aquagenic pruritus
82359|NCT03688425|Intraocular Lens|intraocular lens
82360|NCT03688425|trifocal|trifocal
82361|NCT03688425|hydrophobic|hydrophobic
82362|NCT03688412|Cardiac pacing, artificial|cardiac pacing, artificial
82363|NCT03688412|Cardiac Resynchronizaton Therapy Devices|cardiac resynchronizaton therapy devices
82364|NCT03688412|Defibrillators, Implantable|defibrillators, implantable
82365|NCT03688399|Intraocular Lens|intraocular lens
82366|NCT03688399|trifocal|trifocal
82367|NCT03688399|cataract|cataract
82368|NCT03688399|PhysIOL|physiol
82369|NCT03688386|Language intervention|language intervention
82370|NCT03688386|Preterm reading|preterm reading
82371|NCT03688386|Heart rate variability|heart rate variability
82372|NCT03688386|Mother-infant interaction|mother-infant interaction
82373|NCT03688386|NICU Network Neurobehavioral Scale|nicu network neurobehavioral scale
82374|NCT03688386|LENA|lena
82375|NCT03688321|Probiotics|probiotics
82376|NCT03688321|Group B Streptococcus|group b streptococcus
82377|NCT03688321|Infection|infection
82378|NCT03688321|Prevention|prevention
82379|NCT03688308|Bone marrow aspirate|bone marrow aspirate
82380|NCT03688308|Biologics|biologics
82381|NCT03688295|complicated acute appendicitis|complicated acute appendicitis
82382|NCT03688295|post-operative antibiotic therapy|post-operative antibiotic therapy
82383|NCT03688269|regional anesthesia|regional anesthesia
82384|NCT03688269|dexamethasone|dexamethasone
82385|NCT03688269|ropivacaine|ropivacaine
82386|NCT03688243|AMD|amd
82387|NCT03688243|early AMD|early amd
82388|NCT03688243|intermediate AMD|intermediate amd
82389|NCT03688243|Geographic Atrophy|geographic atrophy
82390|NCT03688243|nascent GA|nascent ga
82391|NCT03688217|exclusive breastfeeding|exclusive breastfeeding
82392|NCT03688217|health education|health education
82393|NCT03688217|entertainment-education|entertainment-education
82394|NCT03688217|low- and middle-income countries|low- and middle-income countries
82395|NCT03688217|video-based|video-based
82396|NCT03688217|narrative|narrative
82397|NCT03688217|community-based|community-based
82398|NCT03688204|Breast Cancer|breast cancer
82399|NCT03688204|Breast Neoplasm|breast neoplasm
82400|NCT03688204|Genetic Testing|genetic testing
82401|NCT03688204|Breast Cancer Risk|breast cancer risk
82402|NCT03688204|Cancer Risk|cancer risk
82403|NCT03688204|Risk Score|risk score
82404|NCT03688204|Genetic Risk Score|genetic risk score
82405|NCT03688204|Polygenic Risk Score|polygenic risk score
82406|NCT03688204|Personalized Risk Score|personalized risk score
82407|NCT03688191|Sirolimus|sirolimus
82408|NCT03688191|connective tissue disease|connective tissue disease
82409|NCT03688191|thrombocytopenia|thrombocytopenia
82410|NCT03688178|Glioblastoma|glioblastoma
82411|NCT03688178|Dendritic cells|dendritic cells
82412|NCT03688178|Temozolomide|temozolomide
82413|NCT03688178|Duke University|duke university
82414|NCT03688178|Varlilumab|varlilumab
82415|NCT03688165|Stroke|stroke
82416|NCT03688165|End-effector|end-effector
82417|NCT03688165|Exoskeleton|exoskeleton
82418|NCT03688165|Treadmill-based gait training|treadmill-based gait training
82419|NCT03688165|Over-ground gait training|over-ground gait training
82420|NCT03688165|Rehabilitation|rehabilitation
82421|NCT03688165|Functional Gait Recovery|functional gait recovery
82422|NCT03688165|Hemiparesis|hemiparesis
82423|NCT03688165|Treadmill-based robotic systems|treadmill-based robotic systems
82424|NCT03688152|Diffuse large B-cell lymphoma|diffuse large b-cell lymphoma
82425|NCT03688152|DLBCL|dlbcl
82426|NCT03688152|Non-Hodgkin lymphoma|non-hodgkin lymphoma
82427|NCT03688152|phosphatidylinositol 3-kinase delta inhibitor|phosphatidylinositol 3-kinase delta inhibitor
82428|NCT03688152|PI3Kδ|pi3kδ
82429|NCT03688152|PIM kinases|pim kinases
82430|NCT03688139|depression|depression
82431|NCT03688139|major depressive disorder|major depressive disorder
82432|NCT03688139|mental health|mental health
82433|NCT03688139|mood disorder|mood disorder
82434|NCT03688139|geriatric|geriatric
82435|NCT03688139|late-life|late-life
82436|NCT03688126|cognitive decline|cognitive decline
82437|NCT03688126|dementia|dementia
82438|NCT03688126|cognitive function|cognitive function
82440|NCT03688074|Uncontrolled asthma|uncontrolled asthma
82441|NCT03688074|Severe uncontrolled asthma|severe uncontrolled asthma
82442|NCT03688061|Hepatitis|hepatitis
82443|NCT03688061|Vaccine|vaccine
82444|NCT03688061|Adenoviral-vector|adenoviral-vector
82445|NCT03688061|human invariant chain|human invariant chain
82446|NCT03688022|Relative Bioavailability and DDI study with MT-7117 and a proton pump inhibitor|relative bioavailability and ddi study with mt-7117 and a proton pump inhibitor
82447|NCT03688009|mindfulness-based intervention|mindfulness-based intervention
82448|NCT03688009|family psychoeducation|family psychoeducation
82449|NCT03688009|Chinese family caregivers|chinese family caregivers
82450|NCT03688009|early psychosis|early psychosis
82451|NCT03688009|mixed methods design|mixed methods design
82452|NCT03687983|GoldenFlow Peripheral Stent System|goldenflow peripheral stent system
82453|NCT03687970|CIPN|cipn
82454|NCT03687970|Neuropathic pain|neuropathic pain
82455|NCT03687970|DLss|dlss
82456|NCT03687970|Peripheral neuropathy|peripheral neuropathy
82457|NCT03687944|Rheumatoid Arthritis|rheumatoid arthritis
82458|NCT03687944|Unsupported Upper Limb Exercise Test|unsupported upper limb exercise test
82459|NCT03687944|Validity|validity
82460|NCT03687892|repetitive Transcranial Magnetic Stimulation|repetitive transcranial magnetic stimulation
82461|NCT03687892|functional MRI|functional mri
82462|NCT03687892|Theta Burst Stimulation|theta burst stimulation
82463|NCT03687866|NIPT|nipt
82464|NCT03687866|digital PCR|digital pcr
82465|NCT03687866|trisomy 21|trisomy 21
82466|NCT03687866|prenatal diagnosis|prenatal diagnosis
82467|NCT03687853|Pancreatic ductal adenocarcinoma|pancreatic ductal adenocarcinoma
82468|NCT03687853|arterial infusion chemotherapy|arterial infusion chemotherapy
82469|NCT03687853|liver metastases|liver metastases
82470|NCT03687840|Diabetic Polyneuropathy|diabetic polyneuropathy
82471|NCT03687840|Lower Extremity Burn Injury|lower extremity burn injury
82472|NCT03687840|Spatio-Temporal Parameters of Gait|spatio-temporal parameters of gait
82473|NCT03687840|Gait Symmetry|gait symmetry
82474|NCT03687801|audiologic rehabilitation|audiologic rehabilitation
82475|NCT03687801|hearing loss|hearing loss
82476|NCT03687801|patient education|patient education
82477|NCT03687801|patient participation|patient participation
82478|NCT03687801|structured rehabilitation|structured rehabilitation
82479|NCT03687801|internet interventions|internet interventions
82480|NCT03687801|counseling|counseling
82481|NCT03687788|Laughter therapy; Loneliness; Life Satisfaction; Older adults; Nursing|laughter therapy; loneliness; life satisfaction; older adults; nursing
82482|NCT03687762|chronic pain|chronic pain
82483|NCT03687762|mechanisms|mechanisms
82484|NCT03687762|cognitive therapy|cognitive therapy
82485|NCT03687762|mindfulness meditation|mindfulness meditation
82486|NCT03687762|activation skills|activation skills
82487|NCT03687697|IVF|ivf
82488|NCT03687606|Gonadotropin treatment|gonadotropin treatment
82489|NCT03687606|human chorionic gonadotropin|human chorionic gonadotropin
82490|NCT03687606|human menopausal gonadotropin|human menopausal gonadotropin
82491|NCT03687580|Photobiomodulation|photobiomodulation
82492|NCT03687580|Low-Level Laser Therapy|low-level laser therapy
82493|NCT03687580|over the counter|over the counter
82494|NCT03687541|In-hospital falls|in-hospital falls
82495|NCT03687541|fall-related bleeding|fall-related bleeding
82496|NCT03687541|anticoagulant-related bleeding|anticoagulant-related bleeding
82497|NCT03687541|antiplatelet-related bleeding|antiplatelet-related bleeding
82498|NCT03687541|antithrombotic-related bleeding|antithrombotic-related bleeding
82499|NCT03687528|emergencies|emergencies
82500|NCT03687528|platelet inhibitors|platelet inhibitors
82501|NCT03687528|minor head injury trauma|minor head injury trauma
82502|NCT03687528|CT-scan|ct-scan
82503|NCT03687489|Abdominal Aortic Aneurysm Stent Graft System|abdominal aortic aneurysm stent graft system
82504|NCT03687463|HSCT|hsct
82505|NCT03687463|PT/Cy|pt/cy
82506|NCT03687463|Decitabine|decitabine
82507|NCT03687463|JMML|jmml
82508|NCT03687450|yoga|yoga
82509|NCT03687450|mindfulness|mindfulness
82510|NCT03687450|meditation|meditation
82511|NCT03687450|resident|resident
82512|NCT03687450|residency|residency
82513|NCT03687437|Oral lichen planus, mean platelet volume|oral lichen planus, mean platelet volume
82514|NCT03687424|"Noninvasive Ventilation[Mesh]"|"noninvasive ventilation[mesh]"
82515|NCT03687424|"Obesity[Mesh]"|"obesity[mesh]"
82516|NCT03687424|"Deep Sedation[Mesh]"|"deep sedation[mesh]"
82517|NCT03687424|"Hypoxia[Mesh]"|"hypoxia[mesh]"
82518|NCT03687424|"Adult[Mesh]"|"adult[mesh]"
82519|NCT03687424|"Airway management[Mesh]"|"airway management[mesh]"
82520|NCT03687424|"Colonoscopy[Mesh]"|"colonoscopy[mesh]"
82521|NCT03687411|spinal anaesthesia|spinal anaesthesia
82522|NCT03687411|Neuraxial ultrasonography|neuraxial ultrasonography
82523|NCT03687411|landmark identification|landmark identification
82524|NCT03687398|genetic analysis|genetic analysis
82525|NCT03687398|endometriosis|endometriosis
82526|NCT03687398|nanoclonal|nanoclonal
82527|NCT03687398|copy number|copy number
82528|NCT03687385|"Noninvasive Ventilation[Mesh]"|"noninvasive ventilation[mesh]"
82529|NCT03687385|"Airway management[Mesh]"|"airway management[mesh]"
82530|NCT03687385|"Adult[Mesh]"|"adult[mesh]"
82531|NCT03687385|"Colonoscopy[Mesh]"|"colonoscopy[mesh]"
82532|NCT03687385|"Deep Sedation[Mesh]"|"deep sedation[mesh]"
82533|NCT03687385|"Hypoxia[Mesh]"|"hypoxia[mesh]"
82534|NCT03687372|common warts|common warts
82535|NCT03687346|fMRI|fmri
82536|NCT03687346|Eating disorder|eating disorder
82537|NCT03687346|adolescent|adolescent
82538|NCT03687320|Photobiomodulation|photobiomodulation
82539|NCT03687320|Low-Level Light Therapy|low-level light therapy
82540|NCT03687320|Low-Level Laser Therapy|low-level laser therapy
82541|NCT03687307|class II,|class ii,
82542|NCT03687307|soft tissue changes|soft tissue changes
82543|NCT03687307|CBCT|cbct
82544|NCT03687229|micro ribonucleic acid-122|micro ribonucleic acid-122
82545|NCT03687229|insulin|insulin
82546|NCT03687203|Activity of daily living function|activity of daily living function
82547|NCT03687203|Cognitive impairment|cognitive impairment
82548|NCT03687203|Parkinson's disease dementia|parkinson's disease dementia
82549|NCT03687099|Glioblastoma|glioblastoma
82550|NCT03687099|CD45|cd45
82551|NCT03687099|Lymphocytes|lymphocytes
82552|NCT03687099|Microglia|microglia
82553|NCT03687099|Macrophage|macrophage
82554|NCT03687047|DENTADURES|dentadures
82555|NCT03687047|EDENTULOUS|edentulous
82556|NCT03687047|MASTIGATORY PERFORMANCE|mastigatory performance
82557|NCT03687021|endometrial receptivity|endometrial receptivity
82558|NCT03687021|RNA|rna
82559|NCT03687021|progesterone|progesterone
82560|NCT03687008|Cognition|cognition
82561|NCT03687008|Working Memory|working memory
82562|NCT03687008|Magnetic Resonance Imaging|magnetic resonance imaging
82563|NCT03687008|Cogmed|cogmed
82564|NCT03686943|Elderly|elderly
82565|NCT03686943|Iatrogenic drug risk|iatrogenic drug risk
82566|NCT03686943|Family pharmacy|family pharmacy
82567|NCT03686917|diabetes|diabetes
82568|NCT03686917|type 2 diabetes|type 2 diabetes
82569|NCT03686917|diabetes mellitus|diabetes mellitus
82570|NCT03686917|type 2 diabetes mellitus|type 2 diabetes mellitus
82571|NCT03686917|outpatient|outpatient
82572|NCT03686878|Keratoconjunctivitis Sicca|keratoconjunctivitis sicca
82573|NCT03686878|Dry Eye Disease|dry eye disease
82574|NCT03686878|Eye Dryness|eye dryness
82575|NCT03686865|regenerated bone, native bone, dental implant|regenerated bone, native bone, dental implant
82576|NCT03686839|Neurofeedback|neurofeedback
82577|NCT03686839|Acceptance technology|acceptance technology
82578|NCT03686839|Electroencephalography|electroencephalography
82579|NCT03686839|MCI|mci
82580|NCT03686826|evoked potentials (EP)|evoked potentials (ep)
82581|NCT03686826|motor evoked potentials (MEP)|motor evoked potentials (mep)
82582|NCT03686826|Somato-sensory evoked potentials (SSEP)|somato-sensory evoked potentials (ssep)
82583|NCT03686826|multimodal evoked potentials (mmEP)|multimodal evoked potentials (mmep)
82584|NCT03686800|VLS|vls
82585|NCT03686787|melasma|melasma
82586|NCT03686787|chloasma|chloasma
82587|NCT03686787|tranexamic acid|tranexamic acid
82588|NCT03686787|nonablative laser resurfacing|nonablative laser resurfacing
82589|NCT03686787|sunscreen|sunscreen
82590|NCT03686787|hyperpigmentation|hyperpigmentation
82591|NCT03686774|Memantine|memantine
82592|NCT03686774|post-mastectomy|post-mastectomy
82593|NCT03686774|prophylaxis|prophylaxis
82594|NCT03686774|Neuropathic pain|neuropathic pain
82595|NCT03686774|Cognitive-emotional parameters|cognitive-emotional parameters
82596|NCT03686761|Inflammation|inflammation
82597|NCT03686761|Healing|healing
82598|NCT03686761|Distraction|distraction
82599|NCT03686761|Periodontium|periodontium
82600|NCT03686748|Pain|pain
82601|NCT03686696|Myocardial infarction|myocardial infarction
82602|NCT03686696|Treatment|treatment
82603|NCT03686696|ACE inhibitors|ace inhibitors
82604|NCT03686696|Angiotensin receptor blockade|angiotensin receptor blockade
82605|NCT03686696|Beta blockers|beta blockers
82606|NCT03686683|ISUP Grade Group 1 or 2|isup grade group 1 or 2
82607|NCT03686683|Number biopsies 1 or >1 (≤12 months of Screening)|number biopsies 1 or >1 (≤12 months of screening)
82608|NCT03686657|Diabetes|diabetes
82609|NCT03686657|Obesity|obesity
82610|NCT03686657|FPG|fpg
82611|NCT03686657|Beta cell function index|beta cell function index
82612|NCT03686657|HbA1c|hba1c
82613|NCT03686657|Atherogenic index|atherogenic index
82614|NCT03686644|night splinting|night splinting
82615|NCT03686644|stiffness|stiffness
82616|NCT03686644|ankle foot orthoses|ankle foot orthoses
82617|NCT03686644|teenager|teenager
82618|NCT03686631|respiratory therapy|respiratory therapy
82619|NCT03686631|Pulmonary Atelectasis|pulmonary atelectasis
82620|NCT03686631|perioperative medicine|perioperative medicine
82621|NCT03686631|incentive spirometry|incentive spirometry
82622|NCT03686631|smartphone|smartphone
82623|NCT03686592|Pancreatic cancer|pancreatic cancer
82626|NCT03686514|Flu vaccine|flu vaccine
82627|NCT03686514|Influenza vaccine|influenza vaccine
82628|NCT03686514|Immune response|immune response
82629|NCT03686514|Influenza strain|influenza strain
82630|NCT03686501|HV|hv
82631|NCT03686475|Pulpotomy, Primary molars, Biodentine, MTA.|pulpotomy, primary molars, biodentine, mta.
82632|NCT03686436|unrecognized condition|unrecognized condition
82633|NCT03686423|Exercise|exercise
82634|NCT03686410|Fibromyalgia|fibromyalgia
82635|NCT03686410|Therapeutic Patient Education|therapeutic patient education
82636|NCT03686410|Educational Technology|educational technology
82637|NCT03686410|Mixed Methods Research|mixed methods research
82638|NCT03686410|Pain|pain
82639|NCT03686410|Poor Sleep Quality|poor sleep quality
82640|NCT03686345|Midostaurin|midostaurin
82641|NCT03686345|Chemotherapy|chemotherapy
82642|NCT03686345|Relapse Incidence|relapse incidence
82643|NCT03686345|Overall Survival|overall survival
82644|NCT03686345|Disease Free Survival|disease free survival
82645|NCT03686345|Minimal Residual Disease monitoring|minimal residual disease monitoring
82646|NCT03686332|Radiotherapy|radiotherapy
82647|NCT03686332|Immunotherapy|immunotherapy
82648|NCT03686332|Atezolizumab|atezolizumab
82649|NCT03686293|Glucose tolerance|glucose tolerance
82650|NCT03686293|Gut microbiota|gut microbiota
82651|NCT03686293|Microbial richness|microbial richness
82652|NCT03686293|Gastric emptying|gastric emptying
82653|NCT03686293|Metabolomics|metabolomics
82654|NCT03686267|implants- titanium abutments- all ceramic crowns- lithium disilicate- color measurements- pink and white aesthetics|implants- titanium abutments- all ceramic crowns- lithium disilicate- color measurements- pink and white aesthetics
822284|NCT00147355|HIV|hiv
82655|NCT03686241|Tibiotalocalcaneal arthrodesis|tibiotalocalcaneal arthrodesis
82656|NCT03686241|Intramedullary Nail|intramedullary nail
82657|NCT03686241|Sustained Compression|sustained compression
82660|NCT03686189|Iliac Bifurcation Stent Graft System|iliac bifurcation stent graft system
82661|NCT03686163|Acute Ischemic stroke|acute ischemic stroke
82662|NCT03686163|Nerve Growth Factor|nerve growth factor
82663|NCT03686163|Intranasal|intranasal
82664|NCT03686163|Neurological Function|neurological function
82665|NCT03686150|pediatric obesity|pediatric obesity
82666|NCT03686124|T-cell therapy|t-cell therapy
82667|NCT03686124|immunotherapy|immunotherapy
82668|NCT03686098|Diet|diet
82669|NCT03686098|Soy|soy
82670|NCT03686098|Prevention|prevention
82671|NCT03686098|Asian|asian
82672|NCT03686098|Breast Cancer|breast cancer
82673|NCT03686098|Mammographic Density|mammographic density
82674|NCT03686098|Isoflavones|isoflavones
82675|NCT03686046|Hearing aid|hearing aid
82676|NCT03686033|E2082|e2082
82677|NCT03686033|Epilepsy|epilepsy
82678|NCT03686033|Photosensitive|photosensitive
82679|NCT03686033|Anti-epileptic|anti-epileptic
82680|NCT03686033|Seizures|seizures
82681|NCT03686033|Photoparoxysmal response|photoparoxysmal response
82682|NCT03686033|PPR|ppr
82683|NCT03686020|Oral potentially malignant lesions|oral potentially malignant lesions
82684|NCT03686020|Oral cancer|oral cancer
82685|NCT03686020|salivary CYFRA21-1|salivary cyfra21-1
82686|NCT03686020|serum CYFRA21-1|serum cyfra21-1
82687|NCT03685942|light therapy|light therapy
82688|NCT03685929|Pressure ulcer|pressure ulcer
82689|NCT03685929|Incontinence-associated dermatitis|incontinence-associated dermatitis
82690|NCT03685929|Histopathology|histopathology
82691|NCT03685929|Ischemia|ischemia
82692|NCT03685929|Irritation|irritation
82693|NCT03685929|Prevention|prevention
82694|NCT03685929|Tissue|tissue
82695|NCT03685929|Skin|skin
82696|NCT03685838|mechano-chemical ablation|mechano-chemical ablation
82697|NCT03685838|compression stockings|compression stockings
82698|NCT03685825|Surgeon experience|surgeon experience
82699|NCT03685825|Endothelial cell loss|endothelial cell loss
82700|NCT03685812|Patellofemoral Pain Syndrome|patellofemoral pain syndrome
82701|NCT03685812|Autocad software|autocad software
82702|NCT03685812|position sense|position sense
82703|NCT03685812|validity|validity
82704|NCT03685812|reliability|reliability
82705|NCT03685799|Barretts Esophagus|barretts esophagus
82706|NCT03685799|Dysplasia|dysplasia
82707|NCT03685773|diabetes|diabetes
82708|NCT03685773|type 2 diabetes|type 2 diabetes
82709|NCT03685773|diazoxide|diazoxide
82710|NCT03685773|insulin resistance|insulin resistance
82711|NCT03685773|MRI|mri
82712|NCT03685773|liver transplant|liver transplant
82713|NCT03685760|Mechanically Ventilated Older Adults|mechanically ventilated older adults
82714|NCT03685760|Reiki|reiki
82715|NCT03685760|Pain|pain
82716|NCT03685760|Agitation|agitation
82717|NCT03685760|Delirium|delirium
82718|NCT03685747|Vancomycin|vancomycin
82719|NCT03685747|Pharmacokinetics|pharmacokinetics
82720|NCT03685747|Pharmacodynamics|pharmacodynamics
82721|NCT03685747|Automated Peritoneal Dialysis|automated peritoneal dialysis
82722|NCT03685734|DSAEK|dsaek
82723|NCT03685721|ATP|atp
82725|NCT03685721|GDP|gdp
82726|NCT03685721|Genetics|genetics
82727|NCT03685708|Ibrutinib|ibrutinib
82728|NCT03685708|Acalabrutinib|acalabrutinib
82729|NCT03685708|Immunology|immunology
82730|NCT03685669|DNA methylation|dna methylation
82731|NCT03685669|ctDNA|ctdna
82732|NCT03685656|Overweight|overweight
82733|NCT03685656|Obesity|obesity
82734|NCT03685656|Slimming gel|slimming gel
82735|NCT03685656|Cosmetic product|cosmetic product
82736|NCT03685656|Waist circumference|waist circumference
82737|NCT03685656|Thigh circumference|thigh circumference
82738|NCT03685643|Peer-led, dating applications, young adults, sexual behavior|peer-led, dating applications, young adults, sexual behavior
82739|NCT03685630|Brivaracetam|brivaracetam
82740|NCT03685630|Epilepsy|epilepsy
82986|NCT03684109|Primary Brain Tumor|primary brain tumor
82741|NCT03685630|Partial seizures with or without secondary generalization|partial seizures with or without secondary generalization
82742|NCT03685630|Japanese subjects|japanese subjects
82743|NCT03685604|chlorhexidine in alcoholic solution|chlorhexidine in alcoholic solution
82744|NCT03685604|PVP iodine in alcoholic solution|pvp iodine in alcoholic solution
82745|NCT03685604|preoperative skin antisepsis|preoperative skin antisepsis
82746|NCT03685591|efficacy|efficacy
82747|NCT03685591|safety|safety
82748|NCT03685591|pharmacokinetics|pharmacokinetics
82749|NCT03685591|dose escalation|dose escalation
82750|NCT03685591|dose expansion|dose expansion
82751|NCT03685591|open-label|open-label
82752|NCT03685591|TGFb|tgfb
82753|NCT03685591|transforming growth factor beta|transforming growth factor beta
82754|NCT03685591|breast cancer|breast cancer
82755|NCT03685591|prostate cancer|prostate cancer
82757|NCT03685591|HER2 negative|her2 negative
82758|NCT03685591|CRPC|crpc
82759|NCT03685591|metastatic|metastatic
82760|NCT03685591|advanced|advanced
82761|NCT03685591|adenocarcinoma|adenocarcinoma
82762|NCT03685578|Mechanical thrombectomy, EmboTrap|mechanical thrombectomy, embotrap
82763|NCT03685565|facial laceration|facial laceration
82764|NCT03685565|pediatric|pediatric
82765|NCT03685565|dermabond|dermabond
82766|NCT03685565|skin glue|skin glue
82767|NCT03685565|steristrips|steristrips
82768|NCT03685565|skin adhesive|skin adhesive
82769|NCT03685565|scar|scar
82770|NCT03685565|cosmesis|cosmesis
82771|NCT03685487|decolonization|decolonization
82772|NCT03685487|mupirocin|mupirocin
82773|NCT03685487|cardiac surgery|cardiac surgery
82774|NCT03685474|Special Learning Needs|special learning needs
82775|NCT03685474|Minority Groups|minority groups
82776|NCT03685461|Hearing Loss|hearing loss
82777|NCT03685461|Cochlear Implant|cochlear implant
82778|NCT03685435|Ultrasound|ultrasound
82779|NCT03685435|Gastric content|gastric content
82780|NCT03685435|Non-fasting|non-fasting
82781|NCT03685435|Rapid Sequence Induction|rapid sequence induction
82782|NCT03685435|Gastric volume|gastric volume
82783|NCT03685422|Virtual Reality|virtual reality
82784|NCT03685422|Pain|pain
82785|NCT03685422|Anxiety|anxiety
82786|NCT03685422|Analgesia|analgesia
82787|NCT03685422|Patient satisfaction|patient satisfaction
82788|NCT03685396|Connective tissue graft|connective tissue graft
82789|NCT03685396|Platelet concentrates|platelet concentrates
82790|NCT03685396|PRF|prf
82791|NCT03685396|Mucogingival surgery|mucogingival surgery
82792|NCT03685383|Extracorporeal Circulation|extracorporeal circulation
82793|NCT03685383|Extracorporeal Membrane Oxygenation|extracorporeal membrane oxygenation
82794|NCT03685383|Cytokine Adsorption|cytokine adsorption
82795|NCT03685383|Post-Cardiac Arrest Syndrome|post-cardiac arrest syndrome
82796|NCT03685383|Cardiac Arrest|cardiac arrest
82797|NCT03685383|Cardio-Pulmonary Resuscitation|cardio-pulmonary resuscitation
82798|NCT03685370|Epidural catheter|epidural catheter
82799|NCT03685370|postoperative pain|postoperative pain
82800|NCT03685370|LOS|los
82801|NCT03685344|Loncastuximab Tesirine in Combination with Durvalumab|loncastuximab tesirine in combination with durvalumab
82802|NCT03685331|HER2-negative|her2-negative
82803|NCT03685305|Weight loss|weight loss
82804|NCT03685305|Cognitive function|cognitive function
82805|NCT03685305|Weight maintenance|weight maintenance
82806|NCT03685253|diabetes|diabetes
82807|NCT03685253|neuropathy|neuropathy
82808|NCT03685253|treatment|treatment
82809|NCT03685253|drug|drug
82810|NCT03685227|Yoga Nidra|yoga nidra
82811|NCT03685227|Electroencephalography|electroencephalography
82812|NCT03685227|Electrocardiography|electrocardiography
82813|NCT03685227|Respiratory rate|respiratory rate
82814|NCT03685214|sepsis|sepsis
82815|NCT03685214|intensive care unit|intensive care unit
82816|NCT03685214|acetated Ringer's solution|acetated ringer's solution
82817|NCT03685214|AKI|aki
82818|NCT03685214|normal saline|normal saline
82819|NCT03685214|prognosis|prognosis
82820|NCT03685214|continuous renal replacement therapy|continuous renal replacement therapy
82821|NCT03685201|orange pomace fiber|orange pomace fiber
82822|NCT03685201|glycemic response|glycemic response
82823|NCT03685201|Orange|orange
82824|NCT03685175|Magnetic Resonance Imaging|magnetic resonance imaging
82825|NCT03685175|Doxorubicin|doxorubicin
82826|NCT03685162|addiction|addiction
82827|NCT03685162|opioid addiction|opioid addiction
82828|NCT03685162|levomethadone|levomethadone
82829|NCT03685162|methadone|methadone
82830|NCT03685162|opioid maintenance treatment|opioid maintenance treatment
82831|NCT03685149|arrhythmogenic right ventricular cardiomyopathy|arrhythmogenic right ventricular cardiomyopathy
82832|NCT03685149|ARVC|arvc
82833|NCT03685149|Flecainide|flecainide
82834|NCT03685149|ventricualr arrhythmias|ventricualr arrhythmias
82835|NCT03685149|implantable cardioverter-defibrillator|implantable cardioverter-defibrillator
82836|NCT03685123|Exercise training|exercise training
82837|NCT03685123|Insulin resistance|insulin resistance
82838|NCT03685123|Lipids|lipids
82839|NCT03685123|Arterial stiffness|arterial stiffness
82840|NCT03685123|Fitness|fitness
82841|NCT03685123|Weight maintenance|weight maintenance
82842|NCT03685123|Body composition|body composition
82843|NCT03685123|Energy expenditure|energy expenditure
82844|NCT03685123|Weight loss|weight loss
82845|NCT03685110|Hip Arthroplasty|hip arthroplasty
82846|NCT03685110|Hip Prosthesis|hip prosthesis
82847|NCT03685058|Initial caries treatment|initial caries treatment
82848|NCT03685058|Non-cavitated caries treatment|non-cavitated caries treatment
82849|NCT03685058|Incipient caries treatment|incipient caries treatment
82850|NCT03685058|Proximal caries|proximal caries
82851|NCT03685058|Primary teeth|primary teeth
82852|NCT03685058|Light curable resin modified glass ionomer varnish|light curable resin modified glass ionomer varnish
82853|NCT03685058|Vanish XT varnish|vanish xt varnish
82854|NCT03685058|Clinpro XT varnish|clinpro xt varnish
82855|NCT03685058|Dental white spot lesions|dental white spot lesions
82856|NCT03685045|hepatitis c|hepatitis c
82857|NCT03685045|opioid substitution settings|opioid substitution settings
82858|NCT03685045|OST|ost
82859|NCT03685045|people who inject drugs|people who inject drugs
82860|NCT03685045|direct-acting antiviral treatment|direct-acting antiviral treatment
82861|NCT03684980|Voraxaze (glucarpidase)|voraxaze (glucarpidase)
82862|NCT03684980|B-cell non-Hodgkin‟s lymphoma involving the brain|b-cell non-hodgkin‟s lymphoma involving the brain
82987|NCT03684109|Malignant Primary Brain Tumor|malignant primary brain tumor
82863|NCT03684980|B-cell non-Hodgkin‟s lymphoma involving spinal cord, and/or leptomeningeal space|b-cell non-hodgkin‟s lymphoma involving spinal cord, and/or leptomeningeal space
82864|NCT03684915|Rotary instrumentation|rotary instrumentation
82865|NCT03684915|pulpectomy|pulpectomy
82866|NCT03684915|primary teeth|primary teeth
82867|NCT03684889|CAR T cell, CD19, pediatric, young adults|car t cell, cd19, pediatric, young adults
82868|NCT03684876|cardiac surgery|cardiac surgery
82869|NCT03684876|venous congestion|venous congestion
82870|NCT03684876|diuretic depletion|diuretic depletion
82871|NCT03684850|Knee brace|knee brace
82872|NCT03684850|biomechanical footwear|biomechanical footwear
82873|NCT03684850|exercise|exercise
82874|NCT03684850|RCT|rct
82875|NCT03684798|MCII|mcii
82876|NCT03684798|Alcohol Use Disorder|alcohol use disorder
82877|NCT03684798|Motivation|motivation
82878|NCT03684798|Mental Contrasting|mental contrasting
82879|NCT03684798|Implementation Intentions|implementation intentions
82880|NCT03684798|Abstinence|abstinence
82881|NCT03684759|Expectoration|expectoration
82882|NCT03684759|Cystic Fibrosis|cystic fibrosis
82883|NCT03684759|Nasopharyngeal|nasopharyngeal
82884|NCT03684759|Viral molecular diagnosis|viral molecular diagnosis
82885|NCT03684733|Breast cancer|breast cancer
82886|NCT03684733|BRCA1/2 mutation carriers|brca1/2 mutation carriers
82887|NCT03684733|Breast screening|breast screening
82888|NCT03684733|Magnetic Resonance Imaging (MRI)|magnetic resonance imaging (mri)
82889|NCT03684733|X-ray mammography (XRM)|x-ray mammography (xrm)
82890|NCT03684733|Background Parenchymal Enhancement (BPE)|background parenchymal enhancement (bpe)
82891|NCT03684720|Medical education|medical education
82892|NCT03684720|Basic Science|basic science
82893|NCT03684720|Procedural skills|procedural skills
82894|NCT03684720|Simulation|simulation
82895|NCT03684720|Transfer|transfer
82896|NCT03684720|Instructional design|instructional design
82897|NCT03684720|Guided Discovery Learning|guided discovery learning
82898|NCT03684720|Retention|retention
82899|NCT03684694|Loncastuximab Tesirine in Combination with Ibrutinib|loncastuximab tesirine in combination with ibrutinib
82900|NCT03684668|sexual behavior|sexual behavior
82901|NCT03684668|condom use|condom use
82902|NCT03684668|Self-Efficacy|self-efficacy
82903|NCT03684668|educational technology|educational technology
82904|NCT03684655|HIV infection|hiv infection
82905|NCT03684655|Positron Emission Tomography|positron emission tomography
82906|NCT03684655|F-AraG|f-arag
82907|NCT03684655|Magnetic Resonance Imaging|magnetic resonance imaging
82908|NCT03684603|Sleep|sleep
82909|NCT03684603|Acoustic Cueing|acoustic cueing
82910|NCT03684577|Hypnosis|hypnosis
82911|NCT03684577|Wait-list|wait-list
82912|NCT03684551|Community Health Worker|community health worker
82913|NCT03684551|Health worker supervision|health worker supervision
82914|NCT03684551|Mali|mali
82915|NCT03684551|Randomized controlled trial|randomized controlled trial
82916|NCT03684525|Mesioangular displaced canines|mesioangular displaced canines
83020|NCT03683927|Microbiome|microbiome
82917|NCT03684525|Interceptive treatment|interceptive treatment
82918|NCT03684486|bronchial cancer|bronchial cancer
82919|NCT03684486|rehabilitation|rehabilitation
82920|NCT03684473|Yoga|yoga
82921|NCT03684473|Mindfulness Meditation|mindfulness meditation
82922|NCT03684473|Online|online
82923|NCT03684473|Posttraumatic Stress Disorder|posttraumatic stress disorder
82924|NCT03684473|Young Adulthood|young adulthood
82925|NCT03684460|circadian misalignment|circadian misalignment
82926|NCT03684460|bright light|bright light
82927|NCT03684460|entrainment|entrainment
82928|NCT03684460|zeitgeber|zeitgeber
82929|NCT03684460|critical illness|critical illness
82930|NCT03684460|delirium|delirium
82931|NCT03684460|actigraphy|actigraphy
82932|NCT03684434|Anxiety|anxiety
82933|NCT03684434|Depression|depression
82934|NCT03684434|Internet-delivered cognitive behaviour therapy|internet-delivered cognitive behaviour therapy
82935|NCT03684434|Motivational Interviewing|motivational interviewing
82936|NCT03684434|Randomized controlled trial|randomized controlled trial
82937|NCT03684434|Pre-treatment|pre-treatment
82938|NCT03684434|Mental health system|mental health system
82939|NCT03684421|Long Antagonist|long antagonist
82940|NCT03684421|Classical Antagonist|classical antagonist
82941|NCT03684421|live birth rate|live birth rate
82942|NCT03684421|clinical pregnancy rate|clinical pregnancy rate
82943|NCT03684421|ovarian stimulation|ovarian stimulation
82944|NCT03684421|IVF|ivf
82945|NCT03684382|anticipatory grief intervention|anticipatory grief intervention
82946|NCT03684382|randomized controlled trial|randomized controlled trial
822387|NCT00146926|pain|pain
107233|NCT03533166|CPC|cpc
82947|NCT03684382|narrative therapy|narrative therapy
82948|NCT03684382|therapist-facilitated e-counselling|therapist-facilitated e-counselling
82949|NCT03684369|walking|walking
82950|NCT03684369|balance|balance
82951|NCT03684369|fatigue|fatigue
82952|NCT03684317|Pharmacology|pharmacology
82953|NCT03684317|Psychiatry|psychiatry
82954|NCT03684291|Mechanical ventilation|mechanical ventilation
82955|NCT03684291|Laparoscopic surgery|laparoscopic surgery
82956|NCT03684291|Hemodynamics|hemodynamics
82957|NCT03684252|Self-stigma|self-stigma
82958|NCT03684252|Drug Use Disorders|drug use disorders
82959|NCT03684252|HIV|hiv
82960|NCT03684213|Racial Differences|racial differences
82961|NCT03684213|Oxidative Stress|oxidative stress
82962|NCT03684213|Antioxidant|antioxidant
82963|NCT03684213|Microvasculature|microvasculature
82964|NCT03684174|Tonometry|tonometry
82965|NCT03684161|Congenital Heart Disease|congenital heart disease
82966|NCT03684161|Ventricular Septal Defect|ventricular septal defect
82967|NCT03684161|Long-term Outcome|long-term outcome
82968|NCT03684161|Cardiopulmonary Function|cardiopulmonary function
82969|NCT03684148|osteoarthritis|osteoarthritis
82970|NCT03684148|muscle voluntary activation|muscle voluntary activation
82971|NCT03684148|knee replacement|knee replacement
82972|NCT03684148|cognitive training|cognitive training
82973|NCT03684148|functional performance|functional performance
82974|NCT03684148|randomized controlled trial|randomized controlled trial
82975|NCT03684135|Breast cancer|breast cancer
82976|NCT03684135|Cosmetics|cosmetics
82977|NCT03684135|Satisfaction|satisfaction
82978|NCT03684135|Chemotherapy|chemotherapy
82979|NCT03684135|Thermal cure|thermal cure
82980|NCT03684122|Umbilical cord Mesenchymal Stem Cells|umbilical cord mesenchymal stem cells
82981|NCT03684122|Parkinson Disease|parkinson disease
82982|NCT03684122|Neurodegenerative|neurodegenerative
82983|NCT03684122|allogeneic|allogeneic
82984|NCT03684109|Glioma|glioma
82985|NCT03684109|Brain Tumor|brain tumor
82988|NCT03684109|Malignant Glioma|malignant glioma
82989|NCT03684109|Non-invasive glioma characterization|non-invasive glioma characterization
82990|NCT03684109|Molecular Imaging|molecular imaging
82991|NCT03684109|Isocitrate Dehydrogenase (IDH) Mutations|isocitrate dehydrogenase (idh) mutations
82992|NCT03684109|MRI-Based Sequencing|mri-based sequencing
82993|NCT03684070|Older adults|older adults
82994|NCT03684070|Asian Americans|asian americans
82996|NCT03684070|behavior change|behavior change
82997|NCT03684057|Worry|worry
82998|NCT03684031|Reactive Aggression|reactive aggression
82999|NCT03684031|Anger|anger
83000|NCT03684031|Cognitive Control Training|cognitive control training
83001|NCT03684031|Anger Rumination|anger rumination
83002|NCT03683979|Reactive aggression|reactive aggression
83003|NCT03683979|High trait anger|high trait anger
83004|NCT03683979|Cognitive bias modification|cognitive bias modification
83005|NCT03683979|Interpretation bias modification|interpretation bias modification
83006|NCT03683966|Fabry|fabry
83007|NCT03683966|Chaperone therapy|chaperone therapy
83008|NCT03683966|Migalastat|migalastat
83009|NCT03683966|Pharmacological adherence|pharmacological adherence
83010|NCT03683953|mesenchymal stem cells|mesenchymal stem cells
83011|NCT03683953|safety|safety
83012|NCT03683953|effect|effect
83013|NCT03683953|BPD|bpd
83014|NCT03683940|Pilot Study|pilot study
83015|NCT03683940|High Risk|high risk
83016|NCT03683940|Prospective|prospective
83017|NCT03683940|Screening|screening
83018|NCT03683927|Respiratory infections|respiratory infections
83019|NCT03683927|Probiotics|probiotics
83021|NCT03683927|Viruses|viruses
83022|NCT03683927|Children|children
83023|NCT03683901|Electrical stimulation therapy|electrical stimulation therapy
83024|NCT03683901|TENS|tens
83025|NCT03683901|t-NMES|t-nmes
83026|NCT03683901|Stroke|stroke
83027|NCT03683888|epicardial fat|epicardial fat
83028|NCT03683862|hawley|hawley
83029|NCT03683862|thermoplastic|thermoplastic
83030|NCT03683862|orthodontic retention|orthodontic retention
83031|NCT03683862|compliance|compliance
83032|NCT03683862|vacuum- formed|vacuum- formed
83033|NCT03683810|hemoglobin|hemoglobin
83034|NCT03683810|quality of life|quality of life
83035|NCT03683758|football|football
83036|NCT03683758|soccer|soccer
83037|NCT03683758|warm-up|warm-up
83038|NCT03683758|FIFA|fifa
83039|NCT03683758|11+|11+
83040|NCT03683758|performance|performance
83041|NCT03683758|speed|speed
83042|NCT03683758|agility|agility
83043|NCT03683758|jump|jump
83044|NCT03683745|disease burden|disease burden
83045|NCT03683693|procalcitonin|procalcitonin
83046|NCT03683693|antibiotic stewardship in ICU|antibiotic stewardship in icu
83047|NCT03683693|Multidrug resistance|multidrug resistance
83048|NCT03683693|neurocritical care|neurocritical care
83049|NCT03683680|Mesothelioma|mesothelioma
83050|NCT03683667|linear growth|linear growth
83051|NCT03683667|infant feeding|infant feeding
822694|NCT00145678|alcohol|alcohol
83052|NCT03683667|environmental enteric dysfunction|environmental enteric dysfunction
83053|NCT03683641|Insertional Achilles Tendinopathy|insertional achilles tendinopathy
83054|NCT03683641|Extracorporeal Shock Wave Therapy|extracorporeal shock wave therapy
83055|NCT03683641|Double-blind Randomized Controlled Trial|double-blind randomized controlled trial
83056|NCT03683615|Resorbable, blow out fractures|resorbable, blow out fractures
83057|NCT03683602|PNF, manual therapy, neck pain|pnf, manual therapy, neck pain
83058|NCT03683576|GB001|gb001
83059|NCT03683576|eosinophilic asthma|eosinophilic asthma
83060|NCT03683576|moderate asthma|moderate asthma
83061|NCT03683576|severe asthma|severe asthma
83062|NCT03683563|Dialysis catheters|dialysis catheters
83063|NCT03683563|Citrate|citrate
83064|NCT03683563|Locking solution|locking solution
83065|NCT03683550|SLNE|slne
83066|NCT03683550|SPECT/CT|spect/ct
83067|NCT03683524|Simplification strategy|simplification strategy
83068|NCT03683524|Multidrug resistant|multidrug resistant
83069|NCT03683524|Dolutegravir|dolutegravir
83070|NCT03683524|Darunavir/cobicistat|darunavir/cobicistat
83071|NCT03683524|Bitherapy|bitherapy
83072|NCT03683511|amikacin|amikacin
83073|NCT03683498|Ruxolitinib|ruxolitinib
83074|NCT03683498|T cells|t cells
83075|NCT03683485|Cholangiopancreatography, Endoscopic Retrograde|cholangiopancreatography, endoscopic retrograde
83076|NCT03683472|Anxiety, worry, mindfulness, meditation|anxiety, worry, mindfulness, meditation
83077|NCT03683459|FemFlow|femflow
83078|NCT03683459|Drug-eluting peripheral balloon catheter|drug-eluting peripheral balloon catheter
83079|NCT03683446|Colorectal Cancer|colorectal cancer
83080|NCT03683446|Colorectal|colorectal
83081|NCT03683446|Colorectal surgery|colorectal surgery
83082|NCT03683446|Surgical complications|surgical complications
83083|NCT03683446|Rectal|rectal
83084|NCT03683446|Rectal Cancer|rectal cancer
83085|NCT03683355|Transcatheter aortic valve replacement|transcatheter aortic valve replacement
83086|NCT03683355|Infective endocarditis|infective endocarditis
83087|NCT03683355|Radionuclide imaging|radionuclide imaging
83088|NCT03683355|Radiolabeled tracer uptake pattern|radiolabeled tracer uptake pattern
83089|NCT03683329|critical care|critical care
83090|NCT03683329|cancer|cancer
83091|NCT03683329|antimicrobial treatment|antimicrobial treatment
83092|NCT03683329|de-escalation|de-escalation
83093|NCT03683329|septic shock|septic shock
83094|NCT03683329|sepsis|sepsis
83095|NCT03683290|Oocyte|oocyte
83096|NCT03683290|Embryo|embryo
83097|NCT03683290|Development|development
83098|NCT03683290|Pregnancy|pregnancy
83099|NCT03683290|Competence|competence
83100|NCT03683212|Emergency department|emergency department
83101|NCT03683212|Elderly|elderly
83102|NCT03683212|Acute heart failure|acute heart failure
83103|NCT03683212|Pulmonary edema|pulmonary edema
83104|NCT03683199|Secondary|secondary
83105|NCT03683199|Cleft|cleft
83106|NCT03683199|Lip|lip
83107|NCT03683199|Nose|nose
83108|NCT03683199|Deformity|deformity
83109|NCT03683199|Correction|correction
83110|NCT03683199|Objective|objective
83111|NCT03683199|Assessment|assessment
83112|NCT03683186|Prostacyclin|prostacyclin
83113|NCT03683186|Connective Tissue Disease-Associated|connective tissue disease-associated
83114|NCT03683186|6 Minute Walk Test|6 minute walk test
83115|NCT03683186|6 Minute Walk Distance|6 minute walk distance
83116|NCT03683186|Pulmonary Vascular Resistance|pulmonary vascular resistance
83117|NCT03683186|Right Ventricular Function|right ventricular function
83118|NCT03683173|Physical Activity|physical activity
83119|NCT03683173|Rural|rural
83120|NCT03683173|Cancer Prevention|cancer prevention
83121|NCT03683160|Stroke, mobility, cognitive strategy training|stroke, mobility, cognitive strategy training
83122|NCT03683134|Cardiovascular Disease|cardiovascular disease
83123|NCT03683134|Mediterranean Diet|mediterranean diet
83124|NCT03683134|Nutrition education|nutrition education
83125|NCT03683121|Esophagogastric variceal hemorrhage|esophagogastric variceal hemorrhage
83126|NCT03683121|cirrhosis|cirrhosis
83127|NCT03683121|secondary prevention|secondary prevention
83128|NCT03683121|Non-selective beta blocker|non-selective beta blocker
83129|NCT03683121|compliance|compliance
83130|NCT03683095|Lymphedema|lymphedema
83131|NCT03683095|Lymphovenous bypass|lymphovenous bypass
83132|NCT03683056|Prevention|prevention
83133|NCT03683056|Promotion|promotion
83134|NCT03683056|Mental Health|mental health
83135|NCT03683030|Interventional|interventional
83136|NCT03683030|Radiofrequency Ablation|radiofrequency ablation
83137|NCT03683030|Paroxysmal Atrial Fibrillation|paroxysmal atrial fibrillation
83138|NCT03683017|Malocclusion|malocclusion
83139|NCT03683017|Photobiomodulation|photobiomodulation
83141|NCT03683017|OrthoPulse|orthopulse
83142|NCT03683017|Low-level laser therapy|low-level laser therapy
83143|NCT03683017|Orthodontics|orthodontics
83144|NCT03682978|Arbaclofen|arbaclofen
83145|NCT03682978|Placebo-Controlled|placebo-controlled
83146|NCT03682978|Randomized|randomized
83147|NCT03682978|Double-Blind|double-blind
83148|NCT03682978|Social Function|social function
83149|NCT03682978|Efficacy|efficacy
83150|NCT03682978|Safety|safety
83151|NCT03682978|Tolerability|tolerability
83152|NCT03682978|Children|children
83153|NCT03682978|Adolescents|adolescents
83154|NCT03682978|ASD|asd
83155|NCT03682965|Mountain Cedar|mountain cedar
83156|NCT03682965|Juniperus Ashei|juniperus ashei
83157|NCT03682965|Pollinosis|pollinosis
83158|NCT03682965|Intra-lymphatic|intra-lymphatic
83159|NCT03682952|Chronic Renal Disease|chronic renal disease
83160|NCT03682952|Nail fold microcirculation|nail fold microcirculation
83161|NCT03682952|Interventional therapy|interventional therapy
83162|NCT03682939|vaccination|vaccination
83163|NCT03682939|HIV|hiv
83164|NCT03682939|meningitis|meningitis
83165|NCT03682939|Vaccine|vaccine
83166|NCT03682939|Immunogenicity|immunogenicity
83167|NCT03682939|Safety|safety
83168|NCT03682939|Bexsero|bexsero
83169|NCT03682939|Menveo|menveo
83170|NCT03682939|co-administration|co-administration
83171|NCT03682900|e-cigarettes|e-cigarettes
83172|NCT03682900|prevention|prevention
83173|NCT03682900|middle school|middle school
83174|NCT03682900|smoking|smoking
83175|NCT03682887|Atrial fibrillation|atrial fibrillation
83176|NCT03682887|Cryoballoon|cryoballoon
83177|NCT03682887|Linear ablation|linear ablation
83178|NCT03682848|Viral load|viral load
83179|NCT03682848|Dolutegravir|dolutegravir
83180|NCT03682848|Lamivudine|lamivudine
83181|NCT03682848|HIV-1|hiv-1
83182|NCT03682848|Fixed dose combination|fixed dose combination
83183|NCT03682835|gastric motility|gastric motility
83184|NCT03682835|gastric emptying|gastric emptying
83185|NCT03682835|nutrient volume tolerance|nutrient volume tolerance
83186|NCT03682835|peppermint oil|peppermint oil
83187|NCT03682835|caraway oil|caraway oil
83188|NCT03682822|Pregnancy|pregnancy
83189|NCT03682822|labor induction|labor induction
83190|NCT03682822|preterm|preterm
83191|NCT03682809|Artificial Tears|artificial tears
83192|NCT03682809|Systane Complete|systane complete
83193|NCT03682809|Contact Lens Discomfort|contact lens discomfort
83194|NCT03682809|Dry Eye|dry eye
83195|NCT03682809|Daily Disposable Contact Lenses|daily disposable contact lenses
83196|NCT03682796|Antibody-Drug Conjugate|antibody-drug conjugate
83197|NCT03682796|ADC|adc
83198|NCT03682796|CD22|cd22
83199|NCT03682796|SMARTag™ technology|smartag™ technology
83200|NCT03682796|TRPH-222|trph-222
83201|NCT03682783|Artificial Intelligence; Glaucoma|artificial intelligence; glaucoma
83202|NCT03682757|Trauma|trauma
83203|NCT03682757|Platelets|platelets
83204|NCT03682757|Coagulopathy|coagulopathy
83205|NCT03682718|misoprostol , intracervical Foley catheter , induction of labor , term pregnancy.|misoprostol , intracervical foley catheter , induction of labor , term pregnancy.
83206|NCT03682705|ABBV-105|abbv-105
83207|NCT03682705|Upadacitinib|upadacitinib
83208|NCT03682705|ABBV-599|abbv-599
83209|NCT03682705|Rheumatoid Arthritis|rheumatoid arthritis
83210|NCT03682679|massive rotator cuff tears|massive rotator cuff tears
83211|NCT03682679|reparability|reparability
83212|NCT03682679|sonoelastography|sonoelastography
83213|NCT03682679|magnetic resonance imaging|magnetic resonance imaging
83214|NCT03682666|stroke|stroke
83215|NCT03682666|Kinesiotaping|kinesiotaping
83216|NCT03682666|constraint induced movement therapy|constraint induced movement therapy
83217|NCT03682666|sonography|sonography
83218|NCT03682653|childhood mortality|childhood mortality
83219|NCT03682653|neonates|neonates
83220|NCT03682653|azithromycin|azithromycin
83221|NCT03682653|mass drug administration|mass drug administration
83222|NCT03682627|kidney transplantation|kidney transplantation
83223|NCT03682627|Lymphatic complications|lymphatic complications
83224|NCT03682627|preventive fenestration|preventive fenestration
83225|NCT03682627|clipping|clipping
83226|NCT03682601|Sexual Pain|sexual pain
83227|NCT03682601|Postmenopausal Symptoms|postmenopausal symptoms
83228|NCT03682601|Vulvovaginal Atrophy|vulvovaginal atrophy
83229|NCT03682601|Vulvodynia|vulvodynia
83230|NCT03682601|Dyspareunia|dyspareunia
83231|NCT03682601|Vestibulodynia|vestibulodynia
83232|NCT03682601|Female Sexual Dysfunction|female sexual dysfunction
83233|NCT03682601|Arousal Disorders, Sexual|arousal disorders, sexual
83234|NCT03682588|Fibromyalgia|fibromyalgia
83235|NCT03682588|Treatment|treatment
83236|NCT03682588|Exercise|exercise
83237|NCT03682536|Luspatercept|luspatercept
83238|NCT03682536|ACE-536|ace-536
83239|NCT03682536|Anemia|anemia
83240|NCT03682536|Myelodysplastic Syndromes|myelodysplastic syndromes
83241|NCT03682536|MDS|mds
83242|NCT03682536|Blood Transfusion|blood transfusion
83243|NCT03682536|RBC Transfusion|rbc transfusion
83244|NCT03682523|Frailty|frailty
83245|NCT03682523|Hospitalization|hospitalization
83246|NCT03682523|Acute care|acute care
83247|NCT03682523|older adults|older adults
83248|NCT03682523|intervention|intervention
83249|NCT03682510|placenta previa|placenta previa
83250|NCT03682510|transverse b lynch suture|transverse b lynch suture
83251|NCT03682510|N&H sandwich technique|n&h sandwich technique
83252|NCT03682497|Heart failure.|heart failure.
83253|NCT03682497|Oral selective mineralocorticoid receptor modulator.|oral selective mineralocorticoid receptor modulator.
83254|NCT03682497|Heart failure with preserved ejection fraction (HFpEF).|heart failure with preserved ejection fraction (hfpef).
83255|NCT03682484|Pharmacokinetics|pharmacokinetics
83256|NCT03682484|MA-0211|ma-0211
83257|NCT03682484|Single Ascending Dose|single ascending dose
83258|NCT03682484|Healthy Volunteer|healthy volunteer
83259|NCT03682484|Multiple Ascending Dose|multiple ascending dose
83260|NCT03682484|Pharmacodynamics|pharmacodynamics
83261|NCT03682471|submental fat reduction|submental fat reduction
83262|NCT03682458|iPS|ips
83263|NCT03682458|genetic mutations|genetic mutations
83264|NCT03682458|neurodegenerative diseases|neurodegenerative diseases
83265|NCT03682458|experimental therapeutic approaches|experimental therapeutic approaches
83266|NCT03682458|molecular processes|molecular processes
83267|NCT03682445|Type 2 diabetes mellitus|type 2 diabetes mellitus
83268|NCT03682445|exercise|exercise
83269|NCT03682445|aerobic|aerobic
83270|NCT03682445|interval|interval
83271|NCT03682445|continuous|continuous
83272|NCT03682393|postoperative|postoperative
83273|NCT03682393|atrial fibrillation|atrial fibrillation
83274|NCT03682393|post cardiac surgery|post cardiac surgery
83275|NCT03682393|corticosteroid|corticosteroid
83276|NCT03682367|Gabapentin|gabapentin
83277|NCT03682367|Narcotic|narcotic
83278|NCT03682367|Cancer|cancer
83279|NCT03682367|Placebo|placebo
83280|NCT03682354|Erector spinae plane block|erector spinae plane block
83281|NCT03682354|Video-assisted thoracic surgery;|video-assisted thoracic surgery;
83282|NCT03682354|Intercostal nerve block|intercostal nerve block
83283|NCT03682354|Patient-controlled intravenous analgesia|patient-controlled intravenous analgesia
83284|NCT03682328|Vertebroplasty|vertebroplasty
83285|NCT03682328|Kyphoplasty|kyphoplasty
83286|NCT03682328|Osteoporosis|osteoporosis
83287|NCT03682328|Vertebral fractures|vertebral fractures
83288|NCT03682315|Maxillary sinus augmentation|maxillary sinus augmentation
83289|NCT03682315|Sinus lift|sinus lift
83290|NCT03682315|Biomaterial|biomaterial
83291|NCT03682315|Anorganic bovine bone|anorganic bovine bone
83292|NCT03682315|Phicogenic biomaterial|phicogenic biomaterial
83293|NCT03682315|Implant Dentistry|implant dentistry
83294|NCT03682302|Pediatric|pediatric
83295|NCT03682237|Hyperglycemia|hyperglycemia
83296|NCT03682237|Hypoglycemia|hypoglycemia
83297|NCT03682237|Carbohydrate counting|carbohydrate counting
83298|NCT03682237|Automated bolus calculation|automated bolus calculation
83299|NCT03682237|Flash glucose monitoring|flash glucose monitoring
83300|NCT03682224|clinical trial|clinical trial
83301|NCT03682224|bupivacaine-epinephrine|bupivacaine-epinephrine
83302|NCT03682224|bupivacaine liposome|bupivacaine liposome
83303|NCT03682224|pain|pain
83304|NCT03682224|Morphine equivalent dose|morphine equivalent dose
83305|NCT03682224|lobectomy|lobectomy
83306|NCT03682224|Laproscopic lobectomy|laproscopic lobectomy
83307|NCT03682224|VATS lobectomy|vats lobectomy
83308|NCT03682224|opioid medications|opioid medications
83309|NCT03682211|Sickle cell disease|sickle cell disease
83310|NCT03682211|Paediatric|paediatric
83311|NCT03682211|Pain|pain
83312|NCT03682211|Analgesia|analgesia
83313|NCT03682211|Intranasal|intranasal
83314|NCT03682211|Fentanyl|fentanyl
83315|NCT03682185|Neuropsychiatric Behaviors|neuropsychiatric behaviors
83316|NCT03682185|Agitation|agitation
83317|NCT03682185|Alzheimer's Disease|alzheimer's disease
83318|NCT03682185|Dementia|dementia
83319|NCT03682172|Gallbladder Motility|gallbladder motility
83320|NCT03682172|Gallbladder Emptying|gallbladder emptying
83321|NCT03682172|Glucagon-Like Peptide 2|glucagon-like peptide 2
83322|NCT03682146|DaVinci|davinci
83323|NCT03682146|Robot Assisted|robot assisted
83324|NCT03682146|Prostatectomy|prostatectomy
83325|NCT03682146|Laparoscopy|laparoscopy
83344|NCT03682094|probiotics|probiotics
83345|NCT03682094|oral microbiome|oral microbiome
83346|NCT03682094|dysphagia|dysphagia
83347|NCT03682081|dementia|dementia
83348|NCT03682081|dysphagia|dysphagia
83354|NCT03682055|Epstein-Barr Virus|epstein-barr virus
83355|NCT03682055|Nasopharyngeal Carcinoma|nasopharyngeal carcinoma
83356|NCT03682055|NPC|npc
83357|NCT03682055|EBV|ebv
83358|NCT03682055|EBNA1 inhibitor|ebna1 inhibitor
83359|NCT03682055|VK-2019|vk-2019
83360|NCT03682055|Nasopharynx cancer|nasopharynx cancer
83361|NCT03682055|Nasopharynx carcinoma|nasopharynx carcinoma
83362|NCT03682029|Clonal Cytopenia of Undetermined Significance|clonal cytopenia of undetermined significance
83363|NCT03682029|Myelodysplastic Syndromes|myelodysplastic syndromes
83364|NCT03682029|Chronic Myelomonocytic Leukemia|chronic myelomonocytic leukemia
83365|NCT03682029|Low-Risk Myeloid Malignancies|low-risk myeloid malignancies
83366|NCT03682029|Vitamin C|vitamin c
83367|NCT03682029|Epigenetics|epigenetics
83368|NCT03682029|TET2|tet2
83369|NCT03682029|Randomized, Placebo-Controlled Trial|randomized, placebo-controlled trial
83370|NCT03682029|Clinical Study|clinical study
83371|NCT03681990|surgical skin prep|surgical skin prep
83372|NCT03681990|CHG|chg
83373|NCT03681990|IPA|ipa
83374|NCT03681977|Total Knee Arthroplasty|total knee arthroplasty
83375|NCT03681977|Medial Pivot Knee Implant Design|medial pivot knee implant design
83376|NCT03681977|Knee Joint Mechanics|knee joint mechanics
83377|NCT03681951|Anticancer Agents|anticancer agents
83378|NCT03681951|FTIH|ftih
83379|NCT03681951|Pembrolizumab|pembrolizumab
83380|NCT03681951|Rip1K|rip1k
83381|NCT03681951|GSK3145095|gsk3145095
83382|NCT03681951|Dose Escalation|dose escalation
83383|NCT03681951|Immunotherapy resistance|immunotherapy resistance
83384|NCT03681951|Dose Expansion|dose expansion
83385|NCT03681951|RECIST 1.1|recist 1.1
83386|NCT03681951|Advanced solid tumors|advanced solid tumors
83387|NCT03681951|Innate immunity|innate immunity
83388|NCT03681925|Patient-centered care|patient-centered care
83389|NCT03681925|Dietitian|dietitian
83390|NCT03681925|Nutrition literacy|nutrition literacy
83391|NCT03681912|Implementation Science|implementation science
83392|NCT03681912|Motivational Interviewing|motivational interviewing
83393|NCT03681912|Youth Living with HIV|youth living with hiv
83394|NCT03681899|Rupture of galenic|rupture of galenic
83395|NCT03681899|Ederly patients|ederly patients
83396|NCT03681899|Geriatry|geriatry
83397|NCT03681899|Drug class|drug class
83398|NCT03681860|BCG|bcg
83399|NCT03681860|Tuberculosis|tuberculosis
83400|NCT03681860|Vaccination|vaccination
83401|NCT03681847|hypertonic saline|hypertonic saline
83402|NCT03681847|colloids|colloids
83403|NCT03681847|normal saline|normal saline
83404|NCT03681821|ostomy|ostomy
83405|NCT03681821|self-management|self-management
83406|NCT03681821|self-efficacy|self-efficacy
83407|NCT03681821|health-promoting behavior|health-promoting behavior
83408|NCT03681795|Gilles de la Tourette syndrome|gilles de la tourette syndrome
83409|NCT03681795|glutamaergic system|glutamaergic system
83410|NCT03681795|PET-scan|pet-scan
83411|NCT03681795|physiopathology|physiopathology
83412|NCT03681782|premature infant, abdominal massage|premature infant, abdominal massage
83413|NCT03681769|Transcranial Magnetic Stimulation|transcranial magnetic stimulation
83414|NCT03681769|Dorsolateral Prefrontal Cortex|dorsolateral prefrontal cortex
83415|NCT03681769|Medial Prefrontal Cortex|medial prefrontal cortex
83416|NCT03681769|Brain Stimulation|brain stimulation
83417|NCT03681743|Virtual Reality|virtual reality
83418|NCT03681743|Pain|pain
83419|NCT03681743|Anxiety|anxiety
83420|NCT03681730|Virtual Reality|virtual reality
83421|NCT03681730|Pain|pain
83422|NCT03681730|Anxiety|anxiety
83423|NCT03681717|Virtual Reality|virtual reality
83424|NCT03681717|Pain|pain
83425|NCT03681717|Anxiety|anxiety
83426|NCT03681704|Diabetic Kidney Disease，Traditional Chinese medicine|diabetic kidney disease，traditional chinese medicine
83427|NCT03681691|women's health|women's health
83428|NCT03681691|estradiol|estradiol
83531|NCT03680976|Obesity|obesity
83432|NCT03681639|Medical Device|medical device
83433|NCT03681639|Safety|safety
83434|NCT03681639|Hip prosthesis|hip prosthesis
83435|NCT03681626|critically ill patient|critically ill patient
83436|NCT03681626|extubation|extubation
83437|NCT03681626|tracheal suction|tracheal suction
83438|NCT03681626|intensive care unit|intensive care unit
83439|NCT03681600|audit|audit
83440|NCT03681600|cancer|cancer
83441|NCT03681600|guidelines|guidelines
83442|NCT03681600|ouctomes|ouctomes
83443|NCT03681600|survival|survival
83444|NCT03681600|digestive cancer surgery|digestive cancer surgery
83445|NCT03681574|pediatric|pediatric
83446|NCT03681574|gabapentin|gabapentin
83447|NCT03681574|agitation|agitation
83448|NCT03681574|induction|induction
83449|NCT03681548|liposomal doxorubicin injection|liposomal doxorubicin injection
83450|NCT03681548|bioequivalence study|bioequivalence study
83451|NCT03681548|ovarian cancer|ovarian cancer
83452|NCT03681535|DLBCL|dlbcl
83453|NCT03681535|Reduce radiation dose|reduce radiation dose
83454|NCT03681522|local anesthesia|local anesthesia
83455|NCT03681522|prostate, biopsy|prostate, biopsy
83456|NCT03681522|transrectal|transrectal
83457|NCT03681509|Pramipexole|pramipexole
83458|NCT03681483|RO5126766 (CH5126766)|ro5126766 (ch5126766)
83459|NCT03681483|KRAS-Mutant|kras-mutant
83460|NCT03681483|18-285|18-285
83461|NCT03681470|skin of color|skin of color
83462|NCT03681470|acne|acne
83463|NCT03681470|skin diseases|skin diseases
83464|NCT03681457|LJN452, tropifexor, PK, safety, healthy subjects, hepatically impaired|ljn452, tropifexor, pk, safety, healthy subjects, hepatically impaired
83465|NCT03681431|Pharmacokinetic|pharmacokinetic
83466|NCT03681431|Ceftriaxone|ceftriaxone
83467|NCT03681431|Enterococcus faecalis|enterococcus faecalis
83468|NCT03681431|Infectious Endocarditis|infectious endocarditis
83469|NCT03681418|Axillary Lymph Node Biopsy in Breast Cancer|axillary lymph node biopsy in breast cancer
83470|NCT03681392|Benign Prostatic Hypertrophy|benign prostatic hypertrophy
83471|NCT03681392|Erectile Dysfunction|erectile dysfunction
83472|NCT03681392|Nutritional Supplements|nutritional supplements
83473|NCT03681392|Prostatism|prostatism
400585|NCT01866137|psychological stress|psychological stress
83474|NCT03681392|Lower Urinary Tract Symptoms, male|lower urinary tract symptoms, male
83475|NCT03681379|Levosimendan|levosimendan
83476|NCT03681379|pharmacokinetics|pharmacokinetics
83477|NCT03681379|children|children
83478|NCT03681379|acute heart failure|acute heart failure
83479|NCT03681366|myopia|myopia
83480|NCT03681366|Myopic Defocus|myopic defocus
83481|NCT03681366|contact lens|contact lens
83482|NCT03681366|myopia control|myopia control
83483|NCT03681288|PTSD|ptsd
83484|NCT03681288|substance use disorder|substance use disorder
83485|NCT03681288|moral injury|moral injury
83486|NCT03681288|self-compassion|self-compassion
83487|NCT03681288|mindfulness|mindfulness
83488|NCT03681288|Veterans|veterans
83489|NCT03681275|Ventilator-induced Diaphragm Dysfunction|ventilator-induced diaphragm dysfunction
83490|NCT03681249|Diabetic Kidney Disease，Traditional Chinese medicine|diabetic kidney disease，traditional chinese medicine
83491|NCT03681236|Alveolar recruitment, laparoscopic surgery|alveolar recruitment, laparoscopic surgery
83495|NCT03681197|metformin,unexplained infertility|metformin,unexplained infertility
83496|NCT03681184|PH1|ph1
83497|NCT03681184|Primary Hyperoxaluria|primary hyperoxaluria
83498|NCT03681184|RNAi therapeutic|rnai therapeutic
83499|NCT03681184|siRNA|sirna
83500|NCT03681184|AGT|agt
83501|NCT03681145|Young Adults|young adults
83502|NCT03681145|Telehealth|telehealth
83503|NCT03681145|Health Disparity|health disparity
83504|NCT03681106|Knee Osteoarthritis|knee osteoarthritis
83505|NCT03681106|Total Knee Arthroplasty|total knee arthroplasty
83506|NCT03681106|Kinesiotaping|kinesiotaping
83507|NCT03681106|Neuro taping|neuro taping
83508|NCT03681106|Rehabilitation|rehabilitation
83509|NCT03681093|Asthma|asthma
83510|NCT03681093|Nasal Polyposis|nasal polyposis
83511|NCT03681093|Nasal polyps score|nasal polyps score
83512|NCT03681093|nasal endoscopy|nasal endoscopy
83513|NCT03681093|nasal congestion score|nasal congestion score
83514|NCT03681093|quality of life|quality of life
83515|NCT03681093|smell|smell
83516|NCT03681067|Crohn's disease|crohn's disease
83517|NCT03681067|CDAID|cdaid
83518|NCT03681067|CDAI|cdai
83519|NCT03681067|GSK1070806|gsk1070806
83520|NCT03681054|Nutrition|nutrition
83521|NCT03681054|Dietary Counseling|dietary counseling
83522|NCT03681054|Diet|diet
83523|NCT03681054|Pregnancy|pregnancy
83524|NCT03681041|Pancreatic injury|pancreatic injury
83525|NCT03681028|Glioblastoma|glioblastoma
83526|NCT03681028|Adult Glioblastoma|adult glioblastoma
83527|NCT03681028|Glioma|glioma
83528|NCT03681028|Precision Medicine|precision medicine
83529|NCT03681028|Specialized Tumor Board|specialized tumor board
83530|NCT03680976|Asthma|asthma
83532|NCT03680976|Nitrated fatty acids|nitrated fatty acids
83533|NCT03680937|Vitrification|vitrification
83534|NCT03680937|In vitro maturation|in vitro maturation
83535|NCT03680937|time lapse|time lapse
83536|NCT03680937|High resolution imaging|high resolution imaging
83537|NCT03680937|quantitative molecular analysis|quantitative molecular analysis
83538|NCT03680924|PTEN|pten
83539|NCT03680924|phosphatase and tensin homology mutation|phosphatase and tensin homology mutation
83540|NCT03680898|Carbapenem|carbapenem
83541|NCT03680898|rectal swab|rectal swab
83542|NCT03680898|infectious disease|infectious disease
83543|NCT03680898|infection|infection
83544|NCT03680885|Lidocaine ineffectiveness|lidocaine ineffectiveness
83545|NCT03680885|ADHD|adhd
83546|NCT03680885|ADD|add
83547|NCT03680872|Physical and Rehabilitation Medicine|physical and rehabilitation medicine
83548|NCT03680872|Biomedical Engineering|biomedical engineering
83549|NCT03680872|Paralysis|paralysis
83550|NCT03680872|Tetraplegia|tetraplegia
83551|NCT03680872|Quadriplegia|quadriplegia
83552|NCT03680872|Movement Restoration|movement restoration
83553|NCT03680872|Muscle Stimulation|muscle stimulation
83554|NCT03680872|Tactile Sensation|tactile sensation
83555|NCT03680807|Knee osteoarthritis|knee osteoarthritis
83556|NCT03680807|power production|power production
83557|NCT03680807|functional capacity|functional capacity
83558|NCT03680768|Health|health
83559|NCT03680768|Risk of disease|risk of disease
83560|NCT03680768|Prediction|prediction
83561|NCT03680768|Lifestyle|lifestyle
83562|NCT03680755|dental avoidance|dental avoidance
83563|NCT03680755|dental phobia|dental phobia
83564|NCT03680755|pain sensitivity|pain sensitivity
83565|NCT03680729|Prevention|prevention
83566|NCT03680729|HIV/AIDS|hiv/aids
83567|NCT03680729|MSM|msm
83568|NCT03680729|Alabama|alabama
83569|NCT03680664|Mild Cognitive Impairment|mild cognitive impairment
83570|NCT03680664|Dementia|dementia
83571|NCT03680664|Mindfulness|mindfulness
83572|NCT03680638|Racial Differences|racial differences
83573|NCT03680638|Oxidative Stress|oxidative stress
83574|NCT03680638|Obesity|obesity
83575|NCT03680638|Local Heating|local heating
83576|NCT03680625|Virtual reality|virtual reality
83577|NCT03680625|Immersive distraction|immersive distraction
83578|NCT03680625|Virtual world|virtual world
83579|NCT03680625|Virtual environment|virtual environment
107893|NCT03529045|VNS|vns
83580|NCT03680625|Passive distraction|passive distraction
83581|NCT03680625|Procedural pain|procedural pain
83582|NCT03680625|Procedural anxiety|procedural anxiety
83583|NCT03680625|Acute pain|acute pain
83584|NCT03680625|Pain management|pain management
83585|NCT03680625|Anxiety|anxiety
83586|NCT03680625|Children, Child|children, child
83587|NCT03680625|Kid, Kids|kid, kids
83588|NCT03680625|Pediatric, Pediatrics|pediatric, pediatrics
83589|NCT03680625|Young children|young children
83590|NCT03680625|Orthopedics|orthopedics
83591|NCT03680625|Kirschner wire, K pin|kirschner wire, k pin
83592|NCT03680625|Bone wires|bone wires
83593|NCT03680625|Percutaneous pins|percutaneous pins
83594|NCT03680625|Non-pharmacological|non-pharmacological
83595|NCT03680625|Clinical Research|clinical research
83596|NCT03680625|Nursing Practice|nursing practice
83597|NCT03680625|User-computer interface|user-computer interface
83598|NCT03680625|Pediatric Nursing|pediatric nursing
83599|NCT03680625|Hospital, Pediatric|hospital, pediatric
83600|NCT03680573|Racial Differences|racial differences
83601|NCT03680573|Oxidative Stress|oxidative stress
83602|NCT03680560|HER2|her2
83603|NCT03680560|ACTR|actr
83604|NCT03680560|ACTR087|actr087
83605|NCT03680560|ACTR707|actr707
83606|NCT03680560|T cell|t cell
83607|NCT03680560|T cell product|t cell product
83608|NCT03680560|adoptive T cells|adoptive t cells
83609|NCT03680560|gene therapy|gene therapy
83610|NCT03680560|breast cancer|breast cancer
83611|NCT03680560|gastric cancer|gastric cancer
83612|NCT03680560|gastro esophageal cancer|gastro esophageal cancer
83613|NCT03680560|immunotherapy|immunotherapy
83614|NCT03680560|solid tumor|solid tumor
83615|NCT03680560|adenoid cystic carcinoma|adenoid cystic carcinoma
83616|NCT03680534|root canal preparation|root canal preparation
83617|NCT03680534|single-file preparation techniques|single-file preparation techniques
83618|NCT03680534|3D reconstruction|3d reconstruction
83619|NCT03680521|ccRCC|ccrcc
83620|NCT03680521|MGCD516|mgcd516
83621|NCT03680521|Antineoplastic Agents|antineoplastic agents
83622|NCT03680521|Immunologic factors|immunologic factors
83623|NCT03680521|nivolumab|nivolumab
83624|NCT03680521|Tyrosine Kinase Inhibitor|tyrosine kinase inhibitor
83625|NCT03680521|VEGFR|vegfr
83626|NCT03680521|TAM RTKs|tam rtks
83627|NCT03680521|PD-1|pd-1
83628|NCT03680521|PD-L1|pd-l1
83629|NCT03680508|immunotherapy|immunotherapy
83630|NCT03680508|PD-1|pd-1
83631|NCT03680508|TIM-3|tim-3
83632|NCT03680495|COPD|copd
83633|NCT03680495|Steroid Resistance|steroid resistance
83634|NCT03680482|High-Intensity Sweeteners|high-intensity sweeteners
83635|NCT03680482|insulin|insulin
83636|NCT03680482|ghrelin|ghrelin
83637|NCT03680482|Glucagon-Like Peptide 1|glucagon-like peptide 1
83638|NCT03680482|Non-Nutritive Sweeteners|non-nutritive sweeteners
83639|NCT03680482|Stevia rebaudiana|stevia rebaudiana
83640|NCT03680469|Ischemic Stroke|ischemic stroke
83642|NCT03680469|Early intervention|early intervention
83643|NCT03680469|Mobilization|mobilization
83644|NCT03680456|Anemia|anemia
83645|NCT03680456|Ferric carboxymaltose|ferric carboxymaltose
83646|NCT03680456|intravenous iron|intravenous iron
83647|NCT03680456|intraoperative blood loss|intraoperative blood loss
83648|NCT03680456|patient blood management|patient blood management
83649|NCT03680456|Red blood cell transfusion|red blood cell transfusion
83650|NCT03680456|postoperative iron replacement|postoperative iron replacement
83651|NCT03680443|revision|revision
83652|NCT03680443|reinforcement|reinforcement
83653|NCT03680430|adaptive image guided radiation therapy|adaptive image guided radiation therapy
83654|NCT03680430|limb soft tissues sarcomas|limb soft tissues sarcomas
83655|NCT03680417|Measles-Rubella|measles-rubella
83656|NCT03680417|Vaccine|vaccine
83657|NCT03680417|Safety|safety
83658|NCT03680417|Immunogenicity|immunogenicity
83659|NCT03680417|Reactogenicity|reactogenicity
83660|NCT03680417|Protectivity|protectivity
83661|NCT03680404|Racial Differences|racial differences
83662|NCT03680404|Oxidative Stress|oxidative stress
83663|NCT03680378|bronchial epithelial lining fluid|bronchial epithelial lining fluid
83664|NCT03680365|Duchenne, DMD|duchenne, dmd
83665|NCT03680313|Cardio-ankle vascular index (CAVI)|cardio-ankle vascular index (cavi)
83666|NCT03680300|agility run test|agility run test
83667|NCT03680300|vertical jump test|vertical jump test
83668|NCT03680300|100 meter sprint|100 meter sprint
83669|NCT03680300|nordic lower test|nordic lower test
83670|NCT03680300|ymca sit and reach box|ymca sit and reach box
83671|NCT03680300|active knee extension|active knee extension
83672|NCT03680300|passive knee extension|passive knee extension
83673|NCT03680300|post isometric relaxation|post isometric relaxation
83674|NCT03680300|post facilitation stretch|post facilitation stretch
83675|NCT03680300|muscle energy technique|muscle energy technique
83676|NCT03680300|friction massage|friction massage
83677|NCT03680300|sports medicine|sports medicine
83678|NCT03680300|physical therapy|physical therapy
83679|NCT03680300|young athlete|young athlete
83680|NCT03680300|pakistan|pakistan
83681|NCT03680261|Gastric Cancer|gastric cancer
83682|NCT03680261|Chemoradiotherapy|chemoradiotherapy
83683|NCT03680261|Chemotherapy|chemotherapy
83684|NCT03680248|hepatic fat content|hepatic fat content
83685|NCT03680248|dietary fat|dietary fat
83686|NCT03680248|glucose|glucose
83687|NCT03680248|fructose|fructose
83688|NCT03680248|non-esterified fatty acid|non-esterified fatty acid
83689|NCT03680248|triglyceride|triglyceride
83690|NCT03680248|insulin|insulin
83691|NCT03680248|postprandial period|postprandial period
83692|NCT03680222|external branches of superior laryngeal nerve|external branches of superior laryngeal nerve
83693|NCT03680222|thyroidectomy|thyroidectomy
83694|NCT03680222|thyroid cancer|thyroid cancer
83695|NCT03680209|Task trainning|task trainning
83696|NCT03680209|Procedural simulation|procedural simulation
83697|NCT03680196|hip dislocation|hip dislocation
83698|NCT03680196|GMFCS level 3,4,5|gmfcs level 3,4,5
83699|NCT03680183|Tyrosine kinase inhibitors|tyrosine kinase inhibitors
83700|NCT03680183|pharmacokinetics|pharmacokinetics
83701|NCT03680183|Hepatitis B|hepatitis b
83702|NCT03680170|Cognitive rehabilitation|cognitive rehabilitation
83703|NCT03680170|Working memory|working memory
83704|NCT03680170|Randomized controlled trial|randomized controlled trial
83705|NCT03680170|Placebo control|placebo control
83706|NCT03680157|Martha G. Welch|martha g. welch
83707|NCT03680157|emotional connection|emotional connection
83708|NCT03680157|child development|child development
83709|NCT03680157|premature birth|premature birth
83710|NCT03680092|cancer|cancer
83711|NCT03680092|Graft-Versus-Host Disease|graft-versus-host disease
83712|NCT03680092|Hematologic Neoplasms|hematologic neoplasms
83713|NCT03680092|Abatacept|abatacept
83714|NCT03680092|Cyclophosphamide|cyclophosphamide
83715|NCT03680092|GVHD prophylaxis|gvhd prophylaxis
83716|NCT03680092|stem cell transplantation|stem cell transplantation
83717|NCT03680092|High risk hematologic malignancy|high risk hematologic malignancy
83718|NCT03680092|hematologic malignancy|hematologic malignancy
83719|NCT03680092|Allogeneic Hematopoetic Stem Cell Transplantation|allogeneic hematopoetic stem cell transplantation
83720|NCT03680092|GVHD|gvhd
83721|NCT03680079|social media|social media
83722|NCT03680079|noncompliance|noncompliance
83723|NCT03680079|youth|youth
83724|NCT03680079|group education|group education
83725|NCT03680066|Peanut allergy|peanut allergy
83726|NCT03680066|Tree Nut allergy|tree nut allergy
83727|NCT03680066|Precautionary allergen labeling|precautionary allergen labeling
83728|NCT03680066|May contain traces|may contain traces
83729|NCT03680066|Allergen threshold|allergen threshold
83730|NCT03680027|Serum lipids|serum lipids
83731|NCT03680027|Hyperlipidemia|hyperlipidemia
83732|NCT03680027|Walnut|walnut
83733|NCT03680001|emotional connection|emotional connection
83734|NCT03680001|Martha G. Welch|martha g. welch
83735|NCT03680001|nursing education|nursing education
83736|NCT03679988|oral health status|oral health status
83737|NCT03679988|oral findings|oral findings
83738|NCT03679988|oral manifestations|oral manifestations
83739|NCT03679988|patient with mucocutaneous ocular disorders|patient with mucocutaneous ocular disorders
83740|NCT03679988|mucocutaneous ocular disorders|mucocutaneous ocular disorders
83741|NCT03679962|Bright Light Therapy|bright light therapy
83742|NCT03679962|Sleep Deprivation|sleep deprivation
83743|NCT03679962|Adolescent|adolescent
83744|NCT03679962|Depression|depression
83745|NCT03679962|Suicidal Ideation|suicidal ideation
83746|NCT03679949|experimental pain|experimental pain
83747|NCT03679949|Cannabis|cannabis
83748|NCT03679949|Cannabidiol|cannabidiol
83749|NCT03679949|THC|thc
83750|NCT03679923|exercise-induced|exercise-induced
83751|NCT03679923|joint pain|joint pain
83752|NCT03679923|joint stiffness|joint stiffness
83753|NCT03679923|cartilage turnover|cartilage turnover
83754|NCT03679923|CTX-II|ctx-ii
83755|NCT03679910|CA 19-9|ca 19-9
83756|NCT03679910|CEA|cea
83757|NCT03679819|multiparametric MRI|multiparametric mri
83758|NCT03679819|ExactVu ultrasound scanner|exactvu ultrasound scanner
83759|NCT03679819|prostatectomy|prostatectomy
83760|NCT03679806|aquatic therapy|aquatic therapy
83761|NCT03679806|Limits of stability|limits of stability
83762|NCT03679806|Halliwick|halliwick
83763|NCT03679806|aquatic plyometric exercises|aquatic plyometric exercises
83764|NCT03679793|Trigger Finger Disorder|trigger finger disorder
83765|NCT03679793|Trigger Thumb|trigger thumb
83766|NCT03679793|Minimally Invasive Surgical Procedures|minimally invasive surgical procedures
83767|NCT03679793|Orthopedics|orthopedics
83768|NCT03679780|Racial Differences|racial differences
83769|NCT03679780|Oxidative Stress|oxidative stress
83770|NCT03679767|PD-1inhibitor|pd-1inhibitor
83771|NCT03679767|non-small cell lung cancer|non-small cell lung cancer
83772|NCT03679767|urothelial cancer|urothelial cancer
83773|NCT03679767|melanoma|melanoma
83774|NCT03679767|renal cell carcinoma|renal cell carcinoma
83775|NCT03679728|Zika virus|zika virus
83776|NCT03679728|Children|children
83777|NCT03679728|Microcephaly|microcephaly
83778|NCT03679715|Community-dwellers|community-dwellers
83779|NCT03679715|older adults|older adults
83780|NCT03679715|museum|museum
83781|NCT03679715|art|art
83782|NCT03679689|Non-Nutritive sweeteners|non-nutritive sweeteners
83783|NCT03679689|Artificially sweeteners|artificially sweeteners
83784|NCT03679689|obesity|obesity
83785|NCT03679689|overweight|overweight
83786|NCT03679676|Food Allergy|food allergy
83787|NCT03679676|Hypersensitivity, Peanut|hypersensitivity, peanut
83788|NCT03679676|Food Hypersensitivity|food hypersensitivity
83789|NCT03679676|Allergy, Food|allergy, food
83790|NCT03679663|ultrasound|ultrasound
83791|NCT03679650|AML|aml
83792|NCT03679624|treatment naive|treatment naive
83793|NCT03679624|relapsed|relapsed
83794|NCT03679624|frontline|frontline
83795|NCT03679624|refractory|refractory
83796|NCT03679624|daratumumab|daratumumab
83797|NCT03679624|ibrutinib|ibrutinib
83798|NCT03679611|Recovery time|recovery time
83799|NCT03679611|reversal of neuromuscular blockers|reversal of neuromuscular blockers
83800|NCT03679611|obstructive sleep apnea|obstructive sleep apnea
83801|NCT03679611|morbid obesity|morbid obesity
83802|NCT03679611|bariatric surgery|bariatric surgery
83803|NCT03679572|partial nephrectomy|partial nephrectomy
83804|NCT03679572|robot-assisted|robot-assisted
83805|NCT03679572|surgery|surgery
83806|NCT03679572|near-infrared fluorescence|near-infrared fluorescence
83807|NCT03679572|ischemia|ischemia
83808|NCT03679533|Cognition|cognition
83809|NCT03679533|Ageing|ageing
83810|NCT03679533|Nutrition|nutrition
83811|NCT03679533|Microbiome|microbiome
83812|NCT03679533|Flavonoids|flavonoids
83813|NCT03679520|Prenatal education|prenatal education
83814|NCT03679520|Parents|parents
83815|NCT03679520|Randomized controlled trial|randomized controlled trial
83816|NCT03679520|Self Efficacy|self efficacy
83817|NCT03679520|Depression, postpartum|depression, postpartum
83818|NCT03679442|macrophage activation, N-acetylcysteine, acetaminophen|macrophage activation, n-acetylcysteine, acetaminophen
83819|NCT03679429|Colonoscopy|colonoscopy
83820|NCT03679429|Adenoma detection rate|adenoma detection rate
83821|NCT03679429|Narrow band imaging|narrow band imaging
83822|NCT03679429|Optical biopsy|optical biopsy
83823|NCT03679429|Accuracy|accuracy
83824|NCT03679377|Orthognathic surgical procedures|orthognathic surgical procedures
83825|NCT03679377|Osteosynthesis|osteosynthesis
83826|NCT03679364|Panax notoginseng|panax notoginseng
83827|NCT03679364|acute ischemic stroke|acute ischemic stroke
83828|NCT03679364|Vietnam|vietnam
83829|NCT03679364|observational registry study|observational registry study
83830|NCT03679364|lyophilized|lyophilized
83831|NCT03679364|injectable|injectable
83832|NCT03679299|Flow-mediated dilation (FMD)|flow-mediated dilation (fmd)
83833|NCT03679299|arterial stiffness|arterial stiffness
84521|NCT03674723|Healthy|healthy
83834|NCT03679299|pulse wave velocity (PWV)|pulse wave velocity (pwv)
83835|NCT03679299|cardiovascular risk and asthma|cardiovascular risk and asthma
83836|NCT03679299|endothelial function|endothelial function
83837|NCT03679299|systemic inflammation|systemic inflammation
83838|NCT03679299|C-reactive protein (CRP)|c-reactive protein (crp)
83839|NCT03679299|eosinophils|eosinophils
83840|NCT03679299|neutrophils|neutrophils
83841|NCT03679299|asthma exacerbation|asthma exacerbation
83842|NCT03679286|Coagulation|coagulation
83843|NCT03679260|Prostate Cancer|prostate cancer
83844|NCT03679260|Prostate Adenocarcinoma|prostate adenocarcinoma
83845|NCT03679260|Active Surveillance|active surveillance
83846|NCT03679260|Diet|diet
83847|NCT03679260|Weight Loss|weight loss
83848|NCT03679260|low carb|low carb
83849|NCT03679260|Ketogenic Diet|ketogenic diet
83850|NCT03679260|Ketogenic|ketogenic
83851|NCT03679195|24h ambulatory blood pressure vascular function inflammation|24h ambulatory blood pressure vascular function inflammation
83852|NCT03679130|Pregnancy|pregnancy
83853|NCT03679130|Physical activity|physical activity
83854|NCT03679130|Healthy|healthy
83855|NCT03679130|Epigenetics|epigenetics
83856|NCT03679130|Process evaluation|process evaluation
83857|NCT03679130|Doubly labeled water|doubly labeled water
83858|NCT03679117|mindfulness|mindfulness
83859|NCT03679117|pregnancy|pregnancy
83860|NCT03679117|hypertension|hypertension
83861|NCT03679104|Gastric Per-oral Endoscopic Pyloromyotomy|gastric per-oral endoscopic pyloromyotomy
83862|NCT03679091|Ticagrelor|ticagrelor
83863|NCT03679091|clopidogrel|clopidogrel
83864|NCT03679091|coronary artery disease|coronary artery disease
83865|NCT03679091|platelet reactivity|platelet reactivity
83866|NCT03679039|colorectal cancer|colorectal cancer
83867|NCT03679039|liver metastases|liver metastases
83868|NCT03679039|conversion therapy|conversion therapy
83869|NCT03679013|cardiac|cardiac
83870|NCT03679013|surgery|surgery
83871|NCT03679013|pain|pain
83872|NCT03679000|environmental exposure|environmental exposure
83873|NCT03679000|epigenetic process|epigenetic process
83874|NCT03679000|embryo development|embryo development
83875|NCT03679000|infertility|infertility
108277|NCT03526848|3BNC117|3bnc117
83876|NCT03679000|cohort study|cohort study
83877|NCT03678987|pharmacokinetics|pharmacokinetics
83878|NCT03678987|mycophenolate mofetil|mycophenolate mofetil
83879|NCT03678974|Cardiorespiratory Fitness|cardiorespiratory fitness
83880|NCT03678974|Intensive Behavioral Therapy for Obesity|intensive behavioral therapy for obesity
83881|NCT03678974|Exercise Prescription|exercise prescription
83882|NCT03678935|Celiac disease|celiac disease
83883|NCT03678935|Irritable bowel syndrome|irritable bowel syndrome
83884|NCT03678922|musculoskeletal pain|musculoskeletal pain
83885|NCT03678922|adolescents|adolescents
83886|NCT03678922|children|children
83887|NCT03678922|prognosis|prognosis
83888|NCT03678922|general practice|general practice
83889|NCT03678922|bio-psycho-social|bio-psycho-social
83890|NCT03678909|Troponin|troponin
83892|NCT03678909|Biomarkers|biomarkers
83893|NCT03678909|Hypoplastic Left Heart|hypoplastic left heart
83894|NCT03678909|Norwood|norwood
83895|NCT03678909|DKS|dks
83896|NCT03678896|Type II Diabetes|type ii diabetes
83897|NCT03678896|Educational methods|educational methods
83898|NCT03678896|Disease self-management|disease self-management
83899|NCT03678883|Refractory cancers|refractory cancers
83900|NCT03678883|9-ING-41|9-ing-41
83901|NCT03678883|Glycogen Synthase Kinase|glycogen synthase kinase
83902|NCT03678883|GSK-3β|gsk-3β
83903|NCT03678883|NF-κβ|nf-κβ
83904|NCT03678883|Apoptosis|apoptosis
83905|NCT03678883|Chemoresistance|chemoresistance
83906|NCT03678883|DNA damage response DDR|dna damage response ddr
83907|NCT03678883|Ataxia telangiectasia mutated and Rad3 related ATR|ataxia telangiectasia mutated and rad3 related atr
83908|NCT03678883|Checkpoint kinase 1 CHK1|checkpoint kinase 1 chk1
83909|NCT03678857|creatine, hypertrophy, strength|creatine, hypertrophy, strength
83910|NCT03678831|Osteoarthritis|osteoarthritis
83911|NCT03678831|prosthetic surgery of the knee|prosthetic surgery of the knee
83912|NCT03678831|obesity|obesity
83913|NCT03678831|type 2 diabetes|type 2 diabetes
83914|NCT03678831|bone marrow fat|bone marrow fat
83915|NCT03678779|child nutrition|child nutrition
83916|NCT03678779|nutrition education|nutrition education
83917|NCT03678779|parent intervention|parent intervention
83918|NCT03678766|Overweight|overweight
83919|NCT03678766|Obesity|obesity
83920|NCT03678766|Binge Eating|binge eating
83921|NCT03678766|Overeating|overeating
83922|NCT03678766|Body Mass Index|body mass index
83923|NCT03678766|Weight|weight
83924|NCT03678766|Treatment|treatment
83925|NCT03678766|Intervention|intervention
83926|NCT03678766|Behavioral Treatment|behavioral treatment
83927|NCT03678753|Primary Generalized Tonic-Clonic Seizures|primary generalized tonic-clonic seizures
83928|NCT03678753|PGTC|pgtc
83929|NCT03678753|Idiopathic Generalized Epilepsy|idiopathic generalized epilepsy
83930|NCT03678753|Generalized Tonic-Clonic Seizures|generalized tonic-clonic seizures
83931|NCT03678714|polycystic ovary syndrome|polycystic ovary syndrome
83932|NCT03678714|exercise|exercise
83933|NCT03678714|physical activity|physical activity
83934|NCT03678714|cardiovascular disease|cardiovascular disease
83935|NCT03678714|low-density lipoprotein|low-density lipoprotein
83936|NCT03678714|metabolism|metabolism
83937|NCT03678701|whey protein|whey protein
83938|NCT03678701|Obesity|obesity
83939|NCT03678675|ketorolac|ketorolac
83940|NCT03678675|opiate|opiate
83941|NCT03678675|cesarean section|cesarean section
83942|NCT03678662|Exercise-induced hypoalgesia, expectation, pain sensitivity|exercise-induced hypoalgesia, expectation, pain sensitivity
83943|NCT03678649|Head and Neck Neoplasms;Capecitabine|head and neck neoplasms;capecitabine
83944|NCT03678623|Musculoskeletal Pain|musculoskeletal pain
83945|NCT03678623|Occupational Exposure|occupational exposure
83946|NCT03678623|Predictive value of tests|predictive value of tests
83947|NCT03678623|Back muscles|back muscles
83948|NCT03678532|sedation|sedation
83949|NCT03678532|COPD|copd
83950|NCT03678532|critically ill|critically ill
83951|NCT03678532|intensive care|intensive care
83952|NCT03678506|Venous thromboembolism|venous thromboembolism
83953|NCT03678506|D-Dimer|d-dimer
83954|NCT03678506|Apixaban|apixaban
83955|NCT03678506|Extended treatment|extended treatment
83956|NCT03678493|AML|aml
83957|NCT03678493|Allo-HCT|allo-hct
83958|NCT03678454|Chronic myeloid leukemia|chronic myeloid leukemia
83959|NCT03678454|Philadelphia chromosome positive acute lymphoblastic leukemia|philadelphia chromosome positive acute lymphoblastic leukemia
83960|NCT03678454|Iclusig®|iclusig®
83961|NCT03678454|ponatinib|ponatinib
83962|NCT03678415|Depression, anxiety and stress|depression, anxiety and stress
83963|NCT03678402|falling|falling
83964|NCT03678402|inpatient|inpatient
83965|NCT03678389|Pituitary Adenoma|pituitary adenoma
83966|NCT03678389|pituitary surgery|pituitary surgery
83967|NCT03678389|Transsphenoidal Surgery|transsphenoidal surgery
83968|NCT03678389|Pituitary Tumors|pituitary tumors
83969|NCT03678376|Diagnostic strategy|diagnostic strategy
83970|NCT03678376|Neurocognitive disorders|neurocognitive disorders
822695|NCT00145678|substance|substance
83971|NCT03678376|Primary Care|primary care
83972|NCT03678363|Rheumatoid Arthritis|rheumatoid arthritis
83973|NCT03678363|Tai chi chuan|tai chi chuan
83974|NCT03678363|Physical Activity|physical activity
83975|NCT03678324|fabry|fabry
83976|NCT03678324|MRI (Magnetic resonance imaging)|mri (magnetic resonance imaging)
83977|NCT03678324|Fabry brain lesions|fabry brain lesions
83978|NCT03678285|High intensity exercise|high intensity exercise
83979|NCT03678285|Proenkephalin-A|proenkephalin-a
83980|NCT03678272|Inguinal hernia|inguinal hernia
83981|NCT03678272|Chronic postoperative inguinal pain|chronic postoperative inguinal pain
83982|NCT03678272|Glue mesh|glue mesh
83983|NCT03678272|Suture mesh|suture mesh
83984|NCT03678259|Amyloidosis, AL, ATTR, ALect2|amyloidosis, al, attr, alect2
83985|NCT03678233|hypermetabolism|hypermetabolism
83986|NCT03678233|hypogonadism|hypogonadism
83987|NCT03678233|testosterone|testosterone
83988|NCT03678220|Laparoscopic Ultrasound|laparoscopic ultrasound
83989|NCT03678194|Depression|depression
83990|NCT03678194|Smartphone|smartphone
83991|NCT03678194|Relapse prevention|relapse prevention
83992|NCT03678194|Mobile support system|mobile support system
83993|NCT03678194|eHealth|ehealth
83994|NCT03678194|Ecological|ecological
83995|NCT03678194|Randomized|randomized
83996|NCT03678194|Multicentric|multicentric
83997|NCT03678181|Prevention|prevention
83998|NCT03678181|Internet|internet
83999|NCT03678181|Adolescence|adolescence
84000|NCT03678181|LGBT|lgbt
84001|NCT03678181|Sexuality|sexuality
84002|NCT03678181|Young Adulthood|young adulthood
84003|NCT03678142|antibiotic drug monitoring in sweat|antibiotic drug monitoring in sweat
84004|NCT03678129|Autism Spectrum Disorder|autism spectrum disorder
84005|NCT03678129|E-I balance|e-i balance
84006|NCT03678129|AZD7325|azd7325
84007|NCT03678129|pharmacological imaging|pharmacological imaging
84008|NCT03678129|GABA|gaba
84009|NCT03678116|caffeine|caffeine
84010|NCT03678116|metabolism|metabolism
84011|NCT03678064|physical therapy|physical therapy
84012|NCT03678064|gait|gait
84013|NCT03678064|pediatric rehabilitation|pediatric rehabilitation
84014|NCT03678064|gross motor function|gross motor function
84015|NCT03678064|participation|participation
84016|NCT03678038|adhesive capsulitis|adhesive capsulitis
84017|NCT03677947|overvalued ideation|overvalued ideation
84018|NCT03677947|treatment acceptability|treatment acceptability
84019|NCT03677947|treatment adherence|treatment adherence
84020|NCT03677947|treatment outcome|treatment outcome
84021|NCT03677947|treatment resistance|treatment resistance
84022|NCT03677947|treatment satisfaction|treatment satisfaction
84023|NCT03677947|insight|insight
84024|NCT03677947|cognitive therapy|cognitive therapy
84025|NCT03677947|inference based cognitive therapy|inference based cognitive therapy
84026|NCT03677947|exposure and response prevention|exposure and response prevention
84027|NCT03677908|Temporoparietal Areas|temporoparietal areas
84028|NCT03677908|Neural Biomarker|neural biomarker
84029|NCT03677895|rotator cuff disorder|rotator cuff disorder
84030|NCT03677882|mind body bridging|mind body bridging
84031|NCT03677882|mindfulness|mindfulness
84032|NCT03677882|suicidal ideation|suicidal ideation
84033|NCT03677882|suicide related behaviors|suicide related behaviors
84034|NCT03677869|Pneumatic Vitreolysis|pneumatic vitreolysis
84035|NCT03677856|Paravertebral block|paravertebral block
84036|NCT03677856|Thoracic epidural block|thoracic epidural block
84037|NCT03677856|Thoracotomy|thoracotomy
84038|NCT03677843|hip dislocation|hip dislocation
84039|NCT03677843|GMFCS level 3,4,5|gmfcs level 3,4,5
84040|NCT03677843|scoliosis|scoliosis
84041|NCT03677817|thoracoscopic surgery|thoracoscopic surgery
84042|NCT03677817|Perioperative intravenous lidocaine administration|perioperative intravenous lidocaine administration
84043|NCT03677817|Lidocaine|lidocaine
84044|NCT03677804|aortic valve reconstruction|aortic valve reconstruction
84045|NCT03677804|OZAKI technique|ozaki technique
84046|NCT03677804|autologous pericardium|autologous pericardium
84047|NCT03677791|counselling|counselling
84048|NCT03677791|computed tomography|computed tomography
84049|NCT03677791|coronary|coronary
84051|NCT03677791|virtual|virtual
84052|NCT03677791|360|360
84053|NCT03677791|anxiety|anxiety
84054|NCT03677765|subclavian venous catheterization|subclavian venous catheterization
84055|NCT03677752|Intervention|intervention
84056|NCT03677752|Maternal sensitivity|maternal sensitivity
84057|NCT03677752|Neurodevelopment|neurodevelopment
84058|NCT03677752|Maternal stress|maternal stress
84059|NCT03677752|Maternal anxiety|maternal anxiety
84060|NCT03677752|Neonatal intensive care unit|neonatal intensive care unit
84061|NCT03677726|Insomnia|insomnia
84062|NCT03677726|Cognitive aging|cognitive aging
84063|NCT03677726|Mindfulness|mindfulness
84064|NCT03677713|endoscopic|endoscopic
84065|NCT03677713|endonasal|endonasal
84066|NCT03677713|transsphenoidal|transsphenoidal
84067|NCT03677713|surgical resection|surgical resection
84068|NCT03677713|pituitary tumour|pituitary tumour
84069|NCT03677713|nasal packing|nasal packing
84070|NCT03677713|Merocel|merocel
84071|NCT03677700|vitrectomy|vitrectomy
84072|NCT03677700|cryoindentation|cryoindentation
84073|NCT03677687|Mindfulness|mindfulness
84074|NCT03677661|Concussion|concussion
84075|NCT03677661|Physical therapy|physical therapy
84076|NCT03677661|Vestibular rehabilitation|vestibular rehabilitation
84077|NCT03677661|Mild traumatic brain injury|mild traumatic brain injury
84078|NCT03677635|Negative Symptoms|negative symptoms
84079|NCT03677635|Autobiographical Memory|autobiographical memory
84080|NCT03677622|Restricted fluid therapy|restricted fluid therapy
84081|NCT03677622|Goal directed fluid therapy|goal directed fluid therapy
84082|NCT03677622|Colorectal surgery|colorectal surgery
84083|NCT03677622|Surgery|surgery
84084|NCT03677622|Enhanced recovery|enhanced recovery
84085|NCT03677622|Fluid therapy|fluid therapy
84086|NCT03677596|Leukemia|leukemia
84087|NCT03677596|Precursor Cell Lymphoblastic Leukemia-Lymphoma|precursor cell lymphoblastic leukemia-lymphoma
84088|NCT03677596|ACUTE LYMPHOBLASTIC leukemia|acute lymphoblastic leukemia
84089|NCT03677596|inotuzumab ozogamicin|inotuzumab ozogamicin
84090|NCT03677596|Besponsa|besponsa
84091|NCT03677596|transplant|transplant
84092|NCT03677544|radical systectomy|radical systectomy
84093|NCT03677544|Ureteral frozen section|ureteral frozen section
84094|NCT03677518|total knee arthroplasty|total knee arthroplasty
84095|NCT03677518|medial-pivot knee system|medial-pivot knee system
84096|NCT03677518|kinematics|kinematics
84097|NCT03677518|survivorship|survivorship
84098|NCT03677505|double lumen intubation|double lumen intubation
84099|NCT03677505|videolaryngoscope|videolaryngoscope
84100|NCT03677479|bone grafts|bone grafts
84101|NCT03677479|xenograft|xenograft
84102|NCT03677466|Intramyocardial haemorrhage|intramyocardial haemorrhage
84103|NCT03677466|Myocardial Infarction|myocardial infarction
84104|NCT03677466|ST Elevation Myocardial Infarction|st elevation myocardial infarction
84105|NCT03677466|Primary Percutaneous Coronary Intervention|primary percutaneous coronary intervention
84106|NCT03677466|Pharmaco invasive strategy|pharmaco invasive strategy
84107|NCT03677466|Fibrinolytic therapy|fibrinolytic therapy
84108|NCT03677466|Global longitudinal strain|global longitudinal strain
84109|NCT03677466|Myocardial Necrosis|myocardial necrosis
84110|NCT03677466|Coronary Artery Disease|coronary artery disease
84111|NCT03677414|circulating-tumor DNA ctDNA|circulating-tumor dna ctdna
84112|NCT03677349|Oral cancer|oral cancer
84113|NCT03677349|Free Flap|free flap
84114|NCT03677349|Neurrorhaphy|neurrorhaphy
84115|NCT03677349|Quality of life|quality of life
84116|NCT03677323|virtual reality|virtual reality
84117|NCT03677323|pain|pain
84118|NCT03677323|anxiety|anxiety
84119|NCT03677297|Intervention Study|intervention study
84120|NCT03677297|Rosuvastatin|rosuvastatin
84121|NCT03677297|Periodontitis|periodontitis
84122|NCT03677284|Intervention study|intervention study
84123|NCT03677284|Assistive products|assistive products
84124|NCT03677284|Elderly people|elderly people
84125|NCT03677258|Collagen|collagen
84126|NCT03677258|anti-age therapy|anti-age therapy
84127|NCT03677258|cosmetology|cosmetology
84128|NCT03677258|lifting|lifting
84129|NCT03677232|Congenital Heart Disease, Hong Kong, Adolescent|congenital heart disease, hong kong, adolescent
84130|NCT03677219|consent|consent
84131|NCT03677219|lumbar puncture|lumbar puncture
84132|NCT03677219|pediatric|pediatric
84133|NCT03677219|video|video
84134|NCT03677180|Cardiogenic shock|cardiogenic shock
84135|NCT03677180|Mechanical circulatory support|mechanical circulatory support
84136|NCT03677180|National Cardiogenic Shock Initiative|national cardiogenic shock initiative
84137|NCT03677180|Myocardial infarction|myocardial infarction
84138|NCT03677180|Heart attack|heart attack
84139|NCT03677180|Acute MI|acute mi
84140|NCT03677180|NCSI|ncsi
84141|NCT03677180|National CSI|national csi
84142|NCT03677180|Impella|impella
84143|NCT03677180|Shock|shock
84144|NCT03677180|Hemodynamic Support|hemodynamic support
84145|NCT03677167|chronic plantar heel pain|chronic plantar heel pain
84146|NCT03677167|barefoot|barefoot
84147|NCT03677167|treadmill|treadmill
84148|NCT03677167|Plantar Fascitis|plantar fascitis
84149|NCT03677128|Digital Health|digital health
84150|NCT03677128|Pediatric Cancer|pediatric cancer
84151|NCT03677128|Low and middle-income country|low and middle-income country
84152|NCT03677128|Tanzania|tanzania
84153|NCT03677128|Healthcare provider decision support|healthcare provider decision support
84154|NCT03677128|Protocol-driven treatment|protocol-driven treatment
84155|NCT03677128|Burkitt lymphoma|burkitt lymphoma
84156|NCT03677128|Retinoblastoma|retinoblastoma
84157|NCT03677128|Treatment abandonment|treatment abandonment
84158|NCT03677128|Client health records|client health records
84159|NCT03677089|ASD|asd
84160|NCT03677089|Autism|autism
84161|NCT03677089|Telehealth|telehealth
84162|NCT03677089|Primary Care Providers|primary care providers
84163|NCT03677063|peritoneal dialysis|peritoneal dialysis
84164|NCT03677063|dressing|dressing
84165|NCT03677063|exit-site|exit-site
84166|NCT03677063|catheter|catheter
84167|NCT03677063|infection|infection
84168|NCT03677037|mentalization-based therapy|mentalization-based therapy
84169|NCT03677037|borderline personality disorder|borderline personality disorder
84170|NCT03677037|randomized clinical trial|randomized clinical trial
84171|NCT03677037|psychotherapy research|psychotherapy research
84172|NCT03677037|treatment intensity|treatment intensity
84173|NCT03677024|Sentinel lymph node policy|sentinel lymph node policy
84174|NCT03677011|myo-inositol|myo-inositol
84175|NCT03677011|fertilization rate|fertilization rate
84176|NCT03677011|infertility|infertility
84177|NCT03677011|Intracytoplasmic Sperm Injection|intracytoplasmic sperm injection
84178|NCT03677011|sperm|sperm
84179|NCT03676998|Prolonged weaning|prolonged weaning
84180|NCT03676998|Diaphragm dysfunction|diaphragm dysfunction
84181|NCT03676998|Liberation from mechanical|liberation from mechanical
84182|NCT03676920|financial toxicity, cancer, treatment cost, patient-provider communication|financial toxicity, cancer, treatment cost, patient-provider communication
84183|NCT03676907|cesarean scar defect|cesarean scar defect
84184|NCT03676907|single suturation technique|single suturation technique
84185|NCT03676907|double suturation technique|double suturation technique
84186|NCT03676907|myometrial thickness|myometrial thickness
84187|NCT03676907|uterine scar|uterine scar
84188|NCT03676816|Chlamydia|chlamydia
84189|NCT03676816|Gonorrhea|gonorrhea
84190|NCT03676790|Osteoarthritis, Knee|osteoarthritis, knee
84191|NCT03676790|Ultrasonic Therapy|ultrasonic therapy
84192|NCT03676790|Exercise Therapy|exercise therapy
84193|NCT03676790|Randomized controlled trial.|randomized controlled trial.
84194|NCT03676777|Bacterial infection|bacterial infection
84195|NCT03676777|Fungal infection|fungal infection
84196|NCT03676777|Cirrhosis|cirrhosis
84197|NCT03676777|Multi-drug resistance|multi-drug resistance
84198|NCT03676777|Antibiotic treatment|antibiotic treatment
84199|NCT03676777|Clinical outcome|clinical outcome
84200|NCT03676777|Organ failure|organ failure
84201|NCT03676777|Acute-on-chronic liver failure|acute-on-chronic liver failure
84202|NCT03676777|Decompensated cirrhosis|decompensated cirrhosis
84203|NCT03676777|Complications of cirrhosis|complications of cirrhosis
84204|NCT03676777|Acute kidney injury|acute kidney injury
84205|NCT03676764|Childhood mortality|childhood mortality
84206|NCT03676764|Azithromycin|azithromycin
84207|NCT03676764|Mass treatment|mass treatment
84208|NCT03676764|Vaccine Visit targeted treatment|vaccine visit targeted treatment
84209|NCT03676751|azithromycin|azithromycin
84210|NCT03676751|mass drug administration|mass drug administration
84211|NCT03676751|childhood mortality|childhood mortality
84212|NCT03676738|Anesthesia, Risk Factors, Age|anesthesia, risk factors, age
84213|NCT03676699|Extravascular lung water, inferior vena cava collapsibility|extravascular lung water, inferior vena cava collapsibility
84214|NCT03676582|swallowing disorders|swallowing disorders
84215|NCT03676582|instrumental swallow assessment|instrumental swallow assessment
84216|NCT03676582|acoustic analysis|acoustic analysis
84217|NCT03676582|respiratory changes|respiratory changes
84218|NCT03676569|autoimmune epilepsy|autoimmune epilepsy
84219|NCT03676569|refractory epilepsy|refractory epilepsy
84220|NCT03676569|ADRC|adrc
84221|NCT03676569|mezenchymal stem cells|mezenchymal stem cells
84222|NCT03676569|anti-neuronal antibody|anti-neuronal antibody
84223|NCT03676569|Rasmussen encephality|rasmussen encephality
84522|NCT03674723|Men|men
84224|NCT03676569|adipose derived regenerative stem cells|adipose derived regenerative stem cells
84225|NCT03676556|wound treatment|wound treatment
84226|NCT03676556|lidocaine|lidocaine
84227|NCT03676556|pain reduction|pain reduction
84228|NCT03676556|local anesthetic|local anesthetic
84229|NCT03676491|unipolar|unipolar
84230|NCT03676491|sleep disturbances|sleep disturbances
84231|NCT03676465|Type 1 Diabetes Mellitus (T1D)|type 1 diabetes mellitus (t1d)
84232|NCT03676465|Continuous Glucose Monitor (CGM)|continuous glucose monitor (cgm)
84233|NCT03676465|Activity Monitor (i.e. Fitbit)|activity monitor (i.e. fitbit)
84234|NCT03676465|Hemoglobin A1c (HbA1c)|hemoglobin a1c (hba1c)
84235|NCT03676465|Companion Medical inPen|companion medical inpen
84236|NCT03676465|Insulin Pump|insulin pump
84237|NCT03676465|Multiple Daily Injections (MDI)|multiple daily injections (mdi)
84238|NCT03676439|Lateral Cord Stimulation|lateral cord stimulation
84239|NCT03676439|Disability|disability
84240|NCT03676439|Magnetic Stimulation|magnetic stimulation
84241|NCT03676439|Spasticity|spasticity
84242|NCT03676439|Spinal Cord Stimulation|spinal cord stimulation
84243|NCT03676413|asthma|asthma
84244|NCT03676413|therapeutic equivalence|therapeutic equivalence
84245|NCT03676413|bioequivalence|bioequivalence
84246|NCT03676413|fluticasone propionate|fluticasone propionate
84247|NCT03676413|salmeterol|salmeterol
84248|NCT03676400|mesenchymal stem cells|mesenchymal stem cells
84249|NCT03676400|conditioned media|conditioned media
84250|NCT03676400|NGF-574H|ngf-574h
84251|NCT03676400|hair growth|hair growth
84252|NCT03676400|androgenic alopecia|androgenic alopecia
84253|NCT03676400|paracrine factors|paracrine factors
84254|NCT03676400|umbilical cord blood|umbilical cord blood
84255|NCT03676387|pediatric|pediatric
84256|NCT03676387|endotracheal tube|endotracheal tube
84257|NCT03676387|ultrasonography|ultrasonography
84258|NCT03676361|Kidney Damage|kidney damage
84259|NCT03676348|quality of life|quality of life
84260|NCT03676348|health related quality of life|health related quality of life
84261|NCT03676348|thyroid cancer|thyroid cancer
84262|NCT03676348|thyroid nodule|thyroid nodule
84263|NCT03676348|thyroid neoplasm|thyroid neoplasm
84264|NCT03676348|thyroid surgery|thyroid surgery
84265|NCT03676348|patient reported outcome measurements|patient reported outcome measurements
84266|NCT03676322|Pharmacokinetics|pharmacokinetics
84267|NCT03676322|M5049|m5049
84268|NCT03676296|Puerarin|puerarin
84269|NCT03676296|Lipids|lipids
84270|NCT03676296|Testosterone|testosterone
84271|NCT03676270|Cancer|cancer
84272|NCT03676270|Phase I trials|phase i trials
84273|NCT03676270|Review|review
84274|NCT03676257|Metastatic breast cancer|metastatic breast cancer
84275|NCT03676257|Real world data|real world data
84276|NCT03676257|Surrogate|surrogate
84277|NCT03676218|Cancer|cancer
84278|NCT03676218|Elderly|elderly
84279|NCT03676218|Randomized controlled trial|randomized controlled trial
84280|NCT03676218|Endpoint|endpoint
84281|NCT03676218|Consensus|consensus
84282|NCT03676205|Platelet-Rich Plasma|platelet-rich plasma
84283|NCT03676205|hamstrings|hamstrings
84284|NCT03676205|cuadriceps|cuadriceps
84285|NCT03676205|football players|football players
84286|NCT03676166|Cannabis|cannabis
84287|NCT03676166|Toxicology|toxicology
84288|NCT03676166|Intoxication|intoxication
84289|NCT03676153|Integrative medicine|integrative medicine
84290|NCT03676153|Supportive and Palliative care|supportive and palliative care
84291|NCT03676140|Neglected Tropical Diseases|neglected tropical diseases
84292|NCT03676127|assessment|assessment
84293|NCT03676127|breast cancer|breast cancer
84294|NCT03676127|diagnosis|diagnosis
84295|NCT03676127|lymphedema|lymphedema
84296|NCT03676127|measurement|measurement
84297|NCT03676127|ultrasound|ultrasound
84298|NCT03676114|Ketamine|ketamine
84299|NCT03676114|Breast Cancer Surgery|breast cancer surgery
84300|NCT03676114|Postoperative Recovery|postoperative recovery
84301|NCT03676075|colorectal cancer|colorectal cancer
84302|NCT03676075|early diagnosis|early diagnosis
84303|NCT03676075|5-hydroxymethylcytosine|5-hydroxymethylcytosine
84304|NCT03676062|exercise, pain, yoga|exercise, pain, yoga
84305|NCT03676049|Children, Epilepsy, Cannabidiol|children, epilepsy, cannabidiol
84306|NCT03676023|mapca|mapca
84307|NCT03676023|tranexamic acid|tranexamic acid
84308|NCT03676023|txa|txa
84309|NCT03676023|pulmonary hemorrhage|pulmonary hemorrhage
84310|NCT03676010|Cancer|cancer
84311|NCT03676010|Randomized controlled trial|randomized controlled trial
84312|NCT03676010|Endpoint|endpoint
84313|NCT03676010|Consensus|consensus
84314|NCT03675997|Autograft|autograft
84315|NCT03675997|Anxiety|anxiety
84316|NCT03675997|Protected environment|protected environment
84317|NCT03675984|surface EMG, cobb angle, exercise, Spinal Curvatures|surface emg, cobb angle, exercise, spinal curvatures
84318|NCT03675971|Pain Management; Analgesics, Opioid; Cannabis|pain management; analgesics, opioid; cannabis
84319|NCT03675958|H Reflex|h reflex
84320|NCT03675958|Johnstone's Pressure Splint|johnstone's pressure splint
84321|NCT03675958|Stretching|stretching
84322|NCT03675958|Functional Reach|functional reach
84323|NCT03675958|Spasticity|spasticity
84324|NCT03675919|Diabetes Mellitus, Type 2|diabetes mellitus, type 2
84325|NCT03675906|hypoalbuminemia|hypoalbuminemia
84326|NCT03675906|Acute Kidney Failure|acute kidney failure
84327|NCT03675906|older age|older age
84328|NCT03675906|hip fracture|hip fracture
84329|NCT03675893|Endometrial Cancer|endometrial cancer
84330|NCT03675893|CDK4/6|cdk4/6
84331|NCT03675893|ER+|er+
84332|NCT03675893|Estrogen Receptor|estrogen receptor
84333|NCT03675854|end stage renal disease|end stage renal disease
84334|NCT03675854|infection|infection
84335|NCT03675854|antibiotic|antibiotic
84336|NCT03675841|Pazufloxacin Mesilate ear drops|pazufloxacin mesilate ear drops
84337|NCT03675828|Heart Failure|heart failure
84338|NCT03675828|Distance Health|distance health
84339|NCT03675828|Virtual Health|virtual health
84340|NCT03675789|Thrombi|thrombi
84341|NCT03675789|LPS|lps
84342|NCT03675789|Platelet Thrombus|platelet thrombus
84343|NCT03675776|Depression|depression
84344|NCT03675763|Skull|skull
84345|NCT03675763|Osteopathic Manipulation|osteopathic manipulation
84346|NCT03675763|Infantile Colic|infantile colic
84347|NCT03675763|Clinical Trial|clinical trial
84348|NCT03675763|Massage|massage
84349|NCT03675763|Infant|infant
84350|NCT03675763|Osteopathic Medicine|osteopathic medicine
84351|NCT03675750|antipsychotic drugs|antipsychotic drugs
84352|NCT03675750|hyperprolactinemia|hyperprolactinemia
84353|NCT03675750|bone metabolism|bone metabolism
84354|NCT03675737|programmed cell death 1 (PD-1, PD1)|programmed cell death 1 (pd-1, pd1)
84355|NCT03675737|programmed cell death ligand 1 (PD-L1, PDL1)|programmed cell death ligand 1 (pd-l1, pdl1)
84356|NCT03675737|programmed cell death ligand 2 (PD-L2, PDL2)|programmed cell death ligand 2 (pd-l2, pdl2)
84357|NCT03675724|Frailty|frailty
84358|NCT03675724|Inflammation|inflammation
84359|NCT03675724|Elderly|elderly
84360|NCT03675724|Aging|aging
84361|NCT03675698|Nasotracheal tube size based on radiological images of nose.|nasotracheal tube size based on radiological images of nose.
84362|NCT03675685|Cellulite|cellulite
84363|NCT03675685|Edematous Fibrosclerotic Panniculopathy|edematous fibrosclerotic panniculopathy
84364|NCT03675685|EFP|efp
84365|NCT03675659|tmj pain|tmj pain
84366|NCT03675646|morphine spinal|morphine spinal
84367|NCT03675646|prostatectomy|prostatectomy
84368|NCT03675646|nephrectomy|nephrectomy
84369|NCT03675607|Infant Nutritional Physiological Phenomena|infant nutritional physiological phenomena
84370|NCT03675607|Complementary feeding|complementary feeding
84371|NCT03675607|Feeding Behavior|feeding behavior
84372|NCT03675607|Food Preferences|food preferences
84373|NCT03675607|Parenting|parenting
84374|NCT03675607|Health Knowledge, Attitudes, Practice|health knowledge, attitudes, practice
84375|NCT03675594|Dislodgement force|dislodgement force
84376|NCT03675594|Digital denture|digital denture
84377|NCT03675594|CAD/CAM metallic dentures|cad/cam metallic dentures
84378|NCT03675529|prostate neoplasm|prostate neoplasm
84379|NCT03675529|exercise|exercise
84380|NCT03675529|high intensity interval training|high intensity interval training
84381|NCT03675529|tumor hypoxia|tumor hypoxia
84382|NCT03675529|immune cells|immune cells
84383|NCT03675503|Fall Prevention|fall prevention
84384|NCT03675503|Hospital Acquired Conditions|hospital acquired conditions
84385|NCT03675503|Nurse Education|nurse education
84386|NCT03675503|Assistive Devices|assistive devices
84387|NCT03675451|PET/CT|pet/ct
84388|NCT03675451|Imaging|imaging
84389|NCT03675451|Nuclear Medicine|nuclear medicine
84390|NCT03675425|Chest shielding|chest shielding
84391|NCT03675425|Patent Ductus Arteriosus|patent ductus arteriosus
84392|NCT03675425|Chest Childing|chest childing
84393|NCT03675412|Primary Open Angle Glaucoma (POAG)|primary open angle glaucoma (poag)
84394|NCT03675412|Optical Coherence Tomography Angiography (OCTA)|optical coherence tomography angiography (octa)
84395|NCT03675412|Caffeine|caffeine
84396|NCT03675412|Macular Blood Flow|macular blood flow
84397|NCT03675412|Peripapillary Blood Flow|peripapillary blood flow
84398|NCT03675399|isometric exercise|isometric exercise
84399|NCT03675399|rotator cuff|rotator cuff
84400|NCT03675399|pain threshold|pain threshold
84401|NCT03675373|chat-based intervention|chat-based intervention
84402|NCT03675373|alcohol brief intervention|alcohol brief intervention
84403|NCT03675373|high-risk drinking|high-risk drinking
84404|NCT03675373|university students|university students
84405|NCT03675373|AUDIT|audit
84406|NCT03675373|instant messaging|instant messaging
84407|NCT03675373|WhatsApp|whatsapp
84408|NCT03675360|Prediabetes|prediabetes
84409|NCT03675360|Diabetes|diabetes
84410|NCT03675360|Low-Carbohydrate Diet|low-carbohydrate diet
84411|NCT03675334|clinical trial|clinical trial
84412|NCT03675334|root coverage|root coverage
84413|NCT03675334|biomaterials|biomaterials
84414|NCT03675334|collagen matrix|collagen matrix
84415|NCT03675334|coronally advanced flap|coronally advanced flap
84416|NCT03675282|MRI|mri
84417|NCT03675282|PET Scan|pet scan
84418|NCT03675243|Transanal endoscopic microsurgery|transanal endoscopic microsurgery
84419|NCT03675243|TEM|tem
84420|NCT03675243|QoL|qol
84421|NCT03675243|quality of life|quality of life
84422|NCT03675243|rectal cancer|rectal cancer
84427|NCT03675178|Clinical endpoint antibiotic application frequency|clinical endpoint antibiotic application frequency
84428|NCT03675178|efficacy and safety|efficacy and safety
84429|NCT03675178|randomized|randomized
84430|NCT03675178|double blind|double blind
84431|NCT03675165|Prevention|prevention
84432|NCT03675165|Psychology|psychology
84433|NCT03675165|Self-Management|self-management
84434|NCT03675152|spondylolysis|spondylolysis
84435|NCT03675152|pediatric|pediatric
84436|NCT03675126|Duchenne muscular dystrophy|duchenne muscular dystrophy
84437|NCT03675126|Exon Skipping|exon skipping
84439|NCT03675126|Exon 51|exon 51
84440|NCT03675126|Ambulatory|ambulatory
84441|NCT03675126|Pediatric|pediatric
84442|NCT03675126|Nonambulatory|nonambulatory
84443|NCT03675126|Peptide-conjugated phosphorodiamidate morpholino oligomer (PPMO)|peptide-conjugated phosphorodiamidate morpholino oligomer (ppmo)
84444|NCT03675126|Duchenne|duchenne
84445|NCT03675113|upper extremity aerobic exercise|upper extremity aerobic exercise
84446|NCT03675113|functional exercise capacity|functional exercise capacity
84447|NCT03675113|maximal exercise capacity|maximal exercise capacity
84448|NCT03675113|respiratory endurance|respiratory endurance
84449|NCT03675113|quality of life|quality of life
84450|NCT03675113|dyspnea|dyspnea
84451|NCT03675113|pulmonary function|pulmonary function
84452|NCT03675113|fatigue|fatigue
84453|NCT03675113|anxiety|anxiety
84454|NCT03675113|depression|depression
84455|NCT03675100|Irritable bowel syndrome|irritable bowel syndrome
84456|NCT03675100|Subtype|subtype
84457|NCT03675100|Tight junction|tight junction
84458|NCT03675100|Sex|sex
84459|NCT03675087|Work Capacity Evaluation|work capacity evaluation
84460|NCT03675087|Fatigue Syndrome,Chronic|fatigue syndrome,chronic
84461|NCT03675087|Exercise Tests|exercise tests
84462|NCT03675048|Gut Microbiota|gut microbiota
84463|NCT03675048|Cesarean Section|cesarean section
84464|NCT03675048|Dysbiosis|dysbiosis
84465|NCT03675009|Child Day Care Centers|child day care centers
84466|NCT03675009|Indoor Air Quality|indoor air quality
84467|NCT03675009|Educational Intervention|educational intervention
84468|NCT03674996|Prostatectomy|prostatectomy
84469|NCT03674996|Patient satisfaction|patient satisfaction
84470|NCT03674996|Questionnaire|questionnaire
84471|NCT03674983|adherence|adherence
84472|NCT03674983|AIDS prevention|aids prevention
84473|NCT03674983|Anti-Retroviral Agents|anti-retroviral agents
84474|NCT03674983|Behavioral Economics|behavioral economics
84475|NCT03674983|Biological Markers|biological markers
84476|NCT03674983|Cost-effectiveness|cost-effectiveness
84477|NCT03674983|MSM|msm
84478|NCT03674983|HIV Prevention|hiv prevention
84479|NCT03674983|PrEP|prep
84484|NCT03674944|Overweight|overweight
84485|NCT03674944|Obesity|obesity
84486|NCT03674944|Overeating|overeating
84487|NCT03674944|Treatment|treatment
84488|NCT03674944|Body Mass Index|body mass index
84489|NCT03674944|Intervention|intervention
84490|NCT03674944|Behavioral Treatment|behavioral treatment
84491|NCT03674944|Dialectical Behavior Therapy|dialectical behavior therapy
84492|NCT03674944|Emotion Regulation|emotion regulation
84493|NCT03674931|countervail age-related cognitive and cerebral decline|countervail age-related cognitive and cerebral decline
84494|NCT03674931|healthy elderly|healthy elderly
84495|NCT03674931|musical training|musical training
84496|NCT03674931|neuroimagery and brain plasticity|neuroimagery and brain plasticity
84497|NCT03674931|psychometrics|psychometrics
84498|NCT03674931|executive function|executive function
84499|NCT03674931|mental health|mental health
84500|NCT03674931|well-being|well-being
84501|NCT03674931|sensorimotor function|sensorimotor function
84502|NCT03674892|Intranasal Neurostimulation|intranasal neurostimulation
84503|NCT03674879|Follow Up|follow up
84504|NCT03674879|Text Messaging|text messaging
84505|NCT03674840|Multifocal Intraocular Lenses|multifocal intraocular lenses
84506|NCT03674840|visual acuity|visual acuity
84507|NCT03674840|kappa angle|kappa angle
84508|NCT03674814|prostate cancer|prostate cancer
84509|NCT03674814|Enzalutamide|enzalutamide
84510|NCT03674814|Relacorilant|relacorilant
84511|NCT03674801|Superficial esophageal cancer|superficial esophageal cancer
84512|NCT03674801|Endoscopic mucosectomy|endoscopic mucosectomy
84513|NCT03674801|Submucosal dissection|submucosal dissection
84514|NCT03674801|therapeutic strategy|therapeutic strategy
84515|NCT03674762|submerged two-stage, nonsubmerged one-stage, dental implants, marginal bone loss|submerged two-stage, nonsubmerged one-stage, dental implants, marginal bone loss
84516|NCT03674736|Healthy|healthy
84517|NCT03674736|Men|men
84518|NCT03674736|Adults|adults
84519|NCT03674736|Methionine|methionine
84520|NCT03674736|Lysine|lysine
84529|NCT03674671|neuroimaging|neuroimaging
84530|NCT03674671|biomarkers|biomarkers
84531|NCT03674671|genomics|genomics
84532|NCT03674671|proteomic|proteomic
84533|NCT03674671|BP|bp
84534|NCT03674645|Healthy volunteers|healthy volunteers
84535|NCT03674645|Test|test
84536|NCT03674645|Optimization|optimization
84537|NCT03674632|breastfeeding|breastfeeding
84538|NCT03674632|maternal stress|maternal stress
84539|NCT03674632|infant behavior|infant behavior
84540|NCT03674632|infant development|infant development
84541|NCT03674632|relaxation|relaxation
84542|NCT03674606|Pre-eclampsia|pre-eclampsia
84543|NCT03674606|Fetal Medicine Foundation|fetal medicine foundation
84544|NCT03674606|FMF screening|fmf screening
84545|NCT03674606|First trimester|first trimester
84546|NCT03674606|Aspirin|aspirin
84547|NCT03674606|Placental disease|placental disease
84548|NCT03674606|nulliparous|nulliparous
84549|NCT03674606|LDA|lda
84550|NCT03674606|low-dose aspirin|low-dose aspirin
84551|NCT03674606|fetal growth restriction|fetal growth restriction
84552|NCT03674606|trans-abdominal uterine artery doppler examination|trans-abdominal uterine artery doppler examination
84553|NCT03674593|Mitral Valve Chordae|mitral valve chordae
84554|NCT03674593|Degenerative Mitral Valve Disease|degenerative mitral valve disease
84555|NCT03674593|Mitral Valve Chordae Replacement|mitral valve chordae replacement
84556|NCT03674593|Mitral Valve Chordae Translocation|mitral valve chordae translocation
84557|NCT03674593|Mitral Valve Chordae Prosthetics|mitral valve chordae prosthetics
84558|NCT03674580|suicidal patients;psychiatry|suicidal patients;psychiatry
84564|NCT03674528|MRI|mri
84565|NCT03674528|MRE|mre
84566|NCT03674528|Liver Disease|liver disease
84567|NCT03674528|Liver Fibrosis|liver fibrosis
84568|NCT03674489|neurodynamics|neurodynamics
84569|NCT03674489|neurodynamic mobilization|neurodynamic mobilization
84570|NCT03674489|quantitative sensory testing|quantitative sensory testing
84571|NCT03674489|median nerve|median nerve
822893|NCT00144820|Randomised|randomised
84572|NCT03674489|pressure pain threshold|pressure pain threshold
84573|NCT03674489|thermal pain threshold|thermal pain threshold
84574|NCT03674489|thermal pain tolerance|thermal pain tolerance
84575|NCT03674437|Quality of Life|quality of life
84576|NCT03674437|Cognitive Function|cognitive function
84577|NCT03674437|18-294|18-294
84578|NCT03674411|AML|aml
84579|NCT03674411|ALL|all
84580|NCT03674411|CML|cml
84581|NCT03674411|MCL|mcl
84582|NCT03674398|post-concussion|post-concussion
84583|NCT03674398|Mild Traumatic Brain Injury|mild traumatic brain injury
84584|NCT03674398|head injury|head injury
84585|NCT03674398|headache|headache
84586|NCT03674398|aerobic exercise|aerobic exercise
84587|NCT03674398|cognitive training|cognitive training
84588|NCT03674398|brain training|brain training
84589|NCT03674398|home-based intervention|home-based intervention
84590|NCT03674398|social cognitive neuroscience|social cognitive neuroscience
84591|NCT03674385|Vitamin E|vitamin e
84592|NCT03674385|Polycystic ovary|polycystic ovary
84593|NCT03674372|tracheal occlusion|tracheal occlusion
84594|NCT03674372|FETO|feto
84595|NCT03674372|Congenital Diaphragmatic Hernia|congenital diaphragmatic hernia
84596|NCT03674359|1, 3-β-D-glucan, Candidemia, Intensive Care Unit|1, 3-β-d-glucan, candidemia, intensive care unit
84597|NCT03674346|hypnoanalgesia|hypnoanalgesia
84598|NCT03674346|cutaneous angioma|cutaneous angioma
84599|NCT03674346|sclerosis treatment|sclerosis treatment
84600|NCT03674333|Folic Acid|folic acid
84601|NCT03674333|Dyslipidemias|dyslipidemias
84602|NCT03674333|Hyperlipidemia|hyperlipidemia
84603|NCT03674281|Closed-Loop Control (CLC)|closed-loop control (clc)
84604|NCT03674281|Sensor-Augmented Therapy (SAP)|sensor-augmented therapy (sap)
84605|NCT03674281|Insulin Pump|insulin pump
84606|NCT03674281|Artificial Pancreas (AP)|artificial pancreas (ap)
84607|NCT03674281|Continuous Glucose Monitor (CGM)|continuous glucose monitor (cgm)
84608|NCT03674255|Stress Echocardiography|stress echocardiography
84609|NCT03674255|Blood Biomarkers|blood biomarkers
84610|NCT03674255|Extracellular Vesicles|extracellular vesicles
84611|NCT03674255|Imaging Biomarkers|imaging biomarkers
84612|NCT03674255|Machine Learning|machine learning
84613|NCT03674255|Artificial Intelligence|artificial intelligence
84614|NCT03674255|Ischaemic Heart Disease|ischaemic heart disease
84615|NCT03674255|Coronary Artery Disease|coronary artery disease
84616|NCT03674255|Angina Pectoris|angina pectoris
84617|NCT03674216|peripherally inserted central venous catheter|peripherally inserted central venous catheter
84618|NCT03674216|midline catheter|midline catheter
84619|NCT03674216|thrombosis|thrombosis
84620|NCT03674216|blood stream infection|blood stream infection
84621|NCT03674203|Platelet-rich plasma|platelet-rich plasma
84622|NCT03674177|Vaccines|vaccines
84623|NCT03674177|Safety|safety
84624|NCT03674177|Immunogenicity|immunogenicity
84625|NCT03674177|Reactogenicity|reactogenicity
84626|NCT03674177|Respiratory Syncytial Viruses|respiratory syncytial viruses
84627|NCT03674151|split-skin|split-skin
84628|NCT03674151|burn wound|burn wound
84629|NCT03674151|wound dressing|wound dressing
84630|NCT03674151|comparison|comparison
84631|NCT03674151|silver|silver
84632|NCT03674151|honey|honey
84633|NCT03674151|PVP-Iod|pvp-iod
84634|NCT03674151|hydrogel|hydrogel
84635|NCT03674125|Hepatitis C Virus|hepatitis c virus
84636|NCT03674125|HCV|hcv
84637|NCT03674125|Vaccine|vaccine
84638|NCT03674125|DNA|dna
84639|NCT03674099|Multiple Sclerosis relaps|multiple sclerosis relaps
84640|NCT03674099|Imatinib|imatinib
84641|NCT03674099|Methylprednisolone|methylprednisolone
84642|NCT03674073|Neoantigen|neoantigen
84643|NCT03674073|Vaccine|vaccine
84644|NCT03674073|Dendritic Cell|dendritic cell
84645|NCT03674073|Personalized|personalized
84646|NCT03674073|Liver cancer|liver cancer
84647|NCT03674060|Healthy Male Volunteers|healthy male volunteers
84648|NCT03674060|Evaluation of the Pharmacokinetic Property|evaluation of the pharmacokinetic property
84649|NCT03674060|A Dose-block Randomized, Active-controlled, Open-label|a dose-block randomized, active-controlled, open-label
84650|NCT03674047|Hematopoietic Cell Transplantation|hematopoietic cell transplantation
84651|NCT03674034|MRI images|mri images
84652|NCT03674034|CTscan|ctscan
84653|NCT03674008|Sedation anesthesia gastrointestinal endoscopy|sedation anesthesia gastrointestinal endoscopy
84654|NCT03673969|Mini Gastric Bypass|mini gastric bypass
84655|NCT03673969|Roux En-Y Gastric Bypass|roux en-y gastric bypass
84656|NCT03673969|Bariatric surgery|bariatric surgery
84657|NCT03673969|Type 2 diabetes|type 2 diabetes
84658|NCT03673930|NIRS|nirs
84659|NCT03673930|mood|mood
84660|NCT03673930|cognitive performance|cognitive performance
84661|NCT03673930|Zanthozylum armatum|zanthozylum armatum
84662|NCT03673930|Nepalese pepper|nepalese pepper
84663|NCT03673865|3D Printer|3d printer
84664|NCT03673865|orbital implants|orbital implants
84665|NCT03673852|Serious Mental Illness (SMI)|serious mental illness (smi)
84666|NCT03673813|Hypothalamic obesity|hypothalamic obesity
84667|NCT03673813|Prader-willi syndrome|prader-willi syndrome
84668|NCT03673813|Physical activity|physical activity
84669|NCT03673800|gambling disorder|gambling disorder
84670|NCT03673800|pathological gambling|pathological gambling
84671|NCT03673800|problem gambling|problem gambling
84672|NCT03673800|addiction|addiction
84673|NCT03673774|pulmonary hypertension|pulmonary hypertension
84674|NCT03673774|impedancemetry|impedancemetry
84675|NCT03673774|cardiac output|cardiac output
84676|NCT03673761|muscle weakness|muscle weakness
84677|NCT03673761|myopathy|myopathy
84678|NCT03673748|Lupus Erythematosus|lupus erythematosus
84679|NCT03673748|Lupus Nephritis|lupus nephritis
84680|NCT03673748|Stem Cell|stem cell
84681|NCT03673748|Mesenchymal Stem Cells|mesenchymal stem cells
84682|NCT03673748|Autoimmune diseases|autoimmune diseases
84683|NCT03673748|Systemic Lupus Erythematosus|systemic lupus erythematosus
84684|NCT03673722|Mediterranean Diet|mediterranean diet
84685|NCT03673722|Physical Activity|physical activity
84686|NCT03673722|Dementia|dementia
84687|NCT03673722|Alzheimer Disease|alzheimer disease
84688|NCT03673722|Cognition|cognition
84689|NCT03673683|Invasive Mechanical Ventilation|invasive mechanical ventilation
84690|NCT03673670|COPD|copd
84691|NCT03673670|Bronchodilation|bronchodilation
84692|NCT03673670|FEV1|fev1
84693|NCT03673657|Local Advanced Non-small Cell Lung Cancer|local advanced non-small cell lung cancer
84694|NCT03673657|Chemoradiotherapy|chemoradiotherapy
84695|NCT03673657|Oral Nutritional Supplements|oral nutritional supplements
84696|NCT03673631|non-invasive ventilation|non-invasive ventilation
84697|NCT03673631|nasal high flow humidified canula oxygenation|nasal high flow humidified canula oxygenation
84698|NCT03673631|palliative|palliative
84699|NCT03673631|acute respiratory failure|acute respiratory failure
84700|NCT03673631|withholding therapies|withholding therapies
84701|NCT03673631|withdrawing therapies|withdrawing therapies
84702|NCT03673592|Mosaicism|mosaicism
84703|NCT03673592|PGT-A|pgt-a
84704|NCT03673592|Blastocyst biopsy|blastocyst biopsy
84705|NCT03673592|Aneuploidy testing|aneuploidy testing
84706|NCT03673592|Preimplantation genetics|preimplantation genetics
84707|NCT03673579|NICU|nicu
84708|NCT03673579|Developmental care|developmental care
84709|NCT03673579|Neuroprotective|neuroprotective
84710|NCT03673579|Technology|technology
84711|NCT03673566|NICU|nicu
84712|NCT03673566|Developmental care|developmental care
84713|NCT03673566|Neuroprotective|neuroprotective
84714|NCT03673566|Technology|technology
84715|NCT03673553|fibromyalgia|fibromyalgia
84716|NCT03673553|pain|pain
84717|NCT03673553|quality of life|quality of life
84718|NCT03673553|multidomal treatment|multidomal treatment
84719|NCT03673540|Bulimia Nervosa|bulimia nervosa
84720|NCT03673540|Eating Disorder|eating disorder
84721|NCT03673540|Binge Eating|binge eating
84722|NCT03673540|Bulimia|bulimia
84723|NCT03673540|Purging|purging
84724|NCT03673527|open-label|open-label
84725|NCT03673527|multiple-dose|multiple-dose
84726|NCT03673527|non-randomised|non-randomised
84727|NCT03673527|non-comparative|non-comparative
84728|NCT03673514|Direct anterior approach|direct anterior approach
84729|NCT03673514|posterior approach|posterior approach
84730|NCT03673488|Incontinence|incontinence
84731|NCT03673449|peripheral nerve injury|peripheral nerve injury
84732|NCT03673449|nerve guide|nerve guide
84733|NCT03673449|silk fibroin|silk fibroin
84734|NCT03673449|silk|silk
84735|NCT03673449|nerve regeneration|nerve regeneration
84736|NCT03673423|Resectability Status|resectability status
84737|NCT03673423|NCCN criteria|nccn criteria
84738|NCT03673397|Exercise|exercise
84739|NCT03673397|Sleep|sleep
84740|NCT03673397|Depression|depression
84741|NCT03673397|Heart rate variability|heart rate variability
84742|NCT03673397|Blood pressure|blood pressure
84743|NCT03673397|randomized controlled trial|randomized controlled trial
84744|NCT03673397|polysomnography|polysomnography
84745|NCT03673384|far-infrared radiation|far-infrared radiation
84746|NCT03673384|allergic rhinitis|allergic rhinitis
84748|NCT03673384|eosinophil cationic protein|eosinophil cationic protein
84878|NCT03672682|chemosensitivity|chemosensitivity
84749|NCT03673384|Taiwanese version of the 20-item Sinonasal Outcome Test|taiwanese version of the 20-item sinonasal outcome test
84750|NCT03673384|WHOQOL-BREF|whoqol-bref
84751|NCT03673371|Limb Prosthesis|limb prosthesis
84752|NCT03673371|Shoe|shoe
84753|NCT03673371|Self Concepts|self concepts
84754|NCT03673345|B Cell|b cell
84755|NCT03673345|Children|children
84756|NCT03673345|Influenza|influenza
84757|NCT03673345|T Cell|t cell
84758|NCT03673345|Vaccination|vaccination
84759|NCT03673332|Elderly cancer patients|elderly cancer patients
84760|NCT03673332|Immunotherapies|immunotherapies
84761|NCT03673306|Breast cancer|breast cancer
84762|NCT03673306|BRCA|brca
84763|NCT03673306|Young|young
84764|NCT03673306|Survivorship|survivorship
84765|NCT03673293|Total Joint Arthroplasty|total joint arthroplasty
84766|NCT03673293|Postoperative mobility|postoperative mobility
84767|NCT03673293|Gait symmetry|gait symmetry
84768|NCT03673293|Feedback|feedback
84769|NCT03673280|intrathecal morphine|intrathecal morphine
84770|NCT03673280|quadratus lumborum block|quadratus lumborum block
84771|NCT03673280|cesarean c-section|cesarean c-section
84772|NCT03673280|postoperative pain|postoperative pain
84773|NCT03673280|chronic pain|chronic pain
84774|NCT03673267|health literacy|health literacy
84775|NCT03673267|nutrition literacy|nutrition literacy
84776|NCT03673267|parenting|parenting
84777|NCT03673254|rotational atherectomy device,|rotational atherectomy device,
84778|NCT03673241|Ischemic Stroke|ischemic stroke
84779|NCT03673241|Motor Recovery|motor recovery
84780|NCT03673241|Length of Stay Reduction|length of stay reduction
84781|NCT03673189|Sensors|sensors
84782|NCT03673189|Health Recording|health recording
84783|NCT03673163|chronic postoperative pain|chronic postoperative pain
84784|NCT03673163|lidocaine infusion|lidocaine infusion
84785|NCT03673163|inguinal herniotomy|inguinal herniotomy
84786|NCT03673137|gemcitabine|gemcitabine
84787|NCT03673137|pancreatic adenocarcinoma|pancreatic adenocarcinoma
84788|NCT03673137|Irreversible electroporation|irreversible electroporation
84789|NCT03673137|overall survival time|overall survival time
84790|NCT03673124|ovary|ovary
84791|NCT03673124|peritoneum|peritoneum
84792|NCT03673124|fallopian tube|fallopian tube
84793|NCT03673098|Resilience|resilience
84794|NCT03673098|Women|women
84795|NCT03673098|HIV/AIDS|hiv/aids
84796|NCT03673059|Microbiome|microbiome
84797|NCT03673059|Eczema|eczema
84798|NCT03673059|Itching|itching
84799|NCT03673059|Quality of life|quality of life
84800|NCT03673059|Moisturization|moisturization
84801|NCT03673033|Transplantation, Hepatic, Cirrhosis, Bile duct|transplantation, hepatic, cirrhosis, bile duct
84802|NCT03673020|Vaccine|vaccine
84803|NCT03673020|Solid Tumor|solid tumor
84804|NCT03673007|contraception|contraception
84805|NCT03673007|financial access|financial access
84806|NCT03673007|unwanted pregnancy|unwanted pregnancy
84807|NCT03672994|Acute Breathlessness|acute breathlessness
84808|NCT03672994|Breathomics|breathomics
84809|NCT03672968|Heredity Optic Atrophy|heredity optic atrophy
84810|NCT03672968|Leber Hereditary Optic Atrophy|leber hereditary optic atrophy
84811|NCT03672968|Leber Hereditary Optic Neuropathy|leber hereditary optic neuropathy
84812|NCT03672968|LHON|lhon
84813|NCT03672968|Eye Diseases|eye diseases
84814|NCT03672968|Hereditary Eye Diseases|hereditary eye diseases
84815|NCT03672968|Inherited retinal dystrophies or degeneration|inherited retinal dystrophies or degeneration
84816|NCT03672968|Inborn Genetic Disease|inborn genetic disease
84817|NCT03672968|Gene Therapy|gene therapy
84818|NCT03672968|Intravitreal Injections|intravitreal injections
84819|NCT03672968|Mitochondrial Disease|mitochondrial disease
84824|NCT03672942|aggression|aggression
84825|NCT03672942|batterers intervention|batterers intervention
84826|NCT03672942|mindfulness|mindfulness
84827|NCT03672942|communication skills|communication skills
84828|NCT03672942|couples|couples
84829|NCT03672929|Total hip arthroplasty|total hip arthroplasty
84830|NCT03672929|Medical Device|medical device
84831|NCT03672929|Safety|safety
84832|NCT03672929|Hip prosthesis|hip prosthesis
84833|NCT03672916|Total hip arthroplasty|total hip arthroplasty
84834|NCT03672916|Medical Device|medical device
84835|NCT03672916|Safety|safety
84836|NCT03672916|Hip prosthesis|hip prosthesis
84837|NCT03672903|obesity|obesity
84838|NCT03672903|weight vest|weight vest
84839|NCT03672903|gravitostat|gravitostat
84840|NCT03672903|appetite|appetite
84841|NCT03672903|obesity treatment|obesity treatment
84842|NCT03672903|leptin|leptin
84843|NCT03672903|body weight|body weight
84844|NCT03672903|weight loss|weight loss
84845|NCT03672903|diet-induced obesity|diet-induced obesity
84846|NCT03672903|osteocytes|osteocytes
84847|NCT03672903|glucose metabolism|glucose metabolism
84848|NCT03672890|Telestroke|telestroke
84849|NCT03672890|Telemedicine|telemedicine
84850|NCT03672890|Stroke|stroke
84851|NCT03672890|Secondary stroke prevention|secondary stroke prevention
84852|NCT03672877|Physical Therapy|physical therapy
84853|NCT03672877|Rehabilitation|rehabilitation
84854|NCT03672877|Walking|walking
84860|NCT03672812|liraglutide|liraglutide
84861|NCT03672812|brain death|brain death
84862|NCT03672812|inflammation|inflammation
84863|NCT03672799|Head and neck cancer|head and neck cancer
84864|NCT03672799|Rehabilitation|rehabilitation
84865|NCT03672799|Rehabilitation planning consult|rehabilitation planning consult
84866|NCT03672799|Self-management|self-management
84867|NCT03672786|Gene Expression|gene expression
84868|NCT03672786|Athletes|athletes
84869|NCT03672786|Micronutrient Intervention|micronutrient intervention
84870|NCT03672786|Whole Blood|whole blood
84871|NCT03672773|Small Cell Lung Cancer|small cell lung cancer
84872|NCT03672773|PARP Inhibitor|parp inhibitor
84873|NCT03672734|pH gastric contents|ph gastric contents
84874|NCT03672734|laparoscopic surgery|laparoscopic surgery
84875|NCT03672734|pH stomach|ph stomach
84876|NCT03672734|volume gastric content|volume gastric content
84877|NCT03672682|DLBCL|dlbcl
84879|NCT03672682|chemoresistance|chemoresistance
84880|NCT03672669|Leukocyte- and platelet rich fibrin|leukocyte- and platelet rich fibrin
84881|NCT03672669|Advanced platelet rich fibrin|advanced platelet rich fibrin
84882|NCT03672669|Impacted mandibular third molar surgery|impacted mandibular third molar surgery
84883|NCT03672656|diabetic retinopathy|diabetic retinopathy
84884|NCT03672656|patterns|patterns
84885|NCT03672656|low time of impulse|low time of impulse
84886|NCT03672656|Pascal|pascal
84887|NCT03672643|NSCLC|nsclc
84888|NCT03672630|NTM|ntm
84889|NCT03672630|MAC|mac
84890|NCT03672630|mycobacteria|mycobacteria
84891|NCT03672630|nontuberculous mycobacteria|nontuberculous mycobacteria
84892|NCT03672630|azithromycin|azithromycin
84893|NCT03672630|ethambutol|ethambutol
84894|NCT03672630|rifampin|rifampin
84895|NCT03672591|Heart failure|heart failure
84896|NCT03672591|Renal clearance technique|renal clearance technique
84897|NCT03672591|Preserved ejection fraction|preserved ejection fraction
84898|NCT03672578|Diet|diet
84899|NCT03672578|Young Adults|young adults
84900|NCT03672578|Health messaging|health messaging
84901|NCT03672565|Exposure and Response prevention ERP|exposure and response prevention erp
84902|NCT03672565|Cognitive-behavioural therapy|cognitive-behavioural therapy
84903|NCT03672565|Pediatric OCD|pediatric ocd
84904|NCT03672565|Childhood-onset OCD|childhood-onset ocd
84905|NCT03672552|Aspiration pneumonia|aspiration pneumonia
84906|NCT03672552|Dementia|dementia
84907|NCT03672552|Dysphagia|dysphagia
84908|NCT03672552|Oral hygiene|oral hygiene
84909|NCT03672552|Long-term care|long-term care
84910|NCT03672552|Frazier Free Water|frazier free water
84911|NCT03672513|Menopuase|menopuase
84912|NCT03672513|Zinc|zinc
84913|NCT03672513|Magnesium|magnesium
84914|NCT03672513|Antioxidant|antioxidant
84915|NCT03672513|Bone loss|bone loss
84916|NCT03672513|Nutritional intervention|nutritional intervention
84917|NCT03672487|Congenital Transmission|congenital transmission
84918|NCT03672487|Trypanosoma cruzi|trypanosoma cruzi
84919|NCT03672487|Benznidazole|benznidazole
84920|NCT03672474|Alzheimer's Disease|alzheimer's disease
84921|NCT03672474|Photobiomodulation|photobiomodulation
84922|NCT03672474|Innovative Therapy|innovative therapy
84923|NCT03672448|dementia|dementia
84924|NCT03672448|depression|depression
84925|NCT03672448|cohort study|cohort study
84926|NCT03672448|sample bank|sample bank
84927|NCT03672448|precision diagnosis|precision diagnosis
84928|NCT03672448|brain imaging|brain imaging
84929|NCT03672435|post operative recovery|post operative recovery
84930|NCT03672435|oculocardiac reflex|oculocardiac reflex
84931|NCT03672435|extra ocular muscle|extra ocular muscle
84932|NCT03672435|conjunctiva|conjunctiva
84933|NCT03672435|numbing drop|numbing drop
84934|NCT03672435|heart rate|heart rate
84935|NCT03672422|Pediatric|pediatric
84936|NCT03672422|Pancreatitis|pancreatitis
84937|NCT03672422|Chronic|chronic
84938|NCT03672422|Acute|acute
84939|NCT03672422|Recurrent|recurrent
84940|NCT03672422|ARP|arp
84941|NCT03672422|CP|cp
84942|NCT03672422|Pancreas|pancreas
84943|NCT03672422|Children|children
84944|NCT03672409|Knowledge in Type 2 diabetes,|knowledge in type 2 diabetes,
84945|NCT03672409|Training program|training program
84946|NCT03672409|Primary health care|primary health care
84947|NCT03672396|exercise|exercise
84948|NCT03672396|hormone therapy|hormone therapy
84949|NCT03672370|Total hip arthroplasty|total hip arthroplasty
84950|NCT03672370|Medical device|medical device
84951|NCT03672370|Performance|performance
84952|NCT03672370|Safety|safety
84953|NCT03672370|Hip prosthesis|hip prosthesis
84954|NCT03672357|Liver resection|liver resection
84955|NCT03672357|Laparoscopic surgery|laparoscopic surgery
84956|NCT03672357|fast recovery|fast recovery
84957|NCT03672331|standard breast screening - risk-based screening program|standard breast screening - risk-based screening program
84958|NCT03672318|CAR T cells|car t cells
84959|NCT03672318|CD138|cd138
84960|NCT03672318|Multiple Myeloma|multiple myeloma
84961|NCT03672292|Aspergillosis|aspergillosis
84962|NCT03672292|SCY-078|scy-078
84963|NCT03672292|Ibrexafungerp|ibrexafungerp
84964|NCT03672292|Coadministration|coadministration
84965|NCT03672240|Urinary Bladder Neoplasms|urinary bladder neoplasms
84966|NCT03672240|Non-Muscle Invasive Bladder Cancer (NMIBC)|non-muscle invasive bladder cancer (nmibc)
84967|NCT03672240|Oral Antineoplastic Agent|oral antineoplastic agent
84968|NCT03672227|Head Start|head start
84969|NCT03672227|Family Style Dining|family style dining
84970|NCT03672201|Aggression|aggression
84971|NCT03672201|Agitation|agitation
84972|NCT03672201|Alzheimer's disease|alzheimer's disease
84973|NCT03672201|Integrated Care Pathway|integrated care pathway
84974|NCT03672201|StaN|stan
84975|NCT03672201|Dementia|dementia
84976|NCT03672188|Hepatitis B Virus|hepatitis b virus
84977|NCT03672188|Chronic Hepatitis B|chronic hepatitis b
84978|NCT03672188|HBV|hbv
84979|NCT03672188|Hepatitis|hepatitis
84980|NCT03672097|Percutaneous Coronary Intervention (PCI)|percutaneous coronary intervention (pci)
84981|NCT03672097|ST elevation myocardial infarction (STEMI)|st elevation myocardial infarction (stemi)
84982|NCT03672097|Non-ST elevation myocardial infarction [NSTEMI]|non-st elevation myocardial infarction [nstemi]
84983|NCT03672097|Unstable angina (UA)|unstable angina (ua)
84984|NCT03672097|Prasugrel|prasugrel
84985|NCT03672097|ACS-PCI|acs-pci
84986|NCT03672071|ephedrine|ephedrine
84987|NCT03672071|norepinephrine|norepinephrine
84988|NCT03672071|maternal hemodynamics|maternal hemodynamics
84989|NCT03672071|spinal anesthesia|spinal anesthesia
84990|NCT03672058|Cystic Fibrosis, CF|cystic fibrosis, cf
84991|NCT03672045|pregnancy|pregnancy
84992|NCT03672045|postpartum hemorrhage|postpartum hemorrhage
84993|NCT03672045|Cesarean delivery|cesarean delivery
84994|NCT03672045|carbetocin|carbetocin
84995|NCT03672019|Percutaneous Biliary Drainage|percutaneous biliary drainage
84996|NCT03672019|Quality of life|quality of life
84997|NCT03672019|18-366|18-366
84998|NCT03671993|urethral pain syndrome|urethral pain syndrome
84999|NCT03671993|electrical pudendal nerve stimulation|electrical pudendal nerve stimulation
85000|NCT03671993|intravesical instillation|intravesical instillation
85001|NCT03671980|Calprotectin|calprotectin
85002|NCT03671967|bacteremia|bacteremia
85003|NCT03671967|enterobacteriaceae|enterobacteriaceae
85004|NCT03671967|extended spectrum beta-lactamase|extended spectrum beta-lactamase
85005|NCT03671967|meropenem|meropenem
85006|NCT03671967|piperacillin tazobactam|piperacillin tazobactam
85007|NCT03671954|knee osteoarthritis|knee osteoarthritis
85008|NCT03671954|rehabilitation strategies|rehabilitation strategies
85009|NCT03671954|soft tissue balance|soft tissue balance
85010|NCT03671915|artificial pancreas|artificial pancreas
85011|NCT03671902|Phonocardiogram|phonocardiogram
85012|NCT03671889|Alzheimer Disease|alzheimer disease
85013|NCT03671889|Alzheimer Syndrome|alzheimer syndrome
85014|NCT03671889|Magnetic Resonance guided Focal Ultrasound (MRgFUS)|magnetic resonance guided focal ultrasound (mrgfus)
85015|NCT03671889|Blood-Brain Barrier|blood-brain barrier
85016|NCT03671889|ExAblate|exablate
85018|NCT03671876|Sub-acute|sub-acute
85019|NCT03671876|Mobility|mobility
85020|NCT03671876|Movement therapy|movement therapy
85021|NCT03671876|Exercise|exercise
85022|NCT03671863|Ultrasound|ultrasound
85023|NCT03671863|Prenatal diagnosis|prenatal diagnosis
85024|NCT03671863|Congenital deformities|congenital deformities
85227|NCT03670823|EEG|eeg
85029|NCT03671772|REM sleep behavior disorder|rem sleep behavior disorder
85031|NCT03671759|Coffee|coffee
85032|NCT03671759|Arrhythmias|arrhythmias
85033|NCT03671759|Palpitations|palpitations
85034|NCT03671759|Cardiac ectopy|cardiac ectopy
85035|NCT03671759|PACs|pacs
85036|NCT03671759|PVCs|pvcs
85037|NCT03671746|Inflammatory cytokine|inflammatory cytokine
85038|NCT03671746|inflammation|inflammation
85039|NCT03671746|trauma|trauma
85040|NCT03671746|opioid|opioid
85041|NCT03671707|tobacco dependence treatment|tobacco dependence treatment
85042|NCT03671707|combined brief intervention|combined brief intervention
85043|NCT03671707|AWARD advice|award advice
85044|NCT03671707|active referral|active referral
85045|NCT03671707|nicotine replacement therapy|nicotine replacement therapy
85046|NCT03671707|pregnancy|pregnancy
85047|NCT03671707|family health|family health
85048|NCT03671707|Chinese|chinese
85049|NCT03671694|laser treatment|laser treatment
85050|NCT03671681|Chronic Migraine|chronic migraine
85051|NCT03671681|Medication Overuse Headache|medication overuse headache
85052|NCT03671681|Mindfulness|mindfulness
85053|NCT03671681|Pharmacological Prophylaxis|pharmacological prophylaxis
85054|NCT03671681|Neuroimaging|neuroimaging
85055|NCT03671681|Neuroinflammation|neuroinflammation
85056|NCT03671681|Disability|disability
85057|NCT03671681|Quality of Life|quality of life
85058|NCT03671681|Depression|depression
85059|NCT03671681|Anxiety|anxiety
85060|NCT03671655|Superficial femoral artery|superficial femoral artery
85061|NCT03671655|chronic total occlusion|chronic total occlusion
85062|NCT03671642|perfusion|perfusion
85063|NCT03671642|indocyanine green angiography|indocyanine green angiography
85064|NCT03671642|feasibility study|feasibility study
85065|NCT03671629|Clinical pharmacist|clinical pharmacist
85066|NCT03671629|Elderly|elderly
85067|NCT03671629|Adherence|adherence
85068|NCT03671629|Drug-related readmission|drug-related readmission
85069|NCT03671564|Oncology|oncology
85070|NCT03671564|MDM2|mdm2
85071|NCT03671564|Escalation with overdose control (EWOC)|escalation with overdose control (ewoc)
85076|NCT03671473|Carpal Tunnel Syndrome|carpal tunnel syndrome
85077|NCT03671473|Extracorporeal shock wave|extracorporeal shock wave
85078|NCT03671460|B-cell acute lymphoblastic leukemia|b-cell acute lymphoblastic leukemia
85079|NCT03671460|CD19 CAR-T|cd19 car-t
85080|NCT03671447|intensive care medicine|intensive care medicine
85081|NCT03671447|critical illness|critical illness
85082|NCT03671447|post intensive care syndrome|post intensive care syndrome
85083|NCT03671447|e-health|e-health
85084|NCT03671447|tele-ICU|tele-icu
85085|NCT03671447|quality indicators (QIs) in intensive care medicine|quality indicators (qis) in intensive care medicine
85086|NCT03671447|German Innovation Fund|german innovation fund
85087|NCT03671434|Research|research
85088|NCT03671434|Knowledge Translation|knowledge translation
85089|NCT03671434|Knowledge Management|knowledge management
85090|NCT03671434|Health Policy|health policy
85091|NCT03671434|Social Policy|social policy
85092|NCT03671434|Public Policy|public policy
85093|NCT03671434|Policy Makers|policy makers
85094|NCT03671434|Legislation as Topic|legislation as topic
85095|NCT03671434|Evidence-based Policy|evidence-based policy
85096|NCT03671434|Use of Research Evidence|use of research evidence
85097|NCT03671434|Dissemination|dissemination
85098|NCT03671434|Policy Training|policy training
85099|NCT03671434|Collaboration|collaboration
85100|NCT03671421|Graft choice|graft choice
85101|NCT03671421|hamstring|hamstring
85102|NCT03671421|quadriceps tendon|quadriceps tendon
85103|NCT03671408|heart transplant|heart transplant
85104|NCT03671408|periodontitis|periodontitis
85105|NCT03671408|hsCRP|hscrp
85106|NCT03671395|Running Injuries|running injuries
85107|NCT03671395|Motion Analysis|motion analysis
85108|NCT03671395|Biomechanics|biomechanics
85109|NCT03671395|Inertial Measurement Unit|inertial measurement unit
85110|NCT03671395|Sensor Technology|sensor technology
85111|NCT03671395|Kinetic|kinetic
85112|NCT03671395|Kinematic|kinematic
85113|NCT03671395|Injury|injury
85114|NCT03671382|Cancer|cancer
85115|NCT03671369|Human Papillomavirus Vaccine|human papillomavirus vaccine
85116|NCT03671369|Adverse events after vaccination|adverse events after vaccination
85117|NCT03671369|Safety|safety
85118|NCT03671369|Serious adverse events after vaccination|serious adverse events after vaccination
85119|NCT03671356|risk score|risk score
85120|NCT03671356|risk management|risk management
85121|NCT03671356|NCDR|ncdr
85122|NCT03671356|interventional cardiology|interventional cardiology
85123|NCT03671343|sarcopenia|sarcopenia
85124|NCT03671343|chronic kidney disease|chronic kidney disease
85125|NCT03671343|older|older
85126|NCT03671330|HR+|hr+
85127|NCT03671330|HER2-|her2-
85128|NCT03671330|breast cancer|breast cancer
85129|NCT03671330|ribociclib|ribociclib
85130|NCT03671330|Advanced breast cancer|advanced breast cancer
85131|NCT03671330|LEE011|lee011
85132|NCT03671330|pre- and postmenopausal Chinese women|pre- and postmenopausal chinese women
85133|NCT03671330|HR positive|hr positive
85134|NCT03671330|HER2-negative|her2-negative
85135|NCT03671330|Endocrine therapy|endocrine therapy
85136|NCT03671317|palliative care|palliative care
85137|NCT03671317|medical clowning|medical clowning
85138|NCT03671317|anxiety relief|anxiety relief
85139|NCT03671317|pain reduction|pain reduction
85140|NCT03671317|distraction|distraction
85141|NCT03671317|humor|humor
85142|NCT03671317|papoose|papoose
85143|NCT03671317|restraints|restraints
85144|NCT03671304|renal call carcinoma|renal call carcinoma
85145|NCT03671304|exercise|exercise
85146|NCT03671304|physical activity|physical activity
85147|NCT03671304|mobile intervention|mobile intervention
85148|NCT03671304|just-in-time adaptive intervention|just-in-time adaptive intervention
85149|NCT03671304|affective framing|affective framing
85150|NCT03671304|intention planning|intention planning
85151|NCT03671291|VIH|vih
85152|NCT03671291|PrEP|prep
85153|NCT03671291|risk factors|risk factors
85154|NCT03671291|Prevention|prevention
85155|NCT03671291|Access to care|access to care
85156|NCT03671278|low back pain|low back pain
85157|NCT03671278|emergency|emergency
85158|NCT03671278|feasibility|feasibility
85159|NCT03671278|implementation|implementation
85160|NCT03671265|Esophageal Cancer|esophageal cancer
85161|NCT03671265|Concurrent chemoradiation|concurrent chemoradiation
85162|NCT03671265|Immunotherapy|immunotherapy
85163|NCT03671265|SHR-1210|shr-1210
85164|NCT03671265|Apatinib|apatinib
85165|NCT03671239|Acceptability|acceptability
85166|NCT03671239|Rectal microbicide|rectal microbicide
85167|NCT03671200|Primary teeth|primary teeth
85168|NCT03671200|Permanent first molar|permanent first molar
85169|NCT03671200|Caries|caries
85170|NCT03671161|Diabetes Type 1|diabetes type 1
85171|NCT03671161|Insulin Pump|insulin pump
85172|NCT03671161|flash glucose monitoring|flash glucose monitoring
85173|NCT03671161|hypoglycemia|hypoglycemia
85174|NCT03671161|ketoacidocetosis|ketoacidocetosis
85175|NCT03671161|DTSQ|dtsq
85176|NCT03671161|HFS|hfs
85177|NCT03671135|Intrastromal|intrastromal
85178|NCT03671135|Corneal Inlay|corneal inlay
85179|NCT03671109|Malaria|malaria
85180|NCT03671109|Dihydroartemisinin-piperaquine|dihydroartemisinin-piperaquine
85181|NCT03671109|HIV|hiv
85182|NCT03671109|Pregnancy|pregnancy
85183|NCT03671109|Treatment|treatment
85184|NCT03671109|Prevention|prevention
85185|NCT03671096|Intrastromal|intrastromal
85186|NCT03671096|Corneal|corneal
85187|NCT03671096|Allograft|allograft
85188|NCT03671083|Concussion|concussion
85189|NCT03671083|Sports Related Concussion|sports related concussion
823284|NCT00142285|children|children
85190|NCT03671083|Mild Traumatic Brain Injury|mild traumatic brain injury
85191|NCT03671083|Non-Sport Related Concussion|non-sport related concussion
85192|NCT03671057|serious game, preoperative anxiety reduction|serious game, preoperative anxiety reduction
85193|NCT03671044|Triple Negative Breast Cancer|triple negative breast cancer
85194|NCT03671044|Docetaxel|docetaxel
85195|NCT03671031|pancreatic fistula|pancreatic fistula
85196|NCT03671031|pancreatic leak|pancreatic leak
85197|NCT03671031|whipple operation|whipple operation
85198|NCT03671031|roux-en-y|roux-en-y
85199|NCT03670992|renal cell carcinoma|renal cell carcinoma
85200|NCT03670992|pancreatic resection|pancreatic resection
85201|NCT03670992|robotic surgery|robotic surgery
85202|NCT03670992|pancreatic metastases|pancreatic metastases
85203|NCT03670992|quality of life|quality of life
85204|NCT03670953|Idiopathic Parkinson's Disease|idiopathic parkinson's disease
85205|NCT03670953|Lewy Body Parkinson's Disease|lewy body parkinson's disease
85206|NCT03670953|Paralysis Agitans|paralysis agitans
85207|NCT03670953|Primary Parkinsonism|primary parkinsonism
85208|NCT03670914|Sleep Disorder Breathing|sleep disorder breathing
85209|NCT03670914|Central Sleep Apnea|central sleep apnea
85210|NCT03670914|Narcotics|narcotics
85211|NCT03670914|Home Sleep Apnea Testing Device|home sleep apnea testing device
85212|NCT03670914|WatchPAT 200|watchpat 200
85213|NCT03670914|In-Lab Polysomnography|in-lab polysomnography
85214|NCT03670914|Comparison|comparison
85215|NCT03670914|Accuracy|accuracy
85216|NCT03670914|Efficacy|efficacy
85217|NCT03670875|Children, obesity, agave-inulin, curcumin, O3FA|children, obesity, agave-inulin, curcumin, o3fa
85218|NCT03670862|Ischemic stroke|ischemic stroke
85219|NCT03670862|CTP|ctp
85220|NCT03670862|CTA|cta
85221|NCT03670849|Laparoscopic Ultrasound|laparoscopic ultrasound
85222|NCT03670836|Misoprostol|misoprostol
85223|NCT03670836|Dilapan|dilapan
85224|NCT03670836|Induction of labor|induction of labor
85225|NCT03670836|Aquacryl hydrogel|aquacryl hydrogel
85226|NCT03670823|Major Depression|major depression
85228|NCT03670823|Eye Tracker|eye tracker
85229|NCT03670823|fMRI|fmri
85230|NCT03670823|MRI|mri
85231|NCT03670823|Resting State Connectivity|resting state connectivity
85232|NCT03670823|Cognition|cognition
85233|NCT03670810|acute treatment|acute treatment
85234|NCT03670810|migraine pain|migraine pain
85235|NCT03670810|multiple attacks|multiple attacks
85236|NCT03670810|headache|headache
85237|NCT03670797|oral health status|oral health status
85238|NCT03670797|oral findings|oral findings
85239|NCT03670797|oral manifestations|oral manifestations
85240|NCT03670797|patients with diabetes|patients with diabetes
85241|NCT03670784|Ectopic pregnancy|ectopic pregnancy
85242|NCT03670784|Electronic medical records|electronic medical records
85243|NCT03670784|Chart Review|chart review
85244|NCT03670784|Intrauterine device (IUD)|intrauterine device (iud)
85245|NCT03670732|Continuous positive airway pressure|continuous positive airway pressure
85246|NCT03670732|Nasal intermittent positive pressure ventilation|nasal intermittent positive pressure ventilation
85247|NCT03670732|Mean airway pressure|mean airway pressure
85248|NCT03670732|Apnea|apnea
85249|NCT03670732|Bradycardia|bradycardia
85250|NCT03670732|Prematurity|prematurity
85251|NCT03670719|manual therapy|manual therapy
85252|NCT03670719|exercise|exercise
85253|NCT03670719|physiotherapy|physiotherapy
85254|NCT03670719|chronic cervical pain|chronic cervical pain
85255|NCT03670719|upper cervical spain|upper cervical spain
85256|NCT03670680|Menorrhagia|menorrhagia
85257|NCT03670680|Lina LibrataTM|lina libratatm
85258|NCT03670680|efficiency|efficiency
85259|NCT03670680|menometrorrhagia|menometrorrhagia
85260|NCT03670654|Asthma|asthma
85261|NCT03670654|Exercise|exercise
85262|NCT03670654|Pilates|pilates
85263|NCT03670654|Quality of life|quality of life
85264|NCT03670654|Clinical control|clinical control
85265|NCT03670641|Insulin therapy|insulin therapy
85266|NCT03670641|Continuous glucose monitor|continuous glucose monitor
85267|NCT03670615|Alzheimer disease|alzheimer disease
85268|NCT03670615|cognition|cognition
85269|NCT03670615|transcranial direct current stimulation|transcranial direct current stimulation
85270|NCT03670615|exercise|exercise
85271|NCT03670615|mild cognitive impairment|mild cognitive impairment
85272|NCT03670589|vestibular schwannoma|vestibular schwannoma
85273|NCT03670589|gammaknife radiosurgery|gammaknife radiosurgery
85274|NCT03670589|vestibular evaluation|vestibular evaluation
85275|NCT03670563|Therapeutic exercise|therapeutic exercise
85276|NCT03670537|Iron deficiency, Non-anemic|iron deficiency, non-anemic
85277|NCT03670537|Pregnancy|pregnancy
85278|NCT03670498|stroke|stroke
85279|NCT03670498|cervical spinal cord injury|cervical spinal cord injury
85280|NCT03670485|stroke|stroke
85281|NCT03670485|cervical spinal cord injury|cervical spinal cord injury
85282|NCT03670472|Cystic fibrosis|cystic fibrosis
85283|NCT03670472|nonsense mutations|nonsense mutations
85284|NCT03670472|CFTR gene|cftr gene
85285|NCT03670472|nasal epithelial cells|nasal epithelial cells
85286|NCT03670472|nonsense mutation readthrough|nonsense mutation readthrough
85287|NCT03670433|Medication reconciliation|medication reconciliation
85288|NCT03670433|Care path|care path
85289|NCT03670433|Prevention|prevention
85290|NCT03670407|Premature Ovarian Failure|premature ovarian failure
85291|NCT03670407|Infertility, Female|infertility, female
85292|NCT03670407|Ovarian tissue fragmentation|ovarian tissue fragmentation
85293|NCT03670290|hip fracture|hip fracture
85294|NCT03670290|fascia iliaca compartment catheter|fascia iliaca compartment catheter
85295|NCT03670290|epidural catheter|epidural catheter
85296|NCT03670290|APS-POQ|aps-poq
85297|NCT03670290|delirium|delirium
85298|NCT03670290|postoperative complications|postoperative complications
85299|NCT03670251|HCV Viral Load, Dried Blood Spot, HCV Core Ag|hcv viral load, dried blood spot, hcv core ag
85300|NCT03670238|Nasogastric intubation|nasogastric intubation
85301|NCT03670238|Orogastric intubation|orogastric intubation
85302|NCT03670238|Feeding tubes|feeding tubes
85303|NCT03670212|cigarette smoking|cigarette smoking
85304|NCT03670212|acute stress|acute stress
85305|NCT03670212|executive function|executive function
85306|NCT03670212|craving|craving
85307|NCT03670212|nicotine seeking|nicotine seeking
85308|NCT03670212|relapse|relapse
85309|NCT03670212|excitatory neural activity|excitatory neural activity
85310|NCT03670212|glutamate|glutamate
85311|NCT03670212|negative affect|negative affect
85312|NCT03670173|Multiple myeloma, Osalmid|multiple myeloma, osalmid
85313|NCT03670134|Laser Endomicroscopy|laser endomicroscopy
85314|NCT03670134|Intestinal Metaplasia|intestinal metaplasia
85315|NCT03670121|COPD, Emphysema, Homogenous, Collateral Ventilation|copd, emphysema, homogenous, collateral ventilation
85316|NCT03670121|vapor|vapor
85317|NCT03670121|ablation|ablation
85318|NCT03670056|combination immunotherapy|combination immunotherapy
85319|NCT03670056|platinum-based chemotherapy|platinum-based chemotherapy
85320|NCT03670004|Artifical Limbs|artifical limbs
85321|NCT03670004|Amputation|amputation
85322|NCT03670004|Accidental Falls|accidental falls
85323|NCT03670004|Stability|stability
85324|NCT03670004|Balance|balance
85325|NCT03670004|Gait|gait
85326|NCT03670004|Electromyography|electromyography
85327|NCT03669978|Occlusive arthritis|occlusive arthritis
85328|NCT03669978|bone panorama|bone panorama
85329|NCT03669978|arterial panorama|arterial panorama
85330|NCT03669952|Breast cancer|breast cancer
85331|NCT03669952|Ductal carcinoma in situ|ductal carcinoma in situ
85332|NCT03669952|Invasive ductal carcinoma|invasive ductal carcinoma
85333|NCT03669952|Prognosis factors|prognosis factors
85334|NCT03669939|Center for Disease Control Guidelines|center for disease control guidelines
85335|NCT03669939|Opioids for chronic pain|opioids for chronic pain
85336|NCT03669939|communication strategies|communication strategies
85337|NCT03669926|Diagnostic Imaging|diagnostic imaging
85338|NCT03669926|Mammography|mammography
85339|NCT03669926|Tomosynthesis|tomosynthesis
85340|NCT03669926|Breast cancer screening|breast cancer screening
85341|NCT03669926|Subsequent screening|subsequent screening
85342|NCT03669926|Cancer detection|cancer detection
85343|NCT03669926|Cost effectiveness|cost effectiveness
85344|NCT03669926|Early performance measures|early performance measures
85345|NCT03669926|Interval cancer|interval cancer
85346|NCT03669913|sexuality|sexuality
85347|NCT03669913|education|education
85348|NCT03669913|adolescents|adolescents
85350|NCT03669900|correction surgery|correction surgery
85351|NCT03669900|Complications|complications
85352|NCT03669900|radiological|radiological
85353|NCT03669900|outcomes|outcomes
85354|NCT03669887|Gestational diabetes|gestational diabetes
85355|NCT03669887|Diabetes|diabetes
85356|NCT03669887|Lifestyle|lifestyle
85357|NCT03669887|Diet Modification|diet modification
85358|NCT03669887|Childhood Obesity|childhood obesity
85359|NCT03669887|Diabetes Mellitus|diabetes mellitus
85360|NCT03669848|carbon monoxide poisoning|carbon monoxide poisoning
85361|NCT03669848|e-cigarette user|e-cigarette user
85362|NCT03669848|transcutaneous saturation measurements|transcutaneous saturation measurements
85363|NCT03669835|Hepatitis C|hepatitis c
85364|NCT03669835|Mare milk|mare milk
85365|NCT03669835|Liver function|liver function
85366|NCT03669822|Ulcerative colitis|ulcerative colitis
85367|NCT03669822|Inflammatory bowel disease|inflammatory bowel disease
85368|NCT03669809|biological rhythm|biological rhythm
85369|NCT03669809|metabolism|metabolism
85370|NCT03669809|hormone|hormone
85371|NCT03669809|lipid|lipid
85372|NCT03669809|bile acids|bile acids
85373|NCT03669809|obesity|obesity
85374|NCT03669796|Dietary Supplements|dietary supplements
85375|NCT03669796|Fish Proteins|fish proteins
85376|NCT03669796|Protein Hydrolysates|protein hydrolysates
85377|NCT03669796|Aged|aged
85378|NCT03669770|Lipohypertrophy|lipohypertrophy
85379|NCT03669770|Type 1 Diabetes Mellitus|type 1 diabetes mellitus
85380|NCT03669770|Ultrasound|ultrasound
85381|NCT03669770|Glucose variability|glucose variability
85382|NCT03669770|Glycaemic control|glycaemic control
85383|NCT03669744|chronic pain|chronic pain
85384|NCT03669744|trigeminal neuralgia|trigeminal neuralgia
85385|NCT03669744|regional anesthesia|regional anesthesia
85386|NCT03669744|trigeminal nerve block|trigeminal nerve block
85387|NCT03669731|Obesity|obesity
85388|NCT03669731|Protein|protein
85389|NCT03669731|Pregnancy|pregnancy
85390|NCT03669731|bariatric surgery|bariatric surgery
85391|NCT03669705|Axillary Surgery|axillary surgery
85392|NCT03669692|Prostate|prostate
85393|NCT03669692|Caloric Restriction|caloric restriction
85394|NCT03669692|Metabolic Syndrome|metabolic syndrome
85395|NCT03669692|Heart Rate Variability|heart rate variability
85396|NCT03669679|breast reduction|breast reduction
85397|NCT03669679|mammaplasty|mammaplasty
85398|NCT03669679|breast-q|breast-q
85399|NCT03669679|patient satisfaction|patient satisfaction
85400|NCT03669679|patient reported outcome measures|patient reported outcome measures
85401|NCT03669679|superomedial pedicle|superomedial pedicle
85402|NCT03669679|inferior pedicle|inferior pedicle
85403|NCT03669666|valvular heart disease|valvular heart disease
85404|NCT03669666|ejection fraction|ejection fraction
85405|NCT03669627|infants|infants
85406|NCT03669627|priming|priming
85407|NCT03669627|Fluad|fluad
85408|NCT03669627|Fluzone|fluzone
85409|NCT03669601|solid tumour|solid tumour
85410|NCT03669601|locally advanced|locally advanced
85411|NCT03669601|metastatic|metastatic
85412|NCT03669549|CAH|cah
85413|NCT03669549|nevanimibe|nevanimibe
85414|NCT03669536|cognitive impairment|cognitive impairment
85415|NCT03669536|dementia|dementia
85416|NCT03669536|geriatrics|geriatrics
85417|NCT03669497|Palliative Radiotherapy|palliative radiotherapy
85418|NCT03669497|Hypo-fractionated Radiotherapy|hypo-fractionated radiotherapy
85419|NCT03669497|Simultaneous integrated boost|simultaneous integrated boost
85420|NCT03669484|anaesthesia|anaesthesia
85421|NCT03669484|surgery|surgery
85422|NCT03669445|Newly Diagnosed Multiple myeloma|newly diagnosed multiple myeloma
85423|NCT03669445|Daratumumab|daratumumab
85424|NCT03669445|Lenalidomide|lenalidomide
85425|NCT03669445|Ixazomib|ixazomib
85426|NCT03669445|Dexamethasone|dexamethasone
85427|NCT03669432|locally advanced thyroid cancers, IMRT, toxicity|locally advanced thyroid cancers, imrt, toxicity
85428|NCT03669419|Outcome|outcome
85429|NCT03669419|Postoperative Complications|postoperative complications
85430|NCT03669419|Failure to rescue|failure to rescue
85431|NCT03669419|QoR-9|qor-9
85432|NCT03669419|patient-centred questionnaire|patient-centred questionnaire
85433|NCT03669406|Healed pelvic eschar|healed pelvic eschar
85434|NCT03669406|Paraplegic patient|paraplegic patient
85435|NCT03669406|Fat autograft|fat autograft
85436|NCT03669354|Prescription Drugs|prescription drugs
85437|NCT03669354|Spinal Manipulation|spinal manipulation
85438|NCT03669341|breath hold|breath hold
85439|NCT03669341|DIBH|dibh
85440|NCT03669341|HFPV|hfpv
85441|NCT03669341|MRI|mri
85442|NCT03669328|Surgery|surgery
85443|NCT03669328|cancer|cancer
85444|NCT03669328|anesthesia|anesthesia
85445|NCT03669328|pain|pain
85446|NCT03669328|outcome patient|outcome patient
85447|NCT03669328|Postoperative Nausea and Vomiting|postoperative nausea and vomiting
85448|NCT03669315|Gambling Disorder|gambling disorder
85449|NCT03669315|Transcranial Magnetic Stimulation|transcranial magnetic stimulation
85450|NCT03669302|locomotor training|locomotor training
85451|NCT03669302|transcutaneous spinal cord stimulation|transcutaneous spinal cord stimulation
85452|NCT03669302|Lokomat|lokomat
85453|NCT03669302|brain stimulation|brain stimulation
85454|NCT03669302|peripheral nerve stimulation|peripheral nerve stimulation
85455|NCT03669302|H-reflex|h-reflex
85456|NCT03669302|spinal neural circuits|spinal neural circuits
85457|NCT03669302|neuroplasticity|neuroplasticity
85458|NCT03669302|recovery|recovery
85459|NCT03669263|Painkyl®|painkyl®
85460|NCT03669263|fentanyl buccal soluble film|fentanyl buccal soluble film
85461|NCT03669263|dose titration|dose titration
85462|NCT03669250|MMN|mmn
85463|NCT03669250|EEG|eeg
85464|NCT03669250|P50|p50
85465|NCT03669250|gamma power|gamma power
85466|NCT03669250|P300|p300
85467|NCT03669250|auditory gating|auditory gating
85468|NCT03669237|Bowel Function|bowel function
85469|NCT03669237|Sphincter Preservation Surgery|sphincter preservation surgery
85470|NCT03669237|Reconstruction Method|reconstruction method
85471|NCT03669224|marginal adptation|marginal adptation
85472|NCT03669224|marginal staining|marginal staining
85473|NCT03669224|post operative sensitivity|post operative sensitivity
85474|NCT03669224|recurrent caries|recurrent caries
85475|NCT03669211|Therapeutic education|therapeutic education
85476|NCT03669211|Cardiac stress test|cardiac stress test
85477|NCT03669198|Acute Heart Failure|acute heart failure
85478|NCT03669198|Cost|cost
85479|NCT03669198|NT-pro BNP|nt-pro bnp
85480|NCT03669185|PETN|petn
85481|NCT03669146|Emmetropization|emmetropization
85482|NCT03669146|Refractive Error|refractive error
85483|NCT03669146|Glasses|glasses
85484|NCT03669146|Accommodation|accommodation
85485|NCT03669133|Fatty liver|fatty liver
85486|NCT03669133|NAFLD|nafld
85487|NCT03669133|NASH|nash
85488|NCT03669133|HIV|hiv
85489|NCT03669133|Vitamin E|vitamin e
85490|NCT03669081|live kidney donor|live kidney donor
85491|NCT03669081|donor nephrectomy|donor nephrectomy
85492|NCT03669068|Gastrointestinal endoscopy|gastrointestinal endoscopy
85493|NCT03669068|Oral anticoagulants|oral anticoagulants
85494|NCT03669068|Gastrointestinal bleeding|gastrointestinal bleeding
85495|NCT03669068|Cardiovascular event|cardiovascular event
85496|NCT03669055|aortic dissection|aortic dissection
85497|NCT03669055|hemodynamic|hemodynamic
85498|NCT03669055|4D flow phase contrast MRI|4d flow phase contrast mri
85499|NCT03669029|Golimumab|golimumab
85500|NCT03669029|Inflammatory Bowel Disease|inflammatory bowel disease
85501|NCT03669029|Optimization|optimization
85502|NCT03669029|Drug levels|drug levels
85503|NCT03669029|Anti-drug antibody levels|anti-drug antibody levels
85504|NCT03669016|well-being|well-being
85505|NCT03669016|functional ability|functional ability
85506|NCT03669016|stress|stress
85507|NCT03669016|mindfulness|mindfulness
85508|NCT03669016|undergaduate students|undergaduate students
85509|NCT03669003|lung biopsy|lung biopsy
85510|NCT03669003|gelfoam|gelfoam
85511|NCT03668964|Intestinal microbiota|intestinal microbiota
85512|NCT03668951|Pediatric|pediatric
85513|NCT03668951|Sedation|sedation
85514|NCT03668951|Dexmedetomidine|dexmedetomidine
85515|NCT03668938|Occupational Therapy|occupational therapy
85516|NCT03668938|Complex Patient|complex patient
85517|NCT03668938|Randomized Control Trial|randomized control trial
85518|NCT03668938|Social Reintegration|social reintegration
85519|NCT03668925|spondyloarthritis|spondyloarthritis
85520|NCT03668925|hidrosadenitis suppurativa|hidrosadenitis suppurativa
85521|NCT03668925|inflammation|inflammation
85522|NCT03668925|magnetic resonance imaging|magnetic resonance imaging
85523|NCT03668873|Parent Training|parent training
85524|NCT03668873|Telehealth|telehealth
85525|NCT03668873|Sleep Problems|sleep problems
85526|NCT03668860|Antenatal Corticosteroids|antenatal corticosteroids
85527|NCT03668860|Betamethasone|betamethasone
85528|NCT03668860|Dexamethasone|dexamethasone
85529|NCT03668821|Vascular Diseases|vascular diseases
85530|NCT03668821|Peripheral Artery Disease|peripheral artery disease
85531|NCT03668808|Insulin Degludec|insulin degludec
85532|NCT03668808|Insulin Glargine|insulin glargine
85533|NCT03668808|Air Travel|air travel
85534|NCT03668808|Continuous Glucose Monitor|continuous glucose monitor
85535|NCT03668743|risk factor|risk factor
85536|NCT03668730|nasopharyngeal carcinoma|nasopharyngeal carcinoma
85537|NCT03668730|IMRT|imrt
85538|NCT03668730|Radiation dose|radiation dose
85539|NCT03668730|induction chemotherapy|induction chemotherapy
85540|NCT03668717|osteoarthritis|osteoarthritis
85541|NCT03668717|medial|medial
85542|NCT03668717|unicompartmental|unicompartmental
85543|NCT03668704|osteoarthritis|osteoarthritis
85544|NCT03668704|medial|medial
85545|NCT03668704|bicompartmental|bicompartmental
85546|NCT03668704|patellofemoral|patellofemoral
85547|NCT03668691|osteoarthritis|osteoarthritis
85548|NCT03668691|medial unicompartmental|medial unicompartmental
85549|NCT03668691|lateral unicompartmental|lateral unicompartmental
85550|NCT03668691|bicompartmental|bicompartmental
85551|NCT03668691|patellofemoral|patellofemoral
85552|NCT03668678|Obesity|obesity
85553|NCT03668678|Physical Activity|physical activity
85554|NCT03668678|Nutrition|nutrition
85555|NCT03668678|Curriculum|curriculum
85556|NCT03668678|Preschool|preschool
85557|NCT03668678|Literacy|literacy
85558|NCT03668665|Split Skin Removal|split skin removal
85559|NCT03668665|Hyaloronic acid|hyaloronic acid
85560|NCT03668665|Split Wound Design|split wound design
85561|NCT03668652|Prostate Cancer|prostate cancer
85562|NCT03668652|HIFU Focal Treatment|hifu focal treatment
85563|NCT03668652|Radical prostatectomy|radical prostatectomy
85564|NCT03668613|pediatric|pediatric
85565|NCT03668613|secukinumab|secukinumab
85566|NCT03668613|plaque psoriasis|plaque psoriasis
85567|NCT03668613|AIN457A|ain457a
85568|NCT03668600|Depression|depression
85569|NCT03668574|Back pain|back pain
85570|NCT03668574|Low back pain|low back pain
85571|NCT03668561|stroke|stroke
85572|NCT03668561|hemiplegia|hemiplegia
85573|NCT03668535|Urinary|urinary
85574|NCT03668535|Bladder|bladder
85575|NCT03668535|Injury|injury
85576|NCT03668535|Cesarean|cesarean
85577|NCT03668522|H3F3AK27M|h3f3ak27m
85578|NCT03668509|SHR1459|shr1459
85579|NCT03668509|Phase 1|phase 1
85580|NCT03668483|rehabilitation|rehabilitation
85581|NCT03668483|exercise|exercise
85582|NCT03668483|maximal inspiratory pressure|maximal inspiratory pressure
85583|NCT03668483|walk test|walk test
85584|NCT03668483|muscle strength|muscle strength
85585|NCT03668483|dyspnea|dyspnea
85586|NCT03668483|lung transplantation|lung transplantation
85587|NCT03668470|type 1 diabetes|type 1 diabetes
85588|NCT03668470|insulin microsecretion|insulin microsecretion
85589|NCT03668470|dulaglutide|dulaglutide
85590|NCT03668470|randomized|randomized
85591|NCT03668470|double-blind placebo-controlled trial|double-blind placebo-controlled trial
85592|NCT03668457|Depression|depression
85593|NCT03668457|Medication adherence|medication adherence
85594|NCT03668457|Multicomponent intervention|multicomponent intervention
85595|NCT03668444|Text Messaging|text messaging
85596|NCT03668431|Metastatic colorectal cancer|metastatic colorectal cancer
85597|NCT03668379|Depression|depression
85598|NCT03668379|HIV|hiv
85599|NCT03668379|Latinos|latinos
85600|NCT03668379|Sequential multiple assignment randomized trial designs|sequential multiple assignment randomized trial designs
85601|NCT03668379|Mobile health|mobile health
85602|NCT03668379|Cognitive-behavioral therapy|cognitive-behavioral therapy
85603|NCT03668366|Nasopharyngeal Carcinoma|nasopharyngeal carcinoma
85604|NCT03668366|IMRT|imrt
85605|NCT03668366|S-1|s-1
85606|NCT03668340|Uterine Cancer|uterine cancer
85607|NCT03668327|Preterm|preterm
85608|NCT03668327|Cohort|cohort
85609|NCT03668327|Early development|early development
85610|NCT03668327|Child|child
85611|NCT03668288|IVIG|ivig
85612|NCT03668288|PID|pid
85613|NCT03668288|home infusion|home infusion
85614|NCT03668288|hyaluronidase|hyaluronidase
85615|NCT03668288|immunoglobulin|immunoglobulin
85616|NCT03668288|secondary and primary immunodeficiency disease|secondary and primary immunodeficiency disease
85617|NCT03668288|tolerance|tolerance
85618|NCT03668249|Drug therapy|drug therapy
85619|NCT03668236|Fluid resuscitation|fluid resuscitation
85620|NCT03668236|Critical care|critical care
85621|NCT03668236|Intensive care|intensive care
85622|NCT03668236|Crystalloid|crystalloid
85623|NCT03668236|IV fluid therapy|iv fluid therapy
85624|NCT03668210|Anterior cruciate ligament|anterior cruciate ligament
85625|NCT03668210|ligamentoplasty|ligamentoplasty
85626|NCT03668210|isokinetics|isokinetics
85627|NCT03668171|Acute-On-Chronic Liver Failure, mesenchymal stem cell,|acute-on-chronic liver failure, mesenchymal stem cell,
85628|NCT03668145|Primary Biliary Cirrhosis (now termed as primary biliary cholangitis), mesenchymal stem cell,|primary biliary cirrhosis (now termed as primary biliary cholangitis), mesenchymal stem cell,
85629|NCT03668132|Aphasia|aphasia
85630|NCT03668132|Functional magnetic resonance imaging|functional magnetic resonance imaging
85656|NCT03667950|anastomotic perfusion, tissue oxygen saturation|anastomotic perfusion, tissue oxygen saturation
85658|NCT03667937|Leg Injuries|leg injuries
85659|NCT03667937|Bacterial Infections|bacterial infections
85660|NCT03667924|Caregiving|caregiving
85661|NCT03667924|Community-based care|community-based care
85662|NCT03667924|Long-term services and supports|long-term services and supports
85663|NCT03667924|Volunteer|volunteer
85664|NCT03667911|bowel preparation|bowel preparation
85665|NCT03667911|colonoscopy|colonoscopy
85666|NCT03667911|virtual reality|virtual reality
85667|NCT03667911|patient education|patient education
85668|NCT03667885|next generation sequencing|next generation sequencing
85669|NCT03667885|multi planar magnetic resonance|multi planar magnetic resonance
85670|NCT03667885|liquid biopsies|liquid biopsies
85671|NCT03667885|non-invasive diagnostics|non-invasive diagnostics
85672|NCT03667885|biomarkers|biomarkers
85673|NCT03667872|Deep Brain Stimulation|deep brain stimulation
85674|NCT03667872|Habenula|habenula
85675|NCT03667872|Functional magnetic resonance imaging|functional magnetic resonance imaging
85676|NCT03667833|Shoulder Brace|shoulder brace
85677|NCT03667768|Dentition, Permanent|dentition, permanent
85678|NCT03667768|Glass Ionomer Cements|glass ionomer cements
85679|NCT03667755|pre-operation whey protein infused carbohydrate loading|pre-operation whey protein infused carbohydrate loading
85680|NCT03667755|early oral feeding post-operation|early oral feeding post-operation
85681|NCT03667742|sweat protein markers in tuberculosis|sweat protein markers in tuberculosis
85682|NCT03667729|PMR, anxiety, psychotic syndrome, quality of life|pmr, anxiety, psychotic syndrome, quality of life
85683|NCT03667716|PVRIG|pvrig
85684|NCT03667716|advanced cancer|advanced cancer
85685|NCT03667716|checkpoint inhibitor|checkpoint inhibitor
85686|NCT03667716|DNAM (DNAX Accessory molecule 1)|dnam (dnax accessory molecule 1)
85687|NCT03667716|PD-1 inhibitor|pd-1 inhibitor
85688|NCT03667716|CD112|cd112
85689|NCT03667716|CD 112R|cd 112r
85690|NCT03667716|Poliovirus receptor-related immunoglobulin|poliovirus receptor-related immunoglobulin
85691|NCT03667716|PVRL2|pvrl2
85692|NCT03667716|Nivolumab|nivolumab
85693|NCT03667716|opdivo|opdivo
85716|NCT03667677|Hypertension|hypertension
85717|NCT03667677|Anxiety|anxiety
85718|NCT03667677|Tandospirone|tandospirone
85719|NCT03667677|Amlodipine|amlodipine
85720|NCT03667664|Autonomy|autonomy
85721|NCT03667664|Elderly|elderly
85722|NCT03667664|Physical exercise|physical exercise
85723|NCT03667664|Nutrition|nutrition
85724|NCT03667664|Prevention|prevention
85725|NCT03667638|Platelet-Rich Plasma|platelet-rich plasma
85726|NCT03667638|Laser Doppler Imaging|laser doppler imaging
85727|NCT03667638|Growth Factors|growth factors
85728|NCT03667638|Wound Healing|wound healing
85729|NCT03667638|Chronic wound healing disorder|chronic wound healing disorder
824735|NCT00135304|Vitamin D|vitamin d
85730|NCT03667638|Wound quality of life|wound quality of life
85731|NCT03667625|aquatherapy|aquatherapy
85732|NCT03667625|stretching exercises|stretching exercises
85733|NCT03667573|aging|aging
85734|NCT03667573|walking|walking
85735|NCT03667573|spinal cord|spinal cord
85736|NCT03667573|electrical stimulation|electrical stimulation
85737|NCT03667560|Mastectomy|mastectomy
85738|NCT03667560|Breast Reconstruction|breast reconstruction
85739|NCT03667560|Acellular dermal matrix|acellular dermal matrix
85740|NCT03667534|cholestasis|cholestasis
85741|NCT03667534|new born screening|new born screening
85742|NCT03667534|dry blood spot|dry blood spot
85743|NCT03667534|biliary atresia|biliary atresia
85744|NCT03667495|microbiota|microbiota
85745|NCT03667495|colorectal cancer|colorectal cancer
85746|NCT03667495|recurrence|recurrence
85747|NCT03667482|Cabozantinib|cabozantinib
85748|NCT03667482|Cetuximab|cetuximab
85749|NCT03667482|18-303|18-303
85750|NCT03667469|Obesity|obesity
85751|NCT03667469|Bariatric surgery|bariatric surgery
85752|NCT03667469|Ospanov's procedure|ospanov's procedure
85753|NCT03667469|Gastric bypass|gastric bypass
85754|NCT03667469|Band-separated gastric bypass|band-separated gastric bypass
85755|NCT03667469|Weight loss therapy|weight loss therapy
85756|NCT03667469|Metabolic syndrom|metabolic syndrom
85757|NCT03667469|Life expectancy|life expectancy
85758|NCT03667469|Telomere lenght|telomere lenght
85759|NCT03667469|Hypocaloric diet|hypocaloric diet
85760|NCT03667456|Parkinson|parkinson
85761|NCT03667456|Serious Game|serious game
85762|NCT03667456|Self management|self management
85763|NCT03667456|Rehabilitation|rehabilitation
85764|NCT03667456|Telemedicine|telemedicine
85765|NCT03667443|myo-inositol|myo-inositol
85766|NCT03667443|alpha-lactalbumin|alpha-lactalbumin
85767|NCT03667443|polycystic ovary syndrome|polycystic ovary syndrome
85768|NCT03667443|anovulation|anovulation
85769|NCT03667443|infertility|infertility
85770|NCT03667417|BRCA gene mutation|brca gene mutation
85771|NCT03667404|Resistant maltodextrin|resistant maltodextrin
85772|NCT03667404|dietary fiber|dietary fiber
85773|NCT03667404|gut microbiome|gut microbiome
85774|NCT03667404|Parkinson's disease|parkinson's disease
85775|NCT03667391|Chronic ThromboEmbolic Pulmonary Hypertension|chronic thromboembolic pulmonary hypertension
85776|NCT03667378|Quality of Life|quality of life
85777|NCT03667378|Supportive Care|supportive care
85778|NCT03667378|18-363|18-363
85779|NCT03667365|severe aortic valve stenosis|severe aortic valve stenosis
85780|NCT03667365|low gradient|low gradient
85781|NCT03667365|preserved left ventricular ejection fraction|preserved left ventricular ejection fraction
85782|NCT03667365|symptomatic patients|symptomatic patients
85783|NCT03667352|Scalp block|scalp block
85784|NCT03667352|Transversus abdominis plane block|transversus abdominis plane block
85785|NCT03667352|Ropivacaine|ropivacaine
85786|NCT03667352|Clonidine|clonidine
85787|NCT03667326|Aspirin|aspirin
85788|NCT03667313|in-stent restenosis; sirolimus-; paclitaxel-eluting balloon|in-stent restenosis; sirolimus-; paclitaxel-eluting balloon
85789|NCT03667300|Type2 Diabetes Mellitus|type2 diabetes mellitus
85790|NCT03667300|Intervention|intervention
85791|NCT03667300|Albuminuria|albuminuria
85792|NCT03667274|aortic valve replacement|aortic valve replacement
85793|NCT03667274|mitral valve reconstruction|mitral valve reconstruction
85794|NCT03667274|mitral valve replacement|mitral valve replacement
85795|NCT03667248|PERCEVAL® sutureless aortic valve prosthesis|perceval® sutureless aortic valve prosthesis
85796|NCT03667248|aortic valve stenosis|aortic valve stenosis
85797|NCT03667248|aortic valve replacement|aortic valve replacement
85798|NCT03667248|preoperative CT scan of the heart|preoperative ct scan of the heart
85799|NCT03667235|OZAKI technique|ozaki technique
85800|NCT03667170|MSI-H|msi-h
85801|NCT03667170|dMMR|dmmr
85802|NCT03667170|Colorectal cancer|colorectal cancer
85803|NCT03667170|Non-Colorectal Cancers|non-colorectal cancers
85804|NCT03667157|Graves Disease|graves disease
85805|NCT03667157|Graves Ophthalmopathy|graves ophthalmopathy
85806|NCT03667157|Dysthyroid Orbitopathy|dysthyroid orbitopathy
85807|NCT03667157|Liver Failure|liver failure
85808|NCT03667157|Liver Injury|liver injury
85809|NCT03667157|Acute Liver Failure|acute liver failure
85810|NCT03667157|Acute Liver Injury|acute liver injury
85811|NCT03667157|Methylprednisolone|methylprednisolone
85812|NCT03667157|Glucocorticoids|glucocorticoids
85813|NCT03667157|Glucocorticoids Toxicity|glucocorticoids toxicity
85814|NCT03667157|Intravenous|intravenous
85815|NCT03667157|Side effects|side effects
85816|NCT03667157|Adverse effects|adverse effects
85817|NCT03667157|Aminotransferase|aminotransferase
85818|NCT03667144|Double inlet left ventricle without Fontan circulation|double inlet left ventricle without fontan circulation
85819|NCT03667131|arterial stiffness|arterial stiffness
85820|NCT03667131|enalapril maleate|enalapril maleate
85821|NCT03667092|Lu-177 Dotatate|lu-177 dotatate
85822|NCT03667092|transcript analysis and variation|transcript analysis and variation
85823|NCT03667092|molecular biomarkers|molecular biomarkers
85824|NCT03667092|midgut neuroendocrine tumors|midgut neuroendocrine tumors
85825|NCT03667053|Glucagon|glucagon
85826|NCT03667027|Diaphragm Dysfunction|diaphragm dysfunction
85827|NCT03667027|Acute Respiratory Failure|acute respiratory failure
85828|NCT03667027|Mechanical Ventilation|mechanical ventilation
85829|NCT03667014|atopic dermatitis|atopic dermatitis
85830|NCT03667014|eczema|eczema
85831|NCT03667014|dupilumab|dupilumab
85832|NCT03667001|systemic lidocain|systemic lidocain
85833|NCT03666988|Dose-escalation|dose-escalation
85834|NCT03666988|First time in humans|first time in humans
85835|NCT03666988|Solid tumors|solid tumors
85836|NCT03666988|GSK3368715|gsk3368715
85837|NCT03666988|Diffuse Large B-Cell Lymphoma|diffuse large b-cell lymphoma
85838|NCT03666975|Low intensity vibration|low intensity vibration
85839|NCT03666975|Paediatric bone growth|paediatric bone growth
85840|NCT03666949|chronic subdural hematoma|chronic subdural hematoma
85841|NCT03666949|general anesthesia|general anesthesia
85842|NCT03666949|locoregional anesthesia|locoregional anesthesia
85843|NCT03666949|length of stay|length of stay
85844|NCT03666936|Cancer|cancer
85845|NCT03666936|Survivors|survivors
85846|NCT03666936|Return to work|return to work
85847|NCT03666936|Europe|europe
85848|NCT03666936|Feasibility Studies|feasibility studies
85849|NCT03666936|Occupational Therapy|occupational therapy
85850|NCT03666884|dry eye|dry eye
85851|NCT03666884|autologous serum|autologous serum
85852|NCT03666884|cyclosporine ophthalmic emulsion|cyclosporine ophthalmic emulsion
85853|NCT03666858|Drug Therapy|drug therapy
85854|NCT03666806|Sickle cell anaemia, stroke, preventing, children, Uganda|sickle cell anaemia, stroke, preventing, children, uganda
85855|NCT03666793|Elderly|elderly
85856|NCT03666793|Medication Reconciliation|medication reconciliation
85857|NCT03666793|Patient Readmission|patient readmission
85858|NCT03666780|Left atrial appendage occluder|left atrial appendage occluder
85859|NCT03666754|Venous Leg Ulcer|venous leg ulcer
85860|NCT03666754|Glue embolization|glue embolization
85861|NCT03666754|saphenous vein reflux|saphenous vein reflux
85862|NCT03666741|Heart Valve Diseases|heart valve diseases
85863|NCT03666741|Heart Diseases|heart diseases
85864|NCT03666741|Cardiovascular Diseases|cardiovascular diseases
85865|NCT03666741|Surgical valve|surgical valve
85866|NCT03666702|upper limb|upper limb
85867|NCT03666702|physiotherapy|physiotherapy
85868|NCT03666702|web-based|web-based
85869|NCT03666637|Adult|adult
85870|NCT03666637|avascular necrosis|avascular necrosis
85871|NCT03666637|Complications|complications
85872|NCT03666637|Delayed fixation|delayed fixation
85873|NCT03666637|nonunion|nonunion
85874|NCT03666637|Surgical timing|surgical timing
85875|NCT03666637|Pauwels|pauwels
85876|NCT03666624|LGBT|lgbt
85877|NCT03666611|Dementia|dementia
85878|NCT03666611|End of Life|end of life
85879|NCT03666611|Palliative|palliative
85880|NCT03666598|Arthroplasty, Replacement, Knee|arthroplasty, replacement, knee
85881|NCT03666598|Tourniquets|tourniquets
85882|NCT03666598|Pain, postoperative|pain, postoperative
85883|NCT03666598|Muscle strength|muscle strength
85884|NCT03666572|Severe Acute Malnutrition|severe acute malnutrition
85885|NCT03666572|Young Infants under 6 months age|young infants under 6 months age
85886|NCT03666572|Microbiome|microbiome
85887|NCT03666572|Prebiotics|prebiotics
85888|NCT03666572|Probiotics|probiotics
85889|NCT03666559|Glioma|glioma
85890|NCT03666559|IDH1/2|idh1/2
85891|NCT03666559|Azacitidine|azacitidine
85892|NCT03666559|PFS|pfs
85893|NCT03666546|Blood glucose|blood glucose
85894|NCT03666546|Diabetes Mellitus, Type 2|diabetes mellitus, type 2
85895|NCT03666546|Lactulose|lactulose
85896|NCT03666546|Constipation|constipation
85897|NCT03666546|Oral intake|oral intake
85898|NCT03666533|Gait therapy|gait therapy
85899|NCT03666533|transcranial Direct Current Stimulation (tDCS)|transcranial direct current stimulation (tdcs)
85900|NCT03666533|Neuroplasticity|neuroplasticity
85901|NCT03666533|walking ability|walking ability
85902|NCT03666533|brain stimulation|brain stimulation
85903|NCT03666533|virtual reality|virtual reality
85904|NCT03666520|medication administration, IV to PO conversion|medication administration, iv to po conversion
85905|NCT03666520|IV to PO conversion|iv to po conversion
85906|NCT03666481|Sleeve gastrectomy|sleeve gastrectomy
85907|NCT03666481|Accelerometer|accelerometer
85908|NCT03666481|Exercise|exercise
85909|NCT03666481|Self-determination theory|self-determination theory
85910|NCT03666481|Morbid obesity|morbid obesity
85911|NCT03666442|rectal cancer；|rectal cancer；
85912|NCT03666442|neoadjuvant Chemotherapy|neoadjuvant chemotherapy
85913|NCT03666403|airway pressure|airway pressure
85914|NCT03666403|bronchomalacia|bronchomalacia
85915|NCT03666403|tracheomalacia|tracheomalacia
85916|NCT03666403|positive pressure ventilation|positive pressure ventilation
85917|NCT03666403|airway expansion|airway expansion
85918|NCT03666403|noninvasive ventilation|noninvasive ventilation
85919|NCT03666390|treatment refractory depression|treatment refractory depression
85920|NCT03666390|suicide|suicide
85921|NCT03666390|ketamine|ketamine
85922|NCT03666351|Aortic Stenosis|aortic stenosis
85929|NCT03666325|skin neoplasm|skin neoplasm
85930|NCT03666325|locally advanced squamous cell cancer of the skin|locally advanced squamous cell cancer of the skin
85931|NCT03666325|immunotherapy|immunotherapy
85932|NCT03666325|pembrolizumab|pembrolizumab
85933|NCT03666325|cetuximab|cetuximab
85934|NCT03666312|Enteric microbiome|enteric microbiome
85935|NCT03666312|Liver transplantation|liver transplantation
85936|NCT03666299|postthoracotomy pain syndrome|postthoracotomy pain syndrome
85937|NCT03666299|chronic pain|chronic pain
85938|NCT03666299|lidocaine|lidocaine
85939|NCT03666286|early mobilization, intensive care, longterm outcomes|early mobilization, intensive care, longterm outcomes
85946|NCT03666260|Total hip replacement surgery|total hip replacement surgery
85947|NCT03666260|post operative pain|post operative pain
85948|NCT03666260|quadratus lumborum block|quadratus lumborum block
85949|NCT03666260|femoral block|femoral block
85950|NCT03666247|AIDS|aids
85951|NCT03666247|Behavioral Science|behavioral science
85952|NCT03666247|Infectious Diseases|infectious diseases
85953|NCT03666247|Health Promotion|health promotion
85954|NCT03666247|Sexually Transmitted Diseases|sexually transmitted diseases
85955|NCT03666234|Idiopathic Pulmonary Fibrosis|idiopathic pulmonary fibrosis
85956|NCT03666234|Epidemiology|epidemiology
85957|NCT03666234|Nature History|nature history
85958|NCT03666221|Nimotuzumab|nimotuzumab
85959|NCT03666221|IMRT|imrt
85960|NCT03666221|Radiation|radiation
85961|NCT03666221|Recurrent|recurrent
85962|NCT03666221|Nasopharyngeal Carcinoma|nasopharyngeal carcinoma
85963|NCT03666195|Nanoparticles|nanoparticles
85964|NCT03666195|Titanium dioxide|titanium dioxide
85965|NCT03666195|biofilm|biofilm
85966|NCT03666195|self cleansing|self cleansing
85967|NCT03666195|denture plaque|denture plaque
85968|NCT03666195|anti microbial|anti microbial
85969|NCT03666091|ESPOIR cohort Rheumatoid arthritis Early arthritis Undifferentiated arthritis|espoir cohort rheumatoid arthritis early arthritis undifferentiated arthritis
85970|NCT03666052|children and adolescent|children and adolescent
85971|NCT03666052|high myopia|high myopia
85972|NCT03666052|prospective study|prospective study
85973|NCT03666026|Reminder Recall (R/R)|reminder recall (r/r)
85974|NCT03666026|Influenza Vaccine|influenza vaccine
85975|NCT03666026|Electronic Health Record|electronic health record
85976|NCT03666013|Mitochondrial health|mitochondrial health
85977|NCT03666013|Muscle function|muscle function
85978|NCT03666013|Aging|aging
85979|NCT03665974|Pregnancy, deficinecy, vitamin D, diabetes, gestational|pregnancy, deficinecy, vitamin d, diabetes, gestational
85980|NCT03665961|gastrointestinal microbiome|gastrointestinal microbiome
85981|NCT03665961|metabolic syndrome|metabolic syndrome
85982|NCT03665961|ethnicity|ethnicity
85983|NCT03665961|dietary components|dietary components
85984|NCT03665948|Sports Nutrition|sports nutrition
85985|NCT03665948|Ketogenic Diet|ketogenic diet
85986|NCT03665948|Low Glycemic Index Diet|low glycemic index diet
85987|NCT03665948|Crossfit|crossfit
85988|NCT03665948|Physical capacity|physical capacity
85989|NCT03665948|Performance|performance
85990|NCT03665948|Exercise metabolism|exercise metabolism
85991|NCT03665948|Training support|training support
85992|NCT03665922|prostatectomy|prostatectomy
85993|NCT03665896|double-lumen endotracheal tube|double-lumen endotracheal tube
85994|NCT03665896|VivaSight double-lumen tube|vivasight double-lumen tube
85995|NCT03665870|Telehealth|telehealth
85996|NCT03665870|Emergency Medicine|emergency medicine
85997|NCT03665870|Paramedicine|paramedicine
85998|NCT03665870|Diabetes|diabetes
85999|NCT03665870|Hypoglycemia|hypoglycemia
86000|NCT03665870|Telecoaching|telecoaching
86001|NCT03665831|dTMS|dtms
86002|NCT03665831|depression|depression
86003|NCT03665831|magnetic|magnetic
86004|NCT03665831|iTBS|itbs
86005|NCT03665805|Muscle Relaxation|muscle relaxation
86006|NCT03665740|Gulf War Illness|gulf war illness
86007|NCT03665740|Chronic Multisymptom Illness|chronic multisymptom illness
86008|NCT03665740|Antioxidants|antioxidants
86009|NCT03665740|Resveratrol|resveratrol
86010|NCT03665740|Gulf War Syndrome|gulf war syndrome
86011|NCT03665688|Cervical ripening|cervical ripening
86012|NCT03665688|Labor induction|labor induction
86013|NCT03665688|Outpatient|outpatient
86014|NCT03665688|Mechanical|mechanical
86015|NCT03665688|Hygroscopic|hygroscopic
86016|NCT03665649|Asherman Syndrome|asherman syndrome
86119|NCT03665259|Perioperative medicine|perioperative medicine
86017|NCT03665649|Bone marrow-derived stem cells|bone marrow-derived stem cells
86018|NCT03665649|Endometrial regeneration|endometrial regeneration
86019|NCT03665649|Assisted reproduction techniques|assisted reproduction techniques
86020|NCT03665649|Endometrial physiopathology|endometrial physiopathology
86021|NCT03665649|CD133+|cd133+
86022|NCT03665649|Endometrial atrophy|endometrial atrophy
86023|NCT03665649|Endometrial thickness|endometrial thickness
86024|NCT03665636|Glycogen Storage Disease Type I|glycogen storage disease type i
86025|NCT03665636|GSD I|gsd i
86026|NCT03665636|Anaplerosis|anaplerosis
86027|NCT03665636|Triheptanoin|triheptanoin
824736|NCT00135304|Sensipar®|sensipar®
86028|NCT03665636|Hypoglycemia|hypoglycemia
86029|NCT03665623|prediction|prediction
86030|NCT03665623|early pregnancy|early pregnancy
86031|NCT03665623|preeclampsia|preeclampsia
86032|NCT03665623|multiple markers|multiple markers
86033|NCT03665610|Pharmacodynamics|pharmacodynamics
86034|NCT03665610|Pharmacokinetics|pharmacokinetics
86035|NCT03665610|Ozanimod|ozanimod
86036|NCT03665610|Safety|safety
86037|NCT03665610|Healthy Subjects|healthy subjects
86038|NCT03665597|Programmed Cell Death 1|programmed cell death 1
86039|NCT03665597|PD1|pd1
86040|NCT03665597|PD-1|pd-1
86041|NCT03665597|Programmed Cell Death-Ligand 1|programmed cell death-ligand 1
86042|NCT03665597|PDL1|pdl1
86043|NCT03665597|PD-L1|pd-l1
86044|NCT03665584|Lichen Sclerosus|lichen sclerosus
86045|NCT03665584|MonaLisa Touch|monalisa touch
86046|NCT03665558|Ventricular contractility|ventricular contractility
86047|NCT03665558|Pacing|pacing
86048|NCT03665558|Ventricular dP/dt|ventricular dp/dt
86049|NCT03665558|Aortic dP/dt|aortic dp/dt
86050|NCT03665545|glioblastoma|glioblastoma
86051|NCT03665519|Primary Biliary Cirrhosis|primary biliary cirrhosis
86052|NCT03665519|Primary Biliary Cholangitis|primary biliary cholangitis
86053|NCT03665519|Mare Milk|mare milk
86054|NCT03665506|mCRC|mcrc
86055|NCT03665506|Trifluridin/Tipiracil|trifluridin/tipiracil
86056|NCT03665493|Levodopa medication|levodopa medication
86057|NCT03665493|stop signal task|stop signal task
86058|NCT03665493|inhibitory control|inhibitory control
86059|NCT03665493|Parkinson's Disease|parkinson's disease
86060|NCT03665493|stop signal reaction time|stop signal reaction time
86061|NCT03665493|proactive inhibition|proactive inhibition
86062|NCT03665454|Parkinson's Disease|parkinson's disease
86063|NCT03665454|Parkinson Disease|parkinson disease
86064|NCT03665454|End-Stage|end-stage
86065|NCT03665454|Progressed|progressed
86066|NCT03665454|Advanced Parkinson's Disease|advanced parkinson's disease
86067|NCT03665454|End-Stage Parkinson's Disease|end-stage parkinson's disease
86068|NCT03665454|Clinical intervention|clinical intervention
86069|NCT03665454|Double-blind, randomized|double-blind, randomized
86070|NCT03665441|pancreatic|pancreatic
86071|NCT03665441|cancer|cancer
86072|NCT03665441|asparaginase|asparaginase
86073|NCT03665441|gemcitabine|gemcitabine
86074|NCT03665441|Abraxane|abraxane
86075|NCT03665441|asparagine depletion|asparagine depletion
86076|NCT03665441|onivyde|onivyde
86077|NCT03665441|nab-paclitaxel|nab-paclitaxel
86078|NCT03665441|folinic acid|folinic acid
86079|NCT03665441|fluorouracil|fluorouracil
86080|NCT03665441|irinotecan|irinotecan
86081|NCT03665441|leucovorin|leucovorin
86082|NCT03665441|amino acid|amino acid
86083|NCT03665441|RECIST 1.1|recist 1.1
86084|NCT03665428|helicobacter pylori infection|helicobacter pylori infection
86085|NCT03665428|Drug Resistance, Microbial|drug resistance, microbial
86086|NCT03665389|FFRct|ffrct
86087|NCT03665389|aortic stenosis|aortic stenosis
86088|NCT03665363|Young adults|young adults
86089|NCT03665363|Psychoeducation|psychoeducation
86090|NCT03665363|Internet-based intervention|internet-based intervention
86091|NCT03665363|Adolescents|adolescents
86092|NCT03665350|Heart Failure|heart failure
86093|NCT03665350|Type 2 diabetes mellitus|type 2 diabetes mellitus
86094|NCT03665350|Insulin|insulin
86095|NCT03665350|Older adults|older adults
86096|NCT03665324|Supraventricular arrhythmias|supraventricular arrhythmias
86097|NCT03665324|veteran athlete|veteran athlete
86098|NCT03665324|ECG|ecg
86099|NCT03665324|ETT|ett
86100|NCT03665311|Albumin|albumin
86101|NCT03665311|Normal Saline|normal saline
86102|NCT03665311|Dialysis|dialysis
86103|NCT03665311|Intensive Care Unit|intensive care unit
86104|NCT03665285|Advanced Cancer|advanced cancer
86105|NCT03665285|Metastatic Cancer|metastatic cancer
86106|NCT03665285|Head and Neck Squamous Cell Carcinoma|head and neck squamous cell carcinoma
86107|NCT03665285|Non Small Cell Lung Cancer|non small cell lung cancer
86108|NCT03665285|Ovarian Cancer|ovarian cancer
86109|NCT03665285|NC318|nc318
86110|NCT03665285|Immunotherapy|immunotherapy
86111|NCT03665285|PD-L1|pd-l1
86112|NCT03665285|dose escalation|dose escalation
86113|NCT03665285|biomarker|biomarker
86114|NCT03665285|PK|pk
86115|NCT03665285|cohort expansion|cohort expansion
86116|NCT03665285|Solid Tumor|solid tumor
86117|NCT03665285|Triple Negative Breast Cancer|triple negative breast cancer
86118|NCT03665259|Oxygen|oxygen
86419|NCT03663166|Radiation|radiation
86120|NCT03665259|General anesthesia|general anesthesia
86121|NCT03665259|Preoxygenation|preoxygenation
86122|NCT03665246|ECD|ecd
86123|NCT03665246|maternal mental health|maternal mental health
86124|NCT03665246|early childhood development|early childhood development
86125|NCT03665246|Ghana|ghana
86126|NCT03665246|ASQ|asq
86127|NCT03665246|SRQ20|srq20
86128|NCT03665246|Integrated Mothers and Babies Course|integrated mothers and babies course
86129|NCT03665246|maternal and child health|maternal and child health
86130|NCT03665194|QT/QTc Interval|qt/qtc interval
86131|NCT03665181|Radioprotection|radioprotection
86132|NCT03665181|dosimetry|dosimetry
86133|NCT03665181|tomodensitometry|tomodensitometry
86134|NCT03665181|pediatrics|pediatrics
86135|NCT03665155|89Zr-DFO-daratumumab|89zr-dfo-daratumumab
86136|NCT03665155|CD38-targeting monoclonal antibody|cd38-targeting monoclonal antibody
86137|NCT03665155|CT|ct
86138|NCT03665155|MR|mr
86139|NCT03665155|FDG PET/CT|fdg pet/ct
86140|NCT03665155|18-267|18-267
86141|NCT03665142|Tension-Type Headache|tension-type headache
86142|NCT03665142|Kinesio Tape|kinesio tape
86143|NCT03665142|Pain|pain
86144|NCT03665116|Gene expression|gene expression
86145|NCT03665116|Molecular phenotype|molecular phenotype
86146|NCT03665116|Osteoarthritis severity grading|osteoarthritis severity grading
86147|NCT03665077|Aromatase Inhibitor Induced Musculoskeletal Syndrome|aromatase inhibitor induced musculoskeletal syndrome
86148|NCT03665077|AIMSS|aimss
86149|NCT03665077|Breast Cancer|breast cancer
86150|NCT03665077|Biomarkers|biomarkers
86151|NCT03665077|Oxylipin|oxylipin
86152|NCT03665064|Pituitary tumor|pituitary tumor
86153|NCT03665064|Acromegaly|acromegaly
86154|NCT03665064|Cushing|cushing
86155|NCT03665064|Prolactinoma|prolactinoma
86156|NCT03664960|Eosinophilic Gastritis|eosinophilic gastritis
86157|NCT03664960|Eosinophilic Gastroenteritis|eosinophilic gastroenteritis
86158|NCT03664960|Eosinophil|eosinophil
86159|NCT03664960|EG|eg
86160|NCT03664960|EGE|ege
86161|NCT03664960|EGID|egid
86162|NCT03664960|Eosinophilic gastrointestinal disorders|eosinophilic gastrointestinal disorders
86163|NCT03664947|exercise|exercise
86164|NCT03664947|sleep problems|sleep problems
86165|NCT03664947|acute lymphoblastic leukemia|acute lymphoblastic leukemia
86166|NCT03664934|Neck pain, Rehabilitation, Muscles, Clinical Trial,|neck pain, rehabilitation, muscles, clinical trial,
86167|NCT03664934|Diagnostics|diagnostics
86168|NCT03664921|Analgesia|analgesia
86169|NCT03664908|Lupus nephritis|lupus nephritis
86170|NCT03664908|systemic lupus erythematosus|systemic lupus erythematosus
86171|NCT03664908|anti-glomerular basement membrane disease anti-GBM antiboby|anti-glomerular basement membrane disease anti-gbm antiboby
86172|NCT03664895|premenopausal women, MMG density, Ovary function suppression|premenopausal women, mmg density, ovary function suppression
86173|NCT03664869|bladder cancer|bladder cancer
86174|NCT03664869|recurrence|recurrence
86175|NCT03664869|BCG|bcg
86176|NCT03664869|mitomycin C|mitomycin c
86177|NCT03664869|electromotive drug administration|electromotive drug administration
86178|NCT03664843|circulating tumor DNA|circulating tumor dna
86179|NCT03664843|lung cancer|lung cancer
86180|NCT03664843|surveillance|surveillance
86181|NCT03664843|longitudinal monitoring|longitudinal monitoring
86182|NCT03664843|lead time|lead time
86183|NCT03664830|plerixafor|plerixafor
86184|NCT03664830|sickle cell disease|sickle cell disease
86185|NCT03664830|mobilization|mobilization
86186|NCT03664830|hematopoietic stem cell|hematopoietic stem cell
86187|NCT03664830|gene therapy|gene therapy
86188|NCT03664817|MSM: Men who have sex with Men|msm: men who have sex with men
86189|NCT03664817|Social Capital|social capital
86190|NCT03664765|OSA|osa
86191|NCT03664765|SCI/D|sci/d
86192|NCT03664765|RMT|rmt
86193|NCT03664765|Upper airway exercise|upper airway exercise
86194|NCT03664726|Delay Discounting, Episodic Future Thinking|delay discounting, episodic future thinking
86195|NCT03664713|Severe Mental Disorder|severe mental disorder
86196|NCT03664713|Psychological Trauma|psychological trauma
86197|NCT03664713|Eye Movement Desensitization and Reprocessing Therapy|eye movement desensitization and reprocessing therapy
86198|NCT03664700|Supraglottic airway device|supraglottic airway device
86199|NCT03664700|LMA Protector|lma protector
86200|NCT03664687|Adjuvant Zoledronate|adjuvant zoledronate
86201|NCT03664674|Meniere's Disease|meniere's disease
86202|NCT03664674|Vertigo|vertigo
86203|NCT03664674|Endolymphatic Hydrops|endolymphatic hydrops
86204|NCT03664674|Labyrinth Diseases|labyrinth diseases
86205|NCT03664674|Ear Diseases|ear diseases
86206|NCT03664674|Otorhinolaryngologic Diseases|otorhinolaryngologic diseases
86207|NCT03664648|Pregnant|pregnant
86208|NCT03664648|Conceived|conceived
86209|NCT03664648|HBV Vaccine|hbv vaccine
86210|NCT03664648|Hepatitis B|hepatitis b
86211|NCT03664648|Hepatitis B vaccine|hepatitis b vaccine
86212|NCT03664648|HBV|hbv
86213|NCT03664648|Hepatitis|hepatitis
86214|NCT03664648|Registry|registry
86215|NCT03664648|Prevention|prevention
86216|NCT03664648|Female volunteers|female volunteers
86217|NCT03664596|Non-alcoholic Steatohepatitis|non-alcoholic steatohepatitis
86218|NCT03664596|Mare milk|mare milk
86219|NCT03664596|Immune markers|immune markers
86220|NCT03664583|Diabetes Mellitus, Type 2|diabetes mellitus, type 2
86221|NCT03664583|Comorbidity|comorbidity
86222|NCT03664583|Aged|aged
86223|NCT03664583|Health Services|health services
86224|NCT03664570|Gastric motility|gastric motility
86225|NCT03664557|Resuscitation|resuscitation
86226|NCT03664557|REBOA|reboa
86227|NCT03664544|Severe Hepatic Impairment|severe hepatic impairment
86228|NCT03664544|Healthy|healthy
86229|NCT03664531|crossover|crossover
86230|NCT03664531|gluten|gluten
86231|NCT03664531|amylase trypsin inhibitors|amylase trypsin inhibitors
86232|NCT03664531|diet|diet
86233|NCT03664531|challenge|challenge
86234|NCT03664492|Communication about weight|communication about weight
86235|NCT03664492|education|education
86236|NCT03664492|parents|parents
86237|NCT03664492|health care professionals|health care professionals
86238|NCT03664479|stroke|stroke
86239|NCT03664479|cervical spinal cord injury|cervical spinal cord injury
86240|NCT03664453|omaveloxolone|omaveloxolone
86241|NCT03664453|omaveloxolone capsules|omaveloxolone capsules
86242|NCT03664453|RTA 408|rta 408
86243|NCT03664440|rilpivirine switch therapy|rilpivirine switch therapy
86244|NCT03664414|oxidative stress|oxidative stress
86245|NCT03664414|fibrosis|fibrosis
86246|NCT03664414|inflammation|inflammation
86247|NCT03664414|quality of life|quality of life
86248|NCT03664388|Acute Coronary Syndrome; Bleeding; Dual antiplatelet therapy|acute coronary syndrome; bleeding; dual antiplatelet therapy
86249|NCT03664375|Dystonia Task-specific training Botulinum toxin type A|dystonia task-specific training botulinum toxin type a
86250|NCT03664336|diffuse large B-cell lymphoma|diffuse large b-cell lymphoma
86251|NCT03664336|refractory|refractory
86252|NCT03664336|rituximab|rituximab
86253|NCT03664323|Immunotherapy|immunotherapy
86254|NCT03664323|chemotherapy|chemotherapy
86255|NCT03664323|anti-PD1|anti-pd1
86256|NCT03664323|re-sensibilization|re-sensibilization
86257|NCT03664297|replased/refractory mature B cell neoplasms|replased/refractory mature b cell neoplasms
86258|NCT03664297|BTK inhibitor|btk inhibitor
86259|NCT03664271|atopic dermatitis|atopic dermatitis
86260|NCT03664271|eczema|eczema
86261|NCT03664206|Treshold Tracking Transcranial Magnetic Stimulation|treshold tracking transcranial magnetic stimulation
86262|NCT03664206|Magnetic Resonance Spectroscopy|magnetic resonance spectroscopy
86263|NCT03664206|Inter-rater agreement|inter-rater agreement
86264|NCT03664206|Reproducibililty of Results|reproducibililty of results
86265|NCT03664206|Case-control Studies|case-control studies
86266|NCT03664206|Biomarkers|biomarkers
86267|NCT03664206|Intra-rater agreement|intra-rater agreement
86268|NCT03664180|anticoagulantion|anticoagulantion
86269|NCT03664180|post-procedure|post-procedure
86270|NCT03664180|STEMI|stemi
86271|NCT03664167|gout|gout
86272|NCT03664167|Obesity|obesity
86273|NCT03664167|arthritis|arthritis
86274|NCT03664141|Malnutrition|malnutrition
86275|NCT03664141|Hemodialysis|hemodialysis
86276|NCT03664141|Appetite|appetite
86277|NCT03664141|Inflammation|inflammation
86278|NCT03664141|Body composition|body composition
86279|NCT03664141|Cannabis oil|cannabis oil
86280|NCT03664115|Non small cell lung cancer|non small cell lung cancer
86281|NCT03664115|itraconazole|itraconazole
86282|NCT03664115|mtor inhibition|mtor inhibition
86283|NCT03664115|antiangiogensis|antiangiogensis
86284|NCT03664115|antifungal|antifungal
86285|NCT03664115|anticancer|anticancer
86286|NCT03664115|platinum based chemotherapy|platinum based chemotherapy
86287|NCT03664050|letrozol|letrozol
86288|NCT03664050|laparoscopic ovarian drilling|laparoscopic ovarian drilling
86289|NCT03664024|Programmed Cell Death 1|programmed cell death 1
86291|NCT03664024|PD-1|pd-1
86292|NCT03664024|Programmed Cell Death Ligand 1|programmed cell death ligand 1
86293|NCT03664024|PDL1|pdl1
86294|NCT03664024|PD-L1|pd-l1
86295|NCT03663998|Antibody|antibody
86296|NCT03663998|Antibody-dependent cell-mediated cytotoxicity|antibody-dependent cell-mediated cytotoxicity
86297|NCT03663998|Investigational Medicinal Product|investigational medicinal product
86298|NCT03663998|neutralizing antibody responses|neutralizing antibody responses
86299|NCT03663985|head and neck squamous cell carcinoma|head and neck squamous cell carcinoma
86300|NCT03663985|surgery|surgery
86301|NCT03663985|anthropology|anthropology
86302|NCT03663985|sociology|sociology
86303|NCT03663972|treatment|treatment
86304|NCT03663972|efficacy|efficacy
86305|NCT03663972|efficiency|efficiency
86306|NCT03663972|late-acquired sounds|late-acquired sounds
86307|NCT03663959|Outcomes|outcomes
86308|NCT03663959|Pectopexy|pectopexy
86309|NCT03663959|Sacrospinous ligament fixation|sacrospinous ligament fixation
86310|NCT03663959|Prolapse surgery|prolapse surgery
86311|NCT03663933|Haploidentical|haploidentical
86312|NCT03663933|Autoimmunity|autoimmunity
86313|NCT03663933|Immune Dysregulation|immune dysregulation
86314|NCT03663933|Congenital|congenital
86315|NCT03663933|Opportunistic Infection|opportunistic infection
86316|NCT03663920|Viral Load|viral load
86317|NCT03663920|CD4|cd4
86318|NCT03663920|Mortality|mortality
86319|NCT03663920|Disease Progression|disease progression
86320|NCT03663907|Telemedicine|telemedicine
86321|NCT03663907|Telemonitoring|telemonitoring
86322|NCT03663907|Disease Management|disease management
86323|NCT03663907|Chronic Care Model|chronic care model
86324|NCT03663907|Transitional Care|transitional care
86325|NCT03663894|Autologous stem cell transplantation|autologous stem cell transplantation
86326|NCT03663894|rituximab|rituximab
86327|NCT03663894|Follicular Lymphoma|follicular lymphoma
86328|NCT03663894|prognosis|prognosis
86329|NCT03663881|Polyphenols|polyphenols
86330|NCT03663881|Safety|safety
86331|NCT03663881|Herbal Extract|herbal extract
86332|NCT03663842|Lumbosacral Plexus|lumbosacral plexus
86333|NCT03663842|Physical Therapy Modalities|physical therapy modalities
86334|NCT03663842|Manual Therapies|manual therapies
86335|NCT03663842|Disability Evaluation.|disability evaluation.
86336|NCT03663816|shoe insert|shoe insert
86337|NCT03663816|orthotics|orthotics
86338|NCT03663816|sway|sway
86339|NCT03663790|osteoarthritis|osteoarthritis
86340|NCT03663790|biomechanics|biomechanics
86341|NCT03663790|gait retraining|gait retraining
86342|NCT03663790|real-time biofeedback|real-time biofeedback
86343|NCT03663790|knee|knee
86344|NCT03663764|Unresectable Thymoma and Thymic Carcinoma|unresectable thymoma and thymic carcinoma
86345|NCT03663764|Chemoradiotherapy|chemoradiotherapy
86346|NCT03663764|Thymosin a1|thymosin a1
86347|NCT03663751|donor chimerism,|donor chimerism,
86348|NCT03663751|decitabine,|decitabine,
86349|NCT03663751|allo-HSCT|allo-hsct
86350|NCT03663725|temozolomide|temozolomide
86351|NCT03663725|Stupp protocol|stupp protocol
86352|NCT03663699|Exercise Therapy|exercise therapy
86353|NCT03663699|Physical Fitness|physical fitness
86354|NCT03663699|Games, Recreational|games, recreational
86355|NCT03663699|Children|children
86356|NCT03663699|Adolescents|adolescents
86357|NCT03663699|Healthy Lifestyle|healthy lifestyle
86358|NCT03663699|Exercise Test|exercise test
86359|NCT03663673|Dermatitis|dermatitis
86360|NCT03663673|pediatric patients|pediatric patients
86361|NCT03663673|Atopic Dermatitis|atopic dermatitis
86362|NCT03663660|Bronchiolitis|bronchiolitis
86363|NCT03663660|Health care|health care
86364|NCT03663660|Organizational change|organizational change
86365|NCT03663660|children|children
86366|NCT03663660|Epidemic|epidemic
86367|NCT03663660|cost|cost
86368|NCT03663595|Patellofemoral pain|patellofemoral pain
86369|NCT03663595|Etiology|etiology
86370|NCT03663595|Multiarticular rehabilitation|multiarticular rehabilitation
86371|NCT03663595|Local factors|local factors
86372|NCT03663595|Nonlocal factors|nonlocal factors
86373|NCT03663556|intestinal microbiota|intestinal microbiota
86374|NCT03663556|preterm infants|preterm infants
86375|NCT03663556|breast milk|breast milk
86376|NCT03663556|donor human milk|donor human milk
86377|NCT03663556|formula|formula
86378|NCT03663530|Food intake|food intake
86379|NCT03663530|Energy expenditure|energy expenditure
86380|NCT03663530|Body composition|body composition
86381|NCT03663530|Meal timing|meal timing
86382|NCT03663517|Thyroid|thyroid
86383|NCT03663517|Reference values|reference values
86384|NCT03663517|Pregnancy|pregnancy
86385|NCT03663504|Oral Antibiotics|oral antibiotics
86386|NCT03663504|Preoperative Mechanical Bowel Preparation|preoperative mechanical bowel preparation
86387|NCT03663504|Surgical Site Infection|surgical site infection
86388|NCT03663504|C. difficile|c. difficile
86389|NCT03663491|Gastroscopy|gastroscopy
86390|NCT03663491|Transnasal Endoscopy|transnasal endoscopy
86391|NCT03663491|Sedation|sedation
86392|NCT03663465|Hawthorn|hawthorn
86393|NCT03663465|TG/HDL ratio|tg/hdl ratio
86394|NCT03663465|dyslipidemia|dyslipidemia
86395|NCT03663465|schizophrenia|schizophrenia
86396|NCT03663465|antipsychotics|antipsychotics
86397|NCT03663439|anterior augmentation,shell technique,onlay bone graft|anterior augmentation,shell technique,onlay bone graft
86398|NCT03663374|alcohol dependence|alcohol dependence
86399|NCT03663374|abstinence|abstinence
86400|NCT03663374|alcohol abuse|alcohol abuse
86401|NCT03663374|LY2196044|ly2196044
86402|NCT03663374|ondelopran|ondelopran
86403|NCT03663361|ankle sprain, sensorimotor, rehabilitation, osteoarthritis|ankle sprain, sensorimotor, rehabilitation, osteoarthritis
86404|NCT03663335|Renal transplantation, CFZ533, CNI-free immunosuppression, transplant rejection, allograft rejection.|renal transplantation, cfz533, cni-free immunosuppression, transplant rejection, allograft rejection.
86405|NCT03663270|goal directed management|goal directed management
86406|NCT03663257|Interventional Neurology|interventional neurology
86407|NCT03663257|Aneurysm|aneurysm
86408|NCT03663257|Neurology|neurology
86409|NCT03663257|Radiology|radiology
86410|NCT03663257|AneurysmFlow|aneurysmflow
86411|NCT03663192|Shock, Septic|shock, septic
86412|NCT03663192|Echocardiography|echocardiography
86413|NCT03663192|speckle tracking|speckle tracking
86414|NCT03663192|strain|strain
86415|NCT03663179|ADHD|adhd
86416|NCT03663179|TMS|tms
86417|NCT03663166|Lung|lung
86418|NCT03663166|Unresectable NSCLC|unresectable nsclc
86420|NCT03663127|gamma-aminobutyric acid|gamma-aminobutyric acid
86421|NCT03663127|blood pressure|blood pressure
86422|NCT03663127|clinical trial|clinical trial
86423|NCT03663127|angiotensin converting enzyme|angiotensin converting enzyme
86424|NCT03663127|Beauty Drink|beauty drink
86425|NCT03663114|Hepatocellular Carcinoma|hepatocellular carcinoma
86426|NCT03663114|Lenvima|lenvima
86427|NCT03663114|Post-marketing surveillance|post-marketing surveillance
86428|NCT03663114|LEN02T|len02t
86429|NCT03663114|Lenvatinib Mesilate|lenvatinib mesilate
86430|NCT03663088|Physiotherapy|physiotherapy
86431|NCT03663088|Global postural re-education|global postural re-education
86432|NCT03663088|Cobb angle|cobb angle
86433|NCT03663088|Posture|posture
86434|NCT03663088|Back pain|back pain
86435|NCT03663088|Participation|participation
86436|NCT03663062|colorectal adenoma|colorectal adenoma
86437|NCT03663062|colorectal cancer|colorectal cancer
86438|NCT03663062|Obesity|obesity
86439|NCT03663062|Non-Alcoholic Fatty Liver Disease|non-alcoholic fatty liver disease
86440|NCT03663062|Metabolic syndrome|metabolic syndrome
86441|NCT03663062|Liver Fibrosis|liver fibrosis
86442|NCT03663036|Arthroscopic Superior Capsular Reconstruction|arthroscopic superior capsular reconstruction
86443|NCT03663036|Fascia Lata|fascia lata
86444|NCT03663036|Autograft|autograft
86445|NCT03663036|Donor Site Morbidity|donor site morbidity
86446|NCT03663036|Rotator Cuff Tear|rotator cuff tear
86447|NCT03662997|Chronic wound|chronic wound
86448|NCT03662997|Venous Leg Ulcer|venous leg ulcer
86449|NCT03662997|Diabetic Foot Ulcer|diabetic foot ulcer
86450|NCT03662997|Wound dressing|wound dressing
86451|NCT03662932|Abdominal surgery|abdominal surgery
86452|NCT03662932|Early mobilization|early mobilization
86453|NCT03662932|Feasibility|feasibility
86454|NCT03662906|Chronic urinary retention|chronic urinary retention
86455|NCT03662906|Electroacupuncture|electroacupuncture
86456|NCT03662906|Urinary function|urinary function
86457|NCT03662906|Randomized controlled trial|randomized controlled trial
86458|NCT03662893|overactive bladder|overactive bladder
86459|NCT03662893|behavioural therapy|behavioural therapy
86460|NCT03662893|adherence|adherence
86461|NCT03662893|drug persistence|drug persistence
86462|NCT03662867|mindfulness training|mindfulness training
86463|NCT03662867|economically disadvantaged families|economically disadvantaged families
86464|NCT03662867|family-based interventions|family-based interventions
86465|NCT03662828|Kaposi's disease|kaposi's disease
86466|NCT03662828|HHV8|hhv8
86467|NCT03662828|Prevalence|prevalence
86468|NCT03662815|Neoantigen|neoantigen
86469|NCT03662815|iNeo-Vac-P01|ineo-vac-p01
86470|NCT03662815|Peptide Vaccine|peptide vaccine
86471|NCT03662802|artificial intelligence|artificial intelligence
86472|NCT03662802|machine learning|machine learning
86473|NCT03662802|neural network|neural network
86474|NCT03662802|cardiac arrhythmia|cardiac arrhythmia
86476|NCT03662802|EKG|ekg
86477|NCT03662789|Heart transplant|heart transplant
86478|NCT03662789|Iron deficiency|iron deficiency
86479|NCT03662789|Intravenous iron supplement|intravenous iron supplement
86480|NCT03662789|Peak oxygen consumption|peak oxygen consumption
86481|NCT03662789|Cardiopulmonary exercise test|cardiopulmonary exercise test
86482|NCT03662789|Cognitive function|cognitive function
86483|NCT03662789|Muscle strength|muscle strength
86484|NCT03662776|Quality of Life|quality of life
86485|NCT03662776|physical health|physical health
86486|NCT03662776|emotional health|emotional health
86487|NCT03662776|18-397|18-397
86488|NCT03662750|TSPO|tspo
86489|NCT03662750|MRI|mri
86490|NCT03662750|PET|pet
86491|NCT03662750|Stroke|stroke
86492|NCT03662750|Brain inflammation|brain inflammation
86493|NCT03662737|Visuomotor task|visuomotor task
86494|NCT03662724|Relapsed/refractory adult acute myeloid leukemia (AML)|relapsed/refractory adult acute myeloid leukemia (aml)
86495|NCT03662711|adult|adult
86496|NCT03662711|drug therapy|drug therapy
86497|NCT03662711|combination|combination
86498|NCT03662711|bronchodilator agents|bronchodilator agents
86499|NCT03662711|male|male
86500|NCT03662711|female|female
86501|NCT03662698|Radiotherapy|radiotherapy
86502|NCT03662698|Guided Imagery|guided imagery
86503|NCT03662698|Therapy|therapy
86504|NCT03662698|Distress|distress
86505|NCT03662698|Anxiety|anxiety
86506|NCT03662698|Depression|depression
86507|NCT03662685|goeckerman|goeckerman
86508|NCT03662685|phototherapy|phototherapy
86509|NCT03662685|psoriasis|psoriasis
86510|NCT03662607|preprocedure|preprocedure
86511|NCT03662607|anxiety|anxiety
86512|NCT03662607|cardiac catheterization|cardiac catheterization
86513|NCT03662594|Anticoagulation|anticoagulation
86514|NCT03662581|Generalized anxiety disorder|generalized anxiety disorder
86515|NCT03662581|Mental health|mental health
86516|NCT03662581|Mindfulness|mindfulness
86517|NCT03662581|Group-based therapy|group-based therapy
86518|NCT03662516|PF-04965842|pf-04965842
86519|NCT03662451|Return-to-work|return-to-work
86520|NCT03662451|Cosmesis|cosmesis
86521|NCT03662451|Visual analogue pain score|visual analogue pain score
86529|NCT03662386|hereditary retinal dystrophies|hereditary retinal dystrophies
86530|NCT03662373|on line monitoring|on line monitoring
86531|NCT03662373|PET in beam|pet in beam
86532|NCT03662373|Hadrontherapy|hadrontherapy
86533|NCT03662360|BPSD (behavioral and psycological symptoms of dementia)|bpsd (behavioral and psycological symptoms of dementia)
86534|NCT03662360|aromatherapy|aromatherapy
86536|NCT03662334|Diabetes|diabetes
86537|NCT03662334|Type 1 Diabetes Mellitus|type 1 diabetes mellitus
86538|NCT03662334|Type 1 Diabetes|type 1 diabetes
86539|NCT03662334|T1DM|t1dm
86540|NCT03662334|Continuous Subcutaneous Insulin Infusion (CSII)|continuous subcutaneous insulin infusion (csii)
86541|NCT03662334|CSII|csii
86542|NCT03662334|Insulin pump|insulin pump
86543|NCT03662334|Insulin|insulin
86544|NCT03662334|rHuPH20|rhuph20
86545|NCT03662334|Hylenex|hylenex
86546|NCT03662334|recombinant human hyaluronidase (rHuPH20)|recombinant human hyaluronidase (rhuph20)
86547|NCT03662334|Recombinant hyaluronidase|recombinant hyaluronidase
86548|NCT03662321|teenager|teenager
86549|NCT03662321|sexuality|sexuality
86550|NCT03662321|internet|internet
86554|NCT03662295|Cognitive Impairment|cognitive impairment
86555|NCT03662282|Omegaven|omegaven
86556|NCT03662282|parenteral nutrition|parenteral nutrition
86557|NCT03662282|Liver disease|liver disease
86558|NCT03662282|Cholestasis|cholestasis
86559|NCT03662256|hearing loss|hearing loss
86560|NCT03662256|deafness|deafness
86561|NCT03662256|hearing disorders|hearing disorders
86562|NCT03662256|ear diseases|ear diseases
86563|NCT03662256|otorhinolaryngologic diseases|otorhinolaryngologic diseases
86564|NCT03662256|child, preschool|child, preschool
86565|NCT03662230|war wounds|war wounds
86566|NCT03662230|intensive care unit|intensive care unit
86567|NCT03662217|Diabetes Type 2|diabetes type 2
86568|NCT03662204|blood draw|blood draw
86569|NCT03662204|sample collection|sample collection
86570|NCT03662165|HIV testing|hiv testing
86571|NCT03662165|Truck drivers|truck drivers
86572|NCT03662165|sex workers|sex workers
86573|NCT03662152|foam roller|foam roller
86574|NCT03662152|vibration foam roller|vibration foam roller
86575|NCT03662152|pressure pain threshold|pressure pain threshold
86576|NCT03662152|oxygen saturation|oxygen saturation
86577|NCT03662152|countermovement jump|countermovement jump
86578|NCT03662152|soreness|soreness
86579|NCT03662113|domperidone|domperidone
86580|NCT03661996|Osteoarthritis|osteoarthritis
86581|NCT03661996|Knee Pain|knee pain
86582|NCT03661996|non opioid|non opioid
86583|NCT03661983|Aripiprazole|aripiprazole
86584|NCT03661983|Tourette's Disorder|tourette's disorder
86585|NCT03661983|Pediatric|pediatric
86586|NCT03661944|sports|sports
86587|NCT03661944|physical therapy|physical therapy
86588|NCT03661944|return to play|return to play
86589|NCT03661944|overhead athletes|overhead athletes
86590|NCT03661918|Parent, adolescent, coaching, weight loss|parent, adolescent, coaching, weight loss
86591|NCT03661905|Treatment acceptability|treatment acceptability
86592|NCT03661905|Cognitive therapy|cognitive therapy
86593|NCT03661905|Anxiety disorders|anxiety disorders
86594|NCT03661892|Breast Cancer|breast cancer
86595|NCT03661892|Bone Metastases|bone metastases
86596|NCT03661892|Pain|pain
86597|NCT03661892|Opioid|opioid
86598|NCT03661892|Syndros|syndros
86599|NCT03661892|Bone pain|bone pain
86600|NCT03661866|Atopic Dermatitis|atopic dermatitis
86601|NCT03661866|IMISC|imisc
86602|NCT03661866|Registry|registry
86603|NCT03661866|Observational|observational
86604|NCT03661866|Immune-mediated Inflammatory Skin Conditions|immune-mediated inflammatory skin conditions
86610|NCT03661814|Negative Pressure Wound Therapy|negative pressure wound therapy
86611|NCT03661814|Colorectal Surgery|colorectal surgery
86612|NCT03661814|Prevena|prevena
86613|NCT03661814|Surgical Site Infection|surgical site infection
86614|NCT03661801|Respiratory|respiratory
86615|NCT03661801|Pleural Effusion|pleural effusion
86616|NCT03661788|Atomoxetin|atomoxetin
86617|NCT03661788|fMRT|fmrt
86618|NCT03661762|eye movements|eye movements
86619|NCT03661762|electronystagmography|electronystagmography
86620|NCT03661762|nystagmus|nystagmus
86621|NCT03661762|electrooculogram|electrooculogram
86622|NCT03661762|vestibular assessment|vestibular assessment
86623|NCT03661723|Glioblastoma|glioblastoma
86624|NCT03661697|skin|skin
86625|NCT03661697|sun damage|sun damage
86626|NCT03661697|photoaging of face|photoaging of face
86627|NCT03661697|skin care|skin care
86628|NCT03661697|laser therapy|laser therapy
86629|NCT03661684|Diabetes|diabetes
86630|NCT03661684|Glucocorticoids|glucocorticoids
86631|NCT03661684|Hyperglycemia|hyperglycemia
86632|NCT03661671|Linked-color imaging|linked-color imaging
86633|NCT03661671|Detection|detection
86634|NCT03661645|Glucocorticoids(GS)|glucocorticoids(gs)
86635|NCT03661645|injection|injection
86636|NCT03661619|Gingival recession|gingival recession
86637|NCT03661619|Root coverage|root coverage
86638|NCT03661619|Periodontal plastic surgery|periodontal plastic surgery
86639|NCT03661619|Subepithelial connective tissue graft|subepithelial connective tissue graft
86640|NCT03661567|methylprednisolone|methylprednisolone
86641|NCT03661567|Split-course Chemoradiotherapy|split-course chemoradiotherapy
86642|NCT03661567|Radiation-induced Pulmonary Injury|radiation-induced pulmonary injury
86643|NCT03661541|Squaric Acid|squaric acid
86644|NCT03661528|thrombosis|thrombosis
86645|NCT03661528|anticoagulant|anticoagulant
86646|NCT03661528|acute intracranial hemorrhage|acute intracranial hemorrhage
86647|NCT03661515|Acute Myeloid Leukemia|acute myeloid leukemia
86648|NCT03661515|Relapsed|relapsed
86649|NCT03661515|Refractory|refractory
86650|NCT03661515|Selinexor|selinexor
86651|NCT03661489|remimazolam|remimazolam
86652|NCT03661476|Intermittent Exotropia|intermittent exotropia
86653|NCT03661476|Oculo-Motor Exercises|oculo-motor exercises
86654|NCT03661476|Physiotherapy|physiotherapy
86655|NCT03661476|Intermittent Exotropia Survey|intermittent exotropia survey
86657|NCT03661463|Magnetic Resonance Vessel Wall Imaging|magnetic resonance vessel wall imaging
86658|NCT03661450|Clinical Decision-Support System|clinical decision-support system
86659|NCT03661424|Metastatic Breast Cancer|metastatic breast cancer
86660|NCT03661424|Adoptive Cell Therapy|adoptive cell therapy
86661|NCT03661424|Armed Activated T-cells|armed activated t-cells
86662|NCT03661424|Bispecific Antibodies|bispecific antibodies
86663|NCT03661424|Immunotherapy|immunotherapy
86664|NCT03661398|Percutaneous mitral valve replacement|percutaneous mitral valve replacement
86665|NCT03661398|Trans-septal mitral valve replacement|trans-septal mitral valve replacement
86666|NCT03661398|Transcatheter mitral valve replacement|transcatheter mitral valve replacement
86667|NCT03661398|TMVR|tmvr
86668|NCT03661398|Primary MR|primary mr
86669|NCT03661398|Secondary MR|secondary mr
86670|NCT03661398|Structural Heart Disease|structural heart disease
86671|NCT03661398|Heart Failure|heart failure
86672|NCT03661398|Degenerative Mitral Valve Disease|degenerative mitral valve disease
86673|NCT03661398|Functional Mitral Valve Disease|functional mitral valve disease
86674|NCT03661385|Cardiopulmonary bypass|cardiopulmonary bypass
86675|NCT03661385|Congenital heart disease|congenital heart disease
86676|NCT03661385|Low cardiac output syndrome|low cardiac output syndrome
86677|NCT03661385|Nitric oxide|nitric oxide
86678|NCT03661385|Transposition of Great Arteries|transposition of great arteries
86679|NCT03661385|Arterial switch operation|arterial switch operation
86680|NCT03661333|dialectical behavior therapy|dialectical behavior therapy
86681|NCT03661294|Energy, spinal cord injury|energy, spinal cord injury
86682|NCT03661255|Suicide Prevention|suicide prevention
86683|NCT03661255|Alaska Native|alaska native
86684|NCT03661255|Community Intervention|community intervention
86685|NCT03661242|Physical activity|physical activity
86686|NCT03661242|Exercise|exercise
86687|NCT03661242|Adjuvant chemotherapy|adjuvant chemotherapy
86688|NCT03661229|CVInsight|cvinsight
86689|NCT03661229|Hemodialysis|hemodialysis
86690|NCT03661229|Cardiovascular stress|cardiovascular stress
86691|NCT03661203|MSM population|msm population
86692|NCT03661203|Hindrances HIV screening|hindrances hiv screening
86693|NCT03661203|Late recourse HIV test|late recourse hiv test
86694|NCT03661203|Healt social psychology|healt social psychology
86695|NCT03661151|Gastroesophageal reflux disease|gastroesophageal reflux disease
86696|NCT03661151|Antireflux surgery|antireflux surgery
86697|NCT03661138|Upadacitinib|upadacitinib
86698|NCT03661138|Topical Corticosteroids|topical corticosteroids
86699|NCT03661138|Atopic Dermatitis|atopic dermatitis
86700|NCT03661112|blood pressure|blood pressure
86701|NCT03661112|mobile device|mobile device
86702|NCT03661086|closed-loop|closed-loop
86703|NCT03661086|oxygen treatment|oxygen treatment
86704|NCT03661060|Acute Heart Failure|acute heart failure
86705|NCT03661060|Chronic Heart Failure|chronic heart failure
86706|NCT03661060|Guideline adherence|guideline adherence
86707|NCT03661060|Clinical registry|clinical registry
86708|NCT03661047|Nutrition|nutrition
86709|NCT03661047|Omega-3 fatty acid|omega-3 fatty acid
86710|NCT03661047|Fish oil|fish oil
86711|NCT03661047|Tumor microenvironment|tumor microenvironment
86712|NCT03661047|Immune response|immune response
86713|NCT03661047|Gut microbiota|gut microbiota
86714|NCT03661034|Dementia|dementia
86715|NCT03661034|Alzheimer's Disease|alzheimer's disease
86716|NCT03661034|Memory Loss|memory loss
86717|NCT03661021|Functional movement disorder|functional movement disorder
86819|NCT03660319|EMT|emt
86718|NCT03661021|Functional neurological disorder|functional neurological disorder
86719|NCT03661021|FMD|fmd
86720|NCT03661021|Psychogenic movement disorder|psychogenic movement disorder
86721|NCT03661021|Movement Disorders|movement disorders
86722|NCT03660995|Slow language impairment|slow language impairment
86723|NCT03660995|semantic|semantic
86724|NCT03660995|pragmatic|pragmatic
86725|NCT03660995|procedural learning|procedural learning
86726|NCT03660995|genotype|genotype
86727|NCT03660969|troponin|troponin
86728|NCT03660943|Osteoarthritis|osteoarthritis
86729|NCT03660943|Knee Pain|knee pain
86730|NCT03660904|vitrification|vitrification
86731|NCT03660904|blastocysts|blastocysts
86732|NCT03660904|home-made media|home-made media
86733|NCT03660865|Light Adjustable Lens|light adjustable lens
86734|NCT03660865|Intraocular lens|intraocular lens
86735|NCT03660865|LAL|lal
86736|NCT03660813|oocyte, double triggering, follicle size|oocyte, double triggering, follicle size
86737|NCT03660787|Adhesion|adhesion
86738|NCT03660787|Efficacy|efficacy
86739|NCT03660748|human microbiota|human microbiota
86740|NCT03660735|Immune Profiling|immune profiling
86741|NCT03660735|Pre-IVF|pre-ivf
86742|NCT03660709|Unprotected anal intercourse|unprotected anal intercourse
86743|NCT03660709|HIV retesting|hiv retesting
86744|NCT03660709|Risk perception|risk perception
86745|NCT03660683|saxagliptin dapagliflozin diabetes cardiovascular diseases EPC|saxagliptin dapagliflozin diabetes cardiovascular diseases epc
86746|NCT03660670|Oral chemotherapy|oral chemotherapy
86747|NCT03660670|cancer outpatient|cancer outpatient
86748|NCT03660670|ONCORAL|oncoral
86749|NCT03660670|medico-economic|medico-economic
86750|NCT03660670|Health related program|health related program
86751|NCT03660670|multidisciplinary|multidisciplinary
86752|NCT03660670|therapeutic education|therapeutic education
86753|NCT03660657|complementary and integrative medicine|complementary and integrative medicine
86754|NCT03660657|cost-effectiveness ratio|cost-effectiveness ratio
86755|NCT03660657|ischemic heart disease|ischemic heart disease
86756|NCT03660657|heart failure|heart failure
86757|NCT03660657|ozone therapy|ozone therapy
86758|NCT03660657|quality of life related to health|quality of life related to health
86759|NCT03660657|shared decision-making tool|shared decision-making tool
86760|NCT03660644|COPD|copd
86761|NCT03660644|Physical Activity|physical activity
86762|NCT03660644|Pulmonary rehabilitation|pulmonary rehabilitation
86763|NCT03660618|perfusion|perfusion
86764|NCT03660618|inflammatory|inflammatory
86765|NCT03660618|ischemia|ischemia
86766|NCT03660618|lesions|lesions
86767|NCT03660618|neuropathy|neuropathy
86768|NCT03660618|burns|burns
86769|NCT03660618|cancer|cancer
86770|NCT03660618|stroke|stroke
86771|NCT03660605|gait|gait
86772|NCT03660605|balance|balance
86773|NCT03660605|auditory cues|auditory cues
86774|NCT03660592|Lung ultrasound|lung ultrasound
86775|NCT03660592|heart failure|heart failure
86776|NCT03660592|diagnosis|diagnosis
86777|NCT03660579|Physical fitness|physical fitness
86778|NCT03660579|Recovery|recovery
86779|NCT03660579|Stress|stress
86780|NCT03660579|Training|training
86781|NCT03660579|HIIT|hiit
86782|NCT03660579|Beer|beer
86783|NCT03660566|Platelet-Rich Fibrin|platelet-rich fibrin
86784|NCT03660566|Dental Implant|dental implant
86785|NCT03660553|Diabetes|diabetes
86786|NCT03660553|Elderly|elderly
86787|NCT03660553|Insulin treatment|insulin treatment
86788|NCT03660553|Quality of life|quality of life
86789|NCT03660527|hemoglobin, vitamin D, vitamin A, TC, TG, HDLC|hemoglobin, vitamin d, vitamin a, tc, tg, hdlc
86790|NCT03660514|Reproductive Coercion|reproductive coercion
86791|NCT03660514|Gender-based violence|gender-based violence
86792|NCT03660514|Contraception|contraception
86793|NCT03660514|Clinic-based screening for IPV|clinic-based screening for ipv
86794|NCT03660514|Clinic-based counseling|clinic-based counseling
86795|NCT03660501|Continuous monitoring|continuous monitoring
86796|NCT03660488|syphilis|syphilis
86797|NCT03660488|cefixime|cefixime
86798|NCT03660488|penicillin|penicillin
86799|NCT03660475|naltrexone|naltrexone
86800|NCT03660475|dry eye|dry eye
86801|NCT03660475|diabetic subjects|diabetic subjects
86802|NCT03660449|Esophageal Squamous Cell Carcinoma|esophageal squamous cell carcinoma
86803|NCT03660449|Hypofractionated Conformal Radiation|hypofractionated conformal radiation
86804|NCT03660449|Cisplatin|cisplatin
86805|NCT03660423|Dance|dance
86806|NCT03660410|indians, south american|indians, south american
86807|NCT03660410|periodontal disease|periodontal disease
86808|NCT03660410|dental caries|dental caries
86809|NCT03660397|Uncontrolled Hypertension|uncontrolled hypertension
86810|NCT03660397|Resistant hypertension|resistant hypertension
86811|NCT03660397|Aldosterone|aldosterone
86812|NCT03660397|Ablation|ablation
86813|NCT03660397|Adrenal Gland|adrenal gland
86814|NCT03660358|preterm infants|preterm infants
86815|NCT03660358|kinesiotape|kinesiotape
86816|NCT03660358|ventilation|ventilation
86817|NCT03660358|respiratory muscles|respiratory muscles
86818|NCT03660319|music therapy|music therapy
86820|NCT03660319|environmental music therapy|environmental music therapy
86821|NCT03660319|radiation oncology|radiation oncology
86822|NCT03660319|anxiety|anxiety
86823|NCT03660319|waiting room|waiting room
86824|NCT03660280|Inflammation|inflammation
86825|NCT03660267|Benign Gynecologic Operation|benign gynecologic operation
86826|NCT03660267|Coffee Ingestion|coffee ingestion
86827|NCT03660267|Recovery of Bowel Function|recovery of bowel function
86828|NCT03660228|MDS|mds
86829|NCT03660228|Myelodysplastic Syndromes|myelodysplastic syndromes
86830|NCT03660228|Quality of life|quality of life
86831|NCT03660228|Tranfusion-dependent|tranfusion-dependent
86832|NCT03660202|Bioresorbable Vascular Scaffold|bioresorbable vascular scaffold
86833|NCT03660189|intravenous fluids|intravenous fluids
86834|NCT03660189|adults|adults
86835|NCT03660189|two bag system|two bag system
86836|NCT03660137|Non-palpable lesion|non-palpable lesion
86837|NCT03660137|Localization|localization
86838|NCT03660137|Lumpectomy|lumpectomy
86839|NCT03660137|Breast-Conserving Surgery|breast-conserving surgery
86840|NCT03660137|Breast Cancer|breast cancer
86841|NCT03660098|FMD|fmd
86842|NCT03660098|functional movement disorder|functional movement disorder
86843|NCT03660098|functional neurological disorder|functional neurological disorder
86844|NCT03660098|functional tremor|functional tremor
86845|NCT03660098|psychogenic tremor|psychogenic tremor
86846|NCT03660085|Prostate Cancer|prostate cancer
86847|NCT03660085|Radical Prostatectomy|radical prostatectomy
86848|NCT03660085|Urological Symptoms|urological symptoms
86849|NCT03660085|Radiation Therapy|radiation therapy
86850|NCT03660085|Mental Health|mental health
86851|NCT03660085|Pre-Habilitation|pre-habilitation
86852|NCT03660085|Exercise|exercise
86853|NCT03660085|Pelvic floor exercises|pelvic floor exercises
86854|NCT03660085|Intimacy and Connection|intimacy and connection
86855|NCT03660085|Social connection|social connection
86856|NCT03660085|Meditation|meditation
86857|NCT03660085|Stress reduction|stress reduction
86858|NCT03660059|rheumatoid arthritis (RA)|rheumatoid arthritis (ra)
86859|NCT03660059|efficacy|efficacy
86860|NCT03660059|ASP015K|asp015k
86861|NCT03660059|Peficitinib|peficitinib
86862|NCT03660059|safety|safety
86863|NCT03660046|Human immunodeficiency virus|human immunodeficiency virus
86864|NCT03660046|Sexually Transmitted Diseases|sexually transmitted diseases
86865|NCT03660046|Contraceptives|contraceptives
86866|NCT03660033|Simulation|simulation
86867|NCT03660033|NRP|nrp
86868|NCT03660033|Resuscitation|resuscitation
86869|NCT03660033|ECG|ecg
86870|NCT03660033|Electrocardiogram|electrocardiogram
86871|NCT03660007|In vitro fertilization|in vitro fertilization
86872|NCT03660007|Assisted Reproductive Techniques|assisted reproductive techniques
86873|NCT03660007|Pulmonary embolism|pulmonary embolism
86874|NCT03660007|Venous Thromboembolism|venous thromboembolism
86875|NCT03660007|Pregnancy|pregnancy
86876|NCT03659994|Facial Hair|facial hair
86877|NCT03659955|Dry eye|dry eye
86878|NCT03659955|Ocular surface|ocular surface
86879|NCT03659955|Autologous blood|autologous blood
86880|NCT03659916|Pediatric|pediatric
86881|NCT03659916|Cholestasis|cholestasis
86882|NCT03659903|pancreatic ductal adenocarcinoma|pancreatic ductal adenocarcinoma
86883|NCT03659903|pancreaticoduodenectomy|pancreaticoduodenectomy
86884|NCT03659877|Physical Activity|physical activity
86885|NCT03659877|Accelerometer|accelerometer
86886|NCT03659864|nanoparticles|nanoparticles
86887|NCT03659864|pollution|pollution
86888|NCT03659851|Heart failure|heart failure
86889|NCT03659851|Left ventricular dysfunction|left ventricular dysfunction
86890|NCT03659838|Asthma|asthma
86891|NCT03659838|Wheeze|wheeze
86892|NCT03659838|Cough|cough
86893|NCT03659838|Snoring|snoring
86894|NCT03659838|Bronchial obstruction|bronchial obstruction
86895|NCT03659838|Air pollution|air pollution
86896|NCT03659812|Magnetic activated cell sorting (MACS)|magnetic activated cell sorting (macs)
86897|NCT03659812|Artificial insemination with donor sperm (AID)|artificial insemination with donor sperm (aid)
86898|NCT03659812|Spermatozoa|spermatozoa
86899|NCT03659812|Sperm|sperm
86900|NCT03659773|Hematopoietic stem cell transplantation|hematopoietic stem cell transplantation
86901|NCT03659773|allogeneic hematopoietic stem cell transplantation|allogeneic hematopoietic stem cell transplantation
86902|NCT03659773|autologous hematopoietic stem cell transplantation|autologous hematopoietic stem cell transplantation
86903|NCT03659773|vaccination|vaccination
86904|NCT03659773|vaccines|vaccines
86905|NCT03659773|immune function|immune function
86906|NCT03659760|Melatonin|melatonin
86907|NCT03659760|Interleukin|interleukin
86908|NCT03659760|Transcranial|transcranial
86909|NCT03659760|Surgery|surgery
86910|NCT03659760|Intensive care|intensive care
86911|NCT03659747|Lactose maldigestion|lactose maldigestion
86912|NCT03659747|gastrointestinal|gastrointestinal
86913|NCT03659747|Single-nucleotide polymorphism|single-nucleotide polymorphism
86914|NCT03659747|probiotic|probiotic
86915|NCT03659721|Pregnant|pregnant
86916|NCT03659721|Infant|infant
86917|NCT03659721|Parent|parent
86918|NCT03659721|Family|family
86919|NCT03659721|Mother|mother
86920|NCT03659721|Support|support
86921|NCT03659708|low molecular weight heparin (LMWH)|low molecular weight heparin (lmwh)
86922|NCT03659708|Lyon VTE-score|lyon vte-score
86923|NCT03659708|pregnancy|pregnancy
86924|NCT03659708|thromboprophylaxis|thromboprophylaxis
86925|NCT03659708|venous thromboembolism|venous thromboembolism
86926|NCT03659708|quality of life|quality of life
86927|NCT03659708|cost utility|cost utility
86928|NCT03659682|GLP1R, neuroprotection, inflammation|glp1r, neuroprotection, inflammation
86929|NCT03659669|Chronic Lymphocytic Leukemia|chronic lymphocytic leukemia
86930|NCT03659669|Cancer|cancer
86931|NCT03659669|venetoclax|venetoclax
86932|NCT03659669|observation|observation
86933|NCT03659643|MCI|mci
86934|NCT03659643|Alzheimer´s disease|alzheimer´s disease
86935|NCT03659643|Lewy Body Dementia|lewy body dementia
86936|NCT03659643|EEG|eeg
86937|NCT03659617|alveolar bone|alveolar bone
86938|NCT03659617|alveolar ridge|alveolar ridge
86939|NCT03659617|bone resorption|bone resorption
86940|NCT03659617|bone grafting|bone grafting
86941|NCT03659617|barrier membrane|barrier membrane
86942|NCT03659604|physical activity|physical activity
86943|NCT03659604|sedentary behavior|sedentary behavior
86944|NCT03659604|serious game|serious game
86945|NCT03659604|exergame|exergame
86946|NCT03659604|behaviour change techniques|behaviour change techniques
86947|NCT03659604|tailored feedback|tailored feedback
86948|NCT03659591|Cognitive Behaviour Therapy|cognitive behaviour therapy
86949|NCT03659591|Community Mental Health|community mental health
86950|NCT03659591|Adaptive Psychological Training|adaptive psychological training
86951|NCT03659591|Quality of Life|quality of life
86952|NCT03659591|Wellbeing|wellbeing
86953|NCT03659591|Treatment|treatment
86954|NCT03659578|Non-small Cell Lung Cancer|non-small cell lung cancer
86955|NCT03659578|Split-course Chemoradiotherapy|split-course chemoradiotherapy
86956|NCT03659578|Thymosin a1|thymosin a1
86957|NCT03659539|propofol|propofol
86958|NCT03659539|desflurane|desflurane
86959|NCT03659539|robotic|robotic
86960|NCT03659539|recovery|recovery
86961|NCT03659526|Myocardial velocity imaging|myocardial velocity imaging
86962|NCT03659526|Strain|strain
86963|NCT03659526|Strain rate|strain rate
86964|NCT03659526|Speckle tracking|speckle tracking
86965|NCT03659526|Deformation|deformation
86966|NCT03659526|Quantitative|quantitative
86967|NCT03659526|Echocardiography|echocardiography
86968|NCT03659526|Machine learning|machine learning
86969|NCT03659513|Hypoxia|hypoxia
86970|NCT03659513|ECMO|ecmo
86971|NCT03659513|Antibiotics|antibiotics
86972|NCT03659513|Pharmacokinetics|pharmacokinetics
86973|NCT03659474|skin temperature|skin temperature
86974|NCT03659474|postural control|postural control
86975|NCT03659474|ankle|ankle
86976|NCT03659448|Fluorescence|fluorescence
86977|NCT03659448|Cancer|cancer
86978|NCT03659448|SGM-101|sgm-101
86979|NCT03659448|Surgery|surgery
86980|NCT03659448|Colorectal|colorectal
86981|NCT03659409|Mindfulness|mindfulness
86982|NCT03659409|Stroke Survivors|stroke survivors
86983|NCT03659409|Caregivers|caregivers
86984|NCT03659370|Osteoarthritis|osteoarthritis
86985|NCT03659370|Knee|knee
86986|NCT03659370|Fumigation|fumigation
86987|NCT03659370|Acupuncture|acupuncture
86988|NCT03659344|sutures|sutures
86989|NCT03659344|Surgical Wound Infection|surgical wound infection
86990|NCT03659344|Polyglactin 910|polyglactin 910
86991|NCT03659305|Bevacizumab|bevacizumab
86992|NCT03659305|oncology|oncology
86993|NCT03659305|VEGF receptor|vegf receptor
86994|NCT03659292|Epidural block|epidural block
86995|NCT03659292|Pancreatic cancer|pancreatic cancer
86996|NCT03659279|Time management|time management
86997|NCT03659279|Group intervention|group intervention
86998|NCT03659279|Executive function|executive function
86999|NCT03659227|Drug reactions|drug reactions
87000|NCT03659227|severe cutaneous adverse reactions (SCARs|severe cutaneous adverse reactions (scars
87001|NCT03659227|Stevens-Johnson syndrome|stevens-johnson syndrome
87002|NCT03659227|Lyell Syndrome|lyell syndrome
87003|NCT03659227|(generalized bullous) fixed drug reaction|(generalized bullous) fixed drug reaction
87004|NCT03659227|AGEP|agep
87005|NCT03659227|DRESS|dress
87006|NCT03659227|drug induced IgA bullous dermatosis|drug induced iga bullous dermatosis
87007|NCT03659227|maculopapular exanthema|maculopapular exanthema
87008|NCT03659227|erythema multiforme|erythema multiforme
87009|NCT03659227|sampling|sampling
87010|NCT03659227|collection|collection
87011|NCT03659214|Cystic Fibrosis|cystic fibrosis
87012|NCT03659214|Orkambi|orkambi
87013|NCT03659214|Adherence|adherence
87014|NCT03659214|Adolescent|adolescent
87015|NCT03659214|Anxiety|anxiety
87016|NCT03659214|Depression|depression
87017|NCT03659214|Psychology|psychology
87018|NCT03659149|Hypertension|hypertension
87019|NCT03659149|Dyslipidemias|dyslipidemias
87020|NCT03659149|CKD-333|ckd-333
87021|NCT03659123|Elderly|elderly
87022|NCT03659123|Prehabilitation|prehabilitation
87023|NCT03659123|Cancer|cancer
87024|NCT03659123|Surgery|surgery
87025|NCT03659110|vaccine|vaccine
87026|NCT03659110|safety|safety
87027|NCT03659084|Acute myeloid leukaemia|acute myeloid leukaemia
87028|NCT03659084|Myelodysplastic syndrome|myelodysplastic syndrome
87029|NCT03659084|Iron Chelation Therapy (Exjade)|iron chelation therapy (exjade)
87030|NCT03659084|allogeneic Hematopoietic Stem Cell transplantation (Allo-HSCT)|allogeneic hematopoietic stem cell transplantation (allo-hsct)
87031|NCT03659058|fibrosis|fibrosis
87032|NCT03659058|HCV|hcv
87033|NCT03659058|Reversal|reversal
87034|NCT03659058|sustained virological response|sustained virological response
87035|NCT03659032|Manual Therapy|manual therapy
87036|NCT03659032|Cranial assymetry|cranial assymetry
87037|NCT03659032|Cranial deformation|cranial deformation
87038|NCT03659032|Physical Therapy|physical therapy
825214|NCT00133744|perinatal|perinatal
87039|NCT03659006|inflammatory Biomarkers, Traumatic brain injury, multimodal MRI, tertiary lesion|inflammatory biomarkers, traumatic brain injury, multimodal mri, tertiary lesion
87040|NCT03658993|Microscopic colitis|microscopic colitis
87041|NCT03658993|Diarrhoea|diarrhoea
87042|NCT03658993|Microbiome|microbiome
87043|NCT03658993|Rifaxamine|rifaxamine
87044|NCT03658980|Diabetes Mellitus|diabetes mellitus
87045|NCT03658980|Diabetic Retinopathy|diabetic retinopathy
87046|NCT03658980|Referral|referral
87047|NCT03658967|Lymphedema|lymphedema
87048|NCT03658967|Breast cancer|breast cancer
87049|NCT03658967|Adenoviral vector|adenoviral vector
87050|NCT03658954|Sleep Disorders|sleep disorders
87051|NCT03658954|Self-Management|self-management
87052|NCT03658954|Telemedicine|telemedicine
87053|NCT03658954|Health Education|health education
87054|NCT03658954|Wearable Electronic Devices|wearable electronic devices
87055|NCT03658941|craniotomy|craniotomy
87056|NCT03658941|dural tenting suture|dural tenting suture
87057|NCT03658941|epidural hematoma|epidural hematoma
87058|NCT03658915|Position sense|position sense
87059|NCT03658915|Smartphone|smartphone
87060|NCT03658915|Validity|validity
87061|NCT03658915|Reliability|reliability
87062|NCT03658915|Knee osteoarthritis|knee osteoarthritis
87063|NCT03658902|Botulism|botulism
87064|NCT03658902|Intensive Care|intensive care
87065|NCT03658876|Hemodialysis|hemodialysis
87066|NCT03658863|choledocholithiasis|choledocholithiasis
87067|NCT03658863|endoscopic ultrasound|endoscopic ultrasound
87068|NCT03658863|ERCP|ercp
87069|NCT03658863|intraoperative cholangiography|intraoperative cholangiography
87070|NCT03658863|common bile duct stone|common bile duct stone
87071|NCT03658863|endoscopic retrograde cholangiopancreatography|endoscopic retrograde cholangiopancreatography
87072|NCT03658863|gallstone disease|gallstone disease
87073|NCT03658863|cholelithiasis|cholelithiasis
87074|NCT03658863|bile duct obstruction|bile duct obstruction
87075|NCT03658863|laparoscopic cholecystectomy|laparoscopic cholecystectomy
87076|NCT03658850|hypernatremia|hypernatremia
87077|NCT03658850|Critical care|critical care
87078|NCT03658824|Behavioural Activation|behavioural activation
87079|NCT03658824|Bipolar Disorder|bipolar disorder
87080|NCT03658824|Bipolar Depression|bipolar depression
87081|NCT03658824|Multiple Baseline|multiple baseline
87082|NCT03658824|Case Series|case series
87083|NCT03658811|meibomian gland dysfunction|meibomian gland dysfunction
87084|NCT03658798|Functional Electrical Stimulation|functional electrical stimulation
87085|NCT03658798|Neuroprosthesis|neuroprosthesis
87086|NCT03658798|Rehabilitation|rehabilitation
87087|NCT03658785|TIL|til
87088|NCT03658785|neo-antigen|neo-antigen
87089|NCT03658772|Keynote-878|keynote-878
87090|NCT03658772|ARY-007|ary-007
87091|NCT03658772|Immuno-Oncology|immuno-oncology
87092|NCT03658772|checkpoint inhibitor|checkpoint inhibitor
87093|NCT03658772|EP4|ep4
87094|NCT03658759|Extra corporeal Life support|extra corporeal life support
87095|NCT03658759|extracorporeal cardiopulmonary resuscitation|extracorporeal cardiopulmonary resuscitation
87096|NCT03658759|refractory out-of-hospital cardiac arrest|refractory out-of-hospital cardiac arrest
87097|NCT03658759|extra corporeal membrane oxygenation|extra corporeal membrane oxygenation
87098|NCT03658759|mechanical circulatory support|mechanical circulatory support
87099|NCT03658759|mechanical chest compressions|mechanical chest compressions
87100|NCT03658746|Antimicrobial Susceptibility Testing|antimicrobial susceptibility testing
87101|NCT03658746|Rescue Therapy|rescue therapy
87102|NCT03658733|Sequential therapy|sequential therapy
87103|NCT03658733|Rescue treatment|rescue treatment
87104|NCT03658707|Functional shoulder score|functional shoulder score
87105|NCT03658707|questionnaire|questionnaire
87106|NCT03658707|subacromial impingement syndrome|subacromial impingement syndrome
87107|NCT03658694|fibromyalgia|fibromyalgia
87108|NCT03658694|repetitive transcranial magnetic stimulation|repetitive transcranial magnetic stimulation
87109|NCT03658681|Fat quality|fat quality
87110|NCT03658681|Blood glucose|blood glucose
87111|NCT03658681|Gut microbiota|gut microbiota
87112|NCT03658681|Satiety|satiety
87113|NCT03658681|Dietary intervention|dietary intervention
87114|NCT03658642|Opioid Use Disorder|opioid use disorder
87115|NCT03658642|Buprenorphine|buprenorphine
87116|NCT03658642|Opioid-use Disorder|opioid-use disorder
87117|NCT03658642|Health IT|health it
87118|NCT03658616|Excessive sweating|excessive sweating
87119|NCT03658577|Actue Coronary Syndrome|actue coronary syndrome
87120|NCT03658577|Beta-Blocker|beta-blocker
87121|NCT03658577|Percutaneous Coronary Intervention|percutaneous coronary intervention
87122|NCT03658564|Insulin resistance|insulin resistance
87123|NCT03658564|Diabetes mellitus|diabetes mellitus
87124|NCT03658564|Carbohydrate|carbohydrate
87125|NCT03658551|Portal hypertension|portal hypertension
87126|NCT03658551|Intestinal permeability|intestinal permeability
87127|NCT03658551|Liver cirrhosis|liver cirrhosis
87128|NCT03658551|bacterial translocation|bacterial translocation
87129|NCT03658551|confocal endoscopy|confocal endoscopy
87130|NCT03658525|MR GUIDED RADIOTHERAPY|mr guided radiotherapy
825215|NCT00133744|anemia|anemia
87131|NCT03658499|intimate partner violence|intimate partner violence
87132|NCT03658499|Domestic Violence|domestic violence
87133|NCT03658499|Treatment adjuncts|treatment adjuncts
87134|NCT03658499|Dialectical behavior therapy|dialectical behavior therapy
87135|NCT03658486|Exercise|exercise
87136|NCT03658486|Metastatic castrate-resistant prostate cancer|metastatic castrate-resistant prostate cancer
87137|NCT03658473|gastroprotection|gastroprotection
87138|NCT03658473|rebamipide|rebamipide
87139|NCT03658473|rabeprazole|rabeprazole
87140|NCT03658473|naproxeno|naproxeno
87141|NCT03658460|immunotherapy|immunotherapy
87142|NCT03658460|immune checkpoint inhibitors|immune checkpoint inhibitors
87143|NCT03658460|biomarkers|biomarkers
87144|NCT03658460|sequencing|sequencing
87145|NCT03658421|femoral nerve blockade|femoral nerve blockade
87146|NCT03658421|dexmedetomidine|dexmedetomidine
87147|NCT03658421|ropivacaine|ropivacaine
87148|NCT03658421|anesthesia|anesthesia
87149|NCT03658395|Vaginal, Prolapse, laparoscopic, sacrocolpopexy|vaginal, prolapse, laparoscopic, sacrocolpopexy
87150|NCT03658343|soft tissue sarcoma|soft tissue sarcoma
87151|NCT03658330|Ketamine|ketamine
87152|NCT03658330|Naltrexone|naltrexone
87153|NCT03658330|Depression|depression
87154|NCT03658330|Alcohol|alcohol
87155|NCT03658291|Sanjin tablets|sanjin tablets
87156|NCT03658291|efficacy and safety|efficacy and safety
87157|NCT03658291|recurrence rate|recurrence rate
87158|NCT03658291|randomized|randomized
87159|NCT03658291|double blind|double blind
87160|NCT03658291|parallel control|parallel control
87161|NCT03658291|multi-center clinical study|multi-center clinical study
87162|NCT03658265|breast cancer modified radical mastectomy|breast cancer modified radical mastectomy
87163|NCT03658265|shoulder dysfunction|shoulder dysfunction
87164|NCT03658265|Rehabilitation Training|rehabilitation training
87165|NCT03658252|steroid phobia|steroid phobia
87166|NCT03658252|topical corticosteroids|topical corticosteroids
87167|NCT03658252|eczema|eczema
87168|NCT03658252|psoriasis|psoriasis
87169|NCT03658252|adherence|adherence
87170|NCT03658252|quality of life|quality of life
87171|NCT03658226|Case Series|case series
87172|NCT03658226|Acceptability|acceptability
87173|NCT03658226|Feasibility|feasibility
87174|NCT03658226|Psychodynamic Interpersonal Therapy|psychodynamic interpersonal therapy
87175|NCT03658213|Early breast cancer|early breast cancer
87176|NCT03658213|Goserelin acetate|goserelin acetate
87177|NCT03658213|Estrogen suppression|estrogen suppression
87178|NCT03658213|Pre-menopausal|pre-menopausal
87179|NCT03658213|Zoladex|zoladex
87180|NCT03658200|Chest CT|chest ct
87181|NCT03658200|Bolus tracking|bolus tracking
87182|NCT03658200|Image quality|image quality
87183|NCT03658200|Contrast media|contrast media
87184|NCT03658174|Nitrate|nitrate
87185|NCT03658148|Acute Kidney Injury|acute kidney injury
87186|NCT03658148|Cardiac Surgery|cardiac surgery
87187|NCT03658148|Cardiopulmonary Bypass|cardiopulmonary bypass
87188|NCT03658148|Congenital Heart Disease|congenital heart disease
87189|NCT03658148|Biomarkers|biomarkers
87190|NCT03658135|CBS, CBD, nfvPPA, FTD, sMAPT, TES|cbs, cbd, nfvppa, ftd, smapt, tes
87191|NCT03658122|Parent-Child Care|parent-child care
87192|NCT03658122|Parent-Child Relationship|parent-child relationship
87193|NCT03658122|Disruptive Behavior|disruptive behavior
87194|NCT03658122|Brief Intervention|brief intervention
87195|NCT03658083|exercise|exercise
87196|NCT03658083|physical activity|physical activity
87197|NCT03658083|quality of life|quality of life
87198|NCT03658083|qualitative|qualitative
87199|NCT03658083|recovery|recovery
87200|NCT03658005|Ticagrelor|ticagrelor
87201|NCT03658005|acute coronary syndrome|acute coronary syndrome
87202|NCT03658005|anti-platelet drug|anti-platelet drug
87203|NCT03657979|analgesia|analgesia
87204|NCT03657979|TAP-block|tap-block
87205|NCT03657966|Immunotherapy|immunotherapy
87206|NCT03657966|Platinum-sensitive|platinum-sensitive
87207|NCT03657966|Biologic|biologic
87208|NCT03657966|Vaccine|vaccine
87209|NCT03657966|Ovarian cancer|ovarian cancer
87210|NCT03657966|Fallopian Tube cancer|fallopian tube cancer
87211|NCT03657966|Primary peritoneal cancer|primary peritoneal cancer
87212|NCT03657966|dendritic cells|dendritic cells
87213|NCT03657966|chemotherapy|chemotherapy
87214|NCT03657966|leukapheresis|leukapheresis
87215|NCT03657966|FIGO III|figo iii
87216|NCT03657966|FIGO IV|figo iv
87217|NCT03657953|Total Hip Arthroplasty|total hip arthroplasty
87218|NCT03657953|minimally invasive|minimally invasive
87219|NCT03657953|Patient-relevant outcomes|patient-relevant outcomes
87220|NCT03657940|Exercise therapy|exercise therapy
87221|NCT03657927|Morbidly Obese|morbidly obese
87222|NCT03657927|Difficult Airway Management|difficult airway management
87223|NCT03657927|Videolaryngoscopy|videolaryngoscopy
87224|NCT03657888|Family|family
87225|NCT03657888|Vulnerable|vulnerable
87226|NCT03657888|Volunteer|volunteer
87227|NCT03657888|Child|child
87228|NCT03657888|Civil society|civil society
87229|NCT03657888|Intervention|intervention
87230|NCT03657836|Acute Bronchitis|acute bronchitis
87231|NCT03657836|Mare milk|mare milk
87232|NCT03657836|Gut mucosa|gut mucosa
87233|NCT03657836|Antibiotics|antibiotics
87234|NCT03657810|Pain|pain
87235|NCT03657810|Nausea|nausea
87236|NCT03657810|Vomiting|vomiting
87237|NCT03657771|Esophagitis|esophagitis
87238|NCT03657771|Diet|diet
87239|NCT03657758|eicosapentaenoic acid|eicosapentaenoic acid
87240|NCT03657758|OCT|oct
87241|NCT03657758|neoatherosclerosis|neoatherosclerosis
87242|NCT03657745|Alzheimer Disease|alzheimer disease
87243|NCT03657745|Alzheimer's|alzheimer's
87244|NCT03657745|Dementia|dementia
87245|NCT03657732|Alzheimer's Disease|alzheimer's disease
87246|NCT03657654|Thyroidectomy|thyroidectomy
87247|NCT03657654|Laryngeal Nerves|laryngeal nerves
87248|NCT03657654|Voice problems|voice problems
87249|NCT03657628|Breast Cancer|breast cancer
87250|NCT03657615|hearing loss|hearing loss
87251|NCT03657615|tinnitus|tinnitus
87252|NCT03657615|neuroimaging|neuroimaging
87253|NCT03657615|hearing aids|hearing aids
87254|NCT03657615|Positron emission Tomography - PET|positron emission tomography - pet
87255|NCT03657576|oncolytic virus|oncolytic virus
87256|NCT03657576|glioma|glioma
87257|NCT03657576|glioblastoma|glioblastoma
87258|NCT03657576|GBM|gbm
87259|NCT03657576|HSV|hsv
87260|NCT03657576|immunotherapy|immunotherapy
87261|NCT03657511|Smoking|smoking
87262|NCT03657498|Tooth color changes|tooth color changes
87263|NCT03657498|Orthognathic surgery|orthognathic surgery
87264|NCT03657498|Spectrophotometer|spectrophotometer
87265|NCT03657459|video education|video education
87266|NCT03657459|self care management|self care management
87267|NCT03657459|symptom recognition|symptom recognition
87268|NCT03657420|Multiple Myeloma|multiple myeloma
87269|NCT03657329|Automated Sleep Staging|automated sleep staging
87270|NCT03657329|Automated Apnea Detection|automated apnea detection
87271|NCT03657303|Joint Diseases|joint diseases
87272|NCT03657303|Musculoskeletal Diseases|musculoskeletal diseases
87273|NCT03657303|Arthritis|arthritis
87274|NCT03657290|Vadadustat|vadadustat
87275|NCT03657290|healthy volunteers|healthy volunteers
87276|NCT03657290|bioequivalence|bioequivalence
87277|NCT03657290|pharmacokinetics|pharmacokinetics
87278|NCT03657277|Peer Reviewed Research|peer reviewed research
87279|NCT03657264|Gadolinium-based contrast agent|gadolinium-based contrast agent
87280|NCT03657264|Cardiac safety|cardiac safety
87281|NCT03657264|ECG|ecg
87282|NCT03657264|Gadopiclenol|gadopiclenol
87283|NCT03657225|miniaturized|miniaturized
87284|NCT03657225|cardiopulmonary bypass|cardiopulmonary bypass
87285|NCT03657186|Probiotics|probiotics
87286|NCT03657186|Microbiome|microbiome
87287|NCT03657186|Microbiota|microbiota
87288|NCT03657186|Hafnia alvei|hafnia alvei
87289|NCT03657186|Overweight|overweight
87290|NCT03657186|Food intake|food intake
87291|NCT03657186|Appetite regulation|appetite regulation
87292|NCT03657186|Satiety|satiety
87293|NCT03657186|Weight loss|weight loss
87294|NCT03657186|Glucose Metabolism|glucose metabolism
87295|NCT03657186|Glycemia|glycemia
87296|NCT03657186|Enterobacteriaceae|enterobacteriaceae
87297|NCT03657186|Gut-brain axis|gut-brain axis
87298|NCT03657186|Molecular mimicry|molecular mimicry
87299|NCT03657160|Drug Therapy|drug therapy
87300|NCT03657121|Prognosis|prognosis
87301|NCT03657121|Palliative Care|palliative care
87302|NCT03657121|End Stage|end stage
87303|NCT03657121|Mortality|mortality
87304|NCT03657121|Palliative|palliative
87305|NCT03657121|Advance Care Planning|advance care planning
87306|NCT03657121|Symptom|symptom
87307|NCT03657121|Exacerbation|exacerbation
87308|NCT03657108|brachytherapy|brachytherapy
87309|NCT03657108|prostatectomy|prostatectomy
87310|NCT03657108|radiation therapy|radiation therapy
87311|NCT03657108|surgery|surgery
87312|NCT03657095|Hypertension|hypertension
87313|NCT03657095|Familial Primary Pulmonary Hypertension|familial primary pulmonary hypertension
87314|NCT03657095|Hypertension, Pulmonary|hypertension, pulmonary
87315|NCT03657095|Lung Diseases|lung diseases
87316|NCT03657095|Vascular Diseases|vascular diseases
87317|NCT03657095|Cardiovascular Diseases|cardiovascular diseases
87318|NCT03657095|Respiratory Tract Diseases|respiratory tract diseases
87319|NCT03657095|Prostacyclin|prostacyclin
87320|NCT03657095|Beraprost|beraprost
87321|NCT03657095|Epoprostenol|epoprostenol
87322|NCT03657095|Platelet Aggregation Inhibitors|platelet aggregation inhibitors
87323|NCT03657095|Vasodilator Agents|vasodilator agents
87324|NCT03657095|Antihypertensive Agents|antihypertensive agents
87325|NCT03657056|Epilepsy|epilepsy
87333|NCT03656978|vascular catheterization|vascular catheterization
87334|NCT03656978|ultrasound-guided|ultrasound-guided
87335|NCT03656978|ultrasonography|ultrasonography
87336|NCT03656978|perioperative|perioperative
87337|NCT03656978|anesthesia|anesthesia
87338|NCT03656978|cardiovascular abnormalities|cardiovascular abnormalities
87339|NCT03656965|EBV|ebv
87340|NCT03656965|Nasopharyngeal Carcinoma|nasopharyngeal carcinoma
87341|NCT03656952|PF-06700841|pf-06700841
87342|NCT03656952|QT effect|qt effect
87343|NCT03656952|concentration-QTc analysis|concentration-qtc analysis
87344|NCT03656913|Kidney Stone|kidney stone
87345|NCT03656913|Renal|renal
87346|NCT03656913|Renal Stone|renal stone
87347|NCT03656874|Decision Support Systems, Clinical|decision support systems, clinical
87348|NCT03656874|Smoking reduction|smoking reduction
87349|NCT03656874|Smoking cessation|smoking cessation
87350|NCT03656874|Smoking, Tobacco|smoking, tobacco
87351|NCT03656861|Aortic Valve|aortic valve
87352|NCT03656861|Sinus of Valsalva|sinus of valsalva
87353|NCT03656861|Echocardiography|echocardiography
87354|NCT03656861|Sudden cardiac death|sudden cardiac death
87361|NCT03656796|PD|pd
87362|NCT03656796|Auditory cueing|auditory cueing
87363|NCT03656796|TMS|tms
87364|NCT03656757|Cardiac Power|cardiac power
87365|NCT03656757|Oscillatory Power|oscillatory power
87366|NCT03656757|Coronary Artery Bypass Graft|coronary artery bypass graft
87367|NCT03656757|Arterioventricular Coupling|arterioventricular coupling
87368|NCT03656731|exercise|exercise
87369|NCT03656731|older|older
87370|NCT03656731|resistance training|resistance training
87371|NCT03656731|breast cancer|breast cancer
87372|NCT03656666|apremilast|apremilast
87373|NCT03656666|genital erosive lichen planus|genital erosive lichen planus
87374|NCT03656627|Autoimmune Diseases|autoimmune diseases
87375|NCT03656627|Non-small Cell Lung Cancer|non-small cell lung cancer
87376|NCT03656627|Ulcerative Colitis|ulcerative colitis
87377|NCT03656627|Multiple Sclerosis|multiple sclerosis
87378|NCT03656627|Crohn Disease|crohn disease
87379|NCT03656627|Systemic Lupus Erythematosus|systemic lupus erythematosus
87380|NCT03656627|Polymyalgia Rheumatica|polymyalgia rheumatica
87381|NCT03656627|Giant Cell Arteritis|giant cell arteritis
87382|NCT03656627|Psoriasis|psoriasis
87383|NCT03656627|Rheumatoid Arthritis|rheumatoid arthritis
87384|NCT03656627|Nivolumab|nivolumab
87385|NCT03656627|Opdivo|opdivo
87386|NCT03656614|sugammadex neostigmine|sugammadex neostigmine
87387|NCT03656601|3D ultrasound|3d ultrasound
87388|NCT03656601|pelvic floor|pelvic floor
87389|NCT03656601|delivery|delivery
87390|NCT03656601|quality of life|quality of life
87391|NCT03656562|Systemic Lupus Erythematosus (SLE)|systemic lupus erythematosus (sle)
87392|NCT03656562|Anti-CD40|anti-cd40
87393|NCT03656562|anti-BAFF-receptor|anti-baff-receptor
87394|NCT03656562|B-cell depletion|b-cell depletion
87395|NCT03656562|BAFF-receptor blockade|baff-receptor blockade
87396|NCT03656562|ianalumab|ianalumab
87397|NCT03656562|VAY736|vay736
87398|NCT03656562|iscalimab|iscalimab
87399|NCT03656562|CFZ533|cfz533
87400|NCT03656536|Cholangiocarcinoma|cholangiocarcinoma
87401|NCT03656536|fibroblast growth factor receptor inhibitor|fibroblast growth factor receptor inhibitor
87402|NCT03656536|FGFR|fgfr
87403|NCT03656536|FGFR rearrangement|fgfr rearrangement
87404|NCT03656523|Acute Coronary Syndrome|acute coronary syndrome
87405|NCT03656523|Atrial Fibrillation|atrial fibrillation
87406|NCT03656523|Percutaneous Coronary Intervention|percutaneous coronary intervention
87407|NCT03656497|genetic mutations, voltage gated sodium channels, phenotype,|genetic mutations, voltage gated sodium channels, phenotype,
87408|NCT03656484|Melatonin|melatonin
87409|NCT03656484|Hyaluronic Acid|hyaluronic acid
87410|NCT03656484|Tetracycline|tetracycline
87411|NCT03656484|Metronidazole|metronidazole
87412|NCT03656484|topic paste|topic paste
87413|NCT03656484|chronic periodontitis|chronic periodontitis
87414|NCT03656458|Impaired Balance|impaired balance
87415|NCT03656458|Geriatrics|geriatrics
87416|NCT03656458|Balance Training|balance training
87417|NCT03656458|Dynamic Stability Training|dynamic stability training
87418|NCT03656458|Fall Risk|fall risk
87419|NCT03656458|Berg Balance Scale|berg balance scale
87420|NCT03656458|Physical Therapy|physical therapy
87421|NCT03656458|Forward Reach Test|forward reach test
87422|NCT03656445|total knee arthroplasty|total knee arthroplasty
87423|NCT03656445|tranexamic acid|tranexamic acid
87424|NCT03656445|without tourniquet|without tourniquet
87425|NCT03656445|blood loss|blood loss
87426|NCT03656445|function|function
87427|NCT03656445|multiple doses|multiple doses
87428|NCT03656432|CPP-ACP pastes|cpp-acp pastes
87429|NCT03656432|CPP_ACPF|cpp_acpf
87430|NCT03656432|Fluoride release|fluoride release
87431|NCT03656432|early carious lesion|early carious lesion
87432|NCT03656419|Halitosis|halitosis
87433|NCT03656419|Photodynamic Therapy|photodynamic therapy
87434|NCT03656419|qPCR|qpcr
87435|NCT03656406|Double-lumen endotracheal tube|double-lumen endotracheal tube
87436|NCT03656406|Cuff pressure|cuff pressure
87437|NCT03656393|EGFR|egfr
87438|NCT03656393|NSCLC|nsclc
87439|NCT03656393|Carboplatin|carboplatin
87440|NCT03656393|vinorelbine|vinorelbine
87441|NCT03656393|Gefitinib|gefitinib
87442|NCT03656367|glycaemia|glycaemia
87443|NCT03656367|insulinemia|insulinemia
87444|NCT03656367|lipaemia|lipaemia
87445|NCT03656367|appetite|appetite
87446|NCT03656354|seismocardiography|seismocardiography
87447|NCT03656341|foot care|foot care
87448|NCT03656341|older adults|older adults
87449|NCT03656341|senior center|senior center
87450|NCT03656341|self-management|self-management
87451|NCT03656341|self-care|self-care
87452|NCT03656328|probiotics|probiotics
87453|NCT03656328|inflammation markers|inflammation markers
87454|NCT03656315|Difficult airway|difficult airway
87455|NCT03656315|Cricothyroid membrane|cricothyroid membrane
87456|NCT03656315|Assessment|assessment
87457|NCT03656302|Bipolar disorder|bipolar disorder
87458|NCT03656302|Circadian Rhythm Disorders|circadian rhythm disorders
87459|NCT03656302|High-risk offspring|high-risk offspring
87460|NCT03656302|Endophenotypes|endophenotypes
87461|NCT03656289|Contraception|contraception
87462|NCT03656289|Etonogestrel implant|etonogestrel implant
87463|NCT03656263|echocardiography|echocardiography
87464|NCT03656263|Portal Doppler|portal doppler
87465|NCT03656263|Cardiac surgery|cardiac surgery
87466|NCT03656211|Uterine AVM|uterine avm
87467|NCT03656198|Non-Specific Effects of Vaccines|non-specific effects of vaccines
87468|NCT03656198|Heterologous Immunity|heterologous immunity
87469|NCT03656198|Rabies|rabies
87470|NCT03656198|Patient Reported Outcome Measures|patient reported outcome measures
87471|NCT03656172|Anemia by functional martial deficiency|anemia by functional martial deficiency
87472|NCT03656172|RET-He|ret-he
87473|NCT03656159|Cognitive-Behavioral Therapy (CBT)|cognitive-behavioral therapy (cbt)
87474|NCT03656159|Psychological Intervention|psychological intervention
87475|NCT03656159|Older adults|older adults
87476|NCT03656159|Caregivers|caregivers
87477|NCT03656146|social determinants of health|social determinants of health
87478|NCT03656146|food insecurity|food insecurity
87479|NCT03656146|screening|screening
87480|NCT03656146|pediatrics|pediatrics
87482|NCT03656133|Radiotherapy Fractionation|radiotherapy fractionation
87483|NCT03656133|Proliferation Saturation Index|proliferation saturation index
87484|NCT03656133|Larynx|larynx
87485|NCT03656133|Pharynx|pharynx
87486|NCT03656120|opioid dependence|opioid dependence
87487|NCT03656120|thienorphine hydrochloride|thienorphine hydrochloride
87488|NCT03656055|MRI|mri
87489|NCT03656055|axonal loss|axonal loss
87490|NCT03656055|MS|ms
87491|NCT03656055|OCT|oct
87492|NCT03656042|Dementia|dementia
87493|NCT03656042|Alzheimer's disease|alzheimer's disease
87494|NCT03656042|Granulocyte-colony stimulating factor|granulocyte-colony stimulating factor
87495|NCT03655990|Dentures Implant|dentures implant
87496|NCT03655977|Cervical cancer|cervical cancer
87497|NCT03655977|Treatment planning|treatment planning
87498|NCT03655977|PET/MRI imaging|pet/mri imaging
87499|NCT03655912|Amblyopia|amblyopia
87500|NCT03655912|Binocular therapy|binocular therapy
87501|NCT03655912|Videogames|videogames
87502|NCT03655899|metabolomics|metabolomics
87503|NCT03655899|systems biology|systems biology
87504|NCT03655899|Sepsis|sepsis
87505|NCT03655886|metastatic|metastatic
87506|NCT03655886|prostate cancer|prostate cancer
87507|NCT03655886|local|local
87508|NCT03655886|cytoreductive|cytoreductive
87509|NCT03655808|Bronchiectasis|bronchiectasis
87510|NCT03655808|Bronchial basal cells|bronchial basal cells
87511|NCT03655808|Autologous transplantation|autologous transplantation
87512|NCT03655756|Unresectable|unresectable
87513|NCT03655756|Melanoma|melanoma
87514|NCT03655756|pDNA|pdna
87515|NCT03655756|Plasmid DNA|plasmid dna
87516|NCT03655756|Gene Therapy|gene therapy
87517|NCT03655730|Depression|depression
87518|NCT03655730|suicidal risk|suicidal risk
87519|NCT03655730|self-harm behavior|self-harm behavior
87520|NCT03655730|young people|young people
87521|NCT03655717|fNIRS|fnirs
87522|NCT03655717|THC|thc
87523|NCT03655717|Intoxication|intoxication
87524|NCT03655704|Pulmonary Arterial Hypertension|pulmonary arterial hypertension
87525|NCT03655704|Apabetalone|apabetalone
87526|NCT03655704|Bromodomain-Containing Protein 4 (BRD4)|bromodomain-containing protein 4 (brd4)
87527|NCT03655704|BRD4 inhibitor|brd4 inhibitor
87528|NCT03655704|Feasibility pilot study|feasibility pilot study
87529|NCT03655704|Phase 2 clinical trial|phase 2 clinical trial
87530|NCT03655704|Open-label|open-label
87531|NCT03655704|Two-centre|two-centre
87532|NCT03655678|CRISPR-Cas9|crispr-cas9
87533|NCT03655678|Beta-Thalassemia|beta-thalassemia
87534|NCT03655678|Hemoglobinopathies|hemoglobinopathies
87535|NCT03655652|positioning|positioning
87536|NCT03655626|Machine Learning|machine learning
87537|NCT03655626|Sepsis|sepsis
87538|NCT03655626|Implementation Science|implementation science
87539|NCT03655626|Health Information Technology|health information technology
87540|NCT03655613|Immunotherapy|immunotherapy
87541|NCT03655613|PD-1 inhibitor|pd-1 inhibitor
87542|NCT03655613|c-Met inhibitor|c-met inhibitor
87543|NCT03655574|Brief intervention|brief intervention
87544|NCT03655574|Behavioral intervention|behavioral intervention
87545|NCT03655574|Juvenile justice|juvenile justice
87546|NCT03655574|Motivational enhancement|motivational enhancement
87547|NCT03655561|Lassa fever|lassa fever
87548|NCT03655561|Lassa virus|lassa virus
87549|NCT03655561|Nigeria|nigeria
87550|NCT03655561|Pregnancy|pregnancy
87551|NCT03655561|Acute kidney injury|acute kidney injury
87552|NCT03655535|BTI320|bti320
87553|NCT03655535|Sugardown|sugardown
87554|NCT03655535|Post-prandial glucose excursions|post-prandial glucose excursions
87555|NCT03655496|patient centred|patient centred
87556|NCT03655496|m-health|m-health
87557|NCT03655496|e-health|e-health
87558|NCT03655496|home-based|home-based
87559|NCT03655496|self-care|self-care
87560|NCT03655470|suicidal behavior|suicidal behavior
87561|NCT03655470|nonsuicidal self injury|nonsuicidal self injury
87562|NCT03655470|adolescents|adolescents
87563|NCT03655457|Lung|lung
87565|NCT03655457|Surfaktant|surfaktant
87566|NCT03655431|multiple sclerosis|multiple sclerosis
87567|NCT03655431|rehabilitation|rehabilitation
87568|NCT03655431|telerehabilitation|telerehabilitation
87569|NCT03655431|telehealth|telehealth
87570|NCT03655431|veteran health|veteran health
87571|NCT03655431|physical therapy|physical therapy
87572|NCT03655405|Deprescribing|deprescribing
87573|NCT03655405|Nursing Home|nursing home
87574|NCT03655405|Potentially Inappropriate Medication|potentially inappropriate medication
87575|NCT03655392|asthma|asthma
87576|NCT03655392|inflammation|inflammation
87577|NCT03655392|patients education|patients education
87578|NCT03655392|spirometry|spirometry
87579|NCT03655379|Preterm birth|preterm birth
87580|NCT03655379|Fetal nasal Doppler|fetal nasal doppler
87581|NCT03655379|Fetal breathing|fetal breathing
87582|NCT03655366|epilepsy|epilepsy
87583|NCT03655366|seizures|seizures
87584|NCT03655366|seizure alert dogs|seizure alert dogs
87585|NCT03655366|seizure response dogs|seizure response dogs
87586|NCT03655366|assistance dogs|assistance dogs
87587|NCT03655340|Blood Coagulation Disorder|blood coagulation disorder
87588|NCT03655340|Hematologic Diseases|hematologic diseases
87589|NCT03655340|Coagulation Protein Disorder|coagulation protein disorder
87590|NCT03655340|Hemorrhagic Disorder|hemorrhagic disorder
87591|NCT03655340|Genetic Diseases, Inborn|genetic diseases, inborn
87592|NCT03655327|stroke rehabilitation|stroke rehabilitation
87593|NCT03655314|formula|formula
87594|NCT03655275|subluxation , platelet rich plasma (PRP), prolotherapy.|subluxation , platelet rich plasma (prp), prolotherapy.
87595|NCT03655262|unconscious fear conditioning|unconscious fear conditioning
87596|NCT03655262|anxiety disorders|anxiety disorders
87597|NCT03655262|decoded neuro-reinforcement|decoded neuro-reinforcement
87598|NCT03655249|Multiple breath washout|multiple breath washout
87599|NCT03655249|Electrical impedance tomography|electrical impedance tomography
87600|NCT03655249|Lung clearance index|lung clearance index
87601|NCT03655249|Chest physiotherapy|chest physiotherapy
87602|NCT03655249|Autogenic drainage|autogenic drainage
87603|NCT03655249|Cystic fibrosis|cystic fibrosis
87604|NCT03655223|Newborn Screening|newborn screening
87605|NCT03655223|Rare Disorders|rare disorders
87606|NCT03655223|Genetic Counseling|genetic counseling
87607|NCT03655223|Families|families
87608|NCT03655223|Development|development
87609|NCT03655223|Risk|risk
87610|NCT03655197|Microbiome|microbiome
87611|NCT03655197|Lipidome|lipidome
87612|NCT03655184|melatonin|melatonin
87613|NCT03655184|medication Overuse Headache|medication overuse headache
87614|NCT03655184|migraine|migraine
87615|NCT03655184|Neuropsychology|neuropsychology
87616|NCT03655171|Parkinson Disease|parkinson disease
87617|NCT03655171|Exploratory study|exploratory study
87618|NCT03655171|Quantitative method|quantitative method
87619|NCT03655171|AI Video analysis|ai video analysis
87620|NCT03655171|Motor dysfunction|motor dysfunction
87621|NCT03655132|chronic pain|chronic pain
87622|NCT03655132|veterans|veterans
87623|NCT03655132|ACT|act
87624|NCT03655132|online treatment|online treatment
87625|NCT03655119|Child|child
87626|NCT03655119|Adoelscent|adoelscent
87627|NCT03655119|Crisis Intervention|crisis intervention
87628|NCT03655106|Ultrasound guided intravenous access|ultrasound guided intravenous access
87629|NCT03655106|vascular access|vascular access
87630|NCT03655106|extended dwell catheter|extended dwell catheter
87631|NCT03655106|IV survival|iv survival
87632|NCT03655093|Multiple sclerosis|multiple sclerosis
87633|NCT03655093|Self-questionnaire|self-questionnaire
87634|NCT03655093|Measurement tools|measurement tools
87635|NCT03655041|Physiological Phenomena|physiological phenomena
87636|NCT03655028|COPD|copd
87637|NCT03655028|Exercise|exercise
87638|NCT03655028|Rehabilitation|rehabilitation
87639|NCT03654989|Iontophoresis|iontophoresis
87640|NCT03654989|Treprostinil|treprostinil
87641|NCT03654989|Diabetic|diabetic
87642|NCT03654989|Foot Ulcer|foot ulcer
87643|NCT03654989|Wound Healing|wound healing
87644|NCT03654976|Allergic asthma, allergic rhinitis, HDM, pediatric|allergic asthma, allergic rhinitis, hdm, pediatric
87645|NCT03654963|medication reconciliation|medication reconciliation
87646|NCT03654963|safe pharmacotherapy|safe pharmacotherapy
87647|NCT03654937|Influenza vaccination|influenza vaccination
87648|NCT03654937|elite athletes|elite athletes
87649|NCT03654937|Immune response|immune response
87650|NCT03654937|Side effects|side effects
87652|NCT03654924|Leak|leak
87653|NCT03654924|Sore Throat|sore throat
87654|NCT03654898|pregnant women|pregnant women
87655|NCT03654898|viral suppression|viral suppression
87656|NCT03654898|retention|retention
87657|NCT03654898|video intervention|video intervention
87658|NCT03654898|pre-ART|pre-art
87659|NCT03654898|counseling|counseling
87660|NCT03654898|HIV|hiv
87661|NCT03654898|adherence|adherence
87662|NCT03654898|PMTCT|pmtct
87663|NCT03654872|ribotypes|ribotypes
87664|NCT03654872|Hong Kong|hong kong
87665|NCT03654872|virulence mechanism|virulence mechanism
87666|NCT03654859|OHCA|ohca
87667|NCT03654859|cardiac arrest|cardiac arrest
87668|NCT03654859|cardiopulmonary resuscitation|cardiopulmonary resuscitation
87669|NCT03654833|Drug: multi-arm|drug: multi-arm
87670|NCT03654833|Phase IIa|phase iia
87671|NCT03654794|Tacrolimus|tacrolimus
87672|NCT03654794|Pharmacokinetics|pharmacokinetics
87673|NCT03654781|periodontal treatment|periodontal treatment
87674|NCT03654781|Initial periodontal therapy|initial periodontal therapy
87675|NCT03654781|H. pylori|h. pylori
87676|NCT03654755|eczema|eczema
87677|NCT03654742|tonsil surgery|tonsil surgery
87678|NCT03654742|tonsillectomy|tonsillectomy
87679|NCT03654742|intracapsular|intracapsular
87680|NCT03654742|microdebrider|microdebrider
87681|NCT03654742|coblation|coblation
87682|NCT03654742|extracapsular|extracapsular
87683|NCT03654742|electrosurgery|electrosurgery
87684|NCT03654742|electrocautery|electrocautery
87685|NCT03654729|Metastatic|metastatic
87686|NCT03654729|Colorectal|colorectal
87687|NCT03654729|Cancer|cancer
87688|NCT03654729|Metastatic Colorectal Cancer|metastatic colorectal cancer
87689|NCT03654729|Oxaliplatin induced CIPN|oxaliplatin induced cipn
87690|NCT03654729|CIPN|cipn
87691|NCT03654729|Oxaliplatin|oxaliplatin
87692|NCT03654716|Leukemia|leukemia
87693|NCT03654716|Solid Tumor|solid tumor
87694|NCT03654716|Brain Tumor|brain tumor
87695|NCT03654716|Lymphoma|lymphoma
87696|NCT03654716|TP53|tp53
87697|NCT03654716|p53|p53
87698|NCT03654716|MDM2|mdm2
87699|NCT03654716|MDMX|mdmx
87700|NCT03654716|PPM1D|ppm1d
87701|NCT03654703|HSCT, AML， R-AML|hsct, aml， r-aml
87702|NCT03654677|Hepatitis A Vaccine|hepatitis a vaccine
87703|NCT03654664|Hepatitis A vaccine|hepatitis a vaccine
87704|NCT03654625|Worry|worry
87705|NCT03654625|Anxiety|anxiety
87706|NCT03654625|Generalized Anxiety Disorder|generalized anxiety disorder
87707|NCT03654625|Written Exposure|written exposure
87708|NCT03654599|Digital Storytelling|digital storytelling
87709|NCT03654599|Narrative|narrative
87710|NCT03654599|Cancer patients|cancer patients
87711|NCT03654599|Psychosocial health|psychosocial health
87712|NCT03654599|bone marrow transplant|bone marrow transplant
87713|NCT03654534|gastric cancer|gastric cancer
87714|NCT03654534|chemothrapy|chemothrapy
87715|NCT03654534|oral nutritional supplements|oral nutritional supplements
87716|NCT03654534|malnutrition|malnutrition
87717|NCT03654508|long-acting beta2-agonist|long-acting beta2-agonist
87718|NCT03654508|pharmacogenetics|pharmacogenetics
87719|NCT03654482|Knotless seton|knotless seton
87720|NCT03654482|Quality of life|quality of life
87721|NCT03654482|Perianal Disease Activity Index|perianal disease activity index
87722|NCT03654456|obstructive sleep apnea|obstructive sleep apnea
87723|NCT03654456|sepsis|sepsis
87724|NCT03654456|outcome|outcome
87725|NCT03654456|prognosis|prognosis
87726|NCT03654456|sleep-disordered breathing|sleep-disordered breathing
87727|NCT03654430|Left ventricular Twist|left ventricular twist
87728|NCT03654430|2D-speckle-tracking|2d-speckle-tracking
87729|NCT03654430|Postnatal adaptation|postnatal adaptation
87730|NCT03654417|vulvar biopsy|vulvar biopsy
87731|NCT03654404|Hematopoietic Stem Cell Transplant|hematopoietic stem cell transplant
87732|NCT03654404|Positive Psychology|positive psychology
87733|NCT03654404|Hematologic malignancy|hematologic malignancy
87734|NCT03654404|Positive Psychological Intervention|positive psychological intervention
87735|NCT03654391|Astragalus and Notoginseng extrats|astragalus and notoginseng extrats
87736|NCT03654391|Body weight|body weight
87737|NCT03654391|BMI|bmi
87738|NCT03654391|Triglyceride|triglyceride
87739|NCT03654391|obese|obese
87740|NCT03654378|Nifedipine|nifedipine
87741|NCT03654378|Pregnancy|pregnancy
87742|NCT03654378|Hypertension|hypertension
87743|NCT03654365|preventative screening|preventative screening
87744|NCT03654365|electronic health records|electronic health records
87745|NCT03654365|personal health records|personal health records
87746|NCT03654365|population health tools|population health tools
87747|NCT03654352|lung|lung
87748|NCT03654352|ceramide|ceramide
87749|NCT03654352|sphingolipid|sphingolipid
87750|NCT03654352|inflammation|inflammation
87751|NCT03654352|pulmonary|pulmonary
87752|NCT03654352|ARDS|ards
87753|NCT03654352|ALI|ali
87754|NCT03654313|Atherosclerosis|atherosclerosis
87755|NCT03654313|Cardiovascular Disease|cardiovascular disease
87756|NCT03654313|CAD|cad
87757|NCT03654313|Atherosclerotic Cardiovascular Disease|atherosclerotic cardiovascular disease
87758|NCT03654287|sepsis|sepsis
87759|NCT03654287|CRRT|crrt
87760|NCT03654287|ECMO|ecmo
87761|NCT03654287|CELS|cels
87762|NCT03654274|Endometriosis|endometriosis
87763|NCT03654274|Dysmenorrhea|dysmenorrhea
87764|NCT03654274|Pain|pain
87765|NCT03654274|Dypareunia|dypareunia
87766|NCT03654261|Cognitive Therapy|cognitive therapy
87767|NCT03654261|Workshop|workshop
87768|NCT03654261|Postpartum Depression|postpartum depression
87769|NCT03654248|Time management|time management
87770|NCT03654248|Group intervention|group intervention
87771|NCT03654248|Executive function|executive function
87772|NCT03654209|Argon Plasma Coagulation|argon plasma coagulation
87773|NCT03654209|Snare Tip Soft Coagulation|snare tip soft coagulation
87774|NCT03654209|Recurrence rates|recurrence rates
87775|NCT03654196|Acute Bronchitis|acute bronchitis
87776|NCT03654118|Arthroscopy|arthroscopy
87777|NCT03654118|Bankart|bankart
87778|NCT03654118|Shoulder|shoulder
87779|NCT03654118|ISIS|isis
87780|NCT03654105|Inflammation|inflammation
87781|NCT03654105|Primary Prevention|primary prevention
87782|NCT03654105|Multiple Prevention|multiple prevention
87783|NCT03654105|Lung Cancer Screening|lung cancer screening
87784|NCT03654105|Smoking Cessation|smoking cessation
87785|NCT03654105|Diet|diet
87786|NCT03654105|Physical Activity|physical activity
87787|NCT03654105|CRP|crp
87788|NCT03654092|Exercise|exercise
87789|NCT03654092|Minimal equipment|minimal equipment
87790|NCT03654092|Home-based|home-based
87791|NCT03654092|COPD|copd
87792|NCT03654092|Exercise training intervention|exercise training intervention
87793|NCT03654092|Randomized controlled trial|randomized controlled trial
87794|NCT03654079|Simulation|simulation
87795|NCT03654079|Pregnancy|pregnancy
87796|NCT03654079|Labor and Delivery|labor and delivery
87797|NCT03654079|Childbirth|childbirth
87798|NCT03654053|cirrhosis|cirrhosis
87799|NCT03654053|hepatic decompensation|hepatic decompensation
87800|NCT03654040|alloantigen-reactive Tregs ( arTreg)|alloantigen-reactive tregs ( artreg)
87801|NCT03654040|immunosuppression|immunosuppression
87802|NCT03654040|operational tolerance|operational tolerance
87803|NCT03654014|Pulsed Electromagnetic Field therapy|pulsed electromagnetic field therapy
87804|NCT03654014|Traumatic Brain Injury|traumatic brain injury
87805|NCT03654014|Neurologic outcome|neurologic outcome
87806|NCT03654014|Cerebrospinal fluid biomarkers|cerebrospinal fluid biomarkers
87807|NCT03654014|serum biomarkers|serum biomarkers
87808|NCT03654001|Septic Shock|septic shock
87809|NCT03654001|Albumin|albumin
87810|NCT03654001|Balanced crystalloids|balanced crystalloids
87811|NCT03653988|Nerve block|nerve block
87812|NCT03653988|Pectoralis nerve blocks|pectoralis nerve blocks
87813|NCT03653988|PECS I|pecs i
87814|NCT03653988|PECS II|pecs ii
87815|NCT03653988|Mastectomy|mastectomy
87816|NCT03653975|Nodding Syndrome|nodding syndrome
87817|NCT03653975|Head Nodding|head nodding
87818|NCT03653975|Epilepsy|epilepsy
87819|NCT03653975|Onchocerciasis|onchocerciasis
87820|NCT03653975|Cognitive impairment|cognitive impairment
87821|NCT03653975|Mahenge|mahenge
87822|NCT03653962|Multimedia|multimedia
87823|NCT03653962|informed consent|informed consent
87824|NCT03653962|metabolic surgery|metabolic surgery
87825|NCT03653962|Roux-en-Y gastric bypass|roux-en-y gastric bypass
87826|NCT03653949|Cystic fibrosis|cystic fibrosis
87827|NCT03653949|Insulin Resistance|insulin resistance
87828|NCT03653949|Aerobic Exercise|aerobic exercise
87829|NCT03653949|Child|child
87830|NCT03653949|Adolescents|adolescents
87831|NCT03653910|double-lumen tube intubation|double-lumen tube intubation
87832|NCT03653910|remifentanil|remifentanil
87833|NCT03653910|target controlled infusion|target controlled infusion
87834|NCT03653897|Ingestion event marker|ingestion event marker
87835|NCT03653897|Ingestible sensor|ingestible sensor
87836|NCT03653897|Medication adherence|medication adherence
87837|NCT03653897|ID-Cap Medication Adherence Feedback System|id-cap medication adherence feedback system
87847|NCT03653845|Ablation|ablation
87848|NCT03653845|Adrenal Gland|adrenal gland
87849|NCT03653832|Sedation|sedation
87850|NCT03653832|Ventilation|ventilation
87851|NCT03653819|Compression Stockings|compression stockings
87852|NCT03653819|Feasibility Study|feasibility study
87853|NCT03653819|Physical Activity|physical activity
87854|NCT03653819|High Intensity Interval Training|high intensity interval training
87855|NCT03653819|Cross over trial|cross over trial
87856|NCT03653806|PEEP|peep
87857|NCT03653806|Electrical Impedance Tomography|electrical impedance tomography
87858|NCT03653780|Wearable Exoskeleton|wearable exoskeleton
87859|NCT03653780|Stroke|stroke
87860|NCT03653780|Oxygen Consumption|oxygen consumption
87861|NCT03653780|Cardiorespiratory Responses|cardiorespiratory responses
87862|NCT03653767|classroom ergonomics|classroom ergonomics
87863|NCT03653767|sedentary behavior|sedentary behavior
825216|NCT00133744|birthweight|birthweight
87864|NCT03653767|school interventions|school interventions
87865|NCT03653767|physical activity|physical activity
87866|NCT03653754|growth|growth
87867|NCT03653754|Body Composition|body composition
87868|NCT03653728|non-invasive monitoring; near-infrared spectroscopy; traumatic brain injury; cerebral contusion|non-invasive monitoring; near-infrared spectroscopy; traumatic brain injury; cerebral contusion
87869|NCT03653715|Refractive Errors|refractive errors
87870|NCT03653715|Myopia|myopia
87871|NCT03653715|Hyperopia|hyperopia
87872|NCT03653715|Astigmatism|astigmatism
87874|NCT03653689|metabotype|metabotype
87875|NCT03653689|FODMAP|fodmap
87876|NCT03653689|gluten|gluten
87877|NCT03653676|Sickle Cell Anemia|sickle cell anemia
87878|NCT03653676|Sickle Cell Disease|sickle cell disease
87879|NCT03653676|Exercise|exercise
87880|NCT03653676|Fitness|fitness
87881|NCT03653676|Asthma|asthma
87882|NCT03653676|Inflammation|inflammation
87883|NCT03653650|Platelet-Rich Plasma|platelet-rich plasma
87884|NCT03653650|Persistent Epithelial Defect|persistent epithelial defect
87885|NCT03653637|Suicide|suicide
87886|NCT03653637|Safety Plan|safety plan
87887|NCT03653637|Group Treatment|group treatment
87888|NCT03653637|Veterans|veterans
87889|NCT03653611|COPD|copd
87890|NCT03653611|CAPTURE|capture
87891|NCT03653611|Chronic Obstructive Pulmonary Disease|chronic obstructive pulmonary disease
87892|NCT03653598|Atrial Fibrillation|atrial fibrillation
87893|NCT03653585|Multiple Sclerosis|multiple sclerosis
87894|NCT03653585|Magnetic Resonance Imaging|magnetic resonance imaging
87895|NCT03653585|Magnetic Resonance Spectroscopy|magnetic resonance spectroscopy
87896|NCT03653585|Transcranial Magnetic Stimulation|transcranial magnetic stimulation
87897|NCT03653585|Functional Neuroimaging|functional neuroimaging
87898|NCT03653585|Cortical Lesion|cortical lesion
87899|NCT03653585|Sensorimotor cortex|sensorimotor cortex
87900|NCT03653585|7T|7t
87901|NCT03653585|7 Tesla|7 tesla
87902|NCT03653572|Ultrasound|ultrasound
87903|NCT03653572|Emergency care|emergency care
87904|NCT03653546|Central Nervous System Metastases|central nervous system metastases
87905|NCT03653546|Respiratory Tract Diseases|respiratory tract diseases
87906|NCT03653546|EGFR|egfr
87907|NCT03653546|Exon 19Del|exon 19del
87908|NCT03653546|L858R|l858r
87909|NCT03653546|Lung Neoplasm|lung neoplasm
87910|NCT03653546|Carcinoma, Non-Small-Cell Lung|carcinoma, non-small-cell lung
87911|NCT03653546|Neoplasms|neoplasms
87923|NCT03653494|non-intubated general anaesthesia|non-intubated general anaesthesia
87924|NCT03653494|video-assisted thoracoscopic surgery|video-assisted thoracoscopic surgery
87925|NCT03653494|phrenic block|phrenic block
87926|NCT03653481|diet|diet
87927|NCT03653481|inulin|inulin
87928|NCT03653481|prebiotic|prebiotic
87929|NCT03653481|IBD|ibd
87930|NCT03653481|Inflammatory Bowel Disease|inflammatory bowel disease
87931|NCT03653455|Shoulder|shoulder
87932|NCT03653455|Arthroscopy|arthroscopy
87933|NCT03653455|sub-acromial decompression|sub-acromial decompression
87934|NCT03653455|distal clavicle resection|distal clavicle resection
87935|NCT03653455|biceps tenodesis|biceps tenodesis
87936|NCT03653455|rotator cuff repair|rotator cuff repair
87937|NCT03653455|Patient reported outcomes|patient reported outcomes
87938|NCT03653442|Induced hypotension|induced hypotension
87939|NCT03653442|Spinal Anaesthesia|spinal anaesthesia
87940|NCT03653442|Elective Caesarean section|elective caesarean section
87941|NCT03653442|non-invasive haemodynamic parameters|non-invasive haemodynamic parameters
87942|NCT03653429|foot and ankle surgeries|foot and ankle surgeries
87943|NCT03653429|tranexamic acid|tranexamic acid
87944|NCT03653429|wound healing|wound healing
87945|NCT03653429|blood loss|blood loss
87946|NCT03653416|Total knee arthroplasty|total knee arthroplasty
87947|NCT03653416|Peri articular infiltration|peri articular infiltration
87948|NCT03653416|Pack block|pack block
87949|NCT03653416|Adductor canal catheter|adductor canal catheter
87950|NCT03653390|health promotion intervention|health promotion intervention
87951|NCT03653390|community participation|community participation
87952|NCT03653390|quality of life|quality of life
87953|NCT03653390|middle age|middle age
87954|NCT03653390|multiple sclerosis|multiple sclerosis
87955|NCT03653390|spinal cord injury|spinal cord injury
87956|NCT03653390|muscular dystrophy|muscular dystrophy
87957|NCT03653390|post-polio syndrome|post-polio syndrome
87958|NCT03653377|mucoviscidosis|mucoviscidosis
87959|NCT03653377|Human Papilloma Virus|human papilloma virus
87960|NCT03653377|Vaccination|vaccination
87961|NCT03653377|Young girl|young girl
87962|NCT03653338|Sickle Cell|sickle cell
87963|NCT03653338|Diamond-Blackfan|diamond-blackfan
87964|NCT03653338|Beta-thalassemia|beta-thalassemia
87965|NCT03653338|Anemia|anemia
87966|NCT03653338|Stem cell transplantation|stem cell transplantation
87967|NCT03653338|Unrelated Donor|unrelated donor
87968|NCT03653338|haploidentical|haploidentical
87969|NCT03653338|hematopoietic stem cell transplant (HSCT)|hematopoietic stem cell transplant (hsct)
87970|NCT03653338|bone marrow transplant (BMT)|bone marrow transplant (bmt)
87971|NCT03653338|mismatched|mismatched
87972|NCT03653338|t-cell depletion|t-cell depletion
87973|NCT03653325|hyperoxia|hyperoxia
87974|NCT03653325|post rosc|post rosc
87975|NCT03653325|oxygen reserve index|oxygen reserve index
87976|NCT03653325|Fi02 titration|fi02 titration
87977|NCT03653325|post cardiac arrest care|post cardiac arrest care
87978|NCT03653325|oxygen|oxygen
87979|NCT03653312|Ischemic Stroke|ischemic stroke
87980|NCT03653312|Neuromuscular electrical stimulation|neuromuscular electrical stimulation
87981|NCT03653312|Activities of daily living|activities of daily living
87982|NCT03653312|Patient reported outcome|patient reported outcome
87983|NCT03653312|Neuroplasticity|neuroplasticity
87984|NCT03653312|Transcranial magnetic stimulation|transcranial magnetic stimulation
87985|NCT03653312|Fugl Meyer|fugl meyer
87986|NCT03653299|stroke|stroke
87987|NCT03653299|phototherapy|phototherapy
87988|NCT03653299|gait|gait
87989|NCT03653299|balance|balance
87990|NCT03653299|functional mobility|functional mobility
87991|NCT03653286|Neuromuscular Eletrical Stimulation|neuromuscular eletrical stimulation
87992|NCT03653286|Torque|torque
87993|NCT03653286|Runners|runners
87994|NCT03653273|multiple sclerosis|multiple sclerosis
87995|NCT03653273|secondary progressive|secondary progressive
87996|NCT03653273|disease modifying treatment|disease modifying treatment
87997|NCT03653273|medico economic impact|medico economic impact
87998|NCT03653273|treatment withdrawal|treatment withdrawal
87999|NCT03653247|Intervention: Genetic: BIVV003|intervention: genetic: bivv003
88000|NCT03653247|Drug: Busulfan|drug: busulfan
88001|NCT03653247|Biological: Plerixafor|biological: plerixafor
88002|NCT03653247|Phase: Phase 1/2|phase: phase 1/2
88003|NCT03653234|active and assisted living|active and assisted living
88004|NCT03653234|assistive technology|assistive technology
88005|NCT03653234|telecare|telecare
88006|NCT03653234|remote consultations|remote consultations
88007|NCT03653234|informal caregivers|informal caregivers
88008|NCT03653234|quality of life|quality of life
88009|NCT03653195|concussion|concussion
88010|NCT03653195|biomarker|biomarker
88011|NCT03653195|metabolomic|metabolomic
88012|NCT03653195|urine|urine
88013|NCT03653195|NMR spectroscopy|nmr spectroscopy
88014|NCT03653169|Transcranial Magnetic Stimulation|transcranial magnetic stimulation
88015|NCT03653143|Behavioral regulation|behavioral regulation
88016|NCT03653143|Emotional regulation|emotional regulation
88017|NCT03653143|Social communication|social communication
88018|NCT03653143|Development|development
88019|NCT03653130|homeless|homeless
88020|NCT03653130|recreational therapy|recreational therapy
88021|NCT03653130|community integration|community integration
88022|NCT03653130|reintegration|reintegration
88023|NCT03653130|Veteran|veteran
88024|NCT03653130|housing insecurity|housing insecurity
88025|NCT03653130|Domiciliary|domiciliary
88026|NCT03653130|Human Occupation|human occupation
88027|NCT03653130|Occupational therapy|occupational therapy
88028|NCT03653130|Music|music
88029|NCT03653117|Transperineal laser ablation|transperineal laser ablation
88030|NCT03653117|LUTS|luts
88031|NCT03653117|BPO|bpo
88032|NCT03653117|Laser ablation|laser ablation
88033|NCT03653104|Melodica|melodica
88034|NCT03653104|pursed lip breathing|pursed lip breathing
88035|NCT03653104|breathing exercise|breathing exercise
88036|NCT03653104|Music|music
88037|NCT03653091|Type 2 diabetes|type 2 diabetes
88038|NCT03653091|Diabetes Mellitus|diabetes mellitus
88039|NCT03653091|Noninsulin-Dependent Diabetes Mellitus|noninsulin-dependent diabetes mellitus
88040|NCT03653091|Glucose Metabolism Disorders|glucose metabolism disorders
88041|NCT03653091|Metabolic Diseases|metabolic diseases
88042|NCT03653091|Endocrine System Diseases|endocrine system diseases
88043|NCT03653091|Revita System|revita system
88044|NCT03653091|Anti-diabetic medications|anti-diabetic medications
88045|NCT03653091|Duodenal Mucosal Resurfacing|duodenal mucosal resurfacing
88046|NCT03653078|Surgical guide|surgical guide
88047|NCT03653078|Surgical stent|surgical stent
88048|NCT03653078|orthodontic mini screw|orthodontic mini screw
88049|NCT03653078|temporary anchorage device|temporary anchorage device
88050|NCT03653026|Upadacitinib|upadacitinib
88051|NCT03653026|ABT-494|abt-494
88052|NCT03653026|Ulcerative Colitis|ulcerative colitis
88053|NCT03653000|Regional anesthesia|regional anesthesia
88054|NCT03653000|Ultrasound guided brachial plexus blockade|ultrasound guided brachial plexus blockade
88055|NCT03653000|Local anesthetics : Ropivacaine|local anesthetics : ropivacaine
88056|NCT03652987|PCOS|pcos
88057|NCT03652987|Hyperandrogenemia|hyperandrogenemia
88058|NCT03652987|Rotterdam Criteria|rotterdam criteria
88059|NCT03652987|Insulin sensitivity|insulin sensitivity
88060|NCT03652987|BMI|bmi
88061|NCT03652987|Antral follicle count|antral follicle count
88062|NCT03652974|Schizophrenia， clozapine， valproate， ECT|schizophrenia， clozapine， valproate， ect
88063|NCT03652948|mobile app|mobile app
88064|NCT03652948|middle age adults|middle age adults
88065|NCT03652948|older adults|older adults
88066|NCT03652935|Breast cancer, mindfulness, immune, stress|breast cancer, mindfulness, immune, stress
88067|NCT03652896|hepatocellular carcinoma|hepatocellular carcinoma
88068|NCT03652896|anatomical liver resection|anatomical liver resection
88069|NCT03652883|Implementation|implementation
88070|NCT03652883|Tailored implementation strategies|tailored implementation strategies
88071|NCT03652883|iCBT|icbt
88072|NCT03652883|Common mental disorders|common mental disorders
88073|NCT03652870|Parkinson's Disease|parkinson's disease
88074|NCT03652857|Apatinib plus Vinorelbine|apatinib plus vinorelbine
88075|NCT03652857|NSCLC|nsclc
88076|NCT03652831|Cervical radiculopathy,|cervical radiculopathy,
88077|NCT03652831|Soft tissue mobilization,|soft tissue mobilization,
88078|NCT03652831|Neural mobilization|neural mobilization
88079|NCT03652766|Overweight|overweight
88080|NCT03652766|Obesity|obesity
88081|NCT03652766|e-Health|e-health
88082|NCT03652766|Gestational Weight Gain|gestational weight gain
88083|NCT03652766|Pregnancy|pregnancy
88084|NCT03652766|Women's Health|women's health
88085|NCT03652766|Prevention|prevention
88086|NCT03652740|over-the-counter|over-the-counter
88087|NCT03652740|prescription medication|prescription medication
88088|NCT03652740|subjective effects|subjective effects
88089|NCT03652727|PICC|picc
88090|NCT03652727|PIC Line|pic line
88091|NCT03652727|ECG|ecg
88092|NCT03652688|clubs|clubs
88093|NCT03652675|Heavy Drinking|heavy drinking
88094|NCT03652675|HIV|hiv
88095|NCT03652675|Hepatitis C|hepatitis c
88096|NCT03652649|type 2 diabetes|type 2 diabetes
88097|NCT03652649|diabetes|diabetes
88098|NCT03652649|ketogenic diet|ketogenic diet
88099|NCT03652649|low carb diet|low carb diet
88100|NCT03652649|weight loss|weight loss
88101|NCT03652649|obesity|obesity
88102|NCT03652649|diet treatment|diet treatment
88103|NCT03652649|nutrition|nutrition
88104|NCT03652649|BMI|bmi
88105|NCT03652623|Transgender|transgender
88106|NCT03652623|Pre-exposure Prophylaxis (PrEP)|pre-exposure prophylaxis (prep)
88107|NCT03652623|HIV Prevention|hiv prevention
88108|NCT03652623|Tenofovir Disoproxil Fumarate/Emtricitabine (TDF/FTC)|tenofovir disoproxil fumarate/emtricitabine (tdf/ftc)
88109|NCT03652623|Cross-sex Hormone Therapy|cross-sex hormone therapy
88110|NCT03652623|Adherence|adherence
88111|NCT03652623|Behavior Change|behavior change
88112|NCT03652623|Gender Affirmation|gender affirmation
88113|NCT03652610|Meningitis|meningitis
88114|NCT03652610|Liquid formulation|liquid formulation
88115|NCT03652610|Meningococcal disease|meningococcal disease
88116|NCT03652597|Target engagement|target engagement
88117|NCT03652597|TMS|tms
88118|NCT03652597|Heart-brain pathway|heart-brain pathway
88119|NCT03652597|Depression|depression
88120|NCT03652597|Neuromodulation|neuromodulation
88121|NCT03652597|DLPFC|dlpfc
88122|NCT03652597|Heart rate|heart rate
88123|NCT03652584|postmenopause|postmenopause
88124|NCT03652584|diet|diet
88125|NCT03652584|Skeletal muscle mass|skeletal muscle mass
88126|NCT03652519|Exercise|exercise
88127|NCT03652519|Immune Signalling|immune signalling
88128|NCT03652519|Cognition|cognition
88129|NCT03652519|Health-related Quality of Life|health-related quality of life
88130|NCT03652493|Anomaly of the Homologous Recombination (HR) pathway|anomaly of the homologous recombination (hr) pathway
88131|NCT03652493|Carboplatin|carboplatin
88132|NCT03652480|shoulder pain|shoulder pain
88133|NCT03652480|type 2 diabetes|type 2 diabetes
88229|NCT03651778|Recreational drugs|recreational drugs
88134|NCT03652480|subacromial corticosteroid injection|subacromial corticosteroid injection
88135|NCT03652480|glycemia|glycemia
88136|NCT03652480|efficacy|efficacy
88137|NCT03652480|safety|safety
88138|NCT03652467|Deferoxamine|deferoxamine
88139|NCT03652467|Transarterial chemoembolization|transarterial chemoembolization
88140|NCT03652467|Unresectable hepatocellular carcinoma|unresectable hepatocellular carcinoma
88141|NCT03652454|regional acceleratory phenomenon|regional acceleratory phenomenon
88142|NCT03652454|micro-osteoperforation|micro-osteoperforation
88143|NCT03652454|orthodontic alignment|orthodontic alignment
88144|NCT03652428|LAPC|lapc
88145|NCT03652428|Nab-paclitaxel +Gemcitabine|nab-paclitaxel +gemcitabine
88146|NCT03652428|Proton Therapy|proton therapy
88147|NCT03652402|Kidney|kidney
88148|NCT03652402|Allogenic transplantation|allogenic transplantation
88149|NCT03652402|Cohort study|cohort study
88150|NCT03652402|Rejection|rejection
88151|NCT03652402|Biomarkers|biomarkers
88152|NCT03652402|Response to treatment|response to treatment
88153|NCT03652402|Integrative medicine|integrative medicine
88154|NCT03652324|coil treatment|coil treatment
88155|NCT03652324|general anesthesia|general anesthesia
88156|NCT03652324|deep sedation|deep sedation
88157|NCT03652311|opiate use disorder|opiate use disorder
88158|NCT03652311|neuromodulation|neuromodulation
88159|NCT03652311|caloric vestibular stimulation|caloric vestibular stimulation
88160|NCT03652311|adjunct therapy|adjunct therapy
88161|NCT03652298|PTSD|ptsd
88162|NCT03652298|Memory Structuring Intervention (MSI)|memory structuring intervention (msi)
88163|NCT03652298|Cancer|cancer
88164|NCT03652298|Vagal breathing|vagal breathing
825217|NCT00133744|preterm|preterm
88165|NCT03652272|medication safety|medication safety
88166|NCT03652272|adherence|adherence
88167|NCT03652272|electronic health record|electronic health record
88168|NCT03652259|limb girdle muscular dystrophy|limb girdle muscular dystrophy
88169|NCT03652259|LGMD2E|lgmd2e
88170|NCT03652259|beta-sarcoglycan|beta-sarcoglycan
88171|NCT03652259|gene transfer|gene transfer
88172|NCT03652259|adeno-associated virus|adeno-associated virus
88173|NCT03652181|CCM (Cerebral Cavernous Malformations)|ccm (cerebral cavernous malformations)
88174|NCT03652181|Dynamic Contrast Enhanced Quantitative Perfusion (DCEQP)|dynamic contrast enhanced quantitative perfusion (dceqp)
88175|NCT03652181|Quantitative Susceptibility Mapping (QSM)|quantitative susceptibility mapping (qsm)
88176|NCT03652181|Cerebral Cavernous Malformation|cerebral cavernous malformation
88177|NCT03652181|Cavernoma|cavernoma
88178|NCT03652181|Cavernous Angioma|cavernous angioma
88179|NCT03652168|stress|stress
88180|NCT03652168|health|health
88181|NCT03652168|mindfulness|mindfulness
88182|NCT03652168|employees|employees
88183|NCT03652142|HNSCC|hnscc
88184|NCT03652142|DDR|ddr
88185|NCT03652142|DNA damage|dna damage
88186|NCT03652142|DNA damage repair|dna damage repair
88187|NCT03652142|PD-L1|pd-l1
88188|NCT03652142|PD-1|pd-1
88189|NCT03652142|NIVOLUMAB|nivolumab
88190|NCT03652142|Head and Neck cancer|head and neck cancer
88191|NCT03652103|Truncal Nerve Blocks, Ultrasound Guided Nerve Blocks|truncal nerve blocks, ultrasound guided nerve blocks
88192|NCT03652090|biomarker|biomarker
88193|NCT03652077|Advanced malignancies|advanced malignancies
88194|NCT03652077|immunoglobulin (Ig)G1k monoclonal antibody|immunoglobulin (ig)g1k monoclonal antibody
88195|NCT03652077|T-cell immunoglobulin and mucin domain 3 (TIM-3)|t-cell immunoglobulin and mucin domain 3 (tim-3)
88196|NCT03652038|Single ascending dose|single ascending dose
88197|NCT03652038|SAD|sad
88198|NCT03652038|Multiple ascending dose|multiple ascending dose
88199|NCT03652038|MAD|mad
88200|NCT03652038|Phase 1|phase 1
88201|NCT03652038|first-in-human|first-in-human
88202|NCT03652038|TD-8236|td-8236
88203|NCT03652038|asthma|asthma
88204|NCT03652012|Mild Cognitive Impairment|mild cognitive impairment
88205|NCT03651986|Circulating Tumor DNA (ctDNA)|circulating tumor dna (ctdna)
88206|NCT03651986|DNA Methylation Analysis|dna methylation analysis
88207|NCT03651986|Next-Generation Sequencing (NGS)|next-generation sequencing (ngs)
88208|NCT03651986|Low-Dose Computed Tomography (LDCT)|low-dose computed tomography (ldct)
88209|NCT03651973|Self massages and self stretching|self massages and self stretching
88210|NCT03651973|Workshops for self massages and stretching learning|workshops for self massages and stretching learning
88211|NCT03651921|Breast Cancer|breast cancer
88212|NCT03651921|Self-Management|self-management
88213|NCT03651921|Cancer Survivorship|cancer survivorship
88214|NCT03651895|Chronic Obstructive Pulmonary Disease|chronic obstructive pulmonary disease
88215|NCT03651869|Smoking|smoking
88216|NCT03651843|high risk|high risk
88217|NCT03651843|pregnant women|pregnant women
88218|NCT03651843|occupational hazard|occupational hazard
88219|NCT03651843|occupational risk|occupational risk
88220|NCT03651830|Amputation|amputation
88221|NCT03651830|Rehabilitation|rehabilitation
88222|NCT03651830|Prescriptions|prescriptions
88223|NCT03651830|Emulator|emulator
88224|NCT03651830|Prosthetics|prosthetics
88225|NCT03651778|GHB|ghb
88226|NCT03651778|gamma-Hydroxybutyric acid|gamma-hydroxybutyric acid
88227|NCT03651778|Substances of abuse|substances of abuse
88228|NCT03651778|Poisoning induced by others|poisoning induced by others
88230|NCT03651778|Poisoning|poisoning
88231|NCT03651778|Intoxication|intoxication
88232|NCT03651765|setmelanotide|setmelanotide
88233|NCT03651765|RM-493|rm-493
88234|NCT03651765|obesity|obesity
88235|NCT03651765|leptin-melanocortin|leptin-melanocortin
88236|NCT03651765|melanocortin 4 receptor|melanocortin 4 receptor
88237|NCT03651739|Rehabilitation|rehabilitation
88238|NCT03651713|exercise|exercise
88239|NCT03651713|glucose|glucose
88240|NCT03651713|vascular function|vascular function
88241|NCT03651687|Head circumference|head circumference
88242|NCT03651687|Neurodevelopment|neurodevelopment
88243|NCT03651687|Newborn|newborn
88244|NCT03651687|Infant|infant
88245|NCT03651687|Surveillance|surveillance
88246|NCT03651687|Prediction|prediction
88247|NCT03651648|apnea; prematurity; kinesthetic stimulation|apnea; prematurity; kinesthetic stimulation
88248|NCT03651635|ICU|icu
88249|NCT03651635|Biomarkers|biomarkers
88250|NCT03651622|Type 1 diabetes|type 1 diabetes
88251|NCT03651622|T1D|t1d
88252|NCT03651622|Type 1 diabetes mellitus (T1DM)|type 1 diabetes mellitus (t1dm)
88253|NCT03651622|weight management|weight management
88254|NCT03651622|overweight|overweight
88255|NCT03651622|obese|obese
88256|NCT03651609|Ulnar neuropathy at the elbow|ulnar neuropathy at the elbow
88257|NCT03651609|Electromyography|electromyography
88258|NCT03651609|Ultrasonography|ultrasonography
88259|NCT03651609|Treatment|treatment
88260|NCT03651609|Surgery|surgery
88261|NCT03651609|Conservative treatment|conservative treatment
88262|NCT03651596|Adherence|adherence
88263|NCT03651596|Adolescence|adolescence
88264|NCT03651596|mHealth|mhealth
88265|NCT03651583|Migraine|migraine
88266|NCT03651583|Kiko|kiko
88267|NCT03651583|Qigong|qigong
88268|NCT03651583|Relaxation|relaxation
88269|NCT03651583|Exercise|exercise
88270|NCT03651557|Neu2000KWL|neu2000kwl
88271|NCT03651557|cerebral performance category|cerebral performance category
88272|NCT03651557|out-of-hospital cardiac arrest|out-of-hospital cardiac arrest
88273|NCT03651557|neuroprotection|neuroprotection
88274|NCT03651557|glutamate|glutamate
88400|NCT03650933|GB241|gb241
88275|NCT03651557|N-Methyl-D-aspartate (NMDA) receptor antagonist|n-methyl-d-aspartate (nmda) receptor antagonist
88276|NCT03651557|Anti-oxidant|anti-oxidant
88277|NCT03651557|free radical|free radical
88278|NCT03651544|influenza|influenza
88279|NCT03651544|vaccine|vaccine
88280|NCT03651544|vector vaccine|vector vaccine
88281|NCT03651531|metformin|metformin
88282|NCT03651518|Personalized treatment|personalized treatment
88283|NCT03651518|Inflammatory diseases|inflammatory diseases
88284|NCT03651518|auto-inflammatory diseases|auto-inflammatory diseases
88285|NCT03651518|auto-immune diseases|auto-immune diseases
88286|NCT03651518|Targeted treatments|targeted treatments
88287|NCT03651518|skin|skin
88288|NCT03651505|X-linked Hypophosphatemia|x-linked hypophosphatemia
88289|NCT03651505|Fibroblast growth factor 23 (FGF23)|fibroblast growth factor 23 (fgf23)
88290|NCT03651505|KRN23|krn23
88291|NCT03651505|XLH|xlh
88292|NCT03651505|Hypophosphatemia|hypophosphatemia
88293|NCT03651505|Familial Hypophosphatemic Rickets|familial hypophosphatemic rickets
88294|NCT03651505|FGF23|fgf23
88295|NCT03651505|Crysvita|crysvita
88296|NCT03651492|nocturnal hypertension|nocturnal hypertension
88297|NCT03651492|renal transplantation|renal transplantation
88298|NCT03651492|sleep quality|sleep quality
88299|NCT03651479|virtual reality|virtual reality
88300|NCT03651479|boxing|boxing
88301|NCT03651479|upper extremity function|upper extremity function
88302|NCT03651479|cognitive function|cognitive function
88303|NCT03651479|balance|balance
88304|NCT03651440|Disc herniation|disc herniation
88305|NCT03651440|Endurance|endurance
88306|NCT03651440|Lumbar stabilization exercise|lumbar stabilization exercise
88307|NCT03651440|PNF|pnf
88308|NCT03651440|Strength|strength
88309|NCT03651427|Estradiol;|estradiol;
88310|NCT03651427|Brain|brain
88311|NCT03651427|glutamate|glutamate
88312|NCT03651427|spectroscopy|spectroscopy
88313|NCT03651427|hypogonadism|hypogonadism
88314|NCT03651414|Outliers|outliers
88315|NCT03651375|Dose Hypofractionation|dose hypofractionation
88316|NCT03651375|Neoadjuvant Therapy|neoadjuvant therapy
88317|NCT03651375|Chemoradiotherapy|chemoradiotherapy
88318|NCT03651375|Sarcoma|sarcoma
88319|NCT03651375|Dose Fractionation|dose fractionation
88320|NCT03651375|Dose-Response Relationship|dose-response relationship
88321|NCT03651375|Antineoplastic Agents|antineoplastic agents
88322|NCT03651375|Drug Therapy|drug therapy
88323|NCT03651375|Antineoplastic Combined Chemotherapy Protocols|antineoplastic combined chemotherapy protocols
88324|NCT03651362|optic neuritis|optic neuritis
88325|NCT03651362|DIR|dir
88326|NCT03651362|visual disability|visual disability
88327|NCT03651362|CIS|cis
88328|NCT03651362|multiple sclerosis|multiple sclerosis
88329|NCT03651362|NMOSD|nmosd
88330|NCT03651336|POAG|poag
88331|NCT03651336|Primary Open Angle Glaucoma|primary open angle glaucoma
88332|NCT03651336|Cataract|cataract
88333|NCT03651336|Intraocular Pressure|intraocular pressure
88334|NCT03651336|Intraocular Pressure Sensor System|intraocular pressure sensor system
88335|NCT03651336|IOP|iop
88336|NCT03651336|Self-monitoring of intraocular pressure|self-monitoring of intraocular pressure
88337|NCT03651323|Atrial fibrillation|atrial fibrillation
88338|NCT03651323|Left atrial appendage|left atrial appendage
88339|NCT03651323|Stroke|stroke
88340|NCT03651297|Harness Assist|harness assist
88341|NCT03651297|Balance training|balance training
88342|NCT03651297|Types of harness assist|types of harness assist
88343|NCT03651297|Fall-arrest harness|fall-arrest harness
88344|NCT03651297|Adjustable harness|adjustable harness
88345|NCT03651284|obesity|obesity
88346|NCT03651284|physical activity|physical activity
88347|NCT03651284|nutrition|nutrition
88348|NCT03651284|adolescents|adolescents
88349|NCT03651284|gamification|gamification
88350|NCT03651284|video game|video game
88351|NCT03651284|sedentary activity|sedentary activity
88352|NCT03651258|Feeding Behavior|feeding behavior
88353|NCT03651245|Alpha-Mannosidosis disease|alpha-mannosidosis disease
88354|NCT03651245|prevalence|prevalence
88355|NCT03651219|SCLC|sclc
88356|NCT03651219|apatinib|apatinib
88357|NCT03651219|Irinotecan|irinotecan
88358|NCT03651206|Malignant mixed Mullerian tumors|malignant mixed mullerian tumors
88359|NCT03651206|Metastatic ovarian carcinosarcoma|metastatic ovarian carcinosarcoma
88360|NCT03651206|Recurrent ovarian carcinosarcoma|recurrent ovarian carcinosarcoma
88361|NCT03651206|Metastatic endometrial carcinosarcoma|metastatic endometrial carcinosarcoma
88362|NCT03651206|Recurrent endometrial carcinosarcoma|recurrent endometrial carcinosarcoma
88363|NCT03651206|Niraparib|niraparib
88364|NCT03651206|TSR-042 (Dostarlimab)|tsr-042 (dostarlimab)
88365|NCT03651193|Adult Onset Still's Disease|adult onset still's disease
88366|NCT03651193|Chinese population|chinese population
88367|NCT03651180|Polymer free drug eluting stent|polymer free drug eluting stent
88368|NCT03651167|skin care|skin care
88369|NCT03651167|skin tone|skin tone
88370|NCT03651167|tanning|tanning
88371|NCT03651167|skin tone preference|skin tone preference
88372|NCT03651141|Hamstring tightness|hamstring tightness
88373|NCT03651141|myofascial decompression|myofascial decompression
88374|NCT03651141|cupping|cupping
88375|NCT03651141|neurodynamic sliding|neurodynamic sliding
88376|NCT03651128|Multiple Myeloma|multiple myeloma
88377|NCT03651128|bb2121|bb2121
88378|NCT03651128|Relapsed and Refractory Multiple Myeloma|relapsed and refractory multiple myeloma
88379|NCT03651128|High Risk Multiple Myeloma|high risk multiple myeloma
88380|NCT03651102|Thalidomide|thalidomide
88381|NCT03651089|acute myocardial infarction|acute myocardial infarction
88382|NCT03651089|inflammation|inflammation
88383|NCT03651063|rehabilitation; social robots|rehabilitation; social robots
88384|NCT03651037|cancer|cancer
88385|NCT03651037|bone health|bone health
88386|NCT03651037|physical activity|physical activity
88387|NCT03651037|technology platfrom|technology platfrom
88388|NCT03651011|Branch Retinal Vein Occlusion|branch retinal vein occlusion
88389|NCT03651011|Navigated laser photocoagulation|navigated laser photocoagulation
88390|NCT03651011|Macular Edema|macular edema
88391|NCT03651011|Oximetry|oximetry
88392|NCT03651011|Retinal vascular caliber measurements|retinal vascular caliber measurements
88393|NCT03651011|Microperimetry|microperimetry
88394|NCT03650998|nerve block|nerve block
88395|NCT03650998|ultrasound|ultrasound
88396|NCT03650998|opioids|opioids
88397|NCT03650998|hysterectomy|hysterectomy
88398|NCT03650946|Prostate cancer|prostate cancer
88399|NCT03650946|Ga-68 PSMA PET|ga-68 psma pet
88401|NCT03650933|Rituximab|rituximab
88402|NCT03650933|Diffuse Large B-cell Lymphoma|diffuse large b-cell lymphoma
88403|NCT03650933|Non Hodgkin's Lymphoma|non hodgkin's lymphoma
88405|NCT03650894|Breast Cancer|breast cancer
88406|NCT03650894|Her2 negative breast cancer|her2 negative breast cancer
88407|NCT03650894|Immunotherapy|immunotherapy
88408|NCT03650894|Opdivo|opdivo
88409|NCT03650894|Nivolumab|nivolumab
88410|NCT03650894|Yervoy|yervoy
88411|NCT03650894|Ipilimumab|ipilimumab
88412|NCT03650894|Bicalutamide|bicalutamide
88413|NCT03650894|Casodex|casodex
88414|NCT03650868|Thoracal Paravertebral Block|thoracal paravertebral block
88415|NCT03650868|Breast Surgery|breast surgery
88416|NCT03650868|Seroma Reduction|seroma reduction
88417|NCT03650855|degenerative spine disease|degenerative spine disease
88418|NCT03650855|screw loosening|screw loosening
88419|NCT03650855|Quantitative CT scan|quantitative ct scan
88420|NCT03650855|vertebral bone density|vertebral bone density
88421|NCT03650829|ART|art
88422|NCT03650829|Offspring|offspring
88423|NCT03650829|Development|development
88424|NCT03650829|Cohort|cohort
88425|NCT03650816|Alzheimer Disease|alzheimer disease
88426|NCT03650816|Subjective cognitive impairment|subjective cognitive impairment
88427|NCT03650816|Cognitive Dysfunction|cognitive dysfunction
88428|NCT03650816|Neurodegenerative Diseases|neurodegenerative diseases
88429|NCT03650816|Cerebrovascular reactivity|cerebrovascular reactivity
88430|NCT03650816|Doppler ultrasonography|doppler ultrasonography
88431|NCT03650816|Biomarker|biomarker
88432|NCT03650816|Endothelin-1|endothelin-1
88638|NCT03649698|Frailty|frailty
88433|NCT03650816|Big-Endothelin-1|big-endothelin-1
88434|NCT03650816|ADMA|adma
88435|NCT03650816|Renin|renin
88436|NCT03650803|3D MR Fingerprinting|3d mr fingerprinting
88437|NCT03650803|Quantitative MR Imaging|quantitative mr imaging
88438|NCT03650790|CTRP|ctrp
88439|NCT03650790|Adipocytokines|adipocytokines
88440|NCT03650790|pre-eclampsia|pre-eclampsia
88441|NCT03650751|stroke；nursing assessment；condition of a patient；deterioration；|stroke；nursing assessment；condition of a patient；deterioration；
88442|NCT03650725|Colonoscopy|colonoscopy
88443|NCT03650725|bowel preparation|bowel preparation
88444|NCT03650712|cystic fibrosis|cystic fibrosis
88445|NCT03650712|insulin|insulin
88446|NCT03650712|glucose|glucose
88447|NCT03650712|children|children
88448|NCT03650712|abnormal glucose tolerance|abnormal glucose tolerance
88449|NCT03650712|impaired glucose tolerance|impaired glucose tolerance
88450|NCT03650712|indeterminate glycemia|indeterminate glycemia
88451|NCT03650712|diabetes|diabetes
88452|NCT03650699|Oral Cavity Squamous Cell Carcinoma|oral cavity squamous cell carcinoma
88453|NCT03650699|Biofeedback|biofeedback
88454|NCT03650699|Rehabilitation|rehabilitation
88455|NCT03650699|Head and Neck Cancer|head and neck cancer
88456|NCT03650699|electropalatography|electropalatography
88457|NCT03650699|EPG|epg
88458|NCT03650673|Hand osteoarthritis|hand osteoarthritis
88459|NCT03650673|Prospective cohort|prospective cohort
88460|NCT03650673|Cartilage|cartilage
88461|NCT03650673|Mobility|mobility
88462|NCT03650647|Dental caries|dental caries
88463|NCT03650647|Dentin|dentin
88464|NCT03650647|Pulp exposure prevention|pulp exposure prevention
88465|NCT03650647|Deep caries lesion|deep caries lesion
88466|NCT03650647|Conservative Treatment|conservative treatment
88467|NCT03650634|supernumerary tooth|supernumerary tooth
88468|NCT03650634|hyperdontia|hyperdontia
88469|NCT03650634|mesiodens|mesiodens
88470|NCT03650634|paramolar|paramolar
88471|NCT03650595|MRI|mri
88472|NCT03650595|Focal Laser Ablation|focal laser ablation
88473|NCT03650595|MR-Guided Focal Laser Ablation|mr-guided focal laser ablation
88474|NCT03650582|food intake|food intake
88475|NCT03650582|energy expenditure|energy expenditure
88476|NCT03650582|central nervous system|central nervous system
88477|NCT03650582|appetite|appetite
88478|NCT03650569|Angelman Syndrome|angelman syndrome
88479|NCT03650569|Caregivers|caregivers
88480|NCT03650569|Parents|parents
88481|NCT03650569|Rare diseases|rare diseases
88482|NCT03650569|Registries|registries
88483|NCT03650530|Family-centred intervention|family-centred intervention
88484|NCT03650530|Support program|support program
88485|NCT03650530|The Family Talk Intervention|the family talk intervention
88486|NCT03650517|Laparoscopic|laparoscopic
88487|NCT03650517|Robotic|robotic
88488|NCT03650517|Right colon tumor|right colon tumor
88489|NCT03650517|Anastomosis|anastomosis
88490|NCT03650517|Intracorporeal|intracorporeal
88491|NCT03650517|Extracorporeal|extracorporeal
88492|NCT03650478|Intensive Care|intensive care
88493|NCT03650478|mechanical ventilation|mechanical ventilation
88494|NCT03650478|noninvasive ventilation|noninvasive ventilation
88495|NCT03650465|generalized anxiety|generalized anxiety
88496|NCT03650465|GAD|gad
88497|NCT03650465|worry|worry
88498|NCT03650465|CBT|cbt
88499|NCT03650465|REBT|rebt
88500|NCT03650465|ACT|act
88501|NCT03650452|Drug Therapy|drug therapy
88502|NCT03650452|Brain Diseases|brain diseases
88503|NCT03650452|Central Nervous System Diseases|central nervous system diseases
88504|NCT03650452|Tuberous Sclerosis|tuberous sclerosis
88505|NCT03650452|CDKL5 deficiency disorder|cdkl5 deficiency disorder
88506|NCT03650452|Duplication 15 Q syndrome|duplication 15 q syndrome
88507|NCT03650452|Dup15Q syndrome|dup15q syndrome
88508|NCT03650452|Anoxic brain injury|anoxic brain injury
88509|NCT03650452|Infantile spams|infantile spams
88510|NCT03650452|West syndrome|west syndrome
88511|NCT03650452|Cortical dysplasia|cortical dysplasia
88512|NCT03650452|SCN1A|scn1a
88513|NCT03650452|OV-935|ov-935
88514|NCT03650452|Cholesterol 24 hydroxylase inhibitor|cholesterol 24 hydroxylase inhibitor
88515|NCT03650452|Cholesterol 24S-hydroxylase inhibitor|cholesterol 24s-hydroxylase inhibitor
88516|NCT03650452|Seizure|seizure
88517|NCT03650452|Anti-epilepsy drug|anti-epilepsy drug
88518|NCT03650452|Anticonvulsants|anticonvulsants
88519|NCT03650452|Nervous System Diseases|nervous system diseases
88520|NCT03650452|Drop seizure|drop seizure
88521|NCT03650452|Atonic seizure|atonic seizure
88522|NCT03650400|Fevipiprant,|fevipiprant,
88523|NCT03650400|GINA 2018,|gina 2018,
88524|NCT03650400|Pediatrics|pediatrics
88525|NCT03650374|Meniscus root tear|meniscus root tear
88526|NCT03650348|HER2-positive breast cancer|her2-positive breast cancer
88527|NCT03650348|HER2-positive gastric cancer|her2-positive gastric cancer
88528|NCT03650348|HER2-positive bladder cancer|her2-positive bladder cancer
88529|NCT03650348|Pieris|pieris
88530|NCT03650348|PRS-343|prs-343
88531|NCT03650348|Anticalin|anticalin
88532|NCT03650348|Bispecific|bispecific
88533|NCT03650348|4-1BB|4-1bb
88534|NCT03650348|CD137|cd137
88535|NCT03650348|HER2|her2
88536|NCT03650348|Atezolizumab|atezolizumab
88537|NCT03650335|erector spine plan block|erector spine plan block
88538|NCT03650335|postoperative opioid consumption|postoperative opioid consumption
88539|NCT03650335|thoracotomy|thoracotomy
88540|NCT03650335|analgesia|analgesia
88541|NCT03650335|anesthesia|anesthesia
88542|NCT03650309|Deep Brain Stimulation|deep brain stimulation
88543|NCT03650309|Functional Neurosurgery|functional neurosurgery
88544|NCT03650309|Neuromodulation|neuromodulation
88545|NCT03650309|Bariatrics|bariatrics
88546|NCT03650309|Weight Loss|weight loss
88547|NCT03650309|Addiction|addiction
88548|NCT03650257|supratentorial glioma|supratentorial glioma
88549|NCT03650231|Epstein-barr virus|epstein-barr virus
88550|NCT03650231|infectious mononucleosis|infectious mononucleosis
88551|NCT03650179|urine stream interruption exercise|urine stream interruption exercise
88552|NCT03650179|voiding function|voiding function
88553|NCT03650179|pelvic floor muscles exercise|pelvic floor muscles exercise
88554|NCT03650166|mhealth|mhealth
88555|NCT03650166|short-messaging system|short-messaging system
88556|NCT03650166|self-management|self-management
88557|NCT03650166|home blood pressure monitoring|home blood pressure monitoring
88558|NCT03650166|health literacy|health literacy
88559|NCT03650140|Gout|gout
88560|NCT03650140|Tart Cherry|tart cherry
825218|NCT00133744|iron|iron
114098|NCT03490331|JEB|jeb
88561|NCT03650140|Pharmacokinetics|pharmacokinetics
88562|NCT03650127|Genetic risk score|genetic risk score
88563|NCT03650127|metabolic risk score|metabolic risk score
88564|NCT03650127|health promotion|health promotion
88565|NCT03650127|web-based|web-based
88566|NCT03650127|intervention|intervention
88567|NCT03650114|ofatumumab|ofatumumab
88568|NCT03650114|relapsing multiple sclerosis|relapsing multiple sclerosis
88569|NCT03650101|Hydrocephalus|hydrocephalus
88570|NCT03650062|Patient Reported Outcome Measures|patient reported outcome measures
88571|NCT03650062|Follow-Up Studies|follow-up studies
88572|NCT03650062|Patient Outcome Assessment|patient outcome assessment
88573|NCT03650062|Treatment Outcome|treatment outcome
88574|NCT03650062|Pancreatitis, Acute Necrotizing|pancreatitis, acute necrotizing
88575|NCT03650036|Primary teeth|primary teeth
88576|NCT03650036|Dental Pulp Necrosis|dental pulp necrosis
88577|NCT03650036|Root Canal Obturation|root canal obturation
88578|NCT03650023|Chitosan Oligosaccharide|chitosan oligosaccharide
88579|NCT03650023|diabetes mellitus|diabetes mellitus
88580|NCT03650023|blood glucose|blood glucose
88581|NCT03650023|fasting blood sugar|fasting blood sugar
88582|NCT03650023|normal blood glucose|normal blood glucose
88583|NCT03650023|impaired fasting glucose|impaired fasting glucose
88584|NCT03650023|Impaired Glucose Tolerance|impaired glucose tolerance
88585|NCT03649984|Symptom-management|symptom-management
88586|NCT03649984|Outpatients|outpatients
88587|NCT03649984|Nurse-led intervention|nurse-led intervention
88588|NCT03649984|Implementation|implementation
88589|NCT03649958|concussion|concussion
88590|NCT03649958|mTBI|mtbi
88591|NCT03649958|headache|headache
88592|NCT03649958|insomnia|insomnia
88593|NCT03649958|PTS|pts
88594|NCT03649958|anxiety|anxiety
88595|NCT03649958|pain|pain
88596|NCT03649958|depression|depression
88597|NCT03649958|sleep|sleep
88598|NCT03649932|Bronchopulmonary dysplasia|bronchopulmonary dysplasia
88599|NCT03649932|Pulmonary hypertension|pulmonary hypertension
88600|NCT03649932|Citrulline|citrulline
88601|NCT03649906|Micro-coil|micro-coil
88602|NCT03649906|CT-guided locate|ct-guided locate
88603|NCT03649893|sedentary behavior|sedentary behavior
88604|NCT03649893|phyical activity|phyical activity
88605|NCT03649893|workplace interventions|workplace interventions
88606|NCT03649893|active breaks|active breaks
88607|NCT03649893|workplace ergonomics|workplace ergonomics
88608|NCT03649854|TAPSE|tapse
88609|NCT03649854|Right heart function|right heart function
88610|NCT03649841|Prostate Cancer|prostate cancer
88611|NCT03649828|kefir|kefir
88612|NCT03649828|Probiotics|probiotics
88613|NCT03649828|Metabolic Syndrome|metabolic syndrome
88614|NCT03649828|Cardiovascular Diseases|cardiovascular diseases
88615|NCT03649828|Hypertension|hypertension
88616|NCT03649815|schizophrenia|schizophrenia
88617|NCT03649815|psychosis|psychosis
88618|NCT03649815|mHealth|mhealth
88619|NCT03649815|digital health|digital health
88620|NCT03649789|healing|healing
88621|NCT03649789|biomarkers|biomarkers
88622|NCT03649789|sanative therapy|sanative therapy
88623|NCT03649789|nutritional supplements|nutritional supplements
88624|NCT03649789|medications|medications
88625|NCT03649789|salivary flow|salivary flow
88626|NCT03649776|Disparities|disparities
88627|NCT03649711|P2Y12 inhibitors|p2y12 inhibitors
88628|NCT03649711|Platelet aggregation|platelet aggregation
88629|NCT03649711|ticagrelor|ticagrelor
88630|NCT03649711|clopidogrel|clopidogrel
88631|NCT03649711|chronic kidney disease|chronic kidney disease
88632|NCT03649698|Sarcopenia|sarcopenia
88633|NCT03649698|Nutrition|nutrition
88634|NCT03649698|Protein|protein
88635|NCT03649698|Vitamin D|vitamin d
88636|NCT03649698|Exercise|exercise
88637|NCT03649698|Older people|older people
88639|NCT03649672|Tof Watch, rocuronium|tof watch, rocuronium
88640|NCT03649646|Hypertension|hypertension
88641|NCT03649646|Fimasartan|fimasartan
88642|NCT03649633|Shock, Septic|shock, septic
88643|NCT03649633|Cerebrovascular Circulation|cerebrovascular circulation
88644|NCT03649633|Spectroscopy, Near-Infrared|spectroscopy, near-infrared
88645|NCT03649633|Patient Reported Outcome Measure|patient reported outcome measure
88646|NCT03649620|cholesterol|cholesterol
88647|NCT03649620|Bokbunja|bokbunja
88648|NCT03649620|Clinical Trial|clinical trial
88649|NCT03649529|HLA-A2|hla-a2
88650|NCT03649529|gp100|gp100
88651|NCT03649516|mHealth|mhealth
88652|NCT03649516|Mobile application|mobile application
88653|NCT03649516|Chronic Kidney Diseases|chronic kidney diseases
88654|NCT03649503|Brain Health|brain health
88655|NCT03649503|Brain Research|brain research
88656|NCT03649503|parkinsonism|parkinsonism
88657|NCT03649503|prospective cohort study|prospective cohort study
88658|NCT03649503|large sample size|large sample size
88659|NCT03649477|PWS|pws
88660|NCT03649477|Prader-Willi syndrome|prader-willi syndrome
88661|NCT03649477|carbetocin|carbetocin
825988|NCT00130442|combination|combination
88662|NCT03649464|recurrent high-grade glioma|recurrent high-grade glioma
88663|NCT03649451|Reference dose levels|reference dose levels
88664|NCT03649451|Surgery|surgery
88665|NCT03649451|C-arm|c-arm
88666|NCT03649451|Orthopedic|orthopedic
88667|NCT03649451|Urology|urology
88668|NCT03649451|Vascular|vascular
88669|NCT03649451|Neurosurgery|neurosurgery
88670|NCT03649451|Cardiology|cardiology
88671|NCT03649451|Digestive|digestive
88672|NCT03649451|Fluoroscopy|fluoroscopy
88673|NCT03649451|Patient radiation protection|patient radiation protection
88674|NCT03649451|X-ray|x-ray
88675|NCT03649451|Interventional radiology|interventional radiology
88676|NCT03649451|Optimization|optimization
88677|NCT03649451|Kerma Area Product|kerma area product
88678|NCT03649425|infection|infection
88679|NCT03649425|pin site|pin site
88680|NCT03649425|external fixator|external fixator
88681|NCT03649425|hydroxyapatite coated|hydroxyapatite coated
88682|NCT03649412|Tablet formulation|tablet formulation
88683|NCT03649412|Sequence|sequence
88684|NCT03649412|Immediate release|immediate release
88685|NCT03649412|Pharmacokinetic|pharmacokinetic
88686|NCT03649373|Shoulder|shoulder
88687|NCT03649373|Dislocation|dislocation
88688|NCT03649373|Noergaard|noergaard
88689|NCT03649373|Reduction|reduction
88690|NCT03649360|Knee pain|knee pain
88691|NCT03649360|Intramedullary tibial nail|intramedullary tibial nail
88692|NCT03649360|KOOS|koos
88693|NCT03649347|Exposure therapy|exposure therapy
88694|NCT03649347|Technology|technology
88695|NCT03649347|Telemedicine|telemedicine
88696|NCT03649308|Negative pressure wound therapy|negative pressure wound therapy
88697|NCT03649308|Skin graft|skin graft
88698|NCT03649308|split-thickness skin graft|split-thickness skin graft
88699|NCT03649282|NCPAP|ncpap
88700|NCT03649282|HFNC|hfnc
88701|NCT03649282|Preterm infants|preterm infants
88702|NCT03649282|Cardiorespiratory behaviour|cardiorespiratory behaviour
88703|NCT03649282|Non-invasive respiratory support|non-invasive respiratory support
88704|NCT03649269|Eryngium heterophyllum|eryngium heterophyllum
88705|NCT03649269|Amphipterygium adstringens|amphipterygium adstringens
88706|NCT03649269|tea|tea
88707|NCT03649256|conventional suture, barbed suture, niche, scar, cesarean section|conventional suture, barbed suture, niche, scar, cesarean section
88708|NCT03649243|Diabetes|diabetes
88709|NCT03649243|Foot wounds|foot wounds
88710|NCT03649243|oxidative stress|oxidative stress
88711|NCT03649243|inflammation|inflammation
88712|NCT03649243|propolis|propolis
88713|NCT03649204|PAD|pad
88714|NCT03649191|Advance Care Planning|advance care planning
88715|NCT03649191|Evidence-based practice|evidence-based practice
88716|NCT03649191|Sustainability|sustainability
88717|NCT03649191|Scalability|scalability
88718|NCT03649165|MEK Inhibitor|mek inhibitor
88719|NCT03649165|Selumetinib capsule|selumetinib capsule
88720|NCT03649165|Selumetinib granule|selumetinib granule
88721|NCT03649165|PK|pk
88722|NCT03649165|Bioavailibilty|bioavailibilty
88723|NCT03649165|Crossover study|crossover study
88724|NCT03649165|Open-label|open-label
88725|NCT03649165|Food effect|food effect
88726|NCT03649126|standardized structured reporting|standardized structured reporting
88727|NCT03649126|treatment decisions|treatment decisions
88728|NCT03649126|multidisciplinary team|multidisciplinary team
88729|NCT03649126|pathology|pathology
88730|NCT03649126|implementation tools|implementation tools
88731|NCT03649100|Dental implants|dental implants
88732|NCT03649100|Implant stability|implant stability
88733|NCT03649100|Osseointegration|osseointegration
88734|NCT03649100|ISQ measurement|isq measurement
88735|NCT03649074|ADHD|adhd
88736|NCT03649061|COBRA-Slim|cobra-slim
88737|NCT03649061|Accelerated access to anti-TNF|accelerated access to anti-tnf
88738|NCT03649061|treat to target|treat to target
88739|NCT03649061|remission induction|remission induction
88740|NCT03649009|Thiamine|thiamine
88741|NCT03649009|Lactate|lactate
88745|NCT03648996|type 2 diabetes|type 2 diabetes
88746|NCT03648996|hyperuricemia|hyperuricemia
88747|NCT03648983|Enhanced Lymphedema|enhanced lymphedema
88748|NCT03648970|Preeclampsia|preeclampsia
88749|NCT03648970|Pravastatin|pravastatin
88750|NCT03648970|Maternal morbidity|maternal morbidity
88751|NCT03648970|Neonatal mortality|neonatal mortality
88752|NCT03648970|Neonatal morbidity|neonatal morbidity
88753|NCT03648944|Rehabilitation Outcome|rehabilitation outcome
88755|NCT03648918|Healthy Controls|healthy controls
88756|NCT03648905|Autonomic Failure|autonomic failure
88757|NCT03648905|Parkinson's Disease|parkinson's disease
88758|NCT03648905|Multiple System Atrophy|multiple system atrophy
88759|NCT03648905|Lewy Body|lewy body
88760|NCT03648905|Catecholamines|catecholamines
88765|NCT03648879|Diagnostic|diagnostic
88766|NCT03648879|Diagnosis|diagnosis
88767|NCT03648879|EGD|egd
88768|NCT03648879|Examination of Stomach|examination of stomach
88769|NCT03648853|photoplethysmography|photoplethysmography
88770|NCT03648853|stress response|stress response
88771|NCT03648814|Neovascular glaucoma|neovascular glaucoma
88772|NCT03648775|Osteosynthesis|osteosynthesis
88773|NCT03648775|Prophylactic consolidation|prophylactic consolidation
88774|NCT03648775|Proximal femur|proximal femur
88775|NCT03648762|Heart failure|heart failure
88776|NCT03648762|Exercise|exercise
88777|NCT03648762|Cardiopulmonary|cardiopulmonary
88778|NCT03648736|FGF23, TASH|fgf23, tash
88779|NCT03648710|Sickle Cell Disease|sickle cell disease
88780|NCT03648684|Nonmedical prescription stimulant use|nonmedical prescription stimulant use
88781|NCT03648684|Expectancy challenge|expectancy challenge
88782|NCT03648684|College students|college students
88783|NCT03648671|Safinamide|safinamide
88784|NCT03648671|Pain|pain
88785|NCT03648671|Parkinson|parkinson
88786|NCT03648645|Pregnancy|pregnancy
88787|NCT03648645|Hypertension|hypertension
88788|NCT03648645|telemonitoring|telemonitoring
88789|NCT03648632|Stereotactic Radiotherapy|stereotactic radiotherapy
88790|NCT03648606|infant|infant
88791|NCT03648606|thermoregulation|thermoregulation
88792|NCT03648606|wakefulness episode|wakefulness episode
88793|NCT03648593|microenterpreneur|microenterpreneur
88794|NCT03648593|work ability|work ability
88795|NCT03648593|work recovery|work recovery
88796|NCT03648593|native mobile app|native mobile app
88797|NCT03648593|health behaviour|health behaviour
88798|NCT03648593|work|work
88799|NCT03648593|stress|stress
88800|NCT03648593|work performance|work performance
88801|NCT03648567|GLILD|glild
88802|NCT03648567|Common variable immunodeficiency|common variable immunodeficiency
88803|NCT03648567|children|children
88804|NCT03648528|Vitamin D Deficiency|vitamin d deficiency
88805|NCT03648528|hyperparathyroidism|hyperparathyroidism
88806|NCT03648528|hemodialysis|hemodialysis
88807|NCT03648515|Validity|validity
88808|NCT03648515|Reliability|reliability
88809|NCT03648515|Reproducibility|reproducibility
88810|NCT03648515|Intra-oral images|intra-oral images
88811|NCT03648515|Plaster models|plaster models
88812|NCT03648515|Digital images|digital images
88813|NCT03648515|Little's index of irregularity|little's index of irregularity
88814|NCT03648515|Bolton's analysis|bolton's analysis
88815|NCT03648515|Tooth-size-arch-length-discrepancy|tooth-size-arch-length-discrepancy
88816|NCT03648502|dementia|dementia
88817|NCT03648502|hearing loss|hearing loss
88818|NCT03648502|auditory process|auditory process
88819|NCT03648489|TAK228|tak228
88820|NCT03648489|TAK-228|tak-228
88821|NCT03648489|Paclitaxel|paclitaxel
88822|NCT03648489|Ovarian cancer|ovarian cancer
88823|NCT03648489|Platinum resistant|platinum resistant
88824|NCT03648476|Anger|anger
88825|NCT03648476|Aggression|aggression
88826|NCT03648476|Hostility|hostility
88827|NCT03648437|acetaminophen|acetaminophen
88828|NCT03648437|ibuprofen|ibuprofen
88829|NCT03648437|preterm infant|preterm infant
88830|NCT03648437|near infra-red spectroscopy|near infra-red spectroscopy
88831|NCT03648424|Linagliptin|linagliptin
88832|NCT03648424|Cardiovascular Death|cardiovascular death
88833|NCT03648424|Stroke|stroke
88834|NCT03648424|Myocardial Infarction|myocardial infarction
88835|NCT03648424|Hospitalization for Unstable Angina|hospitalization for unstable angina
88836|NCT03648424|Type 2 diabetes mellitus|type 2 diabetes mellitus
88837|NCT03648424|Glimepiride|glimepiride
88838|NCT03648411|malaria|malaria
88839|NCT03648411|falciparum|falciparum
88840|NCT03648411|vivax|vivax
88841|NCT03648411|Myanmar|myanmar
88842|NCT03648411|migrant workers|migrant workers
88843|NCT03648411|asymptomatic infection|asymptomatic infection
88844|NCT03648411|drug resistance|drug resistance
88949|NCT03647839|nivolumab|nivolumab
88845|NCT03648398|Therapeutic education program|therapeutic education program
88847|NCT03648372|Drug therapy|drug therapy
88848|NCT03648359|Prostate biopsy|prostate biopsy
88849|NCT03648359|Prostate cancer|prostate cancer
88850|NCT03648359|Magnetic resonance imaging|magnetic resonance imaging
88851|NCT03648359|Neoplasm staging|neoplasm staging
88852|NCT03648333|amlodipine|amlodipine
88853|NCT03648333|valsartan|valsartan
88854|NCT03648333|hypertension|hypertension
88855|NCT03648320|IgE mediated peanut allergy|ige mediated peanut allergy
88856|NCT03648320|Oral immunotherapy|oral immunotherapy
88857|NCT03648320|Desensitisation|desensitisation
88858|NCT03648320|GUPI|gupi
88859|NCT03648307|Splenectomy|splenectomy
88860|NCT03648307|metabolism|metabolism
88861|NCT03648307|diabetes|diabetes
88862|NCT03648307|stem cells|stem cells
88863|NCT03648307|trauma surgery|trauma surgery
88864|NCT03648294|blood pressure|blood pressure
88865|NCT03648268|brain|brain
88866|NCT03648268|networks|networks
88867|NCT03648268|schizophrenia|schizophrenia
88868|NCT03648242|pediatric obesity|pediatric obesity
88869|NCT03648242|electronic health record|electronic health record
88870|NCT03648242|clinical decision support|clinical decision support
88871|NCT03648229|glaucoma|glaucoma
88872|NCT03648229|laser|laser
88873|NCT03648229|Africa|africa
88874|NCT03648216|Sedentary Behaviour|sedentary behaviour
825989|NCT00130442|PI-88|pi-88
88875|NCT03648216|Subjective Well-Being|subjective well-being
88876|NCT03648216|University Students|university students
88877|NCT03648203|asthma|asthma
88878|NCT03648203|quality of life|quality of life
88879|NCT03648203|self-care|self-care
88880|NCT03648203|healthcare utilization|healthcare utilization
88881|NCT03648190|GT|gt
88882|NCT03648190|CD|cd
88883|NCT03648177|Behavioral Intervention|behavioral intervention
88884|NCT03648177|Medication Adherence|medication adherence
88885|NCT03648177|Psychosocial Treatment|psychosocial treatment
88886|NCT03648164|well-being|well-being
88887|NCT03648164|health behavior|health behavior
88888|NCT03648164|choice|choice
88889|NCT03648164|rest|rest
88890|NCT03648164|environment|environment
88891|NCT03648164|activity|activity
88892|NCT03648164|trust|trust
88893|NCT03648164|interpersonal relationships|interpersonal relationships
88894|NCT03648164|outlook|outlook
88895|NCT03648164|nutrition|nutrition
88896|NCT03648164|survey|survey
88897|NCT03648164|student|student
88898|NCT03648164|college|college
88899|NCT03648164|university|university
88900|NCT03648151|Radomic feature|radomic feature
88901|NCT03648151|PET|pet
88902|NCT03648151|CT|ct
88903|NCT03648125|young elite rowers|young elite rowers
88904|NCT03648112|dietary fibres|dietary fibres
88905|NCT03648112|ß-glucan|ß-glucan
88906|NCT03648112|low-density-lipoprotein-cholesterol|low-density-lipoprotein-cholesterol
88907|NCT03648112|insulin|insulin
88908|NCT03648112|fasting glucose|fasting glucose
88909|NCT03648112|microbiota|microbiota
88910|NCT03648099|Labor Pain|labor pain
88911|NCT03648099|Labor dance|labor dance
88912|NCT03648099|Music|music
88913|NCT03648099|Fear of childbirth|fear of childbirth
88914|NCT03648086|NAFLD|nafld
88915|NCT03647995|Probiotics|probiotics
88916|NCT03647995|Diarrhea|diarrhea
88917|NCT03647995|Clostridium difficile|clostridium difficile
88918|NCT03647995|Antibiotics|antibiotics
88919|NCT03647995|Antibiotic-associated diarrhea|antibiotic-associated diarrhea
88920|NCT03647995|Clostridium difficile-associated diarrhea|clostridium difficile-associated diarrhea
88921|NCT03647995|Microbial flora|microbial flora
88922|NCT03647956|Atezolizumab|atezolizumab
88923|NCT03647956|Bevacizumab|bevacizumab
88924|NCT03647956|Carboplatin|carboplatin
88925|NCT03647956|Pemetrexed|pemetrexed
88926|NCT03647956|EGFR-mutant metastatic NSCLC|egfr-mutant metastatic nsclc
88927|NCT03647904|Employment|employment
88928|NCT03647904|Self efficacy|self efficacy
88929|NCT03647891|obstructive sleep apnea|obstructive sleep apnea
88930|NCT03647891|CPAP|cpap
88931|NCT03647891|hospital readmission|hospital readmission
88932|NCT03647891|heart failure|heart failure
88933|NCT03647891|myocardial infarction|myocardial infarction
88934|NCT03647891|cardiac arrhythmia|cardiac arrhythmia
88935|NCT03647865|Computer Guided,|computer guided,
88936|NCT03647865|Osseous Genioplasty|osseous genioplasty
88937|NCT03647865|Custom Made Titanium Plates|custom made titanium plates
88938|NCT03647865|Orthognathic Surgery|orthognathic surgery
88939|NCT03647865|Genioplasty|genioplasty
88940|NCT03647865|patient Specific device|patient specific device
88941|NCT03647852|severe gastrointestinal involvement|severe gastrointestinal involvement
88942|NCT03647839|Microsatellite stable tumour|microsatellite stable tumour
88943|NCT03647839|Refractory colorectal cancer|refractory colorectal cancer
88944|NCT03647839|Tumour microenvironment|tumour microenvironment
88945|NCT03647839|Vascular Disrupting Agent|vascular disrupting agent
88946|NCT03647839|STAT3 inhibitors|stat3 inhibitors
88947|NCT03647839|PD1 inhibitors|pd1 inhibitors
88948|NCT03647839|Unresectable colorectal cancer|unresectable colorectal cancer
88950|NCT03647839|BNC105|bnc105
88951|NCT03647839|BBI-608|bbi-608
88952|NCT03647826|youth mental health|youth mental health
88953|NCT03647826|mental health prevention|mental health prevention
88954|NCT03647826|empowerment|empowerment
88955|NCT03647800|APVO436|apvo436
88956|NCT03647774|Extended release naltrexone|extended release naltrexone
88957|NCT03647774|Opioid dependence|opioid dependence
88958|NCT03647774|Recovery|recovery
88959|NCT03647774|Health economics|health economics
88960|NCT03647761|Tetra-grip|tetra-grip
88961|NCT03647761|Assisting Hand Assessment|assisting hand assessment
88962|NCT03647696|respiratory depression, opioid-induced sedation|respiratory depression, opioid-induced sedation
88963|NCT03647670|PF-04965842|pf-04965842
88964|NCT03647657|Calcitonin|calcitonin
88965|NCT03647657|Medullary thyroid carcinoma|medullary thyroid carcinoma
88966|NCT03647657|Peptide receptor radionuclide therapy|peptide receptor radionuclide therapy
88967|NCT03647657|Gastrin|gastrin
88968|NCT03647657|Cholecystokinin-2 receptor|cholecystokinin-2 receptor
88969|NCT03647644|Cardiac Surgery|cardiac surgery
88970|NCT03647644|Bleeding|bleeding
88971|NCT03647644|Transfusion|transfusion
88972|NCT03647644|Acute Normovolemic Hemodilution|acute normovolemic hemodilution
88974|NCT03647605|virtual reality|virtual reality
88975|NCT03647605|social phobia|social phobia
88976|NCT03647605|vret|vret
88977|NCT03647605|virtual reality exposure therapy|virtual reality exposure therapy
88978|NCT03647592|Non-small Cell Lung Cancer|non-small cell lung cancer
88979|NCT03647592|Bevacizumab|bevacizumab
88980|NCT03647592|Erlotinib/Gefitinib|erlotinib/gefitinib
88981|NCT03647592|EGFR mutation positive|egfr mutation positive
88982|NCT03647566|sodium fluoride|sodium fluoride
88983|NCT03647566|positron emission tomography|positron emission tomography
88984|NCT03647566|computed tomography|computed tomography
88985|NCT03647566|acute aortic syndrome|acute aortic syndrome
88986|NCT03647566|aortic dissection|aortic dissection
88987|NCT03647566|intramural haematoma|intramural haematoma
88988|NCT03647566|penetrating aortic ulcer|penetrating aortic ulcer
88989|NCT03647540|fluorescence laparoscopy|fluorescence laparoscopy
88990|NCT03647540|adenocarcinoma of the esophagogastric junction (AEG)|adenocarcinoma of the esophagogastric junction (aeg)
88991|NCT03647527|nasopharyngeal carcinoma|nasopharyngeal carcinoma
88992|NCT03647527|acute radiation oral mucositis|acute radiation oral mucositis
88993|NCT03647527|intensity modulated radiotherapy|intensity modulated radiotherapy
88994|NCT03647527|tomography radiotherapy|tomography radiotherapy
88995|NCT03647514|neoadjuvant chemotherapy|neoadjuvant chemotherapy
88996|NCT03647514|Abraxane|abraxane
88997|NCT03647514|Xeloda|xeloda
88998|NCT03647501|lumbar spinal arthrodesis|lumbar spinal arthrodesis
88999|NCT03647501|interbody cage|interbody cage
89000|NCT03647501|3D-printing|3d-printing
89001|NCT03647488|Non-small-cell lung carcinoma|non-small-cell lung carcinoma
89002|NCT03647488|Non-small-cell lung cancer|non-small-cell lung cancer
89003|NCT03647488|NSCLC|nsclc
89004|NCT03647488|epidermal growth factor receptor wild type|epidermal growth factor receptor wild type
89005|NCT03647488|EGFRwt|egfrwt
89006|NCT03647488|Anaplastic lymphoma kinase negative|anaplastic lymphoma kinase negative
89007|NCT03647488|ALK-|alk-
89008|NCT03647488|INC280|inc280
89009|NCT03647488|capmatinib and spartalizumab|capmatinib and spartalizumab
89010|NCT03647488|combination therapy|combination therapy
89011|NCT03647488|docetaxel|docetaxel
89012|NCT03647462|obstructive sleep apnea|obstructive sleep apnea
89013|NCT03647462|chronic obstructive sleep apnea|chronic obstructive sleep apnea
89014|NCT03647462|hospital readmission|hospital readmission
89015|NCT03647449|Juice fasting; methylation; microbiome; caloric restriction|juice fasting; methylation; microbiome; caloric restriction
89016|NCT03647397|asthma|asthma
89017|NCT03647397|environmental intervention|environmental intervention
89018|NCT03647397|respiratory distress|respiratory distress
89019|NCT03647397|pediatric hospitalization|pediatric hospitalization
89020|NCT03647397|pneumonia|pneumonia
89021|NCT03647397|bronchiolitis|bronchiolitis
89022|NCT03647384|Traditional Chinese medicine|traditional chinese medicine
89023|NCT03647384|Randomized clinical trial|randomized clinical trial
89024|NCT03647384|Mild-to-moderate cognitive impairment|mild-to-moderate cognitive impairment
89025|NCT03647371|Difficult Intubation|difficult intubation
89026|NCT03647371|Thyromental Height Test|thyromental height test
89027|NCT03647371|Videolaryngoscopy|videolaryngoscopy
89028|NCT03647358|Iodine-124|iodine-124
89029|NCT03647358|PET Scan|pet scan
89030|NCT03647358|18-253|18-253
89031|NCT03647345|Noninvasive brain stimulation|noninvasive brain stimulation
89032|NCT03647345|Repetitive Transcranial Magnetic Stimulation|repetitive transcranial magnetic stimulation
89033|NCT03647345|Transcranial Direct Current Stimulation|transcranial direct current stimulation
89034|NCT03647319|Noninvasive Brain Stimulation|noninvasive brain stimulation
89035|NCT03647319|Repetitive Transcranial Magnetic Stimulation|repetitive transcranial magnetic stimulation
89036|NCT03647319|Transcranial Direct Current Stimulation|transcranial direct current stimulation
89037|NCT03647306|peripheral circadian clock|peripheral circadian clock
89038|NCT03647306|central circadian clocks|central circadian clocks
89039|NCT03647306|chronotype|chronotype
89040|NCT03647306|diet|diet
89042|NCT03647293|Central Line|central line
89043|NCT03647293|Internal Jugular Vein|internal jugular vein
89045|NCT03647293|Peripherally Inserted Central Line|peripherally inserted central line
89046|NCT03647293|Ultrasound Guided|ultrasound guided
89047|NCT03647293|Pain Score|pain score
89048|NCT03647280|Neoadjuvant Chemotherapy|neoadjuvant chemotherapy
89049|NCT03647280|Abraxane|abraxane
89050|NCT03647280|Epirubicin|epirubicin
89051|NCT03647254|Anticoagulants|anticoagulants
89052|NCT03647254|Warfarin|warfarin
89055|NCT03647215|Chronic myeloid leukemia|chronic myeloid leukemia
89056|NCT03647215|chronic phase|chronic phase
89057|NCT03647215|accelerated phase|accelerated phase
89058|NCT03647215|blast phase|blast phase
89059|NCT03647215|Philadelphia chromosome-positive acute lymphoblastic leukemia|philadelphia chromosome-positive acute lymphoblastic leukemia
89060|NCT03647215|tyrosine kinase inhibitor|tyrosine kinase inhibitor
89061|NCT03647176|Cold snare polypectomy|cold snare polypectomy
89062|NCT03647176|Colorectal polyps|colorectal polyps
89063|NCT03647176|CARE Study|care study
89064|NCT03647137|freezing of gait|freezing of gait
89065|NCT03647137|amyloid|amyloid
89066|NCT03647137|cholinergic|cholinergic
89067|NCT03647137|mobility|mobility
89068|NCT03647137|PET|pet
89069|NCT03647137|imaging|imaging
89070|NCT03647137|MRI|mri
89071|NCT03647124|Mantle Cell Lymphoma|mantle cell lymphoma
89072|NCT03647124|MCL|mcl
89073|NCT03647124|Revlimid|revlimid
89074|NCT03647124|Non-Interventional|non-interventional
89075|NCT03647124|PASS|pass
89076|NCT03647124|CC-5013|cc-5013
89077|NCT03647124|Relapsed|relapsed
89078|NCT03647124|Refractory|refractory
89079|NCT03647124|TFR|tfr
89080|NCT03647124|Tumor Flare Reaction|tumor flare reaction
89081|NCT03647124|High Tumor Burden|high tumor burden
89082|NCT03647111|Non-small Cell Lung Cancer|non-small cell lung cancer
89083|NCT03647111|ALK rearranged|alk rearranged
89084|NCT03647111|Crizotinib|crizotinib
89085|NCT03647085|atrial fibrillation|atrial fibrillation
89086|NCT03647085|atrial flutter|atrial flutter
89087|NCT03647085|arrhythmia|arrhythmia
89088|NCT03647046|Keratoconus, scleral lens|keratoconus, scleral lens
89089|NCT03647033|istent|istent
89090|NCT03647033|primary angle closure|primary angle closure
89091|NCT03647020|oocyte|oocyte
89092|NCT03647020|ovarian stimulation|ovarian stimulation
89093|NCT03647020|dysmorphic cytoplasm|dysmorphic cytoplasm
89094|NCT03647007|fat percentage|fat percentage
89095|NCT03647007|physical fitness|physical fitness
89096|NCT03647007|well-being|well-being
89097|NCT03647007|small-sided games|small-sided games
89098|NCT03646994|Non-small Cell Lung Cancer|non-small cell lung cancer
89099|NCT03646994|Crizotinib|crizotinib
89100|NCT03646994|ROS1 Rearranged|ros1 rearranged
89101|NCT03646981|visceral leishmaniasis|visceral leishmaniasis
89102|NCT03646981|diagnostics|diagnostics
89103|NCT03646981|RDT|rdt
89104|NCT03646981|Eastern Africa|eastern africa
89105|NCT03646968|Anlotinib Combined With Docetaxel|anlotinib combined with docetaxel
89106|NCT03646929|facilitation technique|facilitation technique
89107|NCT03646929|multimodal evoked potentials (mmEP) in multiple sclerosis|multimodal evoked potentials (mmep) in multiple sclerosis
89108|NCT03646929|motor evoked potential (MEP) in multiple sclerosis|motor evoked potential (mep) in multiple sclerosis
89109|NCT03646890|Epidemiology|epidemiology
89110|NCT03646890|Clinical features|clinical features
89111|NCT03646890|Etiology|etiology
89112|NCT03646890|Tertiary center|tertiary center
89113|NCT03646838|International adoption|international adoption
89114|NCT03646838|Family experiences|family experiences
89115|NCT03646838|Adolescents|adolescents
89116|NCT03646838|France|france
89117|NCT03646747|head and neck|head and neck
89118|NCT03646747|radiotherapy|radiotherapy
89119|NCT03646747|magnetic resonance imaging|magnetic resonance imaging
89120|NCT03646669|Older adults|older adults
89121|NCT03646669|Asthma|asthma
89122|NCT03646669|Symptom perception|symptom perception
89123|NCT03646669|Self-management behaviors|self-management behaviors
89124|NCT03646669|Medication adherence|medication adherence
89125|NCT03646656|cardiovascular disease|cardiovascular disease
89126|NCT03646656|social support|social support
89127|NCT03646643|Atrial fibrillation|atrial fibrillation
89128|NCT03646643|Coronary sinus-left atrium connection|coronary sinus-left atrium connection
89129|NCT03646643|Ablation|ablation
89130|NCT03646630|lower abdominal surgeries|lower abdominal surgeries
89131|NCT03646630|quadratus lumborum block|quadratus lumborum block
89132|NCT03646630|caudal block|caudal block
89133|NCT03646604|Upadacitinib|upadacitinib
89134|NCT03646604|ABT-494|abt-494
89135|NCT03646604|Atopic Dermatitis|atopic dermatitis
89136|NCT03646591|gastric cancer|gastric cancer
89137|NCT03646591|neoadjuvant chemotherapy|neoadjuvant chemotherapy
89138|NCT03646591|FLOT regimen|flot regimen
89139|NCT03646578|maternal anxiety|maternal anxiety
89140|NCT03646539|Automated conversational agent|automated conversational agent
89141|NCT03646526|Amitriptyline hydrochloride|amitriptyline hydrochloride
89142|NCT03646513|THA|tha
89143|NCT03646487|pregnancy|pregnancy
89144|NCT03646487|iron status|iron status
89145|NCT03646487|structural violence|structural violence
89146|NCT03646461|oropharyngeal|oropharyngeal
89147|NCT03646448|Internet Use Disorders|internet use disorders
89148|NCT03646448|Brief Intervention|brief intervention
89149|NCT03646448|Motivational Interviewing|motivational interviewing
89150|NCT03646448|CBT|cbt
89151|NCT03646448|Proactive|proactive
89152|NCT03646435|inpatients|inpatients
89153|NCT03646435|wearables|wearables
89154|NCT03646435|continuous monitoring|continuous monitoring
89155|NCT03646383|benign thyroid nodule|benign thyroid nodule
89156|NCT03646383|radiofrequency|radiofrequency
89157|NCT03646383|symptomatic thyroid nodule|symptomatic thyroid nodule
89158|NCT03646357|Infarction|infarction
89159|NCT03646357|Myocardial Infarction|myocardial infarction
89160|NCT03646357|ST Elevation Myocardial Infarction|st elevation myocardial infarction
89161|NCT03646357|Non-ST Elevated Myocardial Infarction|non-st elevated myocardial infarction
89162|NCT03646357|Ischemia|ischemia
89163|NCT03646357|Myocardial Ischemia|myocardial ischemia
89164|NCT03646357|Heart Diseases|heart diseases
89165|NCT03646357|Cardiovascular Diseases|cardiovascular diseases
89166|NCT03646357|Metoprolol|metoprolol
89167|NCT03646357|Bisoprolol|bisoprolol
89168|NCT03646357|Betablocker|betablocker
89169|NCT03646357|Anti-Arrhythmia Agents|anti-arrhythmia agents
89170|NCT03646357|Physiological Effects of Drugs|physiological effects of drugs
89171|NCT03646357|Beta-blocker|beta-blocker
89172|NCT03646357|Beta blocker|beta blocker
89173|NCT03646344|Deceased donor renal transplantation|deceased donor renal transplantation
89174|NCT03646344|Heme Arginate|heme arginate
89175|NCT03646344|Delayed graft function|delayed graft function
89176|NCT03646253|Proximal humerus fracture|proximal humerus fracture
89177|NCT03646227|Carbapenem-resistant enterobacteriaceae (CRE)|carbapenem-resistant enterobacteriaceae (cre)
89178|NCT03646227|Carbapenem-resistant Pseudomonas aeruginosa (CRPA)|carbapenem-resistant pseudomonas aeruginosa (crpa)
89179|NCT03646227|Klebsiella pneumoniae|klebsiella pneumoniae
89180|NCT03646227|Acinetobacter baumannii (CRAb)|acinetobacter baumannii (crab)
89181|NCT03646227|Bloodstream infection (BSI)|bloodstream infection (bsi)
89182|NCT03646227|Microbiological characterization|microbiological characterization
89183|NCT03646201|childhood|childhood
89184|NCT03646201|obesity|obesity
89185|NCT03646201|nutrition|nutrition
89186|NCT03646201|intervention|intervention
89187|NCT03646201|portion size|portion size
89188|NCT03646201|behavioral|behavioral
89189|NCT03646201|environmental|environmental
89190|NCT03646201|feeding practices|feeding practices
89191|NCT03646175|Choline|choline
89192|NCT03646175|Trimethylamine N-Oxide|trimethylamine n-oxide
89193|NCT03646175|Vascular health|vascular health
89194|NCT03646149|Social Skills|social skills
89195|NCT03646149|Housing|housing
89196|NCT03646123|Brentuximab vedotin|brentuximab vedotin
89197|NCT03646123|Doxorubicin|doxorubicin
89198|NCT03646123|Vinblastine|vinblastine
89199|NCT03646123|Dacarbazine|dacarbazine
89200|NCT03646123|Nivolumab|nivolumab
89201|NCT03646110|esophageal cancer|esophageal cancer
89202|NCT03646110|Minimally invasive esophagectomy (MIE)|minimally invasive esophagectomy (mie)
89203|NCT03646110|single-incision Minimally invasive esophagectomy (SIMIE)|single-incision minimally invasive esophagectomy (simie)
89204|NCT03646097|OCT|oct
89205|NCT03646097|Co-Registration|co-registration
89206|NCT03646097|Stent|stent
89207|NCT03646097|PCI|pci
89208|NCT03646097|Geographical mismatch|geographical mismatch
89209|NCT03646097|Edge Dissection|edge dissection
89210|NCT03646084|pain|pain
89211|NCT03646084|sleep|sleep
89212|NCT03646084|circadian rhythm|circadian rhythm
89213|NCT03646071|Locally Advanced|locally advanced
89214|NCT03646071|Metastatic|metastatic
89215|NCT03646071|Solid Tumor|solid tumor
89216|NCT03646058|Treatment|treatment
89217|NCT03646058|Suicidal ideas|suicidal ideas
89218|NCT03646058|Depression|depression
89219|NCT03646058|Buprenorphine|buprenorphine
89220|NCT03646058|Opioid agonist|opioid agonist
89221|NCT03646058|Mental pain|mental pain
89222|NCT03646019|Coronary artery disease|coronary artery disease
89223|NCT03646019|paraoxanase 1|paraoxanase 1
89224|NCT03646019|Thiobarbituric Acid Reactive Substances|thiobarbituric acid reactive substances
89225|NCT03646019|Thiol groups|thiol groups
89226|NCT03645993|Early-Onset Alzheimer's disease|early-onset alzheimer's disease
89227|NCT03645980|DKN-01|dkn-01
89228|NCT03645980|Hepatocellular Carcinoma|hepatocellular carcinoma
89229|NCT03645980|WNT signaling|wnt signaling
89230|NCT03645954|Femoral triangle block|femoral triangle block
89231|NCT03645954|Adductor canal block|adductor canal block
89232|NCT03645954|Femoral nerve block|femoral nerve block
89233|NCT03645954|Primary total knee arthroplasty|primary total knee arthroplasty
89234|NCT03645954|Pain management|pain management
89235|NCT03645954|Functional recovery|functional recovery
89236|NCT03645941|Social Media|social media
89237|NCT03645941|Alaska Native|alaska native
89238|NCT03645928|LN-144|ln-144
89239|NCT03645928|LN-145|ln-145
89244|NCT03645928|Tumor Infiltrating Lymphocytes|tumor infiltrating lymphocytes
89246|NCT03645928|IL-2|il-2
89247|NCT03645928|Multiple Tumor Type|multiple tumor type
89248|NCT03645928|Lifileucel|lifileucel
89249|NCT03645928|Pembrolizumab|pembrolizumab
89250|NCT03645915|glut1|glut1
89251|NCT03645915|biomarkers|biomarkers
89252|NCT03645915|diagnosis|diagnosis
89253|NCT03645902|Acute stroke|acute stroke
89254|NCT03645902|Susceptibility-weighted imaging|susceptibility-weighted imaging
89255|NCT03645902|Arterial occlusion|arterial occlusion
89256|NCT03645902|Time of flight|time of flight
89257|NCT03645889|Traditional Chinese Medicine|traditional chinese medicine
89258|NCT03645876|SHR-1210|shr-1210
89259|NCT03645876|BP102|bp102
89260|NCT03645876|Phase II|phase ii
89266|NCT03645811|anxiety|anxiety
89267|NCT03645811|OSCE|osce
89268|NCT03645811|EFT|eft
89269|NCT03645811|breath|breath
89270|NCT03645811|music|music
89271|NCT03645798|burnout|burnout
89272|NCT03645798|turnover intention|turnover intention
89273|NCT03645798|job performance|job performance
89274|NCT03645798|job satisfaction|job satisfaction
89275|NCT03645798|resilience|resilience
89276|NCT03645798|self-efficacy|self-efficacy
89277|NCT03645798|coping style|coping style
89278|NCT03645798|cortisol|cortisol
114918|NCT03484923|ACZ885|acz885
89279|NCT03645798|nurse|nurse
89280|NCT03645759|behavioral treatment|behavioral treatment
89281|NCT03645759|telehealth|telehealth
89282|NCT03645759|stroke self-management|stroke self-management
89283|NCT03645759|psychological distress|psychological distress
89284|NCT03645759|social integration|social integration
89285|NCT03645733|Haemodialysis|haemodialysis
89286|NCT03645733|Kidney Disease|kidney disease
89287|NCT03645733|Mental Health|mental health
89288|NCT03645733|Cognitive Impairment|cognitive impairment
89289|NCT03645707|Critical Care Nurse|critical care nurse
89290|NCT03645707|Resilience|resilience
89291|NCT03645707|Stress Mindset|stress mindset
89292|NCT03645694|Caregiving|caregiving
89293|NCT03645694|Technology|technology
89294|NCT03645694|Social support|social support
89295|NCT03645681|Vascular Access|vascular access
89296|NCT03645681|Hemodialysis Access|hemodialysis access
89297|NCT03645681|End Stage Renal Disease|end stage renal disease
89298|NCT03645681|Kidney Failure|kidney failure
89299|NCT03645681|Hemodialysis|hemodialysis
89300|NCT03645681|Arteriovenous Graft|arteriovenous graft
89301|NCT03645681|AVG|avg
89302|NCT03645681|Cannulation|cannulation
89303|NCT03645681|Quick Sealing dialysis graft|quick sealing dialysis graft
89304|NCT03645668|sepsis，meropenem，2 steps administration|sepsis，meropenem，2 steps administration
89305|NCT03645655|hepatoblastoma|hepatoblastoma
89306|NCT03645655|Hepatic Hemangioendothelioma|hepatic hemangioendothelioma
89307|NCT03645655|Protein induced by vitamin K absence or antagonist-II|protein induced by vitamin k absence or antagonist-ii
89308|NCT03645655|Alpha-fetoprotein|alpha-fetoprotein
89309|NCT03645655|infant|infant
89310|NCT03645655|Differential diagnosis|differential diagnosis
89311|NCT03645616|Musculoskeletal disease|musculoskeletal disease
89312|NCT03645616|Stress test|stress test
89313|NCT03645616|Reproducibility|reproducibility
89314|NCT03645616|Gait Speed|gait speed
89315|NCT03645603|pediatrics|pediatrics
89316|NCT03645603|dexmedetomidine|dexmedetomidine
89317|NCT03645603|analgesia|analgesia
89318|NCT03645603|sedation|sedation
89319|NCT03645603|pediatric intensive care unit|pediatric intensive care unit
89320|NCT03645603|abstinence syndrome|abstinence syndrome
89321|NCT03645603|assessment tool|assessment tool
89322|NCT03645577|Pulmonary vein isolation|pulmonary vein isolation
89323|NCT03645577|Phrenic nerve palsy|phrenic nerve palsy
89324|NCT03645577|Paroxysmal atrial fibrillation|paroxysmal atrial fibrillation
89325|NCT03645577|Persistent atrial fibrillation|persistent atrial fibrillation
89326|NCT03645564|Stroke|stroke
89327|NCT03645564|Anti-vitamin K|anti-vitamin k
89328|NCT03645564|Direct anti-coagulant|direct anti-coagulant
89329|NCT03645564|Nurse|nurse
89330|NCT03645551|dentistry|dentistry
89331|NCT03645551|laminate veneer|laminate veneer
89332|NCT03645551|existing restoration|existing restoration
89333|NCT03645551|survival|survival
89334|NCT03645538|Parkinson's disease|parkinson's disease
89335|NCT03645538|Healthy subjects|healthy subjects
89336|NCT03645525|Bronchopulmonary Dysplasia|bronchopulmonary dysplasia
89337|NCT03645525|Mesenchymal stem cell|mesenchymal stem cell
89338|NCT03645512|Resilience|resilience
89339|NCT03645512|High Performance|high performance
89340|NCT03645512|Critical Care Nurse|critical care nurse
89341|NCT03645486|Chronic granulomatous disease|chronic granulomatous disease
89342|NCT03645486|Lentiviral vector|lentiviral vector
89343|NCT03645460|Adenosine deaminase severe combined immunodeficiency lentiviral vector|adenosine deaminase severe combined immunodeficiency lentiviral vector
89344|NCT03645447|Depression|depression
89345|NCT03645447|Diagnostic aid|diagnostic aid
89346|NCT03645447|Taste|taste
89347|NCT03645434|Moderate to severe COPD|moderate to severe copd
89348|NCT03645434|Muscarinic receptor antagonist|muscarinic receptor antagonist
89349|NCT03645434|β2 adrenoceptor agonist (MABA)|β2 adrenoceptor agonist (maba)
89350|NCT03645434|Long-acting muscarinic antagonist (LAMA)|long-acting muscarinic antagonist (lama)
89351|NCT03645434|Long-acting β2-agonist (LABA)|long-acting β2-agonist (laba)
89352|NCT03645434|Inhaled long-acting bronchodilator|inhaled long-acting bronchodilator
89353|NCT03645434|Small airways disease (obstructive bronchiolitis)|small airways disease (obstructive bronchiolitis)
89354|NCT03645434|Parenchymal destruction (emphysema),|parenchymal destruction (emphysema),
89355|NCT03645421|Diabetes|diabetes
89356|NCT03645421|MEDI0382|medi0382
89357|NCT03645421|D5674C00001|d5674c00001
89358|NCT03645421|T2DM|t2dm
89359|NCT03645421|Type 2 Diabetes|type 2 diabetes
89360|NCT03645408|exenatide|exenatide
89361|NCT03645408|alcohol craving|alcohol craving
89362|NCT03645408|alcohol consumption|alcohol consumption
89363|NCT03645382|overweight|overweight
89364|NCT03645382|body fat|body fat
89365|NCT03645382|diabetic,|diabetic,
89366|NCT03645382|obersity|obersity
89367|NCT03645382|diabetes mellitus|diabetes mellitus
89368|NCT03645382|DM|dm
89369|NCT03645382|glycemic|glycemic
89370|NCT03645369|subcutaneous heparin|subcutaneous heparin
89371|NCT03645369|injection pain|injection pain
89372|NCT03645369|ecchymosis|ecchymosis
89373|NCT03645330|Atezolizumab|atezolizumab
89374|NCT03645291|insect sting allergy|insect sting allergy
89375|NCT03645291|Hymenoptera allergy|hymenoptera allergy
89376|NCT03645291|local insect allergen extracts|local insect allergen extracts
89377|NCT03645265|speech rhythm|speech rhythm
89378|NCT03645265|speech therapy|speech therapy
89379|NCT03645239|Postoperative pain|postoperative pain
89380|NCT03645239|Cesarean delivery|cesarean delivery
89381|NCT03645239|Postoperative nausea and vomiting|postoperative nausea and vomiting
89382|NCT03645226|Idiopathic REM sleep|idiopathic rem sleep
89383|NCT03645226|Parkinson's disease|parkinson's disease
89384|NCT03645226|Gut microbiota|gut microbiota
89385|NCT03645226|Syncleinpathy|syncleinpathy
89386|NCT03645213|School-age children|school-age children
89387|NCT03645213|pain|pain
89388|NCT03645213|fear|fear
89389|NCT03645213|venipuncture|venipuncture
89390|NCT03645213|distraction|distraction
89391|NCT03645200|TP53|tp53
89392|NCT03645200|Solid tumor|solid tumor
89393|NCT03645200|Fluzoparib|fluzoparib
89394|NCT03645200|Apatinib|apatinib
89395|NCT03645174|intubation|intubation
89396|NCT03645174|Aintree|aintree
89397|NCT03645174|Laryngeal mask airway|laryngeal mask airway
89398|NCT03645174|fiberoptic|fiberoptic
89399|NCT03645148|Neoantigen, Pancreatic Cancer, iNeo-Vac-P01,Peptide Vaccine|neoantigen, pancreatic cancer, ineo-vac-p01,peptide vaccine
89400|NCT03645122|Spike timing-dependent plasticity|spike timing-dependent plasticity
89401|NCT03645122|cerebrovasculor accident|cerebrovasculor accident
89402|NCT03645122|paralysis|paralysis
89403|NCT03645122|hemiparesis|hemiparesis
89404|NCT03645122|stimulation|stimulation
89405|NCT03645096|Depression|depression
89406|NCT03645096|Pregnenolone|pregnenolone
89407|NCT03645096|Women|women
89408|NCT03645070|atrial-esophageal fistula|atrial-esophageal fistula
89409|NCT03645070|radiofrequency ablation|radiofrequency ablation
89410|NCT03645070|Atrial Fibrillation ablation|atrial fibrillation ablation
89411|NCT03645044|HBV sAg loss/seroconversion|hbv sag loss/seroconversion
89412|NCT03645044|"HBV e antigen (eAg) loss/seroconversion"|"hbv e antigen (eag) loss/seroconversion"
89413|NCT03645044|antiretroviral therapy|antiretroviral therapy
89414|NCT03645031|acute intermittent hypoxia (AIH)|acute intermittent hypoxia (aih)
89415|NCT03645031|respiratory motor function|respiratory motor function
89416|NCT03645031|hypoxia|hypoxia
89417|NCT03645031|normoxia|normoxia
89418|NCT03645031|EMG (electromyography)|emg (electromyography)
89419|NCT03645018|lung|lung
89420|NCT03645018|cancer|cancer
89421|NCT03645018|early diagnosis|early diagnosis
89422|NCT03645018|DTS|dts
89423|NCT03645005|eHealth|ehealth
89424|NCT03645005|Health Related Quality of Life|health related quality of life
89425|NCT03645005|Symptom Burden|symptom burden
89426|NCT03645005|Breast Cancer|breast cancer
89427|NCT03645005|Hispanic|hispanic
89428|NCT03644966|Probiotics|probiotics
89429|NCT03644966|multi-drug resistant UTI|multi-drug resistant uti
89430|NCT03644966|recurrent UTI|recurrent uti
89431|NCT03644953|Hydroxyurea|hydroxyurea
89432|NCT03644953|Transfusion|transfusion
89433|NCT03644940|Dascena|dascena
89434|NCT03644940|patient mortality|patient mortality
89435|NCT03644940|machine learning|machine learning
89436|NCT03644940|algorithm|algorithm
89437|NCT03644940|diagnostic|diagnostic
89438|NCT03644927|Veterans|veterans
89439|NCT03644927|Cardiopulmonary exercise testing|cardiopulmonary exercise testing
89440|NCT03644927|Exercise maintenance|exercise maintenance
89441|NCT03644927|Neuropeptide Y (NPY)|neuropeptide y (npy)
89442|NCT03644927|Exercise-related intrinsic motivation|exercise-related intrinsic motivation
89443|NCT03644927|Exercise Self efficacy|exercise self efficacy
89444|NCT03644927|Transtheoretical Model (TTM)|transtheoretical model (ttm)
89445|NCT03644927|Self-Determination Theory (SDT)|self-determination theory (sdt)
89446|NCT03644914|Reading|reading
89447|NCT03644914|1st grade|1st grade
89448|NCT03644914|Literacy|literacy
89449|NCT03644888|COPD|copd
89450|NCT03644888|Vibration|vibration
89451|NCT03644888|Rehabilitation|rehabilitation
89452|NCT03644849|Leg Ulcer|leg ulcer
89453|NCT03644849|Lower extremity ulcer|lower extremity ulcer
89454|NCT03644849|carbon dioxide laser|carbon dioxide laser
89455|NCT03644849|CO2 Laser|co2 laser
89456|NCT03644849|Ablative fractional carbon dioxide lasers|ablative fractional carbon dioxide lasers
89457|NCT03644823|radiotherapy|radiotherapy
89458|NCT03644823|PD1-inhibitor|pd1-inhibitor
89459|NCT03644758|Firefighter|firefighter
89460|NCT03644758|Sleep|sleep
89461|NCT03644758|Sleep disorders|sleep disorders
89462|NCT03644758|Pittsburgh Sleep Quality Index (PSQI)|pittsburgh sleep quality index (psqi)
89463|NCT03644758|Epworth Sleepiness Scale|epworth sleepiness scale
89464|NCT03644758|Insomnia Severity Index (ISI)|insomnia severity index (isi)
89465|NCT03644758|stop-BANG questionnaire|stop-bang questionnaire
89466|NCT03644745|Aging|aging
89467|NCT03644732|Cognition|cognition
89468|NCT03644719|Substance Abuse|substance abuse
89469|NCT03644719|Cognitive behavioral treatment|cognitive behavioral treatment
89470|NCT03644719|Ketamine|ketamine
89471|NCT03644719|Stage of Change|stage of change
89472|NCT03644693|Angelman Syndrome|angelman syndrome
89473|NCT03644693|Ketosis|ketosis
89474|NCT03644693|Children|children
89475|NCT03644667|heart transplant recipients|heart transplant recipients
89476|NCT03644667|alloimmunity|alloimmunity
89477|NCT03644667|anti-inflammatory|anti-inflammatory
89478|NCT03644667|tocilizumab|tocilizumab
89479|NCT03644667|efficacy clinical trial|efficacy clinical trial
89480|NCT03644667|immunosuppression (IS)|immunosuppression (is)
89481|NCT03644654|fluid responsiveness, haemodynamical monitoring, ClearSight|fluid responsiveness, haemodynamical monitoring, clearsight
89482|NCT03644641|Desflurane|desflurane
89483|NCT03644641|Near-infrared spectroscopy|near-infrared spectroscopy
89484|NCT03644641|Propofol|propofol
89485|NCT03644641|Spinal surgery|spinal surgery
89486|NCT03644641|Prone position|prone position
89487|NCT03644641|Visual acuity|visual acuity
89488|NCT03644641|Visual loss|visual loss
89489|NCT03644615|Osteoarthritis|osteoarthritis
89490|NCT03644615|Mindfulness|mindfulness
89491|NCT03644615|MBSR|mbsr
89492|NCT03644602|low FODMAPs diet|low fodmaps diet
89493|NCT03644602|Adherence|adherence
89494|NCT03644602|Inflammatory Bowel Diseases|inflammatory bowel diseases
89495|NCT03644602|Irritable Bowel Syndrome|irritable bowel syndrome
89496|NCT03644602|Coeliac Disease|coeliac disease
89497|NCT03644589|Cisplatin|cisplatin
89498|NCT03644589|Pembrolizumab|pembrolizumab
89499|NCT03644589|Keytruda|keytruda
89500|NCT03644589|Triple Negative Breast Cancer|triple negative breast cancer
89501|NCT03644589|Immune-Checkpoint Inhibitor|immune-checkpoint inhibitor
89502|NCT03644589|Metastatic Breast Cancer|metastatic breast cancer
89503|NCT03644589|Breast Carcinoma|breast carcinoma
89504|NCT03644589|Recurrent Breast Cancer|recurrent breast cancer
89505|NCT03644576|Ozanimod|ozanimod
89506|NCT03644576|Pseudoephedrine|pseudoephedrine
89507|NCT03644576|Healthy Adult Subjects|healthy adult subjects
89508|NCT03644563|Oral HPV|oral hpv
89509|NCT03644563|Persistent oncogenic HPV infection|persistent oncogenic hpv infection
89510|NCT03644563|Oropharyngeal cancer (OPC)|oropharyngeal cancer (opc)
89511|NCT03644563|HPV serum E6 antibody|hpv serum e6 antibody
89512|NCT03644563|HPV Screening Study|hpv screening study
89513|NCT03644550|Checkpoint Inhibitor|checkpoint inhibitor
89514|NCT03644550|Immunotherapy|immunotherapy
89515|NCT03644524|heat therapy|heat therapy
89516|NCT03644524|blood pressure|blood pressure
89517|NCT03644524|oral glucose tolerance test|oral glucose tolerance test
89518|NCT03644524|adipose tissue|adipose tissue
89519|NCT03644524|muscle sympathetic nerve activity|muscle sympathetic nerve activity
89520|NCT03644511|HCC|hcc
89521|NCT03644511|Liver cancer|liver cancer
89522|NCT03644511|Live cell carcinoma|live cell carcinoma
89523|NCT03644498|influenza|influenza
89524|NCT03644498|myositis|myositis
89525|NCT03644498|myocarditis|myocarditis
89526|NCT03644498|rhabdomyolysis|rhabdomyolysis
89527|NCT03644498|checkpoint inhibitors|checkpoint inhibitors
89528|NCT03644485|kidney transplant|kidney transplant
89529|NCT03644485|Tacrolimus|tacrolimus
89530|NCT03644485|Prograf|prograf
89531|NCT03644485|Advagraf|advagraf
89532|NCT03644485|FK506|fk506
89533|NCT03644472|dietary nitrate supplementation|dietary nitrate supplementation
89534|NCT03644472|beetroot juice|beetroot juice
89535|NCT03644459|Tolerability|tolerability
89536|NCT03644459|Safety|safety
89540|NCT03644446|Bisoprolol|bisoprolol
89541|NCT03644420|Osteoarthritis|osteoarthritis
89542|NCT03644420|Knee|knee
89543|NCT03644420|Bone|bone
89544|NCT03644420|Bone Marrow|bone marrow
89545|NCT03644420|Magnetic Resonance Imaging|magnetic resonance imaging
89546|NCT03644407|registry|registry
89547|NCT03644407|scoliosis|scoliosis
89548|NCT03644407|disc disease|disc disease
89549|NCT03644407|spinal fracture|spinal fracture
89550|NCT03644407|spinal fusion|spinal fusion
89551|NCT03644407|spine surgery|spine surgery
89552|NCT03644368|cervical phlegmon|cervical phlegmon
89553|NCT03644368|tonsillar abscesses|tonsillar abscesses
89554|NCT03644368|retropharyngeal or parapharyngeal abscesses|retropharyngeal or parapharyngeal abscesses
89555|NCT03644368|medical and chirurgical treatment|medical and chirurgical treatment
89556|NCT03644368|Bacteria in deep neck infections|bacteria in deep neck infections
89557|NCT03644342|cervical cancer|cervical cancer
89558|NCT03644342|Niraparib|niraparib
89559|NCT03644342|radiotherapy|radiotherapy
89560|NCT03644342|carcinoma of the cervix|carcinoma of the cervix
89561|NCT03644329|Breast Cancer Survivors|breast cancer survivors
89562|NCT03644329|resistance Training|resistance training
89563|NCT03644329|fatigability|fatigability
89564|NCT03644329|Body Composition|body composition
89565|NCT03644329|Functional capacity|functional capacity
89566|NCT03644290|vascular ischemic lesion|vascular ischemic lesion
89567|NCT03644264|Chronic Kidney Disease|chronic kidney disease
89568|NCT03644264|Hyperphosphatemia|hyperphosphatemia
89569|NCT03644264|Dialysis|dialysis
89570|NCT03644212|Polycystic Ovary Syndrome|polycystic ovary syndrome
89571|NCT03644212|Vitamin D|vitamin d
89572|NCT03644212|Anti Mullerian Hormone|anti mullerian hormone
89573|NCT03644212|Soluble receptor for Advanced Glycation End Products|soluble receptor for advanced glycation end products
89574|NCT03644199|Gastric emptying|gastric emptying
89575|NCT03644199|Cystic Fibrosis related diabetes|cystic fibrosis related diabetes
89576|NCT03644199|Incretins|incretins
89579|NCT03644173|integrative medicine|integrative medicine
89580|NCT03644173|cancer patients|cancer patients
89581|NCT03644160|Physical activity|physical activity
89582|NCT03644160|Behaviour Change|behaviour change
89583|NCT03644160|Physiotherapy|physiotherapy
89584|NCT03644134|Type 2 Diabetes, Physiological Stress, Sleep Pattern|type 2 diabetes, physiological stress, sleep pattern
89585|NCT03644056|IMC-001|imc-001
89586|NCT03644030|FFM index|ffm index
89587|NCT03644030|tissue edema index [extracellular / total water - ECW / TBW]|tissue edema index [extracellular / total water - ecw / tbw]
89588|NCT03644030|phase angle|phase angle
89589|NCT03644017|Dialysis|dialysis
89590|NCT03644017|Venous Stenosis|venous stenosis
89591|NCT03644017|Venous Occlusion|venous occlusion
89592|NCT03644017|Stent Graft|stent graft
89593|NCT03643991|Agitation|agitation
89594|NCT03643991|Dementia|dementia
89595|NCT03643991|Inpatient|inpatient
89596|NCT03643978|Decision aids|decision aids
89597|NCT03643965|IgA Nephropathy|iga nephropathy
89598|NCT03643952|methicillin-resistant S. aureus (MRSA) infections|methicillin-resistant s. aureus (mrsa) infections
89599|NCT03643952|complicated skin and soft tissue infections (cSSTI)|complicated skin and soft tissue infections (cssti)
89600|NCT03643939|respiratory insufficiency|respiratory insufficiency
89601|NCT03643939|respiratory failure|respiratory failure
89602|NCT03643939|non-invasive ventilation|non-invasive ventilation
89603|NCT03643939|high flow nasal cannula|high flow nasal cannula
89604|NCT03643939|nasal high flow|nasal high flow
89605|NCT03643939|trans-nasal insufflation|trans-nasal insufflation
89606|NCT03643939|NIV|niv
89607|NCT03643939|HFNC|hfnc
89608|NCT03643926|ankle|ankle
89609|NCT03643926|instability|instability
89610|NCT03643926|brostrom|brostrom
89611|NCT03643926|open|open
89612|NCT03643926|arthroscopic|arthroscopic
89613|NCT03643874|Single-dose disposable dry powder inhaler|single-dose disposable dry powder inhaler
89614|NCT03643861|SBRT|sbrt
89615|NCT03643861|Breast cancer|breast cancer
89616|NCT03643861|Early stage|early stage
89617|NCT03643861|Radiation therapy|radiation therapy
89618|NCT03643822|ACB adjuncts|acb adjuncts
89619|NCT03643822|Dexamethasone|dexamethasone
89620|NCT03643822|Dexmedetomidine|dexmedetomidine
89621|NCT03643822|post operative analgesia|post operative analgesia
89622|NCT03643809|Systemic autoinflammatory diseases (SAIDs)|systemic autoinflammatory diseases (saids)
89623|NCT03643783|Bariatric Surgery|bariatric surgery
89624|NCT03643783|Prorenin|prorenin
89625|NCT03643783|Hypertension|hypertension
89626|NCT03643783|Obesity|obesity
89627|NCT03643770|hypoxia|hypoxia
89628|NCT03643757|Blood gas analysis|blood gas analysis
89629|NCT03643757|Epidural analgesia|epidural analgesia
89630|NCT03643757|Lung cancer|lung cancer
89631|NCT03643757|Respiratory function tests|respiratory function tests
89632|NCT03643757|Thoracotomy|thoracotomy
89633|NCT03643744|Actinic Keratosis|actinic keratosis
89634|NCT03643744|Photodynamic Therapy|photodynamic therapy
89635|NCT03643705|Implementation Science|implementation science
89636|NCT03643705|Cardiovascular Disease|cardiovascular disease
89637|NCT03643705|Prevention|prevention
89638|NCT03643692|Diabetes Mellitus|diabetes mellitus
89639|NCT03643692|blood glucose|blood glucose
89640|NCT03643692|environmental case parameters|environmental case parameters
89641|NCT03643653|Bronchiectasis|bronchiectasis
89642|NCT03643653|multi-centered registry|multi-centered registry
89643|NCT03643614|adipose derived stromal cells|adipose derived stromal cells
89644|NCT03643614|stromal vascular fraction|stromal vascular fraction
89645|NCT03643614|mesenchymal stem cells|mesenchymal stem cells
89646|NCT03643614|rectovaginal fistula|rectovaginal fistula
89647|NCT03643601|erythropoiesis stimulating agent|erythropoiesis stimulating agent
89648|NCT03643601|chronic kidney disease associated anemia|chronic kidney disease associated anemia
89649|NCT03643601|ASP1517|asp1517
89650|NCT03643588|Hyaluronan|hyaluronan
89651|NCT03643588|synovial fluid supplement|synovial fluid supplement
89652|NCT03643562|Niemann-Pick|niemann-pick
89653|NCT03643562|NPC1|npc1
89655|NCT03643549|Temozolomide|temozolomide
89656|NCT03643549|Bortezomib|bortezomib
89657|NCT03643549|Recurrent disease|recurrent disease
89658|NCT03643536|left ventricular ejection fraction; quality of life|left ventricular ejection fraction; quality of life
89659|NCT03643523|anastomitic leak, infectious complications, colorectal surgery|anastomitic leak, infectious complications, colorectal surgery
89660|NCT03643510|Hormone Receptor Positive|hormone receptor positive
89661|NCT03643510|Fulvestrant|fulvestrant
89662|NCT03643510|Abemaciclib|abemaciclib
89663|NCT03643510|18-107|18-107
89664|NCT03643484|Lung Diseases, Interstitial|lung diseases, interstitial
89665|NCT03643484|Radiation Pneumonitis|radiation pneumonitis
89666|NCT03643458|NIRS|nirs
89667|NCT03643458|TANEC|tanec
89668|NCT03643458|splanchnic oxygenation|splanchnic oxygenation
89669|NCT03643458|enteral feeding|enteral feeding
89670|NCT03643458|preterm infants|preterm infants
89671|NCT03643445|motivational Interviewing; motivation|motivational interviewing; motivation
89672|NCT03643445|psychoeducation; psychoeducational-oriented treatment|psychoeducation; psychoeducational-oriented treatment
89673|NCT03643367|Sepsis|sepsis
89674|NCT03643367|Septic Shock|septic shock
89675|NCT03643367|Sevoflurane Conditioning|sevoflurane conditioning
89676|NCT03643341|Family-based|family-based
89677|NCT03643341|Community-based|community-based
89678|NCT03643341|Healthy Weights|healthy weights
89679|NCT03643328|Staphylococcus Aureus|staphylococcus aureus
89680|NCT03643328|haemodialysis|haemodialysis
89681|NCT03643328|vaccine|vaccine
89682|NCT03643328|immune response|immune response
89683|NCT03643315|Appetite regulation|appetite regulation
89684|NCT03643315|Eating behaviour|eating behaviour
89685|NCT03643315|Exercise|exercise
89686|NCT03643315|HIIT|hiit
89687|NCT03643276|Acute Lymphoblastic Leukemia|acute lymphoblastic leukemia
89688|NCT03643276|Childhood|childhood
89689|NCT03643276|Pediatric|pediatric
89690|NCT03643276|Immunotherapy|immunotherapy
89691|NCT03643276|Blinatumomab|blinatumomab
89692|NCT03643276|Proteasome Inhibitor|proteasome inhibitor
89693|NCT03643276|Bispecific antibody|bispecific antibody
89694|NCT03643276|Bortezomib|bortezomib
89695|NCT03643276|Chemotherapy|chemotherapy
89696|NCT03643276|Randomized trial|randomized trial
89697|NCT03643237|video game|video game
89698|NCT03643237|older adults|older adults
89699|NCT03643237|active aging|active aging
89700|NCT03643237|health promotion|health promotion
89701|NCT03643237|study protocol|study protocol
89702|NCT03643224|ablation|ablation
89703|NCT03643224|electrophysiology|electrophysiology
89704|NCT03643224|atrial fibrillation|atrial fibrillation
89705|NCT03643224|catheter|catheter
89706|NCT03643224|persistent|persistent
89707|NCT03643211|Xljanz|xljanz
89708|NCT03643211|Ulcerative colitis|ulcerative colitis
89709|NCT03643211|UC|uc
89710|NCT03643211|Long-term|long-term
89711|NCT03643185|cytokine|cytokine
89712|NCT03643185|ABPA|abpa
89713|NCT03643159|Digital Medicine System|digital medicine system
89714|NCT03643133|Bone|bone
89715|NCT03643133|Neoplasm, bone tissue|neoplasm, bone tissue
89716|NCT03643133|Acetylmuramyl-Alanyl-Isoglutamine|acetylmuramyl-alanyl-isoglutamine
89717|NCT03643107|Drug Response Prediction (DRP)|drug response prediction (drp)
89718|NCT03643055|medullary thyroid cancer|medullary thyroid cancer
89719|NCT03643055|imaging|imaging
89720|NCT03643055|hybrid-imaging|hybrid-imaging
89721|NCT03643055|18F-choline|18f-choline
89722|NCT03643055|18F-fluorocholine|18f-fluorocholine
89723|NCT03643055|PET|pet
89724|NCT03643055|PET/CT|pet/ct
89725|NCT03643042|Myelodysplastic Syndromes|myelodysplastic syndromes
89726|NCT03643042|Transfusion|transfusion
89727|NCT03643042|Quality of life|quality of life
89728|NCT03643042|Physical performance|physical performance
89729|NCT03643003|music|music
89730|NCT03643003|music therapy|music therapy
89731|NCT03642990|paclitaxel|paclitaxel
89732|NCT03642990|nicotinamide riboside|nicotinamide riboside
89733|NCT03642990|NIAGEN|niagen
89734|NCT03642990|nab-paclitaxel|nab-paclitaxel
89735|NCT03642977|Longitudinal study|longitudinal study
89736|NCT03642977|Real time PCR|real time pcr
89737|NCT03642951|magnetic|magnetic
89738|NCT03642951|brain|brain
89739|NCT03642951|stimulation|stimulation
89740|NCT03642938|Exercise|exercise
89741|NCT03642938|Dose|dose
89742|NCT03642938|Analgesia|analgesia
89743|NCT03642925|Meal replacement|meal replacement
89744|NCT03642925|calorie restriction|calorie restriction
89745|NCT03642925|body weight|body weight
89746|NCT03642912|ECMO|ecmo
89747|NCT03642912|haemostasis|haemostasis
89748|NCT03642912|coagulation|coagulation
89749|NCT03642912|haemostatic alterations|haemostatic alterations
89750|NCT03642782|electroretinogram pattern|electroretinogram pattern
89751|NCT03642769|Pancreatitis|pancreatitis
89752|NCT03642769|Fluids|fluids
89753|NCT03642769|SIRS|sirs
89754|NCT03642769|Management|management
89755|NCT03642769|Lactated Ringer|lactated ringer
89756|NCT03642769|Normal Saline|normal saline
89757|NCT03642743|hysterectomy|hysterectomy
89758|NCT03642743|minimally invasive surgery|minimally invasive surgery
89759|NCT03642743|gynecology|gynecology
89760|NCT03642743|satisfaction|satisfaction
89761|NCT03642730|echocardiography|echocardiography
89762|NCT03642730|training|training
89763|NCT03642730|follow-up|follow-up
89764|NCT03642704|PMTCT|pmtct
89765|NCT03642704|HIV early diagnosis|hiv early diagnosis
89766|NCT03642704|HIV preventive therapy|hiv preventive therapy
89767|NCT03642704|prevention of mother to child HIV transmission|prevention of mother to child hiv transmission
89768|NCT03642678|Prediction Model|prediction model
89769|NCT03642678|Malnutrition|malnutrition
89770|NCT03642678|Hemodialysis|hemodialysis
89771|NCT03642626|ALL|all
89772|NCT03642626|CAR-T|car-t
89773|NCT03642626|CAR19-T|car19-t
89774|NCT03642626|chimeric antigen receptor T cells|chimeric antigen receptor t cells
89775|NCT03642613|COPD, RWE, Physical Activity|copd, rwe, physical activity
89776|NCT03642574|Preimplantation Methylome Screening|preimplantation methylome screening
89777|NCT03642574|Preimplantation Genetic Screening|preimplantation genetic screening
89778|NCT03642574|single embryo transfer|single embryo transfer
89779|NCT03642574|cumulative live birth rate|cumulative live birth rate
89780|NCT03642548|NSCLC|nsclc
89781|NCT03642548|Bifico|bifico
89782|NCT03642548|gut-lung axis|gut-lung axis
89783|NCT03642535|Photodynamic Therapy|photodynamic therapy
89784|NCT03642535|Actinic Keratoses|actinic keratoses
89785|NCT03642522|repetitive transcranial magnetic stimulation|repetitive transcranial magnetic stimulation
89786|NCT03642522|rTMS|rtms
89787|NCT03642522|neurostimulation|neurostimulation
89788|NCT03642522|biomarker|biomarker
89789|NCT03642522|treatment-resistant|treatment-resistant
89790|NCT03642509|Left atrial appendage occlusion|left atrial appendage occlusion
89791|NCT03642509|Novel oral anticoagulation|novel oral anticoagulation
89792|NCT03642483|type 1 diabetes|type 1 diabetes
89793|NCT03642483|metabolic control|metabolic control
89794|NCT03642483|psychosocial risk factors|psychosocial risk factors
89795|NCT03642483|FEPB|fepb
89796|NCT03642483|children|children
89797|NCT03642483|adolescents|adolescents
89798|NCT03642470|type 1 diabetes|type 1 diabetes
89799|NCT03642470|metabolic control|metabolic control
89800|NCT03642470|psychosocial risk factors|psychosocial risk factors
89801|NCT03642470|cortisol|cortisol
89802|NCT03642470|children|children
89803|NCT03642470|adolescents|adolescents
89804|NCT03642457|Video assisted thoracoscopic surgery|video assisted thoracoscopic surgery
89805|NCT03642457|Serratus plane block|serratus plane block
89806|NCT03642457|local infiltration|local infiltration
89807|NCT03642444|stroke|stroke
89808|NCT03642444|hemiplegia|hemiplegia
89809|NCT03642418|asthma, children, spirometry, lung function, asthma action plan, asthma exacerbation, self management|asthma, children, spirometry, lung function, asthma action plan, asthma exacerbation, self management
89810|NCT03642392|Achilles tendon|achilles tendon
89811|NCT03642392|Patellar tendon|patellar tendon
89812|NCT03642392|Inflammation|inflammation
89813|NCT03642366|Low Intensity Shockwave Therapy|low intensity shockwave therapy
89814|NCT03642353|plaque control|plaque control
89815|NCT03642353|bacteria|bacteria
89816|NCT03642353|inflammation|inflammation
89817|NCT03642353|familial aggregation|familial aggregation
89818|NCT03642353|prevention|prevention
89819|NCT03642327|Child Abuse Prevention|child abuse prevention
89820|NCT03642327|Primary Care|primary care
89821|NCT03642327|Professional Education in Primary Care|professional education in primary care
89822|NCT03642314|pre exposure prophylaxis|pre exposure prophylaxis
89823|NCT03642314|men who have sex with men|men who have sex with men
89824|NCT03642301|Hemoglobin adducts from o-toluidine in blood|hemoglobin adducts from o-toluidine in blood
89825|NCT03642301|Urinary o-toluidine|urinary o-toluidine
89826|NCT03642301|Intrathecal anesthesia|intrathecal anesthesia
89827|NCT03642301|Hyperbaric prilocaine|hyperbaric prilocaine
90234|NCT03639727|citric acid|citric acid
89828|NCT03642301|Ambulatory surgery|ambulatory surgery
89829|NCT03642275|heart failure|heart failure
89830|NCT03642275|mHealth|mhealth
89831|NCT03642275|smartphone|smartphone
89832|NCT03642275|wearable electronic devices|wearable electronic devices
89833|NCT03642275|text messaging|text messaging
89834|NCT03642275|self-management|self-management
89835|NCT03642275|self-care|self-care
89836|NCT03642249|delirium|delirium
89837|NCT03642249|knowledge translation|knowledge translation
89838|NCT03642249|Objective Structured Clinical Examination|objective structured clinical examination
89839|NCT03642249|evidence-based practice|evidence-based practice
89840|NCT03642197|Bariatric Surgery|bariatric surgery
89841|NCT03642197|Obesity|obesity
89842|NCT03642197|Social Support|social support
89843|NCT03642197|Health Behavior|health behavior
89844|NCT03642184|empagliflozin|empagliflozin
89845|NCT03642184|linagliptin|linagliptin
89846|NCT03642184|diabetes|diabetes
89847|NCT03642184|kidney transplantation|kidney transplantation
89848|NCT03642171|Contraception|contraception
89849|NCT03642171|Intrauterine Device|intrauterine device
89850|NCT03642171|UT380|ut380
89851|NCT03642132|untreated epithelial ovarian cancer|untreated epithelial ovarian cancer
89852|NCT03642132|fallopian tube carncer|fallopian tube carncer
89853|NCT03642132|primary peritoneal cancer|primary peritoneal cancer
89854|NCT03642106|Adolescent|adolescent
89855|NCT03642106|Latino|latino
89856|NCT03642106|Immigrant|immigrant
89857|NCT03642093|Frailty|frailty
89858|NCT03642093|Prehabilitation|prehabilitation
89859|NCT03642067|Relatlimab|relatlimab
89860|NCT03642067|Nivolumab|nivolumab
89861|NCT03642067|Immunotherapy|immunotherapy
89862|NCT03642067|Anti-PD-1|anti-pd-1
89863|NCT03642067|Anti-LAG-3|anti-lag-3
89864|NCT03642067|Antibody|antibody
89865|NCT03642067|MSS|mss
89866|NCT03642067|PD-L1|pd-l1
89867|NCT03642067|Microsatellite stability|microsatellite stability
89868|NCT03642067|Colorectal cancer|colorectal cancer
89869|NCT03642067|Colon cancer|colon cancer
89870|NCT03642067|Rectal cancer|rectal cancer
89871|NCT03642041|Smoking|smoking
89872|NCT03642041|Lung cancer|lung cancer
89873|NCT03642041|Survival|survival
89874|NCT03642041|Quality of life|quality of life
89875|NCT03642028|Sleep Initiation and Maintenance Disorders|sleep initiation and maintenance disorders
89876|NCT03642028|Stress Disorders, Posttraumatic|stress disorders, posttraumatic
89877|NCT03642028|Suvorexant|suvorexant
89878|NCT03642028|Veterans|veterans
89879|NCT03642015|music|music
89880|NCT03642015|anxiety|anxiety
89881|NCT03642015|digestive tract endoscopy|digestive tract endoscopy
89882|NCT03642002|music therapy|music therapy
89883|NCT03642002|song of kin|song of kin
89884|NCT03642002|music medicine|music medicine
89885|NCT03641989|Toothpaste|toothpaste
89886|NCT03641989|Inflammation|inflammation
89887|NCT03641989|Periodontal Disease|periodontal disease
89888|NCT03641989|hsCRP|hscrp
89889|NCT03641989|Oral health|oral health
89890|NCT03641989|Oral hygiene|oral hygiene
89891|NCT03641950|Essential Blepharospasm|essential blepharospasm
89892|NCT03641924|Posttraumatic Stress Disorder|posttraumatic stress disorder
89893|NCT03641924|Psychotherapy|psychotherapy
89894|NCT03641924|Neuropsychology|neuropsychology
89895|NCT03641911|incidence|incidence
89896|NCT03641911|surgical ICU|surgical icu
89897|NCT03641898|Fractional flow reserve|fractional flow reserve
89898|NCT03641898|Intravascular ultrasound|intravascular ultrasound
89899|NCT03641898|Major adverse cardiovascular events|major adverse cardiovascular events
89900|NCT03641898|Non-ST-segment acute coronary syndrome|non-st-segment acute coronary syndrome
89901|NCT03641898|Percutaneous coronary intervention|percutaneous coronary intervention
89902|NCT03641872|acute-on-chronic liver disease|acute-on-chronic liver disease
89903|NCT03641872|acute decompensation|acute decompensation
89904|NCT03641872|multiple organ failures|multiple organ failures
89905|NCT03641872|acute-on-chronic liver failure|acute-on-chronic liver failure
89906|NCT03641859|pain|pain
89907|NCT03641859|anxiety|anxiety
89908|NCT03641833|cardiac|cardiac
89909|NCT03641833|surgery|surgery
89910|NCT03641833|postoperative cognitive dysfunction|postoperative cognitive dysfunction
89911|NCT03641833|bypass|bypass
89912|NCT03641833|brain biomarkers|brain biomarkers
89913|NCT03641833|transcranial Doppler|transcranial doppler
89914|NCT03641781|Isokinetic, Isometric, Agility|isokinetic, isometric, agility
89915|NCT03641781|Athletic Single Leg Stability,|athletic single leg stability,
89916|NCT03641781|Vertical Jump Biodex, Knee Pain|vertical jump biodex, knee pain
89917|NCT03641768|Alzheimer Dementia|alzheimer dementia
89918|NCT03641768|PTSD|ptsd
89919|NCT03641768|MRI|mri
89920|NCT03641755|Breast Cancer|breast cancer
89921|NCT03641742|Interstitial Lung Disease|interstitial lung disease
89922|NCT03641742|Pulmonary Fibrosis|pulmonary fibrosis
89923|NCT03641729|hematopoietic stem cell transplantation|hematopoietic stem cell transplantation
89924|NCT03641729|exercise training|exercise training
89925|NCT03641729|feasibility|feasibility
89926|NCT03641729|safety|safety
89927|NCT03641716|early childhood, family, occupational therapy|early childhood, family, occupational therapy
89928|NCT03641690|pandemic influenza|pandemic influenza
89929|NCT03641690|mortality|mortality
89930|NCT03641690|ICU|icu
89931|NCT03641677|EVLP|evlp
89932|NCT03641677|ex vivo lung perfusion|ex vivo lung perfusion
89933|NCT03641677|organ perfusion|organ perfusion
89934|NCT03641677|CLES|cles
89935|NCT03641677|centralized lung evaluation system|centralized lung evaluation system
89936|NCT03641677|united therapeutics|united therapeutics
89937|NCT03641638|Postpartum thyroiditis|postpartum thyroiditis
89938|NCT03641638|PPT|ppt
89939|NCT03641638|TPOAb|tpoab
89940|NCT03641625|Postoperative Nausea and Vomiting|postoperative nausea and vomiting
89941|NCT03641625|Laparoscopic Hysterectomy|laparoscopic hysterectomy
89942|NCT03641625|Muscular Tissue Oxygen Saturation|muscular tissue oxygen saturation
89943|NCT03641625|Hemodynamic Management|hemodynamic management
89944|NCT03641612|rotary instruments|rotary instruments
89945|NCT03641612|endotoxins|endotoxins
89946|NCT03641599|RV systolic function|rv systolic function
89947|NCT03641599|HFpEF|hfpef
89948|NCT03641599|HFmrEF|hfmref
89949|NCT03641599|HFrEF|hfref
89950|NCT03641586|Dose Escalation|dose escalation
89951|NCT03641586|Dose Expansion|dose expansion
89952|NCT03641586|BGB-283|bgb-283
89953|NCT03641560|Progressive Metastatic Castration-Resistant Prostate Cancer (mCRPC)|progressive metastatic castration-resistant prostate cancer (mcrpc)
89954|NCT03641560|Enzalutamide|enzalutamide
89955|NCT03641560|Xtandi|xtandi
89956|NCT03641560|MDV3100|mdv3100
89957|NCT03641547|Oesophageal cancer|oesophageal cancer
89958|NCT03641534|Perfusion|perfusion
89959|NCT03641534|Lung congestion|lung congestion
89960|NCT03641521|child vegetable intake|child vegetable intake
825990|NCT00130429|dementia|dementia
89961|NCT03641521|behavioral strategy|behavioral strategy
89962|NCT03641521|intervention|intervention
89963|NCT03641508|trigger finger|trigger finger
89964|NCT03641495|fibromyalgia|fibromyalgia
89965|NCT03641495|therapeutic exercise|therapeutic exercise
89966|NCT03641495|physiotherapy|physiotherapy
89967|NCT03641482|third molar surgery|third molar surgery
89968|NCT03641482|oral surgery|oral surgery
89969|NCT03641482|propolis|propolis
89970|NCT03641482|NBF gingival gel|nbf gingival gel
89971|NCT03641482|post-surgical complications|post-surgical complications
89972|NCT03641482|clinica trial|clinica trial
89973|NCT03641469|Adolescent Idiopathic Scoliosis|adolescent idiopathic scoliosis
89974|NCT03641469|thoracolumbosacral orthosis|thoracolumbosacral orthosis
89975|NCT03641469|spinal orthotic|spinal orthotic
89976|NCT03641469|health-related quality of life|health-related quality of life
89977|NCT03641469|treatment adherence|treatment adherence
89978|NCT03641417|Obesity|obesity
89979|NCT03641417|Bariatric surgery|bariatric surgery
89980|NCT03641417|Appetite|appetite
89981|NCT03641417|Ghrelin|ghrelin
89982|NCT03641417|Energy intake|energy intake
89983|NCT03641417|Gut hormones|gut hormones
89984|NCT03641417|Adipokines|adipokines
89985|NCT03641404|ergothioneine|ergothioneine
89986|NCT03641404|mild cognitive impairment|mild cognitive impairment
89987|NCT03641404|dementia|dementia
89988|NCT03641404|dietary antioxidant|dietary antioxidant
89989|NCT03641391|Awake surgery|awake surgery
89990|NCT03641391|Direct cortical stimulation|direct cortical stimulation
89991|NCT03641391|Language mapping|language mapping
89992|NCT03641391|Glioma|glioma
89993|NCT03641378|Cancer Care|cancer care
89994|NCT03641365|Intraoral scanner|intraoral scanner
89995|NCT03641365|Guided surgery|guided surgery
89996|NCT03641365|Implant accuracy|implant accuracy
89997|NCT03641365|Dental implants|dental implants
89998|NCT03641339|Mosquito|mosquito
89999|NCT03641339|Saliva|saliva
90000|NCT03641339|Immune Response|immune response
90001|NCT03641339|Sand Fly|sand fly
90002|NCT03641339|Biopsy|biopsy
90003|NCT03641326|Gliosarcoma|gliosarcoma
90004|NCT03641326|Brain Tumor|brain tumor
90005|NCT03641326|MDASI|mdasi
90006|NCT03641300|Magnetic Seizure Therapy|magnetic seizure therapy
90007|NCT03641300|Electroconvulsive Therapy|electroconvulsive therapy
90008|NCT03641300|Bipolar Disorder|bipolar disorder
90009|NCT03641300|Depression|depression
90010|NCT03641300|Suicidal Ideation|suicidal ideation
90011|NCT03641274|Vulnerable populations|vulnerable populations
90012|NCT03641274|Emergency department|emergency department
90013|NCT03641261|Hereditary ichthyosis|hereditary ichthyosis
90014|NCT03641235|pulmonary microbiota|pulmonary microbiota
90015|NCT03641235|Chronic obstructive pulmonary disease|chronic obstructive pulmonary disease
90016|NCT03641222|Acupuncture|acupuncture
90017|NCT03641222|Group|group
90018|NCT03641222|Community Based|community based
90019|NCT03641222|Individual|individual
90020|NCT03641222|Randomized|randomized
90021|NCT03641209|acetaminophen|acetaminophen
90022|NCT03641209|ductus arteriosus|ductus arteriosus
90023|NCT03641209|NIRS|nirs
90024|NCT03641209|intravenous|intravenous
90025|NCT03641196|Orthodontic Appliances|orthodontic appliances
90026|NCT03641196|Dentition, Mixed|dentition, mixed
90027|NCT03641157|Difficult intubation|difficult intubation
90028|NCT03641157|Pediatrics|pediatrics
90029|NCT03641157|predictive tests|predictive tests
90030|NCT03641144|Diabetic Macular Edema|diabetic macular edema
90031|NCT03641144|navigation laser|navigation laser
90032|NCT03641144|laser photocoagulation|laser photocoagulation
90033|NCT03641118|cancer|cancer
90034|NCT03641118|sarcopenia|sarcopenia
90035|NCT03641118|surgery|surgery
90036|NCT03641118|chemotherapy|chemotherapy
90037|NCT03641092|School readiness|school readiness
90038|NCT03641092|Child development|child development
90039|NCT03641092|Child behavior|child behavior
90040|NCT03641092|Parenting behavior|parenting behavior
90041|NCT03641092|CenteringParenting|centeringparenting
90042|NCT03641066|ankle|ankle
90043|NCT03641066|biomechanics|biomechanics
90044|NCT03641053|honey|honey
90045|NCT03641053|povidone-iodine|povidone-iodine
90046|NCT03641053|randomized control trial|randomized control trial
90047|NCT03641053|wound healing|wound healing
90048|NCT03641040|Video-oculography|video-oculography
90049|NCT03641040|Intermittent exotropia|intermittent exotropia
90050|NCT03641040|ocular deviation|ocular deviation
90051|NCT03641027|Obesity|obesity
90052|NCT03641027|Physical Activity|physical activity
90053|NCT03641001|Intervention|intervention
90054|NCT03641001|Food voucher|food voucher
90055|NCT03641001|Child feeding|child feeding
90056|NCT03641001|Growth|growth
90057|NCT03641001|WASH|wash
90058|NCT03640975|eosinophilic esophagitis|eosinophilic esophagitis
90059|NCT03640975|children|children
90060|NCT03640975|innate immunity|innate immunity
90061|NCT03640962|Postmenopause|postmenopause
90062|NCT03640962|Low back pain|low back pain
90063|NCT03640962|Woman|woman
90064|NCT03640936|asthma|asthma
90065|NCT03640936|allergy|allergy
90066|NCT03640936|specific IgE|specific ige
90067|NCT03640910|Dental implants|dental implants
90068|NCT03640910|Overdenture|overdenture
90069|NCT03640910|Randomized controlled trial|randomized controlled trial
90070|NCT03640897|Infant diaper rash|infant diaper rash
90071|NCT03640897|Baby wipes|baby wipes
90072|NCT03640897|Oleocalcareous liniment|oleocalcareous liniment
90073|NCT03640858|Hemodialysis|hemodialysis
90074|NCT03640858|Larger middle molecules|larger middle molecules
90075|NCT03640858|Theranova|theranova
90076|NCT03640793|Snoring, Obstructive Sleep Apnea|snoring, obstructive sleep apnea
90077|NCT03640780|surgical timing|surgical timing
90078|NCT03640780|cataract extraction|cataract extraction
90079|NCT03640780|IOL implantation|iol implantation
90080|NCT03640780|childhood cataract|childhood cataract
90081|NCT03640780|real-world data|real-world data
90082|NCT03640767|Rehabilitation|rehabilitation
90083|NCT03640767|Peripheral artery disease|peripheral artery disease
90084|NCT03640767|Mobile phone text message|mobile phone text message
90085|NCT03640754|Hot Flashes|hot flashes
90086|NCT03640754|Vasomotor Symptoms|vasomotor symptoms
90087|NCT03640754|Menopause|menopause
90088|NCT03640741|intra-abdominal pressure|intra-abdominal pressure
90089|NCT03640741|intra-cerebral pressure|intra-cerebral pressure
90090|NCT03640741|laparoscopy|laparoscopy
90091|NCT03640741|brain perfusion|brain perfusion
90092|NCT03640741|brain oxygenation|brain oxygenation
90093|NCT03640741|time-resolved near infrared spectroscopy|time-resolved near infrared spectroscopy
90094|NCT03640728|Hepatitis B, Acute-on-Chronic liver failure|hepatitis b, acute-on-chronic liver failure
90095|NCT03640689|Venous ulcer|venous ulcer
90096|NCT03640689|Great saphenous incompetence|great saphenous incompetence
90097|NCT03640689|Iliac vein|iliac vein
90098|NCT03640689|Endovenous therapy|endovenous therapy
90099|NCT03640663|Midwifery-led continuity of care|midwifery-led continuity of care
90100|NCT03640663|Birth complications|birth complications
90101|NCT03640650|Sequential bilateral cataract surgery|sequential bilateral cataract surgery
90102|NCT03640637|Positron emission tomography|positron emission tomography
90103|NCT03640637|Magnetic resonance imaging|magnetic resonance imaging
90104|NCT03640624|Physical Therapy Modalities|physical therapy modalities
90105|NCT03640611|cerebral palsy, activity, participation, environmental factors, ICF-CY|cerebral palsy, activity, participation, environmental factors, icf-cy
90106|NCT03640585|Cerebral palsy|cerebral palsy
90107|NCT03640585|Music therapy|music therapy
90108|NCT03640585|Gross motor function|gross motor function
90109|NCT03640559|Adhesion|adhesion
90110|NCT03640559|Safety|safety
90111|NCT03640507|vaginal preparation|vaginal preparation
90112|NCT03640507|antisepsis|antisepsis
90113|NCT03640507|C-section|c-section
90114|NCT03640494|Optical Coherence Tomography|optical coherence tomography
90115|NCT03640494|Newborn|newborn
90116|NCT03640494|Infant|infant
90117|NCT03640416|night on call|night on call
90118|NCT03640416|sleep deprivation|sleep deprivation
90119|NCT03640416|fitbit®|fitbit®
90120|NCT03640416|smart watch|smart watch
90121|NCT03640416|stress|stress
90122|NCT03640403|Malaria|malaria
90123|NCT03640403|school children|school children
90124|NCT03640403|randomized controlled trial|randomized controlled trial
90125|NCT03640403|safety|safety
90126|NCT03640403|effectiveness|effectiveness
90127|NCT03640403|Dihydroartemisinin-piperaquine|dihydroartemisinin-piperaquine
90128|NCT03640403|cognitive|cognitive
90340|NCT03639155|HIF-PHI|hif-phi
90129|NCT03640403|Artesunate-amodiaquine|artesunate-amodiaquine
90130|NCT03640403|malaria serology|malaria serology
90131|NCT03640403|drug resistance|drug resistance
90132|NCT03640364|pelvic organ prolapse|pelvic organ prolapse
90133|NCT03640364|incontinence|incontinence
90134|NCT03640364|minimally invasive|minimally invasive
90135|NCT03640364|vaginal surgery|vaginal surgery
90136|NCT03640364|macroporous|macroporous
90137|NCT03640364|lightweight|lightweight
90138|NCT03640364|mesh|mesh
90139|NCT03640364|polypropylene|polypropylene
90140|NCT03640364|POP|pop
90141|NCT03640364|urge|urge
90142|NCT03640351|Dry eye|dry eye
90143|NCT03640351|Cataract surgery|cataract surgery
90144|NCT03640351|Diquas|diquas
90145|NCT03640351|preservative free|preservative free
90146|NCT03640312|Hypertension|hypertension
90147|NCT03640312|Blood Pressure|blood pressure
90148|NCT03640299|Gynecologic Cancer|gynecologic cancer
90149|NCT03640299|Enhanced Recovery After Surgery|enhanced recovery after surgery
90150|NCT03640299|Laparoscopic surgery|laparoscopic surgery
90151|NCT03640286|Overweight|overweight
90152|NCT03640286|Metabolic syndrome|metabolic syndrome
90153|NCT03640286|Weight loss|weight loss
90154|NCT03640286|Diet|diet
90155|NCT03640286|Atherogenic index|atherogenic index
90156|NCT03640273|Loratadine|loratadine
90157|NCT03640273|Prapchompoothaweep|prapchompoothaweep
90158|NCT03640273|Allergic rhinitis|allergic rhinitis
90159|NCT03640247|Thyroidectomy|thyroidectomy
825991|NCT00130429|memory|memory
90160|NCT03640247|Parathryoidectomy|parathryoidectomy
90161|NCT03640221|Hypertension|hypertension
90162|NCT03640221|Diabetes|diabetes
90163|NCT03640208|health disparities|health disparities
90164|NCT03640208|African American|african american
90165|NCT03640208|risk assessment|risk assessment
90166|NCT03640208|secondary prevention|secondary prevention
90167|NCT03640182|Health Management Model|health management model
90168|NCT03640182|Chinese Medicine|chinese medicine
90169|NCT03640182|Preventive Medicine|preventive medicine
90170|NCT03640182|Body Constitution|body constitution
90171|NCT03640182|Health Promotion|health promotion
90172|NCT03640169|Health Management Model|health management model
90173|NCT03640169|Chinese Medicine|chinese medicine
90174|NCT03640169|Preventive Medicine|preventive medicine
90175|NCT03640169|Body Constitution|body constitution
90176|NCT03640169|Health Promotion|health promotion
90177|NCT03640156|Oxytocin|oxytocin
90178|NCT03640156|Eye Contact|eye contact
90179|NCT03640156|Mirror System|mirror system
90180|NCT03640156|Transcranial Magnetic Stimulation|transcranial magnetic stimulation
90181|NCT03640117|aging|aging
90182|NCT03640117|geriatric assessment|geriatric assessment
90183|NCT03640117|chemotherapy toxicity|chemotherapy toxicity
90184|NCT03640117|overall survival|overall survival
90185|NCT03640104|Food-based intervention|food-based intervention
90186|NCT03640104|postpartum weight management|postpartum weight management
90187|NCT03640104|hepatic retinol|hepatic retinol
90188|NCT03640039|3d strut plate|3d strut plate
90189|NCT03640039|mandibular angle fracture|mandibular angle fracture
90190|NCT03639987|Aducanumab|aducanumab
90191|NCT03639987|BIIB037|biib037
90192|NCT03639961|Integrated|integrated
90193|NCT03639961|leading|leading
90194|NCT03639961|managing|managing
90195|NCT03639961|governing|governing
90196|NCT03639961|practices|practices
90197|NCT03639948|Pembrolizumab|pembrolizumab
90198|NCT03639948|Carboplatin|carboplatin
90199|NCT03639948|Docetaxel|docetaxel
90200|NCT03639948|Pegfilgrastim|pegfilgrastim
90201|NCT03639948|breast cancer|breast cancer
90202|NCT03639935|Metastatic|metastatic
90203|NCT03639935|Platinum|platinum
90204|NCT03639935|Rucaparib|rucaparib
90205|NCT03639935|Nivolumab|nivolumab
90206|NCT03639935|PARP Inhibitor|parp inhibitor
90207|NCT03639935|Anti-PD-1 Antibody|anti-pd-1 antibody
90208|NCT03639922|acute ischaemic stroke|acute ischaemic stroke
90209|NCT03639922|Imatinib|imatinib
90210|NCT03639922|blood-brain-barrier|blood-brain-barrier
90211|NCT03639922|trombectomy|trombectomy
90212|NCT03639922|iv trombolysis|iv trombolysis
90213|NCT03639909|sweat gland|sweat gland
90214|NCT03639883|wound healing|wound healing
90215|NCT03639870|refractory|refractory
90216|NCT03639831|Mood|mood
90217|NCT03639831|Anxiety|anxiety
90218|NCT03639831|Stress|stress
90219|NCT03639831|Dietary supplement|dietary supplement
90220|NCT03639831|Botanical|botanical
90221|NCT03639792|gastric cancer|gastric cancer
90222|NCT03639792|postoperative complication|postoperative complication
90223|NCT03639792|octogenarian|octogenarian
90224|NCT03639779|Calcinosis cutis|calcinosis cutis
90225|NCT03639779|sodium thiosulfate|sodium thiosulfate
90226|NCT03639779|sodium chloride|sodium chloride
90227|NCT03639766|Raynaud Phenomenon|raynaud phenomenon
90228|NCT03639766|AbobotulinumtoxinA|abobotulinumtoxina
90229|NCT03639753|teen driver safety|teen driver safety
90230|NCT03639753|injury prevention|injury prevention
90231|NCT03639727|cough|cough
90232|NCT03639727|cough provocation test|cough provocation test
90233|NCT03639727|mannitol|mannitol
90235|NCT03639714|neoantigen cancer vaccine|neoantigen cancer vaccine
90236|NCT03639714|personalized neoantigen cancer vaccine|personalized neoantigen cancer vaccine
90237|NCT03639714|GRT-C901|grt-c901
90238|NCT03639714|GRT-R902|grt-r902
90239|NCT03639714|immunotherapy|immunotherapy
90240|NCT03639714|nivolumab|nivolumab
90241|NCT03639714|ipilimumab|ipilimumab
90242|NCT03639714|PD-1|pd-1
90243|NCT03639714|CTLA-4|ctla-4
90244|NCT03639701|Thymidine|thymidine
90245|NCT03639701|Deoxycytidine|deoxycytidine
90246|NCT03639636|periodontitis|periodontitis
90247|NCT03639636|sclerostin|sclerostin
90248|NCT03639636|periodontal surgery|periodontal surgery
90249|NCT03639636|scaling and root planing|scaling and root planing
90250|NCT03639623|Peroxisome proliferator-activated receptors|peroxisome proliferator-activated receptors
90251|NCT03639623|NAFLD|nafld
90252|NCT03639623|NASH|nash
90253|NCT03639623|Post Transplant Metabolic Syndrome|post transplant metabolic syndrome
90254|NCT03639597|ablation|ablation
90255|NCT03639597|ultrasound|ultrasound
90256|NCT03639597|automation|automation
90257|NCT03639597|catheter|catheter
90258|NCT03639584|Vitamin D Deficiency|vitamin d deficiency
90259|NCT03639584|Critical Illness|critical illness
90260|NCT03639506|repetition failure|repetition failure
90261|NCT03639506|autologous mitochondria transplantation|autologous mitochondria transplantation
90262|NCT03639506|embryo quality|embryo quality
90263|NCT03639506|live birth rate|live birth rate
90264|NCT03639467|anlotinib|anlotinib
90265|NCT03639467|nasopharyngeal carcinoma|nasopharyngeal carcinoma
90266|NCT03639467|gemcitabine|gemcitabine
90267|NCT03639467|cisplatin|cisplatin
90268|NCT03639454|dry needling|dry needling
90269|NCT03639454|myofascial trigger point|myofascial trigger point
90270|NCT03639454|muscle tone|muscle tone
90271|NCT03639441|dry needling|dry needling
90272|NCT03639441|myofascial trigger point|myofascial trigger point
90273|NCT03639441|muscle tone|muscle tone
90274|NCT03639428|pharmacokinetics|pharmacokinetics
90275|NCT03639428|child|child
90276|NCT03639428|cyclodextrin|cyclodextrin
90277|NCT03639428|moderate sedation|moderate sedation
90278|NCT03639415|Opioid|opioid
90279|NCT03639415|Refractory Pain|refractory pain
90280|NCT03639415|dose frequency|dose frequency
90281|NCT03639415|nausea|nausea
90282|NCT03639415|vomit|vomit
90283|NCT03639415|dizziness|dizziness
90284|NCT03639402|Diet|diet
90285|NCT03639402|Physical activity|physical activity
90286|NCT03639402|Attitude|attitude
90287|NCT03639402|Knowledge|knowledge
90288|NCT03639402|Practice|practice
90289|NCT03639402|Cardiovascular disease|cardiovascular disease
90290|NCT03639402|Mothers|mothers
90291|NCT03639402|Peer education|peer education
90292|NCT03639389|Robot assisted surgery|robot assisted surgery
90293|NCT03639389|Prostatectomy|prostatectomy
90294|NCT03639389|Spinal anesthesia|spinal anesthesia
90295|NCT03639389|Postoperative pain|postoperative pain
90296|NCT03639389|Home discharge|home discharge
90297|NCT03639376|Children|children
90298|NCT03639376|Cotinine|cotinine
90299|NCT03639376|LL-37|ll-37
90300|NCT03639376|Passive smoking|passive smoking
90301|NCT03639376|Periodontal health|periodontal health
90302|NCT03639376|Saliva|saliva
90303|NCT03639363|4% chlorhexidine gluconate|4% chlorhexidine gluconate
90304|NCT03639363|infection control|infection control
90305|NCT03639350|intermittent energy restriction|intermittent energy restriction
90306|NCT03639350|Randomized Controlled Trial|randomized controlled trial
90307|NCT03639350|Adiposity|adiposity
90308|NCT03639337|Probiotic|probiotic
90309|NCT03639337|Food allergy|food allergy
90310|NCT03639324|venetoclax|venetoclax
90311|NCT03639324|idelalisib|idelalisib
90312|NCT03639311|HIV|hiv
90313|NCT03639311|ART|art
90314|NCT03639311|maintenance|maintenance
90315|NCT03639311|Long acting|long acting
90316|NCT03639311|LATTE|latte
90317|NCT03639298|premature children|premature children
90318|NCT03639298|processing speed|processing speed
90319|NCT03639298|executive functions|executive functions
90320|NCT03639272|talar fractures|talar fractures
90321|NCT03639272|talar neck fractures;|talar neck fractures;
90322|NCT03639272|talar body fractures;|talar body fractures;
90323|NCT03639272|talus;|talus;
90324|NCT03639272|ORIF;|orif;
90325|NCT03639272|screw fixation.|screw fixation.
90326|NCT03639246|Ovarian cancer|ovarian cancer
90327|NCT03639246|Platinum resistant|platinum resistant
90328|NCT03639207|IFNL4|ifnl4
90329|NCT03639207|Genetics|genetics
90330|NCT03639207|Ledipasvir/Sofosbuvir Treatment|ledipasvir/sofosbuvir treatment
90331|NCT03639194|Cancer|cancer
90332|NCT03639194|Small Cell Lung Cancer|small cell lung cancer
90333|NCT03639194|Small Cell Lung Carcinoma|small cell lung carcinoma
90334|NCT03639181|B-NHL|b-nhl
90335|NCT03639155|vadadustat|vadadustat
90336|NCT03639155|AKB-6548|akb-6548
90337|NCT03639155|hypoxia-inducible factor|hypoxia-inducible factor
90338|NCT03639155|HIF|hif
90339|NCT03639155|hypoxia-inducible factor prolyl-hydroxylase inhibitor|hypoxia-inducible factor prolyl-hydroxylase inhibitor
90341|NCT03639142|constipation, prunes, children|constipation, prunes, children
90342|NCT03639116|Spike timing-dependent plasticity|spike timing-dependent plasticity
90343|NCT03639116|cerebrovascular accident|cerebrovascular accident
90344|NCT03639116|stroke|stroke
90345|NCT03639116|paralysis|paralysis
90346|NCT03639116|hemiparesis|hemiparesis
90347|NCT03639090|chemotherapy, mass spectrometry|chemotherapy, mass spectrometry
90348|NCT03639077|Bone graft|bone graft
90349|NCT03639077|Lateral window approach|lateral window approach
90350|NCT03639077|Sinus augmentation|sinus augmentation
90351|NCT03639077|Volumetric change|volumetric change
90352|NCT03638960|peripheral nerve block|peripheral nerve block
90353|NCT03638960|interscalene|interscalene
90354|NCT03638960|arthroscopic shoulder surgery|arthroscopic shoulder surgery
90355|NCT03638960|liposomal bupivacaine|liposomal bupivacaine
90356|NCT03638934|Advance care planning|advance care planning
90357|NCT03638895|weight management|weight management
90358|NCT03638895|obesity|obesity
90359|NCT03638895|severe obesity|severe obesity
90360|NCT03638895|structured dietary intervention|structured dietary intervention
90361|NCT03638895|calorie restriction|calorie restriction
90362|NCT03638895|indirect calorimetry|indirect calorimetry
90363|NCT03638895|resting energy expenditure|resting energy expenditure
90364|NCT03638895|resting metabolic rate|resting metabolic rate
826777|NCT00127699|Triple dye|triple dye
90365|NCT03638895|respiratory quotient|respiratory quotient
90366|NCT03638895|substrate oxidation|substrate oxidation
90367|NCT03638895|glycemic variability|glycemic variability
90368|NCT03638895|insulin sensitivity|insulin sensitivity
90369|NCT03638895|peripheral neuropathy|peripheral neuropathy
90370|NCT03638856|Cervical priming|cervical priming
90371|NCT03638856|Diagnosis hysteroscopy|diagnosis hysteroscopy
90372|NCT03638856|Oral Misoprostal|oral misoprostal
90373|NCT03638856|Premenopause|premenopause
90374|NCT03638843|bariatric endoscopy|bariatric endoscopy
90375|NCT03638843|obesity|obesity
90376|NCT03638843|metabolic syndrome|metabolic syndrome
90377|NCT03638843|gastric mucosal devitalization|gastric mucosal devitalization
90378|NCT03638843|Endoscopic bariatric therapies|endoscopic bariatric therapies
90379|NCT03638830|Pseudomonas Aeruginosa|pseudomonas aeruginosa
90380|NCT03638830|antibiotic resistance|antibiotic resistance
90381|NCT03638830|factors of pathogenicity of bacteria|factors of pathogenicity of bacteria
90382|NCT03638830|the system of secretion of type III pathogenic bacteria|the system of secretion of type iii pathogenic bacteria
90383|NCT03638830|Pseudomonas Infections|pseudomonas infections
90384|NCT03638830|Urinary Tract Infections|urinary tract infections
90385|NCT03638817|Inherited thrombocytopenias (IT)|inherited thrombocytopenias (it)
90386|NCT03638817|Platelet concentrates (PC)|platelet concentrates (pc)
90387|NCT03638817|Eltrombopag|eltrombopag
90388|NCT03638817|Surgery|surgery
90389|NCT03638817|Invasive acts|invasive acts
90390|NCT03638817|Perioperative|perioperative
90391|NCT03638817|Rare disease|rare disease
90392|NCT03638817|Thrombopoietin mimetic|thrombopoietin mimetic
90393|NCT03638804|89Zr|89zr
90394|NCT03638804|PD-L1|pd-l1
90395|NCT03638804|KN035|kn035
90396|NCT03638804|PET|pet
90397|NCT03638765|immunotherapy|immunotherapy
90398|NCT03638765|dendritic cells|dendritic cells
90399|NCT03638765|brain metastases|brain metastases
90400|NCT03638726|intraoperative mydriasis|intraoperative mydriasis
90401|NCT03638726|subconjunctival atropine|subconjunctival atropine
90402|NCT03638726|intracameral epinephrine|intracameral epinephrine
90403|NCT03638726|cataract surgery|cataract surgery
90404|NCT03638713|water exchange|water exchange
90405|NCT03638713|colonoscopy|colonoscopy
90406|NCT03638713|cecal insertion time|cecal insertion time
90407|NCT03638713|bidirectional endoscopy|bidirectional endoscopy
90408|NCT03638700|stenosis|stenosis
90409|NCT03638700|bile duct|bile duct
90410|NCT03638700|guidewire|guidewire
90411|NCT03638700|ercp|ercp
90412|NCT03638687|Pregnancy|pregnancy
90413|NCT03638687|Postpartum|postpartum
90414|NCT03638648|breast cancer|breast cancer
90415|NCT03638648|neoadjuvant|neoadjuvant
90416|NCT03638648|multiple gene detection|multiple gene detection
90417|NCT03638635|Bupivacaine|bupivacaine
90418|NCT03638635|Exparel|exparel
90419|NCT03638635|TAP Block|tap block
90420|NCT03638635|Opioids|opioids
90421|NCT03638635|Narcotics|narcotics
90422|NCT03638635|ERAS|eras
90423|NCT03638622|Oral cancer, Photodynamic Therapy, Photosensitizer, ALA|oral cancer, photodynamic therapy, photosensitizer, ala
90424|NCT03638609|IABP|iabp
90425|NCT03638609|Post-Cardiac Arrest Syndrome|post-cardiac arrest syndrome
90426|NCT03638609|Beclin-1|beclin-1
90427|NCT03638609|Caspase-3|caspase-3
90428|NCT03638609|Mortality|mortality
90429|NCT03638596|Alcohol Impaired Driving|alcohol impaired driving
90430|NCT03638596|Driving While Intoxicated|driving while intoxicated
90431|NCT03638596|Driving Under the Influence|driving under the influence
90432|NCT03638596|Driving While Impaired|driving while impaired
90433|NCT03638583|Alzheimer's|alzheimer's
90434|NCT03638583|Prevention|prevention
90435|NCT03638583|Web-Based|web-based
90436|NCT03638531|tDCS|tdcs
90437|NCT03638531|cortical excitability|cortical excitability
90440|NCT03638531|handwriting|handwriting
90441|NCT03638531|micrographia|micrographia
90442|NCT03638518|rehabilitation|rehabilitation
90443|NCT03638518|balance|balance
90444|NCT03638518|functional capacity|functional capacity
90445|NCT03638492|Melanoma/mortality/pathology/*surgery|melanoma/mortality/pathology/*surgery
90446|NCT03638492|Randomized Controlled Trials as Topic|randomized controlled trials as topic
90447|NCT03638492|Survival|survival
90448|NCT03638492|Margin|margin
90449|NCT03638453|Pedi Care|pedi care
90450|NCT03638440|Opioid Induced Constipation|opioid induced constipation
90451|NCT03638440|Naloxegol|naloxegol
90452|NCT03638440|Peripherally Acting Mu-Opioids Receptor Antagonist (PAMORA)|peripherally acting mu-opioids receptor antagonist (pamora)
90453|NCT03638427|menstrual blood, high risk HPV|menstrual blood, high risk hpv
90454|NCT03638375|Metastatic melanoma|metastatic melanoma
90455|NCT03638375|anti-PD1|anti-pd1
90456|NCT03638375|TIL|til
90457|NCT03638375|interferon-alpha|interferon-alpha
90458|NCT03638375|adoptive cell therapy|adoptive cell therapy
90459|NCT03638375|nivolumab|nivolumab
90460|NCT03638362|obese|obese
90461|NCT03638362|overweight|overweight
90462|NCT03638362|tart cherry juice|tart cherry juice
90463|NCT03638297|MSI-H|msi-h
90464|NCT03638297|dMMR|dmmr
90465|NCT03638297|PD-1 antibody|pd-1 antibody
90466|NCT03638297|COX inhibitor|cox inhibitor
90467|NCT03638297|tumor mutation burden|tumor mutation burden
90468|NCT03638284|Dementia|dementia
90469|NCT03638284|neuropsychiatric symptoms|neuropsychiatric symptoms
90470|NCT03638284|tDCS|tdcs
90471|NCT03638284|Transcranial direct current stimulation|transcranial direct current stimulation
90472|NCT03638284|Alzheimer Disease|alzheimer disease
90473|NCT03638284|Mixed Dementia|mixed dementia
90474|NCT03638284|agitation in dementia|agitation in dementia
90475|NCT03638284|non-invasive brain stimulation|non-invasive brain stimulation
90476|NCT03638232|Drug consumption|drug consumption
90477|NCT03638232|Response to treatment|response to treatment
90478|NCT03638232|Non optimal drug use|non optimal drug use
90479|NCT03638167|CNS, CAR T cell, EGFR-positive|cns, car t cell, egfr-positive
90480|NCT03638167|pediatric, young adults, brain tumor|pediatric, young adults, brain tumor
90481|NCT03638141|HCC|hcc
90482|NCT03638141|Durvalumab|durvalumab
90483|NCT03638141|Tremelimumab|tremelimumab
90484|NCT03638141|Immunotherapy|immunotherapy
90485|NCT03638141|PD-L1|pd-l1
90486|NCT03638141|Antibodies|antibodies
90487|NCT03638141|Hepatocellular Carcinoma|hepatocellular carcinoma
90488|NCT03638141|CTLA-4|ctla-4
90489|NCT03638141|DEB-TACE|deb-tace
90492|NCT03638102|sleep duration|sleep duration
90493|NCT03638102|glucose metabolism|glucose metabolism
90494|NCT03638063|Adenosine triphosphate|adenosine triphosphate
90495|NCT03638063|Capsaicin|capsaicin
90496|NCT03638063|cough provocation test|cough provocation test
90497|NCT03638011|Cesarean Section|cesarean section
90498|NCT03638011|Pregnancy|pregnancy
90499|NCT03637998|Gene expression|gene expression
90500|NCT03637998|Quantitative Sensory Testing|quantitative sensory testing
90501|NCT03637998|Genotyping|genotyping
90502|NCT03637985|resistive exercises|resistive exercises
90503|NCT03637985|aerobic|aerobic
90504|NCT03637985|Menopause|menopause
90505|NCT03637985|hypertension|hypertension
90506|NCT03637946|Resin composite|resin composite
90507|NCT03637946|clinical trial|clinical trial
90508|NCT03637946|biocompatibility|biocompatibility
90509|NCT03637946|cytokines|cytokines
90510|NCT03637920|Transmen|transmen
90511|NCT03637920|Sexuality|sexuality
90512|NCT03637920|Sexual behavior|sexual behavior
90513|NCT03637920|Body Image|body image
90514|NCT03637920|Trassexualism|trassexualism
90515|NCT03637894|Newborns|newborns
90516|NCT03637894|Fermented milk|fermented milk
90517|NCT03637894|Innate immunity|innate immunity
90518|NCT03637881|Milk|milk
90519|NCT03637881|Consumer choice|consumer choice
90520|NCT03637868|HER2-negative breast cancer|her2-negative breast cancer
90521|NCT03637868|brain metastases|brain metastases
90522|NCT03637842|cannabis|cannabis
90523|NCT03637842|impulsivity|impulsivity
90524|NCT03637829|Healthy adults|healthy adults
90525|NCT03637829|Cognitive performance|cognitive performance
90526|NCT03637829|Chocolate|chocolate
90527|NCT03637829|Food intake|food intake
90528|NCT03637829|Glycemic response|glycemic response
90529|NCT03637803|MK-3475|mk-3475
90530|NCT03637803|pembrolizumab|pembrolizumab
90531|NCT03637803|MRx0518|mrx0518
90532|NCT03637803|PD-1 Inhibitor|pd-1 inhibitor
90533|NCT03637803|Oncology|oncology
90534|NCT03637803|Live Biotherapeutic Product|live biotherapeutic product
90535|NCT03637790|healthy volunteers|healthy volunteers
90536|NCT03637738|Intrabeam®|intrabeam®
90537|NCT03637738|intraoperative radiation therapy|intraoperative radiation therapy
90538|NCT03637738|conventional external radiotherapy|conventional external radiotherapy
90539|NCT03637738|conservative surgery|conservative surgery
90540|NCT03637699|Positive Psychology|positive psychology
90541|NCT03637699|Positive Affect|positive affect
90542|NCT03637686|Colorectal cancer|colorectal cancer
90543|NCT03637686|Circulating tumor DNA|circulating tumor dna
90544|NCT03637660|Benzathine penicillin G|benzathine penicillin g
90545|NCT03637660|Early Syphillis|early syphillis
90546|NCT03637660|HIV|hiv
90547|NCT03637660|Phase 4|phase 4
90548|NCT03637647|cardiopulmonary exercise testing|cardiopulmonary exercise testing
90549|NCT03637647|oesophagogastric|oesophagogastric
90550|NCT03637647|surgery|surgery
90551|NCT03637647|chemotherapy|chemotherapy
90552|NCT03637634|children and adolescents|children and adolescents
90553|NCT03637582|voiding efficiency|voiding efficiency
90554|NCT03637582|detrusor underactivity|detrusor underactivity
90555|NCT03637582|urodynamics|urodynamics
90556|NCT03637556|thalassemia|thalassemia
90557|NCT03637556|iron|iron
90558|NCT03637556|chelation|chelation
90559|NCT03637556|deferasirox|deferasirox
90560|NCT03637556|DST-0509|dst-0509
90561|NCT03637556|transfusion|transfusion
90562|NCT03637543|Prostate Cancer|prostate cancer
90563|NCT03637504|Feasibility|feasibility
90564|NCT03637504|Mobile Medication Plan Application|mobile medication plan application
90565|NCT03637504|Patient Care|patient care
90566|NCT03637504|Nebulized Medications|nebulized medications
90567|NCT03637504|Oral Medications|oral medications
90568|NCT03637504|MedActionPlan|medactionplan
90569|NCT03637504|eTrack Nebulizer|etrack nebulizer
90570|NCT03637504|AdhereTech Pill Bottles|adheretech pill bottles
90571|NCT03637491|Lung Cancer|lung cancer
90572|NCT03637491|NSCLC|nsclc
90573|NCT03637491|KRAS|kras
90574|NCT03637491|NRAS|nras
90575|NCT03637491|PDAC|pdac
90576|NCT03637491|Pancreatic Cancer|pancreatic cancer
90577|NCT03637465|hydration|hydration
90578|NCT03637465|water intake|water intake
90579|NCT03637465|sugar sweetened beverages|sugar sweetened beverages
90580|NCT03637465|youth|youth
90581|NCT03637465|children|children
90582|NCT03637452|e-cigarettes|e-cigarettes
90583|NCT03637452|juul brand e-cigarette|juul brand e-cigarette
90584|NCT03637452|njoy brand e-cigarette|njoy brand e-cigarette
90585|NCT03637452|evolv/mirage DNA 75c brand e-cigarette|evolv/mirage dna 75c brand e-cigarette
90586|NCT03637426|nano-hydroxyapatite|nano-hydroxyapatite
90587|NCT03637426|Laser|laser
90588|NCT03637426|desensitizing|desensitizing
90589|NCT03637413|preterm infants|preterm infants
90590|NCT03637413|hindmilk|hindmilk
90591|NCT03637387|TGN|tgn
90592|NCT03637387|TN|tn
90593|NCT03637374|aortic aneurysm|aortic aneurysm
90594|NCT03637335|irradiation|irradiation
90595|NCT03637335|placebo|placebo
90596|NCT03637335|carboplatin|carboplatin
90597|NCT03637257|Capnography|capnography
90598|NCT03637257|Pediatric|pediatric
90599|NCT03637257|nasal cannula|nasal cannula
90600|NCT03637257|Guedel airway|guedel airway
90601|NCT03637244|HIV PrEP Decision support African Caribbean Black Canadians|hiv prep decision support african caribbean black canadians
90602|NCT03637218|High Altitude|high altitude
90603|NCT03637218|non-invasive cardiac output|non-invasive cardiac output
90604|NCT03637218|Finapres|finapres
90605|NCT03637192|High Altitude|high altitude
90606|NCT03637192|cognitive function|cognitive function
90607|NCT03637179|High Altitude|high altitude
90608|NCT03637179|Pulmonary artery pressure|pulmonary artery pressure
90609|NCT03637179|Echocardiography|echocardiography
90610|NCT03637179|Right heart function|right heart function
90611|NCT03637179|exercise|exercise
90612|NCT03637166|High Altitude|high altitude
90613|NCT03637166|Pulmonary artery pressure|pulmonary artery pressure
90614|NCT03637166|Echocardiography|echocardiography
90615|NCT03637166|Right heart function|right heart function
90616|NCT03637153|exercise capacity|exercise capacity
90617|NCT03637153|High Altitude|high altitude
90618|NCT03637153|contant loaded exercise test|contant loaded exercise test
90619|NCT03637140|Simulated altitude|simulated altitude
90620|NCT03637140|Pulmonary artery pressure|pulmonary artery pressure
90621|NCT03637140|Echocardiography|echocardiography
90622|NCT03637140|Right heart function|right heart function
90623|NCT03637140|exercise|exercise
90624|NCT03637127|Simulated altitude|simulated altitude
90625|NCT03637127|cognitive function|cognitive function
90626|NCT03637114|Simulated altitude|simulated altitude
90627|NCT03637114|arterial blood gas analysis|arterial blood gas analysis
90628|NCT03637114|near infrared spectroscopy|near infrared spectroscopy
90629|NCT03637101|Ischemia modified albumin|ischemia modified albumin
90630|NCT03637101|Traumatic brain injury|traumatic brain injury
90631|NCT03637101|Troponin|troponin
90632|NCT03637101|Conscious Level|conscious level
90633|NCT03637101|Poor outcome|poor outcome
90634|NCT03637088|Simulated altitude|simulated altitude
90635|NCT03637088|Pulmonary artery pressure|pulmonary artery pressure
90636|NCT03637088|Echocardiography|echocardiography
90637|NCT03637088|Right heart function|right heart function
90638|NCT03637075|Diabetes mellitus, Type 2|diabetes mellitus, type 2
90639|NCT03637075|cerebral insulin resistance|cerebral insulin resistance
91040|NCT03634917|Calcium|calcium
90640|NCT03637075|insulin action in the human brain|insulin action in the human brain
90641|NCT03637075|dopamine signalling|dopamine signalling
90642|NCT03637049|PBI-4050|pbi-4050
90643|NCT03637049|drug-drug interaction|drug-drug interaction
90645|NCT03637049|midazolam|midazolam
90646|NCT03637049|healthy subjects|healthy subjects
90647|NCT03637023|fMRI|fmri
90648|NCT03637023|Virtual Reality Therapy|virtual reality therapy
90649|NCT03637023|Exercise Therapy|exercise therapy
90650|NCT03636906|Safety|safety
90651|NCT03636906|Respiratory syncytial virus (RSV)|respiratory syncytial virus (rsv)
90652|NCT03636906|Vaccine|vaccine
90653|NCT03636906|Reactogenicity|reactogenicity
90654|NCT03636906|Immunogenicity|immunogenicity
90655|NCT03636906|Infants|infants
90656|NCT03636893|Neoadjuvant chemotherapy|neoadjuvant chemotherapy
90657|NCT03636893|perioperative chemotherapy|perioperative chemotherapy
90658|NCT03636893|Systemic chemotherapy|systemic chemotherapy
90659|NCT03636893|FLOT|flot
90660|NCT03636893|SOX|sox
90661|NCT03636893|Gastric cancer|gastric cancer
90662|NCT03636880|heart failure|heart failure
90663|NCT03636880|insomnia|insomnia
90664|NCT03636880|anxiety|anxiety
90665|NCT03636880|depression|depression
90666|NCT03636880|memory|memory
90667|NCT03636880|attention|attention
90668|NCT03636880|executive functioning|executive functioning
90669|NCT03636880|decision making|decision making
90670|NCT03636880|self-care|self-care
90671|NCT03636880|quality of life|quality of life
90672|NCT03636880|functional status|functional status
90673|NCT03636880|walk test|walk test
90674|NCT03636880|sleep monitoring|sleep monitoring
90675|NCT03636854|Eccentric|eccentric
90676|NCT03636854|Concentric|concentric
90677|NCT03636854|Strength|strength
90678|NCT03636854|Balance|balance
90679|NCT03636854|Thickness|thickness
90680|NCT03636815|Left ventricular assist device|left ventricular assist device
90681|NCT03636815|Physical therapy|physical therapy
90682|NCT03636776|Quality of Life|quality of life
90683|NCT03636776|Psychological vulnerability|psychological vulnerability
90684|NCT03636724|E-health intervention|e-health intervention
90685|NCT03636724|multiple health behavior change|multiple health behavior change
90686|NCT03636724|Health Action Process Approach Model|health action process approach model
90687|NCT03636724|Cardiac patients|cardiac patients
90688|NCT03636685|Anlotinib|anlotinib
90689|NCT03636685|NSCLC|nsclc
90690|NCT03636685|platinum-based chemotherapy|platinum-based chemotherapy
90691|NCT03636672|falls|falls
90692|NCT03636672|Balance control|balance control
90693|NCT03636672|Aging|aging
90694|NCT03636672|Balance reactions|balance reactions
90695|NCT03636672|Perturbation|perturbation
90696|NCT03636633|Robotic Heart Surgery|robotic heart surgery
90697|NCT03636633|Inspiratory Muscle Training|inspiratory muscle training
90698|NCT03636633|Pulmonary Function Test|pulmonary function test
90699|NCT03636633|6-Minute Walk Test|6-minute walk test
90700|NCT03636633|Respiratory Muscle Strength|respiratory muscle strength
90701|NCT03636633|Functional Capacity|functional capacity
90702|NCT03636594|Dance|dance
90703|NCT03636594|COPD|copd
90704|NCT03636594|Maintenance program|maintenance program
90705|NCT03636594|Pulmonary rehabilitation|pulmonary rehabilitation
90706|NCT03636568|hyponatremia|hyponatremia
90707|NCT03636568|hyponatremic|hyponatremic
90708|NCT03636568|pituitary tumor|pituitary tumor
90709|NCT03636568|transsphenoidal resection|transsphenoidal resection
90710|NCT03636568|pituitary surgery|pituitary surgery
90711|NCT03636568|pituitary|pituitary
90712|NCT03636555|Oxytocin|oxytocin
90713|NCT03636555|Heavy drinking|heavy drinking
90714|NCT03636555|Moderate drinking|moderate drinking
90715|NCT03636529|obese|obese
90716|NCT03636529|overweight|overweight
90717|NCT03636529|tart cherry juice|tart cherry juice
90718|NCT03636503|Lymphoma|lymphoma
90719|NCT03636490|Non-Dipping Blood Pressure|non-dipping blood pressure
90720|NCT03636464|Pharmacokinetics|pharmacokinetics
90721|NCT03636464|antibiotics|antibiotics
90722|NCT03636464|RRT|rrt
90723|NCT03636451|Dilation & curettage|dilation & curettage
90724|NCT03636451|Paracervical block|paracervical block
90725|NCT03636438|gene therapy|gene therapy
90726|NCT03636438|OTC Deficiency|otc deficiency
90727|NCT03636438|Urea Cycle Disorder|urea cycle disorder
90728|NCT03636425|Running|running
90729|NCT03636425|Resistance Training|resistance training
90730|NCT03636425|Mountain|mountain
90731|NCT03636425|Physiotherapy|physiotherapy
90732|NCT03636412|lung transplant|lung transplant
90733|NCT03636412|frailty|frailty
90734|NCT03636399|adults|adults
90735|NCT03636399|rehabilitation|rehabilitation
90736|NCT03636399|social communication disorder|social communication disorder
90737|NCT03636399|cognitive communication disorder|cognitive communication disorder
90738|NCT03636399|groups|groups
90739|NCT03636399|evidence-based|evidence-based
90740|NCT03636386|Electrotherapy|electrotherapy
90741|NCT03636386|Electrolysis|electrolysis
90742|NCT03636386|Myofascial Pain Syndromes|myofascial pain syndromes
90746|NCT03636347|Neutrophil elastase inhibitor|neutrophil elastase inhibitor
90747|NCT03636347|Alpha-1|alpha-1
90748|NCT03636347|Alvelestat|alvelestat
90749|NCT03636347|AZD9668|azd9668
90750|NCT03636347|MPH966|mph966
90751|NCT03636334|Hypertension|hypertension
90752|NCT03636334|Decision support system|decision support system
90753|NCT03636334|Staged cluster randomized controlled trial|staged cluster randomized controlled trial
90754|NCT03636321|living donor liver transplantation|living donor liver transplantation
90755|NCT03636321|intraductal stent|intraductal stent
90756|NCT03636321|biliary complications after liver transplantation|biliary complications after liver transplantation
90757|NCT03636308|advanced pancreatic cancer|advanced pancreatic cancer
90758|NCT03636308|nanoparticle albumin-bound paclitaxel|nanoparticle albumin-bound paclitaxel
90759|NCT03636308|S-1|s-1
90760|NCT03636308|gemcitabine|gemcitabine
90761|NCT03636295|Mechanical valve replacement|mechanical valve replacement
90762|NCT03636295|Vitamin K antagonist|vitamin k antagonist
90763|NCT03636295|INR targets|inr targets
90764|NCT03636295|Bleeding|bleeding
90765|NCT03636295|Thromboembolism|thromboembolism
90766|NCT03636282|Chronic disease|chronic disease
90767|NCT03636282|Men's health|men's health
90768|NCT03636282|Health promotion|health promotion
90769|NCT03636282|Exercise|exercise
90770|NCT03636282|Healthy diet|healthy diet
90771|NCT03636282|Health Technology|health technology
90772|NCT03636282|Weight loss|weight loss
90773|NCT03636282|Hockey|hockey
90774|NCT03636269|Hemodialysis|hemodialysis
90775|NCT03636269|difelikefalin|difelikefalin
90776|NCT03636269|CR845|cr845
90777|NCT03636269|Pruritus|pruritus
90778|NCT03636269|Chronic Itch|chronic itch
90779|NCT03636269|Itch|itch
90780|NCT03636269|Itching|itching
90781|NCT03636269|Uremic Pruritus|uremic pruritus
90782|NCT03636269|Dialysis|dialysis
90783|NCT03636269|CKD|ckd
90784|NCT03636269|CKD-associated pruritus|ckd-associated pruritus
90785|NCT03636269|CKD-aP|ckd-ap
90786|NCT03636269|ESRD (end stage renal disease)|esrd (end stage renal disease)
90787|NCT03636269|KALM|kalm
90788|NCT03636269|Chronic Kidney Disease|chronic kidney disease
90789|NCT03636269|Kidney failure, chronic|kidney failure, chronic
90790|NCT03636269|Kidney dysfunction|kidney dysfunction
90791|NCT03636269|Generalized pruritus|generalized pruritus
90792|NCT03636256|non-muscle invasive bladder cancer|non-muscle invasive bladder cancer
90793|NCT03636256|muscle invasive bladder cancer|muscle invasive bladder cancer
90794|NCT03636256|high-risk bladder cancer|high-risk bladder cancer
90795|NCT03636256|BCG-unresponsive bladder cancer|bcg-unresponsive bladder cancer
90796|NCT03636256|BCG failure|bcg failure
90797|NCT03636256|BCG-refractory bladder cancer|bcg-refractory bladder cancer
90798|NCT03636256|BCG-resistant bladder cancer|bcg-resistant bladder cancer
90799|NCT03636256|NMIBC|nmibc
90800|NCT03636256|MIBC|mibc
90801|NCT03636217|Appetite|appetite
90802|NCT03636217|Probiotic|probiotic
90803|NCT03636217|Glycemic index|glycemic index
90804|NCT03636178|alar base|alar base
90805|NCT03636178|le fort I osteotomy|le fort i osteotomy
90806|NCT03636165|Postoperative Pain|postoperative pain
90807|NCT03636165|Post-Craniotomy Headache|post-craniotomy headache
90808|NCT03636165|Methylprednisolone|methylprednisolone
90809|NCT03636165|Ropivacaine|ropivacaine
90810|NCT03636165|Pre-emptive Scalp Infiltration|pre-emptive scalp infiltration
90811|NCT03636165|Child|child
90812|NCT03636152|chronic kidney disease|chronic kidney disease
90813|NCT03636152|cardiovascular disease|cardiovascular disease
90814|NCT03636152|Inflammation|inflammation
90815|NCT03636152|Atherosclerosis|atherosclerosis
90816|NCT03636152|Vascular stiffness|vascular stiffness
90817|NCT03636100|Atrial fibrillation|atrial fibrillation
90818|NCT03636100|Catheter ablation|catheter ablation
90819|NCT03636100|Cryoballon ablation|cryoballon ablation
90820|NCT03636100|Acetylcholine|acetylcholine
90821|NCT03636100|Ganglionated plexus|ganglionated plexus
90822|NCT03636100|Pulmonary veins|pulmonary veins
90823|NCT03636100|Pulmonary vein isolation|pulmonary vein isolation
90824|NCT03636035|dietary supplement|dietary supplement
90825|NCT03636035|arthritis|arthritis
90826|NCT03636035|joint|joint
90827|NCT03636035|complementary medicine|complementary medicine
90828|NCT03636009|cervical radiculopathy|cervical radiculopathy
90829|NCT03636009|neck pain|neck pain
90830|NCT03636009|neuromobilizations|neuromobilizations
90831|NCT03635996|Paroxysmal supraventricular tachycardia|paroxysmal supraventricular tachycardia
90832|NCT03635996|cardiac monitoring|cardiac monitoring
90833|NCT03635996|atrioventricular nodal reentrant tachycardia|atrioventricular nodal reentrant tachycardia
90834|NCT03635996|atrioventricular reciprocating tachycardia|atrioventricular reciprocating tachycardia
90835|NCT03635996|calcium channel blocker|calcium channel blocker
90836|NCT03635996|conversion rate|conversion rate
90843|NCT03635944|small for gestational age|small for gestational age
90844|NCT03635944|prematurity|prematurity
90845|NCT03635944|breastfeeding|breastfeeding
90846|NCT03635944|fortification|fortification
90847|NCT03635944|parenteral nutrition|parenteral nutrition
90848|NCT03635944|nutrition|nutrition
90850|NCT03635931|lost interdental papilla|lost interdental papilla
90851|NCT03635905|abortion|abortion
90852|NCT03635905|gabapentin|gabapentin
90853|NCT03635905|Neurontin|neurontin
90854|NCT03635905|Dilation and evacuation|dilation and evacuation
90855|NCT03635892|Nivolumab|nivolumab
90856|NCT03635892|Cabozantinib|cabozantinib
90857|NCT03635892|18-254|18-254
90858|NCT03635840|IABP|iabp
90859|NCT03635840|Cardiogenic Shock|cardiogenic shock
90860|NCT03635840|Myocardial Infarction|myocardial infarction
90861|NCT03635814|Clinicaltrial, DME, DR, AMD, imatinib mesylate|clinicaltrial, dme, dr, amd, imatinib mesylate
90862|NCT03635775|non-invasive brain stimulation|non-invasive brain stimulation
90863|NCT03635775|rehabilitation|rehabilitation
90864|NCT03635775|pediatrics|pediatrics
90865|NCT03635762|Nutrition|nutrition
90866|NCT03635762|Behavioral Intervention|behavioral intervention
90867|NCT03635749|Acute Stroke|acute stroke
90868|NCT03635749|Transient Ischemic Attack|transient ischemic attack
90869|NCT03635749|Antiplatelet Therapy|antiplatelet therapy
90870|NCT03635749|Randomized Controlled Trial|randomized controlled trial
90871|NCT03635749|Double Blind Study|double blind study
90872|NCT03635749|Multicenter Study|multicenter study
826778|NCT00127699|Infant care|infant care
90873|NCT03635749|Symptomatic Extracranial or Intracranial Arterial Stenosis|symptomatic extracranial or intracranial arterial stenosis
90874|NCT03635749|Statin Therapy|statin therapy
90875|NCT03635749|Clinical Trial|clinical trial
90876|NCT03635736|brain damage|brain damage
90877|NCT03635736|sonography|sonography
90878|NCT03635723|Technology|technology
90879|NCT03635723|Rehabilitation|rehabilitation
90880|NCT03635723|Wearables|wearables
90881|NCT03635723|Breast surgery|breast surgery
90882|NCT03635723|Physical activity|physical activity
90883|NCT03635723|Enhanced recovery after surgery|enhanced recovery after surgery
90884|NCT03635697|Pregnancy|pregnancy
90885|NCT03635697|Mindfulness|mindfulness
90886|NCT03635697|Anxiety|anxiety
90887|NCT03635697|Depression|depression
90888|NCT03635697|NST|nst
90889|NCT03635697|Non-stress test|non-stress test
90890|NCT03635684|Acetaminophen|acetaminophen
90891|NCT03635684|Palliative Care|palliative care
90892|NCT03635684|Infusions, Subcutaneous|infusions, subcutaneous
90893|NCT03635684|Treatment Outcome|treatment outcome
90894|NCT03635684|Geriatrics|geriatrics
90895|NCT03635684|Gerontology|gerontology
90896|NCT03635671|Imaging|imaging
90897|NCT03635671|Diabetes|diabetes
90898|NCT03635671|OCTA|octa
90899|NCT03635632|Gene Therapy|gene therapy
90900|NCT03635632|CAR T-cells|car t-cells
90901|NCT03635632|Neuroblastoma|neuroblastoma
90902|NCT03635632|chimeric antigen receptor|chimeric antigen receptor
90903|NCT03635632|Immunotherapy|immunotherapy
90904|NCT03635619|Esophageal Cancer|esophageal cancer
90905|NCT03635619|Magnetic Resonance Imaging|magnetic resonance imaging
90906|NCT03635619|Prognosis|prognosis
90907|NCT03635619|neoplasm staging|neoplasm staging
90908|NCT03635567|Programmed Cell Death 1|programmed cell death 1
90909|NCT03635567|PD1|pd1
90910|NCT03635567|PD-1|pd-1
90911|NCT03635567|Programmed Cell Death Ligand 1|programmed cell death ligand 1
90912|NCT03635567|PDL1|pdl1
90913|NCT03635567|PD-L1|pd-l1
90914|NCT03635554|Aphasia|aphasia
90915|NCT03635541|non alcoholic fatty liver disease|non alcoholic fatty liver disease
90916|NCT03635541|non alcoholic steatohepatitis|non alcoholic steatohepatitis
90917|NCT03635541|steatosis|steatosis
90918|NCT03635541|fibrosis|fibrosis
90919|NCT03635541|progression|progression
90920|NCT03635541|risk factors|risk factors
90921|NCT03635476|Stroke Rehabilitation|stroke rehabilitation
90922|NCT03635476|Personalized Nutrition|personalized nutrition
90923|NCT03635476|Mobile-Health|mobile-health
90924|NCT03635476|Stroke|stroke
90925|NCT03635450|hypoxic-ischemic encephalopathy|hypoxic-ischemic encephalopathy
90926|NCT03635450|newborn infants|newborn infants
90927|NCT03635450|therapeutic hypothermia|therapeutic hypothermia
90928|NCT03635450|hCT-MSC, an Umbilical Cord Tissue-Derived Mesenchymal Stromal Cell Product|hct-msc, an umbilical cord tissue-derived mesenchymal stromal cell product
90929|NCT03635437|Remygen|remygen
90930|NCT03635437|GABA|gaba
90931|NCT03635372|Dyspepsia|dyspepsia
90932|NCT03635372|Emergency Department|emergency department
90933|NCT03635372|Antacid|antacid
90934|NCT03635372|Viscous Lidocaine|viscous lidocaine
90935|NCT03635359|fetal|fetal
90936|NCT03635359|screening test|screening test
90937|NCT03635359|trisomy|trisomy
90938|NCT03635359|aneuploidy|aneuploidy
90939|NCT03635359|copy number variant|copy number variant
90940|NCT03635307|Blood Volume expansion|blood volume expansion
90941|NCT03635307|Fluid responsiveness|fluid responsiveness
90942|NCT03635307|Stroke volume|stroke volume
90949|NCT03635242|healed patients|healed patients
90950|NCT03635229|cardiac surgery|cardiac surgery
90951|NCT03635229|perioperative care|perioperative care
90952|NCT03635229|postoperative delirium|postoperative delirium
90953|NCT03635229|postoperative cognitive dysfunction|postoperative cognitive dysfunction
90954|NCT03635216|Cervical cancer|cervical cancer
90955|NCT03635216|Biomarker|biomarker
90956|NCT03635216|Recurrence|recurrence
90957|NCT03635203|C-shaped root canal / C-shaped canals|c-shaped root canal / c-shaped canals
90958|NCT03635190|Peripheral Arterial Diseases|peripheral arterial diseases
90959|NCT03635190|Peripheral Artery Diseases|peripheral artery diseases
90960|NCT03635190|Arterial Occlusive Diseases|arterial occlusive diseases
90961|NCT03635190|Peripheral Vascular Diseases|peripheral vascular diseases
90962|NCT03635164|HPV Negative|hpv negative
90963|NCT03635164|Durvalumab|durvalumab
90964|NCT03635164|Surgical Resection|surgical resection
90965|NCT03635164|Neoadjuvant|neoadjuvant
90966|NCT03635164|Radiation|radiation
90967|NCT03635151|Clinical trial|clinical trial
90975|NCT03635086|Chikungunya virus|chikungunya virus
90976|NCT03635086|mosquito-borne pathogen|mosquito-borne pathogen
90977|NCT03635086|chikungunya fever|chikungunya fever
90978|NCT03635086|Phase II|phase ii
90979|NCT03635034|urinary catheter|urinary catheter
90980|NCT03635034|catheter ablation procedures|catheter ablation procedures
90981|NCT03635021|colorectal cancer|colorectal cancer
90983|NCT03635021|FOLFIRI|folfiri
90984|NCT03635021|panitumumab|panitumumab
90985|NCT03635021|bevacizumab|bevacizumab
90986|NCT03635021|wild-type RAS|wild-type ras
90987|NCT03635021|primary left-sided|primary left-sided
90988|NCT03634982|SHP2|shp2
90989|NCT03634982|PTPN11|ptpn11
90990|NCT03634982|NSCLC|nsclc
90991|NCT03634982|EGFR|egfr
90992|NCT03634982|RTK|rtk
90993|NCT03634982|KRAS G12|kras g12
90994|NCT03634982|BRAF Class 3|braf class 3
90995|NCT03634982|NF1 LOF|nf1 lof
90996|NCT03634982|advanced solid tumor|advanced solid tumor
90997|NCT03634982|advanced solid malignancies|advanced solid malignancies
90998|NCT03634982|melanoma|melanoma
90999|NCT03634982|skin cancer|skin cancer
91000|NCT03634982|ovarian cancer|ovarian cancer
91001|NCT03634982|pancreatic cancer|pancreatic cancer
91002|NCT03634982|endometrium/uterus cancer|endometrium/uterus cancer
91003|NCT03634982|bladder cancer|bladder cancer
91004|NCT03634982|cervical cancer|cervical cancer
91005|NCT03634982|Carcinoma, Non-Small-Cell Lung|carcinoma, non-small-cell lung
91006|NCT03634982|Neoplasms, Squamous Cell|neoplasms, squamous cell
91007|NCT03634982|Carcinoma, Squamous Cell|carcinoma, squamous cell
91008|NCT03634982|Esophageal Neoplasms|esophageal neoplasms
91009|NCT03634982|Carcinoma, Bronchogenic|carcinoma, bronchogenic
91010|NCT03634982|Bronchial Neoplasms|bronchial neoplasms
91011|NCT03634982|Lung Neoplasms|lung neoplasms
91012|NCT03634982|Respiratory Tract Neoplasms|respiratory tract neoplasms
91013|NCT03634982|Thoracic Neoplasms|thoracic neoplasms
91014|NCT03634982|Neoplasms by Site|neoplasms by site
91015|NCT03634982|Neoplasms|neoplasms
91016|NCT03634982|Lung Diseases|lung diseases
91017|NCT03634982|Respiratory Tract Diseases|respiratory tract diseases
91018|NCT03634982|Neoplasms, Glandular and Epithelial|neoplasms, glandular and epithelial
91019|NCT03634982|Gastrointestinal Neoplasms|gastrointestinal neoplasms
91020|NCT03634982|Digestive System Neoplasms|digestive system neoplasms
91021|NCT03634982|Head and Neck Neoplasms|head and neck neoplasms
91022|NCT03634982|Digestive System Diseases|digestive system diseases
91023|NCT03634982|Esophageal Diseases|esophageal diseases
91024|NCT03634982|Gastrointestinal Diseases|gastrointestinal diseases
91025|NCT03634956|multinoduler goitre|multinoduler goitre
91026|NCT03634956|thyroid cancer|thyroid cancer
91027|NCT03634956|sugammadex sodium|sugammadex sodium
91028|NCT03634956|intraoperative nerve monitorization|intraoperative nerve monitorization
91029|NCT03634943|Clinical Practice Guidelines|clinical practice guidelines
91030|NCT03634930|Breast Feeding, Exclusive versus Formula Feeding, Exclusive|breast feeding, exclusive versus formula feeding, exclusive
91031|NCT03634930|satiety cues|satiety cues
91032|NCT03634930|childhood obesity|childhood obesity
91033|NCT03634930|biomarker|biomarker
91034|NCT03634930|nutritional status|nutritional status
91035|NCT03634930|infant body composition|infant body composition
91036|NCT03634930|infant weight gain velocity|infant weight gain velocity
91037|NCT03634930|metabolic programming|metabolic programming
91038|NCT03634930|inflammation|inflammation
91039|NCT03634917|Acamprosate|acamprosate
91041|NCT03634917|alcohol self-administration|alcohol self-administration
91042|NCT03634904|antibiotic dosing|antibiotic dosing
91043|NCT03634904|pharmacokinetics|pharmacokinetics
91044|NCT03634904|pharmacodynamics|pharmacodynamics
91045|NCT03634904|hemodialysis|hemodialysis
91046|NCT03634865|Bone trauma-fracture|bone trauma-fracture
91047|NCT03634865|Radius|radius
91048|NCT03634865|CT-scan|ct-scan
91049|NCT03634865|Internal fixation|internal fixation
91050|NCT03634852|IC Moxifloxacin hydrochloride|ic moxifloxacin hydrochloride
91051|NCT03634852|SC triamcinolone acetonide|sc triamcinolone acetonide
91052|NCT03634826|circulating tumor DNA|circulating tumor dna
91053|NCT03634826|ctDNA methylation|ctdna methylation
91054|NCT03634826|lung cancer|lung cancer
91055|NCT03634826|surveillance|surveillance
91056|NCT03634787|Heat Shock Proteins, early diagnosis|heat shock proteins, early diagnosis
91057|NCT03634774|meals|meals
91058|NCT03634774|staff training|staff training
91059|NCT03634761|Program Quality|program quality
91060|NCT03634761|Intervention Setting|intervention setting
91061|NCT03634761|Autism|autism
91062|NCT03634735|Inflammatory Bowel Disease|inflammatory bowel disease
91063|NCT03634735|Fatigue|fatigue
91064|NCT03634735|Thiamine|thiamine
91065|NCT03634735|Vitamin B1|vitamin b1
91066|NCT03634722|transcutaneous electrical nerve stimulation;|transcutaneous electrical nerve stimulation;
91067|NCT03634696|Late-stage|late-stage
91068|NCT03634696|Palliative care|palliative care
91069|NCT03634696|Novel technology|novel technology
91070|NCT03634696|Communication|communication
91071|NCT03634683|recurrent hepatocellular carcinoma|recurrent hepatocellular carcinoma
91072|NCT03634683|hepatitis B virus-related|hepatitis b virus-related
91073|NCT03634683|post liver transplantation|post liver transplantation
91074|NCT03634683|HCC|hcc
91075|NCT03634657|Scattered radiation|scattered radiation
91076|NCT03634657|X-ray protection|x-ray protection
91077|NCT03634657|Radiation in cath lab|radiation in cath lab
91078|NCT03634644|male infertility|male infertility
91079|NCT03634644|oligoasthenoteratospermia|oligoasthenoteratospermia
91080|NCT03634618|carpal tunnel syndrome|carpal tunnel syndrome
91081|NCT03634618|mirror therapy|mirror therapy
91082|NCT03634618|postoperative rehabilitation|postoperative rehabilitation
91083|NCT03634618|physical therapy modalities|physical therapy modalities
91084|NCT03634618|median nerve|median nerve
91085|NCT03634605|Tetracycline|tetracycline
91086|NCT03634605|Pleurodesis|pleurodesis
91087|NCT03634579|Cancer/Carcinogenesis|cancer/carcinogenesis
91088|NCT03634579|Laser Treatment|laser treatment
91089|NCT03634579|Magnetic Resonance Imaging (MRI)|magnetic resonance imaging (mri)
91090|NCT03634579|Radiology|radiology
91091|NCT03634488|sickle cell disease|sickle cell disease
91092|NCT03634488|sub-Saharan Africa|sub-saharan africa
91093|NCT03634488|malnutrition|malnutrition
91094|NCT03634488|low-income settings|low-income settings
91095|NCT03634488|severe acute malnutrition|severe acute malnutrition
91096|NCT03634488|sickle cell anemia|sickle cell anemia
91097|NCT03634488|Nigeria|nigeria
91098|NCT03634462|lipedema|lipedema
91099|NCT03634462|lymphedema|lymphedema
91100|NCT03634462|therapy|therapy
91101|NCT03634462|sodium|sodium
91102|NCT03634462|swelling|swelling
91103|NCT03634436|SHR-1209 Phase 1|shr-1209 phase 1
91104|NCT03634423|Interest in exercising more|interest in exercising more
91105|NCT03634384|Myocardial Infarction|myocardial infarction
91106|NCT03634384|Chest Pain|chest pain
91107|NCT03634358|bipolar|bipolar
91108|NCT03634358|scalpel|scalpel
91109|NCT03634358|foreskin|foreskin
91110|NCT03634358|prepuce|prepuce
91111|NCT03634345|Atopic dermatitis|atopic dermatitis
91112|NCT03634332|pancreatic|pancreatic
91113|NCT03634332|pancreas|pancreas
91114|NCT03634332|cancer|cancer
91115|NCT03634332|adenocarcinoma|adenocarcinoma
91116|NCT03634306|Visual clearing System Laparoscopic Hysterectomy Myomectomy|visual clearing system laparoscopic hysterectomy myomectomy
91117|NCT03634293|sepsis|sepsis
91118|NCT03634293|septic shock|septic shock
91119|NCT03634293|PCSK9 INHIBITOR|pcsk9 inhibitor
91120|NCT03634280|Ankle Sprains|ankle sprains
91121|NCT03634280|Kinesio Tape|kinesio tape
91122|NCT03634280|Splint|splint
91123|NCT03634254|AAC|aac
91124|NCT03634254|Satisfaction level of communication quality|satisfaction level of communication quality
91125|NCT03634202|Intensity Modulated Radiotherapy|intensity modulated radiotherapy
91126|NCT03634202|Simultaneous Integrated Boost|simultaneous integrated boost
91127|NCT03634202|Low and middle Rectal carcinoma|low and middle rectal carcinoma
91128|NCT03634189|Cannabidiol|cannabidiol
91129|NCT03634189|Heart Failure|heart failure
91130|NCT03634189|AHA/ACC stage A-C|aha/acc stage a-c
91131|NCT03634163|disability|disability
91132|NCT03634137|Afamelanotide|afamelanotide
91133|NCT03634137|Nontherapeutic Human Experimentation in healthy volunteers|nontherapeutic human experimentation in healthy volunteers
91134|NCT03634111|transversus abdominis plane block (TAP block)|transversus abdominis plane block (tap block)
91135|NCT03634111|postoperative analgesia|postoperative analgesia
91136|NCT03634111|cesarean section|cesarean section
91137|NCT03634098|Patients|patients
91138|NCT03634085|safety|safety
91139|NCT03634085|tolerability|tolerability
91140|NCT03634085|pharmacokinetics|pharmacokinetics
91141|NCT03634046|Lumbar Disc Herniation|lumbar disc herniation
91142|NCT03634046|Low Back Pain|low back pain
91143|NCT03634046|Percutaneous Transforaminal Endoscopic Discectomy|percutaneous transforaminal endoscopic discectomy
91144|NCT03634046|Radiofrequency Ablation|radiofrequency ablation
91145|NCT03634033|Implementation Science|implementation science
91146|NCT03634033|Adoption|adoption
91147|NCT03634033|Sustainability|sustainability
91148|NCT03633994|Randomized controlled trial|randomized controlled trial
91149|NCT03633994|Heparin instillation|heparin instillation
91150|NCT03633968|sinus augmentation,lifting|sinus augmentation,lifting
91151|NCT03633955|FLT|flt
91152|NCT03633916|adolescents|adolescents
91153|NCT03633916|urban|urban
91154|NCT03633916|school|school
91155|NCT03633916|demand for mental health care|demand for mental health care
91156|NCT03633903|Early life stress|early life stress
91157|NCT03633903|Adolescent|adolescent
91158|NCT03633903|Mindfulness|mindfulness
91159|NCT03633903|Neurobiological|neurobiological
91160|NCT03633903|Stress|stress
91161|NCT03633903|Resilience|resilience
91162|NCT03633864|IgA nephropathy|iga nephropathy
91163|NCT03633864|fecal microbiota transplantation|fecal microbiota transplantation
91164|NCT03633825|suicide|suicide
91165|NCT03633825|mental health crisis|mental health crisis
91166|NCT03633825|crisis referrals|crisis referrals
91167|NCT03633825|help-seeking|help-seeking
91168|NCT03633825|risk assessment|risk assessment
91169|NCT03633825|treatment barrier|treatment barrier
91170|NCT03633812|End Stage Liver Disease|end stage liver disease
91171|NCT03633812|Acute Kidney Injury|acute kidney injury
91172|NCT03633812|Beta blocker|beta blocker
91173|NCT03633786|endometriosis|endometriosis
91174|NCT03633786|robot-assisted surgery|robot-assisted surgery
91175|NCT03633786|standard laparoscopic surgery|standard laparoscopic surgery
91177|NCT03633773|Mucin-1|mucin-1
91178|NCT03633773|CAR-T|car-t
91179|NCT03633773|Immunotherapy|immunotherapy
91180|NCT03633747|hepatic hemangioma|hepatic hemangioma
117301|NCT03470142|NOSES|noses
91181|NCT03633747|propranolol|propranolol
91182|NCT03633734|Pancreatic cancer|pancreatic cancer
91183|NCT03633734|Pancreatic Adenocarcinoma|pancreatic adenocarcinoma
91184|NCT03633734|Gemcitabine|gemcitabine
91185|NCT03633734|Nab-paclitaxel|nab-paclitaxel
91186|NCT03633734|Modified Folfirinox|modified folfirinox
91187|NCT03633734|Sequential treatment|sequential treatment
91188|NCT03633721|mobility|mobility
91189|NCT03633721|cognition|cognition
91190|NCT03633721|WIHS|wihs
91191|NCT03633708|sHPT|shpt
91192|NCT03633708|CKD|ckd
91193|NCT03633708|pediatric|pediatric
91194|NCT03633695|Cataract|cataract
91195|NCT03633695|Intraocular lens|intraocular lens
91196|NCT03633643|Greenlight Laser Vaporisation of the Prostate|greenlight laser vaporisation of the prostate
91197|NCT03633643|Transurethral resection of the prostate|transurethral resection of the prostate
91198|NCT03633643|Cotrimoxazole Prophylaxis|cotrimoxazole prophylaxis
91199|NCT03633630|Amla|amla
91200|NCT03633630|Emblica officinalis|emblica officinalis
91201|NCT03633630|Metabolic Syndrome|metabolic syndrome
91202|NCT03633630|Insulin Secretion|insulin secretion
91203|NCT03633630|Insulin Sensitivity|insulin sensitivity
91204|NCT03633604|Hematologic Diseases|hematologic diseases
91205|NCT03633604|Blood Substitutes|blood substitutes
91206|NCT03633552|Glioblastoma Multiforme|glioblastoma multiforme
91207|NCT03633552|Anaplastic Astrocytoma|anaplastic astrocytoma
91208|NCT03633552|Adjuvant treatment|adjuvant treatment
91209|NCT03633552|Extended chemotherapy|extended chemotherapy
91210|NCT03633539|SILS|sils
91211|NCT03633539|colorectal cancer|colorectal cancer
91212|NCT03633513|Immune System|immune system
91213|NCT03633513|Immunology|immunology
91214|NCT03633513|Neuroinflammation|neuroinflammation
91215|NCT03633513|Inflammation|inflammation
91216|NCT03633513|Neuroprotection|neuroprotection
91217|NCT03633500|Colostrum|colostrum
91218|NCT03633500|Oral immune therapy|oral immune therapy
91219|NCT03633500|Preterm|preterm
91220|NCT03633500|Oral feeding|oral feeding
91221|NCT03633500|Sepsis|sepsis
91222|NCT03633474|Healthy volunteer|healthy volunteer
91223|NCT03633474|Human Challenge study|human challenge study
91224|NCT03633422|Rehabilitation|rehabilitation
91225|NCT03633422|Screening|screening
91226|NCT03633422|Enrollment|enrollment
91227|NCT03633409|IBD|ibd
91228|NCT03633409|EBI2|ebi2
91229|NCT03633409|G protein coupled receptor|g protein coupled receptor
91230|NCT03633409|FACS|facs
91231|NCT03633409|UBAC2|ubac2
91232|NCT03633409|lymphocyte migration|lymphocyte migration
91233|NCT03633409|single nucleotide polymorphism|single nucleotide polymorphism
91234|NCT03633396|PPP|ppp
91235|NCT03633370|Cardiac Arrest|cardiac arrest
91236|NCT03633370|Dispatcher|dispatcher
91237|NCT03633370|Cardiopulmonary Resuscitation|cardiopulmonary resuscitation
91238|NCT03633357|Bipolar Disorder|bipolar disorder
91239|NCT03633357|Cognitive Impairment|cognitive impairment
91240|NCT03633344|Diarrhoea|diarrhoea
91241|NCT03633344|Carbowhite|carbowhite
91242|NCT03633344|Colloidal silicon dioxide|colloidal silicon dioxide
91243|NCT03633318|electrical impedance myography|electrical impedance myography
91245|NCT03633305|Insomnia|insomnia
91246|NCT03633305|Pragmatic Clinical Trial|pragmatic clinical trial
91247|NCT03633305|Drug Therapy|drug therapy
91248|NCT03633305|Cognitive Behavior Therapy|cognitive behavior therapy
91249|NCT03633305|Primary Care|primary care
91250|NCT03633227|Primary Biliary Cholangitis|primary biliary cholangitis
91251|NCT03633227|Primary Biliary Cirrhosis|primary biliary cirrhosis
91252|NCT03633227|PBC|pbc
91253|NCT03633227|Hepatic Impairment|hepatic impairment
91254|NCT03633227|Cirrhosis|cirrhosis
91255|NCT03633227|Liver|liver
91256|NCT03633214|Prostatic neoplasms|prostatic neoplasms
91257|NCT03633214|Mass screening|mass screening
91258|NCT03633214|General practitioners|general practitioners
91259|NCT03633214|Primary health care|primary health care
91260|NCT03633214|Clinical trial|clinical trial
91261|NCT03633188|Bone and Joint Infections (BJI)|bone and joint infections (bji)
91262|NCT03633188|gut dysbiosis|gut dysbiosis
91263|NCT03633188|antimicrobial resistance|antimicrobial resistance
91264|NCT03633188|antibiotic resistance gene|antibiotic resistance gene
91265|NCT03633188|mobile genetic elements|mobile genetic elements
91266|NCT03633162|Maternal Grandmother|maternal grandmother
91267|NCT03633162|Genes|genes
91268|NCT03633162|Immune|immune
91269|NCT03633162|Cohort|cohort
91270|NCT03633162|Child development|child development
91271|NCT03633149|prenatal alcohol exposure|prenatal alcohol exposure
91272|NCT03633149|marijuana|marijuana
91273|NCT03633149|smoking cessation|smoking cessation
91274|NCT03633149|computer-delivered intervention|computer-delivered intervention
91275|NCT03633149|contraception|contraception
91276|NCT03633149|behavioral intervention|behavioral intervention
91277|NCT03633149|motivational interviewing|motivational interviewing
91278|NCT03633136|video|video
91279|NCT03633136|patient education|patient education
91280|NCT03633123|Surgical site infection|surgical site infection
91281|NCT03633123|Abdominal surgery|abdominal surgery
91282|NCT03633123|Colon and small bowl surgery|colon and small bowl surgery
91283|NCT03633110|Vaccine|vaccine
91284|NCT03633110|Personalized|personalized
91285|NCT03633110|Immunotherapy|immunotherapy
91286|NCT03633110|Solid Tumor|solid tumor
91287|NCT03633110|Personal|personal
91288|NCT03633110|Skin|skin
91289|NCT03633110|Lung|lung
91290|NCT03633110|Cancer|cancer
91291|NCT03633110|Bladder|bladder
91292|NCT03633110|Kidney|kidney
91293|NCT03633110|Melanoma|melanoma
91294|NCT03633110|Carcinoma|carcinoma
91295|NCT03633058|MECP2|mecp2
91296|NCT03633058|RTT|rtt
91297|NCT03633058|Retts|retts
91298|NCT03633058|ketamine|ketamine
91299|NCT03633045|CLL, chronic lymphocytic leukemia, ibrutinib|cll, chronic lymphocytic leukemia, ibrutinib
91300|NCT03633032|bone imaging; MRI; UTE; radiation-free; ultrashort echo time ; anatomy|bone imaging; mri; ute; radiation-free; ultrashort echo time ; anatomy
91301|NCT03633019|thrombocytopenia|thrombocytopenia
91302|NCT03633019|rhTPO|rhtpo
91303|NCT03633019|real-world study|real-world study
91304|NCT03633019|safety|safety
91305|NCT03633019|efficacy|efficacy
91306|NCT03632993|Edematous Fibrosclerotic Panniculopathy|edematous fibrosclerotic panniculopathy
91307|NCT03632993|Cellulite|cellulite
91308|NCT03632993|Collagenase Clostridium Histolyticum|collagenase clostridium histolyticum
91309|NCT03632980|HIFU|hifu
91310|NCT03632980|Localized Prostate cancer|localized prostate cancer
91312|NCT03632980|PSA nadir|psa nadir
91313|NCT03632980|Biopsy|biopsy
91314|NCT03632980|High Intensity Focused Ultrasound|high intensity focused ultrasound
91315|NCT03632980|Prostate Specific Antigen (PSA)|prostate specific antigen (psa)
91316|NCT03632954|Wounds|wounds
91317|NCT03632954|ACell|acell
91318|NCT03632954|ACell MicroMatrix®|acell micromatrix®
91319|NCT03632954|ACell Cytal® Wound Matrix|acell cytal® wound matrix
91320|NCT03632954|Extracellular Matrix|extracellular matrix
91321|NCT03632954|Urinary Bladder Matrix|urinary bladder matrix
91322|NCT03632941|Cancer|cancer
91323|NCT03632941|Immunotherapy|immunotherapy
91324|NCT03632941|PD-1 Antibody|pd-1 antibody
91325|NCT03632941|HER2|her2
91326|NCT03632941|T cell|t cell
91327|NCT03632928|Ultrasound elastography|ultrasound elastography
91328|NCT03632928|Pressure pain threshold|pressure pain threshold
91329|NCT03632928|variation|variation
91330|NCT03632915|Antiepileptics|antiepileptics
91331|NCT03632915|Continuous Renal Replacement Therapy|continuous renal replacement therapy
91332|NCT03632902|supraglottic devices|supraglottic devices
91333|NCT03632876|Retinol|retinol
91334|NCT03632876|Stable isotope dilution|stable isotope dilution
91335|NCT03632876|DXA|dxa
91336|NCT03632876|retinyl palmitate|retinyl palmitate
91337|NCT03632863|Pregnancy|pregnancy
91338|NCT03632863|Depression|depression
91339|NCT03632863|Antidepressant Use|antidepressant use
91340|NCT03632863|Decision Aid|decision aid
91341|NCT03632850|pancreatic cancer|pancreatic cancer
91342|NCT03632850|shared decision-making|shared decision-making
91345|NCT03632850|mixed methods|mixed methods
91346|NCT03632837|extracorporal circulation|extracorporal circulation
91347|NCT03632837|hemoadsorption|hemoadsorption
91348|NCT03632837|post resuscitation syndrome|post resuscitation syndrome
91349|NCT03632824|Placental abruption|placental abruption
91350|NCT03632824|Placenta previa|placenta previa
91351|NCT03632824|Threatened|threatened
91352|NCT03632824|Miscarriage|miscarriage
91353|NCT03632811|cutaneous mastocytosis|cutaneous mastocytosis
91354|NCT03632811|indolent systemic mastocytosis|indolent systemic mastocytosis
91355|NCT03632811|quality of life questionnaire in mastocytosis patient|quality of life questionnaire in mastocytosis patient
91356|NCT03632798|ChemoID|chemoid
91357|NCT03632798|cancer stem cells|cancer stem cells
91358|NCT03632798|drug response assay|drug response assay
91359|NCT03632798|ovarian cancer|ovarian cancer
91360|NCT03632785|Platelet|platelet
91361|NCT03632785|Coronary stenosis|coronary stenosis
91362|NCT03632785|Coronary angiography|coronary angiography
91363|NCT03632772|Overactive bladder|overactive bladder
91364|NCT03632772|Transurethral Resection of the Prostate|transurethral resection of the prostate
91365|NCT03632772|Pharmacotherapy|pharmacotherapy
91366|NCT03632772|Mirabegron|mirabegron
91367|NCT03632772|Solifenacin|solifenacin
91368|NCT03632694|cancer survivor|cancer survivor
91369|NCT03632694|cancer survivorship|cancer survivorship
91370|NCT03632694|light physical activity|light physical activity
91371|NCT03632694|sedentary behavior|sedentary behavior
91372|NCT03632694|mHealth|mhealth
91373|NCT03632694|Jawbone|jawbone
91374|NCT03632681|Cognitive processes|cognitive processes
91375|NCT03632681|Reward processes|reward processes
91376|NCT03632681|fMRI|fmri
91377|NCT03632681|Insulin|insulin
91378|NCT03632629|cognitive training|cognitive training
91379|NCT03632629|developmental delay|developmental delay
91380|NCT03632629|children|children
91381|NCT03632629|therapeutic effect|therapeutic effect
826779|NCT00127686|cough|cough
117543|NCT03468621|suture|suture
91382|NCT03632616|chronic pancreatitis|chronic pancreatitis
91383|NCT03632616|quality of life|quality of life
91384|NCT03632590|Magnesium|magnesium
91385|NCT03632590|Supplements|supplements
91386|NCT03632577|High Flow Oxygen|high flow oxygen
91387|NCT03632577|Non Invasive Ventilation|non invasive ventilation
91388|NCT03632577|Automated Flow Oxygen Titration|automated flow oxygen titration
91389|NCT03632577|respiratory risk|respiratory risk
91390|NCT03632551|Mismatch negativity|mismatch negativity
91391|NCT03632551|EEG|eeg
91392|NCT03632551|Single sided deafness|single sided deafness
91393|NCT03632551|Cochlear implant|cochlear implant
91394|NCT03632551|Asymmetrical hearing loss|asymmetrical hearing loss
91395|NCT03632551|Spatial hearing|spatial hearing
91396|NCT03632551|Binaural hearing|binaural hearing
91397|NCT03632551|Localization|localization
91398|NCT03632538|Acute Kidney Injury|acute kidney injury
91399|NCT03632538|Cardiac Surgery|cardiac surgery
91400|NCT03632512|Hericium erinaceus|hericium erinaceus
91401|NCT03632512|Hearing|hearing
91402|NCT03632486|Ultrasound|ultrasound
91403|NCT03632486|Dengue|dengue
91404|NCT03632473|Multimodal Evoked potentials|multimodal evoked potentials
91405|NCT03632473|Visual evoked potentials|visual evoked potentials
91406|NCT03632473|Somato-sensory evoked potentials|somato-sensory evoked potentials
91407|NCT03632473|Motor evoked potentials|motor evoked potentials
91408|NCT03632473|Expanded Disability Status Scale (EDSS)|expanded disability status scale (edss)
91409|NCT03632447|Digital Health|digital health
91410|NCT03632447|Female|female
91411|NCT03632395|gastric cancer|gastric cancer
91412|NCT03632395|postoperative complication|postoperative complication
91413|NCT03632395|anastomotic leak|anastomotic leak
91414|NCT03632395|oral contrast agent|oral contrast agent
91415|NCT03632395|computed tomography|computed tomography
91416|NCT03632382|Sleep apnea diagnosis|sleep apnea diagnosis
91417|NCT03632382|3D acquisition|3d acquisition
91418|NCT03632369|MRI|mri
91419|NCT03632369|Hyperpolarized|hyperpolarized
91420|NCT03632369|xenon-129|xenon-129
91421|NCT03632343|self-management|self-management
91422|NCT03632343|pain|pain
91423|NCT03632343|adolescents|adolescents
91424|NCT03632343|mHealth|mhealth
91425|NCT03632317|H3.1K27M|h3.1k27m
91426|NCT03632317|H3.3K27M|h3.3k27m
91427|NCT03632317|diffuse intrinsic pontine glioma|diffuse intrinsic pontine glioma
91428|NCT03632317|DIPG|dipg
91429|NCT03632317|high-grade glioma|high-grade glioma
91430|NCT03632317|pediatric glioma|pediatric glioma
91431|NCT03632317|H3K27M|h3k27m
91432|NCT03632317|panobinostat|panobinostat
91433|NCT03632304|hand surgery|hand surgery
91434|NCT03632304|quality of recovery|quality of recovery
91435|NCT03632304|local anesthesia|local anesthesia
91436|NCT03632304|regional anesthesia|regional anesthesia
91437|NCT03632304|QoR-15|qor-15
91438|NCT03632291|UB-221|ub-221
91439|NCT03632291|anti-IgE monoclonal antibody|anti-ige monoclonal antibody
91440|NCT03632291|chronic spontaneous urticaria (CSU)|chronic spontaneous urticaria (csu)
91448|NCT03632213|Mucopolysaccharidoses|mucopolysaccharidoses
91450|NCT03632213|Aortic root dilatation|aortic root dilatation
91451|NCT03632213|Echocardiogram|echocardiogram
91452|NCT03632213|MPS IV|mps iv
91453|NCT03632213|MPS VI|mps vi
91454|NCT03632174|Probiotic|probiotic
91455|NCT03632174|Atopic Dermatitis|atopic dermatitis
91456|NCT03632174|Lactobacillus reuteri|lactobacillus reuteri
91457|NCT03632135|ChemoID|chemoid
91458|NCT03632135|Cancer stem cells|cancer stem cells
91459|NCT03632135|Drug response assay|drug response assay
91460|NCT03632135|Glioblastoma|glioblastoma
91461|NCT03632135|Brain Cancer|brain cancer
91462|NCT03632122|comorbidity|comorbidity
91463|NCT03632122|pain|pain
91464|NCT03632122|function|function
91465|NCT03632122|older adults|older adults
91466|NCT03632122|Medicare|medicare
91467|NCT03632109|gonorrhea|gonorrhea
91468|NCT03632109|pharynx|pharynx
91469|NCT03632109|treatment|treatment
91470|NCT03632109|gentamicin|gentamicin
91471|NCT03632031|partial and full-thickness wounds|partial and full-thickness wounds
91472|NCT03632031|pressure ulcer|pressure ulcer
91473|NCT03632031|venous ulcer|venous ulcer
91474|NCT03632031|chronic vascular ulcer|chronic vascular ulcer
91475|NCT03632031|diabetic ulcer|diabetic ulcer
91476|NCT03632018|cardiac rehabilitation|cardiac rehabilitation
91477|NCT03632018|physical activity|physical activity
91478|NCT03632005|Surgical Site Infection|surgical site infection
91479|NCT03631992|Children|children
91480|NCT03631992|Sugar|sugar
91481|NCT03631992|Taste|taste
91482|NCT03631992|Snacking|snacking
91483|NCT03631992|Biomarker|biomarker
91484|NCT03631992|Mothers|mothers
91485|NCT03631940|Umbilical Cord Milking|umbilical cord milking
91486|NCT03631940|Immediate Cord Clamping|immediate cord clamping
91487|NCT03631940|Resuscitation|resuscitation
91488|NCT03631927|critical care unit|critical care unit
91489|NCT03631901|Melatonin|melatonin
91490|NCT03631901|Diazepam|diazepam
91491|NCT03631901|recurrence|recurrence
91492|NCT03631901|prophylaxis|prophylaxis
91493|NCT03631901|Febrile convulsions|febrile convulsions
91494|NCT03631862|peripheral T-cell lymphoma|peripheral t-cell lymphoma
91495|NCT03631862|Apatinib|apatinib
91496|NCT03631862|targeted therapy|targeted therapy
91497|NCT03631862|RR|rr
91498|NCT03631862|PFS|pfs
91499|NCT03631810|Acute pulmonary embolism|acute pulmonary embolism
91500|NCT03631810|International guidelines|international guidelines
91501|NCT03631797|Thoracic Surgery|thoracic surgery
91502|NCT03631797|Microcirculation|microcirculation
91503|NCT03631797|Endothelium, vascular|endothelium, vascular
91504|NCT03631797|Microvascular reactivity|microvascular reactivity
91505|NCT03631797|Laser Speckle|laser speckle
91506|NCT03631784|PD1|pd1
91507|NCT03631784|PD-1|pd-1
91508|NCT03631784|PDL1|pdl1
91509|NCT03631784|PD-L1|pd-l1
91510|NCT03631771|Hypothyroidism|hypothyroidism
91511|NCT03631771|Child|child
91512|NCT03631771|Iodine|iodine
91513|NCT03631771|Iodinated contrast medium (ICM)|iodinated contrast medium (icm)
91514|NCT03631771|Thyroid function test (TFT)|thyroid function test (tft)
91515|NCT03631771|Iodixanol|iodixanol
91516|NCT03631771|Iohexol|iohexol
91517|NCT03631771|Iopromide|iopromide
91518|NCT03631771|Ioversol|ioversol
91519|NCT03631758|Screening|screening
91520|NCT03631758|Mammography|mammography
91521|NCT03631758|Patient Decision Aid|patient decision aid
91522|NCT03631745|mental health literacy|mental health literacy
91523|NCT03631745|stigma|stigma
91524|NCT03631745|help-seeking|help-seeking
91525|NCT03631745|Latino|latino
91526|NCT03631745|faith-based|faith-based
91527|NCT03631745|religious congregations|religious congregations
91528|NCT03631745|contact-based interventions|contact-based interventions
91529|NCT03631719|Wolbachia|wolbachia
91530|NCT03631719|Colombia|colombia
91531|NCT03631719|Dengue|dengue
91532|NCT03631719|Zika|zika
91533|NCT03631719|Chikungunya|chikungunya
91534|NCT03631719|Arboviral diseases|arboviral diseases
91535|NCT03631719|Disease surveillance|disease surveillance
91536|NCT03631706|M7824|m7824
91537|NCT03631706|Pembrolizumab|pembrolizumab
91538|NCT03631706|PD-L1-tumor Expression|pd-l1-tumor expression
91539|NCT03631706|INTR@PID Lung 037|intr@pid lung 037
91540|NCT03631706|Bintrafusp alfa|bintrafusp alfa
91541|NCT03631693|postoperative healing|postoperative healing
91542|NCT03631667|Benzo[a]pyrene|benzo[a]pyrene
91543|NCT03631667|Accelerator Mass Spectrometry|accelerator mass spectrometry
91544|NCT03631667|Polycyclic Aromatic Hydrocarbons|polycyclic aromatic hydrocarbons
91545|NCT03631667|Phenanthrene|phenanthrene
91546|NCT03631615|neoadjuvant chemoradiation|neoadjuvant chemoradiation
91547|NCT03631615|PD-1 antibody(SHR-1210)|pd-1 antibody(shr-1210)
91640|NCT03631004|nausea and vomiting|nausea and vomiting
91561|NCT03631407|microsatellite stable (MSS) colorectal cancer (CRC)|microsatellite stable (mss) colorectal cancer (crc)
91562|NCT03631407|chemokine receptor type 5 (CCR5)|chemokine receptor type 5 (ccr5)
91563|NCT03631342|Ventilator Hyperinflation|ventilator hyperinflation
91565|NCT03631342|Mechanical Ventilation|mechanical ventilation
91566|NCT03631316|valganciclovir|valganciclovir
91567|NCT03631316|kidney transplantation|kidney transplantation
91568|NCT03631316|pharmacokinetics|pharmacokinetics
91569|NCT03631303|Implantable cardioverter defibrillator|implantable cardioverter defibrillator
91570|NCT03631303|Post-extrasystolic Potentiation|post-extrasystolic potentiation
91571|NCT03631303|Sudden Cardiac Death|sudden cardiac death
91572|NCT03631290|kidney failure, chronic|kidney failure, chronic
91573|NCT03631290|renal dialysis|renal dialysis
91574|NCT03631290|aged|aged
91575|NCT03631290|inappropriate prescribing|inappropriate prescribing
91576|NCT03631290|preliminary data|preliminary data
91577|NCT03631277|Indirect pulp treatment|indirect pulp treatment
91578|NCT03631277|Photo-activated oral disinfection|photo-activated oral disinfection
91579|NCT03631277|Calcium Hydroxide|calcium hydroxide
91580|NCT03631264|preterm infants|preterm infants
91581|NCT03631264|kinesiotape|kinesiotape
91582|NCT03631264|swallowing|swallowing
91583|NCT03631238|Cholesterol|cholesterol
91584|NCT03631238|Dementia|dementia
91585|NCT03631238|Homocysteine|homocysteine
91586|NCT03631238|Cognitive dysfunctions|cognitive dysfunctions
91587|NCT03631225|Rheumatoid Arthritis|rheumatoid arthritis
91588|NCT03631225|Vectra DA|vectra da
91589|NCT03631225|Radiographic Projections|radiographic projections
91590|NCT03631212|virtual humans|virtual humans
91591|NCT03631212|smoking cessation|smoking cessation
91592|NCT03631212|youth|youth
91593|NCT03631212|digital intervention|digital intervention
91594|NCT03631212|Acceptance and Commitment Therapy|acceptance and commitment therapy
91617|NCT03631173|Pancreaticoduodenectomy|pancreaticoduodenectomy
91618|NCT03631173|Pancreatectomy|pancreatectomy
91619|NCT03631173|Anastomosis, Surgical|anastomosis, surgical
91620|NCT03631160|Laparoscopic Cholecystectomy|laparoscopic cholecystectomy
91621|NCT03631160|Transcutaneous Acupoint Electrical Stimulation|transcutaneous acupoint electrical stimulation
117800|NCT03466710|HPV|hpv
91622|NCT03631160|Postoperative spontaneous voiding|postoperative spontaneous voiding
91623|NCT03631160|Postoperative Dysuria|postoperative dysuria
91624|NCT03631108|Iris Vessel|iris vessel
91625|NCT03631108|OCTA|octa
91626|NCT03631082|effects|effects
91627|NCT03631082|slump stretching|slump stretching
91628|NCT03631082|lumbar mobilization|lumbar mobilization
91629|NCT03631082|non radiculating|non radiculating
91630|NCT03631082|Low back pain|low back pain
91631|NCT03631082|exercises|exercises
91632|NCT03631082|quality of life|quality of life
91633|NCT03631082|modified oswestry low back pain disability|modified oswestry low back pain disability
91634|NCT03631082|numeric pain rating scale|numeric pain rating scale
91635|NCT03631082|fear avoidance beliefs|fear avoidance beliefs
91636|NCT03631030|Cooled radiofrequency ablation|cooled radiofrequency ablation
91638|NCT03631017|Radiation Dosimetry of [18F]PARPi|radiation dosimetry of [18f]parpi
91639|NCT03631017|PET/CT scans|pet/ct scans
91740|NCT03630250|meningitis|meningitis
91641|NCT03630978|hepatocellular carcinoma|hepatocellular carcinoma
91642|NCT03630978|colorectal liver metastases|colorectal liver metastases
91643|NCT03630978|non-colorectal liver metastases|non-colorectal liver metastases
91644|NCT03630978|focal nodular hyperplasia|focal nodular hyperplasia
91645|NCT03630978|liver hemangioma|liver hemangioma
91646|NCT03630978|liver cysts|liver cysts
91647|NCT03630978|surgical morbidity|surgical morbidity
91648|NCT03630978|surgical mortality|surgical mortality
91649|NCT03630978|sarcopenia|sarcopenia
91650|NCT03630926|NV-VPAC1 Prostate Cancer Urine Diagnostic test|nv-vpac1 prostate cancer urine diagnostic test
91651|NCT03630913|Neoadjuvant chemotherapy|neoadjuvant chemotherapy
91652|NCT03630913|Sentinel lymph node|sentinel lymph node
91653|NCT03630913|Axillary lymphadenectomy|axillary lymphadenectomy
91654|NCT03630913|Tagged axillary metastatic node|tagged axillary metastatic node
91655|NCT03630887|Prewarming|prewarming
91656|NCT03630887|Tympanic temperature|tympanic temperature
91657|NCT03630887|Transurethral Resection|transurethral resection
91658|NCT03630861|MicroRNAs|micrornas
91659|NCT03630861|Glioblastoma|glioblastoma
91660|NCT03630861|nonglial tumors|nonglial tumors
91661|NCT03630861|stroke|stroke
91662|NCT03630861|diagnosis|diagnosis
91663|NCT03630835|Complicated carotid atherosclerotic plaques|complicated carotid atherosclerotic plaques
91664|NCT03630835|Endarterectomy|endarterectomy
91665|NCT03630835|99mTc-ANNexin-V-128|99mtc-annexin-v-128
91666|NCT03630809|nonmetastatic|nonmetastatic
91667|NCT03630809|classic HER2|classic her2
91668|NCT03630809|Nonmetastatic classic HER2|nonmetastatic classic her2
91669|NCT03630757|Fibromyalgia syndrome|fibromyalgia syndrome
91670|NCT03630757|Manual Therapies|manual therapies
91671|NCT03630757|Pain|pain
91672|NCT03630744|fluid theraphy|fluid theraphy
91673|NCT03630744|surgical procedures|surgical procedures
91674|NCT03630744|adult patients|adult patients
91675|NCT03630744|glycocalyx|glycocalyx
91677|NCT03630718|Liver Cirrhosis, Biliary|liver cirrhosis, biliary
91678|NCT03630718|Female|female
91679|NCT03630718|Cholangitis|cholangitis
91680|NCT03630718|Hypnosis|hypnosis
91681|NCT03630718|Psychological treatment|psychological treatment
91682|NCT03630692|kidney cancer,|kidney cancer,
91683|NCT03630692|oral drug|oral drug
91684|NCT03630692|safety|safety
91685|NCT03630692|adherence|adherence
91686|NCT03630666|Oligometastatic pelvic lymph nod, IADT, radiotherapy|oligometastatic pelvic lymph nod, iadt, radiotherapy
91687|NCT03630653|Neoplasm Staging|neoplasm staging
91688|NCT03630653|Neoplasm Recurrence|neoplasm recurrence
91689|NCT03630653|Axillary lymph node dissection|axillary lymph node dissection
91690|NCT03630653|Conservative surgery|conservative surgery
91691|NCT03630640|nivolumab; neoadjuvant; electroporation,adjuvant|nivolumab; neoadjuvant; electroporation,adjuvant
91692|NCT03630614|smokers|smokers
91693|NCT03630614|electronic cigarette|electronic cigarette
91694|NCT03630614|nicotine|nicotine
91695|NCT03630614|varenicline|varenicline
91696|NCT03630614|randomized|randomized
91697|NCT03630614|double blind|double blind
91698|NCT03630614|double dummy|double dummy
91699|NCT03630588|probiotics|probiotics
91700|NCT03630588|visceral fat|visceral fat
91701|NCT03630588|abdominal obesity|abdominal obesity
91702|NCT03630549|HIV|hiv
91703|NCT03630549|Village Health Worker|village health worker
91704|NCT03630549|Differentiated Care|differentiated care
91705|NCT03630549|Lesotho|lesotho
91706|NCT03630549|Africa|africa
91707|NCT03630549|antiretroviral therapy|antiretroviral therapy
91708|NCT03630523|PHTS|phts
91709|NCT03630523|PTEN|pten
91710|NCT03630523|Vaccination|vaccination
91711|NCT03630510|Physical Therapy Modalities,|physical therapy modalities,
91712|NCT03630510|Respiration Artificial,|respiration artificial,
91713|NCT03630510|Respiratory Care Units,|respiratory care units,
91714|NCT03630510|Respiratory Mechanics,|respiratory mechanics,
91715|NCT03630510|Positive-Pressure Respiration|positive-pressure respiration
91716|NCT03630497|Acute Optic Neuritis (AON)|acute optic neuritis (aon)
91717|NCT03630497|Demyelination|demyelination
91718|NCT03630497|Optic Neuritis|optic neuritis
91719|NCT03630484|Ventilator Hyperinflation|ventilator hyperinflation
91720|NCT03630484|Expiratory Rib Cage Compression|expiratory rib cage compression
91721|NCT03630484|Physical Therapy|physical therapy
91722|NCT03630484|Mechanical Ventilation|mechanical ventilation
91723|NCT03630471|Adolescents|adolescents
91724|NCT03630432|Severe|severe
91725|NCT03630432|Difficult|difficult
91726|NCT03630432|Overweight and obese|overweight and obese
91727|NCT03630393|Prostatectomy|prostatectomy
91728|NCT03630393|Robotic|robotic
91729|NCT03630393|Urology|urology
91730|NCT03630328|Cogni.Q|cogni.q
91731|NCT03630328|immune enhancement|immune enhancement
91732|NCT03630328|natural killer cells|natural killer cells
91733|NCT03630328|NK cells|nk cells
91734|NCT03630328|Korean Angelica gigas|korean angelica gigas
91735|NCT03630328|AGN|agn
91736|NCT03630289|tissue autograft|tissue autograft
91737|NCT03630289|blood brain barrier|blood brain barrier
91738|NCT03630263|Gastric emptying|gastric emptying
91739|NCT03630263|Postprandial blood glucose|postprandial blood glucose
91741|NCT03630250|GMO|gmo
91742|NCT03630224|Severe trauma|severe trauma
91743|NCT03630224|Acute kidney injury|acute kidney injury
91744|NCT03630224|Fluid resuscitation|fluid resuscitation
91745|NCT03630224|Sodium chloride|sodium chloride
91746|NCT03630224|Plasmalyte|plasmalyte
91747|NCT03630211|Stem Cell Transplantation|stem cell transplantation
91748|NCT03630211|Systemic Sclerosis|systemic sclerosis
91749|NCT03630211|Scleroderma|scleroderma
91750|NCT03630211|Interstitial Lung Disease|interstitial lung disease
91751|NCT03630211|ILD (Interstitial Lung Disease)|ild (interstitial lung disease)
91752|NCT03630211|Pulmonary Hypertension|pulmonary hypertension
91753|NCT03630211|BMT ( bone marrow transplantation)|bmt ( bone marrow transplantation)
91754|NCT03630211|Autologous|autologous
91755|NCT03630198|corticosteroid|corticosteroid
91756|NCT03630198|local anesthetic|local anesthetic
91757|NCT03630172|low back pain|low back pain
91758|NCT03630172|dry needling|dry needling
91759|NCT03630172|flexibility|flexibility
91760|NCT03630172|sympathetic nervous system|sympathetic nervous system
91761|NCT03630159|Lymphoma tisagenlecleucel|lymphoma tisagenlecleucel
91762|NCT03630159|Diffuse Large B-cell Lymphoma|diffuse large b-cell lymphoma
91763|NCT03630159|CTL019|ctl019
91764|NCT03630159|PORTIA|portia
91765|NCT03630159|DLBCL|dlbcl
91766|NCT03630159|tisagenlecleucel|tisagenlecleucel
91767|NCT03630159|pembrolizumab|pembrolizumab
91768|NCT03630159|r/r Diffuse large B-cell Lymphoma|r/r diffuse large b-cell lymphoma
91769|NCT03630159|relapsed/refractory Diffuse large B-cell Lymphoma|relapsed/refractory diffuse large b-cell lymphoma
91770|NCT03630120|Thyroid disease|thyroid disease
91771|NCT03630120|Tyrosine kinase inhibitor|tyrosine kinase inhibitor
91772|NCT03630120|TKI|tki
91773|NCT03630120|Medullary thyroid cancer|medullary thyroid cancer
91774|NCT03630120|DTC|dtc
91775|NCT03630120|Advanced thyroid cancer|advanced thyroid cancer
91776|NCT03630120|Progressive thyroid cancer|progressive thyroid cancer
91777|NCT03630120|MTC|mtc
91778|NCT03630107|itchy scalp|itchy scalp
91779|NCT03630107|chronic pruritus|chronic pruritus
91780|NCT03630068|Liver Neoplasms|liver neoplasms
91781|NCT03630068|Hepatocellular Carcinoma|hepatocellular carcinoma
91782|NCT03630068|Ablation Techniques|ablation techniques
91783|NCT03630068|Stereotaxic Techniques|stereotaxic techniques
91784|NCT03630068|Computer-Assisted Therapy|computer-assisted therapy
91785|NCT03630068|Computer-Assisted Surgery|computer-assisted surgery
91786|NCT03630068|Interventional Radiology|interventional radiology
91787|NCT03630055|Direct oral anticoagulants|direct oral anticoagulants
91788|NCT03630055|Transradial access|transradial access
91789|NCT03630055|Percutaneous coronary intervention|percutaneous coronary intervention
91790|NCT03630042|Waldenstrom Macroglobulinemia|waldenstrom macroglobulinemia
91791|NCT03630042|Relapsed|relapsed
91792|NCT03630042|Refractory|refractory
91793|NCT03630042|Rituximab|rituximab
91794|NCT03630042|Pembrolizumab|pembrolizumab
91795|NCT03630003|ICU|icu
91796|NCT03630003|critical care|critical care
91797|NCT03630003|alternative communication|alternative communication
91798|NCT03630003|augmentative communication|augmentative communication
91799|NCT03629938|Feiss line|feiss line
91800|NCT03629938|Medial longitudinal arch|medial longitudinal arch
91801|NCT03629938|Navicular drop|navicular drop
91802|NCT03629938|Pes planus|pes planus
91803|NCT03629899|Retinitis Pigmentosa|retinitis pigmentosa
91804|NCT03629899|Inherited Retinal Degeneration|inherited retinal degeneration
91805|NCT03629899|Retina Implant|retina implant
91806|NCT03629899|Retinal Prosthesis|retinal prosthesis
91807|NCT03629899|Artificial Vision|artificial vision
91808|NCT03629886|Adults|adults
91809|NCT03629886|Human Papillomavirus (HPV)|human papillomavirus (hpv)
91810|NCT03629886|Cervical cancer|cervical cancer
91811|NCT03629886|Safety|safety
91812|NCT03629860|Atrophic, augmetation, bone regeneration|atrophic, augmetation, bone regeneration
91813|NCT03629847|NETs, MTD, Everolimus.|nets, mtd, everolimus.
91814|NCT03629821|Postural Balance|postural balance
91815|NCT03629821|Dance Therapy|dance therapy
91816|NCT03629821|Exercise Therapy|exercise therapy
91817|NCT03629808|metabolic surgery|metabolic surgery
91818|NCT03629808|laparoscopic sleeve gastrectomy|laparoscopic sleeve gastrectomy
91819|NCT03629769|Prostate inflammation|prostate inflammation
91820|NCT03629769|CPS/CPPS|cps/cpps
91821|NCT03629769|Prostatitis|prostatitis
91822|NCT03629769|Proxelan|proxelan
91823|NCT03629730|coordination|coordination
91824|NCT03629717|Mammographic density|mammographic density
91825|NCT03629717|Premenopausal|premenopausal
91826|NCT03629717|Breast cancer|breast cancer
91827|NCT03629717|Chemoprevention|chemoprevention
91828|NCT03629717|Denosumab|denosumab
91829|NCT03629691|Cavitation|cavitation
91830|NCT03629691|PFS|pfs
91831|NCT03629678|mhealth|mhealth
91832|NCT03629665|chronic aphasia|chronic aphasia
91833|NCT03629665|rehabilitation|rehabilitation
91834|NCT03629665|randomized controlled trial (RCT)|randomized controlled trial (rct)
91835|NCT03629652|head-down position|head-down position
91836|NCT03629652|ischemic stroke|ischemic stroke
91837|NCT03629652|rehabilitation|rehabilitation
91838|NCT03629639|Psoriasis|psoriasis
91839|NCT03629639|Metformin|metformin
91840|NCT03629639|Gut microbiota|gut microbiota
91841|NCT03629626|preoperative / intraoperative/ postoperative management|preoperative / intraoperative/ postoperative management
91842|NCT03629561|"Paraproteinemias[Mesh]"|"paraproteinemias[mesh]"
91843|NCT03629561|"Kidney Diseases[Mesh]"|"kidney diseases[mesh]"
91844|NCT03629548|dinoprostone|dinoprostone
91845|NCT03629548|early amniotomy|early amniotomy
91846|NCT03629548|labor induction|labor induction
91847|NCT03629548|foley bulb|foley bulb
91848|NCT03629509|decision aid|decision aid
91849|NCT03629509|breast cancer|breast cancer
91850|NCT03629509|young females|young females
91851|NCT03629509|implementation|implementation
91852|NCT03629509|stepped wedge trial|stepped wedge trial
91853|NCT03629483|Elderly|elderly
91854|NCT03629483|Knee Arthroplasty|knee arthroplasty
91855|NCT03629483|Nerve Block|nerve block
91856|NCT03629483|Dexmedetomidine|dexmedetomidine
91857|NCT03629483|Postoperative Delirium|postoperative delirium
91858|NCT03629483|Long-term Outcome|long-term outcome
91859|NCT03629431|ARISCAT|ariscat
91860|NCT03629431|complications|complications
91861|NCT03629431|postoperative|postoperative
91862|NCT03629418|Coronary Artery Bypass, Off-Pump|coronary artery bypass, off-pump
91863|NCT03629418|Intraoperative Hypotension|intraoperative hypotension
91864|NCT03629418|Acute Kidney Injury|acute kidney injury
91865|NCT03629418|Preventive Medicine|preventive medicine
91866|NCT03629418|Intraoperative Care|intraoperative care
91867|NCT03629405|pH of the skin|ph of the skin
91868|NCT03629405|SDS|sds
91869|NCT03629405|Lipbarvis|lipbarvis
91870|NCT03629405|TEWL|tewl
91871|NCT03629405|Skin hydration|skin hydration
91872|NCT03629392|Methionine|methionine
91873|NCT03629392|Cysteine|cysteine
91874|NCT03629392|Energy metabolism|energy metabolism
91875|NCT03629392|Sulfur amino acids|sulfur amino acids
91876|NCT03629366|Refugees|refugees
91877|NCT03629366|Supported Employment|supported employment
91878|NCT03629366|Individual Placement and Support|individual placement and support
91879|NCT03629366|Employment|employment
91880|NCT03629366|Vocational Rehabilitation|vocational rehabilitation
91881|NCT03629366|Mental Health|mental health
91882|NCT03629353|airway management|airway management
91883|NCT03629353|high flow nasal cannula|high flow nasal cannula
91884|NCT03629353|laryngeal microsurgery|laryngeal microsurgery
91885|NCT03629314|Opioid|opioid
91886|NCT03629301|Obesity|obesity
91887|NCT03629301|Overweight|overweight
91888|NCT03629301|Lifestyle Intervention|lifestyle intervention
91889|NCT03629301|Randomized controlled Trial|randomized controlled trial
91890|NCT03629301|Internet delivered|internet delivered
91891|NCT03629301|Online|online
91892|NCT03629301|Weight loss|weight loss
91893|NCT03629288|Azithromycin|azithromycin
91894|NCT03629288|Periodontal debridement|periodontal debridement
91895|NCT03629288|Antibiotics|antibiotics
91896|NCT03629288|Periodontitis|periodontitis
91897|NCT03629275|Efficacy|efficacy
91898|NCT03629275|Neural Stem cells|neural stem cells
91899|NCT03629275|Intracerebral|intracerebral
91900|NCT03629275|Cerebral Infarction|cerebral infarction
91901|NCT03629275|Cerebrovascular disorders|cerebrovascular disorders
91902|NCT03629275|Brain diseases|brain diseases
91903|NCT03629275|Stereotactic surgery|stereotactic surgery
91904|NCT03629262|Elderly|elderly
91905|NCT03629262|Orthopedic Surgery|orthopedic surgery
91906|NCT03629262|Analgesia|analgesia
91907|NCT03629262|Dexmedetomidine|dexmedetomidine
91908|NCT03629262|Postoperative Delirium|postoperative delirium
91909|NCT03629262|Long-term Outcome|long-term outcome
91910|NCT03629223|Tepotinib|tepotinib
91911|NCT03629223|Pharmacokinetics|pharmacokinetics
91912|NCT03629223|Bioequivalence|bioequivalence
91913|NCT03629197|primary care|primary care
91914|NCT03629197|chronic pain|chronic pain
91915|NCT03629197|patient-physician communication|patient-physician communication
91916|NCT03629197|opioid analgesics|opioid analgesics
91917|NCT03629197|standardized patients|standardized patients
91918|NCT03629158|Behavioral Medicine|behavioral medicine
91919|NCT03629158|Clinical Trial|clinical trial
91920|NCT03629158|Cardiology|cardiology
91921|NCT03629158|Health Behavior|health behavior
91922|NCT03629158|Healthy Lifestyle|healthy lifestyle
91923|NCT03629158|Self Efficacy|self efficacy
91924|NCT03629106|Bipolar Disorder|bipolar disorder
91925|NCT03629106|Cannabis Use Disorder|cannabis use disorder
91926|NCT03629106|Cognitive Function|cognitive function
91927|NCT03629093|General anesthesia|general anesthesia
91928|NCT03629093|Infant|infant
91929|NCT03629093|Neurodevelopment|neurodevelopment
91930|NCT03629093|Postoperative|postoperative
91931|NCT03629093|the Gesell Developmental Inventory|the gesell developmental inventory
91932|NCT03629080|solid organ transplantation|solid organ transplantation
91933|NCT03629080|vaccine|vaccine
91934|NCT03629067|Hypertension|hypertension
91935|NCT03629028|uterine closure; uterine scar defect; niche; cesarean;|uterine closure; uterine scar defect; niche; cesarean;
91936|NCT03628976|tVNS, training, neuromotor adaptation|tvns, training, neuromotor adaptation
91937|NCT03628963|Diabetes|diabetes
91938|NCT03628963|hypertension|hypertension
91939|NCT03628963|dyslipidemia|dyslipidemia
91940|NCT03628950|Interscalene block|interscalene block
91941|NCT03628950|Postoperative analgesia|postoperative analgesia
91942|NCT03628950|Suprascapular nerve block|suprascapular nerve block
91943|NCT03628950|Infraclavicular nerve block|infraclavicular nerve block
91944|NCT03628950|Arthroscopic rotator cuff repair|arthroscopic rotator cuff repair
91945|NCT03628950|Hemi-diaphragmatic paralysis|hemi-diaphragmatic paralysis
91946|NCT03628937|Green tea polyphenols|green tea polyphenols
91947|NCT03628937|Children obesity|children obesity
91948|NCT03628937|Precocious puberty|precocious puberty
91949|NCT03628937|Prevention|prevention
91950|NCT03628872|Scaling and root planing|scaling and root planing
91951|NCT03628872|Laser scaling|laser scaling
91952|NCT03628859|Renal cancer metastatic|renal cancer metastatic
91953|NCT03628859|Immunotherapy|immunotherapy
91954|NCT03628859|Predictive biomarkers|predictive biomarkers
91955|NCT03628859|Translational study|translational study
91956|NCT03628820|Stress|stress
91957|NCT03628820|Anxiety|anxiety
91958|NCT03628820|Cortisol|cortisol
91959|NCT03628820|Therapy|therapy
91960|NCT03628820|Dog|dog
91961|NCT03628820|Coloring|coloring
91962|NCT03628820|Mandala|mandala
91963|NCT03628807|transjugular intrahepatic portosystemic shunt (TIPS)|transjugular intrahepatic portosystemic shunt (tips)
91964|NCT03628807|non-invasive assessments|non-invasive assessments
91965|NCT03628807|Transthoracic echocardiography (TTE) with Speckle-tracking|transthoracic echocardiography (tte) with speckle-tracking
91966|NCT03628807|Computer tomography scan (CT-scan)|computer tomography scan (ct-scan)
91967|NCT03628807|Magnetic resonance imaging (MRI)|magnetic resonance imaging (mri)
91968|NCT03628807|circulating biomarkers|circulating biomarkers
91969|NCT03628807|Electroencephalography (EEG)|electroencephalography (eeg)
91970|NCT03628781|Behavioral intervention|behavioral intervention
91971|NCT03628755|Fluency shaping therapy|fluency shaping therapy
91972|NCT03628755|Digital Manipulation|digital manipulation
91973|NCT03628755|Stuttering|stuttering
91974|NCT03628755|communication|communication
91975|NCT03628742|periodontal probe|periodontal probe
91976|NCT03628742|gingival thickness|gingival thickness
91977|NCT03628742|gingival biotype|gingival biotype
91978|NCT03628599|Symptomatic|symptomatic
91979|NCT03628586|acute coronary syndrome; biomarkers, HS troponins|acute coronary syndrome; biomarkers, hs troponins
91980|NCT03628573|rTMS|rtms
91981|NCT03628573|Depression|depression
91982|NCT03628573|Theta Burst Stimulation|theta burst stimulation
91983|NCT03628573|Inpatients|inpatients
91984|NCT03628573|Biomarkers|biomarkers
91985|NCT03628560|Healthy volunteer|healthy volunteer
91986|NCT03628560|Oximetry|oximetry
91987|NCT03628560|Pulse oximeter|pulse oximeter
91988|NCT03628560|Hypoxia|hypoxia
91989|NCT03628547|musculoskeletal system pain|musculoskeletal system pain
91990|NCT03628547|athlete|athlete
91991|NCT03628547|psychosocial problems|psychosocial problems
91992|NCT03628547|algometer|algometer
91993|NCT03628534|Cardiac Arrhythmia|cardiac arrhythmia
91994|NCT03628534|Ventricular Tachycardia|ventricular tachycardia
91995|NCT03628534|Arrhythmia|arrhythmia
91996|NCT03628534|Pathological processes|pathological processes
91997|NCT03628521|lung cancer|lung cancer
91998|NCT03628521|first-line|first-line
91999|NCT03628521|combination|combination
92000|NCT03628508|muscle tension|muscle tension
92001|NCT03628508|alignment|alignment
92002|NCT03628508|knee osteoarthritis|knee osteoarthritis
92003|NCT03628508|loading|loading
92004|NCT03628495|insert|insert
92005|NCT03628495|pressure therapy|pressure therapy
92006|NCT03628495|silicone gel|silicone gel
92007|NCT03628443|CKD|ckd
92008|NCT03628443|HFrEF|hfref
92009|NCT03628443|HFpEF|hfpef
92010|NCT03628443|FGF23|fgf23
92011|NCT03628443|Dialysis|dialysis
92012|NCT03628443|Atherosclerosis|atherosclerosis
92013|NCT03628443|Coronary Artery Disease|coronary artery disease
92014|NCT03628430|Anesthesia;|anesthesia;
92015|NCT03628430|lidocaine;|lidocaine;
92016|NCT03628430|patient experience|patient experience
92017|NCT03628430|patient pain|patient pain
92018|NCT03628430|sodium bicarbonate|sodium bicarbonate
92019|NCT03628430|Vascular Access Devices|vascular access devices
92020|NCT03628417|cutaneous metastases|cutaneous metastases
92021|NCT03628417|calcium electroporation|calcium electroporation
92022|NCT03628417|bleomycin electroporation|bleomycin electroporation
92023|NCT03628404|Alzheimer disease|alzheimer disease
92024|NCT03628404|Dementia|dementia
92025|NCT03628404|Faroe Islands|faroe islands
92026|NCT03628404|Isolated population|isolated population
92027|NCT03628404|Environmental exposure|environmental exposure
92028|NCT03628391|delirium|delirium
92029|NCT03628391|intensive care unit|intensive care unit
92030|NCT03628391|critical illness|critical illness
92031|NCT03628391|cognitive impairment|cognitive impairment
92032|NCT03628365|Body composition|body composition
92033|NCT03628365|muscle mass|muscle mass
92034|NCT03628365|protein metabolism|protein metabolism
92035|NCT03628365|enteral nutrition|enteral nutrition
92036|NCT03628365|ICU|icu
92037|NCT03628339|Tepotinib|tepotinib
92038|NCT03628339|Midazolam|midazolam
92039|NCT03628339|Cytochrome P450|cytochrome p450
92040|NCT03628339|Pharmacokinetics|pharmacokinetics
92041|NCT03628326|Pulmonary artery|pulmonary artery
92042|NCT03628326|3D reconstruction|3d reconstruction
92043|NCT03628326|Video-assisted thoracic surgery lobectomy|video-assisted thoracic surgery lobectomy
92044|NCT03628326|CT angiography|ct angiography
92045|NCT03628326|Anatomic variation|anatomic variation
92046|NCT03628313|Echoacrdiography|echoacrdiography
92047|NCT03628313|EchoDoppler|echodoppler
92048|NCT03628313|Aortic valve stenosis|aortic valve stenosis
92049|NCT03628313|Prognosis|prognosis
92050|NCT03628300|neurotoxicity|neurotoxicity
92051|NCT03628287|viral load suppression|viral load suppression
92052|NCT03628287|medical case management|medical case management
92053|NCT03628235|online survey|online survey
92054|NCT03628235|indirect costs|indirect costs
92055|NCT03628235|out-of-pocket costs|out-of-pocket costs
92056|NCT03628235|HD|hd
92057|NCT03628235|Huntington's disease|huntington's disease
92058|NCT03628235|companions|companions
92059|NCT03628235|Enroll-HD|enroll-hd
92060|NCT03628222|Lung lesion|lung lesion
92061|NCT03628222|Electromagnetic navigation bronchoscopy (ENB)|electromagnetic navigation bronchoscopy (enb)
92062|NCT03628222|Transbronchial lung biopsy(TBLB)|transbronchial lung biopsy(tblb)
92063|NCT03628222|bronchoscopy|bronchoscopy
92064|NCT03628209|resectable osteosarcoma|resectable osteosarcoma
92065|NCT03628144|Immunonutrition|immunonutrition
92066|NCT03628144|Radiotherapy|radiotherapy
92067|NCT03628144|Unresectable|unresectable
92068|NCT03628144|Stage IIIA-B|stage iiia-b
92069|NCT03628144|Lung cancer|lung cancer
92070|NCT03628144|Radiation oncology|radiation oncology
92071|NCT03628144|Thoracic oncology|thoracic oncology
92072|NCT03628144|Epidemiology|epidemiology
92073|NCT03628144|Nutrition|nutrition
92074|NCT03628105|Anxiety|anxiety
92075|NCT03628105|Specific Phobia|specific phobia
92076|NCT03628105|Claustrophobia|claustrophobia
92077|NCT03628105|Exposure|exposure
92078|NCT03628105|Cognitive therapy|cognitive therapy
92079|NCT03628105|Cognitive restructuring|cognitive restructuring
92080|NCT03628105|Consolidation|consolidation
92081|NCT03628105|Inhibitory learning|inhibitory learning
92082|NCT03628105|Expectancy violation|expectancy violation
92083|NCT03628105|Expectancy|expectancy
92084|NCT03628105|Exposure therapy|exposure therapy
92085|NCT03628105|Anxiety disorder|anxiety disorder
92086|NCT03628092|genitourinary symptoms of menopause|genitourinary symptoms of menopause
92087|NCT03628092|CO2 fractional ablative laser|co2 fractional ablative laser
92088|NCT03628092|Early breast cancer|early breast cancer
92089|NCT03628092|Vulvovaginal atrophy|vulvovaginal atrophy
92090|NCT03628092|Vaginal dryness|vaginal dryness
92091|NCT03628092|Dyspareunia|dyspareunia
92092|NCT03628092|Vaginal itch|vaginal itch
92093|NCT03628092|Dysuria|dysuria
92094|NCT03628066|Ovarian Suppression|ovarian suppression
92095|NCT03628066|Neoadjuvant|neoadjuvant
92096|NCT03628066|Premenopausal|premenopausal
92097|NCT03628066|Estrogen-Receptor Positive|estrogen-receptor positive
92098|NCT03628066|HER2-Negative|her2-negative
92099|NCT03628066|Primary|primary
92100|NCT03628066|Palbociclib|palbociclib
92101|NCT03628066|Letrozole|letrozole
92102|NCT03628066|Goserelin|goserelin
92103|NCT03628066|Ki67|ki67
92104|NCT03628066|Oncotype DX Breast Recurrence Score|oncotype dx breast recurrence score
92105|NCT03628066|Open-Label|open-label
92106|NCT03628053|Acute lymphoblastic leukemia|acute lymphoblastic leukemia
92107|NCT03628053|tisagenlecleucel|tisagenlecleucel
92108|NCT03628053|intouzumab|intouzumab
92109|NCT03628053|blinatumomab|blinatumomab
92110|NCT03628053|CAR-T|car-t
92111|NCT03628053|CTL019|ctl019
92112|NCT03628027|Major Depressive Disorder|major depressive disorder
92113|NCT03628027|Antidepressant Medication|antidepressant medication
92114|NCT03628027|Digital Health|digital health
92115|NCT03628027|Computerised Decision Support Tool|computerised decision support tool
92116|NCT03628014|older, hospital, program|older, hospital, program
92117|NCT03628001|Endoscopic retrograde cholangiopancreatography (ERCP)|endoscopic retrograde cholangiopancreatography (ercp)
92118|NCT03628001|Distal malignant bile duct obstruction|distal malignant bile duct obstruction
92119|NCT03628001|Sphincterotomy|sphincterotomy
92120|NCT03627988|Breast Cancer Invasive|breast cancer invasive
92121|NCT03627988|TomoTherapy|tomotherapy
92122|NCT03627988|Immediate prosthetic breast reconstruction|immediate prosthetic breast reconstruction
92123|NCT03627975|revascularization|revascularization
92124|NCT03627975|hemorrhagic moyamoya disease|hemorrhagic moyamoya disease
92125|NCT03627962|gaze-directed oculomotor training, reading in Chinese|gaze-directed oculomotor training, reading in chinese
92126|NCT03627949|Web-based intervention|web-based intervention
92127|NCT03627949|Health behavior change|health behavior change
92128|NCT03627949|University students|university students
92129|NCT03627949|Health Action Process Approach Model|health action process approach model
92130|NCT03627936|Lorcaserin|lorcaserin
92131|NCT03627936|Bioequivalence|bioequivalence
92132|NCT03627936|Extended release|extended release
92133|NCT03627936|Tablets|tablets
92134|NCT03627936|Phase 1|phase 1
92135|NCT03627936|Healthy|healthy
92139|NCT03627910|gut microbiota|gut microbiota
92140|NCT03627910|Iatrogenic malnutrition|iatrogenic malnutrition
92141|NCT03627910|pressure ulcer|pressure ulcer
92142|NCT03627884|Central Venous Catheters|central venous catheters
92143|NCT03627884|End Stage Renal Disease|end stage renal disease
92144|NCT03627884|Hemodialysis|hemodialysis
92145|NCT03627884|Catheter-related infection|catheter-related infection
92146|NCT03627884|Catheter loss due to clot formation|catheter loss due to clot formation
92147|NCT03627884|Acute Renal Failure|acute renal failure
92149|NCT03627871|social norms|social norms
92150|NCT03627871|interest in exercising more|interest in exercising more
92156|NCT03627819|Plant sterols|plant sterols
92157|NCT03627819|Plant stanols|plant stanols
92158|NCT03627819|Liver inflammation|liver inflammation
92159|NCT03627806|Disparities|disparities
92160|NCT03627806|Florida-Puerto Rico Stroke Registry|florida-puerto rico stroke registry
92161|NCT03627793|frailty|frailty
92162|NCT03627793|exercise|exercise
92163|NCT03627793|resistance training|resistance training
92164|NCT03627793|strength|strength
92165|NCT03627793|older adults|older adults
92166|NCT03627767|atopic dermatitis|atopic dermatitis
92167|NCT03627767|atopic eczema|atopic eczema
92168|NCT03627767|eczema|eczema
92169|NCT03627767|JAK|jak
92170|NCT03627767|janus kinase|janus kinase
92171|NCT03627754|Glasdegib|glasdegib
92172|NCT03627754|PF-04449913|pf-04449913
92173|NCT03627754|Pharmacokinetics|pharmacokinetics
92174|NCT03627754|Hepatic Impairment|hepatic impairment
92175|NCT03627689|asthma|asthma
92176|NCT03627689|environmental intervention|environmental intervention
92177|NCT03627689|allergies|allergies
92178|NCT03627689|air purifier|air purifier
92179|NCT03627676|Nodules of endometriosis|nodules of endometriosis
92180|NCT03627676|Cryoablation|cryoablation
92181|NCT03627650|burn|burn
92182|NCT03627650|scar|scar
92183|NCT03627650|fat|fat
92184|NCT03627650|grafting|grafting
92185|NCT03627624|MCID|mcid
92186|NCT03627624|30 STS test|30 sts test
92187|NCT03627624|Pulmonary rehabilitation|pulmonary rehabilitation
92188|NCT03627611|Thyroxine|thyroxine
92189|NCT03627611|Triiodothyronine|triiodothyronine
92190|NCT03627598|high flow oxygen|high flow oxygen
92191|NCT03627598|non invasive ventilation|non invasive ventilation
92192|NCT03627598|hypercapnic respiratory failure|hypercapnic respiratory failure
92193|NCT03627585|pacemaker|pacemaker
92194|NCT03627585|heart failure|heart failure
92195|NCT03627585|left ventricular dysfunction|left ventricular dysfunction
92196|NCT03627585|bradycardia|bradycardia
92197|NCT03627585|remodelling|remodelling
92198|NCT03627572|RESCEU (consortium)|resceu (consortium)
92199|NCT03627572|Burden of Disease|burden of disease
92200|NCT03627559|Pancreaticoduodenectomy|pancreaticoduodenectomy
92201|NCT03627559|Pancreatectomy|pancreatectomy
92202|NCT03627546|PWID|pwid
92203|NCT03627507|Hepatitis B, Seroconversion, Seroprotection, Vaccine|hepatitis b, seroconversion, seroprotection, vaccine
92204|NCT03627494|Dose proportionality|dose proportionality
92205|NCT03627494|Food effect|food effect
92206|NCT03627494|Pharmacokinetics|pharmacokinetics
92207|NCT03627494|FTIH|ftih
92208|NCT03627494|Pharmacodynamics|pharmacodynamics
92209|NCT03627494|Dose Escalation|dose escalation
92210|NCT03627481|endoscopic sinus surgery|endoscopic sinus surgery
92211|NCT03627429|temporomandibular arthritis|temporomandibular arthritis
92212|NCT03627429|temporomandibular joint|temporomandibular joint
92213|NCT03627429|rheumatoid arthritis|rheumatoid arthritis
92214|NCT03627429|viscosupplementation|viscosupplementation
92215|NCT03627429|hyaluronic acid|hyaluronic acid
92216|NCT03627416|Hereditary spastic paraplegia|hereditary spastic paraplegia
92217|NCT03627416|repetitive transcranial magnetic stimulation|repetitive transcranial magnetic stimulation
92218|NCT03627416|disturbed gait|disturbed gait
92219|NCT03627416|Adrenomyeloneuropthy|adrenomyeloneuropthy
92220|NCT03627390|Benzene polycarboxylic acids complex with cis-diammineplatinum(II)|benzene polycarboxylic acids complex with cis-diammineplatinum(ii)
92221|NCT03627390|BP-C1|bp-c1
92222|NCT03627390|Cis-coordinated complexes of platinum(II) with polymer of benzene polycarboxylic acids derived from lignin|cis-coordinated complexes of platinum(ii) with polymer of benzene polycarboxylic acids derived from lignin
92223|NCT03627390|Platinum analogue|platinum analogue
92224|NCT03627390|Metronomic chemotherapy|metronomic chemotherapy
92225|NCT03627390|Cisplatin|cisplatin
92226|NCT03627390|Pancreatic cancer|pancreatic cancer
92227|NCT03627390|BP-C2|bp-c2
92228|NCT03627390|molybdenum salts of benzene-polycarboxylic acids|molybdenum salts of benzene-polycarboxylic acids
92229|NCT03627377|Schizophrenia|schizophrenia
92230|NCT03627377|Serious mental illness|serious mental illness
92231|NCT03627377|Obesity|obesity
92236|NCT03627351|Sensory Panel|sensory panel
92238|NCT03627351|Genes|genes
92239|NCT03627351|Pediatric Medicines|pediatric medicines
92240|NCT03627247|cognitive behavioral|cognitive behavioral
92241|NCT03627247|stress management|stress management
92242|NCT03627247|pregnancy|pregnancy
92243|NCT03627247|cortisol|cortisol
92244|NCT03627221|social network|social network
92245|NCT03627221|nursing students|nursing students
92246|NCT03627221|sleep|sleep
92247|NCT03627221|music care|music care
92252|NCT03627195|Schizophrenia|schizophrenia
92253|NCT03627156|Guided counseling|guided counseling
92254|NCT03627156|nutrition outcome|nutrition outcome
92255|NCT03627156|Ethiopia|ethiopia
92256|NCT03627156|Community trial|community trial
92257|NCT03627130|Percutaneous Coronary Intervention|percutaneous coronary intervention
92258|NCT03627130|Nitric Oxide|nitric oxide
92259|NCT03627130|Nitrite|nitrite
92260|NCT03627130|Acute Kidney Injury|acute kidney injury
92261|NCT03627130|Acute Coronary Syndrome|acute coronary syndrome
92262|NCT03627091|Crohn's disease|crohn's disease
92263|NCT03627078|traumatic memories|traumatic memories
92264|NCT03627078|post traumatic stress disorder|post traumatic stress disorder
92265|NCT03627078|motor interference therapy|motor interference therapy
92266|NCT03627078|non pharmacological therapy|non pharmacological therapy
92267|NCT03627078|trauma related disorders|trauma related disorders
92268|NCT03627065|Primary Sjögren's syndrome|primary sjögren's syndrome
92269|NCT03627065|PI3Kδ inhibitor|pi3kδ inhibitor
92270|NCT03627052|Inflammatory bowel disease|inflammatory bowel disease
92271|NCT03627052|ulcerative colitis|ulcerative colitis
92272|NCT03627052|Janus kinase inhibitor|janus kinase inhibitor
92273|NCT03627052|JAK1|jak1
92274|NCT03627026|Melanoma|melanoma
92275|NCT03627026|Sphingolipids|sphingolipids
92276|NCT03627026|Immune checkpoints|immune checkpoints
92277|NCT03627026|Tumor-infiltrating lymphocytes|tumor-infiltrating lymphocytes
92278|NCT03627026|Immunosuppressive cytokines|immunosuppressive cytokines
92279|NCT03627026|Circulating leukocytes|circulating leukocytes
92280|NCT03626961|NEWS|news
92281|NCT03626935|ankle joint|ankle joint
92282|NCT03626935|arthrodesis|arthrodesis
92283|NCT03626935|3d printing|3d printing
92284|NCT03626935|customized guide|customized guide
92285|NCT03626922|NSABP|nsabp
92286|NCT03626922|Merck & Co|merck & co
92287|NCT03626922|Eli Lilly and Company|eli lilly and company
92288|NCT03626922|Pembrolizumab|pembrolizumab
92289|NCT03626922|Pemetrexed|pemetrexed
92290|NCT03626922|Oxaliplatin|oxaliplatin
92291|NCT03626922|MSS mCRC|mss mcrc
92292|NCT03626896|BBB disruption|bbb disruption
92293|NCT03626896|NaviFUS System|navifus system
92294|NCT03626896|Focused Ultrasound|focused ultrasound
92295|NCT03626896|GBM|gbm
92296|NCT03626883|arthroscopy|arthroscopy
92297|NCT03626857|Knee|knee
92298|NCT03626857|ACL|acl
92299|NCT03626857|Reconstruction|reconstruction
92300|NCT03626857|Rehabilitation|rehabilitation
92301|NCT03626857|Eccentric Exercise|eccentric exercise
92302|NCT03626857|Electrical Stimulation|electrical stimulation
92303|NCT03626844|Manual Lysis, Postpartum Hemorrhage, Third Stage of Delivery.|manual lysis, postpartum hemorrhage, third stage of delivery.
92304|NCT03626831|CVD|cvd
92305|NCT03626831|LDL|ldl
92306|NCT03626831|heart failure|heart failure
92307|NCT03626831|PCSK9|pcsk9
92308|NCT03626818|WBRT|wbrt
92309|NCT03626818|NCT|nct
92310|NCT03626792|Pilates|pilates
92311|NCT03626792|Blood Pressure|blood pressure
92312|NCT03626792|Postmenopausal women|postmenopausal women
92313|NCT03626753|Pain|pain
92314|NCT03626753|multimodal|multimodal
92315|NCT03626753|analgesia|analgesia
92316|NCT03626753|postoperative|postoperative
92317|NCT03626753|cesarean section|cesarean section
92318|NCT03626753|obstetric|obstetric
92319|NCT03626753|Agents|agents
92320|NCT03626753|Physiological effects of drugs|physiological effects of drugs
118672|NCT03460977|FL|fl
92321|NCT03626753|opioid|opioid
92322|NCT03626753|Paracetamol|paracetamol
92323|NCT03626753|NSAIDs|nsaids
92324|NCT03626740|dental pulp|dental pulp
92325|NCT03626740|deep carious lesions|deep carious lesions
92326|NCT03626740|treatment effect|treatment effect
92327|NCT03626727|Excessive Daytime Sleepiness|excessive daytime sleepiness
92328|NCT03626727|Prolonged sleep|prolonged sleep
92329|NCT03626727|Traumatic Brain Injury|traumatic brain injury
92330|NCT03626714|Tacrolimus|tacrolimus
92331|NCT03626714|Immunosuppressant|immunosuppressant
92332|NCT03626714|Sustained-release|sustained-release
92333|NCT03626714|Plexis|plexis
92334|NCT03626701|Pediatric|pediatric
92335|NCT03626701|Burns|burns
92336|NCT03626701|Partial-thickness|partial-thickness
92341|NCT03626688|Pulmonary Vascular Resistance|pulmonary vascular resistance
92342|NCT03626688|Right Ventricular Function|right ventricular function
92343|NCT03626623|Diabetes|diabetes
92344|NCT03626623|Foot Ulcer|foot ulcer
92345|NCT03626610|Prehabilitation|prehabilitation
92346|NCT03626610|Exercise|exercise
92347|NCT03626610|Cancer|cancer
92348|NCT03626610|Neo-adjuvant chemotherapy|neo-adjuvant chemotherapy
92349|NCT03626545|ACZ885|acz885
92350|NCT03626545|canakinumab|canakinumab
92351|NCT03626545|docetaxel|docetaxel
92352|NCT03626545|NSCLC|nsclc
92353|NCT03626545|Non Small Cell Lung Cancer|non small cell lung cancer
92354|NCT03626545|Carcinoma|carcinoma
92355|NCT03626545|IL-1β|il-1β
92356|NCT03626545|PD-(L)1|pd-(l)1
92357|NCT03626545|CANOPY|canopy
92358|NCT03626545|CANOPY-2|canopy-2
92359|NCT03626545|second or third line therapy|second or third line therapy
92360|NCT03626545|PD-(L)1 inhibitors|pd-(l)1 inhibitors
92361|NCT03626545|platinum-based chemotherapy|platinum-based chemotherapy
92362|NCT03626532|Mindfulness-based stress reduction|mindfulness-based stress reduction
92363|NCT03626532|Cognitive function|cognitive function
92364|NCT03626532|Emotion regulation|emotion regulation
92365|NCT03626532|Lifestyle education|lifestyle education
92366|NCT03626532|Attentional control|attentional control
92367|NCT03626532|Mindfulness training|mindfulness training
92368|NCT03626532|Aging|aging
92369|NCT03626532|Older adults|older adults
92370|NCT03626532|Mind-wandering|mind-wandering
92371|NCT03626532|Functional connectivity|functional connectivity
92372|NCT03626532|Randomized controlled trial|randomized controlled trial
92373|NCT03626519|COPD|copd
92374|NCT03626519|Menthol|menthol
92375|NCT03626519|Exercise|exercise
92376|NCT03626519|Dyspnea|dyspnea
92382|NCT03626480|Surgery|surgery
92383|NCT03626480|Nutritional outcome|nutritional outcome
92384|NCT03626480|Infants|infants
92385|NCT03626454|Norepinephrine, hypotension, spinal, caesarean section|norepinephrine, hypotension, spinal, caesarean section
92386|NCT03626441|Postoperative Nausea and Vomiting|postoperative nausea and vomiting
92387|NCT03626441|Ginger|ginger
92388|NCT03626428|EEG|eeg
92389|NCT03626428|fMRI|fmri
92390|NCT03626428|correlation clinical data|correlation clinical data
92391|NCT03626428|effective connectivity|effective connectivity
92392|NCT03626402|advanced cancer|advanced cancer
92393|NCT03626402|African American|african american
92394|NCT03626389|physiotherapy|physiotherapy
92395|NCT03626389|primary health care setting|primary health care setting
92396|NCT03626324|Spinal Cord Injury (SCI)|spinal cord injury (sci)
92397|NCT03626324|Neurogenic Lower Urinary Tract Dysfunction (NLUTD)|neurogenic lower urinary tract dysfunction (nlutd)
92398|NCT03626324|Catheter associated Urinary Tract Infection (CAUTI)|catheter associated urinary tract infection (cauti)
92399|NCT03626324|Urinary Catheters|urinary catheters
92400|NCT03626324|Dementia|dementia
92401|NCT03626324|Stroke|stroke
92402|NCT03626324|Diabetes|diabetes
92403|NCT03626324|Parkinson's|parkinson's
92404|NCT03626311|Lupus|lupus
92405|NCT03626311|SLE|sle
92406|NCT03626259|hypertension|hypertension
92407|NCT03626259|losartan/amlodipine|losartan/amlodipine
92408|NCT03626259|arterial stiffness|arterial stiffness
92409|NCT03626246|Bone loss|bone loss
92410|NCT03626246|Bone fracture|bone fracture
92411|NCT03626246|Bone biopsy|bone biopsy
92412|NCT03626246|Kidney|kidney
92413|NCT03626220|acupuncture|acupuncture
92414|NCT03626220|chemotherapy-induced peripheral neuropathy|chemotherapy-induced peripheral neuropathy
92415|NCT03626207|Retinitis pigmentosa|retinitis pigmentosa
92416|NCT03626207|Visual function evaluation|visual function evaluation
92417|NCT03626155|Walking|walking
92418|NCT03626155|type 2 diabetes|type 2 diabetes
92419|NCT03626155|continuous glucose monitoring|continuous glucose monitoring
92420|NCT03626129|Haemostasis|haemostasis
92421|NCT03626129|Trans radial band|trans radial band
92422|NCT03626129|Coronary angiography|coronary angiography
92423|NCT03626129|Radial artery occlusion|radial artery occlusion
92424|NCT03626129|Percutaneous coronary intervention|percutaneous coronary intervention
92425|NCT03626103|depression|depression
92426|NCT03626103|violence|violence
92427|NCT03626103|emergency department|emergency department
92428|NCT03626103|mhealth|mhealth
92429|NCT03626103|text message|text message
92430|NCT03626090|Liver|liver
92431|NCT03626090|Cirrhosis|cirrhosis
92432|NCT03626090|Child B|child b
92433|NCT03626090|Child C|child c
92434|NCT03626090|Advance|advance
92435|NCT03626090|Advanced|advanced
92436|NCT03626090|Singapore|singapore
92437|NCT03626090|MSC|msc
92438|NCT03626090|Mesenchymal|mesenchymal
92439|NCT03626090|Stem Cell|stem cell
92440|NCT03626090|Cell Therapy|cell therapy
92441|NCT03626090|MSC Therapy|msc therapy
92442|NCT03626090|Treatment|treatment
92443|NCT03626077|Biofeedback|biofeedback
92444|NCT03626077|Visual-Motor Integration|visual-motor integration
92445|NCT03626077|Visual Perception|visual perception
92446|NCT03626051|ankle taping|ankle taping
92447|NCT03626038|Trauma|trauma
92448|NCT03626038|Medical Device|medical device
92449|NCT03626038|Performance|performance
92450|NCT03626038|Safety|safety
92451|NCT03626038|Proximal Humeral Fracture|proximal humeral fracture
92452|NCT03625999|Auditory attention|auditory attention
92453|NCT03625986|smoking|smoking
92454|NCT03625986|electronic cigarettes|electronic cigarettes
92455|NCT03625986|nicotine|nicotine
92456|NCT03625986|ecig|ecig
92457|NCT03625973|Dementia|dementia
92458|NCT03625973|Memory, Episodic|memory, episodic
92459|NCT03625973|Printing, Three-Dimensional|printing, three-dimensional
92460|NCT03625960|warts|warts
92461|NCT03625960|trichloroacetic acid|trichloroacetic acid
92462|NCT03625947|Hemoptysis|hemoptysis
92463|NCT03625947|Lung cancer|lung cancer
92464|NCT03625921|Physical Therapy|physical therapy
92465|NCT03625921|Powered Prosthesis|powered prosthesis
92466|NCT03625921|Biomechanical outcomes|biomechanical outcomes
92467|NCT03625908|Coronary artery disease|coronary artery disease
92468|NCT03625908|Optical coherence tomography|optical coherence tomography
92469|NCT03625908|antiplatelet therapy|antiplatelet therapy
92470|NCT03625843|urodynamics|urodynamics
92471|NCT03625804|Electrical Stimulation|electrical stimulation
92472|NCT03625804|Cortical Excitability|cortical excitability
92473|NCT03625804|Transcranial Magnetic Stimulation|transcranial magnetic stimulation
92474|NCT03625791|sarcoma|sarcoma
92475|NCT03625791|genetic|genetic
92476|NCT03625778|Obesity|obesity
92477|NCT03625778|MEDI0382|medi0382
92478|NCT03625778|Overweight|overweight
92479|NCT03625765|Indocyanine green|indocyanine green
92480|NCT03625765|SmartGoggles|smartgoggles
92481|NCT03625726|cirrhosis|cirrhosis
92482|NCT03625726|hypercoagulability|hypercoagulability
92483|NCT03625726|thrombin generation assay|thrombin generation assay
92484|NCT03625726|soluble Endothelial Protein C Receptor|soluble endothelial protein c receptor
92485|NCT03625687|Lung disease|lung disease
92486|NCT03625687|Lung Transplant|lung transplant
92487|NCT03625687|HCV|hcv
92488|NCT03625687|Hepatitis C|hepatitis c
92489|NCT03625661|Treatment Related Cancer,iron deficiency|treatment related cancer,iron deficiency
92490|NCT03625648|Diabetic Kidney disease|diabetic kidney disease
92491|NCT03625648|pentoxifylline|pentoxifylline
92492|NCT03625635|primary noninvasive breast cancer|primary noninvasive breast cancer
92493|NCT03625635|sarcopenic obesity prevention|sarcopenic obesity prevention
92494|NCT03625635|individualized nutrition intervention|individualized nutrition intervention
92495|NCT03625635|food-based intervention|food-based intervention
92496|NCT03625622|Alzheimer's disease|alzheimer's disease
92497|NCT03625570|muscle weakness|muscle weakness
92498|NCT03625570|muscle power|muscle power
92499|NCT03625570|resistance training|resistance training
92500|NCT03625570|treadmill training|treadmill training
92501|NCT03625557|Guardant Health|guardant health
92502|NCT03625557|GRECO|greco
92503|NCT03625544|bone graft|bone graft
92504|NCT03625544|ceramic|ceramic
92505|NCT03625544|spinal fusion|spinal fusion
92506|NCT03625544|RCT|rct
92507|NCT03625531|Acupuncture|acupuncture
92508|NCT03625531|Polycystic Ovary Syndrome|polycystic ovary syndrome
92509|NCT03625531|Personalized protocol|personalized protocol
92510|NCT03625531|Fixed protocol|fixed protocol
92511|NCT03625531|Letrozole|letrozole
92512|NCT03625505|Cancer|cancer
92513|NCT03625505|Acute Myeloid Leukemia (AML)|acute myeloid leukemia (aml)
92514|NCT03625505|Relapsed or Refractory AML|relapsed or refractory aml
92515|NCT03625505|Pharmacokinetics|pharmacokinetics
92516|NCT03625505|venetoclax|venetoclax
92517|NCT03625505|gilteritinib|gilteritinib
92518|NCT03625492|artificial sweeteners|artificial sweeteners
92519|NCT03625492|caffeine|caffeine
92520|NCT03625492|alcohol drinking|alcohol drinking
92521|NCT03625492|urinary urgency|urinary urgency
92522|NCT03625492|overactive bladder|overactive bladder
92523|NCT03625492|urinary incontinence, urge|urinary incontinence, urge
92524|NCT03625492|lower urinary tract symptoms|lower urinary tract symptoms
92525|NCT03625453|Tourette Syndrome|tourette syndrome
92526|NCT03625453|Chronic Motor Tic Disorder|chronic motor tic disorder
92527|NCT03625440|cognitive tests|cognitive tests
92528|NCT03625440|carboxyhemoglobin|carboxyhemoglobin
92529|NCT03625440|nicotine|nicotine
118928|NCT03459287|RBC|rbc
92530|NCT03625427|palmitoleic acid|palmitoleic acid
92531|NCT03625427|monounsaturated fatty acid|monounsaturated fatty acid
92532|NCT03625427|chronic inflammation|chronic inflammation
92533|NCT03625401|mild to moderate|mild to moderate
92534|NCT03625388|Leukemia, Myeloid, Philadelphia Positive|leukemia, myeloid, philadelphia positive
92535|NCT03625388|Dasatinib|dasatinib
92536|NCT03625388|Generic Dasatinib|generic dasatinib
92537|NCT03625388|Dasatinib 50 mg once daily|dasatinib 50 mg once daily
92538|NCT03625388|Early chronic phase chronic myeloid leukemia|early chronic phase chronic myeloid leukemia
92539|NCT03625375|exercise|exercise
92540|NCT03625336|prostate|prostate
92541|NCT03625336|calcification|calcification
92542|NCT03625336|MRI|mri
92543|NCT03625284|fucoxanthin|fucoxanthin
92544|NCT03625284|microalgae|microalgae
92545|NCT03625284|non alcoholic fatty liver|non alcoholic fatty liver
92546|NCT03625271|Electroencephalogram|electroencephalogram
92547|NCT03625271|data base|data base
92548|NCT03625271|machine learning|machine learning
92549|NCT03625258|mutations|mutations
92550|NCT03625258|infected patients|infected patients
92551|NCT03625245|Satiety|satiety
92552|NCT03625245|Vegetable protein|vegetable protein
92553|NCT03625245|Yogurt|yogurt
92554|NCT03625245|Fiber|fiber
92555|NCT03625245|Visual Analogue Scale|visual analogue scale
92556|NCT03625245|Cross-over|cross-over
92557|NCT03625193|Sit-to-stand test|sit-to-stand test
92558|NCT03625193|Psychometric properties|psychometric properties
92559|NCT03625180|nanofractured autologous matrix-induced chondrogenesis|nanofractured autologous matrix-induced chondrogenesis
92560|NCT03625167|skin ageing|skin ageing
92561|NCT03625167|suction blister|suction blister
92562|NCT03625167|dermo-epidermal junction|dermo-epidermal junction
92563|NCT03625115|Early Intervention|early intervention
92564|NCT03625115|Developmental outcomes|developmental outcomes
92565|NCT03625115|Health disparities|health disparities
92566|NCT03625115|Early Childhood|early childhood
92567|NCT03625102|Antroquinonol|antroquinonol
92568|NCT03625102|Hocena|hocena
92569|NCT03625089|Carotid Atherosclerosis|carotid atherosclerosis
92570|NCT03625089|Arterial Stiffness|arterial stiffness
92571|NCT03625089|Cardiovascular Risk|cardiovascular risk
92572|NCT03625063|exercise capacity|exercise capacity
92573|NCT03625063|physical activity|physical activity
92574|NCT03625063|respiratory muscle strength|respiratory muscle strength
92575|NCT03625063|respiratory muscle endurance|respiratory muscle endurance
92576|NCT03625011|Pain Relief|pain relief
92577|NCT03625011|Non-Narcotic Pain relief|non-narcotic pain relief
92578|NCT03624985|lidocaine|lidocaine
92579|NCT03624985|lumbar spine surgery|lumbar spine surgery
92580|NCT03624985|postoperative pain|postoperative pain
92581|NCT03624985|opioid reduction|opioid reduction
92582|NCT03624972|communication|communication
92583|NCT03624972|sexual health|sexual health
92584|NCT03624972|menopausal health|menopausal health
92585|NCT03624959|Healthy Volunteer|healthy volunteer
92586|NCT03624959|Cytochrome P450 (CYP)|cytochrome p450 (cyp)
92587|NCT03624959|ozanimod|ozanimod
92588|NCT03624946|Zika virus|zika virus
92589|NCT03624946|Human immune globulin|human immune globulin
92590|NCT03624946|Hyperimmune|hyperimmune
92591|NCT03624946|Polyclonal antibodies|polyclonal antibodies
92592|NCT03624933|Depression|depression
92593|NCT03624933|Cognitive Functioning|cognitive functioning
92594|NCT03624933|Cannabis Use Disorder|cannabis use disorder
92595|NCT03624907|stereotactic body radiotherapy (SBRT)|stereotactic body radiotherapy (sbrt)
92596|NCT03624894|oral impressions|oral impressions
92597|NCT03624894|glassionomer cements|glassionomer cements
92598|NCT03624894|dental restorations|dental restorations
92599|NCT03624894|dental wear|dental wear
92600|NCT03624868|Tai Chi|tai chi
92601|NCT03624868|Older Veterans|older veterans
92602|NCT03624868|Physical activity|physical activity
92603|NCT03624868|PTSD|ptsd
92604|NCT03624764|promontofixation|promontofixation
92605|NCT03624764|prolapse surgery|prolapse surgery
92606|NCT03624738|Femoro-femoral bypass|femoro-femoral bypass
92607|NCT03624725|Gastric cancer|gastric cancer
92608|NCT03624725|Quality of life|quality of life
92609|NCT03624699|glaucoma|glaucoma
92610|NCT03624699|Minimally Invasive Glaucoma Surgery|minimally invasive glaucoma surgery
92611|NCT03624686|Acute Lymphoblastic Leukemia,Immunotherapy,chimeric antigen receptor,non-Hodgkin's lymphoma|acute lymphoblastic leukemia,immunotherapy,chimeric antigen receptor,non-hodgkin's lymphoma
92612|NCT03624660|High-risk|high-risk
92613|NCT03624660|Prostate cancer|prostate cancer
92614|NCT03624660|Proton Radiation|proton radiation
92615|NCT03624660|Dose-escalated|dose-escalated
92616|NCT03624660|Hypofractionation|hypofractionation
92617|NCT03624660|Simultaneous Integrated Boost (SIB)|simultaneous integrated boost (sib)
92618|NCT03624660|Intraprostatic Tumor (IPT)|intraprostatic tumor (ipt)
92619|NCT03624660|Proton Therapy (PT)|proton therapy (pt)
92620|NCT03624660|Androgen Deprivation Therapy (ADT)|androgen deprivation therapy (adt)
92621|NCT03624660|Magnetic Resonance Imaging (MRI)|magnetic resonance imaging (mri)
92622|NCT03624621|Major Depressive Disorder|major depressive disorder
92623|NCT03624621|Cognitive Remediation|cognitive remediation
92624|NCT03624621|Functioning|functioning
92625|NCT03624621|Full Recovery|full recovery
92626|NCT03624621|Functional Remediation|functional remediation
92627|NCT03624595|Cardiac Surgery|cardiac surgery
92628|NCT03624595|Cardiopulmonary Bypass|cardiopulmonary bypass
92629|NCT03624595|Dexmedetomidine|dexmedetomidine
92630|NCT03624595|Delirium|delirium
92631|NCT03624595|Survival|survival
92632|NCT03624582|Cardiorespiratory fitness|cardiorespiratory fitness
92633|NCT03624582|Sedentary behavior|sedentary behavior
92634|NCT03624582|Physical activity|physical activity
92635|NCT03624582|Decision-making|decision-making
92636|NCT03624582|Cardiometabolic risk factors|cardiometabolic risk factors
92637|NCT03624556|Down Syndrome (DS)|down syndrome (ds)
92638|NCT03624556|Fragile X Syndrome (FXS)|fragile x syndrome (fxs)
92639|NCT03624556|Intellectual Development Disorder (IDD)|intellectual development disorder (idd)
92640|NCT03624556|FontUp|fontup
92641|NCT03624556|EGCG|egcg
92642|NCT03624556|Epigallocatechin gallate|epigallocatechin gallate
92643|NCT03624556|Dual specificity tyrosine-phosphorylation-regulated kinase 1A (Dyrk1A)|dual specificity tyrosine-phosphorylation-regulated kinase 1a (dyrk1a)
92644|NCT03624556|Homocysteine|homocysteine
92645|NCT03624556|Dietary supplement|dietary supplement
92646|NCT03624556|Green tea|green tea
92647|NCT03624556|IMIM|imim
92648|NCT03624556|PERSEUS|perseus
92649|NCT03624504|Transcatheter Pacing System|transcatheter pacing system
92650|NCT03624504|Micra Implantable Device|micra implantable device
92651|NCT03624504|Transfermoral Catheter Delivery System|transfermoral catheter delivery system
92652|NCT03624439|double-lumen tube|double-lumen tube
92653|NCT03624439|ETView|etview
92654|NCT03624439|medical simulation|medical simulation
92655|NCT03624439|anesthesiologist|anesthesiologist
92656|NCT03624439|difficult airway|difficult airway
92657|NCT03624426|nerve monitoring|nerve monitoring
92658|NCT03624426|automated somatosensory evoked potential|automated somatosensory evoked potential
92659|NCT03624426|nerve injury|nerve injury
92660|NCT03624413|adolescent|adolescent
92661|NCT03624413|HIV|hiv
92662|NCT03624413|transition care|transition care
92663|NCT03624413|mobile health|mobile health
92664|NCT03624413|Social media|social media
92665|NCT03624413|South Africa|south africa
92666|NCT03624400|Autism spectrum disorder|autism spectrum disorder
92667|NCT03624400|Sleep|sleep
92668|NCT03624400|Cognitive-behavioral treatment|cognitive-behavioral treatment
92669|NCT03624400|Internet delivered treatment|internet delivered treatment
92670|NCT03624387|older adults, cognitive impairment, art therapy, hospital|older adults, cognitive impairment, art therapy, hospital
92671|NCT03624374|Natural History Study|natural history study
92672|NCT03624374|Kennedy Krieger Institute|kennedy krieger institute
92673|NCT03624374|Virtual assessment|virtual assessment
92674|NCT03624374|DARS2|dars2
92675|NCT03624374|Johns Hopkins Hospital|johns hopkins hospital
92676|NCT03624361|Minimally Invasive Glaucoma Surgery|minimally invasive glaucoma surgery
92677|NCT03624361|Glaucoma Implant|glaucoma implant
92678|NCT03624361|Lower IOP|lower iop
92679|NCT03624361|IOP|iop
92680|NCT03624361|Intraocular Pressure|intraocular pressure
92681|NCT03624348|stress|stress
92682|NCT03624348|mindfulness|mindfulness
92683|NCT03624348|work related stress|work related stress
92684|NCT03624348|health|health
92685|NCT03624348|meditation|meditation
92686|NCT03624335|Umbilical cord clamping|umbilical cord clamping
92687|NCT03624335|Anemia Neonatal|anemia neonatal
92688|NCT03624335|Iron metabolism disorders|iron metabolism disorders
92689|NCT03624322|Agitation|agitation
92690|NCT03624322|Schizophrenia|schizophrenia
92691|NCT03624322|Bipolar I disorder|bipolar i disorder
92692|NCT03624322|OLZ|olz
92693|NCT03624322|Olanzapine|olanzapine
92694|NCT03624322|Zyprexa|zyprexa
92695|NCT03624322|POD® device|pod® device
92696|NCT03624270|Acute promyelocytic leukaemia|acute promyelocytic leukaemia
92697|NCT03624270|Oral arsenic trioxide|oral arsenic trioxide
92698|NCT03624257|Laser treatment|laser treatment
92699|NCT03624257|surgical treatment|surgical treatment
92700|NCT03624257|patient reported outcomes|patient reported outcomes
92701|NCT03624257|microbiology|microbiology
92702|NCT03624257|immunology|immunology
92703|NCT03624257|radiological examination|radiological examination
92704|NCT03624244|Low Grade Endometrial Stromal Sarcoma|low grade endometrial stromal sarcoma
92705|NCT03624244|Aromatase inhibitors|aromatase inhibitors
92706|NCT03624231|Squamous Cell Carcinoma of the Head and Neck|squamous cell carcinoma of the head and neck
92707|NCT03624218|PTSD|ptsd
92708|NCT03624218|SCI|sci
92709|NCT03624218|PE|pe
92710|NCT03624218|Prolonged Exposure|prolonged exposure
92711|NCT03624192|Pediatric, Complex Skin Deformities|pediatric, complex skin deformities
92712|NCT03624140|major pediatric surgery|major pediatric surgery
92713|NCT03624140|hemoglobin measurement|hemoglobin measurement
92714|NCT03624114|pituitary adenoma surgery|pituitary adenoma surgery
827725|NCT00123981|mortality|mortality
92715|NCT03624114|endoscopic transsphenoidal surgery|endoscopic transsphenoidal surgery
92716|NCT03624114|sphenoid septation|sphenoid septation
92717|NCT03624088|Breast Cancer Prevention|breast cancer prevention
92718|NCT03624088|Genetic Testing|genetic testing
92719|NCT03624088|Orthodox Jewish|orthodox jewish
92720|NCT03624088|Community-Based Participatory Research|community-based participatory research
92721|NCT03624088|BRCA|brca
92722|NCT03624088|Decision Support|decision support
92723|NCT03624062|New onset|new onset
92724|NCT03623984|Gallium-DOTATATE (68)|gallium-dotatate (68)
92725|NCT03623984|Neuroendocrine Tumors|neuroendocrine tumors
92726|NCT03623984|Pancreatic neuroendocrine Tumors|pancreatic neuroendocrine tumors
92727|NCT03623984|Molecular|molecular
92728|NCT03623984|Surgery|surgery
92729|NCT03623984|Carcinoid|carcinoid
92730|NCT03623971|Cataract|cataract
92731|NCT03623971|Artificial Intelligence|artificial intelligence
92732|NCT03623971|Medical Referral Pattern|medical referral pattern
92733|NCT03623958|image guided|image guided
92734|NCT03623958|lung nodule|lung nodule
92735|NCT03623958|lung cancer|lung cancer
92736|NCT03623958|lung mass|lung mass
92737|NCT03623893|Metachronous contralateral inguinal hernia|metachronous contralateral inguinal hernia
92738|NCT03623893|Hernia repair|hernia repair
92739|NCT03623893|Contralateral exploration|contralateral exploration
92740|NCT03623893|Cost-effectiveness|cost-effectiveness
92741|NCT03623893|Infants|infants
92742|NCT03623841|Executive function|executive function
92743|NCT03623841|Dual-task performance|dual-task performance
92744|NCT03623841|Dual-task training|dual-task training
92745|NCT03623828|unresponsive wakefulness syndrome|unresponsive wakefulness syndrome
92746|NCT03623828|minimally conscious state|minimally conscious state
92747|NCT03623828|apomorphine|apomorphine
92748|NCT03623828|crs-r|crs-r
92749|NCT03623802|Chronic low back pain|chronic low back pain
92750|NCT03623802|Movement therapy|movement therapy
92751|NCT03623802|Supervised training|supervised training
92752|NCT03623789|Total hip arthroplasty|total hip arthroplasty
92753|NCT03623789|Tranexamic acid|tranexamic acid
92754|NCT03623789|Floseal|floseal
92755|NCT03623789|postoperative blood loss|postoperative blood loss
92756|NCT03623789|Thrombin|thrombin
92757|NCT03623776|Non-Small Cell Lung Cancer|non-small cell lung cancer
92758|NCT03623776|Neoadjuvant|neoadjuvant
92759|NCT03623776|Programmed Death-1|programmed death-1
92760|NCT03623763|vitamin D|vitamin d
92761|NCT03623763|water sport|water sport
92762|NCT03623763|IL-4|il-4
92763|NCT03623763|IL-6|il-6
92764|NCT03623763|TNF-a|tnf-a
92765|NCT03623763|IFN-gamma|ifn-gamma
92766|NCT03623763|athletes|athletes
92767|NCT03623763|respiratory infection|respiratory infection
92768|NCT03623724|Major Depression|major depression
92769|NCT03623724|Blended Therapy|blended therapy
92770|NCT03623724|Randomized Clinical Trials|randomized clinical trials
92771|NCT03623724|e-Mental Health|e-mental health
92772|NCT03623724|Routine Practice|routine practice
92773|NCT03623711|major depressive disorder|major depressive disorder
92774|NCT03623711|Magnetic Resonance Imaging|magnetic resonance imaging
92775|NCT03623711|Antidepressant Treatment|antidepressant treatment
92776|NCT03623698|Hypertonic saline|hypertonic saline
92777|NCT03623698|nebulised|nebulised
92778|NCT03623698|children|children
92779|NCT03623698|young people|young people
92780|NCT03623698|adolescents|adolescents
92781|NCT03623698|respiratory|respiratory
92782|NCT03623685|uterocervical angle|uterocervical angle
92783|NCT03623685|preterm labor|preterm labor
92784|NCT03623672|sleep|sleep
92785|NCT03623672|REM|rem
92786|NCT03623672|rapid eye movement|rapid eye movement
92787|NCT03623672|parkinson|parkinson
92788|NCT03623672|lewy body disease|lewy body disease
92789|NCT03623672|dementia with lewy bodies|dementia with lewy bodies
92790|NCT03623672|Multiple System Atrophy|multiple system atrophy
92791|NCT03623672|parasomnia|parasomnia
92792|NCT03623672|synuclein|synuclein
92793|NCT03623672|synucleinopathy|synucleinopathy
92794|NCT03623659|Assisted hatching|assisted hatching
92795|NCT03623659|Zona pellucida|zona pellucida
92796|NCT03623659|Implantation failure|implantation failure
92797|NCT03623659|Blastocyst|blastocyst
92798|NCT03623659|Cryopreservation|cryopreservation
92799|NCT03623646|Oropharyngeal Squamous Cell Carcinoma|oropharyngeal squamous cell carcinoma
92800|NCT03623646|Anti PD-L1|anti pd-l1
92801|NCT03623646|Durvalumab|durvalumab
92802|NCT03623646|Radiation therapy|radiation therapy
92803|NCT03623646|Cisplatin|cisplatin
92804|NCT03623646|Human Papilloma Virus|human papilloma virus
92805|NCT03623620|Depression|depression
92806|NCT03623620|Pregnancy|pregnancy
92807|NCT03623620|Antidepressants|antidepressants
92808|NCT03623620|Mindfulness|mindfulness
92809|NCT03623620|Medication use during pregnancy|medication use during pregnancy
92810|NCT03623620|Depression Relapse|depression relapse
92811|NCT03623581|ASPS|asps
92812|NCT03623568|CKD|ckd
92813|NCT03623568|HCV|hcv
92814|NCT03623568|Hepatitis C|hepatitis c
92815|NCT03623568|Transplant|transplant
92816|NCT03623555|Stress regulation|stress regulation
92817|NCT03623555|Depression|depression
92818|NCT03623555|Intimate partner violence|intimate partner violence
92819|NCT03623555|Resilience|resilience
92820|NCT03623555|Psychophysiology|psychophysiology
92821|NCT03623555|Endocrine response|endocrine response
92822|NCT03623555|Risk factor|risk factor
92823|NCT03623542|Dementia|dementia
92824|NCT03623542|alzheimer dementia|alzheimer dementia
92825|NCT03623516|Thyroid neoplasms; Thyroid gland; ;|thyroid neoplasms; thyroid gland; ;
92826|NCT03623516|Thyroid gland|thyroid gland
92827|NCT03623516|Incidence|incidence
92828|NCT03623516|Overdiagnosis|overdiagnosis
92829|NCT03623503|newborn|newborn
92830|NCT03623503|neonatal spesis|neonatal spesis
92831|NCT03623503|clinical sriteria|clinical sriteria
92832|NCT03623490|kidney cancer|kidney cancer
92833|NCT03623490|breast cancer|breast cancer
92834|NCT03623490|oral therapy|oral therapy
92835|NCT03623490|managment|managment
92836|NCT03623477|Cognitive Remediation|cognitive remediation
92837|NCT03623477|Social Cognition Training|social cognition training
92838|NCT03623477|Emotion Regulation|emotion regulation
92839|NCT03623477|Urgency|urgency
92840|NCT03623399|postoperative pain|postoperative pain
92841|NCT03623399|Intraabdominal laparoscopic gas pressure|intraabdominal laparoscopic gas pressure
92842|NCT03623360|Gadoxetate disodium|gadoxetate disodium
92843|NCT03623347|bully glioblastoma|bully glioblastoma
92844|NCT03623347|multifocal glioblastoma|multifocal glioblastoma
92845|NCT03623347|bevacizumab|bevacizumab
92846|NCT03623347|temozolomide|temozolomide
92847|NCT03623282|Synatura|synatura
92848|NCT03623282|Chronic Obstructive Pulmonary Disease|chronic obstructive pulmonary disease
92849|NCT03623282|Ahn Gook Pharmaceuticals|ahn gook pharmaceuticals
92850|NCT03623243|Multiple Sclerosis; Advancing Multiple Sclerosis; conversion; siponimod;|multiple sclerosis; advancing multiple sclerosis; conversion; siponimod;
92851|NCT03623230|Femoral nerve block|femoral nerve block
92852|NCT03623230|peripheral nerve block|peripheral nerve block
92853|NCT03623230|Concentration|concentration
92854|NCT03623230|volume|volume
92855|NCT03623230|bupivacaine|bupivacaine
92856|NCT03623230|post operative analgesia|post operative analgesia
92857|NCT03623230|total knee arthroplasty|total knee arthroplasty
92858|NCT03623217|Behavioral|behavioral
92859|NCT03623217|Questionnaire development|questionnaire development
92860|NCT03623217|Questionnaire|questionnaire
92861|NCT03623217|Interview with patients|interview with patients
92862|NCT03623217|Observational|observational
92863|NCT03623217|Tacrolimus|tacrolimus
92864|NCT03623217|Patient reported outcome tool|patient reported outcome tool
92865|NCT03623217|Validation|validation
92866|NCT03623217|Kidney transplantation|kidney transplantation
92867|NCT03623204|Obesity|obesity
92868|NCT03623204|Dyspnea|dyspnea
92869|NCT03623204|Bariatric Surgery|bariatric surgery
92870|NCT03623191|Erosive pustular dermatosis of the leg|erosive pustular dermatosis of the leg
92871|NCT03623191|Erosive pustular dermatosis of the scalp|erosive pustular dermatosis of the scalp
92872|NCT03623191|Venous insufficiency|venous insufficiency
92873|NCT03623178|Substance Use Disorders|substance use disorders
92874|NCT03623178|Assertive Community Treatment|assertive community treatment
92875|NCT03623178|Community Treatment|community treatment
92876|NCT03623178|Treatment engagement|treatment engagement
92877|NCT03623178|Service Use|service use
92878|NCT03623165|Heart Failure|heart failure
92879|NCT03623165|NYHA Class III|nyha class iii
92880|NCT03623139|carbohydrates|carbohydrates
92881|NCT03623139|basic carbohydrate counting|basic carbohydrate counting
92882|NCT03623139|diet|diet
92883|NCT03623139|type 2 diabetes|type 2 diabetes
92884|NCT03623113|Carbohydrate counting|carbohydrate counting
92885|NCT03623113|Basic carbohydrate counting|basic carbohydrate counting
92886|NCT03623113|Advanced carbohydrate counting|advanced carbohydrate counting
92887|NCT03623113|Carbohydrates|carbohydrates
92888|NCT03623113|Diet|diet
92889|NCT03623100|Children|children
92890|NCT03623100|Phonology|phonology
92891|NCT03623100|EEG|eeg
92892|NCT03623100|ERP|erp
92893|NCT03623100|ABR|abr
92894|NCT03623100|FFR|ffr
92895|NCT03623074|Myopia|myopia
92896|NCT03623035|Lumbar Plexus block|lumbar plexus block
92897|NCT03623035|total hip arthroplasty|total hip arthroplasty
92898|NCT03623035|Arthroplasty, direct anterior approach|arthroplasty, direct anterior approach
92899|NCT03623035|Pain|pain
92900|NCT03623022|healthy|healthy
92901|NCT03622944|neck pain|neck pain
92902|NCT03622944|physiotherapy|physiotherapy
92903|NCT03622944|rehabilitation|rehabilitation
92904|NCT03622931|ovarian|ovarian
92905|NCT03622931|cancer|cancer
92906|NCT03622931|romiplostim|romiplostim
92907|NCT03622931|nplate|nplate
92908|NCT03622905|Mild Probable Alzheimer's Disease|mild probable alzheimer's disease
92909|NCT03622892|Non Invasive Prenatal Diagnosis|non invasive prenatal diagnosis
92910|NCT03622879|Mirror therapy|mirror therapy
92911|NCT03622879|Transcutaneous Electric Nerve Stimulation|transcutaneous electric nerve stimulation
119431|NCT03455881|TEF|tef
92912|NCT03622879|Rehabilitation|rehabilitation
92913|NCT03622853|adhesive capsulitis|adhesive capsulitis
92914|NCT03622840|Cognitive Remediation|cognitive remediation
92915|NCT03622827|Adjuvant therapy|adjuvant therapy
92916|NCT03622827|chemoradiotherapy|chemoradiotherapy
92917|NCT03622827|Uterine Cervical Neoplasms|uterine cervical neoplasms
92918|NCT03622827|high risk|high risk
92919|NCT03622827|Endostar|endostar
92920|NCT03622814|caregiving|caregiving
92921|NCT03622814|mealtimes|mealtimes
92922|NCT03622814|respite care|respite care
92923|NCT03622814|train-the-trainer|train-the-trainer
92924|NCT03622762|Green tea extract|green tea extract
92925|NCT03622762|Kidney damage|kidney damage
92926|NCT03622762|type 2 diabetes mellitus|type 2 diabetes mellitus
92927|NCT03622736|Rhizarthrosis|rhizarthrosis
92928|NCT03622736|basal thumb arthritis|basal thumb arthritis
92929|NCT03622736|Osteoarthritis Thumb|osteoarthritis thumb
92930|NCT03622736|viscosupplementation|viscosupplementation
92931|NCT03622736|hyaluronic acid|hyaluronic acid
92932|NCT03622736|rheumatoid arthritis|rheumatoid arthritis
92933|NCT03622723|hallux rigidus|hallux rigidus
92934|NCT03622723|viscosupplementation|viscosupplementation
92935|NCT03622723|hyaluronic acid|hyaluronic acid
92936|NCT03622723|metartarsophalangeal joint|metartarsophalangeal joint
92937|NCT03622723|foot arthritis|foot arthritis
92938|NCT03622723|osteoarthritis of the big toe|osteoarthritis of the big toe
92939|NCT03622710|Rehabilitation|rehabilitation
92940|NCT03622710|Surfaces|surfaces
92941|NCT03622710|Walking|walking
92942|NCT03622710|Spinal cord injury|spinal cord injury
92943|NCT03622697|mindfulness|mindfulness
92944|NCT03622697|meditation|meditation
92945|NCT03622697|facial paralysis|facial paralysis
92946|NCT03622697|quality of life|quality of life
92947|NCT03622697|social functioning|social functioning
92948|NCT03622684|TMJ- temporomandibular joint-disorder|tmj- temporomandibular joint-disorder
92949|NCT03622684|Muscle relaxation|muscle relaxation
92950|NCT03622684|Psychoemotional factor|psychoemotional factor
92951|NCT03622684|Stress|stress
92952|NCT03622671|Coronary Artery By-pass Grafting|coronary artery by-pass grafting
92953|NCT03622671|CABG|cabg
92954|NCT03622671|Fibrin|fibrin
92955|NCT03622671|Clot Lysis Time|clot lysis time
92956|NCT03622671|CLT|clt
92957|NCT03622671|Bleeding|bleeding
92958|NCT03622671|Drainage|drainage
92959|NCT03622671|Rethoracotomy|rethoracotomy
92960|NCT03622645|Range of motion|range of motion
92961|NCT03622645|Wrist|wrist
92962|NCT03622645|Hand|hand
92963|NCT03622645|Finger|finger
92964|NCT03622645|Measurement|measurement
92965|NCT03622632|uric acid|uric acid
92966|NCT03622632|organ failure|organ failure
92967|NCT03622606|Right hemispheric Stroke|right hemispheric stroke
92968|NCT03622606|Crossed aphasia|crossed aphasia
92969|NCT03622606|Acute phase|acute phase
92970|NCT03622502|dexmedetomidine|dexmedetomidine
92971|NCT03622502|remifentanil|remifentanil
92972|NCT03622502|extubation|extubation
92973|NCT03622476|Hemophilia A，pharmacokinetics|hemophilia a，pharmacokinetics
92974|NCT03622463|Antroquinonol|antroquinonol
92975|NCT03622463|Hocena|hocena
92976|NCT03622437|Aftercare|aftercare
92977|NCT03622437|Follow-up|follow-up
92978|NCT03622437|Patient Involvement|patient involvement
92979|NCT03622437|Patient-reported Outcomes (PRO)|patient-reported outcomes (pro)
92980|NCT03622398|total knee arthroplasty|total knee arthroplasty
92981|NCT03622398|highly cross-linked polyethylene|highly cross-linked polyethylene
92982|NCT03622385|DNA Methylation|dna methylation
92983|NCT03622385|DNA Biomarkers|dna biomarkers
92984|NCT03622385|Pelvic Mass|pelvic mass
92985|NCT03622372|FLEXOR TENDON|flexor tendon
92986|NCT03622372|ZONE 2|zone 2
92987|NCT03622359|Radionuclide imaging|radionuclide imaging
92988|NCT03622359|Perfusion imaging|perfusion imaging
92989|NCT03622346|Echinococcosis, Hydatidosis, TKR, Fracture|echinococcosis, hydatidosis, tkr, fracture
92990|NCT03622333|Neuroendocrine tumors|neuroendocrine tumors
92991|NCT03622333|carcinoid tumors|carcinoid tumors
92992|NCT03622333|midgut|midgut
92993|NCT03622333|small intestine|small intestine
92994|NCT03622333|genetic predisposition|genetic predisposition
92995|NCT03622333|hereditary|hereditary
92996|NCT03622320|insulin resistance|insulin resistance
92997|NCT03622307|Subcutaneous ICD Therapy|subcutaneous icd therapy
92998|NCT03622307|VT Ablation|vt ablation
92999|NCT03622268|indirect calorimetry|indirect calorimetry
93000|NCT03622268|energy expenditure assessment|energy expenditure assessment
93001|NCT03622268|intensive care unit|intensive care unit
93002|NCT03622255|Intrabony defects|intrabony defects
93003|NCT03622255|Minimally invasive non-surgical technique|minimally invasive non-surgical technique
93004|NCT03622255|Enamel Matrix Derivative|enamel matrix derivative
93005|NCT03622229|pancreatic cancer, endoscopic ultrasound, fine needle biopsy|pancreatic cancer, endoscopic ultrasound, fine needle biopsy
93006|NCT03622190|playing-related musculoskeletal disorder (PRMD)|playing-related musculoskeletal disorder (prmd)
93007|NCT03622190|music students|music students
93008|NCT03622190|pain|pain
93009|NCT03622190|musculoskeletal (MSK) disorder|musculoskeletal (msk) disorder
93010|NCT03622164|radiotherapy|radiotherapy
93011|NCT03622151|mental health|mental health
93012|NCT03622151|Housing First|housing first
93013|NCT03622151|homeless|homeless
93014|NCT03622138|Evidence-based Prevention Programs|evidence-based prevention programs
93015|NCT03622138|Youth Prevention Programs|youth prevention programs
93016|NCT03622138|Outcomes Data|outcomes data
93017|NCT03622138|Continuous Quality Improvement|continuous quality improvement
93018|NCT03622112|Inhaled non-steroidal glucocorticoid receptor modulator|inhaled non-steroidal glucocorticoid receptor modulator
93019|NCT03622112|Asthma|asthma
93020|NCT03622112|Inhaled corticosteroids.|inhaled corticosteroids.
93021|NCT03622112|Glucocorticoid receptor (GA) agonists.|glucocorticoid receptor (ga) agonists.
93022|NCT03622112|Chronic obstructive pulmonary disease.|chronic obstructive pulmonary disease.
93023|NCT03622112|Short-acting B2 agonist.|short-acting b2 agonist.
93024|NCT03622112|Fluticasone furoate.|fluticasone furoate.
93126|NCT03621488|Depression|depression
93025|NCT03622073|Post abortion care|post abortion care
93026|NCT03622073|Misoprostol|misoprostol
93027|NCT03622073|Second trimester|second trimester
93028|NCT03622047|Labor, Analgesia, Dexmedetomidine, Sufentanil|labor, analgesia, dexmedetomidine, sufentanil
93029|NCT03622034|knee features|knee features
93030|NCT03622034|ethnic changes|ethnic changes
93031|NCT03621982|Camidanlumab tesirine|camidanlumab tesirine
93032|NCT03621969|Vagus Nerve Stimulation|vagus nerve stimulation
93033|NCT03621956|Near-Infrared Spectroscopy|near-infrared spectroscopy
93034|NCT03621943|Neurodevelopmental impairment|neurodevelopmental impairment
93035|NCT03621943|Disability|disability
93036|NCT03621943|Umbilical cord milking|umbilical cord milking
93037|NCT03621943|Early Cord Clamping|early cord clamping
93038|NCT03621930|RESCEU (consortium)|resceu (consortium)
93039|NCT03621930|RSV|rsv
93040|NCT03621930|Respiratory Syncytial Virus|respiratory syncytial virus
93041|NCT03621917|near infrared spectroscopy|near infrared spectroscopy
93042|NCT03621917|acute ischemic stroke|acute ischemic stroke
93043|NCT03621917|thrombolytic therapy|thrombolytic therapy
93044|NCT03621904|Hormonal therapy|hormonal therapy
93045|NCT03621904|Endocrine therapy|endocrine therapy
93046|NCT03621904|Translational research|translational research
93047|NCT03621904|Tumor factors|tumor factors
93048|NCT03621891|hyper-occlusion|hyper-occlusion
93049|NCT03621891|hypoxia|hypoxia
93050|NCT03621891|occlusal trauma|occlusal trauma
93051|NCT03621891|periodontitis|periodontitis
93052|NCT03621891|subgingival microbiota|subgingival microbiota
93053|NCT03621878|Lumbosacral radiculopathy|lumbosacral radiculopathy
93054|NCT03621878|peripheral sensitization|peripheral sensitization
93055|NCT03621878|Neural mobilization|neural mobilization
93056|NCT03621878|radicular LBP|radicular lbp
93057|NCT03621878|slider|slider
93058|NCT03621878|tensioner|tensioner
93059|NCT03621865|bioavailability|bioavailability
93060|NCT03621865|pharmacokinetic study|pharmacokinetic study
93061|NCT03621865|curcuminoids|curcuminoids
93062|NCT03621865|curcumin|curcumin
93063|NCT03621865|healthy volunteers|healthy volunteers
93064|NCT03621852|Endosonography|endosonography
93065|NCT03621852|fine needle biopsy|fine needle biopsy
93066|NCT03621826|sickle cell anemia|sickle cell anemia
93067|NCT03621826|TCD|tcd
93068|NCT03621826|screening|screening
93069|NCT03621826|dissemination|dissemination
93070|NCT03621826|implementation|implementation
93071|NCT03621813|Neuropathic Pain|neuropathic pain
93072|NCT03621813|Exercise|exercise
93073|NCT03621813|Lung Cancer|lung cancer
93074|NCT03621800|Thirst|thirst
93075|NCT03621800|Elderly|elderly
93076|NCT03621800|Postoperative Period|postoperative period
93077|NCT03621800|Surgical Patient|surgical patient
93078|NCT03621800|Menthol|menthol
93079|NCT03621800|Ice|ice
93080|NCT03621800|Randomized Controlled Trial|randomized controlled trial
93081|NCT03621774|Schizophrenia|schizophrenia
93082|NCT03621774|CBT|cbt
93083|NCT03621774|Mobile CBT|mobile cbt
93084|NCT03621774|Negative Symptoms|negative symptoms
93085|NCT03621761|cognitive behavioral therapy|cognitive behavioral therapy
93086|NCT03621761|modafinil|modafinil
93087|NCT03621761|Provigil|provigil
93088|NCT03621761|fatigue|fatigue
93089|NCT03621761|MS|ms
93090|NCT03621748|craniotomy|craniotomy
93091|NCT03621748|awake craniotomy|awake craniotomy
93092|NCT03621735|Tinnitus|tinnitus
93093|NCT03621735|Ringing in the ear|ringing in the ear
93094|NCT03621709|TAVR|tavr
93095|NCT03621709|TAVI|tavi
93096|NCT03621709|Aortic valve stenosis|aortic valve stenosis
93097|NCT03621670|Meningitis|meningitis
93098|NCT03621670|Immune response|immune response
93099|NCT03621670|Sufficiency|sufficiency
93100|NCT03621670|Neisseria meningitides|neisseria meningitides
93101|NCT03621670|Bexsero|bexsero
93102|NCT03621657|FMT|fmt
93103|NCT03621657|Fecal Microbiota Transplant|fecal microbiota transplant
93104|NCT03621644|Pancreatic Cancer|pancreatic cancer
93105|NCT03621644|Radiation Therapy|radiation therapy
93106|NCT03621644|SBRT|sbrt
93107|NCT03621631|knee osteoarthritis|knee osteoarthritis
93108|NCT03621631|Tai Chi|tai chi
93109|NCT03621631|Biofeedback|biofeedback
93110|NCT03621631|External Knee Adduction Moment|external knee adduction moment
93111|NCT03621618|vasoactive medication|vasoactive medication
93112|NCT03621618|dynamic arterial elastance|dynamic arterial elastance
93113|NCT03621579|RNFLT|rnflt
93114|NCT03621540|transcranial direct current stimulation|transcranial direct current stimulation
93115|NCT03621540|schizophrenia|schizophrenia
93116|NCT03621540|cognitive deficits|cognitive deficits
93117|NCT03621540|working memory training|working memory training
93118|NCT03621514|Painless indwelling urethral catheter|painless indwelling urethral catheter
93119|NCT03621514|uniportal video-assisted thoracoscopic surgery|uniportal video-assisted thoracoscopic surgery
93120|NCT03621514|Lobectomy|lobectomy
93121|NCT03621514|Lung cancer|lung cancer
93122|NCT03621501|Percutaneous coronary intervention|percutaneous coronary intervention
93123|NCT03621501|Multivessel disease|multivessel disease
93124|NCT03621488|Behavioral Activation|behavioral activation
93125|NCT03621488|Virtual reality|virtual reality
93130|NCT03621449|transthoracic ultrasound|transthoracic ultrasound
93131|NCT03621449|velocity time integral|velocity time integral
93135|NCT03621384|BsmI|bsmi
93136|NCT03621384|Diabetic kidney disease|diabetic kidney disease
93137|NCT03621384|Polymorphisms|polymorphisms
93138|NCT03621384|Vitamin D receptor gene|vitamin d receptor gene
93139|NCT03621358|Satiety|satiety
93140|NCT03621358|Encapsulated flavour|encapsulated flavour
93141|NCT03621358|Gummies|gummies
93142|NCT03621358|Visual Analogue Scale|visual analogue scale
93143|NCT03621358|Cross-over|cross-over
93144|NCT03621319|Hybrid argon plasma coagulation|hybrid argon plasma coagulation
93145|NCT03621319|Submucosal injection|submucosal injection
93146|NCT03621293|Long term outcome|long term outcome
93147|NCT03621293|Brain|brain
93148|NCT03621293|Lung|lung
93149|NCT03621293|Oxygen strategies|oxygen strategies
93150|NCT03621254|Functional Electrical Stimulation|functional electrical stimulation
93151|NCT03621254|Exercise Training|exercise training
93152|NCT03621254|Aerobic Fitness|aerobic fitness
93153|NCT03621254|Muscle Strength|muscle strength
93154|NCT03621228|Delirium|delirium
93155|NCT03621228|Hyperactive|hyperactive
93156|NCT03621228|Aggression|aggression
93157|NCT03621228|Anxiety|anxiety
93158|NCT03621228|Digital therapy|digital therapy
93159|NCT03621215|tart cherries|tart cherries
93160|NCT03621215|gout|gout
93161|NCT03621215|cardiovascular disease risk|cardiovascular disease risk
93162|NCT03621215|gout attack|gout attack
93163|NCT03621215|gout flare|gout flare
93164|NCT03621202|large bore|large bore
93165|NCT03621202|femoral access|femoral access
93166|NCT03621202|internal bleeding|internal bleeding
93167|NCT03621202|retroperitoneal hematoma|retroperitoneal hematoma
93168|NCT03621202|bleeding complications|bleeding complications
93169|NCT03621176|Exercise|exercise
93170|NCT03621176|Health-related quality of life|health-related quality of life
93171|NCT03621176|Physical function|physical function
93172|NCT03621176|Hemodialysis|hemodialysis
93173|NCT03621176|Peritoneal dialysis|peritoneal dialysis
93174|NCT03621163|bleaching agent|bleaching agent
93175|NCT03621150|mri|mri
93176|NCT03621150|musculoskeletal ultrasound|musculoskeletal ultrasound
93177|NCT03621150|tendinopathy|tendinopathy
93178|NCT03621137|Atopic Eczema|atopic eczema
93179|NCT03621137|Atopic Dermatitis|atopic dermatitis
93180|NCT03621137|Registries|registries
93181|NCT03621137|Systemic therapies|systemic therapies
93182|NCT03621137|Off-label use|off-label use
93183|NCT03621137|Phototherapy|phototherapy
93184|NCT03621137|Child|child
93185|NCT03621137|Adult|adult
93186|NCT03621111|Myocardial Infarct|myocardial infarct
93187|NCT03621111|Medication Adherence|medication adherence
93188|NCT03621111|Community Pharmacist|community pharmacist
93189|NCT03621111|Patient counseling|patient counseling
93190|NCT03621111|Pill counts|pill counts
93191|NCT03621111|Hospital re-admission|hospital re-admission
93192|NCT03621111|Antiplatelet therapy|antiplatelet therapy
93193|NCT03621111|Beta-blockers|beta-blockers
93194|NCT03621111|Lipid-lowering therapy|lipid-lowering therapy
93195|NCT03621111|Angiotensin-Converting Enzyme Inhibitors (ACEi)|angiotensin-converting enzyme inhibitors (acei)
93196|NCT03621111|Renin Angiotensin System Inhibitors (RASi)|renin angiotensin system inhibitors (rasi)
93197|NCT03621111|Mineralocorticoid/aldosterone receptor antagonists|mineralocorticoid/aldosterone receptor antagonists
93198|NCT03621098|Exercise|exercise
93199|NCT03621072|Fluconazole|fluconazole
93200|NCT03621072|Bioequivalence|bioequivalence
93201|NCT03621072|Phase I|phase i
93202|NCT03621072|Chinese|chinese
93203|NCT03621072|Healthy Subjects|healthy subjects
93204|NCT03621059|Tourette syndrome|tourette syndrome
93205|NCT03621059|behavior therapy|behavior therapy
93206|NCT03621059|children and adolescents|children and adolescents
93207|NCT03621046|motor;|motor;
93208|NCT03621046|cognition|cognition
93209|NCT03621033|transendoscopic enteral tubing|transendoscopic enteral tubing
93210|NCT03621033|Microbiota Transplantation|microbiota transplantation
93211|NCT03621033|transparent cap-assisted colonoscopy|transparent cap-assisted colonoscopy
93212|NCT03621007|POMC|pomc
93213|NCT03621007|LEPR|lepr
93214|NCT03621007|PCSK1|pcsk1
93215|NCT03621007|Bi-Allelic Loss|bi-allelic loss
93216|NCT03621007|Obesity|obesity
93217|NCT03620994|Irritable Bowel Syndrome|irritable bowel syndrome
93218|NCT03620994|alarm symptoms|alarm symptoms
93219|NCT03620994|Roman IV|roman iv
93220|NCT03620968|Postoperative cognitive dysfunction|postoperative cognitive dysfunction
93221|NCT03620968|Cognitive training|cognitive training
93222|NCT03620968|Anaesthesia in Non-cardiac surgery|anaesthesia in non-cardiac surgery
93223|NCT03620968|Elderly adult|elderly adult
93224|NCT03620968|Perioperative management.|perioperative management.
93430|NCT03619772|therapy|therapy
93225|NCT03620942|Maternal hypotension|maternal hypotension
93226|NCT03620942|Spinal anaesthesia|spinal anaesthesia
93227|NCT03620942|Caesarean section|caesarean section
93228|NCT03620929|estradiol|estradiol
93229|NCT03620916|liver resection|liver resection
93230|NCT03620916|analgesia|analgesia
93231|NCT03620916|pain|pain
93232|NCT03620916|postoperative recovery|postoperative recovery
93233|NCT03620903|Waldenstrom Macroglobulinemia, Ibrutinib, Bortezomib|waldenstrom macroglobulinemia, ibrutinib, bortezomib
93234|NCT03620890|Pregnancy|pregnancy
93235|NCT03620851|enhanced recovery program|enhanced recovery program
93236|NCT03620851|colorectal surgery|colorectal surgery
93237|NCT03620851|elderly|elderly
93238|NCT03620812|rapeseed, protein, postprandial, glucose|rapeseed, protein, postprandial, glucose
93239|NCT03620799|Roller intervention|roller intervention
93240|NCT03620799|Knee pain|knee pain
93241|NCT03620799|Algometry|algometry
93242|NCT03620760|Unstable Angina|unstable angina
93243|NCT03620760|Stent|stent
93244|NCT03620760|Ticagrelor|ticagrelor
93245|NCT03620760|Platelet aggregation|platelet aggregation
93246|NCT03620760|Percutaneous Coronary Intervention|percutaneous coronary intervention
93247|NCT03620760|Coronary Artery Disease|coronary artery disease
93248|NCT03620760|Major Adverse Cardiovascular and Cerebrovascular Events|major adverse cardiovascular and cerebrovascular events
93249|NCT03620760|Bleeding Events|bleeding events
93250|NCT03620708|tobacco|tobacco
93251|NCT03620708|smoking|smoking
93252|NCT03620708|cigarette|cigarette
93253|NCT03620669|Lung cancer|lung cancer
93254|NCT03620669|Durvalumab|durvalumab
93255|NCT03620669|PD-L1|pd-l1
93256|NCT03620669|NSCLC|nsclc
93257|NCT03620669|Phase II|phase ii
93258|NCT03620669|PS 2|ps 2
93259|NCT03620656|Atrial Fibrillation|atrial fibrillation
93260|NCT03620656|FibriCheck|fibricheck
93261|NCT03620656|Validation|validation
93262|NCT03620656|Smartphone|smartphone
93263|NCT03620656|Smartwatch|smartwatch
93264|NCT03620643|Advanced E-cadherin negative gastric cancer|advanced e-cadherin negative gastric cancer
93265|NCT03620643|Oestrogen receptor positive lobular breast cancer|oestrogen receptor positive lobular breast cancer
93266|NCT03620643|Crizotinib|crizotinib
93267|NCT03620643|Fulvestrant|fulvestrant
93268|NCT03620617|Raspberry|raspberry
93269|NCT03620617|Diet|diet
93270|NCT03620604|single incision sling|single incision sling
93271|NCT03620604|safety|safety
93272|NCT03620604|efficacy|efficacy
93273|NCT03620591|Lidocaine|lidocaine
93274|NCT03620591|Postoperative Pain|postoperative pain
93275|NCT03620591|Opioid consumption|opioid consumption
93276|NCT03620591|Laparoscopic cholecystectomy|laparoscopic cholecystectomy
93277|NCT03620578|DLBCL|dlbcl
93278|NCT03620578|HGBL|hgbl
93279|NCT03620578|BCL-2|bcl-2
93280|NCT03620578|BCL-6|bcl-6
93281|NCT03620578|double-hit|double-hit
93282|NCT03620578|triple-hit|triple-hit
93283|NCT03620578|R-CHOP|r-chop
93284|NCT03620578|DA-EPOCH-R|da-epoch-r
93285|NCT03620578|Nivolumab|nivolumab
93286|NCT03620578|PD1/PDL1 expression|pd1/pdl1 expression
93287|NCT03620565|Pelvic floor reconstructive surgery|pelvic floor reconstructive surgery
93288|NCT03620565|Mesh|mesh
93289|NCT03620565|Native tissue|native tissue
93290|NCT03620565|Tape|tape
93291|NCT03620565|Complication|complication
93292|NCT03620565|the CTS coding|the cts coding
93293|NCT03620552|18F-S16|18f-s16
93294|NCT03620552|Neurodegenerative Dementia|neurodegenerative dementia
93295|NCT03620552|PET/CT|pet/ct
93296|NCT03620539|flow-mediated dilation|flow-mediated dilation
93297|NCT03620539|sauna|sauna
93298|NCT03620539|vascular|vascular
93299|NCT03620539|heat|heat
93300|NCT03620526|Iloprost|iloprost
93301|NCT03620526|Heart failure with preserved ejection fraction|heart failure with preserved ejection fraction
93302|NCT03620526|hemodynamic|hemodynamic
93303|NCT03620526|Pulmonary wedge pressure|pulmonary wedge pressure
93304|NCT03620487|NGS|ngs
93305|NCT03620487|Sequencing|sequencing
93306|NCT03620474|Hepatitis C virus|hepatitis c virus
93307|NCT03620474|Hepatitis B virus|hepatitis b virus
93308|NCT03620474|liver Cirrhosis|liver cirrhosis
119936|NCT03453307|NSCLC|nsclc
93309|NCT03620461|metastatic pancreatic cancer|metastatic pancreatic cancer
93310|NCT03620461|real world data|real world data
93311|NCT03620461|gemcitabine|gemcitabine
93312|NCT03620461|nabpaclitaxel|nabpaclitaxel
93313|NCT03620461|efficacy|efficacy
93314|NCT03620461|safety|safety
93315|NCT03620422|Mannitol|mannitol
93316|NCT03620422|Bronchoconstriction|bronchoconstriction
93317|NCT03620422|Airway nerve function|airway nerve function
93318|NCT03620422|Cough|cough
93319|NCT03620422|Diagnostic Test|diagnostic test
93320|NCT03620422|Osmolarity|osmolarity
93321|NCT03620422|Salbutamol|salbutamol
93322|NCT03620383|Transradial access|transradial access
93323|NCT03620383|Radial artery|radial artery
93324|NCT03620383|Vasodilation|vasodilation
93325|NCT03620383|Heat|heat
93326|NCT03620370|Normobaric hyperoxia;|normobaric hyperoxia;
93327|NCT03620370|Acute ischemic stroke;|acute ischemic stroke;
93328|NCT03620370|vascular recanalization;|vascular recanalization;
93329|NCT03620370|Endovascular treatment;|endovascular treatment;
93330|NCT03620370|reperfusion therapy|reperfusion therapy
93331|NCT03620318|Compassionate use|compassionate use
93332|NCT03620279|motor training for cerebral palsy|motor training for cerebral palsy
93333|NCT03620266|acute myocardial infarction|acute myocardial infarction
93334|NCT03620266|diet therapy|diet therapy
93335|NCT03620266|anthocyanin|anthocyanin
93336|NCT03620266|bilberry bush|bilberry bush
93337|NCT03620266|exercise capacity|exercise capacity
93338|NCT03620266|cholesterol|cholesterol
93339|NCT03620266|beta glucans|beta glucans
93340|NCT03620253|modafinil|modafinil
93341|NCT03620253|remitted depression|remitted depression
93342|NCT03620253|cognition|cognition
93343|NCT03620227|Combined Exercise|combined exercise
93344|NCT03620227|Beetroot juice|beetroot juice
93345|NCT03620227|Women health|women health
93346|NCT03620214|CHILD|child
93347|NCT03620214|GROWTH|growth
93348|NCT03620214|PHYSIOLOGICAL PARAMETERS|physiological parameters
93349|NCT03620214|FACE|face
93350|NCT03620214|MAXILLARY|maxillary
93351|NCT03620188|Patient treatment goals|patient treatment goals
93352|NCT03620175|Healthy Participants|healthy participants
93353|NCT03620175|Skin|skin
93354|NCT03620175|Dermal|dermal
93355|NCT03620175|Biopsy|biopsy
93356|NCT03620149|denosumab|denosumab
93357|NCT03620149|Giant cell tumor of bone|giant cell tumor of bone
93358|NCT03620136|Total knee prosthesis|total knee prosthesis
93359|NCT03620136|Adductor canal block|adductor canal block
93360|NCT03620136|Local peri-articular infiltrations|local peri-articular infiltrations
93361|NCT03620136|Postoperative analgesia|postoperative analgesia
93362|NCT03620136|Early rehabilitation|early rehabilitation
93363|NCT03620136|Patient Controlled Analgesia|patient controlled analgesia
93364|NCT03620123|SCCHN|scchn
93365|NCT03620123|Nivolumab|nivolumab
93366|NCT03620123|Ipilimumab|ipilimumab
93367|NCT03620097|Autism Spectrum Disorders|autism spectrum disorders
93368|NCT03620097|ASD|asd
93369|NCT03620097|Children|children
93370|NCT03620097|Autism|autism
93371|NCT03620097|Docosahexaenoic acid|docosahexaenoic acid
93372|NCT03620097|Inflammation|inflammation
93373|NCT03620097|Oxidative stress|oxidative stress
93374|NCT03620097|Intestinal microbiota|intestinal microbiota
93375|NCT03620097|heavy metals|heavy metals
93376|NCT03620071|complex chronic condition|complex chronic condition
93377|NCT03620071|care coordination|care coordination
93378|NCT03620071|shared decision making|shared decision making
93379|NCT03620071|health literacy|health literacy
93380|NCT03620019|Denosumab|denosumab
93381|NCT03620019|Pembrolizumab|pembrolizumab
93382|NCT03620019|Melanoma|melanoma
93383|NCT03620019|Unresectable|unresectable
93384|NCT03620019|Cutaneous|cutaneous
93385|NCT03620019|Nivolumab|nivolumab
93386|NCT03619993|R-CHOP|r-chop
93387|NCT03619993|G-CSF|g-csf
93388|NCT03619993|Early breast cancer|early breast cancer
93389|NCT03619993|Anthracycline/cyclophosphamide|anthracycline/cyclophosphamide
93390|NCT03619993|1st line|1st line
93391|NCT03619993|immunochemotherapy|immunochemotherapy
93392|NCT03619993|taxane|taxane
93393|NCT03619980|Prostate Cancer|prostate cancer
93394|NCT03619980|Non interventional|non interventional
93395|NCT03619980|Registry|registry
93396|NCT03619967|breast cancer|breast cancer
93397|NCT03619967|sentynel lymph node|sentynel lymph node
93398|NCT03619967|fluorescence imaging|fluorescence imaging
93399|NCT03619954|NK cell infusion|nk cell infusion
93400|NCT03619941|Montmorency Tart Cherry|montmorency tart cherry
93401|NCT03619941|Anthocyanins|anthocyanins
93402|NCT03619941|Polyphenols|polyphenols
93403|NCT03619941|Metabolic Syndrome|metabolic syndrome
93404|NCT03619941|Insulin Resistance|insulin resistance
93405|NCT03619941|Hypertension|hypertension
93406|NCT03619941|Lipid Profile|lipid profile
93407|NCT03619941|Prediabetes|prediabetes
93408|NCT03619928|Dry needling|dry needling
93409|NCT03619928|Massotherapy|massotherapy
93410|NCT03619928|Delayed onset muscle soreness|delayed onset muscle soreness
93411|NCT03619902|GPP|gpp
93412|NCT03619889|Chronic Pain|chronic pain
93413|NCT03619889|Physical Therapy modalities|physical therapy modalities
93414|NCT03619876|CTLA4-Ig|ctla4-ig
93415|NCT03619876|Abatacept|abatacept
93416|NCT03619876|Myocarditis|myocarditis
93417|NCT03619876|RA|ra
93418|NCT03619863|Hemophilia|hemophilia
93419|NCT03619863|Non-Factor Products|non-factor products
93420|NCT03619863|Bypassing Agents|bypassing agents
93421|NCT03619863|Clotting Factor Replacement Products|clotting factor replacement products
93422|NCT03619850|Iron Deficiency Anemia, IDA, Chronic Kidney Disease, CKD, pediatrics, ferumoxytol, iron sucrose, Feraheme, Venofer|iron deficiency anemia, ida, chronic kidney disease, ckd, pediatrics, ferumoxytol, iron sucrose, feraheme, venofer
93423|NCT03619811|esophageal disorders|esophageal disorders
93424|NCT03619785|Nerve Block|nerve block
93425|NCT03619785|Serratus Anterior Plane Block|serratus anterior plane block
93426|NCT03619785|Ultrasound|ultrasound
93427|NCT03619785|Emergency Department|emergency department
93428|NCT03619772|hand|hand
93429|NCT03619772|stroke|stroke
93431|NCT03619772|rehabilitation|rehabilitation
93432|NCT03619759|Sugammadex|sugammadex
93433|NCT03619759|Colorectal surgery|colorectal surgery
93434|NCT03619759|postoperative complication|postoperative complication
93435|NCT03619746|infection|infection
93436|NCT03619733|HEART score, troponins|heart score, troponins
93437|NCT03619720|Emotions, Respiratory Rate, Phonation|emotions, respiratory rate, phonation
93438|NCT03619707|Luteal Phase Support|luteal phase support
93439|NCT03619707|Cryo-warmed Embryo Transfer|cryo-warmed embryo transfer
93440|NCT03619707|Assisted Reproductive Technology|assisted reproductive technology
93441|NCT03619668|Effect of radiotherapy|effect of radiotherapy
93442|NCT03619655|J1835|j1835
93443|NCT03619655|SPECT CT|spect ct
93444|NCT03619655|PSMA|psma
93445|NCT03619655|18F-DCFPyL PET/CT|18f-dcfpyl pet/ct
93446|NCT03619655|WB-MRI|wb-mri
93447|NCT03619655|NaF|naf
93448|NCT03619629|Kinesio-taping|kinesio-taping
93449|NCT03619629|Mulligan|mulligan
93450|NCT03619629|Mobilization|mobilization
93451|NCT03619629|balance|balance
93452|NCT03619629|ankle|ankle
93453|NCT03619590|Teratogenicity|teratogenicity
93454|NCT03619590|Pregnancy|pregnancy
93455|NCT03619590|Hepatitis B|hepatitis b
93456|NCT03619590|Twinrix|twinrix
93457|NCT03619590|Prenatal exposure|prenatal exposure
93458|NCT03619590|Hepatitis A|hepatitis a
93459|NCT03619577|Mild Cognitive Impairment|mild cognitive impairment
93460|NCT03619577|cognitive training|cognitive training
93461|NCT03619577|exercise|exercise
93462|NCT03619512|Richter Syndrome|richter syndrome
93463|NCT03619512|Genomics|genomics
93464|NCT03619512|Proteomics|proteomics
93465|NCT03619512|Chemotherapy resistance|chemotherapy resistance
93466|NCT03619486|Low Energy Shock Wave (LESW)|low energy shock wave (lesw)
93467|NCT03619486|Extracorporeal Shockwave Therapy|extracorporeal shockwave therapy
93468|NCT03619486|interstitial cystitis/bladder pain syndrome (IC/BPS)|interstitial cystitis/bladder pain syndrome (ic/bps)
93469|NCT03619473|standard motorcycle child safety helmet|standard motorcycle child safety helmet
93470|NCT03619473|chinstrap|chinstrap
93471|NCT03619473|toy/game helmet|toy/game helmet
93472|NCT03619460|wisdom teeth|wisdom teeth
93473|NCT03619460|extraction|extraction
93474|NCT03619460|piezoelectric technique|piezoelectric technique
93475|NCT03619434|Femtolaser|femtolaser
93476|NCT03619434|Corneal Transplant|corneal transplant
93477|NCT03619434|Keratoplasty|keratoplasty
93478|NCT03619434|Corneal Graft|corneal graft
93479|NCT03619434|Laser|laser
93480|NCT03619434|Trephine|trephine
93481|NCT03619421|zinc|zinc
93482|NCT03619421|nutrition|nutrition
93483|NCT03619421|supplement|supplement
93484|NCT03619421|food|food
93485|NCT03619408|Esophageal Atresia|esophageal atresia
93486|NCT03619408|Esophagitis|esophagitis
93487|NCT03619408|GER|ger
93488|NCT03619408|Gastroesopheal reflux|gastroesopheal reflux
93489|NCT03619408|PPI|ppi
93490|NCT03619395|Cardiovascular Secondary prevention|cardiovascular secondary prevention
93491|NCT03619395|Cardiovascular risk factors control|cardiovascular risk factors control
93492|NCT03619382|ankle|ankle
93493|NCT03619356|hemoglobin|hemoglobin
93494|NCT03619356|oxygenation concentration|oxygenation concentration
93495|NCT03619317|Heartdisease|heartdisease
93496|NCT03619317|Radiation|radiation
93497|NCT03619317|Chemoradiotherapy|chemoradiotherapy
93498|NCT03619317|cardiovascular disease|cardiovascular disease
93499|NCT03619304|coffee, oral squamous cell carcinoma|coffee, oral squamous cell carcinoma
93500|NCT03619278|HIV|hiv
93501|NCT03619239|Phase 1b/2a|phase 1b/2a
93502|NCT03619200|Primary prevention|primary prevention
93503|NCT03619200|Adults|adults
93504|NCT03619200|Pressure platform|pressure platform
93505|NCT03619200|Inertial Sensors|inertial sensors
93506|NCT03619200|Clinical Protocol|clinical protocol
93507|NCT03619174|incontinence|incontinence
93508|NCT03619174|urine|urine
93509|NCT03619174|urinary|urinary
93510|NCT03619174|pee|pee
93511|NCT03619174|leak|leak
93512|NCT03619174|SUI|sui
93513|NCT03619161|atopic dermatitis|atopic dermatitis
93514|NCT03619161|eczema|eczema
93515|NCT03619161|bleach bath|bleach bath
93516|NCT03619161|bacteria|bacteria
93517|NCT03619161|bathroom|bathroom
93518|NCT03619161|cleaning|cleaning
93519|NCT03619135|Pain|pain
93520|NCT03619135|Anxiety|anxiety
93521|NCT03619135|intravenous access|intravenous access
93522|NCT03619109|C-Reactive Protein|c-reactive protein
93523|NCT03619109|CRP|crp
93524|NCT03619109|Procalcitonin|procalcitonin
93525|NCT03619109|Lactate|lactate
93526|NCT03619109|In Vitro Diagnostic Product|in vitro diagnostic product
93527|NCT03619109|IVD|ivd
93528|NCT03619096|Gingival recession|gingival recession
93529|NCT03619096|porcine collagen matrix|porcine collagen matrix
93530|NCT03619096|multiple gingival recessions|multiple gingival recessions
93531|NCT03619096|tunnel technique|tunnel technique
93532|NCT03619083|Assessments|assessments
93533|NCT03619083|Sensory Gating|sensory gating
93534|NCT03619083|Attention|attention
93535|NCT03619083|Executive Control|executive control
93536|NCT03619083|18-240|18-240
93537|NCT03619070|Fatigability|fatigability
93538|NCT03619070|Postmenopausal Woman|postmenopausal woman
93539|NCT03619070|Resistance training|resistance training
93540|NCT03619070|Physical performance|physical performance
93541|NCT03619070|Older adults|older adults
93542|NCT03619044|Metastatic breast cancer|metastatic breast cancer
93543|NCT03619044|FES-PET|fes-pet
93544|NCT03619044|HER2-positive Breast Cancer|her2-positive breast cancer
93545|NCT03619031|type 1 diabetes|type 1 diabetes
93546|NCT03619031|postprandial glycemia|postprandial glycemia
93547|NCT03619031|pizza leavening|pizza leavening
93548|NCT03619005|Prasterone|prasterone
93549|NCT03619005|DHEA|dhea
93550|NCT03619005|Menopause|menopause
93551|NCT03619005|Sexual Disorder|sexual disorder
93552|NCT03619005|HSDD|hsdd
93553|NCT03618992|Valley Fever|valley fever
93554|NCT03618992|Coccidioidomycosis|coccidioidomycosis
93555|NCT03618979|regenerative medicine|regenerative medicine
93556|NCT03618979|low back pain|low back pain
93557|NCT03618979|multifidus|multifidus
93558|NCT03618979|platelet rich plasma|platelet rich plasma
93559|NCT03618966|Amyotrophic lateral sclerosis|amyotrophic lateral sclerosis
93560|NCT03618966|Muscle disease|muscle disease
93561|NCT03618966|Neuromuscular magnetic stimulation|neuromuscular magnetic stimulation
93562|NCT03618940|fire|fire
93563|NCT03618940|burn injury|burn injury
93564|NCT03618940|children|children
93565|NCT03618940|scalds|scalds
93566|NCT03618927|intervention|intervention
93567|NCT03618927|health policy|health policy
93568|NCT03618927|psychosocial health|psychosocial health
93569|NCT03618927|education|education
93570|NCT03618888|Out-of-Hospital Cardiac arrest|out-of-hospital cardiac arrest
93571|NCT03618888|Cardiopulmonary Resuscitation|cardiopulmonary resuscitation
93572|NCT03618888|Automated External Defibrillator|automated external defibrillator
93573|NCT03618888|Self-learning|self-learning
93574|NCT03618888|Basic Life Support|basic life support
93575|NCT03618849|Disorders of Consciousness|disorders of consciousness
93576|NCT03618849|Transcranial Direct Current Stimulation|transcranial direct current stimulation
93577|NCT03618849|Pediatric|pediatric
93578|NCT03618849|Safety|safety
93579|NCT03618849|Feasibility|feasibility
93580|NCT03618836|Bacterial vaginosis|bacterial vaginosis
93581|NCT03618836|Vaginal microbiota|vaginal microbiota
93582|NCT03618836|Molecular methods|molecular methods
93583|NCT03618836|Next generation sequencing|next generation sequencing
93584|NCT03618823|analgesia|analgesia
93585|NCT03618823|pain control|pain control
93586|NCT03618823|adenotonsillectomy|adenotonsillectomy
93587|NCT03618823|tonsillectomy|tonsillectomy
93588|NCT03618823|opioids|opioids
93589|NCT03618823|post-operative pain|post-operative pain
93590|NCT03618810|breast cancer|breast cancer
93591|NCT03618810|chemotherapy|chemotherapy
93592|NCT03618810|PEG-rhG-CSF|peg-rhg-csf
93593|NCT03618810|prophylactic|prophylactic
93594|NCT03618810|febrile neutropenia|febrile neutropenia
93595|NCT03618784|FURESTEM-RA Inj.|furestem-ra inj.
93596|NCT03618784|Rheumatoid Arthritis|rheumatoid arthritis
93597|NCT03618784|Cell therapy|cell therapy
93598|NCT03618771|Total Knee Arthroplasty|total knee arthroplasty
93599|NCT03618771|Osteoarthritis|osteoarthritis
93600|NCT03618771|Stability|stability
93601|NCT03618771|Knee|knee
93602|NCT03618771|Functional Outcome|functional outcome
93603|NCT03618771|Gait|gait
93604|NCT03618771|Biomechanics|biomechanics
93605|NCT03618758|Gastric cancer|gastric cancer
93606|NCT03618758|Peritoneal carcinomatosis|peritoneal carcinomatosis
93607|NCT03618758|Intraperitoneal chemotherapy|intraperitoneal chemotherapy
93608|NCT03618758|Paclitaxel|paclitaxel
93609|NCT03618758|FOLFOX|folfox
93610|NCT03618732|stroke|stroke
93611|NCT03618732|upper limb|upper limb
93612|NCT03618732|motor control|motor control
93613|NCT03618732|function|function
93614|NCT03618732|bilateral movement|bilateral movement
93615|NCT03618732|virtual reality|virtual reality
93616|NCT03618719|obstructive sleep apnea|obstructive sleep apnea
93617|NCT03618719|intermittent hypoxia|intermittent hypoxia
93618|NCT03618719|granulocyte function|granulocyte function
93619|NCT03618719|continuous positive airway pressure (CPAP) therapy|continuous positive airway pressure (cpap) therapy
93620|NCT03618693|prostatectomy|prostatectomy
93621|NCT03618693|pain|pain
93622|NCT03618693|recovery|recovery
93623|NCT03618680|Sleep|sleep
93624|NCT03618641|Stage IIIB/C/D|stage iiib/c/d
93625|NCT03618563|daily function|daily function
93626|NCT03618563|executive functions|executive functions
93627|NCT03618550|Pembrolizumab|pembrolizumab
93628|NCT03618550|GVD|gvd
93629|NCT03618550|18-160|18-160
93630|NCT03618537|Ixazomib|ixazomib
93631|NCT03618537|18-069|18-069
93632|NCT03618524|heat stress|heat stress
93633|NCT03618524|endothelial function|endothelial function
93634|NCT03618524|hot water immersion|hot water immersion
93635|NCT03618524|arterial stiffness|arterial stiffness
93636|NCT03618498|macular hole|macular hole
93637|NCT03618498|retinal detachment|retinal detachment
93638|NCT03618498|PDR|pdr
93639|NCT03618459|Breast surgery|breast surgery
93640|NCT03618459|Paravertebral block|paravertebral block
93641|NCT03618459|Pain Control|pain control
93642|NCT03618446|Pelvic fractures|pelvic fractures
93643|NCT03618446|mortality|mortality
93644|NCT03618446|predictors|predictors
93645|NCT03618446|trauma registry|trauma registry
93646|NCT03618433|kinect|kinect
93647|NCT03618433|breast cancer|breast cancer
93648|NCT03618433|mastectomy|mastectomy
93649|NCT03618433|upper extremity dysfunction|upper extremity dysfunction
93650|NCT03618407|Influenza|influenza
93651|NCT03618407|Antiviral Treatment|antiviral treatment
93652|NCT03618407|Cough|cough
93653|NCT03618407|Oseltamivir capsule|oseltamivir capsule
93654|NCT03618407|Lotus Clear Capsule|lotus clear capsule
93655|NCT03618394|preterms|preterms
93656|NCT03618394|parenteral|parenteral
93657|NCT03618394|lipid|lipid
93658|NCT03618381|CAR T cell|car t cell
93659|NCT03618381|Pediatric|pediatric
93660|NCT03618381|Young Adults|young adults
93661|NCT03618381|Non-CNS solid tumor|non-cns solid tumor
93662|NCT03618329|COLON CANCER|colon cancer
93663|NCT03618329|ERAS|eras
93664|NCT03618329|NUTRITION|nutrition
93665|NCT03618316|pharmacokinetics|pharmacokinetics
93666|NCT03618316|Drug-drug interaction|drug-drug interaction
93667|NCT03618290|Acute ischemic stroke|acute ischemic stroke
93668|NCT03618290|plasma free fatty acid|plasma free fatty acid
93669|NCT03618264|Postoperative Pain|postoperative pain
93670|NCT03618264|Post-Craniotomy Headache|post-craniotomy headache
93671|NCT03618264|Dexamethasone|dexamethasone
93672|NCT03618264|Ropivacaine|ropivacaine
93673|NCT03618264|Pre-emptive Scalp Infiltration|pre-emptive scalp infiltration
93674|NCT03618238|anlotinib|anlotinib
93675|NCT03618238|L-asparaginase resistant|l-asparaginase resistant
93676|NCT03618199|Caloric testing|caloric testing
93677|NCT03618199|vestibular nystagmography|vestibular nystagmography
93678|NCT03618199|VNG|vng
93679|NCT03618199|Videonystagmography|videonystagmography
93680|NCT03618186|African Americans|african americans
93681|NCT03618186|neurological exam|neurological exam
93682|NCT03618186|Dementia|dementia
93683|NCT03618186|Alzheimer's Disease|alzheimer's disease
93684|NCT03618173|dexamethasone|dexamethasone
93685|NCT03618173|analgesia|analgesia
93686|NCT03618173|lower limb blockade|lower limb blockade
93687|NCT03618173|children|children
93688|NCT03618173|pediatric|pediatric
93689|NCT03618121|Videogames|videogames
93690|NCT03618121|Commercial biofeedback device|commercial biofeedback device
93691|NCT03618082|prospective|prospective
93692|NCT03618082|single blind|single blind
93693|NCT03618082|multicenter|multicenter
93694|NCT03618082|randomized|randomized
93695|NCT03618082|controlled|controlled
93696|NCT03618082|Analgesia Nociception Index (ANI)|analgesia nociception index (ani)
93697|NCT03618082|Postoperative pain|postoperative pain
93698|NCT03618017|Breast cancer|breast cancer
93699|NCT03618017|Survivors|survivors
93700|NCT03618017|Survivorship plan|survivorship plan
93701|NCT03618017|Transitional cancer care|transitional cancer care
93702|NCT03618004|Restriction of blood flow|restriction of blood flow
93703|NCT03618004|Anaerobic capacity|anaerobic capacity
93704|NCT03618004|Subjective perception of effort|subjective perception of effort
93705|NCT03618004|Wingate|wingate
93706|NCT03618004|Isometric strength|isometric strength
93707|NCT03617991|rehabilitation|rehabilitation
93708|NCT03617978|cardiopulmonary resuscitation|cardiopulmonary resuscitation
93709|NCT03617978|hemodynamic|hemodynamic
93710|NCT03617978|medical simulation|medical simulation
93711|NCT03617978|leg elevation|leg elevation
93712|NCT03617952|Cookstoves|cookstoves
93713|NCT03617952|Household Air Pollution|household air pollution
93714|NCT03617952|Behavior Change|behavior change
93715|NCT03617952|Global Health|global health
93716|NCT03617939|Tissue Repository|tissue repository
93717|NCT03617939|Blood Samples|blood samples
93718|NCT03617939|Biological Samples|biological samples
93719|NCT03617939|Surveys|surveys
93720|NCT03617939|Early Detection|early detection
93721|NCT03617939|Risk Assessment|risk assessment
93722|NCT03617900|ginger extract|ginger extract
93723|NCT03617900|pain relief|pain relief
93724|NCT03617900|postpartum women|postpartum women
93725|NCT03617887|Core|core
93726|NCT03617887|Isometric abdominal|isometric abdominal
93727|NCT03617887|Gluteus medius|gluteus medius
93728|NCT03617887|Adductor|adductor
93729|NCT03617887|Lumbo-pelvic stability|lumbo-pelvic stability
93730|NCT03617874|Pre-exposure prophylaxis|pre-exposure prophylaxis
93731|NCT03617874|Human Immunodeficiency Virus|human immunodeficiency virus
93732|NCT03617874|PrEP|prep
93733|NCT03617874|Risk for HIV acquisition|risk for hiv acquisition
93734|NCT03617874|PrEP candidacy|prep candidacy
93735|NCT03617848|HFpEF|hfpef
93736|NCT03617809|Prewarming|prewarming
93737|NCT03617809|Perioperative hypothermia|perioperative hypothermia
93738|NCT03617809|Esophageal thermometer|esophageal thermometer
93739|NCT03617796|markers CD64|markers cd64
93740|NCT03617770|type 1 diabetes|type 1 diabetes
93741|NCT03617770|glycemic control|glycemic control
93742|NCT03617770|sleep|sleep
93743|NCT03617770|diabetes distress|diabetes distress
93744|NCT03617757|Chinese|chinese
93745|NCT03617757|Diabetes Mellitus|diabetes mellitus
93746|NCT03617757|Impaired fasting glucose|impaired fasting glucose
93747|NCT03617757|Incidence|incidence
93748|NCT03617757|Progression|progression
93749|NCT03617757|Risk factors|risk factors
93750|NCT03617705|alcohol consumption|alcohol consumption
93751|NCT03617692|Stage III|stage iii
93752|NCT03617692|Stage IV|stage iv
93753|NCT03617692|Cannabis|cannabis
93754|NCT03617692|Lung Cancer|lung cancer
93755|NCT03617692|Tumors|tumors
93756|NCT03617692|Observational Study|observational study
93757|NCT03617679|Rucaparib|rucaparib
93758|NCT03617679|Placebo|placebo
93759|NCT03617679|Randomized|randomized
93760|NCT03617679|Double Blind|double blind
93761|NCT03617679|Stage III/IV|stage iii/iv
93762|NCT03617666|avelumab|avelumab
93763|NCT03617640|enteric neuropathies|enteric neuropathies
93764|NCT03617640|Immune cells|immune cells
93765|NCT03617640|Nervous cells|nervous cells
93766|NCT03617640|Microbiom|microbiom
93767|NCT03617627|chronic pain|chronic pain
93768|NCT03617627|women|women
93769|NCT03617627|self-management|self-management
93770|NCT03617549|neonatal intensive care|neonatal intensive care
93771|NCT03617536|difelikefalin|difelikefalin
93772|NCT03617536|CR845|cr845
93773|NCT03617536|Pruritus|pruritus
93774|NCT03617536|Chronic Itch|chronic itch
93775|NCT03617536|Itch|itch
93776|NCT03617536|Itching|itching
93777|NCT03617536|uremic pruritus|uremic pruritus
93778|NCT03617536|CKD|ckd
93779|NCT03617536|CKD-aP|ckd-ap
93780|NCT03617536|CKD-associated pruritus|ckd-associated pruritus
93781|NCT03617536|Chronic Kidney Disease|chronic kidney disease
93782|NCT03617536|Kidney dysfunction|kidney dysfunction
93783|NCT03617536|Generalized pruritus|generalized pruritus
93784|NCT03617536|Hemodialysis|hemodialysis
93785|NCT03617536|Dialysis|dialysis
93786|NCT03617536|ESRD (end stage renal disease)|esrd (end stage renal disease)
93787|NCT03617536|Kidney failure, chronic|kidney failure, chronic
93788|NCT03617510|Tolerance; Pharmacokinetic characteristics|tolerance; pharmacokinetic characteristics
93789|NCT03617497|Alzheimer Disease|alzheimer disease
93790|NCT03617497|Alzheimer dementia|alzheimer dementia
93791|NCT03617497|Epilepsy|epilepsy
93792|NCT03617497|Sleep Wake Disorders|sleep wake disorders
93793|NCT03617497|EEG|eeg
93794|NCT03617497|Polysomnography|polysomnography
93795|NCT03617497|Foramen ovale electrodes|foramen ovale electrodes
93796|NCT03617484|Relapsed|relapsed
93797|NCT03617458|PAH|pah
93798|NCT03617406|Low - flow|low - flow
93799|NCT03617406|Low - gradient|low - gradient
93800|NCT03617406|Low - dose dobutamine|low - dose dobutamine
93801|NCT03617406|Volume challenge|volume challenge
93802|NCT03617406|Echocardiography|echocardiography
93803|NCT03617393|Early Warning Model|early warning model
93804|NCT03617393|Clinical Pathway|clinical pathway
93805|NCT03617393|Diabetes|diabetes
93806|NCT03617393|Pulmonary Infection|pulmonary infection
93807|NCT03617367|DAXI|daxi
93808|NCT03617367|Cervical Dystonia|cervical dystonia
93809|NCT03617367|TWSTRS|twstrs
93810|NCT03617367|Toxin|toxin
93811|NCT03617367|multiple treatment|multiple treatment
93812|NCT03617341|Breast cancer|breast cancer
93813|NCT03617341|brain metastases|brain metastases
93814|NCT03617341|screening|screening
93815|NCT03617341|brain MRI|brain mri
93816|NCT03617328|peptide|peptide
93817|NCT03617328|vaccine|vaccine
93818|NCT03617328|adjuvant|adjuvant
93819|NCT03617328|6MHP|6mhp
93820|NCT03617328|polyICLC|polyiclc
93821|NCT03617328|varlilumab|varlilumab
93822|NCT03617328|CDX-1127|cdx-1127
93823|NCT03617328|Montanide ISA-51|montanide isa-51
93824|NCT03617315|Crosslinked Hyaluronic Acid|crosslinked hyaluronic acid
93825|NCT03617315|Meibomian Gland Disfunction|meibomian gland disfunction
93826|NCT03617315|Lubricants|lubricants
93827|NCT03617315|Contact Lens|contact lens
93828|NCT03617315|Dry Eye|dry eye
93829|NCT03617302|Carotid artery stiffness|carotid artery stiffness
93830|NCT03617302|Cerebrovascular function|cerebrovascular function
93831|NCT03617302|Cerebral blood flow|cerebral blood flow
93832|NCT03617302|Pulsatility|pulsatility
93833|NCT03617302|Beetroot juice|beetroot juice
93834|NCT03617302|Dietary Inorganic Nitrate Supplementation|dietary inorganic nitrate supplementation
93835|NCT03617302|Cerebral Small Vessel Disease|cerebral small vessel disease
93836|NCT03617302|Cerebrovascular Reserve|cerebrovascular reserve
93837|NCT03617302|Neurovascular Coupling|neurovascular coupling
93838|NCT03617263|NAFLD|nafld
93839|NCT03617263|PCOS|pcos
93840|NCT03617263|Saroglitazar Magnesium|saroglitazar magnesium
93841|NCT03617224|Mycosis Fungoides (MF), Sezary Syndrome (SS), Pembrolizumab, Total Skin Electron Beam Therapy (TSEBT)|mycosis fungoides (mf), sezary syndrome (ss), pembrolizumab, total skin electron beam therapy (tsebt)
93842|NCT03617211|pelvic reconstructive surgery|pelvic reconstructive surgery
93843|NCT03617211|mesh|mesh
93844|NCT03617211|native tissue|native tissue
93845|NCT03617211|tape|tape
93846|NCT03617211|complications|complications
93847|NCT03617211|Category-time-site (CTS) coding|category-time-site (cts) coding
93848|NCT03617185|Metabolic syndrome|metabolic syndrome
93849|NCT03617185|Exercise|exercise
93850|NCT03617159|magnetic resonance imaging|magnetic resonance imaging
93851|NCT03617159|diffusion weighted imaging|diffusion weighted imaging
93852|NCT03617146|Diabetes Distress|diabetes distress
93853|NCT03617146|Diabetes Mellitus|diabetes mellitus
93854|NCT03617146|Diabetes Control|diabetes control
93855|NCT03617146|Health Coaching|health coaching
93856|NCT03617146|Diabetes Self-management|diabetes self-management
93857|NCT03617120|Scoliosis brace|scoliosis brace
93858|NCT03617120|Conventional treatment for Adolescent Idiopathic Scoliosis|conventional treatment for adolescent idiopathic scoliosis
93859|NCT03617120|In-brace correction|in-brace correction
93860|NCT03617120|Trunk listing|trunk listing
93861|NCT03617120|Vertebral rotation|vertebral rotation
93862|NCT03617120|Interface pressure|interface pressure
93863|NCT03617120|3D body scanning|3d body scanning
93864|NCT03617120|Surface topography|surface topography
93865|NCT03617120|Trunk asymmetry|trunk asymmetry
93866|NCT03617120|Quality of Life|quality of life
93867|NCT03617094|Vertebral fracture|vertebral fracture
93868|NCT03617094|Early Percutaneous Vertebroplasty|early percutaneous vertebroplasty
93869|NCT03617094|Standard Conservative Treatment|standard conservative treatment
93870|NCT03617094|Kyphosis angle|kyphosis angle
93871|NCT03617055|kidney injury, asphyxia,cystatin c|kidney injury, asphyxia,cystatin c
93872|NCT03617029|Deep-seated|deep-seated
93873|NCT03617029|Needle localization|needle localization
93874|NCT03617029|CT-guided|ct-guided
93875|NCT03617029|Thoracoscopy|thoracoscopy
93876|NCT03617029|Fiducial marker|fiducial marker
93877|NCT03617003|WST-11|wst-11
93878|NCT03617003|Phototherapy|phototherapy
93879|NCT03617003|18-140|18-140
93880|NCT03616990|Recidivism|recidivism
93881|NCT03616990|Substance use|substance use
93882|NCT03616990|Jail|jail
93883|NCT03616990|Mental health|mental health
93884|NCT03616990|Continuity of care|continuity of care
93885|NCT03616990|Chicago|chicago
93886|NCT03616990|Needs Assessment|needs assessment
93888|NCT03616938|cardiopulmonary resuscitation|cardiopulmonary resuscitation
93889|NCT03616938|chest compression|chest compression
93890|NCT03616938|medical simulation|medical simulation
93891|NCT03616938|randomization|randomization
93892|NCT03616938|quality|quality
93893|NCT03616912|SLE|sle
93894|NCT03616886|Breast cancer|breast cancer
93895|NCT03616886|Triple negative|triple negative
93896|NCT03616886|Metastatic|metastatic
93897|NCT03616886|Previously untreated|previously untreated
93898|NCT03616886|Locally Recurrent Inoperable|locally recurrent inoperable
93899|NCT03616847|Randomised controlled trial|randomised controlled trial
93900|NCT03616847|Hallux valgus correction|hallux valgus correction
93901|NCT03616847|Hallux rigidus correction|hallux rigidus correction
93902|NCT03616847|Tourniquet|tourniquet
93903|NCT03616847|Foot volume|foot volume
93904|NCT03616808|Traumatic brain injury|traumatic brain injury
93905|NCT03616808|Craniotomy|craniotomy
93906|NCT03616808|Goal-directed treatment|goal-directed treatment
93907|NCT03616808|Thromboelastometry|thromboelastometry
93908|NCT03616769|Uric Acid Serum; Prospective;|uric acid serum; prospective;
93909|NCT03616756|Nurse leader|nurse leader
93910|NCT03616756|Resilience|resilience
93911|NCT03616756|Parenting|parenting
93912|NCT03616756|Stress|stress
93913|NCT03616756|Depression|depression
93914|NCT03616730|Non-invasive cardiac output monitor|non-invasive cardiac output monitor
93915|NCT03616730|Cardiac output|cardiac output
93916|NCT03616704|ARDS|ards
93917|NCT03616704|strain|strain
93918|NCT03616704|stress|stress
93919|NCT03616704|Mechanical Power|mechanical power
93920|NCT03616665|persistent depressive disorder|persistent depressive disorder
93921|NCT03616665|psychotherapy|psychotherapy
93922|NCT03616665|cognitive behavioral therapy|cognitive behavioral therapy
93923|NCT03616665|inpatient treatment|inpatient treatment
93924|NCT03616665|childhood maltreatment|childhood maltreatment
93925|NCT03616665|treatment-resistance|treatment-resistance
93926|NCT03616665|randomized controlled trial|randomized controlled trial
93927|NCT03616665|clinical effectiveness|clinical effectiveness
93928|NCT03616665|personalized psychotherapy|personalized psychotherapy
93929|NCT03616665|comorbidity|comorbidity
93930|NCT03616665|cognitive behavioral analysis system of psychotherapy|cognitive behavioral analysis system of psychotherapy
93931|NCT03616626|Breast Cancer|breast cancer
93932|NCT03616626|Accelerated partial Breast Irradiation|accelerated partial breast irradiation
93933|NCT03616626|Breast cosmesis|breast cosmesis
93934|NCT03616626|radiation Toxicity|radiation toxicity
93935|NCT03616600|Myopia|myopia
93936|NCT03616600|Orthokeratology|orthokeratology
93937|NCT03616587|Breast Cancer|breast cancer
93938|NCT03616587|Phase 1|phase 1
93939|NCT03616587|Safety|safety
93940|NCT03616587|Tolerability|tolerability
93941|NCT03616587|Pharmacokinetics|pharmacokinetics
93942|NCT03616587|ER Positive|er positive
93943|NCT03616587|HER2 Negative|her2 negative
93944|NCT03616587|Advanced Breast Cancer|advanced breast cancer
93945|NCT03616561|Nail psoriasis|nail psoriasis
93946|NCT03616561|apremilast|apremilast
93947|NCT03616561|ultrasound|ultrasound
93948|NCT03616548|intestinal transplantation|intestinal transplantation
93949|NCT03616548|graft rejection|graft rejection
93950|NCT03616548|image enhanced endoscopy|image enhanced endoscopy
93951|NCT03616548|narrow band imaging|narrow band imaging
93952|NCT03616509|Growth Hormone|growth hormone
93953|NCT03616509|Functional Magnetic Resonance|functional magnetic resonance
93954|NCT03616509|Strength|strength
93955|NCT03616509|Body composition|body composition
93956|NCT03616496|PET imaging|pet imaging
93957|NCT03616496|Cardiac Amyloidosis|cardiac amyloidosis
93958|NCT03616496|Florbetaben|florbetaben
93959|NCT03616496|Heart failure|heart failure
93960|NCT03616496|Cardiology|cardiology
93961|NCT03616483|Multiple myeloma|multiple myeloma
93962|NCT03616483|Monoclonal gammopathy of undetermined significance|monoclonal gammopathy of undetermined significance
93963|NCT03616483|Plasmacytoma|plasmacytoma
93964|NCT03616483|Smoldering multiple myeloma|smoldering multiple myeloma
93965|NCT03616470|acute myeloid leukemia|acute myeloid leukemia
93966|NCT03616470|AML|aml
93967|NCT03616470|Relapsed AML|relapsed aml
93968|NCT03616470|Refractory AML|refractory aml
93969|NCT03616457|Screening Diagnostic|screening diagnostic
93970|NCT03616444|colorectal adenomatous polyps|colorectal adenomatous polyps
93971|NCT03616444|Clinical curative effect|clinical curative effect
93972|NCT03616431|Pancreatic malignancy|pancreatic malignancy
93973|NCT03616431|Pancreatic enzyme insufficiency|pancreatic enzyme insufficiency
93974|NCT03616431|Pancreatic enzyme replacement therapy|pancreatic enzyme replacement therapy
93975|NCT03616431|Pancreo-kit breath test|pancreo-kit breath test
93976|NCT03616405|Sequential Therapy|sequential therapy
93977|NCT03616405|Rescue Treatment|rescue treatment
93978|NCT03616392|Diabetes Mellitus, Type II|diabetes mellitus, type ii
93979|NCT03616366|VTE|vte
93980|NCT03616366|SNP|snp
93981|NCT03616366|biomarkers|biomarkers
93982|NCT03616301|bioequivalence|bioequivalence
93983|NCT03616301|amoxicillin|amoxicillin
93984|NCT03616301|clavulanic acid|clavulanic acid
93985|NCT03616301|Augmentin|augmentin
93986|NCT03616223|Intratympanic Administration|intratympanic administration
93987|NCT03616223|Hearing Restoration|hearing restoration
93988|NCT03616210|mechanical ventilation|mechanical ventilation
93989|NCT03616210|protective ventilation|protective ventilation
93990|NCT03616210|vascular surgery|vascular surgery
93991|NCT03616210|postoperative pulmonary complications|postoperative pulmonary complications
93992|NCT03616197|gingival biotype of adjacent teeth|gingival biotype of adjacent teeth
93993|NCT03616197|free gingival graft|free gingival graft
93994|NCT03616197|shrinkage of graft|shrinkage of graft
93995|NCT03616171|Sleep Behavior|sleep behavior
93996|NCT03616171|Insulin resistance|insulin resistance
93997|NCT03616158|Rheumatoid arthritis|rheumatoid arthritis
93998|NCT03616158|Interstitial Lung Disease|interstitial lung disease
93999|NCT03616158|RA|ra
94000|NCT03616158|ILD|ild
94001|NCT03616145|Osteopathic Manipulative Treatment|osteopathic manipulative treatment
94002|NCT03616119|gastoesophageal reflux disease|gastoesophageal reflux disease
94003|NCT03616119|prevalence|prevalence
94004|NCT03616119|Azerbaijan|azerbaijan
94005|NCT03616106|Information Visualization|information visualization
94006|NCT03616080|cerebral palsy|cerebral palsy
94007|NCT03616054|Airway management|airway management
94008|NCT03616041|Severe hematochezia|severe hematochezia
94009|NCT03616015|HSCT|hsct
94010|NCT03616015|intestinal dysbiosis|intestinal dysbiosis
829746|NCT00116532|Open Label|open label
94011|NCT03616015|immune reconstitution|immune reconstitution
94012|NCT03615989|Bone Health|bone health
94013|NCT03615989|Females|females
94014|NCT03615989|Creatine|creatine
94015|NCT03615989|Dairy|dairy
94016|NCT03615989|Exercise|exercise
94017|NCT03615976|arthroscopy|arthroscopy
94018|NCT03615976|Patellofemoral Osteoarthritis|patellofemoral osteoarthritis
94019|NCT03615924|Sickle Cell Disease|sickle cell disease
94020|NCT03615924|Sickle Cell Anemia|sickle cell anemia
94021|NCT03615924|SCD|scd
94022|NCT03615924|Platelet aggregation|platelet aggregation
94023|NCT03615924|Ticagrelor|ticagrelor
94024|NCT03615924|Brilinta|brilinta
94025|NCT03615924|VOC|voc
94026|NCT03615924|Vaso-Occlusive Crises|vaso-occlusive crises
94027|NCT03615924|ACS|acs
94028|NCT03615924|painful crisis|painful crisis
94029|NCT03615911|vaccine|vaccine
94030|NCT03615911|clinical phase 1|clinical phase 1
94031|NCT03615911|modified vaccinia Ankara vector|modified vaccinia ankara vector
94032|NCT03615911|MERS-CoV|mers-cov
94033|NCT03615898|medication incidents reporting system errors morbidity Spain|medication incidents reporting system errors morbidity spain
94034|NCT03615885|Montmorency Tart Cherry|montmorency tart cherry
94035|NCT03615885|Anthocyanins|anthocyanins
94036|NCT03615885|Polyphenols|polyphenols
94037|NCT03615885|Metabolic Syndrome|metabolic syndrome
94038|NCT03615885|Insulin Resistance|insulin resistance
94039|NCT03615885|Hypertension|hypertension
94040|NCT03615885|Lipid Profile|lipid profile
94041|NCT03615872|quality of life|quality of life
94044|NCT03615859|Hydrocortisone|hydrocortisone
94045|NCT03615859|Prednisolone|prednisolone
94046|NCT03615833|peripheral artery disease|peripheral artery disease
94047|NCT03615833|Vitamin D|vitamin d
94048|NCT03615820|Nanovesicles|nanovesicles
94049|NCT03615820|Aphthous ulcer|aphthous ulcer
94050|NCT03615807|diabetic foot infections|diabetic foot infections
94051|NCT03615807|antibiotic reduction|antibiotic reduction
94052|NCT03615807|osteomyelitis|osteomyelitis
94053|NCT03615807|soft tissue infections|soft tissue infections
94054|NCT03615781|septic arthritis|septic arthritis
94055|NCT03615781|surgery|surgery
94056|NCT03615781|antibiotic duration|antibiotic duration
94057|NCT03615781|remission|remission
94058|NCT03615781|sequelae|sequelae
94059|NCT03615755|Hyperbaric Oxygen Therapy|hyperbaric oxygen therapy
94060|NCT03615755|Diabetic Foot Ulcer|diabetic foot ulcer
94061|NCT03615755|HbA1c|hba1c
94062|NCT03615755|Leukocyte|leukocyte
94063|NCT03615755|Serum creatinine|serum creatinine
94064|NCT03615742|Diesel Exhaust|diesel exhaust
94065|NCT03615742|Air Pollution|air pollution
94066|NCT03615742|Inhaled Corticosteroids|inhaled corticosteroids
94067|NCT03615742|Gene Expression|gene expression
94068|NCT03615742|Asthma|asthma
94069|NCT03615742|Controlled Human Exposure Study|controlled human exposure study
94070|NCT03615729|Rheumatoid arthritis|rheumatoid arthritis
94071|NCT03615729|Genetic polymorphism|genetic polymorphism
94072|NCT03615729|RORc2 protein|rorc2 protein
94073|NCT03615729|T helper 17|t helper 17
94074|NCT03615716|violence|violence
94075|NCT03615716|adolescence|adolescence
94076|NCT03615690|ulcerative colitis|ulcerative colitis
94077|NCT03615690|IBD|ibd
94078|NCT03615690|diet|diet
94079|NCT03615690|fasting|fasting
94080|NCT03615690|fasting mimicking diet|fasting mimicking diet
94081|NCT03615690|UC|uc
94082|NCT03615690|intermittent fasting|intermittent fasting
94083|NCT03615664|Lymphoma|lymphoma
94084|NCT03615664|Immunochemotherapy|immunochemotherapy
94085|NCT03615664|Salvage therapy|salvage therapy
94086|NCT03615664|Bendamustine|bendamustine
94087|NCT03615664|Gemcitabine|gemcitabine
94088|NCT03615664|Dexamethasone|dexamethasone
94089|NCT03615664|Hodgkin's Lymphoma|hodgkin's lymphoma
94090|NCT03615664|ASCT|asct
94091|NCT03615638|Fall prevention|fall prevention
94092|NCT03615638|Total knee arthroplasty|total knee arthroplasty
94093|NCT03615638|Commnuity-based|commnuity-based
94094|NCT03615625|Exercise|exercise
94095|NCT03615625|Aging|aging
94096|NCT03615625|Ambulatory Blood Pressure Monitoring|ambulatory blood pressure monitoring
94097|NCT03615625|Power Exercise|power exercise
94098|NCT03615599|Seventh-day Adventists|seventh-day adventists
94099|NCT03615599|vegetarian|vegetarian
94100|NCT03615599|mortality|mortality
94101|NCT03615599|cancer|cancer
94102|NCT03615599|dietary pattern|dietary pattern
94103|NCT03615599|soy consumption|soy consumption
94104|NCT03615599|dairy consumption|dairy consumption
94105|NCT03615599|plant-based|plant-based
94106|NCT03615560|Medical staff|medical staff
94107|NCT03615560|preeclampsia|preeclampsia
94108|NCT03615560|cohort study|cohort study
94109|NCT03615560|further effect|further effect
94110|NCT03615547|azoospermia|azoospermia
94111|NCT03615547|clominophene|clominophene
94112|NCT03615534|Extended Release Niacin|extended release niacin
94113|NCT03615534|Fenofibrate|fenofibrate
94114|NCT03615534|treatment|treatment
94115|NCT03615534|Obesity|obesity
830516|NCT00114062|uveitis|uveitis
94116|NCT03615534|Atherogenic Dyslipidemia|atherogenic dyslipidemia
94117|NCT03615508|Alpha blockers|alpha blockers
94118|NCT03615508|Tamsulosin|tamsulosin
94122|NCT03615469|Neuromuscular Electrical Stimulation|neuromuscular electrical stimulation
94123|NCT03615469|Transcutaneous Electrical Nerve Stimulation|transcutaneous electrical nerve stimulation
94124|NCT03615469|6 minute walk test|6 minute walk test
94125|NCT03615469|DXA|dxa
94126|NCT03615469|Double Blinded randomized control trial|double blinded randomized control trial
94127|NCT03615469|ActivPal|activpal
94128|NCT03615469|EMPI Continuum Device|empi continuum device
94129|NCT03615404|glioblastoma|glioblastoma
94130|NCT03615404|medulloblastoma|medulloblastoma
94131|NCT03615404|glioma|glioma
94132|NCT03615404|pediatric|pediatric
94133|NCT03615404|recurrent|recurrent
94134|NCT03615404|newly diagnosed|newly diagnosed
94135|NCT03615404|Pro00092868|pro00092868
94136|NCT03615404|Landi|landi
94137|NCT03615365|Capnography|capnography
94138|NCT03615365|Diagnosis|diagnosis
94139|NCT03615365|Breathlessness|breathlessness
94140|NCT03615365|Exacerbations|exacerbations
94141|NCT03615365|Device|device
94142|NCT03615352|Endometrioma|endometrioma
94143|NCT03615352|laparoscopy|laparoscopy
94144|NCT03615352|ovarian reserve|ovarian reserve
94145|NCT03615352|pelvic pain|pelvic pain
94146|NCT03615339|Food supplement, Fermented food, Whey|food supplement, fermented food, whey
94344|NCT03614169|HIS-pacing|his-pacing
94147|NCT03615326|programmed cell death receptor 1 (PD-1)|programmed cell death receptor 1 (pd-1)
94148|NCT03615326|programmed cell death ligand 1 (PD-L1)|programmed cell death ligand 1 (pd-l1)
94149|NCT03615326|anti-PD-1|anti-pd-1
94150|NCT03615326|anti PD-1|anti pd-1
94151|NCT03615326|GEJ|gej
94152|NCT03615326|Gastric Cancer|gastric cancer
94153|NCT03615313|mesothelin, PD-1, CAR T cells, solid tumor|mesothelin, pd-1, car t cells, solid tumor
94154|NCT03615274|childhood obesity|childhood obesity
94155|NCT03615274|cognitive training|cognitive training
94156|NCT03615274|executive function|executive function
94157|NCT03615274|quality of life|quality of life
94158|NCT03615274|neuroimaging|neuroimaging
94159|NCT03615274|magnetic resonance|magnetic resonance
94160|NCT03615274|connectivity|connectivity
94161|NCT03615274|decision making|decision making
94162|NCT03615261|prenatal maternal stress|prenatal maternal stress
94163|NCT03615261|mindfulness|mindfulness
94164|NCT03615261|stress reduction|stress reduction
94165|NCT03615261|health sensing|health sensing
94166|NCT03615261|mhealth|mhealth
94167|NCT03615235|Apolopoprotein L1 gene (APOL1)|apolopoprotein l1 gene (apol1)
94168|NCT03615235|Kidney Transplantation|kidney transplantation
94169|NCT03615235|Kidney Donor|kidney donor
94170|NCT03615235|United Network for Organ Sharing (UNOS)|united network for organ sharing (unos)
94171|NCT03615235|Association of Organ Procurement Organizations (AOPO)|association of organ procurement organizations (aopo)
94172|NCT03615235|Kidney Transplantation Outcomes Network|kidney transplantation outcomes network
94173|NCT03615222|functional impairment|functional impairment
94174|NCT03615222|quality of life|quality of life
94175|NCT03615222|Veterans|veterans
94176|NCT03615222|mindfulness|mindfulness
94177|NCT03615222|Acceptance and Commitment Therapy|acceptance and commitment therapy
94178|NCT03615196|NorLeu3-A(1-7)|norleu3-a(1-7)
94179|NCT03615196|USB005|usb005
94180|NCT03615196|aclerastide|aclerastide
94181|NCT03615196|corneal repair|corneal repair
94182|NCT03615196|corneal injury|corneal injury
94183|NCT03615157|Home-based exercise|home-based exercise
94184|NCT03615157|Functional capacity|functional capacity
94185|NCT03615157|Chronic Heart Failure|chronic heart failure
94186|NCT03615144|T-cell|t-cell
94187|NCT03615144|B-cell|b-cell
94188|NCT03615144|CliniMACS System|clinimacs system
94189|NCT03615144|Melphalan|melphalan
94190|NCT03615144|Thiotepa|thiotepa
94191|NCT03615144|Clofarabine|clofarabine
94192|NCT03615144|Fludarabine|fludarabine
94193|NCT03615144|17-596|17-596
94194|NCT03615131|Prostate cancer|prostate cancer
94195|NCT03615131|mpMRI-TRUS fusion biopsy|mpmri-trus fusion biopsy
94196|NCT03615131|PIRADS|pirads
94197|NCT03615131|Gleason score|gleason score
94198|NCT03615105|Allogeneic Hematopoietic Cell Transplantation|allogeneic hematopoietic cell transplantation
94199|NCT03615105|α/β+ T-lymphocyte|α/β+ t-lymphocyte
94200|NCT03615105|18-224|18-224
94201|NCT03615092|Acellular dermal matrix graft|acellular dermal matrix graft
94202|NCT03615092|Clinical Trial|clinical trial
94203|NCT03615092|Root coverage|root coverage
94204|NCT03615092|Noncarious cervical lesion|noncarious cervical lesion
94205|NCT03615053|pharmacokinetics|pharmacokinetics
94206|NCT03615053|popPK|poppk
94207|NCT03615053|PK|pk
94208|NCT03615053|Hemophilia|hemophilia
94209|NCT03615040|COPD|copd
94210|NCT03615040|Exacerbations|exacerbations
94211|NCT03615040|ST2 MAb|st2 mab
94212|NCT03615040|RG6149|rg6149
94213|NCT03615040|MSTT1041A|mstt1041a
94214|NCT03615040|Anti-ST2|anti-st2
94215|NCT03615040|Phase IIa|phase iia
94216|NCT03615040|Placebo controlled|placebo controlled
94217|NCT03614988|Polypharmacy|polypharmacy
94218|NCT03614988|Elderly|elderly
94219|NCT03614975|inactivated|inactivated
94220|NCT03614975|influenza|influenza
94221|NCT03614975|vaccine|vaccine
94222|NCT03614962|Transcutaneous electrical nerve stimulation|transcutaneous electrical nerve stimulation
94223|NCT03614962|Cognitive|cognitive
94224|NCT03614962|Memory|memory
94225|NCT03614949|persistent cervical cancer|persistent cervical cancer
94226|NCT03614923|ANB020|anb020
94227|NCT03614923|Etikomab|etikomab
94228|NCT03614923|CRSwNP|crswnp
94229|NCT03614910|Locally advanced pancreatic cancer|locally advanced pancreatic cancer
94230|NCT03614910|irreversible electroporation|irreversible electroporation
94231|NCT03614910|Nanoknife|nanoknife
94232|NCT03614884|gambling|gambling
94233|NCT03614884|smoking|smoking
94234|NCT03614884|online intervention|online intervention
94235|NCT03614884|Cognitive Behavioural Therapy|cognitive behavioural therapy
94236|NCT03614884|Motivational Interviewing|motivational interviewing
94237|NCT03614884|Randomized Controlled Trial|randomized controlled trial
94238|NCT03614871|Tobacco|tobacco
94239|NCT03614871|Calculus|calculus
94240|NCT03614871|Gingiva|gingiva
94241|NCT03614871|Oral hygiene|oral hygiene
94242|NCT03614871|Periodontitis|periodontitis
94243|NCT03614871|Biofilm|biofilm
94244|NCT03614858|CD19|cd19
94245|NCT03614858|CD22|cd22
94246|NCT03614845|postoperative atelectasis|postoperative atelectasis
94247|NCT03614845|mechanical ventilation|mechanical ventilation
94833|NCT03611062|children|children
94248|NCT03614845|laparoscopic surgery|laparoscopic surgery
94249|NCT03614845|lung ultrasonography|lung ultrasonography
94250|NCT03614845|volume controlled ventilation|volume controlled ventilation
94251|NCT03614845|pressure controlled|pressure controlled
94252|NCT03614832|ticagrelor|ticagrelor
94253|NCT03614832|clopidogrel|clopidogrel
94254|NCT03614832|platelet reactivity|platelet reactivity
94255|NCT03614819|Lasers|lasers
94256|NCT03614819|Dental enamel hypoplasia|dental enamel hypoplasia
94257|NCT03614819|Preventive dentistry|preventive dentistry
94258|NCT03614819|Dental caries|dental caries
94259|NCT03614780|rurality|rurality
94260|NCT03614728|Acute myeloid leukaemia|acute myeloid leukaemia
94261|NCT03614728|Myelodysplastic syndrome|myelodysplastic syndrome
94262|NCT03614728|GSK3326595|gsk3326595
94263|NCT03614702|bOPV|bopv
94264|NCT03614702|IPV|ipv
94265|NCT03614702|sequential immunization|sequential immunization
94266|NCT03614702|immunogenecity|immunogenecity
94267|NCT03614702|safety|safety
94268|NCT03614676|third trimester|third trimester
94269|NCT03614676|Respiratory Syncytial Virus (RSV) illness|respiratory syncytial virus (rsv) illness
94270|NCT03614676|Pregnancy|pregnancy
94271|NCT03614676|Maternal Immunization|maternal immunization
94272|NCT03614676|Pregnant Women|pregnant women
94273|NCT03614676|Neonates|neonates
94274|NCT03614676|Respiratory Tract Illness|respiratory tract illness
94275|NCT03614650|immunotherapyT cellGI cancergene therapy|immunotherapyt cellgi cancergene therapy
94276|NCT03614637|Cannabis Abstinence Sperm Cells|cannabis abstinence sperm cells
94277|NCT03614624|Healthy subject|healthy subject
94278|NCT03614624|Echocardiography|echocardiography
94279|NCT03614624|2D and 3D Strain|2d and 3d strain
94280|NCT03614624|General Electric|general electric
94281|NCT03614624|Philips|philips
94282|NCT03614611|pessaries|pessaries
94283|NCT03614611|Urinary Incontinence/therapy|urinary incontinence/therapy
94284|NCT03614611|Patient Satisfaction|patient satisfaction
94285|NCT03614611|Female|female
94286|NCT03614611|Surveys and Questionnaires|surveys and questionnaires
94287|NCT03614611|Treatment Outcome|treatment outcome
94288|NCT03614585|Stroke|stroke
94289|NCT03614585|Rehabilitation|rehabilitation
94290|NCT03614585|Neurosciences|neurosciences
94291|NCT03614585|Exercise|exercise
94292|NCT03614585|Neurorecovery|neurorecovery
94293|NCT03614585|Cardiovascular health|cardiovascular health
94294|NCT03614585|High-intensity interval training|high-intensity interval training
94295|NCT03614585|Moderate-intensity continuous training|moderate-intensity continuous training
94296|NCT03614572|Sleep deprivation|sleep deprivation
94297|NCT03614572|Motivational Interviewing|motivational interviewing
94298|NCT03614572|Text reminders|text reminders
94299|NCT03614559|chronic total occlusion|chronic total occlusion
94300|NCT03614546|primary hepatocellular carcinoma|primary hepatocellular carcinoma
94301|NCT03614546|radiotherapy|radiotherapy
94302|NCT03614546|transarterial chemoembolization|transarterial chemoembolization
94303|NCT03614533|Typhoid in Burkina Faso|typhoid in burkina faso
94304|NCT03614533|Typhoid Conjugate Vaccine|typhoid conjugate vaccine
94305|NCT03614507|oxygen dependent|oxygen dependent
94306|NCT03614507|Infant Between 1 Month and 12 Months Old|infant between 1 month and 12 months old
94307|NCT03614494|Piroxicam|piroxicam
94308|NCT03614494|Levonorgestrel|levonorgestrel
94309|NCT03614494|Placebo|placebo
94310|NCT03614494|Randomised controlled control|randomised controlled control
94311|NCT03614494|Emergency contraception|emergency contraception
94312|NCT03614468|Infant Formula|infant formula
94313|NCT03614429|Penile Prosthesis|penile prosthesis
94314|NCT03614429|Urethral injury|urethral injury
94315|NCT03614429|Urethral sterilization|urethral sterilization
94316|NCT03614351|protein|protein
94317|NCT03614351|nutritional guidance|nutritional guidance
94318|NCT03614351|ACL surgery|acl surgery
94319|NCT03614273|nebulization|nebulization
94320|NCT03614273|adrenaline|adrenaline
94321|NCT03614273|hypertonic saline|hypertonic saline
94322|NCT03614273|bronchiolitis|bronchiolitis
94323|NCT03614260|Denervation|denervation
94324|NCT03614260|Resistant Hypertension|resistant hypertension
94325|NCT03614260|Essential Hypertension|essential hypertension
94326|NCT03614260|Uncontrolled Hypertension|uncontrolled hypertension
94327|NCT03614247|Lower calyceal stone|lower calyceal stone
94328|NCT03614247|cost-effectiveness|cost-effectiveness
94329|NCT03614247|percutaneous nephrolithotomy|percutaneous nephrolithotomy
94330|NCT03614247|retrograde intrarenal surgery|retrograde intrarenal surgery
94331|NCT03614234|Glomerular filtration rate|glomerular filtration rate
94332|NCT03614234|Proteinuria|proteinuria
94333|NCT03614234|PRX-102|prx-102
94334|NCT03614234|pegunigalsidase alfa|pegunigalsidase alfa
94335|NCT03614234|Fabry disease|fabry disease
94336|NCT03614221|Atopic Dermatitis|atopic dermatitis
94337|NCT03614221|Indigo naturalis|indigo naturalis
94338|NCT03614221|Tacrolimus|tacrolimus
94339|NCT03614208|Systemic sclerosis|systemic sclerosis
94340|NCT03614208|Home based rehabilitation|home based rehabilitation
94341|NCT03614208|Quality of life|quality of life
94342|NCT03614208|Hand mobility|hand mobility
94343|NCT03614208|Exercise capacity|exercise capacity
94345|NCT03614169|Biventricular pacing|biventricular pacing
94346|NCT03614156|Depression|depression
94347|NCT03614104|Mobile health technology|mobile health technology
94348|NCT03614091|Paravertebral block|paravertebral block
94349|NCT03614091|Erector spinae plane block|erector spinae plane block
94350|NCT03614091|Modified radical mastectomy|modified radical mastectomy
94351|NCT03614091|respirometer|respirometer
94352|NCT03614039|diosmectite|diosmectite
94353|NCT03614039|nutraceuticals|nutraceuticals
94354|NCT03614039|non-alcoholic fatty liver disease|non-alcoholic fatty liver disease
94355|NCT03614039|probiotics|probiotics
94356|NCT03614039|Lactobacillus|lactobacillus
94357|NCT03614039|Bifidobacterium|bifidobacterium
94358|NCT03614039|Propionibacterium|propionibacterium
94359|NCT03613974|foot and ankle|foot and ankle
94360|NCT03613974|day case surgery|day case surgery
94361|NCT03613922|manual therapy|manual therapy
94362|NCT03613922|radius fracture|radius fracture
94363|NCT03613922|function|function
94364|NCT03613922|disability|disability
94365|NCT03613922|physiotherapy|physiotherapy
94366|NCT03613883|aneurysm|aneurysm
94367|NCT03613883|embolization|embolization
94368|NCT03613883|stent graft|stent graft
94369|NCT03613870|PermeaDerm, Mepilex Ag, partial thickness burn wounds|permeaderm, mepilex ag, partial thickness burn wounds
94370|NCT03613844|Alzheimer's disease|alzheimer's disease
94371|NCT03613844|Docosahexaenoic Acids|docosahexaenoic acids
94372|NCT03613844|Apolipoprotein E4|apolipoprotein e4
94373|NCT03613792|dynamic|dynamic
94374|NCT03613792|flexible|flexible
94375|NCT03613779|Lung ultrasound|lung ultrasound
94376|NCT03613779|Heart failure|heart failure
94377|NCT03613779|Management|management
94378|NCT03613753|relapsed|relapsed
94379|NCT03613740|Insulin Sensitivity|insulin sensitivity
94380|NCT03613740|Metabolic Syndrome|metabolic syndrome
94381|NCT03613740|Fucoxanthin|fucoxanthin
94382|NCT03613740|Insulin Secretion|insulin secretion
94383|NCT03613727|Vitamin C|vitamin c
94384|NCT03613727|Hematopoietic cell transplant (HCT)|hematopoietic cell transplant (hct)
94385|NCT03613727|Non-relapse mortality|non-relapse mortality
94386|NCT03613727|Graft versus Host Disease (GVHD)|graft versus host disease (gvhd)
94387|NCT03613701|Moyamoya disease|moyamoya disease
94388|NCT03613701|Endothelial progenitor cells|endothelial progenitor cells
94389|NCT03613701|revascularization|revascularization
94390|NCT03613675|video games|video games
94391|NCT03613662|lumbosacral radicular pain|lumbosacral radicular pain
94392|NCT03613662|sciatica|sciatica
94393|NCT03613662|leg pain|leg pain
94394|NCT03613649|AZD0914|azd0914
94395|NCT03613649|Cardiac|cardiac
94396|NCT03613649|ETX0914|etx0914
94397|NCT03613649|Healthy|healthy
94398|NCT03613649|Moxifloxacin|moxifloxacin
94399|NCT03613649|Repolarization|repolarization
94400|NCT03613649|Study|study
94401|NCT03613649|TQT|tqt
94402|NCT03613649|Volunteers|volunteers
94403|NCT03613649|Zoliflodacin|zoliflodacin
94404|NCT03613610|Genicular nerve radio-frequency ablation|genicular nerve radio-frequency ablation
94405|NCT03613558|Dexmedetomidine|dexmedetomidine
94406|NCT03613532|Acute Myeloid Leukemia (AML)|acute myeloid leukemia (aml)
94407|NCT03613532|Myelodysplastic Syndrome (MDS)|myelodysplastic syndrome (mds)
94408|NCT03613532|Chronic Myelomonocytic Leukemia (CMML)|chronic myelomonocytic leukemia (cmml)
94409|NCT03613532|MDS/myeloproliferative neoplasm-unclassifiable (MDS/MPN-unclassifiable)|mds/myeloproliferative neoplasm-unclassifiable (mds/mpn-unclassifiable)
712566|NCT00579683|non-small cell lung cancer|non-small cell lung cancer
94410|NCT03613532|Hematopoietic Stem Cell Transplant|hematopoietic stem cell transplant
94411|NCT03613519|Sleep hygiene|sleep hygiene
94412|NCT03613519|Sleep Healthy Using the Internet (SHUTi)|sleep healthy using the internet (shuti)
94413|NCT03613519|Cognitive-behavioral therapy (CBT)|cognitive-behavioral therapy (cbt)
94414|NCT03613519|Black Women's Health Study|black women's health study
94415|NCT03613493|HPV|hpv
94416|NCT03613493|self-sampling|self-sampling
94417|NCT03613493|culture|culture
94418|NCT03613493|message design|message design
94419|NCT03613493|health communication|health communication
94420|NCT03613493|Jamaica|jamaica
94421|NCT03613467|Vedio-assisted thoracoscopic lobectomy|vedio-assisted thoracoscopic lobectomy
94422|NCT03613467|Thoracotomy lobectomy|thoracotomy lobectomy
94423|NCT03613467|Real-world evidences;|real-world evidences;
94424|NCT03613467|pN2 NSCLC|pn2 nsclc
94425|NCT03613441|Mindfulness|mindfulness
94426|NCT03613441|Residency training|residency training
94427|NCT03613376|Varicose veins|varicose veins
94428|NCT03613376|Compression stockings|compression stockings
94429|NCT03613376|Sclerotherapy|sclerotherapy
94430|NCT03613376|Radiofrequency ablation|radiofrequency ablation
94431|NCT03613350|Cystocele|cystocele
94432|NCT03613350|Urodynamic stress incontinence|urodynamic stress incontinence
94433|NCT03613350|Detrusor overactivity|detrusor overactivity
94434|NCT03613350|Pad test|pad test
94435|NCT03613350|Urodynamic study|urodynamic study
94436|NCT03613324|Cystocele|cystocele
94437|NCT03613324|Bladder outlet obstruction|bladder outlet obstruction
94438|NCT03613324|Detrusor underactivity|detrusor underactivity
94439|NCT03613324|Urodynamic study|urodynamic study
94440|NCT03613311|Cystocele|cystocele
95134|NCT03609463|weight loss|weight loss
94441|NCT03613311|Urodynamic stress incontinence|urodynamic stress incontinence
94442|NCT03613311|Pad test|pad test
94443|NCT03613311|Urodynamic study|urodynamic study
94444|NCT03613298|HIFU|hifu
94445|NCT03613298|High Intensity Focused Ultrasound|high intensity focused ultrasound
94446|NCT03613298|DIE|die
94447|NCT03613298|rectal endometriosis|rectal endometriosis
94448|NCT03613298|safety profile|safety profile
94449|NCT03613298|Deep invasive endometriosis|deep invasive endometriosis
94450|NCT03613298|Endometriosis, rectum|endometriosis, rectum
94451|NCT03613272|thymoma|thymoma
94452|NCT03613272|thymectomy|thymectomy
94453|NCT03613272|Myasthenia Gravis|myasthenia gravis
94454|NCT03613272|VATS|vats
94455|NCT03613272|subxiphoid|subxiphoid
94456|NCT03613272|elevation of the sternum|elevation of the sternum
94457|NCT03613272|curative effect|curative effect
94458|NCT03613246|TAVI|tavi
94459|NCT03613246|Aortic valve stenosis|aortic valve stenosis
94460|NCT03613246|ALLEGRA|allegra
94461|NCT03613233|MIGS|migs
94462|NCT03613233|canaloplasty|canaloplasty
94463|NCT03613233|glaucoma|glaucoma
94464|NCT03613233|glaucoma surgery|glaucoma surgery
94465|NCT03613233|glaucoma implant|glaucoma implant
94466|NCT03613233|deep sclerectomy|deep sclerectomy
94467|NCT03613233|iridencleisis|iridencleisis
94468|NCT03613233|QoL|qol
94469|NCT03613233|quality of life|quality of life
94470|NCT03613233|NEI VFQ 25|nei vfq 25
94471|NCT03613220|advanced HR+ HER2 breast cancer|advanced hr+ her2 breast cancer
94472|NCT03613220|breast cancer|breast cancer
94473|NCT03613220|proteomic analysis|proteomic analysis
94474|NCT03613220|protein expression|protein expression
94475|NCT03613220|ctDNA Analysis|ctdna analysis
94476|NCT03613220|adult|adult
94477|NCT03613220|LEE011|lee011
94478|NCT03613207|Dermal open flow microperfusion|dermal open flow microperfusion
94479|NCT03613207|dOFM|dofm
94480|NCT03613181|ANG1005|ang1005
94481|NCT03613181|Leptomeningeal carcinomatosis|leptomeningeal carcinomatosis
94482|NCT03613181|Leptomeningeal disease|leptomeningeal disease
94483|NCT03613181|Leptomeningeal metastases|leptomeningeal metastases
94484|NCT03613181|Brain metastases|brain metastases
94485|NCT03613181|HER2-negative|her2-negative
94486|NCT03613181|Breast cancer|breast cancer
94487|NCT03613181|Targeted therapy|targeted therapy
94488|NCT03613168|Cholangiocarcinoma|cholangiocarcinoma
94489|NCT03613168|Biliary Tract Cancer|biliary tract cancer
94490|NCT03613168|Trastuzumab|trastuzumab
94491|NCT03613155|Emergency|emergency
94492|NCT03613142|Double tract|double tract
94493|NCT03613142|Esophagogastrostomy|esophagogastrostomy
94494|NCT03613142|Gastric cancer|gastric cancer
94495|NCT03613142|GastroEsophageal Cancer|gastroesophageal cancer
94496|NCT03613129|myalgic encephalomyelitis|myalgic encephalomyelitis
94497|NCT03613129|chronic fatigue syndrome|chronic fatigue syndrome
94498|NCT03613129|corticotropin releasing-factor receptor subtype 2 (CRF2)|corticotropin releasing-factor receptor subtype 2 (crf2)
94499|NCT03613129|corticotropin releasing-hormone receptor subtype 2 (CRH2)|corticotropin releasing-hormone receptor subtype 2 (crh2)
94500|NCT03613116|vitamin D|vitamin d
94501|NCT03613116|cognitive decline|cognitive decline
94502|NCT03613103|video laryngoscopy|video laryngoscopy
94503|NCT03613103|airway|airway
94504|NCT03613103|injury|injury
94505|NCT03613103|direct laryngoscopy|direct laryngoscopy
121480|NCT03443310|DVT|dvt
94506|NCT03613103|intubation|intubation
94507|NCT03613103|endotracheal|endotracheal
94508|NCT03613077|Survival rate|survival rate
94509|NCT03613077|Success rate|success rate
94510|NCT03613077|Straumann® BLX Implant Roxolid® SLActive®,|straumann® blx implant roxolid® slactive®,
94511|NCT03613038|Dysarthria|dysarthria
94512|NCT03613038|Speech motor performance|speech motor performance
94513|NCT03613038|Speech motor control|speech motor control
94514|NCT03613038|Speech kinematics|speech kinematics
94515|NCT03613012|Pain assessment|pain assessment
94516|NCT03613012|electroencephalographic|electroencephalographic
94517|NCT03613012|numerical rating scale|numerical rating scale
94518|NCT03613012|pain index|pain index
94519|NCT03612960|Tobacco|tobacco
94520|NCT03612960|Nicotine|nicotine
94521|NCT03612960|Smoking|smoking
94522|NCT03612960|Functional magnetic resonance imaging|functional magnetic resonance imaging
94523|NCT03612960|Addiction|addiction
94524|NCT03612934|Breast Cancer|breast cancer
94525|NCT03612934|palliative care|palliative care
94526|NCT03612934|life quality|life quality
94527|NCT03612934|performance status|performance status
94528|NCT03612934|esas|esas
94529|NCT03612921|oral amantadine|oral amantadine
94530|NCT03612921|IV amantadine|iv amantadine
94531|NCT03612921|tracheal intubation|tracheal intubation
94532|NCT03612908|Hyperthyroidism|hyperthyroidism
94533|NCT03612908|Polymorphism|polymorphism
94534|NCT03612908|TSHβX1|tshβx1
94535|NCT03612908|D2 THR92ALA|d2 thr92ala
94536|NCT03612908|Hypothyroidism|hypothyroidism
94537|NCT03612882|Sedentary Behaviour|sedentary behaviour
94538|NCT03612882|Subjective Well-Being|subjective well-being
94539|NCT03612882|University Students|university students
94540|NCT03612869|MPS IIIA|mps iiia
95440|NCT03607331|depression|depression
94541|NCT03612869|Sanfilippo syndrome Type A|sanfilippo syndrome type a
94542|NCT03612869|Mucopolysaccharidosis Type IIIA|mucopolysaccharidosis type iiia
94543|NCT03612869|Lysosomal Storage Disease|lysosomal storage disease
94544|NCT03612856|Hemodialysis|hemodialysis
94545|NCT03612843|dry needling|dry needling
94546|NCT03612843|adverse event|adverse event
94547|NCT03612843|physical therapy|physical therapy
94548|NCT03612830|The Third Space|the third space
94549|NCT03612817|tafluprost/timolol fixed combination, 24-hour IOP control|tafluprost/timolol fixed combination, 24-hour iop control
94550|NCT03612804|smoking cessation|smoking cessation
94551|NCT03612804|lung cancer screening|lung cancer screening
94552|NCT03612804|telephone counseling|telephone counseling
94553|NCT03612804|quitline|quitline
94554|NCT03612778|nutrition|nutrition
94555|NCT03612778|dyslipidemia|dyslipidemia
94556|NCT03612778|insulin resistance|insulin resistance
94557|NCT03612778|inflammation|inflammation
94558|NCT03612765|heart failure|heart failure
94559|NCT03612765|self-care|self-care
94560|NCT03612765|behavio*|behavio*
94561|NCT03612765|intervention|intervention
94562|NCT03612765|randomized controlled trial|randomized controlled trial
94563|NCT03612752|Chicken essence, cognitive function|chicken essence, cognitive function
94564|NCT03612739|CAR-T Cells|car-t cells
94565|NCT03612739|NKR-2|nkr-2
94566|NCT03612739|AML|aml
94567|NCT03612739|Epigenetic drug therapy|epigenetic drug therapy
94568|NCT03612700|Cyclopropane fatty acids|cyclopropane fatty acids
94569|NCT03612700|GC-MS|gc-ms
94570|NCT03612687|Hemodynamic Monitoring|hemodynamic monitoring
94571|NCT03612687|Perioperative Fluid Management|perioperative fluid management
94572|NCT03612687|Hepatobiliary and Pancreas Surgery|hepatobiliary and pancreas surgery
94573|NCT03612674|Mass screening|mass screening
94574|NCT03612674|Adenoma detection rate|adenoma detection rate
94575|NCT03612674|ARC Endocuff Vision|arc endocuff vision
94576|NCT03612674|Colonoscopy|colonoscopy
94577|NCT03612661|disordered eating, body image, intuitive eating, undergraduates, college, unhealthy weight control behaviors, eating disorders, weight stigma, weight bias|disordered eating, body image, intuitive eating, undergraduates, college, unhealthy weight control behaviors, eating disorders, weight stigma, weight bias
94578|NCT03612622|Transcranial Magnetic Stimulation|transcranial magnetic stimulation
94579|NCT03612622|Magnetic Resonance Imaging|magnetic resonance imaging
94580|NCT03612622|Alzheimer Disease|alzheimer disease
94581|NCT03612609|Dengue virus|dengue virus
94582|NCT03612609|Semen|semen
94583|NCT03612596|wearable|wearable
94584|NCT03612596|mobile app|mobile app
94585|NCT03612596|physical activity|physical activity
94586|NCT03612596|survivorship|survivorship
94587|NCT03612596|narrative|narrative
94588|NCT03612596|identity|identity
94589|NCT03612583|Diaphragm Dysfunction|diaphragm dysfunction
94590|NCT03612583|Acute Respiratory Failure|acute respiratory failure
94591|NCT03612583|Sedation|sedation
94592|NCT03612583|Mechanical Ventilation|mechanical ventilation
94593|NCT03612583|Lung Stress|lung stress
94594|NCT03612570|Nano-Pulse Stimulation|nano-pulse stimulation
94595|NCT03612570|NPS|nps
94596|NCT03612557|Benzathine benzylpenicillin|benzathine benzylpenicillin
94597|NCT03612557|penicillin G benzathine|penicillin g benzathine
94598|NCT03612518|postpartum family planning|postpartum family planning
94599|NCT03612518|RCT|rct
94600|NCT03612518|mhealth|mhealth
94601|NCT03612492|esmolol|esmolol
94602|NCT03612492|lidocaine|lidocaine
94603|NCT03612492|intubation|intubation
94604|NCT03612492|hemodynamic response|hemodynamic response
94605|NCT03612466|dosimetry|dosimetry
94606|NCT03612466|radiopharmaceutical|radiopharmaceutical
94607|NCT03612466|radiotherapy|radiotherapy
94608|NCT03612466|Maximally tolerated dose|maximally tolerated dose
94609|NCT03612466|MTD|mtd
94610|NCT03612466|tumor|tumor
94611|NCT03612466|myelosuppression|myelosuppression
94612|NCT03612440|dexmedetomidine|dexmedetomidine
94613|NCT03612440|oxygenation index|oxygenation index
94614|NCT03612440|respiratory index|respiratory index
94615|NCT03612440|inflammatory factors|inflammatory factors
94616|NCT03612414|xerostomia|xerostomia
94617|NCT03612414|pH|ph
94618|NCT03612414|Carnosine|carnosine
94619|NCT03612414|karkadé|karkadé
94620|NCT03612414|Aqualief|aqualief
94621|NCT03612414|Mucoadhesive|mucoadhesive
94622|NCT03612401|Spinal cord injury|spinal cord injury
94623|NCT03612401|SCI|sci
94624|NCT03612401|Neurogenic bladder|neurogenic bladder
94625|NCT03612401|Overactive bladder|overactive bladder
94626|NCT03612401|anticholinergic|anticholinergic
94627|NCT03612401|mirabegron|mirabegron
94628|NCT03612401|cognitive|cognitive
94629|NCT03612401|cognition|cognition
94630|NCT03612401|NGB|ngb
94631|NCT03612401|OAB|oab
94632|NCT03612362|Acute Respiratory Infection, Household Air Pollution|acute respiratory infection, household air pollution
94633|NCT03612349|cigarettes|cigarettes
94634|NCT03612349|smoking|smoking
94635|NCT03612297|Antimicrobial resistance|antimicrobial resistance
94636|NCT03612297|Antimicrobial stewardship|antimicrobial stewardship
94637|NCT03612297|Selective reporting antimicrobial susceptibility tests|selective reporting antimicrobial susceptibility tests
94638|NCT03612297|Escherichia coli|escherichia coli
94639|NCT03612284|Contact lens solution|contact lens solution
94640|NCT03612271|Hypertension|hypertension
94641|NCT03612271|mHealth|mhealth
94642|NCT03612258|Fibromyalgia|fibromyalgia
94643|NCT03612258|Pain|pain
94644|NCT03612258|Neuroimaging|neuroimaging
94645|NCT03612258|Sensory sensitivity|sensory sensitivity
94646|NCT03612258|Fatigue|fatigue
94647|NCT03612232|adrenal cancer|adrenal cancer
94648|NCT03612232|adrenal cortex neoplasm|adrenal cortex neoplasm
94649|NCT03612232|adrenal cortical carcinoma|adrenal cortical carcinoma
94650|NCT03612232|cabozantinib|cabozantinib
94651|NCT03612232|c-MET|c-met
94652|NCT03612219|Nasopharyngeal Carcinoma|nasopharyngeal carcinoma
94653|NCT03612219|Apatinib|apatinib
94654|NCT03612219|Adjuvant treatment|adjuvant treatment
94655|NCT03612219|Progression-free survival|progression-free survival
94656|NCT03612141|Severe stroke|severe stroke
94657|NCT03612141|Brain Death|brain death
94658|NCT03612141|organ donation|organ donation
94659|NCT03612128|cerebral palsy|cerebral palsy
94660|NCT03612128|mirror therapy|mirror therapy
94661|NCT03612128|cerebral re-organization|cerebral re-organization
94662|NCT03612128|upper extremity|upper extremity
94663|NCT03612128|daily life activities|daily life activities
94664|NCT03612128|functional motor capacity|functional motor capacity
94665|NCT03612128|motor functions|motor functions
94666|NCT03612102|Selective Mutism|selective mutism
94667|NCT03612102|Treatment|treatment
94668|NCT03612102|Anxiety|anxiety
94669|NCT03612102|Intensive Treatment|intensive treatment
94670|NCT03612102|CBT|cbt
94671|NCT03612102|Group Treatment|group treatment
94672|NCT03612076|prosthetic joint infection|prosthetic joint infection
94673|NCT03612050|Palliative care|palliative care
94674|NCT03612050|Despair|despair
94675|NCT03612050|Spiritual well-being|spiritual well-being
94676|NCT03612037|pre-diabetes|pre-diabetes
94677|NCT03612037|glucose|glucose
94678|NCT03612037|insulin|insulin
94679|NCT03612037|blood lipids|blood lipids
94680|NCT03612037|alpha lipoic acid|alpha lipoic acid
94681|NCT03612011|Hand Foot Syndrome Grade 2|hand foot syndrome grade 2
94682|NCT03612011|Common Terminology Criteria for Adverse Events (CTCAE)|common terminology criteria for adverse events (ctcae)
94683|NCT03612011|Oncology|oncology
94684|NCT03612011|Repair Cream|repair cream
94685|NCT03612011|Cutaneous events|cutaneous events
94686|NCT03612011|Palmar-plantar erythrodysesthesia syndrome|palmar-plantar erythrodysesthesia syndrome
94687|NCT03612011|Targeted Therapies or Conventional Chemotherapy|targeted therapies or conventional chemotherapy
94688|NCT03611998|Sex trafficking|sex trafficking
94689|NCT03611998|Occupational therapy|occupational therapy
94690|NCT03611998|Occupation-based programming|occupation-based programming
94691|NCT03611998|Activity-based programming|activity-based programming
94692|NCT03611998|Brain trauma|brain trauma
94693|NCT03611985|breast cancer|breast cancer
94694|NCT03611985|Epidiferphane|epidiferphane
94695|NCT03611985|taxane|taxane
94696|NCT03611946|Zika virus|zika virus
94697|NCT03611946|Vaccine|vaccine
94698|NCT03611933|Back pain|back pain
94699|NCT03611933|patient positioning|patient positioning
94700|NCT03611933|vascular complications|vascular complications
94701|NCT03611933|vital signs|vital signs
94702|NCT03611894|RMI|rmi
94703|NCT03611881|lung screening|lung screening
94704|NCT03611855|Brain-Computer Interface|brain-computer interface
94705|NCT03611855|Motor Rehabilitation|motor rehabilitation
94706|NCT03611855|Electroencephalography|electroencephalography
94707|NCT03611855|Magnetic Resonance Imaging|magnetic resonance imaging
94708|NCT03611829|emotional eating|emotional eating
94709|NCT03611803|Robotic-assisted gait training|robotic-assisted gait training
94710|NCT03611803|SCI|sci
94711|NCT03611803|Ambulatory activity|ambulatory activity
94712|NCT03611738|Advanced NSCLC|advanced nsclc
94713|NCT03611738|Advanced Non-small Cell Lung Cancer|advanced non-small cell lung cancer
94714|NCT03611738|anaplastic lymphoma kinase (ALK)|anaplastic lymphoma kinase (alk)
94715|NCT03611738|ALK-negative|alk-negative
94716|NCT03611738|epidermal growth factor receptor (EGFR)|epidermal growth factor receptor (egfr)
94717|NCT03611738|wild-type (WT)|wild-type (wt)
94718|NCT03611725|Distal radial approach|distal radial approach
94719|NCT03611725|ST Elevation Myocardial Infarction|st elevation myocardial infarction
94720|NCT03611712|Cancer-related Fatigue|cancer-related fatigue
94721|NCT03611712|Tumor response|tumor response
94722|NCT03611712|Survival|survival
94723|NCT03611712|Chemoradiation|chemoradiation
94724|NCT03611712|esophageal cancer|esophageal cancer
94725|NCT03611673|sense of smell|sense of smell
94726|NCT03611673|smell test|smell test
94727|NCT03611673|at-home smell test|at-home smell test
94728|NCT03611673|essential oil|essential oil
94729|NCT03611673|olfactory loss|olfactory loss
94730|NCT03611660|pediatric obesity, stress|pediatric obesity, stress
94731|NCT03611647|Microbiome|microbiome
94732|NCT03611647|Probiotic|probiotic
94733|NCT03611634|gut microbiote, bone and joint infection, antibiotics|gut microbiote, bone and joint infection, antibiotics
94734|NCT03611595|13-cis-Retinoic Acid|13-cis-retinoic acid
94735|NCT03611595|Children|children
94736|NCT03611595|Relapsed Solid Tumors|relapsed solid tumors
94737|NCT03611595|Refractory Solid Tumors|refractory solid tumors
94738|NCT03611595|Solid Tumors|solid tumors
94739|NCT03611595|cancer|cancer
94740|NCT03611595|cabozantinib|cabozantinib
94741|NCT03611556|MEDI9447|medi9447
94742|NCT03611556|oleclumab|oleclumab
94743|NCT03611556|immunotherapy|immunotherapy
94744|NCT03611556|pancreatic cancer|pancreatic cancer
94745|NCT03611556|durvalumab|durvalumab
94746|NCT03611543|Breast Cancer|breast cancer
94747|NCT03611543|Tomosynthesis|tomosynthesis
94748|NCT03611543|3D Mammogram|3d mammogram
94749|NCT03611543|Diagnostic Mammogram|diagnostic mammogram
94750|NCT03611517|Endometrial cancer|endometrial cancer
94751|NCT03611517|Cervical cancer|cervical cancer
94752|NCT03611517|Vaginal cancer|vaginal cancer
94753|NCT03611517|sexuality|sexuality
94754|NCT03611517|sexual problems|sexual problems
94755|NCT03611517|dilator|dilator
94756|NCT03611517|radiotherapy|radiotherapy
94757|NCT03611517|gynaecological cancer|gynaecological cancer
94758|NCT03611517|sexual rehabilitation programme|sexual rehabilitation programme
94759|NCT03611504|Hemospray, Gastrointestinal bleeding, Gastrointestinal hemorrhage, Hemostatic powder|hemospray, gastrointestinal bleeding, gastrointestinal hemorrhage, hemostatic powder
94760|NCT03611465|Sudden cardiac death|sudden cardiac death
94761|NCT03611465|Electrophisiologic exploration|electrophisiologic exploration
94762|NCT03611465|Myocardial infarction|myocardial infarction
94763|NCT03611426|Serine protease|serine protease
94764|NCT03611426|Tolerance|tolerance
94765|NCT03611426|Immunogenicity|immunogenicity
94766|NCT03611426|Safety|safety
94767|NCT03611413|COLON PERFORATION SURGERY|colon perforation surgery
94768|NCT03611400|Probiotic|probiotic
94769|NCT03611400|Intestinal Permeability|intestinal permeability
94770|NCT03611400|Leaky Gut|leaky gut
94771|NCT03611387|Primary Angle-Closure Glaucoma|primary angle-closure glaucoma
94772|NCT03611387|Artificial Intelligence|artificial intelligence
94773|NCT03611361|peripheral arterial disease|peripheral arterial disease
94774|NCT03611361|re-amputation|re-amputation
94775|NCT03611361|optical imaging|optical imaging
94776|NCT03611361|Computer Assisted Detection (CADe)|computer assisted detection (cade)
94777|NCT03611348|acrofacal vitiligo, latanoprost, microneedling|acrofacal vitiligo, latanoprost, microneedling
94778|NCT03611309|Pancreatic Cancer|pancreatic cancer
94779|NCT03611309|Hepatocellular Cancer|hepatocellular cancer
94780|NCT03611309|Esophageal Cancer|esophageal cancer
94781|NCT03611309|Gastric Cancer|gastric cancer
94782|NCT03611309|Cholangio carcinomas|cholangio carcinomas
94783|NCT03611296|Cardiorespiratory fitness|cardiorespiratory fitness
94784|NCT03611296|Inhibitory control|inhibitory control
94785|NCT03611296|Motivation|motivation
94786|NCT03611296|Food intake|food intake
94787|NCT03611296|Body composition|body composition
94788|NCT03611283|Xerostomia|xerostomia
94789|NCT03611283|Sjögren's syndrome|sjögren's syndrome
94790|NCT03611283|Topical dry mouth products|topical dry mouth products
94791|NCT03611283|Olive Oil|olive oil
121811|NCT03441165|MAT|mat
94792|NCT03611283|Oral Health Impact Profile|oral health impact profile
94793|NCT03611257|Bacteremia|bacteremia
94794|NCT03611257|Optimal targeted antibiotics|optimal targeted antibiotics
94795|NCT03611257|Antibiotic susceptibility test|antibiotic susceptibility test
94796|NCT03611257|Antimicrobial stewardship|antimicrobial stewardship
94797|NCT03611218|Hemodialysis|hemodialysis
94798|NCT03611218|Hemodiafiltration|hemodiafiltration
94799|NCT03611218|Renal replacement therapy|renal replacement therapy
94800|NCT03611205|Oropharyngeal|oropharyngeal
94801|NCT03611205|Squamous Cell Carcinoma|squamous cell carcinoma
94802|NCT03611205|HPV|hpv
94803|NCT03611192|Multicomponent Exercise|multicomponent exercise
94804|NCT03611192|Executive Function|executive function
94805|NCT03611192|Balance|balance
94806|NCT03611192|Pre-frail|pre-frail
94807|NCT03611179|advanced ovarian cancer|advanced ovarian cancer
94808|NCT03611179|upfront treatment|upfront treatment
94809|NCT03611179|bevacizumab|bevacizumab
94810|NCT03611166|proteomics|proteomics
94811|NCT03611166|plasma|plasma
94812|NCT03611166|chronic disorder of consciousness|chronic disorder of consciousness
94813|NCT03611153|Heart Failure|heart failure
94814|NCT03611153|Ejection Fraction|ejection fraction
94815|NCT03611153|Preserved|preserved
94816|NCT03611153|Myeloperoxidase Inhibitor|myeloperoxidase inhibitor
94817|NCT03611153|Exercise|exercise
94818|NCT03611140|metabolic syndrome|metabolic syndrome
94819|NCT03611140|gut microbiota|gut microbiota
94820|NCT03611140|metabolic endotoxemia|metabolic endotoxemia
94821|NCT03611140|functional foods|functional foods
94822|NCT03611114|endothelial function|endothelial function
94823|NCT03611114|flow mediated dilation|flow mediated dilation
94824|NCT03611114|lipid profile|lipid profile
94825|NCT03611114|blood pressure|blood pressure
94826|NCT03611114|flavanones|flavanones
94827|NCT03611114|Caucasian|caucasian
94828|NCT03611088|Child Development|child development
94829|NCT03611088|Kangaroo Mother Care Method|kangaroo mother care method
94830|NCT03611088|Electromyography|electromyography
94831|NCT03611088|Microcirculation|microcirculation
94832|NCT03611088|Premature|premature
94834|NCT03611062|executive function|executive function
94835|NCT03611062|virtual reality|virtual reality
94836|NCT03611062|traumatic brain injury|traumatic brain injury
94837|NCT03610971|CP-CML|cp-cml
94838|NCT03610971|Chronic Myeloid Leukemia|chronic myeloid leukemia
94839|NCT03610971|CML|cml
94840|NCT03610971|combination therapy|combination therapy
94841|NCT03610971|BCR-ABL oncogene|bcr-abl oncogene
94842|NCT03610958|overweight|overweight
94843|NCT03610958|obesity|obesity
94844|NCT03610945|drug-drug interaction|drug-drug interaction
94845|NCT03610919|multiple doses|multiple doses
94846|NCT03610919|oxytocin|oxytocin
94847|NCT03610919|genotype|genotype
94848|NCT03610919|autism trait|autism trait
94849|NCT03610906|Pilot Study|pilot study
94850|NCT03610906|Biological Targets|biological targets
94851|NCT03610906|CTNNB1|ctnnb1
94852|NCT03610906|Tumor|tumor
94853|NCT03610893|nerve block adjuvants|nerve block adjuvants
94854|NCT03610893|dexamethasone|dexamethasone
94855|NCT03610893|dexmedetomidine|dexmedetomidine
94856|NCT03610893|nerve block duration|nerve block duration
94857|NCT03610880|healthy Chinese volunteers|healthy chinese volunteers
94858|NCT03610880|TG-2349|tg-2349
94859|NCT03610880|DAG181|dag181
94860|NCT03610880|pharmacokinetics|pharmacokinetics
94861|NCT03610880|safety|safety
94862|NCT03610880|multiple ascending oral doses|multiple ascending oral doses
94863|NCT03610867|safety|safety
94864|NCT03610867|tolerability|tolerability
94865|NCT03610867|PK|pk
94866|NCT03610867|single ascending oral dose|single ascending oral dose
94867|NCT03610867|multiple ascending oral doses|multiple ascending oral doses
94868|NCT03610828|Vegetarian Diet|vegetarian diet
94869|NCT03610828|Vegan Diet|vegan diet
94870|NCT03610828|Systematic Reviews and Meta-Analysis|systematic reviews and meta-analysis
94871|NCT03610828|Clinical practice guidelines|clinical practice guidelines
94872|NCT03610828|Prospective cohort studies|prospective cohort studies
94873|NCT03610828|Cardiovascular disease|cardiovascular disease
94874|NCT03610828|Coronary heart disease|coronary heart disease
94875|NCT03610828|Stroke|stroke
94876|NCT03610828|Cardiovascular mortality|cardiovascular mortality
94877|NCT03610828|Coronary heart disease mortality|coronary heart disease mortality
94878|NCT03610828|Stroke mortality|stroke mortality
94879|NCT03610815|Alcohol|alcohol
94880|NCT03610815|SBIRT|sbirt
94881|NCT03610815|Mobile Technology|mobile technology
94882|NCT03610815|Implementation Science|implementation science
94883|NCT03610815|Dissemination Research|dissemination research
94884|NCT03610815|Hybrid Effectiveness-Implementation Design|hybrid effectiveness-implementation design
94885|NCT03610802|Immunophenotyping|immunophenotyping
94886|NCT03610802|Functional Assays|functional assays
94887|NCT03610802|Repository|repository
94888|NCT03610802|HLA-Typing|hla-typing
94889|NCT03610802|Next Generation Sequencing|next generation sequencing
121936|NCT03440437|PK|pk
94890|NCT03610776|Portion control plate|portion control plate
94891|NCT03610776|Visual attention|visual attention
94892|NCT03610776|Eating rate|eating rate
94893|NCT03610776|Cephalic satiety response|cephalic satiety response
94894|NCT03610763|Rehabilitation Neuroscience|rehabilitation neuroscience
94895|NCT03610763|Transcranial Direct Current Stimulation|transcranial direct current stimulation
94896|NCT03610763|Rehabilitation Therapy|rehabilitation therapy
94897|NCT03610763|Neuroplasticity|neuroplasticity
94898|NCT03610763|Transplantation|transplantation
94899|NCT03610763|Hand Therapy|hand therapy
94900|NCT03610763|Constraint Induced Movement Therapy|constraint induced movement therapy
94901|NCT03610763|Peripheral Nerve Injuries|peripheral nerve injuries
94902|NCT03610763|tDCS|tdcs
94903|NCT03610763|CIMT|cimt
94904|NCT03610750|Community Mental Health Care|community mental health care
94905|NCT03610750|Task-shifting|task-shifting
94906|NCT03610724|Tisagenlecleucel|tisagenlecleucel
94907|NCT03610724|relapsed/refractory B-cell non-Hodgkin lymphoma|relapsed/refractory b-cell non-hodgkin lymphoma
94908|NCT03610724|pediatric patients|pediatric patients
94909|NCT03610724|Burkitt's lymphoma (BL)|burkitt's lymphoma (bl)
94910|NCT03610724|diffuse large B-cell lymphoma (DLBCL)|diffuse large b-cell lymphoma (dlbcl)
94911|NCT03610724|primary mediastinal large B-cell lymphoma (PMBCL)|primary mediastinal large b-cell lymphoma (pmbcl)
94912|NCT03610724|gray zone lymphoma (GZL)|gray zone lymphoma (gzl)
94913|NCT03610724|follicular lymphoma (FL)|follicular lymphoma (fl)
94914|NCT03610724|leukapheresis|leukapheresis
94915|NCT03610724|lymphodepleting chemotherapy (LD)|lymphodepleting chemotherapy (ld)
94916|NCT03610724|NHL|nhl
94917|NCT03610698|caregiving|caregiving
94918|NCT03610698|psychological well-being|psychological well-being
94919|NCT03610698|alzheimer's|alzheimer's
94920|NCT03610698|positive emotion|positive emotion
94921|NCT03610685|Severe asthma|severe asthma
94922|NCT03610685|Mepolizumab|mepolizumab
94923|NCT03610685|IL5|il5
94924|NCT03610685|Steroid resistance|steroid resistance
94925|NCT03610685|Eosinophilic asthma|eosinophilic asthma
94926|NCT03610685|Type 2 inflammation|type 2 inflammation
94927|NCT03610659|COPD|copd
94928|NCT03610659|Burden of disease|burden of disease
94929|NCT03610646|Diabetic Macular Edema,|diabetic macular edema,
94930|NCT03610646|BCVA,|bcva,
94940|NCT03610568|Adolescent Health|adolescent health
94941|NCT03610542|Test Anxiety|test anxiety
94942|NCT03610542|Wellbeing|wellbeing
94943|NCT03610529|ECG Monitoring|ecg monitoring
94944|NCT03610529|Controlled|controlled
94945|NCT03610529|Comparative|comparative
94946|NCT03610529|Clinical trial|clinical trial
94947|NCT03610516|anti-CD40|anti-cd40
94949|NCT03610516|moderately active lupus nephritis|moderately active lupus nephritis
94950|NCT03610477|Microbiome|microbiome
94951|NCT03610451|Anorexia nervosa|anorexia nervosa
94952|NCT03610451|Floatation therapy|floatation therapy
94953|NCT03610438|Acute Lymphoid Leukemia|acute lymphoid leukemia
94954|NCT03610438|Inotuzumab Ozogamicin|inotuzumab ozogamicin
94955|NCT03610412|Diabetes Mellitus Type 2|diabetes mellitus type 2
94956|NCT03610412|IGF1|igf1
94957|NCT03610412|Cinnamomum cassia|cinnamomum cassia
94958|NCT03610412|Metabolic control|metabolic control
94959|NCT03610412|Metformin|metformin
94960|NCT03610399|treatment response|treatment response
94961|NCT03610399|efficacy|efficacy
94962|NCT03610399|primaquine|primaquine
94963|NCT03610399|chloroquine|chloroquine
94964|NCT03610386|Atopic|atopic
94965|NCT03610386|Dermatitis|dermatitis
94966|NCT03610386|TRPM8|trpm8
94967|NCT03610386|menthol|menthol
94968|NCT03610373|anxiety|anxiety
94969|NCT03610373|depression|depression
94970|NCT03610373|childhood|childhood
94971|NCT03610373|therapy|therapy
94972|NCT03610373|treatment|treatment
94973|NCT03610373|medical decision making|medical decision making
94974|NCT03610360|DENIM|denim
94975|NCT03610334|First-In-Human|first-in-human
94976|NCT03610295|congenital cataract|congenital cataract
94977|NCT03610295|prophylactic peripheral iridectomy|prophylactic peripheral iridectomy
94978|NCT03610295|aphakic angle-closure glaucoma|aphakic angle-closure glaucoma
94979|NCT03610295|aphakic open-angle glaucoma|aphakic open-angle glaucoma
94980|NCT03610295|iris posterior synechia|iris posterior synechia
94981|NCT03610295|visual axis opacity|visual axis opacity
94982|NCT03610282|Propofol|propofol
94983|NCT03610282|Methylphenidate|methylphenidate
94984|NCT03610282|Ritalin|ritalin
94985|NCT03610282|Anesthetics|anesthetics
94986|NCT03610282|Anesthetics, Intravenous|anesthetics, intravenous
94987|NCT03610282|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action
94988|NCT03610282|Anesthetics, General|anesthetics, general
94989|NCT03610282|Neurotransmitter Agents|neurotransmitter agents
94990|NCT03610282|Physiological Effects of Drugs|physiological effects of drugs
94991|NCT03610256|Obesity|obesity
94992|NCT03610256|Bariatric surgery|bariatric surgery
94993|NCT03610256|Single-anastomosis duodeno ileal bypass (SADI)|single-anastomosis duodeno ileal bypass (sadi)
712567|NCT00579683|NSCLC|nsclc
94994|NCT03610256|Roux-en-Y Gastric Bypass|roux-en-y gastric bypass
94995|NCT03610204|Alternative therapy|alternative therapy
94996|NCT03610204|Massage|massage
94997|NCT03610204|Manual therapy|manual therapy
94998|NCT03610204|Myofascial|myofascial
94999|NCT03610191|biomarkers|biomarkers
95000|NCT03610191|MD2|md2
95001|NCT03610191|Cystatin C|cystatin c
95002|NCT03610191|DNA methylation markers|dna methylation markers
95003|NCT03610191|SNP mutations in CTNNA2 gene|snp mutations in ctnna2 gene
95004|NCT03610139|cognitive performance|cognitive performance
95005|NCT03610139|vitamin D3 replacement|vitamin d3 replacement
95006|NCT03610139|Lebanon|lebanon
95007|NCT03610126|BASKA mask|baska mask
95008|NCT03610126|controlled ventilation|controlled ventilation
95009|NCT03610113|Conservative treatment|conservative treatment
95010|NCT03610113|Reverse shoulder arthroplasty|reverse shoulder arthroplasty
95011|NCT03610113|Proximal humeral fractures|proximal humeral fractures
95012|NCT03610100|Pancreatic|pancreatic
95013|NCT03610100|Neoplasms|neoplasms
95014|NCT03610100|Metastatic|metastatic
95015|NCT03610100|Gemcitabine|gemcitabine
95016|NCT03610100|Gemzar|gemzar
95017|NCT03610100|Phosphoramidate|phosphoramidate
95018|NCT03610100|Cytidine Aminohydrolase|cytidine aminohydrolase
95019|NCT03610100|Deoxycytidine Kinase|deoxycytidine kinase
95020|NCT03610100|Nucleoside Transport Proteins|nucleoside transport proteins
95021|NCT03610100|hENT1 protein, human|hent1 protein, human
95022|NCT03610074|thirst|thirst
95023|NCT03610074|mouth|mouth
95024|NCT03610074|critical care|critical care
95025|NCT03610074|water deprivation|water deprivation
95026|NCT03610048|Alkermes|alkermes
95027|NCT03610048|Major depressive disorder|major depressive disorder
95028|NCT03610048|Depression|depression
95029|NCT03610048|ALKS 5461|alks 5461
95030|NCT03610022|Vismodegib|vismodegib
95031|NCT03610022|Pharmacokinetic|pharmacokinetic
95032|NCT03610022|LC-MS/MS-MRM|lc-ms/ms-mrm
95033|NCT03610022|Human plasma concentrations|human plasma concentrations
95034|NCT03610022|Adverse events|adverse events
95035|NCT03609970|Vitamin D|vitamin d
95036|NCT03609970|UVR|uvr
95037|NCT03609970|Immune system|immune system
95038|NCT03609944|ERCP|ercp
95039|NCT03609944|Endoscopic retrograde cholangiopancreatography|endoscopic retrograde cholangiopancreatography
95040|NCT03609931|Mitral Valve|mitral valve
95041|NCT03609918|Chinese NSCLC|chinese nsclc
95042|NCT03609918|next-generation sequencing|next-generation sequencing
95043|NCT03609905|ulcerative colitis (UC)|ulcerative colitis (uc)
95044|NCT03609905|mesenchymal stem cells(MSC)|mesenchymal stem cells(msc)
95045|NCT03609879|cervical collar|cervical collar
95046|NCT03609879|sonography|sonography
95047|NCT03609879|adult patients|adult patients
95048|NCT03609879|Optic nerve sheath diameter|optic nerve sheath diameter
95049|NCT03609879|Ultrasonography|ultrasonography
95050|NCT03609866|intracranial pressure increase|intracranial pressure increase
95051|NCT03609866|chest physiotherapy|chest physiotherapy
95052|NCT03609866|ventilated patients|ventilated patients
95053|NCT03609840|Thiotepa|thiotepa
95054|NCT03609840|TEPA|tepa
95055|NCT03609840|Pediatric|pediatric
95056|NCT03609840|Hematopoietic|hematopoietic
95057|NCT03609840|Transplant|transplant
95058|NCT03609827|Melphalan|melphalan
95059|NCT03609827|Pharmacokinetics|pharmacokinetics
95060|NCT03609827|Pediatric|pediatric
95061|NCT03609827|Allogeneic|allogeneic
95062|NCT03609814|fludarabine|fludarabine
95063|NCT03609814|clofarabine|clofarabine
95064|NCT03609814|pharmacokinetics|pharmacokinetics
95065|NCT03609814|pediatric|pediatric
95066|NCT03609814|allogeneic|allogeneic
95067|NCT03609788|pain sensitivity|pain sensitivity
95068|NCT03609762|Musculoskeletal Problems|musculoskeletal problems
95069|NCT03609762|Health-Related Quality of Life|health-related quality of life
95070|NCT03609762|Routine Measurement|routine measurement
95071|NCT03609762|Randomized Controlled Trial|randomized controlled trial
95072|NCT03609762|Clinical Outcomes|clinical outcomes
95073|NCT03609710|Low rectal cancer|low rectal cancer
95074|NCT03609710|Robotic surgery|robotic surgery
95075|NCT03609710|Anastomotic leak|anastomotic leak
95076|NCT03609697|Diabetes prevention|diabetes prevention
95077|NCT03609697|Pre-diabetes|pre-diabetes
95078|NCT03609697|Weight loss|weight loss
95079|NCT03609697|Cardio-metabolic risks|cardio-metabolic risks
95080|NCT03609697|Obesity|obesity
95081|NCT03609697|Lifestyle intervention|lifestyle intervention
95082|NCT03609697|Community-based|community-based
95083|NCT03609684|core stabilization|core stabilization
95084|NCT03609684|endurance|endurance
95085|NCT03609684|gymnastics|gymnastics
95086|NCT03609684|children|children
95087|NCT03609671|Breast Cancer|breast cancer
95088|NCT03609671|Emotions Immunology|emotions immunology
95089|NCT03609658|Vulnerable Older Adults|vulnerable older adults
95090|NCT03609658|Nurse Navigator|nurse navigator
95091|NCT03609658|Usual Care|usual care
95092|NCT03609658|Family|family
95093|NCT03609658|Multimorbid patients|multimorbid patients
95094|NCT03609645|Fascia Iliaca Block|fascia iliaca block
95095|NCT03609645|Femoral and Obturator Articular Branch Block|femoral and obturator articular branch block
95096|NCT03609632|Roux-en-Y gastric bypass (RYGB)|roux-en-y gastric bypass (rygb)
95097|NCT03609632|Hypoglycaemia|hypoglycaemia
95098|NCT03609632|Insulin|insulin
95099|NCT03609632|Glucose|glucose
95100|NCT03609632|Incretins|incretins
95101|NCT03609632|Stable isotope|stable isotope
95102|NCT03609606|Dyslipidemia|dyslipidemia
95103|NCT03609606|Hypertension|hypertension
95104|NCT03609606|CKD-386|ckd-386
95105|NCT03609606|Drug-Drug Interaction|drug-drug interaction
95106|NCT03609593|Chronic Lymphocytic Leukemia (CLL)|chronic lymphocytic leukemia (cll)
95107|NCT03609593|Leukemia|leukemia
95108|NCT03609593|Bendamustine|bendamustine
95109|NCT03609593|Rituximab|rituximab
95110|NCT03609593|Venetoclax|venetoclax
95111|NCT03609580|post operative urinary retention|post operative urinary retention
95112|NCT03609580|inability to urinate|inability to urinate
95113|NCT03609580|urinary retentions|urinary retentions
95114|NCT03609580|lung cancer|lung cancer
95115|NCT03609580|VATs|vats
95116|NCT03609580|Robotic Lung Surgery|robotic lung surgery
95117|NCT03609580|lung resections|lung resections
95118|NCT03609554|trunk flexor endurance|trunk flexor endurance
95119|NCT03609554|trunk extensor endurance|trunk extensor endurance
95120|NCT03609554|hamstring extensibility|hamstring extensibility
95121|NCT03609502|sleep|sleep
95122|NCT03609502|memory consolidation|memory consolidation
95123|NCT03609502|speech perception|speech perception
95124|NCT03609489|Biliary cancer|biliary cancer
95125|NCT03609489|adjuvant therapy|adjuvant therapy
95126|NCT03609489|apatinib|apatinib
95127|NCT03609489|capecitabine|capecitabine
95128|NCT03609463|diabetes|diabetes
95129|NCT03609463|overweight|overweight
95130|NCT03609463|obesity|obesity
95131|NCT03609463|well-being|well-being
95132|NCT03609463|behavioral|behavioral
95133|NCT03609463|small change|small change
95135|NCT03609437|Embolic stroke|embolic stroke
95136|NCT03609437|Arterial stiffness|arterial stiffness
95137|NCT03609437|Endothelial function|endothelial function
95138|NCT03609437|Endothelial glycocalyx|endothelial glycocalyx
95139|NCT03609437|Left ventricular function|left ventricular function
95140|NCT03609437|Oxidative stress|oxidative stress
95141|NCT03609385|stroke|stroke
95142|NCT03609385|troponin|troponin
95143|NCT03609385|acute coronary syndrome|acute coronary syndrome
95144|NCT03609385|culprit lesion|culprit lesion
95145|NCT03609372|HPV|hpv
95146|NCT03609372|Vaccination|vaccination
95147|NCT03609372|Practice Based Research|practice based research
95148|NCT03609359|lenvatinib, pembrolizumab, phase II, gastric cancer|lenvatinib, pembrolizumab, phase ii, gastric cancer
95149|NCT03609346|STEMI|stemi
95150|NCT03609320|HPV|hpv
95151|NCT03609320|Vaccination|vaccination
95152|NCT03609320|Practice Based Intervention|practice based intervention
95153|NCT03609294|Fimasartan|fimasartan
95154|NCT03609294|Linagliptin|linagliptin
95155|NCT03609268|Recurrent Hepatocellular Carcinoma|recurrent hepatocellular carcinoma
95156|NCT03609268|Microwave ablation|microwave ablation
95157|NCT03609268|Stereotactic body radiotherapy|stereotactic body radiotherapy
95158|NCT03609268|Small liver cancer|small liver cancer
95159|NCT03609242|HPV|hpv
95160|NCT03609242|Vaccination|vaccination
95161|NCT03609242|Practice Based Intervention|practice based intervention
95162|NCT03609177|Cancer Care|cancer care
95163|NCT03609164|arthroscopic surgery|arthroscopic surgery
95164|NCT03609164|massive rotator cuff repair|massive rotator cuff repair
95165|NCT03609164|single-row repair|single-row repair
95166|NCT03609164|suture-spanning augmentation|suture-spanning augmentation
95167|NCT03609151|Hepatocellular carcinoma|hepatocellular carcinoma
95168|NCT03609151|Early-stage liver cancer|early-stage liver cancer
95169|NCT03609151|Hepatectomy|hepatectomy
95170|NCT03609151|Stereotactic body radiotherapy|stereotactic body radiotherapy
95171|NCT03609125|cord blood|cord blood
95172|NCT03609125|neuroprotection|neuroprotection
95173|NCT03609125|growth factors|growth factors
95174|NCT03609073|endoscopy|endoscopy
95175|NCT03609073|mini invasive|mini invasive
95176|NCT03609060|Elderly patients|elderly patients
95177|NCT03609047|Breast cancer|breast cancer
95178|NCT03609047|elderly patients|elderly patients
95179|NCT03609047|CDK4/6 inhibitor|cdk4/6 inhibitor
95180|NCT03608995|preterm labor|preterm labor
95181|NCT03608995|biomarkers|biomarkers
95182|NCT03608995|Preterm delivery threat|preterm delivery threat
95183|NCT03608982|First aid|first aid
95184|NCT03608982|Simulated patient|simulated patient
95185|NCT03608982|Laypeople|laypeople
95186|NCT03608969|Cerebral palsy|cerebral palsy
95187|NCT03608969|Orofacial dysfunction|orofacial dysfunction
95188|NCT03608969|Oral Health|oral health
95189|NCT03608969|Quality of Life|quality of life
95190|NCT03608956|regional oximetry|regional oximetry
95191|NCT03608956|cerebral oximetry|cerebral oximetry
95192|NCT03608943|glucocorticoids|glucocorticoids
95193|NCT03608943|prednisolone|prednisolone
95194|NCT03608943|hydrocortisone|hydrocortisone
95195|NCT03608917|Vitiligo|vitiligo
95196|NCT03608917|Total Glucosides of Paeony(TGP)|total glucosides of paeony(tgp)
95197|NCT03608917|narrow-band ultraviolet B (NB-UVB)|narrow-band ultraviolet b (nb-uvb)
95198|NCT03608904|Stroke|stroke
95199|NCT03608904|Music|music
95200|NCT03608904|Ischemic Stroke|ischemic stroke
95201|NCT03608904|fMRI|fmri
95202|NCT03608904|functional MRI|functional mri
95203|NCT03608839|Diabetic macular edema|diabetic macular edema
95204|NCT03608839|Intravitreal dexamethasone solution|intravitreal dexamethasone solution
95205|NCT03608839|Short term treament|short term treament
95206|NCT03608813|Metabolomics|metabolomics
95207|NCT03608787|Alcohol Intoxication|alcohol intoxication
95208|NCT03608787|Alcohol Overservice|alcohol overservice
95209|NCT03608787|Prevention|prevention
95210|NCT03608787|Alcohol Serving Establishments|alcohol serving establishments
95211|NCT03608774|Azithromycin|azithromycin
95212|NCT03608774|Doxycycline|doxycycline
95213|NCT03608774|Efficacy|efficacy
95214|NCT03608774|MSM|msm
95215|NCT03608774|Phase 4|phase 4
95216|NCT03608774|Rectal Chlamydia|rectal chlamydia
95217|NCT03608761|dry eye|dry eye
95218|NCT03608761|Sjögren syndrome|sjögren syndrome
95219|NCT03608761|Rebamipida 2%|rebamipida 2%
95220|NCT03608761|autologous serum|autologous serum
95221|NCT03608748|Nafld Score|nafld score
95222|NCT03608748|Elastography|elastography
95223|NCT03608709|Accidental falls|accidental falls
95224|NCT03608709|Prediction model|prediction model
95225|NCT03608696|buprenorphine|buprenorphine
95226|NCT03608696|pharmacometrics|pharmacometrics
95227|NCT03608657|Psoriatic Arthritis|psoriatic arthritis
95228|NCT03608657|Canada|canada
95229|NCT03608657|CC-10004|cc-10004
95230|NCT03608657|Apremilast|apremilast
95231|NCT03608657|APPRAISE|appraise
95232|NCT03608657|Safety|safety
95233|NCT03608657|Non-interventional|non-interventional
95234|NCT03608657|Observation|observation
95235|NCT03608657|DMARDs|dmards
95236|NCT03608618|platinum resistant|platinum resistant
95237|NCT03608618|high grade serous adenocarcinoma|high grade serous adenocarcinoma
95238|NCT03608618|recurrence after chemotherapy|recurrence after chemotherapy
95239|NCT03608618|intraperitoneal|intraperitoneal
95240|NCT03608592|refractory acuter respiratory distress syndrome|refractory acuter respiratory distress syndrome
95241|NCT03608592|mesenchymal stem cells|mesenchymal stem cells
95242|NCT03608592|salvage therapy|salvage therapy
95243|NCT03608566|severe asthma|severe asthma
95245|NCT03608553|BBB|bbb
95246|NCT03608553|Blood Brain Barrier Disruption|blood brain barrier disruption
95247|NCT03608527|Upper limb motor rehabilitation|upper limb motor rehabilitation
95248|NCT03608527|Voluntary movements|voluntary movements
95249|NCT03608527|functional magnetic resonance imaging|functional magnetic resonance imaging
95250|NCT03608501|Drug therapy|drug therapy
95251|NCT03608488|balance|balance
95252|NCT03608488|vitamin D|vitamin d
95253|NCT03608488|exercise|exercise
95254|NCT03608488|fall risk|fall risk
95255|NCT03608462|first episode schizophrenia|first episode schizophrenia
95256|NCT03608462|rTMS|rtms
95257|NCT03608462|hippocampal neurogenesis|hippocampal neurogenesis
95258|NCT03608462|MRS|mrs
95259|NCT03608462|cognitive function|cognitive function
95260|NCT03608436|Quality of recovery|quality of recovery
95261|NCT03608436|Laparoscopic surgery|laparoscopic surgery
95262|NCT03608436|Deep neuromuscular block|deep neuromuscular block
95263|NCT03608436|Low pressure pneumoperitoneum|low pressure pneumoperitoneum
95264|NCT03608423|Intracerebral Hemorrhage|intracerebral hemorrhage
95265|NCT03608423|Surgical Procedures, Minimally Invasive|surgical procedures, minimally invasive
95266|NCT03608423|Surgical Procedures, Endoscopic|surgical procedures, endoscopic
95267|NCT03608410|Patient reported outcomes|patient reported outcomes
95268|NCT03608410|Internet|internet
95269|NCT03608410|TelePRO|telepro
95270|NCT03608397|DAXI|daxi
95271|NCT03608397|Cervical Dystonia|cervical dystonia
95272|NCT03608397|TWSTRS|twstrs
95273|NCT03608397|Toxin|toxin
95274|NCT03608358|DPP-4 inhibitor|dpp-4 inhibitor
95275|NCT03608358|HbA1c|hba1c
95276|NCT03608358|Incretin|incretin
95277|NCT03608358|Dapagliflozin|dapagliflozin
95278|NCT03608345|oral health|oral health
95279|NCT03608345|dental plaque|dental plaque
95280|NCT03608345|space maintenance|space maintenance
95281|NCT03608306|Clinical Performance|clinical performance
95282|NCT03608306|Bioactive Restorative Material|bioactive restorative material
95283|NCT03608306|Glass Hybrid Restorative|glass hybrid restorative
95284|NCT03608280|orbital reconstruction|orbital reconstruction
95285|NCT03608280|3D-printed patient specific porous titanium implant|3d-printed patient specific porous titanium implant
95286|NCT03608280|autologous bone graft|autologous bone graft
95287|NCT03608280|medico-economic study|medico-economic study
95288|NCT03608267|endoscopy|endoscopy
95289|NCT03608267|mini invasive|mini invasive
95290|NCT03608241|female|female
95291|NCT03608241|post-menopausal|post-menopausal
95292|NCT03608241|healthy|healthy
95293|NCT03608241|oral contraceptive|oral contraceptive
95294|NCT03608215|Dysmenorrhea|dysmenorrhea
95295|NCT03608215|Neuromodulation|neuromodulation
95296|NCT03608215|Transcranial direct current stimulation|transcranial direct current stimulation
95297|NCT03608215|Neuroplasticity|neuroplasticity
95298|NCT03608215|Neuroimaging|neuroimaging
95299|NCT03608202|Intensive Care|intensive care
95300|NCT03608202|Point-of-Care Ultrasound|point-of-care ultrasound
95301|NCT03608202|Thoracic Ultrasound|thoracic ultrasound
95302|NCT03608202|Diagnostic Techniques and procedures.|diagnostic techniques and procedures.
95303|NCT03608189|Osteoarthritis|osteoarthritis
95304|NCT03608189|ACL injury|acl injury
95305|NCT03608189|Knee trauma|knee trauma
95306|NCT03608189|Meniscus tear|meniscus tear
95307|NCT03608176|Obesity|obesity
95308|NCT03608176|Randomized Controlled Trial|randomized controlled trial
95309|NCT03608176|Lifestyle Intervention|lifestyle intervention
95310|NCT03608176|Plants|plants
95311|NCT03608176|Water|water
95312|NCT03608176|Weight loss|weight loss
95313|NCT03608176|Diet|diet
95314|NCT03608176|Overweight|overweight
95315|NCT03608163|diabetes|diabetes
95316|NCT03608163|hypoglycemia|hypoglycemia
95317|NCT03608163|diazoxide|diazoxide
95318|NCT03608163|naloxone|naloxone
95319|NCT03608163|healthy subjects|healthy subjects
95320|NCT03608163|low blood sugar|low blood sugar
95321|NCT03608137|Schizophrenia ; Cannabis|schizophrenia ; cannabis
95322|NCT03608098|Basketing|basketing
95323|NCT03608098|Dusting|dusting
95324|NCT03608098|Holmium Laser|holmium laser
95325|NCT03608098|Laser Lithotripsy|laser lithotripsy
95326|NCT03608098|Intracorporeal Lithotripsy|intracorporeal lithotripsy
95327|NCT03608098|Urolithiasis|urolithiasis
95328|NCT03608059|ATG|atg
95329|NCT03608059|PTCy|ptcy
95330|NCT03608059|haplo-PBSCT|haplo-pbsct
95331|NCT03608059|GVHD|gvhd
95332|NCT03608007|ROS1 NSCLC|ros1 nsclc
95333|NCT03608007|X-396|x-396
95334|NCT03607994|Neurotechnology|neurotechnology
95335|NCT03607994|Autonomic Dysregulation|autonomic dysregulation
95336|NCT03607994|Hyperarousal|hyperarousal
95343|NCT03607994|Sleep Deprivation|sleep deprivation
95344|NCT03607968|Pelvic organ prolapse|pelvic organ prolapse
95345|NCT03607968|Transvaginal mesh|transvaginal mesh
95346|NCT03607968|Urodynamic stress incontinence|urodynamic stress incontinence
95347|NCT03607929|ARE|are
95348|NCT03607929|deshydration|deshydration
95349|NCT03607929|adverse events|adverse events
95350|NCT03607929|cesarean|cesarean
95351|NCT03607929|fever|fever
95352|NCT03607916|Scheduled cesarean delivery,spinal anesthesia,local anesthesia|scheduled cesarean delivery,spinal anesthesia,local anesthesia
95353|NCT03607903|intradermal|intradermal
95354|NCT03607903|adalimumab|adalimumab
95355|NCT03607903|microneedle|microneedle
95356|NCT03607903|subcutaneous|subcutaneous
95357|NCT03607903|healthy volunteers|healthy volunteers
95358|NCT03607890|Relatlimab|relatlimab
95359|NCT03607890|Nivolumab|nivolumab
95360|NCT03607890|Immunotherapy|immunotherapy
95361|NCT03607890|Anti - PD-1|anti - pd-1
95362|NCT03607890|Anti - LAG-3|anti - lag-3
95363|NCT03607890|Antibodies|antibodies
95364|NCT03607890|MSI|msi
95365|NCT03607890|MMR deficient|mmr deficient
95366|NCT03607890|Microsatellite instability|microsatellite instability
95367|NCT03607877|Positive education|positive education
95368|NCT03607877|Walking exercise|walking exercise
95369|NCT03607877|Well-being|well-being
95370|NCT03607877|Pedometer|pedometer
95371|NCT03607877|Cardiovascular fitness|cardiovascular fitness
95372|NCT03607838|Lumbar disc herniation|lumbar disc herniation
95373|NCT03607838|Radiculopathy|radiculopathy
95374|NCT03607838|Sciatica|sciatica
95375|NCT03607838|Intradiscal injection|intradiscal injection
95376|NCT03607838|Chemonucleolysis|chemonucleolysis
95377|NCT03607825|aneurysmal|aneurysmal
95378|NCT03607812|Hypertension|hypertension
95379|NCT03607812|ABPM|abpm
95380|NCT03607799|South Asian|south asian
95381|NCT03607799|diet|diet
95382|NCT03607773|Multiple Sclerosis|multiple sclerosis
95383|NCT03607773|Mindfulness|mindfulness
95384|NCT03607747|Arterial Stiffness|arterial stiffness
95385|NCT03607747|Pulse Wave Velocity|pulse wave velocity
95386|NCT03607747|Peritoneal Dialysis|peritoneal dialysis
95387|NCT03607721|deep brain stimulation|deep brain stimulation
95388|NCT03607721|kinematics|kinematics
95389|NCT03607721|markerless|markerless
95390|NCT03607721|body motion evaluation|body motion evaluation
95391|NCT03607721|gait analysis|gait analysis
95396|NCT03607630|Imagery rescripting|imagery rescripting
95397|NCT03607630|case series|case series
95398|NCT03607630|ImRs|imrs
95399|NCT03607630|Psychosis|psychosis
95400|NCT03607617|social determinants of health|social determinants of health
95401|NCT03607617|community health clinic|community health clinic
95402|NCT03607617|primary care|primary care
95403|NCT03607617|electronic medical record|electronic medical record
95404|NCT03607604|MODY|mody
95405|NCT03607604|Diabetes Mellitus|diabetes mellitus
95406|NCT03607604|UCPCR|ucpcr
95407|NCT03607604|Monogenic Diabetes|monogenic diabetes
95408|NCT03607591|rTMS|rtms
95409|NCT03607591|Craving|craving
95410|NCT03607591|Mood and cognitive behavior|mood and cognitive behavior
95411|NCT03607591|Substance-Related Disorders|substance-related disorders
95412|NCT03607578|Prevention|prevention
95413|NCT03607552|Supplemental Screening|supplemental screening
95414|NCT03607552|Dense Breasts|dense breasts
95415|NCT03607552|Diffusion Weighted Imaging|diffusion weighted imaging
95416|NCT03607526|Vegetable Intake|vegetable intake
95417|NCT03607500|Caloric Intake Reduction|caloric intake reduction
95418|NCT03607500|Dietician|dietician
95419|NCT03607487|Hidradenitis suppurativa|hidradenitis suppurativa
95420|NCT03607487|Janus kinase (JAK) inhibitor|janus kinase (jak) inhibitor
95421|NCT03607487|skin disease|skin disease
95425|NCT03607383|statins|statins
95426|NCT03607383|red rice yeast|red rice yeast
95427|NCT03607383|adverse effects|adverse effects
95428|NCT03607383|cholesterol, LDL|cholesterol, ldl
95429|NCT03607383|treatment outcome|treatment outcome
95430|NCT03607383|tolerability|tolerability
95431|NCT03607370|Rectal cancer|rectal cancer
95432|NCT03607370|Chemoradiotherapy|chemoradiotherapy
95433|NCT03607370|Surgery|surgery
95434|NCT03607357|High Flow Nasal Oxygen|high flow nasal oxygen
95435|NCT03607357|Non-invasive Ventilation|non-invasive ventilation
95436|NCT03607357|Acute Left Heart Failure|acute left heart failure
95437|NCT03607344|Sacrocolpopexy|sacrocolpopexy
95438|NCT03607344|Day case surgery|day case surgery
95439|NCT03607344|Laparoscopic|laparoscopic
95441|NCT03607331|electro-acupuncture|electro-acupuncture
95442|NCT03607331|auricular concha|auricular concha
95443|NCT03607318|alcohol|alcohol
95444|NCT03607318|suicide|suicide
95445|NCT03607318|adolescents|adolescents
95446|NCT03607292|Sciatic Nerve Blocks|sciatic nerve blocks
95447|NCT03607292|Ankle surgery|ankle surgery
95448|NCT03607279|NGAL|ngal
95449|NCT03607279|Prostatectomy|prostatectomy
95450|NCT03607279|Acute kidney injury|acute kidney injury
95451|NCT03607266|ibuprofen ,|ibuprofen ,
95452|NCT03607266|Preemptive analgesia|preemptive analgesia
95453|NCT03607266|laparoscopic cholecystectomy|laparoscopic cholecystectomy
95454|NCT03607266|preemptive|preemptive
95455|NCT03607253|medial longitudinal arch|medial longitudinal arch
95456|NCT03607253|foot|foot
95457|NCT03607227|microsurgical free flaps|microsurgical free flaps
95458|NCT03607227|popliteal nerve block|popliteal nerve block
95459|NCT03607227|head and neck cancer|head and neck cancer
95460|NCT03607227|postoperative pain|postoperative pain
95461|NCT03607201|acute coronary syndrome|acute coronary syndrome
95462|NCT03607201|diabetes|diabetes
95463|NCT03607201|heart failure|heart failure
95464|NCT03607201|acute pulmonary edema|acute pulmonary edema
95465|NCT03607201|malignant arrhythmia|malignant arrhythmia
95466|NCT03607162|Bacteriemia|bacteriemia
95467|NCT03607162|meningitis|meningitis
95468|NCT03607162|Urinary tract infection|urinary tract infection
95469|NCT03607162|antibiotic treatment|antibiotic treatment
95470|NCT03607149|Pemetrexed|pemetrexed
95471|NCT03607149|Non-small cell lung cancer|non-small cell lung cancer
95472|NCT03607149|Clearance of creatine|clearance of creatine
95473|NCT03607136|early detection|early detection
95474|NCT03607136|health promotion|health promotion
95475|NCT03607136|community-dwelling|community-dwelling
95476|NCT03607136|elderly|elderly
95477|NCT03607097|secondary prevention|secondary prevention
95478|NCT03607097|pharmaceutical care|pharmaceutical care
95479|NCT03607097|drug related problems|drug related problems
95480|NCT03607097|emergency department|emergency department
95481|NCT03607084|school-aged children|school-aged children
95482|NCT03607084|school-based health program|school-based health program
95483|NCT03607084|Zambia|zambia
95484|NCT03607084|child and adolescent health|child and adolescent health
95485|NCT03607045|Boxer's Fracture|boxer's fracture
95486|NCT03607019|Intensive care|intensive care
95487|NCT03607019|Critical care|critical care
95488|NCT03607019|Poverty|poverty
95489|NCT03607019|inequalities|inequalities
95490|NCT03607006|Anterior maxillary region|anterior maxillary region
95491|NCT03607006|Patient specific|patient specific
95492|NCT03607006|Autogenous bone shell|autogenous bone shell
95493|NCT03607006|PEEK|peek
95494|NCT03607006|Ridge augmentation|ridge augmentation
95495|NCT03606993|Iron-deficiency|iron-deficiency
95496|NCT03606993|Iron Deficiency Anemia|iron deficiency anemia
95497|NCT03606941|electroacupuncture; delirium; the elderly; surgery, major|electroacupuncture; delirium; the elderly; surgery, major
95498|NCT03606915|pain|pain
95499|NCT03606902|Epidural, Fentanyl, Kidney, Continuous, nephrotoxic.|epidural, fentanyl, kidney, continuous, nephrotoxic.
95500|NCT03606850|cortical excitability|cortical excitability
95501|NCT03606850|marker of response|marker of response
95502|NCT03606837|Prostate Cancer|prostate cancer
95503|NCT03606837|68Ga-RM2|68ga-rm2
95504|NCT03606837|68Ga-Prostate Specific Membrane Antigen|68ga-prostate specific membrane antigen
95505|NCT03606837|PET/CT|pet/ct
95506|NCT03606837|Prostate cancer imaging|prostate cancer imaging
830812|NCT00113165|lamotrigine|lamotrigine
95507|NCT03606824|Thyroid Hormone Replacement|thyroid hormone replacement
95508|NCT03606824|Subclinical Hypothyroidism|subclinical hypothyroidism
95509|NCT03606824|Dyslipidemia|dyslipidemia
95510|NCT03606824|ASCVD|ascvd
95511|NCT03606824|Statin|statin
95512|NCT03606798|Frontotemporal Lobar Degeneration|frontotemporal lobar degeneration
95513|NCT03606798|Behavioral disorders|behavioral disorders
95514|NCT03606785|colorectal,blood, transfusion,haemorrhage,tranexamic acid.|colorectal,blood, transfusion,haemorrhage,tranexamic acid.
95515|NCT03606759|Addiction|addiction
95516|NCT03606759|High-risk relapse situation|high-risk relapse situation
95517|NCT03606759|Craving|craving
95518|NCT03606759|Individual cues|individual cues
95519|NCT03606759|Individually tailored treatment|individually tailored treatment
95520|NCT03606746|Kidney Transplant|kidney transplant
95521|NCT03606746|Kidney Failure|kidney failure
95522|NCT03606746|Anti-rejection therapy|anti-rejection therapy
95523|NCT03606746|Living Donor|living donor
95524|NCT03606746|HLA-matched|hla-matched
95525|NCT03606746|Hematopoietic Stem Cells (HSC)|hematopoietic stem cells (hsc)
95526|NCT03606746|CD34+|cd34+
95527|NCT03606746|CD3+|cd3+
95528|NCT03606746|T cells|t cells
95529|NCT03606746|Cellular Therapy|cellular therapy
95530|NCT03606746|Immunotherapy|immunotherapy
95531|NCT03606746|Immunosuppression|immunosuppression
95532|NCT03606720|Pelvic Girdle Pain|pelvic girdle pain
95533|NCT03606720|low level laser therapy|low level laser therapy
95534|NCT03606720|pelvic stabilization exercises|pelvic stabilization exercises
95535|NCT03606720|postpartum pain|postpartum pain
95536|NCT03606694|dihydromyricetin|dihydromyricetin
95540|NCT03606681|calcium hydroxide|calcium hydroxide
95541|NCT03606681|Dental Pulp Capping|dental pulp capping
95543|NCT03606655|tobacco|tobacco
95544|NCT03606655|cessation|cessation
95545|NCT03606655|cancer|cancer
95546|NCT03606655|nicotine|nicotine
95548|NCT03606655|metabolism|metabolism
95549|NCT03606655|carcinogen|carcinogen
95553|NCT03606616|ACOSOG Z0011|acosog z0011
95554|NCT03606616|Chinese breast cancer|chinese breast cancer
95555|NCT03606616|sentinel lymph node|sentinel lymph node
95556|NCT03606616|overall survival|overall survival
95557|NCT03606616|disease-free survival|disease-free survival
95558|NCT03606603|nutritional status|nutritional status
95559|NCT03606603|malnutrition|malnutrition
95560|NCT03606603|energy intake|energy intake
95561|NCT03606603|protein intake|protein intake
95562|NCT03606603|ICU|icu
95563|NCT03606603|surgical ward|surgical ward
95564|NCT03606603|hospital|hospital
95565|NCT03606603|enteral nutrition|enteral nutrition
95566|NCT03606603|parenteral nutrition|parenteral nutrition
95567|NCT03606603|nutrition|nutrition
95568|NCT03606590|Hepatocellular Carcinoma|hepatocellular carcinoma
95569|NCT03606590|Treatment|treatment
95570|NCT03606590|Minimal toxicity|minimal toxicity
95571|NCT03606590|TTFields|ttfields
95572|NCT03606590|Tumor Treating Fields|tumor treating fields
95573|NCT03606590|Novocure|novocure
95574|NCT03606590|Sorafenib|sorafenib
95575|NCT03606590|Nexavar|nexavar
95576|NCT03606577|Multiple Myeloma|multiple myeloma
95577|NCT03606577|Newly Diagnosed|newly diagnosed
95578|NCT03606577|High Risk|high risk
95579|NCT03606577|Revlimid|revlimid
95580|NCT03606577|Carfilzomib|carfilzomib
95581|NCT03606577|Daratumumab|daratumumab
95582|NCT03606577|Dexaméthasone|dexaméthasone
95583|NCT03606564|compliance|compliance
95584|NCT03606564|fasting guidelines|fasting guidelines
95585|NCT03606551|Self-ligating|self-ligating
95586|NCT03606551|Orthodontic|orthodontic
95587|NCT03606551|Esthetic|esthetic
95588|NCT03606538|MDMA|mdma
95589|NCT03606538|metabolism|metabolism
95590|NCT03606538|methylenedioxymethamphetamine|methylenedioxymethamphetamine
95591|NCT03606473|prenatal exposure|prenatal exposure
95592|NCT03606408|Cushing's syndrome|cushing's syndrome
95593|NCT03606408|osilodrostat|osilodrostat
95594|NCT03606408|LCI699|lci699
95595|NCT03606408|endogenous Cushing's syndrome|endogenous cushing's syndrome
95596|NCT03606369|Breast Neoplasm|breast neoplasm
95597|NCT03606369|Antiemetics|antiemetics
95598|NCT03606369|Quality of Life|quality of life
95599|NCT03606369|Palonosetron|palonosetron
95600|NCT03606369|Ondansetron|ondansetron
95601|NCT03606330|coronary artery disease|coronary artery disease
95602|NCT03606330|myocardial infarction|myocardial infarction
95603|NCT03606330|cardiac imaging techniques|cardiac imaging techniques
95604|NCT03606330|major adverse cardiovascular events|major adverse cardiovascular events
95605|NCT03606330|vulnerable coronary plaques|vulnerable coronary plaques
95606|NCT03606330|serum biomarkers|serum biomarkers
95607|NCT03606330|coronary shear stress|coronary shear stress
95608|NCT03606317|Lung and Pancreatic Cancer|lung and pancreatic cancer
95609|NCT03606304|self-care|self-care
95610|NCT03606304|quality of life|quality of life
95611|NCT03606291|isotoxic|isotoxic
95612|NCT03606291|hypofractionation|hypofractionation
95613|NCT03606291|Non-Small-Cell Lung|non-small-cell lung
95614|NCT03606278|Debriefing|debriefing
122847|NCT03435146|3HP|3hp
95615|NCT03606252|Pneumocystis jirovecii|pneumocystis jirovecii
95616|NCT03606252|Pneumonia|pneumonia
95617|NCT03606252|Specialized Proresolving Mediators|specialized proresolving mediators
95618|NCT03606252|Inflammation|inflammation
95619|NCT03606252|prognosis|prognosis
95620|NCT03606239|isotoxic|isotoxic
95621|NCT03606239|hypofractionated radiotherapy|hypofractionated radiotherapy
95622|NCT03606239|Non-Small-Cell Lung|non-small-cell lung
95623|NCT03606213|HIV Vaccine|hiv vaccine
95624|NCT03606213|Electroporation|electroporation
95625|NCT03606187|Back Pain, Spinal Cord Stimulation|back pain, spinal cord stimulation
95626|NCT03606174|MGCD516|mgcd516
95627|NCT03606174|Antineoplastic Agents|antineoplastic agents
95628|NCT03606174|Immunologic Factors|immunologic factors
95629|NCT03606174|Nivolumab|nivolumab
95630|NCT03606174|Tyrosine Kinase Inhibitor|tyrosine kinase inhibitor
95631|NCT03606174|VEGFR|vegfr
95632|NCT03606174|TAM RTKs|tam rtks
95633|NCT03606174|PD-1|pd-1
95634|NCT03606174|PD-L1|pd-l1
95635|NCT03606135|Pneumonia|pneumonia
95636|NCT03606135|Streptococcus pneumoniae|streptococcus pneumoniae
95637|NCT03606135|Incidence|incidence
95638|NCT03606135|Ethiology|ethiology
95639|NCT03606135|Serotype|serotype
95640|NCT03606122|Actinic keratosis on the upper extremities|actinic keratosis on the upper extremities
95641|NCT03606109|Tranexamic acid (TXA)|tranexamic acid (txa)
95642|NCT03606096|immune response|immune response
95643|NCT03606096|impact of acellular pertussis vaccination|impact of acellular pertussis vaccination
95644|NCT03606083|aorto-iliac|aorto-iliac
95645|NCT03606083|iliac|iliac
95646|NCT03606083|aneurysm|aneurysm
95647|NCT03606018|Pharmacokinetics|pharmacokinetics
95648|NCT03606018|Pharmacodynamics|pharmacodynamics
95649|NCT03606018|Insulin Lispro|insulin lispro
95650|NCT03606005|stem cell transplantation|stem cell transplantation
95651|NCT03606005|Pulmonary Functions|pulmonary functions
95652|NCT03606005|exercise capacity|exercise capacity
95653|NCT03606005|dyspnea|dyspnea
95654|NCT03606005|Quality of Life|quality of life
95655|NCT03606005|physical activity|physical activity
95656|NCT03605992|Rehabilitation|rehabilitation
95657|NCT03605992|Coronary artery disease|coronary artery disease
95658|NCT03605992|Home-based|home-based
95659|NCT03605992|Randomized Controlled Trial|randomized controlled trial
95660|NCT03605992|Protocol|protocol
95661|NCT03605979|type 1 diabetes|type 1 diabetes
95662|NCT03605979|hypoglycemia unawareness|hypoglycemia unawareness
95663|NCT03605979|Insulin pump|insulin pump
95664|NCT03605979|Continuous glucose monitoring systems|continuous glucose monitoring systems
95665|NCT03605979|Low glucose suspend|low glucose suspend
95666|NCT03605966|analgesia|analgesia
95667|NCT03605966|pain|pain
95668|NCT03605966|nociception|nociception
95669|NCT03605966|pupillometry|pupillometry
95670|NCT03605966|analgesic|analgesic
95671|NCT03605966|opioid|opioid
95672|NCT03605953|Cell therapy|cell therapy
95673|NCT03605953|immuno-modulation|immuno-modulation
95674|NCT03605953|immunotherapy|immunotherapy
95675|NCT03605953|Hematology|hematology
95676|NCT03605940|Acute-graft-versus-host Disease|acute-graft-versus-host disease
95677|NCT03605940|Extracorporal Photopheresis|extracorporal photopheresis
95679|NCT03605927|hematopoietic cell transplantation|hematopoietic cell transplantation
95680|NCT03605927|antibody therapy|antibody therapy
95681|NCT03605901|Post-operative pain|post-operative pain
95682|NCT03605901|Spine surgery|spine surgery
95683|NCT03605901|Methadone|methadone
95684|NCT03605901|Opioid|opioid
95685|NCT03605888|Nutrition|nutrition
95686|NCT03605862|Enterovirus|enterovirus
95687|NCT03605862|Rhinovirus|rhinovirus
95688|NCT03605849|Centanafadine|centanafadine
95689|NCT03605849|ADD|add
95690|NCT03605849|ADHD|adhd
95691|NCT03605836|Centanafadine|centanafadine
95692|NCT03605836|ADD|add
95693|NCT03605836|ADHD|adhd
95694|NCT03605823|Express Mini shunt; Pars plana; Vitrectomized eye|express mini shunt; pars plana; vitrectomized eye
95695|NCT03605810|Renal function, eGRF, Atrial fibrillation, Coronary artery disease, Type 2 diabetes mellitus, Machine learning, Prognostic modeling|renal function, egrf, atrial fibrillation, coronary artery disease, type 2 diabetes mellitus, machine learning, prognostic modeling
95696|NCT03605758|Ivermectin|ivermectin
95697|NCT03605758|S. stercoralis|s. stercoralis
95698|NCT03605758|parasite|parasite
95699|NCT03605758|helminth|helminth
95700|NCT03605758|Filariform|filariform
95701|NCT03605758|larvae|larvae
95702|NCT03605758|Baermann technique|baermann technique
95703|NCT03605745|BPH|bph
95704|NCT03605745|Minimally Invasive|minimally invasive
95705|NCT03605745|Water Vapor Therapy|water vapor therapy
95706|NCT03605745|Rezum|rezum
95707|NCT03605680|Centanafadine|centanafadine
95708|NCT03605680|ADHD|adhd
95709|NCT03605680|ADD|add
95710|NCT03605641|E-Cigarettes|e-cigarettes
95711|NCT03605641|Conventional Cigarettes|conventional cigarettes
95712|NCT03605641|JUUL|juul
95713|NCT03605641|VUSE|vuse
831040|NCT00112242|Vaccination|vaccination
122992|NCT03434314|SCI|sci
95714|NCT03605615|vaginal delivery|vaginal delivery
95715|NCT03605615|perineal tear|perineal tear
95716|NCT03605615|randomized controled trial|randomized controled trial
95717|NCT03605589|Blinatumomab|blinatumomab
95718|NCT03605589|Pembrolizumab|pembrolizumab
95719|NCT03605589|CD19 positive|cd19 positive
95720|NCT03605589|Relapsed|relapsed
95721|NCT03605589|Refractory|refractory
95722|NCT03605576|Fu's subcutaneous needle|fu's subcutaneous needle
95723|NCT03605576|Transcutaneous electrical nerve stimulation|transcutaneous electrical nerve stimulation
95724|NCT03605563|Fu's subcutaneous needling (FSN)|fu's subcutaneous needling (fsn)
95725|NCT03605563|Myofascial trigger point|myofascial trigger point
95726|NCT03605550|DIPG|dipg
95727|NCT03605550|High Grade Glioma|high grade glioma
95728|NCT03605524|Sensory training|sensory training
95729|NCT03605524|Depression|depression
95730|NCT03605524|Olfaction|olfaction
95731|NCT03605524|Emotion|emotion
95732|NCT03605524|Perception|perception
95733|NCT03605472|primary hyperparathyroidism|primary hyperparathyroidism
95734|NCT03605472|cervical ultrasound|cervical ultrasound
95735|NCT03605472|echoscintigraphy|echoscintigraphy
95736|NCT03605394|Maxillary sinus|maxillary sinus
95737|NCT03605394|sinus septa|sinus septa
95738|NCT03605394|sinus septum|sinus septum
95739|NCT03605394|CBCT|cbct
95740|NCT03605381|Stroke|stroke
95741|NCT03605381|PROMs|proms
95742|NCT03605381|Cohort|cohort
95743|NCT03605368|Intervention|intervention
95744|NCT03605368|Technology|technology
95745|NCT03605355|minor stroke|minor stroke
95746|NCT03605355|cost-effectiveness|cost-effectiveness
95747|NCT03605355|feasibility|feasibility
95748|NCT03605355|day clinic|day clinic
95749|NCT03605342|PTSD|ptsd
95750|NCT03605342|Opiate Use Disorder|opiate use disorder
95751|NCT03605329|Sleep Apnea, Obstructive|sleep apnea, obstructive
95752|NCT03605329|diabetes|diabetes
95753|NCT03605316|Deep brain stimulation|deep brain stimulation
95754|NCT03605316|obsessive-compulsive disorder|obsessive-compulsive disorder
95755|NCT03605316|neuromodulation|neuromodulation
95756|NCT03605316|psychiatry|psychiatry
95757|NCT03605316|quality of life|quality of life
95758|NCT03605290|total knee replacement|total knee replacement
95759|NCT03605290|gait analysis|gait analysis
95760|NCT03605290|PROMS|proms
95761|NCT03605290|mechanical aligment|mechanical aligment
95762|NCT03605290|kinematic alignment|kinematic alignment
95763|NCT03605277|ABL001|abl001
95764|NCT03605277|asciminib|asciminib
95765|NCT03605277|impaired renal function|impaired renal function
95766|NCT03605277|pharmacokinetics|pharmacokinetics
95767|NCT03605238|Neuromyelitis Optica Spectrum Disorder|neuromyelitis optica spectrum disorder
95768|NCT03605238|aquaporin4-IgG|aquaporin4-igg
95769|NCT03605238|CAR-T therapy|car-t therapy
95770|NCT03605225|Android application|android application
95771|NCT03605225|Anesthesia|anesthesia
95772|NCT03605225|intraoperative|intraoperative
95774|NCT03605212|FLO-02|flo-02
95775|NCT03605212|Hematological Malignancies|hematological malignancies
95776|NCT03605199|denosumab|denosumab
95777|NCT03605199|giant cell rich tumor of bone|giant cell rich tumor of bone
95778|NCT03605186|chamomile cryotherapy|chamomile cryotherapy
95779|NCT03605186|cryotherapy|cryotherapy
95780|NCT03605186|cancer|cancer
95781|NCT03605186|children|children
95782|NCT03605186|pediatric|pediatric
95783|NCT03605186|chemotherapy|chemotherapy
95784|NCT03605160|cataract surgery|cataract surgery
95785|NCT03605160|polish|polish
95786|NCT03605160|residual lens fibers|residual lens fibers
95787|NCT03605160|fluid-jet|fluid-jet
95788|NCT03605147|HMB|hmb
95789|NCT03605147|sarcopenia|sarcopenia
95790|NCT03605147|liver cirrhosis|liver cirrhosis
95791|NCT03605147|chronic liver disease|chronic liver disease
95792|NCT03605147|malnutrition|malnutrition
95793|NCT03605147|muscle wasting|muscle wasting
95794|NCT03605134|troponin|troponin
95795|NCT03605134|diastolic function|diastolic function
95796|NCT03605121|waist circumference|waist circumference
95797|NCT03605121|body mass index|body mass index
95798|NCT03605121|cardiac surgery|cardiac surgery
95799|NCT03605121|mortality|mortality
95800|NCT03605095|spreading vasodilation|spreading vasodilation
95801|NCT03605095|gingival microcirculation|gingival microcirculation
95802|NCT03605082|UCB0107|ucb0107
95803|NCT03605082|Phase 1|phase 1
95804|NCT03605069|Recessive Dystrophic Epidermolysis Bullosa|recessive dystrophic epidermolysis bullosa
95805|NCT03605069|EB|eb
95806|NCT03605069|COL7A1|col7a1
95807|NCT03605069|RNA Therapies|rna therapies
95808|NCT03605069|Antisense oligonucleotide|antisense oligonucleotide
95809|NCT03605069|Exon skipping|exon skipping
95810|NCT03605069|WINGS|wings
95811|NCT03605069|Topical treatment|topical treatment
95812|NCT03605069|RDEB|rdeb
95813|NCT03605069|Exon 73|exon 73
95814|NCT03605069|Mutations in exon 73|mutations in exon 73
95815|NCT03605043|Integrated|integrated
95816|NCT03605043|Care cascade|care cascade
95817|NCT03605043|Uganda|uganda
95818|NCT03605030|Cardiac Catheterization|cardiac catheterization
95819|NCT03605030|Percutaneous Coronary Intervention|percutaneous coronary intervention
95820|NCT03605030|Radiation|radiation
95821|NCT03605030|Lead Shielding|lead shielding
95822|NCT03605017|cognitive rehabilitation|cognitive rehabilitation
95823|NCT03605017|attention|attention
95824|NCT03605017|executive function|executive function
95825|NCT03605004|Genetic Testing|genetic testing
95826|NCT03605004|Variant of Uncertain Significance|variant of uncertain significance
95827|NCT03605004|Uncertainty|uncertainty
95828|NCT03605004|Qualitative|qualitative
95829|NCT03604952|chronic obstructive pulmonary disease|chronic obstructive pulmonary disease
95830|NCT03604952|Ramadan observance|ramadan observance
95831|NCT03604952|pulmonary variables|pulmonary variables
95832|NCT03604952|postural balance|postural balance
95833|NCT03604952|exercise performance|exercise performance
95834|NCT03604939|cardio-vascular disease|cardio-vascular disease
95835|NCT03604939|stroke cancer|stroke cancer
95836|NCT03604939|breast cancer|breast cancer
95837|NCT03604939|oral cancer|oral cancer
95838|NCT03604939|cervical cancer|cervical cancer
95839|NCT03604913|Valve sparing aortic root replacement|valve sparing aortic root replacement
95840|NCT03604861|Opioid recovery|opioid recovery
95841|NCT03604861|Recovery|recovery
95842|NCT03604861|Opioid-related disorders|opioid-related disorders
95843|NCT03604861|Substance-related disorders|substance-related disorders
95844|NCT03604861|Heroin dependence|heroin dependence
95845|NCT03604861|Opioid dependence|opioid dependence
95846|NCT03604861|Addiction|addiction
95847|NCT03604861|Buprenorphine|buprenorphine
95848|NCT03604861|Opiate substitution treatment|opiate substitution treatment
95849|NCT03604861|Analgesics|analgesics
95850|NCT03604861|Opioid|opioid
95851|NCT03604861|Narcotics|narcotics
95852|NCT03604861|Patient outcome assessment|patient outcome assessment
95853|NCT03604861|Patient-centered care|patient-centered care
95854|NCT03604861|Cost of illness|cost of illness
95855|NCT03604861|Employment|employment
95856|NCT03604861|Health-related quality-of-life|health-related quality-of-life
95857|NCT03604861|Family relations|family relations
95858|NCT03604861|Lifestyle|lifestyle
95859|NCT03604861|Citizenship|citizenship
95860|NCT03604848|Multidrug Resistant Tuberculosis|multidrug resistant tuberculosis
95861|NCT03604848|next generation sequencing|next generation sequencing
95862|NCT03604848|drug susceptibility test|drug susceptibility test
95863|NCT03604848|precision treatment|precision treatment
95864|NCT03604835|UX003|ux003
95865|NCT03604835|Mepsevii|mepsevii
95866|NCT03604835|vestronidase alfa-vjbk|vestronidase alfa-vjbk
95867|NCT03604835|vestronidase alfa|vestronidase alfa
95868|NCT03604835|recombinant human beta-glucuronidase|recombinant human beta-glucuronidase
95869|NCT03604822|Music Therapy|music therapy
95870|NCT03604822|Neurologic Music Therapy|neurologic music therapy
95871|NCT03604822|Rehabilitation|rehabilitation
95872|NCT03604822|Amyotrophic Lateral Sclerosis|amyotrophic lateral sclerosis
95873|NCT03604822|ALS|als
95874|NCT03604796|acetaminophen|acetaminophen
95875|NCT03604783|Tolero|tolero
95876|NCT03604783|Phase 1|phase 1
95877|NCT03604783|First in human|first in human
95878|NCT03604783|Advanced Malignancy|advanced malignancy
95879|NCT03604783|Cancer|cancer
95880|NCT03604783|Metastatic|metastatic
95881|NCT03604783|Progressive|progressive
95882|NCT03604770|Caloric Intake|caloric intake
95883|NCT03604770|Anti-mullerian hormone (AMH)|anti-mullerian hormone (amh)
95884|NCT03604770|Antral follicles (AFC)|antral follicles (afc)
95885|NCT03604770|Infertility|infertility
95886|NCT03604770|Fertility|fertility
95887|NCT03604770|Diet|diet
95888|NCT03604770|Ovarian Reserve|ovarian reserve
95889|NCT03604770|Obesity|obesity
95890|NCT03604770|Nutrition|nutrition
95891|NCT03604757|Prostate Cancer|prostate cancer
95892|NCT03604757|68Ga-RM2|68ga-rm2
95893|NCT03604757|bombesin|bombesin
95894|NCT03604757|GRP-R|grp-r
95895|NCT03604757|68Ga-Prostate Specific Membrane Antigen|68ga-prostate specific membrane antigen
95896|NCT03604757|PSMA|psma
95897|NCT03604757|PET/CT|pet/ct
95898|NCT03604731|Immunology, Suppression, Inflammation, Cardiac, Surgery|immunology, suppression, inflammation, cardiac, surgery
95899|NCT03604692|cGVHD|cgvhd
95900|NCT03604666|Breast Cancer|breast cancer
95901|NCT03604666|Skin cancer|skin cancer
95902|NCT03604666|Surgery|surgery
95903|NCT03604666|Ambulatory|ambulatory
95904|NCT03604653|HIPEC|hipec
95905|NCT03604653|Stomach cancer|stomach cancer
95906|NCT03604653|colorectal cancer|colorectal cancer
95907|NCT03604653|appendiceal cancer|appendiceal cancer
95908|NCT03604653|ovarian cancer|ovarian cancer
95909|NCT03604653|uterine cancer|uterine cancer
95910|NCT03604653|cervical cancer|cervical cancer
95911|NCT03604653|fallopian tube cancer|fallopian tube cancer
95912|NCT03604653|primary peritoneal carcinoma|primary peritoneal carcinoma
95913|NCT03604653|intraperitoneal chemotherapy|intraperitoneal chemotherapy
95914|NCT03604640|Functional impairment|functional impairment
831041|NCT00112242|Melanoma|melanoma
95915|NCT03604640|Hospital associated disability|hospital associated disability
95916|NCT03604614|peritoneal metastatis|peritoneal metastatis
95917|NCT03604614|Hyperthermic Intraperitoneal Chemotherapy|hyperthermic intraperitoneal chemotherapy
95918|NCT03604614|Advanced gastric adenocarcinoma|advanced gastric adenocarcinoma
95919|NCT03604601|salvage surgery|salvage surgery
95920|NCT03604601|recurrent laryngeal carcinoma|recurrent laryngeal carcinoma
95921|NCT03604601|experience|experience
95922|NCT03604575|Pharmacokinetics|pharmacokinetics
95923|NCT03604575|Pharmacodynamics|pharmacodynamics
95924|NCT03604575|Insulin Lispro|insulin lispro
95925|NCT03604536|Adherence|adherence
95926|NCT03604536|eHealth|ehealth
95927|NCT03604536|Aminosalicylate|aminosalicylate
95928|NCT03604458|Universal Health Coverage, Surgery in resource limited settings|universal health coverage, surgery in resource limited settings
95929|NCT03604406|Shingles|shingles
95930|NCT03604406|abatacept|abatacept
95931|NCT03604406|Varicella Zoster Vaccine|varicella zoster vaccine
95932|NCT03604393|Immunization|immunization
95933|NCT03604367|fMRI|fmri
95934|NCT03604367|BOLD Signal|bold signal
95935|NCT03604367|Rehabilitation|rehabilitation
95936|NCT03604354|osteoarthritis knee,pre-emptive analgesia,TKA,Opioids,gabapentinoids|osteoarthritis knee,pre-emptive analgesia,tka,opioids,gabapentinoids
95937|NCT03604341|Medical Abortion|medical abortion
95938|NCT03604341|Pain|pain
95939|NCT03604341|Cannabis|cannabis
95940|NCT03604302|Functional Magnetic Resonance Imaging (fMRI)|functional magnetic resonance imaging (fmri)
95941|NCT03604302|18-331|18-331
95942|NCT03604289|angiotensin-1-7|angiotensin-1-7
95943|NCT03604276|Headache|headache
96137|NCT03603028|Walking|walking
95944|NCT03604276|Subarachnoid hemorrhage|subarachnoid hemorrhage
95945|NCT03604276|Neuroinflammation|neuroinflammation
95946|NCT03604237|forceps biopsy|forceps biopsy
95947|NCT03604237|colorectal tumors|colorectal tumors
95948|NCT03604198|Cushing Syndrome|cushing syndrome
95949|NCT03604198|Cushing Disease|cushing disease
95950|NCT03604198|Cushing|cushing
95951|NCT03604198|Hypercortisolemia|hypercortisolemia
95952|NCT03604198|Cushingoid|cushingoid
95953|NCT03604198|Type 2 Diabetes|type 2 diabetes
95954|NCT03604198|Impaired Glucose Intolerance|impaired glucose intolerance
95955|NCT03604198|Hypertension|hypertension
95956|NCT03604198|Adrenal Corticotrophic Hormone (ACTH)|adrenal corticotrophic hormone (acth)
95957|NCT03604198|Adrenocortical Carcinoma|adrenocortical carcinoma
95958|NCT03604198|Primary Pigmented Nodular Adrenal Disease (PPNAD)|primary pigmented nodular adrenal disease (ppnad)
95959|NCT03604198|Moon Facies|moon facies
95960|NCT03604198|Dorsocervical Fat Pad|dorsocervical fat pad
95961|NCT03604198|Adrenal Adenoma|adrenal adenoma
95962|NCT03604198|Adrenal Carcinoma|adrenal carcinoma
95963|NCT03604198|Adrenal Autonomy|adrenal autonomy
95964|NCT03604198|Cortisol|cortisol
95965|NCT03604185|Hearing Loss|hearing loss
95966|NCT03604185|Auditory Processing|auditory processing
95967|NCT03604185|Aging|aging
95968|NCT03604185|Speech Perception in Noise (SIN)|speech perception in noise (sin)
95969|NCT03604185|Pitch Discrimination|pitch discrimination
95970|NCT03604185|Frequency Following Response (FFR)|frequency following response (ffr)
95971|NCT03604185|Choir Singing|choir singing
95972|NCT03604185|Musical Training|musical training
95973|NCT03604172|binge eating disorder|binge eating disorder
95974|NCT03604172|obesity|obesity
95975|NCT03604172|cognitive behavioral therapy|cognitive behavioral therapy
95976|NCT03604159|Opioid dependence|opioid dependence
95977|NCT03604159|Buprenorphine|buprenorphine
95978|NCT03604159|primary care treatment|primary care treatment
95979|NCT03604159|extended-release buprenorphine|extended-release buprenorphine
95980|NCT03604146|COPD|copd
95981|NCT03604146|Quality Control|quality control
95982|NCT03604120|Preoxygenation|preoxygenation
95983|NCT03604120|High flow nasal cannula|high flow nasal cannula
95984|NCT03604094|central venous catheter, pediatrics, ultrasound imaging|central venous catheter, pediatrics, ultrasound imaging
95985|NCT03604081|Constraint Induced Movement Therapy|constraint induced movement therapy
95986|NCT03604068|Caesarean section|caesarean section
95987|NCT03604055|Hamartoma, Cryotherapy|hamartoma, cryotherapy
95988|NCT03604029|ACS|acs
95989|NCT03604003|CKD, bedtime dosing, isolated nocturnal hypertension|ckd, bedtime dosing, isolated nocturnal hypertension
95990|NCT03603990|Edema|edema
95991|NCT03603990|Macular Edema|macular edema
95992|NCT03603990|Diabetic Retinopathy|diabetic retinopathy
95993|NCT03603990|Macular Degeneration|macular degeneration
95994|NCT03603990|Diabetic Angiopathies|diabetic angiopathies
95995|NCT03603990|Retinal Disease|retinal disease
95996|NCT03603990|Signs and Symptoms|signs and symptoms
95997|NCT03603990|Vitrectomy|vitrectomy
95998|NCT03603977|Simplified Therapy Regimen|simplified therapy regimen
95999|NCT03603977|Real World Study|real world study
96000|NCT03603977|HIV-1-infected patients|hiv-1-infected patients
96001|NCT03603964|Guadecitabine|guadecitabine
96002|NCT03603951|SHR2554|shr2554
96003|NCT03603951|EZH2 inhibitor|ezh2 inhibitor
96004|NCT03603951|phase 1|phase 1
96005|NCT03603951|mature lymphoid neoplasm|mature lymphoid neoplasm
96006|NCT03603938|potassium losartan, CKD, nondipping BP pattern|potassium losartan, ckd, nondipping bp pattern
96007|NCT03603925|Computed tomography|computed tomography
96008|NCT03603925|standardized update values|standardized update values
96009|NCT03603873|Anxiety|anxiety
96010|NCT03603873|Premedication|premedication
96011|NCT03603873|general anaesthetic|general anaesthetic
96012|NCT03603860|vital signs|vital signs
96013|NCT03603860|blood pressure|blood pressure
96014|NCT03603860|cardiac surgery|cardiac surgery
96015|NCT03603860|non-invasive monitoring|non-invasive monitoring
96016|NCT03603834|Neoadjuvant|neoadjuvant
96017|NCT03603834|Potentially resectable|potentially resectable
96018|NCT03603834|Chemotherapy|chemotherapy
96019|NCT03603834|Bile duct cancer|bile duct cancer
96020|NCT03603821|LUTS|luts
96021|NCT03603821|QUESTIONNAIRE|questionnaire
96022|NCT03603821|IPSS|ipss
96023|NCT03603743|exercise training|exercise training
96024|NCT03603743|chronic heart failure|chronic heart failure
96025|NCT03603743|parasympathetic|parasympathetic
96026|NCT03603743|autonomic nervous system|autonomic nervous system
96027|NCT03603743|cardiorespiratory fitness|cardiorespiratory fitness
96028|NCT03603743|cardiac rehabilitation|cardiac rehabilitation
96029|NCT03603730|Functional Dyspepsia|functional dyspepsia
96030|NCT03603730|Gastroparesis|gastroparesis
96031|NCT03603717|insomnia|insomnia
96032|NCT03603717|suicidal ideation|suicidal ideation
96033|NCT03603717|depression|depression
96034|NCT03603717|posttraumatic stress disorder|posttraumatic stress disorder
96035|NCT03603717|cognitive behavioral therapy for insomnia|cognitive behavioral therapy for insomnia
96036|NCT03603717|sleep|sleep
96037|NCT03603717|suicide|suicide
96038|NCT03603678|Obstructive sleep apnea|obstructive sleep apnea
96039|NCT03603678|Potassium channel blocker|potassium channel blocker
96040|NCT03603678|Polysomnography|polysomnography
96041|NCT03603678|PSG|psg
96042|NCT03603665|Botulism|botulism
96043|NCT03603665|Dose Escalation|dose escalation
96044|NCT03603665|Double-Blind|double-blind
96045|NCT03603665|NTM-1633|ntm-1633
96046|NCT03603665|Pharmacokinetics|pharmacokinetics
96047|NCT03603665|Phase I|phase i
96048|NCT03603665|Safety|safety
96049|NCT03603652|Lung Lesions; Soft Tissue- Lung|lung lesions; soft tissue- lung
96050|NCT03603639|E2730|e2730
96051|NCT03603639|Epilepsy|epilepsy
96052|NCT03603639|Photosensitive|photosensitive
96053|NCT03603639|Seizures|seizures
96054|NCT03603639|PPR|ppr
96055|NCT03603639|Anti-epileptic|anti-epileptic
96056|NCT03603626|Endoscopic ear surgery|endoscopic ear surgery
96057|NCT03603626|Myringoplasty|myringoplasty
96058|NCT03603626|Pregabalin|pregabalin
96059|NCT03603626|Preemptive analgesia|preemptive analgesia
96060|NCT03603587|biologic markers|biologic markers
96061|NCT03603587|skin cancer|skin cancer
96062|NCT03603587|solar aging of skin|solar aging of skin
96063|NCT03603587|alopecic scalp|alopecic scalp
96064|NCT03603574|Abdomen/surgery|abdomen/surgery
96065|NCT03603574|Thoracic Surgery|thoracic surgery
96066|NCT03603561|bipolar depression|bipolar depression
96067|NCT03603561|TMS|tms
96068|NCT03603561|transcranial magnetic stimulation|transcranial magnetic stimulation
96069|NCT03603561|add-on treatment|add-on treatment
96070|NCT03603535|Stress urinary incontinence|stress urinary incontinence
96071|NCT03603535|objective outcome|objective outcome
96072|NCT03603522|Cough|cough
96073|NCT03603522|Capsaicin|capsaicin
96074|NCT03603522|Probiotics|probiotics
96075|NCT03603522|TRPV1|trpv1
96076|NCT03603509|Fluad, MF59, Fluzone, HDFlu, Influenza, Vaccine|fluad, mf59, fluzone, hdflu, influenza, vaccine
96077|NCT03603496|Tobacco|tobacco
96078|NCT03603496|Cessation|cessation
96079|NCT03603496|Hospitalization|hospitalization
96080|NCT03603496|eReferral|ereferral
96081|NCT03603496|Interactive Voice Response|interactive voice response
96082|NCT03603496|Tobacco Quitline|tobacco quitline
96083|NCT03603483|patients- prosthesis mismatching|patients- prosthesis mismatching
96084|NCT03603457|Epidemiology|epidemiology
96085|NCT03603457|Prognostic factors|prognostic factors
96086|NCT03603457|Stratified medicine|stratified medicine
96087|NCT03603457|Quality of life|quality of life
96088|NCT03603457|Economic assessment|economic assessment
96089|NCT03603431|Healthy Volunteers|healthy volunteers
96090|NCT03603431|MicroRNAs|micrornas
96091|NCT03603431|Angiogenesis Inducing Agents|angiogenesis inducing agents
96092|NCT03603405|GBM, AA, Glioblastoma, Astrocytoma|gbm, aa, glioblastoma, astrocytoma
96093|NCT03603379|anti- EGFR- immunoliposomes|anti- egfr- immunoliposomes
96094|NCT03603288|respiratory function in DMD|respiratory function in dmd
96095|NCT03603249|platelet inhibition|platelet inhibition
96096|NCT03603249|platelet reactivity|platelet reactivity
96097|NCT03603249|clopidogrel|clopidogrel
96098|NCT03603249|trimetazidine|trimetazidine
96099|NCT03603210|Ischaemic heart disease|ischaemic heart disease
96100|NCT03603210|coronary angioplasty|coronary angioplasty
96101|NCT03603210|drug coated balloons (DCB)|drug coated balloons (dcb)
96102|NCT03603197|BP-C1|bp-c1
400586|NCT01866137|The Trier Social Stress Test (TSST)|the trier social stress test (tsst)
96103|NCT03603197|cis-coordinated complexes of platinum(II) with polymer of benzene polycarboxylic acids derived from lignin|cis-coordinated complexes of platinum(ii) with polymer of benzene polycarboxylic acids derived from lignin
96104|NCT03603197|Benzene polycarboxylic acids complex with cis-diammineplatinum(II)|benzene polycarboxylic acids complex with cis-diammineplatinum(ii)
96105|NCT03603197|Metastatic Breast Cancer|metastatic breast cancer
96106|NCT03603197|Platinum analogue|platinum analogue
96107|NCT03603197|Metronomic chemotherapy|metronomic chemotherapy
96108|NCT03603197|Breast cancer|breast cancer
96109|NCT03603197|Cisplatin|cisplatin
96110|NCT03603184|endometrial cancer|endometrial cancer
96111|NCT03603184|neoplasm|neoplasm
96112|NCT03603184|immunotherapy|immunotherapy
96113|NCT03603171|myotonic dystrophy type 2|myotonic dystrophy type 2
96114|NCT03603171|outcome scale|outcome scale
96115|NCT03603171|muscle strength|muscle strength
96116|NCT03603171|outcome measures|outcome measures
96117|NCT03603171|disease specific severity scale|disease specific severity scale
96118|NCT03603158|HERG|herg
96119|NCT03603158|KCNH2|kcnh2
96120|NCT03603158|METHADONE|methadone
96121|NCT03603158|OPIOID|opioid
96122|NCT03603119|Postoperative Nausea and Vomiting|postoperative nausea and vomiting
96123|NCT03603119|Dexamethasone|dexamethasone
96124|NCT03603119|Ondansetron|ondansetron
96125|NCT03603119|Midazolam|midazolam
96126|NCT03603119|Laparoscopy|laparoscopy
96127|NCT03603119|High risk|high risk
96128|NCT03603093|Esophagogastroduodenoscopy|esophagogastroduodenoscopy
96129|NCT03603093|Paediatric|paediatric
96130|NCT03603067|monophthalmos|monophthalmos
96131|NCT03603067|social psychology|social psychology
96132|NCT03603067|ocular surgery|ocular surgery
96133|NCT03603054|Neck pain|neck pain
96134|NCT03603054|Neural mobilization|neural mobilization
96135|NCT03603054|Myofascial trigger point|myofascial trigger point
96136|NCT03603054|Sciatic nerve|sciatic nerve
96138|NCT03603028|Exercise|exercise
96139|NCT03603028|Exergaming|exergaming
96140|NCT03603015|bladder|bladder
96141|NCT03603015|urinary tract|urinary tract
96142|NCT03603015|symptoms|symptoms
96143|NCT03603015|contractility|contractility
96144|NCT03603015|urodynamics|urodynamics
96145|NCT03603015|penile cuff test|penile cuff test
96146|NCT03602976|hepatic sarcoidosis|hepatic sarcoidosis
96147|NCT03602976|elevated alp|elevated alp
96148|NCT03602963|Diabetes Mellitus|diabetes mellitus
96149|NCT03602963|Child|child
96150|NCT03602963|Glucose sensor|glucose sensor
96151|NCT03602963|Accuracy|accuracy
96152|NCT03602963|Usability|usability
96153|NCT03602937|Acceptability|acceptability
96154|NCT03602937|Renal|renal
96155|NCT03602937|CKD|ckd
96156|NCT03602937|Kidney|kidney
96157|NCT03602937|Vitaflo|vitaflo
96158|NCT03602937|High energy, low volume|high energy, low volume
96159|NCT03602937|Low potassium|low potassium
96160|NCT03602937|Low phosphorus|low phosphorus
96161|NCT03602937|Low vitamin A|low vitamin a
96162|NCT03602924|levodopa infusion|levodopa infusion
96163|NCT03602885|Gastrointestinal Cancer|gastrointestinal cancer
96164|NCT03602885|cancer|cancer
96165|NCT03602885|palliative|palliative
96166|NCT03602885|chemotherapy|chemotherapy
96167|NCT03602885|metastatic|metastatic
96168|NCT03602885|colorectal|colorectal
96169|NCT03602885|pancreatic|pancreatic
96170|NCT03602885|communication|communication
96171|NCT03602885|informed consent|informed consent
96172|NCT03602885|video|video
96173|NCT03602885|education|education
96174|NCT03602885|oncology|oncology
96175|NCT03602885|patient-centered|patient-centered
96176|NCT03602885|outcomes research|outcomes research
96177|NCT03602872|Knee osteoarthritis, safety, MSCs|knee osteoarthritis, safety, mscs
96178|NCT03602859|FIRST|first
96179|NCT03602859|FIRST trial|first trial
96180|NCT03602859|Niraparib|niraparib
96181|NCT03602859|TSR-042|tsr-042
96182|NCT03602846|diabetes mellitus in pregnancy|diabetes mellitus in pregnancy
96183|NCT03602846|gestational diabetes|gestational diabetes
96184|NCT03602846|pregnancy outcomes|pregnancy outcomes
96185|NCT03602820|Leber congenital amaurosis, retinitis pigmentosa|leber congenital amaurosis, retinitis pigmentosa
96186|NCT03602781|PAH|pah
96187|NCT03602781|Inhaled Nitric Oxide|inhaled nitric oxide
96188|NCT03602781|iNO|ino
96189|NCT03602781|Long Term Oxygen Therapy|long term oxygen therapy
96190|NCT03602781|Oxygen therapy|oxygen therapy
96191|NCT03602768|Healthy aging|healthy aging
96192|NCT03602768|executive functions|executive functions
96193|NCT03602768|memory|memory
96194|NCT03602768|cognitive training|cognitive training
96195|NCT03602768|cognitive intervention|cognitive intervention
96196|NCT03602768|subjective cognitive impairment|subjective cognitive impairment
96197|NCT03602755|Transplant|transplant
96198|NCT03602755|Multiple Myeloma|multiple myeloma
96199|NCT03602755|Spain|spain
96200|NCT03602742|Atrial Fibrillation|atrial fibrillation
96201|NCT03602742|Arrhythmias, Cardiac|arrhythmias, cardiac
96202|NCT03602742|EZYPRO ECG Recorder|ezypro ecg recorder
96203|NCT03602742|ECG monitor|ecg monitor
96204|NCT03602742|Long term ECG monitor|long term ecg monitor
96205|NCT03602742|14-day ECG monitor|14-day ecg monitor
96206|NCT03602729|Breastfeeding|breastfeeding
96207|NCT03602729|Teaching|teaching
96208|NCT03602729|Intervention|intervention
96209|NCT03602729|NICU|nicu
96210|NCT03602716|schizophrenia|schizophrenia
96211|NCT03602716|HD-tDCS|hd-tdcs
96212|NCT03602716|negative symptoms|negative symptoms
96213|NCT03602703|Direct acting antiviral drugs immune responses|direct acting antiviral drugs immune responses
96214|NCT03602690|Third-line regimen|third-line regimen
96215|NCT03602690|Dolutegravir|dolutegravir
96216|NCT03602690|Darunavir|darunavir
96217|NCT03602690|Cambodia|cambodia
96218|NCT03602677|Colorectal surgery|colorectal surgery
96219|NCT03602677|Anastomosis|anastomosis
96220|NCT03602677|Anastomosis leak|anastomosis leak
96221|NCT03602677|Fluorescence imaging|fluorescence imaging
96222|NCT03602625|Premature birth; Risk factors|premature birth; risk factors
96223|NCT03602612|B-cell Maturation Antigen|b-cell maturation antigen
96224|NCT03602612|Immunotherapy|immunotherapy
96225|NCT03602612|Chimeric Antigen Receptors|chimeric antigen receptors
96226|NCT03602612|Adoptive T Cell Therapy|adoptive t cell therapy
96227|NCT03602599|Mouth|mouth
96228|NCT03602599|Alloimmunity|alloimmunity
96229|NCT03602599|Autoimmunity|autoimmunity
96230|NCT03602599|Salivary Gland|salivary gland
96231|NCT03602599|Ulcer|ulcer
96232|NCT03602573|Nonalcoholic steatohepatitis|nonalcoholic steatohepatitis
96233|NCT03602573|Liver fibrosis|liver fibrosis
96234|NCT03602573|Menopause|menopause
96235|NCT03602573|Hormone|hormone
96236|NCT03602560|PBC|pbc
96237|NCT03602560|Primary Biliary Cholangitis (PBC)|primary biliary cholangitis (pbc)
96238|NCT03602534|acne vulgaris|acne vulgaris
96239|NCT03602534|thyroid dysfunction|thyroid dysfunction
96240|NCT03602521|Psychiatry|psychiatry
96241|NCT03602521|Suicidal Behavior|suicidal behavior
96347|NCT03602001|weight loss|weight loss
96242|NCT03602521|Borderline Personality Disorder|borderline personality disorder
96243|NCT03602521|Interpersonal Relations|interpersonal relations
96244|NCT03602521|Social Stress|social stress
96245|NCT03602521|Oxytocin|oxytocin
96246|NCT03602521|Neuropeptide|neuropeptide
96247|NCT03602508|darifenacin|darifenacin
96248|NCT03602508|fesoterodine|fesoterodine
96249|NCT03602508|trospium|trospium
96250|NCT03602508|solifenacin|solifenacin
96251|NCT03602508|oxybutynin|oxybutynin
96252|NCT03602508|tolterodine|tolterodine
96253|NCT03602508|Betmiga|betmiga
96254|NCT03602508|YM178|ym178
96255|NCT03602508|mirabegron|mirabegron
96256|NCT03602508|Overactive bladder|overactive bladder
96257|NCT03602508|propiverine|propiverine
96258|NCT03602508|antimuscarinics|antimuscarinics
96259|NCT03602508|OAB|oab
96260|NCT03602508|imidafenacin|imidafenacin
96261|NCT03602482|postural tachycardia syndrome|postural tachycardia syndrome
96262|NCT03602482|cognition|cognition
96263|NCT03602443|Upper Extremity Hemiparesis|upper extremity hemiparesis
96264|NCT03602417|colorectal cancer|colorectal cancer
96265|NCT03602417|stent|stent
96266|NCT03602404|Iodine|iodine
96267|NCT03602378|Parents|parents
96268|NCT03602378|Quality of life|quality of life
96269|NCT03602378|Stress|stress
96270|NCT03602378|Children with developmental disability|children with developmental disability
96271|NCT03602378|Children with chronic disease|children with chronic disease
96272|NCT03602378|Cortisol|cortisol
96273|NCT03602378|Heart rate variability|heart rate variability
96274|NCT03602378|Advanced glycation end products|advanced glycation end products
96275|NCT03602378|Sleep quality|sleep quality
96276|NCT03602378|Family cohesion|family cohesion
96277|NCT03602378|Stigma|stigma
96278|NCT03602378|Resilience|resilience
96279|NCT03602378|Anxiety|anxiety
96280|NCT03602378|Depression|depression
96281|NCT03602378|Self Esteem|self esteem
96282|NCT03602365|Oxygen Consumption|oxygen consumption
96283|NCT03602365|Physical Activity|physical activity
96284|NCT03602365|Passive Motion|passive motion
96285|NCT03602352|Cohort|cohort
96286|NCT03602352|Surgery|surgery
96287|NCT03602352|Adhesive Small Bowel Obstruction|adhesive small bowel obstruction
96288|NCT03602352|Cost|cost
96289|NCT03602339|Gadolinium|gadolinium
96290|NCT03602339|Contrast enhancement|contrast enhancement
96291|NCT03602339|Central nervous system lesion|central nervous system lesion
96292|NCT03602326|Stroke|stroke
96293|NCT03602326|Early term|early term
96294|NCT03602326|Bobath|bobath
96295|NCT03602326|Neurodevelopmental treatment|neurodevelopmental treatment
96296|NCT03602326|Rehabilitation|rehabilitation
96297|NCT03602313|Body Weight Support|body weight support
96298|NCT03602287|anterior nasal pack|anterior nasal pack
96299|NCT03602287|nasal pack removal|nasal pack removal
96300|NCT03602287|2% lignocaine|2% lignocaine
96301|NCT03602274|Paracetamol|paracetamol
96302|NCT03602274|APAP|apap
96303|NCT03602274|malnutrition|malnutrition
96304|NCT03602274|biomarker|biomarker
96305|NCT03602274|liver toxicity|liver toxicity
96306|NCT03602274|NAPQI|napqi
96307|NCT03602222|LGBT mental health|lgbt mental health
96308|NCT03602222|provider training in LGBT-affirmative clinical practice|provider training in lgbt-affirmative clinical practice
96309|NCT03602209|implant-related infections|implant-related infections
96310|NCT03602209|orthopaedics|orthopaedics
96311|NCT03602209|implant removal|implant removal
96312|NCT03602209|antibiotic duration|antibiotic duration
96313|NCT03602209|outcome|outcome
96314|NCT03602183|difficult airway|difficult airway
96315|NCT03602183|endotracheal intubation|endotracheal intubation
96316|NCT03602183|chest compression|chest compression
96317|NCT03602183|physician|physician
96318|NCT03602170|High-Intensity Interval Training|high-intensity interval training
96319|NCT03602170|Exercise|exercise
96320|NCT03602170|Cardiovascular Health|cardiovascular health
96321|NCT03602170|Blood Pressure|blood pressure
96322|NCT03602157|CAR T cells|car t cells
96323|NCT03602157|CD30|cd30
96324|NCT03602157|CCR4|ccr4
96325|NCT03602157|Lymphoma|lymphoma
96326|NCT03602157|T lymphocytes|t lymphocytes
96327|NCT03602131|Chidamide|chidamide
96328|NCT03602131|autologous stem cell transplantation|autologous stem cell transplantation
96329|NCT03602118|clinical seizures,|clinical seizures,
96330|NCT03602105|exercise|exercise
96331|NCT03602105|prehabilitation|prehabilitation
96332|NCT03602105|arthritis|arthritis
96333|NCT03602105|quality of life|quality of life
96334|NCT03602105|osteoarthritis|osteoarthritis
96335|NCT03602105|rehabilitation|rehabilitation
96336|NCT03602053|diarrhea|diarrhea
96337|NCT03602053|Rotavirus|rotavirus
96338|NCT03602053|ROTAVAC|rotavac
96339|NCT03602053|Rotavirus vaccine|rotavirus vaccine
96340|NCT03602014|Hypotension|hypotension
96341|NCT03602014|Spinal Cord Injury|spinal cord injury
96342|NCT03602014|Droxidopa|droxidopa
96343|NCT03602014|Northera|northera
96344|NCT03602014|Neurogenic Orthostatic Hypotension|neurogenic orthostatic hypotension
96345|NCT03602001|attentive eating|attentive eating
96346|NCT03602001|e-health|e-health
96348|NCT03602001|food intake|food intake
96349|NCT03601988|gastric cancer|gastric cancer
96350|NCT03601988|radiotherapy|radiotherapy
96351|NCT03601988|postoperative|postoperative
96352|NCT03601962|Xerostomia|xerostomia
96353|NCT03601962|pH|ph
96354|NCT03601962|Saliva|saliva
96355|NCT03601962|Aqualief|aqualief
96356|NCT03601962|Carnosine|carnosine
96357|NCT03601962|hibiscus|hibiscus
96358|NCT03601962|oral health|oral health
96359|NCT03601949|Back Pain|back pain
96360|NCT03601949|Low Back Pain|low back pain
96361|NCT03601949|Sacroiliac Back Pain|sacroiliac back pain
96362|NCT03601923|Pancreatic Cancer|pancreatic cancer
96363|NCT03601897|rebastinib|rebastinib
96364|NCT03601897|paclitaxel|paclitaxel
96365|NCT03601897|breast cancer|breast cancer
96366|NCT03601897|ovarian cancer|ovarian cancer
96367|NCT03601897|endometrial cancer|endometrial cancer
96368|NCT03601884|Well-being|well-being
96369|NCT03601884|Self-efficacy|self-efficacy
96370|NCT03601884|Self-management|self-management
96371|NCT03601884|Psychosocial|psychosocial
96372|NCT03601884|Malaysia|malaysia
96373|NCT03601871|Thalidomide|thalidomide
96374|NCT03601871|Chemotherapy-induced Nausea and Vomiting|chemotherapy-induced nausea and vomiting
96375|NCT03601871|cisplatin|cisplatin
96376|NCT03601858|Attention deficit|attention deficit
96377|NCT03601858|hyperactivity disorder|hyperactivity disorder
96378|NCT03601858|Adult|adult
96379|NCT03601858|Epidemiology|epidemiology
96380|NCT03601858|Evolution|evolution
96381|NCT03601858|treatment|treatment
96382|NCT03601845|Magnetic resonance elastography|magnetic resonance elastography
96383|NCT03601845|Intrinsic activation|intrinsic activation
96384|NCT03601845|Liver disease|liver disease
96385|NCT03601845|Cerebral function|cerebral function
96386|NCT03601832|scar-related|scar-related
96387|NCT03601832|ventricular tachycardia|ventricular tachycardia
96388|NCT03601832|substrate ablation|substrate ablation
96389|NCT03601832|stereotactic radiosurgery|stereotactic radiosurgery
96390|NCT03601832|functional radiosurgery|functional radiosurgery
96391|NCT03601832|4D navigation|4d navigation
96392|NCT03601819|Relapsed|relapsed
96393|NCT03601819|Refractory|refractory
96394|NCT03601819|MyD88|myd88
96395|NCT03601819|JAK2|jak2
96396|NCT03601819|JAK3|jak3
96397|NCT03601819|TYK2|tyk2
96398|NCT03601819|IRAK1|irak1
96399|NCT03601819|CLL|cll
96400|NCT03601819|SMZL|smzl
96401|NCT03601819|LPL|lpl
96402|NCT03601819|WM|wm
96403|NCT03601819|MCL|mcl
96404|NCT03601819|CTCL|ctcl
96405|NCT03601819|PTCL|ptcl
96406|NCT03601767|sepsis|sepsis
96407|NCT03601767|score|score
96408|NCT03601728|elective|elective
96409|NCT03601715|Diathermy|diathermy
96410|NCT03601715|Short-Wave Therapy|short-wave therapy
96411|NCT03601715|Body temperature|body temperature
96412|NCT03601715|Skin Temperature|skin temperature
96413|NCT03601702|acute ischemic stroke|acute ischemic stroke
96414|NCT03601702|endovascular treatment|endovascular treatment
96415|NCT03601702|stent retriever device|stent retriever device
96416|NCT03601702|mechanical thrombectomy|mechanical thrombectomy
96417|NCT03601689|Low rectal cancer|low rectal cancer
96418|NCT03601689|Neoadjuvant treatment|neoadjuvant treatment
96419|NCT03601689|Complete pathological response|complete pathological response
96420|NCT03601689|ypT0N0|ypt0n0
96421|NCT03601689|disease free survival|disease free survival
96422|NCT03601689|Predictive factors|predictive factors
96423|NCT03601663|physical activity|physical activity
96424|NCT03601663|obesity|obesity
96425|NCT03601663|pilot study|pilot study
96426|NCT03601663|randomized controlled trial|randomized controlled trial
96427|NCT03601663|women|women
96428|NCT03601663|eHealth|ehealth
96429|NCT03601624|Multiple Myeloma|multiple myeloma
96430|NCT03601624|Relapse|relapse
96431|NCT03601624|Progression|progression
96432|NCT03601624|Pomalidomide|pomalidomide
96433|NCT03601559|gut-brain axis, cognitve demand battery, probiotics|gut-brain axis, cognitve demand battery, probiotics
96434|NCT03601494|Diabetic Neuropathies|diabetic neuropathies
96435|NCT03601494|Chronic pain|chronic pain
96436|NCT03601481|telemedicine|telemedicine
96437|NCT03601481|cardiac images|cardiac images
96438|NCT03601442|Acute Lymphoblastic Leukemia|acute lymphoblastic leukemia
96439|NCT03601442|ALL|all
96440|NCT03601442|Pediatric|pediatric
96441|NCT03601442|Diffuse Large b-cell Lymphoma|diffuse large b-cell lymphoma
96442|NCT03601442|DLBCL|dlbcl
96443|NCT03601442|Adult|adult
96444|NCT03601442|Relapse|relapse
96445|NCT03601442|Refractory|refractory
96446|NCT03601442|CTL019|ctl019
96447|NCT03601442|tisagenlecleucel|tisagenlecleucel
96448|NCT03601442|Kymriah|kymriah
96449|NCT03601442|CART19|cart19
96450|NCT03601442|CART|cart
96451|NCT03601442|CAR T cells|car t cells
96452|NCT03601442|Chimeric antigen receptor|chimeric antigen receptor
96453|NCT03601442|Manufacturing|manufacturing
96454|NCT03601442|Expanded Access|expanded access
96455|NCT03601442|Out of Specification|out of specification
96456|NCT03601416|human umbilical cord -derived mesenchymal stem cells|human umbilical cord -derived mesenchymal stem cells
96457|NCT03601416|moderate and severe bronchopulmonary dysplasia|moderate and severe bronchopulmonary dysplasia
96458|NCT03601403|Education|education
96459|NCT03601403|Dry Powder Inhalers|dry powder inhalers
96460|NCT03601403|Metered Dose Inhalers|metered dose inhalers
96461|NCT03601403|Pulmonary Disease|pulmonary disease
96462|NCT03601403|Chronic Obstructive|chronic obstructive
96463|NCT03601390|PET/CT|pet/ct
96464|NCT03601390|EBV DNA|ebv dna
96465|NCT03601390|predicting predicting|predicting predicting
96466|NCT03601377|attention bias|attention bias
96467|NCT03601377|treatment predictors|treatment predictors
96468|NCT03601364|peep, tidal volume, cardiopulmonary bypass, oxidative stress|peep, tidal volume, cardiopulmonary bypass, oxidative stress
96469|NCT03601351|CANCER, COLON, OPIOIDS, MOR-1|cancer, colon, opioids, mor-1
96470|NCT03601338|Unexplained stillbirth|unexplained stillbirth
96471|NCT03601338|Low molecular Weight Heparin|low molecular weight heparin
96472|NCT03601338|Umbilical artery|umbilical artery
96473|NCT03601338|Doppler Ultrasound|doppler ultrasound
96474|NCT03601338|Antenatal care|antenatal care
96475|NCT03601325|pancreatitis|pancreatitis
96476|NCT03601273|left gastric artery embolization|left gastric artery embolization
96477|NCT03601273|bariatric embolization|bariatric embolization
96478|NCT03601273|interventional radiology|interventional radiology
96479|NCT03601273|obesity|obesity
96480|NCT03601273|morbid obesity|morbid obesity
96481|NCT03601273|weight loss|weight loss
96482|NCT03601234|Gastric stromal tumors|gastric stromal tumors
96483|NCT03601195|Sonoelastography|sonoelastography
96484|NCT03601169|cognition|cognition
96485|NCT03601169|mood|mood
96486|NCT03601169|sleep|sleep
96487|NCT03601156|rectal cancer|rectal cancer
96488|NCT03601156|intraarterial chemoembolization|intraarterial chemoembolization
96489|NCT03601156|radiotherpy|radiotherpy
96490|NCT03601156|Oxaliplatin|oxaliplatin
96491|NCT03601156|Tegafur Gimeracil and Oteracil Porassium Capsule|tegafur gimeracil and oteracil porassium capsule
96492|NCT03601130|osteotomy|osteotomy
96493|NCT03601130|osteoarthritis|osteoarthritis
96494|NCT03601130|bone graft substitute|bone graft substitute
96495|NCT03601104|Eccentric Training|eccentric training
96496|NCT03601104|Resistance Training|resistance training
96497|NCT03601091|dexmedetomidine|dexmedetomidine
96498|NCT03601091|coronary artery bypass graft|coronary artery bypass graft
96499|NCT03601091|heart rate variability|heart rate variability
96500|NCT03601078|Multiple Myeloma|multiple myeloma
96501|NCT03601078|bb2121|bb2121
96502|NCT03601078|Relapsed and Refractory Multiple Myeloma|relapsed and refractory multiple myeloma
96503|NCT03601078|High Risk Multiple Myeloma|high risk multiple myeloma
96504|NCT03601052|Keloid|keloid
96505|NCT03601052|MicroRNAs|micrornas
96506|NCT03601052|Wound healing|wound healing
96507|NCT03601039|Absnow Absorbable Occluder|absnow absorbable occluder
96508|NCT03601039|ASD Occluder|asd occluder
831544|NCT00110331|ADHD|adhd
96509|NCT03601026|Severe mental illness|severe mental illness
96510|NCT03601026|Developmental psychopathology|developmental psychopathology
96511|NCT03601026|Trial-within-cohort|trial-within-cohort
96512|NCT03601026|Genetic counselling|genetic counselling
96513|NCT03601026|Cannabis use|cannabis use
96514|NCT03601026|Prevention|prevention
96515|NCT03601000|amnestic|amnestic
96516|NCT03600987|left middle cerebral artery|left middle cerebral artery
96517|NCT03600987|cerebrovascular accident (CVA)|cerebrovascular accident (cva)
96518|NCT03600987|stroke|stroke
96519|NCT03600935|Transcatheter Aortic Valve Replacement|transcatheter aortic valve replacement
96520|NCT03600922|Osteoarthritis|osteoarthritis
96521|NCT03600922|Patellar resurfacing|patellar resurfacing
96522|NCT03600922|Anterior knee pain|anterior knee pain
96523|NCT03600909|Blood Stem Cell Transplant|blood stem cell transplant
96524|NCT03600909|busulfan|busulfan
96525|NCT03600909|cyclophosphamide|cyclophosphamide
96526|NCT03600909|fludarabine|fludarabine
96527|NCT03600909|17-498|17-498
96528|NCT03600896|Umbilical Cord Blood Transplant|umbilical cord blood transplant
96529|NCT03600896|Recombinant human interleukin-7|recombinant human interleukin-7
96530|NCT03600896|CYT107|cyt107
96531|NCT03600896|T-Cell Recovery after Cord Blood Transplantation|t-cell recovery after cord blood transplantation
96532|NCT03600896|CBT|cbt
96533|NCT03600857|medical abortion|medical abortion
96534|NCT03600857|mifepristone|mifepristone
96535|NCT03600857|misoprostol|misoprostol
96536|NCT03600857|home use|home use
96537|NCT03600831|esophageal neoplasma|esophageal neoplasma
96538|NCT03600831|adjuvant therapy|adjuvant therapy
96539|NCT03600831|chemotherapy|chemotherapy
96540|NCT03600831|radiotherapy|radiotherapy
96541|NCT03600792|Agenesis of the corpus callosum|agenesis of the corpus callosum
96542|NCT03600792|whole exome sequencing|whole exome sequencing
96543|NCT03600792|prenatal diagnosis|prenatal diagnosis
96544|NCT03600740|Parkinson Disease|parkinson disease
96545|NCT03600740|Deep Brain Stimulation|deep brain stimulation
96546|NCT03600740|Diffusion Tensor Imaging|diffusion tensor imaging
96547|NCT03600714|Hepatitis D|hepatitis d
96548|NCT03600714|Hepatitis D Virus|hepatitis d virus
96549|NCT03600714|Cirrhosis|cirrhosis
96550|NCT03600675|Body composition|body composition
96551|NCT03600675|Abdominal fat|abdominal fat
96552|NCT03600675|Inflammatory cytokines|inflammatory cytokines
96553|NCT03600675|Bone markers|bone markers
96554|NCT03600675|Bone mineral density|bone mineral density
96555|NCT03600662|aortic stenosis|aortic stenosis
96556|NCT03600662|aortic regurgitation|aortic regurgitation
96557|NCT03600662|Trileaflet reconstruction of the aortic valve|trileaflet reconstruction of the aortic valve
96558|NCT03600662|Biological aortic valve prosthesis|biological aortic valve prosthesis
96559|NCT03600662|Effective orifice area|effective orifice area
96560|NCT03600623|advanced pancreatic cancer|advanced pancreatic cancer
96561|NCT03600623|inoperable pancreatic cancer|inoperable pancreatic cancer
96562|NCT03600623|Folfirinox|folfirinox
96563|NCT03600623|Gemcitabine-Abraxane|gemcitabine-abraxane
96564|NCT03600623|Gemcitabine-nab-Paclitaxel|gemcitabine-nab-paclitaxel
96565|NCT03600623|Stereotactic Body Radiotherapy|stereotactic body radiotherapy
96566|NCT03600571|Viscosupplementation|viscosupplementation
96567|NCT03600571|Hyaluronate|hyaluronate
96568|NCT03600571|Distribution|distribution
96569|NCT03600571|Knee osteoarthritis|knee osteoarthritis
96570|NCT03600571|Injection approach|injection approach
96572|NCT03600532|experimental pain|experimental pain
96573|NCT03600467|Androgen Receptor Positive|androgen receptor positive
96574|NCT03600467|Seviteronel|seviteronel
96575|NCT03600467|Advanced Cancers|advanced cancers
96576|NCT03600441|cancer|cancer
96577|NCT03600428|asthma|asthma
96578|NCT03600428|influenza vaccine|influenza vaccine
96579|NCT03600428|inactivated influenza vaccine|inactivated influenza vaccine
96580|NCT03600428|live attenuated influenza vaccine|live attenuated influenza vaccine
96581|NCT03600415|High Altitude|high altitude
96582|NCT03600415|arterial blood gas analysis|arterial blood gas analysis
96583|NCT03600415|near infrared spectroscopy|near infrared spectroscopy
96584|NCT03600402|ROM|rom
96585|NCT03600402|Manual Therapy|manual therapy
96586|NCT03600402|Mobilization|mobilization
96587|NCT03600402|Ankle|ankle
96588|NCT03600389|Patient Health Priorities|patient health priorities
96589|NCT03600389|Health Outcome Goals|health outcome goals
96590|NCT03600389|Healthcare Preferences|healthcare preferences
96591|NCT03600324|mild traumatic brain injury|mild traumatic brain injury
96592|NCT03600324|vestibular impairment|vestibular impairment
96593|NCT03600324|vestibular rehabilitation|vestibular rehabilitation
96594|NCT03600285|VIVIAN|vivian
96595|NCT03600272|Combined spinal-epidural analgesia|combined spinal-epidural analgesia
96596|NCT03600272|Epidural analgesia|epidural analgesia
96597|NCT03600272|Labor duration|labor duration
96598|NCT03600259|Myocardial Infarction|myocardial infarction
96599|NCT03600259|Coronary Disease|coronary disease
96600|NCT03600259|Coronary Artery Disease|coronary artery disease
96601|NCT03600259|Myocardial Ischemia|myocardial ischemia
96602|NCT03600233|Oncology|oncology
96603|NCT03600233|Neuroendocrine Tumors|neuroendocrine tumors
96604|NCT03600233|NET|net
96605|NCT03600233|Vasculogenic mimicry|vasculogenic mimicry
96606|NCT03600220|acupuncture, hypertension, elderly, home health care|acupuncture, hypertension, elderly, home health care
96607|NCT03600207|Low Back Pain|low back pain
96608|NCT03600207|Diaphragm|diaphragm
96609|NCT03600181|Preoxygenation|preoxygenation
96610|NCT03600181|Hypoxemia|hypoxemia
96611|NCT03600181|ICU|icu
96612|NCT03600181|ORI|ori
96613|NCT03600181|Orotracheal intubation|orotracheal intubation
96614|NCT03600142|Stigma|stigma
96615|NCT03600142|HIV|hiv
96616|NCT03600142|Counseling|counseling
96617|NCT03600142|Tanzania|tanzania
96618|NCT03600142|Pregnancy|pregnancy
96619|NCT03600142|Cognitive-behavioral therapy|cognitive-behavioral therapy
96620|NCT03600142|Retention in care|retention in care
96621|NCT03600142|Prevention of mother to child transmission|prevention of mother to child transmission
96622|NCT03600129|regional anesthesia|regional anesthesia
96623|NCT03600129|quadratus lumborum block|quadratus lumborum block
96624|NCT03600129|patient controlled anesthesia|patient controlled anesthesia
96625|NCT03600129|laparoscopic prostatectomy|laparoscopic prostatectomy
96626|NCT03600103|adolescent|adolescent
96627|NCT03600103|community health nursing|community health nursing
96628|NCT03600103|text messaging|text messaging
96629|NCT03600103|mobile health|mobile health
96630|NCT03600090|Breast Cancer|breast cancer
96631|NCT03600038|Smoking cessation|smoking cessation
96632|NCT03600038|App for quitting smoking|app for quitting smoking
96633|NCT03600038|Cancer|cancer
96634|NCT03600038|Oncology|oncology
96635|NCT03600012|Diplegic Cerebral Palsy|diplegic cerebral palsy
96636|NCT03600012|Cycling With Functional Electrical Stimulation|cycling with functional electrical stimulation
96637|NCT03600012|Gait Analysis|gait analysis
96638|NCT03600012|Functional Strenght Training|functional strenght training
96639|NCT03600012|Quality of Life|quality of life
96640|NCT03600012|Qxygen Consumption|qxygen consumption
96641|NCT03599986|RA|ra
96642|NCT03599973|Rehydration Solutions|rehydration solutions
96643|NCT03599947|colorectal cancer|colorectal cancer
96644|NCT03599947|early diagnosis|early diagnosis
96645|NCT03599947|5-hydroxymethylcytosine|5-hydroxymethylcytosine
96646|NCT03599934|Elderly|elderly
96647|NCT03599934|Exercise|exercise
96648|NCT03599934|Fall|fall
96649|NCT03599934|Home safety|home safety
96650|NCT03599921|Family-based Treatment|family-based treatment
96651|NCT03599921|Enhanced Cognitive Behavioral Therapy|enhanced cognitive behavioral therapy
96652|NCT03599921|Anorexia Nervosa|anorexia nervosa
96653|NCT03599921|Other Specified Feeding or Eating Disorder|other specified feeding or eating disorder
96654|NCT03599921|Bulimia Nervosa|bulimia nervosa
96655|NCT03599921|Unspecified Feeding or Eating Disorder|unspecified feeding or eating disorder
96656|NCT03599921|Avoidant/Restrictive Food Intake Disorder|avoidant/restrictive food intake disorder
96657|NCT03599921|Unified Protocol for the Transdiagnostic Treatment of Emotional Disorders in Children and Adolescents|unified protocol for the transdiagnostic treatment of emotional disorders in children and adolescents
96658|NCT03599908|IgE|ige
96659|NCT03599908|skin prick tests|skin prick tests
96660|NCT03599908|diagnosis|diagnosis
96661|NCT03599908|rhinitis|rhinitis
96662|NCT03599908|asthma|asthma
96663|NCT03599908|allergy|allergy
96664|NCT03599908|laboratory|laboratory
96665|NCT03599895|3D printing technology|3d printing technology
96666|NCT03599882|human immunodeficiency virus|human immunodeficiency virus
96667|NCT03599882|liver steatosis|liver steatosis
96668|NCT03599882|liver fibrosis|liver fibrosis
96669|NCT03599882|controlled attenuation parameter|controlled attenuation parameter
96670|NCT03599882|transient elastography|transient elastography
96671|NCT03599856|Checklist|checklist
96672|NCT03599856|Intensive Care Unit|intensive care unit
96673|NCT03599856|Clinical decision support systems|clinical decision support systems
96674|NCT03599856|Medical errors|medical errors
96675|NCT03599856|Patient safety|patient safety
96676|NCT03599830|Immunotherapy|immunotherapy
96677|NCT03599830|Cognition|cognition
96678|NCT03599830|Cancer|cancer
96679|NCT03599804|Vestibular|vestibular
96680|NCT03599804|Cochlear|cochlear
96681|NCT03599804|Implant|implant
96682|NCT03599804|Hearing|hearing
96683|NCT03599804|Child|child
96684|NCT03599791|Allergic Rhinitis|allergic rhinitis
96685|NCT03599791|hayfever|hayfever
96686|NCT03599791|rhinoconjunctivitis|rhinoconjunctivitis
96687|NCT03599791|azelastine|azelastine
96688|NCT03599791|fluticasone|fluticasone
96689|NCT03599791|nasal spray|nasal spray
96690|NCT03599791|seasonal|seasonal
96691|NCT03599791|perennial|perennial
96692|NCT03599791|TNSS|tnss
96693|NCT03599791|TOSS|toss
96694|NCT03599778|apatinib|apatinib
96695|NCT03599778|Gastric Carcinoma|gastric carcinoma
96696|NCT03599778|post-operative chemotherapy|post-operative chemotherapy
96697|NCT03599739|Influenza|influenza
96698|NCT03599739|Vaccine|vaccine
96699|NCT03599739|Vaccination|vaccination
96700|NCT03599739|Nursing Home|nursing home
96701|NCT03599739|Respiratory-Related Hospitalizations|respiratory-related hospitalizations
96702|NCT03599713|Metastatic merkel cell carcinoma|metastatic merkel cell carcinoma
96703|NCT03599713|anti-PD-1 antibody|anti-pd-1 antibody
96704|NCT03599713|immunoglobulin G4 (IgG4) monoclonal antibody|immunoglobulin g4 (igg4) monoclonal antibody
96705|NCT03599713|INCMGA00012|incmga00012
96706|NCT03599700|thrombosis|thrombosis
96707|NCT03599700|myeloproliferative neoplasms|myeloproliferative neoplasms
96708|NCT03599661|Cancer|cancer
96709|NCT03599661|Fertility|fertility
96710|NCT03599661|Preservation|preservation
96711|NCT03599648|intervention|intervention
96712|NCT03599648|behavioral parent training|behavioral parent training
96713|NCT03599648|mindfulness-based stress reduction|mindfulness-based stress reduction
96714|NCT03599583|HPV|hpv
96715|NCT03599583|Vaccination|vaccination
96716|NCT03599583|Practice based intervention|practice based intervention
96717|NCT03599570|HPV|hpv
96718|NCT03599570|Vaccination|vaccination
96719|NCT03599570|Practice based intervention|practice based intervention
96720|NCT03599557|HPV|hpv
96721|NCT03599557|Vaccination|vaccination
96722|NCT03599557|Practice based intervention|practice based intervention
96723|NCT03599544|Upper limb function|upper limb function
96724|NCT03599544|Arm and hand weakness|arm and hand weakness
96725|NCT03599505|intraoperative ultrasonographic localization|intraoperative ultrasonographic localization
96726|NCT03599505|pulmonary nodules|pulmonary nodules
96727|NCT03599505|video-assisted thoracoscopic surgery|video-assisted thoracoscopic surgery
96728|NCT03599492|Gut Microflora|gut microflora
96729|NCT03599492|Transjugular Intraheptic Portosystemic Shunting|transjugular intraheptic portosystemic shunting
96730|NCT03599479|Virtual reality|virtual reality
96731|NCT03599479|Acute pain|acute pain
96732|NCT03599479|Anxiety|anxiety
96733|NCT03599440|cardiac output|cardiac output
96734|NCT03599440|pulse contour analysis|pulse contour analysis
96735|NCT03599440|stroke volume|stroke volume
96736|NCT03599440|hemodynamic monitoring|hemodynamic monitoring
96737|NCT03599427|postoperative analgesia|postoperative analgesia
96738|NCT03599427|knee surgery|knee surgery
96739|NCT03599427|intravenous lidocaine|intravenous lidocaine
96740|NCT03599414|sarcoidosis|sarcoidosis
96741|NCT03599414|cardiac|cardiac
96742|NCT03599414|MRI|mri
96745|NCT03599414|cytokine|cytokine
96746|NCT03599375|Chimeric Antigen Receptor-Modified T Cells|chimeric antigen receptor-modified t cells
96747|NCT03599375|CART|cart
96748|NCT03599375|Recurrent B Cell Acute Lymphoblastic Leukemia|recurrent b cell acute lymphoblastic leukemia
96749|NCT03599375|refractory B Cell Acute Lymphoblastic Leukemia|refractory b cell acute lymphoblastic leukemia
96750|NCT03599375|ALL|all
96751|NCT03599310|Advance care planning|advance care planning
96752|NCT03599310|Communication|communication
96753|NCT03599310|Nurse|nurse
96754|NCT03599310|End-of-life|end-of-life
96755|NCT03599232|formative assessment|formative assessment
96756|NCT03599232|objective structured clinical examination (OSCE)|objective structured clinical examination (osce)
96757|NCT03599232|Iraq|iraq
96758|NCT03599232|impact|impact
96759|NCT03599232|feedback|feedback
96760|NCT03599219|platelets|platelets
96761|NCT03599219|bleeding|bleeding
96762|NCT03599206|genetic: CXCR3 polymorphism rs2280964|genetic: cxcr3 polymorphism rs2280964
96763|NCT03599180|Knee Osteoarthritis|knee osteoarthritis
96764|NCT03599180|Sensitized Acupoints|sensitized acupoints
96765|NCT03599180|Microdialysis|microdialysis
96766|NCT03599180|High performance liquid chromatography（HPLC）|high performance liquid chromatography（hplc）
96767|NCT03599167|red blood cell transfusion|red blood cell transfusion
96768|NCT03599167|preterm infant|preterm infant
96769|NCT03599167|HAS guideline|has guideline
96770|NCT03599167|transfusion guidelines|transfusion guidelines
96771|NCT03599167|kappa agreement test application|kappa agreement test application
96772|NCT03599154|Gemcitabine|gemcitabine
96775|NCT03599115|inhibitory control training|inhibitory control training
96776|NCT03599115|food|food
96777|NCT03599115|event-related potentials|event-related potentials
96778|NCT03599115|weight reduction|weight reduction
96779|NCT03599037|ICOUGH Recovery App|icough recovery app
96780|NCT03599037|Length of stay|length of stay
96781|NCT03599037|Care coach|care coach
96782|NCT03599037|Incentive spirometry|incentive spirometry
96783|NCT03599037|Coughing|coughing
96784|NCT03599037|Post operative ambulation|post operative ambulation
96785|NCT03599037|Deep breathing|deep breathing
96786|NCT03599037|Smartphone|smartphone
96787|NCT03599024|patient-controlled analgesia|patient-controlled analgesia
96788|NCT03599024|epidural analgesia|epidural analgesia
96789|NCT03599024|analgesics|analgesics
96790|NCT03599024|drug consumption|drug consumption
96791|NCT03599024|total hip replacement|total hip replacement
96792|NCT03599024|pain relief|pain relief
96793|NCT03598985|Balance|balance
96794|NCT03598985|Smartphone|smartphone
96795|NCT03598985|Validity|validity
96796|NCT03598985|Reliability|reliability
96797|NCT03598985|chronic ankle instability|chronic ankle instability
96798|NCT03598933|Upper Esophageal Sphincter|upper esophageal sphincter
96799|NCT03598933|botulinum toxin|botulinum toxin
96800|NCT03598933|Cricopharyngeal dysfunction|cricopharyngeal dysfunction
96801|NCT03598933|Cricopharyngeal botulinum toxin injection|cricopharyngeal botulinum toxin injection
96802|NCT03598920|obesity|obesity
96803|NCT03598920|bariatric medicine|bariatric medicine
96804|NCT03598920|endoscopy treatment|endoscopy treatment
96805|NCT03598920|body composition|body composition
96806|NCT03598920|Adipokines|adipokines
96807|NCT03598920|Ghrelin|ghrelin
96808|NCT03598920|Quality of Life|quality of life
96809|NCT03598920|nutrition status|nutrition status
96810|NCT03598920|vitamins|vitamins
96811|NCT03598907|point of care|point of care
96812|NCT03598907|coagulopathy|coagulopathy
96813|NCT03598907|lung transplantation|lung transplantation
96814|NCT03598907|primary graft dysfunction|primary graft dysfunction
96815|NCT03598868|Bipolar Disorder|bipolar disorder
96816|NCT03598868|Depression, Bipolar|depression, bipolar
96817|NCT03598868|vortioxetine|vortioxetine
96818|NCT03598842|blood signature of Tb risk|blood signature of tb risk
96819|NCT03598842|anti Mtb immunity|anti mtb immunity
96820|NCT03598842|RNA biomarkers|rna biomarkers
96821|NCT03598842|RePORT Study|report study
96822|NCT03598842|India|india
96823|NCT03598790|Bimekizumab|bimekizumab
96824|NCT03598790|PSO|pso
96825|NCT03598790|Psoriasis|psoriasis
96826|NCT03598738|Esomeprazole|esomeprazole
96827|NCT03598738|Gastrin|gastrin
96828|NCT03598738|HbA1c|hba1c
96829|NCT03598738|Glycaemic Regulation|glycaemic regulation
96830|NCT03598686|HIV|hiv
96831|NCT03598686|HIV/AIDS|hiv/aids
96832|NCT03598686|self-testing|self-testing
96833|NCT03598686|HIVST|hivst
96834|NCT03598686|home-based|home-based
96835|NCT03598686|community-based|community-based
96836|NCT03598686|lesotho|lesotho
96837|NCT03598686|oraquick|oraquick
96838|NCT03598686|testing coverage|testing coverage
96839|NCT03598686|htc campaign|htc campaign
96840|NCT03598660|Breast cancer, SORCIN, Annexin A3|breast cancer, sorcin, annexin a3
96841|NCT03598647|exercise|exercise
96842|NCT03598647|physical activity|physical activity
96843|NCT03598647|obesity|obesity
96844|NCT03598647|weight loss|weight loss
96845|NCT03598634|cross-linking|cross-linking
96846|NCT03598608|programmed cell death 1 (PD-1, PD1)|programmed cell death 1 (pd-1, pd1)
96847|NCT03598608|programmed cell death ligand 1 (PD-L1, PDL1)|programmed cell death ligand 1 (pd-l1, pdl1)
96848|NCT03598608|programmed cell death ligand 2 (PD-L2, PDL2)|programmed cell death ligand 2 (pd-l2, pdl2)
96849|NCT03598582|myelodysplastic syndromes|myelodysplastic syndromes
96850|NCT03598582|erythropoiesis stimulating agents|erythropoiesis stimulating agents
96851|NCT03598582|factors of response|factors of response
96852|NCT03598556|China|china
96853|NCT03598556|Anti-retroviral Therapy|anti-retroviral therapy
96854|NCT03598556|Vitamin D|vitamin d
96855|NCT03598556|Tenofovir|tenofovir
96856|NCT03598556|Efavirenz|efavirenz
96857|NCT03598556|Lamivudine|lamivudine
96858|NCT03598530|Fracture fixation|fracture fixation
96859|NCT03598530|Surgical treatment|surgical treatment
96860|NCT03598530|Fracture reduction|fracture reduction
96861|NCT03598504|SCI|sci
96862|NCT03598504|Spasms|spasms
96863|NCT03598504|Vibration|vibration
96864|NCT03598465|Post-hepatectomy liver failure|post-hepatectomy liver failure
96865|NCT03598465|Sphingolipids metabolism|sphingolipids metabolism
96866|NCT03598452|Cytomegalovirus retinopathy|cytomegalovirus retinopathy
96867|NCT03598452|High-dose|high-dose
96868|NCT03598452|Ganciclovir|ganciclovir
96869|NCT03598452|Intravitreal injection|intravitreal injection
96870|NCT03598439|influenza vaccine|influenza vaccine
96871|NCT03598439|adults|adults
96872|NCT03598439|Immune response|immune response
96873|NCT03598413|enhanced recovery|enhanced recovery
96874|NCT03598413|perioperative nutrition|perioperative nutrition
96875|NCT03598413|macrophages|macrophages
96876|NCT03598413|omega 3 fatty acids|omega 3 fatty acids
96877|NCT03598387|acute kidney injury|acute kidney injury
96878|NCT03598387|automated peritoneal dialysis|automated peritoneal dialysis
96879|NCT03598387|intermittent hemodialysis|intermittent hemodialysis
96880|NCT03598387|renal recovery|renal recovery
96881|NCT03598374|Inositol|inositol
96882|NCT03598374|Polycystic ovarian syndrome|polycystic ovarian syndrome
96883|NCT03598374|Fertility|fertility
96884|NCT03598374|Clinical pregnancy rate|clinical pregnancy rate
96885|NCT03598374|Miscarriage rate|miscarriage rate
96886|NCT03598374|Live birth rate|live birth rate
96887|NCT03598361|pregnancy outcomes, minerals|pregnancy outcomes, minerals
96888|NCT03598348|advanced gastric cancer, apatinib, capecitabine, maintenance|advanced gastric cancer, apatinib, capecitabine, maintenance
96889|NCT03598309|Lung RADS 3|lung rads 3
96890|NCT03598309|Lung nodule|lung nodule
96891|NCT03598309|Lung cancer risk|lung cancer risk
96892|NCT03598309|Chemoprevention|chemoprevention
96893|NCT03598296|ERAS(Enhanced Recovery After Surgery)|eras(enhanced recovery after surgery)
96894|NCT03598296|Video-assisted thoracoscope lobectomy|video-assisted thoracoscope lobectomy
96895|NCT03598296|Non-Small Cell Lung Cancer (NSCLC)|non-small cell lung cancer (nsclc)
96896|NCT03598296|Chest tube|chest tube
96897|NCT03598270|Ovarian|ovarian
96898|NCT03598270|Atezolizumab|atezolizumab
96899|NCT03598270|Niraparib|niraparib
96900|NCT03598257|Inflammatory breast cancer|inflammatory breast cancer
96901|NCT03598257|Olaparib|olaparib
96902|NCT03598257|Radiation therapy|radiation therapy
96903|NCT03598218|Hypofractionated Radiation|hypofractionated radiation
96904|NCT03598218|initial distant metastases|initial distant metastases
96905|NCT03598218|nasopharyngeal carcinoma|nasopharyngeal carcinoma
96906|NCT03598205|Therapy for diabetic macular edema|therapy for diabetic macular edema
96907|NCT03598205|Curcumin formulation (DIABEC)|curcumin formulation (diabec)
96908|NCT03598192|Hepatectomy|hepatectomy
96909|NCT03598192|Transversus abdominis plane block (TAP block)|transversus abdominis plane block (tap block)
96910|NCT03598192|Paravertebral block|paravertebral block
96911|NCT03598192|Postoperative analgesia|postoperative analgesia
96912|NCT03598192|Liver resection|liver resection
96913|NCT03598166|colorectal cancer screening|colorectal cancer screening
96914|NCT03598166|septin 9|septin 9
96915|NCT03598153|Waist and knee pain|waist and knee pain
96916|NCT03598153|sciatica|sciatica
96917|NCT03598140|Sildenafil|sildenafil
96918|NCT03598140|Concussion|concussion
96919|NCT03598140|CBF|cbf
96920|NCT03598140|CVR|cvr
96921|NCT03598127|Vitamin A|vitamin a
96922|NCT03598127|status|status
96923|NCT03598127|sepsis|sepsis
96924|NCT03598127|illness severity|illness severity
96925|NCT03598049|Implants|implants
96926|NCT03598049|Stability|stability
96927|NCT03598049|Bone loss|bone loss
96928|NCT03598049|Success|success
96929|NCT03598036|calcineurin inhibitors|calcineurin inhibitors
96930|NCT03598036|Focal Segmental Glomerulosclerosis|focal segmental glomerulosclerosis
96931|NCT03598023|ACell|acell
96932|NCT03598023|Hand|hand
96933|NCT03598023|Burn|burn
96934|NCT03598023|ACell Cytal Burn Matrix®|acell cytal burn matrix®
96935|NCT03598023|Extracellular Matrix|extracellular matrix
96936|NCT03598023|Urinary Bladder Matrix|urinary bladder matrix
96937|NCT03598023|Wound|wound
96938|NCT03598023|Partial-Thickness|partial-thickness
96939|NCT03598023|Burn Management|burn management
96940|NCT03597997|Postoperative pain|postoperative pain
96941|NCT03597997|Total intravenous anaesthesia|total intravenous anaesthesia
96942|NCT03597997|TIVA|tiva
96943|NCT03597997|Propofol|propofol
96944|NCT03597997|Hepatectomy|hepatectomy
96945|NCT03597958|Familial Hypercholesterolemia|familial hypercholesterolemia
96946|NCT03597958|Hypercholesterolemia|hypercholesterolemia
96947|NCT03597958|Cascade Screening|cascade screening
96948|NCT03597958|Novel FH Genes|novel fh genes
96949|NCT03597958|Novel FH Mutations|novel fh mutations
96950|NCT03597958|Next generation sequencing|next generation sequencing
96951|NCT03597945|Magnesium sulfate|magnesium sulfate
96952|NCT03597945|lidocaine|lidocaine
96953|NCT03597945|femoral nerve block|femoral nerve block
96954|NCT03597945|prehospital|prehospital
96955|NCT03597945|pain|pain
96956|NCT03597932|major surgery|major surgery
96957|NCT03597932|ansethesia care|ansethesia care
96958|NCT03597932|postoperative complication|postoperative complication
96959|NCT03597932|handover checklist|handover checklist
96960|NCT03597932|anesthesiologist burnout|anesthesiologist burnout
96961|NCT03597919|Inactivated Poliovirus Vaccine|inactivated poliovirus vaccine
96962|NCT03597919|Sabin strain|sabin strain
96963|NCT03597906|Topography guided ablation|topography guided ablation
96964|NCT03597906|Astigmatism|astigmatism
96965|NCT03597906|LASIK|lasik
96966|NCT03597893|intranasal oxytocin|intranasal oxytocin
96967|NCT03597893|stress|stress
96968|NCT03597893|belief updating|belief updating
96969|NCT03597880|difficult airway, obese patient,|difficult airway, obese patient,
96970|NCT03597867|vitreoretinal surgery|vitreoretinal surgery
96971|NCT03597867|epiretinal membrane|epiretinal membrane
96972|NCT03597867|macular hole|macular hole
96973|NCT03597867|non steroidal antinflammatory drugs|non steroidal antinflammatory drugs
96974|NCT03597867|prostaglandin E2|prostaglandin e2
96975|NCT03597854|Acute kidney disease|acute kidney disease
96976|NCT03597854|critically ill|critically ill
96977|NCT03597841|Monotherapy|monotherapy
96978|NCT03597841|Combination therapy|combination therapy
96979|NCT03597841|Colistin-resistant|colistin-resistant
96980|NCT03597841|Klebsiella Pneumonia|klebsiella pneumonia
96981|NCT03597841|Bacteremia|bacteremia
96982|NCT03597841|Blood stream infection|blood stream infection
96983|NCT03597828|Monitored Anesthesia Care|monitored anesthesia care
96984|NCT03597828|Pleuroscopy|pleuroscopy
96985|NCT03597828|dexmedetomidine|dexmedetomidine
96986|NCT03597828|fentanyl|fentanyl
96987|NCT03597828|midazolam|midazolam
96988|NCT03597828|sedation|sedation
96989|NCT03597802|Ergonomics|ergonomics
96990|NCT03597802|Workplace|workplace
96991|NCT03597802|Exercise|exercise
96992|NCT03597789|Tantrums|tantrums
96993|NCT03597789|Inattentive|inattentive
96994|NCT03597789|Noncompliance|noncompliance
96995|NCT03597776|intravenous lidocaine|intravenous lidocaine
96996|NCT03597776|pain|pain
96997|NCT03597776|total knee replacement|total knee replacement
96998|NCT03597776|spinal anaesthesia|spinal anaesthesia
96999|NCT03597763|persistent fatigue|persistent fatigue
97000|NCT03597763|traumatic brain injury|traumatic brain injury
97001|NCT03597750|Static air support devices|static air support devices
97002|NCT03597750|Alternating-pressure devices|alternating-pressure devices
97003|NCT03597750|High risk population|high risk population
97004|NCT03597750|Elderly|elderly
97005|NCT03597750|Prevention|prevention
97006|NCT03597711|Peripheral Intravenous cannulation|peripheral intravenous cannulation
97007|NCT03597698|job loss|job loss
97008|NCT03597698|unfit for a job|unfit for a job
97009|NCT03597672|Gastric carcinoma|gastric carcinoma
97010|NCT03597672|Early diagnosis|early diagnosis
97011|NCT03597672|screening stragety|screening stragety
97012|NCT03597672|health population cohort|health population cohort
97013|NCT03597646|Kinesio Taping|kinesio taping
97014|NCT03597646|inspiratory muscle training|inspiratory muscle training
97015|NCT03597646|respiratory|respiratory
97016|NCT03597607|Smoking cessation|smoking cessation
97017|NCT03597607|pharmacist|pharmacist
97018|NCT03597607|self-efficacy|self-efficacy
97019|NCT03597594|Severe Combined Immunodeficiency|severe combined immunodeficiency
97020|NCT03597594|SCID|scid
97021|NCT03597594|TCRα/β/CD19-depleted graft|tcrα/β/cd19-depleted graft
97022|NCT03597594|CD45RA-depleted DLI|cd45ra-depleted dli
97023|NCT03597594|Graft-Versus-Host-Disease|graft-versus-host-disease
97024|NCT03597594|Transplant|transplant
97025|NCT03597581|SLC6a8|slc6a8
97026|NCT03597581|Creatine transporter|creatine transporter
97027|NCT03597581|FOLFIRI|folfiri
97028|NCT03597568|Resveratrol|resveratrol
97029|NCT03597568|Kidney Diseases|kidney diseases
97030|NCT03597568|Renal Insufficiency|renal insufficiency
97031|NCT03597568|Diabetes|diabetes
97032|NCT03597568|Oxidative stress|oxidative stress
97033|NCT03597568|Endothelial dysfunction|endothelial dysfunction
97034|NCT03597555|Idiopathic Hypersomnia|idiopathic hypersomnia
97035|NCT03597542|Children|children
97036|NCT03597542|Inflammation|inflammation
97037|NCT03597542|Obesity|obesity
97038|NCT03597516|Lactose Intolerance|lactose intolerance
97043|NCT03597464|lupus nephritis|lupus nephritis
97044|NCT03597464|calcineurin inhibitors|calcineurin inhibitors
97045|NCT03597464|voclosporin|voclosporin
97046|NCT03597451|strength|strength
97048|NCT03597451|sit-to-stand|sit-to-stand
97049|NCT03597425|Cardiac arrest|cardiac arrest
97050|NCT03597425|Cardiopulmonary resuscitation|cardiopulmonary resuscitation
97051|NCT03597425|Survival|survival
97052|NCT03597425|Prediction|prediction
97053|NCT03597399|Leber Congenital Amaurosis (LCA)|leber congenital amaurosis (lca)
97054|NCT03597399|Inherited Retinal Dystrophy|inherited retinal dystrophy
97055|NCT03597399|RPE65|rpe65
97056|NCT03597399|Retinitis Pigmentosa (RP)|retinitis pigmentosa (rp)
97057|NCT03597373|Prediction|prediction
97058|NCT03597373|Myasthenia gravis|myasthenia gravis
97059|NCT03597373|Reintubation|reintubation
97060|NCT03597347|Nontuberculosis mycobacterial (NTM) infection|nontuberculosis mycobacterial (ntm) infection
97061|NCT03597347|Cystic Fibrosis (CF)|cystic fibrosis (cf)
97062|NCT03597347|M. avium complex (MAC)|m. avium complex (mac)
97063|NCT03597347|M. abscessus complex (MABSC)|m. abscessus complex (mabsc)
97064|NCT03597347|Mycobacterium Infections, Nontuberculous|mycobacterium infections, nontuberculous
97065|NCT03597334|administration,inhalation|administration,inhalation
97066|NCT03597334|metered dose inhalers|metered dose inhalers
97067|NCT03597334|nebulizers and vaporizers|nebulizers and vaporizers
97068|NCT03597334|bronchodilator agents|bronchodilator agents
97069|NCT03597334|anti-bacterial agents|anti-bacterial agents
97070|NCT03597321|Allogeneic hematopoietic stem cell transplantation|allogeneic hematopoietic stem cell transplantation
97071|NCT03597321|donor lymphocyte infusion|donor lymphocyte infusion
97072|NCT03597295|Squamous carcinoma of the anal canal|squamous carcinoma of the anal canal
97073|NCT03597295|anti-PD-1 antibody|anti-pd-1 antibody
97074|NCT03597295|IgG4 monoclonal antibody|igg4 monoclonal antibody
97075|NCT03597295|INCMGA00012|incmga00012
97082|NCT03597256|Hyaluronic acid|hyaluronic acid
97083|NCT03597256|Chin Retrusion|chin retrusion
97084|NCT03597243|Cash transfer|cash transfer
97085|NCT03597243|HIV|hiv
97086|NCT03597243|adolescent girls|adolescent girls
97087|NCT03597243|Tanzania|tanzania
97088|NCT03597217|PF-05221304, PK, Japanese, NASH, ACC inhibitor|pf-05221304, pk, japanese, nash, acc inhibitor
97089|NCT03597191|Y-balance test|y-balance test
97090|NCT03597191|Functional Movement Screen|functional movement screen
97091|NCT03597191|Spinal stabilization exercises|spinal stabilization exercises
97092|NCT03597191|Dynamic balance|dynamic balance
97093|NCT03597191|Postural control|postural control
97094|NCT03597191|Physical performance|physical performance
97095|NCT03597165|Incidental Findings|incidental findings
97096|NCT03597165|Genomic Sequencing|genomic sequencing
97097|NCT03597165|Randomized Controlled Trial|randomized controlled trial
97098|NCT03597165|Clinical Utility|clinical utility
97099|NCT03597165|Personal Utility|personal utility
97100|NCT03597152|uncomplicated recurrent urinary tract infection|uncomplicated recurrent urinary tract infection
97101|NCT03597139|Dry Eye|dry eye
97102|NCT03597139|Calcineurin Inhibitors|calcineurin inhibitors
97103|NCT03597126|Robotic|robotic
97104|NCT03597126|Intersphincteric Resection|intersphincteric resection
97105|NCT03597126|rectal cancer|rectal cancer
97106|NCT03597126|pelvic autonomic nerve anal function|pelvic autonomic nerve anal function
97107|NCT03597087|Anesthesia, Bladder cancer, Recurrence rate, Transurethral resection of bladder mass|anesthesia, bladder cancer, recurrence rate, transurethral resection of bladder mass
97108|NCT03597074|ICU|icu
97109|NCT03597074|Renal Resistive Index|renal resistive index
97110|NCT03597074|Acute Kidney Injury|acute kidney injury
97111|NCT03597074|Sepsis|sepsis
97112|NCT03597061|obesity prevention|obesity prevention
97113|NCT03597061|infant|infant
97114|NCT03597061|complementary feeding|complementary feeding
97115|NCT03597061|diet variety|diet variety
97116|NCT03597061|weight-for-length|weight-for-length
97117|NCT03597061|food responsiveness|food responsiveness
97118|NCT03597061|satiety responsiveness|satiety responsiveness
97119|NCT03597048|stigma intervention|stigma intervention
97120|NCT03597022|Subcutaneous|subcutaneous
97121|NCT03597022|Prophylaxis|prophylaxis
97122|NCT03597022|Non-Inhibitors|non-inhibitors
97123|NCT03597022|Inhibitors|inhibitors
97124|NCT03597009|talimogene laherparepvec|talimogene laherparepvec
97125|NCT03597009|Nivolumab|nivolumab
97126|NCT03597009|PleurX|pleurx
97127|NCT03596983|Short Sleeping|short sleeping
97128|NCT03596970|Open-label|open-label
97129|NCT03596970|randomized|randomized
97130|NCT03596970|calcineurin-inhibitor|calcineurin-inhibitor
97131|NCT03596970|CNI|cni
97132|NCT03596970|tacrolimus|tacrolimus
97137|NCT03596970|liver transplant|liver transplant
97138|NCT03596970|transplantation|transplantation
97139|NCT03596944|acute coronary syndrome|acute coronary syndrome
97140|NCT03596944|statin|statin
97141|NCT03596944|mortality|mortality
97142|NCT03596944|GRACE score|grace score
97143|NCT03596944|TIMI score|timi score
97144|NCT03596931|acute coronary syndrome|acute coronary syndrome
97145|NCT03596931|statin|statin
97146|NCT03596931|acute pulmonary edema|acute pulmonary edema
97147|NCT03596931|malignant arrhythmia|malignant arrhythmia
97148|NCT03596931|heart failure|heart failure
97149|NCT03596879|insomnia|insomnia
97150|NCT03596879|post partum depression (PPD)|post partum depression (ppd)
97151|NCT03596879|digital CBTI (dCBTI)|digital cbti (dcbti)
97152|NCT03596879|online CBTI|online cbti
97153|NCT03596879|rumination|rumination
97154|NCT03596866|Drug Therapy|drug therapy
97155|NCT03596840|Hypertension|hypertension
97156|NCT03596840|Microalbuminuria|microalbuminuria
97157|NCT03596840|Effectiveness|effectiveness
97158|NCT03596840|Antihypertensive medications|antihypertensive medications
97159|NCT03596827|Diarrhea|diarrhea
97160|NCT03596827|Gastroenteritis|gastroenteritis
97161|NCT03596827|Bacterial Infections|bacterial infections
97162|NCT03596827|Escherichia Coli Infections|escherichia coli infections
97163|NCT03596827|E.coli|e.coli
97164|NCT03596814|Hemophilia A|hemophilia a
97165|NCT03596814|Hemophilia B|hemophilia b
97166|NCT03596814|Research database|research database
97167|NCT03596814|Clotting Factors|clotting factors
97168|NCT03596814|Regimen of Treatment|regimen of treatment
97169|NCT03596814|Impact Budget Analysis|impact budget analysis
97170|NCT03596736|Distal Humerus Fracture|distal humerus fracture
97171|NCT03596736|Arthroplasty, Replacement, Elbow|arthroplasty, replacement, elbow
97172|NCT03596697|CRV431|crv431
97173|NCT03596697|Hepatitis B Virus|hepatitis b virus
97174|NCT03596697|Hepatitis Virus|hepatitis virus
97175|NCT03596684|Carbohydrate Metabolism|carbohydrate metabolism
97176|NCT03596684|Citrulline|citrulline
97177|NCT03596684|Statine|statine
97178|NCT03596619|plum-blossom needling|plum-blossom needling
97179|NCT03596619|Photodynamic Therapy|photodynamic therapy
97180|NCT03596619|Actinic Keratoses|actinic keratoses
97181|NCT03596606|Chronic Facial Pain|chronic facial pain
97182|NCT03596606|Osteopathic Manual treatment|osteopathic manual treatment
97183|NCT03596606|Therapeutic Exercise|therapeutic exercise
97184|NCT03596593|Solid tumor|solid tumor
97185|NCT03596593|China|china
97187|NCT03596593|ctDNA|ctdna
97188|NCT03596580|Screening tool|screening tool
97189|NCT03596567|Glasdegib|glasdegib
97190|NCT03596567|PF-04449913|pf-04449913
97191|NCT03596567|Pharmacokinetics|pharmacokinetics
97192|NCT03596567|Renal Impairment|renal impairment
97193|NCT03596541|Telemedicina|telemedicina
97194|NCT03596541|Respiratory sounds|respiratory sounds
97195|NCT03596541|Tele-stethoscopy|tele-stethoscopy
97196|NCT03596541|Wireless|wireless
97197|NCT03596541|Real-time|real-time
97198|NCT03596541|e-health|e-health
97199|NCT03596541|Heart sounds|heart sounds
97200|NCT03596528|Interstitial lung disease, cryobiopsy, surgical biopsy|interstitial lung disease, cryobiopsy, surgical biopsy
97201|NCT03596502|Direct oral anticoagulants|direct oral anticoagulants
97202|NCT03596502|Safety|safety
97203|NCT03596502|Atrial fibrillation|atrial fibrillation
97204|NCT03596502|Ischemic stroke|ischemic stroke
97205|NCT03596502|Systemic embolization|systemic embolization
97206|NCT03596476|Gastro-esophageal reflux|gastro-esophageal reflux
97207|NCT03596476|High resolution Impedance Manometry|high resolution impedance manometry
97208|NCT03596476|Resistance to proton pump inhibitors (PPI)|resistance to proton pump inhibitors (ppi)
97209|NCT03596437|Fibromuscular dysplasia|fibromuscular dysplasia
97210|NCT03596437|Vascular Ehler-Danlos Syndrome|vascular ehler-danlos syndrome
97211|NCT03596437|Ultrasound|ultrasound
97212|NCT03596398|Fabry disease|fabry disease
97213|NCT03596398|Young stroke|young stroke
97214|NCT03596372|First-in-human|first-in-human
97215|NCT03596372|Immuno-oncology|immuno-oncology
97216|NCT03596372|CEACAM6|ceacam6
97217|NCT03596372|Checkpoint inhibition|checkpoint inhibition
97218|NCT03596359|Self Care|self care
97219|NCT03596359|Heart Failure|heart failure
97220|NCT03596359|Quality of Life|quality of life
97221|NCT03596359|Teach-Back|teach-back
97222|NCT03596346|Rapeseed|rapeseed
97223|NCT03596346|Ingredient|ingredient
97224|NCT03596346|Safety|safety
97225|NCT03596346|Tolerability|tolerability
97226|NCT03596307|Ashwagandha|ashwagandha
97227|NCT03596307|Endurance|endurance
97228|NCT03596307|VO2 max|vo2 max
97229|NCT03596307|Glycowithanolides|glycowithanolides
97230|NCT03596307|Shoden|shoden
97235|NCT03596229|carotid endarterectomy|carotid endarterectomy
97236|NCT03596229|adverse cardiac events|adverse cardiac events
97237|NCT03596177|Diabetes Mellitus, Type II|diabetes mellitus, type ii
97239|NCT03596177|MEDI0382|medi0382
97240|NCT03596151|Chlamydia trachomatis|chlamydia trachomatis
97241|NCT03596151|device|device
97242|NCT03596151|diagnostic|diagnostic
97243|NCT03596151|molecular|molecular
97244|NCT03596151|Neisseria gonorrhoeae|neisseria gonorrhoeae
97245|NCT03596151|Trichomonas vaginalis|trichomonas vaginalis
97246|NCT03596138|angle measurement|angle measurement
97247|NCT03596138|automated|automated
97248|NCT03596138|strabismus|strabismus
97249|NCT03596125|Glutathione|glutathione
97250|NCT03596125|Antioxidant|antioxidant
97251|NCT03596125|Oxidative stress|oxidative stress
97252|NCT03596125|Preterm|preterm
97253|NCT03596099|Prehypertension|prehypertension
97254|NCT03596099|Rice vinegar|rice vinegar
97255|NCT03596099|vinegar|vinegar
97256|NCT03596099|acetic acid|acetic acid
97257|NCT03596086|GBM|gbm
97258|NCT03596086|glioblastoma|glioblastoma
97259|NCT03596086|Astrocytoma|astrocytoma
97260|NCT03596073|Breast Cancer|breast cancer
97261|NCT03596060|hip fracture, general anesthesia, regional anesthesia, clopidogrel, cognitive impairment, mortality|hip fracture, general anesthesia, regional anesthesia, clopidogrel, cognitive impairment, mortality
97262|NCT03596047|radial wave therapy|radial wave therapy
97263|NCT03596034|Electronic Nicotine Delivery System (ENDS)|electronic nicotine delivery system (ends)
97264|NCT03596034|ENDS|ends
97265|NCT03596034|Puff Topography|puff topography
97266|NCT03596021|exercise|exercise
97267|NCT03596021|toe walking|toe walking
97268|NCT03596021|scale|scale
97269|NCT03596021|reliability|reliability
97270|NCT03596021|validity|validity
97271|NCT03596008|strawberry|strawberry
97272|NCT03596008|monocytes|monocytes
97273|NCT03596008|endothelial function|endothelial function
97274|NCT03595982|chronic hypertension|chronic hypertension
97275|NCT03595982|postpartum hypertension|postpartum hypertension
97276|NCT03595982|preeclampsia|preeclampsia
97277|NCT03595982|treatment|treatment
97278|NCT03595982|Procardia XL|procardia xl
97279|NCT03595969|mitochondrial DNA|mitochondrial dna
97280|NCT03595956|Transgender|transgender
97281|NCT03595956|HIV/AIDS|hiv/aids
97282|NCT03595956|Gender affirmation|gender affirmation
97283|NCT03595956|PrEP|prep
97284|NCT03595930|ARNUITY|arnuity
97285|NCT03595930|Effectiveness|effectiveness
97286|NCT03595930|Asthma|asthma
97287|NCT03595930|Post-marketing surveillance|post-marketing surveillance
97288|NCT03595930|Safety|safety
97289|NCT03595917|B-cell Acute Lymphoblastic Leukemia|b-cell acute lymphoblastic leukemia
97290|NCT03595917|Chronic Myeloid Leukemia (CML) in lymphoid blast crisis|chronic myeloid leukemia (cml) in lymphoid blast crisis
97291|NCT03595917|Philadelphia chromosome positive Acute Lymphoblastic Leukemia (Ph+ ALL).|philadelphia chromosome positive acute lymphoblastic leukemia (ph+ all).
97292|NCT03595904|colorectal neoplasms|colorectal neoplasms
97293|NCT03595904|colonoscopy|colonoscopy
97294|NCT03595904|African Americans|african americans
97295|NCT03595904|Telemedicine|telemedicine
97296|NCT03595878|Whole Brain Radiation|whole brain radiation
97297|NCT03595826|ADHD/ADD DCD Exercises Neurostimulant Drugs|adhd/add dcd exercises neurostimulant drugs
97298|NCT03595813|Immune check point blockade|immune check point blockade
97299|NCT03595813|biomarkers|biomarkers
97300|NCT03595813|immunomonitoring|immunomonitoring
97301|NCT03595787|prehabilitation|prehabilitation
97302|NCT03595787|coaching|coaching
97303|NCT03595787|nutritional support|nutritional support
97304|NCT03595787|physical activity|physical activity
97305|NCT03595787|allogeneic stem cells transplantation|allogeneic stem cells transplantation
97306|NCT03595774|nitric oxide|nitric oxide
97307|NCT03595761|cerebral vasculitis|cerebral vasculitis
97308|NCT03595748|Hospitalizations|hospitalizations
97309|NCT03595748|Dialysis patients|dialysis patients
97310|NCT03595748|Peer mentorship|peer mentorship
97311|NCT03595722|Pelvic cancer|pelvic cancer
97312|NCT03595722|rectal cancer|rectal cancer
97313|NCT03595722|HIFU|hifu
97314|NCT03595722|QoL|qol
97315|NCT03595722|complications|complications
97316|NCT03595709|EFV|efv
97317|NCT03595709|HIV Infections|hiv infections
97318|NCT03595631|neurodynamics|neurodynamics
97319|NCT03595631|pain|pain
97320|NCT03595592|Unilateral, HER2 positive|unilateral, her2 positive
97321|NCT03595579|AXS-05|axs-05
97322|NCT03595579|Major Depressive Disorder|major depressive disorder
97323|NCT03595579|MDD|mdd
97324|NCT03595579|Axsome|axsome
97325|NCT03595579|NMDA Receptor|nmda receptor
97326|NCT03595579|Depression|depression
97327|NCT03595579|Dextromethorphan|dextromethorphan
97328|NCT03595579|Bupropion|bupropion
97329|NCT03595540|fasting-mimicking diet|fasting-mimicking diet
97330|NCT03595540|cancer|cancer
97331|NCT03595540|nutritional status|nutritional status
97332|NCT03595540|body composition|body composition
97333|NCT03595540|fasting|fasting
97334|NCT03595527|Screening|screening
97335|NCT03595527|Linkage to care|linkage to care
97336|NCT03595475|Prodromal markers|prodromal markers
97337|NCT03595475|Psychiatric disorders|psychiatric disorders
97338|NCT03595475|α-synucleinopathy|α-synucleinopathy
97339|NCT03595475|Family study|family study
97340|NCT03595423|long-term survival|long-term survival
97341|NCT03595423|bioprosthesis|bioprosthesis
97342|NCT03595410|risk of recurrence|risk of recurrence
97343|NCT03595410|Nomograms|nomograms
97344|NCT03595410|Laryngeal cancer|laryngeal cancer
97345|NCT03595384|Behavioral intervention|behavioral intervention
97346|NCT03595371|Schnitzler|schnitzler
97347|NCT03595345|delisting|delisting
97348|NCT03595345|tumor-specific death|tumor-specific death
97349|NCT03595345|Milan Criteria|milan criteria
97350|NCT03595319|Hypotension|hypotension
97351|NCT03595319|Sevoflurane|sevoflurane
97352|NCT03595319|Elderly|elderly
97353|NCT03595293|Prescription Opioid Use Disorder|prescription opioid use disorder
97354|NCT03595293|Alcohol Use Disorder|alcohol use disorder
97355|NCT03595293|Functional Near-infrared Spectroscopy|functional near-infrared spectroscopy
97356|NCT03595293|Treatment Outcome|treatment outcome
97357|NCT03595293|Resisting Craving|resisting craving
97358|NCT03595267|Indigenous Canadians|indigenous canadians
97359|NCT03595267|Screening Study|screening study
97360|NCT03595215|TENS|tens
97361|NCT03595176|Intravascular Lithotripsy|intravascular lithotripsy
97362|NCT03595176|Percutaneous Coronary Intervention|percutaneous coronary intervention
97363|NCT03595163|Sevoflurane|sevoflurane
97364|NCT03595163|Propofol|propofol
97365|NCT03595163|Folic Acid Concentrations|folic acid concentrations
97366|NCT03595163|Homocysteine Concentrations|homocysteine concentrations
97367|NCT03595163|Cochlear Implant Surgery|cochlear implant surgery
97368|NCT03595150|Endoscopic Retrograde Cholangiopancreatography|endoscopic retrograde cholangiopancreatography
97369|NCT03595150|Pancreatitis|pancreatitis
97370|NCT03595150|Diclofenac|diclofenac
97371|NCT03595111|Cardiac Protection|cardiac protection
97372|NCT03595111|Pediatric|pediatric
97373|NCT03595111|Myocardial biopsy|myocardial biopsy
97374|NCT03595111|Cardiopulmonary Bypass|cardiopulmonary bypass
97375|NCT03595098|OCD|ocd
97376|NCT03595059|Cancer|cancer
97377|NCT03595059|Advanced Solid Tumors|advanced solid tumors
97378|NCT03595059|Relapsed and/or Refractory Solid Tumors|relapsed and/or refractory solid tumors
97379|NCT03595059|ABBV-155|abbv-155
97380|NCT03595059|Taxane|taxane
97381|NCT03595059|Paclitaxel|paclitaxel
97382|NCT03595059|Docetaxel|docetaxel
97383|NCT03595059|breast cancer|breast cancer
97384|NCT03595059|non-small cell lung cancer (NSCLC)|non-small cell lung cancer (nsclc)
97385|NCT03595059|small cell lung cancer (SCLC)|small cell lung cancer (sclc)
97386|NCT03595046|thoracic paravertebral block|thoracic paravertebral block
97387|NCT03595046|erector spinae plane block|erector spinae plane block
97388|NCT03595046|thoracic postherpetic neuralgia|thoracic postherpetic neuralgia
97389|NCT03595020|major depression disorder|major depression disorder
97390|NCT03595020|functional near-infrared spectroscopy|functional near-infrared spectroscopy
97391|NCT03595020|facial emotion recognition|facial emotion recognition
97392|NCT03594916|Dysmenorrhea|dysmenorrhea
97393|NCT03594916|Neuromodulation|neuromodulation
97394|NCT03594916|Transcranial direct current stimulation|transcranial direct current stimulation
97395|NCT03594916|Neuroimaging|neuroimaging
97396|NCT03594916|Neuroplasticity|neuroplasticity
97397|NCT03594903|therapy expectation|therapy expectation
97398|NCT03594903|therapy motivation|therapy motivation
97399|NCT03594903|critical attitudes towards psychotherapy|critical attitudes towards psychotherapy
97400|NCT03594903|expectation violation|expectation violation
832563|NCT00107783|Arthritis|arthritis
97401|NCT03594903|Violex model|violex model
97402|NCT03594903|psychological online-experiment|psychological online-experiment
97403|NCT03594890|influenza|influenza
97404|NCT03594890|vaccine|vaccine
97405|NCT03594890|nucleoprotein|nucleoprotein
97406|NCT03594877|mare milk|mare milk
97407|NCT03594877|gut microbiome|gut microbiome
97408|NCT03594877|psoriasis|psoriasis
97409|NCT03594877|immune markers|immune markers
97410|NCT03594864|Liver|liver
97411|NCT03594864|Transplantation|transplantation
97412|NCT03594864|Hyper-reduction|hyper-reduction
97413|NCT03594864|Graft survival|graft survival
97414|NCT03594864|Overall survival|overall survival
97415|NCT03594851|quality of sleep|quality of sleep
97416|NCT03594851|elderly|elderly
97417|NCT03594851|health education|health education
97418|NCT03594851|quantity of sleep|quantity of sleep
97419|NCT03594851|caregiver's burden|caregiver's burden
97420|NCT03594838|HCV viremia testing|hcv viremia testing
97421|NCT03594825|Nocturnal Hypertension; Hemodialysis; Valsartan|nocturnal hypertension; hemodialysis; valsartan
97422|NCT03594799|Simulated Microgravity|simulated microgravity
97423|NCT03594799|Weightlessness|weightlessness
97424|NCT03594799|Countermeasure|countermeasure
97425|NCT03594799|Bedrest|bedrest
97426|NCT03594734|Traumatic Brain Injury|traumatic brain injury
97427|NCT03594734|Group Lifestyle Balance|group lifestyle balance
97428|NCT03594734|Weight-Loss|weight-loss
97429|NCT03594695|cesarean section, anesthesia, hs-CRP, NLR|cesarean section, anesthesia, hs-crp, nlr
97430|NCT03594682|Apatinib,NSCLC,Dose titration|apatinib,nsclc,dose titration
97431|NCT03594656|Parkinson's disease|parkinson's disease
97432|NCT03594656|Lingzhi|lingzhi
97433|NCT03594656|Traditional Chinese Medicine|traditional chinese medicine
97434|NCT03594643|electronic|electronic
97435|NCT03594643|surgery|surgery
97436|NCT03594643|outcome|outcome
97437|NCT03594643|anesthesia|anesthesia
97438|NCT03594643|cigarette|cigarette
97439|NCT03594604|norethindrone|norethindrone
97440|NCT03594552|Autism Spectrum Disorder|autism spectrum disorder
97441|NCT03594552|Arbaclofen|arbaclofen
97442|NCT03594552|E-I balance|e-i balance
97443|NCT03594552|pharmacological imaging|pharmacological imaging
97444|NCT03594552|GABA|gaba
97445|NCT03594539|ESRD|esrd
97446|NCT03594539|Microvascular|microvascular
97447|NCT03594539|Hyperphosphatemia|hyperphosphatemia
97448|NCT03594539|LDF|ldf
97449|NCT03594526|Nursing Care|nursing care
97450|NCT03594526|Mothers|mothers
97451|NCT03594526|Research|research
97452|NCT03594526|Support|support
97453|NCT03594513|Gingival Recession|gingival recession
97454|NCT03594513|Tooth Abrasion|tooth abrasion
97455|NCT03594513|Mucoderm|mucoderm
97456|NCT03594500|Emergency service|emergency service
97457|NCT03594500|Hearing loss|hearing loss
97458|NCT03594500|Patient readmission|patient readmission
97459|NCT03594500|Communication|communication
97460|NCT03594487|Multiple Sclerosis|multiple sclerosis
97461|NCT03594487|Relapsing Remitting Multiple Sclerosis|relapsing remitting multiple sclerosis
97462|NCT03594487|Fecal Microbiota Transplantation|fecal microbiota transplantation
97463|NCT03594474|intravenous fat emulsions|intravenous fat emulsions
97464|NCT03594474|preterm infants|preterm infants
97465|NCT03594435|ibudilast, treatment, medication development|ibudilast, treatment, medication development
97466|NCT03594383|Lung|lung
97467|NCT03594383|POCUS|pocus
97468|NCT03594383|Pneumonia|pneumonia
97469|NCT03594383|ARI|ari
97470|NCT03594383|CHWs|chws
97471|NCT03594357|Multiple sclerosis|multiple sclerosis
97472|NCT03594357|Balance|balance
97473|NCT03594357|Cognition|cognition
97474|NCT03594357|Functional exercise capacity|functional exercise capacity
97475|NCT03594357|Fatigue|fatigue
97476|NCT03594357|Sleep quality|sleep quality
97477|NCT03594344|Diabetic foot|diabetic foot
97478|NCT03594344|Diabetes|diabetes
97479|NCT03594344|Lower extremity amputation|lower extremity amputation
97480|NCT03594344|Hyperbaric oxygen therapy|hyperbaric oxygen therapy
97481|NCT03594344|HBOT|hbot
97482|NCT03594292|hallux valgus and Bunion|hallux valgus and bunion
97483|NCT03594253|oppositional defiant disorder|oppositional defiant disorder
97484|NCT03594253|regulation focused psychotherapy for children|regulation focused psychotherapy for children
97485|NCT03594253|emotion regulation|emotion regulation
97486|NCT03594253|psychodynamic psychotherapy|psychodynamic psychotherapy
97487|NCT03594214|breast cancer|breast cancer
97488|NCT03594214|vitamin d|vitamin d
97489|NCT03594214|prognosis|prognosis
97490|NCT03594201|ICSI, progressive sperm count, embryo|icsi, progressive sperm count, embryo
97491|NCT03594175|CVAD|cvad
97492|NCT03594175|CUSA-081|cusa-081
97493|NCT03594175|reteplase|reteplase
97494|NCT03594175|alteplase|alteplase
97495|NCT03594175|occluded catheters|occluded catheters
97496|NCT03594175|catheter|catheter
97497|NCT03594175|occlusion|occlusion
97498|NCT03594175|thrombosis|thrombosis
97499|NCT03594175|thrombotic occlusion|thrombotic occlusion
97500|NCT03594162|CAR T cells|car t cells
97501|NCT03594162|CD19|cd19
125229|NCT03420495|OCD|ocd
97502|NCT03594162|Leukemia|leukemia
97503|NCT03594162|T Lymphocytes|t lymphocytes
97504|NCT03594162|AP1903|ap1903
97505|NCT03594149|levofloxacin, antibacterial prophylaxis, febrile episode|levofloxacin, antibacterial prophylaxis, febrile episode
97506|NCT03594136|Intracranial pressure|intracranial pressure
97507|NCT03594136|ICP|icp
97508|NCT03594136|Normal value|normal value
97509|NCT03594136|Reference value|reference value
97510|NCT03594136|Hydrocephalus|hydrocephalus
97511|NCT03594123|Agitation|agitation
97512|NCT03594084|Malaria|malaria
97513|NCT03594084|Malaria imported cases|malaria imported cases
97514|NCT03594084|Recurrent malaria|recurrent malaria
97515|NCT03594084|Endemic malaria areas|endemic malaria areas
97516|NCT03594084|Biological diagnosis|biological diagnosis
97517|NCT03594084|Hospital vs private laboratory diagnosis|hospital vs private laboratory diagnosis
97518|NCT03594058|overactive bladder|overactive bladder
97519|NCT03594058|urinary conditions|urinary conditions
97520|NCT03594058|urgency urinary incontinence|urgency urinary incontinence
97521|NCT03594058|urgency|urgency
97522|NCT03594058|micturitions|micturitions
97523|NCT03594045|Heparin-induced Thrombocytopenia|heparin-induced thrombocytopenia
97524|NCT03594032|bronchiectasis|bronchiectasis
97525|NCT03594032|NTM infections|ntm infections
97526|NCT03594032|Middle-aged and old women|middle-aged and old women
97527|NCT03594019|immediate implant placement|immediate implant placement
97528|NCT03594019|connective tissue graft|connective tissue graft
97529|NCT03594019|samll dehiscence|samll dehiscence
97530|NCT03594006|Active Therapy|active therapy
97531|NCT03593980|Gastric Ultrasound|gastric ultrasound
97532|NCT03593967|wellbeing|wellbeing
97533|NCT03593967|intergenerational arts|intergenerational arts
97534|NCT03593967|aspiration|aspiration
97535|NCT03593967|resilience|resilience
97536|NCT03593967|storytelling|storytelling
97537|NCT03593967|art making|art making
97538|NCT03593967|seniors|seniors
97539|NCT03593967|youth|youth
97540|NCT03593941|Ageing|ageing
97541|NCT03593941|Gut Microbiota|gut microbiota
97542|NCT03593941|Challenging behaviour|challenging behaviour
97543|NCT03593941|Dementia|dementia
97544|NCT03593928|biomarker|biomarker
97545|NCT03593928|plaque morphology|plaque morphology
97546|NCT03593915|Previously untreated MDS|previously untreated mds
97547|NCT03593915|MDS who have received <6 cycles of treatment with hypomethylating agents (HMAs)|mds who have received <6 cycles of treatment with hypomethylating agents (hmas)
97548|NCT03593915|De novo or secondary MDS (treatment-related) who are not eligible for intensive induction chemotherapy or stem cell transplant|de novo or secondary mds (treatment-related) who are not eligible for intensive induction chemotherapy or stem cell transplant
97549|NCT03593915|FAB subtypes: refractory anemia [RA], RA w/ ringed sideroblasts, RA w/ excess blasts, RA w/ excess blasts in transformation or chronic myelomonocytic leukemia|fab subtypes: refractory anemia [ra], ra w/ ringed sideroblasts, ra w/ excess blasts, ra w/ excess blasts in transformation or chronic myelomonocytic leukemia
97550|NCT03593915|Intermediate and above per the Revised International Prognostic Scoring System (IPSS-R) groups|intermediate and above per the revised international prognostic scoring system (ipss-r) groups
97551|NCT03593915|Tolero|tolero
97552|NCT03593915|Cancer|cancer
97553|NCT03593915|Phase 1b/2|phase 1b/2
97554|NCT03593902|Autologous Stem Cell Transplantation|autologous stem cell transplantation
97555|NCT03593902|Hematopoietic Stem Cell Transplant|hematopoietic stem cell transplant
97556|NCT03593889|Collaborative stepped care|collaborative stepped care
97557|NCT03593889|Peer support|peer support
97558|NCT03593889|Early identification|early identification
97559|NCT03593889|Selective prevention|selective prevention
97560|NCT03593889|Indicated prevention|indicated prevention
97561|NCT03593876|Stroke|stroke
97562|NCT03593876|Aphasia|aphasia
97563|NCT03593876|Rehabilitation|rehabilitation
97564|NCT03593876|Cognition|cognition
97565|NCT03593876|Disability|disability
97566|NCT03593863|Brain structure and function|brain structure and function
97567|NCT03593863|Adolescents|adolescents
97568|NCT03593863|Physical activity|physical activity
97569|NCT03593863|Cognitive function|cognitive function
97570|NCT03593863|Mental health|mental health
97571|NCT03593863|Fitness|fitness
97572|NCT03593850|Pain management|pain management
97573|NCT03593850|Pain|pain
97574|NCT03593850|Primary dysmenorrhea|primary dysmenorrhea
97575|NCT03593850|Music|music
97576|NCT03593850|Music Therapy|music therapy
97577|NCT03593824|Phenotypic plasticity|phenotypic plasticity
97578|NCT03593824|Adversity|adversity
97579|NCT03593824|Prosperity|prosperity
97580|NCT03593785|Cholesterol|cholesterol
97581|NCT03593785|Biomarkers|biomarkers
97582|NCT03593772|chronic pain|chronic pain
97583|NCT03593772|PTSD|ptsd
97584|NCT03593759|Cardiac Sarcoidosis|cardiac sarcoidosis
97585|NCT03593759|Prednisone|prednisone
97586|NCT03593759|Methotrexate|methotrexate
97587|NCT03593746|Cardiopulmonary Exercise Test|cardiopulmonary exercise test
97588|NCT03593746|Rehabilitation|rehabilitation
97589|NCT03593746|Diabetes Mellitus, Type 2|diabetes mellitus, type 2
97590|NCT03593746|Functional Capacity|functional capacity
97591|NCT03593746|Photobiomodulation Therapy|photobiomodulation therapy
97592|NCT03593720|hypaspadias|hypaspadias
97593|NCT03593707|PF-06865571|pf-06865571
97594|NCT03593707|Metformin|metformin
97595|NCT03593707|Drug-drug interaction|drug-drug interaction
97596|NCT03593707|Pharmacokinetics|pharmacokinetics
97597|NCT03593681|salpingo-oophorectomy|salpingo-oophorectomy
97598|NCT03593681|salpingectomy|salpingectomy
97599|NCT03593681|ovarian cancer|ovarian cancer
97600|NCT03593681|fallopian tube cancer|fallopian tube cancer
97601|NCT03593681|high grade serous carcinoma|high grade serous carcinoma
97602|NCT03593681|hysteroscopic biopsy|hysteroscopic biopsy
97603|NCT03593681|fallopian tube cell collection|fallopian tube cell collection
97604|NCT03593681|peritoneal cancer|peritoneal cancer
97605|NCT03593668|Metformin|metformin
97606|NCT03593668|Benaglutide|benaglutide
97608|NCT03593629|AIDS|aids
97609|NCT03593629|PrEP|prep
97610|NCT03593629|Truvada|truvada
97611|NCT03593629|Public Health|public health
97612|NCT03593629|Global Health|global health
97613|NCT03593629|Infectious Disease|infectious disease
97614|NCT03593629|Self-Testing|self-testing
97615|NCT03593629|Kenya|kenya
97616|NCT03593629|Africa|africa
97617|NCT03593629|Low and/or Middle Income Countries (LMIC)|low and/or middle income countries (lmic)
97618|NCT03593629|Cost-Effectiveness|cost-effectiveness
97619|NCT03593577|Schwannoma|schwannoma
97620|NCT03593577|saccular dilatation|saccular dilatation
97621|NCT03593577|endolymphatic hydrops|endolymphatic hydrops
97622|NCT03593577|magnetic resonnance imaging|magnetic resonnance imaging
97623|NCT03593577|vertigo|vertigo
97624|NCT03593564|Randomized Controlled Trial|randomized controlled trial
97625|NCT03593564|Cognitive Behavioral Therapy|cognitive behavioral therapy
97626|NCT03593564|Intervention Study|intervention study
97627|NCT03593551|stress|stress
97628|NCT03593551|anxiety|anxiety
97629|NCT03593551|breastfeeding|breastfeeding
97630|NCT03593551|relaxation|relaxation
97631|NCT03593551|meditation|meditation
97632|NCT03593551|music|music
97633|NCT03593525|Pediatric Oncology|pediatric oncology
97634|NCT03593525|Randomized Control Trial|randomized control trial
97635|NCT03593525|Symptom Screening|symptom screening
97636|NCT03593525|Quality of Life|quality of life
97637|NCT03593512|multiple system atrophy|multiple system atrophy
97638|NCT03593512|autonomic|autonomic
97639|NCT03593499|melanoma|melanoma
97640|NCT03593499|omaveloxolone|omaveloxolone
97641|NCT03593499|expanded access|expanded access
97642|NCT03593473|Oxytocin|oxytocin
97643|NCT03593473|Hypothalamic-pituitary-adrenal axis (HPA)|hypothalamic-pituitary-adrenal axis (hpa)
97644|NCT03593447|Chronic hepatics C virus (HCV) genotype 1|chronic hepatics c virus (hcv) genotype 1
97645|NCT03593447|treatment naïve|treatment naïve
97646|NCT03593447|non-cirrhotic|non-cirrhotic
97647|NCT03593447|cirrhotic|cirrhotic
97648|NCT03593447|efficacy|efficacy
97649|NCT03593447|safety|safety
97650|NCT03593447|TG-2349|tg-2349
97651|NCT03593447|DAG181|dag181
97652|NCT03593447|Ribavirin|ribavirin
97653|NCT03593395|Transition|transition
97654|NCT03593395|Emerging Adults|emerging adults
97655|NCT03593395|Peer Mentoring|peer mentoring
97656|NCT03593382|Female endurance athletes|female endurance athletes
97657|NCT03593382|Energy Availability|energy availability
97658|NCT03593382|Nutrient Availability|nutrient availability
97659|NCT03593382|Bone Mineral Density|bone mineral density
97660|NCT03593382|Menstrual dysfunction|menstrual dysfunction
97661|NCT03593382|Female athlete triad|female athlete triad
97662|NCT03593382|Energy metabolism|energy metabolism
97663|NCT03593382|Recovery after exercise|recovery after exercise
97664|NCT03593382|Endothelial function|endothelial function
97665|NCT03593382|Eating disorders|eating disorders
97666|NCT03593382|Performance|performance
97667|NCT03593356|Poverty|poverty
97668|NCT03593356|Income|income
97669|NCT03593356|Child Development|child development
97670|NCT03593356|Brain Development|brain development
97671|NCT03593330|Transitional Care|transitional care
97672|NCT03593330|Discharge Planning|discharge planning
97673|NCT03593330|Readmission|readmission
97674|NCT03593330|Elective Neurosurgery|elective neurosurgery
97675|NCT03593330|Elective Spinal Surgery|elective spinal surgery
97676|NCT03593330|Elective Brain Surgery|elective brain surgery
97677|NCT03593330|Transitional Care Program|transitional care program
97678|NCT03593330|TCP|tcp
97679|NCT03593317|Heart Failure|heart failure
97680|NCT03593317|Right ventricle|right ventricle
97681|NCT03593291|Stroke, VTE prophylaxis, Anti Xa|stroke, vte prophylaxis, anti xa
97682|NCT03593239|Electronic Nicotine Delivery System|electronic nicotine delivery system
97683|NCT03593239|Combustible Cigarettes|combustible cigarettes
97684|NCT03593239|Nicotine|nicotine
97685|NCT03593187|HIV-1|hiv-1
97686|NCT03593187|Lymphoma|lymphoma
97687|NCT03593187|Gene therapy|gene therapy
97688|NCT03593174|Amputation|amputation
97689|NCT03593161|stem cell transplantation|stem cell transplantation
97690|NCT03593161|allogeneic|allogeneic
97691|NCT03593161|humor therapy|humor therapy
97692|NCT03593161|distress|distress
97693|NCT03593161|supportive care|supportive care
97694|NCT03593135|vinegar|vinegar
97695|NCT03593135|diabetes|diabetes
97696|NCT03593135|hyperglycemia|hyperglycemia
97697|NCT03593135|hypercholesterolemia|hypercholesterolemia
97698|NCT03593135|nutraceutical|nutraceutical
97699|NCT03593122|Vulvovaginal Dryness|vulvovaginal dryness
97700|NCT03593109|Chimeric Antigen Receptor T cells|chimeric antigen receptor t cells
97701|NCT03593109|CD19 and CD22|cd19 and cd22
97702|NCT03593096|High Altitude|high altitude
97703|NCT03593096|Exercise|exercise
97704|NCT03593096|Ventilation|ventilation
97705|NCT03593096|Heart rate|heart rate
97706|NCT03593083|High Altitude|high altitude
97707|NCT03593083|Exercise|exercise
97708|NCT03593083|Electrocardiography|electrocardiography
97709|NCT03593083|Non-invasive Blood Pressure|non-invasive blood pressure
97710|NCT03593083|Finapres|finapres
97711|NCT03593070|online group intervention|online group intervention
97712|NCT03593057|dysmenorrhoea|dysmenorrhoea
97713|NCT03593057|manual therapy|manual therapy
97714|NCT03593044|atropine|atropine
97715|NCT03593044|photophobia|photophobia
97717|NCT03593044|reading speed|reading speed
97718|NCT03593044|myopia|myopia
97719|NCT03593044|Surveys and Questionnaires|surveys and questionnaires
97720|NCT03593018|oral azacitidine|oral azacitidine
97721|NCT03593005|High Altitude|high altitude
97722|NCT03593005|Altitude related symptoms|altitude related symptoms
97723|NCT03592979|Simulated altitude|simulated altitude
97724|NCT03592979|exercise|exercise
97725|NCT03592979|ventilation|ventilation
97726|NCT03592979|heart rate|heart rate
97727|NCT03592966|(Poly)phenols|(poly)phenols
97728|NCT03592966|Blueberries|blueberries
97729|NCT03592966|Anthocyanins|anthocyanins
97730|NCT03592966|Cognitive function|cognitive function
97731|NCT03592966|Vascular function|vascular function
97732|NCT03592953|Serious game|serious game
97733|NCT03592953|Post partum hemorrhage|post partum hemorrhage
97734|NCT03592953|Non technical skills|non technical skills
97735|NCT03592927|exercise capacity|exercise capacity
97736|NCT03592927|simulated altitude|simulated altitude
97737|NCT03592888|Pancreatic Adenocarcinoma|pancreatic adenocarcinoma
97738|NCT03592888|Cancer vaccine|cancer vaccine
97739|NCT03592888|Dendritic cell vaccine|dendritic cell vaccine
97740|NCT03592888|Mutant KRAS|mutant kras
97741|NCT03592849|thin endometrium|thin endometrium
97742|NCT03592849|infertility|infertility
97743|NCT03592797|Low-level laser therapy|low-level laser therapy
97744|NCT03592797|Laser acupuncture|laser acupuncture
97745|NCT03592797|Sequelae of Bell's palsy|sequelae of bell's palsy
97746|NCT03592797|Randomized controlled trial|randomized controlled trial
97747|NCT03592745|Transcutaneous vagus nerve stimulation (tVNS)|transcutaneous vagus nerve stimulation (tvns)
97748|NCT03592745|VNS|vns
97749|NCT03592745|robotic therapy|robotic therapy
97750|NCT03592745|occupational therapy|occupational therapy
97751|NCT03592745|motor rehabilitation|motor rehabilitation
97752|NCT03592719|HIV Prevention|hiv prevention
97753|NCT03592719|PrEP|prep
97754|NCT03592719|Black|black
97755|NCT03592719|African American|african american
97756|NCT03592719|Women|women
97757|NCT03592719|Motivational Interviewing|motivational interviewing
97758|NCT03592706|HepatoCellular Carcinoma|hepatocellular carcinoma
97759|NCT03592706|Liver Cancer|liver cancer
97760|NCT03592706|Immune Killer Cells|immune killer cells
97761|NCT03592706|IKC|ikc
97762|NCT03592706|Immune Therapy|immune therapy
97763|NCT03592706|Immunotherapy|immunotherapy
97764|NCT03592706|Cell Therapy|cell therapy
97765|NCT03592706|IVY|ivy
97766|NCT03592706|IVY02|ivy02
97767|NCT03592693|Shock, Septic|shock, septic
97768|NCT03592693|Vitamin C|vitamin c
97769|NCT03592693|Hydrocortisone|hydrocortisone
97770|NCT03592680|Post-operative atrial fibrillation|post-operative atrial fibrillation
97771|NCT03592680|Ascorbic Acid|ascorbic acid
97772|NCT03592680|Vitamin C|vitamin c
97773|NCT03592680|antioxidant|antioxidant
97774|NCT03592680|Cardiac surgery|cardiac surgery
97775|NCT03592667|Stage I Hypertension|stage i hypertension
97776|NCT03592667|Without type 2 diabetes mellitus|without type 2 diabetes mellitus
97777|NCT03592667|Variability of blood pressure|variability of blood pressure
97778|NCT03592667|Ambulatory arterial stiffness index|ambulatory arterial stiffness index
97779|NCT03592667|Dapagliflozin|dapagliflozin
97780|NCT03592667|ABPM|abpm
97781|NCT03592615|prevalence|prevalence
97782|NCT03592615|binocular vision disorders|binocular vision disorders
97783|NCT03592615|accommodative disorders|accommodative disorders
97784|NCT03592615|cataract surgery|cataract surgery
97785|NCT03592615|corneal refractive surgery|corneal refractive surgery
97786|NCT03592576|Expanded Access|expanded access
97787|NCT03592576|Pre-approval Access|pre-approval access
97788|NCT03592576|Compassionate Use|compassionate use
97789|NCT03592576|Special Access Program|special access program
834489|NCT00100672|Anti-cancer|anti-cancer
125585|NCT03418272|ICU|icu
97790|NCT03592576|Named Patient Basis|named patient basis
97791|NCT03592576|Special Access Scheme|special access scheme
97792|NCT03592563|stroke|stroke
97793|NCT03592563|dementia|dementia
97794|NCT03592563|Alzheimer disease|alzheimer disease
97795|NCT03592563|Health Brain|health brain
97796|NCT03592563|Health knowledge|health knowledge
97797|NCT03592537|Fentanyl versus midazolam|fentanyl versus midazolam
97798|NCT03592511|Intervention study|intervention study
97799|NCT03592511|Functional food|functional food
97800|NCT03592511|Grape pomace|grape pomace
97801|NCT03592498|Burns|burns
97802|NCT03592498|Wounds and Injuries|wounds and injuries
97803|NCT03592498|Biocompatible Materials|biocompatible materials
97804|NCT03592498|Nile Tilapia|nile tilapia
97805|NCT03592498|Oreochromis niloticus.|oreochromis niloticus.
97806|NCT03592485|Erector Spinae Plane blockade|erector spinae plane blockade
97807|NCT03592485|Pectoral Fascia block|pectoral fascia block
97808|NCT03592485|patient control anlagesia|patient control anlagesia
97809|NCT03592485|mitral valve replacement|mitral valve replacement
97810|NCT03592472|Renal Cell Carcinoma|renal cell carcinoma
97811|NCT03592472|Progression-free survival|progression-free survival
97812|NCT03592472|Abexinostat|abexinostat
97813|NCT03592472|Pazopanib|pazopanib
97814|NCT03592472|RECIST|recist
97815|NCT03592472|Cancer therapy|cancer therapy
97816|NCT03592433|Decision Making|decision making
97817|NCT03592433|Decision Support|decision support
97818|NCT03592433|Health Literacy|health literacy
97819|NCT03592420|Accidental falls|accidental falls
97820|NCT03592420|Clinical trial|clinical trial
97821|NCT03592420|Aged|aged
97822|NCT03592420|Parkinson's Disease|parkinson's disease
97823|NCT03592420|Stroke|stroke
97824|NCT03592420|Exercise|exercise
97825|NCT03592420|Education|education
97826|NCT03592355|virtual care|virtual care
97827|NCT03592355|virtual visit|virtual visit
97828|NCT03592355|telemedicine|telemedicine
97829|NCT03592342|Patch|patch
97830|NCT03592342|Rivelin-Clo Patch|rivelin-clo patch
97831|NCT03592342|Oral Lichen Planus|oral lichen planus
97832|NCT03592342|Ulcerative|ulcerative
97833|NCT03592342|Erythematous|erythematous
97835|NCT03592342|OLPClinROM|olpclinrom
97836|NCT03592342|OLPSSM|olpssm
97837|NCT03592303|Post-partum haemorrhage|post-partum haemorrhage
97838|NCT03592303|Thromboelastography|thromboelastography
97839|NCT03592303|Coagulopathy|coagulopathy
97840|NCT03592303|Fibrinogenemia|fibrinogenemia
97841|NCT03592277|Sepsis|sepsis
97842|NCT03592277|Septic Shock|septic shock
97843|NCT03592277|Vitamin C|vitamin c
97844|NCT03592277|Thiamine|thiamine
97845|NCT03592225|General Practitioners|general practitioners
97846|NCT03592225|France|france
97847|NCT03592225|RCT|rct
97848|NCT03592225|HPV vaccination|hpv vaccination
97849|NCT03592212|Asthma|asthma
97850|NCT03592212|Salbutamol response|salbutamol response
97851|NCT03592212|Phosphodiesterase 4 variant|phosphodiesterase 4 variant
97852|NCT03592212|lung function|lung function
97853|NCT03592212|airflow limitation|airflow limitation
97854|NCT03592199|biomarker|biomarker
97855|NCT03592199|metastatic|metastatic
97856|NCT03592199|sunitinib|sunitinib
97857|NCT03592199|axitinib|axitinib
97858|NCT03592199|next generation sequencing|next generation sequencing
97859|NCT03592199|clear cell renal cell carcinoma|clear cell renal cell carcinoma
97860|NCT03592186|adolescent|adolescent
97861|NCT03592186|substance use|substance use
97862|NCT03592147|Meditation|meditation
97863|NCT03592147|Music|music
97864|NCT03592147|Relaxation|relaxation
97865|NCT03592147|Light Therapy|light therapy
97866|NCT03592147|Stress|stress
97867|NCT03592121|Nipple Neuropathy, Cancer Survivor|nipple neuropathy, cancer survivor
97868|NCT03592108|Obstructive sleep apnea (OAS)|obstructive sleep apnea (oas)
97869|NCT03592108|Cheyne-Stokes respiration (CSR)|cheyne-stokes respiration (csr)
97870|NCT03592108|Continuous positive airway pressure (CPAP)|continuous positive airway pressure (cpap)
97871|NCT03592108|Telemedicine|telemedicine
97872|NCT03592108|Heart failure|heart failure
97873|NCT03592095|Dry needling|dry needling
97874|NCT03592095|Placebo|placebo
97875|NCT03592095|Myofascial pain sindrome|myofascial pain sindrome
97876|NCT03592095|Masking|masking
97877|NCT03592056|hemidiaphragmatic paralysis|hemidiaphragmatic paralysis
97878|NCT03592056|continuous plexus block|continuous plexus block
97879|NCT03592056|interscalene plexus block|interscalene plexus block
97880|NCT03592056|diluted local anesthetic infusion|diluted local anesthetic infusion
97881|NCT03592056|ambulatory regional analgesia|ambulatory regional analgesia
97882|NCT03592056|ambulatory continuous nerve block|ambulatory continuous nerve block
97883|NCT03592056|continuous local anesthetic infusion|continuous local anesthetic infusion
97884|NCT03592043|MitraClip|mitraclip
97885|NCT03592043|Degenerative Mitral Regurgitation|degenerative mitral regurgitation
97886|NCT03592030|Idiopathic nephrotic syndrome|idiopathic nephrotic syndrome
97887|NCT03592030|Minimal change diseases|minimal change diseases
97888|NCT03592030|Primitive FSGS|primitive fsgs
97889|NCT03591991|Empagliflozin|empagliflozin
97890|NCT03591991|Percutaneous coronary intervention|percutaneous coronary intervention
97891|NCT03591991|Reperfusion Injury|reperfusion injury
97892|NCT03591991|Microvascular protection|microvascular protection
97893|NCT03591991|CI-AKI|ci-aki
97894|NCT03591991|No-Reflow Phenomenon|no-reflow phenomenon
97895|NCT03591978|Disease progression|disease progression
97896|NCT03591978|Circulating Pulmonary Cells|circulating pulmonary cells
97897|NCT03591965|HCC|hcc
97898|NCT03591952|Thoracentesis|thoracentesis
97899|NCT03591926|SM04646|sm04646
97900|NCT03591926|IPF|ipf
97901|NCT03591926|nebulized|nebulized
97902|NCT03591926|inhalation|inhalation
97903|NCT03591900|early diabetes|early diabetes
97904|NCT03591900|prediabetes|prediabetes
97905|NCT03591900|continuous glucose monitoring system|continuous glucose monitoring system
97906|NCT03591900|detection|detection
97907|NCT03591874|ogvhd|ogvhd
97908|NCT03591874|ocular graft vs host|ocular graft vs host
97909|NCT03591874|Ocular Surface Disease|ocular surface disease
97910|NCT03591874|Ocular Graft vs Host Disease|ocular graft vs host disease
97911|NCT03591874|Brimonidine Tartrate|brimonidine tartrate
97912|NCT03591874|Lubricant Eye Drops|lubricant eye drops
97913|NCT03591874|Ophthalmic Solutions|ophthalmic solutions
97914|NCT03591874|Graft vs Host Disease|graft vs host disease
97915|NCT03591848|Breast cancer|breast cancer
97916|NCT03591848|Preservation of fertility|preservation of fertility
97917|NCT03591848|Online support decision tool|online support decision tool
97918|NCT03591835|Nasal septum-tragus length; newborn|nasal septum-tragus length; newborn
97919|NCT03591822|Dementia|dementia
97920|NCT03591822|Pain|pain
97921|NCT03591822|Nursing care|nursing care
97922|NCT03591822|Psychosocial intervention|psychosocial intervention
97923|NCT03591822|Robot-assisted therapy|robot-assisted therapy
97924|NCT03591822|paro robot|paro robot
97925|NCT03591809|cognitive function|cognitive function
97926|NCT03591809|fatigue|fatigue
97927|NCT03591809|quality of life|quality of life
97928|NCT03591809|Functional exercise capacity|functional exercise capacity
97929|NCT03591770|Shingrix vaccine|shingrix vaccine
97930|NCT03591770|tofacitinib monotherapy|tofacitinib monotherapy
97931|NCT03591770|anti-TNF monotherapy|anti-tnf monotherapy
97932|NCT03591770|anti-TNF agent|anti-tnf agent
97933|NCT03591770|thiopurine|thiopurine
97934|NCT03591770|aminosalicylates|aminosalicylates
97935|NCT03591757|Tolcapone|tolcapone
97936|NCT03591757|Transthyretin (TTR)|transthyretin (ttr)
97937|NCT03591757|Mutant TTR|mutant ttr
97938|NCT03591757|Plasma TTR|plasma ttr
97939|NCT03591757|CSF TTR|csf ttr
97940|NCT03591757|Tetramer stability|tetramer stability
97941|NCT03591757|Leptomeningeal|leptomeningeal
97942|NCT03591757|Amyloidosis|amyloidosis
97943|NCT03591731|IFCT|ifct
97944|NCT03591731|NIPINEC|nipinec
97945|NCT03591731|Neuroendocrine|neuroendocrine
97946|NCT03591731|FFCD|ffcd
97947|NCT03591731|GERCOR|gercor
97948|NCT03591666|head and neck adenocarcinoma|head and neck adenocarcinoma
97949|NCT03591666|Anlotinib|anlotinib
97950|NCT03591627|Atrial fibrillation|atrial fibrillation
97951|NCT03591627|Atrial Flutter|atrial flutter
97952|NCT03591627|Transesophageal echocardiography|transesophageal echocardiography
97953|NCT03591627|Ablation|ablation
97954|NCT03591627|Cardioversion|cardioversion
97955|NCT03591627|Thrombus; Embolism|thrombus; embolism
97956|NCT03591614|Vaccine|vaccine
97957|NCT03591614|DKK1|dkk1
97958|NCT03591601|Tension-type headache|tension-type headache
97959|NCT03591601|Pain|pain
97960|NCT03591575|thalassemia|thalassemia
97961|NCT03591575|iron overload|iron overload
97962|NCT03591575|chelation|chelation
97963|NCT03591575|deferiprone|deferiprone
97964|NCT03591575|Ferriprox|ferriprox
97965|NCT03591562|MRI|mri
97966|NCT03591562|COPD|copd
97967|NCT03591562|Disease Progression|disease progression
97968|NCT03591523|cerebrovascular circulation|cerebrovascular circulation
97969|NCT03591523|arterial blood flow|arterial blood flow
97970|NCT03591523|magnetic resonance|magnetic resonance
97971|NCT03591523|duplex sonography|duplex sonography
97972|NCT03591510|PKC412|pkc412
97973|NCT03591510|Acute Myeloid Leukemia|acute myeloid leukemia
97974|NCT03591510|AML|aml
97975|NCT03591510|FLT3-mutated|flt3-mutated
97976|NCT03591510|pediatric population|pediatric population
97977|NCT03591510|midostaurin|midostaurin
97978|NCT03591510|midostaurin combined with standard chemotherapy|midostaurin combined with standard chemotherapy
97979|NCT03591510|single agent post-consolidation therapy|single agent post-consolidation therapy
97980|NCT03591510|untreated FLT3-mutated AML|untreated flt3-mutated aml
97981|NCT03591497|Myelopathy|myelopathy
97982|NCT03591497|Virtual Reality|virtual reality
97983|NCT03591497|Rehabilitation|rehabilitation
97984|NCT03591497|Balance|balance
97985|NCT03591484|Halitosis|halitosis
97986|NCT03591484|photodynamic therapy|photodynamic therapy
97987|NCT03591484|bronchiectasis|bronchiectasis
97988|NCT03591471|Children，|children，
125879|NCT03416504|OCD|ocd
97989|NCT03591471|Henoch-Schönlein Purpura Nephritis|henoch-schönlein purpura nephritis
97990|NCT03591471|Integrated and Stepped Treatment in TCM|integrated and stepped treatment in tcm
97991|NCT03591380|Donor Specific Antibody|donor specific antibody
97992|NCT03591380|Donors, Living|donors, living
97993|NCT03591380|Allograft Tolerance|allograft tolerance
97994|NCT03591354|Artificial Pancreas (AP)|artificial pancreas (ap)
97995|NCT03591354|Type 1 Diabetes Mellitus|type 1 diabetes mellitus
97996|NCT03591354|Insulin Pump|insulin pump
97997|NCT03591354|Continuous Glucose Monitor (CGM)|continuous glucose monitor (cgm)
97998|NCT03591354|Closed Loop Control (CLC)|closed loop control (clc)
97999|NCT03591354|Sensor-Augmented Pump (SAP)|sensor-augmented pump (sap)
98000|NCT03591341|melatonin|melatonin
98001|NCT03591341|breast milk|breast milk
98002|NCT03591328|Acute myocardial infarction|acute myocardial infarction
98003|NCT03591328|Unstable angina|unstable angina
98004|NCT03591328|Acute coronary syndrome|acute coronary syndrome
98005|NCT03591328|Computational fluid dynamics|computational fluid dynamics
98006|NCT03591328|Coronary computed tomography angiography|coronary computed tomography angiography
98007|NCT03591328|Fractional flow reserve|fractional flow reserve
98008|NCT03591315|visual pathway|visual pathway
98009|NCT03591315|functional magnetic resonance imaging|functional magnetic resonance imaging
98010|NCT03591315|pituitary adenoma|pituitary adenoma
98011|NCT03591302|Kidney Transplantation|kidney transplantation
98012|NCT03591302|Blood Stem Cell Transplantation|blood stem cell transplantation
98013|NCT03591289|Robotic Surgery|robotic surgery
98014|NCT03591276|metastatic breast cancer|metastatic breast cancer
98015|NCT03591276|immune check point inhibitors|immune check point inhibitors
98016|NCT03591276|chemotherapy|chemotherapy
98017|NCT03591276|liposomal doxorubicin|liposomal doxorubicin
98018|NCT03591276|pharmacokinetics|pharmacokinetics
98019|NCT03591276|Anti-PD1 antibodies|anti-pd1 antibodies
98020|NCT03591250|Healthcare renunciation|healthcare renunciation
98021|NCT03591250|Continuous positive airway pressure|continuous positive airway pressure
98022|NCT03591250|Non-invasive ventilation|non-invasive ventilation
98023|NCT03591250|Oxygen therapy|oxygen therapy
98024|NCT03591237|cancer|cancer
98025|NCT03591237|late effects|late effects
98026|NCT03591237|pain|pain
98027|NCT03591224|pharmacogenetics|pharmacogenetics
98028|NCT03591224|pharmacogenomics|pharmacogenomics
98029|NCT03591224|antidepressants|antidepressants
98030|NCT03591224|pharmacy|pharmacy
98031|NCT03591224|pharmacist|pharmacist
98032|NCT03591224|community|community
98033|NCT03591185|Accidental Falls|accidental falls
98034|NCT03591185|Primary prevention|primary prevention
98035|NCT03591185|Pressure platform|pressure platform
98036|NCT03591185|Inertial Sensor|inertial sensor
98037|NCT03591146|Postsurgical Pain Management|postsurgical pain management
98038|NCT03591081|Diabetic foot|diabetic foot
98039|NCT03591055|Frail elderly|frail elderly
98040|NCT03591055|Clinical Trial|clinical trial
98041|NCT03590977|Streptococcus Mutans|streptococcus mutans
98042|NCT03590977|licorice|licorice
98043|NCT03590977|chlorohexidine|chlorohexidine
98044|NCT03590977|caries index|caries index
98045|NCT03590964|Implant, Bone ring, Sinus lift.|implant, bone ring, sinus lift.
98046|NCT03590847|Intermittent fasting|intermittent fasting
98047|NCT03590847|Inflammation|inflammation
98048|NCT03590847|Diet|diet
98049|NCT03590847|Lifestyle|lifestyle
98050|NCT03590847|Eating habits|eating habits
98051|NCT03590847|Time Restricted Feeding|time restricted feeding
98052|NCT03590808|Influenza|influenza
98053|NCT03590808|vaccine|vaccine
98054|NCT03590808|solid carcinoma|solid carcinoma
98055|NCT03590808|immune checkpoint|immune checkpoint
98056|NCT03590808|efficacy|efficacy
98057|NCT03590808|safety|safety
98058|NCT03590769|Peripheral Arterial Disease|peripheral arterial disease
98059|NCT03590769|PAD|pad
98060|NCT03590769|Claudication, Intermittent|claudication, intermittent
98061|NCT03590769|Claudication|claudication
98062|NCT03590769|SFA Occlusion|sfa occlusion
98063|NCT03590769|Arterial Occlusion|arterial occlusion
98064|NCT03590769|Iliac Artery Occlusion|iliac artery occlusion
98065|NCT03590769|Vascular Calcification|vascular calcification
98066|NCT03590756|Skin Health|skin health
98067|NCT03590756|Skin Wrinkle|skin wrinkle
98068|NCT03590756|Skin Redness|skin redness
98069|NCT03590756|Carotenoid|carotenoid
98070|NCT03590756|Mango|mango
98071|NCT03590717|dietary diversity|dietary diversity
98072|NCT03590717|minimum acceptable diet|minimum acceptable diet
98073|NCT03590717|fruits|fruits
98074|NCT03590717|vegetables|vegetables
98075|NCT03590717|animal sourced foods|animal sourced foods
98076|NCT03590704|Taping|taping
98077|NCT03590704|Seroma|seroma
98078|NCT03590704|Safety|safety
98079|NCT03590704|Breast Cancer|breast cancer
98080|NCT03590704|Physiotherapy|physiotherapy
98081|NCT03590691|storytelling|storytelling
98208|NCT03590002|Patient Transfer|patient transfer
400587|NCT01866124|acute malnutrition|acute malnutrition
126007|NCT03415802|S-1|s-1
98082|NCT03590665|exercise, blood flow, strength, blood pressure, heart rate,|exercise, blood flow, strength, blood pressure, heart rate,
98083|NCT03590652|multiple myeloma|multiple myeloma
98084|NCT03590652|relapsed/refractory multiple myeloma|relapsed/refractory multiple myeloma
98085|NCT03590652|Daratumumab|daratumumab
98086|NCT03590652|Pomalidomide|pomalidomide
98087|NCT03590652|Ixazomib|ixazomib
98088|NCT03590652|Dexamethasone|dexamethasone
98089|NCT03590652|cancer|cancer
98090|NCT03590652|Phase 2|phase 2
98091|NCT03590652|Darzalex|darzalex
98092|NCT03590652|Pomalyst|pomalyst
98093|NCT03590652|Ninlaro|ninlaro
98094|NCT03590652|Decadron|decadron
98095|NCT03590639|Inflammatory Bowel Diseases|inflammatory bowel diseases
98096|NCT03590639|disability|disability
98097|NCT03590639|quality of life|quality of life
98098|NCT03590639|IBD Disk|ibd disk
98099|NCT03590639|IBD-Disability Index|ibd-disability index
98100|NCT03590639|Patient-Reported Outcomes|patient-reported outcomes
98101|NCT03590626|Non Alcoholic Fatty Liver Disease|non alcoholic fatty liver disease
98102|NCT03590626|Type 2 Diabetes Mellitus|type 2 diabetes mellitus
98103|NCT03590626|GLP-1 receptor agonist|glp-1 receptor agonist
98104|NCT03590626|Dulaglutide|dulaglutide
98105|NCT03590626|MRI-Proton density fat fraction|mri-proton density fat fraction
98106|NCT03590626|Fat Mapping|fat mapping
98107|NCT03590626|Non Alcoholic Steatohepatitis|non alcoholic steatohepatitis
98108|NCT03590613|Sentinel-dosing|sentinel-dosing
98109|NCT03590613|GSK2982772|gsk2982772
98110|NCT03590613|Japnese|japnese
98111|NCT03590613|Dose-ascending|dose-ascending
98112|NCT03590613|Crossover|crossover
98113|NCT03590613|Healthy|healthy
98114|NCT03590600|Phase 1|phase 1
98115|NCT03590600|Anti-Bacterial Agents|anti-bacterial agents
98116|NCT03590600|Respiratory Tract Infections|respiratory tract infections
98117|NCT03590574|T cell lymphoma|t cell lymphoma
98118|NCT03590574|Relapsed T cell Non-Hodgkin Lymphoma|relapsed t cell non-hodgkin lymphoma
98119|NCT03590574|Refractory T cell Non-Hodgkin Lymphoma|refractory t cell non-hodgkin lymphoma
98120|NCT03590574|AUTO4|auto4
98121|NCT03590522|pathogenesis of heart failure|pathogenesis of heart failure
98122|NCT03590522|cardiac ryanodine Receptor 2|cardiac ryanodine receptor 2
98123|NCT03590522|Amino acids|amino acids
98124|NCT03590509|Telemedicine|telemedicine
98125|NCT03590496|propionate|propionate
98126|NCT03590483|Twins|twins
98127|NCT03590483|ART|art
98128|NCT03590483|Induction of Ovulation|induction of ovulation
98129|NCT03590483|Perinatal mortality|perinatal mortality
98130|NCT03590470|avoidable hospitalisations|avoidable hospitalisations
98131|NCT03590470|quality of care|quality of care
98132|NCT03590470|nursing homes|nursing homes
98133|NCT03590470|implementation science|implementation science
98134|NCT03590470|quality improvement|quality improvement
98135|NCT03590431|iodine|iodine
98136|NCT03590431|bioavailability|bioavailability
98137|NCT03590431|milk|milk
98138|NCT03590418|Intestinal failure|intestinal failure
98139|NCT03590418|Microbiota|microbiota
98140|NCT03590405|uterus|uterus
98141|NCT03590405|infertility|infertility
98142|NCT03590405|transplantation|transplantation
98143|NCT03590392|Vaccine|vaccine
98144|NCT03590392|Chikungunya Virus|chikungunya virus
98145|NCT03590392|Chikungunya Fever|chikungunya fever
98146|NCT03590366|Type 1 erythematotelangiectatic rosacea|type 1 erythematotelangiectatic rosacea
98147|NCT03590340|Plasmodium falciparum|plasmodium falciparum
98148|NCT03590340|PfSPZ Vaccine|pfspz vaccine
98149|NCT03590340|PfSPZ Challenge (NF54)|pfspz challenge (nf54)
98150|NCT03590340|CHMI|chmi
98151|NCT03590314|Stroke|stroke
98152|NCT03590314|Upper limb|upper limb
98153|NCT03590314|Recovery|recovery
98154|NCT03590288|Liver cirrhosis|liver cirrhosis
98155|NCT03590288|Transjugular intrahepatic portosystemic shunt|transjugular intrahepatic portosystemic shunt
98156|NCT03590288|Pressure gradient|pressure gradient
98157|NCT03590288|Outcome prediction|outcome prediction
98158|NCT03590275|pancreatic cancer|pancreatic cancer
98159|NCT03590275|chemotherapy|chemotherapy
98160|NCT03590275|FOLFIRINOX|folfirinox
98161|NCT03590275|prognostic|prognostic
98162|NCT03590249|osteopathic manipulative treatment|osteopathic manipulative treatment
98163|NCT03590236|women|women
98164|NCT03590236|chronic pelvic pain|chronic pelvic pain
98165|NCT03590236|fear avoidance|fear avoidance
98166|NCT03590197|Melatonin|melatonin
98167|NCT03590197|Neuron-specific Enolase|neuron-specific enolase
98168|NCT03590197|Responder rate|responder rate
98169|NCT03590184|Abdominal wall repair|abdominal wall repair
98170|NCT03590184|Infection|infection
98171|NCT03590184|Biologic mesh|biologic mesh
98172|NCT03590184|Biosynthetic mesh|biosynthetic mesh
98173|NCT03590184|Cost-effectiveness|cost-effectiveness
98174|NCT03590171|ALL|all
98175|NCT03590145|Groin pain|groin pain
98176|NCT03590145|Adductor-related|adductor-related
98177|NCT03590145|Inguinal-related|inguinal-related
98178|NCT03590145|Pubic-related|pubic-related
98179|NCT03590145|Iliopsoas-related|iliopsoas-related
98180|NCT03590145|Hip-related|hip-related
98181|NCT03590132|adolescent|adolescent
98182|NCT03590132|alcohol|alcohol
98183|NCT03590132|family-centered prevention|family-centered prevention
98184|NCT03590132|African American|african american
98185|NCT03590119|LUTIA|lutia
98186|NCT03590119|neuroendocrine tumor|neuroendocrine tumor
98187|NCT03590119|lutetium-177-dotatate|lutetium-177-dotatate
98188|NCT03590119|intra-arterial|intra-arterial
98189|NCT03590119|liver metastases|liver metastases
98190|NCT03590080|Graves' Disease|graves' disease
98191|NCT03590080|Graves' Ophthalmopathy|graves' ophthalmopathy
98192|NCT03590080|Hypertension|hypertension
98193|NCT03590080|Blood Pressure|blood pressure
98194|NCT03590080|Methylprednisolone|methylprednisolone
98195|NCT03590080|Glucocorticoids|glucocorticoids
98196|NCT03590067|End stage renal disease|end stage renal disease
98197|NCT03590067|Haemodialysis|haemodialysis
98198|NCT03590067|Renal transplantation|renal transplantation
98199|NCT03590067|pediatric|pediatric
98200|NCT03590067|chronic kidney disease|chronic kidney disease
98201|NCT03590067|oral finding|oral finding
98202|NCT03590067|oral manifestation|oral manifestation
98203|NCT03590041|Diabetes Mellitus Type 2, Comparative Effectiveness Trial|diabetes mellitus type 2, comparative effectiveness trial
98204|NCT03590015|Recruitment|recruitment
98205|NCT03590015|Invitation Letter|invitation letter
98206|NCT03590015|patients|patients
98207|NCT03590015|Schizophrenia|schizophrenia
98209|NCT03590002|Patient Discharge Summaries|patient discharge summaries
98210|NCT03590002|Continuity of Patient Care|continuity of patient care
98211|NCT03590002|Intensive Care Unit|intensive care unit
98212|NCT03590002|Critical Care|critical care
98213|NCT03590002|Health Information Exchange|health information exchange
98214|NCT03590002|Medical Order Entry Systems|medical order entry systems
98215|NCT03590002|Point-of-Care Systems|point-of-care systems
98216|NCT03590002|Medical Informatics|medical informatics
98217|NCT03589950|anlotinib|anlotinib
98218|NCT03589950|docetaxel|docetaxel
98219|NCT03589950|pemetrexed|pemetrexed
98220|NCT03589937|refractive error|refractive error
98221|NCT03589937|ocular structural parameters|ocular structural parameters
98222|NCT03589924|Immediate implant reconstruction|immediate implant reconstruction
98223|NCT03589924|TiLoop® Bra|tiloop® bra
98224|NCT03589898|magnetic resonance imaging|magnetic resonance imaging
98225|NCT03589898|spectroscopy|spectroscopy
98226|NCT03589898|GABA|gaba
98227|NCT03589898|glutamate|glutamate
98228|NCT03589898|social cognition|social cognition
98239|NCT03589820|plasma exchange|plasma exchange
98240|NCT03589820|continuous hemodiafiltration|continuous hemodiafiltration
98250|NCT03589794|AP 10-602 [GLA-LSQ]|ap 10-602 [gla-lsq]
98251|NCT03589794|Challenge|challenge
98252|NCT03589794|Healthy adults|healthy adults
98253|NCT03589794|Malaria|malaria
98254|NCT03589794|P. falciparum|p. falciparum
98255|NCT03589794|rCSP|rcsp
98256|NCT03589794|Vaccine|vaccine
98265|NCT03589755|mindfulness|mindfulness
98266|NCT03589755|meditation|meditation
98267|NCT03589755|anxiety|anxiety
98268|NCT03589755|depression|depression
98269|NCT03589742|Atrial Fibrillation|atrial fibrillation
98270|NCT03589742|Atrial Flutter|atrial flutter
98271|NCT03589742|Radiofrequency Ablation|radiofrequency ablation
98272|NCT03589742|Pulmonary Vein Isolation|pulmonary vein isolation
98273|NCT03589742|Catheter|catheter
98274|NCT03589742|AblaView Ablation Catheter|ablaview ablation catheter
98275|NCT03589742|Atrioventricular node|atrioventricular node
98276|NCT03589716|Vital Signs|vital signs
98277|NCT03589703|Chronic Low Back Pain|chronic low back pain
98278|NCT03589703|cLBP|clbp
98279|NCT03589703|pain|pain
98280|NCT03589703|acupressure|acupressure
98281|NCT03589690|Metabolic Syndrome|metabolic syndrome
98282|NCT03589690|Thioctic Acid|thioctic acid
98283|NCT03589690|Inflammation|inflammation
98284|NCT03589690|Insulin Resistance|insulin resistance
98285|NCT03589677|DM1|dm1
98286|NCT03589677|Brain|brain
98287|NCT03589677|MRI|mri
98288|NCT03589651|Solid tumors|solid tumors
98289|NCT03589651|locally advanced unresectable tumor|locally advanced unresectable tumor
98290|NCT03589651|metastatic solid tumors|metastatic solid tumors
98291|NCT03589638|tracheal intubation|tracheal intubation
98292|NCT03589638|videolaryngoscopy|videolaryngoscopy
98293|NCT03589638|hemodynamics|hemodynamics
98294|NCT03589638|intraocular pressure|intraocular pressure
98295|NCT03589625|electricity and health|electricity and health
98296|NCT03589625|maternal health|maternal health
98297|NCT03589625|quality of care|quality of care
98298|NCT03589625|solar power|solar power
98299|NCT03589612|Duchenne Muscular Dystrophy|duchenne muscular dystrophy
98300|NCT03589612|performance|performance
98301|NCT03589612|hamstring flexibility|hamstring flexibility
98302|NCT03589612|regression|regression
98303|NCT03589573|Duchenne Muscular Dystrophy|duchenne muscular dystrophy
98304|NCT03589573|muscle strength|muscle strength
98305|NCT03589573|hamstring flexibility|hamstring flexibility
98306|NCT03589573|back muscle|back muscle
98307|NCT03589573|lower extremity|lower extremity
98308|NCT03589560|revascularization|revascularization
98309|NCT03589560|necrotic|necrotic
98310|NCT03589560|immature|immature
98311|NCT03589560|coronal plug|coronal plug
98312|NCT03589547|Lung cancer|lung cancer
98313|NCT03589547|NSCLC|nsclc
98314|NCT03589547|Stage III|stage iii
98315|NCT03589547|Post chemoradiation|post chemoradiation
98316|NCT03589521|Veterans|veterans
98317|NCT03589521|Cognitive Therapy|cognitive therapy
98318|NCT03589521|Couple Therapy|couple therapy
98319|NCT03589508|National Guard|national guard
98320|NCT03589508|Telehealth|telehealth
98321|NCT03589508|Prevention|prevention
98322|NCT03589469|Loncastuximab tesirine|loncastuximab tesirine
98323|NCT03589456|lung cancer|lung cancer
98324|NCT03589456|lung carcinoma|lung carcinoma
98325|NCT03589456|lung metastases|lung metastases
98326|NCT03589456|metastases|metastases
98327|NCT03589391|Epidural injection|epidural injection
98328|NCT03589391|loss of resistance detection|loss of resistance detection
98329|NCT03589391|mechatronic device|mechatronic device
98330|NCT03589352|gynaecological aftercare|gynaecological aftercare
98331|NCT03589352|contraception|contraception
98332|NCT03589352|breast cancer|breast cancer
98930|NCT03585179|Chloasma|chloasma
98333|NCT03589352|cervix cancer|cervix cancer
98334|NCT03589352|cervical screening|cervical screening
98335|NCT03589352|breast self examination|breast self examination
98336|NCT03589352|mammography|mammography
98337|NCT03589352|midwife|midwife
98338|NCT03589352|body knowledge|body knowledge
98339|NCT03589352|prevention|prevention
98340|NCT03589352|self care|self care
98341|NCT03589326|Ponatinib|ponatinib
98342|NCT03589326|Imatinib mesylate|imatinib mesylate
98343|NCT03589326|Bcr-Abl Tyrosine Kinase|bcr-abl tyrosine kinase
98344|NCT03589326|Bcr-abl fusion proteins|bcr-abl fusion proteins
98345|NCT03589326|Iclusig|iclusig
98346|NCT03589326|Gleevec|gleevec
98347|NCT03589287|Intra-articular (IA), Allogeneic, MSC, OA|intra-articular (ia), allogeneic, msc, oa
98348|NCT03589274|alcohol use disorder|alcohol use disorder
98349|NCT03589274|women|women
98350|NCT03589274|female specific therapy|female specific therapy
98351|NCT03589274|cognitive behavior therapy|cognitive behavior therapy
98352|NCT03589274|group therapy|group therapy
98353|NCT03589235|autografts|autografts
98354|NCT03589235|gingival recession|gingival recession
98355|NCT03589235|free gingival graft|free gingival graft
98356|NCT03589235|Attached gingival width|attached gingival width
98357|NCT03589235|Platelet-Rich Fibrin dressing|platelet-rich fibrin dressing
98358|NCT03589209|Round window visibility|round window visibility
98359|NCT03589209|Cochlear implantation|cochlear implantation
98360|NCT03589183|Gut Microbiome|gut microbiome
98361|NCT03589183|Ulcerative colitis|ulcerative colitis
98362|NCT03589183|Crohn disease|crohn disease
98363|NCT03589183|Multi-omics|multi-omics
98364|NCT03589183|Psychometrics|psychometrics
98365|NCT03589183|anxiety|anxiety
98366|NCT03589183|depression|depression
98367|NCT03589170|Atrial fibrillation|atrial fibrillation
98368|NCT03589170|Opportunistic screening|opportunistic screening
98369|NCT03589170|ischaemic stroke|ischaemic stroke
98370|NCT03589118|Substance Addiction|substance addiction
98371|NCT03589118|Craving|craving
98372|NCT03589118|Chinese Medecine|chinese medecine
98373|NCT03589118|Qi Gong|qi gong
98374|NCT03589118|Psychology|psychology
98376|NCT03589092|MODY|mody
98377|NCT03589092|Genetic testing|genetic testing
98378|NCT03589092|Next Generation Sequencing|next generation sequencing
98379|NCT03589092|NGS|ngs
98380|NCT03589079|Monogenic Disorder|monogenic disorder
98381|NCT03589079|Mendelian Disease|mendelian disease
98382|NCT03589079|Single Gene Disorder|single gene disorder
98383|NCT03589079|Next Generation Sequencing|next generation sequencing
98384|NCT03589079|Genetic testing|genetic testing
98385|NCT03589066|rotigotine|rotigotine
98386|NCT03589066|parkinson|parkinson
98387|NCT03589066|parkinsons|parkinsons
98388|NCT03589066|intramuscular injection|intramuscular injection
98389|NCT03589066|UPDRS|updrs
98390|NCT03589053|Limb remote ischemic conditioning|limb remote ischemic conditioning
98391|NCT03589053|Cerebrovascular reserve|cerebrovascular reserve
98392|NCT03589014|Cerebral Cavernous Malformation|cerebral cavernous malformation
98393|NCT03589014|Propranolol|propranolol
98394|NCT03589014|Magnetic Resonance Imaging|magnetic resonance imaging
98395|NCT03588962|allergy to metals, restenosis, in-stent restenosis|allergy to metals, restenosis, in-stent restenosis
98396|NCT03588962|coronary artery disease|coronary artery disease
98397|NCT03588923|HCV|hcv
98398|NCT03588923|NS5B|ns5b
98399|NCT03588923|SH229|sh229
98400|NCT03588910|ambulatory|ambulatory
98401|NCT03588910|narcotics|narcotics
98402|NCT03588910|opioids|opioids
98403|NCT03588910|postoperative|postoperative
98404|NCT03588910|gynecology|gynecology
98405|NCT03588910|laparoscopy|laparoscopy
98406|NCT03588910|pain|pain
98407|NCT03588910|surgery|surgery
98408|NCT03588897|nutritional status|nutritional status
98409|NCT03588897|Nutridrink|nutridrink
835319|NCT00097604|Aged|aged
98410|NCT03588897|elderly nutrition|elderly nutrition
98411|NCT03588871|Tooth bleaching|tooth bleaching
98412|NCT03588871|Quality of life|quality of life
98413|NCT03588832|Stroke|stroke
98414|NCT03588832|Spasticity|spasticity
98415|NCT03588832|Upper Extremity|upper extremity
98416|NCT03588832|Quality of Life|quality of life
98417|NCT03588806|Abuse-deterrent opioid drugs|abuse-deterrent opioid drugs
98418|NCT03588806|Xtampza ER|xtampza er
98419|NCT03588780|acute stroke|acute stroke
98420|NCT03588780|thrombectomy|thrombectomy
98421|NCT03588780|tandem lesions|tandem lesions
98422|NCT03588767|polytrauma|polytrauma
98423|NCT03588767|endocrine response|endocrine response
98424|NCT03588767|metabolic response|metabolic response
98425|NCT03588767|bone metabolism|bone metabolism
98426|NCT03588767|anabolic substance|anabolic substance
98427|NCT03588767|vitamin D|vitamin d
98428|NCT03588728|Transcranial Direct Current Stimulation|transcranial direct current stimulation
98429|NCT03588728|Smoking|smoking
98430|NCT03588728|Schizophrenia|schizophrenia
98431|NCT03588715|HIV|hiv
98432|NCT03588715|HIV/AIDS|hiv/aids
98433|NCT03588715|HIV Cure|hiv cure
98434|NCT03588715|HIV-1|hiv-1
98435|NCT03588715|HIV-1 Infection|hiv-1 infection
98436|NCT03588715|BEAT-HIV|beat-hiv
98437|NCT03588715|bNAbs|bnabs
98931|NCT03585179|Melanosis|melanosis
98438|NCT03588715|Broadly neutralizing antibodies|broadly neutralizing antibodies
98439|NCT03588702|radiofrequency|radiofrequency
98440|NCT03588702|pulsed electro-magnetic fields|pulsed electro-magnetic fields
98441|NCT03588702|liposuction|liposuction
98442|NCT03588689|hip fracture|hip fracture
98443|NCT03588689|fascia iliaca block|fascia iliaca block
98444|NCT03588689|continuous fascia iliaca block|continuous fascia iliaca block
98445|NCT03588689|neuromuscular blockade|neuromuscular blockade
98446|NCT03588676|Hypoxia|hypoxia
98447|NCT03588676|High Altitude|high altitude
98448|NCT03588676|Melatonin|melatonin
98449|NCT03588676|Neurocognitive|neurocognitive
98450|NCT03588663|Robotics|robotics
98451|NCT03588663|Walking|walking
98452|NCT03588663|Balance|balance
98453|NCT03588611|bivalirudin|bivalirudin
98454|NCT03588611|bolus injection|bolus injection
98455|NCT03588611|activated clotting time|activated clotting time
98456|NCT03588611|Renal insufficiency|renal insufficiency
98457|NCT03588598|CLL|cll
98458|NCT03588598|SLL|sll
98459|NCT03588598|NHL|nhl
98460|NCT03588598|SHC014748M|shc014748m
98461|NCT03588598|Phosphatidylinositol 3-kinase (PI3K)|phosphatidylinositol 3-kinase (pi3k)
98462|NCT03588572|Behavioural evaluation|behavioural evaluation
98463|NCT03588572|Functional magnetic resonance imaging|functional magnetic resonance imaging
98464|NCT03588572|Venlafaxine|venlafaxine
98465|NCT03588559|Monitors, Blood Pressure|monitors, blood pressure
98466|NCT03588546|Fasenra Benralizumab Bronchial asthma|fasenra benralizumab bronchial asthma
98467|NCT03588533|HER-2 Positive|her-2 positive
98468|NCT03588533|Gastric or gastroesophageal adenocarcinoma|gastric or gastroesophageal adenocarcinoma
98469|NCT03588533|Herzuma|herzuma
98470|NCT03588520|Hypertension|hypertension
98471|NCT03588520|Chronic Kidney Disease|chronic kidney disease
98472|NCT03588520|Home Blood Pressure Monitoring|home blood pressure monitoring
98473|NCT03588520|Blood Pressure Management|blood pressure management
98474|NCT03588520|Masked Hypertension|masked hypertension
98475|NCT03588520|White Coat Hypertension|white coat hypertension
98476|NCT03588520|Renal Insufficiency|renal insufficiency
98477|NCT03588520|Cardiovascular Risk|cardiovascular risk
98478|NCT03588507|papilla preservation|papilla preservation
98479|NCT03588507|modified papilla preservation|modified papilla preservation
98480|NCT03588507|simplified papilla preservation|simplified papilla preservation
98481|NCT03588507|nanocrystalline hydroxyapetite|nanocrystalline hydroxyapetite
98482|NCT03588507|nanobone graft|nanobone graft
98483|NCT03588494|Recombinant human endostatin|recombinant human endostatin
98484|NCT03588494|NSCLC|nsclc
98485|NCT03588494|chemoradiotherapy|chemoradiotherapy
98486|NCT03588481|PCI|pci
98487|NCT03588481|DES|des
98488|NCT03588481|real world|real world
98489|NCT03588429|Sevoflurane|sevoflurane
98490|NCT03588429|Isoflurane|isoflurane
98491|NCT03588416|pT1|pt1
98492|NCT03588416|Polypectomy|polypectomy
98493|NCT03588416|Lymph node metastasis|lymph node metastasis
98494|NCT03588416|Colorectal neoplasm|colorectal neoplasm
98495|NCT03588364|osteopathic manipulation|osteopathic manipulation
98496|NCT03588338|PONV|ponv
98497|NCT03588338|Paracetamol|paracetamol
98498|NCT03588325|MDW|mdw
98499|NCT03588325|Sepsis|sepsis
98500|NCT03588312|Aortic arch hypoplasia|aortic arch hypoplasia
98501|NCT03588312|Glutaraldehyde treated autologous pericardium|glutaraldehyde treated autologous pericardium
98502|NCT03588312|Single stage repair|single stage repair
98503|NCT03588312|Congenital heart defects|congenital heart defects
98504|NCT03588312|Newborns|newborns
98505|NCT03588299|Severe hemophilia A (<1% FVIII activity)|severe hemophilia a (<1% fviii activity)
98506|NCT03588299|Factor VIII gene therapy|factor viii gene therapy
98507|NCT03588273|Bariatric surgery|bariatric surgery
126463|NCT03412851|ADAPT|adapt
98508|NCT03588273|Pharmacokinetics|pharmacokinetics
98509|NCT03588273|Amoxicillin|amoxicillin
98510|NCT03588273|Obesity|obesity
98511|NCT03588260|idiopathic pulmonary fibrosis|idiopathic pulmonary fibrosis
98512|NCT03588260|respiratory muscle strength|respiratory muscle strength
98513|NCT03588260|physical activity|physical activity
98514|NCT03588260|quality of life|quality of life
98515|NCT03588260|dyspnea|dyspnea
98516|NCT03588260|fatigue severity|fatigue severity
98517|NCT03588260|exercise capacity|exercise capacity
98518|NCT03588208|Fibromyalgia|fibromyalgia
98519|NCT03588208|Pain|pain
98520|NCT03588208|Function|function
98521|NCT03588208|Quality of life|quality of life
98522|NCT03588195|Education|education
98523|NCT03588195|Pain|pain
98524|NCT03588195|Function|function
98525|NCT03588195|Quality of life|quality of life
98526|NCT03588182|Virtual Reality (VR)|virtual reality (vr)
98527|NCT03588156|Healthy Subject|healthy subject
98528|NCT03588156|PK Study|pk study
98529|NCT03588156|Tolerability|tolerability
98530|NCT03588156|Safety Evaluation|safety evaluation
98531|NCT03588143|Subacromial pain|subacromial pain
98532|NCT03588143|Joint range of motion|joint range of motion
98533|NCT03588143|Electrotherapy|electrotherapy
98534|NCT03588143|Physiotherapy|physiotherapy
98535|NCT03588143|Impingement|impingement
98536|NCT03588130|Debridement|debridement
98537|NCT03588117|Metabolic Syndrome|metabolic syndrome
98538|NCT03588104|Electronic Health (eHealth)|electronic health (ehealth)
98540|NCT03588065|public health|public health
98541|NCT03588065|Soccer|soccer
98542|NCT03588052|Vestibular incision subperiosteal tunnel access, Subepithelial connective tissue graft, Platelets rich fibrin, Multiple gingival recessions|vestibular incision subperiosteal tunnel access, subepithelial connective tissue graft, platelets rich fibrin, multiple gingival recessions
98543|NCT03587935|Colon Adenoma|colon adenoma
98544|NCT03587935|Colon Polyp|colon polyp
98545|NCT03587935|Adenoma detection rate|adenoma detection rate
98546|NCT03587935|Magnetic Endoscopy Imaging|magnetic endoscopy imaging
98547|NCT03587909|FLACS|flacs
98548|NCT03587909|Phaco|phaco
98549|NCT03587909|Shallow Anterior Chamber|shallow anterior chamber
98550|NCT03587896|distress|distress
98551|NCT03587896|post-traumatic stress disorder|post-traumatic stress disorder
98552|NCT03587896|prevention|prevention
98553|NCT03587896|refugees|refugees
98554|NCT03587896|Self Help Plus|self help plus
98555|NCT03587896|Turkey|turkey
98556|NCT03587883|flavanol|flavanol
98557|NCT03587883|cocoa flavanols|cocoa flavanols
98558|NCT03587883|arterial stiffness|arterial stiffness
98559|NCT03587883|blood pressure|blood pressure
98560|NCT03587883|step test|step test
98561|NCT03587870|intensive care unit|intensive care unit
98562|NCT03587870|intermittent enteral nutrition|intermittent enteral nutrition
98563|NCT03587870|continuous enteral nutrition|continuous enteral nutrition
98564|NCT03587870|muscle wasting|muscle wasting
98565|NCT03587857|Health Disparity|health disparity
98566|NCT03587844|Brentuximab Vedotin|brentuximab vedotin
98567|NCT03587844|18-147|18-147
98568|NCT03587818|Patient-Centered Care|patient-centered care
98569|NCT03587818|Health Communication|health communication
98570|NCT03587818|Clinical trial|clinical trial
98571|NCT03587818|Colorectal neoplasms|colorectal neoplasms
98572|NCT03587818|Colorectal surgery|colorectal surgery
98573|NCT03587818|Continuity of patient care|continuity of patient care
98574|NCT03587818|Medical-surgical nursing|medical-surgical nursing
98575|NCT03587818|Qualitative Research|qualitative research
98576|NCT03587779|patient state index|patient state index
98577|NCT03587779|sevoflurane|sevoflurane
98578|NCT03587779|desflurane|desflurane
98579|NCT03587779|minimum alveolar concentration|minimum alveolar concentration
98580|NCT03587766|Trypanosoma cruzi Infection|trypanosoma cruzi infection
98581|NCT03587766|Chagas' Disease|chagas' disease
98582|NCT03587766|Trypanosomiasis, South American|trypanosomiasis, south american
98583|NCT03587766|American Trypanosomiasis|american trypanosomiasis
98584|NCT03587766|Kissing bug|kissing bug
98586|NCT03587727|bariatric surgery|bariatric surgery
98587|NCT03587727|hepatic mitochondria|hepatic mitochondria
98588|NCT03587727|insulin secretion|insulin secretion
98589|NCT03587649|AD|ad
98590|NCT03587649|PD|pd
98591|NCT03587649|HV|hv
98592|NCT03587610|vaccination coverage|vaccination coverage
98593|NCT03587558|carvedilol|carvedilol
98594|NCT03587558|SOICR|soicr
98595|NCT03587558|triggered activity|triggered activity
98596|NCT03587558|outflow tract PVC/VT|outflow tract pvc/vt
98597|NCT03587532|esophagectomy|esophagectomy
98598|NCT03587532|indocyanine green|indocyanine green
98599|NCT03587532|near infrared fluorescence|near infrared fluorescence
98600|NCT03587506|Generalized epilepsy, idiopathic, periodic limb movement|generalized epilepsy, idiopathic, periodic limb movement
98601|NCT03587480|Low rectal cancer|low rectal cancer
98602|NCT03587480|Total Mesorectal Excision (TME)|total mesorectal excision (tme)
98603|NCT03587480|neoadjuvant Chemo-radiotherapy (nCRT)|neoadjuvant chemo-radiotherapy (ncrt)
98604|NCT03587480|lateral lymph node dissection (LLND)|lateral lymph node dissection (llnd)
98605|NCT03587454|teleglaucoma|teleglaucoma
98606|NCT03587454|teleophthalmology|teleophthalmology
98607|NCT03587441|postural headache|postural headache
98608|NCT03587441|intrathecal neostigmine for prevention of PDPH|intrathecal neostigmine for prevention of pdph
98609|NCT03587415|amylin; obesity; polycystic ovarian syndrome; preptin|amylin; obesity; polycystic ovarian syndrome; preptin
98610|NCT03587389|Rotavirus|rotavirus
98611|NCT03587389|Vaccine|vaccine
98612|NCT03587389|Diarrhea|diarrhea
98613|NCT03587389|Host genetics|host genetics
98614|NCT03587337|Per-Oral Endoscopy Myotomy|per-oral endoscopy myotomy
98615|NCT03587337|Microbial Translocation|microbial translocation
98616|NCT03587298|ShearWave Elastography|shearwave elastography
98617|NCT03587285|prostate cancer|prostate cancer
98618|NCT03587285|central memory T cell|central memory t cell
98619|NCT03587259|breast cancer screening|breast cancer screening
98620|NCT03587259|tomosynthesis|tomosynthesis
98621|NCT03587259|digital mammography|digital mammography
98622|NCT03587233|Weight status|weight status
98623|NCT03587233|Body mass index|body mass index
98624|NCT03587233|Physical activity level|physical activity level
98625|NCT03587233|Lifestyle behaviour|lifestyle behaviour
98626|NCT03587207|Meningitis|meningitis
98627|NCT03587207|Concomitantly|concomitantly
98628|NCT03587207|Adolescent|adolescent
98629|NCT03587207|Neisseria meningitidis|neisseria meningitidis
98630|NCT03587207|Healthy subjects|healthy subjects
98631|NCT03587207|Adult|adult
98632|NCT03587181|Cryoballoon, Cryoablation, biobanking, Loop recorder, biopsy|cryoballoon, cryoablation, biobanking, loop recorder, biopsy
98633|NCT03587168|Parkinson's Disease|parkinson's disease
98634|NCT03587168|The Timed 360° Turn Test|the timed 360° turn test
98635|NCT03587168|Validity|validity
98636|NCT03587168|Reliability|reliability
98637|NCT03587155|ASNS, single cell RNA seq, Neurodevelopmental Dysplasia,|asns, single cell rna seq, neurodevelopmental dysplasia,
98638|NCT03587142|gastroparesis|gastroparesis
98639|NCT03587142|early satiety|early satiety
98640|NCT03587142|stomach|stomach
98641|NCT03587142|buspirone|buspirone
98642|NCT03587142|5-HT 1a receptor agonist|5-ht 1a receptor agonist
98643|NCT03587129|epithelial ovarian cancer|epithelial ovarian cancer
98644|NCT03587129|ovarian cancer|ovarian cancer
98645|NCT03587129|platinum-resistant|platinum-resistant
98646|NCT03587129|platinum-refractory|platinum-refractory
98647|NCT03587064|CRT-D|crt-d
98648|NCT03587064|CRT-DX|crt-dx
98649|NCT03587064|Atrial pacing|atrial pacing
98650|NCT03587025|amitryptyline|amitryptyline
98651|NCT03587025|Analgesia|analgesia
98652|NCT03587025|Hysterectomy|hysterectomy
98653|NCT03587025|Pain, Postoperative|pain, postoperative
98654|NCT03586999|Nivolumab|nivolumab
98655|NCT03586999|First Line Treatment|first line treatment
98656|NCT03586999|EPOCH|epoch
98657|NCT03586999|Standard of Care|standard of care
98658|NCT03586986|First degree relative|first degree relative
98659|NCT03586856|Continuous positive airway pressure|continuous positive airway pressure
98660|NCT03586856|Air Leakage|air leakage
98661|NCT03586856|Work of breathing|work of breathing
98662|NCT03586804|menstrual|menstrual
98663|NCT03586804|postural sway|postural sway
98664|NCT03586804|dual task|dual task
98665|NCT03586778|Back Pain|back pain
98666|NCT03586778|Dry Needling|dry needling
98667|NCT03586765|incontinence|incontinence
98668|NCT03586765|female|female
98669|NCT03586765|observational study|observational study
98670|NCT03586765|self filled survey|self filled survey
98671|NCT03586765|epidemiology|epidemiology
98672|NCT03586752|HQCPR between standard and on-line program|hqcpr between standard and on-line program
98673|NCT03586752|Education|education
98674|NCT03586739|Mesenteric Ischemia Chronic|mesenteric ischemia chronic
98675|NCT03586739|Atherosclerosis|atherosclerosis
98676|NCT03586739|Restenosis|restenosis
98677|NCT03586739|Primary endovascular treatment|primary endovascular treatment
98678|NCT03586739|Covered stents|covered stents
98679|NCT03586739|Bare metal stents|bare metal stents
98680|NCT03586700|Knee Osteoarthritis|knee osteoarthritis
98681|NCT03586700|Synovium effusion|synovium effusion
98682|NCT03586700|RCT|rct
98683|NCT03586700|placebo|placebo
98684|NCT03586687|Ultrasound guided injection|ultrasound guided injection
98685|NCT03586674|pediatric cholestasis, Fibrate|pediatric cholestasis, fibrate
98686|NCT03586622|Home monitoring|home monitoring
98687|NCT03586622|Irritable Bowel Syndrome|irritable bowel syndrome
98688|NCT03586596|Smokers|smokers
98689|NCT03586596|Mobile intervention|mobile intervention
98690|NCT03586596|Latino|latino
98691|NCT03586596|Promotores de Salud|promotores de salud
98692|NCT03586596|Pharmacotherapy|pharmacotherapy
98693|NCT03586596|Cultural accomodation|cultural accomodation
98694|NCT03586596|Tobacco use|tobacco use
98695|NCT03586596|Health Disparities|health disparities
98696|NCT03586596|Cancer Disparities|cancer disparities
98697|NCT03586557|Optic Neuritis|optic neuritis
98698|NCT03586557|aquaporin4-IgG|aquaporin4-igg
98699|NCT03586557|Treatment|treatment
98700|NCT03586544|pediatric|pediatric
98701|NCT03586544|bronchoconstriction|bronchoconstriction
98702|NCT03586531|renal biopsy|renal biopsy
98703|NCT03586518|Cardiac MRI|cardiac mri
98704|NCT03586518|Hemodialysis|hemodialysis
98705|NCT03586518|Myocardial Fibrosis|myocardial fibrosis
98706|NCT03586518|Myocardial Inflammation|myocardial inflammation
98707|NCT03586505|Keratitis|keratitis
98708|NCT03586505|Eye Infection|eye infection
98709|NCT03586505|Photophobia|photophobia
98710|NCT03586505|Red light|red light
98711|NCT03586505|Infrared light|infrared light
98712|NCT03586492|CFR|cfr
98713|NCT03586492|SPECT|spect
98714|NCT03586492|CZT|czt
98715|NCT03586492|Coronary|coronary
98716|NCT03586492|Calcium score|calcium score
98717|NCT03586492|Scintigraphy|scintigraphy
98718|NCT03586492|Myocardial perfusion|myocardial perfusion
98719|NCT03586479|Vocabulary|vocabulary
98720|NCT03586466|opioid abuse|opioid abuse
98721|NCT03586466|opioid dependence|opioid dependence
98722|NCT03586466|medication assisted treatment|medication assisted treatment
98723|NCT03586466|opioids|opioids
98724|NCT03586466|buprenorphine|buprenorphine
98725|NCT03586466|buprenorphine/naloxone|buprenorphine/naloxone
98726|NCT03586466|MedicaSafe|medicasafe
98727|NCT03586453|Non-Small Cell Lung Cancer (NSCLC) with an Epidermal Growth Factor Receptor (EGFR) mutation|non-small cell lung cancer (nsclc) with an epidermal growth factor receptor (egfr) mutation
98728|NCT03586440|RS-FHRSP-grip strength|rs-fhrsp-grip strength
98729|NCT03586414|MitoQ|mitoq
98730|NCT03586401|Children who have been treated for cancer|children who have been treated for cancer
99435|NCT03582111|Pregnancy|pregnancy
98731|NCT03586401|Qualification of health|qualification of health
98732|NCT03586401|Physical insolvency|physical insolvency
98733|NCT03586401|Late toxic effects|late toxic effects
98734|NCT03586401|Physical therapy|physical therapy
98735|NCT03586401|Physical activity|physical activity
98736|NCT03586401|Systems for decision making support|systems for decision making support
98737|NCT03586388|Hypersensitivity, Milk|hypersensitivity, milk
98738|NCT03586388|Cow's Milk|cow's milk
98739|NCT03586388|Immunotherapy|immunotherapy
98740|NCT03586388|Infant|infant
98741|NCT03586362|Vancomycin|vancomycin
98742|NCT03586362|MRSA nasal swab|mrsa nasal swab
98743|NCT03586362|Pneumonia|pneumonia
98744|NCT03586297|BCRF|bcrf
98745|NCT03586297|Microbiome|microbiome
98746|NCT03586297|Intratumoal microbiota|intratumoal microbiota
98747|NCT03586284|Cytomegalovirus uveitis|cytomegalovirus uveitis
98748|NCT03586284|Cytomegalovirus endotheliitis|cytomegalovirus endotheliitis
98749|NCT03586284|Cytomegalovirus keratouveitis|cytomegalovirus keratouveitis
98750|NCT03586284|Cytomegalovirus iridocyclitis|cytomegalovirus iridocyclitis
98751|NCT03586258|Neuropsychological study|neuropsychological study
98752|NCT03586258|Brain imaging|brain imaging
98753|NCT03586245|Iron Bioavailability|iron bioavailability
98754|NCT03586245|Iron Fortification|iron fortification
98755|NCT03586245|ferrous sulfate|ferrous sulfate
98756|NCT03586245|ferric pyrophosphate|ferric pyrophosphate
98757|NCT03586245|aspergillus oryzae|aspergillus oryzae
98758|NCT03586245|stable isotope|stable isotope
98759|NCT03586232|Rhinoplasty|rhinoplasty
98760|NCT03586232|Arnica Montana|arnica montana
98761|NCT03586232|Bromelain|bromelain
98762|NCT03586232|Body healing post op|body healing post op
98763|NCT03586232|Rhinoplasty Outcome Evaluation|rhinoplasty outcome evaluation
98764|NCT03586219|Surgery|surgery
98765|NCT03586219|Patient Education|patient education
98766|NCT03586219|Opioid|opioid
98767|NCT03586219|Medication Storage|medication storage
98768|NCT03586219|Medication Disposal|medication disposal
98769|NCT03586206|Clostridium difficile|clostridium difficile
98770|NCT03586206|toxins|toxins
98771|NCT03586206|serum|serum
98772|NCT03586206|infection|infection
98773|NCT03586154|Ketamine; pain; platelet rich plasma; mastectomy; shoulder|ketamine; pain; platelet rich plasma; mastectomy; shoulder
98774|NCT03586102|Protein supplementation|protein supplementation
98775|NCT03586102|Human milk fortification|human milk fortification
98776|NCT03586089|Phenobarbital|phenobarbital
98777|NCT03586089|Alcohol|alcohol
98778|NCT03586089|Withdrawal|withdrawal
98779|NCT03586050|Hepatocellular Carcinoma; liver cancer; cancer; liver|hepatocellular carcinoma; liver cancer; cancer; liver
98780|NCT03586011|Physical activity on prescription|physical activity on prescription
98781|NCT03586011|Correlate of physical activity|correlate of physical activity
98782|NCT03586011|Predicting factor|predicting factor
98783|NCT03585933|Myocardial fibrosis|myocardial fibrosis
98784|NCT03585933|Severe aortic stenosis|severe aortic stenosis
98785|NCT03585933|Cardiovascular magnetic resonance|cardiovascular magnetic resonance
98786|NCT03585933|Scintigraphy|scintigraphy
98787|NCT03585933|SAVR/TAVI|savr/tavi
98788|NCT03585920|Fat|fat
98789|NCT03585920|Oral sensitivity|oral sensitivity
98790|NCT03585920|Appetite|appetite
98791|NCT03585920|Metabolism|metabolism
98792|NCT03585868|flavonoids|flavonoids
98793|NCT03585842|Scale Translation|scale translation
98794|NCT03585842|Substance Use Disorder|substance use disorder
98795|NCT03585842|Comorbidities psychiatric|comorbidities psychiatric
98796|NCT03585829|treatment|treatment
98797|NCT03585829|quality of life|quality of life
98798|NCT03585829|hypoglycemia|hypoglycemia
98799|NCT03585816|Pneumoperitoneum|pneumoperitoneum
98800|NCT03585816|Exhaust gas|exhaust gas
98801|NCT03585816|chromatographic study|chromatographic study
98802|NCT03585816|Nitrous oxide|nitrous oxide
98803|NCT03585816|Nitrogen dioxide|nitrogen dioxide
98804|NCT03585790|Eye Fatigue|eye fatigue
98805|NCT03585751|non vital|non vital
98806|NCT03585751|deciduous|deciduous
98807|NCT03585751|3mixstatin|3mixstatin
98808|NCT03585751|simvastatin|simvastatin
98809|NCT03585751|triple antibiotic mix|triple antibiotic mix
98810|NCT03585751|3 mix|3 mix
98811|NCT03585738|Inositol|inositol
98812|NCT03585738|Polycystic ovarian syndrome|polycystic ovarian syndrome
98813|NCT03585738|Pregnancy|pregnancy
98814|NCT03585738|Obstetrics outcomes|obstetrics outcomes
98815|NCT03585738|Gestational diabetes|gestational diabetes
98816|NCT03585738|Preeclampsia|preeclampsia
98817|NCT03585725|Ribavirin|ribavirin
98818|NCT03585725|Follicular Lymphoma|follicular lymphoma
98819|NCT03585725|Mantle Cell Lymphoma|mantle cell lymphoma
98820|NCT03585725|Lymphoma|lymphoma
98821|NCT03585725|Non-Hodgkin lymphoma|non-hodgkin lymphoma
98822|NCT03585725|Indolent Lymphoma|indolent lymphoma
98823|NCT03585712|Birth Control|birth control
98824|NCT03585712|Progestin Only Pill|progestin only pill
98825|NCT03585712|Estrogen Free Pill|estrogen free pill
98826|NCT03585712|Norgestrel|norgestrel
98827|NCT03585712|Oral Contraception|oral contraception
98828|NCT03585712|Female Contraception|female contraception
98829|NCT03585712|Cervical Mucus|cervical mucus
98830|NCT03585712|Ovarian Activity|ovarian activity
98831|NCT03585699|spinal biopsy|spinal biopsy
98832|NCT03585699|prospective randomizd trial|prospective randomizd trial
98834|NCT03585686|Langerhans|langerhans
98835|NCT03585686|histiocytosis|histiocytosis
98836|NCT03585686|vemurafenib|vemurafenib
98837|NCT03585686|BRAF|braf
98838|NCT03585673|esophageal cancer|esophageal cancer
98839|NCT03585673|metastatic|metastatic
98840|NCT03585673|inoperable|inoperable
98841|NCT03585673|relapsed|relapsed
98842|NCT03585647|General anesthesia|general anesthesia
98843|NCT03585647|Regional anesthesia|regional anesthesia
98844|NCT03585647|Integrated anesthesia|integrated anesthesia
98845|NCT03585647|Hip arthroplasty|hip arthroplasty
98846|NCT03585647|Toxicological gene expression|toxicological gene expression
98847|NCT03585634|Fathers|fathers
98848|NCT03585634|Masculinity|masculinity
98849|NCT03585634|Gender role|gender role
98850|NCT03585634|Health Behaviour|health behaviour
98851|NCT03585634|Family health|family health
98852|NCT03585595|Antihypertensive treatment|antihypertensive treatment
98853|NCT03585582|Respiratory Health|respiratory health
98854|NCT03585556|Wet Age-related Macular Degeneration|wet age-related macular degeneration
98855|NCT03585556|Gene therapy|gene therapy
98856|NCT03585556|Wet AMD|wet amd
98857|NCT03585530|Esophageal neoplasma|esophageal neoplasma
98858|NCT03585530|adjuvant therapy|adjuvant therapy
98859|NCT03585530|raltitrexed|raltitrexed
98860|NCT03585530|radiotherapy|radiotherapy
98861|NCT03585504|Implanon|implanon
98862|NCT03585504|Bleeding Acceptability|bleeding acceptability
98863|NCT03585504|Contraceptive Implant|contraceptive implant
98864|NCT03585504|Adolescent Pregnancy Prevention|adolescent pregnancy prevention
98865|NCT03585504|Post Partum Insertion of Implanon|post partum insertion of implanon
98866|NCT03585478|Celiac|celiac
98867|NCT03585452|dexmedetomidine|dexmedetomidine
98868|NCT03585452|cardiac surgery|cardiac surgery
98869|NCT03585452|brain injury biomarkers|brain injury biomarkers
98870|NCT03585452|cognitive examination|cognitive examination
98871|NCT03585439|Isthmic spondylolisthesis|isthmic spondylolisthesis
98872|NCT03585439|vertebral fusion|vertebral fusion
98873|NCT03585439|combined approach|combined approach
98874|NCT03585439|circumferential fusion|circumferential fusion
98875|NCT03585439|ALIF|alif
98876|NCT03585439|posterior fusion|posterior fusion
98877|NCT03585413|Bariatric surgery|bariatric surgery
98878|NCT03585413|Obesity|obesity
98879|NCT03585413|NAFLD|nafld
98880|NCT03585413|Micronutrient supplementation|micronutrient supplementation
98881|NCT03585413|Probiotic supplementation|probiotic supplementation
98882|NCT03585400|Neuromuscular Blockade Agents|neuromuscular blockade agents
98883|NCT03585400|Neuromuscular Blockade Reversal|neuromuscular blockade reversal
98884|NCT03585400|Perioperative Care|perioperative care
98885|NCT03585400|Quality Improvement|quality improvement
98886|NCT03585374|pain|pain
98887|NCT03585374|methoxyflurane|methoxyflurane
98888|NCT03585374|Penthrox|penthrox
98889|NCT03585361|Contraceptive Usage|contraceptive usage
98890|NCT03585361|Pregnancy|pregnancy
98891|NCT03585361|Postpartum Family Planning|postpartum family planning
98892|NCT03585361|Contraception|contraception
98893|NCT03585361|Prenatal Care|prenatal care
98894|NCT03585361|Postnatal Care|postnatal care
98895|NCT03585361|Postpartum Care|postpartum care
98896|NCT03585361|Family Planning|family planning
98897|NCT03585361|Ethiopia|ethiopia
98898|NCT03585361|Community Health Workers|community health workers
98899|NCT03585361|Community Based Care|community based care
98900|NCT03585361|Health Extension Workers|health extension workers
98901|NCT03585348|Neuromuscular Blockade Agents|neuromuscular blockade agents
98902|NCT03585348|Provider Variability|provider variability
98903|NCT03585348|Quality Improvement|quality improvement
98904|NCT03585348|Perioperative Care|perioperative care
98905|NCT03585348|Neuromuscular Blockade Reversal|neuromuscular blockade reversal
98906|NCT03585335|Cardiorespiratory Fitness Score|cardiorespiratory fitness score
98908|NCT03585283|Myofascial Release|myofascial release
98909|NCT03585283|Manual Therapies|manual therapies
98910|NCT03585257|covert hepatic encephalopathy|covert hepatic encephalopathy
98911|NCT03585257|inflammation|inflammation
98912|NCT03585257|cognition|cognition
98913|NCT03585257|quality of life|quality of life
98914|NCT03585231|Smoking|smoking
98915|NCT03585231|Chatbot|chatbot
98916|NCT03585231|Conversational agent|conversational agent
98917|NCT03585231|Chatbot for quitting smoking|chatbot for quitting smoking
98918|NCT03585231|Messaging|messaging
98919|NCT03585231|Text messaging|text messaging
98920|NCT03585231|SMS|sms
98921|NCT03585218|Quality of Life|quality of life
98922|NCT03585218|Breast Cancer|breast cancer
98923|NCT03585218|Essentials Oils|essentials oils
98924|NCT03585218|Adjuvant Chemotherapy|adjuvant chemotherapy
98925|NCT03585218|Salivary cortisol|salivary cortisol
98926|NCT03585218|Neuropsychophysiology|neuropsychophysiology
98927|NCT03585205|Stress response|stress response
98928|NCT03585205|Cognitive Load|cognitive load
98929|NCT03585179|Melasma|melasma
98932|NCT03585179|Tranexamic acid|tranexamic acid
98933|NCT03585179|Hydroquinone|hydroquinone
98934|NCT03585179|Therapeutics|therapeutics
98935|NCT03585166|Liver Cancer|liver cancer
98936|NCT03585166|laparoscopic hepatectomy|laparoscopic hepatectomy
98937|NCT03585166|open hepatectomy|open hepatectomy
98938|NCT03585140|Acne Vulgaris|acne vulgaris
98939|NCT03585140|Low Glycemic Diet|low glycemic diet
98940|NCT03585140|Doxycycline|doxycycline
98941|NCT03585140|Adapalene|adapalene
98942|NCT03585127|Auditory verbal hallucinations|auditory verbal hallucinations
98943|NCT03585127|Schizophrenia|schizophrenia
98944|NCT03585127|Treatment-resistant|treatment-resistant
98945|NCT03585127|Psychotherapy|psychotherapy
98946|NCT03585127|Cognitive Behavioral Therapy|cognitive behavioral therapy
98947|NCT03585127|Avatar Therapy|avatar therapy
98948|NCT03585127|Virtual reality|virtual reality
98949|NCT03585101|Hepatitis C virus|hepatitis c virus
98950|NCT03585101|Endothelial function|endothelial function
98951|NCT03585101|Cardiovascular disease risk|cardiovascular disease risk
98952|NCT03585101|Metabolic disease|metabolic disease
98953|NCT03585101|Inflammation|inflammation
98954|NCT03585101|Insulin resistance|insulin resistance
98956|NCT03585062|Paclitaxel-albumin|paclitaxel-albumin
98957|NCT03585062|Unresectable Pancreatic Cancer|unresectable pancreatic cancer
98958|NCT03585062|Neoadjuvant chemotherapy|neoadjuvant chemotherapy
98959|NCT03585010|anxiety disorders|anxiety disorders
98960|NCT03584971|estradiol|estradiol
98961|NCT03584971|cooperation|cooperation
98962|NCT03584971|competitiveness|competitiveness
98963|NCT03584971|risk preferences|risk preferences
98964|NCT03584958|glaucoma surgery|glaucoma surgery
98965|NCT03584958|MIGS, minimally invasive glaucoma surgery|migs, minimally invasive glaucoma surgery
98966|NCT03584958|refractive outcomes|refractive outcomes
98967|NCT03584958|visual outcomes|visual outcomes
98968|NCT03584932|Youth,|youth,
98969|NCT03584932|Criminal justice|criminal justice
98970|NCT03584932|Sexual/gender minorities|sexual/gender minorities
98971|NCT03584932|Navigation|navigation
98972|NCT03584893|Juvenile Cataract|juvenile cataract
98973|NCT03584893|CTX|ctx
98974|NCT03584893|Diarrhea|diarrhea
98975|NCT03584893|Neonatal Jaundice|neonatal jaundice
98976|NCT03584893|Xanthoma|xanthoma
98977|NCT03584880|postoperative pain|postoperative pain
98978|NCT03584880|Diode laser|diode laser
98979|NCT03584880|retreatment|retreatment
98980|NCT03584867|Basic life support|basic life support
98981|NCT03584867|CPR skills|cpr skills
98982|NCT03584867|Training|training
98983|NCT03584867|High quality CPR|high quality cpr
98984|NCT03584828|Cardiac Rehabilitation|cardiac rehabilitation
98985|NCT03584828|exercise|exercise
98986|NCT03584802|severe acute exacerbation of idiopathic pulmonary fibrosis|severe acute exacerbation of idiopathic pulmonary fibrosis
98987|NCT03584789|Decision Support Systems, Clinical|decision support systems, clinical
98988|NCT03584789|Pain Management|pain management
98989|NCT03584789|Analgesics|analgesics
98990|NCT03584776|Virtual reality|virtual reality
98991|NCT03584750|Somatic and psychological factors|somatic and psychological factors
98992|NCT03584737|acute sinusitis|acute sinusitis
98993|NCT03584737|bacterial sinusitis|bacterial sinusitis
98994|NCT03584737|point-of-care|point-of-care
98995|NCT03584737|in vitro diagnostic device (IVD)|in vitro diagnostic device (ivd)
98996|NCT03584724|HLA-B27|hla-b27
98997|NCT03584724|relapses|relapses
98998|NCT03584724|curcumin|curcumin
98999|NCT03584711|Stop and Go strategy|stop and go strategy
99000|NCT03584711|RAS Wild-type|ras wild-type
99001|NCT03584672|Multiple Sclerosis|multiple sclerosis
99002|NCT03584672|Static Balance Test|static balance test
99003|NCT03584672|Balance|balance
99004|NCT03584672|Reliability|reliability
99005|NCT03584672|Validity|validity
99006|NCT03584659|Patient-reported outcomes|patient-reported outcomes
99007|NCT03584659|Electronic reporting of symptoms|electronic reporting of symptoms
99008|NCT03584659|Immunotherapy|immunotherapy
99009|NCT03584659|Chemotherapy|chemotherapy
99010|NCT03584646|liver transplantation|liver transplantation
99011|NCT03584646|malnutrition|malnutrition
99012|NCT03584646|exercise|exercise
99013|NCT03584646|prehabilitation|prehabilitation
99014|NCT03584646|nutrition|nutrition
99015|NCT03584646|sarcopenia|sarcopenia
99016|NCT03584633|Indocyanine Green|indocyanine green
99017|NCT03584633|Indocyanine Green Lymphography|indocyanine green lymphography
99018|NCT03584633|Exercise|exercise
99019|NCT03584620|lung transplantation|lung transplantation
99020|NCT03584620|inspiratory muscle training|inspiratory muscle training
99021|NCT03584620|pulmonary rehabilitation|pulmonary rehabilitation
99022|NCT03584620|quality of life|quality of life
99023|NCT03584620|physical activity|physical activity
99024|NCT03584594|presepsin|presepsin
99025|NCT03584594|biomarkers|biomarkers
99026|NCT03584594|sepsis|sepsis
99027|NCT03584594|diagnosis|diagnosis
99028|NCT03584568|Caregiving|caregiving
99029|NCT03584568|Intergeneration|intergeneration
99030|NCT03584568|Reappraisal through perspective taking|reappraisal through perspective taking
99035|NCT03584542|Drug and narcotic control|drug and narcotic control
99036|NCT03584542|Drug prescription|drug prescription
99037|NCT03584542|Substance-related Disorders|substance-related disorders
99038|NCT03584542|Health Impact Assessment|health impact assessment
99039|NCT03584516|Graft-versus-host-disease|graft-versus-host-disease
99040|NCT03584516|itacitinib|itacitinib
99041|NCT03584516|Janus kinase inhibitor|janus kinase inhibitor
99042|NCT03584516|corticosteroids|corticosteroids
99043|NCT03584503|general anesthesia|general anesthesia
99044|NCT03584503|laryngospasm|laryngospasm
99045|NCT03584503|postoperative complications|postoperative complications
99046|NCT03584503|rhinoplasty|rhinoplasty
99047|NCT03584503|Suction Above Cuff Endotracheal Tube|suction above cuff endotracheal tube
99048|NCT03584477|Stroke|stroke
99049|NCT03584477|Robot,|robot,
99050|NCT03584477|Rehabilitation|rehabilitation
99051|NCT03584477|Hemiparesis|hemiparesis
99052|NCT03584477|Upper limb|upper limb
99053|NCT03584477|Function|function
99054|NCT03584477|Motor control|motor control
99055|NCT03584438|TMS|tms
99056|NCT03584438|Motor Cortex|motor cortex
99057|NCT03584438|Excitability|excitability
99058|NCT03584438|LTP|ltp
99059|NCT03584438|LTD|ltd
99060|NCT03584425|BOLD Signal|bold signal
99061|NCT03584425|Functional Magnetic Resonance Imaging|functional magnetic resonance imaging
99062|NCT03584425|MR Spectroscopy|mr spectroscopy
99063|NCT03584425|Anatomical Imaging|anatomical imaging
99064|NCT03584425|Kinematics|kinematics
99065|NCT03584386|Suicidality|suicidality
99066|NCT03584386|Collaborative Assessment and Management of Suicidality|collaborative assessment and management of suicidality
99067|NCT03584386|CAMS|cams
99068|NCT03584386|Technology|technology
99069|NCT03584386|Emergency Department|emergency department
99070|NCT03584386|Suicide Intervention|suicide intervention
99071|NCT03584386|Suicide Assessment|suicide assessment
99072|NCT03584386|Suicide Prevention|suicide prevention
99073|NCT03584373|Pain Outcomes|pain outcomes
99074|NCT03584373|Ureteroscopy|ureteroscopy
99075|NCT03584373|Percutaneous Nephrolithotomy|percutaneous nephrolithotomy
99076|NCT03584373|Opioids|opioids
99077|NCT03584321|Non-Obstructive Coronary Artery Disease|non-obstructive coronary artery disease
99078|NCT03584321|Coronary Angiography|coronary angiography
99079|NCT03584308|Papillomavirus|papillomavirus
99080|NCT03584308|Viusid|viusid
99081|NCT03584308|Glizigen|glizigen
99082|NCT03584308|Papilloma virus Esophageal|papilloma virus esophageal
99083|NCT03584308|Antioxidant|antioxidant
99084|NCT03584282|Pre-Exposure Prophylaxis (PrEP)|pre-exposure prophylaxis (prep)
99085|NCT03584282|Methamphetamine|methamphetamine
99086|NCT03584269|COPD|copd
99087|NCT03584269|Oxygenation Long term|oxygenation long term
99088|NCT03584269|Non invasive Ventilation|non invasive ventilation
99089|NCT03584269|Nocturnal Hypoventilation|nocturnal hypoventilation
99090|NCT03584243|collagen crosslinking|collagen crosslinking
99091|NCT03584243|transepithelial crosslinking|transepithelial crosslinking
99092|NCT03584178|ACTH-axis|acth-axis
99093|NCT03584178|Budesonide|budesonide
99094|NCT03584178|MAD|mad
99095|NCT03584178|INSI|insi
99096|NCT03584178|Intraocular pressure|intraocular pressure
99097|NCT03584178|Bone density|bone density
99098|NCT03584165|NightstaRx|nightstarx
99099|NCT03584165|NSR-REP1|nsr-rep1
127206|NCT03408171|FNA|fna
99100|NCT03584165|Choroideremia|choroideremia
99101|NCT03584165|CHM|chm
99102|NCT03584165|Gene Therapy|gene therapy
99103|NCT03584165|AAV|aav
99104|NCT03584165|REP1|rep1
99105|NCT03584152|Postoperative pain|postoperative pain
99106|NCT03584152|Rhinoplasty|rhinoplasty
99107|NCT03584087|Terlipressin, Variceal Haemorrhage, EVL|terlipressin, variceal haemorrhage, evl
99108|NCT03584074|Pregabalin|pregabalin
99109|NCT03584074|Selective COX-2 inhibitor|selective cox-2 inhibitor
99110|NCT03584061|Chronic Pain|chronic pain
99111|NCT03584061|Herpes Zoster|herpes zoster
99112|NCT03584061|Pain|pain
99113|NCT03584035|sensory motor integration exercise|sensory motor integration exercise
99114|NCT03583983|Physical Activity|physical activity
99115|NCT03583983|Dietary Habits|dietary habits
99116|NCT03583983|Genetic Scores|genetic scores
99117|NCT03583983|Cardiovascular Health|cardiovascular health
99118|NCT03583970|Left Ventricular Assist Device|left ventricular assist device
99119|NCT03583970|Extracorporeal Membrane Oxygenation|extracorporeal membrane oxygenation
99120|NCT03583970|Refractory Cardiogenic Shock|refractory cardiogenic shock
99121|NCT03583970|Heart Failure|heart failure
99122|NCT03583970|Cardiovascular diseases|cardiovascular diseases
99123|NCT03583970|Myocardial Infarction|myocardial infarction
99124|NCT03583970|Myocardial Ischemia|myocardial ischemia
99125|NCT03583970|Shock|shock
99139|NCT03583892|Gabapentin, laparoscopic cholecystectomy, postoperative pain|gabapentin, laparoscopic cholecystectomy, postoperative pain
99140|NCT03583879|Exoskeleton|exoskeleton
99141|NCT03583879|Functional exercise|functional exercise
99142|NCT03583866|blood pressure|blood pressure
99143|NCT03583866|microdialysis|microdialysis
99144|NCT03583840|men's health|men's health
99145|NCT03583840|internet|internet
99146|NCT03583840|telemedicine|telemedicine
99147|NCT03583840|mass screening|mass screening
99148|NCT03583840|health behavior|health behavior
99149|NCT03583827|Cerebrovascular disorders|cerebrovascular disorders
99150|NCT03583827|Upper extremity|upper extremity
99151|NCT03583827|Paresis|paresis
99152|NCT03583827|Electroencephalography|electroencephalography
99153|NCT03583827|Psychomotor Performance|psychomotor performance
99154|NCT03583801|Perioperative Anxiety|perioperative anxiety
99155|NCT03583801|Aromatherapy|aromatherapy
99156|NCT03583801|Surgery|surgery
99157|NCT03583801|Loco-regional Anesthesia|loco-regional anesthesia
99158|NCT03583801|Ambulatory|ambulatory
99159|NCT03583762|Microarray Assay Technique|microarray assay technique
99160|NCT03583762|Mass Spectrometry Technique|mass spectrometry technique
99161|NCT03583762|Time to appropriate antibiotic|time to appropriate antibiotic
99162|NCT03583749|Antimicrobial agents|antimicrobial agents
99163|NCT03583749|subcutaneous administration|subcutaneous administration
99164|NCT03583749|safety|safety
99165|NCT03583749|pharmacokinetics|pharmacokinetics
99166|NCT03583749|elderly|elderly
99167|NCT03583723|Adaptive radiotherapy|adaptive radiotherapy
99168|NCT03583697|Dwarfism|dwarfism
99169|NCT03583697|Bone Diseases|bone diseases
99170|NCT03583697|Bone Diseases, Developmental|bone diseases, developmental
99171|NCT03583697|ACH|ach
99172|NCT03583697|Natriuretic Peptide, C-Type|natriuretic peptide, c-type
99173|NCT03583697|Musculoskeletal Diseases|musculoskeletal diseases
99174|NCT03583697|Natriuretic Agents|natriuretic agents
99175|NCT03583697|Physiological Effect of Drugs|physiological effect of drugs
99176|NCT03583697|Skeletal Dysplasias|skeletal dysplasias
99177|NCT03583697|Genetic Diseases, Inborn|genetic diseases, inborn
99178|NCT03583697|Osteochondrodysplasias|osteochondrodysplasias
99179|NCT03583684|Pivotal Response Treatment|pivotal response treatment
99180|NCT03583684|Imaging|imaging
99181|NCT03583671|Molar Incisor Hypomineralization , enamel defects.|molar incisor hypomineralization , enamel defects.
99182|NCT03583645|Adolescence|adolescence
99183|NCT03583645|Prevention|prevention
99184|NCT03583645|Aggressive behavior|aggressive behavior
99185|NCT03583645|Dating Violence|dating violence
99194|NCT03583593|Diabetes|diabetes
99195|NCT03583593|Insulin|insulin
99196|NCT03583593|Diabetic Foot|diabetic foot
99197|NCT03583593|Nutritional supplement|nutritional supplement
99198|NCT03583593|Diamel|diamel
99199|NCT03583580|Breast conserving surgery|breast conserving surgery
99200|NCT03583580|Accelerate partial breast irradiation|accelerate partial breast irradiation
99201|NCT03583580|intensity-modulated radiation therapy|intensity-modulated radiation therapy
99202|NCT03583580|phase II|phase ii
99203|NCT03583567|protamine|protamine
99204|NCT03583567|antihistamine|antihistamine
99205|NCT03583554|Suicide|suicide
99206|NCT03583554|Kynurenine|kynurenine
99207|NCT03583554|metabolic pathway|metabolic pathway
99208|NCT03583554|Veterans|veterans
99209|NCT03583554|OEF/OIF/OND|oef/oif/ond
99210|NCT03583554|electrophysiology|electrophysiology
99211|NCT03583554|NMDA receptor|nmda receptor
99212|NCT03583554|suicidal ideation|suicidal ideation
99213|NCT03583541|Vulnerable women|vulnerable women
99214|NCT03583541|Female sex workers|female sex workers
835320|NCT00097604|Valerian|valerian
127324|NCT03407469|VTE|vte
99215|NCT03583541|Combination interventions|combination interventions
99216|NCT03583541|Economic empowerment|economic empowerment
99217|NCT03583541|HIV/AIDS|hiv/aids
99218|NCT03583541|Sexually transmitted infections|sexually transmitted infections
99219|NCT03583541|Sub-Saharan Africa|sub-saharan africa
99220|NCT03583541|Uganda|uganda
99221|NCT03583502|LCPUFA|lcpufa
99222|NCT03583502|DHA|dha
99223|NCT03583502|krill oil|krill oil
99224|NCT03583502|supplementation|supplementation
99225|NCT03583502|breast milk|breast milk
99226|NCT03583476|Helicobacter pylori|helicobacter pylori
99227|NCT03583476|Resistance|resistance
99228|NCT03583476|Minimal inhibitory concentration|minimal inhibitory concentration
99229|NCT03583476|Treatment efficacy|treatment efficacy
99230|NCT03583411|thrombocytopenia|thrombocytopenia
99231|NCT03583411|thrombocytosis|thrombocytosis
99232|NCT03583398|TAVI|tavi
99233|NCT03583398|quality of life|quality of life
99234|NCT03583398|SAVR|savr
99235|NCT03583372|Beta-3 adrenergic receptor (β3-AR) agonists|beta-3 adrenergic receptor (β3-ar) agonists
99236|NCT03583372|incontinence|incontinence
99237|NCT03583372|OAB|oab
99238|NCT03583372|vibegron|vibegron
99239|NCT03583372|urge urinary incontinence|urge urinary incontinence
99240|NCT03583372|Urinary bladder, overactive|urinary bladder, overactive
99241|NCT03583372|Urologic Diseases|urologic diseases
99242|NCT03583372|Lower Urinary Tract Symptoms|lower urinary tract symptoms
99243|NCT03583372|Urological Agents|urological agents
99244|NCT03583346|M6495|m6495
99245|NCT03583346|Anti-ADAMTS-5 Nanobody|anti-adamts-5 nanobody
99246|NCT03583346|Osteoarthritis|osteoarthritis
99247|NCT03583307|Sirolimus|sirolimus
99248|NCT03583307|Vascular anomalies|vascular anomalies
99249|NCT03583268|Type 1 diabetes|type 1 diabetes
99250|NCT03583268|Physical activity|physical activity
99251|NCT03583268|Hypoglycemia|hypoglycemia
99252|NCT03583268|Glucose variability|glucose variability
99253|NCT03583229|Heart Transplantation|heart transplantation
99254|NCT03583229|Cardiac Allograft Vasculopathy|cardiac allograft vasculopathy
99255|NCT03583216|Diabetic pregnancies, Factor XII|diabetic pregnancies, factor xii
99256|NCT03583203|schizophrenia|schizophrenia
99257|NCT03583203|bipolar disorder|bipolar disorder
99258|NCT03583203|tobacco|tobacco
99259|NCT03583203|COPD|copd
99260|NCT03583190|Neck pain|neck pain
99261|NCT03583190|Headache|headache
99262|NCT03583190|Dry needling|dry needling
99263|NCT03583190|manual therapy|manual therapy
99264|NCT03583177|Proteolysis|proteolysis
99265|NCT03583177|Muscle|muscle
99266|NCT03583177|Cachexia|cachexia
99267|NCT03583164|Anti fungal|anti fungal
99268|NCT03583164|Invasive aspergillosis|invasive aspergillosis
99269|NCT03583164|Rare moulds|rare moulds
99270|NCT03583151|Corticosteroid|corticosteroid
99271|NCT03583138|HIV|hiv
99272|NCT03583138|AIDS|aids
99273|NCT03583138|Opiate Addiction|opiate addiction
99274|NCT03583138|Drug Dependence|drug dependence
99275|NCT03583138|Buprenorphine|buprenorphine
99276|NCT03583125|bladder cancer|bladder cancer
99277|NCT03583125|cholangiocarcinoma|cholangiocarcinoma
99278|NCT03583125|gastric cancer|gastric cancer
99279|NCT03583125|breast cancer|breast cancer
99280|NCT03583125|hepatocellular carcinoma|hepatocellular carcinoma
99281|NCT03583073|psychosis|psychosis
99282|NCT03583073|clinical high risk|clinical high risk
99283|NCT03583047|MACE|mace
99284|NCT03583047|EPCs|epcs
99285|NCT03583047|Cardiovascular risk|cardiovascular risk
99286|NCT03583047|Endothelial dysfunction|endothelial dysfunction
99287|NCT03583047|Prognosis|prognosis
99288|NCT03583034|HoLEP|holep
99289|NCT03583034|Prostate|prostate
99290|NCT03582982|resistance exercise|resistance exercise
99291|NCT03582982|muscle fatigue|muscle fatigue
99292|NCT03582982|physical function|physical function
99293|NCT03582969|IBD|ibd
99294|NCT03582969|UC|uc
99295|NCT03582969|fecal-transplantation|fecal-transplantation
99296|NCT03582969|capsules|capsules
99297|NCT03582969|microbiota|microbiota
99298|NCT03582969|microbiome|microbiome
99299|NCT03582969|colitis|colitis
99300|NCT03582969|pediatric|pediatric
99301|NCT03582943|remote ischemic conditioning, motor learning|remote ischemic conditioning, motor learning
99302|NCT03582930|Infasurf|infasurf
99303|NCT03582930|Surfactant|surfactant
99304|NCT03582930|RDS|rds
99305|NCT03582930|Respiratory Distress Syndrome|respiratory distress syndrome
99306|NCT03582930|Aerosolized|aerosolized
99307|NCT03582930|Nebulized|nebulized
99308|NCT03582930|Inhaled|inhaled
99309|NCT03582930|Pre-term|pre-term
99310|NCT03582930|Premature|premature
99311|NCT03582904|motor learning|motor learning
99312|NCT03582904|tDCS|tdcs
99313|NCT03582904|locomotion|locomotion
99314|NCT03582865|Breast cancer|breast cancer
99315|NCT03582865|Genotyping|genotyping
99316|NCT03582865|Tamoxifen|tamoxifen
99317|NCT03582826|systemic malodor|systemic malodor
99318|NCT03582826|body odor|body odor
127455|NCT03406728|Balance|balance
99319|NCT03582826|bad breath|bad breath
99320|NCT03582826|PATM|patm
99321|NCT03582826|microbiome|microbiome
99322|NCT03582826|TMAU|tmau
99323|NCT03582826|Malabsorption|malabsorption
99324|NCT03582826|Dysbiosis|dysbiosis
99325|NCT03582813|self-directed care|self-directed care
99326|NCT03582813|mental health services|mental health services
99327|NCT03582813|mental health recovery|mental health recovery
99328|NCT03582813|behavioral health service financing|behavioral health service financing
99329|NCT03582800|Sodium thiosulfate|sodium thiosulfate
99330|NCT03582800|Ectopic calcification|ectopic calcification
99331|NCT03582800|Ectopic Ossification|ectopic ossification
99332|NCT03582735|Carpal Tunnel Syndrome|carpal tunnel syndrome
99333|NCT03582735|Ultrasound Imaging|ultrasound imaging
99334|NCT03582735|Preoperative Care|preoperative care
99335|NCT03582735|Exercise Therapy|exercise therapy
99336|NCT03582722|Polybrominated Biphenyl Exposure|polybrominated biphenyl exposure
99337|NCT03582722|Gastrointestinal lipase inhibitor|gastrointestinal lipase inhibitor
99338|NCT03582683|Self-Management Programs|self-management programs
99339|NCT03582683|Behavioral Health|behavioral health
99340|NCT03582670|Prospective Memory|prospective memory
99341|NCT03582670|Occupational Therapy|occupational therapy
99342|NCT03582657|nanostructured-implant|nanostructured-implant
99343|NCT03582657|titanium implant|titanium implant
99344|NCT03582657|nano-roughness surface|nano-roughness surface
99345|NCT03582657|hydrophilic surface|hydrophilic surface
99346|NCT03582657|KONTACT N|kontact n
99347|NCT03582657|BIOTECH DENTAL|biotech dental
99348|NCT03582644|Osteoarthritis, Knee|osteoarthritis, knee
99349|NCT03582644|Cryotherapy|cryotherapy
99350|NCT03582644|Physiotherapy|physiotherapy
99351|NCT03582644|Physical Agent|physical agent
99352|NCT03582618|Oncology|oncology
99353|NCT03582618|Hepatocellular Carcinoma (HCC)|hepatocellular carcinoma (hcc)
99354|NCT03582618|Sorafenib|sorafenib
99355|NCT03582618|Hepatoma|hepatoma
99356|NCT03582605|antibiotics|antibiotics
99357|NCT03582605|prophylaxis|prophylaxis
99358|NCT03582605|temporary anchorage devices|temporary anchorage devices
99359|NCT03582605|mini-screw implants|mini-screw implants
99360|NCT03582605|TADs|tads
99361|NCT03582605|MSIs|msis
99362|NCT03582605|failure rate|failure rate
99363|NCT03582592|Fluid distribution timetable|fluid distribution timetable
99364|NCT03582592|Fluid restriction adherence|fluid restriction adherence
99365|NCT03582592|End-Stage Kidney Disease|end-stage kidney disease
99366|NCT03582592|Hemodialysis|hemodialysis
99367|NCT03582592|Thirst|thirst
99368|NCT03582592|Interdialytic Weight Gain|interdialytic weight gain
99369|NCT03582592|Nursing|nursing
99370|NCT03582527|osteosarcoma|osteosarcoma
99371|NCT03582527|refractory to chemotherapy|refractory to chemotherapy
99372|NCT03582527|unresectable|unresectable
99373|NCT03582527|PD-L1|pd-l1
99374|NCT03582527|VENTANA PD-L1 (SP263)|ventana pd-l1 (sp263)
99375|NCT03582514|Radiotherapy|radiotherapy
99376|NCT03582514|Preoperative single fraction|preoperative single fraction
99377|NCT03582514|3+3 design|3+3 design
99378|NCT03582462|IONIS FXI-L|ionis fxi-l
99379|NCT03582462|Factor XI|factor xi
99380|NCT03582449|Hunter syndrome (Mucopolysaccharydosis II)|hunter syndrome (mucopolysaccharydosis ii)
99381|NCT03582436|Kidney|kidney
99382|NCT03582436|Allogeneic transplantation|allogeneic transplantation
99383|NCT03582436|Cohort study|cohort study
99384|NCT03582436|Rejection|rejection
99385|NCT03582436|Biomarkers|biomarkers
99386|NCT03582436|Integrative medicine|integrative medicine
99387|NCT03582371|Parkinson's Disease|parkinson's disease
99388|NCT03582371|Rehabilitation|rehabilitation
99389|NCT03582371|Balance|balance
99390|NCT03582371|Aquatic therapy|aquatic therapy
99391|NCT03582371|Stand Up Paddle|stand up paddle
99392|NCT03582306|colon cancer|colon cancer
99393|NCT03582306|dietary intervention|dietary intervention
99394|NCT03582306|vegetables|vegetables
99395|NCT03582306|microbiota|microbiota
99396|NCT03582293|Tranexamic Acid|tranexamic acid
99397|NCT03582293|Antifibrinolytic Agents|antifibrinolytic agents
99398|NCT03582241|Acute myeloid leukemia|acute myeloid leukemia
99399|NCT03582241|Relapse|relapse
99400|NCT03582241|Mutations|mutations
99401|NCT03582228|Virtual Environments|virtual environments
99402|NCT03582228|Social Communication|social communication
99403|NCT03582215|Sunscreen|sunscreen
99404|NCT03582215|Pharmacokinetics|pharmacokinetics
99405|NCT03582202|dietitic service, organization of service|dietitic service, organization of service
99406|NCT03582189|Liver Cancer|liver cancer
99407|NCT03582189|Pancreatic Cancer|pancreatic cancer
99408|NCT03582189|Radiation|radiation
99409|NCT03582176|Acute elbow fractures and/or dislocations|acute elbow fractures and/or dislocations
99410|NCT03582163|Deep Brain Stimulation|deep brain stimulation
99411|NCT03582163|Longitudinal Outcomes|longitudinal outcomes
99412|NCT03582163|Subthalamic Nucleus|subthalamic nucleus
99413|NCT03582163|Globus Pallidus Interna|globus pallidus interna
99414|NCT03582150|Ambulatory alcohol detoxification|ambulatory alcohol detoxification
99415|NCT03582150|alcohol withdrawal|alcohol withdrawal
99416|NCT03582150|remote monitoring with breathalyzer|remote monitoring with breathalyzer
99417|NCT03582137|Parkinson's Disease|parkinson's disease
99418|NCT03582137|Motor symptoms|motor symptoms
99419|NCT03582137|Tremor|tremor
99420|NCT03582137|tolerability|tolerability
99421|NCT03582137|safety|safety
99422|NCT03582137|cognition|cognition
99423|NCT03582137|anxiety|anxiety
99424|NCT03582137|psychosis|psychosis
99425|NCT03582137|mood|mood
99426|NCT03582137|dyskinesia|dyskinesia
99427|NCT03582137|sleep|sleep
99428|NCT03582137|cannabidiol|cannabidiol
99429|NCT03582137|cannabis|cannabis
99430|NCT03582137|efficacy|efficacy
99431|NCT03582137|non-motor symptoms|non-motor symptoms
99432|NCT03582137|quality of life|quality of life
99433|NCT03582137|seborrhea|seborrhea
99434|NCT03582111|Ultrasound|ultrasound
99436|NCT03582111|Diagnosis|diagnosis
99437|NCT03582098|Idelalisib|idelalisib
99438|NCT03582098|Zydelig|zydelig
99439|NCT03582085|Fibromyalgia|fibromyalgia
99440|NCT03582033|RRMM|rrmm
99441|NCT03582033|Antibodies, monoclonal|antibodies, monoclonal
99442|NCT03582033|Antigens, BCMA|antigens, bcma
99443|NCT03582033|Immunotherapy|immunotherapy
99444|NCT03582033|Hematologic diseases|hematologic diseases
99445|NCT03582033|Myeloma|myeloma
99446|NCT03582020|vegetarians|vegetarians
99447|NCT03582020|vegans|vegans
99448|NCT03582020|flexitarians|flexitarians
99449|NCT03582020|western diet|western diet
99450|NCT03581981|posttraumatic stress disorder|posttraumatic stress disorder
99451|NCT03581968|diabetes|diabetes
99452|NCT03581968|type 1 diabetes|type 1 diabetes
99453|NCT03581968|diabetes mellitus|diabetes mellitus
99454|NCT03581968|pediatrics|pediatrics
99455|NCT03581968|diabetes camp|diabetes camp
99456|NCT03581955|biomarkers|biomarkers
99457|NCT03581955|diet|diet
99458|NCT03581955|banana|banana
99459|NCT03581955|tomato|tomato
99460|NCT03581955|urine|urine
99461|NCT03581955|plasma|plasma
99462|NCT03581955|intake|intake
99463|NCT03581955|exposure|exposure
99464|NCT03581955|metabolomics|metabolomics
99465|NCT03581942|Copanlisib|copanlisib
99466|NCT03581942|Ibrutinib|ibrutinib
99467|NCT03581942|Recurrent/ Refractory|recurrent/ refractory
99468|NCT03581942|PCNSL|pcnsl
99469|NCT03581942|Brain lymphoma|brain lymphoma
99470|NCT03581942|Primary Central Nervous System Lymphoma|primary central nervous system lymphoma
99471|NCT03581942|BTK|btk
99472|NCT03581942|PI3K|pi3k
99473|NCT03581929|Mild Cognitive Impairment|mild cognitive impairment
99474|NCT03581929|Dementia|dementia
99475|NCT03581929|Memormax|memormax
99476|NCT03581929|Food Supplement|food supplement
99477|NCT03581929|Microbiota|microbiota
99478|NCT03581890|Colorectal cancer|colorectal cancer
99479|NCT03581890|Socioeconomic position|socioeconomic position
99480|NCT03581877|Alteplase|alteplase
99481|NCT03581877|submassive pulmonary embolism|submassive pulmonary embolism
99482|NCT03581877|Thrombolysis|thrombolysis
99483|NCT03581877|pulmonary catheter|pulmonary catheter
99484|NCT03581864|aphakia|aphakia
99485|NCT03581864|black diaphragmintraocular lens|black diaphragmintraocular lens
99486|NCT03581864|eye rupture|eye rupture
99487|NCT03581864|aniridia|aniridia
99488|NCT03581851|simulated altitude|simulated altitude
99489|NCT03581851|exercise|exercise
99490|NCT03581851|electrocardiography|electrocardiography
99491|NCT03581851|non- invasive blood pressure|non- invasive blood pressure
99492|NCT03581838|EoE|eoe
99493|NCT03581838|Dysphagia|dysphagia
99494|NCT03581812|Gut Microbiota|gut microbiota
99495|NCT03581812|Microbiome|microbiome
99496|NCT03581812|Gut Health|gut health
99497|NCT03581812|Snack|snack
99498|NCT03581799|Child|child
99499|NCT03581760|cycling exercise|cycling exercise
99500|NCT03581760|mechanically ventilated patient|mechanically ventilated patient
99501|NCT03581760|muscle strength assessment|muscle strength assessment
99502|NCT03581760|muscle weakness|muscle weakness
99503|NCT03581747|Atopic dermatis|atopic dermatis
99504|NCT03581747|Epithelial barrier|epithelial barrier
99505|NCT03581747|Electrical impedance spectroscopy|electrical impedance spectroscopy
99506|NCT03581747|Allergy|allergy
99507|NCT03581734|Oral Polio Vaccine|oral polio vaccine
99508|NCT03581734|Oral Cholera Vaccine|oral cholera vaccine
99509|NCT03581734|Co-administration|co-administration
99510|NCT03581734|Immunogenecity|immunogenecity
99511|NCT03581721|Postoperative hypothermia|postoperative hypothermia
99512|NCT03581721|caesarean section|caesarean section
99513|NCT03581721|IV fluids warming|iv fluids warming
99514|NCT03581708|lung cancer|lung cancer
99515|NCT03581708|Venous Thromboembolism|venous thromboembolism
99516|NCT03581656|Degenerative Mitral Leaflet Prolapse|degenerative mitral leaflet prolapse
99517|NCT03581656|Heart Disease|heart disease
99518|NCT03581656|Minimally Invasive|minimally invasive
99519|NCT03581643|Montreal Cognitive Assessment|montreal cognitive assessment
127716|NCT03404960|DDR|ddr
99520|NCT03581643|Sensitivity|sensitivity
99521|NCT03581643|Specificity|specificity
99522|NCT03581643|Validation Study|validation study
99523|NCT03581617|Infertility|infertility
99524|NCT03581617|NK cells|nk cells
99525|NCT03581617|HLA-G|hla-g
99526|NCT03581604|Penicillin/b-lactams|penicillin/b-lactams
99527|NCT03581578|Troponin|troponin
99528|NCT03581565|cementation|cementation
99529|NCT03581565|dental implant|dental implant
99530|NCT03581565|crown|crown
99531|NCT03581565|periimplantitis|periimplantitis
99532|NCT03581552|Post Menopausal|post menopausal
99533|NCT03581552|ER positive|er positive
99534|NCT03581552|Aromatase Inhibitor Therapy|aromatase inhibitor therapy
99535|NCT03581552|Breast Cancer|breast cancer
99536|NCT03581539|Laparoscopic Nephrectomy,|laparoscopic nephrectomy,
99537|NCT03581539|Simple Nephrectomy|simple nephrectomy
99538|NCT03581539|Partial Nephrectomy|partial nephrectomy
99539|NCT03581539|Pain,acute|pain,acute
99540|NCT03581539|Pain,postoperative|pain,postoperative
99541|NCT03581461|Trauma|trauma
99542|NCT03581461|Yoga|yoga
99543|NCT03581461|Mindfulness|mindfulness
99544|NCT03581409|antiplatelet preparation|antiplatelet preparation
99545|NCT03581409|cerebral aneurysm|cerebral aneurysm
99546|NCT03581409|coil embolization|coil embolization
99547|NCT03581396|Hydrops sacculaire|hydrops sacculaire
99548|NCT03581396|schwannoma intralabyrinth|schwannoma intralabyrinth
99549|NCT03581383|Hepatitis C|hepatitis c
99550|NCT03581383|Hep C|hep c
99551|NCT03581383|CARE-C|care-c
99552|NCT03581383|Kentucky|kentucky
99553|NCT03581370|Pneumonia|pneumonia
99554|NCT03581370|Pseudomonas aeruginosa|pseudomonas aeruginosa
99555|NCT03581370|pharmacokinetics|pharmacokinetics
99556|NCT03581357|Previous diagnosis of cancer, completed primary treatment of cancer|previous diagnosis of cancer, completed primary treatment of cancer
99557|NCT03581344|Conservative Treatment|conservative treatment
99558|NCT03581344|Neoadjuvant Therapy|neoadjuvant therapy
99559|NCT03581344|Radiotherapy|radiotherapy
99560|NCT03581318|MRI Technology Improvement|mri technology improvement
99561|NCT03581305|18F-Fluoro-L-dopa|18f-fluoro-l-dopa
99562|NCT03581305|Positron Emission Tomograhy (PET)|positron emission tomograhy (pet)
99563|NCT03581305|HIV|hiv
99564|NCT03581305|Depression|depression
99565|NCT03581266|Rye|rye
99566|NCT03581266|Wheat|wheat
99567|NCT03581266|Rye factor|rye factor
99568|NCT03581266|Glucose kinetics|glucose kinetics
99569|NCT03581227|CAPTURE, COPD|capture, copd
99570|NCT03581201|intestinal microbiome|intestinal microbiome
99571|NCT03581201|oral contraceptives|oral contraceptives
99572|NCT03581201|estrogens|estrogens
99573|NCT03581201|bacterial population|bacterial population
99574|NCT03581201|hormone status|hormone status
99575|NCT03581201|glucose profiles|glucose profiles
99576|NCT03581201|lipid parameters|lipid parameters
99577|NCT03581201|body composition|body composition
99578|NCT03581123|acute/subacute low back pain|acute/subacute low back pain
99579|NCT03581123|randomized clinical trial|randomized clinical trial
99580|NCT03581123|self-management|self-management
99581|NCT03581123|behavioral modification|behavioral modification
99582|NCT03581123|spinal manipulation therapy|spinal manipulation therapy
99583|NCT03581123|standard medical care|standard medical care
99584|NCT03581123|secondary prevention|secondary prevention
99585|NCT03581110|COPD|copd
99586|NCT03581110|Computed tomography|computed tomography
99587|NCT03581110|Expiration|expiration
99588|NCT03581110|organ specific radiation dose|organ specific radiation dose
99589|NCT03581097|Anxiety disorders|anxiety disorders
99590|NCT03581097|hand surgery|hand surgery
99591|NCT03581097|Educational Video|educational video
99592|NCT03581071|Dialysis, CKD|dialysis, ckd
99593|NCT03581058|MRI|mri
99594|NCT03581058|Cannabis|cannabis
99595|NCT03581058|Driving|driving
99596|NCT03581045|Acute Lymphoblastic Leukemia|acute lymphoblastic leukemia
99597|NCT03581045|ALL|all
99598|NCT03581045|Survivors|survivors
99599|NCT03581045|Cognitive performance|cognitive performance
99600|NCT03581045|Postural control|postural control
99601|NCT03581019|infertility, uterus, transplantation, MRKH|infertility, uterus, transplantation, mrkh
99602|NCT03581006|World Trade Center|world trade center
99603|NCT03581006|Firefighters|firefighters
99604|NCT03581006|FDNY|fdny
99605|NCT03581006|9/11|9/11
99606|NCT03581006|Metabolomics|metabolomics
99607|NCT03581006|FIREHOUSE|firehouse
99608|NCT03580993|Critical Illness|critical illness
99609|NCT03580993|Ultrasonography|ultrasonography
99610|NCT03580967|Type 2 Diabetes|type 2 diabetes
99611|NCT03580967|Major Depressive Disorder|major depressive disorder
99612|NCT03580967|Vortioxetine|vortioxetine
99613|NCT03580941|Pregnancy|pregnancy
99614|NCT03580941|Hemolytic-Uremic Syndrome|hemolytic-uremic syndrome
99615|NCT03580928|Chronic Lymphocytic Leukemia (CLL)|chronic lymphocytic leukemia (cll)
99616|NCT03580915|functional literacy|functional literacy
99617|NCT03580915|homelessness|homelessness
835525|NCT00096928|efalizumab|efalizumab
99618|NCT03580915|daily life activities|daily life activities
99619|NCT03580863|Pediatric|pediatric
99620|NCT03580863|emergency surgical and medical service|emergency surgical and medical service
99621|NCT03580863|Liberal doctor|liberal doctor
99622|NCT03580863|complaint|complaint
99623|NCT03580850|intra labyrinthine schwannoma|intra labyrinthine schwannoma
99624|NCT03580850|schwannoma|schwannoma
99625|NCT03580850|magnetic resonance imaging (MRI)|magnetic resonance imaging (mri)
99626|NCT03580850|gadolinium|gadolinium
99627|NCT03580850|T2 weighted gradient echo|t2 weighted gradient echo
99628|NCT03580837|Breast Cancer|breast cancer
99629|NCT03580837|Neoadjuvant chemotherapy|neoadjuvant chemotherapy
99630|NCT03580811|Alloderm|alloderm
99631|NCT03580811|Dental Implants|dental implants
99632|NCT03580811|Alveolar bone grafting|alveolar bone grafting
99633|NCT03580772|Total knee replacement|total knee replacement
99634|NCT03580772|Total knee arthroplasty|total knee arthroplasty
99635|NCT03580772|Gait analysis|gait analysis
99636|NCT03580733|ICU|icu
99637|NCT03580733|yeast intra abdominal infection|yeast intra abdominal infection
99638|NCT03580733|candidiasis|candidiasis
99639|NCT03580733|ß-D-glucan|ß-d-glucan
99640|NCT03580733|caspofungin|caspofungin
99641|NCT03580720|Monitoring|monitoring
99642|NCT03580720|Breathing effort|breathing effort
99643|NCT03580720|Intensive Care|intensive care
99644|NCT03580720|Diaphragm weakness|diaphragm weakness
99645|NCT03580694|Non-Small Cell Lung Cancer|non-small cell lung cancer
99646|NCT03580694|NSCLC|nsclc
99647|NCT03580694|Anti-PD-1|anti-pd-1
99648|NCT03580694|Anti-CTLA-4|anti-ctla-4
99649|NCT03580694|Immunotherapy|immunotherapy
99650|NCT03580681|Rheumatoid Arthritis|rheumatoid arthritis
99651|NCT03580681|Diet|diet
99652|NCT03580681|Fat-Restricted|fat-restricted
99653|NCT03580681|Vegeterian|vegeterian
99654|NCT03580668|Observational|observational
99655|NCT03580629|Live Donor Liver Transplant|live donor liver transplant
99656|NCT03580629|Education|education
99657|NCT03580629|Advocacy|advocacy
99658|NCT03580629|Live Donor Champion|live donor champion
99659|NCT03580551|Veterans|veterans
99660|NCT03580551|Sedentary|sedentary
99661|NCT03580551|Chronic illness|chronic illness
99662|NCT03580486|Parkinson's Disease|parkinson's disease
99663|NCT03580486|Hand Function|hand function
99664|NCT03580486|Squares Test|squares test
99665|NCT03580421|Endometrial Cancer|endometrial cancer
99666|NCT03580421|Health-economics analysis|health-economics analysis
99667|NCT03580421|Ambulatory surgery|ambulatory surgery
99668|NCT03580421|QALY|qaly
99669|NCT03580421|discrete choice experiment|discrete choice experiment
99670|NCT03580408|Nivolumab|nivolumab
99671|NCT03580408|Lymphoma|lymphoma
99672|NCT03580408|Anti-PD1|anti-pd1
99673|NCT03580395|apatinib|apatinib
99674|NCT03580395|neoadjuvant therapy|neoadjuvant therapy
99675|NCT03580395|breast cancer|breast cancer
99676|NCT03580369|Anti-IgE, CSU (chronic spontaneous urticarial), hives severity score, itch severity score, urticaria activity score|anti-ige, csu (chronic spontaneous urticarial), hives severity score, itch severity score, urticaria activity score
99677|NCT03580356|Anti-IgE, CSU (Chronic Spontaneous Urticaria), hives severity score, itch severity score, urticaria activity score|anti-ige, csu (chronic spontaneous urticaria), hives severity score, itch severity score, urticaria activity score
99678|NCT03580330|noncommunicable diseases|noncommunicable diseases
99679|NCT03580330|hypertension|hypertension
99680|NCT03580330|diabetes mellitus|diabetes mellitus
99681|NCT03580330|telemedicine|telemedicine
99682|NCT03580330|mobile health|mobile health
99683|NCT03580330|rural health|rural health
99684|NCT03580330|refugees|refugees
99685|NCT03580317|Classical trigeminal neuralgia|classical trigeminal neuralgia
99686|NCT03580317|Electroacupuncture|electroacupuncture
99687|NCT03580317|Randomized controlled clinical trial|randomized controlled clinical trial
99688|NCT03580304|Fatigue Mental|fatigue mental
99689|NCT03580304|Fatigue Signs and Symptoms|fatigue signs and symptoms
99690|NCT03580304|Behavioral Symptoms|behavioral symptoms
99691|NCT03580304|Industrial work|industrial work
99692|NCT03580304|physical effort|physical effort
99693|NCT03580304|mental effort|mental effort
99694|NCT03580304|questionnaires|questionnaires
99695|NCT03580304|ergonomic evaluation|ergonomic evaluation
99696|NCT03580291|Lupus Nephritis|lupus nephritis
99697|NCT03580291|Mesenchymal stem cell|mesenchymal stem cell
99698|NCT03580252|preterm|preterm
99699|NCT03580252|Child Development Disorders|child development disorders
99700|NCT03580252|Hammersmith|hammersmith
99701|NCT03580252|neurological outcomes|neurological outcomes
99702|NCT03580252|epidemiology|epidemiology
99703|NCT03580239|CRPC|crpc
99704|NCT03580239|Everolimus|everolimus
99705|NCT03580239|mTOR|mtor
99706|NCT03580226|Diabetes mellitus|diabetes mellitus
99707|NCT03580226|Glycemic control|glycemic control
99708|NCT03580226|Lipid profile|lipid profile
99709|NCT03580226|Kidney profile|kidney profile
99710|NCT03580226|Uric acid|uric acid
99711|NCT03580213|Occupational Therapy|occupational therapy
99712|NCT03580213|Physical Therapy|physical therapy
127981|NCT03403192|DLT|dlt
99713|NCT03580213|Hand Therapy|hand therapy
99714|NCT03580213|ADL|adl
99715|NCT03580213|COPM|copm
99716|NCT03580213|URAM|uram
99717|NCT03580213|ROM|rom
99718|NCT03580213|Hand exercise|hand exercise
99719|NCT03580213|Scar|scar
99720|NCT03580213|Oedema|oedema
99721|NCT03580213|Splint|splint
99722|NCT03580213|Orthosis|orthosis
99723|NCT03580200|Latent Trigger Point|latent trigger point
99724|NCT03580200|Myofascial Trigger Point|myofascial trigger point
99725|NCT03580200|Trigger Point Dry Needling|trigger point dry needling
99726|NCT03580200|Deep Dry Needling|deep dry needling
99727|NCT03580200|Muscle Strength|muscle strength
99728|NCT03580200|Gluteus Medius|gluteus medius
99729|NCT03580174|Physical therapy|physical therapy
99731|NCT03580174|Botulinum toxin|botulinum toxin
99732|NCT03580174|Activity|activity
99733|NCT03580174|Function|function
99734|NCT03580161|Absorbed Radiation Dose|absorbed radiation dose
99735|NCT03580161|Radiation Risks|radiation risks
99736|NCT03580161|Radiation Protection|radiation protection
99737|NCT03580161|Dosimetry|dosimetry
99738|NCT03580148|osteoarthritis|osteoarthritis
99739|NCT03580148|glenohumeral joint|glenohumeral joint
99740|NCT03580148|arthritis|arthritis
99741|NCT03580148|shoulder|shoulder
99742|NCT03580135|pulpotomy|pulpotomy
99743|NCT03580135|primary molars|primary molars
99744|NCT03580135|propolis|propolis
99745|NCT03580109|Lymphoedema|lymphoedema
99746|NCT03580109|Post breast cancer|post breast cancer
99747|NCT03580109|Spa therapy|spa therapy
99748|NCT03580109|Education therapeutic|education therapeutic
99749|NCT03580083|MPS I , gene therapy, Hurler, Hurler- Scheie|mps i , gene therapy, hurler, hurler- scheie
99750|NCT03580070|Head cancers|head cancers
99751|NCT03580070|Neck squamous cells carcinoma|neck squamous cells carcinoma
99753|NCT03580070|Immunotherapy|immunotherapy
99754|NCT03580044|Serious bacterial infection|serious bacterial infection
99755|NCT03580044|cIAI|ciai
99756|NCT03580044|HAP/(VAP|hap/(vap
99757|NCT03580044|cUTI|cuti
99758|NCT03580044|BSI|bsi
99759|NCT03580044|MBL|mbl
99760|NCT03580031|LUF|luf
99761|NCT03580031|HCG|hcg
99762|NCT03580031|Booster dose|booster dose
99763|NCT03580031|Ovulation rate|ovulation rate
99764|NCT03580031|pregnancy rate|pregnancy rate
99765|NCT03580018|Anterior cruciate ligament reconstruction, knee, hemarthrosis, tranexamic acid|anterior cruciate ligament reconstruction, knee, hemarthrosis, tranexamic acid
99766|NCT03579979|Near-infrared fluorescence|near-infrared fluorescence
99767|NCT03579979|Image guided surgery|image guided surgery
99768|NCT03579979|Sentinel lymph node biopsy|sentinel lymph node biopsy
99769|NCT03579979|Indocyanine green|indocyanine green
99770|NCT03579979|Methylene blue|methylene blue
99771|NCT03579953|Brain Stimulation|brain stimulation
99772|NCT03579914|Anterior Myocardial Infarction|anterior myocardial infarction
99773|NCT03579914|Intravenous Metoprolol|intravenous metoprolol
99774|NCT03579914|RIPC|ripc
99775|NCT03579914|Myocardial Protection|myocardial protection
99776|NCT03579901|Breast Implants|breast implants
99777|NCT03579901|Breast Surgery|breast surgery
99778|NCT03579901|Breast Augmentation|breast augmentation
99779|NCT03579901|Breast Reconstruction|breast reconstruction
99780|NCT03579836|Pancreatic Cancer|pancreatic cancer
99781|NCT03579810|Behavioral Modification|behavioral modification
99782|NCT03579810|Health Community|health community
99783|NCT03579810|Community Intervention|community intervention
99784|NCT03579810|Prevention|prevention
99785|NCT03579810|Education Intervention|education intervention
99786|NCT03579810|Cardiovascular Health|cardiovascular health
99787|NCT03579810|Colombia|colombia
99788|NCT03579797|diabetic eye diseases|diabetic eye diseases
99789|NCT03579797|diabetic retinopathy|diabetic retinopathy
99790|NCT03579745|lingual orthodontics|lingual orthodontics
99791|NCT03579745|Lever arm|lever arm
99792|NCT03579745|En masse retraction|en masse retraction
99793|NCT03579732|Low-dose aspirin,|low-dose aspirin,
99794|NCT03579732|Cancer prevention|cancer prevention
99795|NCT03579693|Mitochondria|mitochondria
99796|NCT03579693|Antioxidants|antioxidants
99797|NCT03579693|CoQ10|coq10
99798|NCT03579693|Nicotinamide riboside|nicotinamide riboside
99799|NCT03579693|Ergometry|ergometry
99800|NCT03579693|Fatigue|fatigue
99801|NCT03579693|Aerobic capacity|aerobic capacity
99802|NCT03579680|Prostatic Neoplasms|prostatic neoplasms
99803|NCT03579680|De-implementation|de-implementation
99804|NCT03579680|androgen deprivation therapy|androgen deprivation therapy
99805|NCT03579680|Provider Preferences|provider preferences
99806|NCT03579654|Prostate Specific Antigen|prostate specific antigen
99807|NCT03579654|Immunotherapy|immunotherapy
99808|NCT03579641|Heart Failure|heart failure
99809|NCT03579641|Implantable Cardioverter Defibrillator|implantable cardioverter defibrillator
99810|NCT03579641|Cardiac Resynchronization Therapy Defibrillator|cardiac resynchronization therapy defibrillator
99811|NCT03579641|HF Sensor Data|hf sensor data
839950|NCT00088309|HIV|hiv
99812|NCT03579641|30-day HF Readmission|30-day hf readmission
99813|NCT03579641|VT/VF Therapy|vt/vf therapy
99814|NCT03579641|non-HF Hospitalization|non-hf hospitalization
99815|NCT03579641|HeartLogic Feature|heartlogic feature
99816|NCT03579641|Latitude Remote Patient Monitor|latitude remote patient monitor
99817|NCT03579641|Data Linkage|data linkage
99818|NCT03579641|Sleep Incline Sensor|sleep incline sensor
99819|NCT03579641|Respiratory Sensor|respiratory sensor
99820|NCT03579641|Decongestive IV therapy|decongestive iv therapy
99821|NCT03579641|Decompensation|decompensation
99822|NCT03579602|Tumor Paint|tumor paint
99823|NCT03579602|tozuleristide|tozuleristide
99824|NCT03579602|Canvas imaging system|canvas imaging system
99825|NCT03579602|BLZ-100|blz-100
99826|NCT03579602|CNS tumor|cns tumor
99827|NCT03579602|brain cancer|brain cancer
99828|NCT03579602|pediatrics|pediatrics
99829|NCT03579602|fluorescence guided surgery|fluorescence guided surgery
99830|NCT03579589|Neuromuscular Blockade Reversal|neuromuscular blockade reversal
99831|NCT03579589|Outpatient Surgery|outpatient surgery
99832|NCT03579576|PWID|pwid
99833|NCT03579576|MSM|msm
99834|NCT03579576|HCV|hcv
99835|NCT03579576|HIV|hiv
99836|NCT03579563|Presbycusis|presbycusis
99837|NCT03579563|Hearing aid|hearing aid
99838|NCT03579550|dysmorphic uterus, metroplasty, hysteroscopy|dysmorphic uterus, metroplasty, hysteroscopy
99839|NCT03579537|Hemodialysis|hemodialysis
99840|NCT03579537|Klotho Protein|klotho protein
99841|NCT03579537|Excercise|excercise
99842|NCT03579537|Lifestyle condition|lifestyle condition
99843|NCT03579524|Erector Spinae Plane Block|erector spinae plane block
99844|NCT03579524|Serratus Anterior Plane Block|serratus anterior plane block
99845|NCT03579498|Cardiac arrest|cardiac arrest
99846|NCT03579498|Cognitive impairment|cognitive impairment
99847|NCT03579498|Depression|depression
99848|NCT03579498|Anxiety|anxiety
99849|NCT03579498|PTSD|ptsd
99850|NCT03579498|Health- related quality of life|health- related quality of life
99851|NCT03579498|functional MRI|functional mri
99852|NCT03579485|raltegravir|raltegravir
99853|NCT03579485|naive|naive
99854|NCT03579485|Aging|aging
99855|NCT03579459|Clostridium Difficile|clostridium difficile
99856|NCT03579459|vaccine|vaccine
99857|NCT03579407|osteoarthritis|osteoarthritis
99858|NCT03579407|cell therapy|cell therapy
99859|NCT03579407|stem cells|stem cells
99860|NCT03579407|needle|needle
99861|NCT03579407|bone marrow aspiration|bone marrow aspiration
99862|NCT03579394|ovarian cancer|ovarian cancer
99863|NCT03579394|retarded surgery|retarded surgery
99864|NCT03579394|neoadjuvant chemotherapy|neoadjuvant chemotherapy
99865|NCT03579368|Cataract|cataract
99866|NCT03579368|IOL|iol
99867|NCT03579368|Presbyopia Correcting IOL|presbyopia correcting iol
99868|NCT03579368|Patient Satisfaction|patient satisfaction
99869|NCT03579368|Spectacle Independence|spectacle independence
99870|NCT03579329|sarcopenia|sarcopenia
99871|NCT03579329|Osteoarthritis|osteoarthritis
99872|NCT03579329|Total Knee Arthroplasty|total knee arthroplasty
99873|NCT03579303|Homoeopathy|homoeopathy
99874|NCT03579303|Yoga|yoga
99875|NCT03579277|Radial Forearm Free Flap|radial forearm free flap
99876|NCT03579277|Ulnar Forearm Free Flap|ulnar forearm free flap
99877|NCT03579277|Free Tissue Transfer|free tissue transfer
99878|NCT03579212|Osteosynthesis|osteosynthesis
99879|NCT03579212|Prophylactic consolidation|prophylactic consolidation
99880|NCT03579212|Proximal femur|proximal femur
99881|NCT03579199|hepatic tumor|hepatic tumor
99882|NCT03579199|liver|liver
99883|NCT03579199|ICG|icg
99884|NCT03579199|ICG camera|icg camera
99885|NCT03579199|laparoscopy|laparoscopy
99886|NCT03579173|Nutritional Status|nutritional status
99887|NCT03579173|Infant Pulmonary Function Testing|infant pulmonary function testing
99888|NCT03579173|Lung Clearance Index|lung clearance index
99889|NCT03579173|Multiple Breath Washout|multiple breath washout
99890|NCT03579121|pharmacogenomics|pharmacogenomics
99891|NCT03579121|preoperative evaluation|preoperative evaluation
99892|NCT03579121|perioperative opioid use|perioperative opioid use
99893|NCT03579108|Hypertension|hypertension
99894|NCT03579082|Decitabine|decitabine
99895|NCT03579082|ORR|orr
99896|NCT03579082|TTP|ttp
99897|NCT03579082|OS|os
99898|NCT03579082|PFS|pfs
99899|NCT03579069|Ductus venosus Doppler|ductus venosus doppler
99900|NCT03579030|RTA 1701|rta 1701
99901|NCT03579030|RTA 1701 capsules|rta 1701 capsules
99902|NCT03579017|Amyotrophic lateral sclerosis|amyotrophic lateral sclerosis
99903|NCT03579017|Cognitive|cognitive
99904|NCT03579017|Screening|screening
99905|NCT03579017|Validation|validation
99906|NCT03579004|esophageal squamous cell carcinoma|esophageal squamous cell carcinoma
99907|NCT03579004|preoperative chemoradiotherapy|preoperative chemoradiotherapy
99908|NCT03579004|preoperative chemotherapy|preoperative chemotherapy
99909|NCT03578991|Type 2 diabetes mellitus|type 2 diabetes mellitus
99910|NCT03578991|Mild cognitive impairment|mild cognitive impairment
99911|NCT03578991|Alzheimer disease|alzheimer disease
839951|NCT00088309|Pediatrics|pediatrics
99912|NCT03578991|Intervention|intervention
99913|NCT03578991|Clinical trial|clinical trial
99914|NCT03578991|mHealth|mhealth
99915|NCT03578991|Smart electronic pillbox|smart electronic pillbox
99916|NCT03578991|Interactive digital platform|interactive digital platform
99917|NCT03578952|TAVR|tavr
99918|NCT03578952|TAVI|tavi
99919|NCT03578952|Pure AR|pure ar
99920|NCT03578913|PFM implant supported restoration|pfm implant supported restoration
99921|NCT03578913|Clinical assessment|clinical assessment
99922|NCT03578913|radiographic assessment|radiographic assessment
99923|NCT03578900|Xerostomia|xerostomia
99924|NCT03578900|Hyposalivation|hyposalivation
99925|NCT03578900|Quality of Life|quality of life
99926|NCT03578900|Sjogren's Syndrome|sjogren's syndrome
99927|NCT03578887|Obesity, Gliosis, Weight-Loss, Roux-en-Y Gastric Bypass, Type 2 Diabetes Mellitus|obesity, gliosis, weight-loss, roux-en-y gastric bypass, type 2 diabetes mellitus
99928|NCT03578848|blood pressure monitoring|blood pressure monitoring
99929|NCT03578848|sphygmomanometer|sphygmomanometer
99930|NCT03578835|BSI|bsi
99931|NCT03578835|SF-36|sf-36
99932|NCT03578835|Clinical Outcome|clinical outcome
99933|NCT03578835|Whole Genome Sequencing|whole genome sequencing
99934|NCT03578835|Predictive Score|predictive score
99935|NCT03578835|Bloodstream Infection|bloodstream infection
99936|NCT03578835|Septic Shock|septic shock
99937|NCT03578835|Multi-resistant Bacteria|multi-resistant bacteria
99938|NCT03578796|Amyotrophic Lateral Sclerosis|amyotrophic lateral sclerosis
99939|NCT03578796|Cognitive|cognitive
99940|NCT03578796|Predictor|predictor
99941|NCT03578757|stress|stress
99942|NCT03578757|prevention|prevention
99943|NCT03578757|obesity|obesity
99944|NCT03578757|spa|spa
99945|NCT03578757|psychology|psychology
99946|NCT03578757|biomarkers|biomarkers
99947|NCT03578731|APP|app
99948|NCT03578705|Orthopedic trauma|orthopedic trauma
99949|NCT03578692|acute severe ulcerative colitis|acute severe ulcerative colitis
99950|NCT03578692|predictive indicator|predictive indicator
99951|NCT03578692|surgery|surgery
99952|NCT03578666|recovery intervention|recovery intervention
99953|NCT03578666|fatigue|fatigue
99954|NCT03578666|running|running
99955|NCT03578666|cryotherapy|cryotherapy
99956|NCT03578666|running economy|running economy
99957|NCT03578640|Hepatitis C Virus|hepatitis c virus
99958|NCT03578640|Chronic Hepatitis C|chronic hepatitis c
99959|NCT03578640|Genotype 4|genotype 4
99960|NCT03578640|Treatment-naive|treatment-naive
99961|NCT03578640|Non-cirrhotic|non-cirrhotic
99962|NCT03578614|Vascular cognitive impairment|vascular cognitive impairment
99963|NCT03578614|Physical Activity|physical activity
99964|NCT03578614|Randomized Clinical Trial|randomized clinical trial
99965|NCT03578614|Stroke|stroke
99966|NCT03578614|TIA|tia
99967|NCT03578614|Small Vessel Disease|small vessel disease
99968|NCT03578601|Intubation|intubation
99969|NCT03578601|Difficult|difficult
99970|NCT03578601|thyroid|thyroid
99971|NCT03578588|single dose|single dose
99972|NCT03578588|multiple dose|multiple dose
99973|NCT03578588|Pharmacokinetic|pharmacokinetic
99974|NCT03578588|Tolerability|tolerability
99975|NCT03578588|Healthy Subject|healthy subject
99976|NCT03578588|Benapenem|benapenem
99977|NCT03578575|Nasopharyngeal carcinoma|nasopharyngeal carcinoma
99978|NCT03578575|Concurrent chemo-radiotherapy|concurrent chemo-radiotherapy
99979|NCT03578562|Femoroacetabular Impingement|femoroacetabular impingement
99980|NCT03578562|Anterior Pelvic Tilt|anterior pelvic tilt
99981|NCT03578549|Dental Pulp Test|dental pulp test
99982|NCT03578549|Vitality Testing|vitality testing
99983|NCT03578549|Pulpal Blood Flow Measure|pulpal blood flow measure
99984|NCT03578536|Stroke|stroke
99985|NCT03578536|Therapy, Occupational|therapy, occupational
99986|NCT03578536|Hemiplegia|hemiplegia
99987|NCT03578510|Hemodialysis, sodium, endothelium, sympathetic activity, vasopressin|hemodialysis, sodium, endothelium, sympathetic activity, vasopressin
99988|NCT03578497|Interleukin-1 receptor antagonism|interleukin-1 receptor antagonism
99989|NCT03578497|Kineret/Anakinra|kineret/anakinra
99990|NCT03578497|testosteron|testosteron
99991|NCT03578484|Breast Aesthetics|breast aesthetics
99992|NCT03578484|3D scanning|3d scanning
99993|NCT03578484|Aesthetic rating|aesthetic rating
99994|NCT03578484|Cultural Differences Aesthetics|cultural differences aesthetics
99995|NCT03578484|Mammometrics|mammometrics
99996|NCT03578445|EUS|eus
99997|NCT03578445|EUS-FNA|eus-fna
99998|NCT03578445|microbiopsy|microbiopsy
99999|NCT03578432|Xerostomia|xerostomia
100000|NCT03578432|Dry Mouth|dry mouth
100001|NCT03578432|Salivary Gland Dysfunction|salivary gland dysfunction
100002|NCT03578432|Head and Neck Cancer|head and neck cancer
100003|NCT03578432|Mouth Cancer|mouth cancer
100004|NCT03578432|Everolimus|everolimus
100005|NCT03578432|Rapamycin|rapamycin
100006|NCT03578432|Neck Cancer|neck cancer
100007|NCT03578432|Saliva|saliva
100008|NCT03578419|Anemia|anemia
100009|NCT03578419|Blood transfusion|blood transfusion
100010|NCT03578419|Intensive Care Unit|intensive care unit
100011|NCT03578419|Blood sampling|blood sampling
128376|NCT03400397|CBT|cbt
100012|NCT03578419|Stepped wedge|stepped wedge
100013|NCT03578419|Red blood cells|red blood cells
100014|NCT03578393|Preanesthetic visit|preanesthetic visit
100015|NCT03578380|Lymphovenous bypass|lymphovenous bypass
100016|NCT03578380|Lymphovenous anastomosis|lymphovenous anastomosis
100017|NCT03578380|Supermicrosurgery|supermicrosurgery
100018|NCT03578380|Lymphangiography|lymphangiography
100019|NCT03578380|MD Anderson Lymphedema Stage|md anderson lymphedema stage
100020|NCT03578367|CML|cml
100021|NCT03578367|Chronic Myelogenous Leukemia|chronic myelogenous leukemia
100022|NCT03578367|leukemia, myeloid chronic|leukemia, myeloid chronic
100023|NCT03578367|Hematologic Diseases|hematologic diseases
100024|NCT03578367|Asciminib|asciminib
100025|NCT03578367|ABL001|abl001
100026|NCT03578367|Imatinib|imatinib
100027|NCT03578367|Nilotinib|nilotinib
100028|NCT03578367|deep molecular response|deep molecular response
100029|NCT03578367|DMR|dmr
100030|NCT03578367|Ph+ CML|ph+ cml
100031|NCT03578367|chronic phase|chronic phase
100032|NCT03578367|cancer of the white blood cells|cancer of the white blood cells
100033|NCT03578367|tyrosine kinase inhibitor|tyrosine kinase inhibitor
100034|NCT03578367|leukemia, myeloid|leukemia, myeloid
100035|NCT03578367|leukemia|leukemia
100036|NCT03578341|Immunoglobulins A, G and M|immunoglobulins a, g and m
100037|NCT03578341|Neonatal Sepsis|neonatal sepsis
100038|NCT03578341|Human Milk|human milk
100039|NCT03578341|Orally Colostrum|orally colostrum
100040|NCT03578315|Solar Lentigo|solar lentigo
100041|NCT03578315|Nevus Zygomaticus|nevus zygomaticus
100541|NCT03575390|Pomegranate|pomegranate
100042|NCT03578315|Harmonic Generation Microscopy|harmonic generation microscopy
100043|NCT03578315|In Vivo|in vivo
100044|NCT03578289|Parents of children with disabilities|parents of children with disabilities
100045|NCT03578289|emotional functioning|emotional functioning
100046|NCT03578276|cataract surgery|cataract surgery
100047|NCT03578276|Prophylaxis|prophylaxis
100048|NCT03578263|cesarean section|cesarean section
100049|NCT03578263|post-partum hemorrhage|post-partum hemorrhage
100050|NCT03578263|multiple pregnancy|multiple pregnancy
100051|NCT03578250|Stroke|stroke
100052|NCT03578250|Error augmentation|error augmentation
100053|NCT03578250|Rehabilitation|rehabilitation
100054|NCT03578250|Cerebellum|cerebellum
100055|NCT03578250|Motor learning|motor learning
100056|NCT03578250|Adaptation|adaptation
100057|NCT03578133|pneumonia|pneumonia
100058|NCT03578133|melioidosis|melioidosis
100059|NCT03578133|Myanmar|myanmar
100060|NCT03578133|diagnosis|diagnosis
100061|NCT03578107|acute ischemic stroke|acute ischemic stroke
100062|NCT03578107|IV-tPA|iv-tpa
100063|NCT03578107|endovascular treatment|endovascular treatment
100064|NCT03578107|intervention|intervention
100065|NCT03578094|cohort|cohort
100066|NCT03578094|Noncommunicable diseases|noncommunicable diseases
100067|NCT03578094|pregnancy|pregnancy
100068|NCT03578094|infant|infant
100069|NCT03578094|cognition|cognition
100070|NCT03578094|United Arab Emirates|united arab emirates
100071|NCT03578094|gestational diabetes|gestational diabetes
100072|NCT03578068|Quality of Recovery|quality of recovery
100073|NCT03578068|Postoperative|postoperative
100074|NCT03578068|Surgery|surgery
100075|NCT03578068|French|french
100076|NCT03578068|Translation|translation
100077|NCT03578068|Validation|validation
100078|NCT03578029|Epidermolysis Bullosa|epidermolysis bullosa
100079|NCT03578016|attachment|attachment
100080|NCT03578016|parent|parent
100081|NCT03578016|training|training
100082|NCT03578016|sensitivity|sensitivity
100083|NCT03578003|Sleep|sleep
100084|NCT03578003|Bright Light|bright light
100085|NCT03577990|hypertension, Black women, self-management, coaching|hypertension, black women, self-management, coaching
100086|NCT03577977|Multiple sclerosis (MS), Betaseron, Betaferon|multiple sclerosis (ms), betaseron, betaferon
100087|NCT03577964|Pneumonia|pneumonia
100088|NCT03577964|Glucose|glucose
100089|NCT03577964|Infections|infections
100090|NCT03577964|Respiratory Tract Infection|respiratory tract infection
100091|NCT03577964|Hyperglycemia|hyperglycemia
100092|NCT03577964|Critical Care|critical care
100093|NCT03577938|Liver Failure|liver failure
100094|NCT03577938|traditional Chinese medicine|traditional chinese medicine
100095|NCT03577938|Hepatitis B|hepatitis b
100096|NCT03577912|ERAS|eras
100097|NCT03577912|transversus_abdominis_plane_block|transversus_abdominis_plane_block
100098|NCT03577912|postoperative_pain|postoperative_pain
100099|NCT03577873|gallbladder stones|gallbladder stones
100100|NCT03577873|common bile duct stones|common bile duct stones
100101|NCT03577873|Endoscopic retrograde cholangiopancreatography|endoscopic retrograde cholangiopancreatography
100102|NCT03577847|Stroke, Thrombolysis, Rural CT|stroke, thrombolysis, rural ct
100103|NCT03577834|randomized clinical trial|randomized clinical trial
100104|NCT03577834|vinegar|vinegar
100105|NCT03577834|adiposity|adiposity
100106|NCT03577834|insulin resistance|insulin resistance
100107|NCT03577795|COPD, ACO, RWE|copd, aco, rwe
100108|NCT03577782|HIV|hiv
100109|NCT03577782|CD4+|cd4+
100110|NCT03577782|T-cell|t-cell
100111|NCT03577782|Reservoir|reservoir
100112|NCT03577782|Cure|cure
100113|NCT03577782|Antiretroviral therapy|antiretroviral therapy
100114|NCT03577782|Vedolizumab|vedolizumab
100115|NCT03577782|Gut|gut
100116|NCT03577782|Alpha4Beta7|alpha4beta7
100117|NCT03577782|gp120|gp120
100118|NCT03577782|Interruption|interruption
100119|NCT03577769|Health care associated urinary tract infection|health care associated urinary tract infection
100120|NCT03577769|Bacteriuria|bacteriuria
100121|NCT03577769|Elderly|elderly
100122|NCT03577769|Geriatrics|geriatrics
100123|NCT03577769|Antimicrobial resistance|antimicrobial resistance
100124|NCT03577769|Multi-resistant bacteria|multi-resistant bacteria
100125|NCT03577756|cystic fibrosis|cystic fibrosis
100126|NCT03577756|neurodevelopment|neurodevelopment
100127|NCT03577756|early rehabilitation|early rehabilitation
100128|NCT03577743|antiangiogenesis|antiangiogenesis
100129|NCT03577743|taxanes and carboplatin|taxanes and carboplatin
100130|NCT03577743|metastatic TNBC|metastatic tnbc
100131|NCT03577730|Opioid Use|opioid use
100132|NCT03577730|Opioid Dependence|opioid dependence
100133|NCT03577730|Opioid-Related Disorders|opioid-related disorders
100134|NCT03577730|Opioid Abuse|opioid abuse
100135|NCT03577730|Opioid-use Disorder|opioid-use disorder
100136|NCT03577730|Pain|pain
100137|NCT03577730|Pain, Postoperative|pain, postoperative
100138|NCT03577730|Cognitive Impairment|cognitive impairment
100139|NCT03577730|Delirium|delirium
100140|NCT03577730|Delirium on Emergence|delirium on emergence
100141|NCT03577730|Depression|depression
100142|NCT03577730|Anxiety|anxiety
100143|NCT03577730|Anxiety Disorders|anxiety disorders
100144|NCT03577730|Affect|affect
100145|NCT03577691|Blood Disorders|blood disorders
100146|NCT03577691|Hydroxyurea (HU)|hydroxyurea (hu)
100147|NCT03577691|Decision Aid|decision aid
100148|NCT03577678|Comminuted lateral clavicle fracture , New prosthesis,|comminuted lateral clavicle fracture , new prosthesis,
100149|NCT03577665|Liver Metastasis, Curative Proton Beam Therapy|liver metastasis, curative proton beam therapy
100150|NCT03577652|Ticagrelor|ticagrelor
100151|NCT03577652|Clopidogrel|clopidogrel
100152|NCT03577652|Switching strategy|switching strategy
100153|NCT03577613|radical hysterectomy|radical hysterectomy
100154|NCT03577613|minimally invasive surgery|minimally invasive surgery
100155|NCT03577600|Recurrent Ependymoma|recurrent ependymoma
100156|NCT03577600|Brainstem Gliomas|brainstem gliomas
100157|NCT03577600|Rotational Field Quantum Magnetic Resonance (RFQMR)|rotational field quantum magnetic resonance (rfqmr)
100158|NCT03577600|Cytotron®|cytotron®
100159|NCT03577600|High Grade Gliomas|high grade gliomas
100160|NCT03577600|Quantum Magnetic Resonance Therapy (QMRT)|quantum magnetic resonance therapy (qmrt)
100161|NCT03577600|Brain Tumor Recurrence|brain tumor recurrence
100162|NCT03577587|galactagogue|galactagogue
100163|NCT03577587|milk thistle|milk thistle
100164|NCT03577587|silymarin|silymarin
100165|NCT03577587|Silitidil|silitidil
100166|NCT03577535|Oral Mucositis|oral mucositis
100167|NCT03577535|Nutritional supplement|nutritional supplement
100168|NCT03577535|Chemotherapy|chemotherapy
100169|NCT03577535|Radiotherapy|radiotherapy
100170|NCT03577535|Ocoxin / Oncoxin|ocoxin / oncoxin
100171|NCT03577457|oxytocin|oxytocin
100172|NCT03577457|serotonin|serotonin
100173|NCT03577457|social reward|social reward
100174|NCT03577457|decision making|decision making
100175|NCT03577444|gene polymorphism|gene polymorphism
100176|NCT03577444|stroke|stroke
100177|NCT03577444|dysphagia|dysphagia
100178|NCT03577444|poststroke recovery|poststroke recovery
100179|NCT03577431|alloantigen-reactive Tregs ( arTreg)|alloantigen-reactive tregs ( artreg)
100180|NCT03577431|immunosuppression|immunosuppression
100181|NCT03577431|operational tolerance|operational tolerance
100182|NCT03577405|Critical Illness|critical illness
100183|NCT03577405|Acute Disease|acute disease
100184|NCT03577405|Shock|shock
100185|NCT03577405|Acute Kidney Injury|acute kidney injury
100186|NCT03577405|Ultrasonography|ultrasonography
100187|NCT03577379|Rotator cuff repair, whole blood fibrin clot|rotator cuff repair, whole blood fibrin clot
100188|NCT03577366|Bacteremia|bacteremia
100189|NCT03577366|Sepsis|sepsis
100190|NCT03577366|Diagnostic Error|diagnostic error
100191|NCT03577301|HIV|hiv
100192|NCT03577301|Intervention|intervention
100193|NCT03577301|Men Who Have Sex with Men (MSM)|men who have sex with men (msm)
100194|NCT03577301|PrEP|prep
100195|NCT03577301|YMHP|ymhp
100196|NCT03577301|YMSM|ymsm
100197|NCT03577288|Feelings|feelings
100198|NCT03577288|Emotions|emotions
100199|NCT03577288|Virtual Reality|virtual reality
100200|NCT03577288|Young Adult|young adult
100201|NCT03577288|Child|child
100202|NCT03577223|Egg|egg
100203|NCT03577223|HDL|hdl
100204|NCT03577223|Inflammation|inflammation
100205|NCT03577210|chin deficiency|chin deficiency
100206|NCT03577210|chin asymmetry|chin asymmetry
100207|NCT03577197|Breast neoplasms|breast neoplasms
100208|NCT03577197|Neoplasm Metastasis|neoplasm metastasis
100209|NCT03577197|Registry|registry
100210|NCT03577184|GRIP, DM|grip, dm
100211|NCT03577171|CHB|chb
100212|NCT03577171|HBV|hbv
100213|NCT03577171|HBeAg-positive|hbeag-positive
100214|NCT03577171|hepatitis B|hepatitis b
100215|NCT03577158|Diabetes Mellitus, Type 1|diabetes mellitus, type 1
100216|NCT03577158|Insulin|insulin
100217|NCT03577158|Exercise|exercise
100218|NCT03577158|Closed-loop|closed-loop
100219|NCT03577158|Artificial Pancreas|artificial pancreas
100220|NCT03577145|Bioavailability|bioavailability
100221|NCT03577145|Polyphenols|polyphenols
100222|NCT03577145|Dietary fibre|dietary fibre
100223|NCT03577145|Phenolic acids|phenolic acids
100224|NCT03577132|neoadjuvant chemotherapy|neoadjuvant chemotherapy
100225|NCT03577132|atezolizumab|atezolizumab
100226|NCT03577119|Prediabetes|prediabetes
100227|NCT03577119|Glucose Tolerance|glucose tolerance
100228|NCT03577119|Bioactive fatty acids|bioactive fatty acids
100229|NCT03577119|Insulin sensitivity|insulin sensitivity
100231|NCT03577119|Milk fat|milk fat
100232|NCT03577119|Lipid metabolism|lipid metabolism
100233|NCT03577119|Inflammation markers|inflammation markers
100234|NCT03577119|Fecal microbiota composition|fecal microbiota composition
100235|NCT03577119|Dairy|dairy
100236|NCT03577106|transcranial magnetic stimulation|transcranial magnetic stimulation
100237|NCT03577106|TMS|tms
100238|NCT03577106|MRI|mri
100239|NCT03577106|magnetic resonance imaging|magnetic resonance imaging
100240|NCT03577106|fMRI|fmri
100241|NCT03577106|functional magnetic resonance imaging|functional magnetic resonance imaging
100242|NCT03577106|sleep|sleep
100243|NCT03577106|intermittent theta burst stimulation|intermittent theta burst stimulation
100244|NCT03577106|iTBS|itbs
100245|NCT03577093|stroke, miR-494, neuroprotection, CDK|stroke, mir-494, neuroprotection, cdk
100246|NCT03577080|COPD, Exercise training|copd, exercise training
100247|NCT03577054|Helping Babies Breathe|helping babies breathe
100248|NCT03577054|newborn resuscitation|newborn resuscitation
100249|NCT03577054|skills retention|skills retention
100250|NCT03577054|mobile health|mobile health
100251|NCT03577054|user-centred design|user-centred design
100252|NCT03577041|Neovascular Age-Related Macular Degeneration|neovascular age-related macular degeneration
100253|NCT03577041|Bevacizumab|bevacizumab
100254|NCT03577041|Cost-Effective|cost-effective
100255|NCT03577041|Quality of life|quality of life
100256|NCT03577015|disseminated intravascular coagulation|disseminated intravascular coagulation
100257|NCT03577015|sepsis|sepsis
100258|NCT03577015|trauma|trauma
100259|NCT03577015|pancreatitis|pancreatitis
100260|NCT03577015|malignancy|malignancy
100261|NCT03577015|obstetric complication|obstetric complication
100262|NCT03577002|Advance care planning|advance care planning
100263|NCT03577002|Patient-provider communications|patient-provider communications
100264|NCT03577002|Interdisciplinary teams|interdisciplinary teams
100265|NCT03577002|Practice-based research networks|practice-based research networks
100266|NCT03577002|Cluster-randomized controlled trial|cluster-randomized controlled trial
100267|NCT03577002|Primary care|primary care
100268|NCT03576989|leg ulcer, fish oil, wounds|leg ulcer, fish oil, wounds
100269|NCT03576976|Cognitive Remediation|cognitive remediation
100270|NCT03576950|Uterine rupture|uterine rupture
100271|NCT03576950|Cesarean section|cesarean section
100272|NCT03576950|Labour|labour
100273|NCT03576950|Myomectomy|myomectomy
100274|NCT03576950|Delivery|delivery
100275|NCT03576924|Physical activity adherence|physical activity adherence
100276|NCT03576924|Exercise motivation|exercise motivation
100277|NCT03576924|Exercise enjoyment|exercise enjoyment
100278|NCT03576924|Prediabetes|prediabetes
100279|NCT03576872|Gastro Intestinal Cancer|gastro intestinal cancer
100280|NCT03576846|neck pain|neck pain
100281|NCT03576846|spinal manipulative therapy|spinal manipulative therapy
100282|NCT03576846|heart rate variability|heart rate variability
100283|NCT03576846|conditioned pain modulation|conditioned pain modulation
100284|NCT03576820|pediatrics|pediatrics
100285|NCT03576820|intranasal lidocaine|intranasal lidocaine
100286|NCT03576820|migraine|migraine
100287|NCT03576820|headache|headache
100288|NCT03576820|emergency department|emergency department
100289|NCT03576820|pain|pain
100290|NCT03576807|B-cell leukemia|b-cell leukemia
100291|NCT03576794|PMR RCT|pmr rct
100292|NCT03576794|Leflunomide|leflunomide
100293|NCT03576781|Brain Stimulation|brain stimulation
100294|NCT03576781|Treatment|treatment
100295|NCT03576768|Transcranial Magnetic Stimulation|transcranial magnetic stimulation
100296|NCT03576768|Brain Stimulation|brain stimulation
100297|NCT03576768|Treatment|treatment
100298|NCT03576768|Neuroimaging|neuroimaging
100299|NCT03576742|pancytopenia|pancytopenia
100300|NCT03576742|aplastic anemia|aplastic anemia
100301|NCT03576742|myelodysplastic syndrome|myelodysplastic syndrome
100302|NCT03576742|primary immunodeficiency|primary immunodeficiency
100303|NCT03576742|immune dysregulation|immune dysregulation
100304|NCT03576742|autoimmune cytopenia|autoimmune cytopenia
100305|NCT03576729|Mucopolysaccharidosis type I|mucopolysaccharidosis type i
100306|NCT03576729|MPS I|mps i
100307|NCT03576729|MPS IH|mps ih
100308|NCT03576729|MPS IHS|mps ihs
100309|NCT03576729|MPS IS|mps is
100310|NCT03576729|Mucopolysaccharidosis I|mucopolysaccharidosis i
100311|NCT03576716|chronic kidney disease|chronic kidney disease
100312|NCT03576716|vitamin d catabolism|vitamin d catabolism
100313|NCT03576703|metabolic syndrome|metabolic syndrome
100314|NCT03576703|inflammation|inflammation
100315|NCT03576703|insulin sensitivity|insulin sensitivity
100316|NCT03576703|metabolic flexibility|metabolic flexibility
100317|NCT03576703|overweight/obese|overweight/obese
100318|NCT03576690|Positive Ebola Virus (EBOV) diagnostic test|positive ebola virus (ebov) diagnostic test
100319|NCT03576690|symptomatic|symptomatic
100320|NCT03576677|Advanced chronic heart failure|advanced chronic heart failure
100321|NCT03576677|Exercise capacity|exercise capacity
100322|NCT03576677|Exercise hemodynamics|exercise hemodynamics
100323|NCT03576677|Levosimendan|levosimendan
100324|NCT03576664|carvedilol|carvedilol
100325|NCT03576664|adrenergic antagonists|adrenergic antagonists
100326|NCT03576664|glymphatic system|glymphatic system
100327|NCT03576664|volunteers|volunteers
100328|NCT03576664|Molecular Mechanisms of Pharmacological|molecular mechanisms of pharmacological
100329|NCT03576625|Buglossoides arvensis|buglossoides arvensis
100330|NCT03576625|vegetable oil|vegetable oil
100331|NCT03576625|omega-3 fatty acids|omega-3 fatty acids
100332|NCT03576625|participants|participants
100333|NCT03576612|glioblastoma, newly diagnosed, GMCI, Checkpoint inhibitor|glioblastoma, newly diagnosed, gmci, checkpoint inhibitor
100334|NCT03576573|Osteoarthritis|osteoarthritis
100335|NCT03576573|Avascular necrosis|avascular necrosis
100336|NCT03576573|Ankylosis|ankylosis
100337|NCT03576573|Protrusio acetabuli|protrusio acetabuli
100338|NCT03576573|Painful hip dysplasia|painful hip dysplasia
100339|NCT03576573|Rheumatoid arthritis|rheumatoid arthritis
100340|NCT03576573|Correction of functional deformity|correction of functional deformity
100341|NCT03576521|breast cancer|breast cancer
100342|NCT03576521|chemotherapy toxicity|chemotherapy toxicity
100343|NCT03576521|Oxidative Stress|oxidative stress
100344|NCT03576521|Nutritional supplement|nutritional supplement
100345|NCT03576521|Ocoxin Viusid|ocoxin viusid
100346|NCT03576508|Osteoarthritis|osteoarthritis
100347|NCT03576508|Knee|knee
100348|NCT03576495|Medical education|medical education
100349|NCT03576495|Patient-reported Satisfaction|patient-reported satisfaction
100350|NCT03576495|Patient-reported outcomes|patient-reported outcomes
100351|NCT03576495|Cultural dexterity|cultural dexterity
100352|NCT03576495|Cross cultural care|cross cultural care
100353|NCT03576495|Resident physician education|resident physician education
100354|NCT03576482|Anxiety disorders|anxiety disorders
100355|NCT03576482|Depression|depression
100356|NCT03576482|Transport to operating room|transport to operating room
100357|NCT03576469|Intravenous Immunoglobulin|intravenous immunoglobulin
100358|NCT03576469|C1-esterase inhibitor|c1-esterase inhibitor
100359|NCT03576469|Adverse drug reaction (ADR)|adverse drug reaction (adr)
100360|NCT03576456|coronary angiography|coronary angiography
100361|NCT03576456|premedication|premedication
100362|NCT03576456|pain|pain
100363|NCT03576456|anxiety|anxiety
100364|NCT03576391|Sensorimotor control|sensorimotor control
100365|NCT03576391|Feedforward|feedforward
100366|NCT03576391|Physical Fatigue|physical fatigue
100367|NCT03576391|Cognitive Fatigue|cognitive fatigue
100368|NCT03576391|Event-related potentials|event-related potentials
100369|NCT03576365|Perceived Control|perceived control
100370|NCT03576365|Distress|distress
100371|NCT03576339|Wound Healing|wound healing
100372|NCT03576339|Electrical Stimulation|electrical stimulation
100373|NCT03576339|Palatal|palatal
100374|NCT03576326|Preventive Dentistry|preventive dentistry
100375|NCT03576326|Health Disparities|health disparities
100376|NCT03576326|Health Behavior|health behavior
100377|NCT03576326|Behavioral Economics|behavioral economics
100378|NCT03576313|transmission|transmission
100379|NCT03576313|reduction|reduction
100380|NCT03576300|ocular surface|ocular surface
100381|NCT03576287|apremilast|apremilast
100382|NCT03576274|cancer related fatigue|cancer related fatigue
100383|NCT03576274|Exercise|exercise
100384|NCT03576274|biomarkers|biomarkers
100385|NCT03576261|hemodynamics|hemodynamics
100386|NCT03576261|venous return|venous return
100387|NCT03576261|heart failure|heart failure
100388|NCT03576261|anesthesia|anesthesia
100389|NCT03576248|State of consciousness|state of consciousness
100390|NCT03576248|tACS|tacs
100391|NCT03576248|tDCS|tdcs
100392|NCT03576248|Global neuronal workspace|global neuronal workspace
100393|NCT03576248|Brain injury|brain injury
100394|NCT03576235|Uremic pruritus|uremic pruritus
100395|NCT03576235|Hemodialysis|hemodialysis
100396|NCT03576222|PICO; incisional hernia; surgical site occurrences|pico; incisional hernia; surgical site occurrences
100397|NCT03576209|Physical activity|physical activity
100398|NCT03576209|sedentary behaviour|sedentary behaviour
100399|NCT03576209|sleep|sleep
100400|NCT03576209|Quality of life|quality of life
100401|NCT03576209|functional ability|functional ability
100402|NCT03576209|well-being|well-being
100403|NCT03576209|Social identity and leadership|social identity and leadership
100404|NCT03576209|social support and motivation|social support and motivation
100405|NCT03576209|Aged, older adults|aged, older adults
100406|NCT03576196|physical therapy|physical therapy
100407|NCT03576196|Pain|pain
100408|NCT03576196|disability|disability
100409|NCT03576196|kinesiophobia.|kinesiophobia.
100410|NCT03576157|mobile health, Pregnant and postpartum women, Frontline health workers, India|mobile health, pregnant and postpartum women, frontline health workers, india
100411|NCT03576118|biotrauma|biotrauma
100412|NCT03576118|laparoscopic surgery|laparoscopic surgery
100413|NCT03576118|neuromuscular block|neuromuscular block
100414|NCT03576118|sugammadex|sugammadex
100415|NCT03576105|third molar|third molar
100416|NCT03576105|pericoronitis|pericoronitis
100417|NCT03576105|photodynamic therapy|photodynamic therapy
100418|NCT03576105|microbiological analysis|microbiological analysis
100419|NCT03576105|laser|laser
100420|NCT03576105|randomized controlled clinical study|randomized controlled clinical study
100421|NCT03576079|laser therapy|laser therapy
100422|NCT03576079|anterior re-positioning splint|anterior re-positioning splint
100423|NCT03576066|CHB|chb
100424|NCT03576066|HBV|hbv
100425|NCT03576066|HBeAg-positive|hbeag-positive
100426|NCT03576066|hepatitis B|hepatitis b
100427|NCT03576066|HBeAg-negative|hbeag-negative
100428|NCT03576040|Positron Emission Tomography Computed Tomography|positron emission tomography computed tomography
100429|NCT03576040|whole body dynamic acquisition|whole body dynamic acquisition
100430|NCT03576040|Gallium 68|gallium 68
100431|NCT03576014|CMV|cmv
100432|NCT03576014|BKV|bkv
100433|NCT03576014|CMV Reactivation|cmv reactivation
100434|NCT03576014|BKV Reactivation|bkv reactivation
100435|NCT03576014|DNA Vaccine|dna vaccine
100436|NCT03576014|Kidney transplant|kidney transplant
100437|NCT03576014|Cytomegalovirus|cytomegalovirus
100438|NCT03576014|BK virus|bk virus
100439|NCT03575988|Type 2 diabetes|type 2 diabetes
100542|NCT03575390|Hearing|hearing
100440|NCT03575988|Pulmonary function|pulmonary function
100441|NCT03575988|Vascular endothelial function|vascular endothelial function
100442|NCT03575988|Ultrasound|ultrasound
100443|NCT03575975|x-ray motion analysis|x-ray motion analysis
100444|NCT03575975|joint kinematics|joint kinematics
100445|NCT03575975|functional range of motion|functional range of motion
100446|NCT03575962|2-period|2-period
100447|NCT03575962|Pharmacokinetics|pharmacokinetics
100448|NCT03575962|FTIH|ftih
100449|NCT03575962|GSK3640254|gsk3640254
100450|NCT03575962|healthy subject|healthy subject
100451|NCT03575962|bioavailability|bioavailability
100452|NCT03575936|Pharmacists Intervention|pharmacists intervention
100453|NCT03575923|Physical activity|physical activity
100454|NCT03575923|Wellbeing|wellbeing
100455|NCT03575923|Urban green space|urban green space
100456|NCT03575923|Older adults|older adults
100457|NCT03575923|Natural experiment|natural experiment
100458|NCT03575923|Protocol|protocol
100459|NCT03575923|GHIA|ghia
100460|NCT03575910|Heart|heart
100461|NCT03575910|Transplantation|transplantation
100462|NCT03575910|Acute cardiac rejection|acute cardiac rejection
100463|NCT03575910|Biomarkers|biomarkers
100464|NCT03575910|Genomics|genomics
100465|NCT03575897|Premature Infants|premature infants
100466|NCT03575897|Body composition|body composition
100467|NCT03575871|atopic dermatitis|atopic dermatitis
100468|NCT03575871|atopic eczema|atopic eczema
100469|NCT03575871|eczema|eczema
100470|NCT03575871|JAK|jak
100471|NCT03575871|janus kinase|janus kinase
100472|NCT03575858|Single dental implants|single dental implants
100473|NCT03575858|Barrel Shaped Interdental toothbrush|barrel shaped interdental toothbrush
100474|NCT03575858|Tapered Interdental toothbrush|tapered interdental toothbrush
100475|NCT03575858|peri-implant mucositis and gingivitis|peri-implant mucositis and gingivitis
100476|NCT03575845|Yoga|yoga
100477|NCT03575819|castration-resistant|castration-resistant
100478|NCT03575819|androgen-signaling blockade progression|androgen-signaling blockade progression
100479|NCT03575767|TCR Repertoire|tcr repertoire
100480|NCT03575767|Next Generation Sequencing|next generation sequencing
100481|NCT03575767|ALL|all
100482|NCT03575767|AML|aml
100483|NCT03575767|MDS|mds
100484|NCT03575767|Myeloablative|myeloablative
100485|NCT03575741|postural control|postural control
100486|NCT03575741|rehabilitation|rehabilitation
100487|NCT03575741|return-to-sport|return-to-sport
100488|NCT03575741|mTBI|mtbi
100489|NCT03575728|Mental Health|mental health
100490|NCT03575728|Information Technology|information technology
100491|NCT03575728|Chronic Disease Prevention and Management|chronic disease prevention and management
100492|NCT03575728|Support Patient Self-Care|support patient self-care
100493|NCT03575715|endobronchial ultrasound|endobronchial ultrasound
100494|NCT03575715|peripheral pulmonary lesions|peripheral pulmonary lesions
100495|NCT03575715|image features|image features
100496|NCT03575702|overactive bladder|overactive bladder
100497|NCT03575702|urinary incontinence|urinary incontinence
100498|NCT03575702|frequent urination|frequent urination
100499|NCT03575702|urge incontinence|urge incontinence
100500|NCT03575702|urgency episodes|urgency episodes
100501|NCT03575689|Nasal Splint|nasal splint
100502|NCT03575689|Septum deviation|septum deviation
100503|NCT03575689|Septoplasty|septoplasty
100504|NCT03575676|Huntington|huntington
100505|NCT03575676|Chorea|chorea
100506|NCT03575676|SOM3355|som3355
100507|NCT03575663|Breathomics|breathomics
100508|NCT03575663|Metabolomics|metabolomics
100509|NCT03575663|Exhaled breath test|exhaled breath test
100510|NCT03575663|Biomarker|biomarker
100511|NCT03575637|Olanzapine|olanzapine
100512|NCT03575637|Gastric Cancer|gastric cancer
100513|NCT03575637|Tolerance|tolerance
100514|NCT03575611|Malignant neoplasms of urinary tract|malignant neoplasms of urinary tract
100515|NCT03575611|Oligometastatic renal cell carcinoma|oligometastatic renal cell carcinoma
100516|NCT03575611|RCC|rcc
100517|NCT03575611|Stereotactic Body Radiation Therapy|stereotactic body radiation therapy
100518|NCT03575611|SBRT|sbrt
100519|NCT03575611|XRT|xrt
100520|NCT03575611|Radiation therapy|radiation therapy
100521|NCT03575585|HIV|hiv
100522|NCT03575585|Counselor Skills Training|counselor skills training
100523|NCT03575585|Behavioral Intervention|behavioral intervention
100524|NCT03575585|Personalized Feedback Report|personalized feedback report
100525|NCT03575572|Fontan|fontan
100526|NCT03575572|Colchicine|colchicine
100527|NCT03575572|heart surgery|heart surgery
100528|NCT03575520|breast cancer|breast cancer
100529|NCT03575520|dose-dense chemotherapy|dose-dense chemotherapy
100530|NCT03575520|pegfilgrastim|pegfilgrastim
100531|NCT03575468|e-cigarette|e-cigarette
100532|NCT03575468|vaping|vaping
100533|NCT03575468|electronic nicotine delivery system (ENDS)|electronic nicotine delivery system (ends)
100534|NCT03575468|smoking cessation|smoking cessation
100535|NCT03575455|concussion|concussion
100536|NCT03575455|aerobic exercise|aerobic exercise
100537|NCT03575455|sub-acute|sub-acute
100538|NCT03575429|Pediatrics|pediatrics
100539|NCT03575429|Social Communication|social communication
100540|NCT03575429|Family Navigators|family navigators
100547|NCT03575351|Efficacy|efficacy
100548|NCT03575351|Safety|safety
100549|NCT03575351|JCAR017|jcar017
100550|NCT03575351|Liso-cel|liso-cel
100551|NCT03575351|High-Risk|high-risk
100552|NCT03575351|Relapsed|relapsed
100553|NCT03575351|Refractory|refractory
100554|NCT03575351|B-cell NHL|b-cell nhl
100555|NCT03575338|scarf|scarf
100556|NCT03575338|minimally invasive surgery|minimally invasive surgery
100557|NCT03575338|hallux valgus|hallux valgus
100558|NCT03575325|T-cell acute lymphoblastic leukemia|t-cell acute lymphoblastic leukemia
100559|NCT03575325|B-cell acute lymphoblastic leukemia|b-cell acute lymphoblastic leukemia
100560|NCT03575299|MDR-TB|mdr-tb
100561|NCT03575299|Allogeneic γδT cells|allogeneic γδt cells
100562|NCT03575299|adoptive treatment|adoptive treatment
100563|NCT03575286|Pregnancy|pregnancy
100564|NCT03575286|Urine Testing|urine testing
100565|NCT03575286|Medical Diagnostics|medical diagnostics
100566|NCT03575273|methadone|methadone
100567|NCT03575273|opioid dependence|opioid dependence
100568|NCT03575273|obesity|obesity
100569|NCT03575273|food reward|food reward
100570|NCT03575273|olfactory|olfactory
100571|NCT03575260|Fulvestrant|fulvestrant
100572|NCT03575260|Exemestane|exemestane
100573|NCT03575221|Osteogenesis Imperfecta|osteogenesis imperfecta
100574|NCT03575221|Collagen|collagen
100575|NCT03575221|Short Stature|short stature
100576|NCT03575208|Hepatitis B|hepatitis b
100577|NCT03575208|Immune Response|immune response
100578|NCT03575208|HBsAg Loss|hbsag loss
100579|NCT03575208|Hepatitis B Virus|hepatitis b virus
100580|NCT03575208|Interferon|interferon
100581|NCT03575169|Bispectral index|bispectral index
100582|NCT03575169|Monitoring|monitoring
100583|NCT03575169|Sedation|sedation
100584|NCT03575169|Traumatic Brain Injury|traumatic brain injury
100585|NCT03575156|Systemic Lupus Erythematosus|systemic lupus erythematosus
100586|NCT03575156|Systemic Scleroderma|systemic scleroderma
100587|NCT03575156|autoimmunity|autoimmunity
100588|NCT03575156|microparticles|microparticles
100589|NCT03575156|platelets|platelets
100590|NCT03575143|HIV|hiv
100591|NCT03575143|OSA|osa
100592|NCT03575143|PLWH|plwh
100593|NCT03575143|Sleep|sleep
100594|NCT03575143|Obstructive Sleep Apnea|obstructive sleep apnea
100595|NCT03575143|Human Immunodeficiency Virus|human immunodeficiency virus
100596|NCT03575143|CPAP|cpap
100597|NCT03575091|Infant|infant
100598|NCT03575091|Respiration|respiration
100599|NCT03575026|Early dementia|early dementia
100600|NCT03575026|Caregiver|caregiver
100601|NCT03575026|Anxiety|anxiety
100602|NCT03575026|Well-being|well-being
100603|NCT03574987|Physical Activity|physical activity
100604|NCT03574987|Nutrition|nutrition
100605|NCT03574987|Carbohydrates|carbohydrates
100606|NCT03574987|Sugar|sugar
100607|NCT03574987|Energy Balance|energy balance
100608|NCT03574974|PTSD|ptsd
100609|NCT03574974|Neurofeedback|neurofeedback
100610|NCT03574961|depression|depression
100611|NCT03574961|social isolation|social isolation
100612|NCT03574935|"Qing-Hua-Bu"|"qing-hua-bu"
100613|NCT03574935|Dynamic sequential treatment|dynamic sequential treatment
100614|NCT03574935|Clinical evaluation|clinical evaluation
100615|NCT03574935|Generalized application|generalized application
100616|NCT03574883|Conscious access|conscious access
100617|NCT03574883|transcranial electric stimulation|transcranial electric stimulation
100618|NCT03574883|tACS|tacs
100619|NCT03574883|Global neuronal workspace|global neuronal workspace
100620|NCT03574883|Masking paradigm|masking paradigm
100621|NCT03574883|tDCS|tdcs
100622|NCT03574857|Loop diuretics|loop diuretics
100623|NCT03574857|Heart failure|heart failure
100624|NCT03574857|Diuretic resistance|diuretic resistance
100625|NCT03574857|Thiazide diuretics|thiazide diuretics
100626|NCT03574831|GERD|gerd
100627|NCT03574831|Radiofrequency ablation|radiofrequency ablation
100628|NCT03574831|efficiency|efficiency
100629|NCT03574831|safety|safety
100630|NCT03574818|Neoadjuvant Chemotherapy; NSCLC; nacitumumab|neoadjuvant chemotherapy; nsclc; nacitumumab
100631|NCT03574805|Asthma|asthma
100632|NCT03574805|Anticalin|anticalin
100633|NCT03574805|PRS-060|prs-060
100634|NCT03574805|Pieris|pieris
100635|NCT03574805|IL-4 receptor alpha|il-4 receptor alpha
100636|NCT03574805|IL-13|il-13
100637|NCT03574805|IL-4|il-4
100638|NCT03574779|PARP Inhibitor|parp inhibitor
100639|NCT03574779|OPAL|opal
100640|NCT03574779|OPAL Clinical Trial|opal clinical trial
100641|NCT03574779|OPAL Study|opal study
100642|NCT03574701|olfactory|olfactory
100643|NCT03574701|Vitamin A|vitamin a
100644|NCT03574701|Olfactory training|olfactory training
100645|NCT03574701|CRS|crs
100646|NCT03574688|Hydration|hydration
100647|NCT03574688|Water|water
100648|NCT03574688|Vasopressin|vasopressin
100649|NCT03574688|Copeptin|copeptin
100650|NCT03574688|Glucose|glucose
100651|NCT03574675|simulated altitude|simulated altitude
100652|NCT03574675|exercise|exercise
100653|NCT03574675|non-invasive cardiac output|non-invasive cardiac output
100654|NCT03574662|frailty|frailty
100655|NCT03574662|advanced|advanced
100656|NCT03574623|stroke|stroke
100657|NCT03574623|rehabilitation|rehabilitation
100658|NCT03574623|therapy|therapy
100659|NCT03574623|electrical stimulation|electrical stimulation
100660|NCT03574623|hand|hand
100661|NCT03574610|Neurogenic bladder|neurogenic bladder
100662|NCT03574610|Functional Neuroimaging|functional neuroimaging
100663|NCT03574610|Transcranial Rotating Permanent Magnet Stimulator (TRPMS)|transcranial rotating permanent magnet stimulator (trpms)
100664|NCT03574571|Radium-223|radium-223
100665|NCT03574571|Docetaxel|docetaxel
100666|NCT03574571|18-150|18-150
100667|NCT03574571|C16-174|c16-174
100668|NCT03574571|DORA Trial|dora trial
100669|NCT03574558|Pump therapy|pump therapy
100670|NCT03574558|Multiple Daily Injections (MDI)|multiple daily injections (mdi)
100671|NCT03574558|Decision Support System (DSS)|decision support system (dss)
100672|NCT03574545|Rheumatoid Arthritis|rheumatoid arthritis
100673|NCT03574545|VAY736|vay736
100674|NCT03574545|Ianalumab|ianalumab
100675|NCT03574506|Atypical Hemolytic Uremic Syndrome|atypical hemolytic uremic syndrome
100676|NCT03574506|Pregnancy|pregnancy
100677|NCT03574493|laparotomy|laparotomy
100678|NCT03574493|laparoscopy|laparoscopy
100679|NCT03574493|low anterior resection|low anterior resection
100680|NCT03574493|rectal cancer|rectal cancer
100681|NCT03574493|robot assisted surgery|robot assisted surgery
100682|NCT03574493|total mesorectal excision|total mesorectal excision
100683|NCT03574493|transanal surgery|transanal surgery
100684|NCT03574480|mHealth|mhealth
100685|NCT03574480|Lifestyles|lifestyles
100686|NCT03574480|Elderly|elderly
100687|NCT03574480|Body composition|body composition
100688|NCT03574480|Cognitive performance|cognitive performance
100689|NCT03574480|Quality of life|quality of life
100690|NCT03574467|brain neoplasms|brain neoplasms
100691|NCT03574467|stroke|stroke
100692|NCT03574467|rehabilitation|rehabilitation
100693|NCT03574454|Whole Body Diffusion Weighted|whole body diffusion weighted
100694|NCT03574454|Magnetic Resonance Imaging|magnetic resonance imaging
100695|NCT03574454|Machine Learning|machine learning
100696|NCT03574454|Reading Time|reading time
100697|NCT03574454|Convolutional Neural Network|convolutional neural network
100698|NCT03574454|Algorithm|algorithm
100699|NCT03574454|Diagnostic performance|diagnostic performance
100700|NCT03574376|Rib trauma, intercostal nerve block, liposomal bupivacaine|rib trauma, intercostal nerve block, liposomal bupivacaine
100701|NCT03574363|Chronic Kidney Disease|chronic kidney disease
100702|NCT03574363|Hypertension|hypertension
100703|NCT03574350|Kangaroo position|kangaroo position
100704|NCT03574350|Kinesthetic Stimulation|kinesthetic stimulation
100705|NCT03574350|Kangaroo Mother Care|kangaroo mother care
100706|NCT03574350|Bonding|bonding
100707|NCT03574337|Residual neuromuscular blockade|residual neuromuscular blockade
100708|NCT03574337|Reversal|reversal
100709|NCT03574337|Cardiac surgery|cardiac surgery
100710|NCT03574311|CABG|cabg
100711|NCT03574311|cardiac surgery|cardiac surgery
100712|NCT03574311|blood transfusion|blood transfusion
100713|NCT03574311|intravenous iron|intravenous iron
100714|NCT03574311|postoperative infection|postoperative infection
100715|NCT03574298|Radical prostatectomy|radical prostatectomy
100716|NCT03574298|urinary incontinence|urinary incontinence
100717|NCT03574298|pelvic floor muscle|pelvic floor muscle
100718|NCT03574298|reaction time|reaction time
100719|NCT03574272|mobile IoT technology|mobile iot technology
100720|NCT03574272|Patient Transfer Monitoring System|patient transfer monitoring system
100721|NCT03574220|pembrolizumab|pembrolizumab
100722|NCT03574220|radiotherapy|radiotherapy
100723|NCT03574220|immunotherapy|immunotherapy
100724|NCT03574181|Wrist watch blood alcohol level|wrist watch blood alcohol level
100725|NCT03574181|Blood alcohol|blood alcohol
100726|NCT03574181|Objective alcohol measure|objective alcohol measure
100727|NCT03574155|Gynecological cancer|gynecological cancer
100728|NCT03574155|Anxiety|anxiety
100729|NCT03574155|Pre-operative counseling|pre-operative counseling
100730|NCT03574142|Pharmacokinetics|pharmacokinetics
100731|NCT03574142|Safety|safety
100732|NCT03574142|Tolerability|tolerability
100733|NCT03574142|Epanova|epanova
100734|NCT03574142|Omega-3 carboxylic acids|omega-3 carboxylic acids
100735|NCT03574142|Chinese|chinese
100736|NCT03574116|Sarcopenia|sarcopenia
100737|NCT03574116|jejunostomy|jejunostomy
100738|NCT03574116|oesogastric adenocarcinoma|oesogastric adenocarcinoma
100739|NCT03574116|scanography|scanography
100740|NCT03574103|Obesity|obesity
100741|NCT03574103|Overweight|overweight
100742|NCT03574103|Weight loss|weight loss
100743|NCT03574103|Fasting|fasting
100744|NCT03574090|topical antibiotic|topical antibiotic
100745|NCT03574090|surgical wound infection|surgical wound infection
100746|NCT03574090|prevention of surgical wound infection|prevention of surgical wound infection
100747|NCT03574051|oral microbiota|oral microbiota
100748|NCT03574051|16S rRNA gene|16s rrna gene
100749|NCT03574051|thyroid cancer|thyroid cancer
100750|NCT03574051|iodine 131 treatment|iodine 131 treatment
100751|NCT03574051|fecal microbiota|fecal microbiota
100752|NCT03574051|radiotherapy|radiotherapy
100753|NCT03574025|Observational, Paediatric, Cardiac Arrest, PICU,|observational, paediatric, cardiac arrest, picu,
100754|NCT03573999|mannitol|mannitol
100755|NCT03573999|hypertonic saline|hypertonic saline
100756|NCT03573999|brain metabolism|brain metabolism
100757|NCT03573999|brain oxygenation|brain oxygenation
100758|NCT03573973|Dietary inequalities|dietary inequalities
100759|NCT03573973|Public Health|public health
100760|NCT03573973|Choice architecture|choice architecture
100761|NCT03573973|Supermarkets|supermarkets
100762|NCT03573960|Lenvatinib, E7080, Refractory Differentiated Thyroid Cancer|lenvatinib, e7080, refractory differentiated thyroid cancer
100763|NCT03573947|Stage IV Non-Small Cell Lung Cancer|stage iv non-small cell lung cancer
100764|NCT03573947|nivolumab|nivolumab
100765|NCT03573947|ipilimumab|ipilimumab
100766|NCT03573947|paclitaxel|paclitaxel
100767|NCT03573947|immunotherapy|immunotherapy
100768|NCT03573921|Paediatrics|paediatrics
100769|NCT03573921|Gastrografin|gastrografin
100770|NCT03573882|Open Label Extension|open label extension
100771|NCT03573843|Delirium|delirium
100772|NCT03573843|Prevention|prevention
100773|NCT03573843|Cognitive stimulation|cognitive stimulation
100774|NCT03573830|Child Passenger Injury|child passenger injury
100775|NCT03573830|Child Restraint Systems|child restraint systems
100776|NCT03573830|Traffic Accidents|traffic accidents
100777|NCT03573817|Chronic Obstructive Pulmonary Disease|chronic obstructive pulmonary disease
100778|NCT03573817|Pulmonary Function|pulmonary function
100779|NCT03573817|COPD|copd
100780|NCT03573804|Breast Cancer Locator|breast cancer locator
100781|NCT03573778|health|health
100782|NCT03573778|quality of life|quality of life
100783|NCT03573778|safety|safety
100784|NCT03573778|health promotion|health promotion
100785|NCT03573778|intimate partner violence|intimate partner violence
100786|NCT03573778|domestic violence|domestic violence
100787|NCT03573778|confidence|confidence
100788|NCT03573778|control|control
100789|NCT03573778|nursing intervention|nursing intervention
100790|NCT03573765|epidemiology|epidemiology
100791|NCT03573765|upper limb|upper limb
100792|NCT03573765|hand surgery|hand surgery
100793|NCT03573765|wrist surgery|wrist surgery
100794|NCT03573765|shoulder surgery|shoulder surgery
100795|NCT03573765|elbow surgery|elbow surgery
100796|NCT03573765|outcomes|outcomes
100797|NCT03573765|complications|complications
100798|NCT03573765|revision surgery|revision surgery
100799|NCT03573752|Laparoscopic Promontofixation|laparoscopic promontofixation
100800|NCT03573752|Outpatient management|outpatient management
100801|NCT03573713|Hygiene practices|hygiene practices
100802|NCT03573713|Sanitation|sanitation
100803|NCT03573713|Nutrition|nutrition
100804|NCT03573713|Interpersonal Psychotherapy|interpersonal psychotherapy
100805|NCT03573713|Maternal depression|maternal depression
100806|NCT03573713|clustered randomized controlled trial|clustered randomized controlled trial
100807|NCT03573700|Leukemia|leukemia
100808|NCT03573700|Leukemia, lymphoid|leukemia, lymphoid
100809|NCT03573700|Leukemia, B-cell|leukemia, b-cell
100810|NCT03573700|Relapsed|relapsed
100811|NCT03573700|Refractory|refractory
100812|NCT03573700|Pediatric|pediatric
100813|NCT03573700|Chimeric antigen receptor|chimeric antigen receptor
100814|NCT03573700|CAR|car
100815|NCT03573700|CAR T cell|car t cell
100816|NCT03573700|Anti-CD19|anti-cd19
100817|NCT03573700|CD19|cd19
100818|NCT03573687|protein|protein
100819|NCT03573687|lipolysis|lipolysis
100820|NCT03573687|fat oxidation|fat oxidation
100821|NCT03573687|resistance training|resistance training
100822|NCT03573687|nutrient timing|nutrient timing
100823|NCT03573674|Working conditions,|working conditions,
100824|NCT03573674|cognitive load|cognitive load
100825|NCT03573674|disruptions|disruptions
100826|NCT03573674|interruptions|interruptions
100827|NCT03573674|information overload|information overload
100828|NCT03573674|Mental contrasting with implementation intentions MCII|mental contrasting with implementation intentions mcii
100829|NCT03573674|Cognitive ergonomics|cognitive ergonomics
100830|NCT03573661|Breast Conserving Surgery|breast conserving surgery
100831|NCT03573661|Breast Imaging|breast imaging
100832|NCT03573661|Breast Cancer Locator|breast cancer locator
100833|NCT03573661|Supine MRI|supine mri
100834|NCT03573596|CML|cml
100835|NCT03573596|second stop|second stop
100836|NCT03573596|dasatinib|dasatinib
100837|NCT03573583|muscle mass|muscle mass
100838|NCT03573583|muscle loss|muscle loss
100839|NCT03573583|Deuterated creatine (D3Cr) dilution|deuterated creatine (d3cr) dilution
100840|NCT03573583|older adults|older adults
100841|NCT03573583|resistance training|resistance training
100842|NCT03573583|physical function|physical function
100843|NCT03573544|mAbs|mabs
100844|NCT03573544|monoclonal antibodies|monoclonal antibodies
100845|NCT03573531|donor human milk|donor human milk
100846|NCT03573531|lipid peroxidation|lipid peroxidation
100847|NCT03573531|neonate|neonate
100848|NCT03573531|omega-3 fatty acids|omega-3 fatty acids
100849|NCT03573531|omega-6 fatty acids|omega-6 fatty acids
100850|NCT03573531|preterm infants|preterm infants
100851|NCT03573531|malondialdehyde|malondialdehyde
100852|NCT03573518|Synthetic CBD|synthetic cbd
100853|NCT03573518|Cannabidiol|cannabidiol
100854|NCT03573479|rehabilitation|rehabilitation
100855|NCT03573479|critical care|critical care
100856|NCT03573479|child health|child health
100857|NCT03573479|quality improvement|quality improvement
100859|NCT03573466|Motor Neuron|motor neuron
100860|NCT03573466|Neuromuscular Junction|neuromuscular junction
100861|NCT03573453|Critical Care|critical care
100862|NCT03573453|Enteral Nutrition|enteral nutrition
100863|NCT03573453|Ventilator Associated Pneumonia|ventilator associated pneumonia
100864|NCT03573453|Gastric Residual Volume|gastric residual volume
100865|NCT03573414|Cardiovascular system|cardiovascular system
100866|NCT03573414|Polyphenols|polyphenols
100867|NCT03573401|ALA-PDT|ala-pdt
100868|NCT03573388|Intermediate coronary lesions|intermediate coronary lesions
100869|NCT03573388|Fractional flow reserve|fractional flow reserve
100870|NCT03573388|Optical coherence tomography|optical coherence tomography
100871|NCT03573375|Questionnaires|questionnaires
100872|NCT03573375|Surveys|surveys
100873|NCT03573362|sarcoidosis|sarcoidosis
100874|NCT03573362|ebus|ebus
100875|NCT03573362|endobronchial ultrasound|endobronchial ultrasound
100876|NCT03573323|biologic|biologic
100877|NCT03573323|biologic therapy|biologic therapy
100878|NCT03573310|Lower risk MDS|lower risk mds
100879|NCT03573310|Low risk MDS|low risk mds
100880|NCT03573310|Lower-risk MDS|lower-risk mds
100881|NCT03573310|Low-risk MDS|low-risk mds
100882|NCT03573310|Intermediate 1 risk MDS|intermediate 1 risk mds
100883|NCT03573310|Intermediate-1 risk MDS|intermediate-1 risk mds
100884|NCT03573284|cough variant asthma|cough variant asthma
100885|NCT03573284|chronic cough|chronic cough
100886|NCT03573284|fractional exhaled nitric oxide|fractional exhaled nitric oxide
100887|NCT03573284|impulse oscillometry|impulse oscillometry
100888|NCT03573284|forced mid-expiratory flow|forced mid-expiratory flow
100889|NCT03573271|facial wrinkles|facial wrinkles
100890|NCT03573271|skin laxity|skin laxity
100891|NCT03573271|sagging skin|sagging skin
100892|NCT03573232|Parkinson Disease|parkinson disease
100893|NCT03573232|Pisa Syndrome|pisa syndrome
100894|NCT03573232|Camptocormia|camptocormia
100895|NCT03573232|Antecollis|antecollis
100896|NCT03573232|Striatal deformities|striatal deformities
100897|NCT03573219|Short-Wave Diathermy|short-wave diathermy
100898|NCT03573219|Transient muscle pain|transient muscle pain
100899|NCT03573219|Non-invasive pain model|non-invasive pain model
100900|NCT03573206|vessel closure|vessel closure
100901|NCT03573206|venous access site|venous access site
100902|NCT03573206|femoral venotomy|femoral venotomy
100903|NCT03573206|medium bore|medium bore
100904|NCT03573206|multiple access sites|multiple access sites
100905|NCT03573193|xenograft bone|xenograft bone
100906|NCT03573193|synthetic bone substitutes|synthetic bone substitutes
100907|NCT03573180|CAST index, prevalence of caries, primary dentition caries|cast index, prevalence of caries, primary dentition caries
100908|NCT03573154|nicotine|nicotine
100909|NCT03573154|e-cigarette|e-cigarette
100910|NCT03573154|exhaled breath|exhaled breath
100911|NCT03573154|pharmacokinetic model|pharmacokinetic model
100912|NCT03573115|Optical Coherence Tomography|optical coherence tomography
100913|NCT03573115|Reflectance Confocal Microscopy|reflectance confocal microscopy
100914|NCT03573115|Gold microparticles|gold microparticles
100915|NCT03573115|Adapalene|adapalene
100916|NCT03573115|Benzoyl Peroxide|benzoyl peroxide
100917|NCT03573102|proteinuria , SGLT2 inhibitors , diabetes|proteinuria , sglt2 inhibitors , diabetes
100918|NCT03573089|Renal dialysis|renal dialysis
100919|NCT03573089|Randomised controlled trial|randomised controlled trial
100920|NCT03573089|Bone markers|bone markers
100921|NCT03573089|Cardiovascular risk factors|cardiovascular risk factors
100922|NCT03573089|Phosphate lowering agent|phosphate lowering agent
100923|NCT03573089|End stage kidney disease|end stage kidney disease
100924|NCT03573089|Hyperphosphatemia|hyperphosphatemia
100925|NCT03573063|starvation|starvation
100926|NCT03573063|androgens|androgens
100927|NCT03573063|healthy women|healthy women
100928|NCT03573063|PCOS|pcos
100929|NCT03573024|Venetoclax|venetoclax
100930|NCT03573024|Azacitidine|azacitidine
100931|NCT03573024|Non-Elderly|non-elderly
100932|NCT03573024|Previously Untreated|previously untreated
100933|NCT03573011|prostate cancer|prostate cancer
100934|NCT03573011|biochemical recurrence|biochemical recurrence
100935|NCT03573011|18F-PET imaging|18f-pet imaging
100936|NCT03572933|refractory seizures|refractory seizures
100937|NCT03572933|genetic pediatric encephalopathies|genetic pediatric encephalopathies
100938|NCT03572933|epilepsy in children|epilepsy in children
100939|NCT03572933|seizure disorder|seizure disorder
100940|NCT03572920|Sleep|sleep
100941|NCT03572920|Actigraphy|actigraphy
100942|NCT03572920|Pain|pain
100943|NCT03572920|Patients|patients
100944|NCT03572920|Hospitalization|hospitalization
100945|NCT03572920|Hip Replacement|hip replacement
100946|NCT03572920|Knee Replacement|knee replacement
100947|NCT03572920|Arthroplasty|arthroplasty
100948|NCT03572881|Brugada syndrome|brugada syndrome
100949|NCT03572881|ventricular arrhythmia|ventricular arrhythmia
100950|NCT03572881|sudden death|sudden death
100951|NCT03572803|ntratissue Percutaneous Electrolysis|ntratissue percutaneous electrolysis
100952|NCT03572803|Dry needling|dry needling
100953|NCT03572803|Eccentric exercise|eccentric exercise
100954|NCT03572803|Lateral epicondyle|lateral epicondyle
100956|NCT03572790|Prucalopride|prucalopride
100957|NCT03572790|Resolor|resolor
100958|NCT03572790|Functional Magnetic Resonance Imaging (fMRI)|functional magnetic resonance imaging (fmri)
100959|NCT03572790|Emotional Processing|emotional processing
100960|NCT03572790|Healthy Volunteers|healthy volunteers
100961|NCT03572777|Helicobacter pylori, eradication, hybrid therapy, concomitant therapy|helicobacter pylori, eradication, hybrid therapy, concomitant therapy
100962|NCT03572751|Sensor|sensor
100963|NCT03572751|Wearable|wearable
100964|NCT03572738|acne inversa|acne inversa
100965|NCT03572738|HS|hs
100966|NCT03572738|Verneuil's Disease|verneuil's disease
100967|NCT03572712|Obesity Hypoventilation Syndrome|obesity hypoventilation syndrome
100968|NCT03572712|Non Invasive Ventilation|non invasive ventilation
100969|NCT03572712|Transcutaneous capnography|transcutaneous capnography
100970|NCT03572686|supraclavicular nerve block|supraclavicular nerve block
100971|NCT03572686|dexamethasone|dexamethasone
100972|NCT03572686|Ropivacaine|ropivacaine
100973|NCT03572660|stem cell|stem cell
100974|NCT03572660|circulatory support|circulatory support
100975|NCT03572647|Erythropoeitin|erythropoeitin
100976|NCT03572647|Chronic Kidney Disease|chronic kidney disease
100977|NCT03572647|Anaemia|anaemia
100978|NCT03572634|Tolero|tolero
100979|NCT03572634|Phase 1/2|phase 1/2
100980|NCT03572634|First in human|first in human
100981|NCT03572634|Previously treated Chronic Lymphocytic Leukemia (CLL)|previously treated chronic lymphocytic leukemia (cll)
100982|NCT03572634|Previously treated Small Lymphocytic Lymphoma (SLL)|previously treated small lymphocytic lymphoma (sll)
100983|NCT03572634|AXL inhibitor|axl inhibitor
100984|NCT03572634|Cancer|cancer
100985|NCT03572634|Advanced Cancer|advanced cancer
100986|NCT03572634|Relapsed / Refractory CLL|relapsed / refractory cll
100987|NCT03572621|Prostatectomy|prostatectomy
100988|NCT03572608|acupuncture|acupuncture
100989|NCT03572608|infertility|infertility
100990|NCT03572608|pregnancy|pregnancy
100991|NCT03572595|FDG-PET/CT|fdg-pet/ct
100992|NCT03572595|Staging and restaging|staging and restaging
100993|NCT03572569|Pediatrics|pediatrics
100994|NCT03572569|Cardiomyopathy|cardiomyopathy
100995|NCT03572569|Heart failure|heart failure
100996|NCT03572569|Risk stratification|risk stratification
100997|NCT03572569|Family screening|family screening
100998|NCT03572569|Genetics|genetics
100999|NCT03572517|Delirium|delirium
101000|NCT03572517|Anesthesia|anesthesia
101001|NCT03572517|Surgical Oncology|surgical oncology
101002|NCT03572465|Chronic liver disease|chronic liver disease
101003|NCT03572465|Fibrosis|fibrosis
101004|NCT03572465|Elastography|elastography
101005|NCT03572465|Ultrasound|ultrasound
101006|NCT03572465|Magnetic resonance elastography|magnetic resonance elastography
101007|NCT03572465|Diagnostic performance|diagnostic performance
101008|NCT03572465|Sensitivity and specificity|sensitivity and specificity
101009|NCT03572439|epidural|epidural
101010|NCT03572439|sensory block level|sensory block level
101011|NCT03572439|dermatome|dermatome
101012|NCT03572413|Laparoscopic surgery|laparoscopic surgery
101013|NCT03572413|Deep neuromuscular block|deep neuromuscular block
101014|NCT03572413|Low pressure pneumoperitoneum|low pressure pneumoperitoneum
101015|NCT03572413|Postoperative immune suppression|postoperative immune suppression
101016|NCT03572400|pancreatic cancer|pancreatic cancer
101017|NCT03572400|pancreas cancer|pancreas cancer
101018|NCT03572387|Prostate Neoplasms|prostate neoplasms
101019|NCT03572387|Prostatic Neoplasms|prostatic neoplasms
101020|NCT03572387|5-Azacitidine|5-azacitidine
101021|NCT03572387|all-trans retinoic acid|all-trans retinoic acid
101022|NCT03572387|PSA|psa
101023|NCT03572374|Workforce|workforce
101024|NCT03572374|Employers|employers
101025|NCT03572374|Talking to Employers and Medical Staff About Work (TEAMWork)|talking to employers and medical staff about work (teamwork)
101026|NCT03572374|18-217|18-217
101027|NCT03572348|urethral stricture|urethral stricture
101028|NCT03572348|urethroplasty|urethroplasty
101029|NCT03572348|bulbar urethra|bulbar urethra
101030|NCT03572348|reconstructive surgery|reconstructive surgery
101031|NCT03572348|lower urinary tract symptoms|lower urinary tract symptoms
101032|NCT03572348|erectile function|erectile function
101033|NCT03572335|HIV|hiv
101034|NCT03572335|emphysema|emphysema
101035|NCT03572335|diffusing capacity|diffusing capacity
101036|NCT03572335|chronic obstructive pulmonary disease(COPD)|chronic obstructive pulmonary disease(copd)
101037|NCT03572309|trauma induced coagulopathy|trauma induced coagulopathy
101038|NCT03572309|multiple trauma|multiple trauma
101039|NCT03572309|fibrinogen|fibrinogen
101040|NCT03572296|Blackcurrant|blackcurrant
101041|NCT03572296|Polyphenols|polyphenols
101042|NCT03572296|Pulp|pulp
101043|NCT03572296|Fibre|fibre
101044|NCT03572296|Glucose|glucose
101045|NCT03572296|Postprandial|postprandial
101046|NCT03572296|Metabolism|metabolism
101047|NCT03572296|Cognition|cognition
101048|NCT03572283|Pancreas|pancreas
101049|NCT03572283|pancreatic adenocarcinoma|pancreatic adenocarcinoma
101050|NCT03572283|adenocarcinoma|adenocarcinoma
101051|NCT03572283|bethanechol|bethanechol
101052|NCT03572283|parasympathetic|parasympathetic
101053|NCT03572270|HIV|hiv
101054|NCT03572270|Ovarian reserve|ovarian reserve
101055|NCT03572270|Fertility preservation|fertility preservation
101056|NCT03572270|Anti HIV agents|anti hiv agents
101057|NCT03572244|Laser-Lok|laser-lok
101058|NCT03572244|Crevicular fluid|crevicular fluid
101059|NCT03572244|Machined|machined
101060|NCT03572244|Abutment|abutment
101061|NCT03572231|Betmiga|betmiga
101062|NCT03572231|OAB|oab
101063|NCT03572231|YM178|ym178
101064|NCT03572231|Overactive Bladder|overactive bladder
101065|NCT03572231|mirabegron|mirabegron
101066|NCT03572205|Nutrigenetics|nutrigenetics
101067|NCT03572179|3d printed positioning tray|3d printed positioning tray
101068|NCT03572166|Copeptin|copeptin
101069|NCT03572153|Hot Flashes|hot flashes
101070|NCT03572153|Postmenopausal Symptoms|postmenopausal symptoms
101071|NCT03572153|Hypnotic Relaxation Therapy|hypnotic relaxation therapy
101072|NCT03572153|Mind Body|mind body
101073|NCT03572153|Hypnosis|hypnosis
101074|NCT03572140|HCV|hcv
101075|NCT03572140|Sofosbuvir|sofosbuvir
101076|NCT03572140|Safety|safety
101077|NCT03572140|RAVs|ravs
101078|NCT03572140|Daclatasvir|daclatasvir
101079|NCT03572127|Protein|protein
101080|NCT03572127|Resistance Exercise|resistance exercise
101081|NCT03572127|Skeletal Muscle|skeletal muscle
101082|NCT03572127|Mycoprotein|mycoprotein
101083|NCT03572127|Sustainability|sustainability
101084|NCT03572101|colorectal cancer|colorectal cancer
101085|NCT03572101|palliative care|palliative care
101086|NCT03572101|patients|patients
101087|NCT03572101|caregivers|caregivers
101088|NCT03572101|quality of life|quality of life
101089|NCT03572062|Respiratory tract infection, RSV, Adjuvant, vaccine|respiratory tract infection, rsv, adjuvant, vaccine
101090|NCT03572036|Outcomes Assessment|outcomes assessment
101091|NCT03572036|Sickle Cell Disease|sickle cell disease
101092|NCT03572023|Acute coronary syndrome|acute coronary syndrome
101093|NCT03572023|Non-obstructive coronary artery atherosclerosis|non-obstructive coronary artery atherosclerosis
101094|NCT03572023|MINOCA|minoca
101095|NCT03572023|Myocardial infarction|myocardial infarction
101096|NCT03572023|Proinflammatory interleukins|proinflammatory interleukins
101097|NCT03572023|Thrombophilia|thrombophilia
101098|NCT03572023|Genetic testing|genetic testing
101099|NCT03572023|SPECT|spect
101100|NCT03572023|MSCT|msct
101101|NCT03572023|MRI|mri
101102|NCT03571984|Breast cancer|breast cancer
101103|NCT03571984|depression|depression
101104|NCT03571984|Moving on ABC Plus|moving on abc plus
101105|NCT03571984|Pakistan|pakistan
101106|NCT03571919|Lidocaine infusion|lidocaine infusion
101107|NCT03571906|Rehabilitation|rehabilitation
101108|NCT03571867|Adenotonsillectomy|adenotonsillectomy
101109|NCT03571867|Severity of Agitation|severity of agitation
101110|NCT03571867|Sugammadex|sugammadex
101111|NCT03571841|Breast Cancer Survivors|breast cancer survivors
101112|NCT03571841|Sexual Function Disturbances|sexual function disturbances
101113|NCT03571841|Ovarian Suppression Treatment|ovarian suppression treatment
101114|NCT03571815|Fluoride varnish|fluoride varnish
101115|NCT03571815|clinical trial|clinical trial
101116|NCT03571815|dental caries|dental caries
101117|NCT03571802|pharmacokinetics|pharmacokinetics
101118|NCT03571802|simvastatin|simvastatin
101119|NCT03571802|bariatric surgery|bariatric surgery
101120|NCT03571802|laparoscopic sleeve gastrectomy|laparoscopic sleeve gastrectomy
101121|NCT03571789|AF|af
101122|NCT03571763|Cerebral Hemorrhage|cerebral hemorrhage
101123|NCT03571763|anti-thrombosis|anti-thrombosis
101124|NCT03571750|Suicide|suicide
101125|NCT03571750|Prevention|prevention
101126|NCT03571750|Risk Factor|risk factor
101127|NCT03571750|Intervention|intervention
101128|NCT03571750|Military|military
101129|NCT03571737|acute pain|acute pain
101130|NCT03571737|muscle strain|muscle strain
101131|NCT03571737|muscle sprain|muscle sprain
101132|NCT03571737|injury|injury
101133|NCT03571737|emergency department|emergency department
101134|NCT03571724|Very Low Nicotine|very low nicotine
101135|NCT03571724|Cigarette|cigarette
101136|NCT03571724|VLN|vln
101137|NCT03571698|Knee Osteoarthritis|knee osteoarthritis
101138|NCT03571698|Neuromuscular Electrical Stimulation|neuromuscular electrical stimulation
101139|NCT03571698|Exercise|exercise
101140|NCT03571698|Pain|pain
101141|NCT03571698|Function|function
101142|NCT03571672|Left Ventricular Ejection Fraction|left ventricular ejection fraction
101143|NCT03571672|DEFINITY|definity
101144|NCT03571672|Enhanced Echocardiogram|enhanced echocardiogram
101145|NCT03571672|Cardiac Magnetic Resonance|cardiac magnetic resonance
101146|NCT03571633|Pegfilgrastim|pegfilgrastim
101147|NCT03571633|Trastuzumab/Paclitaxel|trastuzumab/paclitaxel
101148|NCT03571633|Antibody-dependent cell-mediated cytotoxicity|antibody-dependent cell-mediated cytotoxicity
101149|NCT03571581|Medication adherence|medication adherence
101150|NCT03571581|Heart failure|heart failure
101151|NCT03571581|Mindfulness interventions|mindfulness interventions
101152|NCT03571555|HIV|hiv
101153|NCT03571555|perinatal|perinatal
101154|NCT03571555|adolescent|adolescent
101155|NCT03571555|camp|camp
101156|NCT03571555|psychosocial|psychosocial
101157|NCT03571542|Children|children
101158|NCT03571542|transplanted|transplanted
101159|NCT03571542|kidney transplantation|kidney transplantation
101160|NCT03571542|respiratory function|respiratory function
101161|NCT03571542|pulmonary function tests|pulmonary function tests
101162|NCT03571542|respiratory disease|respiratory disease
101163|NCT03571542|immunosuppression|immunosuppression
101164|NCT03571529|EMG driven exoskeleton|emg driven exoskeleton
101165|NCT03571529|hand rehabilitation|hand rehabilitation
101166|NCT03571529|hand function|hand function
101167|NCT03571529|upper extremity outcome|upper extremity outcome
101168|NCT03571516|Short bowel syndrome|short bowel syndrome
101169|NCT03571516|Teduglutide|teduglutide
101170|NCT03571503|Complementary Therapies|complementary therapies
101171|NCT03571503|Exercise|exercise
101172|NCT03571503|Acupuncture|acupuncture
101173|NCT03571477|Sleep apnea diagnosis|sleep apnea diagnosis
101174|NCT03571477|Sleep apnea monitoring|sleep apnea monitoring
101175|NCT03571464|obsessive compulsive disorder|obsessive compulsive disorder
101176|NCT03571464|cognitive therapy|cognitive therapy
101177|NCT03571464|maladaptive beliefs|maladaptive beliefs
101178|NCT03571464|mobile app|mobile app
101179|NCT03571451|peritoneal dialysis|peritoneal dialysis
101180|NCT03571451|survival rate|survival rate
101181|NCT03571451|technique survival rate|technique survival rate
101182|NCT03571451|risk factors|risk factors
101183|NCT03571451|end stage renal disease|end stage renal disease
101184|NCT03571412|Depression|depression
101185|NCT03571412|Major Depressive Disorder|major depressive disorder
101186|NCT03571386|Mindfulness|mindfulness
101187|NCT03571386|Depression|depression
101188|NCT03571386|Anxiety|anxiety
101189|NCT03571386|stress|stress
101190|NCT03571360|Immunotherapy|immunotherapy
101191|NCT03571347|distress|distress
101192|NCT03571347|post-traumatic stress disorder|post-traumatic stress disorder
101193|NCT03571347|prevention|prevention
101194|NCT03571347|asylum seekers|asylum seekers
101195|NCT03571347|refugees|refugees
101196|NCT03571347|Self Help Plus|self help plus
101197|NCT03571347|Europe|europe
101198|NCT03571308|Diffused Large B-Cell Lymphoma|diffused large b-cell lymphoma
101199|NCT03571308|Acalabrunitib|acalabrunitib
101200|NCT03571308|Bruton Tyrosine Kinase|bruton tyrosine kinase
101201|NCT03571308|R-CHOP|r-chop
101202|NCT03571308|Molecular Profiling|molecular profiling
101203|NCT03571308|Chemoimmunotherapy|chemoimmunotherapy
101204|NCT03571295|pediatric airway management|pediatric airway management
101205|NCT03571295|learning curve|learning curve
101206|NCT03571282|conbercept|conbercept
101207|NCT03571282|circumscribed choroidal haemangioma|circumscribed choroidal haemangioma
101208|NCT03571282|safety|safety
101209|NCT03571282|effectiveness|effectiveness
129815|NCT03391778|Safety|safety
101210|NCT03571230|Helicobacter Pylori Infection|helicobacter pylori infection
101211|NCT03571230|Antimicrobial Susceptibility testing(AST)|antimicrobial susceptibility testing(ast)
101212|NCT03571217|Type 2 diabetes mellitus|type 2 diabetes mellitus
101213|NCT03571217|diabetic retinopathy|diabetic retinopathy
101214|NCT03571217|visual impairment|visual impairment
101215|NCT03571217|diabetic choroidopathy|diabetic choroidopathy
101216|NCT03571204|Treatment Interruption|treatment interruption
101217|NCT03571204|Neutralizing Monoclonal Antibody|neutralizing monoclonal antibody
101218|NCT03571191|Bone Diseases|bone diseases
101219|NCT03571191|Fibrous Dysplasia (FD)|fibrous dysplasia (fd)
101220|NCT03571191|Bone Turnover|bone turnover
101221|NCT03571165|carers|carers
101222|NCT03571165|quality of life|quality of life
101223|NCT03571165|dementia|dementia
101224|NCT03571165|web-based intervention|web-based intervention
101225|NCT03571152|Caregivers|caregivers
101226|NCT03571152|Educational videos|educational videos
101227|NCT03571152|Subacute phase|subacute phase
101228|NCT03571139|OCT angiography|oct angiography
101229|NCT03571139|Diabetic retinopathy|diabetic retinopathy
101230|NCT03571139|Cataract surgery|cataract surgery
101231|NCT03571113|cardiac arrest, OHCA survival score, predicting survival, German Resuscitation Registry|cardiac arrest, ohca survival score, predicting survival, german resuscitation registry
101232|NCT03571061|water-aided colonoscopy; difficult colonoscopy|water-aided colonoscopy; difficult colonoscopy
101233|NCT03571035|Mandibular deviation|mandibular deviation
101234|NCT03571035|mandibular movement recording|mandibular movement recording
101235|NCT03570996|esophageal cancer|esophageal cancer
101236|NCT03570996|transversus abdominis plane catheter|transversus abdominis plane catheter
101237|NCT03570996|epidural|epidural
101238|NCT03570996|pain, postoperative|pain, postoperative
101239|NCT03570944|Postoperative Complications|postoperative complications
101241|NCT03570931|Infantile Neuroaxonal Dystrophy|infantile neuroaxonal dystrophy
101242|NCT03570918|HIV, Latent HIV-1 infection, HIV therapy, antibody-based therapy|hiv, latent hiv-1 infection, hiv therapy, antibody-based therapy
101243|NCT03570905|acute, displaced distal radius fracture|acute, displaced distal radius fracture
101244|NCT03570892|Non-Hodgkin's Lympoma|non-hodgkin's lympoma
101245|NCT03570892|B-Cell Lymphoma|b-cell lymphoma
101246|NCT03570892|Diffuse Large B-cell Lymphoma|diffuse large b-cell lymphoma
101247|NCT03570892|High Grade B-cell Lymphoma|high grade b-cell lymphoma
101248|NCT03570892|Follicular Lymphoma grade 3B|follicular lymphoma grade 3b
101249|NCT03570892|CAR-T|car-t
101250|NCT03570892|Tisagenlecleucel|tisagenlecleucel
101251|NCT03570892|Kymriah|kymriah
101252|NCT03570892|Immunotherapy|immunotherapy
101253|NCT03570892|Cellular therapy|cellular therapy
101254|NCT03570892|CTL019|ctl019
101255|NCT03570879|Laparoscopy|laparoscopy
101256|NCT03570879|Power morcellation|power morcellation
101257|NCT03570879|Transvaginal extraction|transvaginal extraction
101258|NCT03570866|Endometrial cancer|endometrial cancer
101259|NCT03570866|Positron emission tomography|positron emission tomography
101260|NCT03570853|Resiliency|resiliency
101261|NCT03570840|pediatric metabolic syndrome|pediatric metabolic syndrome
101262|NCT03570801|Lumbar Spondylolisthesis|lumbar spondylolisthesis
101263|NCT03570801|Grade 1 Spondylolisthesis|grade 1 spondylolisthesis
101264|NCT03570801|Lumbar Spinal Stenosis|lumbar spinal stenosis
101265|NCT03570801|Degenerative Spondylolisthesis|degenerative spondylolisthesis
101266|NCT03570775|hyperbilirubinemia|hyperbilirubinemia
101267|NCT03570775|treatment|treatment
101268|NCT03570775|devices|devices
101269|NCT03570775|newborn|newborn
101270|NCT03570775|phototherapy|phototherapy
101271|NCT03570762|bioresorbable vascular scaffold|bioresorbable vascular scaffold
101272|NCT03570710|cesarean section|cesarean section
101273|NCT03570710|placenta accreta spectrum|placenta accreta spectrum
101274|NCT03570710|tranexamic acid|tranexamic acid
101275|NCT03570697|Optical coherence tomography (OCT)|optical coherence tomography (oct)
101276|NCT03570697|Intravascular ultrasound (IVUS)|intravascular ultrasound (ivus)
101277|NCT03570697|Coronary angiography|coronary angiography
101278|NCT03570697|Coronary artery disease|coronary artery disease
101279|NCT03570697|Cardiovascular events|cardiovascular events
101280|NCT03570697|Coronary atherosclerotic plaques|coronary atherosclerotic plaques
101281|NCT03570697|Lipid-lowering therapy|lipid-lowering therapy
101282|NCT03570697|Statin|statin
101283|NCT03570697|Maximally tolerated statin therapy|maximally tolerated statin therapy
101284|NCT03570671|MDCTA|mdcta
101285|NCT03570671|Coronary artery spasm|coronary artery spasm
101286|NCT03570619|Metastatic Cancer|metastatic cancer
101287|NCT03570619|Metastatic Castration Resistant Prostate Cancer|metastatic castration resistant prostate cancer
101288|NCT03570619|mCRPC|mcrpc
101289|NCT03570619|Immunotherapy|immunotherapy
101290|NCT03570619|CDK12|cdk12
101291|NCT03570580|Sleep Apnea, Obstructive, Mass Screening|sleep apnea, obstructive, mass screening
101292|NCT03570541|Colon cancer|colon cancer
101293|NCT03570541|nerve block|nerve block
101294|NCT03570541|ultra-sound|ultra-sound
101295|NCT03570541|opioids|opioids
101296|NCT03570541|surgical stress|surgical stress
129934|NCT03390907|EMR|emr
101297|NCT03570489|Cardiovascular fitness, refractory epilepsy,|cardiovascular fitness, refractory epilepsy,
101298|NCT03570450|Cell therapy|cell therapy
101299|NCT03570450|stem cell|stem cell
101300|NCT03570450|transplantation|transplantation
101301|NCT03570450|graft|graft
101302|NCT03570450|recovery|recovery
101303|NCT03570450|repair|repair
101304|NCT03570450|stroke|stroke
101305|NCT03570450|msesenchymal stem cell|msesenchymal stem cell
101306|NCT03570450|regenerative|regenerative
101307|NCT03570437|Endometrial|endometrial
101308|NCT03570437|Cancer|cancer
101309|NCT03570437|Paclitaxel|paclitaxel
101310|NCT03570437|Cediranib|cediranib
101311|NCT03570437|Olaparib|olaparib
101312|NCT03570424|Organelle Biogenesis|organelle biogenesis
101313|NCT03570424|Adaptation, Physiological|adaptation, physiological
101314|NCT03570424|Whey Proteins|whey proteins
101315|NCT03570424|Protein Hydrolysates|protein hydrolysates
101316|NCT03570372|Life quality|life quality
101318|NCT03570372|Internet based treatment|internet based treatment
101319|NCT03570372|Autism|autism
101320|NCT03570372|ICBT|icbt
101321|NCT03570359|COPD|copd
101322|NCT03570333|gingival recession|gingival recession
101323|NCT03570333|gingival graft|gingival graft
101324|NCT03570333|Palate|palate
101325|NCT03570333|Gingival mesenchymal stem cells|gingival mesenchymal stem cells
101326|NCT03570333|molar|molar
101327|NCT03570333|premolar|premolar
101328|NCT03570320|opioid|opioid
101329|NCT03570320|narcotic|narcotic
101330|NCT03570320|postoperative|postoperative
101331|NCT03570320|prescription|prescription
101332|NCT03570320|refill|refill
101333|NCT03570320|upper extremity surgery|upper extremity surgery
101334|NCT03570307|MISCARRAGE, CURATTAGE MISOPROSTOL|miscarrage, curattage misoprostol
101335|NCT03570281|cancer-related stroke|cancer-related stroke
101336|NCT03570281|coagulopathy|coagulopathy
101337|NCT03570281|D-dimer|d-dimer
101338|NCT03570281|Edoxaban|edoxaban
101339|NCT03570281|enoxaparine|enoxaparine
101340|NCT03570268|Falls prevention|falls prevention
101341|NCT03570268|Education|education
101342|NCT03570268|Neurological disease|neurological disease
101343|NCT03570242|gynecologic cancer|gynecologic cancer
101344|NCT03570242|WB-EMS|wb-ems
101345|NCT03570242|whole-body electromyostimulation|whole-body electromyostimulation
101346|NCT03570242|nutrition|nutrition
101347|NCT03570242|protein|protein
101348|NCT03570242|exercise|exercise
101349|NCT03570242|cancer cachexia|cancer cachexia
101350|NCT03570229|Quality of life (QOL)|quality of life (qol)
101351|NCT03570229|Hyperbaric oxygen treatment (HBOT)|hyperbaric oxygen treatment (hbot)
101352|NCT03570229|Late radiation tissue injury (LRTI)|late radiation tissue injury (lrti)
101353|NCT03570229|Longitudinal|longitudinal
101354|NCT03570229|Mixed methods|mixed methods
101355|NCT03570229|Patient experiences|patient experiences
101356|NCT03570216|acute exercise|acute exercise
101357|NCT03570216|High-intensity interval exercise|high-intensity interval exercise
101358|NCT03570216|feasibility|feasibility
101359|NCT03570216|arterial stiffness|arterial stiffness
101360|NCT03570203|Hyponatremia|hyponatremia
101361|NCT03570203|Dysnatremia|dysnatremia
101362|NCT03570203|Neurosurgery|neurosurgery
101363|NCT03570203|Neurointensive Care|neurointensive care
101364|NCT03570177|osteoporotic fractures|osteoporotic fractures
101365|NCT03570177|QCT|qct
101366|NCT03570177|BND|bnd
101367|NCT03570177|automatic measurement|automatic measurement
101368|NCT03570138|Freestyle libre|freestyle libre
101369|NCT03570138|Type 2 diabetes|type 2 diabetes
101370|NCT03570138|Hypoglycemia-induced cardiac arrhythmias|hypoglycemia-induced cardiac arrhythmias
101371|NCT03570138|Flash Continuous Glucose Monitoring|flash continuous glucose monitoring
101372|NCT03570099|opioid overdose|opioid overdose
101373|NCT03570099|mortality|mortality
101374|NCT03570099|naloxone|naloxone
101375|NCT03570099|substance use disorder|substance use disorder
101376|NCT03570099|prevention|prevention
101377|NCT03570047|Non-valvular atrial fibrillation, NVAF|non-valvular atrial fibrillation, nvaf
101378|NCT03570008|prevention|prevention
101379|NCT03570008|bone|bone
101380|NCT03570008|physical activity|physical activity
101381|NCT03570008|spa bath|spa bath
101382|NCT03570008|women|women
101383|NCT03569982|Integrative medicine|integrative medicine
101384|NCT03569982|Peri-operative anxiety|peri-operative anxiety
101385|NCT03569982|Pain|pain
101386|NCT03569982|MOHS surgery|mohs surgery
101387|NCT03569969|amniotic membrane|amniotic membrane
101388|NCT03569969|Tympanic Membrane Perforation|tympanic membrane perforation
101389|NCT03569956|Razor bumps|razor bumps
101390|NCT03569956|Skin Irritation|skin irritation
101391|NCT03569956|Shaving|shaving
101392|NCT03569943|Robot based procedure|robot based procedure
101393|NCT03569943|RobOtol|robotol
101394|NCT03569943|Tympanic drain|tympanic drain
101395|NCT03569930|Flavonoid-based supplements|flavonoid-based supplements
101396|NCT03569930|Centella asiatica|centella asiatica
101397|NCT03569930|Hemorrhoids|hemorrhoids
101398|NCT03569930|defecation|defecation
101399|NCT03569930|bleeding|bleeding
101400|NCT03569930|pain|pain
101401|NCT03569904|Cystic fibrosis|cystic fibrosis
101402|NCT03569904|Pulmonary Dysbiosis|pulmonary dysbiosis
101403|NCT03569904|pulmonary exacerbation|pulmonary exacerbation
101404|NCT03569904|Fungal bacterial pulmonary dysbiosis|fungal bacterial pulmonary dysbiosis
101405|NCT03569904|Viral bacterial pulmonary dysbiosis|viral bacterial pulmonary dysbiosis
101406|NCT03569904|Microbiota|microbiota
101407|NCT03569891|Gene therapy|gene therapy
101408|NCT03569891|FIX|fix
101409|NCT03569891|factor IX|factor ix
101410|NCT03569891|Bleeding|bleeding
101411|NCT03569891|Viral vector|viral vector
101412|NCT03569891|Padua|padua
101413|NCT03569891|hemophilia|hemophilia
101414|NCT03569891|AAV (adeno-associated virus)|aav (adeno-associated virus)
101415|NCT03569891|serotype 5 AAV (adeno-associated virus)|serotype 5 aav (adeno-associated virus)
101416|NCT03569891|serotype 5|serotype 5
101417|NCT03569878|PTSD|ptsd
101418|NCT03569878|Physical Injury|physical injury
101419|NCT03569878|Patient Concerns|patient concerns
101420|NCT03569878|Emergency Department Utilization|emergency department utilization
101421|NCT03569813|Pre-exposure prophylaxis (PrEP)|pre-exposure prophylaxis (prep)
101422|NCT03569813|Home-based monitoring|home-based monitoring
101423|NCT03569800|Levothyrox®|levothyrox®
101424|NCT03569800|thyroid hormones|thyroid hormones
101425|NCT03569800|bioequivalent|bioequivalent
101426|NCT03569761|colorectal cancer screening|colorectal cancer screening
101427|NCT03569761|decision aids|decision aids
101428|NCT03569761|American Indians|american indians
101429|NCT03569748|smoking|smoking
101430|NCT03569748|harm reduction|harm reduction
101431|NCT03569748|electronic cigarette|electronic cigarette
101432|NCT03569748|heated tobacco product|heated tobacco product
101433|NCT03569735|Prospective Cohort Study|prospective cohort study
101434|NCT03569735|Nutrition|nutrition
101435|NCT03569735|Chronic diseases|chronic diseases
101436|NCT03569735|Nanshan|nanshan
101437|NCT03569735|Chinese|chinese
101438|NCT03569722|Cognitive screen|cognitive screen
101439|NCT03569670|cost|cost
101440|NCT03569670|total knee replacement|total knee replacement
101441|NCT03569670|arthroplasty|arthroplasty
101442|NCT03569670|posterior stabilized|posterior stabilized
101443|NCT03569670|cruciate retaining|cruciate retaining
101444|NCT03569670|all-polyethylene|all-polyethylene
101445|NCT03569657|Caregivers|caregivers
101446|NCT03569631|Phosphodiesterase Type 4D|phosphodiesterase type 4d
101448|NCT03569631|Cognitive Dysfunction|cognitive dysfunction
101449|NCT03569631|Neurocognitive Disorders|neurocognitive disorders
101450|NCT03569631|Fragile X Syndrome|fragile x syndrome
101451|NCT03569631|Fragile X|fragile x
101452|NCT03569631|FXS|fxs
101453|NCT03569631|Brain Diseases|brain diseases
101454|NCT03569631|Central Nervous System Diseases|central nervous system diseases
101455|NCT03569631|Nervous System Diseases|nervous system diseases
101456|NCT03569631|Mental Disorders|mental disorders
101457|NCT03569631|Cognition Disorders|cognition disorders
101458|NCT03569631|Enzyme Inhibitors|enzyme inhibitors
101459|NCT03569631|Nootropic Agents|nootropic agents
101460|NCT03569631|Developmental Disorder|developmental disorder
101461|NCT03569631|Autism|autism
101462|NCT03569631|Autistic Spectrum Disorder|autistic spectrum disorder
101463|NCT03569631|Genetic Disease|genetic disease
101464|NCT03569631|Behavioral Disorder|behavioral disorder
101465|NCT03569631|Learning Disorder|learning disorder
101466|NCT03569605|young adult|young adult
101467|NCT03569605|cancer survivor|cancer survivor
101468|NCT03569592|HIV/AIDS|hiv/aids
101469|NCT03569592|naloxone|naloxone
101470|NCT03569592|incarceration|incarceration
101471|NCT03569566|Age|age
101472|NCT03569566|Genes|genes
101473|NCT03569566|Training volume|training volume
101474|NCT03569566|Training intensity|training intensity
101475|NCT03569566|Tick-bourne disease|tick-bourne disease
101476|NCT03569566|Endurance performance|endurance performance
101477|NCT03569566|Elite endurance athletes|elite endurance athletes
101478|NCT03569553|Anthrax|anthrax
101479|NCT03569553|Bacillus anthracis|bacillus anthracis
101480|NCT03569553|Inhalational anthrax|inhalational anthrax
101481|NCT03569553|Bacterial infection|bacterial infection
101482|NCT03569553|AIGIV|aigiv
101483|NCT03569553|Anthrasil|anthrasil
101484|NCT03569553|Anthrax immune globulin|anthrax immune globulin
101485|NCT03569553|Anti toxin|anti toxin
101486|NCT03569553|Poluclonal antibodies|poluclonal antibodies
101487|NCT03569540|Subarachnoid hemorrhage|subarachnoid hemorrhage
101488|NCT03569540|Glibenclamide|glibenclamide
101489|NCT03569527|Kiwifruit|kiwifruit
101490|NCT03569514|Anthrax|anthrax
101491|NCT03569514|Bacillus anthracis|bacillus anthracis
101492|NCT03569514|Bacterial infection|bacterial infection
101493|NCT03569514|AIGIV|aigiv
101494|NCT03569514|Anthrax immune globulin|anthrax immune globulin
101495|NCT03569514|Anti toxin|anti toxin
101496|NCT03569514|Polyclonal antibodies|polyclonal antibodies
101497|NCT03569501|gestational diabetes mellitus|gestational diabetes mellitus
101498|NCT03569501|oat|oat
101499|NCT03569501|docosahexaenoic acid|docosahexaenoic acid
101500|NCT03569501|glycemic control|glycemic control
101501|NCT03569501|intestinal flora|intestinal flora
101502|NCT03569501|newborn|newborn
101503|NCT03569501|leptin|leptin
101504|NCT03569488|quality of life|quality of life
101505|NCT03569488|sphincter-sparing surgery|sphincter-sparing surgery
101506|NCT03569488|LARS score|lars score
101507|NCT03569462|HIV self-testing|hiv self-testing
101508|NCT03569462|Mobile Health|mobile health
101509|NCT03569462|Men who have sex with men|men who have sex with men
101510|NCT03569462|China|china
101511|NCT03569449|Family navigation|family navigation
101512|NCT03569449|Family partners|family partners
101513|NCT03569449|Multiphase optimization strategy (MOST)|multiphase optimization strategy (most)
101514|NCT03569449|Pediatric Symptom Checklist-17|pediatric symptom checklist-17
101515|NCT03569449|Survey of Wellbeing of Young children (SWYC)|survey of wellbeing of young children (swyc)
101516|NCT03569449|Family Resource Scale|family resource scale
101517|NCT03569449|Federally qualified community health center|federally qualified community health center
101518|NCT03569410|peritoneal dialysis|peritoneal dialysis
101519|NCT03569410|albumin|albumin
101520|NCT03569410|end stage renal disease|end stage renal disease
101521|NCT03569371|Hidradenitis suppurativa (HS)|hidradenitis suppurativa (hs)
101522|NCT03569371|Janus kinase (JAK)|janus kinase (jak)
101523|NCT03569371|Janus kinase 1 (JAK1) inhibitor|janus kinase 1 (jak1) inhibitor
101524|NCT03569358|Randomised Controlled Study|randomised controlled study
101525|NCT03569358|Unblinded|unblinded
101526|NCT03569358|Electroencephalogram|electroencephalogram
101527|NCT03569358|Feasibility|feasibility
101528|NCT03569332|Incentive Spirometer|incentive spirometer
101529|NCT03569319|Mediterranean Diet|mediterranean diet
101530|NCT03569319|Lifestyle|lifestyle
101531|NCT03569306|Electromagnetic navigation bronchoscopy(ENB)|electromagnetic navigation bronchoscopy(enb)
101532|NCT03569306|peripheral pulmonary nodules|peripheral pulmonary nodules
101533|NCT03569306|diagnostic yield|diagnostic yield
101534|NCT03569293|Atopic Dermatitis|atopic dermatitis
101535|NCT03569293|Upadacitinib|upadacitinib
101536|NCT03569280|KPG-121|kpg-121
101537|NCT03569280|enzalutamide|enzalutamide
101538|NCT03569280|prostate|prostate
101539|NCT03569280|cancer|cancer
101540|NCT03569280|metastatic|metastatic
101541|NCT03569254|infant, newborn|infant, newborn
101542|NCT03569254|devices|devices
101543|NCT03569254|treatment|treatment
101560|NCT03569176|mobile health, autism, ASD, mobile therapy, digital, wearable computing, technology|mobile health, autism, asd, mobile therapy, digital, wearable computing, technology
101561|NCT03569150|palliative care|palliative care
101562|NCT03569150|end-of-life care|end-of-life care
101563|NCT03569150|advance care planning|advance care planning
101564|NCT03569150|communication|communication
101565|NCT03569150|health literacy|health literacy
101566|NCT03569150|serious life-limiting illness|serious life-limiting illness
101567|NCT03569137|Gut Microbiome|gut microbiome
101568|NCT03569137|hematologic malignancies B|hematologic malignancies b
101569|NCT03569137|biomarkers|biomarkers
101570|NCT03569137|targeted therapy|targeted therapy
101571|NCT03569137|Gut microbiota|gut microbiota
101572|NCT03569111|Lung Nodule|lung nodule
101573|NCT03569111|Bronchoscopy|bronchoscopy
101574|NCT03569111|Ablation, Microwave|ablation, microwave
101575|NCT03569059|Stroke|stroke
101576|NCT03569059|Virtual Environment|virtual environment
101577|NCT03569059|Robotics|robotics
101578|NCT03569059|Upper Extremity|upper extremity
101579|NCT03569059|Hand|hand
101580|NCT03569059|Transcranial Magnetic Stimulation|transcranial magnetic stimulation
101602|NCT03568968|Parkinson's Disease|parkinson's disease
101603|NCT03568968|NAD metabolism|nad metabolism
101604|NCT03568968|Mitochondria|mitochondria
101605|NCT03568968|Nicotinamide Riboside|nicotinamide riboside
101606|NCT03568955|assessment|assessment
101607|NCT03568955|validation|validation
101608|NCT03568955|prolonged grief disorder|prolonged grief disorder
101609|NCT03568955|cross cultural|cross cultural
101610|NCT03568955|questionnaire|questionnaire
101611|NCT03568942|gepotidacin|gepotidacin
101612|NCT03568942|GSK2140944|gsk2140944
101613|NCT03568942|acute cystitis|acute cystitis
101614|NCT03568942|pharmacokinetics|pharmacokinetics
101615|NCT03568942|urinary tract infections|urinary tract infections
101616|NCT03568916|Direct oral anticoagulants|direct oral anticoagulants
101617|NCT03568916|Safety|safety
101618|NCT03568916|Atrial fibrillation|atrial fibrillation
101619|NCT03568916|Ischemic stroke|ischemic stroke
101620|NCT03568916|Systemic embolization|systemic embolization
101621|NCT03568903|Parkinson Disease|parkinson disease
101622|NCT03568903|Gait|gait
101623|NCT03568903|Physical therapy|physical therapy
101624|NCT03568903|functional performance|functional performance
101625|NCT03568903|group therapy|group therapy
101626|NCT03568890|Left Atrial Appendage Closure|left atrial appendage closure
101627|NCT03568890|Anticoagulation therapy|anticoagulation therapy
101628|NCT03568890|Antiplatelet therapy|antiplatelet therapy
101629|NCT03568825|Two-dimensional randomized response surface pathway design|two-dimensional randomized response surface pathway design
101630|NCT03568825|Osteopathic Manual Therapy|osteopathic manual therapy
101631|NCT03568825|OMT in treatment of GERD|omt in treatment of gerd
101632|NCT03568825|Dose-response|dose-response
101633|NCT03568812|HIV|hiv
101634|NCT03568812|immunological non responder|immunological non responder
101635|NCT03568812|gut inflammation|gut inflammation
101636|NCT03568786|end-inspiratory pause|end-inspiratory pause
101637|NCT03568786|lung protection|lung protection
101638|NCT03568786|intraoperative ventilation|intraoperative ventilation
101639|NCT03568786|lung compliance|lung compliance
101640|NCT03568760|Anomia|anomia
101641|NCT03568734|microbiome|microbiome
101642|NCT03568734|transplant|transplant
101643|NCT03568734|infant|infant
101644|NCT03568734|newborn|newborn
101645|NCT03568721|pain|pain
101646|NCT03568721|orthodontics|orthodontics
101647|NCT03568708|Primary Ovarian Insufficiency|primary ovarian insufficiency
101648|NCT03568708|Hormone Replacement Therapy|hormone replacement therapy
101649|NCT03568708|Estrogen Deficiency|estrogen deficiency
101650|NCT03568695|pooled analysis|pooled analysis
101651|NCT03568695|sensitivity|sensitivity
101652|NCT03568695|men who have sex with men|men who have sex with men
101653|NCT03568682|food insecurity|food insecurity
101654|NCT03568682|nutrition|nutrition
101655|NCT03568682|treatment adherence|treatment adherence
101656|NCT03568669|NIH Toolbox|nih toolbox
101657|NCT03568669|Toolbox|toolbox
101658|NCT03568669|Congenital Central Hypoventilation Syndrome|congenital central hypoventilation syndrome
101659|NCT03568669|CCHS|cchs
101660|NCT03568669|Autonomic Nervous System Dysregulation|autonomic nervous system dysregulation
101661|NCT03568669|PHOX2B|phox2b
101662|NCT03568617|Transcranial Magnetic Stimulation|transcranial magnetic stimulation
101663|NCT03568617|Migraine Disorders|migraine disorders
101664|NCT03568617|Prophylaxis|prophylaxis
101665|NCT03568617|Treatment Outcome|treatment outcome
101666|NCT03568617|Brain|brain
101667|NCT03568604|vulvovaginal atrophy|vulvovaginal atrophy
101668|NCT03568604|dyspareunia|dyspareunia
101669|NCT03568604|prasterone|prasterone
101670|NCT03568604|vulvoscopy|vulvoscopy
101671|NCT03568591|Psychosensory Therapy|psychosensory therapy
101672|NCT03568591|Trauma, Psychological|trauma, psychological
101673|NCT03568591|DS14|ds14
101674|NCT03568591|CD-RISC|cd-risc
101675|NCT03568591|Resilience|resilience
101676|NCT03568591|Psychosomatic Medicine|psychosomatic medicine
101677|NCT03568591|Type D Personality|type d personality
101678|NCT03568591|Salivary Cortisol|salivary cortisol
101679|NCT03568591|Blood Pressure|blood pressure
101680|NCT03568591|Havening Techniques|havening techniques
101681|NCT03568578|Fibrosis|fibrosis
101682|NCT03568578|Liver Cirrhosis|liver cirrhosis
101683|NCT03568578|non-invasive biopsy|non-invasive biopsy
101684|NCT03568578|hepatitis B virus|hepatitis b virus
101685|NCT03568552|Opioid Use Disorder (OUD)|opioid use disorder (oud)
101686|NCT03568552|Medication Assisted Therapy (MAT)|medication assisted therapy (mat)
101687|NCT03568552|Patient Decision Aid|patient decision aid
101688|NCT03568552|Medication Treatment for Opioid Use Disorder (MOUD)|medication treatment for opioid use disorder (moud)
101689|NCT03568539|Advanced/metastatic solid malignancies, TMB high|advanced/metastatic solid malignancies, tmb high
101690|NCT03568513|Curcumin|curcumin
101691|NCT03568513|IBS and microbiota|ibs and microbiota
101692|NCT03568500|Digital Medicine System|digital medicine system
101693|NCT03568487|scapular dyskinesis|scapular dyskinesis
101694|NCT03568487|EMG biofeedback|emg biofeedback
101695|NCT03568487|scapulometer|scapulometer
101696|NCT03568461|Refractory or relapsed Follicular Lymphoma|refractory or relapsed follicular lymphoma
101697|NCT03568461|Refractory|refractory
101698|NCT03568461|Relapsed|relapsed
101699|NCT03568461|Follicular lymphoma|follicular lymphoma
101700|NCT03568461|CTL019|ctl019
101701|NCT03568461|Tisagenlecleucel|tisagenlecleucel
101702|NCT03568461|Chimeric antigen receptor|chimeric antigen receptor
101703|NCT03568448|HER2 negative breast cancer|her2 negative breast cancer
101704|NCT03568396|Nociceptive stimulation|nociceptive stimulation
101705|NCT03568383|Tuberculosis|tuberculosis
101706|NCT03568383|Multidrug Resistance|multidrug resistance
101707|NCT03568383|Prevention|prevention
101708|NCT03568383|Household Contact|household contact
101709|NCT03568357|tetralogy of Fallot|tetralogy of fallot
101710|NCT03568344|Severe malaria|severe malaria
101711|NCT03568344|Mortality|mortality
101712|NCT03568344|Referral|referral
101713|NCT03568344|Rectal artesunate|rectal artesunate
101714|NCT03568344|iCCM|iccm
101715|NCT03568344|Community based treatment|community based treatment
101716|NCT03568331|Chronic Pruritus|chronic pruritus
101717|NCT03568331|Eczema|eczema
101718|NCT03568318|Atopic Dermatitis|atopic dermatitis
101719|NCT03568318|Upadacitinib|upadacitinib
101720|NCT03568305|asthma|asthma
101721|NCT03568305|occupational asthma|occupational asthma
101722|NCT03568253|Bulk composite|bulk composite
101723|NCT03568253|High viscisity glassionomer|high viscisity glassionomer
101724|NCT03568253|Cambra application (Caries management by risk assessment)|cambra application (caries management by risk assessment)
101725|NCT03568253|E-dentistry|e-dentistry
101726|NCT03568227|Hypnosis|hypnosis
101727|NCT03568227|Neurophysiology|neurophysiology
101728|NCT03568227|fMRI|fmri
101729|NCT03568227|Resting-State|resting-state
101730|NCT03568227|Hypnotic Sub-States|hypnotic sub-states
101731|NCT03568214|Primary Prevention|primary prevention
101732|NCT03568201|Diagnosis|diagnosis
101733|NCT03568201|Peripheral artery disease|peripheral artery disease
101734|NCT03568201|Sports|sports
101735|NCT03568188|prostate cancer|prostate cancer
101736|NCT03568188|HIFU focal|hifu focal
101737|NCT03568188|adverse effect|adverse effect
101738|NCT03568188|intermediate risk|intermediate risk
101739|NCT03568162|GRB 830 for the treatment of moderate to severe atopic dermatitis|grb 830 for the treatment of moderate to severe atopic dermatitis
101740|NCT03568136|neurodermatitis|neurodermatitis
101741|NCT03568136|moderate to severe inflammatory reaction of the skin|moderate to severe inflammatory reaction of the skin
101744|NCT03568084|physical activity|physical activity
101745|NCT03568084|exercise|exercise
101746|NCT03568084|frailty|frailty
101747|NCT03568058|immunotherapy|immunotherapy
101748|NCT03568058|personalized cancer vaccine|personalized cancer vaccine
101749|NCT03568058|personalized immunotherapy|personalized immunotherapy
101750|NCT03568058|pembrolizumab|pembrolizumab
101751|NCT03568058|Keytruda|keytruda
101752|NCT03568058|cancer|cancer
101753|NCT03568058|neoantigen|neoantigen
101754|NCT03568058|solid tumor|solid tumor
101755|NCT03568058|vaccine|vaccine
101756|NCT03568045|circadian misalignment|circadian misalignment
101757|NCT03568045|entrainment|entrainment
101758|NCT03568045|zeitgeber|zeitgeber
101759|NCT03568045|bright light|bright light
101760|NCT03568045|critical illness|critical illness
101761|NCT03568032|intima media thickness|intima media thickness
101762|NCT03568006|subacromial impingement|subacromial impingement
101763|NCT03568006|pain|pain
101764|NCT03568006|shoulder|shoulder
101765|NCT03568006|passive mobilization|passive mobilization
101766|NCT03567993|mhealth|mhealth
101767|NCT03567993|Tobacco cessation|tobacco cessation
101768|NCT03567993|Vietnam|vietnam
101769|NCT03567993|Smoking cessation|smoking cessation
101770|NCT03567967|nutrition|nutrition
101771|NCT03567967|fruits and vegetables|fruits and vegetables
101772|NCT03567967|sugar-sweetened beverages|sugar-sweetened beverages
101773|NCT03567954|Diagnostic ultrasound|diagnostic ultrasound
101774|NCT03567902|C-MAC|c-mac
101775|NCT03567876|Mantle cell lymphoma|mantle cell lymphoma
101776|NCT03567876|Elderly patients|elderly patients
101777|NCT03567876|First line|first line
101778|NCT03567785|Therapy adherence|therapy adherence
101779|NCT03567772|Video-game assisted rehabilitation|video-game assisted rehabilitation
101780|NCT03567772|COPD|copd
101781|NCT03567772|Exercise tolerance|exercise tolerance
101782|NCT03567746|Colonic Polyp|colonic polyp
101783|NCT03567746|Endoscopic mucosal resection|endoscopic mucosal resection
101786|NCT03567720|Metastatic|metastatic
101787|NCT03567720|Inoperable Locally Advanced|inoperable locally advanced
101788|NCT03567720|TNBC|tnbc
101789|NCT03567720|pIL-12|pil-12
101790|NCT03567720|tavokinogene telseplasmid|tavokinogene telseplasmid
101791|NCT03567720|pembrolizumab|pembrolizumab
101792|NCT03567707|Vaginal seeding|vaginal seeding
101793|NCT03567707|Immune responses|immune responses
101794|NCT03567707|Allergen sensitization|allergen sensitization
101795|NCT03567694|asthma, allergic rhinitis, HA115, CRTH2 antagonists|asthma, allergic rhinitis, ha115, crth2 antagonists
101796|NCT03567694|CT133|ct133
101797|NCT03567655|medroxyprogestrone acetate|medroxyprogestrone acetate
101798|NCT03567642|Osimertinib|osimertinib
101799|NCT03567642|Platinum|platinum
101800|NCT03567642|Etoposide|etoposide
101801|NCT03567642|EGFR Mutant|egfr mutant
101802|NCT03567642|18-211|18-211
101803|NCT03567629|Irinotecan|irinotecan
101804|NCT03567629|Oxaliplatin|oxaliplatin
101805|NCT03567629|refractory|refractory
101806|NCT03567629|mCRC|mcrc
101807|NCT03567616|Cancer|cancer
101808|NCT03567616|Multiple Myeloma (MM)|multiple myeloma (mm)
101809|NCT03567616|Relapsed or Refractory (R/R)|relapsed or refractory (r/r)
101810|NCT03567616|venetoclax|venetoclax
101811|NCT03567616|pomalidomide|pomalidomide
101812|NCT03567616|dexamethasone|dexamethasone
101813|NCT03567590|Cluster Headache, pulsed radiofrequency|cluster headache, pulsed radiofrequency
101814|NCT03567577|Peptide|peptide
101815|NCT03567564|abdominal muscles|abdominal muscles
101816|NCT03567564|spontaneous breathing trial|spontaneous breathing trial
101817|NCT03567564|critically ill patients|critically ill patients
101818|NCT03567551|Preeclampsia|preeclampsia
101819|NCT03567551|Pregnancy|pregnancy
101820|NCT03567551|Complications|complications
101821|NCT03567551|Eclampsia|eclampsia
101822|NCT03567551|Aquaporin|aquaporin
101823|NCT03567551|Aquaporin 4|aquaporin 4
101824|NCT03567538|Thoracic surgery|thoracic surgery
101825|NCT03567538|Lung surgery|lung surgery
101826|NCT03567538|Epidemiologic Methods|epidemiologic methods
101827|NCT03567499|Pro-arrhythmic|pro-arrhythmic
101828|NCT03567499|Holter ECG|holter ecg
101830|NCT03567499|Cardiac telemetry|cardiac telemetry
101831|NCT03567499|Benign arrhythmic|benign arrhythmic
101832|NCT03567447|Parkinsons Disease|parkinsons disease
101833|NCT03567447|PD|pd
101834|NCT03567447|Patient Falls|patient falls
101835|NCT03567447|Neurogenic Orthostatic Hypotension|neurogenic orthostatic hypotension
101836|NCT03567421|stone disease|stone disease
101837|NCT03567421|ureteral stent|ureteral stent
101838|NCT03567421|stenting|stenting
101839|NCT03567421|ureteroscopy treatment|ureteroscopy treatment
101840|NCT03567421|stent placement|stent placement
101841|NCT03567421|postoperative ureteral stenting|postoperative ureteral stenting
101842|NCT03567421|Société Internationale d'Urologie|société internationale d'urologie
101843|NCT03567421|uCARE|ucare
101844|NCT03567369|Third molar|third molar
101845|NCT03567369|Surgery|surgery
101846|NCT03567369|Swelling|swelling
101847|NCT03567343|sleep|sleep
101848|NCT03567317|CPAP|cpap
101849|NCT03567317|Weight Gain|weight gain
101850|NCT03567317|obstructive sleep apnea|obstructive sleep apnea
101851|NCT03567304|HIV|hiv
101852|NCT03567304|Neurocognitive disorder|neurocognitive disorder
101853|NCT03567304|Efavirenz|efavirenz
101854|NCT03567304|Rilpivirine|rilpivirine
101855|NCT03567291|adolescents|adolescents
101856|NCT03567291|children|children
101857|NCT03567278|Severe Symptomatic Aortic Valve Stenosis|severe symptomatic aortic valve stenosis
101858|NCT03567252|Appalachia|appalachia
101859|NCT03567252|Exercise|exercise
101860|NCT03567239|Rehabilitation Engineering|rehabilitation engineering
101861|NCT03567239|Adaptive Devices|adaptive devices
101862|NCT03567239|Assistive Technology|assistive technology
101863|NCT03567213|Tetraplegia|tetraplegia
101864|NCT03567213|ALS|als
101865|NCT03567213|Locked-in Syndrome|locked-in syndrome
101866|NCT03567213|Brainstem stroke|brainstem stroke
101867|NCT03567213|Brain Computer Interface|brain computer interface
101868|NCT03567213|Rehabilitation|rehabilitation
101869|NCT03567213|Stroke|stroke
101870|NCT03567213|Hopkins|hopkins
101871|NCT03567187|Cryoneurolysis|cryoneurolysis
101872|NCT03567187|iovera|iovera
101873|NCT03567187|Superficial nerves treatment|superficial nerves treatment
101874|NCT03567187|Deep Fibular Nerve|deep fibular nerve
101875|NCT03567174|hepatitis C|hepatitis c
101876|NCT03567148|Graft|graft
101877|NCT03567148|Pain|pain
101878|NCT03567148|Palate|palate
101879|NCT03567148|Wound healing|wound healing
101880|NCT03567135|Temozolomide|temozolomide
101881|NCT03567135|Apatinib|apatinib
101882|NCT03567135|Radiotherapy|radiotherapy
101883|NCT03567122|Cranio-cervical|cranio-cervical
101884|NCT03567122|Motor Control|motor control
101885|NCT03567122|Deep Flexor muscles|deep flexor muscles
101886|NCT03567096|Cardiac resynchronization therapy|cardiac resynchronization therapy
101887|NCT03567096|MultiPoint Pacing|multipoint pacing
101888|NCT03567083|Refugees|refugees
101889|NCT03567083|Mental Health Problems|mental health problems
101890|NCT03567031|Pediatric Anesthesia|pediatric anesthesia
101891|NCT03567031|Near-Infrared Spectroscopy|near-infrared spectroscopy
101892|NCT03567031|End-Tidal CO2|end-tidal co2
101893|NCT03567031|Cerebral Blood Flow|cerebral blood flow
101894|NCT03566966|hepatitis C virus infection|hepatitis c virus infection
101895|NCT03566966|non-organ-specific antibodies|non-organ-specific antibodies
101896|NCT03566966|prognostic value|prognostic value
101897|NCT03566966|sustained virological response|sustained virological response
101898|NCT03566953|Dental Decay|dental decay
101899|NCT03566927|Arteriovenous Fistula|arteriovenous fistula
101900|NCT03566927|Vascular Fistula|vascular fistula
101901|NCT03566927|Scoring|scoring
101902|NCT03566927|Fistula|fistula
101903|NCT03566927|Cardiovascular Disease|cardiovascular disease
101904|NCT03566901|Balance, Gait, Rehabilitation, Stroke, Robotics, Postural|balance, gait, rehabilitation, stroke, robotics, postural
101905|NCT03566875|TKA robot assisted with the Stryker's MAKO™ system|tka robot assisted with the stryker's mako™ system
101906|NCT03566875|surgery precision|surgery precision
101907|NCT03566849|Volleyball|volleyball
101908|NCT03566849|Shoulder impingement|shoulder impingement
101909|NCT03566849|Scapular dyskinesis|scapular dyskinesis
101910|NCT03566849|Kinetic chain|kinetic chain
101911|NCT03566836|Smart Watch|smart watch
101912|NCT03566836|Garmin|garmin
101913|NCT03566836|Wearable|wearable
101914|NCT03566836|Cardioversion|cardioversion
101915|NCT03566810|Diabetes Mellitus|diabetes mellitus
101916|NCT03566810|Glucophage Extended Release (GXR)|glucophage extended release (gxr)
101917|NCT03566810|Bioequivalence Study|bioequivalence study
101918|NCT03566784|inguinal hernia repair|inguinal hernia repair
101919|NCT03566784|electrocoagulation|electrocoagulation
101920|NCT03566784|postoperative pain|postoperative pain
101921|NCT03566784|thermal injury|thermal injury
101922|NCT03566784|neuralgia|neuralgia
101923|NCT03566771|Mobile Health|mobile health
101924|NCT03566771|Self-Monitoring|self-monitoring
101925|NCT03566771|Behavioural Treatment|behavioural treatment
101926|NCT03566732|questionnaire survey|questionnaire survey
101927|NCT03566732|care for dying patients|care for dying patients
101928|NCT03566719|Prevention|prevention
101929|NCT03566719|Active Ageing|active ageing
101930|NCT03566719|Fall|fall
101931|NCT03566719|Fall Risk|fall risk
101932|NCT03566719|Exercise Programs|exercise programs
101933|NCT03566667|Beta-blockers|beta-blockers
101934|NCT03566654|remote ischemic conditioning|remote ischemic conditioning
101935|NCT03566628|Cerebral Angiography|cerebral angiography
101936|NCT03566628|Shivering|shivering
101937|NCT03566628|Anaesthesia|anaesthesia
101938|NCT03566628|Warmed solutions|warmed solutions
101939|NCT03566615|colonoscopy|colonoscopy
101940|NCT03566615|adenoma detection rate|adenoma detection rate
101941|NCT03566615|caps|caps
101942|NCT03566563|Community Screening|community screening
101943|NCT03566563|Halfway house|halfway house
101944|NCT03566563|People who inject drugs|people who inject drugs
101945|NCT03566563|Substance users|substance users
101946|NCT03566563|Released prisoners|released prisoners
101947|NCT03566511|diabetes|diabetes
101948|NCT03566511|type 2 diabetes|type 2 diabetes
101949|NCT03566511|insulin resistance|insulin resistance
101950|NCT03566511|diazoxide|diazoxide
101951|NCT03566511|MRI|mri
101952|NCT03566459|Opioid Use Disorder (OUD)|opioid use disorder (oud)
101953|NCT03566459|Medication Assisted Treatment (MAT)|medication assisted treatment (mat)
101954|NCT03566459|Telemedicine|telemedicine
101955|NCT03566459|Veteran|veteran
101956|NCT03566446|CALR mutation|calr mutation
101957|NCT03566381|Wearable sensor, sweat sensor|wearable sensor, sweat sensor
101958|NCT03566368|Cardiac Dysfunction|cardiac dysfunction
101959|NCT03566368|Traumatic Brain Injury|traumatic brain injury
101960|NCT03566355|Lung Metastasis, Curative Proton Beam Therapy|lung metastasis, curative proton beam therapy
101961|NCT03566329|craniotomy- Emergence- hypertension|craniotomy- emergence- hypertension
101962|NCT03566303|Valve Heart Disease|valve heart disease
101963|NCT03566303|Rivaroxaban|rivaroxaban
101964|NCT03566303|Warfarin|warfarin
101965|NCT03566251|Multiple Sclerosis|multiple sclerosis
101966|NCT03566251|Balance|balance
101967|NCT03566251|Core Stability|core stability
101968|NCT03566251|Proprioception|proprioception
101969|NCT03566251|Functional Mobility|functional mobility
101970|NCT03566238|Pediatric|pediatric
101971|NCT03566238|Cholestasis|cholestasis
101972|NCT03566212|Anxiety|anxiety
101973|NCT03566212|Camouflaged syringe|camouflaged syringe
101974|NCT03566212|Conventional syringe|conventional syringe
101975|NCT03566186|Photobiomodulation|photobiomodulation
101976|NCT03566186|Autonomic nervous system|autonomic nervous system
101977|NCT03566186|Heart rate variability|heart rate variability
101978|NCT03566186|Recovery of function|recovery of function
101979|NCT03566186|Super-pulsed laser|super-pulsed laser
101980|NCT03566186|Led light|led light
101981|NCT03566160|Biopsy|biopsy
101982|NCT03566160|EGD|egd
101983|NCT03566160|Endoscopy|endoscopy
101984|NCT03566160|Cryobiopsy|cryobiopsy
101985|NCT03566160|OCT|oct
101986|NCT03566108|Gingival phenotype|gingival phenotype
101987|NCT03566108|Keratinized gingiva|keratinized gingiva
101988|NCT03566108|Gingival recession|gingival recession
101989|NCT03566108|Soft tissue recession|soft tissue recession
101990|NCT03566095|Rural|rural
101991|NCT03566095|Food Policy Councils|food policy councils
101992|NCT03566095|Food Pantry|food pantry
101993|NCT03566095|Community Coaching|community coaching
101994|NCT03566069|Oxytocin|oxytocin
101995|NCT03566069|Psychotherapy|psychotherapy
101996|NCT03566069|Depression|depression
101997|NCT03566069|Anxiety|anxiety
101998|NCT03566069|Therapeutic working Alliance|therapeutic working alliance
101999|NCT03566043|MPS II|mps ii
102000|NCT03566043|gene therapy|gene therapy
102001|NCT03566043|Hunter|hunter
102002|NCT03566030|Hepatitis B|hepatitis b
102003|NCT03566030|Tenofovir Disoproxil Fumarate|tenofovir disoproxil fumarate
102004|NCT03566030|Tenofovir Alafenamide|tenofovir alafenamide
102005|NCT03566030|Switch|switch
102006|NCT03566017|Glomerular filtration rate|glomerular filtration rate
102007|NCT03566017|Proteinuria|proteinuria
102008|NCT03566017|PRX-102|prx-102
102009|NCT03566017|pegunigalsidase alfa|pegunigalsidase alfa
102010|NCT03566017|Fabry disease|fabry disease
102011|NCT03565991|BRCA, ATM|brca, atm
102012|NCT03565965|Randomized clinical trial|randomized clinical trial
102013|NCT03565965|Parkinson's disease|parkinson's disease
102014|NCT03565965|Gait disorders|gait disorders
102015|NCT03565965|Locomotor imagery training|locomotor imagery training
102016|NCT03565952|Menopausal women|menopausal women
102017|NCT03565952|Insomnia|insomnia
102018|NCT03565939|Ulcerative Colitis|ulcerative colitis
102019|NCT03565939|Trichuris suis|trichuris suis
102020|NCT03565939|Trichuris suis ova|trichuris suis ova
102021|NCT03565939|Probiotic|probiotic
102022|NCT03565939|IBD|ibd
102023|NCT03565939|Inflammatory bowel diseases|inflammatory bowel diseases
102024|NCT03565939|Anti inflammatory|anti inflammatory
102025|NCT03565939|Hygiene Hypothesis|hygiene hypothesis
102026|NCT03565939|Helminths|helminths
102027|NCT03565939|Microbiome|microbiome
102028|NCT03565939|MAYO|mayo
102029|NCT03565926|low back pain|low back pain
102030|NCT03565926|manual therapy|manual therapy
102031|NCT03565926|hypopressive therapeutic exercises|hypopressive therapeutic exercises
102032|NCT03565848|Laparoscopy|laparoscopy
102033|NCT03565848|Colorectal resection|colorectal resection
102034|NCT03565848|Deep infiltrating endometriosis|deep infiltrating endometriosis
102035|NCT03565848|Constipation|constipation
102036|NCT03565835|abiraterone|abiraterone
102037|NCT03565835|prostate cancer|prostate cancer
102038|NCT03565835|androgen deprivation therapy|androgen deprivation therapy
102039|NCT03565822|Oesophageal Atresia|oesophageal atresia
102040|NCT03565822|Congenital Diaphragmatic Hernia|congenital diaphragmatic hernia
102041|NCT03565822|Short Bowel Syndrome|short bowel syndrome
102042|NCT03565809|Diabetes mellitus|diabetes mellitus
102043|NCT03565809|Alzheimer Disease or related disorders|alzheimer disease or related disorders
102044|NCT03565796|Smoking cessation|smoking cessation
102045|NCT03565796|Quit to Win|quit to win
102058|NCT03565744|adolescents|adolescents
102059|NCT03565744|school-based|school-based
102060|NCT03565744|weight management|weight management
102061|NCT03565744|wellness|wellness
102062|NCT03565692|Microbiome|microbiome
102063|NCT03565692|Microbiota|microbiota
102064|NCT03565692|Mycobiota|mycobiota
102065|NCT03565692|Mycobiome|mycobiome
102066|NCT03565692|Deep-Sequencing|deep-sequencing
102067|NCT03565692|Cystic Fibrosis|cystic fibrosis
102068|NCT03565666|bionic pancreas|bionic pancreas
102069|NCT03565666|closed loop|closed loop
102070|NCT03565666|insulin|insulin
102071|NCT03565666|continuous glucose monitor|continuous glucose monitor
102072|NCT03565640|Buttock pain|buttock pain
102073|NCT03565640|Thigh pain|thigh pain
102074|NCT03565640|Sacrospinous ligament fixation|sacrospinous ligament fixation
102075|NCT03565627|mHealth|mhealth
102076|NCT03565627|digital health|digital health
102077|NCT03565627|behavior change|behavior change
102078|NCT03565627|physical activity|physical activity
102079|NCT03565627|mobile apps|mobile apps
102080|NCT03565614|reablement|reablement
102081|NCT03565614|older people|older people
102082|NCT03565614|personal care services|personal care services
102083|NCT03565614|rehabilitation|rehabilitation
102084|NCT03565614|multimorbidity|multimorbidity
102085|NCT03565614|disability|disability
102086|NCT03565588|Voluntary medical male circumcision|voluntary medical male circumcision
102087|NCT03565588|HIV prevention|hiv prevention
102088|NCT03565588|Risk perception|risk perception
102089|NCT03565575|Pre-Exposure Prophylaxis (PrEP) for HIV|pre-exposure prophylaxis (prep) for hiv
102090|NCT03565575|Risk perception|risk perception
102092|NCT03565562|Health promotion|health promotion
102093|NCT03565562|Local authorities involvement|local authorities involvement
102094|NCT03565562|Suicide and attempted suicide|suicide and attempted suicide
102095|NCT03565562|Primary prevention|primary prevention
102096|NCT03565562|Psychological Distress|psychological distress
102097|NCT03565549|Brain|brain
102098|NCT03565549|Trauma|trauma
102099|NCT03565549|Medical education|medical education
102100|NCT03565549|Emergency department|emergency department
102101|NCT03565536|Nexavar|nexavar
102102|NCT03565536|Anaplastic Thyroid Cancer|anaplastic thyroid cancer
102103|NCT03565536|Neoadjuvant Treatment|neoadjuvant treatment
102104|NCT03565510|High-protein diet|high-protein diet
102105|NCT03565510|Energy metabolism|energy metabolism
102106|NCT03565484|Antimicrobial Susceptibility Testing|antimicrobial susceptibility testing
102107|NCT03565484|Rescue Therapy|rescue therapy
102108|NCT03565471|Atrial Septal Defect|atrial septal defect
102109|NCT03565471|Exercise Capacity|exercise capacity
102110|NCT03565471|Pulmonary Hypertension|pulmonary hypertension
102111|NCT03565471|Heart Rate Variability|heart rate variability
102112|NCT03565471|Congenital Heart Disease|congenital heart disease
102124|NCT03565432|work disability|work disability
102125|NCT03565432|quality of life|quality of life
102126|NCT03565432|psychosocial distress|psychosocial distress
102127|NCT03565393|Tolerability|tolerability
102128|NCT03565393|Acceptability|acceptability
102129|NCT03565393|Fibersol-2|fibersol-2
102130|NCT03565393|Children|children
102131|NCT03565380|Tai Chi|tai chi
102132|NCT03565380|Fall|fall
102133|NCT03565380|Balance|balance
102134|NCT03565380|Post operative|post operative
102135|NCT03565380|Elderly|elderly
102136|NCT03565354|Patient blood management|patient blood management
102137|NCT03565328|Mitochondrial bioenergetic dysfunction|mitochondrial bioenergetic dysfunction
102138|NCT03565328|Mitochondrial oxidative phosphorylation in sceletal muscles|mitochondrial oxidative phosphorylation in sceletal muscles
102139|NCT03565328|Hyperacetylation of mitochondrial bioenergetic enzymes|hyperacetylation of mitochondrial bioenergetic enzymes
102140|NCT03565328|NAD+ dependent sirtuin enzymes|nad+ dependent sirtuin enzymes
102141|NCT03565328|NAD+/NADH ratio|nad+/nadh ratio
102142|NCT03565315|HIV Prevention|hiv prevention
102143|NCT03565315|Broadly Neutralizing Monoclonal Antibodies|broadly neutralizing monoclonal antibodies
102244|NCT03564782|PVSRIPO|pvsripo
102144|NCT03565315|First in Human Study|first in human study
102145|NCT03565315|Anti-Drug Antibody Response to 10E8VLS or VRC07-523LS|anti-drug antibody response to 10e8vls or vrc07-523ls
102146|NCT03565302|Proteome|proteome
102147|NCT03565302|VO2max|vo2max
102148|NCT03565302|Muscle function|muscle function
102149|NCT03565302|Exercise performance|exercise performance
102150|NCT03565302|Skeletal muscle|skeletal muscle
102151|NCT03565302|Doping|doping
102152|NCT03565302|Anti-Doping|anti-doping
102153|NCT03565302|Enantiomeric analysis|enantiomeric analysis
102154|NCT03565276|Post partum hemorrhage|post partum hemorrhage
102155|NCT03565276|Tranexamic acid|tranexamic acid
102156|NCT03565276|TXA|txa
102157|NCT03565276|Dose-finding|dose-finding
102158|NCT03565276|Prevention|prevention
102159|NCT03565250|Attention Deficit Disorder with Hyperactivity|attention deficit disorder with hyperactivity
102160|NCT03565250|Self concept|self concept
102161|NCT03565250|Child|child
102162|NCT03565250|Neuropsychology|neuropsychology
102163|NCT03565224|Cervical vertebrae|cervical vertebrae
102164|NCT03565224|Postoperative complications|postoperative complications
102165|NCT03565224|Radiography|radiography
102166|NCT03565224|Spinal fusion|spinal fusion
102167|NCT03565224|Coating|coating
102168|NCT03565211|Progesterone vaginal ring (PVR)|progesterone vaginal ring (pvr)
102169|NCT03565211|Vaginal progesterone ring|vaginal progesterone ring
102170|NCT03565211|Assisted reproductive technology (ART)|assisted reproductive technology (art)
102171|NCT03565211|Infertility|infertility
102172|NCT03565172|cerebral palsy|cerebral palsy
102173|NCT03565172|stretching|stretching
102174|NCT03565172|isokinetic dynamometer|isokinetic dynamometer
102175|NCT03565172|ultrasound|ultrasound
102176|NCT03565172|ankle|ankle
102177|NCT03565172|children|children
102178|NCT03565107|Epigenetic|epigenetic
102179|NCT03565107|Female age|female age
102180|NCT03565107|Gene regulation|gene regulation
102181|NCT03565107|Methylation pattern|methylation pattern
102182|NCT03565081|Prader-Willi Syndrome|prader-willi syndrome
102183|NCT03565081|Resistance Training|resistance training
102184|NCT03565081|Body Composition|body composition
102185|NCT03565042|Arthritis, Psoriatic|arthritis, psoriatic
102186|NCT03565042|Mechanism of Action|mechanism of action
102187|NCT03565042|Ustekinumab|ustekinumab
102188|NCT03565042|anti-p40|anti-p40
102189|NCT03565042|anti-IL23/Il12 p40|anti-il23/il12 p40
102190|NCT03565029|rectal cancer|rectal cancer
102191|NCT03565029|neoadjuvant|neoadjuvant
102192|NCT03565029|non operative management|non operative management
102193|NCT03565016|Alcohol use disorders|alcohol use disorders
102194|NCT03565016|agitation|agitation
102195|NCT03565016|intensive care unit|intensive care unit
102196|NCT03565016|restlessness|restlessness
102197|NCT03565016|alcohol withdrawal syndrome|alcohol withdrawal syndrome
102198|NCT03565016|alcohol-dependence|alcohol-dependence
102199|NCT03565016|heavy drinking|heavy drinking
102200|NCT03565003|JAB-3068|jab-3068
102201|NCT03565003|SHP2|shp2
102202|NCT03565003|PTPN11|ptpn11
102203|NCT03565003|ESCC|escc
102204|NCT03565003|NSCLC|nsclc
102205|NCT03565003|HNSCC|hnscc
102206|NCT03565003|Colorectal cancer (CRC)|colorectal cancer (crc)
102207|NCT03565003|EGFR|egfr
102208|NCT03564977|CAR-T|car-t
102209|NCT03564977|minimal residual disease|minimal residual disease
102210|NCT03564977|B cell maliganacy|b cell maliganacy
102211|NCT03564964|SUVN-502|suvn-502
102212|NCT03564964|Expanded Access|expanded access
102213|NCT03564938|metastatic colorectal cancer|metastatic colorectal cancer
102214|NCT03564938|mCRC|mcrc
102215|NCT03564925|Atrial Fibrillation|atrial fibrillation
102216|NCT03564925|CryoAblation|cryoablation
102217|NCT03564925|pulmonary vein isolation|pulmonary vein isolation
102218|NCT03564925|wide area circumferential ablation|wide area circumferential ablation
102219|NCT03564925|contact force|contact force
102220|NCT03564899|Breast cancer|breast cancer
102221|NCT03564899|Survivorship|survivorship
102222|NCT03564899|Physical activity intervention|physical activity intervention
102223|NCT03564899|Activity trackers|activity trackers
102224|NCT03564899|Sedentary time|sedentary time
102225|NCT03564873|Omacetaxine|omacetaxine
102226|NCT03564873|Azacitidine|azacitidine
102227|NCT03564873|Previously Untreated|previously untreated
102228|NCT03564873|Phase I/II|phase i/ii
102229|NCT03564873|Dose Escalation|dose escalation
102230|NCT03564873|Maximum Tolerated Dose|maximum tolerated dose
102231|NCT03564847|Learning Through Play Plus|learning through play plus
102232|NCT03564847|Cognitive Behavior Therapy|cognitive behavior therapy
102233|NCT03564847|Parenting Intervention|parenting intervention
102234|NCT03564847|Low and middle-income country|low and middle-income country
102235|NCT03564834|Elderly patients|elderly patients
102236|NCT03564834|Open gastrectomy|open gastrectomy
102237|NCT03564834|Laparoscopic gastrectomy|laparoscopic gastrectomy
102238|NCT03564821|myeloid neoplasms|myeloid neoplasms
102239|NCT03564808|Contour defects, Pigmentation, Enriched fat grafting|contour defects, pigmentation, enriched fat grafting
102240|NCT03564795|Wound Dressing|wound dressing
102241|NCT03564795|Keratin|keratin
102242|NCT03564795|Hydrogel|hydrogel
102243|NCT03564795|Burn Dressing|burn dressing
102245|NCT03564782|Invasive Breast Cancer|invasive breast cancer
102246|NCT03564769|screening|screening
102247|NCT03564756|Anemia|anemia
102248|NCT03564756|Pregnancy|pregnancy
102249|NCT03564756|Iron|iron
102250|NCT03564756|Vitamin C|vitamin c
102251|NCT03564743|Spondyloarthritis|spondyloarthritis
102252|NCT03564743|ASAS criteria|asas criteria
102253|NCT03564743|Diagnosis criteria|diagnosis criteria
102254|NCT03564743|Classification criteria|classification criteria
102255|NCT03564730|Bilateral, staged, simultaneous|bilateral, staged, simultaneous
102256|NCT03564691|PD1|pd1
102257|NCT03564691|PD-1|pd-1
102258|NCT03564691|PDL1|pdl1
102259|NCT03564691|PD-L1|pd-l1
102260|NCT03564613|HIV|hiv
102261|NCT03564613|Dolutegravir|dolutegravir
102262|NCT03564613|Europe|europe
102263|NCT03564613|NEAT ID|neat id
102264|NCT03564613|pregnancy|pregnancy
102265|NCT03564613|Safety|safety
102266|NCT03564613|Antiretroviral|antiretroviral
102267|NCT03564600|low back pain|low back pain
102268|NCT03564587|Cancer Survivors|cancer survivors
102269|NCT03564587|Adolescent|adolescent
102270|NCT03564587|Achieving Wellness After Kancer in Early Life|achieving wellness after kancer in early life
102271|NCT03564587|AWAKE|awake
102272|NCT03564587|Health-Promoting Behaviors|health-promoting behaviors
102273|NCT03564561|glycogen storage disease type II, adult|glycogen storage disease type ii, adult
102274|NCT03564561|Pompe disease|pompe disease
102275|NCT03564561|clinical evolution|clinical evolution
102276|NCT03564561|molecular evolution|molecular evolution
102277|NCT03564561|follow-up|follow-up
102278|NCT03564561|c.-32-13T>G mutation|c.-32-13t>g mutation
102279|NCT03564561|antisense oligonucleotide treatment|antisense oligonucleotide treatment
102280|NCT03564561|in vitro|in vitro
102281|NCT03564535|Adult|adult
102282|NCT03564535|Inguinal hernia|inguinal hernia
102283|NCT03564535|Inflammatory|inflammatory
102284|NCT03564535|Surgical Mesh|surgical mesh
102285|NCT03564535|Laparoscopy/Methods|laparoscopy/methods
102286|NCT03564535|Postoperative pain|postoperative pain
102287|NCT03564535|Recurrence|recurrence
102288|NCT03564535|Randomized Controlled Trials|randomized controlled trials
102289|NCT03564535|Double-Blind Method|double-blind method
102290|NCT03564535|Pain|pain
102291|NCT03564535|Chronic pain|chronic pain
102292|NCT03564535|Seroma|seroma
102293|NCT03564535|Total extraperitoneal repair|total extraperitoneal repair
102294|NCT03564535|Tacker|tacker
102295|NCT03564535|Mesh fixation|mesh fixation
102296|NCT03564535|Self gripping|self gripping
102297|NCT03564509|Human Chorionic Gonadotropin (hCG)|human chorionic gonadotropin (hcg)
102298|NCT03564509|Recombinant Human Chorionic Gonadotropin (rhCG)|recombinant human chorionic gonadotropin (rhcg)
102299|NCT03564509|Controlled Ovarian Stimulation (COS)|controlled ovarian stimulation (cos)
102300|NCT03564509|Assisted Reproductive Technologies (ART)|assisted reproductive technologies (art)
102301|NCT03564496|Anodal transcranial stimulation (tDCS)|anodal transcranial stimulation (tdcs)
102302|NCT03564470|Acute Lymphoblastic Leukemia|acute lymphoblastic leukemia
102303|NCT03564470|Ph-like|ph-like
102304|NCT03564470|Tyrosine Kinase Inhibitor|tyrosine kinase inhibitor
102305|NCT03564470|Histone Deacetylase Inhibitor|histone deacetylase inhibitor
102306|NCT03564444|Bivalent.|bivalent.
102307|NCT03564444|Influenza.|influenza.
102308|NCT03564444|FluMist Quadrivalent.|flumist quadrivalent.
102309|NCT03564444|Vaccine Prevention in Healthy Adults.|vaccine prevention in healthy adults.
102310|NCT03564353|transcranial Direct Current Stimulation (tDCS)|transcranial direct current stimulation (tdcs)
102311|NCT03564353|memory|memory
102312|NCT03564314|Acute kidney injury|acute kidney injury
102313|NCT03564314|Major surgery|major surgery
102314|NCT03564314|Clinical decision support|clinical decision support
102315|NCT03564301|Peri-implantitis|peri-implantitis
102316|NCT03564301|antibiotics|antibiotics
102317|NCT03564301|Metronidazole|metronidazole
102318|NCT03564301|non- surgical treatment|non- surgical treatment
102319|NCT03564275|Radiation Therapy|radiation therapy
102320|NCT03564275|Proton Therapy|proton therapy
102321|NCT03564223|Adolescent|adolescent
102322|NCT03564223|Parental concerns|parental concerns
102323|NCT03564223|Child Health|child health
102324|NCT03564223|Paediatrician Concerns|paediatrician concerns
102325|NCT03564210|screen time|screen time
102326|NCT03564197|EGFR WT|egfr wt
102327|NCT03564197|negative EML4-ALK fusion|negative eml4-alk fusion
102328|NCT03564197|eligible for first line chemo-immunotherapy or 2nd line and beyond PD-(L)1 immunotherapy monotherapy|eligible for first line chemo-immunotherapy or 2nd line and beyond pd-(l)1 immunotherapy monotherapy
102329|NCT03564184|Parent-infant bonding|parent-infant bonding
102330|NCT03564184|Music therapy|music therapy
102331|NCT03564132|Yigansan|yigansan
102332|NCT03564132|YGTSS|ygtss
102333|NCT03564119|papulopustular rosacea|papulopustular rosacea
102334|NCT03564106|chronic sacroilitis,radiofrequancy,intraarticular steroids injection|chronic sacroilitis,radiofrequancy,intraarticular steroids injection
102335|NCT03564093|pediatrics|pediatrics
102336|NCT03564093|sedation|sedation
102337|NCT03564093|emergency room sedation|emergency room sedation
102338|NCT03564093|intranasal sedation|intranasal sedation
102339|NCT03564093|dexmedetomidine|dexmedetomidine
103137|NCT03559140|pain|pain
102340|NCT03564093|intranasal dexmedetomidine|intranasal dexmedetomidine
102341|NCT03564093|children|children
102342|NCT03564093|pediatric|pediatric
102343|NCT03564093|pediatric sedation|pediatric sedation
102344|NCT03564080|exercise rehabilitation|exercise rehabilitation
102345|NCT03564080|supervised exercise programmes|supervised exercise programmes
102347|NCT03564067|tDCS|tdcs
102348|NCT03564067|cCBT|ccbt
102349|NCT03564067|Home-based tDCS-cCBT|home-based tdcs-ccbt
102350|NCT03564054|non small cell lung cancer|non small cell lung cancer
102351|NCT03564054|photodynamic therapy|photodynamic therapy
102352|NCT03564054|argon plasma coagulation|argon plasma coagulation
102353|NCT03564054|endobronchial obstruction|endobronchial obstruction
102354|NCT03564041|depression|depression
102355|NCT03564041|late-life|late-life
102356|NCT03564041|executive functioning|executive functioning
102357|NCT03564041|sahaj samadhi|sahaj samadhi
102358|NCT03564041|meditation|meditation
102359|NCT03564041|treatment-resistant|treatment-resistant
102360|NCT03564028|COPD|copd
102361|NCT03564028|daily activity|daily activity
102362|NCT03564028|stair climbing|stair climbing
102363|NCT03564028|rehabilitation|rehabilitation
102364|NCT03563989|Chronic total occlusion|chronic total occlusion
102365|NCT03563989|Self-expandable stent|self-expandable stent
102366|NCT03563989|Percutaneous coronary intervention|percutaneous coronary intervention
102367|NCT03563989|Coronary artery disease|coronary artery disease
102368|NCT03563976|Early Stage Lung Cancer|early stage lung cancer
102369|NCT03563872|hypertension|hypertension
102370|NCT03563872|team-based|team-based
102371|NCT03563872|guidelines|guidelines
102372|NCT03563872|implementation|implementation
102373|NCT03563833|Minimal Flow Anesthesia|minimal flow anesthesia
102374|NCT03563833|Thiol/disulfide balance|thiol/disulfide balance
102375|NCT03563833|Tissue oxygen saturation|tissue oxygen saturation
102376|NCT03563833|hypotensive anesthesia|hypotensive anesthesia
102377|NCT03563820|Positive Psychology|positive psychology
102378|NCT03563820|Resilience|resilience
102379|NCT03563820|Well-Being|well-being
102380|NCT03563781|ovarian cancer|ovarian cancer
102381|NCT03563781|laparoscopy|laparoscopy
102382|NCT03563781|sentinel node|sentinel node
102383|NCT03563781|lymphadenectomy|lymphadenectomy
102384|NCT03563768|coronary artery disease|coronary artery disease
102385|NCT03563768|aortic atherosclerotic disease|aortic atherosclerotic disease
102386|NCT03563768|one-stop|one-stop
102387|NCT03563768|endovascular aortic repair|endovascular aortic repair
102388|NCT03563768|percutaneous coronary intervention|percutaneous coronary intervention
102389|NCT03563742|Treatment-naive|treatment-naive
102390|NCT03563742|rilpivirine|rilpivirine
102391|NCT03563742|India|india
102392|NCT03563729|Immune therapy|immune therapy
102393|NCT03563729|checkpoint inhibitor|checkpoint inhibitor
102394|NCT03563729|pembrolizumab|pembrolizumab
102395|NCT03563729|ipilimumab|ipilimumab
102396|NCT03563729|nivolumab|nivolumab
102397|NCT03563729|steroid|steroid
102398|NCT03563729|brain metastasis|brain metastasis
102399|NCT03563703|Catheterization, Peripheral|catheterization, peripheral
102400|NCT03563703|Ultrasound|ultrasound
102401|NCT03563703|Near Infrared Light|near infrared light
102402|NCT03563690|KOA|koa
102403|NCT03563690|Acupuncture treatment|acupuncture treatment
102404|NCT03563690|Multi-center RCT|multi-center rct
102405|NCT03563677|psychosomatic|psychosomatic
102406|NCT03563677|unclear diagnosis|unclear diagnosis
102407|NCT03563625|Local anesthetic|local anesthetic
102408|NCT03563625|Hernioraphy|hernioraphy
102409|NCT03563625|Wound healing|wound healing
102410|NCT03563612|one lung ventilation|one lung ventilation
102411|NCT03563612|continuous positive airway pressure|continuous positive airway pressure
102412|NCT03563612|differential lung ventilation|differential lung ventilation
102413|NCT03563586|oral antibiotic|oral antibiotic
102414|NCT03563586|mechanical bowel preparation|mechanical bowel preparation
102415|NCT03563586|colorectal cancer|colorectal cancer
102416|NCT03563586|surgical site infection|surgical site infection
102417|NCT03563573|Conditions in which lidocaine is ineffective|conditions in which lidocaine is ineffective
102418|NCT03563560|Newly diagnosed AML|newly diagnosed aml
102419|NCT03563560|Relapsed/refractory AML|relapsed/refractory aml
102420|NCT03563560|Alvocidib|alvocidib
102421|NCT03563547|LDL-Cholesterol|ldl-cholesterol
102422|NCT03563547|Heterozygous Familial Hypercholesterolemia|heterozygous familial hypercholesterolemia
102423|NCT03563547|Paediatrics|paediatrics
102424|NCT03563547|Dietary Treatment|dietary treatment
102425|NCT03563534|Silver diamine fluoride, dental caries children|silver diamine fluoride, dental caries children
102426|NCT03563521|severe asthma|severe asthma
102427|NCT03563521|inflammatory phenotypes|inflammatory phenotypes
102428|NCT03563521|serum cytokines|serum cytokines
102429|NCT03563521|eosinophilia|eosinophilia
102430|NCT03563521|atopy|atopy
102431|NCT03563521|chronic rhinosinusitis with nasal polyposis|chronic rhinosinusitis with nasal polyposis
102432|NCT03563508|cone beam computed tomography|cone beam computed tomography
102433|NCT03563508|maxillary premolars|maxillary premolars
102434|NCT03563508|root canal anatomy|root canal anatomy
102435|NCT03563508|root canal morphology|root canal morphology
102436|NCT03563508|Egyptian population|egyptian population
102437|NCT03563495|tissue engineering.|tissue engineering.
102438|NCT03563495|stem cells.|stem cells.
102439|NCT03563495|autogenous grafts.|autogenous grafts.
102440|NCT03563456|structured exercise|structured exercise
102441|NCT03563456|glycemic control|glycemic control
102442|NCT03563456|Type 2 Diabetes Mellitus|type 2 diabetes mellitus
102443|NCT03563456|interval training|interval training
102444|NCT03563456|resistance training|resistance training
102445|NCT03563456|oxydative stress|oxydative stress
102446|NCT03563456|physical fitness|physical fitness
102447|NCT03563443|Bladder Cancer|bladder cancer
102448|NCT03563443|Genomic imprinting|genomic imprinting
102449|NCT03563443|Urine biomarker|urine biomarker
102450|NCT03563443|Diagnosis|diagnosis
102451|NCT03563443|Surveillance|surveillance
102452|NCT03563430|foam roller|foam roller
102453|NCT03563430|electrical stimulation|electrical stimulation
102454|NCT03563430|low intensity aerobic training|low intensity aerobic training
102455|NCT03563430|lactate removal|lactate removal
102456|NCT03563326|Epithelial Cell Adhesion Molecule|epithelial cell adhesion molecule
102457|NCT03563326|Chimeric Antigen Receptor-modified T cell|chimeric antigen receptor-modified t cell
102458|NCT03563326|Gastric carcinoma|gastric carcinoma
102459|NCT03563326|Peritoneal metastasis|peritoneal metastasis
102460|NCT03563313|Artificial Pancreas (AP)|artificial pancreas (ap)
102461|NCT03563313|Type 1 Diabetes Mellitus|type 1 diabetes mellitus
102462|NCT03563313|Insulin Pump|insulin pump
102463|NCT03563313|Continuous Glucose Monitor (CGM)|continuous glucose monitor (cgm)
102464|NCT03563313|Closed Loop Control (CLC)|closed loop control (clc)
102465|NCT03563313|Sensor-Augmented Pump (SAP)|sensor-augmented pump (sap)
102466|NCT03563274|Hepatocellular Carcinoma,Holmium-166,SIRT,QuiremSpheres®|hepatocellular carcinoma,holmium-166,sirt,quiremspheres®
102467|NCT03563261|Older Adults|older adults
102468|NCT03563261|Collagen supplementation|collagen supplementation
102469|NCT03563261|Locomotor behaviour|locomotor behaviour
102470|NCT03563248|Pancreatic Cancer|pancreatic cancer
102471|NCT03563235|Osteoporosis|osteoporosis
102472|NCT03563235|kidney deficiency and blood stasis syndrome|kidney deficiency and blood stasis syndrome
102473|NCT03563235|Xuling Jiangu Granules|xuling jiangu granules
102474|NCT03563222|Parenteral nutrition|parenteral nutrition
102475|NCT03563222|Pediatrics|pediatrics
102476|NCT03563222|Malnutrition|malnutrition
102477|NCT03563222|Nutritional needs|nutritional needs
102478|NCT03563209|Elbow spasticity|elbow spasticity
102479|NCT03563209|Stroke|stroke
102480|NCT03563183|immunogenicity|immunogenicity
102481|NCT03563183|Herpes Zoster|herpes zoster
102482|NCT03563183|efficacy|efficacy
102483|NCT03563183|safety|safety
102484|NCT03563183|frailty|frailty
102485|NCT03563183|Shingles vaccine|shingles vaccine
102486|NCT03563170|HCC|hcc
102487|NCT03563157|Colorectal Cancer|colorectal cancer
102488|NCT03563157|Metastatic Colorectal Cancer|metastatic colorectal cancer
102489|NCT03563131|Osteoarthritis|osteoarthritis
102490|NCT03563131|Knee|knee
102491|NCT03563131|Arthroplasties|arthroplasties
102492|NCT03563118|Prolidase Activity|prolidase activity
102493|NCT03563118|Obstructive Sleep-Apnea Syndrome|obstructive sleep-apnea syndrome
102494|NCT03563105|tissue oxygen saturation|tissue oxygen saturation
102495|NCT03563092|Complete Inguinal Hernia|complete inguinal hernia
102496|NCT03563092|Inguinoscrotal Hernia|inguinoscrotal hernia
102497|NCT03563092|Laparoscopic hernia repair|laparoscopic hernia repair
102498|NCT03563079|Handling, Musculoskeletal|handling, musculoskeletal
102499|NCT03563079|Tissue, Subcutaneous|tissue, subcutaneous
102500|NCT03563079|Myofascial Release|myofascial release
102501|NCT03563079|Instrument-Mobilized Soft Tissue Mobilization|instrument-mobilized soft tissue mobilization
102502|NCT03563066|Skin Lesions|skin lesions
102503|NCT03563066|Benralizumab|benralizumab
102504|NCT03563066|Eosinophils|eosinophils
102505|NCT03563066|Intra-dermal challenge|intra-dermal challenge
102506|NCT03563066|Anti-inflammatory agents|anti-inflammatory agents
102507|NCT03563066|Physiological Effects of Drugs|physiological effects of drugs
102508|NCT03563027|Physical activity|physical activity
102509|NCT03563027|Incentive|incentive
102510|NCT03563027|Wearable device|wearable device
102511|NCT03563027|Gamification|gamification
102512|NCT03563014|Radium-223|radium-223
102513|NCT03563014|Metastatic castration-resistant prostate cancer|metastatic castration-resistant prostate cancer
102514|NCT03563014|CRPC|crpc
102515|NCT03563014|Phase IV|phase iv
102516|NCT03563001|chronic obstructive pulmonary disease|chronic obstructive pulmonary disease
102517|NCT03563001|asthma-chronic obstructive pulmonary disease overlap|asthma-chronic obstructive pulmonary disease overlap
102518|NCT03563001|small airway|small airway
102519|NCT03563001|quality of life|quality of life
102520|NCT03562962|Functional Analytic Psychotherapy|functional analytic psychotherapy
102521|NCT03562962|Process-Outcome Psychotherapies|process-outcome psychotherapies
102522|NCT03562962|Mechanism of change|mechanism of change
102523|NCT03562962|Interpersonal Functioning|interpersonal functioning
102524|NCT03562962|Psychological Distress|psychological distress
102525|NCT03562962|Contingencies of reinforcement|contingencies of reinforcement
102526|NCT03562936|LSS,DS|lss,ds
102527|NCT03562897|Dietary supplements|dietary supplements
102546|NCT03562819|Epidermal Growth Factor Receptor|epidermal growth factor receptor
102547|NCT03562793|pain|pain
102548|NCT03562793|healthcare disparities|healthcare disparities
102549|NCT03562793|communication|communication
102550|NCT03562767|Culturally-Tailored Cognitive Behavior intervention (CT-CB)|culturally-tailored cognitive behavior intervention (ct-cb)
102551|NCT03562767|Family Practice|family practice
102552|NCT03562767|Diabetes|diabetes
102553|NCT03562728|Transplant|transplant
102554|NCT03562728|ECMO|ecmo
102555|NCT03562728|Sarcopenia|sarcopenia
102556|NCT03562728|Deconditioning|deconditioning
102557|NCT03562728|Physical therapy|physical therapy
102558|NCT03562715|microRNAs|micrornas
102559|NCT03562715|exosomes|exosomes
102560|NCT03562715|preeclampsia|preeclampsia
102561|NCT03562715|mesenchymal stem cells|mesenchymal stem cells
102562|NCT03562702|vomiting|vomiting
102563|NCT03562702|diarrhea|diarrhea
102564|NCT03562689|Sepsis|sepsis
102565|NCT03562689|Encephalopathy|encephalopathy
102566|NCT03562689|Delirium|delirium
102567|NCT03562689|ICU|icu
102568|NCT03562689|EEG|eeg
102569|NCT03562689|MRI|mri
102570|NCT03562689|Cognitive tests|cognitive tests
102571|NCT03562663|robotics|robotics
102572|NCT03562663|transcranial direct current stimulation|transcranial direct current stimulation
102573|NCT03562663|neurorehabilitation|neurorehabilitation
102574|NCT03562663|transcranial magnetic stimulation|transcranial magnetic stimulation
102575|NCT03562637|Neoadjuvant chemotherapy|neoadjuvant chemotherapy
102576|NCT03562637|Adjuvant chemotherapy|adjuvant chemotherapy
102577|NCT03562637|TNBC|tnbc
102578|NCT03562611|postoperative pain|postoperative pain
102579|NCT03562611|general anesthesia|general anesthesia
102580|NCT03562611|postoperative discomfort|postoperative discomfort
102581|NCT03562585|Chronic hepatitis B|chronic hepatitis b
102582|NCT03562585|Alanine Aminotransferase|alanine aminotransferase
102583|NCT03562585|Aspartate Aminotransferase|aspartate aminotransferase
102584|NCT03562559|Total Knee Arthroplasty|total knee arthroplasty
102585|NCT03562559|Adductor Canal Block|adductor canal block
102586|NCT03562546|CVI|cvi
102587|NCT03562546|Calf Muscle Pump Function|calf muscle pump function
102588|NCT03562546|Structured Exercise|structured exercise
102589|NCT03562546|Varicose Veins|varicose veins
102590|NCT03562520|Aerobic fitness|aerobic fitness
102591|NCT03562520|Aerobic exercise|aerobic exercise
102592|NCT03562520|Behavior change counseling|behavior change counseling
102593|NCT03562507|ESK981|esk981
102594|NCT03562494|PD, Parkinson's disease|pd, parkinson's disease
102595|NCT03562494|Aromatic L-Amino Acid Decarboxylase|aromatic l-amino acid decarboxylase
102596|NCT03562494|AADC|aadc
102597|NCT03562494|AAV2-AADC|aav2-aadc
102598|NCT03562494|AAV2|aav2
102599|NCT03562494|VY-AADC|vy-aadc
102600|NCT03562494|AAV2-hAADC|aav2-haadc
102601|NCT03562481|Healthy pediatric volunteers|healthy pediatric volunteers
102602|NCT03562468|Nicotinamide riboside|nicotinamide riboside
102603|NCT03562468|NAD|nad
102604|NCT03562468|TRU NIAGEN|tru niagen
102605|NCT03562455|Virtual Reality|virtual reality
102606|NCT03562455|Wheelchairs|wheelchairs
102607|NCT03562403|deep brain stimulation|deep brain stimulation
102608|NCT03562364|anti-gravity|anti-gravity
102609|NCT03562338|chronic nonspecific neck pain|chronic nonspecific neck pain
102610|NCT03562338|disability|disability
102611|NCT03562338|predictive model|predictive model
102612|NCT03562338|rehabilitation|rehabilitation
102613|NCT03562338|pain intensity|pain intensity
102614|NCT03562312|MPA|mpa
102615|NCT03562312|Music Performance Anxiety|music performance anxiety
102616|NCT03562312|HIIT|hiit
102617|NCT03562312|Exercise|exercise
102618|NCT03562312|Cortisol|cortisol
102619|NCT03562312|HRV|hrv
102620|NCT03562312|Heart Rate|heart rate
102621|NCT03562286|Open spina bifida|open spina bifida
102622|NCT03562286|spinal dysraphism|spinal dysraphism
102623|NCT03562273|Breast Nomogram|breast nomogram
102624|NCT03562273|Breast Cancer Quality of Life|breast cancer quality of life
102625|NCT03562273|GammaPod Registry|gammapod registry
102626|NCT03562234|Colorectal Cancer|colorectal cancer
102627|NCT03562234|Colorectal Liver Metastases|colorectal liver metastases
102628|NCT03562234|Obesity Related Cancer|obesity related cancer
102629|NCT03562234|Chemotherapy|chemotherapy
102630|NCT03562221|coeliac disease|coeliac disease
102631|NCT03562221|celiac disease autoimmunity|celiac disease autoimmunity
102632|NCT03562208|Diabetes Mellitus|diabetes mellitus
102633|NCT03562208|Bone Marrow|bone marrow
102634|NCT03562208|Transplant|transplant
102635|NCT03562195|Eosinophilic inflammation|eosinophilic inflammation
102636|NCT03562195|Mepolizumab|mepolizumab
102637|NCT03562195|Asthma|asthma
102638|NCT03562143|Iron|iron
102639|NCT03562143|Deficiency|deficiency
102640|NCT03562143|Anemia|anemia
102641|NCT03562143|Supplementation|supplementation
102642|NCT03562143|Pregnancy|pregnancy
102643|NCT03562130|Teduglutide|teduglutide
102644|NCT03562130|Short Bowel Syndrome|short bowel syndrome
102645|NCT03562130|Parenteral nutrition|parenteral nutrition
102646|NCT03562130|Intestinal failure|intestinal failure
102647|NCT03562117|Child-Pugh classification|child-pugh classification
102648|NCT03562117|Open label|open label
102649|NCT03562117|Hepatic Impairment|hepatic impairment
102650|NCT03562117|Gepotidacin|gepotidacin
102651|NCT03562078|Tai Chi Quan|tai chi quan
102652|NCT03562078|HbA1c|hba1c
102653|NCT03562078|quality of life|quality of life
102654|NCT03562052|Cancer|cancer
102655|NCT03562052|Lung|lung
102656|NCT03562052|Occupational carcinogens|occupational carcinogens
102657|NCT03562052|Tobacco smoking|tobacco smoking
102658|NCT03562052|Screening|screening
102659|NCT03562052|Chest CT Scan|chest ct scan
102660|NCT03562052|Asbestos|asbestos
102661|NCT03562000|ICU|icu
102662|NCT03562000|Cough|cough
102663|NCT03562000|Randomised study|randomised study
102664|NCT03562000|Cough assistance|cough assistance
102665|NCT03562000|Medical device|medical device
102666|NCT03562000|Physiotherapy|physiotherapy
102667|NCT03561987|ADIPOSE TISSUE, CARDIOVASCULAR, OBESE PATIENTS|adipose tissue, cardiovascular, obese patients
102668|NCT03561948|intraperitoneal chemotherapy|intraperitoneal chemotherapy
102669|NCT03561948|Peritoneal Carcinomatosis|peritoneal carcinomatosis
102670|NCT03561948|Colonic Diseases|colonic diseases
102671|NCT03561922|Retinal Degeneration|retinal degeneration
102672|NCT03561922|Artificial Vision|artificial vision
102673|NCT03561922|Retinal Prosthesis|retinal prosthesis
102674|NCT03561922|Subretinal Implant|subretinal implant
102675|NCT03561922|Inherited Retinal Dystrophy|inherited retinal dystrophy
102676|NCT03561922|Vision Restoration|vision restoration
102677|NCT03561922|Bionic Eye|bionic eye
102678|NCT03561922|Bionic Vision|bionic vision
102679|NCT03561922|Retinitis Pigmentosa|retinitis pigmentosa
102680|NCT03561922|Artificial Retina|artificial retina
102681|NCT03561922|Retina Implant|retina implant
102682|NCT03561922|Cone-Rod Dystrophy|cone-rod dystrophy
102683|NCT03561922|Choroideremia|choroideremia
102684|NCT03561922|Retinopathia Pigmentosa|retinopathia pigmentosa
102685|NCT03561896|Radation therapy|radation therapy
102686|NCT03561896|sterotactic radiosurgery|sterotactic radiosurgery
102687|NCT03561896|quality of life|quality of life
102688|NCT03561896|solid cancer|solid cancer
102689|NCT03561896|palliation|palliation
102690|NCT03561896|neurologic functionning|neurologic functionning
102691|NCT03561883|Gastroesophageal Reflux Disease|gastroesophageal reflux disease
102692|NCT03561883|GERD|gerd
102693|NCT03561883|Proton Pump Inhibitor|proton pump inhibitor
102694|NCT03561883|IW-3718|iw-3718
102695|NCT03561870|IDH-mutant|idh-mutant
102696|NCT03561870|recurrent|recurrent
102697|NCT03561870|glioma|glioma
102698|NCT03561805|TAVI|tavi
102699|NCT03561805|ECG monitoring|ecg monitoring
102700|NCT03561779|Osteoarthritis|osteoarthritis
102701|NCT03561753|Tuberculosis|tuberculosis
102702|NCT03561740|breast cancer|breast cancer
102703|NCT03561740|HER2-positive|her2-positive
102704|NCT03561740|metronomic chemotherapy|metronomic chemotherapy
102705|NCT03561740|capecitabine|capecitabine
102706|NCT03561740|high-risk|high-risk
102707|NCT03561727|incisional hernia|incisional hernia
102708|NCT03561727|malignancy|malignancy
102709|NCT03561727|transverse incision|transverse incision
102710|NCT03561727|abdominal closure|abdominal closure
102711|NCT03561727|surgical technique|surgical technique
102712|NCT03561727|insicion|insicion
102713|NCT03561727|surgery|surgery
102714|NCT03561688|Biomechanics|biomechanics
102715|NCT03561688|Pain|pain
102716|NCT03561688|Gait|gait
102717|NCT03561688|Foot orthotics|foot orthotics
102718|NCT03561688|Rheumatoid Arthritis|rheumatoid arthritis
102719|NCT03561675|healthy participants older than 40 years|healthy participants older than 40 years
102720|NCT03561675|altitude|altitude
102721|NCT03561675|prevention|prevention
102722|NCT03561675|acetazolamide|acetazolamide
102723|NCT03561662|soya|soya
102724|NCT03561662|menopause|menopause
102725|NCT03561662|cognitive function|cognitive function
102726|NCT03561662|isoflavones|isoflavones
102727|NCT03561649|TNF inhibitor|tnf inhibitor
102728|NCT03561649|Adalimumab|adalimumab
102729|NCT03561649|Spondyloarthritis|spondyloarthritis
102730|NCT03561649|Biomarkers analysis|biomarkers analysis
102731|NCT03561649|Personalized medicine|personalized medicine
102732|NCT03561636|Health literacy|health literacy
102733|NCT03561610|cancer cachexia|cancer cachexia
102734|NCT03561610|malnutrition|malnutrition
102741|NCT03561584|Cholangitis|cholangitis
102742|NCT03561571|chylomicrons|chylomicrons
102743|NCT03561571|Very Low Density Lipoprotein|very low density lipoprotein
102744|NCT03561571|saturated fat|saturated fat
102745|NCT03561571|platelet function|platelet function
102746|NCT03561571|type 2 diabetes|type 2 diabetes
102747|NCT03561571|post prandial phase|post prandial phase
102748|NCT03561558|Bioequivalence|bioequivalence
102749|NCT03561441|Endoscopic retrograde pancreatocholangiography|endoscopic retrograde pancreatocholangiography
102750|NCT03561441|Pancreatitis|pancreatitis
102751|NCT03561441|Lactate ringer's solution|lactate ringer's solution
102752|NCT03561441|Tailored therapy|tailored therapy
102753|NCT03561428|lichen sclerosus|lichen sclerosus
102754|NCT03561415|Lung transplant, prophylaxis, pre-emptive|lung transplant, prophylaxis, pre-emptive
102755|NCT03561402|biomarker|biomarker
102756|NCT03561402|teriflunomide|teriflunomide
102757|NCT03561402|activity|activity
102759|NCT03561363|insulin sensitivity|insulin sensitivity
102760|NCT03561363|high-fat diet|high-fat diet
102761|NCT03561350|Microsatellite Instability|microsatellite instability
102762|NCT03561350|Circulating Tumor DNA|circulating tumor dna
102763|NCT03561350|Colorectal Neoplasms|colorectal neoplasms
102764|NCT03561298|Pharmacokinetics|pharmacokinetics
102765|NCT03561298|Healthy subjects|healthy subjects
102766|NCT03561259|Iobenguane Avid High-risk Neuroblastoma|iobenguane avid high-risk neuroblastoma
102767|NCT03561259|3-Iodobenzylguanidine|3-iodobenzylguanidine
102768|NCT03561259|Radiopharmaceutical|radiopharmaceutical
102769|NCT03561246|Stroke|stroke
102770|NCT03561246|Rehabilitation|rehabilitation
102771|NCT03561246|Walking|walking
102772|NCT03561246|Biomechanics|biomechanics
102773|NCT03561220|Prostate Cancer|prostate cancer
102774|NCT03561220|Proton Radiation|proton radiation
102775|NCT03561220|Photon Radiation|photon radiation
102776|NCT03561220|Cancer of the Prostate|cancer of the prostate
102777|NCT03561168|Pediatric|pediatric
102778|NCT03561168|MRI Indications|mri indications
102779|NCT03561168|Anesthesia|anesthesia
102780|NCT03561168|Anesthetic Neurotoxicity|anesthetic neurotoxicity
102781|NCT03561168|MRI Diagnostic Yield|mri diagnostic yield
102782|NCT03561155|Upper Extremity|upper extremity
102783|NCT03561155|Recovery|recovery
102784|NCT03561116|Metabolic Syndrome|metabolic syndrome
102785|NCT03561116|Xanthohumol|xanthohumol
102786|NCT03561116|Glucose metabolism|glucose metabolism
102787|NCT03561116|DNA damage|dna damage
102788|NCT03561090|Gastroesophageal Reflux Disease|gastroesophageal reflux disease
102789|NCT03561090|GERD|gerd
102790|NCT03561090|Proton Pump Inhibitors|proton pump inhibitors
102791|NCT03561090|IW-3718|iw-3718
102792|NCT03561077|Pain|pain
102793|NCT03561077|Pediatrics|pediatrics
102794|NCT03561077|Mindfulness|mindfulness
102795|NCT03561077|Adolescents|adolescents
102796|NCT03561064|cancer|cancer
102797|NCT03561064|insomnia|insomnia
102798|NCT03561064|CBT|cbt
102799|NCT03561064|CBT-I|cbt-i
102800|NCT03561064|cognitive behavioral therapy|cognitive behavioral therapy
102801|NCT03561051|T-MACS|t-macs
102802|NCT03561051|Pre-hospital environment|pre-hospital environment
102803|NCT03561025|Diagnostic Imaging|diagnostic imaging
102804|NCT03561025|Positron Emission Tomography Computed Tomography|positron emission tomography computed tomography
102805|NCT03561025|Magnetic Resonance Imaging|magnetic resonance imaging
102806|NCT03561012|health|health
102807|NCT03561012|nutrition|nutrition
102808|NCT03561012|pregnancy|pregnancy
102809|NCT03561012|infant|infant
102810|NCT03561012|child|child
102811|NCT03560986|Neridronic Acid|neridronic acid
102812|NCT03560986|Neridronate|neridronate
102813|NCT03560986|CRPS|crps
102814|NCT03560986|RSD (reflex sympathetic dystrophy)|rsd (reflex sympathetic dystrophy)
102822|NCT03560947|chronic nonspecific neck pain|chronic nonspecific neck pain
102823|NCT03560947|exercise|exercise
102824|NCT03560947|manual therapy|manual therapy
102825|NCT03560921|biomarkers|biomarkers
102826|NCT03560908|leukemia,myeloid, acute|leukemia,myeloid, acute
102827|NCT03560908|relapse|relapse
102828|NCT03560908|mutation|mutation
102829|NCT03560908|KIT|kit
102830|NCT03560908|dasatinib|dasatinib
102831|NCT03560882|atorvastatin|atorvastatin
102832|NCT03560882|p53|p53
102833|NCT03560882|tumor resection|tumor resection
102834|NCT03560869|Dehydration|dehydration
102835|NCT03560843|MBSR, TBI, insomnia|mbsr, tbi, insomnia
102836|NCT03560817|QALY|qaly
102837|NCT03560817|Cost-utility analysis|cost-utility analysis
102839|NCT03560817|Discrete choice experiment method|discrete choice experiment method
102840|NCT03560804|olmesartan|olmesartan
102841|NCT03560804|chlorthalidone|chlorthalidone
102842|NCT03560804|hemodynamics|hemodynamics
102843|NCT03560778|Urinary Bladder, Overactive|urinary bladder, overactive
102844|NCT03560778|Urinary Incontinence, Urge|urinary incontinence, urge
102845|NCT03560778|Urodynamics|urodynamics
102846|NCT03560765|Rehabilitation|rehabilitation
102847|NCT03560765|Assistive technology|assistive technology
102848|NCT03560739|Relapsing Multiple Sclerosis|relapsing multiple sclerosis
102849|NCT03560739|Relapsing-remitting Multiple Sclerosis|relapsing-remitting multiple sclerosis
102850|NCT03560739|Secondary progressive Multiple Sclerosis|secondary progressive multiple sclerosis
102851|NCT03560739|Bioequivalence|bioequivalence
102852|NCT03560739|Pharmacokinetics|pharmacokinetics
102853|NCT03560739|Neurofilament light chain|neurofilament light chain
102854|NCT03560739|Pre-filled Syringe|pre-filled syringe
102855|NCT03560739|Auto-injector|auto-injector
102857|NCT03560687|Heart Surgery|heart surgery
102858|NCT03560687|Iron Supplementation|iron supplementation
102859|NCT03560674|Dental trauma|dental trauma
102860|NCT03560674|emergency management|emergency management
102861|NCT03560674|traumatic injures.|traumatic injures.
102862|NCT03560661|Acoustic and perceptual markers|acoustic and perceptual markers
102863|NCT03560661|Dysarthria|dysarthria
102864|NCT03560661|Amyotrophic lateral sclerosis|amyotrophic lateral sclerosis
102865|NCT03560661|Primitive lateral sclerosis|primitive lateral sclerosis
102866|NCT03560661|Kennedy's disease|kennedy's disease
102867|NCT03560648|muscle aging|muscle aging
102868|NCT03560648|sarcopenia|sarcopenia
102869|NCT03560648|neuromuscular dysfunction|neuromuscular dysfunction
102870|NCT03560635|weight loss maintenance|weight loss maintenance
102871|NCT03560635|reverse diet|reverse diet
102872|NCT03560635|body composition|body composition
102873|NCT03560635|metabolic rate|metabolic rate
102874|NCT03560635|dietary adherence|dietary adherence
102875|NCT03560635|resting energy expenditure|resting energy expenditure
102876|NCT03560635|weight loss|weight loss
102877|NCT03560635|weight regain|weight regain
102880|NCT03560596|Latino|latino
102881|NCT03560570|stroke-like|stroke-like
102882|NCT03560570|thrombosis|thrombosis
102883|NCT03560570|haemorrhages|haemorrhages
102884|NCT03560557|Pharmacokinetics|pharmacokinetics
102885|NCT03560557|Meropenem|meropenem
102886|NCT03560557|Critical illness|critical illness
102887|NCT03560557|Capillary leak|capillary leak
102888|NCT03560557|Augmented renal clearance|augmented renal clearance
102889|NCT03560531|Estrogen receptor|estrogen receptor
102890|NCT03560531|Hormone receptor|hormone receptor
102891|NCT03560531|Selective estrogen receptor degrader|selective estrogen receptor degrader
102892|NCT03560531|Hormone sensitive|hormone sensitive
102893|NCT03560531|Phase 1 Dose Escalation|phase 1 dose escalation
102894|NCT03560531|Phase 2 Combination|phase 2 combination
102895|NCT03560518|Depression|depression
102896|NCT03560505|Ultrasound reference material|ultrasound reference material
102897|NCT03560505|Sensitivity|sensitivity
102898|NCT03560505|Specificity|specificity
102899|NCT03560505|Common fibular compression neuropathy|common fibular compression neuropathy
102900|NCT03560505|Type 2 diabetes polyneuropathy|type 2 diabetes polyneuropathy
102901|NCT03560505|Intra-rater reliability|intra-rater reliability
102902|NCT03560505|Inter-rater reliability|inter-rater reliability
102903|NCT03560492|posture|posture
102904|NCT03560492|cervical pain|cervical pain
102905|NCT03560492|exercise|exercise
102906|NCT03560479|First-in human|first-in human
102907|NCT03560479|Phase 1|phase 1
102908|NCT03560479|Phase 2|phase 2
102909|NCT03560479|Safety|safety
102910|NCT03560479|Tolerability|tolerability
102911|NCT03560479|Cancer|cancer
102912|NCT03560479|Bladder cancer|bladder cancer
102913|NCT03560479|Clinical trial|clinical trial
102914|NCT03560479|Anti-cancer|anti-cancer
102915|NCT03560479|Antineoplastic|antineoplastic
102916|NCT03560479|alpha1H|alpha1h
102917|NCT03560479|HAMLET|hamlet
102918|NCT03560479|Urothelial|urothelial
102919|NCT03560479|Malignant|malignant
102920|NCT03560479|Papillary|papillary
102921|NCT03560479|Transurethral|transurethral
102922|NCT03560479|Non-muscle invasive|non-muscle invasive
102923|NCT03560479|Instillation|instillation
102924|NCT03560479|Intravesical|intravesical
102925|NCT03560453|Autism|autism
102926|NCT03560453|ASD|asd
102927|NCT03560453|Competitive Integrated Employment|competitive integrated employment
102928|NCT03560453|Project SEARCH|project search
102929|NCT03560453|Outcomes|outcomes
102930|NCT03560453|Support Intensity|support intensity
102931|NCT03560440|Vancomycin|vancomycin
102932|NCT03560440|Pharmacokinetics|pharmacokinetics
102933|NCT03560440|Trough level|trough level
102934|NCT03560440|Pediatric|pediatric
102935|NCT03560401|Bracing; transforaminal lumbar interbody fusion (TLIF); outcome; fusion rate|bracing; transforaminal lumbar interbody fusion (tlif); outcome; fusion rate
104946|NCT03548051|Stool|stool
102936|NCT03560388|Integrative medicine|integrative medicine
102937|NCT03560388|Acupuncture|acupuncture
102938|NCT03560388|Gynecological oncology|gynecological oncology
102939|NCT03560388|Surgery|surgery
102940|NCT03560388|Analgesia|analgesia
102941|NCT03560388|Pain|pain
102942|NCT03560388|Anxiety|anxiety
102943|NCT03560375|Weight loss; Diabetes; Frailty; Sarcopenia|weight loss; diabetes; frailty; sarcopenia
102944|NCT03560362|bupivacaine|bupivacaine
102945|NCT03560362|lipossomal extended release bupivacaine|lipossomal extended release bupivacaine
102946|NCT03560362|Intercostal nerve block|intercostal nerve block
102947|NCT03560362|thoracic surgery|thoracic surgery
102948|NCT03560362|minimally invasive surgery|minimally invasive surgery
102949|NCT03560323|Ketone Body Metabolism|ketone body metabolism
102950|NCT03560323|Myocardial Glucose Uptake|myocardial glucose uptake
102951|NCT03560323|Positron Emission Tomography|positron emission tomography
102952|NCT03560323|Myocardial Function|myocardial function
102953|NCT03560310|Coronary Bypass Grafting|coronary bypass grafting
102954|NCT03560310|Antiplatelet treatment|antiplatelet treatment
102955|NCT03560284|Marathon|marathon
102956|NCT03560284|Half Marathon|half marathon
102957|NCT03560284|Runners|runners
102958|NCT03560284|Ederly|ederly
102959|NCT03560284|Aging process|aging process
102960|NCT03560284|Sport Addiction|sport addiction
102961|NCT03560232|Open Fracture|open fracture
102962|NCT03560232|Wound Infection|wound infection
102963|NCT03560232|Antimicrobial Prophylaxis|antimicrobial prophylaxis
102964|NCT03560232|Cefazolin|cefazolin
102965|NCT03560232|Gentamicin|gentamicin
102966|NCT03560232|Ceftriaxone|ceftriaxone
102967|NCT03560232|Ampicillin/Sulbactam|ampicillin/sulbactam
102968|NCT03560232|Clindamycin|clindamycin
102969|NCT03560232|Piperacillin/tazobactam|piperacillin/tazobactam
102970|NCT03560219|Atrial Fibrillation|atrial fibrillation
102971|NCT03560219|Atrial Fibrosis|atrial fibrosis
102972|NCT03560219|Genome Wide Association Studies|genome wide association studies
102973|NCT03560219|Biomarkers|biomarkers
102974|NCT03560219|Echocardiography|echocardiography
102975|NCT03560219|Magnetic Resonance Imaging|magnetic resonance imaging
102976|NCT03560219|Flow Mediated Dilatation|flow mediated dilatation
102977|NCT03560219|Thrombogenic Substrate|thrombogenic substrate
102978|NCT03560206|Diet, low-sodium|diet, low-sodium
102979|NCT03560206|caregivers|caregivers
102980|NCT03560193|Skin antisepsis|skin antisepsis
102981|NCT03560193|Chlorhexidine|chlorhexidine
102982|NCT03560193|Povidone Iodine|povidone iodine
102983|NCT03560193|Surgical site infection|surgical site infection
102984|NCT03560180|Anastomotic Leak|anastomotic leak
102985|NCT03560180|Colorectal Surgery|colorectal surgery
102986|NCT03560154|Pulmonary Function Test|pulmonary function test
102987|NCT03560154|Peripheral Muscle strength|peripheral muscle strength
102988|NCT03560154|Postural balance|postural balance
102989|NCT03560154|Dyspnea|dyspnea
102990|NCT03560154|Pulmonary Muscle Strength|pulmonary muscle strength
102991|NCT03560154|Functional Capacity|functional capacity
102992|NCT03560154|Fatigue|fatigue
102993|NCT03560154|Quality of Life|quality of life
102994|NCT03560128|Colonoscopy|colonoscopy
102995|NCT03560115|Children|children
102996|NCT03560115|Heel|heel
102997|NCT03560115|Reliability|reliability
102998|NCT03560089|Parkinson's disease|parkinson's disease
102999|NCT03560089|Gait|gait
103000|NCT03560089|Rehabilitation|rehabilitation
103001|NCT03560089|Serious game|serious game
103002|NCT03560076|Acute Care|acute care
103003|NCT03560076|SBIRT|sbirt
103004|NCT03560076|Substance Use|substance use
103005|NCT03560076|Alcohol|alcohol
103006|NCT03560076|Opioid|opioid
103007|NCT03560076|Tobacco|tobacco
103008|NCT03560076|Nurse|nurse
103009|NCT03560076|Toolkit|toolkit
103010|NCT03560076|Implementation|implementation
103011|NCT03560063|arthroplasty|arthroplasty
103012|NCT03560063|dislocation|dislocation
103013|NCT03560063|templating|templating
103014|NCT03560050|early childhood education|early childhood education
103015|NCT03560050|family child care home|family child care home
103016|NCT03560050|food environment|food environment
103017|NCT03559998|Simulation training|simulation training
103018|NCT03559998|role-play|role-play
103019|NCT03559998|psychiatry|psychiatry
103020|NCT03559998|students|students
103021|NCT03559998|medical|medical
103022|NCT03559998|psychology|psychology
103023|NCT03559998|educational|educational
103024|NCT03559998|learning|learning
103025|NCT03559985|Paracetamol|paracetamol
103026|NCT03559985|Neuropathic pain|neuropathic pain
103027|NCT03559985|Analgesic effect|analgesic effect
103028|NCT03559985|Pharmacogenetics|pharmacogenetics
103029|NCT03559985|Biological parameters|biological parameters
103030|NCT03559985|Cognitivo-emotional parameters|cognitivo-emotional parameters
103031|NCT03559946|Overactive Bladder Syndrome|overactive bladder syndrome
103032|NCT03559946|Percutaneous Tibial Nerve Stimulation|percutaneous tibial nerve stimulation
103033|NCT03559907|prevention|prevention
103034|NCT03559907|nutrition|nutrition
103035|NCT03559907|early childhood|early childhood
103036|NCT03559907|parent training|parent training
103037|NCT03559907|underserved|underserved
105148|NCT03546712|forearm|forearm
103038|NCT03559881|Skeletal muscle mass, muscle strength, dairy products, high protein diet, cancer treatment, lung cancer|skeletal muscle mass, muscle strength, dairy products, high protein diet, cancer treatment, lung cancer
103039|NCT03559816|Episiotomy|episiotomy
103040|NCT03559816|Vaginal delivery|vaginal delivery
103041|NCT03559816|Perineal trauma|perineal trauma
103042|NCT03559816|Laceration|laceration
103043|NCT03559816|Classification of second-degree laceration|classification of second-degree laceration
103044|NCT03559803|Cervical Cancer|cervical cancer
103045|NCT03559803|PD-L1|pd-l1
103046|NCT03559803|Concurrent Chemoradiotherapy|concurrent chemoradiotherapy
103047|NCT03559790|chronic hepatitis B|chronic hepatitis b
103048|NCT03559790|tenofovir alafenamide|tenofovir alafenamide
103049|NCT03559790|tenofovir disoproxil fumarate|tenofovir disoproxil fumarate
103050|NCT03559790|Safety|safety
103051|NCT03559790|Efficacy|efficacy
103052|NCT03559777|closed sinus lifiting|closed sinus lifiting
103053|NCT03559777|implant stability|implant stability
103054|NCT03559777|osteotome|osteotome
103055|NCT03559777|densah bur|densah bur
103056|NCT03559751|Abuse liability|abuse liability
103057|NCT03559725|Abuse liability|abuse liability
103058|NCT03559712|Attention Deficit Hyperactivity Disorder|attention deficit hyperactivity disorder
103059|NCT03559712|Collaborative Care|collaborative care
103060|NCT03559712|Telemedecine|telemedecine
103061|NCT03559712|Telemental Health|telemental health
103062|NCT03559608|arterial hypertension|arterial hypertension
103063|NCT03559608|male health|male health
103064|NCT03559608|Warmia-Masuria region|warmia-masuria region
103065|NCT03559569|Shock|shock
103066|NCT03559569|Cardiovascular Diseases|cardiovascular diseases
103067|NCT03559569|Infection|infection
103068|NCT03559543|Nutritional supplement|nutritional supplement
103069|NCT03559543|Metastatic colorectal Cancer|metastatic colorectal cancer
103070|NCT03559543|Oxidative Stress|oxidative stress
103071|NCT03559543|Ocoxin Viusid|ocoxin viusid
103072|NCT03559543|Antioxidant|antioxidant
103073|NCT03559530|osteomyelitis|osteomyelitis
103074|NCT03559530|Acinetobacter baumannii|acinetobacter baumannii
103075|NCT03559530|Anti-Infective Agents|anti-infective agents
103076|NCT03559504|electroencephalography|electroencephalography
103077|NCT03559504|general anesthesia|general anesthesia
103078|NCT03559504|sevoflurane|sevoflurane
103079|NCT03559491|steroid|steroid
103080|NCT03559491|retinal vein occlusion|retinal vein occlusion
103081|NCT03559491|macular edema|macular edema
103082|NCT03559465|systemic sclerosis|systemic sclerosis
103083|NCT03559465|B lymphocyte|b lymphocyte
103084|NCT03559452|Muscle damage|muscle damage
103085|NCT03559452|Inflammation|inflammation
103086|NCT03559452|Immobilisation|immobilisation
103087|NCT03559426|antipsychotics|antipsychotics
103088|NCT03559426|schizophrenia|schizophrenia
103089|NCT03559426|reduction|reduction
103090|NCT03559413|Individualized peptide vaccination|individualized peptide vaccination
103091|NCT03559413|Immunotherapy|immunotherapy
103092|NCT03559413|Tumor-specific mutations|tumor-specific mutations
103093|NCT03559413|Neoantigens|neoantigens
103094|NCT03559374|Vanadis NIPT system|vanadis nipt system
103095|NCT03559348|in Elderly Patients|in elderly patients
103096|NCT03559335|Colorectal cancer|colorectal cancer
103097|NCT03559335|Biomarkers|biomarkers
103098|NCT03559335|Neutrophil CD64|neutrophil cd64
103099|NCT03559335|Monocyte Human Leukocyte Antigen - DR|monocyte human leukocyte antigen - dr
103100|NCT03559335|Postoperative Infectious Complications|postoperative infectious complications
103101|NCT03559335|C-reactive protein (CRP)|c-reactive protein (crp)
103102|NCT03559335|Procalcitonin (PCT)|procalcitonin (pct)
103103|NCT03559296|imaging|imaging
103104|NCT03559296|assessment|assessment
103105|NCT03559296|edema|edema
103106|NCT03559296|dermis|dermis
103107|NCT03559296|postmastectomy Lymphedema|postmastectomy lymphedema
103108|NCT03559296|reliability|reliability
103109|NCT03559296|ultrasound|ultrasound
103110|NCT03559296|grade|grade
103111|NCT03559283|stroke, dual-task, gait parameters, fNIRS|stroke, dual-task, gait parameters, fnirs
103112|NCT03559270|eczema|eczema
103113|NCT03559270|atopic eczema|atopic eczema
103114|NCT03559257|prevention|prevention
103115|NCT03559257|prophylaxis|prophylaxis
103116|NCT03559257|headache|headache
103117|NCT03559257|treatment-resistant|treatment-resistant
103118|NCT03559257|treatment resistant|treatment resistant
103119|NCT03559244|exercise|exercise
103120|NCT03559244|pectus carinatum|pectus carinatum
103121|NCT03559244|orthosis|orthosis
103122|NCT03559244|dynamic compression brace|dynamic compression brace
103123|NCT03559231|duodenal adenoma|duodenal adenoma
103124|NCT03559231|FTRD|ftrd
103125|NCT03559231|dFTRD|dftrd
103126|NCT03559231|EMR|emr
103127|NCT03559231|endoscopic mucosal resection|endoscopic mucosal resection
103128|NCT03559205|Musculoskeletal|musculoskeletal
103129|NCT03559205|MSK|msk
103130|NCT03559179|CDS|cds
103131|NCT03559179|Medication Assisted Therapy|medication assisted therapy
103132|NCT03559153|Office workers|office workers
103133|NCT03559153|Worker health|worker health
103134|NCT03559153|Work ability|work ability
103135|NCT03559153|Musculoskeletal disease|musculoskeletal disease
103136|NCT03559140|post-endodontic pain|post-endodontic pain
103138|NCT03559140|root canal treatment|root canal treatment
103139|NCT03559140|cryotherapy|cryotherapy
103140|NCT03559127|post-endodontic pain|post-endodontic pain
103141|NCT03559127|pain|pain
103142|NCT03559127|criotherapy|criotherapy
103143|NCT03559127|cold irrigation|cold irrigation
103144|NCT03559114|Sequential Compression Device|sequential compression device
103145|NCT03559114|Anticoagulant Thromboprophylaxis|anticoagulant thromboprophylaxis
103146|NCT03559114|Deep Vein Thrombosis|deep vein thrombosis
103147|NCT03559114|Sub Cutaneous|sub cutaneous
103148|NCT03559114|VTE|vte
103149|NCT03559101|Hydration|hydration
103150|NCT03559101|Plasma Volume|plasma volume
103151|NCT03559101|Amino acids|amino acids
103152|NCT03559101|Glucose|glucose
103153|NCT03559101|Electrolytes|electrolytes
103154|NCT03559101|Fluid Retention|fluid retention
103155|NCT03559101|Aging|aging
103156|NCT03559101|Beverage Hydration Index|beverage hydration index
103157|NCT03559101|Dehydration|dehydration
103158|NCT03559101|Oral Rehydration|oral rehydration
103159|NCT03559075|atopic dermatitis|atopic dermatitis
103160|NCT03559075|eczema|eczema
103161|NCT03559075|children|children
103162|NCT03559036|Locomotor Training|locomotor training
103163|NCT03559036|Urodynamics|urodynamics
103164|NCT03559023|Thoracic epidural|thoracic epidural
103165|NCT03559010|Daily birth control|daily birth control
103166|NCT03558984|Cardiac|cardiac
103167|NCT03558984|Surgery|surgery
103168|NCT03558984|Sternotomy|sternotomy
103169|NCT03558984|Heart|heart
103170|NCT03558984|CABG|cabg
103171|NCT03558984|Valve-replacement|valve-replacement
103172|NCT03558984|Aorta-replacement|aorta-replacement
103173|NCT03558971|Cortisol|cortisol
103174|NCT03558945|pancreatic tumor|pancreatic tumor
103175|NCT03558945|neoantigen|neoantigen
103176|NCT03558945|vaccine|vaccine
103177|NCT03558906|Periodontal disease|periodontal disease
103178|NCT03558906|Hypoxia|hypoxia
103179|NCT03558906|Cytokines|cytokines
103180|NCT03558906|Gingival crevicular fluid|gingival crevicular fluid
103181|NCT03558906|Saliva|saliva
103182|NCT03558893|circadian rhythm|circadian rhythm
103183|NCT03558867|Pre Diabetes|pre diabetes
103184|NCT03558867|Insulin resistance|insulin resistance
103185|NCT03558867|Metformin|metformin
103186|NCT03558867|Gut microbiota|gut microbiota
103187|NCT03558867|Type 2 Diabetes Mellitus|type 2 diabetes mellitus
103188|NCT03558854|Systemic sclerosis|systemic sclerosis
103189|NCT03558854|Acetylsalicylic acid|acetylsalicylic acid
103190|NCT03558854|Vascular dysfunction|vascular dysfunction
103191|NCT03558841|gait|gait
103192|NCT03558841|mobility|mobility
103193|NCT03558841|geriatric|geriatric
103194|NCT03558841|rehabilitation|rehabilitation
103195|NCT03558841|inpatient|inpatient
103196|NCT03558828|physical activity|physical activity
103197|NCT03558828|women|women
103198|NCT03558828|sedentary|sedentary
103199|NCT03558828|accelerometer|accelerometer
103200|NCT03558828|text message|text message
103201|NCT03558828|group meeting|group meeting
103202|NCT03558828|personal call|personal call
103203|NCT03558828|workplace|workplace
103204|NCT03558828|cost-effectiveness|cost-effectiveness
103205|NCT03558828|Sequential Multiple Assignment Randomized Trial|sequential multiple assignment randomized trial
103206|NCT03558828|adaptive intervention|adaptive intervention
103207|NCT03558828|Actigraph|actigraph
103208|NCT03558828|Fitbit|fitbit
103209|NCT03558828|iCardia|icardia
103210|NCT03558815|intellectual disability|intellectual disability
103211|NCT03558815|psychotropic medication|psychotropic medication
103212|NCT03558815|mental health services evaluation|mental health services evaluation
103213|NCT03558776|alpha linolenic acid, linseed oil, eicosapentaenoic acid, docosahexaenoic acid|alpha linolenic acid, linseed oil, eicosapentaenoic acid, docosahexaenoic acid
103214|NCT03558763|Monitoring|monitoring
103215|NCT03558737|non-invasive high frequency ventilation (nHFJV)|non-invasive high frequency ventilation (nhfjv)
103216|NCT03558737|nasal intermittent positive pressure ventilation (NIPPV)|nasal intermittent positive pressure ventilation (nippv)
103217|NCT03558724|Fluorescence|fluorescence
103218|NCT03558724|Endoscopy|endoscopy
103219|NCT03558724|Bevacizumab-800CW|bevacizumab-800cw
103220|NCT03558724|Locally advanced esophageal cancer|locally advanced esophageal cancer
103221|NCT03558711|prostate cancer|prostate cancer
103222|NCT03558711|biochemical recurrence|biochemical recurrence
103223|NCT03558711|18F-PET imaging|18f-pet imaging
103224|NCT03558698|cognition|cognition
103225|NCT03558698|sleep|sleep
103226|NCT03558698|carbon dioxide|carbon dioxide
103227|NCT03558698|bio effluents|bio effluents
103228|NCT03558672|Flexitouch|flexitouch
103229|NCT03558659|Stroke|stroke
103230|NCT03558659|Obstructive sleep apnea|obstructive sleep apnea
103231|NCT03558659|Positional therapy|positional therapy
103232|NCT03558646|Smoke inhalation injury|smoke inhalation injury
103233|NCT03558646|Acute kidney injury|acute kidney injury
103234|NCT03558646|Intensive care unit|intensive care unit
103235|NCT03558646|Burns|burns
103236|NCT03558646|Prognosis|prognosis
103237|NCT03558646|Hydroxocobalamin|hydroxocobalamin
103238|NCT03558633|Cricoid pressure|cricoid pressure
105149|NCT03546712|perception|perception
103239|NCT03558633|Paralaryngeal pressure|paralaryngeal pressure
103240|NCT03558633|Intubation|intubation
103241|NCT03558620|manual ventilation|manual ventilation
103242|NCT03558581|Nursing Process|nursing process
103243|NCT03558581|Nephrology Nursing|nephrology nursing
103244|NCT03558581|Education Health|education health
103245|NCT03558568|Parkinson's Disease|parkinson's disease
103246|NCT03558568|Deep Brain Stimulation|deep brain stimulation
103247|NCT03558568|Subthalamic Nucleus|subthalamic nucleus
103248|NCT03558568|DBS|dbs
103249|NCT03558568|STN|stn
103250|NCT03558568|Face|face
103251|NCT03558568|Facial expressions|facial expressions
103252|NCT03558568|Parkinson|parkinson
103253|NCT03558555|Acetaminophen|acetaminophen
103254|NCT03558555|Tylenol|tylenol
103255|NCT03558555|Intravenous versus oral|intravenous versus oral
103256|NCT03558529|relapse|relapse
103257|NCT03558529|early signs|early signs
103258|NCT03558529|basic symptoms|basic symptoms
103259|NCT03558529|smartphone app|smartphone app
103260|NCT03558529|mhealth|mhealth
103261|NCT03558516|Meningioma|meningioma
103262|NCT03558516|Magnesium sulphate|magnesium sulphate
103263|NCT03558516|Montreal cognitive assessment|montreal cognitive assessment
103264|NCT03558516|Intraoperative blood loss|intraoperative blood loss
103265|NCT03558503|UGN-102|ugn-102
103266|NCT03558503|UG-1 gel|ug-1 gel
103267|NCT03558503|Bladder cancer|bladder cancer
103268|NCT03558503|Gel|gel
103269|NCT03558503|Slow Release|slow release
103270|NCT03558503|Non Muscle Invasive Bladder Cancer (NMIBC)|non muscle invasive bladder cancer (nmibc)
103271|NCT03558503|Low grade (LG)|low grade (lg)
103272|NCT03558503|Prolonged Release|prolonged release
103273|NCT03558503|Mitomycin C|mitomycin c
103274|NCT03558503|Local|local
103275|NCT03558503|Intravesical|intravesical
103276|NCT03558503|Ta|ta
103277|NCT03558503|T1|t1
103278|NCT03558503|MMC|mmc
103279|NCT03558451|Primary health care|primary health care
103280|NCT03558425|CKD-381|ckd-381
103281|NCT03558425|D026|d026
103282|NCT03558412|Decitabine|decitabine
103283|NCT03558412|RR|rr
103284|NCT03558412|TTP|ttp
103285|NCT03558412|OS|os
103286|NCT03558412|MST|mst
103287|NCT03558399|Endometrial receptivity analysis|endometrial receptivity analysis
103288|NCT03558399|Window of implantation|window of implantation
103289|NCT03558399|Euploid|euploid
103290|NCT03558399|Infertility, Female|infertility, female
103291|NCT03558399|Implantation failure|implantation failure
103292|NCT03558399|Frozen embryo transfer FET|frozen embryo transfer fet
103293|NCT03558399|ERA|era
103294|NCT03558399|WOI|woi
103295|NCT03558399|FET|fet
103296|NCT03558399|Synchrony|synchrony
103297|NCT03558373|adherence|adherence
103298|NCT03558373|tacrolimus|tacrolimus
103299|NCT03558373|once-daily|once-daily
103300|NCT03558360|lean body mass|lean body mass
103301|NCT03558360|bariatric surgery|bariatric surgery
103302|NCT03558334|Bronchopulmonary Dysplasia|bronchopulmonary dysplasia
103303|NCT03558334|human umbilical cord -derived mesenchymal stem cells|human umbilical cord -derived mesenchymal stem cells
103304|NCT03558295|Percutaneous coronary intervention (PCI), oral anticoagulants, atrial fibrillation, DOAC.|percutaneous coronary intervention (pci), oral anticoagulants, atrial fibrillation, doac.
103305|NCT03558269|Autologous Umbilical cord blood infusion|autologous umbilical cord blood infusion
103306|NCT03558269|Congenital Heart Disease|congenital heart disease
103307|NCT03558269|Brain Injuries|brain injuries
103308|NCT03558269|Low Cardiac Output Syndrome|low cardiac output syndrome
103309|NCT03558269|Neonatal Disorder|neonatal disorder
103310|NCT03558256|Mindfulness-Based Cognitive Therapy|mindfulness-based cognitive therapy
103311|NCT03558243|radial artery occlusion|radial artery occlusion
103312|NCT03558243|prevention|prevention
103313|NCT03558243|patent hemostasis|patent hemostasis
103314|NCT03558243|transradial intervention|transradial intervention
103315|NCT03558243|ulnar compression|ulnar compression
103316|NCT03558230|pediatric|pediatric
103317|NCT03558230|hemiplegic|hemiplegic
103318|NCT03558230|hand function|hand function
103319|NCT03558217|total hip arthroplasty|total hip arthroplasty
103320|NCT03558217|collarless femoral implant|collarless femoral implant
103321|NCT03558217|collared femoral implant|collared femoral implant
103322|NCT03558217|direct anterior approach|direct anterior approach
103323|NCT03558217|direct lateral approach|direct lateral approach
103324|NCT03558191|Recurrent/Metastatic Nasopharyngeal Carcinoma|recurrent/metastatic nasopharyngeal carcinoma
103325|NCT03558191|PD-1|pd-1
103326|NCT03558126|silicone tube|silicone tube
103327|NCT03558126|miniature drainage device|miniature drainage device
103328|NCT03558126|POAG|poag
103329|NCT03558126|IOP|iop
103330|NCT03558100|obesity|obesity
103331|NCT03558100|gait|gait
103332|NCT03558100|bariatric surgery|bariatric surgery
103333|NCT03558100|walking|walking
103334|NCT03558100|obstacles|obstacles
103335|NCT03558087|muscle-invasive|muscle-invasive
103336|NCT03558074|Refractory wAMD|refractory wamd
103337|NCT03558048|Prostate Specific Antigen|prostate specific antigen
103338|NCT03558048|IBD|ibd
103339|NCT03558048|PSA|psa
103340|NCT03558035|Hypopharyngeal carcinoma|hypopharyngeal carcinoma
103341|NCT03558035|Locally advanced|locally advanced
103342|NCT03558035|Multi-disciplinary treatment|multi-disciplinary treatment
103343|NCT03558035|Functional Magnetic Resonance Imaging|functional magnetic resonance imaging
103344|NCT03558035|Prognosis|prognosis
103345|NCT03558009|Hereditary Angioedema|hereditary angioedema
103346|NCT03558009|DBS-based biochemical and genetic assay for HAE type I/II|dbs-based biochemical and genetic assay for hae type i/ii
103347|NCT03557931|aripiprazole|aripiprazole
103348|NCT03557931|ziprasidone|ziprasidone
103349|NCT03557931|lurasidone|lurasidone
103350|NCT03557931|schizophrenia|schizophrenia
103351|NCT03557931|ASP4345|asp4345
103352|NCT03557931|quetiapine|quetiapine
103353|NCT03557931|olanzapine|olanzapine
103354|NCT03557931|brexpiprazole|brexpiprazole
103355|NCT03557931|risperidone|risperidone
103356|NCT03557931|paliperidone|paliperidone
103357|NCT03557879|Hearing impairment|hearing impairment
103358|NCT03557879|familial|familial
103359|NCT03557866|foot posture|foot posture
103360|NCT03557866|running|running
103361|NCT03557866|foot index|foot index
103362|NCT03557840|temocillin|temocillin
103363|NCT03557840|free concentration|free concentration
103364|NCT03557840|total concentration|total concentration
103365|NCT03557840|pharmacokinetics|pharmacokinetics
103366|NCT03557840|pharmacodynamic|pharmacodynamic
103367|NCT03557840|probability of target attainment|probability of target attainment
103368|NCT03557840|non-ICU|non-icu
103369|NCT03557827|periodontitis|periodontitis
103370|NCT03557827|photodynamic therapy|photodynamic therapy
103371|NCT03557814|chronic periodontitis|chronic periodontitis
103372|NCT03557814|light-emitting diodes|light-emitting diodes
103373|NCT03557788|Rifaximin|rifaximin
103374|NCT03557762|Cancer survivors|cancer survivors
103375|NCT03557762|Smartphone app|smartphone app
103376|NCT03557762|Mindfulness|mindfulness
103377|NCT03557723|Community-dwellers,older adults, museum, art|community-dwellers,older adults, museum, art
103378|NCT03557710|eating|eating
103379|NCT03557710|overweight|overweight
103380|NCT03557710|obesity|obesity
103381|NCT03557710|cancer risk|cancer risk
103382|NCT03557710|translational neuroscience|translational neuroscience
103383|NCT03557710|cognitive reappraisal|cognitive reappraisal
103384|NCT03557710|functional magnetic resonance imaging (fMRI)|functional magnetic resonance imaging (fmri)
103385|NCT03557710|vmPFC|vmpfc
103386|NCT03557710|inhibitory control|inhibitory control
103387|NCT03557710|valuation|valuation
103388|NCT03557697|Chinese Americans|chinese americans
103389|NCT03557697|SMS intervention|sms intervention
103390|NCT03557645|mechanical ventilation|mechanical ventilation
103391|NCT03557645|physiotherapy|physiotherapy
103392|NCT03557645|ventilator hyperinflation|ventilator hyperinflation
103393|NCT03557645|airway clearance technique|airway clearance technique
103394|NCT03557632|Opioid Dependence|opioid dependence
103395|NCT03557632|Injection Drug Use|injection drug use
103396|NCT03557632|Hispanics|hispanics
103397|NCT03557632|Mexican Americans|mexican americans
103398|NCT03557632|Virtual Reality Cue Exposure|virtual reality cue exposure
103399|NCT03557619|Cancer|cancer
103400|NCT03557619|Hematologic Malignancies, venetoclax|hematologic malignancies, venetoclax
103401|NCT03557619|ethinyl estradiol|ethinyl estradiol
103402|NCT03557619|relapsed or refractory non-Hodgkin's lymphoma|relapsed or refractory non-hodgkin's lymphoma
103403|NCT03557619|non-Hodgkin's lymphoma|non-hodgkin's lymphoma
103405|NCT03557606|Bone Marrow Concentrate|bone marrow concentrate
103406|NCT03557606|Stem Cell Therapy|stem cell therapy
103407|NCT03557606|Alar Ligament|alar ligament
103408|NCT03557606|Transverse Ligament|transverse ligament
103409|NCT03557593|Antipsychotic|antipsychotic
103410|NCT03557593|Nursing home|nursing home
103411|NCT03557593|Long-term care|long-term care
103412|NCT03557554|Massage|massage
103413|NCT03557554|Breast Cancer|breast cancer
103414|NCT03557554|Neuropathy|neuropathy
103415|NCT03557541|diabetes|diabetes
103416|NCT03557541|T2D|t2d
103417|NCT03557541|diet|diet
103418|NCT03557541|nutrition|nutrition
103419|NCT03557541|prediabetes|prediabetes
103420|NCT03557541|sardine|sardine
103421|NCT03557541|elderly|elderly
103422|NCT03557515|Depression|depression
103423|NCT03557515|Cognitive Behavioral Therapy|cognitive behavioral therapy
103424|NCT03557515|Coping|coping
103425|NCT03557515|Meditation|meditation
103426|NCT03557515|Anxiety|anxiety
103427|NCT03557502|Stage 1 hypertension|stage 1 hypertension
103428|NCT03557502|Arterial Stiffness|arterial stiffness
103429|NCT03557476|Octacosanol|octacosanol
103430|NCT03557476|Taekwondo|taekwondo
103431|NCT03557476|Lipid Profiles|lipid profiles
103432|NCT03557476|Oxidative Stress|oxidative stress
103433|NCT03557437|Helicobacter pylori Therapy|helicobacter pylori therapy
103434|NCT03557424|Polyglucosamine|polyglucosamine
103435|NCT03557424|Glucomannan|glucomannan
103436|NCT03557424|Weight reduction|weight reduction
103437|NCT03557424|Weight loss|weight loss
103438|NCT03557424|without change in lifestyle|without change in lifestyle
103439|NCT03557411|SHR-1210,radiotherapy,Oligometastases,NSCLC|shr-1210,radiotherapy,oligometastases,nsclc
103440|NCT03557398|Hyaluronic acid|hyaluronic acid
103441|NCT03557398|Post-menopause|post-menopause
103443|NCT03557372|Recurrent glioblastoma|recurrent glioblastoma
103444|NCT03557372|Radiation Therapy|radiation therapy
103445|NCT03557359|Recurrent|recurrent
103446|NCT03557359|Progressive|progressive
103447|NCT03557359|High Grade Glioma|high grade glioma
103448|NCT03557359|IDH Mutant|idh mutant
103449|NCT03557320|environment|environment
103450|NCT03557320|pressure|pressure
103451|NCT03557320|temperature|temperature
103452|NCT03557320|case-crossover|case-crossover
103453|NCT03557307|Asthma|asthma
103454|NCT03557307|Severe Asthma|severe asthma
103455|NCT03557307|Oral Corticosteroids|oral corticosteroids
103456|NCT03557281|Early bactericidal activity|early bactericidal activity
103457|NCT03557281|Mycobacterium Tuberculosis|mycobacterium tuberculosis
103458|NCT03557281|GSK3036656|gsk3036656
103459|NCT03557281|Pulmonary tuberculosis|pulmonary tuberculosis
103460|NCT03557281|Colony forming units|colony forming units
103461|NCT03557229|Oxidative Stress|oxidative stress
103462|NCT03557229|Sepsis|sepsis
103463|NCT03557229|Treatment|treatment
103464|NCT03557229|Antioxidant therapy|antioxidant therapy
103465|NCT03557216|Diverticulitis|diverticulitis
103466|NCT03557216|Advanced colonic neoplasm|advanced colonic neoplasm
103467|NCT03557216|Colonoscopy|colonoscopy
103468|NCT03557203|Vernal Keratoconjunctivitis|vernal keratoconjunctivitis
103469|NCT03557203|Atopic Keratoconjunctivitis|atopic keratoconjunctivitis
103470|NCT03557203|tacrolimus|tacrolimus
103471|NCT03557190|VEGF inhibitors|vegf inhibitors
103472|NCT03557190|hypertension|hypertension
103473|NCT03557190|endothelial function|endothelial function
103474|NCT03557190|thrombosis|thrombosis
103475|NCT03557190|venous occlusion plethysmography|venous occlusion plethysmography
103476|NCT03557177|cisplatin|cisplatin
103477|NCT03557177|flow mediated dilatation|flow mediated dilatation
103478|NCT03557138|SGLT2 inhibitor|sglt2 inhibitor
103479|NCT03557138|18F-FDG|18f-fdg
103480|NCT03557138|alpha-Methyl-4-18F-FDG|alpha-methyl-4-18f-fdg
103481|NCT03557112|Locally Advanced Nasopharyngeal Carcinoma|locally advanced nasopharyngeal carcinoma
103482|NCT03557112|nimotuzumab|nimotuzumab
103483|NCT03557112|chemoradiotherapy|chemoradiotherapy
103484|NCT03557112|cisplatin|cisplatin
103485|NCT03557099|SAA|saa
103486|NCT03557073|Hand injuries|hand injuries
103487|NCT03557073|Hand trauma|hand trauma
103488|NCT03557073|Patient reported outcomes|patient reported outcomes
103489|NCT03557060|Nucala|nucala
103490|NCT03557060|Drug use investigation|drug use investigation
103491|NCT03557060|EGPA|egpa
103492|NCT03557060|Long-term|long-term
103493|NCT03557034|pulmonary vein isolation|pulmonary vein isolation
103494|NCT03557034|atrial fibrillation|atrial fibrillation
103495|NCT03557034|remote monitoring|remote monitoring
103496|NCT03557034|heart rhythm monitor|heart rhythm monitor
103497|NCT03557008|Rabies Vaccine|rabies vaccine
103498|NCT03557008|Antibiotics|antibiotics
103499|NCT03557008|Biopsy|biopsy
103500|NCT03556982|Acute Myeloid Leukemia|acute myeloid leukemia
103501|NCT03556982|Relapsed|relapsed
103502|NCT03556982|Refractory|refractory
103504|NCT03556878|Circadian rhythm disorders|circadian rhythm disorders
103505|NCT03556878|Sleep disorders|sleep disorders
103506|NCT03556878|Acceptability|acceptability
103507|NCT03556878|Adaptation|adaptation
103508|NCT03556878|Feasibility|feasibility
103509|NCT03556839|Cervix|cervix
103510|NCT03556839|Carcinoma|carcinoma
103511|NCT03556839|Atezolizumab|atezolizumab
103512|NCT03556813|Patient information|patient information
103513|NCT03556813|Natural Language Processing|natural language processing
103514|NCT03556813|Conversational agent|conversational agent
103515|NCT03556813|Chatbot|chatbot
103516|NCT03556800|Hypoestrogenism|hypoestrogenism
103517|NCT03556800|Menopausal hormone therapy|menopausal hormone therapy
103518|NCT03556761|Furosemide|furosemide
103519|NCT03556761|Postpartum|postpartum
103520|NCT03556761|Hypertension|hypertension
103521|NCT03556748|hematological malignancies|hematological malignancies
103522|NCT03556748|leukemia|leukemia
103523|NCT03556748|myeloma|myeloma
103524|NCT03556748|lymphoma|lymphoma
103525|NCT03556748|exercise|exercise
103526|NCT03556748|nutrition|nutrition
103527|NCT03556748|protein|protein
103528|NCT03556748|WB-EMS|wb-ems
103529|NCT03556748|whole-body electromyostimulation|whole-body electromyostimulation
103530|NCT03556735|Depression, unipolar|depression, unipolar
103531|NCT03556735|Treatment resistant|treatment resistant
103532|NCT03556735|PEMF|pemf
103533|NCT03556722|Repetitive Transcranial Magnetic Stimulation|repetitive transcranial magnetic stimulation
103534|NCT03556722|Transcranial Doppler|transcranial doppler
103535|NCT03556722|Neuromodulation|neuromodulation
103536|NCT03556722|Randomized Controlled Trials|randomized controlled trials
103537|NCT03556722|Pain|pain
103538|NCT03556722|Migraine prophylaxis|migraine prophylaxis
103539|NCT03556722|Dorsolateral Prefrontal Cortex|dorsolateral prefrontal cortex
103540|NCT03556722|Protocol|protocol
103541|NCT03556696|general anesthesia|general anesthesia
103542|NCT03556696|analgesia/nociception balance monitoring|analgesia/nociception balance monitoring
103543|NCT03556696|expert system|expert system
103544|NCT03556683|asthma, hypertonic saline|asthma, hypertonic saline
103545|NCT03556657|Music Therapy|music therapy
103546|NCT03556657|Sickle Cell Disease|sickle cell disease
103547|NCT03556657|Quality of Life|quality of life
103548|NCT03556657|Chronic Pain|chronic pain
103549|NCT03556644|Near Infrared Spectroscopy|near infrared spectroscopy
103550|NCT03556644|Computed Tomography Coronary Angiography|computed tomography coronary angiography
103551|NCT03556644|Atherosclerosis|atherosclerosis
103552|NCT03556644|Endothelial Shear Stress|endothelial shear stress
103553|NCT03556566|ovary|ovary
103554|NCT03556566|ovarian|ovarian
103555|NCT03556566|immunotherapy|immunotherapy
103556|NCT03556566|cancer|cancer
103557|NCT03556553|composite resin|composite resin
103558|NCT03556553|occlusal caries|occlusal caries
103559|NCT03556540|Chronic Kidney Disease|chronic kidney disease
103560|NCT03556540|Hemodialysis|hemodialysis
103561|NCT03556540|Exercise|exercise
103562|NCT03556527|osteotomy|osteotomy
103563|NCT03556527|reverse oblique sigmoid notch|reverse oblique sigmoid notch
103564|NCT03556527|ulnar impaction syndrome|ulnar impaction syndrome
103565|NCT03556527|ulnar shortening|ulnar shortening
103566|NCT03556514|Locking Plate Fixaion|locking plate fixaion
103567|NCT03556488|Chest ultrasound|chest ultrasound
103568|NCT03556488|Pediatric community acquired pneumonia|pediatric community acquired pneumonia
103569|NCT03556488|Air bronchogram|air bronchogram
103570|NCT03556449|scapula/innervation*|scapula/innervation*
103571|NCT03556449|Thoracic Nerves/injuries*|thoracic nerves/injuries*
103572|NCT03556449|Peripheral Nerve Injuries|peripheral nerve injuries
103573|NCT03556449|Shoulder|shoulder
103574|NCT03556449|Musculoskeletal Diseases/diagnosis*|musculoskeletal diseases/diagnosis*
103575|NCT03556436|YH25448|yh25448
103576|NCT03556436|Non-Small Cell Lung Cancer|non-small cell lung cancer
103577|NCT03556423|Arthritis|arthritis
103578|NCT03556423|Chronic pain|chronic pain
103579|NCT03556423|Transcranial magnetic stimulation (TMS)|transcranial magnetic stimulation (tms)
103580|NCT03556423|Magnetic resonance imaging (MRI)|magnetic resonance imaging (mri)
103581|NCT03556423|Conditioned pain modulation (CPM)|conditioned pain modulation (cpm)
103582|NCT03556423|Clinical measures|clinical measures
103583|NCT03556423|Knee osteoarthritis|knee osteoarthritis
103584|NCT03556410|Sleep|sleep
103585|NCT03556410|Obesity|obesity
103586|NCT03556410|Metabolic Syndrome|metabolic syndrome
103587|NCT03556410|Physical Activity|physical activity
103588|NCT03556397|breast cancer|breast cancer
103589|NCT03556397|neoadjuvant therapy|neoadjuvant therapy
103590|NCT03556397|sentinel lymph node biopsy|sentinel lymph node biopsy
103591|NCT03556397|axillary dissection|axillary dissection
103592|NCT03556384|cancer|cancer
103593|NCT03556384|Temozolomide|temozolomide
103594|NCT03556384|GIST|gist
103595|NCT03556384|SDH-Mutant/Deficient|sdh-mutant/deficient
103596|NCT03556384|SDH|sdh
103597|NCT03556384|Succinate Dehydrogenase|succinate dehydrogenase
103598|NCT03556371|Cocaine|cocaine
103599|NCT03556371|Coca Paste|coca paste
103600|NCT03556371|N-Acetylcysteine|n-acetylcysteine
103601|NCT03556371|Craving|craving
103602|NCT03556371|Abstinence|abstinence
103603|NCT03556358|trastuzumab|trastuzumab
103604|NCT03556358|Herceptin|herceptin
103605|NCT03556345|RC48-ADC|rc48-adc
103606|NCT03556345|HER2 overexpression|her2 overexpression
103607|NCT03556345|Gastric cancer|gastric cancer
103608|NCT03556332|Carfilzomib|carfilzomib
103609|NCT03556332|Lenalidomide|lenalidomide
103610|NCT03556332|Dexamethasone|dexamethasone
103611|NCT03556332|Daratumumab|daratumumab
103612|NCT03556332|salvage autologous hematopoietic cell transplantation|salvage autologous hematopoietic cell transplantation
103613|NCT03556332|17-493|17-493
103614|NCT03556319|Multiple Dosage|multiple dosage
103615|NCT03556280|Dementia|dementia
103616|NCT03556280|Alzheimer's Disease|alzheimer's disease
103617|NCT03556280|Cognitive Impairment|cognitive impairment
103618|NCT03556254|Helicobacter pylori infection|helicobacter pylori infection
103619|NCT03556254|Genotypic resistance|genotypic resistance
103620|NCT03556254|Antimicrobial susceptibility|antimicrobial susceptibility
103621|NCT03556228|TrkA|trka
103622|NCT03556228|NTRK1|ntrk1
103623|NCT03556228|Thymic|thymic
103624|NCT03556228|Pancreatic|pancreatic
103625|NCT03556228|TNBC|tnbc
103626|NCT03556215|otitis media with effusion|otitis media with effusion
103627|NCT03556215|balloon tuboplasty|balloon tuboplasty
103628|NCT03556215|Eustachian tube|eustachian tube
103629|NCT03556215|Eustachian tube dysfunction|eustachian tube dysfunction
103630|NCT03556202|IL-23|il-23
103631|NCT03556202|Interleukin-23|interleukin-23
103632|NCT03556202|Psoriasis|psoriasis
103633|NCT03556176|Anxiety|anxiety
103634|NCT03556176|Mood|mood
103635|NCT03556176|Physical activity|physical activity
103636|NCT03556176|Polymorphisms|polymorphisms
103637|NCT03556163|Chronic periodontitis|chronic periodontitis
103638|NCT03556163|Modified Widman flap surgery|modified widman flap surgery
103639|NCT03556163|Suturing technique|suturing technique
103640|NCT03556137|PET/MRI|pet/mri
103641|NCT03556137|Chronic Pain|chronic pain
103743|NCT03555435|Problem-solving|problem-solving
103642|NCT03556124|Transcranial direct current stimulation|transcranial direct current stimulation
103643|NCT03556124|major depression|major depression
103645|NCT03556111|implant , sticky bone|implant , sticky bone
103646|NCT03556098|Diabetes Mellitus, Type 1|diabetes mellitus, type 1
103647|NCT03556098|Hypoglycemia|hypoglycemia
103648|NCT03556098|Gastric Inhibitory Polypeptide|gastric inhibitory polypeptide
103649|NCT03556098|Glucagon|glucagon
103650|NCT03556098|Incretin|incretin
103651|NCT03556085|idiopathic intracranial hypertension|idiopathic intracranial hypertension
103652|NCT03556085|venous sinus stenting|venous sinus stenting
103653|NCT03556072|ERCP|ercp
103654|NCT03556072|periampullary diverticula|periampullary diverticula
103655|NCT03556072|difficulty cannulation|difficulty cannulation
103656|NCT03556072|complication|complication
103657|NCT03556072|biliary disorder|biliary disorder
103658|NCT03556059|EOSS|eoss
103659|NCT03556059|Obesity and metabolic surgery|obesity and metabolic surgery
103660|NCT03556059|postoperative outcome|postoperative outcome
103661|NCT03556059|procedure selection|procedure selection
103662|NCT03556046|Clear Cell Renal Carcinoma|clear cell renal carcinoma
103663|NCT03556007|T regulatory cells|t regulatory cells
103664|NCT03555994|0382, T2DM|0382, t2dm
103665|NCT03555968|THC|thc
103666|NCT03555968|Alcohol|alcohol
103667|NCT03555968|Driving|driving
103668|NCT03555968|Dronabinol|dronabinol
103669|NCT03555929|Axillary block|axillary block
103670|NCT03555929|Dexamethasone|dexamethasone
103671|NCT03555929|anesthesia|anesthesia
103672|NCT03555916|BOTOX®-Allergan|botox®-allergan
103673|NCT03555916|PPTTN|ppttn
103674|NCT03555916|Pain measurements|pain measurements
103675|NCT03555890|Oral disintegrating tablet|oral disintegrating tablet
103676|NCT03555890|Levocetirizine|levocetirizine
103677|NCT03555890|Immediate release tablet|immediate release tablet
103678|NCT03555890|Bioequivalence|bioequivalence
103679|NCT03555890|Japanese subjects|japanese subjects
103680|NCT03555877|Ribociclib|ribociclib
103681|NCT03555877|Anti-hormonal maintainance treatment|anti-hormonal maintainance treatment
103682|NCT03555877|HR-positive|hr-positive
103683|NCT03555877|HER2-negative|her2-negative
103684|NCT03555812|Hip, Arthroplasty, pelvic inclination, ultrasound|hip, arthroplasty, pelvic inclination, ultrasound
103685|NCT03555773|perianal Crohn's disease|perianal crohn's disease
103686|NCT03555773|mesenchymal stromal cells|mesenchymal stromal cells
103687|NCT03555773|complex anal fistulas|complex anal fistulas
103688|NCT03555773|micro-fragmented adipose tissue|micro-fragmented adipose tissue
103689|NCT03555773|regenerative medicine|regenerative medicine
103690|NCT03555747|Canine distalization|canine distalization
103691|NCT03555747|Gingival crevicular fluid|gingival crevicular fluid
103692|NCT03555747|Cytokines|cytokines
103693|NCT03555747|Orthodontic force|orthodontic force
103694|NCT03555747|Periodontium|periodontium
103695|NCT03555747|Gingivitis|gingivitis
103696|NCT03555734|Pulses (beans, chickpeas, lentils, dry peas)|pulses (beans, chickpeas, lentils, dry peas)
103697|NCT03555734|Legumes|legumes
103698|NCT03555734|Cardiovascular disease|cardiovascular disease
103699|NCT03555734|Coronary heart disease|coronary heart disease
103700|NCT03555734|Stroke|stroke
103701|NCT03555734|Diabetes|diabetes
103702|NCT03555734|Hypertension|hypertension
103703|NCT03555734|Obesity|obesity
103704|NCT03555734|Prospective cohort studies|prospective cohort studies
103705|NCT03555734|Umbrella review|umbrella review
103706|NCT03555734|Systematic review and meta-analysis|systematic review and meta-analysis
103707|NCT03555708|Gait Training|gait training
103708|NCT03555708|Power Training|power training
103709|NCT03555708|Action-Perception Training|action-perception training
103710|NCT03555708|Brain Imaging|brain imaging
103711|NCT03555708|Mobility|mobility
103712|NCT03555695|karate|karate
103713|NCT03555695|exercise|exercise
103714|NCT03555682|Multiple Dosage|multiple dosage
103715|NCT03555669|Implementation Science|implementation science
103716|NCT03555669|Malawi|malawi
103717|NCT03555643|TIA|tia
103718|NCT03555643|Stroke|stroke
103719|NCT03555643|Ischemia|ischemia
103720|NCT03555643|MRI|mri
103721|NCT03555643|FLAIR|flair
103722|NCT03555643|hyperintense acute reperfusion marker|hyperintense acute reperfusion marker
103723|NCT03555617|healthy volunteers|healthy volunteers
103724|NCT03555617|drug-drug interaction|drug-drug interaction
103725|NCT03555617|itraconazole|itraconazole
103726|NCT03555617|CYP3A|cyp3a
103727|NCT03555617|P-gp|p-gp
103728|NCT03555617|Inflammatory Bowel Disease|inflammatory bowel disease
103729|NCT03555617|IBD|ibd
103730|NCT03555617|Irritable Bowel Syndrome|irritable bowel syndrome
103731|NCT03555617|IBS|ibs
103732|NCT03555539|Hepatic Impairment|hepatic impairment
103733|NCT03555539|ACH-0144471|ach-0144471
103734|NCT03555500|Fasting|fasting
103735|NCT03555500|Non fasting|non fasting
103736|NCT03555500|Cardiac catheterization|cardiac catheterization
103737|NCT03555487|Hyperparathyroidism|hyperparathyroidism
103738|NCT03555487|18F choline|18f choline
103739|NCT03555487|PET|pet
103740|NCT03555487|Tc-99m sestaMIBI|tc-99m sestamibi
103741|NCT03555487|SPECT|spect
103742|NCT03555448|Immunosuppression|immunosuppression
103744|NCT03555435|Stigma reduction|stigma reduction
103745|NCT03555435|Peer support|peer support
103746|NCT03555435|Online mental health program|online mental health program
103747|NCT03555422|Endometrial Neoplasms|endometrial neoplasms
103748|NCT03555422|Uterine Neoplasms|uterine neoplasms
103749|NCT03555422|Genital Neoplasms|genital neoplasms
103750|NCT03555422|Neoplasms by Site|neoplasms by site
103751|NCT03555422|Neoplasms|neoplasms
103752|NCT03555422|Uterine Diseases|uterine diseases
103753|NCT03555422|Genital Diseases|genital diseases
103754|NCT03555422|Female|female
103755|NCT03555383|bloodless transplantation|bloodless transplantation
103756|NCT03555383|hemostasis reserve capacity|hemostasis reserve capacity
103757|NCT03555383|surgery|surgery
103758|NCT03555370|adolescent|adolescent
103759|NCT03555370|concussion|concussion
103760|NCT03555357|Abdomen|abdomen
103761|NCT03555357|Abdominoplasty|abdominoplasty
103762|NCT03555357|Scar Therapy|scar therapy
103763|NCT03555357|Scar|scar
103764|NCT03555331|responsive parenting|responsive parenting
103765|NCT03555318|Heart failure|heart failure
103766|NCT03555318|Frailty|frailty
103767|NCT03555318|Outcome|outcome
103768|NCT03555318|Hospitalization|hospitalization
103769|NCT03555318|Mortality|mortality
103770|NCT03555292|11C-PIB|11c-pib
103771|NCT03555292|Parkinson's disease|parkinson's disease
103772|NCT03555292|dementia|dementia
103773|NCT03555292|mild cognitive impairment|mild cognitive impairment
103774|NCT03555279|HIV Prevention|hiv prevention
103775|NCT03555279|Juvenile Justice|juvenile justice
103776|NCT03555279|Sexual Health|sexual health
103777|NCT03555279|Evidence Based Intervention|evidence based intervention
103778|NCT03555266|Pain Therapy|pain therapy
103779|NCT03555266|Auricular Therapy|auricular therapy
103780|NCT03555253|Resilience|resilience
103781|NCT03555253|Telehealth|telehealth
103782|NCT03555253|Well-being|well-being
103783|NCT03555253|Support|support
103784|NCT03555253|Caregiving|caregiving
103785|NCT03555240|Rheumatoid Arthritis|rheumatoid arthritis
103786|NCT03555227|breast cancer analgesia|breast cancer analgesia
103787|NCT03555227|pecs2 blocks|pecs2 blocks
103788|NCT03555227|ultrasound|ultrasound
103789|NCT03555214|migraine|migraine
103790|NCT03555214|manual therapy|manual therapy
103791|NCT03555188|Diarrhoea|diarrhoea
103792|NCT03555162|Tool|tool
103793|NCT03555162|fMRI|fmri
103794|NCT03555162|neuroimaging|neuroimaging
103795|NCT03555162|Evolution|evolution
103796|NCT03555110|EMDR Therapy|emdr therapy
103797|NCT03555110|Bariatric Surgery|bariatric surgery
103798|NCT03555110|Obesity|obesity
103799|NCT03555097|Chronic Obstructive Pulmonary Disease|chronic obstructive pulmonary disease
103800|NCT03555097|Non-invasive Positive Pressure Ventilation|non-invasive positive pressure ventilation
103801|NCT03555097|Respiratory Mechanics|respiratory mechanics
103802|NCT03555097|Neural Respiratory Drive|neural respiratory drive
103803|NCT03555071|live attenuated varicella vaccine|live attenuated varicella vaccine
103804|NCT03555071|consistency|consistency
103805|NCT03555071|immunogenicity|immunogenicity
103806|NCT03555071|safety|safety
103807|NCT03555071|children|children
103808|NCT03555019|Brain maturation|brain maturation
103809|NCT03555019|Postnatal growth|postnatal growth
103810|NCT03554993|Healthy Volunteer|healthy volunteer
103811|NCT03554993|Safety|safety
103812|NCT03554993|CC-99677|cc-99677
103813|NCT03554967|Oral Squamous Cell Carcinoma|oral squamous cell carcinoma
103814|NCT03554967|Toluidine Blue|toluidine blue
103815|NCT03554967|Frozen Section|frozen section
103816|NCT03554967|Tumor margin assessment|tumor margin assessment
103817|NCT03554954|Nutrients|nutrients
103818|NCT03554954|Diet|diet
103819|NCT03554954|Sleep Quality|sleep quality
103820|NCT03554954|Middle-aged adults|middle-aged adults
103821|NCT03554954|Older adults|older adults
103822|NCT03554915|Agitation, Ketamine, Midazolam, Emergency Medical Services|agitation, ketamine, midazolam, emergency medical services
103823|NCT03554902|Endoscopic gastric tubulization|endoscopic gastric tubulization
103824|NCT03554902|Weight loss|weight loss
103825|NCT03554902|Quality of life|quality of life
103826|NCT03554876|Biofilm|biofilm
103827|NCT03554876|peri-implantitis|peri-implantitis
103828|NCT03554876|metagenomic analysis|metagenomic analysis
103829|NCT03554876|abutment|abutment
103830|NCT03554863|Anesthesia genral, Oxygen|anesthesia genral, oxygen
103831|NCT03554837|safety|safety
103832|NCT03554837|effectiveness|effectiveness
103833|NCT03554837|low dose|low dose
103834|NCT03554759|Chronic Liver Disease|chronic liver disease
103835|NCT03554759|Low Platelet Count|low platelet count
103836|NCT03554733|self efficacy|self efficacy
103837|NCT03554733|participation|participation
103838|NCT03554733|satisfaction with life|satisfaction with life
103839|NCT03554707|Childhood CNS tumor|childhood cns tumor
103840|NCT03554707|Recurrent CNS malignancies|recurrent cns malignancies
103841|NCT03554707|Progressive CNS malignancies|progressive cns malignancies
103842|NCT03554707|Refractory CNS malignancies|refractory cns malignancies
103843|NCT03554681|Bayes Model|bayes model
103844|NCT03554655|Shared decision making|shared decision making
104143|NCT03552926|Stroke|stroke
103855|NCT03554590|carbohydrate counting|carbohydrate counting
103856|NCT03554590|insulin therapy|insulin therapy
103862|NCT03554551|Parasympathetic|parasympathetic
103863|NCT03554538|Shoulder impingement syndrome|shoulder impingement syndrome
103864|NCT03554538|Exercise web app|exercise web app
103865|NCT03554538|Efficacy|efficacy
103866|NCT03554525|Obesity|obesity
103867|NCT03554525|Overweight|overweight
103868|NCT03554525|Weight Loss|weight loss
103869|NCT03554525|Body weight maintenance|body weight maintenance
103870|NCT03554525|Weight Change, Body|weight change, body
103871|NCT03554525|Saccharomyces Cerevisiae|saccharomyces cerevisiae
103872|NCT03554525|Beta-glucans|beta-glucans
103873|NCT03554512|Neonatal Intensive Care|neonatal intensive care
103874|NCT03554512|Telehealth|telehealth
103875|NCT03554512|Anxiety|anxiety
103876|NCT03554512|Self Efficacy|self efficacy
103877|NCT03554512|Parenting/psychology|parenting/psychology
103878|NCT03554499|Facial aging|facial aging
103879|NCT03554499|Buccal fat pad|buccal fat pad
103885|NCT03554447|Pentoxifylline|pentoxifylline
103886|NCT03554447|Anti-inflammatory|anti-inflammatory
103887|NCT03554447|MDD|mdd
103888|NCT03554447|phosphodiastrase inhibitors|phosphodiastrase inhibitors
103889|NCT03554421|Key Words: Anal Fissure, tibial nerve stimulation|key words: anal fissure, tibial nerve stimulation
103890|NCT03554408|10-1074-LS|10-1074-ls
103891|NCT03554408|3BNC117-LS|3bnc117-ls
103892|NCT03554408|First in Human|first in human
103893|NCT03554408|Dose Escalation|dose escalation
103894|NCT03554395|PD-1 activated CIK|pd-1 activated cik
103895|NCT03554395|MUC1|muc1
103896|NCT03554395|bispecific antibody|bispecific antibody
103897|NCT03554395|gastric cancer|gastric cancer
103898|NCT03554382|person-centred care (PCC)|person-centred care (pcc)
103899|NCT03554382|self-efficacy|self-efficacy
103900|NCT03554369|Prostate|prostate
103901|NCT03554369|Dose-Limiting Toxicity|dose-limiting toxicity
103902|NCT03554369|Maximum Tolerated Dose|maximum tolerated dose
103903|NCT03554369|Stereotactic Body Radiation Therapy (SBRT)|stereotactic body radiation therapy (sbrt)
103904|NCT03554343|newborn screening|newborn screening
103905|NCT03554330|pulmonary arterial hypertension|pulmonary arterial hypertension
103906|NCT03554330|balloon atrial septostomy|balloon atrial septostomy
103907|NCT03554330|radiofrequency catheter ablation|radiofrequency catheter ablation
103908|NCT03554330|spontaneous closure|spontaneous closure
103909|NCT03554317|Bipolar Androgen Therapy|bipolar androgen therapy
103910|NCT03554317|Testosterone|testosterone
103911|NCT03554317|Nivolumab|nivolumab
103912|NCT03554291|famotidine|famotidine
103913|NCT03554291|H2 blocker|h2 blocker
103914|NCT03554291|H2 antagonist|h2 antagonist
103915|NCT03554278|NEC|nec
103916|NCT03554278|transfusion|transfusion
103917|NCT03554278|microbiome|microbiome
103918|NCT03554278|premature|premature
103919|NCT03554265|growth hormone|growth hormone
103920|NCT03554265|Traumatic Brain injury|traumatic brain injury
103921|NCT03554265|concussion|concussion
103922|NCT03554265|mTBI|mtbi
103923|NCT03554265|fatigue|fatigue
103924|NCT03554265|cognitive impairment|cognitive impairment
103925|NCT03554265|BIAFAC|biafac
103926|NCT03554239|Genotyping techniques|genotyping techniques
103927|NCT03554239|Fungal infection|fungal infection
103928|NCT03554226|agitation|agitation
103929|NCT03554226|aggressivity|aggressivity
103930|NCT03554200|Empagliflozin|empagliflozin
103931|NCT03554200|acute heart failure|acute heart failure
103932|NCT03554200|cardiac output|cardiac output
103933|NCT03554200|left ventricular systolic and diastolic function|left ventricular systolic and diastolic function
103934|NCT03554200|exercise capacity|exercise capacity
103935|NCT03554174|psilocybin|psilocybin
103936|NCT03554161|Tocilizumab|tocilizumab
103937|NCT03554161|Refractory uveitis|refractory uveitis
103938|NCT03554109|TNBC|tnbc
103939|NCT03554096|Multiple Dosage|multiple dosage
103940|NCT03554070|Prostate|prostate
103941|NCT03554070|BPH|bph
103942|NCT03554070|Laser|laser
103943|NCT03554070|Endoscopic Enucleation of the Prostate|endoscopic enucleation of the prostate
103944|NCT03554070|Thulium|thulium
103945|NCT03554070|Thulium Fiber Laser|thulium fiber laser
103950|NCT03553992|Cessation|cessation
103951|NCT03553992|Intervention|intervention
103952|NCT03553992|Young Adults|young adults
103953|NCT03553992|Social Media|social media
103954|NCT03553992|Internet|internet
103955|NCT03553992|Cigarette|cigarette
103956|NCT03553979|stress management|stress management
103957|NCT03553979|stress intervention|stress intervention
103958|NCT03553979|smoking intervention|smoking intervention
103959|NCT03553979|lower SES|lower ses
103960|NCT03553979|lower income|lower income
103961|NCT03553966|Dental caries|dental caries
103962|NCT03553966|Toothpaste|toothpaste
103963|NCT03553966|Fluoride|fluoride
103964|NCT03553966|Hydroxyapatite|hydroxyapatite
103965|NCT03553953|Anesthesia|anesthesia
103966|NCT03553953|Bispectral index (BIS™)|bispectral index (bis™)
103974|NCT03553927|Male Infertility|male infertility
103975|NCT03553927|Obesity|obesity
103976|NCT03553888|Hidradenitis Suppurativa|hidradenitis suppurativa
103977|NCT03553888|Periodontal diseases|periodontal diseases
103978|NCT03553888|Multicenter cross-sectional study|multicenter cross-sectional study
103979|NCT03553888|Vibrational spectroscopies|vibrational spectroscopies
103980|NCT03553888|Salivary biomarkers|salivary biomarkers
103981|NCT03553875|Autism|autism
103982|NCT03553875|Massachusetts General Hospital|massachusetts general hospital
103983|NCT03553849|Very low calorie diet|very low calorie diet
103984|NCT03553849|General surgery|general surgery
103985|NCT03553836|Programmed Cell Death Receptor 1 (PD1)|programmed cell death receptor 1 (pd1)
103986|NCT03553836|Programmed Cell Death Receptor 1 (PD-1)|programmed cell death receptor 1 (pd-1)
103987|NCT03553836|Programmed Cell Death Receptor Ligand 1 (PDL1)|programmed cell death receptor ligand 1 (pdl1)
103988|NCT03553836|Programmed Cell Death Receptor Ligand 1 (PD-L1)|programmed cell death receptor ligand 1 (pd-l1)
103989|NCT03553823|Psoriasis|psoriasis
103990|NCT03553784|Cancer|cancer
103991|NCT03553784|Therapy|therapy
103992|NCT03553771|aneurysm|aneurysm
103993|NCT03553771|endovascular|endovascular
103994|NCT03553732|active surveillance|active surveillance
103995|NCT03553732|health information technology|health information technology
103996|NCT03553732|patient safety|patient safety
103997|NCT03553732|adherence|adherence
103998|NCT03553732|ambulatory|ambulatory
103999|NCT03553732|outpatient|outpatient
104000|NCT03553732|human factors|human factors
104001|NCT03553732|systems engineering|systems engineering
104002|NCT03553732|vulnerable populations|vulnerable populations
104003|NCT03553732|chronic disease|chronic disease
104129|NCT03552991|Diabetes Mellitus, Type 2|diabetes mellitus, type 2
104004|NCT03553706|growth restriction, nutritive status, comorbide disorders, Down Syndrome|growth restriction, nutritive status, comorbide disorders, down syndrome
104005|NCT03553693|HIV|hiv
104006|NCT03553693|Viral Load|viral load
104007|NCT03553693|Counseling|counseling
104008|NCT03553693|Costs and Costs Analysis|costs and costs analysis
104009|NCT03553693|Point-Of-Care Systems|point-of-care systems
104010|NCT03553667|Hemodynamic Monitoring|hemodynamic monitoring
104011|NCT03553667|Perioperative Care|perioperative care
104012|NCT03553667|Outcome Assessment|outcome assessment
104013|NCT03553641|capacity|capacity
104014|NCT03553641|clinical ethics|clinical ethics
104015|NCT03553641|autonomy|autonomy
104016|NCT03553641|competence|competence
104017|NCT03553628|dental caries|dental caries
104018|NCT03553628|propolis|propolis
104019|NCT03553628|chlorhexidine|chlorhexidine
104020|NCT03553628|clove oil|clove oil
104021|NCT03553628|bee wax|bee wax
104022|NCT03553602|Prostate Cancer|prostate cancer
104023|NCT03553602|HDR brachytherapy|hdr brachytherapy
104024|NCT03553602|Recurrent Prostate Cancer|recurrent prostate cancer
104025|NCT03553602|Oligometastasis|oligometastasis
104026|NCT03553602|Salvage Brachytherapy|salvage brachytherapy
104027|NCT03553602|Salvage Radiotherapy|salvage radiotherapy
104028|NCT03553589|metabolomics|metabolomics
104029|NCT03553589|proteomics|proteomics
104030|NCT03553589|early diagnosis|early diagnosis
104031|NCT03553589|prognosis|prognosis
104032|NCT03553576|Labor pain|labor pain
104033|NCT03553576|Epidural|epidural
104034|NCT03553576|Obstetric|obstetric
104035|NCT03553576|Labor Analgesia|labor analgesia
104036|NCT03553563|D961H|d961h
104037|NCT03553563|paediatric|paediatric
104038|NCT03553563|reflux esophagitis|reflux esophagitis
104039|NCT03553563|gastric ulcer|gastric ulcer
104040|NCT03553537|Peripheral T-cell Lymphoma, decitabine|peripheral t-cell lymphoma, decitabine
104041|NCT03553524|Type 2 Diabetes|type 2 diabetes
104042|NCT03553524|Insulin independent|insulin independent
104043|NCT03553524|HIIT|hiit
104639|NCT03549819|Cannabis|cannabis
104044|NCT03553524|CGM-based blood glucose|cgm-based blood glucose
104045|NCT03553511|Laparoscopy|laparoscopy
104046|NCT03553511|Hysterectomy|hysterectomy
104047|NCT03553511|Uterosacral ligaments suspension|uterosacral ligaments suspension
104048|NCT03553511|McCall culdoplasty|mccall culdoplasty
104049|NCT03553511|Post-hysterectomy vault prolapse|post-hysterectomy vault prolapse
104050|NCT03553498|pain|pain
104051|NCT03553498|opioid analgesics|opioid analgesics
104052|NCT03553498|Emergency Department|emergency department
104053|NCT03553498|randomized controlled trial|randomized controlled trial
104054|NCT03553498|acetaminophen|acetaminophen
104055|NCT03553498|hydromorphone|hydromorphone
104056|NCT03553459|fluid responsiveness|fluid responsiveness
104057|NCT03553459|trendelenburg|trendelenburg
104058|NCT03553459|extracorporeal membrane oxygenation|extracorporeal membrane oxygenation
104059|NCT03553446|Sevoflurane|sevoflurane
104060|NCT03553446|Motion|motion
104061|NCT03553446|Botulinum toxins|botulinum toxins
104062|NCT03553446|Cerebral palsy|cerebral palsy
104063|NCT03553433|apremilast|apremilast
104064|NCT03553433|quality of life|quality of life
104065|NCT03553433|pruritus|pruritus
104066|NCT03553433|oral drug|oral drug
104067|NCT03553433|placebo|placebo
104068|NCT03553420|lipodystrophy|lipodystrophy
104069|NCT03553407|Low level laser|low level laser
104070|NCT03553407|Pulpitis|pulpitis
104071|NCT03553407|Mandibular molars|mandibular molars
104072|NCT03553368|lung nodules|lung nodules
104073|NCT03553355|infrared laser moxibustion|infrared laser moxibustion
104074|NCT03553355|cancer-related fatigue|cancer-related fatigue
104075|NCT03553355|breast cancer|breast cancer
104076|NCT03553290|Dentistry|dentistry
104077|NCT03553290|Dentinal Hypersensitivity|dentinal hypersensitivity
104078|NCT03553290|lower-level laser therapy|lower-level laser therapy
104079|NCT03553277|Dengue|dengue
104080|NCT03553277|Zika|zika
104081|NCT03553277|Chikungunya|chikungunya
104082|NCT03553277|Spatial repellent|spatial repellent
104083|NCT03553277|transfluthrin|transfluthrin
104084|NCT03553251|Hypersensitivity|hypersensitivity
104085|NCT03553251|Beta Lactam Adverse Reaction|beta lactam adverse reaction
104086|NCT03553238|Early T-cell Precursor|early t-cell precursor
104087|NCT03553238|Acute Lymphoblastic Leukemia|acute lymphoblastic leukemia
104088|NCT03553238|Histone Deacetylase Inhibitor|histone deacetylase inhibitor
104089|NCT03553238|Chidamide|chidamide
104090|NCT03553225|vascular function|vascular function
104091|NCT03553225|endothelial function|endothelial function
104092|NCT03553225|polyphenols|polyphenols
104093|NCT03553225|Concord Grape|concord grape
104094|NCT03553212|Prostate cancer|prostate cancer
104095|NCT03553212|organ-confined|organ-confined
104096|NCT03553212|external beam Radiotherapy|external beam radiotherapy
104097|NCT03553212|Image-guided tomotherapy|image-guided tomotherapy
104098|NCT03553199|Tissue Retraction System|tissue retraction system
104099|NCT03553199|Colorectal polyps|colorectal polyps
104100|NCT03553173|Smoking Cessation|smoking cessation
104101|NCT03553173|App|app
104102|NCT03553173|Decision Support System|decision support system
104103|NCT03553147|denutrition screening tool|denutrition screening tool
104104|NCT03553147|SARC-F score|sarc-f score
104105|NCT03553147|denutrition in geriatric population|denutrition in geriatric population
104106|NCT03553147|sarc-f score associated with denutrition|sarc-f score associated with denutrition
104107|NCT03553121|gynecologic cancer|gynecologic cancer
104108|NCT03553121|postoperative bowel function|postoperative bowel function
104109|NCT03553121|walking|walking
104110|NCT03553121|debulking|debulking
104111|NCT03553108|Solid Tumor|solid tumor
104112|NCT03553056|alcohol|alcohol
104113|NCT03553056|hazardous drinking|hazardous drinking
104114|NCT03553056|mobile phone app|mobile phone app
104115|NCT03553056|clinical trial|clinical trial
104116|NCT03553043|consumer behaviour|consumer behaviour
104117|NCT03553043|alcohol labelling|alcohol labelling
104118|NCT03553043|energy labelling|energy labelling
104119|NCT03553017|Optical Coherence Tomography|optical coherence tomography
104120|NCT03553017|Automated|automated
104121|NCT03553017|Binocular|binocular
104122|NCT03553004|Metastatic pancreatic cancer|metastatic pancreatic cancer
104123|NCT03553004|germline mutation|germline mutation
104124|NCT03553004|somatic mutation|somatic mutation
104125|NCT03553004|Niraparib|niraparib
104126|NCT03553004|pancreas|pancreas
104127|NCT03552991|Dietary Fiber|dietary fiber
104128|NCT03552991|Microbiota|microbiota
104130|NCT03552991|Metformin|metformin
104131|NCT03552991|Sulfonylurea Compounds|sulfonylurea compounds
104132|NCT03552965|xerostomia|xerostomia
104133|NCT03552965|Robust photon radiotherapy|robust photon radiotherapy
104134|NCT03552965|Margin based radiotherapy|margin based radiotherapy
104135|NCT03552939|microbiota|microbiota
104136|NCT03552939|breast milk|breast milk
104137|NCT03552939|diet|diet
104138|NCT03552926|Small subcortical infarct|small subcortical infarct
104139|NCT03552926|Cerebrovascular disorders|cerebrovascular disorders
104140|NCT03552926|Neurocognitive and cardiovascular disorders|neurocognitive and cardiovascular disorders
104141|NCT03552926|Disability|disability
104142|NCT03552926|Dementia|dementia
104150|NCT03552887|Adverse Event|adverse event
104151|NCT03552887|Physiotherapy|physiotherapy
104152|NCT03552887|Cardiac Surgery|cardiac surgery
104153|NCT03552861|Parkinson's disease|parkinson's disease
104154|NCT03552861|rTMS|rtms
104155|NCT03552861|Dorsal prefrontal cortex|dorsal prefrontal cortex
104156|NCT03552861|Depression|depression
104157|NCT03552861|Cognitive impairment|cognitive impairment
104158|NCT03552835|no caries removal|no caries removal
104159|NCT03552835|partial caries removal upto soft dentin|partial caries removal upto soft dentin
104160|NCT03552835|partial caries removal upto firm dentin|partial caries removal upto firm dentin
104161|NCT03552783|fathers|fathers
104162|NCT03552783|parenting|parenting
104163|NCT03552783|African American|african american
104164|NCT03552770|neovascular age-related macular degeneration|neovascular age-related macular degeneration
104165|NCT03552770|bevacizumab|bevacizumab
104166|NCT03552770|pro-re-nata regimens|pro-re-nata regimens
104167|NCT03552770|clinical governance|clinical governance
104168|NCT03552718|solid tumors|solid tumors
104175|NCT03552679|Right Heart Failure|right heart failure
104176|NCT03552679|Ventricular Assist Device|ventricular assist device
104177|NCT03552679|Mortality|mortality
104178|NCT03552679|ICU Stay|icu stay
104179|NCT03552679|Acute Kidney Injury|acute kidney injury
104180|NCT03552666|Vitamin D|vitamin d
104181|NCT03552640|Orthodontics|orthodontics
104182|NCT03552640|Digitized Models|digitized models
104183|NCT03552640|Root Position|root position
104184|NCT03552627|hyperoxia|hyperoxia
104185|NCT03552627|oxygen|oxygen
104186|NCT03552627|surgery|surgery
104187|NCT03552627|perioperative|perioperative
104188|NCT03552614|robot-assisted rehabilitation|robot-assisted rehabilitation
104189|NCT03552614|Armeo®Spring|armeo®spring
104190|NCT03552614|quantitative assessment|quantitative assessment
104191|NCT03552575|sacubritil|sacubritil
104192|NCT03552575|valsartan|valsartan
104193|NCT03552575|left ventricular remodelling|left ventricular remodelling
104194|NCT03552575|asymptomatic left ventricular systolic dysfunction|asymptomatic left ventricular systolic dysfunction
104195|NCT03552575|myocardial infarction|myocardial infarction
104196|NCT03552523|bionic pancreas|bionic pancreas
104198|NCT03552497|Radiomics|radiomics
104199|NCT03552497|Bosniak classification|bosniak classification
133419|NCT03368703|COPD|copd
104200|NCT03552497|Renal cell carcinoma|renal cell carcinoma
104201|NCT03552497|Medical imaging|medical imaging
104202|NCT03552458|oral mucositis|oral mucositis
104203|NCT03552458|probiotics|probiotics
104204|NCT03552458|anti-neoplastic chemotherapy|anti-neoplastic chemotherapy
104205|NCT03552432|alirocumab|alirocumab
104206|NCT03552432|Thin-cap fIbroatheroma (TCFA)|thin-cap fibroatheroma (tcfa)
104207|NCT03552432|vulnerable plaque|vulnerable plaque
104208|NCT03552432|Optical Coherence Tomography (OCT)|optical coherence tomography (oct)
104209|NCT03552419|Operating room leveling|operating room leveling
104210|NCT03552419|Obstetric anesthesia|obstetric anesthesia
104211|NCT03552419|Time to incision|time to incision
104212|NCT03552406|Solid tumor|solid tumor
104213|NCT03552406|Breast cancer|breast cancer
104214|NCT03552406|Head & Neck cancer|head & neck cancer
104215|NCT03552367|Obesity|obesity
104216|NCT03552367|Children|children
104217|NCT03552367|Non-alcoholic fatty acid liver disease|non-alcoholic fatty acid liver disease
104218|NCT03552367|Exercise|exercise
104219|NCT03552367|Metabolic syndrome|metabolic syndrome
104220|NCT03552367|Cardiovascular risk|cardiovascular risk
104221|NCT03552341|Iodine|iodine
104222|NCT03552341|Cognitive function|cognitive function
104223|NCT03552341|Birth outcomes|birth outcomes
104224|NCT03552341|Pregnancy|pregnancy
104225|NCT03552302|Yoga|yoga
104226|NCT03552302|Tinnitus|tinnitus
104227|NCT03552302|Sleep|sleep
104228|NCT03552289|Dialysis|dialysis
104229|NCT03552289|Renal|renal
104230|NCT03552289|Hemodialysis|hemodialysis
104231|NCT03552289|Stenosis(es)|stenosis(es)
104232|NCT03552289|Transluminal|transluminal
104233|NCT03552289|Percutaneous Transluminal Angioplasty|percutaneous transluminal angioplasty
104234|NCT03552263|Acute mountain sickness|acute mountain sickness
104235|NCT03552250|Parenting Program|parenting program
104236|NCT03552224|Evoked auditory nerve activity|evoked auditory nerve activity
104237|NCT03552224|Hearing Loss|hearing loss
104238|NCT03552224|Tinnitus|tinnitus
104239|NCT03552211|Multiple Sclerosis|multiple sclerosis
104240|NCT03552211|Progressive Multiple Sclerosis|progressive multiple sclerosis
104241|NCT03552211|Biotin|biotin
104242|NCT03552211|Relapse|relapse
104243|NCT03552198|Air quality alerts|air quality alerts
104244|NCT03552198|Health behaviour change|health behaviour change
104245|NCT03552198|Adherence|adherence
104246|NCT03552185|Neurogenic Dysphagia|neurogenic dysphagia
104247|NCT03552185|Multiple Sclerosis|multiple sclerosis
104248|NCT03552146|sedation|sedation
104249|NCT03552133|variable deadspace|variable deadspace
104250|NCT03552133|rebreathe|rebreathe
104251|NCT03552133|hypercapnic side-effects|hypercapnic side-effects
104252|NCT03552107|Lorcaserin|lorcaserin
104253|NCT03552107|Belviq|belviq
104254|NCT03552094|Arbovirus|arbovirus
104255|NCT03552081|spermatogenesis|spermatogenesis
104256|NCT03552081|tobacco|tobacco
104257|NCT03552081|DNA Fragmentation Index|dna fragmentation index
104258|NCT03552068|Parkinson's disease|parkinson's disease
104259|NCT03552068|Impulse control disorder|impulse control disorder
104260|NCT03552068|Clonidine|clonidine
104261|NCT03552068|Noradrenergic system|noradrenergic system
104262|NCT03552055|placental proteins|placental proteins
104263|NCT03552029|Relapsed/Refractory|relapsed/refractory
104264|NCT03552029|Newly Diagnosed|newly diagnosed
104265|NCT03552029|Unfit for Chemotherapy|unfit for chemotherapy
104266|NCT03552029|Positive for FLT3-ITD Mutation|positive for flt3-itd mutation
104267|NCT03552016|Myopia|myopia
104268|NCT03552016|Axial Myopia|axial myopia
104269|NCT03552016|Children|children
104270|NCT03552016|Refractive Error|refractive error
104271|NCT03552016|Riboflavin|riboflavin
104272|NCT03552016|Vitamin B2|vitamin b2
104273|NCT03552003|Hodgkin|hodgkin
104274|NCT03552003|Elderly patients|elderly patients
104275|NCT03552003|CGA|cga
104276|NCT03551990|Whole-body electromyostimulation|whole-body electromyostimulation
104277|NCT03551990|WB-EMS|wb-ems
104278|NCT03551990|Cancer|cancer
104279|NCT03551990|Muscle atrophy|muscle atrophy
104280|NCT03551990|Muscle protein|muscle protein
104281|NCT03551990|Exercise|exercise
104282|NCT03551990|Muscle fiber|muscle fiber
104283|NCT03551964|Acute myocardial infarction|acute myocardial infarction
104284|NCT03551964|Cardiogenic shock|cardiogenic shock
104285|NCT03551964|Primary percutaneous coronary intervention|primary percutaneous coronary intervention
104286|NCT03551964|Dual antiplatelet therapy|dual antiplatelet therapy
104287|NCT03551964|Cangrelor|cangrelor
104288|NCT03551964|Ticagrelor|ticagrelor
104289|NCT03551938|HIV, telehealth, HIV testing, YMSM, couples|hiv, telehealth, hiv testing, ymsm, couples
104290|NCT03551873|Breast milk|breast milk
104291|NCT03551873|Lactating|lactating
104292|NCT03551860|Total hip replacement|total hip replacement
104293|NCT03551860|Motor block post-operatively|motor block post-operatively
104294|NCT03551860|Morphine consumption post-operatively|morphine consumption post-operatively
104295|NCT03551860|Transmuscular Quadratus Nerve Block|transmuscular quadratus nerve block
104296|NCT03551860|Fascia Iliaca Nerve Block|fascia iliaca nerve block
104297|NCT03551704|Smoking|smoking
104298|NCT03551704|Substance addiction|substance addiction
104299|NCT03551704|Cocaine|cocaine
104300|NCT03551704|Alcohol|alcohol
104301|NCT03551704|Behavioral treatment|behavioral treatment
104302|NCT03551691|fat absorption|fat absorption
104303|NCT03551691|pancreatic enzyme|pancreatic enzyme
104304|NCT03551665|Multiple Sclerosis|multiple sclerosis
104305|NCT03551665|Falls|falls
104306|NCT03551665|Posture|posture
104307|NCT03551665|Rehabilitation|rehabilitation
104308|NCT03551665|Cognition|cognition
104309|NCT03551665|Neuroimaging|neuroimaging
104310|NCT03551626|dabrafenib|dabrafenib
104311|NCT03551626|trametinib|trametinib
104312|NCT03551626|adjuvant|adjuvant
104313|NCT03551626|melanoma|melanoma
104314|NCT03551626|combination treatment|combination treatment
104315|NCT03551626|pyrexia|pyrexia
104316|NCT03551600|Near-infrared spectroscopy (NIRS)|near-infrared spectroscopy (nirs)
104317|NCT03551600|renal oxygen saturations|renal oxygen saturations
104318|NCT03551600|splanchnic oxygen saturations|splanchnic oxygen saturations
104319|NCT03551561|Chlorhexidine|chlorhexidine
104320|NCT03551561|Infection|infection
104321|NCT03551561|Orthopedics|orthopedics
104322|NCT03551561|Surgical rooms|surgical rooms
104323|NCT03551561|Antisepsis|antisepsis
104324|NCT03551561|Surgical Procedures.|surgical procedures.
104325|NCT03551535|Wearable technology|wearable technology
104326|NCT03551535|Pregnancy|pregnancy
104327|NCT03551535|Exercise|exercise
104328|NCT03551535|Mobile Health|mobile health
104329|NCT03551509|Rotator Cuff Tear|rotator cuff tear
104330|NCT03551509|Large Rotator Cuff Tear|large rotator cuff tear
104331|NCT03551509|Massive Rotator Cuff Tear|massive rotator cuff tear
104332|NCT03551509|ECM|ecm
104333|NCT03551509|Extracellular Matrix|extracellular matrix
104334|NCT03551509|ArthroFLEX|arthroflex
104335|NCT03551483|Arts-based Intervention|arts-based intervention
104336|NCT03551483|Mobile Health|mobile health
104337|NCT03551483|Online Recreation|online recreation
104338|NCT03551470|robotic|robotic
104339|NCT03551470|laparoscopy|laparoscopy
104340|NCT03551470|liver surgery|liver surgery
104341|NCT03551470|colorectal and synchronous liver metastases|colorectal and synchronous liver metastases
104342|NCT03551470|simultaneous surgery|simultaneous surgery
104343|NCT03551457|Patient Derived Xenograft|patient derived xenograft
104344|NCT03551457|Treatment Response Phenotype|treatment response phenotype
104345|NCT03551457|Personalised|personalised
104346|NCT03551392|Cognitive Aging|cognitive aging
104347|NCT03551392|Photobiomodulation|photobiomodulation
104348|NCT03551392|Low Level Light Therapy|low level light therapy
104349|NCT03551392|Near Infrared (NIR) Light|near infrared (nir) light
104350|NCT03551392|Neuromodulation|neuromodulation
104351|NCT03551379|Endoscopic Submucosal Dissection|endoscopic submucosal dissection
104352|NCT03551366|Physical Activity|physical activity
104353|NCT03551366|Physical Education|physical education
104354|NCT03551366|Children|children
104355|NCT03551366|Pedagogy|pedagogy
104356|NCT03551366|Motor Competence|motor competence
104357|NCT03551366|Perceived Motor Competence|perceived motor competence
104358|NCT03551366|Self-perception|self-perception
104359|NCT03551366|Cognition|cognition
104360|NCT03551366|Fundamental Movement Skills|fundamental movement skills
104361|NCT03551353|video feedback|video feedback
104362|NCT03551353|checkout prosedures|checkout prosedures
104363|NCT03551340|Gastroenteritis, panel by PCR, antibiotic use|gastroenteritis, panel by pcr, antibiotic use
104364|NCT03551327|Post-stroke fatigue|post-stroke fatigue
104365|NCT03551314|Non-invasive ventilation|non-invasive ventilation
104366|NCT03551314|Preterm infant|preterm infant
104367|NCT03551314|Breathing pattern|breathing pattern
104368|NCT03551301|Substance Use Disorders|substance use disorders
104369|NCT03551301|Case Management|case management
104370|NCT03551301|Community Treatment|community treatment
104371|NCT03551301|Hospital discharge|hospital discharge
104372|NCT03551288|SUVN-911|suvn-911
104373|NCT03551288|Depression|depression
104374|NCT03551288|alpha4 beta2 receptor|alpha4 beta2 receptor
104375|NCT03551275|BCD-132|bcd-132
104376|NCT03551275|Multiple Sclerosis|multiple sclerosis
104377|NCT03551275|anti-CD20|anti-cd20
104378|NCT03551210|nemonoxacin|nemonoxacin
104627|NCT03549845|Healthcare Utilization|healthcare utilization
104379|NCT03551210|community-acquired pneumonia|community-acquired pneumonia
104380|NCT03551210|quinolones|quinolones
104381|NCT03551197|Pulmonary Disease, Chronic Obstructive|pulmonary disease, chronic obstructive
104382|NCT03551197|exercise|exercise
104383|NCT03551197|lung function|lung function
104384|NCT03551197|quality of life|quality of life
104385|NCT03551184|Sickness behavior|sickness behavior
104386|NCT03551184|Endotoxin|endotoxin
104387|NCT03551184|Lipopolysaccharide|lipopolysaccharide
104388|NCT03551184|Psychoneuroimmunology|psychoneuroimmunology
104389|NCT03551171|PARP inhibitor|parp inhibitor
104390|NCT03551171|BRCA mutation|brca mutation
104391|NCT03551132|elderly|elderly
104392|NCT03551132|resistance training|resistance training
104393|NCT03551132|health|health
104394|NCT03551106|e-learning|e-learning
104395|NCT03551106|web based learning module|web based learning module
104396|NCT03551093|Ischemic Stroke|ischemic stroke
104397|NCT03551093|Mild Acute Ischemic Stroke|mild acute ischemic stroke
104398|NCT03551093|Safety|safety
104399|NCT03551093|Signal of Efficacy|signal of efficacy
104400|NCT03551080|Sickness behavior|sickness behavior
104401|NCT03551080|Cytokines|cytokines
104402|NCT03551080|Psychoneuroimmunology|psychoneuroimmunology
104403|NCT03551067|Dexmedetomidine|dexmedetomidine
104404|NCT03551067|Adenotonsillectomy|adenotonsillectomy
104405|NCT03551067|Parental Separation|parental separation
104406|NCT03551067|Face Mask Acceptance|face mask acceptance
104407|NCT03551041|depression, self-referential, neural representation|depression, self-referential, neural representation
104408|NCT03551015|Coronary Artery Bypass Grafting|coronary artery bypass grafting
104409|NCT03551015|Median sternotomy|median sternotomy
104410|NCT03551015|Post-operative outpatient review|post-operative outpatient review
104411|NCT03551015|Cardiac rehabilitation|cardiac rehabilitation
104412|NCT03551015|Quality of life|quality of life
104413|NCT03551002|HIV|hiv
104414|NCT03551002|Hepatitis C|hepatitis c
104415|NCT03551002|Direct acting antivirals|direct acting antivirals
104416|NCT03551002|Hepatitis C modeling|hepatitis c modeling
104417|NCT03550989|Environmental Aerosol Exposure|environmental aerosol exposure
104418|NCT03550989|Environmental Tobacco Smoke|environmental tobacco smoke
104419|NCT03550989|Indoor Air Quality|indoor air quality
104420|NCT03550898|Dynamic Ultrasonography|dynamic ultrasonography
104421|NCT03550898|Spinal Dysraphism|spinal dysraphism
104422|NCT03550885|microbiome, human|microbiome, human
104423|NCT03550885|bile acids and salts|bile acids and salts
104424|NCT03550885|diet, western|diet, western
104425|NCT03550872|heart failure, atrial fibrillation and exercise training|heart failure, atrial fibrillation and exercise training
104426|NCT03550846|Spinal Fusion|spinal fusion
104427|NCT03550833|Rheumatoid arthritis|rheumatoid arthritis
104428|NCT03550833|Stress|stress
104429|NCT03550820|pulmonary MAC|pulmonary mac
104430|NCT03550820|energy metabolism|energy metabolism
104431|NCT03550781|Takayasu Arteritis|takayasu arteritis
104432|NCT03550781|Anti-Inflammatory Agents|anti-inflammatory agents
104433|NCT03550781|Positron Emission Tomography Computed Tomography|positron emission tomography computed tomography
104434|NCT03550768|ERCP|ercp
104435|NCT03550768|anatomy of major duodenal papilla|anatomy of major duodenal papilla
104436|NCT03550755|cervix|cervix
104437|NCT03550755|uterus|uterus
104438|NCT03550742|Human Milk Oligosaccharides|human milk oligosaccharides
104439|NCT03550742|IBS-C|ibs-c
104440|NCT03550742|IBS-D|ibs-d
104441|NCT03550742|IBS-M|ibs-m
104442|NCT03550729|Exercise training|exercise training
104443|NCT03550729|Biomarkers|biomarkers
104444|NCT03550716|azoospermia|azoospermia
104445|NCT03550716|microdissection testicular sperm extraction|microdissection testicular sperm extraction
104446|NCT03550716|testicular sperm aspiration|testicular sperm aspiration
104447|NCT03550716|male infertility|male infertility
104448|NCT03550716|surgical sperm retrieval|surgical sperm retrieval
104449|NCT03550677|Ankle nerve block|ankle nerve block
104450|NCT03550677|post operative analgesia|post operative analgesia
104451|NCT03550677|patient satisfaction|patient satisfaction
104452|NCT03550677|foot surgery|foot surgery
104453|NCT03550651|Plaque|plaque
104454|NCT03550651|Plaque regrowth|plaque regrowth
104455|NCT03550651|Licorice extract|licorice extract
104456|NCT03550651|Mouthrinse|mouthrinse
104457|NCT03550651|Chlorhexidine mouthrinse|chlorhexidine mouthrinse
104458|NCT03550651|Hypertonic salt solution|hypertonic salt solution
104459|NCT03550651|Essential oils|essential oils
104460|NCT03550573|Hypertrophic cardiomyopathy|hypertrophic cardiomyopathy
104461|NCT03550573|sudden death|sudden death
104462|NCT03550573|3D mapping|3d mapping
104463|NCT03550560|Endoscopic Ultrasound-Guided|endoscopic ultrasound-guided
104464|NCT03550560|EUS-Guided|eus-guided
104465|NCT03550560|Transgastric plastic prostheses|transgastric plastic prostheses
104466|NCT03550547|Physical Activity|physical activity
104467|NCT03550547|Education|education
104468|NCT03550547|Dietary|dietary
104469|NCT03550547|Self-management|self-management
104470|NCT03550534|Calcium carbonate|calcium carbonate
104471|NCT03550534|Chronic kidney disease|chronic kidney disease
104472|NCT03550534|Normophosphatemia|normophosphatemia
104473|NCT03550534|FGF23|fgf23
104474|NCT03550534|Phosphate binder|phosphate binder
104475|NCT03550508|JMT103 in Patients with Bone Metastases from Tumors|jmt103 in patients with bone metastases from tumors
104476|NCT03550495|ICU delirium|icu delirium
104477|NCT03550495|prevention|prevention
104478|NCT03550495|psychiatry|psychiatry
104479|NCT03550482|Oncoxin|oncoxin
104480|NCT03550482|Nutritional supplement|nutritional supplement
104481|NCT03550482|Chemotherapy|chemotherapy
104482|NCT03550482|Oxidative stress|oxidative stress
104483|NCT03550482|Antioxidant|antioxidant
104484|NCT03550469|hyperoxia|hyperoxia
104485|NCT03550469|hypoxia|hypoxia
104486|NCT03550456|Exercise Induced Asthma (EIA)|exercise induced asthma (eia)
104487|NCT03550456|Exercise Induced Laryngeal Obstruction (EILO)|exercise induced laryngeal obstruction (eilo)
133783|NCT03366428|ADC|adc
104488|NCT03550456|Quality of life|quality of life
104489|NCT03550456|Exercise challenge in cold chamber (ECC)|exercise challenge in cold chamber (ecc)
104490|NCT03550456|Continous laryngoscopy while exercising (CLE)|continous laryngoscopy while exercising (cle)
104491|NCT03550443|Bardoxolone Methyl|bardoxolone methyl
104492|NCT03550443|Diabetic Kidney Disease|diabetic kidney disease
104493|NCT03550443|Diabetes Mellitus|diabetes mellitus
104494|NCT03550443|Kidney Diseases|kidney diseases
104495|NCT03550430|tinnitus distress|tinnitus distress
104496|NCT03550430|tinnitus intrusiveness|tinnitus intrusiveness
104497|NCT03550430|synchronization by loss of inhibition model (SLIM)|synchronization by loss of inhibition model (slim)
104498|NCT03550430|neurofeedback|neurofeedback
104499|NCT03550430|alpha/delta neurofeedback|alpha/delta neurofeedback
104500|NCT03550430|beta/theta neurofeedback|beta/theta neurofeedback
104501|NCT03550430|electroencephalography (EEG)|electroencephalography (eeg)
104502|NCT03550430|tinnitus intensity|tinnitus intensity
104503|NCT03550430|tinnitus loudness|tinnitus loudness
104504|NCT03550417|disease management|disease management
104505|NCT03550417|best practice guidelines|best practice guidelines
104506|NCT03550378|Type 2 Diabetes Mellitus|type 2 diabetes mellitus
104507|NCT03550378|MEDI0382|medi0382
104508|NCT03550378|Renal Impairment|renal impairment
104509|NCT03550352|HIV|hiv
104510|NCT03550352|Cannabinoids|cannabinoids
104511|NCT03550352|HIV reservoir|hiv reservoir
104512|NCT03550352|Microbiome|microbiome
104513|NCT03550352|CBD|cbd
104514|NCT03550352|THC|thc
104515|NCT03550352|Inflammation|inflammation
104516|NCT03550352|Immune activation|immune activation
104517|NCT03550339|obesity|obesity
104518|NCT03550339|appetite|appetite
104519|NCT03550339|food reward|food reward
104520|NCT03550339|hormonal responses|hormonal responses
104521|NCT03550339|psychophysiological responses|psychophysiological responses
104522|NCT03550339|implicit measures|implicit measures
104523|NCT03550339|explicit measures|explicit measures
104524|NCT03550326|anesthesia|anesthesia
104525|NCT03550326|difficult airway|difficult airway
104526|NCT03550326|supraglottic airway device|supraglottic airway device
104527|NCT03550326|difficult intubation|difficult intubation
104528|NCT03550326|airway complications|airway complications
104529|NCT03550274|Acute lateral ankle sprain|acute lateral ankle sprain
104530|NCT03550274|Acute ankle injury|acute ankle injury
104531|NCT03550274|Ankle sprain|ankle sprain
104532|NCT03550274|Exercise therapy|exercise therapy
104533|NCT03550274|App-based rehabilitation|app-based rehabilitation
104534|NCT03550274|Mixed-method|mixed-method
104535|NCT03550274|Pilot Study|pilot study
104537|NCT03550261|Salt-wasting|salt-wasting
104538|NCT03550261|LC-MSMS|lc-msms
104539|NCT03550261|plasma and urine steroid profile|plasma and urine steroid profile
104540|NCT03550261|Fludrocortisone|fludrocortisone
104541|NCT03550248|Healthy Weights|healthy weights
104542|NCT03550248|Health Promotion|health promotion
104543|NCT03550248|Scale-up|scale-up
104544|NCT03550248|Family Health|family health
104545|NCT03550248|Prevention|prevention
104546|NCT03550248|Childhood Obesity|childhood obesity
104547|NCT03550248|Physical Activity|physical activity
104548|NCT03550248|Cooking Activity|cooking activity
104549|NCT03550248|Family education model|family education model
104550|NCT03550235|Heart failure|heart failure
104551|NCT03550235|dyspnea|dyspnea
104552|NCT03550235|stress test|stress test
104553|NCT03550222|Diaphragmatic dysfunction|diaphragmatic dysfunction
104554|NCT03550222|Mechanical Ventilation|mechanical ventilation
104555|NCT03550222|ICU acquired weakness|icu acquired weakness
104556|NCT03550222|Weaning|weaning
104557|NCT03550222|Skeletal muscles|skeletal muscles
104558|NCT03550222|Respiratory muscles|respiratory muscles
104559|NCT03550170|Fatigue|fatigue
104560|NCT03550170|Wellness|wellness
104561|NCT03550170|Multiple Sclerosis|multiple sclerosis
104562|NCT03550170|Quality of life|quality of life
104563|NCT03550157|Cellulite|cellulite
104564|NCT03550157|Cutaneous ultrasound|cutaneous ultrasound
104565|NCT03550157|PnKCelulitis® program|pnkcelulitis® program
104566|NCT03550144|Awe|awe
104567|NCT03550144|Compassion|compassion
104568|NCT03550144|Anxiety|anxiety
104569|NCT03550144|Positive emotions|positive emotions
104570|NCT03550144|Aging|aging
104571|NCT03550131|LGBT|lgbt
104572|NCT03550118|Prosthetic Socket|prosthetic socket
104573|NCT03550118|Amputee|amputee
104574|NCT03550118|Adjustable Socket|adjustable socket
104575|NCT03550105|Glucose|glucose
104576|NCT03550105|Diabetes|diabetes
104577|NCT03550105|Physical Activity|physical activity
104578|NCT03550105|Passive Exercise|passive exercise
104579|NCT03550105|Blood Pressure|blood pressure
104580|NCT03550105|Muscle Strength|muscle strength
104581|NCT03550105|Muscle Endurance|muscle endurance
104582|NCT03550105|Hypertension|hypertension
104583|NCT03550105|Physical Inactivity|physical inactivity
104584|NCT03550092|aphasia|aphasia
104585|NCT03550092|treatment|treatment
104586|NCT03550092|therapy|therapy
104587|NCT03550092|anomia|anomia
104588|NCT03550092|fMRI|fmri
104589|NCT03550092|neuroimaging|neuroimaging
104590|NCT03550092|semantics|semantics
104591|NCT03550066|Diabetes, gestational|diabetes, gestational
104592|NCT03550066|Diabetes Mellitus|diabetes mellitus
104593|NCT03550040|radical prostatectomy|radical prostatectomy
104594|NCT03550040|laparoscopic prostatectomy|laparoscopic prostatectomy
104595|NCT03550040|robot assisted prostatectomy|robot assisted prostatectomy
104596|NCT03550014|Low Back Pain|low back pain
104597|NCT03550014|Hip|hip
104598|NCT03550014|Physical Therapy|physical therapy
104599|NCT03550001|locally advanced rectal cancer|locally advanced rectal cancer
104600|NCT03550001|lymph node yeild|lymph node yeild
104601|NCT03550001|lymph node tracer|lymph node tracer
104602|NCT03550001|stage shift|stage shift
104603|NCT03550001|prognosis|prognosis
104604|NCT03549988|Ulcerative colitis|ulcerative colitis
104605|NCT03549988|Fecal calprotectin|fecal calprotectin
104606|NCT03549975|stroke|stroke
104607|NCT03549975|hand|hand
104608|NCT03549975|botulinum toxin|botulinum toxin
104609|NCT03549975|functional electrical stimulation|functional electrical stimulation
104610|NCT03549962|Preoperative|preoperative
104611|NCT03549962|Nutritional Status|nutritional status
104612|NCT03549962|Arthroplasty|arthroplasty
104613|NCT03549962|Replacement|replacement
104614|NCT03549962|Osteoarthritis|osteoarthritis
104615|NCT03549962|Knee|knee
104616|NCT03549949|pulmonary arteriovenous malformations|pulmonary arteriovenous malformations
104617|NCT03549936|NAS, low lactose formula|nas, low lactose formula
104618|NCT03549923|extracorporeal membrane oxygenation|extracorporeal membrane oxygenation
104619|NCT03549923|renal replacement therapy|renal replacement therapy
104620|NCT03549923|beta-blocker|beta-blocker
104621|NCT03549884|Early cord Clamping|early cord clamping
104622|NCT03549884|Delayed cord clamping|delayed cord clamping
104623|NCT03549884|Full term infant|full term infant
104624|NCT03549884|Elective cesarean section|elective cesarean section
104625|NCT03549884|Hematocrit|hematocrit
104626|NCT03549884|Postnatal adaptation|postnatal adaptation
104628|NCT03549845|Emergency Department|emergency department
104629|NCT03549845|Hospitalization|hospitalization
104630|NCT03549845|Low Income|low income
104631|NCT03549845|Social Housing|social housing
104632|NCT03549845|Older Adults|older adults
104633|NCT03549845|Quality of Life|quality of life
104634|NCT03549832|HCV|hcv
104635|NCT03549832|DAAs|daas
104636|NCT03549832|Non-responder|non-responder
104637|NCT03549819|Anxiety Disorders|anxiety disorders
104638|NCT03549819|Cannabidiol|cannabidiol
104640|NCT03549806|Atrium, tachyarrhythmias|atrium, tachyarrhythmias
104641|NCT03549780|Brooke Ileostomy|brooke ileostomy
104642|NCT03549780|stoma|stoma
104643|NCT03549780|ileostomy|ileostomy
104644|NCT03549754|Registry|registry
104645|NCT03549754|Type 2 Diabetes|type 2 diabetes
104646|NCT03549754|T2DM|t2dm
104647|NCT03549754|Adult population|adult population
104648|NCT03549728|endometriosis|endometriosis
104649|NCT03549728|granulocyte colony-stimulating factor|granulocyte colony-stimulating factor
104650|NCT03549728|recurrent implantation failure|recurrent implantation failure
104651|NCT03549676|FMT|fmt
104652|NCT03549676|GVHD|gvhd
104653|NCT03549676|HSCT|hsct
104654|NCT03549650|Non-Muscle-Invasive Bladder Cancer|non-muscle-invasive bladder cancer
104655|NCT03549650|LUTS|luts
104656|NCT03549637|Psychiatry, hypobetalipoproteinemia, LDL-Cholesterol|psychiatry, hypobetalipoproteinemia, ldl-cholesterol
104657|NCT03549611|ureteroscopy|ureteroscopy
104658|NCT03549611|opioids|opioids
104659|NCT03549611|narcotics|narcotics
104660|NCT03549611|text messaging|text messaging
104661|NCT03549611|real time data acquisition|real time data acquisition
104662|NCT03549611|ecologic momentary assessments|ecologic momentary assessments
104663|NCT03549611|pre-emptive analgesia|pre-emptive analgesia
104664|NCT03549611|gabapentin|gabapentin
104665|NCT03549611|meloxicam|meloxicam
104666|NCT03549611|tamsulosin|tamsulosin
104667|NCT03549611|kidney stones|kidney stones
104668|NCT03549611|lithotripsy|lithotripsy
104669|NCT03549611|nephrolithiasis|nephrolithiasis
104670|NCT03549585|End of life|end of life
104671|NCT03549585|Spotting|spotting
104672|NCT03549585|Emergency|emergency
104673|NCT03549585|criSTAL|cristal
104674|NCT03549546|Lymphopenia|lymphopenia
104675|NCT03549546|Lung cancer surgery|lung cancer surgery
104676|NCT03549546|TIM-3|tim-3
104677|NCT03549546|PD-1|pd-1
104678|NCT03549546|CTLA-4|ctla-4
104679|NCT03549546|lymphocytes|lymphocytes
104680|NCT03549546|CD4|cd4
104681|NCT03549546|CD8|cd8
104682|NCT03549533|Aluminum|aluminum
104683|NCT03549533|Sperm|sperm
104684|NCT03549533|DNA methylation|dna methylation
104685|NCT03549533|DNA fragmentation|dna fragmentation
104686|NCT03549533|Seminal plasma|seminal plasma
104687|NCT03549520|Ultrasound|ultrasound
104688|NCT03549520|Contrast-enhanced ultrasound|contrast-enhanced ultrasound
104689|NCT03549507|Ultrasound|ultrasound
104690|NCT03549507|Contrast-enhanced ultrasound|contrast-enhanced ultrasound
104691|NCT03549481|risk score|risk score
104692|NCT03549481|acute coronary syndrome|acute coronary syndrome
104693|NCT03549481|left ventricular remodelng|left ventricular remodelng
104694|NCT03549468|ischemic cardiomyopathy; neuromodulation; repolarization alternans|ischemic cardiomyopathy; neuromodulation; repolarization alternans
104695|NCT03549455|anxious|anxious
104696|NCT03549455|anxiety|anxiety
104697|NCT03549442|Multiple Myeloma|multiple myeloma
104698|NCT03549442|BCMA CART|bcma cart
104699|NCT03549442|huCART19|hucart19
104700|NCT03549416|Atopic dermatitis|atopic dermatitis
104701|NCT03549416|Dupilumab|dupilumab
104702|NCT03549416|Dupixent|dupixent
104703|NCT03549416|BioDay|bioday
104704|NCT03549416|Daily practice|daily practice
104705|NCT03549416|Real world|real world
104706|NCT03549416|Atopic Diseases Registry|atopic diseases registry
104707|NCT03549416|Registry|registry
104708|NCT03549416|Multi center|multi center
104709|NCT03549403|Telephone education|telephone education
104710|NCT03549403|Effectiveness|effectiveness
104711|NCT03549403|Health|health
104712|NCT03549403|Cost|cost
104713|NCT03549403|Day surgery|day surgery
104714|NCT03549403|Adult patient|adult patient
104715|NCT03549390|Type 2 diabetes|type 2 diabetes
104716|NCT03549390|ethnicity|ethnicity
104717|NCT03549390|physical activity|physical activity
104718|NCT03549390|yoga|yoga
104719|NCT03549377|Sleep|sleep
104720|NCT03549377|Academic functioning|academic functioning
104721|NCT03549377|Problem behaviors|problem behaviors
104722|NCT03549377|College age youth|college age youth
104723|NCT03549377|Self-regulation|self-regulation
104724|NCT03549351|Leukemia, Myeloid, Acute|leukemia, myeloid, acute
104725|NCT03549351|measurable residual disease|measurable residual disease
104726|NCT03549351|surrogate endpoint|surrogate endpoint
104727|NCT03549351|multiparameter flow cytometry|multiparameter flow cytometry
104728|NCT03549338|Metastatic Colorectal Cancer|metastatic colorectal cancer
104729|NCT03549338|Colorectal Cancer|colorectal cancer
104730|NCT03549338|Carcinoma|carcinoma
104731|NCT03549338|Sym004|sym004
104732|NCT03549338|futuximab|futuximab
104733|NCT03549338|modotuximab|modotuximab
104734|NCT03549325|Neisseria lactamica|neisseria lactamica
104735|NCT03549325|healthy volunteers|healthy volunteers
104736|NCT03549325|nasal inoculation|nasal inoculation
104737|NCT03549325|colonisation|colonisation
104738|NCT03549312|HIV|hiv
104739|NCT03549312|HCV|hcv
104740|NCT03549312|Hepatitis C|hepatitis c
104741|NCT03549312|Methadone|methadone
104742|NCT03549312|HIV/HCV Co-Infection|hiv/hcv co-infection
104743|NCT03549312|Opioid Substitution Therapy|opioid substitution therapy
104744|NCT03549312|Drug Abuse|drug abuse
104745|NCT03549299|limbal stem cell deficiency|limbal stem cell deficiency
104746|NCT03549299|ABCB5|abcb5
104747|NCT03549299|Limbal stem cells|limbal stem cells
104748|NCT03549299|LSCs|lscs
104749|NCT03549299|LSC|lsc
104750|NCT03549299|allogeneic|allogeneic
104751|NCT03549299|tissue engineered product|tissue engineered product
104752|NCT03549299|phase I/IIa|phase i/iia
104753|NCT03549286|Pregnancy|pregnancy
104754|NCT03549286|Down's syndrome|down's syndrome
104755|NCT03549286|non invasive prenatal testing|non invasive prenatal testing
104756|NCT03549273|carcinoma|carcinoma
104757|NCT03549273|intraepithelial cervix lesions|intraepithelial cervix lesions
104758|NCT03549273|Oxidative Stress|oxidative stress
104759|NCT03549273|Ocoxin Viusid|ocoxin viusid
104760|NCT03549273|Glizigen Spray|glizigen spray
104761|NCT03549260|low density lipoprotein cholesterol|low density lipoprotein cholesterol
104762|NCT03549260|PCSK9|pcsk9
104763|NCT03549247|OHIP-14|ohip-14
104764|NCT03549247|Periodontitis|periodontitis
104765|NCT03549234|Regional anesthesia|regional anesthesia
104766|NCT03549234|Paravertebral|paravertebral
104767|NCT03549234|Erector spinae|erector spinae
104768|NCT03549234|Nerve block|nerve block
104769|NCT03549221|total knee arthroplasty|total knee arthroplasty
104770|NCT03549221|multimodal anesthetic cocktail|multimodal anesthetic cocktail
104771|NCT03549221|adrenaline|adrenaline
104772|NCT03549221|morphine consumption|morphine consumption
104773|NCT03549221|blood loss|blood loss
104774|NCT03549221|Levobupivacaine|levobupivacaine
104775|NCT03549182|acute tryptophan depletion|acute tryptophan depletion
104776|NCT03549182|tryptophan hydroxylase 2 gene|tryptophan hydroxylase 2 gene
104777|NCT03549182|emotion|emotion
104778|NCT03549169|Intervention|intervention
104779|NCT03549169|Heart Failure|heart failure
104780|NCT03549169|Symptoms management|symptoms management
104781|NCT03549169|Selft-care|selft-care
104782|NCT03549156|Moderate Acute Malnutrition, Malnutrition|moderate acute malnutrition, malnutrition
104783|NCT03549143|IBS; Irritable Bowel Syndrome; spasmolytics; mebeverine; Duspatalin|ibs; irritable bowel syndrome; spasmolytics; mebeverine; duspatalin
104784|NCT03549104|fear of hypoglycemia|fear of hypoglycemia
104785|NCT03549104|glycemic control|glycemic control
104786|NCT03549104|glycemic variability|glycemic variability
104787|NCT03549104|self-management behavior|self-management behavior
104788|NCT03549065|Brain stimulation|brain stimulation
104789|NCT03549039|quality of life|quality of life
104790|NCT03549039|cleft lip|cleft lip
104791|NCT03549039|cleft palate|cleft palate
104792|NCT03549013|Tumor-related Trigeminal Neuralgia|tumor-related trigeminal neuralgia
104793|NCT03549013|Percutaneous Radiofrequency Thermocoagulation|percutaneous radiofrequency thermocoagulation
104794|NCT03549013|Three‐dimensional Computed Tomography|three‐dimensional computed tomography
104795|NCT03549000|NZV930|nzv930
104796|NCT03549000|PDR001|pdr001
104797|NCT03549000|NIR178|nir178
104798|NCT03549000|Immune checkpoint inhibitor|immune checkpoint inhibitor
104799|NCT03549000|immunotherapy|immunotherapy
104800|NCT03549000|CD73|cd73
104801|NCT03549000|PD-1|pd-1
104802|NCT03549000|PD-L1|pd-l1
104803|NCT03549000|A2aR|a2ar
104804|NCT03549000|Adenosine|adenosine
104805|NCT03548974|Multiple Sclerosis|multiple sclerosis
104806|NCT03548974|Spasticity|spasticity
104807|NCT03548974|MOTOmed training|motomed training
104808|NCT03548974|internet|internet
104809|NCT03548922|Risser|risser
104810|NCT03548922|Tanner|tanner
104811|NCT03548922|pressure of correction|pressure of correction
104812|NCT03548909|NT-proBNP|nt-probnp
104813|NCT03548896|implant|implant
104814|NCT03548857|Muscle dysfunction|muscle dysfunction
104815|NCT03548857|Cardiovascular regulation|cardiovascular regulation
104816|NCT03548857|Lung transplantation (LTx)|lung transplantation (ltx)
104817|NCT03548831|Minilaparotomy|minilaparotomy
104818|NCT03548831|Hysterectomy|hysterectomy
104819|NCT03548831|Laparoscopic assisted vaginal hysterectomy|laparoscopic assisted vaginal hysterectomy
104820|NCT03548831|Benign|benign
104821|NCT03548831|Gynaecology|gynaecology
104822|NCT03548792|Arthroplasty Knee|arthroplasty knee
104823|NCT03548753|Angina|angina
104824|NCT03548753|Chest pain|chest pain
104825|NCT03548753|Diagnostic tests|diagnostic tests
104826|NCT03548714|Alcohol|alcohol
104827|NCT03548714|Alcoholic|alcoholic
104828|NCT03548714|Alcoholism|alcoholism
104829|NCT03548714|Alcohol abuse|alcohol abuse
104830|NCT03548714|Alcohol interaction|alcohol interaction
104831|NCT03548714|Alcohol Use Disorder|alcohol use disorder
104832|NCT03548714|Alcohol use|alcohol use
104833|NCT03548714|Alcohol dependence|alcohol dependence
104834|NCT03548714|Alcohol dependent|alcohol dependent
104835|NCT03548714|Ethanol abuse|ethanol abuse
104836|NCT03548714|Ethanol use|ethanol use
104837|NCT03548701|Thromboelastometry|thromboelastometry
104838|NCT03548701|Vaginal Bleeding|vaginal bleeding
104839|NCT03548701|Early Pregnancy|early pregnancy
104840|NCT03548688|Bladder Cancer|bladder cancer
104841|NCT03548688|Haematuria|haematuria
104842|NCT03548688|Collaborative study|collaborative study
104843|NCT03548675|Pharmacogenetics|pharmacogenetics
104844|NCT03548675|Antidepressive Agents|antidepressive agents
104945|NCT03548051|Safety|safety
104845|NCT03548662|Rotator Cuff Tear|rotator cuff tear
104846|NCT03548662|Platelet Rich Plasma|platelet rich plasma
104847|NCT03548662|Ultrasound|ultrasound
104848|NCT03548662|Exercise|exercise
104849|NCT03548662|Hyaluronic Acid|hyaluronic acid
104850|NCT03548649|spinal cord injury|spinal cord injury
104851|NCT03548649|complete spinal cord injury|complete spinal cord injury
104852|NCT03548649|incomplete spinal cord injury|incomplete spinal cord injury
104853|NCT03548649|exoskeleton robot|exoskeleton robot
104854|NCT03548649|gait training|gait training
104855|NCT03548649|security testing|security testing
104856|NCT03548649|functional testing|functional testing
104857|NCT03548623|Hypertension|hypertension
104858|NCT03548623|renal denervation|renal denervation
104859|NCT03548623|preference|preference
104860|NCT03548623|shared decision making|shared decision making
104861|NCT03548610|nanofat|nanofat
104862|NCT03548610|tumor defect|tumor defect
104863|NCT03548584|Agitation|agitation
104864|NCT03548558|Early Childhood Development|early childhood development
104865|NCT03548558|Parenting Behaviors|parenting behaviors
104866|NCT03548558|Group-based curriculum|group-based curriculum
104867|NCT03548558|Kenya|kenya
104868|NCT03548558|Child Outcomes|child outcomes
104869|NCT03548558|Community Health Volunteers|community health volunteers
104870|NCT03548545|MDD|mdd
104871|NCT03548545|CBT|cbt
104872|NCT03548545|tDCS|tdcs
104873|NCT03548532|temperature|temperature
104874|NCT03548506|STN|stn
104875|NCT03548506|DBS|dbs
104876|NCT03548506|steering|steering
104877|NCT03548506|segmented electrode leads|segmented electrode leads
104878|NCT03548493|Magnesium sulphate|magnesium sulphate
104879|NCT03548493|Fentanyl|fentanyl
104880|NCT03548493|Conscious sedation|conscious sedation
104881|NCT03548493|chronic subdural haematoma|chronic subdural haematoma
104882|NCT03548493|Propofol|propofol
104883|NCT03548493|Burr hole|burr hole
104884|NCT03548467|melanoma|melanoma
104885|NCT03548467|NSCLC|nsclc
104886|NCT03548467|clear renal cell carcinoma|clear renal cell carcinoma
104887|NCT03548467|urothelial cancer or SCCHN|urothelial cancer or scchn
104888|NCT03548428|Atezolizumab|atezolizumab
104889|NCT03548428|Oligometastatic Sarcomas|oligometastatic sarcomas
104890|NCT03548428|stereotactic body radiation therapy|stereotactic body radiation therapy
104891|NCT03548415|Acromegaly, IONIS-GHR-LRx|acromegaly, ionis-ghr-lrx
104892|NCT03548376|rehabilitation|rehabilitation
104893|NCT03548376|cerebral palsy|cerebral palsy
104894|NCT03548376|postural control|postural control
104895|NCT03548376|balance|balance
104896|NCT03548376|gross-motor function|gross-motor function
104897|NCT03548376|quality of life|quality of life
104898|NCT03548376|hippotherapy|hippotherapy
104899|NCT03548324|Feeding Tolerance|feeding tolerance
104900|NCT03548324|RDS|rds
104901|NCT03548324|HFNC|hfnc
104902|NCT03548324|NCPAP|ncpap
104903|NCT03548324|Preterm|preterm
104904|NCT03548324|NEC|nec
104905|NCT03548324|Enteral Nutrition|enteral nutrition
104906|NCT03548324|Non Invasive Respiratory Support|non invasive respiratory support
104907|NCT03548324|Very Low Birth Weight Infant|very low birth weight infant
104908|NCT03548311|ALS|als
104909|NCT03548311|motor neuron disease|motor neuron disease
104910|NCT03548311|Lou Gehrig's disease|lou gehrig's disease
104911|NCT03548298|GERD, Hybrid-APC, efficacy, safety|gerd, hybrid-apc, efficacy, safety
104912|NCT03548298|ARAT|arat
104913|NCT03548272|dedicated bifurcation stent|dedicated bifurcation stent
104914|NCT03548272|non-LM bifurcation|non-lm bifurcation
104915|NCT03548272|sirolimus-eluting stent|sirolimus-eluting stent
104916|NCT03548259|Carpal Tunnel Syndrome|carpal tunnel syndrome
104917|NCT03548259|Platelet-rich plasma|platelet-rich plasma
104918|NCT03548259|Surgery|surgery
104919|NCT03548181|Tele-rehabilitation|tele-rehabilitation
104920|NCT03548155|schizophrenia；berberine；symptoms；inflammation|schizophrenia；berberine；symptoms；inflammation
104921|NCT03548142|Palliative Care|palliative care
104922|NCT03548142|advanced dementia|advanced dementia
104923|NCT03548142|life-prolonging treatment|life-prolonging treatment
104924|NCT03548142|patient will|patient will
104925|NCT03548142|advanced care planning|advanced care planning
104926|NCT03548116|Healthy Volunteer|healthy volunteer
104927|NCT03548116|Ultrasound|ultrasound
104928|NCT03548116|Insonification|insonification
104929|NCT03548116|Spleen|spleen
104930|NCT03548090|stroke rehabilitation|stroke rehabilitation
104931|NCT03548090|walking limitations|walking limitations
104932|NCT03548090|gait rehabilitation|gait rehabilitation
104933|NCT03548064|dmLT|dmlt
104934|NCT03548064|E. coli|e. coli
104935|NCT03548064|Enterotoxigenic Escherichia coli (ETEC)|enterotoxigenic escherichia coli (etec)
104936|NCT03548064|LTR192G/L211A|ltr192g/l211a
104937|NCT03548051|Clinical Trial|clinical trial
104938|NCT03548051|Clostridium difficile|clostridium difficile
104939|NCT03548051|Clostridium difficle Associated Disease (CDAD)|clostridium difficle associated disease (cdad)
104940|NCT03548051|Efficacy|efficacy
104941|NCT03548051|Fecal Microbiota Transplantation (FMT)|fecal microbiota transplantation (fmt)
104942|NCT03548051|Microbial Restoration|microbial restoration
104943|NCT03548051|Partially-Blinded|partially-blinded
104944|NCT03548051|Placebo|placebo
104947|NCT03548038|taste perception|taste perception
104948|NCT03548038|bariatric surgery|bariatric surgery
104949|NCT03548038|taste preference|taste preference
104950|NCT03548038|weight loss surgery|weight loss surgery
104951|NCT03548012|Caregivers|caregivers
104952|NCT03548012|Support Needs|support needs
104953|NCT03548012|Intervention|intervention
104954|NCT03548012|Randomised controlled trial|randomised controlled trial
104955|NCT03547999|CV301 Vaccination|cv301 vaccination
104956|NCT03547999|mFOLFOX6|mfolfox6
104957|NCT03547999|Fowlpox (FP)-CV301|fowlpox (fp)-cv301
104958|NCT03547999|nivolumab|nivolumab
104959|NCT03547999|MVA-BN-CV301|mva-bn-cv301
104960|NCT03547986|flow-limiting dissection|flow-limiting dissection
104961|NCT03547986|residual stenosis|residual stenosis
104962|NCT03547960|Gestational diabetes|gestational diabetes
104963|NCT03547934|Abdominal fat|abdominal fat
104964|NCT03547882|Opioid|opioid
104965|NCT03547882|Buprenorphine|buprenorphine
104966|NCT03547882|Naltrexone|naltrexone
104967|NCT03547882|methadone|methadone
104968|NCT03547869|Transcranial Direct Current Stimulation|transcranial direct current stimulation
104969|NCT03547869|Gulf War Illness|gulf war illness
104970|NCT03547869|Pain modulation|pain modulation
104971|NCT03547843|Behavior therapy|behavior therapy
104972|NCT03547843|Peer groups|peer groups
104973|NCT03547843|Patient satisfaction|patient satisfaction
104974|NCT03547843|Feasibility studies|feasibility studies
104975|NCT03547830|chronic granulomatous disease|chronic granulomatous disease
104976|NCT03547830|graft failure|graft failure
104977|NCT03547830|stem cell transplantation|stem cell transplantation
104978|NCT03547830|plerixafor|plerixafor
104979|NCT03547830|conditioning regimen|conditioning regimen
104980|NCT03547791|Antenatal corticosteroid|antenatal corticosteroid
104981|NCT03547791|Twin pregnancies|twin pregnancies
104982|NCT03547791|Respiratory morbidity|respiratory morbidity
104983|NCT03547791|Randomized controlled trial|randomized controlled trial
104984|NCT03547765|Obesity|obesity
104985|NCT03547765|Sexual Dysfunction|sexual dysfunction
104986|NCT03547752|motor imaginery|motor imaginery
104987|NCT03547752|mental training|mental training
104988|NCT03547687|Electrical stimulation|electrical stimulation
104989|NCT03547687|Intubation|intubation
104990|NCT03547687|ICU discharge|icu discharge
104991|NCT03547661|Premenstrual Syndrome|premenstrual syndrome
104992|NCT03547661|Open-Label Placebo Effect|open-label placebo effect
104993|NCT03547661|randomized controlled trial|randomized controlled trial
104994|NCT03547609|Kabuki Syndrome|kabuki syndrome
104995|NCT03547609|Intellectual Profile|intellectual profile
104996|NCT03547609|Memory|memory
104997|NCT03547596|Lower urinary tract symptoms|lower urinary tract symptoms
104998|NCT03547596|Erectile dysfunction|erectile dysfunction
104999|NCT03547596|Obstructive Sleep Apneas Syndrom|obstructive sleep apneas syndrom
105000|NCT03547570|Joint instability|joint instability
105001|NCT03547570|Hypermobility|hypermobility
105002|NCT03547570|Shoulder|shoulder
105003|NCT03547570|Strength training|strength training
105004|NCT03547557|Bone Tumors|bone tumors
105005|NCT03547544|helicobacter pylori|helicobacter pylori
105006|NCT03547544|urease test|urease test
105007|NCT03547544|helicotec|helicotec
105008|NCT03547518|Urinary Urgency|urinary urgency
105009|NCT03547518|Urinary Frequency|urinary frequency
105010|NCT03547518|Urge Incontinence|urge incontinence
105011|NCT03547505|Glide path|glide path
105012|NCT03547505|postoperative pain|postoperative pain
105013|NCT03547505|R-Pilot|r-pilot
105014|NCT03547505|ProGlider|proglider
105015|NCT03547492|language|language
105016|NCT03547492|LENA|lena
105017|NCT03547492|adolescent|adolescent
105018|NCT03547453|Menstrual cycles|menstrual cycles
105019|NCT03547453|Ultrasound|ultrasound
105020|NCT03547453|Ovary|ovary
105021|NCT03547453|Polycystic Ovary Syndrome (PCOS)|polycystic ovary syndrome (pcos)
105022|NCT03547440|Type 1 Diabetes Mellitus|type 1 diabetes mellitus
105023|NCT03547440|immigrant|immigrant
105024|NCT03547440|microbiota|microbiota
105025|NCT03547440|bioindicator|bioindicator
105026|NCT03547440|Methanobrevibacter smithii|methanobrevibacter smithii
105027|NCT03547427|Type 1 Diabetes Mellitus|type 1 diabetes mellitus
105028|NCT03547427|Pramlintide|pramlintide
105029|NCT03547427|Lispro Insulin|lispro insulin
105030|NCT03547427|Continuous Glucose Monitor (CGM)|continuous glucose monitor (cgm)
105031|NCT03547427|Acetaminophen|acetaminophen
105032|NCT03547427|Hypoglycemia|hypoglycemia
105033|NCT03547427|Exercise|exercise
105034|NCT03547388|head and neck squamous cell carcinoma|head and neck squamous cell carcinoma
105035|NCT03547388|hyperthermia|hyperthermia
105036|NCT03547388|hypoxia|hypoxia
105037|NCT03547388|18f-fluoromisonidazole|18f-fluoromisonidazole
105038|NCT03547388|positron emission tomography|positron emission tomography
105039|NCT03547388|FMISO|fmiso
105040|NCT03547388|PET|pet
105041|NCT03547388|whole body hyperthermia|whole body hyperthermia
105042|NCT03547388|local recurrence|local recurrence
105043|NCT03547388|lymph node recurrence|lymph node recurrence
105044|NCT03547388|radiochemotherapy|radiochemotherapy
105045|NCT03547362|Amino acids|amino acids
105046|NCT03547362|Dairy proteins|dairy proteins
105047|NCT03547362|Postprandial|postprandial
105048|NCT03547362|Older adults|older adults
105049|NCT03547349|respiratory therapy|respiratory therapy
105050|NCT03547349|videogaming therapy|videogaming therapy
105051|NCT03547349|incentive spirometry|incentive spirometry
105052|NCT03547349|atelectases|atelectases
105053|NCT03547310|EMG|emg
105054|NCT03547310|Prosthesis control|prosthesis control
105055|NCT03547310|Neuromuscular rehabilitation|neuromuscular rehabilitation
105056|NCT03547310|Games for health|games for health
105057|NCT03547297|Acute Hepatic Porphyria|acute hepatic porphyria
105058|NCT03547297|Hepatic Porphyrias|hepatic porphyrias
105059|NCT03547297|Acute Intermittent Porphyria (AIP)|acute intermittent porphyria (aip)
105060|NCT03547297|Hereditary Coproporphyria (HCP)|hereditary coproporphyria (hcp)
105061|NCT03547297|Variegate Porphyria (VP)|variegate porphyria (vp)
105062|NCT03547297|ALA Dehydratase Deficient Porphyria (ADP)|ala dehydratase deficient porphyria (adp)
105063|NCT03547297|Porphyria Acute|porphyria acute
105064|NCT03547271|Meningococcal meningitis|meningococcal meningitis
105065|NCT03547271|MenACYW conjugate vaccine|menacyw conjugate vaccine
105066|NCT03547271|Quadrivalent meningococcal vaccine|quadrivalent meningococcal vaccine
105067|NCT03547258|AML|aml
105068|NCT03547258|Italian observational study|italian observational study
105069|NCT03547258|FLT3-ITD Mutation|flt3-itd mutation
105070|NCT03547258|FLT3-TKD Mutation|flt3-tkd mutation
105071|NCT03547232|Acute pancreatitis|acute pancreatitis
105072|NCT03547232|Indomethacin|indomethacin
105073|NCT03547232|Prognosis|prognosis
105074|NCT03547232|Organ dysfunction|organ dysfunction
105075|NCT03547219|Depression|depression
105076|NCT03547219|Adolescent|adolescent
105077|NCT03547219|Biomarker|biomarker
105078|NCT03547219|Inflammation|inflammation
105079|NCT03547219|Brain-derived neurotrophic factor (BDNF)|brain-derived neurotrophic factor (bdnf)
105080|NCT03547219|Functional MRI|functional mri
105081|NCT03547219|Antidepressant|antidepressant
105082|NCT03547219|Machine learning|machine learning
105083|NCT03547206|NAION|naion
105084|NCT03547206|ischemic optic neuropathy|ischemic optic neuropathy
105085|NCT03547193|difficult laringoscopy|difficult laringoscopy
105086|NCT03547193|difficult airway|difficult airway
105087|NCT03547193|airway management|airway management
105088|NCT03547180|Respiration panic|respiration panic
105089|NCT03547180|Cognitions|cognitions
105090|NCT03547180|Panic|panic
105091|NCT03547180|Treatment|treatment
105092|NCT03547180|Mediators|mediators
105093|NCT03547180|Moderators|moderators
105094|NCT03547128|fluoride|fluoride
105095|NCT03547128|genetics|genetics
105096|NCT03547128|physical activity|physical activity
105097|NCT03547128|diet|diet
105098|NCT03547115|B-Cell Malignancies, AML, Voruciclib, Cyclin Dependent Kinase Inhibitor|b-cell malignancies, aml, voruciclib, cyclin dependent kinase inhibitor
105099|NCT03547076|Pocket sized imaging device|pocket sized imaging device
105100|NCT03547076|Handheld ultrasound device|handheld ultrasound device
105101|NCT03547076|General practitioner|general practitioner
105102|NCT03547076|Nurse|nurse
105103|NCT03547076|Focused cardiac ultrasound|focused cardiac ultrasound
105104|NCT03547076|FoCUS|focus
105105|NCT03547076|Telemedicine|telemedicine
105106|NCT03547076|Support|support
105107|NCT03547063|Obesity, appetite, taste, fMRI|obesity, appetite, taste, fmri
105108|NCT03547050|Epilepsy|epilepsy
105109|NCT03547050|Rolandic|rolandic
105110|NCT03547050|Genetics|genetics
105111|NCT03547050|Genomewide Association Study|genomewide association study
105112|NCT03547050|RE|re
105113|NCT03547050|Neurology|neurology
105114|NCT03547050|Pediatrics|pediatrics
105115|NCT03546998|epidermoid carcinoma|epidermoid carcinoma
105116|NCT03546998|esophageal achalasia|esophageal achalasia
105117|NCT03546998|risk factors|risk factors
105118|NCT03546959|stroke|stroke
105119|NCT03546959|spasticity|spasticity
105120|NCT03546959|lycra|lycra
105121|NCT03546959|orthosis|orthosis
105122|NCT03546959|splint|splint
105123|NCT03546959|treatment|treatment
105124|NCT03546959|upper extremity|upper extremity
105125|NCT03546946|Attention|attention
105126|NCT03546946|Anxiety|anxiety
105127|NCT03546946|Adolescence|adolescence
105128|NCT03546894|Drug Therapy|drug therapy
105129|NCT03546881|PAOD|paod
105130|NCT03546881|endovascular|endovascular
105131|NCT03546881|fusion|fusion
105132|NCT03546881|radiation|radiation
105133|NCT03546881|exposure|exposure
105134|NCT03546790|Cannabis|cannabis
105135|NCT03546777|Shoulder pain, coracoacromial ligament thickness|shoulder pain, coracoacromial ligament thickness
105136|NCT03546764|Percutatneous catheter|percutatneous catheter
105137|NCT03546764|chest tube|chest tube
105138|NCT03546764|trauma|trauma
105139|NCT03546764|hemothorax|hemothorax
105140|NCT03546751|Endothelial Dysfunction|endothelial dysfunction
105141|NCT03546751|Micro RNA|micro rna
105142|NCT03546738|Lumbar Vertebrae|lumbar vertebrae
105143|NCT03546738|Surgery|surgery
105144|NCT03546738|Postoperational Complications|postoperational complications
105145|NCT03546738|Spinal Cord Stimulation|spinal cord stimulation
105146|NCT03546712|Acuity|acuity
105147|NCT03546712|children|children
105150|NCT03546712|touch location|touch location
105151|NCT03546686|Hormone Receptor Negative|hormone receptor negative
105152|NCT03546686|Her2- Negative|her2- negative
105153|NCT03546686|Resectable Breast Cancer|resectable breast cancer
105154|NCT03546686|breast cancer|breast cancer
105155|NCT03546686|immunotherapy|immunotherapy
105156|NCT03546686|Ipilimumab|ipilimumab
105157|NCT03546686|Nivolumab|nivolumab
105158|NCT03546686|Cryoablation|cryoablation
105159|NCT03546673|Chinese breast cancer survivors expressive writing|chinese breast cancer survivors expressive writing
105161|NCT03546660|Eosinophilic Esophagitis|eosinophilic esophagitis
105162|NCT03546660|Barrett's Esophagus|barrett's esophagus
105163|NCT03546660|Capsule|capsule
105164|NCT03546660|SECM|secm
105165|NCT03546660|Tethered Capsule Endomicroscopy|tethered capsule endomicroscopy
105166|NCT03546634|Inactivated Poliovirus Vaccine|inactivated poliovirus vaccine
105167|NCT03546634|Sabin strain|sabin strain
105168|NCT03546621|Hepatitis D|hepatitis d
105169|NCT03546608|Hepatic Impairment|hepatic impairment
105170|NCT03546608|Tepotinib|tepotinib
105171|NCT03546608|Pharmacokinetics|pharmacokinetics
105172|NCT03546595|Polycystic Ovary Syndrome|polycystic ovary syndrome
105173|NCT03546595|Insulin Resistance|insulin resistance
105174|NCT03546582|HNSCC|hnscc
105175|NCT03546582|Head and Neck Squamous Cell Carcinoma|head and neck squamous cell carcinoma
105176|NCT03546582|KEYSTROKE|keystroke
105177|NCT03546517|myofascial trigger point|myofascial trigger point
105178|NCT03546517|dry needling|dry needling
105179|NCT03546517|spasticity|spasticity
105180|NCT03546517|stroke|stroke
105181|NCT03546504|child|child
105182|NCT03546504|dental|dental
105183|NCT03546504|oral health|oral health
105184|NCT03546504|sensory desensitization|sensory desensitization
105185|NCT03546504|sensory processing|sensory processing
105186|NCT03546504|occupational therapy|occupational therapy
105187|NCT03546478|SPECT/CT|spect/ct
105188|NCT03546478|HER2 imaging|her2 imaging
105189|NCT03546452|NSCLC|nsclc
105190|NCT03546452|malignant hydrothorax|malignant hydrothorax
105191|NCT03546452|prospective study|prospective study
105192|NCT03546439|atrial fibrillation|atrial fibrillation
105193|NCT03546439|vascular closure|vascular closure
105194|NCT03546426|Mesothelioma, Malignant|mesothelioma, malignant
105195|NCT03546426|PDL-1 negative|pdl-1 negative
105196|NCT03546426|advanced disease|advanced disease
105197|NCT03546426|progressive disease|progressive disease
105198|NCT03546413|food|food
105199|NCT03546413|peanut|peanut
105200|NCT03546413|allergy|allergy
105201|NCT03546413|prevention|prevention
105202|NCT03546387|18-126|18-126
105203|NCT03546387|Memorial Sloan Kettering Cancer Center|memorial sloan kettering cancer center
105204|NCT03546322|head and neck cancer|head and neck cancer
105205|NCT03546322|health information technology|health information technology
105206|NCT03546322|patient safety|patient safety
105207|NCT03546322|adherence|adherence
105208|NCT03546322|ambulatory|ambulatory
105209|NCT03546322|outpatient|outpatient
105210|NCT03546322|human factors|human factors
105211|NCT03546322|vulnerable populations|vulnerable populations
105212|NCT03546322|chronic disease|chronic disease
105213|NCT03546309|pediatric moyamoya disease|pediatric moyamoya disease
105214|NCT03546309|remote ischemic conditioning|remote ischemic conditioning
105215|NCT03546309|revascularization therapy|revascularization therapy
105216|NCT03546296|Dietary Exposure|dietary exposure
105217|NCT03546296|gallbladder carcinoma|gallbladder carcinoma
105218|NCT03546270|Swimming|swimming
105219|NCT03546270|Arterial Stiffness|arterial stiffness
105220|NCT03546270|Blood Pressure|blood pressure
105221|NCT03546270|Muscular Strength|muscular strength
105222|NCT03546270|Cardiorespiratory Endurance|cardiorespiratory endurance
105223|NCT03546257|Early gastric cancer|early gastric cancer
105224|NCT03546257|Invasion depth|invasion depth
105225|NCT03546257|Narrow band imaging|narrow band imaging
105226|NCT03546257|Endoscopic ultrasonography|endoscopic ultrasonography
105227|NCT03546231|Tricuspid regurgitation|tricuspid regurgitation
105228|NCT03546231|tricuspid valve|tricuspid valve
105229|NCT03546231|surgery|surgery
105230|NCT03546231|outcome|outcome
105231|NCT03546231|prognosis|prognosis
105232|NCT03546231|mortality|mortality
105233|NCT03546231|right ventricle|right ventricle
105234|NCT03546231|asymptomatic|asymptomatic
105235|NCT03546192|Influenza|influenza
105236|NCT03546192|Influenza virus vaccine|influenza virus vaccine
105237|NCT03546192|Fluzone® Quadrivalent Influenza Vaccine (No Preservative)|fluzone® quadrivalent influenza vaccine (no preservative)
105238|NCT03546179|PVI, Tidal volume challenge|pvi, tidal volume challenge
105239|NCT03546166|basal cell carcinoma|basal cell carcinoma
105240|NCT03546127|Next Generation Sequencing|next generation sequencing
105241|NCT03546127|Exome|exome
105242|NCT03546127|RNA sequencing|rna sequencing
105243|NCT03546127|Soft-tissue sarcoma|soft-tissue sarcoma
105244|NCT03546127|Colorectal carcinoma|colorectal carcinoma
105245|NCT03546114|Gender|gender
105246|NCT03546114|Sex and gender|sex and gender
105247|NCT03546114|Patient preference|patient preference
105248|NCT03546114|Osteopathic medicine|osteopathic medicine
105249|NCT03546088|awake intubation|awake intubation
105250|NCT03546088|nasal fiberscope|nasal fiberscope
105251|NCT03546088|topical anesthesia|topical anesthesia
105252|NCT03546075|Cognition|cognition
105253|NCT03546075|Resveratrol|resveratrol
105254|NCT03546075|Whole body metabolism|whole body metabolism
105255|NCT03546049|ultrasound-guided percutaneous transhepatic biliary drainage|ultrasound-guided percutaneous transhepatic biliary drainage
105256|NCT03546049|endoscopic ultrasound-guided antegrade biliary drainage|endoscopic ultrasound-guided antegrade biliary drainage
105257|NCT03546049|endoscopic ultrasound-guided transhepatic biliary drainage|endoscopic ultrasound-guided transhepatic biliary drainage
105507|NCT03544242|Pancreatic islet cells|pancreatic islet cells
105258|NCT03546049|endoscopic ultrasound-guided choledochal biliary drainage|endoscopic ultrasound-guided choledochal biliary drainage
105259|NCT03546049|self-expandable metal stent|self-expandable metal stent
105260|NCT03546049|malignant bile duct obstruction|malignant bile duct obstruction
105261|NCT03546023|Chronic cancer pain|chronic cancer pain
105262|NCT03546023|pain clinic|pain clinic
105263|NCT03546023|Brief Pain Inventory|brief pain inventory
105264|NCT03545997|Montelukast|montelukast
105265|NCT03545997|leukotriene pathway|leukotriene pathway
105266|NCT03545997|endothelial function|endothelial function
105267|NCT03545997|flux-mediated dilation|flux-mediated dilation
105268|NCT03545958|Older adults|older adults
105269|NCT03545958|Community-based|community-based
105270|NCT03545958|High-intensity interval training (HIT)|high-intensity interval training (hit)
105271|NCT03545958|Mind-motor training|mind-motor training
105272|NCT03545932|Hydrogymnastics|hydrogymnastics
105273|NCT03545932|Physical Condition|physical condition
105274|NCT03545932|Physical Activity and Health|physical activity and health
105275|NCT03545932|Gerontomotricity|gerontomotricity
105276|NCT03545919|respiratory viral infections|respiratory viral infections
105277|NCT03545919|chronic lung allograft dysfunction|chronic lung allograft dysfunction
105278|NCT03545919|lung microbiome|lung microbiome
105279|NCT03545867|postprandial|postprandial
105280|NCT03545867|glycemia|glycemia
105281|NCT03545867|lipemia|lipemia
105282|NCT03545867|macronutrient metabolism|macronutrient metabolism
105283|NCT03545867|physical activity|physical activity
105284|NCT03545815|mesothelin, CRISPR-Cas9, PD-1, TCR|mesothelin, crispr-cas9, pd-1, tcr
105285|NCT03545789|HV|hv
105286|NCT03545789|AD|ad
105287|NCT03545789|PSP|psp
105288|NCT03545763|Hypertension|hypertension
105289|NCT03545763|Social Determinants of Health|social determinants of health
105290|NCT03545763|Health Insurance|health insurance
105291|NCT03545763|Medicaid|medicaid
105292|NCT03545763|Affordable Care Act|affordable care act
105293|NCT03545750|Acute kidney injury|acute kidney injury
105294|NCT03545750|Continuous renal replacement therapy|continuous renal replacement therapy
105295|NCT03545750|Citrate|citrate
105296|NCT03545750|Heparin|heparin
105297|NCT03545672|Primary Biliary Cholangitis|primary biliary cholangitis
105298|NCT03545672|Cardiac impairment|cardiac impairment
105299|NCT03545672|Cardiovascular Magnetic Resonance|cardiovascular magnetic resonance
105300|NCT03545646|Abdominal tissues|abdominal tissues
105301|NCT03545633|Abdominal tissues|abdominal tissues
105302|NCT03545620|difficult airway|difficult airway
105303|NCT03545620|difficult intubation|difficult intubation
105304|NCT03545620|videolaryngoscope|videolaryngoscope
105305|NCT03545620|exchange catheter|exchange catheter
105306|NCT03545620|fiberoptic bronchoscope|fiberoptic bronchoscope
105307|NCT03545620|Laryngeal subglottic airway device|laryngeal subglottic airway device
105308|NCT03545620|tracheostomy|tracheostomy
105309|NCT03545607|ischemic stroke|ischemic stroke
105310|NCT03545607|adult stem cells|adult stem cells
105311|NCT03545594|Randomized trial,|randomized trial,
105312|NCT03545594|Health care needs|health care needs
105313|NCT03545594|Traumatic brain injury|traumatic brain injury
105314|NCT03545594|Community|community
105315|NCT03545594|Goal attainment|goal attainment
105316|NCT03545581|Fructose|fructose
105317|NCT03545581|Uric acid|uric acid
105318|NCT03545581|Glucose homeostasis|glucose homeostasis
105319|NCT03545568|Sialic acid|sialic acid
105320|NCT03545568|Monosaccharide|monosaccharide
105321|NCT03545555|kale|kale
105322|NCT03545555|antioxidant capacity|antioxidant capacity
105323|NCT03545555|cholesterol|cholesterol
105324|NCT03545555|lipid status|lipid status
105325|NCT03545542|Microbiome|microbiome
105326|NCT03545542|Volatilome|volatilome
105327|NCT03545542|Neuroblastoma|neuroblastoma
105328|NCT03545516|Wound infiltration|wound infiltration
105329|NCT03545516|Post Cesarean|post cesarean
105330|NCT03545516|Pain management|pain management
105331|NCT03545516|bupivacaine|bupivacaine
105332|NCT03545516|dexmedetomidine|dexmedetomidine
105333|NCT03545516|postoperative pain|postoperative pain
105334|NCT03545503|Rapid Sequence Intubation|rapid sequence intubation
105335|NCT03545503|Hemodynamics|hemodynamics
105336|NCT03545503|Etomidate|etomidate
105337|NCT03545503|Ketamine|ketamine
105338|NCT03545477|gait rehabilitation|gait rehabilitation
105339|NCT03545477|curved walking training|curved walking training
105340|NCT03545477|lower limb|lower limb
105341|NCT03545464|Acute urticaria|acute urticaria
105446|NCT03544658|Tooth extrinsic stain|tooth extrinsic stain
105344|NCT03545425|Biomarker|biomarker
105345|NCT03545425|LRRK2|lrrk2
105346|NCT03545373|antimicrobial resistance|antimicrobial resistance
105347|NCT03545373|TB|tb
105348|NCT03545373|Cough|cough
105349|NCT03545373|antibiotics|antibiotics
105350|NCT03545373|anti-infective agents|anti-infective agents
105351|NCT03545347|Rehabilitation|rehabilitation
105352|NCT03545347|Physiotherapy|physiotherapy
105353|NCT03545347|Strength training|strength training
105354|NCT03545347|Anabolic steroids|anabolic steroids
105355|NCT03545347|Nutritional supplement|nutritional supplement
105356|NCT03545334|transcutaneous identification of SLNs with ICG|transcutaneous identification of slns with icg
105357|NCT03545321|Naloxone|naloxone
105358|NCT03545321|Community pharmacies|community pharmacies
105359|NCT03545321|Academic detailing|academic detailing
105360|NCT03545321|MOON|moon
105361|NCT03545321|MOON+|moon+
105362|NCT03545321|RESPOND|respond
105363|NCT03545308|Neuromuscular|neuromuscular
105364|NCT03545308|Deep Anesthesia|deep anesthesia
105365|NCT03545308|Rocuronium|rocuronium
105366|NCT03545282|Mental Health|mental health
105367|NCT03545282|Minority Health|minority health
105368|NCT03545282|Latina|latina
105369|NCT03545269|Degenerative Arthritis|degenerative arthritis
105370|NCT03545269|Autologous Chondrocyte Implantation|autologous chondrocyte implantation
105371|NCT03545269|Cartilage defects|cartilage defects
105372|NCT03545269|Cartilage lesion|cartilage lesion
105373|NCT03545269|Arthritis|arthritis
105374|NCT03545256|Outpatient|outpatient
105375|NCT03545256|head neck cancer|head neck cancer
105376|NCT03545256|Lymph node metastasis|lymph node metastasis
105377|NCT03545256|surgery|surgery
105378|NCT03545256|Quality of life|quality of life
105379|NCT03545256|economical study|economical study
105380|NCT03545243|duodenum|duodenum
105381|NCT03545243|microbiome|microbiome
105382|NCT03545243|proton pump inhibitor|proton pump inhibitor
712568|NCT00579683|metastatic disease|metastatic disease
105383|NCT03545204|Neonatal Mortality & Neurodevelopment of an Infant.|neonatal mortality & neurodevelopment of an infant.
105384|NCT03545178|white coat adherence|white coat adherence
105385|NCT03545178|continuous glucose monitoring|continuous glucose monitoring
105386|NCT03545178|flash glucose monitoring|flash glucose monitoring
105387|NCT03545178|hypoglycemia prediction|hypoglycemia prediction
105388|NCT03545178|deep learning algorithm|deep learning algorithm
105389|NCT03545139|pulp revascularization|pulp revascularization
105390|NCT03545139|endodontic regeneration|endodontic regeneration
105392|NCT03545126|Tauopathies|tauopathies
105397|NCT03545100|oral cancer|oral cancer
105398|NCT03545100|shoulder dysfunction|shoulder dysfunction
105399|NCT03545100|quality of life|quality of life
105400|NCT03545100|motor control|motor control
105401|NCT03545100|strengthening exercise|strengthening exercise
105402|NCT03545074|mindfulness|mindfulness
105403|NCT03545074|depression|depression
105404|NCT03545074|Spanish|spanish
105405|NCT03545048|web-based exercises|web-based exercises
105406|NCT03545048|Digital health|digital health
105407|NCT03545048|knee exercises|knee exercises
105408|NCT03545035|Chronic Lymphocytic Leukemia|chronic lymphocytic leukemia
105409|NCT03545035|Idelalisib|idelalisib
105410|NCT03545035|Rituximab|rituximab
105411|NCT03545022|third molar|third molar
105412|NCT03545022|acupuncture|acupuncture
105413|NCT03545022|pain|pain
105414|NCT03545022|edema|edema
105415|NCT03545022|trismus|trismus
105416|NCT03545022|anxiety|anxiety
105417|NCT03544996|Insulin, needle-less, transdermal|insulin, needle-less, transdermal
105418|NCT03544983|Breast Cancer|breast cancer
105419|NCT03544983|Ovarian Cancer|ovarian cancer
105420|NCT03544983|Prostate Cancer|prostate cancer
105421|NCT03544983|BRCA1|brca1
105422|NCT03544983|BRCA2|brca2
105423|NCT03544970|fetal MRI|fetal mri
105424|NCT03544970|Posterior fossa|posterior fossa
105425|NCT03544957|Screening instrument|screening instrument
105426|NCT03544944|bowel preparation|bowel preparation
105427|NCT03544892|Low carbohydrate diet|low carbohydrate diet
105428|NCT03544853|Prosthetic socket|prosthetic socket
105429|NCT03544853|Biomechanics|biomechanics
105430|NCT03544827|Atropine|atropine
105431|NCT03544788|mobile compression device|mobile compression device
105432|NCT03544762|breast cancer|breast cancer
105433|NCT03544762|PET|pet
105434|NCT03544762|[18F]FES|[18f]fes
105435|NCT03544762|estrogen receptor|estrogen receptor
105436|NCT03544762|hormone treatment|hormone treatment
105437|NCT03544762|personalized cancer care|personalized cancer care
105438|NCT03544736|Nivolumab|nivolumab
105439|NCT03544736|Immunotherapy|immunotherapy
105440|NCT03544710|surgical site infection|surgical site infection
105441|NCT03544671|Vitamin D|vitamin d
105442|NCT03544671|Nutritional deficiencies|nutritional deficiencies
105443|NCT03544671|Miconutrients|miconutrients
105444|NCT03544671|Children|children
105445|NCT03544671|Mexico|mexico
105447|NCT03544658|Tooth color|tooth color
105448|NCT03544658|Dental prophylaxis|dental prophylaxis
105449|NCT03544658|Visual shade guide|visual shade guide
105450|NCT03544658|Dental spectrophotometer|dental spectrophotometer
105451|NCT03544645|Diabetic Education|diabetic education
105452|NCT03544645|audiovisual material|audiovisual material
105453|NCT03544645|Manual material|manual material
105454|NCT03544632|adipose-derived extracellular matrix (ECM)|adipose-derived extracellular matrix (ecm)
105455|NCT03544632|acellular adipose tissue (AAT)|acellular adipose tissue (aat)
105456|NCT03544580|dentin|dentin
105457|NCT03544580|immediate implant|immediate implant
105458|NCT03544580|buccal bone resorption|buccal bone resorption
105459|NCT03544580|crestal bone loss|crestal bone loss
105460|NCT03544554|Overactive bladder|overactive bladder
105461|NCT03544554|healthy lifestyle behaviors|healthy lifestyle behaviors
105462|NCT03544554|quality of life|quality of life
105463|NCT03544515|peri-implantitis|peri-implantitis
105464|NCT03544515|laser treatment|laser treatment
105465|NCT03544515|Biolase|biolase
105466|NCT03544515|Er,Cr:YSGG|er,cr:ysgg
105467|NCT03544502|music, anesthesia, surgery|music, anesthesia, surgery
105468|NCT03544476|mobile Health|mobile health
105469|NCT03544437|lymph node dissection|lymph node dissection
105470|NCT03544437|upper tract urothelial carcinoma|upper tract urothelial carcinoma
105471|NCT03544437|nephroureterectomy|nephroureterectomy
105472|NCT03544411|Olive oil|olive oil
105473|NCT03544411|Bran oil|bran oil
105474|NCT03544411|Type 2 Diabetes Mellitus|type 2 diabetes mellitus
105475|NCT03544411|Antioxidant|antioxidant
105476|NCT03544411|glycemic control|glycemic control
105477|NCT03544411|lipid profile|lipid profile
105478|NCT03544372|concussion, rugby, self-report, concussion history, reliability|concussion, rugby, self-report, concussion history, reliability
105479|NCT03544359|transcranial direct current stimulation (tDCS)|transcranial direct current stimulation (tdcs)
105480|NCT03544359|functional magnetic resonance imaging (MRI)|functional magnetic resonance imaging (mri)
105481|NCT03544346|brain health, professional athlete, retired, neuropsychological assessment|brain health, professional athlete, retired, neuropsychological assessment
105482|NCT03544333|transcranial magnetic stimulation (TMS)|transcranial magnetic stimulation (tms)
105483|NCT03544333|brain stimulation|brain stimulation
105484|NCT03544333|medication-free|medication-free
105485|NCT03544320|Pre-diabetes|pre-diabetes
105486|NCT03544320|diabetes|diabetes
105487|NCT03544320|wearable devices|wearable devices
105488|NCT03544320|mobile health|mobile health
105489|NCT03544307|Taekwondo|taekwondo
105490|NCT03544307|Menopause|menopause
105491|NCT03544307|Hypertension|hypertension
105492|NCT03544307|Arterial Stiffness|arterial stiffness
105493|NCT03544307|Blood Catecholamines|blood catecholamines
105494|NCT03544281|Relapsed / Refractory Multiple Myeloma|relapsed / refractory multiple myeloma
105495|NCT03544281|Dose escalation|dose escalation
105496|NCT03544281|Antibody-Drug Conjugate|antibody-drug conjugate
105497|NCT03544281|Dose expansion|dose expansion
105498|NCT03544268|ultrasound|ultrasound
105499|NCT03544268|breast|breast
105500|NCT03544268|angiography|angiography
105501|NCT03544255|pancreatic cancer|pancreatic cancer
105502|NCT03544255|EUS-FNA|eus-fna
105503|NCT03544255|organoid|organoid
105504|NCT03544242|Diabetes|diabetes
105505|NCT03544242|Insulin Resistance|insulin resistance
105506|NCT03544242|Nitrite|nitrite
105508|NCT03544242|Autotransplantation|autotransplantation
105509|NCT03544242|Ischemia reperfusion injury|ischemia reperfusion injury
105510|NCT03544242|Mitigation|mitigation
105511|NCT03544242|Cure|cure
105512|NCT03544242|Nitric oxide|nitric oxide
105513|NCT03544242|Sodium nitrite|sodium nitrite
105514|NCT03544242|Islet cell|islet cell
105515|NCT03544242|Survival|survival
105516|NCT03544242|Pancreas|pancreas
105517|NCT03544242|Liver|liver
105518|NCT03544229|Drug Therapy|drug therapy
105519|NCT03544216|Contact Lens|contact lens
105520|NCT03544216|Multifocal|multifocal
105521|NCT03544216|Accommodation|accommodation
105522|NCT03544216|Presbyopia|presbyopia
105523|NCT03544203|intraabdominal infections|intraabdominal infections
105524|NCT03544203|peritonitis|peritonitis
105525|NCT03544203|critically ill|critically ill
105526|NCT03544177|mobility|mobility
105527|NCT03544177|exercise therapy|exercise therapy
105528|NCT03544177|blood flow restricted exercise|blood flow restricted exercise
105529|NCT03544177|rehabilitation|rehabilitation
105530|NCT03544099|nasopharyngeal carcinoma|nasopharyngeal carcinoma
105531|NCT03544073|in-vitro fertilization|in-vitro fertilization
105532|NCT03544060|Familial Chylomicronemia|familial chylomicronemia
105533|NCT03544060|Familial Lipoprotein Lipase Deficiency|familial lipoprotein lipase deficiency
105534|NCT03544060|Hyperlipoproteinemias|hyperlipoproteinemias
105535|NCT03544060|Familial Hyperlipoproteinemia Type 1|familial hyperlipoproteinemia type 1
105536|NCT03544060|Hyperlipoproteinemia Type 1|hyperlipoproteinemia type 1
105537|NCT03544060|Hyperchylomicronemia, Familial|hyperchylomicronemia, familial
105538|NCT03544060|Lipoprotein Lipase Deficiency, Familial|lipoprotein lipase deficiency, familial
105539|NCT03544060|Hyperlipidemias|hyperlipidemias
105540|NCT03544060|Dyslipidemias|dyslipidemias
105541|NCT03544060|Lipid Metabolism Disorders|lipid metabolism disorders
105542|NCT03544060|Lipid Metabolism, Inborn Errors|lipid metabolism, inborn errors
105543|NCT03544060|Metabolic Diseases|metabolic diseases
105544|NCT03544060|Metabolism, Inborn Errors|metabolism, inborn errors
105545|NCT03544060|Genetic Diseases, Inborn|genetic diseases, inborn
105546|NCT03544021|Acute Lymphocytic Leukemia|acute lymphocytic leukemia
105547|NCT03544021|Relapsed|relapsed
105548|NCT03544021|Refractory|refractory
105549|NCT03543995|lower urinary tract symptoms|lower urinary tract symptoms
105550|NCT03543995|nocturnal enuresis|nocturnal enuresis
105551|NCT03543995|spina bifida occulta|spina bifida occulta
105552|NCT03543995|treatment response|treatment response
105553|NCT03543956|Silica|silica
105554|NCT03543956|Organic Solvents|organic solvents
105555|NCT03543956|Toxic substances exposure|toxic substances exposure
105556|NCT03543904|Abdomen|abdomen
105557|NCT03543904|Children|children
105558|NCT03543904|Chest physical therapy|chest physical therapy
105559|NCT03543904|Surgery|surgery
105560|NCT03543891|Gut microbiota|gut microbiota
105561|NCT03543891|16S rRNA gene|16s rrna gene
105562|NCT03543891|Thyroid cancer|thyroid cancer
105563|NCT03543891|Metabonomics|metabonomics
105564|NCT03543865|American Indian|american indian
105565|NCT03543865|Resilience|resilience
105566|NCT03543865|Native American|native american
105567|NCT03543852|Cancer survivor|cancer survivor
105568|NCT03543852|Health promotion|health promotion
105569|NCT03543852|Health education|health education
105570|NCT03543839|lupus|lupus
105571|NCT03543839|early lupus|early lupus
105572|NCT03543839|belimumab|belimumab
105573|NCT03543839|autoreactivity|autoreactivity
105574|NCT03543826|neostigmine|neostigmine
105575|NCT03543826|sugammadex|sugammadex
105576|NCT03543826|rocuronium|rocuronium
105577|NCT03543826|neuromuscular blocking agents|neuromuscular blocking agents
105578|NCT03543813|cancer|cancer
105579|NCT03543813|solid tumor|solid tumor
105580|NCT03543813|DLBCL|dlbcl
105581|NCT03543813|CX-2029|cx-2029
105582|NCT03543813|PROBODY™ Therapeutic|probody™ therapeutic
105583|NCT03543813|Drug Conjugate|drug conjugate
135160|NCT03357783|Ovarian|ovarian
105584|NCT03543813|Antibody drug conjugate|antibody drug conjugate
105585|NCT03543813|CD71|cd71
105586|NCT03543813|Transferrin receptor 1|transferrin receptor 1
105587|NCT03543787|Referral networks|referral networks
105588|NCT03543787|low and middle income countries|low and middle income countries
105589|NCT03543787|PRECEDE-PROCEED|precede-proceed
105590|NCT03543787|implementation research|implementation research
105591|NCT03543787|hypertension|hypertension
105592|NCT03543787|cardiovascular disease|cardiovascular disease
105593|NCT03543787|process evaluation|process evaluation
105594|NCT03543774|Chronic kidney disease|chronic kidney disease
105595|NCT03543774|Lipid lowering therapy|lipid lowering therapy
105596|NCT03543774|Hypercholesterolemia|hypercholesterolemia
105597|NCT03543748|Transcranial Magnetic Stimulation|transcranial magnetic stimulation
105598|NCT03543748|cognitive impairment|cognitive impairment
105599|NCT03543722|Veterans|veterans
105600|NCT03543722|Disability|disability
105601|NCT03543722|Employment|employment
105602|NCT03543722|Vocational Rehabilitation|vocational rehabilitation
105603|NCT03543722|Supported Employment|supported employment
105604|NCT03543709|Behcet's disease|behcet's disease
105605|NCT03543709|Fibromyalgia|fibromyalgia
105606|NCT03543709|Disease activity|disease activity
105607|NCT03543683|Non-Small Cell Lung Cancer|non-small cell lung cancer
105608|NCT03543683|Aspirin|aspirin
105609|NCT03543683|Osimertinib|osimertinib
105610|NCT03543683|EGFR-TKI|egfr-tki
105611|NCT03543683|T790M|t790m
105612|NCT03543644|Microbiome|microbiome
105613|NCT03543644|Sugar Sweetened Beverages|sugar sweetened beverages
105614|NCT03543644|Diet Beverages|diet beverages
105615|NCT03543644|Non-Nutritive Sweetened Beverages|non-nutritive sweetened beverages
105616|NCT03543644|Glucose response|glucose response
105617|NCT03543618|dental implant|dental implant
105618|NCT03543618|edentulous ridge|edentulous ridge
105619|NCT03543592|postmenopausal bleeding|postmenopausal bleeding
105620|NCT03543592|ultrasound|ultrasound
105621|NCT03543592|power doppler|power doppler
105622|NCT03543592|endometrium|endometrium
105623|NCT03543579|multiple myeloma|multiple myeloma
105624|NCT03543579|Carfilzomib|carfilzomib
105625|NCT03543579|Proteasome inhibition|proteasome inhibition
105626|NCT03543566|antimuscarinic medication|antimuscarinic medication
105627|NCT03543566|medical management|medical management
105628|NCT03543566|dual incontinence|dual incontinence
105629|NCT03543566|darifenacin|darifenacin
105630|NCT03543566|quality of life|quality of life
105631|NCT03543566|bowel diary|bowel diary
105632|NCT03543514|colon cancer, rectal cancer, prehabilitation|colon cancer, rectal cancer, prehabilitation
105633|NCT03543462|Ovarian Cancer|ovarian cancer
105634|NCT03543462|Diaphragm|diaphragm
105635|NCT03543462|Chest Drain|chest drain
105636|NCT03543462|Diaphragmatic Resection|diaphragmatic resection
105637|NCT03543462|Pleural Effusion|pleural effusion
105638|NCT03543436|Non-inferiority study|non-inferiority study
105639|NCT03543436|Temocillin|temocillin
105640|NCT03543436|Carbapenem|carbapenem
105641|NCT03543436|ESBL infection|esbl infection
105739|NCT03542890|Baska|baska
105642|NCT03543436|Urinary tract infection|urinary tract infection
105643|NCT03543423|Gut hormone secretion|gut hormone secretion
105644|NCT03543423|Glucose absorption|glucose absorption
105645|NCT03543423|early meal phase|early meal phase
105646|NCT03543423|Insulin and glucagon secretion|insulin and glucagon secretion
105647|NCT03543410|Depression, Depressive episode, Bipolar, Bipolar 1, Bipolar 1 depression|depression, depressive episode, bipolar, bipolar 1, bipolar 1 depression
105648|NCT03543397|ductal carcinomas|ductal carcinomas
105649|NCT03543397|ductal carcinoma in situ (DCIS)|ductal carcinoma in situ (dcis)
105650|NCT03543397|MRI|mri
105651|NCT03543384|facial neuritis|facial neuritis
105652|NCT03543384|T2 weighted gradient-echo|t2 weighted gradient-echo
105653|NCT03543384|fast imaging employing steady state acquisition (FIESTA-C)|fast imaging employing steady state acquisition (fiesta-c)
105654|NCT03543384|magnetic resonance imaging (MRI)|magnetic resonance imaging (mri)
105655|NCT03543371|Neuropsychology|neuropsychology
105656|NCT03543358|rovalpituzumab tesirine|rovalpituzumab tesirine
105657|NCT03543358|rollover study|rollover study
105658|NCT03543358|cancer|cancer
105659|NCT03543345|RCA|rca
105660|NCT03543345|PCI|pci
105661|NCT03543345|right ventricular function|right ventricular function
105662|NCT03543332|Physical training|physical training
105663|NCT03543332|Kinesiophobia|kinesiophobia
105664|NCT03543293|perilymphatic fistulas|perilymphatic fistulas
105665|NCT03543293|magnetic resonance imaging (MRI)|magnetic resonance imaging (mri)
105666|NCT03543293|surgery|surgery
105667|NCT03543293|round window|round window
105668|NCT03543293|vertigo|vertigo
105669|NCT03543293|tinnitus|tinnitus
105670|NCT03543293|cophosis|cophosis
105671|NCT03543280|fatigability post stroke|fatigability post stroke
105672|NCT03543280|post stroke|post stroke
105673|NCT03543280|high-speed CT|high-speed ct
105674|NCT03543280|MRI|mri
105675|NCT03543254|Botulinum Toxins, Type A|botulinum toxins, type a
105676|NCT03543254|Injections|injections
105677|NCT03543254|Cranial Sutures|cranial sutures
105678|NCT03543254|Head|head
105679|NCT03543241|Strain|strain
105680|NCT03543228|Strain|strain
105681|NCT03543215|MRI|mri
105682|NCT03543215|Radiomics|radiomics
105683|NCT03543215|Texture features|texture features
105684|NCT03543215|Prognostication|prognostication
105685|NCT03543215|Endometrial cancer|endometrial cancer
105686|NCT03543202|Unilateral transversus abdominal plane block|unilateral transversus abdominal plane block
105687|NCT03543202|Local infiltration anesthesia|local infiltration anesthesia
105688|NCT03543202|Cholecystectomy|cholecystectomy
105689|NCT03543202|Postoperative analgesia|postoperative analgesia
105690|NCT03543189|Gleason Group 5|gleason group 5
105691|NCT03543189|PCa|pca
105692|NCT03543189|Advanced Stage Prostate Cancer|advanced stage prostate cancer
105693|NCT03543189|Immunotherapy|immunotherapy
105694|NCT03543189|Oligometastaic Disease|oligometastaic disease
105695|NCT03543189|Brachytherapy|brachytherapy
105696|NCT03543189|Androgen Deprivation Therapy|androgen deprivation therapy
105697|NCT03543176|Cohort|cohort
105698|NCT03543176|Chronic obstructive pulmonary disease|chronic obstructive pulmonary disease
105699|NCT03543176|Observational|observational
105700|NCT03543176|GOLD|gold
105701|NCT03543176|Claims|claims
105702|NCT03543176|Health plan recruitment|health plan recruitment
105703|NCT03543163|buccal fat pad graft|buccal fat pad graft
105704|NCT03543163|sub-epithelial connective tissue graft|sub-epithelial connective tissue graft
105705|NCT03543150|Spasmodic Dysphonia|spasmodic dysphonia
105706|NCT03543150|VHI-10 scores|vhi-10 scores
105707|NCT03543150|BOTOX|botox
105708|NCT03543150|Drug use investigation|drug use investigation
105709|NCT03543124|colonoscopy|colonoscopy
105710|NCT03543124|pain|pain
105711|NCT03543124|water exchange|water exchange
105712|NCT03543124|cap|cap
105713|NCT03543098|Knee Injury|knee injury
105714|NCT03543098|Knee Injuries|knee injuries
105715|NCT03543098|Knee Surgery|knee surgery
105716|NCT03543098|Rehabilitation|rehabilitation
105717|NCT03543098|Knee Dislocation|knee dislocation
105718|NCT03543098|Multiple Ligament Knee Injury|multiple ligament knee injury
105719|NCT03543033|lumbar radiculopathy|lumbar radiculopathy
105720|NCT03543033|corticosteroid epidural injection|corticosteroid epidural injection
105721|NCT03543020|radiation induced alopecia|radiation induced alopecia
105722|NCT03543020|whole brain radiation|whole brain radiation
105723|NCT03543020|partial brain radiation|partial brain radiation
105724|NCT03543020|radiotherapy|radiotherapy
105725|NCT03542981|pain|pain
105726|NCT03542981|surgery|surgery
105727|NCT03542981|interferential current|interferential current
105728|NCT03542981|total knee arthroplasty|total knee arthroplasty
105729|NCT03542968|Congenital heart disease|congenital heart disease
105730|NCT03542968|Tetralogy of Fallot|tetralogy of fallot
105731|NCT03542968|Imaging by 4D Flow,|imaging by 4d flow,
105732|NCT03542968|Magnetic resonance imaging|magnetic resonance imaging
105733|NCT03542968|Prevention of ventricular dysfunction|prevention of ventricular dysfunction
105734|NCT03542942|locally advanced|locally advanced
105735|NCT03542942|radiotherapy|radiotherapy
105736|NCT03542942|DW-MRI|dw-mri
105737|NCT03542942|target volume|target volume
105738|NCT03542890|Anesthesia, General|anesthesia, general
105740|NCT03542890|I-gel|i-gel
105741|NCT03542877|Cabozantinib|cabozantinib
105742|NCT03542877|Progression Free Survival|progression free survival
105743|NCT03542877|Metastatic Colorectal Cancer|metastatic colorectal cancer
105744|NCT03542877|Tumor|tumor
105745|NCT03542864|obesity|obesity
105746|NCT03542864|overweight|overweight
105747|NCT03542864|fat percentage|fat percentage
105748|NCT03542864|body fat|body fat
105749|NCT03542864|enteral feeding|enteral feeding
105750|NCT03542864|fat loss|fat loss
105751|NCT03542825|Iron|iron
105752|NCT03542825|Deficiency|deficiency
105753|NCT03542812|L-citrulline|l-citrulline
105754|NCT03542812|Nitric oxide|nitric oxide
105755|NCT03542786|HIV-1|hiv-1
105756|NCT03542760|Methylene Blue|methylene blue
105757|NCT03542747|Airway|airway
105758|NCT03542747|extraglottic|extraglottic
105759|NCT03542747|simulation|simulation
105760|NCT03542747|laryngeal mask|laryngeal mask
105761|NCT03542721|chronic fatigue symptom|chronic fatigue symptom
105762|NCT03542721|blood circulation|blood circulation
105763|NCT03542656|Stroke|stroke
105764|NCT03542656|intracerebral hemorrhage|intracerebral hemorrhage
105765|NCT03542656|amyoid PET|amyoid pet
105766|NCT03542656|cerebral amyloid angiopathy|cerebral amyloid angiopathy
105767|NCT03542643|ADHD|adhd
105768|NCT03542643|n-3 polyunsaturated fatty acids|n-3 polyunsaturated fatty acids
105769|NCT03542643|children|children
105770|NCT03542643|adolescents|adolescents
105771|NCT03542513|Human Papillomavirus|human papillomavirus
105772|NCT03542513|Biomarker|biomarker
105773|NCT03542513|Self-sampling|self-sampling
105774|NCT03542513|First-void urine|first-void urine
105775|NCT03542513|Cervical Intraepithelial Neoplasia|cervical intraepithelial neoplasia
105776|NCT03542513|LLETZ|lletz
105777|NCT03542487|Self Monitoring of Blood Glucose|self monitoring of blood glucose
105778|NCT03542487|Electronic Medical Records|electronic medical records
105779|NCT03542487|Nudge|nudge
105780|NCT03542487|Secure Messaging|secure messaging
105781|NCT03542487|Behavioral Economics|behavioral economics
105782|NCT03542461|Squamous NSCLC|squamous nsclc
105783|NCT03542461|Nivolumab|nivolumab
105785|NCT03542396|Endurance exercise|endurance exercise
105786|NCT03542383|Gulf War Illness|gulf war illness
105787|NCT03542383|Memory|memory
105788|NCT03542383|Word Finding|word finding
105789|NCT03542383|High Definition Transcranial Direct Current Stimulation|high definition transcranial direct current stimulation
105790|NCT03542383|Transcranial Direct Current Stimulation|transcranial direct current stimulation
105791|NCT03542370|dietary approaches to stop hypertension|dietary approaches to stop hypertension
105792|NCT03542370|DASH|dash
105793|NCT03542370|cardiometabolic health|cardiometabolic health
105794|NCT03542370|Umbrella Review|umbrella review
105795|NCT03542370|GRADE|grade
105796|NCT03542370|Systematic review and meta-analysis|systematic review and meta-analysis
105797|NCT03542318|Pulmonary Rehabilitation|pulmonary rehabilitation
105798|NCT03542318|Functional outcomes|functional outcomes
105799|NCT03542318|Health Status|health status
105800|NCT03542318|Exercise|exercise
105801|NCT03542279|Autoimmune encephalitis, Plasma exchange, Immunotherapy, Outcome|autoimmune encephalitis, plasma exchange, immunotherapy, outcome
105802|NCT03542266|Peripheral T-cell Lymphoma|peripheral t-cell lymphoma
105803|NCT03542266|Azacitidine|azacitidine
105804|NCT03542266|Lymphoma|lymphoma
105805|NCT03542253|Early lung cancer,ground-glass nodule,CT,exosome|early lung cancer,ground-glass nodule,ct,exosome
105806|NCT03542240|curcumin|curcumin
105807|NCT03542240|microbiome|microbiome
105808|NCT03542240|dietary supplements|dietary supplements
105809|NCT03542240|gut bacteria|gut bacteria
105810|NCT03542227|Antibodies|antibodies
105811|NCT03542227|Vaccination|vaccination
105812|NCT03542227|Self-sampling|self-sampling
105813|NCT03542227|First-void urine|first-void urine
105814|NCT03542188|Large Vessel Occlusion|large vessel occlusion
105815|NCT03542188|Stroke|stroke
105816|NCT03542188|EVT|evt
105817|NCT03542175|Rucaparib|rucaparib
105818|NCT03542175|Radiotherapy|radiotherapy
105819|NCT03542175|Triple Negative Breast Cancer|triple negative breast cancer
105820|NCT03542175|18-002|18-002
105821|NCT03542162|Healaflow|healaflow
105822|NCT03542162|Rhegmatogenous retinal detachment|rhegmatogenous retinal detachment
105823|NCT03542162|27-gauge Pars plana vitrectomy|27-gauge pars plana vitrectomy
105824|NCT03542162|Minimally invasive surgery|minimally invasive surgery
105825|NCT03542162|Complications|complications
105826|NCT03542136|Polyneuropathy|polyneuropathy
105827|NCT03542136|Oxaliplatin|oxaliplatin
105828|NCT03542136|Colorectal cancer|colorectal cancer
105829|NCT03542123|Electrical Stimulation Therapy; Electrodes; Parasympathetic Nervous System; Sympathetic Fibers, Post Ganglionic; Congestive Heart Failure; Heart Failure|electrical stimulation therapy; electrodes; parasympathetic nervous system; sympathetic fibers, post ganglionic; congestive heart failure; heart failure
105830|NCT03542097|Ewing Sarcoma|ewing sarcoma
105831|NCT03542032|i-gel|i-gel
105832|NCT03542032|jaw-thrust|jaw-thrust
105833|NCT03541993|Resveratrol|resveratrol
105834|NCT03541993|Cerebral blood flow|cerebral blood flow
105835|NCT03541993|Cognition|cognition
105836|NCT03541993|Hypoxia|hypoxia
105840|NCT03541980|opioid-sparing|opioid-sparing
105841|NCT03541967|bone conduction|bone conduction
105842|NCT03541954|sensitization|sensitization
105843|NCT03541954|pain thresholds|pain thresholds
105844|NCT03541941|Liposomal Bupivacaine|liposomal bupivacaine
105845|NCT03541941|Exparel|exparel
105846|NCT03541941|Transversus Abdominis Plane block|transversus abdominis plane block
105847|NCT03541941|Hernia|hernia
105848|NCT03541928|gene therapy|gene therapy
105849|NCT03541928|untreated prostate cancer|untreated prostate cancer
105850|NCT03541902|Malignant Neoplasms of Urinary Tract|malignant neoplasms of urinary tract
105851|NCT03541902|Renal cell carcinoma|renal cell carcinoma
105852|NCT03541902|Cabozantinib|cabozantinib
105853|NCT03541902|XL-184|xl-184
105854|NCT03541902|XL184|xl184
105855|NCT03541902|Sunitinib|sunitinib
105856|NCT03541902|Sunitinib Malate|sunitinib malate
105857|NCT03541902|SU011248|su011248
105858|NCT03541902|Sutent|sutent
105859|NCT03541876|children|children
105860|NCT03541876|treatment|treatment
105861|NCT03541876|observatory|observatory
105862|NCT03541863|Fulvestrant|fulvestrant
105863|NCT03541863|Progression|progression
105864|NCT03541863|Endocrine sensitivity|endocrine sensitivity
105865|NCT03541837|Bilateral ESP Catheter|bilateral esp catheter
105866|NCT03541837|Open heart surgery|open heart surgery
105867|NCT03541837|opioid free post op analgesia|opioid free post op analgesia
105868|NCT03541811|gait|gait
105869|NCT03541811|motion capture|motion capture
105870|NCT03541811|hemophilia joint health score|hemophilia joint health score
105871|NCT03541811|physical activity|physical activity
105872|NCT03541811|body composition|body composition
105873|NCT03541811|gait deviation index|gait deviation index
105874|NCT03541811|hemophilia|hemophilia
105875|NCT03541798|traditional sitting position|traditional sitting position
105876|NCT03541798|combine spinal-epidural anesthesia|combine spinal-epidural anesthesia
105877|NCT03541798|orthopedic surgery|orthopedic surgery
105878|NCT03541785|NGAL|ngal
105879|NCT03541785|Renal Angina Index|renal angina index
105880|NCT03541772|Head Carcinoma|head carcinoma
105881|NCT03541772|Neck Carcinoma|neck carcinoma
105882|NCT03541772|Chemotherapy|chemotherapy
105883|NCT03541772|Radiotherapy|radiotherapy
105884|NCT03541772|Oncoxin Viusid|oncoxin viusid
105885|NCT03541772|Nutritional supplement|nutritional supplement
105886|NCT03541759|Elective shoulder surgery, hydromorphone, piritramide|elective shoulder surgery, hydromorphone, piritramide
105887|NCT03541733|magnetic resonance enterography|magnetic resonance enterography
105888|NCT03541733|bowel preparation|bowel preparation
105890|NCT03541707|EEG|eeg
105891|NCT03541707|Depression|depression
105892|NCT03541707|adolescents|adolescents
105893|NCT03541694|Yellow fever|yellow fever
105894|NCT03541694|Stamaril®|stamaril®
105895|NCT03541681|Epidural Steroid Injections|epidural steroid injections
105896|NCT03541681|Cervical Epidural Injections|cervical epidural injections
105897|NCT03541681|Transforaminal Epidural Injections|transforaminal epidural injections
105898|NCT03541681|Steroids|steroids
105899|NCT03541681|Local Anesthetic|local anesthetic
105900|NCT03541655|total knee replacement|total knee replacement
105901|NCT03541655|pain|pain
105902|NCT03541655|celecoxib|celecoxib
105903|NCT03541655|intra-articular|intra-articular
105904|NCT03541603|PH-HFpEF|ph-hfpef
105905|NCT03541590|percutaneous biliary drainage|percutaneous biliary drainage
105906|NCT03541538|joint manipulation|joint manipulation
105907|NCT03541538|cervical|cervical
105908|NCT03541538|pressure pain|pressure pain
105909|NCT03541538|manual therapy|manual therapy
105910|NCT03541512|Mindfulness therapy|mindfulness therapy
105911|NCT03541512|Vulvodynia|vulvodynia
105912|NCT03541512|Vulvar pain|vulvar pain
105917|NCT03541486|ascorbic acid|ascorbic acid
105918|NCT03541486|ascorbate|ascorbate
105919|NCT03541486|sodium ascorbate|sodium ascorbate
105920|NCT03541486|radiotherapy|radiotherapy
105921|NCT03541486|radiotherapy, image-guided|radiotherapy, image-guided
105922|NCT03541486|gemcitabine|gemcitabine
105923|NCT03541460|centenarians|centenarians
105924|NCT03541460|epigenome|epigenome
105925|NCT03541460|longevity|longevity
105926|NCT03541460|healthy aging|healthy aging
105927|NCT03541460|epigenetic|epigenetic
105928|NCT03541447|ADPKD, Tolvaptan, Octrotide LAR|adpkd, tolvaptan, octrotide lar
105929|NCT03541434|obstructive sleep apnea|obstructive sleep apnea
105930|NCT03541434|tonsillitis|tonsillitis
105931|NCT03541434|middle ear effusion|middle ear effusion
105932|NCT03541434|pathophysiology|pathophysiology
105933|NCT03541434|score|score
105934|NCT03541382|HIV|hiv
105935|NCT03541382|HIV Self-Testing|hiv self-testing
105936|NCT03541382|Malawi|malawi
105937|NCT03541356|Parkinsons|parkinsons
105938|NCT03541356|L-dopa|l-dopa
105939|NCT03541356|levodopa|levodopa
105940|NCT03541356|ON|on
105941|NCT03541356|OFF|off
105942|NCT03541356|PD|pd
105943|NCT03541356|POD device|pod device
105944|NCT03541356|I231|i231
105945|NCT03541356|benserazide|benserazide
105946|NCT03541356|Precision olfactory delivery|precision olfactory delivery
105947|NCT03541356|MDS-UPDRS|mds-updrs
105948|NCT03541356|Carbidopa|carbidopa
105949|NCT03541356|DCI|dci
105950|NCT03541356|Decarboxylase Inhibitor|decarboxylase inhibitor
105951|NCT03541330|Siblings|siblings
105952|NCT03541330|information|information
105953|NCT03541330|malignant haemopathy|malignant haemopathy
105954|NCT03541317|Adaptive implementation|adaptive implementation
105955|NCT03541317|Coaching|coaching
105956|NCT03541317|Facilitation|facilitation
105957|NCT03541317|School mental health|school mental health
105958|NCT03541317|Implementation intervention|implementation intervention
105959|NCT03541304|high dose radiotherapy|high dose radiotherapy
105960|NCT03541304|rectal cancer|rectal cancer
105961|NCT03541278|Breast Cancer|breast cancer
105962|NCT03541278|Internal Mammary Lymph Node|internal mammary lymph node
105963|NCT03541278|Internal Mammary Sentinel Lymph Node Biopsy|internal mammary sentinel lymph node biopsy
105964|NCT03541278|Detection Rate|detection rate
105965|NCT03541265|liposomal bupivacaine|liposomal bupivacaine
105966|NCT03541265|total knee arthroplasty|total knee arthroplasty
105967|NCT03541213|ferric carboxymaltose|ferric carboxymaltose
105968|NCT03541213|mitochondrial metabolism|mitochondrial metabolism
105969|NCT03541213|cardiomyocyte|cardiomyocyte
105970|NCT03541187|cockroach|cockroach
105971|NCT03541187|immunotherapy|immunotherapy
105972|NCT03541187|inner city asthma|inner city asthma
105973|NCT03541187|subcutaneous immunotherapy (SCIT)|subcutaneous immunotherapy (scit)
105974|NCT03541187|Nasal Allergen Challenge (NAC)|nasal allergen challenge (nac)
105975|NCT03541161|Early rehabilitation|early rehabilitation
105976|NCT03541161|Conventional protocol|conventional protocol
105977|NCT03541161|Tissue expander insertion|tissue expander insertion
105978|NCT03541148|Cutaneous malignant melanoma|cutaneous malignant melanoma
105979|NCT03541148|Nutritional supplement|nutritional supplement
105980|NCT03541148|survival|survival
105981|NCT03541148|Green tea|green tea
105982|NCT03541135|Cardiovascular health|cardiovascular health
105983|NCT03541135|Diet|diet
105984|NCT03541135|Functional limitations|functional limitations
105985|NCT03541135|Frailty|frailty
105986|NCT03541135|Older Adults|older adults
105987|NCT03541109|Cardiovascular disease|cardiovascular disease
105988|NCT03541109|fixed dose combination therapy|fixed dose combination therapy
105989|NCT03541109|cost effectiveness|cost effectiveness
105990|NCT03541070|kinesiology taping|kinesiology taping
105991|NCT03541070|balance|balance
105992|NCT03541070|Duchenne Muscular Dystrophy|duchenne muscular dystrophy
105993|NCT03541018|TRV Reposition Chair|trv reposition chair
105994|NCT03541018|Epley Maneuvre|epley maneuvre
105995|NCT03541005|Overweight|overweight
105996|NCT03541005|Obesity|obesity
105997|NCT03541005|Nutritional supplement|nutritional supplement
105998|NCT03541005|Weight loss|weight loss
105999|NCT03541005|waist|waist
106000|NCT03540953|Endoscopic injection of Mitomycin C|endoscopic injection of mitomycin c
106001|NCT03540927|Well-being|well-being
106002|NCT03540927|Entrepreneurs|entrepreneurs
106003|NCT03540927|Conflict affected settings|conflict affected settings
106004|NCT03540927|Psychosocial intervention|psychosocial intervention
106005|NCT03540927|Psychological Capital|psychological capital
106006|NCT03540914|healthy participants older than 40 years|healthy participants older than 40 years
106007|NCT03540914|right heart function|right heart function
106008|NCT03540914|prevention|prevention
106009|NCT03540914|acetazolamide|acetazolamide
106010|NCT03540901|prevention|prevention
106011|NCT03540901|acetazolamide|acetazolamide
106012|NCT03540901|obstructive airway disease|obstructive airway disease
106013|NCT03540901|lung water|lung water
106014|NCT03540888|Dynamic Stretching|dynamic stretching
106015|NCT03540888|Static Stretching|static stretching
106016|NCT03540888|Manual Therapy|manual therapy
106017|NCT03540875|Anesthesia, general|anesthesia, general
106018|NCT03540875|Total intravenous anesthesia|total intravenous anesthesia
106019|NCT03540875|Closed loop anesthesia|closed loop anesthesia
106020|NCT03540875|Conox|conox
106021|NCT03540875|EEG monitoring|eeg monitoring
106022|NCT03540875|qCon|qcon
106023|NCT03540875|qNox|qnox
106024|NCT03540862|Chronic obstructive pulmonary disease|chronic obstructive pulmonary disease
106025|NCT03540862|Maintenance Negative Pressure Ventilation- assisted pulmonary rehabilitation|maintenance negative pressure ventilation- assisted pulmonary rehabilitation
106026|NCT03540862|Six minute walk test|six minute walk test
106027|NCT03540862|Overall survival|overall survival
106028|NCT03540810|antiphospholipid syndrome|antiphospholipid syndrome
106029|NCT03540810|thrombosis|thrombosis
106030|NCT03540810|hydroxychloroquine|hydroxychloroquine
106031|NCT03540784|muscle weakness|muscle weakness
106032|NCT03540784|muscle mass|muscle mass
106033|NCT03540784|whole-body electromyostimulation|whole-body electromyostimulation
106034|NCT03540784|WB-EMS|wb-ems
106035|NCT03540784|nutrition|nutrition
106036|NCT03540784|protein|protein
106037|NCT03540784|crohn's disease|crohn's disease
106038|NCT03540784|ulcerative colitis|ulcerative colitis
106039|NCT03540771|palliative care|palliative care
106040|NCT03540771|hepatology|hepatology
106041|NCT03540758|type 2 diabetes|type 2 diabetes
106042|NCT03540758|diabetes|diabetes
106043|NCT03540758|insulin resistance|insulin resistance
106044|NCT03540758|diazoxide|diazoxide
106045|NCT03540719|classification|classification
106046|NCT03540719|questionnaires|questionnaires
106047|NCT03540719|open reduction|open reduction
106048|NCT03540719|internal fixation|internal fixation
106049|NCT03540706|Respiratory Infections|respiratory infections
106050|NCT03540706|C-reactive protein|c-reactive protein
106051|NCT03540706|antibiotic prescription|antibiotic prescription
106052|NCT03540693|Bariatric surgery|bariatric surgery
106053|NCT03540693|gastric bypass surgery|gastric bypass surgery
106054|NCT03540693|sleeve gastrectomy|sleeve gastrectomy
106055|NCT03540693|laparoscopic gastric banding|laparoscopic gastric banding
106056|NCT03540693|food preferences|food preferences
106057|NCT03540693|flavor perception|flavor perception
106058|NCT03540667|Total hip arthroplasty|total hip arthroplasty
106059|NCT03540667|Total knee arthroplasty|total knee arthroplasty
106060|NCT03540667|Total joint arthroplasty|total joint arthroplasty
106061|NCT03540667|Low middle income country|low middle income country
106062|NCT03540667|Enhanced recovery pathway|enhanced recovery pathway
106063|NCT03540641|Binge Eating Disorder|binge eating disorder
106064|NCT03540641|Transcranial Magnetic Stimulation|transcranial magnetic stimulation
106065|NCT03540641|Food Craving|food craving
106066|NCT03540602|Polyphenol rich supplementation|polyphenol rich supplementation
106067|NCT03540602|Tart cherry|tart cherry
106068|NCT03540602|Lifting|lifting
106069|NCT03540602|Recovery|recovery
106070|NCT03540563|ctDNA|ctdna
106071|NCT03540511|cardiac surgery|cardiac surgery
106072|NCT03540511|troponin|troponin
106073|NCT03540511|mortality|mortality
106074|NCT03540498|Oral health|oral health
106075|NCT03540498|Probiotics|probiotics
106076|NCT03540498|L. plantarum|l. plantarum
106077|NCT03540498|L. brevis|l. brevis
106078|NCT03540498|Periodontics|periodontics
106079|NCT03540472|tacrolimus|tacrolimus
106080|NCT03540472|refractory pure red cell aplasia|refractory pure red cell aplasia
106081|NCT03540472|prospective study|prospective study
106082|NCT03540446|First Relief|first relief
106083|NCT03540446|Diebetes|diebetes
106084|NCT03540446|Pheripheral Neuropathy|pheripheral neuropathy
106085|NCT03540446|Pain Releif|pain releif
106086|NCT03540420|Atezolizumab|atezolizumab
106087|NCT03540420|Chemoradiotherapy|chemoradiotherapy
106088|NCT03540420|Immunotherapy|immunotherapy
106089|NCT03540407|Cervical carcinoma|cervical carcinoma
106090|NCT03540407|Endometrial adenocarcinoma|endometrial adenocarcinoma
106091|NCT03540407|Oncoxin-Viusid|oncoxin-viusid
106092|NCT03540407|Nutritional supplement|nutritional supplement
106093|NCT03540407|Antioxidant|antioxidant
106094|NCT03540381|Neoatherosclerosis|neoatherosclerosis
106095|NCT03540381|Cholesterol Uptake Capacity|cholesterol uptake capacity
106096|NCT03540368|Gastrointestinal bleeding|gastrointestinal bleeding
106097|NCT03540368|Tranexamic acid|tranexamic acid
106098|NCT03540368|Clinical trial|clinical trial
106099|NCT03540342|coronary artery disease|coronary artery disease
106100|NCT03540342|aortic atherosclerotic disease|aortic atherosclerotic disease
106101|NCT03540342|one-stop|one-stop
106102|NCT03540342|percutaneous coronary intervention|percutaneous coronary intervention
106103|NCT03540342|endovascular aortic repair|endovascular aortic repair
106104|NCT03540329|osteogenesis|osteogenesis
106105|NCT03540329|distraction|distraction
106106|NCT03540329|Lower face asymmetry|lower face asymmetry
106107|NCT03540303|relapsed/refractory, B cell, lymphoma, CAR|relapsed/refractory, b cell, lymphoma, car
106108|NCT03540277|prevention program|prevention program
106109|NCT03540277|body-image|body-image
106110|NCT03540277|self-esteem|self-esteem
106111|NCT03540277|parents|parents
106112|NCT03540277|adolescents|adolescents
106113|NCT03540238|sedation|sedation
106114|NCT03540238|endoscopy|endoscopy
106115|NCT03540238|anesthesia|anesthesia
106116|NCT03540238|gastroenterologist|gastroenterologist
106117|NCT03540225|Progesterone|progesterone
106118|NCT03540199|activated CIK|activated cik
106119|NCT03540199|MUC1|muc1
106120|NCT03540199|bispecific antibody|bispecific antibody
106121|NCT03540199|kidney cancer|kidney cancer
106122|NCT03540147|blood flow restriction|blood flow restriction
106123|NCT03540147|blood pressure|blood pressure
106124|NCT03540147|yoga|yoga
106125|NCT03540134|DBS|dbs
106126|NCT03540121|video|video
106127|NCT03540121|contract|contract
106128|NCT03540121|patient education|patient education
106129|NCT03540108|hypercholesterolemia|hypercholesterolemia
106130|NCT03540108|bile acid synthesis|bile acid synthesis
106131|NCT03540108|cholesterol|cholesterol
106132|NCT03540108|bile salt hydrolysis|bile salt hydrolysis
106133|NCT03540108|vitamin D|vitamin d
106134|NCT03540108|probiotic L plantarum LPLDL®|probiotic l plantarum lpldl®
106135|NCT03540082|Aging|aging
106136|NCT03540082|Older Adults|older adults
106137|NCT03540082|Fall prevention|fall prevention
106138|NCT03540082|Fall safety|fall safety
106149|NCT03539965|Predictive Biomarkers|predictive biomarkers
106150|NCT03539965|Prognostic Biomarkers|prognostic biomarkers
106151|NCT03539965|Complete Pathological Response|complete pathological response
106152|NCT03539965|Tumor Infiltrating Lymphocytes|tumor infiltrating lymphocytes
106153|NCT03539965|PD-L1|pd-l1
106154|NCT03539965|PD-L2|pd-l2
106155|NCT03539939|Gingival crevicular fluid|gingival crevicular fluid
106156|NCT03539939|Gingival recession|gingival recession
106157|NCT03539939|Saliva|saliva
106158|NCT03539939|Smoking|smoking
106159|NCT03539939|Wound healing|wound healing
106160|NCT03539926|Cystinuria|cystinuria
106161|NCT03539926|pH Control|ph control
106162|NCT03539887|Ketamine|ketamine
106163|NCT03539887|Depression|depression
106164|NCT03539887|Suicidal Ideation|suicidal ideation
106165|NCT03539887|Alcohol Abuse|alcohol abuse
106166|NCT03539861|End Stage Renal Disease|end stage renal disease
106167|NCT03539861|Hemodialysis|hemodialysis
106168|NCT03539861|Chronic Kidney Disease Stage 5|chronic kidney disease stage 5
106172|NCT03539835|Breast Cancer Survivors|breast cancer survivors
106173|NCT03539835|Resistance Training|resistance training
106174|NCT03539835|Fatigue|fatigue
106175|NCT03539835|Physical Function|physical function
106176|NCT03539835|Behavioral Function|behavioral function
106177|NCT03539835|Kynurenine metabolism|kynurenine metabolism
106178|NCT03539822|Cabozantinib|cabozantinib
106179|NCT03539822|Durvalumab|durvalumab
106180|NCT03539822|MEDI4736|medi4736
106181|NCT03539809|Branched Chain Amino Acids|branched chain amino acids
106182|NCT03539809|Direct Amino Acid Oxidation|direct amino acid oxidation
106183|NCT03539809|Stable isotopes|stable isotopes
106184|NCT03539796|dural puncture epidurals|dural puncture epidurals
106185|NCT03539796|DPE|dpe
106186|NCT03539796|combined-spinal epidural|combined-spinal epidural
106187|NCT03539796|CSE|cse
106188|NCT03539796|cesarean section|cesarean section
106189|NCT03539796|patient satisfaction|patient satisfaction
106190|NCT03539783|Endotype|endotype
106191|NCT03539783|Pediatric Acute Respiratory Distress Syndrome|pediatric acute respiratory distress syndrome
106192|NCT03539783|Gene Expression|gene expression
106193|NCT03539783|Transcriptomics|transcriptomics
106194|NCT03539770|Lung Development|lung development
106195|NCT03539770|Lung Regeneration|lung regeneration
106196|NCT03539770|Hyperpolarized Helium|hyperpolarized helium
106197|NCT03539757|Liver fibrosis|liver fibrosis
106198|NCT03539757|Fontan surgery|fontan surgery
106199|NCT03539757|MRI|mri
106200|NCT03539757|Novel Methods|novel methods
106201|NCT03539744|Cancer|cancer
106202|NCT03539744|Multiple Myeloma (MM)|multiple myeloma (mm)
106203|NCT03539744|Relapsed or Refractory Multiple Myeloma (R/R MM)|relapsed or refractory multiple myeloma (r/r mm)
106204|NCT03539744|pharmacokinetics|pharmacokinetics
106205|NCT03539679|Exercise, sickness absences, health, military fitness|exercise, sickness absences, health, military fitness
106206|NCT03539640|PEEP|peep
106207|NCT03539640|Diaphragm|diaphragm
106208|NCT03539627|diabetes mellitus|diabetes mellitus
106209|NCT03539627|Edarbi|edarbi
106210|NCT03539627|hypertension|hypertension
106211|NCT03539614|Prazosin|prazosin
106212|NCT03539614|Nightmares|nightmares
106213|NCT03539614|N-of-1|n-of-1
106214|NCT03539601|Atopic Dermatitis, Crisaborole ointment 2%, TCS, TCI|atopic dermatitis, crisaborole ointment 2%, tcs, tci
106215|NCT03539588|dry needling|dry needling
106216|NCT03539588|electrical stimulation|electrical stimulation
106217|NCT03539588|E-Stim|e-stim
106218|NCT03539588|LBP|lbp
106219|NCT03539588|low back pain|low back pain
106220|NCT03539588|trigger point|trigger point
106221|NCT03539588|chronic|chronic
106222|NCT03539588|subacute|subacute
106233|NCT03539523|L test|l test
106234|NCT03539523|cerebral palsy|cerebral palsy
106235|NCT03539523|children|children
106236|NCT03539523|validity|validity
106237|NCT03539523|reliability|reliability
106238|NCT03539497|biomarker|biomarker
106239|NCT03539445|AIS|ais
106240|NCT03539445|butylphthalide|butylphthalide
106241|NCT03539445|mechanical thrombectomy|mechanical thrombectomy
106242|NCT03539445|iv-rtPA|iv-rtpa
106243|NCT03539445|recovery of dysfunction|recovery of dysfunction
106244|NCT03539419|Psoriasis|psoriasis
106245|NCT03539419|Plaque Psoriasis|plaque psoriasis
106246|NCT03539419|Apremilast|apremilast
106247|NCT03539419|CC-10004|cc-10004
106248|NCT03539367|healthy participants older than 40 years|healthy participants older than 40 years
106249|NCT03539367|lung water|lung water
106250|NCT03539367|prevention|prevention
106251|NCT03539367|acetazolamide|acetazolamide
106252|NCT03539354|Atrial fibrillation|atrial fibrillation
106253|NCT03539354|Spinal cord stimulatoin|spinal cord stimulatoin
106254|NCT03539354|Coronary artery bypass grafting|coronary artery bypass grafting
106255|NCT03539302|Inhaled Flecainide|inhaled flecainide
106256|NCT03539289|IPF|ipf
106257|NCT03539289|Mitigating Adverse Events|mitigating adverse events
106258|NCT03539276|quality improvement|quality improvement
106259|NCT03539276|long term care|long term care
106260|NCT03539276|polypharmacy|polypharmacy
106261|NCT03539250|Radiation-induced temporal lobe injury;NPC|radiation-induced temporal lobe injury;npc
106262|NCT03539250|Nasopharyngeal carcinoma|nasopharyngeal carcinoma
106263|NCT03539250|Intensity-modulated radiotherapy|intensity-modulated radiotherapy
106264|NCT03539237|Video demonstration|video demonstration
106265|NCT03539237|Intensity levels|intensity levels
106266|NCT03539237|Physical activity|physical activity
106267|NCT03539237|Self-report|self-report
106268|NCT03539237|Accelerometer|accelerometer
106269|NCT03539185|Airtraq|airtraq
106270|NCT03539185|Fiberoptic|fiberoptic
106271|NCT03539185|Awake|awake
106272|NCT03539185|Tracheal intubation|tracheal intubation
106273|NCT03539185|laryngeal nerve blocks|laryngeal nerve blocks
106274|NCT03539185|sedation|sedation
106275|NCT03539185|remifentanil|remifentanil
106276|NCT03539159|Allogeneic serum eye drops|allogeneic serum eye drops
106277|NCT03539159|Micro eye drops|micro eye drops
106278|NCT03539159|Cross-over multicenter trial|cross-over multicenter trial
106279|NCT03539159|Ocular Surface Disease Index (OSDI)|ocular surface disease index (osdi)
106280|NCT03539146|byproducts|byproducts
106281|NCT03539146|functional yogurt|functional yogurt
106282|NCT03539146|satiety|satiety
106283|NCT03539146|sensory analysis|sensory analysis
106284|NCT03539146|sustainable health|sustainable health
106285|NCT03539146|novel food ingredient|novel food ingredient
106286|NCT03539133|STEMI|stemi
106287|NCT03539133|infarction|infarction
106288|NCT03539133|coronary artery disease|coronary artery disease
106289|NCT03539133|comorbidities|comorbidities
106290|NCT03539133|diabetes|diabetes
106291|NCT03539133|anemia|anemia
106292|NCT03539094|Multiple Sclerosis|multiple sclerosis
106293|NCT03539094|Intermittent fasting|intermittent fasting
106294|NCT03539094|western diet|western diet
106295|NCT03539094|microbiome|microbiome
106296|NCT03539081|Epidural Spinal Cord Stimulation|epidural spinal cord stimulation
106297|NCT03539081|Muscle Sympathetic Nerve Activity|muscle sympathetic nerve activity
106298|NCT03539081|Blood Flow|blood flow
106299|NCT03539068|Veteran|veteran
106300|NCT03539068|Mental Health|mental health
106301|NCT03539068|War|war
106302|NCT03539068|Shared decision-making|shared decision-making
106303|NCT03539068|Access to care|access to care
106304|NCT03539055|DRT|drt
106305|NCT03539055|Device related thrombus|device related thrombus
106306|NCT03539055|Dabigatran etexilate|dabigatran etexilate
106307|NCT03539055|Aspirin|aspirin
106308|NCT03539055|Watchman|watchman
106309|NCT03539042|DNA methylation|dna methylation
106310|NCT03539042|Physical activity|physical activity
106311|NCT03539042|Exercise capacity|exercise capacity
106312|NCT03539016|Chronic hepatitis B, Mother-to-child transmission|chronic hepatitis b, mother-to-child transmission
106313|NCT03538990|Nutrition|nutrition
106314|NCT03538990|Dietary Approaches to Stop Hypertension|dietary approaches to stop hypertension
106315|NCT03538990|Cardiometabolic Outcomes|cardiometabolic outcomes
106316|NCT03538990|Pulmonary Artery Pressure|pulmonary artery pressure
106317|NCT03538990|CardioMEMS|cardiomems
106318|NCT03538977|Bronchopulmonary Dysplasia|bronchopulmonary dysplasia
106319|NCT03538977|Hydrotherapy|hydrotherapy
106320|NCT03538977|Electromyography|electromyography
106321|NCT03538977|Pain|pain
106322|NCT03538977|Prematurity|prematurity
106323|NCT03538964|Cataract|cataract
106324|NCT03538964|Low Astigmatism|low astigmatism
106325|NCT03538951|actinic keratosis|actinic keratosis
106326|NCT03538951|efficacy|efficacy
106327|NCT03538951|safety|safety
106328|NCT03538951|VDA-1102|vda-1102
106329|NCT03538938|Smoking|smoking
106330|NCT03538938|Smoking cessation|smoking cessation
106331|NCT03538938|Quitline|quitline
106332|NCT03538938|Nicotine Replacement Therapy|nicotine replacement therapy
106333|NCT03538938|SmokefreeTXT text messages|smokefreetxt text messages
106334|NCT03538938|Financial incentives|financial incentives
106335|NCT03538912|empirical antifungal therapy|empirical antifungal therapy
106336|NCT03538912|invasive candidiasis|invasive candidiasis
106337|NCT03538912|biomarkers|biomarkers
106338|NCT03538912|de-escalation|de-escalation
106339|NCT03538912|ICU|icu
106347|NCT03538873|Physical activity|physical activity
106348|NCT03538873|Population-based study|population-based study
106349|NCT03538860|Telepsychiatry|telepsychiatry
106350|NCT03538860|AsynchronousTelepsychiatry|asynchronoustelepsychiatry
106351|NCT03538860|Automated Translation|automated translation
106352|NCT03538847|postoperative pain|postoperative pain
106353|NCT03538847|eye surgery|eye surgery
106354|NCT03538847|vitrectomy|vitrectomy
106355|NCT03538847|pain control protocol|pain control protocol
106356|NCT03538795|stroke|stroke
106357|NCT03538795|hemiplegia|hemiplegia
106358|NCT03538795|hemiparesis|hemiparesis
106359|NCT03538795|arm|arm
106360|NCT03538795|upper-extremity|upper-extremity
106361|NCT03538795|motor impairment|motor impairment
106362|NCT03538795|TMS|tms
106363|NCT03538795|brain stimulation|brain stimulation
106364|NCT03538795|neuroplasticity|neuroplasticity
106365|NCT03538782|percutaneous biliary drainage|percutaneous biliary drainage
106366|NCT03538782|radiation exposure|radiation exposure
106367|NCT03538756|Balance|balance
106368|NCT03538756|Peripheral Neuropathy|peripheral neuropathy
106369|NCT03538756|Neuropathy|neuropathy
106370|NCT03538743|Type 2 diabetes mellitus|type 2 diabetes mellitus
106371|NCT03538717|Axitinib,|axitinib,
106372|NCT03538717|Renal Carcinoma,|renal carcinoma,
106373|NCT03538717|Long responders|long responders
106374|NCT03538704|Endometrial cancer|endometrial cancer
106375|NCT03538704|Atypical hyperplasia|atypical hyperplasia
106376|NCT03538704|Fertility-preserving|fertility-preserving
106377|NCT03538704|Remission time|remission time
106378|NCT03538704|Recurrence|recurrence
106379|NCT03538704|Pregnancy|pregnancy
106380|NCT03538704|Progesterone receptor|progesterone receptor
106381|NCT03538691|Brexpiprazole|brexpiprazole
106382|NCT03538691|MDD|mdd
106393|NCT03538639|Etiology of Rare and Orphan Diseases with Vascular Phenotype|etiology of rare and orphan diseases with vascular phenotype
106394|NCT03538639|Natural History of Rare and Orphan Diseases with Vascular Phenotype|natural history of rare and orphan diseases with vascular phenotype
106395|NCT03538639|Pathophysiology of Uncommon Vascular Diseases|pathophysiology of uncommon vascular diseases
106396|NCT03538639|Undiagnosed Diseases|undiagnosed diseases
106397|NCT03538639|Rare Human Diseases with Vascular Features|rare human diseases with vascular features
106398|NCT03538626|Immune Cells|immune cells
106399|NCT03538626|bNAb|bnab
106400|NCT03538626|Plasma Cell|plasma cell
106401|NCT03538626|HIV|hiv
106402|NCT03538626|Immunotherapy|immunotherapy
106403|NCT03538613|Adoptive Cell Therapy|adoptive cell therapy
106404|NCT03538613|Immunotherapy|immunotherapy
106405|NCT03538613|Gene Therapy|gene therapy
106406|NCT03538600|Blood|blood
106407|NCT03538600|Microbiome Analysis|microbiome analysis
106408|NCT03538600|Stool|stool
106409|NCT03538600|Saliva|saliva
106410|NCT03538600|Skin|skin
106411|NCT03538587|Refractory Metastic Sarcoma|refractory metastic sarcoma
106412|NCT03538587|Diffuse Intrinsic Pontine Glioma DIPG|diffuse intrinsic pontine glioma dipg
106413|NCT03538587|Relapsed-Refractory Leukemia|relapsed-refractory leukemia
106414|NCT03538587|Meditation|meditation
106415|NCT03538587|Quality of Life|quality of life
106416|NCT03538548|Cocaine Abuse|cocaine abuse
106417|NCT03538548|Cocaine Use Disorder|cocaine use disorder
106418|NCT03538548|Substance-Related Disorders|substance-related disorders
106419|NCT03538535|reinforcement learning|reinforcement learning
106420|NCT03538535|computational models|computational models
106421|NCT03538535|neuroimaging|neuroimaging
106422|NCT03538457|Bariatric surgery|bariatric surgery
106423|NCT03538457|Gastrointestinal tract|gastrointestinal tract
106424|NCT03538457|Biological availability|biological availability
106425|NCT03538457|Pharmacokinetics|pharmacokinetics
106426|NCT03538457|Acetaminophen|acetaminophen
106427|NCT03538431|Autism Spectrum Disorder|autism spectrum disorder
106428|NCT03538431|ASD|asd
106429|NCT03538431|Anxiety|anxiety
106430|NCT03538418|Frailty|frailty
106431|NCT03538418|Wearable technology|wearable technology
106432|NCT03538418|Physical activity|physical activity
106433|NCT03538418|Behaviour change|behaviour change
106434|NCT03538405|harmonic techniques|harmonic techniques
106435|NCT03538405|supporting cushions|supporting cushions
106436|NCT03538405|intervention|intervention
106437|NCT03538379|Tourniquets|tourniquets
106438|NCT03538379|Bleeding Control Basic (B-Con) Course|bleeding control basic (b-con) course
106439|NCT03538379|Layperson training|layperson training
106440|NCT03538366|Ulcerative Colitis|ulcerative colitis
106441|NCT03538366|Inflammatory bowel disease|inflammatory bowel disease
106442|NCT03538366|Pouchitis|pouchitis
106443|NCT03538366|Fecal microbiota transplant|fecal microbiota transplant
106444|NCT03538366|Fecal microbiota treatment|fecal microbiota treatment
106445|NCT03538340|Thoracotomy|thoracotomy
106446|NCT03538340|Cryoanalgesia|cryoanalgesia
106447|NCT03538340|Pain|pain
106448|NCT03538327|essential hypertension|essential hypertension
106449|NCT03538327|insulin resistance|insulin resistance
106450|NCT03538327|silybin|silybin
106451|NCT03538262|SURE-PD3|sure-pd3
106452|NCT03538262|STEADY-PD III|steady-pd iii
106453|NCT03538262|Parkinson disease|parkinson disease
106455|NCT03538262|Parkinson Study Group (PSG)|parkinson study group (psg)
106456|NCT03538262|Telemedicine|telemedicine
106457|NCT03538262|Smartphone|smartphone
106458|NCT03538262|Disease progression|disease progression
106459|NCT03538262|Televisits|televisits
106460|NCT03538262|Patient-reported outcomes|patient-reported outcomes
106461|NCT03538249|Heart Failure|heart failure
106462|NCT03538249|Aerobic Exercise|aerobic exercise
106463|NCT03538249|Respiratory Muscle Training|respiratory muscle training
106464|NCT03538249|Strength Training|strength training
106465|NCT03538223|Music listening|music listening
106466|NCT03538223|Radiotherapy|radiotherapy
106467|NCT03538223|Breast cancer|breast cancer
106468|NCT03538223|Psychological rehabilitation|psychological rehabilitation
106469|NCT03538210|obesity, bariatric surgery, gastrointestinal functions, adipose tissu, steatohepatitis|obesity, bariatric surgery, gastrointestinal functions, adipose tissu, steatohepatitis
106470|NCT03538197|suicide attempt|suicide attempt
106471|NCT03538197|suicide re attempt|suicide re attempt
106472|NCT03538158|Older adults|older adults
106473|NCT03538158|Physical well-being|physical well-being
106474|NCT03538158|Quality of life|quality of life
106475|NCT03538119|Cardiac Rehabilitation|cardiac rehabilitation
106476|NCT03538119|High Intensity Interval Training|high intensity interval training
106477|NCT03538119|Exercise-based Rehabilitation|exercise-based rehabilitation
106478|NCT03538119|Secondary prevention|secondary prevention
106479|NCT03538119|Sedentary Behavior|sedentary behavior
106480|NCT03538106|Cesrean delivery|cesrean delivery
106481|NCT03538106|Risks factors|risks factors
106482|NCT03538106|Diabetes Type 1|diabetes type 1
106483|NCT03538093|arthrodesis|arthrodesis
106484|NCT03538093|core stabilization|core stabilization
106485|NCT03538093|physical therapy|physical therapy
106486|NCT03538080|venous disease|venous disease
106487|NCT03538080|peripheral vascular disease|peripheral vascular disease
106488|NCT03538080|vascular surgery|vascular surgery
106489|NCT03538080|ultrasound imaging|ultrasound imaging
106490|NCT03538067|percutaneous coronary intervention|percutaneous coronary intervention
106491|NCT03538067|stent apposition|stent apposition
106492|NCT03538067|stent deployment|stent deployment
106493|NCT03538067|stent expansion|stent expansion
106494|NCT03538067|intravascular ultrasound|intravascular ultrasound
106495|NCT03538054|Fibromyalgia|fibromyalgia
106496|NCT03538041|autoimmune hemolytic anemia|autoimmune hemolytic anemia
106497|NCT03538041|phosphatidylinositol 3-kinase (PI3K) inhibitor|phosphatidylinositol 3-kinase (pi3k) inhibitor
106498|NCT03538028|lymphocyte activation gene (LAG)|lymphocyte activation gene (lag)
106499|NCT03538028|LAG-3|lag-3
106500|NCT03538028|advanced solid tumor|advanced solid tumor
106501|NCT03538028|metastatic solid tumor|metastatic solid tumor
106502|NCT03538028|relapsed/refractory DLCBL|relapsed/refractory dlcbl
106503|NCT03538015|Type 1 Diabetes Mellitus|type 1 diabetes mellitus
106504|NCT03538015|β-blocker|β-blocker
106505|NCT03538002|blue light filtering spectacle lens|blue light filtering spectacle lens
106506|NCT03537989|fluid therapy|fluid therapy
106507|NCT03537989|Restricted fluid therapy|restricted fluid therapy
106508|NCT03537989|saline|saline
106509|NCT03537963|HCT survivors|hct survivors
106510|NCT03537963|hematopoietic stem cell transplant (HCT)|hematopoietic stem cell transplant (hct)
106511|NCT03537963|survivors of hematopoietic stem cell transplant|survivors of hematopoietic stem cell transplant
106512|NCT03537950|Cannabidiol|cannabidiol
106513|NCT03537950|Cannabidivarin|cannabidivarin
106514|NCT03537950|E-I balance|e-i balance
106515|NCT03537950|pharmacological imaging|pharmacological imaging
106516|NCT03537924|healthy participants older than 40 years|healthy participants older than 40 years
106517|NCT03537924|right heart function during exercise|right heart function during exercise
106518|NCT03537924|prevention|prevention
106519|NCT03537924|acetazolamide|acetazolamide
106520|NCT03537898|balanced crystalloid|balanced crystalloid
106521|NCT03537898|crystalloid|crystalloid
106522|NCT03537898|isotonic|isotonic
106523|NCT03537898|acetate|acetate
106524|NCT03537898|non-acetate|non-acetate
106525|NCT03537898|lactated Ringer's|lactated ringer's
106526|NCT03537898|Normosol|normosol
106527|NCT03537859|hospitalized child|hospitalized child
106528|NCT03537859|salivary cortisol|salivary cortisol
106529|NCT03537859|augmented reality|augmented reality
106533|NCT03537807|Lou Gehrig's Disease|lou gehrig's disease
106534|NCT03537807|Lou-Gehrigs Disease|lou-gehrigs disease
106535|NCT03537807|Motor Neuron Disease, Amyotrophic Lateral Sclerosis|motor neuron disease, amyotrophic lateral sclerosis
106536|NCT03537807|Riluzole|riluzole
106537|NCT03537807|Rilutek®|rilutek®
106538|NCT03537807|Sublingual|sublingual
106539|NCT03537807|Oral formulation|oral formulation
106540|NCT03537807|Neuroprotective Agents|neuroprotective agents
106541|NCT03537807|Administration, Sublingual|administration, sublingual
106542|NCT03537807|Administration, Oral|administration, oral
106543|NCT03537807|Biological Availability|biological availability
106544|NCT03537781|food choice, food labels|food choice, food labels
106545|NCT03537742|Heart Transplant|heart transplant
106546|NCT03537729|Alzheimer's disease|alzheimer's disease
106547|NCT03537729|Age related memory disorders|age related memory disorders
106548|NCT03537729|Environment design|environment design
106549|NCT03537729|Long term care|long term care
106550|NCT03537729|Dementia|dementia
106551|NCT03537716|Abdominal Fat|abdominal fat
106552|NCT03537703|Transcranial Direct Current Stimulation|transcranial direct current stimulation
106553|NCT03537703|tDCS|tdcs
106554|NCT03537703|Auditory Processing|auditory processing
106555|NCT03537703|tone matching|tone matching
106556|NCT03537664|Periapical Periodontitis|periapical periodontitis
106557|NCT03537664|Bacterial Infections|bacterial infections
106558|NCT03537664|Root Canal Preparation|root canal preparation
106559|NCT03537664|Calcium Hydroxide|calcium hydroxide
106560|NCT03537664|Real-Time Polymerase Chain Reaction|real-time polymerase chain reaction
106561|NCT03537664|RNA-Directed DNA Polymerase|rna-directed dna polymerase
106562|NCT03537638|Lupus|lupus
106563|NCT03537638|Quality of life|quality of life
106564|NCT03537638|Multicomponent intervention|multicomponent intervention
106565|NCT03537638|Clinical Practice Guideline|clinical practice guideline
106566|NCT03537638|Computerized clinical decision support system|computerized clinical decision support system
106567|NCT03537638|Activity|activity
106568|NCT03537612|Post-operative pain|post-operative pain
106569|NCT03537573|Pragmatic clinical trial|pragmatic clinical trial
106570|NCT03537573|Primary care|primary care
106571|NCT03537573|Provider-targeted|provider-targeted
106572|NCT03537573|Behavioral intervention|behavioral intervention
106573|NCT03537573|Electronic health record|electronic health record
106574|NCT03537547|treatment naive|treatment naive
106575|NCT03537547|major depression|major depression
106576|NCT03537547|pharmacotherapy|pharmacotherapy
106577|NCT03537547|pharmacogenomic|pharmacogenomic
106578|NCT03537547|genomics|genomics
106579|NCT03537521|severe bleeding|severe bleeding
106580|NCT03537521|dabigatran|dabigatran
106581|NCT03537521|rivaroxaban|rivaroxaban
106582|NCT03537521|apixaban|apixaban
106583|NCT03537521|edoxaban|edoxaban
106584|NCT03537521|PCC|pcc
106585|NCT03537521|aPCC|apcc
106586|NCT03537521|rVIIa|rviia
106587|NCT03537521|hemodialysis|hemodialysis
106588|NCT03537521|antidots|antidots
106589|NCT03537521|idarucizumab|idarucizumab
106590|NCT03537521|urgent surgery|urgent surgery
106591|NCT03537521|andexanet alpha|andexanet alpha
106592|NCT03537508|Meningococcal meningitis|meningococcal meningitis
106593|NCT03537508|MenACYW conjugate vaccine|menacyw conjugate vaccine
106594|NCT03537508|Quadrivalent meningococcal vaccine|quadrivalent meningococcal vaccine
106598|NCT03537456|Dermal Filler|dermal filler
106599|NCT03537456|Hyaluronic Acid|hyaluronic acid
106600|NCT03537443|Childhood|childhood
106601|NCT03537443|Vitamin D|vitamin d
106602|NCT03537443|Bone mineral density|bone mineral density
106603|NCT03537443|Bone mineral content|bone mineral content
106604|NCT03537430|TNT (Totally no tube)|tnt (totally no tube)
106605|NCT03537430|uniportal VATS|uniportal vats
106606|NCT03537430|mediastinal tumor|mediastinal tumor
106607|NCT03537404|hepatitis C|hepatitis c
106608|NCT03537404|chronic|chronic
106609|NCT03537404|pharmacokinetics|pharmacokinetics
106610|NCT03537404|HIV|hiv
106611|NCT03537404|coinfection|coinfection
106612|NCT03537404|concomitant therapy|concomitant therapy
106613|NCT03537391|prostate cancer|prostate cancer
106614|NCT03537391|imaging of prostate cancer|imaging of prostate cancer
106615|NCT03537391|staging of prostate cancer|staging of prostate cancer
106616|NCT03537391|prostate specific membrane antigen (PSMA)|prostate specific membrane antigen (psma)
106617|NCT03537391|positron emission tomography|positron emission tomography
106618|NCT03537391|bone scintigraphy|bone scintigraphy
106619|NCT03537391|whole body magnetic resonance imaging|whole body magnetic resonance imaging
106620|NCT03537391|whole body computer tomography|whole body computer tomography
106621|NCT03537391|single photon emission tomography (SPECT)|single photon emission tomography (spect)
106622|NCT03537378|Hybrid APC,Early Central Lung Neoplasms,|hybrid apc,early central lung neoplasms,
106623|NCT03537365|Human Milk Fortification|human milk fortification
106729|NCT03536611|warfarin|warfarin
106624|NCT03537365|Bovine Colostrum|bovine colostrum
106625|NCT03537365|Very Preterm Infants|very preterm infants
106626|NCT03537365|Enteral feeding|enteral feeding
106627|NCT03537365|Human Milk|human milk
106628|NCT03537365|Neonatology|neonatology
106629|NCT03537365|Colostrum|colostrum
106631|NCT03537261|Parent Training|parent training
106632|NCT03537261|Aggressive Behavior|aggressive behavior
106633|NCT03537235|Libramed|libramed
106634|NCT03537235|Policaptil Gel retard|policaptil gel retard
106635|NCT03537235|Overweigth|overweigth
106636|NCT03537235|Obesity|obesity
106637|NCT03537235|Medical Device|medical device
106638|NCT03537235|glycemic profile|glycemic profile
106639|NCT03537235|incretin|incretin
106640|NCT03537222|quality of life|quality of life
106641|NCT03537222|psychometrics|psychometrics
106642|NCT03537196|People who inject drugs|people who inject drugs
106643|NCT03537196|Hepatitis C|hepatitis c
106644|NCT03537196|Direct Acting Antiviral|direct acting antiviral
106645|NCT03537196|HCV Elimination|hcv elimination
106646|NCT03537196|Vietnam|vietnam
106647|NCT03537196|Viral hepatitis C|viral hepatitis c
106648|NCT03537183|hypertrophic cardiomyopathy|hypertrophic cardiomyopathy
106649|NCT03537183|exercise training|exercise training
106650|NCT03537183|PCWP|pcwp
106651|NCT03537157|Crohn Disease recurrence|crohn disease recurrence
106652|NCT03537144|Patent ductus arteriosus|patent ductus arteriosus
106653|NCT03537144|acetaminophen|acetaminophen
106654|NCT03537144|indomethacin|indomethacin
106655|NCT03537131|diabetes|diabetes
106656|NCT03537131|dapagliflozin|dapagliflozin
106657|NCT03537131|exercise|exercise
106658|NCT03537131|hypoglycemia|hypoglycemia
106659|NCT03537105|cytokine|cytokine
106660|NCT03537105|skin inflammation|skin inflammation
106661|NCT03537079|hypoxia|hypoxia
106662|NCT03537079|exercise training|exercise training
106663|NCT03537079|heart failure|heart failure
106664|NCT03537079|cardiac remodeling|cardiac remodeling
106665|NCT03537053|Sedentary Lifestyle|sedentary lifestyle
106666|NCT03537027|vitamin D3|vitamin d3
106667|NCT03537027|cholecalciferol|cholecalciferol
106668|NCT03537027|calcidiol|calcidiol
106669|NCT03537027|25-hydroxyvitamin D|25-hydroxyvitamin d
106670|NCT03537027|gene expression|gene expression
106671|NCT03537027|vitamin D receptor|vitamin d receptor
106672|NCT03537027|adults|adults
106673|NCT03537027|clinical trial|clinical trial
106674|NCT03537001|Methoxyflurane|methoxyflurane
106675|NCT03537001|Penthrox|penthrox
106676|NCT03537001|anesthetic|anesthetic
106677|NCT03537001|analgesia|analgesia
106678|NCT03537001|acute|acute
106679|NCT03537001|traumatic|traumatic
106680|NCT03537001|pain|pain
106681|NCT03537001|prehospital setting|prehospital setting
106682|NCT03537001|visual numeric scale|visual numeric scale
106683|NCT03536988|Ulcerative Colitiis|ulcerative colitiis
106684|NCT03536988|Ileal pouch anal anastomosis|ileal pouch anal anastomosis
106685|NCT03536988|Transanal Minimally Invasive Surgery|transanal minimally invasive surgery
106686|NCT03536988|Postoperative Outcome|postoperative outcome
106687|NCT03536975|Dementia|dementia
106688|NCT03536975|Mild Dementia|mild dementia
106689|NCT03536975|Cognitive Impairment|cognitive impairment
106690|NCT03536923|Female|female
106691|NCT03536910|copeptin levels|copeptin levels
106692|NCT03536910|Cesarean section|cesarean section
106693|NCT03536910|general anesthesia|general anesthesia
106694|NCT03536910|spinal anesthesia|spinal anesthesia
106695|NCT03536897|breast cancer|breast cancer
106696|NCT03536897|invasive ductal carcinoma|invasive ductal carcinoma
106697|NCT03536897|intraoperative radiation therapy|intraoperative radiation therapy
106698|NCT03536897|iort|iort
106699|NCT03536884|Bimekizumab|bimekizumab
106700|NCT03536884|PSO|pso
106701|NCT03536884|Psoriasis|psoriasis
106702|NCT03536858|End Stage Renal Disease|end stage renal disease
106703|NCT03536858|Hemodialysis|hemodialysis
106704|NCT03536858|Social Network|social network
106705|NCT03536832|Cesarean Section; Complications|cesarean section; complications
106706|NCT03536832|suture material|suture material
106707|NCT03536806|Pharmacological cardioversion|pharmacological cardioversion
106708|NCT03536806|Canrenone|canrenone
106709|NCT03536793|Early detection of pancreatic cancer|early detection of pancreatic cancer
106710|NCT03536793|Endo180|endo180
106711|NCT03536793|Urinary tissue factor|urinary tissue factor
106712|NCT03536728|DFMO|dfmo
106713|NCT03536728|AMXT 1501|amxt 1501
106714|NCT03536689|Amniotic fluid index|amniotic fluid index
106715|NCT03536676|Breakfast|breakfast
106716|NCT03536676|Obesity|obesity
106717|NCT03536676|Mood|mood
106718|NCT03536676|Eating Behavior|eating behavior
106719|NCT03536676|Cognitive Function|cognitive function
106720|NCT03536650|Metabolic diseases|metabolic diseases
106721|NCT03536624|prevention|prevention
106722|NCT03536624|biomarkers|biomarkers
106723|NCT03536624|stress|stress
106724|NCT03536624|burn out|burn out
106725|NCT03536624|occupation|occupation
106726|NCT03536624|work|work
106727|NCT03536624|spa bath|spa bath
106728|NCT03536611|dabigatran|dabigatran
106730|NCT03536611|non-valve atrial fibrillation|non-valve atrial fibrillation
106731|NCT03536611|percutaneous coronary intervention|percutaneous coronary intervention
106732|NCT03536572|Sleep Apnea Syndromes|sleep apnea syndromes
106733|NCT03536572|Chronic Disease|chronic disease
106734|NCT03536572|Adherence|adherence
106735|NCT03536572|Self-Care|self-care
106736|NCT03536572|Patient Outcomes|patient outcomes
106737|NCT03536559|gold|gold
106738|NCT03536559|nanocrystal|nanocrystal
106739|NCT03536559|multifocal visual evoked potential|multifocal visual evoked potential
106740|NCT03536559|full field visual evoked potential|full field visual evoked potential
106741|NCT03536559|low contrast vision|low contrast vision
106742|NCT03536559|low contrast letter acuity|low contrast letter acuity
106743|NCT03536559|remyelination|remyelination
106744|NCT03536559|demyelination|demyelination
106745|NCT03536546|Veterans Health|veterans health
106746|NCT03536546|Intervention, Brief|intervention, brief
106747|NCT03536546|Peer|peer
106748|NCT03536520|healthy participants older than 40 years|healthy participants older than 40 years
106749|NCT03536520|cognition|cognition
106750|NCT03536520|visuo-motor learning performance|visuo-motor learning performance
106751|NCT03536520|prevention|prevention
106752|NCT03536520|acetazolamide|acetazolamide
106753|NCT03536507|healthy participants older than 40 years|healthy participants older than 40 years
106754|NCT03536507|sleep disordered breathing|sleep disordered breathing
106755|NCT03536507|periodic breathing|periodic breathing
106756|NCT03536507|prevention|prevention
106757|NCT03536507|acetazolamide|acetazolamide
106758|NCT03536494|Overactive bladder|overactive bladder
106759|NCT03536494|Mirabegron|mirabegron
106760|NCT03536494|Persistence|persistence
106761|NCT03536494|Patient-Centered Care|patient-centered care
106762|NCT03536494|Inappropriate prescribing|inappropriate prescribing
106763|NCT03536494|Discontinuation|discontinuation
106764|NCT03536468|Tooth loss, edentulousness, psychology, oral health-related|tooth loss, edentulousness, psychology, oral health-related
106765|NCT03536455|healthy participants older than 40 years|healthy participants older than 40 years
106766|NCT03536455|exercise performance|exercise performance
106767|NCT03536455|prevention|prevention
106768|NCT03536455|acetazolamide|acetazolamide
106769|NCT03536442|antenatal|antenatal
106770|NCT03536442|postpartum|postpartum
106771|NCT03536442|mental health|mental health
106772|NCT03536429|healthy participants older than 40 years|healthy participants older than 40 years
106773|NCT03536429|postural control|postural control
106774|NCT03536429|prevention|prevention
106775|NCT03536429|acetazolamide|acetazolamide
106776|NCT03536416|Self-management|self-management
106777|NCT03536416|Children and young people|children and young people
106778|NCT03536416|Schools|schools
106779|NCT03536377|Diabetes Mellitus Remission|diabetes mellitus remission
106780|NCT03536377|Prediabetic State|prediabetic state
106781|NCT03536377|caloric restriction|caloric restriction
106782|NCT03536377|weight loss|weight loss
106783|NCT03536377|diet|diet
106784|NCT03536377|Barbados|barbados
106785|NCT03536351|social skills|social skills
106786|NCT03536351|child|child
106787|NCT03536351|theory of mind|theory of mind
106788|NCT03536351|drama|drama
106789|NCT03536351|occupational therapy|occupational therapy
106790|NCT03536351|speech-language pathology|speech-language pathology
106791|NCT03536351|neural activation|neural activation
106792|NCT03536338|Sit-to-stand; Spinal Stimulation; transcutaneous|sit-to-stand; spinal stimulation; transcutaneous
106793|NCT03536299|Physical therapy|physical therapy
106794|NCT03536299|Gait training|gait training
106795|NCT03536299|Cognitive-motor interference|cognitive-motor interference
106796|NCT03536299|Rehabilitation|rehabilitation
106797|NCT03536273|sedentary|sedentary
106798|NCT03536273|pilates exercises|pilates exercises
106799|NCT03536273|functional movement screen|functional movement screen
106800|NCT03536273|posture|posture
106801|NCT03536273|quality of life|quality of life
106802|NCT03536247|bile duct stones|bile duct stones
106803|NCT03536247|choledocholithiasis|choledocholithiasis
106804|NCT03536247|ERCP|ercp
136653|NCT03347630|MRI|mri
106805|NCT03536247|endoscopic retrograde cholangiopancreatograhy|endoscopic retrograde cholangiopancreatograhy
106806|NCT03536195|renal replacement therapy|renal replacement therapy
106807|NCT03536195|acute renal failure|acute renal failure
106808|NCT03536195|coagulation|coagulation
106809|NCT03536195|bleeding|bleeding
106810|NCT03536182|Pancreas|pancreas
106811|NCT03536182|Adenocarcinoma.|adenocarcinoma.
106812|NCT03536156|Dental implant|dental implant
106813|NCT03536156|Implant Emergence Profile|implant emergence profile
106814|NCT03536143|bullosa|bullosa
106816|NCT03536143|RDEB|rdeb
106817|NCT03536143|Krystal|krystal
106818|NCT03536143|epidermolysis|epidermolysis
106819|NCT03536143|bercolagene|bercolagene
106820|NCT03536143|telserpavec|telserpavec
106821|NCT03536143|KB103|kb103
106822|NCT03536143|HSV-COL7A1|hsv-col7a1
106823|NCT03536130|chest tube, lung resection, air leakage|chest tube, lung resection, air leakage
106824|NCT03536078|home phototherapy|home phototherapy
106825|NCT03536078|parental bonding|parental bonding
106826|NCT03536039|CNS lymphoma|cns lymphoma
106827|NCT03536039|BBB permeabilization|bbb permeabilization
106828|NCT03536039|R-CHOP|r-chop
106829|NCT03536039|TNF|tnf
106830|NCT03536000|Cardiac function|cardiac function
106831|NCT03536000|Fetal|fetal
106832|NCT03536000|Strain|strain
106833|NCT03535935|Chinese medicine|chinese medicine
106834|NCT03535935|Astragalus|astragalus
106835|NCT03535935|Pragmatic trial|pragmatic trial
106836|NCT03535922|Hemodialysis|hemodialysis
106837|NCT03535922|Chronic Kidney Disease|chronic kidney disease
106838|NCT03535909|CHF|chf
106839|NCT03535909|central venous pressure|central venous pressure
106840|NCT03535909|noninvasive|noninvasive
106841|NCT03535909|ADHF|adhf
106842|NCT03535909|stroke volume|stroke volume
106843|NCT03535857|overactive bladder|overactive bladder
106844|NCT03535857|OAB|oab
106845|NCT03535857|urge urinary incontinence|urge urinary incontinence
106846|NCT03535857|PTNS|ptns
106847|NCT03535844|Wolfberry (Goji berry)|wolfberry (goji berry)
106848|NCT03535844|Healthy diet|healthy diet
106849|NCT03535844|Cardiovascular diseases|cardiovascular diseases
106850|NCT03535844|Endothelial function|endothelial function
106851|NCT03535844|Lipidomics|lipidomics
106852|NCT03535844|Middle-aged and older adults|middle-aged and older adults
106853|NCT03535844|Oxidative stress|oxidative stress
106854|NCT03535844|Inflammation|inflammation
106855|NCT03535805|Cognitive and Behavioral Therapies|cognitive and behavioral therapies
106856|NCT03535805|Children and Adolescents|children and adolescents
106857|NCT03535805|Community Health Care|community health care
106858|NCT03535805|Early Intervention|early intervention
106859|NCT03535740|Drug Therapy|drug therapy
106860|NCT03535714|Treatment|treatment
106861|NCT03535714|Psychotherapy|psychotherapy
106862|NCT03535714|Young Adult|young adult
106863|NCT03535714|Adolescence|adolescence
106864|NCT03535688|Chronic Pain|chronic pain
106865|NCT03535688|Low Back Pain|low back pain
106866|NCT03535688|D-cycloserine|d-cycloserine
106867|NCT03535649|Drug therapy|drug therapy
106868|NCT03535636|Polysomnography|polysomnography
106869|NCT03535636|Refugees|refugees
106870|NCT03535623|remote ischemic preconditioning|remote ischemic preconditioning
106871|NCT03535623|free flap reconstruction|free flap reconstruction
106872|NCT03535623|preoperative radiotherapy|preoperative radiotherapy
106873|NCT03535610|Embolization|embolization
106874|NCT03535610|Uterine Leiomyoma|uterine leiomyoma
106875|NCT03535610|Embospheres|embospheres
106876|NCT03535610|Microspheres|microspheres
106877|NCT03535597|Transradial Access|transradial access
106878|NCT03535597|Hemostasis|hemostasis
106879|NCT03535571|Energy increase|energy increase
106880|NCT03535571|Energy|energy
106881|NCT03535571|Healthy|healthy
106882|NCT03535571|anti-inflammatory|anti-inflammatory
106883|NCT03535571|Open-label|open-label
106884|NCT03535571|Salmon protein|salmon protein
106885|NCT03535571|Natural health product|natural health product
106886|NCT03535571|Dietary supplement|dietary supplement
106887|NCT03535545|PET Imaging|pet imaging
106888|NCT03535545|Molecular Imaging|molecular imaging
106889|NCT03535532|resistant hypertension|resistant hypertension
106890|NCT03535532|Adrenal Disease|adrenal disease
106891|NCT03535532|medical treatment|medical treatment
106892|NCT03535532|laparoscopic adrenalectomy|laparoscopic adrenalectomy
106893|NCT03535506|Breast Cancer|breast cancer
106894|NCT03535506|DCIS|dcis
106895|NCT03535506|Ductal Carcinoma In Situ|ductal carcinoma in situ
106896|NCT03535506|Palbociclib|palbociclib
106897|NCT03535480|ovarian reserve|ovarian reserve
106898|NCT03535467|Caregivers|caregivers
106899|NCT03535467|Exoskeleton Device|exoskeleton device
106900|NCT03535467|Stroke Rehabilitation|stroke rehabilitation
106901|NCT03535454|Fibromyalgia|fibromyalgia
106902|NCT03535454|Musculoskeletal Diseases|musculoskeletal diseases
106903|NCT03535454|Work|work
106904|NCT03535441|hemorrhagic shock|hemorrhagic shock
106905|NCT03535441|HMGB1|hmgb1
106906|NCT03535376|Bariatric surgery|bariatric surgery
106907|NCT03535376|Gastrointestinal tract|gastrointestinal tract
106908|NCT03535376|Biological availability|biological availability
106909|NCT03535376|Pharmacokinetics|pharmacokinetics
106910|NCT03535376|Valsartan|valsartan
106911|NCT03535363|Osimertinib|osimertinib
106912|NCT03535350|ibrutinib|ibrutinib
106913|NCT03535350|temozolomide|temozolomide
106914|NCT03535350|brain cancer|brain cancer
106915|NCT03535337|Interventions|interventions
106916|NCT03535337|youth living with HIV|youth living with hiv
106917|NCT03535337|mHealth|mhealth
106918|NCT03535337|ART adherence|art adherence
106919|NCT03535337|adaptive intervention|adaptive intervention
106920|NCT03535337|cell phone|cell phone
106921|NCT03535337|text messaging|text messaging
106922|NCT03535285|periodontal ligament|periodontal ligament
106923|NCT03535285|dentoalveolar|dentoalveolar
106924|NCT03535285|distraction|distraction
106925|NCT03535285|orthodontic|orthodontic
106926|NCT03535259|hepatocellular carcinoma|hepatocellular carcinoma
106927|NCT03535259|intensity-modulated radiotherapy|intensity-modulated radiotherapy
106928|NCT03535259|sorafenib|sorafenib
106929|NCT03535259|portal vein thrombosis|portal vein thrombosis
106930|NCT03535259|lymph node metastasis|lymph node metastasis
106931|NCT03535246|immunotherapy|immunotherapy
106932|NCT03535246|T cell|t cell
106933|NCT03535246|Cancer|cancer
106934|NCT03535246|Gene therapy|gene therapy
106935|NCT03535233|Alopecia areata, intralesional corticosteroid, minoxidil, clobetasol propionate, IL-23, TGFβ-1|alopecia areata, intralesional corticosteroid, minoxidil, clobetasol propionate, il-23, tgfβ-1
106936|NCT03535220|Multiple Myeloma|multiple myeloma
106937|NCT03535220|Sickle Cell Disease|sickle cell disease
106938|NCT03535194|Interleukin-23 (IL-23)|interleukin-23 (il-23)
106939|NCT03535168|Healthy volunteers|healthy volunteers
106940|NCT03535155|Ultrasound image, Neuraxial anesthesia, Landmark|ultrasound image, neuraxial anesthesia, landmark
106941|NCT03535129|Functional Magnetic Resonance Imaging (fMRI)|functional magnetic resonance imaging (fmri)
106942|NCT03535129|Neurofeedback|neurofeedback
106943|NCT03535129|Drug Relapse|drug relapse
106944|NCT03535090|Graves' Disease|graves' disease
106945|NCT03535090|Graves Ophthalmopathy|graves ophthalmopathy
106946|NCT03535090|Blood Coagulation|blood coagulation
106947|NCT03535090|Venous Thromboembolism|venous thromboembolism
106948|NCT03535090|Methylprednisolone|methylprednisolone
106949|NCT03535077|Melanoma|melanoma
106950|NCT03535077|Nevus|nevus
106951|NCT03535077|Mole|mole
106952|NCT03535077|Atypical Nevi|atypical nevi
106953|NCT03535064|HAND HYGIENE, HAND WASHING, INFLUENZA, SCHOOL ABSENCE, SCHOOL CHILDREN, UPPER RESPIRATORY INFECTIONS|hand hygiene, hand washing, influenza, school absence, school children, upper respiratory infections
106954|NCT03535051|vitiligo|vitiligo
106955|NCT03535051|fractional carbon dioxide laser|fractional carbon dioxide laser
106956|NCT03535051|tacrolimus|tacrolimus
106957|NCT03535051|drug delivery|drug delivery
106958|NCT03535038|Intravascular volume|intravascular volume
106959|NCT03535038|Inferior vena cava diameter|inferior vena cava diameter
106960|NCT03535038|Ultrasonography|ultrasonography
106961|NCT03535038|Vascular Pedicle Width|vascular pedicle width
106962|NCT03535038|Chest x-ray|chest x-ray
106963|NCT03534999|TENS,|tens,
106964|NCT03534999|VAS,|vas,
106965|NCT03534999|Oxford-Hip-score,|oxford-hip-score,
106966|NCT03534999|Hip-arthroplasthy,|hip-arthroplasthy,
106967|NCT03534999|Pain-intensity|pain-intensity
106968|NCT03534973|Cataract|cataract
106969|NCT03534973|Caffeine|caffeine
106970|NCT03534947|Neoadjuvant|neoadjuvant
106971|NCT03534947|Sonidegib|sonidegib
106972|NCT03534934|COPD|copd
106973|NCT03534934|Osteoporosis|osteoporosis
106974|NCT03534921|Diabetes mellitus|diabetes mellitus
106975|NCT03534921|Schizophrenia|schizophrenia
106976|NCT03534921|Schizoaffective disorder|schizoaffective disorder
106977|NCT03534921|Bipolar disorder|bipolar disorder
106978|NCT03534921|Severe mental illness|severe mental illness
106979|NCT03534895|midazolam|midazolam
106980|NCT03534895|ambulatory surgery|ambulatory surgery
106981|NCT03534882|anti-glaucoma medications|anti-glaucoma medications
106982|NCT03534882|glaucoma|glaucoma
106983|NCT03534882|prostaglandin analogues|prostaglandin analogues
106984|NCT03534882|medication washout|medication washout
106985|NCT03534869|auricular acupuncture|auricular acupuncture
106986|NCT03534869|episiotomy|episiotomy
106987|NCT03534869|acupuncture|acupuncture
106988|NCT03534869|pain relief|pain relief
106989|NCT03534869|analgesic therapy|analgesic therapy
106990|NCT03534843|Spontaneous rupture|spontaneous rupture
106991|NCT03534843|survival|survival
106992|NCT03534843|hepatocellular carcinoma|hepatocellular carcinoma
106993|NCT03534843|Child-Pugh|child-pugh
106994|NCT03534843|Albumin-bilirubin|albumin-bilirubin
106995|NCT03534817|Cardiac Rehabilitation|cardiac rehabilitation
106996|NCT03534817|Early Access Cardiac Rehabilitation|early access cardiac rehabilitation
106997|NCT03534817|Cardiac Rehabilitation Adherence|cardiac rehabilitation adherence
106998|NCT03534817|Myocardial Infarction|myocardial infarction
106999|NCT03534817|Ventricular Remodeling|ventricular remodeling
107000|NCT03534765|Laparotomy|laparotomy
107001|NCT03534765|Frailty|frailty
136899|NCT03345914|Eczema|eczema
107002|NCT03534765|Sacropenia|sacropenia
107003|NCT03534752|Inborn errors of Metabolism|inborn errors of metabolism
107004|NCT03534752|Adulthood|adulthood
107131|NCT03533985|Music therapy|music therapy
107005|NCT03534752|Clinical characteristics|clinical characteristics
107006|NCT03534739|conditioned pain modulation (CPM)|conditioned pain modulation (cpm)
107007|NCT03534739|diffuse noxious inhibitory control (DNIC)|diffuse noxious inhibitory control (dnic)
107008|NCT03534739|massage|massage
107009|NCT03534739|hypoalgesia|hypoalgesia
107010|NCT03534713|Neoadjuvant chemotherapy|neoadjuvant chemotherapy
107011|NCT03534713|Cervical Cancer|cervical cancer
107012|NCT03534713|Paraaortic Lymph Node Involvement|paraaortic lymph node involvement
107013|NCT03534713|Carboplatin|carboplatin
107014|NCT03534713|Paclitaxel|paclitaxel
107015|NCT03534700|sacrococcygeal pilonidal disease|sacrococcygeal pilonidal disease
107016|NCT03534687|RAGE|rage
107017|NCT03534687|ADAM10|adam10
107018|NCT03534687|Exercise|exercise
107019|NCT03534687|sRAGE|srage
107020|NCT03534635|metastatic melanoma|metastatic melanoma
107021|NCT03534635|tumor microenvironment|tumor microenvironment
107022|NCT03534635|pembrolizumab|pembrolizumab
107023|NCT03534635|PD1|pd1
107024|NCT03534596|cohort|cohort
107025|NCT03534596|surgery|surgery
107026|NCT03534596|adhesive small bowel obstruction|adhesive small bowel obstruction
107027|NCT03534557|spirometry|spirometry
107028|NCT03534544|artificial pancreas|artificial pancreas
107029|NCT03534544|pediatric|pediatric
107030|NCT03534544|parents|parents
107031|NCT03534544|adherence|adherence
107032|NCT03534505|Inguinal Herniorrhaphy|inguinal herniorrhaphy
107033|NCT03534505|Analgesic Effects of Local Wound|analgesic effects of local wound
107034|NCT03534492|urothelial|urothelial
107035|NCT03534492|bladder cancer|bladder cancer
107036|NCT03534492|olaparib|olaparib
107037|NCT03534492|durvalumab|durvalumab
107038|NCT03534466|treadmill|treadmill
107039|NCT03534466|infants|infants
107040|NCT03534466|neonatal encephalopathy|neonatal encephalopathy
107041|NCT03534466|neonatal brain injury|neonatal brain injury
107042|NCT03534453|ovarian cancer|ovarian cancer
107043|NCT03534453|PARP Inhibitor|parp inhibitor
107044|NCT03534453|Platinum sensitive|platinum sensitive
107045|NCT03534440|Diastolic Dysfunction|diastolic dysfunction
107046|NCT03534440|Anesthesia|anesthesia
107047|NCT03534440|Preoperative assessment|preoperative assessment
107048|NCT03534440|Postoperative care|postoperative care
107049|NCT03534440|TEVAR|tevar
107050|NCT03534427|arterial stiffness|arterial stiffness
107051|NCT03534427|endothelin-1|endothelin-1
107052|NCT03534427|c-reactive protein|c-reactive protein
107053|NCT03534427|adiposity|adiposity
107054|NCT03534427|exercise|exercise
107055|NCT03534427|jump rope|jump rope
107056|NCT03534414|dietary portfolio|dietary portfolio
107057|NCT03534414|plant sterols|plant sterols
107058|NCT03534414|plant protein|plant protein
107059|NCT03534414|viscous fibre|viscous fibre
107060|NCT03534414|nuts|nuts
107061|NCT03534401|Reproductive Coercion|reproductive coercion
107062|NCT03534401|Gender-based violence|gender-based violence
107063|NCT03534401|Contraception|contraception
107064|NCT03534401|Clinic-based screening for IPV|clinic-based screening for ipv
107065|NCT03534401|Clinic-based counseling|clinic-based counseling
107066|NCT03534362|Propel Stent|propel stent
107067|NCT03534362|Nasopore|nasopore
107068|NCT03534349|Duchenne Muscular Dystrophy|duchenne muscular dystrophy
107069|NCT03534349|lower limb flexibility|lower limb flexibility
107070|NCT03534349|performance|performance
107071|NCT03534336|Weight Reduction|weight reduction
107072|NCT03534336|Health Literacy|health literacy
107073|NCT03534336|Financial Incentives|financial incentives
107074|NCT03534336|Lifestyle Change|lifestyle change
107075|NCT03534323|chronic lymphocytic leukemia (CLL)|chronic lymphocytic leukemia (cll)
107076|NCT03534323|Richter's Syndrome|richter's syndrome
107077|NCT03534323|Richter's Transformation|richter's transformation
107078|NCT03534310|obesity|obesity
107079|NCT03534310|sleeve-gastrectomy|sleeve-gastrectomy
107080|NCT03534310|liraglutide|liraglutide
107081|NCT03534310|Weight-loss|weight-loss
107082|NCT03534297|heart failure|heart failure
107083|NCT03534297|systolic heart failure|systolic heart failure
107084|NCT03534284|Hemodialysis|hemodialysis
107085|NCT03534284|Kidney disease|kidney disease
107086|NCT03534284|Trazodone|trazodone
107087|NCT03534284|Cognitive behavioral therapy|cognitive behavioral therapy
107088|NCT03534245|Mosquito Salivary Protein|mosquito salivary protein
107089|NCT03534245|Dengue Fever|dengue fever
107090|NCT03534245|Zika|zika
107091|NCT03534245|Chikungunya|chikungunya
107092|NCT03534245|Kampong Speu|kampong speu
107093|NCT03534219|Earpopper|earpopper
107094|NCT03534219|Prophylaxis|prophylaxis
107095|NCT03534219|Randomized controlled trial|randomized controlled trial
107096|NCT03534167|depression|depression
107097|NCT03534167|anxiety|anxiety
107098|NCT03534167|gay|gay
107099|NCT03534167|youth|youth
107100|NCT03534167|Cognitive Behavior Therapy|cognitive behavior therapy
107101|NCT03534141|Hypothermia|hypothermia
107102|NCT03534141|NGAL - Neutrophil Gelatinase-associated Lipocalin|ngal - neutrophil gelatinase-associated lipocalin
107103|NCT03534128|Traumatic Brain Injury|traumatic brain injury
107104|NCT03534128|Spatial navigation|spatial navigation
107105|NCT03534128|Virtual Reality|virtual reality
107106|NCT03534128|Cues|cues
107107|NCT03534115|bleaching, toxicity, NAC|bleaching, toxicity, nac
107108|NCT03534102|Total Hip Arthroplasty|total hip arthroplasty
107109|NCT03534102|Total Knee Arthroplasty|total knee arthroplasty
107110|NCT03534102|Opioid Dependence|opioid dependence
107111|NCT03534102|Opioid Tapering|opioid tapering
107112|NCT03534063|Arthroplasty Surgery|arthroplasty surgery
107113|NCT03534063|Genotype-Guided Pain Management|genotype-guided pain management
107114|NCT03534050|Glioma|glioma
107115|NCT03534050|Low-Grade Glioma (LGG)|low-grade glioma (lgg)
107116|NCT03534050|Neurobehavioral Assessments|neurobehavioral assessments
107117|NCT03534050|Neurocognitive Functions (NCF)|neurocognitive functions (ncf)
107118|NCT03534050|Radiation Therapy (RT)|radiation therapy (rt)
107119|NCT03534050|Hippocampus|hippocampus
107120|NCT03534050|Progression-Free Survival (PFS)|progression-free survival (pfs)
107121|NCT03534037|Serum uric acid|serum uric acid
107122|NCT03534037|Metabolic syndrome|metabolic syndrome
107123|NCT03534037|Left ventricular diastolic dysfunction|left ventricular diastolic dysfunction
107124|NCT03534037|Febuxostat|febuxostat
107125|NCT03534037|Benzbromarone|benzbromarone
107126|NCT03534011|Balloon occlusion|balloon occlusion
107127|NCT03534011|Air ambulances|air ambulances
107128|NCT03534011|Aorta|aorta
107129|NCT03534011|Resuscitation|resuscitation
107130|NCT03533985|Neonatal Abstinence Syndrome|neonatal abstinence syndrome
107132|NCT03533985|Attachment|attachment
107133|NCT03533985|Music medicine|music medicine
107134|NCT03533985|Multi-modal stimulation|multi-modal stimulation
107135|NCT03533959|in-stent neoatherosclerosis|in-stent neoatherosclerosis
107136|NCT03533959|alirocumab|alirocumab
107137|NCT03533933|collagen matrix|collagen matrix
107138|NCT03533933|connective tissue graft|connective tissue graft
107139|NCT03533933|histometry|histometry
107140|NCT03533933|xenograft|xenograft
107141|NCT03533933|periodontal regeneration|periodontal regeneration
107142|NCT03533933|biometry|biometry
107143|NCT03533881|collagen|collagen
107144|NCT03533881|volatile oils|volatile oils
107145|NCT03533881|metabolic syndrome|metabolic syndrome
107146|NCT03533881|insulin resistance|insulin resistance
107147|NCT03533868|Point-of-care|point-of-care
107148|NCT03533868|Viral load monitoring|viral load monitoring
107149|NCT03533868|Nigeria|nigeria
107150|NCT03533842|Triage|triage
107151|NCT03533842|Algorithms|algorithms
107152|NCT03533842|Emergencies|emergencies
107153|NCT03533842|Eyes emergencies|eyes emergencies
107154|NCT03533842|Ophtalmology|ophtalmology
107155|NCT03533829|vaccination|vaccination
107156|NCT03533829|pre-syncope|pre-syncope
107157|NCT03533829|syncope prevention|syncope prevention
107158|NCT03533816|Gamma delta T-cells|gamma delta t-cells
107159|NCT03533816|Hematopoietic Stem Cell Transplantation (HCT)|hematopoietic stem cell transplantation (hct)
107160|NCT03533816|Post-transplant Cyclophosphamide (PTCy)|post-transplant cyclophosphamide (ptcy)
107161|NCT03533816|Expanded/Activated gamma delta (EAGD)|expanded/activated gamma delta (eagd)
107162|NCT03533816|Graft versus host disease (GVHD)|graft versus host disease (gvhd)
107163|NCT03533816|haploidentical|haploidentical
107164|NCT03533764|Asthma Self-Management for Adolescents (ASMA)|asthma self-management for adolescents (asma)
107165|NCT03533764|Community Health Workers (CHW)|community health workers (chw)
107166|NCT03533751|ANB020|anb020
107167|NCT03533751|etokimab|etokimab
107168|NCT03533751|eczema|eczema
107169|NCT03533751|moderate to severe|moderate to severe
107170|NCT03533725|Initiation, Exclusivity, Duration|initiation, exclusivity, duration
107171|NCT03533647|high myopia|high myopia
107172|NCT03533647|ocular biometric parameters|ocular biometric parameters
107173|NCT03533647|adolescent|adolescent
107174|NCT03533647|children|children
107175|NCT03533634|midshaft clavicle fracture|midshaft clavicle fracture
107176|NCT03533634|functional outcome|functional outcome
107177|NCT03533634|anteroinferior plate|anteroinferior plate
107178|NCT03533634|superior plate|superior plate
107179|NCT03533634|reconstruction plate|reconstruction plate
107180|NCT03533608|PTSD|ptsd
107181|NCT03533608|Prolonged Exposure|prolonged exposure
107182|NCT03533608|Group Therapy|group therapy
107183|NCT03533569|pain|pain
107184|NCT03533569|inflammation|inflammation
107185|NCT03533543|Myocardial infarction|myocardial infarction
107186|NCT03533543|New-onset atrial fibrillation|new-onset atrial fibrillation
107187|NCT03533543|Retrospective|retrospective
107188|NCT03533543|Prognosis|prognosis
107189|NCT03533530|Electrical source imaging|electrical source imaging
107190|NCT03533504|pharmacokinetics|pharmacokinetics
107191|NCT03533504|hemophilia|hemophilia
107192|NCT03533504|factor VII|factor vii
107193|NCT03533504|factor IX|factor ix
107194|NCT03533504|population pharmacokinetics|population pharmacokinetics
107195|NCT03533478|Nutritional supplement|nutritional supplement
107196|NCT03533478|Diabetic Macular Edema|diabetic macular edema
107197|NCT03533478|Diabetes|diabetes
107198|NCT03533478|Alzer|alzer
107199|NCT03533478|Oxidative Stress|oxidative stress
107200|NCT03533478|Diamel|diamel
107201|NCT03533400|respiratory therapy|respiratory therapy
107202|NCT03533400|videogaming therapy|videogaming therapy
107203|NCT03533400|incentive spirometry|incentive spirometry
107204|NCT03533374|Accuracy|accuracy
107205|NCT03533374|Inter-ictal EEG Discharges|inter-ictal eeg discharges
107206|NCT03533374|Inter-rater agreement|inter-rater agreement
107207|NCT03533374|Long Term Monitoring|long term monitoring
107208|NCT03533374|Sensitivity|sensitivity
107209|NCT03533374|Sharp transients|sharp transients
107210|NCT03533374|Specificity|specificity
107211|NCT03533374|Source Space|source space
107212|NCT03533374|Voltage maps|voltage maps
107213|NCT03533361|expanded access program|expanded access program
107214|NCT03533361|radioiodine refractory|radioiodine refractory
107215|NCT03533361|differentiated|differentiated
107216|NCT03533361|lenvatinib|lenvatinib
107217|NCT03533335|Oral Hygiene|oral hygiene
107218|NCT03533335|Oral Sprays|oral sprays
107219|NCT03533335|Oral Health|oral health
107220|NCT03533335|Frail Elderly|frail elderly
107221|NCT03533335|Nursing Homes|nursing homes
107222|NCT03533335|Chlorhexidine|chlorhexidine
107223|NCT03533335|Chlorine Dioxide|chlorine dioxide
107224|NCT03533309|horizontal defect, Anterior maxillary|horizontal defect, anterior maxillary
107225|NCT03533244|Hyperemia|hyperemia
107226|NCT03533231|Pulp regeneration, intracanal medication|pulp regeneration, intracanal medication
107227|NCT03533218|endotracheal tube, point of care ultrasound|endotracheal tube, point of care ultrasound
107228|NCT03533179|Glucagon|glucagon
107229|NCT03533179|Beta-adrenergic antagonist|beta-adrenergic antagonist
107230|NCT03533179|poisoning|poisoning
107231|NCT03533166|Peri-implant mucositis|peri-implant mucositis
107232|NCT03533166|Chlorhexidine|chlorhexidine
107234|NCT03533166|Treatment|treatment
107235|NCT03533153|MSC|msc
107236|NCT03533101|Tocilizumab|tocilizumab
107237|NCT03533101|Haploidentical|haploidentical
107238|NCT03533101|Peripheral blood|peripheral blood
107239|NCT03533088|shoulder|shoulder
107240|NCT03533088|rotator cuff|rotator cuff
107241|NCT03533088|scapula|scapula
107242|NCT03533062|OAB , Botox , anticholinergics , quality of life|oab , botox , anticholinergics , quality of life
107243|NCT03533036|Virtual Reality|virtual reality
107244|NCT03533036|Anxiety|anxiety
107245|NCT03533023|Firefighters|firefighters
107246|NCT03533023|San Diego Fire and Rescue|san diego fire and rescue
107247|NCT03533023|Cardiometabolic Health|cardiometabolic health
107248|NCT03533023|First Responder|first responder
107249|NCT03533023|Shift Workers|shift workers
107250|NCT03533023|Time-Restricted Eating|time-restricted eating
107251|NCT03533023|Fasting|fasting
107252|NCT03533010|Adolescent Idiopathic Scoliosis|adolescent idiopathic scoliosis
107253|NCT03533010|Bone Health|bone health
107254|NCT03533010|Treatment|treatment
107255|NCT03533010|Vitamin D|vitamin d
107256|NCT03533010|Calcium|calcium
107257|NCT03532971|BK virus|bk virus
107258|NCT03532971|BK polyomavirus|bk polyomavirus
107259|NCT03532971|hematopoietic-cell transplantation|hematopoietic-cell transplantation
107260|NCT03532932|Drug therapy|drug therapy
107261|NCT03532893|COPD incidence|copd incidence
107262|NCT03532893|Decline in FEV1|decline in fev1
107263|NCT03532893|Inflammatory biomarkers|inflammatory biomarkers
107264|NCT03532893|EBC|ebc
107265|NCT03532893|microRNA-23a|microrna-23a
107266|NCT03532880|Olaparib|olaparib
107267|NCT03532880|Radiation therapy|radiation therapy
107268|NCT03532880|18-195|18-195
107269|NCT03532880|Memorial Sloan Kettering Cancer Center|memorial sloan kettering cancer center
107270|NCT03532867|Exercise Test|exercise test
107271|NCT03532867|Blood Pressure|blood pressure
107272|NCT03532867|Choroid|choroid
107273|NCT03532815|Cardiovascular Diseases, Framingham risk score, Life style modification, Randomized Controlled Trial|cardiovascular diseases, framingham risk score, life style modification, randomized controlled trial
107274|NCT03532802|metoprolol|metoprolol
107275|NCT03532802|heart diseases|heart diseases
107276|NCT03532802|cardiovascular diseases|cardiovascular diseases
107277|NCT03532802|ventricular outflow obstruction|ventricular outflow obstruction
107278|NCT03532802|hemodynamics|hemodynamics
107279|NCT03532763|Inflammation|inflammation
107280|NCT03532763|Tocotrienols|tocotrienols
107281|NCT03532763|Cardiovascular disease|cardiovascular disease
107282|NCT03532737|head and neck cancer|head and neck cancer
107283|NCT03532737|check point inhibitor|check point inhibitor
107284|NCT03532737|Pembrolizumab|pembrolizumab
107285|NCT03532737|Chemoradiation|chemoradiation
107286|NCT03532724|Patient Self-management, Acenocoumarol, Warfarin|patient self-management, acenocoumarol, warfarin
107287|NCT03532698|lung cancer|lung cancer
107288|NCT03532698|Aspirin|aspirin
107289|NCT03532698|Osimertinib|osimertinib
107290|NCT03532698|EGFR-TKI|egfr-tki
107291|NCT03532698|resistance|resistance
107292|NCT03532685|Asthma|asthma
107293|NCT03532685|severity|severity
107294|NCT03532685|follow up|follow up
107295|NCT03532685|obesity|obesity
107296|NCT03532685|bariatric surgery|bariatric surgery
107297|NCT03532672|Acute fasting|acute fasting
107298|NCT03532672|Inflammatory response|inflammatory response
107299|NCT03532672|Energy Expenditure|energy expenditure
107300|NCT03532659|adolescents|adolescents
107301|NCT03532659|obesity|obesity
107302|NCT03532659|lung function|lung function
107303|NCT03532659|microcirculation|microcirculation
107304|NCT03532659|intima media thickness|intima media thickness
107305|NCT03532633|infant|infant
107306|NCT03532633|cord|cord
107307|NCT03532633|micronutrients|micronutrients
107308|NCT03532633|purine|purine
107309|NCT03532633|pyrimidine|pyrimidine
107310|NCT03532620|Pitavastatin|pitavastatin
107311|NCT03532620|Prediabetic State|prediabetic state
107312|NCT03532620|Hypertension|hypertension
107313|NCT03532620|Dyslipidemias|dyslipidemias
107314|NCT03532620|Cardiovascular Disease|cardiovascular disease
107315|NCT03532607|Chronic|chronic
107316|NCT03532594|Protamine|protamine
107317|NCT03532594|Heparin Antagonists|heparin antagonists
107318|NCT03532594|Cardiopulmonary Bypass|cardiopulmonary bypass
107319|NCT03532555|zinc|zinc
107320|NCT03532542|Duchenne muscular dystrophy|duchenne muscular dystrophy
107321|NCT03532542|Exon Skipping|exon skipping
107322|NCT03532542|DMD|dmd
107323|NCT03532542|Exon 53|exon 53
107324|NCT03532542|Exon 45|exon 45
107325|NCT03532542|Duchenne|duchenne
107326|NCT03532503|pregnancy termination|pregnancy termination
107327|NCT03532503|second trimester|second trimester
107328|NCT03532503|foley catheter|foley catheter
107329|NCT03532477|Bariatric surgery|bariatric surgery
107330|NCT03532477|Gastrointestinal tract|gastrointestinal tract
107331|NCT03532477|Biological availability|biological availability
107332|NCT03532477|Pharmacokinetics|pharmacokinetics
107333|NCT03532477|Venlafaxine Hydrochloride|venlafaxine hydrochloride
107334|NCT03532464|Chlamydia Trachomatis|chlamydia trachomatis
107335|NCT03532464|Infection|infection
107336|NCT03532464|Vaginal|vaginal
107337|NCT03532464|Anal|anal
107338|NCT03532451|Muscle-Invasive|muscle-invasive
107339|NCT03532451|Cisplatin-Ineligible|cisplatin-ineligible
107340|NCT03532451|Nivolumab|nivolumab
107341|NCT03532451|Lirilumab|lirilumab
107342|NCT03532412|Polysomnography, Sleep apnea, Central sleep apnea|polysomnography, sleep apnea, central sleep apnea
107343|NCT03532399|Bivalirudin|bivalirudin
107344|NCT03532386|Infertility|infertility
107345|NCT03532386|male factor infertility|male factor infertility
107346|NCT03532386|oligoasthenospermia|oligoasthenospermia
107347|NCT03532386|vaginal hydrocele|vaginal hydrocele
107348|NCT03532334|19F MRI gas Ventilation|19f mri gas ventilation
107349|NCT03532334|133 XE ventilation Scintigraphy|133 xe ventilation scintigraphy
107350|NCT03532321|Stress|stress
107351|NCT03532321|occupational risks|occupational risks
107352|NCT03532321|hospital organization|hospital organization
107353|NCT03532321|longitudinal|longitudinal
107354|NCT03532308|Fermented Soy|fermented soy
107355|NCT03532269|sleep|sleep
107356|NCT03532269|nightmare|nightmare
107357|NCT03532269|app|app
107358|NCT03532256|Quality Improvement|quality improvement
107359|NCT03532256|Prescription Use|prescription use
107360|NCT03532256|Patient Experience|patient experience
107361|NCT03532256|SMS Messaging|sms messaging
107362|NCT03532256|Crowd Sourcing|crowd sourcing
107363|NCT03532243|Chronic Obstructive Pulmonary Disease|chronic obstructive pulmonary disease
107364|NCT03532243|inspiratory muscle training|inspiratory muscle training
107365|NCT03532243|Central Drive|central drive
107366|NCT03532230|Chronic Low Back Pain|chronic low back pain
107367|NCT03532230|Osteopathic Manipulative Medicine|osteopathic manipulative medicine
107368|NCT03532204|Oligometastatis|oligometastatis
107369|NCT03532204|SBRT|sbrt
107370|NCT03532191|Quality Improvement|quality improvement
107371|NCT03532191|Healthcare Providers|healthcare providers
107372|NCT03532191|Health Disparity|health disparity
107373|NCT03532178|Electroconvulsive Therapy, Neuromuscular Blockade|electroconvulsive therapy, neuromuscular blockade
107374|NCT03532152|VR|vr
107375|NCT03532152|moderate stress|moderate stress
107376|NCT03532139|Ovarian Cancer|ovarian cancer
107377|NCT03532113|Cognitive intervention|cognitive intervention
107378|NCT03532113|Cognitive training|cognitive training
107379|NCT03532113|Aging|aging
107380|NCT03532113|Working memory|working memory
107381|NCT03532113|Cognitive reserve|cognitive reserve
107382|NCT03532113|Brain imaging|brain imaging
107383|NCT03532113|Brain plasticity|brain plasticity
107384|NCT03532113|Polymorphisms|polymorphisms
107385|NCT03532113|Transfer|transfer
107386|NCT03532113|Inhibition|inhibition
107387|NCT03532113|Updating|updating
107388|NCT03532100|lower limb prosthesis|lower limb prosthesis
107389|NCT03532100|transtibial amputation|transtibial amputation
107390|NCT03532100|below knee amputation|below knee amputation
107391|NCT03532100|biomechanics|biomechanics
107392|NCT03532100|gait|gait
107393|NCT03532087|Breast cancer|breast cancer
107394|NCT03532087|Denosumab|denosumab
107395|NCT03532087|Chemotherapy|chemotherapy
107396|NCT03532087|Immunity|immunity
107397|NCT03532087|Immune system|immune system
107398|NCT03532087|PERIDENO|perideno
107399|NCT03532061|Familial Caregiver|familial caregiver
107400|NCT03532061|Cancer|cancer
107401|NCT03532061|Symptom Management|symptom management
107402|NCT03532061|COPE Principles|cope principles
107403|NCT03532061|Problem-solving Skills Training Program|problem-solving skills training program
107404|NCT03532048|Hispanic|hispanic
107405|NCT03532048|Fathers|fathers
107406|NCT03532048|Child|child
107407|NCT03532048|Obesity Prevention|obesity prevention
107408|NCT03532048|Cultural adaptation|cultural adaptation
107409|NCT03532048|Weight Loss|weight loss
107410|NCT03532009|Heart Failure|heart failure
107411|NCT03532009|Chronic Heart Failure|chronic heart failure
107412|NCT03532009|Hyperkalaemia|hyperkalaemia
107413|NCT03531996|Pulmonary Surfactant|pulmonary surfactant
107414|NCT03531996|Rare Lung Disease|rare lung disease
107415|NCT03531996|Registry|registry
107416|NCT03531983|gamma nail|gamma nail
107417|NCT03531970|inferior alveolar nerve block|inferior alveolar nerve block
107418|NCT03531970|irreversible pulpitis|irreversible pulpitis
107419|NCT03531970|local anesthesia|local anesthesia
107420|NCT03531970|dexamethasone|dexamethasone
107421|NCT03531957|eczema|eczema
107422|NCT03531905|diabetes|diabetes
107423|NCT03531905|cholesterolemia|cholesterolemia
107424|NCT03531905|type 2 diabetes|type 2 diabetes
107425|NCT03531905|LDL-C|ldl-c
107426|NCT03531905|T2D|t2d
107427|NCT03531905|diabetes mellitus|diabetes mellitus
107428|NCT03531892|Ulcerative Colitis|ulcerative colitis
107626|NCT03530397|Bispecific|bispecific
107429|NCT03531892|Inflammatory Bowel Disease, Ulcerative Colitis Type|inflammatory bowel disease, ulcerative colitis type
107430|NCT03531892|Colitis|colitis
107431|NCT03531892|AJM300|ajm300
107432|NCT03531840|DNA Mismatch Repair|dna mismatch repair
107433|NCT03531840|BAP1|bap1
107434|NCT03531840|BRCA|brca
107435|NCT03531827|Androgen Receptor Antagonist|androgen receptor antagonist
107436|NCT03531827|PSA|psa
107437|NCT03531827|Hormonal Therapy|hormonal therapy
107438|NCT03531827|Nanoparticle Drug|nanoparticle drug
107439|NCT03531827|Antitumor|antitumor
107440|NCT03531814|Plexiform Neurofibromas|plexiform neurofibromas
107441|NCT03531814|Medication Event Monitoring Systems|medication event monitoring systems
107442|NCT03531814|Oral Medication|oral medication
107443|NCT03531801|Referred pain|referred pain
107444|NCT03531801|pressure algometry|pressure algometry
107445|NCT03531801|pain mapping|pain mapping
107446|NCT03531788|dynamic arm support|dynamic arm support
107447|NCT03531788|mobile arm support|mobile arm support
107448|NCT03531788|rehabilitation|rehabilitation
107449|NCT03531788|occupational therapy|occupational therapy
107450|NCT03531775|upright MRI|upright mri
107451|NCT03531775|COPD with hyperinflation|copd with hyperinflation
107452|NCT03531775|Diaphragmatic weakness|diaphragmatic weakness
107453|NCT03531762|Proton Pump Inhibitor|proton pump inhibitor
107454|NCT03531762|Omeprazole|omeprazole
107455|NCT03531762|Tepotinib|tepotinib
107456|NCT03531762|Non-small cell lung cancer (NSCLC)|non-small cell lung cancer (nsclc)
107457|NCT03531762|Pharmacokinetics|pharmacokinetics
107458|NCT03531736|Allogeneic Hematopoietic Stem Cell Transplantation|allogeneic hematopoietic stem cell transplantation
107459|NCT03531736|intensity conditioning regimen|intensity conditioning regimen
107460|NCT03531736|17-639|17-639
107461|NCT03531723|external ventricular derivation|external ventricular derivation
107462|NCT03531697|Loteprednol Etabonate|loteprednol etabonate
107463|NCT03531645|Malignant neoplasms of female genital organs|malignant neoplasms of female genital organs
107464|NCT03531645|Advanced low grade serous ovarian, primary peritoneal, or fallopian tube carcinomas|advanced low grade serous ovarian, primary peritoneal, or fallopian tube carcinomas
107465|NCT03531645|Fulvestrant|fulvestrant
107466|NCT03531645|Faslodex|faslodex
107467|NCT03531645|Abemaciclib|abemaciclib
107468|NCT03531645|PD-0332991|pd-0332991
107469|NCT03531645|Ibrance|ibrance
107470|NCT03531619|posturography|posturography
107471|NCT03531619|quality of life|quality of life
107472|NCT03531619|pressure algometry|pressure algometry
107473|NCT03531619|cervicogenic dizziness|cervicogenic dizziness
107474|NCT03531593|MTX|mtx
107475|NCT03531593|IBD|ibd
107476|NCT03531593|US Elastography|us elastography
107477|NCT03531593|Liver Fibrosis|liver fibrosis
107478|NCT03531567|Upper Extremity Hemiparesis|upper extremity hemiparesis
107479|NCT03531567|Virtual Reality (VR)|virtual reality (vr)
107480|NCT03531554|Fatty acid Oxidation Disorders|fatty acid oxidation disorders
107481|NCT03531554|ketone ester|ketone ester
107482|NCT03531554|VLCAD deficiency|vlcad deficiency
107483|NCT03531541|TENS|tens
107484|NCT03531541|cervical manipulation|cervical manipulation
107485|NCT03531541|pressure pain|pressure pain
107486|NCT03531502|tachycardia|tachycardia
107487|NCT03531502|defibrillator|defibrillator
107488|NCT03531502|arrythmia|arrythmia
107489|NCT03531476|Mindfulness|mindfulness
107490|NCT03531476|Chronic Pain|chronic pain
107491|NCT03531476|Disability|disability
107492|NCT03531476|Quality of Life|quality of life
107493|NCT03531476|Online|online
107494|NCT03531463|Displaced|displaced
107495|NCT03531463|Non-Operative treatment|non-operative treatment
107496|NCT03531463|Reversed Total Shoulder Prosthesis|reversed total shoulder prosthesis
107497|NCT03531450|Gastroparesis|gastroparesis
107498|NCT03531424|Coronary Stenosis|coronary stenosis
107499|NCT03531424|Percutaneous Coronary Intervention|percutaneous coronary intervention
107500|NCT03531424|Stents|stents
107501|NCT03531424|Computed Tomography Angiography|computed tomography angiography
107502|NCT03531424|Augmented Reality|augmented reality
107503|NCT03531385|Behcet's disease|behcet's disease
107504|NCT03531385|Central sensitisation|central sensitisation
107505|NCT03531385|Neuropathic pain|neuropathic pain
107506|NCT03531385|Sleep disturbance|sleep disturbance
107507|NCT03531346|Tear film|tear film
107508|NCT03531346|Tear osmolarity|tear osmolarity
107509|NCT03531346|Contact lenses|contact lenses
107510|NCT03531333|Glioma, intraoperative ultrasound, gross total resection, quality of life|glioma, intraoperative ultrasound, gross total resection, quality of life
107511|NCT03531307|Lactate|lactate
107512|NCT03531307|Ki-67|ki-67
107513|NCT03531307|Mitotic index|mitotic index
107514|NCT03531307|Brain tumor|brain tumor
107515|NCT03531268|Pharmacogenomic Analysis|pharmacogenomic analysis
107516|NCT03531268|Clinical Utility|clinical utility
107517|NCT03531268|Outcomes|outcomes
107518|NCT03531203|soursop|soursop
107519|NCT03531203|supplementation|supplementation
107520|NCT03531203|prehypertension|prehypertension
107521|NCT03531203|uric acid|uric acid
107522|NCT03531203|randomized controlled trial|randomized controlled trial
107523|NCT03531190|Head and neck cancer|head and neck cancer
107524|NCT03531190|wound healing|wound healing
107727|NCT03529890|cystectomy|cystectomy
107526|NCT03531190|zinc, arginine, vitamin C, protein, oral supplements|zinc, arginine, vitamin c, protein, oral supplements
107527|NCT03531177|type 2 diabetes|type 2 diabetes
107528|NCT03531177|Ethnicity|ethnicity
107529|NCT03531177|African-caribbean|african-caribbean
107530|NCT03531177|Education|education
107531|NCT03531177|Self-management|self-management
107532|NCT03531164|spinal cord injuries|spinal cord injuries
107533|NCT03531164|kayak|kayak
107534|NCT03531164|trunk control|trunk control
107535|NCT03531138|performance test|performance test
107536|NCT03531138|exercise capacity|exercise capacity
107537|NCT03531138|rehabilitation outcome|rehabilitation outcome
107538|NCT03531138|pulmonary rehabilitation|pulmonary rehabilitation
107539|NCT03531099|Prostate cancer|prostate cancer
107540|NCT03531099|HIFU focal|hifu focal
107541|NCT03531099|adverse effect|adverse effect
107542|NCT03531099|low risk|low risk
107544|NCT03531073|treat to target|treat to target
107545|NCT03531047|progressive|progressive
107546|NCT03531047|cross-linking|cross-linking
107547|NCT03531047|customised|customised
107548|NCT03531047|refractive|refractive
107549|NCT03531034|Blood Pressure Variability|blood pressure variability
107550|NCT03531034|Ambulatorial Blood Pressure Monitoring|ambulatorial blood pressure monitoring
107551|NCT03531034|Combined Exercise|combined exercise
107552|NCT03531021|type 1 diabetes|type 1 diabetes
107553|NCT03531021|cardiovascular risk factor|cardiovascular risk factor
107554|NCT03531021|teenager|teenager
107555|NCT03531008|focal;|focal;
107556|NCT03530956|AMPfoot|ampfoot
107557|NCT03530956|dual-task|dual-task
107558|NCT03530956|cognitive performance|cognitive performance
107559|NCT03530956|physical performance|physical performance
107560|NCT03530956|lower-limb prosthesis|lower-limb prosthesis
107561|NCT03530891|anterior mandible fracture|anterior mandible fracture
107562|NCT03530891|surgery computer assisted|surgery computer assisted
107563|NCT03530865|mandibular molars|mandibular molars
107564|NCT03530865|extra root|extra root
107565|NCT03530865|extra root canal|extra root canal
107566|NCT03530865|root morphology|root morphology
107567|NCT03530865|cbct endodontics|cbct endodontics
107568|NCT03530839|lesser toe deformity|lesser toe deformity
107569|NCT03530839|claw toe|claw toe
107570|NCT03530839|PIP joint|pip joint
107571|NCT03530839|arthrodesis|arthrodesis
107572|NCT03530839|resection arthroplasty|resection arthroplasty
107573|NCT03530813|School|school
107574|NCT03530813|Management|management
107575|NCT03530813|Technology|technology
107576|NCT03530813|Asthma Education|asthma education
107577|NCT03530787|Ginger|ginger
107578|NCT03530787|Curcumin|curcumin
107579|NCT03530787|Zingerone|zingerone
107580|NCT03530774|physical performance battery|physical performance battery
107581|NCT03530774|24-hour dietary recalls|24-hour dietary recalls
107582|NCT03530774|dual-energy X-ray absorptimetry|dual-energy x-ray absorptimetry
107583|NCT03530774|dietary supplement|dietary supplement
107584|NCT03530774|protein|protein
107585|NCT03530735|Fingerprick Autologous Blood|fingerprick autologous blood
107586|NCT03530696|Breast Cancer|breast cancer
107587|NCT03530696|HER2-positive|her2-positive
107588|NCT03530696|T-DM1|t-dm1
107589|NCT03530696|HER2-positive Breast Cancer|her2-positive breast cancer
107590|NCT03530696|Recurrent Breast Cancer|recurrent breast cancer
107591|NCT03530696|Metastatic Breast Cancer|metastatic breast cancer
107592|NCT03530683|Neoplasms|neoplasms
107593|NCT03530683|Lymphoma|lymphoma
107594|NCT03530683|Myeloma|myeloma
107595|NCT03530644|Non-invasive glucose monitoring|non-invasive glucose monitoring
107596|NCT03530605|PCNSL, primary central nervous system lymphoma|pcnsl, primary central nervous system lymphoma
107597|NCT03530579|Diabetes Prevention|diabetes prevention
107598|NCT03530566|PnK Method|pnk method
107599|NCT03530566|obesity|obesity
107600|NCT03530566|very low calorie ketogenic diet|very low calorie ketogenic diet
107601|NCT03530566|Comorbidity|comorbidity
107602|NCT03530566|Bariatric Surgery|bariatric surgery
107603|NCT03530566|weight loss|weight loss
107604|NCT03530527|ERCP|ercp
107605|NCT03530527|Endoscopic ultrasound (EUS) guided biliary drainage|endoscopic ultrasound (eus) guided biliary drainage
107606|NCT03530501|microbiota|microbiota
107607|NCT03530501|obesity|obesity
107608|NCT03530462|episodic memory|episodic memory
107609|NCT03530462|executive control|executive control
107610|NCT03530462|fMRI|fmri
107611|NCT03530436|Bioavailability|bioavailability
107612|NCT03530436|Pharmacokinetics|pharmacokinetics
107613|NCT03530436|Curcumin|curcumin
107614|NCT03530436|Demethoxycurcumin|demethoxycurcumin
107615|NCT03530436|Bisdemethoxycurcumin|bisdemethoxycurcumin
107616|NCT03530397|Advanced solid tumors|advanced solid tumors
107617|NCT03530397|NSCLC|nsclc
107618|NCT03530397|lung cancer|lung cancer
107619|NCT03530397|MEDI5752|medi5752
107620|NCT03530397|durvalumab|durvalumab
107621|NCT03530397|immuno-oncology|immuno-oncology
107622|NCT03530397|Cancer|cancer
107623|NCT03530397|PD-1/CTLA-4 Bispecific|pd-1/ctla-4 bispecific
107624|NCT03530397|PD-1|pd-1
107625|NCT03530397|CTLA-4|ctla-4
107627|NCT03530397|Chemotherapy|chemotherapy
107628|NCT03530397|Pemetrexed|pemetrexed
107629|NCT03530397|Carboplatin|carboplatin
107630|NCT03530397|Pembrolizumab|pembrolizumab
107631|NCT03530358|Muscle Synergies|muscle synergies
107633|NCT03530358|Virtual Reality|virtual reality
107634|NCT03530358|Robotics|robotics
107635|NCT03530345|Neridronic Acid|neridronic acid
107636|NCT03530345|Neridronate|neridronate
107637|NCT03530345|CRPS|crps
107638|NCT03530345|RSD (reflex sympathetic dystrophy)|rsd (reflex sympathetic dystrophy)
107639|NCT03530332|Preterm Birth|preterm birth
107640|NCT03530332|Prematurity Prevention Clinic|prematurity prevention clinic
107641|NCT03530332|Maternal-Fetal Medicine|maternal-fetal medicine
107642|NCT03530319|Mycoplasma pneumoniae|mycoplasma pneumoniae
107643|NCT03530319|Macrolide-resistance|macrolide-resistance
107644|NCT03530319|Children|children
107645|NCT03530280|pregabalin|pregabalin
107646|NCT03530280|adductor canal block|adductor canal block
107647|NCT03530280|postoperative pain|postoperative pain
107648|NCT03530267|colorectal cancer|colorectal cancer
107649|NCT03530267|5-FU|5-fu
107650|NCT03530267|Aflibercept|aflibercept
107651|NCT03530267|Oxaliplatin|oxaliplatin
107652|NCT03530254|Endometrial receptivity|endometrial receptivity
107653|NCT03530254|Preimplantation Genetic Diagnosis (PGD)|preimplantation genetic diagnosis (pgd)
107654|NCT03530254|Preimplantation Genetic Testing for Aneuploidy (PGT-A)|preimplantation genetic testing for aneuploidy (pgt-a)
107655|NCT03530254|Embryo Transfer (ET)|embryo transfer (et)
107656|NCT03530254|Endometrial Receptivity Analysis (ERA)|endometrial receptivity analysis (era)
107657|NCT03530254|Endometrial Diagnosis|endometrial diagnosis
107658|NCT03530254|Live Newborn Rate (LBR)|live newborn rate (lbr)
107659|NCT03530241|fluorescence|fluorescence
107660|NCT03530241|cholangiography|cholangiography
107661|NCT03530241|cholecystectomy, laparoscopic|cholecystectomy, laparoscopic
107662|NCT03530215|Cardiotoxicity|cardiotoxicity
107663|NCT03530215|Antineoplastic and immunomodulating agents|antineoplastic and immunomodulating agents
107664|NCT03530202|muscle thickness|muscle thickness
107665|NCT03530202|strength|strength
107666|NCT03530202|power|power
107667|NCT03530202|functionality|functionality
107668|NCT03530189|Hyperglycemia;|hyperglycemia;
107669|NCT03530189|Hypoglycemia;|hypoglycemia;
107670|NCT03530189|Neurodevelopment;|neurodevelopment;
107671|NCT03530189|Prematurity|prematurity
107672|NCT03530163|Exercise|exercise
107673|NCT03530163|Aerobic|aerobic
107674|NCT03530163|Cognitive Function|cognitive function
107675|NCT03530150|Burns|burns
107676|NCT03530150|Partial-thickness burn wounds|partial-thickness burn wounds
107677|NCT03530150|Re-epithelization|re-epithelization
107678|NCT03530150|Second-Degree Wound|second-degree wound
107679|NCT03530150|Pirfenidone|pirfenidone
107680|NCT03530150|Wound Healing|wound healing
107681|NCT03530137|homelessness|homelessness
107682|NCT03530137|homeless children|homeless children
107683|NCT03530137|homeless families|homeless families
107684|NCT03530124|apnea following vaccination|apnea following vaccination
107685|NCT03530111|Adipose tissue|adipose tissue
107686|NCT03530111|Adipose turnover|adipose turnover
107687|NCT03530111|Adipose kinetics|adipose kinetics
107688|NCT03530111|Exercise|exercise
107689|NCT03530111|Deuterium|deuterium
107690|NCT03530098|Age Determination by Skeleton|age determination by skeleton
107691|NCT03530098|Machine Learning|machine learning
107692|NCT03530098|Deep Learning|deep learning
107693|NCT03530098|Artificial Intelligence|artificial intelligence
107694|NCT03530098|Prospective|prospective
107695|NCT03530098|Clinical Validation|clinical validation
107696|NCT03530059|Home-based training program|home-based training program
107697|NCT03530020|monolithic zirconia|monolithic zirconia
107698|NCT03530020|tooth wear|tooth wear
107699|NCT03530020|all ceramic crown|all ceramic crown
107700|NCT03529981|mindfulness, awareness|mindfulness, awareness
107701|NCT03529968|esophageal adenocarcinoma|esophageal adenocarcinoma
107702|NCT03529968|staging|staging
107703|NCT03529968|CT|ct
107704|NCT03529968|PET-CT|pet-ct
107705|NCT03529968|EUS|eus
107706|NCT03529955|dermatomyositis|dermatomyositis
107707|NCT03529955|apremilast|apremilast
107708|NCT03529955|recalcitrant cutaneous disease|recalcitrant cutaneous disease
107709|NCT03529942|Osteoarthritis|osteoarthritis
107710|NCT03529942|Knee|knee
107711|NCT03529942|Pain|pain
107712|NCT03529942|Intra-articular|intra-articular
107713|NCT03529942|Injection|injection
107714|NCT03529942|Corticosteroid|corticosteroid
107715|NCT03529929|glucocorticoids|glucocorticoids
107716|NCT03529929|aging|aging
107717|NCT03529929|NFKB|nfkb
107718|NCT03529929|Medrol|medrol
107719|NCT03529929|methylprednisolone|methylprednisolone
107720|NCT03529903|behavior change|behavior change
107721|NCT03529903|health coaching|health coaching
107722|NCT03529903|wearable activity tracker|wearable activity tracker
107723|NCT03529903|text messaging|text messaging
107724|NCT03529903|lifestyle-related chronic diseases|lifestyle-related chronic diseases
107725|NCT03529890|locally advanced urothelial carcinoma|locally advanced urothelial carcinoma
107726|NCT03529890|immunotherapy|immunotherapy
107728|NCT03529890|radiation|radiation
107729|NCT03529890|nivolumab|nivolumab
107730|NCT03529877|Epidermolysis Bullosa|epidermolysis bullosa
107731|NCT03529877|Epidermolysis Bullosa Dystrophica|epidermolysis bullosa dystrophica
107732|NCT03529877|Skin Abnormalities|skin abnormalities
107733|NCT03529877|Congenital Abnormalities|congenital abnormalities
107734|NCT03529877|Skin Diseases, Genetic|skin diseases, genetic
107735|NCT03529877|Somatic Cell Therapy|somatic cell therapy
107736|NCT03529877|Mesenchymal Stem Cells|mesenchymal stem cells
107737|NCT03529877|ABCB5|abcb5
107738|NCT03529877|Allogeneic|allogeneic
107739|NCT03529851|Patient reported outcomes|patient reported outcomes
107740|NCT03529851|Symptom monitoring|symptom monitoring
107741|NCT03529851|Follow-up|follow-up
107742|NCT03529838|Combined Exercise|combined exercise
107743|NCT03529838|Ambulatorial Blood Pressure Monitoring|ambulatorial blood pressure monitoring
107744|NCT03529838|Blood analysis|blood analysis
107745|NCT03529838|Salivary analysis|salivary analysis
107746|NCT03529838|Heart rate variability|heart rate variability
107747|NCT03529825|Rifaximin|rifaximin
107748|NCT03529825|Microbiome|microbiome
107749|NCT03529825|Allogeneic hematopoietic stem cell transplantation|allogeneic hematopoietic stem cell transplantation
107750|NCT03529825|Blood stream infections|blood stream infections
107751|NCT03529825|Acute graft versus host disease|acute graft versus host disease
107752|NCT03529812|Behavioral intervention|behavioral intervention
107753|NCT03529812|Social intervention|social intervention
107754|NCT03529799|mTBI|mtbi
107755|NCT03529799|TBI|tbi
107756|NCT03529799|brain injury|brain injury
107757|NCT03529799|concussion|concussion
107758|NCT03529786|Hunter Syndrome|hunter syndrome
107759|NCT03529786|Natural History|natural history
107760|NCT03529786|Iduronate-2-sulfatase|iduronate-2-sulfatase
107761|NCT03529786|glycosaminoglycans|glycosaminoglycans
107762|NCT03529773|Respiratory tract infections, RSV, vaccine|respiratory tract infections, rsv, vaccine
107763|NCT03529760|Leukemia, occult hepatitis B virus infection|leukemia, occult hepatitis b virus infection
107764|NCT03529734|Anticipatory postural adjustments|anticipatory postural adjustments
107765|NCT03529734|Trunk muscles reflex responses|trunk muscles reflex responses
107766|NCT03529734|Sitting balance|sitting balance
107767|NCT03529734|Kinesthesia|kinesthesia
107768|NCT03529695|obesity|obesity
107769|NCT03529695|childhood obesity|childhood obesity
107770|NCT03529695|maternal and child health|maternal and child health
107771|NCT03529695|health disparities|health disparities
107772|NCT03529695|prevention|prevention
107773|NCT03529695|low-income|low-income
107774|NCT03529695|social network|social network
107775|NCT03529695|home environment|home environment
107776|NCT03529682|Circuit Exercise|circuit exercise
107777|NCT03529682|Trunk Control|trunk control
107778|NCT03529682|Functional Strength Training|functional strength training
107779|NCT03529669|Cancer|cancer
107780|NCT03529669|Oesophageal Cancer|oesophageal cancer
107781|NCT03529669|Gastrointestinal|gastrointestinal
107782|NCT03529656|Liver transplantation|liver transplantation
107783|NCT03529656|rehabilitation|rehabilitation
107784|NCT03529656|ICU acquired weakness|icu acquired weakness
107785|NCT03529604|Oral Cancer|oral cancer
107786|NCT03529604|Potentially Malignant Oral Disorders|potentially malignant oral disorders
107787|NCT03529604|Saliva|saliva
107788|NCT03529604|Squamous cell carcinoma antigen 1|squamous cell carcinoma antigen 1
107789|NCT03529604|Squamous cell carcinoma antigen 2|squamous cell carcinoma antigen 2
107790|NCT03529604|Trophoblast cell surface antigen|trophoblast cell surface antigen
107791|NCT03529604|Diadenosine tetraphosphate|diadenosine tetraphosphate
107792|NCT03529578|Pressure Ulcer, Decubitus Ulcer|pressure ulcer, decubitus ulcer
107793|NCT03529539|Cancer|cancer
107794|NCT03529500|dental caries|dental caries
107795|NCT03529500|saliva|saliva
107796|NCT03529500|child|child
107797|NCT03529461|severe obesity|severe obesity
107798|NCT03529461|non-invasive positive pressure ventilation|non-invasive positive pressure ventilation
107799|NCT03529461|endoscopy|endoscopy
107800|NCT03529461|hypoxia|hypoxia
107801|NCT03529461|bariatric surgery|bariatric surgery
107802|NCT03529461|sedation|sedation
107803|NCT03529461|adverse events|adverse events
107804|NCT03529461|BMI|bmi
107805|NCT03529461|anesthesia|anesthesia
107806|NCT03529461|complications|complications
107807|NCT03529448|Glioblastoma|glioblastoma
107808|NCT03529435|Posttraumatic Stress Disorder|posttraumatic stress disorder
107809|NCT03529435|PTSD|ptsd
107810|NCT03529435|Post-Traumatic Stress|post-traumatic stress
107811|NCT03529435|Trauma and Stressor Related Disorders|trauma and stressor related disorders
107812|NCT03529435|Trauma|trauma
107813|NCT03529435|Combat|combat
107814|NCT03529435|Military|military
107815|NCT03529435|Veterans|veterans
107816|NCT03529435|Prolonged Exposure|prolonged exposure
107817|NCT03529435|Exposure Therapy|exposure therapy
107818|NCT03529435|Behavior Therapy|behavior therapy
107819|NCT03529435|Psychological Treatment|psychological treatment
107820|NCT03529435|Psychotherapy|psychotherapy
107821|NCT03529422|Head and Neck|head and neck
107822|NCT03529422|Larynx|larynx
107823|NCT03529422|Lip|lip
107824|NCT03529422|Oral Cancer|oral cancer
107825|NCT03529409|Immunologic Deficiency Syndromes|immunologic deficiency syndromes
107826|NCT03529409|Substance Use|substance use
107827|NCT03529409|Acquired Immunodeficiency Syndrome|acquired immunodeficiency syndrome
107828|NCT03529409|Immune System Diseases|immune system diseases
107829|NCT03529409|Behavioral Symptoms|behavioral symptoms
107830|NCT03529409|RNA Virus Infections|rna virus infections
107831|NCT03529409|HIV Infections|hiv infections
107832|NCT03529409|Alcohol Use|alcohol use
107833|NCT03529409|Drug Use|drug use
107834|NCT03529396|G6PD deficiency|g6pd deficiency
107835|NCT03529396|Acute hemolytic anemia|acute hemolytic anemia
107836|NCT03529396|Vivax malaria|vivax malaria
107837|NCT03529396|Primaquine|primaquine
107838|NCT03529396|Weekly primaquine|weekly primaquine
107839|NCT03529396|Chloroquine|chloroquine
107840|NCT03529396|Weekly chloroquine|weekly chloroquine
107841|NCT03529396|Brazilian Amazon|brazilian amazon
107842|NCT03529396|Oxidative stress|oxidative stress
107843|NCT03529383|Localized breast cancer|localized breast cancer
107844|NCT03529383|Exercise|exercise
107845|NCT03529383|Adapted physical activity|adapted physical activity
107846|NCT03529383|Sedentary|sedentary
107847|NCT03529383|Connected device|connected device
107848|NCT03529383|Activity trackers|activity trackers
107849|NCT03529383|Therapeutic education|therapeutic education
107851|NCT03529357|Biological Age|biological age
107852|NCT03529357|Motivation|motivation
107853|NCT03529331|Pain Medications, Analgesia, Emergency Medicine|pain medications, analgesia, emergency medicine
107854|NCT03529305|Stroke|stroke
107855|NCT03529305|rTMS|rtms
107856|NCT03529305|MRI|mri
107857|NCT03529253|Alirocumab|alirocumab
107858|NCT03529253|NIRS-IVUS|nirs-ivus
107859|NCT03529253|LCBI|lcbi
107860|NCT03529240|kinesiology taping|kinesiology taping
107861|NCT03529240|performance|performance
107862|NCT03529240|energy consumption|energy consumption
107863|NCT03529240|gait|gait
107864|NCT03529240|Duchenne Muscular Dystrophy|duchenne muscular dystrophy
107865|NCT03529227|chlorambucil|chlorambucil
107866|NCT03529227|obinutuzumab|obinutuzumab
107867|NCT03529214|Quality Improvement|quality improvement
107868|NCT03529214|Program Evaluation|program evaluation
107869|NCT03529214|Quality Assurance|quality assurance
107870|NCT03529214|Feasibility|feasibility
107871|NCT03529214|Acceptability|acceptability
107872|NCT03529188|Diabetes type 1|diabetes type 1
107873|NCT03529188|Child ans teenager|child ans teenager
107874|NCT03529188|Fear of Hypoglycaemia|fear of hypoglycaemia
107875|NCT03529162|Biceps Tendinitis|biceps tendinitis
107876|NCT03529162|Subpectoral biceps tenodesis|subpectoral biceps tenodesis
107877|NCT03529162|Biceps tendon disorder|biceps tendon disorder
107878|NCT03529136|Mesenchymal Stem Cell|mesenchymal stem cell
107879|NCT03529136|MSC|msc
107880|NCT03529110|Breast Cancer|breast cancer
107881|NCT03529110|Metastatic breast cancer|metastatic breast cancer
107882|NCT03529110|DS-8201a|ds-8201a
107883|NCT03529110|DESTINY - Breast 03|destiny - breast 03
107884|NCT03529084|Non small cell lung cancer|non small cell lung cancer
107885|NCT03529084|NSCLC|nsclc
107886|NCT03529084|EGFR mutation|egfr mutation
107887|NCT03529084|EGF816|egf816
107888|NCT03529084|nazartinib|nazartinib
138041|NCT03338699|HIV|hiv
107889|NCT03529084|erlotinib|erlotinib
107890|NCT03529084|gefitinib|gefitinib
107891|NCT03529071|communication|communication
107892|NCT03529071|patient activation|patient activation
107894|NCT03529045|VNS Therapy|vns therapy
107895|NCT03529045|Vagus Nerve Stimulation|vagus nerve stimulation
107896|NCT03529032|methadone|methadone
107897|NCT03529032|postoperative pain|postoperative pain
107898|NCT03529032|acute pain therapy|acute pain therapy
107899|NCT03529032|postoperative pain therapy|postoperative pain therapy
107900|NCT03529019|Enhanced Recovery After Surgery Protocol|enhanced recovery after surgery protocol
107901|NCT03529006|bioresorbable vascular scaffold|bioresorbable vascular scaffold
107902|NCT03529006|drug eluting balloon|drug eluting balloon
107903|NCT03528993|stroke, hippotherapy, balance, postural control, gait|stroke, hippotherapy, balance, postural control, gait
107904|NCT03528980|fertility|fertility
107905|NCT03528980|bariatric surgery|bariatric surgery
107906|NCT03528954|Emergence agitation|emergence agitation
107907|NCT03528954|Propofol|propofol
107908|NCT03528954|General anesthesia|general anesthesia
107909|NCT03528941|Chronic Lymphoid Leukemia|chronic lymphoid leukemia
107910|NCT03528941|Hepatitis B|hepatitis b
107911|NCT03528941|Ibrutinib|ibrutinib
107912|NCT03528928|pelvic floor|pelvic floor
107913|NCT03528928|electrical stimulation|electrical stimulation
107914|NCT03528928|bladder|bladder
107915|NCT03528928|ultrasound|ultrasound
107916|NCT03528915|neonate, infant; eyewash; delivery room; prophylaxis; risk factor's|neonate, infant; eyewash; delivery room; prophylaxis; risk factor's
107917|NCT03528876|gastric cancer|gastric cancer
107918|NCT03528876|esophageal cancer|esophageal cancer
107919|NCT03528876|adnocarcinoma|adnocarcinoma
107920|NCT03528876|FOLFIRI|folfiri
107921|NCT03528876|FOLFOX|folfox
107922|NCT03528876|Metastatic cancer|metastatic cancer
107923|NCT03528811|Diabetes|diabetes
107924|NCT03528811|Peripheral Vascular Disease|peripheral vascular disease
107925|NCT03528811|Microcirculation|microcirculation
107926|NCT03528785|Pancreatic Adenocarcinoma|pancreatic adenocarcinoma
107927|NCT03528785|Liposomial IrinoTecan|liposomial irinotecan
107928|NCT03528785|nal-IRI|nal-iri
107929|NCT03528785|Resectable pancreatic cancer|resectable pancreatic cancer
107930|NCT03528772|anal fissure, minoxidil, glycreyl trinitrate|anal fissure, minoxidil, glycreyl trinitrate
107931|NCT03528746|Patellar tendinopathy|patellar tendinopathy
107932|NCT03528720|Tomography, Optical Coherence|tomography, optical coherence
107933|NCT03528720|Fluorescein Angiography|fluorescein angiography
107934|NCT03528720|Fundus photographs|fundus photographs
107935|NCT03528694|Durvalumab|durvalumab
107936|NCT03528694|BCG|bcg
107937|NCT03528694|MEDI4736|medi4736
107938|NCT03528694|NMIBC|nmibc
107939|NCT03528694|PD-L1|pd-l1
107940|NCT03528694|DFS|dfs
107941|NCT03528694|OS|os
107942|NCT03528655|separation care|separation care
107943|NCT03528655|rooming-in care|rooming-in care
107944|NCT03528655|patient decision aid|patient decision aid
107945|NCT03528629|zolbetuximab|zolbetuximab
107946|NCT03528629|IMAB362|imab362
107947|NCT03528629|pharmacokinetics|pharmacokinetics
107948|NCT03528629|tolerability|tolerability
107949|NCT03528629|safety|safety
107950|NCT03528629|ASP8951|asp8951
107951|NCT03528629|immunogenicity|immunogenicity
107952|NCT03528603|platelet, aggregation, phenolic, olive oil, oleocanthal|platelet, aggregation, phenolic, olive oil, oleocanthal
107953|NCT03528590|laryngeal mask airway|laryngeal mask airway
107954|NCT03528590|breast surgery|breast surgery
107955|NCT03528564|Preoperative Anemia|preoperative anemia
107956|NCT03528564|Intravenous Iron|intravenous iron
107957|NCT03528564|Erythropoietin|erythropoietin
107958|NCT03528538|Fenugreek|fenugreek
107959|NCT03528538|Aging Male Symptoms|aging male symptoms
107960|NCT03528538|Testosterone|testosterone
107961|NCT03528538|Supplementation|supplementation
107962|NCT03528538|Double Blind|double blind
107963|NCT03528538|Body Composition|body composition
107964|NCT03528525|Diseases|diseases
107965|NCT03528525|Children|children
107966|NCT03528525|Respiratory|respiratory
107967|NCT03528525|Monogenic diseases|monogenic diseases
107968|NCT03528525|China|china
107969|NCT03528512|Pediatric|pediatric
107970|NCT03528512|analgesia|analgesia
107971|NCT03528512|pain control|pain control
107972|NCT03528512|sedation|sedation
107973|NCT03528512|intranasal ketamine|intranasal ketamine
107974|NCT03528512|intranasal midazolam|intranasal midazolam
107975|NCT03528512|intranasal fentanyl|intranasal fentanyl
107976|NCT03528499|Scapula|scapula
107977|NCT03528499|Physical Therapy|physical therapy
107978|NCT03528499|Movement|movement
107979|NCT03528499|Rehabilitation|rehabilitation
107980|NCT03528460|Parkinson Disease|parkinson disease
107981|NCT03528460|Deep Brain Stimulation|deep brain stimulation
107982|NCT03528460|Subthalamic Nucleus|subthalamic nucleus
107983|NCT03528460|Predictive factors|predictive factors
107984|NCT03528447|lung transplantation|lung transplantation
107985|NCT03528447|cognition|cognition
107986|NCT03528447|MOCA|moca
107987|NCT03528447|exercise|exercise
107988|NCT03528447|pulmonary rehabilitation|pulmonary rehabilitation
107989|NCT03528434|Zinc|zinc
107990|NCT03528421|CAR-T|car-t
107991|NCT03528395|Balance|balance
107992|NCT03528395|Baropodometry|baropodometry
107993|NCT03528395|Video games|video games
107994|NCT03528395|Virtual reality|virtual reality
107995|NCT03528343|appendicitis|appendicitis
107996|NCT03528343|postoperative pain|postoperative pain
107997|NCT03528343|patient satisfaction|patient satisfaction
107998|NCT03528343|children|children
107999|NCT03528343|pediatric|pediatric
108000|NCT03528343|narcotic|narcotic
108001|NCT03528343|pain control|pain control
108002|NCT03528304|Obesity|obesity
108003|NCT03528304|Overweight|overweight
108004|NCT03528304|Current smoker|current smoker
108005|NCT03528304|American Indian/Alaska Native|american indian/alaska native
108006|NCT03528291|Human,|human,
108007|NCT03528291|adult,|adult,
108008|NCT03528291|intensive care unit,|intensive care unit,
108009|NCT03528291|cardiogenic shock,|cardiogenic shock,
108010|NCT03528291|Transient circulatory support,|transient circulatory support,
108011|NCT03528291|extra corporeal life support|extra corporeal life support
108012|NCT03528291|Impella|impella
108013|NCT03528265|lateral flow immunoassay|lateral flow immunoassay
108014|NCT03528265|validation|validation
108015|NCT03528252|cholesterol|cholesterol
108016|NCT03528252|LDL cholesterol|ldl cholesterol
108017|NCT03528252|Triglycerides|triglycerides
108018|NCT03528252|Diet|diet
108019|NCT03528252|Food|food
108020|NCT03528252|Lipoproteins|lipoproteins
108021|NCT03528226|Type 1 diabetes|type 1 diabetes
108022|NCT03528226|endothelial function|endothelial function
108023|NCT03528226|exercise training|exercise training
108024|NCT03528226|physical activity|physical activity
108025|NCT03528213|sepsis|sepsis
108026|NCT03528213|fluid balance|fluid balance
108027|NCT03528213|metabolism|metabolism
108028|NCT03528213|ischemia-reperfusion|ischemia-reperfusion
108029|NCT03528213|treatment|treatment
108039|NCT03528122|retinal detachment|retinal detachment
108040|NCT03528122|Myopic|myopic
108041|NCT03528122|macular hole|macular hole
108042|NCT03528122|internal limiting membrane|internal limiting membrane
108043|NCT03528083|Bronchiolitis|bronchiolitis
108044|NCT03528083|Children|children
108045|NCT03528083|Hospital|hospital
108046|NCT03528070|Sarcoidosis|sarcoidosis
108047|NCT03528070|Tranilast|tranilast
108048|NCT03528070|skin|skin
108049|NCT03528070|lung|lung
108050|NCT03528057|Kidney|kidney
108051|NCT03528044|Bariatric surgery|bariatric surgery
108052|NCT03528044|Reward|reward
108053|NCT03528044|Cognition|cognition
108054|NCT03528044|Working memory|working memory
108055|NCT03528044|Grey matter|grey matter
108056|NCT03528044|GLP-1|glp-1
108057|NCT03528044|Inflammation|inflammation
108058|NCT03528044|Stress|stress
108059|NCT03528044|Follow-up|follow-up
108060|NCT03528044|Psychiatric|psychiatric
108061|NCT03528018|Virtual Reality|virtual reality
108062|NCT03528018|Rehabilitation|rehabilitation
108063|NCT03528018|Physical therapy|physical therapy
108064|NCT03528005|Integrated Health Care Systems|integrated health care systems
108065|NCT03528005|Multimorbid|multimorbid
108066|NCT03528005|Multi-domain intervention|multi-domain intervention
108067|NCT03528005|Clinical Trials, Randomized|clinical trials, randomized
108068|NCT03527992|Randomized Therapeutic trial|randomized therapeutic trial
108069|NCT03527992|Hypoxemic pneumonia|hypoxemic pneumonia
108070|NCT03527992|Automated oxygen therapy|automated oxygen therapy
108071|NCT03527992|Length of stay|length of stay
108072|NCT03527992|medico-economic cost|medico-economic cost
108073|NCT03527953|bulk-fill restorative resins, dental caries|bulk-fill restorative resins, dental caries
108074|NCT03527927|COPD|copd
108075|NCT03527914|Depression|depression
108076|NCT03527914|Psychosis|psychosis
108077|NCT03527914|Personality Disorder|personality disorder
108078|NCT03527914|Substance Abuse|substance abuse
108079|NCT03527901|aggressive periodontitis|aggressive periodontitis
108080|NCT03527901|healthy peri-implant|healthy peri-implant
108081|NCT03527901|chairside test|chairside test
108082|NCT03527901|chronic periodontitis|chronic periodontitis
108083|NCT03527849|Osteoarthritis|osteoarthritis
108084|NCT03527849|Knee Osteoarthritis|knee osteoarthritis
108085|NCT03527849|Knee Pain|knee pain
108086|NCT03527823|Fertilization in Vitro|fertilization in vitro
108087|NCT03527823|Granulosa Cells|granulosa cells
108088|NCT03527823|Apoptosis|apoptosis
108089|NCT03527810|sleeve gastrectomy|sleeve gastrectomy
108090|NCT03527810|hiatal interrogation|hiatal interrogation
108091|NCT03527810|GERD|gerd
108092|NCT03527797|Critical illness associated diaphragm weakness|critical illness associated diaphragm weakness
108093|NCT03527797|Mechanical ventilation|mechanical ventilation
108094|NCT03527797|Critical illness|critical illness
108095|NCT03527797|Respiratory muscle dysfunction|respiratory muscle dysfunction
108096|NCT03527784|rectal adenocarcinoma|rectal adenocarcinoma
108097|NCT03527784|abdominoperineal resection|abdominoperineal resection
108098|NCT03527784|hernia prophylaxis|hernia prophylaxis
108099|NCT03527758|Biomarkers|biomarkers
108100|NCT03527758|Hypotension|hypotension
108101|NCT03527758|Organ Protection|organ protection
108102|NCT03527758|Intraoperative|intraoperative
108103|NCT03527719|Hypertension|hypertension
108104|NCT03527719|Stroke|stroke
108105|NCT03527719|China|china
108106|NCT03527719|Protocol-based treatment|protocol-based treatment
108107|NCT03527693|Knee Chondropathy, Osteoarthritis, Micro-fragmented fat.|knee chondropathy, osteoarthritis, micro-fragmented fat.
108108|NCT03527628|Stage II B Classical Hodgkin Lymphoma|stage ii b classical hodgkin lymphoma
108109|NCT03527628|Stage III Classical Hodgkin Lymphoma|stage iii classical hodgkin lymphoma
108110|NCT03527628|Stage IV Classical Hodgkin Lymphoma|stage iv classical hodgkin lymphoma
108111|NCT03527602|Apical patency|apical patency
108112|NCT03527602|Endodontics|endodontics
108122|NCT03527563|Hypertension|hypertension
108123|NCT03527550|impulsivity|impulsivity
108124|NCT03527550|Inhibition (Psychology)|inhibition (psychology)
108125|NCT03527550|Working memory|working memory
108126|NCT03527550|Cognitive Remediation|cognitive remediation
108127|NCT03527524|exercise|exercise
108128|NCT03527472|cognitive dysfunction|cognitive dysfunction
108129|NCT03527472|memantine|memantine
108130|NCT03527472|lupus|lupus
108131|NCT03527446|Metabolic flexibility|metabolic flexibility
108132|NCT03527446|Insulin sensitivity|insulin sensitivity
108133|NCT03527446|Sprint interval training|sprint interval training
108134|NCT03527446|Obesity|obesity
108135|NCT03527446|Exercise intensity|exercise intensity
108136|NCT03527433|Incisional hernia|incisional hernia
108137|NCT03527433|Wound infection|wound infection
108138|NCT03527433|Midline laparotomy|midline laparotomy
108139|NCT03527420|Obesity|obesity
108140|NCT03527420|DNA methylation|dna methylation
108141|NCT03527420|Exercise|exercise
108142|NCT03527420|Weight loss|weight loss
108143|NCT03527420|Bariatric|bariatric
108144|NCT03527420|Macrovascular|macrovascular
108145|NCT03527420|Microvascular|microvascular
108146|NCT03527420|Epigenetics|epigenetics
108147|NCT03527420|Adipose tissue|adipose tissue
108148|NCT03527420|Adipocytokines|adipocytokines
108149|NCT03527420|Inflammation|inflammation
108150|NCT03527420|Cardiovascular|cardiovascular
108151|NCT03527394|Obesity|obesity
108152|NCT03527394|Pediatric|pediatric
108153|NCT03527394|Parent|parent
108154|NCT03527394|Family|family
108155|NCT03527394|Motivational Interviewing|motivational interviewing
108156|NCT03527394|Lifestyle|lifestyle
108157|NCT03527394|Health Behavior|health behavior
108158|NCT03527381|Cardiopulmonary Bypass|cardiopulmonary bypass
108159|NCT03527381|Nitric Oxide|nitric oxide
108160|NCT03527381|Kidney Function Tests|kidney function tests
108161|NCT03527381|Renal Insufficiency|renal insufficiency
108162|NCT03527381|Protective Agents|protective agents
108163|NCT03527381|Coronary Artery Bypass|coronary artery bypass
108164|NCT03527381|Cardiac Surgery|cardiac surgery
108165|NCT03527355|Typhoid|typhoid
108166|NCT03527355|Vi-DT|vi-dt
108167|NCT03527355|Conjugate vaccine|conjugate vaccine
108168|NCT03527355|First in human|first in human
108169|NCT03527355|New vaccine|new vaccine
108170|NCT03527329|Prewarming|prewarming
108171|NCT03527329|Tympanic temperature|tympanic temperature
108172|NCT03527303|stress|stress
108173|NCT03527303|health|health
108174|NCT03527303|meditation|meditation
108175|NCT03527303|mindfulness|mindfulness
108176|NCT03527303|employees|employees
108177|NCT03527303|job strain|job strain
108178|NCT03527303|burnout|burnout
108179|NCT03527303|work|work
108180|NCT03527303|mood|mood
108181|NCT03527303|affect|affect
108182|NCT03527303|work related stress|work related stress
108183|NCT03527277|orange juice|orange juice
108184|NCT03527277|sugar-sweetened beverage|sugar-sweetened beverage
108185|NCT03527277|triglyceride|triglyceride
108186|NCT03527277|low density lipoprotein cholesterol|low density lipoprotein cholesterol
108187|NCT03527277|apolipoprotein B|apolipoprotein b
108188|NCT03527277|uric acid|uric acid
108189|NCT03527277|de novo lipogenesis|de novo lipogenesis
108190|NCT03527277|hepatic triglyceride|hepatic triglyceride
108191|NCT03527277|hepatic glucose production|hepatic glucose production
108192|NCT03527277|whole body insulin sensitivity|whole body insulin sensitivity
108193|NCT03527264|cervical cancer|cervical cancer
108194|NCT03527264|Stage IB|stage ib
108195|NCT03527264|Stage IIA|stage iia
108196|NCT03527264|Stage IIB|stage iib
108197|NCT03527264|Stage IIIA|stage iiia
108198|NCT03527264|Stage IIIB|stage iiib
108199|NCT03527264|Stage IVA|stage iva
108200|NCT03527251|clinical trial, phase I|clinical trial, phase i
108201|NCT03527251|CTLA-4 antibody|ctla-4 antibody
108202|NCT03527251|PD-1 antibody|pd-1 antibody
108203|NCT03527251|non-small cell lung cancer|non-small cell lung cancer
108204|NCT03527238|Phenotypic Precision Medicine (PPM)|phenotypic precision medicine (ppm)
108205|NCT03527238|Tacrolimus|tacrolimus
108206|NCT03527238|Calcineurin Inhibitors|calcineurin inhibitors
108207|NCT03527225|Music Therapy|music therapy
108208|NCT03527225|First Radiotherapy|first radiotherapy
108209|NCT03527225|Anxiety Reduction|anxiety reduction
108210|NCT03527225|Psychosocial Functioning|psychosocial functioning
108211|NCT03527225|State - Trait Anxiety Inventory (STAI)|state - trait anxiety inventory (stai)
108212|NCT03527225|Symptom Distress Thermometer (SDT)|symptom distress thermometer (sdt)
108213|NCT03527212|Dry Eye Disease|dry eye disease
108214|NCT03527212|Corneal Epithelial Disorders|corneal epithelial disorders
108215|NCT03527212|Re-Epithelialization|re-epithelialization
108216|NCT03527173|Challenge|challenge
108217|NCT03527173|Efficacy|efficacy
108218|NCT03527173|Shigellosis|shigellosis
108219|NCT03527173|Vaccination|vaccination
108220|NCT03527160|AKI|aki
108221|NCT03527160|NGAL|ngal
108222|NCT03527147|Acalabrutinib|acalabrutinib
108223|NCT03527147|CALQUENCE®|calquence®
108224|NCT03527147|ACP-196|acp-196
108225|NCT03527147|Platform study|platform study
108226|NCT03527147|Master protocol|master protocol
108227|NCT03527147|PRISM|prism
108228|NCT03527147|Hu-5F9|hu-5f9
108229|NCT03527147|Rituximab|rituximab
108230|NCT03527147|ATR|atr
108231|NCT03527147|STAT3|stat3
108232|NCT03527147|Anti-CD47|anti-cd47
108233|NCT03527147|BRD4|brd4
108234|NCT03527121|Ankle|ankle
108235|NCT03527121|Exercise|exercise
108236|NCT03527121|Activities of daily living|activities of daily living
108237|NCT03527121|Treatment outcome|treatment outcome
108238|NCT03527108|Non-small cell lung cancer|non-small cell lung cancer
108239|NCT03527108|Immunotherapy|immunotherapy
108240|NCT03527095|Cystic Fibrosis|cystic fibrosis
108241|NCT03527082|mesh|mesh
108242|NCT03527082|erosion|erosion
108243|NCT03527082|transvaginal|transvaginal
108244|NCT03527082|prolapse|prolapse
108245|NCT03527082|laparoscopic|laparoscopic
108246|NCT03527082|tension free tape|tension free tape
108247|NCT03527056|CRE|cre
108248|NCT03527030|Tobacco Use|tobacco use
108249|NCT03527030|IQOS|iqos
108250|NCT03527017|Tobacco Use|tobacco use
108251|NCT03527017|IQOS|iqos
108252|NCT03527004|Tobacco Use|tobacco use
108253|NCT03527004|IQOS|iqos
108254|NCT03526991|Freezing of Gait|freezing of gait
108255|NCT03526991|Locomotion|locomotion
108256|NCT03526991|Spinal cord stimulation|spinal cord stimulation
108257|NCT03526978|Sabin strain|sabin strain
108258|NCT03526978|Inactivated poliovirus vaccine|inactivated poliovirus vaccine
108259|NCT03526978|poliomyelitis|poliomyelitis
108260|NCT03526978|safety|safety
108261|NCT03526978|immunogenicity|immunogenicity
108262|NCT03526978|infant|infant
108263|NCT03526939|Persons who inject drugs|persons who inject drugs
108264|NCT03526939|HIV|hiv
108265|NCT03526939|Hepatitis C|hepatitis c
108266|NCT03526939|Vietnam|vietnam
108267|NCT03526939|Behavioral Intervention|behavioral intervention
108268|NCT03526926|newly-diagnosed t-AML or AML-MRC|newly-diagnosed t-aml or aml-mrc
108269|NCT03526913|chronic leg ulcers, PRP|chronic leg ulcers, prp
108270|NCT03526913|split-thickness skin graft|split-thickness skin graft
108271|NCT03526913|platelet-rich plasma|platelet-rich plasma
108272|NCT03526874|Pain|pain
108273|NCT03526874|Chronic Migraine|chronic migraine
108274|NCT03526874|Episodic Migraine|episodic migraine
108275|NCT03526874|Headache|headache
108276|NCT03526874|Nerve Block|nerve block
108278|NCT03526848|10-1074|10-1074
108279|NCT03526848|Broadly Neutralizing Antibody|broadly neutralizing antibody
108280|NCT03526835|Bispecific antibody|bispecific antibody
108281|NCT03526835|First-in-human|first-in-human
108282|NCT03526835|MCLA-158|mcla-158
108283|NCT03526835|Antibodies|antibodies
108284|NCT03526835|Bispecific|bispecific
108285|NCT03526835|immunologic factors|immunologic factors
108286|NCT03526835|Cytokines|cytokines
108287|NCT03526835|EGFR|egfr
108288|NCT03526835|LGR5|lgr5
108289|NCT03526809|Magnetic resonance imaging|magnetic resonance imaging
108290|NCT03526796|Pouchitis|pouchitis
108291|NCT03526796|Hyperbaric oxygen therapy|hyperbaric oxygen therapy
108292|NCT03526783|Obesity Surgery|obesity surgery
108293|NCT03526783|Failed Sleeve Gastrectomy|failed sleeve gastrectomy
108294|NCT03526783|Roux-en-Y gastric bypass|roux-en-y gastric bypass
108295|NCT03526783|Mini/One anastomosis gastric bypass|mini/one anastomosis gastric bypass
108296|NCT03526770|pH of saliva|ph of saliva
108297|NCT03526770|carbonated drink|carbonated drink
108298|NCT03526770|buffering agent|buffering agent
108299|NCT03526770|oral hygiene|oral hygiene
108300|NCT03526757|Postural balance|postural balance
108301|NCT03526757|Pilates method|pilates method
108302|NCT03526757|Elderly|elderly
108303|NCT03526744|Dietary Supplements|dietary supplements
108304|NCT03526744|Fish Proteins|fish proteins
108305|NCT03526744|Protein Hydrolysates|protein hydrolysates
108306|NCT03526744|Aged|aged
108307|NCT03526718|Transmission|transmission
108308|NCT03526718|Genotyping|genotyping
108309|NCT03526718|Risk factors|risk factors
108310|NCT03526692|Mild cognitive impairment|mild cognitive impairment
108311|NCT03526692|Neurofeedback|neurofeedback
108312|NCT03526692|electroencephalography|electroencephalography
108313|NCT03526692|attention|attention
108314|NCT03526692|memory|memory
108315|NCT03526679|soft tissue sarcoma|soft tissue sarcoma
108316|NCT03526679|phase Ib/II|phase ib/ii
108317|NCT03526679|advanced cancer|advanced cancer
108318|NCT03526666|Vitamin C|vitamin c
108319|NCT03526666|Ascorbic Acid|ascorbic acid
108320|NCT03526666|Epigenetics|epigenetics
108321|NCT03526666|5-hydroxymethylcytosine|5-hydroxymethylcytosine
108322|NCT03526666|5-methylcytosine|5-methylcytosine
108323|NCT03526627|advanced care management, advanced heart failure|advanced care management, advanced heart failure
108324|NCT03526601|heart failure|heart failure
108325|NCT03526601|prevalence|prevalence
108326|NCT03526588|CDH|cdh
108327|NCT03526523|Mindfulness based stress reduction|mindfulness based stress reduction
108328|NCT03526523|Perimenopausal depression|perimenopausal depression
108329|NCT03526523|Menopause transition|menopause transition
108330|NCT03526510|High Risk Prostate Cancer|high risk prostate cancer
108331|NCT03526510|Radiotherapy|radiotherapy
108332|NCT03526497|Catheterization, Peripheral/methods|catheterization, peripheral/methods
108333|NCT03526497|Humans|humans
108334|NCT03526497|Acute Disease|acute disease
108335|NCT03526497|Aged|aged
108336|NCT03526497|Female|female
108337|NCT03526497|Male|male
108338|NCT03526497|Follow-Up Studies|follow-up studies
108339|NCT03526497|Heart Failure/physiopathology|heart failure/physiopathology
108340|NCT03526497|Prospective Studies|prospective studies
108341|NCT03526497|Stroke Volume/physiology|stroke volume/physiology
108342|NCT03526497|Venous Pressure/physiology|venous pressure/physiology
108343|NCT03526484|UTI|uti
108344|NCT03526484|Urinalysis|urinalysis
108345|NCT03526484|Urine Culture|urine culture
108346|NCT03526484|Cystoscopy|cystoscopy
108347|NCT03526484|BCG treatment|bcg treatment
108348|NCT03526484|Prostate Biopsy|prostate biopsy
108349|NCT03526471|Left Atrial Appendage|left atrial appendage
108350|NCT03526471|Non-valvular atrial fibrillation|non-valvular atrial fibrillation
108351|NCT03526458|Holmium Laser|holmium laser
108352|NCT03526458|Laser setting|laser setting
108353|NCT03526458|Stone fragmentation|stone fragmentation
108354|NCT03526445|Glucagon|glucagon
108355|NCT03526445|Stable isotope|stable isotope
108356|NCT03526445|Energy expenditure|energy expenditure
108357|NCT03526445|Lipid metabolism|lipid metabolism
108358|NCT03526445|Glucose metabolism|glucose metabolism
108359|NCT03526445|Appetite|appetite
108360|NCT03526419|Liposomal bupivacaine|liposomal bupivacaine
108361|NCT03526419|TAP block|tap block
108362|NCT03526419|cesarean section|cesarean section
108363|NCT03526406|Cognition|cognition
108364|NCT03526406|Mood|mood
108365|NCT03526406|Flavonoid|flavonoid
108366|NCT03526406|Grape Seed|grape seed
108367|NCT03526406|Catechin|catechin
108368|NCT03526406|Epicatechin|epicatechin
108369|NCT03526406|Proanthocyanidin|proanthocyanidin
108370|NCT03526380|Drug overdose|drug overdose
108371|NCT03526380|Substance-Related Disorders|substance-related disorders
108372|NCT03526380|Chemically-Induced Disorders|chemically-induced disorders
108373|NCT03526380|Risk Reduction Behavior|risk reduction behavior
108374|NCT03526380|Harm Reduction|harm reduction
108375|NCT03526354|Schizophrenia|schizophrenia
108376|NCT03526354|Schizoaffective Disorder|schizoaffective disorder
108377|NCT03526354|Substance Use Disorders|substance use disorders
108378|NCT03526354|Alcohol Use Disorder|alcohol use disorder
108379|NCT03526354|Cannabis Use Disorder|cannabis use disorder
108380|NCT03526354|Cocaine Use Disorder|cocaine use disorder
108381|NCT03526354|Heroin Use Disorder|heroin use disorder
108382|NCT03526328|DCLK1|dclk1
108383|NCT03526328|Serum Biomarker|serum biomarker
108384|NCT03526328|Barrett's Esophagus|barrett's esophagus
108385|NCT03526328|Esophageal Adenocarcinoma|esophageal adenocarcinoma
108386|NCT03526328|Tumor Stem Cell Marker|tumor stem cell marker
108387|NCT03526315|CPP-ACP paste|cpp-acp paste
108388|NCT03526315|Fluoride toothpaste|fluoride toothpaste
108389|NCT03526315|Combined use of fluoride and CPP-ACP paste|combined use of fluoride and cpp-acp paste
108390|NCT03526315|MS reduction|ms reduction
108391|NCT03526315|Antibacterial|antibacterial
108392|NCT03526315|Children|children
108393|NCT03526276|Quantitative Laser Fluorescence (QLF)|quantitative laser fluorescence (qlf)
108394|NCT03526276|CPP-ACP paste|cpp-acp paste
108395|NCT03526276|Fluoride toothpaste|fluoride toothpaste
108396|NCT03526276|Combined use of fluoride and CPP-ACP paste|combined use of fluoride and cpp-acp paste
108397|NCT03526276|Primary teeth|primary teeth
108398|NCT03526263|Gastric Mucosal Devitalization|gastric mucosal devitalization
108399|NCT03526263|Obesity|obesity
108400|NCT03526263|Endoscopic Bariatric Therapies|endoscopic bariatric therapies
108401|NCT03526263|Bariatric surgery|bariatric surgery
108402|NCT03526237|diabetes|diabetes
108403|NCT03526237|prevention|prevention
108404|NCT03526237|risk|risk
108405|NCT03526237|obesity|obesity
108406|NCT03526237|weight loss|weight loss
108407|NCT03526237|community based|community based
108408|NCT03526211|Intensive care unit acquired muscle weakness|intensive care unit acquired muscle weakness
108409|NCT03526211|Cycloergometer|cycloergometer
108410|NCT03526211|Neuromuscular electrical stimulation|neuromuscular electrical stimulation
108411|NCT03526211|FES Cycling|fes cycling
108412|NCT03526198|Force plate|force plate
108413|NCT03526198|Center of mass|center of mass
108414|NCT03526159|Herlitz|herlitz
108415|NCT03526159|Laminin 332|laminin 332
108416|NCT03526159|Laminin beta 3|laminin beta 3
108417|NCT03526159|JEB|jeb
108418|NCT03526133|sleep apnea|sleep apnea
108419|NCT03526133|polygraph|polygraph
108420|NCT03526133|home sleep apnea test (HSAT)|home sleep apnea test (hsat)
108421|NCT03526133|apnea hypopnea index (AHI)|apnea hypopnea index (ahi)
108422|NCT03526133|oxygen desaturation index (ODI)|oxygen desaturation index (odi)
108423|NCT03526133|portable monitor|portable monitor
108424|NCT03526133|sleep actimetry|sleep actimetry
108425|NCT03526133|snoring|snoring
108426|NCT03526120|Human subjects|human subjects
108427|NCT03526120|Pistachio snack|pistachio snack
108428|NCT03526120|Body mass index|body mass index
108429|NCT03526120|Energy intake|energy intake
108430|NCT03526120|Fat mass|fat mass
108431|NCT03526107|flavanol|flavanol
108432|NCT03526107|ADME|adme
108433|NCT03526107|polyphenols|polyphenols
108434|NCT03526107|cocoa|cocoa
108435|NCT03526107|epicatechin|epicatechin
108436|NCT03526107|methylxanthine|methylxanthine
108437|NCT03526107|caffeine|caffeine
108438|NCT03526094|flavanol|flavanol
108439|NCT03526094|ADME|adme
108440|NCT03526094|polyphenols|polyphenols
108441|NCT03526094|Cocoa|cocoa
108442|NCT03526094|Banana|banana
108443|NCT03526094|epicatechin|epicatechin
108444|NCT03526081|flavone|flavone
108445|NCT03526081|ADME|adme
108446|NCT03526081|apigenin|apigenin
108447|NCT03526081|parsley|parsley
108448|NCT03526081|chamomile|chamomile
108449|NCT03526081|polyphenols|polyphenols
108450|NCT03526016|Sleep Apnea|sleep apnea
108451|NCT03526016|Acromegaly|acromegaly
108452|NCT03526016|Transsphenoidal surgery|transsphenoidal surgery
108453|NCT03526016|Respiratory polygraphy|respiratory polygraphy
108454|NCT03525964|Individualized treatment|individualized treatment
108455|NCT03525964|Functional outcome|functional outcome
108456|NCT03525847|Contrast endosonograpy|contrast endosonograpy
108457|NCT03525834|TSC|tsc
108458|NCT03525834|tuberous sclerosis complex|tuberous sclerosis complex
108459|NCT03525834|AML|aml
108460|NCT03525834|afinitor|afinitor
108461|NCT03525834|everolimus|everolimus
108462|NCT03525834|RAD001|rad001
108463|NCT03525834|mTOR|mtor
108464|NCT03525834|kidney|kidney
108465|NCT03525834|lymphangioleiomyomatosis|lymphangioleiomyomatosis
108466|NCT03525834|renal angiomyolipoma|renal angiomyolipoma
108467|NCT03525808|Pancreatic necrosis|pancreatic necrosis
108468|NCT03525795|Phase 1/2|phase 1/2
108469|NCT03525795|Oncology|oncology
108470|NCT03525795|EZH2 Inhibitor|ezh2 inhibitor
108471|NCT03525782|CAR-T cell therapy|car-t cell therapy
108472|NCT03525782|MUC+|muc+
108473|NCT03525782|PD-1 Knockout|pd-1 knockout
108474|NCT03525782|Non-small cell lung cancer|non-small cell lung cancer
108475|NCT03525756|cystogram|cystogram
108476|NCT03525756|Foley catheter|foley catheter
108477|NCT03525743|Intubation|intubation
108478|NCT03525730|HIV|hiv
108479|NCT03525730|Latency reversing agents|latency reversing agents
108480|NCT03525730|HDAC inhibitor|hdac inhibitor
108481|NCT03525730|BAF inhibitor|baf inhibitor
108482|NCT03525730|HIV reservoir|hiv reservoir
108483|NCT03525730|HIV cure|hiv cure
108484|NCT03525717|healthy volunteers|healthy volunteers
108485|NCT03525717|metabolism|metabolism
108486|NCT03525717|fat oxidation|fat oxidation
108487|NCT03525717|obesity|obesity
108488|NCT03525717|sleep|sleep
108489|NCT03525678|Relapsed|relapsed
108490|NCT03525678|Refractory multiple myeloma|refractory multiple myeloma
108491|NCT03525678|Antibody-drug conjugate|antibody-drug conjugate
108492|NCT03525678|Patient-Reported Outcome Version of the Common Term Criteria for Adverse Events|patient-reported outcome version of the common term criteria for adverse events
108493|NCT03525678|Quality of Life Questionnaire 20-item Multiple Myeloma module|quality of life questionnaire 20-item multiple myeloma module
108494|NCT03525678|Multiple Myeloma|multiple myeloma
108495|NCT03525678|Quality of Life Questionnaire 30-item Core module|quality of life questionnaire 30-item core module
108496|NCT03525665|Follicular lymphoma|follicular lymphoma
108497|NCT03525665|FDG-PET|fdg-pet
108498|NCT03525665|Relapse/progression|relapse/progression
108499|NCT03525652|Prostate Cancer|prostate cancer
108500|NCT03525652|Therapeutic vaccine|therapeutic vaccine
108501|NCT03525652|PD-1 knockout|pd-1 knockout
108502|NCT03525639|Cardiac Magnetic Resonance|cardiac magnetic resonance
108503|NCT03525639|Acute Myocarditis|acute myocarditis
108504|NCT03525639|Myocardial Inflammation|myocardial inflammation
108505|NCT03525626|Tic Disorders|tic disorders
108506|NCT03525626|Mindfulness|mindfulness
108507|NCT03525626|Meditation|meditation
108508|NCT03525626|Online|online
108509|NCT03525626|Internet-based|internet-based
108510|NCT03525626|Treatment|treatment
108511|NCT03525587|Quality Improvement|quality improvement
108512|NCT03525587|Quality of Life|quality of life
108513|NCT03525587|Smartphone APP|smartphone app
108514|NCT03525522|Lichen sclerosus|lichen sclerosus
108515|NCT03525522|laser|laser
108516|NCT03525522|Nd:YAG|nd:yag
108517|NCT03525522|randomized controlled trial|randomized controlled trial
108518|NCT03525509|Methadone|methadone
108519|NCT03525509|Morphine|morphine
108520|NCT03525509|Quantitative sensory testing|quantitative sensory testing
108521|NCT03525509|Epidural|epidural
108522|NCT03525496|Iodinated contrast agents|iodinated contrast agents
108523|NCT03525496|Immediate hypersensitivity reactions|immediate hypersensitivity reactions
108524|NCT03525496|Reintroduction tests|reintroduction tests
108525|NCT03525483|ECMO|ecmo
108526|NCT03525483|Acute renal failure|acute renal failure
108527|NCT03525470|Hydration|hydration
108528|NCT03525470|Brain functioning|brain functioning
108529|NCT03525470|Heart-rate variability|heart-rate variability
108530|NCT03525457|Glomerular filtration rate|glomerular filtration rate
108531|NCT03525457|Periodontitis|periodontitis
108532|NCT03525457|Chronic kidney disease|chronic kidney disease
108533|NCT03525431|Exome|exome
108534|NCT03525431|Sequencing|sequencing
108535|NCT03525431|Clinical Utility|clinical utility
108536|NCT03525431|Pediatric|pediatric
108537|NCT03525431|Underrepresented|underrepresented
108538|NCT03525431|Underserved|underserved
108539|NCT03525418|Pediatrics|pediatrics
108540|NCT03525379|Skeletal Muscle Blood Flow|skeletal muscle blood flow
108541|NCT03525379|(calf muscle) targeted exercise|(calf muscle) targeted exercise
108542|NCT03525340|Engagement to care, peer navigation, transgender|engagement to care, peer navigation, transgender
108543|NCT03525327|Dance|dance
108544|NCT03525301|Short Course Radiotherapy|short course radiotherapy
108545|NCT03525301|Symptomatic brain metastases|symptomatic brain metastases
108546|NCT03525262|Erectile dysfunction, Neurovascular, Prostate, Rectal spacer, Radiotherapy|erectile dysfunction, neurovascular, prostate, rectal spacer, radiotherapy
108547|NCT03525223|23Na MRI|23na mri
108548|NCT03525197|Muscle Physiology|muscle physiology
108549|NCT03525197|Nutrition|nutrition
108550|NCT03525145|Platelet Reactivity|platelet reactivity
108551|NCT03525145|Thrombotic Events|thrombotic events
108552|NCT03525119|Vaccine|vaccine
108553|NCT03525054|Psychotic Disorders|psychotic disorders
108554|NCT03525054|Diagnosis, Psychiatric|diagnosis, psychiatric
108555|NCT03525054|Schizophrenia Prodromal|schizophrenia prodromal
108556|NCT03525054|Ultra High Risk|ultra high risk
108557|NCT03525054|Prediction Of Psychosis|prediction of psychosis
108558|NCT03525054|Machine Learning|machine learning
108559|NCT03525054|Automated Language Analysis|automated language analysis
108560|NCT03525054|Semantic Coherence|semantic coherence
108561|NCT03525054|Syntaxic Complexity|syntaxic complexity
108562|NCT03524989|hbot|hbot
108563|NCT03524989|hyperbaric oxygen|hyperbaric oxygen
108564|NCT03524989|sport|sport
108565|NCT03524989|mitochondria|mitochondria
108566|NCT03524989|athletes|athletes
108567|NCT03524989|aerobic|aerobic
108568|NCT03524976|endovascular treatment|endovascular treatment
108569|NCT03524976|liquid embolization|liquid embolization
108570|NCT03524950|stress|stress
108571|NCT03524950|dexmedetomidine|dexmedetomidine
108572|NCT03524937|Delirium|delirium
108573|NCT03524937|Mechanical ventilation|mechanical ventilation
108574|NCT03524937|Intensive care unit|intensive care unit
108575|NCT03524937|Prevention|prevention
108576|NCT03524937|Pharmacokinetics|pharmacokinetics
108577|NCT03524937|Melatonin|melatonin
108578|NCT03524924|atrial fibrillation|atrial fibrillation
108579|NCT03524924|elderly|elderly
108580|NCT03524924|edoxaban|edoxaban
108581|NCT03524924|frailty|frailty
108582|NCT03524924|SHARE-FI|share-fi
108583|NCT03524924|Stroke|stroke
108584|NCT03524924|Major bleeding|major bleeding
108585|NCT03524911|Nutrition education|nutrition education
108586|NCT03524911|Evaluation|evaluation
108587|NCT03524911|Child diet|child diet
108588|NCT03524911|EFNEP|efnep
108589|NCT03524898|Nab-Paclitaxel|nab-paclitaxel
108590|NCT03524898|Gemcitabine|gemcitabine
108591|NCT03524898|Advanced soft tissue sarcoma|advanced soft tissue sarcoma
108592|NCT03524898|Cancer|cancer
108593|NCT03524898|Sarcoma|sarcoma
108594|NCT03524898|Abraxane®|abraxane®
108595|NCT03524859|Cystic Fibrosis|cystic fibrosis
108596|NCT03524859|Sit-to-stand|sit-to-stand
108597|NCT03524859|Lung Function|lung function
108598|NCT03524859|Handgrip|handgrip
108599|NCT03524859|Walking Speed|walking speed
108600|NCT03524859|Power|power
108601|NCT03524859|Velocity|velocity
108602|NCT03524859|Gait Speed|gait speed
108603|NCT03524859|Chair rise|chair rise
108604|NCT03524846|Ascorbic acid|ascorbic acid
108605|NCT03524846|hemodialysis vascular access|hemodialysis vascular access
108606|NCT03524846|restenosis|restenosis
108607|NCT03524833|Lansoprazole, Amoxicillin, Metronidazole|lansoprazole, amoxicillin, metronidazole
108608|NCT03524820|cetuximab, colon cancer, RAS|cetuximab, colon cancer, ras
108609|NCT03524807|pelvic floor muscle electrophysiologic therapy|pelvic floor muscle electrophysiologic therapy
108610|NCT03524807|enhanced recovery|enhanced recovery
108611|NCT03524807|muscle soreness|muscle soreness
108612|NCT03524807|postoperative retention of urine|postoperative retention of urine
108613|NCT03524807|Intrauterine Adhesions|intrauterine adhesions
108614|NCT03524807|enhanced recovery after gynecologic surgery|enhanced recovery after gynecologic surgery
108615|NCT03524781|Anti-reflux surgery|anti-reflux surgery
108616|NCT03524781|Proton-pump inhibitors|proton-pump inhibitors
108617|NCT03524781|Upper endoscopy|upper endoscopy
108618|NCT03524768|endothelial function, microvascular|endothelial function, microvascular
108619|NCT03524768|laser speckle contrast imaging|laser speckle contrast imaging
108620|NCT03524768|capillaroscopy, skin|capillaroscopy, skin
108621|NCT03524742|Diet|diet
108622|NCT03524742|Cholesterol|cholesterol
108623|NCT03524729|Rocker bottom shoe|rocker bottom shoe
108624|NCT03524729|Ankle-foot orthosis|ankle-foot orthosis
108625|NCT03524729|Ankle osteoarthritis|ankle osteoarthritis
108626|NCT03524716|physical activity|physical activity
108627|NCT03524716|digital health|digital health
108628|NCT03524716|text messages|text messages
108629|NCT03524716|intervention|intervention
108630|NCT03524716|exercise|exercise
108631|NCT03524716|randomized|randomized
108632|NCT03524716|Fitbit|fitbit
108633|NCT03524703|dysphagia|dysphagia
108634|NCT03524703|anterior cervical fusion|anterior cervical fusion
108635|NCT03524703|chewing gum|chewing gum
108636|NCT03524677|pancreatic cancer|pancreatic cancer
108637|NCT03524677|liquid biopsy|liquid biopsy
108638|NCT03524677|vascular invasion|vascular invasion
108639|NCT03524677|early recurrence|early recurrence
108640|NCT03524651|Iron Deficiency Anemia|iron deficiency anemia
108641|NCT03524651|Fe-ASP|fe-asp
108642|NCT03524651|Casein|casein
108835|NCT03523247|HDL|hdl
108643|NCT03524651|Iron protein acetyl aspartate|iron protein acetyl aspartate
108644|NCT03524651|Restoration of decreased hemoglobin|restoration of decreased hemoglobin
108645|NCT03524651|Ferrous sulfate|ferrous sulfate
108646|NCT03524612|Thrombocytopenic|thrombocytopenic
108647|NCT03524612|Immune|immune
108648|NCT03524612|Platelets|platelets
108649|NCT03524612|Bleeding|bleeding
108650|NCT03524612|ITP|itp
108651|NCT03524612|eltrombopag|eltrombopag
108652|NCT03524612|ETB115|etb115
108653|NCT03524612|induce sustained remission|induce sustained remission
108654|NCT03524612|refractory or relapsed|refractory or relapsed
108655|NCT03524612|first-line steroids|first-line steroids
108656|NCT03524599|Heavy drinking|heavy drinking
108657|NCT03524599|Primary health care|primary health care
108658|NCT03524599|Training|training
108659|NCT03524599|Community|community
108660|NCT03524560|comprehensive geriatric assesment, polypharmacy,geriatric depression scale,neutrophil/lymphocyte ratio|comprehensive geriatric assesment, polypharmacy,geriatric depression scale,neutrophil/lymphocyte ratio
108661|NCT03524482|culturally specific|culturally specific
108662|NCT03524456|home blood pressure monitoring|home blood pressure monitoring
108663|NCT03524456|sms|sms
108664|NCT03524456|primary care|primary care
108665|NCT03524443|Affective symptom|affective symptom
108666|NCT03524443|Art Therapy|art therapy
108667|NCT03524443|alexithymia|alexithymia
108668|NCT03524443|emotional disturbance|emotional disturbance
108669|NCT03524443|hyperphagia|hyperphagia
108670|NCT03524443|psychotherapy|psychotherapy
108671|NCT03524443|rehabilitation|rehabilitation
108672|NCT03524443|factor of resistance|factor of resistance
108673|NCT03524430|Early breast cancer|early breast cancer
108674|NCT03524417|Rabies immunoglobulin|rabies immunoglobulin
108675|NCT03524378|repetitive strain|repetitive strain
108676|NCT03524378|ergonomics|ergonomics
108677|NCT03524378|participatory ergonomics|participatory ergonomics
108678|NCT03524378|chronic low back pain|chronic low back pain
108679|NCT03524378|seafood workers|seafood workers
108680|NCT03524352|recurrent pouchitis|recurrent pouchitis
108681|NCT03524352|fecal microbiota transplant|fecal microbiota transplant
108682|NCT03524326|cetuximab|cetuximab
108683|NCT03524326|Lenvatinib|lenvatinib
108684|NCT03524326|Memorial Sloan Kettering Cancer Center|memorial sloan kettering cancer center
108685|NCT03524326|17-635|17-635
108686|NCT03524313|cardiac output|cardiac output
108687|NCT03524313|end tidal carbon monoxide|end tidal carbon monoxide
108688|NCT03524313|echocardiography|echocardiography
108689|NCT03524313|intensive care|intensive care
108690|NCT03524300|Stomach Neoplasm|stomach neoplasm
108691|NCT03524300|Robotic Surgery|robotic surgery
108692|NCT03524300|Total Gastrectomy|total gastrectomy
108693|NCT03524287|Stomach Neoplasms|stomach neoplasms
108694|NCT03524287|Robotic Surgery|robotic surgery
108695|NCT03524287|Spleen-Preserving|spleen-preserving
108696|NCT03524287|No.10 Lymph Node Dissection|no.10 lymph node dissection
108697|NCT03524274|PD-1 activated CIK|pd-1 activated cik
108698|NCT03524274|MUC1|muc1
108699|NCT03524274|bispecific antibody|bispecific antibody
108700|NCT03524274|Colorectal Cancer|colorectal cancer
108701|NCT03524261|activated CIK|activated cik
108702|NCT03524261|MUC1|muc1
108703|NCT03524261|bispecific antibody|bispecific antibody
108704|NCT03524261|breast cancer|breast cancer
108705|NCT03524235|Relapsed/Refractory Lymphoma|relapsed/refractory lymphoma
108706|NCT03524235|Multiple Myeloma|multiple myeloma
108707|NCT03524235|CLL|cll
108708|NCT03524235|Bendamustine|bendamustine
108709|NCT03524235|Haploidentical Stem Cell Transplantation|haploidentical stem cell transplantation
139124|NCT03332537|IBS|ibs
108710|NCT03524235|GVHD|gvhd
108711|NCT03524235|Allogeneic Stem Cell Transplantation|allogeneic stem cell transplantation
108712|NCT03524235|Natural Killer Cell|natural killer cell
108713|NCT03524235|CliniMACS|clinimacs
108714|NCT03524235|Post-transplantation cyclophosphamide|post-transplantation cyclophosphamide
108715|NCT03524235|Donor Lymphocyte Infusion|donor lymphocyte infusion
108716|NCT03524235|Minimal Residual Disease|minimal residual disease
108717|NCT03524235|Hodgkin Lymphoma|hodgkin lymphoma
108718|NCT03524209|Spondylodiscitis|spondylodiscitis
108719|NCT03524209|spinal infection|spinal infection
108720|NCT03524209|back pain|back pain
108721|NCT03524209|quality of life|quality of life
108722|NCT03524209|fusion|fusion
108723|NCT03524209|minimal invasive surgery|minimal invasive surgery
108724|NCT03524209|brace treatment|brace treatment
108725|NCT03524157|Humylub PF|humylub pf
108726|NCT03524157|artificial tears|artificial tears
108727|NCT03524157|Ophthalmic lubricant|ophthalmic lubricant
108728|NCT03524157|Chondroitin sulfate|chondroitin sulfate
108729|NCT03524157|Sodium hyaluronate|sodium hyaluronate
108730|NCT03524105|Socio Economic Adversity|socio economic adversity
108731|NCT03524105|Child Development|child development
108732|NCT03524105|Poverty|poverty
108733|NCT03524105|racial disparity|racial disparity
108734|NCT03524105|ethnic disparity|ethnic disparity
108735|NCT03524092|Interleukin-23 (IL-23)|interleukin-23 (il-23)
108736|NCT03524092|IL-23p19|il-23p19
108737|NCT03524092|Inflammatory Bowel Disease|inflammatory bowel disease
108738|NCT03524040|Selective Photothermolysis|selective photothermolysis
108936|NCT03522597|Obesity|obesity
108739|NCT03524040|Reflectance Confocal Microscopy|reflectance confocal microscopy
108740|NCT03524040|Optical Coherence Tomography|optical coherence tomography
108741|NCT03524040|Pilosebaceous Unit|pilosebaceous unit
108742|NCT03524040|Gold Microparticles|gold microparticles
108743|NCT03524027|Vertebral Column Resection|vertebral column resection
108744|NCT03524027|Congenital Spinal Deformity|congenital spinal deformity
108745|NCT03524027|Congenital Thoracolumbar Kyphoscoliosis|congenital thoracolumbar kyphoscoliosis
108746|NCT03523988|Pre-emptive analgesics|pre-emptive analgesics
108747|NCT03523988|Acetaminophen|acetaminophen
108748|NCT03523988|Ibuprofen|ibuprofen
108749|NCT03523962|Surgical Site Infection|surgical site infection
108750|NCT03523962|Open Fracture|open fracture
108751|NCT03523962|Lower Extremity Fracture|lower extremity fracture
108752|NCT03523962|Pelvis; Fracture|pelvis; fracture
108753|NCT03523962|DuraPrep|duraprep
108754|NCT03523962|ChloraPrep|chloraprep
108755|NCT03523962|Peri-operative Preparation Solutions|peri-operative preparation solutions
108756|NCT03523949|Pain Neuroscience Education|pain neuroscience education
108757|NCT03523949|Elderly|elderly
108758|NCT03523949|Pain Education|pain education
108759|NCT03523936|antibiotics, prebiotics, dysbiosis|antibiotics, prebiotics, dysbiosis
108760|NCT03523923|Collaborative Care|collaborative care
108761|NCT03523923|Effectiveness Study|effectiveness study
108762|NCT03523845|"early apical peri-implantitis; implant periapical lesion; retrograde peri-implantitis; implant failure"|"early apical peri-implantitis; implant periapical lesion; retrograde peri-implantitis; implant failure"
108763|NCT03523819|Solid Tumors|solid tumors
108764|NCT03523793|Outpatient Physical Therapy|outpatient physical therapy
108765|NCT03523754|Induction of labor|induction of labor
108766|NCT03523754|isosorbide mononitrate|isosorbide mononitrate
108767|NCT03523754|misoprostol|misoprostol
108768|NCT03523741|genetic polymorphism|genetic polymorphism
108769|NCT03523741|pharmacodynamic variability|pharmacodynamic variability
108770|NCT03523741|personalized pharmacotherapy|personalized pharmacotherapy
108771|NCT03523741|adverse drug reaction|adverse drug reaction
108772|NCT03523741|quality of life|quality of life
108773|NCT03523689|Malignant neoplasms of respiratory and intrathoracic organs|malignant neoplasms of respiratory and intrathoracic organs
108774|NCT03523689|Endobronchial ultrasound-guided transbronchial needle aspiration|endobronchial ultrasound-guided transbronchial needle aspiration
108775|NCT03523689|EBUS-TBNA|ebus-tbna
108776|NCT03523624|factor XIII|factor xiii
108777|NCT03523624|intramyocardial haemorrhage|intramyocardial haemorrhage
108778|NCT03523624|microvascular injury|microvascular injury
108779|NCT03523624|STEMI|stemi
108780|NCT03523624|cardiac magnetic resonance|cardiac magnetic resonance
108781|NCT03523611|lung cancer|lung cancer
108782|NCT03523611|Ventricular Failure|ventricular failure
108783|NCT03523585|Breast Cancer|breast cancer
108784|NCT03523585|Metastatic breast cancer|metastatic breast cancer
108785|NCT03523585|DS 8201a|ds 8201a
108786|NCT03523585|DESTINY - Breast 02|destiny - breast 02
108787|NCT03523572|Human epidermal growth factor receptor-2|human epidermal growth factor receptor-2
108788|NCT03523572|HER2|her2
108789|NCT03523572|Refractory|refractory
108790|NCT03523572|Metastatic|metastatic
108791|NCT03523572|Urothelial cancer|urothelial cancer
108792|NCT03523572|Breast Cancer|breast cancer
108793|NCT03523520|constipation|constipation
108794|NCT03523520|opioid|opioid
108795|NCT03523507|Repetitive Transcranial Magnetic Stimulation|repetitive transcranial magnetic stimulation
108796|NCT03523507|Military|military
108797|NCT03523468|VATS|vats
108798|NCT03523468|Lung Cancer|lung cancer
108799|NCT03523455|Iron|iron
108800|NCT03523455|Exercise Performance|exercise performance
108801|NCT03523455|Fatigue|fatigue
108802|NCT03523403|Obesity|obesity
108803|NCT03523403|Diet|diet
108804|NCT03523403|Apples|apples
108805|NCT03523403|Polyphenols|polyphenols
108806|NCT03523403|Soluble fibre|soluble fibre
108807|NCT03523403|Blood lipids|blood lipids
108808|NCT03523403|Lipid digestion|lipid digestion
108809|NCT03523403|Inflammation|inflammation
108810|NCT03523403|Cytokines|cytokines
108811|NCT03523403|Microbiota|microbiota
108812|NCT03523403|Dysbiosis|dysbiosis
108813|NCT03523403|Type 2 diabetes risk|type 2 diabetes risk
108814|NCT03523403|Cardiovascular disease risk|cardiovascular disease risk
108815|NCT03523390|Metastatic Solid Tumors|metastatic solid tumors
108816|NCT03523390|Avelumab|avelumab
108817|NCT03523390|MSB0010718C|msb0010718c
108818|NCT03523377|Fasting|fasting
108819|NCT03523377|18-199|18-199
108820|NCT03523351|Palliative Radiation|palliative radiation
108821|NCT03523351|18-196|18-196
108822|NCT03523325|Tendinopathy|tendinopathy
108823|NCT03523325|Tendon|tendon
108824|NCT03523325|Rehabilitation|rehabilitation
108825|NCT03523325|Exercise treatment|exercise treatment
108826|NCT03523312|Ablative Irradiation|ablative irradiation
108827|NCT03523312|18-090|18-090
108828|NCT03523299|invasive ductal carcinoma|invasive ductal carcinoma
108829|NCT03523299|breast cancer|breast cancer
108830|NCT03523299|cryoablation|cryoablation
108831|NCT03523286|Catheter ablation|catheter ablation
108832|NCT03523286|ECG imaging|ecg imaging
108833|NCT03523247|Cholesterol|cholesterol
108834|NCT03523247|LDL|ldl
108836|NCT03523247|triglycerides|triglycerides
108837|NCT03523247|c-reactive protein|c-reactive protein
108838|NCT03523247|whole food diet|whole food diet
108839|NCT03523247|plant based diet|plant based diet
108840|NCT03523247|community based enrollment|community based enrollment
108841|NCT03523234|neoadjuvant therapy|neoadjuvant therapy
108842|NCT03523234|surgery|surgery
108843|NCT03523182|Micronutrient supplementation|micronutrient supplementation
108844|NCT03523182|Home fortification|home fortification
108845|NCT03523182|Spirulina|spirulina
108846|NCT03523182|Zambia|zambia
108847|NCT03523169|Septic associated encephalopathy|septic associated encephalopathy
108848|NCT03523169|Cerebral oxygenation|cerebral oxygenation
108849|NCT03523169|Prognosis|prognosis
108850|NCT03523169|Passive leg raising|passive leg raising
108851|NCT03523156|Antibiotics|antibiotics
108852|NCT03523156|Infectious diseases|infectious diseases
108853|NCT03523156|Tropical medicine|tropical medicine
108854|NCT03523156|Public health|public health
108855|NCT03523143|early screening|early screening
108856|NCT03523143|early intervention|early intervention
108857|NCT03523143|gestational diabetes mellitus|gestational diabetes mellitus
108858|NCT03523143|pregnancy outcomes|pregnancy outcomes
108859|NCT03523143|randomized controlled trial|randomized controlled trial
108860|NCT03523130|Macrophage-specific inflammation|macrophage-specific inflammation
108861|NCT03523130|Arterial inflammation|arterial inflammation
108862|NCT03523130|Neuroinflammation|neuroinflammation
108863|NCT03523130|SPECT/CT|spect/ct
108864|NCT03523130|Tilmanocept|tilmanocept
108865|NCT03523091|OnabotulinumtoxinA|onabotulinumtoxina
108866|NCT03523091|Bladder Injections|bladder injections
108867|NCT03523039|Cardiac Arrest|cardiac arrest
108868|NCT03523039|Cytokine Hemoadsorption|cytokine hemoadsorption
108869|NCT03523026|Metabolic Syndrome|metabolic syndrome
108870|NCT03523026|Coronary Artery Patients|coronary artery patients
108871|NCT03523026|Neuromuscular Electrical Stimulation|neuromuscular electrical stimulation
108872|NCT03523026|Respiratory Muscle Training|respiratory muscle training
108873|NCT03523026|Peripheral Muscle Training|peripheral muscle training
108874|NCT03523000|intractable chronic low back pain|intractable chronic low back pain
108875|NCT03523000|lumbar post-laminectomy syndrome|lumbar post-laminectomy syndrome
108876|NCT03523000|vertebral compression fracture|vertebral compression fracture
108877|NCT03523000|intrathecal drug delivery system|intrathecal drug delivery system
108878|NCT03522987|Neurologic Disorders|neurologic disorders
108879|NCT03522987|Chronic Care|chronic care
108880|NCT03522987|Management|management
108881|NCT03522987|Treatment|treatment
108882|NCT03522987|SSRI Medication|ssri medication
108883|NCT03522987|SNRI Medication|snri medication
108884|NCT03522987|Learning Healthcare System|learning healthcare system
108885|NCT03522948|heavy drinking|heavy drinking
108886|NCT03522948|sexual risk behavior|sexual risk behavior
108887|NCT03522922|Acne scars|acne scars
108888|NCT03522922|dermaroller|dermaroller
108889|NCT03522922|vitamin C|vitamin c
108890|NCT03522909|obstetric anesthesia|obstetric anesthesia
108891|NCT03522909|telemedicine|telemedicine
108892|NCT03522883|Martial Arts|martial arts
108893|NCT03522870|Flash glucose monitoring system|flash glucose monitoring system
108894|NCT03522870|FGMS|fgms
108895|NCT03522844|mindfulness|mindfulness
108896|NCT03522844|escitalopram|escitalopram
108897|NCT03522844|anxiety|anxiety
108898|NCT03522831|dyspnea|dyspnea
108899|NCT03522831|exercise endurance|exercise endurance
108900|NCT03522831|lung disease|lung disease
108901|NCT03522805|copd|copd
108902|NCT03522805|lung|lung
108903|NCT03522805|non-invasive ventilation|non-invasive ventilation
108904|NCT03522805|hypercapnia|hypercapnia
108905|NCT03522805|hypoventilation|hypoventilation
108906|NCT03522792|food intake|food intake
108907|NCT03522792|appetite|appetite
108908|NCT03522792|obesity treatment|obesity treatment
108909|NCT03522792|neurotensin|neurotensin
108910|NCT03522792|gastrointestinal|gastrointestinal
108911|NCT03522792|peptide|peptide
108912|NCT03522740|Chronic Kidney Disease|chronic kidney disease
108913|NCT03522740|Chronic Kidney Failure|chronic kidney failure
108914|NCT03522740|Palliative Care|palliative care
108915|NCT03522740|Dialysis|dialysis
108916|NCT03522740|End-of-life care|end-of-life care
108917|NCT03522740|Decision making|decision making
108918|NCT03522714|support surface, pressure ulcer, flap closure|support surface, pressure ulcer, flap closure
108919|NCT03522701|Adolescents|adolescents
108920|NCT03522701|Youth|youth
108921|NCT03522701|Insomnia|insomnia
108922|NCT03522688|dexmedetomidine|dexmedetomidine
108923|NCT03522688|acute kidney injury|acute kidney injury
108924|NCT03522688|liver transplantation|liver transplantation
108925|NCT03522649|CRC|crc
108926|NCT03522636|Prehospital transfusion|prehospital transfusion
108927|NCT03522636|Trauma|trauma
108928|NCT03522636|Trauma induced coagulopathy|trauma induced coagulopathy
108929|NCT03522623|colitis|colitis
108930|NCT03522623|costs|costs
108931|NCT03522623|Crohn|crohn
108932|NCT03522623|IBD|ibd
108933|NCT03522610|Prevention|prevention
108934|NCT03522610|Military Families|military families
108935|NCT03522610|Parenting|parenting
108937|NCT03522597|Gestational Diabetes|gestational diabetes
108938|NCT03522597|Breast Milk|breast milk
108939|NCT03522597|Microbiome|microbiome
108940|NCT03522597|Infant Growth|infant growth
108941|NCT03522545|treatment-resistant bipolar depression|treatment-resistant bipolar depression
108942|NCT03522545|bipolar disorder|bipolar disorder
108943|NCT03522545|manic depression|manic depression
108944|NCT03522532|dental restorations|dental restorations
108945|NCT03522532|gingival crevicular fluid|gingival crevicular fluid
108946|NCT03522532|glutathione|glutathione
108947|NCT03522532|lipid peroxidation|lipid peroxidation
108948|NCT03522532|superoxide dismutase|superoxide dismutase
108949|NCT03522519|Physical Activity|physical activity
108950|NCT03522519|Upper Extremity|upper extremity
108951|NCT03522519|Movement Sensors|movement sensors
108952|NCT03522519|Prognosis|prognosis
108953|NCT03522519|Observational Cohort Study|observational cohort study
108954|NCT03522506|Drug Therapy|drug therapy
108955|NCT03522480|cystic fibrosis|cystic fibrosis
108956|NCT03522480|autogenic drainage|autogenic drainage
108957|NCT03522480|respiratory therapy|respiratory therapy
108958|NCT03522480|videogaming therapy|videogaming therapy
108959|NCT03522467|Cannabis oil|cannabis oil
108960|NCT03522467|Cannabis|cannabis
108961|NCT03522467|Pain|pain
108962|NCT03522467|Cancer|cancer
108963|NCT03522454|Frailty|frailty
108964|NCT03522454|TAVR|tavr
108965|NCT03522428|vitamin b12|vitamin b12
108966|NCT03522428|pregnancy|pregnancy
108967|NCT03522428|anemia|anemia
108968|NCT03522402|head position|head position
108969|NCT03522402|obstructive airway|obstructive airway
108970|NCT03522402|minimum alveolar concentration(MACendotracheal intubation)|minimum alveolar concentration(macendotracheal intubation)
108971|NCT03522402|sevoflurane concentration|sevoflurane concentration
108972|NCT03522389|Action Observation Training|action observation training
108973|NCT03522389|Gait|gait
108974|NCT03522363|oral health|oral health
108975|NCT03522363|Streptococcus dentisani|streptococcus dentisani
108976|NCT03522350|Infertility|infertility
108977|NCT03522350|Embryo develpoment|embryo develpoment
108978|NCT03522350|IVF|ivf
108979|NCT03522350|ICSI|icsi
108980|NCT03522350|EmbryoScope|embryoscope
108981|NCT03522337|preschool children|preschool children
108982|NCT03522337|special needs|special needs
108983|NCT03522337|tooth brushing|tooth brushing
108984|NCT03522337|social story|social story
108985|NCT03522337|visual pedagogy|visual pedagogy
108986|NCT03522324|Cannabis|cannabis
108987|NCT03522324|Pain|pain
108988|NCT03522324|Cytokines|cytokines
108989|NCT03522324|Inflammation|inflammation
108990|NCT03522324|Cognition|cognition
108991|NCT03522298|newly diagnosed|newly diagnosed
108992|NCT03522298|unmethylated O6 methylguanine-methyltransferase (MGMT) promoter status|unmethylated o6 methylguanine-methyltransferase (mgmt) promoter status
108993|NCT03522285|hip arthroplasty|hip arthroplasty
108994|NCT03522285|chronic renal diseases|chronic renal diseases
108995|NCT03522272|denture|denture
108996|NCT03522272|removable partial denture|removable partial denture
108997|NCT03522272|denture cleansers|denture cleansers
108998|NCT03522272|ultrasonics|ultrasonics
108999|NCT03522272|cetylpyridinium chloride|cetylpyridinium chloride
109000|NCT03522272|Staphylococcus aureus|staphylococcus aureus
109001|NCT03522272|Gram negative bacilli|gram negative bacilli
109002|NCT03522272|Candida|candida
109003|NCT03522272|yeast|yeast
109004|NCT03522259|Rivaroxaban|rivaroxaban
109005|NCT03522259|Thromboembolic prophylaxis|thromboembolic prophylaxis
109006|NCT03522259|Venous thromboembolism|venous thromboembolism
109007|NCT03522246|PARP inhibitor|parp inhibitor
109008|NCT03522246|PARPi|parpi
109009|NCT03522246|HRD|hrd
109010|NCT03522246|ATHENA|athena
109011|NCT03522246|homologous recombination|homologous recombination
109012|NCT03522246|DNA repair|dna repair
109013|NCT03522246|LOH|loh
109014|NCT03522246|DNA defect|dna defect
109015|NCT03522246|DNA anomaly|dna anomaly
109016|NCT03522246|Rucaparib|rucaparib
109017|NCT03522246|Nivolumab|nivolumab
109018|NCT03522246|PD-1|pd-1
109019|NCT03522246|Immuno-|immuno-
109020|NCT03522246|oncology|oncology
109021|NCT03522246|Tumor|tumor
109022|NCT03522246|mutational|mutational
109023|NCT03522246|burden|burden
109024|NCT03522246|BRCA|brca
109025|NCT03522246|First-line|first-line
109026|NCT03522246|Primary Therapy|primary therapy
109027|NCT03522246|Primary Treatment|primary treatment
109028|NCT03522155|Conjoint Analysis|conjoint analysis
109029|NCT03522155|Life Expectancy|life expectancy
109030|NCT03522155|Patient-centered|patient-centered
109031|NCT03522142|Advanced solid tumors|advanced solid tumors
109032|NCT03522142|AXL|axl
109033|NCT03522142|MER|mer
109034|NCT03522142|AXL/MER|axl/mer
109035|NCT03522129|Alzheimer's Disease|alzheimer's disease
109036|NCT03522103|Cannabis|cannabis
109037|NCT03522103|Marijuana|marijuana
109038|NCT03522103|Cognition|cognition
109039|NCT03522077|Angiogram|angiogram
109040|NCT03522077|Hemostatic|hemostatic
109041|NCT03522077|Activated clotting time|activated clotting time
109042|NCT03522077|Quality of Life|quality of life
109043|NCT03522064|Castrate-resistant prostate cancer|castrate-resistant prostate cancer
109044|NCT03522064|bipolar androgen therapy|bipolar androgen therapy
109045|NCT03522064|homologous recombination deficiency|homologous recombination deficiency
109046|NCT03522064|BRCA|brca
109047|NCT03522051|teeth|teeth
109048|NCT03522051|pulpitis|pulpitis
109049|NCT03522051|deep caries|deep caries
109050|NCT03522051|pulpotomy|pulpotomy
109051|NCT03522051|Mineral Trioxide Aggregate (MTA)|mineral trioxide aggregate (mta)
109052|NCT03522038|coronary chronic total occlusion|coronary chronic total occlusion
109053|NCT03522038|functional evaluation|functional evaluation
109054|NCT03522012|Pharmacokinetics|pharmacokinetics
109055|NCT03522012|Tocilizumab|tocilizumab
109056|NCT03521999|PTSD|ptsd
109057|NCT03521999|peer resource|peer resource
109058|NCT03521999|Veterans|veterans
109059|NCT03521999|web-based intervention|web-based intervention
109060|NCT03521999|digital story telling|digital story telling
109061|NCT03521986|Mediastinal Neoplasms|mediastinal neoplasms
109062|NCT03521986|Pain|pain
109063|NCT03521986|Quality of life|quality of life
109064|NCT03521973|Plasmodium falciparum|plasmodium falciparum
109065|NCT03521973|PfSPZ Vaccine|pfspz vaccine
109066|NCT03521960|Buspirone|buspirone
109067|NCT03521947|MCP|mcp
109068|NCT03521856|spinal cord injuries|spinal cord injuries
109069|NCT03521856|SCI|sci
109070|NCT03521843|femoropopliteal occlusive disease|femoropopliteal occlusive disease
109071|NCT03521843|local drug delivery|local drug delivery
109072|NCT03521843|endovascular treatment|endovascular treatment
109073|NCT03521804|Chronic Total Occlusion|chronic total occlusion
109074|NCT03521804|coronary|coronary
109075|NCT03521804|SoundBite™ Crossing System|soundbite™ crossing system
109076|NCT03521804|CTO|cto
109077|NCT03521804|distal cap|distal cap
109078|NCT03521804|true lumen|true lumen
109079|NCT03521804|Active wire|active wire
109080|NCT03521804|Device|device
109081|NCT03521804|Procedure|procedure
109082|NCT03521804|Stenosis|stenosis
109083|NCT03521804|CAD|cad
109084|NCT03521804|Coronary Artery Disease|coronary artery disease
109085|NCT03521791|zebesten|zebesten
109086|NCT03521791|ocular anti-inflammatory|ocular anti-inflammatory
109087|NCT03521791|ocular analgesic|ocular analgesic
109088|NCT03521791|pterygium|pterygium
109089|NCT03521791|anti-inflammatory non-steroidal ophthalmic|anti-inflammatory non-steroidal ophthalmic
109090|NCT03521765|quality of life|quality of life
109091|NCT03521765|occupational therapy|occupational therapy
109092|NCT03521752|BALANCE|balance
109093|NCT03521752|INSTITUTIONALIZED ELDERLY PEOPLE|institutionalized elderly people
109094|NCT03521752|THERAPEUTIC EXERCISE|therapeutic exercise
109095|NCT03521752|FUNCTIONAL CAPACITY|functional capacity
109096|NCT03521739|blood pressure|blood pressure
109097|NCT03521739|pulse wave velocity|pulse wave velocity
109098|NCT03521739|ankle brachial index|ankle brachial index
109099|NCT03521739|cardiovascular events|cardiovascular events
109100|NCT03521726|Rabeprazole|rabeprazole
109101|NCT03521726|Amoxicillin|amoxicillin
109102|NCT03521726|Helicobacter Pylori|helicobacter pylori
109103|NCT03521700|Renal Artery Obstruction|renal artery obstruction
109104|NCT03521700|Stents|stents
109105|NCT03521700|Glomerular filtration rate|glomerular filtration rate
109106|NCT03521687|Central centrifugal cicatricial alopecia|central centrifugal cicatricial alopecia
109107|NCT03521687|open-label pilot study|open-label pilot study
109108|NCT03521674|second trimester pregnancy termination|second trimester pregnancy termination
109109|NCT03521674|double-balloon catheter|double-balloon catheter
109110|NCT03521674|foley catheter|foley catheter
109111|NCT03521661|Vertebral fracture|vertebral fracture
109112|NCT03521661|Kyphotic deformity|kyphotic deformity
109113|NCT03521661|Kyphoplasty|kyphoplasty
109114|NCT03521661|Vertebroplasty|vertebroplasty
109115|NCT03521648|Prostatic Artery Embolization|prostatic artery embolization
109116|NCT03521648|Transurethral Prostate Resection|transurethral prostate resection
109117|NCT03521648|Transurethral Electroresection of Prostate|transurethral electroresection of prostate
109118|NCT03521648|Contact Laser Ablation of Prostate|contact laser ablation of prostate
109119|NCT03521648|Laser Enucleation of Prostate|laser enucleation of prostate
109120|NCT03521648|Open prostatectomy|open prostatectomy
109121|NCT03521622|counseling|counseling
109122|NCT03521622|behavioral therapy|behavioral therapy
109123|NCT03521622|tobacco|tobacco
109124|NCT03521622|alcohol drinking|alcohol drinking
109125|NCT03521596|IgM monoclonal gammopathy|igm monoclonal gammopathy
109126|NCT03521596|Waldenström's Macroglobulinemia|waldenström's macroglobulinemia
109127|NCT03521596|Minimal residual disease|minimal residual disease
109128|NCT03521596|Clonal evolution|clonal evolution
109129|NCT03521583|von Willebrand disease|von willebrand disease
109130|NCT03521583|von Willebrand factor|von willebrand factor
109131|NCT03521583|Nationwide study|nationwide study
109132|NCT03521583|Prospective study|prospective study
109133|NCT03521531|Quality of Life|quality of life
109134|NCT03521531|Sarcoma|sarcoma
109135|NCT03521531|Patient Reported Outcomes|patient reported outcomes
109136|NCT03521505|Sedation|sedation
109137|NCT03521505|dexmedetomidine|dexmedetomidine
109138|NCT03521505|brain perfusion|brain perfusion
109139|NCT03521505|bronchoscopy|bronchoscopy
109140|NCT03521492|Early childhood caries, Vitamin D deficiency, Parathyroid hormone, Calcium|early childhood caries, vitamin d deficiency, parathyroid hormone, calcium
109141|NCT03521479|Squaric Acid|squaric acid
109142|NCT03521479|SADBE|sadbe
109143|NCT03521479|Squaric acid dibutyl ester|squaric acid dibutyl ester
109144|NCT03521466|Smoking cessation counselling|smoking cessation counselling
109145|NCT03521466|Medical Student education|medical student education
109146|NCT03521466|India|india
109147|NCT03521440|Therapeutic relaxation|therapeutic relaxation
109148|NCT03521440|Elderly|elderly
109149|NCT03521440|Community dwelling|community dwelling
109150|NCT03521427|Intensive Therapy|intensive therapy
109151|NCT03521427|Cerebral Palsy|cerebral palsy
109152|NCT03521414|Bispectral index|bispectral index
109153|NCT03521414|Glasgow Coma Scale|glasgow coma scale
109154|NCT03521414|intracranial pathology|intracranial pathology
109155|NCT03521401|Adverse Childhood Experiences|adverse childhood experiences
109156|NCT03521401|Exercise Intervention|exercise intervention
109157|NCT03521401|Inflammation|inflammation
109158|NCT03521401|Resilience|resilience
109159|NCT03521401|Health|health
109160|NCT03521388|depression|depression
109161|NCT03521388|adolescence|adolescence
109162|NCT03521388|prevention|prevention
109163|NCT03521388|early intervention|early intervention
109164|NCT03521388|internet-based|internet-based
109165|NCT03521375|lung|lung
109166|NCT03521375|cancer|cancer
109167|NCT03521375|lobectomy|lobectomy
109168|NCT03521362|mHealth|mhealth
109169|NCT03521362|Adolescent|adolescent
109170|NCT03521349|Electroencephalography|electroencephalography
109171|NCT03521349|Executive Function|executive function
109172|NCT03521349|Egg|egg
109173|NCT03521349|Diet|diet
109174|NCT03521336|Spinal cord injury|spinal cord injury
109175|NCT03521336|Umbilical Cord Mesenchymal Stem Cells|umbilical cord mesenchymal stem cells
109176|NCT03521323|umbilical cord mesenchymal stem cells|umbilical cord mesenchymal stem cells
109177|NCT03521323|spinal cord injury|spinal cord injury
109178|NCT03521310|IPISTOSS|ipistoss
109179|NCT03521310|Skin to skin|skin to skin
109180|NCT03521310|SSC|ssc
109181|NCT03521310|Neonatal|neonatal
109182|NCT03521284|perinatal period|perinatal period
109183|NCT03521271|Duchenne Muscular Dystrophy|duchenne muscular dystrophy
109184|NCT03521271|Upper limb|upper limb
109185|NCT03521271|Hand functions|hand functions
109186|NCT03521271|Performance|performance
109187|NCT03521271|Grip Strength|grip strength
109188|NCT03521245|breast cancer|breast cancer
109189|NCT03521245|epidermal growth factor receptor|epidermal growth factor receptor
109190|NCT03521245|HER2|her2
109191|NCT03521245|EGFR|egfr
109192|NCT03521245|biomarkers|biomarkers
109193|NCT03521245|targeted therapy|targeted therapy
109194|NCT03521245|NGS|ngs
109195|NCT03521245|RNAseq|rnaseq
109196|NCT03521245|mRNA|mrna
109197|NCT03521245|transcriptome analysis|transcriptome analysis
109198|NCT03521245|signaling pathway|signaling pathway
109199|NCT03521245|intracellular molecular pathway|intracellular molecular pathway
109200|NCT03521245|Oncobox|oncobox
109201|NCT03521245|trastuzumab|trastuzumab
109202|NCT03521206|Advance directives|advance directives
109203|NCT03521206|Effectiveness|effectiveness
109204|NCT03521206|Process evaluation|process evaluation
109205|NCT03521206|Care staff|care staff
109206|NCT03521193|Migraine;|migraine;
109207|NCT03521193|PFO|pfo
109208|NCT03521193|platelet reactivity|platelet reactivity
109209|NCT03521193|aura|aura
109210|NCT03521180|Celiac Disease|celiac disease
109211|NCT03521180|Gluten|gluten
109212|NCT03521180|Immune Response|immune response
109213|NCT03521180|Challenge|challenge
109214|NCT03521154|Phase III|phase iii
109215|NCT03521154|Osimertinib|osimertinib
109216|NCT03521154|Non Small Cell Lung Cancer (Stage III)|non small cell lung cancer (stage iii)
109217|NCT03521154|Unresectable NSCLC|unresectable nsclc
109218|NCT03521154|EGFR|egfr
109219|NCT03521154|chemoradiation therapy|chemoradiation therapy
109220|NCT03521141|Tobacco Use Cessation|tobacco use cessation
109221|NCT03521141|Precision Medicine|precision medicine
109222|NCT03521089|Mild Cognitive Impairment (MCI)|mild cognitive impairment (mci)
109223|NCT03521089|Transcranial Direct Current Stimulation (tDCS)|transcranial direct current stimulation (tdcs)
109224|NCT03521076|Botulinum Toxin Injections|botulinum toxin injections
109225|NCT03521076|Virtual Reality|virtual reality
109226|NCT03521063|bronchopulmonary dysplasia|bronchopulmonary dysplasia
109227|NCT03521063|respiratory distress syndrome|respiratory distress syndrome
109228|NCT03521063|budesonide|budesonide
109229|NCT03521063|poractant alfa|poractant alfa
109230|NCT03521037|rucaparib|rucaparib
109231|NCT03521037|CO-338|co-338
109232|NCT03521037|Clovis|clovis
109233|NCT03521037|Clovis Oncology|clovis oncology
109234|NCT03521037|PARP inhibitor|parp inhibitor
109235|NCT03521037|hepatic impairment|hepatic impairment
109236|NCT03521024|Zirconia implants|zirconia implants
109237|NCT03521024|PEKK crowns|pekk crowns
109238|NCT03521024|high performance polymer crowns|high performance polymer crowns
109239|NCT03520985|refractory Multiple Myeloma|refractory multiple myeloma
109240|NCT03520985|Phase II|phase ii
109241|NCT03520985|Pomalidomide|pomalidomide
109242|NCT03520985|OptiPOM|optipom
109243|NCT03520959|Synovate Study|synovate study
109244|NCT03520959|NY-ESO-1|ny-eso-1
109245|NCT03520959|cancer vaccine|cancer vaccine
109246|NCT03520959|Sarcoma|sarcoma
109247|NCT03520959|soft tissue sarcoma|soft tissue sarcoma
109248|NCT03520959|immunotherapy|immunotherapy
109249|NCT03520946|colorectal cancer|colorectal cancer
109250|NCT03520946|ramucirumab|ramucirumab
109251|NCT03520946|tas102|tas102
109252|NCT03520933|Embryo|embryo
109253|NCT03520933|Blastocyst|blastocyst
109254|NCT03520933|Non-invasive|non-invasive
109255|NCT03520933|PGT-A|pgt-a
109256|NCT03520933|Chromosome|chromosome
109257|NCT03520933|Aneuploidy|aneuploidy
109258|NCT03520933|Spent culture medium|spent culture medium
109259|NCT03520933|Trophectoderm biopsy|trophectoderm biopsy
109260|NCT03520907|transversalis fascia|transversalis fascia
109261|NCT03520907|ilioinguinal/iliohypogastric nerve|ilioinguinal/iliohypogastric nerve
109262|NCT03520907|inguinal hernia repair|inguinal hernia repair
109263|NCT03520907|children|children
109264|NCT03520881|asthma|asthma
109265|NCT03520855|Type 1 Diabetes|type 1 diabetes
109266|NCT03520855|Paediatrics patients|paediatrics patients
109267|NCT03520816|Fibronectin|fibronectin
109268|NCT03520816|Prealbumin|prealbumin
109269|NCT03520816|Physiotherapy|physiotherapy
109270|NCT03520816|Major Burns|major burns
109271|NCT03520816|biochemical parameters|biochemical parameters
109272|NCT03520803|obesity|obesity
109273|NCT03520803|bariatric surgery|bariatric surgery
109274|NCT03520803|enhanced recovery after surgery|enhanced recovery after surgery
109275|NCT03520803|sleeve gastrectomy|sleeve gastrectomy
109276|NCT03520803|gastric bypass|gastric bypass
109277|NCT03520790|Pancreatic Cancer|pancreatic cancer
109278|NCT03520751|CMT1A|cmt1a
109279|NCT03520751|scAAV1.tMCK.NTF3|scaav1.tmck.ntf3
109280|NCT03520751|NTF3|ntf3
109281|NCT03520725|antioxidant capacity|antioxidant capacity
109282|NCT03520712|Hemophilia A|hemophilia a
109283|NCT03520712|Blood Coagulation Disorders, Inherited|blood coagulation disorders, inherited
109284|NCT03520712|Blood Coagulation Disorders|blood coagulation disorders
109285|NCT03520712|Hematologic Diseases|hematologic diseases
109286|NCT03520712|Coagulation Protein Disorders|coagulation protein disorders
109287|NCT03520712|Hemorrhagic Disorders|hemorrhagic disorders
109288|NCT03520712|Genetic Diseases, Inborn|genetic diseases, inborn
109289|NCT03520712|Factor VIII|factor viii
109290|NCT03520712|Coagulants|coagulants
109291|NCT03520712|AAV5 antibodies|aav5 antibodies
109292|NCT03520699|metabolic surgery|metabolic surgery
109293|NCT03520699|metabolic disease|metabolic disease
109294|NCT03520686|Pembrolizumab|pembrolizumab
109295|NCT03520686|N-803|n-803
109296|NCT03520686|Non-Small Cell Lung Cancer|non-small cell lung cancer
109297|NCT03520686|Immunotherapy|immunotherapy
109298|NCT03520673|Lower Urinary Tract Symptoms|lower urinary tract symptoms
109299|NCT03520673|Primary Care|primary care
109300|NCT03520673|Urology|urology
109301|NCT03520660|Natural History|natural history
139770|NCT03328637|CBT|cbt
109302|NCT03520660|Hepatitis C Virus|hepatitis c virus
109303|NCT03520660|Hepatocellular Carcinoma|hepatocellular carcinoma
109304|NCT03520660|Fibrosis|fibrosis
109305|NCT03520660|Immune Response|immune response
109306|NCT03520647|Haploidentical CD34+cells|haploidentical cd34+cells
109307|NCT03520647|Non-Myeloablative|non-myeloablative
109308|NCT03520634|Melanoma|melanoma
109309|NCT03520634|PD-L1|pd-l1
109310|NCT03520634|Brain metastases|brain metastases
109311|NCT03520634|PET imaging|pet imaging
109312|NCT03520621|sulfur amino acid|sulfur amino acid
109314|NCT03520556|DHA|dha
109315|NCT03520556|low-grade inflammation|low-grade inflammation
109316|NCT03520556|CRP|crp
109317|NCT03520556|IL-6|il-6
109318|NCT03520556|TNF-alpha|tnf-alpha
109319|NCT03520556|adiponectin|adiponectin
109320|NCT03520556|randomized controlled trials|randomized controlled trials
109321|NCT03520556|systematic review and meta-analysis|systematic review and meta-analysis
109322|NCT03520543|PET imaging|pet imaging
109323|NCT03520543|Noradrenaline|noradrenaline
109324|NCT03520543|Radiotracer|radiotracer
109325|NCT03520530|second stage|second stage
109326|NCT03520530|spontaneous vaginal delivery|spontaneous vaginal delivery
109327|NCT03520517|Amyotrophic Lateral Sclerosis|amyotrophic lateral sclerosis
109328|NCT03520517|ALS|als
109329|NCT03520517|Biohaven|biohaven
109330|NCT03520517|Motor Neuron Disease, Amyotrophic Lateral Sclerosis|motor neuron disease, amyotrophic lateral sclerosis
109331|NCT03520517|Lou Gehrig's Disease|lou gehrig's disease
109332|NCT03520517|Lou-Gehrigs Disease|lou-gehrigs disease
109333|NCT03520517|Lou Gehrig Disease|lou gehrig disease
109334|NCT03520517|Riluzole|riluzole
109335|NCT03520517|Rilutek®|rilutek®
109336|NCT03520517|Neuroprotective Agents|neuroprotective agents
109337|NCT03520517|Administration, Sublingual|administration, sublingual
109338|NCT03520517|Administration, Oral|administration, oral
109339|NCT03520517|Biological Availability|biological availability
109340|NCT03520504|Proton Radiation|proton radiation
109341|NCT03520504|craniospinal irradiation (CSI)|craniospinal irradiation (csi)
109343|NCT03520491|Immunotherapy|immunotherapy
109344|NCT03520491|Nivolumab|nivolumab
109345|NCT03520491|Ipilimumab|ipilimumab
109346|NCT03520491|18-042|18-042
109347|NCT03520478|Hormone sensitive prostate cancer|hormone sensitive prostate cancer
109348|NCT03520478|SHR3680|shr3680
109349|NCT03520478|Anti-androgen receptor|anti-androgen receptor
109350|NCT03520439|Adenomyosis|adenomyosis
109351|NCT03520439|mifepristone|mifepristone
109352|NCT03520439|the selective progesterone receptor modulators|the selective progesterone receptor modulators
109353|NCT03520439|treatment|treatment
109354|NCT03520413|Complex Care|complex care
109355|NCT03520413|Outcomes|outcomes
109356|NCT03520413|Telemedicine|telemedicine
109357|NCT03520413|Rural Health|rural health
109358|NCT03520413|Diabetes|diabetes
109359|NCT03520400|Cardiovascular Disease|cardiovascular disease
109360|NCT03520400|Percutaneous Intervention|percutaneous intervention
109361|NCT03520400|coronary artery disease|coronary artery disease
109362|NCT03520400|exercise therapy|exercise therapy
109363|NCT03520387|Randomized controlled trial|randomized controlled trial
109364|NCT03520387|Chronic pain|chronic pain
109365|NCT03520374|ultrasound|ultrasound
109366|NCT03520374|gastric contents|gastric contents
109367|NCT03520361|Colonoscopy|colonoscopy
109368|NCT03520361|Bowel preparation|bowel preparation
109369|NCT03520361|Oral sulfate solution|oral sulfate solution
109370|NCT03520361|Polyethylene glycol|polyethylene glycol
109371|NCT03520361|Ascorbic acid|ascorbic acid
109372|NCT03520348|dry eye|dry eye
109373|NCT03520348|eye lubricants|eye lubricants
109374|NCT03520348|eye lubricant gel|eye lubricant gel
109375|NCT03520348|PRO-167|pro-167
109376|NCT03520335|stroke|stroke
109377|NCT03520335|conjugated eye deviation|conjugated eye deviation
109378|NCT03520335|prehospital|prehospital
109379|NCT03520335|stroke scale|stroke scale
109380|NCT03520335|large vessel occlusion|large vessel occlusion
109381|NCT03520309|Diagnosis|diagnosis
109382|NCT03520309|Visual inspection|visual inspection
109383|NCT03520309|Quality of Life|quality of life
109384|NCT03520309|Restorations|restorations
109385|NCT03520244|Microbiome|microbiome
109386|NCT03520244|High intensity interval training|high intensity interval training
109387|NCT03520244|Exercise|exercise
109388|NCT03520244|Holistic education|holistic education
109389|NCT03520244|Quality of life|quality of life
109390|NCT03520244|Fatigue|fatigue
109391|NCT03520205|stress response|stress response
109392|NCT03520205|kidney donor|kidney donor
109393|NCT03520205|Cellular Imunological Function|cellular imunological function
109394|NCT03520205|quadratus lumborum block|quadratus lumborum block
109395|NCT03520205|numerical rating scale|numerical rating scale
109396|NCT03520205|morphine patient controlled analgesia|morphine patient controlled analgesia
109397|NCT03520192|Paediatric|paediatric
109398|NCT03520192|Critical care|critical care
109399|NCT03520192|Transport|transport
109400|NCT03520166|urgency|urgency
109401|NCT03520166|frequency|frequency
109402|NCT03520166|overactive bladder|overactive bladder
109403|NCT03520166|LUTS|luts
109404|NCT03520166|pelvic pain|pelvic pain
109405|NCT03520166|electrostimulation|electrostimulation
109406|NCT03520140|Familial hypercholesterolemia|familial hypercholesterolemia
109407|NCT03520140|Coronary artery disease|coronary artery disease
109408|NCT03520114|Retropubic sling|retropubic sling
109409|NCT03520114|Single-incision sling|single-incision sling
109410|NCT03520114|Vaginal repair|vaginal repair
109411|NCT03520114|Management|management
109412|NCT03520088|Rectal cancer|rectal cancer
109413|NCT03520088|Sexual dysfunction|sexual dysfunction
109414|NCT03520088|Urinary dysfunction|urinary dysfunction
109415|NCT03520088|Rectal nerves damage|rectal nerves damage
109416|NCT03520088|Total Mesorectal Excision|total mesorectal excision
109417|NCT03520075|Neoplasms|neoplasms
109418|NCT03520075|Solid Tumors|solid tumors
109419|NCT03520075|Antineoplastic Agents|antineoplastic agents
109420|NCT03520075|MAPK|mapk
109421|NCT03520075|ERK|erk
109422|NCT03520062|Amylase|amylase
109423|NCT03520062|Lipase|lipase
109424|NCT03520062|GLP-1|glp-1
109425|NCT03520049|Thrombocytopenia|thrombocytopenia
109426|NCT03520049|ITP|itp
109427|NCT03520049|Platelets|platelets
109428|NCT03520049|Bleeding|bleeding
109429|NCT03520049|Immune|immune
109430|NCT03520049|Oseltamivir|oseltamivir
109431|NCT03520049|Glycoprotein|glycoprotein
109432|NCT03520049|Sialylation|sialylation
109433|NCT03520049|Antibody|antibody
109434|NCT03520049|Autoantibody|autoantibody
109435|NCT03519971|Locally Advanced, Unresectable Non-small Cell Lung Cancer, NSCLC, Carcinoma, Non-Small-Cell Lung Cancer|locally advanced, unresectable non-small cell lung cancer, nsclc, carcinoma, non-small-cell lung cancer
109436|NCT03519945|Inflammatory Bowel Disease|inflammatory bowel disease
109437|NCT03519906|Bariatric surgery|bariatric surgery
109438|NCT03519906|Gastrointestinal tract|gastrointestinal tract
109439|NCT03519906|Biological availability|biological availability
109440|NCT03519906|Pharmacokinetics|pharmacokinetics
109441|NCT03519906|Metoprolol|metoprolol
109442|NCT03519893|Bariatric surgery|bariatric surgery
109443|NCT03519893|Gastrointestinal tract|gastrointestinal tract
109444|NCT03519893|Biological availability|biological availability
109445|NCT03519893|Pharmacokinetics|pharmacokinetics
109446|NCT03519893|Losartan|losartan
109447|NCT03519880|amyotrophic lateral sclerosis, non-invasive ventilation, mask, custom, 3D-printing|amyotrophic lateral sclerosis, non-invasive ventilation, mask, custom, 3d-printing
109448|NCT03519841|Non-invasive glucose monitoring|non-invasive glucose monitoring
109449|NCT03519841|Raman spectroscopy|raman spectroscopy
109450|NCT03519815|dry eye|dry eye
109451|NCT03519815|eye spray|eye spray
109452|NCT03519802|Cognitive functions|cognitive functions
109453|NCT03519802|MoCA test|moca test
109454|NCT03519789|Change blindness|change blindness
109455|NCT03519789|Eye tracking|eye tracking
109456|NCT03519789|Implicit response|implicit response
109457|NCT03519750|Melatonin|melatonin
109458|NCT03519750|Safety|safety
109459|NCT03519750|Pharmacokinetics|pharmacokinetics
109460|NCT03519737|Stroke|stroke
109461|NCT03519737|Acute Stroke|acute stroke
109462|NCT03519685|Contraception|contraception
109463|NCT03519685|Hormonal contraception|hormonal contraception
109464|NCT03519685|Long-acting reversible contraception|long-acting reversible contraception
109465|NCT03519685|Condoms|condoms
109466|NCT03519685|Emergency contraception|emergency contraception
109467|NCT03519685|Family planning services|family planning services
109468|NCT03519646|Enzyme Replacement Therapy|enzyme replacement therapy
109469|NCT03519646|Eliglustat (Cerdelga®)|eliglustat (cerdelga®)
109470|NCT03519607|Infertility|infertility
109471|NCT03519607|Distress|distress
109472|NCT03519607|Coping|coping
109474|NCT03519594|angioembolization|angioembolization
109475|NCT03519594|computed tomography|computed tomography
109476|NCT03519581|DME|dme
109477|NCT03519581|micropulse laser|micropulse laser
109478|NCT03519529|sex hormone-binding globulin|sex hormone-binding globulin
109479|NCT03519516|ocular antibiotic|ocular antibiotic
109480|NCT03519516|quinolone|quinolone
109481|NCT03519516|levofloxacin|levofloxacin
109482|NCT03519516|ophthalmic antibiotic|ophthalmic antibiotic
109483|NCT03519516|antibiotic in drops|antibiotic in drops
109484|NCT03519503|HIV|hiv
109485|NCT03519503|Neuropsychological tests|neuropsychological tests
109486|NCT03519503|PMTCT|pmtct
109487|NCT03519503|PreP|prep
109488|NCT03519490|Myopia|myopia
109489|NCT03519490|Myopia Control|myopia control
109490|NCT03519490|Bifocal Contact Lenses|bifocal contact lenses
109491|NCT03519490|Multifocal Contact Lenses|multifocal contact lenses
109492|NCT03519490|Hybrid Contact Lenses|hybrid contact lenses
109493|NCT03519490|Randomized Controlled Clinical Trial|randomized controlled clinical trial
109494|NCT03519490|Distance Center Multifocal Contact Lens|distance center multifocal contact lens
109495|NCT03519490|Near Center Multifocal Contact Lens|near center multifocal contact lens
109496|NCT03519477|clinical decision support|clinical decision support
109497|NCT03519477|drug levels in blood|drug levels in blood
109498|NCT03519477|therapeutic drug monitoring|therapeutic drug monitoring
109499|NCT03519477|medication adherence|medication adherence
109500|NCT03519477|medication therapy management|medication therapy management
109501|NCT03519464|Gardasil 9|gardasil 9
109502|NCT03519464|Seroconversion|seroconversion
109503|NCT03519464|Humoral immune response|humoral immune response
109504|NCT03519464|Cellular Immune Response|cellular immune response
109505|NCT03519464|Mucosal Lesions|mucosal lesions
109506|NCT03519425|Tuberculosis|tuberculosis
109507|NCT03519425|HIV|hiv
109508|NCT03519425|Randomised controlled trial|randomised controlled trial
109509|NCT03519425|Africa|africa
109510|NCT03519425|Public Health|public health
109511|NCT03519425|Screening|screening
109512|NCT03519412|DNA Mismatch Repair|dna mismatch repair
109513|NCT03519412|Pembrolizumab|pembrolizumab
109514|NCT03519399|Bile Acids, Fetal ECG, Stillbirth,|bile acids, fetal ecg, stillbirth,
109515|NCT03519360|arrythmia|arrythmia
109516|NCT03519360|hemodialysis|hemodialysis
109517|NCT03519347|arrythmia|arrythmia
109518|NCT03519347|hemodialysis|hemodialysis
109519|NCT03519334|Employment|employment
109520|NCT03519334|Return to work|return to work
109521|NCT03519334|Career Mobility|career mobility
109522|NCT03519334|Employment supported|employment supported
109523|NCT03519334|Workplace|workplace
109524|NCT03519334|Chronic disease|chronic disease
109525|NCT03519321|Early Onset Scoliosis (EOS)|early onset scoliosis (eos)
109526|NCT03519295|Epidermoid Cancers of the Anal Canal|epidermoid cancers of the anal canal
109527|NCT03519269|total knee replacement|total knee replacement
109528|NCT03519269|robotic surgery|robotic surgery
109529|NCT03519191|teen dating violence|teen dating violence
109530|NCT03519191|sexual assault|sexual assault
109531|NCT03519191|reproductive coercion|reproductive coercion
109532|NCT03519178|Hormone Receptor (HR) Positive Breast Cancer|hormone receptor (hr) positive breast cancer
109533|NCT03519178|Estrogen receptor (ER) positive|estrogen receptor (er) positive
109534|NCT03519178|Progesterone receptor (PR) positive|progesterone receptor (pr) positive
109535|NCT03519178|Cyclin-dependent kinase (CDK)|cyclin-dependent kinase (cdk)
109536|NCT03519178|Human epidermal growth factor receptor 2 (HER2) negative|human epidermal growth factor receptor 2 (her2) negative
109537|NCT03519178|Advanced breast cancer|advanced breast cancer
109538|NCT03519178|Metastatic breast cancer (MBC)|metastatic breast cancer (mbc)
109539|NCT03519178|Triple negative breast cancer (TNBC)|triple negative breast cancer (tnbc)
109540|NCT03519178|Epithelial ovarian cancer (EOC)|epithelial ovarian cancer (eoc)
109541|NCT03519178|Fallopian tube cancer|fallopian tube cancer
109542|NCT03519178|Primary peritoneal cancer (PPC)|primary peritoneal cancer (ppc)
109543|NCT03519178|CDK4/6 inhibitor|cdk4/6 inhibitor
109544|NCT03519178|Endocrine Therapy (ET)|endocrine therapy (et)
109545|NCT03519178|Measurable disease|measurable disease
109546|NCT03519178|Luteinizing Hormone Releasing Hormone (LHRH) Agonist|luteinizing hormone releasing hormone (lhrh) agonist
109547|NCT03519178|Goserelin|goserelin
109548|NCT03519178|Leuprolide acetate|leuprolide acetate
109549|NCT03519165|Ovarian cancer|ovarian cancer
109550|NCT03519165|goal-directed fluid therapy|goal-directed fluid therapy
109551|NCT03519165|SVV|svv
109552|NCT03519139|Geriatric patients, nutritional counselling, homevisit|geriatric patients, nutritional counselling, homevisit
109553|NCT03519126|Urinary Bladder, Overactive; Electric Stimulation|urinary bladder, overactive; electric stimulation
109554|NCT03519113|HBV-related liver transplantation|hbv-related liver transplantation
109555|NCT03519113|Hepatitis B immunoglobulin|hepatitis b immunoglobulin
109556|NCT03519035|borderline|borderline
109557|NCT03519035|hallucinations|hallucinations
109558|NCT03519035|dissociation|dissociation
109559|NCT03519035|post-traumatic stress disorder|post-traumatic stress disorder
109560|NCT03519009|Employment|employment
109561|NCT03518970|uncertainty|uncertainty
109562|NCT03518970|caregivers|caregivers
109563|NCT03518970|palliative care|palliative care
109564|NCT03518970|nursing|nursing
109565|NCT03518970|Hospice and Palliative Care Nursing|hospice and palliative care nursing
109566|NCT03518918|Premature ovarian insufficiency|premature ovarian insufficiency
109567|NCT03518918|Diagnosis standard|diagnosis standard
109568|NCT03518918|Risk factors|risk factors
109569|NCT03518892|Resting Metabolic Rate|resting metabolic rate
109570|NCT03518879|informatics|informatics
109571|NCT03518879|asthma|asthma
109572|NCT03518827|asymmetry|asymmetry
109573|NCT03518827|pain|pain
109574|NCT03518827|sport|sport
109575|NCT03518827|injury|injury
109576|NCT03518827|risk factor|risk factor
109577|NCT03518814|Melanoma stage IV|melanoma stage iv
109578|NCT03518814|Remission|remission
109579|NCT03518814|Quality of life|quality of life
109580|NCT03518801|cannabidiol|cannabidiol
109581|NCT03518801|CBD|cbd
109582|NCT03518801|PTSD|ptsd
109583|NCT03518801|Veterans|veterans
109584|NCT03518749|Depression|depression
109585|NCT03518749|transcranial direct current stimulation (tDCS)|transcranial direct current stimulation (tdcs)
109586|NCT03518723|Muscle dysfunction|muscle dysfunction
109587|NCT03518710|child|child
109588|NCT03518710|reading|reading
109589|NCT03518710|vision|vision
109590|NCT03518710|attention|attention
109591|NCT03518710|therapeutical perspectives|therapeutical perspectives
109592|NCT03518697|Exercise|exercise
109593|NCT03518697|Physical fitness|physical fitness
109594|NCT03518697|Physical activity|physical activity
109595|NCT03518697|Accelerometer|accelerometer
109596|NCT03518697|Sleep|sleep
109597|NCT03518671|head and neck cancer|head and neck cancer
109598|NCT03518671|body image disturbance|body image disturbance
109599|NCT03518671|cognitive behavioral therapy|cognitive behavioral therapy
109600|NCT03518671|survivorship|survivorship
109601|NCT03518658|remote monitoring|remote monitoring
109602|NCT03518658|transmission compliance|transmission compliance
109603|NCT03518658|patient engagement|patient engagement
109604|NCT03518645|Coronary Artery Disease|coronary artery disease
109605|NCT03518645|OPN NC|opn nc
109606|NCT03518645|Angina|angina
109607|NCT03518645|Stable|stable
109608|NCT03518645|Unstable|unstable
109609|NCT03518632|Exercise|exercise
109610|NCT03518632|Adapted physical activity|adapted physical activity
109611|NCT03518632|preoperative|preoperative
109612|NCT03518632|liver resection|liver resection
109613|NCT03518632|hepatectomy|hepatectomy
109614|NCT03518606|Advanced solid tumours|advanced solid tumours
109615|NCT03518606|Durvalumab|durvalumab
109616|NCT03518606|Tremelimumab|tremelimumab
109617|NCT03518606|Metronomic vinorelbine|metronomic vinorelbine
109618|NCT03518606|High mutational load malignancies|high mutational load malignancies
109619|NCT03518606|Immunotherapy|immunotherapy
109620|NCT03518606|Early phase|early phase
109621|NCT03518606|Combination study|combination study
109622|NCT03518580|mobile technology|mobile technology
109623|NCT03518580|real-time assessment|real-time assessment
109624|NCT03518580|active life engagement|active life engagement
109625|NCT03518554|JAB-3068|jab-3068
109626|NCT03518554|SHP2|shp2
109627|NCT03518554|advanced solid tumor|advanced solid tumor
109628|NCT03518554|NSCLC|nsclc
109629|NCT03518554|ESCC|escc
109630|NCT03518554|HNSCC|hnscc
109631|NCT03518554|PTPN11|ptpn11
109632|NCT03518554|EGFR|egfr
109633|NCT03518554|Colorectal cancer|colorectal cancer
109634|NCT03518515|nutrition intervention|nutrition intervention
109635|NCT03518515|potato consumption|potato consumption
109829|NCT03517436|CENTERA|centera
109640|NCT03518424|Association football|association football
109642|NCT03518424|Injury|injury
109643|NCT03518424|Epidemiology|epidemiology
109644|NCT03518398|Intense pulsed light|intense pulsed light
109645|NCT03518398|Meibomian gland dysfunction|meibomian gland dysfunction
109646|NCT03518398|Dry eye|dry eye
109647|NCT03518398|cytokines|cytokines
109648|NCT03518372|Hypoxia|hypoxia
109649|NCT03518372|Myocardial Injury|myocardial injury
109650|NCT03518372|Surgery--Complications|surgery--complications
109651|NCT03518372|Tissue Oximetry|tissue oximetry
109652|NCT03518372|Near-infrared Spectroscopy (NIRS)|near-infrared spectroscopy (nirs)
109653|NCT03518359|Residents|residents
109654|NCT03518359|Stress|stress
109655|NCT03518359|Well-being|well-being
109656|NCT03518320|Bladder Cancer|bladder cancer
109657|NCT03518320|Urothelial Carcinoma|urothelial carcinoma
109658|NCT03518320|Cystectomy|cystectomy
109659|NCT03518320|Radical Cystectomy|radical cystectomy
109660|NCT03518307|Merkel carcinoma|merkel carcinoma
109661|NCT03518294|NAFLD|nafld
109662|NCT03518294|NASH|nash
109663|NCT03518268|probiotics|probiotics
109664|NCT03518268|aromatase inhibitors|aromatase inhibitors
109665|NCT03518268|bone mass|bone mass
109666|NCT03518268|postmenopausal|postmenopausal
109667|NCT03518255|Nursing Care|nursing care
109668|NCT03518255|Complementary therapies|complementary therapies
109669|NCT03518255|Oncological Nursing|oncological nursing
109670|NCT03518255|Photography|photography
109671|NCT03518229|cancer prevention|cancer prevention
109672|NCT03518229|sunburn|sunburn
109673|NCT03518216|cognitive behavioral therapy|cognitive behavioral therapy
109674|NCT03518216|mindfulness meditation|mindfulness meditation
109675|NCT03518216|fMRI|fmri
109676|NCT03518216|neuroimaging|neuroimaging
109677|NCT03518203|Hematopoietic Stem Cell Transplant|hematopoietic stem cell transplant
109678|NCT03518151|public health|public health
109679|NCT03518151|dietary inequalities|dietary inequalities
109680|NCT03518151|environment design|environment design
109681|NCT03518125|Anthrax|anthrax
109682|NCT03518125|Bacillaceae Infections|bacillaceae infections
109683|NCT03518125|Gram-Positive Bacterial Infections|gram-positive bacterial infections
109684|NCT03518125|Bacterial Infections|bacterial infections
109685|NCT03518125|Anthrax Vaccine Adsorbed|anthrax vaccine adsorbed
109686|NCT03518125|BioThrax|biothrax
109687|NCT03518125|AV7909|av7909
109688|NCT03518125|CPG 7909|cpg 7909
109689|NCT03518125|Adjuvant|adjuvant
109690|NCT03518125|Vaccines|vaccines
109691|NCT03518125|Post-exposure Prophylaxis|post-exposure prophylaxis
109692|NCT03518086|Interleukin-23 (IL-23) antibody|interleukin-23 (il-23) antibody
109693|NCT03518086|IL-23p19|il-23p19
109694|NCT03518073|Memory problems|memory problems
109695|NCT03518073|Cognitive impairment|cognitive impairment
109696|NCT03518073|PERISCOPE-ALZ|periscope-alz
109697|NCT03518073|Dementia|dementia
109698|NCT03518073|Tauopathy|tauopathy
109699|NCT03518073|Neurofibrillary tangles|neurofibrillary tangles
109700|NCT03518060|2 drug regimen|2 drug regimen
109701|NCT03518060|Juluca|juluca
109702|NCT03518060|Rilpivirine|rilpivirine
109703|NCT03518060|Dolutegravir|dolutegravir
109704|NCT03518060|Antiretroviral|antiretroviral
109705|NCT03518060|One pill regimen|one pill regimen
109706|NCT03518047|Plaque Psoriasis|plaque psoriasis
109711|NCT03518021|Naloxone|naloxone
109712|NCT03518021|Administration, Intranasal|administration, intranasal
109713|NCT03518021|Injections, Intramuscular|injections, intramuscular
109714|NCT03518021|Narcotic Antagonists|narcotic antagonists
109715|NCT03518008|soft contact lenses|soft contact lenses
109716|NCT03518008|vision|vision
109717|NCT03518008|eyesight|eyesight
109718|NCT03517995|primary bladder tumor|primary bladder tumor
109719|NCT03517995|non-muscle invasive bladder tumor|non-muscle invasive bladder tumor
109720|NCT03517995|muscle invasive bladder tumor|muscle invasive bladder tumor
109721|NCT03517995|sulforaphane|sulforaphane
109722|NCT03517995|chemoprevention|chemoprevention
109723|NCT03517982|MyOra|myora
109724|NCT03517982|Mycophenolate Mofetil|mycophenolate mofetil
109725|NCT03517982|End stage renal disease|end stage renal disease
109726|NCT03517982|De novo Renal transplant|de novo renal transplant
109727|NCT03517982|Post authorization safety study|post authorization safety study
109728|NCT03517982|Immunosuppressant|immunosuppressant
109729|NCT03517982|Cohort study|cohort study
109730|NCT03517956|Phase I|phase i
109731|NCT03517956|Locally advanced or metastatic solid tumor|locally advanced or metastatic solid tumor
109732|NCT03517956|Urothelial cancer|urothelial cancer
109733|NCT03517956|FGFR inhibitor|fgfr inhibitor
109734|NCT03517943|Upper respiratory allergy symptoms including congestion|upper respiratory allergy symptoms including congestion
109927|NCT03516890|Staged|staged
109735|NCT03517930|Upper respiratory allergy symptoms including congestion|upper respiratory allergy symptoms including congestion
109736|NCT03517904|Femoropopliteal artery disease, drug-coated balloon, angioplasty, antiplatelet therapy|femoropopliteal artery disease, drug-coated balloon, angioplasty, antiplatelet therapy
109737|NCT03517891|Physical activity|physical activity
109738|NCT03517891|Sleep pattern|sleep pattern
109739|NCT03517891|Nutrition|nutrition
109740|NCT03517891|Education|education
109741|NCT03517878|Community Health Worker|community health worker
109742|NCT03517878|Pregnancy|pregnancy
109743|NCT03517878|Breast Feeding|breast feeding
109744|NCT03517878|Child Development|child development
109745|NCT03517878|Home Visits|home visits
109746|NCT03517878|Infants|infants
109747|NCT03517839|Dyspnea|dyspnea
109748|NCT03517839|Inspiratory Muscle Training|inspiratory muscle training
109749|NCT03517839|Kinesiophobia|kinesiophobia
109750|NCT03517826|COPD|copd
109751|NCT03517826|Dyspnea|dyspnea
109752|NCT03517826|Kinesiophobia|kinesiophobia
109753|NCT03517800|Embolization|embolization
109754|NCT03517800|surgery|surgery
109755|NCT03517800|hysterectomy|hysterectomy
109756|NCT03517800|arterial ligation|arterial ligation
109757|NCT03517761|CCJ|ccj
109758|NCT03517761|Bone Marrow Concentrate|bone marrow concentrate
109759|NCT03517761|Stem Cell Therapy|stem cell therapy
109760|NCT03517761|Alar Ligament|alar ligament
109761|NCT03517761|Transverse Ligament|transverse ligament
109762|NCT03517670|Cerebral vasospasm|cerebral vasospasm
109763|NCT03517670|Subarachnoid hemorrhage|subarachnoid hemorrhage
109764|NCT03517670|Milrinone|milrinone
109765|NCT03517670|Hemodynamic tolerance|hemodynamic tolerance
109766|NCT03517657|upper limb|upper limb
109767|NCT03517657|occupational therapy|occupational therapy
109768|NCT03517657|bilateral priming|bilateral priming
109769|NCT03517631|HIV|hiv
109770|NCT03517631|AIDS|aids
109771|NCT03517631|Lentivirus|lentivirus
109772|NCT03517631|shRNA|shrna
109773|NCT03517631|Multiplex|multiplex
109774|NCT03517631|Gene therapy|gene therapy
109775|NCT03517618|A phase II study|a phase ii study
109776|NCT03517618|Heavily pre-treated metastatic colorectal cancer|heavily pre-treated metastatic colorectal cancer
109777|NCT03517618|S-1|s-1
109778|NCT03517618|oral leucovrin|oral leucovrin
109779|NCT03517605|Cardiac Rehabilitation|cardiac rehabilitation
109780|NCT03517605|Quality of Life|quality of life
109781|NCT03517605|Rehabilitation Nursing|rehabilitation nursing
109782|NCT03517566|atopic dermatitis, AD, eczema, atopic eczema, itch, pruritus, histamine 4 receptor|atopic dermatitis, ad, eczema, atopic eczema, itch, pruritus, histamine 4 receptor
109783|NCT03517566|antagonist, H4R, ZPL389, ZPL389A2203, dermatitis|antagonist, h4r, zpl389, zpl389a2203, dermatitis
109784|NCT03517553|electrical muscle stimulation|electrical muscle stimulation
109785|NCT03517540|Steatohepatitis|steatohepatitis
109786|NCT03517540|NASH|nash
109787|NCT03517540|NAFLD|nafld
109788|NCT03517540|Fatty Liver Disease|fatty liver disease
109789|NCT03517540|Liver|liver
109790|NCT03517527|Type 2 Diabetes Mellitus|type 2 diabetes mellitus
109791|NCT03517527|Metabolic Control|metabolic control
109792|NCT03517527|Walking Exercise|walking exercise
109793|NCT03517527|Transtheoretical Model|transtheoretical model
109794|NCT03517527|Nurse|nurse
109795|NCT03517514|Heart Failure|heart failure
109796|NCT03517514|Physical Therapy|physical therapy
109797|NCT03517514|Hospital Readmission|hospital readmission
109798|NCT03517488|DUET-2|duet-2
109799|NCT03517488|Melanoma|melanoma
109800|NCT03517488|Triple Negative Breast Cancer|triple negative breast cancer
109801|NCT03517488|Hepatocellular Cancer|hepatocellular cancer
109802|NCT03517488|Urothelial Cancer|urothelial cancer
109803|NCT03517488|Bladder Cancer|bladder cancer
109804|NCT03517488|Renal Cell Cancer|renal cell cancer
109805|NCT03517488|Head and Neck Cancer|head and neck cancer
109806|NCT03517488|MSI-high Colorectal Cancer|msi-high colorectal cancer
109807|NCT03517488|MSI-high Endometrial Cancer|msi-high endometrial cancer
109808|NCT03517488|Non-small Cell Lung Cancer|non-small cell lung cancer
109809|NCT03517488|Gastric Cancer|gastric cancer
109810|NCT03517488|Gastroesophageal Junction Cancer|gastroesophageal junction cancer
109811|NCT03517488|Mesothelioma|mesothelioma
109812|NCT03517488|High-grade Neuroendocrine Cancer|high-grade neuroendocrine cancer
109813|NCT03517488|Cervical Cancer|cervical cancer
109814|NCT03517488|Small Cell Lung Cancer|small cell lung cancer
109815|NCT03517488|Anal Cancer|anal cancer
109816|NCT03517462|mass drug administration|mass drug administration
109817|NCT03517462|ophthalmology|ophthalmology
109818|NCT03517449|programmed cell death 1 (PD-1, PD1)|programmed cell death 1 (pd-1, pd1)
109819|NCT03517449|programmed cell death ligand 1 (PD-L1, PDL1)|programmed cell death ligand 1 (pd-l1, pdl1)
109820|NCT03517449|programmed cell death ligand 2 (PD-L2, PDL2)|programmed cell death ligand 2 (pd-l2, pdl2)
109821|NCT03517449|vascular endothelial growth factor (VEGF) receptors|vascular endothelial growth factor (vegf) receptors
109822|NCT03517449|lenvatinib|lenvatinib
109823|NCT03517449|pembrolizumab|pembrolizumab
109824|NCT03517449|doxorubicin|doxorubicin
109825|NCT03517449|paclitaxel|paclitaxel
109826|NCT03517449|phase 3 endometrial cancer|phase 3 endometrial cancer
109827|NCT03517436|THV|thv
109828|NCT03517436|Transcatheter Heart Valve|transcatheter heart valve
109830|NCT03517436|self-expanding|self-expanding
109831|NCT03517423|brivaracetam|brivaracetam
109832|NCT03517423|post-marketing observational study|post-marketing observational study
109833|NCT03517410|Mechanical Low Back Pain|mechanical low back pain
109834|NCT03517410|Smart phone|smart phone
109835|NCT03517410|Low Back Pain|low back pain
109836|NCT03517410|Chronic Mechanical Low Back Pain|chronic mechanical low back pain
109837|NCT03517410|CLBP|clbp
109838|NCT03517397|Smoking Cessation|smoking cessation
109839|NCT03517397|Socioeconomic Disadvantage|socioeconomic disadvantage
109840|NCT03517397|Contingency Management|contingency management
109841|NCT03517397|Financial Incentives|financial incentives
109842|NCT03517397|Mobile Health|mobile health
109843|NCT03517397|Biochemical Verification|biochemical verification
109844|NCT03517371|Parkinson disease|parkinson disease
109845|NCT03517371|Walking|walking
109846|NCT03517371|Exercise|exercise
109847|NCT03517371|Mobile Health|mobile health
109848|NCT03517371|Physical Therapy|physical therapy
109849|NCT03517371|Cognitive Behavioral|cognitive behavioral
109850|NCT03517345|Bariatric surgery|bariatric surgery
109851|NCT03517345|Prebiotics|prebiotics
109852|NCT03517345|gut microbiota|gut microbiota
109853|NCT03517345|GLP-1|glp-1
109854|NCT03517345|PYY|pyy
109855|NCT03517306|lung cancer, FDG, PET/CT, radiomics|lung cancer, fdg, pet/ct, radiomics
109856|NCT03517280|Malnutrition|malnutrition
109857|NCT03517280|Childhood Cancer|childhood cancer
109858|NCT03517280|Nutrition Aspect of Cancer|nutrition aspect of cancer
109859|NCT03517280|Child Malnutrition|child malnutrition
109860|NCT03517280|Brazil|brazil
109861|NCT03517280|Sao Paolo|sao paolo
109862|NCT03517254|Glutamine,|glutamine,
109863|NCT03517228|Robotic Uterine Manipulator|robotic uterine manipulator
109864|NCT03517228|18-173|18-173
109865|NCT03517202|Urologic surgery|urologic surgery
109866|NCT03517202|Urinary incontinence|urinary incontinence
109867|NCT03517202|Tension Free Vaginal Tape|tension free vaginal tape
109868|NCT03517202|Post-operative urinary retention|post-operative urinary retention
109869|NCT03517202|Outpatient surgery|outpatient surgery
109870|NCT03517163|Asperger's|asperger's
109871|NCT03517163|autism|autism
109872|NCT03517163|autism spectrum disorder|autism spectrum disorder
109873|NCT03517163|ASD|asd
109874|NCT03517137|advanced Hodgkin lymphoma|advanced hodgkin lymphoma
109875|NCT03517137|brentuximab vedotin|brentuximab vedotin
109876|NCT03517137|phase 2|phase 2
109877|NCT03517124|Zirconium oxide|zirconium oxide
109878|NCT03517124|surface treatment|surface treatment
109879|NCT03517124|resin cement|resin cement
109880|NCT03517098|Enhanced recovery after surgery|enhanced recovery after surgery
109881|NCT03517098|General anesthesia|general anesthesia
109882|NCT03517098|Total hip arthroplasty|total hip arthroplasty
109883|NCT03517098|Total knee arthroplasty|total knee arthroplasty
109884|NCT03517085|glycogen storage disorder Ia|glycogen storage disorder ia
109885|NCT03517085|AAV|aav
109886|NCT03517085|gene therapy|gene therapy
109887|NCT03517085|von Gierke disease|von gierke disease
109888|NCT03517085|glucose metabolism disorder|glucose metabolism disorder
109889|NCT03517059|Levodopa|levodopa
109890|NCT03517059|axial symptoms|axial symptoms
109891|NCT03517046|Arthritis|arthritis
109892|NCT03517046|Articular Cartilage|articular cartilage
109893|NCT03517046|Autologous Chondrocyte Implantation|autologous chondrocyte implantation
109894|NCT03517046|Degenerative Arthritis|degenerative arthritis
109895|NCT03517046|Cartilage Lesion|cartilage lesion
109896|NCT03517046|Cartilage Defect|cartilage defect
109897|NCT03517007|antibiotic de-escalation|antibiotic de-escalation
109898|NCT03517007|sepsis|sepsis
109899|NCT03517007|antimicrobial stewardship|antimicrobial stewardship
109900|NCT03516994|Advance Care Planning|advance care planning
109901|NCT03516994|Disparities|disparities
109902|NCT03516994|Palliative Care|palliative care
109903|NCT03516994|End of Life Care|end of life care
109904|NCT03516994|African Americans|african americans
109905|NCT03516981|Programmed Cell Death-1 (PD1, PD-1)|programmed cell death-1 (pd1, pd-1)
109906|NCT03516981|Programmed Death-Ligand 1 (PDL1, PD-L1)|programmed death-ligand 1 (pdl1, pd-l1)
109907|NCT03516968|Obesity|obesity
109908|NCT03516968|Vitamin D deficiency,|vitamin d deficiency,
109909|NCT03516968|supplementation,|supplementation,
109910|NCT03516968|Child|child
109911|NCT03516968|Adolescent|adolescent
109912|NCT03516955|Superstat|superstat
109913|NCT03516955|Rosuvastatin|rosuvastatin
109914|NCT03516955|Statins|statins
109915|NCT03516955|LDL-C|ldl-c
109916|NCT03516955|Cholesterol|cholesterol
109917|NCT03516955|Hypercholesterolemia|hypercholesterolemia
109918|NCT03516955|Dyslipidemia|dyslipidemia
109919|NCT03516955|Coronary Artery Disease|coronary artery disease
109920|NCT03516955|Cardiovascular Disease|cardiovascular disease
109921|NCT03516916|Rectal cancer, HRQoL, Stoma, Colostomy, Patient reported outcome measure (PROM)|rectal cancer, hrqol, stoma, colostomy, patient reported outcome measure (prom)
109922|NCT03516903|Anterior myocardial infarction|anterior myocardial infarction
109923|NCT03516903|Methotrexate|methotrexate
109924|NCT03516903|Myocardial remodeling|myocardial remodeling
109925|NCT03516890|Partial hepatectomy|partial hepatectomy
109926|NCT03516890|Emergency|emergency
109928|NCT03516890|Peritoneal dissemination|peritoneal dissemination
109929|NCT03516890|Propensity score matching|propensity score matching
109930|NCT03516877|Mindfulness-Bases Stress Reduction, Stress, Resilience, Well-being|mindfulness-bases stress reduction, stress, resilience, well-being
109931|NCT03516864|tissue oxygenation|tissue oxygenation
109932|NCT03516864|near-infrared|near-infrared
109933|NCT03516864|diabetic foot ulcer (DFU)|diabetic foot ulcer (dfu)
109934|NCT03516864|diabetes|diabetes
109935|NCT03516864|vascularity|vascularity
109936|NCT03516851|Moyamoya Disease|moyamoya disease
109937|NCT03516851|multimodal neuronavigation|multimodal neuronavigation
109938|NCT03516851|flow800|flow800
109939|NCT03516851|direct revascularization|direct revascularization
109940|NCT03516838|Dental caries|dental caries
109941|NCT03516838|Class II|class ii
109942|NCT03516838|Primary molar|primary molar
109943|NCT03516838|Restorative material|restorative material
109944|NCT03516838|Bioactive material|bioactive material
109945|NCT03516838|Compomer|compomer
109946|NCT03516838|Activa bioactive|activa bioactive
109947|NCT03516838|Ryge criteria|ryge criteria
109948|NCT03516825|Musical Neglect Training|musical neglect training
109949|NCT03516825|Neurologic Music Therapy|neurologic music therapy
109950|NCT03516825|unilateral visual neglect|unilateral visual neglect
109951|NCT03516825|hemispatial neglect|hemispatial neglect
109952|NCT03516825|stroke|stroke
109953|NCT03516825|spatial perception and attention|spatial perception and attention
109954|NCT03516825|music therapy|music therapy
109955|NCT03516799|pain management of adolescent and young adults with cancer|pain management of adolescent and young adults with cancer
109956|NCT03516773|Hypoparathyroidism, PTH(1-34), Parathyroid Hormone|hypoparathyroidism, pth(1-34), parathyroid hormone
109957|NCT03516747|cytology|cytology
109958|NCT03516747|parathyroidectomy|parathyroidectomy
109959|NCT03516747|parathyroid hormone level|parathyroid hormone level
109960|NCT03516734|Iron deficiency|iron deficiency
109961|NCT03516734|Food-based dietary intervention|food-based dietary intervention
109962|NCT03516695|Registry|registry
109963|NCT03516695|Liver Cancers|liver cancers
109964|NCT03516695|HCC|hcc
109965|NCT03516695|Dosimetry|dosimetry
109966|NCT03516695|Simplicit90Y™|simplicit90y™
109967|NCT03516695|TheraSphere®|therasphere®
109968|NCT03516682|Logistic Barriers to Vaccination|logistic barriers to vaccination
109969|NCT03516669|Lansoprazole, Amoxicillin, clarithromycin|lansoprazole, amoxicillin, clarithromycin
109970|NCT03516630|Trazodone|trazodone
109971|NCT03516630|QTc interval|qtc interval
109972|NCT03516630|Moxifloxacin|moxifloxacin
109973|NCT03516578|non-ST-elevation myocardial infarction|non-st-elevation myocardial infarction
109974|NCT03516578|cardiac magnetic resonance|cardiac magnetic resonance
109975|NCT03516578|prognosis|prognosis
109976|NCT03516565|gingivitis|gingivitis
109977|NCT03516565|saliva|saliva
109978|NCT03516565|gingival crevicular fluid|gingival crevicular fluid
109979|NCT03516539|Videolaryngoscopy|videolaryngoscopy
109980|NCT03516526|natalizumab|natalizumab
109981|NCT03516487|PKU|pku
109982|NCT03516474|nir|nir
109983|NCT03516474|diabetes|diabetes
109984|NCT03516474|diabetic foot ulcer (DFU).|diabetic foot ulcer (dfu).
109985|NCT03516474|wound|wound
109986|NCT03516461|Gut Microbiota|gut microbiota
109987|NCT03516461|Radiation Enteritis|radiation enteritis
109988|NCT03516461|Selective Microbiota Transplantation|selective microbiota transplantation
109989|NCT03516461|Fecal Microbiota Transplantation|fecal microbiota transplantation
109990|NCT03516435|Intravaginal electrical stimulation|intravaginal electrical stimulation
109991|NCT03516435|Parasacral transcutaneous electrical stimulation|parasacral transcutaneous electrical stimulation
109992|NCT03516422|ultrasound debridement|ultrasound debridement
109993|NCT03516422|diabetic foot ulcer|diabetic foot ulcer
109994|NCT03516422|chronic wound|chronic wound
109995|NCT03516422|biofilm|biofilm
109996|NCT03516409|probiotics|probiotics
109997|NCT03516409|prebiotics|prebiotics
109998|NCT03516409|diarrhoea|diarrhoea
109999|NCT03516396|Nepal|nepal
110000|NCT03516396|child growth|child growth
110001|NCT03516396|nutrition education|nutrition education
110002|NCT03516396|community development|community development
110003|NCT03516370|chronic periodontitis|chronic periodontitis
110004|NCT03516370|Sacchraomyces boulardii|sacchraomyces boulardii
110005|NCT03516370|probiotics|probiotics
110006|NCT03516344|Breathing Exercises|breathing exercises
110007|NCT03516344|Manipulation, Osteopathic|manipulation, osteopathic
110008|NCT03516344|Quantitative Ultrasonography|quantitative ultrasonography
110009|NCT03516344|Therapy, Soft Tissue|therapy, soft tissue
110010|NCT03516344|Portal Vein|portal vein
110011|NCT03516344|Venous flow|venous flow
110012|NCT03516331|Cystic Fibrosis|cystic fibrosis
110013|NCT03516318|HIV|hiv
110014|NCT03516318|Youth|youth
110015|NCT03516318|Social support|social support
110016|NCT03516318|Social media|social media
110017|NCT03516318|Retention|retention
110018|NCT03516292|overactive bladder|overactive bladder
110019|NCT03516292|biomarker|biomarker
110020|NCT03516292|nerve growth factor|nerve growth factor
110021|NCT03516292|vaginal prolapse|vaginal prolapse
110022|NCT03516292|urinary incontinence|urinary incontinence
110277|NCT03514680|Cancer Care|cancer care
110023|NCT03516266|Pelvic floor muscle strength|pelvic floor muscle strength
110024|NCT03516266|Premenopausal nullipara|premenopausal nullipara
110025|NCT03516266|Childbirth|childbirth
110026|NCT03516266|Postmenopausal|postmenopausal
110027|NCT03516214|acquired resistance|acquired resistance
110028|NCT03516214|EGFR p.T790M-positive|egfr p.t790m-positive
110029|NCT03516214|osimertinib resistance|osimertinib resistance
110030|NCT03516214|EGFR p.T790M-negative|egfr p.t790m-negative
110031|NCT03516201|bariatric surgery|bariatric surgery
110032|NCT03516201|Periodontitis|periodontitis
110033|NCT03516201|Caries|caries
110034|NCT03516201|erosive tooth wear|erosive tooth wear
110035|NCT03516201|Gingivitis|gingivitis
110036|NCT03516201|BMI|bmi
110037|NCT03516201|oral health|oral health
110038|NCT03516201|obesity|obesity
110039|NCT03516188|Gastroesophageal Reflux Disease|gastroesophageal reflux disease
110040|NCT03516188|Acid pocket|acid pocket
110041|NCT03516188|Acid Reflux|acid reflux
110042|NCT03516188|Alginate antacid|alginate antacid
110043|NCT03516188|Obesity|obesity
110044|NCT03516162|Behaviour|behaviour
110045|NCT03516162|Brain Tumor|brain tumor
110046|NCT03516162|Hydrocephalus|hydrocephalus
110047|NCT03516162|Smartphone|smartphone
110048|NCT03516162|Big Data|big data
110049|NCT03516162|Neuropsychology|neuropsychology
110050|NCT03516162|Neuroradiology|neuroradiology
110051|NCT03516162|Neurosurgery|neurosurgery
110052|NCT03516162|Outcome Assessment|outcome assessment
110053|NCT03516162|Functional Impairment|functional impairment
110054|NCT03516162|Cognitive Function|cognitive function
110055|NCT03516162|Touchscreen|touchscreen
110056|NCT03516162|Arteriovenous malformation|arteriovenous malformation
110057|NCT03516162|AVM|avm
110058|NCT03516149|elbow|elbow
110059|NCT03516149|foam rolling|foam rolling
110060|NCT03516149|proprioception|proprioception
110061|NCT03516149|sensorimotor|sensorimotor
110062|NCT03516149|acute|acute
110063|NCT03516071|Hepatocellular Carcinoma|hepatocellular carcinoma
110064|NCT03516071|HCC|hcc
110065|NCT03516071|Brivanib|brivanib
110066|NCT03516045|18F-AlF-NOTA-neurotensin|18f-alf-nota-neurotensin
110067|NCT03516032|exercises therapy|exercises therapy
110068|NCT03516032|rehabilitation|rehabilitation
110069|NCT03516032|aged|aged
110070|NCT03516032|inpatients|inpatients
110071|NCT03516019|mHealth|mhealth
110072|NCT03516019|digital BP monitoring|digital bp monitoring
110073|NCT03516019|patient provider communication|patient provider communication
110074|NCT03516019|smart watch|smart watch
110075|NCT03516019|user engagement|user engagement
110076|NCT03516019|population health data|population health data
110077|NCT03515993|long-term survival|long-term survival
110078|NCT03515993|gynecologic cancer|gynecologic cancer
110079|NCT03515993|quality of life|quality of life
110080|NCT03515967|concussion, mild traumatic brain injury|concussion, mild traumatic brain injury
110081|NCT03515954|conjunctiva|conjunctiva
110082|NCT03515954|squamous neoplasia|squamous neoplasia
110083|NCT03515954|amniotic|amniotic
110084|NCT03515941|chemotherapy|chemotherapy
110085|NCT03515941|chemoradiation|chemoradiation
110086|NCT03515928|Ultrasound, Hearing|ultrasound, hearing
110087|NCT03515915|multiple myeloma|multiple myeloma
110088|NCT03515915|HDAC inhibitor|hdac inhibitor
110089|NCT03515915|Biomarker|biomarker
110090|NCT03515902|Dentine Hypersensitivity|dentine hypersensitivity
110091|NCT03515902|Toothpaste|toothpaste
110092|NCT03515902|Tooth erosion|tooth erosion
110093|NCT03515837|PD1|pd1
110094|NCT03515837|PD-1|pd-1
110095|NCT03515837|PDL1|pdl1
110096|NCT03515837|PD-L1|pd-l1
110097|NCT03515785|acute lymphoblastic leukemia|acute lymphoblastic leukemia
110098|NCT03515785|ponatinib|ponatinib
110099|NCT03515785|tyrosine kinase inhibitor|tyrosine kinase inhibitor
110100|NCT03515772|dolutegravir|dolutegravir
110101|NCT03515772|darunavir|darunavir
110102|NCT03515772|amlodipine|amlodipine
110103|NCT03515772|rosuvastatin|rosuvastatin
110104|NCT03515772|atorvastatin|atorvastatin
110105|NCT03515759|PREECLAMPSIA|preeclampsia
110106|NCT03515759|DOPPLER|doppler
110107|NCT03515759|IUGR|iugr
110108|NCT03515759|UMBILICAL ARTERY|umbilical artery
110109|NCT03515759|MIDDLE CEREBRAL ARTERY|middle cerebral artery
110110|NCT03515746|exergaming|exergaming
110111|NCT03515746|physiotherapy|physiotherapy
110112|NCT03515746|upper extremities|upper extremities
110113|NCT03515746|telerehabilitation|telerehabilitation
110114|NCT03515694|Bridion|bridion
110115|NCT03515694|Sugammadex|sugammadex
110116|NCT03515694|TOF|tof
110117|NCT03515681|Text messaging|text messaging
110118|NCT03515642|Gut microbiota|gut microbiota
110119|NCT03515642|Hepatic function|hepatic function
110120|NCT03515642|Obesity|obesity
110121|NCT03515642|Exercise|exercise
110122|NCT03515629|Stage IIIB|stage iiib
110123|NCT03515629|Stage IV|stage iv
110124|NCT03515629|Non-squamous NSCLC|non-squamous nsclc
110125|NCT03515629|Squamous NSCLC|squamous nsclc
110126|NCT03515551|IMCnyeso|imcnyeso
110127|NCT03515551|Immunotherapy|immunotherapy
110128|NCT03515538|head and neck cancer|head and neck cancer
110129|NCT03515538|squamous|squamous
110130|NCT03515538|neck cancer|neck cancer
110131|NCT03515538|oral cancer|oral cancer
110132|NCT03515538|mucositis|mucositis
110133|NCT03515538|sores|sores
110134|NCT03515538|mouth|mouth
110135|NCT03515525|Breast surgery|breast surgery
110136|NCT03515525|Closed-suction drains|closed-suction drains
110137|NCT03515512|Acute Myeloid Leukemia|acute myeloid leukemia
110138|NCT03515512|Chronic Myelomonocytic Leukemia|chronic myelomonocytic leukemia
110139|NCT03515499|Adherence|adherence
110140|NCT03515499|Incentives|incentives
110141|NCT03515486|Stroke|stroke
110142|NCT03515486|Cerebellum|cerebellum
110143|NCT03515486|Depression|depression
110144|NCT03515486|Anxiety|anxiety
110145|NCT03515486|Mood|mood
110146|NCT03515486|Magnetic resonance imaging (MRI)|magnetic resonance imaging (mri)
110147|NCT03515473|cochlear implant|cochlear implant
110148|NCT03515473|CI532|ci532
110149|NCT03515473|CI512|ci512
110150|NCT03515473|CI522|ci522
110151|NCT03515473|electrode array|electrode array
110152|NCT03515473|perimodiolar|perimodiolar
110153|NCT03515473|electrophysiology|electrophysiology
110154|NCT03515460|vascular endothelial function|vascular endothelial function
110155|NCT03515460|systemic microvascular reactivity|systemic microvascular reactivity
110156|NCT03515460|dysglycemia|dysglycemia
110157|NCT03515460|dyslipidemia|dyslipidemia
110158|NCT03515447|transfusion saving strategy|transfusion saving strategy
110159|NCT03515447|heart or lung transplantation|heart or lung transplantation
110160|NCT03515447|assist device|assist device
110161|NCT03515447|Extra Corporal Life Support (ECLS)|extra corporal life support (ecls)
110162|NCT03515447|Left Ventricular Assist Device (LVAD )|left ventricular assist device (lvad )
110163|NCT03515447|Total artificial Heart|total artificial heart
110164|NCT03515408|fMRI|fmri
110165|NCT03515408|rTMS|rtms
110166|NCT03515408|functional connectivity|functional connectivity
110167|NCT03515395|exergaming|exergaming
110168|NCT03515395|hip fracture|hip fracture
110169|NCT03515395|training|training
110170|NCT03515395|acceptance|acceptance
110171|NCT03515369|hepatocellular carcinoma|hepatocellular carcinoma
110172|NCT03515369|tumor recurrence|tumor recurrence
110173|NCT03515369|adjuvant therapy|adjuvant therapy
110174|NCT03515369|traditional Chinese medicine|traditional chinese medicine
110175|NCT03515343|Cancer prevention|cancer prevention
110176|NCT03515343|Endoscopy|endoscopy
110177|NCT03515343|Gastroenterology|gastroenterology
110178|NCT03515330|mHealth|mhealth
110179|NCT03515330|liver transplantation|liver transplantation
110180|NCT03515330|medication adherence|medication adherence
110181|NCT03515330|video directly observed therapy|video directly observed therapy
110182|NCT03515317|Cognitive impairments|cognitive impairments
110183|NCT03515317|Low Resolution tomography|low resolution tomography
110184|NCT03515317|Neurofeedback|neurofeedback
110185|NCT03515317|Traumatic brain injury|traumatic brain injury
110186|NCT03515291|Heart|heart
110187|NCT03515291|CABG|cabg
110188|NCT03515291|Injection|injection
110189|NCT03515291|Scar|scar
110190|NCT03515291|Fibrosis|fibrosis
110191|NCT03515291|Cell|cell
110192|NCT03515291|Progenitor|progenitor
110193|NCT03515291|Immunomodulatory|immunomodulatory
110194|NCT03515291|MRI|mri
110195|NCT03515291|Randomized|randomized
110196|NCT03515278|Frozen shoulder|frozen shoulder
110197|NCT03515278|adhesive capsulitis|adhesive capsulitis
110198|NCT03515278|ultrasound-guided intervention|ultrasound-guided intervention
110199|NCT03515278|suprascapular nerve block|suprascapular nerve block
110200|NCT03515278|intra-articular injection|intra-articular injection
110201|NCT03515265|Fiber reinforced composite|fiber reinforced composite
110202|NCT03515265|Microhybrid composite|microhybrid composite
110203|NCT03515226|workforce development|workforce development
110204|NCT03515226|intelligent tutoring systems|intelligent tutoring systems
110205|NCT03515187|Dug induced dry eye|dug induced dry eye
110206|NCT03515187|meibomian gland dysfunction, MGD|meibomian gland dysfunction, mgd
110207|NCT03515187|Sodium hyaluronate ophthalmic solution|sodium hyaluronate ophthalmic solution
110208|NCT03515187|Sodium bromide hydrate eye drops|sodium bromide hydrate eye drops
110209|NCT03515187|Meibomian gland massage|meibomian gland massage
110210|NCT03515174|Adolescent and Young Adult Oncology|adolescent and young adult oncology
110211|NCT03515174|Carcinoma|carcinoma
110212|NCT03515174|Lymphoma|lymphoma
110213|NCT03515174|Sarcoma|sarcoma
110214|NCT03515174|Cancer|cancer
110215|NCT03515161|closedloop|closedloop
110216|NCT03515161|vasopressor|vasopressor
110217|NCT03515148|Achilles Tendinopathy|achilles tendinopathy
110218|NCT03515148|Rectus Abominis|rectus abominis
110219|NCT03515148|Vibration|vibration
110220|NCT03515148|Cryotherapy|cryotherapy
110221|NCT03515148|Eccentric Exercise|eccentric exercise
110222|NCT03515135|ADHD|adhd
110223|NCT03515135|executive function|executive function
110224|NCT03515135|preschool|preschool
110225|NCT03515135|intervention|intervention
110226|NCT03515122|Epidemiology|epidemiology
110227|NCT03515122|Rehabilitation|rehabilitation
110228|NCT03515122|Clinical protocols|clinical protocols
110229|NCT03515122|Middle aged|middle aged
110324|NCT03514329|BTVA|btva
110233|NCT03515109|transobturator tape|transobturator tape
110234|NCT03515109|minisling|minisling
110235|NCT03515096|rhTPO|rhtpo
110236|NCT03515096|HSCT|hsct
110237|NCT03515096|Thrombopoietin|thrombopoietin
110238|NCT03515083|apixaban|apixaban
110239|NCT03515083|atrial fibrillation|atrial fibrillation
110240|NCT03515070|Gastrointestinal Microbiome|gastrointestinal microbiome
110241|NCT03515070|Genetics|genetics
110242|NCT03515031|High Flow Nasal Cannula|high flow nasal cannula
110243|NCT03515031|Venturi mask|venturi mask
110244|NCT03515018|Leukemia, Myeloid, Chronic-Phase|leukemia, myeloid, chronic-phase
110245|NCT03515018|hydroxyurea|hydroxyurea
110246|NCT03515018|Imatinib Mesylate|imatinib mesylate
110247|NCT03515018|Pulse Therapy, Drug|pulse therapy, drug
110248|NCT03515005|Hypertension|hypertension
110249|NCT03515005|Community Health Workers|community health workers
110250|NCT03515005|Community-Based Participatory Research|community-based participatory research
110251|NCT03515005|Health Equity|health equity
110252|NCT03514966|Position change|position change
110253|NCT03514966|Gastric cleanliness|gastric cleanliness
110254|NCT03514966|Magnetically controlled capsule endoscopy|magnetically controlled capsule endoscopy
110255|NCT03514914|LARC, contraception, family planning, India, male engagement|larc, contraception, family planning, india, male engagement
110256|NCT03514888|High-risk bladder cancer|high-risk bladder cancer
110257|NCT03514888|Urothelial cancer|urothelial cancer
110258|NCT03514888|HIPEC|hipec
110259|NCT03514888|Mitomycin|mitomycin
110260|NCT03514836|Castrate-resistant|castrate-resistant
110261|NCT03514810|Major depressive disorder|major depressive disorder
110262|NCT03514810|sertraline|sertraline
110263|NCT03514810|ketoprofen|ketoprofen
110264|NCT03514797|Tooth bleaching|tooth bleaching
110265|NCT03514797|Hydrogen peroxide|hydrogen peroxide
110266|NCT03514797|Carbamide peroxide|carbamide peroxide
110267|NCT03514797|Tooth Bleaching Agents|tooth bleaching agents
110268|NCT03514784|Autism Spectrum Disorder, ASD, Gastrointestinal Symptoms, Constipation, Diarrhea|autism spectrum disorder, asd, gastrointestinal symptoms, constipation, diarrhea
110269|NCT03514719|89Zr-avelumab PET|89zr-avelumab pet
110270|NCT03514719|avelumab|avelumab
110271|NCT03514706|Extravascular lung water|extravascular lung water
110272|NCT03514706|one lung ventilation|one lung ventilation
110273|NCT03514706|volume controlled ventilation|volume controlled ventilation
110274|NCT03514706|pressure controlled ventilation|pressure controlled ventilation
110275|NCT03514693|Persistent atrial fibrillation|persistent atrial fibrillation
110276|NCT03514693|non-inferiority trial|non-inferiority trial
110278|NCT03514680|Chemotherapy-induced peripheral neuropathy|chemotherapy-induced peripheral neuropathy
110279|NCT03514654|Breast Cancer|breast cancer
110280|NCT03514654|Mastectomy|mastectomy
110281|NCT03514654|Therapeutic Mammoplasty|therapeutic mammoplasty
110282|NCT03514654|Multiple Ipsilateral Breast Cancers|multiple ipsilateral breast cancers
110283|NCT03514628|Valsalva Manoeuvre|valsalva manoeuvre
110284|NCT03514628|SVT|svt
110285|NCT03514628|Valsalva Assist Device|valsalva assist device
110286|NCT03514576|gastric bypass|gastric bypass
110287|NCT03514576|hypoglycemia|hypoglycemia
110288|NCT03514576|hyperinsulinemia|hyperinsulinemia
110289|NCT03514563|Cleft Lip and Palate|cleft lip and palate
110290|NCT03514563|Maxillofacial|maxillofacial
110291|NCT03514563|Growth|growth
110292|NCT03514563|3D|3d
110293|NCT03514498|anesthesia|anesthesia
110294|NCT03514485|asthma disparities|asthma disparities
110295|NCT03514485|community health worker|community health worker
110296|NCT03514485|childhood asthma|childhood asthma
110297|NCT03514472|Hb, Anemia,|hb, anemia,
110301|NCT03514420|Lipodystrophy|lipodystrophy
110302|NCT03514420|Lipodystrophy, Familial Partial|lipodystrophy, familial partial
110303|NCT03514420|Lipid Metabolism Disorders|lipid metabolism disorders
110304|NCT03514420|Dyslipidemias|dyslipidemias
110305|NCT03514420|Kobberling-Dunnigan syndrome (type 1 and 2)|kobberling-dunnigan syndrome (type 1 and 2)
110306|NCT03514420|Lipoatrophic Diabetes|lipoatrophic diabetes
110307|NCT03514407|Relapsed Ewing sarcoma|relapsed ewing sarcoma
110308|NCT03514407|bromodomain-containing protein (BRD) inhibitor|bromodomain-containing protein (brd) inhibitor
110309|NCT03514407|lysine demethylase 1 (LSD1) inhibitor|lysine demethylase 1 (lsd1) inhibitor
110310|NCT03514381|Soft Tissue Sarcoma|soft tissue sarcoma
110311|NCT03514381|Ifosfamide|ifosfamide
110312|NCT03514381|Aprepitant|aprepitant
110313|NCT03514381|Doxorubicin|doxorubicin
110314|NCT03514368|Immune checkpoint modulation|immune checkpoint modulation
110315|NCT03514368|Tumor antigens|tumor antigens
110316|NCT03514368|Adaptive immune responses|adaptive immune responses
110317|NCT03514368|Tumor molecular signature|tumor molecular signature
110318|NCT03514342|Heart rate variability|heart rate variability
110319|NCT03514342|Scotopic pupil size|scotopic pupil size
110320|NCT03514329|Non Small Cell Lung Cancer|non small cell lung cancer
110321|NCT03514329|Metastatic Lung Cancer|metastatic lung cancer
110322|NCT03514329|Lung Cancer|lung cancer
110323|NCT03514329|Vapor Ablation|vapor ablation
110325|NCT03514316|gingival overgrowth|gingival overgrowth
110326|NCT03514316|diode laser gingivectomy|diode laser gingivectomy
110327|NCT03514316|scalpel gingivectomy|scalpel gingivectomy
110328|NCT03514316|orthodontic treatment|orthodontic treatment
110329|NCT03514303|Skin test, Microarray test|skin test, microarray test
110330|NCT03514290|Laser|laser
110331|NCT03514290|Color|color
110332|NCT03514264|Endodontics|endodontics
110333|NCT03514264|Biomaterials|biomaterials
110334|NCT03514264|Dental pulp cavity|dental pulp cavity
110335|NCT03514264|Periapical abscess|periapical abscess
110336|NCT03514264|Root canal therapy|root canal therapy
110337|NCT03514264|Root canal obturation|root canal obturation
110338|NCT03514251|Thyroid Cancer|thyroid cancer
110339|NCT03514251|Hypoparathyroidism|hypoparathyroidism
110340|NCT03514251|parathyroid marker|parathyroid marker
110341|NCT03514238|Exercise|exercise
110342|NCT03514238|Physical Activity|physical activity
110343|NCT03514238|Cardio-metabolic Health|cardio-metabolic health
110344|NCT03514238|Myokines|myokines
110345|NCT03514238|Cardiorespiratory Fitness|cardiorespiratory fitness
110346|NCT03514238|Obesity|obesity
110347|NCT03514238|Type 2 Diabetes|type 2 diabetes
110348|NCT03514225|Metacognitive Therapy|metacognitive therapy
110349|NCT03514212|physical activity|physical activity
110350|NCT03514212|intervention|intervention
110351|NCT03514212|walking|walking
110352|NCT03514186|Aphasia|aphasia
110353|NCT03514186|Speech and Language Treatment|speech and language treatment
110354|NCT03514186|ICAP|icap
110355|NCT03514186|Intensive Comprehensive Aphasia Program|intensive comprehensive aphasia program
110356|NCT03514147|Women|women
110357|NCT03514147|Pelvic Floor Muscles|pelvic floor muscles
110358|NCT03514108|Heart failure|heart failure
110359|NCT03514108|Diabetes|diabetes
110360|NCT03514108|Insulin resistance|insulin resistance
110361|NCT03514108|Metformin|metformin
110362|NCT03514108|Hydralazine|hydralazine
110363|NCT03514108|Isosorbide Dinitrate|isosorbide dinitrate
110364|NCT03514069|ruxolitinib|ruxolitinib
110365|NCT03514069|radiation|radiation
110366|NCT03514069|temozolomide|temozolomide
110367|NCT03514056|Fibromyalgia|fibromyalgia
110368|NCT03514056|Behcet Disease|behcet disease
110369|NCT03514056|Trigger points|trigger points
110370|NCT03514043|Ambulatory care|ambulatory care
110371|NCT03514043|Emergency general surgery|emergency general surgery
110372|NCT03514043|Patient satisfaction|patient satisfaction
110373|NCT03514017|Lymphocytic|lymphocytic
110374|NCT03514017|Leukemia|leukemia
110375|NCT03514017|CLL|cll
110376|NCT03514017|Blood disease|blood disease
110377|NCT03514017|White blood cells|white blood cells
110378|NCT03514017|Bone marrow disease|bone marrow disease
110379|NCT03514017|Immunotherapy|immunotherapy
110380|NCT03514004|Suicide prevention|suicide prevention
110381|NCT03514004|Information and Communication Technologies|information and communication technologies
110382|NCT03514004|Cluster Randomized Controlled Trial|cluster randomized controlled trial
110383|NCT03514004|Latin America|latin america
110384|NCT03513991|human milk|human milk
110385|NCT03513991|infant formula with low protein|infant formula with low protein
110386|NCT03513991|alpha lactoalbumin|alpha lactoalbumin
110387|NCT03513991|growth velocity|growth velocity
110388|NCT03513991|gastrointestinal events|gastrointestinal events
110389|NCT03513978|Soccer|soccer
110390|NCT03513978|Prevention injury|prevention injury
110391|NCT03513965|food allergy|food allergy
110392|NCT03513965|oral immunotherapy|oral immunotherapy
110393|NCT03513965|mindsets|mindsets
110394|NCT03513965|patient experience|patient experience
110395|NCT03513939|Type 1 Diabetes Mellitus, Diabetes, hypoglycemia|type 1 diabetes mellitus, diabetes, hypoglycemia
110396|NCT03513926|miRNA|mirna
110397|NCT03513926|Cardiovascular Risk|cardiovascular risk
110398|NCT03513926|CPAP|cpap
110399|NCT03513926|Obstructive Sleep Apnea|obstructive sleep apnea
110400|NCT03513926|Hypertension|hypertension
110401|NCT03513926|Molecular profile|molecular profile
110402|NCT03513913|in vitro fertilization|in vitro fertilization
110403|NCT03513913|intracytoplasmic sperm injection|intracytoplasmic sperm injection
110404|NCT03513913|fertilization|fertilization
110405|NCT03513913|Assisted reproduction|assisted reproduction
110406|NCT03513900|Non-invasive methods|non-invasive methods
110407|NCT03513900|Cirrhosis|cirrhosis
110408|NCT03513900|Potal hypertensive gastropathy|potal hypertensive gastropathy
110409|NCT03513900|Diagnostic accuracy|diagnostic accuracy
110410|NCT03513887|cirrhosis,varices,variceal bleeding, noninvasive tests,TE|cirrhosis,varices,variceal bleeding, noninvasive tests,te
110411|NCT03513861|Low and Middle Income Countries|low and middle income countries
110412|NCT03513861|Limited resource settings|limited resource settings
110413|NCT03513861|Early warning signs|early warning signs
110414|NCT03513822|KETAMINE|ketamine
110415|NCT03513822|CHRONIC PAIN|chronic pain
110416|NCT03513822|NEUROPATHIC PAIN|neuropathic pain
110417|NCT03513822|KYNURENINE|kynurenine
110418|NCT03513822|KYNURENINE PATHWAY|kynurenine pathway
110419|NCT03513822|BEDSORES|bedsores
110420|NCT03513822|ANTI-INFLAMMATORY|anti-inflammatory
110421|NCT03513822|ULCER PRESSURE|ulcer pressure
110422|NCT03513809|Acute Hypoxemic Respiratory Failure|acute hypoxemic respiratory failure
110423|NCT03513809|Acute Respiratory Distress Syndrome|acute respiratory distress syndrome
110424|NCT03513809|Electrical impedance tomography|electrical impedance tomography
110425|NCT03513809|Spontaneous breathing|spontaneous breathing
110426|NCT03513809|Ventilation induced-lung injury|ventilation induced-lung injury
110427|NCT03513809|Patient self-inflicted lung injury|patient self-inflicted lung injury
110428|NCT03513783|Spinal Cord Injury|spinal cord injury
110429|NCT03513783|tendon transfer|tendon transfer
110430|NCT03513783|muscle synergy|muscle synergy
110431|NCT03513783|muscle co-activation|muscle co-activation
110432|NCT03513783|electromyography|electromyography
110433|NCT03513744|human milk oligosaccharides|human milk oligosaccharides
110434|NCT03513744|infant formula|infant formula
110435|NCT03513718|Acute kidney injury, AKI|acute kidney injury, aki
110436|NCT03513705|implementation|implementation
110437|NCT03513705|randomized trial|randomized trial
110438|NCT03513705|pancreatic cancer|pancreatic cancer
110439|NCT03513705|nationwide|nationwide
110440|NCT03513705|survival|survival
110441|NCT03513705|quality of life|quality of life
110442|NCT03513653|acute heart failure|acute heart failure
110443|NCT03513653|global longitudinal strain|global longitudinal strain
110444|NCT03513653|ejection fraction|ejection fraction
110445|NCT03513653|echocardiography|echocardiography
110446|NCT03513653|mortality|mortality
110447|NCT03513627|periimplant soft tissue|periimplant soft tissue
110448|NCT03513627|gingiva|gingiva
110449|NCT03513627|human|human
110450|NCT03513627|microcirculation|microcirculation
110451|NCT03513614|Tailored Axillary Surgery|tailored axillary surgery
110452|NCT03513614|TAXIS|taxis
110453|NCT03513614|Breast Cancer|breast cancer
110454|NCT03513614|node-positive breast cancer|node-positive breast cancer
110455|NCT03513614|phase III trial|phase iii trial
110456|NCT03513614|IBCSG 57-18|ibcsg 57-18
110457|NCT03513614|ABCSG|abcsg
110458|NCT03513601|Curative effect evaluation|curative effect evaluation
110459|NCT03513601|Adverse reactions|adverse reactions
110460|NCT03513601|Clinical characteristics|clinical characteristics
110461|NCT03513601|PR|pr
110462|NCT03513601|PFS|pfs
110463|NCT03513601|OS|os
110464|NCT03513575|pH of saliva|ph of saliva
110465|NCT03513575|Flavored Milk|flavored milk
110466|NCT03513575|buffering agent|buffering agent
110467|NCT03513575|oral hygiene|oral hygiene
110468|NCT03513549|Agitation|agitation
110469|NCT03513549|Schizophrenia|schizophrenia
110470|NCT03513549|Bipolar I disorder|bipolar i disorder
110471|NCT03513536|Aromatherapy|aromatherapy
110472|NCT03513536|Essential Oils|essential oils
110473|NCT03513510|evidence-based programs|evidence-based programs
110474|NCT03513510|community-based participatory research|community-based participatory research
110475|NCT03513510|program adoption|program adoption
110476|NCT03513497|Teeth|teeth
110477|NCT03513497|Periodontal disease|periodontal disease
110478|NCT03513497|acute inflammatory response|acute inflammatory response
110479|NCT03513497|stent-induced biofilm overgrowth|stent-induced biofilm overgrowth
110480|NCT03513497|periodontal pathogens|periodontal pathogens
110481|NCT03513471|Late Phase Asthmatic Response|late phase asthmatic response
110482|NCT03513471|Allergen Challenge|allergen challenge
110483|NCT03513458|Late Phase Asthmatic Response|late phase asthmatic response
110484|NCT03513458|Allergen Challenge|allergen challenge
110485|NCT03513432|Gut microbiota|gut microbiota
110486|NCT03513432|Beer|beer
110487|NCT03513432|Alcohol|alcohol
110488|NCT03513432|Cardiovascular disease|cardiovascular disease
110489|NCT03513406|muscle function|muscle function
110490|NCT03513393|velpatasvir|velpatasvir
110491|NCT03513393|cola|cola
110492|NCT03513393|omeprazole|omeprazole
110493|NCT03513393|proton pump inhibitors|proton pump inhibitors
110494|NCT03513380|Exercise therapy|exercise therapy
110495|NCT03513380|Physical fitness|physical fitness
110496|NCT03513380|Gaming|gaming
110497|NCT03513380|Adult|adult
110498|NCT03513380|Healthy lifestyle|healthy lifestyle
110499|NCT03513380|Fitness testing|fitness testing
110500|NCT03513367|Duchenne Muscular Dystrophy,|duchenne muscular dystrophy,
110501|NCT03513367|Pediatric Quality of Life Inventory|pediatric quality of life inventory
110502|NCT03513367|disability paradox|disability paradox
110503|NCT03513354|Aging|aging
110504|NCT03513354|Physical activity|physical activity
110505|NCT03513354|Motor activity|motor activity
110506|NCT03513341|Physical activity|physical activity
110507|NCT03513341|Sedentary behaviour|sedentary behaviour
110508|NCT03513341|Undergraduate|undergraduate
110509|NCT03513328|human leukocyte antigen (HLA)|human leukocyte antigen (hla)
110510|NCT03513315|Heat-related illnesses|heat-related illnesses
110511|NCT03513315|Heat Illnesses|heat illnesses
110512|NCT03513315|Community based interventions|community based interventions
110513|NCT03513315|heatwave|heatwave
110514|NCT03513315|Pakistan|pakistan
110515|NCT03513315|emergency preparedness|emergency preparedness
110516|NCT03513315|emergency medicine|emergency medicine
110517|NCT03513315|heat stroke|heat stroke
110518|NCT03513315|heat exhaustion|heat exhaustion
110519|NCT03513315|urban health|urban health
110520|NCT03513302|nitric oxide|nitric oxide
110521|NCT03513289|ICU delirium|icu delirium
110522|NCT03513289|post-intensive care syndrome|post-intensive care syndrome
110523|NCT03513289|critical illness myopathy|critical illness myopathy
110524|NCT03513211|Biochemically recurrent prostate cancer|biochemically recurrent prostate cancer
110525|NCT03513211|Hormone sensitive prostate cancer|hormone sensitive prostate cancer
110526|NCT03513198|contrast-enhanced endoscopic ultrasound|contrast-enhanced endoscopic ultrasound
110527|NCT03513198|endoscopic ultrasound elastography|endoscopic ultrasound elastography
110528|NCT03513198|tumor vascularity|tumor vascularity
110529|NCT03513198|prognostic|prognostic
110530|NCT03513185|somatic symptom disorder|somatic symptom disorder
110531|NCT03513185|the Somatic Symptom Scale-China|the somatic symptom scale-china
110532|NCT03513185|mental disorders management|mental disorders management
110533|NCT03513172|Intraocular Pressure|intraocular pressure
110534|NCT03513172|Anti-VEGF Agents|anti-vegf agents
110535|NCT03513172|alpha2-agonists|alpha2-agonists
110536|NCT03513159|transitional care, geriatric, readmission|transitional care, geriatric, readmission
110537|NCT03513133|working memory|working memory
110538|NCT03513133|cognitive rehabilitation|cognitive rehabilitation
110539|NCT03513133|functional neuroimaging|functional neuroimaging
110540|NCT03513120|Adolescent Idiopathic Scoliosis|adolescent idiopathic scoliosis
110541|NCT03513120|Posterior Spinal Fusion|posterior spinal fusion
110542|NCT03513120|Return to Sport|return to sport
110543|NCT03513107|Osteoporosis|osteoporosis
110544|NCT03513094|Kinetics|kinetics
110545|NCT03513094|Transversus abdominis|transversus abdominis
110546|NCT03513081|food neophobia|food neophobia
110547|NCT03513081|preschool|preschool
110548|NCT03513081|children|children
110549|NCT03513068|COPD|copd
110550|NCT03513068|POC|poc
110551|NCT03513068|Oxygen|oxygen
110552|NCT03513068|QoL|qol
110553|NCT03513055|glucose excursions|glucose excursions
110554|NCT03513055|insulin technique|insulin technique
110555|NCT03513055|insulin antibodies|insulin antibodies
110556|NCT03513055|premixed insulin|premixed insulin
110557|NCT03513042|intensity-modulated proton therapy|intensity-modulated proton therapy
110558|NCT03513042|therapy response evaluation|therapy response evaluation
110559|NCT03513042|positron emission tomography (PET)|positron emission tomography (pet)
110560|NCT03513042|hypoxia|hypoxia
110561|NCT03513042|metabolism|metabolism
110562|NCT03513042|18F-fluoroazomycin-arabinoside (FAZA)|18f-fluoroazomycin-arabinoside (faza)
110563|NCT03513042|18F-2-fluoro-2-deoxy-D-glucose (FDG)|18f-2-fluoro-2-deoxy-d-glucose (fdg)
110564|NCT03513042|head and neck neoplasms|head and neck neoplasms
110565|NCT03513042|image-guided proton therapy|image-guided proton therapy
110566|NCT03513042|treatment outcome|treatment outcome
110567|NCT03513042|predictive biomarker|predictive biomarker
110568|NCT03513029|PAF|paf
110569|NCT03513029|atrial fibrillation|atrial fibrillation
110570|NCT03513029|ablation|ablation
110571|NCT03513029|low intensity collimated ultrasound|low intensity collimated ultrasound
110572|NCT03513016|Osteoarthritis|osteoarthritis
110573|NCT03513016|Painful Osteoarthritis|painful osteoarthritis
110574|NCT03513016|Osteoarthritis, Knee|osteoarthritis, knee
110575|NCT03513016|Senescence|senescence
110576|NCT03512990|Brachial Plexus Block|brachial plexus block
110577|NCT03512990|Superior Trunk|superior trunk
110578|NCT03512990|Phrenic Nerve|phrenic nerve
110579|NCT03512977|spinal anesthesia|spinal anesthesia
110580|NCT03512977|sphenopalatine ganglion block|sphenopalatine ganglion block
110581|NCT03512977|postspinal headache|postspinal headache
110582|NCT03512951|Hearing aids|hearing aids
110583|NCT03512951|Remote microphone systems|remote microphone systems
110584|NCT03512951|Roger technology|roger technology
110585|NCT03512951|Sound externalization|sound externalization
110586|NCT03512951|Auditory distance estimation|auditory distance estimation
110587|NCT03512938|Generalized aggressive periodontitis|generalized aggressive periodontitis
110588|NCT03512938|Non-surgical periodontal therapy|non-surgical periodontal therapy
110589|NCT03512938|Periodontopathogens|periodontopathogens
110590|NCT03512938|Smoking|smoking
110591|NCT03512938|Gingival crevicular fluid|gingival crevicular fluid
110592|NCT03512925|Coercion|coercion
110593|NCT03512925|Post-coercion review|post-coercion review
110594|NCT03512925|Mental health|mental health
110595|NCT03512925|Seclusion|seclusion
110596|NCT03512925|Mechanical restraint|mechanical restraint
110597|NCT03512899|implantable port|implantable port
110598|NCT03512886|Multiple sclerosis|multiple sclerosis
110599|NCT03512886|Multi-task training|multi-task training
110600|NCT03512886|Balance|balance
110601|NCT03512886|Mobility|mobility
110602|NCT03512886|Cognition|cognition
110603|NCT03512886|Upper extremity function|upper extremity function
110604|NCT03512873|Scleredema Diabeticorum|scleredema diabeticorum
110605|NCT03512873|Tranilast|tranilast
110606|NCT03512860|Estetrol|estetrol
110607|NCT03512860|Drospirenone|drospirenone
110608|NCT03512860|Uridine diphosphate glucuronosyltransferase-2B7|uridine diphosphate glucuronosyltransferase-2b7
110609|NCT03512860|Drug-drug interaction|drug-drug interaction
110610|NCT03512860|Valproic acid|valproic acid
110611|NCT03512847|liquid biopsy|liquid biopsy
110612|NCT03512847|genomic profiling|genomic profiling
110613|NCT03512847|ctDNA|ctdna
110614|NCT03512834|angiosarcoma|angiosarcoma
110615|NCT03512834|paclitaxel|paclitaxel
110616|NCT03512834|avelumab|avelumab
110617|NCT03512769|jaw support device, third molars, wisdom teeth, partially erupted or impacted|jaw support device, third molars, wisdom teeth, partially erupted or impacted
110618|NCT03512756|Pancreatic cancer|pancreatic cancer
110619|NCT03512756|Pancreas cancer|pancreas cancer
110620|NCT03512756|Pancreatic|pancreatic
110621|NCT03512756|Pancreas|pancreas
110622|NCT03512756|cancer|cancer
110623|NCT03512756|low toxicity|low toxicity
110624|NCT03512756|chemotherapy|chemotherapy
110625|NCT03512756|metastatic|metastatic
110626|NCT03512756|SM-88|sm-88
110627|NCT03512756|SM88|sm88
110628|NCT03512756|3rd line|3rd line
110629|NCT03512756|third line|third line
110630|NCT03512756|CMBT|cmbt
110631|NCT03512756|well tolerated|well tolerated
110632|NCT03512756|MPS|mps
110633|NCT03512756|Racemetyrosine|racemetyrosine
110634|NCT03512756|Methoxsalen|methoxsalen
110635|NCT03512756|Sirolimus|sirolimus
110636|NCT03512756|Phenytoin|phenytoin
110637|NCT03512743|bone mineral density|bone mineral density
110638|NCT03512743|bone turnover markers|bone turnover markers
110639|NCT03512743|ferritin|ferritin
110640|NCT03512730|regenera|regenera
110641|NCT03512704|Heart failure|heart failure
110642|NCT03512704|clinical prediction rules|clinical prediction rules
110643|NCT03512704|health services research|health services research
110644|NCT03512691|Risk perceptions and attitudes, time preference, information|risk perceptions and attitudes, time preference, information
110645|NCT03512665|Pre-diabetes|pre-diabetes
110646|NCT03512665|cardiovascular risk|cardiovascular risk
110647|NCT03512665|lipids|lipids
110648|NCT03512665|insulin resistance|insulin resistance
110649|NCT03512665|obesity|obesity
110650|NCT03512665|overweight|overweight
110651|NCT03512639|Mastectomy, Breast Reconstruction, Homeopathic Treatment|mastectomy, breast reconstruction, homeopathic treatment
110652|NCT03512626|OptiVis|optivis
110653|NCT03512626|hybrid multifocal intraocular lens|hybrid multifocal intraocular lens
110654|NCT03512626|multifocal intraocular lens|multifocal intraocular lens
110655|NCT03512626|presbyopia|presbyopia
110656|NCT03512600|lithiasis|lithiasis
110657|NCT03512600|uric acid|uric acid
110658|NCT03512600|crystallization|crystallization
110659|NCT03512587|Personalized quantum sonotherapy|personalized quantum sonotherapy
110660|NCT03512587|Regional anesthesia|regional anesthesia
110661|NCT03512587|Peripheral nerve block|peripheral nerve block
110662|NCT03512574|pregabalin, dexmedetomidine, postoperative pain|pregabalin, dexmedetomidine, postoperative pain
110663|NCT03512522|chronic pain|chronic pain
110664|NCT03512522|pain self-management|pain self-management
110665|NCT03512522|remote delivery|remote delivery
110666|NCT03512522|workbook|workbook
110667|NCT03512522|online|online
110668|NCT03512496|Energy Drink|energy drink
110669|NCT03512496|Pediatric|pediatric
110670|NCT03512496|Metabolism|metabolism
110671|NCT03512496|Glucose|glucose
110672|NCT03512496|Caffeine|caffeine
110673|NCT03512496|Obesity|obesity
110674|NCT03512496|Nutrition|nutrition
110675|NCT03512496|Metabolomics|metabolomics
110676|NCT03512496|Health Behavior|health behavior
110677|NCT03512496|Glucose Intolerance|glucose intolerance
110678|NCT03512483|Atrial Fibrillation|atrial fibrillation
110679|NCT03512483|Rural|rural
110680|NCT03512483|Virtual|virtual
110681|NCT03512483|Older Adults|older adults
110682|NCT03512470|surgical wound|surgical wound
110683|NCT03512470|Prevena System|prevena system
110684|NCT03512457|Melanoma|melanoma
110685|NCT03512457|Skin self-examination|skin self-examination
110686|NCT03512457|mammogram|mammogram
110687|NCT03512444|negative pressure therapy|negative pressure therapy
110688|NCT03512444|negative pressure|negative pressure
110689|NCT03512444|Wound therapy|wound therapy
110690|NCT03512444|NPWT|npwt
110691|NCT03512444|Vacuum therapy|vacuum therapy
110692|NCT03512444|VAC|vac
110693|NCT03512431|analytical method validation|analytical method validation
110694|NCT03512431|renal transplantation|renal transplantation
110695|NCT03512431|limited sampling strategy|limited sampling strategy
110696|NCT03512418|HIV prevention|hiv prevention
110697|NCT03512418|Pre-exposure prophylaxis|pre-exposure prophylaxis
110698|NCT03512418|Digital Pill|digital pill
110699|NCT03512418|Substance use disorder|substance use disorder
110700|NCT03512418|Stimulant use|stimulant use
110701|NCT03512392|fluid therapy|fluid therapy
110702|NCT03512392|furosemide|furosemide
110703|NCT03512392|diuretics|diuretics
110704|NCT03512392|Injections, Intravenous|injections, intravenous
110705|NCT03512392|Infusions, Intravenous|infusions, intravenous
110706|NCT03512392|Spironolactone|spironolactone
110707|NCT03512392|Indapamide|indapamide
110708|NCT03512379|robot-assisted surgery|robot-assisted surgery
110709|NCT03512379|pedicle screw|pedicle screw
110710|NCT03512379|spine|spine
110711|NCT03512366|inguinal hernia|inguinal hernia
110712|NCT03512366|lichtenstein's technique|lichtenstein's technique
110713|NCT03512366|desarda's technique|desarda's technique
110714|NCT03512366|local anaesthesia|local anaesthesia
110715|NCT03512340|CD47|cd47
110716|NCT03512340|SiRP α|sirp α
110717|NCT03512340|tumor microenvironment|tumor microenvironment
110718|NCT03512340|macrophage|macrophage
110719|NCT03512340|solid tumor|solid tumor
110720|NCT03512340|Phase 1|phase 1
110721|NCT03512340|safety|safety
110722|NCT03512340|efficacy|efficacy
110723|NCT03512340|hematologic malignancies|hematologic malignancies
110724|NCT03512340|SRF231|srf231
110725|NCT03512275|Hidradenitis Suppurativa|hidradenitis suppurativa
110726|NCT03512262|BA058|ba058
110727|NCT03512262|abaloparatide|abaloparatide
110728|NCT03512262|abaloparatide-SC|abaloparatide-sc
110729|NCT03512262|osteoporosis|osteoporosis
110730|NCT03512262|male osteoporosis|male osteoporosis
110731|NCT03512262|TYMLOS™|tymlos™
110732|NCT03512262|fracture|fracture
110733|NCT03512262|bone loss|bone loss
110734|NCT03512197|Newly diagnosed FLT3-mutation negative|newly diagnosed flt3-mutation negative
110735|NCT03512197|PKC412|pkc412
110736|NCT03512197|midostaurin|midostaurin
110737|NCT03512197|cytarabine|cytarabine
110738|NCT03512197|daunorubicin|daunorubicin
110739|NCT03512197|idarubicin|idarubicin
110740|NCT03512197|acute myeloid leukemia|acute myeloid leukemia
110741|NCT03512197|AML|aml
110742|NCT03512197|FLT3-MN (SR<0.05)|flt3-mn (sr<0.05)
110743|NCT03512197|combination treatment|combination treatment
110744|NCT03512197|induction failure|induction failure
110745|NCT03512197|event free survival|event free survival
110746|NCT03512197|EFS|efs
110747|NCT03512197|minimal residual disease|minimal residual disease
110748|NCT03512119|Cystic fibrosis|cystic fibrosis
110749|NCT03512119|Glucose tolerance abnormalities|glucose tolerance abnormalities
110750|NCT03512119|CFTR corrector and potentiator|cftr corrector and potentiator
110751|NCT03512106|Arterial Hypertension|arterial hypertension
110752|NCT03512106|Acupuncture|acupuncture
110753|NCT03512093|Preterm Infant|preterm infant
110754|NCT03512080|Warfarin|warfarin
110755|NCT03512080|Anticoagulation|anticoagulation
110756|NCT03512080|Clinical Dosing Algorithm|clinical dosing algorithm
110757|NCT03512080|Genetic Dosing Algorithm|genetic dosing algorithm
110758|NCT03512080|International Normalised Ratio|international normalised ratio
110759|NCT03512080|Uganda|uganda
110760|NCT03512080|Cape Town|cape town
110761|NCT03512080|Cardiovascular Disease|cardiovascular disease
110762|NCT03512080|Genome-wide Association Study|genome-wide association study
110763|NCT03512080|Stratified Medicine|stratified medicine
110764|NCT03512080|Pharmacogenetics|pharmacogenetics
110765|NCT03512067|Mechanical Ventilation|mechanical ventilation
110766|NCT03512067|Respiratory Support|respiratory support
110767|NCT03512054|Tracheostomy|tracheostomy
110768|NCT03512054|Decannulation|decannulation
110769|NCT03512054|Rehabilitation|rehabilitation
110770|NCT03512054|Brain injury|brain injury
110771|NCT03512054|Neurosurgery|neurosurgery
110772|NCT03512041|ischemic conditioning, motor learning|ischemic conditioning, motor learning
110773|NCT03512028|ischemic conditioning, motor learning, strength, cognition|ischemic conditioning, motor learning, strength, cognition
110774|NCT03512015|Lung Cancer|lung cancer
110775|NCT03512002|Neurotechnology|neurotechnology
110776|NCT03512002|Autonomic Dysregulation|autonomic dysregulation
110777|NCT03512002|Hyperarousal|hyperarousal
110778|NCT03512002|Brain Electrical Activity|brain electrical activity
110779|NCT03512002|HIRREM|hirrem
110780|NCT03512002|Acoustic Stimulation|acoustic stimulation
110781|NCT03512002|Perimenopausal|perimenopausal
110782|NCT03512002|Postmenopausal|postmenopausal
110783|NCT03512002|Hot Flashes|hot flashes
110784|NCT03512002|Night Sweats|night sweats
110785|NCT03512002|Vasomotor Symptoms|vasomotor symptoms
110786|NCT03512002|Allostatis|allostatis
110787|NCT03511937|Food and beverage purchases|food and beverage purchases
110788|NCT03511937|Sugar-sweetened beverages|sugar-sweetened beverages
110789|NCT03511937|Beverages|beverages
110790|NCT03511924|resistance training|resistance training
110791|NCT03511924|circulating miRNA|circulating mirna
110792|NCT03511924|muscle strength|muscle strength
110793|NCT03511911|Pelvic floor muscle strength|pelvic floor muscle strength
110794|NCT03511911|modified Oxford Grading Scale|modified oxford grading scale
110795|NCT03511911|Levator ani testing|levator ani testing
110796|NCT03511911|vaginal contraction pressure|vaginal contraction pressure
110797|NCT03511911|reliability|reliability
110798|NCT03511885|Cardiovascular|cardiovascular
110799|NCT03511885|Prevention|prevention
110800|NCT03511885|EUROASPIRE|euroaspire
110801|NCT03511872|Basic life support|basic life support
110802|NCT03511872|cardiopulmonary resuscitation|cardiopulmonary resuscitation
110803|NCT03511872|medical undergraduate students|medical undergraduate students
110804|NCT03511872|crisis|crisis
110805|NCT03511872|randomized controlled trial.|randomized controlled trial.
110806|NCT03511859|Breast cancer. Circulating tumor cells. CTCs. Cell free DNA. cfDNA|breast cancer. circulating tumor cells. ctcs. cell free dna. cfdna
110807|NCT03511846|Brain Freeze|brain freeze
110808|NCT03511846|Capsaicin|capsaicin
110809|NCT03511833|Intra nasal ketamine|intra nasal ketamine
110810|NCT03511833|IV morphine|iv morphine
110811|NCT03511833|acute traumatic pain|acute traumatic pain
110812|NCT03511820|Amphotericin B|amphotericin b
110813|NCT03511820|liposome|liposome
111110|NCT03509688|hepatitis B|hepatitis b
110818|NCT03511729|Tau/P-Tau|tau/p-tau
110819|NCT03511729|biomarker|biomarker
110820|NCT03511729|neurocognitive|neurocognitive
110821|NCT03511729|outcomes|outcomes
110822|NCT03511729|children|children
110823|NCT03511716|Mitral Insufficiency|mitral insufficiency
110824|NCT03511716|Mitral Valve Incompetence|mitral valve incompetence
110825|NCT03511690|Latinas, African Americans|latinas, african americans
110826|NCT03511677|Insole|insole
110827|NCT03511677|Morton Neuroma|morton neuroma
110828|NCT03511677|Pain|pain
110829|NCT03511677|Function|function
110830|NCT03511664|mCRPC|mcrpc
110831|NCT03511664|177Lu-PSMA-617|177lu-psma-617
110832|NCT03511664|PSMA-617|psma-617
110833|NCT03511664|PSMA-11|psma-11
110834|NCT03511664|radioligand therapy|radioligand therapy
110835|NCT03511560|Envarsus XR|envarsus xr
110836|NCT03511560|Tacrolimus|tacrolimus
110837|NCT03511560|Kidney Transplantation|kidney transplantation
110838|NCT03511534|treatment, psychotherapy, pharmacotherapy|treatment, psychotherapy, pharmacotherapy
110839|NCT03511521|steroid|steroid
110840|NCT03511521|prednisone|prednisone
110841|NCT03511521|methylprednisolone|methylprednisolone
110842|NCT03511521|hyperglycemia|hyperglycemia
110843|NCT03511521|insulin|insulin
110844|NCT03511521|hypoglycemia|hypoglycemia
110845|NCT03511508|pregnancy|pregnancy
110846|NCT03511508|maternity Care|maternity care
110847|NCT03511508|complex intervention|complex intervention
110848|NCT03511508|interdisiplinary team|interdisiplinary team
110849|NCT03511508|chronic disease|chronic disease
110850|NCT03511508|interdisciplinary|interdisciplinary
110851|NCT03511508|midwifery|midwifery
110852|NCT03511469|Kontralateral Education, Bankart, Rehabilitation, Shoulder,|kontralateral education, bankart, rehabilitation, shoulder,
110853|NCT03511456|leg pain|leg pain
110854|NCT03511456|waist pain|waist pain
110855|NCT03511456|life quality|life quality
110856|NCT03511443|hsRDT|hsrdt
110857|NCT03511443|usRDT|usrdt
110858|NCT03511443|Reactive Case Detection (RCD)|reactive case detection (rcd)
110859|NCT03511443|High risk for malaria|high risk for malaria
110860|NCT03511430|Acute Coronary Syndrome|acute coronary syndrome
110861|NCT03511430|Heart Diseases|heart diseases
110862|NCT03511430|Cardiovascular Diseases|cardiovascular diseases
110863|NCT03511430|Vascular Diseases|vascular diseases
110864|NCT03511404|Non specific chronic low back pain|non specific chronic low back pain
110865|NCT03511404|surface electromyography (EMG)|surface electromyography (emg)
110866|NCT03511404|neuromuscular function|neuromuscular function
110867|NCT03511404|physiotherapy|physiotherapy
110868|NCT03511404|Numeric Pain Rating Scale|numeric pain rating scale
110869|NCT03511391|radiotherapy|radiotherapy
110870|NCT03511391|checkpoint inhibitors|checkpoint inhibitors
110871|NCT03511378|Breast Carcinoma|breast carcinoma
110872|NCT03511378|Breast neoplasms|breast neoplasms
110873|NCT03511378|Breast Tumors|breast tumors
110874|NCT03511378|Cancer of Breast|cancer of breast
110875|NCT03511378|Anti-Drug Antibodies (ADA)|anti-drug antibodies (ada)
110876|NCT03511378|Immunogenicity|immunogenicity
110877|NCT03511365|Probiotic|probiotic
110878|NCT03511365|Microbiome|microbiome
110879|NCT03511365|Inflammation|inflammation
110880|NCT03511365|Non-Alcoholic Fatty Liver Disease|non-alcoholic fatty liver disease
110881|NCT03511339|Concussion|concussion
110882|NCT03511326|field-treatment|field-treatment
110883|NCT03511313|Primary Hypertension|primary hypertension
110884|NCT03511313|Renal Denervation|renal denervation
110885|NCT03511300|Cognition|cognition
110886|NCT03511300|Apathy|apathy
110887|NCT03511287|inspiratory muscle training|inspiratory muscle training
110888|NCT03511287|advanced lung disease|advanced lung disease
110889|NCT03511287|maximal inspiratory pressure|maximal inspiratory pressure
110890|NCT03511287|inspiratory endurance|inspiratory endurance
110891|NCT03511274|Cytomegalovirus Congenital|cytomegalovirus congenital
110892|NCT03511274|CMV|cmv
110893|NCT03511274|Cytomegalovirus infections|cytomegalovirus infections
110894|NCT03511261|Oral submucous fibrosis|oral submucous fibrosis
110895|NCT03511261|curcumin|curcumin
110896|NCT03511261|potentially malignant disease|potentially malignant disease
110897|NCT03511248|Heart Failure|heart failure
110898|NCT03511248|Heart Failure with Reduced Ejection Fraction|heart failure with reduced ejection fraction
110899|NCT03511248|Nitric Oxide|nitric oxide
110900|NCT03511248|Inorganic Nitrate|inorganic nitrate
110901|NCT03511209|Sleep Initiation and Maintenance Disorders|sleep initiation and maintenance disorders
110902|NCT03511209|Hypnotics and Sedatives|hypnotics and sedatives
110903|NCT03511196|stage IV castration sensitive prostate cancer|stage iv castration sensitive prostate cancer
110904|NCT03511196|advanced castration sensitive prostate cancer|advanced castration sensitive prostate cancer
110905|NCT03511157|ischemic preconditioning|ischemic preconditioning
110906|NCT03511131|HIV prevention|hiv prevention
110907|NCT03511131|Adolescent risk-taking behaviors|adolescent risk-taking behaviors
110908|NCT03511105|Lipopolysaccharide|lipopolysaccharide
110909|NCT03511105|Pharmacodynamics|pharmacodynamics
110910|NCT03511105|Healthy subjects|healthy subjects
110911|NCT03511105|GSK2798745|gsk2798745
110912|NCT03511105|Placebo|placebo
110913|NCT03511105|Segmental challenge|segmental challenge
110914|NCT03511092|Leucine metabolites|leucine metabolites
110915|NCT03511092|Resistance training|resistance training
110916|NCT03511092|Hypertrophy|hypertrophy
110917|NCT03511092|Strength|strength
110918|NCT03511092|Supplement|supplement
110919|NCT03511079|Music|music
110920|NCT03511066|efficacy|efficacy
110921|NCT03511066|safety|safety
110922|NCT03511027|Medication Adherence|medication adherence
110923|NCT03511027|Medication Dispensing|medication dispensing
110924|NCT03511027|Homecare|homecare
110925|NCT03511027|Elderly|elderly
110926|NCT03510975|behavioural therapy|behavioural therapy
110927|NCT03510975|mono symptomatic nocturnal enuresis|mono symptomatic nocturnal enuresis
110928|NCT03510975|compliance|compliance
110929|NCT03510975|response|response
110930|NCT03510962|pH of saliva|ph of saliva
110931|NCT03510962|Fruit juice|fruit juice
110932|NCT03510962|buffering agent|buffering agent
110933|NCT03510962|oral hygiene|oral hygiene
110934|NCT03510936|Probiotics|probiotics
110935|NCT03510936|Gut Microbiome|gut microbiome
110936|NCT03510936|Infants|infants
110937|NCT03510936|Jaundice|jaundice
110938|NCT03510923|Appendix|appendix
110939|NCT03510923|Appendectomy|appendectomy
110940|NCT03510923|Gallbladder|gallbladder
110941|NCT03510923|Cholecystectomy|cholecystectomy
110942|NCT03510923|Neoplasms|neoplasms
110943|NCT03510923|Pathology|pathology
110944|NCT03510923|Selective|selective
110945|NCT03510923|Routine|routine
110946|NCT03510897|MAKE|make
110947|NCT03510897|AKI|aki
110948|NCT03510871|neoadjuvant therapy|neoadjuvant therapy
110949|NCT03510819|Dental trauma|dental trauma
110950|NCT03510819|Emergency management|emergency management
110951|NCT03510819|Tooth avulsion|tooth avulsion
110952|NCT03510819|Knowledge|knowledge
110953|NCT03510819|Practice|practice
110954|NCT03510819|Traumatic injuries|traumatic injuries
110955|NCT03510819|Attitude|attitude
110956|NCT03510793|microcirculation; aortic aneurysm; anesthesia|microcirculation; aortic aneurysm; anesthesia
110957|NCT03510780|Platlet rich fibrin|platlet rich fibrin
110958|NCT03510780|Enamel Matrix Derivative|enamel matrix derivative
110959|NCT03510780|Bone graft|bone graft
110960|NCT03510780|Non-inferiority study|non-inferiority study
110961|NCT03510754|Endoscopic ultrasound|endoscopic ultrasound
110962|NCT03510754|Biliary drainage|biliary drainage
110963|NCT03510754|Endoscopic ultrasound guided biliary drainage|endoscopic ultrasound guided biliary drainage
110964|NCT03510741|Schizophrenia|schizophrenia
110965|NCT03510741|Sodium Benzoate|sodium benzoate
110966|NCT03510741|N-Acetylcysteine|n-acetylcysteine
110967|NCT03510741|NMDA receptor|nmda receptor
110968|NCT03510741|Psychopharmacology|psychopharmacology
110969|NCT03510741|Anti-oxidant|anti-oxidant
110970|NCT03510741|Inflammation|inflammation
110971|NCT03510728|Protective Behavioral Strategies|protective behavioral strategies
110972|NCT03510702|Epigenetic.|epigenetic.
110973|NCT03510702|microRNA.|microrna.
110974|NCT03510702|Periodontitis.|periodontitis.
110975|NCT03510689|Cardio-oncology|cardio-oncology
110976|NCT03510650|Hemophagocytic Lymphohistiocytosis (HLH)|hemophagocytic lymphohistiocytosis (hlh)
110977|NCT03510650|Hemophagocytic syndrome (HPS)|hemophagocytic syndrome (hps)
110978|NCT03510650|critically ill|critically ill
110979|NCT03510650|Intensive care unit (ICU)|intensive care unit (icu)
110980|NCT03510637|Hepatitis C, Genotype 4, DAAs, Real life evaluation|hepatitis c, genotype 4, daas, real life evaluation
110981|NCT03510585|mucociliary clearance|mucociliary clearance
110982|NCT03510585|air pollution|air pollution
110983|NCT03510585|nasal lavage|nasal lavage
110984|NCT03510585|exhaled breath condensate|exhaled breath condensate
110985|NCT03510585|inflammation|inflammation
110986|NCT03510572|[18F]PI-2620, tauopathy, positron emission computed tomography|[18f]pi-2620, tauopathy, positron emission computed tomography
110987|NCT03510533|autoantibodies (autoAc) circulating|autoantibodies (autoac) circulating
110988|NCT03510533|neuropeptides (Ghrelin, l'α-MSH)|neuropeptides (ghrelin, l'α-msh)
110989|NCT03510533|potential digestive origin|potential digestive origin
110990|NCT03510520|Hemodialysis|hemodialysis
110991|NCT03510520|Haemodialysis|haemodialysis
110992|NCT03510520|Hemodiafiltration|hemodiafiltration
110993|NCT03510520|Haemodiafiltration|haemodiafiltration
110994|NCT03510520|Dialysis membrane|dialysis membrane
110995|NCT03510520|Endothelial Microvesicles|endothelial microvesicles
110996|NCT03510520|Pulse Wave Velocity|pulse wave velocity
110997|NCT03510507|Lyme arthritis|lyme arthritis
110998|NCT03510507|Borrelia burgdorferi|borrelia burgdorferi
110999|NCT03510507|vector tick|vector tick
111000|NCT03510507|Arthritis|arthritis
111001|NCT03510507|joints|joints
111002|NCT03510481|VENOUS|venous
111003|NCT03510481|Malaria|malaria
111004|NCT03510481|Efficacy|efficacy
111005|NCT03510481|Booster|booster
111006|NCT03510468|Antiretrovial Therapy|antiretrovial therapy
111007|NCT03510468|Human Immunodeficiency Virus|human immunodeficiency virus
111709|NCT03505710|NSCLC|nsclc
111008|NCT03510468|Latent Tuberculosis Infection (LTBI)|latent tuberculosis infection (ltbi)
111009|NCT03510468|Drug-Drug Interaction|drug-drug interaction
111010|NCT03510468|Rifamycin|rifamycin
111012|NCT03510455|Fibroblast Growth Factor (FGF23)|fibroblast growth factor (fgf23)
111013|NCT03510455|Hypophosphatemia|hypophosphatemia
111014|NCT03510442|Inflammation|inflammation
111015|NCT03510442|Fever|fever
111016|NCT03510442|Arthritis|arthritis
111017|NCT03510442|Sequencing|sequencing
111018|NCT03510416|apatinib，TACE， hepatocellular carcinoma|apatinib，tace， hepatocellular carcinoma
111019|NCT03510390|head and neck cancer|head and neck cancer
111020|NCT03510390|tissue hypoxia|tissue hypoxia
111021|NCT03510390|metformin|metformin
111022|NCT03510364|Subjective social status|subjective social status
111023|NCT03510364|Obesity|obesity
111024|NCT03510364|High calorie intake|high calorie intake
111025|NCT03510364|Energy balance|energy balance
111026|NCT03510364|Eating behavior|eating behavior
111027|NCT03510325|Schizophrenia; Antipsychotics；Cost-Effectiveness Analyses|schizophrenia; antipsychotics；cost-effectiveness analyses
111028|NCT03510286|proteinuria|proteinuria
111029|NCT03510286|preeclampsia|preeclampsia
111030|NCT03510286|diagnostic|diagnostic
111031|NCT03510286|dipstick|dipstick
111032|NCT03510286|protein|protein
111033|NCT03510286|urine|urine
111034|NCT03510286|creatinine|creatinine
111035|NCT03510273|Thermocoagulation|thermocoagulation
111036|NCT03510273|Treatment|treatment
111037|NCT03510273|Cervical precancer|cervical precancer
111038|NCT03510260|Cesarean, Consent, Electronic, Satisfaction|cesarean, consent, electronic, satisfaction
111039|NCT03510234|Pigmentary retinopathy|pigmentary retinopathy
111040|NCT03510234|Argus II retinal prosthesis|argus ii retinal prosthesis
111041|NCT03510234|Self-confidence|self-confidence
111042|NCT03510221|Hypertension|hypertension
111043|NCT03510221|Oxidative stress|oxidative stress
111044|NCT03510221|Antioxidant|antioxidant
111045|NCT03510221|Autonomic imbalance|autonomic imbalance
111046|NCT03510221|Insulin resistance|insulin resistance
111047|NCT03510221|Cytokines|cytokines
111048|NCT03510143|thyroid cancer|thyroid cancer
111049|NCT03510143|Neoveil|neoveil
111050|NCT03510143|seroma|seroma
111051|NCT03510143|chyle leakage|chyle leakage
111052|NCT03510117|Mindfulness|mindfulness
111053|NCT03510117|Patient reported outcomes measures|patient reported outcomes measures
111054|NCT03510117|PROMIS|promis
111055|NCT03510104|MerTK|mertk
111056|NCT03510078|Diabetes Mellitus|diabetes mellitus
111057|NCT03510078|hyperglycemic control|hyperglycemic control
111058|NCT03510078|hospitalization|hospitalization
111059|NCT03510078|internal medicine|internal medicine
111060|NCT03510065|hip arthroplasty|hip arthroplasty
111061|NCT03510065|revision arthroplasty|revision arthroplasty
111062|NCT03510065|survival|survival
111063|NCT03510052|diet|diet
111064|NCT03510052|Fecal Incontinence|fecal incontinence
111065|NCT03510052|FI|fi
111066|NCT03510052|ABL|abl
111067|NCT03510039|Involuntary commitment hospitalization|involuntary commitment hospitalization
111068|NCT03510039|close relative|close relative
111069|NCT03510026|internal thoracic artery harvesting|internal thoracic artery harvesting
111070|NCT03510026|arterial graft patency|arterial graft patency
111071|NCT03510026|electrosurgery|electrosurgery
111072|NCT03510026|arterial graft preparation|arterial graft preparation
111073|NCT03510013|low flow anesthesia|low flow anesthesia
111074|NCT03510013|wash-in|wash-in
111075|NCT03510013|sevoflurane|sevoflurane
111076|NCT03510000|T1DM|t1dm
111077|NCT03510000|artificial pancreas|artificial pancreas
111078|NCT03510000|insulin pump|insulin pump
111079|NCT03510000|empagliflozin|empagliflozin
111080|NCT03510000|SGLT2 inhibitor|sglt2 inhibitor
111081|NCT03510000|carbohydrate counting|carbohydrate counting
111082|NCT03509935|ultrasound,|ultrasound,
111083|NCT03509935|high-risk surgery|high-risk surgery
111084|NCT03509935|intensive care|intensive care
111085|NCT03509909|yoga|yoga
111086|NCT03509909|exercise|exercise
111087|NCT03509909|randomized controlled trial|randomized controlled trial
111088|NCT03509870|diabetes|diabetes
111089|NCT03509818|Klotho|klotho
111090|NCT03509818|Exercise|exercise
111091|NCT03509818|Physical Fitness|physical fitness
111092|NCT03509805|sleep apnea syndrome|sleep apnea syndrome
111093|NCT03509805|obesity|obesity
111094|NCT03509805|pregnancy|pregnancy
111095|NCT03509805|preeclampsia|preeclampsia
111096|NCT03509766|allergic|allergic
111097|NCT03509766|rhinitis|rhinitis
111098|NCT03509766|allergy|allergy
111099|NCT03509766|asthma|asthma
111100|NCT03509766|food allergy|food allergy
111101|NCT03509766|skin testing|skin testing
111102|NCT03509766|skin prick test|skin prick test
111103|NCT03509753|Prebiotic fiber|prebiotic fiber
111104|NCT03509701|Reversible cerebral vasoconstriction syndrome|reversible cerebral vasoconstriction syndrome
111105|NCT03509701|Herpes zoster|herpes zoster
111106|NCT03509701|Varicella-zoster virus infection|varicella-zoster virus infection
111107|NCT03509688|entecavir|entecavir
111108|NCT03509688|resveratrol|resveratrol
111109|NCT03509688|thymosin|thymosin
111111|NCT03509675|Oral Ulceration|oral ulceration
111112|NCT03509662|Vitamin C|vitamin c
111113|NCT03509662|Cardiac Arrest|cardiac arrest
111114|NCT03509662|Post-cardiac arrest syndrome|post-cardiac arrest syndrome
111115|NCT03509662|Oxidative stress|oxidative stress
111116|NCT03509623|neovascular age-related macular degeneration|neovascular age-related macular degeneration
111117|NCT03509623|aflibercept|aflibercept
111118|NCT03509623|intravitreal anti-VEGF|intravitreal anti-vegf
111119|NCT03509623|coagulation|coagulation
111120|NCT03509623|platelet count|platelet count
111121|NCT03509623|D-Dimer|d-dimer
111122|NCT03509623|Fibrinogen|fibrinogen
111123|NCT03509610|Nutrition|nutrition
111124|NCT03509610|Carbohydrates|carbohydrates
111125|NCT03509597|Cognitive remediation|cognitive remediation
111126|NCT03509597|Aerobic exercise|aerobic exercise
111127|NCT03509597|Physical exercise|physical exercise
111128|NCT03509597|Negative symptoms|negative symptoms
111129|NCT03509597|Functional outcome|functional outcome
111130|NCT03509597|Cognition|cognition
111131|NCT03509558|Spinal electrical stimulation|spinal electrical stimulation
111132|NCT03509545|natriuresis|natriuresis
111133|NCT03509519|neuromuscular electrical stimulation|neuromuscular electrical stimulation
111134|NCT03509519|physical activity|physical activity
111135|NCT03509519|muscular strength|muscular strength
111136|NCT03509493|Primary prevention|primary prevention
111137|NCT03509493|Secondary prevention|secondary prevention
111138|NCT03509493|Clinical practice|clinical practice
111139|NCT03509467|skin cancer prevention|skin cancer prevention
111140|NCT03509467|educational materials|educational materials
111141|NCT03509467|skin cancer risk|skin cancer risk
111142|NCT03509467|questionnaire|questionnaire
111143|NCT03509467|MC1R genotype|mc1r genotype
111144|NCT03509441|South Asian|south asian
111145|NCT03509441|Insulin Resistance|insulin resistance
111146|NCT03509441|Cardiac Fibrosis|cardiac fibrosis
111148|NCT03509441|Diabetes|diabetes
111149|NCT03509441|Cardiomyopathy|cardiomyopathy
111150|NCT03509428|Exercise|exercise
111151|NCT03509428|mortality|mortality
111152|NCT03509428|morbidity|morbidity
111153|NCT03509428|surgery|surgery
111154|NCT03509428|colorectal|colorectal
111155|NCT03509428|upper gastrointestinal|upper gastrointestinal
111156|NCT03509428|hepatobiliary|hepatobiliary
111157|NCT03509428|urology|urology
111158|NCT03509428|lung|lung
111159|NCT03509428|nutrition|nutrition
111160|NCT03509428|psychology|psychology
111161|NCT03509415|Confocal|confocal
111162|NCT03509415|RCM|rcm
111163|NCT03509415|Imaging|imaging
111164|NCT03509415|Skin cancer|skin cancer
111165|NCT03509402|short dental implants|short dental implants
111166|NCT03509402|full-arch prosthesis|full-arch prosthesis
111167|NCT03509350|Vitamin C|vitamin c
111168|NCT03509350|Thiamine|thiamine
111169|NCT03509350|Corticosteroid|corticosteroid
111170|NCT03509337|Elastography, Nervous tissue, Muscle tonus|elastography, nervous tissue, muscle tonus
111171|NCT03509311|Asthma|asthma
111172|NCT03509311|Physical activity|physical activity
111173|NCT03509311|Cardiorespiratory fitness|cardiorespiratory fitness
111174|NCT03509311|Quality of life|quality of life
111175|NCT03509298|activated CIK|activated cik
111176|NCT03509298|MUC1|muc1
111177|NCT03509298|bispecific antibody|bispecific antibody
111178|NCT03509298|pancreatic cancer|pancreatic cancer
111179|NCT03509233|periodontitis|periodontitis
111180|NCT03509233|full mouth scaling|full mouth scaling
111181|NCT03509233|air abrasion|air abrasion
111182|NCT03509233|scaling|scaling
111183|NCT03509220|Colonoscopy|colonoscopy
111184|NCT03509220|PBK-1701TC|pbk-1701tc
111185|NCT03509220|Bowel cleansing|bowel cleansing
111186|NCT03509207|Uterine sarcoma|uterine sarcoma
111187|NCT03509207|Histone deacetylases|histone deacetylases
111188|NCT03509194|liver|liver
111189|NCT03509194|children|children
111190|NCT03509194|liver transplantation|liver transplantation
111191|NCT03509194|liver cirrhosis|liver cirrhosis
111192|NCT03509181|interpretation bias|interpretation bias
111193|NCT03509181|smartphone|smartphone
111194|NCT03509181|partial hospital|partial hospital
111195|NCT03509155|Infant and Young Child Feeding|infant and young child feeding
111196|NCT03509155|Program Evaluation|program evaluation
111197|NCT03509155|Food Supplementation|food supplementation
111198|NCT03509155|Biscuit|biscuit
111199|NCT03509155|wasting children|wasting children
111200|NCT03509116|patient experience|patient experience
111201|NCT03509116|disease-related malnutrition|disease-related malnutrition
111202|NCT03509116|nutritional care|nutritional care
111203|NCT03509116|dietetic consultation|dietetic consultation
111204|NCT03509116|older adults|older adults
111205|NCT03509116|oral nutritional support|oral nutritional support
111206|NCT03509103|Partograpgh|partograpgh
111207|NCT03509090|regional anesthesia|regional anesthesia
111208|NCT03509090|erector spinae plane block|erector spinae plane block
111209|NCT03509090|postoperative pain|postoperative pain
111210|NCT03509077|geriatric|geriatric
111211|NCT03509077|addiction|addiction
111212|NCT03509064|Primary sjogren syndrome|primary sjogren syndrome
111213|NCT03509064|Small fiber neuropathy|small fiber neuropathy
111214|NCT03509064|Quality of life|quality of life
111215|NCT03509064|Medico-economic impact|medico-economic impact
111216|NCT03509051|Allogeneic stem cell transplantation|allogeneic stem cell transplantation
111217|NCT03509012|Durvalumab|durvalumab
111218|NCT03509012|Chemotherapy|chemotherapy
111219|NCT03509012|Radiotherapy|radiotherapy
111220|NCT03509012|HNSCC|hnscc
111221|NCT03509012|NSCLC|nsclc
111222|NCT03509012|SCLC|sclc
111223|NCT03509012|locally-advanced|locally-advanced
111224|NCT03509012|limited stage|limited stage
111225|NCT03509012|first line|first line
111226|NCT03508934|Diabetes Mellitus, Type 2|diabetes mellitus, type 2
111227|NCT03508934|hypoglycemia|hypoglycemia
111228|NCT03508934|Continuous Glucose Monitoring|continuous glucose monitoring
111229|NCT03508934|hospital|hospital
111230|NCT03508934|inpatient|inpatient
111231|NCT03508921|Onabotulinumtoxin|onabotulinumtoxin
111232|NCT03508908|HIV testing|hiv testing
111233|NCT03508908|ART|art
111234|NCT03508908|partner notification|partner notification
111235|NCT03508908|PrEP|prep
111236|NCT03508895|Hemp protein|hemp protein
111237|NCT03508895|Protein hydrolysate|protein hydrolysate
111238|NCT03508895|Bioactive peptides|bioactive peptides
111239|NCT03508895|Cannabis sativa|cannabis sativa
111240|NCT03508882|Eyelid|eyelid
111241|NCT03508882|Dystonia|dystonia
111242|NCT03508882|Botulinum injection|botulinum injection
111243|NCT03508882|Oculoplastics|oculoplastics
111244|NCT03508830|Liposomal Bupivacaine|liposomal bupivacaine
111245|NCT03508830|Intercostal Nerve Block|intercostal nerve block
111246|NCT03508830|Minimally Invasive Thoracic Surgery|minimally invasive thoracic surgery
111247|NCT03508817|Atropine, myopia, children|atropine, myopia, children
111248|NCT03508804|surgical abortion|surgical abortion
111249|NCT03508804|cervical anesthesia|cervical anesthesia
111250|NCT03508804|pain control|pain control
111251|NCT03508765|ASCT|asct
111252|NCT03508765|Memorial Sloan Kettering Cancer Center|memorial sloan kettering cancer center
111253|NCT03508765|18-154|18-154
111254|NCT03508726|Sarcoma|sarcoma
111255|NCT03508726|Soft tissue|soft tissue
111256|NCT03508713|Rheumatoid Arthritis|rheumatoid arthritis
111257|NCT03508713|prognosis|prognosis
111258|NCT03508700|TNX-102 SL|tnx-102 sl
111259|NCT03508700|Bedtime|bedtime
111260|NCT03508700|Sublingual|sublingual
111261|NCT03508700|Safety|safety
111262|NCT03508700|PTSD|ptsd
111263|NCT03508661|Scleroderma|scleroderma
111264|NCT03508661|Systemic Sclerosis|systemic sclerosis
111265|NCT03508661|Support group|support group
111266|NCT03508661|Training|training
111267|NCT03508661|Feasibility|feasibility
712569|NCT00579683|resistent disease|resistent disease
142267|NCT03312881|pain|pain
111268|NCT03508635|Glucocorticoid receptor; antagonist|glucocorticoid receptor; antagonist
111269|NCT03508583|mpoc|mpoc
111270|NCT03508583|Validity and Reliability|validity and reliability
111271|NCT03508518|Accessibility of health services|accessibility of health services
111272|NCT03508518|Access to psychiatric care|access to psychiatric care
111273|NCT03508518|Consultation-liaison|consultation-liaison
111274|NCT03508518|General practitioner and psychiatrist collaboration|general practitioner and psychiatrist collaboration
111275|NCT03508518|Care pathway|care pathway
111276|NCT03508505|Acute Heart Failure|acute heart failure
111277|NCT03508505|Low Output Heart Failure|low output heart failure
111278|NCT03508505|Cardiac Low Output|cardiac low output
111279|NCT03508505|Extracorporeal Membrane Oxygenation|extracorporeal membrane oxygenation
111280|NCT03508505|ECMO|ecmo
111281|NCT03508505|Venoarterial Extracorporeal membrane oxygenation|venoarterial extracorporeal membrane oxygenation
111282|NCT03508505|Cardiac Surgery|cardiac surgery
111283|NCT03508466|hypersensitivity|hypersensitivity
111284|NCT03508453|monoclonal antibody|monoclonal antibody
111285|NCT03508427|Bipolar Disorder|bipolar disorder
111286|NCT03508427|Smartphone|smartphone
111287|NCT03508427|Self-monitoring|self-monitoring
111288|NCT03508427|Objective data|objective data
111289|NCT03508414|Relapse-remitting Multiple Sclerosis|relapse-remitting multiple sclerosis
111290|NCT03508401|superior vena cava|superior vena cava
111291|NCT03508388|Liver volume|liver volume
111292|NCT03508388|Alcoholic cirrhosis|alcoholic cirrhosis
111293|NCT03508388|Liver transplantation|liver transplantation
111294|NCT03508336|disorders of consciousness|disorders of consciousness
111295|NCT03508336|swallowing|swallowing
111296|NCT03508336|prognosis prediction|prognosis prediction
111297|NCT03508336|minimally conscious state|minimally conscious state
111298|NCT03508336|vegetative state|vegetative state
111299|NCT03508297|Confocal|confocal
111300|NCT03508297|RCM|rcm
111301|NCT03508297|Imaging|imaging
111302|NCT03508297|Skin cancer|skin cancer
111303|NCT03508284|Multiple sclerosis|multiple sclerosis
111304|NCT03508284|Dual-task|dual-task
111305|NCT03508284|Balance|balance
111306|NCT03508284|Mobility|mobility
111307|NCT03508284|Cognition|cognition
111308|NCT03508245|Tourette Syndrome|tourette syndrome
111309|NCT03508245|Tourette's|tourette's
111310|NCT03508245|Tics|tics
111311|NCT03508245|Circadian|circadian
111312|NCT03508245|Sleep|sleep
111313|NCT03508219|Coronary Artery Disease (CAD)|coronary artery disease (cad)
111314|NCT03508219|Percutaneous Coronary Intervention (PCI)|percutaneous coronary intervention (pci)
111315|NCT03508219|Left Main Bifurcation|left main bifurcation
111316|NCT03508206|Students, cognitive functions, memory|students, cognitive functions, memory
111317|NCT03508193|EEN|een
111318|NCT03508193|Nutrition|nutrition
111319|NCT03508193|Diet|diet
111320|NCT03508193|IBD|ibd
111321|NCT03508180|Supportive care|supportive care
111322|NCT03508180|cancer|cancer
111323|NCT03508180|foot reflexology|foot reflexology
111324|NCT03508180|nausea|nausea
111325|NCT03508180|vomiting|vomiting
111326|NCT03508141|Fibrinogen Concentrate|fibrinogen concentrate
111327|NCT03508141|Cryoprecipitate|cryoprecipitate
111328|NCT03508102|remifentanil|remifentanil
111329|NCT03508102|bispectral index|bispectral index
111330|NCT03508102|Caesarean delivery|caesarean delivery
111331|NCT03508102|general anesthesia|general anesthesia
111332|NCT03508076|Vibrating Capsule|vibrating capsule
111333|NCT03508076|Efficacy and Safety|efficacy and safety
111334|NCT03508076|Chronic Constipation|chronic constipation
111335|NCT03508076|different vibrating modes|different vibrating modes
111336|NCT03508011|Breast Cancer|breast cancer
111337|NCT03508011|Ovarian Cancer|ovarian cancer
111338|NCT03508011|Prostate Cancer|prostate cancer
111339|NCT03508011|Advanced solid tumours|advanced solid tumours
111340|NCT03507985|morphine|morphine
111341|NCT03507985|attention disorders|attention disorders
111342|NCT03507972|ankle|ankle
111343|NCT03507972|diagnostic|diagnostic
111344|NCT03507972|ankle's ultrasound|ankle's ultrasound
111345|NCT03507972|traumatic lesion|traumatic lesion
111346|NCT03507933|villo-nodular synovitis|villo-nodular synovitis
111347|NCT03507933|Hip|hip
111348|NCT03507933|Surgery|surgery
111349|NCT03507907|neck pain|neck pain
111350|NCT03507907|older adults|older adults
111351|NCT03507907|mobilization|mobilization
111352|NCT03507894|rehabilitation|rehabilitation
111353|NCT03507894|exercise|exercise
111354|NCT03507894|stroke|stroke
111355|NCT03507894|adherence|adherence
111356|NCT03507881|isthmic spondylolisthesis|isthmic spondylolisthesis
111357|NCT03507816|Tuberculosis|tuberculosis
111358|NCT03507816|Multi-drug Resistant Tuberculosis|multi-drug resistant tuberculosis
111359|NCT03507816|Observational retrospective study|observational retrospective study
111360|NCT03507816|Clinical epidemiology|clinical epidemiology
111361|NCT03507816|Treatment outcome|treatment outcome
111362|NCT03507816|Migrant|migrant
111363|NCT03507816|Precarity|precarity
111364|NCT03507803|Gait training|gait training
142414|NCT03311997|RCT|rct
111365|NCT03507803|Walking|walking
111366|NCT03507790|Alzheimer's Disease|alzheimer's disease
111367|NCT03507764|Treadmills|treadmills
111368|NCT03507764|Exercise|exercise
111369|NCT03507764|Number of steps|number of steps
111370|NCT03507764|Dispatchers|dispatchers
111371|NCT03507725|mind-body intervention|mind-body intervention
111372|NCT03507725|18-189|18-189
111373|NCT03507712|Asymmetric, Inferior Oblique, Overaction, Surgery, Symmetric|asymmetric, inferior oblique, overaction, surgery, symmetric
111374|NCT03507699|radiotherapy|radiotherapy
111375|NCT03507699|radiosurgery|radiosurgery
111376|NCT03507699|immunotherapy|immunotherapy
111377|NCT03507699|PD-1|pd-1
111378|NCT03507699|CTLA-4|ctla-4
111379|NCT03507699|TLR9|tlr9
111380|NCT03507686|NightstaRx|nightstarx
111381|NCT03507686|NSR-REP1|nsr-rep1
111382|NCT03507686|Choroideremia|choroideremia
111383|NCT03507686|CHM|chm
111384|NCT03507686|Gene Therapy|gene therapy
111385|NCT03507686|AAV|aav
111386|NCT03507686|REP1|rep1
111387|NCT03507660|verbal instruction, pelvic diaphragm, muscle contraction|verbal instruction, pelvic diaphragm, muscle contraction
111388|NCT03507647|randomized controlled trial|randomized controlled trial
111389|NCT03507647|Mindfulness based cognitive therapy|mindfulness based cognitive therapy
111390|NCT03507647|clinical effectiveness|clinical effectiveness
111391|NCT03507647|cost-effectiveness|cost-effectiveness
111392|NCT03507647|working mechanisms|working mechanisms
111393|NCT03507634|Lidocaine|lidocaine
111394|NCT03507634|Dexmedetomidine|dexmedetomidine
111395|NCT03507634|Opioid Free|opioid free
111396|NCT03507634|Bariatric surgery|bariatric surgery
111397|NCT03507595|prostate specific membrane antigen(PMSA)|prostate specific membrane antigen(pmsa)
111398|NCT03507595|prostate cancer|prostate cancer
111399|NCT03507595|PET/CT|pet/ct
111400|NCT03507556|immature teeth, necrotic teeth|immature teeth, necrotic teeth
111401|NCT03507543|Breast Cancer|breast cancer
111402|NCT03507543|Ovarian Cancer|ovarian cancer
111403|NCT03507543|Prostate Cancer|prostate cancer
111404|NCT03507543|Advanced solid tumours|advanced solid tumours
111405|NCT03507543|primary peritoneal Cancer|primary peritoneal cancer
111406|NCT03507530|physiotherapy and rehabilitation|physiotherapy and rehabilitation
111407|NCT03507530|fear of falling|fear of falling
111408|NCT03507530|quality of life|quality of life
111409|NCT03507517|prevention|prevention
111410|NCT03507504|psychiatric aspects|psychiatric aspects
111411|NCT03507491|Pediatric|pediatric
111412|NCT03507491|Sarcoma|sarcoma
111413|NCT03507491|Neuroblastoma|neuroblastoma
111414|NCT03507491|Ewing sarcoma|ewing sarcoma
111415|NCT03507491|Osteosarcoma|osteosarcoma
111420|NCT03507491|Germ cell tumor|germ cell tumor
111421|NCT03507465|letrozole|letrozole
111422|NCT03507465|metronomic|metronomic
111423|NCT03507465|capecitabine|capecitabine
111424|NCT03507465|neoadjuvant|neoadjuvant
111425|NCT03507465|chemotherapy|chemotherapy
111426|NCT03507465|ER+/HER2-|er+/her2-
111427|NCT03507452|Malignant Mesothelioma|malignant mesothelioma
111428|NCT03507452|Malignant Pleural Epithelioid Mesothelioma|malignant pleural epithelioid mesothelioma
111429|NCT03507452|Malignant Peritoneal Epithelioid Mesothelioma|malignant peritoneal epithelioid mesothelioma
111432|NCT03507426|Retrobulbar block|retrobulbar block
111433|NCT03507426|Ketamine|ketamine
111434|NCT03507426|Ocular enucleation|ocular enucleation
111435|NCT03507426|Analgesia|analgesia
111436|NCT03507413|abdominal aortic aneurysm|abdominal aortic aneurysm
111437|NCT03507413|metformin|metformin
111438|NCT03507413|non-diabetic|non-diabetic
111439|NCT03507413|placebo|placebo
111440|NCT03507400|Introvision: mental and emotional self-regulation technique|introvision: mental and emotional self-regulation technique
111441|NCT03507400|Mindfulness, perception technique|mindfulness, perception technique
111442|NCT03507400|Migraine|migraine
111443|NCT03507387|Intramuscular|intramuscular
111444|NCT03507387|Phenylephrine|phenylephrine
111445|NCT03507374|Stroke|stroke
111446|NCT03507374|alirocumab|alirocumab
111447|NCT03507374|Intracranial Atherosclerosis|intracranial atherosclerosis
111448|NCT03507374|Intraplaque Hemorrhage|intraplaque hemorrhage
111449|NCT03507374|atorvastatin|atorvastatin
111450|NCT03507374|praluent|praluent
111451|NCT03507348|Anti-HLA alloantibodies|anti-hla alloantibodies
111452|NCT03507348|Desensitization therapy|desensitization therapy
111453|NCT03507348|Tocilizumab|tocilizumab
111454|NCT03507348|Rituximab|rituximab
111455|NCT03507335|Arrhythmia Atrial|arrhythmia atrial
111456|NCT03507335|heart rate monitoring|heart rate monitoring
111457|NCT03507335|stroke|stroke
111458|NCT03507335|atrial fibrillation|atrial fibrillation
111459|NCT03507322|texturization|texturization
111460|NCT03507322|pregnancy rate|pregnancy rate
111461|NCT03507322|oocyte donation|oocyte donation
111462|NCT03507322|2D ultrasound|2d ultrasound
111463|NCT03507322|3D ultrasound|3d ultrasound
111464|NCT03507322|assisted reproductive technology (ART)|assisted reproductive technology (art)
111465|NCT03507283|Pterygium|pterygium
111466|NCT03507283|double-headed|double-headed
111467|NCT03507283|vertical|vertical
111468|NCT03507270|FABP|fabp
111469|NCT03507270|non ST Segment Elevation Myocardial Infarction|non st segment elevation myocardial infarction
111470|NCT03507257|Cognitively Normal|cognitively normal
111471|NCT03507257|Amyloid|amyloid
111472|NCT03507257|Plaques|plaques
111473|NCT03507257|Neuroimaging|neuroimaging
111474|NCT03507257|Biomarkers|biomarkers
111475|NCT03507257|Cognition Disorder|cognition disorder
111476|NCT03507257|Dementia|dementia
111477|NCT03507257|Tau|tau
111478|NCT03507257|Early Onset Alzheimer's Disease|early onset alzheimer's disease
111479|NCT03507257|Alzheimer's Disease|alzheimer's disease
111480|NCT03507257|Mild Cognitive Impairment|mild cognitive impairment
111481|NCT03507244|Leptomeningeal metastasis|leptomeningeal metastasis
111482|NCT03507244|Malignant solid tumors|malignant solid tumors
111483|NCT03507244|Pemetrexed|pemetrexed
111484|NCT03507244|Intrathecal chemotherapy|intrathecal chemotherapy
111485|NCT03507244|Radiotherapy|radiotherapy
111486|NCT03507231|incentives|incentives
111487|NCT03507231|field study|field study
111488|NCT03507231|vaccination|vaccination
111489|NCT03507218|Obsessive Compulsive Disorder|obsessive compulsive disorder
111490|NCT03507218|Anxiety Disorder|anxiety disorder
111491|NCT03507218|PANDAS (Pediatric Autoimmune Neuropsychiatric Disorders Associated d|pandas (pediatric autoimmune neuropsychiatric disorders associated d
111492|NCT03507218|Eating Disorders|eating disorders
111493|NCT03507205|Everolimus|everolimus
111494|NCT03507205|Sirolimus|sirolimus
111495|NCT03507205|Zotarolimus|zotarolimus
111496|NCT03507205|Biolimus|biolimus
111497|NCT03507205|Drug-eluting stent|drug-eluting stent
111498|NCT03507192|MCI, Alzheimer's disease, muscle relaxation|mci, alzheimer's disease, muscle relaxation
111499|NCT03507166|RC48-ADC|rc48-adc
111500|NCT03507166|HER2|her2
111501|NCT03507153|"Nylon denture base and PEEK partial denture"|"nylon denture base and peek partial denture"
111502|NCT03507140|cirrhosis|cirrhosis
111503|NCT03507140|hepatocellular carcinoma|hepatocellular carcinoma
111504|NCT03507140|Liver transplantation|liver transplantation
111505|NCT03507140|Microbiota|microbiota
111506|NCT03507114|Rumination|rumination
111507|NCT03507114|Cognitive behavioural therapy (CBT)|cognitive behavioural therapy (cbt)
111508|NCT03507114|Depression|depression
111509|NCT03507114|Anxiety|anxiety
111510|NCT03507088|fulvestrant 500 mg|fulvestrant 500 mg
111710|NCT03505697|rehabilitation|rehabilitation
111511|NCT03507088|fluorine-18 fluoroestradiol PET-CT|fluorine-18 fluoroestradiol pet-ct
111512|NCT03507062|pH|ph
111513|NCT03507062|crystalloids|crystalloids
111514|NCT03507036|knee area|knee area
111515|NCT03507036|suprapatellar skin|suprapatellar skin
111516|NCT03507036|aging|aging
111517|NCT03507036|laxity|laxity
111518|NCT03507010|Radiotherapy|radiotherapy
111519|NCT03507010|Pain|pain
111520|NCT03506997|Immune checkpoint inhibitor|immune checkpoint inhibitor
111521|NCT03506997|Pembrolizumab|pembrolizumab
111522|NCT03506971|Young child's development|young child's development
111523|NCT03506971|Home visits|home visits
111524|NCT03506971|Early interactions|early interactions
111525|NCT03506971|attachment|attachment
111526|NCT03506971|parenthood|parenthood
111527|NCT03506932|blood sugar|blood sugar
111528|NCT03506932|insulin|insulin
111529|NCT03506932|peas|peas
111530|NCT03506932|bread|bread
111531|NCT03506932|metabolites|metabolites
111532|NCT03506906|Chronic hypoventilation syndrome|chronic hypoventilation syndrome
111533|NCT03506906|Polysomnography|polysomnography
111534|NCT03506906|Transcutaneous Capnometry|transcutaneous capnometry
111535|NCT03506906|Noninvasive Ventilation|noninvasive ventilation
111536|NCT03506906|home mechanical ventilation|home mechanical ventilation
111537|NCT03506906|Ventilator´s set-up|ventilator´s set-up
111538|NCT03506893|refractory ascite|refractory ascite
111539|NCT03506893|pump system|pump system
111540|NCT03506867|Health Equity|health equity
111541|NCT03506867|Community Based Participatory Action Research|community based participatory action research
111542|NCT03506867|Poverty Reduction|poverty reduction
111543|NCT03506815|Upper Extremity Deep Vein Thrombosis|upper extremity deep vein thrombosis
111544|NCT03506815|Thromboprophylaxis|thromboprophylaxis
111545|NCT03506815|Cancer|cancer
111546|NCT03506815|Randomized Trial|randomized trial
111547|NCT03506763|office hysteroscopy, pain measure|office hysteroscopy, pain measure
111548|NCT03506750|Conbercept|conbercept
111549|NCT03506750|PLGF|plgf
111550|NCT03506724|Hypertension, Pregnancy-induced|hypertension, pregnancy-induced
111551|NCT03506724|Pregnancy Induced Hypertension|pregnancy induced hypertension
111552|NCT03506724|Gestational Hypertension|gestational hypertension
111553|NCT03506724|Transient Hypertension, Pregnancy|transient hypertension, pregnancy
111554|NCT03506724|Pharmacogenetics|pharmacogenetics
111555|NCT03506711|Type 1 Diabetes Mellitus|type 1 diabetes mellitus
111556|NCT03506711|MRI|mri
111557|NCT03506711|Isometric handgrip exercise|isometric handgrip exercise
111558|NCT03506711|Children|children
111559|NCT03506711|Adolescents|adolescents
111560|NCT03506698|Birth weight|birth weight
111561|NCT03506685|dry needling|dry needling
111562|NCT03506685|ACL reconstruction|acl reconstruction
111563|NCT03506685|knee ROM|knee rom
111564|NCT03506685|pain management|pain management
111565|NCT03506685|opioid use|opioid use
111566|NCT03506672|Behavioral and psychological symptoms of dementia|behavioral and psychological symptoms of dementia
111567|NCT03506672|Psychosocial interventions|psychosocial interventions
111568|NCT03506672|Well-being|well-being
111569|NCT03506672|Long-term care facilities|long-term care facilities
111570|NCT03506672|Family and formal caregivers|family and formal caregivers
111571|NCT03506672|Partnership|partnership
111572|NCT03506620|femoroacetabular impingement|femoroacetabular impingement
111573|NCT03506620|hip arthroscopy|hip arthroscopy
111574|NCT03506620|QL nerve block|ql nerve block
111575|NCT03506607|exercise|exercise
111576|NCT03506607|cardiovascular|cardiovascular
111577|NCT03506607|normobaric hypoxia|normobaric hypoxia
111578|NCT03506568|Adherence|adherence
111579|NCT03506568|Medication|medication
111580|NCT03506568|Glaucoma|glaucoma
111581|NCT03506568|Device|device
111582|NCT03506555|Laparoscopy|laparoscopy
111583|NCT03506555|Hasson technique|hasson technique
111584|NCT03506555|Veress needle technique|veress needle technique
111585|NCT03506555|complications|complications
111586|NCT03506529|TEP|tep
111587|NCT03506529|hypermetabolism|hypermetabolism
111588|NCT03506516|alcohol, hangover|alcohol, hangover
111589|NCT03506503|nanofat|nanofat
111590|NCT03506503|hair loss|hair loss
111591|NCT03506503|prp|prp
111592|NCT03506477|skin of color|skin of color
111593|NCT03506477|psoriasis|psoriasis
111594|NCT03506477|Enstilar|enstilar
111595|NCT03506477|skin diseases|skin diseases
111596|NCT03506464|Plantar Fasciitis|plantar fasciitis
111597|NCT03506464|physical therapy|physical therapy
111598|NCT03506464|sonoelastography|sonoelastography
111599|NCT03506451|Financial toxicity|financial toxicity
111600|NCT03506438|critical illness|critical illness
111601|NCT03506438|palliative care|palliative care
111602|NCT03506438|mobile app|mobile app
111603|NCT03506438|psychological distress|psychological distress
111604|NCT03506438|depression|depression
111605|NCT03506438|anxiety|anxiety
111606|NCT03506438|informal caregiver|informal caregiver
111607|NCT03506412|Heart Failure|heart failure
111608|NCT03506412|HFpEF|hfpef
111609|NCT03506412|Entresto™|entresto™
111610|NCT03506412|Neprilysin|neprilysin
111611|NCT03506412|Diastolic Heart Failure|diastolic heart failure
111711|NCT03505697|exercise|exercise
111612|NCT03506386|Real World Evidence , Multiple Myeloma Profile, Brazil|real world evidence , multiple myeloma profile, brazil
111613|NCT03506321|colonoscopy|colonoscopy
111614|NCT03506321|Residual adenoma|residual adenoma
111615|NCT03506321|Recurrent adenoma|recurrent adenoma
111616|NCT03506282|Running biomechanics|running biomechanics
111617|NCT03506282|Vertical loading rate|vertical loading rate
111618|NCT03506282|Music exercise|music exercise
111619|NCT03506282|Gait analysis|gait analysis
111620|NCT03506256|urinary tract infection|urinary tract infection
111621|NCT03506256|Norfloxacin|norfloxacin
111622|NCT03506256|Fluroquinolone|fluroquinolone
111623|NCT03506256|Safety|safety
111624|NCT03506256|Pakistan|pakistan
111625|NCT03506243|IVF, rhFSH|ivf, rhfsh
111626|NCT03506230|Rewards|rewards
111627|NCT03506230|Medication Adherence|medication adherence
111628|NCT03506230|Health Behavior|health behavior
111629|NCT03506230|Diabetes Mellitus|diabetes mellitus
111630|NCT03506230|Copayments|copayments
111631|NCT03506217|mitral valve prolaps,|mitral valve prolaps,
111632|NCT03506217|chorda tendinea,|chorda tendinea,
111633|NCT03506217|cardiac output|cardiac output
111634|NCT03506204|Pelvic floor muscle strength|pelvic floor muscle strength
111635|NCT03506204|Pelvic floor dysfunction|pelvic floor dysfunction
111636|NCT03506204|Postpartum|postpartum
111637|NCT03506204|primipara|primipara
111638|NCT03506191|Stenotrophomonas maltophilia|stenotrophomonas maltophilia
111639|NCT03506191|Pneumonia|pneumonia
111640|NCT03506191|Intensive Care Unit|intensive care unit
111641|NCT03506178|Upper airway|upper airway
111642|NCT03506178|Obstructive sleep apnea|obstructive sleep apnea
111643|NCT03506178|Polysomnography|polysomnography
111644|NCT03506139|Radiotherapy|radiotherapy
111645|NCT03506139|Magnetic Resonance Imaging|magnetic resonance imaging
111646|NCT03506126|amino acid requirement|amino acid requirement
111647|NCT03506126|elderly|elderly
111648|NCT03506126|leucine|leucine
111649|NCT03506126|dietary requirement|dietary requirement
111650|NCT03506113|Gram staining|gram staining
111651|NCT03506113|Antimicrobial therapy|antimicrobial therapy
111652|NCT03506113|Empirical therapy|empirical therapy
111653|NCT03506113|Nosocomial infection|nosocomial infection
111654|NCT03506113|Mechanical ventilation|mechanical ventilation
111655|NCT03506113|Intensive care|intensive care
111656|NCT03506113|Sepsis|sepsis
111657|NCT03506100|Spirometry|spirometry
111658|NCT03506100|swimming|swimming
111659|NCT03506100|water walking|water walking
111660|NCT03506087|Advance Care Planning|advance care planning
111661|NCT03506087|Shared Decision Making|shared decision making
111662|NCT03506074|Obesity|obesity
111663|NCT03506074|Flavor|flavor
111664|NCT03506035|Shared epitope|shared epitope
111665|NCT03506035|HLA-DRB1|hla-drb1
111666|NCT03506035|Citrullinated peptides|citrullinated peptides
111667|NCT03506035|Autoantibodies|autoantibodies
111668|NCT03506022|Sleep apnea syndrome, polysomnography and glucose monitoring continu glycemia (CGMS )|sleep apnea syndrome, polysomnography and glucose monitoring continu glycemia (cgms )
111669|NCT03505983|Prosthetic Limb Design|prosthetic limb design
111670|NCT03505983|Prosthesis Fitting|prosthesis fitting
111671|NCT03505970|Physiological Phenomena|physiological phenomena
111672|NCT03505957|IV Dislodgement|iv dislodgement
111673|NCT03505931|Peripheral artery disease|peripheral artery disease
111674|NCT03505931|femoropopliteal|femoropopliteal
111675|NCT03505931|drug-eluting stent|drug-eluting stent
111676|NCT03505931|restenosis|restenosis
111677|NCT03505905|Pregnenolone|pregnenolone
111678|NCT03505892|Ankylosing Spondylitis (AS)|ankylosing spondylitis (as)
111679|NCT03505892|Adalimumab|adalimumab
111680|NCT03505892|Humira|humira
111681|NCT03505879|Next Generation Sequencing|next generation sequencing
111682|NCT03505866|HIV|hiv
111683|NCT03505866|Anti-retroviral therapy|anti-retroviral therapy
111684|NCT03505866|Intervention|intervention
111685|NCT03505866|Mental Health|mental health
111686|NCT03505853|RNAi therapeutic|rnai therapeutic
111687|NCT03505853|Porphyria|porphyria
111688|NCT03505853|Acute Hepatic Porphyria (AHP)|acute hepatic porphyria (ahp)
111689|NCT03505853|Acute Intermittent Porphyria (AIP)|acute intermittent porphyria (aip)
111690|NCT03505827|TECNIS Symfony|tecnis symfony
111691|NCT03505814|post extubation care|post extubation care
111692|NCT03505814|neonatal surgical critical care|neonatal surgical critical care
111693|NCT03505814|oxygen therapy|oxygen therapy
111694|NCT03505814|high nasal flow cannula|high nasal flow cannula
111695|NCT03505775|Hormone replacement|hormone replacement
111696|NCT03505775|Mineralocorticoids|mineralocorticoids
111697|NCT03505775|23Na-magnetic resonance imaging|23na-magnetic resonance imaging
111698|NCT03505775|Tissue sodium content|tissue sodium content
111699|NCT03505723|Noncardiac surgery|noncardiac surgery
111700|NCT03505723|Myocardial injury|myocardial injury
111701|NCT03505723|Perioperative myocardial infarction|perioperative myocardial infarction
111702|NCT03505723|Tranexamic Acid|tranexamic acid
111703|NCT03505723|Hypotension|hypotension
111704|NCT03505723|Hypertension|hypertension
111705|NCT03505710|HER2 over-expression|her2 over-expression
111706|NCT03505710|HER2 mutation|her2 mutation
111707|NCT03505710|Unresectable or metastatic|unresectable or metastatic
111708|NCT03505710|Non-squamous|non-squamous
111718|NCT03505606|Visual Acuity|visual acuity
111719|NCT03505606|Crowding|crowding
111720|NCT03505554|ALK|alk
111721|NCT03505554|relapsed|relapsed
111722|NCT03505554|lorlatinib|lorlatinib
111723|NCT03505528|Nanoparticle albumin-bound paclitaxel (Abraxane)|nanoparticle albumin-bound paclitaxel (abraxane)
111724|NCT03505528|Phenelzine Sulfate|phenelzine sulfate
111725|NCT03505528|Cancer stem cells|cancer stem cells
111726|NCT03505528|epigenetics|epigenetics
111727|NCT03505528|LSD1|lsd1
111728|NCT03505502|Cesarean Myomectomy|cesarean myomectomy
111729|NCT03505502|Tranexamic Acid|tranexamic acid
111730|NCT03505489|Mannitol|mannitol
111731|NCT03505489|Methacholine|methacholine
111732|NCT03505489|Deep inhalation|deep inhalation
111733|NCT03505489|Tidal breathing|tidal breathing
111734|NCT03505476|Ileus|ileus
111735|NCT03505476|Abdominal surgery|abdominal surgery
111736|NCT03505476|Bowel obstruction|bowel obstruction
111737|NCT03505476|Postoperative Ileus|postoperative ileus
111738|NCT03505463|Spinal cord injury|spinal cord injury
111739|NCT03505463|Biomarkers|biomarkers
111740|NCT03505463|Inflammation|inflammation
111741|NCT03505463|Trauma|trauma
111742|NCT03505450|decision support tools,|decision support tools,
111743|NCT03505437|anxiety disorders|anxiety disorders
111744|NCT03505437|spider phobia|spider phobia
111745|NCT03505437|stress|stress
111746|NCT03505437|exposure therapy|exposure therapy
111747|NCT03505437|generalization|generalization
111748|NCT03505424|Premature Infant|premature infant
111749|NCT03505424|Premature Birth|premature birth
111750|NCT03505424|Smartphone App|smartphone app
111751|NCT03505424|NICU|nicu
111752|NCT03505411|Melatonin|melatonin
111753|NCT03505411|Glutathione|glutathione
111754|NCT03505411|Glutathione peroxidase|glutathione peroxidase
111755|NCT03505411|Malondialdehyde|malondialdehyde
111756|NCT03505411|Isoprostanes|isoprostanes
111757|NCT03505411|anti-ox-LDL|anti-ox-ldl
111758|NCT03505411|Superoxide dismutase|superoxide dismutase
111759|NCT03505411|Glutathione reductase|glutathione reductase
111760|NCT03505411|Interleukin-6|interleukin-6
111761|NCT03505411|C-reactive protein|c-reactive protein
111762|NCT03505411|Autonomic nervous system|autonomic nervous system
111763|NCT03505385|Co-creation|co-creation
111764|NCT03505385|Service-learning methodology|service-learning methodology
111765|NCT03505372|Atypical ductal hyperplasia|atypical ductal hyperplasia
111766|NCT03505372|ADH|adh
111767|NCT03505346|Positron Emission Tomography|positron emission tomography
111768|NCT03505346|nuclear medicine|nuclear medicine
111769|NCT03505346|prognosis|prognosis
111777|NCT03505294|Multiple Sclerosis|multiple sclerosis
111778|NCT03505294|task-oriented training|task-oriented training
111779|NCT03505294|physical performance|physical performance
111780|NCT03505294|cognition|cognition
111781|NCT03505268|Glycosylated hemoglobin A1c (HbA1c), Telemedicine|glycosylated hemoglobin a1c (hba1c), telemedicine
111782|NCT03505164|Doxorubicin|doxorubicin
111783|NCT03505164|suPAR|supar
111784|NCT03505164|Caridomyopathy|caridomyopathy
111785|NCT03505164|Heart Failure|heart failure
111786|NCT03505164|Breast Cancer|breast cancer
111787|NCT03505138|COPD|copd
111788|NCT03505138|hospitalization|hospitalization
111789|NCT03505138|telemedicine platform|telemedicine platform
111790|NCT03505112|Goal-directed therapy|goal-directed therapy
111791|NCT03505112|stroke volume index|stroke volume index
111792|NCT03505099|gene therapy|gene therapy
111793|NCT03505047|second trimester medical abortion|second trimester medical abortion
111794|NCT03505047|Immediate versus delayed insertion|immediate versus delayed insertion
111795|NCT03505047|copper intrauterine device|copper intrauterine device
111796|NCT03505034|Spinal cord injury，Umbilical Cord Mesenchymal Stem Cells|spinal cord injury，umbilical cord mesenchymal stem cells
111797|NCT03505008|Methotrexate|methotrexate
111798|NCT03505008|Adalimumab|adalimumab
111799|NCT03505008|Autoimmune Disease|autoimmune disease
111800|NCT03505008|Connective Tissue Diseases|connective tissue diseases
111801|NCT03505008|Rheumatic Disease|rheumatic disease
111802|NCT03505008|Rheumatoid Arthritis|rheumatoid arthritis
111803|NCT03504995|Prostate|prostate
111804|NCT03504995|Irreversible Electroporation|irreversible electroporation
111805|NCT03504995|Prostate Cancer|prostate cancer
111806|NCT03504982|Vericiguat|vericiguat
111807|NCT03504982|Stable CAD|stable cad
111808|NCT03504982|QT/QTc|qt/qtc
111809|NCT03504969|umbilical cord|umbilical cord
111810|NCT03504956|MRI technique|mri technique
111811|NCT03504956|High Resolution MRI Technique|high resolution mri technique
111812|NCT03504943|Exercise|exercise
111813|NCT03504943|Hemodialysis|hemodialysis
111814|NCT03504943|Intradialytic hypotension|intradialytic hypotension
111815|NCT03504930|Surgical|surgical
111816|NCT03504930|Ileal pouch-anal anastomosis|ileal pouch-anal anastomosis
111817|NCT03504904|Chronic pain|chronic pain
111818|NCT03504904|Self-criticism|self-criticism
111819|NCT03504904|Internet-based treatment|internet-based treatment
111820|NCT03504904|ACT|act
111821|NCT03504904|CFT|cft
111822|NCT03504904|Guided self-help|guided self-help
111823|NCT03504904|Acceptance|acceptance
111824|NCT03504904|Compassion|compassion
111825|NCT03504865|Exparel|exparel
111826|NCT03504865|Bupivacaine|bupivacaine
111827|NCT03504852|psoriasis|psoriasis
111828|NCT03504852|secukinumab|secukinumab
111829|NCT03504852|immune-mediated systemic disease|immune-mediated systemic disease
111830|NCT03504852|papules|papules
111831|NCT03504852|plaques|plaques
111832|NCT03504852|itching|itching
111833|NCT03504839|defibrillator|defibrillator
111834|NCT03504826|adaptive robotics|adaptive robotics
111835|NCT03504826|locomotor training|locomotor training
111836|NCT03504826|Spinal Cord diseases|spinal cord diseases
111837|NCT03504826|walking rehabilitation|walking rehabilitation
111838|NCT03504826|Spinal Cord Injury|spinal cord injury
111839|NCT03504813|Elderly|elderly
111840|NCT03504813|Quality of life|quality of life
111841|NCT03504813|Wearables|wearables
111842|NCT03504813|Urinary incontinence|urinary incontinence
111843|NCT03504813|Insomnia|insomnia
111844|NCT03504813|Risk of falls|risk of falls
111845|NCT03504800|OCT|oct
111846|NCT03504800|Keratoconus|keratoconus
111847|NCT03504787|cerebral palsy|cerebral palsy
111848|NCT03504787|upper extremity|upper extremity
111849|NCT03504787|selective motor control|selective motor control
111850|NCT03504774|OIT|oit
111851|NCT03504774|Oral Immunotherapy|oral immunotherapy
111852|NCT03504774|Cashew Allergy|cashew allergy
111853|NCT03504774|Shrimp Allergy|shrimp allergy
111854|NCT03504748|deep repetitive transcranial magnetic stimulation|deep repetitive transcranial magnetic stimulation
111855|NCT03504748|chronic pain|chronic pain
111856|NCT03504748|parkinson|parkinson
111857|NCT03504748|treatment|treatment
111858|NCT03504748|non-motor symptom|non-motor symptom
111859|NCT03504670|Labor induction|labor induction
111860|NCT03504670|Cesarean delivery|cesarean delivery
111861|NCT03504670|Preterm labor induction|preterm labor induction
111862|NCT03504670|Duration of labor induction|duration of labor induction
111863|NCT03504657|Vertebral Artery Stenosis|vertebral artery stenosis
111864|NCT03504657|Drug-coated balloon angioplasty|drug-coated balloon angioplasty
111865|NCT03504657|Stenting|stenting
111866|NCT03504631|tamoxifen|tamoxifen
111867|NCT03504631|breast cancer|breast cancer
111868|NCT03504631|Z-endoxifen|z-endoxifen
111869|NCT03504579|rt-fMRI|rt-fmri
111870|NCT03504579|MRI|mri
111871|NCT03504579|schizophrenia|schizophrenia
111872|NCT03504579|auditory hallucinations|auditory hallucinations
111873|NCT03504579|neurofeedback|neurofeedback
111874|NCT03504540|Lupus Erythematosus, Systemic|lupus erythematosus, systemic
111875|NCT03504540|Age Related Macular Degeneration|age related macular degeneration
143021|NCT03308045|plasmid|plasmid
111876|NCT03504540|"Pseudo-drusen-like deposits"|"pseudo-drusen-like deposits"
111877|NCT03504527|ICS|ics
111878|NCT03504527|LABA|laba
111879|NCT03504527|LAMA|lama
111880|NCT03504527|therapy|therapy
111881|NCT03504527|asthma|asthma
111882|NCT03504527|COPD|copd
111883|NCT03504527|ACO|aco
111884|NCT03504514|non invasive ventilation|non invasive ventilation
111885|NCT03504514|invasive ventilation|invasive ventilation
111886|NCT03504514|neuromuscular disorder|neuromuscular disorder
111887|NCT03504514|phonation|phonation
111888|NCT03504514|speech|speech
111889|NCT03504501|RASopathies, neurofibromatosis type 1, noonan syndrome, synaptic plasticity, transcranial magnetic stimulation|rasopathies, neurofibromatosis type 1, noonan syndrome, synaptic plasticity, transcranial magnetic stimulation
111890|NCT03504462|Foot surgery|foot surgery
111891|NCT03504462|Regional Anesthesia|regional anesthesia
111892|NCT03504462|Regional Analgesia|regional analgesia
111893|NCT03504462|Ultrasound|ultrasound
111894|NCT03504462|Distal block|distal block
111895|NCT03504462|Plantar nerve block|plantar nerve block
111896|NCT03504397|HER2|her2
111897|NCT03504397|IMAB362|imab362
111898|NCT03504397|leucovorin|leucovorin
111899|NCT03504397|fluorouracil|fluorouracil
111900|NCT03504397|Gastric cancer|gastric cancer
111901|NCT03504397|claudiximab|claudiximab
111902|NCT03504397|zolbetuximab|zolbetuximab
111903|NCT03504397|oxaliplatin|oxaliplatin
111904|NCT03504397|adenocarcinoma|adenocarcinoma
112025|NCT03503747|Infants|infants
111905|NCT03504397|Gastro-Esophageal Junction cancer|gastro-esophageal junction cancer
111906|NCT03504397|HER2 Negative mFOLFOX6|her2 negative mfolfox6
111907|NCT03504371|oesophageal surgeries-epidural-erector block|oesophageal surgeries-epidural-erector block
111908|NCT03504358|surgery|surgery
111909|NCT03504358|scoring system|scoring system
111910|NCT03504358|hepatocellular carcinoma|hepatocellular carcinoma
111911|NCT03504358|homogeneity and discriminatory ability|homogeneity and discriminatory ability
111912|NCT03504358|survival|survival
111913|NCT03504332|immature teeth, revascularization|immature teeth, revascularization
111914|NCT03504319|exercise|exercise
111915|NCT03504319|inflammation|inflammation
111916|NCT03504319|metabolic inflexibility|metabolic inflexibility
111917|NCT03504319|insulin resistance|insulin resistance
111918|NCT03504319|neonatal adiposity|neonatal adiposity
111919|NCT03504293|Endosonography|endosonography
111920|NCT03504293|Endoscopic retrograde choledochography|endoscopic retrograde choledochography
111921|NCT03504280|hypovitaminosis D|hypovitaminosis d
111922|NCT03504280|cholecalciferol|cholecalciferol
111923|NCT03504280|mehadose|mehadose
111924|NCT03504267|physical activity|physical activity
111925|NCT03504267|exercise|exercise
111926|NCT03504267|patient-provider communication|patient-provider communication
111927|NCT03504254|cervical spondylotic myelopathy|cervical spondylotic myelopathy
111928|NCT03504254|diffusion tensor imaging|diffusion tensor imaging
111929|NCT03504254|functional magnetic resonance imaging|functional magnetic resonance imaging
111930|NCT03504241|mesenchymal stromal cells (MSCs)|mesenchymal stromal cells (mscs)
111931|NCT03504241|anti-rejection drugs|anti-rejection drugs
111932|NCT03504241|operational tolerance|operational tolerance
111933|NCT03504215|extremely preterm|extremely preterm
111934|NCT03504215|young adults|young adults
111936|NCT03504215|exercise capacity|exercise capacity
111937|NCT03504215|pulmonary function|pulmonary function
111938|NCT03504215|muscle oxygenation|muscle oxygenation
111939|NCT03504189|Fetal monitoring, Prenatal monitoring|fetal monitoring, prenatal monitoring
111940|NCT03504163|Pembrolizumab (MK-3475)|pembrolizumab (mk-3475)
111941|NCT03504163|17-602|17-602
111942|NCT03504137|mHealth|mhealth
111943|NCT03504137|kidney transplantation|kidney transplantation
111944|NCT03504137|medication adherence|medication adherence
111945|NCT03504137|video directly observed therapy|video directly observed therapy
111946|NCT03504098|One-carbon metabolism|one-carbon metabolism
111947|NCT03504098|Folate|folate
111948|NCT03504098|Choline|choline
111949|NCT03504098|metabolomic marker|metabolomic marker
111950|NCT03504098|Cancer risk|cancer risk
111951|NCT03504085|Chronic Low Back Pain|chronic low back pain
111952|NCT03504085|CLBP|clbp
111953|NCT03504085|Chronic Neck Pain|chronic neck pain
111954|NCT03504085|CNP|cnp
111955|NCT03504085|Chronic Pain|chronic pain
111956|NCT03504085|Military|military
111957|NCT03504085|Active Duty|active duty
111958|NCT03504085|Yoga|yoga
111959|NCT03504085|Mindbody|mindbody
111960|NCT03504072|Etanercept|etanercept
111961|NCT03504072|Infection|infection
111962|NCT03504072|Tofacitinib|tofacitinib
111963|NCT03504072|Tuberculosis|tuberculosis
111964|NCT03504072|Spondyloarthritis|spondyloarthritis
111965|NCT03504059|Obesity|obesity
111966|NCT03504059|Cardiovascular Health|cardiovascular health
111967|NCT03504059|Diabetes|diabetes
111968|NCT03504059|Adolescents|adolescents
111969|NCT03504059|Physical Activity|physical activity
111970|NCT03504059|Diet|diet
111971|NCT03504059|School-Based|school-based
111972|NCT03504046|artificial pancreas|artificial pancreas
111973|NCT03504046|hyperglycemia|hyperglycemia
111974|NCT03504046|hypoglycemia|hypoglycemia
111975|NCT03504033|Xenon|xenon
111976|NCT03504033|Liver resection|liver resection
111977|NCT03504033|post-operative liver failure|post-operative liver failure
111978|NCT03504033|anesthetics, inhalation|anesthetics, inhalation
111979|NCT03504033|Desflurane|desflurane
111980|NCT03504033|Randomized controlled trail|randomized controlled trail
111981|NCT03504033|RCT|rct
111982|NCT03504007|Deep Vein Thrombosis|deep vein thrombosis
111983|NCT03504007|Pulmonary Embolism|pulmonary embolism
111984|NCT03504007|Apixaban|apixaban
111985|NCT03504007|Rivaroxaban|rivaroxaban
111986|NCT03504007|Dabigatran|dabigatran
111987|NCT03504007|Edoxaban|edoxaban
111988|NCT03503981|Process-outcome study|process-outcome study
111989|NCT03503981|Mechanisms of change|mechanisms of change
111990|NCT03503916|Accidental fall|accidental fall
111991|NCT03503916|Postural Balance|postural balance
111992|NCT03503903|Wet cupping therapy|wet cupping therapy
111993|NCT03503903|antioxidant capacity|antioxidant capacity
111994|NCT03503890|Expanded Access, Pre-approval Access, Compassionate Use, Special Access Program, Named Patient Basis, Special Access Scheme|expanded access, pre-approval access, compassionate use, special access program, named patient basis, special access scheme
111995|NCT03503864|Neuroblastoma|neuroblastoma
111996|NCT03503864|Arsenic Trioxide|arsenic trioxide
111997|NCT03503864|Children|children
111998|NCT03503851|Mitral Regurgitation|mitral regurgitation
111999|NCT03503851|transcatheter mitral valve repair|transcatheter mitral valve repair
112000|NCT03503851|MitraClip|mitraclip
112001|NCT03503812|Randomized clinical trial|randomized clinical trial
112002|NCT03503812|Public Health Intervention|public health intervention
112003|NCT03503812|Behavioral Intervention|behavioral intervention
112004|NCT03503812|Exposure-Reduction Approaches|exposure-reduction approaches
112005|NCT03503812|Desert dust storm events|desert dust storm events
112006|NCT03503812|Climate change|climate change
112007|NCT03503812|Asthma in children|asthma in children
112008|NCT03503812|Atrial Fibrillation|atrial fibrillation
112009|NCT03503812|Air pollution|air pollution
112010|NCT03503799|breast cancer|breast cancer
112011|NCT03503799|EndoPredict®|endopredict®
112012|NCT03503799|endocrine therapy|endocrine therapy
112013|NCT03503786|PD-L1 Expression|pd-l1 expression
112014|NCT03503786|advanced endometrial cancer|advanced endometrial cancer
112015|NCT03503786|recurrent endometrial cancer|recurrent endometrial cancer
112016|NCT03503786|Patient reported outcomes|patient reported outcomes
112017|NCT03503773|Renal Denervation|renal denervation
112018|NCT03503773|Neurolysis|neurolysis
112019|NCT03503760|Extremely low magnetic field (ELF)|extremely low magnetic field (elf)
112020|NCT03503760|Fibromyalgia impact questionnaire (FIQ)|fibromyalgia impact questionnaire (fiq)
112021|NCT03503760|Pittsburgh Sleep Quality Index (PSQI)|pittsburgh sleep quality index (psqi)
112022|NCT03503760|Short Form-12 of Physical and Mental Health Summary (SF-12)|short form-12 of physical and mental health summary (sf-12)
112023|NCT03503760|"LIMFA Therapy® machine from Eywa Srl system"|"limfa therapy® machine from eywa srl system"
112024|NCT03503747|type 1 diabetes|type 1 diabetes
112027|NCT03503721|BipolEP|bipolep
112028|NCT03503721|TURP|turp
112029|NCT03503695|auricular acupuncture|auricular acupuncture
112030|NCT03503695|battlefield acupuncture|battlefield acupuncture
112031|NCT03503695|insomnia|insomnia
112032|NCT03503695|chronic pain|chronic pain
112033|NCT03503695|randomized|randomized
112034|NCT03503682|Short Course Radiotherapy|short course radiotherapy
112035|NCT03503682|Complicated Bone Metastases|complicated bone metastases
112036|NCT03503669|Memory impairment|memory impairment
112037|NCT03503669|Meditation|meditation
112038|NCT03503669|Yoga|yoga
112039|NCT03503669|Memory Training|memory training
112040|NCT03503669|Mild Cognitive Impairment|mild cognitive impairment
112041|NCT03503669|MCI|mci
112042|NCT03503669|Geriatric|geriatric
112043|NCT03503669|fMRI|fmri
112044|NCT03503669|Alzheimer's disease|alzheimer's disease
112045|NCT03503669|Cardiovascular risk|cardiovascular risk
112046|NCT03503643|prostate cancer|prostate cancer
112047|NCT03503643|cryoablation|cryoablation
112048|NCT03503630|Locally advanced rectal cancer|locally advanced rectal cancer
112049|NCT03503630|Immunotherapy|immunotherapy
112050|NCT03503630|Short course radiation|short course radiation
112051|NCT03503630|Folfox|folfox
112052|NCT03503630|Response rate|response rate
112053|NCT03503604|mAb|mab
112054|NCT03503604|VEGF|vegf
112055|NCT03503604|antibody|antibody
112056|NCT03503604|phase1|phase1
112057|NCT03503591|tympanostomy|tympanostomy
112058|NCT03503591|myringotomy|myringotomy
112059|NCT03503591|otitis media|otitis media
112060|NCT03503591|ear tubes|ear tubes
112061|NCT03503591|ear infection|ear infection
112062|NCT03503565|one-lung ventilation|one-lung ventilation
112063|NCT03503565|thoracic surgery|thoracic surgery
112064|NCT03503565|atelectasis|atelectasis
112065|NCT03503565|postoperative pulmonary complication|postoperative pulmonary complication
112066|NCT03503500|Breastfeeding|breastfeeding
143280|NCT03306381|IBS|ibs
112067|NCT03503500|Laid-back position|laid-back position
112068|NCT03503500|Breast problems|breast problems
112069|NCT03503500|Exclusive breastfeeding|exclusive breastfeeding
112070|NCT03503461|Calcineurin inhibitors|calcineurin inhibitors
112071|NCT03503461|hypertension|hypertension
112072|NCT03503461|kidney transplant|kidney transplant
112073|NCT03503461|acidosis|acidosis
112074|NCT03503461|Gordon syndrome|gordon syndrome
112075|NCT03503448|surgically assisted rapid maxillary expansion|surgically assisted rapid maxillary expansion
112076|NCT03503448|surgically assisted rapid palatal expansion|surgically assisted rapid palatal expansion
112077|NCT03503448|Malocclusion|malocclusion
112078|NCT03503435|Art Therapy|art therapy
112079|NCT03503435|Total Laryngectomy|total laryngectomy
112080|NCT03503396|drunk driving|drunk driving
112081|NCT03503396|alcohol impaired driving|alcohol impaired driving
112082|NCT03503396|drinking and driving|drinking and driving
112083|NCT03503396|ambulatory assessment|ambulatory assessment
112084|NCT03503383|Hypertension with pregnancy|hypertension with pregnancy
112085|NCT03503383|anxiety|anxiety
112086|NCT03503383|depression|depression
112087|NCT03503383|preeclampsia|preeclampsia
112088|NCT03503383|mental health|mental health
112089|NCT03503370|topical chlorhexidine|topical chlorhexidine
112090|NCT03503370|prevention|prevention
112091|NCT03503370|clinical trial|clinical trial
112092|NCT03503357|Consciousness|consciousness
112093|NCT03503357|Electroencephalography|electroencephalography
112094|NCT03503357|Anesthesia|anesthesia
112095|NCT03503305|Adipose-derived stem cells|adipose-derived stem cells
112096|NCT03503305|osteoarthritis|osteoarthritis
112097|NCT03503292|Pharmacogenetics|pharmacogenetics
112098|NCT03503292|CYP2D6|cyp2d6
112099|NCT03503292|Ondansetron|ondansetron
112100|NCT03503292|Granisetron|granisetron
112101|NCT03503292|Bariatric surgery|bariatric surgery
112102|NCT03503266|Mass Balance Study with MT-7117|mass balance study with mt-7117
112103|NCT03503240|Quality of Life|quality of life
112104|NCT03503240|survey|survey
112105|NCT03503240|18-168|18-168
112106|NCT03503214|Acid-base equilibrium|acid-base equilibrium
112107|NCT03503214|Stewart's approach|stewart's approach
112108|NCT03503214|In vitro study|in vitro study
112109|NCT03503214|Respiratory acid-base derangements|respiratory acid-base derangements
112110|NCT03503162|bowel prepartion|bowel prepartion
112111|NCT03503136|Nasopharyngeal Carcinoma|nasopharyngeal carcinoma
112112|NCT03503136|Induction chemotherapy|induction chemotherapy
112113|NCT03503136|Concurrent chemoradiotherapy|concurrent chemoradiotherapy
112114|NCT03503136|Nedaplatin|nedaplatin
112115|NCT03503136|Capecitabine|capecitabine
112116|NCT03503097|Prostate cancer|prostate cancer
112117|NCT03503097|metastatic|metastatic
112118|NCT03503097|genetic testing|genetic testing
112119|NCT03503097|cancer risk|cancer risk
112120|NCT03503097|BRCA1|brca1
112121|NCT03503097|BRCA2|brca2
112122|NCT03503084|Tai Chi Chuan|tai chi chuan
112123|NCT03503084|insulin resistance|insulin resistance
112124|NCT03503084|cholesterol|cholesterol
112125|NCT03503084|endothelin-1|endothelin-1
112126|NCT03503058|Plasmodium falciparum|plasmodium falciparum
112127|NCT03503058|Sporozoites|sporozoites
112128|NCT03503058|PfSPZ|pfspz
112129|NCT03503045|Diabetes Mellitus|diabetes mellitus
112130|NCT03503045|Polypharmacy|polypharmacy
112131|NCT03503045|Overtreatment|overtreatment
112132|NCT03503045|Undertreatment|undertreatment
112133|NCT03503032|Extracardiac Fontan|extracardiac fontan
112134|NCT03503032|Total cavo-pulmonary connection|total cavo-pulmonary connection
112135|NCT03503032|Fenestrated|fenestrated
112136|NCT03503032|Congenital heart defects|congenital heart defects
112137|NCT03503032|Pediatrics|pediatrics
112138|NCT03502993|children|children
112139|NCT03502980|Peripherally Inserted Central Catheter Line Insertion|peripherally inserted central catheter line insertion
112140|NCT03502980|Catheterization, Peripheral Venous|catheterization, peripheral venous
112141|NCT03502967|Traumatic Brain Injury|traumatic brain injury
112142|NCT03502967|TBI|tbi
112143|NCT03502928|Dry Needling|dry needling
112144|NCT03502928|Manual Therapy|manual therapy
112145|NCT03502928|Motor Control|motor control
112146|NCT03502928|Whiplash|whiplash
112147|NCT03502915|breech presentation|breech presentation
112148|NCT03502915|nitrous oxide|nitrous oxide
112149|NCT03502915|analgesia|analgesia
112150|NCT03502915|pregnancy|pregnancy
112151|NCT03502889|Total Knee Arthroplasty|total knee arthroplasty
112152|NCT03502889|SPANK Block|spank block
112153|NCT03502889|Adductor Canal Block|adductor canal block
112154|NCT03502889|Regional Anesthesia|regional anesthesia
112155|NCT03502837|ERP;DOC;auditory|erp;doc;auditory
112156|NCT03502824|Chronic wounds|chronic wounds
112157|NCT03502824|PHMB|phmb
112158|NCT03502824|Pressure Ulcer|pressure ulcer
112159|NCT03502824|Wound Management|wound management
112160|NCT03502824|Collagen|collagen
112161|NCT03502824|Stage II|stage ii
112162|NCT03502824|Stage III|stage iii
112163|NCT03502824|Stage IV|stage iv
112164|NCT03502824|Pressure Injury|pressure injury
112165|NCT03502811|MitraClip|mitraclip
112166|NCT03502811|MitraClip NTR|mitraclip ntr
112167|NCT03502811|MitraClip XTR|mitraclip xtr
112168|NCT03502811|Mitral Regurgitation|mitral regurgitation
112169|NCT03502759|SUDEP|sudep
112170|NCT03502759|Epilepsy|epilepsy
112171|NCT03502681|Cisplatin-Ineligible|cisplatin-ineligible
112172|NCT03502681|Avelumab|avelumab
112173|NCT03502681|PD-L1 Monoclonal Antibody|pd-l1 monoclonal antibody
112174|NCT03502681|Eribulin Mesylate|eribulin mesylate
112175|NCT03502668|low risk myelodysplastic syndromes, MDS, ASTX727|low risk myelodysplastic syndromes, mds, astx727
112176|NCT03502655|Pain|pain
112177|NCT03502655|Peripheral intravenous catheter|peripheral intravenous catheter
112178|NCT03502655|Peripheral catheterization|peripheral catheterization
112179|NCT03502655|Communication|communication
112180|NCT03502655|Emergency Department|emergency department
112181|NCT03502642|Ropivacaine|ropivacaine
112182|NCT03502642|wound infusion|wound infusion
112183|NCT03502642|analgesia|analgesia
112184|NCT03502642|cesarean|cesarean
112185|NCT03502642|intrathecal morphine|intrathecal morphine
112186|NCT03502642|randomized controlled trial|randomized controlled trial
112187|NCT03502564|Posttraumatic stress disorder|posttraumatic stress disorder
112188|NCT03502564|Eating disorders|eating disorders
112189|NCT03502564|Cognitive behavior therapy|cognitive behavior therapy
112190|NCT03502564|Cognitive processing therapy|cognitive processing therapy
112191|NCT03502564|Randomized controlled trial|randomized controlled trial
112192|NCT03502551|ketamine|ketamine
112193|NCT03502551|suicide|suicide
112194|NCT03502473|fat flanks|fat flanks
112195|NCT03502460|Lung ultrasonography|lung ultrasonography
112196|NCT03502460|fluid administration|fluid administration
112197|NCT03502460|limitation|limitation
112198|NCT03502460|stroke volume variation|stroke volume variation
112199|NCT03502460|esophageal Doppler|esophageal doppler
112200|NCT03502421|Ketamine|ketamine
112201|NCT03502343|Pancreatic cancer|pancreatic cancer
112202|NCT03502343|Metastatic|metastatic
112203|NCT03502343|Modified|modified
112204|NCT03502343|Gemcitabine|gemcitabine
112205|NCT03502343|nab-Paclitaxel|nab-paclitaxel
112206|NCT03502317|Prehabilitation|prehabilitation
112207|NCT03502317|Gastrointestinal Cancer|gastrointestinal cancer
112600|NCT03499912|Prognosis|prognosis
112208|NCT03502317|Physical Activity|physical activity
112209|NCT03502317|Exercise|exercise
112210|NCT03502317|Surgery|surgery
112211|NCT03502304|Metabolic syndrome|metabolic syndrome
112212|NCT03502304|Obesity|obesity
112213|NCT03502291|Human challenge models|human challenge models
112214|NCT03502291|Immunity|immunity
112215|NCT03502291|Streptococcus pneumoniae|streptococcus pneumoniae
112216|NCT03502291|Live Attenuated Influenza Vaccine|live attenuated influenza vaccine
112217|NCT03502278|refugee|refugee
112218|NCT03502252|early childhood development|early childhood development
112219|NCT03502252|social and emotional development|social and emotional development
112220|NCT03502252|secure parenting relationships|secure parenting relationships
112221|NCT03502213|Prostate Cancer|prostate cancer
112222|NCT03502213|Localized Prostate Cancer|localized prostate cancer
112223|NCT03502213|Low Risk Prostate Cancer|low risk prostate cancer
112224|NCT03502213|Active Surveillance|active surveillance
112225|NCT03502213|Active Monitoring|active monitoring
112226|NCT03502213|OncotypeDX GPS|oncotypedx gps
112227|NCT03502213|Genomic Prostate Score|genomic prostate score
112228|NCT03502213|Genomic Test|genomic test
112229|NCT03502213|Molecular Test|molecular test
112230|NCT03502122|stroke|stroke
112231|NCT03502122|rehabilitation|rehabilitation
112232|NCT03502109|Medication review|medication review
112233|NCT03502109|Pharmacist|pharmacist
112234|NCT03502109|Medication therapy management|medication therapy management
112235|NCT03502109|Cardiovascular diseases|cardiovascular diseases
112236|NCT03502109|Economics|economics
112237|NCT03502109|Elderly|elderly
112238|NCT03502109|Primary Care|primary care
112239|NCT03502096|portion size|portion size
112240|NCT03502096|food intake|food intake
112241|NCT03502096|energy intake|energy intake
112242|NCT03502096|food choice|food choice
112243|NCT03502070|CF, Human Factors, TOBI® Podhaler™, user interface, IFU|cf, human factors, tobi® podhaler™, user interface, ifu
112244|NCT03502044|Myalgic Encephalomyelitis|myalgic encephalomyelitis
112245|NCT03502044|Chronic Fatigue Syndrome|chronic fatigue syndrome
112246|NCT03502044|Kinetic Oscillatory Stimulation in nasal cavity|kinetic oscillatory stimulation in nasal cavity
112247|NCT03502018|Exparel|exparel
112248|NCT03502018|Bupivacaine|bupivacaine
112249|NCT03502018|Intracapsular Fracture of the Femur|intracapsular fracture of the femur
112250|NCT03502018|Femoral Neck Fracture|femoral neck fracture
112251|NCT03502018|Hip Hemiarthroplasty|hip hemiarthroplasty
112252|NCT03501992|Papillomavirus vaccines|papillomavirus vaccines
112253|NCT03501992|Vaccination|vaccination
112254|NCT03501992|Patient acceptance of health care|patient acceptance of health care
112255|NCT03501992|Child|child
112256|NCT03501992|Parents|parents
112257|NCT03501992|Primary health care|primary health care
112258|NCT03501992|Health personnel|health personnel
112259|NCT03501992|Primary prevention|primary prevention
112260|NCT03501992|Neoplasms|neoplasms
112261|NCT03501979|HER2+|her2+
112262|NCT03501979|metastatic breast cancer|metastatic breast cancer
112263|NCT03501979|leptomeningeal disease|leptomeningeal disease
112264|NCT03501979|tucatinib|tucatinib
112265|NCT03501979|trastuzumab|trastuzumab
112266|NCT03501979|capecitabine|capecitabine
112267|NCT03501966|headache|headache
112268|NCT03501966|idiopathic intracranial hypertension (IIH)|idiopathic intracranial hypertension (iih)
112269|NCT03501966|shunt|shunt
112270|NCT03501966|fenestration|fenestration
112271|NCT03501966|acetazolamide|acetazolamide
112272|NCT03501966|visual loss|visual loss
112273|NCT03501966|diamox|diamox
112274|NCT03501953|Cognitive Change|cognitive change
112275|NCT03501953|Physical Activity|physical activity
112276|NCT03501953|Environmental Exposure|environmental exposure
112277|NCT03501953|Health Behavior|health behavior
112278|NCT03501927|Ultrasound|ultrasound
112279|NCT03501927|FOCUS|focus
112280|NCT03501927|Surgery|surgery
112281|NCT03501927|Anesthesia|anesthesia
112282|NCT03501914|Care givers|care givers
112283|NCT03501914|Adults|adults
112284|NCT03501914|Intellectual Disability|intellectual disability
112285|NCT03501914|Mindfulness|mindfulness
112286|NCT03501901|ESBL-producing enterobacteria|esbl-producing enterobacteria
112287|NCT03501901|hospital- and community-acquired urinary tract infections|hospital- and community-acquired urinary tract infections
112288|NCT03501888|Acceptance and Commitment Therapy|acceptance and commitment therapy
112289|NCT03501888|ACT|act
112290|NCT03501888|Cognitive Behavior Therapy|cognitive behavior therapy
112291|NCT03501888|CBT|cbt
112292|NCT03501888|Schizophrenia|schizophrenia
112293|NCT03501888|Psychoses|psychoses
112294|NCT03501862|Mindfulness|mindfulness
112295|NCT03501862|Cognitive therapy|cognitive therapy
112296|NCT03501849|Cancer prevention|cancer prevention
112297|NCT03501849|Cancer detection|cancer detection
112298|NCT03501849|Colonoscopy|colonoscopy
112299|NCT03501849|Polypectomy|polypectomy
112300|NCT03501849|Cold Snare|cold snare
112301|NCT03501849|Optivista|optivista
112302|NCT03501771|Acupuncture|acupuncture
112303|NCT03501771|Back pain|back pain
112304|NCT03501771|Low Back Pain|low back pain
112305|NCT03501771|Lumbago|lumbago
112306|NCT03501771|pulse diagnosis|pulse diagnosis
112307|NCT03501771|radial pressure pulse|radial pressure pulse
112308|NCT03501758|ulcerative colitis|ulcerative colitis
112309|NCT03501758|ultrasound|ultrasound
112310|NCT03501758|remission|remission
112311|NCT03501758|relapse|relapse
112313|NCT03501719|inflammation|inflammation
112314|NCT03501719|antiretroviral therapy|antiretroviral therapy
112315|NCT03501719|cohort studies|cohort studies
112316|NCT03501719|mortality|mortality
112317|NCT03501719|non-AIDS events|non-aids events
112318|NCT03501706|intertemporal tradeoffs|intertemporal tradeoffs
112319|NCT03501706|delayed gratification|delayed gratification
112320|NCT03501706|executive functioning|executive functioning
112321|NCT03501706|delay discounting|delay discounting
112322|NCT03501706|working memory|working memory
112323|NCT03501680|hyperlipidaemic pancreatitis|hyperlipidaemic pancreatitis
112324|NCT03501680|Plasmapheresis|plasmapheresis
112325|NCT03501680|insulin|insulin
112326|NCT03501654|Lenses, Intraocular|lenses, intraocular
112327|NCT03501641|cognitive load|cognitive load
112328|NCT03501641|competence|competence
112329|NCT03501641|heart rate variation|heart rate variation
112330|NCT03501641|learning|learning
112331|NCT03501641|otolaryngology|otolaryngology
112332|NCT03501641|video|video
112333|NCT03501641|virtual reality|virtual reality
112334|NCT03501615|Early Access|early access
112335|NCT03501615|Leukemia|leukemia
112336|NCT03501615|Hairy cell|hairy cell
112337|NCT03501615|Moxetumomab Pasudotox|moxetumomab pasudotox
112338|NCT03501615|PNA|pna
112339|NCT03501615|Purine analog|purine analog
112340|NCT03501615|BRAF Inhibitor|braf inhibitor
112341|NCT03501615|Rituximab|rituximab
112342|NCT03501615|Pseudomonas-immunotoxin naïve|pseudomonas-immunotoxin naïve
112343|NCT03501602|aintree, LMA protector; I-gel LMA, Fiberoptic Bronchoscope|aintree, lma protector; i-gel lma, fiberoptic bronchoscope
112344|NCT03501563|hypotensive anesthesia|hypotensive anesthesia
112345|NCT03501563|thiol / disulfide|thiol / disulfide
112346|NCT03501563|oxidative stress markers|oxidative stress markers
112347|NCT03501563|septoplasty|septoplasty
112348|NCT03501550|HCV|hcv
112349|NCT03501550|GT1|gt1
112350|NCT03501511|Diabetes MellitusType1;Fasting;Health Education;Hypoglycemia|diabetes mellitustype1;fasting;health education;hypoglycemia
112351|NCT03501498|Intestinal Transit, Bile Salts, Gut Bacteria, Volatile Organic Compounds|intestinal transit, bile salts, gut bacteria, volatile organic compounds
112352|NCT03501472|pictorial warning labels|pictorial warning labels
112353|NCT03501472|risk knowledge|risk knowledge
112354|NCT03501472|emotion|emotion
112355|NCT03501472|memory|memory
112356|NCT03501472|risk perceptions|risk perceptions
112357|NCT03501472|quit intentions|quit intentions
112358|NCT03501472|numeracy|numeracy
112359|NCT03501446|PEEP optimization|peep optimization
112360|NCT03501446|Lung volumes|lung volumes
112361|NCT03501433|postpandial|postpandial
112362|NCT03501433|lipemia|lipemia
112363|NCT03501433|microvascular|microvascular
112364|NCT03501420|Belimumab|belimumab
112365|NCT03501420|Disease Specific Programme|disease specific programme
112366|NCT03501420|rheumatologist|rheumatologist
112367|NCT03501420|Benlysta|benlysta
112368|NCT03501420|Primary Sjögren's Syndrome|primary sjögren's syndrome
112369|NCT03501420|Adelphi pSS DSP|adelphi pss dsp
112370|NCT03501394|Magnetic Resonance Imaging|magnetic resonance imaging
112371|NCT03501394|Neoadjuvant Chemotherapy|neoadjuvant chemotherapy
112372|NCT03501368|cutaneous|cutaneous
112373|NCT03501368|refractory|refractory
112374|NCT03501368|melanoma|melanoma
112375|NCT03501368|ceritinib|ceritinib
112376|NCT03501355|pacemaker|pacemaker
112377|NCT03501355|inspiratory muscle training|inspiratory muscle training
112378|NCT03501355|exercise capacity|exercise capacity
112379|NCT03501355|Quality of Life|quality of life
112380|NCT03501355|Respiratory Muscle Strength|respiratory muscle strength
112381|NCT03501342|Multiple Sclerosis|multiple sclerosis
112382|NCT03501342|virtual reality|virtual reality
112383|NCT03501342|balance|balance
112384|NCT03501342|mobility|mobility
112385|NCT03501342|fatigue|fatigue
112386|NCT03501316|Root Surface Debridement|root surface debridement
112387|NCT03501316|Hand Instrumentation|hand instrumentation
112388|NCT03501316|Ultrasonic Instrumentation|ultrasonic instrumentation
112389|NCT03501316|Systemic|systemic
112390|NCT03501316|Immune|immune
112391|NCT03501316|CRP|crp
112392|NCT03501290|Frailty|frailty
112393|NCT03501290|Malnutrition|malnutrition
112394|NCT03501290|Older adults|older adults
112395|NCT03501290|Oral Nutritional Supplements|oral nutritional supplements
112396|NCT03501290|Compliance|compliance
112397|NCT03501277|Drug therapy|drug therapy
112398|NCT03501199|immediate implant placement|immediate implant placement
112399|NCT03501186|Backward walking, stroke, gait training|backward walking, stroke, gait training
112400|NCT03501160|Regressive behaviors|regressive behaviors
112401|NCT03501160|Childish behaviors|childish behaviors
112402|NCT03501160|Socially Inappropriate Behaviors|socially inappropriate behaviors
112403|NCT03501160|Qualitative study|qualitative study
112404|NCT03501160|Schizophrenic spectrum disorder|schizophrenic spectrum disorder
112405|NCT03501160|First episode psychosis|first episode psychosis
112406|NCT03501160|Caregiving experience|caregiving experience
112407|NCT03501160|Caregiving distress|caregiving distress
112408|NCT03501134|Pro000888900|pro000888900
112409|NCT03501134|Katherine Peters|katherine peters
112410|NCT03501134|Optune|optune
112411|NCT03501134|NovoTTF|novottf
112412|NCT03501134|ACTION|action
112413|NCT03501134|Quality of life|quality of life
112414|NCT03501134|Tumor treating fields|tumor treating fields
112415|NCT03501121|intra-operative radiation therapy|intra-operative radiation therapy
112416|NCT03501108|Polypharmacy|polypharmacy
112417|NCT03501108|Multi-morbidity|multi-morbidity
112418|NCT03501108|Deprescribing|deprescribing
112419|NCT03501108|Older people|older people
112420|NCT03501108|Elderly|elderly
112421|NCT03501082|Gut microbiome|gut microbiome
112422|NCT03501069|Drug Therapy|drug therapy
112423|NCT03501056|PD-1 activated CIK|pd-1 activated cik
112424|NCT03501056|MUC1|muc1
112425|NCT03501056|Bispecific antibody|bispecific antibody
112426|NCT03501056|lung cancer|lung cancer
112427|NCT03500991|CNS, CAR T cell, HER2-positive, brain tumor|cns, car t cell, her2-positive, brain tumor
112428|NCT03500991|pediatric, young adults|pediatric, young adults
112429|NCT03500965|pictorial warning labels|pictorial warning labels
112430|NCT03500965|risk knowledge|risk knowledge
112431|NCT03500965|emotion|emotion
112432|NCT03500965|memory|memory
112433|NCT03500965|risk perceptions|risk perceptions
112434|NCT03500965|quit intentions|quit intentions
112435|NCT03500913|Growth Hormone Deficiency|growth hormone deficiency
112436|NCT03500913|Adipose Tissue|adipose tissue
112437|NCT03500913|Inflammation|inflammation
112438|NCT03500900|gastric accommodation|gastric accommodation
112439|NCT03500900|food intake|food intake
112440|NCT03500900|gastrointestinal hormones|gastrointestinal hormones
112441|NCT03500861|headache characteristics, health-related quality of life.|headache characteristics, health-related quality of life.
112442|NCT03500848|Liver transplantation|liver transplantation
112443|NCT03500848|Sirolimus|sirolimus
112444|NCT03500848|Tacrolimus|tacrolimus
112445|NCT03500848|HCC recurrence free survival|hcc recurrence free survival
112446|NCT03500822|dynamic hyperinflation|dynamic hyperinflation
112447|NCT03500822|diastolic dysfunction|diastolic dysfunction
112448|NCT03500822|COPD|copd
112449|NCT03500822|Chronic Obstructive Pulmonary Disease|chronic obstructive pulmonary disease
112450|NCT03500822|Metronome-paced Tachypnea|metronome-paced tachypnea
112451|NCT03500822|Expiratory-stenosis Breathing|expiratory-stenosis breathing
112452|NCT03500783|Cardioprotection|cardioprotection
112453|NCT03500783|Ischemia-reperfusion injury|ischemia-reperfusion injury
112454|NCT03500783|Nitric oxide|nitric oxide
112455|NCT03500783|Cardiopulmonary bypass|cardiopulmonary bypass
112456|NCT03500783|Coronary artery bypass grafting|coronary artery bypass grafting
112457|NCT03500770|Post Treatment Lyme Disease Syndrome|post treatment lyme disease syndrome
112458|NCT03500757|HoloLens|hololens
112459|NCT03500757|3D holographic guidance|3d holographic guidance
112460|NCT03500731|Lung Transplantation|lung transplantation
112461|NCT03500731|Stem Cell Transplantation|stem cell transplantation
112462|NCT03500731|Idiopathic Pulmonary Fibrosis|idiopathic pulmonary fibrosis
112463|NCT03500731|Emphysema or COPD|emphysema or copd
112464|NCT03500731|Bone marrow transplantation|bone marrow transplantation
112465|NCT03500731|Cadaveric donor|cadaveric donor
112466|NCT03500731|Unrelated donor|unrelated donor
112467|NCT03500731|HLA-Mismatch|hla-mismatch
112468|NCT03500731|BMT|bmt
112469|NCT03500731|HSCT|hsct
112470|NCT03500731|IPF|ipf
112471|NCT03500731|Pulmonary fibrosis|pulmonary fibrosis
112472|NCT03500718|cochlear implant|cochlear implant
112473|NCT03500718|threshold of electrically evoked compound action potential|threshold of electrically evoked compound action potential
112474|NCT03500718|neural response telemetry|neural response telemetry
112475|NCT03500692|Mitral Valve Regurgitation|mitral valve regurgitation
112476|NCT03500692|MitraClip|mitraclip
112477|NCT03500692|MitraClip NT|mitraclip nt
112478|NCT03500692|Japan MitraClip NT Postmarketing Surveillance|japan mitraclip nt postmarketing surveillance
112479|NCT03500666|Thyroid carcinoma|thyroid carcinoma
112480|NCT03500666|Robot surgery|robot surgery
112481|NCT03500666|Endoscopic surgery|endoscopic surgery
112482|NCT03500640|Intervention|intervention
112483|NCT03500640|Prevention|prevention
112484|NCT03500640|Weight Management|weight management
112485|NCT03500640|Physical Activity|physical activity
112486|NCT03500640|Physical Function|physical function
112487|NCT03500627|Adrenoleukodystrophy (ALD)|adrenoleukodystrophy (ald)
112488|NCT03500627|Childhood Cerebral Adrenoleukodystrophy (ccALD)|childhood cerebral adrenoleukodystrophy (ccald)
112489|NCT03500627|OP-101|op-101
112490|NCT03500627|Dendrimer|dendrimer
112491|NCT03500627|N-Acetyl-Cysteine (NAC)|n-acetyl-cysteine (nac)
112492|NCT03500614|particulate matter|particulate matter
112493|NCT03500614|phthalates|phthalates
112494|NCT03500614|cytokines|cytokines
112495|NCT03500614|chemokines|chemokines
112496|NCT03500614|epigenetics|epigenetics
112497|NCT03500614|DNA methylation|dna methylation
112498|NCT03500614|peripheral blood mononuclear cells|peripheral blood mononuclear cells
112499|NCT03500614|immune function|immune function
112500|NCT03500601|Cognition|cognition
112501|NCT03500601|Metagenomics|metagenomics
112502|NCT03500601|Metabolomics|metabolomics
112503|NCT03500575|induction therapy, photopheresis|induction therapy, photopheresis
112504|NCT03500497|reticulocyte hemoglobin content (RetHe)|reticulocyte hemoglobin content (rethe)
112505|NCT03500497|perioperative|perioperative
112506|NCT03500497|colorectal surgery|colorectal surgery
112507|NCT03500497|anemia|anemia
112508|NCT03500471|Laparoscopic|laparoscopic
112509|NCT03500471|Robotic|robotic
112510|NCT03500471|Total Gastrectomy|total gastrectomy
112511|NCT03500471|AGC|agc
112512|NCT03500432|transperineal prostate biopsy|transperineal prostate biopsy
112513|NCT03500432|local anesthesia|local anesthesia
112514|NCT03500432|prostate cancer diagnosis|prostate cancer diagnosis
112515|NCT03500367|mammilian target of rapamycin inhibitor|mammilian target of rapamycin inhibitor
112516|NCT03500367|Rapamycin (sirolimus)|rapamycin (sirolimus)
112517|NCT03500367|Treatment|treatment
112518|NCT03500367|Complications|complications
112519|NCT03500354|malnutrition|malnutrition
112520|NCT03500276|yoga|yoga
112521|NCT03500276|health-related quality of life|health-related quality of life
112522|NCT03500276|proinflammatory genes|proinflammatory genes
112523|NCT03500276|inflammatory markers|inflammatory markers
112524|NCT03500276|rheumatoid arthritis|rheumatoid arthritis
112525|NCT03500250|Complex intervention|complex intervention
112526|NCT03500250|Depression|depression
112527|NCT03500250|Nursing|nursing
112528|NCT03500250|Stroke|stroke
112529|NCT03500250|Feasibility|feasibility
112530|NCT03500237|anxiety|anxiety
112531|NCT03500237|depression|depression
112532|NCT03500237|internet-delivered cognitive behaviour therapy|internet-delivered cognitive behaviour therapy
112533|NCT03500237|randomized controlled trial|randomized controlled trial
112534|NCT03500237|patient-centered|patient-centered
112535|NCT03500237|knowledge implementation|knowledge implementation
112536|NCT03500237|mental health system|mental health system
112537|NCT03500237|therapist-assistance|therapist-assistance
112538|NCT03500224|Drug therapy|drug therapy
112539|NCT03500211|Cesarean section|cesarean section
112540|NCT03500211|Postoperative pain|postoperative pain
112541|NCT03500185|Physiotherapy|physiotherapy
112542|NCT03500185|Pelvic floor|pelvic floor
112543|NCT03500185|Urinary Incontinence|urinary incontinence
112544|NCT03500172|HIV|hiv
112545|NCT03500172|Female Sex Workers|female sex workers
112546|NCT03500172|Viral Suppression|viral suppression
112547|NCT03500172|South Africa|south africa
112548|NCT03500172|Decentralized care|decentralized care
112549|NCT03500172|Antiretroviral therapy|antiretroviral therapy
112550|NCT03500172|Differentiated care|differentiated care
112551|NCT03500133|Pediatric Hodgkin Lymphoma, therapy, reduced radiotherapy|pediatric hodgkin lymphoma, therapy, reduced radiotherapy
112552|NCT03500120|Saline suppression testing, Seated, Recumbent|saline suppression testing, seated, recumbent
112553|NCT03500107|Blue Light Emitting Diode|blue light emitting diode
112554|NCT03500107|Women|women
112555|NCT03500094|Lysosomal storage disease|lysosomal storage disease
112556|NCT03500094|migalastat|migalastat
112557|NCT03500094|AT1001|at1001
112558|NCT03500068|Pancreatic cancer|pancreatic cancer
112559|NCT03500068|Organoids|organoids
112560|NCT03500042|Chronic Obstructive Pulmonary Disease|chronic obstructive pulmonary disease
112561|NCT03500042|inspiratory muscle training|inspiratory muscle training
112562|NCT03500042|expiratory muscle training|expiratory muscle training
112563|NCT03500042|Neural Respiratory Drive|neural respiratory drive
112564|NCT03500029|Depression|depression
112565|NCT03500029|Transcranial magnetic stimulation(TMS)|transcranial magnetic stimulation(tms)
112566|NCT03500029|Resting-state functional MRI(fMRI)|resting-state functional mri(fmri)
112567|NCT03500016|Insulin resistance|insulin resistance
112568|NCT03500016|Obesity|obesity
112569|NCT03500016|Type 2 diabetes|type 2 diabetes
112570|NCT03500016|Exercise training|exercise training
112571|NCT03500003|dairy products|dairy products
112572|NCT03500003|milk|milk
112573|NCT03500003|yogurt|yogurt
112574|NCT03500003|metabolomics|metabolomics
112575|NCT03500003|elderly|elderly
112576|NCT03499990|Adrenal crisis|adrenal crisis
112577|NCT03499990|Risk factors|risk factors
112578|NCT03499977|Physical Activity|physical activity
112579|NCT03499977|Executive function|executive function
112580|NCT03499977|Anti-saccade|anti-saccade
112581|NCT03499964|pivotal trial|pivotal trial
112582|NCT03499964|randomized|randomized
112583|NCT03499964|lower urinary tract symptoms (LUTS)|lower urinary tract symptoms (luts)
112584|NCT03499964|urethral stricture|urethral stricture
112585|NCT03499964|obstruction|obstruction
112586|NCT03499951|Quality of life|quality of life
112587|NCT03499951|Participation|participation
112588|NCT03499951|Training|training
112589|NCT03499938|Asthma|asthma
112590|NCT03499938|Bronchiolitis|bronchiolitis
112591|NCT03499938|Wheezing|wheezing
112592|NCT03499938|Structured Light Plethysmography|structured light plethysmography
112593|NCT03499925|mental health|mental health
112594|NCT03499925|intervention|intervention
112595|NCT03499925|pregnancy-related complications|pregnancy-related complications
112596|NCT03499912|Acute myeloid leukemia|acute myeloid leukemia
112597|NCT03499912|IDH1|idh1
112598|NCT03499912|IDH2|idh2
112599|NCT03499912|Genetic mutations|genetic mutations
112614|NCT03499795|Anal intraepithelial neoplasia 2 (AIN2)|anal intraepithelial neoplasia 2 (ain2)
112615|NCT03499795|Anal intraepithelial neoplasia 3 (AIN3)|anal intraepithelial neoplasia 3 (ain3)
112616|NCT03499795|Peri-anal intraepithelial neoplasia 2 (PAIN2)|peri-anal intraepithelial neoplasia 2 (pain2)
112617|NCT03499795|Peri-anal intraepithelial neoplasia 3 (PAIN3)|peri-anal intraepithelial neoplasia 3 (pain3)
112619|NCT03499782|Surgery options|surgery options
112620|NCT03499782|Bayesian networks|bayesian networks
112621|NCT03499756|Postnatal depression, interpersonal psychotherapy|postnatal depression, interpersonal psychotherapy
112622|NCT03499730|Midazolam|midazolam
112623|NCT03499730|Inguinal hernia|inguinal hernia
112624|NCT03499717|Fall Risk|fall risk
112625|NCT03499717|Patient Falls|patient falls
112626|NCT03499717|Fall Prevention|fall prevention
112627|NCT03499717|Patient Safety|patient safety
112628|NCT03499704|Drug therapy|drug therapy
112629|NCT03499665|Bruxism|bruxism
112630|NCT03499665|Pain|pain
112631|NCT03499665|Exercises|exercises
112632|NCT03499665|Myofascial|myofascial
112633|NCT03499665|Releasing|releasing
112634|NCT03499613|Movement analysis|movement analysis
112635|NCT03499613|Spinal kinematics|spinal kinematics
112636|NCT03499613|Muscle activity|muscle activity
112637|NCT03499613|Pain-related fear|pain-related fear
112638|NCT03499613|Rehabilitation|rehabilitation
112639|NCT03499613|Spine|spine
112640|NCT03499600|Cultural assessment|cultural assessment
112641|NCT03499600|Engagement|engagement
112642|NCT03499600|Diverse Populations|diverse populations
112643|NCT03499548|Intensive|intensive
112644|NCT03499548|Cognitive Behavioral Therapy|cognitive behavioral therapy
112645|NCT03499548|Male prisoners|male prisoners
112646|NCT03499535|Risk Perception|risk perception
112647|NCT03499522|Hemophilic arthropathy|hemophilic arthropathy
112648|NCT03499522|Pain|pain
112649|NCT03499522|Functional Disease Present|functional disease present
112650|NCT03499522|Quality of life|quality of life
112651|NCT03499522|Anxiety|anxiety
112652|NCT03499522|Stress|stress
112653|NCT03499522|Coping strategies|coping strategies
112654|NCT03499496|plaques detection by ultrasound|plaques detection by ultrasound
112655|NCT03499483|Post-Exposure-Prophylaxis|post-exposure-prophylaxis
112656|NCT03499470|copd|copd
112657|NCT03499470|exacerbation|exacerbation
112658|NCT03499470|structured discharge|structured discharge
112659|NCT03499470|readmission|readmission
112660|NCT03499470|chronic respiratory failure|chronic respiratory failure
112661|NCT03499457|Penicillin Allergy|penicillin allergy
112662|NCT03499457|chalenge test|chalenge test
112663|NCT03499457|primary clinic|primary clinic
112664|NCT03499418|newborn|newborn
112665|NCT03499418|TTN|ttn
112666|NCT03499418|PPHN|pphn
112667|NCT03499405|development and health disparities and navigation|development and health disparities and navigation
112668|NCT03499392|psychological factors|psychological factors
112669|NCT03499379|Intrauterine device (IUD)|intrauterine device (iud)
112670|NCT03499379|Depression|depression
112671|NCT03499379|Stress hormones|stress hormones
112672|NCT03499379|Mood changes|mood changes
112673|NCT03499366|enterovirus D68|enterovirus d68
112674|NCT03499366|AFP|afp
112675|NCT03499366|AFM|afm
112676|NCT03499366|EV-D68|ev-d68
112677|NCT03499366|acute flaccid myelitis|acute flaccid myelitis
112678|NCT03499366|acute flaccid paresis|acute flaccid paresis
112679|NCT03499353|Neoadjuvant Therapy, Triple Negative Breast Cancer, BRACA Positive|neoadjuvant therapy, triple negative breast cancer, braca positive
112680|NCT03499340|pictorial warning labels|pictorial warning labels
112681|NCT03499340|risk knowledge|risk knowledge
112682|NCT03499340|emotion|emotion
112683|NCT03499340|memory|memory
112684|NCT03499340|risk perceptions|risk perceptions
112685|NCT03499340|quit intentions|quit intentions
112686|NCT03499327|vitamin D|vitamin d
112687|NCT03499327|ergosterol|ergosterol
112688|NCT03499327|7-dehydro-cholesterol|7-dehydro-cholesterol
112689|NCT03499327|wheat germ oil|wheat germ oil
112690|NCT03499314|Anodal transcranial stimulation (tDCS)|anodal transcranial stimulation (tdcs)
112691|NCT03499301|Chronic pain|chronic pain
112692|NCT03499301|Emergency|emergency
112693|NCT03499301|Satisfaction|satisfaction
112694|NCT03499288|Cerebral Palsy|cerebral palsy
112695|NCT03499275|Neuromuscular electrical stimulation|neuromuscular electrical stimulation
112696|NCT03499262|Social ABCs|social abcs
112697|NCT03499262|Early Intervention|early intervention
112698|NCT03499262|Autism Spectrum Disorder (ASD)|autism spectrum disorder (asd)
112705|NCT03499262|Positive Affect|positive affect
112706|NCT03499262|Social Smiling|social smiling
112707|NCT03499262|Social Orienting|social orienting
112708|NCT03499262|Naturalistic Developmental Behaviour Intervention|naturalistic developmental behaviour intervention
112709|NCT03499262|NDBI|ndbi
112710|NCT03499262|Autism|autism
112711|NCT03499262|Early Identification|early identification
112719|NCT03499210|Stroke|stroke
112720|NCT03499210|Exoskeleton|exoskeleton
112721|NCT03499210|Hemiparesis|hemiparesis
112722|NCT03499210|Hemiplegia|hemiplegia
112723|NCT03499145|conjunctivitis|conjunctivitis
112724|NCT03499145|keratitis|keratitis
112725|NCT03499145|pterygium|pterygium
112726|NCT03499145|cataracts|cataracts
112727|NCT03499132|anesthesia, obstructive sleep apnea|anesthesia, obstructive sleep apnea
112728|NCT03499093|esthetics|esthetics
112729|NCT03499093|orofacial esthetic scale|orofacial esthetic scale
112730|NCT03499080|Medication free treatment, mental illness, outcome|medication free treatment, mental illness, outcome
112731|NCT03499054|Breathing exercises|breathing exercises
112732|NCT03499054|fatigue|fatigue
112733|NCT03499054|quality of life|quality of life
112734|NCT03499002|Simulation|simulation
112735|NCT03499002|Medical Students|medical students
112736|NCT03499002|In Situ Simulation|in situ simulation
112737|NCT03498976|painful shoulder|painful shoulder
112738|NCT03498937|Borderline Personality Disorder|borderline personality disorder
112739|NCT03498937|Impulsive behavior|impulsive behavior
112740|NCT03498937|Suicidal behavior|suicidal behavior
112741|NCT03498937|Cognitive control|cognitive control
112742|NCT03498937|tDCS|tdcs
112743|NCT03498937|Noninvasive brain stimulation|noninvasive brain stimulation
112744|NCT03498924|tumor marker|tumor marker
112746|NCT03498924|CA125|ca125
112747|NCT03498924|staging|staging
112748|NCT03498924|diagnosis|diagnosis
112749|NCT03498924|Endometrial Cancer|endometrial cancer
112750|NCT03498898|Beta adrenergic receptor blockers|beta adrenergic receptor blockers
112751|NCT03498898|Analgesia nociceptive index|analgesia nociceptive index
112752|NCT03498898|Total hip replacement|total hip replacement
112753|NCT03498898|Total knee replacement|total knee replacement
112754|NCT03498885|Rectal Cancer|rectal cancer
112755|NCT03498885|inferior mesenteric artery|inferior mesenteric artery
112756|NCT03498885|Laparoscopic|laparoscopic
112757|NCT03498872|AMPfoot|ampfoot
112758|NCT03498872|Prosthetics|prosthetics
112759|NCT03498872|gait|gait
112760|NCT03498872|electro-encephalography|electro-encephalography
112761|NCT03498872|dual-task walking|dual-task walking
112762|NCT03498859|Rehabilitation|rehabilitation
112763|NCT03498833|domains|domains
112764|NCT03498833|item development|item development
112765|NCT03498833|osteoarthritis|osteoarthritis
112766|NCT03498833|scale formulation|scale formulation
112767|NCT03498833|test retest reliability|test retest reliability
112768|NCT03498820|Analgesia-Nociception Index (ANI)|analgesia-nociception index (ani)
112769|NCT03498820|General anesthesia|general anesthesia
112770|NCT03498820|Opioids|opioids
112771|NCT03498820|Remifentanil|remifentanil
144156|NCT03300804|IBS|ibs
112772|NCT03498820|Pain|pain
112773|NCT03498820|Monitoring|monitoring
112774|NCT03498807|ARDS|ards
112775|NCT03498807|Acute Respiratory Distress Syndrome|acute respiratory distress syndrome
112776|NCT03498807|PEEP|peep
112777|NCT03498807|pressure-volume loop|pressure-volume loop
112778|NCT03498807|Positive End-Expiratory Pressure|positive end-expiratory pressure
112779|NCT03498807|hysteresis|hysteresis
112780|NCT03498781|Exercise|exercise
112781|NCT03498755|fisheries|fisheries
112782|NCT03498755|Ghana|ghana
112783|NCT03498755|sub-Saharan Africa|sub-saharan africa
112784|NCT03498755|value chain|value chain
112785|NCT03498755|fish processing|fish processing
112786|NCT03498755|fish smoking|fish smoking
112787|NCT03498742|asthma|asthma
112788|NCT03498742|SABA|saba
112789|NCT03498729|Autoimmune Diseases|autoimmune diseases
112790|NCT03498690|online trial|online trial
112791|NCT03498690|decision analysis|decision analysis
112792|NCT03498677|online trial|online trial
112793|NCT03498677|decision analysis|decision analysis
112794|NCT03498664|EMR-C; EMR-S; LST|emr-c; emr-s; lst
112795|NCT03498651|Anxiety|anxiety
112796|NCT03498651|Cognitive bias|cognitive bias
112797|NCT03498651|Telemedicine|telemedicine
112798|NCT03498599|neuroimaging|neuroimaging
112799|NCT03498599|fear conditioning|fear conditioning
112800|NCT03498547|caudal block|caudal block
112801|NCT03498547|saddle block|saddle block
112802|NCT03498534|Treatment|treatment
112803|NCT03498534|Latent infection|latent infection
112804|NCT03498534|Tuberculosis|tuberculosis
112805|NCT03498534|Interferon gamma|interferon gamma
112806|NCT03498508|Cardiopulmonary Resuscitation|cardiopulmonary resuscitation
112807|NCT03498508|Knowledge|knowledge
112808|NCT03498508|In-hospital cardiac arrest|in-hospital cardiac arrest
112809|NCT03498508|Skills|skills
112810|NCT03498469|reintegration, reunification, child development|reintegration, reunification, child development
112811|NCT03498430|Indolent Non-Hodgkin's Lymphoma (iNHL) (excluding CLL)|indolent non-hodgkin's lymphoma (inhl) (excluding cll)
112812|NCT03498378|Avelumab|avelumab
112813|NCT03498378|Palbociclib|palbociclib
112814|NCT03498378|Cetuximab|cetuximab
112815|NCT03498378|Head and Neck Squamous Cell Carcinoma|head and neck squamous cell carcinoma
112816|NCT03498378|cancer|cancer
112817|NCT03498378|Recurrent Head and Neck Squamous Cell Carcinoma|recurrent head and neck squamous cell carcinoma
112818|NCT03498378|Metastatic Head and Neck Squamous Cell Carcinoma|metastatic head and neck squamous cell carcinoma
112819|NCT03498365|decision analysis|decision analysis
112820|NCT03498365|decision support|decision support
112821|NCT03498352|cardiopulmonary exercise testing, thoracic surgery|cardiopulmonary exercise testing, thoracic surgery
112822|NCT03498326|pancreatic cancer|pancreatic cancer
112823|NCT03498326|gemcitabine|gemcitabine
112824|NCT03498326|celecoxib|celecoxib
112825|NCT03498326|R0 resection|r0 resection
112826|NCT03498313|steroid hormones|steroid hormones
112827|NCT03498313|estradiol|estradiol
112828|NCT03498313|estrogen|estrogen
112829|NCT03498313|progesterone|progesterone
112830|NCT03498313|depression|depression
112831|NCT03498313|suicide|suicide
112832|NCT03498287|carpal tunnel syndrome|carpal tunnel syndrome
112833|NCT03498287|carpal tunnel|carpal tunnel
112834|NCT03498287|CTS|cts
112835|NCT03498287|musculoskeletal disorder|musculoskeletal disorder
112836|NCT03498287|peripheral neuropathy|peripheral neuropathy
112837|NCT03498287|repetitive stress injury|repetitive stress injury
112838|NCT03498287|non-invasive device|non-invasive device
112839|NCT03498287|non-significant risk|non-significant risk
112840|NCT03498287|medical device|medical device
112841|NCT03498287|wrist pain|wrist pain
112842|NCT03498274|Fitting|fitting
112843|NCT03498235|sevoflurane|sevoflurane
112844|NCT03498235|propofol|propofol
112845|NCT03498235|intracranial pressure|intracranial pressure
112846|NCT03498235|optic nerve sheath diameter|optic nerve sheath diameter
112847|NCT03498196|muscle invasive bladder cancer|muscle invasive bladder cancer
112848|NCT03498196|non-muscle invasive bladder cancer|non-muscle invasive bladder cancer
112849|NCT03498196|radical cystectomy|radical cystectomy
112850|NCT03498196|monoclonal antibodies|monoclonal antibodies
112851|NCT03498196|Avelumab|avelumab
112852|NCT03498196|Invasive Resectable disease|invasive resectable disease
112853|NCT03498196|MIBC|mibc
112854|NCT03498196|NMIBC|nmibc
112855|NCT03498196|neoadjuvant chemotherapy|neoadjuvant chemotherapy
112856|NCT03498170|Healthy Male Volunteers|healthy male volunteers
112857|NCT03498157|Prehabilitation|prehabilitation
112858|NCT03498157|Exercise|exercise
112859|NCT03498157|Breast Cancer|breast cancer
112860|NCT03498157|Physical Activity|physical activity
112861|NCT03498157|Surgery|surgery
112862|NCT03498144|acquired punctal stenosis|acquired punctal stenosis
112863|NCT03498144|epiphora|epiphora
112864|NCT03498144|lower punctum|lower punctum
112865|NCT03498144|AS-OCT|as-oct
112866|NCT03498131|Multiple Sclerosis|multiple sclerosis
112867|NCT03498131|MS|ms
112868|NCT03498131|Melatonin|melatonin
112869|NCT03498131|Supplement|supplement
112870|NCT03498118|Transversus Abdominis Plane Block|transversus abdominis plane block
112871|NCT03498118|Cesarean Delivery|cesarean delivery
112872|NCT03498105|Acute Chest Syndrome|acute chest syndrome
112873|NCT03498066|Myocardial Infarction|myocardial infarction
112874|NCT03498066|Beta-Blockers|beta-blockers
112875|NCT03498066|Stable Coronary Artery Disease|stable coronary artery disease
112876|NCT03497936|vaccine narratives|vaccine narratives
112877|NCT03497936|HPV prevention|hpv prevention
112878|NCT03497936|vaccine promotion|vaccine promotion
112879|NCT03497923|rocuronium, magnesium sulphate, neostigmine, sugammadex|rocuronium, magnesium sulphate, neostigmine, sugammadex
112880|NCT03497897|Acne, efficacy, safety|acne, efficacy, safety
112881|NCT03497884|fMRI|fmri
112882|NCT03497884|rTMS|rtms
112883|NCT03497884|functional connectivity|functional connectivity
112884|NCT03497871|Heart failure|heart failure
112885|NCT03497871|Self-management|self-management
112886|NCT03497871|Health-related quality of life|health-related quality of life
112887|NCT03497871|mHealth|mhealth
112888|NCT03497845|vaccine|vaccine
112889|NCT03497845|adjuvant|adjuvant
112890|NCT03497845|Influenza in Birds|influenza in birds
112891|NCT03497845|MF59|mf59
112892|NCT03497845|AS03|as03
112893|NCT03497832|Proton Magnetic Resonance Spectroscopy|proton magnetic resonance spectroscopy
112894|NCT03497819|CART|cart
112895|NCT03497819|Pancreatic Cancer|pancreatic cancer
112896|NCT03497819|artery infusion|artery infusion
112897|NCT03497780|Healthy Volunteers|healthy volunteers
112898|NCT03497780|ACL (Anterior Cruciate Ligament) tear|acl (anterior cruciate ligament) tear
112899|NCT03497767|Non Small Cell Lung Cancer (NSCLC)|non small cell lung cancer (nsclc)
112900|NCT03497767|EGFR mutation|egfr mutation
112901|NCT03497767|Osimertinib|osimertinib
113153|NCT03496181|MRI|mri
112902|NCT03497767|Stereotactic Radiosurgery|stereotactic radiosurgery
112903|NCT03497754|ultrasound|ultrasound
112904|NCT03497754|cardiac output|cardiac output
112905|NCT03497754|Probefix|probefix
112906|NCT03497754|passive leg raising test|passive leg raising test
112907|NCT03497741|Intensive Care Unit|intensive care unit
112908|NCT03497689|pulmonary hypertension|pulmonary hypertension
112909|NCT03497689|treprostinil|treprostinil
112910|NCT03497689|pulmonary arterial hypertension|pulmonary arterial hypertension
112911|NCT03497689|PAH|pah
112912|NCT03497689|Remodulin|remodulin
112913|NCT03497689|Orenitram|orenitram
112914|NCT03497663|Familial high risk|familial high risk
112915|NCT03497663|offspring|offspring
112916|NCT03497663|schizophrenia|schizophrenia
112917|NCT03497663|bipolar disorder|bipolar disorder
112918|NCT03497663|recurrent depression|recurrent depression
112919|NCT03497663|early intervention|early intervention
112920|NCT03497663|parental training|parental training
112921|NCT03497663|family based intervention|family based intervention
112922|NCT03497611|Transcatheter aortic valve implantation|transcatheter aortic valve implantation
112923|NCT03497611|Pacemaker|pacemaker
112924|NCT03497611|Aortic valve calcification|aortic valve calcification
112925|NCT03497611|PPI|ppi
112926|NCT03497598|D-mannose|d-mannose
112927|NCT03497585|Rehabilitation|rehabilitation
112928|NCT03497585|Pain Management|pain management
112929|NCT03497572|Leptospirosis|leptospirosis
112930|NCT03497546|Morbid obesity|morbid obesity
112931|NCT03497546|Exercise|exercise
112932|NCT03497546|Weight loss|weight loss
112933|NCT03497546|Cardiometabolic risk|cardiometabolic risk
112934|NCT03497546|Bariatric surgery|bariatric surgery
112935|NCT03497533|CD19|cd19
112936|NCT03497533|CAR-T|car-t
112937|NCT03497533|TriCAR-T-CD19|tricar-t-cd19
112938|NCT03497533|non-Hodgkin lymphoma|non-hodgkin lymphoma
112939|NCT03497533|NHL|nhl
112940|NCT03497520|surface EMG|surface emg
112941|NCT03497520|cobb angle|cobb angle
112942|NCT03497520|exercise|exercise
112943|NCT03497520|Spinal Curvatures|spinal curvatures
112944|NCT03497507|Shivering|shivering
112945|NCT03497507|Cesarean delivery|cesarean delivery
112946|NCT03497507|acupressure|acupressure
112947|NCT03497507|P6 acupoint|p6 acupoint
112948|NCT03497481|eye's anterior chamber fluid|eye's anterior chamber fluid
112949|NCT03497481|cerebrospinal fluid|cerebrospinal fluid
112950|NCT03497481|inflammatory pathology|inflammatory pathology
112951|NCT03497468|task-oriented training|task-oriented training
112952|NCT03497468|exercise training|exercise training
112953|NCT03497468|mobility|mobility
112954|NCT03497468|balance|balance
112955|NCT03497468|fatigue|fatigue
112956|NCT03497468|quality of life|quality of life
112957|NCT03497416|Preoperative Anemia|preoperative anemia
112958|NCT03497416|elderly|elderly
112959|NCT03497416|healthcare outcomes|healthcare outcomes
112960|NCT03497390|Type 2 diabetes|type 2 diabetes
112961|NCT03497390|Obesity|obesity
112962|NCT03497364|Cesarean Section|cesarean section
112963|NCT03497364|Hypotension|hypotension
112964|NCT03497364|Combined spinal-epidural anesthesia|combined spinal-epidural anesthesia
112965|NCT03497312|Rehabilitation|rehabilitation
112966|NCT03497312|children with disabilities|children with disabilities
112967|NCT03497312|general anesthesia|general anesthesia
112968|NCT03497312|Children with special healthcare need|children with special healthcare need
112969|NCT03497312|handicapped children|handicapped children
112970|NCT03497312|full mouth rehabilitation|full mouth rehabilitation
112971|NCT03497299|Schizophrenia|schizophrenia
112972|NCT03497299|Smoking|smoking
112973|NCT03497299|Lapse|lapse
112974|NCT03497299|Varenicline|varenicline
112975|NCT03497299|Sham Repetitive Transcranial Magnetic Stimulation (rTMS)|sham repetitive transcranial magnetic stimulation (rtms)
112976|NCT03497286|maternal health|maternal health
112977|NCT03497286|maternal stress|maternal stress
112978|NCT03497286|infant health|infant health
112979|NCT03497273|JAK1 inhibitor|jak1 inhibitor
112980|NCT03497273|GVHD|gvhd
112981|NCT03497273|acute GVHD|acute gvhd
112982|NCT03497273|Japan|japan
112983|NCT03497273|corticosteroids|corticosteroids
112984|NCT03497260|Type 1 Diabetes, Fructose, Exercise, Hypoglycaemia, Degludec|type 1 diabetes, fructose, exercise, hypoglycaemia, degludec
112985|NCT03497221|Nursing Education|nursing education
112986|NCT03497208|Surgery|surgery
112987|NCT03497208|melanocytes|melanocytes
112988|NCT03497208|dermarolling system|dermarolling system
112989|NCT03497169|Bariatric surgery|bariatric surgery
112990|NCT03497169|Gastrointestinal tract|gastrointestinal tract
112991|NCT03497169|Biological availability|biological availability
112992|NCT03497169|Pharmacokinetics|pharmacokinetics
112993|NCT03497169|Lisdexamfetamine Dimesylate|lisdexamfetamine dimesylate
112994|NCT03497156|Bariatric surgery|bariatric surgery
112995|NCT03497156|Gastrointestinal tract|gastrointestinal tract
112996|NCT03497156|Biological availability|biological availability
112997|NCT03497156|Pharmacokinetics|pharmacokinetics
112998|NCT03497156|Lercanidipine|lercanidipine
112999|NCT03497143|Bariatric surgery|bariatric surgery
113000|NCT03497143|Gastrointestinal tract|gastrointestinal tract
113001|NCT03497143|Biological availability|biological availability
113002|NCT03497143|Pharmacokinetics|pharmacokinetics
113003|NCT03497143|Lamotrigine|lamotrigine
113004|NCT03497130|skin regimen|skin regimen
113005|NCT03497130|moisturizer|moisturizer
113006|NCT03497130|dry skin|dry skin
113007|NCT03497130|dry|dry
113008|NCT03497130|itchy skin|itchy skin
113009|NCT03497130|skin care|skin care
113010|NCT03497117|imaging|imaging
113011|NCT03497117|hyperpolarized|hyperpolarized
113012|NCT03497117|perfluorinated|perfluorinated
113013|NCT03497117|MRI|mri
113014|NCT03497117|lung|lung
113015|NCT03497117|multiple breath washout|multiple breath washout
113016|NCT03497117|lung clearance index|lung clearance index
113017|NCT03497078|collimator|collimator
113018|NCT03497078|bone scintigraphy|bone scintigraphy
113019|NCT03497078|image quality|image quality
113020|NCT03497078|scintigraphy|scintigraphy
113021|NCT03497065|Dental devices|dental devices
113022|NCT03497065|Home care|home care
113023|NCT03497065|Awareness|awareness
113024|NCT03497065|Peri-implant mucositis|peri-implant mucositis
113025|NCT03497065|Peri-implantitis|peri-implantitis
113026|NCT03497052|IVF culture media|ivf culture media
113027|NCT03497052|Blastocyst|blastocyst
113028|NCT03497052|Time-lapse microscopy|time-lapse microscopy
113029|NCT03497013|transcranial Direct Current Stimulation|transcranial direct current stimulation
113030|NCT03497013|Randomized Controlled Trial|randomized controlled trial
113031|NCT03497013|Schizophrenia|schizophrenia
113032|NCT03497013|Tardive Dyskinesia|tardive dyskinesia
113033|NCT03497013|Abnormal Involuntary Movements Scale|abnormal involuntary movements scale
113034|NCT03497013|Tardive Dyskinesia Rating Scale|tardive dyskinesia rating scale
113035|NCT03497013|Cognition|cognition
113036|NCT03497000|optical coherence tomography angiography|optical coherence tomography angiography
113037|NCT03497000|central serous chorioretinopathy|central serous chorioretinopathy
113038|NCT03497000|photodynamic therapy|photodynamic therapy
113039|NCT03496987|Pleural Effusion|pleural effusion
113040|NCT03496987|Pleural Drainage|pleural drainage
113041|NCT03496987|Thoracentesis|thoracentesis
113042|NCT03496961|Yan Nian Jiu Zhuan Fa|yan nian jiu zhuan fa
113043|NCT03496948|PAD|pad
113044|NCT03496948|Peripheral Artery Disease|peripheral artery disease
113045|NCT03496948|Peripheral Arterial Disease|peripheral arterial disease
113046|NCT03496935|Renal replacement therapy|renal replacement therapy
113047|NCT03496922|Unventilated Cigarettes|unventilated cigarettes
113048|NCT03496922|Experimental Tobacco Marketplace|experimental tobacco marketplace
113049|NCT03496922|Demand|demand
113050|NCT03496922|Delay Discounting|delay discounting
113051|NCT03496896|Randomized Controlled Trial|randomized controlled trial
113052|NCT03496896|Patient readmission|patient readmission
113053|NCT03496896|Patient transfer|patient transfer
113054|NCT03496896|Health care utilization|health care utilization
113055|NCT03496896|Prognosis|prognosis
113056|NCT03496896|Multimorbidity|multimorbidity
113057|NCT03496896|Internal medicine|internal medicine
113058|NCT03496857|labor pain|labor pain
113059|NCT03496831|Hospitalization|hospitalization
113060|NCT03496831|Infection|infection
113061|NCT03496805|Muscadine Grape Extract|muscadine grape extract
113062|NCT03496805|Androgen Deprivation Therapy|androgen deprivation therapy
113063|NCT03496792|venous distension reflex|venous distension reflex
113064|NCT03496779|Brentuximab Vedotin|brentuximab vedotin
113065|NCT03496779|T-cell lymphoma|t-cell lymphoma
113066|NCT03496753|nipple fissure|nipple fissure
113067|NCT03496740|Postoperative pain|postoperative pain
113068|NCT03496740|Ultrasound|ultrasound
113069|NCT03496740|Dorsal Penile Nerve Block|dorsal penile nerve block
113070|NCT03496740|Pudendal Block|pudendal block
113071|NCT03496740|Hypospadias|hypospadias
113072|NCT03496727|pain, VATS|pain, vats
113073|NCT03496714|Posttraumatic stress disorder|posttraumatic stress disorder
113074|NCT03496714|Safety behaviors|safety behaviors
113075|NCT03496714|Threat appraisal|threat appraisal
113076|NCT03496714|Secondary prevention|secondary prevention
113077|NCT03496714|Internet-based|internet-based
113078|NCT03496714|PTSD|ptsd
113079|NCT03496688|Sinus floor augmentation|sinus floor augmentation
113080|NCT03496688|Bone regeneration|bone regeneration
113081|NCT03496688|Histology|histology
113082|NCT03496688|Biocompatible materials|biocompatible materials
113083|NCT03496688|Bone transplantation|bone transplantation
113084|NCT03496649|Primary Adductor tendinopathies|primary adductor tendinopathies
113085|NCT03496649|Pubalgia|pubalgia
113086|NCT03496649|Botulinum toxin type A|botulinum toxin type a
113087|NCT03496636|Ovary|ovary
113088|NCT03496636|Transplant|transplant
113089|NCT03496623|Pulmonary Hypertension|pulmonary hypertension
113090|NCT03496623|COPD|copd
113091|NCT03496623|Inhaled Treprostinil|inhaled treprostinil
113092|NCT03496623|6-Minute Walk Test|6-minute walk test
113093|NCT03496623|Tyvaso|tyvaso
113094|NCT03496610|Bupivacaine|bupivacaine
113299|NCT03495479|Chemonaiive|chemonaiive
113100|NCT03496571|EGE|ege
113101|NCT03496571|Eosinophilic gastrointestinal disorders|eosinophilic gastrointestinal disorders
113102|NCT03496571|EGID|egid
113103|NCT03496558|lactogenesis, pregnant, TG, lipidic profile, breastfeeding.|lactogenesis, pregnant, tg, lipidic profile, breastfeeding.
113104|NCT03496545|fever|fever
113105|NCT03496545|central fever|central fever
113106|NCT03496545|neurogenic fever|neurogenic fever
113107|NCT03496545|hyperthermia|hyperthermia
113108|NCT03496545|bromocriptine|bromocriptine
113109|NCT03496545|subarachnoid hemorrhage|subarachnoid hemorrhage
113110|NCT03496545|SAH|sah
113111|NCT03496545|subdural hematoma|subdural hematoma
113112|NCT03496545|SDH|sdh
113113|NCT03496545|intracerebral hemorrhage|intracerebral hemorrhage
113114|NCT03496545|ICH|ich
113115|NCT03496545|traumatic brain injury|traumatic brain injury
113116|NCT03496545|TBI|tbi
113117|NCT03496545|ischemic stroke|ischemic stroke
113118|NCT03496519|Durvalumab|durvalumab
113119|NCT03496519|Trabectedin|trabectedin
113120|NCT03496519|Maximum Tolerated Dose|maximum tolerated dose
113121|NCT03496519|Lung Cancer|lung cancer
113122|NCT03496519|Sarcoma|sarcoma
113123|NCT03496506|selexipag|selexipag
113124|NCT03496506|clopidogrel|clopidogrel
113125|NCT03496493|perioperative|perioperative
113126|NCT03496493|monitoring|monitoring
113127|NCT03496493|plethysmography|plethysmography
113128|NCT03496493|pulse oximetery|pulse oximetery
113129|NCT03496480|ptsd|ptsd
113130|NCT03496480|stress|stress
113131|NCT03496480|traumatization|traumatization
113132|NCT03496467|Treatment of pain and inflammation after Cataract Surgery|treatment of pain and inflammation after cataract surgery
113133|NCT03496454|malaria|malaria
113134|NCT03496454|infection|infection
113135|NCT03496454|controlled|controlled
113136|NCT03496428|intra-oral scanner|intra-oral scanner
113137|NCT03496428|customized impression coping|customized impression coping
113138|NCT03496428|extra-oral scanner|extra-oral scanner
113139|NCT03496428|accuracy|accuracy
113140|NCT03496376|kinesio taping|kinesio taping
113141|NCT03496376|COPD|copd
113142|NCT03496376|functional capacity|functional capacity
113143|NCT03496376|pulmonary functions|pulmonary functions
113144|NCT03496376|pulmonary rehabilitation|pulmonary rehabilitation
113145|NCT03496363|Children|children
113146|NCT03496337|activities of daily living|activities of daily living
113147|NCT03496337|assessment of motor and process skills|assessment of motor and process skills
113148|NCT03496337|validation study|validation study
113149|NCT03496337|responsiveness study|responsiveness study
113150|NCT03496259|Postoperative pain, on-Q pump, epidural, children|postoperative pain, on-q pump, epidural, children
113151|NCT03496207|PAH|pah
113152|NCT03496181|fMRI|fmri
113154|NCT03496181|18-121|18-121
113155|NCT03496181|Memorial Sloan Kettering Cancer Center|memorial sloan kettering cancer center
113156|NCT03496168|Symptomatic|symptomatic
113157|NCT03496168|Obstructive|obstructive
113158|NCT03496168|Left ventricular outflow tract gradient|left ventricular outflow tract gradient
113159|NCT03496155|parent-teen communication|parent-teen communication
113160|NCT03496155|teen strengths|teen strengths
113161|NCT03496155|adolescence|adolescence
113162|NCT03496142|Prostate biopsy approach|prostate biopsy approach
113163|NCT03496142|Transrectal prostate biopsy|transrectal prostate biopsy
113164|NCT03496142|Transperineal prostate biopsy|transperineal prostate biopsy
113165|NCT03496142|Iatrogenic infection|iatrogenic infection
144679|NCT03297125|MRI|mri
113166|NCT03496142|Prevention|prevention
113167|NCT03496090|Diverticulitis|diverticulitis
113168|NCT03496090|Uncomplicated Diverticular Disease|uncomplicated diverticular disease
113169|NCT03496090|Free diet|free diet
113170|NCT03496090|Dietary restriction|dietary restriction
113171|NCT03496090|Acute Diverticulitis|acute diverticulitis
113177|NCT03496064|Thrombectomy|thrombectomy
113178|NCT03496064|Eligibility|eligibility
113179|NCT03496064|Large vessel occlusion|large vessel occlusion
113180|NCT03496025|facial nerve palsy|facial nerve palsy
113181|NCT03496025|facial paralysis|facial paralysis
113182|NCT03496025|functional electrical stimulation|functional electrical stimulation
113183|NCT03496025|facial pacing|facial pacing
113184|NCT03496012|NightstaRx|nightstarx
113185|NCT03496012|NSR-REP1|nsr-rep1
113186|NCT03496012|Choroideremia|choroideremia
113187|NCT03496012|CHM|chm
113188|NCT03496012|Gene Therapy|gene therapy
113189|NCT03496012|AAV|aav
113190|NCT03496012|REP1|rep1
113191|NCT03495999|Hyperuricemia|hyperuricemia
113192|NCT03495999|Metabolic syndrome|metabolic syndrome
113193|NCT03495999|Left ventricular diastolic dysfunction|left ventricular diastolic dysfunction
113194|NCT03495999|Inflammation|inflammation
113300|NCT03495479|OMN54|omn54
113195|NCT03495986|Functional Electrical Stimulation|functional electrical stimulation
113196|NCT03495986|Exercise|exercise
113197|NCT03495986|Body Composition|body composition
113198|NCT03495960|non-Hodgkin's lymphoma|non-hodgkin's lymphoma
113199|NCT03495960|elderly|elderly
113200|NCT03495960|PCNSL|pcnsl
113201|NCT03495947|High Flow Nasal Cannula (HFNC).|high flow nasal cannula (hfnc).
113202|NCT03495947|Mechanical ventilation|mechanical ventilation
113203|NCT03495947|Extubation failure|extubation failure
113204|NCT03495921|ESFT|esft
113205|NCT03495921|Immunotherapy|immunotherapy
113206|NCT03495921|Phase 3|phase 3
113207|NCT03495921|irinotecan|irinotecan
113208|NCT03495921|temozolomide|temozolomide
113209|NCT03495921|First Relapse|first relapse
113210|NCT03495921|Second Line|second line
113211|NCT03495921|Vigil|vigil
113212|NCT03495921|vaccine|vaccine
113213|NCT03495921|orphan drug|orphan drug
113214|NCT03495921|soft bone|soft bone
113215|NCT03495921|pediatric|pediatric
113216|NCT03495921|FLI|fli
113217|NCT03495921|EWS|ews
113218|NCT03495921|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action
113219|NCT03495921|Antineoplastic Agents|antineoplastic agents
113220|NCT03495908|VGo|vgo
113221|NCT03495908|Insulin|insulin
113222|NCT03495908|Type 2 Diabetes|type 2 diabetes
113223|NCT03495895|Disadvantaged families|disadvantaged families
113224|NCT03495895|Pregnancy|pregnancy
113225|NCT03495895|Intervention|intervention
113226|NCT03495895|Minding the Baby|minding the baby
113227|NCT03495856|Mindfulness-based stress reduction|mindfulness-based stress reduction
113228|NCT03495856|Mindfulness|mindfulness
113229|NCT03495856|chronic pain|chronic pain
113230|NCT03495856|Feasibility|feasibility
113231|NCT03495856|Intervention|intervention
113232|NCT03495804|CT enterography|ct enterography
113233|NCT03495804|oral contrast agent|oral contrast agent
113234|NCT03495791|RA|ra
113235|NCT03495791|Rheumatoid Arthritis|rheumatoid arthritis
113236|NCT03495791|Arthritis|arthritis
113237|NCT03495765|Diabetic macular oedema|diabetic macular oedema
113238|NCT03495765|Lucentis|lucentis
113239|NCT03495752|muscle performance|muscle performance
113240|NCT03495752|injury prevention|injury prevention
113241|NCT03495752|step down|step down
113242|NCT03495752|fatigue|fatigue
113243|NCT03495726|Contemplative|contemplative
113244|NCT03495726|Applications|applications
113245|NCT03495726|Well-being|well-being
113246|NCT03495687|Respiratory function|respiratory function
113247|NCT03495687|Spinal mobility|spinal mobility
113248|NCT03495687|Chest expansion|chest expansion
113249|NCT03495661|lumbar spine stenosis|lumbar spine stenosis
113250|NCT03495661|decompression|decompression
113251|NCT03495661|laminectomy|laminectomy
113252|NCT03495661|physiotherapy|physiotherapy
113253|NCT03495661|physical therapy|physical therapy
113254|NCT03495661|electroneurography|electroneurography
113255|NCT03495661|ENG|eng
113256|NCT03495661|electromyography|electromyography
113257|NCT03495661|EMG|emg
113258|NCT03495661|Neurogenic Claudication|neurogenic claudication
113259|NCT03495661|Pseudoclaudication|pseudoclaudication
113260|NCT03495648|farmers market|farmers market
113261|NCT03495648|Appalachia|appalachia
113262|NCT03495648|physical activity|physical activity
113263|NCT03495648|fruit and vegetable voucher program|fruit and vegetable voucher program
113264|NCT03495635|mentoring|mentoring
113265|NCT03495635|prevention|prevention
113266|NCT03495622|Text messaging|text messaging
113267|NCT03495622|Community health worker|community health worker
113268|NCT03495622|Smoking cessation|smoking cessation
113269|NCT03495622|India|india
113270|NCT03495622|Cardiovascular mortality|cardiovascular mortality
113271|NCT03495583|Food allergy|food allergy
113272|NCT03495583|Child Health|child health
113273|NCT03495583|Oral tolerance induction|oral tolerance induction
113274|NCT03495583|Food allergic sensitisation|food allergic sensitisation
113275|NCT03495583|Obesity|obesity
113276|NCT03495570|immunological|immunological
113277|NCT03495557|Hernia|hernia
113278|NCT03495557|Cholecystectomy|cholecystectomy
113279|NCT03495557|Mesh fixation|mesh fixation
113280|NCT03495531|virtual reality|virtual reality
113281|NCT03495531|obstetrics|obstetrics
113282|NCT03495531|labor procedures|labor procedures
113283|NCT03495531|regional anesthesia|regional anesthesia
113284|NCT03495518|Cancer|cancer
113285|NCT03495518|Randomized Control Trial|randomized control trial
113286|NCT03495518|Children|children
113287|NCT03495518|Hematopoietic stem cell transplantation|hematopoietic stem cell transplantation
113288|NCT03495518|Quality of Life|quality of life
113289|NCT03495505|WiSE-CRT|wise-crt
113290|NCT03495505|Endocardial Pacing Optimisation|endocardial pacing optimisation
113291|NCT03495505|Cardiac Resynchronisation Therapy|cardiac resynchronisation therapy
113292|NCT03495492|Chronic Lymphocytic Leukemia|chronic lymphocytic leukemia
113293|NCT03495492|CLL|cll
113294|NCT03495492|Dermal Chelation|dermal chelation
113295|NCT03495492|Nutritional Therapy|nutritional therapy
113296|NCT03495479|Prostate Cancer|prostate cancer
113297|NCT03495479|PC|pc
113298|NCT03495479|Active Surveillance|active surveillance
113301|NCT03495479|Aneustat (TM)|aneustat (tm)
113303|NCT03495479|BPH|bph
113304|NCT03495440|Emotional Security|emotional security
113305|NCT03495440|Intellectual Disability|intellectual disability
113306|NCT03495440|Developmental Disability|developmental disability
113307|NCT03495427|radioactive diagnostic imaging|radioactive diagnostic imaging
113308|NCT03495375|Impulsivity|impulsivity
113309|NCT03495375|Compulsivity|compulsivity
113310|NCT03495375|Aggression|aggression
113311|NCT03495375|Microbiome|microbiome
113312|NCT03495375|Probiotic|probiotic
113313|NCT03495375|Nutrition|nutrition
113314|NCT03495375|Psychiatric disorders|psychiatric disorders
113315|NCT03495375|Synbiotic2000Forte|synbiotic2000forte
113316|NCT03495362|Yeast Beta-glucan|yeast beta-glucan
113317|NCT03495362|Immune Function|immune function
113318|NCT03495362|Prediabetes|prediabetes
113319|NCT03495362|Gut Microbiota|gut microbiota
113320|NCT03495336|Boiled coffee|boiled coffee
113321|NCT03495336|Cardiovascular disease|cardiovascular disease
113322|NCT03495336|Cholesterol|cholesterol
113323|NCT03495336|Homocysteine|homocysteine
113324|NCT03495336|Turkish coffee|turkish coffee
113325|NCT03495336|Diterpenes|diterpenes
113326|NCT03495336|Unfiltered coffee|unfiltered coffee
113327|NCT03495323|Cancer Care|cancer care
113328|NCT03495297|subcutaneous implantable cardioverter defibrillator|subcutaneous implantable cardioverter defibrillator
113329|NCT03495297|Defibrillation testing|defibrillation testing
113330|NCT03495271|Hemodialysis|hemodialysis
113331|NCT03495271|Taste|taste
113332|NCT03495271|Blood|blood
113333|NCT03495271|Saliva|saliva
113334|NCT03495245|pain|pain
113335|NCT03495245|opioid|opioid
113336|NCT03495245|fibromyalgia|fibromyalgia
113337|NCT03495232|Total Knee Arthroplasty|total knee arthroplasty
113338|NCT03495232|Persona knee system|persona knee system
113339|NCT03495232|osteoarthrosis|osteoarthrosis
113340|NCT03495232|Knee|knee
113341|NCT03495193|exercise|exercise
113342|NCT03495128|muscle protein breakdown|muscle protein breakdown
113343|NCT03495128|inactivity|inactivity
113344|NCT03495128|bed rest|bed rest
113345|NCT03495115|Breast Cancer|breast cancer
113346|NCT03495089|Screening; Sudomotor reflex; DEC; Primary Care|screening; sudomotor reflex; dec; primary care
113347|NCT03495076|Tactile acuity|tactile acuity
113348|NCT03495076|Tactile dysfunction|tactile dysfunction
113349|NCT03495076|Sensory dissociation|sensory dissociation
113350|NCT03495076|Two-point discrimination|two-point discrimination
113351|NCT03495076|Perception|perception
113352|NCT03495050|Bicuspid|bicuspid
113353|NCT03495050|TAVI|tavi
113354|NCT03495050|TAVR|tavr
113355|NCT03495050|self-expanding|self-expanding
113356|NCT03495050|Evolut|evolut
113357|NCT03495037|Age-related cognitive changes|age-related cognitive changes
113358|NCT03495024|Schizophrenia|schizophrenia
113359|NCT03495024|Schizoaffective disorder|schizoaffective disorder
113360|NCT03495024|Antipsychotics|antipsychotics
113361|NCT03495024|Tobacco smoking|tobacco smoking
113362|NCT03495024|Tardive dyskinesia|tardive dyskinesia
113363|NCT03495024|Parkinsonism|parkinsonism
113364|NCT03495011|Ductal Carcinoma in Situ|ductal carcinoma in situ
113365|NCT03495011|MRI|mri
113366|NCT03495011|Oncotype Dx|oncotype dx
113367|NCT03494959|Pentaglobin|pentaglobin
113368|NCT03494959|Carbapenem-resistant Klebsiella pneumoniae|carbapenem-resistant klebsiella pneumoniae
113369|NCT03494959|Pseudomonas aeruginosa|pseudomonas aeruginosa
113370|NCT03494959|febrile neutropenia|febrile neutropenia
113371|NCT03494959|infection-related mortality|infection-related mortality
113372|NCT03494946|Liver metastasis|liver metastasis
113373|NCT03494946|Colorectal cancer|colorectal cancer
113374|NCT03494920|Stroke|stroke
113375|NCT03494920|Ischemia|ischemia
113376|NCT03494920|Cerebral Infarction|cerebral infarction
113377|NCT03494920|Cerebrovascular Disorders|cerebrovascular disorders
113378|NCT03494920|Brain Diseases|brain diseases
113379|NCT03494920|Central Nervous System Diseases|central nervous system diseases
113380|NCT03494920|Nervous System Diseases|nervous system diseases
113381|NCT03494920|Vascular Diseases|vascular diseases
113382|NCT03494920|Cardiovascular Diseases|cardiovascular diseases
113383|NCT03494920|Pathologic Processes|pathologic processes
113384|NCT03494920|Brain Infarction|brain infarction
113385|NCT03494920|Brain Ischemia|brain ischemia
113386|NCT03494920|Tissue Plasminogen Activator|tissue plasminogen activator
113387|NCT03494920|Plasminogen|plasminogen
113388|NCT03494920|Fibrinolytic Agents|fibrinolytic agents
113389|NCT03494920|Fibrin Modulating Agents|fibrin modulating agents
113390|NCT03494920|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action
113391|NCT03494842|TENS|tens
113392|NCT03494842|pain relief|pain relief
113393|NCT03494842|STOP|stop
113394|NCT03494842|surgical abortion|surgical abortion
113395|NCT03494829|early onset scoliosis|early onset scoliosis
113396|NCT03494829|motor competence|motor competence
113397|NCT03494829|physical activity|physical activity
113398|NCT03494829|pulmonary function|pulmonary function
113399|NCT03494829|health related quality of life|health related quality of life
113400|NCT03494816|Neoadjuvant|neoadjuvant
113401|NCT03494816|Venous Tumour Thrombus|venous tumour thrombus
113402|NCT03494816|Axitinib|axitinib
113403|NCT03494816|Mayo Classification|mayo classification
113404|NCT03494816|Nephrectomy|nephrectomy
113405|NCT03494816|Thrombectomy|thrombectomy
113406|NCT03494790|MMP|mmp
113407|NCT03494790|Matrix metalloproteinase|matrix metalloproteinase
113408|NCT03494790|Metabolomics|metabolomics
113409|NCT03494790|FGF-21|fgf-21
113410|NCT03494790|Quick SOFA|quick sofa
113411|NCT03494790|Infection|infection
113412|NCT03494790|Triage|triage
113413|NCT03494777|ART adherence|art adherence
113414|NCT03494764|Hyperbaric Oxygen Therapy|hyperbaric oxygen therapy
113415|NCT03494751|Monitoring|monitoring
113416|NCT03494751|Myocardial infarction|myocardial infarction
113417|NCT03494751|Clinical trial|clinical trial
113418|NCT03494738|Prenatal alcohol exposure|prenatal alcohol exposure
113419|NCT03494725|Probiotic|probiotic
113420|NCT03494725|Gut-brain axis|gut-brain axis
113421|NCT03494725|Stress|stress
113422|NCT03494725|Anxiety|anxiety
113423|NCT03494712|healthy volunteer|healthy volunteer
113424|NCT03494712|antimiR|antimir
113425|NCT03494712|single ascending dose|single ascending dose
113426|NCT03494686|conization|conization
113427|NCT03494686|LLETZ|lletz
113428|NCT03494686|randomized controlled trial|randomized controlled trial
113429|NCT03494686|loop excision|loop excision
113430|NCT03494686|general anaesthesia|general anaesthesia
113431|NCT03494686|local anaesthesia|local anaesthesia
113432|NCT03494673|White matter hyperintensity|white matter hyperintensity
113433|NCT03494673|Cerebrovascular reactivity|cerebrovascular reactivity
113434|NCT03494660|Subchondroplasty|subchondroplasty
113435|NCT03494660|Bone Marrow Lesion|bone marrow lesion
113436|NCT03494660|Arthroscopy|arthroscopy
113437|NCT03494660|Bone Substitute Material|bone substitute material
113438|NCT03494660|AccuFill|accufill
113439|NCT03494660|Subchondral Bone Defect|subchondral bone defect
113440|NCT03494608|cognitive function|cognitive function
113441|NCT03494608|quality of life|quality of life
113442|NCT03494608|anxiety|anxiety
113443|NCT03494608|depression|depression
113444|NCT03494608|neurological function|neurological function
113445|NCT03494595|Pediatric Liver Transplantation, Thromboelastometry|pediatric liver transplantation, thromboelastometry
113446|NCT03494543|Ampullary Adenoma|ampullary adenoma
113447|NCT03494543|Endoscopic Papillectomy|endoscopic papillectomy
113448|NCT03494543|Familial Adenomatous Polyposis|familial adenomatous polyposis
113449|NCT03494504|reproxalap|reproxalap
113450|NCT03494478|Cohort study|cohort study
113451|NCT03494478|Emotion dysregulation|emotion dysregulation
113452|NCT03494478|Questionnaires|questionnaires
113453|NCT03494478|Actimetry|actimetry
113454|NCT03494478|Neuropsychology|neuropsychology
113455|NCT03494452|electromyography, strength, strength endurance|electromyography, strength, strength endurance
113456|NCT03494400|Breast cancer|breast cancer
113457|NCT03494400|Physical exercise|physical exercise
113458|NCT03494400|Body mass|body mass
113459|NCT03494387|Antioxidant|antioxidant
113460|NCT03494387|Hyperoxia|hyperoxia
113461|NCT03494387|Troponin|troponin
113462|NCT03494387|MINS|mins
113463|NCT03494387|Ascorbic acid|ascorbic acid
113464|NCT03494387|N-acetylcysteine|n-acetylcysteine
113465|NCT03494374|pes planus|pes planus
113466|NCT03494374|UCBL|ucbl
113467|NCT03494374|exercise|exercise
113468|NCT03494361|deglutition disorders|deglutition disorders
113469|NCT03494361|electromyography|electromyography
113470|NCT03494348|Radiostereometry (RSA)|radiostereometry (rsa)
113471|NCT03494348|Total Knee Arthroplasty|total knee arthroplasty
113472|NCT03494309|Mandibular Subcondylar Fractures|mandibular subcondylar fractures
113473|NCT03494309|Mouth Opening|mouth opening
113474|NCT03494309|Open Reduction and Internal Fixation|open reduction and internal fixation
113475|NCT03494309|Closed Reduction with External Fixation|closed reduction with external fixation
113476|NCT03494283|CrossFit injuries|crossfit injuries
113477|NCT03494257|phacoemulsification|phacoemulsification
113478|NCT03494257|intraocular pressure|intraocular pressure
113479|NCT03494257|cataract|cataract
113480|NCT03494257|brinzolamide|brinzolamide
113481|NCT03494257|brimonidinde|brimonidinde
113482|NCT03494257|fixed combination|fixed combination
113483|NCT03494244|acellular dermal matrix|acellular dermal matrix
113484|NCT03494244|breast reconstruction|breast reconstruction
113485|NCT03494244|efficacy|efficacy
113486|NCT03494231|Metastatic|metastatic
113487|NCT03494231|Refractory|refractory
113488|NCT03494231|Cancer|cancer
113489|NCT03494231|Solid|solid
113490|NCT03494231|Tumor|tumor
113491|NCT03494218|disorders of consciousness|disorders of consciousness
113492|NCT03494218|vegetative state|vegetative state
113493|NCT03494218|minimally conscious state|minimally conscious state
113494|NCT03494218|consciousness|consciousness
113495|NCT03494218|pain assessment|pain assessment
113496|NCT03494218|nociception test|nociception test
113497|NCT03494205|Radiation Dermatitis|radiation dermatitis
113498|NCT03494205|Urtica comp.|urtica comp.
113499|NCT03494192|acromiohumeral distance|acromiohumeral distance
113500|NCT03494192|pain|pain
113501|NCT03494192|functional level|functional level
113502|NCT03494192|Subacromial Impingement Syndrome|subacromial impingement syndrome
113503|NCT03494127|wheelchair seating|wheelchair seating
113504|NCT03494127|tissue health|tissue health
113505|NCT03494088|Autism|autism
113506|NCT03494088|Abdominal Pain|abdominal pain
113507|NCT03494075|Patients|patients
113508|NCT03494075|Caregivers|caregivers
113509|NCT03494036|synbiotic|synbiotic
113510|NCT03494036|probiotic|probiotic
113511|NCT03494036|lupus|lupus
113512|NCT03494036|connective tissue disease|connective tissue disease
113513|NCT03494010|Kidney Transplantation|kidney transplantation
113514|NCT03493971|carotid endarterectomy|carotid endarterectomy
113515|NCT03493971|carotid stenting|carotid stenting
113516|NCT03493971|autonomic function|autonomic function
113517|NCT03493971|computational fluid dynamic|computational fluid dynamic
113518|NCT03493971|cognitive function|cognitive function
113519|NCT03493958|Alcohol Dependence|alcohol dependence
113520|NCT03493958|Alcohol use Disorder|alcohol use disorder
113521|NCT03493958|Insomnia|insomnia
113522|NCT03493945|Immunotherapy|immunotherapy
113523|NCT03493945|Combined Treatment|combined treatment
113524|NCT03493945|PD-1/PD-L1|pd-1/pd-l1
113525|NCT03493945|Tumor-Specific T Cells|tumor-specific t cells
113526|NCT03493945|Novel Cancer Vaccine|novel cancer vaccine
113527|NCT03493932|Glioblastoma|glioblastoma
113528|NCT03493932|Glioma|glioma
113529|NCT03493932|Brain Tumor|brain tumor
113530|NCT03493932|Immune Therapy|immune therapy
113531|NCT03493932|Checkpoint Inhibition|checkpoint inhibition
113532|NCT03493919|Immunological assays|immunological assays
113533|NCT03493919|Human blood donors|human blood donors
113534|NCT03493919|Meningococcal vaccination|meningococcal vaccination
113535|NCT03493919|Meningococcal disease|meningococcal disease
113536|NCT03493867|Non-invasive blood pressure monitoring|non-invasive blood pressure monitoring
113537|NCT03493867|Wearable device|wearable device
113538|NCT03493867|Medical device verification study|medical device verification study
113539|NCT03493802|ADPKD|adpkd
113540|NCT03493802|Endothelial dysfunction|endothelial dysfunction
113541|NCT03493802|Oxidative stress|oxidative stress
113542|NCT03493802|NADPH oxidase 4 (NOX4)|nadph oxidase 4 (nox4)
113543|NCT03493802|Mitochondria|mitochondria
113544|NCT03493763|Recurrence Monitoring|recurrence monitoring
113545|NCT03493763|5-Hydroxymethylcytosine|5-hydroxymethylcytosine
113546|NCT03493763|Liquid biopsy|liquid biopsy
113547|NCT03493763|Cell-free DNA|cell-free dna
113548|NCT03493672|Phase I clinical trial|phase i clinical trial
113549|NCT03493672|Phase II clinical trial|phase ii clinical trial
113550|NCT03493672|Early trial discontinuation|early trial discontinuation
113551|NCT03493672|Objective smartphone measurements|objective smartphone measurements
113552|NCT03493672|Physical activity|physical activity
113553|NCT03493672|Physical fitness|physical fitness
113554|NCT03493659|Standing|standing
113555|NCT03493659|Sitting|sitting
113556|NCT03493659|Learning|learning
113557|NCT03493659|Problem-Based Learning|problem-based learning
113558|NCT03493659|Undergraduate|undergraduate
113559|NCT03493646|Myelodysplastic Syndrome|myelodysplastic syndrome
113561|NCT03493646|Acute Myeloid Leukemia|acute myeloid leukemia
113562|NCT03493646|AML|aml
113563|NCT03493646|Chronic Myelomonocytic Leukemia|chronic myelomonocytic leukemia
113564|NCT03493646|CMML|cmml
113565|NCT03493607|AMO-01|amo-01
113566|NCT03493607|Shank3|shank3
113567|NCT03493607|Clinical Trial|clinical trial
113568|NCT03493594|Early nutrition|early nutrition
113569|NCT03493594|Breastfeeding|breastfeeding
113570|NCT03493594|Infant growth|infant growth
113571|NCT03493529|Endometrial microbiome|endometrial microbiome
113572|NCT03493529|Obesity|obesity
113573|NCT03493529|Bacterial pathogens|bacterial pathogens
113574|NCT03493529|Dysbiosis|dysbiosis
113575|NCT03493529|Endometrial receptivity|endometrial receptivity
113576|NCT03493516|Positron Emission Tomography|positron emission tomography
113577|NCT03493516|Sympathetic Innervation|sympathetic innervation
113578|NCT03493516|Sudden Death|sudden death
113579|NCT03493516|Ventricular Fibrillation|ventricular fibrillation
113580|NCT03493516|LMI-1195|lmi-1195
113581|NCT03493516|Ischemic Cardiomyopathy|ischemic cardiomyopathy
113582|NCT03493516|Risk Prediction|risk prediction
113583|NCT03493490|Double-Blind Method|double-blind method
113584|NCT03493490|placebo-controlled|placebo-controlled
113585|NCT03493490|parallel-group|parallel-group
113586|NCT03493490|single-centre|single-centre
113587|NCT03493490|exploratory clinical study|exploratory clinical study
113588|NCT03493451|T/NK-cell|t/nk-cell
113589|NCT03493451|NK/T-cell|nk/t-cell
113590|NCT03493451|extranodal|extranodal
113591|NCT03493451|nasal|nasal
113592|NCT03493451|NK-cell|nk-cell
113593|NCT03493451|ENKTL|enktl
113594|NCT03493451|peripheral T-cell|peripheral t-cell
113595|NCT03493451|anaplastic large cell|anaplastic large cell
113596|NCT03493451|ALCL|alcl
113597|NCT03493451|angioimmunoblastic|angioimmunoblastic
113598|NCT03493451|PTCL-NOS|ptcl-nos
113599|NCT03493451|Relapsed|relapsed
113600|NCT03493451|Refractory|refractory
113601|NCT03493399|Gambling|gambling
113602|NCT03493399|Craving|craving
113603|NCT03493399|Urge|urge
113604|NCT03493399|Desire|desire
113605|NCT03493399|Interference|interference
113606|NCT03493399|Elaborated Intrusion Theory|elaborated intrusion theory
113607|NCT03493399|Treatment|treatment
113608|NCT03493399|Intervention|intervention
113609|NCT03493399|Clinical Sample|clinical sample
113610|NCT03493399|Single case|single case
113611|NCT03493386|Japan|japan
113612|NCT03493386|Crossover|crossover
113613|NCT03493386|Daprodustat|daprodustat
113614|NCT03493386|Bioequivalence|bioequivalence
113615|NCT03493386|Pharmacokinetics|pharmacokinetics
113616|NCT03493269|Psoriasis|psoriasis
113617|NCT03493243|Adolescent|adolescent
113618|NCT03493243|Post Traumatic Stress Disorder|post traumatic stress disorder
113619|NCT03493243|Terrorist Attack|terrorist attack
113620|NCT03493204|Hepatic Encephalopathy|hepatic encephalopathy
113621|NCT03493204|Ascites|ascites
113622|NCT03493204|Liver Diseases|liver diseases
113623|NCT03493204|Cirrhosis|cirrhosis
113624|NCT03493126|postpartum, local estrogen|postpartum, local estrogen
113625|NCT03493113|EEG|eeg
113626|NCT03493100|oral nutritional supplementation|oral nutritional supplementation
113627|NCT03493100|geriatrics|geriatrics
113628|NCT03493100|bone fracture|bone fracture
113629|NCT03493087|Dialysis, Vitamin-K, Malnutrition|dialysis, vitamin-k, malnutrition
113630|NCT03493035|Middle Cerebral Artery|middle cerebral artery
113631|NCT03493035|Cerebral Aneurysm|cerebral aneurysm
113632|NCT03493035|Transcranial Color-Coded Sonography|transcranial color-coded sonography
113633|NCT03493035|Three-Dimensional Computed Tomography Angiography|three-dimensional computed tomography angiography
113634|NCT03492983|Cocoa|cocoa
113635|NCT03492983|Vascular function|vascular function
113636|NCT03492983|Body composition|body composition
113637|NCT03492983|Quality of life|quality of life
113638|NCT03492983|Cognitive performance|cognitive performance
113639|NCT03492983|Postmenopausal women|postmenopausal women
113640|NCT03492957|physical activity|physical activity
113641|NCT03492957|exercise|exercise
113642|NCT03492957|non-ambulatory|non-ambulatory
113643|NCT03492957|feasibility|feasibility
113644|NCT03492957|mixed methods|mixed methods
113645|NCT03492931|Hb SS disease, Hb S Beta 0 Thalassemia|hb ss disease, hb s beta 0 thalassemia
113646|NCT03492892|acupuncture|acupuncture
113647|NCT03492892|hypertension|hypertension
113648|NCT03492892|targeted metabolome|targeted metabolome
113649|NCT03492892|pilot clinical trial|pilot clinical trial
113650|NCT03492814|impacted third molar|impacted third molar
113651|NCT03492814|suturing|suturing
113652|NCT03492814|post-operative morbidity|post-operative morbidity
113653|NCT03492788|cardiac resynchronization therapy|cardiac resynchronization therapy
113654|NCT03492788|electrocardiographic imaging|electrocardiographic imaging
113655|NCT03492775|indolent lymphoma|indolent lymphoma
113656|NCT03492775|Obinutuzumab|obinutuzumab
113657|NCT03492775|GA101|ga101
113658|NCT03492775|Bendamustine|bendamustine
113659|NCT03492775|medically non-fit patients|medically non-fit patients
113660|NCT03492684|nerve injury after total hip arthroplasty|nerve injury after total hip arthroplasty
113661|NCT03492671|Pancreatic Cancer|pancreatic cancer
113662|NCT03492658|abatacept|abatacept
113663|NCT03492658|ACPA expressing B cells|acpa expressing b cells
113664|NCT03492632|psoriasis|psoriasis
113665|NCT03492632|Anti mullerian hormone|anti mullerian hormone
113666|NCT03492632|ovarian reserve|ovarian reserve
113667|NCT03492632|antral follicle count|antral follicle count
113668|NCT03492619|obesity|obesity
113669|NCT03492619|food insecurity|food insecurity
113670|NCT03492619|depressive symptoms|depressive symptoms
113671|NCT03492619|empowerment|empowerment
113672|NCT03492593|carotenoids|carotenoids
113673|NCT03492593|vitamin E|vitamin e
113674|NCT03492593|digestion|digestion
113675|NCT03492593|stability|stability
113676|NCT03492593|metabolism|metabolism
113677|NCT03492567|Cystic fibrosis|cystic fibrosis
113678|NCT03492567|CFTR|cftr
113679|NCT03492567|CFTR modulators|cftr modulators
113680|NCT03492567|Monocyte|monocyte
113681|NCT03492567|Osteoclast|osteoclast
113682|NCT03492567|Osteoporosis|osteoporosis
113683|NCT03492541|mixed dry eye|mixed dry eye
113684|NCT03492541|aqueous-deficient dry eye|aqueous-deficient dry eye
113685|NCT03492541|lipid-deficient dry eye|lipid-deficient dry eye
113686|NCT03492541|evaporative dry eye|evaporative dry eye
113687|NCT03492541|tear film|tear film
113688|NCT03492541|eye drops|eye drops
113689|NCT03492541|artificial tears|artificial tears
113690|NCT03492541|lipid layer|lipid layer
113691|NCT03492541|eye symptoms|eye symptoms
113692|NCT03492541|meibomian gland dysfunction|meibomian gland dysfunction
113693|NCT03492541|MGD|mgd
113694|NCT03492541|SYSTANE|systane
113695|NCT03492541|SYSTANE Complete|systane complete
113696|NCT03492541|nanoemulsion|nanoemulsion
113697|NCT03492515|immune thrombocytopenia|immune thrombocytopenia
113698|NCT03492502|Fecal microbiota transplantation|fecal microbiota transplantation
113699|NCT03492502|allogeneic stem cell transplantation|allogeneic stem cell transplantation
113700|NCT03492502|microbiome|microbiome
113701|NCT03492476|Lymphedema of Upper Arm reduction|lymphedema of upper arm reduction
113906|NCT03491384|cannabis|cannabis
113702|NCT03492476|Lymphedema Upper Arm device|lymphedema upper arm device
113703|NCT03492463|Nicotine addiction|nicotine addiction
113704|NCT03492463|Cigarette smoking|cigarette smoking
113705|NCT03492463|Nicotine patches|nicotine patches
113706|NCT03492463|E-cigarettes|e-cigarettes
113707|NCT03492450|Treadmill training|treadmill training
113708|NCT03492450|Instrumented assessment|instrumented assessment
113709|NCT03492450|Disease progression|disease progression
113710|NCT03492437|Non-small cell lung cancer (NSCLC)|non-small cell lung cancer (nsclc)
113711|NCT03492437|P-glycoprotein|p-glycoprotein
113712|NCT03492437|Tepotinib|tepotinib
113713|NCT03492437|Dabigatran Etexilate|dabigatran etexilate
113714|NCT03492424|prostate cancer|prostate cancer
113715|NCT03492424|cryotherapy|cryotherapy
113716|NCT03492424|focal therapy|focal therapy
113717|NCT03492411|Breastfeeding|breastfeeding
113718|NCT03492411|Co-parenting|co-parenting
113720|NCT03492411|patient education|patient education
113721|NCT03492411|fathers|fathers
113722|NCT03492398|atopic dermatitis|atopic dermatitis
113723|NCT03492359|COPD, Structured Light Plethysmography, COPD severity|copd, structured light plethysmography, copd severity
113724|NCT03492346|LGMD2E|lgmd2e
113725|NCT03492346|Limb Girdle Muscular Dystrophy|limb girdle muscular dystrophy
113726|NCT03492346|sarcoglycanopathy|sarcoglycanopathy
113727|NCT03492346|β -sarcoglycan|β -sarcoglycan
113728|NCT03492346|Natural History|natural history
113729|NCT03492333|antigliadin, gluten free diet, transit|antigliadin, gluten free diet, transit
113730|NCT03492320|HRQoL|hrqol
113731|NCT03492320|Quality of Life|quality of life
113732|NCT03492320|End Stage Osteoarthritis|end stage osteoarthritis
113733|NCT03492320|Total Knee Arthroplasty|total knee arthroplasty
113734|NCT03492320|WOMAC|womac
113735|NCT03492320|SF 36|sf 36
113736|NCT03492320|Total Knee Replacement|total knee replacement
113737|NCT03492307|High Flow Nasal Cannula|high flow nasal cannula
113738|NCT03492294|disorders of consciousness|disorders of consciousness
113739|NCT03492294|music stimulation|music stimulation
113740|NCT03492294|functional magnetic resonance imaging|functional magnetic resonance imaging
113741|NCT03492281|Beta-3 adrenergic receptor (β3-AR) agonists|beta-3 adrenergic receptor (β3-ar) agonists
113742|NCT03492281|Incontinence|incontinence
113743|NCT03492281|OAB|oab
113744|NCT03492281|Vibegron|vibegron
113745|NCT03492281|Urge urinary incontinence|urge urinary incontinence
113746|NCT03492281|Urinary bladder, overactive|urinary bladder, overactive
113747|NCT03492281|Urologic Diseases|urologic diseases
113748|NCT03492281|Lower Urinary Tract Symptoms|lower urinary tract symptoms
113749|NCT03492281|Urological Agents|urological agents
113750|NCT03492242|Anti-PD-1|anti-pd-1
113751|NCT03492242|Anti-PD-L1|anti-pd-l1
113752|NCT03492242|Anti-CTLA-4|anti-ctla-4
113753|NCT03492242|Immune checkpoint inhibitors|immune checkpoint inhibitors
113754|NCT03492242|Immune adverse drug reactions|immune adverse drug reactions
113755|NCT03492229|Gait|gait
113756|NCT03492229|Brain stimulation|brain stimulation
113757|NCT03492229|tDCS|tdcs
113758|NCT03492229|Walking|walking
113759|NCT03492203|Cognitive Remediation|cognitive remediation
113760|NCT03492203|Neurocognition|neurocognition
113761|NCT03492203|Severe mental illness|severe mental illness
113762|NCT03492203|Remote treatment|remote treatment
113763|NCT03492190|protein availability|protein availability
113764|NCT03492190|beans|beans
113765|NCT03492190|children|children
113766|NCT03492190|elderly|elderly
113767|NCT03492177|Pediatric|pediatric
113768|NCT03492151|Confocal laser endomicroscopy|confocal laser endomicroscopy
113769|NCT03492138|Multiple Myeloma|multiple myeloma
113770|NCT03492138|Relapsed and Refractory|relapsed and refractory
113771|NCT03492086|Rosmarinus officinalis L|rosmarinus officinalis l
113772|NCT03492086|alkylglycerols|alkylglycerols
113773|NCT03492086|immuno-nutrition|immuno-nutrition
113774|NCT03492086|colon cancer|colon cancer
113775|NCT03492073|Mindfulness|mindfulness
113776|NCT03492073|Oncology|oncology
113777|NCT03492073|Cancer|cancer
113778|NCT03492073|Emotional distress|emotional distress
113779|NCT03492073|Quality of life|quality of life
113780|NCT03492060|Gene Variant|gene variant
113781|NCT03492060|HNRNPA1|hnrnpa1
113782|NCT03492060|HNRNPA2|hnrnpa2
113783|NCT03492060|HNRNPB1|hnrnpb1
113784|NCT03492060|HNRNPC1|hnrnpc1
113785|NCT03492060|HNRNPC2|hnrnpc2
113786|NCT03492060|HNRNPD|hnrnpd
113787|NCT03492060|HNRNPE1|hnrnpe1
113788|NCT03492060|HNRNPE2|hnrnpe2
113789|NCT03492060|HNRNPE3|hnrnpe3
113790|NCT03492060|HNRNPE4|hnrnpe4
113791|NCT03492060|HNRNPG|hnrnpg
113792|NCT03492060|HNRNPH1|hnrnph1
113793|NCT03492060|HNRNPH2|hnrnph2
113794|NCT03492060|HNRNPI|hnrnpi
113795|NCT03492060|HNRNPK|hnrnpk
113796|NCT03492060|HNRNPL|hnrnpl
113797|NCT03492060|HNRNPM|hnrnpm
113798|NCT03492060|HNRNPP|hnrnpp
113799|NCT03492060|HNRNPQ1|hnrnpq1
113800|NCT03492060|HNRNPQ2|hnrnpq2
113801|NCT03492060|HNRNPQ3|hnrnpq3
113802|NCT03492060|HNRNPR|hnrnpr
113803|NCT03492060|HNRNPU|hnrnpu
113804|NCT03492047|paclitaxel|paclitaxel
113805|NCT03492047|peripheral neuropathy|peripheral neuropathy
113806|NCT03492047|N-acetyl cysteine|n-acetyl cysteine
113807|NCT03492021|rehabilitative nutrition|rehabilitative nutrition
113808|NCT03492021|protein|protein
113809|NCT03492021|beef|beef
113810|NCT03492021|ACL reconstruction|acl reconstruction
113811|NCT03492021|protein synthesis|protein synthesis
113812|NCT03492021|proteolysis|proteolysis
113813|NCT03492021|muscle mass|muscle mass
113814|NCT03492021|muscle strength|muscle strength
113815|NCT03492008|nasogastric tube|nasogastric tube
113816|NCT03492008|general anesthesia|general anesthesia
113817|NCT03492008|head position|head position
113818|NCT03491982|Cardiac Rehabilitation|cardiac rehabilitation
113819|NCT03491930|Weight Loss|weight loss
113820|NCT03491930|Obesity|obesity
113821|NCT03491930|Pre-Diabetes|pre-diabetes
113822|NCT03491930|Metabolic Syndrome|metabolic syndrome
113823|NCT03491891|Very Late Stent Thrombosis|very late stent thrombosis
113824|NCT03491891|New generation DES|new generation des
113825|NCT03491774|memory impairment, montessori intervention, neurocognitive disorder|memory impairment, montessori intervention, neurocognitive disorder
113826|NCT03491761|Platelet Rich Plasma (PRP)|platelet rich plasma (prp)
113827|NCT03491761|Viscosupplementation|viscosupplementation
113828|NCT03491761|Knee Osteoarthritis|knee osteoarthritis
113829|NCT03491761|Hyaluronic Acid (HA)|hyaluronic acid (ha)
113830|NCT03491761|WOMAC|womac
113831|NCT03491761|KOOS|koos
113832|NCT03491761|Euflexxa|euflexxa
113833|NCT03491748|Pharmacokinetics|pharmacokinetics
113834|NCT03491748|ETX0282|etx0282
113835|NCT03491748|Single Ascending Dose|single ascending dose
113836|NCT03491748|Multiple Ascending Doses|multiple ascending doses
113837|NCT03491748|ETX1317|etx1317
113838|NCT03491748|Cefpodoxime Proxetil|cefpodoxime proxetil
113839|NCT03491748|Cefpodoxime|cefpodoxime
113840|NCT03491748|Enterobacteriaceae Infections|enterobacteriaceae infections
113841|NCT03491735|patterns|patterns
113842|NCT03491735|glaucoma|glaucoma
113843|NCT03491735|egypt|egypt
113844|NCT03491735|india|india
113845|NCT03491735|2018|2018
113846|NCT03491696|Depressive disorder|depressive disorder
113847|NCT03491696|Metyrapone|metyrapone
113848|NCT03491696|Dexamethasone Suppression Test|dexamethasone suppression test
113849|NCT03491696|Antidepressive association|antidepressive association
113850|NCT03491696|Hypothalamic-pituitary-adrenal axis|hypothalamic-pituitary-adrenal axis
113851|NCT03491696|Cortisol|cortisol
113852|NCT03491696|Selective Serotonin Reuptake Inhibitor|selective serotonin reuptake inhibitor
113853|NCT03491696|Serotonin and Norepinephrine Reuptake Inhibitor|serotonin and norepinephrine reuptake inhibitor
113854|NCT03491683|Glioblastoma|glioblastoma
113855|NCT03491683|immunotherapy|immunotherapy
113856|NCT03491683|DNA therapy|dna therapy
113857|NCT03491683|checkpoint inhibitor|checkpoint inhibitor
113858|NCT03491657|virtual reality pain|virtual reality pain
113859|NCT03491657|opioid|opioid
113860|NCT03491657|pediatric burn|pediatric burn
113861|NCT03491657|wound care|wound care
113862|NCT03491644|Traumatic accident|traumatic accident
113863|NCT03491644|Oxygen|oxygen
113864|NCT03491644|Intensive Care|intensive care
113865|NCT03491644|Emergency|emergency
113866|NCT03491618|lumbar facet joint pain|lumbar facet joint pain
113867|NCT03491618|Lumbar Medial Branch Neurotomy|lumbar medial branch neurotomy
113868|NCT03491618|Chronic Low Back Pain|chronic low back pain
113869|NCT03491605|chronic EBV infection, hemophagocytic lymphohistiocytosis|chronic ebv infection, hemophagocytic lymphohistiocytosis
113870|NCT03491592|Physical Activity|physical activity
113871|NCT03491592|Latinas|latinas
113872|NCT03491592|Spanish-language|spanish-language
113873|NCT03491592|Text-Message|text-message
113874|NCT03491592|Exercise|exercise
113875|NCT03491592|Web-based|web-based
113876|NCT03491579|AML|aml
113877|NCT03491579|Epacadostat|epacadostat
113878|NCT03491579|Cladribine|cladribine
113879|NCT03491579|Cytarabine|cytarabine
113880|NCT03491540|Mechanical Bowel Preparation (MBP)|mechanical bowel preparation (mbp)
113881|NCT03491540|Oral antibiotics|oral antibiotics
113882|NCT03491540|Rectal cancer surgery|rectal cancer surgery
113883|NCT03491540|Surgical site infection|surgical site infection
113884|NCT03491501|Industrial work|industrial work
113885|NCT03491501|physical effort|physical effort
113886|NCT03491501|mental effort|mental effort
113887|NCT03491501|questionnaires|questionnaires
113888|NCT03491501|ergonomic evaluation|ergonomic evaluation
113889|NCT03491488|executive function|executive function
113890|NCT03491488|Early childhood education|early childhood education
113891|NCT03491488|self regulation|self regulation
113892|NCT03491475|Ajmaline test|ajmaline test
113893|NCT03491462|arimoclomol|arimoclomol
113894|NCT03491462|ALS|als
113895|NCT03491449|Brain ischemia|brain ischemia
113896|NCT03491449|Cerebral ischemia|cerebral ischemia
113897|NCT03491410|Metastatic|metastatic
113898|NCT03491410|Active Surveillance|active surveillance
113899|NCT03491397|Microspheres|microspheres
113900|NCT03491397|Artery Embolization|artery embolization
113901|NCT03491397|Knee Osteoarthritis|knee osteoarthritis
113902|NCT03491397|Chronic Pain|chronic pain
113903|NCT03491397|Embozene|embozene
113904|NCT03491384|anxiety|anxiety
113905|NCT03491384|inflammation|inflammation
113907|NCT03491384|marijuana|marijuana
113908|NCT03491384|stress|stress
113909|NCT03491371|apatinib|apatinib
113910|NCT03491371|tyrosine-kinase inhibitors|tyrosine-kinase inhibitors
113911|NCT03491371|osteosarcoma|osteosarcoma
113912|NCT03491371|Ewing sarcoma|ewing sarcoma
113913|NCT03491371|chondrosarcoma|chondrosarcoma
113914|NCT03491371|soft-tissue sarcoma|soft-tissue sarcoma
113915|NCT03491358|vibrating mesh nebulizer|vibrating mesh nebulizer
113916|NCT03491358|allergen challenge|allergen challenge
113917|NCT03491319|Anesthetics, Local|anesthetics, local
113918|NCT03491319|Head-Down Tilt|head-down tilt
113919|NCT03491319|Anesthesia, Spinal|anesthesia, spinal
113920|NCT03491319|hypotension|hypotension
113921|NCT03491306|PEEK|peek
113922|NCT03491306|Breflex|breflex
113923|NCT03491293|internet|internet
113924|NCT03491293|behavioral weight loss|behavioral weight loss
113925|NCT03491293|obesity|obesity
113926|NCT03491280|Rare Diseases|rare diseases
113927|NCT03491280|Genetic Predisposition|genetic predisposition
113928|NCT03491280|Omics Technology|omics technology
113929|NCT03491280|Next Generation Sequencing (NGS)|next generation sequencing (ngs)
113930|NCT03491267|alopecia|alopecia
113931|NCT03491215|Graft versus host disease|graft versus host disease
113932|NCT03491215|GvHD|gvhd
113933|NCT03491215|acute graft versus host disease|acute graft versus host disease
113934|NCT03491215|aGvHD|agvhd
113935|NCT03491215|Steroid refractory acute graft versus host disease|steroid refractory acute graft versus host disease
113936|NCT03491215|SR-aGvHD|sr-agvhd
113937|NCT03491215|Ruxolitinib|ruxolitinib
113938|NCT03491215|INC424|inc424
113939|NCT03491215|allogeneic stem cell transplantation|allogeneic stem cell transplantation
113940|NCT03491176|Head and Neck Cancer|head and neck cancer
113941|NCT03491176|Magnetic resonance imaging|magnetic resonance imaging
113942|NCT03491176|MRI|mri
113943|NCT03491176|Biomarker testing|biomarker testing
113944|NCT03491176|Blood draws|blood draws
113945|NCT03491176|Questionnaires|questionnaires
113946|NCT03491176|Surveys|surveys
113947|NCT03491163|syndecan-1|syndecan-1
113948|NCT03491163|endothelial glycocalyx|endothelial glycocalyx
113949|NCT03491163|On-pump heart surgery|on-pump heart surgery
113950|NCT03491150|Dementia|dementia
113951|NCT03491150|Neurodegenerative Diseases|neurodegenerative diseases
113952|NCT03491150|Brain Diseases|brain diseases
113953|NCT03491150|Central Nervous System Diseases|central nervous system diseases
113954|NCT03491150|Nervous System Diseases|nervous system diseases
113955|NCT03491150|Tauopathies|tauopathies
113956|NCT03491150|Neurocognitive Disorders|neurocognitive disorders
113957|NCT03491150|Mental Disorders|mental disorders
113958|NCT03491137|Wireless monitoring, postoperative complications|wireless monitoring, postoperative complications
113959|NCT03491111|Cerebrovascular disease|cerebrovascular disease
113960|NCT03491111|respiratory muscle training|respiratory muscle training
113961|NCT03491111|spirometry|spirometry
113962|NCT03491111|peak flow|peak flow
113963|NCT03491111|maximal inspiratory pressure, maximal expiratory pressure|maximal inspiratory pressure, maximal expiratory pressure
113964|NCT03491098|Otitis Media with Effusion|otitis media with effusion
113965|NCT03491072|extracorporeal shock-wave Lithotripsy,|extracorporeal shock-wave lithotripsy,
113966|NCT03491072|pain relief during extracorporeal shock-wave Lithotripsy|pain relief during extracorporeal shock-wave lithotripsy
113967|NCT03491072|fentanyl|fentanyl
712570|NCT00579683|RNA analysis|rna analysis
113968|NCT03491072|Transcutaneous electrical nerve stimulation|transcutaneous electrical nerve stimulation
113969|NCT03491033|advanced-stage ovarian cancer|advanced-stage ovarian cancer
113970|NCT03491033|neoadjuvant chemotherapy|neoadjuvant chemotherapy
113971|NCT03491033|residual disease|residual disease
113972|NCT03491033|genomic profiling|genomic profiling
113973|NCT03491033|immunohistochemistry|immunohistochemistry
113974|NCT03491020|Emission Patterns|emission patterns
113975|NCT03491020|Respiratory|respiratory
113976|NCT03491020|Aerosolization|aerosolization
113977|NCT03491020|Airborne|airborne
113978|NCT03491007|PTSD|ptsd
113979|NCT03491007|DHEA|dhea
113980|NCT03490981|primary care|primary care
113981|NCT03490981|chronic pain|chronic pain
113982|NCT03490981|musculoskeletal pain|musculoskeletal pain
113983|NCT03490981|cognitive behavioral therapy|cognitive behavioral therapy
113984|NCT03490981|integrated primary care|integrated primary care
113985|NCT03490942|glucagon|glucagon
113986|NCT03490942|hypoglycemia counter-regulation|hypoglycemia counter-regulation
113987|NCT03490916|Acetazolamide|acetazolamide
113988|NCT03490916|High-altitude illness|high-altitude illness
113989|NCT03490916|High-altitude pulmonary edema|high-altitude pulmonary edema
113990|NCT03490916|Lung comets|lung comets
113991|NCT03490916|Lung ultrasound|lung ultrasound
113992|NCT03490916|Subclinical high-altitude pulmonary edema|subclinical high-altitude pulmonary edema
113993|NCT03490903|virtual reality|virtual reality
113994|NCT03490903|anxiety|anxiety
113995|NCT03490903|vasospasm|vasospasm
113996|NCT03490903|pain|pain
113997|NCT03490903|coronary artery angiography|coronary artery angiography
113998|NCT03490903|angiogram|angiogram
113999|NCT03490903|VR|vr
114000|NCT03490890|microwave ablation|microwave ablation
114001|NCT03490890|lung cancer|lung cancer
114002|NCT03490890|ground glass nodules|ground glass nodules
114003|NCT03490877|Atopic Dermatitis|atopic dermatitis
114004|NCT03490877|Pruritus|pruritus
114005|NCT03490877|Sleep Disturbance|sleep disturbance
114006|NCT03490786|GT-001|gt-001
114007|NCT03490773|Cpeptide|cpeptide
114008|NCT03490773|Immunology|immunology
114009|NCT03490760|Metastatic Adenocarcinoma of the Pancreas|metastatic adenocarcinoma of the pancreas
114010|NCT03490747|Physical Activity|physical activity
114011|NCT03490747|Pragmatic Evaluation|pragmatic evaluation
114012|NCT03490747|Exercise Referral|exercise referral
114013|NCT03490747|Mixed-methods|mixed-methods
114014|NCT03490747|Behaviour Change|behaviour change
114015|NCT03490747|Intervention|intervention
114016|NCT03490734|nutrition|nutrition
114017|NCT03490734|obesity|obesity
114018|NCT03490734|weight gain|weight gain
114019|NCT03490734|sugar|sugar
114020|NCT03490734|sugar sweetened beverage|sugar sweetened beverage
114021|NCT03490734|dopamine|dopamine
114022|NCT03490734|neurobehavioral adaptation|neurobehavioral adaptation
114023|NCT03490708|Mucinoses|mucinoses
114024|NCT03490708|Tranilast|tranilast
114025|NCT03490643|Plantar Pressure Distribution|plantar pressure distribution
114026|NCT03490643|Posture|posture
114027|NCT03490643|Posturescreen Mobile|posturescreen mobile
114028|NCT03490643|RDC/TMD|rdc/tmd
114029|NCT03490643|TMD|tmd
114030|NCT03490630|patient reported outcome|patient reported outcome
114031|NCT03490630|postoperative pain|postoperative pain
114032|NCT03490630|pain related impairment|pain related impairment
114033|NCT03490630|quality of life|quality of life
114034|NCT03490630|prospective association study|prospective association study
114035|NCT03490617|Intrauterine device|intrauterine device
114036|NCT03490617|Misoprostol|misoprostol
114037|NCT03490617|Nulliparous women|nulliparous women
114038|NCT03490617|Contraception|contraception
114039|NCT03490591|Cerebral Palsy|cerebral palsy
114040|NCT03490591|Robotic rehabilitation|robotic rehabilitation
114041|NCT03490591|Hand function|hand function
114042|NCT03490591|Activities of Daily Living|activities of daily living
114043|NCT03490578|Parkinson Disease|parkinson disease
114044|NCT03490578|Gait|gait
114045|NCT03490578|Balance|balance
114046|NCT03490578|Rehabilitation|rehabilitation
114047|NCT03490578|Robot-assisted gait training|robot-assisted gait training
114048|NCT03490565|exercise training|exercise training
114049|NCT03490565|treatment tolerability|treatment tolerability
114050|NCT03490565|treatment complications|treatment complications
114051|NCT03490539|observational|observational
114052|NCT03490539|comparative effectiveness|comparative effectiveness
114053|NCT03490539|myasthenia gravis|myasthenia gravis
114054|NCT03490500|protein S100B|protein s100b
114055|NCT03490500|negative predictive value|negative predictive value
114056|NCT03490500|headache|headache
114057|NCT03490500|intracranial hemorrhage|intracranial hemorrhage
114058|NCT03490474|conditioned pain modulation (CPM)|conditioned pain modulation (cpm)
114059|NCT03490474|diffuse noxious inhibitory control (DNIC)|diffuse noxious inhibitory control (dnic)
114060|NCT03490474|massage|massage
114061|NCT03490474|hypoalgesia|hypoalgesia
114062|NCT03490448|vitamin D|vitamin d
114063|NCT03490448|obesity|obesity
114064|NCT03490448|body composition|body composition
114065|NCT03490448|glucose metabolism|glucose metabolism
114066|NCT03490448|lipid metabolism|lipid metabolism
114067|NCT03490435|Per os invasions|per os invasions
114068|NCT03490435|Giardiasis|giardiasis
114069|NCT03490435|Toxoplasmosis|toxoplasmosis
114070|NCT03490435|Taeniasis|taeniasis
114071|NCT03490435|Cryptosporidiosis|cryptosporidiosis
114072|NCT03490435|Trichinosis|trichinosis
114073|NCT03490435|Ascariasis|ascariasis
114074|NCT03490435|Echinococcosis|echinococcosis
114075|NCT03490422|pulpotomy|pulpotomy
114076|NCT03490422|permanent teeth|permanent teeth
114077|NCT03490422|deep caries management|deep caries management
114078|NCT03490422|risk factors|risk factors
114079|NCT03490422|clinical indicators for pulpotomy|clinical indicators for pulpotomy
114080|NCT03490409|Arthroplasty|arthroplasty
114081|NCT03490409|Replacement|replacement
114082|NCT03490409|Knee|knee
114083|NCT03490409|Compression|compression
114084|NCT03490409|Edema|edema
114085|NCT03490409|Pain|pain
114086|NCT03490396|Oral Mucositis|oral mucositis
114087|NCT03490396|Stomatitis|stomatitis
114088|NCT03490396|Myeloablative|myeloablative
114089|NCT03490383|ERCP|ercp
114090|NCT03490383|CBD stone|cbd stone
114091|NCT03490383|Microbial Colonization|microbial colonization
114092|NCT03490344|bony plasmacytoma|bony plasmacytoma
114093|NCT03490344|extramedullary plasmacytoma|extramedullary plasmacytoma
114094|NCT03490344|Daratumumab|daratumumab
114095|NCT03490344|lenalidomide|lenalidomide
114096|NCT03490344|Memorial Sloan Kettering Cancer Center|memorial sloan kettering cancer center
114097|NCT03490344|18-048|18-048
114099|NCT03490331|Stem cells|stem cells
114100|NCT03490331|Gene Therapy|gene therapy
114101|NCT03490305|War injury|war injury
114102|NCT03490305|Penetrating abdominal trauma|penetrating abdominal trauma
114103|NCT03490305|Exploratory laparotomy|exploratory laparotomy
114104|NCT03490305|Improvised explosive device|improvised explosive device
114105|NCT03490305|Mosul|mosul
114106|NCT03490266|Ventral Hernia|ventral hernia
114107|NCT03490266|Hernia Repair|hernia repair
114108|NCT03490227|neonates|neonates
114109|NCT03490227|brown adipose tissue|brown adipose tissue
114110|NCT03490227|body composition|body composition
114111|NCT03490214|Optoacoustics|optoacoustics
114112|NCT03490214|MSOT|msot
114113|NCT03490214|Multispectral Optoacoustic Tomography|multispectral optoacoustic tomography
114114|NCT03490175|genetic association study|genetic association study
114115|NCT03490175|postoperative nausea and vomiting|postoperative nausea and vomiting
114116|NCT03490175|patient reported outcome|patient reported outcome
114117|NCT03490175|antiemetics|antiemetics
114118|NCT03490162|Anti-Malarial|anti-malarial
114119|NCT03490162|DM1157|dm1157
114120|NCT03490162|Pharmacokinetics|pharmacokinetics
114121|NCT03490162|Safety|safety
114122|NCT03490149|ECT|ect
114123|NCT03490149|Electroconvulsive Therapy|electroconvulsive therapy
114124|NCT03490149|Depression|depression
114125|NCT03490149|Memory|memory
114126|NCT03490149|Memory Impairment|memory impairment
114127|NCT03490123|Azithromycin|azithromycin
114128|NCT03490123|Endemic treponematoses|endemic treponematoses
114129|NCT03490123|Mass drug administration|mass drug administration
114130|NCT03490123|Eradication|eradication
114131|NCT03490123|Papua New Guinea|papua new guinea
114132|NCT03490110|cognitive rehabilitation|cognitive rehabilitation
114133|NCT03490110|EEG|eeg
114134|NCT03490110|TBI|tbi
114135|NCT03490110|brain networks|brain networks
114136|NCT03490110|attention|attention
114137|NCT03490110|memory|memory
114138|NCT03490110|executive function|executive function
114139|NCT03490084|multiple myeloma|multiple myeloma
114140|NCT03490084|elderly patients|elderly patients
114141|NCT03490084|health outcomes|health outcomes
114142|NCT03490084|hospital-at-home|hospital-at-home
114143|NCT03490084|day hospitalization|day hospitalization
114144|NCT03490084|quality of life|quality of life
114145|NCT03490084|medico-economic evaluation|medico-economic evaluation
114146|NCT03490084|qualitative study|qualitative study
114147|NCT03490071|Longstanding hip and groin pain|longstanding hip and groin pain
114148|NCT03490071|Patient reported outcome|patient reported outcome
114149|NCT03490058|pre-exposure prophylaxis|pre-exposure prophylaxis
114150|NCT03490058|young women|young women
114151|NCT03490058|delivery of health care|delivery of health care
114152|NCT03490058|HIV infections/prevention|hiv infections/prevention
114153|NCT03490045|Diaper Need|diaper need
114154|NCT03490045|Well-Child Care|well-child care
114155|NCT03490045|Infant Immunizations|infant immunizations
114156|NCT03490045|Incentives|incentives
114157|NCT03490045|Basic Needs|basic needs
114158|NCT03490006|regional anesthesia|regional anesthesia
114159|NCT03490006|postoperative pain|postoperative pain
114160|NCT03490006|mastectomy|mastectomy
114161|NCT03490006|erector spinae plane block|erector spinae plane block
114162|NCT03490006|paravertebral block|paravertebral block
114163|NCT03489993|FGF23|fgf23
114164|NCT03489993|Angiotensin-(1-7)|angiotensin-(1-7)
114165|NCT03489993|Hypophosphatemia|hypophosphatemia
114166|NCT03489980|STAI Questionnaire|stai questionnaire
114167|NCT03489980|ECTM2-Qa|ectm2-qa
114168|NCT03489967|Hypoglycemia, carbohydrates|hypoglycemia, carbohydrates
114169|NCT03489954|Non-specific Chronic Neck Pain|non-specific chronic neck pain
114170|NCT03489954|Balance Master|balance master
114171|NCT03489954|Joint Position Error|joint position error
114172|NCT03489954|Neck pain|neck pain
114173|NCT03489928|Labour|labour
114174|NCT03489928|Induction|induction
114175|NCT03489928|Misoprostol|misoprostol
114176|NCT03489928|Dinoprostone|dinoprostone
114177|NCT03489928|Oxytocin|oxytocin
114178|NCT03489889|Liver Cirrhosis, Biliary|liver cirrhosis, biliary
114179|NCT03489889|Ursodeoxycholic Acid|ursodeoxycholic acid
114180|NCT03489876|Metatarsophalangeal Joint|metatarsophalangeal joint
114181|NCT03489876|Arthritis|arthritis
114182|NCT03489876|Synthetic Cartilage Implant|synthetic cartilage implant
114183|NCT03489876|Cartiva|cartiva
114184|NCT03489876|Osteochondral Autograft Transfer|osteochondral autograft transfer
114185|NCT03489863|clopidogrel|clopidogrel
114186|NCT03489863|prasugrel|prasugrel
114187|NCT03489863|ticagrelor|ticagrelor
114188|NCT03489811|Essential Oils|essential oils
114189|NCT03489811|Aromatherapy|aromatherapy
114190|NCT03489811|Anxiety|anxiety
114191|NCT03489811|Autism Spectrum Disorder|autism spectrum disorder
114192|NCT03489798|Induction of labor|induction of labor
114193|NCT03489798|Misoprostol|misoprostol
114194|NCT03489798|Failed induction|failed induction
114195|NCT03489785|Predicted factor|predicted factor
114196|NCT03489785|Motor Evoked Potentials|motor evoked potentials
114197|NCT03489759|Acute Kidney Injury|acute kidney injury
114198|NCT03489759|Oxidative Stress|oxidative stress
114199|NCT03489759|Renal Replacement Therapy|renal replacement therapy
114200|NCT03489759|Vitamine E-coated Polysulfone Membrane|vitamine e-coated polysulfone membrane
114201|NCT03489746|Inhaled corticosteroids|inhaled corticosteroids
114202|NCT03489746|Quality improvement|quality improvement
114203|NCT03489746|Cluster randomized Trial|cluster randomized trial
114204|NCT03489707|anal cancer|anal cancer
114304|NCT03489291|Bleeding|bleeding
114205|NCT03489707|human papillomavirus|human papillomavirus
114206|NCT03489694|skin test endpoint|skin test endpoint
114207|NCT03489681|acupuncture, sciatica, default mode network|acupuncture, sciatica, default mode network
114208|NCT03489668|PCOS|pcos
114209|NCT03489668|Androgen|androgen
114210|NCT03489668|3D ultrasound|3d ultrasound
114211|NCT03489655|Healthy Homes|healthy homes
114212|NCT03489655|Asthma|asthma
114213|NCT03489655|Community Health Worker|community health worker
114214|NCT03489629|Methicillin-resistant Staphylococcus aureus (MRSA)|methicillin-resistant staphylococcus aureus (mrsa)
114215|NCT03489629|Early infection|early infection
114216|NCT03489629|Treatment|treatment
114217|NCT03489629|Forced Expiratory Volume in 1 Second (FEV1)|forced expiratory volume in 1 second (fev1)
114218|NCT03489603|Troponin|troponin
114219|NCT03489590|Lung|lung
114220|NCT03489590|Imaging|imaging
114221|NCT03489590|Hyperpolarized|hyperpolarized
114222|NCT03489590|Perfluorinated|perfluorinated
114223|NCT03489590|MRI|mri
114224|NCT03489577|Inflammation|inflammation
114225|NCT03489577|Multiple Organ Failure|multiple organ failure
114226|NCT03489577|Sepsis|sepsis
114227|NCT03489577|Wounds and Injuries|wounds and injuries
114228|NCT03489577|Pathologic Processes|pathologic processes
114229|NCT03489577|Shock|shock
114230|NCT03489577|Infection|infection
114231|NCT03489577|Systemic Inflammatory Response Syndrome|systemic inflammatory response syndrome
114232|NCT03489577|Neutrophils|neutrophils
114233|NCT03489577|PMN|pmn
114234|NCT03489577|Granulocytes|granulocytes
114235|NCT03489577|Innate immunity|innate immunity
114236|NCT03489577|ICU|icu
114237|NCT03489577|Intensive Care|intensive care
114238|NCT03489577|polytrauma|polytrauma
114239|NCT03489577|host-pathogen|host-pathogen
114240|NCT03489564|Pregnancy|pregnancy
114241|NCT03489564|Mitochondrial metabolism|mitochondrial metabolism
114242|NCT03489564|Placenta|placenta
114243|NCT03489538|bariatric surgery|bariatric surgery
114244|NCT03489538|gastric bypass|gastric bypass
114245|NCT03489538|homocysteine|homocysteine
114246|NCT03489538|folate|folate
114247|NCT03489538|vitamin b12|vitamin b12
114248|NCT03489525|multiple myeloma|multiple myeloma
114249|NCT03489525|relapsed/refractory|relapsed/refractory
114250|NCT03489525|open-label|open-label
114251|NCT03489499|postoperative pain|postoperative pain
114252|NCT03489499|analgesics|analgesics
114253|NCT03489499|patient reported outcome|patient reported outcome
114254|NCT03489499|pain related impairment|pain related impairment
114255|NCT03489499|genetic association study|genetic association study
114256|NCT03489486|Presepsin|presepsin
114257|NCT03489486|sCD14-ST|scd14-st
114258|NCT03489486|biomarker|biomarker
114259|NCT03489486|perioperative risk|perioperative risk
114260|NCT03489473|Hormonal therapy|hormonal therapy
114261|NCT03489473|FES PET scan|fes pet scan
114262|NCT03489473|Estrogen receptor|estrogen receptor
114263|NCT03489460|sleep health|sleep health
114264|NCT03489434|adolescents|adolescents
114265|NCT03489434|primary care|primary care
114266|NCT03489434|sexual assault|sexual assault
114267|NCT03489434|substance use|substance use
114268|NCT03489434|sexual risk behavior|sexual risk behavior
114269|NCT03489408|Proximal humerus fracture fixation|proximal humerus fracture fixation
114270|NCT03489408|trauma|trauma
114271|NCT03489382|self-harm|self-harm
114272|NCT03489382|problem-solving therapy|problem-solving therapy
114273|NCT03489382|emergency department|emergency department
114274|NCT03489382|e-therapy|e-therapy
114275|NCT03489382|suicide prevention|suicide prevention
114276|NCT03489369|Locally advanced/unresectable|locally advanced/unresectable
114277|NCT03489369|Metastatic solid tumor|metastatic solid tumor
114278|NCT03489369|Lymphoma|lymphoma
114279|NCT03489369|Anti-LAG-3|anti-lag-3
114280|NCT03489369|LAG-3|lag-3
114281|NCT03489369|LAG3|lag3
114282|NCT03489356|Addressing Behavior Change (ABC)|addressing behavior change (abc)
114283|NCT03489356|Addressing Behavior Change (ABC) Intervention|addressing behavior change (abc) intervention
114284|NCT03489356|Addressing Behavior Change (ABC) Intervention Method|addressing behavior change (abc) intervention method
114285|NCT03489343|Locally advanced/unresectable|locally advanced/unresectable
114286|NCT03489343|Metastatic solid tumor|metastatic solid tumor
114287|NCT03489343|Lymphoma|lymphoma
114288|NCT03489343|Anti-TIM-3|anti-tim-3
114289|NCT03489343|TIM-3|tim-3
114290|NCT03489343|TIM3|tim3
114291|NCT03489330|Anti-Bacterial Agents/therapeutic use|anti-bacterial agents/therapeutic use
114292|NCT03489330|Drug Utilization/statistics & numerical data|drug utilization/statistics & numerical data
114293|NCT03489330|Hospitals/statistics & numerical data|hospitals/statistics & numerical data
114294|NCT03489330|Data Analysis, Statistical|data analysis, statistical
114295|NCT03489330|Interpretation, Statistical Data|interpretation, statistical data
114296|NCT03489330|Antibiotic Stewardship|antibiotic stewardship
114297|NCT03489330|Electronic Medical Record|electronic medical record
114298|NCT03489317|gut microbiome|gut microbiome
114299|NCT03489317|stool|stool
114300|NCT03489304|Insomnia|insomnia
114301|NCT03489304|Zaleplon|zaleplon
114302|NCT03489291|Hemophilia,|hemophilia,
114303|NCT03489291|Gene Therapy|gene therapy
114305|NCT03489291|Factor IX|factor ix
114306|NCT03489291|FIX|fix
114307|NCT03489291|viral vector|viral vector
114308|NCT03489291|Padua|padua
114309|NCT03489226|capsaicin|capsaicin
114310|NCT03489226|energy expenditure|energy expenditure
114311|NCT03489226|satiety|satiety
114312|NCT03489226|food intake|food intake
114313|NCT03489174|Opioid Substitution Therapy|opioid substitution therapy
114314|NCT03489174|Pregnancy Tests|pregnancy tests
114315|NCT03489148|Stress|stress
114316|NCT03489148|Relaxation|relaxation
114317|NCT03489148|Health promotion|health promotion
114318|NCT03489122|Depressive Disorder, Major|depressive disorder, major
114319|NCT03489122|yoga|yoga
114320|NCT03489122|breathing exercise|breathing exercise
114321|NCT03489122|parasympathetic|parasympathetic
114322|NCT03489122|anxiety|anxiety
114323|NCT03489122|Post Traumatic Stress Disorder|post traumatic stress disorder
114324|NCT03489122|polyvagal|polyvagal
114325|NCT03489109|Fasting|fasting
114326|NCT03489096|Cryoballoon Ablation|cryoballoon ablation
114327|NCT03489096|Persistent atrial fibrillation|persistent atrial fibrillation
114328|NCT03489096|Paroxysmal atrial fibrillation|paroxysmal atrial fibrillation
114329|NCT03489083|Diabetes|diabetes
114330|NCT03489083|Heat Shock Response|heat shock response
114331|NCT03489083|Aging|aging
114332|NCT03489083|Exercise|exercise
114333|NCT03489070|Liver resection|liver resection
114334|NCT03489070|Liver Hemorrhage|liver hemorrhage
114335|NCT03489070|Traumastem|traumastem
114336|NCT03489070|Surgicel|surgicel
114337|NCT03489057|symptom|symptom
114338|NCT03489057|family research|family research
114339|NCT03489057|self-management|self-management
114340|NCT03489057|caregiving|caregiving
114341|NCT03489057|social support|social support
114342|NCT03489057|mHealth|mhealth
114343|NCT03489057|healthy behavior|healthy behavior
114344|NCT03489057|self-efficacy|self-efficacy
114345|NCT03489057|quality of life|quality of life
114346|NCT03489057|care transition|care transition
114347|NCT03489044|Alzheimer|alzheimer
114348|NCT03489044|Seizure|seizure
114349|NCT03489044|Epilepsy|epilepsy
114350|NCT03489044|Anti-epileptic drug|anti-epileptic drug
114351|NCT03489044|Levetiracetam|levetiracetam
114352|NCT03489018|Pneumococcal Vaccines;|pneumococcal vaccines;
114353|NCT03489018|Immunogenicity, Vaccine|immunogenicity, vaccine
114354|NCT03489018|10-valent pneumococcal vaccine|10-valent pneumococcal vaccine
114355|NCT03489018|13-valent pneumococcal vaccine|13-valent pneumococcal vaccine
114356|NCT03489018|Schedule|schedule
114357|NCT03489018|Pneumococcal Infection|pneumococcal infection
114358|NCT03489018|Kenya|kenya
114359|NCT03489018|Infant|infant
114360|NCT03489018|Vaccines, Conjugate|vaccines, conjugate
114361|NCT03489018|Humans|humans
114362|NCT03489018|Immunization schedule|immunization schedule
114363|NCT03489018|Streptococcus pneumoniae|streptococcus pneumoniae
114364|NCT03489018|vaccine|vaccine
114365|NCT03489018|Dose-Response Relationship, immunologic|dose-response relationship, immunologic
114366|NCT03489018|Equivalence Trial as Topic|equivalence trial as topic
114367|NCT03489005|BIA 5-1058|bia 5-1058
114368|NCT03489005|Pulmonary arterial hypertension|pulmonary arterial hypertension
114369|NCT03489005|Heart failure|heart failure
114370|NCT03489005|Cardiovascular Disease|cardiovascular disease
114371|NCT03488992|dietary supplement, cardiovascular health, oxidative stress|dietary supplement, cardiovascular health, oxidative stress
114372|NCT03488979|Heart Failure|heart failure
114373|NCT03488979|Medication Adherence|medication adherence
114374|NCT03488966|Mindfulness|mindfulness
114375|NCT03488966|Bariatric Surgery|bariatric surgery
114376|NCT03488966|Obesity|obesity
114377|NCT03488966|Group psychotherapy|group psychotherapy
114378|NCT03488953|Liver transplantation|liver transplantation
114379|NCT03488953|Two-stage hepatectomy|two-stage hepatectomy
114380|NCT03488953|Living donor liver transplantation|living donor liver transplantation
114381|NCT03488940|Sepsis|sepsis
114382|NCT03488940|intestinal dysfunction|intestinal dysfunction
114383|NCT03488940|enteral feeding|enteral feeding
114384|NCT03488927|Sexual Violence|sexual violence
114385|NCT03488927|Interpersonal Violence|interpersonal violence
114386|NCT03488927|Prevention|prevention
114387|NCT03488927|Mixed-Methods|mixed-methods
114388|NCT03488927|Randomized Controlled Trial|randomized controlled trial
114389|NCT03488927|Outcome Evaluation|outcome evaluation
114390|NCT03488927|College Students|college students
114391|NCT03488927|Post-traumatic Stress Disorder|post-traumatic stress disorder
114392|NCT03488927|Alcohol|alcohol
114393|NCT03488927|Sexual Assault|sexual assault
114394|NCT03488927|Disclosure|disclosure
114395|NCT03488927|Social Reactions|social reactions
114396|NCT03488927|Coping|coping
114397|NCT03488927|Depression|depression
114398|NCT03488927|Intervention|intervention
114399|NCT03488823|Endothelial Function|endothelial function
114400|NCT03488823|Flavonols|flavonols
114401|NCT03488823|Intima Injury|intima injury
114402|NCT03488810|Apalutamide Prostate Cancer Radiotherapy|apalutamide prostate cancer radiotherapy
114403|NCT03488771|kidney transplantation|kidney transplantation
114404|NCT03488771|rejection|rejection
114405|NCT03488771|infection|infection
114406|NCT03488771|immunosuppression|immunosuppression
114407|NCT03488667|resectable adenocarcinoma of Gastroesophageal Junction|resectable adenocarcinoma of gastroesophageal junction
114408|NCT03488667|resectable adenocarcinoma of Stomach|resectable adenocarcinoma of stomach
114409|NCT03488641|Biomarker|biomarker
114410|NCT03488641|Signal Transduction Pathway Deregulation|signal transduction pathway deregulation
114411|NCT03488641|Outcome|outcome
114412|NCT03488641|Drug sensitivity testing|drug sensitivity testing
114413|NCT03488641|Targeted Therapy|targeted therapy
114414|NCT03488641|Genomic landscape|genomic landscape
114415|NCT03488628|respiratory failure|respiratory failure
114416|NCT03488628|oxygen therapy|oxygen therapy
114417|NCT03488628|Noninvasive ventilation|noninvasive ventilation
114418|NCT03488563|Headache|headache
114419|NCT03488498|Balneotherapy|balneotherapy
114420|NCT03488498|Chronic low back pain|chronic low back pain
114421|NCT03488498|Controlled|controlled
114422|NCT03488498|Randomized trial|randomized trial
114423|NCT03488498|weight bath traction|weight bath traction
114424|NCT03488498|follow-up|follow-up
114425|NCT03488485|Mukh Mantri Punjab Hepatitis C Relief Fund,MMPHCRF|mukh mantri punjab hepatitis c relief fund,mmphcrf
114426|NCT03488485|Direct antivirals, DAAs|direct antivirals, daas
114427|NCT03488485|Chronic hepatitis C|chronic hepatitis c
114428|NCT03488459|anxiety|anxiety
114429|NCT03488459|preoperative education|preoperative education
114430|NCT03488459|psychologist|psychologist
114431|NCT03488459|thoracotomy|thoracotomy
114432|NCT03488459|Ravitch procedure|ravitch procedure
114433|NCT03488459|postoperative pain|postoperative pain
114434|NCT03488446|Gastric Cancer|gastric cancer
114435|NCT03488446|Radiomics|radiomics
114436|NCT03488446|Computed Tomograpy|computed tomograpy
114437|NCT03488446|Lymph Node Metastasis|lymph node metastasis
114438|NCT03488446|Prediction|prediction
114439|NCT03488433|Postoperative shoulder immobilization|postoperative shoulder immobilization
114440|NCT03488433|Reverse total shoulder arthroplasty|reverse total shoulder arthroplasty
114441|NCT03488433|Neutral rotation shoulder brace|neutral rotation shoulder brace
114442|NCT03488433|Antirotation sling|antirotation sling
114443|NCT03488407|Primary angioplasty|primary angioplasty
114444|NCT03488407|Radial access|radial access
114445|NCT03488407|STEMI|stemi
114446|NCT03488394|Mucopolysaccharidosis IH|mucopolysaccharidosis ih
114447|NCT03488394|Gene Therapy|gene therapy
114448|NCT03488394|Transplantation, Autologous|transplantation, autologous
114449|NCT03488394|Lentiviral vector|lentiviral vector
114450|NCT03488355|Catheter|catheter
114451|NCT03488342|Rives technique|rives technique
114452|NCT03488342|Lichtenstein repair|lichtenstein repair
114453|NCT03488329|Hospital readmissions|hospital readmissions
114454|NCT03488329|Seniors|seniors
114455|NCT03488290|Parents|parents
114456|NCT03488290|Young Children|young children
114457|NCT03488290|Trauma Focused Cognitive Behavior Therapy|trauma focused cognitive behavior therapy
114458|NCT03488290|Learning Through Play|learning through play
114459|NCT03488160|lymphoma CAR-T|lymphoma car-t
114460|NCT03488147|Esomeprazole Magnesium|esomeprazole magnesium
114461|NCT03488147|Postoperative dysphagia|postoperative dysphagia
114462|NCT03488147|Gastroesophageal reflux disease|gastroesophageal reflux disease
114463|NCT03488147|Anterior cervical surgery|anterior cervical surgery
114464|NCT03488147|Proton pump inhibitor|proton pump inhibitor
114465|NCT03488134|Exosome|exosome
114466|NCT03488134|Anaplastic thyroid cancer|anaplastic thyroid cancer
114467|NCT03488134|Urine|urine
114468|NCT03488134|Biological marker|biological marker
114469|NCT03488134|Thyroglobuin|thyroglobuin
114470|NCT03488134|Galectin-3|galectin-3
114471|NCT03488095|Tobacco, smokeless, chewing, betel quid|tobacco, smokeless, chewing, betel quid
114472|NCT03488082|saccadic adaptation|saccadic adaptation
114473|NCT03488082|visual-spatial perception|visual-spatial perception
114474|NCT03488082|fMRI|fmri
114475|NCT03488069|critical care|critical care
114476|NCT03488069|sedation|sedation
114477|NCT03488069|practice|practice
114478|NCT03488069|survey|survey
114479|NCT03488056|Dental Caries, ICCMS, Risk Assessment|dental caries, iccms, risk assessment
114480|NCT03488043|Lung lesions|lung lesions
114481|NCT03488043|Pneumothorax|pneumothorax
114482|NCT03488043|CT-guided transthoracic biopsy|ct-guided transthoracic biopsy
114483|NCT03488043|Risk score|risk score
114484|NCT03488030|Drug therapy|drug therapy
114485|NCT03487991|autonomic balance|autonomic balance
114486|NCT03487991|sleep|sleep
114487|NCT03487991|endothelial function|endothelial function
114488|NCT03487991|behavior|behavior
114489|NCT03487991|stress|stress
114490|NCT03487965|dicarbonyl compounds|dicarbonyl compounds
114491|NCT03487965|skin elasticity|skin elasticity
114492|NCT03487965|glycation|glycation
114493|NCT03487952|Lung nodule|lung nodule
114494|NCT03487952|Computed tomography|computed tomography
114495|NCT03487952|Artificial intelligence|artificial intelligence
114496|NCT03487887|continuous glucose monitoring|continuous glucose monitoring
114497|NCT03487887|glycemic variability|glycemic variability
114498|NCT03487887|hypoglycemia|hypoglycemia
114499|NCT03487874|8th cervical nerve root block|8th cervical nerve root block
114500|NCT03487861|transglutaminase type 2|transglutaminase type 2
114501|NCT03487861|kidney transplantation|kidney transplantation
114502|NCT03487861|chronic allograft nephropathy|chronic allograft nephropathy
114503|NCT03487861|biomarker|biomarker
114504|NCT03487835|Athletic tape. Accidental Falls. Aging.|athletic tape. accidental falls. aging.
114505|NCT03487809|Asthma|asthma
114506|NCT03487809|Inhaled corticosteroid|inhaled corticosteroid
114507|NCT03487809|pharmacogenomics|pharmacogenomics
114508|NCT03487809|Therapeutic effect|therapeutic effect
114509|NCT03487783|Tourette|tourette
114510|NCT03487783|Aripiprazole Oral Solution|aripiprazole oral solution
114511|NCT03487770|Autistic|autistic
114512|NCT03487770|Aripiprazole Oral Solution|aripiprazole oral solution
114513|NCT03487744|Tube Feeding|tube feeding
114514|NCT03487744|Diarrhea|diarrhea
114515|NCT03487744|Enteral Nutrition|enteral nutrition
114516|NCT03487744|Critically Ill|critically ill
114517|NCT03487744|Surgical|surgical
114518|NCT03487744|Cardiovascular|cardiovascular
114519|NCT03487731|stem cells|stem cells
114520|NCT03487731|back pain|back pain
114521|NCT03487718|Platelet-Rich Fibrin|platelet-rich fibrin
114522|NCT03487718|high-density polytetrafluoroethylene membrane|high-density polytetrafluoroethylene membrane
114523|NCT03487692|diabetes|diabetes
114524|NCT03487692|group visit|group visit
114525|NCT03487692|shared medical appointment|shared medical appointment
114526|NCT03487692|text messaging|text messaging
114527|NCT03487679|Microbiome|microbiome
114528|NCT03487679|High Density Lipoprotein|high density lipoprotein
114529|NCT03487679|Inflammation|inflammation
114530|NCT03487666|Triple Negative Breast Cancer|triple negative breast cancer
114531|NCT03487666|Nivolumab|nivolumab
114532|NCT03487666|Capecitabine|capecitabine
114533|NCT03487640|constipation, surgery|constipation, surgery
114534|NCT03487627|adolescent|adolescent
114535|NCT03487627|parental support|parental support
114536|NCT03487627|parental coping|parental coping
114537|NCT03487614|pediatric obesity|pediatric obesity
114538|NCT03487614|preschool children|preschool children
114539|NCT03487614|non-responsive feeding|non-responsive feeding
114540|NCT03487614|body mass index|body mass index
114541|NCT03487614|parenting|parenting
114542|NCT03487601|docetaxel|docetaxel
114543|NCT03487601|Stage I - IV|stage i - iv
114544|NCT03487601|chemotherapy|chemotherapy
114545|NCT03487575|Adolescent|adolescent
114546|NCT03487575|Parental Support|parental support
114547|NCT03487575|Parental Coping|parental coping
114548|NCT03487523|Behavioural Economics|behavioural economics
114549|NCT03487510|treatment standards|treatment standards
114550|NCT03487510|diagnostical approaches|diagnostical approaches
114551|NCT03487510|descriptive|descriptive
114552|NCT03487497|gait analysis|gait analysis
114553|NCT03487497|electromyography|electromyography
114554|NCT03487497|strength test|strength test
114555|NCT03487497|walking|walking
712571|NCT00579683|04-103|04-103
114556|NCT03487419|left atrial echocardiography|left atrial echocardiography
114557|NCT03487419|new onset atrial fibrillation|new onset atrial fibrillation
114558|NCT03487419|coronary artery bypass grafting|coronary artery bypass grafting
114559|NCT03487419|speckle tracking echocardiography|speckle tracking echocardiography
114560|NCT03487393|facial nerve|facial nerve
114561|NCT03487393|magnetic stimulation|magnetic stimulation
114562|NCT03487393|cerebral blood flow|cerebral blood flow
114563|NCT03487367|spinocerebellar ataxia|spinocerebellar ataxia
114564|NCT03487367|ataxia|ataxia
114565|NCT03487367|ataxias|ataxias
114566|NCT03487367|SCA1|sca1
114567|NCT03487367|SCA3|sca3
114568|NCT03487367|spinocerebellar ataxia type 1|spinocerebellar ataxia type 1
114569|NCT03487367|spinocerebellar ataxia type 3|spinocerebellar ataxia type 3
114570|NCT03487367|READISCA|readisca
114571|NCT03487328|treatment|treatment
114572|NCT03487276|hidradenitis suppurativa|hidradenitis suppurativa
114573|NCT03487276|monoclonal antibody|monoclonal antibody
114574|NCT03487276|complement factor C5a|complement factor c5a
114575|NCT03487276|IFX-1|ifx-1
114576|NCT03487276|hidradenitis Suppurativa Clinical Response|hidradenitis suppurativa clinical response
114577|NCT03487276|Inflammation|inflammation
114578|NCT03487276|skin diseases|skin diseases
114579|NCT03487263|motor neurone disease|motor neurone disease
114580|NCT03487263|amyotrophic lateral sclerosis|amyotrophic lateral sclerosis
114581|NCT03487263|IC14 [anti-CD14 (cluster of differentiation 14) monoclonal antibody]|ic14 [anti-cd14 (cluster of differentiation 14) monoclonal antibody]
114582|NCT03487263|monoclonal antibody|monoclonal antibody
114583|NCT03487263|anti-CD14|anti-cd14
114584|NCT03487237|Syncope|syncope
114585|NCT03487237|Pulmonary embolism|pulmonary embolism
114586|NCT03487237|emergency department|emergency department
114587|NCT03487237|clinical decision rule|clinical decision rule
114588|NCT03487224|Hoarding Disorder|hoarding disorder
114589|NCT03487211|Fibromyalgia treatment|fibromyalgia treatment
114590|NCT03487211|Duloxetine|duloxetine
114591|NCT03487211|Escitalopram|escitalopram
114592|NCT03487198|Major Depressive Disorder|major depressive disorder
114593|NCT03487198|Brexpiprazole|brexpiprazole
114594|NCT03487185|CPAP|cpap
114595|NCT03487185|Apnea|apnea
114596|NCT03487185|pregnancy|pregnancy
114597|NCT03487107|Chronic Genotype 1 HCV Infection|chronic genotype 1 hcv infection
114598|NCT03487029|diabetes|diabetes
114599|NCT03487029|high intensity interval training|high intensity interval training
114600|NCT03487029|cardiorespiratory fitness|cardiorespiratory fitness
114601|NCT03487016|Pancreatic Cancer|pancreatic cancer
114602|NCT03487016|First line|first line
114603|NCT03487016|Metastatic|metastatic
114604|NCT03487003|laryngeal mask airway|laryngeal mask airway
114605|NCT03487003|children, preschool|children, preschool
114606|NCT03487003|muscle relaxant|muscle relaxant
114607|NCT03486990|safety|safety
114608|NCT03486990|tolerability|tolerability
114609|NCT03486990|pharmacokinetics|pharmacokinetics
114610|NCT03486990|celiac|celiac
114611|NCT03486990|gliadin|gliadin
114612|NCT03486990|gluten|gluten
114613|NCT03486951|outpatient surgery|outpatient surgery
114614|NCT03486951|ambulatory surgery|ambulatory surgery
114615|NCT03486951|length of hospital stay|length of hospital stay
114616|NCT03486925|oxytocin, eye-tracking, attention inhibition|oxytocin, eye-tracking, attention inhibition
114618|NCT03486873|PD-1|pd-1
114619|NCT03486873|PDL1|pdl1
114620|NCT03486873|PD-L1|pd-l1
114621|NCT03486821|Radiation Therapy|radiation therapy
114622|NCT03486821|ultra-short Radiation|ultra-short radiation
114623|NCT03486821|SBRT|sbrt
114624|NCT03486821|prostate|prostate
114625|NCT03486821|quality of life|quality of life
114626|NCT03486821|financial toxicity|financial toxicity
114627|NCT03486808|transcranial direct current stimulation|transcranial direct current stimulation
114628|NCT03486808|motor function|motor function
114629|NCT03486795|transcranial direct current stimulation|transcranial direct current stimulation
114630|NCT03486795|motor function|motor function
114631|NCT03486782|transcranial direct current stimulation|transcranial direct current stimulation
114632|NCT03486782|dual stimulation|dual stimulation
114633|NCT03486769|transcranial direct current stimulation|transcranial direct current stimulation
114634|NCT03486769|dual stimulation|dual stimulation
114635|NCT03486756|Asthma|asthma
114636|NCT03486756|Anxiety|anxiety
114637|NCT03486756|Stress|stress
114638|NCT03486743|LARC contraception cultural acceptance|larc contraception cultural acceptance
114639|NCT03486678|BTC|btc
114640|NCT03486678|PD-1 antibody|pd-1 antibody
114641|NCT03486639|Urodynamics|urodynamics
114642|NCT03486639|Bladder sensation|bladder sensation
114643|NCT03486639|confounding factors|confounding factors
114644|NCT03486587|afatinib|afatinib
114645|NCT03486587|diarrhea|diarrhea
114646|NCT03486587|Bacillus Cereus|bacillus cereus
114647|NCT03486587|NSCLC|nsclc
114648|NCT03486561|Ranolazine|ranolazine
114649|NCT03486561|Pakistan|pakistan
114650|NCT03486561|Ischemic Heart Disease|ischemic heart disease
114651|NCT03486548|popliteal sciatic nerve block|popliteal sciatic nerve block
114652|NCT03486548|total knee artgroplasty|total knee artgroplasty
114653|NCT03486548|adductor canal block|adductor canal block
114654|NCT03486548|dexamethasone|dexamethasone
114655|NCT03486535|Diabetes mellitus|diabetes mellitus
114656|NCT03486535|Infraclavicular brachial plexus block|infraclavicular brachial plexus block
114657|NCT03486535|Block duration|block duration
114658|NCT03486535|Time-to-first pain|time-to-first pain
114659|NCT03486535|Postoperative analgesia|postoperative analgesia
114660|NCT03486522|termination of pregnancy|termination of pregnancy
114661|NCT03486509|afatinib|afatinib
114662|NCT03486496|Lung Adenocarcinoma|lung adenocarcinoma
114663|NCT03486496|EGFR mutation|egfr mutation
114664|NCT03486496|Gefitinib|gefitinib
114665|NCT03486496|Berberine|berberine
114666|NCT03486457|psoriatic arthritis|psoriatic arthritis
114667|NCT03486457|tofacitinib|tofacitinib
114668|NCT03486431|Stereotactic Ablative Body Radiotherapy (SABR)|stereotactic ablative body radiotherapy (sabr)
114669|NCT03486366|epilepsy, TSC, biomarkers, mTOR pathway|epilepsy, tsc, biomarkers, mtor pathway
114670|NCT03486353|myelodysplastic syndrome (MDS)|myelodysplastic syndrome (mds)
114671|NCT03486314|Drug therapy|drug therapy
114672|NCT03486301|TLR|tlr
114673|NCT03486301|Immuno-oncology|immuno-oncology
114674|NCT03486288|delirium|delirium
114675|NCT03486288|postoperative cognitive dysfunction|postoperative cognitive dysfunction
114676|NCT03486288|spine surgery|spine surgery
114677|NCT03486288|elderly|elderly
114678|NCT03486288|neuroinflammation|neuroinflammation
114679|NCT03486288|magnetic resonance imaging|magnetic resonance imaging
114680|NCT03486288|resting state fmri|resting state fmri
114681|NCT03486288|cerebral vasculature|cerebral vasculature
114682|NCT03486288|quality of life|quality of life
114683|NCT03486275|GENERAL PRACTICE|general practice
114684|NCT03486275|SERIOUS GAME|serious game
114685|NCT03486275|EVIDENCE BASED MEDICINE|evidence based medicine
114686|NCT03486275|RANDOMIZED CONTROLLED TRIAL|randomized controlled trial
114687|NCT03486275|PEDAGOGY|pedagogy
114688|NCT03486262|Lung cancer; Idiopathic pulmonary fibrosis|lung cancer; idiopathic pulmonary fibrosis
114689|NCT03486249|diaphragm dysfunction|diaphragm dysfunction
114690|NCT03486249|ventilator weaning|ventilator weaning
114691|NCT03486249|pulmonary edema|pulmonary edema
114692|NCT03486171|difficult intubation|difficult intubation
114693|NCT03486171|prehospital emergency|prehospital emergency
114694|NCT03486171|risk factors|risk factors
114695|NCT03486158|Leukocyte L1 Antigen Complex|leukocyte l1 antigen complex
114696|NCT03486158|Feces|feces
114697|NCT03486158|Cell Phone|cell phone
114698|NCT03486158|Biomarkers|biomarkers
114699|NCT03486158|Recurrence|recurrence
114700|NCT03486158|Prognosis|prognosis
114701|NCT03486158|Clinical Chemistry Tests|clinical chemistry tests
114702|NCT03486145|beetroot juice|beetroot juice
114703|NCT03486145|nitrates and nitrites|nitrates and nitrites
114704|NCT03486119|Non -small cell lung cancer|non -small cell lung cancer
114705|NCT03486093|Venous central catheter|venous central catheter
114706|NCT03486093|Central line-associated bloodstream infections|central line-associated bloodstream infections
114707|NCT03486093|Port protector|port protector
114708|NCT03486093|Respiratory semi-Intensive Care Unit|respiratory semi-intensive care unit
114709|NCT03486067|Multiple Myeloma|multiple myeloma
114710|NCT03486067|BCMA X CD3 T Cell|bcma x cd3 t cell
114711|NCT03486067|Antibody|antibody
114712|NCT03486067|CC-93269|cc-93269
114713|NCT03486067|Relapsed and Refractory|relapsed and refractory
114714|NCT03486054|Anemia|anemia
114715|NCT03486054|Transfusion|transfusion
114716|NCT03486054|Pathogen inactivation|pathogen inactivation
114717|NCT03486054|low-resource|low-resource
114718|NCT03486054|Sub-saharan Africa|sub-saharan africa
114719|NCT03486054|Côte d'Ivoire|côte d'ivoire
114720|NCT03486054|Transfusion-transmitted infection|transfusion-transmitted infection
114721|NCT03486054|Red Blood Cells|red blood cells
114722|NCT03486054|Whole blood|whole blood
114723|NCT03486054|Pathogen reduction|pathogen reduction
114724|NCT03486028|Patient-Centered Outcomes Research Institute (PCORI)|patient-centered outcomes research institute (pcori)
114725|NCT03486028|American Society of Addiction Medicine (ASAM)|american society of addiction medicine (asam)
114726|NCT03486028|substance use|substance use
114727|NCT03486028|addiction|addiction
114728|NCT03486028|treatment|treatment
114729|NCT03486028|RTI International|rti international
114730|NCT03486028|UCLA|ucla
114731|NCT03485989|hazelnuts|hazelnuts
114732|NCT03485989|vitamin E|vitamin e
114733|NCT03485989|aging|aging
114734|NCT03485976|Ixekizumab|ixekizumab
114735|NCT03485976|IL-17|il-17
114736|NCT03485976|Pityriasis Rubra Pilaris (PRP)|pityriasis rubra pilaris (prp)
114737|NCT03485950|Other infectious diseases|other infectious diseases
114738|NCT03485950|Febrile neutropenic adults with cancer|febrile neutropenic adults with cancer
114739|NCT03485950|Ceftolozane-Tazobactam|ceftolozane-tazobactam
114740|NCT03485950|Cefepime|cefepime
114741|NCT03485950|Meropenem|meropenem
114742|NCT03485950|Piperacillin/Tazobactam|piperacillin/tazobactam
114743|NCT03485937|anxiety|anxiety
114744|NCT03485937|patient satisfaction|patient satisfaction
114745|NCT03485937|video education|video education
114746|NCT03485937|skin cancer|skin cancer
114747|NCT03485937|linear closure on the face|linear closure on the face
114748|NCT03485911|BCX7353|bcx7353
114749|NCT03485898|UCC|ucc
114750|NCT03485898|mortality|mortality
114751|NCT03485898|alzheimer's disease|alzheimer's disease
114752|NCT03485898|longitudinal study|longitudinal study
114753|NCT03485885|anthocyanins, maqui berries, bioavailability|anthocyanins, maqui berries, bioavailability
114754|NCT03485846|hepatitis C|hepatitis c
114755|NCT03485846|chronic|chronic
114756|NCT03485846|1b genotype|1b genotype
114757|NCT03485846|oral treatment|oral treatment
114758|NCT03485833|end-expiratory occlusion test|end-expiratory occlusion test
114759|NCT03485833|end-inspiratory occlusion test|end-inspiratory occlusion test
114760|NCT03485833|transesophageal echocardiography|transesophageal echocardiography
114761|NCT03485833|passive legs raising|passive legs raising
114762|NCT03485833|fluid challenge|fluid challenge
114763|NCT03485820|environmental modifications|environmental modifications
114764|NCT03485820|activity performance|activity performance
114765|NCT03485807|stress|stress
114766|NCT03485807|mindfulness|mindfulness
114767|NCT03485807|active coping|active coping
114768|NCT03485781|EEG|eeg
114769|NCT03485781|Intensive Care|intensive care
114770|NCT03485781|Propofol|propofol
114771|NCT03485768|cervical vertigo|cervical vertigo
114772|NCT03485768|percutaneous disc decompression with coblation nucleoplasty|percutaneous disc decompression with coblation nucleoplasty
114773|NCT03485768|manual therapy|manual therapy
114774|NCT03485768|clinical efficacy|clinical efficacy
114775|NCT03485768|randomized controlled trial|randomized controlled trial
114776|NCT03485755|microflora|microflora
114777|NCT03485755|microbiome|microbiome
114778|NCT03485755|bacteria taxa|bacteria taxa
114779|NCT03485716|metabolism|metabolism
114780|NCT03485716|metabolome|metabolome
114781|NCT03485716|physical activity|physical activity
114782|NCT03485716|hypoxia|hypoxia
114783|NCT03485690|COPD|copd
114784|NCT03485690|Cohort study|cohort study
114785|NCT03485690|Prospective|prospective
114786|NCT03485651|adrexal mass|adrexal mass
114787|NCT03485651|ovarian cancer|ovarian cancer
114788|NCT03485651|fallopian tube cancer|fallopian tube cancer
114789|NCT03485651|peritoneal cancer|peritoneal cancer
114790|NCT03485612|Optic Nerve Sheath Diameter|optic nerve sheath diameter
114791|NCT03485612|Urological Anaesthesia|urological anaesthesia
114792|NCT03485612|point of care USG|point of care usg
114898|NCT03484988|Gut Microbiota|gut microbiota
114899|NCT03484962|activated CIK|activated cik
114793|NCT03485586|cataract, higher order aberration,vitrectomy,diabetic retinopathy|cataract, higher order aberration,vitrectomy,diabetic retinopathy
114794|NCT03485560|chronic skin disease|chronic skin disease
114795|NCT03485560|psoriasis|psoriasis
114796|NCT03485560|Eczema|eczema
114797|NCT03485560|atopic dermatitis|atopic dermatitis
114798|NCT03485547|Blastic Plasmacytoid Dendritic Cell Neoplasm|blastic plasmacytoid dendritic cell neoplasm
114799|NCT03485547|BPDCN|bpdcn
114800|NCT03485521|High Fidelity Simulation Training|high fidelity simulation training
114801|NCT03485521|physiotherapy|physiotherapy
114802|NCT03485521|tracheobronchial aspiration.|tracheobronchial aspiration.
114803|NCT03485482|Pharmacokinetic drug interaction|pharmacokinetic drug interaction
114804|NCT03485482|ivabtadine|ivabtadine
114805|NCT03485482|bisoprolol|bisoprolol
114806|NCT03485469|Obesity|obesity
114807|NCT03485469|bariatric surgery|bariatric surgery
114808|NCT03485469|Hypnosis|hypnosis
114809|NCT03485456|Dry powder inhalation|dry powder inhalation
114810|NCT03485456|Tobramycin|tobramycin
114811|NCT03485443|fluid infusion|fluid infusion
114812|NCT03485443|vomiting|vomiting
114813|NCT03485443|otorhinolaringology|otorhinolaringology
114814|NCT03485417|stimulant|stimulant
114815|NCT03485417|psychosis|psychosis
114816|NCT03485417|schizophrenia|schizophrenia
114817|NCT03485417|dependence|dependence
114818|NCT03485417|pharmacotherapy|pharmacotherapy
114819|NCT03485404|POCD|pocd
114820|NCT03485404|vitamin B12|vitamin b12
114821|NCT03485404|folic acid|folic acid
114822|NCT03485378|Stereotactic|stereotactic
114823|NCT03485378|Ablative|ablative
114824|NCT03485378|Radiation|radiation
114825|NCT03485365|Pain|pain
114826|NCT03485365|Osteoarthritis of the knee|osteoarthritis of the knee
114827|NCT03485365|Target engagement|target engagement
114828|NCT03485365|GSK3858279|gsk3858279
114829|NCT03485365|Pharmacokinetics|pharmacokinetics
114830|NCT03485365|Sequential|sequential
114831|NCT03485352|Bariatric Surgery|bariatric surgery
114832|NCT03485352|Sleep|sleep
114833|NCT03485352|Chronotype|chronotype
114834|NCT03485326|Osimertinib|osimertinib
114835|NCT03485326|Tagrisso|tagrisso
114836|NCT03485326|NSCLC|nsclc
114837|NCT03485326|Non-small cell lung cancer|non-small cell lung cancer
114838|NCT03485326|Safety|safety
114839|NCT03485313|Healthy|healthy
114840|NCT03485313|Volunteer|volunteer
114841|NCT03485313|Female|female
114842|NCT03485313|Pregnancy|pregnancy
114843|NCT03485287|PTSD|ptsd
114844|NCT03485287|MDMA|mdma
114845|NCT03485287|Psychotherapy|psychotherapy
114846|NCT03485274|Cannabis|cannabis
114847|NCT03485274|depression|depression
114848|NCT03485274|anxiety|anxiety
114849|NCT03485274|medication|medication
114850|NCT03485248|HIV/AIDS|hiv/aids
114851|NCT03485248|Arterial stiffness|arterial stiffness
114852|NCT03485248|Flow mediated-dilatation|flow mediated-dilatation
114853|NCT03485248|Muscle oxygenation parameters|muscle oxygenation parameters
114854|NCT03485248|Microcirculation|microcirculation
114855|NCT03485248|Dietary Nitrate|dietary nitrate
114856|NCT03485222|Cardiovascular diseases|cardiovascular diseases
114857|NCT03485222|Heart Failure|heart failure
114858|NCT03485222|LV remodeling|lv remodeling
114859|NCT03485222|SGLT-2 Inhibitors|sglt-2 inhibitors
114860|NCT03485222|Empagliflozin|empagliflozin
114861|NCT03485222|Cardiac MRI|cardiac mri
114862|NCT03485209|Colorectal cancer|colorectal cancer
114863|NCT03485209|NSCLC|nsclc
114864|NCT03485209|SCCHN|scchn
114865|NCT03485209|CRC|crc
114866|NCT03485209|Pancreatic cancer|pancreatic cancer
114867|NCT03485209|Head and neck cancer|head and neck cancer
114868|NCT03485196|Microsatellite Instability|microsatellite instability
114869|NCT03485196|Fluorouracil|fluorouracil
114870|NCT03485196|Adjuvant chemotherapy|adjuvant chemotherapy
114871|NCT03485196|Efficacy|efficacy
114872|NCT03485196|Operation|operation
114873|NCT03485183|delirium|delirium
114874|NCT03485183|white noise|white noise
114875|NCT03485183|pink noise|pink noise
114876|NCT03485170|Hemophilia|hemophilia
114877|NCT03485170|Hemophilic arthropathy|hemophilic arthropathy
114878|NCT03485170|PET|pet
114879|NCT03485144|Dengue Vaccine|dengue vaccine
114880|NCT03485118|Previously untreated DLBCL|previously untreated dlbcl
114881|NCT03485105|Gastric cancer|gastric cancer
114882|NCT03485105|biomarker|biomarker
114883|NCT03485105|chemotherapy|chemotherapy
114884|NCT03485105|precise medicine|precise medicine
114885|NCT03485092|heart failure|heart failure
114886|NCT03485092|diabetes mellitus|diabetes mellitus
114887|NCT03485092|empagliflozin|empagliflozin
114888|NCT03485092|Randomised, placebo controlled trial|randomised, placebo controlled trial
114889|NCT03485040|Rehabilitation|rehabilitation
114890|NCT03485040|Neurorehabilitation|neurorehabilitation
114891|NCT03485040|Neurotechnology|neurotechnology
114892|NCT03485040|Neurorecovery|neurorecovery
114893|NCT03485040|Neurorestoration|neurorestoration
114894|NCT03484988|Polyunsaturated fatty acids|polyunsaturated fatty acids
114895|NCT03484988|Echium oil|echium oil
114896|NCT03484988|Hyperlipidemias|hyperlipidemias
114897|NCT03484988|Metabolites|metabolites
114900|NCT03484962|MUC1|muc1
114901|NCT03484962|bispecific antibody|bispecific antibody
114902|NCT03484962|liver cancer|liver cancer
114903|NCT03484949|Gastric cancer|gastric cancer
114904|NCT03484949|Screening|screening
114905|NCT03484949|Risk assessment|risk assessment
114906|NCT03484936|Intracranial Hemorrhages|intracranial hemorrhages
114907|NCT03484936|remote ischemic conditioning|remote ischemic conditioning
114908|NCT03484923|Unresectable|unresectable
114909|NCT03484923|melanoma|melanoma
114910|NCT03484923|metastatic melanoma|metastatic melanoma
114911|NCT03484923|advanced melanoma|advanced melanoma
114912|NCT03484923|spartalizumab|spartalizumab
114913|NCT03484923|PDR001|pdr001
114914|NCT03484923|LAG525|lag525
114915|NCT03484923|capmatinib|capmatinib
114916|NCT03484923|INC280|inc280
114917|NCT03484923|canakinumab|canakinumab
114919|NCT03484923|ribociclib|ribociclib
114920|NCT03484923|LEE011|lee011
114921|NCT03484923|immunotherapy|immunotherapy
114922|NCT03484923|platform study|platform study
114923|NCT03484884|nodal metastases|nodal metastases
114924|NCT03484884|17-538|17-538
114925|NCT03484884|Memorial Sloan Kettering Cancer Center|memorial sloan kettering cancer center
114926|NCT03484793|AESOP Model|aesop model
114927|NCT03484793|Big data|big data
114928|NCT03484793|medication error|medication error
114929|NCT03484793|data mining|data mining
114930|NCT03484793|patient safety|patient safety
114931|NCT03484793|CPOE|cpoe
114932|NCT03484793|CDSS|cdss
114933|NCT03484793|alarm fatigue|alarm fatigue
114934|NCT03484793|association rule mining.|association rule mining.
114935|NCT03484780|Implantable Heart Failure Device Therapy|implantable heart failure device therapy
114936|NCT03484780|Asymptomatic Diaphragmatic Stimulation|asymptomatic diaphragmatic stimulation
114937|NCT03484767|methylmalonic acidemia|methylmalonic acidemia
114938|NCT03484767|MMA|mma
114939|NCT03484767|organic acidemia|organic acidemia
114940|NCT03484767|mut deficiency|mut deficiency
114941|NCT03484767|inborn errors of metabolism|inborn errors of metabolism
114942|NCT03484767|mut0|mut0
114943|NCT03484767|mut-|mut-
114944|NCT03484767|PA|pa
114945|NCT03484767|PCCA|pcca
114946|NCT03484767|PCCB|pccb
114947|NCT03484767|propionic acidemia|propionic acidemia
114948|NCT03484728|Conditional pain modulation|conditional pain modulation
114949|NCT03484728|pain|pain
114950|NCT03484728|placebo|placebo
114951|NCT03484715|Physical Activity|physical activity
114952|NCT03484715|Nursing Home|nursing home
114953|NCT03484715|Feasibility|feasibility
114954|NCT03484715|Older Adults|older adults
114955|NCT03484702|Non-Hodgkin lymphoma|non-hodgkin lymphoma
114956|NCT03484702|Aggressive B-cell non-Hodgkin lymphoma|aggressive b-cell non-hodgkin lymphoma
114957|NCT03484702|Diffuse large B-cell lymphoma|diffuse large b-cell lymphoma
114958|NCT03484702|Relapse / refractory lymphoma|relapse / refractory lymphoma
114959|NCT03484702|Transplant not eligible|transplant not eligible
114960|NCT03484702|Double-hit lymphoma|double-hit lymphoma
114961|NCT03484702|Triple-hit lymphoma|triple-hit lymphoma
114962|NCT03484702|Primary/secondary central nervous system lymphoma|primary/secondary central nervous system lymphoma
114963|NCT03484702|Richter's transformation/syndrome|richter's transformation/syndrome
114964|NCT03484702|Transformed follicular lymphoma|transformed follicular lymphoma
114965|NCT03484702|Follicular lymphoma Grade 3B|follicular lymphoma grade 3b
114966|NCT03484702|JCAR017|jcar017
114967|NCT03484702|CAR T cell therapy|car t cell therapy
114968|NCT03484702|CD19 targeted therapy.|cd19 targeted therapy.
114969|NCT03484702|Efficacy and safety|efficacy and safety
114970|NCT03484702|Europe / Japan|europe / japan
114971|NCT03484702|TPTD|tptd
114972|NCT03484689|Diabetes-related distress|diabetes-related distress
114973|NCT03484689|Mindfulness|mindfulness
114974|NCT03484637|motivation|motivation
114975|NCT03484637|Treatment adherence|treatment adherence
114976|NCT03484637|Waist circumference|waist circumference
114977|NCT03484637|obesity|obesity
114978|NCT03484637|overweight|overweight
114979|NCT03484624|Muscle; Fatigue|muscle; fatigue
114980|NCT03484624|Wearable hip assist robot|wearable hip assist robot
114981|NCT03484624|Metabolic energy expenditure|metabolic energy expenditure
114982|NCT03484585|Mass Balance, metabolism and excretion pattern|mass balance, metabolism and excretion pattern
114983|NCT03484559|In-hospital Cardiac Arrest|in-hospital cardiac arrest
114984|NCT03484546|ovarian reserve|ovarian reserve
114985|NCT03484546|endometriosis|endometriosis
114986|NCT03484546|endometrioma|endometrioma
114987|NCT03484520|Cancer|cancer
114988|NCT03484520|Acute Myeloid Leukemia (AML)|acute myeloid leukemia (aml)
114989|NCT03484520|venetoclax|venetoclax
114990|NCT03484520|dinaciclib|dinaciclib
114991|NCT03484520|Relapsed/refractory AML|relapsed/refractory aml
114992|NCT03484520|Pharmacokinetics|pharmacokinetics
114993|NCT03484494|Geriatric|geriatric
114994|NCT03484494|Low Field Magnetic Stimulation|low field magnetic stimulation
114995|NCT03484494|Antidepressant|antidepressant
114996|NCT03484494|fMRI|fmri
114997|NCT03484494|MRS|mrs
114998|NCT03484468|lasik|lasik
114999|NCT03484468|flap_thickness|flap_thickness
115000|NCT03484468|femtosecond|femtosecond
115001|NCT03484468|laser|laser
115002|NCT03484468|moria|moria
115003|NCT03484468|microkeratome|microkeratome
115004|NCT03484429|Neurostimulation|neurostimulation
115005|NCT03484429|Peripheral nerve stimulation|peripheral nerve stimulation
115006|NCT03484390|mindfulness|mindfulness
115007|NCT03484390|posttraumatic stress disorder|posttraumatic stress disorder
115008|NCT03484351|Falls|falls
115009|NCT03484325|Registry|registry
115010|NCT03484325|Joint Registry|joint registry
115011|NCT03484325|OA|oa
115012|NCT03484325|Osteoarthritis|osteoarthritis
115013|NCT03484325|Osteo arthritis|osteo arthritis
115014|NCT03484325|knee|knee
115015|NCT03484325|hip|hip
115016|NCT03484325|tka|tka
115017|NCT03484325|tha|tha
115018|NCT03484273|Tilt Table|tilt table
115019|NCT03484273|Compression|compression
115020|NCT03484273|Dysautonomia|dysautonomia
115021|NCT03484273|POTS|pots
115022|NCT03484260|Risk factors predicting the initiation of testosterone use|risk factors predicting the initiation of testosterone use
115023|NCT03484247|infraclavicular block|infraclavicular block
115024|NCT03484247|axillary block|axillary block
115025|NCT03484234|Drug eluting stent|drug eluting stent
115026|NCT03484234|everolimus eluting stent|everolimus eluting stent
115027|NCT03484234|sirolimus eluting stent|sirolimus eluting stent
115028|NCT03484182|Upper extremity|upper extremity
115029|NCT03484182|Stroke|stroke
115030|NCT03484182|Web-based program|web-based program
115031|NCT03484182|Home exercise training|home exercise training
115032|NCT03484169|Muscle Stretching Exercises|muscle stretching exercises
115033|NCT03484169|Pelvic Floor|pelvic floor
115034|NCT03484169|motor control|motor control
115035|NCT03484169|motor skill|motor skill
115036|NCT03484169|motor activity|motor activity
115037|NCT03484156|Elderly|elderly
115038|NCT03484156|Frailty|frailty
115039|NCT03484156|Tele-monitoring|tele-monitoring
115040|NCT03484156|Disability|disability
115041|NCT03484143|Moderate to Severe Alzheimer's Disease,|moderate to severe alzheimer's disease,
115042|NCT03484130|primary aldosteronism|primary aldosteronism
115043|NCT03484104|Cardiopulmonary bypass|cardiopulmonary bypass
115044|NCT03484104|Hypothermic circulatory arrest|hypothermic circulatory arrest
115045|NCT03484104|Aortic arch surgery|aortic arch surgery
115046|NCT03484091|Hyruan-One|hyruan-one
115047|NCT03484091|Hylan G-F 20|hylan g-f 20
115048|NCT03484091|Hyaluronic acid|hyaluronic acid
115049|NCT03484091|Knee osteoarthritis|knee osteoarthritis
115050|NCT03484091|Pain level|pain level
115051|NCT03484065|Congenital fibrinogen disorders|congenital fibrinogen disorders
115052|NCT03484039|memory problems|memory problems
115053|NCT03484039|stress|stress
115054|NCT03484039|depression|depression
115055|NCT03484039|adherence|adherence
115056|NCT03484039|seizure documentation|seizure documentation
115057|NCT03484026|Iron Deficiency|iron deficiency
115058|NCT03484026|Anemia|anemia
115059|NCT03484026|Medical Food|medical food
115060|NCT03483987|Hepatitis c virus|hepatitis c virus
115061|NCT03483987|Direct acting antiviral drugs|direct acting antiviral drugs
115062|NCT03483987|Virological relapse|virological relapse
115063|NCT03483974|Hyperspectrum, excreta, neoplasm,|hyperspectrum, excreta, neoplasm,
115064|NCT03483909|gesture|gesture
115065|NCT03483909|rTMS|rtms
115066|NCT03483909|nonverbal communication|nonverbal communication
115067|NCT03483909|schizophrenia|schizophrenia
115068|NCT03483909|psychosis|psychosis
115069|NCT03483870|Granisetron, serum serotonin, morphine|granisetron, serum serotonin, morphine
115070|NCT03483857|Peer Navigation|peer navigation
115071|NCT03483844|scoliosis|scoliosis
115072|NCT03483844|low dose|low dose
115073|NCT03483844|arthrodesis|arthrodesis
115074|NCT03483844|dual-energy CT|dual-energy ct
115075|NCT03483818|Community Pharmacy|community pharmacy
115076|NCT03483818|Antiviral Therapy|antiviral therapy
115077|NCT03483805|synbiotic|synbiotic
115078|NCT03483805|nutrition|nutrition
115079|NCT03483805|permeability|permeability
115080|NCT03483805|gluten free diet|gluten free diet
115081|NCT03483805|quality of life|quality of life
115082|NCT03483805|digestive comfort|digestive comfort
115083|NCT03483792|PCOS|pcos
115084|NCT03483792|AMH|amh
115085|NCT03483792|Pregnancy|pregnancy
115086|NCT03483792|Heritability|heritability
115087|NCT03483792|LH|lh
115088|NCT03483753|Vasopressin|vasopressin
115089|NCT03483753|Norepinephrine|norepinephrine
115090|NCT03483753|Post-operative|post-operative
115091|NCT03483753|Critical Care|critical care
115092|NCT03483740|HIV-Associated Neurocognitive Disorder (HAND)|hiv-associated neurocognitive disorder (hand)
115093|NCT03483740|Cognitive remediation group therapy|cognitive remediation group therapy
115094|NCT03483740|Mutual aid group therapy|mutual aid group therapy
115095|NCT03483714|Manipulation|manipulation
115096|NCT03483714|Spinal|spinal
115097|NCT03483714|electromyography|electromyography
115098|NCT03483714|kinetics|kinetics
115099|NCT03483714|kinematic|kinematic
115100|NCT03483701|Cognitive Remediation Therapy|cognitive remediation therapy
115101|NCT03483688|B-cell Non-Hodgkin Lymphoma|b-cell non-hodgkin lymphoma
115102|NCT03483688|Refractory|refractory
115103|NCT03483688|Relapsed|relapsed
115104|NCT03483662|hypertension|hypertension
115105|NCT03483662|blood pressure|blood pressure
115106|NCT03483662|medication adherence|medication adherence
115107|NCT03483662|lifestyle modification|lifestyle modification
115108|NCT03483662|blood pressure control|blood pressure control
115109|NCT03483662|implementation|implementation
115110|NCT03483636|Drug-alcohol interaction|drug-alcohol interaction
115111|NCT03483636|Lemborexant|lemborexant
115112|NCT03483636|E2006|e2006
115113|NCT03483636|Postural stability|postural stability
115114|NCT03483636|Cognitive performance|cognitive performance
115115|NCT03483623|NATO Litter|nato litter
115116|NCT03483623|Dolphin Fluid Immersion System|dolphin fluid immersion system
115117|NCT03483623|Raven 90C litter|raven 90c litter
115118|NCT03483623|Laser doppler pressure monitor|laser doppler pressure monitor
115119|NCT03483623|Transcutanous oxygenation|transcutanous oxygenation
115120|NCT03483623|WELP mattress|welp mattress
115121|NCT03483571|asymptomatic|asymptomatic
115122|NCT03483571|submicroscopic|submicroscopic
115123|NCT03483571|PCR|pcr
115124|NCT03483558|vegetable metabolite signature|vegetable metabolite signature
115125|NCT03483558|human serum/urinary metabolite|human serum/urinary metabolite
115126|NCT03483558|liquid chromatography mass spectrometry|liquid chromatography mass spectrometry
115127|NCT03483545|Ovarian Response|ovarian response
115128|NCT03483545|In vitro fertilization|in vitro fertilization
115129|NCT03483545|Controlled ovarian stimulation|controlled ovarian stimulation
115130|NCT03483532|lithiasis|lithiasis
115131|NCT03483532|uric acid|uric acid
115132|NCT03483532|crystallization|crystallization
115133|NCT03483493|Tic disorders|tic disorders
115134|NCT03483493|Tourette Syndrome|tourette syndrome
115135|NCT03483493|Online delivered therapy|online delivered therapy
115136|NCT03483454|exercise, fitness, sleep, children, obesity|exercise, fitness, sleep, children, obesity
115137|NCT03483402|Pseudoexfoliation Glaucoma|pseudoexfoliation glaucoma
115138|NCT03483402|Primary Open-angle Glaucoma|primary open-angle glaucoma
115139|NCT03483402|Micropulse Laser Trabeculoplasty|micropulse laser trabeculoplasty
115140|NCT03483402|Intraocular Pressure|intraocular pressure
115141|NCT03483376|black stain|black stain
115142|NCT03483376|dental plaque|dental plaque
115143|NCT03483376|antimicrobial photodynamic therapy|antimicrobial photodynamic therapy
115144|NCT03483376|curcumin|curcumin
115145|NCT03483376|tooth discoloration|tooth discoloration
115146|NCT03483337|(DW)-MRI|(dw)-mri
147194|NCT03281031|MRI|mri
115147|NCT03483337|oncological biomarkers|oncological biomarkers
115148|NCT03483337|18-053|18-053
115149|NCT03483285|intubation|intubation
115150|NCT03483285|airtraq|airtraq
115151|NCT03483285|open heart surgery|open heart surgery
115152|NCT03483285|hemodynamic parameters|hemodynamic parameters
115153|NCT03483272|Terlipressin|terlipressin
115154|NCT03483272|Pharmacological respons|pharmacological respons
115155|NCT03483272|Magnetic Resonance Imaging|magnetic resonance imaging
115156|NCT03483272|Hemodynamic assessments|hemodynamic assessments
115157|NCT03483272|Echocardiography|echocardiography
115158|NCT03483272|Hepatorenal syndrome - acute kidney injury|hepatorenal syndrome - acute kidney injury
115159|NCT03483259|Pharmacokinetics|pharmacokinetics
115160|NCT03483259|Relative bioavailability|relative bioavailability
115161|NCT03483246|Ulcerative colitis|ulcerative colitis
115162|NCT03483246|Inflammatory bowel disease|inflammatory bowel disease
115163|NCT03483246|Fecal microbiota transplantation|fecal microbiota transplantation
115164|NCT03483233|Gyrus Cinguli|gyrus cinguli
115165|NCT03483233|Cognitive Control Process|cognitive control process
115166|NCT03483233|Check process|check process
115167|NCT03483233|Decision Making|decision making
115168|NCT03483233|fMRI|fmri
115169|NCT03483220|Addiction, MRI, Decision making|addiction, mri, decision making
115170|NCT03483194|Therapeutic Virtual Reality|therapeutic virtual reality
115171|NCT03483194|Pain related medical procedure management|pain related medical procedure management
115172|NCT03483194|Anxiety management|anxiety management
115173|NCT03483194|Osteo-medullary biopsy|osteo-medullary biopsy
115174|NCT03483116|Dose ranging|dose ranging
115175|NCT03483116|Neonatal vaccine|neonatal vaccine
115176|NCT03483116|RV3-BB vaccine|rv3-bb vaccine
115177|NCT03483103|JCAR017|jcar017
115178|NCT03483103|lisocabtagene maraleucel|lisocabtagene maraleucel
115179|NCT03483103|NHL|nhl
115180|NCT03483103|chimeric antigen receptor|chimeric antigen receptor
115181|NCT03483103|CAR|car
115182|NCT03483103|CAR T cell|car t cell
115183|NCT03483103|autologous T cell therapy|autologous t cell therapy
115184|NCT03483103|immunotherapy|immunotherapy
115185|NCT03483103|cell therapy|cell therapy
115186|NCT03483103|liso-cel|liso-cel
115187|NCT03483090|mild|mild
115188|NCT03483090|moderate|moderate
115189|NCT03483090|krill oil|krill oil
115190|NCT03483090|pain|pain
115191|NCT03483090|osteoarthritis|osteoarthritis
115192|NCT03483090|supplement|supplement
115193|NCT03483051|aortic stenosis, aortic valve replacement|aortic stenosis, aortic valve replacement
115194|NCT03483038|pancreatic adenocarcinoma|pancreatic adenocarcinoma
115195|NCT03483038|neoadjuvant|neoadjuvant
115196|NCT03483038|ONIVYDE|onivyde
115197|NCT03483038|chemotherapy|chemotherapy
115198|NCT03483038|borderline resectable|borderline resectable
115199|NCT03483012|Breast Cancer|breast cancer
115200|NCT03482986|Diet|diet
115201|NCT03482986|Dietary Habits|dietary habits
115202|NCT03482986|Weight changes|weight changes
115203|NCT03482973|Cardiopulmonary Bypass|cardiopulmonary bypass
115204|NCT03482973|Cardiac Surgery|cardiac surgery
115205|NCT03482973|Sternotomy|sternotomy
115206|NCT03482960|imaging|imaging
115207|NCT03482960|hyperpolarized|hyperpolarized
115208|NCT03482960|perfluorinated|perfluorinated
115209|NCT03482960|MRI|mri
115210|NCT03482960|lung|lung
115211|NCT03482947|Dexmedetomidine|dexmedetomidine
115212|NCT03482947|pediatrics; postoperative;|pediatrics; postoperative;
115213|NCT03482947|Analgesia; caudal|analgesia; caudal
115214|NCT03482908|Responsive parenting|responsive parenting
115215|NCT03482895|Gastric Bypass|gastric bypass
115216|NCT03482895|Intestinal Absorption|intestinal absorption
115217|NCT03482895|Gastrointestinal Hormones|gastrointestinal hormones
115218|NCT03482895|Enteroendocrine Cells|enteroendocrine cells
115219|NCT03482869|walking impairment|walking impairment
115220|NCT03482869|disability|disability
115221|NCT03482869|diabetes mellitus|diabetes mellitus
115222|NCT03482830|Inflammation|inflammation
115223|NCT03482830|Insulin-glucose homeostasis|insulin-glucose homeostasis
115224|NCT03482830|Hypothalamic-pituitary-adrenal axis|hypothalamic-pituitary-adrenal axis
115225|NCT03482830|Endothelial function and damage|endothelial function and damage
115226|NCT03482830|Thyroid hormones|thyroid hormones
115227|NCT03482778|PROMIS|promis
115228|NCT03482778|AYA|aya
115229|NCT03482778|ONCOLOGY|oncology
115230|NCT03482778|HRQOL|hrqol
115231|NCT03482778|Adolescent and Young Adult|adolescent and young adult
115232|NCT03482778|Health Related Quality of Life Measurement|health related quality of life measurement
115233|NCT03482778|Patient-Reported Outcomes Measurement Information System|patient-reported outcomes measurement information system
115234|NCT03482726|bicycle|bicycle
115235|NCT03482726|cadence|cadence
115236|NCT03482726|cyclist|cyclist
115237|NCT03482726|modulation|modulation
115238|NCT03482700|COPD; GP Surgeries|copd; gp surgeries
115239|NCT03482687|adolescent behavior|adolescent behavior
115240|NCT03482687|interpersonal relationships|interpersonal relationships
115241|NCT03482687|intimate partner violence|intimate partner violence
115242|NCT03482687|violence/prevention & control|violence/prevention & control
115243|NCT03482687|program evaluation|program evaluation
115244|NCT03482687|teen dating violence|teen dating violence
115245|NCT03482674|Health literacy|health literacy
115246|NCT03482674|Innovation Fund|innovation fund
115247|NCT03482674|lifestyle intervention|lifestyle intervention
115248|NCT03482674|risk screening|risk screening
115249|NCT03482674|type 2 diabetes mellitus|type 2 diabetes mellitus
115250|NCT03482674|Diabetes Mellitus, Type 2|diabetes mellitus, type 2
115251|NCT03482661|Magnetic steering|magnetic steering
115252|NCT03482661|MCE|mce
115253|NCT03482661|CECR|cecr
115254|NCT03482648|Pellino-1|pellino-1
115255|NCT03482622|Raman spectroscopy|raman spectroscopy
115256|NCT03482596|Sedentary Behaviour|sedentary behaviour
115257|NCT03482596|Prevention|prevention
115258|NCT03482583|Smoking, Cancer, Treatment|smoking, cancer, treatment
115259|NCT03482570|Activity behaviors|activity behaviors
115260|NCT03482570|Malignant pleural effusion|malignant pleural effusion
115261|NCT03482557|Breast Cancer|breast cancer
115262|NCT03482557|screening|screening
115263|NCT03482557|breast MRI|breast mri
115264|NCT03482557|contrast enhanced spectral mammography|contrast enhanced spectral mammography
115265|NCT03482544|pregabalin|pregabalin
115266|NCT03482544|ischemia reperfusion injury|ischemia reperfusion injury
115267|NCT03482544|muscle|muscle
115268|NCT03482531|limit nocturnal activity|limit nocturnal activity
115269|NCT03482531|cervical ripening|cervical ripening
115270|NCT03482492|Acetaminophen|acetaminophen
115271|NCT03482492|Tramadol|tramadol
115272|NCT03482492|Discogenic pain|discogenic pain
115273|NCT03482492|Lumbar Discectomy|lumbar discectomy
115274|NCT03482453|Drug Therapy|drug therapy
115275|NCT03482440|preeclampsia|preeclampsia
115276|NCT03482440|microvascular|microvascular
115277|NCT03482440|inflammation|inflammation
115278|NCT03482440|angiotensin II|angiotensin ii
115279|NCT03482414|stroke|stroke
115280|NCT03482414|upper limb rehabilitation|upper limb rehabilitation
115281|NCT03482414|neuro-rehabilitation|neuro-rehabilitation
115282|NCT03482401|Polyphenol|polyphenol
115283|NCT03482401|Methylxanthine|methylxanthine
115284|NCT03482401|Metabolism|metabolism
115285|NCT03482401|Breast tissue|breast tissue
115286|NCT03482401|Disposition|disposition
115287|NCT03482401|UPLC-QTOF|uplc-qtof
115288|NCT03482388|Hepatitis|hepatitis
115289|NCT03482388|Hepatitis B|hepatitis b
115290|NCT03482388|Hepatitis C|hepatitis c
115291|NCT03482388|Men who have sex with men|men who have sex with men
115292|NCT03482388|Crowdsourcing|crowdsourcing
115293|NCT03482388|China|china
115294|NCT03482388|Testing|testing
115295|NCT03482375|Gall Stones|gall stones
115296|NCT03482375|ERCP|ercp
115297|NCT03482375|Cholangioscopy|cholangioscopy
115298|NCT03482362|vinorelbine|vinorelbine
115299|NCT03482336|labeling|labeling
115300|NCT03482336|Front of pack|front of pack
115301|NCT03482336|nutrition|nutrition
115302|NCT03482336|nutrition facts panel|nutrition facts panel
115303|NCT03482310|Brain computer interface|brain computer interface
115304|NCT03482310|electric stimulation|electric stimulation
115305|NCT03482258|Stress|stress
115306|NCT03482258|Galactooligosaccharide|galactooligosaccharide
115307|NCT03482258|Prebiotic|prebiotic
115308|NCT03482258|Early life stress|early life stress
115309|NCT03482258|Emotional eating|emotional eating
115310|NCT03482258|Gut microbiota|gut microbiota
115311|NCT03482258|Short-chain fatty acids|short-chain fatty acids
115312|NCT03482258|Serotonin|serotonin
115313|NCT03482258|Cortisol|cortisol
115314|NCT03482245|pneumonia|pneumonia
115315|NCT03482245|appendicitis|appendicitis
115316|NCT03482245|diverticulitis|diverticulitis
115317|NCT03482245|circadian rhythms|circadian rhythms
115318|NCT03482245|blue light|blue light
115319|NCT03482245|sepsis|sepsis
115320|NCT03482232|patient safety|patient safety
115321|NCT03482232|quality assurance|quality assurance
115322|NCT03482232|overuse|overuse
115323|NCT03482167|blood pressure|blood pressure
115324|NCT03482167|arterial stiffness|arterial stiffness
115325|NCT03482167|cerebrovascular function|cerebrovascular function
115326|NCT03482167|cognitive function|cognitive function
115327|NCT03482128|transfusion|transfusion
115328|NCT03482128|coagulation|coagulation
115329|NCT03482128|cardiac surgery|cardiac surgery
115330|NCT03482115|coma|coma
115331|NCT03482115|traumatic brain injury|traumatic brain injury
115332|NCT03482115|anoxic encephalopathy|anoxic encephalopathy
115333|NCT03482115|brain connectome|brain connectome
115334|NCT03482115|neuroinflammation|neuroinflammation
115335|NCT03482115|prognosis|prognosis
115336|NCT03482102|Hepatocellular Carcinoma|hepatocellular carcinoma
115337|NCT03482102|Biliary Tract Cancer|biliary tract cancer
115338|NCT03482063|B vitamin|b vitamin
115339|NCT03482063|herbal supplement|herbal supplement
115340|NCT03482063|attention|attention
115341|NCT03482011|Psoriasis|psoriasis
115342|NCT03482011|IL-23|il-23
115343|NCT03481998|CDK4/6 inhibitor|cdk4/6 inhibitor
115344|NCT03481998|Breast cancer|breast cancer
115345|NCT03481998|Postmenopausal women|postmenopausal women
115346|NCT03481998|Hormone-receptor positive|hormone-receptor positive
115347|NCT03481998|HER2 negative|her2 negative
115348|NCT03481998|Premenopausal women|premenopausal women
115349|NCT03481985|Fontan-associated liver disease|fontan-associated liver disease
115350|NCT03481959|TDAH|tdah
115351|NCT03481959|Methylphenidate|methylphenidate
115352|NCT03481959|Cannabis|cannabis
115353|NCT03481920|pancreatic cancer, inmunotherapy|pancreatic cancer, inmunotherapy
115354|NCT03481907|collagen powder|collagen powder
115355|NCT03481907|punch biopsy wound|punch biopsy wound
115356|NCT03481894|Parenteral nutrition|parenteral nutrition
115357|NCT03481894|Malnutrition|malnutrition
115358|NCT03481894|Pediatrics|pediatrics
115359|NCT03481894|nutritional needs|nutritional needs
115360|NCT03481881|pharmacokinetics|pharmacokinetics
115361|NCT03481868|chronic myeloid leukemia|chronic myeloid leukemia
115362|NCT03481868|epigenetic|epigenetic
115363|NCT03481868|leukemic stem cell|leukemic stem cell
115364|NCT03481842|Endometriosis|endometriosis
115365|NCT03481842|VEGF(R)|vegf(r)
115366|NCT03481829|American Indians|american indians
115367|NCT03481829|Obesity|obesity
115368|NCT03481829|Pregnancy|pregnancy
115369|NCT03481829|Diabetes|diabetes
115370|NCT03481829|Children|children
115371|NCT03481816|mCRPC|mcrpc
115372|NCT03481816|Therapeutic Cancer Vaccines|therapeutic cancer vaccines
115373|NCT03481816|ETBX-071|etbx-071
115374|NCT03481816|ETBX-061|etbx-061
115375|NCT03481816|ETBX-051|etbx-051
115376|NCT03481803|Exocrine Pancreatic Insufficiency|exocrine pancreatic insufficiency
115377|NCT03481790|iron deficiency anemia of pregnancy - lactoferrin|iron deficiency anemia of pregnancy - lactoferrin
115378|NCT03481777|Remote Ischemic Conditioning|remote ischemic conditioning
115379|NCT03481777|Neuroprotection|neuroprotection
115380|NCT03481764|febrile seizure|febrile seizure
115381|NCT03481764|HRC-test|hrc-test
115382|NCT03481764|genetic variation|genetic variation
115383|NCT03481764|epilepsy|epilepsy
115384|NCT03481751|Crohn Disease|crohn disease
115385|NCT03481751|Ultrasound|ultrasound
115386|NCT03481751|Monitoring|monitoring
115387|NCT03481751|Disease activity|disease activity
115388|NCT03481738|Glycolytic enzymopathy|glycolytic enzymopathy
115389|NCT03481738|Congenital Non-spherocytic hemolytic anemia (CNSA)|congenital non-spherocytic hemolytic anemia (cnsa)
115390|NCT03481699|Adolescence|adolescence
115391|NCT03481699|Prevention|prevention
115392|NCT03481699|Emotional disorders|emotional disorders
115393|NCT03481699|Aggressive behavior|aggressive behavior
115394|NCT03481686|Erythropoiesis|erythropoiesis
115395|NCT03481686|stimulating|stimulating
115396|NCT03481686|agents|agents
115397|NCT03481686|therapeutic|therapeutic
115398|NCT03481686|education|education
115399|NCT03481686|program|program
115400|NCT03481673|Childhood Asthma|childhood asthma
115401|NCT03481673|Childhood Anxiety|childhood anxiety
115402|NCT03481673|Childhood Depression|childhood depression
115403|NCT03481673|Childhood Quality of Life|childhood quality of life
115404|NCT03481660|Diabetic Macular Edema|diabetic macular edema
115405|NCT03481660|intravitreal injection|intravitreal injection
115406|NCT03481660|brolucizumab|brolucizumab
115407|NCT03481660|aflibercept|aflibercept
115408|NCT03481660|double-masked|double-masked
115409|NCT03481634|Diabetic Macular Edema|diabetic macular edema
115410|NCT03481634|intravitreal injection|intravitreal injection
115411|NCT03481634|brolucizumab|brolucizumab
115412|NCT03481634|aflibercept|aflibercept
115413|NCT03481634|double-masked|double-masked
115414|NCT03481621|Vulvodynia|vulvodynia
115415|NCT03481608|fatty acid|fatty acid
115416|NCT03481608|nutrition|nutrition
115417|NCT03481608|metabolism|metabolism
115418|NCT03481608|lauric acid|lauric acid
115419|NCT03481608|dilauroylphosphatidylcholine|dilauroylphosphatidylcholine
115540|NCT03480620|Telehealth|telehealth
115421|NCT03481582|Nitroglycerin Trans-dermal Patch|nitroglycerin trans-dermal patch
115422|NCT03481543|Chronic Obstructive Pulmonary Disease (COPD)|chronic obstructive pulmonary disease (copd)
115423|NCT03481543|Nebulization|nebulization
115424|NCT03481543|Respiratory failure|respiratory failure
115425|NCT03481543|Non-invasive ventilation(NIV)|non-invasive ventilation(niv)
115426|NCT03481517|adult|adult
115427|NCT03481517|appendectomy|appendectomy
115428|NCT03481517|appendicitis|appendicitis
115429|NCT03481517|local anesthesia|local anesthesia
115430|NCT03481517|pain|pain
115431|NCT03481491|Cerebellum|cerebellum
115432|NCT03481491|Striatum|striatum
115433|NCT03481491|Human|human
115434|NCT03481491|fMRI|fmri
115435|NCT03481491|Transcranial magnetic stimulation|transcranial magnetic stimulation
115436|NCT03481491|Genetic dystonia|genetic dystonia
115437|NCT03481478|occult|occult
115438|NCT03481478|proximal humeral neck fractures|proximal humeral neck fractures
115439|NCT03481478|greater tuberosity|greater tuberosity
115440|NCT03481478|shoulder dislocation|shoulder dislocation
115441|NCT03481465|Biomarkers|biomarkers
115442|NCT03481465|Hepatic dysfunction|hepatic dysfunction
115443|NCT03481465|Metabolic dysfunction|metabolic dysfunction
115444|NCT03481465|Endothelial dysfunction|endothelial dysfunction
115445|NCT03481465|Antipsychotics|antipsychotics
115446|NCT03481465|Non-alcoholic fatty liver disease|non-alcoholic fatty liver disease
115447|NCT03481452|anxiety|anxiety
115448|NCT03481452|regulation of states|regulation of states
115449|NCT03481452|NBO|nbo
115450|NCT03481452|HAMA|hama
115451|NCT03481439|Pharmacist|pharmacist
115452|NCT03481439|Led medication review|led medication review
115453|NCT03481439|Orthopaedic surgery|orthopaedic surgery
115454|NCT03481439|Traumatology|traumatology
115455|NCT03481426|musculoskelelal disorder|musculoskelelal disorder
115456|NCT03481426|occupational health service|occupational health service
115457|NCT03481400|Calcitonin gene-related peptide|calcitonin gene-related peptide
115458|NCT03481361|Obstructive sleep apnoea (OSA)|obstructive sleep apnoea (osa)
115459|NCT03481361|Type 1 diabetes (T1D)|type 1 diabetes (t1d)
115460|NCT03481361|Type 2 diabetes (T2D)|type 2 diabetes (t2d)
115461|NCT03481361|Insulin-Dependent Diabetes Mellitus (IDDM)|insulin-dependent diabetes mellitus (iddm)
115462|NCT03481322|sodium chloride|sodium chloride
115463|NCT03481322|diet|diet
115464|NCT03481322|cooking|cooking
115465|NCT03481309|transcranial magnetic stimulation (TMS)|transcranial magnetic stimulation (tms)
115466|NCT03481309|transcranial direct current stimulation (tDCS)|transcranial direct current stimulation (tdcs)
115467|NCT03481309|electroencephalography (EEG)|electroencephalography (eeg)
115468|NCT03481296|Colorectal Cancer Screening|colorectal cancer screening
115469|NCT03481296|Asian Americans|asian americans
115470|NCT03481296|Patient Navigation|patient navigation
115471|NCT03481296|Decision Counseling Program|decision counseling program
115472|NCT03481283|Amylin|amylin
115473|NCT03481218|Type 1 diabetes|type 1 diabetes
115474|NCT03481218|Quality of life|quality of life
115475|NCT03481218|Personality traits|personality traits
115476|NCT03481218|Young adults|young adults
115477|NCT03481205|remote limb ischemic conditioning|remote limb ischemic conditioning
115478|NCT03481205|large vessel occlusion|large vessel occlusion
115479|NCT03481205|helicopter transport|helicopter transport
115480|NCT03481179|Repetitive transcranial magnetic stimulation, Physiotherapy, Stroke, Spasticity|repetitive transcranial magnetic stimulation, physiotherapy, stroke, spasticity
115481|NCT03481166|pilot|pilot
115482|NCT03481166|randomized controlled trial|randomized controlled trial
115483|NCT03481166|prenatal education|prenatal education
115484|NCT03481166|anticipatory guidance|anticipatory guidance
115485|NCT03481114|radiation therapy|radiation therapy
115486|NCT03481114|chemotherapy|chemotherapy
115487|NCT03481114|PET Imaging|pet imaging
115488|NCT03481101|early response evaluation|early response evaluation
115489|NCT03481101|immunotherapy|immunotherapy
115490|NCT03481101|chemotherapy|chemotherapy
115491|NCT03481101|liquid biopsy|liquid biopsy
115492|NCT03481101|FDG-PET/CT|fdg-pet/ct
115493|NCT03481075|Aortic Aneurysm, Abdominal|aortic aneurysm, abdominal
115494|NCT03481075|Imaging, Three-Dimensional|imaging, three-dimensional
115495|NCT03481075|Tomography Scanners, X-Ray Computed|tomography scanners, x-ray computed
115496|NCT03481075|Angiography, Digital Subtraction|angiography, digital subtraction
115497|NCT03481075|Endovascular Procedures|endovascular procedures
115498|NCT03481075|Radiography, Interventional|radiography, interventional
115499|NCT03481036|Mukh Mantri Punjab Hepatitis C Relief Fund,MMPHCRF|mukh mantri punjab hepatitis c relief fund,mmphcrf
115500|NCT03481036|Direct acting antiviral agents (DAA)|direct acting antiviral agents (daa)
115501|NCT03481036|Chronic Hepatitis C|chronic hepatitis c
115502|NCT03481036|Pediatric population|pediatric population
115503|NCT03481036|Adolescent Chronic Hepatitis C|adolescent chronic hepatitis c
115504|NCT03481023|Atrial Fibrillation|atrial fibrillation
115505|NCT03481023|Esophageal Cooling Device|esophageal cooling device
115506|NCT03481023|Radiofrequency Ablation|radiofrequency ablation
115507|NCT03481023|Arrhythmia|arrhythmia
115508|NCT03480971|cisplatin toxicity|cisplatin toxicity
115509|NCT03480958|erector spinae plane block|erector spinae plane block
115510|NCT03480958|thoracic paravertebral block|thoracic paravertebral block
115511|NCT03480958|breast surgery|breast surgery
115512|NCT03480958|postoperative pain|postoperative pain
115513|NCT03480932|directly observed therapy|directly observed therapy
115514|NCT03480932|sofosbuvir|sofosbuvir
115515|NCT03480932|daclatasvir|daclatasvir
115516|NCT03480932|pegylated interferon|pegylated interferon
115517|NCT03480932|resource-limited setting|resource-limited setting
115518|NCT03480893|laminectomy|laminectomy
115519|NCT03480893|laminotomy|laminotomy
115520|NCT03480893|lumbar canal stenosis|lumbar canal stenosis
115521|NCT03480880|Bispectral Index|bispectral index
115522|NCT03480815|Asthma|asthma
115523|NCT03480815|Controlled Laminar Airflow Device|controlled laminar airflow device
115524|NCT03480815|Omalizumab|omalizumab
115525|NCT03480802|Conjugate pneumococcal vaccine, 15-valent, 22F, 33F|conjugate pneumococcal vaccine, 15-valent, 22f, 33f
115526|NCT03480750|Copper chelator|copper chelator
115527|NCT03480750|Epithelial ovarian cancer|epithelial ovarian cancer
115528|NCT03480750|Tubal cancer|tubal cancer
115529|NCT03480750|Peritoneal cancer|peritoneal cancer
115530|NCT03480750|Trientine|trientine
115531|NCT03480750|Pegylated liposomal doxorubicin|pegylated liposomal doxorubicin
115532|NCT03480750|Carboplatin|carboplatin
115533|NCT03480711|subscleral trabeculectomy|subscleral trabeculectomy
115534|NCT03480711|extended subscleral tunnel|extended subscleral tunnel
115535|NCT03480711|mitomycinC|mitomycinc
115536|NCT03480698|acute ischemic stroke|acute ischemic stroke
115537|NCT03480646|Phase 1/2|phase 1/2
115538|NCT03480646|Oncology|oncology
115539|NCT03480646|EZH2 Inhibitor|ezh2 inhibitor
115541|NCT03480620|Telerehabilitation|telerehabilitation
115542|NCT03480620|Chronic pain|chronic pain
115543|NCT03480620|Post-discharge care|post-discharge care
115544|NCT03480581|Neurological|neurological
115545|NCT03480581|Gait|gait
115546|NCT03480581|Cardiorespiratory fitness|cardiorespiratory fitness
115547|NCT03480581|Rehabilitation|rehabilitation
115548|NCT03480581|Walking|walking
115549|NCT03480581|Locomotor training|locomotor training
115550|NCT03480581|Robotics|robotics
115551|NCT03480568|Alirocumab|alirocumab
115552|NCT03480555|Enteral nutrition, Intensive Care Units, caloric restriction, infections, insulin, mortality, protein catabolism, NUTRIC score|enteral nutrition, intensive care units, caloric restriction, infections, insulin, mortality, protein catabolism, nutric score
115553|NCT03480529|adverse event|adverse event
115554|NCT03480529|arthritis|arthritis
115555|NCT03480529|Systemic Lupus Erythematosus|systemic lupus erythematosus
115556|NCT03480529|Capillary Leak Syndrome|capillary leak syndrome
115557|NCT03480529|Hepatitis|hepatitis
115558|NCT03480516|Silver Diamine Fluoride|silver diamine fluoride
115559|NCT03480516|Sodium Fluoride Varnish|sodium fluoride varnish
115560|NCT03480516|Arrest caries|arrest caries
115561|NCT03480516|Caries prevention|caries prevention
115562|NCT03480516|Cost Effectiveness|cost effectiveness
115563|NCT03480516|Oral Health|oral health
115564|NCT03480516|Quality of Life|quality of life
115565|NCT03480503|Apelin12|apelin12
115566|NCT03480477|Adverse Childhood Experiences|adverse childhood experiences
115567|NCT03480412|Luteal Phase Stimulation|luteal phase stimulation
115568|NCT03480412|Poor Ovarian Response|poor ovarian response
115569|NCT03480412|In Vitro Fertilization|in vitro fertilization
115570|NCT03480399|retroperitoneal sarcoma|retroperitoneal sarcoma
115571|NCT03480399|quality of life|quality of life
115572|NCT03480399|morbidity|morbidity
115573|NCT03480399|surgery|surgery
115574|NCT03480386|Pulmonary Rehabilitation|pulmonary rehabilitation
115575|NCT03480373|Nicotine|nicotine
115576|NCT03480373|Nicotine addiction|nicotine addiction
115577|NCT03480373|Tobacco Use Disorder|tobacco use disorder
115578|NCT03480373|Pregnancy|pregnancy
115579|NCT03480373|Electronic cigarettes|electronic cigarettes
115580|NCT03480373|Cigarettes|cigarettes
115581|NCT03480373|Vaping|vaping
115582|NCT03480373|Carcinoma|carcinoma
115583|NCT03480373|Pregnant|pregnant
115584|NCT03480373|Birth Outcomes|birth outcomes
115585|NCT03480373|E-liquid|e-liquid
115586|NCT03480360|haploidentical|haploidentical
115587|NCT03480360|transplant|transplant
115588|NCT03480360|peripheral blood|peripheral blood
115589|NCT03480360|allogeneic|allogeneic
115590|NCT03480321|Peripheral Artery Disease|peripheral artery disease
115591|NCT03480321|Cilostazol|cilostazol
115592|NCT03480321|PMR|pmr
115593|NCT03480321|Extended-Release Tablet of Cilostazol|extended-release tablet of cilostazol
115600|NCT03480256|gastric cancer|gastric cancer
115601|NCT03480256|Her-2 positive|her-2 positive
115603|NCT03480230|Non-small cell lung cancer|non-small cell lung cancer
115604|NCT03480230|Platinum doublet chemotherapy|platinum doublet chemotherapy
115605|NCT03480230|Neoadjuvant|neoadjuvant
115606|NCT03480217|hypertension|hypertension
115607|NCT03480217|screening|screening
115608|NCT03480217|guidelines|guidelines
115609|NCT03480217|implementation|implementation
115610|NCT03480217|randomized|randomized
115611|NCT03480204|Telemetry, Patch Monitor, Alarm Fatigue|telemetry, patch monitor, alarm fatigue
115612|NCT03480165|Randomized controlled trial|randomized controlled trial
115613|NCT03480165|Double blind|double blind
115614|NCT03480165|Parallel group|parallel group
115615|NCT03480152|Metastatic Cancer|metastatic cancer
115616|NCT03480152|Immunotherapy|immunotherapy
115617|NCT03480152|Tumor Regression|tumor regression
115618|NCT03480152|Cancer Vaccine|cancer vaccine
115619|NCT03480152|Gene Therapy|gene therapy
115625|NCT03480100|rhinosinusitis|rhinosinusitis
115626|NCT03480100|nasal irrigation|nasal irrigation
115627|NCT03480100|nasal douche|nasal douche
115628|NCT03480100|Ectoin|ectoin
115629|NCT03480087|strain-rate echocardiography|strain-rate echocardiography
115630|NCT03480087|chemotherapy|chemotherapy
115631|NCT03480087|radiotherapy, mediastinal|radiotherapy, mediastinal
115632|NCT03480087|Lymphoma|lymphoma
115633|NCT03480087|Hodgkin|hodgkin
115634|NCT03480022|prediabetes|prediabetes
115635|NCT03480022|PCOS|pcos
115636|NCT03480022|GLP-1 agonist|glp-1 agonist
115637|NCT03480022|weight loss|weight loss
115638|NCT03480009|medication abortion|medication abortion
115639|NCT03480009|dextromethorphan|dextromethorphan
115640|NCT03480009|pain control|pain control
115641|NCT03479983|Indian gooseberry|indian gooseberry
115642|NCT03479983|Total cholesterol|total cholesterol
115643|NCT03479983|Triglycerides|triglycerides
115644|NCT03479866|Gut microbiome|gut microbiome
115645|NCT03479866|Personalised Nutrition|personalised nutrition
115646|NCT03479866|Metabolic health|metabolic health
115647|NCT03479853|Ocular Rosacea|ocular rosacea
115648|NCT03479853|Keratoconjunctivitis|keratoconjunctivitis
115649|NCT03479853|Meibomian Gland|meibomian gland
115650|NCT03479853|Interferometry|interferometry
115651|NCT03479853|Child|child
115652|NCT03479840|SYNTAX score, PCI, elderly|syntax score, pci, elderly
115653|NCT03479814|rectal cancer|rectal cancer
115654|NCT03479814|neoadjuvant chemoradiation|neoadjuvant chemoradiation
115655|NCT03479814|IMRT-SIB|imrt-sib
115656|NCT03479814|adaptive radiotherapy|adaptive radiotherapy
115657|NCT03479788|sleep apnea, coronary artery, diabetes|sleep apnea, coronary artery, diabetes
115658|NCT03479697|HIRREM|hirrem
115659|NCT03479697|Neurotechnology|neurotechnology
115660|NCT03479697|Closed-Loop|closed-loop
115661|NCT03479697|Allostasis|allostasis
115662|NCT03479697|Stress|stress
115663|NCT03479697|Autonomic Dysregulation|autonomic dysregulation
115664|NCT03479697|Hyperarousal|hyperarousal
115665|NCT03479697|Brain Electrical Activity|brain electrical activity
115666|NCT03479697|Acoustic Stimulation|acoustic stimulation
115667|NCT03479697|Primary Hypertension|primary hypertension
115668|NCT03479697|High Blood Pressure|high blood pressure
115669|NCT03479684|warfarin|warfarin
115670|NCT03479684|gene|gene
115671|NCT03479658|HIIT|hiit
115672|NCT03479658|nutritional education|nutritional education
115673|NCT03479658|Dose-effect|dose-effect
115674|NCT03479658|school|school
115675|NCT03479658|children|children
115676|NCT03479658|cardiovascular|cardiovascular
115677|NCT03479658|adiposity|adiposity
115678|NCT03479658|blood pressure|blood pressure
115679|NCT03479658|fitness|fitness
115680|NCT03479645|Colon cancer|colon cancer
115681|NCT03479645|Bowel cancer|bowel cancer
115682|NCT03479645|Cancer screening|cancer screening
115683|NCT03479645|text message|text message
115684|NCT03479645|Fecal immunochemistry test (FIT)|fecal immunochemistry test (fit)
115685|NCT03479645|opt-out|opt-out
115686|NCT03479645|behavioral intervention|behavioral intervention
115687|NCT03479619|lancing device|lancing device
115688|NCT03479619|lancet|lancet
115689|NCT03479606|Traumatic Brain Injury|traumatic brain injury
115690|NCT03479606|TBI|tbi
115691|NCT03479606|Executive Dysfunction|executive dysfunction
115692|NCT03479606|Emotional Regulation|emotional regulation
115693|NCT03479606|Emotional Dysfunction|emotional dysfunction
115694|NCT03479606|Problem Solving|problem solving
115695|NCT03479606|Self-regulation|self-regulation
115696|NCT03479606|Cognitive Rehabilitation|cognitive rehabilitation
115697|NCT03479606|Metacognitive Strategies|metacognitive strategies
115698|NCT03479606|Cognitive-behavioral therapy|cognitive-behavioral therapy
115699|NCT03479606|Online Therapy|online therapy
115700|NCT03479606|GroupTherapy|grouptherapy
115701|NCT03479606|Group videoconference|group videoconference
115702|NCT03479606|Telehealth|telehealth
115703|NCT03479606|Telerehabilitation|telerehabilitation
115704|NCT03479593|NSTEMI|nstemi
115705|NCT03479593|Culprit|culprit
115706|NCT03479593|Cardiac magnetic resonance|cardiac magnetic resonance
115707|NCT03479593|Optical Coherence Tomography|optical coherence tomography
115708|NCT03479580|Cardiomyopathy|cardiomyopathy
115709|NCT03479580|Multimodal imaging|multimodal imaging
115710|NCT03479580|Coronary artery disease|coronary artery disease
115711|NCT03479580|Coronary microvascular disease|coronary microvascular disease
115712|NCT03479580|Prognosis|prognosis
115713|NCT03479580|Atherosclerosis|atherosclerosis
115714|NCT03479580|Myocardial ischemia|myocardial ischemia
115715|NCT03479554|antihypertensive treatment|antihypertensive treatment
115716|NCT03479541|mild traumatic brain injury|mild traumatic brain injury
115717|NCT03479541|vestibular impairment|vestibular impairment
115718|NCT03479541|balance and gait|balance and gait
115719|NCT03479541|dual-tasking|dual-tasking
115720|NCT03479541|veterans|veterans
115721|NCT03479541|quality of life|quality of life
115722|NCT03479541|rehabilitation|rehabilitation
115723|NCT03479528|Dyspepsia,alarm symptoms，Roman IV|dyspepsia,alarm symptoms，roman iv
115724|NCT03479476|Congenital Abnormalities|congenital abnormalities
115725|NCT03479476|Metformin|metformin
115726|NCT03479476|Nervous System Diseases|nervous system diseases
115727|NCT03479476|Chromosome Disorders|chromosome disorders
115728|NCT03479437|Obesity|obesity
115729|NCT03479437|Melanocortin|melanocortin
115730|NCT03479437|TEMPO|tempo
115731|NCT03479437|MC4R|mc4r
115732|NCT03479437|Genetic Obesity|genetic obesity
115733|NCT03479437|hypothalamic|hypothalamic
115734|NCT03479437|POMC|pomc
115735|NCT03479437|LEPR|lepr
115736|NCT03479437|PCSK1|pcsk1
115737|NCT03479424|hospitalization|hospitalization
115738|NCT03479398|Fidelity|fidelity
115739|NCT03479398|Cognitive Behavioral Therapy|cognitive behavioral therapy
115740|NCT03479398|Mobile Application|mobile application
115741|NCT03479398|Routine Practice|routine practice
115743|NCT03479372|wet AMD|wet amd
115744|NCT03479372|exudative AMD|exudative amd
115745|NCT03479372|macular degeneration|macular degeneration
115746|NCT03479359|Prostate cancer; Benign Prostatic Hyperplasia; Digital Rectal Examination; Accuracy|prostate cancer; benign prostatic hyperplasia; digital rectal examination; accuracy
115747|NCT03479346|Obesity|obesity
115748|NCT03479346|Metabolic syndrome|metabolic syndrome
115749|NCT03479346|Traditional Korean Medicine|traditional korean medicine
115750|NCT03479346|Galgeun-tang|galgeun-tang
115751|NCT03479255|Smartphone|smartphone
115752|NCT03479255|Exercise|exercise
115753|NCT03479255|Functional capacity|functional capacity
115754|NCT03479229|vaginal laxity|vaginal laxity
115755|NCT03479229|sexual function|sexual function
115756|NCT03479229|vaginal childbirth|vaginal childbirth
115757|NCT03479229|sexual dysfunction|sexual dysfunction
115758|NCT03479229|diminished sexual function|diminished sexual function
115759|NCT03479229|satisfaction|satisfaction
115760|NCT03479229|arousal|arousal
115761|NCT03479229|desire|desire
115762|NCT03479229|lubrication|lubrication
115763|NCT03479229|orgasm|orgasm
115764|NCT03479216|Analgesia|analgesia
115765|NCT03479216|Anesthesia|anesthesia
115766|NCT03479216|Arthroscopy|arthroscopy
115767|NCT03479216|Bupivacaine|bupivacaine
115768|NCT03479216|Dexmedetomidine|dexmedetomidine
115769|NCT03479216|Injections, Intra-Articular|injections, intra-articular
115770|NCT03479216|Magnesium|magnesium
115771|NCT03479216|Pain, Postoperative|pain, postoperative
115772|NCT03479203|Inflammation|inflammation
115773|NCT03479151|Magnetic Resonance Imaging (MRI)|magnetic resonance imaging (mri)
115774|NCT03479151|High Intensity Focused Ultrasound (HIFU)|high intensity focused ultrasound (hifu)
115775|NCT03479138|severe asthma|severe asthma
115776|NCT03479138|induced sputum|induced sputum
115777|NCT03479138|asthma phenotypes|asthma phenotypes
115778|NCT03479138|neutrophilic inflammation|neutrophilic inflammation
115779|NCT03479138|microbiome|microbiome
115780|NCT03479112|Tourniquets, Layperson, hemorrhage control, first responder|tourniquets, layperson, hemorrhage control, first responder
115781|NCT03479099|Lung cancer|lung cancer
115782|NCT03479099|Circulating Tumor Cell|circulating tumor cell
115783|NCT03479099|Cell-Free Tumor DNA|cell-free tumor dna
115784|NCT03479099|Liquid Biopsy|liquid biopsy
115785|NCT03479060|Wet cupping therapy|wet cupping therapy
115786|NCT03479060|Migraine|migraine
115787|NCT03479060|MIDAS|midas
115788|NCT03479047|diaphragm ultrasound|diaphragm ultrasound
115789|NCT03479047|spontaneous breathing trial|spontaneous breathing trial
115790|NCT03479047|mechanical ventilation weaning|mechanical ventilation weaning
115791|NCT03479047|rapid shallow breathing index|rapid shallow breathing index
115792|NCT03479034|digital|digital
115793|NCT03479034|prescription|prescription
115809|NCT03478878|Age-Related Macular Degeneration (AMD)|age-related macular degeneration (amd)
115810|NCT03478878|Retinal Pigment Epithelium|retinal pigment epithelium
115811|NCT03478865|Eye Examinations|eye examinations
115812|NCT03478865|Retinal Pigment Epithelium|retinal pigment epithelium
115813|NCT03478852|Seizure Disorder|seizure disorder
115814|NCT03478852|Seizures|seizures
115815|NCT03478852|Antiepileptic Drug|antiepileptic drug
115816|NCT03478852|Natural History Study|natural history study
115817|NCT03478852|Screening Protocol|screening protocol
115818|NCT03478839|Generalized Arterial Calcification of Infancy|generalized arterial calcification of infancy
115819|NCT03478839|Autosomal Recessive Hypophosphatemic Rickets|autosomal recessive hypophosphatemic rickets
115820|NCT03478839|Pseudoxanthoma Elasticum|pseudoxanthoma elasticum
115821|NCT03478839|Idiopathic Infantile Arterial Calcification|idiopathic infantile arterial calcification
115822|NCT03478826|ILD|ild
115823|NCT03478813|Intervention|intervention
115824|NCT03478813|Implementation|implementation
115825|NCT03478813|Children|children
115826|NCT03478813|Urotherapy|urotherapy
115827|NCT03478787|Plaque Psoriasis|plaque psoriasis
115828|NCT03478761|CYP24A1 mutation|cyp24a1 mutation
115829|NCT03478761|CYP24A1|cyp24a1
115830|NCT03478761|24-hydroxylase deficiency|24-hydroxylase deficiency
115831|NCT03478748|Dental caries|dental caries
115832|NCT03478748|Oral health literacy|oral health literacy
115833|NCT03478709|vasoplegia|vasoplegia
115834|NCT03478709|dynamic arterial elastance|dynamic arterial elastance
115835|NCT03478709|microcirculation|microcirculation
115836|NCT03478696|fluticasone furoate/umeclidinium/vilanterol|fluticasone furoate/umeclidinium/vilanterol
115837|NCT03478696|HRQoL|hrqol
115838|NCT03478696|COPD|copd
115839|NCT03478696|long-acting muscarinic receptor antagonists|long-acting muscarinic receptor antagonists
115840|NCT03478696|Tiotropium|tiotropium
115841|NCT03478696|Budesonide/formoterol|budesonide/formoterol
115842|NCT03478683|long-acting muscarinic receptor antagonists|long-acting muscarinic receptor antagonists
115843|NCT03478683|tiotropium|tiotropium
115844|NCT03478683|HRQoL|hrqol
115845|NCT03478683|Budesonide/formoterol|budesonide/formoterol
115846|NCT03478683|chronic obstructive pulmonary disease|chronic obstructive pulmonary disease
115847|NCT03478683|COPD|copd
115848|NCT03478670|gene therapy|gene therapy
115849|NCT03478670|retroviral vector|retroviral vector
115850|NCT03478670|inherited immune disorder|inherited immune disorder
148127|NCT03274674|PRF|prf
115851|NCT03478670|ADA-SCID|ada-scid
115852|NCT03478670|previously GSK2696273|previously gsk2696273
115853|NCT03478670|Strimvelis|strimvelis
115854|NCT03478657|Asthma|asthma
115855|NCT03478657|Dry Powder Inhaler|dry powder inhaler
115856|NCT03478657|Metered Dose Inhaler|metered dose inhaler
115857|NCT03478657|Long Acting beta 2 Agonist|long acting beta 2 agonist
115858|NCT03478657|ELLIPTA|ellipta
115859|NCT03478631|nitrate|nitrate
115860|NCT03478631|vegetables|vegetables
115861|NCT03478605|olanzapine|olanzapine
115862|NCT03478605|aprepitant|aprepitant
115863|NCT03478605|CINV|cinv
115864|NCT03478605|nausea|nausea
115865|NCT03478605|vomiting|vomiting
115866|NCT03478605|nausea and vomiting|nausea and vomiting
115867|NCT03478605|antiemetics|antiemetics
115868|NCT03478592|Slow-freezing|slow-freezing
115869|NCT03478592|Vitrification|vitrification
115870|NCT03478592|Automated system|automated system
115871|NCT03478592|Embryos|embryos
115872|NCT03478592|Implantation|implantation
115873|NCT03478579|serious game|serious game
115874|NCT03478579|simulation|simulation
115875|NCT03478579|virtual emergency department|virtual emergency department
115876|NCT03478579|nontechnical skills|nontechnical skills
115877|NCT03478527|Probiotics|probiotics
115878|NCT03478527|Psychiatric Symptoms|psychiatric symptoms
115879|NCT03478527|Cognitive Function|cognitive function
115880|NCT03478527|Hippocampus|hippocampus
115881|NCT03478527|Oxytocin|oxytocin
115882|NCT03478527|Immunological Parameters|immunological parameters
115883|NCT03478514|mantle cell lymphoma|mantle cell lymphoma
115884|NCT03478514|B-cell lymphoma|b-cell lymphoma
115885|NCT03478514|palbociclib|palbociclib
115886|NCT03478501|firearm|firearm
115887|NCT03478501|lethal means|lethal means
115888|NCT03478501|decision aid|decision aid
115889|NCT03478475|Vitamin D|vitamin d
115890|NCT03478475|HOMA-IR|homa-ir
115891|NCT03478475|Glucose|glucose
115892|NCT03478475|HbA1C|hba1c
115994|NCT03477747|Recovery|recovery
115893|NCT03478475|insulin resistance|insulin resistance
115894|NCT03478462|medulloblastoma|medulloblastoma
115895|NCT03478462|ependymoma|ependymoma
115896|NCT03478462|high-grade glioma|high-grade glioma
115897|NCT03478462|glioblastoma|glioblastoma
115898|NCT03478462|DIPG|dipg
115899|NCT03478462|diffuse-intrinsic pontine glioma|diffuse-intrinsic pontine glioma
115900|NCT03478462|ATRT|atrt
115901|NCT03478462|atypical teratoid rhabdoid tumor|atypical teratoid rhabdoid tumor
115902|NCT03478462|PNET|pnet
115903|NCT03478462|primitive neuroectodermal tumor|primitive neuroectodermal tumor
115904|NCT03478462|gliosarcoma|gliosarcoma
115905|NCT03478462|gliomatosis cerebri|gliomatosis cerebri
115906|NCT03478462|neuroblastoma|neuroblastoma
115907|NCT03478462|rhabdomyosarcoma|rhabdomyosarcoma
115908|NCT03478462|Ewing sarcoma|ewing sarcoma
115909|NCT03478462|osteosarcoma|osteosarcoma
115910|NCT03478462|DSRCT|dsrct
115911|NCT03478462|desmoplastic small round cell tumor|desmoplastic small round cell tumor
115912|NCT03478462|sarcoma|sarcoma
115913|NCT03478462|malignant germ cell tumor|malignant germ cell tumor
115914|NCT03478462|synovial sarcoma|synovial sarcoma
115915|NCT03478462|rare cancer|rare cancer
115916|NCT03478462|Wilms tumor|wilms tumor
115917|NCT03478462|lymphoma|lymphoma
115918|NCT03478462|Hodgkin Lymphoma|hodgkin lymphoma
115919|NCT03478462|Non-Hodgkin Lymphoma|non-hodgkin lymphoma
115920|NCT03478436|pharmacokinetics|pharmacokinetics
115921|NCT03478436|microdialysis|microdialysis
115922|NCT03478436|healthy volunteers|healthy volunteers
115923|NCT03478410|Epicardial fat|epicardial fat
115924|NCT03478397|cervical cancer prevention|cervical cancer prevention
115925|NCT03478397|self-collection HPV test|self-collection hpv test
115926|NCT03478397|mHealth|mhealth
115927|NCT03478397|Argentina|argentina
115928|NCT03478384|self-efficacy expectation|self-efficacy expectation
115929|NCT03478371|tampon|tampon
115930|NCT03478319|ACE-2494|ace-2494
115931|NCT03478241|Endodontic retreatment|endodontic retreatment
115932|NCT03478241|postoperative pain|postoperative pain
115933|NCT03478241|OneShape|oneshape
115934|NCT03478241|Revo-S|revo-s
115935|NCT03478241|WaveOne|waveone
115936|NCT03478228|fracture|fracture
115937|NCT03478228|rehabilitation|rehabilitation
115938|NCT03478228|wrist|wrist
115939|NCT03478228|sensation|sensation
115940|NCT03478228|exercise|exercise
115941|NCT03478215|kidney transplantation|kidney transplantation
115942|NCT03478215|graft rejection|graft rejection
115943|NCT03478176|Intraabdominal hypertension|intraabdominal hypertension
115944|NCT03478176|Kidney transplantation|kidney transplantation
115945|NCT03478163|Bakri|bakri
115946|NCT03478163|Intrauterine balloon tamponade|intrauterine balloon tamponade
115947|NCT03478163|Antibiotics|antibiotics
115948|NCT03478137|Cognition|cognition
115949|NCT03478137|Intervention|intervention
115950|NCT03478098|Gut hormones|gut hormones
115951|NCT03478098|Glucose excursions|glucose excursions
115952|NCT03478033|Tuberculosis|tuberculosis
115953|NCT03478033|AIDS|aids
115954|NCT03478033|Rifampicin|rifampicin
115955|NCT03478033|Rifabutin|rifabutin
115956|NCT03478007|Exercise Compliance|exercise compliance
115957|NCT03478007|Health Coaching|health coaching
115958|NCT03477994|dexmedetomidine, clonidine, postoperative, CABG|dexmedetomidine, clonidine, postoperative, cabg
115959|NCT03477955|spinopelvic alignment|spinopelvic alignment
115960|NCT03477955|short lumbosacral instrumentation|short lumbosacral instrumentation
115961|NCT03477955|PEEK|peek
115962|NCT03477955|silicon spacer|silicon spacer
115963|NCT03477929|In vitro fertilization|in vitro fertilization
115964|NCT03477929|gnrh antagonist|gnrh antagonist
115965|NCT03477929|pituitary suppression|pituitary suppression
115966|NCT03477903|Drug therapy|drug therapy
115967|NCT03477877|Intimate Partner Violence|intimate partner violence
115968|NCT03477877|Gender-Based violence|gender-based violence
115969|NCT03477877|Spouse Abuse|spouse abuse
115970|NCT03477877|Rwanda|rwanda
115971|NCT03477877|Heterosexual Couples|heterosexual couples
115972|NCT03477877|Activists|activists
115973|NCT03477877|Opinion Leaders|opinion leaders
115974|NCT03477877|Social Change|social change
115975|NCT03477877|Social-Ecological Model|social-ecological model
115976|NCT03477877|Diffusion of Innovation|diffusion of innovation
115977|NCT03477877|Cluster Randomized Controlled Trial|cluster randomized controlled trial
115978|NCT03477877|Community Randomized Controlled Trial|community randomized controlled trial
115979|NCT03477851|sciatic nerve block|sciatic nerve block
115980|NCT03477851|tramadol|tramadol
115981|NCT03477851|foot fracture|foot fracture
115982|NCT03477838|continuous glucose monitoring|continuous glucose monitoring
115983|NCT03477799|gambling disorder|gambling disorder
115984|NCT03477799|cognition|cognition
115985|NCT03477773|high-intensity interval training|high-intensity interval training
115986|NCT03477773|video games|video games
115987|NCT03477773|heart rate|heart rate
115988|NCT03477773|boxing|boxing
115989|NCT03477773|metabolic syndrome|metabolic syndrome
115990|NCT03477747|Microcurrent|microcurrent
115991|NCT03477747|Exercise training|exercise training
115992|NCT03477747|Hypertrophy|hypertrophy
115993|NCT03477747|Muscle damage|muscle damage
115995|NCT03477747|Performance|performance
115996|NCT03477721|Agrin Fragment C-terminus (CAF)|agrin fragment c-terminus (caf)
115997|NCT03477669|Colic|colic
115998|NCT03477656|ABO incompatible kidney transplantation|abo incompatible kidney transplantation
115999|NCT03477656|Desensitization|desensitization
116000|NCT03477656|Double Filtration PlasmaPherisis (DFPP)|double filtration plasmapherisis (dfpp)
116001|NCT03477656|Specific immunoadsorption|specific immunoadsorption
116002|NCT03477656|Living donor kidney transplantation|living donor kidney transplantation
116003|NCT03477630|gonarthrosis|gonarthrosis
116004|NCT03477604|Below the knee|below the knee
116005|NCT03477604|Stent|stent
116006|NCT03477591|Screening|screening
116007|NCT03477591|PSA testing|psa testing
116008|NCT03477591|Patient Decision Aid|patient decision aid
116009|NCT03477552|Sickle Cell Crisis|sickle cell crisis
116010|NCT03477552|intravenous catheter|intravenous catheter
116011|NCT03477552|transillumination|transillumination
116012|NCT03477526|pulmonary fibrosis|pulmonary fibrosis
116013|NCT03477526|COPD|copd
116014|NCT03477526|pulmonary rehabilitation|pulmonary rehabilitation
116015|NCT03477526|mental status (anxiety and depression)|mental status (anxiety and depression)
116016|NCT03477526|quality of life|quality of life
116017|NCT03477526|physical activity|physical activity
116018|NCT03477500|multiple sclerosis,|multiple sclerosis,
116019|NCT03477500|HSCT|hsct
116020|NCT03477500|alemtuzumab|alemtuzumab
116021|NCT03477500|RCT|rct
116022|NCT03477487|inflammation|inflammation
116023|NCT03477487|Cytokines|cytokines
116024|NCT03477487|Interleukin-10|interleukin-10
116025|NCT03477487|Gene therapy|gene therapy
116026|NCT03477474|Guardant Health|guardant health
116027|NCT03477435|smoking|smoking
116028|NCT03477435|tobacco dependence|tobacco dependence
116029|NCT03477435|quitline|quitline
116030|NCT03477435|smoking cessation|smoking cessation
116031|NCT03477422|CSE-1034 Double Blind Study|cse-1034 double blind study
116032|NCT03477422|Elores|elores
116033|NCT03477422|Meropenem|meropenem
116034|NCT03477422|PLEA-CT|plea-ct
116035|NCT03477422|Bacterial Infections|bacterial infections
116036|NCT03477422|ESBL|esbl
116037|NCT03477422|MBL|mbl
116038|NCT03477422|beta-lactamase|beta-lactamase
116039|NCT03477422|Anti-Infective Agents, Urinary|anti-infective agents, urinary
116040|NCT03477422|Anti-Infective Agents|anti-infective agents
116041|NCT03477422|Urinary Tract Infections|urinary tract infections
116042|NCT03477422|Pyelonephritis|pyelonephritis
116043|NCT03477422|Infection|infection
116044|NCT03477422|Sulbactam|sulbactam
116045|NCT03477422|EDTA|edta
116046|NCT03477422|Disodium EDTA|disodium edta
116047|NCT03477422|Antibiotic Adjuvant Entity|antibiotic adjuvant entity
116048|NCT03477422|Antibiotic Resistance Breaker|antibiotic resistance breaker
116049|NCT03477409|plasticizers|plasticizers
116050|NCT03477409|medical devices|medical devices
116051|NCT03477409|neonates|neonates
116052|NCT03477409|exposition|exposition
116053|NCT03477383|diagnosis|diagnosis
116054|NCT03477383|economics|economics
116055|NCT03477383|cell-free DNA|cell-free dna
116056|NCT03477383|digital droplet PCR|digital droplet pcr
116057|NCT03477383|heart failure|heart failure
116058|NCT03477344|Cardiac Surgery|cardiac surgery
116059|NCT03477344|Delirium|delirium
116060|NCT03477344|Sleep deprivation|sleep deprivation
116061|NCT03477331|Direct oral anticoagulant|direct oral anticoagulant
116062|NCT03477331|P2Y12 inhibitors|p2y12 inhibitors
116063|NCT03477331|Physiologically-based pharmacokinetic model (PBPK)|physiologically-based pharmacokinetic model (pbpk)
116064|NCT03477331|Population-based pharmacokinetic model (POPPK)|population-based pharmacokinetic model (poppk)
116065|NCT03477318|colonoscopy, polyp, endoscopist|colonoscopy, polyp, endoscopist
116066|NCT03477305|older adults|older adults
116067|NCT03477305|community gardening|community gardening
116068|NCT03477305|cooperative extension|cooperative extension
116069|NCT03477279|couple HIV testing and counseling|couple hiv testing and counseling
116070|NCT03477279|disclosure|disclosure
116071|NCT03477279|Malawi|malawi
116072|NCT03477266|Postoperative ileus|postoperative ileus
116073|NCT03477266|mosapride|mosapride
116074|NCT03477266|mouth dissolving tablets|mouth dissolving tablets
116075|NCT03477266|Intraoperative vomiting|intraoperative vomiting
116076|NCT03477240|Cervical Cancer|cervical cancer
116077|NCT03477240|TELEPHONIC QUESTIONNAIRE|telephonic questionnaire
116078|NCT03477240|Follow up|follow up
116079|NCT03477227|compression stocking|compression stocking
116080|NCT03477227|elastic stocking|elastic stocking
116081|NCT03477227|endovenous radiofrequency ablation|endovenous radiofrequency ablation
116082|NCT03477227|compression therapy|compression therapy
116083|NCT03477188|Stroke|stroke
116084|NCT03477188|Vestibular|vestibular
116085|NCT03477188|Somatosensory|somatosensory
116086|NCT03477188|Rehabilitation|rehabilitation
116087|NCT03477188|Balance|balance
116088|NCT03477175|lenvatinib|lenvatinib
116089|NCT03477175|E7080|e7080
116090|NCT03477149|liquid embolics|liquid embolics
116091|NCT03477123|Incomplete spinal cord injury|incomplete spinal cord injury
116092|NCT03477123|Walking|walking
116093|NCT03477123|Rehabilitation|rehabilitation
116094|NCT03477123|Robotic exoskeleton|robotic exoskeleton
116095|NCT03477097|Frailty|frailty
116096|NCT03477097|Social Determinants|social determinants
116097|NCT03477097|Biological Risk Factors|biological risk factors
116098|NCT03477097|Intervention|intervention
116099|NCT03477097|Cost Effectiveness|cost effectiveness
116100|NCT03477071|Transplant renal artery stenosis|transplant renal artery stenosis
116101|NCT03477071|Endovascular repair|endovascular repair
116102|NCT03477071|Post-operative outcome|post-operative outcome
116103|NCT03477058|chronic pruritus|chronic pruritus
116104|NCT03477058|acute pruritus|acute pruritus
116105|NCT03477045|omega 3 polyunsaturated fatty acid|omega 3 polyunsaturated fatty acid
116106|NCT03477045|camelina sativa|camelina sativa
116107|NCT03477045|fatty acid composition|fatty acid composition
116108|NCT03477045|immune modulation|immune modulation
116109|NCT03477019|Contrast Agent BR|contrast agent br
116110|NCT03477019|SonoVue|sonovue
116111|NCT03477019|Ultrasonic Therapy|ultrasonic therapy
116112|NCT03477019|Neoplasm Metastasis|neoplasm metastasis
116113|NCT03477019|Liver|liver
116114|NCT03477019|Microbubbles|microbubbles
116115|NCT03476993|primary biliary cholangitis|primary biliary cholangitis
116116|NCT03476993|IL-17 monoclonal antibody|il-17 monoclonal antibody
116117|NCT03476980|Neurodevelopmental impairment, prematurity|neurodevelopmental impairment, prematurity
116118|NCT03476980|Disability|disability
116119|NCT03476980|Umbilical cord milking|umbilical cord milking
116120|NCT03476980|Delayed cord clamping|delayed cord clamping
116121|NCT03476967|optic disc topography|optic disc topography
116122|NCT03476967|panretinal photocoagulation|panretinal photocoagulation
116123|NCT03476967|confocal scanning laser ophthalmoscopy|confocal scanning laser ophthalmoscopy
116124|NCT03476967|stereoscopic disc photographs|stereoscopic disc photographs
116125|NCT03476967|diabetic retinopathy|diabetic retinopathy
116126|NCT03476967|optic nerve head parameters|optic nerve head parameters
116127|NCT03476902|OCD|ocd
116128|NCT03476902|Mobile|mobile
116129|NCT03476902|Technology|technology
116130|NCT03476902|CBT|cbt
116131|NCT03476902|Cognitive-Behavioral Therapy|cognitive-behavioral therapy
116132|NCT03476876|acellular matrix|acellular matrix
116133|NCT03476837|secondhand smoke, African Americans, policies, tobacco use|secondhand smoke, african americans, policies, tobacco use
116134|NCT03476785|LVH|lvh
116135|NCT03476785|Ventricular Stiffness|ventricular stiffness
116136|NCT03476785|Fitness|fitness
116137|NCT03476785|HFpEF|hfpef
116138|NCT03476733|Drug related problem|drug related problem
116139|NCT03476733|inpatient|inpatient
116140|NCT03476733|Medication Error|medication error
116141|NCT03476733|Clinical Pharmacist|clinical pharmacist
116142|NCT03476681|NEO-201|neo-201
116143|NCT03476681|Monoclonal Antibody|monoclonal antibody
116144|NCT03476681|Colorectal Cancer|colorectal cancer
116145|NCT03476681|Pancreatic Cancer|pancreatic cancer
116146|NCT03476681|Adenocarcinoma of Lung|adenocarcinoma of lung
116147|NCT03476681|Squamous Cell Lung Cancer|squamous cell lung cancer
116148|NCT03476681|Breast Cancer|breast cancer
116149|NCT03476681|Mucinous Carcinoma of Ovary|mucinous carcinoma of ovary
116150|NCT03476681|Signet Ring Cell Carcinoma of Ovary|signet ring cell carcinoma of ovary
116151|NCT03476629|Cardiopulmonary Exercise Test|cardiopulmonary exercise test
116152|NCT03476629|Rehabilitation|rehabilitation
116153|NCT03476629|Distance Traveled|distance traveled
116154|NCT03476629|Functional Capacity|functional capacity
116155|NCT03476629|Autonomic Nervous System|autonomic nervous system
116156|NCT03476616|Hypertension|hypertension
116157|NCT03476616|Obesity|obesity
116158|NCT03476616|Ambulatory Blood Pressure|ambulatory blood pressure
116159|NCT03476616|Eplerenone|eplerenone
116160|NCT03476616|Valsartan|valsartan
116161|NCT03476616|Mineralocorticoid Receptor Antagonists|mineralocorticoid receptor antagonists
116162|NCT03476616|Angiotensin II Receptor Blockers|angiotensin ii receptor blockers
116163|NCT03476603|Bariatric surgery|bariatric surgery
116164|NCT03476603|Gastrointestinal tract|gastrointestinal tract
116165|NCT03476603|Biological availability|biological availability
116166|NCT03476603|Pharmacokinetics|pharmacokinetics
116167|NCT03476603|Irbesartan|irbesartan
116168|NCT03476590|heart failure|heart failure
116169|NCT03476590|ambulatory care|ambulatory care
116170|NCT03476590|telemedicine|telemedicine
116171|NCT03476590|impedance cardiography|impedance cardiography
116172|NCT03476577|Bariatric surgery|bariatric surgery
116173|NCT03476577|Gastrointestinal tract|gastrointestinal tract
116174|NCT03476577|Biological availability|biological availability
116175|NCT03476577|Pharmacokinetics|pharmacokinetics
116176|NCT03476577|Ibuprofen|ibuprofen
116177|NCT03476564|assisted reproductive techniques|assisted reproductive techniques
116178|NCT03476551|Bariatric surgery|bariatric surgery
116179|NCT03476551|Gastrointestinal tract|gastrointestinal tract
116180|NCT03476551|Biological availability|biological availability
116181|NCT03476551|Pharmacokinetics|pharmacokinetics
116182|NCT03476551|Hydrochlorothiazide|hydrochlorothiazide
116183|NCT03476538|Bariatric surgery|bariatric surgery
116184|NCT03476538|Gastrointestinal tract|gastrointestinal tract
116185|NCT03476538|Biological availability|biological availability
116186|NCT03476538|Pharmacokinetics|pharmacokinetics
116187|NCT03476538|Gabapentin|gabapentin
116188|NCT03476525|Bariatric surgery|bariatric surgery
116189|NCT03476525|Gastrointestinal tract|gastrointestinal tract
116190|NCT03476525|Biological availability|biological availability
116191|NCT03476525|Pharmacokinetics|pharmacokinetics
116192|NCT03476525|Fluoxetine|fluoxetine
116193|NCT03476512|Treatment adherence|treatment adherence
116194|NCT03476512|Ambulatory hypertensive patients|ambulatory hypertensive patients
116195|NCT03476512|Blood pressure|blood pressure
116196|NCT03476512|Non-pharmacological measures|non-pharmacological measures
116197|NCT03476473|Asthma|asthma
116198|NCT03476473|Chronic obstructive pulmonary disease|chronic obstructive pulmonary disease
116199|NCT03476473|Spirometry|spirometry
116200|NCT03476473|Lung disease|lung disease
116201|NCT03476473|Smoke|smoke
116202|NCT03476460|Acute kidney failure|acute kidney failure
116203|NCT03476460|CT scan|ct scan
116204|NCT03476460|Iodine contrast|iodine contrast
116205|NCT03476460|Sodium chloride|sodium chloride
116206|NCT03476434|sessile serrated polyp|sessile serrated polyp
116207|NCT03476434|chromoendoscopy|chromoendoscopy
116208|NCT03476434|indigo carmine|indigo carmine
116209|NCT03476382|Osteoarthritis|osteoarthritis
116210|NCT03476382|Knee|knee
116211|NCT03476382|Bone Growth Stimulators|bone growth stimulators
116212|NCT03476382|Rheumatic Diseases|rheumatic diseases
116213|NCT03476382|Musculoskeletal Diseases|musculoskeletal diseases
116214|NCT03476382|Joint Diseases|joint diseases
116215|NCT03476382|Arthritis|arthritis
116216|NCT03476343|NICU|nicu
116217|NCT03476343|MRI|mri
116218|NCT03476343|Neonatal|neonatal
116219|NCT03476343|Cincinnati|cincinnati
116220|NCT03476330|Hematopoietic cell transplantation|hematopoietic cell transplantation
116221|NCT03476291|macular diseases|macular diseases
116222|NCT03476291|screening|screening
116223|NCT03476291|OCT|oct
116224|NCT03476291|Deep learning|deep learning
116225|NCT03476291|AI|ai
116226|NCT03476278|Outcome Assessment (Health Care)|outcome assessment (health care)
116227|NCT03476278|Patient Satisfaction|patient satisfaction
116228|NCT03476278|Perioperative Period|perioperative period
116229|NCT03476278|Regional Anesthesia|regional anesthesia
116230|NCT03476278|Surveys and Questionnaires|surveys and questionnaires
116231|NCT03476239|Relapsed|relapsed
116232|NCT03476239|Refractory|refractory
116233|NCT03476239|B-precursor|b-precursor
116234|NCT03476239|Acute Lymphoblastic|acute lymphoblastic
116235|NCT03476239|Leukemia ALL|leukemia all
116236|NCT03476239|Blinatumomab|blinatumomab
116237|NCT03476239|Chinese Adult Subjects|chinese adult subjects
116238|NCT03476226|Quality of Life|quality of life
116239|NCT03476226|Cognitive Dysfunction|cognitive dysfunction
116240|NCT03476226|Breast Cancer|breast cancer
116241|NCT03476213|Anesthesia Awareness|anesthesia awareness
116242|NCT03476213|Dreaming in anesthesia|dreaming in anesthesia
116243|NCT03476213|Total intravenous anesthesia|total intravenous anesthesia
116244|NCT03476213|Target-controll infusion|target-controll infusion
116245|NCT03476200|Cognitive Behavioral Therapy|cognitive behavioral therapy
116246|NCT03476200|Hair Cortisol|hair cortisol
116247|NCT03476200|Hypothalamic Pituitary Adrenal Axis|hypothalamic pituitary adrenal axis
116248|NCT03476200|Stress|stress
116249|NCT03476200|Psychopathology|psychopathology
116250|NCT03476135|Meningococcal Meningitis|meningococcal meningitis
116251|NCT03476135|MenACYW conjugate vaccine|menacyw conjugate vaccine
116252|NCT03476135|Quadrivalent meningococcal vaccine|quadrivalent meningococcal vaccine
116253|NCT03476122|Colorectal cancer|colorectal cancer
116254|NCT03476122|CRC|crc
116255|NCT03476122|Circulating tumor cells|circulating tumor cells
116256|NCT03476122|CTCs|ctcs
116257|NCT03476122|Early detection|early detection
116258|NCT03476122|Automated|automated
116259|NCT03476096|pregnancy|pregnancy
116260|NCT03476096|microcirculation|microcirculation
116261|NCT03476083|Mother to Child Transmission|mother to child transmission
116262|NCT03476083|Hepatitis B Infection|hepatitis b infection
116263|NCT03476083|Congenital Defects or Malformation|congenital defects or malformation
116264|NCT03476083|Hepatitis B Vaccine|hepatitis b vaccine
116265|NCT03476083|Hepatitis B Immunoglobulin|hepatitis b immunoglobulin
116266|NCT03476083|Pregnancy|pregnancy
116267|NCT03476083|Antiviral Treatment|antiviral treatment
116268|NCT03476070|Adolescents and Young Adults (AYA)|adolescents and young adults (aya)
116269|NCT03476070|breast cancer|breast cancer
116270|NCT03476070|lymphoma|lymphoma
116271|NCT03476070|germ cell tumor|germ cell tumor
116272|NCT03476070|cognitive impairment|cognitive impairment
116273|NCT03476070|survivorship|survivorship
116274|NCT03476070|Singapore|singapore
116275|NCT03476057|NGS|ngs
116276|NCT03476057|cfDNA|cfdna
116277|NCT03476057|OS|os
116278|NCT03476057|Tumor Burden|tumor burden
116279|NCT03475966|Nutrition|nutrition
116280|NCT03475966|Exercise|exercise
116281|NCT03475966|Relaxation techniques|relaxation techniques
116282|NCT03475966|Prehabilitation|prehabilitation
116283|NCT03475953|Advanced solid tumor|advanced solid tumor
116284|NCT03475953|Metastatic tumor|metastatic tumor
116285|NCT03475953|Phase Ib/II trial|phase ib/ii trial
116286|NCT03475953|Colorectal cancer not MSI-H or MMR-deficient|colorectal cancer not msi-h or mmr-deficient
116287|NCT03475953|GIST|gist
116292|NCT03475953|Thyroid cancer|thyroid cancer
116293|NCT03475953|Neuroendocrine gastroenteropancreatic tumors|neuroendocrine gastroenteropancreatic tumors
116294|NCT03475914|Psoriasis Guttate, Psoriasis vulgaris|psoriasis guttate, psoriasis vulgaris
116295|NCT03475901|procedural anxiety|procedural anxiety
116296|NCT03475901|virtual reality|virtual reality
116297|NCT03475901|anxiolysis|anxiolysis
116298|NCT03475901|laceration repair|laceration repair
116299|NCT03475901|pediatric|pediatric
116300|NCT03475888|Chronic Total Occlusion of Coronary Artery|chronic total occlusion of coronary artery
116301|NCT03475888|Ventricular Arrythmia|ventricular arrythmia
116302|NCT03475888|Sustained VT|sustained vt
116303|NCT03475888|Ventricular Fibrillation|ventricular fibrillation
116304|NCT03475888|Implantable loop recorder|implantable loop recorder
116305|NCT03475849|Roux-en-Y Gastric Bypass Surgery|roux-en-y gastric bypass surgery
116306|NCT03475849|Bile Acid Circulation|bile acid circulation
116307|NCT03475849|Obesity|obesity
116308|NCT03475849|Bariatric Surgery|bariatric surgery
116309|NCT03475836|Mentha|mentha
116310|NCT03475836|Mint|mint
116311|NCT03475836|Essential oil|essential oil
116312|NCT03475836|Cognition|cognition
116313|NCT03475836|Mood|mood
116314|NCT03475836|Humans|humans
116315|NCT03475810|VIRTUAL REALITY|virtual reality
116316|NCT03475810|ANXIETY|anxiety
116317|NCT03475810|SPINAL ANESTHESIA|spinal anesthesia
116318|NCT03475745|resting-state|resting-state
116319|NCT03475745|DTI|dti
116320|NCT03475745|aphasia|aphasia
116321|NCT03475745|stroke|stroke
116322|NCT03475732|XueBiJing injection|xuebijing injection
116323|NCT03475732|Sepsis|sepsis
116324|NCT03475732|Septic shock|septic shock
116325|NCT03475732|Pharmacokinetics|pharmacokinetics
116326|NCT03475706|overactive bladder|overactive bladder
116327|NCT03475706|urinary conditions|urinary conditions
116328|NCT03475706|urgency urinary incontinence|urgency urinary incontinence
116329|NCT03475706|urgency|urgency
116330|NCT03475706|micturitions|micturitions
116331|NCT03475680|Mechanical Bowel Preparation (MBP)|mechanical bowel preparation (mbp)
116332|NCT03475680|Oral antibiotics|oral antibiotics
116333|NCT03475680|Colon cancer surgery|colon cancer surgery
116334|NCT03475680|Surgical site infection|surgical site infection
116335|NCT03475667|Septic Shock|septic shock
116336|NCT03475667|hemodynamic monitoring|hemodynamic monitoring
116337|NCT03475667|blood pressure determination|blood pressure determination
116338|NCT03475654|exercise|exercise
116339|NCT03475654|therapy|therapy
116340|NCT03475654|rehabilitation|rehabilitation
116341|NCT03475654|home|home
116342|NCT03475641|pain|pain
116343|NCT03475641|femoral nerve blockade|femoral nerve blockade
148720|NCT03270709|HIV|hiv
116344|NCT03475641|varicose vein|varicose vein
116345|NCT03475589|apatinib； Adverse drug reactions； gastric cancer; non-small cell lung cancer;breast cancer; ovarian cancer|apatinib； adverse drug reactions； gastric cancer; non-small cell lung cancer;breast cancer; ovarian cancer
116346|NCT03475576|elderly|elderly
116347|NCT03475576|caregiving|caregiving
116348|NCT03475576|needs|needs
116349|NCT03475576|support|support
116354|NCT03475485|Ingestion event marker|ingestion event marker
116355|NCT03475485|Ingestible sensor|ingestible sensor
116356|NCT03475485|Medication adherence|medication adherence
116357|NCT03475485|ID-Cap Medication Adherence Feedback System|id-cap medication adherence feedback system
116358|NCT03475459|QTc prolongation effect|qtc prolongation effect
116359|NCT03475446|Cognitive Training|cognitive training
116360|NCT03475446|Memory Impairment|memory impairment
116361|NCT03475446|Mild Cognitive Impairment|mild cognitive impairment
116362|NCT03475446|Alzheimer's Disease|alzheimer's disease
116363|NCT03475446|tES|tes
116364|NCT03475446|tACS|tacs
116365|NCT03475446|tDCS|tdcs
116366|NCT03475433|Cancer|cancer
116367|NCT03475433|Questionnaire|questionnaire
116368|NCT03475433|Survey|survey
116369|NCT03475433|Sleep Disturbance|sleep disturbance
116370|NCT03475433|Sleep Quality|sleep quality
116371|NCT03475433|E-health|e-health
116372|NCT03475433|M-health|m-health
116373|NCT03475433|Actigraphy|actigraphy
116374|NCT03475433|Physical activity|physical activity
116375|NCT03475433|Dyssomnias Medical Subject Headings [MeSH]|dyssomnias medical subject headings [mesh]
116376|NCT03475433|Sleep Wake Disorders [MeSH]|sleep wake disorders [mesh]
116377|NCT03475433|Parasomnias [MeSH]|parasomnias [mesh]
116378|NCT03475433|Nervous System Diseases [MeSH]|nervous system diseases [mesh]
116379|NCT03475433|Mental Disorders [MeSH]|mental disorders [mesh]
116380|NCT03475433|Neurologic Manifestations [MeSH]|neurologic manifestations [mesh]
116381|NCT03475433|Signs and Symptoms [MeSH]|signs and symptoms [mesh]
116382|NCT03475433|Telemedicine [MeSH]|telemedicine [mesh]
116383|NCT03475433|Actigraphy [MeSH]|actigraphy [mesh]
116384|NCT03475433|Quality of Life [MeSH]|quality of life [mesh]
116385|NCT03475433|Motor Activity [MeSH]|motor activity [mesh]
116386|NCT03475433|Breast Neoplasms [MeSH]|breast neoplasms [mesh]
116387|NCT03475433|Prostatic Neoplasms [MeSH]|prostatic neoplasms [mesh]
116388|NCT03475433|Sleep Hygiene [MeSH]|sleep hygiene [mesh]
116389|NCT03475433|Neoplasms [MeSH]|neoplasms [mesh]
116390|NCT03475407|Diabetic macular edema|diabetic macular edema
116391|NCT03475407|cytokine|cytokine
116392|NCT03475407|dexamethasone|dexamethasone
116393|NCT03475394|Chlorhexidine gluconate|chlorhexidine gluconate
116394|NCT03475394|Morus alba|morus alba
116395|NCT03475394|Microbiology|microbiology
116396|NCT03475394|Gel|gel
116397|NCT03475394|Root planing|root planing
116398|NCT03475381|Cystic Fibrosis|cystic fibrosis
116399|NCT03475381|ivacaftor|ivacaftor
116400|NCT03475381|lumacaftor|lumacaftor
116401|NCT03475355|action observation|action observation
116402|NCT03475355|parkinson's disease|parkinson's disease
116403|NCT03475355|physical therapy|physical therapy
116404|NCT03475355|home-based|home-based
116405|NCT03475355|neural plasticity|neural plasticity
116406|NCT03475355|telerehabilitation|telerehabilitation
116407|NCT03475342|prevention, postpartum haemorrhage|prevention, postpartum haemorrhage
116408|NCT03475342|moderate anaemia|moderate anaemia
116409|NCT03475342|severe anaemia|severe anaemia
116410|NCT03475342|antifibrinolytic|antifibrinolytic
116411|NCT03475342|tranexamic acid|tranexamic acid
116412|NCT03475342|pregnancy|pregnancy
116413|NCT03475329|pediatric obstructive sleep disordered breathing-partial tonsillectomy -unilateral complete tonsillectomy -adenoidectomy|pediatric obstructive sleep disordered breathing-partial tonsillectomy -unilateral complete tonsillectomy -adenoidectomy
116414|NCT03475290|e-mental health|e-mental health
116415|NCT03475290|stress|stress
116416|NCT03475290|burnout|burnout
116417|NCT03475290|self-efficacy|self-efficacy
116418|NCT03475290|social support|social support
116419|NCT03475264|Lung MRI, Bronchopulmonary Dysplasia, hyperpolarized xenon,|lung mri, bronchopulmonary dysplasia, hyperpolarized xenon,
116420|NCT03475238|critical care|critical care
116421|NCT03475225|Epilepsy|epilepsy
116422|NCT03475225|Drug-resistance|drug-resistance
116423|NCT03475225|Vitamin D deficiency|vitamin d deficiency
116424|NCT03475225|Metabolism|metabolism
116425|NCT03475225|Controlled study antiepileptic drugs|controlled study antiepileptic drugs
116426|NCT03475212|Hematopoietic Stem Cell Transplant|hematopoietic stem cell transplant
116427|NCT03475212|Primary Immune Deficiency Disease|primary immune deficiency disease
116428|NCT03475186|Memory|memory
116429|NCT03475186|Brain Cancer|brain cancer
116430|NCT03475186|Ramipril|ramipril
116431|NCT03475173|Optic Neuropathy|optic neuropathy
116432|NCT03475173|, Retinopathy|, retinopathy
116433|NCT03475095|Low Back Pain|low back pain
116434|NCT03475095|Tuina therapy|tuina therapy
116435|NCT03475095|lumbar disc herniation|lumbar disc herniation
116436|NCT03475095|central motion control|central motion control
116437|NCT03475095|functional magnetic resonanceimaging|functional magnetic resonanceimaging
116438|NCT03475095|effect mechanism|effect mechanism
116439|NCT03475095|Chronic nonspecific low Back pain|chronic nonspecific low back pain
116440|NCT03475069|Type 2 Diabetes Mellitus|type 2 diabetes mellitus
116441|NCT03475069|Exercise|exercise
116442|NCT03475069|Physical Performance|physical performance
116443|NCT03475069|Physiological Cost Index|physiological cost index
116444|NCT03475056|Marburg virus|marburg virus
116445|NCT03475056|Marburg vaccine|marburg vaccine
116446|NCT03475056|cAd3-Marburg vaccine|cad3-marburg vaccine
116447|NCT03475004|Pembrolizumab|pembrolizumab
116448|NCT03475004|Binimetinib|binimetinib
116449|NCT03475004|Bevacizumab|bevacizumab
116450|NCT03475004|Combination Therapy|combination therapy
116451|NCT03474965|SEG101|seg101
116452|NCT03474965|Sickle cell disease|sickle cell disease
116453|NCT03474965|crizanlizumab|crizanlizumab
116454|NCT03474965|pediatric|pediatric
116455|NCT03474965|pharmacokinetic|pharmacokinetic
116456|NCT03474965|P-selectin|p-selectin
116457|NCT03474952|remote ischemic preconditioning|remote ischemic preconditioning
116458|NCT03474952|free flap reconstruction|free flap reconstruction
116459|NCT03474952|tissue oxygen saturation|tissue oxygen saturation
116460|NCT03474926|urothelial cancer|urothelial cancer
116461|NCT03474926|nephroureterectomy|nephroureterectomy
116462|NCT03474926|Upper urinary tract|upper urinary tract
116463|NCT03474913|Prostate Cancer|prostate cancer
116464|NCT03474913|Magnetic Resonance Imaging|magnetic resonance imaging
116465|NCT03474913|case cross over|case cross over
116466|NCT03474913|diagnostic|diagnostic
116467|NCT03474913|clinical trial|clinical trial
116468|NCT03474913|prostate imaging|prostate imaging
116469|NCT03474913|PSA|psa
116470|NCT03474900|intramedullary nailing|intramedullary nailing
116471|NCT03474900|randomised controlled trial|randomised controlled trial
116472|NCT03474900|biodegradable|biodegradable
116473|NCT03474900|children|children
116474|NCT03474900|forearm shaft fractures|forearm shaft fractures
116475|NCT03474887|Telemedicine|telemedicine
116476|NCT03474887|Remote consultation|remote consultation
116477|NCT03474887|Mobile health|mobile health
116478|NCT03474887|Telehealth|telehealth
116479|NCT03474887|mhealth|mhealth
116483|NCT03474848|cerebral palsy|cerebral palsy
116484|NCT03474848|rehabilitation|rehabilitation
116485|NCT03474848|hand function|hand function
116486|NCT03474848|daily functioning|daily functioning
116487|NCT03474848|hand-arm bimanual intensive training|hand-arm bimanual intensive training
116488|NCT03474835|atherosclerosis|atherosclerosis
116489|NCT03474835|angiogenesis|angiogenesis
116490|NCT03474835|cardiooncology|cardiooncology
116491|NCT03474822|Advanced breast cancer|advanced breast cancer
116492|NCT03474822|advanced liver cancer|advanced liver cancer
116493|NCT03474822|Plasmodium immunotherapy|plasmodium immunotherapy
116494|NCT03474822|Plasmodiun vivax|plasmodiun vivax
116495|NCT03474809|Sepsis, PSP, Abionic|sepsis, psp, abionic
116499|NCT03474705|Clinical Pain|clinical pain
116500|NCT03474705|Hyperalgesia|hyperalgesia
116501|NCT03474705|Intervention|intervention
116502|NCT03474705|Musculoskeletal disorders|musculoskeletal disorders
116503|NCT03474705|Computer Work|computer work
116504|NCT03474705|Strength Training|strength training
116505|NCT03474666|Liver Transplantation|liver transplantation
116506|NCT03474666|Surgical Wound Infection|surgical wound infection
116507|NCT03474666|Hiperglycemia|hiperglycemia
116508|NCT03474653|Stress urinary incontinence|stress urinary incontinence
116509|NCT03474653|Bulking|bulking
116510|NCT03474653|Bulkamid|bulkamid
116511|NCT03474640|immunotherapy|immunotherapy
116512|NCT03474640|check point inhibitor|check point inhibitor
116513|NCT03474640|PD-1 antibody|pd-1 antibody
116514|NCT03474640|solid tumor|solid tumor
116515|NCT03474640|esophageal carcinoma|esophageal carcinoma
116516|NCT03474640|gastric carcinoma|gastric carcinoma
116517|NCT03474640|nasopharyngeal carcinoma|nasopharyngeal carcinoma
116518|NCT03474640|hepatocellular carcinoma|hepatocellular carcinoma
116519|NCT03474640|soft tissue sarcoma|soft tissue sarcoma
116520|NCT03474640|chondrosarcoma|chondrosarcoma
116521|NCT03474640|orphan tumors|orphan tumors
116522|NCT03474640|phase 1 trial|phase 1 trial
116523|NCT03474601|Pituitary Diseases|pituitary diseases
116524|NCT03474601|Pituitary incidentaloma|pituitary incidentaloma
116525|NCT03474601|Central Diabetes Insipidus|central diabetes insipidus
116526|NCT03474601|Pituitary Neoplasms|pituitary neoplasms
116527|NCT03474575|homecare, COPD, Exacerbation|homecare, copd, exacerbation
116528|NCT03474549|Mechanical thrombectomy,|mechanical thrombectomy,
116529|NCT03474549|Brain|brain
116530|NCT03474549|Brain clot|brain clot
116531|NCT03474549|Brain infarction|brain infarction
116532|NCT03474549|Cerebral ischemia|cerebral ischemia
116533|NCT03474549|Neurovascular intervention|neurovascular intervention
116534|NCT03474549|Revascularization|revascularization
116535|NCT03474549|Reperfusion|reperfusion
116536|NCT03474549|Stent retriever|stent retriever
116537|NCT03474549|Tigertriever|tigertriever
116538|NCT03474549|Stroke|stroke
116539|NCT03474549|Rapid Medical|rapid medical
116540|NCT03474536|Lung transplantation|lung transplantation
116541|NCT03474536|HLA antibodies|hla antibodies
116542|NCT03474536|concentration|concentration
116543|NCT03474536|affinity|affinity
116544|NCT03474536|surface plasmon resonance|surface plasmon resonance
116545|NCT03474523|radio frequency diathermy|radio frequency diathermy
116546|NCT03474523|cavitation|cavitation
116547|NCT03474523|ultrasound|ultrasound
116548|NCT03474523|edemato-fibrosclerotic panniculopathy|edemato-fibrosclerotic panniculopathy
116549|NCT03474523|cellulitis|cellulitis
116550|NCT03474510|pain control|pain control
116551|NCT03474510|EXPAREL|exparel
116552|NCT03474510|shoulder surgery|shoulder surgery
116553|NCT03474510|continuous interscalene nerve block|continuous interscalene nerve block
116554|NCT03474484|Biomarkers|biomarkers
116555|NCT03474484|Sensitivity and Specificity|sensitivity and specificity
116556|NCT03474484|Clinical Deterioration|clinical deterioration
116557|NCT03474380|Caregiver|caregiver
116558|NCT03474380|Veterans|veterans
116559|NCT03474380|Skills training|skills training
116560|NCT03474380|Informal care|informal care
116561|NCT03474380|Days at home|days at home
116562|NCT03474367|Unplanned Peritoneal Dialysis|unplanned peritoneal dialysis
116563|NCT03474367|Unplanned Hemodialysis|unplanned hemodialysis
116564|NCT03474367|Cost-Benefit Analysis|cost-benefit analysis
116565|NCT03474367|Dialysis|dialysis
116566|NCT03474367|Peritoneal Dialysis|peritoneal dialysis
116567|NCT03474367|Hemodialysis|hemodialysis
116568|NCT03474354|chemoembolization|chemoembolization
116569|NCT03474354|drug eluting beads|drug eluting beads
116570|NCT03474341|Neoadjuvant chemoradiotherapy (nCRT)|neoadjuvant chemoradiotherapy (ncrt)
116571|NCT03474341|Pathologic complete response (pCR)|pathologic complete response (pcr)
116572|NCT03474341|Magnetic Resonance Imaging (MRI)|magnetic resonance imaging (mri)
116573|NCT03474341|PET-CT|pet-ct
116574|NCT03474341|Circulating tumor DNA (ctDNA)|circulating tumor dna (ctdna)
116575|NCT03474341|endoscopy|endoscopy
116576|NCT03474315|Cardiac implantable electronic device|cardiac implantable electronic device
116580|NCT03474315|Mobile application|mobile application
116581|NCT03474315|Patient's assistance|patient's assistance
116582|NCT03474302|African American|african american
116584|NCT03474302|Physical activity|physical activity
116585|NCT03474302|Cognition|cognition
116586|NCT03474276|Children|children
116587|NCT03474276|Africa|africa
116588|NCT03474276|Metagenomic|metagenomic
116589|NCT03474276|Prebiotic|prebiotic
116590|NCT03474276|Randomized Controlled Trial|randomized controlled trial
116591|NCT03474276|Pragmatic trial|pragmatic trial
116592|NCT03474276|Azithromycin|azithromycin
116593|NCT03474276|Cognitive impairment|cognitive impairment
116594|NCT03474263|Motor Neurone Disease (MND)|motor neurone disease (mnd)
116595|NCT03474263|Amyotrophic Lateral Sclerosis (ALS)|amyotrophic lateral sclerosis (als)
116596|NCT03474237|algorithms|algorithms
116597|NCT03474237|adrenal adenoma|adrenal adenoma
116598|NCT03474237|cushing syndrome|cushing syndrome
116599|NCT03474237|pheochromocytoma|pheochromocytoma
116600|NCT03474237|adrenal incidentaloma|adrenal incidentaloma
116601|NCT03474237|adreocortical carcinoma|adreocortical carcinoma
116602|NCT03474237|primary hyperaldosteronism|primary hyperaldosteronism
116603|NCT03474224|stroke volume|stroke volume
116604|NCT03474224|goal directed therapy|goal directed therapy
116605|NCT03474224|major abdominal surgery|major abdominal surgery
116606|NCT03474172|Pediatric Tuina|pediatric tuina
116607|NCT03474172|Massage therapy|massage therapy
116608|NCT03474172|Sham Tuina|sham tuina
116609|NCT03474172|Sham massage|sham massage
116610|NCT03474172|Sham device|sham device
116611|NCT03474159|Bicuspid aortic valve|bicuspid aortic valve
116612|NCT03474159|aortic aneurysm|aortic aneurysm
116613|NCT03474159|stiffness|stiffness
116614|NCT03474159|Pulse wave velocity|pulse wave velocity
116615|NCT03474146|Mouthrinse|mouthrinse
116616|NCT03474146|Ocimum sanctum|ocimum sanctum
116617|NCT03474146|Periodontal Diseases|periodontal diseases
116618|NCT03474146|Tulsi|tulsi
116619|NCT03474133|Hodgkin's lymphoma|hodgkin's lymphoma
116620|NCT03474133|Hodgkin lymphoma|hodgkin lymphoma
116621|NCT03474133|relapsed|relapsed
116622|NCT03474133|refractory|refractory
116623|NCT03474133|brentuximab vedotin|brentuximab vedotin
116624|NCT03474133|autologous stem cell transplantation|autologous stem cell transplantation
116625|NCT03474120|Genetic causes|genetic causes
116626|NCT03474120|etiology|etiology
116627|NCT03474120|POI|poi
116628|NCT03474120|DOR|dor
116634|NCT03474094|Clinical Trial|clinical trial
116635|NCT03474094|randomized|randomized
116636|NCT03474094|phase II|phase ii
116637|NCT03474094|atezolizumab|atezolizumab
116638|NCT03474094|PD-L1|pd-l1
116639|NCT03474081|Umeclidinium|umeclidinium
116640|NCT03474081|Lung function|lung function
116641|NCT03474081|RESPIMAT|respimat
116642|NCT03474081|Chronic obstructive pulmonary disease|chronic obstructive pulmonary disease
116643|NCT03474081|Triple Therapy|triple therapy
116644|NCT03474081|Vilanterol|vilanterol
116645|NCT03474081|HANDIHALER|handihaler
116646|NCT03474081|Tiotropium|tiotropium
116647|NCT03474081|Fluticasone furoate|fluticasone furoate
116648|NCT03474068|Emergency Medical Services, Stroke, Ambulances|emergency medical services, stroke, ambulances
116649|NCT03474055|Liquid rotavirus vaccine|liquid rotavirus vaccine
116650|NCT03474055|LBRV-PV|lbrv-pv
116651|NCT03474055|Gastroenteritis|gastroenteritis
116652|NCT03474055|Diarrhoea|diarrhoea
116653|NCT03474029|latent tuberculosis|latent tuberculosis
116654|NCT03474029|rifapentine|rifapentine
116655|NCT03474003|Score prediction|score prediction
116656|NCT03474003|Allograft survival|allograft survival
116657|NCT03473990|Home-based|home-based
116658|NCT03473990|Short-term|short-term
116659|NCT03473990|Randomised Control Trial|randomised control trial
116660|NCT03473951|Hyperuricemia|hyperuricemia
116661|NCT03473951|Metabolic syndrome|metabolic syndrome
116662|NCT03473951|Left ventricular hypertrophy|left ventricular hypertrophy
116663|NCT03473938|Obesity|obesity
116664|NCT03473938|Weight loss|weight loss
116665|NCT03473938|Intragastric balloons|intragastric balloons
116666|NCT03473938|Adjustable gastric balloon|adjustable gastric balloon
116667|NCT03473938|Weight loss plateau|weight loss plateau
116668|NCT03473938|Intolerance|intolerance
116669|NCT03473860|prognosis|prognosis
116670|NCT03473860|all-cause mortality|all-cause mortality
116671|NCT03473860|myocardial infarction|myocardial infarction
116672|NCT03473860|stroke|stroke
116673|NCT03473847|VHF digital ultrasound|vhf digital ultrasound
116674|NCT03473847|Optical coherence tomography|optical coherence tomography
116675|NCT03473847|Corneal thickness|corneal thickness
116676|NCT03473847|Epithelial thickness|epithelial thickness
116677|NCT03473847|LASIK|lasik
116678|NCT03473847|SMILE|smile
116679|NCT03473834|Parkinson's disease|parkinson's disease
116680|NCT03473834|Exercise|exercise
116681|NCT03473834|Rigidity|rigidity
116682|NCT03473834|Turning|turning
116683|NCT03473821|ACL Injury|acl injury
116684|NCT03473821|Return to Sport|return to sport
116685|NCT03473821|Mental Training|mental training
116686|NCT03473821|Dynamic Motor Imagery|dynamic motor imagery
116687|NCT03473821|Anterior Cruciate Ligament|anterior cruciate ligament
116688|NCT03473821|Knee Injury|knee injury
116689|NCT03473808|Hand Function|hand function
116690|NCT03473808|Occupational Therapy|occupational therapy
116691|NCT03473808|Physical Stimulation|physical stimulation
116692|NCT03473795|Patient Outcomes|patient outcomes
116693|NCT03473795|18-114|18-114
116694|NCT03473769|Hospital Admission|hospital admission
116695|NCT03473756|Locally advanced or metastatic urothelial carcinoma|locally advanced or metastatic urothelial carcinoma
116696|NCT03473756|Bladder cancer|bladder cancer
116697|NCT03473756|Checkpoint inhibition|checkpoint inhibition
116698|NCT03473756|FGFR inhibition|fgfr inhibition
116699|NCT03473717|pain|pain
116700|NCT03473717|Intrauterine device (IUD)|intrauterine device (iud)
116701|NCT03473717|Intrauterine system (IUS)|intrauterine system (ius)
116702|NCT03473717|Patient-Reported Outcome|patient-reported outcome
116703|NCT03473704|Type 1 diabetes|type 1 diabetes
116704|NCT03473704|Depression|depression
116705|NCT03473704|Telematic Program|telematic program
116706|NCT03473704|Treatment|treatment
116707|NCT03473704|Web-based|web-based
116708|NCT03473665|ankylsoing spondylitis|ankylsoing spondylitis
116709|NCT03473665|spondyloarthritis|spondyloarthritis
116710|NCT03473639|Residual invasive breast cancer|residual invasive breast cancer
116711|NCT03473639|Metastatic breast cancer|metastatic breast cancer
116712|NCT03473613|Calcium infusion|calcium infusion
116713|NCT03473613|Cabergoline|cabergoline
116714|NCT03473548|Childhood OSA|childhood osa
116715|NCT03473535|self-harm|self-harm
116716|NCT03473535|problem-solving therapy|problem-solving therapy
116717|NCT03473535|emergency department|emergency department
116718|NCT03473535|e-therapy|e-therapy
116719|NCT03473535|suicide prevention|suicide prevention
116720|NCT03473522|Transcranial Direct Current Stimulation|transcranial direct current stimulation
116721|NCT03473522|therapeutic exercises|therapeutic exercises
116722|NCT03473522|Parkinson|parkinson
116723|NCT03473496|BCMA-CART|bcma-cart
116724|NCT03473496|CD138-CART|cd138-cart
116725|NCT03473496|CD56-CART|cd56-cart
116726|NCT03473496|CD38-CART|cd38-cart
116727|NCT03473483|nicotine|nicotine
116728|NCT03473483|tobacco|tobacco
116729|NCT03473483|research electronic cigarette|research electronic cigarette
116730|NCT03473483|e-cigarette|e-cigarette
116731|NCT03473483|SREC|srec
116732|NCT03473470|Maternal and Neonatal Hypothermia, cesarean delivery|maternal and neonatal hypothermia, cesarean delivery
116733|NCT03473457|CD38-CART|cd38-cart
116734|NCT03473457|CD33-CART|cd33-cart
116735|NCT03473457|CD56-CART|cd56-cart
116736|NCT03473457|CD123-CART|cd123-cart
116737|NCT03473457|CD117-CART|cd117-cart
116738|NCT03473457|CD133-CART|cd133-cart
116739|NCT03473457|CD34-CART|cd34-cart
116740|NCT03473457|Mucl-CART|mucl-cart
116741|NCT03473444|uric acid|uric acid
116742|NCT03473444|prevalence|prevalence
116743|NCT03473444|pakistan|pakistan
116744|NCT03473405|Total knee replacement|total knee replacement
116745|NCT03473405|Operating room airborne CFU|operating room airborne cfu
116746|NCT03473392|pre-treatment|pre-treatment
116747|NCT03473392|antibiotherapy|antibiotherapy
116748|NCT03473392|prosthetic joint infection|prosthetic joint infection
116749|NCT03473392|treatment failure|treatment failure
116750|NCT03473379|economic difficulty, financial toxicity|economic difficulty, financial toxicity
116751|NCT03473353|Medical Scribe|medical scribe
116752|NCT03473353|Outpatient|outpatient
116753|NCT03473353|EHR|ehr
116754|NCT03473340|CLAD|clad
116755|NCT03473340|Chronic Rejection|chronic rejection
116756|NCT03473340|Lung Transplant|lung transplant
116757|NCT03473327|colorectal neoplasms|colorectal neoplasms
116758|NCT03473327|Immunologic Factors|immunologic factors
116759|NCT03473327|Postoperative Period|postoperative period
116760|NCT03473314|Inhaled nitric oxide|inhaled nitric oxide
116761|NCT03473314|Non-tuberculous mycobacteria|non-tuberculous mycobacteria
116762|NCT03473314|Drug resistant bacteria|drug resistant bacteria
116763|NCT03473314|Antimicrobial drug resistance|antimicrobial drug resistance
116764|NCT03473301|CP|cp
116765|NCT03473301|Cerebral Palsy|cerebral palsy
116766|NCT03473301|Stem Cell|stem cell
116767|NCT03473301|Cord Blood|cord blood
116768|NCT03473301|MSCs|mscs
116769|NCT03473275|Sympathetic nervous system|sympathetic nervous system
116770|NCT03473275|Blood oxygen level dependent|blood oxygen level dependent
116771|NCT03473275|Brainstem|brainstem
116772|NCT03473275|Contrast enhanced ultrasound|contrast enhanced ultrasound
116773|NCT03473275|Kidney function|kidney function
116774|NCT03473275|Hypertension|hypertension
116775|NCT03473275|Renal denervation|renal denervation
116776|NCT03473262|Type 2 diabetes|type 2 diabetes
116777|NCT03473262|Sodium glucose cotransporter 2 inhibitor|sodium glucose cotransporter 2 inhibitor
116778|NCT03473262|Empagliflozin|empagliflozin
116779|NCT03473262|Insulin glargine|insulin glargine
116780|NCT03473171|nasal non-invasive ventilation|nasal non-invasive ventilation
116781|NCT03473171|RAM Cannula|ram cannula
116782|NCT03473171|Pediatric Complex Care|pediatric complex care
116783|NCT03473171|Tracheostomy Avoidance|tracheostomy avoidance
116784|NCT03473158|fetal reduction|fetal reduction
116785|NCT03473158|embryo reduction|embryo reduction
116786|NCT03473158|feticide|feticide
116787|NCT03473158|potassium chloride|potassium chloride
116788|NCT03473158|multiple pregnancy|multiple pregnancy
116789|NCT03473158|multifetal pregnancy|multifetal pregnancy
116790|NCT03473119|Sphingosine-1-phosphate|sphingosine-1-phosphate
116791|NCT03473106|Pneumatic Tourniquet|pneumatic tourniquet
116792|NCT03473106|Postoperative Muscle Dysfunction|postoperative muscle dysfunction
116793|NCT03473080|OCD|ocd
116794|NCT03473080|ASD|asd
116795|NCT03473080|Obsessive Compulsive Disorder|obsessive compulsive disorder
116796|NCT03473080|Autism Spectrum Disorder|autism spectrum disorder
116797|NCT03473080|ICBT|icbt
116798|NCT03473080|eHealth|ehealth
116799|NCT03473080|Internet|internet
116800|NCT03473080|CBT|cbt
116801|NCT03473080|Pediatric|pediatric
116802|NCT03473080|Adolescents|adolescents
116803|NCT03473080|Children|children
116804|NCT03473080|Internet-delivered|internet-delivered
116805|NCT03473054|Stroke|stroke
116806|NCT03473054|Cerebrovascular Accident|cerebrovascular accident
116807|NCT03473054|Stress|stress
116808|NCT03473054|Anxiety|anxiety
116809|NCT03473054|Depression|depression
116810|NCT03473054|Mindfulness|mindfulness
116811|NCT03473054|Family caregivers|family caregivers
116812|NCT03473054|Web-based|web-based
116813|NCT03473041|female stress incontinence|female stress incontinence
116814|NCT03473041|Transobturator tension free vaginal tape TVTO|transobturator tension free vaginal tape tvto
116815|NCT03473028|obesity|obesity
116816|NCT03473028|embryo transfer|embryo transfer
116817|NCT03473028|invitro fertilization|invitro fertilization
116818|NCT03473002|Immunogenicity|immunogenicity
116819|NCT03473002|Respiratory Syncytial Virus|respiratory syncytial virus
116820|NCT03473002|Safety|safety
116821|NCT03473002|Sendai Virus|sendai virus
116822|NCT03473002|Vaccine|vaccine
116823|NCT03472989|plantar fasciopathy|plantar fasciopathy
116824|NCT03472989|plantar fasciitis|plantar fasciitis
116825|NCT03472989|radial extracorporeal shock wave therapy|radial extracorporeal shock wave therapy
116826|NCT03472989|sham- radial extracorporeal shock wave therapy|sham- radial extracorporeal shock wave therapy
116827|NCT03472989|high-load strength training|high-load strength training
116828|NCT03472989|foot orthosis|foot orthosis
116829|NCT03472976|Healthy Young Adults|healthy young adults
116830|NCT03472976|Immunogenicity|immunogenicity
116831|NCT03472976|Inactivated Influenza A/H5N1 Vaccine|inactivated influenza a/h5n1 vaccine
116832|NCT03472976|Phase I Clinical Trial|phase i clinical trial
116833|NCT03472976|Reactogenicity|reactogenicity
116834|NCT03472976|Safety|safety
116835|NCT03472976|Topical Aldara(R)|topical aldara(r)
116836|NCT03472963|Post-Exposure Prophylaxis|post-exposure prophylaxis
116837|NCT03472963|Anti-Retroviral|anti-retroviral
116838|NCT03472963|Pharmacokinetics|pharmacokinetics
116839|NCT03472937|Mechanical cervical ripening|mechanical cervical ripening
116840|NCT03472937|Transcervical catheter|transcervical catheter
116841|NCT03472937|Foley catheter for labor induction|foley catheter for labor induction
116842|NCT03472937|Cervical ripening|cervical ripening
116843|NCT03472937|Induction of labor|induction of labor
116844|NCT03472924|AMI|ami
116845|NCT03472885|PNH|pnh
116846|NCT03472885|Paroxysmal Nocturnal Hemoglobinuria|paroxysmal nocturnal hemoglobinuria
116847|NCT03472885|ACH-0144471|ach-0144471
116848|NCT03472885|eculizumab|eculizumab
116849|NCT03472872|acetaminophen|acetaminophen
116850|NCT03472872|ketorolac|ketorolac
116851|NCT03472872|prochlorperazine|prochlorperazine
116852|NCT03472872|diphenhydramine|diphenhydramine
116853|NCT03472859|laser|laser
116854|NCT03472859|lasers|lasers
116855|NCT03472859|KTP|ktp
116856|NCT03472859|semiconductor|semiconductor
116857|NCT03472859|tgs|tgs
116858|NCT03472859|rosacea|rosacea
116859|NCT03472859|telangiectasia|telangiectasia
116860|NCT03472833|V|v
116861|NCT03472820|Diet|diet
116862|NCT03472820|Lifestyle|lifestyle
116863|NCT03472820|DNA methylation|dna methylation
116864|NCT03472768|ECMO|ecmo
116865|NCT03472755|hip arthroplasty, surgeries, physical fitness, perception, energetic cost, autonomy|hip arthroplasty, surgeries, physical fitness, perception, energetic cost, autonomy
116866|NCT03472729|Social isolation|social isolation
116867|NCT03472729|Older adults|older adults
116868|NCT03472729|Technology|technology
116869|NCT03472716|Pancreatic adenocarcinoma|pancreatic adenocarcinoma
116870|NCT03472716|βig-h3|βig-h3
116871|NCT03472716|Pronostic marker|pronostic marker
116872|NCT03472703|fMRI|fmri
116873|NCT03472703|Cognitive processes|cognitive processes
116874|NCT03472703|Inhibition|inhibition
116875|NCT03472703|Food reward|food reward
116876|NCT03472703|Appetite|appetite
116877|NCT03472690|Inflammatory Bowel Disease 1|inflammatory bowel disease 1
116878|NCT03472677|Osteoarthritis|osteoarthritis
116879|NCT03472677|Knee Pain|knee pain
116880|NCT03472664|Memory|memory
116881|NCT03472664|Diet|diet
116882|NCT03472664|ketogenic|ketogenic
116883|NCT03472612|OSA|osa
116884|NCT03472612|CPAP|cpap
116885|NCT03472612|upper airway collapse|upper airway collapse
116886|NCT03472612|neural respiratory drive|neural respiratory drive
116887|NCT03472599|Neurogenic bladder dysfunction|neurogenic bladder dysfunction
116888|NCT03472599|Genital Nerve Stimulation|genital nerve stimulation
116889|NCT03472599|Electrical Stimulation|electrical stimulation
116890|NCT03472599|Urinary Incontinence|urinary incontinence
116891|NCT03472599|Spinal cord injury|spinal cord injury
116892|NCT03472560|Cancer|cancer
116893|NCT03472560|non-small cell lung cancer|non-small cell lung cancer
116894|NCT03472560|non small cell lung cancer|non small cell lung cancer
116895|NCT03472560|NSCLC|nsclc
116896|NCT03472560|lung cancer|lung cancer
116897|NCT03472560|urothelial cancer|urothelial cancer
116898|NCT03472560|bladder cancer|bladder cancer
116899|NCT03472560|Avelumab|avelumab
116900|NCT03472560|Bavencio|bavencio
116901|NCT03472560|Axitinib|axitinib
116902|NCT03472560|Inlyta|inlyta
116903|NCT03472508|Folic acid|folic acid
116904|NCT03472508|Homocysteine|homocysteine
116905|NCT03472508|MTHFR C677T|mthfr c677t
116906|NCT03472508|RCT|rct
116907|NCT03472508|Precision treatment|precision treatment
116908|NCT03472495|Diltiazem|diltiazem
116909|NCT03472495|Atrial Fibrillation|atrial fibrillation
116910|NCT03472495|Atrial Flutter|atrial flutter
116911|NCT03472495|Emergency Medicine|emergency medicine
116912|NCT03472482|Alzheimer's disease|alzheimer's disease
116913|NCT03472482|Dementia|dementia
116914|NCT03472482|Lewy body disease|lewy body disease
116915|NCT03472482|Retina|retina
116916|NCT03472482|Retinal imaging|retinal imaging
116917|NCT03472482|Optical Coherence Tomography|optical coherence tomography
116918|NCT03472482|Hyperspectral imaging|hyperspectral imaging
116919|NCT03472482|Mild Cognitive Impairment|mild cognitive impairment
116920|NCT03472430|Oocyte Retrieval|oocyte retrieval
116921|NCT03472430|Transcutaneous Electric Nerve Stimulation|transcutaneous electric nerve stimulation
116922|NCT03472430|Pain relief|pain relief
116923|NCT03472430|Conscious sedation|conscious sedation
116924|NCT03472365|PD-1|pd-1
116925|NCT03472365|SHR-1210|shr-1210
116926|NCT03472365|Capecitabine|capecitabine
116927|NCT03472365|Oxaliplatin|oxaliplatin
116928|NCT03472365|Apatinib|apatinib
116929|NCT03472339|Acute limb injury, Diclofenac, pain management|acute limb injury, diclofenac, pain management
116930|NCT03472313|HV|hv
116931|NCT03472300|Knee Osteoarthritis|knee osteoarthritis
116932|NCT03472300|pain|pain
116933|NCT03472300|Complementary Therapies|complementary therapies
116934|NCT03472300|Survey|survey
116935|NCT03472300|questionnaire|questionnaire
116936|NCT03472261|cerebral palsy|cerebral palsy
116937|NCT03472261|botulinum toxin-A|botulinum toxin-a
116938|NCT03472261|pronator deformity|pronator deformity
116939|NCT03472248|Adolescents|adolescents
116940|NCT03472248|Acceptance and Commitment Therapy|acceptance and commitment therapy
116941|NCT03472248|Smartphone|smartphone
116942|NCT03472209|Postoperative Nausea and Vomiting|postoperative nausea and vomiting
116943|NCT03472209|Gynecological Laparoscopic Surgery|gynecological laparoscopic surgery
149478|NCT03265782|PDA|pda
116944|NCT03472209|End-tidal carbon dioxide|end-tidal carbon dioxide
116945|NCT03472183|Enteric nervous system|enteric nervous system
116946|NCT03472183|Alzheimer disease|alzheimer disease
116947|NCT03472183|biomarker|biomarker
116948|NCT03472183|colonic biopsies|colonic biopsies
116949|NCT03472183|neurodegenerative disease|neurodegenerative disease
116950|NCT03472170|bovine lactoferrin|bovine lactoferrin
116951|NCT03472170|late sepsis|late sepsis
116952|NCT03472157|Gastric bypass|gastric bypass
116953|NCT03472157|Sleeve gastrectomy|sleeve gastrectomy
116954|NCT03472157|Lifestyle therapy|lifestyle therapy
116955|NCT03472157|NASH|nash
116956|NCT03472157|Advanced fibrosis|advanced fibrosis
116957|NCT03472157|Cirrhosis|cirrhosis
116958|NCT03472131|Spondylodiscitis|spondylodiscitis
116959|NCT03472131|Titanium Cage|titanium cage
116960|NCT03472131|Posterolateral Debridement|posterolateral debridement
116961|NCT03472131|Immunosuppressed|immunosuppressed
116962|NCT03472131|Less Invasive|less invasive
116963|NCT03472131|Spine Infection|spine infection
116964|NCT03472118|Anesthesia, general|anesthesia, general
116965|NCT03472118|Adult|adult
116966|NCT03472118|Humans|humans
116967|NCT03472118|Apnea|apnea
116968|NCT03472118|Oxygen|oxygen
116969|NCT03472118|Carbon dioxide|carbon dioxide
116970|NCT03472118|Acidosis, respiratory|acidosis, respiratory
116971|NCT03472118|Administration, Intranals/methods|administration, intranals/methods
116972|NCT03472118|Airway management/methods|airway management/methods
116973|NCT03472118|Continuous positive airway pressure/methods|continuous positive airway pressure/methods
116974|NCT03472118|Insufflation/methods|insufflation/methods
116975|NCT03472118|Oxygen/administration&dosage|oxygen/administration&dosage
116976|NCT03472118|Laryngoscopy|laryngoscopy
116977|NCT03472118|Larynx/surgery|larynx/surgery
116978|NCT03472092|headache|headache
116979|NCT03472092|migraine|migraine
116980|NCT03472092|cognitive behavioral therapy|cognitive behavioral therapy
116981|NCT03472092|amitriptyline|amitriptyline
116982|NCT03472092|functional magnetic resonance imaging|functional magnetic resonance imaging
116983|NCT03472092|conditioned pain modulation|conditioned pain modulation
116984|NCT03472092|brain connectivity|brain connectivity
116985|NCT03472092|pediatrics|pediatrics
116986|NCT03472079|Acute kidney injury|acute kidney injury
116987|NCT03472079|Septic shock|septic shock
116988|NCT03472079|TIMP2*IGFBP7|timp2*igfbp7
116989|NCT03472053|Lung cancer|lung cancer
116990|NCT03472053|non small cell|non small cell
116991|NCT03472053|metastasis|metastasis
116992|NCT03472040|BCX7353|bcx7353
116993|NCT03472040|Hereditary Angioedema|hereditary angioedema
116994|NCT03472040|HAE|hae
116995|NCT03471988|deep mycosis|deep mycosis
116996|NCT03471988|aspergillosis|aspergillosis
116997|NCT03471988|mucormycosis|mucormycosis
116998|NCT03471988|cryptococcosis|cryptococcosis
116999|NCT03471988|isavuconazonium sulfate|isavuconazonium sulfate
117000|NCT03471988|isavuconazole|isavuconazole
117001|NCT03471988|AK1820|ak1820
117002|NCT03471988|Cresemba|cresemba
117003|NCT03471975|Video laryngoscopy|video laryngoscopy
117004|NCT03471962|respiratory quotient (RQ)|respiratory quotient (rq)
117005|NCT03471962|anaerobic metabolism|anaerobic metabolism
117006|NCT03471962|major surgery|major surgery
117007|NCT03471936|Congenital Heart Disease|congenital heart disease
117008|NCT03471936|pressure-volume loops|pressure-volume loops
117009|NCT03471936|diastolic function|diastolic function
117010|NCT03471910|Chronic venous insufficiency|chronic venous insufficiency
117011|NCT03471910|Diosmin|diosmin
117012|NCT03471910|Hesperidin|hesperidin
117013|NCT03471897|glycosaminoglycans|glycosaminoglycans
117014|NCT03471897|biomarkers|biomarkers
117015|NCT03471897|diagnostics|diagnostics
117016|NCT03471897|prognostic|prognostic
117017|NCT03471897|liquid biopsy|liquid biopsy
117018|NCT03471884|Thoracoscopic surgery,Airway Management,Anesthesia|thoracoscopic surgery,airway management,anesthesia
117019|NCT03471871|Elderly Healthy Subjects|elderly healthy subjects
117020|NCT03471871|Adult Healthy Subjects|adult healthy subjects
117021|NCT03471871|Lemborexant|lemborexant
117022|NCT03471871|Respiratory Safety|respiratory safety
117023|NCT03471871|Peripheral Oxygen Saturation|peripheral oxygen saturation
117024|NCT03471871|Total Sleep Time|total sleep time
117025|NCT03471858|caesarean, uterus|caesarean, uterus
117026|NCT03471845|Major Adverse Cardiac Events (MACE)|major adverse cardiac events (mace)
117027|NCT03471845|Myocardial Infarction (MI)|myocardial infarction (mi)
117028|NCT03471845|Late Lumen Loss (LLL)|late lumen loss (lll)
117029|NCT03471845|Target Lesion Revascularization (TLR)|target lesion revascularization (tlr)
117030|NCT03471845|Target Vessel Revascularization (TVR)|target vessel revascularization (tvr)
117031|NCT03471845|Target Vessel Failure (TVF)|target vessel failure (tvf)
117032|NCT03471845|Target Lesion Failure (TLF)|target lesion failure (tlf)
117033|NCT03471845|Stent Thrombosis (ST)|stent thrombosis (st)
117034|NCT03471845|PERCUTANEOUS CORONARY INTERVENTION (PCI)|percutaneous coronary intervention (pci)
117035|NCT03471819|Atopic Dermatitis|atopic dermatitis
117036|NCT03471819|serotonin|serotonin
117037|NCT03471806|Bulimia Nervosa|bulimia nervosa
117038|NCT03471806|Eating disorder|eating disorder
117039|NCT03471806|Dopamine|dopamine
117040|NCT03471806|Food|food
117041|NCT03471806|Reward|reward
117042|NCT03471806|Positron Emission Tomography|positron emission tomography
117043|NCT03471806|Magnetic Resonance|magnetic resonance
117044|NCT03471806|Metabolic hormones|metabolic hormones
117045|NCT03471767|Smoking cessation|smoking cessation
117046|NCT03471767|Nicotine dependence|nicotine dependence
117047|NCT03471767|Bupropion|bupropion
117048|NCT03471767|DXM|dxm
117049|NCT03471767|Nicotine addiction|nicotine addiction
117050|NCT03471767|Cigarette smoking|cigarette smoking
117051|NCT03471767|Dextromethorphan|dextromethorphan
117052|NCT03471754|Depression, transcranial electronic stimulation, pilot, open label, safety, efficacy|depression, transcranial electronic stimulation, pilot, open label, safety, efficacy
117053|NCT03471741|breast cancer|breast cancer
117054|NCT03471741|radiotherapy|radiotherapy
117055|NCT03471741|cutaneous toxicity|cutaneous toxicity
117056|NCT03471741|subcutaneous toxicity|subcutaneous toxicity
117057|NCT03471741|local control|local control
117058|NCT03471741|IMRT|imrt
117059|NCT03471728|Linaclotide|linaclotide
117060|NCT03471728|Linzess|linzess
117061|NCT03471728|Irritable Bowel Syndrome|irritable bowel syndrome
117062|NCT03471728|Chronic Constipation|chronic constipation
117063|NCT03471715|frequency fenesration dehiscence cbct population|frequency fenesration dehiscence cbct population
117064|NCT03471689|Multimodal|multimodal
117065|NCT03471689|Pain perception|pain perception
117066|NCT03471689|Regulation|regulation
117067|NCT03471689|Mindfulness|mindfulness
117068|NCT03471650|J17149|j17149
117069|NCT03471650|PSMA|psma
117070|NCT03471650|18F-DCFPyL PET/CT|18f-dcfpyl pet/ct
117071|NCT03471637|Chronic Pain|chronic pain
117072|NCT03471637|Compassion-Focused Therapy|compassion-focused therapy
117073|NCT03471637|Self-Compassion|self-compassion
117074|NCT03471637|Psychological Flexibility|psychological flexibility
117276|NCT03470311|asthma|asthma
117075|NCT03471624|Tenofovir alafenamide (TAF)|tenofovir alafenamide (taf)
117076|NCT03471585|THC|thc
117077|NCT03471585|adult|adult
117078|NCT03471572|BRCA, ovarian cancer, fallopian tube cancer|brca, ovarian cancer, fallopian tube cancer
117079|NCT03471546|Palliative Care|palliative care
117080|NCT03471546|Pro00091481|pro00091481
117081|NCT03471546|Malignant Glioma|malignant glioma
117082|NCT03471546|Katherine Peters|katherine peters
117083|NCT03471546|David Casarett|david casarett
117084|NCT03471494|Surgery|surgery
117085|NCT03471494|Quality|quality
117086|NCT03471494|Outcomes|outcomes
117087|NCT03471468|Microparticles|microparticles
117088|NCT03471468|Pancreatic cancer|pancreatic cancer
117089|NCT03471468|Gastric cancer|gastric cancer
117090|NCT03471468|Chemotherapy|chemotherapy
117091|NCT03471468|Venous thromboembolism|venous thromboembolism
117092|NCT03471429|Anxiety|anxiety
117093|NCT03471429|Dog|dog
117094|NCT03471429|Canine|canine
117095|NCT03471429|Therapy|therapy
117096|NCT03471429|Depression|depression
117097|NCT03471429|Pain|pain
117098|NCT03471416|Guatemala|guatemala
117099|NCT03471416|Guatemala City|guatemala city
117100|NCT03471416|Malnutrition|malnutrition
117101|NCT03471416|Leukemia|leukemia
117102|NCT03471416|Childhood Cancer|childhood cancer
117103|NCT03471403|Cold snare polypectomy|cold snare polypectomy
117104|NCT03471390|Nursing Home|nursing home
117105|NCT03471377|Planned Surgical Case|planned surgical case
117106|NCT03471377|Predictive Modeling|predictive modeling
117107|NCT03471377|18-115|18-115
117108|NCT03471351|Hodgkin lymphoma|hodgkin lymphoma
117109|NCT03471351|RP6530|rp6530
117110|NCT03471351|Pembrolizumab|pembrolizumab
117111|NCT03471351|Tenalisib|tenalisib
117112|NCT03471338|multiple sclerosis|multiple sclerosis
117113|NCT03471338|cognition|cognition
117114|NCT03471338|neuropsychology|neuropsychology
117115|NCT03471338|cognitive rehabilitation|cognitive rehabilitation
117116|NCT03471325|plaque removal|plaque removal
117117|NCT03471299|Ultrafiltration rate|ultrafiltration rate
117118|NCT03471234|coronary disease|coronary disease
117119|NCT03471234|drug eluting stent|drug eluting stent
117120|NCT03471234|Inspiron|inspiron
117121|NCT03471182|Cocaine Dependence|cocaine dependence
117122|NCT03471182|Cocaine Addiction|cocaine addiction
117123|NCT03471169|antithrombotic therapy|antithrombotic therapy
117124|NCT03471117|blood pressure|blood pressure
117125|NCT03471117|pioglitazone|pioglitazone
117126|NCT03471117|hypertension|hypertension
117127|NCT03471104|Diabetes-related distress|diabetes-related distress
117128|NCT03471104|Living with diabetes|living with diabetes
117129|NCT03471104|Patient-Reported Outcome Measures (PROMs)|patient-reported outcome measures (proms)
117130|NCT03471078|CIT|cit
117131|NCT03471078|Thrombocytopenia|thrombocytopenia
117132|NCT03471065|Transcatheter|transcatheter
117133|NCT03471065|Transcatheter Valve Replacement|transcatheter valve replacement
117134|NCT03471065|SAPIEN 3 Ultra|sapien 3 ultra
117135|NCT03471013|schizophrenia|schizophrenia
117136|NCT03471013|beliefs|beliefs
117137|NCT03471013|caregiver|caregiver
117138|NCT03471000|implant|implant
117139|NCT03471000|dental implant|dental implant
117140|NCT03470987|obesity|obesity
117141|NCT03470987|periodontitis|periodontitis
117142|NCT03470987|cytokines|cytokines
117143|NCT03470961|Grafalon ATG SPK|grafalon atg spk
117144|NCT03470948|surgical apgar score, postoperative complication|surgical apgar score, postoperative complication
117145|NCT03470935|breast cancer|breast cancer
117146|NCT03470935|young women|young women
117147|NCT03470922|Cancer|cancer
117148|NCT03470922|Advanced Cancer|advanced cancer
117149|NCT03470909|Remaining breast tissue|remaining breast tissue
117150|NCT03470909|Skin-Sparing Mastectomy|skin-sparing mastectomy
117151|NCT03470909|Nipple-Sparing Mastectomy|nipple-sparing mastectomy
117152|NCT03470909|Prophylactic|prophylactic
117153|NCT03470896|preanesthesia teleconsultation|preanesthesia teleconsultation
117154|NCT03470896|video-conference|video-conference
117155|NCT03470896|ambulatory surgery|ambulatory surgery
117156|NCT03470896|telemedicine|telemedicine
117157|NCT03470883|endoscopic resection|endoscopic resection
117158|NCT03470883|colorectal adenomas|colorectal adenomas
117159|NCT03470883|Colorectal adenocarcinomas|colorectal adenocarcinomas
117160|NCT03470870|Enhanced recovery after surgery|enhanced recovery after surgery
117161|NCT03470870|gynecologic oncology surgery|gynecologic oncology surgery
117162|NCT03470870|Nomogram control|nomogram control
117163|NCT03470857|Positron Emission Tomography Computed Tomography|positron emission tomography computed tomography
117164|NCT03470857|Fluorodeoxyglucose F18|fluorodeoxyglucose f18
117165|NCT03470857|Cancer|cancer
117166|NCT03470857|Superooxide Dismutase|superooxide dismutase
117167|NCT03470857|Catalase|catalase
117168|NCT03470857|Glutathione Peroxidase|glutathione peroxidase
117169|NCT03470857|Malondialdehyde|malondialdehyde
117170|NCT03470857|Conjugated Dienes|conjugated dienes
117171|NCT03470857|Acid Phosphatase|acid phosphatase
117172|NCT03470857|Cathepsin D|cathepsin d
117173|NCT03470857|Alpha-1-Antitrypsin|alpha-1-antitrypsin
117174|NCT03470857|Arylsulfatase|arylsulfatase
117175|NCT03470857|8-iso-Prostaglandin F2alpha|8-iso-prostaglandin f2alpha
117176|NCT03470857|4-Hydroxynonenal|4-hydroxynonenal
117177|NCT03470857|Total Antioxidant Capacity|total antioxidant capacity
117178|NCT03470857|Vitamin A|vitamin a
117179|NCT03470857|Vitamin E|vitamin e
117180|NCT03470844|Major burns|major burns
117181|NCT03470844|Intensive Care Medicine|intensive care medicine
117182|NCT03470844|Neurocognitive dysfunction|neurocognitive dysfunction
117183|NCT03470844|Functional magnetic resonance imaging|functional magnetic resonance imaging
117184|NCT03470844|Neuroinflammation|neuroinflammation
117185|NCT03470844|Long term quality of life|long term quality of life
117186|NCT03470818|Medical Education|medical education
117187|NCT03470818|Flipped Classroom|flipped classroom
117188|NCT03470818|Anxiety|anxiety
117189|NCT03470818|Simulation|simulation
117190|NCT03470818|Achievement Emotions|achievement emotions
117191|NCT03470792|Microcirculation, extracorporeal membrane oxygenation|microcirculation, extracorporeal membrane oxygenation
117192|NCT03470766|Neuromodulation|neuromodulation
117193|NCT03470766|HF10|hf10
117194|NCT03470766|HF-10|hf-10
117195|NCT03470766|Nevro|nevro
117196|NCT03470766|High-frequency|high-frequency
117197|NCT03470766|10kHz|10khz
117198|NCT03470766|Spinal Cord Stimulation|spinal cord stimulation
117199|NCT03470766|CNLBP|cnlbp
117200|NCT03470766|Chronic Neuropathic Low Back Pain|chronic neuropathic low back pain
117201|NCT03470766|Double blind randomised sham-controlled|double blind randomised sham-controlled
117202|NCT03470766|PANARC|panarc
117204|NCT03470740|rheumatoid arthritis, self-management, self-efficacy|rheumatoid arthritis, self-management, self-efficacy
117205|NCT03470714|Force Irradiation|force irradiation
117206|NCT03470714|Kinesiotaping|kinesiotaping
117207|NCT03470714|EMG|emg
117208|NCT03470662|Hip fractures|hip fractures
117209|NCT03470662|Delirium|delirium
117210|NCT03470662|Aged|aged
117211|NCT03470662|Care bundle|care bundle
117212|NCT03470623|hallux valgus|hallux valgus
117213|NCT03470623|chevron osteotomy|chevron osteotomy
117214|NCT03470623|bioabsorbable screw|bioabsorbable screw
117215|NCT03470623|steel screw|steel screw
117216|NCT03470610|Progesterone|progesterone
117217|NCT03470610|HRT|hrt
117218|NCT03470610|frozen embryo transfer|frozen embryo transfer
117219|NCT03470584|Diet, vegetarian|diet, vegetarian
117220|NCT03470584|Dementia|dementia
117221|NCT03470584|Depression|depression
117222|NCT03470584|Cardiovascular Diseases|cardiovascular diseases
117223|NCT03470584|Stroke|stroke
117224|NCT03470584|Gout|gout
117225|NCT03470584|Cataract|cataract
117226|NCT03470584|Gallstone|gallstone
117227|NCT03470584|Urinary Tract Infections|urinary tract infections
117228|NCT03470558|Diet|diet
117229|NCT03470558|Dietary Habits|dietary habits
117230|NCT03470558|Weight changes|weight changes
117231|NCT03470545|Symptomatic, left ventricular outflow tract gradient|symptomatic, left ventricular outflow tract gradient
117232|NCT03470428|Fontan|fontan
117233|NCT03470428|Single Ventricle|single ventricle
117234|NCT03470402|Breast Cancer Prevention|breast cancer prevention
117235|NCT03470402|Genetic Testing|genetic testing
117236|NCT03470402|Genetic Counseling|genetic counseling
117237|NCT03470402|Personalized Prevention|personalized prevention
117238|NCT03470402|Precision Prevention|precision prevention
117239|NCT03470402|Precision Medicine|precision medicine
117240|NCT03470402|Risk Assessment|risk assessment
117241|NCT03470402|Decision Making|decision making
117242|NCT03470402|Decision Aid|decision aid
117243|NCT03470389|Liver Cirrhosis|liver cirrhosis
117244|NCT03470389|Hypertension, Portal|hypertension, portal
117245|NCT03470389|Hepatic Venous Pressure Gradient (HVPG)|hepatic venous pressure gradient (hvpg)
117246|NCT03470389|Biofluid Mechanics|biofluid mechanics
117247|NCT03470389|Noninvasive|noninvasive
117248|NCT03470376|cholesterol|cholesterol
117249|NCT03470376|nutraceutical|nutraceutical
117250|NCT03470376|HIV|hiv
117251|NCT03470376|PCSK9|pcsk9
117252|NCT03470376|hsCRP|hscrp
117253|NCT03470376|stiffness|stiffness
117254|NCT03470363|total knee arthroplasty|total knee arthroplasty
117255|NCT03470363|tourniquet|tourniquet
117256|NCT03470363|sevoflurane|sevoflurane
117257|NCT03470363|spinal anesthesia|spinal anesthesia
117258|NCT03470363|myeloperoxidase|myeloperoxidase
117259|NCT03470363|elastase|elastase
117260|NCT03470363|neutrophil|neutrophil
117261|NCT03470350|TGF-beta activatied|tgf-beta activatied
117262|NCT03470337|Thrombophlebitis|thrombophlebitis
117263|NCT03470324|Parkinson's disease|parkinson's disease
117264|NCT03470324|Dysphagia|dysphagia
117265|NCT03470324|Parkinsonian Disorders|parkinsonian disorders
117266|NCT03470324|Neurodegenerative Diseases|neurodegenerative diseases
117267|NCT03470324|Movement Disorders|movement disorders
117268|NCT03470324|Nervous System Diseases|nervous system diseases
117269|NCT03470324|Basal Ganglia Diseases|basal ganglia diseases
117270|NCT03470324|Brain Diseases|brain diseases
117271|NCT03470324|Central Nervous System Diseases|central nervous system diseases
117272|NCT03470324|Deep brain stimulation|deep brain stimulation
117273|NCT03470324|substantia nigra pars reticulata|substantia nigra pars reticulata
117274|NCT03470324|subthalamic nucleus|subthalamic nucleus
117275|NCT03470311|Eosinophils|eosinophils
117277|NCT03470311|inflammation|inflammation
117278|NCT03470311|prednisone|prednisone
117279|NCT03470298|Endometrial Scratching|endometrial scratching
117280|NCT03470298|Unexplained infertility|unexplained infertility
117281|NCT03470298|ICSI|icsi
117282|NCT03470285|Mulitparametric MR Imaging|mulitparametric mr imaging
117283|NCT03470285|Small solid renal tumors|small solid renal tumors
117284|NCT03470246|Accelerometer|accelerometer
117285|NCT03470246|Aortic valve replacement|aortic valve replacement
117286|NCT03470246|Aortic valve stenosis|aortic valve stenosis
117287|NCT03470246|Coronary artery bypass grafting|coronary artery bypass grafting
117288|NCT03470246|Coronary artery disease|coronary artery disease
117289|NCT03470246|eHealth|ehealth
117290|NCT03470246|Interactive guidance|interactive guidance
117291|NCT03470246|Mitral valve insufficiency|mitral valve insufficiency
117292|NCT03470246|Mitral valve repair|mitral valve repair
117293|NCT03470246|Rehabilitation|rehabilitation
117294|NCT03470194|Quality Care|quality care
117295|NCT03470194|Access to health care|access to health care
117296|NCT03470194|Interpretation services|interpretation services
117297|NCT03470181|Chronic nausea, intermittent vomiting, impaired accommodation|chronic nausea, intermittent vomiting, impaired accommodation
117298|NCT03470155|annuloplasty mitral valve|annuloplasty mitral valve
117299|NCT03470155|reduced LV function|reduced lv function
117300|NCT03470142|laparoscopy-assisted surgery|laparoscopy-assisted surgery
117302|NCT03470116|MacGrath MAC|macgrath mac
117303|NCT03470116|curarization|curarization
117304|NCT03470116|intubation|intubation
117305|NCT03470116|MacIntosh|macintosh
117306|NCT03470116|laryngoscope|laryngoscope
117307|NCT03470103|Wet age-related macular degeneration(wAMD)|wet age-related macular degeneration(wamd)
117308|NCT03470103|Diabetic macular edema(DME)|diabetic macular edema(dme)
117309|NCT03470090|Physical activity|physical activity
117310|NCT03470090|Function|function
117311|NCT03470090|Balance|balance
117312|NCT03470090|Neuromuscular exercises|neuromuscular exercises
117313|NCT03470090|Osteoarthritis|osteoarthritis
117314|NCT03470038|NGF-induced pain|ngf-induced pain
117315|NCT03470038|Ischemia-induced pain|ischemia-induced pain
117316|NCT03470038|Hyperalgesia|hyperalgesia
117317|NCT03470038|NGF pain model|ngf pain model
117318|NCT03470025|Rehabilitation|rehabilitation
117319|NCT03470025|Psychological Intervention|psychological intervention
117320|NCT03470025|Quality of life|quality of life
117321|NCT03469999|Botulinum toxin A|botulinum toxin a
117322|NCT03469999|Walking efficiency|walking efficiency
117323|NCT03469999|Spasticity|spasticity
117324|NCT03469999|Dysport|dysport
117325|NCT03469999|Pediatric|pediatric
117326|NCT03469960|IFCT|ifct
117327|NCT03469960|DICIPLE|diciple
117328|NCT03469960|NSCLC|nsclc
117329|NCT03469947|Tranexamic Acid|tranexamic acid
117330|NCT03469947|TXA|txa
117331|NCT03469921|Malignant haemopathies|malignant haemopathies
117332|NCT03469921|Acute Leukemia|acute leukemia
117333|NCT03469921|Non-hodgkin Lymphoma|non-hodgkin lymphoma
117334|NCT03469921|Hodgkin Lymphoma|hodgkin lymphoma
117335|NCT03469921|Young adults|young adults
117336|NCT03469921|Adolescent|adolescent
117337|NCT03469895|Chronic Lymphocytic Leukemia|chronic lymphocytic leukemia
117338|NCT03469895|Autoimmune Cytopenias|autoimmune cytopenias
117339|NCT03469895|BCR inhibitors|bcr inhibitors
117340|NCT03469882|Protein, exercise, critical illness, outcome,|protein, exercise, critical illness, outcome,
117341|NCT03469869|Obesity|obesity
117342|NCT03469843|Congenital Heart Disease|congenital heart disease
117343|NCT03469843|Cardiac denervation|cardiac denervation
117344|NCT03469843|123I-metaiodobenzylguanidine|123i-metaiodobenzylguanidine
117345|NCT03469843|Arterial switch operation|arterial switch operation
117346|NCT03469830|insert|insert
117347|NCT03469830|pressure therapy|pressure therapy
117348|NCT03469830|silicone gel|silicone gel
117349|NCT03469817|Bone apposition|bone apposition
117350|NCT03469817|Stryker|stryker
117351|NCT03469817|MRI|mri
117352|NCT03469817|Trident II|trident ii
117353|NCT03469817|Total Hip Replacement|total hip replacement
117354|NCT03469791|Degenerative Spondylolisthesis|degenerative spondylolisthesis
117355|NCT03469791|Treatment|treatment
117356|NCT03469791|Decompression alone|decompression alone
117357|NCT03469791|Instrumented fusion|instrumented fusion
117358|NCT03469791|Oswestry Disability Index|oswestry disability index
117359|NCT03469778|stroke|stroke
117360|NCT03469778|rehabilitation|rehabilitation
117361|NCT03469778|upper limb|upper limb
117362|NCT03469778|motor activity|motor activity
117363|NCT03469778|robotic|robotic
117364|NCT03469765|AKI|aki
117365|NCT03469752|Hispanic Latino families|hispanic latino families
117366|NCT03469739|Intimate Partner Violence|intimate partner violence
117367|NCT03469726|Liver metastases|liver metastases
117368|NCT03469726|Diffusion weighted MRI|diffusion weighted mri
117369|NCT03469674|Radiotherapy|radiotherapy
117370|NCT03469674|Vaginal brachytherapy|vaginal brachytherapy
117371|NCT03469674|Molecular risk factors|molecular risk factors
117372|NCT03469622|Adenoma|adenoma
117373|NCT03469622|Polyp|polyp
117374|NCT03469622|EndoRings|endorings
117375|NCT03469622|Colonoscopy|colonoscopy
117376|NCT03469622|Endoscopic device|endoscopic device
117377|NCT03469622|Colon cancer screening|colon cancer screening
117378|NCT03469609|infants|infants
117379|NCT03469609|necrotizing enterocolitis (NEC)|necrotizing enterocolitis (nec)
117380|NCT03469609|focal intestinal perforation (FIP)|focal intestinal perforation (fip)
117381|NCT03469609|enterostomy creation|enterostomy creation
117382|NCT03469609|bowel reanastomosis|bowel reanastomosis
117383|NCT03469609|enteral feeding|enteral feeding
117384|NCT03469609|caloric intake|caloric intake
117385|NCT03469609|parenteral nutrition|parenteral nutrition
117386|NCT03469609|complication rate|complication rate
117387|NCT03469609|reduction of hospital expenses|reduction of hospital expenses
117388|NCT03469609|length of hospital stay|length of hospital stay
117389|NCT03469570|Non-Cardiac|non-cardiac
117390|NCT03469570|Non-Thoracic|non-thoracic
117391|NCT03469570|Fluid Management|fluid management
117392|NCT03469570|Perioperative Goal Directed Therapy|perioperative goal directed therapy
117393|NCT03469531|Cervical Cancer|cervical cancer
117394|NCT03469531|Radiation Therapy|radiation therapy
117395|NCT03469531|Chemotherapy|chemotherapy
117396|NCT03469531|Nimotuzumab|nimotuzumab
117397|NCT03469531|Cisplatin|cisplatin
117398|NCT03469518|beta-cryptoxanthin|beta-cryptoxanthin
117399|NCT03469518|cholesterol|cholesterol
117400|NCT03469518|Galactooligosaccharides|galactooligosaccharides
117401|NCT03469518|Plant Sterols|plant sterols
117402|NCT03469518|Cardiovascular risk|cardiovascular risk
117403|NCT03469518|Bone Turnover markers|bone turnover markers
117404|NCT03469518|Intestinal Inflammatory markers|intestinal inflammatory markers
117405|NCT03469518|Microbiota|microbiota
117406|NCT03469479|Neoadjuvant hepatic arterial infusion chemotherapy|neoadjuvant hepatic arterial infusion chemotherapy
117407|NCT03469479|BCLC A/B|bclc a/b
117408|NCT03469479|FOLFOX|folfox
117409|NCT03469479|Resection|resection
117410|NCT03469453|GAD|gad
117411|NCT03469453|Adolescents|adolescents
117412|NCT03469453|Internet-delivered Cognitive behavioral therapy|internet-delivered cognitive behavioral therapy
117413|NCT03469453|ICBT|icbt
117414|NCT03469453|CBT|cbt
117415|NCT03469440|lactate|lactate
117416|NCT03469440|central venous saturation|central venous saturation
117417|NCT03469440|Pediatric Cardiac Surgery|pediatric cardiac surgery
117418|NCT03469388|EVAR, central pressure, arterial stiffness, AAA, elective surgery|evar, central pressure, arterial stiffness, aaa, elective surgery
117419|NCT03469375|FOLFIRINOX|folfirinox
117420|NCT03469375|Pancreatic cancer|pancreatic cancer
117421|NCT03469375|Conversion surgery|conversion surgery
117422|NCT03469375|Overall survival|overall survival
117423|NCT03469349|Drug Therapy|drug therapy
117424|NCT03469336|Psoriasis|psoriasis
117425|NCT03469336|Topical|topical
117426|NCT03469323|Nonintubated video-assisted thoracic surgery (VATS)|nonintubated video-assisted thoracic surgery (vats)
117427|NCT03469310|endocrine surgery|endocrine surgery
117428|NCT03469310|opioid addiction|opioid addiction
117429|NCT03469310|pain management|pain management
117430|NCT03469310|analgesia|analgesia
117431|NCT03469271|Pneumonia|pneumonia
117432|NCT03469258|Pancreatic Cancer|pancreatic cancer
117433|NCT03469245|Endovascular|endovascular
117434|NCT03469245|Fenestrated endovascular repair|fenestrated endovascular repair
117435|NCT03469245|numerical simulation|numerical simulation
117436|NCT03469219|granulysin|granulysin
117437|NCT03469193|knee unicompartmental prosthesis|knee unicompartmental prosthesis
117438|NCT03469193|KneeKG system|kneekg system
117439|NCT03469193|robotic-assisted|robotic-assisted
117440|NCT03469193|alignment|alignment
117441|NCT03469193|implants positioning|implants positioning
117442|NCT03469193|International Knee Society|international knee society
117443|NCT03469193|Forgotten joint score|forgotten joint score
117444|NCT03469180|Treadmill Training|treadmill training
117445|NCT03469180|Whole Body Vibration Training|whole body vibration training
117446|NCT03469167|Bleeding|bleeding
117447|NCT03469154|Layperson|layperson
117448|NCT03469154|Paediatric Basic life Support|paediatric basic life support
117449|NCT03469154|education|education
117450|NCT03469141|Wheelchair|wheelchair
117451|NCT03469141|Pressure Relief|pressure relief
117452|NCT03469141|Activity|activity
117453|NCT03469141|Monitor|monitor
117454|NCT03469128|PTSD|ptsd
117455|NCT03469128|CPT|cpt
117456|NCT03469128|SUD|sud
117457|NCT03469102|Positron emission tomography|positron emission tomography
117458|NCT03469102|Texture indices|texture indices
117459|NCT03469102|Diagnostic performance|diagnostic performance
117460|NCT03469089|schizophrenia|schizophrenia
117461|NCT03469089|cognitive symptom|cognitive symptom
117462|NCT03469089|healthy volunteer|healthy volunteer
117463|NCT03469089|cognitive testing|cognitive testing
117464|NCT03469076|Acne, Comedonal, Mild to Moderate Papulopustular Acne|acne, comedonal, mild to moderate papulopustular acne
117465|NCT03469050|Recurrent acute diverticulitis|recurrent acute diverticulitis
117466|NCT03469050|Prevention|prevention
117467|NCT03469050|Diverticular complications|diverticular complications
117468|NCT03469050|Rifaximin delayed release|rifaximin delayed release
117469|NCT03469050|Diverticulitis|diverticulitis
117470|NCT03469050|SIBO|sibo
117471|NCT03469037|Dyspnea, High flow nasal cannula|dyspnea, high flow nasal cannula
117472|NCT03469024|Low back pain|low back pain
117473|NCT03469024|Electroanalgesia|electroanalgesia
117474|NCT03469024|Exercise program|exercise program
117475|NCT03469024|Randomized clinical trial|randomized clinical trial
117476|NCT03468998|Bone allograft|bone allograft
117477|NCT03468998|Particle size|particle size
117478|NCT03468998|Ridge preservation|ridge preservation
117479|NCT03468998|Ridge augmentation|ridge augmentation
117480|NCT03468998|Socket grafting|socket grafting
117481|NCT03468998|Histology|histology
117482|NCT03468998|New bone|new bone
117483|NCT03468972|IgA nephropathy|iga nephropathy
117484|NCT03468972|immunosuppression|immunosuppression
117485|NCT03468946|taste perception|taste perception
117486|NCT03468946|caries risk|caries risk
117487|NCT03468946|cariogram|cariogram
117488|NCT03468946|children|children
117489|NCT03468907|hepatitis B virus|hepatitis b virus
117490|NCT03468907|exacerbation|exacerbation
117491|NCT03468907|antiviral agents|antiviral agents
117492|NCT03468907|pregnancy|pregnancy
117493|NCT03468907|flare|flare
117494|NCT03468894|prolonged sitting|prolonged sitting
117495|NCT03468894|sedentary behaviour|sedentary behaviour
117496|NCT03468894|physical activity|physical activity
117497|NCT03468894|office workplace|office workplace
117498|NCT03468868|Multiple sclerosis|multiple sclerosis
117499|NCT03468868|Exercise|exercise
117500|NCT03468868|Physical activity|physical activity
117501|NCT03468868|Telerehabilitation|telerehabilitation
117502|NCT03468868|Comparative effectiveness study|comparative effectiveness study
117503|NCT03468868|Social cognitive theory|social cognitive theory
117504|NCT03468868|Health behavior change|health behavior change
117505|NCT03468842|Streptococcus dentisani|streptococcus dentisani
117506|NCT03468842|caries|caries
117507|NCT03468842|salivary pH|salivary ph
117508|NCT03468842|S. mutans|s. mutans
117509|NCT03468764|anesthesia|anesthesia
117510|NCT03468764|hemodynamic management|hemodynamic management
117511|NCT03468764|lung recruitment maneuver|lung recruitment maneuver
117512|NCT03468764|hypovolemia|hypovolemia
117513|NCT03468751|Metastatic; Refractory; Cancer; Solid; Tumor|metastatic; refractory; cancer; solid; tumor
117514|NCT03468725|Transcranial magnetic stimulation|transcranial magnetic stimulation
117515|NCT03468712|mortality|mortality
117516|NCT03468712|morbidity|morbidity
117517|NCT03468712|neoadjuvant chemotherapy|neoadjuvant chemotherapy
117518|NCT03468712|laparoscopic gastrectomy|laparoscopic gastrectomy
117519|NCT03468712|gastric cancer|gastric cancer
117520|NCT03468699|Autologous bone marrow Transplantation|autologous bone marrow transplantation
117521|NCT03468699|biliary atresia|biliary atresia
117522|NCT03468699|Kasai's operation|kasai's operation
117523|NCT03468699|liver cirrhosis|liver cirrhosis
117524|NCT03468673|AIDS|aids
117525|NCT03468673|HCV|hcv
117526|NCT03468673|Questionnaire|questionnaire
117527|NCT03468673|Qualitative analysis|qualitative analysis
117528|NCT03468673|Sexual Quality of Life|sexual quality of life
117529|NCT03468673|Psychometric validation|psychometric validation
117530|NCT03468660|Accented speech perception|accented speech perception
117531|NCT03468647|frailty|frailty
117532|NCT03468647|tele-monitoring|tele-monitoring
117533|NCT03468647|self-management|self-management
117534|NCT03468634|endoscopy|endoscopy
117535|NCT03468634|Raman spectroscopy|raman spectroscopy
117536|NCT03468621|woundclosure|woundclosure
117537|NCT03468621|technique|technique
117538|NCT03468621|surgical|surgical
117539|NCT03468621|site|site
117540|NCT03468621|infection|infection
117541|NCT03468621|intrademal|intrademal
117542|NCT03468621|transdermal|transdermal
117544|NCT03468608|procedural sedation|procedural sedation
117545|NCT03468608|paediatric|paediatric
117546|NCT03468608|parental satisfaction|parental satisfaction
117547|NCT03468595|Listerine, CHX|listerine, chx
117548|NCT03468569|Athletic Performance|athletic performance
117549|NCT03468569|Functional Movement Screen|functional movement screen
117550|NCT03468569|Handball Athletes|handball athletes
117551|NCT03468569|Injury Prevention|injury prevention
117552|NCT03468569|Injury History|injury history
117553|NCT03468517|General Anaesthesia|general anaesthesia
117554|NCT03468517|Preoperative Anxiety|preoperative anxiety
117555|NCT03468517|BATHE method|bathe method
117556|NCT03468465|Hyperactive Bladder Syndrome|hyperactive bladder syndrome
117557|NCT03468439|nerve block|nerve block
117558|NCT03468413|CP1050|cp1050
117559|NCT03468413|Phase 1|phase 1
117560|NCT03468413|Healthy subjects|healthy subjects
117561|NCT03468400|sleep disorders|sleep disorders
117562|NCT03468400|assessment|assessment
117563|NCT03468400|diagnosis|diagnosis
117564|NCT03468348|duloxetine|duloxetine
117565|NCT03468348|mastectomy|mastectomy
117566|NCT03468348|postoperative pain|postoperative pain
117567|NCT03468335|Second-line therapy|second-line therapy
117568|NCT03468335|Nal-IRI|nal-iri
117569|NCT03468335|failure gemcitabine/nab-paclitaxel|failure gemcitabine/nab-paclitaxel
117570|NCT03468335|predictive role of 1st-line therapy|predictive role of 1st-line therapy
117571|NCT03468309|polypharmacy|polypharmacy
117572|NCT03468309|drug interactions|drug interactions
117573|NCT03468309|DNA testing|dna testing
117574|NCT03468309|mental health diagnosis|mental health diagnosis
117575|NCT03468309|drug side effects|drug side effects
117576|NCT03468309|presciption treatment plans|presciption treatment plans
117577|NCT03468309|mental health medication treatment plans|mental health medication treatment plans
117578|NCT03468296|age-related macular degeneration|age-related macular degeneration
117579|NCT03468283|Mobile healthcare|mobile healthcare
117580|NCT03468283|Health Services Research|health services research
117581|NCT03468283|Community Health Services|community health services
117582|NCT03468283|Diabetes self-management education|diabetes self-management education
117583|NCT03468231|Hepatocellular Carcinoma|hepatocellular carcinoma
117584|NCT03468231|Hepatic arterial infusion chemotherapy|hepatic arterial infusion chemotherapy
117585|NCT03468231|Sorafenib|sorafenib
117586|NCT03468231|Oxaliplatin plus Fluorouracil/Leucovorin|oxaliplatin plus fluorouracil/leucovorin
117587|NCT03468231|Oxaliplatin|oxaliplatin
117588|NCT03468205|breathlessness|breathlessness
117589|NCT03468205|dyspnea|dyspnea
117590|NCT03468205|measurement|measurement
117591|NCT03468179|Diet|diet
117592|NCT03468179|N-acyl-phosphatidylethanolamine|n-acyl-phosphatidylethanolamine
117593|NCT03468179|N-acyl-ethanolamine|n-acyl-ethanolamine
117594|NCT03468179|NAPE|nape
117595|NCT03468179|NAE|nae
117596|NCT03468179|Oatmeal|oatmeal
117597|NCT03468166|Motor function|motor function
117598|NCT03468166|Gait pattern|gait pattern
117599|NCT03468127|Soy protein|soy protein
117600|NCT03468127|LDL-Cholesterol|ldl-cholesterol
117601|NCT03468127|Total Cholesterol|total cholesterol
117602|NCT03468127|Cardiovascular disease|cardiovascular disease
117603|NCT03468101|COPD|copd
117604|NCT03468101|Dairy farmers|dairy farmers
117605|NCT03468101|Exposure Occupational|exposure occupational
117606|NCT03468101|FEV1|fev1
117607|NCT03468075|Sarcoma|sarcoma
117608|NCT03468075|Soft tissue|soft tissue
117609|NCT03468075|Ascorbate|ascorbate
117610|NCT03468036|critical illness|critical illness
117611|NCT03468036|ICU|icu
117612|NCT03468036|extubation|extubation
117613|NCT03468036|respiratory failure|respiratory failure
117614|NCT03468023|Cast treatment|cast treatment
117615|NCT03468023|above-elbow cast|above-elbow cast
117616|NCT03468023|below-elbow cast|below-elbow cast
117617|NCT03468023|long arm cast|long arm cast
117618|NCT03468023|short arm cast|short arm cast
117619|NCT03467971|Metformin|metformin
117620|NCT03467971|Bioavailability|bioavailability
117621|NCT03467971|Food effect|food effect
117622|NCT03467971|Pharmacokinetics|pharmacokinetics
117623|NCT03467958|Crohn's Disease|crohn's disease
117624|NCT03467958|Crohn Disease|crohn disease
117625|NCT03467958|Oral|oral
117626|NCT03467958|Ozanimod|ozanimod
117627|NCT03467958|Moderately active|moderately active
117628|NCT03467958|Severely active|severely active
117629|NCT03467958|RPC01|rpc01
117630|NCT03467958|RPC01-3204|rpc01-3204
117631|NCT03467945|Metformin|metformin
117632|NCT03467945|Gliclazide|gliclazide
117633|NCT03467945|Bioequivalence|bioequivalence
117634|NCT03467945|Drug-drug Interaction|drug-drug interaction
117635|NCT03467945|Pharmacokinetics|pharmacokinetics
117636|NCT03467919|osteoarthritis|osteoarthritis
117637|NCT03467919|stem cell|stem cell
117638|NCT03467919|knee pain|knee pain
117639|NCT03467919|adipose derived stem cell|adipose derived stem cell
117640|NCT03467919|injection|injection
117641|NCT03467906|Diet|diet
117642|NCT03467906|Dietary Habits|dietary habits
117643|NCT03467906|Weight changes|weight changes
117644|NCT03467880|Impulse Oscillometry|impulse oscillometry
117645|NCT03467880|Chinese|chinese
117646|NCT03467880|Healthy Subjects|healthy subjects
117647|NCT03467880|Chronic Obstructive Pulmonary Disease|chronic obstructive pulmonary disease
117648|NCT03467880|Asthma|asthma
117649|NCT03467880|Interstitial Lung Disease|interstitial lung disease
117650|NCT03467880|Upper Airway Obstruction|upper airway obstruction
117651|NCT03467880|Reference Values|reference values
117652|NCT03467867|Chronic Lymphocytic Leukemia|chronic lymphocytic leukemia
117653|NCT03467867|Leukemia|leukemia
117654|NCT03467867|Venetoclax|venetoclax
117655|NCT03467867|Rituximab|rituximab
117656|NCT03467867|Lymphoid|lymphoid
117657|NCT03467867|Lymphoproliferative Disorders|lymphoproliferative disorders
117658|NCT03467867|Antineoplastic Agents|antineoplastic agents
117659|NCT03467867|Neoplasm|neoplasm
117660|NCT03467854|ECMO|ecmo
117661|NCT03467854|Antimicrobials|antimicrobials
117662|NCT03467815|Wireless monitoring|wireless monitoring
117663|NCT03467815|Continuous monitoring|continuous monitoring
117664|NCT03467815|Vital parameters|vital parameters
117665|NCT03467815|Clinical deterioration|clinical deterioration
117666|NCT03467802|Gingival Recession|gingival recession
117667|NCT03467802|Enamel Matrix Derivative|enamel matrix derivative
117668|NCT03467802|Porcine Collagen Matrix|porcine collagen matrix
117669|NCT03467789|Vitamin D|vitamin d
117670|NCT03467789|Photodynamic Therapy|photodynamic therapy
117671|NCT03467776|infants|infants
117672|NCT03467776|asthma|asthma
117673|NCT03467776|bronchial dilation test|bronchial dilation test
117674|NCT03467776|plethysmography|plethysmography
117675|NCT03467750|Adenotonsillectomy|adenotonsillectomy
117676|NCT03467750|Opioids|opioids
117677|NCT03467750|Post-surgical pain|post-surgical pain
117678|NCT03467750|Anesthesiology|anesthesiology
117679|NCT03467750|Pediatrics|pediatrics
117680|NCT03467724|Fractional Radiofrequency|fractional radiofrequency
117681|NCT03467698|Aging|aging
117682|NCT03467698|Memory|memory
117683|NCT03467698|Associative learning|associative learning
117684|NCT03467698|transcranial direct current stimulation|transcranial direct current stimulation
117685|NCT03467581|gastric sleeve|gastric sleeve
117686|NCT03467568|Mood Salt|mood salt
117687|NCT03467542|Fistula|fistula
117688|NCT03467542|Intracranial|intracranial
117689|NCT03467542|Dural|dural
117690|NCT03467542|Arteriovenous|arteriovenous
117691|NCT03467542|Liquid Embolic|liquid embolic
117692|NCT03467529|Superficial esophageal cancer|superficial esophageal cancer
117693|NCT03467529|Squamous cell cancer|squamous cell cancer
117694|NCT03467529|Mini invasive imaging|mini invasive imaging
117695|NCT03467529|Pre therapeutic assessment|pre therapeutic assessment
117696|NCT03467529|Optical coherence tomography|optical coherence tomography
117697|NCT03467516|Metastatic Uveal Melanoma|metastatic uveal melanoma
117698|NCT03467516|Uveal Diseases|uveal diseases
117699|NCT03467516|Melanoma|melanoma
117700|NCT03467464|Autism, EMDR; Children|autism, emdr; children
117701|NCT03467438|heartburn|heartburn
117702|NCT03467438|pyrosis|pyrosis
117703|NCT03467438|regurgitation|regurgitation
117704|NCT03467425|FF/VI/UMEC|ff/vi/umec
117705|NCT03467425|TRELEGY ELLIPTA|trelegy ellipta
117706|NCT03467425|COPD|copd
117707|NCT03467425|Effectiveness|effectiveness
117708|NCT03467347|Healthy Women|healthy women
117709|NCT03467347|Contraception|contraception
117710|NCT03467347|Vaginal Ring|vaginal ring
117711|NCT03467347|dapivirine|dapivirine
117712|NCT03467347|Levonorgestrel|levonorgestrel
117713|NCT03467334|Infant colic|infant colic
117714|NCT03467334|Bifidobacterium breve|bifidobacterium breve
117715|NCT03467334|Lactobacillus fermentum|lactobacillus fermentum
117716|NCT03467308|colorectal cancer|colorectal cancer
117717|NCT03467308|TIGAR|tigar
117718|NCT03467308|TRIM59|trim59
117719|NCT03467295|Cavernous Malformations, treatment.|cavernous malformations, treatment.
117720|NCT03467243|schizophrenia|schizophrenia
117721|NCT03467243|Veterans|veterans
117722|NCT03467243|depression|depression
117723|NCT03467243|peer specialist|peer specialist
117724|NCT03467243|social skills training|social skills training
117725|NCT03467217|Losartan|losartan
117726|NCT03467217|Nonalcoholic Fatty Liver Disease|nonalcoholic fatty liver disease
117727|NCT03467165|MRgFUS|mrgfus
117728|NCT03467165|Pain|pain
117729|NCT03467165|Hip|hip
117730|NCT03467165|Trapeziometacarpal joint|trapeziometacarpal joint
117731|NCT03467165|Osteoarthritis|osteoarthritis
117732|NCT03467152|E2027|e2027
117733|NCT03467152|Montreal Cognitive Assessment|montreal cognitive assessment
117734|NCT03467152|Neuropsychiatric Inventory|neuropsychiatric inventory
117735|NCT03467152|Mini-Mental State Examination|mini-mental state examination
117736|NCT03467152|Cognitive Fluctuation Inventory|cognitive fluctuation inventory
117737|NCT03467139|Adhesive Capsulitis|adhesive capsulitis
117738|NCT03467139|Breathing exercises|breathing exercises
117739|NCT03467139|Pain|pain
117740|NCT03467139|Sleep quality|sleep quality
117741|NCT03467139|Quality of life|quality of life
117742|NCT03467113|Dravet Syndrome|dravet syndrome
117743|NCT03467113|LGS|lgs
117744|NCT03467087|Stem cell transplantation|stem cell transplantation
117745|NCT03467087|Chemotherapy|chemotherapy
117746|NCT03467087|Rehabilitation|rehabilitation
117747|NCT03467087|Electrical muscle stimulation|electrical muscle stimulation
117748|NCT03467022|alcohol withdrawal|alcohol withdrawal
117749|NCT03467022|scurvy|scurvy
117750|NCT03467022|vitamin C|vitamin c
117751|NCT03467022|tiredness|tiredness
117752|NCT03467009|cyber-victimization|cyber-victimization
117753|NCT03467009|text message|text message
117754|NCT03467009|mhealth|mhealth
117755|NCT03466996|Transition to adult care|transition to adult care
117756|NCT03466996|Telemedicine|telemedicine
117757|NCT03466996|Myelomeningocele|myelomeningocele
117758|NCT03466957|image guided brachytherapy|image guided brachytherapy
117759|NCT03466957|3D print|3d print
117760|NCT03466957|gynecological cancer|gynecological cancer
117761|NCT03466944|Magnetic Resonance Imaging (MRI)|magnetic resonance imaging (mri)
117762|NCT03466944|Leukaemia|leukaemia
117763|NCT03466944|Whole-Body DiffusionWeighted-Magnetic Resonance Imaging (WB DW-MRI)|whole-body diffusionweighted-magnetic resonance imaging (wb dw-mri)
117764|NCT03466944|Paediatrics|paediatrics
117765|NCT03466918|TAVI|tavi
117766|NCT03466918|TAVR|tavr
117767|NCT03466918|CHINA|china
117768|NCT03466918|SAPIEN 3|sapien 3
117769|NCT03466918|High Risk|high risk
117770|NCT03466918|Transcatheter aortic valve implantation|transcatheter aortic valve implantation
117771|NCT03466918|Transcatheter aortic valve replacement|transcatheter aortic valve replacement
117772|NCT03466892|Repetitive Negative Thinking|repetitive negative thinking
117773|NCT03466892|Rumination|rumination
117774|NCT03466892|Fibromyalgia|fibromyalgia
117775|NCT03466892|Chronic pain|chronic pain
117776|NCT03466892|Attentional Bias|attentional bias
117777|NCT03466840|Ridge Augmentation|ridge augmentation
117778|NCT03466840|Titanium mesh|titanium mesh
117779|NCT03466840|Flap advancement|flap advancement
117780|NCT03466801|prednisone alone|prednisone alone
117781|NCT03466801|methylprednisolone and cyclophosphamide|methylprednisolone and cyclophosphamide
117782|NCT03466801|membranous nephropathy in stage I|membranous nephropathy in stage i
117783|NCT03466775|Kidney transplantation|kidney transplantation
117784|NCT03466775|Allograft rejection|allograft rejection
117785|NCT03466775|Allograft survival|allograft survival
117786|NCT03466775|Anti-angiotensin II type 1 receptor antibody|anti-angiotensin ii type 1 receptor antibody
117787|NCT03466762|Quality of life|quality of life
117788|NCT03466762|Resilience|resilience
117789|NCT03466762|Cancer Survivors|cancer survivors
117790|NCT03466762|Life Satisfaction|life satisfaction
117791|NCT03466762|Post-Cancer Depression|post-cancer depression
117792|NCT03466762|Coping|coping
117793|NCT03466749|Coronary Disease|coronary disease
117794|NCT03466749|Drug eluting balloon|drug eluting balloon
117795|NCT03466749|De-novo lesions|de-novo lesions
117796|NCT03466736|practice effects|practice effects
117797|NCT03466736|amyloid imaging|amyloid imaging
117798|NCT03466710|Colposcopy|colposcopy
117799|NCT03466710|Uterine cervical neoplasm|uterine cervical neoplasm
117801|NCT03466710|Pap|pap
117802|NCT03466684|Trauma|trauma
117803|NCT03466684|Open abdomen|open abdomen
117804|NCT03466684|Fluid resuscitation|fluid resuscitation
117805|NCT03466684|Fascial closure|fascial closure
117806|NCT03466684|Bioelectrical impedance analysis|bioelectrical impedance analysis
117807|NCT03466645|SSI|ssi
117808|NCT03466645|elective Craniotomy|elective craniotomy
117809|NCT03466645|Vancomycin|vancomycin
117810|NCT03466645|Cefazolin|cefazolin
117811|NCT03466645|Antibiotic|antibiotic
117812|NCT03466593|Prehabilitation|prehabilitation
117813|NCT03466593|Recovery|recovery
117814|NCT03466593|Complications|complications
117815|NCT03466580|Caregivers|caregivers
117816|NCT03466580|Support needs|support needs
117817|NCT03466580|Intervention|intervention
117818|NCT03466580|Randomised controlled trial|randomised controlled trial
117819|NCT03466541|Alcohol consumption|alcohol consumption
117820|NCT03466541|Sick leave|sick leave
117821|NCT03466541|Workplace interventions|workplace interventions
117822|NCT03466541|Presenteeism|presenteeism
117823|NCT03466515|stem cells therapy|stem cells therapy
117824|NCT03466502|vancomycin|vancomycin
117825|NCT03466502|Clostridium difficile|clostridium difficile
117826|NCT03466502|Clostridium difficile infection|clostridium difficile infection
117827|NCT03466502|Recurrent Clostridium difficile infection|recurrent clostridium difficile infection
150556|NCT03258814|pain|pain
117828|NCT03466489|total joint arthroplasty|total joint arthroplasty
117829|NCT03466476|Wearable Technology|wearable technology
117830|NCT03466476|Total Knee Arthroplasty|total knee arthroplasty
117831|NCT03466463|Crigler-Najjar|crigler-najjar
117832|NCT03466463|Adeno Associated Virus|adeno associated virus
117833|NCT03466450|glioblastoma|glioblastoma
117834|NCT03466450|glasdegib|glasdegib
117835|NCT03466450|temozolomide|temozolomide
117836|NCT03466450|combined therapy|combined therapy
117837|NCT03466424|Short-course radiotherapy|short-course radiotherapy
117838|NCT03466424|dose escalation|dose escalation
117839|NCT03466424|neo-adjuvant chemotherapy|neo-adjuvant chemotherapy
117840|NCT03466424|mFOLFOX6|mfolfox6
117841|NCT03466424|rectal cancer|rectal cancer
117842|NCT03466424|Phase I trial|phase i trial
117843|NCT03466398|Remote Patient Monitoring|remote patient monitoring
117844|NCT03466398|Adolescents|adolescents
117845|NCT03466385|Non-invasive ventilation|non-invasive ventilation
117846|NCT03466385|Nasal High Flow|nasal high flow
117847|NCT03466372|gait biofeedback|gait biofeedback
117848|NCT03466372|gait rehabilitation|gait rehabilitation
117849|NCT03466372|paretic propulsion|paretic propulsion
117850|NCT03466372|gait motor learning|gait motor learning
117851|NCT03466359|appetite control|appetite control
117852|NCT03466359|obesity|obesity
117853|NCT03466359|Adolescents|adolescents
117854|NCT03466359|Physical activity|physical activity
117855|NCT03466333|preterm pre-eclampsia|preterm pre-eclampsia
117856|NCT03466333|cardiovascular dysfunction|cardiovascular dysfunction
117857|NCT03466307|Nocturnal pain|nocturnal pain
117858|NCT03466307|shoulder pain|shoulder pain
117859|NCT03466307|ultrasonography|ultrasonography
117860|NCT03466307|resistive index|resistive index
117861|NCT03466307|quality of life|quality of life
117862|NCT03466307|anterior circumflex humeral artery|anterior circumflex humeral artery
117863|NCT03466294|Azacitidine|azacitidine
117864|NCT03466294|Venetoclax|venetoclax
117865|NCT03466294|AML|aml
117866|NCT03466268|Safety|safety
117867|NCT03466268|Tolerability|tolerability
117868|NCT03466268|Pharmacokinetics|pharmacokinetics
117869|NCT03466268|Anti-tumor activity|anti-tumor activity
117870|NCT03466242|intranasal dexmedetomidine|intranasal dexmedetomidine
117871|NCT03466229|sperm DNA strand breaks|sperm dna strand breaks
117872|NCT03466229|antioxidants|antioxidants
117873|NCT03466216|somatostatin receptor|somatostatin receptor
117874|NCT03466203|obesity|obesity
117875|NCT03466203|hypertriglyceridemia|hypertriglyceridemia
118268|NCT03463967|adolescents|adolescents
117885|NCT03466151|Late Lumen Loss (LLL)|late lumen loss (lll)
117886|NCT03466151|Target Lesion Revascularization (TLR)|target lesion revascularization (tlr)
117887|NCT03466151|Target Vessel Revascularization (TVR)|target vessel revascularization (tvr)
117888|NCT03466151|Target Vessel Failure (TVF)|target vessel failure (tvf)
117889|NCT03466151|Target Lesion Failure (TLF)|target lesion failure (tlf)
117890|NCT03466151|Stent Thrombosis (ST)|stent thrombosis (st)
117891|NCT03466151|The Randomized Controlled Trial|the randomized controlled trial
117892|NCT03466151|PERCUTANEOUS CORONARY INTERVENTION (PCI)|percutaneous coronary intervention (pci)
117894|NCT03466073|recombinant human plasma gelsolin (rhu-pGSN)|recombinant human plasma gelsolin (rhu-pgsn)
117895|NCT03466073|severe community-acquired pneumonia (sCAP)|severe community-acquired pneumonia (scap)
117896|NCT03466073|adjunctive therapy|adjunctive therapy
117897|NCT03466034|TP53|tp53
117898|NCT03466034|Hypoxia|hypoxia
117899|NCT03466034|Endometriod and Mucinous Carcinomas|endometriod and mucinous carcinomas
117900|NCT03466034|Serous and Clear Cell Carcinomas|serous and clear cell carcinomas
117901|NCT03466034|Magnetic Resonance Imaging, MRI|magnetic resonance imaging, mri
117902|NCT03466021|GLP-1 receptor agonist|glp-1 receptor agonist
117903|NCT03466021|Chronic obstructive pulmonary disease|chronic obstructive pulmonary disease
117904|NCT03466021|FDG/PET-CT|fdg/pet-ct
117905|NCT03466021|inflammation|inflammation
117906|NCT03466021|weightloss|weightloss
117907|NCT03466021|quality of life|quality of life
117908|NCT03466008|whole body cryotherapy|whole body cryotherapy
117909|NCT03466008|fibromyalgia|fibromyalgia
117910|NCT03466008|chronic pain|chronic pain
117911|NCT03466008|quality of life|quality of life
117912|NCT03466008|perceived health|perceived health
117913|NCT03465982|rectal cancer|rectal cancer
117914|NCT03465982|robotic rectal cancer resection|robotic rectal cancer resection
117915|NCT03465982|minimally invasive surgery|minimally invasive surgery
117916|NCT03465982|Colorectal Cancer|colorectal cancer
117917|NCT03465982|chemoradiation treatment rectal cancer|chemoradiation treatment rectal cancer
117918|NCT03465969|Kidney transplantation|kidney transplantation
117919|NCT03465969|A Bioanalytical Method Cross-validation|a bioanalytical method cross-validation
117920|NCT03465969|Advagraf|advagraf
117921|NCT03465969|Liver transplantation|liver transplantation
117922|NCT03465930|Lymphedema|lymphedema
117923|NCT03465930|Lymphatic collecting vessels|lymphatic collecting vessels
117924|NCT03465930|Supermicrosurgery|supermicrosurgery
117925|NCT03465930|Lymphatic-venous anastomoses|lymphatic-venous anastomoses
117926|NCT03465930|Immunohistochemistry|immunohistochemistry
117927|NCT03465891|Advanced Stage Follicular Lymphoma|advanced stage follicular lymphoma
117928|NCT03465891|Relapsed|relapsed
117929|NCT03465891|Refractory|refractory
117930|NCT03465891|Atezolizumab|atezolizumab
117931|NCT03465891|Dose Local Radiotherapy (2 x 2Gy)|dose local radiotherapy (2 x 2gy)
117932|NCT03465891|17-360|17-360
117933|NCT03465800|overweight|overweight
117934|NCT03465800|obesity|obesity
117935|NCT03465800|physical activity|physical activity
117936|NCT03465800|exercise|exercise
117937|NCT03465787|Schizophrenia|schizophrenia
117938|NCT03465787|Acutely Psychotic Patients with Schizophrenia|acutely psychotic patients with schizophrenia
117939|NCT03465787|Latuda|latuda
117940|NCT03465787|Lurasidone|lurasidone
117941|NCT03465761|MRgFUS|mrgfus
117942|NCT03465761|ExAblate|exablate
117943|NCT03465761|Bilateral Essential Tremor|bilateral essential tremor
117944|NCT03465735|Deep|deep
117945|NCT03465735|Pulmonary|pulmonary
117946|NCT03465735|Venous|venous
117947|NCT03465735|Vascular|vascular
117948|NCT03465735|Post|post
117949|NCT03465735|Vein|vein
117950|NCT03465735|Thrombosis|thrombosis
117951|NCT03465735|Embolism|embolism
117952|NCT03465735|Thromboembolism|thromboembolism
117953|NCT03465735|Thrombotic|thrombotic
117954|NCT03465735|Syndrome|syndrome
118067|NCT03465267|stroke rehabilitation|stroke rehabilitation
117996|NCT03465631|stroke rehabilitation|stroke rehabilitation
117997|NCT03465618|89Zr-cRGDY Ultrasmall Silica Particle Tracers|89zr-crgdy ultrasmall silica particle tracers
117998|NCT03465618|Pet Scan|pet scan
117999|NCT03465618|17-599|17-599
118000|NCT03465579|Diagnosis Prostate Cancer|diagnosis prostate cancer
118001|NCT03465579|TNM staging|tnm staging
118002|NCT03465579|68Ga-PSMA PET/CT guided prostate biopsy|68ga-psma pet/ct guided prostate biopsy
118003|NCT03465579|mp-3TMRI guided prostate biopsy|mp-3tmri guided prostate biopsy
118004|NCT03465579|pre-surgical staging|pre-surgical staging
118005|NCT03465579|clinically-suspected prostate cancer|clinically-suspected prostate cancer
118006|NCT03465566|Emotion|emotion
118007|NCT03465566|Social cognition|social cognition
118008|NCT03465566|Childhood epilepsy|childhood epilepsy
118009|NCT03465553|palliative care|palliative care
118010|NCT03465553|thoracic cancer|thoracic cancer
118011|NCT03465553|radiotherapy|radiotherapy
118012|NCT03465553|pain|pain
118013|NCT03465553|quality of life|quality of life
118014|NCT03465540|Multiple Myeloma|multiple myeloma
118015|NCT03465540|Non-Hodgkin's Lymphoma|non-hodgkin's lymphoma
118016|NCT03465540|Acute Myeloid Leukemia|acute myeloid leukemia
118017|NCT03465540|AML|aml
118018|NCT03465540|NHL|nhl
118019|NCT03465540|MM|mm
118020|NCT03465540|DLBCL|dlbcl
118021|NCT03465540|Myeloid Cell Leukemia 1 Inhibitor|myeloid cell leukemia 1 inhibitor
118022|NCT03465540|MCL1 Inhibitor|mcl1 inhibitor
118023|NCT03465540|MCL1|mcl1
118024|NCT03465501|Anal Canal Cancer|anal canal cancer
118025|NCT03465501|brachytherapy|brachytherapy
118026|NCT03465488|parasitology|parasitology
118027|NCT03465488|helminth infections|helminth infections
118028|NCT03465488|diagnosis|diagnosis
118029|NCT03465488|drug resistance|drug resistance
118030|NCT03465488|albendazole|albendazole
118031|NCT03465488|benzimidazole drugs|benzimidazole drugs
118032|NCT03465488|Ascaris|ascaris
118033|NCT03465488|Trichuris|trichuris
118034|NCT03465488|hookworm|hookworm
118035|NCT03465488|qPCR|qpcr
118036|NCT03465488|microscopy|microscopy
118037|NCT03465475|Low flow anesthesia|low flow anesthesia
118038|NCT03465475|Desflurane|desflurane
118039|NCT03465475|Cost analysis|cost analysis
118040|NCT03465462|hypertension,|hypertension,
118041|NCT03465462|zinc|zinc
118042|NCT03465462|zinc supplementation|zinc supplementation
118043|NCT03465462|antihypertensive monotherapy|antihypertensive monotherapy
118044|NCT03465462|mineral status|mineral status
118045|NCT03465384|Parent-Child relations|parent-child relations
118046|NCT03465384|Parenting|parenting
118047|NCT03465384|Non-inferiority trial|non-inferiority trial
118048|NCT03465384|Externalizing behaviors|externalizing behaviors
118049|NCT03465384|Randomized controlled trial|randomized controlled trial
118050|NCT03465384|Cost-effectiveness|cost-effectiveness
118051|NCT03465332|blood eosinophil count|blood eosinophil count
118052|NCT03465332|COPD|copd
118053|NCT03465332|diagnostic test|diagnostic test
118054|NCT03465332|doctor's questionnaire|doctor's questionnaire
118055|NCT03465332|Lung specialist|lung specialist
118056|NCT03465319|oxygen concentration|oxygen concentration
118057|NCT03465319|volatile anesthetics concentration|volatile anesthetics concentration
118058|NCT03465319|prediction model|prediction model
118059|NCT03465306|Obesity|obesity
118060|NCT03465306|Cognitive Behavioral Therapy|cognitive behavioral therapy
118061|NCT03465293|Symptomatic diverticulosis|symptomatic diverticulosis
118062|NCT03465293|Microbiota|microbiota
118063|NCT03465293|Bowel preparation|bowel preparation
118064|NCT03465280|Recurrent respiratory papillomatosis|recurrent respiratory papillomatosis
118065|NCT03465267|stroke|stroke
118066|NCT03465267|upper extremity rehabilitation robot|upper extremity rehabilitation robot
118068|NCT03465241|Non-Small Cell Lung Cancer|non-small cell lung cancer
118069|NCT03465241|stage II to IIIA|stage ii to iiia
118070|NCT03465241|circulating tumor DNA|circulating tumor dna
118071|NCT03465241|The next generation of high-throughput gene sequencing|the next generation of high-throughput gene sequencing
118072|NCT03465228|Low Back Pain|low back pain
118073|NCT03465228|Photobiomodulation|photobiomodulation
118074|NCT03465228|Deep Water Running|deep water running
118075|NCT03465228|Training|training
118076|NCT03465228|Running|running
118077|NCT03465202|Capecitabine|capecitabine
118078|NCT03465202|Pharmacokinetics|pharmacokinetics
118079|NCT03465202|Ageing|ageing
118080|NCT03465202|Frailty|frailty
118081|NCT03465202|Breast cancer|breast cancer
118082|NCT03465202|Colorectal cancer|colorectal cancer
118083|NCT03465176|aromatherapy|aromatherapy
118084|NCT03465176|fatigue|fatigue
118085|NCT03465176|hypothyroidism|hypothyroidism
118086|NCT03465176|essential oils|essential oils
118087|NCT03465150|Acne|acne
118088|NCT03465150|Cohort|cohort
118089|NCT03465150|prospective|prospective
118090|NCT03465150|risk factors|risk factors
118091|NCT03465137|Exposure therapy|exposure therapy
118092|NCT03465137|Behavioral therapy|behavioral therapy
118093|NCT03465137|fMRI|fmri
118094|NCT03465137|Extinction learning|extinction learning
118095|NCT03465137|Social anxiety|social anxiety
118096|NCT03465111|Scleritis|scleritis
118097|NCT03465111|anterior|anterior
118098|NCT03465111|adrenocorticotropic hormone|adrenocorticotropic hormone
118099|NCT03465111|ACTH|acth
118100|NCT03465111|Non-infectious|non-infectious
118101|NCT03465098|Infective endocarditis|infective endocarditis
118102|NCT03465098|PET/CT 18F-FDG|pet/ct 18f-fdg
118103|NCT03465098|Low carbohydrate diet as Atkins diet|low carbohydrate diet as atkins diet
118104|NCT03465085|ARDS|ards
118105|NCT03465085|Streptokinase|streptokinase
118106|NCT03465085|Heparin|heparin
118107|NCT03465085|Nebulization|nebulization
118108|NCT03465085|Inhaled Thrombolytics|inhaled thrombolytics
118109|NCT03465085|Inhaled Anticoagulation|inhaled anticoagulation
118110|NCT03465059|BGB-3111|bgb-3111
118111|NCT03465059|Zanubrutinib|zanubrutinib
118112|NCT03465059|pharmacokinetics|pharmacokinetics
118113|NCT03465059|healthy subjects|healthy subjects
118114|NCT03465059|hepatic impairment|hepatic impairment
118115|NCT03465046|infantile hemiplegia|infantile hemiplegia
118116|NCT03465046|upper extremity|upper extremity
118117|NCT03465046|physical therapy|physical therapy
118118|NCT03465033|Orthognathic surgery|orthognathic surgery
118119|NCT03465033|Jaw rehabilitation|jaw rehabilitation
118120|NCT03465033|Jaw Physiotherapy|jaw physiotherapy
118121|NCT03465033|Pain|pain
118122|NCT03465033|Mandibular range of motion|mandibular range of motion
118123|NCT03465033|Sensorial disturbance|sensorial disturbance
118124|NCT03465020|Idiopathic|idiopathic
118125|NCT03465020|Thrombocytopenic|thrombocytopenic
118126|NCT03465020|Purpura|purpura
118127|NCT03465007|hemodialysis|hemodialysis
118128|NCT03465007|cortisol|cortisol
118129|NCT03465007|Hydrocortisone|hydrocortisone
118130|NCT03464994|Hereditary ichthyosis|hereditary ichthyosis
118131|NCT03464994|keratoconus|keratoconus
118132|NCT03464968|second line|second line
118133|NCT03464968|FOLFOX|folfox
118134|NCT03464968|FOLFIRI|folfiri
118135|NCT03464916|CAR2 Anti-CD38 A2 CAR-T Cells|car2 anti-cd38 a2 car-t cells
118136|NCT03464903|amyotrophic lateral sclerosis|amyotrophic lateral sclerosis
118137|NCT03464903|progressive muscular atrophy|progressive muscular atrophy
118138|NCT03464903|motor neuron disease|motor neuron disease
118139|NCT03464903|ALS reversals|als reversals
118140|NCT03464903|whole genome sequencing|whole genome sequencing
118141|NCT03464851|carotid artery stenosis|carotid artery stenosis
118142|NCT03464851|plaque|plaque
118143|NCT03464851|carotid duplex|carotid duplex
118144|NCT03464851|ultrasound|ultrasound
118145|NCT03464851|fibromsucular dysplasia|fibromsucular dysplasia
118146|NCT03464851|carotid atherosclerosis|carotid atherosclerosis
118147|NCT03464812|Diabetes education|diabetes education
118148|NCT03464812|Psychosocial management of diabetes|psychosocial management of diabetes
118149|NCT03464747|Lactic Acid|lactic acid
118150|NCT03464708|Critical illness|critical illness
118151|NCT03464708|HMB|hmb
118152|NCT03464708|Nutrition|nutrition
118153|NCT03464708|Muscle wasting|muscle wasting
118154|NCT03464708|Recovery|recovery
118155|NCT03464695|closed-loop|closed-loop
118156|NCT03464695|oxygen treatment|oxygen treatment
118157|NCT03464656|semen|semen
118158|NCT03464656|male infertility|male infertility
118159|NCT03464656|semen quality|semen quality
118160|NCT03464656|sperm DNA fragmentation|sperm dna fragmentation
118161|NCT03464656|oxidation reduction potential|oxidation reduction potential
118162|NCT03464565|Large Vessel Occlusion|large vessel occlusion
118163|NCT03464565|Acute Ischemic Stroke|acute ischemic stroke
118164|NCT03464565|Mechanical Thrombectomy|mechanical thrombectomy
118165|NCT03464565|Penumbra System|penumbra system
118166|NCT03464565|3D Revascularization|3d revascularization
712669|NCT00579215|Enhanced Care|enhanced care
118167|NCT03464552|colposcopy - colposcopic directed biopsy - celecoxib|colposcopy - colposcopic directed biopsy - celecoxib
118267|NCT03463967|children|children
118168|NCT03464448|Teriflunomide|teriflunomide
118169|NCT03464448|B cell|b cell
118170|NCT03464448|T cell|t cell
118171|NCT03464448|cytokines|cytokines
118172|NCT03464435|Refractory Vernal Keratoconjunctivitis|refractory vernal keratoconjunctivitis
118173|NCT03464435|0.1% tacrolimus|0.1% tacrolimus
118174|NCT03464435|loteprednol etabonate 0.5%/tobramycin 0.3%|loteprednol etabonate 0.5%/tobramycin 0.3%
118175|NCT03464422|HIV|hiv
118176|NCT03464422|MSM|msm
118177|NCT03464409|Nerve Transfer Surgery|nerve transfer surgery
118178|NCT03464409|Tendon Transfer Surgery|tendon transfer surgery
118179|NCT03464409|Decision Support Intervention|decision support intervention
118180|NCT03464396|Periodic breathing|periodic breathing
118181|NCT03464396|Apnea of prematurity|apnea of prematurity
118182|NCT03464396|Chronic Lung disease|chronic lung disease
118183|NCT03464396|Prematurity|prematurity
118184|NCT03464396|Respiratory disease|respiratory disease
118185|NCT03464396|Hypoxia|hypoxia
118186|NCT03464396|Pulmonary Hypertension|pulmonary hypertension
118187|NCT03464383|Neurologic Disorders|neurologic disorders
118188|NCT03464383|Chronic Care|chronic care
118189|NCT03464383|Management|management
118190|NCT03464383|Treatment|treatment
118191|NCT03464383|SSRI Medication|ssri medication
118192|NCT03464383|SNRI Medication|snri medication
118193|NCT03464383|Learning Healthcare System|learning healthcare system
118194|NCT03464370|amygdala enlargement|amygdala enlargement
118195|NCT03464370|temporal lobe epilepsy|temporal lobe epilepsy
118196|NCT03464370|stress|stress
118197|NCT03464370|attentional bias|attentional bias
118198|NCT03464370|anxiety|anxiety
118199|NCT03464370|depression|depression
118200|NCT03464370|PTSD|ptsd
118201|NCT03464357|functional MRI|functional mri
118202|NCT03464344|intracerebral hemorrhage|intracerebral hemorrhage
118203|NCT03464344|cerebral amyloid angiopathy|cerebral amyloid angiopathy
118204|NCT03464344|cortical superficial siderosis|cortical superficial siderosis
118205|NCT03464344|Magnetic Resonance Imaging|magnetic resonance imaging
118206|NCT03464318|idiopathic scoliosis|idiopathic scoliosis
118207|NCT03464318|radiographs|radiographs
118208|NCT03464318|low dose|low dose
118209|NCT03464305|Colonic Neoplasms|colonic neoplasms
118210|NCT03464305|Colorectal Neoplasms|colorectal neoplasms
118211|NCT03464305|Intestinal Neoplasms|intestinal neoplasms
118212|NCT03464305|Gastrointestinal Neoplasms|gastrointestinal neoplasms
118213|NCT03464305|Digestive System Neoplasms|digestive system neoplasms
118214|NCT03464305|Neoplasms by Site|neoplasms by site
118215|NCT03464305|Neoplasms|neoplasms
118216|NCT03464305|Colonic Diseases|colonic diseases
118217|NCT03464305|Aspirin|aspirin
118218|NCT03464305|Recurrence|recurrence
118219|NCT03464305|Digestive System Diseases|digestive system diseases
118220|NCT03464305|Intestinal Diseases|intestinal diseases
118221|NCT03464305|Disease Attributes|disease attributes
118222|NCT03464305|Pathologic Processes|pathologic processes
118223|NCT03464227|Phase 1|phase 1
118224|NCT03464227|UCB0107|ucb0107
118225|NCT03464214|Vibration|vibration
118226|NCT03464214|Cervical stabilization exercises|cervical stabilization exercises
118227|NCT03464214|Physiotherapy and rehabilitation|physiotherapy and rehabilitation
118228|NCT03464214|Sensory organization test|sensory organization test
118229|NCT03464214|Balance|balance
118230|NCT03464188|early palliative care|early palliative care
118231|NCT03464188|family caregiver|family caregiver
118232|NCT03464188|rural|rural
118233|NCT03464188|African-American|african-american
118234|NCT03464188|telehealth|telehealth
118235|NCT03464162|Social Network Meetings|social network meetings
118236|NCT03464162|First Episode Psychosis|first episode psychosis
118237|NCT03464162|OnTrackNY|ontrackny
118238|NCT03464097|Crohn's Disease|crohn's disease
118239|NCT03464097|Crohn Disease|crohn disease
118240|NCT03464097|Oral|oral
118241|NCT03464097|Ozanimod|ozanimod
118242|NCT03464097|Moderately active|moderately active
118243|NCT03464097|Severely active|severely active
118244|NCT03464097|RPC01|rpc01
118245|NCT03464097|RPC01-3203|rpc01-3203
118246|NCT03464071|sepsis|sepsis
118247|NCT03464071|biomarkers|biomarkers
118248|NCT03464071|lung injury|lung injury
118249|NCT03464058|Pharmacokinetics|pharmacokinetics
118250|NCT03464058|Food Effect|food effect
118251|NCT03464058|Proton Pump Inhibitors|proton pump inhibitors
118252|NCT03464058|Drug Interaction|drug interaction
118253|NCT03464058|Oral Prototype Formulations|oral prototype formulations
118254|NCT03464019|Paroxysmal supraventricular tachycardia|paroxysmal supraventricular tachycardia
118255|NCT03464019|cardiac monitoring|cardiac monitoring
118256|NCT03464019|atrioventricular nodal reentrant tachycardia|atrioventricular nodal reentrant tachycardia
118257|NCT03464019|atrioventricular reciprocating tachycardia|atrioventricular reciprocating tachycardia
118258|NCT03464019|calcium channel blocker|calcium channel blocker
118259|NCT03464019|conversion rate|conversion rate
118260|NCT03463980|Meditation|meditation
118261|NCT03463980|African American|african american
118262|NCT03463980|Randomized controlled trial|randomized controlled trial
118263|NCT03463967|nonalcoholic steatohepatitis|nonalcoholic steatohepatitis
118264|NCT03463967|obesity|obesity
118265|NCT03463967|dyslipidemia|dyslipidemia
118266|NCT03463967|diet|diet
118272|NCT03463941|Dyads|dyads
118273|NCT03463941|Health disparities|health disparities
118274|NCT03463915|Interstitial cystitis|interstitial cystitis
118275|NCT03463915|Bladder pain syndrome|bladder pain syndrome
118276|NCT03463915|IC/BPS|ic/bps
118277|NCT03463915|Women|women
118278|NCT03463915|Pelvic pain|pelvic pain
118279|NCT03463915|Urologic pain|urologic pain
118280|NCT03463915|Bladder instillation|bladder instillation
118281|NCT03463915|Kenalog|kenalog
118282|NCT03463915|Steroid|steroid
118283|NCT03463902|Gesture|gesture
118284|NCT03463902|tDCS|tdcs
118285|NCT03463902|schizophrenia|schizophrenia
118286|NCT03463902|nonverbal communication|nonverbal communication
118287|NCT03463798|structured light plethysmography|structured light plethysmography
118288|NCT03463798|sonar|sonar
118289|NCT03463798|transdiaphragmatic pressure|transdiaphragmatic pressure
118290|NCT03463785|obstructive sleep apnea|obstructive sleep apnea
118291|NCT03463785|race|race
118292|NCT03463785|upper airway|upper airway
118293|NCT03463785|cone beam computed tomography|cone beam computed tomography
118294|NCT03463772|in vitro maturation|in vitro maturation
118295|NCT03463772|polycystic ovarian syndrome|polycystic ovarian syndrome
118296|NCT03463772|oocyte|oocyte
118297|NCT03463733|Glioma|glioma
118298|NCT03463733|Recurrent glioma|recurrent glioma
118299|NCT03463733|Glioblastoma multiforme|glioblastoma multiforme
118300|NCT03463733|Recurrent Glioblastoma multiforme|recurrent glioblastoma multiforme
118301|NCT03463733|Hydroxyurea|hydroxyurea
118302|NCT03463733|Temozolomide|temozolomide
118303|NCT03463668|duodenal stenosis|duodenal stenosis
118304|NCT03463668|pyloric stenosis|pyloric stenosis
118305|NCT03463668|digestive neoplasias|digestive neoplasias
118306|NCT03463668|non-digestive neoplasias|non-digestive neoplasias
118307|NCT03463668|duodenal prosthesis|duodenal prosthesis
118308|NCT03463655|palliative|palliative
118309|NCT03463655|solid tumor|solid tumor
118310|NCT03463655|ascites|ascites
118311|NCT03463629|Multidisciplinary Team|multidisciplinary team
118312|NCT03463629|Hispanic adults|hispanic adults
118317|NCT03463603|ischemic heart disease|ischemic heart disease
118318|NCT03463603|acute coronary syndrome|acute coronary syndrome
118319|NCT03463603|racial bias|racial bias
118320|NCT03463590|Habenula|habenula
118321|NCT03463590|Obsessive-Compulsive Disorder|obsessive-compulsive disorder
118322|NCT03463590|Deep brain stimulation|deep brain stimulation
118323|NCT03463577|whooping cough, Boostrix, Tdap, safety, pregnancy, infants|whooping cough, boostrix, tdap, safety, pregnancy, infants
118324|NCT03463564|type 1 diabetes|type 1 diabetes
118325|NCT03463564|transition|transition
118326|NCT03463564|CSII|csii
118327|NCT03463564|MDI|mdi
118328|NCT03463564|glycemic control|glycemic control
118329|NCT03463564|glucose variability|glucose variability
118330|NCT03463525|Carcinoma, Non-Small-Cell Lung|carcinoma, non-small-cell lung
118331|NCT03463486|outpatient cardiac rehabilitation, exercise training,|outpatient cardiac rehabilitation, exercise training,
118332|NCT03463447|Dynamometer|dynamometer
118333|NCT03463447|Handgrip|handgrip
118334|NCT03463447|children|children
118335|NCT03463434|pressure ulcer treatment|pressure ulcer treatment
118336|NCT03463434|wound healing|wound healing
118337|NCT03463421|Adherence to oral anticoagulation|adherence to oral anticoagulation
118338|NCT03463421|Persistence to oral anticoagulation|persistence to oral anticoagulation
118339|NCT03463421|AF patients|af patients
118340|NCT03463421|Previous ischemic stroke|previous ischemic stroke
118341|NCT03463408|Sarcoma|sarcoma
118342|NCT03463382|Pediatric Surgery|pediatric surgery
118343|NCT03463382|Postoperative Pain|postoperative pain
118344|NCT03463382|Erector spinae plane block|erector spinae plane block
118345|NCT03463382|quadratus lumborum block|quadratus lumborum block
118346|NCT03463317|Atrial Fibrillation|atrial fibrillation
118347|NCT03463317|Anticoagulation|anticoagulation
118348|NCT03463317|Left atrial appendage closure|left atrial appendage closure
118349|NCT03463317|Stroke|stroke
118350|NCT03463304|Gut Microbiota|gut microbiota
118351|NCT03463304|endocannabinoide|endocannabinoide
118352|NCT03463304|Metabolic health|metabolic health
118353|NCT03463304|Gastrointestinal health|gastrointestinal health
118354|NCT03463304|Mental wellbeing|mental wellbeing
118355|NCT03463278|blastocyst|blastocyst
118356|NCT03463278|Freeze-all|freeze-all
118357|NCT03463278|IVF|ivf
118358|NCT03463278|Cumulative results|cumulative results
118359|NCT03463278|cumulative delivery rate|cumulative delivery rate
118360|NCT03463239|Autologous tissue engineered corpora|autologous tissue engineered corpora
118361|NCT03463226|Testosterone Deficiency|testosterone deficiency
118362|NCT03463226|Sympathetic overactivity|sympathetic overactivity
118363|NCT03463226|Exercise Intolerance|exercise intolerance
118364|NCT03463213|health behavior|health behavior
118365|NCT03463213|chronic disease prevention|chronic disease prevention
118668|NCT03460977|CRPC|crpc
118366|NCT03463213|healthy lifestyle|healthy lifestyle
118367|NCT03463200|bandage|bandage
118368|NCT03463200|low back pain|low back pain
118369|NCT03463200|muscle fatigue|muscle fatigue
118370|NCT03463200|electromyography|electromyography
118371|NCT03463174|overdenture|overdenture
118372|NCT03463174|edentulism|edentulism
118373|NCT03463174|dental implant|dental implant
118374|NCT03463174|cost-effectiveness|cost-effectiveness
118375|NCT03463174|economic analysis|economic analysis
118376|NCT03463174|effectiveness|effectiveness
118377|NCT03463122|stroke|stroke
118378|NCT03463122|neglect|neglect
118379|NCT03463122|virtual reality|virtual reality
118380|NCT03463122|head mount display|head mount display
118381|NCT03463122|rehabilitation|rehabilitation
118382|NCT03463109|Chronic low back pain|chronic low back pain
118383|NCT03463096|respiratory|respiratory
118384|NCT03463096|physiology|physiology
118385|NCT03463096|gravity|gravity
118386|NCT03463070|misoprostol|misoprostol
118387|NCT03463070|postpartum haemorrhage|postpartum haemorrhage
118388|NCT03463031|GSP 301 nasal spray for the treatment of Seasonal Allergic Rhinitis|gsp 301 nasal spray for the treatment of seasonal allergic rhinitis
118389|NCT03463018|Echinacea, Subthreshold Anxiety|echinacea, subthreshold anxiety
118390|NCT03462979|Gluten-free diet|gluten-free diet
118391|NCT03462979|Urine|urine
118392|NCT03462979|Stool|stool
118393|NCT03462979|home testing|home testing
118394|NCT03462966|Rifaximin|rifaximin
118395|NCT03462966|Xifaxan|xifaxan
118396|NCT03462940|Tauroursodeoxycholic acid (TUDCA)|tauroursodeoxycholic acid (tudca)
118397|NCT03462940|Endothelial function in humans|endothelial function in humans
118398|NCT03462940|Endoplasmic Reticulum Stress|endoplasmic reticulum stress
118399|NCT03462901|Fixation of midshaft clavicular fracture by intramedullary|fixation of midshaft clavicular fracture by intramedullary
118400|NCT03462888|Rhabdomyosarcoma|rhabdomyosarcoma
118401|NCT03462888|Adolescents and young adults|adolescents and young adults
118402|NCT03462888|prognostic factors|prognostic factors
118403|NCT03462888|molecular profiling|molecular profiling
118404|NCT03462875|Crohn's Disease|crohn's disease
118405|NCT03462875|Microbiota|microbiota
118406|NCT03462875|Dietary Pattern|dietary pattern
118407|NCT03462875|Environmental factors|environmental factors
118408|NCT03462862|PEEK|peek
118409|NCT03462862|Breflex|breflex
118410|NCT03462849|ARDS|ards
118411|NCT03462849|expiratory flow limitation|expiratory flow limitation
118412|NCT03462849|trans-pulmonary pressure|trans-pulmonary pressure
118413|NCT03462849|airway closure|airway closure
118414|NCT03462823|ACL Reconstruction|acl reconstruction
118415|NCT03462823|Osteoconductive Scaffold|osteoconductive scaffold
118416|NCT03462823|Bone Tunnel Widening|bone tunnel widening
118417|NCT03462810|cabotegravir, CAB|cabotegravir, cab
118418|NCT03462810|GSK1265744|gsk1265744
118419|NCT03462810|Individual Patient Compassionate Use|individual patient compassionate use
118420|NCT03462810|HIV|hiv
118421|NCT03462771|elderly|elderly
118422|NCT03462771|sarcopenia|sarcopenia
118423|NCT03462771|dietary supplementation|dietary supplementation
118424|NCT03462771|omega-3 fatty acid|omega-3 fatty acid
118425|NCT03462758|Mirena|mirena
118426|NCT03462758|ParaGard|paragard
118427|NCT03462758|Skyla|skyla
118428|NCT03462758|Liletta|liletta
118429|NCT03462758|Kyleena|kyleena
118430|NCT03462758|Intrauterine Device|intrauterine device
118431|NCT03462758|Intrauterine System|intrauterine system
118432|NCT03462758|Postpartum|postpartum
118433|NCT03462758|Expulsion|expulsion
118434|NCT03462706|Polyp Resection|polyp resection
118435|NCT03462706|Cold Snare|cold snare
118436|NCT03462706|Hot Snare|hot snare
118437|NCT03462706|Cold Endoscopic Mucosal Resection (EMR)|cold endoscopic mucosal resection (emr)
118438|NCT03462706|Hot Endoscopic Mucosal Resection (EMR)|hot endoscopic mucosal resection (emr)
118439|NCT03462706|Colonoscopy|colonoscopy
118440|NCT03462654|Health promotion|health promotion
118441|NCT03462654|Behaviour change|behaviour change
118442|NCT03462654|Physical activity|physical activity
118443|NCT03462654|Fall prevention|fall prevention
118444|NCT03462641|Gait|gait
118445|NCT03462641|Balance|balance
118446|NCT03462641|Flumazenil|flumazenil
118447|NCT03462641|PET Imaging|pet imaging
118448|NCT03462641|MRI|mri
118449|NCT03462641|Mobility|mobility
118450|NCT03462641|Intravenous|intravenous
118451|NCT03462628|substrate modification|substrate modification
118452|NCT03462628|pulmonary vein isolation|pulmonary vein isolation
118453|NCT03462628|ablation|ablation
118454|NCT03462628|Paroxysmal Atrial Fibrillation|paroxysmal atrial fibrillation
118455|NCT03462615|malaria|malaria
118456|NCT03462615|pregnancy|pregnancy
118457|NCT03462615|diagnosis|diagnosis
118458|NCT03462615|rapid diagnostic test|rapid diagnostic test
118459|NCT03462537|Aerobic Exercise|aerobic exercise
118460|NCT03462537|Lipolytic Laser|lipolytic laser
118461|NCT03462537|Lipid Profile|lipid profile
118462|NCT03462537|C-reactive protein|c-reactive protein
118463|NCT03462537|Lipolysis|lipolysis
118464|NCT03462511|Hydroxyurea|hydroxyurea
118465|NCT03462511|Community health worker (CHW)|community health worker (chw)
118466|NCT03462511|Text messages|text messages
118467|NCT03462511|Medication adherence|medication adherence
118469|NCT03462498|Acute Myocardial Infarction|acute myocardial infarction
118470|NCT03462498|Coronary Artery Disease|coronary artery disease
118471|NCT03462498|Percutaneous Coronary Intervention|percutaneous coronary intervention
118472|NCT03462498|Platelet Aggregation Inhibitors|platelet aggregation inhibitors
118473|NCT03462459|Oral vancomycin|oral vancomycin
118474|NCT03462459|vancomycin|vancomycin
118475|NCT03462459|antibiotic|antibiotic
118476|NCT03462446|Atrial fibrillation|atrial fibrillation
118477|NCT03462446|VKA|vka
118478|NCT03462446|Stroke|stroke
118479|NCT03462433|Ruptured Intracranial Aneurysms|ruptured intracranial aneurysms
118480|NCT03462433|Unruptured Intracranial Aneurysms|unruptured intracranial aneurysms
118481|NCT03462433|Prospective cohort study|prospective cohort study
118482|NCT03462433|China|china
118483|NCT03462420|Adhesive capsulitis|adhesive capsulitis
118484|NCT03462420|Frozen shoulder|frozen shoulder
118485|NCT03462420|Diabetes|diabetes
118486|NCT03462420|Physiotherapy|physiotherapy
118487|NCT03462329|Post-Lyme symptoms|post-lyme symptoms
118488|NCT03462329|Pretreatment expectations|pretreatment expectations
118489|NCT03462290|Botulinum Toxins, Type A|botulinum toxins, type a
118490|NCT03462290|Injections|injections
118491|NCT03462290|Sphenopalatine Ganglion Block|sphenopalatine ganglion block
118492|NCT03462277|methylation|methylation
118493|NCT03462277|hydroxymethylation|hydroxymethylation
118494|NCT03462277|atherosclerosis|atherosclerosis
118495|NCT03462277|coronary heart disease|coronary heart disease
118496|NCT03462251|Breast Cancer|breast cancer
118497|NCT03462251|HR positive|hr positive
118498|NCT03462251|HER2 negative|her2 negative
118499|NCT03462251|Mamma carcinoma|mamma carcinoma
118500|NCT03462199|Kiwi|kiwi
118501|NCT03462199|Constipation|constipation
118502|NCT03462199|Bowel Movements|bowel movements
118503|NCT03462199|Healthy|healthy
118504|NCT03462199|Functional Constipation|functional constipation
118505|NCT03462160|Urinary Tract Infection|urinary tract infection
118506|NCT03462160|prophylaxis|prophylaxis
118507|NCT03462160|probiotics|probiotics
118508|NCT03462121|Alzheimer's Disease,|alzheimer's disease,
118509|NCT03462121|Dementia|dementia
118510|NCT03462082|Parkinson's disease|parkinson's disease
118511|NCT03462082|axial motor dysfunction|axial motor dysfunction
118512|NCT03462082|asymmetric neuromodulation|asymmetric neuromodulation
118513|NCT03462082|subthalamic nucleus deep brain stimulation|subthalamic nucleus deep brain stimulation
118514|NCT03462030|food allergy|food allergy
118515|NCT03462030|oral immunotherapy|oral immunotherapy
118517|NCT03461965|3D printing|3d printing
118518|NCT03461965|Patient education|patient education
118519|NCT03461939|ePRIME|eprime
118520|NCT03461939|PRO|pro
118521|NCT03461939|PROM|prom
118522|NCT03461939|Adverse event|adverse event
118523|NCT03461939|QTool|qtool
118524|NCT03461939|Early phase|early phase
118525|NCT03461939|CTCAE|ctcae
118526|NCT03461926|Sedentary Behaviour|sedentary behaviour
118527|NCT03461926|Health Behaviour Change|health behaviour change
118528|NCT03461926|Health Action Process Approach|health action process approach
118529|NCT03461926|mHealth|mhealth
118530|NCT03461926|Intervention|intervention
118531|NCT03461926|Non-Sedentary Behaviours|non-sedentary behaviours
118532|NCT03461926|Break Frequency|break frequency
118533|NCT03461926|Break Duration|break duration
118534|NCT03461926|Action Planning|action planning
118535|NCT03461926|Coping Planning|coping planning
118536|NCT03461926|Work Performance|work performance
118537|NCT03461926|Health Outcomes|health outcomes
118538|NCT03461900|Septic shock|septic shock
118539|NCT03461900|Fluid optimisation|fluid optimisation
118540|NCT03461900|Minifluid challenge|minifluid challenge
118541|NCT03461900|Fluid overload|fluid overload
118542|NCT03461887|exercise|exercise
118543|NCT03461887|minimal equipment|minimal equipment
118544|NCT03461887|home-based|home-based
118545|NCT03461887|COPD|copd
118546|NCT03461874|High-Frequency Migraine without aura|high-frequency migraine without aura
118547|NCT03461874|ACT|act
118548|NCT03461861|Healthy|healthy
118549|NCT03461861|Adult|adult
118550|NCT03461861|Normal Memory|normal memory
118551|NCT03461861|APOE 4|apoe 4
118552|NCT03461861|Brain|brain
118553|NCT03461861|Magnetic Resonance Imaging|magnetic resonance imaging
118554|NCT03461861|MRI|mri
118555|NCT03461861|Alzheimer's disease|alzheimer's disease
118556|NCT03461861|Hippocampus|hippocampus
118557|NCT03461861|Genetic testing|genetic testing
118558|NCT03461861|Dementia|dementia
118559|NCT03461861|AGB101|agb101
118560|NCT03461809|diplopia; ocular motor nerve palsy; acupuncture|diplopia; ocular motor nerve palsy; acupuncture
118561|NCT03461770|atelectasis|atelectasis
118562|NCT03461770|children|children
118563|NCT03461770|ultrasound|ultrasound
118564|NCT03461757|Acute Migraine|acute migraine
118565|NCT03461757|phonophobia|phonophobia
118566|NCT03461757|photophobia|photophobia
118567|NCT03461757|nausea|nausea
118568|NCT03461731|Low-Level Light Therapy|low-level light therapy
118569|NCT03461705|Coronary Artery Stenosis|coronary artery stenosis
118570|NCT03461705|Stenosis|stenosis
118571|NCT03461705|Resting Flow Reserve (RFR)|resting flow reserve (rfr)
151481|NCT03253445|ACT|act
118572|NCT03461705|Volcano Verrata Pressure Wire|volcano verrata pressure wire
118573|NCT03461666|Primary insomnia|primary insomnia
118574|NCT03461666|Behavioral treatment of primary insomnia|behavioral treatment of primary insomnia
118575|NCT03461666|Focus of attention|focus of attention
118576|NCT03461666|cognitive behavioral therapy for insomnia|cognitive behavioral therapy for insomnia
118577|NCT03461627|randomized|randomized
118578|NCT03461627|double-blind|double-blind
118579|NCT03461627|double-dummy|double-dummy
118580|NCT03461627|positive-controlled|positive-controlled
118581|NCT03461627|parallel-group|parallel-group
118582|NCT03461614|pulmonary function|pulmonary function
118583|NCT03461614|respiratory muscle strength|respiratory muscle strength
118584|NCT03461614|functional capacity|functional capacity
118585|NCT03461614|core exercises|core exercises
118586|NCT03461614|rehabilitation|rehabilitation
118587|NCT03461562|Aerobic Exercise|aerobic exercise
118588|NCT03461562|Whole Body Vibration Therapy|whole body vibration therapy
118589|NCT03461549|pressure sensor|pressure sensor
118590|NCT03461549|temperature sensor|temperature sensor
118591|NCT03461549|wearables|wearables
118592|NCT03461510|Cognition|cognition
118593|NCT03461510|MRI|mri
118594|NCT03461510|Functional MRI|functional mri
118595|NCT03461510|Pediatric Obesity|pediatric obesity
118596|NCT03461510|Type 2 Diabetes Mellitus|type 2 diabetes mellitus
118597|NCT03461510|Adolescents|adolescents
118598|NCT03461510|Continuous Glucose Monitoring|continuous glucose monitoring
118599|NCT03461510|Insulin Clamp|insulin clamp
118600|NCT03461497|Patient-Reported Outcome|patient-reported outcome
118601|NCT03461497|Patient Outcome Assessment|patient outcome assessment
118602|NCT03461497|Questionnaire|questionnaire
118603|NCT03461497|Self-Report|self-report
118604|NCT03461497|Abdominal Surgery|abdominal surgery
118605|NCT03461497|Postoperative Period|postoperative period
118606|NCT03461497|Recovery of Function|recovery of function
118607|NCT03461497|Psychometrics|psychometrics
118608|NCT03461497|Qualitative Research|qualitative research
118609|NCT03461497|Patient-Centered|patient-centered
118610|NCT03461458|Degenerative Disc Disease|degenerative disc disease
118611|NCT03461458|Musculoskeletal Diseases|musculoskeletal diseases
118612|NCT03461458|Lumbar|lumbar
118613|NCT03461445|Elderly|elderly
118614|NCT03461445|Neurotoxicity|neurotoxicity
118615|NCT03461445|Calcineurin inhibitors|calcineurin inhibitors
118616|NCT03461445|Tacrolimus|tacrolimus
118617|NCT03461432|Cognitive Remediation Therapy CRT|cognitive remediation therapy crt
118618|NCT03461419|Multiple Sclerosis|multiple sclerosis
118619|NCT03461419|Demyelinating Disease|demyelinating disease
118620|NCT03461419|Nervous System Degenerative Disease|nervous system degenerative disease
118621|NCT03461419|Autoimmune Disease|autoimmune disease
118622|NCT03461393|AMD|amd
118623|NCT03461393|Mobile Device|mobile device
118624|NCT03461393|Training|training
118625|NCT03461380|Cimicifuga, Rhodiola, Menopause Symptoms|cimicifuga, rhodiola, menopause symptoms
118626|NCT03461328|magnesium sulphate, chronic obstructive pulmonary diseases|magnesium sulphate, chronic obstructive pulmonary diseases
118627|NCT03461315|home care|home care
118628|NCT03461315|primary care|primary care
118629|NCT03461315|preventive home visits|preventive home visits
118630|NCT03461250|HCV infection|hcv infection
118631|NCT03461250|hemodialysis|hemodialysis
118632|NCT03461250|HCV genotype|hcv genotype
118633|NCT03461250|Liver Fibrosis stage|liver fibrosis stage
118634|NCT03461237|Second Hip Fracture|second hip fracture
118635|NCT03461237|Quantitative Computed Tomography|quantitative computed tomography
118636|NCT03461237|Bone structure|bone structure
118637|NCT03461237|Muscle|muscle
118638|NCT03461224|breast cancer|breast cancer
118639|NCT03461224|radiotherapy|radiotherapy
118640|NCT03461224|cutaneous toxicity|cutaneous toxicity
118641|NCT03461224|subcutaneous toxicity|subcutaneous toxicity
118642|NCT03461224|IMRT|imrt
118643|NCT03461172|surgery|surgery
118644|NCT03461172|breast cancer|breast cancer
118645|NCT03461159|operant conditioning|operant conditioning
118646|NCT03461159|H-reflex|h-reflex
118647|NCT03461159|motor evoked potential|motor evoked potential
118648|NCT03461159|transcranial magnetic stimulation|transcranial magnetic stimulation
118649|NCT03461159|motor control|motor control
118650|NCT03461042|Chronic insomnia|chronic insomnia
118651|NCT03461042|Ramelteon|ramelteon
118652|NCT03461042|Rozerem|rozerem
118653|NCT03461042|dose reduction|dose reduction
118654|NCT03461029|Sedation|sedation
118655|NCT03461016|Smartphones|smartphones
118656|NCT03461016|Exposure Therapy|exposure therapy
118657|NCT03461016|Dental Anxiety|dental anxiety
118658|NCT03460977|efficacy|efficacy
118659|NCT03460977|safety|safety
118660|NCT03460977|pharmacokinetics|pharmacokinetics
118661|NCT03460977|pharmacodynamics|pharmacodynamics
118662|NCT03460977|dose escalation|dose escalation
118663|NCT03460977|dose expansion|dose expansion
118664|NCT03460977|open-label|open-label
118665|NCT03460977|EZH2|ezh2
118666|NCT03460977|enhancer of zeste homolog 2|enhancer of zeste homolog 2
118667|NCT03460977|castrate resistant prostate cancer|castrate resistant prostate cancer
118669|NCT03460977|small cell lung cancer|small cell lung cancer
118670|NCT03460977|SCLC|sclc
118671|NCT03460977|follicular lymphoma|follicular lymphoma
118673|NCT03460977|relapsed|relapsed
118674|NCT03460977|refractory|refractory
118675|NCT03460964|Sensor|sensor
118676|NCT03460964|Glucose|glucose
118677|NCT03460964|Sweat|sweat
118678|NCT03460951|Feasibility and reproductibility|feasibility and reproductibility
118679|NCT03460951|DTI parameters (Fractional Anisotropy, Apparent Diffusion Coefficient)|dti parameters (fractional anisotropy, apparent diffusion coefficient)
118680|NCT03460951|MRI morphological parameters (T1, STIR)|mri morphological parameters (t1, stir)
118681|NCT03460925|pancreatic cancer|pancreatic cancer
118682|NCT03460925|stereotactic body radiotherapy|stereotactic body radiotherapy
118683|NCT03460925|resectability|resectability
118684|NCT03460912|IONM|ionm
118685|NCT03460912|thyroidectomy|thyroidectomy
118686|NCT03460912|bipolar probe|bipolar probe
118687|NCT03460912|monopolar probe|monopolar probe
118688|NCT03460899|Hypoglycaemia|hypoglycaemia
118689|NCT03460899|Platelet activity|platelet activity
118690|NCT03460899|Type 2 diabetes mellitus|type 2 diabetes mellitus
118691|NCT03460886|transcranial direct current stimulation|transcranial direct current stimulation
118692|NCT03460834|Asthma|asthma
118693|NCT03460834|Obesity|obesity
118694|NCT03460834|Observational Study|observational study
118695|NCT03460808|steroid-resistant|steroid-resistant
118696|NCT03460808|refractory|refractory
118697|NCT03460808|Atorvastatin|atorvastatin
118698|NCT03460808|Acetylcysteine|acetylcysteine
118699|NCT03460808|Danazol|danazol
118700|NCT03460782|Ipilimumab|ipilimumab
118701|NCT03460782|Glioblastoma|glioblastoma
118702|NCT03460782|Glioma|glioma
118703|NCT03460769|Pancreatic Cancer|pancreatic cancer
118704|NCT03460769|Chronic Pancreatitis|chronic pancreatitis
118705|NCT03460769|Diabetes Mellitus Type 3c|diabetes mellitus type 3c
118706|NCT03460769|Data management|data management
118707|NCT03460756|Postpartum Care|postpartum care
118708|NCT03460756|Postpartum Depression|postpartum depression
118709|NCT03460743|hemagglutinin influenza vaccine|hemagglutinin influenza vaccine
118710|NCT03460743|recombinant influenza vaccine|recombinant influenza vaccine
118711|NCT03460730|Invasive Pneumococcal Disease|invasive pneumococcal disease
118712|NCT03460691|bariatric surgery|bariatric surgery
118713|NCT03460691|central sensitization|central sensitization
118714|NCT03460691|knee pain|knee pain
118715|NCT03460691|function|function
118716|NCT03460691|quality of life|quality of life
118717|NCT03460678|Generic Erlotinib|generic erlotinib
118718|NCT03460678|Generic Pemetrexed|generic pemetrexed
118719|NCT03460678|NSCLC|nsclc
118720|NCT03460678|Non-squamous|non-squamous
118721|NCT03460678|Randomized Study|randomized study
118722|NCT03460678|Maintenance Therapy|maintenance therapy
118723|NCT03460678|Tyrosine kinase inhibitor|tyrosine kinase inhibitor
118724|NCT03460678|Antifolate antineoplastic agents|antifolate antineoplastic agents
118725|NCT03460639|Masseter muscle|masseter muscle
118726|NCT03460639|initial fatigue|initial fatigue
118727|NCT03460639|low-level laser|low-level laser
118728|NCT03460626|stress|stress
118729|NCT03460626|pharmacy students|pharmacy students
118730|NCT03460626|Saudi Arabia|saudi arabia
118731|NCT03460561|TEA|tea
118732|NCT03460561|Rectus sheath block|rectus sheath block
118733|NCT03460561|Major abdominal cancer surgery|major abdominal cancer surgery
118734|NCT03460535|Rythmia system|rythmia system
118735|NCT03460496|preterm infants|preterm infants
118736|NCT03460496|transition to home|transition to home
118737|NCT03460496|advanced practice nurse|advanced practice nurse
118738|NCT03460496|cost-analysis|cost-analysis
118739|NCT03460444|NLR Family, Pyrin Domain-Containing 3 Protein|nlr family, pyrin domain-containing 3 protein
118740|NCT03460444|Caspase 1|caspase 1
118741|NCT03460444|3-Hydroxybutyric Acid|3-hydroxybutyric acid
118742|NCT03460444|Histone Deacetylase Inhibitors|histone deacetylase inhibitors
118743|NCT03460444|MCT Oil|mct oil
118744|NCT03460392|Human microbiota|human microbiota
118745|NCT03460379|Bariatric surgery|bariatric surgery
118746|NCT03460379|Gastrointestinal tract|gastrointestinal tract
118747|NCT03460379|Biological availability|biological availability
118748|NCT03460379|Pharmacokinetics|pharmacokinetics
118749|NCT03460379|Citalopram|citalopram
118750|NCT03460366|Bariatric surgery|bariatric surgery
118751|NCT03460366|Gastrointestinal tract|gastrointestinal tract
118752|NCT03460366|Biological availability|biological availability
118753|NCT03460366|Pharmacokinetics|pharmacokinetics
118754|NCT03460366|Enalapril|enalapril
118755|NCT03460353|Bariatric surgery|bariatric surgery
118756|NCT03460353|Gastrointestinal tract|gastrointestinal tract
118757|NCT03460353|Biological availability|biological availability
118758|NCT03460353|Pharmacokinetics|pharmacokinetics
118759|NCT03460353|Dextroamphetamine|dextroamphetamine
118760|NCT03460340|dTMS|dtms
118761|NCT03460340|Fibromyalgia|fibromyalgia
118762|NCT03460327|Bariatric surgery|bariatric surgery
118763|NCT03460327|Gastrointestinal tract|gastrointestinal tract
118764|NCT03460327|Biological availability|biological availability
118765|NCT03460327|Pharmacokinetics|pharmacokinetics
118766|NCT03460327|Candesartan|candesartan
118866|NCT03459677|Anxiety|anxiety
118767|NCT03460314|Bariatric surgery|bariatric surgery
118768|NCT03460314|Gastrointestinal tract|gastrointestinal tract
118769|NCT03460314|Biological availability|biological availability
118770|NCT03460314|Pharmacokinetics|pharmacokinetics
118771|NCT03460314|Buprenorphine|buprenorphine
118772|NCT03460288|Gambling, Problematic Gambling, Pathological Gambling|gambling, problematic gambling, pathological gambling
118773|NCT03460275|Osimertinib|osimertinib
118774|NCT03460236|PRP|prp
118775|NCT03460236|osteoarthritis|osteoarthritis
118776|NCT03460236|MRI|mri
118777|NCT03460236|gait|gait
118778|NCT03460236|patient reported outcome|patient reported outcome
118779|NCT03460210|Bariatric surgery|bariatric surgery
118780|NCT03460210|Gastrointestinal tract|gastrointestinal tract
118781|NCT03460210|Biological availability|biological availability
118782|NCT03460210|Pharmacokinetics|pharmacokinetics
118783|NCT03460210|Atomoxetine hydrochloride|atomoxetine hydrochloride
118784|NCT03460197|Capillary technique|capillary technique
118785|NCT03460197|Wet technique|wet technique
118786|NCT03460197|Endoscopic Ultrasound-Guided Fine-Needle Aspiration|endoscopic ultrasound-guided fine-needle aspiration
118787|NCT03460171|Human Metapneumovirus|human metapneumovirus
118788|NCT03460171|Paramyxoviridae infections|paramyxoviridae infections
118789|NCT03460171|Lower-respiratory tract infections|lower-respiratory tract infections
118790|NCT03460171|Pneumonia|pneumonia
118791|NCT03460158|facial filler|facial filler
118792|NCT03460158|Retylane|retylane
118793|NCT03460158|aesthetic improvement|aesthetic improvement
118794|NCT03460158|volumizing fillers|volumizing fillers
118795|NCT03460145|Lavender Oil,|lavender oil,
118796|NCT03460145|Propofol|propofol
118797|NCT03460132|orthodontic miniscrews|orthodontic miniscrews
118798|NCT03460132|biological effect|biological effect
118799|NCT03460132|cytotoxicity|cytotoxicity
118800|NCT03460132|metal release|metal release
118801|NCT03460119|High Flow Nasal Cannula|high flow nasal cannula
118802|NCT03460119|Emergency department|emergency department
118803|NCT03460119|Respiratory care|respiratory care
118804|NCT03460106|Asthma Medical Adherence|asthma medical adherence
118805|NCT03460093|nerve blockade|nerve blockade
118806|NCT03460093|hypogastric plexus|hypogastric plexus
118807|NCT03460093|cesarean section|cesarean section
118808|NCT03460080|Hepatocellular carcinoma|hepatocellular carcinoma
118809|NCT03460080|AFP-L3|afp-l3
118810|NCT03460080|PIVKA-II|pivka-ii
118811|NCT03460067|omission of radiation|omission of radiation
118812|NCT03460067|trastuzumab|trastuzumab
118813|NCT03460067|pertuzumab|pertuzumab
118814|NCT03460067|biospecimen collection|biospecimen collection
118815|NCT03460067|lumpectomy|lumpectomy
118816|NCT03460015|COPD exacerbation|copd exacerbation
118817|NCT03460015|Sevoflurane|sevoflurane
118818|NCT03460015|Airway Resistance|airway resistance
118819|NCT03460002|Measles vaccine|measles vaccine
118820|NCT03460002|Oral polio vaccine|oral polio vaccine
118821|NCT03460002|Campaign|campaign
118822|NCT03460002|Child mortality|child mortality
118823|NCT03460002|Child morbidity|child morbidity
118824|NCT03460002|Non-specific effects|non-specific effects
118825|NCT03459989|hadlock|hadlock
118826|NCT03459989|thigh soft tissue|thigh soft tissue
118827|NCT03459963|catheter|catheter
118828|NCT03459963|cesarean section|cesarean section
118829|NCT03459963|urinary tract infection|urinary tract infection
118830|NCT03459963|patient's satisfaction|patient's satisfaction
118831|NCT03459937|obesity|obesity
118832|NCT03459937|yoga|yoga
118833|NCT03459937|mindfulness|mindfulness
118834|NCT03459937|weight loss|weight loss
118835|NCT03459937|physical activity|physical activity
118836|NCT03459924|Right ventricular function|right ventricular function
118837|NCT03459924|Liver transplantation|liver transplantation
118838|NCT03459924|Transesophageal echocardiography|transesophageal echocardiography
118839|NCT03459911|Bioequivalence|bioequivalence
118840|NCT03459872|acupuncture|acupuncture
118841|NCT03459872|quantitative data|quantitative data
118842|NCT03459872|outcomes based rehabilitation|outcomes based rehabilitation
118843|NCT03459872|fine motor control|fine motor control
118844|NCT03459846|Urinary Bladder Neoplasms|urinary bladder neoplasms
118845|NCT03459833|premature ejaculation|premature ejaculation
118846|NCT03459833|IELT|ielt
118847|NCT03459833|hyaluronic acid|hyaluronic acid
118848|NCT03459833|glans penis augmentation|glans penis augmentation
118849|NCT03459807|Blood pressure|blood pressure
118850|NCT03459807|Hemodialysis|hemodialysis
118851|NCT03459807|End-stage-renal-disease|end-stage-renal-disease
118852|NCT03459807|Chronic kidney disease|chronic kidney disease
118853|NCT03459742|Obesity|obesity
118854|NCT03459742|Gamification|gamification
118855|NCT03459742|Schools|schools
118856|NCT03459742|Cluster Randomized Trial|cluster randomized trial
118857|NCT03459729|Anti-tumor B|anti-tumor b
118858|NCT03459729|ACAPHA|acapha
118859|NCT03459729|Pharmacokinetics|pharmacokinetics
118860|NCT03459716|Biomarkers|biomarkers
118861|NCT03459716|Endothelial microparticles|endothelial microparticles
118862|NCT03459690|Meditation, EEG|meditation, eeg
118863|NCT03459677|School Refusal|school refusal
118864|NCT03459677|Truancy|truancy
118865|NCT03459677|School Absenteeism|school absenteeism
118867|NCT03459677|Depression|depression
118868|NCT03459677|Behavioral problems|behavioral problems
118869|NCT03459677|CBT|cbt
118870|NCT03459664|stepped care|stepped care
118871|NCT03459664|common mental disorders|common mental disorders
118872|NCT03459664|managed care|managed care
118873|NCT03459664|integrated care|integrated care
118874|NCT03459664|psychiatric disorders|psychiatric disorders
118875|NCT03459664|psychotherapy|psychotherapy
118876|NCT03459664|severe mental disorders|severe mental disorders
118877|NCT03459651|numeracy|numeracy
118878|NCT03459651|number sense|number sense
118879|NCT03459638|Screening|screening
118880|NCT03459599|Antibiotic|antibiotic
118881|NCT03459599|Endometritis|endometritis
118882|NCT03459599|Placental membranes|placental membranes
118883|NCT03459599|Prophylaxis|prophylaxis
118884|NCT03459599|Ragged membranes|ragged membranes
118885|NCT03459586|Parkinson|parkinson
118886|NCT03459560|antihypertensive agents|antihypertensive agents
118887|NCT03459560|acetylsalicylic acid|acetylsalicylic acid
118888|NCT03459560|atorvastatin|atorvastatin
118889|NCT03459508|Antiphospholipid Syndrome - Bad obstetric history - Ocular|antiphospholipid syndrome - bad obstetric history - ocular
118890|NCT03459495|migraine, therapeutic ultrasound, pain, disability|migraine, therapeutic ultrasound, pain, disability
118891|NCT03459456|OCD|ocd
118892|NCT03459456|Obsessive-Compulsive Disorder|obsessive-compulsive disorder
118893|NCT03459443|factor D|factor d
118894|NCT03459443|fD|fd
118895|NCT03459443|alternative pathway|alternative pathway
118896|NCT03459443|complement mediated disease|complement mediated disease
118897|NCT03459443|C3GN|c3gn
118898|NCT03459443|DDD|ddd
118899|NCT03459443|idiopathic MPGN|idiopathic mpgn
118900|NCT03459443|MPGN Type I|mpgn type i
118901|NCT03459443|MPGN Type II|mpgn type ii
118902|NCT03459443|MPGN Type III|mpgn type iii
118903|NCT03459443|Primary MPGN|primary mpgn
118904|NCT03459443|MCGN|mcgn
118905|NCT03459443|Mesangiocapillary Glomerulonephritis|mesangiocapillary glomerulonephritis
118906|NCT03459430|trunk stability|trunk stability
118907|NCT03459430|accelerometer|accelerometer
118908|NCT03459430|smartphone|smartphone
118909|NCT03459430|core training|core training
118910|NCT03459430|isometric exercises|isometric exercises
118911|NCT03459391|Healthy volunteers|healthy volunteers
118912|NCT03459391|Phase I|phase i
118913|NCT03459391|PHARMENTERPRISES|pharmenterprises
118914|NCT03459352|Cancer|cancer
118915|NCT03459352|Patient Reported Outcomes|patient reported outcomes
118916|NCT03459352|Symptom management|symptom management
118917|NCT03459339|Barrett's Esophagus|barrett's esophagus
118918|NCT03459339|Natural History|natural history
118919|NCT03459339|Capsule|capsule
118920|NCT03459339|OCT|oct
119044|NCT03458585|patient knowledge|patient knowledge
118921|NCT03459339|Tethered Capsule Endomicroscopy|tethered capsule endomicroscopy
118922|NCT03459326|male sexuality|male sexuality
118923|NCT03459326|medical assisted to procreation|medical assisted to procreation
118924|NCT03459326|International Index of Erectile Function questionnaire|international index of erectile function questionnaire
118925|NCT03459300|actimetry|actimetry
118926|NCT03459287|INTERCEPT|intercept
118927|NCT03459287|Red Blood Cells|red blood cells
118929|NCT03459287|Pathogen Inactivation|pathogen inactivation
118930|NCT03459287|Cerus|cerus
118931|NCT03459287|Pathogen Reduction|pathogen reduction
118932|NCT03459287|Cardiovascular surgery|cardiovascular surgery
118933|NCT03459261|osteomyelitis|osteomyelitis
118934|NCT03459261|tibial fracture|tibial fracture
118935|NCT03459261|cytokines|cytokines
118936|NCT03459261|PCT|pct
118937|NCT03459261|CRP|crp
118938|NCT03459261|albumin|albumin
118939|NCT03459235|rectal cancer|rectal cancer
118940|NCT03459235|proctectomy|proctectomy
118941|NCT03459235|digestive sequelae|digestive sequelae
118942|NCT03459235|quality of life|quality of life
118943|NCT03459235|Urinary and Sexual sequelae|urinary and sexual sequelae
118944|NCT03459222|immunotherapy|immunotherapy
118945|NCT03459222|Relatlimab|relatlimab
118946|NCT03459196|Interventional|interventional
118947|NCT03459196|Radiofrequency Ablation|radiofrequency ablation
118948|NCT03459196|Paroxysmal Atrial Fibrillation|paroxysmal atrial fibrillation
118949|NCT03459170|leukemia|leukemia
118950|NCT03459170|myelodysplastic syndrome|myelodysplastic syndrome
118951|NCT03459170|lymphoma|lymphoma
118952|NCT03459170|minimal residual disease|minimal residual disease
118953|NCT03459170|BPX-501|bpx-501
118954|NCT03459170|AP1903|ap1903
118955|NCT03459170|rimiducid|rimiducid
118956|NCT03459157|HIV infection|hiv infection
118957|NCT03459157|Men who have sex with men|men who have sex with men
118958|NCT03459157|Pre-exposure prophylaxis|pre-exposure prophylaxis
118959|NCT03459144|polypoidal choroidal vasculopathy|polypoidal choroidal vasculopathy
118960|NCT03459144|photodynamic therapy|photodynamic therapy
118961|NCT03459144|ranibizumab|ranibizumab
118962|NCT03459144|combination therapy|combination therapy
118963|NCT03459144|cost-benefit|cost-benefit
118964|NCT03459092|Botulinum toxin, strabismus surgery, binocular vision|botulinum toxin, strabismus surgery, binocular vision
118965|NCT03459066|Spasticity|spasticity
118966|NCT03459066|Stroke|stroke
118967|NCT03459066|Predictors|predictors
118968|NCT03459066|Functionality|functionality
118969|NCT03459066|Quality of life|quality of life
118970|NCT03459027|exercise hyperemia|exercise hyperemia
118971|NCT03459027|vasodilation|vasodilation
118972|NCT03459027|nitric oxide|nitric oxide
118973|NCT03459027|dietary nitrate|dietary nitrate
118974|NCT03459014|Robot-Assisted Gait Training|robot-assisted gait training
118975|NCT03459014|Virtual Reality|virtual reality
118976|NCT03459014|Optic Flow|optic flow
118977|NCT03459014|Active Participation|active participation
118978|NCT03458988|Blood pressure measuring|blood pressure measuring
118979|NCT03458975|microbubbles|microbubbles
118980|NCT03458975|sonoporation|sonoporation
118981|NCT03458975|hepatic metastases of colorectal cancer|hepatic metastases of colorectal cancer
118982|NCT03458962|Nicklaus Children's|nicklaus children's
118983|NCT03458962|Pediatric|pediatric
118984|NCT03458962|Genomic|genomic
118985|NCT03458962|Precision Medicine|precision medicine
118986|NCT03458962|Biorepository|biorepository
118987|NCT03458962|Rady Children's|rady children's
118988|NCT03458936|Depression|depression
118989|NCT03458936|Adolescence|adolescence
118990|NCT03458936|Resilience|resilience
118991|NCT03458936|Risk Factor|risk factor
118992|NCT03458936|Biomarker|biomarker
118993|NCT03458923|Diclofenac|diclofenac
118994|NCT03458923|Ranibizumab|ranibizumab
118995|NCT03458923|Diabetic Macular Edema|diabetic macular edema
118996|NCT03458910|heart rate variability, HRV|heart rate variability, hrv
118997|NCT03458897|bone marrow cellularity|bone marrow cellularity
118998|NCT03458897|bone marrow transplant|bone marrow transplant
118999|NCT03458884|Stroke|stroke
119000|NCT03458884|Fatigue|fatigue
119001|NCT03458884|PROBE design|probe design
119002|NCT03458884|Cardiorespiratory fitness|cardiorespiratory fitness
119003|NCT03458884|Cardiorespiratory training|cardiorespiratory training
119004|NCT03458871|electric stimulation|electric stimulation
119005|NCT03458845|Cirrhosis|cirrhosis
119006|NCT03458845|Sarcopenia|sarcopenia
119007|NCT03458845|Malnutrition|malnutrition
119008|NCT03458845|Inguinal hernia|inguinal hernia
119009|NCT03458845|Umbilical hernia|umbilical hernia
119010|NCT03458845|Undernutrition|undernutrition
119011|NCT03458832|muscular dystrophy.|muscular dystrophy.
119012|NCT03458832|FSHD|fshd
119013|NCT03458806|Auscultation|auscultation
119014|NCT03458806|Phonocardiogram|phonocardiogram
119015|NCT03458806|Machine Learning|machine learning
119016|NCT03458806|Heart Sounds|heart sounds
119017|NCT03458793|randomised controlled study|randomised controlled study
119018|NCT03458793|physical activity|physical activity
119019|NCT03458793|loneliness|loneliness
119020|NCT03458780|yellow fever vaccine|yellow fever vaccine
119021|NCT03458780|immune response|immune response
119022|NCT03458780|"droplet microfluidics single cell (inDrop) RNA-Seq"|"droplet microfluidics single cell (indrop) rna-seq"
119023|NCT03458767|Cognitive function|cognitive function
119024|NCT03458767|Physical activity|physical activity
119025|NCT03458767|Self-management|self-management
119026|NCT03458754|Peripheral Arterial Disease|peripheral arterial disease
119027|NCT03458754|Exercise capacity|exercise capacity
119028|NCT03458754|Physical activity|physical activity
119029|NCT03458754|Respiratory muscle strength|respiratory muscle strength
119030|NCT03458754|Peripheric muscle strength|peripheric muscle strength
119031|NCT03458728|Phase I: relapsed or refractory solid tumors or lymphoma|phase i: relapsed or refractory solid tumors or lymphoma
119032|NCT03458728|Phase II: relapsed or refractory solid tumors (neuroblastoma, osteosarcoma, rhabdomyosarcoma or Ewing sarcoma)|phase ii: relapsed or refractory solid tumors (neuroblastoma, osteosarcoma, rhabdomyosarcoma or ewing sarcoma)
119033|NCT03458715|SGLT2 inhibitor|sglt2 inhibitor
119034|NCT03458715|DPP4 inhibitor|dpp4 inhibitor
119035|NCT03458702|autonomic function|autonomic function
119036|NCT03458702|emotion|emotion
119037|NCT03458702|heart rate variability|heart rate variability
119038|NCT03458676|Advanced magnetic resonance imaging|advanced magnetic resonance imaging
119039|NCT03458676|AMRI|amri
119040|NCT03458624|FURESTEM-AD Inj.|furestem-ad inj.
119041|NCT03458624|Stem cells|stem cells
119042|NCT03458585|ionising radiation|ionising radiation
119043|NCT03458585|patient awareness|patient awareness
119045|NCT03458572|Caesarean section|caesarean section
119046|NCT03458559|Bone metastases|bone metastases
119047|NCT03458559|Rhenium-188-HEDP|rhenium-188-hedp
119048|NCT03458559|Radium 223-chloride|radium 223-chloride
119049|NCT03458559|Survival|survival
119050|NCT03458559|Prostate cancer|prostate cancer
119051|NCT03458533|Pituitary|pituitary
119052|NCT03458533|Obesity|obesity
119053|NCT03458533|Overweight|overweight
119054|NCT03458533|Metabolic syndrome|metabolic syndrome
119055|NCT03458533|MRI|mri
119056|NCT03458507|Neuromuscular diseases|neuromuscular diseases
119057|NCT03458507|Non-invasive ventilation|non-invasive ventilation
119058|NCT03458507|Nasal mask|nasal mask
152050|NCT03249649|CBPR|cbpr
119059|NCT03458507|Oronasal mask|oronasal mask
119060|NCT03458507|Alveolar hypoventilation|alveolar hypoventilation
119061|NCT03458507|leaks|leaks
119062|NCT03458507|Sleep disorder breathing|sleep disorder breathing
119063|NCT03458507|Side effects|side effects
119064|NCT03458494|type 2 diabetes|type 2 diabetes
119065|NCT03458494|glucose|glucose
119066|NCT03458494|insulin|insulin
119072|NCT03458468|tranexamic acid|tranexamic acid
119073|NCT03458468|anterior shoulder instability|anterior shoulder instability
119074|NCT03458468|latarjet|latarjet
119075|NCT03458468|hematoma|hematoma
119076|NCT03458455|TREATMENT|treatment
119077|NCT03458455|Vessel Architectural Imaging|vessel architectural imaging
119078|NCT03458455|Brain Metastases|brain metastases
119079|NCT03458442|education|education
119080|NCT03458442|developing country|developing country
119081|NCT03458442|developing countries|developing countries
119082|NCT03458442|low-and middle-income country|low-and middle-income country
119083|NCT03458442|low-and middle-income countries|low-and middle-income countries
119084|NCT03458442|surgical training|surgical training
119085|NCT03458442|blindness|blindness
119086|NCT03458442|china|china
119087|NCT03458442|simulation|simulation
119088|NCT03458442|model|model
119089|NCT03458429|Young Donor Plasma|young donor plasma
119090|NCT03458429|Frailty|frailty
119091|NCT03458429|Aging|aging
119092|NCT03458429|Immune Function|immune function
119093|NCT03458429|G-CSF|g-csf
119094|NCT03458403|Digestive endoscopy|digestive endoscopy
119095|NCT03458403|Tracking motion|tracking motion
119096|NCT03458377|Colonoscopy|colonoscopy
119097|NCT03458377|Quality|quality
119098|NCT03458377|Telephone intervention|telephone intervention
119099|NCT03458364|Weaning; Noninvasive ventilation; High flow nasal cannula|weaning; noninvasive ventilation; high flow nasal cannula
119100|NCT03458351|platelet activation|platelet activation
119101|NCT03458351|remote ischemic preconditioning|remote ischemic preconditioning
119102|NCT03458338|chronic kidney disease|chronic kidney disease
119103|NCT03458338|communicable disease|communicable disease
119104|NCT03458338|sub-Saharan Africa|sub-saharan africa
119105|NCT03458338|Tanzania|tanzania
119106|NCT03458338|neglected disease|neglected disease
119107|NCT03458338|prevalence|prevalence
119108|NCT03458338|double burden|double burden
119109|NCT03458299|American Indian|american indian
119110|NCT03458286|Diabetic Foot Ulcers|diabetic foot ulcers
119111|NCT03458286|Chronic|chronic
119112|NCT03458286|Combined ultrasound and electric current stimulation|combined ultrasound and electric current stimulation
119113|NCT03458286|Adjunctive therapy|adjunctive therapy
119114|NCT03458273|Atrial Arrhythmia|atrial arrhythmia
119115|NCT03458273|Ventricular Arrythmia|ventricular arrythmia
119116|NCT03458273|ablation|ablation
119117|NCT03458273|fluoroscopy|fluoroscopy
119118|NCT03458260|Diffuse Large B-Cell Lymphoma (DLBCL)|diffuse large b-cell lymphoma (dlbcl)
119119|NCT03458260|relapsed or refractory|relapsed or refractory
119120|NCT03458247|Prostate Cancer|prostate cancer
119121|NCT03458247|Castration resistance|castration resistance
119122|NCT03458247|Drug monitoring|drug monitoring
119123|NCT03458247|Abiraterone acetate|abiraterone acetate
119124|NCT03458234|Focal therapy|focal therapy
119125|NCT03458234|Prostate cancer|prostate cancer
119126|NCT03458234|SBRT|sbrt
119127|NCT03458234|Intra-urethral transponder|intra-urethral transponder
119128|NCT03458221|ovarian carcinoma|ovarian carcinoma
119129|NCT03458221|Signal Transduction Pathway|signal transduction pathway
119130|NCT03458221|therapy|therapy
119131|NCT03458208|AUC|auc
119132|NCT03458208|Cmax|cmax
119133|NCT03458208|Pharmacokinetics|pharmacokinetics
119134|NCT03458208|metformin|metformin
119135|NCT03458208|fed|fed
119136|NCT03458208|fasting|fasting
119137|NCT03458195|ileo-caecal resection; post-operative recurrence|ileo-caecal resection; post-operative recurrence
119138|NCT03458143|ketamine|ketamine
119139|NCT03458143|remifentanil|remifentanil
119140|NCT03458078|Bupivacaine,|bupivacaine,
119141|NCT03458078|Anesthetics|anesthetics
119142|NCT03458078|Adjuvants|adjuvants
119143|NCT03458078|Analgesics|analgesics
119144|NCT03458078|Peripheral system|peripheral system
119145|NCT03458078|Central Nervous|central nervous
119146|NCT03458078|sensory system|sensory system
119147|NCT03458078|Agents|agents
119148|NCT03458078|Physiological effects of drugs|physiological effects of drugs
119149|NCT03458078|opioid|opioid
119150|NCT03458078|Pain|pain
119151|NCT03458078|Postoperative|postoperative
119152|NCT03458078|Signs and Symptoms|signs and symptoms
119153|NCT03458052|Intensive and critical care|intensive and critical care
119154|NCT03458052|Organ donation|organ donation
119155|NCT03458052|Knowledge|knowledge
119160|NCT03458026|activity|activity
119161|NCT03458026|Connected object|connected object
119162|NCT03458013|Mindfulness|mindfulness
119163|NCT03458013|Complementary Medicine|complementary medicine
119164|NCT03458013|Integrative Health|integrative health
119165|NCT03458013|Hand Therapy|hand therapy
119166|NCT03457987|protein load|protein load
119167|NCT03457987|cardiac surgery|cardiac surgery
119168|NCT03457974|saliva composition|saliva composition
119169|NCT03457974|antioxidant activity|antioxidant activity
119170|NCT03457974|caries risk factors|caries risk factors
119171|NCT03457974|congenital cardiac disease|congenital cardiac disease
119172|NCT03457961|Perampanel|perampanel
119173|NCT03457961|focal onset seizure|focal onset seizure
119174|NCT03457961|epilepsy|epilepsy
119175|NCT03457909|string|string
119176|NCT03457909|capsule endoscopy|capsule endoscopy
119177|NCT03457896|NSABP|nsabp
119178|NCT03457896|PUMA|puma
119179|NCT03457896|Neratinib|neratinib
119180|NCT03457896|Trastuzumab|trastuzumab
119181|NCT03457896|Cetuximab|cetuximab
119182|NCT03457896|RAS|ras
119183|NCT03457896|NRAS|nras
119184|NCT03457896|BRAF|braf
119185|NCT03457896|PIK3CA wild-type|pik3ca wild-type
119186|NCT03457896|Quadruple wild-type|quadruple wild-type
119187|NCT03457896|HER2 status|her2 status
119188|NCT03457883|Pelvic organ prolapse|pelvic organ prolapse
119189|NCT03457883|Vaginal mesh|vaginal mesh
119190|NCT03457883|biological graft|biological graft
119191|NCT03457883|Recurrence|recurrence
119192|NCT03457870|Intermittent fasting|intermittent fasting
119193|NCT03457870|Adult hippocampal neurogenesis|adult hippocampal neurogenesis
119194|NCT03457870|Mastication|mastication
119195|NCT03457870|Pattern separation|pattern separation
119196|NCT03457870|Recognition memory|recognition memory
119197|NCT03457870|Klotho|klotho
119198|NCT03457857|Microbiome|microbiome
119199|NCT03457857|Microbiota|microbiota
119200|NCT03457818|Prolia|prolia
119201|NCT03457818|Denosumab|denosumab
119202|NCT03457818|Diabetes|diabetes
119203|NCT03457805|prostate cancer|prostate cancer
119204|NCT03457805|prostate|prostate
119205|NCT03457805|embolization|embolization
119206|NCT03457805|minimally invasive|minimally invasive
119207|NCT03457805|cytoreductive therapy|cytoreductive therapy
119208|NCT03457753|Amyotrophic Lateral Sclerosis|amyotrophic lateral sclerosis
119209|NCT03457740|muscular strength|muscular strength
119210|NCT03457740|testosterone|testosterone
119211|NCT03457740|sexual function|sexual function
119212|NCT03457740|quality of life|quality of life
119213|NCT03457727|Danirixin|danirixin
119214|NCT03457727|Healthy|healthy
119215|NCT03457727|Food effect|food effect
119216|NCT03457727|Relative Bioavailability|relative bioavailability
119217|NCT03457727|Hydrobromide Salt|hydrobromide salt
119218|NCT03457714|spinal cord injuries|spinal cord injuries
119219|NCT03457714|anxiety|anxiety
119220|NCT03457714|depression|depression
119221|NCT03457714|internet-delivered cognitive behaviour therapy|internet-delivered cognitive behaviour therapy
119222|NCT03457714|pilot study|pilot study
119223|NCT03457701|recombinant human erythropoietin|recombinant human erythropoietin
119224|NCT03457701|anemia|anemia
119225|NCT03457701|daprodustat|daprodustat
119226|NCT03457701|chronic kidney disease|chronic kidney disease
119227|NCT03457675|Deep Brain Stimulation (DBS)|deep brain stimulation (dbs)
119228|NCT03457675|Treatment Resistant OCD|treatment resistant ocd
119229|NCT03457675|Intractable OCD|intractable ocd
119230|NCT03457675|Obsessive Compulsive Disorder (OCD)|obsessive compulsive disorder (ocd)
119231|NCT03457675|Cognitive Behavior Therapy (CBT)|cognitive behavior therapy (cbt)
119232|NCT03457675|Exposure and Response Prevention (ERP)|exposure and response prevention (erp)
119233|NCT03457610|chronic cough|chronic cough
119234|NCT03457610|speech and language intervention|speech and language intervention
119235|NCT03457610|difficult-to-treat cough|difficult-to-treat cough
119236|NCT03457532|Safety, Tolerability, Pharmacokinetics, Anti-tumor Activity|safety, tolerability, pharmacokinetics, anti-tumor activity
119237|NCT03457519|ChARM|charm
119238|NCT03457519|community health worker|community health worker
119239|NCT03457506|Cancer|cancer
119240|NCT03457506|Digital pet|digital pet
119241|NCT03457506|Conventional pet|conventional pet
119242|NCT03457480|Cancer Prevention|cancer prevention
119243|NCT03457480|Focus Group|focus group
119244|NCT03457480|Text messaging|text messaging
119245|NCT03457480|Questionnaires|questionnaires
119246|NCT03457480|Surveys|surveys
119247|NCT03457467|oligometacosis|oligometacosis
119248|NCT03457467|anti-angiogenic|anti-angiogenic
119249|NCT03457467|apatinib|apatinib
119250|NCT03457428|obstructive sleep apnea|obstructive sleep apnea
119251|NCT03457428|home sleep testing|home sleep testing
119252|NCT03457415|LDCT|ldct
119253|NCT03457415|Sputum|sputum
119254|NCT03457415|High-risk Smoker|high-risk smoker
119255|NCT03457415|Porphyrin|porphyrin
119256|NCT03457415|Early detection|early detection
119257|NCT03457402|delay discounting|delay discounting
119258|NCT03457402|shaping|shaping
119259|NCT03457389|Prolactinoma|prolactinoma
119260|NCT03457389|Cabergoline|cabergoline
119261|NCT03457389|Recurrence|recurrence
119262|NCT03457363|oxygen|oxygen
119263|NCT03457363|nasal cannula|nasal cannula
119264|NCT03457363|double trunk mask|double trunk mask
119265|NCT03457363|hypoxia|hypoxia
119266|NCT03457350|hysteroscopy|hysteroscopy
119267|NCT03457350|cervical stenosis|cervical stenosis
119268|NCT03457350|probing|probing
119269|NCT03457324|JCM-16021|jcm-16021
119271|NCT03457324|Irritable Bowel Syndrome|irritable bowel syndrome
119272|NCT03457324|Chinese Medicine|chinese medicine
119273|NCT03457311|GSP, oral galactose single point (OGSP)|gsp, oral galactose single point (ogsp)
119274|NCT03457285|Ankylosing spondylitis; physiotherapy; Salaso|ankylosing spondylitis; physiotherapy; salaso
119275|NCT03457272|Patient Safety|patient safety
119276|NCT03457272|Risk Factors|risk factors
119277|NCT03457272|Quality Indicators, Health Care|quality indicators, health care
119278|NCT03457272|Risk Assessment|risk assessment
119279|NCT03457259|Midline catheter, peripheral venous catheter, central venous catheter, complication rate|midline catheter, peripheral venous catheter, central venous catheter, complication rate
119280|NCT03457246|solar lentigos|solar lentigos
119281|NCT03457246|physical Hyperpigmentation therapies|physical hyperpigmentation therapies
119282|NCT03457246|cosmetic topical depigmenting product|cosmetic topical depigmenting product
119283|NCT03457246|topical Hyperpigmentation therapies|topical hyperpigmentation therapies
119284|NCT03457194|Obesity|obesity
119285|NCT03457194|Vaccination|vaccination
119286|NCT03457194|Pregnancy|pregnancy
119287|NCT03457194|Influenza|influenza
119288|NCT03457194|Pertussis|pertussis
119289|NCT03457194|Maternal antibodies|maternal antibodies
119290|NCT03457168|Sleep-time hypertension|sleep-time hypertension
119291|NCT03457168|Ambulatory blood pressure monitoring|ambulatory blood pressure monitoring
119292|NCT03457168|Hypertension chronotherapy|hypertension chronotherapy
119293|NCT03457168|Asleep blood pressure|asleep blood pressure
119294|NCT03457168|Cardiovascular risk|cardiovascular risk
119295|NCT03457168|Type 2 diabetes|type 2 diabetes
119296|NCT03457168|Chronic kidney disease|chronic kidney disease
119297|NCT03457129|Epilepsy|epilepsy
119298|NCT03457129|Epilepsy, partial onset|epilepsy, partial onset
119299|NCT03457129|Epilepsy, generalized onset|epilepsy, generalized onset
119300|NCT03457129|Fycompa|fycompa
119301|NCT03457129|perampanel|perampanel
119302|NCT03457090|neurologic complication, transcranial Doppler ultrasound|neurologic complication, transcranial doppler ultrasound
119303|NCT03457077|brief intervention|brief intervention
119304|NCT03457077|fMRI|fmri
119305|NCT03457038|Mannose-Binding Lectin, PAMPs,|mannose-binding lectin, pamps,
119306|NCT03457025|Oxygen Therapy|oxygen therapy
119307|NCT03457025|Bells Palsy|bells palsy
119308|NCT03456999|BKV, renal transplant, renal and kidney transplant|bkv, renal transplant, renal and kidney transplant
119309|NCT03456960|Drug Therapy|drug therapy
119310|NCT03456934|Protein requirements|protein requirements
119311|NCT03456934|Adiposity|adiposity
119312|NCT03456934|Body composition|body composition
119313|NCT03456934|Cardiovascular health|cardiovascular health
119314|NCT03456921|health games|health games
119315|NCT03456921|community engagement|community engagement
119316|NCT03456921|serious games|serious games
119317|NCT03456882|AMYOTROPHIC LATERAL SCLEROSIS|amyotrophic lateral sclerosis
119318|NCT03456882|RNS60|rns60
119319|NCT03456882|Biomarkers|biomarkers
119320|NCT03456882|clinical trial|clinical trial
119321|NCT03456882|therapy|therapy
119322|NCT03456869|patient specific implant|patient specific implant
119323|NCT03456869|computer-aided surgery|computer-aided surgery
119324|NCT03456869|clinical accuracy|clinical accuracy
119325|NCT03456856|Cardiac|cardiac
119326|NCT03456856|Congestive|congestive
119327|NCT03456856|Decompensation|decompensation
119328|NCT03456856|Heart Failure|heart failure
119329|NCT03456856|Left-Sided|left-sided
119330|NCT03456856|Myocardial|myocardial
119331|NCT03456856|Corlanor|corlanor
119332|NCT03456856|Ivabradine|ivabradine
119333|NCT03456856|African American|african american
119334|NCT03456856|Black|black
119335|NCT03456856|Michigan|michigan
119336|NCT03456830|Kidney stones|kidney stones
119337|NCT03456830|Hyperoxaluria|hyperoxaluria
119338|NCT03456830|Enteric hyperoxaluria|enteric hyperoxaluria
119339|NCT03456830|Oxalate|oxalate
119340|NCT03456791|Epididymal secretory protein E4|epididymal secretory protein e4
119341|NCT03456791|Major epididymis specific protein E4|major epididymis specific protein e4
119342|NCT03456778|Sonographic imaging|sonographic imaging
119343|NCT03456778|Platelet-rich plasma (PRP) injection|platelet-rich plasma (prp) injection
119344|NCT03456778|Shear Wave Elastography|shear wave elastography
119345|NCT03456752|Inflammatory Bowel Diseases|inflammatory bowel diseases
119346|NCT03456752|Glucocorticosteroids|glucocorticosteroids
119347|NCT03456752|Postoperative Outcome|postoperative outcome
119348|NCT03456726|EZH2 gene mutation|ezh2 gene mutation
119349|NCT03456726|Tazemetostat|tazemetostat
119350|NCT03456726|Diffuse large B-cell lymphoma|diffuse large b-cell lymphoma
119351|NCT03456726|Follicular lymphoma|follicular lymphoma
119352|NCT03456687|Exenatide|exenatide
119353|NCT03456661|Pectoral block|pectoral block
119354|NCT03456661|Ultrasound|ultrasound
119355|NCT03456661|Mastectomy|mastectomy
119356|NCT03456661|Levobupivacaine|levobupivacaine
119357|NCT03456661|Dexmedetomidine|dexmedetomidine
119358|NCT03456635|antimicrobial|antimicrobial
119359|NCT03456635|prophylaxys|prophylaxys
119360|NCT03456635|CDSS|cdss
119361|NCT03456622|G7|g7
119362|NCT03456596|CBPR|cbpr
119363|NCT03456596|RE-AIM|re-aim
119364|NCT03456583|Breast Biopsy|breast biopsy
119365|NCT03456583|Breast Biopsy Imaging|breast biopsy imaging
119366|NCT03456583|Stereotactic Imaging|stereotactic imaging
119367|NCT03456414|exercise|exercise
119368|NCT03456414|physical function|physical function
119369|NCT03456414|health related quality of life|health related quality of life
119370|NCT03456375|progesterone|progesterone
119371|NCT03456375|artificial endometrial preparation cycle|artificial endometrial preparation cycle
119372|NCT03456375|endometrial receptivity|endometrial receptivity
119373|NCT03456349|Alzheimer's disease|alzheimer's disease
119374|NCT03456323|Critical Illness|critical illness
119376|NCT03456323|Palliative Care|palliative care
119377|NCT03456297|Web-based clinical pedagogy program|web-based clinical pedagogy program
119378|NCT03456297|nurse preceptors|nurse preceptors
119379|NCT03456297|teaching competency|teaching competency
119380|NCT03456232|hemodialysis|hemodialysis
119381|NCT03456232|hemodiafiltration|hemodiafiltration
119382|NCT03456232|end-stage renal disease|end-stage renal disease
119383|NCT03456219|Food intake|food intake
119384|NCT03456219|Sleep|sleep
119385|NCT03456219|Shift work|shift work
119386|NCT03456219|Postprandial metabolic response|postprandial metabolic response
119387|NCT03456206|Life Style|life style
119388|NCT03456206|Diet|diet
119389|NCT03456206|Food|food
119390|NCT03456206|CID|cid
119391|NCT03456206|Disease risk|disease risk
119392|NCT03456180|septic shock|septic shock
119393|NCT03456180|microcirculation|microcirculation
119394|NCT03456180|acute renal failure|acute renal failure
119395|NCT03456180|renal replacement therapy|renal replacement therapy
119396|NCT03456180|haemoadsorption|haemoadsorption
119397|NCT03456167|telemedicine|telemedicine
119398|NCT03456167|mobile applications|mobile applications
119399|NCT03456167|ERAS|eras
119400|NCT03456167|postoperative care|postoperative care
119401|NCT03456167|patient satisfaction|patient satisfaction
119402|NCT03456167|breast reconstruction|breast reconstruction
119403|NCT03456167|gynecologic oncology|gynecologic oncology
119404|NCT03456167|mastectomy|mastectomy
119405|NCT03456128|Older Adult|older adult
119406|NCT03456128|Rehospitalization|rehospitalization
119407|NCT03456128|Physical function|physical function
119408|NCT03456115|nasal obstruction|nasal obstruction
119409|NCT03456115|nasal valve collapse|nasal valve collapse
119410|NCT03456089|urodynamics|urodynamics
119411|NCT03456089|neurogenic|neurogenic
119412|NCT03456089|bladder|bladder
119413|NCT03456076|NSCLC, alectinib, ALK positive,adjuvant treatment, platinum based chemotherapy, complete resection, Stage IB-IIIA.|nsclc, alectinib, alk positive,adjuvant treatment, platinum based chemotherapy, complete resection, stage ib-iiia.
119414|NCT03456037|HBsAg|hbsag
119415|NCT03456037|Anti-HCV,|anti-hcv,
119416|NCT03456037|seropositivity|seropositivity
119417|NCT03455998|morbid obesity|morbid obesity
119418|NCT03455998|gastric bypass|gastric bypass
119419|NCT03455998|pain|pain
119420|NCT03455998|symptoms|symptoms
119421|NCT03455959|Asthma|asthma
119422|NCT03455959|Allergic|allergic
119423|NCT03455959|Inflammation|inflammation
119424|NCT03455959|Airway|airway
119425|NCT03455946|Digital Health|digital health
119426|NCT03455946|Amazon Alexa|amazon alexa
119427|NCT03455907|Bevacizumab|bevacizumab
119428|NCT03455894|Fall detection|fall detection
119429|NCT03455894|Smart carpet|smart carpet
119430|NCT03455894|Elderly people|elderly people
119432|NCT03455881|EA|ea
119433|NCT03455881|Tracheal Esophageal birth Defect (TED)|tracheal esophageal birth defect (ted)
119434|NCT03455855|Atherectomy|atherectomy
119435|NCT03455855|occlusive atherosclerotic lesions|occlusive atherosclerotic lesions
119436|NCT03455829|Lung Cancer|lung cancer
119437|NCT03455829|Non-small Cell Lung Cancer|non-small cell lung cancer
119438|NCT03455829|CDK 4/6 Inhibitor|cdk 4/6 inhibitor
119439|NCT03455829|EGFR-Positive|egfr-positive
119440|NCT03455829|EGFR Mutation- Positive|egfr mutation- positive
119441|NCT03455829|T790M|t790m
119442|NCT03455829|EGFR Mutant|egfr mutant
119443|NCT03455816|mobile app|mobile app
119444|NCT03455790|Wheelchair Basketball,|wheelchair basketball,
119445|NCT03455790|Isokinetic|isokinetic
119446|NCT03455790|Anaerobic Capacity|anaerobic capacity
119447|NCT03455790|Shoulder Muscle Strength|shoulder muscle strength
119448|NCT03455790|Aerobic Capacity,|aerobic capacity,
119449|NCT03455790|Sportive Performance|sportive performance
119450|NCT03455764|Melanoma|melanoma
119451|NCT03455751|Pain Management|pain management
119452|NCT03455751|Pharmacogenomics|pharmacogenomics
119453|NCT03455738|Vasoplegia, norepinephrine, dynamic arterial elastance|vasoplegia, norepinephrine, dynamic arterial elastance
119454|NCT03455725|Cardiovascular Stem Cell Therapy|cardiovascular stem cell therapy
119455|NCT03455725|Bone Marrow Mononuclear Stem Cells|bone marrow mononuclear stem cells
119456|NCT03455725|Intramyocardial Injection|intramyocardial injection
119457|NCT03455712|Pregnancy|pregnancy
119458|NCT03455712|Gestational weight gain|gestational weight gain
119459|NCT03455712|Weight gain|weight gain
119460|NCT03455712|Patient education|patient education
119461|NCT03455712|Patient knowledge|patient knowledge
119462|NCT03455712|Institute of Medicine|institute of medicine
119463|NCT03455699|GSV|gsv
119464|NCT03455686|magnetic resonance imaging|magnetic resonance imaging
119465|NCT03455686|hyperpolarized xenon-129|hyperpolarized xenon-129
119466|NCT03455686|lung function|lung function
119467|NCT03455686|lung structure|lung structure
119468|NCT03455660|Cesarean|cesarean
119469|NCT03455660|C-Section|c-section
119470|NCT03455647|stunting|stunting
119471|NCT03455647|underweight|underweight
119472|NCT03455647|wasting|wasting
119473|NCT03455634|quality of life|quality of life
119474|NCT03455621|dental caries|dental caries
119475|NCT03455621|fluoride|fluoride
119476|NCT03455621|toothpaste|toothpaste
119477|NCT03455621|dentifrice|dentifrice
119478|NCT03455608|dysphagia|dysphagia
119479|NCT03455608|swallowing disorder|swallowing disorder
119480|NCT03455608|speech pathology|speech pathology
119481|NCT03455608|swallowing therapy|swallowing therapy
119482|NCT03455608|head and neck cancer|head and neck cancer
119483|NCT03455608|radiotherapy|radiotherapy
119484|NCT03455608|toxicity|toxicity
119485|NCT03455608|supportive care|supportive care
119486|NCT03455582|cognitive impairment|cognitive impairment
119487|NCT03455582|ecological assessment|ecological assessment
119488|NCT03455582|brain MRI|brain mri
119489|NCT03455569|Behavioral sleep management|behavioral sleep management
119490|NCT03455569|Alzheimer's disease|alzheimer's disease
119491|NCT03455569|Informal caregiver|informal caregiver
119492|NCT03455517|Chronic myeloid leukemia|chronic myeloid leukemia
119493|NCT03455517|Umutated IGVH|umutated igvh
119494|NCT03455517|Disrupted TP53|disrupted tp53
119495|NCT03455504|Acute myeloid leukemia|acute myeloid leukemia
119496|NCT03455504|Venetoclax|venetoclax
119497|NCT03455413|electrical impedance tomography|electrical impedance tomography
119498|NCT03455387|sFLt1|sflt1
119499|NCT03455387|PlGF|plgf
119500|NCT03455361|implant stability, dental implants, primary stability|implant stability, dental implants, primary stability
119501|NCT03455309|Als3|als3
119502|NCT03455309|SSTI|ssti
119503|NCT03455309|vaccine|vaccine
119504|NCT03455309|NDV-3A|ndv-3a
119505|NCT03455309|incident nasal colonization|incident nasal colonization
119506|NCT03455270|Breast Cancer|breast cancer
119507|NCT03455270|Oral SERD|oral serd
119508|NCT03455270|SERD|serd
119509|NCT03455270|HER2-Negative|her2-negative
119510|NCT03455270|ER-Positive|er-positive
119511|NCT03455270|ER+|er+
119512|NCT03455270|HER2-|her2-
119513|NCT03455270|HER2 -ve|her2 -ve
119514|NCT03455270|ER +ve|er +ve
119515|NCT03455231|palliative care|palliative care
119516|NCT03455231|complicated bone metastases|complicated bone metastases
119517|NCT03455231|radiotherapy|radiotherapy
119518|NCT03455231|pain|pain
119519|NCT03455231|quality of life|quality of life
119520|NCT03455218|Cardiopulmonary Bypass|cardiopulmonary bypass
119521|NCT03455218|Infant|infant
119522|NCT03455218|Nitric Oxide|nitric oxide
119523|NCT03455218|Thrombocytopenia|thrombocytopenia
119524|NCT03455218|Blood Platelets|blood platelets
119525|NCT03455192|gingivitis|gingivitis
119526|NCT03455192|gingival crevicular fluid|gingival crevicular fluid
119527|NCT03455192|probiotics|probiotics
119528|NCT03455192|smoking|smoking
119529|NCT03455192|periodontal medicine|periodontal medicine
119530|NCT03455179|Older|older
119531|NCT03455179|Physical function|physical function
119532|NCT03455179|Power training|power training
119533|NCT03455179|Oxidative stress|oxidative stress
119534|NCT03455179|Elastic band|elastic band
119535|NCT03455179|OMNI-RES perceived exertion scale|omni-res perceived exertion scale
119536|NCT03455179|Strength training|strength training
119537|NCT03455153|Pulmonary Rehabilitation|pulmonary rehabilitation
119538|NCT03455153|Neutrophils|neutrophils
119539|NCT03455140|Arginine|arginine
119540|NCT03455140|Arginase|arginase
119541|NCT03455140|Children|children
119542|NCT03455140|Young Adult|young adult
119543|NCT03455127|Child Development|child development
119544|NCT03455127|Home Visiting|home visiting
119545|NCT03455127|Parenting Program|parenting program
119546|NCT03455127|Social Protection|social protection
119547|NCT03455127|Public Works|public works
119548|NCT03455101|Cardiovascular risk status|cardiovascular risk status
119549|NCT03455101|Optimal metabolic control|optimal metabolic control
119550|NCT03455075|Healthy Men|healthy men
119551|NCT03455075|Male Contraception|male contraception
119552|NCT03455075|Androgen|androgen
119553|NCT03455075|Dimethandrolone|dimethandrolone
119554|NCT03455075|Levonorgestrel|levonorgestrel
119555|NCT03455062|Transplant, fertility|transplant, fertility
119556|NCT03455036|whole body vibration, erythema, tryptase, unpleasantness|whole body vibration, erythema, tryptase, unpleasantness
119557|NCT03455023|Cancer pain|cancer pain
119558|NCT03455023|Pharmaceutical care|pharmaceutical care
119559|NCT03455010|Ambulatory load|ambulatory load
119560|NCT03455010|Biomarker|biomarker
119561|NCT03455010|Articular cartilage|articular cartilage
119562|NCT03454945|Mycosis fungoides|mycosis fungoides
119563|NCT03454945|Doxycycline|doxycycline
119564|NCT03454932|Rheumatoid Arthritis|rheumatoid arthritis
119565|NCT03454932|Psoriatic Arthritis|psoriatic arthritis
119566|NCT03454932|Spondylarthritis|spondylarthritis
119567|NCT03454932|Rheumatic diseases|rheumatic diseases
119568|NCT03454932|Inflammation|inflammation
119569|NCT03454932|Autoimmune diseases|autoimmune diseases
119570|NCT03454932|Osteoimmunology|osteoimmunology
119571|NCT03454906|hemodialysis|hemodialysis
119572|NCT03454906|hemoglobin variability|hemoglobin variability
119573|NCT03454906|mortality|mortality
119574|NCT03454906|nutrition|nutrition
119575|NCT03454906|inflammation|inflammation
119576|NCT03454880|Accelerometry|accelerometry
119577|NCT03454880|Wearable electronic devices|wearable electronic devices
119578|NCT03454854|risk evaluation|risk evaluation
119579|NCT03454854|individualized treatment|individualized treatment
119580|NCT03454854|coronary artery disease|coronary artery disease
119581|NCT03454854|antithrombotic therapy|antithrombotic therapy
119582|NCT03454854|Chinese people|chinese people
119583|NCT03454854|Application|application
119584|NCT03454841|prasugrel|prasugrel
119585|NCT03454841|ticagrelor|ticagrelor
119586|NCT03454841|VASP|vasp
119587|NCT03454841|platelet reactivity|platelet reactivity
119588|NCT03454841|STEMI|stemi
119589|NCT03454841|NSTEMI|nstemi
119590|NCT03454815|Apical Patency|apical patency
119591|NCT03454815|Root Canal Treatment|root canal treatment
119592|NCT03454789|brachial plexus block|brachial plexus block
119593|NCT03454789|local anesthetic mixture solution|local anesthetic mixture solution
119594|NCT03454789|axillary-supraclavicular approach|axillary-supraclavicular approach
119595|NCT03454789|outcome quality|outcome quality
119596|NCT03454789|lidocaine, bupivacaine|lidocaine, bupivacaine
119597|NCT03454789|onset time|onset time
119598|NCT03454789|duration action local anesthetic|duration action local anesthetic
119599|NCT03454789|postoperative analgesia|postoperative analgesia
119600|NCT03454763|sst2-positive tumors|sst2-positive tumors
119601|NCT03454763|Neuroendocrine Tumors|neuroendocrine tumors
119602|NCT03454763|radiolabelled somatostatin analogues (PRRT)|radiolabelled somatostatin analogues (prrt)
119603|NCT03454750|Metastatic castration resistant prostate cancer|metastatic castration resistant prostate cancer
119604|NCT03454750|68Ga-PSMA PET/CT positive|68ga-psma pet/ct positive
119605|NCT03454724|BioResorbable Vascular Scaffold System|bioresorbable vascular scaffold system
119606|NCT03454711|Obesity|obesity
119607|NCT03454711|Food addictions|food addictions
119608|NCT03454711|Functional magnetic resonance imaging (fMRI)|functional magnetic resonance imaging (fmri)
119609|NCT03454711|Metabolomics|metabolomics
119610|NCT03454633|Hyperthermic circulatory arrest; Surgery|hyperthermic circulatory arrest; surgery
119611|NCT03454607|FREE|free
119612|NCT03454607|Robotic|robotic
119613|NCT03454594|hypertension|hypertension
119614|NCT03454594|high blood viscosity|high blood viscosity
119615|NCT03454594|hypercholesterolemia|hypercholesterolemia
119616|NCT03454581|Temporomandibular Diseases|temporomandibular diseases
119617|NCT03454581|Photobiomodulation|photobiomodulation
119618|NCT03454581|Low level laser|low level laser
119619|NCT03454581|Treatment|treatment
119620|NCT03454581|Manual Therapy|manual therapy
119621|NCT03454568|Stem Cell Transplant|stem cell transplant
119622|NCT03454555|Pragmatic Clinical Trial|pragmatic clinical trial
119623|NCT03454555|Comparative Effectiveness Research|comparative effectiveness research
119624|NCT03454555|Analgesics, Opioid|analgesics, opioid
119625|NCT03454555|Decision Making, Shared|decision making, shared
119626|NCT03454555|Motivational Interviewing|motivational interviewing
119627|NCT03454555|Cognitive Therapy|cognitive therapy
119628|NCT03454555|Patient Reported Outcome Measures|patient reported outcome measures
119629|NCT03454516|Hypertension|hypertension
119630|NCT03454516|Telemonitoring|telemonitoring
119631|NCT03454516|Digital Health|digital health
119632|NCT03454503|Imatinib|imatinib
119633|NCT03454503|Generic Imatinib|generic imatinib
119634|NCT03454503|Leukemia|leukemia
119635|NCT03454503|Chronic myeloid leukemia|chronic myeloid leukemia
119636|NCT03454503|Philadelphia chromosome-positive|philadelphia chromosome-positive
119637|NCT03454503|Chronic phase|chronic phase
119638|NCT03454503|Observational study|observational study
119639|NCT03454503|Switched patients|switched patients
119640|NCT03454503|Tyrosine kinase inhibitor|tyrosine kinase inhibitor
119641|NCT03454490|Gingival graft|gingival graft
119642|NCT03454490|Pseudoaneurysm|pseudoaneurysm
119643|NCT03454490|Postoperative complication|postoperative complication
119644|NCT03454490|Gingival recession treatment|gingival recession treatment
119645|NCT03454490|Palatine mass|palatine mass
119646|NCT03454490|Palatine bleeding|palatine bleeding
119647|NCT03454477|Endoscopy|endoscopy
119648|NCT03454477|Robotics|robotics
119649|NCT03454477|Thyroidectomy|thyroidectomy
119650|NCT03454477|Papillary Thyroid Carcinoma|papillary thyroid carcinoma
119651|NCT03454451|NSCLC|nsclc
119652|NCT03454451|RCC|rcc
119653|NCT03454451|TNBC|tnbc
119654|NCT03454451|mCRPC|mcrpc
119655|NCT03454451|CRC|crc
119656|NCT03454451|Lung Cancer|lung cancer
119657|NCT03454451|Kidney Cancer|kidney cancer
119658|NCT03454451|Rectal Cancer|rectal cancer
119659|NCT03454451|Breast Cancer|breast cancer
119660|NCT03454451|Sarcoma|sarcoma
119661|NCT03454451|Endometrial|endometrial
119662|NCT03454451|Pancreatic|pancreatic
119663|NCT03454451|Ovarian|ovarian
119664|NCT03454451|SCCHN|scchn
119665|NCT03454451|NHL|nhl
119666|NCT03454438|Referral|referral
119667|NCT03454438|Primary care|primary care
119668|NCT03454438|Rheumatologist|rheumatologist
119669|NCT03454425|Parkinson's Disease|parkinson's disease
119670|NCT03454425|ExAblate|exablate
119671|NCT03454425|MRgFUS|mrgfus
119672|NCT03454425|Sub-Thalamotomy|sub-thalamotomy
119673|NCT03454412|Cerebral Palsy|cerebral palsy
119674|NCT03454412|Rehabilitation|rehabilitation
119675|NCT03454412|Hand|hand
119676|NCT03454386|Irritable Bowel Syndrome (IBS)|irritable bowel syndrome (ibs)
119677|NCT03454386|Stress|stress
119678|NCT03454386|Resilience|resilience
119679|NCT03454386|Stress Management and Resilience Training Program (SMART)|stress management and resilience training program (smart)
119680|NCT03454373|HIV|hiv
119681|NCT03454373|Food Insecurities|food insecurities
119682|NCT03454373|Antiretroviral Therapy|antiretroviral therapy
119683|NCT03454360|TAVI|tavi
119684|NCT03454360|Transcatheter Aortic Valve Replacement|transcatheter aortic valve replacement
119685|NCT03454360|Transcatheter Aortic Valve|transcatheter aortic valve
119686|NCT03454360|Transapical Access|transapical access
119687|NCT03454321|Rotator cuff tendinopathy|rotator cuff tendinopathy
119688|NCT03454321|ultrasound|ultrasound
119689|NCT03454321|subacromial bursitis|subacromial bursitis
119690|NCT03454321|steroid injection|steroid injection
119691|NCT03454295|Cancer Caregivers|cancer caregivers
119692|NCT03454295|Caregiver|caregiver
119693|NCT03454295|Caregivers|caregivers
119694|NCT03454295|Memorial Sloan Kettering Cancer Center|memorial sloan kettering cancer center
119695|NCT03454295|18-075|18-075
119696|NCT03454282|Breast|breast
119697|NCT03454282|Cancer|cancer
119698|NCT03454282|Malignant|malignant
119699|NCT03454282|Melanoma|melanoma
119700|NCT03454282|Fasting Mimicking Diet (FMD)|fasting mimicking diet (fmd)
119701|NCT03454282|Tumor|tumor
119702|NCT03454282|Immunity|immunity
119703|NCT03454282|Metabolic Effects|metabolic effects
119704|NCT03454282|Immunological Effects|immunological effects
119705|NCT03454269|Parkinson disease|parkinson disease
119706|NCT03454269|Visual Hallucinations|visual hallucinations
119707|NCT03454269|Illusions|illusions
119708|NCT03454269|Retina|retina
119709|NCT03454256|Virtual Reality|virtual reality
119710|NCT03454256|Total Knee Replacement|total knee replacement
119711|NCT03454256|Proprioception|proprioception
119712|NCT03454256|Balance|balance
119713|NCT03454256|Gait|gait
119714|NCT03454243|Solid Tumors|solid tumors
119715|NCT03454243|TYRO3|tyro3
119716|NCT03454243|AXL|axl
119717|NCT03454243|MER|mer
119718|NCT03454243|Receptor tyrosine kinases (RTKs)|receptor tyrosine kinases (rtks)
119719|NCT03454243|Checkpoint inhibitors|checkpoint inhibitors
119720|NCT03454243|Melanoma|melanoma
119721|NCT03454243|Non-small cell lung cancer (NSCLC)|non-small cell lung cancer (nsclc)
119722|NCT03454243|Squamous cell carcinoma|squamous cell carcinoma
119723|NCT03454243|Hodgkin lymphoma|hodgkin lymphoma
119724|NCT03454243|Urothelial carcinoma|urothelial carcinoma
119725|NCT03454243|Microsatellite instability-high carcinomas|microsatellite instability-high carcinomas
119726|NCT03454243|TAM Inhibitor|tam inhibitor
119727|NCT03454230|Intensive care unit|intensive care unit
119728|NCT03454230|ICU|icu
119729|NCT03454230|adult critical care patients|adult critical care patients
119730|NCT03454230|repositioning schedule|repositioning schedule
119731|NCT03454230|patient handling|patient handling
119732|NCT03454230|practical nursing|practical nursing
119733|NCT03454230|nursing care|nursing care
119734|NCT03454230|pressure ulcers|pressure ulcers
119735|NCT03454230|decubitus ulcers|decubitus ulcers
119736|NCT03454230|pressure injury|pressure injury
119737|NCT03454178|AOBP|aobp
119738|NCT03454178|ABPM|abpm
119739|NCT03454139|percutaneous nephrolithotomy|percutaneous nephrolithotomy
119740|NCT03454139|subcostal transversus abdominis plane block|subcostal transversus abdominis plane block
119741|NCT03454139|pain|pain
119742|NCT03454139|paracetamol|paracetamol
119743|NCT03454139|tramadol|tramadol
119744|NCT03454139|morphine|morphine
119745|NCT03454139|nephrolithiasis|nephrolithiasis
119746|NCT03454139|lidocaine|lidocaine
119747|NCT03454139|bupivacaine|bupivacaine
119748|NCT03454126|Chronic pain|chronic pain
119749|NCT03454126|Neuropathic pain|neuropathic pain
119750|NCT03454126|Neuralgia|neuralgia
119751|NCT03454126|Healthy volunteers|healthy volunteers
119752|NCT03454113|dialysis autogenous arterio-venous fistula|dialysis autogenous arterio-venous fistula
119753|NCT03454087|enteral nutrition|enteral nutrition
119754|NCT03454087|inflammation|inflammation
119755|NCT03454087|incretin hormones|incretin hormones
119756|NCT03454087|microbiome|microbiome
119757|NCT03454074|healthy aging|healthy aging
119758|NCT03454074|behavior change|behavior change
119759|NCT03454074|older adults|older adults
119760|NCT03454061|sport|sport
119761|NCT03454061|physical activity|physical activity
119762|NCT03454061|education|education
119763|NCT03454061|fundamental motor skills|fundamental motor skills
119764|NCT03454061|childhood|childhood
119765|NCT03454061|exercise|exercise
119766|NCT03454061|health|health
119767|NCT03454061|training|training
119768|NCT03454061|intervention|intervention
119769|NCT03454061|gross motor development|gross motor development
119770|NCT03454009|multi-modal intervention;|multi-modal intervention;
119771|NCT03454009|office-based employees|office-based employees
119772|NCT03454009|hand hygiene|hand hygiene
119773|NCT03454009|hand sanitizer|hand sanitizer
119774|NCT03454009|hand sanitizer surface wipes|hand sanitizer surface wipes
119775|NCT03454009|self-reported infections|self-reported infections
119776|NCT03454009|absenteeism|absenteeism
119777|NCT03454009|presenteeism|presenteeism
119778|NCT03453996|acute kidney injury|acute kidney injury
119779|NCT03453996|heart disease|heart disease
119780|NCT03453996|cardiac catheterization|cardiac catheterization
119781|NCT03453983|Neurodevelopment|neurodevelopment
119782|NCT03453983|Pediatrics|pediatrics
119783|NCT03453983|Motor Learning|motor learning
119784|NCT03453983|Brain Imaging|brain imaging
119785|NCT03453983|Neuroscience|neuroscience
119786|NCT03453970|patient education|patient education
119787|NCT03453970|self-care|self-care
119788|NCT03453970|Controlled Trial|controlled trial
119789|NCT03453957|Practice based research|practice based research
119790|NCT03453944|Expiratory muscles|expiratory muscles
119791|NCT03453944|Mechanically ventilated patients|mechanically ventilated patients
119792|NCT03453944|Neuromuscular electrical stimulation|neuromuscular electrical stimulation
119793|NCT03453944|Respiratory function|respiratory function
119794|NCT03453944|Ventilator-acquired muscle atrophy|ventilator-acquired muscle atrophy
119795|NCT03453931|Corticosteroids|corticosteroids
119796|NCT03453931|Arrhythmia|arrhythmia
119797|NCT03453931|Heart Rate Variability|heart rate variability
119798|NCT03453931|Albuminuria|albuminuria
119799|NCT03453918|Iron absorption|iron absorption
119800|NCT03453918|Polyphenols|polyphenols
119801|NCT03453918|Dysmetabolic iron overload syndrome|dysmetabolic iron overload syndrome
119802|NCT03453918|Metabolic syndrome X|metabolic syndrome x
119803|NCT03453918|Genetic Hemochromatosis|genetic hemochromatosis
119804|NCT03453918|Oxylipin|oxylipin
119805|NCT03453918|Lipidomic analysis|lipidomic analysis
119806|NCT03453905|CT-based Finite Element Analysis|ct-based finite element analysis
119807|NCT03453905|Randomized Controlled Study|randomized controlled study
119808|NCT03453905|Preventive bone fixation|preventive bone fixation
119809|NCT03453905|Randomized Controlled Trial|randomized controlled trial
119810|NCT03453892|Metastatic cancer|metastatic cancer
119811|NCT03453892|Radiotherapy|radiotherapy
119812|NCT03453892|Immunotherapy|immunotherapy
119813|NCT03453892|radioimmuno therapy|radioimmuno therapy
119814|NCT03453866|Hip Arthroscopy|hip arthroscopy
119815|NCT03453866|Warmed Fluids|warmed fluids
119816|NCT03453853|Percutaneous mitral valve repair|percutaneous mitral valve repair
119817|NCT03453853|Coronary sinus annuloplasty|coronary sinus annuloplasty
119818|NCT03453853|Mitral loop cerclage|mitral loop cerclage
119819|NCT03453853|atrial fibrillation|atrial fibrillation
119820|NCT03453853|Mitral Regurgitation|mitral regurgitation
119821|NCT03453840|malaria|malaria
119822|NCT03453840|HIV|hiv
119823|NCT03453840|Children|children
119824|NCT03453840|Efavirenz|efavirenz
119825|NCT03453840|artemether|artemether
119826|NCT03453840|lumefantrine|lumefantrine
119827|NCT03453827|Pseudoexfoliation Syndrome|pseudoexfoliation syndrome
119828|NCT03453827|Cataract|cataract
119829|NCT03453827|Aberration|aberration
119830|NCT03453827|IOL decentration|iol decentration
119831|NCT03453827|IOL tilt|iol tilt
119832|NCT03453814|PICU|picu
119833|NCT03453814|critical care|critical care
119834|NCT03453814|music|music
119835|NCT03453814|music therapy|music therapy
119836|NCT03453814|agitation|agitation
119837|NCT03453801|Inactivated, influenza vaccine quadrivalent|inactivated, influenza vaccine quadrivalent
119838|NCT03453801|Live, attenuated influenza vaccine quadrivalent|live, attenuated influenza vaccine quadrivalent
119839|NCT03453801|Young children|young children
119840|NCT03453801|Identical twins|identical twins
119841|NCT03453788|follow up|follow up
119842|NCT03453788|side effects|side effects
119843|NCT03453788|smartphone app|smartphone app
119844|NCT03453788|physical activity|physical activity
119845|NCT03453788|empowerment|empowerment
119846|NCT03453788|patient reported outcomes|patient reported outcomes
119847|NCT03453749|Traumatic brain injury|traumatic brain injury
119848|NCT03453749|Cerebral edema|cerebral edema
119849|NCT03453749|Microdialysis|microdialysis
119850|NCT03453749|Inflammatory cytokines|inflammatory cytokines
119851|NCT03453736|Robotic surgery|robotic surgery
119852|NCT03453736|theatre staff|theatre staff
119853|NCT03453736|teamwork|teamwork
119854|NCT03453736|patient safety|patient safety
119855|NCT03453723|hypnoanalgesia|hypnoanalgesia
119856|NCT03453723|lidocaine|lidocaine
119857|NCT03453723|propofol|propofol
119858|NCT03453723|children|children
119859|NCT03453710|Bankart Repair|bankart repair
119860|NCT03453710|Remplissage|remplissage
119861|NCT03453710|Latarjet coracoid transfer|latarjet coracoid transfer
119862|NCT03453697|Intermittent Hypoxemia|intermittent hypoxemia
119863|NCT03453697|diffusion tensor imaging|diffusion tensor imaging
119864|NCT03453697|oxidative stress|oxidative stress
119865|NCT03453658|Endodontics|endodontics
119866|NCT03453658|Primary Teeth|primary teeth
119867|NCT03453658|Reciprocating instrumentation|reciprocating instrumentation
119868|NCT03453658|Mechanized instrumentation|mechanized instrumentation
119869|NCT03453645|ablation|ablation
119870|NCT03453645|sudden death|sudden death
119871|NCT03453645|signal averaged ECG|signal averaged ecg
119872|NCT03453645|T wave alternans|t wave alternans
119873|NCT03453645|heart rate variability|heart rate variability
119874|NCT03453632|Dermatology|dermatology
119875|NCT03453632|Rare skin diseases|rare skin diseases
119876|NCT03453632|epidermolysis bullosa simplex|epidermolysis bullosa simplex
119877|NCT03453632|botulinic toxin|botulinic toxin
119878|NCT03453632|blisters|blisters
119879|NCT03453606|Pulmonary rehabilitation|pulmonary rehabilitation
119880|NCT03453606|home-based|home-based
119881|NCT03453593|Trauma|trauma
119882|NCT03453593|India|india
119883|NCT03453593|Computed tomography|computed tomography
119884|NCT03453567|TAVR|tavr
119885|NCT03453567|SAVR|savr
119886|NCT03453567|TAVI|tavi
119887|NCT03453567|Conventional AVR|conventional avr
119888|NCT03453567|Sutureless AVR|sutureless avr
119889|NCT03453554|technology|technology
119890|NCT03453554|activities of daily living|activities of daily living
119891|NCT03453554|everyday functioning|everyday functioning
119892|NCT03453554|quality of life|quality of life
119893|NCT03453554|memory impairment|memory impairment
119894|NCT03453528|mCRPC or advanced/metastatic solid tumors|mcrpc or advanced/metastatic solid tumors
119895|NCT03453528|Prostate-specific membrane antigen|prostate-specific membrane antigen
119896|NCT03453502|quality improvement|quality improvement
119897|NCT03453502|breast milk|breast milk
119898|NCT03453476|Photodynamic therapy|photodynamic therapy
119899|NCT03453476|Interleukin 1-beta|interleukin 1-beta
119900|NCT03453476|Tumour necrosis factor - alpha|tumour necrosis factor - alpha
119901|NCT03453476|Interleukin-6|interleukin-6
119902|NCT03453476|Interleukin-8|interleukin-8
119903|NCT03453476|Matrix metalloproteinase-8|matrix metalloproteinase-8
119904|NCT03453463|sarcopenia|sarcopenia
119905|NCT03453463|osteopenia|osteopenia
119906|NCT03453463|older men|older men
119907|NCT03453463|community dwelling|community dwelling
119908|NCT03453463|physical functioning|physical functioning
119909|NCT03453450|Primary Care|primary care
119910|NCT03453411|Equimolar Mixture of Oxygen and Nitrous Oxide (EMONO)|equimolar mixture of oxygen and nitrous oxide (emono)
119911|NCT03453411|Substance-Related Disorders|substance-related disorders
119912|NCT03453398|Chronotype|chronotype
119913|NCT03453398|Shift work|shift work
119914|NCT03453398|Health status|health status
119915|NCT03453385|Smoking|smoking
119916|NCT03453385|Nicotine|nicotine
119917|NCT03453385|Tobacco|tobacco
119918|NCT03453385|Electronic Cigarette|electronic cigarette
119919|NCT03453372|Osteoarthritis|osteoarthritis
119920|NCT03453372|Knee|knee
119921|NCT03453372|MRgFUS|mrgfus
119922|NCT03453372|ExAblate|exablate
119923|NCT03453372|Pain|pain
119924|NCT03453372|High-Intensity Focused Ultrasound Ablation|high-intensity focused ultrasound ablation
119925|NCT03453359|deep sedation|deep sedation
119926|NCT03453359|spontaneous ventilation|spontaneous ventilation
119927|NCT03453346|Hepatitis C virus|hepatitis c virus
119928|NCT03453346|Sofosbuvir|sofosbuvir
119929|NCT03453346|RNA polymerase inhibitor|rna polymerase inhibitor
119930|NCT03453346|Ribavirin|ribavirin
119931|NCT03453346|Genotype 2|genotype 2
119932|NCT03453346|Sustained virologic response|sustained virologic response
119933|NCT03453346|Confirmatory study|confirmatory study
119934|NCT03453307|Tumor Organoids|tumor organoids
119935|NCT03453307|Drug Sensitivity|drug sensitivity
119937|NCT03453294|THRIVE|thrive
119938|NCT03453281|Aflibercept|aflibercept
119939|NCT03453281|Diabetic Macular Edema|diabetic macular edema
119940|NCT03453281|Electroretinogram|electroretinogram
119941|NCT03453281|Central Macular Thickness|central macular thickness
119942|NCT03453281|ETDRS|etdrs
119943|NCT03453268|Blood pressure|blood pressure
119944|NCT03453268|Aged|aged
119945|NCT03453268|Frailty|frailty
119946|NCT03453268|Polypharmacy|polypharmacy
119947|NCT03453255|AML, chidamide, decitabine|aml, chidamide, decitabine
119948|NCT03453242|Osteoporosis|osteoporosis
119949|NCT03453203|Chronic migraine|chronic migraine
119950|NCT03453203|Osteopathic manipulative treatment|osteopathic manipulative treatment
119951|NCT03453203|Cervicalgia|cervicalgia
119952|NCT03453164|Radiotherapy|radiotherapy
119953|NCT03453164|anti-PD-1 antibody|anti-pd-1 antibody
119954|NCT03453138|laryngel mask airway|laryngel mask airway
119955|NCT03453138|laparoscopic surgery|laparoscopic surgery
119956|NCT03453125|cognitive rehabilitation|cognitive rehabilitation
119957|NCT03453125|memory|memory
119958|NCT03453112|Peek Expiratory Flow (PEF) Lung function tests|peek expiratory flow (pef) lung function tests
119959|NCT03453099|propofol|propofol
119960|NCT03453099|anaesthetic dose|anaesthetic dose
119961|NCT03453099|sleep|sleep
119962|NCT03453099|caffeine|caffeine
119963|NCT03453099|anxiety|anxiety
119964|NCT03453099|induction|induction
119965|NCT03453073|Coronary heart disease|coronary heart disease
119967|NCT03453073|chocolate consumption|chocolate consumption
119968|NCT03453073|postmenopausal women|postmenopausal women
119969|NCT03453073|nutrition|nutrition
119970|NCT03453073|dietary intake|dietary intake
119971|NCT03453073|epidemiology|epidemiology
119972|NCT03453047|S100β|s100β
119973|NCT03453047|Neuron specific enolase|neuron specific enolase
119974|NCT03453047|Liver transplantation|liver transplantation
119975|NCT03453034|TQ-B3233|tq-b3233
119976|NCT03453034|tumor|tumor
119977|NCT03453034|toleration|toleration
119978|NCT03453034|pharmacokinetics|pharmacokinetics
119979|NCT03453021|asthma|asthma
119980|NCT03453021|mepolizumab|mepolizumab
119981|NCT03453021|corticosteroids|corticosteroids
119982|NCT03453008|Cerebrovascular Accident|cerebrovascular accident
119983|NCT03453008|Botulinum toxin A|botulinum toxin a
119984|NCT03453008|Stroke|stroke
119985|NCT03452982|SENTINEL LYMPH NODE|sentinel lymph node
119986|NCT03452969|visual outcomes|visual outcomes
119987|NCT03452969|mulitfocal intraocular lens|mulitfocal intraocular lens
119988|NCT03452969|patient satisfaction|patient satisfaction
119989|NCT03452969|spectacle independence|spectacle independence
119990|NCT03452969|contrast sensitivity|contrast sensitivity
119991|NCT03452943|Tourette Syndrome|tourette syndrome
119992|NCT03452943|adolescents|adolescents
119993|NCT03452943|children|children
119994|NCT03452904|In suit coronary lesions|in suit coronary lesions
119995|NCT03452904|Drug-coated balloon|drug-coated balloon
119996|NCT03452904|Drug-eluting stent|drug-eluting stent
119997|NCT03452904|Restenosis|restenosis
119998|NCT03452878|Amygdala, neurosurgery, aggressive behavior|amygdala, neurosurgery, aggressive behavior
119999|NCT03452865|proton pump inhibitor|proton pump inhibitor
120000|NCT03452865|esomeprazole|esomeprazole
120001|NCT03452865|sepsis|sepsis
120002|NCT03452865|septic shock|septic shock
120003|NCT03452865|organ failure|organ failure
120004|NCT03452865|SOFA|sofa
120005|NCT03452865|mortality|mortality
120006|NCT03452852|Split thickness skin graft|split thickness skin graft
120007|NCT03452852|Lower leg|lower leg
120008|NCT03452852|Compression therapy|compression therapy
120009|NCT03452852|PICO|pico
120010|NCT03452852|Coban 2 lite|coban 2 lite
120011|NCT03452839|meropenem|meropenem
120012|NCT03452839|antibiotic resistance|antibiotic resistance
120013|NCT03452839|critical illness|critical illness
120014|NCT03452839|β-lactams|β-lactams
120015|NCT03452839|continuous antibacterial drug infusion|continuous antibacterial drug infusion
120016|NCT03452839|mortality|mortality
120017|NCT03452813|transitions of care|transitions of care
120018|NCT03452813|stroke disparities|stroke disparities
120019|NCT03452800|addiction|addiction
120020|NCT03452800|mental health|mental health
120021|NCT03452787|Body mass index|body mass index
120022|NCT03452787|genetics|genetics
120023|NCT03452787|diet|diet
120024|NCT03452787|saturated fat|saturated fat
120025|NCT03452774|artificial intelligence|artificial intelligence
120026|NCT03452774|virtual tumor board|virtual tumor board
120027|NCT03452774|clinical trial|clinical trial
120028|NCT03452774|clinical trial matching|clinical trial matching
120029|NCT03452774|electronic medical record|electronic medical record
120030|NCT03452774|machine learning|machine learning
120031|NCT03452774|cost of care|cost of care
120032|NCT03452774|targeted therapy|targeted therapy
120033|NCT03452774|immunotherapy|immunotherapy
120034|NCT03452774|precision medicine|precision medicine
120035|NCT03452774|precision oncology|precision oncology
120036|NCT03452774|cancer|cancer
120037|NCT03452774|value based care|value based care
120038|NCT03452774|real world data|real world data
120039|NCT03452774|data analytics|data analytics
120040|NCT03452761|exogenous ketone salts|exogenous ketone salts
120041|NCT03452761|ketosis|ketosis
120042|NCT03452761|safety|safety
120043|NCT03452761|comprehensive metabolic panel|comprehensive metabolic panel
120044|NCT03452761|complete blood count|complete blood count
120045|NCT03452761|lipid panel|lipid panel
120046|NCT03452761|insulin|insulin
120047|NCT03452735|Chronic inflammatory rheumatism|chronic inflammatory rheumatism
120048|NCT03452735|Fertility|fertility
120049|NCT03452735|Procreation|procreation
120050|NCT03452722|secondary brain injury|secondary brain injury
120051|NCT03452722|neuroinflammation|neuroinflammation
120052|NCT03452709|Cardiovascular Disease;|cardiovascular disease;
120053|NCT03452709|primary prevention;|primary prevention;
120054|NCT03452709|physical activity;|physical activity;
120055|NCT03452709|Blood Pressure Monitoring, Ambulatory|blood pressure monitoring, ambulatory
120056|NCT03452670|Workplace|workplace
120057|NCT03452670|Applications|applications
120058|NCT03452670|Anxiety|anxiety
120059|NCT03452670|Burnout|burnout
120060|NCT03452670|Meditation|meditation
120061|NCT03452670|Mindfulness|mindfulness
120062|NCT03452644|US-CNB|us-cnb
120063|NCT03452644|Soft Tissue Mass|soft tissue mass
120064|NCT03452644|Soft Tissue Sarcoma|soft tissue sarcoma
120065|NCT03452644|Soft Tissue Neoplasm|soft tissue neoplasm
120066|NCT03452644|Soft Tissue Lesion|soft tissue lesion
120067|NCT03452631|Psoas hematomas|psoas hematomas
120068|NCT03452618|diagnostic criteria|diagnostic criteria
120069|NCT03452579|Nivolumab|nivolumab
120070|NCT03452579|Bevacizumab|bevacizumab
120071|NCT03452566|actinic cheilitis|actinic cheilitis
120072|NCT03452566|ingenol mebutate|ingenol mebutate
120073|NCT03452566|treatment|treatment
120074|NCT03452566|phase 1/2 clinical trial|phase 1/2 clinical trial
120075|NCT03452553|Liver Cancer|liver cancer
120076|NCT03452553|Hepatocellular Carcinoma (HCC)|hepatocellular carcinoma (hcc)
120077|NCT03452553|Trans Arterial Chemo Embolization (TACE)|trans arterial chemo embolization (tace)
120078|NCT03452553|Drug Eluting Beads (DEB)|drug eluting beads (deb)
120079|NCT03452553|Doxorubicin (DOX)|doxorubicin (dox)
120080|NCT03452501|Infliximab|infliximab
120081|NCT03452501|Remsima|remsima
120082|NCT03452501|Biosimilar|biosimilar
120083|NCT03452501|Inflammatory Bowel Diseases|inflammatory bowel diseases
120084|NCT03452501|Crohn's Disease|crohn's disease
120085|NCT03452501|Ulcerative Colitis|ulcerative colitis
120086|NCT03452501|Fistulizing Crohn's Disease|fistulizing crohn's disease
120087|NCT03452501|Observational|observational
120088|NCT03452501|Follow up|follow up
120089|NCT03452501|Safety|safety
120090|NCT03452501|Effectiveness|effectiveness
120091|NCT03452501|Disease modifying anti-rheumatic drugs|disease modifying anti-rheumatic drugs
120092|NCT03452501|Tumor necrosis factor-alpha inhibitors|tumor necrosis factor-alpha inhibitors
120093|NCT03452488|Sarcopenia|sarcopenia
120094|NCT03452488|Sarcopenic Obesity|sarcopenic obesity
120095|NCT03452488|6-minute walking distance|6-minute walking distance
120096|NCT03452488|400 meters walking test|400 meters walking test
120097|NCT03452488|Patient Reported Outcomes|patient reported outcomes
120098|NCT03452488|BIO101|bio101
120099|NCT03452488|SPPB|sppb
120100|NCT03452488|ALM; ALM/BMI|alm; alm/bmi
120101|NCT03452449|activity monitor|activity monitor
120102|NCT03452449|questionnaire|questionnaire
120103|NCT03452449|Oswestry Disability Index|oswestry disability index
120104|NCT03452436|Cancer-related Cognitive Impairment|cancer-related cognitive impairment
120105|NCT03452436|Cognitive Dysfunction|cognitive dysfunction
120106|NCT03452436|Cognition Disorders|cognition disorders
120107|NCT03452436|Neurocognitive Disorder|neurocognitive disorder
120108|NCT03452436|Testosterone|testosterone
120109|NCT03452436|Endocrinology|endocrinology
120110|NCT03452436|Testicular Cancer|testicular cancer
120111|NCT03452436|Prostate Cancer|prostate cancer
120112|NCT03452423|Osteoarthritis of knees|osteoarthritis of knees
120113|NCT03452423|Arthroscopic cartilage regeneration facilitating procedure (ACRFP)|arthroscopic cartilage regeneration facilitating procedure (acrfp)
120114|NCT03452423|Foot pressure|foot pressure
120115|NCT03452423|Gait|gait
120116|NCT03452410|Vestibular neuritis|vestibular neuritis
120117|NCT03452410|Magnetic resonance imaging (MRI)|magnetic resonance imaging (mri)
120118|NCT03452410|Vertigo|vertigo
120119|NCT03452410|Fluid attenuated inversion recuperation (FLAIR)|fluid attenuated inversion recuperation (flair)
120120|NCT03452384|Acupuncture|acupuncture
120121|NCT03452384|Traditional chinese medicine|traditional chinese medicine
120122|NCT03452384|Major depressive disorder|major depressive disorder
120123|NCT03452371|Patient Navigation|patient navigation
120124|NCT03452371|Hospitalized smokers|hospitalized smokers
120125|NCT03452319|Thoracoabdominal surgery|thoracoabdominal surgery
120126|NCT03452319|Physical Therapy|physical therapy
120127|NCT03452319|Inspiratory Muscle Training|inspiratory muscle training
120128|NCT03452319|Physical Activity|physical activity
120129|NCT03452306|AUC|auc
120130|NCT03452306|Cmax|cmax
120131|NCT03452306|Pharmacokinetics|pharmacokinetics
120132|NCT03452306|metformin|metformin
120133|NCT03452306|fed|fed
120134|NCT03452306|fasting|fasting
120135|NCT03452254|Stroke|stroke
120136|NCT03452254|Upper Extremity Paresis|upper extremity paresis
120137|NCT03452254|Neuro Rehabilitation|neuro rehabilitation
120138|NCT03452254|tDCS|tdcs
120139|NCT03452254|mCIMT|mcimt
120140|NCT03452254|Occupational Therapy|occupational therapy
120141|NCT03452241|Screening, Brief Intervention, and Referral to Treatment|screening, brief intervention, and referral to treatment
120142|NCT03452241|Substance Use|substance use
120143|NCT03452215|Pregnancy|pregnancy
120144|NCT03452215|Mobile Phone Application|mobile phone application
120145|NCT03452202|Stroke|stroke
120146|NCT03452111|Healthy Men|healthy men
120147|NCT03452111|Couple|couple
120148|NCT03452111|Gel|gel
120149|NCT03452111|Male Contraception|male contraception
120150|NCT03452111|Nestorone|nestorone
120151|NCT03452111|Testosterone|testosterone
120152|NCT03452085|xerostomia|xerostomia
120153|NCT03452085|diabetes type II|diabetes type ii
120154|NCT03452085|salivary flow|salivary flow
153412|NCT03240133|HAE|hae
120155|NCT03452085|antioxidant capacity of saliva|antioxidant capacity of saliva
120156|NCT03452085|aldiamed|aldiamed
120157|NCT03452059|Paralysis|paralysis
120158|NCT03452059|Lower Extremities|lower extremities
120159|NCT03452059|Ai-Robotics|ai-robotics
120160|NCT03452046|Ultrasound,inferior vena cava, positive pressure|ultrasound,inferior vena cava, positive pressure
120161|NCT03452033|glaucoma|glaucoma
120162|NCT03452007|Epidural Stimulation|epidural stimulation
120163|NCT03452007|Bladder dysfunction|bladder dysfunction
120269|NCT03451344|China|china
120164|NCT03452007|Spinal cord injury|spinal cord injury
120165|NCT03451981|non surgical therapy|non surgical therapy
120166|NCT03451981|laser|laser
120167|NCT03451981|air powder|air powder
120168|NCT03451981|chlorhexidine|chlorhexidine
120169|NCT03451968|amino acid|amino acid
120170|NCT03451968|stable isotope|stable isotope
120171|NCT03451968|critical care|critical care
120172|NCT03451955|gluten|gluten
120173|NCT03451955|gluten free diet|gluten free diet
120174|NCT03451955|blood brain barrier permeability|blood brain barrier permeability
120175|NCT03451955|intestinal permeability|intestinal permeability
120176|NCT03451955|neuroinflammation|neuroinflammation
120177|NCT03451955|autoimmunity|autoimmunity
120178|NCT03451929|primary healthcare|primary healthcare
120179|NCT03451929|cohort|cohort
120180|NCT03451903|stroke|stroke
120181|NCT03451903|thrombectomy|thrombectomy
120182|NCT03451903|procedure time|procedure time
120183|NCT03451903|revascularisation|revascularisation
120184|NCT03451903|thrombolytic therapy|thrombolytic therapy
120185|NCT03451890|Healthy participants|healthy participants
120186|NCT03451890|E2730|e2730
120187|NCT03451890|Pharmacokinetics|pharmacokinetics
120188|NCT03451877|High myopia|high myopia
120189|NCT03451877|TGFB1Gene Polymorphisms|tgfb1gene polymorphisms
120190|NCT03451877|LAMA1 Gene Polymorphisms|lama1 gene polymorphisms
120191|NCT03451825|Avelumab|avelumab
120192|NCT03451825|Anti PD-L1|anti pd-l1
120193|NCT03451825|Solid tumors|solid tumors
120194|NCT03451825|CNS tumors|cns tumors
120195|NCT03451825|Lymphoma|lymphoma
120196|NCT03451825|Pediatric subjects|pediatric subjects
120197|NCT03451812|prostate cancer|prostate cancer
120198|NCT03451812|metabolomics|metabolomics
120199|NCT03451812|molecular imaging|molecular imaging
120200|NCT03451812|PET|pet
120201|NCT03451812|MRI|mri
120202|NCT03451812|11C-choline tracer|11c-choline tracer
120203|NCT03451799|Glioblastoma|glioblastoma
120204|NCT03451799|Ketogenic diet|ketogenic diet
120205|NCT03451799|Keto diet|keto diet
120206|NCT03451799|GBM|gbm
120207|NCT03451773|TGF Ligand Trap|tgf ligand trap
120208|NCT03451773|Extracellular Domain of Human TGF Receptor II|extracellular domain of human tgf receptor ii
120209|NCT03451773|Avelumab|avelumab
120210|NCT03451773|Human IgG1 mAb Directed Against Human PD-L1|human igg1 mab directed against human pd-l1
120211|NCT03451773|Health-Related Quality of Life|health-related quality of life
120212|NCT03451747|hypertension|hypertension
120213|NCT03451747|female|female
120214|NCT03451643|colorectal cancer|colorectal cancer
120215|NCT03451643|liver metastases|liver metastases
120216|NCT03451643|stage IV|stage iv
120217|NCT03451591|Cerebral Small Vessel Diseases|cerebral small vessel diseases
120218|NCT03451591|Stroke, Lacunar|stroke, lacunar
120219|NCT03451591|Dementia|dementia
120220|NCT03451591|Alzheimer's disease|alzheimer's disease
120221|NCT03451578|macular degeneration|macular degeneration
120222|NCT03451578|blindness|blindness
120223|NCT03451565|Hypotension|hypotension
120224|NCT03451565|Systemic blood pressure|systemic blood pressure
120225|NCT03451552|Community Resources, Patient Navigator|community resources, patient navigator
120226|NCT03451539|Anaesthetist|anaesthetist
120227|NCT03451539|ICU|icu
120228|NCT03451539|Intensif care unit|intensif care unit
120229|NCT03451526|Chinese|chinese
120230|NCT03451526|real-world evidences|real-world evidences
120231|NCT03451526|NSCLC|nsclc
120232|NCT03451526|surgeries|surgeries
120233|NCT03451513|Prevention|prevention
120234|NCT03451513|Sexual minority men|sexual minority men
120235|NCT03451513|Internalization of the appearance ideal|internalization of the appearance ideal
120236|NCT03451513|Body dissatisfaction|body dissatisfaction
120237|NCT03451500|GPR 143|gpr 143
120238|NCT03451500|PEDF|pedf
120239|NCT03451500|VEGF|vegf
120240|NCT03451500|LDOPA|ldopa
120241|NCT03451487|acetaminophen|acetaminophen
120242|NCT03451487|acute liver failure|acute liver failure
120243|NCT03451461|Asynchronies|asynchronies
120244|NCT03451448|PET/MRI|pet/mri
120245|NCT03451448|ultra-small-superparamagnetic particles|ultra-small-superparamagnetic particles
120246|NCT03451422|AMG 592|amg 592
120247|NCT03451422|Systemic lupus erythematosus|systemic lupus erythematosus
120248|NCT03451422|Phase 1b/2a|phase 1b/2a
120249|NCT03451396|Dry eye|dry eye
120250|NCT03451396|Tear osmolarity|tear osmolarity
120251|NCT03451396|Lifitegrast|lifitegrast
120252|NCT03451383|breast cancer|breast cancer
120253|NCT03451383|cognitive decline|cognitive decline
120254|NCT03451370|Bevacizumab|bevacizumab
120255|NCT03451370|Capecitabine|capecitabine
120256|NCT03451370|Oxaliplatin|oxaliplatin
120257|NCT03451370|CRASH score|crash score
120258|NCT03451370|ECOG PS|ecog ps
120259|NCT03451370|G8 score|g8 score
120260|NCT03451357|stroke|stroke
120261|NCT03451357|dependence degree|dependence degree
120262|NCT03451357|social care|social care
120263|NCT03451357|health care|health care
120264|NCT03451357|disability|disability
120265|NCT03451344|Mobile Health|mobile health
120266|NCT03451344|Illicit drug use|illicit drug use
120267|NCT03451344|Rehabilitation|rehabilitation
120268|NCT03451344|Community|community
120270|NCT03451331|cisplatin-ineligible|cisplatin-ineligible
120271|NCT03451331|gemcitabine|gemcitabine
120272|NCT03451331|carboplatin|carboplatin
120273|NCT03451331|nivolumab|nivolumab
120274|NCT03451331|oxaliplatin|oxaliplatin
120275|NCT03451305|Compression fracture, postural reduction, vertebroplasty|compression fracture, postural reduction, vertebroplasty
120276|NCT03451266|preeclampsia|preeclampsia
120277|NCT03451266|vitamin C|vitamin c
120278|NCT03451266|lung ultrasound|lung ultrasound
120279|NCT03451240|Stress|stress
120280|NCT03451240|Resilience|resilience
120281|NCT03451227|Sedation, Analgesia|sedation, analgesia
120282|NCT03451201|Exercise|exercise
120283|NCT03451201|High-Intensity Interval Training|high-intensity interval training
120284|NCT03451201|Type 1 diabetes|type 1 diabetes
120285|NCT03451201|Endothelial Dysfunction|endothelial dysfunction
120286|NCT03451175|Overactive Detrusor|overactive detrusor
120287|NCT03451175|Multiple Sclerosis|multiple sclerosis
120288|NCT03451175|Reproductibility|reproductibility
120289|NCT03451175|Cystometry|cystometry
120290|NCT03451149|TIPS|tips
120291|NCT03451136|Placenta previa|placenta previa
120292|NCT03451136|Cervical length|cervical length
120293|NCT03451136|Antepartum haemorrhage|antepartum haemorrhage
120294|NCT03451110|Drug-Drug Interactions|drug-drug interactions
120295|NCT03451110|Lemborexant|lemborexant
120296|NCT03451110|Oral Contraceptive|oral contraceptive
120297|NCT03451110|Famotidine|famotidine
120298|NCT03451110|Fluconazole|fluconazole
120299|NCT03451110|Pharmacokinetics|pharmacokinetics
120300|NCT03451110|Proton pump inhibitors|proton pump inhibitors
120301|NCT03451110|CYP3A inhibitors|cyp3a inhibitors
120302|NCT03451084|AML, ASLAN, DHODH|aml, aslan, dhodh
120303|NCT03451058|Traumatic brain injury, eye tracking, EEG, cognition|traumatic brain injury, eye tracking, eeg, cognition
120304|NCT03451045|Pulmonary exacerbation, lenabasum, JBT-101|pulmonary exacerbation, lenabasum, jbt-101
120305|NCT03451032|HIV exposition treatment|hiv exposition treatment
120306|NCT03451032|sexual risk|sexual risk
120307|NCT03451032|blood risk|blood risk
120308|NCT03451019|chronic kidney disease - mineral bone disorder, phosphate-binders|chronic kidney disease - mineral bone disorder, phosphate-binders
120309|NCT03450993|Mind-Body|mind-body
120310|NCT03450980|Double Vision, Amblyopia|double vision, amblyopia
120311|NCT03450928|Peroral Endoscopic Myotomy|peroral endoscopic myotomy
120312|NCT03450928|Endoscopy|endoscopy
120313|NCT03450928|POEM|poem
120314|NCT03450928|Submucosal endoscopy|submucosal endoscopy
120315|NCT03450915|Influenza|influenza
120316|NCT03450915|vaccine|vaccine
120317|NCT03450915|universal|universal
120318|NCT03450915|M-001|m-001
120319|NCT03450915|Multimeric-001|multimeric-001
120320|NCT03450915|Flu|flu
120321|NCT03450902|Urinary incontinence, Chinese herb, Acupuncture|urinary incontinence, chinese herb, acupuncture
120322|NCT03450837|Coronary artery disease; HDL; anabolic steroids|coronary artery disease; hdl; anabolic steroids
120323|NCT03450824|Patellofemoral Pain Syndrome|patellofemoral pain syndrome
120324|NCT03450824|Anterior Knee Pain|anterior knee pain
120325|NCT03450824|Knee Varus|knee varus
120326|NCT03450811|complication|complication
120327|NCT03450811|uroflowmetry|uroflowmetry
120328|NCT03450759|Heart failure.|heart failure.
120329|NCT03450759|Mineralocorticoid receptor modulator.|mineralocorticoid receptor modulator.
120330|NCT03450759|Heart failure with preserved ejection fraction (HFpEF).|heart failure with preserved ejection fraction (hfpef).
120331|NCT03450733|Metal-on-Metal|metal-on-metal
120332|NCT03450733|MOM|mom
120333|NCT03450733|Total Hip Arthroplasty|total hip arthroplasty
120334|NCT03450733|THA|tha
120335|NCT03450707|cardiac arrest|cardiac arrest
120336|NCT03450707|post-arrest|post-arrest
120337|NCT03450681|Pain Management|pain management
120338|NCT03450681|Knee Replacement Arthroplasty|knee replacement arthroplasty
120339|NCT03450681|Postoperative Pain|postoperative pain
120340|NCT03450681|Pulsed Radiofrequency Treatment|pulsed radiofrequency treatment
120341|NCT03450668|neonatal, incubator, thermal-regulation|neonatal, incubator, thermal-regulation
120342|NCT03450590|heart rate variability|heart rate variability
120343|NCT03450590|intraarterial chemotherapy|intraarterial chemotherapy
120344|NCT03450590|ophthalmic arterial chemotherapy|ophthalmic arterial chemotherapy
120345|NCT03450538|Trauma|trauma
120346|NCT03450538|Computed tomography|computed tomography
120347|NCT03450538|India|india
120348|NCT03450512|Neutropenic enterocolitis|neutropenic enterocolitis
120349|NCT03450512|Acute myeloid leukemia|acute myeloid leukemia
120350|NCT03450512|Abdominal tomodensitometry|abdominal tomodensitometry
120351|NCT03450486|dynamic balance|dynamic balance
120352|NCT03450486|star excursion balance test|star excursion balance test
120353|NCT03450486|exercise|exercise
120354|NCT03450473|Mesh|mesh
120355|NCT03450460|peer support|peer support
120356|NCT03450460|feasibility trial|feasibility trial
120357|NCT03450460|mixed methods|mixed methods
120358|NCT03450447|Head and Neck Cancer|head and neck cancer
120359|NCT03450447|Esophageal Cancer|esophageal cancer
120360|NCT03450447|endoscopic submucosal dissection|endoscopic submucosal dissection
120361|NCT03450447|quality of life|quality of life
120362|NCT03450447|median survival time|median survival time
120363|NCT03450382|community health|community health
120364|NCT03450382|mental health|mental health
120365|NCT03450382|behavior change|behavior change
120366|NCT03450382|social support|social support
120367|NCT03450382|health promotion|health promotion
120368|NCT03450304|Multidetector Computed Tomography|multidetector computed tomography
120369|NCT03450304|Pulmonary Embolism|pulmonary embolism
120370|NCT03450304|Hypertension Pulmonary Secondary|hypertension pulmonary secondary
120371|NCT03450291|Computational|computational
120372|NCT03450252|HCM|hcm
120373|NCT03450252|Mid-cavity|mid-cavity
120374|NCT03450252|Pacing|pacing
120375|NCT03450239|MRI|mri
120376|NCT03450200|Diabetic Peripheral Neuropathy, Exercises|diabetic peripheral neuropathy, exercises
120377|NCT03450148|aversive therapy|aversive therapy
120378|NCT03450135|puberty|puberty
120379|NCT03450135|EEG|eeg
120380|NCT03450135|estradiol|estradiol
120381|NCT03450135|mood|mood
120382|NCT03450135|stress|stress
120383|NCT03450044|Chemotherapy|chemotherapy
120384|NCT03450044|Breast Cancer|breast cancer
120385|NCT03450044|Dendritic cells|dendritic cells
120386|NCT03450044|Immunotherapy|immunotherapy
120387|NCT03450044|Doxorubicine|doxorubicine
120388|NCT03450018|Gemcitabine|gemcitabine
120389|NCT03450018|SLC-0111|slc-0111
120390|NCT03450018|PDAC|pdac
120391|NCT03449979|tACS|tacs
120392|NCT03449979|transcranial alternating current stimulation|transcranial alternating current stimulation
120393|NCT03449979|stimulation|stimulation
120394|NCT03449979|heart rate variability|heart rate variability
120395|NCT03449979|electroencephalogram|electroencephalogram
120396|NCT03449979|EEG|eeg
120397|NCT03449966|pCLE|pcle
120398|NCT03449966|confocal|confocal
120399|NCT03449966|Advanced gastric cancer|advanced gastric cancer
120400|NCT03449966|chemotherapy|chemotherapy
120401|NCT03449940|Penile fracture|penile fracture
120402|NCT03449940|Delayed|delayed
120403|NCT03449940|Localized|localized
120404|NCT03449940|Repair|repair
120405|NCT03449927|Nutrition Tool|nutrition tool
120406|NCT03449927|Melphalan Autologous Transplant|melphalan autologous transplant
120407|NCT03449914|ECOG PS|ecog ps
120408|NCT03449914|Timed Up and Go test|timed up and go test
120409|NCT03449914|G8 score|g8 score
120410|NCT03449823|Renal Artery Doppler|renal artery doppler
120411|NCT03449810|Muscles Energy Technique, Low Back Pain|muscles energy technique, low back pain
120412|NCT03449797|aldosterone|aldosterone
120413|NCT03449797|cortisol|cortisol
120414|NCT03449797|adrenal vein sampling|adrenal vein sampling
120415|NCT03449797|primary aldosteronism|primary aldosteronism
120416|NCT03449784|dyslipidemia|dyslipidemia
120417|NCT03449784|lipid-lowering therapy|lipid-lowering therapy
120418|NCT03449784|cardiovascular risk|cardiovascular risk
120419|NCT03449784|diabetes|diabetes
120420|NCT03449784|low-density lipoprotein cholesterol|low-density lipoprotein cholesterol
120421|NCT03449771|HIV|hiv
120422|NCT03449771|Pre-exposure prophylaxis|pre-exposure prophylaxis
120423|NCT03449771|Recreational drugs|recreational drugs
120424|NCT03449771|Chemsex|chemsex
120425|NCT03449771|Mental disorders|mental disorders
120426|NCT03449745|Acute Myeloid Leukemia|acute myeloid leukemia
120427|NCT03449745|Immune Checkpoint Ligand|immune checkpoint ligand
120428|NCT03449745|Flow Cytometry|flow cytometry
120429|NCT03449706|Reservoir|reservoir
120430|NCT03449680|hip arthroscopy|hip arthroscopy
120431|NCT03449680|femoral articular branch block|femoral articular branch block
120432|NCT03449615|Cutaneous melanoma|cutaneous melanoma
120433|NCT03449615|Sentinel node biopsy|sentinel node biopsy
120434|NCT03449602|thoracoscopy|thoracoscopy
120435|NCT03449602|pleuroscopy|pleuroscopy
120436|NCT03449602|metastatic cancer|metastatic cancer
120437|NCT03449602|lung cancer|lung cancer
120438|NCT03449602|malignant pleural effusion|malignant pleural effusion
120439|NCT03449602|tuberculosis|tuberculosis
120440|NCT03449576|PTSD|ptsd
120441|NCT03449576|neuroimaging|neuroimaging
120442|NCT03449576|fMRI|fmri
120443|NCT03449576|veterans|veterans
120444|NCT03449576|exposure therapy|exposure therapy
120445|NCT03449576|treatment|treatment
120446|NCT03449563|thoracic paravertebral block|thoracic paravertebral block
120447|NCT03449563|postoperative analgesia|postoperative analgesia
120448|NCT03449563|pulmonary lobectomy|pulmonary lobectomy
120449|NCT03449550|Child obstructive sleep apnea|child obstructive sleep apnea
120450|NCT03449550|Home Respiratory Polygraphy|home respiratory polygraphy
120451|NCT03449550|Diagnosis|diagnosis
120452|NCT03449550|Validity|validity
120453|NCT03449550|Polysomnography|polysomnography
120454|NCT03449524|Pulmonary Arterial Hypertension|pulmonary arterial hypertension
120455|NCT03449524|Pulmonary Hypertension|pulmonary hypertension
120456|NCT03449524|PAH|pah
120457|NCT03449524|Connective Tissue Disease-Associated|connective tissue disease-associated
120458|NCT03449524|6 Minute Walk Test|6 minute walk test
120459|NCT03449524|6 Minute Walk Distance|6 minute walk distance
120460|NCT03449524|Pulmonary Vascular Resistance|pulmonary vascular resistance
120461|NCT03449524|Cardiac MRI|cardiac mri
120462|NCT03449524|Right Ventricular Function|right ventricular function
120463|NCT03449524|Hypertension|hypertension
120464|NCT03449524|Familial Primary Pulmonary Hypertension|familial primary pulmonary hypertension
120860|NCT03447002|pvc|pvc
120465|NCT03449524|Connective Tissue Diseases|connective tissue diseases
120466|NCT03449524|Vascular Diseases|vascular diseases
120467|NCT03449524|Cardiovascular Diseases|cardiovascular diseases
120468|NCT03449524|Hypertension, Pulmonary|hypertension, pulmonary
120469|NCT03449524|Lung Diseases|lung diseases
120470|NCT03449485|Bariatric surgery|bariatric surgery
120471|NCT03449485|Gastrointestinal tract|gastrointestinal tract
120472|NCT03449485|Biological availability|biological availability
120473|NCT03449485|Pharmacokinetics|pharmacokinetics
120474|NCT03449485|Chlorprothixene|chlorprothixene
120475|NCT03449472|Bariatric surgery|bariatric surgery
120476|NCT03449472|Gastrointestinal tract|gastrointestinal tract
120477|NCT03449472|Biological availability|biological availability
120478|NCT03449472|Pharmacokinetics|pharmacokinetics
120479|NCT03449472|Quetiapine fumarate|quetiapine fumarate
120480|NCT03449459|chronic obstructive pulmonary disease|chronic obstructive pulmonary disease
120481|NCT03449459|aerosol inhaled amikacin|aerosol inhaled amikacin
120482|NCT03449459|oral probiotics|oral probiotics
120483|NCT03449459|combined influenza and pneumococcal vaccine inoculation|combined influenza and pneumococcal vaccine inoculation
120484|NCT03449459|bacterial decolonization in lower respiratory tract|bacterial decolonization in lower respiratory tract
120485|NCT03449420|thromboelastography|thromboelastography
120486|NCT03449407|Auditory hallucinations|auditory hallucinations
120487|NCT03449407|Psychosis|psychosis
120488|NCT03449407|Mood|mood
120489|NCT03449407|Brain imaging|brain imaging
120490|NCT03449407|Experience sampling method|experience sampling method
120491|NCT03449394|Psychosis|psychosis
120492|NCT03449394|Depression|depression
120493|NCT03449394|Metacognition|metacognition
120494|NCT03449394|Attribution|attribution
120495|NCT03449394|Emotions|emotions
120496|NCT03449355|sexuality|sexuality
120497|NCT03449355|mode of delivery|mode of delivery
120498|NCT03449355|quality of life|quality of life
120499|NCT03449316|Nebulizers and Vaporizers|nebulizers and vaporizers
120500|NCT03449303|breast cancer|breast cancer
120501|NCT03449303|CIPN|cipn
120502|NCT03449303|Pain|pain
120503|NCT03449303|QOL|qol
120504|NCT03449303|Essential Oils|essential oils
120505|NCT03449251|Apelin|apelin
120506|NCT03449251|Relaxin|relaxin
120507|NCT03449212|SOD1|sod1
120508|NCT03449212|Amyotrophic Lateral Sclerosis|amyotrophic lateral sclerosis
120509|NCT03449212|ALS|als
120510|NCT03449212|Kinetics|kinetics
120511|NCT03449212|Amyotrophic Lateral Sclerosis, Familial|amyotrophic lateral sclerosis, familial
120512|NCT03449212|Amyotrophic Lateral Sclerosis, Sporadic|amyotrophic lateral sclerosis, sporadic
120513|NCT03449186|periodontitis|periodontitis
120514|NCT03449186|postpartum|postpartum
120515|NCT03449121|Breathing|breathing
120516|NCT03449121|Mind-body|mind-body
120517|NCT03449082|adipose derived mesenchymal stem cell|adipose derived mesenchymal stem cell
120518|NCT03449082|allogeneic stem cell|allogeneic stem cell
120519|NCT03449030|Drug Therapy|drug therapy
120520|NCT03449017|nicotine|nicotine
120521|NCT03449017|alcohol|alcohol
120522|NCT03449017|vape|vape
120523|NCT03449017|electronic cigarette|electronic cigarette
120524|NCT03449004|Validation|validation
120525|NCT03449004|questionnaire|questionnaire
120526|NCT03449004|satisfaction|satisfaction
120527|NCT03449004|online information|online information
120528|NCT03448991|NPO time|npo time
120529|NCT03448991|Gastric content|gastric content
120530|NCT03448991|Gastric pH|gastric ph
120531|NCT03448978|Descartes-08|descartes-08
120532|NCT03448978|CAR T Cell|car t cell
120533|NCT03448978|CART|cart
120534|NCT03448978|CAR-T|car-t
120535|NCT03448978|CAR T-Cell|car t-cell
120536|NCT03448978|Multiple Myeloma|multiple myeloma
120537|NCT03448978|BCMA|bcma
120538|NCT03448978|B-cell maturation antigen|b-cell maturation antigen
120539|NCT03448978|B cell maturation antigen|b cell maturation antigen
120540|NCT03448939|papulopustular rosacea|papulopustular rosacea
120541|NCT03448926|DCIS|dcis
120542|NCT03448926|molecular testing|molecular testing
120543|NCT03448926|risk of recurrence|risk of recurrence
120544|NCT03448913|Anesthesia, Regional ;PECS block|anesthesia, regional ;pecs block
120545|NCT03448900|Cessation|cessation
120546|NCT03448900|College student|college student
120547|NCT03448900|Motivational Interview|motivational interview
120548|NCT03448900|Self-efficacy|self-efficacy
120549|NCT03448900|Intention|intention
120550|NCT03448900|Beliefs|beliefs
120551|NCT03448900|Young adult|young adult
120552|NCT03448887|End-stage renal disease|end-stage renal disease
120553|NCT03448887|Medium cut-off dialyzer|medium cut-off dialyzer
120554|NCT03448887|Hemodiafiltration|hemodiafiltration
120555|NCT03448887|Cardiovascular|cardiovascular
120556|NCT03448887|Pulse wave velocity|pulse wave velocity
120557|NCT03448835|short term immunotherapy|short term immunotherapy
120558|NCT03448835|surgical resection|surgical resection
120559|NCT03448835|atezolizumab|atezolizumab
120560|NCT03448835|capecitabine|capecitabine
120561|NCT03448835|oxaliplatin|oxaliplatin
120562|NCT03448835|docetaxel|docetaxel
120563|NCT03448809|Cognitive and Behavioral Therapies|cognitive and behavioral therapies
120564|NCT03448809|Children and Adolescents|children and adolescents
120566|NCT03448809|Early Intervention|early intervention
120567|NCT03448809|Feasibility Study|feasibility study
120568|NCT03448796|High tibial osteotomy|high tibial osteotomy
120569|NCT03448796|Osteoarthrosis|osteoarthrosis
120570|NCT03448796|Tomofix|tomofix
120571|NCT03448796|Randomized controlled trial|randomized controlled trial
120572|NCT03448783|Bariatric surgery|bariatric surgery
120573|NCT03448783|Gastrointestinal tract|gastrointestinal tract
120574|NCT03448783|Biological availability|biological availability
120575|NCT03448783|Pharmacokinetics|pharmacokinetics
120576|NCT03448783|Apixaban|apixaban
120577|NCT03448757|LEEF|leef
120578|NCT03448757|hemodynamic parameters|hemodynamic parameters
120579|NCT03448757|heart beat|heart beat
120580|NCT03448757|biofeedback effect|biofeedback effect
120581|NCT03448744|thymosin alpha|thymosin alpha
120582|NCT03448744|entecavir|entecavir
120583|NCT03448705|influenza|influenza
120585|NCT03448679|glycocalyx|glycocalyx
120586|NCT03448679|serum albumin|serum albumin
120587|NCT03448679|orthotopic liver transplantation|orthotopic liver transplantation
120588|NCT03448679|colloid osmotic pressure|colloid osmotic pressure
120589|NCT03448679|endothelial dysfunction|endothelial dysfunction
120590|NCT03448666|ECT|ect
120591|NCT03448666|pembrolizumab|pembrolizumab
120592|NCT03448666|advanced melanoma|advanced melanoma
120593|NCT03448627|stem cell transplantation|stem cell transplantation
120594|NCT03448627|Pulmonary Functions|pulmonary functions
120595|NCT03448627|muscle strength|muscle strength
120596|NCT03448627|exercise capacity|exercise capacity
120597|NCT03448614|skull base reconstrction|skull base reconstrction
120598|NCT03448601|Precision Medicine|precision medicine
120599|NCT03448575|Youth|youth
120600|NCT03448575|Mental Health|mental health
120601|NCT03448575|Psychotropic|psychotropic
120602|NCT03448575|Medication Safety|medication safety
120603|NCT03448575|Quality Improvement|quality improvement
120604|NCT03448562|Atrial Fibrillation|atrial fibrillation
120605|NCT03448562|Pulmonary Vein Isolation|pulmonary vein isolation
120606|NCT03448562|Catheter Ablation|catheter ablation
120607|NCT03448562|Substrate Modification|substrate modification
120608|NCT03448549|Tegafur，gimeracil and oteracil potassium|tegafur，gimeracil and oteracil potassium
120609|NCT03448549|Capecitabine|capecitabine
120610|NCT03448549|compliance|compliance
120611|NCT03448549|quality of life|quality of life
120612|NCT03448549|adverse reaction|adverse reaction
120613|NCT03448549|disease free survival|disease free survival
120614|NCT03448549|overall survival|overall survival
120615|NCT03448536|Primary dysmenorrhea of at least moderate severity|primary dysmenorrhea of at least moderate severity
120616|NCT03448510|lower urinary tract symptoms|lower urinary tract symptoms
120617|NCT03448510|male|male
120618|NCT03448510|benign prostatic obstruction|benign prostatic obstruction
120619|NCT03448510|irreversible electroporation|irreversible electroporation
120620|NCT03448510|urodynamics|urodynamics
120621|NCT03448471|stem cell transplantation|stem cell transplantation
120622|NCT03448471|Fatigue|fatigue
120623|NCT03448471|muscle strength|muscle strength
120624|NCT03448471|exercise capacity|exercise capacity
120625|NCT03448471|Depression|depression
120626|NCT03448471|Quality of Life|quality of life
120627|NCT03448445|High-risk|high-risk
120628|NCT03448445|Low-risk|low-risk
120629|NCT03448445|Alzheimer's disease|alzheimer's disease
120630|NCT03448445|Observational study|observational study
120631|NCT03448432|Pregnancy Anemia|pregnancy anemia
120632|NCT03448393|CD-19 expressing tumor|cd-19 expressing tumor
120633|NCT03448393|CD-22 Expressing Tumor|cd-22 expressing tumor
120634|NCT03448393|Adoptive Immunotherapy|adoptive immunotherapy
120635|NCT03448393|Philadelphia chromosome (Ph)+ ALL|philadelphia chromosome (ph)+ all
120636|NCT03448393|Lymphoma|lymphoma
120637|NCT03448354|HIPEC|hipec
120638|NCT03448354|Interval debulking surgery|interval debulking surgery
120639|NCT03448341|radiotherapy|radiotherapy
120640|NCT03448341|IMRT|imrt
120641|NCT03448341|dysphagia|dysphagia
120642|NCT03448341|Oropharynx|oropharynx
120643|NCT03448341|Nasopharynx|nasopharynx
120644|NCT03448341|FEES|fees
120645|NCT03448341|VFS|vfs
120646|NCT03448328|muscular strength|muscular strength
120647|NCT03448328|inflammation|inflammation
120648|NCT03448328|protein|protein
120649|NCT03448315|brain stimulation, tDCS, acute postoperative pain, chronic pain|brain stimulation, tdcs, acute postoperative pain, chronic pain
120650|NCT03448289|Postpartum|postpartum
120651|NCT03448289|Contraception|contraception
120652|NCT03448276|Osteoporosis|osteoporosis
120653|NCT03448276|Muscle Strength|muscle strength
120654|NCT03448276|Postural Balance|postural balance
120655|NCT03448276|Vibration|vibration
120656|NCT03448276|Walking|walking
120657|NCT03448263|pain|pain
120658|NCT03448263|post endodontic pain|post endodontic pain
120659|NCT03448263|root canal treatment|root canal treatment
120660|NCT03448198|total knee arthroplasty|total knee arthroplasty
120661|NCT03448198|patellar resurfacing|patellar resurfacing
120662|NCT03448198|patellar tracking|patellar tracking
121157|NCT03445104|Huperzine A|huperzine a
120663|NCT03448198|patello-femoral joint kinematics|patello-femoral joint kinematics
120664|NCT03448198|surgical navigation|surgical navigation
120665|NCT03448198|computer-aided surgery|computer-aided surgery
120666|NCT03448159|Stroke|stroke
120667|NCT03448159|Exercise|exercise
120668|NCT03448159|Fluoxetine|fluoxetine
120669|NCT03448159|Randomized Control Trial|randomized control trial
120670|NCT03448159|Rehabilitation|rehabilitation
120671|NCT03448120|Muscle fatigue|muscle fatigue
120672|NCT03448120|Thermography|thermography
120673|NCT03448120|Acupuncture|acupuncture
120674|NCT03448120|Dry needling|dry needling
120675|NCT03448107|dental caries|dental caries
120676|NCT03448107|caries arrest|caries arrest
120677|NCT03448107|caries prevention|caries prevention
120678|NCT03448107|silver diamine fluoride|silver diamine fluoride
120679|NCT03448107|sealants|sealants
120680|NCT03448107|interim therapeutic restorations|interim therapeutic restorations
120681|NCT03448055|MCI, AD, MRI, GSH, Immunocal, brain health, neuropsychological evaluation|mci, ad, mri, gsh, immunocal, brain health, neuropsychological evaluation
120682|NCT03448029|Vascular Diseases|vascular diseases
120683|NCT03448029|Peripheral Artery Disease|peripheral artery disease
120684|NCT03448029|Revascularisation|revascularisation
120685|NCT03448029|Outcome|outcome
120686|NCT03448029|Quality Management|quality management
120687|NCT03448029|Registry|registry
120688|NCT03448029|Endovascular Intervention|endovascular intervention
120689|NCT03448029|Limb Amputation|limb amputation
120690|NCT03447977|neck pain|neck pain
120691|NCT03447977|manual therapy|manual therapy
120692|NCT03447977|respiratory function|respiratory function
120693|NCT03447964|sphingolipids|sphingolipids
120694|NCT03447964|hepatic steatosis|hepatic steatosis
120695|NCT03447964|non-alcoholic fatty liver disease|non-alcoholic fatty liver disease
120696|NCT03447964|macrovascular complications|macrovascular complications
120697|NCT03447964|insulin resistance|insulin resistance
120698|NCT03447964|microvasclar complications|microvasclar complications
120699|NCT03447964|NAFLD|nafld
120700|NCT03447925|callosities; keratosis; diabetes mellitus; plants, medicinal; herbal medicine; keratolytic agents|callosities; keratosis; diabetes mellitus; plants, medicinal; herbal medicine; keratolytic agents
120701|NCT03447912|Behavioral intervention|behavioral intervention
120702|NCT03447912|Social intervention|social intervention
120703|NCT03447912|Public health|public health
120704|NCT03447912|Smoking behavior|smoking behavior
120705|NCT03447886|Breast Cancer|breast cancer
120706|NCT03447873|Antiretroviral treatment|antiretroviral treatment
120707|NCT03447873|Treatment simplification|treatment simplification
120708|NCT03447873|Dual therapy|dual therapy
120709|NCT03447873|Immune recovery|immune recovery
120710|NCT03447834|intracoronary cooling|intracoronary cooling
120711|NCT03447821|Infectious diarrhoea|infectious diarrhoea
120712|NCT03447821|rifamycin SV|rifamycin sv
120713|NCT03447821|rifamycin SV MMX|rifamycin sv mmx
120714|NCT03447821|MMX|mmx
120715|NCT03447782|New Daily Persistent Headache|new daily persistent headache
120716|NCT03447782|Chronic Headache|chronic headache
120717|NCT03447769|Non-Small Cell Lung Cancer|non-small cell lung cancer
120718|NCT03447769|NSCLC|nsclc
120719|NCT03447769|ACZ885|acz885
120720|NCT03447769|canakinumab|canakinumab
120721|NCT03447769|adjuvant|adjuvant
120722|NCT03447769|AJCC/UICC v. 8 stages II-IIIA and IIIB (T>5cm N2)|ajcc/uicc v. 8 stages ii-iiia and iiib (t>5cm n2)
120723|NCT03447717|hemiplegic gait|hemiplegic gait
120724|NCT03447717|peroneal nerve stimulation|peroneal nerve stimulation
120725|NCT03447717|gait analysis|gait analysis
120726|NCT03447704|Ankylosing Spondylitis|ankylosing spondylitis
120727|NCT03447704|interleukin 17|interleukin 17
120728|NCT03447704|monoclonal antibody|monoclonal antibody
120729|NCT03447665|Infant behavioral sleep intervention|infant behavioral sleep intervention
120730|NCT03447665|Infant sleep|infant sleep
120731|NCT03447665|Pediatric insomnia|pediatric insomnia
120732|NCT03447665|Infant night wakings|infant night wakings
120733|NCT03447639|Catheter associated UTI|catheter associated uti
120734|NCT03447639|Povidine iodine|povidine iodine
120735|NCT03447639|Bladder Irrigation|bladder irrigation
120736|NCT03447613|retinal nerve fiber layer|retinal nerve fiber layer
120737|NCT03447613|cerebrospinal fluid Aβ and Tau|cerebrospinal fluid aβ and tau
120738|NCT03447587|Randomized controlled trial|randomized controlled trial
120739|NCT03447587|Sleep|sleep
120740|NCT03447587|Traditional Chinese medicine|traditional chinese medicine
120741|NCT03447587|Oxidative stress|oxidative stress
120742|NCT03447561|Dopamine|dopamine
120743|NCT03447561|Food|food
120744|NCT03447561|Reward|reward
120745|NCT03447561|Anticipatory|anticipatory
120746|NCT03447561|Consummatory|consummatory
120747|NCT03447561|Positron Emission Tomography|positron emission tomography
120748|NCT03447561|Magnetic Resonance|magnetic resonance
120749|NCT03447561|Metabolic hormones|metabolic hormones
120750|NCT03447548|Cognitive training|cognitive training
120751|NCT03447548|Social function|social function
120752|NCT03447548|Processing speed|processing speed
120753|NCT03447535|Oppositional defiant disorder|oppositional defiant disorder
120754|NCT03447535|Family|family
120755|NCT03447535|Disruptive, impulse control and conduct disorders|disruptive, impulse control and conduct disorders
120756|NCT03447535|Anxiety disorder|anxiety disorder
120757|NCT03447535|Intrafamilial disruptive behaviours disorder|intrafamilial disruptive behaviours disorder
120758|NCT03447509|Spinal cord injury|spinal cord injury
120759|NCT03447509|neural control|neural control
120760|NCT03447509|motor function|motor function
120761|NCT03447509|hand movement|hand movement
120762|NCT03447483|Solid tumor|solid tumor
120763|NCT03447483|Immune Checkpoint Inhibitor|immune checkpoint inhibitor
120764|NCT03447483|immune-related Adverse Event|immune-related adverse event
120765|NCT03447444|dignity|dignity
120766|NCT03447444|music therapy|music therapy
120767|NCT03447444|physical activity|physical activity
120768|NCT03447431|colorectal cancers|colorectal cancers
120769|NCT03447431|Microsatellite Instability|microsatellite instability
120770|NCT03447431|Tumor development|tumor development
120771|NCT03447418|Lung Clearance Index|lung clearance index
120772|NCT03447418|Breath Nitrogen Washout|breath nitrogen washout
120773|NCT03447418|Healthy subjects|healthy subjects
120774|NCT03447405|Music Therapy|music therapy
120775|NCT03447405|NICU|nicu
120776|NCT03447405|Infants|infants
120777|NCT03447405|multisensory processing|multisensory processing
120778|NCT03447392|Patient Education|patient education
120779|NCT03447392|Chinese Medicine|chinese medicine
120780|NCT03447353|driving|driving
120781|NCT03447353|Xanax|xanax
120782|NCT03447353|Norco|norco
120783|NCT03447353|simulation|simulation
120784|NCT03447314|pembrolizumab|pembrolizumab
120785|NCT03447314|GSK1795091|gsk1795091
120786|NCT03447314|Dose-escalation|dose-escalation
120787|NCT03447314|204686|204686
120788|NCT03447314|Immunotherapies|immunotherapies
120789|NCT03447314|GSK3359609|gsk3359609
120790|NCT03447314|Phase I|phase i
120791|NCT03447314|anticancer agent|anticancer agent
120792|NCT03447314|OX40|ox40
120793|NCT03447314|201212|201212
120794|NCT03447314|204691|204691
120795|NCT03447314|ICOS|icos
120796|NCT03447314|TLR4|tlr4
120797|NCT03447314|GSK3174998|gsk3174998
120798|NCT03447314|Advanced Solid Tumors|advanced solid tumors
120799|NCT03447301|Saudi Arabia, Extra Virgin Olive Oil, Blood Glucose|saudi arabia, extra virgin olive oil, blood glucose
120800|NCT03447288|Dyssynchrony|dyssynchrony
120801|NCT03447288|Breath-stacking|breath-stacking
120802|NCT03447288|Asynchrony|asynchrony
120803|NCT03447288|Reverse Triggering|reverse triggering
120804|NCT03447288|Mechanical Ventilation|mechanical ventilation
120805|NCT03447288|Sedation|sedation
120806|NCT03447236|Older people|older people
120807|NCT03447236|Cognitive training|cognitive training
120808|NCT03447236|MCI|mci
120809|NCT03447223|Attention-deficit/hyperactivity disorder|attention-deficit/hyperactivity disorder
120810|NCT03447223|circulating metabolites|circulating metabolites
120811|NCT03447223|metagenome|metagenome
120812|NCT03447210|Persons who inject drugs (PWID)|persons who inject drugs (pwid)
120813|NCT03447210|Phylogenetics|phylogenetics
120814|NCT03447210|HIV testing|hiv testing
120815|NCT03447210|HCV testing|hcv testing
120816|NCT03447210|HIV care cascade|hiv care cascade
120817|NCT03447210|Assisted partner services|assisted partner services
120818|NCT03447171|Amblyopia|amblyopia
120819|NCT03447171|Myopia|myopia
120820|NCT03447171|Hyperopia|hyperopia
120821|NCT03447171|Risk Factors|risk factors
120822|NCT03447171|Amblyopia Risk Factors|amblyopia risk factors
120823|NCT03447171|Smartphone Application (App)|smartphone application (app)
120824|NCT03447171|Photoscreening|photoscreening
120825|NCT03447171|Vision Screening|vision screening
120826|NCT03447171|Mobile Vision Screening|mobile vision screening
120827|NCT03447171|Vision Screening App|vision screening app
120828|NCT03447171|Preschool children|preschool children
120829|NCT03447171|Objective vision screening|objective vision screening
120830|NCT03447132|Breast Cancer|breast cancer
120831|NCT03447132|Luminal|luminal
120832|NCT03447132|Neoadjuvant|neoadjuvant
120833|NCT03447132|pCR|pcr
120834|NCT03447132|Surgery|surgery
120835|NCT03447093|oral microbiota|oral microbiota
120836|NCT03447093|16S rRNA gene|16s rrna gene
120837|NCT03447093|Graves' disease|graves' disease
120838|NCT03447093|Methimazole|methimazole
120839|NCT03447093|Propylthiouracil|propylthiouracil
120840|NCT03447093|Hashimoto's thyroiditis|hashimoto's thyroiditis
120841|NCT03447054|Alcohol|alcohol
120842|NCT03447054|tDCS|tdcs
120843|NCT03447054|inhibition|inhibition
120844|NCT03447054|cognitive training|cognitive training
120845|NCT03447054|implicit cognition|implicit cognition
120846|NCT03447054|relapse|relapse
120847|NCT03447054|craving|craving
120848|NCT03447041|Keratopathy|keratopathy
120849|NCT03447041|Visual Quality|visual quality
120850|NCT03447041|Contrast Sensitivity Function|contrast sensitivity function
120851|NCT03447028|Triglyseride-Glucose index|triglyseride-glucose index
120852|NCT03447028|prostate cancer|prostate cancer
120853|NCT03447028|radical prostatectomy|radical prostatectomy
120854|NCT03447028|metabolic syndrome|metabolic syndrome
120855|NCT03447015|ambulation|ambulation
120856|NCT03447015|labour|labour
120857|NCT03447015|Randomized Controlled Trial|randomized controlled trial
120858|NCT03447015|Jordan|jordan
120859|NCT03447002|premature|premature
120861|NCT03446989|case management|case management
120862|NCT03446989|rheumatoid arthritis|rheumatoid arthritis
120863|NCT03446989|Effectiveness|effectiveness
120864|NCT03446989|Generalized Estimating Equations|generalized estimating equations
120865|NCT03446950|vaginal surgery|vaginal surgery
120866|NCT03446950|patient position|patient position
120867|NCT03446950|stirrups|stirrups
120868|NCT03446950|functional status|functional status
120869|NCT03446950|urogynecology|urogynecology
120870|NCT03446937|Antenal corticosteroids|antenal corticosteroids
120871|NCT03446937|Late preterm delivery|late preterm delivery
120872|NCT03446937|Neonatal morbidity|neonatal morbidity
120873|NCT03446924|Nutraceuticals|nutraceuticals
120874|NCT03446924|Muscle anabolism|muscle anabolism
120875|NCT03446924|Ageing|ageing
120876|NCT03446911|SABR|sabr
120877|NCT03446911|Immunotherapy|immunotherapy
120878|NCT03446859|Transcutaneous nerve electrical stimulation,|transcutaneous nerve electrical stimulation,
120879|NCT03446859|Pain intensity|pain intensity
120880|NCT03446859|Primary dysmenorrhea|primary dysmenorrhea
120881|NCT03446859|Female|female
120882|NCT03446859|Undergraduates|undergraduates
120883|NCT03446833|Parkinson's Disease|parkinson's disease
120884|NCT03446833|Deep Brain Stimulation|deep brain stimulation
120885|NCT03446807|fatigue|fatigue
120886|NCT03446807|Droxidopa|droxidopa
120887|NCT03446794|Left Atrial Appendage Closure|left atrial appendage closure
120888|NCT03446794|Watchman device|watchman device
120889|NCT03446768|COPD|copd
120890|NCT03446768|OSA|osa
120891|NCT03446742|Rehabilitation Service|rehabilitation service
120892|NCT03446742|Signals and symptons|signals and symptons
120893|NCT03446742|Heart Rate|heart rate
120894|NCT03446742|Blood pressure|blood pressure
120895|NCT03446742|Respiratory Muscles|respiratory muscles
120896|NCT03446742|autonomic modulation|autonomic modulation
120897|NCT03446742|exercise|exercise
120898|NCT03446742|risk measurement|risk measurement
120899|NCT03446742|muscle strength|muscle strength
120900|NCT03446742|inflammation|inflammation
120901|NCT03446742|cytosines|cytosines
120902|NCT03446703|social cognition|social cognition
120903|NCT03446703|psychotherapy|psychotherapy
120904|NCT03446703|rehabilitation|rehabilitation
120905|NCT03446703|theory of mind|theory of mind
120906|NCT03446690|Enamel decalcification|enamel decalcification
120907|NCT03446677|HIV|hiv
120908|NCT03446677|Balance|balance
120909|NCT03446677|Vestibular|vestibular
120910|NCT03446677|Somatosensory|somatosensory
120911|NCT03446677|postural stability|postural stability
120912|NCT03446677|center of pressure|center of pressure
120913|NCT03446651|Sodium Homeostasis|sodium homeostasis
120914|NCT03446638|myelodysplastic syndromes|myelodysplastic syndromes
120915|NCT03446638|MDS|mds
120916|NCT03446638|computational biology|computational biology
120917|NCT03446638|relapsed|relapsed
120918|NCT03446638|refractory|refractory
120919|NCT03446625|resveratrol|resveratrol
120920|NCT03446625|OHSS|ohss
120921|NCT03446625|PCOS|pcos
120922|NCT03446612|darbepoetin alpha|darbepoetin alpha
120923|NCT03446612|challenge agents|challenge agents
120924|NCT03446612|daprodustat|daprodustat
120925|NCT03446612|FBF-CKD|fbf-ckd
120926|NCT03446599|cardiac surgery|cardiac surgery
120927|NCT03446599|vasoplegia|vasoplegia
120928|NCT03446599|cardiopulmonary bypass|cardiopulmonary bypass
120929|NCT03446573|Switch study|switch study
120930|NCT03446573|non-inferiority|non-inferiority
120931|NCT03446573|HIV-1|hiv-1
120932|NCT03446573|tenofovir alafenamide|tenofovir alafenamide
120933|NCT03446573|dolutegravir plus lamivudine|dolutegravir plus lamivudine
120934|NCT03446560|Compliance|compliance
120935|NCT03446560|Telemedicine|telemedicine
120936|NCT03446560|Patient related outcome measures|patient related outcome measures
120937|NCT03446547|SBRT|sbrt
120938|NCT03446547|Immunotherapy|immunotherapy
120939|NCT03446534|pneumonia|pneumonia
120940|NCT03446534|pre-school children|pre-school children
120941|NCT03446534|antibiotics|antibiotics
154457|NCT03234036|PK|pk
120942|NCT03446534|amoxicillin|amoxicillin
120943|NCT03446508|High definition transcranial direct stimulation|high definition transcranial direct stimulation
120944|NCT03446508|Mild Cognitive Impairment|mild cognitive impairment
120945|NCT03446508|Memory|memory
120946|NCT03446495|ovarian cancer, trabectedin, recurrent ovarian cancer|ovarian cancer, trabectedin, recurrent ovarian cancer
120947|NCT03446469|Chronic ankle instability|chronic ankle instability
120948|NCT03446469|Functional instability|functional instability
120949|NCT03446469|Ankle sprain|ankle sprain
120950|NCT03446469|postural sway|postural sway
120951|NCT03446469|Fascial Manipulation|fascial manipulation
120952|NCT03446456|Magnetic Resonance Imaging|magnetic resonance imaging
120953|NCT03446456|Healthy Volunteers|healthy volunteers
120954|NCT03446430|arterial stiffness|arterial stiffness
120955|NCT03446430|pulse wave velocity|pulse wave velocity
120956|NCT03446430|laser Doppler vibrometry|laser doppler vibrometry
120957|NCT03446365|Asthma|asthma
120958|NCT03446365|Latino children|latino children
120959|NCT03446365|middle school|middle school
120960|NCT03446365|peer models|peer models
120961|NCT03446365|educational intervention|educational intervention
120962|NCT03446365|high school students|high school students
120963|NCT03446352|Falls|falls
120964|NCT03446352|Elderly|elderly
120965|NCT03446352|Psychomotor exercise program|psychomotor exercise program
120966|NCT03446352|Whole body vibration|whole body vibration
120967|NCT03446326|pacemaker|pacemaker
120968|NCT03446326|stroke volume|stroke volume
120969|NCT03446326|cardiac output|cardiac output
120970|NCT03446326|heart rate|heart rate
120971|NCT03446300|High Myopia, fundus structure, early visual impairment|high myopia, fundus structure, early visual impairment
120972|NCT03446248|vibroacoustic stimulation|vibroacoustic stimulation
120973|NCT03446235|Obesity|obesity
120974|NCT03446235|Physical Activity|physical activity
120975|NCT03446235|Exercise|exercise
120976|NCT03446235|Wearable device|wearable device
120977|NCT03446196|Transplantation, Fluid Balance|transplantation, fluid balance
120978|NCT03446170|Young adults|young adults
120979|NCT03446170|Cigarette smoking|cigarette smoking
120980|NCT03446170|Warning labels|warning labels
120981|NCT03446157|colon cancer|colon cancer
120982|NCT03446157|metastatic colon cancer|metastatic colon cancer
120983|NCT03446157|palbociclib|palbociclib
120984|NCT03446157|cetuximab|cetuximab
120985|NCT03446144|Geographic Atrophy|geographic atrophy
120986|NCT03446144|Age Related Macular Degeneration|age related macular degeneration
120987|NCT03446144|IONIS-FB-Lrx|ionis-fb-lrx
120988|NCT03446144|Complement Factor B|complement factor b
120989|NCT03446131|transfemoral amputation|transfemoral amputation
120990|NCT03446131|limb salvage|limb salvage
120991|NCT03446131|bilateral amputation|bilateral amputation
120992|NCT03446131|Department of Defense|department of defense
120993|NCT03446131|orthosis|orthosis
120994|NCT03446131|prosthesis|prosthesis
120995|NCT03446131|rehabilitation|rehabilitation
120996|NCT03446131|military treatment facilities|military treatment facilities
120997|NCT03446131|military|military
120998|NCT03446131|injured lower extremity|injured lower extremity
120999|NCT03446131|prevent falls|prevent falls
121000|NCT03446131|trauma lower extremity|trauma lower extremity
121001|NCT03446131|service members|service members
121002|NCT03446131|retired service members|retired service members
121003|NCT03446131|active service members|active service members
121004|NCT03446131|unilateral lower extremity trauma|unilateral lower extremity trauma
121005|NCT03446131|limb amputation|limb amputation
121006|NCT03446131|limb preservation|limb preservation
121007|NCT03446131|preserved limb|preserved limb
121008|NCT03446131|trips|trips
121009|NCT03446131|slips|slips
121010|NCT03446131|transtibial amputation|transtibial amputation
121011|NCT03446118|EoE|eoe
121012|NCT03446105|Cancer survivor|cancer survivor
121013|NCT03446105|App-based intervention|app-based intervention
121014|NCT03446105|Behavioral intervention|behavioral intervention
121015|NCT03446092|Cancer|cancer
121016|NCT03446092|Mindfulness|mindfulness
121017|NCT03446092|Palliative care|palliative care
121018|NCT03446079|Genetic|genetic
121019|NCT03446079|Skin|skin
121020|NCT03446079|Anti Aging|anti aging
121021|NCT03446079|SNP|snp
121022|NCT03446053|Methicillin-Resistant Staphylococcus Aureus|methicillin-resistant staphylococcus aureus
121023|NCT03446053|Methicillin-Sensitive Staphylococcus Aureus|methicillin-sensitive staphylococcus aureus
121024|NCT03446053|N-Rephasin SAL200|n-rephasin sal200
121025|NCT03445962|Autonomic nervous system|autonomic nervous system
121026|NCT03445962|Heart rate variability|heart rate variability
121027|NCT03445962|Physical Activity|physical activity
121028|NCT03445962|exercise|exercise
121029|NCT03445962|biological parameters|biological parameters
121030|NCT03445962|cephalometry|cephalometry
121031|NCT03445962|body composition|body composition
121032|NCT03445962|actigraphy|actigraphy
121033|NCT03445962|motor capacity|motor capacity
121034|NCT03445962|physical fitness|physical fitness
121035|NCT03445962|aerobic capacity|aerobic capacity
121036|NCT03445962|seismocardiography|seismocardiography
121037|NCT03445949|atrial fibrillation, stroke, bleeding, left atrial appendage|atrial fibrillation, stroke, bleeding, left atrial appendage
121038|NCT03445936|loop-ileostomy reversal|loop-ileostomy reversal
121039|NCT03445936|hernia prevention|hernia prevention
121040|NCT03445910|human chorionic gonadotropin|human chorionic gonadotropin
121041|NCT03445884|positron emission tomography|positron emission tomography
121042|NCT03445884|nuclear medicine|nuclear medicine
121043|NCT03445884|prognosis|prognosis
121044|NCT03445871|Rheumatoid Arthritis|rheumatoid arthritis
121045|NCT03445871|Methotrexate|methotrexate
121046|NCT03445871|Erythrocyte polyglutamate|erythrocyte polyglutamate
121047|NCT03445871|Compliance Questionnaire Rheumatology|compliance questionnaire rheumatology
121048|NCT03445845|TNF blocker|tnf blocker
121049|NCT03445845|change of biotherapy|change of biotherapy
121050|NCT03445819|Patella Fracture, elderly|patella fracture, elderly
121051|NCT03445806|IOP fluctuations|iop fluctuations
121052|NCT03445806|iCare Home|icare home
121053|NCT03445806|Trabeculectomy|trabeculectomy
121054|NCT03445806|self-tonometry|self-tonometry
121180|NCT03444987|Autophagy|autophagy
121055|NCT03445793|DeltaF508deletion (F508del) mutation in 2 copies|deltaf508deletion (f508del) mutation in 2 copies
121056|NCT03445767|Peri-operative care|peri-operative care
121077|NCT03445559|Veterans Affairs|veterans affairs
121078|NCT03445559|Guideline Adherence|guideline adherence
121079|NCT03445559|Implementation|implementation
121095|NCT03445520|Passport|passport
121096|NCT03445520|Building Better Bridges|building better bridges
121097|NCT03445520|Snapshot|snapshot
121098|NCT03445507|tobacco|tobacco
121099|NCT03445507|cessation|cessation
121100|NCT03445507|medical apps for smartphones|medical apps for smartphones
121101|NCT03445468|Influenza vaccine|influenza vaccine
121102|NCT03445468|Split influenza vaccine|split influenza vaccine
121103|NCT03445468|Seasonal influenza vaccine|seasonal influenza vaccine
121104|NCT03445442|Elderly|elderly
121105|NCT03445442|Native tissue repair|native tissue repair
121106|NCT03445442|Pelvic Organ Prolapse|pelvic organ prolapse
121107|NCT03445442|Sacrocolpopexy|sacrocolpopexy
121108|NCT03445442|Vaginal mesh repair|vaginal mesh repair
121109|NCT03445403|Offset analgesia|offset analgesia
121110|NCT03445403|Quantitive sensory testing|quantitive sensory testing
121111|NCT03445364|Primary PCI|primary pci
121112|NCT03445364|Coronary injection pressure|coronary injection pressure
121113|NCT03445364|Reperfusion|reperfusion
121114|NCT03445364|Resolution of ST elevation|resolution of st elevation
121115|NCT03445364|Myocardial Blush Grade|myocardial blush grade
121116|NCT03445351|Exercise Therapy;|exercise therapy;
121117|NCT03445351|Sleep;|sleep;
121118|NCT03445351|; Immune Markers;|; immune markers;
121119|NCT03445351|HIV|hiv
121120|NCT03445325|obesity|obesity
121121|NCT03445325|physical activity|physical activity
121122|NCT03445325|nutrition|nutrition
121123|NCT03445325|adolescents|adolescents
121124|NCT03445325|gamification|gamification
121125|NCT03445325|sedentary activity|sedentary activity
121126|NCT03445286|Gingivitis and geriatric patients|gingivitis and geriatric patients
121127|NCT03445286|Silver Diamine Fluoride and gingivitis|silver diamine fluoride and gingivitis
121128|NCT03445286|Sliver Diamine Fluoride|sliver diamine fluoride
121129|NCT03445247|Diabetic Nephropathies|diabetic nephropathies
121130|NCT03445247|Extracorporeal low intensity shockwave therapy|extracorporeal low intensity shockwave therapy
121131|NCT03445247|Proteinuria|proteinuria
121132|NCT03445234|exercise|exercise
121133|NCT03445234|innate immune function|innate immune function
121134|NCT03445234|metabolomics|metabolomics
121135|NCT03445234|inflammation|inflammation
121136|NCT03445221|Oral Immunonutrition|oral immunonutrition
121137|NCT03445221|Cardiac Patient|cardiac patient
121138|NCT03445221|Mitral Valve Replacement|mitral valve replacement
121139|NCT03445182|pain control|pain control
121140|NCT03445182|paediatric dental patients|paediatric dental patients
121141|NCT03445182|local anaesthesia|local anaesthesia
121142|NCT03445182|dentalvibe|dentalvibe
121143|NCT03445156|First-person shooter (FPS)|first-person shooter (fps)
121144|NCT03445156|Violent video game|violent video game
121145|NCT03445156|Headshot|headshot
121146|NCT03445156|Gun|gun
121147|NCT03445156|Operant conditioning theory|operant conditioning theory
121148|NCT03445130|Preoperative Anxiety|preoperative anxiety
121149|NCT03445130|Breast Surgery|breast surgery
121150|NCT03445130|Lavender Aromatherapy|lavender aromatherapy
121151|NCT03445117|Influenza Vaccines|influenza vaccines
121152|NCT03445117|Pneumococcal Vaccines|pneumococcal vaccines
121153|NCT03445117|Primary Health Care|primary health care
121154|NCT03445117|Health Communication|health communication
121155|NCT03445117|Cross-Over Studies|cross-over studies
121156|NCT03445117|Randomized Controlled Trial|randomized controlled trial
121158|NCT03445104|acetylcholinesterase inhibitor|acetylcholinesterase inhibitor
121160|NCT03445104|exercise|exercise
121161|NCT03445104|Physical performance|physical performance
121162|NCT03445104|cognitive function|cognitive function
121163|NCT03445104|rating of perceived exertion|rating of perceived exertion
121164|NCT03445104|RPE|rpe
121165|NCT03445091|compression socks|compression socks
121166|NCT03445091|venous insufficiency|venous insufficiency
121167|NCT03445091|compression stockings|compression stockings
121168|NCT03445091|compression|compression
121169|NCT03445091|compression therapy|compression therapy
121170|NCT03445052|Adherence|adherence
121171|NCT03445052|Behaviour change|behaviour change
121172|NCT03445052|Intervention|intervention
121173|NCT03445052|Photoprotection|photoprotection
121174|NCT03445052|Ultraviolet radiation|ultraviolet radiation
121175|NCT03445039|Dental implants, Trans-alveolar sinus floor elevation, Bone grafting|dental implants, trans-alveolar sinus floor elevation, bone grafting
121176|NCT03445000|RET-rearrangement|ret-rearrangement
121177|NCT03445000|advanced NSCLC|advanced nsclc
121178|NCT03444987|Uterine fibroid|uterine fibroid
121179|NCT03444987|FAP|fap
121181|NCT03444974|drugs|drugs
121182|NCT03444974|youth|youth
121183|NCT03444974|adolescence|adolescence
121184|NCT03444974|abuse|abuse
121185|NCT03444974|dependence|dependence
121186|NCT03444974|Tetrahydrocannabinol (THC)|tetrahydrocannabinol (thc)
121187|NCT03444974|Methamphetamine (Crystal Meth)|methamphetamine (crystal meth)
121188|NCT03444974|Marihuana|marihuana
121189|NCT03444974|comorbidity|comorbidity
121190|NCT03444974|treatment|treatment
121191|NCT03444974|etiopathology|etiopathology
121192|NCT03444974|sociodemographics|sociodemographics
121193|NCT03444974|Saxony|saxony
121194|NCT03444974|MATRIX|matrix
121195|NCT03444974|Psychotherapy|psychotherapy
121196|NCT03444961|Argus II Retinal Prosthesis System|argus ii retinal prosthesis system
121197|NCT03444961|Rehabilitation|rehabilitation
121198|NCT03444935|Phone|phone
121199|NCT03444935|Brief Contact Intervention|brief contact intervention
121200|NCT03444935|Caring Contact|caring contact
121201|NCT03444935|Follow-up|follow-up
121202|NCT03444935|Suicide|suicide
121203|NCT03444935|Suicidal Ideation|suicidal ideation
121204|NCT03444935|Suicidal Behaviour|suicidal behaviour
121205|NCT03444935|Suicide Attempt|suicide attempt
121206|NCT03444909|Monitoring|monitoring
121207|NCT03444857|Continuous Positive Airway Pressure|continuous positive airway pressure
121208|NCT03444857|Myocardial Salvage|myocardial salvage
121209|NCT03444857|Obstructive Sleep Apnea|obstructive sleep apnea
121210|NCT03444857|ST Elevation Myocardial Infarction|st elevation myocardial infarction
121211|NCT03444831|Functional Dyspepsia|functional dyspepsia
121212|NCT03444818|E6007|e6007
121213|NCT03444818|Pharmacokinetics|pharmacokinetics
121214|NCT03444818|Radioactivity|radioactivity
121215|NCT03444805|Autoimmune diseases|autoimmune diseases
121216|NCT03444805|Systemic sclerosis|systemic sclerosis
121217|NCT03444805|Autologous hematopoietic stem cell transplant (AHSCT)|autologous hematopoietic stem cell transplant (ahsct)
121218|NCT03444805|Post-AHSCT management|post-ahsct management
121219|NCT03444805|Immune reconstitution|immune reconstitution
121220|NCT03444779|tibial plateau fracture|tibial plateau fracture
121221|NCT03444779|minimally invasive surgery|minimally invasive surgery
121222|NCT03444779|ballon reduction|ballon reduction
121223|NCT03444727|vulvar biopsy|vulvar biopsy
121224|NCT03444727|ice|ice
121225|NCT03444727|anesthesia|anesthesia
121226|NCT03444727|pain|pain
121227|NCT03444727|vulva|vulva
121228|NCT03444714|intratumoral|intratumoral
121229|NCT03444701|Solid tumors|solid tumors
121230|NCT03444701|Her2-negative breast cancer|her2-negative breast cancer
121231|NCT03444701|Squamous cell carcinoma of the head and neck|squamous cell carcinoma of the head and neck
121232|NCT03444688|Robotic Walker|robotic walker
121233|NCT03444675|Transplantation; intestine|transplantation; intestine
121234|NCT03444675|endoscopy|endoscopy
121235|NCT03444675|severity score|severity score
121236|NCT03444675|transplant rejection|transplant rejection
121237|NCT03444675|transplant; complications|transplant; complications
121238|NCT03444649|AML|aml
121239|NCT03444649|Epacadostat|epacadostat
121240|NCT03444649|Idarubicin|idarubicin
121241|NCT03444649|Cytarabine|cytarabine
121242|NCT03444636|Multimodal analgesia|multimodal analgesia
121243|NCT03444636|Thoracic epidural|thoracic epidural
121244|NCT03444636|Postoperative pain|postoperative pain
121245|NCT03444636|Postoperative Complications|postoperative complications
121246|NCT03444636|Patient Satisfaction|patient satisfaction
121247|NCT03444623|predictive factor|predictive factor
121248|NCT03444623|prognostic factor|prognostic factor
121249|NCT03444584|0382, T2DM|0382, t2dm
121250|NCT03444558|metabolic parameters|metabolic parameters
121251|NCT03444558|cardio-metabolic parameters|cardio-metabolic parameters
121252|NCT03444545|Cardiac output|cardiac output
121253|NCT03444545|Carbon dioxide|carbon dioxide
121254|NCT03444545|Intraoperative monitoring|intraoperative monitoring
121255|NCT03444545|Pulmonary blood flow|pulmonary blood flow
121256|NCT03444519|brain relaxation|brain relaxation
121257|NCT03444519|mannitol|mannitol
121258|NCT03444519|supratentorial tumours|supratentorial tumours
121260|NCT03444454|Telerehabilitation|telerehabilitation
121261|NCT03444454|Virtual reality|virtual reality
121262|NCT03444454|Quality of life|quality of life
121263|NCT03444441|Foot|foot
121264|NCT03444441|Ankle|ankle
121265|NCT03444441|Finnish|finnish
121266|NCT03444441|Validation|validation
121267|NCT03444441|FAOS|faos
121268|NCT03444441|EFAS|efas
121269|NCT03444441|LEFS|lefs
121270|NCT03444441|FAAM|faam
121271|NCT03444441|VAS-FA|vas-fa
121272|NCT03444441|MOxFA|moxfa
121273|NCT03444415|Obesity|obesity
121274|NCT03444415|Children|children
121275|NCT03444415|Pregnancy|pregnancy
121276|NCT03444415|Motivational interview|motivational interview
121277|NCT03444415|Family Care|family care
121278|NCT03444415|Primary Care|primary care
121279|NCT03444402|CKD-381|ckd-381
121280|NCT03444402|Nexium|nexium
121281|NCT03444376|keytruda|keytruda
121282|NCT03444376|pembrolizumab|pembrolizumab
121283|NCT03444376|GX-188E|gx-188e
121284|NCT03444376|TDS-IM device|tds-im device
121285|NCT03444363|laser|laser
121286|NCT03444363|periodontal treatment|periodontal treatment
121287|NCT03444363|systemic inflammation|systemic inflammation
121288|NCT03444363|glycemic control|glycemic control
121289|NCT03444350|Periodontal treatment|periodontal treatment
121290|NCT03444350|Ozone|ozone
121291|NCT03444350|oxidative stress|oxidative stress
121292|NCT03444337|ablation|ablation
121293|NCT03444337|atrial fibrillation|atrial fibrillation
121294|NCT03444337|FIRM|firm
121295|NCT03444324|Fibrinogen|fibrinogen
121296|NCT03444311|microbiota|microbiota
121297|NCT03444311|ulcerative colitis|ulcerative colitis
121298|NCT03444311|fiber|fiber
121299|NCT03444311|probiotic|probiotic
121300|NCT03444285|Thermotherapy|thermotherapy
121301|NCT03444285|warm-up|warm-up
121302|NCT03444285|extensibility|extensibility
121303|NCT03444285|pain|pain
121304|NCT03444285|athletes|athletes
121305|NCT03444259|Atrial fibrillation|atrial fibrillation
121306|NCT03444259|Aortic stenosis|aortic stenosis
121307|NCT03444259|Coronary artery disease|coronary artery disease
121308|NCT03444259|Cardiac surgery|cardiac surgery
121309|NCT03444259|Atrial appendage|atrial appendage
121310|NCT03444207|obesity|obesity
121311|NCT03444207|inflammation|inflammation
121312|NCT03444207|C-reactive protein|c-reactive protein
121313|NCT03444207|training|training
121314|NCT03444207|tumor necrosis factor alfa|tumor necrosis factor alfa
121315|NCT03444194|liver metastasis|liver metastasis
121316|NCT03444194|chemotherapy|chemotherapy
121317|NCT03444194|liver biopsy|liver biopsy
121318|NCT03444194|colorectal caner|colorectal caner
121319|NCT03444168|lumbar spine surgery|lumbar spine surgery
121320|NCT03444168|lumbar failed back surgery syndrome|lumbar failed back surgery syndrome
121321|NCT03444142|Diabetes|diabetes
121322|NCT03444142|Hyperglycemia|hyperglycemia
121323|NCT03444142|ABPM|abpm
121324|NCT03444142|Variability of blood pressure|variability of blood pressure
121325|NCT03444142|Exenatide LAR or Dulaglutide 0.75mg|exenatide lar or dulaglutide 0.75mg
121326|NCT03444142|Glucagon-like peptide analogues type 1 (GLP1).|glucagon-like peptide analogues type 1 (glp1).
121327|NCT03444103|IL-6 blockade|il-6 blockade
121328|NCT03444064|Islet transplantation|islet transplantation
121329|NCT03444064|Diabetes treatment|diabetes treatment
121330|NCT03444064|PolyTregs|polytregs
121331|NCT03444064|Immunotherapy|immunotherapy
121332|NCT03444051|EUS-FNB|eus-fnb
121333|NCT03444051|comparative study|comparative study
121334|NCT03443999|Coronary Artery Disease|coronary artery disease
121335|NCT03443999|Sirolimus-eluting Stent|sirolimus-eluting stent
121336|NCT03443999|Biodegradable Polymers|biodegradable polymers
121337|NCT03443986|Diabetes Mellitus|diabetes mellitus
121338|NCT03443986|Blood Flow Velocity|blood flow velocity
121339|NCT03443986|Skin Temperature|skin temperature
121340|NCT03443986|Postural Balance|postural balance
121341|NCT03443986|Combined Modality Therapy|combined modality therapy
121342|NCT03443986|Vibration|vibration
121343|NCT03443986|Resistance Training|resistance training
121344|NCT03443934|Hemodynamic assessments|hemodynamic assessments
121345|NCT03443934|Echocardiography|echocardiography
121346|NCT03443934|MR-Elastography|mr-elastography
121347|NCT03443934|Liver vein catheterization|liver vein catheterization
121348|NCT03443934|Liver Cirrhosis|liver cirrhosis
121349|NCT03443934|Cirrhotic cardiomyopathy|cirrhotic cardiomyopathy
121350|NCT03443934|Cirrhotic complications|cirrhotic complications
121351|NCT03443934|Magnetic Resonance Imaging|magnetic resonance imaging
121352|NCT03443921|Artery Divestment Technique|artery divestment technique
121353|NCT03443921|Locally Advanced Pancreatic Cancer|locally advanced pancreatic cancer
121354|NCT03443921|Neoadjuvant Therapy|neoadjuvant therapy
121355|NCT03443921|Borderline Resectable Pancreatic Cancer|borderline resectable pancreatic cancer
121356|NCT03443908|lung cancer|lung cancer
121357|NCT03443908|non small cell lung cancer|non small cell lung cancer
121358|NCT03443908|nsclc|nsclc
121359|NCT03443908|small cell lung cancer|small cell lung cancer
121360|NCT03443908|sclc|sclc
121361|NCT03443908|metastic lung mass|metastic lung mass
121362|NCT03443908|sleep disordered breathing|sleep disordered breathing
121363|NCT03443908|sdb|sdb
121364|NCT03443908|obstructive sleep apnea|obstructive sleep apnea
121365|NCT03443830|Zika virus|zika virus
121366|NCT03443830|Tyzivumab|tyzivumab
121367|NCT03443830|Monoclonal antibody|monoclonal antibody
121368|NCT03443830|Infectious diseases|infectious diseases
121369|NCT03443830|Phase 1A first in human study|phase 1a first in human study
121370|NCT03443830|Singapore|singapore
121371|NCT03443817|Feasibility|feasibility
121372|NCT03443817|tele-rehabilitation|tele-rehabilitation
121373|NCT03443817|follow-up|follow-up
121374|NCT03443817|COPD|copd
121375|NCT03443791|CMV|cmv
121376|NCT03443791|Congenital Birth|congenital birth
121377|NCT03443791|Infectious Diseases|infectious diseases
121378|NCT03443778|tonsillectomy pain|tonsillectomy pain
121379|NCT03443778|dexamethasone|dexamethasone
121380|NCT03443778|bupivacaine|bupivacaine
121381|NCT03443739|Intermittent Fasting|intermittent fasting
121382|NCT03443739|Religious Fast|religious fast
121383|NCT03443739|Bahá'í|bahá'í
121384|NCT03443739|Hydration|hydration
121385|NCT03443739|Calorimetry|calorimetry
121386|NCT03443739|Microdialysis|microdialysis
121387|NCT03443739|circadian clock|circadian clock
121388|NCT03443739|circadian rhythm|circadian rhythm
121389|NCT03443739|spirituality|spirituality
121390|NCT03443739|self-efficacy|self-efficacy
121391|NCT03443726|Lower third molar extraction|lower third molar extraction
121392|NCT03443726|Infiltration anesthesia|infiltration anesthesia
121393|NCT03443726|Articaine|articaine
121394|NCT03443700|SCI|sci
121395|NCT03443700|gait|gait
121396|NCT03443700|incomplete motor SCI|incomplete motor sci
121397|NCT03443700|robotic gait training|robotic gait training
121398|NCT03443700|locomotor training|locomotor training
121399|NCT03443700|walking training|walking training
121400|NCT03443700|rehabilitation|rehabilitation
121401|NCT03443700|exoskeleton|exoskeleton
121402|NCT03443700|EKSO|ekso
121403|NCT03443700|EKSO-GT|ekso-gt
121404|NCT03443700|neuroplasticity|neuroplasticity
121405|NCT03443700|brain cortical plasticity|brain cortical plasticity
121406|NCT03443661|5-Fluorouracil|5-fluorouracil
121407|NCT03443661|rectal cancer|rectal cancer
121408|NCT03443661|irinotecan|irinotecan
121409|NCT03443661|oxaliplatin|oxaliplatin
121410|NCT03443661|neoadjuvant chemotherapy|neoadjuvant chemotherapy
121411|NCT03443622|SC-43|sc-43
121412|NCT03443622|refractory solid tumor|refractory solid tumor
121413|NCT03443622|Phase I|phase i
121414|NCT03443609|occult prostate cancer recurrence|occult prostate cancer recurrence
121415|NCT03443609|PSA|psa
121416|NCT03443609|68Ga-HBED-CC-PSMA PET / CT|68ga-hbed-cc-psma pet / ct
121417|NCT03443596|stroke|stroke
121418|NCT03443596|blood pressure|blood pressure
121419|NCT03443596|hemodynamic|hemodynamic
121420|NCT03443570|immune thrombocytopenia|immune thrombocytopenia
121421|NCT03443570|Thrombocytopenia|thrombocytopenia
121422|NCT03443557|Oral nutrition supplement|oral nutrition supplement
121423|NCT03443557|malnutrition|malnutrition
121424|NCT03443557|mortality|mortality
121425|NCT03443544|fournier's|fournier's
121426|NCT03443544|gangrene|gangrene
121427|NCT03443531|Bronchiectasis|bronchiectasis
121428|NCT03443531|Traditional Chinese Medicine|traditional chinese medicine
121429|NCT03443518|EVAR, analgesia|evar, analgesia
121430|NCT03443505|Chronic obstructive pulmonary disease|chronic obstructive pulmonary disease
121431|NCT03443505|Acute exacerbation|acute exacerbation
121432|NCT03443505|Neural respiratory drive|neural respiratory drive
121433|NCT03443505|Parasternal electromyography|parasternal electromyography
121434|NCT03443505|Respiratory physiology|respiratory physiology
121435|NCT03443505|Lung function|lung function
121436|NCT03443479|Non invasive ventilation|non invasive ventilation
121437|NCT03443479|BiPAP|bipap
121438|NCT03443479|High-Flow Oxygen Therapy|high-flow oxygen therapy
121439|NCT03443479|High-Flow Nasal Cannula|high-flow nasal cannula
121440|NCT03443479|COPD|copd
121441|NCT03443479|Hypercapnia|hypercapnia
121442|NCT03443479|Hypercapnic Respiratory failure|hypercapnic respiratory failure
121443|NCT03443479|Chronic obstructive Pulmonary Disease|chronic obstructive pulmonary disease
121444|NCT03443466|Electric stimulation|electric stimulation
121445|NCT03443466|Cesarean section|cesarean section
121446|NCT03443427|Non-typeable Haemophilus influenzae|non-typeable haemophilus influenzae
121447|NCT03443427|Moraxella catarrhalis|moraxella catarrhalis
121448|NCT03443427|Safety|safety
121449|NCT03443427|Third vaccine dose|third vaccine dose
121450|NCT03443427|Vaccination|vaccination
121451|NCT03443427|Immunogenicity|immunogenicity
121452|NCT03443414|COPD, bronchodilation, FEV1|copd, bronchodilation, fev1
121453|NCT03443388|head injury from seizures|head injury from seizures
121454|NCT03443388|seizures resulting in fall|seizures resulting in fall
121455|NCT03443388|helmet for seizures|helmet for seizures
121456|NCT03443388|novel helmet design|novel helmet design
121457|NCT03443388|inflatable helmet|inflatable helmet
121458|NCT03443388|Hovding Inc|hovding inc
121459|NCT03443388|helmet|helmet
121460|NCT03443388|device|device
121461|NCT03443375|Older adults|older adults
121462|NCT03443375|Physical function|physical function
121463|NCT03443375|Muscle mass|muscle mass
121464|NCT03443375|Short-term memory|short-term memory
121465|NCT03443375|Executive function|executive function
121466|NCT03443375|Blood Pressure|blood pressure
121467|NCT03443375|Resistance training|resistance training
121468|NCT03443375|Exercise training|exercise training
121469|NCT03443375|Periodization|periodization
121470|NCT03443362|Chronic Urticaria|chronic urticaria
121471|NCT03443362|Endothelial cells|endothelial cells
121472|NCT03443349|Delivering Women|delivering women
121473|NCT03443323|Executive Function|executive function
121474|NCT03443323|Behavioral Research|behavioral research
121475|NCT03443323|Cost Analysis|cost analysis
121476|NCT03443323|Students|students
121477|NCT03443323|Schools|schools
121478|NCT03443323|Randomized Controlled Trial|randomized controlled trial
121479|NCT03443323|Behavior Therapy|behavior therapy
121482|NCT03443310|THA|tha
121483|NCT03443310|Hip Fracture|hip fracture
121484|NCT03443310|High risk|high risk
121485|NCT03443310|Ultrasound|ultrasound
121486|NCT03443310|U/S|u/s
121487|NCT03443284|Total Knee Arthroplasty|total knee arthroplasty
121488|NCT03443284|Total Hip Arthroplasty|total hip arthroplasty
121489|NCT03443284|Total Knee Replacement|total knee replacement
121490|NCT03443284|Total Hip Replacement|total hip replacement
121491|NCT03443284|Hospital Care Plan|hospital care plan
121492|NCT03443284|mHealth|mhealth
121493|NCT03443271|transversus abdominis plane block|transversus abdominis plane block
121494|NCT03443271|abdominal hysterectomy|abdominal hysterectomy
121495|NCT03443271|stress response|stress response
121496|NCT03443219|Airway Management|airway management
121497|NCT03443219|Extraglottic airway device|extraglottic airway device
121498|NCT03443219|Laryngeal mask airway|laryngeal mask airway
121499|NCT03443219|Spritztube|spritztube
121500|NCT03443206|adolescent|adolescent
121501|NCT03443206|mental health|mental health
121502|NCT03443206|social media|social media
121503|NCT03443193|aerobic exercise training|aerobic exercise training
121504|NCT03443193|periodization|periodization
121505|NCT03443193|cerebral oxygenation and perfusion|cerebral oxygenation and perfusion
121506|NCT03443193|cognition|cognition
121507|NCT03443180|Siblings|siblings
121508|NCT03443167|Cardiopulmonary Resuscitation|cardiopulmonary resuscitation
121509|NCT03443167|Teaching Material|teaching material
121510|NCT03443167|Primary education|primary education
121511|NCT03443154|Cerclage|cerclage
121512|NCT03443154|Preterm birth|preterm birth
121513|NCT03443128|Anaplastic Large Cell Lymphoma|anaplastic large cell lymphoma
121514|NCT03443128|Recurrent|recurrent
121515|NCT03443128|Childhood|childhood
121516|NCT03443128|Adolescent|adolescent
121517|NCT03443128|Treatment|treatment
121518|NCT03443089|medroxyprogesterone acetate|medroxyprogesterone acetate
121519|NCT03443089|estradiol cypionate|estradiol cypionate
121520|NCT03443089|bioavailability|bioavailability
121521|NCT03443089|monthly contraceptive|monthly contraceptive
121522|NCT03443063|severe renal impairment|severe renal impairment
121523|NCT03443063|lemborexant|lemborexant
121524|NCT03443063|normal renal function|normal renal function
121525|NCT03443063|healthy participants|healthy participants
121526|NCT03443063|metabolites|metabolites
121527|NCT03443063|E2006|e2006
121528|NCT03443063|pharmacokinetics|pharmacokinetics
121529|NCT03443037|Coma|coma
121530|NCT03443037|Disability|disability
121531|NCT03443037|amantadine|amantadine
121532|NCT03443024|Eczema|eczema
121533|NCT03442985|Multiple osteochondromas|multiple osteochondromas
121534|NCT03442985|Osteochondroma|osteochondroma
121535|NCT03442985|Palovarotene|palovarotene
121536|NCT03442985|Hereditary multiple exostoses|hereditary multiple exostoses
121537|NCT03442985|HME|hme
121538|NCT03442985|MO|mo
121539|NCT03442985|Retinoic acid receptor gamma agonist|retinoic acid receptor gamma agonist
121540|NCT03442985|Retinoic acid receptor agonist|retinoic acid receptor agonist
121541|NCT03442972|Intestinal lipoprotein|intestinal lipoprotein
121542|NCT03442972|Duodenal biopsy|duodenal biopsy
121543|NCT03442972|Gut Peptide|gut peptide
121544|NCT03442972|Chylomicrons|chylomicrons
121545|NCT03442959|Small intestine neuroendocrine tumor|small intestine neuroendocrine tumor
121546|NCT03442959|palliative surgery|palliative surgery
121547|NCT03442946|nutrition guidelines|nutrition guidelines
121548|NCT03442946|critical care|critical care
121549|NCT03442946|cardiovascular|cardiovascular
121550|NCT03442946|nutrition therapy|nutrition therapy
121551|NCT03442933|Muscle Fatigue|muscle fatigue
121552|NCT03442933|Cycling|cycling
121553|NCT03442933|MTB|mtb
121554|NCT03442933|Tensiomiography|tensiomiography
121555|NCT03442920|obesity|obesity
121556|NCT03442920|periodontal diseases|periodontal diseases
121557|NCT03442920|gingival crevicular fluid|gingival crevicular fluid
121558|NCT03442920|saliva|saliva
121559|NCT03442920|serum|serum
121560|NCT03442894|Shoulder pain|shoulder pain
121561|NCT03442894|Subacromial|subacromial
121562|NCT03442894|bursitis|bursitis
121563|NCT03442894|rotator cuff|rotator cuff
121564|NCT03442894|tendinopathy|tendinopathy
121565|NCT03442894|dry needling|dry needling
121566|NCT03442894|myofascial trigger point|myofascial trigger point
121567|NCT03442855|Arthroplasty, Replacement, Hip|arthroplasty, replacement, hip
121568|NCT03442829|sweet taste, food preferences, food intake|sweet taste, food preferences, food intake
121569|NCT03442803|sedation|sedation
121570|NCT03442803|Emergency Department|emergency department
121571|NCT03442803|Target Controlled infusion|target controlled infusion
121572|NCT03442803|propofol|propofol
121573|NCT03442790|CVC confirmation|cvc confirmation
121574|NCT03442790|Agitated Saline|agitated saline
121575|NCT03442790|CXR|cxr
121576|NCT03442738|ADR|adr
121577|NCT03442738|adenoma|adenoma
121578|NCT03442738|polyp|polyp
121579|NCT03442738|colon|colon
121580|NCT03442738|screening|screening
121581|NCT03442738|colorectal carcinoma (CRC)|colorectal carcinoma (crc)
121582|NCT03442738|cap|cap
121583|NCT03442738|endoscopy|endoscopy
121584|NCT03442738|colonoscopy|colonoscopy
121585|NCT03442738|private practice|private practice
121586|NCT03442712|obesity|obesity
121587|NCT03442712|weight loss|weight loss
121588|NCT03442712|ear acupressure|ear acupressure
121589|NCT03442712|smartphone application|smartphone application
121590|NCT03442699|cognitive behavioral therapy|cognitive behavioral therapy
121591|NCT03442699|suicidal ideology|suicidal ideology
121592|NCT03442699|suicidal behavior|suicidal behavior
121593|NCT03442673|Multiple Myeloma|multiple myeloma
121594|NCT03442673|Vinorelbine|vinorelbine
121595|NCT03442673|Gemcitabine|gemcitabine
121596|NCT03442673|G-CSF|g-csf
121597|NCT03442673|ASCT|asct
121598|NCT03442634|bowel movements|bowel movements
121599|NCT03442634|cesarean section|cesarean section
121600|NCT03442634|oral hydration|oral hydration
121601|NCT03442543|sentinel lymph node biopsy|sentinel lymph node biopsy
121602|NCT03442530|pregnancy, smoking cessation, tobacco, preterm birth, ToPIC|pregnancy, smoking cessation, tobacco, preterm birth, topic
121603|NCT03442517|group-based counseling|group-based counseling
121604|NCT03442517|phone counseling|phone counseling
121605|NCT03442517|conference calls|conference calls
121606|NCT03442504|metastatic Breast cancer|metastatic breast cancer
121607|NCT03442504|FES PET/CT|fes pet/ct
121608|NCT03442504|menopausal patients|menopausal patients
121609|NCT03442504|recurrence after a 1st line of hormone therapy|recurrence after a 1st line of hormone therapy
121610|NCT03442491|Postpartum Hemorrhage|postpartum hemorrhage
121611|NCT03442491|Hayman's Haemostatic Suture|hayman's haemostatic suture
121612|NCT03442465|18-014|18-014
121613|NCT03442465|Memorial Sloan Kettering Cancer Center|memorial sloan kettering cancer center
121614|NCT03442439|Family Nurture Intervention|family nurture intervention
121615|NCT03442439|Martha G. Welch MD|martha g. welch md
121616|NCT03442439|Randomized Controlled Trial|randomized controlled trial
121617|NCT03442439|Preschool Intervention|preschool intervention
121618|NCT03442439|Pre-school Intervention|pre-school intervention
121619|NCT03442439|Multiple Family Group Intervention|multiple family group intervention
121620|NCT03442439|Emotional Connection|emotional connection
121621|NCT03442439|Co-regulation|co-regulation
121622|NCT03442426|Primary Health Care|primary health care
121623|NCT03442426|Frail Elderly|frail elderly
121624|NCT03442426|Qualitative Methods|qualitative methods
121625|NCT03442426|Quantitative Methods|quantitative methods
121626|NCT03442426|Cost-Benefit Analysis|cost-benefit analysis
121627|NCT03442426|Patient Participation|patient participation
121628|NCT03442400|Coronary Artery Stenoses|coronary artery stenoses
121629|NCT03442400|Aortic Stenosis|aortic stenosis
121630|NCT03442374|Multifidus|multifidus
121631|NCT03442374|Muscle|muscle
121632|NCT03442374|Degeneration|degeneration
121633|NCT03442374|Lumbar Spine|lumbar spine
121634|NCT03442374|Disc|disc
121635|NCT03442348|Omega 3|omega 3
121636|NCT03442348|Fibre|fibre
121637|NCT03442348|Gut microbiome|gut microbiome
121638|NCT03442348|Metabolic profile|metabolic profile
121639|NCT03442348|Dietary intervention|dietary intervention
121640|NCT03442348|Randomised Control Trial|randomised control trial
121641|NCT03442335|embryo implantation|embryo implantation
121642|NCT03442335|endometrial receptivity|endometrial receptivity
121643|NCT03442335|chromohysteroscopy|chromohysteroscopy
121644|NCT03442335|transcriptomics|transcriptomics
121645|NCT03442335|proteomics|proteomics
121646|NCT03442335|metabolomics|metabolomics
121647|NCT03442335|implantation window|implantation window
121648|NCT03442335|luteal phase|luteal phase
121649|NCT03442322|long term care residents|long term care residents
121650|NCT03442322|nursing home care|nursing home care
121651|NCT03442309|dental caries|dental caries
121652|NCT03442309|caries arrest|caries arrest
121653|NCT03442309|caries prevention|caries prevention
121654|NCT03442309|quality of life|quality of life
121655|NCT03442309|silver diamine fluoride|silver diamine fluoride
121656|NCT03442309|sealants|sealants
121657|NCT03442309|interim therapeutic restorations|interim therapeutic restorations
121658|NCT03442309|student achievement|student achievement
121659|NCT03442309|school attendance|school attendance
121756|NCT03441672|Prenatal Screening|prenatal screening
121858|NCT03440892|sulfasalazin|sulfasalazin
121660|NCT03442283|Supplements, Cardiovascular Diseases, All-cause mortality, Meta-Analysis|supplements, cardiovascular diseases, all-cause mortality, meta-analysis
121661|NCT03442270|Serrated Adenoma, Colonoscopy|serrated adenoma, colonoscopy
121662|NCT03442257|Hypertension|hypertension
121663|NCT03442257|Text Messaging|text messaging
121664|NCT03442257|Primary Prevention|primary prevention
121665|NCT03442257|Cardiovascular Risk Factor|cardiovascular risk factor
121666|NCT03442257|Primary Health Care|primary health care
121667|NCT03442257|Health Promotion|health promotion
121668|NCT03442231|osteoarthritis|osteoarthritis
121669|NCT03442231|traumatic arthritis|traumatic arthritis
121670|NCT03442231|avascular necrosis|avascular necrosis
121671|NCT03442218|Cesarean|cesarean
121672|NCT03442218|Operative site infection|operative site infection
121673|NCT03442218|Vaginal wash|vaginal wash
121674|NCT03442218|Clorhexidine|clorhexidine
121675|NCT03442218|Endometritis|endometritis
121676|NCT03442205|Common Bile Duct Stone;|common bile duct stone;
121677|NCT03442205|Laparoscopic Common Bile Duct Exploration;|laparoscopic common bile duct exploration;
121678|NCT03442205|ERCP;|ercp;
121679|NCT03442192|PrEP|prep
121680|NCT03442192|virtual|virtual
121681|NCT03442192|adherence|adherence
121682|NCT03442192|retention|retention
121683|NCT03442179|Aging|aging
121684|NCT03442179|Anesthesia|anesthesia
121685|NCT03442179|EEG monitoring|eeg monitoring
121686|NCT03442179|Burst suppression|burst suppression
121687|NCT03442140|COPD|copd
121688|NCT03442140|Shortness of breath|shortness of breath
121689|NCT03442140|Harmonica|harmonica
121690|NCT03442114|shared decision making|shared decision making
121691|NCT03442114|parent-provider communication|parent-provider communication
121692|NCT03442114|hydroxyurea|hydroxyurea
121693|NCT03442114|sickle cell disease|sickle cell disease
121694|NCT03442075|Cancer of Prostate|cancer of prostate
121695|NCT03442075|Analgesic method|analgesic method
121696|NCT03442062|quality improvement|quality improvement
121697|NCT03442062|HPV vaccine|hpv vaccine
121698|NCT03442049|Multiple Sclerosis|multiple sclerosis
121699|NCT03442049|Gait|gait
121700|NCT03442049|Spinal Stabilization Exercises|spinal stabilization exercises
121701|NCT03442049|Plantar Pressure Distribution|plantar pressure distribution
121702|NCT03442049|Rehabilitation|rehabilitation
121703|NCT03442036|Regional Anesthesia|regional anesthesia
121704|NCT03442036|Sciatic Nerve Block|sciatic nerve block
121705|NCT03442036|Continuous Nerve Block|continuous nerve block
121706|NCT03442036|Perineural Catheter|perineural catheter
121707|NCT03442023|Chlorhexidine|chlorhexidine
121708|NCT03442023|Gram-negative|gram-negative
121709|NCT03442023|Colonization|colonization
121710|NCT03442010|Emergency department|emergency department
121711|NCT03442010|Clinical Pharmacist|clinical pharmacist
121712|NCT03442010|Adverse drug event|adverse drug event
121713|NCT03441997|exercise|exercise
121714|NCT03441997|low intensity exercise|low intensity exercise
121715|NCT03441997|pain|pain
121716|NCT03441997|fatigue|fatigue
121717|NCT03441997|sleep problems|sleep problems
121718|NCT03441984|Pediatric dispersible tablets|pediatric dispersible tablets
121719|NCT03441984|Bioavailability|bioavailability
121720|NCT03441958|hematopoietic stem cell transplant|hematopoietic stem cell transplant
121721|NCT03441958|Expanded cord blood|expanded cord blood
121722|NCT03441945|Magnetic|magnetic
121723|NCT03441945|Capsule Endoscopy|capsule endoscopy
121724|NCT03441945|enhance|enhance
121725|NCT03441945|gastric emptying|gastric emptying
121726|NCT03441932|Dysphagia|dysphagia
121727|NCT03441932|Pharyngeal residue scale|pharyngeal residue scale
121728|NCT03441932|Stroke|stroke
121729|NCT03441932|Pneumonia|pneumonia
121730|NCT03441893|ulcerative colitis, intestinal parasites, helminths, intestinal protozoan, nitazoxanide, mesalazine, combination therapy|ulcerative colitis, intestinal parasites, helminths, intestinal protozoan, nitazoxanide, mesalazine, combination therapy
121731|NCT03441867|Cognitive Behavioral Therapy|cognitive behavioral therapy
121732|NCT03441867|Veterans|veterans
121733|NCT03441867|Quality of Life|quality of life
121734|NCT03441867|Stress Disorders, Post-Traumatic|stress disorders, post-traumatic
121735|NCT03441867|Convulsion, Non-Epileptic|convulsion, non-epileptic
121736|NCT03441867|civilians|civilians
121737|NCT03441854|Gas exchange|gas exchange
121738|NCT03441854|Non invasive ventilation|non invasive ventilation
121739|NCT03441854|Liver transplantation|liver transplantation
121740|NCT03441841|local anesthetics|local anesthetics
121741|NCT03441841|pharmacokinetics|pharmacokinetics
121742|NCT03441841|nanotechnology|nanotechnology
121743|NCT03441815|Healthy volunteers|healthy volunteers
121744|NCT03441815|Phase I|phase i
121745|NCT03441815|Histamine glutarimide|histamine glutarimide
121746|NCT03441815|PHARMENTERPRISES|pharmenterprises
121748|NCT03441776|Rehabilitation|rehabilitation
121749|NCT03441776|Vestibular|vestibular
121750|NCT03441776|Dizziness|dizziness
121751|NCT03441763|Foot pressure, Obese, and normal Subjects|foot pressure, obese, and normal subjects
121752|NCT03441737|Aerobic exercise|aerobic exercise
121753|NCT03441737|Antisaccades|antisaccades
121754|NCT03441737|Urge to Smoke|urge to smoke
121755|NCT03441737|Adults|adults
121757|NCT03441672|Interactive educational technology|interactive educational technology
121758|NCT03441633|atrial fibrillation|atrial fibrillation
121759|NCT03441633|apixaban|apixaban
121760|NCT03441633|stroke|stroke
121761|NCT03441594|Food Insecurity|food insecurity
121762|NCT03441581|IBS-D|ibs-d
121763|NCT03441581|BAM|bam
121764|NCT03441555|Cancer|cancer
121765|NCT03441555|Acute Myeloid Leukemia (AML)|acute myeloid leukemia (aml)
121766|NCT03441555|relapsed Acute Myeloid Leukemia|relapsed acute myeloid leukemia
121767|NCT03441555|refractory Acute Myeloid Leukemia|refractory acute myeloid leukemia
121768|NCT03441542|Care cascade|care cascade
121769|NCT03441542|Patient navigation services|patient navigation services
121770|NCT03441542|Injection drug users|injection drug users
121771|NCT03441542|Opioid substitution therapy|opioid substitution therapy
121772|NCT03441490|Learning Support|learning support
121773|NCT03441490|Chat|chat
121774|NCT03441490|Adolescents|adolescents
121775|NCT03441464|Fluorescence|fluorescence
121776|NCT03441464|Prostate|prostate
121777|NCT03441464|Cancer detection|cancer detection
121778|NCT03441451|Bariatric Surgery|bariatric surgery
121779|NCT03441438|alcohol sensitivity|alcohol sensitivity
121780|NCT03441438|red wine|red wine
121781|NCT03441438|aerd|aerd
121782|NCT03441425|CRM Skills|crm skills
121783|NCT03441425|ACLS|acls
121784|NCT03441425|Simulation|simulation
121785|NCT03441425|Stress|stress
121786|NCT03441399|Medication Adherence|medication adherence
121787|NCT03441360|eribulin mesylate|eribulin mesylate
121788|NCT03441360|pediatric|pediatric
121789|NCT03441347|Physical therapy|physical therapy
121790|NCT03441347|Occupational therapy|occupational therapy
121791|NCT03441347|Rehabilitation|rehabilitation
121792|NCT03441347|Motor control|motor control
121793|NCT03441308|Dieting|dieting
121794|NCT03441308|learning to eat|learning to eat
121795|NCT03441308|group treatment|group treatment
121796|NCT03441295|ACL|acl
121797|NCT03441269|Emergency Medicine|emergency medicine
121798|NCT03441269|Acute Pain|acute pain
121799|NCT03441269|Oral Ibuprofen|oral ibuprofen
121800|NCT03441230|stomach|stomach
121801|NCT03441230|motility|motility
121802|NCT03441217|Duration of labor|duration of labor
121803|NCT03441217|Hyoscine butylbromide|hyoscine butylbromide
121804|NCT03441204|COPD|copd
121805|NCT03441204|Long-term oxygen therapy (LTOT)|long-term oxygen therapy (ltot)
121806|NCT03441204|Registry|registry
121807|NCT03441204|Registry-based randomized controlled trial (R-RCT)|registry-based randomized controlled trial (r-rct)
121808|NCT03441204|Treatment duration|treatment duration
121809|NCT03441204|Mortality|mortality
121810|NCT03441165|ACL|acl
121812|NCT03441165|REVISION|revision
121813|NCT03441165|LAXITY|laxity
121814|NCT03441152|Mild Cognitive Impairment|mild cognitive impairment
121815|NCT03441152|Neuromodulation|neuromodulation
121816|NCT03441139|Randomized controlled trial|randomized controlled trial
121817|NCT03441139|Musculoskeletal metastasis|musculoskeletal metastasis
121818|NCT03441139|Cancer pain|cancer pain
121819|NCT03441139|Percutaneous cryotherapy|percutaneous cryotherapy
121820|NCT03441139|Medical supportive care|medical supportive care
121821|NCT03441126|Diagnostic Stewardship|diagnostic stewardship
121822|NCT03441126|Pediatric|pediatric
121823|NCT03441126|Blood Culture Test|blood culture test
121824|NCT03441100|T-Cell therapy|t-cell therapy
121825|NCT03441100|Immunotherapy|immunotherapy
121826|NCT03441100|Adoptive cellular therapy|adoptive cellular therapy
121827|NCT03441100|T-Cell Receptor|t-cell receptor
121828|NCT03441100|Cell Therapy|cell therapy
121829|NCT03441100|Cytotherapy|cytotherapy
121830|NCT03441100|IMA202|ima202
121831|NCT03441087|transvaginal ultrasonography|transvaginal ultrasonography
121832|NCT03441087|hysteroscopy|hysteroscopy
121833|NCT03441087|abnormal uterine bleeding|abnormal uterine bleeding
121834|NCT03441048|Acute myeloid leukemia|acute myeloid leukemia
121835|NCT03441048|Relapsed/refractory acute myeloid leukemia|relapsed/refractory acute myeloid leukemia
121836|NCT03441048|CLAG-M|clag-m
121837|NCT03441048|Lintuzumab|lintuzumab
121838|NCT03441022|Cardioversion|cardioversion
121839|NCT03441022|BodyGuardian|bodyguardian
121840|NCT03441022|Amiigo Wristband|amiigo wristband
121841|NCT03441009|PSH, Rehabilitation, Medication, ANS|psh, rehabilitation, medication, ans
121842|NCT03440996|toothpaste|toothpaste
121843|NCT03440983|optimize the imaging protocols|optimize the imaging protocols
121844|NCT03440983|validate technical parameters in healthy volunteers|validate technical parameters in healthy volunteers
121845|NCT03440970|Chloride homeostasisH|chloride homeostasish
121846|NCT03440957|advanced cancer|advanced cancer
121847|NCT03440957|osteopathy|osteopathy
121848|NCT03440957|pain|pain
121849|NCT03440957|bedridden|bedridden
121850|NCT03440944|vascular access|vascular access
121851|NCT03440944|midline cather|midline cather
121852|NCT03440944|ultrasound guided IV|ultrasound guided iv
121853|NCT03440918|Infection|infection
121854|NCT03440892|survivin|survivin
121855|NCT03440892|biomarker of pharmacological response|biomarker of pharmacological response
121856|NCT03440892|antirheumatic treatment|antirheumatic treatment
121857|NCT03440892|methotrexate|methotrexate
121859|NCT03440892|abatacept|abatacept
121860|NCT03440892|tocilizumab|tocilizumab
121861|NCT03440892|tofacitinib/baricitinib|tofacitinib/baricitinib
121862|NCT03440827|low-flow vascular malformations, scale of life's quality|low-flow vascular malformations, scale of life's quality
121863|NCT03440814|PWS|pws
121864|NCT03440814|Prader-Willi Syndrome|prader-willi syndrome
121865|NCT03440762|Screening|screening
121866|NCT03440762|Education|education
121867|NCT03440762|AFib Awareness|afib awareness
121868|NCT03440762|Stroke prevention|stroke prevention
121869|NCT03440749|rhythm|rhythm
121870|NCT03440749|serial Reaction Time Task|serial reaction time task
121871|NCT03440736|Psoriasis|psoriasis
121872|NCT03440736|Metabolic syndrome|metabolic syndrome
121873|NCT03440736|Diabetes|diabetes
121874|NCT03440736|Obesity|obesity
121875|NCT03440736|Life-style|life-style
121876|NCT03440736|Life-style intervention|life-style intervention
121877|NCT03440736|Secukinumab|secukinumab
121878|NCT03440736|CAIN457A|cain457a
121879|NCT03440736|CAIN457ADE08|cain457ade08
121880|NCT03440736|AIN457A|ain457a
121881|NCT03440736|Skin condition|skin condition
121882|NCT03440736|skin disease|skin disease
121883|NCT03440736|itching condition|itching condition
121884|NCT03440736|psoriasis vulgaris|psoriasis vulgaris
121885|NCT03440736|relapsing/remitting psoriasis|relapsing/remitting psoriasis
121886|NCT03440736|immune-mediated systemic disease|immune-mediated systemic disease
121887|NCT03440736|skin lesions|skin lesions
121888|NCT03440736|red skin lesions|red skin lesions
121889|NCT03440736|scaly patches|scaly patches
121890|NCT03440736|papules|papules
121891|NCT03440736|plaques|plaques
121892|NCT03440736|itching|itching
121893|NCT03440723|Cervical Dilation|cervical dilation
121894|NCT03440723|Dilation|dilation
121895|NCT03440723|Sterile vaginal examination|sterile vaginal examination
121896|NCT03440697|Cardiovascular Disease|cardiovascular disease
121897|NCT03440684|Core stability, hand, function, balance, strength|core stability, hand, function, balance, strength
121898|NCT03440658|brachial plexus palsy|brachial plexus palsy
121899|NCT03440658|isokinetics|isokinetics
121900|NCT03440658|shoulder|shoulder
121901|NCT03440658|strenght|strenght
121902|NCT03440606|Randomized Wait-List Control Trial|randomized wait-list control trial
121903|NCT03440606|Mindful-Compassion Art Therapy Supervision|mindful-compassion art therapy supervision
121904|NCT03440606|End-of-Life Care|end-of-life care
121905|NCT03440606|Self-Care|self-care
121906|NCT03440593|sepsis|sepsis
121907|NCT03440593|nutrition|nutrition
121908|NCT03440593|indirect calorimetry|indirect calorimetry
121909|NCT03440593|muscle thickness|muscle thickness
121910|NCT03440580|physical activity|physical activity
121911|NCT03440580|serious game|serious game
121912|NCT03440580|school intervention|school intervention
121913|NCT03440580|children|children
121914|NCT03440554|Prostate Cancer|prostate cancer
121915|NCT03440554|Restriction spectrum imaging|restriction spectrum imaging
121916|NCT03440554|Magnetic resonance imaging|magnetic resonance imaging
121917|NCT03440554|MRI|mri
121918|NCT03440554|RSI|rsi
121919|NCT03440541|Amniotic membrane|amniotic membrane
121920|NCT03440541|Psoriasis|psoriasis
121921|NCT03440541|Treatment|treatment
121922|NCT03440528|Skin ulcer, Human amniotic membrane, Treatment|skin ulcer, human amniotic membrane, treatment
121923|NCT03440515|gastrointestinal stromal tumor|gastrointestinal stromal tumor
121924|NCT03440515|skin rash|skin rash
121925|NCT03440515|imatinib|imatinib
121926|NCT03440502|spinal anaesthesia|spinal anaesthesia
121927|NCT03440502|cesarean section|cesarean section
121928|NCT03440502|diabetes mellitus|diabetes mellitus
121929|NCT03440450|Liposomal gemcitabine|liposomal gemcitabine
121930|NCT03440437|FS118|fs118
121931|NCT03440437|Immuno-oncology|immuno-oncology
121932|NCT03440437|bispecific antibody|bispecific antibody
121933|NCT03440437|check-point inhibitor|check-point inhibitor
121934|NCT03440437|dose escalation|dose escalation
121935|NCT03440437|cohort expansion|cohort expansion
121937|NCT03440437|PD|pd
121938|NCT03440437|biomarker|biomarker
121939|NCT03440424|mild hepatic impairment|mild hepatic impairment
121940|NCT03440424|moderate hepatic impairment|moderate hepatic impairment
121941|NCT03440424|lemborexant|lemborexant
121942|NCT03440424|healthy participants|healthy participants
121943|NCT03440424|metabolites|metabolites
121944|NCT03440424|E2006|e2006
121945|NCT03440424|pharmacokinetics|pharmacokinetics
121946|NCT03440411|biochemical relapse|biochemical relapse
121947|NCT03440398|Robotic Mastectomy|robotic mastectomy
121948|NCT03440398|Nipple Sparing Mastectomy|nipple sparing mastectomy
121949|NCT03440398|Conservative mastectomy|conservative mastectomy
121950|NCT03440398|Breast reconstruction|breast reconstruction
121951|NCT03440385|Crohn's Disease|crohn's disease
121952|NCT03440385|Crohn Disease|crohn disease
121953|NCT03440385|Oral|oral
121954|NCT03440385|Ozanimod|ozanimod
121955|NCT03440385|Moderately active|moderately active
121956|NCT03440385|Severely active|severely active
121957|NCT03440385|RPC01|rpc01
121958|NCT03440385|RPC01-3202|rpc01-3202
121959|NCT03440372|Crohn's Disease|crohn's disease
121960|NCT03440372|Crohn Disease|crohn disease
121961|NCT03440372|Oral|oral
121962|NCT03440372|Ozanimod|ozanimod
121963|NCT03440372|Moderately active|moderately active
121964|NCT03440372|Severely active|severely active
121965|NCT03440372|RPC01|rpc01
121966|NCT03440372|RPC01-3201|rpc01-3201
121967|NCT03440359|PCOS, crinone, vaginal progesterone, ovulation induction|pcos, crinone, vaginal progesterone, ovulation induction
121968|NCT03440346|Attention Deficit Hyperactivity Disorder|attention deficit hyperactivity disorder
121969|NCT03440346|ADHD|adhd
121970|NCT03440346|child|child
121971|NCT03440346|human|human
121972|NCT03440346|diet|diet
121973|NCT03440346|few-foods diet|few-foods diet
121974|NCT03440346|brain|brain
121975|NCT03440346|gut|gut
121976|NCT03440346|microbiota|microbiota
121977|NCT03440320|Caregiving Dyad|caregiving dyad
121978|NCT03440320|Pain-related Disability|pain-related disability
121979|NCT03440294|windsurfer|windsurfer
121980|NCT03440294|wetsuit|wetsuit
121981|NCT03440294|spirometry|spirometry
121982|NCT03440294|cardiopulmonary exercise testing|cardiopulmonary exercise testing
121983|NCT03440294|lung function|lung function
121984|NCT03440294|pulmonary function|pulmonary function
121985|NCT03440294|oxygen uptake|oxygen uptake
121986|NCT03440268|cardiac surgery|cardiac surgery
121987|NCT03440268|post operatory complications|post operatory complications
121988|NCT03440268|Acute kidney injury|acute kidney injury
121989|NCT03440268|N-acetylcystein|n-acetylcystein
121990|NCT03440255|Transcutaneous Vagus nerve Stimulation|transcutaneous vagus nerve stimulation
121991|NCT03440255|Generalized Anxiety Disorder|generalized anxiety disorder
121992|NCT03440255|Chronic Pain|chronic pain
121993|NCT03440255|Irritable Bowel Syndrome|irritable bowel syndrome
121994|NCT03440255|Private Practice|private practice
121995|NCT03440216|temocillin|temocillin
121996|NCT03440216|ceftriaxone|ceftriaxone
121997|NCT03440216|meropenem|meropenem
121998|NCT03440216|pharmacokinetics|pharmacokinetics
121999|NCT03440216|pharmacodynamics|pharmacodynamics
122000|NCT03440216|Intensive Care|intensive care
122001|NCT03440216|dosing|dosing
122002|NCT03440216|total concentration|total concentration
122003|NCT03440216|free concentration|free concentration
122004|NCT03440190|Bariatric surgery|bariatric surgery
122005|NCT03440190|Gastrointestinal tract|gastrointestinal tract
122006|NCT03440190|Biological availability|biological availability
122007|NCT03440190|Pharmacokinetics|pharmacokinetics
122008|NCT03440190|Methylphenidate|methylphenidate
122009|NCT03440177|Bariatric surgery|bariatric surgery
122010|NCT03440177|Gastrointestinal tract|gastrointestinal tract
122011|NCT03440177|Biological availability|biological availability
122012|NCT03440177|Pharmacokinetics|pharmacokinetics
122013|NCT03440177|Ramipril|ramipril
122014|NCT03440164|liver fibrosis|liver fibrosis
122015|NCT03440164|Hepatoprotective|hepatoprotective
122016|NCT03440164|Sylimarin|sylimarin
122017|NCT03440151|Tongue Squamous Cell Carcinoma,|tongue squamous cell carcinoma,
122018|NCT03440151|Contralateral Submental Flap|contralateral submental flap
122019|NCT03440151|Submental Flap|submental flap
122020|NCT03440151|oncological safety|oncological safety
122021|NCT03440125|Low Back Pain|low back pain
122022|NCT03440125|Capsicum|capsicum
122023|NCT03440125|Physical Therapy|physical therapy
122024|NCT03440125|Pain|pain
122025|NCT03440112|Gait|gait
122026|NCT03440112|Balance|balance
122027|NCT03440112|GABA|gaba
122028|NCT03440112|Clarithromycin|clarithromycin
122029|NCT03440112|PET Imaging|pet imaging
122030|NCT03440112|MRI|mri
122031|NCT03440112|Mobility|mobility
122032|NCT03440099|Resistance Training|resistance training
122033|NCT03440099|Sex Differences|sex differences
122034|NCT03440086|Laparoscopic surgery|laparoscopic surgery
122035|NCT03440086|Pain|pain
122036|NCT03440086|Jackson-Pratt drain|jackson-pratt drain
122037|NCT03440073|pregnancy|pregnancy
122038|NCT03440073|pain|pain
122039|NCT03440073|pelvis|pelvis
122040|NCT03440073|spine|spine
122041|NCT03440073|manual therapy|manual therapy
122042|NCT03440060|procalcitonin|procalcitonin
122043|NCT03440060|mechanical ventilation|mechanical ventilation
122044|NCT03440060|COPD exacerbation|copd exacerbation
122045|NCT03440047|endoscopic image|endoscopic image
122046|NCT03440047|Fujifilm|fujifilm
122047|NCT03440047|Blue light imaging|blue light imaging
122048|NCT03440034|IBM|ibm
122049|NCT03440034|inclusion body myositis|inclusion body myositis
122050|NCT03440021|Noradrenalin Agents|noradrenalin agents
122051|NCT03440021|Physiological Effects of Drugs|physiological effects of drugs
122052|NCT03440021|Mood disorders|mood disorders
122053|NCT03440021|Behavioral Symptoms|behavioral symptoms
122054|NCT03439982|Hepatic encephalopathy, fecal microbiota transplant|hepatic encephalopathy, fecal microbiota transplant
122055|NCT03439969|Gingivitis|gingivitis
122056|NCT03439969|SMS|sms
122057|NCT03439969|Text messages|text messages
122058|NCT03439969|Behavior change|behavior change
122059|NCT03439969|HAPA|hapa
122060|NCT03439969|Dental Hygiene|dental hygiene
122061|NCT03439956|Obstetric outcomes|obstetric outcomes
122062|NCT03439956|Transvaginal specimen extraction|transvaginal specimen extraction
123156|NCT03433690|Adolescents|adolescents
122067|NCT03439839|Complement, alternative pathway, paroxysmal nocturnal hemoglobinuria,|complement, alternative pathway, paroxysmal nocturnal hemoglobinuria,
122068|NCT03439839|hemolysis|hemolysis
122069|NCT03439813|stroke|stroke
122070|NCT03439813|transient ischemic attack|transient ischemic attack
122071|NCT03439813|anxiety|anxiety
122072|NCT03439813|psychotherapy|psychotherapy
122073|NCT03439787|Arthroplasty, Replacement, Knee|arthroplasty, replacement, knee
122074|NCT03439787|Anesthetics, Local|anesthetics, local
122075|NCT03439787|Pain, Postoperative|pain, postoperative
122076|NCT03439787|Nerve Block|nerve block
122077|NCT03439787|Bupivacaine|bupivacaine
122078|NCT03439787|Epinephrine|epinephrine
122079|NCT03439735|Breast Cancer|breast cancer
122080|NCT03439735|Metastatic Breast Cancer|metastatic breast cancer
122081|NCT03439735|Aromatase Inhibitors|aromatase inhibitors
122082|NCT03439735|Palbociclib|palbociclib
122083|NCT03439735|Hormone Receptor Positive Metastatic Breast Cancer|hormone receptor positive metastatic breast cancer
122084|NCT03439722|cluster headache|cluster headache
122085|NCT03439722|sleep disturbances|sleep disturbances
122086|NCT03439709|acromegaly|acromegaly
122087|NCT03439709|pituitary adenoma|pituitary adenoma
122088|NCT03439709|gamma knife radiosurgery|gamma knife radiosurgery
122089|NCT03439709|adjuvant treatment|adjuvant treatment
122090|NCT03439696|Thoracoscopy|thoracoscopy
122091|NCT03439696|VATS|vats
122092|NCT03439696|Needlescopy|needlescopy
122093|NCT03439696|Uniportal|uniportal
122094|NCT03439670|Duchenne Muscular Dystrophy|duchenne muscular dystrophy
122095|NCT03439670|Vamorolone|vamorolone
122096|NCT03439657|HZ|hz
122097|NCT03439657|Safety|safety
122098|NCT03439657|Immunogenicity|immunogenicity
122099|NCT03439657|Shingles|shingles
122100|NCT03439657|Adults|adults
122101|NCT03439657|Prevenar 13|prevenar 13
122102|NCT03439605|Troponin-T|troponin-t
122103|NCT03439605|Haemolysis|haemolysis
122104|NCT03439579|Telehealth|telehealth
122105|NCT03439579|Remote weight loss|remote weight loss
122106|NCT03439579|Self-monitoring|self-monitoring
122107|NCT03439579|Diet|diet
122108|NCT03439579|Physical activity|physical activity
122109|NCT03439566|pain measures|pain measures
122110|NCT03439566|prediction of pain|prediction of pain
122111|NCT03439566|pain management|pain management
122112|NCT03439540|Plantago major|plantago major
122113|NCT03439540|obesity|obesity
122114|NCT03439540|mineral content|mineral content
122115|NCT03439540|adipose tissue|adipose tissue
122116|NCT03439527|Muscle Precursor Cells|muscle precursor cells
122121|NCT03439488|First in Human|first in human
122122|NCT03439488|Healthy Volunteers|healthy volunteers
122123|NCT03439488|Hepatitis B Virus|hepatitis b virus
122124|NCT03439488|JNJ-64530440|jnj-64530440
122125|NCT03439475|Refractory Celiac Disease Type II|refractory celiac disease type ii
122126|NCT03439449|History taking, Risk stratification|history taking, risk stratification
122127|NCT03439410|Internal medicine|internal medicine
122128|NCT03439410|Chronic disease|chronic disease
122129|NCT03439410|Healthcare expenditure|healthcare expenditure
122130|NCT03439371|Acute Myeloid Leukemia|acute myeloid leukemia
122131|NCT03439371|Micro-transplantation|micro-transplantation
122132|NCT03439371|Elderly|elderly
122133|NCT03439371|Graft-versus-leukemia|graft-versus-leukemia
122134|NCT03439358|Epidural top-up|epidural top-up
122135|NCT03439358|Shivering|shivering
122136|NCT03439358|Magnesium|magnesium
122137|NCT03439332|Highly infiltrative|highly infiltrative
122138|NCT03439332|Deeply invasive|deeply invasive
122139|NCT03439332|Strong vascular proliferation|strong vascular proliferation
122140|NCT03439332|Robust angiogenesis|robust angiogenesis
122141|NCT03439332|Vascular heterogeneity|vascular heterogeneity
122142|NCT03439332|Perfusion Biormarker|perfusion biormarker
122143|NCT03439332|Non-Invasive Biomarker|non-invasive biomarker
122144|NCT03439332|Predictor of overall survival|predictor of overall survival
122145|NCT03439332|Predictor of progression-free survival|predictor of progression-free survival
122146|NCT03439319|MyndMove|myndmove
122147|NCT03439319|Electrical neuromodulation|electrical neuromodulation
122148|NCT03439319|conventional therapy|conventional therapy
122149|NCT03439293|Drug Therapy|drug therapy
122150|NCT03439293|Ixazomib|ixazomib
122151|NCT03439293|Daratumumab|daratumumab
122152|NCT03439293|Dexamethasone|dexamethasone
122153|NCT03439280|Drug therapy, TAK-079, pomalidomide and dexamethasone, CD38 monoclonal antibody|drug therapy, tak-079, pomalidomide and dexamethasone, cd38 monoclonal antibody
122154|NCT03439254|Compensated Cirrhosis|compensated cirrhosis
122155|NCT03439254|Nonalcoholic Steatohepatitis|nonalcoholic steatohepatitis
122156|NCT03439254|Fatty Liver Disease|fatty liver disease
122157|NCT03439254|NASH|nash
122158|NCT03439215|ROS1 positive|ros1 positive
122159|NCT03439215|NSCLC|nsclc
122160|NCT03439202|Hypoxia|hypoxia
122161|NCT03439202|Baro-reflex sensitivity|baro-reflex sensitivity
122162|NCT03439202|Low-intensity exercise|low-intensity exercise
122163|NCT03439202|Hear rate variability|hear rate variability
122164|NCT03439202|EEG|eeg
155897|NCT03224988|MCI|mci
122165|NCT03439202|Concentration performance|concentration performance
122166|NCT03439150|Absolute flow measurement|absolute flow measurement
122167|NCT03439150|Microvascular resistance|microvascular resistance
122168|NCT03439150|Left ventricular function|left ventricular function
122169|NCT03439111|Lycium chinense fruit|lycium chinense fruit
122170|NCT03439072|glucagon|glucagon
122171|NCT03439072|hypoglycemia|hypoglycemia
122172|NCT03439059|Older adults|older adults
122173|NCT03439059|Sedentary behaviour|sedentary behaviour
122174|NCT03439059|Assisted living facility|assisted living facility
122175|NCT03439059|cognitive function|cognitive function
122176|NCT03439046|HR-positive HER2-negative|hr-positive her2-negative
122177|NCT03439046|advanced breast cancer|advanced breast cancer
122178|NCT03439046|LEE011|lee011
122179|NCT03439046|ribociclib|ribociclib
122180|NCT03439046|letrozole|letrozole
122181|NCT03439046|CDK|cdk
122182|NCT03439046|CDK4|cdk4
122183|NCT03439046|CDK6|cdk6
122184|NCT03439046|CDK4/6|cdk4/6
122185|NCT03439046|Phase IIIb|phase iiib
122186|NCT03439046|ER-positive|er-positive
122187|NCT03439046|PR-positive|pr-positive
122188|NCT03439046|postmenopausal|postmenopausal
122189|NCT03439046|biomarker|biomarker
122190|NCT03439046|ctDNA|ctdna
122191|NCT03439046|liquid biopsy|liquid biopsy
122192|NCT03439046|PIK3CA|pik3ca
122193|NCT03439046|alpelisib|alpelisib
122194|NCT03439046|fulvestrant|fulvestrant
122195|NCT03439046|BYL719|byl719
122196|NCT03439033|prostate cancer|prostate cancer
122197|NCT03439007|Dehydration|dehydration
122198|NCT03438994|autism|autism
122199|NCT03438994|movement|movement
122200|NCT03438994|tablet|tablet
122201|NCT03438994|gameplay|gameplay
122202|NCT03438981|Pharmacokinetics|pharmacokinetics
122203|NCT03438981|Ceftriaxone|ceftriaxone
122204|NCT03438981|critical illness|critical illness
122205|NCT03438981|capillary leak|capillary leak
122206|NCT03438981|hypoalbuminemia|hypoalbuminemia
122207|NCT03438942|iron|iron
122208|NCT03438942|folate|folate
122209|NCT03438942|childbearing age|childbearing age
122210|NCT03438942|bioavailability|bioavailability
122211|NCT03438916|Non-selective beta-blocker|non-selective beta-blocker
122212|NCT03438916|Pharmacological respons|pharmacological respons
122213|NCT03438916|Magnetic Resonance Imaging|magnetic resonance imaging
122214|NCT03438916|Hemodynamic assessments|hemodynamic assessments
122215|NCT03438916|Echocardiography|echocardiography
122216|NCT03438916|MR-elastography|mr-elastography
122217|NCT03438916|Propranolol|propranolol
122218|NCT03438916|Liver vein catheterization|liver vein catheterization
122219|NCT03438877|acute kidney injury|acute kidney injury
122220|NCT03438877|peritoneal dialysis|peritoneal dialysis
122221|NCT03438877|dosage|dosage
122222|NCT03438864|Radius fracture, Interferential current, edema, pain|radius fracture, interferential current, edema, pain
122223|NCT03438838|Achalasia, LHM, Anterior fundoplication|achalasia, lhm, anterior fundoplication
122224|NCT03438773|Hispanic|hispanic
122225|NCT03438773|First time kidney recipients|first time kidney recipients
122226|NCT03438760|Language Disorders|language disorders
122227|NCT03438760|Communication Disorders|communication disorders
122228|NCT03438760|Neurobehavioral Manifestations|neurobehavioral manifestations
122229|NCT03438760|Developmental Language Disorder|developmental language disorder
122230|NCT03438760|Randomized Controlled Trial|randomized controlled trial
122231|NCT03438734|Bariatric surgery|bariatric surgery
122232|NCT03438734|Low flow anesthesia|low flow anesthesia
122233|NCT03438734|Bispectral index|bispectral index
122234|NCT03438734|Regional cerebral oximetry|regional cerebral oximetry
122235|NCT03438708|Renal Cell Carcinoma|renal cell carcinoma
122236|NCT03438708|Axitinib|axitinib
122237|NCT03438708|Nephrectomy|nephrectomy
122238|NCT03438708|Neoadjuvant|neoadjuvant
122239|NCT03438708|Clear Cell Renal Carcinoma|clear cell renal carcinoma
122240|NCT03438695|endoscopy, motorized spiral enteroscopy|endoscopy, motorized spiral enteroscopy
122241|NCT03438669|visual acuity|visual acuity
122242|NCT03438669|ETDRS|etdrs
122243|NCT03438669|quality of life|quality of life
122244|NCT03438656|Depression|depression
122245|NCT03438656|Childhood adversity|childhood adversity
122246|NCT03438656|Behavioral Activation|behavioral activation
122247|NCT03438656|Reward Processing|reward processing
122248|NCT03438656|fMRI|fmri
122249|NCT03438643|Graft versus host disease|graft versus host disease
122250|NCT03438643|Extracorporeal photopheresis|extracorporeal photopheresis
122251|NCT03438643|Immunomodulatory|immunomodulatory
122252|NCT03438630|socioeconomic factors|socioeconomic factors
122253|NCT03438630|comorbidity|comorbidity
122254|NCT03438630|replacement surgery|replacement surgery
122255|NCT03438617|Diabetes|diabetes
122256|NCT03438617|Self-Management|self-management
122257|NCT03438617|Primary Care|primary care
122258|NCT03438617|Community Health Center|community health center
122259|NCT03438617|Peer Support|peer support
122260|NCT03438617|Group Support|group support
123256|NCT03432910|CPAP|cpap
122261|NCT03438617|Integrated Care|integrated care
122262|NCT03438617|China|china
122263|NCT03438617|Urban|urban
122264|NCT03438591|cerclage pacing|cerclage pacing
122265|NCT03438591|cerclage-CRT|cerclage-crt
122266|NCT03438591|wide QRS|wide qrs
122267|NCT03438578|Patient safety|patient safety
122268|NCT03438578|Postoperative care|postoperative care
122269|NCT03438578|Monitoring, physiologic|monitoring, physiologic
122270|NCT03438578|Safety management|safety management
122271|NCT03438565|Asahi Chikai Black 18 Neurovascular Guidewire|asahi chikai black 18 neurovascular guidewire
122272|NCT03438565|Prospective|prospective
122273|NCT03438565|Retrospective|retrospective
122274|NCT03438513|Caregivers|caregivers
122275|NCT03438513|Burden|burden
122276|NCT03438513|Coping|coping
122277|NCT03438513|Quality of life|quality of life
122278|NCT03438513|Problem solving therapy|problem solving therapy
122279|NCT03438448|Ultrasensitive Troponin T|ultrasensitive troponin t
122280|NCT03438448|MINS|mins
122281|NCT03438448|Cost-effectiveness|cost-effectiveness
122282|NCT03438448|Myocardial Ischemia|myocardial ischemia
122283|NCT03438383|Bi-PAP|bi-pap
122284|NCT03438383|BiPAP|bipap
122285|NCT03438383|morbid obesity|morbid obesity
122286|NCT03438383|anesthesia|anesthesia
122287|NCT03438383|bariatric surgery|bariatric surgery
122288|NCT03438383|sham Bi-PAP|sham bi-pap
122289|NCT03438383|sham BiPAP|sham bipap
122290|NCT03438383|postoperative complications|postoperative complications
122291|NCT03438331|Insomnia|insomnia
122292|NCT03438331|Depression|depression
122293|NCT03438331|Adolescents|adolescents
122294|NCT03438331|Youth|youth
122295|NCT03438292|Berberine|berberine
122296|NCT03438292|TPGS|tpgs
122297|NCT03438292|Pharmacokinetics|pharmacokinetics
122298|NCT03438292|Human intervention study|human intervention study
122299|NCT03438292|Quillaja extract|quillaja extract
122300|NCT03438253|Intraoperative penile engorgement|intraoperative penile engorgement
122301|NCT03438253|Anaesthesia|anaesthesia
122302|NCT03438253|Urogenital surgery|urogenital surgery
122303|NCT03438227|Iron Deficiency Anemia of Pregnancy|iron deficiency anemia of pregnancy
122304|NCT03438227|oral iron supplementation|oral iron supplementation
122305|NCT03438227|parenteral iron supplementation|parenteral iron supplementation
122306|NCT03438227|maternal anemia|maternal anemia
122307|NCT03438214|Vancomycin infusion|vancomycin infusion
122308|NCT03438214|critical ill patients|critical ill patients
122309|NCT03438214|MRSA|mrsa
122310|NCT03438201|Cancer, ICU, Surgery, Protein, Physical Activity|cancer, icu, surgery, protein, physical activity
122311|NCT03438188|Nicotine Addiction|nicotine addiction
122312|NCT03438188|Quitting Smoking|quitting smoking
122313|NCT03438175|Post-traumatic Stress Disorder|post-traumatic stress disorder
122314|NCT03438175|Web-site|web-site
122315|NCT03438175|Communication|communication
122316|NCT03438175|Intensive Care Unit|intensive care unit
122317|NCT03438175|Comprehension|comprehension
122318|NCT03438149|microparticles|microparticles
122319|NCT03438149|cardiovascular outcomes|cardiovascular outcomes
122320|NCT03438110|Preterm birth|preterm birth
122321|NCT03438110|Neonatal death|neonatal death
122322|NCT03438110|Stillbirth|stillbirth
122323|NCT03438110|Asia|asia
122324|NCT03438110|Africa|africa
122325|NCT03438097|Fluid therapy|fluid therapy
122326|NCT03438097|Non-resuscitation fluids|non-resuscitation fluids
122327|NCT03438097|Septic shock|septic shock
122328|NCT03438084|Interesterified|interesterified
122329|NCT03438084|Postprandial|postprandial
122330|NCT03438084|Lipid|lipid
122331|NCT03438058|Solid Organ Transplantation|solid organ transplantation
122332|NCT03438058|Graft survival|graft survival
122333|NCT03438058|Rejection|rejection
122334|NCT03438058|Complement-activating anti-HLA DSA|complement-activating anti-hla dsa
122335|NCT03438058|Meta-analysis|meta-analysis
122336|NCT03438058|Prognosis|prognosis
122337|NCT03438045|Chinese American|chinese american
122338|NCT03438045|implementation science|implementation science
122339|NCT03438045|feasibility|feasibility
122340|NCT03438045|acceptability|acceptability
122341|NCT03438045|oral health|oral health
122342|NCT03438045|dental care|dental care
122343|NCT03438045|health equity|health equity
122344|NCT03438045|urban health|urban health
122345|NCT03438019|Maximal Respiratory Pressures, Inspiratory Muscle Training, TIRE, COPD|maximal respiratory pressures, inspiratory muscle training, tire, copd
122346|NCT03438006|Safety|safety
122347|NCT03438006|Human Papillomavirus Vaccine|human papillomavirus vaccine
122348|NCT03438006|Adverse Event Following Immunization|adverse event following immunization
122349|NCT03437993|ADHD|adhd
122350|NCT03437993|executive functioning|executive functioning
122351|NCT03437993|game|game
122352|NCT03437941|Prostate Cancer|prostate cancer
122353|NCT03437941|Castration-Resistant Prostate Cancer|castration-resistant prostate cancer
122354|NCT03437941|Glucocorticoid receptor|glucocorticoid receptor
122355|NCT03437941|Antagonist|antagonist
122356|NCT03437941|mCRPC|mcrpc
122357|NCT03437941|enzalutamide|enzalutamide
122358|NCT03437941|androgen receptor|androgen receptor
122359|NCT03437928|Major Depressive Disorder (MDD)|major depressive disorder (mdd)
122361|NCT03437928|Neuromodulation|neuromodulation
122362|NCT03437928|Deep Brain Stimulation (DBS)|deep brain stimulation (dbs)
122363|NCT03437928|DBS|dbs
122364|NCT03437928|Electrophysiology|electrophysiology
122365|NCT03437928|Imaging|imaging
122366|NCT03437902|Type 2 diabetes|type 2 diabetes
122367|NCT03437902|Rutin|rutin
122368|NCT03437902|Vitamin C|vitamin c
122369|NCT03437902|oxidative stress|oxidative stress
122370|NCT03437902|Insulin resistance|insulin resistance
122371|NCT03437902|lipid profile|lipid profile
122372|NCT03437889|epidural|epidural
122373|NCT03437876|HBV induced cirrhosis|hbv induced cirrhosis
122374|NCT03437876|intestinal microbiota transplantation|intestinal microbiota transplantation
122375|NCT03437876|microbiota|microbiota
122376|NCT03437863|self-management|self-management
122377|NCT03437863|health assets|health assets
122378|NCT03437863|Strengths|strengths
122379|NCT03437863|mHealth|mhealth
122380|NCT03437863|Feasibility|feasibility
122381|NCT03437811|airway clearance system|airway clearance system
122382|NCT03437811|cystic fibrosis|cystic fibrosis
122383|NCT03437811|lung secretion clearance|lung secretion clearance
122384|NCT03437798|Periodontal Disease|periodontal disease
122385|NCT03437798|Diabetes|diabetes
122386|NCT03437798|Osteoporosis|osteoporosis
122387|NCT03437798|Cardiovascular Risk Factor|cardiovascular risk factor
122388|NCT03437798|Genomic|genomic
122389|NCT03437785|Acute Gastritis|acute gastritis
122390|NCT03437785|Chronic Gastritis|chronic gastritis
122391|NCT03437785|Cinnamic acid|cinnamic acid
122392|NCT03437785|CKD-495|ckd-495
122393|NCT03437759|macular hole (MH)|macular hole (mh)
122394|NCT03437759|exosomes|exosomes
122395|NCT03437759|mesenchymal stem cells|mesenchymal stem cells
122396|NCT03437759|pars plana vitrectomy|pars plana vitrectomy
122397|NCT03437733|Radiofrequency Ablation|radiofrequency ablation
122398|NCT03437733|Paroxysmal Atrial Fibrillation|paroxysmal atrial fibrillation
122399|NCT03437707|Postoperative pain|postoperative pain
122400|NCT03437707|Intravenous ibuprofen|intravenous ibuprofen
122401|NCT03437707|Intravenous paracetamol|intravenous paracetamol
122402|NCT03437707|Lumbar disc surgery|lumbar disc surgery
122403|NCT03437694|HIV|hiv
122404|NCT03437694|AIDS|aids
122405|NCT03437694|Diabetes Melliltus, Type 2|diabetes melliltus, type 2
122406|NCT03437694|Hypertension|hypertension
122407|NCT03437694|Pharmacist|pharmacist
122408|NCT03437694|Medication optimization|medication optimization
122409|NCT03437694|medication therapy management|medication therapy management
122410|NCT03437681|Sleep|sleep
122411|NCT03437681|Blood Sugar|blood sugar
122412|NCT03437668|Schizophrenia|schizophrenia
122413|NCT03437668|Withania Somnifera|withania somnifera
122414|NCT03437616|Rehabilitation|rehabilitation
122415|NCT03437616|Coronary heart disease|coronary heart disease
122416|NCT03437616|Cardiovascular diseases|cardiovascular diseases
122417|NCT03437616|Risk factors|risk factors
122418|NCT03437616|Life-style changes|life-style changes
122419|NCT03437616|Efficacy|efficacy
122420|NCT03437603|Eltrombopag|eltrombopag
122421|NCT03437603|Allogenetic Hematopoietic Stem Cell Transplantation|allogenetic hematopoietic stem cell transplantation
122422|NCT03437603|Poor Graft Function|poor graft function
122423|NCT03437577|Kidney|kidney
122424|NCT03437577|Transplant|transplant
122425|NCT03437551|Diabetes Mellitus 1|diabetes mellitus 1
122426|NCT03437551|long-term intensified insulin therapy|long-term intensified insulin therapy
122427|NCT03437551|diabetic retinopathy|diabetic retinopathy
122428|NCT03437551|diabetic macular edema|diabetic macular edema
122429|NCT03437538|Dialysis|dialysis
122430|NCT03437538|MCO|mco
122431|NCT03437538|Middle molecules|middle molecules
122432|NCT03437538|High Retention Onset|high retention onset
122433|NCT03437538|Medium Cut-Off|medium cut-off
122434|NCT03437525|Diabetes|diabetes
122435|NCT03437525|Self-Management|self-management
122436|NCT03437525|Primary Care|primary care
122437|NCT03437525|Community Health Center|community health center
122438|NCT03437525|Peer Support|peer support
122439|NCT03437525|Group Support|group support
122440|NCT03437525|Integrated Care|integrated care
122441|NCT03437525|Insulin|insulin
122442|NCT03437525|China|china
122443|NCT03437525|Urban|urban
122444|NCT03437512|tDCS|tdcs
122445|NCT03437512|MRI|mri
122446|NCT03437512|Speech|speech
122447|NCT03437512|fluency|fluency
122448|NCT03437460|Productivity|productivity
122449|NCT03437460|Cognitive Function|cognitive function
122450|NCT03437460|Decision Making|decision making
122451|NCT03437460|Well-Being|well-being
122452|NCT03437460|Health|health
122453|NCT03437460|Labor|labor
122454|NCT03437447|Bioavailability|bioavailability
122455|NCT03437447|Bioequivalence|bioequivalence
122456|NCT03437447|Praziquantel|praziquantel
122457|NCT03437447|Cysticide|cysticide
122458|NCT03437447|Pharmacokinetics|pharmacokinetics
122459|NCT03437421|myocardial function|myocardial function
122460|NCT03437421|vitamin D|vitamin d
122461|NCT03437421|stress echocardiography|stress echocardiography
122462|NCT03437421|diabetes|diabetes
122463|NCT03437408|Ventricular Tachycardia|ventricular tachycardia
122464|NCT03437408|Catheter Ablation|catheter ablation
122465|NCT03437408|Late Potential|late potential
122466|NCT03437408|Ablation Index|ablation index
122467|NCT03437408|Pacing|pacing
122468|NCT03437395|Lumpectomy|lumpectomy
122469|NCT03437395|Unifocal Disease|unifocal disease
122470|NCT03437395|Stage 0 or 1 Disease|stage 0 or 1 disease
122471|NCT03437382|Hepatocellular carcinoma|hepatocellular carcinoma
122472|NCT03437382|Radiofrequency ablation (RFA)|radiofrequency ablation (rfa)
122473|NCT03437382|Radioembolization|radioembolization
122474|NCT03437382|Quirem Spheres|quirem spheres
122475|NCT03437382|Selective internal radiation therapy|selective internal radiation therapy
122476|NCT03437369|Ivabradine, heart rate, acute heart failure|ivabradine, heart rate, acute heart failure
122477|NCT03437356|persistent atrial fibrillation|persistent atrial fibrillation
122478|NCT03437356|pulmonary vein isolation|pulmonary vein isolation
122479|NCT03437356|antiarrhythmic drug therapy|antiarrhythmic drug therapy
122481|NCT03437343|total hip arthroplasty|total hip arthroplasty
122482|NCT03437343|performance of surgeons|performance of surgeons
122483|NCT03437343|leg length discrepancy|leg length discrepancy
122484|NCT03437343|HOOS|hoos
122485|NCT03437317|Social Anxiety|social anxiety
122486|NCT03437317|Threat processing|threat processing
122487|NCT03437317|Magnetoencephalography (MEG)|magnetoencephalography (meg)
122488|NCT03437304|Vaccine|vaccine
122489|NCT03437278|Anti-IgE|anti-ige
122490|NCT03437278|Chronic spontaneous urticaria,|chronic spontaneous urticaria,
122491|NCT03437252|COPD|copd
122492|NCT03437252|COPD exacerbation|copd exacerbation
122493|NCT03437252|COPD AE|copd ae
122494|NCT03437252|Physical activity|physical activity
122495|NCT03437252|Wearable arm device|wearable arm device
122496|NCT03437239|Bicep tenodesis|bicep tenodesis
122497|NCT03437226|Heart Failure, Levosimendan|heart failure, levosimendan
122498|NCT03437200|œsophageal cancer nivolumab ipilimumab|œsophageal cancer nivolumab ipilimumab
122499|NCT03437174|Hypoparathyroidism|hypoparathyroidism
122500|NCT03437174|Parathyroid Disease|parathyroid disease
122501|NCT03437174|Burden of Illness|burden of illness
122502|NCT03437174|SF-36|sf-36
122503|NCT03437174|Quality of Life|quality of life
122504|NCT03437161|Radiation|radiation
122505|NCT03437161|Prone position|prone position
122506|NCT03437161|Supine position|supine position
122507|NCT03437161|DIBH|dibh
122508|NCT03437161|Invasive Breast Carcinoma|invasive breast carcinoma
122509|NCT03437161|Ductal Breast Carcinoma In Situ|ductal breast carcinoma in situ
122510|NCT03437148|Pulmonary to systemic blood flow|pulmonary to systemic blood flow
122511|NCT03437148|Non-invasive measurement|non-invasive measurement
122512|NCT03437148|Inert gas rebreathing|inert gas rebreathing
122513|NCT03437148|Bioimpedance cardiograph|bioimpedance cardiograph
122514|NCT03437148|Atrial Septal Defect|atrial septal defect
122515|NCT03437148|Congenital heart disease|congenital heart disease
122516|NCT03437148|Cardiac Output|cardiac output
122517|NCT03437135|diabetes|diabetes
122518|NCT03437135|hearing problems|hearing problems
122519|NCT03437135|otoscopy|otoscopy
122520|NCT03437122|lung, nasal mucosa, respiratory mucosa|lung, nasal mucosa, respiratory mucosa
122521|NCT03437083|Breast neoplasms|breast neoplasms
122522|NCT03437083|Metastatic breast cancer|metastatic breast cancer
122523|NCT03437083|E7389|e7389
122524|NCT03437070|Advanced Leiomyosarcoma|advanced leiomyosarcoma
122525|NCT03437070|Recurrent Leiomyosarcoma|recurrent leiomyosarcoma
122526|NCT03437057|ECL|ecl
122527|NCT03437057|Hematoma|hematoma
122528|NCT03437057|Antiplatelet|antiplatelet
122529|NCT03437044|diabetes mellitus|diabetes mellitus
122530|NCT03437044|percutaneous coronary intervention|percutaneous coronary intervention
122531|NCT03437044|ticagrelor|ticagrelor
122532|NCT03437044|clopidogrel|clopidogrel
122533|NCT03437044|coronary artery disease|coronary artery disease
122534|NCT03437031|Labor Pain|labor pain
122535|NCT03437031|Virtual Reality|virtual reality
122536|NCT03437031|Alternative Medicine|alternative medicine
122537|NCT03437018|moderate diabetic retinopathy|moderate diabetic retinopathy
122538|NCT03437018|tele-expertise|tele-expertise
122539|NCT03437005|Human microbiome|human microbiome
122540|NCT03437005|Topical|topical
122541|NCT03437005|Steroid|steroid
122542|NCT03437005|Anti-fungal|anti-fungal
122543|NCT03436992|Estrogen, Diabetes|estrogen, diabetes
122544|NCT03436979|prolapse|prolapse
122545|NCT03436979|sacrospinous fixation|sacrospinous fixation
122546|NCT03436979|minimally invasive|minimally invasive
122547|NCT03436927|Multiple Sclerosis|multiple sclerosis
122548|NCT03436927|rehabilitation|rehabilitation
122549|NCT03436927|postural balance|postural balance
122550|NCT03436927|exercise|exercise
122551|NCT03436901|magnetic resonance imaging|magnetic resonance imaging
122552|NCT03436901|diffusion weighted imaging|diffusion weighted imaging
122553|NCT03436862|Nivolumab|nivolumab
122554|NCT03436862|Autologous Stem Cell Transplant|autologous stem cell transplant
122555|NCT03436862|Blood cancers|blood cancers
122556|NCT03436849|ASP2693|asp2693
122557|NCT03436849|Pharmacodynamics|pharmacodynamics
122558|NCT03436849|Pharmacokinetics|pharmacokinetics
122559|NCT03436849|ESN364|esn364
122560|NCT03436849|Safety|safety
122561|NCT03436810|Motor Imagery|motor imagery
122562|NCT03436810|Task-Oriented Circuit Class Training|task-oriented circuit class training
122563|NCT03436810|Health Education|health education
122564|NCT03436771|long-term follow-up|long-term follow-up
122565|NCT03436771|chimeric antigen receptor (CAR) T cells|chimeric antigen receptor (car) t cells
122566|NCT03436771|JCAR017|jcar017
122567|NCT03436771|JCARH125|jcarh125
122568|NCT03436758|uterine fluids|uterine fluids
122569|NCT03436758|Biobank|biobank
122570|NCT03436758|culture medium|culture medium
122571|NCT03436745|Insomnia|insomnia
122572|NCT03436745|Enzyme Expression|enzyme expression
122573|NCT03436745|PSA|psa
122574|NCT03436745|TESTOSTERONE|testosterone
122575|NCT03436745|Recommended Dose|recommended dose
122576|NCT03436732|Immunotoxin|immunotoxin
122577|NCT03436732|Rapamycin|rapamycin
122578|NCT03436732|Targeted Therapy|targeted therapy
122579|NCT03436732|Mesothelin|mesothelin
122580|NCT03436719|Surgical Site Infection|surgical site infection
122581|NCT03436719|Rectal Cancer Surgery|rectal cancer surgery
122582|NCT03436719|Oral Antibiotic|oral antibiotic
122583|NCT03436719|Antibiotic Prophylaxis|antibiotic prophylaxis
122584|NCT03436693|Diabetic Nephropathy|diabetic nephropathy
122585|NCT03436693|Canagliflozin|canagliflozin
122586|NCT03436693|Canaglu|canaglu
122587|NCT03436693|Diabetes Mellitus, Type 2|diabetes mellitus, type 2
122588|NCT03436654|prostate cancer|prostate cancer
122589|NCT03436654|apalutamide|apalutamide
122590|NCT03436654|abiraterone acetate|abiraterone acetate
122591|NCT03436654|memorial sloan kettering cancer center|memorial sloan kettering cancer center
122592|NCT03436654|17-646|17-646
122593|NCT03436602|Personalized risk assessment|personalized risk assessment
122594|NCT03436602|Risk stratification model|risk stratification model
122595|NCT03436589|Supplemental Nutrition Assistance Program-Education|supplemental nutrition assistance program-education
122596|NCT03436589|nutrition education intervention|nutrition education intervention
122597|NCT03436576|Autologous serum|autologous serum
122598|NCT03436576|Concentration|concentration
122599|NCT03436576|Autologous serum 20%|autologous serum 20%
122600|NCT03436576|Autologous serum 50%|autologous serum 50%
122601|NCT03436576|Severe dry eye|severe dry eye
122602|NCT03436563|colon cancer|colon cancer
122603|NCT03436563|rectal cancer|rectal cancer
122604|NCT03436563|colorectal cancer|colorectal cancer
122605|NCT03436563|microsatellite instability|microsatellite instability
122606|NCT03436563|circulating tumor DNA|circulating tumor dna
122607|NCT03436563|metastasis|metastasis
122608|NCT03436563|Immunotherapy|immunotherapy
122609|NCT03436550|Hepatic Venous Pressure Gradient|hepatic venous pressure gradient
122610|NCT03436550|Magnetic Resonance Imaging|magnetic resonance imaging
122611|NCT03436550|Acoustic Radiation Force Impulse|acoustic radiation force impulse
122612|NCT03436550|Elastography|elastography
122613|NCT03436550|Ultrasound|ultrasound
122614|NCT03436550|Liver Cirrhosis|liver cirrhosis
122615|NCT03436537|aesthetic|aesthetic
122616|NCT03436537|development|development
122617|NCT03436537|periodontal|periodontal
122618|NCT03436537|reliability|reliability
122619|NCT03436537|validity|validity
122620|NCT03436524|Early stage CLL|early stage cll
122621|NCT03436524|Binet A|binet a
122622|NCT03436524|Prognosis|prognosis
122623|NCT03436511|Health resource utilization|health resource utilization
122624|NCT03436511|Eosinophilic COPD|eosinophilic copd
122625|NCT03436511|Mepolizumab|mepolizumab
122626|NCT03436472|aged|aged
122627|NCT03436472|operative|operative
122628|NCT03436472|delirium|delirium
122629|NCT03436472|dexmedetomidine|dexmedetomidine
122630|NCT03436472|long-term outcome|long-term outcome
122631|NCT03436459|extracorporeal shock wave therapy (ESWT)|extracorporeal shock wave therapy (eswt)
122632|NCT03436459|Low level laser therapy (LLLT)|low level laser therapy (lllt)
122633|NCT03436459|Myofascial Pain Syndrome|myofascial pain syndrome
122634|NCT03436446|Patient Reported Outcomes (PRO)|patient reported outcomes (pro)
122635|NCT03436446|Social Incentives|social incentives
122636|NCT03436433|anti-epileptic drugs|anti-epileptic drugs
122637|NCT03436433|seizure prophylaxis|seizure prophylaxis
122638|NCT03436433|levetiracetam|levetiracetam
122639|NCT03436420|Pediatrics|pediatrics
122640|NCT03436420|Lipids|lipids
122641|NCT03436420|Liver Diseases|liver diseases
122642|NCT03436420|Obesity|obesity
122643|NCT03436394|Renal Impairment|renal impairment
122644|NCT03436394|Evobrutinib|evobrutinib
122645|NCT03436394|Pharmacokinetics|pharmacokinetics
122646|NCT03436368|Continuous spinal anesthesia|continuous spinal anesthesia
122647|NCT03436368|General anesthesia|general anesthesia
122648|NCT03436368|Renal transplantation|renal transplantation
122649|NCT03436368|Chronic renal failure|chronic renal failure
122650|NCT03436355|Behavioral|behavioral
122651|NCT03436355|Physical activity|physical activity
122652|NCT03436355|Intervention|intervention
122653|NCT03436355|School children|school children
122654|NCT03436329|Lung cancer|lung cancer
122655|NCT03436329|Surgical technique|surgical technique
122656|NCT03436329|vessel ligation|vessel ligation
122657|NCT03436329|Circulating tumor cell|circulating tumor cell
122658|NCT03436316|Phosphoinositide 3-kinase (PI3K) inhibitor|phosphoinositide 3-kinase (pi3k) inhibitor
123461|NCT03431415|VATS|vats
122659|NCT03436316|First-in-human (FiH) study|first-in-human (fih) study
122660|NCT03436303|Menopause Syndrome|menopause syndrome
122661|NCT03436303|low dose estrogen|low dose estrogen
122662|NCT03436303|progestin|progestin
122663|NCT03436290|Palliative Care|palliative care
122664|NCT03436277|Overweight|overweight
122665|NCT03436277|Obesity|obesity
122666|NCT03436277|L-Carnitine|l-carnitine
122667|NCT03436277|Body weight|body weight
122668|NCT03436277|Body fat percentage|body fat percentage
122669|NCT03436251|hyperthermia|hyperthermia
122670|NCT03436251|human papillomavirus virus|human papillomavirus virus
122671|NCT03436251|cervical intraepithelial neoplasia|cervical intraepithelial neoplasia
122672|NCT03436238|Perioperative|perioperative
122673|NCT03436238|Biomarkers|biomarkers
122674|NCT03436238|Troponin|troponin
122675|NCT03436238|Prodrenomedullin|prodrenomedullin
122676|NCT03436238|Endothelin|endothelin
122677|NCT03436238|Perioperative Complications|perioperative complications
122678|NCT03436225|steroid therapy.|steroid therapy.
122679|NCT03436186|Thyroidectomy|thyroidectomy
122680|NCT03436186|voice|voice
122681|NCT03436186|swallowing problems|swallowing problems
122682|NCT03436186|dysphagia|dysphagia
122683|NCT03436147|vaginal hysterectomy|vaginal hysterectomy
122684|NCT03436147|laparoscopic hysteropexy|laparoscopic hysteropexy
122685|NCT03436147|pelvic organ prolapse quantification|pelvic organ prolapse quantification
122686|NCT03436134|Donor-specific antibodies|donor-specific antibodies
122687|NCT03436134|Double-Filtration PlasmaPheresis (DFPP)|double-filtration plasmapheresis (dfpp)
122688|NCT03436134|Plasma Exchange (PE)|plasma exchange (pe)
122689|NCT03436095|Bundle|bundle
122690|NCT03436095|difficult ventilator weaning|difficult ventilator weaning
122691|NCT03436069|Breast cancer|breast cancer
122692|NCT03436069|biomarkers|biomarkers
122693|NCT03436069|prognostic|prognostic
122694|NCT03436069|ectopic gene expression|ectopic gene expression
122695|NCT03436069|expression profile|expression profile
122696|NCT03436069|tissue-specific genes|tissue-specific genes
122697|NCT03436069|response to treatment|response to treatment
122698|NCT03436056|Non-small-cell lunG cancer|non-small-cell lung cancer
122699|NCT03436056|NSCLC|nsclc
122700|NCT03436056|metastatic|metastatic
122701|NCT03436056|pembrolizumab|pembrolizumab
122702|NCT03436056|radiotherapy|radiotherapy
122703|NCT03436043|Walled of necrosis|walled of necrosis
122704|NCT03436017|adhd|adhd
122705|NCT03436017|metabolomics|metabolomics
122706|NCT03436017|child|child
122707|NCT03436004|Colonoscopy|colonoscopy
122708|NCT03436004|Adenoma|adenoma
122709|NCT03436004|Adenoma detection rate|adenoma detection rate
122710|NCT03435991|Experience Sampling Method|experience sampling method
122711|NCT03435991|Ecological Momentary Assessment|ecological momentary assessment
122712|NCT03435991|Momentary Symptom Assessment|momentary symptom assessment
122713|NCT03435991|Patient Reported Outcome Measure|patient reported outcome measure
122714|NCT03435978|diet|diet
122715|NCT03435978|metabolic syndrome|metabolic syndrome
122716|NCT03435978|obese children|obese children
122717|NCT03435952|Pembrolizumab|pembrolizumab
122718|NCT03435952|Keytruda|keytruda
122719|NCT03435952|MK-3475|mk-3475
122720|NCT03435952|SCH-900475|sch-900475
122721|NCT03435952|Clostridium Novyi-NT|clostridium novyi-nt
122722|NCT03435952|C. novyi-NT|c. novyi-nt
122723|NCT03435952|Doxycycline|doxycycline
122724|NCT03435952|Vibramycin|vibramycin
122725|NCT03435952|Periostat|periostat
122726|NCT03435952|Doryx|doryx
122727|NCT03435952|Solid tumor malignancies|solid tumor malignancies
122728|NCT03435913|Mechanical ventilation|mechanical ventilation
122729|NCT03435913|Driving Pressure|driving pressure
122730|NCT03435913|Protective Lung VEntilation|protective lung ventilation
122731|NCT03435887|Point of Care Testing|point of care testing
122732|NCT03435887|HIV|hiv
122733|NCT03435887|Pediatric HIV-exposed infants|pediatric hiv-exposed infants
122734|NCT03435887|at-birth testing|at-birth testing
122735|NCT03435887|early infant diagnosis|early infant diagnosis
122736|NCT03435887|Kenya|kenya
122737|NCT03435848|Acute Myeloid Leukemia|acute myeloid leukemia
122738|NCT03435848|Unfit for standard induction therapy|unfit for standard induction therapy
122739|NCT03435848|Cytarabine|cytarabine
122740|NCT03435822|asthma|asthma
122741|NCT03435822|children|children
122742|NCT03435822|action plan|action plan
122743|NCT03435822|China|china
122744|NCT03435822|CCAAP|ccaap
122745|NCT03435796|Long-term follow up|long-term follow up
122746|NCT03435796|Gene-Modified T Cells|gene-modified t cells
122747|NCT03435796|CAR T Cell|car t cell
122748|NCT03435770|EUS-guided RFA|eus-guided rfa
122749|NCT03435770|Endoscopic ultrasound|endoscopic ultrasound
122750|NCT03435770|radio frequency ablation|radio frequency ablation
122751|NCT03435731|OSA|osa
122752|NCT03435731|Continous Positive Airway Pressure (CPAP)|continous positive airway pressure (cpap)
122753|NCT03435731|Mandibular Advancement Split (MAS)|mandibular advancement split (mas)
122754|NCT03435731|Mandibular Advancement Oral Appliance|mandibular advancement oral appliance
122755|NCT03435731|Dual Therapy|dual therapy
122756|NCT03435718|oxfendazole|oxfendazole
122757|NCT03435718|albendazole|albendazole
123462|NCT03431415|SBRT|sbrt
122758|NCT03435718|Trichuris trichiura|trichuris trichiura
122759|NCT03435679|infection|infection
122760|NCT03435679|knee arthroplasty|knee arthroplasty
122761|NCT03435679|surgical treatment|surgical treatment
122762|NCT03435679|one-stage|one-stage
122763|NCT03435679|two-stage|two-stage
122764|NCT03435679|outcome|outcome
122765|NCT03435640|Bempegaldesleukin (NKTR-214)|bempegaldesleukin (nktr-214)
122766|NCT03435640|NKTR-262|nktr-262
122767|NCT03435640|Nivolumab|nivolumab
122768|NCT03435640|Opdivo®|opdivo®
122769|NCT03435640|Metastatic|metastatic
122770|NCT03435640|Locally advanced|locally advanced
122771|NCT03435640|Relapsed/Refractory|relapsed/refractory
122772|NCT03435640|TLR7/8|tlr7/8
122773|NCT03435640|CD122|cd122
122774|NCT03435614|Opioid|opioid
122775|NCT03435614|Withdrawal|withdrawal
122776|NCT03435614|Critically ill adults|critically ill adults
122777|NCT03435614|Cortisol|cortisol
122778|NCT03435601|Rheumatoid Arthritis|rheumatoid arthritis
122779|NCT03435601|RA|ra
122780|NCT03435601|IFN-Signature|ifn-signature
122781|NCT03435601|Anifrolumab|anifrolumab
122782|NCT03435575|physical activity|physical activity
122783|NCT03435575|serious game|serious game
122784|NCT03435575|childhood obesity|childhood obesity
122785|NCT03435536|circulating tumor DNA|circulating tumor dna
122786|NCT03435536|kinetic|kinetic
122787|NCT03435536|pancreatic cancer|pancreatic cancer
122788|NCT03435536|pancreatoduodenectomy|pancreatoduodenectomy
122789|NCT03435536|Next Generation Sequencing|next generation sequencing
122790|NCT03435510|Live Donor Kidney Transplant|live donor kidney transplant
122791|NCT03435510|Education|education
122792|NCT03435510|Advocacy|advocacy
122793|NCT03435510|Live Donor|live donor
122794|NCT03435471|Prophylactic Swallowing Therapy|prophylactic swallowing therapy
122795|NCT03435458|Induced labor|induced labor
122796|NCT03435458|Maternal obesity|maternal obesity
122797|NCT03435445|obesity|obesity
122798|NCT03435445|overweight|overweight
122799|NCT03435445|telemedicine|telemedicine
122800|NCT03435445|ehealth|ehealth
122801|NCT03435419|cutaneous leishmaniasis|cutaneous leishmaniasis
122802|NCT03435419|RDT|rdt
122803|NCT03435419|LAMP|lamp
122804|NCT03435419|PCR|pcr
122805|NCT03435406|Hepatitis B, Chronic|hepatitis b, chronic
122806|NCT03435406|Cirrhosis|cirrhosis
122807|NCT03435406|Hepatopulmonary Syndrome|hepatopulmonary syndrome
122808|NCT03435380|Cancer Survivors|cancer survivors
122809|NCT03435380|Smartphone|smartphone
122810|NCT03435380|Mobile Applications|mobile applications
122811|NCT03435354|Physical activity|physical activity
122812|NCT03435354|Quality of life|quality of life
122813|NCT03435354|Activity motivation|activity motivation
122814|NCT03435354|Children|children
122815|NCT03435354|Adolescents|adolescents
122816|NCT03435354|Cluster-randomized trial|cluster-randomized trial
122817|NCT03435341|Acute Myeloid Leukemia (AML)|acute myeloid leukemia (aml)
122818|NCT03435341|Observational|observational
122819|NCT03435341|Standard Clinical Practice|standard clinical practice
122820|NCT03435341|Survival|survival
122821|NCT03435341|Tolerability|tolerability
122822|NCT03435341|Spain|spain
122823|NCT03435328|TENS|tens
122824|NCT03435302|Mucosal Melanoma,Adjuvant Therapy,IFN-a2b,Temozolomide|mucosal melanoma,adjuvant therapy,ifn-a2b,temozolomide
122825|NCT03435289|Advanced Pancreatic Cancer|advanced pancreatic cancer
122826|NCT03435276|Heart failure.|heart failure.
122827|NCT03435276|Oral selective mineralocorticoid receptor modulator.|oral selective mineralocorticoid receptor modulator.
122828|NCT03435276|Heart failure with preserved ejection fraction (HFpEF).|heart failure with preserved ejection fraction (hfpef).
122829|NCT03435263|premature rupture of membranes|premature rupture of membranes
122830|NCT03435250|MTAP|mtap
122831|NCT03435250|MTAP deletion|mtap deletion
122832|NCT03435250|CDKN2A deletion|cdkn2a deletion
122833|NCT03435250|MAT2A inhibitor|mat2a inhibitor
122834|NCT03435250|Advanced solid tumors|advanced solid tumors
122835|NCT03435250|Lymphoma|lymphoma
122836|NCT03435237|Optical Coherence Tomography|optical coherence tomography
122837|NCT03435237|Bronchial Thermoplasty|bronchial thermoplasty
122838|NCT03435185|Pain|pain
122839|NCT03435185|Nerve Blocks|nerve blocks
122840|NCT03435185|Headache|headache
122841|NCT03435185|Local Anaesthetics|local anaesthetics
122842|NCT03435185|Migraine|migraine
122843|NCT03435172|Thermal Burn|thermal burn
122844|NCT03435172|Adipose Derived Regenerative Cells|adipose derived regenerative cells
122845|NCT03435172|Skin Graft|skin graft
122846|NCT03435159|Chiropractic, Manipulation, Vertebrobasilar Artery|chiropractic, manipulation, vertebrobasilar artery
122848|NCT03435146|LTBI|ltbi
122849|NCT03435146|IMPAACT4TB|impaact4tb
122850|NCT03435146|DDI|ddi
122851|NCT03435146|Pharmacokinetics|pharmacokinetics
122852|NCT03435146|Dolutegravir|dolutegravir
122853|NCT03435133|Primary angioplasty|primary angioplasty
122854|NCT03435133|Prasugrel|prasugrel
122855|NCT03435133|Ticagrelor|ticagrelor
122856|NCT03435133|STEMI|stemi
122857|NCT03435133|cardiac magnetic resonance|cardiac magnetic resonance
122858|NCT03435133|infarct size|infarct size
122859|NCT03435133|infarct injury|infarct injury
123664|NCT03429972|Paclitaxel|paclitaxel
122860|NCT03435120|Breakthrough Cancer Pain|breakthrough cancer pain
122861|NCT03435120|Quality of life|quality of life
122862|NCT03435120|Medical Oncology|medical oncology
122863|NCT03435081|eczema|eczema
122864|NCT03435081|atopic eczema|atopic eczema
122865|NCT03435068|rotary|rotary
122866|NCT03435068|diode laser|diode laser
122867|NCT03435068|gingivectomy|gingivectomy
122868|NCT03435068|wound healing|wound healing
122869|NCT03435029|aging|aging
122870|NCT03435029|cognitive rehabilitation|cognitive rehabilitation
122871|NCT03435029|REHACOP|rehacop
122872|NCT03435003|Bariatric Procedure|bariatric procedure
122873|NCT03434990|spinal manipulative therapy|spinal manipulative therapy
122874|NCT03434990|Myofascial release|myofascial release
122875|NCT03434990|Low back pain|low back pain
122876|NCT03434977|Drug Therapy|drug therapy
122877|NCT03434938|Stroke|stroke
122878|NCT03434938|Geriatric|geriatric
122879|NCT03434938|Rehabilitation|rehabilitation
122880|NCT03434938|Functional recovery|functional recovery
122881|NCT03434938|Physical activity|physical activity
122882|NCT03434938|Motivational interviewing|motivational interviewing
122883|NCT03434938|Adherence|adherence
122884|NCT03434938|Clinical trial|clinical trial
122885|NCT03434925|colorectal neoplasia|colorectal neoplasia
122886|NCT03434925|adenoma|adenoma
122887|NCT03434925|colonoscopy|colonoscopy
122888|NCT03434925|gene mutation|gene mutation
122889|NCT03434925|follow-up|follow-up
122890|NCT03434925|recurrence|recurrence
122891|NCT03434925|multiparametric test|multiparametric test
122892|NCT03434873|magnetic stimulation, multiple sclerosis|magnetic stimulation, multiple sclerosis
122893|NCT03434821|Hyperoxemia|hyperoxemia
122894|NCT03434821|ventilator-associated|ventilator-associated
122895|NCT03434821|pneumonia|pneumonia
122896|NCT03434821|critical illness|critical illness
122897|NCT03434769|Cyclophosphamide|cyclophosphamide
122898|NCT03434769|Fludarabine|fludarabine
122899|NCT03434769|Chimeric antigen receptor T cells|chimeric antigen receptor t cells
122900|NCT03434756|ultrasound imaging|ultrasound imaging
122901|NCT03434756|propioception|propioception
122902|NCT03434756|training|training
122903|NCT03434743|oral feeding|oral feeding
122904|NCT03434743|early intervention|early intervention
122905|NCT03434743|premature infant|premature infant
122906|NCT03434743|sucking|sucking
122907|NCT03434730|tocilizumab|tocilizumab
122908|NCT03434730|17-616|17-616
122909|NCT03434730|Memorial Sloan Kettering Cancer Center|memorial sloan kettering cancer center
122910|NCT03434678|General Anesthesia|general anesthesia
122911|NCT03434678|Epidural|epidural
122912|NCT03434678|Pancreaticoduodenectomy|pancreaticoduodenectomy
122913|NCT03434678|18-056|18-056
122914|NCT03434665|Angiography|angiography
122915|NCT03434665|Bariatric embolization|bariatric embolization
122916|NCT03434665|Gastric artery|gastric artery
122917|NCT03434665|Obesity|obesity
122918|NCT03434665|Transradial|transradial
122919|NCT03434639|Gut permeability|gut permeability
122920|NCT03434639|Fluorescence|fluorescence
122921|NCT03434639|Spectroscopy|spectroscopy
122922|NCT03434639|Wearable sensor|wearable sensor
122923|NCT03434639|Leaky gut|leaky gut
122924|NCT03434587|fifth metacarpal neck, fracture, syndactyly, inmobilization, RCT|fifth metacarpal neck, fracture, syndactyly, inmobilization, rct
122925|NCT03434574|(Poly)phenols|(poly)phenols
122926|NCT03434574|Aronia berry|aronia berry
122927|NCT03434574|Blood pressure|blood pressure
122928|NCT03434574|Vascular function|vascular function
122929|NCT03434561|hematopoietic stem cell transplantation|hematopoietic stem cell transplantation
122930|NCT03434509|Motor Control|motor control
122931|NCT03434509|Attention|attention
122932|NCT03434509|Cognitive Control|cognitive control
122933|NCT03434496|PD; Gait training 3; treadmill.|pd; gait training 3; treadmill.
122934|NCT03434483|Microbiota|microbiota
122935|NCT03434483|Immunity|immunity
122936|NCT03434483|Genetics|genetics
122937|NCT03434483|Atherosclerosis|atherosclerosis
122938|NCT03434470|Ultrasound|ultrasound
122939|NCT03434470|Shear wave elastography|shear wave elastography
122940|NCT03434470|SWE|swe
122941|NCT03434470|Hepatitis C|hepatitis c
122942|NCT03434470|HCV|hcv
122943|NCT03434457|Fetal growth retardation|fetal growth retardation
122944|NCT03434457|Early adversity|early adversity
122945|NCT03434457|Depressive Symptoms|depressive symptoms
122946|NCT03434444|propranolol|propranolol
122947|NCT03434444|oxytocin|oxytocin
122948|NCT03434444|uterine contraction|uterine contraction
122949|NCT03434431|metabolic adaptation|metabolic adaptation
122950|NCT03434431|weight regain|weight regain
122951|NCT03434431|reverse dieting|reverse dieting
122952|NCT03434418|EGFR Mutation|egfr mutation
122953|NCT03434418|osimertinib|osimertinib
122954|NCT03434418|exon 18 G719X|exon 18 g719x
122955|NCT03434418|exon 20 S7681|exon 20 s7681
122956|NCT03434418|exon 21 L861Q|exon 21 l861q
122957|NCT03434405|schizophrenia|schizophrenia
122958|NCT03434405|mindfulness|mindfulness
122959|NCT03434405|social cognition|social cognition
122960|NCT03434405|SocialMind|socialmind
122961|NCT03434405|AGES-Mind|ages-mind
122962|NCT03434392|Chronic Pain|chronic pain
123665|NCT03429972|Neuropathy|neuropathy
122963|NCT03434392|Chronic Pancreatitis|chronic pancreatitis
122964|NCT03434392|Sphincter of Oddi Dysfunction|sphincter of oddi dysfunction
122965|NCT03434392|Recurrent Acute Pancreatitis|recurrent acute pancreatitis
122966|NCT03434392|Chronic Abdominal Pain|chronic abdominal pain
122967|NCT03434392|Functional Dyspepsia|functional dyspepsia
122968|NCT03434366|Autism Spectrum Disorder|autism spectrum disorder
122969|NCT03434366|ketamine|ketamine
122970|NCT03434366|dexmedetomidine|dexmedetomidine
122971|NCT03434340|peppermint oil|peppermint oil
122972|NCT03434340|intrathecal morphine|intrathecal morphine
122973|NCT03434340|PONV|ponv
122974|NCT03434340|lower segment cesarean section|lower segment cesarean section
122975|NCT03434340|dexamethasone|dexamethasone
122976|NCT03434340|granisetron|granisetron
122977|NCT03434314|Paraplegia|paraplegia
122978|NCT03434314|Aortic Aneurysm Repair|aortic aneurysm repair
122979|NCT03434314|Staging|staging
122980|NCT03434314|Embolization|embolization
122981|NCT03434314|TAAA|taaa
122982|NCT03434314|Thoracoabdominal aortic aneurysm|thoracoabdominal aortic aneurysm
122983|NCT03434314|MISACE|misace
122984|NCT03434314|Spinal cord ischemia|spinal cord ischemia
122985|NCT03434314|Spinal cord ischaemia|spinal cord ischaemia
122986|NCT03434314|Spinal cord injury|spinal cord injury
122987|NCT03434314|Spinal cord ischemic injury|spinal cord ischemic injury
122988|NCT03434314|Spinal cord ischaemic injury|spinal cord ischaemic injury
122989|NCT03434314|Permanent paraplegia|permanent paraplegia
122990|NCT03434314|Temporary paraplegia|temporary paraplegia
122991|NCT03434314|Paraparesis|paraparesis
122993|NCT03434314|TAAA repair|taaa repair
122994|NCT03434314|Open TAAA repair|open taaa repair
122995|NCT03434314|Open surgical TAAA repair|open surgical taaa repair
122996|NCT03434314|Endovascular TAAA repair|endovascular taaa repair
122997|NCT03434314|TEVAR|tevar
122998|NCT03434314|Aortic surgery|aortic surgery
122999|NCT03434314|Thoracoabdominal aortic surgery|thoracoabdominal aortic surgery
123000|NCT03434314|Type B aortic dissection|type b aortic dissection
123001|NCT03434314|Chronic type B aortic dissection|chronic type b aortic dissection
123002|NCT03434314|Stanford type B aortic dissection|stanford type b aortic dissection
123003|NCT03434314|Collateral network|collateral network
123004|NCT03434314|Paraspinal collateral network|paraspinal collateral network
123005|NCT03434314|Paraspinous collateral network|paraspinous collateral network
123006|NCT03434314|Arteriogenesis|arteriogenesis
123007|NCT03434314|Intercostal arteries|intercostal arteries
123008|NCT03434301|Surgery|surgery
123009|NCT03434301|Laparotomy|laparotomy
123010|NCT03434301|Tack|tack
123011|NCT03434301|Non-absorbable Tack|non-absorbable tack
123012|NCT03434301|Absorbable Tack|absorbable tack
123013|NCT03434301|Pain|pain
123014|NCT03434288|Diabetes|diabetes
123015|NCT03434288|Diabetic foot|diabetic foot
123016|NCT03434288|Osteomyelitis|osteomyelitis
123017|NCT03434275|Total Knee Arthroplasty|total knee arthroplasty
123018|NCT03434275|Pain|pain
123019|NCT03434275|Analgesia|analgesia
123020|NCT03434275|N1539|n1539
123021|NCT03434275|Phase 3b|phase 3b
123022|NCT03434275|Knee Replacement|knee replacement
123023|NCT03434262|ATRT|atrt
123024|NCT03434262|Brain Tumors in Adolescents|brain tumors in adolescents
123025|NCT03434262|Brain Tumors in Children|brain tumors in children
123026|NCT03434262|Brain Tumors in Young Adults|brain tumors in young adults
123027|NCT03434262|CDK4 amplification|cdk4 amplification
123028|NCT03434262|CDK 4/6|cdk 4/6
123029|NCT03434262|CDK 4/6 inhibitor|cdk 4/6 inhibitor
123030|NCT03434262|CDK 4/6 pathway|cdk 4/6 pathway
123031|NCT03434262|CDK 4/6/cyclin/RB/E2F pathway|cdk 4/6/cyclin/rb/e2f pathway
123032|NCT03434262|CDK6 amplification|cdk6 amplification
123033|NCT03434262|CyclinD1|cyclind1
123034|NCT03434262|DAWN|dawn
123035|NCT03434262|D-type Cyclins|d-type cyclins
123036|NCT03434262|Hedgehog pathway inhibitor|hedgehog pathway inhibitor
123037|NCT03434262|HGG|hgg
123038|NCT03434262|MAPK pathway|mapk pathway
123039|NCT03434262|MEK|mek
123040|NCT03434262|MEK inhibitor|mek inhibitor
123041|NCT03434262|MEK1|mek1
123042|NCT03434262|MEK2|mek2
123043|NCT03434262|Mekinist|mekinist
123044|NCT03434262|Molecular|molecular
123045|NCT03434262|Molecular therapy|molecular therapy
123046|NCT03434262|MYC amplification|myc amplification
123047|NCT03434262|PTCH1|ptch1
123048|NCT03434262|Rare brain tumor|rare brain tumor
123049|NCT03434262|Recurrent ATRT|recurrent atrt
123050|NCT03434262|Recurrent brain tumor|recurrent brain tumor
123051|NCT03434262|Recurrent ependymoma|recurrent ependymoma
123052|NCT03434262|Recurrent high grade glioma|recurrent high grade glioma
123053|NCT03434262|Recurrent malignant glioma|recurrent malignant glioma
157101|NCT03216980|GAD|gad
123054|NCT03434262|Recurrent medulloblastoma|recurrent medulloblastoma
123055|NCT03434262|Refractory brain tumor|refractory brain tumor
123056|NCT03434262|Small molecule inhibitor|small molecule inhibitor
123057|NCT03434262|SMO antagonist|smo antagonist
123058|NCT03434262|Smoothened protein|smoothened protein
123059|NCT03434262|Sonic hedgehog|sonic hedgehog
123060|NCT03434262|Combination therapy|combination therapy
123061|NCT03434249|Bifidobacterium|bifidobacterium
123062|NCT03434236|omega-3|omega-3
123063|NCT03434236|specialized proresolving mediators|specialized proresolving mediators
123064|NCT03434210|schizophrenia|schizophrenia
123065|NCT03434210|violence risk|violence risk
123066|NCT03434210|long-acting antipsychotics|long-acting antipsychotics
123067|NCT03434210|community-based|community-based
123068|NCT03434197|Osteoarthritis Knee Pain|osteoarthritis knee pain
123069|NCT03434184|Walking analysis|walking analysis
123070|NCT03434184|spinal surgery|spinal surgery
123071|NCT03434184|scoliosis|scoliosis
123072|NCT03434184|pelvic fixation|pelvic fixation
123073|NCT03434158|Metastatic Prostate Cancer Resistant to Castration|metastatic prostate cancer resistant to castration
123074|NCT03434132|Open Radical Cystectomy|open radical cystectomy
123075|NCT03434132|Robotic Radical cystectomy|robotic radical cystectomy
123076|NCT03434132|Intracorporeal urinary diversion|intracorporeal urinary diversion
123077|NCT03434132|Prospective randdomized trial|prospective randdomized trial
123078|NCT03434106|meibomian gland dysfunction|meibomian gland dysfunction
123079|NCT03434106|Sjögren's syndrome|sjögren's syndrome
123080|NCT03434106|dry eye disease|dry eye disease
123081|NCT03434093|Paired Associative Stimulation (PAS)|paired associative stimulation (pas)
123082|NCT03434093|Functional Magnetic Resonance Imaging (fMRI)|functional magnetic resonance imaging (fmri)
123083|NCT03434093|Electrical Field Modeling|electrical field modeling
123084|NCT03434093|Working Memory|working memory
123085|NCT03434080|Infant and Toddler at Risk|infant and toddler at risk
123086|NCT03434080|Pediatric|pediatric
123087|NCT03434080|Neuroimaging|neuroimaging
123088|NCT03434080|Brain Function|brain function
123089|NCT03434080|Voluntary Movement|voluntary movement
123090|NCT03434067|hyperthyroidism|hyperthyroidism
123091|NCT03434067|thyroidectomy|thyroidectomy
123093|NCT03434067|immunochromatographic assay|immunochromatographic assay
123094|NCT03434054|losartan|losartan
123095|NCT03434054|emotional processing|emotional processing
123096|NCT03434054|anxiety|anxiety
123097|NCT03434054|magnet resonance imaging|magnet resonance imaging
123098|NCT03434054|MRI|mri
123099|NCT03434028|Fluid management|fluid management
123100|NCT03434028|Sepsis-induced hypotension|sepsis-induced hypotension
123101|NCT03434028|vasopressors|vasopressors
123102|NCT03434015|Atrial fibrillation|atrial fibrillation
123103|NCT03434015|Left atrial septal closure|left atrial septal closure
123104|NCT03434002|Virtual Reality Simulation|virtual reality simulation
123105|NCT03434002|Teaching and Assessment|teaching and assessment
123106|NCT03434002|Anesthesia Crisis Management|anesthesia crisis management
123107|NCT03433989|Post-Traumatic Stress Disorder|post-traumatic stress disorder
123108|NCT03433989|Pregnancy loss|pregnancy loss
123109|NCT03433976|Caesarean section|caesarean section
123110|NCT03433976|spinal anesthesia|spinal anesthesia
123111|NCT03433976|Prilocaïne|prilocaïne
123112|NCT03433976|motor block|motor block
123113|NCT03433963|air pollution|air pollution
123114|NCT03433963|blood pressure|blood pressure
123115|NCT03433963|cardiac ischemia|cardiac ischemia
123116|NCT03433963|L-arginine|l-arginine
123117|NCT03433963|nitric oxide|nitric oxide
123118|NCT03433950|antiparkinson|antiparkinson
123119|NCT03433911|Permanent contraception|permanent contraception
123120|NCT03433911|Birth control|birth control
123121|NCT03433885|macular pigment optical density (MPOD)|macular pigment optical density (mpod)
123122|NCT03433885|Age-related Macular Degeneration (AMD)|age-related macular degeneration (amd)
123123|NCT03433885|drusen|drusen
123124|NCT03433885|Chroidal neovascularization (CNV)|chroidal neovascularization (cnv)
123125|NCT03433885|lutein|lutein
123126|NCT03433885|zeaxanthin|zeaxanthin
123127|NCT03433872|Infant-toddler care|infant-toddler care
123128|NCT03433872|Early child development|early child development
123129|NCT03433872|Professional development|professional development
123130|NCT03433846|Sepsis|sepsis
123131|NCT03433846|Prematurity|prematurity
123132|NCT03433807|idebenone, DMD, Duchenne|idebenone, dmd, duchenne
123133|NCT03433781|ASCORBIC ACID|ascorbic acid
123134|NCT03433755|Evolocumab|evolocumab
123135|NCT03433755|Repatha|repatha
123136|NCT03433755|Statin|statin
123137|NCT03433755|Chinese|chinese
123138|NCT03433755|China|china
123139|NCT03433755|Hypercholesterolemia|hypercholesterolemia
123140|NCT03433755|Mixed Dyslipidemia|mixed dyslipidemia
123141|NCT03433755|High Cholesterol|high cholesterol
123142|NCT03433755|Lowering cholesterol|lowering cholesterol
123143|NCT03433742|metal ion levels, total hip replacement, Trident II cup.|metal ion levels, total hip replacement, trident ii cup.
123144|NCT03433729|Outpatient Clinics, Hospital|outpatient clinics, hospital
123145|NCT03433729|Humans|humans
123146|NCT03433729|Outcome Assessment (Health Care)|outcome assessment (health care)
123147|NCT03433729|Patient Outcome Assessment|patient outcome assessment
123148|NCT03433729|Patient satisfaction|patient satisfaction
123149|NCT03433729|Hospitalists|hospitalists
123150|NCT03433729|Secondary care|secondary care
123151|NCT03433716|Percutaneous Neuromodulation, radial nerve, pain|percutaneous neuromodulation, radial nerve, pain
123152|NCT03433703|Unresectable hepatocellular carcinoma|unresectable hepatocellular carcinoma
123153|NCT03433703|Lenvatinib|lenvatinib
123154|NCT03433703|E7080|e7080
123155|NCT03433690|Child Obesity|child obesity
123157|NCT03433690|High Intensity Interval Training|high intensity interval training
123158|NCT03433690|Moderate training|moderate training
123159|NCT03433677|insulin pump|insulin pump
123160|NCT03433664|CO2 laser|co2 laser
123161|NCT03433664|Ablative fractional laser|ablative fractional laser
123162|NCT03433651|depression|depression
123163|NCT03433638|Juvenile dermatomyositis|juvenile dermatomyositis
123164|NCT03433638|Inflammatory myopathy|inflammatory myopathy
123165|NCT03433638|Clinical features|clinical features
123166|NCT03433638|Treatment|treatment
123167|NCT03433625|Cognitive-behavioural therapy|cognitive-behavioural therapy
123168|NCT03433612|Anatomical Landmarks|anatomical landmarks
123169|NCT03433599|Intermittent Hypoxia|intermittent hypoxia
123170|NCT03433599|Transcranial Magnetic Stimulation|transcranial magnetic stimulation
123171|NCT03433560|febrile neutropenia|febrile neutropenia
123172|NCT03433560|neutropenia|neutropenia
123173|NCT03433547|macular buckling|macular buckling
123174|NCT03433547|full-thickness macular hole|full-thickness macular hole
123175|NCT03433547|macular detachment|macular detachment
123176|NCT03433547|internal limiting membrane peeling|internal limiting membrane peeling
123177|NCT03433547|high myopia|high myopia
123178|NCT03433534|nivolumab|nivolumab
123179|NCT03433534|monoclonal antibody|monoclonal antibody
123180|NCT03433534|Opdivo|opdivo
123181|NCT03433534|antineoplastic agent|antineoplastic agent
123182|NCT03433534|ELISA|elisa
123183|NCT03433534|pharmacokinetic|pharmacokinetic
123184|NCT03433521|Spatio-Temporal Diagnostic Pattern|spatio-temporal diagnostic pattern
123185|NCT03433495|stroke|stroke
123186|NCT03433495|aphasia|aphasia
123187|NCT03433495|melodic intonation therapy|melodic intonation therapy
123188|NCT03433482|Meningococcal disease|meningococcal disease
123189|NCT03433482|Liquid formulation|liquid formulation
123190|NCT03433482|Meningitis|meningitis
123191|NCT03433456|obesity|obesity
123192|NCT03433456|low-income|low-income
123193|NCT03433456|health disparities|health disparities
123194|NCT03433456|home visitation|home visitation
123195|NCT03433456|prevention|prevention
123196|NCT03433456|childhood obesity|childhood obesity
123197|NCT03433456|habit|habit
123198|NCT03433443|Spinal Fusion|spinal fusion
123199|NCT03433443|Case Managers|case managers
123200|NCT03433443|Rehabilitation|rehabilitation
123201|NCT03433352|gut microbiota|gut microbiota
123202|NCT03433352|16S rRNA gene|16s rrna gene
123203|NCT03433352|Graves' disease|graves' disease
123204|NCT03433352|Methimazole|methimazole
123205|NCT03433352|Propylthiouracil|propylthiouracil
123206|NCT03433339|depression|depression
123207|NCT03433339|transcutaneous spinal direct current stimulation|transcutaneous spinal direct current stimulation
123208|NCT03433339|non-invasive|non-invasive
123209|NCT03433339|major depressive disorder|major depressive disorder
123210|NCT03433248|Type 2 diabetes mellitus|type 2 diabetes mellitus
123211|NCT03433248|Diabetic kidney disease|diabetic kidney disease
123212|NCT03433248|Diabetic nephropathy|diabetic nephropathy
123213|NCT03433248|Renoprotection|renoprotection
123214|NCT03433248|SGLT2 inhibitor|sglt2 inhibitor
123215|NCT03433248|Empagliflozin|empagliflozin
123216|NCT03433248|DPP-4 inhibitor|dpp-4 inhibitor
123217|NCT03433248|Linagliptin|linagliptin
123218|NCT03433248|SU derivative|su derivative
123219|NCT03433248|Gliclazide|gliclazide
123220|NCT03433222|light emitting diode-red light|light emitting diode-red light
123221|NCT03433222|high fluence|high fluence
123222|NCT03433222|red light|red light
123224|NCT03433209|Advanced bipolar energy devices|advanced bipolar energy devices
123225|NCT03433209|ENSEAL|enseal
123226|NCT03433209|LigaSure|ligasure
123227|NCT03433209|Operative time|operative time
123228|NCT03433209|Total laparoscopic hysterectomy|total laparoscopic hysterectomy
123229|NCT03433157|stainless stain crowns|stainless stain crowns
123230|NCT03433157|Hall technique|hall technique
123231|NCT03433157|children|children
123232|NCT03433118|fatigue|fatigue
123233|NCT03433118|health-related quality of life|health-related quality of life
123234|NCT03433105|oxygen uptake|oxygen uptake
123235|NCT03433105|prolonged mechanical ventilation|prolonged mechanical ventilation
123236|NCT03433105|weaning|weaning
123237|NCT03433092|Serum carotenoids|serum carotenoids
123238|NCT03433092|Gastrointestinal tract cancer|gastrointestinal tract cancer
123239|NCT03433092|Meta-analysis|meta-analysis
123240|NCT03433079|Acute Kidney Injury|acute kidney injury
123241|NCT03433079|Severe Trauma|severe trauma
123242|NCT03433079|NGAL|ngal
123243|NCT03433079|Tissue Hypoxia|tissue hypoxia
123244|NCT03433079|Inflammatory Response|inflammatory response
123245|NCT03433079|Rhabdomyolysis|rhabdomyolysis
123246|NCT03433066|advanced platelet-rich fibrin|advanced platelet-rich fibrin
123247|NCT03432988|Nursing Solution-Focused|nursing solution-focused
123248|NCT03432988|hemodialysis|hemodialysis
123249|NCT03432988|Psychosocial intervention|psychosocial intervention
123250|NCT03432988|Adherence|adherence
123251|NCT03432949|Radium-223|radium-223
123252|NCT03432949|Dexamethasone|dexamethasone
123253|NCT03432949|mCRPC|mcrpc
123254|NCT03432910|Forced Breath Technique|forced breath technique
123255|NCT03432910|auto-CPAP|auto-cpap
123257|NCT03432910|Obstructive sleep apnea|obstructive sleep apnea
123258|NCT03432910|central sleep apnea|central sleep apnea
123259|NCT03432897|High risk|high risk
123260|NCT03432897|Defects|defects
123261|NCT03432897|prostate|prostate
123262|NCT03432884|Phase 1|phase 1
123263|NCT03432884|pharmacokinetics|pharmacokinetics
123264|NCT03432884|safety|safety
123265|NCT03432871|Mitochondria|mitochondria
123266|NCT03432871|Mitochondrial disease|mitochondrial disease
123267|NCT03432871|Nicotinamide Riboside|nicotinamide riboside
123268|NCT03432871|Niagen|niagen
123269|NCT03432871|PEO|peo
123270|NCT03432871|Single deletion|single deletion
123271|NCT03432871|mtDNA deletion|mtdna deletion
123272|NCT03432871|MELAS|melas
123273|NCT03432871|m.3243A>G|m.3243a>g
123274|NCT03432858|Endoscopic Carpal Tunnel Release|endoscopic carpal tunnel release
123275|NCT03432858|Prophylactic Antibiotics|prophylactic antibiotics
123276|NCT03432819|Latino, men who have sex with men|latino, men who have sex with men
123277|NCT03432806|Tissue samples|tissue samples
123278|NCT03432806|17-594|17-594
123279|NCT03432793|DDI|ddi
123280|NCT03432793|Itraconazole|itraconazole
123281|NCT03432793|Fluvoxamine|fluvoxamine
123282|NCT03432793|TD-9855|td-9855
123283|NCT03432793|Smoking|smoking
123284|NCT03432793|Caffeine|caffeine
123285|NCT03432793|CYP1A2|cyp1a2
123286|NCT03432793|CYP3A4|cyp3a4
123287|NCT03432767|pregnancy|pregnancy
123288|NCT03432767|postpartum hemorrhage|postpartum hemorrhage
123289|NCT03432767|vaginal delivery|vaginal delivery
123290|NCT03432767|shock index|shock index
123291|NCT03432767|hemoglobin|hemoglobin
123292|NCT03432754|Older adults|older adults
123293|NCT03432754|Mindfulness|mindfulness
123294|NCT03432754|Mind wandering|mind wandering
123295|NCT03432754|Health education|health education
123296|NCT03432754|Working memory|working memory
123297|NCT03432754|Cognitive functioning|cognitive functioning
123298|NCT03432754|Emotion regulation|emotion regulation
123299|NCT03432754|Emotional functioning|emotional functioning
123300|NCT03432728|Antioxidant Capacity|antioxidant capacity
123301|NCT03432715|School|school
123302|NCT03432715|Policy|policy
123303|NCT03432715|Nutrition|nutrition
123304|NCT03432715|Physical Activity|physical activity
123305|NCT03432715|Local Wellness Policy|local wellness policy
123306|NCT03432663|Atrial Fibrillation|atrial fibrillation
123307|NCT03432663|Intravenous Amiodarone|intravenous amiodarone
123308|NCT03432663|Drug safety profile|drug safety profile
123309|NCT03432663|Chemical cardioversion|chemical cardioversion
123310|NCT03432637|Complications, Postoperative/Perioperative|complications, postoperative/perioperative
123311|NCT03432637|video assisted thoracic surgery|video assisted thoracic surgery
123312|NCT03432637|non-intubated anaesthesia|non-intubated anaesthesia
123313|NCT03432611|mHealth|mhealth
123314|NCT03432611|dysmenorrhea|dysmenorrhea
123315|NCT03432611|acupressure|acupressure
123316|NCT03432611|self-management|self-management
123317|NCT03432611|self-care|self-care
123318|NCT03432585|feasibility|feasibility
123319|NCT03432585|attendance|attendance
123320|NCT03432585|conference|conference
123321|NCT03432559|endoscopy|endoscopy
123322|NCT03432533|Post-Menopausal osteoporosis|post-menopausal osteoporosis
123323|NCT03432494|Transcather|transcather
123324|NCT03432494|Transcaval|transcaval
123325|NCT03432494|Bioprosthesis|bioprosthesis
123326|NCT03432494|Closure Device|closure device
123327|NCT03432494|Aortic Stenosis|aortic stenosis
123328|NCT03432481|Osteoarthritis, Knee|osteoarthritis, knee
123329|NCT03432468|Hypertension|hypertension
123330|NCT03432468|Left Ventricular Hypertrophy|left ventricular hypertrophy
123331|NCT03432468|Women|women
123332|NCT03432455|Incidence|incidence
123333|NCT03432455|prevalence|prevalence
123334|NCT03432455|epidemiology|epidemiology
123335|NCT03432455|juvenile dermatomyositis|juvenile dermatomyositis
123336|NCT03432455|inflammatory myopathy|inflammatory myopathy
123337|NCT03432429|Tumours|tumours
123338|NCT03432429|Breast conserving surgery|breast conserving surgery
123339|NCT03432429|Margin assessment technology|margin assessment technology
123340|NCT03432429|Mass spectrometry|mass spectrometry
123341|NCT03432416|Healthy Women|healthy women
123342|NCT03432416|Female Contraception|female contraception
123343|NCT03432416|Vaginal Ring|vaginal ring
123344|NCT03432416|Contraceptive Vaginal Ring|contraceptive vaginal ring
123345|NCT03432364|Beta thalassemia|beta thalassemia
123346|NCT03432364|Beta-thalassemia|beta-thalassemia
123347|NCT03432364|Thalassemia major|thalassemia major
123348|NCT03432364|Cooley's anemia|cooley's anemia
123349|NCT03432364|ZFN mediated genome editing|zfn mediated genome editing
123350|NCT03432364|zinc finger nuclease|zinc finger nuclease
123351|NCT03432351|EEG|eeg
123352|NCT03432351|Electroencephalography|electroencephalography
123353|NCT03432351|Pediatric anesthesia|pediatric anesthesia
123354|NCT03432299|Thyroid Diseases|thyroid diseases
123355|NCT03432299|Radiofrequency Ablation|radiofrequency ablation
123356|NCT03432286|pediatric|pediatric
123357|NCT03432286|children|children
123358|NCT03432260|Alcoholic Hepatitis|alcoholic hepatitis
123359|NCT03432260|acute alcoholic liver disease|acute alcoholic liver disease
123360|NCT03432260|progressive inflammatory liver injury|progressive inflammatory liver injury
123361|NCT03432260|IV infusion|iv infusion
123362|NCT03432247|music therapy|music therapy
123363|NCT03432247|bone pain|bone pain
123364|NCT03432247|pain management|pain management
123365|NCT03432247|advanced cancer|advanced cancer
123366|NCT03432234|COPD|copd
123367|NCT03432234|Microbiome|microbiome
123368|NCT03432234|Exacerbation|exacerbation
123369|NCT03432221|Cognition, antidepressants drugs, SNRI, hot cognition, functioning|cognition, antidepressants drugs, snri, hot cognition, functioning
123370|NCT03432182|Premature infant|premature infant
123371|NCT03432182|sleep state|sleep state
123372|NCT03432182|body movement|body movement
123373|NCT03432182|neurodevelopmental outcome|neurodevelopmental outcome
123374|NCT03432156|immunotherapy|immunotherapy
123375|NCT03432156|NSCLC|nsclc
123376|NCT03432143|Peer Review|peer review
123377|NCT03432143|Community-Based Research|community-based research
123378|NCT03432143|Community Perspectives|community perspectives
123379|NCT03432130|hip-hop dance, injuries, body fat|hip-hop dance, injuries, body fat
123380|NCT03432117|respiratory rehabilitation|respiratory rehabilitation
123381|NCT03432117|personalized mobile services|personalized mobile services
123382|NCT03432091|melatonin|melatonin
123383|NCT03432091|melatonin receptor agonist|melatonin receptor agonist
123384|NCT03432091|circadian-clock-related genes|circadian-clock-related genes
123385|NCT03432065|Autism Spectrum Disorders|autism spectrum disorders
123386|NCT03432065|Anxiety|anxiety
123387|NCT03432065|Pervasive Developmental Disorders|pervasive developmental disorders
123388|NCT03432065|Buspar|buspar
123389|NCT03432065|Buspirone|buspirone
123390|NCT03432052|centralization|centralization
123391|NCT03431987|Marijuana|marijuana
123392|NCT03431987|Alcohol|alcohol
123393|NCT03431987|THC|thc
123394|NCT03431987|fMRI|fmri
123395|NCT03431987|MRI|mri
123396|NCT03431987|Driving Simulation|driving simulation
123397|NCT03431987|Cannabis|cannabis
123398|NCT03431987|Intoxication|intoxication
123399|NCT03431974|Anti-folate|anti-folate
123400|NCT03431935|Health Care Transition|health care transition
123401|NCT03431935|Adolescent|adolescent
123402|NCT03431935|Young Adult|young adult
123403|NCT03431909|Human Urinary Kallidinogenase|human urinary kallidinogenase
123404|NCT03431909|Acute ischemic stroke|acute ischemic stroke
123405|NCT03431909|Magnetic resonance spectroscopy|magnetic resonance spectroscopy
123406|NCT03431909|CT perfusion|ct perfusion
123407|NCT03431857|Shoulder arthroplasty|shoulder arthroplasty
123408|NCT03431857|Medical device|medical device
123409|NCT03431857|Shoulder prosthesis|shoulder prosthesis
123410|NCT03431857|Performance|performance
123411|NCT03431805|Randomized|randomized
123412|NCT03431805|double blind placebo controlled trial|double blind placebo controlled trial
123413|NCT03431805|prevention|prevention
123414|NCT03431805|tranexamic acid|tranexamic acid
123415|NCT03431805|postpartum hemorrhage|postpartum hemorrhage
123416|NCT03431805|cesarean|cesarean
123417|NCT03431792|CDH, FETO, fetal surgery, long tail FETO|cdh, feto, fetal surgery, long tail feto
123418|NCT03431766|chlorhexidine gel|chlorhexidine gel
123419|NCT03431766|dental implant|dental implant
123420|NCT03431753|STHLM3-test|sthlm3-test
123421|NCT03431753|prostate cancer|prostate cancer
123422|NCT03431753|MR-imaging|mr-imaging
123423|NCT03431753|MR-targeted biopsy|mr-targeted biopsy
123424|NCT03431753|MRI|mri
123425|NCT03431753|Novel biomarkers|novel biomarkers
123426|NCT03431753|Genetic screening|genetic screening
123427|NCT03431636|sports for people with disabilities|sports for people with disabilities
123428|NCT03431636|immersion therapy|immersion therapy
123429|NCT03431636|cryotherapy|cryotherapy
123430|NCT03431636|physiotherapy|physiotherapy
123431|NCT03431571|ReLEx|relex
123432|NCT03431571|SMILE|smile
123433|NCT03431571|Hyperopia|hyperopia
123434|NCT03431571|VisuMax|visumax
123435|NCT03431571|Small Incision Lenticule Extraction|small incision lenticule extraction
123436|NCT03431571|Lenticule|lenticule
123437|NCT03431571|Farsightedness|farsightedness
123438|NCT03431558|Bovine Lactoferrin, Neonatal infection, Low Birth Weight|bovine lactoferrin, neonatal infection, low birth weight
123439|NCT03431532|anesthesia|anesthesia
123440|NCT03431532|general anesthesia|general anesthesia
123441|NCT03431532|neuraxial anesthesia|neuraxial anesthesia
123442|NCT03431532|monocyte funtion|monocyte funtion
123443|NCT03431532|CD 14, HLA-DR|cd 14, hla-dr
123444|NCT03431532|Interleukines|interleukines
123445|NCT03431519|Thoracolumbar fractures|thoracolumbar fractures
123446|NCT03431519|PMMA|pmma
123447|NCT03431519|KIVA|kiva
123448|NCT03431519|PEEK|peek
123449|NCT03431480|cord blood stem cell|cord blood stem cell
123450|NCT03431480|Norwood heart surgery|norwood heart surgery
123451|NCT03431480|congenital|congenital
123452|NCT03431480|heart|heart
123453|NCT03431467|ECMO|ecmo
123454|NCT03431467|Heart Failure|heart failure
123455|NCT03431467|RCT|rct
123456|NCT03431467|Mechanical unloading|mechanical unloading
123457|NCT03431415|Lung|lung
123458|NCT03431415|Cancer|cancer
123459|NCT03431415|Early-Stage|early-stage
123460|NCT03431415|Video-assisted Thoracic Surgery|video-assisted thoracic surgery
123463|NCT03431415|Stereotactic Body Radiation Therapy|stereotactic body radiation therapy
123464|NCT03431376|potato consumption|potato consumption
123465|NCT03431376|hypertension|hypertension
123466|NCT03431376|CHNS|chns
123467|NCT03431311|MSI|msi
123468|NCT03431298|Knee osteoarthritis|knee osteoarthritis
123469|NCT03431298|Physical activity|physical activity
123470|NCT03431298|Exercise|exercise
123471|NCT03431272|contact lens, discomfort, dry eye|contact lens, discomfort, dry eye
123472|NCT03431233|protein-enriched bar|protein-enriched bar
123473|NCT03431233|food intake|food intake
123474|NCT03431233|appetite|appetite
123475|NCT03431233|satiety related hormones|satiety related hormones
123476|NCT03431194|Acute Kidney Injury|acute kidney injury
123477|NCT03431194|midodrine|midodrine
123478|NCT03431194|intensive care unit|intensive care unit
123479|NCT03431168|STI Prevention|sti prevention
123480|NCT03431168|Cameroon|cameroon
123481|NCT03431168|sub-Saharan Africa|sub-saharan africa
123482|NCT03431168|HIV pregnancy|hiv pregnancy
123483|NCT03431168|Malaria in pregnancy|malaria in pregnancy
123484|NCT03431155|children|children
123485|NCT03431155|cancer|cancer
123486|NCT03431155|care giver|care giver
123487|NCT03431155|uncertainty|uncertainty
123488|NCT03431155|nursing intervention|nursing intervention
123489|NCT03431155|education|education
123490|NCT03431129|Xenon MRI, Lung, Radiation Induced Lung Injury,|xenon mri, lung, radiation induced lung injury,
123491|NCT03431103|overlap|overlap
123492|NCT03431103|exercise|exercise
123493|NCT03431103|inflammation|inflammation
123494|NCT03431051|Healthy Beverage Initiative, Sugar Sweetened Beverages|healthy beverage initiative, sugar sweetened beverages
123495|NCT03431012|Adherence, medication|adherence, medication
123496|NCT03431012|Pandemic Influenza|pandemic influenza
123497|NCT03430973|aggressive driving; road rage|aggressive driving; road rage
123498|NCT03430960|mCare|mcare
123499|NCT03430960|post surgery|post surgery
123500|NCT03430960|mobile|mobile
123501|NCT03430960|healthcare|healthcare
123502|NCT03430960|application|application
123503|NCT03430947|Stereotactic radiosurgery|stereotactic radiosurgery
123504|NCT03430947|BRAF inhibitor|braf inhibitor
123505|NCT03430947|MEK inhibitor|mek inhibitor
123506|NCT03430947|Vemurafenib|vemurafenib
123507|NCT03430947|Cobimetinib|cobimetinib
123508|NCT03430934|Mohs tumor|mohs tumor
123509|NCT03430908|endotracheal tube|endotracheal tube
123510|NCT03430908|gastric tube|gastric tube
123511|NCT03430908|17-653|17-653
123512|NCT03430908|Memorial Sloan Kettering Cancer Center|memorial sloan kettering cancer center
123513|NCT03430895|Durvalumab (MEDI4736)|durvalumab (medi4736)
123514|NCT03430895|Tremelimumab|tremelimumab
123515|NCT03430895|immunotherapy|immunotherapy
123516|NCT03430895|17-511|17-511
123517|NCT03430869|late-life depression|late-life depression
123518|NCT03430869|major depressive disorder|major depressive disorder
123519|NCT03430869|Alzheimer's disease dementia|alzheimer's disease dementia
123520|NCT03430869|neurodegeneration|neurodegeneration
123521|NCT03430869|amyloid plague, tau protein|amyloid plague, tau protein
123522|NCT03430856|Oral insulin|oral insulin
123523|NCT03430843|Unresectable|unresectable
123524|NCT03430843|metastatic|metastatic
123525|NCT03430843|second-line|second-line
123526|NCT03430843|squamous|squamous
123527|NCT03430843|esophagus|esophagus
123528|NCT03430843|chemotherapy|chemotherapy
123529|NCT03430843|paclitaxel|paclitaxel
123530|NCT03430843|docetaxel|docetaxel
123531|NCT03430843|irinotecan|irinotecan
123532|NCT03430791|recurrent glioblastoma|recurrent glioblastoma
123533|NCT03430739|Deformational Plagiocephaly, Orthotics, Helmet|deformational plagiocephaly, orthotics, helmet
123534|NCT03430726|Probiotics; paediatrics; gut microbiota|probiotics; paediatrics; gut microbiota
123535|NCT03430713|tooth color|tooth color
123536|NCT03430713|measurement|measurement
123537|NCT03430713|accuracy|accuracy
123538|NCT03430713|shade guide|shade guide
123539|NCT03430713|spectrophotometer|spectrophotometer
123540|NCT03430700|platinum-resistant|platinum-resistant
123541|NCT03430648|Tau protein|tau protein
123542|NCT03430648|PET imaging|pet imaging
123543|NCT03430648|Alzheimer's disease|alzheimer's disease
123544|NCT03430609|endometrioma|endometrioma
123545|NCT03430609|laparoscopy|laparoscopy
123546|NCT03430609|ovarian reserve|ovarian reserve
123547|NCT03430609|anti-mullerian hormone|anti-mullerian hormone
123548|NCT03430583|Fontan|fontan
123549|NCT03430583|Ultrasound|ultrasound
123550|NCT03430583|Magnetic Resonance Imaging Elastography|magnetic resonance imaging elastography
123551|NCT03430570|Adolescent risk behavior|adolescent risk behavior
123552|NCT03430570|digital|digital
123553|NCT03430570|early adolescence|early adolescence
123554|NCT03430570|emotion regulation|emotion regulation
123555|NCT03430570|prevention|prevention
123556|NCT03430557|Endodontic surgery|endodontic surgery
123557|NCT03430544|cariprazine|cariprazine
123558|NCT03430544|fMRI|fmri
123559|NCT03430544|D3 receptor|d3 receptor
123560|NCT03430544|cocaine use disorder|cocaine use disorder
123561|NCT03430544|urine|urine
123562|NCT03430518|Durvalumab (MEDI4736) (Anti-PDL1)|durvalumab (medi4736) (anti-pdl1)
123563|NCT03430518|Eribulin|eribulin
123570|NCT03430492|Biomarkers|biomarkers
123571|NCT03430492|Molecular Fingerprint|molecular fingerprint
123572|NCT03430492|Quality of Life (QoL)|quality of life (qol)
123573|NCT03430492|Body and Mind|body and mind
123574|NCT03430492|CD-RISC|cd-risc
123575|NCT03430492|SF-36|sf-36
123576|NCT03430453|Regional Anesthesia|regional anesthesia
123577|NCT03430453|Ultrasound guidance|ultrasound guidance
123578|NCT03430453|Nerve stimulation|nerve stimulation
123579|NCT03430453|Orthopedic surgery|orthopedic surgery
123580|NCT03430427|BNET|bnet
123581|NCT03430427|Brain Networks|brain networks
123582|NCT03430427|Mobility Function|mobility function
123583|NCT03430427|SMCCS|smccs
123584|NCT03430401|memory encoding|memory encoding
123585|NCT03430401|functional performance|functional performance
123586|NCT03430388|vaccine|vaccine
123587|NCT03430388|Yellow Fever|yellow fever
123588|NCT03430388|Rheumatic disease|rheumatic disease
123589|NCT03430375|wheelchair cushion|wheelchair cushion
123590|NCT03430375|pressure mapping|pressure mapping
123591|NCT03430375|pressure wounds|pressure wounds
123592|NCT03430349|IPV-primed|ipv-primed
123593|NCT03430349|adults|adults
123594|NCT03430349|vaccination|vaccination
123595|NCT03430349|containment|containment
123596|NCT03430349|shedding|shedding
123597|NCT03430349|genetic stability|genetic stability
123598|NCT03430349|safety|safety
123599|NCT03430349|neurovirulence|neurovirulence
123600|NCT03430349|novel polio vaccine candidates|novel polio vaccine candidates
123601|NCT03430297|anti-PD-1 monoclonal antibody|anti-pd-1 monoclonal antibody
123602|NCT03430297|the First Line Therapy|the first line therapy
123603|NCT03430297|Dacarbazine|dacarbazine
123604|NCT03430297|Melanoma|melanoma
123605|NCT03430284|Type 2 Diabetes Mellitus|type 2 diabetes mellitus
123606|NCT03430284|Diabetic Vascular Complications|diabetic vascular complications
123607|NCT03430284|Multifactorial Intervention|multifactorial intervention
123608|NCT03430284|Digital and Network Management|digital and network management
123609|NCT03430245|Circumference reduction|circumference reduction
123610|NCT03430219|AccuFill|accufill
123611|NCT03430219|Injectable Calcium Phosphate|injectable calcium phosphate
123612|NCT03430219|Subchondroplasty|subchondroplasty
123613|NCT03430206|high-flow|high-flow
123614|NCT03430206|nasal cannula|nasal cannula
123615|NCT03430206|laryngoscopy|laryngoscopy
123616|NCT03430206|otolaryngology|otolaryngology
123617|NCT03430206|oxygen|oxygen
123618|NCT03430206|desaturation|desaturation
123619|NCT03430206|anesthesia|anesthesia
123620|NCT03430206|pediatric|pediatric
123621|NCT03430193|rehabilitation|rehabilitation
123622|NCT03430193|multi-disciplinary rehabilitation|multi-disciplinary rehabilitation
123623|NCT03430193|clinical pathway|clinical pathway
123624|NCT03430193|Fragility|fragility
123625|NCT03430167|Reverse Total Shoulder Arthroplasty|reverse total shoulder arthroplasty
123626|NCT03430167|post operative physical therapy|post operative physical therapy
123627|NCT03430115|Obese|obese
123628|NCT03430115|Exercise|exercise
123629|NCT03430089|Influenza|influenza
123630|NCT03430089|Flu|flu
123631|NCT03430076|vascular prostheses|vascular prostheses
123632|NCT03430076|heparin|heparin
123633|NCT03430076|ischemia lesions|ischemia lesions
123634|NCT03430076|vascular|vascular
123635|NCT03430076|critical limb ischemia lesions|critical limb ischemia lesions
123636|NCT03430063|Advanced non-squamous NSCLC|advanced non-squamous nsclc
123637|NCT03430063|Advanced squamous NSCLC|advanced squamous nsclc
123638|NCT03430050|Progesterone|progesterone
123639|NCT03430050|Ovarian hormones|ovarian hormones
123640|NCT03430050|Gender|gender
123641|NCT03430050|Cannabis|cannabis
123642|NCT03430050|Withdrawal|withdrawal
123643|NCT03430050|Cognitive functioning|cognitive functioning
123644|NCT03430037|Inflammation|inflammation
123645|NCT03430037|Frailty|frailty
123646|NCT03430024|Myosin VI|myosin vi
123647|NCT03430024|Estrogen receptor|estrogen receptor
123656|NCT03429998|cardiovascular risk|cardiovascular risk
123657|NCT03429998|evolocumab|evolocumab
123658|NCT03429998|LDL-apheresis|ldl-apheresis
123659|NCT03429985|Sexual and Reproductive Health|sexual and reproductive health
123660|NCT03429985|Parent-based Intervention|parent-based intervention
123661|NCT03429985|Sexual risk behavior|sexual risk behavior
123662|NCT03429985|Adolescent males|adolescent males
123663|NCT03429985|Father-son Intervention|father-son intervention
123667|NCT03429920|Cardiovascular Disease|cardiovascular disease
123668|NCT03429920|Inflammation|inflammation
123669|NCT03429920|DNA Methylation|dna methylation
123670|NCT03429907|Malignant neoplasm of breast|malignant neoplasm of breast
123671|NCT03429907|Mind-Body Exercises|mind-body exercises
123672|NCT03429907|Questionnaires|questionnaires
123673|NCT03429907|Surveys|surveys
123674|NCT03429868|Nasopharyngeal carcinoma|nasopharyngeal carcinoma
123675|NCT03429868|Nead neck cancer|nead neck cancer
123676|NCT03429868|Prognosis|prognosis
123677|NCT03429868|PET|pet
123678|NCT03429868|MRI|mri
123679|NCT03429855|Physiotherapy|physiotherapy
123680|NCT03429855|Trunk control|trunk control
123681|NCT03429855|Bobath concept|bobath concept
123682|NCT03429855|Stroke rehabilitation|stroke rehabilitation
123683|NCT03429829|Caries|caries
123684|NCT03429829|Fluoride Varnish|fluoride varnish
123685|NCT03429829|Dental Health|dental health
123686|NCT03429803|low-grade glioma|low-grade glioma
123687|NCT03429790|caesarean section|caesarean section
123688|NCT03429790|cell salvage|cell salvage
123689|NCT03429790|blood transfusion|blood transfusion
123690|NCT03429777|Smartphone|smartphone
123691|NCT03429777|Medical application|medical application
123692|NCT03429777|Hearing-in-noise test|hearing-in-noise test
123693|NCT03429777|Digits-in-noise test|digits-in-noise test
123694|NCT03429777|Speech reception threshold|speech reception threshold
123695|NCT03429777|Hearing Loss|hearing loss
123696|NCT03429777|Hearing Disorders|hearing disorders
123697|NCT03429777|Hearing Abnormalities|hearing abnormalities
123698|NCT03429777|Tinnitus|tinnitus
123699|NCT03429777|Hearing aids|hearing aids
123700|NCT03429777|Cochlear implants|cochlear implants
123701|NCT03429751|lung ultrasound, fluid, hysterectomy, B lines|lung ultrasound, fluid, hysterectomy, b lines
123702|NCT03429738|Ibuprofen|ibuprofen
123703|NCT03429738|phase-I-study|phase-i-study
123704|NCT03429738|pharmacokinetic|pharmacokinetic
123705|NCT03429738|combination therapy|combination therapy
123706|NCT03429738|bioavailability|bioavailability
123707|NCT03429738|bioequivalence|bioequivalence
123708|NCT03429738|pseudoephedrine hydrochloride|pseudoephedrine hydrochloride
123710|NCT03429686|dementia|dementia
123711|NCT03429686|reminiscence therapy|reminiscence therapy
123712|NCT03429686|touch screen technology|touch screen technology
123713|NCT03429686|digital reminiscence therapy|digital reminiscence therapy
123714|NCT03429673|Chinese|chinese
123715|NCT03429673|real-world evidences|real-world evidences
123716|NCT03429673|NSCLC|nsclc
123717|NCT03429673|surgeries|surgeries
123718|NCT03429660|Disease epidemiology|disease epidemiology
123719|NCT03429660|Risk assessment|risk assessment
123720|NCT03429660|Drug utilisation study|drug utilisation study
123721|NCT03429660|Effectiveness evaluation|effectiveness evaluation
123722|NCT03429582|Human Papilloma Virus|human papilloma virus
123723|NCT03429582|Thermoablation|thermoablation
123724|NCT03429582|Thermocoagulation|thermocoagulation
123725|NCT03429582|Cryotherapy|cryotherapy
123726|NCT03429582|Cervica Pre-cancer|cervica pre-cancer
123727|NCT03429582|Low and Middle Income Countries (LMICs)|low and middle income countries (lmics)
123728|NCT03429569|Keratoconus|keratoconus
123729|NCT03429569|Cross-linking|cross-linking
123730|NCT03429569|Confocal microscopy|confocal microscopy
123731|NCT03429569|Postoperative morphological|postoperative morphological
123732|NCT03429569|Iotonphoresis|iotonphoresis
123733|NCT03429556|pain, neurotoxin|pain, neurotoxin
123734|NCT03429517|HDL-C|hdl-c
123735|NCT03429517|Triglycerides|triglycerides
123736|NCT03429517|Non HDL-C and Acute coronary syndrome|non hdl-c and acute coronary syndrome
123737|NCT03429504|Obesity|obesity
123738|NCT03429504|Breast cancer|breast cancer
123739|NCT03429504|Body mass index|body mass index
123740|NCT03429478|Music|music
123741|NCT03429478|Laparoscopic Surgery|laparoscopic surgery
123742|NCT03429478|Sterile Inflammation|sterile inflammation
123743|NCT03429465|Digital Health Intervention|digital health intervention
123744|NCT03429465|Executive Function|executive function
123745|NCT03429465|Depression|depression
123746|NCT03429465|Anxiety|anxiety
123747|NCT03429452|structural heart abnormality|structural heart abnormality
123748|NCT03429452|spatial method|spatial method
123749|NCT03429452|echocardiography|echocardiography
123750|NCT03429452|electrocardiogram|electrocardiogram
123751|NCT03429452|mediterranean diet|mediterranean diet
123752|NCT03429452|exercise|exercise
123753|NCT03429452|social status|social status
123754|NCT03429452|rural|rural
123755|NCT03429439|chronic hepatitis B|chronic hepatitis b
123756|NCT03429439|intestinal microbiota transplantation|intestinal microbiota transplantation
123757|NCT03429439|microbiota|microbiota
123758|NCT03429439|antiviral therapy|antiviral therapy
123759|NCT03429426|Rheumatoid Arthritis|rheumatoid arthritis
123760|NCT03429426|High-resolution peripheral quantitative computed tomography|high-resolution peripheral quantitative computed tomography
123761|NCT03429426|Radiography|radiography
123762|NCT03429413|Health Information Technology (HIT)|health information technology (hit)
123763|NCT03429387|Diagnosis|diagnosis
123764|NCT03429348|Firefighter|firefighter
123765|NCT03429348|Post-Fire Rehabilitation|post-fire rehabilitation
123766|NCT03429348|Sauna|sauna
123767|NCT03429335|Transition|transition
123768|NCT03429335|Adolescents|adolescents
123769|NCT03429335|Smart phone|smart phone
123770|NCT03429322|traumatic brain injury|traumatic brain injury
123771|NCT03429322|pragmatic clinical trial|pragmatic clinical trial
123772|NCT03429322|telemedicine|telemedicine
123773|NCT03429322|cost|cost
123774|NCT03429309|telomere|telomere
123775|NCT03429309|propofol|propofol
123776|NCT03429309|anesthesia-induction|anesthesia-induction
123777|NCT03429296|Cancer|cancer
123778|NCT03429296|Autohypnosis|autohypnosis
123779|NCT03429296|Quality of life|quality of life
123780|NCT03429283|Epidemiology,|epidemiology,
123781|NCT03429283|Achromobacter xylosoxidans,|achromobacter xylosoxidans,
123782|NCT03429283|antibiotic resistance|antibiotic resistance
123783|NCT03429257|Aflatoxin B1|aflatoxin b1
123784|NCT03429257|Environmental Enteric Dysfunction|environmental enteric dysfunction
123785|NCT03429257|L:M Test|l:m test
123786|NCT03429257|Pregnancy|pregnancy
123787|NCT03429257|Linear Growth Faltering|linear growth faltering
123788|NCT03429257|Birth Outcomes|birth outcomes
123789|NCT03429257|Uganda|uganda
123790|NCT03429218|Tolero|tolero
123791|NCT03429218|Phase 1|phase 1
123792|NCT03429218|First in human|first in human
123793|NCT03429218|Solid Tumors|solid tumors
123794|NCT03429218|Advanced Malignancy|advanced malignancy
123795|NCT03429218|Cancer|cancer
123796|NCT03429205|Sleeve gastrectomy|sleeve gastrectomy
123797|NCT03429205|Roux-Y gastric bypass|roux-y gastric bypass
123798|NCT03429205|Single anastomosis gastric bypass|single anastomosis gastric bypass
123799|NCT03429205|Hypothermia|hypothermia
123800|NCT03429205|External heating blanket|external heating blanket
123801|NCT03429192|Chinese, real-world evidences, NSCLC, lymph skip metastases|chinese, real-world evidences, nsclc, lymph skip metastases
123802|NCT03429179|butorphanol|butorphanol
123803|NCT03429179|preoperative anxiety|preoperative anxiety
123804|NCT03429179|sedation|sedation
123805|NCT03429179|recommend dose|recommend dose
123806|NCT03429153|endocarditis|endocarditis
123807|NCT03429127|balanced fluids, neurosurgery, plasma osmolality|balanced fluids, neurosurgery, plasma osmolality
123808|NCT03429101|Poziotinib|poziotinib
123809|NCT03429101|HER2 Positive|her2 positive
123810|NCT03429101|T-DM1|t-dm1
123811|NCT03429075|depression|depression
123812|NCT03429075|mdd|mdd
123813|NCT03429075|major depression|major depression
123814|NCT03429075|major depressive disorder|major depressive disorder
123815|NCT03429075|unipolar depression|unipolar depression
123816|NCT03429075|psilocybin|psilocybin
123817|NCT03429075|psychedelics|psychedelics
123818|NCT03429075|psychedelic|psychedelic
123819|NCT03429075|escitalopram|escitalopram
123820|NCT03429075|ssri|ssri
123821|NCT03429062|balance|balance
123822|NCT03429062|gait|gait
123823|NCT03429062|Multiple Sclerosis|multiple sclerosis
123824|NCT03429036|Genomic DNA|genomic dna
123825|NCT03429036|DNA Banking|dna banking
123826|NCT03429036|Tissue Sample|tissue sample
123827|NCT03429036|Saliva|saliva
123828|NCT03429036|Blood Collection|blood collection
123829|NCT03429023|Mucormycosis|mucormycosis
123830|NCT03429010|Anesthesia|anesthesia
123831|NCT03429010|Hip Fracture|hip fracture
123832|NCT03428971|atrial fibrillation|atrial fibrillation
123833|NCT03428971|p-wave|p-wave
123834|NCT03428971|hospitalization|hospitalization
123835|NCT03428958|Relapsed metastatic adenocarcinoma of colon/rectum|relapsed metastatic adenocarcinoma of colon/rectum
123836|NCT03428945|TrialNet|trialnet
123837|NCT03428932|Insulin pump|insulin pump
123838|NCT03428932|Closed loop|closed loop
123839|NCT03428932|Brain development|brain development
123840|NCT03428932|Pediatric|pediatric
123841|NCT03428932|Type 1 Diabetes|type 1 diabetes
123842|NCT03428932|MRI|mri
123843|NCT03428932|Cognitive development|cognitive development
123844|NCT03428919|ICSI|icsi
123845|NCT03428919|Conventional IVF|conventional ivf
123846|NCT03428919|Non-male factor|non-male factor
123847|NCT03428906|intranasal oxytocin|intranasal oxytocin
123848|NCT03428906|functional brain network|functional brain network
123849|NCT03428906|multiple tasks|multiple tasks
123850|NCT03428906|resting state|resting state
123851|NCT03428893|Exercise, mhealth, physical therapy|exercise, mhealth, physical therapy
123852|NCT03428880|quadratus lumborum block|quadratus lumborum block
123853|NCT03428880|cesarean section|cesarean section
123854|NCT03428880|spinal morphine|spinal morphine
123855|NCT03428880|ultrasound guidance|ultrasound guidance
123856|NCT03428841|audiometry|audiometry
123857|NCT03428841|dural puncture|dural puncture
123858|NCT03428841|epidural|epidural
123859|NCT03428828|Neurofeedback|neurofeedback
123860|NCT03428828|major depressive disorder|major depressive disorder
123861|NCT03428828|treatment resistant|treatment resistant
123862|NCT03428828|amygdala|amygdala
123863|NCT03428789|breast reconstruction|breast reconstruction
123864|NCT03428789|DIEP flap|diep flap
123865|NCT03428789|Nerve coaptation|nerve coaptation
123866|NCT03428789|Sensory recovery|sensory recovery
123867|NCT03428763|Arthritis, Rheumatoid|arthritis, rheumatoid
123868|NCT03428763|Telerehabilitation|telerehabilitation
123869|NCT03428763|controlled randomised trial|controlled randomised trial
123870|NCT03428737|pressure support ventilation|pressure support ventilation
123871|NCT03428737|pressure control ventilation|pressure control ventilation
123872|NCT03428737|sleep, weaning|sleep, weaning
123873|NCT03428737|chronic obstructive respiratory disease|chronic obstructive respiratory disease
123874|NCT03428737|weaning duration period|weaning duration period
123875|NCT03428711|Superficial Venous Thrombosis of Leg|superficial venous thrombosis of leg
123876|NCT03428711|secondary prevention|secondary prevention
123877|NCT03428711|prophylaxis|prophylaxis
123878|NCT03428698|third molar extraction|third molar extraction
123879|NCT03428698|hyaluronic acid|hyaluronic acid
123880|NCT03428659|Motor function|motor function
123881|NCT03428659|Recovery|recovery
123883|NCT03428659|Magnetic resonance imaging|magnetic resonance imaging
123884|NCT03428646|Eczema|eczema
123885|NCT03428620|Functional Performance|functional performance
123886|NCT03428620|Rehabilitation|rehabilitation
123887|NCT03428620|Manipulation|manipulation
123888|NCT03428581|Axillary|axillary
123889|NCT03428581|Lymph node|lymph node
123890|NCT03428581|Dissection|dissection
123891|NCT03428581|Reverse Mapping|reverse mapping
123892|NCT03428581|Lympho-venous Bypass|lympho-venous bypass
123893|NCT03428568|Herbal Melanin|herbal melanin
123894|NCT03428568|H.Pylori|h.pylori
123895|NCT03428542|yoga|yoga
123896|NCT03428542|stress|stress
123897|NCT03428542|anxiety|anxiety
123898|NCT03428542|depression|depression
123899|NCT03428542|sleep quality|sleep quality
123900|NCT03428542|physiological stress|physiological stress
123901|NCT03428542|biomarkers|biomarkers
123902|NCT03428503|paracetamol|paracetamol
123903|NCT03428503|dexketoprofen|dexketoprofen
123904|NCT03428503|emergency department|emergency department
123905|NCT03428503|musculoskeletal pain|musculoskeletal pain
123906|NCT03428490|Integrated Treatment|integrated treatment
123907|NCT03428490|Alcohol Use Disorder|alcohol use disorder
123908|NCT03428490|Social Anxiety Disorder|social anxiety disorder
123909|NCT03428490|Comorbidity|comorbidity
123910|NCT03428490|Cognitive Behavioral Therapy|cognitive behavioral therapy
123911|NCT03428477|Liver metastases|liver metastases
123912|NCT03428477|Colon Cancer|colon cancer
123913|NCT03428451|TURP|turp
123914|NCT03428451|hypertonic saline|hypertonic saline
123915|NCT03428451|TURP syndrome|turp syndrome
123916|NCT03428451|hyponatraemia|hyponatraemia
123917|NCT03428412|Chronic Obstructive Pulmonary Disease|chronic obstructive pulmonary disease
123918|NCT03428412|Acute exacerbation|acute exacerbation
123919|NCT03428412|Traditional Chinese medicine|traditional chinese medicine
123920|NCT03428399|breast reconstruction|breast reconstruction
123921|NCT03428399|mastectomy|mastectomy
123922|NCT03428373|Multiple Myeloma|multiple myeloma
123923|NCT03428360|Seizure|seizure
123924|NCT03428347|Ebola|ebola
123925|NCT03428347|Ebola Virus Disease|ebola virus disease
123926|NCT03428347|Monoclonal antibody|monoclonal antibody
123927|NCT03428334|Sputum leukocyte density|sputum leukocyte density
123928|NCT03428321|Microwave ablation|microwave ablation
123929|NCT03428321|Percutaneous thermalablation|percutaneous thermalablation
123930|NCT03428321|High risk location|high risk location
123931|NCT03428321|Articifial pneumothorax|articifial pneumothorax
123932|NCT03428321|Lipiodol marked|lipiodol marked
123933|NCT03428321|Prognostic factor|prognostic factor
123934|NCT03428295|artificial pancreas|artificial pancreas
123935|NCT03428295|automated insulin delivery|automated insulin delivery
123936|NCT03428295|hybrid closed loop|hybrid closed loop
123937|NCT03428295|APDS|apds
123938|NCT03428295|fully automated closed loop|fully automated closed loop
123939|NCT03428269|simulation|simulation
123940|NCT03428269|clinical reasoning|clinical reasoning
123941|NCT03428269|patient deterioration|patient deterioration
123942|NCT03428256|Obesity|obesity
123943|NCT03428256|Bariatric Surgery|bariatric surgery
123944|NCT03428217|Tumor Metabolism|tumor metabolism
123945|NCT03428217|RCC|rcc
123946|NCT03428217|Glutaminase Inhibitor|glutaminase inhibitor
123947|NCT03428217|CB-839|cb-839
123948|NCT03428217|CANTATA|cantata
123949|NCT03428217|TKI|tki
123950|NCT03428217|Tyrosine Kinase Inhibitor|tyrosine kinase inhibitor
123951|NCT03428217|cabozantinib|cabozantinib
123952|NCT03428217|Cabometyx|cabometyx
123953|NCT03428217|Cometriq|cometriq
123954|NCT03428217|glutaminase|glutaminase
123955|NCT03428217|glutamine|glutamine
123956|NCT03428217|renal cell|renal cell
123957|NCT03428217|clear cell|clear cell
123958|NCT03428217|kidney cancer|kidney cancer
123959|NCT03428217|cMET|cmet
123960|NCT03428217|MET|met
123961|NCT03428217|HGFR|hgfr
123962|NCT03428217|telaglenastat|telaglenastat
123963|NCT03428191|dexmedetomidine|dexmedetomidine
123964|NCT03428191|remifentanil|remifentanil
123965|NCT03428191|prostate puncture and biopsy|prostate puncture and biopsy
123966|NCT03428178|Acute LHON|acute lhon
123967|NCT03428178|onset within three months|onset within three months
123968|NCT03428178|onset between 3 to 6 months|onset between 3 to 6 months
123969|NCT03428178|onset between 6 to 12 months|onset between 6 to 12 months
123970|NCT03428178|onset between 12 to 24 months|onset between 12 to 24 months
123971|NCT03428178|onset between 24 to 60 months|onset between 24 to 60 months
123972|NCT03428178|onset over 60 months|onset over 60 months
123973|NCT03428152|superior hypogastric plexus block|superior hypogastric plexus block
123974|NCT03428152|hysterectomy|hysterectomy
123975|NCT03428152|postoperative pain|postoperative pain
123976|NCT03428139|lumbosacral radicular pain|lumbosacral radicular pain
123977|NCT03428139|pulsed radiofrequency|pulsed radiofrequency
123978|NCT03428139|Alpha Lipoic acid|alpha lipoic acid
123979|NCT03428126|Malignant neoplasms of digestive organs|malignant neoplasms of digestive organs
123980|NCT03428126|Colorectal Cancer|colorectal cancer
123981|NCT03428126|Colon Cancer|colon cancer
123982|NCT03428126|Durvalumab|durvalumab
123983|NCT03428126|MEDI4736|medi4736
123984|NCT03428126|Trametinib|trametinib
123985|NCT03428126|GSK1120212|gsk1120212
123986|NCT03428100|eczema|eczema
123987|NCT03428100|atopic eczema|atopic eczema
123988|NCT03428074|Chinese, esophageal cancer, surgeries of Ivor-Lewis/Mckeown|chinese, esophageal cancer, surgeries of ivor-lewis/mckeown
123989|NCT03428061|Prevention|prevention
123990|NCT03428061|Disease Management|disease management
123991|NCT03428061|Integrated care|integrated care
123992|NCT03428061|Primary Health Care|primary health care
123993|NCT03428035|Randomized controlled trial|randomized controlled trial
123994|NCT03428035|package insert|package insert
123995|NCT03428035|nocebo|nocebo
123996|NCT03428022|Apatinib|apatinib
123997|NCT03428022|EGFR-TKI resistance|egfr-tki resistance
123998|NCT03428022|slowly progress|slowly progress
123999|NCT03428009|Dystonia|dystonia
124000|NCT03428009|Control|control
124001|NCT03428009|Magnetic Resonance Imagine|magnetic resonance imagine
124002|NCT03428009|Genotype|genotype
124003|NCT03428009|Phenotype|phenotype
124004|NCT03427996|rotational atherectomy|rotational atherectomy
124005|NCT03427957|Hysteroscopy|hysteroscopy
124006|NCT03427957|Endometrial biopsy|endometrial biopsy
124007|NCT03427957|Menopause|menopause
124008|NCT03427944|Calcium Dobesilate|calcium dobesilate
124009|NCT03427944|Non Dialysis Patients With CKD(3-5)|non dialysis patients with ckd(3-5)
124010|NCT03427944|Glomerular filtration rate|glomerular filtration rate
124011|NCT03427944|serum creatinine|serum creatinine
124012|NCT03427931|Type 1 Diabetes Mellitus|type 1 diabetes mellitus
124013|NCT03427931|Islet Transplantation|islet transplantation
124014|NCT03427931|Continuous Glucose Monitor (CGM)|continuous glucose monitor (cgm)
124015|NCT03427892|mood|mood
124016|NCT03427892|bipolar|bipolar
124017|NCT03427892|depression|depression
124018|NCT03427866|Myelofibrosis|myelofibrosis
124019|NCT03427840|Superior Hypogastric Plexus Block|superior hypogastric plexus block
124020|NCT03427840|Hysterectomy|hysterectomy
124021|NCT03427840|Minimally invasive surgery|minimally invasive surgery
124022|NCT03427840|Laparoscopy|laparoscopy
124023|NCT03427840|Pain|pain
124024|NCT03427840|Gynecologic Disease|gynecologic disease
124025|NCT03427827|PD-1 antibody|pd-1 antibody
124026|NCT03427827|Adjuvant treatment|adjuvant treatment
124027|NCT03427827|Immune checkpoint inhibitors|immune checkpoint inhibitors
124028|NCT03427814|BGB-290|bgb-290
124029|NCT03427814|PARP inhibitor|parp inhibitor
124030|NCT03427814|Phase 3|phase 3
124031|NCT03427814|maintenance therapy|maintenance therapy
124032|NCT03427814|gastric cancer|gastric cancer
124033|NCT03427814|oral treatment|oral treatment
124034|NCT03427814|PARALLEL303|parallel303
124035|NCT03427814|PARALLEL 303|parallel 303
124036|NCT03427814|PARALLEL|parallel
124037|NCT03427814|BGB290303|bgb290303
124038|NCT03427814|BGB-290-303|bgb-290-303
124039|NCT03427801|erythropoiesis-stimulating agent|erythropoiesis-stimulating agent
124040|NCT03427775|multimodal analgesia|multimodal analgesia
124041|NCT03427775|quality of recovery|quality of recovery
124042|NCT03427775|quality of pain management|quality of pain management
124043|NCT03427762|balance|balance
124044|NCT03427762|postural controll|postural controll
124045|NCT03427762|motor controll|motor controll
124046|NCT03427762|posturgraphy|posturgraphy
124047|NCT03427762|quality of life|quality of life
124048|NCT03427749|Myocardial Blood Flow|myocardial blood flow
124049|NCT03427749|SPECT|spect
124050|NCT03427723|Peripheral intravenous cannulation|peripheral intravenous cannulation
124051|NCT03427723|children|children
124052|NCT03427723|near-infrared light|near-infrared light
124053|NCT03427684|Gastric cancer|gastric cancer
124054|NCT03427684|Chemo-radiotherapy|chemo-radiotherapy
124055|NCT03427684|Phase I study|phase i study
124056|NCT03427684|Hypo-fractionated radiotherapy|hypo-fractionated radiotherapy
124057|NCT03427658|sweet taste|sweet taste
124058|NCT03427658|food preferences|food preferences
124059|NCT03427658|food intake|food intake
124060|NCT03427645|surrogate decision maker|surrogate decision maker
124061|NCT03427632|PVP|pvp
124062|NCT03427632|bone tumor|bone tumor
124063|NCT03427606|sacral colpopexy|sacral colpopexy
124064|NCT03427606|laparoscopy|laparoscopy
124065|NCT03427606|mesh fixation|mesh fixation
124066|NCT03427593|CVID|cvid
124074|NCT03427580|Outcome|outcome
124075|NCT03427567|Chinese|chinese
124076|NCT03427567|real-world evidences|real-world evidences
124077|NCT03427567|NSCLC|nsclc
124078|NCT03427567|sublobar dissection|sublobar dissection
124079|NCT03427541|Chinese|chinese
124080|NCT03427541|non-small cell lung cancer|non-small cell lung cancer
124081|NCT03427541|oligometastases|oligometastases
124082|NCT03427515|Psychobiotics|psychobiotics
124083|NCT03427515|Probiotics|probiotics
124084|NCT03427515|Examination|examination
124085|NCT03427515|Stress|stress
124086|NCT03427502|general anesthesia|general anesthesia
124087|NCT03427502|nasal surgery|nasal surgery
124088|NCT03427502|anterior ehtmoidal nerve block|anterior ehtmoidal nerve block
124089|NCT03427502|bupivacaine|bupivacaine
124090|NCT03427502|postoperative confusion|postoperative confusion
124091|NCT03427489|Biomarkers|biomarkers
124092|NCT03427489|Genetic Markers|genetic markers
124093|NCT03427489|Controls|controls
124094|NCT03427476|renal cell carcinoma|renal cell carcinoma
124095|NCT03427476|RCC|rcc
124096|NCT03427476|prostate specific membrane antigen|prostate specific membrane antigen
124097|NCT03427476|PSMA|psma
124098|NCT03427476|metastatic renal cancer|metastatic renal cancer
124099|NCT03427476|positron emission tomography|positron emission tomography
124100|NCT03427476|PET|pet
124101|NCT03427450|circulating tumor cells|circulating tumor cells
124102|NCT03427450|liquid biopsy|liquid biopsy
124103|NCT03427450|microfluidics|microfluidics
124104|NCT03427437|sacral canal|sacral canal
124105|NCT03427437|sacral hiatus|sacral hiatus
124106|NCT03427437|ultrasound|ultrasound
124107|NCT03427424|Opioid use Disorder|opioid use disorder
124108|NCT03427424|Alcohol use Disorder|alcohol use disorder
124109|NCT03427424|Physician Health Program|physician health program
124110|NCT03427424|Functional Magnetic Resonance Imaging (fMRI)|functional magnetic resonance imaging (fmri)
124111|NCT03427424|Magnetic Resonance Spectroscopy|magnetic resonance spectroscopy
124112|NCT03427411|TGFR1 pathway signaling and overexpression|tgfr1 pathway signaling and overexpression
124113|NCT03427411|PD-1 inhibitors|pd-1 inhibitors
124114|NCT03427411|Manageable Safety Profile|manageable safety profile
124115|NCT03427411|Bifunctional Fusion Protein|bifunctional fusion protein
124116|NCT03427411|Refractory/Recurrent HPV Associated Malignancies|refractory/recurrent hpv associated malignancies
124117|NCT03427385|Neuromuscular blockade|neuromuscular blockade
124118|NCT03427359|nasopharyngeal carcinoma|nasopharyngeal carcinoma
124119|NCT03427359|induction chemotherapy|induction chemotherapy
124120|NCT03427359|cisplatin|cisplatin
124121|NCT03427359|capecitabine|capecitabine
124122|NCT03427359|chemoradiotherapy|chemoradiotherapy
124123|NCT03427346|Barrett Esophagus|barrett esophagus
124124|NCT03427346|ESD|esd
124125|NCT03427346|EMR|emr
124126|NCT03427346|Esophagus Neoplasm|esophagus neoplasm
124127|NCT03427346|endoscopic resection technique|endoscopic resection technique
124128|NCT03427346|ablation of esophageal mucosa|ablation of esophageal mucosa
124129|NCT03427333|VT|vt
124130|NCT03427333|Pacemaker Lead Extraction|pacemaker lead extraction
124131|NCT03427333|epicardial access|epicardial access
124132|NCT03427333|pericardial access|pericardial access
124133|NCT03427320|[131]I-IAZA Imaging study|[131]i-iaza imaging study
124134|NCT03427307|Lipopolysaccharide-binding protein|lipopolysaccharide-binding protein
124135|NCT03427307|inflammation|inflammation
124136|NCT03427307|ASCVD|ascvd
124137|NCT03427255|superficial dyspareunia; CBT|superficial dyspareunia; cbt
124138|NCT03427242|biliary tract carcinoma|biliary tract carcinoma
124139|NCT03427242|apatinib|apatinib
124140|NCT03427229|fecal microbiota transplantation|fecal microbiota transplantation
124141|NCT03427229|Clostridium difficile infection|clostridium difficile infection
124142|NCT03427229|pseudomembranous colitis|pseudomembranous colitis
124143|NCT03427190|Suicide|suicide
124144|NCT03427190|Suicide attempted|suicide attempted
124145|NCT03427190|Secondary Prevention|secondary prevention
124146|NCT03427190|Relapse prevention|relapse prevention
124147|NCT03427190|Case Management|case management
124148|NCT03427190|Intervention Study|intervention study
124156|NCT03427086|Amyotrophic lateral sclerosis|amyotrophic lateral sclerosis
124157|NCT03427086|Biotin|biotin
124158|NCT03427034|Urine|urine
124159|NCT03427034|Haematuria|haematuria
124160|NCT03427034|Flexible cystoscopy|flexible cystoscopy
124161|NCT03427034|Recurrence|recurrence
124162|NCT03427034|Cytology|cytology
124163|NCT03427008|mHealth|mhealth
124164|NCT03427008|kidney transplantation|kidney transplantation
124165|NCT03427008|medication adherence|medication adherence
124166|NCT03427008|video directly observed therapy|video directly observed therapy
124167|NCT03426956|Glucagon-like Peptide-1|glucagon-like peptide-1
124168|NCT03426956|Glucose|glucose
124169|NCT03426956|Gastric bypass|gastric bypass
124170|NCT03426956|Bariatric surgery|bariatric surgery
124171|NCT03426956|Obesity|obesity
124172|NCT03426956|Diabetes|diabetes
124173|NCT03426891|Immunotherapy|immunotherapy
124174|NCT03426891|Radiotherapy|radiotherapy
124175|NCT03426891|Glioblastoma|glioblastoma
124176|NCT03426878|Lynch syndrome|lynch syndrome
124177|NCT03426878|Hereditary breast and ovarian cancer|hereditary breast and ovarian cancer
124178|NCT03426865|retroperitoneal lymph node dissection|retroperitoneal lymph node dissection
124179|NCT03426865|testicular cancer|testicular cancer
124180|NCT03426865|testis cancer|testis cancer
124181|NCT03426865|germ cell tumor|germ cell tumor
124182|NCT03426865|PET scan|pet scan
124183|NCT03426865|Axumin|axumin
124184|NCT03426865|teratoma|teratoma
124185|NCT03426852|Biomechanical Phenomenon|biomechanical phenomenon
124186|NCT03426852|Gait|gait
124187|NCT03426852|Lumbar Disc Degeneration|lumbar disc degeneration
124188|NCT03426839|hemostatic techniques|hemostatic techniques
124189|NCT03426839|perioperative hemorrhage|perioperative hemorrhage
124190|NCT03426839|platelet function test|platelet function test
124191|NCT03426839|point of care technology|point of care technology
124192|NCT03426839|thromboelastometry|thromboelastometry
124193|NCT03426839|vascular surgical procedures|vascular surgical procedures
124194|NCT03426826|FMT|fmt
124195|NCT03426826|Gut Microbiome|gut microbiome
124196|NCT03426826|Fecal Microbiata Transplantation|fecal microbiata transplantation
124197|NCT03426826|Autism Spectrum Disorder|autism spectrum disorder
124198|NCT03426826|16s rRNA|16s rrna
124199|NCT03426826|Gastro-Intestinal Disorder|gastro-intestinal disorder
124200|NCT03426813|mobilization|mobilization
124201|NCT03426813|physiotherapy|physiotherapy
124202|NCT03426813|community-acquired pneumonia|community-acquired pneumonia
124203|NCT03426800|Acupuncture|acupuncture
124204|NCT03426800|Training|training
124205|NCT03426800|Children|children
124206|NCT03426800|Effect|effect
124207|NCT03426787|Patient Centered|patient centered
124208|NCT03426787|Pre-Post Design|pre-post design
124209|NCT03426787|Decision Support|decision support
124210|NCT03426787|Health Literacy|health literacy
124211|NCT03426748|Brachytherapy|brachytherapy
124212|NCT03426748|Quality of life|quality of life
124213|NCT03426748|High dose rate vs. low dose rate|high dose rate vs. low dose rate
124214|NCT03426748|Intermediate risk group|intermediate risk group
124215|NCT03426735|Iodine|iodine
124216|NCT03426735|Iodized|iodized
124217|NCT03426735|Computerized Tomography|computerized tomography
124218|NCT03426735|Extravasation|extravasation
124219|NCT03426735|contrast media|contrast media
124220|NCT03426709|Depression|depression
124221|NCT03426709|Multimorbidity|multimorbidity
124222|NCT03426709|Computer-delivered psychotherapy|computer-delivered psychotherapy
124223|NCT03426709|Randomized-controlled trial|randomized-controlled trial
124224|NCT03426709|Cost-effectiveness|cost-effectiveness
124225|NCT03426696|psychological status|psychological status
124226|NCT03426696|Related Factors|related factors
124227|NCT03426696|Thyroid Related Eye Disease|thyroid related eye disease
124228|NCT03426683|Inflammatory Bowel Disease(IBD)|inflammatory bowel disease(ibd)
124229|NCT03426683|Ulcerative colitis(UC)|ulcerative colitis(uc)
124230|NCT03426683|Crohn's disease(CD)|crohn's disease(cd)
124231|NCT03426683|intestinal microbiota transplantation|intestinal microbiota transplantation
124232|NCT03426683|microbiota|microbiota
124233|NCT03426670|HIV self-testing|hiv self-testing
124234|NCT03426670|Pre-exposure prophylaxis|pre-exposure prophylaxis
124235|NCT03426670|Sex workers|sex workers
124236|NCT03426644|Childhood sleep promotion|childhood sleep promotion
124237|NCT03426644|Sleep promotion|sleep promotion
124238|NCT03426644|Sleep|sleep
124239|NCT03426592|HIV|hiv
124240|NCT03426592|Inflammation|inflammation
124241|NCT03426592|Vitamin D|vitamin d
124242|NCT03426592|Immunomodulation|immunomodulation
124243|NCT03426592|Virus latency|virus latency
124244|NCT03426566|diabetic foot|diabetic foot
124245|NCT03426566|pedobarography|pedobarography
124246|NCT03426566|diabetic neuropathy|diabetic neuropathy
124247|NCT03426566|plantar pressure|plantar pressure
124248|NCT03426553|Patogen inactivation|patogen inactivation
124249|NCT03426553|Pathogen reduction|pathogen reduction
124250|NCT03426553|clinical use|clinical use
124251|NCT03426553|riboflavin+UV|riboflavin+uv
124252|NCT03426553|RBC transfusion|rbc transfusion
124253|NCT03426553|whole blood|whole blood
124254|NCT03426514|Colorectal cancer|colorectal cancer
124255|NCT03426514|Laparoscopic surgery|laparoscopic surgery
124256|NCT03426514|Three-port|three-port
124257|NCT03426501|heart rate variability|heart rate variability
124258|NCT03426501|prognosis|prognosis
124259|NCT03426475|nursing home residents|nursing home residents
124260|NCT03426475|interprofessional collaboration|interprofessional collaboration
124261|NCT03426475|reduction of hospitalisation|reduction of hospitalisation
124262|NCT03426462|Pharmacodynamic|pharmacodynamic
124263|NCT03426462|Permutation Entropy|permutation entropy
124264|NCT03426462|EEG|eeg
124265|NCT03426423|Gender|gender
124266|NCT03426423|Metabolism|metabolism
124267|NCT03426423|Microbiota|microbiota
124268|NCT03426397|Complete response|complete response
124269|NCT03426397|Organ preservation|organ preservation
124270|NCT03426397|Wait-and-See|wait-and-see
124271|NCT03426397|Watch-and-Wait|watch-and-wait
124272|NCT03426397|Watchful Waiting|watchful waiting
124273|NCT03426384|SLE|sle
124274|NCT03426384|FLARE|flare
124275|NCT03426384|Lupus|lupus
124276|NCT03426384|Digital Therapeutics|digital therapeutics
124277|NCT03426384|Health Coaching|health coaching
124278|NCT03426384|Smartphone App|smartphone app
124279|NCT03426358|Veno Occlusive Disease|veno occlusive disease
124280|NCT03426358|Sinusoidal Obstruction Syndrome|sinusoidal obstruction syndrome
124281|NCT03426358|HSCT|hsct
124282|NCT03426358|Hematopoietic Stem Cell Transplantation|hematopoietic stem cell transplantation
124283|NCT03426358|Stem Cell Transplant Complications|stem cell transplant complications
124284|NCT03426358|Liver Stiffness Measurement|liver stiffness measurement
124285|NCT03426358|Sinusoidal Obstructive Syndrome|sinusoidal obstructive syndrome
124286|NCT03426358|Transient Elastography|transient elastography
124287|NCT03426332|Adrenal Insufficiency|adrenal insufficiency
124288|NCT03426332|Adrenal crisis|adrenal crisis
124289|NCT03426332|Adrenal emergency|adrenal emergency
124290|NCT03426332|Glucocorticoid injection|glucocorticoid injection
124291|NCT03426319|Primary adrenal insufficiency|primary adrenal insufficiency
124292|NCT03426319|Cardiovascular status|cardiovascular status
124293|NCT03426319|Metabolic profile|metabolic profile
124294|NCT03426306|4-Dimensional Computed Tomography|4-dimensional computed tomography
124295|NCT03426293|heparin;ACT;non-cardiac vascular;peri-procedural|heparin;act;non-cardiac vascular;peri-procedural
124296|NCT03426254|Subcutaneously Talazoparib|subcutaneously talazoparib
124297|NCT03426241|chronic periodontitis|chronic periodontitis
124298|NCT03426241|smoking|smoking
124299|NCT03426241|mmp-2|mmp-2
124300|NCT03426241|mmp-9|mmp-9
124301|NCT03426228|IVF, Glucose Homeostasis, Metabolic Parameters|ivf, glucose homeostasis, metabolic parameters
124302|NCT03426202|modafinil|modafinil
124303|NCT03426202|emotion|emotion
124304|NCT03426202|cognitive processing|cognitive processing
124305|NCT03426189|HIV|hiv
124306|NCT03426189|Latent reservoir|latent reservoir
124307|NCT03426189|Leukapheresis|leukapheresis
124308|NCT03426189|Inguinal lymph node biopsy|inguinal lymph node biopsy
124309|NCT03426189|Immune checkpoint|immune checkpoint
124310|NCT03426189|PD1|pd1
124311|NCT03426189|CTLA4|ctla4
124312|NCT03426176|oxytocin|oxytocin
124313|NCT03426176|acute tryptophan depletion|acute tryptophan depletion
124314|NCT03426176|emotion|emotion
124315|NCT03426163|virtual reality|virtual reality
124316|NCT03426163|knee|knee
124317|NCT03426137|Oxycodone|oxycodone
124318|NCT03426137|Placebo|placebo
124319|NCT03426137|Expectancy Induced Analgesia|expectancy induced analgesia
124320|NCT03426137|NSAID|nsaid
124321|NCT03426124|venous thromboembolism|venous thromboembolism
124322|NCT03426111|Non-Alcoholic Fatty Liver Disease|non-alcoholic fatty liver disease
124323|NCT03426111|NASH|nash
124324|NCT03426111|Obesity|obesity
124325|NCT03426111|Endoscopic gastric tubulization|endoscopic gastric tubulization
124326|NCT03426111|Non-alcoholic steatohepatitis|non-alcoholic steatohepatitis
124327|NCT03426072|quality improvement|quality improvement
124328|NCT03426059|Phelan-McDermid Syndrome|phelan-mcdermid syndrome
124329|NCT03426059|PMS|pms
124330|NCT03426059|Genotype|genotype
124331|NCT03426059|Phenotype|phenotype
124332|NCT03426059|Mapping|mapping
124333|NCT03426059|22q13 Deletion Syndrome|22q13 deletion syndrome
124334|NCT03426059|SHANK3|shank3
124335|NCT03426059|Autism Spectrum Disorder|autism spectrum disorder
124336|NCT03426059|ASD|asd
124337|NCT03426059|Intellectual Disability|intellectual disability
124338|NCT03426059|ID|id
124339|NCT03426046|Biodentine|biodentine
124340|NCT03426046|Cariously exposed pulp|cariously exposed pulp
124341|NCT03426046|MTA|mta
124342|NCT03426046|Partial pulpotomy|partial pulpotomy
124343|NCT03426046|Image J Software|image j software
124344|NCT03426020|Premedication|premedication
124345|NCT03426020|Pediatric patients|pediatric patients
124346|NCT03426020|Emergence agitation|emergence agitation
124347|NCT03426007|uterine lavage|uterine lavage
124348|NCT03426007|intrauterine insemination|intrauterine insemination
124349|NCT03426007|embryo|embryo
124350|NCT03426007|blastocyst|blastocyst
124351|NCT03426007|in vivo|in vivo
124352|NCT03426007|superovulation|superovulation
124353|NCT03425981|WB-EMS|wb-ems
124354|NCT03425981|Running economy|running economy
124355|NCT03425981|VO2max|vo2max
124356|NCT03425968|Injury rate|injury rate
124357|NCT03425942|Cognitive Behavioral Therapy|cognitive behavioral therapy
124358|NCT03425942|Applied Relaxation Techniques|applied relaxation techniques
124359|NCT03425942|Internet treatment|internet treatment
124360|NCT03425929|amygdala, fear, intrusion, oxytocin, trauma disclosure|amygdala, fear, intrusion, oxytocin, trauma disclosure
124361|NCT03425916|Hypopressive exercises|hypopressive exercises
124363|NCT03425903|Fibromyalgia, Whole body cryotherapy|fibromyalgia, whole body cryotherapy
124365|NCT03425890|Self-exercise|self-exercise
712670|NCT00579215|Decision-Making|decision-making
124366|NCT03425877|arousal, valence, emotion, heart rate variability, electrodermal activity, u-shape curve, performance, neurorehabilitation|arousal, valence, emotion, heart rate variability, electrodermal activity, u-shape curve, performance, neurorehabilitation
124367|NCT03425864|immediate implant|immediate implant
124368|NCT03425864|connective tissue graft|connective tissue graft
124369|NCT03425851|Diaper need|diaper need
124370|NCT03425851|Infants|infants
124371|NCT03425851|Well baby visits|well baby visits
124372|NCT03425851|Low-income families|low-income families
124373|NCT03425851|Caregiver stress|caregiver stress
124374|NCT03425838|CDK 4/6 inhibitor|cdk 4/6 inhibitor
124375|NCT03425825|Small Cell Lung Cancer (SCLC)|small cell lung cancer (sclc)
124376|NCT03425812|Axial Spondyloarthritis|axial spondyloarthritis
124377|NCT03425812|Anti-Inflammatory Drugs|anti-inflammatory drugs
124378|NCT03425812|Flare|flare
124379|NCT03425773|HER2/neu|her2/neu
124380|NCT03425773|IHC 1+|ihc 1+
124381|NCT03425773|BVAC|bvac
124382|NCT03425773|Cellid|cellid
124383|NCT03425773|B-cell|b-cell
124384|NCT03425773|Monocyte|monocyte
124385|NCT03425773|Immunotherapeutic vaccine|immunotherapeutic vaccine
124386|NCT03425773|Breast cancer|breast cancer
124387|NCT03425773|Colorectal cancer|colorectal cancer
124388|NCT03425773|Pancreatic cancer|pancreatic cancer
124389|NCT03425747|calcium carbonate|calcium carbonate
124390|NCT03425747|calcium citrate|calcium citrate
124391|NCT03425747|quality of life|quality of life
124392|NCT03425747|hypoparathyroidism|hypoparathyroidism
124393|NCT03425747|hypocalcemia|hypocalcemia
124394|NCT03425708|Uric Acid|uric acid
124395|NCT03425708|Febuxostat|febuxostat
124396|NCT03425708|Chronic Renal Disease|chronic renal disease
124397|NCT03425695|Free gingival graft, Low level laser therapy, Shrinkage|free gingival graft, low level laser therapy, shrinkage
124398|NCT03425682|Anterior Cervical Discectomy and Fusion (ACDF)|anterior cervical discectomy and fusion (acdf)
124399|NCT03425682|Transforaminal Lumbar Interbody Fusion (TLIF)|transforaminal lumbar interbody fusion (tlif)
124400|NCT03425682|Posterior Lumbar Interbody Fusion (PLIF)|posterior lumbar interbody fusion (plif)
124401|NCT03425669|Acoustic and vestibular noise stimulation|acoustic and vestibular noise stimulation
124402|NCT03425656|breast cancer|breast cancer
124403|NCT03425656|AryoTrust™|aryotrust™
124404|NCT03425656|Herceptin®|herceptin®
124405|NCT03425656|non-Inferiority|non-inferiority
124406|NCT03425578|Monosodium glutamate|monosodium glutamate
124407|NCT03425578|Amino acids|amino acids
124408|NCT03425578|Glucose tolerance|glucose tolerance
124409|NCT03425513|Belgium|belgium
124410|NCT03425513|Prevalence|prevalence
124411|NCT03425513|Risk factor|risk factor
124412|NCT03425513|Ethnicity|ethnicity
124413|NCT03425513|Linkage of care|linkage of care
124414|NCT03425487|Mindfulness|mindfulness
124415|NCT03425487|Compassion|compassion
124416|NCT03425487|Mental Health Services|mental health services
124417|NCT03425422|Vagus nerve stimulation|vagus nerve stimulation
124418|NCT03425383|Cardiovascular disease, FMD, c-IMT|cardiovascular disease, fmd, c-imt
124419|NCT03425370|Surgical wounds|surgical wounds
124420|NCT03425370|Tissue adhesive|tissue adhesive
124421|NCT03425370|Sutures|sutures
124422|NCT03425370|Wound healing|wound healing
124423|NCT03425331|Non-Small Cell Lung Cancer|non-small cell lung cancer
124424|NCT03425305|Serum uric acid|serum uric acid
124425|NCT03425305|Cardiovascular disease|cardiovascular disease
124426|NCT03425305|Atherosclerosis|atherosclerosis
124427|NCT03425292|immunotherapy|immunotherapy
124428|NCT03425292|nivolumab|nivolumab
124429|NCT03425292|ipilimumab|ipilimumab
124430|NCT03425292|bevcizumab|bevcizumab
124431|NCT03425292|temozolomide|temozolomide
124432|NCT03425266|shared decision-making|shared decision-making
124433|NCT03425266|decision support tool|decision support tool
124434|NCT03425266|patient-provider communication|patient-provider communication
124435|NCT03425266|managing chronic pain|managing chronic pain
124436|NCT03425266|patient preferences|patient preferences
124437|NCT03425266|values clarification|values clarification
124439|NCT03425240|Erectile Dysfunction|erectile dysfunction
124440|NCT03425240|Prostate Cancer|prostate cancer
124441|NCT03425240|Neuromodulation|neuromodulation
124442|NCT03425227|Frailty|frailty
124443|NCT03425227|Elderly People|elderly people
124444|NCT03425227|Exergame|exergame
124445|NCT03425227|Physical Activity|physical activity
124446|NCT03425227|Kinect|kinect
124447|NCT03425227|Biofeeback|biofeeback
124448|NCT03425214|functional MRI|functional mri
124449|NCT03425214|Reward system|reward system
124450|NCT03425214|REM sleep behaviour disorder|rem sleep behaviour disorder
124451|NCT03425214|Narco-cataplexy|narco-cataplexy
124452|NCT03425175|Non-relevant conversation|non-relevant conversation
124453|NCT03425175|Surgical safety|surgical safety
124454|NCT03425175|Audio recording|audio recording
124455|NCT03425162|quadratus lumborum block|quadratus lumborum block
124456|NCT03425162|pain|pain
124457|NCT03425162|ultrasound|ultrasound
124467|NCT03425123|Permanent non-vital tooth|permanent non-vital tooth
124468|NCT03425123|Children 7-18 years of age|children 7-18 years of age
124469|NCT03425071|Tacrolimus|tacrolimus
124470|NCT03425071|T Lymphocytes|t lymphocytes
124471|NCT03425071|B lymphocytes|b lymphocytes
124472|NCT03425071|Monitoring, Immunologic|monitoring, immunologic
124473|NCT03425058|Molecular Evaluation|molecular evaluation
124474|NCT03425058|Locally Advanced Gastric Cancer|locally advanced gastric cancer
124475|NCT03425058|Neoadjuvant Chemotherapy|neoadjuvant chemotherapy
124476|NCT03425058|ctDNA|ctdna
124477|NCT03425058|CTC|ctc
124478|NCT03425058|dMMR/MSI|dmmr/msi
124479|NCT03425045|chronic tinnitus|chronic tinnitus
124480|NCT03425045|repetitive transcranial magnetic stimulation|repetitive transcranial magnetic stimulation
124481|NCT03425045|hypacusion|hypacusion
124482|NCT03425045|depression|depression
124483|NCT03425045|treatment|treatment
124484|NCT03425045|placebo|placebo
124485|NCT03425045|medication therapy|medication therapy
124486|NCT03425019|Knee Osteoarthritis|knee osteoarthritis
124487|NCT03425019|Chronic Pain|chronic pain
124488|NCT03425019|Osteoarthritis|osteoarthritis
124489|NCT03425019|Transcranial Direct Current Stimulation|transcranial direct current stimulation
124490|NCT03425019|tDCS|tdcs
124491|NCT03424993|Endothelium, vascular|endothelium, vascular
124492|NCT03424993|Cardiovascular Disease|cardiovascular disease
124493|NCT03424993|Hemodynamics|hemodynamics
124494|NCT03424993|Oxidative Stress|oxidative stress
124495|NCT03424993|Dietary Sodium|dietary sodium
124496|NCT03424993|Dietary Counseling|dietary counseling
124497|NCT03424980|Non-small cell lung cancer, Chinese, brain metastases|non-small cell lung cancer, chinese, brain metastases
124498|NCT03424967|attention-bias modification|attention-bias modification
124499|NCT03424967|statistical learning|statistical learning
124500|NCT03424967|social anxiety disorder|social anxiety disorder
124501|NCT03424967|treatment outcome|treatment outcome
124509|NCT03424928|Pomalidomide|pomalidomide
124510|NCT03424928|Multiple myeloma|multiple myeloma
124511|NCT03424928|Bioequivalence|bioequivalence
124512|NCT03424889|Bronchoscopy|bronchoscopy
124513|NCT03424889|Lignocaine|lignocaine
124514|NCT03424889|Anaesthesia|anaesthesia
124515|NCT03424876|Sunitinib Imatinib|sunitinib imatinib
124516|NCT03424798|mechanical ventilation|mechanical ventilation
124517|NCT03424798|lung function|lung function
124518|NCT03424798|cardiopulmonary monitoring|cardiopulmonary monitoring
124519|NCT03424785|Aortic intramural hematoma|aortic intramural hematoma
124520|NCT03424785|Chinese patients|chinese patients
124521|NCT03424785|Clinical outcomes|clinical outcomes
124522|NCT03424733|demyelination|demyelination
124523|NCT03424733|relapse rate|relapse rate
124524|NCT03424733|Pegylated interferon beta-1a|pegylated interferon beta-1a
124525|NCT03424733|side effects|side effects
124526|NCT03424733|flu-like symptoms|flu-like symptoms
124527|NCT03424733|injection site reactions|injection site reactions
124528|NCT03424733|prednisone|prednisone
124529|NCT03424694|Brachytherapy|brachytherapy
124530|NCT03424694|Monotherapy|monotherapy
124531|NCT03424694|HDR Brachytherapy|hdr brachytherapy
124532|NCT03424694|Toxicity|toxicity
124533|NCT03424694|Quality of Life|quality of life
124534|NCT03424694|Progression Free Survival|progression free survival
124535|NCT03424668|nutrition|nutrition
124536|NCT03424668|physical activity|physical activity
124537|NCT03424668|lifestyle|lifestyle
124538|NCT03424668|smoking|smoking
124539|NCT03424655|post -endodontic pain|post -endodontic pain
124540|NCT03424655|endodontic pain|endodontic pain
124541|NCT03424655|pain|pain
124542|NCT03424642|prenatal depression|prenatal depression
124543|NCT03424642|prenatal anxiety|prenatal anxiety
124544|NCT03424642|prenatal mental disorders|prenatal mental disorders
124545|NCT03424642|interactive ultrasound examination|interactive ultrasound examination
124546|NCT03424642|maternal-fetal relations|maternal-fetal relations
124547|NCT03424629|psoriasis|psoriasis
124548|NCT03424629|UC-MSCs|uc-mscs
124549|NCT03424616|Opiate dependence|opiate dependence
124550|NCT03424616|Deep brain stimulation|deep brain stimulation
124551|NCT03424616|Nucleus accumbens|nucleus accumbens
124552|NCT03424577|H3B-6527|h3b-6527
124553|NCT03424577|Healthy Participants|healthy participants
124554|NCT03424577|Pharmacokinetics|pharmacokinetics
124555|NCT03424564|Perampanel|perampanel
124556|NCT03424564|Pharmacokinetics|pharmacokinetics
124558|NCT03424564|Chinese|chinese
124559|NCT03424551|vibration|vibration
124560|NCT03424551|muscle spindle|muscle spindle
124561|NCT03424551|H reflex|h reflex
124562|NCT03424551|tonic vibration reflex|tonic vibration reflex
124563|NCT03424538|multiple sclerosis|multiple sclerosis
124564|NCT03424538|posture|posture
124565|NCT03424538|neurorehabilitation|neurorehabilitation
124566|NCT03424538|balance|balance
124567|NCT03424499|neurogenic bladder|neurogenic bladder
124568|NCT03424499|intermittent urethral catheterization|intermittent urethral catheterization
124569|NCT03424499|Clean intermittent catheterization|clean intermittent catheterization
124570|NCT03424486|Cystic fibrosis|cystic fibrosis
124571|NCT03424486|Anxiety|anxiety
124572|NCT03424486|Depression|depression
124573|NCT03424486|Adolescence|adolescence
124574|NCT03424473|tucatinib|tucatinib
124575|NCT03424473|Breast Cancer|breast cancer
124576|NCT03424473|ARRY-380|arry-380
124577|NCT03424473|ONT-380|ont-380
124578|NCT03424473|HER2 Positive Breast Carcinoma|her2 positive breast carcinoma
124579|NCT03424473|HER2 Positive Locally Advanced Breast Cancer|her2 positive locally advanced breast cancer
124580|NCT03424473|HER-2 Positive Breast Cancer|her-2 positive breast cancer
124581|NCT03424473|HER-2 Positive Locally Advanced Breast Cancer|her-2 positive locally advanced breast cancer
124582|NCT03424473|Recurrent Breast Carcinoma|recurrent breast carcinoma
124583|NCT03424473|Stage IV Breast Cancer|stage iv breast cancer
124584|NCT03424473|Metastatic Breast Cancer|metastatic breast cancer
124585|NCT03424473|Breast Carcinoma|breast carcinoma
124586|NCT03424473|Metastatic Malignant Neoplasm in the Brain|metastatic malignant neoplasm in the brain
124587|NCT03424473|Brain Metastases in Breast Cancer|brain metastases in breast cancer
124588|NCT03424473|Breast Neoplasms|breast neoplasms
124589|NCT03424473|Neoplasms by Site|neoplasms by site
124590|NCT03424473|Neoplasms|neoplasms
124591|NCT03424473|Breast Diseases|breast diseases
124592|NCT03424460|Myotonic dystrophy 1|myotonic dystrophy 1
124593|NCT03424460|Venous thromboembolism|venous thromboembolism
124594|NCT03424460|Pulmonary embolism|pulmonary embolism
124595|NCT03424460|Deep vein thrombosis|deep vein thrombosis
124596|NCT03424460|Hypercoagulability|hypercoagulability
124597|NCT03424460|Thrombophilia|thrombophilia
124598|NCT03424460|RNA alternative splicing|rna alternative splicing
124599|NCT03424434|Occupational blood exposure|occupational blood exposure
124600|NCT03424434|underreporting|underreporting
124601|NCT03424434|medical|medical
124602|NCT03424434|hospital|hospital
124603|NCT03424421|Shoulder Joint|shoulder joint
124604|NCT03424421|Orthopedics|orthopedics
124605|NCT03424421|Arthroscopy|arthroscopy
124606|NCT03424395|personalized dietary and wellness program|personalized dietary and wellness program
124607|NCT03424395|oral protein glucose lipid tolerance test|oral protein glucose lipid tolerance test
124608|NCT03424395|metabolism|metabolism
124609|NCT03424395|behavior|behavior
124610|NCT03424395|health|health
124611|NCT03424395|body composition|body composition
124612|NCT03424395|single nucleotide polymorphisms|single nucleotide polymorphisms
124613|NCT03424395|genotype|genotype
124614|NCT03424395|dietary and wellness coaching/advice|dietary and wellness coaching/advice
124615|NCT03424395|liquid meal challenge test|liquid meal challenge test
124616|NCT03424356|LMA|lma
124617|NCT03424356|Rocuronium bromur|rocuronium bromur
124618|NCT03424356|propofol|propofol
124619|NCT03424343|survivors|survivors
124620|NCT03424343|parents|parents
124621|NCT03424343|sibling|sibling
124622|NCT03424343|family environment|family environment
124623|NCT03424343|psychosocial functioning|psychosocial functioning
124624|NCT03424343|longitudinal|longitudinal
124625|NCT03424343|cancer|cancer
124626|NCT03424343|identity|identity
124627|NCT03424343|adolescence|adolescence
124628|NCT03424343|emerging adulthood|emerging adulthood
124629|NCT03424278|Low back pain|low back pain
124630|NCT03424278|Exercise|exercise
124631|NCT03424252|Cystic Fibrosis|cystic fibrosis
124632|NCT03424239|Roux-en-Y gastric bypass, sleeve gastrectomy|roux-en-y gastric bypass, sleeve gastrectomy
124633|NCT03424174|TKA, cytokine, coating|tka, cytokine, coating
124634|NCT03424122|Diffuse large B-cell lymphoma (DLBCL)|diffuse large b-cell lymphoma (dlbcl)
124635|NCT03424122|follicular lymphoma (FL)|follicular lymphoma (fl)
124636|NCT03424122|marginal zone lymphoma (MZL)|marginal zone lymphoma (mzl)
124637|NCT03424122|mantle cell lymphoma (MCL)|mantle cell lymphoma (mcl)
124638|NCT03424122|phosphatidylinositol 3-kinase delta (PI3Kδ) inhibitor|phosphatidylinositol 3-kinase delta (pi3kδ) inhibitor
124639|NCT03424109|Emergency Department|emergency department
124640|NCT03424109|Palliative Care|palliative care
124641|NCT03424070|laryngoscopy|laryngoscopy
124642|NCT03424070|pediatric|pediatric
124643|NCT03424070|airway|airway
124644|NCT03424070|gel roll|gel roll
124645|NCT03424070|larynx|larynx
124646|NCT03424070|glottis|glottis
124647|NCT03424057|Karydakis modification|karydakis modification
124648|NCT03424057|pilonidal sinus|pilonidal sinus
124649|NCT03424057|seroma|seroma
124650|NCT03424044|glucagon|glucagon
124651|NCT03424044|closed-loop|closed-loop
124652|NCT03424044|Omnipod|omnipod
124653|NCT03424044|exercise|exercise
124654|NCT03424018|ACH|ach
124655|NCT03424018|Achondroplasia|achondroplasia
124656|NCT03424018|Bone Diseases|bone diseases
124657|NCT03424018|Bone Diseases, Developmental|bone diseases, developmental
124658|NCT03424018|Dwarfism|dwarfism
124659|NCT03424018|Genetic Diseases, Inborn|genetic diseases, inborn
124660|NCT03424018|Musculoskeletal Diseases|musculoskeletal diseases
124661|NCT03424018|Natriuretic Agents|natriuretic agents
124662|NCT03424018|Natriuretic Peptide, C-Type|natriuretic peptide, c-type
124663|NCT03424018|Osteochondrodysplasias|osteochondrodysplasias
124664|NCT03424018|Physiological Effects of Drugs|physiological effects of drugs
124665|NCT03424018|Skeletal Dysplasias|skeletal dysplasias
124666|NCT03423979|BPH|bph
124667|NCT03423953|osteoarthritis|osteoarthritis
124668|NCT03423953|avascular necrosis|avascular necrosis
124669|NCT03423953|rheumatoid arthritis|rheumatoid arthritis
124670|NCT03423940|Functional communication training|functional communication training
124671|NCT03423940|Reinforcement Schedule Thinning|reinforcement schedule thinning
124672|NCT03423940|Resurgence|resurgence
124673|NCT03423940|Treatment Dosage|treatment dosage
124674|NCT03423940|Treatment Relapse|treatment relapse
124675|NCT03423914|writing|writing
124676|NCT03423914|postraumatic stress|postraumatic stress
124677|NCT03423914|coping|coping
124678|NCT03423901|Complications|complications
124679|NCT03423888|Dyspnea|dyspnea
124680|NCT03423888|palliative care|palliative care
124681|NCT03423888|high-flow nasal oxygen|high-flow nasal oxygen
124682|NCT03423888|pilot study|pilot study
124683|NCT03423875|Delirium, Delirium Recognition|delirium, delirium recognition
124684|NCT03423823|Neovascularization|neovascularization
124685|NCT03423797|silver nitrate|silver nitrate
124686|NCT03423797|sodium fluoride|sodium fluoride
124687|NCT03423797|dental caries|dental caries
124688|NCT03423797|equivalence trial|equivalence trial
124689|NCT03423784|teething in infants and children|teething in infants and children
124690|NCT03423784|oral gels|oral gels
124691|NCT03423784|paediatric dentistry|paediatric dentistry
124692|NCT03423758|Pseudoexfoliation Glaucoma, Angle block glaucoma, Genetic|pseudoexfoliation glaucoma, angle block glaucoma, genetic
124693|NCT03423745|intubation|intubation
124694|NCT03423745|cardiopulmonary resuscitation|cardiopulmonary resuscitation
124695|NCT03423745|number of endotracheal intubation experience|number of endotracheal intubation experience
124696|NCT03423693|Small airway obstruction|small airway obstruction
124697|NCT03423693|Asthma|asthma
124698|NCT03423693|COPD|copd
124699|NCT03423693|ACOS|acos
124700|NCT03423667|N-acetylcysteine|n-acetylcysteine
124701|NCT03423667|Craving|craving
124702|NCT03423641|Drug-Related Side Effects and Adverse Reactions|drug-related side effects and adverse reactions
124703|NCT03423641|Antiviral Agents / Adverse Effects|antiviral agents / adverse effects
124704|NCT03423641|Antiviral Agents / Toxicity|antiviral agents / toxicity
124705|NCT03423641|Simeprevir|simeprevir
124706|NCT03423641|Sofosbuvir|sofosbuvir
124707|NCT03423641|Ledipasvir|ledipasvir
124708|NCT03423641|Ombitasvir|ombitasvir
124709|NCT03423641|Paritaprevir|paritaprevir
124710|NCT03423641|Ritonavir|ritonavir
124711|NCT03423641|Dasabuvir|dasabuvir
124712|NCT03423641|Daclatasvir|daclatasvir
124713|NCT03423641|Elbasvir|elbasvir
124714|NCT03423641|Grazoprevir|grazoprevir
124715|NCT03423641|Velpatasvir|velpatasvir
124716|NCT03423641|Ribavirin|ribavirin
124717|NCT03423628|glioblastoma|glioblastoma
124718|NCT03423628|brain metastases|brain metastases
124719|NCT03423628|Ataxia-telangiectasia mutated kinase (ATM) inhibition|ataxia-telangiectasia mutated kinase (atm) inhibition
124720|NCT03423628|radiation therapy|radiation therapy
124721|NCT03423615|School Health Services|school health services
124722|NCT03423615|Health Education|health education
124723|NCT03423615|Primary Schools|primary schools
124724|NCT03423615|Republic of India|republic of india
124725|NCT03423602|Percutaneous vascular closure device|percutaneous vascular closure device
124726|NCT03423602|Large hole closure device|large hole closure device
124727|NCT03423602|Arteriotomy closure|arteriotomy closure
124728|NCT03423602|Vascular closure device|vascular closure device
124729|NCT03423589|Siblings|siblings
124730|NCT03423576|health services|health services
124731|NCT03423576|FEV1|fev1
124732|NCT03423576|BMI|bmi
124733|NCT03423576|quality of life|quality of life
124734|NCT03423576|mental stress|mental stress
124735|NCT03423524|Intraocular lens|intraocular lens
124736|NCT03423524|Monofocal|monofocal
124737|NCT03423524|Hydrophobic|hydrophobic
124738|NCT03423511|MiStent|mistent
124739|NCT03423511|Coronary Artery Disease|coronary artery disease
124740|NCT03423511|Coronary Disease|coronary disease
124741|NCT03423511|Myocardial Ischemia|myocardial ischemia
124742|NCT03423511|Heart Disease|heart disease
124743|NCT03423511|Cardiovascular Diseases|cardiovascular diseases
124744|NCT03423511|Arteriosclerosis|arteriosclerosis
124847|NCT03422939|FBDG|fbdg
124745|NCT03423511|Arterial Occlusive Diseases|arterial occlusive diseases
124746|NCT03423511|Vascular Diseases|vascular diseases
124747|NCT03423498|hallux valgus,|hallux valgus,
124748|NCT03423498|toe-spread-out exercise|toe-spread-out exercise
124749|NCT03423498|abductor hallucis muscle|abductor hallucis muscle
124750|NCT03423498|surface electromyography|surface electromyography
124751|NCT03423485|Colorectal Surgery|colorectal surgery
124752|NCT03423472|Nutrition|nutrition
124753|NCT03423472|Women|women
124754|NCT03423472|Young children|young children
124755|NCT03423472|Ethiopia|ethiopia
124756|NCT03423472|Vitamin A|vitamin a
124757|NCT03423472|Orange flesh sweet potato|orange flesh sweet potato
124758|NCT03423433|Chronic|chronic
124759|NCT03423433|Stroke|stroke
124760|NCT03423433|Blood Pressure|blood pressure
124761|NCT03423433|Oxygen Perfusion|oxygen perfusion
124762|NCT03423433|Stroop|stroop
124763|NCT03423433|Cognitive Performance|cognitive performance
124764|NCT03423433|Cognition|cognition
124765|NCT03423394|Motivational enhancement therapy|motivational enhancement therapy
124766|NCT03423368|Libramed|libramed
124767|NCT03423368|Policaptil Gel Retard|policaptil gel retard
124768|NCT03423368|Overweight|overweight
124769|NCT03423368|Obesity|obesity
124770|NCT03423368|Medical Device|medical device
124771|NCT03423368|glycemic profile|glycemic profile
124772|NCT03423368|lipid profile|lipid profile
124773|NCT03423342|nicotinamide riboside|nicotinamide riboside
124774|NCT03423342|Nicotinamide-Adenine Dinucleotide|nicotinamide-adenine dinucleotide
124775|NCT03423303|Prostate cancer|prostate cancer
124776|NCT03423303|Screening|screening
124777|NCT03423303|Randomised trial|randomised trial
124778|NCT03423303|Kallikrein|kallikrein
124779|NCT03423303|Magnetic resonance imaging|magnetic resonance imaging
124780|NCT03423303|Prostate-specific antigen|prostate-specific antigen
124781|NCT03423264|HPV-related oropharyngeal cancer|hpv-related oropharyngeal cancer
124782|NCT03423264|oropharyngeal cancer|oropharyngeal cancer
124783|NCT03423264|HPV-related squamous cell carcinoma|hpv-related squamous cell carcinoma
124784|NCT03423264|prophylactic gabapentin|prophylactic gabapentin
124785|NCT03423264|Optima II study|optima ii study
124786|NCT03423238|Cardiac|cardiac
124787|NCT03423238|Rehab|rehab
124788|NCT03423238|Diet|diet
124789|NCT03423238|Exercise|exercise
124790|NCT03423238|Obese|obese
124791|NCT03423225|ADVAGRAF®|advagraf®
124792|NCT03423225|Liver Transplantation|liver transplantation
124793|NCT03423225|tacrolimus|tacrolimus
124794|NCT03423199|breast Cancer|breast cancer
124795|NCT03423199|palbociclib (PD-0332991)|palbociclib (pd-0332991)
124796|NCT03423199|tamoxifen|tamoxifen
124797|NCT03423199|goserelin|goserelin
124798|NCT03423199|any menopausal status|any menopausal status
124799|NCT03423199|hormone receptor positive|hormone receptor positive
124800|NCT03423199|HER2 negative|her2 negative
124801|NCT03423199|locally advanced|locally advanced
124802|NCT03423199|metastatic|metastatic
124803|NCT03423173|Vaccine|vaccine
124804|NCT03423147|Cesarean section|cesarean section
124805|NCT03423147|Labor|labor
124806|NCT03423147|Surgical Site Infections|surgical site infections
124807|NCT03423147|Chlorhexidine gluconate|chlorhexidine gluconate
124808|NCT03423108|Exercise|exercise
124809|NCT03423108|Aging|aging
124810|NCT03423108|Elderly|elderly
124811|NCT03423108|Physical Activity|physical activity
124812|NCT03423108|Cardiovascular Disease|cardiovascular disease
124813|NCT03423069|Irritable bowel syndrome|irritable bowel syndrome
124814|NCT03423069|FODMAPs|fodmaps
124815|NCT03423069|Dietary advice|dietary advice
124816|NCT03423069|Gastrointestinal symptoms|gastrointestinal symptoms
124817|NCT03423069|Intestinal permeability|intestinal permeability
124818|NCT03423069|Gastrointestinal peptides|gastrointestinal peptides
124819|NCT03423069|Microbiome|microbiome
124820|NCT03423069|Lipidomic profile|lipidomic profile
124821|NCT03423056|Gastrointestinal Neoplasms|gastrointestinal neoplasms
124822|NCT03423056|Exercise|exercise
124823|NCT03423056|Preoperative Period|preoperative period
124824|NCT03423056|Preoperative Care|preoperative care
124825|NCT03423017|Pierre Robin sequence|pierre robin sequence
124826|NCT03423017|Brainstem|brainstem
124827|NCT03423017|pathogenesis|pathogenesis
124828|NCT03423017|swallowing|swallowing
124829|NCT03423017|apnea|apnea
124830|NCT03423004|psoriasis|psoriasis
124831|NCT03423004|IL-22|il-22
124832|NCT03423004|miR-21|mir-21
124833|NCT03422991|Heart Failure|heart failure
124834|NCT03422991|Heart Diseases|heart diseases
124835|NCT03422991|Cardiovascular Diseases|cardiovascular diseases
124836|NCT03422991|Vascular Diseases|vascular diseases
124837|NCT03422991|Cohort|cohort
124838|NCT03422978|Dexmedetomidine|dexmedetomidine
124839|NCT03422965|Retina|retina
124840|NCT03422965|OCT|oct
124841|NCT03422965|Optical Coherence Tomography|optical coherence tomography
124842|NCT03422965|Optical Coherence Tomography Angiography|optical coherence tomography angiography
124843|NCT03422965|Systemic|systemic
124844|NCT03422965|Blood|blood
124845|NCT03422965|Diabetes Mellitus|diabetes mellitus
124846|NCT03422965|Diabetic Retinopathy|diabetic retinopathy
124848|NCT03422939|dietitians|dietitians
124849|NCT03422939|portion sizes|portion sizes
124850|NCT03422939|time frame|time frame
124851|NCT03422939|visual references|visual references
124852|NCT03422887|postoperative pain|postoperative pain
124853|NCT03422887|general anesthesia|general anesthesia
124854|NCT03422887|postoperative discomfort|postoperative discomfort
124855|NCT03422874|Advanced Solid Tumors|advanced solid tumors
124856|NCT03422874|Lymphoma|lymphoma
124857|NCT03422874|Nelfinavir|nelfinavir
124859|NCT03422874|proteasome inhibitor|proteasome inhibitor
124860|NCT03422861|Nabilone|nabilone
124861|NCT03422861|Inflammatory Bowel Disease|inflammatory bowel disease
124862|NCT03422861|Opioid|opioid
124863|NCT03422848|hydration|hydration
124864|NCT03422848|water|water
124865|NCT03422848|vasopressin|vasopressin
124866|NCT03422848|copeptin|copeptin
124867|NCT03422848|glucose|glucose
124868|NCT03422848|OGTT|ogtt
124869|NCT03422848|insulin|insulin
124870|NCT03422848|glucagon|glucagon
159392|NCT03202004|PGA|pga
124871|NCT03422835|transanal surgery|transanal surgery
124872|NCT03422835|robotic surgery|robotic surgery
124873|NCT03422835|total mesorectal excision|total mesorectal excision
124874|NCT03422822|atopic dermatitis|atopic dermatitis
124875|NCT03422822|atopic eczema|atopic eczema
124876|NCT03422822|eczema|eczema
124877|NCT03422822|JAK|jak
124878|NCT03422822|janus kinase|janus kinase
124879|NCT03422809|Plasma volume, micronutrient, estrogen, progesterone|plasma volume, micronutrient, estrogen, progesterone
124880|NCT03422783|Monitoring|monitoring
124881|NCT03422783|Biomarker|biomarker
124882|NCT03422783|Thoracoscopy|thoracoscopy
124883|NCT03422770|Myocardium|myocardium
124884|NCT03422770|Predictive Value of Tests|predictive value of tests
124885|NCT03422770|Prognosis|prognosis
124886|NCT03422770|Clinical Decision-making|clinical decision-making
124887|NCT03422770|Heart Ventricles|heart ventricles
124888|NCT03422770|Echocardiography|echocardiography
124889|NCT03422718|stroke|stroke
124890|NCT03422718|hypertension|hypertension
124891|NCT03422692|Resorbable membrane, amnion-chorion membrane, collagen membrane, ridge preservation.|resorbable membrane, amnion-chorion membrane, collagen membrane, ridge preservation.
124892|NCT03422679|advanced solid tumours|advanced solid tumours
124893|NCT03422679|haematological malignancies|haematological malignancies
124894|NCT03422679|phase I/II|phase i/ii
124895|NCT03422679|NOTCH pathway|notch pathway
124896|NCT03422679|pan-NOTCH inhibitor|pan-notch inhibitor
124897|NCT03422666|Intestinal lipoprotein|intestinal lipoprotein
124898|NCT03422666|Gut Peptide|gut peptide
124899|NCT03422666|Chylomicrons|chylomicrons
124900|NCT03422653|CR845|cr845
124901|NCT03422653|Pruritus|pruritus
124902|NCT03422653|Chronic Itch|chronic itch
124903|NCT03422653|Itch|itch
124904|NCT03422653|Itching|itching
124905|NCT03422653|difelikefalin|difelikefalin
124906|NCT03422653|Hemodialysis|hemodialysis
124907|NCT03422653|Uremic Pruritus|uremic pruritus
124908|NCT03422653|Dialysis|dialysis
124909|NCT03422653|CKD|ckd
124910|NCT03422653|CKD-associated pruritus|ckd-associated pruritus
124911|NCT03422653|CKD-aP|ckd-ap
124912|NCT03422653|ESRD (end stage renal disease)|esrd (end stage renal disease)
124913|NCT03422653|KALM|kalm
124914|NCT03422653|Chronic Kidney Disease|chronic kidney disease
124915|NCT03422653|Kidney failure, chronic|kidney failure, chronic
124916|NCT03422653|Kidney dysfunction|kidney dysfunction
124917|NCT03422653|Generalized pruritus|generalized pruritus
124918|NCT03422640|Frontal Fibrosing Alopecia|frontal fibrosing alopecia
124919|NCT03422640|Apremilast|apremilast
124920|NCT03422549|diaphragm|diaphragm
124921|NCT03422549|non-invasive ventilation|non-invasive ventilation
124922|NCT03422549|high-frequency oscillation|high-frequency oscillation
124923|NCT03422549|CPAP|cpap
124924|NCT03422536|Head and Neck Cancer|head and neck cancer
124925|NCT03422536|Oropharyngeal Cancer|oropharyngeal cancer
124926|NCT03422536|Squamous Cell Carcinoma|squamous cell carcinoma
124927|NCT03422536|lip carcinoma|lip carcinoma
124928|NCT03422536|oral cavity carcinoma|oral cavity carcinoma
124929|NCT03422536|HNSCC|hnscc
124930|NCT03422536|Head and Neck Squamous Cell Carcinoma|head and neck squamous cell carcinoma
124931|NCT03422536|AVEO|aveo
124932|NCT03422523|Refractory|refractory
124933|NCT03422523|Relapsed|relapsed
124934|NCT03422523|Hematological cancer|hematological cancer
124935|NCT03422510|FSGS|fsgs
124936|NCT03422510|Kidney Disease|kidney disease
124937|NCT03422510|Proteinuria|proteinuria
124938|NCT03422510|Nephrotic Syndrome|nephrotic syndrome
124939|NCT03422510|FIRSTx|firstx
124940|NCT03422510|Nitro fatty acids|nitro fatty acids
124941|NCT03422510|OA-NO2|oa-no2
124942|NCT03422510|10-nitro oleic acid|10-nitro oleic acid
124943|NCT03422510|Nitro oleic acid|nitro oleic acid
124944|NCT03422484|Internal medecine unit|internal medecine unit
124945|NCT03422484|Medication Error|medication error
124946|NCT03422484|Clinical Pharmacist|clinical pharmacist
124947|NCT03422484|Medication reconciliation|medication reconciliation
124948|NCT03422445|Apatinib|apatinib
124949|NCT03422445|Temozolomide|temozolomide
124950|NCT03422445|Advanced Melanoma|advanced melanoma
124951|NCT03422406|Iodine excess|iodine excess
124953|NCT03422406|Pregnancy|pregnancy
124954|NCT03422406|Urinary iodine concentration|urinary iodine concentration
124955|NCT03422406|Serum iodine concentration|serum iodine concentration
124956|NCT03422406|Breast milk iodine concentration|breast milk iodine concentration
124957|NCT03422393|venetoclax|venetoclax
124958|NCT03422393|ibrutinib|ibrutinib
124959|NCT03422393|high-dose ibrutinib|high-dose ibrutinib
124960|NCT03422393|chronic lymphocytic leukemia|chronic lymphocytic leukemia
124961|NCT03422393|progressive disease|progressive disease
124962|NCT03422393|Small Lymphocytic Lymphoma|small lymphocytic lymphoma
124963|NCT03422393|cancer|cancer
124964|NCT03422380|energy expenditure|energy expenditure
124965|NCT03422380|adaptive thermogenesis|adaptive thermogenesis
124966|NCT03422380|metabolic adaptation|metabolic adaptation
124967|NCT03422380|weight loss maintenance|weight loss maintenance
124968|NCT03422367|autism|autism
124969|NCT03422367|epilepsy|epilepsy
124970|NCT03422367|asd|asd
124971|NCT03422367|TSC|tsc
124972|NCT03422367|UCLA|ucla
124973|NCT03422367|Los Angeles|los angeles
124974|NCT03422367|JASPER|jasper
124975|NCT03422367|intervention|intervention
124976|NCT03422367|Boston|boston
124977|NCT03422367|BCH|bch
124978|NCT03422367|MGH|mgh
124979|NCT03422328|macitentan|macitentan
124980|NCT03422328|long-term safety|long-term safety
124981|NCT03422328|open-label|open-label
124982|NCT03422328|single-arm|single-arm
124983|NCT03422315|Propofol|propofol
124984|NCT03422315|Population pharmacokinetics|population pharmacokinetics
124985|NCT03422315|Individualized administration|individualized administration
124986|NCT03422289|myo-inositol|myo-inositol
124987|NCT03422289|alpha-lactalbumin|alpha-lactalbumin
124988|NCT03422289|anovulation|anovulation
124989|NCT03422289|infertility|infertility
124990|NCT03422276|Transition|transition
124991|NCT03422276|Rehabilitation Discharge|rehabilitation discharge
124992|NCT03422263|Type 2 diabetes mellitus, SGLT-2-Inhibitors, Empagliflozin, Canagliflozin, Dapagliflozin, 6-minute walk test.|type 2 diabetes mellitus, sglt-2-inhibitors, empagliflozin, canagliflozin, dapagliflozin, 6-minute walk test.
124993|NCT03422172|GSK1265744|gsk1265744
124994|NCT03422172|Pre-Exposure Prophylaxis|pre-exposure prophylaxis
124995|NCT03422172|Human immunodeficiency virus|human immunodeficiency virus
124996|NCT03422172|Cabotegravir|cabotegravir
124997|NCT03422172|Pharmacokinetics|pharmacokinetics
124998|NCT03422120|Immune Suppression|immune suppression
124999|NCT03422120|Natural Killer Cell Mediated Immunity|natural killer cell mediated immunity
125000|NCT03422120|Natural Killer Cell Cytokine Production|natural killer cell cytokine production
125001|NCT03422120|Perioperative/Postoperative Complications|perioperative/postoperative complications
125002|NCT03422107|Peripheral Nerve Injuries|peripheral nerve injuries
125003|NCT03422107|Thoracic Surgery|thoracic surgery
125004|NCT03422107|Minimally invasive cardiac surgery|minimally invasive cardiac surgery
125005|NCT03422081|endothelial dysfunction|endothelial dysfunction
125006|NCT03422081|doppler ultrasound examination|doppler ultrasound examination
125007|NCT03422081|nitric oxide|nitric oxide
125008|NCT03422055|safety 99mTc-Fucoïdane scintigraphy|safety 99mtc-fucoïdane scintigraphy
125009|NCT03422029|ORR|orr
125010|NCT03422029|Safety|safety
125011|NCT03422029|PFS|pfs
125012|NCT03422016|electroretinogram|electroretinogram
125013|NCT03422003|Breast Cancer|breast cancer
125014|NCT03422003|Radiation|radiation
125015|NCT03422003|Hypofractionation|hypofractionation
125016|NCT03422003|Randomization|randomization
125017|NCT03421951|spine|spine
125018|NCT03421951|lower limb|lower limb
125019|NCT03421938|total knee arthroplasty|total knee arthroplasty
125020|NCT03421938|walking exercises|walking exercises
125021|NCT03421938|uphill-downhill walking exercises|uphill-downhill walking exercises
125022|NCT03421938|functional level|functional level
125023|NCT03421912|Prevention strategy|prevention strategy
125024|NCT03421912|Cutaneous toxicity|cutaneous toxicity
125025|NCT03421912|Quality of life|quality of life
125026|NCT03421912|Patient satisfaction|patient satisfaction
125027|NCT03421912|Dermatology Life Quality Index (DLQI)|dermatology life quality index (dlqi)
125028|NCT03421912|Epidermal Repair Score (SCOREPI)|epidermal repair score (scorepi)
125029|NCT03421912|Topical treatment|topical treatment
125030|NCT03421899|Mitochondria|mitochondria
125031|NCT03421899|Mitochondrial dysfunction|mitochondrial dysfunction
125032|NCT03421899|Parkin|parkin
125033|NCT03421899|PINK1|pink1
125034|NCT03421860|Spinal anesthesia|spinal anesthesia
125035|NCT03421860|cardiac output|cardiac output
125036|NCT03421860|vasopressor|vasopressor
125037|NCT03421847|depression|depression
125038|NCT03421847|vestibular disorder|vestibular disorder
125039|NCT03421847|rotatory test|rotatory test
125040|NCT03421847|electronystagmography|electronystagmography
125041|NCT03421834|Ventricular Tachycardia|ventricular tachycardia
125042|NCT03421834|Ischemic Cardiomyopathy|ischemic cardiomyopathy
125043|NCT03421834|Primary prevention|primary prevention
125044|NCT03421834|Heart Failure|heart failure
125045|NCT03421821|quadratus lumborum block|quadratus lumborum block
125046|NCT03421821|anterior thoracolumbar fascia|anterior thoracolumbar fascia
125047|NCT03421821|subfascial injection|subfascial injection
125048|NCT03421821|extrafascial injection|extrafascial injection
125049|NCT03421808|TMS|tms
125050|NCT03421808|transcranial magnetic stimulation|transcranial magnetic stimulation
125051|NCT03421808|brain stimulation|brain stimulation
125052|NCT03421795|pain assessment/management|pain assessment/management
125053|NCT03421795|developmental disabilities|developmental disabilities
125054|NCT03421795|children|children
125055|NCT03421795|education|education
125056|NCT03421795|respite workers|respite workers
125057|NCT03421730|mild asthma|mild asthma
125058|NCT03421730|budesonide|budesonide
125059|NCT03421730|nebulizer|nebulizer
125060|NCT03421730|pediatric|pediatric
125061|NCT03421730|pharmacokinetics|pharmacokinetics
125062|NCT03421665|titanium wedge|titanium wedge
125063|NCT03421665|Evans|evans
125064|NCT03421665|Cotton|cotton
125065|NCT03421613|PHN, acute, herpes zoster|phn, acute, herpes zoster
125066|NCT03421600|image enhanced endoscopy|image enhanced endoscopy
125067|NCT03421600|colonoscopy|colonoscopy
125068|NCT03421600|colonic polyp|colonic polyp
125069|NCT03421600|colonic adenoma|colonic adenoma
125070|NCT03421535|Glenohumeral internal rotational deficit|glenohumeral internal rotational deficit
125071|NCT03421535|GIRD|gird
125072|NCT03421535|Sleeper stretch|sleeper stretch
125073|NCT03421535|SI joint stretch|si joint stretch
125074|NCT03421522|PPSP|ppsp
125075|NCT03421522|ICBN|icbn
125076|NCT03421509|cutaneous silent period|cutaneous silent period
125077|NCT03421509|spasticity|spasticity
125078|NCT03421509|stroke|stroke
125079|NCT03421483|Folate|folate
125080|NCT03421483|Absorption|absorption
125081|NCT03421483|Metabolism|metabolism
125082|NCT03421483|Colon|colon
125083|NCT03421483|Receptor|receptor
125084|NCT03421483|Enzyme|enzyme
125085|NCT03421457|Pelvic Organ Prolapse|pelvic organ prolapse
125086|NCT03421457|Translabial ultrasound|translabial ultrasound
125087|NCT03421457|Transperineal ultrasound|transperineal ultrasound
125088|NCT03421457|Lateral Mesh Suspension|lateral mesh suspension
125089|NCT03421457|Descensus uteri|descensus uteri
125090|NCT03421457|Laparoscopic pelvic organ prolapse repair|laparoscopic pelvic organ prolapse repair
125091|NCT03421457|Uterus preserving|uterus preserving
125092|NCT03421457|hysteropexy|hysteropexy
125093|NCT03421457|uterine-preserving|uterine-preserving
125094|NCT03421457|fertility-sparing|fertility-sparing
125095|NCT03421457|sacropexy|sacropexy
125096|NCT03421457|cervicopexy|cervicopexy
125097|NCT03421457|sacrocervicopexy|sacrocervicopexy
125098|NCT03421457|sacrohysteropexy|sacrohysteropexy
125099|NCT03421457|mesh prolapse surgery|mesh prolapse surgery
125100|NCT03421444|Children|children
125101|NCT03421444|Obesity|obesity
125102|NCT03421444|Metabolic Disease|metabolic disease
125103|NCT03421431|NASH|nash
125104|NCT03421431|Non-Alcoholic Steatohepatitis (NASH)|non-alcoholic steatohepatitis (nash)
125105|NCT03421392|constitutive thrombocytopenia|constitutive thrombocytopenia
125106|NCT03421392|central thrombocytopenia|central thrombocytopenia
125107|NCT03421392|platelets|platelets
125108|NCT03421392|sialylation|sialylation
125109|NCT03421392|flow cytometry|flow cytometry
125110|NCT03421366|posaconazole|posaconazole
125111|NCT03421353|AZD9150|azd9150
125112|NCT03421353|Durvalumab|durvalumab
125113|NCT03421353|Advanced solid tumours|advanced solid tumours
125114|NCT03421340|ERCP|ercp
125115|NCT03421340|DSC|dsc
125116|NCT03421340|Spy Glass|spy glass
125117|NCT03421340|Biliary Stones|biliary stones
125118|NCT03421340|Choledocholithiasis|choledocholithiasis
125119|NCT03421340|Non-Complex|non-complex
125120|NCT03421340|Stones|stones
125121|NCT03421301|gut microbiota|gut microbiota
125122|NCT03421301|functional foods|functional foods
125123|NCT03421301|branched chain amino acids|branched chain amino acids
125124|NCT03421301|TMAO|tmao
125125|NCT03421301|type 2 diabetes|type 2 diabetes
125126|NCT03421275|fentanyl|fentanyl
125127|NCT03421275|esketamine|esketamine
125128|NCT03421275|ketamine|ketamine
125129|NCT03421275|analgesia|analgesia
125130|NCT03421275|acute pain|acute pain
125131|NCT03421275|minor trauma|minor trauma
125132|NCT03421184|autoimmune disease|autoimmune disease
125133|NCT03421184|endocrine disruptors|endocrine disruptors
125134|NCT03421184|isoflavones|isoflavones
125135|NCT03421184|lignans|lignans
125136|NCT03421184|diet exposure|diet exposure
125137|NCT03421184|risk factor|risk factor
125138|NCT03421158|neonates|neonates
125139|NCT03421158|Non-pharmacological|non-pharmacological
125140|NCT03421119|type 2 diabetes|type 2 diabetes
125141|NCT03421119|liraglutide|liraglutide
125142|NCT03421119|efficacy|efficacy
125143|NCT03421119|safety|safety
125144|NCT03421106|Food insecurity|food insecurity
125145|NCT03421106|Food pantries|food pantries
125146|NCT03421093|Lung cancer|lung cancer
125147|NCT03421093|Chinese|chinese
125148|NCT03421093|surgeries|surgeries
125149|NCT03421093|adjuvant therapies|adjuvant therapies
125150|NCT03421015|localized prostate cancer|localized prostate cancer
125252|NCT03420313|waitlist|waitlist
125151|NCT03421015|prostatectomy|prostatectomy
125152|NCT03421015|biomarkers|biomarkers
125153|NCT03421015|metastatic recurrence|metastatic recurrence
125154|NCT03421015|genomic|genomic
125155|NCT03421002|candida meningitis|candida meningitis
125156|NCT03421002|Mycamine|mycamine
125157|NCT03421002|candidiasis, systemic|candidiasis, systemic
125158|NCT03421002|micafungin|micafungin
125159|NCT03420989|carob|carob
125160|NCT03420989|seaweed|seaweed
125161|NCT03420989|snack food|snack food
125162|NCT03420989|obese subjects|obese subjects
125163|NCT03420976|Small Intestinal Bacterial Overgrowth|small intestinal bacterial overgrowth
125164|NCT03420976|SIBO|sibo
125165|NCT03420937|deep neuromuscular block|deep neuromuscular block
125166|NCT03420937|laparoscopic surgery|laparoscopic surgery
125167|NCT03420937|robotic surgery|robotic surgery
159669|NCT03200197|Saliva|saliva
125168|NCT03420937|lung protective ventilation|lung protective ventilation
125169|NCT03420937|respiratory functions|respiratory functions
125170|NCT03420937|post-operative recovery|post-operative recovery
125171|NCT03420924|intraoperative hypothermia|intraoperative hypothermia
125172|NCT03420924|thermal suit|thermal suit
125173|NCT03420924|forced-air warming|forced-air warming
125174|NCT03420911|pain|pain
125175|NCT03420911|anxiety|anxiety
125176|NCT03420911|emergency department|emergency department
125177|NCT03420911|pain management|pain management
125178|NCT03420885|Ba Duan Jin|ba duan jin
125179|NCT03420885|Pulmonary Nodules|pulmonary nodules
125180|NCT03420885|Clinical Intervention|clinical intervention
125181|NCT03420872|Nutrition|nutrition
125182|NCT03420872|Nutrients|nutrients
125183|NCT03420872|Mixtures|mixtures
125184|NCT03420872|Neurodevelopment|neurodevelopment
125185|NCT03420872|Prenatal|prenatal
125186|NCT03420872|Children|children
125187|NCT03420820|intravitreal injection|intravitreal injection
125188|NCT03420820|povidone-iodine|povidone-iodine
125189|NCT03420820|ocular surface flora|ocular surface flora
125190|NCT03420820|endophthalmitis|endophthalmitis
125191|NCT03420820|betadine|betadine
125192|NCT03420781|diabetic gastroparesis|diabetic gastroparesis
125193|NCT03420781|vomiting|vomiting
125194|NCT03420742|Drug therapy, brigatinib, lung cancer, ALK, ROS1|drug therapy, brigatinib, lung cancer, alk, ros1
125195|NCT03420716|functional foods|functional foods
125196|NCT03420716|dairy foods|dairy foods
125197|NCT03420716|calcium absorption|calcium absorption
125198|NCT03420716|prebiotics and probiotics|prebiotics and probiotics
125199|NCT03420716|young women|young women
125200|NCT03420716|bone health|bone health
125201|NCT03420703|erector spinae plane block|erector spinae plane block
125202|NCT03420703|laparoscopic cholecystectomy|laparoscopic cholecystectomy
125203|NCT03420703|postoperative pain|postoperative pain
125204|NCT03420664|cast|cast
125205|NCT03420664|orthosis|orthosis
125206|NCT03420664|immobilisation|immobilisation
125207|NCT03420664|venous stasis|venous stasis
125208|NCT03420664|circulation|circulation
125209|NCT03420638|Adults|adults
125210|NCT03420638|Pain|pain
125211|NCT03420625|Intermittent Pneumatic Compression Devices|intermittent pneumatic compression devices
125212|NCT03420625|Electric Stimulation Therapy|electric stimulation therapy
125213|NCT03420625|Blood Flow Velocity|blood flow velocity
125214|NCT03420625|Hemodynamics|hemodynamics
125215|NCT03420599|Gut microbiota|gut microbiota
125216|NCT03420599|Splenectomy|splenectomy
125217|NCT03420599|Infection|infection
125218|NCT03420599|Immune|immune
125219|NCT03420599|Cytokines|cytokines
125220|NCT03420586|Anesthetics, Inhalation|anesthetics, inhalation
125221|NCT03420586|Anesthesia Recovery Period|anesthesia recovery period
125222|NCT03420586|Postoperative Nausea and Vomiting|postoperative nausea and vomiting
125223|NCT03420586|Pain, Postoperative|pain, postoperative
125224|NCT03420508|Ensartinib|ensartinib
125225|NCT03420508|ALK Inhibitor|alk inhibitor
125226|NCT03420508|ALK Alterations|alk alterations
125227|NCT03420508|Aberrant ALK Expression|aberrant alk expression
125228|NCT03420508|17-471|17-471
125230|NCT03420495|Intolerance of Uncertainty|intolerance of uncertainty
125231|NCT03420482|Microbiome|microbiome
125232|NCT03420482|Fecal Microbiota Transplant|fecal microbiota transplant
125233|NCT03420443|radiotherapy, probiotics|radiotherapy, probiotics
125234|NCT03420417|Mechanical ventilation|mechanical ventilation
125235|NCT03420391|phototherapy|phototherapy
125236|NCT03420391|performance|performance
125237|NCT03420391|muscular recovery|muscular recovery
125238|NCT03420391|photobiomodulation therapy|photobiomodulation therapy
125239|NCT03420391|time-window|time-window
125240|NCT03420378|Central Sensitisation|central sensitisation
125241|NCT03420378|Cutaneous Silent Period|cutaneous silent period
125242|NCT03420378|Vitamin D Deficiency|vitamin d deficiency
125243|NCT03420339|stimulant medication|stimulant medication
125244|NCT03420339|behavioral function|behavioral function
125245|NCT03420339|preferences|preferences
125246|NCT03420339|delay discounting|delay discounting
125247|NCT03420326|Atrial Fibrillation|atrial fibrillation
125248|NCT03420326|Frailty status|frailty status
125249|NCT03420326|Body composition|body composition
125250|NCT03420326|Sarcopenia|sarcopenia
125251|NCT03420313|buprenorphine|buprenorphine
125253|NCT03420313|interim treatment|interim treatment
125254|NCT03420313|opioid use disorder|opioid use disorder
125255|NCT03420300|Hepatitis C virus|hepatitis c virus
125256|NCT03420300|Hemodialysis|hemodialysis
125257|NCT03420300|Direct acting antiviral agent|direct acting antiviral agent
125258|NCT03420274|Shared decision-making|shared decision-making
125259|NCT03420274|Prenatal genetic testing|prenatal genetic testing
125260|NCT03420274|Noninvasive prenatal testing (NIPT)|noninvasive prenatal testing (nipt)
125261|NCT03420274|Cell free fetal DNA (cfDNA)|cell free fetal dna (cfdna)
125262|NCT03420274|Informed consent|informed consent
125263|NCT03420261|Goal-directed therapy|goal-directed therapy
125264|NCT03420261|Fluid loading|fluid loading
125265|NCT03420261|Abdominal surgery|abdominal surgery
125266|NCT03420261|Postoperative morbidity|postoperative morbidity
125267|NCT03420261|Postoperative mortality|postoperative mortality
125268|NCT03420261|Individualized goal-directed fluid therapy|individualized goal-directed fluid therapy
125269|NCT03420261|Elective or emergency abdominal surgery|elective or emergency abdominal surgery
125270|NCT03420261|General Anesthesia|general anesthesia
125271|NCT03420261|Moderate-to-high risk surgical patients|moderate-to-high risk surgical patients
125272|NCT03420235|quality of life|quality of life
125274|NCT03420235|patient-reported outcomes|patient-reported outcomes
125275|NCT03420235|home spirometry|home spirometry
125276|NCT03420235|cost-effectiveness|cost-effectiveness
125277|NCT03420235|home monitoring|home monitoring
125278|NCT03420222|Intermittent Explosive Disorder|intermittent explosive disorder
125279|NCT03420222|AVP-786|avp-786
125280|NCT03420209|proprioceptive neuromuscular facilitation|proprioceptive neuromuscular facilitation
125281|NCT03420209|respiratory functions|respiratory functions
125282|NCT03420209|elastic band|elastic band
125283|NCT03420209|posture|posture
125284|NCT03420196|low back pain|low back pain
125285|NCT03420196|physical therapy|physical therapy
125286|NCT03420196|randomized clinical trial|randomized clinical trial
125287|NCT03420196|exercise program|exercise program
125288|NCT03420170|Spinal Cord Injuries|spinal cord injuries
125289|NCT03420170|Physical Fitness|physical fitness
125290|NCT03420170|Exercise Self-Efficacy|exercise self-efficacy
125291|NCT03420170|Physical Activity|physical activity
125292|NCT03420157|Cervical cancer screening|cervical cancer screening
125293|NCT03420157|vaginal self-sampling|vaginal self-sampling
125294|NCT03420157|Focus group|focus group
125295|NCT03420157|communication|communication
125296|NCT03420144|Growth hormone|growth hormone
125297|NCT03420144|cirrhosis|cirrhosis
125298|NCT03420131|instantaneous Flow Ratio|instantaneous flow ratio
125299|NCT03420131|Quantitative Flow Ratio|quantitative flow ratio
125300|NCT03420131|Fractional Flow Reserve|fractional flow reserve
125301|NCT03420092|vasoactive leukotrienes by leukocytes|vasoactive leukotrienes by leukocytes
125302|NCT03420092|bioavailability|bioavailability
125303|NCT03420053|PfSPZ Vaccine|pfspz vaccine
125304|NCT03420053|HIV+|hiv+
125305|NCT03420053|Plasmodium falciparum|plasmodium falciparum
125306|NCT03420053|Sporozoites|sporozoites
125307|NCT03420040|Glargine Insulin|glargine insulin
125308|NCT03420040|QS-M Needle Free Injector|qs-m needle free injector
125309|NCT03420027|predictive score|predictive score
125310|NCT03420027|difficult intubation|difficult intubation
125311|NCT03420001|VBAC, levator ani avulsion, quality of life|vbac, levator ani avulsion, quality of life
125312|NCT03419988|Nrf2|nrf2
125313|NCT03419949|pain|pain
125314|NCT03419936|Stomach Neoplasms|stomach neoplasms
125315|NCT03419936|Helicobacter pylori|helicobacter pylori
125316|NCT03419936|Subtotal gastrectomy|subtotal gastrectomy
125317|NCT03419897|Advanced liver cancer|advanced liver cancer
125318|NCT03419897|RATIONALE-208|rationale-208
125319|NCT03419871|economically stressed communities|economically stressed communities
125320|NCT03419858|Pain|pain
125321|NCT03419858|Slow-Breathing|slow-breathing
125322|NCT03419858|Mindfulness|mindfulness
125323|NCT03419858|Opioids|opioids
125324|NCT03419858|Placebo|placebo
125325|NCT03419832|ARIC|aric
125326|NCT03419819|Phenylketonuria|phenylketonuria
125327|NCT03419819|GMP|gmp
125328|NCT03419819|Sphere|sphere
125329|NCT03419819|Child|child
125330|NCT03419819|Adult|adult
125331|NCT03419819|Phenylalanine|phenylalanine
125332|NCT03419819|PKU|pku
125333|NCT03419819|Glycomacropeptide|glycomacropeptide
125334|NCT03419767|carotid stenosis|carotid stenosis
125335|NCT03419767|melatonin|melatonin
125336|NCT03419767|insulin resistance|insulin resistance
125337|NCT03419767|inflammation|inflammation
125338|NCT03419767|carotid revascularization|carotid revascularization
125339|NCT03419767|antioxidants|antioxidants
125340|NCT03419741|Cancer, Nicotine Addiction, Smoking Cessation|cancer, nicotine addiction, smoking cessation
125341|NCT03419728|Teen pregnancy prevention|teen pregnancy prevention
125342|NCT03419728|Long-acting reversible contraception (LARCs)|long-acting reversible contraception (larcs)
125343|NCT03419728|Healthy Families Healthy Futures|healthy families healthy futures
125344|NCT03419728|Home visiting|home visiting
125345|NCT03419715|migraine|migraine
125346|NCT03419715|headache|headache
125347|NCT03419715|bimatoprost|bimatoprost
125348|NCT03419676|Pancreatoduodenectomy|pancreatoduodenectomy
125349|NCT03419676|Postoperative pancreatic fistula|postoperative pancreatic fistula
125350|NCT03419676|Sealant|sealant
125351|NCT03419676|Hemopatch|hemopatch
125352|NCT03419663|cereal|cereal
125353|NCT03419663|whole grain|whole grain
125354|NCT03419663|refined grain|refined grain
125355|NCT03419663|gastric cancer|gastric cancer
125356|NCT03419663|meta analysis|meta analysis
125357|NCT03419650|PsA|psa
125358|NCT03419624|Dapagliflozin|dapagliflozin
125359|NCT03419624|Exenatide|exenatide
125360|NCT03419624|high-dose insulin therapy|high-dose insulin therapy
125361|NCT03419624|SGLT-2 inhibitor|sglt-2 inhibitor
159933|NCT03198533|Knee|knee
125362|NCT03419624|GLP-1 receptor agonist|glp-1 receptor agonist
125363|NCT03419611|Communication Intervention|communication intervention
125364|NCT03419598|virtual clinical trial|virtual clinical trial
125365|NCT03419598|high tibial osteotomy|high tibial osteotomy
125366|NCT03419598|3D|3d
125367|NCT03419598|computer simulation|computer simulation
125368|NCT03419598|finite element analysis|finite element analysis
125369|NCT03419598|medial unicompartmental knee osteoarthritis|medial unicompartmental knee osteoarthritis
125370|NCT03419559|LN-145|ln-145
125371|NCT03419559|Cell Therapy|cell therapy
125372|NCT03419559|Autologous Adoptive Cell Transfer|autologous adoptive cell transfer
125373|NCT03419559|Cellular Immuno-therapy|cellular immuno-therapy
125374|NCT03419559|TIL|til
125375|NCT03419559|IL-2|il-2
125376|NCT03419559|Durvalumab|durvalumab
125377|NCT03419520|Schoolchildren|schoolchildren
125378|NCT03419520|Overweight|overweight
125379|NCT03419520|Obesity|obesity
125380|NCT03419520|Polymorphisms|polymorphisms
125381|NCT03419520|Genetics|genetics
125382|NCT03419520|Nutritional counseling|nutritional counseling
125383|NCT03419520|Healthy strategies|healthy strategies
125384|NCT03419507|endotracheal tube introducer|endotracheal tube introducer
125385|NCT03419507|manikin|manikin
125386|NCT03419507|chest compression|chest compression
125387|NCT03419455|Obesity|obesity
125388|NCT03419455|Lifelong Obesity|lifelong obesity
125389|NCT03419455|Metabolic abnormalties|metabolic abnormalties
125390|NCT03419455|Low-grade chronic inflammation|low-grade chronic inflammation
125391|NCT03419455|Hyperinsulinemia|hyperinsulinemia
125392|NCT03419455|IGF signalling|igf signalling
125393|NCT03419455|Sex hormones|sex hormones
125394|NCT03419455|Inflammatory response|inflammatory response
125395|NCT03419455|Adipokines|adipokines
125396|NCT03419455|Diet|diet
125397|NCT03419442|Prostate cancer|prostate cancer
125398|NCT03419442|Bone metastases|bone metastases
125399|NCT03419442|Xofigo|xofigo
125400|NCT03419429|Guided tissue membranes|guided tissue membranes
125401|NCT03419429|EDTA|edta
125402|NCT03419429|Simvastatin|simvastatin
125403|NCT03419403|Glioblastoma Multiforme (GBM)|glioblastoma multiforme (gbm)
125404|NCT03419403|cancer|cancer
125405|NCT03419403|chemoradiation therapy|chemoradiation therapy
125406|NCT03419403|epidermal growth factor receptor-amplified glioblastoma|epidermal growth factor receptor-amplified glioblastoma
125407|NCT03419403|radiation|radiation
125408|NCT03419403|temozolomide|temozolomide
125409|NCT03419390|Hydra01|hydra01
125410|NCT03419377|Treatment|treatment
125411|NCT03419377|Quality of Life|quality of life
125412|NCT03419377|Sexology|sexology
125413|NCT03419377|Women|women
125414|NCT03419338|Maxillary Sinus|maxillary sinus
125415|NCT03419338|Sinus lifting|sinus lifting
125416|NCT03419338|Bone graft|bone graft
125417|NCT03419325|percutaneous coronary interventions (PCI)|percutaneous coronary interventions (pci)
125418|NCT03419325|secondary stroke prevention|secondary stroke prevention
125419|NCT03419325|dual antiplatelet therapy (DAPT)|dual antiplatelet therapy (dapt)
125420|NCT03419312|Spinal Cord Stimulation|spinal cord stimulation
125421|NCT03419312|Burst Spinal Cord Stimulation|burst spinal cord stimulation
125422|NCT03419312|SCS|scs
125423|NCT03419260|seizures|seizures
125424|NCT03419260|status epilepticus|status epilepticus
125425|NCT03419260|EEG monitoring|eeg monitoring
125426|NCT03419221|Staphylococcus aureus|staphylococcus aureus
125427|NCT03419221|bloodstream infection|bloodstream infection
125428|NCT03419221|deep foci of infection|deep foci of infection
125429|NCT03419221|18 FDG PET/CT|18 fdg pet/ct
125430|NCT03419221|antibiotics|antibiotics
125431|NCT03419208|Systemic Sclerosis|systemic sclerosis
125432|NCT03419208|Scleroderma|scleroderma
125433|NCT03419208|Hand Function|hand function
125434|NCT03419208|Intervention|intervention
125435|NCT03419208|Exercise|exercise
125436|NCT03419208|Telerehabilitation|telerehabilitation
125437|NCT03419208|eHealth|ehealth
125438|NCT03419208|Physical Therapy|physical therapy
125439|NCT03419195|Type 2 Diabetes|type 2 diabetes
125440|NCT03419195|Overweight|overweight
125441|NCT03419195|Exercise Training|exercise training
125442|NCT03419195|Exercise Impairment|exercise impairment
125443|NCT03419195|Healthy Control|healthy control
125444|NCT03419195|Veteran|veteran
125445|NCT03419195|Blood Flow|blood flow
125446|NCT03419182|Geriatric|geriatric
125447|NCT03419182|Acetabular|acetabular
125448|NCT03419182|Arthroplasty|arthroplasty
125449|NCT03419169|Patient|patient
125450|NCT03419169|Rehabilitation|rehabilitation
125451|NCT03419169|Ligament reconstruction|ligament reconstruction
125452|NCT03419169|Surgery|surgery
125453|NCT03419156|text message|text message
125454|NCT03419156|telemedicine|telemedicine
125455|NCT03419104|bariatric surgery|bariatric surgery
125456|NCT03419104|extubation|extubation
125457|NCT03419091|ureteroscopy|ureteroscopy
125458|NCT03419091|lithovue|lithovue
125459|NCT03419091|nephrolithiasis|nephrolithiasis
125460|NCT03419091|single use ureteroscope|single use ureteroscope
125461|NCT03419078|enteral nutrition|enteral nutrition
125462|NCT03419078|parenteral nutrition|parenteral nutrition
125463|NCT03419078|artificial nutrition support|artificial nutrition support
125464|NCT03419078|non-relapse mortality|non-relapse mortality
125465|NCT03419078|survival|survival
125466|NCT03419039|Mild Cognitive Impairment|mild cognitive impairment
125467|NCT03419000|GTCS|gtcs
125468|NCT03419000|Epilepsies, Partial|epilepsies, partial
125469|NCT03419000|Drug Resistant Epilepsy|drug resistant epilepsy
125470|NCT03419000|Circulating MicroRNA|circulating microrna
125471|NCT03419000|Diagnostic|diagnostic
125472|NCT03418987|3D imaging|3d imaging
125473|NCT03418987|vertebral vector|vertebral vector
125474|NCT03418987|Scoliosis|scoliosis
125475|NCT03418974|Dyslipidemia|dyslipidemia
125476|NCT03418974|Cardiovascular Diseases|cardiovascular diseases
125477|NCT03418974|Hypertension|hypertension
125478|NCT03418974|LDL-C|ldl-c
125479|NCT03418935|obstructive jaundice, non-malignant|obstructive jaundice, non-malignant
125480|NCT03418935|mechanical jaundice, non-malignant|mechanical jaundice, non-malignant
125481|NCT03418935|Methionine|methionine
125482|NCT03418935|Succinic acid|succinic acid
125483|NCT03418883|Stroke|stroke
125484|NCT03418883|rehabilitation|rehabilitation
125485|NCT03418883|mirror therapy|mirror therapy
125486|NCT03418883|upper limb|upper limb
125487|NCT03418870|Intensive Care Units, Neonatal|intensive care units, neonatal
125488|NCT03418870|Parents|parents
125489|NCT03418870|Mobile application|mobile application
125490|NCT03418857|probiotics|probiotics
125491|NCT03418857|Human|human
125492|NCT03418857|obesity|obesity
125493|NCT03418857|non-pharmacologic therapy|non-pharmacologic therapy
125494|NCT03418857|gut health|gut health
125495|NCT03418857|microbiome|microbiome
125496|NCT03418857|inflammation|inflammation
125497|NCT03418831|negtive symptoms|negtive symptoms
125498|NCT03418831|cognitive function|cognitive function
125499|NCT03418818|hypoxia|hypoxia
125500|NCT03418818|sarcoma|sarcoma
125501|NCT03418818|FAZA|faza
125502|NCT03418818|PET Imaging|pet imaging
125503|NCT03418805|Ibuprofen|ibuprofen
125504|NCT03418805|Controlled-Release|controlled-release
125505|NCT03418805|pain control|pain control
125506|NCT03418805|Healthy Volunteers|healthy volunteers
125507|NCT03418805|Food Effect|food effect
125508|NCT03418779|IgA nephropathy|iga nephropathy
125509|NCT03418779|immunosuppressive therapy|immunosuppressive therapy
125510|NCT03418779|Yi-Qi-Qing-Jie herbal compound|yi-qi-qing-jie herbal compound
125511|NCT03418779|high-risk IgAN|high-risk igan
125512|NCT03418779|traditional chinese medicine|traditional chinese medicine
125513|NCT03418766|Right-to-left Shunt|right-to-left shunt
125514|NCT03418766|Brain White Matter Lesions|brain white matter lesions
125515|NCT03418766|Migraine|migraine
125516|NCT03418753|noninvasive diagnosis|noninvasive diagnosis
125517|NCT03418740|Friedreich|friedreich
125518|NCT03418740|Ataxia|ataxia
125519|NCT03418740|FRDA|frda
125520|NCT03418740|FA|fa
125521|NCT03418740|Friedrich Ataxia (FRDA)|friedrich ataxia (frda)
125522|NCT03418701|Women's health|women's health
125523|NCT03418662|Colonoscopy|colonoscopy
125524|NCT03418649|low back pain|low back pain
125525|NCT03418649|radicular pain|radicular pain
125526|NCT03418649|degenerative disc disease|degenerative disc disease
125527|NCT03418636|People who inject drugs|people who inject drugs
125528|NCT03418636|Hepatitis C prevention|hepatitis c prevention
125529|NCT03418636|Young adults|young adults
125530|NCT03418636|Behavioral interventions|behavioral interventions
125531|NCT03418623|Glutamate|glutamate
125532|NCT03418623|Alcohol use|alcohol use
125533|NCT03418623|GABA|gaba
125534|NCT03418623|GET73|get73
125535|NCT03418623|Non-treatment seeking|non-treatment seeking
125536|NCT03418610|Rosacea|rosacea
125537|NCT03418597|Virtual reality|virtual reality
125538|NCT03418597|Radio-guided biopsy|radio-guided biopsy
125539|NCT03418597|Pain|pain
125540|NCT03418597|Anxiety|anxiety
125541|NCT03418597|Patient's satisfaction|patient's satisfaction
125542|NCT03418584|argon plasma coagulation|argon plasma coagulation
125543|NCT03418584|submucosal injection|submucosal injection
125544|NCT03418584|Barrett Esophagus|barrett esophagus
125545|NCT03418558|HER2 AMPLIFICATION|her2 amplification
125546|NCT03418532|DARPin®protein|darpin®protein
125547|NCT03418532|MP0250|mp0250
125548|NCT03418532|VEGF|vegf
125549|NCT03418532|HGF|hgf
125550|NCT03418532|NSCLC|nsclc
125551|NCT03418532|EGFR mutated|egfr mutated
125552|NCT03418532|Osimertinib|osimertinib
125553|NCT03418506|Smokeless tobacco|smokeless tobacco
125554|NCT03418506|adolescent|adolescent
125555|NCT03418506|oral cancer|oral cancer
125556|NCT03418506|betal quid|betal quid
125557|NCT03418506|areca nut|areca nut
125558|NCT03418467|Tachycardiomyopathy|tachycardiomyopathy
125559|NCT03418467|atrial fibrillation|atrial fibrillation
125560|NCT03418467|EMID (enrichment of mitochondria at the intercalated discs)|emid (enrichment of mitochondria at the intercalated discs)
125561|NCT03418467|Biopsy|biopsy
125562|NCT03418467|empathy|empathy
125563|NCT03418441|Nationwide prospective observational cohort study|nationwide prospective observational cohort study
125564|NCT03418441|Epidemiology|epidemiology
125565|NCT03418441|Central Nervous System Infections|central nervous system infections
125566|NCT03418441|Meningitis|meningitis
125567|NCT03418441|Encephalitis|encephalitis
125568|NCT03418441|Brain abscess|brain abscess
125569|NCT03418441|Lyme disease|lyme disease
125570|NCT03418441|Neuroborreliosis|neuroborreliosis
125571|NCT03418441|Neurosyphilis|neurosyphilis
125572|NCT03418441|Tertiary syphilis|tertiary syphilis
125573|NCT03418363|Oral contraceptives|oral contraceptives
125574|NCT03418363|Venous thromboembolism|venous thromboembolism
125575|NCT03418363|androgenic combined oral contraception|androgenic combined oral contraception
125576|NCT03418337|cough, dexlansoprazole, GERD, globus, non-cardiac chest pain|cough, dexlansoprazole, gerd, globus, non-cardiac chest pain
125577|NCT03418324|Prostate Cancer|prostate cancer
125578|NCT03418324|Metastatic Prostate Cancer|metastatic prostate cancer
125579|NCT03418324|Castration Resistant Prostate Cancer|castration resistant prostate cancer
125580|NCT03418324|Metastatic Castration Resistant|metastatic castration resistant
125581|NCT03418311|Twin pregnancy|twin pregnancy
125582|NCT03418311|Cervical Pessary|cervical pessary
125583|NCT03418311|short cervix|short cervix
125584|NCT03418311|Prevention|prevention
125586|NCT03418272|OR|or
125587|NCT03418272|Pneumonia|pneumonia
125588|NCT03418272|PICU|picu
125589|NCT03418272|Pediatric|pediatric
125590|NCT03418272|PCR|pcr
125591|NCT03418246|gingiva|gingiva
125592|NCT03418246|plaque|plaque
125593|NCT03418246|pocket depth|pocket depth
125594|NCT03418220|Age related Macular Degeneration|age related macular degeneration
125595|NCT03418220|Atrophy|atrophy
125596|NCT03418220|Inflammation|inflammation
125597|NCT03418220|Cytokines|cytokines
125598|NCT03418220|test LUMINEX®|test luminex®
125599|NCT03418207|TPS system|tps system
125600|NCT03418207|trans-perineal template-guided mapping biopsy|trans-perineal template-guided mapping biopsy
125601|NCT03418207|prostate cancer|prostate cancer
125602|NCT03418207|spatial distribution|spatial distribution
125603|NCT03418207|large tissue slice|large tissue slice
125604|NCT03418194|Anesthesia, General|anesthesia, general
125605|NCT03418181|Residual Kidney Function|residual kidney function
125606|NCT03418181|Haemodialysis|haemodialysis
125607|NCT03418181|Preserve Residual Kidney Function|preserve residual kidney function
125608|NCT03418129|Military Veterans|military veterans
125609|NCT03418051|Ankle Instability|ankle instability
125610|NCT03418051|Manual Therapy|manual therapy
125611|NCT03418051|Massage|massage
125612|NCT03418051|Ankle Joint Mobilization|ankle joint mobilization
125613|NCT03418051|Biomechanics|biomechanics
125614|NCT03418051|Neuromuscular|neuromuscular
125615|NCT03418012|Cervical Pessary|cervical pessary
125616|NCT03418012|Short Cervix|short cervix
125617|NCT03418012|Recurrent Preterm Birth|recurrent preterm birth
125618|NCT03418012|history of cervical surgery|history of cervical surgery
125619|NCT03418012|history of conisation|history of conisation
125620|NCT03417999|Intranasal|intranasal
125621|NCT03417999|Pharmacokinetic|pharmacokinetic
125622|NCT03417999|Pediatric|pediatric
125623|NCT03417986|Thiethylperazine|thiethylperazine
125624|NCT03417986|Alzheimer Disease|alzheimer disease
125625|NCT03417973|dorsal root ganglion|dorsal root ganglion
125626|NCT03417960|post partum depression|post partum depression
125627|NCT03417960|theta burst|theta burst
125628|NCT03417960|transcranial magnetic stimulation|transcranial magnetic stimulation
125629|NCT03417947|Bolus supplementation|bolus supplementation
125630|NCT03417947|Pilot randomised controlled trial|pilot randomised controlled trial
125631|NCT03417947|Vitamin D|vitamin d
125632|NCT03417908|Proprioceptive neuromuscular facilitation|proprioceptive neuromuscular facilitation
125633|NCT03417908|Pulmonary Rehabilitation|pulmonary rehabilitation
125634|NCT03417908|muscle activation|muscle activation
125635|NCT03417908|COPD|copd
125636|NCT03417882|PD-L1+|pd-l1+
125637|NCT03417856|Ichthyosis|ichthyosis
125638|NCT03417856|Netherton Syndrome|netherton syndrome
125639|NCT03417843|ablation catheter|ablation catheter
125640|NCT03417843|pancreatic premalignant and early malignant cystic lesion|pancreatic premalignant and early malignant cystic lesion
125641|NCT03417830|miridesap|miridesap
125642|NCT03417830|GSK2315698|gsk2315698
125643|NCT03417830|89Zirconium labelled|89zirconium labelled
125644|NCT03417830|Positron Emission Tomography|positron emission tomography
125645|NCT03417830|Transthyretin cardiomyopathy|transthyretin cardiomyopathy
125646|NCT03417830|GSK2398852|gsk2398852
125647|NCT03417830|dezamizumab|dezamizumab
125648|NCT03417791|recovery|recovery
125649|NCT03417791|serum creatinine|serum creatinine
125650|NCT03417765|gastrointestinal mucositis|gastrointestinal mucositis
126429|NCT03412942|Comfort|comfort
125651|NCT03417765|myeloablative chemotherapy|myeloablative chemotherapy
125652|NCT03417765|autologous transplantation|autologous transplantation
125653|NCT03417739|Uveal Melanoma|uveal melanoma
125654|NCT03417726|Cerebral Palsy|cerebral palsy
125655|NCT03417726|Balance|balance
125656|NCT03417700|vitamin D|vitamin d
125657|NCT03417700|exercise|exercise
125658|NCT03417700|training|training
125659|NCT03417700|aging|aging
125660|NCT03417648|Rheumatoid Arthritis, Diet, Fat-Restricted, Diet, Vegetarian|rheumatoid arthritis, diet, fat-restricted, diet, vegetarian
125661|NCT03417635|Meditation|meditation
125662|NCT03417635|Cognitive assessment|cognitive assessment
125663|NCT03417635|Executive function|executive function
125664|NCT03417635|Older adults|older adults
125665|NCT03417635|Randomized control trial|randomized control trial
125666|NCT03417635|Mobility|mobility
125667|NCT03417622|resection margin|resection margin
125668|NCT03417622|neoadjuvant therapy|neoadjuvant therapy
125669|NCT03417622|breast conservative surgery|breast conservative surgery
125670|NCT03417622|locally advanced breast cancer|locally advanced breast cancer
125671|NCT03417609|Sarcopenia|sarcopenia
125672|NCT03417609|Tongue strength|tongue strength
125673|NCT03417544|HER2-positive metastatic Breast Cancer|her2-positive metastatic breast cancer
125674|NCT03417544|Central Nervous System Metastases|central nervous system metastases
125675|NCT03417531|Protein supplementation|protein supplementation
125676|NCT03417531|Home exercise program|home exercise program
125677|NCT03417531|Falls prevention|falls prevention
125678|NCT03417531|Seniors|seniors
125679|NCT03417531|Autonomy|autonomy
125680|NCT03417518|Oxidative stress|oxidative stress
125681|NCT03417518|Bariatric surgery|bariatric surgery
125682|NCT03417505|Contact lens discomfort|contact lens discomfort
125683|NCT03417505|Scleral lens|scleral lens
125684|NCT03417505|Tangible Hydra-PEG|tangible hydra-peg
125685|NCT03417492|TBI|tbi
125686|NCT03417492|CVR|cvr
125687|NCT03417492|Hypercapnia|hypercapnia
125688|NCT03417492|fNIRS|fnirs
125689|NCT03417492|functional magnetic resonance imaging (fMRI)|functional magnetic resonance imaging (fmri)
125690|NCT03417492|American football|american football
125691|NCT03417466|Diabetes Type I Type II|diabetes type i type ii
125692|NCT03417453|normal patients|normal patients
125693|NCT03417453|eye drops dispensers|eye drops dispensers
125694|NCT03417453|aids|aids
125695|NCT03417453|glacuoma|glacuoma
125696|NCT03417453|cataract|cataract
125697|NCT03417440|smartphone app, physical activity, older adults|smartphone app, physical activity, older adults
125698|NCT03417427|acute myeloid leukemia|acute myeloid leukemia
125699|NCT03417427|Intermediate-risk|intermediate-risk
125700|NCT03417427|demethylation drug|demethylation drug
125701|NCT03417427|complete remission|complete remission
125702|NCT03417388|Coronary Angiography|coronary angiography
125703|NCT03417388|Coronary CT Angiogram|coronary ct angiogram
125704|NCT03417388|Ischemia|ischemia
125705|NCT03417388|Non-obstructive CAD|non-obstructive cad
125706|NCT03417362|education|education
125707|NCT03417362|audiovisual|audiovisual
125708|NCT03417362|information|information
125709|NCT03417362|acceptability|acceptability
125710|NCT03417349|Acute Ischemic Stroke|acute ischemic stroke
125711|NCT03417349|Thrombectomy|thrombectomy
125712|NCT03417349|Aspiration Thrombectomy|aspiration thrombectomy
125713|NCT03417349|Observational study|observational study
125714|NCT03417310|closed reduction|closed reduction
125715|NCT03417310|locked intramedullary nailing|locked intramedullary nailing
125716|NCT03417284|Multiple Myeloma|multiple myeloma
125717|NCT03417284|MM|mm
125718|NCT03417284|Evomela|evomela
125719|NCT03417284|Melphalan|melphalan
125720|NCT03417284|Alkeran|alkeran
125721|NCT03417284|G-CSF|g-csf
125722|NCT03417284|Filgrastim|filgrastim
125723|NCT03417284|Neupogen|neupogen
125724|NCT03417284|Stem cell transplant|stem cell transplant
125725|NCT03417258|phytoestrogens|phytoestrogens
125726|NCT03417258|isoflavones|isoflavones
125727|NCT03417258|adenomatous polyps|adenomatous polyps
125728|NCT03417258|microbiome|microbiome
125729|NCT03417245|RNAi therapeutic|rnai therapeutic
125730|NCT03417245|Hemophilia A|hemophilia a
125731|NCT03417245|Hemophilia B|hemophilia b
125732|NCT03417245|Hemophilia A, Severe|hemophilia a, severe
125733|NCT03417245|Hemophilia B, Severe|hemophilia b, severe
125734|NCT03417245|Blood Coagulation Disorders, Inherited|blood coagulation disorders, inherited
125735|NCT03417245|Blood Coagulation Disorders|blood coagulation disorders
125736|NCT03417245|Hematologic Diseases|hematologic diseases
125737|NCT03417245|Coagulation Protein Disorders|coagulation protein disorders
125738|NCT03417245|Hemorrhagic Disorders|hemorrhagic disorders
125739|NCT03417245|Genetic Diseases, Inborn|genetic diseases, inborn
125740|NCT03417245|Genetic Diseases, X-Linked|genetic diseases, x-linked
125741|NCT03417245|Factor VIII|factor viii
125742|NCT03417245|Factor IX|factor ix
125743|NCT03417245|Coagulants|coagulants
125744|NCT03417245|Fitusiran|fitusiran
125745|NCT03417232|gingival recession|gingival recession
125746|NCT03417232|coronally advanced flap|coronally advanced flap
125747|NCT03417232|complete root coverage|complete root coverage
125748|NCT03417232|flap elevation|flap elevation
125749|NCT03417232|flap thickness|flap thickness
125750|NCT03417219|Caregivers|caregivers
125751|NCT03417219|Family|family
125752|NCT03417219|Veterans|veterans
125753|NCT03417219|Alzheimer Disease|alzheimer disease
125754|NCT03417219|Memory|memory
125755|NCT03417206|Pupillary Dilatation Reflex (PRD)|pupillary dilatation reflex (prd)
125756|NCT03417206|Intraoperative Blood Loss (IBL)|intraoperative blood loss (ibl)
125757|NCT03417206|Boezaart Bleeding Scale (BBS)|boezaart bleeding scale (bbs)
125758|NCT03417206|Spectral Entropy (SE)|spectral entropy (se)
125759|NCT03417206|Adequacy of Anaesthesia (AoA)|adequacy of anaesthesia (aoa)
125760|NCT03417206|Total Intravenous Anaesthesia (TIVA)|total intravenous anaesthesia (tiva)
125761|NCT03417206|Sevoflurane|sevoflurane
125762|NCT03417206|Desflurane|desflurane
125763|NCT03417193|Lidocaine|lidocaine
125764|NCT03417193|Dexmedetomidine|dexmedetomidine
125765|NCT03417193|Opioid-free|opioid-free
125766|NCT03417180|Surgical Pleth Index (SPI)|surgical pleth index (spi)
125767|NCT03417180|Intraoperative Blood Loss (IBL)|intraoperative blood loss (ibl)
125768|NCT03417180|Boezaart Bleeding Scale (BBS)|boezaart bleeding scale (bbs)
125769|NCT03417180|Spectral Entropy (SE)|spectral entropy (se)
125770|NCT03417180|Adequacy of Anaesthesia (AoA)|adequacy of anaesthesia (aoa)
125771|NCT03417180|Total Intravenous Anaesthesia (TIVA)|total intravenous anaesthesia (tiva)
125772|NCT03417180|Sevoflurane|sevoflurane
125773|NCT03417180|Desflurane|desflurane
125774|NCT03417167|synovial biopsy|synovial biopsy
125775|NCT03417167|US guided synovial biopsy|us guided synovial biopsy
125776|NCT03417154|AML|aml
125777|NCT03417154|MDS|mds
125778|NCT03417141|Valchor|valchor
125779|NCT03417115|Breast Cancer|breast cancer
125780|NCT03417115|Epidemiology|epidemiology
125781|NCT03417115|Registry|registry
125782|NCT03417115|Health Services Research|health services research
125783|NCT03417115|Germany|germany
125784|NCT03417115|Palliative Treatment|palliative treatment
125785|NCT03417102|RNAi therapeutic|rnai therapeutic
125786|NCT03417102|Hemophilia A|hemophilia a
125787|NCT03417102|Hemophilia B|hemophilia b
125788|NCT03417102|Hemophilia A, Severe|hemophilia a, severe
125789|NCT03417102|Hemophilia B, Severe|hemophilia b, severe
125790|NCT03417102|Blood Coagulation Disorders, Inherited|blood coagulation disorders, inherited
125791|NCT03417102|Blood Coagulation Disorders|blood coagulation disorders
125792|NCT03417102|Hematologic Diseases|hematologic diseases
125793|NCT03417102|Coagulation Protein Disorders|coagulation protein disorders
125794|NCT03417102|Hemorrhagic Disorders|hemorrhagic disorders
125795|NCT03417102|Genetic Diseases, Inborn|genetic diseases, inborn
125796|NCT03417102|Genetic Diseases, X-Linked|genetic diseases, x-linked
125797|NCT03417102|Factor VIII|factor viii
125798|NCT03417102|Factor IX|factor ix
125799|NCT03417102|Inhibitor|inhibitor
125800|NCT03417102|Bypassing agents|bypassing agents
125801|NCT03417102|Coagulants|coagulants
125802|NCT03417102|Fitusiran|fitusiran
125803|NCT03417063|Intracranial artery|intracranial artery
125804|NCT03417063|Atherosclerosis|atherosclerosis
125805|NCT03417063|Intracranial artery stenosis|intracranial artery stenosis
125806|NCT03417063|High-Resolution Magnetic Resonance|high-resolution magnetic resonance
125807|NCT03417050|coronary artery bypass grafting|coronary artery bypass grafting
125808|NCT03417050|percutaneous coronary intervention|percutaneous coronary intervention
125809|NCT03417050|drug eluting stent|drug eluting stent
125810|NCT03417050|survival status|survival status
125811|NCT03417050|long-term follow-up|long-term follow-up
125812|NCT03417050|complex coronary artery disease|complex coronary artery disease
125813|NCT03416998|Photherapy|photherapy
125814|NCT03416998|Photobiomodulation|photobiomodulation
125815|NCT03416998|Creatine Kinase|creatine kinase
125816|NCT03416998|Soccer|soccer
125817|NCT03416998|Muscle Recovery|muscle recovery
125818|NCT03416946|Total knee replacement|total knee replacement
125819|NCT03416933|ctDNA|ctdna
125820|NCT03416933|MAPK inhibition|mapk inhibition
125821|NCT03416933|BRAF(V600) mutated|braf(v600) mutated
125822|NCT03416907|Informed consent|informed consent
125823|NCT03416881|HIV infection|hiv infection
125824|NCT03416881|antiretroviral|antiretroviral
125825|NCT03416881|aging population|aging population
125826|NCT03416881|drug interactions|drug interactions
125827|NCT03416881|cross-sectional study|cross-sectional study
125828|NCT03416881|SNIIRAM|sniiram
125829|NCT03416868|Ambulatory|ambulatory
125830|NCT03416868|Biofeedback|biofeedback
125831|NCT03416868|Voice|voice
125832|NCT03416842|outpatient|outpatient
125833|NCT03416842|wearable sensors|wearable sensors
125834|NCT03416842|home exercise|home exercise
125835|NCT03416829|Ambulatory|ambulatory
125836|NCT03416829|Biofeedback|biofeedback
125837|NCT03416829|Voice|voice
125838|NCT03416816|DSP-0337|dsp-0337
125839|NCT03416790|Central Nervous System|central nervous system
125840|NCT03416790|HIV Persistence|hiv persistence
125841|NCT03416790|HIV Reservoirs|hiv reservoirs
125842|NCT03416777|vegetarian|vegetarian
125843|NCT03416777|meat|meat
125844|NCT03416777|fish|fish
125845|NCT03416764|PTSD, neurofeedback (NF)|ptsd, neurofeedback (nf)
125846|NCT03416712|Social Determinants of Health|social determinants of health
126430|NCT03412942|Confidence|confidence
125847|NCT03416699|Transnal Total Mesorectal Excision|transnal total mesorectal excision
125848|NCT03416699|Rectal Cancer|rectal cancer
125849|NCT03416686|differentiated thyroid cancer|differentiated thyroid cancer
125850|NCT03416686|Radiofrequency|radiofrequency
125851|NCT03416660|Fractional laser|fractional laser
125852|NCT03416660|Postburn scar|postburn scar
125853|NCT03416660|Density|density
125854|NCT03416647|Superior Mesenteric Artery Syndrome|superior mesenteric artery syndrome
125855|NCT03416647|Chronic duodenal obstruction|chronic duodenal obstruction
125856|NCT03416647|Duodenojejunostomy|duodenojejunostomy
125857|NCT03416647|Wilkie's syndrome|wilkie's syndrome
125858|NCT03416634|Health promotion|health promotion
125859|NCT03416634|Behavioral research|behavioral research
125860|NCT03416634|Preventive medicine|preventive medicine
125861|NCT03416634|Obesity|obesity
125862|NCT03416634|Cardiovascular disease|cardiovascular disease
125863|NCT03416621|Light Smoker|light smoker
125864|NCT03416608|ultrasound|ultrasound
125865|NCT03416608|patient experience|patient experience
125866|NCT03416608|diagnostic test|diagnostic test
125867|NCT03416608|general practice|general practice
125868|NCT03416608|family medicine|family medicine
125869|NCT03416595|probiotic|probiotic
125870|NCT03416595|Lactobacillus paracasei N1115|lactobacillus paracasei n1115
125871|NCT03416595|young children|young children
125872|NCT03416543|Rheumatoid arthritis|rheumatoid arthritis
125873|NCT03416543|Dendritics cells|dendritics cells
125874|NCT03416517|Ewing Sarcoma|ewing sarcoma
125875|NCT03416517|Anlotinib|anlotinib
125876|NCT03416517|Irinotecan|irinotecan
125877|NCT03416517|Refractory|refractory
125878|NCT03416517|Metastatic|metastatic
125880|NCT03416491|Chronic hepatitis C|chronic hepatitis c
125881|NCT03416491|Hepatitis C virus|hepatitis c virus
125882|NCT03416491|KW-136|kw-136
125883|NCT03416491|sofosbuvir|sofosbuvir
125884|NCT03416491|nonstructural protein 5A|nonstructural protein 5a
125885|NCT03416491|nonstructural protein 5B|nonstructural protein 5b
125886|NCT03416491|panogentypic regimen|panogentypic regimen
125887|NCT03416478|Colorectal Cancer|colorectal cancer
125888|NCT03416478|ctDNA|ctdna
125889|NCT03416478|Surveillance|surveillance
125890|NCT03416465|hospitalization|hospitalization
125891|NCT03416465|cancer|cancer
125892|NCT03416465|general practitioner|general practitioner
125893|NCT03416452|Gait|gait
125894|NCT03416452|Parkinson's Disease|parkinson's disease
125895|NCT03416426|patent foramen ovale|patent foramen ovale
125896|NCT03416426|PFO closure|pfo closure
125897|NCT03416426|residual shunt|residual shunt
125898|NCT03416426|bubble contrast transesophageal echocardiography|bubble contrast transesophageal echocardiography
125899|NCT03416400|Vitrification|vitrification
125900|NCT03416400|In vitro maturation|in vitro maturation
125901|NCT03416400|Cytoskeleton|cytoskeleton
125902|NCT03416400|chromosomes|chromosomes
125903|NCT03416400|High resolution imaging|high resolution imaging
125904|NCT03416387|complex liver surgery|complex liver surgery
125905|NCT03416387|3D printing|3d printing
125906|NCT03416361|Left ventricular dysfunction|left ventricular dysfunction
125907|NCT03416361|Vitamin D|vitamin d
125908|NCT03416348|amputation|amputation
125909|NCT03416348|amputations|amputations
125910|NCT03416348|sweating|sweating
125911|NCT03416348|residual limb|residual limb
125912|NCT03416348|service members|service members
125913|NCT03416348|civilians|civilians
125914|NCT03416335|DSP-0509|dsp-0509
125915|NCT03416335|Toll-Like Receptor 7 (TLR-7)|toll-like receptor 7 (tlr-7)
125916|NCT03416335|BLRM (Bayesian Logistic Regression Model)|blrm (bayesian logistic regression model)
125917|NCT03416322|Adenoma|adenoma
125918|NCT03416322|Adenoma detection rate|adenoma detection rate
125919|NCT03416322|Colorectal cancer|colorectal cancer
125920|NCT03416309|pharmacokinetics|pharmacokinetics
125921|NCT03416309|pharmacogenetics|pharmacogenetics
125922|NCT03416309|Time To Positivity|time to positivity
125923|NCT03416270|SGLT2 inhibtion|sglt2 inhibtion
125924|NCT03416270|Ertugliflozin|ertugliflozin
125925|NCT03416270|Type 2 Diabetes|type 2 diabetes
125926|NCT03416270|Heart Failure|heart failure
125927|NCT03416231|apatinib|apatinib
125928|NCT03416231|Docetaxel|docetaxel
125929|NCT03416218|STEM Skills|stem skills
125930|NCT03416192|Dialysis|dialysis
125931|NCT03416192|MCO|mco
125932|NCT03416192|Middle molecules|middle molecules
125933|NCT03416179|glasdegib;|glasdegib;
125934|NCT03416179|untreated;|untreated;
125935|NCT03416179|Hedgehog Inhibitor|hedgehog inhibitor
125936|NCT03416166|Tricuspid Valve|tricuspid valve
125937|NCT03416166|tricuspid regurgitation|tricuspid regurgitation
125938|NCT03416166|transcatheter tricuspid regurgitation|transcatheter tricuspid regurgitation
125939|NCT03416127|Diabetes Mellitus type 2|diabetes mellitus type 2
125940|NCT03416127|Glycemic control|glycemic control
125941|NCT03416127|Propolis|propolis
125942|NCT03416127|Metformin|metformin
125943|NCT03416114|rare headaches|rare headaches
125944|NCT03416114|epidemiology|epidemiology
125945|NCT03416101|esophageal cancer|esophageal cancer
125946|NCT03416101|adenocarcinoma of the esophagus|adenocarcinoma of the esophagus
125947|NCT03416101|esophageal surgery|esophageal surgery
125948|NCT03416088|wine,coffee,reading,retinal microcirculation,optical coherence tomography angiography|wine,coffee,reading,retinal microcirculation,optical coherence tomography angiography
125949|NCT03416062|Jaundice, obstructive|jaundice, obstructive
125950|NCT03416062|Methionine|methionine
125951|NCT03416062|Succinic acid|succinic acid
125952|NCT03416049|ulcers|ulcers
125953|NCT03416049|leg ulcers|leg ulcers
125954|NCT03416049|venous stasis|venous stasis
125955|NCT03416049|ulcer treatment|ulcer treatment
125956|NCT03416049|leg ulcer treatment|leg ulcer treatment
125957|NCT03416049|venous stasis treatment|venous stasis treatment
125958|NCT03416049|non invasive treatment|non invasive treatment
125959|NCT03416049|pulsed electromagnetic|pulsed electromagnetic
125960|NCT03416049|pulsed electromagnetic therapy|pulsed electromagnetic therapy
125961|NCT03416049|pulsed electromagnetic treatment|pulsed electromagnetic treatment
125962|NCT03416049|pulsed magnetic|pulsed magnetic
125963|NCT03416049|pulsed magnetic therapy|pulsed magnetic therapy
125964|NCT03416049|pulsed magnetic treatment|pulsed magnetic treatment
125965|NCT03416049|varicose Ulcer|varicose ulcer
125966|NCT03416049|ulcer pain|ulcer pain
125967|NCT03416023|Implant|implant
125968|NCT03416023|continence control|continence control
125969|NCT03416023|titanium|titanium
125970|NCT03416010|emotional distress pregnancy disparities minority depression|emotional distress pregnancy disparities minority depression
125971|NCT03415984|Parkinson Disease|parkinson disease
125972|NCT03415984|Age Related Macular Degeneration|age related macular degeneration
125973|NCT03415984|L-DOPA|l-dopa
125974|NCT03415958|prospective|prospective
125975|NCT03415958|adolescent|adolescent
125976|NCT03415958|displaced|displaced
125977|NCT03415958|clavicle|clavicle
125978|NCT03415958|fracture|fracture
125979|NCT03415958|mid-shaft|mid-shaft
125980|NCT03415906|angiotensin receptor blocker|angiotensin receptor blocker
125981|NCT03415906|neprilysin inhibition|neprilysin inhibition
125982|NCT03415906|sympathetic activity|sympathetic activity
125983|NCT03415906|baroreflex|baroreflex
125984|NCT03415906|microneurography|microneurography
125985|NCT03415906|functional MRI|functional mri
125986|NCT03415893|high-resolution manometry|high-resolution manometry
125987|NCT03415893|esophageal atresia|esophageal atresia
125988|NCT03415893|teenagers|teenagers
125989|NCT03415880|Diabetes mellitus|diabetes mellitus
125990|NCT03415880|Type2 Diabetes|type2 diabetes
125991|NCT03415880|Sedentary Lifestyle|sedentary lifestyle
125992|NCT03415880|Physical Activity|physical activity
125993|NCT03415880|Pulse wave velocity|pulse wave velocity
125994|NCT03415880|arterial stiffness|arterial stiffness
125995|NCT03415880|aortic stiffness|aortic stiffness
125996|NCT03415880|artery disease|artery disease
125997|NCT03415880|light intensity physical activity|light intensity physical activity
125998|NCT03415867|Graft-versus-host disease|graft-versus-host disease
125999|NCT03415867|Bone marrow transplantation|bone marrow transplantation
126000|NCT03415867|Hedgehog inhibitor|hedgehog inhibitor
126001|NCT03415841|Post MI|post mi
126002|NCT03415841|Cardiac Rehabilitation|cardiac rehabilitation
126003|NCT03415841|Wearable Devices|wearable devices
126004|NCT03415841|Smartphone-based Program|smartphone-based program
126005|NCT03415815|Chinese, real-world evidences, T1-T3 esophageal cancer|chinese, real-world evidences, t1-t3 esophageal cancer
126006|NCT03415802|Nab-Paclitaxel|nab-paclitaxel
126008|NCT03415802|Advanced Pancreatic Cancer|advanced pancreatic cancer
126009|NCT03415789|Non ischemic dilated cardiomyopathy|non ischemic dilated cardiomyopathy
126010|NCT03415789|Cardiac thrombosis|cardiac thrombosis
126011|NCT03415789|Silent brain infarct|silent brain infarct
126012|NCT03415789|Fluid dynamics|fluid dynamics
126013|NCT03415789|Intracardiac blood flow|intracardiac blood flow
126014|NCT03415789|Echocardiography|echocardiography
126015|NCT03415776|Hemodialysis|hemodialysis
126016|NCT03415776|Sessions frequency|sessions frequency
126017|NCT03415776|Mortality|mortality
126018|NCT03415776|Morbidity|morbidity
126019|NCT03415763|Rectal Neoplasms|rectal neoplasms
126020|NCT03415763|Adjuvant Chemotherapy|adjuvant chemotherapy
126021|NCT03415763|Neoadjuvant Chemoradiotherapy|neoadjuvant chemoradiotherapy
126022|NCT03415750|Renal transplant|renal transplant
126023|NCT03415698|Regenerative medicine|regenerative medicine
126024|NCT03415672|Interleukin-2|interleukin-2
126025|NCT03415672|Hepatitis B Vaccines|hepatitis b vaccines
126026|NCT03415672|Non-responders|non-responders
126027|NCT03415672|Liver Diseases|liver diseases
126028|NCT03415672|Digestive system|digestive system
126029|NCT03415672|Vaccines|vaccines
126030|NCT03415659|HWH340|hwh340
126031|NCT03415659|pharmacokinetics|pharmacokinetics
126032|NCT03415659|dose-escalation|dose-escalation
126033|NCT03415659|safety|safety
126034|NCT03415659|tolerability|tolerability
126035|NCT03415646|erector spinae plane block|erector spinae plane block
126036|NCT03415646|breast surgery|breast surgery
126037|NCT03415646|postoperative pain|postoperative pain
126038|NCT03415633|Home Respiratory Polygraphy|home respiratory polygraphy
126039|NCT03415633|Standard Polysomnography|standard polysomnography
126040|NCT03415633|Validity|validity
126041|NCT03415633|Cost-effectiveness|cost-effectiveness
126042|NCT03415568|Postprandial lipid metabolism|postprandial lipid metabolism
126043|NCT03415568|Medium-chain triglycerides|medium-chain triglycerides
126044|NCT03415568|Diacylglycerols|diacylglycerols
126045|NCT03415568|Serum triglycerides|serum triglycerides
126046|NCT03415568|Chylomicron triglycerides|chylomicron triglycerides
126047|NCT03415555|Erector Spinae Plane blockade|erector spinae plane blockade
126048|NCT03415555|patient control anlagesia|patient control anlagesia
126049|NCT03415555|mitral valve replacement|mitral valve replacement
126050|NCT03415542|Attitudes|attitudes
126051|NCT03415542|Ecological momentary assessment|ecological momentary assessment
126052|NCT03415529|Lung|lung
126053|NCT03415529|ARDS|ards
126054|NCT03415529|Acute Respiratory Syndrome|acute respiratory syndrome
126055|NCT03415529|Prognosis|prognosis
126056|NCT03415529|Outcome Research|outcome research
126057|NCT03415529|Respiratory infection|respiratory infection
126058|NCT03415529|Sepsis|sepsis
126059|NCT03415529|Organ failure|organ failure
126060|NCT03415529|Hypercapnia|hypercapnia
126061|NCT03415503|anthocyanins|anthocyanins
126062|NCT03415503|dyslipidemias|dyslipidemias
126063|NCT03415503|Hyperglycemia|hyperglycemia
126064|NCT03415490|general anesthesia|general anesthesia
126065|NCT03415490|self-adherent wrap|self-adherent wrap
126066|NCT03415490|pressure|pressure
126067|NCT03415477|aneurysmal bone cyst, denosumab, surgical treatment, complication|aneurysmal bone cyst, denosumab, surgical treatment, complication
126068|NCT03415451|cancer patients, Nutritional status|cancer patients, nutritional status
126069|NCT03415438|thoracolumbar fascia|thoracolumbar fascia
126070|NCT03415438|subacromial impingement syndrome|subacromial impingement syndrome
126071|NCT03415412|non-caries cervical lesion|non-caries cervical lesion
126072|NCT03415412|universal adhesives|universal adhesives
126073|NCT03415399|relapsed/refractory CD19+ Lymphomas, B-Cell|relapsed/refractory cd19+ lymphomas, b-cell
126074|NCT03415360|cryoablation|cryoablation
126075|NCT03415347|Pilonidal abscess|pilonidal abscess
126076|NCT03415347|Pilonidal disease|pilonidal disease
126077|NCT03415347|Pilonidal sinus|pilonidal sinus
126078|NCT03415334|Hepatitis C|hepatitis c
126079|NCT03415334|social marketing|social marketing
126080|NCT03415334|Communication for behavior development|communication for behavior development
126081|NCT03415321|Postpartum, Sense of Security, Mobile Support Application|postpartum, sense of security, mobile support application
126082|NCT03415308|Implicit Bias|implicit bias
126083|NCT03415308|Healthcare Equity|healthcare equity
126084|NCT03415295|Trimethylamine-N-oxide; Gestational diabetes mellitus|trimethylamine-n-oxide; gestational diabetes mellitus
126085|NCT03415269|acute|acute
126086|NCT03415191|ketamine, post-thoracotomy pain, analgesia|ketamine, post-thoracotomy pain, analgesia
126087|NCT03415152|Omacor|omacor
126088|NCT03415152|Omega-3-acid ethyl esters|omega-3-acid ethyl esters
126089|NCT03415152|patient adherence|patient adherence
126090|NCT03415152|patient reported outcomes|patient reported outcomes
126091|NCT03415126|KRAS mutant|kras mutant
126092|NCT03415126|NRAS mutant|nras mutant
126093|NCT03415126|BRAF mutant|braf mutant
126094|NCT03415126|HRAS mutant|hras mutant
126095|NCT03415126|ERK 1/2 inhibitor|erk 1/2 inhibitor
126096|NCT03415113|Medication reconciliation at discharge, potentially inappropriate medications, elderly.|medication reconciliation at discharge, potentially inappropriate medications, elderly.
126097|NCT03415074|low protein diet|low protein diet
126098|NCT03415074|Diabetic Kidney Disease|diabetic kidney disease
126099|NCT03415035|Venetoclax|venetoclax
126100|NCT03415035|Venclyxto|venclyxto
126101|NCT03415035|Cancer|cancer
126102|NCT03415035|Chronic Lymphocytic Leukemia (CLL)|chronic lymphocytic leukemia (cll)
126103|NCT03415022|SAD|sad
126104|NCT03415022|Social Anxiety|social anxiety
126105|NCT03415022|Social Phobia|social phobia
126106|NCT03415009|IL28B gene|il28b gene
126107|NCT03414996|Interval training|interval training
126108|NCT03414996|Autonomic nervous system|autonomic nervous system
126109|NCT03414996|Post-acute coronary syndrome|post-acute coronary syndrome
126110|NCT03414957|Malay women, PCOS, Metabolic Syndrome, Rotterdam criteria|malay women, pcos, metabolic syndrome, rotterdam criteria
126111|NCT03414944|Non-small cell lung cancer|non-small cell lung cancer
126112|NCT03414944|Brain metastases|brain metastases
126113|NCT03414944|SIB|sib
126114|NCT03414944|hippocampus avoidance|hippocampus avoidance
126115|NCT03414944|inner ear avoidance|inner ear avoidance
126116|NCT03414918|Macrolides, KCNJ5 potassium channel, aldosteronism|macrolides, kcnj5 potassium channel, aldosteronism
126117|NCT03414892|Type 2 Diabetes Mellitus|type 2 diabetes mellitus
126118|NCT03414892|Glucokinase Activator|glucokinase activator
126119|NCT03414866|Thoracic Aorta|thoracic aorta
126120|NCT03414866|Dissection|dissection
126121|NCT03414866|Aneurysm|aneurysm
126122|NCT03414866|Frozen Elephant Trunk|frozen elephant trunk
126123|NCT03414853|Appendicitis, abdominal pain, free text prediction|appendicitis, abdominal pain, free text prediction
126124|NCT03414840|coronary artery disease|coronary artery disease
126125|NCT03414840|coronary computed tomography angiography|coronary computed tomography angiography
126126|NCT03414840|statins|statins
126127|NCT03414840|coronary atherosclerosis|coronary atherosclerosis
126128|NCT03414814|NSCLC|nsclc
126129|NCT03414814|Osimertinib|osimertinib
126130|NCT03414814|EGFR exon 20 insertion mutation|egfr exon 20 insertion mutation
126131|NCT03414801|Environmental Exposure Unit|environmental exposure unit
126132|NCT03414801|Cat Allergen|cat allergen
126133|NCT03414801|Rhinitis|rhinitis
126134|NCT03414801|Subject Validation|subject validation
126135|NCT03414788|Positron Emission Tomography (PET), Ulcerative Colitis, Safety, PKPlasma|positron emission tomography (pet), ulcerative colitis, safety, pkplasma
126136|NCT03414775|microbiome|microbiome
126137|NCT03414775|gastrointestinal microbiome|gastrointestinal microbiome
126138|NCT03414775|pediatrics|pediatrics
126139|NCT03414775|critical illness|critical illness
126140|NCT03414762|cesarean section|cesarean section
126141|NCT03414762|negative-pressure wound therapy|negative-pressure wound therapy
126142|NCT03414762|surgical wound dehiscence|surgical wound dehiscence
126143|NCT03414762|hospital readmission|hospital readmission
126144|NCT03414762|surgical site infection|surgical site infection
126145|NCT03414749|Chiropractic|chiropractic
126146|NCT03414749|postural sway|postural sway
126147|NCT03414749|manipulation|manipulation
126148|NCT03414710|uptake of voluntary medical male circumcision|uptake of voluntary medical male circumcision
126149|NCT03414697|umbilical cord-derived mesenchymal stem cells|umbilical cord-derived mesenchymal stem cells
126150|NCT03414697|cerebral palsy|cerebral palsy
126151|NCT03414684|Breast Cancer|breast cancer
126152|NCT03414671|apnea|apnea
126153|NCT03414658|Breast Cancer|breast cancer
126154|NCT03414632|Heart Failure|heart failure
126155|NCT03414632|Diastolic Heart Failure|diastolic heart failure
126156|NCT03414632|Heart Failure with Preserved Ejection Fraction|heart failure with preserved ejection fraction
126157|NCT03414632|Transthyretin Cardiac Amyloidosis|transthyretin cardiac amyloidosis
126158|NCT03414632|Amyloidosis|amyloidosis
126159|NCT03414619|OCD|ocd
126160|NCT03414619|GAD|gad
126161|NCT03414619|MDD|mdd
126162|NCT03414619|Rumination|rumination
126163|NCT03414619|Obsession|obsession
126164|NCT03414619|Worry|worry
126165|NCT03414593|preemptive analgic effect|preemptive analgic effect
126166|NCT03414593|popliteal sciatic nerve block|popliteal sciatic nerve block
126167|NCT03414593|Bilateral Hallux Valgus|bilateral hallux valgus
126168|NCT03414567|Follicular fluid|follicular fluid
126169|NCT03414567|nicotine|nicotine
126170|NCT03414567|cotinine|cotinine
126171|NCT03414567|Benzo(a)pyrene|benzo(a)pyrene
126172|NCT03414502|Methotrexate|methotrexate
126173|NCT03414489|Clinical Trial, Phase II|clinical trial, phase ii
126174|NCT03414489|Multicenter Trials|multicenter trials
126175|NCT03414489|Clinical Study|clinical study
126176|NCT03414489|Clinical Trials, Non-Randomized|clinical trials, non-randomized
126177|NCT03414489|Oral capsule|oral capsule
126178|NCT03414489|Single arm|single arm
126179|NCT03414489|Anti-cancer|anti-cancer
126180|NCT03414489|Anti-inflammatory|anti-inflammatory
126181|NCT03414489|ABC294640|abc294640
126182|NCT03414489|Expanded Access Program|expanded access program
126183|NCT03414489|Compassionate Use|compassionate use
126184|NCT03414489|Special Access Program|special access program
126185|NCT03414489|Yeliva ®|yeliva ®
126186|NCT03414489|opaganib|opaganib
126187|NCT03414463|Brain Injury|brain injury
126188|NCT03414450|Mnk kinase inhibitor, Mnk kinase|mnk kinase inhibitor, mnk kinase
126189|NCT03414424|transcutaneous electric nerve stimulation|transcutaneous electric nerve stimulation
126190|NCT03414424|transcranial magnetic stimulation|transcranial magnetic stimulation
126191|NCT03414411|HIV|hiv
126192|NCT03414411|Alcohol Use|alcohol use
126193|NCT03414411|Substance Use|substance use
126194|NCT03414411|Bone Disease|bone disease
126195|NCT03414411|Falls|falls
126196|NCT03414411|Fractures|fractures
126197|NCT03414372|MSM|msm
126198|NCT03414372|HIV|hiv
126199|NCT03414372|disclosure|disclosure
126200|NCT03414372|eHealth|ehealth
126201|NCT03414372|virtual reality|virtual reality
126202|NCT03414346|Cryotherapy|cryotherapy
126203|NCT03414346|Skin temperature|skin temperature
126204|NCT03414346|Physical therapy modalities|physical therapy modalities
126205|NCT03414346|Physical therapy|physical therapy
126206|NCT03414346|Thermography|thermography
126207|NCT03414346|Pain measurement|pain measurement
126208|NCT03414333|obesity|obesity
126209|NCT03414333|cognitive dysfunction|cognitive dysfunction
126210|NCT03414320|type 1 diabetes|type 1 diabetes
126211|NCT03414320|insulin pump|insulin pump
126212|NCT03414320|bolus calculator|bolus calculator
126213|NCT03414320|continuous glucose monitoring|continuous glucose monitoring
126214|NCT03414320|carbohydrate to insulin ratio|carbohydrate to insulin ratio
126215|NCT03414320|insulin sensitivity factor|insulin sensitivity factor
126216|NCT03414281|quadratus lumborum block, thoracic paravertebral block, nephrectomy|quadratus lumborum block, thoracic paravertebral block, nephrectomy
126217|NCT03414268|Chronic plantar fasciitis|chronic plantar fasciitis
126218|NCT03414268|Heel pain|heel pain
126219|NCT03414255|Chronic Achilles Tendonitis|chronic achilles tendonitis
126220|NCT03414229|Epacadostat|epacadostat
126221|NCT03414229|Pembrolizumab|pembrolizumab
126222|NCT03414229|17-508|17-508
126223|NCT03414203|Transcranial Direct Current Stimulation|transcranial direct current stimulation
126224|NCT03414203|Migraine Disorders|migraine disorders
126225|NCT03414203|Cognitive Symptoms|cognitive symptoms
126226|NCT03414190|Acute Coronary Syndrome|acute coronary syndrome
126227|NCT03414190|Text Messaging|text messaging
126228|NCT03414190|Risk Factors|risk factors
126229|NCT03414177|Telemedicine|telemedicine
126230|NCT03414177|Clinical follow up visits|clinical follow up visits
126231|NCT03414138|Pain|pain
126232|NCT03414138|Mindfulness|mindfulness
126233|NCT03414138|Meditation|meditation
126234|NCT03414138|fMRI|fmri
126235|NCT03414125|Colorectal Cancer|colorectal cancer
126236|NCT03414125|Colon Cancer|colon cancer
126237|NCT03414125|FIT Screening Strategy|fit screening strategy
126238|NCT03414125|Colon Screening Strategy|colon screening strategy
126239|NCT03414125|Colorectal Neoplasms|colorectal neoplasms
126240|NCT03414125|Mass Screening|mass screening
126241|NCT03414125|Health Services Research|health services research
126242|NCT03414125|Comparative Effectiveness Research|comparative effectiveness research
126243|NCT03414099|Pain|pain
126244|NCT03414099|Kratom|kratom
126245|NCT03414099|Ketum|ketum
126246|NCT03414099|mitragynine|mitragynine
126247|NCT03414086|PM|pm
126248|NCT03414086|DM|dm
126249|NCT03414073|dental floss|dental floss
126250|NCT03414073|gingival embrasure|gingival embrasure
126251|NCT03414073|oral hygiene|oral hygiene
126252|NCT03414073|interdental brush|interdental brush
126253|NCT03414060|obstetric fistula|obstetric fistula
126254|NCT03414060|vesicovaginal fistula|vesicovaginal fistula
126255|NCT03414060|menstrual cup|menstrual cup
126256|NCT03414060|pad test|pad test
126257|NCT03414060|non-surgical management|non-surgical management
126258|NCT03414060|feasibility|feasibility
126259|NCT03414060|acceptability|acceptability
126260|NCT03414060|innovation|innovation
126261|NCT03414060|coping|coping
126262|NCT03414060|incontinence|incontinence
126263|NCT03414047|DNA damage repair|dna damage repair
126264|NCT03414047|replication stress|replication stress
126265|NCT03414034|PLK1|plk1
126266|NCT03414034|PLK Inhibitor|plk inhibitor
126267|NCT03414034|Onvansertib|onvansertib
126268|NCT03414021|Nuclear Medicine|nuclear medicine
126269|NCT03414021|SPECT-CT Scan|spect-ct scan
126270|NCT03414021|gamma-camera with semiconductor|gamma-camera with semiconductor
126271|NCT03413995|metastatic hormone sensitive|metastatic hormone sensitive
126272|NCT03413956|Chinese|chinese
126273|NCT03413956|T1 non-small cell lung cancer|t1 non-small cell lung cancer
126274|NCT03413956|Lymph metastases|lymph metastases
126275|NCT03413930|TaTME|tatme
126276|NCT03413930|Rectal cancer|rectal cancer
126277|NCT03413930|Laparoscopic Surgery|laparoscopic surgery
126278|NCT03413917|genomic markers|genomic markers
126279|NCT03413904|taTME|tatme
126280|NCT03413891|Anticoagulants|anticoagulants
126281|NCT03413891|Tranexamic Acid|tranexamic acid
126282|NCT03413878|snow|snow
126283|NCT03413878|avalanche|avalanche
126284|NCT03413878|hypercapnia|hypercapnia
126285|NCT03413878|work of breathing|work of breathing
126286|NCT03413839|Scoliosis|scoliosis
126287|NCT03413839|PSSE|psse
126288|NCT03413826|weight loss|weight loss
126289|NCT03413826|exercise|exercise
126290|NCT03413826|reinforcement|reinforcement
126291|NCT03413826|compensation|compensation
126292|NCT03413813|Magmaris|magmaris
126293|NCT03413800|hematopoietic stem cell transplant|hematopoietic stem cell transplant
126294|NCT03413800|lenalidomide|lenalidomide
126295|NCT03413800|DLI|dli
126296|NCT03413722|Liver transplant|liver transplant
126297|NCT03413722|Cognitive function|cognitive function
126298|NCT03413709|Parenting Time, Father Involvement|parenting time, father involvement
126299|NCT03413696|HIV|hiv
126300|NCT03413696|Health literacy|health literacy
126301|NCT03413696|Hepatitis C|hepatitis c
126302|NCT03413696|Hepatitis C knowledge|hepatitis c knowledge
126303|NCT03413696|HIV knowledge|hiv knowledge
126304|NCT03413696|Hepatitis C treatment|hepatitis c treatment
126305|NCT03413644|Hematological diseases|hematological diseases
126306|NCT03413631|prenatal substance abuse|prenatal substance abuse
126307|NCT03413631|mentalization|mentalization
126308|NCT03413631|prenatal depression|prenatal depression
126309|NCT03413631|prenatal anxiety|prenatal anxiety
126310|NCT03413631|maternal-fetal attachment|maternal-fetal attachment
126311|NCT03413631|prenatal intervention|prenatal intervention
126312|NCT03413631|ultrasound|ultrasound
126313|NCT03413631|perinatal outcome|perinatal outcome
126314|NCT03413631|fetal exposure|fetal exposure
126315|NCT03413631|parenting|parenting
126316|NCT03413631|parenthood|parenthood
126317|NCT03413631|prenatal treatment|prenatal treatment
126318|NCT03413618|deep vein thrombosis|deep vein thrombosis
126319|NCT03413618|postthrombotic syndrome|postthrombotic syndrome
126320|NCT03413618|anticoagulation|anticoagulation
126321|NCT03413618|treatment|treatment
126322|NCT03413618|prevention|prevention
126323|NCT03413579|Cervix|cervix
126324|NCT03413579|Oncology,|oncology,
126325|NCT03413579|hR3,|hr3,
126326|NCT03413579|Nimotuzumab,|nimotuzumab,
126327|NCT03413579|Chemotherapy,|chemotherapy,
126328|NCT03413579|Survival|survival
161168|NCT03191045|MRI|mri
126329|NCT03413579|Monoclonal antibody|monoclonal antibody
126330|NCT03413579|RECIST|recist
126331|NCT03413579|Cisplatin|cisplatin
126332|NCT03413579|Vinorelbine|vinorelbine
126333|NCT03413579|Paclitaxel|paclitaxel
126334|NCT03413579|Carboplatine|carboplatine
126335|NCT03413579|Randomisation|randomisation
126336|NCT03413579|Placebo|placebo
126337|NCT03413579|cancer|cancer
126338|NCT03413579|cimahope|cimahope
126339|NCT03413566|Trends|trends
126340|NCT03413566|Prevalence|prevalence
126341|NCT03413566|Registries/statistics & numerical data|registries/statistics & numerical data
126342|NCT03413566|Epidemiology|epidemiology
126343|NCT03413553|immediate implant|immediate implant
126344|NCT03413553|connective tissue graft|connective tissue graft
126345|NCT03413553|platelet rich fibrin|platelet rich fibrin
126346|NCT03413540|jumping|jumping
126347|NCT03413540|bone health|bone health
126348|NCT03413527|rTMS|rtms
126349|NCT03413514|shared decision making|shared decision making
126350|NCT03413514|neoadjuvant chemotherapy|neoadjuvant chemotherapy
126351|NCT03413514|cycle|cycle
126352|NCT03413514|MRI|mri
126353|NCT03413514|clinical response|clinical response
126354|NCT03413488|Shoulder impingement syndrome|shoulder impingement syndrome
126355|NCT03413488|Kinesio tape|kinesio tape
126356|NCT03413488|Round shoulder posture|round shoulder posture
126357|NCT03413475|Edentulism|edentulism
126358|NCT03413475|complete removable prosthesis|complete removable prosthesis
126359|NCT03413475|quality of life|quality of life
126360|NCT03413436|adjuvant chemotherapy|adjuvant chemotherapy
126361|NCT03413436|multicenter retrospective study|multicenter retrospective study
126362|NCT03413423|smoking|smoking
126363|NCT03413423|depression|depression
126364|NCT03413423|Behavioral Activation|behavioral activation
126365|NCT03413423|Mood management|mood management
126366|NCT03413423|Secondary Prevention|secondary prevention
126367|NCT03413384|Parkinson's Disease|parkinson's disease
126368|NCT03413384|Parkinson's Disease Dementia|parkinson's disease dementia
126369|NCT03413371|Surgical Pleth Index (SPI)|surgical pleth index (spi)
126370|NCT03413371|General Anaesthesia (GA),|general anaesthesia (ga),
126371|NCT03413371|Numerical Rating Scale (NRS)|numerical rating scale (nrs)
126372|NCT03413371|Adequacy of Anaesthesia (AoA)|adequacy of anaesthesia (aoa)
126373|NCT03413371|Peribulbar Block (PBB)|peribulbar block (pbb)
126374|NCT03413371|bupivacaine|bupivacaine
126375|NCT03413371|ropivacaine|ropivacaine
126376|NCT03413371|lidocaine|lidocaine
126377|NCT03413332|Chinese American Women|chinese american women
126378|NCT03413332|Provider-patient Communication|provider-patient communication
126379|NCT03413332|Survivorship Care|survivorship care
126380|NCT03413306|aplastic anemia|aplastic anemia
126381|NCT03413306|immunosupressive therapy|immunosupressive therapy
126382|NCT03413306|ATG|atg
126383|NCT03413306|eltrombopag|eltrombopag
126384|NCT03413280|preemptive analgic effect|preemptive analgic effect
126385|NCT03413280|Rectus Sheath Block|rectus sheath block
126386|NCT03413280|laparoscopic cholecystectomy|laparoscopic cholecystectomy
126387|NCT03413267|micronutrient|micronutrient
126388|NCT03413267|bioavailability|bioavailability
126389|NCT03413267|bioaccessibility|bioaccessibility
126390|NCT03413267|food structure|food structure
126391|NCT03413267|food texture|food texture
126392|NCT03413254|pT4 colon cancer|pt4 colon cancer
126393|NCT03413254|Peritoneal metastases|peritoneal metastases
126394|NCT03413254|Early detection|early detection
126395|NCT03413254|Diagnostic laparoscopy|diagnostic laparoscopy
126396|NCT03413254|Second look surgery|second look surgery
126397|NCT03413254|Third look surgery|third look surgery
126398|NCT03413241|autism spectrum disorder|autism spectrum disorder
126399|NCT03413202|butylphthalide(NBP)|butylphthalide(nbp)
126400|NCT03413202|large-artery atherosclerosis acute ischemic stroke|large-artery atherosclerosis acute ischemic stroke
126401|NCT03413202|dynamic Cerebral Autoregulation(dCA)|dynamic cerebral autoregulation(dca)
126402|NCT03413189|Exercise|exercise
126403|NCT03413189|Dosage|dosage
126404|NCT03413189|Function|function
126405|NCT03413176|VEGFR|vegfr
126406|NCT03413176|VEGF|vegf
126407|NCT03413176|antiangiogenics|antiangiogenics
126408|NCT03413176|angiogenesis|angiogenesis
126409|NCT03413163|Ultrasound Guided Erector Spinae Plane Block|ultrasound guided erector spinae plane block
126410|NCT03413163|postoperative pain|postoperative pain
126411|NCT03413163|retropubic radical prostatectomy|retropubic radical prostatectomy
126412|NCT03413137|Prostate cancer|prostate cancer
126413|NCT03413137|transperineal mp-MRI-fusion/TRUS biopsies|transperineal mp-mri-fusion/trus biopsies
126414|NCT03413137|mp-MRI fusion/TRUS transrectal biopsy|mp-mri fusion/trus transrectal biopsy
126415|NCT03413111|ERCP|ercp
126416|NCT03413111|double guidewire technique|double guidewire technique
126417|NCT03413085|Myopia control|myopia control
126418|NCT03413046|Regulatory T cell|regulatory t cell
126419|NCT03413046|Acute lymphoblastic leukemia|acute lymphoblastic leukemia
126420|NCT03413046|Minimal residual disease|minimal residual disease
126421|NCT03413033|Semi-occluded vocal tract|semi-occluded vocal tract
126422|NCT03413033|resonance tubes|resonance tubes
126423|NCT03413033|tongue trill|tongue trill
126424|NCT03413033|voice therapy|voice therapy
126425|NCT03413020|Helicobacter pylori|helicobacter pylori
126426|NCT03413020|Rescue therapy|rescue therapy
126427|NCT03413020|Tailored therapy|tailored therapy
126428|NCT03413020|Antimicrobial susceptibility testing|antimicrobial susceptibility testing
126431|NCT03412942|Usage outcomes|usage outcomes
126432|NCT03412916|Chronic Pain|chronic pain
126433|NCT03412916|Physical Activity|physical activity
126434|NCT03412916|Mind-body|mind-body
126435|NCT03412903|Acute geriatric treatment|acute geriatric treatment
126436|NCT03412903|Inpatient treatment team|inpatient treatment team
126437|NCT03412903|Elderly|elderly
126438|NCT03412903|Pharmacist|pharmacist
126439|NCT03412903|Comprehensive pharmaceutical assessment|comprehensive pharmaceutical assessment
126440|NCT03412903|Medication history|medication history
126441|NCT03412903|Medication reconciliation|medication reconciliation
126442|NCT03412903|Adherence|adherence
126443|NCT03412903|Medication therapy management|medication therapy management
126444|NCT03412903|Pharmaceutical consultation|pharmaceutical consultation
126445|NCT03412903|Drug-Related Side Effects and Adverse Reactions|drug-related side effects and adverse reactions
126446|NCT03412903|Drug interactions|drug interactions
126447|NCT03412903|Pharmaceutical Council|pharmaceutical council
126448|NCT03412903|Drug regime acceptance|drug regime acceptance
126449|NCT03412903|Patient Care Team|patient care team
126450|NCT03412903|Hospital Pharmacy Service|hospital pharmacy service
126451|NCT03412903|Polypharmacy|polypharmacy
126452|NCT03412903|Hospitalization|hospitalization
126453|NCT03412903|Pharmaceutical Services|pharmaceutical services
126454|NCT03412877|Gene Therapy|gene therapy
126455|NCT03412877|Immunotherapy|immunotherapy
126456|NCT03412877|Cell Therapy|cell therapy
126457|NCT03412877|Adoptive Cell Therapy|adoptive cell therapy
126458|NCT03412864|chondrocyte cells|chondrocyte cells
126459|NCT03412864|osteoarthritis|osteoarthritis
126460|NCT03412864|gene therapy|gene therapy
126461|NCT03412851|Thrombectomy|thrombectomy
126462|NCT03412851|Stentriever|stentriever
126464|NCT03412838|Bone block allograft|bone block allograft
126465|NCT03412838|Bone density|bone density
126466|NCT03412838|Graft resorption|graft resorption
126467|NCT03412838|PRP|prp
126468|NCT03412838|RCT|rct
126469|NCT03412812|Brain Metastases|brain metastases
126470|NCT03412812|Stereotactic Radiosurgery|stereotactic radiosurgery
126471|NCT03412773|Advanced liver cancer|advanced liver cancer
126472|NCT03412773|RATIONALE-301|rationale-301
126473|NCT03412760|hydrops fetalis|hydrops fetalis
126474|NCT03412760|birth defect|birth defect
126475|NCT03412760|fetal anomaly|fetal anomaly
126476|NCT03412760|whole exome sequencing|whole exome sequencing
126477|NCT03412747|Bimekizumab|bimekizumab
126478|NCT03412747|PSO|pso
126479|NCT03412747|Psoriasis|psoriasis
126480|NCT03412721|laser analgesia|laser analgesia
126481|NCT03412721|pediatric dentistry|pediatric dentistry
126482|NCT03412695|Disease-related malnutrition|disease-related malnutrition
126483|NCT03412695|eHealth|ehealth
126484|NCT03412695|Decision support system|decision support system
126485|NCT03412695|Clinical nutrition|clinical nutrition
126486|NCT03412682|Ulcerative colitis|ulcerative colitis
126487|NCT03412682|FE999315|fe999315
126488|NCT03412682|Mesalazine|mesalazine
126489|NCT03412682|Colitis|colitis
126490|NCT03412682|Colitis, Ulcerative|colitis, ulcerative
126491|NCT03412669|Addiction affected family members|addiction affected family members
126492|NCT03412669|Counselling|counselling
126493|NCT03412669|Psychosocial intervention|psychosocial intervention
126494|NCT03412669|Low and Middle Income Countries|low and middle income countries
126495|NCT03412669|India|india
126496|NCT03412669|Pilot Randomised Controlled Trial|pilot randomised controlled trial
126497|NCT03412656|CUFF|cuff
126498|NCT03412656|Soft Hand Pro|soft hand pro
126499|NCT03412656|SHP|shp
126500|NCT03412656|SH Pro|sh pro
126501|NCT03412656|SoftHand|softhand
126502|NCT03412617|Healthy Eating|healthy eating
126503|NCT03412617|Blood glucose|blood glucose
126504|NCT03412617|Bifidobacterium|bifidobacterium
126505|NCT03412617|Obese women|obese women
126506|NCT03412604|Alzheimer Disease|alzheimer disease
126507|NCT03412539|resistant pain|resistant pain
126508|NCT03412513|Overactive Bladder|overactive bladder
126509|NCT03412513|Parkinson Disease|parkinson disease
126510|NCT03412500|Methicillin-Resistant Staphylococcus aureus|methicillin-resistant staphylococcus aureus
126511|NCT03412500|Vancomycin|vancomycin
126512|NCT03412474|suprazygomatic block, dexmedetomidine|suprazygomatic block, dexmedetomidine
126513|NCT03412461|Transition-aged youth|transition-aged youth
126514|NCT03412461|Mental Health|mental health
126515|NCT03412461|Accessibility|accessibility
126516|NCT03412448|chronic pain|chronic pain
126517|NCT03412448|cardiac surgery|cardiac surgery
126518|NCT03412448|opioids|opioids
126519|NCT03412435|Acute myocardial infarction|acute myocardial infarction
126520|NCT03412435|Myocardial infarction|myocardial infarction
126521|NCT03412422|Passive Leg Raise|passive leg raise
126522|NCT03412422|Fluid Challenge|fluid challenge
126523|NCT03412422|Common carotid artery|common carotid artery
126524|NCT03412409|RIC regimen|ric regimen
126525|NCT03412409|comorbidity|comorbidity
126526|NCT03412409|elderly|elderly
126527|NCT03412409|haploidentical|haploidentical
126528|NCT03412409|transplant-related mortality|transplant-related mortality
126529|NCT03412357|pleurectomy/decortication|pleurectomy/decortication
126530|NCT03412357|indwelling pleural catheter|indwelling pleural catheter
126531|NCT03412344|clinical trial|clinical trial
126532|NCT03412344|patient|patient
126533|NCT03412344|questionnaire|questionnaire
126534|NCT03412305|Dental implants, antibiotic prophylaxis|dental implants, antibiotic prophylaxis
126535|NCT03412279|Chronic Low Back Pain|chronic low back pain
126536|NCT03412279|Oswestry Disability Index|oswestry disability index
126537|NCT03412279|Numeric Pain Rating Scale|numeric pain rating scale
126538|NCT03412279|Roland Morris Disability Questionnaire|roland morris disability questionnaire
126539|NCT03412279|SF-12 Health Survey|sf-12 health survey
126540|NCT03412279|Fear-Avoidance Beliefs Questionnaire|fear-avoidance beliefs questionnaire
126541|NCT03412279|Pain Catastrophizing Scale|pain catastrophizing scale
126542|NCT03412279|Global Rating of Change Scale|global rating of change scale
126543|NCT03412279|Back Beliefs Questionnaire|back beliefs questionnaire
126544|NCT03412266|RIC regimen; MDS; haplo-HSCT; survival|ric regimen; mds; haplo-hsct; survival
126545|NCT03412253|metabolic surgery, BMI 25-30 kg/m2, SAGB, T2DM remission.|metabolic surgery, bmi 25-30 kg/m2, sagb, t2dm remission.
126546|NCT03412227|Anxiety|anxiety
126547|NCT03412227|Depression|depression
126548|NCT03412227|Children|children
126549|NCT03412227|Adolescents|adolescents
126550|NCT03412227|CBT|cbt
126551|NCT03412201|Disease management|disease management
126552|NCT03412201|Medication therapy management|medication therapy management
126553|NCT03412201|Biomarkers|biomarkers
126554|NCT03412188|Chronic ITP|chronic itp
126555|NCT03412188|persistent ITP|persistent itp
126556|NCT03412188|Eltrombopag|eltrombopag
126557|NCT03412188|GPVI receptor|gpvi receptor
126558|NCT03412162|Discrimination|discrimination
126559|NCT03412162|Cortisol|cortisol
126560|NCT03412162|Sleep|sleep
126561|NCT03412162|Identity|identity
126562|NCT03412149|Malabsorption, Mini Gastric Bypass, Roux en Y Gastric Bypass|malabsorption, mini gastric bypass, roux en y gastric bypass
126563|NCT03412136|Testosterone|testosterone
126564|NCT03412136|Food Intake|food intake
126565|NCT03412136|Appetite|appetite
126566|NCT03412110|chiropractic|chiropractic
126567|NCT03412110|SMT|smt
126568|NCT03412110|Active surveillance reporting system|active surveillance reporting system
126569|NCT03412097|chiropractic|chiropractic
126570|NCT03412097|SMT|smt
126571|NCT03412097|active surveillance reporting system|active surveillance reporting system
126572|NCT03412084|Sedentary Lifestyle|sedentary lifestyle
126573|NCT03412084|physical function|physical function
126574|NCT03412058|PD-1|pd-1
126575|NCT03412058|PD-L1|pd-l1
126576|NCT03412019|Music|music
126577|NCT03412019|Patient Satisfaction|patient satisfaction
126578|NCT03412006|type II diabetes|type ii diabetes
126579|NCT03412006|diabetic kidney disease|diabetic kidney disease
126580|NCT03411980|Pharmacokinetics|pharmacokinetics
126581|NCT03411954|hippocampus avoidance|hippocampus avoidance
126582|NCT03411954|cognitive changes|cognitive changes
126583|NCT03411954|intensity modulated radiotherapy|intensity modulated radiotherapy
126584|NCT03411941|nAMD: neovascular Age-related Macular Degeneration|namd: neovascular age-related macular degeneration
126585|NCT03411915|NET|net
126586|NCT03411915|GIST|gist
126587|NCT03411915|DUET-1|duet-1
126588|NCT03411902|Bone Health|bone health
126589|NCT03411876|IPF|ipf
126590|NCT03411876|Oxymizer|oxymizer
126591|NCT03411876|oxygen conserving device|oxygen conserving device
126592|NCT03411876|pulmonary disease|pulmonary disease
126593|NCT03411863|Transcutaneous Electric Nerve Stimulation|transcutaneous electric nerve stimulation
126594|NCT03411863|transcranial magnetic stimulation|transcranial magnetic stimulation
126595|NCT03411837|Atopic Dermatitis, dupilumab|atopic dermatitis, dupilumab
126596|NCT03411824|diagnosis|diagnosis
126597|NCT03411824|Point-of-Care-Ultrasound|point-of-care-ultrasound
126598|NCT03411824|lung ultrasound|lung ultrasound
126599|NCT03411811|tendinopathy|tendinopathy
126600|NCT03411811|wrist|wrist
126601|NCT03411811|chronic pain|chronic pain
126602|NCT03411811|sprain|sprain
126603|NCT03411798|ankylosing spondylitis(AS)|ankylosing spondylitis(as)
126604|NCT03411798|TNFi|tnfi
126605|NCT03411798|Yisaipu®|yisaipu®
126606|NCT03411798|Disease modifying anti-rheumatic drugs (DMARDs)|disease modifying anti-rheumatic drugs (dmards)
126607|NCT03411759|CYP2D6|cyp2d6
126608|NCT03411759|Chronic pain|chronic pain
126609|NCT03411759|Cytochrome P450|cytochrome p450
126610|NCT03411759|Opioids|opioids
126611|NCT03411733|acne vlugaris|acne vlugaris
126612|NCT03411733|prevalence|prevalence
126613|NCT03411733|Helicobacter Pylori|helicobacter pylori
126614|NCT03411707|Colorectal cancer screening|colorectal cancer screening
126615|NCT03411707|Stool DNA test|stool dna test
126616|NCT03411707|Blood mRNA test|blood mrna test
161560|NCT03188380|nec|nec
126617|NCT03411694|Survey|survey
126618|NCT03411694|Anesthesia|anesthesia
126619|NCT03411694|Anesthesiologist|anesthesiologist
126620|NCT03411694|Patient perspective|patient perspective
126621|NCT03411668|undergraduate nursing students|undergraduate nursing students
126622|NCT03411668|evidence based practice beliefs|evidence based practice beliefs
126623|NCT03411668|evidence based practice knowledge|evidence based practice knowledge
126624|NCT03411668|evidence based practice implementation|evidence based practice implementation
126625|NCT03411668|Evidence based practice Education programme|evidence based practice education programme
126626|NCT03411642|Stroke, echocardiography|stroke, echocardiography
126627|NCT03411629|Necrotizing Pancreatitis|necrotizing pancreatitis
126628|NCT03411629|Critically ill|critically ill
126629|NCT03411629|Mortality|mortality
126630|NCT03411616|Eating behavior|eating behavior
126631|NCT03411616|Excessive weight|excessive weight
126632|NCT03411616|Food craving|food craving
126633|NCT03411616|Liver transplantation|liver transplantation
126634|NCT03411616|Obesity|obesity
126635|NCT03411616|Weight gain|weight gain
126636|NCT03411603|nutrient profiling|nutrient profiling
126637|NCT03411564|dating violence|dating violence
126638|NCT03411564|health promotion|health promotion
126639|NCT03411564|educational intervention|educational intervention
126640|NCT03411564|health assets|health assets
126641|NCT03411564|participation action research|participation action research
126642|NCT03411551|Intravenous anesthesia|intravenous anesthesia
126643|NCT03411551|Nerve Block|nerve block
126644|NCT03411551|Regional anesthesia|regional anesthesia
126645|NCT03411538|antibiotic-resistant infections|antibiotic-resistant infections
126646|NCT03411538|risk factors|risk factors
126647|NCT03411538|prospective surveillance|prospective surveillance
126648|NCT03411512|congenital heart defects|congenital heart defects
126649|NCT03411512|near-infrared spectroscopy|near-infrared spectroscopy
126650|NCT03411512|newborn|newborn
126651|NCT03411512|tissue oxygenation|tissue oxygenation
126652|NCT03411499|Adult|adult
126653|NCT03411499|Endocarditis/surgery|endocarditis/surgery
126654|NCT03411499|Embolism/prevention & control|embolism/prevention & control
126655|NCT03411499|Cardiovascular Diseases|cardiovascular diseases
126656|NCT03411499|Costs and Cost Analysis|costs and cost analysis
126657|NCT03411499|Quality of life|quality of life
126658|NCT03411447|vasoactive drug|vasoactive drug
126659|NCT03411447|mechanical ventilation|mechanical ventilation
126660|NCT03411447|early enteral nutrition|early enteral nutrition
126661|NCT03411447|intensive care unit|intensive care unit
126662|NCT03411447|early parenteral nutrition|early parenteral nutrition
126663|NCT03411447|critical care medicine|critical care medicine
126664|NCT03411447|nosocomial infection|nosocomial infection
126665|NCT03411447|mortality|mortality
126666|NCT03411447|shock|shock
126667|NCT03411434|oculomotor performances|oculomotor performances
126668|NCT03411434|neurocognition|neurocognition
126669|NCT03411434|methylphenidate|methylphenidate
126670|NCT03411408|Hypofractionated radiotherapy|hypofractionated radiotherapy
126671|NCT03411408|image - guided helical tomotherapy|image - guided helical tomotherapy
126672|NCT03411408|hyperbaric oxygen therapy|hyperbaric oxygen therapy
126673|NCT03411408|malignant glioma|malignant glioma
126674|NCT03411408|high grade glioma|high grade glioma
126675|NCT03411408|recurrent glioma|recurrent glioma
126676|NCT03411395|Diabetes|diabetes
126677|NCT03411395|Prediabetes|prediabetes
126678|NCT03411395|Blood sugar regulation|blood sugar regulation
126679|NCT03411369|Creatine, ribose, ischemic heart disease.|creatine, ribose, ischemic heart disease.
126680|NCT03411343|Postoperative Shoulder Analgesia|postoperative shoulder analgesia
126681|NCT03411343|Hemidiaphragmatic Paralysis|hemidiaphragmatic paralysis
126682|NCT03411343|Alternative blocks|alternative blocks
126683|NCT03411317|Aortic stenosis|aortic stenosis
126684|NCT03411317|progression|progression
126685|NCT03411317|Left ventricular remodeling|left ventricular remodeling
126686|NCT03411304|Aortic valvular replacement|aortic valvular replacement
126687|NCT03411304|Aortic stenosis|aortic stenosis
126688|NCT03411304|Left ventricular remodeling|left ventricular remodeling
126689|NCT03411304|biomarkers|biomarkers
126690|NCT03411291|Alzheimer's, magnetic resonance imaging|alzheimer's, magnetic resonance imaging
126691|NCT03411278|recovery|recovery
126692|NCT03411278|deep oscillation|deep oscillation
126693|NCT03411278|soccer|soccer
126694|NCT03411278|sports|sports
126695|NCT03411278|training|training
126696|NCT03411278|electrotherapy|electrotherapy
126697|NCT03411278|physical therapy|physical therapy
126698|NCT03411239|Airway pressure|airway pressure
126699|NCT03411239|Oesophageal pressure|oesophageal pressure
126700|NCT03411239|transpulmonary pressure|transpulmonary pressure
126701|NCT03411239|laparoscopic surgery|laparoscopic surgery
126702|NCT03411226|Inguinal Hernia|inguinal hernia
126703|NCT03411226|TREPP|trepp
126704|NCT03411226|Recurrence|recurrence
126705|NCT03411200|Older|older
126706|NCT03411200|Advanced Cancer|advanced cancer
126707|NCT03411200|Exercise|exercise
126708|NCT03411200|Resistance training|resistance training
126709|NCT03411200|Counseling|counseling
126710|NCT03411200|Mobilization|mobilization
126711|NCT03411187|Endoscopy|endoscopy
126712|NCT03411187|Thyroidectomy|thyroidectomy
126713|NCT03411187|Thyroid Cancer|thyroid cancer
126714|NCT03411174|breast cancer|breast cancer
126715|NCT03411174|hypofractionated partial breast irradiation|hypofractionated partial breast irradiation
126716|NCT03411161|Mps1|mps1
126717|NCT03411161|Mps1i|mps1i
126718|NCT03411161|S81694|s81694
126719|NCT03411161|breast cancer|breast cancer
126720|NCT03411161|triple negative breast cancer|triple negative breast cancer
126721|NCT03411161|phase I|phase i
126722|NCT03411161|phase II|phase ii
126723|NCT03411148|fear avoidance|fear avoidance
126724|NCT03411148|cognitive behavioral therapy|cognitive behavioral therapy
126725|NCT03411148|physical therapy|physical therapy
126726|NCT03411148|prosthetic|prosthetic
126727|NCT03411148|fear of falling|fear of falling
126728|NCT03411148|gait|gait
126729|NCT03411122|Enzyme Inhibitors|enzyme inhibitors
126730|NCT03411122|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers
126731|NCT03411109|intrathecal analgesia|intrathecal analgesia
126732|NCT03411109|colorectal|colorectal
126733|NCT03411109|enhanced recovery|enhanced recovery
126734|NCT03411083|Rehabilitation|rehabilitation
126735|NCT03411083|Recovery of function|recovery of function
126736|NCT03411083|Outcome Assessment (Health Care)|outcome assessment (health care)
126737|NCT03411083|Patient Reported outcome Measures|patient reported outcome measures
126738|NCT03411083|Treatment Outcome|treatment outcome
126739|NCT03411083|Pain, Postoperative|pain, postoperative
126740|NCT03411083|Pain Management|pain management
126741|NCT03411083|Orthopedic Surgery|orthopedic surgery
126742|NCT03411057|Mindfulness|mindfulness
126743|NCT03411057|Mindfulness Based Stress Reduction|mindfulness based stress reduction
126744|NCT03411057|Rheumatoid Arthritis|rheumatoid arthritis
126745|NCT03411057|Anxiety|anxiety
126746|NCT03411057|Depression|depression
126747|NCT03411057|Psoriatic Arthritis|psoriatic arthritis
126748|NCT03411057|scleroderma|scleroderma
126749|NCT03411044|Total Hip Arthroplasty|total hip arthroplasty
126750|NCT03411044|Fitmore|fitmore
126751|NCT03411044|Minimal Invasive Surgery|minimal invasive surgery
126752|NCT03411044|Short Stem|short stem
126753|NCT03411031|lenalidomide maintenance|lenalidomide maintenance
126754|NCT03411031|hematopoietic cell transplantation|hematopoietic cell transplantation
126755|NCT03411031|serologic relapse|serologic relapse
126756|NCT03411018|lung protective strategies|lung protective strategies
126757|NCT03411018|Less invasive respiratory support|less invasive respiratory support
126758|NCT03411018|preterm infant|preterm infant
126759|NCT03411005|Lysine, Adult, Protein Quality|lysine, adult, protein quality
126760|NCT03410992|Bimekizumab|bimekizumab
126761|NCT03410992|PSO|pso
126762|NCT03410992|Psoriasis|psoriasis
126763|NCT03410940|Total Hip Arthroplasty|total hip arthroplasty
126764|NCT03410940|CLS Brevius|cls brevius
126765|NCT03410940|Kinectiv|kinectiv
126766|NCT03410940|Medical Device|medical device
126767|NCT03410940|Performance|performance
126768|NCT03410940|Safety|safety
126769|NCT03410940|Hip Prosthesis|hip prosthesis
126770|NCT03410927|Phase I|phase i
126771|NCT03410927|solid tumors|solid tumors
126772|NCT03410927|pharmacokinetics|pharmacokinetics
126773|NCT03410927|pharmacodynamics|pharmacodynamics
126774|NCT03410927|MTD|mtd
126775|NCT03410927|TAS0728|tas0728
126776|NCT03410927|HER2|her2
126777|NCT03410927|HER3 mutation|her3 mutation
126778|NCT03410927|amplification or overexpression|amplification or overexpression
126779|NCT03410927|Urothelial cancer with HER2 or HER3 mutation|urothelial cancer with her2 or her3 mutation
126780|NCT03410927|Biliary tract cancer with HER2 or HER3 mutation|biliary tract cancer with her2 or her3 mutation
126781|NCT03410927|MBC with HER2 amplification or overexpression or HER3 mutation|mbc with her2 amplification or overexpression or her3 mutation
126782|NCT03410927|NSCLC with HER2 or HER3 mutation|nsclc with her2 or her3 mutation
126783|NCT03410927|CRC with HER2 or HER3 mutation|crc with her2 or her3 mutation
126784|NCT03410927|amplification|amplification
126785|NCT03410914|Hemopatch|hemopatch
126786|NCT03410888|sciatic nerve block|sciatic nerve block
126787|NCT03410888|infragluteal approach|infragluteal approach
126788|NCT03410888|popliteal approach|popliteal approach
126789|NCT03410875|Leukemia|leukemia
126790|NCT03410875|Hairy Cell Leukemia|hairy cell leukemia
126791|NCT03410875|BRAF|braf
126792|NCT03410875|vemurafenib|vemurafenib
126793|NCT03410875|obinutuzumab|obinutuzumab
126794|NCT03410875|Memorial Sloan Kettering Cancer Center|memorial sloan kettering cancer center
126795|NCT03410875|17-513|17-513
126796|NCT03410862|Elderberry|elderberry
126797|NCT03410862|Influenza|influenza
126798|NCT03410836|lidocaine|lidocaine
126799|NCT03410836|colorectal cancer|colorectal cancer
126800|NCT03410836|laparoscopy surgery|laparoscopy surgery
126801|NCT03410836|anesthesia|anesthesia
126802|NCT03410836|inflammation|inflammation
126803|NCT03410836|cytokine|cytokine
126804|NCT03410836|post-operative immunosuppression|post-operative immunosuppression
126805|NCT03410823|hip fracture|hip fracture
126806|NCT03410823|exercise|exercise
126807|NCT03410823|protein|protein
126808|NCT03410810|Prematurity|prematurity
126809|NCT03410810|Neuroimaging|neuroimaging
126810|NCT03410797|SOVT|sovt
126811|NCT03410797|semi occluded vocal tract|semi occluded vocal tract
126812|NCT03410797|voice disorder|voice disorder
126813|NCT03410797|voice therapy|voice therapy
126814|NCT03410797|muscle tension dysphonia|muscle tension dysphonia
126815|NCT03410797|MTD|mtd
126816|NCT03410797|vocal fold lesions|vocal fold lesions
126817|NCT03410797|vocal fold atrophy|vocal fold atrophy
126818|NCT03410784|PD-L1 Expression|pd-l1 expression
126819|NCT03410784|prognostic factors|prognostic factors
126820|NCT03410784|predictive factors|predictive factors
126821|NCT03410784|Patient reported outcomes|patient reported outcomes
126828|NCT03410732|immunotherapy|immunotherapy
126829|NCT03410732|tumor cell membrane proteins|tumor cell membrane proteins
126830|NCT03410706|Venous thromboembolism|venous thromboembolism
126831|NCT03410706|Anticoagulation|anticoagulation
126832|NCT03410706|Rivaroxaban|rivaroxaban
126833|NCT03410706|Observation study|observation study
126835|NCT03410680|Antiretroviral Therapy|antiretroviral therapy
126836|NCT03410680|Adherence|adherence
126837|NCT03410680|HIV|hiv
126838|NCT03410680|Men who have sex with men|men who have sex with men
126839|NCT03410680|Sexual minorities|sexual minorities
126840|NCT03410680|habit-formation|habit-formation
126841|NCT03410680|gamification|gamification
126842|NCT03410641|cancer risk|cancer risk
126843|NCT03410641|randomised trial|randomised trial
126844|NCT03410641|intervention|intervention
126845|NCT03410641|smoking cessation|smoking cessation
126846|NCT03410641|dietary intervention|dietary intervention
126847|NCT03410641|weight loss|weight loss
126848|NCT03410602|Nonsurgical periodontal therapy|nonsurgical periodontal therapy
126849|NCT03410602|Orthodontic bands|orthodontic bands
126850|NCT03410576|Matrix metalloproteinase|matrix metalloproteinase
126851|NCT03410576|Carotid artery stenting|carotid artery stenting
126852|NCT03410576|Carotid endarterectomy|carotid endarterectomy
126853|NCT03410563|Pain|pain
126854|NCT03410563|Auditory inputs|auditory inputs
126855|NCT03410524|Bowel wall visualization|bowel wall visualization
126856|NCT03410524|Intraluminal bubbles|intraluminal bubbles
126857|NCT03410524|Intraluminal foam|intraluminal foam
126858|NCT03410524|Simethicone|simethicone
126859|NCT03410485|NoL index|nol index
126860|NCT03410485|Bispectral index|bispectral index
126861|NCT03410485|Intraoperative monitoring|intraoperative monitoring
126862|NCT03410420|Thoracic Aortic Aneurysm|thoracic aortic aneurysm
126863|NCT03410420|Hypoxia|hypoxia
126864|NCT03410420|Ascending Aorta|ascending aorta
126865|NCT03410420|Hypoxyprobe|hypoxyprobe
126866|NCT03410420|Pimonidazole|pimonidazole
126867|NCT03410407|Acute Myeloid Leukemia|acute myeloid leukemia
126868|NCT03410407|Central Nervous System|central nervous system
126869|NCT03410407|Relapse|relapse
126870|NCT03410407|Prognostic factors|prognostic factors
126871|NCT03410394|adrenal|adrenal
126872|NCT03410394|thyroid|thyroid
126873|NCT03410394|parathyroid|parathyroid
126874|NCT03410394|endocrine pancreas|endocrine pancreas
126875|NCT03410394|endocrine digestive tube|endocrine digestive tube
126876|NCT03410381|Psychiatry|psychiatry
126877|NCT03410381|Suicide|suicide
126878|NCT03410381|Prediction|prediction
126879|NCT03410381|Smartphone application|smartphone application
126880|NCT03410381|Ecological Momentary Assessment|ecological momentary assessment
126881|NCT03410368|maintenance therapy|maintenance therapy
126882|NCT03410368|immunotherapy|immunotherapy
126883|NCT03410368|adoptive cell transfer|adoptive cell transfer
126884|NCT03410368|natural killer cell|natural killer cell
126885|NCT03410316|Obesity|obesity
126886|NCT03410316|Common diseases|common diseases
126887|NCT03410316|Epidemiology|epidemiology
126888|NCT03410316|Etiology|etiology
126889|NCT03410225|Pregnancy Prevention|pregnancy prevention
126890|NCT03410225|Male Involvement|male involvement
126891|NCT03410212|Inferior alveolar nerve block|inferior alveolar nerve block
126892|NCT03410212|ketorolac|ketorolac
126893|NCT03410212|success|success
126894|NCT03410160|adrenal crisis|adrenal crisis
126895|NCT03410160|predisposing factors|predisposing factors
126896|NCT03410134|Permanent teeth|permanent teeth
126897|NCT03410134|Vital pulp therapy|vital pulp therapy
126898|NCT03410134|MTA|mta
126899|NCT03410017|Functional Listening Index|functional listening index
126900|NCT03409991|Psychiatric Rehabilitation|psychiatric rehabilitation
126901|NCT03409991|Career Counseling|career counseling
126902|NCT03409978|Infants, newborn|infants, newborn
126903|NCT03409978|General Movements|general movements
126904|NCT03409978|Video Recording|video recording
126905|NCT03409978|Mobile Applications|mobile applications
126906|NCT03409978|Prognosis|prognosis
126907|NCT03409978|Parents|parents
126908|NCT03409939|nutrition|nutrition
126909|NCT03409939|phenylalanine|phenylalanine
126910|NCT03409939|tyrosine|tyrosine
126911|NCT03409939|stable isotope|stable isotope
126912|NCT03409926|Heart Disease|heart disease
126913|NCT03409926|Cardiovascular Disease|cardiovascular disease
126914|NCT03409926|Diet|diet
126915|NCT03409926|Fiber|fiber
126916|NCT03409926|Microbiome|microbiome
126917|NCT03409913|positron emissions tomography|positron emissions tomography
126918|NCT03409913|diagnostic accuracy|diagnostic accuracy
126919|NCT03409913|case-control|case-control
126925|NCT03409887|root canal treatment, intraorifice barrier.|root canal treatment, intraorifice barrier.
126927|NCT03409809|Eating Disorder|eating disorder
126928|NCT03409809|Dissemination|dissemination
126929|NCT03409809|Prevention|prevention
126930|NCT03409809|Peer Leader|peer leader
126931|NCT03409796|Gluten Challenge|gluten challenge
126932|NCT03409757|microbiome|microbiome
126933|NCT03409744|HoFH|hofh
126934|NCT03409731|Drug eluting Bio-resolvable Scaffold (BRS)|drug eluting bio-resolvable scaffold (brs)
126935|NCT03409731|Bio-resolvable Scaffold (BRS)|bio-resolvable scaffold (brs)
126936|NCT03409731|Real world|real world
126937|NCT03409718|Total Shoulder Arthroplasty|total shoulder arthroplasty
126938|NCT03409718|Medical Device|medical device
126939|NCT03409718|Performance|performance
126940|NCT03409718|Safety|safety
126941|NCT03409718|Shoulder Prosthesis|shoulder prosthesis
126942|NCT03409666|Total Hip Arthroplasty|total hip arthroplasty
126943|NCT03409666|Medical Device|medical device
126944|NCT03409666|Performance|performance
126945|NCT03409666|Safety|safety
126946|NCT03409666|Hip prosthesis|hip prosthesis
126947|NCT03409666|Roentgen Stereophotogrammetric Analysis|roentgen stereophotogrammetric analysis
126948|NCT03409627|retrograde coronary sinus infusion|retrograde coronary sinus infusion
126949|NCT03409627|DNA|dna
126950|NCT03409627|non-viral|non-viral
126951|NCT03409627|triple effector plasmid|triple effector plasmid
126952|NCT03409627|gene therapy|gene therapy
126953|NCT03409627|regenerative medicine|regenerative medicine
126954|NCT03409627|non-stem cell|non-stem cell
126955|NCT03409614|Stage IIIB|stage iiib
126956|NCT03409614|Stage IIIC|stage iiic
126957|NCT03409614|Stage IV|stage iv
126958|NCT03409614|Non-squamous NSCLC|non-squamous nsclc
126959|NCT03409614|Squamous NSCLC|squamous nsclc
126960|NCT03409601|Obesity, eating behavior, food, nutrition|obesity, eating behavior, food, nutrition
126961|NCT03409588|Chronic Thromboembolic Disease|chronic thromboembolic disease
126962|NCT03409588|CTED|cted
126963|NCT03409588|Treatment Post PEA surgery|treatment post pea surgery
126964|NCT03409575|neuromuscular electrical stimulation|neuromuscular electrical stimulation
126965|NCT03409575|geriatric population|geriatric population
126966|NCT03409575|physical function|physical function
126967|NCT03409575|quadriceps|quadriceps
126968|NCT03409575|fatigue|fatigue
126969|NCT03409562|low back pain|low back pain
126970|NCT03409562|pain neurophysiology education|pain neurophysiology education
126971|NCT03409562|motor control|motor control
126972|NCT03409536|SSEP Monitoring|ssep monitoring
126973|NCT03409536|Diagnostic threshold|diagnostic threshold
126974|NCT03409510|vitamin D|vitamin d
126975|NCT03409510|25(OH)D|25(oh)d
126976|NCT03409510|skin pigmentation|skin pigmentation
126977|NCT03409510|UVB|uvb
126978|NCT03409510|pigment genes|pigment genes
126979|NCT03409471|Urine|urine
126980|NCT03409471|Cervical Intraepithelial Neoplasia|cervical intraepithelial neoplasia
126981|NCT03409471|Self-Sampling|self-sampling
126982|NCT03409471|HPV Testing|hpv testing
126983|NCT03409471|Cervical Cancer Screening|cervical cancer screening
126984|NCT03409471|ASCUS|ascus
126985|NCT03409471|LSIL|lsil
126986|NCT03409458|Advanced Solid Tumors|advanced solid tumors
126987|NCT03409458|NSCLC|nsclc
126988|NCT03409458|mUC|muc
126989|NCT03409458|mBC|mbc
126990|NCT03409458|CRPC|crpc
126991|NCT03409458|SCCHN|scchn
126992|NCT03409419|Advanced|advanced
126993|NCT03409419|Recurrent|recurrent
126994|NCT03409419|Immune Therapy|immune therapy
126995|NCT03409406|developmental disability|developmental disability
126996|NCT03409406|speech and language disorder|speech and language disorder
126997|NCT03409406|mobile health technology|mobile health technology
126998|NCT03409406|parent training|parent training
126999|NCT03409406|communication intervention|communication intervention
127000|NCT03409393|Human|human
127001|NCT03409393|Denmark|denmark
127002|NCT03409393|Adult|adult
127003|NCT03409393|Adolescent|adolescent
127004|NCT03409393|Young Adult|young adult
127005|NCT03409393|Male|male
127006|NCT03409393|Female|female
127007|NCT03409393|Physical Activity|physical activity
127008|NCT03409393|Maximum Oxygen Consumption|maximum oxygen consumption
127009|NCT03409393|Resistance Training|resistance training
127010|NCT03409393|High-Intensity Functional Training|high-intensity functional training
127011|NCT03409393|Aerobic Exercise|aerobic exercise
127012|NCT03409393|Motivation|motivation
127013|NCT03409393|Feasibility|feasibility
127014|NCT03409393|Relevance|relevance
127015|NCT03409393|Health Behavior|health behavior
127016|NCT03409380|growth hormone|growth hormone
127017|NCT03409367|Prevention|prevention
127018|NCT03409367|Emollient|emollient
127019|NCT03409367|Pragmatic clinical trial|pragmatic clinical trial
127020|NCT03409315|Centralized Therapeutic Drug Monitoring|centralized therapeutic drug monitoring
127021|NCT03409315|Fluoroquinolones|fluoroquinolones
127022|NCT03409302|ACT|act
127023|NCT03409302|digital intervention|digital intervention
127024|NCT03409302|web-based|web-based
127025|NCT03409302|adherence|adherence
127026|NCT03409289|Spontaneous Circulation (ROSC)|spontaneous circulation (rosc)
127027|NCT03409289|Shock and Hypotension (RUSH) exam|shock and hypotension (rush) exam
127028|NCT03409263|Cirrhosis|cirrhosis
127029|NCT03409263|Advanced chronic liver disease|advanced chronic liver disease
127030|NCT03409263|Ascites|ascites
127031|NCT03409263|Variceal hemorrhage|variceal hemorrhage
127032|NCT03409263|Transjugular intrahepatic portosystemic shunt|transjugular intrahepatic portosystemic shunt
127033|NCT03409250|CNV due to Age Related Macular Degeneration|cnv due to age related macular degeneration
127034|NCT03409198|Neoplasms|neoplasms
127035|NCT03409185|Cataract surgery|cataract surgery
127036|NCT03409185|Intraocular lens|intraocular lens
127037|NCT03409185|Glistenings|glistenings
127038|NCT03409172|High intensity interval training|high intensity interval training
127039|NCT03409172|Inflammation|inflammation
127040|NCT03409172|Obesity|obesity
127041|NCT03409172|adipokines|adipokines
127042|NCT03409133|Prosthesis User|prosthesis user
127043|NCT03409133|Phantom Sensation|phantom sensation
127044|NCT03409133|Sensory Feedback|sensory feedback
127045|NCT03409120|Dystonia|dystonia
127046|NCT03409120|Parkinson's Disease|parkinson's disease
127047|NCT03409107|Non-Dialysis|non-dialysis
127048|NCT03409107|Anemia|anemia
127049|NCT03409107|Chronic kidney disease|chronic kidney disease
127050|NCT03409107|Recombinant human erythropoietin naïve|recombinant human erythropoietin naïve
127051|NCT03409107|Hemoglobin|hemoglobin
127052|NCT03409107|Daprodustat|daprodustat
127053|NCT03409081|Expanded Access|expanded access
127054|NCT03409081|FMS-like Tyrosine Kinase 3|fms-like tyrosine kinase 3
127055|NCT03409081|Acute Myeloid Leukemia (AML)|acute myeloid leukemia (aml)
127056|NCT03409081|gilteritinib|gilteritinib
127057|NCT03409081|ASP2215|asp2215
127058|NCT03409068|Carotid thromboendarterectomy|carotid thromboendarterectomy
127059|NCT03409068|Carotidodynia|carotidodynia
127060|NCT03409042|Caloric compensation|caloric compensation
127061|NCT03409029|bladder|bladder
127062|NCT03409029|radiotherapy|radiotherapy
127063|NCT03409029|magnetic resonance imaging|magnetic resonance imaging
127064|NCT03409016|Immune Checkpoint Inhibitors|immune checkpoint inhibitors
127065|NCT03409016|Biomarkers|biomarkers
127066|NCT03409016|Immune Related Adverse Event|immune related adverse event
127067|NCT03409003|urea cycle disorder|urea cycle disorder
127068|NCT03408977|meal ingestion|meal ingestion
127069|NCT03408977|meal tolerance|meal tolerance
127070|NCT03408977|postprandial responses|postprandial responses
127071|NCT03408977|hedonic sensations|hedonic sensations
127072|NCT03408977|homeostatic sensations|homeostatic sensations
127073|NCT03408925|elite orienteering|elite orienteering
127074|NCT03408899|Microbicides|microbicides
127075|NCT03408886|fecal transplant|fecal transplant
127076|NCT03408886|fecal microbiota transplant|fecal microbiota transplant
127077|NCT03408886|microbiota transplant|microbiota transplant
127078|NCT03408886|vancomycin|vancomycin
127079|NCT03408886|moviprep|moviprep
127080|NCT03408873|Antipsychotic Drugs|antipsychotic drugs
127081|NCT03408873|Antipsychotics|antipsychotics
127082|NCT03408873|Injectables|injectables
127083|NCT03408873|Long Acting Injectable Antipsychotic|long acting injectable antipsychotic
127084|NCT03408873|Bipolar Disorder|bipolar disorder
127085|NCT03408873|Medication Adherence|medication adherence
127086|NCT03408873|Medication Non-Adherence|medication non-adherence
127087|NCT03408847|Ulcerative colitis|ulcerative colitis
127088|NCT03408847|UC|uc
127089|NCT03408847|Extra virgin olive oil|extra virgin olive oil
127090|NCT03408847|Polyphenols|polyphenols
127091|NCT03408834|NGAL|ngal
127092|NCT03408834|PVI|pvi
127093|NCT03408808|wrist|wrist
127094|NCT03408808|ganglion|ganglion
127095|NCT03408808|platelet rich plasma|platelet rich plasma
127096|NCT03408808|aspiration|aspiration
127097|NCT03408782|Surgical Site Infection|surgical site infection
127098|NCT03408782|Surgical drains|surgical drains
127099|NCT03408769|Cancer|cancer
127100|NCT03408769|Sexuality|sexuality
127101|NCT03408769|Quality of life|quality of life
127102|NCT03408769|Intimacy|intimacy
127103|NCT03408769|BISF-WBrief Index of Sexual Functioning for Women questionnaire|bisf-wbrief index of sexual functioning for women questionnaire
127104|NCT03408769|Quality of life questionnaire (EORTC QLQ-BR23):|quality of life questionnaire (eortc qlq-br23):
127105|NCT03408769|Partnership questionnaire (partnerschaftsfragebogen; PFB)|partnership questionnaire (partnerschaftsfragebogen; pfb)
127106|NCT03408743|Multiphase optimization strategy|multiphase optimization strategy
127107|NCT03408743|College students|college students
127108|NCT03408730|Hepatitis B Vaccines|hepatitis b vaccines
127109|NCT03408717|Breast cancer|breast cancer
127110|NCT03408717|Chronic pain|chronic pain
127111|NCT03408717|Acute Pain|acute pain
127112|NCT03408717|Depression|depression
127113|NCT03408717|Anxiety|anxiety
127114|NCT03408704|Streptococcus Pyogenes Infection|streptococcus pyogenes infection
127115|NCT03408704|Randomized Controlled Trial|randomized controlled trial
127116|NCT03408691|probiotic|probiotic
127117|NCT03408691|permeability|permeability
127118|NCT03408691|stress|stress
127119|NCT03408678|body composition|body composition
127120|NCT03408678|glucocorticoids|glucocorticoids
127121|NCT03408678|inflammation|inflammation
127122|NCT03408678|black African|black african
127123|NCT03408678|sex|sex
127124|NCT03408678|gonadal steroid hormones|gonadal steroid hormones
127125|NCT03408652|Bone Metastases|bone metastases
127126|NCT03408639|End-Stage Renal Disease, Anemia, Erythropoietin, Hemoglobin|end-stage renal disease, anemia, erythropoietin, hemoglobin
127127|NCT03408613|Obstructive Sleep Apnea|obstructive sleep apnea
127128|NCT03408613|Glucose Metabolism|glucose metabolism
127129|NCT03408600|Abdominal sepsis|abdominal sepsis
127130|NCT03408600|Secondary peritonitis|secondary peritonitis
127131|NCT03408600|Complicated intra-abdominal infections|complicated intra-abdominal infections
127132|NCT03408587|CVA21|cva21
127133|NCT03408587|CAVATAK|cavatak
127134|NCT03408587|Coxsackievirus|coxsackievirus
127135|NCT03408587|ocular|ocular
127136|NCT03408587|eye|eye
127137|NCT03408587|ipilimumab|ipilimumab
127138|NCT03408587|yervoy|yervoy
127139|NCT03408587|oncolytic|oncolytic
127140|NCT03408587|virus|virus
127141|NCT03408587|checkpoint|checkpoint
127142|NCT03408587|CTLA-4|ctla-4
127143|NCT03408574|nicotinic system|nicotinic system
127144|NCT03408574|cognitive aging|cognitive aging
127145|NCT03408574|working memory|working memory
127146|NCT03408574|fMRI|fmri
127147|NCT03408548|Bifidobacterium animalis subsp. lactis|bifidobacterium animalis subsp. lactis
127148|NCT03408548|Probiotic|probiotic
127149|NCT03408548|Periodontitis treatment|periodontitis treatment
127150|NCT03408548|Periodontitis|periodontitis
127151|NCT03408535|eHealth|ehealth
127152|NCT03408535|Online Rehabilitation|online rehabilitation
127153|NCT03408535|Hearing Problems|hearing problems
127154|NCT03408535|Adult|adult
127155|NCT03408535|Hearing Aids|hearing aids
127156|NCT03408496|Myofascial release|myofascial release
127157|NCT03408496|Pain|pain
127158|NCT03408496|Manual therapy|manual therapy
127159|NCT03408496|Muscle stretching|muscle stretching
127160|NCT03408496|Quality of life|quality of life
127161|NCT03408483|Quadratus Lumborum Block|quadratus lumborum block
127162|NCT03408470|Absolute Bioavailability|absolute bioavailability
127163|NCT03408470|ADME|adme
127164|NCT03408470|Healthy Normal Males|healthy normal males
127165|NCT03408457|Surgical wound infection|surgical wound infection
127166|NCT03408457|antibiotic concentration|antibiotic concentration
127167|NCT03408457|blood level|blood level
127168|NCT03408418|Platelet-rich fibrin|platelet-rich fibrin
127169|NCT03408418|Tooth Extraction|tooth extraction
127170|NCT03408418|Alveolar Bone Grafting|alveolar bone grafting
127171|NCT03408392|Single dose|single dose
127172|NCT03408392|Oral suspension|oral suspension
127173|NCT03408392|Bioequivalence|bioequivalence
127174|NCT03408392|Cefixime|cefixime
127175|NCT03408392|Two-way crossover|two-way crossover
127176|NCT03408379|intracranial aneurysms|intracranial aneurysms
127177|NCT03408379|ruptured aneurysm|ruptured aneurysm
127178|NCT03408379|platelet activity|platelet activity
127179|NCT03408366|Laparotomy|laparotomy
127180|NCT03408366|Surgical Incisions|surgical incisions
127181|NCT03408366|Wound Perfusion|wound perfusion
127182|NCT03408366|17-650|17-650
127183|NCT03408340|Anesthesiology|anesthesiology
127184|NCT03408340|Pediatric surgery|pediatric surgery
127185|NCT03408340|Anesthesia, Regional|anesthesia, regional
127186|NCT03408340|Anesthesia, Cardiac Procedures|anesthesia, cardiac procedures
127187|NCT03408340|Nerve Block|nerve block
127188|NCT03408327|Schizophrenia|schizophrenia
127189|NCT03408327|Physical Activity|physical activity
127190|NCT03408327|Health Promotion|health promotion
127191|NCT03408327|Wearable Technology|wearable technology
127192|NCT03408327|Fitness Wristband|fitness wristband
127193|NCT03408327|mobile health, mHealth|mobile health, mhealth
127194|NCT03408314|Advanced Cancer|advanced cancer
127195|NCT03408275|Dietary patterns|dietary patterns
127196|NCT03408275|Pregnancy|pregnancy
127197|NCT03408275|Woman|woman
127198|NCT03408275|Diet|diet
127199|NCT03408275|Lead|lead
127200|NCT03408275|ALSPAC|alspac
127201|NCT03408249|Crohn's disease, ulcerative colitis, fecal calprotectin|crohn's disease, ulcerative colitis, fecal calprotectin
127202|NCT03408197|inadvertent, intraoperative hypothermia, prewarming|inadvertent, intraoperative hypothermia, prewarming
127203|NCT03408197|core temperature monitoring|core temperature monitoring
127204|NCT03408171|liver biopsy|liver biopsy
127205|NCT03408171|endoscopic ultrasound guided liver biopsy|endoscopic ultrasound guided liver biopsy
127207|NCT03408171|FNB|fnb
127208|NCT03408158|HPA|hpa
127209|NCT03408158|Blood disease|blood disease
127210|NCT03408145|Stem Cell Therapy|stem cell therapy
127211|NCT03408145|Injection|injection
127212|NCT03408145|Hyaluronic Acid|hyaluronic acid
127213|NCT03408145|Synovial Fluid|synovial fluid
127214|NCT03408119|prune|prune
127215|NCT03408119|dried plum|dried plum
127216|NCT03408119|osteoporosis|osteoporosis
127217|NCT03408119|osteopenia|osteopenia
127218|NCT03408119|men|men
127219|NCT03408093|Interferon beta-1b (INFb-1b)|interferon beta-1b (infb-1b)
127220|NCT03408093|Multiple Sclerosis (MS)|multiple sclerosis (ms)
127221|NCT03408093|Relapsing-remitting MS (RRMS)|relapsing-remitting ms (rrms)
127222|NCT03408093|Secondary progressive MS (SPMS)|secondary progressive ms (spms)
127622|NCT03405675|Nutrition|nutrition
127223|NCT03408093|Clinically isolated syndrome (CIS)|clinically isolated syndrome (cis)
127224|NCT03408054|Uterine contraction|uterine contraction
127225|NCT03408054|Oxytocin|oxytocin
127226|NCT03408054|Nitroglycerin|nitroglycerin
127227|NCT03408041|Alzheimer Disease|alzheimer disease
127228|NCT03408041|Objective parameters|objective parameters
127229|NCT03408041|Scheltens index|scheltens index
127230|NCT03408028|Therapeutic code|therapeutic code
127231|NCT03408028|Geriatry|geriatry
127232|NCT03408015|dry eye disease|dry eye disease
127233|NCT03408015|neutrophil|neutrophil
127234|NCT03408015|T cell|t cell
127235|NCT03408015|lifitegrast|lifitegrast
127236|NCT03408015|contact lens discomfort|contact lens discomfort
127237|NCT03408015|ocular surface homeostasis|ocular surface homeostasis
127238|NCT03408002|preoperative anxiety|preoperative anxiety
127239|NCT03408002|self-efficacy|self-efficacy
127240|NCT03408002|psychophysiology|psychophysiology
127241|NCT03408002|psychotherapy|psychotherapy
127242|NCT03408002|pancreatic surgery|pancreatic surgery
127243|NCT03407950|Deficit Schizophrenia|deficit schizophrenia
127244|NCT03407950|long stay inpatients|long stay inpatients
127245|NCT03407950|cognitive remediation|cognitive remediation
127246|NCT03407950|negative symptoms|negative symptoms
127247|NCT03407937|Hypnosis|hypnosis
127248|NCT03407937|Meditation|meditation
127249|NCT03407937|Conditioned pain modulation|conditioned pain modulation
127250|NCT03407937|Placebo|placebo
127251|NCT03407937|Endocannabinoids|endocannabinoids
127252|NCT03407937|Opioid peptides|opioid peptides
127253|NCT03407937|Norepinephrine|norepinephrine
127254|NCT03407937|Pain|pain
127255|NCT03407937|Analgesia|analgesia
127256|NCT03407937|Genes|genes
127257|NCT03407937|Heart rate variability|heart rate variability
127258|NCT03407911|Peri-implant pocket microbiota|peri-implant pocket microbiota
127259|NCT03407911|Periodontal pocket microbiota|periodontal pocket microbiota
127260|NCT03407859|CD19-CART|cd19-cart
127261|NCT03407859|CD20-CART|cd20-cart
127262|NCT03407859|CD10-CART|cd10-cart
127263|NCT03407859|CD22-CART|cd22-cart
127264|NCT03407859|Relapsed/Refractory B-ALL|relapsed/refractory b-all
127265|NCT03407859|MRD|mrd
127266|NCT03407807|Fetal Splenic cyst|fetal splenic cyst
127267|NCT03407807|Differential Diagnosis|differential diagnosis
127268|NCT03407807|Evolution and complication|evolution and complication
127269|NCT03407768|Premenopausal breast cancer|premenopausal breast cancer
127270|NCT03407768|Individualized interventions|individualized interventions
127271|NCT03407768|Exercise|exercise
127272|NCT03407768|Combination hormone therapy|combination hormone therapy
127273|NCT03407768|Massage therapy|massage therapy
127274|NCT03407768|Yoga|yoga
127275|NCT03407768|Acupuncture|acupuncture
127276|NCT03407768|Treatment tolerance|treatment tolerance
127277|NCT03407768|Treatment adherence|treatment adherence
127278|NCT03407768|Adverse effects|adverse effects
127279|NCT03407768|Quality of life|quality of life
127280|NCT03407755|Intraocular gas|intraocular gas
127281|NCT03407755|Positioning|positioning
127282|NCT03407755|DMEK|dmek
127283|NCT03407755|Endothelial keratoplasty|endothelial keratoplasty
127284|NCT03407729|Hypoxia, Brain|hypoxia, brain
127285|NCT03407729|Neural networks|neural networks
127286|NCT03407729|Magnetic Resonance Imaging|magnetic resonance imaging
127287|NCT03407729|EEG|eeg
127288|NCT03407703|genotype 1|genotype 1
127289|NCT03407703|genotype 4|genotype 4
127290|NCT03407638|Opioid Use Disorder|opioid use disorder
127291|NCT03407638|Primary Care|primary care
127292|NCT03407638|Buprenorphine|buprenorphine
127293|NCT03407638|Naltrexone|naltrexone
127294|NCT03407625|Pregnancy|pregnancy
127295|NCT03407625|Labor Induction|labor induction
127296|NCT03407625|Cervical Ripening|cervical ripening
127297|NCT03407612|continuous passive motion device|continuous passive motion device
127298|NCT03407612|HOS-ADL|hos-adl
127299|NCT03407612|hip arthroscopy|hip arthroscopy
127300|NCT03407586|point-of-care testing|point-of-care testing
127301|NCT03407586|sexually transmitted infections|sexually transmitted infections
127302|NCT03407586|expedited partner therapy|expedited partner therapy
127303|NCT03407586|genital inflammation|genital inflammation
127304|NCT03407560|bone substitute|bone substitute
127305|NCT03407560|spinal fusion|spinal fusion
127306|NCT03407560|lumbar spine disease|lumbar spine disease
127307|NCT03407547|upper limb|upper limb
127308|NCT03407547|recovery|recovery
127309|NCT03407547|somatosensory|somatosensory
127310|NCT03407547|impairment|impairment
127311|NCT03407547|electroencephalography|electroencephalography
127312|NCT03407547|acute phase|acute phase
127313|NCT03407534|Exocrine|exocrine
127314|NCT03407534|Pancreatic Insufficiency|pancreatic insufficiency
127315|NCT03407534|Diarrhea|diarrhea
127316|NCT03407534|Bloating|bloating
127317|NCT03407534|Loose Stool|loose stool
127318|NCT03407521|second trimester abortion|second trimester abortion
127319|NCT03407495|Hepatocellular Carcinoma|hepatocellular carcinoma
127320|NCT03407495|Magnetic Resonance Imaging|magnetic resonance imaging
127321|NCT03407469|Questionnaires|questionnaires
127322|NCT03407469|Surveys|surveys
127323|NCT03407469|Cancer-related Venous Thromboembolism|cancer-related venous thromboembolism
127325|NCT03407443|mental health promotion campaign|mental health promotion campaign
127326|NCT03407443|veterans|veterans
127327|NCT03407430|Pregabalin|pregabalin
127328|NCT03407430|Bone pain|bone pain
127329|NCT03407430|Pegfilgrastim|pegfilgrastim
127330|NCT03407430|Supportive care|supportive care
127331|NCT03407430|prevention|prevention
127332|NCT03407391|Picky eater|picky eater
127333|NCT03407391|Fussy eater|fussy eater
127334|NCT03407391|Faddy eater|faddy eater
127335|NCT03407391|Nutrition|nutrition
127336|NCT03407352|Exercise|exercise
127337|NCT03407352|Video Games|video games
127338|NCT03407352|Physical Activity|physical activity
127339|NCT03407352|Children|children
127340|NCT03407352|Appetite|appetite
127341|NCT03407326|severe acute malnutrition, SAM|severe acute malnutrition, sam
127342|NCT03407313|Submental fullness|submental fullness
127343|NCT03407313|Submental fat|submental fat
127344|NCT03407313|Loose skin|loose skin
127345|NCT03407300|Non-small Cell Lung Cancer (NSCLC), XH1|non-small cell lung cancer (nsclc), xh1
127346|NCT03407222|Type 2 Diabetes Mellitus|type 2 diabetes mellitus
127347|NCT03407222|Physical Activity|physical activity
127348|NCT03407222|Personal health record|personal health record
127349|NCT03407222|Intervention|intervention
127350|NCT03407209|Epidural analgesia|epidural analgesia
127351|NCT03407209|Patient Controlled Epidural Analgesia (PCEA)|patient controlled epidural analgesia (pcea)
127352|NCT03407209|Patient Epidural Intermittent Bolus (PEIB)|patient epidural intermittent bolus (peib)
127353|NCT03407209|Local anesthetics|local anesthetics
127354|NCT03407196|Diabetes|diabetes
127355|NCT03407196|Dapagliflozin|dapagliflozin
127356|NCT03407196|Endocrinology|endocrinology
127357|NCT03407196|Internal diseases|internal diseases
127358|NCT03407196|Type II diabetes mellitus|type ii diabetes mellitus
127359|NCT03407196|HbA1c|hba1c
127360|NCT03407196|BMI|bmi
127361|NCT03407196|BP|bp
127362|NCT03407170|Programmed Cell Death-1 (PD-1)|programmed cell death-1 (pd-1)
127363|NCT03407170|PD1|pd1
127364|NCT03407170|Programmed Cell Death-Ligand 1 (PD-L1)|programmed cell death-ligand 1 (pd-l1)
127365|NCT03407170|Programmed Cell Death-Ligand 2 (PD-L2)|programmed cell death-ligand 2 (pd-l2)
127366|NCT03407170|PDL1|pdl1
127367|NCT03407170|PDL2|pdl2
127368|NCT03407157|Probiotics|probiotics
127369|NCT03407157|Pregnancy|pregnancy
127370|NCT03407157|GBS|gbs
127371|NCT03407157|Group B Streptococcus|group b streptococcus
127372|NCT03407144|Programmed Death-1 (PD-1)|programmed death-1 (pd-1)
127373|NCT03407144|PD1|pd1
127374|NCT03407144|Programmed Death-Ligand 1 (PD-L1)|programmed death-ligand 1 (pd-l1)
127375|NCT03407144|PDL1|pdl1
127376|NCT03407131|Intertrochanteric fracture, Medical complications|intertrochanteric fracture, medical complications
127377|NCT03407079|Drug Metabolism|drug metabolism
127378|NCT03407079|Artificial Sweetner|artificial sweetner
127379|NCT03407079|P-Glycoprotein|p-glycoprotein
127380|NCT03407079|Cytochrome P 450|cytochrome p 450
127381|NCT03407079|Microbiome|microbiome
127382|NCT03407066|Magnetic Resonance Imaging (MRI)|magnetic resonance imaging (mri)
127383|NCT03407066|MEG|meg
127384|NCT03407066|Color Vision|color vision
127385|NCT03407066|Neuroimaging|neuroimaging
127386|NCT03407053|Calories|calories
127387|NCT03407053|Food Intake|food intake
127388|NCT03407053|Glucose|glucose
127389|NCT03407053|Body Composition|body composition
127390|NCT03407053|Body Weight Regulation|body weight regulation
127391|NCT03407040|Blood|blood
127392|NCT03407040|Tissue|tissue
127393|NCT03407040|Immunotherapy|immunotherapy
127394|NCT03407040|Tumor|tumor
127395|NCT03407040|Somatic|somatic
127396|NCT03407027|Quadratus lumborum syndrome; ultrasound- guided infiltration|quadratus lumborum syndrome; ultrasound- guided infiltration
127397|NCT03406988|Systemic Sclerosis|systemic sclerosis
127398|NCT03406988|Digital Ulcer|digital ulcer
127399|NCT03406988|Autologous fat grafting|autologous fat grafting
127400|NCT03406988|Adipose tissue stem cells|adipose tissue stem cells
127401|NCT03406962|inherited metabolic disorders|inherited metabolic disorders
127402|NCT03406962|cerebral adrenoleukodystrophy|cerebral adrenoleukodystrophy
127403|NCT03406962|Hurler syndrome|hurler syndrome
127404|NCT03406962|globoid cell leukodystrophy|globoid cell leukodystrophy
127405|NCT03406962|Krabbe disease|krabbe disease
127406|NCT03406962|metachromatic leukodystrophy|metachromatic leukodystrophy
127407|NCT03406962|hematopoietic stem cells|hematopoietic stem cells
127408|NCT03406962|hematopoietic stem cell transplant|hematopoietic stem cell transplant
127409|NCT03406962|umbilical cord blood|umbilical cord blood
127410|NCT03406962|umbilical cord blood transplant|umbilical cord blood transplant
127411|NCT03406962|MGTA-456|mgta-456
127412|NCT03406962|myeloablative conditioning regimen|myeloablative conditioning regimen
127413|NCT03406962|bone marrow transplant|bone marrow transplant
127414|NCT03406962|mucopolysaccharidosis-1H|mucopolysaccharidosis-1h
127415|NCT03406923|Health literacy|health literacy
127416|NCT03406923|Self-efficacy|self-efficacy
127417|NCT03406923|Beliefs about diabetes|beliefs about diabetes
127418|NCT03406923|Beliefs in medicines|beliefs in medicines
127419|NCT03406910|egg|egg
127420|NCT03406910|meat|meat
127421|NCT03406910|western diet|western diet
127422|NCT03406910|type 2 diabetes|type 2 diabetes
127424|NCT03406910|Vegetarian cohort|vegetarian cohort
127425|NCT03406910|Adventist|adventist
127428|NCT03406871|Regorafenib|regorafenib
127429|NCT03406871|Nivolumab|nivolumab
127430|NCT03406871|Phase I clinical trial|phase i clinical trial
127431|NCT03406832|Prevention|prevention
127432|NCT03406832|Slow flow|slow flow
127433|NCT03406832|No reflow|no reflow
127434|NCT03406832|Nitroprusside|nitroprusside
127435|NCT03406832|Tirofiban|tirofiban
127436|NCT03406819|Prevention|prevention
127437|NCT03406819|Slow flow|slow flow
127438|NCT03406819|No reflow|no reflow
127439|NCT03406819|Nitroprusside|nitroprusside
127440|NCT03406819|Tirofiban|tirofiban
127441|NCT03406793|Zinc|zinc
127442|NCT03406793|Multiple micronutrient powders|multiple micronutrient powders
127443|NCT03406793|Diarrhea|diarrhea
127444|NCT03406793|Stunting|stunting
127445|NCT03406780|Duchenne Muscular Dystrophy|duchenne muscular dystrophy
127446|NCT03406780|Cell Therapy|cell therapy
127447|NCT03406780|Performance of the Upper Limb|performance of the upper limb
127448|NCT03406780|Pulmonary Function|pulmonary function
127449|NCT03406780|Ambulatory|ambulatory
127450|NCT03406780|Non-Ambulatory|non-ambulatory
127451|NCT03406780|Glucocorticoids|glucocorticoids
127452|NCT03406728|Parkinson's Disease|parkinson's disease
127453|NCT03406728|Virtual Reality|virtual reality
127454|NCT03406728|Training|training
127456|NCT03406728|Falls|falls
127457|NCT03406728|PDSAFEX|pdsafex
127458|NCT03406715|SCLC|sclc
127459|NCT03406715|Lung Cancer|lung cancer
127460|NCT03406715|Lung Disease|lung disease
127461|NCT03406715|Relapsed SCLC|relapsed sclc
127462|NCT03406702|Epilepsy, Idiopathic Generalized Epilepsy, Absence Seizures|epilepsy, idiopathic generalized epilepsy, absence seizures
127463|NCT03406689|Pain|pain
127464|NCT03406689|Intravitreal Injection|intravitreal injection
127465|NCT03406689|Anti-VEGF|anti-vegf
127466|NCT03406689|Nepafenac eye drops|nepafenac eye drops
127467|NCT03406689|Short Form McGill Pain Questionnaire|short form mcgill pain questionnaire
127468|NCT03406676|Methylene blue; Peripheral vascular resistance|methylene blue; peripheral vascular resistance
127469|NCT03406663|Insulin|insulin
127470|NCT03406650|muscle invasive urothelial cancer|muscle invasive urothelial cancer
127471|NCT03406650|cancer|cancer
127472|NCT03406650|immunotherapy|immunotherapy
127473|NCT03406650|durvalumab|durvalumab
127474|NCT03406650|MEDI4736|medi4736
127475|NCT03406650|adjuvant|adjuvant
127476|NCT03406650|neoadjuvant|neoadjuvant
127477|NCT03406650|radical cystectomy|radical cystectomy
127478|NCT03406650|bladder|bladder
127479|NCT03406624|Modic changes|modic changes
127480|NCT03406624|biomarkers|biomarkers
127481|NCT03406624|low back pain|low back pain
127482|NCT03406598|Shock|shock
127483|NCT03406598|Microcirculation|microcirculation
127484|NCT03406598|Nurses|nurses
127485|NCT03406572|Acute on chronic respiratory failure|acute on chronic respiratory failure
127486|NCT03406572|High-Flow heated and humidified nasal oxygen therapy|high-flow heated and humidified nasal oxygen therapy
127487|NCT03406520|peritoneal dialysis|peritoneal dialysis
127488|NCT03406520|chlorhexidine|chlorhexidine
127489|NCT03406520|exit site infection|exit site infection
127490|NCT03406520|tunnel tract infection|tunnel tract infection
127491|NCT03406494|sepsis|sepsis
127492|NCT03406494|critical illness|critical illness
127493|NCT03406494|intensive care unit|intensive care unit
127494|NCT03406494|mechanical ventilation|mechanical ventilation
127495|NCT03406494|rehabilitation|rehabilitation
127496|NCT03406494|mortality|mortality
127497|NCT03406494|physical function|physical function
127498|NCT03406494|health-related quality of life|health-related quality of life
127499|NCT03406468|non small cell lung cancer|non small cell lung cancer
127500|NCT03406468|immune therapy|immune therapy
127501|NCT03406468|radiotherapy|radiotherapy
127502|NCT03406455|wearable|wearable
127503|NCT03406455|mhealth|mhealth
127504|NCT03406429|rTMS|rtms
127506|NCT03406390|contrast sensitivity|contrast sensitivity
127507|NCT03406390|Pterygium|pterygium
127508|NCT03406325|mast cell|mast cell
127509|NCT03406325|allergy|allergy
127510|NCT03406325|genomic|genomic
127511|NCT03406325|biomarkers|biomarkers
127512|NCT03406312|Roux en Y Gastric Bypass Surgery, Hypoglycemia, Postprandial|roux en y gastric bypass surgery, hypoglycemia, postprandial
127513|NCT03406299|SLOG|slog
127514|NCT03406286|Post Marketing Surveillance|post marketing surveillance
127515|NCT03406208|Psychiatry|psychiatry
127516|NCT03406208|Psychology|psychology
127517|NCT03406208|Psychosocial|psychosocial
127518|NCT03406208|Behavioral|behavioral
127519|NCT03406195|transcranial magnetic stimulation|transcranial magnetic stimulation
127520|NCT03406182|stunting|stunting
127521|NCT03406182|under-weight|under-weight
127522|NCT03406182|Pakistan|pakistan
127523|NCT03406182|infant|infant
127524|NCT03406182|time-use|time-use
127525|NCT03406182|women|women
127526|NCT03406182|body mass index|body mass index
127527|NCT03406182|growth|growth
127528|NCT03406169|penile rehabilitation|penile rehabilitation
127529|NCT03406156|Cancer|cancer
127530|NCT03406156|Chronic Lymphocytic Leukemia|chronic lymphocytic leukemia
127531|NCT03406156|17p Deletion|17p deletion
127532|NCT03406156|debulking|debulking
127533|NCT03406156|obinutuzumab|obinutuzumab
127534|NCT03406156|bendamustine|bendamustine
127535|NCT03406156|tumor lysis syndrome|tumor lysis syndrome
127536|NCT03406156|venetoclax|venetoclax
127537|NCT03406156|Small Lymphocytic Lymphoma|small lymphocytic lymphoma
127538|NCT03406104|Heredity Optic Atrophy|heredity optic atrophy
127539|NCT03406104|Leber Hereditary Optic Atrophy|leber hereditary optic atrophy
127540|NCT03406104|Leber Hereditary Optic Neuropathy|leber hereditary optic neuropathy
127541|NCT03406104|LHON|lhon
127542|NCT03406104|Eye Diseases|eye diseases
127543|NCT03406104|Hereditary Eye Diseases|hereditary eye diseases
127544|NCT03406104|Inborn Genetic Disease|inborn genetic disease
127545|NCT03406104|Gene Therapy|gene therapy
127546|NCT03406104|Intravitreal Injections|intravitreal injections
127547|NCT03406104|Mitochondrial Disease|mitochondrial disease
127548|NCT03406104|AAV2 Vectors|aav2 vectors
127549|NCT03406104|Nervous System Diseases|nervous system diseases
127550|NCT03406104|Neurodegenerative Disease|neurodegenerative disease
127551|NCT03406104|Heredodegenerative Disorders of the Nervous System|heredodegenerative disorders of the nervous system
127552|NCT03406078|Asthma|asthma
127553|NCT03406065|Sodium bicarbonate|sodium bicarbonate
127554|NCT03406065|NaHCO3|nahco3
127555|NCT03406065|Combat Sports|combat sports
127556|NCT03406065|Physical capacity|physical capacity
127557|NCT03406065|Dummy test|dummy test
127558|NCT03406039|Alcohol Use Disorder|alcohol use disorder
127559|NCT03406039|Emotional Disorder|emotional disorder
127560|NCT03406039|Cognitive Behavioural Therapy|cognitive behavioural therapy
127561|NCT03406039|Motivational Interviewing|motivational interviewing
127562|NCT03406039|Online Intervention|online intervention
127563|NCT03406039|Randomized Controlled Trial|randomized controlled trial
127564|NCT03406026|Stroke|stroke
127565|NCT03406026|Balance rehabilitation|balance rehabilitation
127566|NCT03406026|Physiotherapy|physiotherapy
127567|NCT03405974|Osteonecrosis|osteonecrosis
127568|NCT03405974|Aspirin|aspirin
127569|NCT03405961|PAR scoring|par scoring
127570|NCT03405961|Digital study models|digital study models
127571|NCT03405909|contrast-enhanced ultrasound|contrast-enhanced ultrasound
127572|NCT03405909|non-invasive diagnosis|non-invasive diagnosis
127573|NCT03405909|focal liver lesion|focal liver lesion
127574|NCT03405909|liver cirrhosis|liver cirrhosis
127575|NCT03405909|standardised diagnostic algorithm|standardised diagnostic algorithm
127576|NCT03405909|intrahepatic cholangiocellular carcinoma|intrahepatic cholangiocellular carcinoma
127577|NCT03405909|ESCULAP|esculap
127578|NCT03405909|CEUS LI-RADS|ceus li-rads
127579|NCT03405909|imaging|imaging
127580|NCT03405909|hepatocellular carcinoma|hepatocellular carcinoma
127581|NCT03405909|MRI|mri
127582|NCT03405909|diagnostic accuracy|diagnostic accuracy
127583|NCT03405909|interobserver agreement|interobserver agreement
127584|NCT03405909|Erlanger Synopsis of CEUS for Liver lesion Assessment in Patients at risk|erlanger synopsis of ceus for liver lesion assessment in patients at risk
127585|NCT03405909|CEUS Liver Imaging Reporting and Data System|ceus liver imaging reporting and data system
127586|NCT03405870|cholesterol|cholesterol
127587|NCT03405870|lipids|lipids
127588|NCT03405870|total parenteral nutrition|total parenteral nutrition
127589|NCT03405857|mild cognitive impairment|mild cognitive impairment
127590|NCT03405857|cognitive training program|cognitive training program
127591|NCT03405844|Shoulder|shoulder
127592|NCT03405844|glenohumeral|glenohumeral
127593|NCT03405844|stretching|stretching
127594|NCT03405831|Heart transplantation|heart transplantation
127595|NCT03405831|Exercise capacity|exercise capacity
127596|NCT03405831|Heart rate|heart rate
127597|NCT03405831|Cardiac allograft vasculopathy|cardiac allograft vasculopathy
127598|NCT03405818|Fungal infection of the nail|fungal infection of the nail
127599|NCT03405792|Tumor Treating Electric Fields (TTFields)|tumor treating electric fields (ttfields)
127600|NCT03405714|Epilepsy|epilepsy
127601|NCT03405714|Brivaracetam|brivaracetam
127602|NCT03405714|Briviact|briviact
127603|NCT03405714|Open-label|open-label
127604|NCT03405714|pediatric|pediatric
127605|NCT03405714|intravenous|intravenous
127606|NCT03405688|Sickle cell|sickle cell
127607|NCT03405688|Heterozygous|heterozygous
127608|NCT03405688|Blood donor|blood donor
127609|NCT03405675|Dementia|dementia
127610|NCT03405675|Mild cognitive impairment|mild cognitive impairment
127611|NCT03405675|Cognitive abilities and changes|cognitive abilities and changes
127612|NCT03405675|Functional change and disabilities|functional change and disabilities
127613|NCT03405675|Depression|depression
127614|NCT03405675|Health and social services utilization|health and social services utilization
127615|NCT03405675|Quality of life|quality of life
127616|NCT03405675|Adverse drug effects|adverse drug effects
127617|NCT03405675|Social network and support|social network and support
127618|NCT03405675|Self-rated health|self-rated health
127619|NCT03405675|Medical morbidities|medical morbidities
127620|NCT03405675|Falls|falls
127621|NCT03405675|Health risk behaviors|health risk behaviors
127623|NCT03405675|Apo-E lipoprotein|apo-e lipoprotein
127624|NCT03405675|Phytochemicals|phytochemicals
127625|NCT03405675|B12|b12
127626|NCT03405675|Folate|folate
127627|NCT03405675|Homocysteine|homocysteine
127628|NCT03405675|Lifestyle|lifestyle
127629|NCT03405675|Physical activity|physical activity
127630|NCT03405675|Leisure activity|leisure activity
127631|NCT03405675|Successful ageing|successful ageing
127632|NCT03405675|Mortality|mortality
127633|NCT03405649|postpartum|postpartum
127634|NCT03405649|exercise|exercise
127635|NCT03405649|intervention|intervention
127636|NCT03405610|Psychiatry|psychiatry
127637|NCT03405610|Psychology|psychology
127638|NCT03405610|Psychosocial|psychosocial
127639|NCT03405610|Mind-Body|mind-body
127640|NCT03405584|Helicobacter pylori|helicobacter pylori
127641|NCT03405584|Therapy|therapy
127642|NCT03405506|Fractional Flow Reserve|fractional flow reserve
127643|NCT03405506|Quantitative Coronary Angiography|quantitative coronary angiography
127644|NCT03405506|Coronary artery disease|coronary artery disease
127645|NCT03405506|Quantitative Flow Ratio|quantitative flow ratio
127646|NCT03405506|Tandem lesion|tandem lesion
127647|NCT03405506|Virtual stenting|virtual stenting
127648|NCT03405493|Circadian Rhythm|circadian rhythm
127649|NCT03405493|Light Therapy|light therapy
127650|NCT03405493|Wake Therapy|wake therapy
127651|NCT03405493|Sleep Phase Advance|sleep phase advance
127652|NCT03405493|Major Depression|major depression
127653|NCT03405480|Pulmonary embolism|pulmonary embolism
127654|NCT03405480|Dyspnea|dyspnea
127655|NCT03405480|Post Pulmonary Embolism Syndrome|post pulmonary embolism syndrome
127656|NCT03405480|PPS|pps
127657|NCT03405480|Rehabilitation|rehabilitation
127658|NCT03405480|Cardiac magnetic resonance imaging (CMR)|cardiac magnetic resonance imaging (cmr)
127659|NCT03405428|Ultrasonography|ultrasonography
127660|NCT03405428|Radial Artery Diameter|radial artery diameter
127661|NCT03405428|Allen Test|allen test
127662|NCT03405428|Arterial Cannulation|arterial cannulation
127663|NCT03405428|Doppler Ultrasonography|doppler ultrasonography
127664|NCT03405428|Ulnar Artery|ulnar artery
127665|NCT03405402|Sickle cell disease|sickle cell disease
127666|NCT03405402|Allo-immunization|allo-immunization
127667|NCT03405402|Blood transfusion|blood transfusion
127668|NCT03405389|mandibulo-maxillary fixation|mandibulo-maxillary fixation
127669|NCT03405389|malocclusion|malocclusion
127670|NCT03405324|brain stimulation, tDCS, nausea and vomiting|brain stimulation, tdcs, nausea and vomiting
127671|NCT03405311|Labor analgesia|labor analgesia
127672|NCT03405311|Ultrasound|ultrasound
127673|NCT03405311|Obesity, Morbid|obesity, morbid
127674|NCT03405311|Pregnancy|pregnancy
127675|NCT03405311|Labor Epidural Analgesia|labor epidural analgesia
127676|NCT03405285|Improved Bladder Management|improved bladder management
127677|NCT03405285|Neurogenic Lower Urinary Tract Dysfunction|neurogenic lower urinary tract dysfunction
127678|NCT03405285|Bladder function following Spinal Cord Injury|bladder function following spinal cord injury
127679|NCT03405285|Urinary Retention|urinary retention
127680|NCT03405272|Full human anti-EGFR monoclonal antibody (SCT200)|full human anti-egfr monoclonal antibody (sct200)
127681|NCT03405272|metastatic colorectal cancer （mCRC）|metastatic colorectal cancer （mcrc）
127682|NCT03405246|Childhood obesity|childhood obesity
127683|NCT03405246|Weight gain in children|weight gain in children
127684|NCT03405246|Diet intervention|diet intervention
127685|NCT03405233|ESRD|esrd
127686|NCT03405233|ePTFE|eptfe
127687|NCT03405233|neointemal hyperplasia|neointemal hyperplasia
127688|NCT03405220|smoking|smoking
127689|NCT03405220|self-affirmation|self-affirmation
127690|NCT03405220|mobile application|mobile application
127691|NCT03405220|cessation|cessation
127692|NCT03405194|HIV/AIDS|hiv/aids
127693|NCT03405194|Same-Day ART|same-day art
127694|NCT03405194|Genvoya|genvoya
127695|NCT03405194|Efavirenz|efavirenz
127696|NCT03405129|Smoking Cessation|smoking cessation
127697|NCT03405129|Smartphone App|smartphone app
127698|NCT03405129|Dynamic Treatment|dynamic treatment
127699|NCT03405103|self-management|self-management
127700|NCT03405103|m-Health|m-health
127701|NCT03405077|interpersonal psychotherapy|interpersonal psychotherapy
127702|NCT03405077|treatment|treatment
127703|NCT03405077|training|training
127704|NCT03405077|dissemination and implementation|dissemination and implementation
127705|NCT03405077|eating disorders|eating disorders
127706|NCT03405051|hypokalemia|hypokalemia
127707|NCT03405051|cardiac failure|cardiac failure
127708|NCT03404960|Platinum|platinum
127709|NCT03404960|chemotherapy|chemotherapy
127710|NCT03404960|Niraparib|niraparib
127711|NCT03404960|Ipilimumab|ipilimumab
127712|NCT03404960|Nivolumab|nivolumab
127713|NCT03404960|Pancreatic adenocarcinoma|pancreatic adenocarcinoma
127714|NCT03404960|PARP inhibitor|parp inhibitor
127715|NCT03404960|Pancreatic ductal adenocarcinoma|pancreatic ductal adenocarcinoma
127717|NCT03404960|PDAC|pdac
127718|NCT03404947|Exercise|exercise
127719|NCT03404947|Metabolism|metabolism
127720|NCT03404947|Nutrition|nutrition
127721|NCT03404934|Adaptive anastomosis|adaptive anastomosis
127722|NCT03404934|C-REX|c-rex
129486|NCT03393546|alzheimer|alzheimer
127723|NCT03404934|Colorectal cancer|colorectal cancer
127724|NCT03404921|Endoscopic submucosal dissection|endoscopic submucosal dissection
127725|NCT03404921|Endoscopic submucosal tunnelling dissection|endoscopic submucosal tunnelling dissection
127726|NCT03404921|procedure time|procedure time
127727|NCT03404908|transversus abdominis plane block|transversus abdominis plane block
127728|NCT03404908|quadratus lumborum block|quadratus lumborum block
127729|NCT03404908|neuropathic pain|neuropathic pain
127730|NCT03404895|DFU|dfu
127731|NCT03404895|Vein|vein
127732|NCT03404895|Stent|stent
127733|NCT03404869|CDGIb MANNOSEPHOSPHATE ISOMERASE DEFICIENCY MPI DEFICIENCY PROTEIN-LOSING ENTEROPATHY-HEPATIC FIBROSIS SYNDROME SAGUENAY-LAC SAINT-JEAN SYNDROME SLSJ SYNDROME|cdgib mannosephosphate isomerase deficiency mpi deficiency protein-losing enteropathy-hepatic fibrosis syndrome saguenay-lac saint-jean syndrome slsj syndrome
127734|NCT03404856|CDG It; CDGIt PHOSPHOGLUCOMUTASE 1 DEFICIENCY PGM1 DEFICIENCY GLYCOGEN STORAGE DISEASE XIV; GSD14 GSD XIV|cdg it; cdgit phosphoglucomutase 1 deficiency pgm1 deficiency glycogen storage disease xiv; gsd14 gsd xiv
127735|NCT03404791|Bladder Cancer|bladder cancer
127736|NCT03404791|Urothelial Carcinoma|urothelial carcinoma
127737|NCT03404791|Cystectomy|cystectomy
127738|NCT03404791|Radical Cystectomy|radical cystectomy
127739|NCT03404778|Reverse Shoulder Arthroplasty|reverse shoulder arthroplasty
127740|NCT03404778|Medical Device|medical device
127741|NCT03404778|Performance|performance
127742|NCT03404778|Safety|safety
127743|NCT03404778|Shoulder Prosthesis|shoulder prosthesis
127744|NCT03404778|Glenoid Erosion|glenoid erosion
127745|NCT03404765|Tai Chi|tai chi
127746|NCT03404765|Cognition|cognition
127747|NCT03404765|Instrumental activities of daily living|instrumental activities of daily living
127748|NCT03404765|Health-related Quality of Life|health-related quality of life
127749|NCT03404752|breast cancer|breast cancer
127750|NCT03404752|chemotherapy|chemotherapy
127751|NCT03404752|Neutropenia|neutropenia
127752|NCT03404752|Peg-filgrastim|peg-filgrastim
127753|NCT03404752|biosimilar|biosimilar
127754|NCT03404739|Antibiotic prophylaxis|antibiotic prophylaxis
127755|NCT03404739|Infectious complications|infectious complications
127756|NCT03404739|Peroral endoscopic myotomy|peroral endoscopic myotomy
127757|NCT03404726|Acute myeloid leukemia|acute myeloid leukemia
127758|NCT03404726|Myelodysplastic Syndromes|myelodysplastic syndromes
127759|NCT03404726|Chronic myelomonocytic leukemia|chronic myelomonocytic leukemia
127760|NCT03404726|Dihydroorotate dehydrogenase (DHODH) inhibitor|dihydroorotate dehydrogenase (dhodh) inhibitor
127761|NCT03404713|adolescence|adolescence
127762|NCT03404713|adolescent|adolescent
127763|NCT03404713|binge eating|binge eating
127764|NCT03404713|loss-of-control eating|loss-of-control eating
127765|NCT03404713|behavioral weight loss|behavioral weight loss
127766|NCT03404713|weight management|weight management
127767|NCT03404713|acceptance commitment therapy|acceptance commitment therapy
127768|NCT03404713|overweight|overweight
127769|NCT03404713|obesity|obesity
127770|NCT03404700|Eggs, saturated fat, insulin resistance,|eggs, saturated fat, insulin resistance,
127771|NCT03404674|ETEC|etec
127772|NCT03404674|Escherichia coli|escherichia coli
127773|NCT03404674|enteric|enteric
127774|NCT03404648|high risk|high risk
127775|NCT03404648|prostate cancer|prostate cancer
127776|NCT03404648|C11-choline|c11-choline
127777|NCT03404648|PET/MR|pet/mr
127778|NCT03404648|mpMRI|mpmri
127779|NCT03404596|cigarettes|cigarettes
127780|NCT03404596|quit smoking|quit smoking
127781|NCT03404596|nicotine|nicotine
127782|NCT03404596|mindfulness|mindfulness
127783|NCT03404596|mHealth|mhealth
127784|NCT03404596|mobile health|mobile health
127785|NCT03404583|Person-centred care|person-centred care
127786|NCT03404570|Sweaty Hands|sweaty hands
127787|NCT03404557|Crohn's Disease|crohn's disease
127788|NCT03404557|Ulcerative colitis|ulcerative colitis
127789|NCT03404557|Macrophages|macrophages
127790|NCT03404557|Adherent-Invasive Escherichia coli|adherent-invasive escherichia coli
127791|NCT03404557|Proteomic analysis|proteomic analysis
127792|NCT03404518|Thyroidectomy|thyroidectomy
127793|NCT03404518|Parotidectomy|parotidectomy
127794|NCT03404518|Tympanoplasty|tympanoplasty
127795|NCT03404518|Mastoidectomy|mastoidectomy
127796|NCT03404518|Septoplasty|septoplasty
127797|NCT03404518|Sinus Surgery|sinus surgery
127798|NCT03404518|Postoperative pain|postoperative pain
127799|NCT03404518|Outpatient surgery|outpatient surgery
127800|NCT03404505|infant|infant
127801|NCT03404505|play|play
127802|NCT03404505|parents|parents
127803|NCT03404479|Knee Osteoarthritis|knee osteoarthritis
127804|NCT03404479|Diacerein|diacerein
127805|NCT03404453|Airway prediction|airway prediction
127806|NCT03404453|Difficult airway|difficult airway
127807|NCT03404440|helicobacter pylori|helicobacter pylori
127808|NCT03404440|L. Reuteri|l. reuteri
127809|NCT03404440|Proton Pump Inhibitor|proton pump inhibitor
127810|NCT03404375|scheduled cesarean section|scheduled cesarean section
127811|NCT03404375|term pregnancy|term pregnancy
127812|NCT03404375|estimated blood loss|estimated blood loss
127813|NCT03404375|postpartum hemorrhage|postpartum hemorrhage
127814|NCT03404362|Bone Metastases|bone metastases
127815|NCT03404336|migraine|migraine
127816|NCT03404336|chronic|chronic
127817|NCT03404336|well-being therapy|well-being therapy
127818|NCT03404336|psychotherapy|psychotherapy
127819|NCT03404336|therapy|therapy
127820|NCT03404323|central retinal thickness|central retinal thickness
127821|NCT03404323|epiretinal membrane|epiretinal membrane
127822|NCT03404323|cataract surgery|cataract surgery
127823|NCT03404323|pseudophakic cystoid macular edema|pseudophakic cystoid macular edema
127824|NCT03404310|HPV|hpv
127825|NCT03404310|ASCUS|ascus
127826|NCT03404310|LSIL|lsil
127827|NCT03404310|Cervical Cancer|cervical cancer
127828|NCT03404297|compression therapy|compression therapy
127829|NCT03404297|Kenya|kenya
127830|NCT03404297|Kaposi Sarcoma|kaposi sarcoma
127831|NCT03404297|Locally sourced|locally sourced
127832|NCT03404297|wrapping|wrapping
127833|NCT03404297|chronic leg ulcers|chronic leg ulcers
127834|NCT03404284|Immunization|immunization
127835|NCT03404245|Physical Activity|physical activity
127836|NCT03404245|Exercise|exercise
127837|NCT03404245|Rheumatoid|rheumatoid
127838|NCT03404245|Arthritis|arthritis
127839|NCT03404245|Self-management|self-management
127840|NCT03404245|Symptoms|symptoms
127841|NCT03404206|Postsurgical pain|postsurgical pain
127842|NCT03404193|Other diseases of blood and blood-forming organs|other diseases of blood and blood-forming organs
127843|NCT03404193|Acute Myeloid Leukemia|acute myeloid leukemia
127844|NCT03404193|AML|aml
127845|NCT03404193|Myelodysplastic Syndrome|myelodysplastic syndrome
127846|NCT03404193|MDS|mds
127847|NCT03404193|Decitabine|decitabine
127848|NCT03404193|Dacogen|dacogen
127849|NCT03404193|Ventoclax|ventoclax
127850|NCT03404193|ABT-199|abt-199
127851|NCT03404193|GDC-0199|gdc-0199
127852|NCT03404167|ETX0914|etx0914
127853|NCT03404167|Plasma Pharmacokinetic|plasma pharmacokinetic
127854|NCT03404167|Safety|safety
127855|NCT03404167|Tolerability|tolerability
127856|NCT03404167|Zoliflodacin|zoliflodacin
127857|NCT03404141|Stress|stress
127858|NCT03404141|pregnancy|pregnancy
127859|NCT03404141|psychological therapy|psychological therapy
127860|NCT03404141|cortisol|cortisol
127861|NCT03404115|reproxalap|reproxalap
127862|NCT03404089|device drug monitoring|device drug monitoring
127863|NCT03404089|β-lactam antibiotic|β-lactam antibiotic
127864|NCT03404089|health care-associated infection|health care-associated infection
127865|NCT03404089|MON4STRAT|mon4strat
127866|NCT03404076|Gastrointestinal Stromal Tumor (GIST)|gastrointestinal stromal tumor (gist)
127867|NCT03404076|Dual Energy CT|dual energy ct
127868|NCT03404076|Tyrosine Kinase Inhibitor (TKI)|tyrosine kinase inhibitor (tki)
127869|NCT03404024|gene therapy|gene therapy
127870|NCT03403998|Pain|pain
127871|NCT03403998|Temporomandibular Disorders|temporomandibular disorders
127872|NCT03403998|Therapeutic exercises|therapeutic exercises
127873|NCT03403998|Musculoskeletal disorders|musculoskeletal disorders
127874|NCT03403998|Randomized controlled trial|randomized controlled trial
127875|NCT03403998|Imaging|imaging
127876|NCT03403998|Brain plasticity|brain plasticity
127877|NCT03403998|Clinical outcomes|clinical outcomes
127878|NCT03403998|Chronic pain|chronic pain
127879|NCT03403998|Neck|neck
127880|NCT03403972|pharmacokinetics|pharmacokinetics
127881|NCT03403972|simvastatin|simvastatin
127882|NCT03403972|vancomycin|vancomycin
127883|NCT03403972|gut microbiome|gut microbiome
127884|NCT03403959|pupillometry|pupillometry
127885|NCT03403959|light therapy|light therapy
127886|NCT03403959|visual impairment|visual impairment
127887|NCT03403959|melatonin|melatonin
127888|NCT03403959|ipRGC|iprgc
127889|NCT03403946|difficult airway|difficult airway
127890|NCT03403946|carvical collar|carvical collar
127891|NCT03403946|endotracheal intubation|endotracheal intubation
127892|NCT03403920|validity|validity
127893|NCT03403920|low back pain|low back pain
127894|NCT03403920|functional|functional
127895|NCT03403920|pain|pain
127896|NCT03403920|questionnaire|questionnaire
127897|NCT03403907|epilepsy|epilepsy
127898|NCT03403907|microbiota|microbiota
127899|NCT03403907|probiotics|probiotics
127900|NCT03403881|Exercise|exercise
127901|NCT03403881|Physical activity|physical activity
127902|NCT03403881|Behavioral change|behavioral change
127903|NCT03403881|Depression|depression
127904|NCT03403881|Major Depressive Disorder|major depressive disorder
127905|NCT03403881|Health promotion|health promotion
127906|NCT03403803|Glioblastoma|glioblastoma
127907|NCT03403803|Brain Tumor|brain tumor
127908|NCT03403790|Bipresso|bipresso
127909|NCT03403790|Drug use-results survey|drug use-results survey
127910|NCT03403790|Quetiapine|quetiapine
127911|NCT03403777|Multiple relapsed/refractory testicular germ cell tumors|multiple relapsed/refractory testicular germ cell tumors
127912|NCT03403777|Avelumab|avelumab
127913|NCT03403777|Anti PD-L1|anti pd-l1
127914|NCT03403764|Intention|intention
127915|NCT03403764|Distant Healing|distant healing
127916|NCT03403764|Wellness|wellness
127917|NCT03403764|Distant Intentionality|distant intentionality
127918|NCT03403764|Distant Healing Intention|distant healing intention
127919|NCT03403751|Abdominal sepsis|abdominal sepsis
127920|NCT03403751|AKI|aki
127921|NCT03403751|NSTI|nsti
127922|NCT03403725|Solid Tumors|solid tumors
127923|NCT03403725|Non-Hodgkin Lymphoma|non-hodgkin lymphoma
127924|NCT03403725|NHL|nhl
127925|NCT03403725|MEN1309|men1309
127926|NCT03403725|CD205|cd205
127927|NCT03403725|Relapsed|relapsed
127928|NCT03403725|Refractory|refractory
127929|NCT03403725|R-R NHL|r-r nhl
127930|NCT03403725|ADC|adc
127931|NCT03403725|Antibody-Drug Coniugate|antibody-drug coniugate
127932|NCT03403725|Metastatic Tumors|metastatic tumors
127933|NCT03403699|inducible pluripotent stem cells|inducible pluripotent stem cells
127934|NCT03403686|Liver X receptor|liver x receptor
127935|NCT03403686|Circulating angiogenic cells|circulating angiogenic cells
127936|NCT03403660|Attire|attire
127937|NCT03403660|White coat|white coat
127938|NCT03403660|Patient physician communication|patient physician communication
127939|NCT03403569|CD4 cell recovery|cd4 cell recovery
127940|NCT03403569|immune activation|immune activation
127941|NCT03403569|anti-inflammation|anti-inflammation
127942|NCT03403556|High ASCVD risk patients with type 2 diabetes|high ascvd risk patients with type 2 diabetes
127943|NCT03403530|IgM|igm
127944|NCT03403530|Immunoglobulin|immunoglobulin
127945|NCT03403530|Neonatal sepsis|neonatal sepsis
127946|NCT03403530|very low birth weight preterm|very low birth weight preterm
127947|NCT03403517|steroids|steroids
127948|NCT03403517|glucocorticoids|glucocorticoids
127949|NCT03403517|liver surgery|liver surgery
127950|NCT03403517|hepatectomy|hepatectomy
127951|NCT03403478|Hemodynamics|hemodynamics
127952|NCT03403478|Aquatic exercise|aquatic exercise
127953|NCT03403478|Elderly|elderly
127954|NCT03403374|Evolocumab|evolocumab
127955|NCT03403374|Hypercholesterolemia|hypercholesterolemia
127956|NCT03403322|intervention|intervention
127957|NCT03403322|children|children
127958|NCT03403309|Multiple system atrophy|multiple system atrophy
127959|NCT03403309|Uric acid|uric acid
127960|NCT03403309|Inosine 5'-monophosphate|inosine 5'-monophosphate
127961|NCT03403309|Inosine monophosphate|inosine monophosphate
127962|NCT03403309|Inosinic acid|inosinic acid
127963|NCT03403270|Mobile App|mobile app
127964|NCT03403270|Sedentary Behaviour|sedentary behaviour
127965|NCT03403270|Workplace Wellness|workplace wellness
127966|NCT03403270|Sitting Time|sitting time
127967|NCT03403257|Caregiving|caregiving
127968|NCT03403257|Hispanic|hispanic
127969|NCT03403257|Mexican American|mexican american
127970|NCT03403257|Epidemiology|epidemiology
127971|NCT03403257|Community|community
127972|NCT03403231|Veterans|veterans
127973|NCT03403231|Type 2 diabetes mellitus|type 2 diabetes mellitus
127974|NCT03403231|Prediabetes|prediabetes
127975|NCT03403231|Secure Messaging|secure messaging
127976|NCT03403231|Health Promotion|health promotion
127977|NCT03403231|Prevention and Control|prevention and control
127978|NCT03403231|Motivation|motivation
127979|NCT03403218|balance, risk of falling|balance, risk of falling
127980|NCT03403192|EZ Blocker|ez blocker
127982|NCT03403192|Double Lumen Tube|double lumen tube
127983|NCT03403192|Thoracic Surgery|thoracic surgery
127984|NCT03403179|Cognition|cognition
127985|NCT03403179|Cognitive Remediation|cognitive remediation
127986|NCT03403179|Mood Disorder|mood disorder
127987|NCT03403179|Functional Impairment|functional impairment
127988|NCT03403179|Psychosocial intervention|psychosocial intervention
127989|NCT03403153|Parent-Child Relationship|parent-child relationship
127990|NCT03403153|military family|military family
127991|NCT03403153|veterans health|veterans health
127992|NCT03403153|stress disorders|stress disorders
127993|NCT03403114|Vaccine hesitancy|vaccine hesitancy
127994|NCT03403114|Hospital specialists (HS)|hospital specialists (hs)
127995|NCT03403114|Vaccination survey|vaccination survey
127996|NCT03403088|Non-carious cervical lesions|non-carious cervical lesions
127997|NCT03403088|dentin hypersensitivity|dentin hypersensitivity
127998|NCT03403075|blood cancer|blood cancer
127999|NCT03403075|exercise|exercise
128000|NCT03403075|therapeutic education|therapeutic education
128001|NCT03403075|fatigue|fatigue
128002|NCT03403075|feasibility|feasibility
128003|NCT03403062|Sepsis|sepsis
128004|NCT03403062|red cell distribution width (RDW)|red cell distribution width (rdw)
128005|NCT03403062|Late onset sepsis (LOS)|late onset sepsis (los)
128006|NCT03403062|Early onset sepsis (EOS)|early onset sepsis (eos)
128007|NCT03403049|pancreatic cancer|pancreatic cancer
128008|NCT03403049|pancreas|pancreas
128009|NCT03403049|cancer|cancer
128010|NCT03403049|locally advanced|locally advanced
128011|NCT03403049|unresectable|unresectable
128012|NCT03403049|radiation|radiation
128013|NCT03403049|radiation therapy|radiation therapy
128014|NCT03403049|radiotherapy|radiotherapy
128015|NCT03403049|carbon|carbon
128016|NCT03403049|carbon ion|carbon ion
128017|NCT03403049|ion|ion
128018|NCT03403036|Psoriasis|psoriasis
128019|NCT03403036|brodalumab|brodalumab
128020|NCT03403023|Dry Eye Disease|dry eye disease
128021|NCT03403023|Tear Film Imager|tear film imager
128022|NCT03403023|tear film|tear film
128023|NCT03403023|Cyclosporine|cyclosporine
128024|NCT03403023|dry eye syndrome|dry eye syndrome
128025|NCT03403023|keratoconjunctivitis sicca|keratoconjunctivitis sicca
128026|NCT03402984|Gastric motility|gastric motility
128027|NCT03402984|Gastric emptying|gastric emptying
128028|NCT03402971|right heart|right heart
128029|NCT03402971|pregnancy|pregnancy
128030|NCT03402971|echocardiography|echocardiography
128031|NCT03402971|reference values|reference values
128032|NCT03402945|negative pressure wound management system|negative pressure wound management system
128033|NCT03402945|open-heart surgery|open-heart surgery
128034|NCT03402945|antibiotic prophylaxis|antibiotic prophylaxis
128035|NCT03402945|surgical site infection|surgical site infection
128036|NCT03402854|pediatric|pediatric
128037|NCT03402854|children|children
128038|NCT03402854|non-invasive brain stimulation|non-invasive brain stimulation
128039|NCT03402854|transcranial direct current stimulation|transcranial direct current stimulation
128040|NCT03402854|bimanual training|bimanual training
128041|NCT03402854|hand training|hand training
128042|NCT03402841|Ovarian cancer|ovarian cancer
128043|NCT03402841|non-gBRCA|non-gbrca
128044|NCT03402841|Platinum|platinum
128045|NCT03402841|Chemotherapy|chemotherapy
128046|NCT03402828|Topicals|topicals
128047|NCT03402828|Long-term|long-term
128048|NCT03402815|HIV|hiv
128049|NCT03402815|Maraviroc|maraviroc
128050|NCT03402815|Atherosclerosis|atherosclerosis
128051|NCT03402802|eye drop|eye drop
128052|NCT03402789|Docosahexaenoic acid|docosahexaenoic acid
128053|NCT03402789|Long chain fatty acid|long chain fatty acid
128054|NCT03402776|haemopoietic stem cell transplantation|haemopoietic stem cell transplantation
128055|NCT03402776|vaccine|vaccine
128056|NCT03402776|diphteria|diphteria
128057|NCT03402776|tetanus|tetanus
128058|NCT03402776|haemophilus influenza|haemophilus influenza
128059|NCT03402776|poliomyelitis|poliomyelitis
128060|NCT03402776|hepatitis B|hepatitis b
128061|NCT03402763|Advance care planning|advance care planning
128062|NCT03402763|Older adults|older adults
128063|NCT03402763|Emergency department|emergency department
128064|NCT03402750|Adherence, Medication, Prescription|adherence, medication, prescription
128065|NCT03402737|Stereotactic body radiotherapy|stereotactic body radiotherapy
128066|NCT03402737|Immunomodulating systemic therapy|immunomodulating systemic therapy
128067|NCT03402711|ACS|acs
128068|NCT03402711|PCI|pci
128069|NCT03402711|Bleeding risk|bleeding risk
128070|NCT03402698|cholecalciferol|cholecalciferol
128071|NCT03402698|BMI|bmi
128072|NCT03402698|winter|winter
128073|NCT03402607|Unresectable|unresectable
128074|NCT03402594|High flow oxygen therapy|high flow oxygen therapy
128075|NCT03402594|Oxygen desaturation index|oxygen desaturation index
128076|NCT03402594|Acute ischemic stroke|acute ischemic stroke
128077|NCT03402568|alcohol|alcohol
128078|NCT03402568|targeted metabolomics|targeted metabolomics
128079|NCT03402568|lipid metabolites|lipid metabolites
128080|NCT03402568|amino acids|amino acids
128081|NCT03402568|acylcarnitines|acylcarnitines
128082|NCT03402529|Contrast Enhanced Spectral Mammography|contrast enhanced spectral mammography
128083|NCT03402516|hysteroscopic myomectomy|hysteroscopic myomectomy
128084|NCT03402516|26Fr resector|26fr resector
128085|NCT03402516|18.5Fr resector|18.5fr resector
128086|NCT03402490|Motivational interviewing|motivational interviewing
128087|NCT03402490|physical activity|physical activity
128088|NCT03402490|feasibility|feasibility
128089|NCT03402490|HFpEF|hfpef
128090|NCT03402477|locally advanced, neo-adjuvant treatment, Watch & Wait|locally advanced, neo-adjuvant treatment, watch & wait
128091|NCT03402425|FET|fet
128092|NCT03402425|PET/MRI|pet/mri
128093|NCT03402425|child|child
128094|NCT03402360|Virtual Reality|virtual reality
128095|NCT03402360|Rehabilitation|rehabilitation
128096|NCT03402360|Acquired Brain Injury|acquired brain injury
128097|NCT03402347|Ex vivo|ex vivo
128098|NCT03402347|Gastric bypass|gastric bypass
128099|NCT03402321|alveogyl, gelatin sponge, free gingival graft, palate, pain|alveogyl, gelatin sponge, free gingival graft, palate, pain
128100|NCT03402282|hemorrhoidal disease|hemorrhoidal disease
128101|NCT03402282|embolization|embolization
128102|NCT03402256|Mobile Technology|mobile technology
128103|NCT03402256|Alcohol|alcohol
128104|NCT03402256|Alcoholic Liver Disease|alcoholic liver disease
128105|NCT03402256|Ethyl Glucuronide|ethyl glucuronide
128106|NCT03402217|Contraception|contraception
128107|NCT03402217|Post Partum Contraception|post partum contraception
128108|NCT03402204|Simvastatin|simvastatin
128109|NCT03402204|Plaque stability|plaque stability
128110|NCT03402204|Acute ischemic stroke|acute ischemic stroke
128111|NCT03402178|E2082|e2082
128112|NCT03402178|male|male
128113|NCT03402178|single ascending dose|single ascending dose
128114|NCT03402178|multiple ascending dose|multiple ascending dose
128115|NCT03402152|Biomarker|biomarker
128116|NCT03402100|myopia|myopia
128117|NCT03402100|schoolchildren|schoolchildren
128118|NCT03402100|atropine|atropine
128119|NCT03402100|allergy|allergy
128120|NCT03402100|eye drops|eye drops
128121|NCT03402100|outdoor|outdoor
128122|NCT03402100|near work|near work
128123|NCT03402048|Lung Cancer|lung cancer
128124|NCT03402048|Elderly|elderly
128125|NCT03402048|First line|first line
128126|NCT03402048|Customized chemotherapy|customized chemotherapy
128136|NCT03402009|Mindfulness|mindfulness
128137|NCT03402009|stress|stress
128138|NCT03402009|anxiety|anxiety
128139|NCT03401983|exercise|exercise
128140|NCT03401983|pelvic floor|pelvic floor
128141|NCT03401983|stress urinary incontinence|stress urinary incontinence
128142|NCT03401970|Body composition|body composition
128143|NCT03401970|Internal body fat|internal body fat
128144|NCT03401970|Dietary pattern|dietary pattern
128145|NCT03401970|Dietary carbohydrate|dietary carbohydrate
128146|NCT03401957|colorectal cancer|colorectal cancer
128147|NCT03401957|cetuximab resistance|cetuximab resistance
128148|NCT03401957|liquid biopsy|liquid biopsy
128149|NCT03401957|RAS mutation|ras mutation
128150|NCT03401905|Percutaneous electrical nerve stimulation|percutaneous electrical nerve stimulation
128151|NCT03401905|Myofascial trigger point|myofascial trigger point
128152|NCT03401866|brain tumor|brain tumor
128153|NCT03401840|Head and neck cancers|head and neck cancers
128154|NCT03401840|Radiation oncology|radiation oncology
128155|NCT03401840|Stereotactic radiotherapy|stereotactic radiotherapy
128156|NCT03401827|pancreatic cancer|pancreatic cancer
128157|NCT03401827|second line chemotherapy|second line chemotherapy
128158|NCT03401827|nab-paclitaxel|nab-paclitaxel
128159|NCT03401775|aging, computerized cognitive training|aging, computerized cognitive training
128160|NCT03401762|rehabilitation|rehabilitation
128161|NCT03401736|Sedatives and Hypnotics,Mechanical Ventilation|sedatives and hypnotics,mechanical ventilation
128162|NCT03401723|Validation study|validation study
128163|NCT03401723|Simulation|simulation
128164|NCT03401723|Endoscopy|endoscopy
128165|NCT03401710|Anemia, Acute Kidney injury, ESA, Erythropoietin|anemia, acute kidney injury, esa, erythropoietin
128166|NCT03401684|firefighters|firefighters
128167|NCT03401684|mental resiliency|mental resiliency
128168|NCT03401684|peer support|peer support
128169|NCT03401671|Lanadelumab|lanadelumab
128170|NCT03401632|Enteral nutrition|enteral nutrition
128171|NCT03401632|Vasoactive Drugs|vasoactive drugs
128172|NCT03401632|Critical Care|critical care
128173|NCT03401606|sedation|sedation
128174|NCT03401606|dexmedetomidine|dexmedetomidine
128175|NCT03401606|remifentanil|remifentanil
128176|NCT03401606|cataract surgery|cataract surgery
128177|NCT03401606|surgeon satisfaction|surgeon satisfaction
128178|NCT03401606|patient satisfaction|patient satisfaction
128179|NCT03401593|ablation|ablation
128180|NCT03401593|atrial fibrillation|atrial fibrillation
128181|NCT03401593|stroke|stroke
128182|NCT03401567|blood flow restriction|blood flow restriction
128183|NCT03401567|proprioception|proprioception
128184|NCT03401567|functional performance|functional performance
128185|NCT03401567|muscle strength|muscle strength
128186|NCT03401541|Calcifediol (25(OH)D)|calcifediol (25(oh)d)
128187|NCT03401541|Calciferol (Vitamin D)|calciferol (vitamin d)
128188|NCT03401463|endotracheal tube cuff pressure|endotracheal tube cuff pressure
128189|NCT03401463|Ventilator-Induced Lung Injury|ventilator-induced lung injury
128190|NCT03401463|traning|traning
128191|NCT03401437|adverse effects|adverse effects
128192|NCT03401437|Salpingectomy|salpingectomy
128193|NCT03401437|Essure® device ablation|essure® device ablation
128194|NCT03401437|Cornual resection|cornual resection
128195|NCT03401424|congenital cyst of common bile duct|congenital cyst of common bile duct
128196|NCT03401424|Biliary enteric anastomosis|biliary enteric anastomosis
128197|NCT03401411|ICU|icu
128198|NCT03401411|ICU Triage Practices|icu triage practices
128199|NCT03401411|Cancer Patients|cancer patients
128200|NCT03401411|Oncology ICU|oncology icu
128209|NCT03401385|Non-small cell lung cancer|non-small cell lung cancer
128210|NCT03401385|NSCLC|nsclc
128211|NCT03401385|Other solid tumors|other solid tumors
128212|NCT03401372|Primary light chain amyloidosis|primary light chain amyloidosis
128213|NCT03401372|Doxycycline|doxycycline
128214|NCT03401372|Bortezomib|bortezomib
128215|NCT03401372|Prognosis|prognosis
128216|NCT03401372|Progression-free survival|progression-free survival
128217|NCT03401372|Overall survival|overall survival
128218|NCT03401372|Organ response|organ response
128219|NCT03401320|pharmacokinetics|pharmacokinetics
163561|NCT03175939|NPC|npc
128220|NCT03401320|letrozole|letrozole
128221|NCT03401294|Metastatic colorectal cancer|metastatic colorectal cancer
128222|NCT03401294|Conversion therapy|conversion therapy
128223|NCT03401294|Liver Metastasectomy|liver metastasectomy
128224|NCT03401268|hypogammaglobulinemia|hypogammaglobulinemia
128225|NCT03401268|allogeneic hematopoietic cell transplantation|allogeneic hematopoietic cell transplantation
128226|NCT03401255|Placental alpha microglobulin-1|placental alpha microglobulin-1
128227|NCT03401255|PAMG-1|pamg-1
128228|NCT03401255|preterm labor|preterm labor
128229|NCT03401255|preterm delivery|preterm delivery
128230|NCT03401255|preterm birth|preterm birth
128231|NCT03401255|cervical length|cervical length
128232|NCT03401255|transvaginal ultrasound|transvaginal ultrasound
128233|NCT03401255|corticosteroid|corticosteroid
128234|NCT03401242|Carbapenemase|carbapenemase
128235|NCT03401242|Enterobacteriaceae|enterobacteriaceae
128236|NCT03401242|extended spectrum beta-lactamases|extended spectrum beta-lactamases
128237|NCT03401242|nursing homes|nursing homes
128238|NCT03401242|prevalence|prevalence
128239|NCT03401229|Polyps|polyps
128240|NCT03401229|Nasal polyps|nasal polyps
128241|NCT03401229|Nasal polyposis|nasal polyposis
128242|NCT03401229|Nose diseases|nose diseases
128243|NCT03401229|Respiratory tract diseases|respiratory tract diseases
128244|NCT03401229|Otorhinolaryngologic diseases|otorhinolaryngologic diseases
128245|NCT03401229|Benralizumab|benralizumab
128246|NCT03401229|Mometasone furoate|mometasone furoate
128247|NCT03401216|Optical coherence tomography|optical coherence tomography
128248|NCT03401216|Healing score|healing score
128249|NCT03401216|Neointimal coverage|neointimal coverage
128250|NCT03401216|synergy 48|synergy 48
128251|NCT03401216|long lesion|long lesion
128252|NCT03401203|ISR|isr
128253|NCT03401203|ROTA|rota
128254|NCT03401203|DEB|deb
128255|NCT03401203|PCI|pci
128256|NCT03401151|Heart failure|heart failure
128257|NCT03401151|Skeletal muscle|skeletal muscle
128258|NCT03401151|Exercise capacity|exercise capacity
128259|NCT03401151|Lung function|lung function
128260|NCT03401151|Gene expression|gene expression
128261|NCT03401138|Peripheral perfusion|peripheral perfusion
128262|NCT03401138|Blood Volume|blood volume
128263|NCT03401138|Tissue Prefusion|tissue prefusion
128264|NCT03401138|Near-infrared spectroscopy|near-infrared spectroscopy
128265|NCT03401138|Hemodynamic monitoring|hemodynamic monitoring
128266|NCT03401138|Hemodynamic optimization|hemodynamic optimization
128267|NCT03401138|Preoperative resuscitation|preoperative resuscitation
128268|NCT03401125|Sickle cell disease|sickle cell disease
128269|NCT03401125|Allo-immunization|allo-immunization
128270|NCT03401099|Radiofrequency ablation|radiofrequency ablation
128271|NCT03401099|Cavo-tricuspid isthmus|cavo-tricuspid isthmus
128272|NCT03401099|Pulmonary Vein Isolation|pulmonary vein isolation
128273|NCT03401099|Cryoballoon ablation|cryoballoon ablation
128274|NCT03401073|small Fiber Neuropathy|small fiber neuropathy
128275|NCT03401073|Idiopathic Peripheral Neuropathy|idiopathic peripheral neuropathy
128276|NCT03401073|IVIg|ivig
128277|NCT03401073|Gamunex-C|gamunex-c
128278|NCT03401060|Systemic mastocytosis|systemic mastocytosis
128279|NCT03401060|Osteoporosis|osteoporosis
128280|NCT03401060|Bone mineral density (BMD)|bone mineral density (bmd)
128281|NCT03401060|Denosumab|denosumab
128282|NCT03401060|RANKL|rankl
128283|NCT03401047|Polycystic ovary syndrome|polycystic ovary syndrome
128284|NCT03401021|intention to quit smoking|intention to quit smoking
128285|NCT03401021|male smoker|male smoker
128286|NCT03401021|smoking cessation|smoking cessation
128287|NCT03401021|expectant fathers|expectant fathers
128288|NCT03401008|Acromegaly|acromegaly
128289|NCT03401008|Oral manifestations|oral manifestations
128290|NCT03400969|Palliative|palliative
128291|NCT03400969|Moisturisers|moisturisers
128292|NCT03400969|Dry mouth|dry mouth
128293|NCT03400969|Xerostomia|xerostomia
128294|NCT03400956|Uterine fibroids|uterine fibroids
128295|NCT03400956|Heavy menstrual bleeding|heavy menstrual bleeding
128296|NCT03400943|Uterine fibroids|uterine fibroids
128297|NCT03400943|Heavy menstrual bleeding|heavy menstrual bleeding
128298|NCT03400930|Severe Acute Malnutrition|severe acute malnutrition
128299|NCT03400865|cabergoline|cabergoline
128300|NCT03400865|prolactinomas|prolactinomas
128301|NCT03400865|resistant|resistant
128302|NCT03400865|hydroxychloroquine|hydroxychloroquine
128303|NCT03400865|chloroquine|chloroquine
128304|NCT03400852|Muscular Dystrophy|muscular dystrophy
128305|NCT03400852|DMD|dmd
128306|NCT03400852|Duchenne|duchenne
128307|NCT03400839|Interstitial Lung disease|interstitial lung disease
128308|NCT03400839|prognosis|prognosis
128309|NCT03400839|clinical endpoints|clinical endpoints
128310|NCT03400839|association|association
128311|NCT03400826|simvastatin|simvastatin
128312|NCT03400826|fibroids|fibroids
128313|NCT03400826|medical management|medical management
128314|NCT03400826|uterine fibroids|uterine fibroids
128315|NCT03400826|leiomyoma|leiomyoma
128316|NCT03400813|Eye-Movement Desensitization|eye-movement desensitization
128317|NCT03400813|Reprocessing|reprocessing
128318|NCT03400800|Inclisiran sodium|inclisiran sodium
128319|NCT03400800|ASCVD|ascvd
128320|NCT03400800|LDL-C|ldl-c
128321|NCT03400748|Electrosurgery|electrosurgery
128322|NCT03400748|RF ablation|rf ablation
128323|NCT03400748|Minimally invasive|minimally invasive
128324|NCT03400748|Lung cancer|lung cancer
128325|NCT03400748|Lung metastasis|lung metastasis
128326|NCT03400748|Lung tumor|lung tumor
128327|NCT03400748|Primary|primary
128328|NCT03400748|Metastatic|metastatic
128329|NCT03400748|Endobronchial ultrasound|endobronchial ultrasound
128330|NCT03400748|EBUS|ebus
128331|NCT03400722|Suboptimal ovarian response|suboptimal ovarian response
128332|NCT03400722|Ovarian Stimulation|ovarian stimulation
128333|NCT03400722|Infertility, Female|infertility, female
128334|NCT03400722|In Vitro Fertilisation|in vitro fertilisation
128335|NCT03400709|Cisplatin|cisplatin
128336|NCT03400709|Ototoxicity|ototoxicity
128337|NCT03400709|N-acetylcisteine|n-acetylcisteine
128338|NCT03400696|nutrition, diet, genetics, physical activity, weight loss|nutrition, diet, genetics, physical activity, weight loss
128339|NCT03400670|NCPAP|ncpap
128340|NCT03400670|Respiratory Distress Syndrome|respiratory distress syndrome
128341|NCT03400644|open-door laminoplasty, laminoplasty, cervical collars|open-door laminoplasty, laminoplasty, cervical collars
128342|NCT03400631|Cytokine|cytokine
128343|NCT03400618|Carbohydrates|carbohydrates
128344|NCT03400618|Diet|diet
128345|NCT03400618|Diabetes Mellitus, Type 1|diabetes mellitus, type 1
128346|NCT03400592|gastric adenocarcinoma|gastric adenocarcinoma
128347|NCT03400592|EGFR|egfr
128348|NCT03400592|Irinotecan|irinotecan
128349|NCT03400592|Nimotuzumab|nimotuzumab
128350|NCT03400592|biomarker|biomarker
128351|NCT03400579|Emergency Medical Services|emergency medical services
128352|NCT03400540|verbal instruction, pelvic diaphragm, muscle contraction|verbal instruction, pelvic diaphragm, muscle contraction
128353|NCT03400514|Artificial intelligence|artificial intelligence
128354|NCT03400514|concordance|concordance
128355|NCT03400488|Coronary Artery Disease,|coronary artery disease,
128356|NCT03400488|Cardiovascular disease (CAD),|cardiovascular disease (cad),
128357|NCT03400488|5-lipoxygenase activating protein (FLAP) inhibitor,|5-lipoxygenase activating protein (flap) inhibitor,
128358|NCT03400488|Leukotrienes.|leukotrienes.
128359|NCT03400475|topical|topical
128360|NCT03400475|subgingival|subgingival
128361|NCT03400475|simvastatin|simvastatin
128362|NCT03400462|Dry needling, occlusal splint, NSAID, nimesulide|dry needling, occlusal splint, nsaid, nimesulide
128363|NCT03400423|Caffeine|caffeine
128364|NCT03400423|Caffeine Withdrawal|caffeine withdrawal
128365|NCT03400423|Acute Aerobic Exercise|acute aerobic exercise
128366|NCT03400423|Cognition|cognition
128367|NCT03400423|Working Memory|working memory
128368|NCT03400410|Contraception|contraception
128369|NCT03400410|Education|education
128370|NCT03400410|Male adolescents|male adolescents
128371|NCT03400410|Emergency Department|emergency department
128372|NCT03400410|Unintended pregnancy|unintended pregnancy
128373|NCT03400397|Anxiety|anxiety
128374|NCT03400397|Child|child
128375|NCT03400397|Cognitive behaviour therapy|cognitive behaviour therapy
128377|NCT03400397|effectiveness|effectiveness
128378|NCT03400397|treatment|treatment
128379|NCT03400397|Cool Kids|cool kids
128380|NCT03400384|Deprescribing|deprescribing
128381|NCT03400371|JME|jme
128382|NCT03400371|Epilepsy|epilepsy
128383|NCT03400371|Juvenile Myoclonic Epilepsy|juvenile myoclonic epilepsy
128384|NCT03400371|Genomewide Association Study|genomewide association study
128385|NCT03400371|Genetics|genetics
128386|NCT03400358|uterocervical angle|uterocervical angle
128387|NCT03400358|multiparous|multiparous
128388|NCT03400345|Hand Transplant|hand transplant
128389|NCT03400345|composite tissue allograft (CTA)|composite tissue allograft (cta)
128390|NCT03400345|Vascularized Composite Allotransplantation (VCA)|vascularized composite allotransplantation (vca)
128391|NCT03400345|Amputation|amputation
128392|NCT03400345|Upper Limb|upper limb
128393|NCT03400345|Immunosuppression|immunosuppression
128394|NCT03400319|Thoracic Aortic Aneurysm|thoracic aortic aneurysm
128395|NCT03400319|Obstructive Sleep Apnea|obstructive sleep apnea
128396|NCT03400306|Cancer - Ovarian cancer|cancer - ovarian cancer
128397|NCT03400306|Bioavailability|bioavailability
128398|NCT03400306|Pharmacokinetics|pharmacokinetics
128399|NCT03400306|Bioequivalence|bioequivalence
128400|NCT03400293|Human Immunodeficiency virus|human immunodeficiency virus
128401|NCT03400293|Health Related Quality of Life|health related quality of life
128402|NCT03400293|Functional Assessment of HIV Infection|functional assessment of hiv infection
128403|NCT03400293|Mobile app|mobile app
128404|NCT03400280|Postoperative pancreatic fistula|postoperative pancreatic fistula
128405|NCT03400280|Pancreatic resection|pancreatic resection
128406|NCT03400228|Probiotics|probiotics
128407|NCT03400228|Chronic kidney disease|chronic kidney disease
128408|NCT03400228|Cardiovascular risk|cardiovascular risk
128409|NCT03400176|Ibrutinib|ibrutinib
128410|NCT03400176|VAY736|vay736
128411|NCT03400176|Chronic lymphocytic leukemia|chronic lymphocytic leukemia
128412|NCT03400176|CLL|cll
128413|NCT03400176|Bruton's Tyrosine Kinase|bruton's tyrosine kinase
128414|NCT03400176|BTK mutation|btk mutation
128415|NCT03400163|First Line Therapy|first line therapy
128416|NCT03400163|NASH|nash
128417|NCT03400085|mHealth|mhealth
128418|NCT03400085|living donor kidney transplant|living donor kidney transplant
128419|NCT03400085|follow-up|follow-up
128420|NCT03400085|health utilization|health utilization
129868|NCT03391362|Lung cancer|lung cancer
128421|NCT03400059|Prophylaxis, Headache, Preventative Treatment|prophylaxis, headache, preventative treatment
128422|NCT03400033|CKD, EPO, rhEPO, Hemodialysis dependent, Daprodustat|ckd, epo, rhepo, hemodialysis dependent, daprodustat
128423|NCT03400007|dynamic floor magnetic resonance imaging|dynamic floor magnetic resonance imaging
128424|NCT03400007|colpocystodefecagraphy|colpocystodefecagraphy
128425|NCT03400007|prolapse surgery|prolapse surgery
128426|NCT03399968|shockwave|shockwave
128427|NCT03399968|ESWT|eswt
128428|NCT03399929|Rehabilitation|rehabilitation
128429|NCT03399929|Long term outcome|long term outcome
128430|NCT03399838|Procedural Sedation and Analgesia|procedural sedation and analgesia
128431|NCT03399838|Pediatric Emergency Department|pediatric emergency department
128432|NCT03399838|intranasal|intranasal
128433|NCT03399838|dexmedetomidine|dexmedetomidine
128434|NCT03399838|midazolam|midazolam
128435|NCT03399838|anxiety relief|anxiety relief
128436|NCT03399786|HoFH|hofh
128437|NCT03399760|i-PRF (injectable platelet rich fibrin)|i-prf (injectable platelet rich fibrin)
128438|NCT03399760|alveolar bone height|alveolar bone height
128439|NCT03399760|canine root resorption|canine root resorption
128440|NCT03399760|bone density|bone density
128441|NCT03399760|cone-beam computed tomography|cone-beam computed tomography
128442|NCT03399734|Perampanel|perampanel
128443|NCT03399734|Bioequivalence|bioequivalence
128444|NCT03399734|fine granules|fine granules
128445|NCT03399734|E2007|e2007
128446|NCT03399734|Japanese|japanese
128447|NCT03399708|apremilast|apremilast
128448|NCT03399708|PDE4 inhibition|pde4 inhibition
128449|NCT03399708|cardiometabolic|cardiometabolic
128450|NCT03399708|immune profile|immune profile
128451|NCT03399695|preoxygenation|preoxygenation
128452|NCT03399695|high flow oxygen|high flow oxygen
128453|NCT03399682|cystography|cystography
128454|NCT03399682|pediatry|pediatry
128455|NCT03399682|urinary infection|urinary infection
128456|NCT03399630|Osteo Arthritis Knee|osteo arthritis knee
128457|NCT03399630|Autologous Adipose Tissue|autologous adipose tissue
128458|NCT03399617|Stunting|stunting
128459|NCT03399617|Obesity|obesity
128460|NCT03399617|Lipid-based Nutrient Supplements (LNS)|lipid-based nutrient supplements (lns)
128461|NCT03399617|Latin America|latin america
128462|NCT03399617|Child nutrition|child nutrition
128463|NCT03399617|Feeding practices|feeding practices
128464|NCT03399604|Pulmonary Arterial Hypertension|pulmonary arterial hypertension
128465|NCT03399604|Idiopathic Pulmonary Arterial Hypertension|idiopathic pulmonary arterial hypertension
128466|NCT03399604|Heritable Pulmonary Arterial Hypertension|heritable pulmonary arterial hypertension
128467|NCT03399604|Drug Induced Pulmonary Arterial Hypertension|drug induced pulmonary arterial hypertension
128468|NCT03399604|Toxin Induced Pulmonary Arterial Hypertension|toxin induced pulmonary arterial hypertension
128469|NCT03399604|Connective tissue disease|connective tissue disease
128470|NCT03399591|Gait Disorders|gait disorders
128471|NCT03399591|Spatio-temporal parameters of walking|spatio-temporal parameters of walking
128472|NCT03399591|Alzheimer's disease|alzheimer's disease
128473|NCT03399591|Lewy body disease|lewy body disease
128474|NCT03399552|Stereotactic Body Radiation Therapy|stereotactic body radiation therapy
128475|NCT03399552|Avelumab Immunotherapy|avelumab immunotherapy
128476|NCT03399552|17-358|17-358
128477|NCT03399513|Ibrutinib|ibrutinib
128478|NCT03399500|Case Management|case management
128479|NCT03399500|Homelessness|homelessness
128480|NCT03399500|Smartphone|smartphone
128481|NCT03399500|Health Related Quality of Life|health related quality of life
128482|NCT03399500|Mental Health|mental health
128483|NCT03399500|Substance Use Disorders|substance use disorders
128484|NCT03399487|NSCLC|nsclc
128485|NCT03399487|ROS1 rearrangement|ros1 rearrangement
128486|NCT03399487|Ceritinib|ceritinib
128487|NCT03399487|LDK378|ldk378
128488|NCT03399474|Regional Anesthesia, Dexmedetomidine and lidocaine|regional anesthesia, dexmedetomidine and lidocaine
128489|NCT03399461|United States|united states
128490|NCT03399461|United Kingdom|united kingdom
128491|NCT03399461|Wiskott-Aldrich Syndrome|wiskott-aldrich syndrome
128492|NCT03399461|Caregiver|caregiver
128493|NCT03399461|Interview|interview
128494|NCT03399461|immune deficiency|immune deficiency
128495|NCT03399461|France|france
128496|NCT03399435|Regional anesthesia|regional anesthesia
128497|NCT03399435|Brachial plexus blockade|brachial plexus blockade
128498|NCT03399435|Sensory and motor function testing|sensory and motor function testing
128499|NCT03399422|i-PRF (injectable platelet rich fibrin)|i-prf (injectable platelet rich fibrin)
128500|NCT03399422|canine retraction|canine retraction
128501|NCT03399422|pain and discomfort|pain and discomfort
128502|NCT03399383|Adrenal Insufficiency|adrenal insufficiency
128503|NCT03399383|Adrenal crisis|adrenal crisis
128504|NCT03399383|Adherence|adherence
128505|NCT03399383|Standardized patient education|standardized patient education
128506|NCT03399370|Inclisiran sodium|inclisiran sodium
128507|NCT03399370|ASCVD|ascvd
128508|NCT03399370|LDL-C|ldl-c
128509|NCT03399331|honey, olive oil, oral mucositis, pain|honey, olive oil, oral mucositis, pain
128510|NCT03399318|HRP2|hrp2
128511|NCT03399292|Lipid based eye drops|lipid based eye drops
128512|NCT03399292|Tearfilm lipid layer thickness|tearfilm lipid layer thickness
129967|NCT03390673|randomized|randomized
128513|NCT03399279|nanohydroxyapatite|nanohydroxyapatite
128514|NCT03399279|Perforated membrane|perforated membrane
128515|NCT03399279|occlusive membrane|occlusive membrane
128516|NCT03399279|Aggressive periodontitis|aggressive periodontitis
128517|NCT03399266|Induction of labor|induction of labor
128518|NCT03399266|Previous cesarean delivery|previous cesarean delivery
128519|NCT03399266|Trial of labor after cesarean|trial of labor after cesarean
128520|NCT03399266|Prelabor rupture of membranes|prelabor rupture of membranes
128521|NCT03399266|balloon induction|balloon induction
128522|NCT03399253|Distal Gastric Cancer, Gastrectomy, Metastasectomy|distal gastric cancer, gastrectomy, metastasectomy
128523|NCT03399227|Bone microarchitecture|bone microarchitecture
128524|NCT03399188|Inflammatory Bowel Diseases, Fecal microbiota transplantation, microbiome|inflammatory bowel diseases, fecal microbiota transplantation, microbiome
128525|NCT03399175|Vogt-Koyanagi-Harada disease|vogt-koyanagi-harada disease
128526|NCT03399175|Immunosuppressive therapy|immunosuppressive therapy
128527|NCT03399175|Indocyanine green angiography|indocyanine green angiography
128528|NCT03399175|Enhanced depth imaging optical coherence tomography|enhanced depth imaging optical coherence tomography
128529|NCT03399175|Electroretinogram|electroretinogram
128530|NCT03399149|Respiratory Insufficiency|respiratory insufficiency
128531|NCT03399149|Hematologic Malignancy|hematologic malignancy
128532|NCT03399149|Intensive Care Unit|intensive care unit
128533|NCT03399136|Exercise training|exercise training
128534|NCT03399136|Intervention|intervention
128535|NCT03399136|Aerobic capacity|aerobic capacity
128536|NCT03399123|Laparoscopic hepatectomy|laparoscopic hepatectomy
128537|NCT03399123|Low tidal volume|low tidal volume
128538|NCT03399123|Blood loss|blood loss
128539|NCT03399110|Gastric cancer,Adjuvant chemtherapy|gastric cancer,adjuvant chemtherapy
128540|NCT03399097|Obesity|obesity
128541|NCT03399084|Ferric carboxymaltose|ferric carboxymaltose
128542|NCT03399084|Anemia|anemia
128543|NCT03399071|Gastric cancer|gastric cancer
128544|NCT03399071|Oesophageal cancer|oesophageal cancer
128545|NCT03399071|Gastro-oesophageal cancer|gastro-oesophageal cancer
128546|NCT03399071|Perioperative|perioperative
128547|NCT03399071|Immunotherapy|immunotherapy
128548|NCT03399071|Anti PDL1|anti pdl1
128549|NCT03399071|Avelumab|avelumab
128550|NCT03399071|FLOT|flot
128551|NCT03399032|caspofungin|caspofungin
128552|NCT03399032|pharmacokinetics|pharmacokinetics
128553|NCT03399019|Bispectral index monitor|bispectral index monitor
128554|NCT03398980|Childhood and Adolescent|childhood and adolescent
128555|NCT03398980|Survivors|survivors
128556|NCT03398980|Radiotherapy|radiotherapy
128557|NCT03398980|Late Sequelae|late sequelae
128558|NCT03398941|Pancreatic fistula|pancreatic fistula
128559|NCT03398915|robotic|robotic
128560|NCT03398915|robot-guided|robot-guided
128561|NCT03398915|navigated|navigated
128562|NCT03398915|computer-assisted|computer-assisted
128563|NCT03398915|pedicle screw|pedicle screw
128564|NCT03398915|instrumentation|instrumentation
128565|NCT03398915|thoracolumbar|thoracolumbar
128566|NCT03398902|sleep|sleep
128567|NCT03398902|sleep extension|sleep extension
128568|NCT03398902|sleep patterns|sleep patterns
128569|NCT03398902|type 2 diabetes|type 2 diabetes
128570|NCT03398902|glucose regulation|glucose regulation
128571|NCT03398902|behavioral intervention|behavioral intervention
128572|NCT03398902|adults|adults
128573|NCT03398889|intestinal microbiome|intestinal microbiome
128574|NCT03398889|atherosclerosis|atherosclerosis
128575|NCT03398889|nutrients|nutrients
128576|NCT03398889|renal function|renal function
128577|NCT03398850|spontaneous coronary artery dissection|spontaneous coronary artery dissection
128578|NCT03398850|acute coronary syndrome|acute coronary syndrome
128579|NCT03398850|coronary angiography|coronary angiography
128580|NCT03398850|coronary tomography|coronary tomography
128581|NCT03398837|Scleroderma|scleroderma
128582|NCT03398837|cannabinoid receptor type 2 agonist|cannabinoid receptor type 2 agonist
128583|NCT03398837|anabasum|anabasum
128584|NCT03398837|JBT-101|jbt-101
128585|NCT03398837|lenabasum|lenabasum
128586|NCT03398824|Fanconi Anemia|fanconi anemia
128587|NCT03398824|Metformin|metformin
128588|NCT03398798|archwire dimension|archwire dimension
128589|NCT03398798|ligation method|ligation method
128590|NCT03398798|bracket type|bracket type
128591|NCT03398785|Primary Aldosteronism|primary aldosteronism
128592|NCT03398785|Hypertension|hypertension
128593|NCT03398785|Ablation|ablation
128594|NCT03398785|Adrenal Gland|adrenal gland
128595|NCT03398759|Butorphanol|butorphanol
128596|NCT03398759|Functional endoscopic sinus surgery|functional endoscopic sinus surgery
128597|NCT03398759|Emergence agitation|emergence agitation
128598|NCT03398746|soft tissue infection|soft tissue infection
128599|NCT03398746|MRSA|mrsa
128600|NCT03398733|Obstructive Sleep Apnea|obstructive sleep apnea
128601|NCT03398733|heart valve replacement|heart valve replacement
128602|NCT03398733|CPAP treatment|cpap treatment
128603|NCT03398707|PICs|pics
128604|NCT03398707|diagnosis|diagnosis
128605|NCT03398707|prevention|prevention
128606|NCT03398707|outcome|outcome
128607|NCT03398681|Heart failure|heart failure
128608|NCT03398681|Iron deficiency|iron deficiency
131230|NCT03382548|Pneumonia|pneumonia
128609|NCT03398681|Cardiac magnetic resonance|cardiac magnetic resonance
128610|NCT03398681|Ferric carboxymaltose|ferric carboxymaltose
128611|NCT03398681|Myocardial iron|myocardial iron
128612|NCT03398655|Recurrent Ovarian cancer|recurrent ovarian cancer
128613|NCT03398655|Platinum resistant ovarian cancer|platinum resistant ovarian cancer
128614|NCT03398655|Ovarian cancer|ovarian cancer
128615|NCT03398655|Ovarian carcinoma|ovarian carcinoma
128616|NCT03398655|Epithelial ovarian cancer|epithelial ovarian cancer
128617|NCT03398655|paclitaxel|paclitaxel
128618|NCT03398642|Occupational therapy|occupational therapy
128619|NCT03398642|Health promotion|health promotion
128620|NCT03398642|Life Style|life style
128621|NCT03398642|Quality of life|quality of life
128622|NCT03398642|Aging|aging
128623|NCT03398642|Aged|aged
128624|NCT03398642|Community participation|community participation
128625|NCT03398616|Retinal Bloodflow Pressure|retinal bloodflow pressure
128626|NCT03398603|"AMH measurement ElecSys"|"amh measurement elecsys"
128627|NCT03398590|Type 2 Diabetes|type 2 diabetes
128628|NCT03398590|Obesity|obesity
128629|NCT03398577|Coronary disease|coronary disease
128630|NCT03398577|diabetes|diabetes
128631|NCT03398577|SGLT2I|sglt2i
128632|NCT03398577|Inflammation Mediators|inflammation mediators
128633|NCT03398564|Erecror Spinae Plan Block|erecror spinae plan block
128634|NCT03398564|postoperative pain|postoperative pain
128635|NCT03398564|Laparoscopic cholecystectomy|laparoscopic cholecystectomy
128636|NCT03398551|pregnancy|pregnancy
128637|NCT03398551|machine learning|machine learning
128638|NCT03398551|fetal Doppler echocardiography|fetal doppler echocardiography
128639|NCT03398538|DFU|dfu
128640|NCT03398538|Ulcer|ulcer
128641|NCT03398525|central venous catheter|central venous catheter
128642|NCT03398525|intensive care|intensive care
128643|NCT03398525|music therapy|music therapy
128644|NCT03398499|pain|pain
128645|NCT03398499|orthognathic surgery|orthognathic surgery
128646|NCT03398499|temporomandibular disorders (TMD)|temporomandibular disorders (tmd)
128647|NCT03398499|Electromagnetic Therapy|electromagnetic therapy
128648|NCT03398499|Light therapy|light therapy
128649|NCT03398486|Kinesiotaping, Manual therapy|kinesiotaping, manual therapy
128650|NCT03398486|Physiotherapy|physiotherapy
128651|NCT03398473|Epoetin Hospira|epoetin hospira
128652|NCT03398473|Pharmacokinetics|pharmacokinetics
128653|NCT03398434|MAA868|maa868
128654|NCT03398434|apixaban|apixaban
128655|NCT03398434|atrial fibrillation|atrial fibrillation
128656|NCT03398434|anticoagulant|anticoagulant
128657|NCT03398434|Factor XI|factor xi
128658|NCT03398434|D-dimer|d-dimer
128659|NCT03398434|systemic thromboembolic events|systemic thromboembolic events
128660|NCT03398421|Nemiralisib|nemiralisib
128661|NCT03398421|Pharmacokinetics|pharmacokinetics
128662|NCT03398421|Itraconazole|itraconazole
128663|NCT03398421|Drug-drug Interaction|drug-drug interaction
128664|NCT03398421|Cross-over|cross-over
128665|NCT03398382|Magnesium citrate|magnesium citrate
128666|NCT03398382|Trismus after surgical removal of the lower third molars|trismus after surgical removal of the lower third molars
128667|NCT03398382|Local anesthesia|local anesthesia
128668|NCT03398382|Analgesia after surgical removal of the lower third molars|analgesia after surgical removal of the lower third molars
128669|NCT03398382|Swelling after surgical removal of the lower third molars|swelling after surgical removal of the lower third molars
128670|NCT03398382|Surgical removal of the lower third molars|surgical removal of the lower third molars
128671|NCT03398382|Oral surgical procedures|oral surgical procedures
128672|NCT03398382|Placebo effect|placebo effect
128673|NCT03398356|prediabetes|prediabetes
128674|NCT03398356|impaired fasting glucose|impaired fasting glucose
128675|NCT03398356|impaired glucose tolerance|impaired glucose tolerance
128676|NCT03398356|metformin|metformin
128677|NCT03398356|nitric oxide|nitric oxide
128678|NCT03398317|SDF|sdf
128679|NCT03398317|DFI|dfi
128680|NCT03398317|sperm selection|sperm selection
128681|NCT03398317|PICSI|picsi
128682|NCT03398317|MACS|macs
128683|NCT03398239|respiratory failure, hypercapnia, BPAP, AVAPS|respiratory failure, hypercapnia, bpap, avaps
128684|NCT03398174|Rural dwellers|rural dwellers
128685|NCT03398174|Patient Education|patient education
128686|NCT03398174|Exercise|exercise
128687|NCT03398148|ABBV-066|abbv-066
128688|NCT03398148|BI 655066|bi 655066
128689|NCT03398135|ABBV-066|abbv-066
128690|NCT03398135|BI 655066|bi 655066
128691|NCT03398122|Apatinib|apatinib
128692|NCT03398122|advanced hepatocellular carcinoma|advanced hepatocellular carcinoma
128693|NCT03398070|Functional Neurological Disorder|functional neurological disorder
128694|NCT03398070|Functional Movement Disorder|functional movement disorder
128695|NCT03398070|Psychogenic Nonepileptic Seizures|psychogenic nonepileptic seizures
128696|NCT03398070|Functional Limb Weakness|functional limb weakness
128697|NCT03398057|Breast cancer screening; health education; breast self-examination; clinical breast examination; mammography.|breast cancer screening; health education; breast self-examination; clinical breast examination; mammography.
128698|NCT03398018|dry eye|dry eye
128699|NCT03398018|corticotropin|corticotropin
128700|NCT03398005|Omega-3 Fatty acids|omega-3 fatty acids
128701|NCT03398005|Triglycerides|triglycerides
131624|NCT03380052|pepsinogen|pepsinogen
128702|NCT03397979|atopic dermatitis|atopic dermatitis
128703|NCT03397979|bathing|bathing
128704|NCT03397979|baths|baths
128705|NCT03397966|obesity|obesity
128706|NCT03397966|Cardiovascular Physiological Phenomena|cardiovascular physiological phenomena
128707|NCT03397966|metabolism|metabolism
128708|NCT03397966|Energy Metabolism|energy metabolism
128709|NCT03397953|Anaplastic Large Cell Lymphoma|anaplastic large cell lymphoma
128710|NCT03397953|Childhood|childhood
128711|NCT03397953|Adolescent|adolescent
128712|NCT03397953|Recurrent|recurrent
128713|NCT03397953|Treatment|treatment
128714|NCT03397927|ballet shoe|ballet shoe
128715|NCT03397927|orthosis|orthosis
128716|NCT03397927|pain|pain
128717|NCT03397901|chronic radiation proctitis|chronic radiation proctitis
128718|NCT03397901|rectal bleeding|rectal bleeding
128719|NCT03397901|transverse colostomy|transverse colostomy
128720|NCT03397901|refractory|refractory
128721|NCT03397901|moderate to severe anemia|moderate to severe anemia
128722|NCT03397849|Primary prevention|primary prevention
128723|NCT03397849|Lifestyle intervention|lifestyle intervention
128724|NCT03397849|Digital health|digital health
128725|NCT03397849|Cardiovascular disease prevention|cardiovascular disease prevention
128726|NCT03397836|Older adults|older adults
128727|NCT03397836|Optimal aging|optimal aging
128728|NCT03397836|Primary health care|primary health care
128729|NCT03397836|Randomized control trial|randomized control trial
128730|NCT03397836|Integrated care|integrated care
128731|NCT03397836|Health care volunteers|health care volunteers
128732|NCT03397836|interdisciplinary health care teams|interdisciplinary health care teams
128733|NCT03397836|Implementation|implementation
128734|NCT03397836|Health services research|health services research
128735|NCT03397836|Patient centered care|patient centered care
128736|NCT03397810|cardiac amyloidosis|cardiac amyloidosis
128737|NCT03397810|radiotherapy|radiotherapy
128738|NCT03397797|muscle relaxant|muscle relaxant
128739|NCT03397784|Tidal volume challenge|tidal volume challenge
128740|NCT03397784|Fluid responsiveness|fluid responsiveness
128741|NCT03397784|Preload responsiveness|preload responsiveness
128742|NCT03397784|Functional hemodynamic monitoring|functional hemodynamic monitoring
128743|NCT03397784|Cardiac surgery|cardiac surgery
128744|NCT03397784|inferior vena cava variation|inferior vena cava variation
128745|NCT03397771|urinary incontinence, SSRI|urinary incontinence, ssri
128746|NCT03397745|bispectral index|bispectral index
128747|NCT03397745|lateral decubitus position|lateral decubitus position
128748|NCT03397745|one lung ventilation|one lung ventilation
128749|NCT03397732|Matrix metalloproteinase|matrix metalloproteinase
128750|NCT03397732|Tissue inhibitor of matrix metalloproteinase|tissue inhibitor of matrix metalloproteinase
128751|NCT03397732|Vascular surgery|vascular surgery
128752|NCT03397732|Aorta stent implantation|aorta stent implantation
128753|NCT03397732|Aorto-bifemoral bypass surgery|aorto-bifemoral bypass surgery
128754|NCT03397719|Autism Spectrum Disorder|autism spectrum disorder
128755|NCT03397719|Early Intervention|early intervention
128756|NCT03397719|Parent-Mediated Intervention|parent-mediated intervention
128757|NCT03397706|EBV+ post-transplant lymphoproliferative malignancy|ebv+ post-transplant lymphoproliferative malignancy
128758|NCT03397706|EBV-associated lymphoproliferative disorders associated with acquired immunodeficiency including HIV-positive|ebv-associated lymphoproliferative disorders associated with acquired immunodeficiency including hiv-positive
128759|NCT03397706|Relapsed, refractory, EBV+ lymphoid malignancy|relapsed, refractory, ebv+ lymphoid malignancy
128760|NCT03397693|PCOS|pcos
128761|NCT03397693|Unexplained infertiltiy|unexplained infertiltiy
128762|NCT03397693|3D Power Doppler|3d power doppler
128763|NCT03397693|Endometrial thickness|endometrial thickness
128764|NCT03397693|Subendometrial blood perfusion|subendometrial blood perfusion
128765|NCT03397680|Helicobacter Pylori infection|helicobacter pylori infection
128766|NCT03397680|Non-ulcer Dyspepsia|non-ulcer dyspepsia
128767|NCT03397680|Rabeprazole-Levofloxacin|rabeprazole-levofloxacin
128768|NCT03397602|atrial fibrillation|atrial fibrillation
128769|NCT03397602|exercise|exercise
128770|NCT03397576|Prisoner|prisoner
128771|NCT03397563|Continuous Positive Airway Pressure|continuous positive airway pressure
128772|NCT03397563|Sleep Apnea, Obstructive|sleep apnea, obstructive
128773|NCT03397563|Polysomnography|polysomnography
128774|NCT03397550|taste threshold|taste threshold
128775|NCT03397550|salt restriction|salt restriction
128776|NCT03397537|Breast Neoplasms Endocrine-responsive Neoadjuvant Duration Letrozole|breast neoplasms endocrine-responsive neoadjuvant duration letrozole
128777|NCT03397498|computerized cognitive training|computerized cognitive training
128778|NCT03397472|Insomnia|insomnia
128779|NCT03397472|Treatment|treatment
128780|NCT03397472|magnetic field modulation|magnetic field modulation
128781|NCT03397459|cervicobrachial neuralgia|cervicobrachial neuralgia
128782|NCT03397459|sagittal balance|sagittal balance
128783|NCT03397459|lordosis|lordosis
128784|NCT03397446|Lisdexamfetamine Dimesylate|lisdexamfetamine dimesylate
128785|NCT03397446|Lisdexamfetamine|lisdexamfetamine
128786|NCT03397446|Vyvanse|vyvanse
128787|NCT03397446|Eating Disorders|eating disorders
128788|NCT03397446|Mental Disorders|mental disorders
128789|NCT03397446|Central Nervous System Stimulants|central nervous system stimulants
131625|NCT03380026|CTCL|ctcl
128790|NCT03397446|Dextroamphetamine|dextroamphetamine
128792|NCT03397446|Binge Eating|binge eating
128793|NCT03397446|Purging|purging
128794|NCT03397446|Bulimia Nervosa|bulimia nervosa
128795|NCT03397433|Antibiotic Stewardship|antibiotic stewardship
128796|NCT03397433|Information Technology|information technology
128797|NCT03397433|Healthcare Outcomes|healthcare outcomes
128798|NCT03397433|Antibiotic Resistance|antibiotic resistance
128799|NCT03397433|Bacterial Infection|bacterial infection
128800|NCT03397394|PARP inhibitor|parp inhibitor
128801|NCT03397394|PARPi|parpi
128802|NCT03397394|HRD|hrd
128803|NCT03397394|ATLAS|atlas
128804|NCT03397394|homologous recombination|homologous recombination
128805|NCT03397394|DNA repair|dna repair
128806|NCT03397394|LOH|loh
128807|NCT03397394|DNA defect|dna defect
128808|NCT03397394|DNA anomaly|dna anomaly
128809|NCT03397394|Rucaparib|rucaparib
128810|NCT03397394|MIBC|mibc
128811|NCT03397355|Pulmonary Nodule; Lung Cancer; Biopsy; Biomarker.|pulmonary nodule; lung cancer; biopsy; biomarker.
128812|NCT03397329|Healthy Volunteers|healthy volunteers
128813|NCT03397316|immediate implant|immediate implant
128814|NCT03397316|upper esthetic zone|upper esthetic zone
128815|NCT03397316|marginal bone loss|marginal bone loss
128816|NCT03397290|Chest X-ray|chest x-ray
128817|NCT03397290|Ultrasound|ultrasound
128818|NCT03397277|IPV|ipv
128819|NCT03397238|myeloid cell|myeloid cell
128820|NCT03397238|reprogramming|reprogramming
128821|NCT03397238|monocyte|monocyte
128822|NCT03397238|tumor-associated macrophage|tumor-associated macrophage
128823|NCT03397212|NADA|nada
128824|NCT03397173|Azacitidine|azacitidine
128825|NCT03397173|Ascorbic Acid|ascorbic acid
128826|NCT03397160|Prostate cancer|prostate cancer
128827|NCT03397160|Transformative Impact Award|transformative impact award
128828|NCT03397160|Early stage|early stage
128829|NCT03397160|Active surveillance|active surveillance
128830|NCT03397160|Decision aid|decision aid
128831|NCT03397160|Coaching session|coaching session
128832|NCT03397160|Personalized|personalized
128833|NCT03397160|University of California, San Francisco (UCSF)|university of california, san francisco (ucsf)
128834|NCT03397160|Validation|validation
128835|NCT03397121|HeFH|hefh
128836|NCT03397121|LDL-C|ldl-c
128837|NCT03397121|Inclisiran|inclisiran
128838|NCT03397108|Inflammatory Bowel Disease|inflammatory bowel disease
128839|NCT03397108|Crohn disease|crohn disease
128840|NCT03397108|Colitis|colitis
128841|NCT03397108|TNF|tnf
128842|NCT03397108|Breast milk|breast milk
128843|NCT03397108|monoclonal antibody|monoclonal antibody
128844|NCT03397095|stem cells, ischemic heart disease.|stem cells, ischemic heart disease.
128845|NCT03397082|Endouterine manual aspiration|endouterine manual aspiration
128846|NCT03397082|Paracervical blockade|paracervical blockade
128847|NCT03397082|Lidocaine gel|lidocaine gel
128848|NCT03397069|peribubar block - midazolam|peribubar block - midazolam
128849|NCT03397056|Patient willingness|patient willingness
128850|NCT03397056|Participation|participation
128851|NCT03397030|Prostate Cancer|prostate cancer
128852|NCT03397030|Biomarkers|biomarkers
128853|NCT03397030|Exercise|exercise
128854|NCT03397004|Hereditary hemorrhagic telangiectasia|hereditary hemorrhagic telangiectasia
128855|NCT03397004|HHT|hht
128856|NCT03397004|Doxycycline|doxycycline
128857|NCT03396991|Analgesia technique|analgesia technique
128858|NCT03396991|Pain control|pain control
128859|NCT03396939|Stroke|stroke
128860|NCT03396939|Rehabilitation|rehabilitation
128861|NCT03396939|Task oriented training|task oriented training
128862|NCT03396939|Motor recovery|motor recovery
128863|NCT03396939|Hand function|hand function
128864|NCT03396939|Arm function|arm function
128865|NCT03396913|Intense Pulsed Light|intense pulsed light
128866|NCT03396913|Meibomian Gland Dysfunction|meibomian gland dysfunction
128867|NCT03396913|Dry Eye Disease|dry eye disease
128868|NCT03396887|Alcohol Use Disorder|alcohol use disorder
128869|NCT03396887|Smartphone Application|smartphone application
128870|NCT03396861|macular edema|macular edema
128871|NCT03396861|pseudophakia|pseudophakia
128872|NCT03396861|pseudophakic macular edema|pseudophakic macular edema
128873|NCT03396861|retinal swelling|retinal swelling
128874|NCT03396861|aflibercept|aflibercept
128875|NCT03396861|anti-vascular endothelial growth factor|anti-vascular endothelial growth factor
128876|NCT03396861|subconjunctival injection|subconjunctival injection
128877|NCT03396848|Rehabilitation|rehabilitation
128878|NCT03396848|Online Clinic|online clinic
128879|NCT03396822|multiple sclerosis|multiple sclerosis
128880|NCT03396822|7T MRI|7t mri
128881|NCT03396822|Meningeal inflammation|meningeal inflammation
128882|NCT03396809|punctal plugs|punctal plugs
128883|NCT03396809|dry eye|dry eye
128884|NCT03396809|ocular surface disease index|ocular surface disease index
128885|NCT03396796|Vagus nerve|vagus nerve
128886|NCT03396796|Delayed gastric emptying|delayed gastric emptying
128887|NCT03396796|Cirrhosis|cirrhosis
128888|NCT03396796|Hypertension|hypertension
128889|NCT03396796|laparoscopy|laparoscopy
128890|NCT03396770|Urinary biomarkers|urinary biomarkers
128891|NCT03396770|Intensive Care Unit|intensive care unit
128892|NCT03396757|Acute Kidney Injury|acute kidney injury
128893|NCT03396757|Critical Care|critical care
128894|NCT03396757|Renal Replacement Therapy|renal replacement therapy
128896|NCT03396731|Venous Leg Ulcer|venous leg ulcer
128897|NCT03396731|Leg Ulcer|leg ulcer
128898|NCT03396731|Leg Wound|leg wound
128899|NCT03396718|Head and neck cancer|head and neck cancer
128900|NCT03396718|Oropharyngeal cancer|oropharyngeal cancer
128901|NCT03396718|postoperative|postoperative
128902|NCT03396718|radiotherapy|radiotherapy
128903|NCT03396718|radiochemotherapy|radiochemotherapy
128904|NCT03396718|de-intensification|de-intensification
128905|NCT03396718|HPV|hpv
128906|NCT03396679|Psoriatic arthritis|psoriatic arthritis
128907|NCT03396679|remission|remission
128908|NCT03396679|ultrasound|ultrasound
128909|NCT03396653|weight loss|weight loss
128910|NCT03396653|weight maintenance|weight maintenance
128911|NCT03396653|weight control|weight control
128912|NCT03396653|peer support|peer support
128913|NCT03396653|patient-provided care|patient-provided care
128914|NCT03396640|anteromedial|anteromedial
128915|NCT03396627|eyelid|eyelid
128916|NCT03396627|Muller|muller
128917|NCT03396588|Opiate use during pregnancy|opiate use during pregnancy
128918|NCT03396588|Clonidine|clonidine
128919|NCT03396588|Morphine|morphine
128920|NCT03396588|Prenatal opiate|prenatal opiate
128921|NCT03396588|Neonatal Abstinence Syndrome|neonatal abstinence syndrome
128922|NCT03396588|Infant, Newborn, Diseases|infant, newborn, diseases
128923|NCT03396588|Substance-Related Disorders|substance-related disorders
128924|NCT03396588|Chemically-Induced Disorders|chemically-induced disorders
128925|NCT03396588|Opiate Alkaloids|opiate alkaloids
128926|NCT03396588|Mental Disorders|mental disorders
128927|NCT03396588|Narcotics|narcotics
128928|NCT03396588|Central Nervous System Depressants|central nervous system depressants
128929|NCT03396588|Physiological Effects of Drugs|physiological effects of drugs
128930|NCT03396588|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists
128931|NCT03396588|Adrenergic alpha-Agonists|adrenergic alpha-agonists
128932|NCT03396588|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action
128933|NCT03396588|Antihypertensive Agents|antihypertensive agents
128934|NCT03396588|Analgesics|analgesics
128935|NCT03396588|Peripheral Nervous System Agents|peripheral nervous system agents
128936|NCT03396588|Sympatholytics|sympatholytics
128937|NCT03396588|Autonomic Agents|autonomic agents
128938|NCT03396588|Neurotransmitter Agents|neurotransmitter agents
128939|NCT03396575|Total tumor mRNA-pulsed autologous Dendritic Cells (DCs) (TTRNA-DCs)|total tumor mrna-pulsed autologous dendritic cells (dcs) (ttrna-dcs)
128940|NCT03396575|Tumor-specific ex vivo expanded autologous lymphocyte transfer (TTRNA-xALT)|tumor-specific ex vivo expanded autologous lymphocyte transfer (ttrna-xalt)
128941|NCT03396575|Autologous G-CSF mobilized HSCs|autologous g-csf mobilized hscs
128942|NCT03396575|Temozolomide (TMZ)|temozolomide (tmz)
128943|NCT03396575|Cyclophosphamide (CTX)|cyclophosphamide (ctx)
128944|NCT03396575|Fludarabine (Flu)|fludarabine (flu)
128945|NCT03396575|Granulocyte Colony Stimulating Factor (G-CSF)|granulocyte colony stimulating factor (g-csf)
128946|NCT03396575|Granulocyte Macrophage Colony Stimulating Factor (GM-CSF)|granulocyte macrophage colony stimulating factor (gm-csf)
128947|NCT03396575|Tetanus Toxoid|tetanus toxoid
128948|NCT03396575|Mesna|mesna
128949|NCT03396562|body composition|body composition
128950|NCT03396562|klinefelter syndrome|klinefelter syndrome
128951|NCT03396562|XXY|xxy
128952|NCT03396562|Trisomy X|trisomy x
128953|NCT03396562|XXX|xxx
128954|NCT03396562|XYY|xyy
128955|NCT03396562|XXYY|xxyy
128956|NCT03396562|XXXY|xxxy
128957|NCT03396562|XXXXY|xxxxy
128958|NCT03396562|sex chromosome variation|sex chromosome variation
128959|NCT03396562|sex chromosome aneuploidy|sex chromosome aneuploidy
128960|NCT03396562|sex chromosome trisomy|sex chromosome trisomy
128961|NCT03396562|testosterone|testosterone
128962|NCT03396562|XYYY|xyyy
128963|NCT03396562|XXXX|xxxx
128964|NCT03396562|XXXXX|xxxxx
128965|NCT03396562|XXXYY|xxxyy
128966|NCT03396562|XXYYY|xxyyy
128967|NCT03396562|XYYYY|xyyyy
128968|NCT03396562|developmental delay|developmental delay
128969|NCT03396562|speech development|speech development
128970|NCT03396549|tDCS|tdcs
128971|NCT03396549|food craving|food craving
128972|NCT03396549|tDCS sham procedure|tdcs sham procedure
128973|NCT03396549|montage|montage
128974|NCT03396549|food intake|food intake
128975|NCT03396536|implant|implant
128976|NCT03396536|oral hygiene|oral hygiene
128977|NCT03396536|discomfort|discomfort
128978|NCT03396523|Losartan|losartan
128979|NCT03396523|Fear extinction|fear extinction
128980|NCT03396510|Cancer Care|cancer care
128981|NCT03396484|TrialNet|trialnet
128982|NCT03396458|Hepatitis B|hepatitis b
128983|NCT03396458|Disease prevalence|disease prevalence
128984|NCT03396458|Screening|screening
128985|NCT03396458|Migrant|migrant
128986|NCT03396458|Turkish|turkish
128987|NCT03396458|Belgium|belgium
128988|NCT03396432|laryngoscope|laryngoscope
128989|NCT03396432|intubation|intubation
128990|NCT03396432|first attempt success|first attempt success
128991|NCT03396432|oxygen saturation|oxygen saturation
128992|NCT03396432|airway management|airway management
128993|NCT03396432|Videolaryngoscopy|videolaryngoscopy
128994|NCT03396432|Direct laryngoscopy|direct laryngoscopy
128995|NCT03396406|trigeminal neuralgia, radiofrequency|trigeminal neuralgia, radiofrequency
128996|NCT03396393|Dihydroartemisinin;Systemic Lupus Erythematosus|dihydroartemisinin;systemic lupus erythematosus
128997|NCT03396367|Relationships|relationships
128998|NCT03396367|YMSM|ymsm
128999|NCT03396367|HIV/AIDS|hiv/aids
129000|NCT03396367|PrEP|prep
129001|NCT03396367|Drug Use|drug use
129002|NCT03396341|BRCA1/2 Mutations|brca1/2 mutations
129003|NCT03396341|17-489|17-489
129004|NCT03396315|premenopausal women|premenopausal women
129005|NCT03396302|Exercise|exercise
129006|NCT03396302|Nutrition|nutrition
129007|NCT03396302|Internet|internet
129008|NCT03396302|Obesity|obesity
129009|NCT03396302|Hypertension|hypertension
129010|NCT03396289|Cerebral Palsy|cerebral palsy
129011|NCT03396289|Balance|balance
129012|NCT03396289|Inspiratory Muscle Training|inspiratory muscle training
129013|NCT03396289|6-Minute Walk Test|6-minute walk test
129014|NCT03396289|Pulmonary Function Test|pulmonary function test
129015|NCT03396289|Postural Stability|postural stability
129016|NCT03396263|Personalised nutrition|personalised nutrition
129017|NCT03396263|Mobile web application|mobile web application
129018|NCT03396224|Total hip arthroplasty|total hip arthroplasty
129019|NCT03396224|Hip implant|hip implant
129020|NCT03396211|Metastatic|metastatic
129021|NCT03396211|Unresectable|unresectable
129022|NCT03396198|Gastrointestinal Microbiome|gastrointestinal microbiome
129023|NCT03396198|Infants|infants
129024|NCT03396172|COPD|copd
129025|NCT03396172|Homecare|homecare
129026|NCT03396172|Oxygen|oxygen
129027|NCT03396172|Telemedicine|telemedicine
129028|NCT03396172|Automated oxygen adjustment|automated oxygen adjustment
129029|NCT03396172|Rehabilitation program|rehabilitation program
129030|NCT03396159|liver transplantation|liver transplantation
129031|NCT03396159|mini fluid challenge|mini fluid challenge
129032|NCT03396146|Pancreatic polypeptide|pancreatic polypeptide
129033|NCT03396146|Type 1 diabetes|type 1 diabetes
129034|NCT03396146|Chronic pancreatitis|chronic pancreatitis
129035|NCT03396133|Snap|snap
129036|NCT03396133|symptomatic arrhythmia|symptomatic arrhythmia
129037|NCT03396133|diagnosis|diagnosis
129038|NCT03396133|follow-up|follow-up
129039|NCT03396094|high flow oxygenation, rapid sequence intubation|high flow oxygenation, rapid sequence intubation
129040|NCT03396081|Heart Failure|heart failure
129041|NCT03396081|Care pathway|care pathway
129042|NCT03396081|Transition program|transition program
129043|NCT03396081|Efficiency|efficiency
129044|NCT03396055|decompression surgery|decompression surgery
129045|NCT03396055|functional outcome|functional outcome
129046|NCT03396055|biomechanic|biomechanic
129047|NCT03396055|rehabilitation|rehabilitation
129048|NCT03396042|CEP290|cep290
129049|NCT03396042|LCA10|lca10
129050|NCT03396042|Retinal degenerative diseases (RDD)|retinal degenerative diseases (rdd)
129051|NCT03396042|Leber congenital amaurosis (LCA)|leber congenital amaurosis (lca)
129052|NCT03396042|Congenital Retinal Blindness|congenital retinal blindness
129053|NCT03396042|p.Cys998X|p.cys998x
129054|NCT03396042|c.2991+1655A>G|c.2991+1655a>g
129055|NCT03396042|Eye Diseases Signs and Symptoms|eye diseases signs and symptoms
129056|NCT03396042|Genetic Diseases, Inborn|genetic diseases, inborn
129057|NCT03396042|Congenital Abnormalities|congenital abnormalities
129058|NCT03396042|Eye Abnormalities|eye abnormalities
129059|NCT03396029|Lifestyle intervention|lifestyle intervention
129060|NCT03396029|Diet|diet
129061|NCT03396029|Smoking cessation|smoking cessation
129062|NCT03396029|Physical activity|physical activity
129063|NCT03396029|Alcohol|alcohol
129064|NCT03396029|Body mass index|body mass index
129065|NCT03396029|colorectal cancer screening|colorectal cancer screening
129066|NCT03396029|sigmoidoscopy|sigmoidoscopy
129067|NCT03395990|femoral nerve block|femoral nerve block
129068|NCT03395990|adductor canal block|adductor canal block
129069|NCT03395990|analgesia|analgesia
164666|NCT03168048|mhealth|mhealth
129070|NCT03395977|uric acid|uric acid
129071|NCT03395977|xanthin oxydoreductase|xanthin oxydoreductase
129072|NCT03395977|febuxostat|febuxostat
129073|NCT03395977|uricase|uricase
129074|NCT03395951|Mean Systemic Filling Pressure|mean systemic filling pressure
129075|NCT03395951|Diuretics|diuretics
129076|NCT03395951|Pressure for venous return|pressure for venous return
129077|NCT03395951|Fluid Balance|fluid balance
129078|NCT03395951|De-escalation fluid therapy|de-escalation fluid therapy
129079|NCT03395951|De-resuscitation|de-resuscitation
129080|NCT03395951|Guyton|guyton
129081|NCT03395951|Guytonian Approach|guytonian approach
129082|NCT03395951|Furosemide|furosemide
129083|NCT03395951|Cardiac Output|cardiac output
129084|NCT03395951|Cardiac Index|cardiac index
129085|NCT03395938|SCREENING|screening
129086|NCT03395925|Thyroid Nodule|thyroid nodule
129087|NCT03395925|Bipolar coagulation electrode|bipolar coagulation electrode
129088|NCT03395925|radiofrequency ablation|radiofrequency ablation
129089|NCT03395912|local anesthetics infiltration|local anesthetics infiltration
129111|NCT03395795|Infantile Spinal Muscular Atrophy|infantile spinal muscular atrophy
129112|NCT03395795|Respiratory Decompensations|respiratory decompensations
129113|NCT03395756|Depot Medroxyprogesterone acetate|depot medroxyprogesterone acetate
129114|NCT03395756|Injectable birth control|injectable birth control
129115|NCT03395717|Stroke|stroke
129116|NCT03395717|Robot|robot
129117|NCT03395717|Hemiparesis|hemiparesis
129118|NCT03395717|Gait Training|gait training
129119|NCT03395717|Rehabilitation|rehabilitation
129120|NCT03395717|Exoskeleton|exoskeleton
129121|NCT03395717|Functional Recovery|functional recovery
129122|NCT03395691|axillary vein|axillary vein
129123|NCT03395691|central venous catheterization|central venous catheterization
129124|NCT03395691|ultrasound|ultrasound
129125|NCT03395691|cardiac surgery|cardiac surgery
129126|NCT03395691|complication|complication
129127|NCT03395678|Microneedling|microneedling
129128|NCT03395678|Nonablative fractional lasers|nonablative fractional lasers
129129|NCT03395678|Fitzpatrick skin types III-V|fitzpatrick skin types iii-v
129130|NCT03395678|Arophic acne scarring|arophic acne scarring
129131|NCT03395652|pregnancy, physical activity, fetal growth|pregnancy, physical activity, fetal growth
129132|NCT03395639|Children|children
129133|NCT03395639|Pediatrics|pediatrics
129134|NCT03395639|Cardiac disease with potential for thromboembolic complications|cardiac disease with potential for thromboembolic complications
129135|NCT03395639|Prophylactic treatment|prophylactic treatment
129136|NCT03395639|Anticoagulant drugs|anticoagulant drugs
129137|NCT03395587|glioblastoma,|glioblastoma,
129138|NCT03395587|immunotherapy|immunotherapy
129139|NCT03395587|dendritic cells|dendritic cells
129140|NCT03395587|vaccination|vaccination
129141|NCT03395535|Primary Open Angle Glaucoma|primary open angle glaucoma
129142|NCT03395535|Glaucoma|glaucoma
129143|NCT03395535|Ocular Hypertension|ocular hypertension
129144|NCT03395535|POAG|poag
129145|NCT03395535|SLT|slt
129146|NCT03395535|Laser|laser
129147|NCT03395509|Mass screening|mass screening
129148|NCT03395509|cardiovascular disease|cardiovascular disease
129149|NCT03395509|diabetes|diabetes
129150|NCT03395496|pulpotomy|pulpotomy
129151|NCT03395496|pediatric dentistry|pediatric dentistry
129152|NCT03395496|primary molars|primary molars
129153|NCT03395483|peripheral perfusion|peripheral perfusion
129154|NCT03395483|Haemodynamic Instability|haemodynamic instability
129155|NCT03395483|mesenteric bloodflow|mesenteric bloodflow
129156|NCT03395431|Autologuous serum|autologuous serum
129157|NCT03395431|dry eyes disease|dry eyes disease
129158|NCT03395431|fingerprick blood|fingerprick blood
129159|NCT03395418|COPD|copd
129160|NCT03395418|Asthma|asthma
129161|NCT03395418|Inhaled Therapeutics|inhaled therapeutics
129170|NCT03395379|Radiofrequency|radiofrequency
129171|NCT03395379|Thermal Protection|thermal protection
129172|NCT03395379|Percutaneous thermal ablation|percutaneous thermal ablation
129173|NCT03395379|Kidney neoplasms|kidney neoplasms
129174|NCT03395366|Hemodialysis|hemodialysis
129175|NCT03395366|End Stage Renal Disease|end stage renal disease
129176|NCT03395340|cGVHD|cgvhd
129177|NCT03395340|Epidermal|epidermal
129178|NCT03395340|JAK Inhibitors|jak inhibitors
129179|NCT03395340|Skin|skin
129180|NCT03395340|JAK-STAT|jak-stat
129185|NCT03395301|hysteroscopy|hysteroscopy
129186|NCT03395301|fiber platinum coil|fiber platinum coil
129187|NCT03395301|tubal occlusion|tubal occlusion
129188|NCT03395288|UTI|uti
129189|NCT03395288|recurrent UTI|recurrent uti
129190|NCT03395249|safety|safety
129191|NCT03395249|tolerability|tolerability
129192|NCT03395249|pharmacokinetics|pharmacokinetics
129193|NCT03395249|SPR994|spr994
129194|NCT03395223|Acquired Methaemoglobinemia|acquired methaemoglobinemia
129195|NCT03395223|Methylene Blue|methylene blue
129196|NCT03395197|mCRPC (metastatic castration-resistant prostate cancer)|mcrpc (metastatic castration-resistant prostate cancer)
129197|NCT03395119|Ozone exposure|ozone exposure
129198|NCT03395119|Healthy Adults|healthy adults
129199|NCT03395106|vaccine|vaccine
129200|NCT03395106|public health|public health
129201|NCT03395093|bronchoscopy|bronchoscopy
129202|NCT03395093|conscious sedation|conscious sedation
129203|NCT03395093|fentanyl|fentanyl
129204|NCT03395093|Bispectral Index|bispectral index
129205|NCT03395080|epithelial histology|epithelial histology
129206|NCT03395080|Wnt pathway|wnt pathway
129207|NCT03395080|DKK1|dkk1
129208|NCT03395080|endometrial|endometrial
129209|NCT03395080|uterine|uterine
129210|NCT03395080|ovarian|ovarian
129211|NCT03395080|carcinosarcoma|carcinosarcoma
129212|NCT03395067|Obesity|obesity
129213|NCT03395067|Infertility|infertility
129214|NCT03395067|In vitro fertilization|in vitro fertilization
129215|NCT03395054|neck pain|neck pain
129216|NCT03395054|pulmonary function test|pulmonary function test
129217|NCT03395054|respiratory muscle strength|respiratory muscle strength
129218|NCT03395054|cervical stabilization exercises|cervical stabilization exercises
129219|NCT03395041|vulnerable plaque, CT imaging, oral bacteria, inflammation|vulnerable plaque, ct imaging, oral bacteria, inflammation
129220|NCT03395028|Biliary Atresia|biliary atresia
129221|NCT03395028|Granulocyte Colony Stimulating Factor|granulocyte colony stimulating factor
129222|NCT03395028|GCSF|gcsf
129223|NCT03395015|Reconstructive surgical procedures|reconstructive surgical procedures
129224|NCT03395015|Therapy, soft tissue|therapy, soft tissue
129225|NCT03395015|Treatment outcome|treatment outcome
129226|NCT03395015|Outcome Assessment (Health Care)|outcome assessment (health care)
129227|NCT03395015|Photogrammetry|photogrammetry
129228|NCT03395015|Physical Appearance, Body|physical appearance, body
129229|NCT03395002|Tiotropium|tiotropium
129230|NCT03395002|Salmeterol|salmeterol
129231|NCT03395002|Fluticasone|fluticasone
129232|NCT03395002|COPD|copd
129233|NCT03395002|Bronchodilator effect|bronchodilator effect
129234|NCT03395002|Discair|discair
129235|NCT03395002|Diskus|diskus
129236|NCT03395002|Spirometry|spirometry
129237|NCT03394963|Food-Based Dietary guideline|food-based dietary guideline
129238|NCT03394963|Healthy Eating Index|healthy eating index
129239|NCT03394963|Healthy Diet|healthy diet
129240|NCT03394963|Protocol|protocol
129241|NCT03394963|Ethiopia|ethiopia
129242|NCT03394950|thrombolysis|thrombolysis
129243|NCT03394950|Butyphthalide|butyphthalide
129244|NCT03394924|PBC|pbc
129245|NCT03394924|Primary Biliary Cholangitis (PBC)|primary biliary cholangitis (pbc)
129246|NCT03394898|Chronic Pain|chronic pain
129247|NCT03394898|Body Mass Index|body mass index
129248|NCT03394898|Eating Habits|eating habits
129249|NCT03394872|Pleural effusion|pleural effusion
129250|NCT03394872|Mechanical Ventilation|mechanical ventilation
129251|NCT03394872|Ultrasonography|ultrasonography
129252|NCT03394872|Drainage|drainage
129253|NCT03394833|preoperative|preoperative
129254|NCT03394833|fluid therapy|fluid therapy
129255|NCT03394833|hemodynamics|hemodynamics
129256|NCT03394833|anesthesia induction|anesthesia induction
129257|NCT03394833|rapid sequence induction|rapid sequence induction
129258|NCT03394833|TCI|tci
129259|NCT03394820|Dexamethasone|dexamethasone
129260|NCT03394820|Supraclavicular block|supraclavicular block
129261|NCT03394794|anorectal physiology|anorectal physiology
129262|NCT03394794|therapies|therapies
129263|NCT03394794|quality fo life|quality fo life
129264|NCT03394755|thrombocytopenia|thrombocytopenia
129265|NCT03394755|bleeding|bleeding
129266|NCT03394742|Peer Group|peer group
129267|NCT03394742|Quality of Life|quality of life
129268|NCT03394729|Propole|propole
129269|NCT03394729|Xylitol|xylitol
129270|NCT03394729|Saliva|saliva
129271|NCT03394716|MRI|mri
129272|NCT03394716|Radiotherapy|radiotherapy
129273|NCT03394703|Lung cancer|lung cancer
129274|NCT03394703|screening|screening
129275|NCT03394703|Low-dose Computed Tomography|low-dose computed tomography
129276|NCT03394703|Smokers|smokers
129277|NCT03394664|Body composition|body composition
129278|NCT03394664|Feeding study|feeding study
129279|NCT03394664|Ketogenic diet|ketogenic diet
129280|NCT03394664|Weight loss|weight loss
129281|NCT03394664|Energy Expenditure|energy expenditure
129282|NCT03394651|male|male
129283|NCT03394651|lower urinary tract symptoms|lower urinary tract symptoms
129284|NCT03394651|comorbidities|comorbidities
129285|NCT03394651|chronic kidney diseases|chronic kidney diseases
129286|NCT03394651|urodynamics|urodynamics
129287|NCT03394651|medical therapy|medical therapy
129288|NCT03394651|surgical treatment|surgical treatment
129289|NCT03394638|eHealth|ehealth
129290|NCT03394638|Bariatric surgery|bariatric surgery
129291|NCT03394638|Obesity|obesity
129292|NCT03394638|Telemedicine|telemedicine
129293|NCT03394625|Socket Shield|socket shield
129294|NCT03394625|immediate implant|immediate implant
129295|NCT03394625|ridge preservation|ridge preservation
129296|NCT03394612|Scar|scar
129297|NCT03394612|Skin|skin
129298|NCT03394612|Wound Healing|wound healing
129299|NCT03394612|Tissue Engineering|tissue engineering
129300|NCT03394612|Dermis|dermis
129301|NCT03394612|Epidermis|epidermis
164919|NCT03166085|PU-H71|pu-h71
129302|NCT03394599|Physical Activity|physical activity
129303|NCT03394599|Rehabilitation|rehabilitation
129304|NCT03394599|Exercise|exercise
129305|NCT03394599|Engagement|engagement
129306|NCT03394599|Older Adults|older adults
129307|NCT03394586|Golimumab|golimumab
129308|NCT03394586|TNF-inhibitors|tnf-inhibitors
129309|NCT03394586|Clinical Response|clinical response
129310|NCT03394586|Clinical Remission|clinical remission
129311|NCT03394586|Ulcerative Colitis|ulcerative colitis
129312|NCT03394573|Diabetic macular edema|diabetic macular edema
129313|NCT03394560|Spinal Cord Injury|spinal cord injury
129314|NCT03394560|transcranial magnetic stimulation|transcranial magnetic stimulation
129315|NCT03394560|body weight-support treadmill training|body weight-support treadmill training
129316|NCT03394560|gait|gait
129317|NCT03394534|Comprehensive Geriatric Assessment|comprehensive geriatric assessment
129318|NCT03394534|Frailty|frailty
129319|NCT03394534|electronic Frailty Index|electronic frailty index
129320|NCT03394534|eFI|efi
129321|NCT03394534|Care and Support plan|care and support plan
129322|NCT03394534|Primary Care|primary care
129323|NCT03394521|glaucoma suspect|glaucoma suspect
129324|NCT03394521|ocular hypertension|ocular hypertension
129325|NCT03394521|progression|progression
129326|NCT03394495|Fatigue|fatigue
129327|NCT03394495|Frailty|frailty
129328|NCT03394495|Cluster-RCT|cluster-rct
129329|NCT03394495|Exercise|exercise
129330|NCT03394495|Behavioral change|behavioral change
129331|NCT03394469|Obesity|obesity
129332|NCT03394469|Sarcopenia|sarcopenia
129333|NCT03394430|sevoflurane|sevoflurane
129334|NCT03394430|epileptiform EEG|epileptiform eeg
129335|NCT03394430|midazolam|midazolam
129336|NCT03394430|dexmedetomidine|dexmedetomidine
129337|NCT03394404|ECG-I Mapping Pulmonary Vein Isolation|ecg-i mapping pulmonary vein isolation
129338|NCT03394391|Adherence|adherence
129339|NCT03394391|Adolescents|adolescents
129340|NCT03394391|Antiretroviral therapy|antiretroviral therapy
129341|NCT03394391|HIV|hiv
129342|NCT03394391|Nigeria|nigeria
129343|NCT03394391|Randomized controlled trial|randomized controlled trial
129344|NCT03394391|Short message services|short message services
129345|NCT03394365|Epstein-Barr Virus (EBV)-associated Lymphoproliferative Disease (LPD)|epstein-barr virus (ebv)-associated lymphoproliferative disease (lpd)
129346|NCT03394365|Epstein-Barr Virus (EBV)|epstein-barr virus (ebv)
129347|NCT03394365|Cytotoxic T lymphocyte (CTL)|cytotoxic t lymphocyte (ctl)
129348|NCT03394365|Cancer After Transplant|cancer after transplant
129349|NCT03394365|Kidney transplant|kidney transplant
129350|NCT03394365|Renal transplant|renal transplant
129351|NCT03394365|Liver transplant|liver transplant
129352|NCT03394365|Heart transplant|heart transplant
129353|NCT03394365|Lung transplant|lung transplant
129354|NCT03394365|Intestinal transplant|intestinal transplant
129355|NCT03394365|Pancreas transplant|pancreas transplant
129356|NCT03394365|Post-transplant Lymphoma|post-transplant lymphoma
129357|NCT03394365|Solid Organ Transplant (SOT)|solid organ transplant (sot)
129358|NCT03394365|Bone Marrow Transplant Complications|bone marrow transplant complications
129359|NCT03394365|Epstein-Barr Virus-specific Cytotoxic T Lymphocytes (EBV-CTL)|epstein-barr virus-specific cytotoxic t lymphocytes (ebv-ctl)
129360|NCT03394365|Hematopoietic Cell Transplant (HCT)|hematopoietic cell transplant (hct)
129361|NCT03394365|Hematopoietic Stem Cell Transplantation (HSCT)|hematopoietic stem cell transplantation (hsct)
129362|NCT03394365|Allogeneic Hematopoietic Cell Transplant|allogeneic hematopoietic cell transplant
129363|NCT03394365|Allogeneic, Off-The-Shelf T-cell Immunotherapy|allogeneic, off-the-shelf t-cell immunotherapy
129364|NCT03394352|Type 1 Diabetes Mellitus|type 1 diabetes mellitus
129365|NCT03394352|Insulin pump|insulin pump
129366|NCT03394352|Continuous Glucose Monitor (CGM)|continuous glucose monitor (cgm)
129367|NCT03394352|Exercise|exercise
129368|NCT03394352|Activity on Board|activity on board
129369|NCT03394352|Decision Support System|decision support system
129370|NCT03394339|Systematic review and meta-anaylsis|systematic review and meta-anaylsis
129371|NCT03394339|Evidence-based nutrition (EBN)|evidence-based nutrition (ebn)
129372|NCT03394339|Dietary guidelines|dietary guidelines
129373|NCT03394339|Fruit|fruit
129374|NCT03394339|Vegetables|vegetables
129375|NCT03394313|Registry|registry
129376|NCT03394274|transfusion|transfusion
129377|NCT03394274|liberal|liberal
129378|NCT03394274|restrictive|restrictive
129379|NCT03394261|Opioid Use Disorder (OUD)|opioid use disorder (oud)
129380|NCT03394261|Medication Assisted Therapy (MAT)|medication assisted therapy (mat)
129381|NCT03394261|Patient Decision Aid|patient decision aid
129382|NCT03394248|Subconcussive head injury|subconcussive head injury
129383|NCT03394235|hair transplant|hair transplant
129384|NCT03394235|hairline|hairline
129385|NCT03394235|laser hair removal|laser hair removal
129386|NCT03394209|Favipiravir, Influenza, Human, Critical Illness, Pharmacokinetics|favipiravir, influenza, human, critical illness, pharmacokinetics
129392|NCT03394157|sleeve gastrectomy , MGB , type 2 diabetes , obesity , SASI|sleeve gastrectomy , mgb , type 2 diabetes , obesity , sasi
129393|NCT03394118|T790 mutation|t790 mutation
129394|NCT03394118|Liquid biopsy|liquid biopsy
129395|NCT03394105|Pleurodesis|pleurodesis
129396|NCT03394092|immunoglobulin G|immunoglobulin g
129397|NCT03394079|OCT|oct
129398|NCT03394079|IVUS|ivus
129399|NCT03394079|PCI|pci
129400|NCT03394066|Repetitive TMS (rTMS)|repetitive tms (rtms)
129401|NCT03394066|Simultaneous TMS and MRI|simultaneous tms and mri
129407|NCT03394040|Diarrhea|diarrhea
129408|NCT03394040|Point-of-Need|point-of-need
129409|NCT03394040|Pathogen Identification|pathogen identification
129410|NCT03394027|Impiridones|impiridones
129411|NCT03394027|TNBC|tnbc
129412|NCT03394027|Metastatic|metastatic
129413|NCT03394027|Male Breast Cancer|male breast cancer
129414|NCT03393988|Transversus abdominis plane block,|transversus abdominis plane block,
129415|NCT03393988|Dexmedetomidine|dexmedetomidine
129416|NCT03393988|Fentanyl|fentanyl
129417|NCT03393988|Live liver donor|live liver donor
129418|NCT03393988|Liver transplantation|liver transplantation
129419|NCT03393962|Ovarian cancer|ovarian cancer
129420|NCT03393962|Cytotoxic lymphocyte|cytotoxic lymphocyte
129421|NCT03393962|Cancer specific antigen|cancer specific antigen
129422|NCT03393949|Methylprednisolone|methylprednisolone
129423|NCT03393949|Postoperative cognitive function|postoperative cognitive function
129424|NCT03393949|Immunological function|immunological function
129425|NCT03393936|CCT301-38|cct301-38
129426|NCT03393936|CCT301-59|cct301-59
129427|NCT03393936|stage IV metastatic renal cell carcinoma|stage iv metastatic renal cell carcinoma
129428|NCT03393936|AXL|axl
129429|NCT03393936|ROR2|ror2
129430|NCT03393897|fluid responsiveness|fluid responsiveness
129431|NCT03393897|cardiac surgery|cardiac surgery
129432|NCT03393832|Oral care|oral care
129433|NCT03393832|Oropharyngeal mother's milk|oropharyngeal mother's milk
129434|NCT03393819|antimicrobial skin solution|antimicrobial skin solution
129435|NCT03393819|skin preparation|skin preparation
129436|NCT03393806|Asthma Control Questionnaire|asthma control questionnaire
129437|NCT03393806|Allergic fungal airway disease|allergic fungal airway disease
129438|NCT03393806|Asthma Quality of Life Questionnaire|asthma quality of life questionnaire
129439|NCT03393806|Holter monitoring|holter monitoring
129440|NCT03393806|Asthma|asthma
129441|NCT03393793|Heart transplantation|heart transplantation
129442|NCT03393767|CNV|cnv
129443|NCT03393767|AMD|amd
129444|NCT03393767|ranibizumab|ranibizumab
129445|NCT03393754|Hepatitis B Vaccines|hepatitis b vaccines
129446|NCT03393741|Metastatic breast cancer|metastatic breast cancer
129447|NCT03393728|hyperthyroidism|hyperthyroidism
129448|NCT03393728|heart rate variability|heart rate variability
129449|NCT03393728|propanolol|propanolol
129450|NCT03393728|Africa|africa
129451|NCT03393715|Diabetes|diabetes
129452|NCT03393715|Hypertension|hypertension
129453|NCT03393715|Perindopril|perindopril
129454|NCT03393715|chronobiology|chronobiology
129455|NCT03393715|Africa|africa
129456|NCT03393702|Postoperative pain|postoperative pain
129457|NCT03393702|Anxiety|anxiety
129458|NCT03393702|Postoperative Complications|postoperative complications
129459|NCT03393702|Patient Satisfaction|patient satisfaction
129460|NCT03393689|68Ga-NODAGA-E[c(RGDyK)]2|68ga-nodaga-e[c(rgdyk)]2
129461|NCT03393689|Angiogenesis PET/MR|angiogenesis pet/mr
129462|NCT03393689|Acoustic Neuroma|acoustic neuroma
129463|NCT03393676|Postoperative Cognitive Dysfunction|postoperative cognitive dysfunction
129464|NCT03393676|elderly patients|elderly patients
129465|NCT03393676|Preoperative Pain|preoperative pain
129466|NCT03393663|chronic kidney disease|chronic kidney disease
129467|NCT03393663|cardiovascular disease|cardiovascular disease
129468|NCT03393663|mortality|mortality
129469|NCT03393663|end stage renal disease|end stage renal disease
129470|NCT03393650|exercise|exercise
129471|NCT03393650|protein|protein
129472|NCT03393650|muscle function|muscle function
129473|NCT03393650|aging|aging
129474|NCT03393637|prenatal anxiety|prenatal anxiety
129475|NCT03393637|pregnancy|pregnancy
129476|NCT03393637|depression|depression
129477|NCT03393637|military|military
129478|NCT03393637|intervention|intervention
129479|NCT03393624|Dark circles|dark circles
129480|NCT03393624|Periorbital hyperchromia|periorbital hyperchromia
129481|NCT03393624|Sleep Quality|sleep quality
129482|NCT03393624|Facial aesthetics|facial aesthetics
129483|NCT03393585|Respiratory Rates|respiratory rates
129484|NCT03393546|pain|pain
129485|NCT03393546|acupressure|acupressure
129500|NCT03393481|venous thromboembolism,|venous thromboembolism,
129501|NCT03393481|unilateral knee arthroplasty|unilateral knee arthroplasty
129502|NCT03393455|Fetal pathology|fetal pathology
129503|NCT03393455|Obstetrical outcome|obstetrical outcome
129504|NCT03393455|Pediatric outcome|pediatric outcome
129505|NCT03393442|Magnetic Resonance Imaging|magnetic resonance imaging
129506|NCT03393442|Gd-based contrast media|gd-based contrast media
129507|NCT03393442|Gd-deposits|gd-deposits
129508|NCT03393442|brain imaging|brain imaging
129509|NCT03393442|breast cancer screening|breast cancer screening
129510|NCT03393416|MASCT-I|masct-i
129511|NCT03393403|Subcostal transversus abdominis plane block|subcostal transversus abdominis plane block
129512|NCT03393377|arterial stiffness|arterial stiffness
129513|NCT03393377|endothelial dysfunction|endothelial dysfunction
129514|NCT03393377|fluvastatin|fluvastatin
129515|NCT03393377|valsartan|valsartan
129516|NCT03393377|inflammatory markers|inflammatory markers
129517|NCT03393377|oxidative stress|oxidative stress
129518|NCT03393377|SIRT1|sirt1
129519|NCT03393351|Shared Decision-Making|shared decision-making
129520|NCT03393351|Decision Making|decision making
129521|NCT03393351|Patient Participation|patient participation
129522|NCT03393351|Patient Centeredness|patient centeredness
129523|NCT03393351|Health Services Research|health services research
129524|NCT03393351|Implementation Research|implementation research
129525|NCT03393351|Oncology|oncology
129526|NCT03393351|Stepped Wedge Design|stepped wedge design
129527|NCT03393351|Mixed Methods|mixed methods
129528|NCT03393338|Diabetes|diabetes
129529|NCT03393338|African American|african american
129530|NCT03393338|Emergency Department visits|emergency department visits
129531|NCT03393312|Transcranial direct current stimulation|transcranial direct current stimulation
129532|NCT03393312|Biological Psychiatry|biological psychiatry
129533|NCT03393312|Depression|depression
129534|NCT03393312|Decision-making|decision-making
129535|NCT03393299|elderly people|elderly people
129536|NCT03393299|geriatric short-stay|geriatric short-stay
129537|NCT03393299|STOPP/START criteria|stopp/start criteria
129538|NCT03393273|Stem Cell autologous graft|stem cell autologous graft
129539|NCT03393273|Elotuzumab|elotuzumab
129540|NCT03393273|Multiple myeloma|multiple myeloma
129541|NCT03393273|Elderly|elderly
129542|NCT03393260|cancer|cancer
129543|NCT03393260|emergency departments (ED)|emergency departments (ed)
129544|NCT03393247|infliximab|infliximab
129545|NCT03393247|azathioprine|azathioprine
129546|NCT03393234|Ultra-low rectal cancer|ultra-low rectal cancer
129547|NCT03393234|Intersphincteric resection|intersphincteric resection
129548|NCT03393234|IORT|iort
129549|NCT03393208|Diabetes Mellitus|diabetes mellitus
129550|NCT03393208|Glucophage Immediate Release (GIR)|glucophage immediate release (gir)
129551|NCT03393208|Bioequivalence Study|bioequivalence study
129552|NCT03393195|Weight loss|weight loss
129553|NCT03393195|Diet|diet
129554|NCT03393195|Time-restricted feeding|time-restricted feeding
129555|NCT03393143|Primary Health Care; Analgesics, Opioid; Medicaid|primary health care; analgesics, opioid; medicaid
129556|NCT03393130|Burns|burns
129557|NCT03393130|Young Adult|young adult
129558|NCT03393130|Cognitive Impairment|cognitive impairment
129559|NCT03393130|Apolipoprotein E, Deficiency or Defect of|apolipoprotein e, deficiency or defect of
129560|NCT03393130|Intensive Care Neurological Disorder|intensive care neurological disorder
129561|NCT03393130|Quality of Life|quality of life
129562|NCT03393130|Inflammation, Brain|inflammation, brain
129563|NCT03393117|Reconstruction|reconstruction
129564|NCT03393117|Bupivacaine|bupivacaine
129565|NCT03393117|Liposomal Bupivacaine|liposomal bupivacaine
129566|NCT03393104|Chronic Low Back Pain|chronic low back pain
129567|NCT03393104|Motor Control Exercise|motor control exercise
129568|NCT03393104|Patient Education|patient education
129569|NCT03393065|lung ultrasounds|lung ultrasounds
129570|NCT03393065|fluid managements|fluid managements
129571|NCT03393065|critical care patients|critical care patients
129572|NCT03393052|L-RECORD|l-record
129573|NCT03393052|Radial|radial
129574|NCT03393052|Femoral|femoral
129575|NCT03393052|CABG|cabg
129576|NCT03393052|coronary artery bypass graft|coronary artery bypass graft
129577|NCT03393039|fMRI|fmri
129578|NCT03393039|Reward|reward
129579|NCT03393039|Food Choices|food choices
129580|NCT03393039|Negative Affect|negative affect
129581|NCT03393013|immunoproteasome inhibition|immunoproteasome inhibition
129582|NCT03393013|selective proteasome inhibition|selective proteasome inhibition
129583|NCT03393013|proteasome|proteasome
129584|NCT03392987|OTL-200|otl-200
129585|NCT03392987|Cryopreserved formulation|cryopreserved formulation
129586|NCT03392987|Gene therapy|gene therapy
129587|NCT03392987|Metachromatic leukodystrophy|metachromatic leukodystrophy
129588|NCT03392987|MLD|mld
129589|NCT03392987|Previously GSK2696274|previously gsk2696274
129590|NCT03392974|Hemophilia A|hemophilia a
129591|NCT03392974|Gene Therapy|gene therapy
129592|NCT03392974|Clotting Disorders|clotting disorders
129593|NCT03392974|Blood Disorder|blood disorder
129594|NCT03392974|Blood Coagulation Disorders|blood coagulation disorders
129595|NCT03392974|Inherited Blood Coagulation Disorders|inherited blood coagulation disorders
129596|NCT03392974|Hematologic Diseases|hematologic diseases
129597|NCT03392974|Coagulation Protein Disorders|coagulation protein disorders
129598|NCT03392974|Hemorrhagic Disorders|hemorrhagic disorders
129599|NCT03392974|Genetic Diseases|genetic diseases
129600|NCT03392974|Inborn|inborn
129601|NCT03392974|Factor VIII|factor viii
129602|NCT03392974|Coagulants|coagulants
129603|NCT03392961|Oral insulin|oral insulin
129604|NCT03392961|Dosing time|dosing time
129605|NCT03392961|Insulin concentration|insulin concentration
129606|NCT03392961|Prandial insulin|prandial insulin
129607|NCT03392961|Post Prandial Glucose (PPG)|post prandial glucose (ppg)
129608|NCT03392948|atrial fibrillation|atrial fibrillation
129609|NCT03392948|prosthetic valves|prosthetic valves
129610|NCT03392948|pulmonary embolism|pulmonary embolism
129611|NCT03392948|venous thrombosis|venous thrombosis
129612|NCT03392948|percutaneous coronary interventions|percutaneous coronary interventions
129613|NCT03392948|chronic anticoagulant treatment|chronic anticoagulant treatment
129614|NCT03392909|Nonsense Mutations|nonsense mutations
129615|NCT03392883|Latin America|latin america
129616|NCT03392883|Depression|depression
129617|NCT03392883|mHealth|mhealth
129618|NCT03392883|Problematic Alcohol Use|problematic alcohol use
129619|NCT03392870|Autism Spectrum Disorder (ASD)|autism spectrum disorder (asd)
129620|NCT03392870|Transition program|transition program
129621|NCT03392857|Critical care|critical care
129622|NCT03392831|Central Venous Catheters|central venous catheters
129623|NCT03392831|Vascular Access Devices|vascular access devices
129624|NCT03392831|Nursing|nursing
129625|NCT03392831|Cost Effectiveness|cost effectiveness
129626|NCT03392831|PICC|picc
129627|NCT03392766|fibreoptic intubation|fibreoptic intubation
129628|NCT03392766|double lumen tube|double lumen tube
129629|NCT03392766|difficult intubation|difficult intubation
129630|NCT03392714|Bendamustine|bendamustine
129631|NCT03392714|CSF|csf
129632|NCT03392714|Pharmacokinetics|pharmacokinetics
129633|NCT03392714|PCNSL|pcnsl
129634|NCT03392714|Salvage therapy|salvage therapy
129635|NCT03392688|onset , hamstring muscles, patellofemoral pain|onset , hamstring muscles, patellofemoral pain
129636|NCT03392675|Breast and Nipple Pain|breast and nipple pain
129637|NCT03392675|Quantitative Sensory Testing|quantitative sensory testing
129638|NCT03392675|Genotyping|genotyping
129639|NCT03392675|Breastfeeding|breastfeeding
129640|NCT03392649|Postoperative Atrial Fibrillation|postoperative atrial fibrillation
129641|NCT03392649|Tragus Stimulation|tragus stimulation
129642|NCT03392623|Epigenetics, Malar melasma,|epigenetics, malar melasma,
129643|NCT03392610|Intratracheal intubation, bronchoscopy, bronchoalveolar lavage, endoscopy, pulmonary medicine, critical care, anesthesia department, disinfection|intratracheal intubation, bronchoscopy, bronchoalveolar lavage, endoscopy, pulmonary medicine, critical care, anesthesia department, disinfection
129644|NCT03392584|Locally advanced rectal cancer|locally advanced rectal cancer
129645|NCT03392584|Deep infection|deep infection
129646|NCT03392584|Microdialysis|microdialysis
129647|NCT03392584|Surgical site infection|surgical site infection
129648|NCT03392571|Resectable pancreatic cancer, NGC-triple regimen|resectable pancreatic cancer, ngc-triple regimen
129649|NCT03392545|gliomas|gliomas
129650|NCT03392545|radiotherapy|radiotherapy
129651|NCT03392545|immunetherapy|immunetherapy
129652|NCT03392532|Astigmatism|astigmatism
129653|NCT03392532|Axis orientation|axis orientation
129654|NCT03392519|Brain connectivity|brain connectivity
129655|NCT03392519|Magnetic resonance imaging|magnetic resonance imaging
129656|NCT03392519|Brain plasticity|brain plasticity
129657|NCT03392519|Recovery|recovery
129658|NCT03392506|CP-EBUS|cp-ebus
129659|NCT03392506|EBUS-TBNA|ebus-tbna
129660|NCT03392506|Real time elasticity|real time elasticity
129661|NCT03392506|Staging of lung cancer|staging of lung cancer
129662|NCT03392493|Stroke|stroke
129663|NCT03392493|Robotic rehabilitation|robotic rehabilitation
129664|NCT03392493|Hand function|hand function
129665|NCT03392493|Activities of Daily Living|activities of daily living
129666|NCT03392454|Partial Trapeziectomy|partial trapeziectomy
129667|NCT03392454|Tendon Interposition|tendon interposition
129668|NCT03392454|Trapeziectomy|trapeziectomy
129669|NCT03392454|Thumb Carpometacarpal Joint|thumb carpometacarpal joint
129670|NCT03392441|dementia|dementia
129671|NCT03392441|cognition|cognition
129672|NCT03392441|insulin|insulin
129673|NCT03392441|adolescent|adolescent
129674|NCT03392415|chronic total occlusion|chronic total occlusion
129675|NCT03392415|CTO|cto
129676|NCT03392415|PCI|pci
129677|NCT03392415|percutaneus coronary intervention|percutaneus coronary intervention
129678|NCT03392402|Thyroid nodule|thyroid nodule
129686|NCT03392376|Haloperidol|haloperidol
129695|NCT03392298|Thalassemia|thalassemia
129696|NCT03392298|Pregnancy|pregnancy
129697|NCT03392298|Globin expression|globin expression
129698|NCT03392298|Colla corii asini|colla corii asini
129699|NCT03392272|Ptosis|ptosis
129700|NCT03392272|Müller's Muscle-Conjunctival Resection (MMCR)|müller's muscle-conjunctival resection (mmcr)
129701|NCT03392272|Fibrin Glue|fibrin glue
129702|NCT03392246|Non-Small Cell Lung Cancer|non-small cell lung cancer
129703|NCT03392233|spinal metastases|spinal metastases
129704|NCT03392233|Stereotactic body radiation therapy(SBRT)|stereotactic body radiation therapy(sbrt)
129705|NCT03392233|breast cancer|breast cancer
129706|NCT03392233|prostate cancer|prostate cancer
129707|NCT03392233|non small cell lung cancer|non small cell lung cancer
129708|NCT03392220|clinically negative neck|clinically negative neck
129709|NCT03392220|regional control rate|regional control rate
129710|NCT03392194|Behavioral interventions|behavioral interventions
129711|NCT03392194|Sleep hygiene|sleep hygiene
129712|NCT03392194|Yoga|yoga
129713|NCT03392194|Community research|community research
129714|NCT03392194|Short sleep duration|short sleep duration
129715|NCT03392194|Low-income population|low-income population
129716|NCT03392168|Psoriasis|psoriasis
129717|NCT03392168|Plaque Psoriasis|plaque psoriasis
129718|NCT03392142|Epstein-Barr Virus (EBV)-associated Lymphoproliferative Disease (LPD)|epstein-barr virus (ebv)-associated lymphoproliferative disease (lpd)
129719|NCT03392142|Hematopoietic Cell Transplantation (HCT)|hematopoietic cell transplantation (hct)
129720|NCT03392142|Hematopoietic Stem Cell Transplantation (HSCT)|hematopoietic stem cell transplantation (hsct)
129721|NCT03392142|Allogeneic Hematopoietic Cell Transplant|allogeneic hematopoietic cell transplant
129722|NCT03392142|Bone Marrow Transplant Complications|bone marrow transplant complications
129723|NCT03392142|Cancer After Transplant|cancer after transplant
129724|NCT03392142|Cytotoxic T lymphocyte (CTL)|cytotoxic t lymphocyte (ctl)
129725|NCT03392142|Epstein-Barr Virus-specific Cytotoxic T Lymphocytes (EBV-CTL)|epstein-barr virus-specific cytotoxic t lymphocytes (ebv-ctl)
129726|NCT03392142|Allogeneic, Off-The-Shelf T-cell Immunotherapy|allogeneic, off-the-shelf t-cell immunotherapy
129727|NCT03392142|Post-transplant Lymphoma|post-transplant lymphoma
129728|NCT03392142|Epstein-Barr Virus (EBV)|epstein-barr virus (ebv)
129729|NCT03392129|Asthma|asthma
129730|NCT03392129|Child|child
129731|NCT03392129|respiratory exercises|respiratory exercises
129732|NCT03392129|Hydrotherapy|hydrotherapy
129733|NCT03392129|Physical Therapy Specialty|physical therapy specialty
129734|NCT03392129|Sleep|sleep
129735|NCT03392129|Quality of life|quality of life
129736|NCT03392129|Anxiety|anxiety
129737|NCT03392129|Spirometry|spirometry
129738|NCT03392129|Clinical trial|clinical trial
129739|NCT03392103|Raltitrexed|raltitrexed
129740|NCT03392103|IMRT|imrt
129741|NCT03392090|Cancer|cancer
129742|NCT03392064|AMG 119|amg 119
129743|NCT03392064|CART|cart
129744|NCT03392064|DLL3|dll3
129745|NCT03392012|anesthesia, patient safety, respiratory complications|anesthesia, patient safety, respiratory complications
129746|NCT03391999|Mental Health, Physical Health|mental health, physical health
129747|NCT03391973|CUP|cup
129748|NCT03391973|Pembrolizumab|pembrolizumab
129749|NCT03391973|KEYTRUDA|keytruda
129750|NCT03391960|CLABSI|clabsi
129751|NCT03391960|Septicemia|septicemia
129752|NCT03391960|Bloodstream infection|bloodstream infection
129753|NCT03391960|Central line associated bloodstream infection|central line associated bloodstream infection
129754|NCT03391960|Catheter related bloodstream infection|catheter related bloodstream infection
129755|NCT03391960|Intravascular device|intravascular device
129756|NCT03391960|Catheter port|catheter port
129757|NCT03391947|gingival recession|gingival recession
129758|NCT03391947|semilunar coronally flap|semilunar coronally flap
129759|NCT03391947|coronally advanced flap|coronally advanced flap
129760|NCT03391934|RAS Wild-type|ras wild-type
129761|NCT03391934|Cetuximab|cetuximab
129762|NCT03391934|Metastatic Colorectal Cancer|metastatic colorectal cancer
129763|NCT03391921|vaccine|vaccine
129764|NCT03391921|woman|woman
129765|NCT03391908|vulnerable plaque, ACS, NSTEMI, vulnerable patient|vulnerable plaque, acs, nstemi, vulnerable patient
129766|NCT03391895|Adolescent Idiopathic Scoliosis|adolescent idiopathic scoliosis
129767|NCT03391895|Scoliosis|scoliosis
129768|NCT03391895|Inspiratory Muscle Training|inspiratory muscle training
129769|NCT03391895|Exercise Training|exercise training
129770|NCT03391895|Respiratory Exercise Training|respiratory exercise training
129771|NCT03391895|Pulmonary Function Test|pulmonary function test
129772|NCT03391895|6-Minute Walk test|6-minute walk test
129773|NCT03391895|Respiratory Muscle Strength|respiratory muscle strength
129774|NCT03391882|Parkinson's Disease|parkinson's disease
129775|NCT03391882|"Off Episodes"|"off episodes"
129776|NCT03391882|motor fluctuations associated with Parkinson's Disease|motor fluctuations associated with parkinson's disease
129777|NCT03391869|Malignant neoplasms of respiratory and intrathoracic organs|malignant neoplasms of respiratory and intrathoracic organs
129778|NCT03391869|Non-small cell lung cancer|non-small cell lung cancer
129779|NCT03391869|NSCLC|nsclc
129780|NCT03391869|Ipilimumab|ipilimumab
129781|NCT03391869|Yervoy|yervoy
129782|NCT03391869|BMS-734016|bms-734016
129783|NCT03391869|MDX010|mdx010
129784|NCT03391869|Nivolumab|nivolumab
129785|NCT03391869|BMS-936558|bms-936558
129786|NCT03391869|Opdivo|opdivo
129787|NCT03391869|Local Consolidative Therapy|local consolidative therapy
129788|NCT03391869|LCT|lct
129789|NCT03391843|Local Advanced Rectal Cancer|local advanced rectal cancer
129790|NCT03391843|Neoadjuvant Chemotherapy|neoadjuvant chemotherapy
129791|NCT03391843|FOLFOXIRI|folfoxiri
129792|NCT03391843|Cetuximab|cetuximab
129793|NCT03391843|EGFR wild type|egfr wild type
129794|NCT03391804|Oxalate|oxalate
129795|NCT03391804|Kidney Stones|kidney stones
129796|NCT03391804|oxalate nephropathy|oxalate nephropathy
129797|NCT03391804|systemic oxalosis|systemic oxalosis
129798|NCT03391791|Cell Therapy|cell therapy
129799|NCT03391791|T Cell Therapy|t cell therapy
129800|NCT03391791|SPEAR T Cell|spear t cell
129801|NCT03391791|Immuno-oncology|immuno-oncology
129802|NCT03391791|Metastatic|metastatic
129803|NCT03391791|T Cell Receptor|t cell receptor
129804|NCT03391791|Long Term Follow Up|long term follow up
129805|NCT03391791|Genetically Engineered|genetically engineered
129806|NCT03391778|Genetically engineered|genetically engineered
129807|NCT03391778|Immuno-oncology|immuno-oncology
129808|NCT03391778|T Cell Therapy|t cell therapy
129809|NCT03391778|T Cell Receptor|t cell receptor
129810|NCT03391778|Previously Treated|previously treated
129811|NCT03391778|Cell Therapy|cell therapy
129812|NCT03391778|SPEAR T Cell|spear t cell
129813|NCT03391778|Metastatic|metastatic
129814|NCT03391778|Solid and Hematological Malignancies|solid and hematological malignancies
129816|NCT03391778|Long Term Follow Up|long term follow up
129817|NCT03391778|NY-ESO-1|ny-eso-1
129818|NCT03391765|tauopathy|tauopathy
129819|NCT03391765|Steele-Richardson-Olszewski Syndrome|steele-richardson-olszewski syndrome
129820|NCT03391765|PSP|psp
129821|NCT03391752|malnutrition, screening, assessment, treatment|malnutrition, screening, assessment, treatment
129822|NCT03391713|awareness|awareness
129823|NCT03391713|poster|poster
129824|NCT03391713|stroke|stroke
129825|NCT03391700|muscle relaxant|muscle relaxant
129826|NCT03391687|Gastric Cancer|gastric cancer
129827|NCT03391687|Pancreatic Fistula|pancreatic fistula
129828|NCT03391687|Gastrectomy|gastrectomy
129829|NCT03391635|acupuncture|acupuncture
129830|NCT03391635|functional constipation|functional constipation
129831|NCT03391635|transcutaneous electric nerve stimulation|transcutaneous electric nerve stimulation
129832|NCT03391635|randomized controlled trial|randomized controlled trial
129833|NCT03391622|thrombin generation|thrombin generation
129834|NCT03391622|calibrated automated thrombogram|calibrated automated thrombogram
129835|NCT03391622|ischemic heart disease|ischemic heart disease
129836|NCT03391622|Percutaneous Coronary Intervention|percutaneous coronary intervention
129837|NCT03391596|Family caregivers|family caregivers
129838|NCT03391596|Depressive symptoms|depressive symptoms
129839|NCT03391596|Psychological wellbeing|psychological wellbeing
129840|NCT03391596|Internet-based intervention|internet-based intervention
129841|NCT03391596|Acceptance and Commitment Therapy|acceptance and commitment therapy
129842|NCT03391583|Education|education
129843|NCT03391583|Pain|pain
129844|NCT03391570|Laparoscopic surgery|laparoscopic surgery
129845|NCT03391570|COX-2 inhibitor|cox-2 inhibitor
129846|NCT03391570|Celecoxib|celecoxib
129847|NCT03391570|Prostanoid|prostanoid
129848|NCT03391557|Elastography|elastography
129849|NCT03391557|Lymph node|lymph node
129850|NCT03391557|Diagnosis|diagnosis
129851|NCT03391531|surgery: laparoscopic cholecystectomy|surgery: laparoscopic cholecystectomy
129852|NCT03391531|analgesia: postoperative|analgesia: postoperative
129853|NCT03391531|locoregional analgesia: transversus abdominis plane block|locoregional analgesia: transversus abdominis plane block
129854|NCT03391531|opioid: side effects|opioid: side effects
129855|NCT03391505|Cognition|cognition
129856|NCT03391505|Physical activity|physical activity
129857|NCT03391505|Memory|memory
129858|NCT03391505|Health|health
129859|NCT03391492|ICU|icu
129860|NCT03391427|Lidocaine|lidocaine
129861|NCT03391427|Ketamine|ketamine
129862|NCT03391427|postoperative analgesia|postoperative analgesia
129863|NCT03391414|thick mucus|thick mucus
129864|NCT03391414|obstructive lung disease|obstructive lung disease
129865|NCT03391362|Small Cell Lung Cancer|small cell lung cancer
129866|NCT03391362|Brain Metastases|brain metastases
129867|NCT03391362|Brain metastasis|brain metastasis
129869|NCT03391362|Stereotactic radiation|stereotactic radiation
129870|NCT03391362|Stereotactic radiosurgery|stereotactic radiosurgery
129871|NCT03391362|SRS|srs
129872|NCT03391362|Stereotactic|stereotactic
129873|NCT03391362|Radiation|radiation
129874|NCT03391362|Quality of life|quality of life
129875|NCT03391362|Neurocognitive|neurocognitive
129876|NCT03391362|Neurocognition|neurocognition
129877|NCT03391349|proteomes, chronic periodontitis|proteomes, chronic periodontitis
129878|NCT03391336|Carpal tunnel syndrome|carpal tunnel syndrome
129879|NCT03391336|Median nerve injury|median nerve injury
129880|NCT03391336|Steroids|steroids
129881|NCT03391336|Ultrasound|ultrasound
129882|NCT03391336|Injections|injections
129883|NCT03391297|PTSD; prolonged exposure; posttraumatic growth|ptsd; prolonged exposure; posttraumatic growth
129884|NCT03391258|Maxilary atrophy|maxilary atrophy
129885|NCT03391258|Leucocyte-platelet-rich-fibrin|leucocyte-platelet-rich-fibrin
129886|NCT03391258|bone resorption|bone resorption
129887|NCT03391258|autologous growth factors|autologous growth factors
129888|NCT03391258|guided-bone-regeneration|guided-bone-regeneration
129889|NCT03391258|lip support|lip support
129890|NCT03391206|Breast cancer related lymphedemas|breast cancer related lymphedemas
129891|NCT03391206|Sentinel Lymph Node Biopsy|sentinel lymph node biopsy
129892|NCT03391206|Axillary Lymph Node Dissection|axillary lymph node dissection
129893|NCT03391206|Bioelectrical Impedance Analysis|bioelectrical impedance analysis
129894|NCT03391206|Dietary Fat|dietary fat
129895|NCT03391193|Influenza|influenza
129896|NCT03391193|Quadrivalent Inactivated Influenza Vaccine|quadrivalent inactivated influenza vaccine
129897|NCT03391193|Multi-dose Presentation|multi-dose presentation
129898|NCT03391141|obstructive sleep apnea|obstructive sleep apnea
129899|NCT03391141|sleep endoscopy|sleep endoscopy
129900|NCT03391141|drug induced sleep endoscopy|drug induced sleep endoscopy
129901|NCT03391141|diagnostic validation|diagnostic validation
129902|NCT03391115|Psychosocial|psychosocial
129903|NCT03391115|Underserved|underserved
129904|NCT03391115|Palliative|palliative
129905|NCT03391115|Electronic Health Record|electronic health record
129906|NCT03391115|Narrative|narrative
129907|NCT03391102|Epidemiology|epidemiology
129908|NCT03391102|Community-based study|community-based study
129909|NCT03391050|Melanoma|melanoma
129910|NCT03391050|Malignant melanoma|malignant melanoma
129911|NCT03391050|Skin cancer|skin cancer
129912|NCT03391050|Resistant cancer|resistant cancer
129913|NCT03391050|Unresectable cancer|unresectable cancer
129914|NCT03391050|Metastatic cancer|metastatic cancer
129915|NCT03391050|BRAF mutant|braf mutant
129916|NCT03390998|Pregnancy-related SCAD|pregnancy-related scad
129917|NCT03390998|Myocardial Infarction|myocardial infarction
129918|NCT03390972|Dexmedetomidine|dexmedetomidine
129919|NCT03390972|Swallowing function|swallowing function
129920|NCT03390972|Anesthetic sedation|anesthetic sedation
129921|NCT03390959|Proprioception|proprioception
129922|NCT03390959|Diabetes Mellitus, Type 2|diabetes mellitus, type 2
129923|NCT03390959|Postural Balance|postural balance
129924|NCT03390959|Gait|gait
129925|NCT03390959|Posture|posture
129926|NCT03390946|four-drugs, interval-compression|four-drugs, interval-compression
129927|NCT03390920|regenerative medicine|regenerative medicine
129928|NCT03390920|arthritis|arthritis
129929|NCT03390920|amniotic|amniotic
129930|NCT03390920|stem cell|stem cell
129931|NCT03390920|growth factor|growth factor
129932|NCT03390920|cartilage|cartilage
129933|NCT03390907|Colon polyp|colon polyp
129935|NCT03390907|Hybrid-APC|hybrid-apc
129936|NCT03390907|Laterally spreading tumor|laterally spreading tumor
129937|NCT03390894|Long-term Follow-Up|long-term follow-up
129938|NCT03390894|Invasive Breast Cancer Early Stages|invasive breast cancer early stages
129939|NCT03390894|Previous Neoadjuvant treatment|previous neoadjuvant treatment
129940|NCT03390894|Previous Adjuvant treatment|previous adjuvant treatment
129941|NCT03390881|breath acetone|breath acetone
129942|NCT03390881|energy balance|energy balance
129943|NCT03390868|Interaction|interaction
129944|NCT03390868|challenging behaviour|challenging behaviour
129945|NCT03390868|training|training
129946|NCT03390855|IL-6|il-6
129947|NCT03390855|Glucosinolate|glucosinolate
129948|NCT03390855|Brassica oleracea|brassica oleracea
129949|NCT03390855|Sulphoraphane|sulphoraphane
129950|NCT03390855|Biomarkers|biomarkers
129951|NCT03390855|Bioavailability|bioavailability
129952|NCT03390855|Inflammation|inflammation
129953|NCT03390842|blood bicarbonate, kidney disease|blood bicarbonate, kidney disease
129954|NCT03390816|malnutrition|malnutrition
129955|NCT03390816|cancer|cancer
129956|NCT03390816|elderly|elderly
129957|NCT03390764|Incisional hernia|incisional hernia
129958|NCT03390764|4:1-technique|4:1-technique
129959|NCT03390764|RTL-suture|rtl-suture
129960|NCT03390751|atropinic drugs|atropinic drugs
129961|NCT03390751|confusion|confusion
129962|NCT03390751|elderly patients|elderly patients
129963|NCT03390725|Prevention, obesity, parenting, diet, physical activity|prevention, obesity, parenting, diet, physical activity
129964|NCT03390712|Paliperidone palmitate|paliperidone palmitate
129965|NCT03390712|Risperidone long-acting injection|risperidone long-acting injection
129966|NCT03390712|mirror-image|mirror-image
129968|NCT03390673|double-blind|double-blind
129969|NCT03390647|E6130|e6130
129970|NCT03390647|Healthy adult male participants|healthy adult male participants
129971|NCT03390647|Phase 1|phase 1
129972|NCT03390647|Pharmacokinetics|pharmacokinetics
129973|NCT03390621|parent feeding styles|parent feeding styles
129974|NCT03390621|dietary quality|dietary quality
129975|NCT03390621|dinner meal|dinner meal
129976|NCT03390621|preschool|preschool
129977|NCT03390621|low-income|low-income
129978|NCT03390595|Urothelial carcinoma|urothelial carcinoma
129979|NCT03390582|Gut Microbiota|gut microbiota
129980|NCT03390582|Hashimoto Thyroiditis|hashimoto thyroiditis
129981|NCT03390582|Graves' Disease|graves' disease
129982|NCT03390582|Methimazole|methimazole
129983|NCT03390582|Levothyroxine sodium|levothyroxine sodium
129984|NCT03390582|16S rRNA gene|16s rrna gene
129985|NCT03390582|Metabonomics|metabonomics
129986|NCT03390569|GBM|gbm
129987|NCT03390569|Glioblastoma|glioblastoma
129988|NCT03390569|Brain Cancer|brain cancer
129989|NCT03390569|High-Grade Glioma|high-grade glioma
129990|NCT03390569|Glioma|glioma
129991|NCT03390530|Thyroxine|thyroxine
129992|NCT03390530|Intraventricular hemorrhage|intraventricular hemorrhage
129993|NCT03390530|MRI with DTI,|mri with dti,
129994|NCT03390530|Neurodevelopmental outcome|neurodevelopmental outcome
129995|NCT03390517|fluorescence angiography|fluorescence angiography
129996|NCT03390517|indocyanine green|indocyanine green
129997|NCT03390517|anastomotic leakage|anastomotic leakage
129998|NCT03390478|Frailty|frailty
129999|NCT03390478|Aged|aged
130000|NCT03390478|Cognitive Stimulation|cognitive stimulation
130001|NCT03390478|Technology|technology
130002|NCT03390452|mHealth|mhealth
130003|NCT03390452|Oral Health|oral health
130004|NCT03390452|Primary School Children|primary school children
165786|NCT03160768|p16|p16
130005|NCT03390452|Mobile Phone Messaging|mobile phone messaging
130006|NCT03390439|Striae alba|striae alba
130007|NCT03390439|Microneedling|microneedling
130008|NCT03390439|Fractional nonablative laser|fractional nonablative laser
130009|NCT03390439|dermaroller|dermaroller
130010|NCT03390439|Nd-yap 1340nm laser|nd-yap 1340nm laser
130011|NCT03390439|Percutaneous Collagen Induction Therapy|percutaneous collagen induction therapy
130012|NCT03390426|Perifemoral|perifemoral
130013|NCT03390426|Tourniquet|tourniquet
130014|NCT03390426|Mepivacaine|mepivacaine
130015|NCT03390426|Tourniquet Hypertension|tourniquet hypertension
130016|NCT03390413|Cryoablation|cryoablation
130017|NCT03390413|Robot-assisted surgical resection|robot-assisted surgical resection
130018|NCT03390400|Laser Cataract Surgery|laser cataract surgery
130019|NCT03390387|Acute lymphoblastic leukemia, children, adolescents, treatment|acute lymphoblastic leukemia, children, adolescents, treatment
130020|NCT03390374|Nystatin|nystatin
130021|NCT03390374|Fungal colonization|fungal colonization
130022|NCT03390374|Systemic fungal infections|systemic fungal infections
130023|NCT03390361|Laser Cataract Surgery|laser cataract surgery
130024|NCT03390361|Prostaglandin|prostaglandin
130025|NCT03390270|intensive care units|intensive care units
130026|NCT03390270|critical care|critical care
130027|NCT03390270|risk assessment|risk assessment
130028|NCT03390270|electronic health records|electronic health records
130029|NCT03390257|Endoscopy, BSD|endoscopy, bsd
130030|NCT03390231|Stem Cell Educator|stem cell educator
130031|NCT03390231|Immune modulation|immune modulation
130032|NCT03390231|Diabetes|diabetes
130033|NCT03390231|Autoimmune|autoimmune
130034|NCT03390231|Insulin resistance|insulin resistance
130035|NCT03390231|Pancreatic islets|pancreatic islets
130036|NCT03390192|Noninvasive brain stimulation|noninvasive brain stimulation
130037|NCT03390192|Repetitive Transcranial Magnetic Stimulation|repetitive transcranial magnetic stimulation
130038|NCT03390192|Transcranial Direct Current Stimulation|transcranial direct current stimulation
130039|NCT03390179|diabetes|diabetes
130040|NCT03390179|anesthesia|anesthesia
130041|NCT03390179|surgery|surgery
130042|NCT03390179|glucose|glucose
130043|NCT03390166|GPO Tri Fluvac Vaccine|gpo tri fluvac vaccine
130044|NCT03390166|Tri Fluvac vaccine|tri fluvac vaccine
130045|NCT03390140|Spinal Cord Injuries|spinal cord injuries
130046|NCT03390140|Group Intervention|group intervention
130047|NCT03390140|Self Efficacy|self efficacy
130048|NCT03390127|elderly|elderly
130049|NCT03390127|lithotomy position|lithotomy position
130050|NCT03390127|PEEP|peep
130051|NCT03390127|laryngeal mask airway|laryngeal mask airway
130052|NCT03390114|HIV|hiv
130053|NCT03390114|Insomnia|insomnia
130054|NCT03390114|Cognitive Behavioral Therapy|cognitive behavioral therapy
130055|NCT03390088|Heart failure|heart failure
130056|NCT03390075|shelf nutrition label, NuVal|shelf nutrition label, nuval
130057|NCT03390049|SmartXide 2 V 2 LR|smartxide 2 v 2 lr
130058|NCT03390049|MonaLisa Touch|monalisa touch
130059|NCT03390049|DEKA|deka
130060|NCT03390049|Fractional CO2 Laser|fractional co2 laser
130061|NCT03390049|Sham Laser|sham laser
130062|NCT03390049|Vulvodynia|vulvodynia
130063|NCT03390049|PVD|pvd
130064|NCT03390049|Provoked vestibulodynia|provoked vestibulodynia
130065|NCT03390023|Prenatal Care|prenatal care
130066|NCT03390023|Barriers|barriers
130067|NCT03390023|Clinical Trials|clinical trials
130068|NCT03389997|respiratory tract infections|respiratory tract infections
130069|NCT03389997|virus shedding|virus shedding
130070|NCT03389997|cancer|cancer
130071|NCT03389997|Immunocompromised Host|immunocompromised host
130072|NCT03389958|intrauterine device|intrauterine device
130073|NCT03389958|postpartum contraception|postpartum contraception
130074|NCT03389958|repeat pregnancy|repeat pregnancy
130075|NCT03389958|adolescent pregnancy|adolescent pregnancy
130076|NCT03389945|Labor analgesia|labor analgesia
130077|NCT03389945|Dural puncture epidural|dural puncture epidural
130078|NCT03389945|Postdural puncture headache|postdural puncture headache
130079|NCT03389945|Neuraxial analgesia|neuraxial analgesia
130080|NCT03389893|randomized double-masked (blind) placebo-controlled trial|randomized double-masked (blind) placebo-controlled trial
130081|NCT03389893|Thelper2 (Th2) effect|thelper2 (th2) effect
130082|NCT03389893|cutaneous microbial community|cutaneous microbial community
130083|NCT03389893|skin barrier|skin barrier
130084|NCT03389867|Male sexual health|male sexual health
130085|NCT03389867|Erectile function|erectile function
130086|NCT03389841|home care services|home care services
130087|NCT03389841|comorbidity|comorbidity
130088|NCT03389841|heart failure|heart failure
130089|NCT03389841|caregivers|caregivers
130090|NCT03389841|health education|health education
130091|NCT03389841|patient admission|patient admission
130092|NCT03389828|Focus Group|focus group
130093|NCT03389828|Health Disparities|health disparities
130094|NCT03389828|Occupational Health|occupational health
130095|NCT03389828|Behaviors|behaviors
130096|NCT03389789|pain|pain
130097|NCT03389789|infant|infant
130098|NCT03389789|near-infrared spectroscopy|near-infrared spectroscopy
130099|NCT03389789|non pharmacological analgesia|non pharmacological analgesia
130100|NCT03389763|Surgical Pleth Index (SPI)|surgical pleth index (spi)
130101|NCT03389763|Pupillary Dilatation Reflex (PRD)|pupillary dilatation reflex (prd)
130102|NCT03389763|Intraoperative Blood Loss (IBL)|intraoperative blood loss (ibl)
130103|NCT03389763|Boezaart Bleeding Scale (BBS)|boezaart bleeding scale (bbs)
130104|NCT03389763|Spectral Entropy (SE)|spectral entropy (se)
130105|NCT03389763|Adequacy of Anaesthesia (AoA)|adequacy of anaesthesia (aoa)
130106|NCT03389763|Total Intravenous Anaesthesia (TIVA)|total intravenous anaesthesia (tiva)
130107|NCT03389711|Rheumatoid Arthritis Mexico|rheumatoid arthritis mexico
130108|NCT03389711|Early Rheumatoid Arthritis Cohort Mexico|early rheumatoid arthritis cohort mexico
130109|NCT03389685|Platelet Rich Plasma|platelet rich plasma
130110|NCT03389672|patient safety|patient safety
130111|NCT03389672|residency training|residency training
130112|NCT03389659|mCRC|mcrc
130113|NCT03389659|oxaliplatin plus fluoropyrimidine|oxaliplatin plus fluoropyrimidine
130114|NCT03389620|CT-fluoroscopy|ct-fluoroscopy
130115|NCT03389620|Corticosteroid injection|corticosteroid injection
130116|NCT03389607|SCUBE-1|scube-1
130117|NCT03389594|Surgical guide|surgical guide
130118|NCT03389594|Computer guided implantology|computer guided implantology
130119|NCT03389594|CBCT voxel size|cbct voxel size
130120|NCT03389555|Sepsis|sepsis
130121|NCT03389555|Metabolic Resuscitation|metabolic resuscitation
130122|NCT03389503|Access site|access site
130123|NCT03389503|Transradial access|transradial access
130124|NCT03389503|Coronary artery disease|coronary artery disease
130125|NCT03389503|Learning curve|learning curve
130126|NCT03389451|68Ga-PSMA-11|68ga-psma-11
130127|NCT03389451|(68Ga)Glu-urea-Lys(Ahx)-HBED-CC|(68ga)glu-urea-lys(ahx)-hbed-cc
130128|NCT03389451|68Ga PSMA-HBED-CC|68ga psma-hbed-cc
130129|NCT03389438|Immunotherapy|immunotherapy
130130|NCT03389399|Brigatinib|brigatinib
130131|NCT03389399|Early Onset Pulmonary Events|early onset pulmonary events
130132|NCT03389386|Congestive Heart Failure|congestive heart failure
130133|NCT03389386|Catestatin|catestatin
130134|NCT03389386|Chromogranin A|chromogranin a
130135|NCT03389386|Echocardiography|echocardiography
130136|NCT03389386|Biomarkers|biomarkers
130137|NCT03389386|Ventricular Dysfunction, Left|ventricular dysfunction, left
130138|NCT03389386|Comorbidity|comorbidity
130139|NCT03389373|Dental Caries|dental caries
130140|NCT03389321|pharmacokinetics|pharmacokinetics
130141|NCT03389321|macitentan|macitentan
130142|NCT03389321|riociguat|riociguat
130143|NCT03389308|Epidermolysis Bullosa Simplex|epidermolysis bullosa simplex
130144|NCT03389308|Epidermolysis Bullosa|epidermolysis bullosa
130145|NCT03389308|Skin Blister|skin blister
130146|NCT03389308|Erosions|erosions
130147|NCT03389295|Nasopharyngeal Carcinoma|nasopharyngeal carcinoma
130148|NCT03389295|Reduced Target Delineation|reduced target delineation
130149|NCT03389295|Sequential chemoradiotherapy|sequential chemoradiotherapy
130150|NCT03389282|Tear, Metabolite|tear, metabolite
130151|NCT03389256|apatinib|apatinib
130152|NCT03389256|T790 negative|t790 negative
130153|NCT03389256|NSCLC|nsclc
130154|NCT03389243|Surgical Pleth Index (SPI)|surgical pleth index (spi)
130155|NCT03389243|General Anaesthesia (GA),|general anaesthesia (ga),
130156|NCT03389243|Numerical Rating Scale (NRS)|numerical rating scale (nrs)
130157|NCT03389243|Adequacy of Anaesthesia (AoA)|adequacy of anaesthesia (aoa)
130158|NCT03389243|Oculocardiac reflex (OCR)|oculocardiac reflex (ocr)
130159|NCT03389243|paracetamol|paracetamol
130160|NCT03389243|metamizole|metamizole
130161|NCT03389217|Multiple Sclerosis|multiple sclerosis
130162|NCT03389217|Pain|pain
130163|NCT03389217|Transcranial Direct Current Stimulation|transcranial direct current stimulation
130164|NCT03389217|tDCS|tdcs
130165|NCT03389204|Breast surgery|breast surgery
130166|NCT03389204|Physiotherapy|physiotherapy
130167|NCT03389204|Breast Cancer|breast cancer
130168|NCT03389204|Shoulder pain|shoulder pain
130169|NCT03389204|Shoulder motion|shoulder motion
130170|NCT03389178|prenatal stress|prenatal stress
130171|NCT03389178|fetal autonomic nervous system|fetal autonomic nervous system
130172|NCT03389178|multidimensional FHR variability assessment|multidimensional fhr variability assessment
130173|NCT03389165|Wearable hip assist robot|wearable hip assist robot
130174|NCT03389165|Elderly adult|elderly adult
130175|NCT03389165|Metabolic energy expenditure|metabolic energy expenditure
130176|NCT03389165|Stair ascent|stair ascent
130177|NCT03389139|Cesarean|cesarean
130178|NCT03389139|newborn|newborn
130179|NCT03389139|cerebral and renal oxygenation|cerebral and renal oxygenation
130180|NCT03389139|anesthesia|anesthesia
130181|NCT03389100|diabetes|diabetes
130182|NCT03389100|hyperglycemia|hyperglycemia
130183|NCT03389100|tau|tau
130184|NCT03389061|Epclusa|epclusa
130185|NCT03389061|Pharmacokinetics|pharmacokinetics
130186|NCT03389061|Crushing|crushing
130187|NCT03389035|Acute Lymphoblastic Leukemia|acute lymphoblastic leukemia
130188|NCT03389035|CAR-T|car-t
130189|NCT03389035|CARCIK|carcik
130190|NCT03389035|Transposon|transposon
130191|NCT03388983|Prehabilitation|prehabilitation
130192|NCT03388983|Physical activity|physical activity
130193|NCT03388983|Lumbar decompression surgery|lumbar decompression surgery
130194|NCT03388983|Randomized controlled trial|randomized controlled trial
130195|NCT03388970|vitamin K1|vitamin k1
130196|NCT03388970|spontaneous intracerebral hemorrhage|spontaneous intracerebral hemorrhage
130197|NCT03388970|effectiveness|effectiveness
130198|NCT03388970|outcome|outcome
130199|NCT03388931|Radiotherapy Dose Escalation|radiotherapy dose escalation
130200|NCT03388918|Quality of life|quality of life
130201|NCT03388918|Telerehabilitation|telerehabilitation
130202|NCT03388918|Cardiac patients|cardiac patients
130203|NCT03388918|Heart failure|heart failure
130204|NCT03388905|LifeVest wearable|lifevest wearable
130205|NCT03388905|cardioverter defibrillator|cardioverter defibrillator
130206|NCT03388905|LVEF|lvef
130207|NCT03388892|Angioplasty|angioplasty
130208|NCT03388892|Drug Eluting Balloon|drug eluting balloon
130209|NCT03388892|Arteriovenous Graft|arteriovenous graft
130210|NCT03388866|inhaled aeroallergens|inhaled aeroallergens
130211|NCT03388866|eczema|eczema
130212|NCT03388866|pruritus|pruritus
130213|NCT03388866|life quality|life quality
130214|NCT03388866|immunotheraphy|immunotheraphy
130215|NCT03388866|atopic dermatitis|atopic dermatitis
130216|NCT03388853|Acetylcysteine/Doxofylline|acetylcysteine/doxofylline
130217|NCT03388853|Acetylcysteine|acetylcysteine
130218|NCT03388853|Doxofylline|doxofylline
130219|NCT03388853|Effervescent Tablet|effervescent tablet
130220|NCT03388853|COPD|copd
130221|NCT03388840|platelet rich plasma|platelet rich plasma
130222|NCT03388840|adipose derived stem cells|adipose derived stem cells
130223|NCT03388840|follicular unit extraction|follicular unit extraction
130224|NCT03388840|hair transplantation|hair transplantation
130225|NCT03388814|PPBCS|ppbcs
130226|NCT03388814|Acute|acute
130227|NCT03388814|Postoperative|postoperative
130228|NCT03388814|Mastectomy|mastectomy
130229|NCT03388814|Breast Reconstruction|breast reconstruction
130230|NCT03388775|deep vein thrombosis|deep vein thrombosis
130231|NCT03388775|assessment|assessment
130232|NCT03388775|risk factors|risk factors
130233|NCT03388762|Hyperglycemia|hyperglycemia
130234|NCT03388762|Prediabetes|prediabetes
130235|NCT03388762|Botanical|botanical
130236|NCT03388762|Phytochemicals|phytochemicals
130237|NCT03388762|Dietary Supplements|dietary supplements
130238|NCT03388762|Berberine|berberine
130239|NCT03388762|Fenugreek|fenugreek
130240|NCT03388762|American Ginseng|american ginseng
130241|NCT03388762|Gymnema|gymnema
130242|NCT03388762|Banaba|banaba
130243|NCT03388762|Kudzu|kudzu
130244|NCT03388762|Cinnamon|cinnamon
130245|NCT03388762|Glycated hemoglobin|glycated hemoglobin
130246|NCT03388762|Trigonella|trigonella
130247|NCT03388762|Blood Glucose|blood glucose
130248|NCT03388762|Panax|panax
130249|NCT03388762|Plant Extracts|plant extracts
130250|NCT03388762|Public Health|public health
130251|NCT03388762|Chronic Disease|chronic disease
130252|NCT03388736|preoperative|preoperative
130253|NCT03388736|anxiety|anxiety
130254|NCT03388736|orthognathic surgery|orthognathic surgery
130255|NCT03388736|lavender oil|lavender oil
130256|NCT03388723|Epigenetics|epigenetics
130257|NCT03388723|Cardiometabolic risk factors|cardiometabolic risk factors
130258|NCT03388710|airway, children, endotracheal tube, cuff|airway, children, endotracheal tube, cuff
130259|NCT03388658|Atrial Fibrillation; Cryoballoon; Ablation;|atrial fibrillation; cryoballoon; ablation;
130260|NCT03388645|RSV Shedding|rsv shedding
130261|NCT03388645|Immune Responses|immune responses
131822|NCT03378596|Exercise|exercise
130262|NCT03388645|Neutralizing Antibody Titer|neutralizing antibody titer
130263|NCT03388645|Upper Respiratory Tract Infection|upper respiratory tract infection
130264|NCT03388632|Immunotherapy|immunotherapy
130266|NCT03388632|Checkpoint Inhibitor|checkpoint inhibitor
130267|NCT03388632|IL-15|il-15
130268|NCT03388632|Combination Therapy|combination therapy
130269|NCT03388619|Rising PSA|rising psa
130270|NCT03388619|No evidence of metastatic disease|no evidence of metastatic disease
130271|NCT03388619|Entire Prostate Bed|entire prostate bed
130272|NCT03388619|Quality of Life|quality of life
130273|NCT03388619|Irradiation|irradiation
130274|NCT03388606|Cognitive Behavior Therapy|cognitive behavior therapy
130275|NCT03388606|Major Depressive Disorder|major depressive disorder
130276|NCT03388606|Mood Disorder|mood disorder
130277|NCT03388606|Biomarkers|biomarkers
130278|NCT03388606|Mechanism|mechanism
130279|NCT03388593|chronic heart failure|chronic heart failure
130280|NCT03388593|neuregulin|neuregulin
130281|NCT03388593|mortality|mortality
130282|NCT03388567|Dispensation|dispensation
130283|NCT03388567|Health Education|health education
130284|NCT03388567|Pharmacovigilance|pharmacovigilance
130285|NCT03388567|Pharmacists|pharmacists
130286|NCT03388528|Dysmotility|dysmotility
130287|NCT03388528|Microbiome|microbiome
130288|NCT03388528|Transit Time|transit time
130289|NCT03388528|Gastrointestinal|gastrointestinal
130290|NCT03388502|Total knee arthroplasty|total knee arthroplasty
130291|NCT03388502|Total hip arthroplasty|total hip arthroplasty
130292|NCT03388476|pulmonary hypertension|pulmonary hypertension
130293|NCT03388476|endtidal co2|endtidal co2
130294|NCT03388476|endtidal carbon dioxide|endtidal carbon dioxide
130295|NCT03388476|pulmonary arterial hypertension|pulmonary arterial hypertension
130296|NCT03388437|Non-invasive Neurally Adjusted Ventilatory Assist NI-NAVA|non-invasive neurally adjusted ventilatory assist ni-nava
130297|NCT03388437|Nasal Intermittent Positive Pressure Ventilation NIPPV|nasal intermittent positive pressure ventilation nippv
130298|NCT03388437|post extubation|post extubation
130299|NCT03388424|bacterial DNA, RNA16S gene|bacterial dna, rna16s gene
130300|NCT03388411|Microbiome|microbiome
130301|NCT03388411|Gut|gut
130302|NCT03388398|Mother-to-child transmission of HIV (MTCT)|mother-to-child transmission of hiv (mtct)
130303|NCT03388398|Prevention of mother-to-child HIV transmission (PMTCT)|prevention of mother-to-child hiv transmission (pmtct)
130304|NCT03388398|Antiretroviral therapy (ART)|antiretroviral therapy (art)
130305|NCT03388398|Antenatal care (ANC)|antenatal care (anc)
130306|NCT03388398|Pediatric infections|pediatric infections
130307|NCT03388398|Pregnancy|pregnancy
130308|NCT03388385|CKD, anemia, iron, endothelial dysfunction, oxidative stress|ckd, anemia, iron, endothelial dysfunction, oxidative stress
130309|NCT03388372|glioma|glioma
130310|NCT03388372|phase 2|phase 2
130311|NCT03388372|nimotozumab|nimotozumab
130312|NCT03388372|temozolomide|temozolomide
130313|NCT03388372|radiotherapy|radiotherapy
130314|NCT03388359|asthma|asthma
130315|NCT03388359|eosinophils|eosinophils
130316|NCT03388359|Extracellular matrix|extracellular matrix
130317|NCT03388359|airway smooth muscle|airway smooth muscle
130318|NCT03388359|airway remodelling|airway remodelling
130319|NCT03388359|fibroblast|fibroblast
130320|NCT03388346|68Ga-PSMA-11|68ga-psma-11
130321|NCT03388346|(68Ga)Glu-urea-Lys(Ahx)-HBED-CC|(68ga)glu-urea-lys(ahx)-hbed-cc
130322|NCT03388346|68Ga PSMA-HBED-CC|68ga psma-hbed-cc
130323|NCT03388294|communication|communication
130324|NCT03388294|sensory|sensory
130325|NCT03388294|early intervention|early intervention
130326|NCT03388294|parent coaching|parent coaching
130327|NCT03388281|Pacemaker|pacemaker
130328|NCT03388281|Gender differences|gender differences
130329|NCT03388281|Survival|survival
130330|NCT03388281|Retrospective|retrospective
130331|NCT03388268|Clostridium difficile|clostridium difficile
130332|NCT03388268|Diarrhea|diarrhea
130333|NCT03388255|Polydeoxyribonucletide|polydeoxyribonucletide
130334|NCT03388255|Placentex|placentex
130335|NCT03388255|PDRN|pdrn
130336|NCT03388229|Dietary pattern|dietary pattern
130337|NCT03388229|glycemic control|glycemic control
130338|NCT03388229|type 2 diabetes|type 2 diabetes
130339|NCT03388229|UAE|uae
130340|NCT03388203|25(OH)D|25(oh)d
130341|NCT03388203|PTH|pth
130342|NCT03388203|mass spectrometry|mass spectrometry
130343|NCT03388203|data mining|data mining
130344|NCT03388190|Colorectal|colorectal
130345|NCT03388190|Cancer|cancer
130346|NCT03388190|Neoplasm|neoplasm
130347|NCT03388190|Nivolumab|nivolumab
130348|NCT03388190|Fluorouracil|fluorouracil
130349|NCT03388190|Metastatic|metastatic
130350|NCT03388190|Oxaliplatin|oxaliplatin
130351|NCT03388190|Leucovorin|leucovorin
130352|NCT03388177|Depression|depression
130353|NCT03388177|Young adult women|young adult women
130354|NCT03388177|Yoga|yoga
130355|NCT03388112|Probiotics,Gut Microbiome,Antibiotics,Infants|probiotics,gut microbiome,antibiotics,infants
130356|NCT03388099|gonadotrophin receptor polymorphism|gonadotrophin receptor polymorphism
130357|NCT03388099|antimüllerian hormone|antimüllerian hormone
130358|NCT03388099|ovarian response|ovarian response
130359|NCT03388099|ovarian stimulation|ovarian stimulation
130360|NCT03388060|Oral Dissolution Therapy|oral dissolution therapy
130361|NCT03388060|Kidney stone|kidney stone
130363|NCT03388047|Barrett Esophagus|barrett esophagus
130364|NCT03388047|Endoscopy|endoscopy
130365|NCT03388047|Adenocarcinoma|adenocarcinoma
130366|NCT03388021|limb ischemia|limb ischemia
130367|NCT03388021|completion angiography|completion angiography
130368|NCT03388021|thromboembolectomy|thromboembolectomy
130369|NCT03388008|donor-specific HLA antibodies|donor-specific hla antibodies
130370|NCT03388008|lung transplantation|lung transplantation
130371|NCT03387995|treatment outcome|treatment outcome
130372|NCT03387956|Postoperative Nuasea|postoperative nuasea
130373|NCT03387930|Low back pain|low back pain
130374|NCT03387930|lumbar multifidus|lumbar multifidus
130375|NCT03387930|Proprioception|proprioception
130376|NCT03387930|Elastography|elastography
130377|NCT03387930|Magnetic resonance imaging|magnetic resonance imaging
130378|NCT03387917|Advanced Solid Tumors|advanced solid tumors
130379|NCT03387917|doxorubicin|doxorubicin
130380|NCT03387917|TLD-1|tld-1
130381|NCT03387917|phase I|phase i
130382|NCT03387917|Talidox|talidox
130383|NCT03387917|Liposomal|liposomal
130384|NCT03387904|Anlotinib|anlotinib
130385|NCT03387865|banking, biological sampling, tumor tissue, tumor response|banking, biological sampling, tumor tissue, tumor response
130386|NCT03387826|ticagrelor|ticagrelor
130387|NCT03387826|prasugrel|prasugrel
130388|NCT03387813|Heart Failure|heart failure
130389|NCT03387813|Hemodynamic Monitoring|hemodynamic monitoring
130390|NCT03387813|CardioMEMS|cardiomems
130391|NCT03387813|Pulmonary Artery Pressure|pulmonary artery pressure
130392|NCT03387800|randomized controlled trial|randomized controlled trial
130393|NCT03387800|smoking cessation|smoking cessation
130394|NCT03387800|social support|social support
130395|NCT03387800|positive effect|positive effect
130396|NCT03387800|online social networking|online social networking
130397|NCT03387800|theory-based|theory-based
130398|NCT03387787|GlucoTab, Tresiba, Type 2 Diabetes|glucotab, tresiba, type 2 diabetes
130399|NCT03387774|Ulinastatin|ulinastatin
130400|NCT03387774|Radiation-induced acute oral mucositis|radiation-induced acute oral mucositis
130401|NCT03387774|Localregionally Advanced Nasopharyngeal Carcinoma|localregionally advanced nasopharyngeal carcinoma
130402|NCT03387774|Intensity Modulated Radiation Therapy|intensity modulated radiation therapy
130403|NCT03387761|Urothelial cancer|urothelial cancer
130404|NCT03387761|Bladder cancer|bladder cancer
130405|NCT03387761|Cancer|cancer
130406|NCT03387761|Resectable|resectable
130407|NCT03387761|Operable|operable
130408|NCT03387761|immunotherapy|immunotherapy
130409|NCT03387761|Ipilimumab|ipilimumab
130410|NCT03387761|Nivolumab|nivolumab
130411|NCT03387761|Neo-Adjuvant|neo-adjuvant
130412|NCT03387735|Hypertension, Hyperlipidemia, Diabetes, Arthritis, Obesity|hypertension, hyperlipidemia, diabetes, arthritis, obesity
130413|NCT03387709|Nondiabetic|nondiabetic
130414|NCT03387709|Overweight|overweight
130415|NCT03387709|Obesity|obesity
130416|NCT03387709|Men|men
130417|NCT03387709|Women|women
130418|NCT03387709|San Diego|san diego
130419|NCT03387709|Weight Loss|weight loss
130420|NCT03387696|Mucormycosis|mucormycosis
130421|NCT03387696|Intensive Care Medicine|intensive care medicine
130422|NCT03387631|Efficacy safety uncomplicated malaria AL|efficacy safety uncomplicated malaria al
130423|NCT03387592|Neuroendocrine Carcinoma|neuroendocrine carcinoma
130424|NCT03387592|second line therapy|second line therapy
130425|NCT03387592|PET imaging|pet imaging
130426|NCT03387592|FOLFIRI|folfiri
130427|NCT03387592|CAPTEM|captem
130428|NCT03387553|Immunotherapy|immunotherapy
130429|NCT03387553|Dendritic Cell Vaccine|dendritic cell vaccine
130430|NCT03387553|DC1|dc1
130431|NCT03387540|Anti-PD-1|anti-pd-1
130432|NCT03387540|Anti-PD-L1|anti-pd-l1
130433|NCT03387540|Anti CTLA-4|anti ctla-4
130434|NCT03387540|Immune checkpoint inhibitors|immune checkpoint inhibitors
130435|NCT03387527|Decision Aid|decision aid
130436|NCT03387514|Clear Cell|clear cell
130437|NCT03387514|Kidney Cancer|kidney cancer
130438|NCT03387514|RCC|rcc
130439|NCT03387475|efficacy|efficacy
130440|NCT03387475|safety|safety
130441|NCT03387462|Adherence|adherence
130442|NCT03387462|PrEP|prep
130443|NCT03387462|HIV Prevention|hiv prevention
130444|NCT03387462|Truvada|truvada
130445|NCT03387462|HIV Risk Reduction|hiv risk reduction
130446|NCT03387462|Mobile App|mobile app
130447|NCT03387436|Palliative care|palliative care
130448|NCT03387436|Advance care planning|advance care planning
130449|NCT03387436|psychological intervention|psychological intervention
130450|NCT03387410|Laparoscopic surgery|laparoscopic surgery
130451|NCT03387410|Fluorescence|fluorescence
130452|NCT03387397|Co-morbidities|co-morbidities
130453|NCT03387371|chronic periodontitis, laser|chronic periodontitis, laser
130454|NCT03387358|intensive care unit|intensive care unit
130455|NCT03387358|nasal bridle securement device|nasal bridle securement device
130456|NCT03387358|small bore feeding tube|small bore feeding tube
130457|NCT03387358|adverse events|adverse events
130458|NCT03387358|enteral nutrition|enteral nutrition
130459|NCT03387345|glucose|glucose
130460|NCT03387345|dietary fiber|dietary fiber
130461|NCT03387345|glycemia|glycemia
130462|NCT03387345|whole grain|whole grain
130463|NCT03387332|Bcl-2/Bcl-xL dual inhibitor|bcl-2/bcl-xl dual inhibitor
130464|NCT03387319|Social stress|social stress
130465|NCT03387319|Inflammation|inflammation
130466|NCT03387306|serum bilirubin|serum bilirubin
130467|NCT03387306|normal-tension glaucoma|normal-tension glaucoma
130468|NCT03387306|oxidative stress|oxidative stress
130469|NCT03387293|Pediatric Obesity|pediatric obesity
130470|NCT03387293|Insulin Resistance|insulin resistance
130471|NCT03387293|Diet|diet
130472|NCT03387280|acute myocardial infarction|acute myocardial infarction
130473|NCT03387280|electrocardiogram|electrocardiogram
130474|NCT03387280|coronary angiography|coronary angiography
130475|NCT03387254|virtual reality|virtual reality
130476|NCT03387254|brain stimulation|brain stimulation
130477|NCT03387241|moderate|moderate
130478|NCT03387241|severe|severe
130479|NCT03387241|persistent|persistent
130480|NCT03387241|reversible|reversible
130481|NCT03387241|Seretide|seretide
130482|NCT03387241|Flutiform|flutiform
130483|NCT03387228|back pain|back pain
130484|NCT03387228|low back pain|low back pain
130485|NCT03387228|Explain Pain|explain pain
130486|NCT03387228|Pain education|pain education
130487|NCT03387202|Pelvic Organ Prolapse|pelvic organ prolapse
130488|NCT03387202|Translabial ultrasound|translabial ultrasound
130489|NCT03387202|Transperineal ultrasound|transperineal ultrasound
130490|NCT03387202|Lateral Mesh Suspension|lateral mesh suspension
130491|NCT03387202|Descensus uteri|descensus uteri
130492|NCT03387202|Laparoscopic pelvic organ prolapse repair|laparoscopic pelvic organ prolapse repair
130493|NCT03387163|Heart failure|heart failure
130494|NCT03387163|Reduced left ventricular ejection fraction|reduced left ventricular ejection fraction
130495|NCT03387163|Chronic Systolic Heart failure|chronic systolic heart failure
130496|NCT03387163|Sacubitril /Valsartan|sacubitril /valsartan
130497|NCT03387163|Patient reported outcomes (PRO)|patient reported outcomes (pro)
130498|NCT03387163|Kansas City Cardiomyopathy Questionnaire (KCCQ)|kansas city cardiomyopathy questionnaire (kccq)
130499|NCT03387163|Patient Centered Outcomes Research Network (PCORNeT)|patient centered outcomes research network (pcornet)
130500|NCT03387163|Common Data Model (CDM)|common data model (cdm)
130501|NCT03387072|Mental stress|mental stress
130502|NCT03387072|Sudden cardiac death|sudden cardiac death
130503|NCT03387072|arrhythmias|arrhythmias
130504|NCT03387072|long QT syndrome|long qt syndrome
130505|NCT03387059|Infertility|infertility
130506|NCT03387059|Forielle|forielle
130507|NCT03387059|Assisted Reproductive Technique (ART)|assisted reproductive technique (art)
130508|NCT03387059|Controlled Ovarian Stimulation (COS)|controlled ovarian stimulation (cos)
130509|NCT03387046|Relapsing remitting multiple sclerosis|relapsing remitting multiple sclerosis
130510|NCT03387046|D-Aspartate|d-aspartate
130511|NCT03387046|interferon beta-1a|interferon beta-1a
130512|NCT03387007|adolescent|adolescent
130513|NCT03387007|mental health|mental health
130514|NCT03387007|hope|hope
130515|NCT03387007|psycho-social support|psycho-social support
130516|NCT03387007|school teachers|school teachers
130517|NCT03387007|earthquake|earthquake
130518|NCT03386981|Energy metabolism|energy metabolism
130519|NCT03386981|Homeostasis|homeostasis
130520|NCT03386981|Bone turnover markers|bone turnover markers
130521|NCT03386968|virtual reality|virtual reality
130522|NCT03386968|hemiplegia|hemiplegia
130523|NCT03386968|diplegia|diplegia
130524|NCT03386968|video gaming|video gaming
130525|NCT03386968|active video games|active video games
130526|NCT03386968|Playstation X-Box 360|playstation x-box 360
130527|NCT03386968|Rutgers V-Step|rutgers v-step
130528|NCT03386968|Microsoft Kinect|microsoft kinect
130529|NCT03386955|non-small cell lung cancer|non-small cell lung cancer
130530|NCT03386955|NSCLC|nsclc
130531|NCT03386942|Solid Tumors|solid tumors
130532|NCT03386942|Folate Receptor α (FRA)-Positive Triple Negative Breast Cancer|folate receptor α (fra)-positive triple negative breast cancer
130533|NCT03386942|FRA-Positive Type 2 Endometrial Carcinoma|fra-positive type 2 endometrial carcinoma
130534|NCT03386929|NSCLC|nsclc
130535|NCT03386929|tri-therapy|tri-therapy
130536|NCT03386929|avelumab|avelumab
130537|NCT03386929|axitinib|axitinib
130538|NCT03386929|palbociclib|palbociclib
130539|NCT03386929|dual matched normal and tumor biopsies|dual matched normal and tumor biopsies
130540|NCT03386929|SIMS algorithm|sims algorithm
130541|NCT03386929|Sequencing|sequencing
130542|NCT03386929|Gene expression|gene expression
130663|NCT03386006|behavioral activation|behavioral activation
130543|NCT03386916|Technology, Radiologic - Radiography, Interventional - Image-Guided Biopsy - Early Detection of Cancer - Carcinoma, Bronchogenic / diagnosis - Outpatients|technology, radiologic - radiography, interventional - image-guided biopsy - early detection of cancer - carcinoma, bronchogenic / diagnosis - outpatients
130544|NCT03386890|Non-invasive Assessment|non-invasive assessment
130545|NCT03386890|Transient Elastography|transient elastography
130546|NCT03386890|Controlled Attenuation Parameter|controlled attenuation parameter
130547|NCT03386864|Heart Failure, Diabetes Mellitus, Mitochondrial Respiration|heart failure, diabetes mellitus, mitochondrial respiration
130548|NCT03386825|Metastatic Colorectal Cancer|metastatic colorectal cancer
131823|NCT03378596|Arginine|arginine
130549|NCT03386812|androgen deprivation therapy|androgen deprivation therapy
130550|NCT03386812|sarcopenia|sarcopenia
130551|NCT03386812|bone loss|bone loss
130552|NCT03386799|Power assistance device|power assistance device
130553|NCT03386799|Wheelchair|wheelchair
130554|NCT03386786|Total Knee Arthroplasty|total knee arthroplasty
130555|NCT03386786|Total Hip Arthroplasty|total hip arthroplasty
130556|NCT03386786|Total Knee Replacement|total knee replacement
130557|NCT03386786|Total Hip Replacement|total hip replacement
130558|NCT03386786|Hospital Care Plan|hospital care plan
130559|NCT03386786|mHealth|mhealth
130560|NCT03386773|patient generated health data|patient generated health data
130561|NCT03386773|patient reported outcome measures|patient reported outcome measures
130562|NCT03386773|health information technology|health information technology
130563|NCT03386773|mobile health|mobile health
130564|NCT03386773|consumer health informatics|consumer health informatics
130565|NCT03386760|tattoo|tattoo
130566|NCT03386747|child development|child development
130567|NCT03386747|neonatal mortality|neonatal mortality
130568|NCT03386708|Healing Poor After Uterus Injury, Mesenchymal Stem Cell|healing poor after uterus injury, mesenchymal stem cell
130569|NCT03386695|Cervical Cancer and HPV infection|cervical cancer and hpv infection
130570|NCT03386669|18F-THK5351 PET|18f-thk5351 pet
130571|NCT03386669|Tauopathies|tauopathies
130572|NCT03386656|Osteoarthritis|osteoarthritis
130573|NCT03386656|Tranexamic acid|tranexamic acid
130574|NCT03386643|Oral lichen planus|oral lichen planus
130575|NCT03386643|Probiotics|probiotics
130576|NCT03386643|Immunomodulation.|immunomodulation.
130577|NCT03386604|Whey Protein|whey protein
130578|NCT03386539|heart transplantation|heart transplantation
130579|NCT03386539|children|children
130580|NCT03386539|everolimus|everolimus
130581|NCT03386539|tacrolimus|tacrolimus
130582|NCT03386539|mycophenolate mofetil|mycophenolate mofetil
130583|NCT03386539|randomized clinical trial|randomized clinical trial
130584|NCT03386526|IAP inhibitor|iap inhibitor
130585|NCT03386513|Antibody Drug Conjugate|antibody drug conjugate
130586|NCT03386513|Other Hematologic Malignancies|other hematologic malignancies
130587|NCT03386513|Myeloproliferative Neoplasms|myeloproliferative neoplasms
130588|NCT03386513|CD123|cd123
130589|NCT03386513|MDS|mds
130590|NCT03386513|Relapsed, Refractory|relapsed, refractory
130591|NCT03386513|Acute Lymphocytic Leukaemia|acute lymphocytic leukaemia
130592|NCT03386513|Blastic Plasmacytoid Dendritic Cell Neoplasm|blastic plasmacytoid dendritic cell neoplasm
130593|NCT03386513|Acute Myeloid Leukemia|acute myeloid leukemia
130594|NCT03386474|double-masked, extension study|double-masked, extension study
130595|NCT03386474|neovascular age-related macular degeneration|neovascular age-related macular degeneration
130596|NCT03386474|intravitreal injection|intravitreal injection
130597|NCT03386474|brolucizumab|brolucizumab
130598|NCT03386474|aflibercept|aflibercept
130599|NCT03386461|elderly|elderly
130600|NCT03386461|exercise training|exercise training
130601|NCT03386461|adipose tissue|adipose tissue
130602|NCT03386461|omega-3 polyunsaturated fatty acids|omega-3 polyunsaturated fatty acids
130603|NCT03386461|inflammation|inflammation
130604|NCT03386461|diferentiation of preadipocytes|diferentiation of preadipocytes
130605|NCT03386435|remote ischemic preconditioning|remote ischemic preconditioning
130606|NCT03386435|liver donors|liver donors
130607|NCT03386422|Mindfulness|mindfulness
130608|NCT03386422|Self-Compassion|self-compassion
130609|NCT03386422|Chronic Pain|chronic pain
130610|NCT03386422|Psychological Intervention|psychological intervention
130611|NCT03386422|Cognitive-Behavioural therapy|cognitive-behavioural therapy
130612|NCT03386422|acceptance|acceptance
130613|NCT03386422|catastrophising|catastrophising
130614|NCT03386422|Self-Care|self-care
130615|NCT03386422|Quality of life|quality of life
130616|NCT03386409|Injury prevention|injury prevention
130617|NCT03386383|adolescent and young adult|adolescent and young adult
130618|NCT03386383|cancer survivor|cancer survivor
130619|NCT03386370|Acute ischemia|acute ischemia
130620|NCT03386370|Lower Limb|lower limb
130621|NCT03386318|concentration|concentration
130622|NCT03386292|prevalence|prevalence
130623|NCT03386292|urinary incontinence|urinary incontinence
130624|NCT03386292|anal incontinence|anal incontinence
130625|NCT03386292|risk factors|risk factors
130626|NCT03386292|women|women
130627|NCT03386279|healthy volunteers|healthy volunteers
130628|NCT03386266|Biomarkers|biomarkers
130629|NCT03386266|CMT1A|cmt1a
130630|NCT03386266|Charcot-Marie-Tooth disease|charcot-marie-tooth disease
130631|NCT03386227|Assisted Reproductive Technology|assisted reproductive technology
130632|NCT03386227|Antibiotic Prophylaxis|antibiotic prophylaxis
130633|NCT03386227|Microbiome|microbiome
130634|NCT03386201|Laparoscopic cholecystectomy|laparoscopic cholecystectomy
130635|NCT03386201|Fluorescence|fluorescence
130636|NCT03386162|Breast cancer, PI3K, alpelisib|breast cancer, pi3k, alpelisib
130637|NCT03386149|Herniated Intervertebral Disc of Lumbar Spine|herniated intervertebral disc of lumbar spine
130638|NCT03386149|Low Back Pain|low back pain
130639|NCT03386149|Radiculopathy|radiculopathy
130640|NCT03386149|Bosinji|bosinji
130641|NCT03386149|Herbal Medicine|herbal medicine
130642|NCT03386136|bowel ischemia|bowel ischemia
131824|NCT03378596|Citrulline|citrulline
130643|NCT03386136|bowel perforation|bowel perforation
130644|NCT03386123|Tinnitus|tinnitus
130645|NCT03386123|Insomnia|insomnia
130646|NCT03386123|Cognitive Behaviour Therapy|cognitive behaviour therapy
130647|NCT03386110|Couples|couples
130648|NCT03386110|MSM|msm
130649|NCT03386110|HIV|hiv
130650|NCT03386110|Drug Use|drug use
130651|NCT03386097|Cholesterol|cholesterol
130652|NCT03386097|Interstitial fluid|interstitial fluid
130653|NCT03386084|capacitive resistive diathermy|capacitive resistive diathermy
130654|NCT03386084|motor control|motor control
130655|NCT03386019|lymphatic massage|lymphatic massage
130656|NCT03386019|static stretching|static stretching
130657|NCT03386019|cold water immersion|cold water immersion
130658|NCT03386006|bariatric surgery|bariatric surgery
130659|NCT03386006|mobile health (mHealth)|mobile health (mhealth)
130660|NCT03386006|psychosocial functioning|psychosocial functioning
130661|NCT03386006|obesity|obesity
130662|NCT03386006|weight loss|weight loss
130664|NCT03385993|Delirium Prevention|delirium prevention
130665|NCT03385993|Virtual Reality|virtual reality
130666|NCT03385993|VR|vr
130667|NCT03385967|upper extremity bone fracture|upper extremity bone fracture
130668|NCT03385954|nursing|nursing
130669|NCT03385954|distance|distance
130670|NCT03385954|education|education
130671|NCT03385954|RSI/WRMD|rsi/wrmd
130672|NCT03385928|ICH|ich
130673|NCT03385928|Stroke|stroke
130674|NCT03385928|Cerebrovascular Disorders|cerebrovascular disorders
130675|NCT03385928|Brain Diseases|brain diseases
130676|NCT03385928|Central Nervous System Diseases|central nervous system diseases
130677|NCT03385928|Nervous System Diseases|nervous system diseases
130678|NCT03385928|Vascular Diseases|vascular diseases
130679|NCT03385928|Cardiovascular Diseases|cardiovascular diseases
130680|NCT03385928|Tranexamic Acid|tranexamic acid
130681|NCT03385928|Antifibrinolytic Agents|antifibrinolytic agents
130682|NCT03385928|Fibrin Modulating Agents|fibrin modulating agents
130683|NCT03385928|Pharmacologic Actions|pharmacologic actions
130684|NCT03385928|Cardiovascular Agents|cardiovascular agents
130685|NCT03385928|Therapeutic Uses|therapeutic uses
130686|NCT03385928|Hematologic Agents|hematologic agents
130687|NCT03385928|Hemostatics|hemostatics
130688|NCT03385928|Contrast Media|contrast media
130689|NCT03385928|Angiography|angiography
130690|NCT03385928|Cerebral Angiography|cerebral angiography
130691|NCT03385928|Tomography, X-Ray Computed|tomography, x-ray computed
130692|NCT03385915|Transcatheter aortic valve replacement|transcatheter aortic valve replacement
130693|NCT03385915|Transcatheter aortic valve implantation|transcatheter aortic valve implantation
130694|NCT03385915|TAVI|tavi
130695|NCT03385915|TAVR|tavr
130696|NCT03385915|Aortic valve replacement|aortic valve replacement
130697|NCT03385915|Surgical aortic valve replacement|surgical aortic valve replacement
130698|NCT03385915|Sutureless|sutureless
130699|NCT03385902|advanced chronic kidney disease|advanced chronic kidney disease
130700|NCT03385902|timing of dialysis initiation|timing of dialysis initiation
130701|NCT03385902|hemodialysis|hemodialysis
130702|NCT03385902|fuzzy mathematics|fuzzy mathematics
130703|NCT03385902|glomerular filtration rate|glomerular filtration rate
130704|NCT03385889|Cervicogenic Headache|cervicogenic headache
130705|NCT03385889|Manual Therapy|manual therapy
130706|NCT03385889|Joint Position Sense|joint position sense
130707|NCT03385889|Balance|balance
130708|NCT03385876|Rady Children's|rady children's
130709|NCT03385876|Pediatric|pediatric
130710|NCT03385876|Genomic|genomic
130711|NCT03385876|Precision Medicine|precision medicine
130712|NCT03385876|Biorepository|biorepository
130713|NCT03385824|traumatic brain injury|traumatic brain injury
130714|NCT03385824|advocacy|advocacy
130715|NCT03385811|Professional quality of life, Medical Professionals, Job Involvement, Intention to Stay,|professional quality of life, medical professionals, job involvement, intention to stay,
130716|NCT03385798|Endo-GIA Stapler|endo-gia stapler
130717|NCT03385798|Endowrist Stapler|endowrist stapler
130718|NCT03385785|Transcatheter aortic valve replacement|transcatheter aortic valve replacement
130719|NCT03385785|Pressure Recording Analytical Method|pressure recording analytical method
130720|NCT03385785|Ventriculo-arterial coupling|ventriculo-arterial coupling
130721|NCT03385785|Monitoring|monitoring
130722|NCT03385785|Hemodynamic|hemodynamic
130723|NCT03385772|sphenopalatine block|sphenopalatine block
130724|NCT03385759|unicompartmental knee|unicompartmental knee
130725|NCT03385759|total knee arthroplasty|total knee arthroplasty
130726|NCT03385759|osteoarthritis|osteoarthritis
130727|NCT03385733|pulmonary hypertension|pulmonary hypertension
130728|NCT03385733|inspiratory muscle training|inspiratory muscle training
130729|NCT03385733|functional capacity|functional capacity
130730|NCT03385733|physical activity|physical activity
130731|NCT03385707|Post-bariatric hypoglycemia|post-bariatric hypoglycemia
130732|NCT03385681|pediatric pain|pediatric pain
130733|NCT03385681|postoperative pain|postoperative pain
130734|NCT03385681|pain assessment|pain assessment
130735|NCT03385681|pain management|pain management
130736|NCT03385681|knowledge|knowledge
130737|NCT03385681|children|children
130738|NCT03385681|nurses|nurses
130739|NCT03385668|Pulmonary fibrosis|pulmonary fibrosis
131927|NCT03377933|Safety|safety
130740|NCT03385668|Antibodies, Antineutrophil Cytoplasmic|antibodies, antineutrophil cytoplasmic
130741|NCT03385668|Anti-Neutrophil Cytoplasmic Antibody (ANCA)-Associated Vasculitis|anti-neutrophil cytoplasmic antibody (anca)-associated vasculitis
130742|NCT03385668|Pirfenidone|pirfenidone
130743|NCT03385668|Microscopic Polyangiitis|microscopic polyangiitis
130744|NCT03385668|Interstitial lung disease|interstitial lung disease
130745|NCT03385629|Dental Care|dental care
130746|NCT03385629|Dental Caries|dental caries
130747|NCT03385629|Common Sense Model of Self-Regulation|common sense model of self-regulation
130749|NCT03385577|Gastrointestinal (GI)|gastrointestinal (gi)
130750|NCT03385577|Fear of Cancer Recurrence (FCR)|fear of cancer recurrence (fcr)
130751|NCT03385551|Vulvovaginal Atrophy|vulvovaginal atrophy
130752|NCT03385525|Healthy Volunteer|healthy volunteer
130753|NCT03385512|Virtual standardized patient coaching|virtual standardized patient coaching
130754|NCT03385512|Standardized patient instructor coaching|standardized patient instructor coaching
130755|NCT03385512|Patient centered communication|patient centered communication
130756|NCT03385499|Congenital toxoplasmosis|congenital toxoplasmosis
400588|NCT01866124|multiannual and seasonal cash transfers|multiannual and seasonal cash transfers
130757|NCT03385499|Neonatal biological diagnosis of congenital toxoplasmosis|neonatal biological diagnosis of congenital toxoplasmosis
130758|NCT03385499|neonatal diagnosis|neonatal diagnosis
130759|NCT03385499|ELISPOT|elispot
130760|NCT03385499|IgG|igg
130761|NCT03385486|Melanoma|melanoma
130762|NCT03385486|Resistant|resistant
130763|NCT03385486|Refractory|refractory
130764|NCT03385460|Overactive bladder|overactive bladder
130765|NCT03385460|Botulinum Toxin|botulinum toxin
130766|NCT03385460|low energy shock waves|low energy shock waves
130767|NCT03385460|Intravesical|intravesical
130768|NCT03385434|Colonoscopy; adenoma detection rate; endorings-2; endorings; device-assisted colonoscopy|colonoscopy; adenoma detection rate; endorings-2; endorings; device-assisted colonoscopy
130769|NCT03385369|MEDI0382|medi0382
130770|NCT03385369|Safety|safety
130771|NCT03385369|Tolerability|tolerability
130772|NCT03385369|Pharmacokinetics|pharmacokinetics
130773|NCT03385369|Immunogenicity|immunogenicity
130774|NCT03385330|BPD|bpd
130775|NCT03385330|Prematurity|prematurity
130776|NCT03385330|Supplemental Oxygen|supplemental oxygen
130777|NCT03385330|Oximetry|oximetry
130778|NCT03385330|Infants|infants
130779|NCT03385304|Surgical Site Infection|surgical site infection
130780|NCT03385304|Open Fracture|open fracture
130781|NCT03385304|Povidone-iodine|povidone-iodine
130782|NCT03385304|Chlorhexidine gluconate|chlorhexidine gluconate
130783|NCT03385304|Peri-operative Preparation Solutions|peri-operative preparation solutions
130784|NCT03385291|EEG;DOC;auditory|eeg;doc;auditory
130785|NCT03385278|TMS;DOC|tms;doc
130786|NCT03385252|complementary feeding|complementary feeding
130787|NCT03385252|eggs|eggs
130788|NCT03385252|infant growth|infant growth
130789|NCT03385252|stunting|stunting
130790|NCT03385252|cognitive development|cognitive development
130791|NCT03385252|choline|choline
130792|NCT03385252|vitamin B12|vitamin b12
130793|NCT03385252|microbiome|microbiome
130794|NCT03385239|AKCEA-APOCIII-LRx|akcea-apociii-lrx
130795|NCT03385239|IONIS-APOCIII-LRx|ionis-apociii-lrx
130796|NCT03385239|Dyslipidemia|dyslipidemia
130797|NCT03385239|Metabolic Disease|metabolic disease
130798|NCT03385239|Hyperlipidemia|hyperlipidemia
130799|NCT03385239|Cardiac Disease|cardiac disease
130800|NCT03385239|Lipid Metabolism Disorders|lipid metabolism disorders
130801|NCT03385239|Triglycerides High|triglycerides high
130802|NCT03385239|Vascular Diseases|vascular diseases
130803|NCT03385226|Relapsed|relapsed
130804|NCT03385226|Refractory|refractory
130805|NCT03385213|Microbiota|microbiota
130806|NCT03385213|colorectal cancer|colorectal cancer
130807|NCT03385213|relapse|relapse
130808|NCT03385213|surveillance|surveillance
130809|NCT03385200|breast cancer, neoadjuvant chemotherapy, ultrasound, microbubbles|breast cancer, neoadjuvant chemotherapy, ultrasound, microbubbles
130810|NCT03385161|ethanol ablation of the prostate|ethanol ablation of the prostate
130811|NCT03385161|Benign prostatic hyperplasia (BPH)|benign prostatic hyperplasia (bph)
130812|NCT03385161|Prostate|prostate
130813|NCT03385161|Ethanol|ethanol
130814|NCT03385161|Transrectal|transrectal
130815|NCT03385161|BPH|bph
130816|NCT03385161|onaBoNT-A|onabont-a
130817|NCT03385161|Botox|botox
130818|NCT03385161|Lower urinary tract symptoms|lower urinary tract symptoms
130819|NCT03385161|Botulinum toxin|botulinum toxin
130820|NCT03385161|OnabotulinumtoxinA|onabotulinumtoxina
130821|NCT03385161|Quality of life|quality of life
130822|NCT03385161|IPSS|ipss
130823|NCT03385161|Randomised controlled study|randomised controlled study
130824|NCT03385135|allopurinol|allopurinol
130825|NCT03385135|coronary artery disease|coronary artery disease
130826|NCT03385135|diabetes|diabetes
130827|NCT03385135|endothelial function|endothelial function
130828|NCT03385122|Cardiovascular disease|cardiovascular disease
130829|NCT03385109|Robotic|robotic
130830|NCT03385109|Laparoscopic|laparoscopic
130831|NCT03385044|Endotracheal tube|endotracheal tube
130832|NCT03385044|Intracuff pressure|intracuff pressure
130833|NCT03385044|Minimal occlusive volume technique|minimal occlusive volume technique
130834|NCT03385044|Spirometer|spirometer
130840|NCT03385005|Healthy Volunteer|healthy volunteer
130841|NCT03385005|Spinal Cord Injury|spinal cord injury
130842|NCT03385005|Biomedical Engineering|biomedical engineering
130843|NCT03384992|Fear of Cancer Recurrence|fear of cancer recurrence
130844|NCT03384992|ehealth interventions|ehealth interventions
130845|NCT03384992|PROMIS|promis
130846|NCT03384992|FoR|for
130847|NCT03384940|Oncology|oncology
130848|NCT03384940|HER2|her2
130849|NCT03384940|Colorectal cancer|colorectal cancer
130850|NCT03384940|Antibody drug conjugate|antibody drug conjugate
130851|NCT03384940|ADC|adc
130852|NCT03384927|Treatment diary|treatment diary
130853|NCT03384914|axillary nodes|axillary nodes
130854|NCT03384914|HER-2 directed treatment|her-2 directed treatment
130855|NCT03384888|Fibromyalgia, Neurostimulation, TDCS|fibromyalgia, neurostimulation, tdcs
130862|NCT03384862|Arsenic exposure|arsenic exposure
130863|NCT03384849|Fiber-optic sensor system|fiber-optic sensor system
130864|NCT03384849|Magnetic resonance imaging|magnetic resonance imaging
130865|NCT03384849|Medical monitoring|medical monitoring
130866|NCT03384849|Physiological parameters|physiological parameters
130867|NCT03384836|Melanoma|melanoma
130868|NCT03384836|Immune Checkpoint Inhibitors|immune checkpoint inhibitors
130869|NCT03384836|Beta Adrenergic Blockers|beta adrenergic blockers
130870|NCT03384823|First-in-Human|first-in-human
130871|NCT03384823|Single Ascending Dose|single ascending dose
130872|NCT03384823|Multiple Ascending Dose|multiple ascending dose
130873|NCT03384810|CPR|cpr
130874|NCT03384810|cardiac arrest|cardiac arrest
130875|NCT03384810|inhospital|inhospital
130876|NCT03384797|blood|blood
130877|NCT03384797|biomarker|biomarker
130878|NCT03384797|Parkinson's disease|parkinson's disease
130879|NCT03384784|HIV|hiv
130880|NCT03384784|Neurocognition|neurocognition
130881|NCT03384784|Inflammation|inflammation
130882|NCT03384784|Galantamine|galantamine
130883|NCT03384784|Nicotine|nicotine
130884|NCT03384784|Tobacco Use|tobacco use
130885|NCT03384771|mindfulness, MBSR, teaching|mindfulness, mbsr, teaching
130886|NCT03384758|Compression therapy|compression therapy
130887|NCT03384758|Microcirculation|microcirculation
130888|NCT03384758|Diabetes mellitus|diabetes mellitus
130889|NCT03384758|Peripheral Arterial Disease|peripheral arterial disease
130890|NCT03384732|community-dwelling elderly|community-dwelling elderly
130891|NCT03384732|ICF|icf
130892|NCT03384732|core set development|core set development
130893|NCT03384732|geriatric|geriatric
130894|NCT03384732|functioning|functioning
130895|NCT03384732|health|health
130896|NCT03384732|ageing|ageing
130897|NCT03384719|Growth factor|growth factor
130898|NCT03384719|Protein|protein
130899|NCT03384719|Milk protein|milk protein
130900|NCT03384719|Plant protein|plant protein
130901|NCT03384719|Insulin-like growth factor-1 (IGF-1)|insulin-like growth factor-1 (igf-1)
130902|NCT03384719|Insulin|insulin
130903|NCT03384719|Insulin-like growth factor-binding protein-3 (IGFBP-3)|insulin-like growth factor-binding protein-3 (igfbp-3)
130904|NCT03384706|posttraumatic stress disorder (PTSD)|posttraumatic stress disorder (ptsd)
130905|NCT03384706|Clinical Trial|clinical trial
130906|NCT03384706|Psychotherapy|psychotherapy
130907|NCT03384706|Assessment|assessment
130908|NCT03384706|Effectiveness|effectiveness
130909|NCT03384693|hematopoeitic stem cell transplant|hematopoeitic stem cell transplant
130910|NCT03384693|prophylactic defibrotide|prophylactic defibrotide
130911|NCT03384667|Maekmoondong-tang|maekmoondong-tang
130912|NCT03384667|Mai-men-dong-tang|mai-men-dong-tang
130913|NCT03384667|Bakumondo-to|bakumondo-to
130914|NCT03384628|Contact lens|contact lens
130915|NCT03384628|The Young Theory|the young theory
130916|NCT03384602|subjective cognitive decline|subjective cognitive decline
130917|NCT03384602|falls prevention|falls prevention
130918|NCT03384602|cognitive function|cognitive function
130919|NCT03384602|dalcroze eurhythmics|dalcroze eurhythmics
130920|NCT03384602|home exercise program|home exercise program
130921|NCT03384602|seniors|seniors
130922|NCT03384576|Music|music
130923|NCT03384576|Emergency|emergency
130924|NCT03384576|caregivers|caregivers
130925|NCT03384563|pediatric|pediatric
130926|NCT03384563|anesthesia|anesthesia
130927|NCT03384563|dexmedetomidine|dexmedetomidine
130928|NCT03384537|intra-oral microorganisms.|intra-oral microorganisms.
130929|NCT03384537|cariogenic microorganisms|cariogenic microorganisms
130930|NCT03384511|RGD PET-CT|rgd pet-ct
130931|NCT03384511|Apatinib|apatinib
130932|NCT03384498|Genetic epidemiology|genetic epidemiology
130933|NCT03384498|Antimalarial drug resistance|antimalarial drug resistance
130934|NCT03384472|Malaria Genetic Surveillance|malaria genetic surveillance
130935|NCT03384472|Cambodia|cambodia
130936|NCT03384459|vitiligo|vitiligo
130937|NCT03384459|308-nm excimer laser|308-nm excimer laser
130938|NCT03384459|maintenance therapy|maintenance therapy
130939|NCT03384459|recurrence|recurrence
130940|NCT03384420|Autologous stem cell transplantation|autologous stem cell transplantation
130941|NCT03384355|varicose veins|varicose veins
130942|NCT03384355|chronic venous disease|chronic venous disease
130943|NCT03384355|ecchymosis|ecchymosis
130944|NCT03384355|symptoms|symptoms
130945|NCT03384316|Combination Vaccine|combination vaccine
130946|NCT03384316|Adenoviral|adenoviral
130947|NCT03384316|ETBX-011|etbx-011
130948|NCT03384316|ETBX-061|etbx-061
130949|NCT03384316|ETBX-051|etbx-051
130950|NCT03384303|Incretines|incretines
130951|NCT03384303|Bile acids|bile acids
130952|NCT03384303|Gut hormones|gut hormones
130953|NCT03384303|Limb lengths|limb lengths
130954|NCT03384303|Biliopancreatic limb|biliopancreatic limb
130955|NCT03384303|Bariatric surgery|bariatric surgery
130956|NCT03384303|Gastric bypass|gastric bypass
130957|NCT03384290|Asthma|asthma
130958|NCT03384290|Anticalin|anticalin
130959|NCT03384290|PRS-060|prs-060
130960|NCT03384290|Healthy Volunteers|healthy volunteers
130961|NCT03384290|Pieris|pieris
130962|NCT03384290|IL-4 receptor alpha|il-4 receptor alpha
130963|NCT03384290|IL-13|il-13
130964|NCT03384290|IL-4|il-4
130965|NCT03384277|Acquired hemophilia A|acquired hemophilia a
400589|NCT01866124|safety nets|safety nets
130966|NCT03384277|Cyclophosphamide|cyclophosphamide
130967|NCT03384277|Rituximab|rituximab
130968|NCT03384277|Steroid|steroid
130969|NCT03384251|Adolescent pregnancy|adolescent pregnancy
130970|NCT03384251|Teenage pregnancy|teenage pregnancy
130971|NCT03384251|Prevention|prevention
130972|NCT03384251|Ghana|ghana
130973|NCT03384225|cladribine|cladribine
130974|NCT03384225|fludarabine|fludarabine
130975|NCT03384225|relapse|relapse
130976|NCT03384212|cladribine|cladribine
130977|NCT03384212|fludarabine|fludarabine
130978|NCT03384212|relapse|relapse
130979|NCT03384199|Localized Prostate|localized prostate
130980|NCT03384199|VMAT|vmat
130981|NCT03384199|Dose escalation|dose escalation
130982|NCT03384199|Fiducial marker|fiducial marker
130983|NCT03384199|Focal Lesion|focal lesion
130984|NCT03384199|Random error during dose escalation radiotherapy|random error during dose escalation radiotherapy
130985|NCT03384199|fiducial marker image guided technique|fiducial marker image guided technique
130986|NCT03384173|Near Infrared Spectroscopy|near infrared spectroscopy
130987|NCT03384173|Creatinine|creatinine
130988|NCT03384173|Urine Output|urine output
130989|NCT03384160|Pain|pain
130990|NCT03384160|Third molar|third molar
130991|NCT03384160|Articaine|articaine
130992|NCT03384160|Mepivacaine|mepivacaine
130993|NCT03384134|cancer|cancer
130994|NCT03384134|cognitive and behavioral skills training intervention|cognitive and behavioral skills training intervention
130995|NCT03384134|pain|pain
130996|NCT03384134|symptoms|symptoms
130997|NCT03384134|quality of life|quality of life
130998|NCT03384121|CYP24A1|cyp24a1
130999|NCT03384121|Nephrocalcinosis|nephrocalcinosis
131000|NCT03384121|Hypercalcemia|hypercalcemia
131001|NCT03384121|Hypercalcuria|hypercalcuria
131002|NCT03384095|Aromatase Inhibitors|aromatase inhibitors
131003|NCT03384069|Cognitive Impairment|cognitive impairment
131004|NCT03384069|Cognitive- behavioral therapy|cognitive- behavioral therapy
131005|NCT03384069|African Americans|african americans
131006|NCT03384030|Malodor|malodor
131007|NCT03384030|Stress|stress
131008|NCT03384030|STMST|stmst
131009|NCT03384004|Root Canal Treatment|root canal treatment
131010|NCT03383991|Humeral Fracture, Proximal|humeral fracture, proximal
131011|NCT03383991|Arthroplasty, Replacement, Shoulder|arthroplasty, replacement, shoulder
131012|NCT03383991|Reverse Total Shoulder Arthroplasty|reverse total shoulder arthroplasty
131013|NCT03383991|Shoulder Hemiarthroplasty|shoulder hemiarthroplasty
131014|NCT03383939|bronchiectasis|bronchiectasis
131015|NCT03383939|alpha1-antitrypsin|alpha1-antitrypsin
131016|NCT03383939|neutrophilic elastase|neutrophilic elastase
131017|NCT03383926|Longo|longo
131018|NCT03383926|Hemorrhoids|hemorrhoids
131019|NCT03383926|Rectal|rectal
131020|NCT03383926|Prolapse|prolapse
131021|NCT03383926|Anal|anal
131022|NCT03383913|Heart Rate Variability Biofeedback|heart rate variability biofeedback
131023|NCT03383913|Sickle Cell Disease|sickle cell disease
131024|NCT03383835|Omega 3 supplement|omega 3 supplement
131025|NCT03383835|pre-menopausal|pre-menopausal
131026|NCT03383835|pregnancy|pregnancy
131027|NCT03383809|Self-reported healthy adults|self-reported healthy adults
131028|NCT03383796|Cholangiocarcinoma perihilar|cholangiocarcinoma perihilar
131029|NCT03383796|three dimension laparoscopic|three dimension laparoscopic
131030|NCT03383783|Caries|caries
131031|NCT03383731|Operation mode|operation mode
131032|NCT03383731|Air tamponade|air tamponade
131033|NCT03383731|High myopia|high myopia
131034|NCT03383731|Macular hole retinal detachment|macular hole retinal detachment
131035|NCT03383718|Coronary Artery Disease|coronary artery disease
131036|NCT03383718|Fractional Flow Reserve|fractional flow reserve
131037|NCT03383718|Dobutamine Stress Echocardiography|dobutamine stress echocardiography
131038|NCT03383718|Stable Coronary Artery Disease|stable coronary artery disease
131039|NCT03383718|Bystander Coronary Artery Disease|bystander coronary artery disease
131040|NCT03383718|Non-Culprit Lesions|non-culprit lesions
131041|NCT03383718|Acute Myocardial Infarction|acute myocardial infarction
131042|NCT03383705|Photoaged Skin|photoaged skin
131043|NCT03383692|Unresectable or metastatic solid malignant tumors|unresectable or metastatic solid malignant tumors
131044|NCT03383692|Solid malignant tumors|solid malignant tumors
131045|NCT03383692|Oncology|oncology
131046|NCT03383692|HER2|her2
131047|NCT03383692|Antibody drug conjugate|antibody drug conjugate
131048|NCT03383692|ADC|adc
131049|NCT03383666|Unruptured|unruptured
131050|NCT03383666|intracranial aneurysms|intracranial aneurysms
131051|NCT03383666|Endovascular|endovascular
131052|NCT03383653|Td Vaccine|td vaccine
131053|NCT03383653|Safety|safety
131054|NCT03383653|Pregnant|pregnant
131055|NCT03383653|Pregnant Women|pregnant women
131056|NCT03383627|Chronic Kidney Disease|chronic kidney disease
131057|NCT03383601|COPD|copd
131058|NCT03383601|Exacerbation of respiratory symptoms|exacerbation of respiratory symptoms
131059|NCT03383601|Functional exercise capacity|functional exercise capacity
131060|NCT03383601|Heated Tobacco Products|heated tobacco products
131061|NCT03383601|Respiratory symptoms|respiratory symptoms
131062|NCT03383549|Telerehabilitation [E02.831.891]|telerehabilitation [e02.831.891]
131063|NCT03383549|Cognitive Aging [G07.345.124.260]|cognitive aging [g07.345.124.260]
131064|NCT03383549|Exercise Therapy [E02.760.169.063.500.387]|exercise therapy [e02.760.169.063.500.387]
131065|NCT03383536|fMRI|fmri
131066|NCT03383536|stress|stress
131067|NCT03383536|peptide|peptide
131068|NCT03383536|social|social
131069|NCT03383536|neuroimaging|neuroimaging
131070|NCT03383484|polycystic ovary syndrome|polycystic ovary syndrome
131071|NCT03383484|hyperandrogenism|hyperandrogenism
131072|NCT03383484|nonpharmacological|nonpharmacological
131073|NCT03383484|yoga|yoga
131074|NCT03383484|osteopathic manipulative medicine|osteopathic manipulative medicine
131075|NCT03383471|chondrocyte cells|chondrocyte cells
131076|NCT03383471|osteoarthritis|osteoarthritis
131077|NCT03383471|gene therapy|gene therapy
131078|NCT03383419|Heart Failure, Heart Transplant|heart failure, heart transplant
131079|NCT03383380|Activated PI3K-delta Syndrome|activated pi3k-delta syndrome
131080|NCT03383380|Immunodeficiency Primary|immunodeficiency primary
131081|NCT03383380|Akt/mTOR pathway|akt/mtor pathway
131082|NCT03383380|Rapamycin Therapy|rapamycin therapy
131083|NCT03383380|Hyperphosphorylation|hyperphosphorylation
131084|NCT03383367|mass screening|mass screening
131085|NCT03383367|colonoscopy surveillance|colonoscopy surveillance
131086|NCT03383367|high risk patients|high risk patients
131087|NCT03383341|gut microbiota|gut microbiota
131088|NCT03383341|cricket powder|cricket powder
131089|NCT03383341|prebiotic fiber|prebiotic fiber
131090|NCT03383341|inflammation|inflammation
131091|NCT03383341|dietary intervention|dietary intervention
131092|NCT03383328|Cataract|cataract
131093|NCT03383328|Cataract Surgery|cataract surgery
131094|NCT03383302|Non-small cell lung cancer|non-small cell lung cancer
131095|NCT03383302|NSCLC|nsclc
131096|NCT03383263|Humira®|humira®
131097|NCT03383263|polyarticular juvenile arthritis|polyarticular juvenile arthritis
131098|NCT03383263|Adalimumab|adalimumab
131099|NCT03383250|meal ingestion|meal ingestion
131100|NCT03383250|postprandial sensations|postprandial sensations
131101|NCT03383250|circulating metabolites|circulating metabolites
131102|NCT03383224|smoking cessation treatment|smoking cessation treatment
131103|NCT03383211|RNAseq|rnaseq
131104|NCT03383211|Next Generation Sequencing|next generation sequencing
131105|NCT03383211|Transcriptome|transcriptome
131106|NCT03383211|Peripheral blood transcripts|peripheral blood transcripts
131107|NCT03383211|Tempus Blood RNA Tubes|tempus blood rna tubes
131108|NCT03383185|contraception|contraception
131109|NCT03383185|Body mass index|body mass index
131110|NCT03383185|Metabolic Syndrome|metabolic syndrome
131111|NCT03383185|obesity|obesity
131112|NCT03383172|Prevention|prevention
131113|NCT03383172|Promotion|promotion
131114|NCT03383172|Mental Health|mental health
131115|NCT03383159|Microbiota|microbiota
131116|NCT03383159|Metachronous Adenoma|metachronous adenoma
131117|NCT03383159|Colorectal Cancer|colorectal cancer
131118|NCT03383159|Colonoscopy|colonoscopy
131119|NCT03383146|diabetic gastroparesis|diabetic gastroparesis
131120|NCT03383146|vomiting|vomiting
131121|NCT03383133|sulfotransferase|sulfotransferase
131122|NCT03383133|metabolism|metabolism
131123|NCT03383133|acetaminophen|acetaminophen
131124|NCT03383133|dehydroepiandrosterone|dehydroepiandrosterone
131125|NCT03383133|mefenamic acid|mefenamic acid
131126|NCT03383133|allostery|allostery
131127|NCT03383120|Peri-implantitis|peri-implantitis
131128|NCT03383120|Diode laser|diode laser
131129|NCT03383120|Surgical debridement|surgical debridement
131130|NCT03383094|cancer|cancer
131131|NCT03383094|Head and Neck|head and neck
131132|NCT03383094|Pembrolizumab|pembrolizumab
131133|NCT03383094|Cisplatin|cisplatin
131134|NCT03383094|Radiotherapy|radiotherapy
131135|NCT03383094|Head and Neck Squamous Cell Carcinoma|head and neck squamous cell carcinoma
131136|NCT03383094|p16+|p16+
131137|NCT03383094|immunotherapy|immunotherapy
131138|NCT03383094|pd-1|pd-1
131139|NCT03383094|chemotherapy|chemotherapy
131140|NCT03383094|T1|t1
131141|NCT03383094|T2|t2
131142|NCT03383094|T3|t3
131143|NCT03383094|N2|n2
131144|NCT03383094|M0|m0
131145|NCT03383094|T4|t4
131146|NCT03383094|N3|n3
131147|NCT03383094|N1|n1
131148|NCT03383081|osteoarthritis, mesenchymal stem cell|osteoarthritis, mesenchymal stem cell
131149|NCT03383068|PCOS|pcos
131150|NCT03383068|imparied glucose tolerance|imparied glucose tolerance
131151|NCT03383029|Nutrition|nutrition
131152|NCT03383029|Behavioral|behavioral
131153|NCT03383016|Prostate cancer risk|prostate cancer risk
131154|NCT03383016|Environmental risk factors|environmental risk factors
131155|NCT03383016|Biomarkers|biomarkers
131156|NCT03383016|Inflammation and prostate cancer|inflammation and prostate cancer
131157|NCT03383003|Helicobacter pylori eradication|helicobacter pylori eradication
131158|NCT03383003|High dose proton pump inhibitor|high dose proton pump inhibitor
131159|NCT03383003|High dose Amoxicillin|high dose amoxicillin
131160|NCT03383003|Concomitant therapy|concomitant therapy
131161|NCT03382990|Atrial fibrillation|atrial fibrillation
131162|NCT03382990|Acute myocardial infarction|acute myocardial infarction
131163|NCT03382990|Drug-eluting stent|drug-eluting stent
131164|NCT03382977|GBM|gbm
131165|NCT03382977|Glioblastoma|glioblastoma
131166|NCT03382977|eVLP|evlp
131167|NCT03382977|VBI-1901|vbi-1901
131168|NCT03382977|vaccine|vaccine
131169|NCT03382977|immunotherapy|immunotherapy
131170|NCT03382977|CMV|cmv
131171|NCT03382977|CNS|cns
131172|NCT03382977|Brain|brain
131173|NCT03382977|Cancer|cancer
131174|NCT03382964|VLA1553|vla1553
131175|NCT03382964|Chikungunya|chikungunya
131176|NCT03382964|CHIKV|chikv
131177|NCT03382964|Live-attenuated Chikungunya virus vaccine|live-attenuated chikungunya virus vaccine
131178|NCT03382938|dexmedetomidine|dexmedetomidine
131179|NCT03382938|ropivacaine|ropivacaine
131180|NCT03382938|wound infiltration|wound infiltration
131181|NCT03382938|ceasarean section|ceasarean section
131182|NCT03382925|cervical epidural steroid injection|cervical epidural steroid injection
131183|NCT03382925|local anesthetic|local anesthetic
131184|NCT03382925|upper extremity weakness|upper extremity weakness
131185|NCT03382886|Advanced and/or metastatic|advanced and/or metastatic
131186|NCT03382873|Hyperglycemia|hyperglycemia
131187|NCT03382873|Obese|obese
131188|NCT03382873|Overweight|overweight
131189|NCT03382860|Intracranial Hypertension|intracranial hypertension
131190|NCT03382860|Intracranial pressure monitoring|intracranial pressure monitoring
131191|NCT03382860|Non-invasive point-of-care device|non-invasive point-of-care device
131192|NCT03382860|Normal pressure hydrocephalus|normal pressure hydrocephalus
131193|NCT03382821|cervical epidural steroid injection|cervical epidural steroid injection
131194|NCT03382821|transforaminal approach|transforaminal approach
131195|NCT03382821|epidural catheter targeted|epidural catheter targeted
131196|NCT03382821|interlaminar approach|interlaminar approach
131197|NCT03382821|cervical radicular pain|cervical radicular pain
131198|NCT03382795|Epidermal growth factor receptor tyrosine kinase inhibitor|epidermal growth factor receptor tyrosine kinase inhibitor
131199|NCT03382795|Cytotoxic chemotherapy|cytotoxic chemotherapy
131200|NCT03382795|Epidermal growth factor receptor mutation|epidermal growth factor receptor mutation
131201|NCT03382782|Obesity|obesity
131202|NCT03382782|Mental Disorder|mental disorder
131203|NCT03382782|Peer Navigator|peer navigator
131204|NCT03382782|Physical Health|physical health
131205|NCT03382782|Overweight|overweight
131206|NCT03382782|Serious Mental Illness|serious mental illness
131207|NCT03382743|office hysteroscopy|office hysteroscopy
131208|NCT03382743|Lidocaine spray|lidocaine spray
131209|NCT03382704|Peri-ocular|peri-ocular
131210|NCT03382678|Eosinophilic Gastrointestinal Disorders|eosinophilic gastrointestinal disorders
131211|NCT03382665|Revision total hip arthroplasty|revision total hip arthroplasty
131212|NCT03382665|Medical Device|medical device
131213|NCT03382665|Post Market Surveillance Study|post market surveillance study
131214|NCT03382665|Primary total hip arthroplasty|primary total hip arthroplasty
131215|NCT03382652|Total hip arthroplasty|total hip arthroplasty
131216|NCT03382652|Medical Device|medical device
131217|NCT03382652|Post Market Surveillance Study|post market surveillance study
131218|NCT03382652|Performance|performance
131219|NCT03382652|Safety|safety
131220|NCT03382639|Drug therapy|drug therapy
131221|NCT03382626|Traumatic Brain Injury|traumatic brain injury
131222|NCT03382626|Transcranial Direct Current Stimulation|transcranial direct current stimulation
131223|NCT03382626|Computer-assisted training|computer-assisted training
131224|NCT03382626|Cognitive training|cognitive training
131225|NCT03382626|Cognitive function|cognitive function
131226|NCT03382626|Executive function|executive function
131227|NCT03382626|Working memory|working memory
131228|NCT03382626|Attention|attention
131229|NCT03382548|Ventilator Associated Pneumonia|ventilator associated pneumonia
131231|NCT03382535|Voice disorder|voice disorder
131232|NCT03382535|Teacher's voice|teacher's voice
131233|NCT03382535|Voice SPL (Voice sound pressure level)|voice spl (voice sound pressure level)
131234|NCT03382535|Voice F0 (Voice fundamental frequency)|voice f0 (voice fundamental frequency)
131235|NCT03382535|Voice therapy|voice therapy
131236|NCT03382535|Voice accumulator|voice accumulator
131237|NCT03382535|Activity noise|activity noise
131238|NCT03382535|Classroom|classroom
131239|NCT03382522|bone scintigraphy|bone scintigraphy
131240|NCT03382522|quantification|quantification
131241|NCT03382522|prostate cancer|prostate cancer
131242|NCT03382522|prognosis|prognosis
131243|NCT03382457|Functional|functional
131244|NCT03382457|TR|tr
131245|NCT03382457|FTR|ftr
131246|NCT03382457|Transcatheter|transcatheter
131247|NCT03382457|Reconstruction|reconstruction
131248|NCT03382444|cognitive impairment|cognitive impairment
131249|NCT03382444|hemodialysis|hemodialysis
131250|NCT03382444|dementia|dementia
131251|NCT03382444|end stage renal disease|end stage renal disease
131252|NCT03382405|cytomegalovirus vaccine|cytomegalovirus vaccine
131253|NCT03382405|mRNA-1647|mrna-1647
131254|NCT03382405|mRNA-1443|mrna-1443
131255|NCT03382405|Moderna|moderna
131256|NCT03382392|Amyotrophic lateral sclerosis,|amyotrophic lateral sclerosis,
131257|NCT03382392|Resting energy expenditure|resting energy expenditure
131258|NCT03382392|Predictive equation|predictive equation
131259|NCT03382379|methamphetamine|methamphetamine
131260|NCT03382379|transcranial Direct Current Stimulation|transcranial direct current stimulation
131261|NCT03382379|functional Magnetic Resonance Imaging|functional magnetic resonance imaging
131262|NCT03382379|amphetamine|amphetamine
131263|NCT03382379|drug craving|drug craving
131264|NCT03382366|Sarcopenia|sarcopenia
131265|NCT03382366|Risk of fall|risk of fall
131266|NCT03382366|Osteoporosis|osteoporosis
131267|NCT03382366|Muscle|muscle
131268|NCT03382366|DXA|dxa
131269|NCT03382366|MR|mr
131270|NCT03382366|Muscle metabolism|muscle metabolism
131271|NCT03382353|primary prevention|primary prevention
131272|NCT03382353|Subjective Cognitive Decline|subjective cognitive decline
131273|NCT03382353|Neuroimaging|neuroimaging
131274|NCT03382353|Alzheimer's disease|alzheimer's disease
131275|NCT03382353|nonpharmacological interventions|nonpharmacological interventions
131276|NCT03382353|multidomain lifestyle interventions|multidomain lifestyle interventions
131277|NCT03382327|Surgical planning|surgical planning
131278|NCT03382327|CT-scan|ct-scan
131279|NCT03382327|MRI|mri
131280|NCT03382327|3D model|3d model
131281|NCT03382327|Hepatocarcinoma eligible for surgical resection|hepatocarcinoma eligible for surgical resection
131282|NCT03382301|Ischemia reperfusion injuries|ischemia reperfusion injuries
131283|NCT03382301|Renal artery stenosis|renal artery stenosis
131284|NCT03382301|Renal functional imaging|renal functional imaging
131285|NCT03382262|Osteoarthritis|osteoarthritis
131286|NCT03382262|Shoulder|shoulder
131287|NCT03382262|Hip|hip
131288|NCT03382262|Pain|pain
131289|NCT03382262|Intra-articular|intra-articular
131290|NCT03382262|Injection|injection
131291|NCT03382262|Corticosteroid|corticosteroid
131292|NCT03382210|Enhanced Recovery Program|enhanced recovery program
131293|NCT03382197|aerosol therapy|aerosol therapy
131294|NCT03382197|positive pressure|positive pressure
131295|NCT03382197|electrical impedance tomography|electrical impedance tomography
131296|NCT03382197|pulmonary scintigraphy|pulmonary scintigraphy
131297|NCT03382158|pleuropulmonary blastoma|pleuropulmonary blastoma
131298|NCT03382158|PPB|ppb
131299|NCT03382158|DICER1|dicer1
131300|NCT03382158|Sertoli-Leydig cell tumor|sertoli-leydig cell tumor
131301|NCT03382158|cystic nephroma|cystic nephroma
131302|NCT03382119|liver stiffness Fontan|liver stiffness fontan
131303|NCT03382093|Anxiety Sensitivity|anxiety sensitivity
131304|NCT03382093|Tobacco|tobacco
131305|NCT03382093|Smoking|smoking
131306|NCT03382093|Anxiety|anxiety
131307|NCT03382093|Feedback|feedback
131308|NCT03382093|Stress|stress
131309|NCT03382080|randomized controlled trial|randomized controlled trial
131310|NCT03382080|drop out|drop out
131311|NCT03382080|upper secondary school|upper secondary school
131312|NCT03382080|psychosocial learning environments|psychosocial learning environments
131313|NCT03382028|developmental abnormalities|developmental abnormalities
131314|NCT03382028|psychomotor development|psychomotor development
131315|NCT03381989|TAVR|tavr
131316|NCT03381989|Native Aortic Valve Failure|native aortic valve failure
131317|NCT03381989|TAVR Associated Coronary Artery Obstruction|tavr associated coronary artery obstruction
131318|NCT03381989|Electrosurgery|electrosurgery
131319|NCT03381963|tamoxifen|tamoxifen
131320|NCT03381963|aromatase inhibitors|aromatase inhibitors
131321|NCT03381963|breast cancer|breast cancer
131322|NCT03381963|venous thromboembolism|venous thromboembolism
131323|NCT03381950|chronic kidney disease|chronic kidney disease
131324|NCT03381950|prospective cohort study|prospective cohort study
131325|NCT03381950|risk profile|risk profile
131326|NCT03381950|patient-reported-outcomes|patient-reported-outcomes
131327|NCT03381937|mechanical ventilation|mechanical ventilation
131328|NCT03381937|noninvasive ventilation|noninvasive ventilation
132226|NCT03376308|withdrawal|withdrawal
131329|NCT03381937|neuromuscular disorder|neuromuscular disorder
131330|NCT03381937|phonation|phonation
131331|NCT03381937|mouthpiece ventilation|mouthpiece ventilation
131332|NCT03381924|Migraine disorders|migraine disorders
131333|NCT03381924|Educational models|educational models
131334|NCT03381924|Neuroscience|neuroscience
131335|NCT03381898|Telehealth|telehealth
131336|NCT03381898|Physical therapy exercise|physical therapy exercise
131337|NCT03381898|Speech therapy Lee Silverman voice treatment|speech therapy lee silverman voice treatment
131338|NCT03381898|Pharmacy medication management|pharmacy medication management
131339|NCT03381872|Intravascular Imaging|intravascular imaging
131340|NCT03381872|Intravascular Ultrasound|intravascular ultrasound
131341|NCT03381872|Optical Coherence Tomography|optical coherence tomography
131342|NCT03381872|Complex Lesion|complex lesion
131343|NCT03381872|Percutaneous Coronary Intervention|percutaneous coronary intervention
131344|NCT03381859|Hepatitis C Virus|hepatitis c virus
131345|NCT03381859|Genotype 4|genotype 4
131346|NCT03381859|End Stage Renal Disease|end stage renal disease
131347|NCT03381820|music therapy|music therapy
131348|NCT03381820|hypertension|hypertension
131349|NCT03381820|Asian|asian
131350|NCT03381820|stage-2 hypertension|stage-2 hypertension
167598|NCT03150004|AML|aml
131351|NCT03381794|Keratoplasty Registry, PKP, DSAEK, DMEK, DALK|keratoplasty registry, pkp, dsaek, dmek, dalk
131352|NCT03381781|p53 mutation|p53 mutation
131353|NCT03381781|acute myeloid leukemia|acute myeloid leukemia
131354|NCT03381781|decitabine|decitabine
131355|NCT03381781|Arsenic trioxide|arsenic trioxide
131356|NCT03381781|cytarabine|cytarabine
131357|NCT03381768|PD-L1|pd-l1
131358|NCT03381768|PD-L2|pd-l2
131359|NCT03381768|peptide vaccine|peptide vaccine
131360|NCT03381729|Gene Transfer|gene transfer
131361|NCT03381729|Gene Therapy|gene therapy
131362|NCT03381729|Adeno-associated virus|adeno-associated virus
131363|NCT03381729|Survival Motor Neuron|survival motor neuron
131364|NCT03381729|SMN|smn
131365|NCT03381729|AAV9|aav9
131366|NCT03381716|aortic dissection|aortic dissection
131367|NCT03381716|sex|sex
131368|NCT03381716|treatment|treatment
131369|NCT03381703|Accelerated Mass Spectrometry|accelerated mass spectrometry
131370|NCT03381703|Microtracer|microtracer
131371|NCT03381703|Microdose|microdose
131372|NCT03381703|hAME|hame
131373|NCT03381703|Absolute bioavailability|absolute bioavailability
131374|NCT03381677|pedicle lengthening osteotomy|pedicle lengthening osteotomy
131375|NCT03381677|spinal stenosis|spinal stenosis
131376|NCT03381677|decompression|decompression
131377|NCT03381664|bioavailability|bioavailability
131378|NCT03381664|pharmacokinetics|pharmacokinetics
131379|NCT03381664|safety|safety
131380|NCT03381664|tolerability|tolerability
131381|NCT03381664|AVP-923|avp-923
131382|NCT03381664|dextromethorphan|dextromethorphan
131383|NCT03381664|quinidine|quinidine
131384|NCT03381651|Radiation dose|radiation dose
131385|NCT03381638|Concussion|concussion
131386|NCT03381638|TBI|tbi
131387|NCT03381638|Sports|sports
131388|NCT03381638|Medical Device|medical device
131389|NCT03381638|Fast|fast
131390|NCT03381612|Female circumcision, Young Women, Dysmenorrhea,Dysuria|female circumcision, young women, dysmenorrhea,dysuria
131391|NCT03381586|ALT-803|alt-803
131392|NCT03381586|PK|pk
131393|NCT03381560|LASSYC; COPD symptoms.|lassyc; copd symptoms.
131394|NCT03381534|vertebral artery origin|vertebral artery origin
131395|NCT03381534|angioplasty|angioplasty
131396|NCT03381534|distal embolic protection|distal embolic protection
131397|NCT03381521|nerve hydrodissection|nerve hydrodissection
131398|NCT03381508|CPAP|cpap
131399|NCT03381508|masks|masks
131400|NCT03381508|unintentional leak|unintentional leak
131401|NCT03381508|leakage|leakage
131402|NCT03381495|Epidural Labor Analgesia|epidural labor analgesia
131403|NCT03381495|length of labor stage|length of labor stage
131404|NCT03381495|fetal outcomes|fetal outcomes
131405|NCT03381495|maternal outcomes|maternal outcomes
131406|NCT03381495|postpartum depression|postpartum depression
131407|NCT03381495|exercise|exercise
131408|NCT03381482|Alzheimer disease|alzheimer disease
131409|NCT03381482|Extracellular vesicles|extracellular vesicles
131410|NCT03381482|Biomarker|biomarker
131411|NCT03381482|Tau|tau
131412|NCT03381482|CSF|csf
131413|NCT03381482|Plasma|plasma
131414|NCT03381404|Mass Balance Study with MT-8554|mass balance study with mt-8554
131415|NCT03381378|Vitamin D|vitamin d
131416|NCT03381378|s-25-hydroxyvitamin D|s-25-hydroxyvitamin d
131417|NCT03381378|hand grip strength|hand grip strength
131418|NCT03381378|myopathy|myopathy
131419|NCT03381378|muscle|muscle
131420|NCT03381352|Radiotherapy|radiotherapy
131421|NCT03381352|Anal cancer|anal cancer
131422|NCT03381352|IMRT|imrt
131423|NCT03381339|power toothbrush, oscillating rotating|power toothbrush, oscillating rotating
131424|NCT03381326|circulating tumor cells|circulating tumor cells
131425|NCT03381326|Castration-resistant Prostate Cancer|castration-resistant prostate cancer
131426|NCT03381326|cabazitaxel|cabazitaxel
131427|NCT03381326|biomarker|biomarker
131428|NCT03381326|free DNA|free dna
131429|NCT03381326|stem cells|stem cells
132615|NCT03373604|18F-MK-6240|18f-mk-6240
131433|NCT03381261|trigeminal neuralgia|trigeminal neuralgia
131434|NCT03381261|migraine surgery|migraine surgery
131435|NCT03381261|nerve decompression|nerve decompression
131436|NCT03381248|randomized clinical trial|randomized clinical trial
131437|NCT03381248|osteoarthritis|osteoarthritis
131438|NCT03381248|radiofrequency ablation|radiofrequency ablation
131440|NCT03381248|genicular|genicular
131441|NCT03381248|cross-over|cross-over
131442|NCT03381248|viscosupplemention|viscosupplemention
131443|NCT03381235|Exercise|exercise
131444|NCT03381235|Quality of life|quality of life
131445|NCT03381235|Progression of disease|progression of disease
131446|NCT03381235|Retinitis|retinitis
131447|NCT03381209|Sugammadex|sugammadex
131448|NCT03381209|morbidly obese patients|morbidly obese patients
131449|NCT03381209|bariatric surgery|bariatric surgery
131450|NCT03381209|neuromuscular blockade|neuromuscular blockade
131451|NCT03381170|Relapsing Multiple Sclerosis|relapsing multiple sclerosis
131452|NCT03381157|general movements, fidgety movements, motor optimality score|general movements, fidgety movements, motor optimality score
131453|NCT03381105|Diagnostics, over-diagnosis|diagnostics, over-diagnosis
167675|NCT03149575|STAR-3|star-3
131454|NCT03381092|neoadjuvant chemotherapy|neoadjuvant chemotherapy
131455|NCT03381092|sentinel lymph node biopsy|sentinel lymph node biopsy
131456|NCT03381092|axillary lymph node dissection|axillary lymph node dissection
131457|NCT03381092|Predictive model|predictive model
131458|NCT03381066|NSCLC|nsclc
131459|NCT03381066|EGFR|egfr
131460|NCT03381066|adjuvant|adjuvant
131461|NCT03381066|gefitinib|gefitinib
131462|NCT03381066|intercalating|intercalating
131463|NCT03381053|GIST|gist
131464|NCT03381053|Grading and Staging|grading and staging
131465|NCT03381027|Infant Sleep|infant sleep
131466|NCT03381027|Baby Massage|baby massage
131467|NCT03381027|Neurodevelopmental Disorders|neurodevelopmental disorders
131468|NCT03381001|cryopreservation|cryopreservation
131469|NCT03381001|human embryos|human embryos
131470|NCT03381001|vitrification|vitrification
131471|NCT03381001|embryo culture|embryo culture
131472|NCT03381001|embryo transfer|embryo transfer
131473|NCT03381001|pregnancy rate|pregnancy rate
131474|NCT03380975|MAAP|maap
131475|NCT03380975|Asthma|asthma
131476|NCT03380975|Allergic rhinits|allergic rhinits
131477|NCT03380962|Donor-Specific Anti-HLA Antibodies|donor-specific anti-hla antibodies
131478|NCT03380962|Kidney Transplantation|kidney transplantation
131479|NCT03380962|Donor Specific Antibody|donor specific antibody
131480|NCT03380949|Analgesia|analgesia
131481|NCT03380949|Monitoring|monitoring
131482|NCT03380949|Opioid|opioid
131483|NCT03380949|Sufentanil|sufentanil
131484|NCT03380949|Sevoflurane|sevoflurane
131485|NCT03380936|subclinical|subclinical
131486|NCT03380936|graft rejection|graft rejection
131487|NCT03380936|AMR (antibody-mediated rejection)|amr (antibody-mediated rejection)
131488|NCT03380936|AMBR (acute antibody-mediated rejection)|ambr (acute antibody-mediated rejection)
131489|NCT03380936|DSA (donor specific antibodies)|dsa (donor specific antibodies)
131490|NCT03380923|epigenetics|epigenetics
131491|NCT03380923|exercise dose-response|exercise dose-response
131492|NCT03380923|inter-individual response heterogeneity|inter-individual response heterogeneity
131493|NCT03380923|exercise training adaptations|exercise training adaptations
131494|NCT03380897|induction of labor|induction of labor
131495|NCT03380897|double balloon catheter|double balloon catheter
131496|NCT03380897|mechanical ripening|mechanical ripening
131497|NCT03380884|Distal Radius Fracture, Osteoporosis, Vibration Therapy|distal radius fracture, osteoporosis, vibration therapy
131504|NCT03380806|stereotactic body radiotherapy (SBRT)|stereotactic body radiotherapy (sbrt)
131505|NCT03380806|conventional radiotherapy (CRT)|conventional radiotherapy (crt)
131506|NCT03380806|High risk prostate cancer|high risk prostate cancer
131507|NCT03380806|quality of life (QoL)|quality of life (qol)
131508|NCT03380806|The Expanded Prostate cancer Index Composite (EPIC-26)|the expanded prostate cancer index composite (epic-26)
131509|NCT03380806|International Prostate Symptom Score (IPSS)|international prostate symptom score (ipss)
131510|NCT03380767|trauma-induced coagulopathy|trauma-induced coagulopathy
131511|NCT03380754|Nausea|nausea
131512|NCT03380754|Vomiting|vomiting
131513|NCT03380754|Knee Arthroplasty|knee arthroplasty
131514|NCT03380754|PONV|ponv
131515|NCT03380754|TKA|tka
131516|NCT03380715|Sinusitis|sinusitis
131517|NCT03380715|Endoscopy|endoscopy
131518|NCT03380715|Rhinitis|rhinitis
131519|NCT03380702|colour|colour
131520|NCT03380702|dental aesthetics|dental aesthetics
131521|NCT03380702|perceptions|perceptions
131522|NCT03380702|quality of life|quality of life
131523|NCT03380702|tooth whitening|tooth whitening
131524|NCT03380663|blood flow restricted resistance exercise|blood flow restricted resistance exercise
131525|NCT03380663|remote ischemic conditioning|remote ischemic conditioning
131526|NCT03380663|miRNA|mirna
131527|NCT03380650|femoropopliteal occlusive disease|femoropopliteal occlusive disease
131528|NCT03380650|directional atherectomy|directional atherectomy
131529|NCT03380650|local drug delivery|local drug delivery
131530|NCT03380650|endovascular treatment|endovascular treatment
131531|NCT03380598|Mobile Health, Self-Monitoring, Behavioural Treatment|mobile health, self-monitoring, behavioural treatment
131532|NCT03380572|Robotic Surgery|robotic surgery
131533|NCT03380559|Epicondylitis|epicondylitis
131534|NCT03380559|Botulinum toxin|botulinum toxin
131535|NCT03380559|Corticoid|corticoid
131536|NCT03380546|Diabetes|diabetes
131537|NCT03380546|Pregnancy|pregnancy
131538|NCT03380546|Gestational|gestational
131539|NCT03380546|Acarbose|acarbose
131540|NCT03380507|Septic Shock|septic shock
131541|NCT03380507|Vitamin C|vitamin c
131542|NCT03380507|Thiamine|thiamine
131543|NCT03380507|Hydrocortisone|hydrocortisone
131544|NCT03380507|Critically Ill|critically ill
131545|NCT03380494|Overhead perturbation training; instability, glenohumeral joint|overhead perturbation training; instability, glenohumeral joint
131546|NCT03380468|Lung adenocarcinoma|lung adenocarcinoma
131547|NCT03380468|adjuvant chemotherapy|adjuvant chemotherapy
131548|NCT03380442|fMRI|fmri
131549|NCT03380442|psilocybin|psilocybin
131550|NCT03380442|ketamine|ketamine
131551|NCT03380442|biomarker|biomarker
131552|NCT03380442|rapid-acting antidepressants|rapid-acting antidepressants
131553|NCT03380429|Connected Inhaler System|connected inhaler system
131554|NCT03380429|Metered Dose Inhaler|metered dose inhaler
131555|NCT03380429|ELLIPTA|ellipta
131556|NCT03380429|RELVAR/BREO|relvar/breo
131557|NCT03380429|Dry Powder Inhaler|dry powder inhaler
131558|NCT03380429|Salbutamol|salbutamol
131559|NCT03380429|Asthma|asthma
131560|NCT03380403|diabetic foot|diabetic foot
131561|NCT03380403|Osteomyelitis|osteomyelitis
131562|NCT03380403|PACT|pact
131564|NCT03380403|Singlet oxygen|singlet oxygen
131565|NCT03380403|antimicrobial|antimicrobial
131566|NCT03380403|diabetes|diabetes
131567|NCT03380403|Wagner scale|wagner scale
131568|NCT03380377|kidney transplant|kidney transplant
131569|NCT03380377|Chronic antibody mediated rejection|chronic antibody mediated rejection
131570|NCT03380377|donor specific antibody|donor specific antibody
131571|NCT03380338|Gut microbiota|gut microbiota
131572|NCT03380325|Capillary recruitment|capillary recruitment
131573|NCT03380286|Firehawk|firehawk
131574|NCT03380286|Coronary Artery Disease|coronary artery disease
131575|NCT03380286|Drug Eluting Stent|drug eluting stent
131576|NCT03380247|Emergency, trauma pain, analgesia, Methoxyfurane|emergency, trauma pain, analgesia, methoxyfurane
131577|NCT03380234|Smoking|smoking
131578|NCT03380234|Secondhand smoke|secondhand smoke
131579|NCT03380234|Thirdhand smoke|thirdhand smoke
131580|NCT03380234|Children|children
131581|NCT03380234|Cluster randomised controlled trial|cluster randomised controlled trial
131582|NCT03380182|acupuncture|acupuncture
131583|NCT03380182|acupressure|acupressure
131584|NCT03380143|Children|children
131585|NCT03380143|Cancer Prevention|cancer prevention
131586|NCT03380143|Population Health|population health
131587|NCT03380143|Rural|rural
131588|NCT03380143|Community|community
131589|NCT03380143|School|school
131590|NCT03380143|After School|after school
131591|NCT03380143|Youth Sport|youth sport
131592|NCT03380143|Intervention|intervention
131593|NCT03380143|Multilevel|multilevel
131594|NCT03380143|Systems|systems
131595|NCT03380130|Hepatocellular Carcinoma|hepatocellular carcinoma
131596|NCT03380130|Liver cancer|liver cancer
131597|NCT03380130|Hepatoma|hepatoma
131598|NCT03380117|Suicidal Ideation|suicidal ideation
131599|NCT03380117|Suicide Attempt|suicide attempt
131600|NCT03380117|Risk Screening|risk screening
131601|NCT03380117|Online Intervention|online intervention
131602|NCT03380117|Online Counseling|online counseling
131603|NCT03380117|College Students|college students
131604|NCT03380117|Motivational Interviewing|motivational interviewing
131605|NCT03380117|Linkage to Care|linkage to care
131606|NCT03380104|Percutaneous Electrical Nerve Stimulation|percutaneous electrical nerve stimulation
131607|NCT03380091|PCOS|pcos
131608|NCT03380091|Depression|depression
131609|NCT03380091|Vitamin D|vitamin d
131610|NCT03380091|Insulin Resistance|insulin resistance
131611|NCT03380091|Anxiety|anxiety
131612|NCT03380091|Quality of life|quality of life
131613|NCT03380091|Mood disorders|mood disorders
131614|NCT03380078|Implementation Mechanism|implementation mechanism
131615|NCT03380078|Autism Spectrum Disorder|autism spectrum disorder
131616|NCT03380078|Children's Mental Health Services|children's mental health services
131617|NCT03380078|School Services|school services
131618|NCT03380065|coronary angiogram|coronary angiogram
131619|NCT03380065|radial artery|radial artery
131620|NCT03380052|OLGA|olga
131621|NCT03380052|OLGIM|olgim
131622|NCT03380052|Helicobacter pylori|helicobacter pylori
131623|NCT03380052|Gastric cancer|gastric cancer
131626|NCT03380026|topical mechlorethamine|topical mechlorethamine
131627|NCT03380026|Valchlor|valchlor
131628|NCT03380026|contact dermatitis|contact dermatitis
131629|NCT03380026|triamcinolone|triamcinolone
131631|NCT03380026|Cutaneous T-cell Lymphoma|cutaneous t-cell lymphoma
131632|NCT03380013|hypothermia treatment|hypothermia treatment
131633|NCT03380013|OMT in infants|omt in infants
131634|NCT03380000|Dietary nitrate supplementation|dietary nitrate supplementation
131635|NCT03380000|Beetroot juice|beetroot juice
131636|NCT03379961|social categorization|social categorization
131637|NCT03379961|nurse sorting|nurse sorting
131638|NCT03379961|emergencies units|emergencies units
131639|NCT03379909|metformin|metformin
131640|NCT03379909|marker lesion|marker lesion
131641|NCT03379870|cochlear implant|cochlear implant
131642|NCT03379870|electric acoustic stimulation|electric acoustic stimulation
131643|NCT03379870|EAS|eas
131644|NCT03379870|hearing loss|hearing loss
131645|NCT03379870|pediatric|pediatric
131646|NCT03379831|systemic right ventricle|systemic right ventricle
131647|NCT03379831|quality of life|quality of life
131648|NCT03379831|VO2|vo2
131649|NCT03379831|oxygen uptake|oxygen uptake
131650|NCT03379831|exercise test|exercise test
131651|NCT03379831|congenital heart disease|congenital heart disease
131652|NCT03379818|Shape bias|shape bias
131653|NCT03379818|Late Talkers|late talkers
131654|NCT03379792|Obesity|obesity
131655|NCT03379779|Microbiota|microbiota
131656|NCT03379779|Respiratory Failure|respiratory failure
167916|NCT03147703|Obesity|obesity
131657|NCT03379779|Pneumonia|pneumonia
131658|NCT03379779|Lower Respiratory Tract Infection|lower respiratory tract infection
131659|NCT03379740|Nicotine-containing product|nicotine-containing product
131660|NCT03379740|Alternative to cigarettes|alternative to cigarettes
131661|NCT03379727|Midostaurin|midostaurin
131662|NCT03379727|PKC412|pkc412
131663|NCT03379727|FMS-like tyrosine kinase receptor|fms-like tyrosine kinase receptor
131664|NCT03379727|FLT3|flt3
131665|NCT03379727|Acute Myeloid Leukemia|acute myeloid leukemia
131666|NCT03379727|AML|aml
131667|NCT03379727|7+3 chemotherapy|7+3 chemotherapy
131668|NCT03379727|5+2 chemotherapy|5+2 chemotherapy
131669|NCT03379727|Daunorubicin|daunorubicin
131670|NCT03379727|Idarubicin|idarubicin
131671|NCT03379727|Cytarabine|cytarabine
131672|NCT03379701|chronic rhinosinusitis, nasal polyposis|chronic rhinosinusitis, nasal polyposis
131673|NCT03379662|Autism|autism
131674|NCT03379662|Autistic Disorder|autistic disorder
131675|NCT03379662|Autistic Spectrum Disorder|autistic spectrum disorder
131676|NCT03379662|Irritability|irritability
131677|NCT03379662|laser|laser
131678|NCT03379662|light therapy|light therapy
131679|NCT03379649|Recurrent implantation failure|recurrent implantation failure
131680|NCT03379636|Athletic tape|athletic tape
131681|NCT03379636|Electromyography|electromyography
131682|NCT03379636|Rehabilitation|rehabilitation
131683|NCT03379636|Shoulder|shoulder
131684|NCT03379597|Schizophrenia|schizophrenia
131685|NCT03379597|probiotics|probiotics
131686|NCT03379597|cognitive impairment|cognitive impairment
131687|NCT03379597|Metabolic syndrome|metabolic syndrome
131688|NCT03379597|clinical trail|clinical trail
131689|NCT03379597|Efficacy|efficacy
131690|NCT03379597|Safety|safety
131691|NCT03379584|Multiple myeloma|multiple myeloma
131692|NCT03379584|Antibody-drug conjugate|antibody-drug conjugate
131693|NCT03379571|Chronic kidney disease|chronic kidney disease
131694|NCT03379571|Competing-risk analysis|competing-risk analysis
131695|NCT03379571|Epidemiological study|epidemiological study
131696|NCT03379571|Incidence|incidence
131697|NCT03379571|Outcomes|outcomes
131698|NCT03379571|Risk factors|risk factors
131699|NCT03379493|relapsed/refractory CD19+ Lymphomas Non-Hodgkin's B-Cell|relapsed/refractory cd19+ lymphomas non-hodgkin's b-cell
131700|NCT03379480|Schizophrenia|schizophrenia
131701|NCT03379480|Yoga|yoga
131702|NCT03379480|fMRI|fmri
131703|NCT03379467|SMS Reminder|sms reminder
131704|NCT03379467|Two-way Reminder|two-way reminder
131705|NCT03379428|Breast Cancer|breast cancer
131706|NCT03379428|Metastatic Breast Cancer|metastatic breast cancer
131707|NCT03379428|HER2-amplified Metastatic Breast Cancer|her2-amplified metastatic breast cancer
131708|NCT03379428|HER2-positive Metastatic Breast Cancer|her2-positive metastatic breast cancer
131709|NCT03379415|Meniscectomy|meniscectomy
131710|NCT03379415|Footwear|footwear
131711|NCT03379415|Osteoarthritis|osteoarthritis
131712|NCT03379402|causes of community-acquired sepsis|causes of community-acquired sepsis
131713|NCT03379402|diagnostic tests|diagnostic tests
131714|NCT03379363|cushing syndrome, hypercortisolism|cushing syndrome, hypercortisolism
131715|NCT03379350|lung cancer|lung cancer
131716|NCT03379350|surgery|surgery
131717|NCT03379350|chest tube clamping|chest tube clamping
131718|NCT03379350|duration of chest tube drainage|duration of chest tube drainage
131719|NCT03379350|postoperative stay|postoperative stay
131720|NCT03379337|Imaging|imaging
131721|NCT03379324|Rotator Cuff|rotator cuff
131722|NCT03379324|Human Amniotic Fluid|human amniotic fluid
131723|NCT03379324|Amniotic Fluid Allograft|amniotic fluid allograft
131724|NCT03379324|FlōGraft®|flōgraft®
131725|NCT03379324|Amniotic Fluid Biologic|amniotic fluid biologic
131726|NCT03379324|Fatty Atrophy|fatty atrophy
131727|NCT03379324|Fat Degeneration|fat degeneration
131729|NCT03379311|PAC|pac
131730|NCT03379311|VKC|vkc
131731|NCT03379285|Gastro Intestinal Bleeding;|gastro intestinal bleeding;
131732|NCT03379285|Transfusion,|transfusion,
131733|NCT03379285|Outcomes|outcomes
131734|NCT03379272|Electroencephalography|electroencephalography
131735|NCT03379272|Epilepsy|epilepsy
131736|NCT03379272|EEG|eeg
131737|NCT03379233|Chronic Obstructive Pulmonary Disease|chronic obstructive pulmonary disease
131738|NCT03379233|Adherence|adherence
131739|NCT03379233|Dose Tracking|dose tracking
131740|NCT03379233|Concept2|concept2
131741|NCT03379233|Digital Adherence System|digital adherence system
131742|NCT03379233|Ultibro Breezhaler|ultibro breezhaler
131743|NCT03379207|Community-acquired Pneumonia|community-acquired pneumonia
131744|NCT03379207|Acute Respiratory Distress Syndrome|acute respiratory distress syndrome
131745|NCT03379207|Innate Immunity|innate immunity
131746|NCT03379207|Non Conventional T Lymphocytes|non conventional t lymphocytes
131747|NCT03379194|antibiotic prescriptions|antibiotic prescriptions
131748|NCT03379194|resistance|resistance
131749|NCT03379194|feedback|feedback
131750|NCT03379194|primary care|primary care
131751|NCT03379181|Brown adipose tissue (BAT)|brown adipose tissue (bat)
131752|NCT03379181|Hyperthyroidism|hyperthyroidism
131753|NCT03379168|knee osteoarthritis|knee osteoarthritis
131754|NCT03379168|mesenchymal stem cell|mesenchymal stem cell
131755|NCT03379168|adipose tissue|adipose tissue
131756|NCT03379168|injection|injection
131757|NCT03379168|nonoperative treatment|nonoperative treatment
131758|NCT03379142|Faith-Based; Community-engaged; Text messaging; Tobacco|faith-based; community-engaged; text messaging; tobacco
131759|NCT03379103|Blood Loss, Surgical|blood loss, surgical
131760|NCT03379103|Blood Transfusion|blood transfusion
131761|NCT03379103|Arthroplasty, Replacement, Knee|arthroplasty, replacement, knee
131762|NCT03379077|Mothers|mothers
131763|NCT03379077|young children|young children
131764|NCT03379077|Implementation|implementation
131765|NCT03379077|Learning through play Plus|learning through play plus
131766|NCT03379077|Cognitive Behavior Therapy|cognitive behavior therapy
131767|NCT03379064|Irritable Bowel Syndrome, Low Income Country|irritable bowel syndrome, low income country
131768|NCT03379038|Cerebral Palsy|cerebral palsy
131769|NCT03379038|Spasticity|spasticity
131770|NCT03379038|Constipation|constipation
131771|NCT03379038|Gross Motor Functional Classification Scale|gross motor functional classification scale
131772|NCT03379038|Defecation Frequency|defecation frequency
131773|NCT03379038|Constipation Severity|constipation severity
131774|NCT03379025|electronic cigarettes; e-cigarettes|electronic cigarettes; e-cigarettes
131775|NCT03378973|motor evoked potentials|motor evoked potentials
131776|NCT03378947|EBV, DLBCL|ebv, dlbcl
131777|NCT03378934|Coronary Artery Disease|coronary artery disease
131778|NCT03378934|Percutaneous Coronary Intervention|percutaneous coronary intervention
131779|NCT03378934|Antiplatelet|antiplatelet
131780|NCT03378934|Berberine|berberine
131781|NCT03378921|FMT|fmt
131782|NCT03378908|medical therapy nutrition|medical therapy nutrition
131783|NCT03378908|meal|meal
131784|NCT03378908|carbohydrates|carbohydrates
131785|NCT03378908|intervention|intervention
131786|NCT03378908|food intake|food intake
131787|NCT03378882|Angiostrongylosis|angiostrongylosis
131788|NCT03378882|Hypereosinophilia|hypereosinophilia
131789|NCT03378882|Eosinophilic meningitis|eosinophilic meningitis
131790|NCT03378882|Meningoencephalitis|meningoencephalitis
131791|NCT03378882|Achatina fulica|achatina fulica
131792|NCT03378882|Angiostrongylus cantonensis|angiostrongylus cantonensis
131793|NCT03378882|Angiostrongylus costaricensis|angiostrongylus costaricensis
131794|NCT03378843|Polyamine, cardiovascular disease, cancer|polyamine, cardiovascular disease, cancer
131795|NCT03378830|Pain|pain
131796|NCT03378830|Sleep Disordered Breathing|sleep disordered breathing
131797|NCT03378817|Extended criteria donor|extended criteria donor
131798|NCT03378817|Donation after brain death|donation after brain death
131799|NCT03378817|HOPE|hope
131800|NCT03378817|Kidney transplantation|kidney transplantation
131801|NCT03378804|PCEA|pcea
131802|NCT03378804|PIEB|pieb
131803|NCT03378804|epidural analgesia|epidural analgesia
131804|NCT03378752|Computer tomography|computer tomography
131805|NCT03378752|Liver tumor thermoablation|liver tumor thermoablation
131806|NCT03378739|cardiogenic|cardiogenic
131807|NCT03378739|shock|shock
131808|NCT03378713|Poor Ovarian Response|poor ovarian response
131809|NCT03378700|CKD|ckd
131810|NCT03378700|Hope Intervention|hope intervention
131811|NCT03378700|decision making|decision making
131812|NCT03378687|Status Epilepticus|status epilepticus
131813|NCT03378687|Children|children
131814|NCT03378687|Multi-center|multi-center
131815|NCT03378687|etiology|etiology
131816|NCT03378687|treatment|treatment
131817|NCT03378687|outcome|outcome
131818|NCT03378687|risk factor|risk factor
131819|NCT03378661|Chronic, Indeterminate|chronic, indeterminate
131820|NCT03378635|Glucagon|glucagon
131821|NCT03378596|Post-Exercise Hypotension|post-exercise hypotension
131825|NCT03378570|Transcranial Magnetic Stimulation|transcranial magnetic stimulation
131826|NCT03378570|rTMS|rtms
131827|NCT03378570|TMS|tms
131828|NCT03378570|F3|f3
131829|NCT03378570|5.5cm rule|5.5cm rule
131830|NCT03378570|Targeting|targeting
131831|NCT03378518|In-hospital Cardiac Arrest, mortality|in-hospital cardiac arrest, mortality
131832|NCT03378479|Influenza|influenza
131833|NCT03378453|Narcolepsy|narcolepsy
131834|NCT03378453|Alzheimer|alzheimer
131835|NCT03378453|Orexin|orexin
131836|NCT03378453|Amyloid|amyloid
131837|NCT03378453|PET-amyloid imaging|pet-amyloid imaging
131838|NCT03378427|Tedizolid|tedizolid
131839|NCT03378427|Adverse effects|adverse effects
131840|NCT03378427|Efficacy|efficacy
131841|NCT03378427|prosthetic joint infection|prosthetic joint infection
131842|NCT03378414|Spinocerebellar Ataxia,Mesenchymal Stem Cells|spinocerebellar ataxia,mesenchymal stem cells
131843|NCT03378388|Drug therapy|drug therapy
131844|NCT03378323|upper extremity surgery|upper extremity surgery
131845|NCT03378297|Ovarian cancer|ovarian cancer
131846|NCT03378297|Phase 0|phase 0
131847|NCT03378297|Window-of-opportunity|window-of-opportunity
131848|NCT03378297|Suregry|suregry
131849|NCT03378297|Repurposing|repurposing
131850|NCT03378297|Metformin|metformin
131851|NCT03378297|Acetylsalicylic acid|acetylsalicylic acid
131852|NCT03378297|Olaparib|olaparib
131853|NCT03378297|Letrozol|letrozol
131854|NCT03378271|Continuous Glucose Monitoring|continuous glucose monitoring
131855|NCT03378271|Flash glucose Monitoring|flash glucose monitoring
131856|NCT03378271|Renal Impairment|renal impairment
131857|NCT03378271|Type 1 Diabetes|type 1 diabetes
131858|NCT03378271|Type 2 Diabetes|type 2 diabetes
131859|NCT03378258|meningococcal|meningococcal
131860|NCT03378258|neisseria meningitidis|neisseria meningitidis
131861|NCT03378258|sepsis|sepsis
131862|NCT03378258|meningitis|meningitis
131863|NCT03378258|procalcitonin|procalcitonin
131864|NCT03378258|PCT|pct
131865|NCT03378258|LAMP|lamp
131866|NCT03378258|loop-mediated-isothermal AMPlification|loop-mediated-isothermal amplification
131867|NCT03378232|DHA|dha
131868|NCT03378232|EPA|epa
131869|NCT03378232|fatty acids|fatty acids
131870|NCT03378232|blood pressure|blood pressure
131871|NCT03378232|resting metabolic rate|resting metabolic rate
131872|NCT03378232|blood lipids|blood lipids
131873|NCT03378232|muscle sympathetic nerve activity (MSNA)|muscle sympathetic nerve activity (msna)
131874|NCT03378206|genu valgum or varum|genu valgum or varum
131875|NCT03378206|eight-plate|eight-plate
131876|NCT03378206|epiphysis arrest|epiphysis arrest
131877|NCT03378206|hemiepiphysiodesis|hemiepiphysiodesis
131878|NCT03378193|Squamous cell carcinoma|squamous cell carcinoma
131879|NCT03378193|FDG PET/CT|fdg pet/ct
131880|NCT03378193|Textural analysis|textural analysis
131881|NCT03378167|Paediatrics|paediatrics
131882|NCT03378167|Pediatrics|pediatrics
131883|NCT03378167|Crohn's|crohn's
131884|NCT03378167|Crohn|crohn
131885|NCT03378167|Microbiome|microbiome
131886|NCT03378167|Microbiota|microbiota
131887|NCT03378167|FMT|fmt
131888|NCT03378167|Fecal Transplant|fecal transplant
131889|NCT03378167|Fecal Microbiota Transplant|fecal microbiota transplant
131890|NCT03378167|IBD-U|ibd-u
131891|NCT03378167|Inflammatory Bowel Disease Unclassified|inflammatory bowel disease unclassified
131892|NCT03378167|Inflammatory Bowel Disease Indeterminate|inflammatory bowel disease indeterminate
131893|NCT03378167|IBD|ibd
131894|NCT03378167|Colitis|colitis
131895|NCT03378154|King vision|king vision
131896|NCT03378154|Difficult airway|difficult airway
131897|NCT03378154|Videolaryngoscope|videolaryngoscope
131898|NCT03378154|Paediatric intubation|paediatric intubation
131899|NCT03378128|debulking surgery|debulking surgery
131900|NCT03378128|Ovarian Cancer|ovarian cancer
131901|NCT03378102|T Cell Therapy|t cell therapy
131902|NCT03378102|Opportunistic Infection|opportunistic infection
131903|NCT03378089|Music Therapy|music therapy
131904|NCT03378076|Osteoarthritis|osteoarthritis
131905|NCT03378076|Knee|knee
131906|NCT03378076|Corticosteroid|corticosteroid
131907|NCT03378076|Bilateral|bilateral
131908|NCT03378076|Pain|pain
131909|NCT03378076|Intra-articular|intra-articular
131910|NCT03378076|Injection|injection
131911|NCT03378037|Brain Injuries, Traumatic|brain injuries, traumatic
131912|NCT03378037|Alzheimer's disease|alzheimer's disease
131913|NCT03378037|Magnetic resonance imaging|magnetic resonance imaging
131914|NCT03378037|white matter integrity|white matter integrity
131915|NCT03378037|beta-Amyloid|beta-amyloid
131916|NCT03378024|Oscillometric device|oscillometric device
131917|NCT03378024|repetitive Active Pedal Plantarflexion (APP) exercise test|repetitive active pedal plantarflexion (app) exercise test
131918|NCT03378024|brachial-ankle pulse wave velocity (baPWV)|brachial-ankle pulse wave velocity (bapwv)
131919|NCT03377959|dance|dance
131920|NCT03377959|ballet|ballet
131921|NCT03377959|Exercise Movement Techniques|exercise movement techniques
131922|NCT03377959|turnout|turnout
131923|NCT03377946|pre-diabetes,diabetes,probiotics|pre-diabetes,diabetes,probiotics
131924|NCT03377933|Helicobacter pylori|helicobacter pylori
131925|NCT03377933|Probiotics|probiotics
131926|NCT03377933|Efficacy|efficacy
131928|NCT03377933|gastromicroecology|gastromicroecology
131929|NCT03377907|IVRA|ivra
131930|NCT03377907|hematoma block|hematoma block
131931|NCT03377842|apatinib|apatinib
131932|NCT03377829|Papillary Thyroid Microcarcinoma|papillary thyroid microcarcinoma
131933|NCT03377829|Percutaneous Laser Ablation|percutaneous laser ablation
131934|NCT03377829|thyroidectomy|thyroidectomy
131935|NCT03377829|ultrasonography|ultrasonography
131936|NCT03377829|double-blind|double-blind
131937|NCT03377816|Emotion Processing|emotion processing
131938|NCT03377816|Art Therapy|art therapy
131939|NCT03377816|Breast Cancer|breast cancer
131940|NCT03377816|Cholinergic anti-inflammatory pathway|cholinergic anti-inflammatory pathway
131941|NCT03377803|Molluscum|molluscum
131942|NCT03377803|Skin Diseases|skin diseases
131943|NCT03377803|Poxviridae Infections|poxviridae infections
131944|NCT03377803|Skin Diseases; Infectious|skin diseases; infectious
131945|NCT03377803|Skin Diseases; Viral|skin diseases; viral
131946|NCT03377803|DNA Poxvirus|dna poxvirus
131947|NCT03377790|Molluscum|molluscum
131948|NCT03377790|Skin Diseases|skin diseases
131949|NCT03377790|Poxviridae Infections|poxviridae infections
131950|NCT03377790|Skin Diseases; Infectious|skin diseases; infectious
131951|NCT03377790|Skin Diseases; Viral|skin diseases; viral
131952|NCT03377790|DNA Poxvirus|dna poxvirus
131953|NCT03377777|Anemia|anemia
131954|NCT03377777|Iron-deficiency|iron-deficiency
131955|NCT03377777|Iron-deficiency anemia|iron-deficiency anemia
131956|NCT03377777|Infants|infants
131957|NCT03377777|Metabolomics|metabolomics
131958|NCT03377777|Microbiome|microbiome
131959|NCT03377764|Spinal Anesthetic,|spinal anesthetic,
131960|NCT03377764|Ultrasound guided Neuroaxial block,|ultrasound guided neuroaxial block,
131961|NCT03377764|Anesthesia Trainees|anesthesia trainees
131962|NCT03377751|Catheter ablation|catheter ablation
131963|NCT03377751|Atrial fibrillation|atrial fibrillation
131964|NCT03377751|Low voltage area|low voltage area
131965|NCT03377738|Spirometry|spirometry
131966|NCT03377738|Primary care|primary care
131967|NCT03377738|Smoking Cessations|smoking cessations
131968|NCT03377725|Myelodysplastic Syndromes|myelodysplastic syndromes
131969|NCT03377725|Decitabine|decitabine
131970|NCT03377725|Arsenic Trioxide|arsenic trioxide
131971|NCT03377725|P53 Mutations|p53 mutations
131972|NCT03377686|paediatrics|paediatrics
131973|NCT03377686|breath analysis|breath analysis
131974|NCT03377686|volatile organic compounds|volatile organic compounds
131975|NCT03377686|respiratory diseases|respiratory diseases
131976|NCT03377660|Esophagectomy|esophagectomy
131977|NCT03377660|Unintentional weight loss|unintentional weight loss
131978|NCT03377660|Gut hormones|gut hormones
131979|NCT03377634|Older Adults|older adults
131980|NCT03377634|Physical Activity|physical activity
131981|NCT03377634|MORPH|morph
131982|NCT03377634|Telecoaching|telecoaching
131983|NCT03377634|mHealth|mhealth
131984|NCT03377634|Weight Loss|weight loss
131985|NCT03377634|Sedentary Behavior|sedentary behavior
131986|NCT03377634|Pain|pain
131987|NCT03377634|Design|design
131988|NCT03377634|RCT|rct
131989|NCT03377634|Randomized Controlled Trial|randomized controlled trial
131990|NCT03377621|whole body vibration|whole body vibration
131991|NCT03377621|sleep|sleep
131992|NCT03377621|apnea|apnea
131993|NCT03377608|tenofovir|tenofovir
131994|NCT03377608|microbiome|microbiome
131995|NCT03377608|inflammation|inflammation
131996|NCT03377582|cardiovascular diseases|cardiovascular diseases
131997|NCT03377582|cardiac rehabilitation|cardiac rehabilitation
131998|NCT03377582|sympathetic nervous system|sympathetic nervous system
131999|NCT03377582|heart rate|heart rate
132000|NCT03377582|blood pressure|blood pressure
132001|NCT03377582|clinical trial|clinical trial
132002|NCT03377582|virtual reality exposure therapy|virtual reality exposure therapy
132003|NCT03377582|barriers to cardiac rehabilitation|barriers to cardiac rehabilitation
132004|NCT03377582|motivation|motivation
132005|NCT03377582|adherence patient|adherence patient
132006|NCT03377582|engagement|engagement
132007|NCT03377582|perceived exertion|perceived exertion
132008|NCT03377582|oxygen saturation|oxygen saturation
132009|NCT03377569|Deep Brain Stimulation|deep brain stimulation
132010|NCT03377569|Polysomnography|polysomnography
132011|NCT03377569|Actigraphy|actigraphy
132012|NCT03377530|Bacillus Cereus|bacillus cereus
132013|NCT03377530|Premature neonates|premature neonates
132014|NCT03377504|complex regional pain syndrome|complex regional pain syndrome
132015|NCT03377504|mirror therapy|mirror therapy
132016|NCT03377504|rehabilitation|rehabilitation
132017|NCT03377491|Locally Advanced Pancreatic Adenocarcinoma|locally advanced pancreatic adenocarcinoma
132018|NCT03377491|TTFields|ttfields
132019|NCT03377491|Tumor Treating Fields|tumor treating fields
132020|NCT03377491|Gemcitabine|gemcitabine
132021|NCT03377491|nab-Paclitaxel|nab-paclitaxel
132022|NCT03377491|Minimal toxicity|minimal toxicity
132023|NCT03377491|TTF|ttf
132024|NCT03377491|Novocure|novocure
132025|NCT03377439|Platelet function|platelet function
132026|NCT03377439|Bleeding risk|bleeding risk
132027|NCT03377439|Immune Thrombocytopenia|immune thrombocytopenia
132713|NCT03373032|Acupuncture|acupuncture
132028|NCT03377426|Urinary tract infection, LYS228, beta-lactam antibiotics, creatinine clearance, Enterobactericeae|urinary tract infection, lys228, beta-lactam antibiotics, creatinine clearance, enterobactericeae
132029|NCT03377387|Capecitabine|capecitabine
132030|NCT03377387|Neratinib|neratinib
132031|NCT03377387|HER2-Positive|her2-positive
132032|NCT03377387|17-585|17-585
132033|NCT03377335|Dapagliflozin|dapagliflozin
132034|NCT03377335|Type 2 diabetes mellitus|type 2 diabetes mellitus
132035|NCT03377335|Carotid intima-media thickness|carotid intima-media thickness
132036|NCT03377335|Endothelial dysfunction|endothelial dysfunction
132037|NCT03377335|Atherogenic lipoproteins|atherogenic lipoproteins
132038|NCT03377335|Inflammatory markers|inflammatory markers
132039|NCT03377335|microRNAs|micrornas
132040|NCT03377309|Safety|safety
132041|NCT03377309|Tolerability|tolerability
132042|NCT03377309|Perampanel|perampanel
132043|NCT03377270|Oropharyngeal Head and Neck Cancer|oropharyngeal head and neck cancer
132044|NCT03377270|dysphagia|dysphagia
132045|NCT03377270|Respiratory Swallow Training|respiratory swallow training
132046|NCT03377257|Cluster headache|cluster headache
132047|NCT03377257|zolmitriptan|zolmitriptan
132048|NCT03377257|Sublingual administration|sublingual administration
132049|NCT03377231|Pregnancy, Striae gravidarum, Striae distensae, Women's health|pregnancy, striae gravidarum, striae distensae, women's health
132050|NCT03377192|Impedance pneumography|impedance pneumography
132051|NCT03377192|Respiratory function|respiratory function
132052|NCT03377192|Asthma management|asthma management
132053|NCT03377179|Clinical Trial, Phase II|clinical trial, phase ii
132054|NCT03377179|Multicenter Trials|multicenter trials
132055|NCT03377179|Clinical Study|clinical study
132056|NCT03377179|Clinical Trials, Non-Randomized|clinical trials, non-randomized
132057|NCT03377179|Oral capsule|oral capsule
132058|NCT03377179|Single arm|single arm
132059|NCT03377179|Anti-cancer|anti-cancer
132060|NCT03377179|Anti-inflammatory|anti-inflammatory
132061|NCT03377179|ABC294640|abc294640
132062|NCT03377179|Yeliva ®|yeliva ®
132063|NCT03377179|opaganib|opaganib
132064|NCT03377127|diabetes|diabetes
132065|NCT03377127|pharmacy clinic|pharmacy clinic
132066|NCT03377127|education|education
132067|NCT03377127|diabetes complications|diabetes complications
132068|NCT03377127|hemoglobin A1c|hemoglobin a1c
132069|NCT03377127|health-care cost|health-care cost
132070|NCT03377127|'no show' rate|'no show' rate
132071|NCT03377127|compliance|compliance
132072|NCT03377127|diabetes core measures|diabetes core measures
132073|NCT03377114|Nasotracheal intubation|nasotracheal intubation
132074|NCT03377049|acetazolamide challenge|acetazolamide challenge
132075|NCT03377049|cerebral vasospasm|cerebral vasospasm
132076|NCT03377049|aneurysmal subarachnoid hemorrhage|aneurysmal subarachnoid hemorrhage
132077|NCT03377036|Breast Cancer|breast cancer
132078|NCT03377036|Population-based Screening|population-based screening
132079|NCT03377036|Digital Breast Tomosynthesis plus synthesized Mammography|digital breast tomosynthesis plus synthesized mammography
132080|NCT03377036|Reconstructed Mammography|reconstructed mammography
132081|NCT03377036|Full-Field Digital Mammography (FFDM)|full-field digital mammography (ffdm)
132082|NCT03377036|Multicentric Randomized Controlled Trial|multicentric randomized controlled trial
132083|NCT03377036|Diagnostic Performance|diagnostic performance
132084|NCT03377036|Recall Rate|recall rate
132085|NCT03377036|Interval Cancer|interval cancer
132086|NCT03377023|Nivolumab|nivolumab
132087|NCT03377023|Ipilimumab|ipilimumab
132088|NCT03377023|Nintedanib|nintedanib
132089|NCT03377023|Immunotherapy|immunotherapy
132090|NCT03377023|Advanced stage non-small cell lung cancer|advanced stage non-small cell lung cancer
132091|NCT03377023|Locally advanced non-small cell lung cancer|locally advanced non-small cell lung cancer
132092|NCT03376997|Bioavailability|bioavailability
132093|NCT03376997|Perampanel|perampanel
132094|NCT03376984|Root Canal Therapy|root canal therapy
132095|NCT03376971|Lesion|lesion
132096|NCT03376971|Lung|lung
132097|NCT03376971|Cancer|cancer
132098|NCT03376971|Diagnosis|diagnosis
132099|NCT03376971|Optical Biopsy|optical biopsy
132100|NCT03376971|Biopsy|biopsy
132101|NCT03376958|R R DLBCL|r r dlbcl
132102|NCT03376958|ORR|orr
132103|NCT03376958|PFS|pfs
132104|NCT03376958|OS|os
132105|NCT03376945|n-3|n-3
132106|NCT03376945|Parenteral nutrition|parenteral nutrition
132107|NCT03376945|Jaundice|jaundice
132108|NCT03376945|Propensity score match|propensity score match
132109|NCT03376932|Vilanterol|vilanterol
132110|NCT03376932|Fluticasone furoate|fluticasone furoate
132111|NCT03376932|Connected Inhaler System|connected inhaler system
132112|NCT03376932|Dry powder inhaler|dry powder inhaler
132113|NCT03376932|Umeclidinium|umeclidinium
132114|NCT03376932|Asthma|asthma
132115|NCT03376919|wearable robotics|wearable robotics
132116|NCT03376919|Unilateral Lower Limb Amputation|unilateral lower limb amputation
132117|NCT03376919|gait efficiency|gait efficiency
132118|NCT03376906|Obesity|obesity
132119|NCT03376906|aerobic exercise|aerobic exercise
132120|NCT03376906|interval exercise|interval exercise
132121|NCT03376867|conditioned pain modulation (CPM)|conditioned pain modulation (cpm)
132122|NCT03376867|Diffuse Noxious Inhibitory Controls (DNIC)|diffuse noxious inhibitory controls (dnic)
132123|NCT03376867|pressure pain threshold (PPT)|pressure pain threshold (ppt)
132124|NCT03376867|reference values|reference values
132125|NCT03376867|clinical decision rule|clinical decision rule
132126|NCT03376854|ARDS, temperature management, neuromuscular blockade|ards, temperature management, neuromuscular blockade
132127|NCT03376841|Liver insufficiency|liver insufficiency
132128|NCT03376841|Hepatic Impairment|hepatic impairment
132129|NCT03376841|Cenicriviroc|cenicriviroc
132130|NCT03376841|Pharmacokinetics|pharmacokinetics
132131|NCT03376828|laryngoscopy|laryngoscopy
132132|NCT03376828|videolaryngoscopy|videolaryngoscopy
132133|NCT03376828|hypertension|hypertension
132134|NCT03376815|Tumor ,landscape ,pathological diagnosis|tumor ,landscape ,pathological diagnosis
132135|NCT03376776|idiopathic macular hole|idiopathic macular hole
132136|NCT03376763|aripiprazole|aripiprazole
132137|NCT03376763|Long-Acting Injection|long-acting injection
132138|NCT03376750|telerehabilitation|telerehabilitation
132139|NCT03376750|occupational therapy|occupational therapy
132140|NCT03376750|RCT|rct
132141|NCT03376750|participation|participation
132142|NCT03376750|quality of life|quality of life
132143|NCT03376750|intervention|intervention
132144|NCT03376750|older adults|older adults
132145|NCT03376659|PD-L1|pd-l1
132146|NCT03376633|Randomized Controlled Trial|randomized controlled trial
132147|NCT03376633|RCT|rct
132148|NCT03376633|Chicago Public Schools|chicago public schools
132149|NCT03376633|high school|high school
132150|NCT03376633|trauma-informed counseling|trauma-informed counseling
132151|NCT03376633|group-based counseling|group-based counseling
132152|NCT03376633|counseling|counseling
132153|NCT03376633|mentoring|mentoring
132154|NCT03376633|Cognitive Behavioral Therapy|cognitive behavioral therapy
132155|NCT03376633|CBT|cbt
132156|NCT03376633|adolescents|adolescents
132157|NCT03376633|females|females
132158|NCT03376633|trauma|trauma
132159|NCT03376633|stress|stress
132160|NCT03376633|PTSD|ptsd
132161|NCT03376633|anxiety|anxiety
132162|NCT03376633|depression|depression
132163|NCT03376633|graduation|graduation
132164|NCT03376620|Prevention of hypertrophic scar|prevention of hypertrophic scar
132165|NCT03376607|Primary Health Care|primary health care
132166|NCT03376607|Health Behavior|health behavior
132167|NCT03376607|Quality of Life|quality of life
132168|NCT03376607|Health Literacy|health literacy
132169|NCT03376607|Global Health|global health
132170|NCT03376607|Medication Adherence|medication adherence
132171|NCT03376594|Benjakul Extract|benjakul extract
132172|NCT03376594|Allergic Rhinitis|allergic rhinitis
132173|NCT03376594|Herbal Medicine|herbal medicine
132174|NCT03376568|polysomnographic|polysomnographic
132175|NCT03376568|multiple sleep latency test|multiple sleep latency test
132176|NCT03376568|fMRI|fmri
132177|NCT03376555|Sodium|sodium
132178|NCT03376555|Hypertension|hypertension
132179|NCT03376555|Blood Pressure|blood pressure
132180|NCT03376555|Cardiovascular Disease|cardiovascular disease
132181|NCT03376555|Nitric Oxide|nitric oxide
132182|NCT03376555|Skin|skin
132183|NCT03376555|Dairy|dairy
132184|NCT03376555|Cheese|cheese
132185|NCT03376555|Oxidative Stress|oxidative stress
132186|NCT03376555|Diet|diet
132187|NCT03376555|Flow Mediated Vasodilation|flow mediated vasodilation
132188|NCT03376555|Nitroglycerin|nitroglycerin
132189|NCT03376555|Superoxide|superoxide
132190|NCT03376555|Microcirculation|microcirculation
132191|NCT03376529|safety|safety
132192|NCT03376529|tolerability|tolerability
132193|NCT03376529|pharmacokinetics|pharmacokinetics
132194|NCT03376529|drug-drug interaction|drug-drug interaction
132195|NCT03376529|SPR741|spr741
132196|NCT03376529|antibiotic|antibiotic
132197|NCT03376477|Lenalidomide|lenalidomide
132198|NCT03376477|M-spike negative|m-spike negative
132199|NCT03376477|GVax|gvax
132200|NCT03376477|GM-CSF secreting myeloma vaccine|gm-csf secreting myeloma vaccine
132201|NCT03376477|MRD positive|mrd positive
132202|NCT03376464|Xeomin Cosmetic;|xeomin cosmetic;
132203|NCT03376464|Masseteric Hypertrophy|masseteric hypertrophy
132204|NCT03376425|Chest ultrasound,Lung tumor|chest ultrasound,lung tumor
132205|NCT03376399|Sleeve Gastrectomy|sleeve gastrectomy
132206|NCT03376399|Gastric Emptying|gastric emptying
132207|NCT03376399|Diabetic Gastroparesis|diabetic gastroparesis
132208|NCT03376399|Bariatric Surgery Candidate|bariatric surgery candidate
132209|NCT03376386|Adaptive|adaptive
132210|NCT03376386|Image-guided|image-guided
132211|NCT03376386|Radiotherapy|radiotherapy
132212|NCT03376386|Head and Neck cancer|head and neck cancer
132213|NCT03376360|prostate cancer|prostate cancer
132214|NCT03376360|Fcholine|fcholine
132215|NCT03376360|positron emission tomography|positron emission tomography
132216|NCT03376360|MRI|mri
132217|NCT03376347|intraoperative|intraoperative
132218|NCT03376347|hypotension|hypotension
132219|NCT03376347|Hypotension Probability Index|hypotension probability index
132220|NCT03376347|HPI|hpi
132221|NCT03376334|Mental motor imagery|mental motor imagery
132222|NCT03376334|SEBT|sebt
132223|NCT03376308|rocuronium|rocuronium
132224|NCT03376308|propofol|propofol
132225|NCT03376308|pain|pain
132227|NCT03376308|venous diameter|venous diameter
132228|NCT03376282|HBO|hbo
132229|NCT03376282|kidney functions|kidney functions
132230|NCT03376282|markers|markers
132231|NCT03376269|more than 1 year|more than 1 year
132232|NCT03376256|thoracic epidural|thoracic epidural
132233|NCT03376256|pressure measurement|pressure measurement
132234|NCT03376256|device|device
132235|NCT03376243|Atopic eczema, prevention|atopic eczema, prevention
132236|NCT03376230|Environmental risk factors|environmental risk factors
132237|NCT03376230|Xenobiotic detoxification|xenobiotic detoxification
132238|NCT03376217|malaria|malaria
132239|NCT03376217|malaria in pregnancy|malaria in pregnancy
132240|NCT03376217|intermittent preventive treatment in pregnancy (IPTp)|intermittent preventive treatment in pregnancy (iptp)
132241|NCT03376217|community health workers|community health workers
132242|NCT03376217|Sulfadoxine-pyrimethamine (SP)|sulfadoxine-pyrimethamine (sp)
132243|NCT03376204|Bronchiectasis|bronchiectasis
132244|NCT03376204|Pain mechanisms|pain mechanisms
132245|NCT03376204|Pressure pain threshold|pressure pain threshold
132246|NCT03376204|Referred pain|referred pain
132247|NCT03376191|Apatinib|apatinib
132248|NCT03376191|lung cancer|lung cancer
132249|NCT03376191|angiogenesis inhibitors|angiogenesis inhibitors
132250|NCT03376191|efficacy|efficacy
132251|NCT03376191|safety|safety
132252|NCT03376178|multiorifice or endhole femoral nerve catheter|multiorifice or endhole femoral nerve catheter
132253|NCT03376165|prognosis|prognosis
132254|NCT03376165|translational research|translational research
132255|NCT03376139|Alcohol|alcohol
132256|NCT03376139|Alcoholic|alcoholic
132257|NCT03376139|Alcoholism|alcoholism
132258|NCT03376139|Alcohol abuse|alcohol abuse
132259|NCT03376139|Alcohol Use Disorder|alcohol use disorder
132260|NCT03376139|Alcohol use|alcohol use
132261|NCT03376139|Alcohol dependence|alcohol dependence
132262|NCT03376139|Alcohol dependent|alcohol dependent
132263|NCT03376139|PTSD|ptsd
132264|NCT03376139|Post-Traumatic Stress Disorder|post-traumatic stress disorder
132265|NCT03376139|Veteran|veteran
132266|NCT03376126|isolated limb perfusion|isolated limb perfusion
132267|NCT03376113|self-harm|self-harm
132268|NCT03376113|psychological intervention|psychological intervention
132269|NCT03376087|Epilepsy|epilepsy
132270|NCT03376087|heart block|heart block
132271|NCT03376087|sudden cardiac death|sudden cardiac death
132272|NCT03376087|loop recorder|loop recorder
132273|NCT03376074|liver transplantation|liver transplantation
132274|NCT03376074|hypothermic machine liver perfusion|hypothermic machine liver perfusion
132275|NCT03376074|extended criteria liver grafts|extended criteria liver grafts
132276|NCT03376061|Tranexamic Acid|tranexamic acid
132277|NCT03376061|Cardiac surgery|cardiac surgery
132278|NCT03376022|Attitudes|attitudes
132279|NCT03376022|Knowledge|knowledge
132280|NCT03376022|Oral Health|oral health
132281|NCT03376022|Nursing personnel|nursing personnel
132282|NCT03376009|Biomarker|biomarker
132283|NCT03375983|Advanced cancer|advanced cancer
132284|NCT03375983|Plasmodium immunotherapy|plasmodium immunotherapy
132285|NCT03375983|Plasmodiun vivax|plasmodiun vivax
132409|NCT03375099|Means Safety|means safety
132286|NCT03375944|Cardiac tele-rehabilitation, Myocardial revascularization|cardiac tele-rehabilitation, myocardial revascularization
132287|NCT03375931|Quality of Recovery 40 Questionaries|quality of recovery 40 questionaries
132288|NCT03375918|Healthcare disparities|healthcare disparities
132289|NCT03375918|Racial Bias|racial bias
132290|NCT03375905|ethnic Japanese|ethnic japanese
132291|NCT03375892|radiation|radiation
132292|NCT03375892|Deep Inspiration Breath Hold|deep inspiration breath hold
132293|NCT03375892|stage I|stage i
132294|NCT03375892|stage II|stage ii
132295|NCT03375892|stage IIa|stage iia
132296|NCT03375879|Ptosis|ptosis
132297|NCT03375879|Blepharoptosis|blepharoptosis
132298|NCT03375879|bandage contact lens|bandage contact lens
132299|NCT03375879|fasanella servat procedure|fasanella servat procedure
132300|NCT03375853|Obesity|obesity
132301|NCT03375853|Dissonance|dissonance
132302|NCT03375853|Response Training|response training
132303|NCT03375853|Eating Disorder|eating disorder
132304|NCT03375853|Computer-based Training|computer-based training
132305|NCT03375840|pictorial warning labels|pictorial warning labels
132306|NCT03375840|risk knowledge|risk knowledge
132307|NCT03375840|emotion|emotion
132308|NCT03375840|memory|memory
132309|NCT03375840|risk perceptions|risk perceptions
132310|NCT03375840|quit intentions|quit intentions
132311|NCT03375827|Breast Cancer|breast cancer
132312|NCT03375814|Crocin, osteoarthritis, Inflammation, IL-17,T-helper,T-reg|crocin, osteoarthritis, inflammation, il-17,t-helper,t-reg
132313|NCT03375788|tesamorelin|tesamorelin
132314|NCT03375788|obesity|obesity
132315|NCT03375788|fatty liver|fatty liver
132316|NCT03375749|sitting|sitting
132317|NCT03375736|whole body vibration|whole body vibration
132318|NCT03375736|cerebral palsy|cerebral palsy
132319|NCT03375736|functional abilities|functional abilities
132320|NCT03375736|children|children
132321|NCT03375736|adults|adults
132322|NCT03375723|Pain measurement|pain measurement
132323|NCT03375723|Pain|pain
132324|NCT03375710|Heart Failure|heart failure
132714|NCT03373019|chidamide|chidamide
132325|NCT03375710|Heart Diseases|heart diseases
132326|NCT03375710|Cardiovascular Disease|cardiovascular disease
132327|NCT03375684|Cystic Fibrosis|cystic fibrosis
132328|NCT03375684|Inspiratory Muscle Training|inspiratory muscle training
132329|NCT03375684|Chest Physiotherapy|chest physiotherapy
132330|NCT03375684|Balance|balance
132331|NCT03375684|Postural Stability|postural stability
132332|NCT03375684|Pulmonary Function Test|pulmonary function test
132333|NCT03375684|6-Minute Walk Test|6-minute walk test
132334|NCT03375671|ketamine|ketamine
132335|NCT03375671|aggressive behaviour|aggressive behaviour
132336|NCT03375671|midazolam|midazolam
132337|NCT03375671|haloperidol|haloperidol
132338|NCT03375671|emergency department|emergency department
132339|NCT03375658|Information Science: Algorithms|information science: algorithms
132340|NCT03375658|Information Science: Informatics: Nursing Informatics|information science: informatics: nursing informatics
400590|NCT01866124|Burkina Faso|burkina faso
132341|NCT03375658|Information Science: Data Display: Computer graphics|information science: data display: computer graphics
132342|NCT03375658|Diagnosis: Diagnostic Techiques and Procedures: Monitoring, Physiologic|diagnosis: diagnostic techiques and procedures: monitoring, physiologic
132343|NCT03375658|Health care facilities, Manpower and services: Health services: Emergency Medical Services: Triage|health care facilities, manpower and services: health services: emergency medical services: triage
132344|NCT03375619|CAR-20/19 T-Cell Therapy|car-20/19 t-cell therapy
132345|NCT03375593|pain management|pain management
132346|NCT03375593|RCT|rct
132347|NCT03375554|esophageal steothoscope, tracheal intubation|esophageal steothoscope, tracheal intubation
132348|NCT03375528|Matrix metalloproteinase|matrix metalloproteinase
132349|NCT03375528|neointimal hyperplasia|neointimal hyperplasia
132350|NCT03375515|hydromorphone titration|hydromorphone titration
132351|NCT03375489|Lung Cancer palliative care|lung cancer palliative care
132352|NCT03375476|postoperative myocardial infraction|postoperative myocardial infraction
132353|NCT03375476|myocardial injury|myocardial injury
132354|NCT03375476|general anesthesia|general anesthesia
132355|NCT03375476|vascular surgery|vascular surgery
132356|NCT03375476|surgical stress|surgical stress
132357|NCT03375476|surgical plethysmographic index|surgical plethysmographic index
132358|NCT03375450|Epidemiology, Chronic Obstructive Disease, Comparative Effectiveness, Exacerbation|epidemiology, chronic obstructive disease, comparative effectiveness, exacerbation
132359|NCT03375437|Clinical Trial|clinical trial
132360|NCT03375437|Multicenter Trial|multicenter trial
132361|NCT03375437|NTRK1|ntrk1
132362|NCT03375437|NTRK2|ntrk2
132363|NCT03375437|NTRK3|ntrk3
132364|NCT03375437|ROS1|ros1
132365|NCT03375437|ALK|alk
132366|NCT03375437|RNAseq|rnaseq
132367|NCT03375437|entrectinib|entrectinib
132368|NCT03375437|STARTRK-2|startrk-2
132369|NCT03375424|Vedolizumab, Crohns disease, Ulcerative colitis, safety|vedolizumab, crohns disease, ulcerative colitis, safety
132370|NCT03375398|SUGARDOWN™|sugardown™
132371|NCT03375398|Galactomannan|galactomannan
132372|NCT03375398|Postprandial blood glucose|postprandial blood glucose
132373|NCT03375398|Insulin|insulin
132374|NCT03375346|Whole body vibration exercise|whole body vibration exercise
132375|NCT03375333|ultrasound|ultrasound
132376|NCT03375333|diagnostics|diagnostics
132377|NCT03375333|general practice|general practice
132378|NCT03375333|family medicine|family medicine
132379|NCT03375294|PTSD|ptsd
132380|NCT03375255|Duchenne Muscular Dystrophy|duchenne muscular dystrophy
132381|NCT03375255|Exon Skipping|exon skipping
132382|NCT03375255|DMD|dmd
132383|NCT03375255|Exon 51|exon 51
132384|NCT03375255|Ambulatory|ambulatory
132385|NCT03375255|Pediatric|pediatric
132386|NCT03375255|Nonambulatory|nonambulatory
132387|NCT03375255|Peptide-conjugated phosphorodiamidate morpholino oligomer (PPMO)|peptide-conjugated phosphorodiamidate morpholino oligomer (ppmo)
132388|NCT03375255|Duchenne|duchenne
132389|NCT03375229|Myofascial Pain|myofascial pain
132390|NCT03375229|Pain Pressure Threshold|pain pressure threshold
132391|NCT03375229|Low-Level Laser Therapy|low-level laser therapy
132392|NCT03375229|Dry Needling|dry needling
132393|NCT03375177|multiple sclerosis|multiple sclerosis
132394|NCT03375177|Argentina|argentina
132395|NCT03375177|epidemiology|epidemiology
132396|NCT03375177|registry|registry
132397|NCT03375164|Duchenne|duchenne
132398|NCT03375164|gene therapy|gene therapy
132399|NCT03375164|DMD|dmd
132400|NCT03375164|dystrophin|dystrophin
132401|NCT03375138|Healthy volunteers|healthy volunteers
132402|NCT03375112|Total Hip Arthroplasty|total hip arthroplasty
132403|NCT03375112|Fascia Iliaca|fascia iliaca
132404|NCT03375112|Nerve Block|nerve block
132405|NCT03375112|Pain Control|pain control
132406|NCT03375099|Firearms|firearms
132407|NCT03375099|Guns|guns
132408|NCT03375099|Suicide|suicide
132410|NCT03375099|Means Restriction|means restriction
132411|NCT03375099|Lethal Means Counseling|lethal means counseling
132412|NCT03375047|Cystic Fibrosis|cystic fibrosis
132413|NCT03375047|CF|cf
132414|NCT03375034|Chronic pain|chronic pain
132415|NCT03375034|Benzodiazepine|benzodiazepine
132416|NCT03375034|Central sensitization|central sensitization
132417|NCT03375034|Selective compound|selective compound
132418|NCT03375034|GABAA receptors|gabaa receptors
132419|NCT03375034|Antihyperalgesia|antihyperalgesia
132420|NCT03375034|RCT|rct
132421|NCT03375021|ADHD, ampakine, Phase II clinical trial|adhd, ampakine, phase ii clinical trial
132422|NCT03375008|Magnetic resonance imager(MRI)|magnetic resonance imager(mri)
132423|NCT03375008|Nonalcoholic fatty liver disease(NAFLD)|nonalcoholic fatty liver disease(nafld)
132424|NCT03375008|Imaging diagnostic|imaging diagnostic
132425|NCT03374956|Pharmacological|pharmacological
132426|NCT03374956|Obesity Management|obesity management
132427|NCT03374956|Individualized|individualized
132428|NCT03374917|carbidopa|carbidopa
132429|NCT03374917|levodopa|levodopa
132430|NCT03374904|Parenting|parenting
132431|NCT03374904|Parental Mentalization|parental mentalization
132432|NCT03374904|Parental Reflective Function|parental reflective function
132433|NCT03374904|Child Psychopathology|child psychopathology
132434|NCT03374891|Shared Decision Making;|shared decision making;
168949|NCT03140488|BMI|bmi
132435|NCT03374891|Defibrillator|defibrillator
132436|NCT03374878|exercise|exercise
132437|NCT03374878|oral contraceptive|oral contraceptive
132438|NCT03374878|strength training|strength training
132439|NCT03374813|Bone graft substitutes|bone graft substitutes
132440|NCT03374813|Synthetic graft|synthetic graft
132441|NCT03374813|Xenograft|xenograft
132442|NCT03374813|Ridge preservation|ridge preservation
132443|NCT03374813|Alveolar defect|alveolar defect
132444|NCT03374761|child abuse|child abuse
132445|NCT03374761|parenting|parenting
132446|NCT03374761|low and middle income countries|low and middle income countries
132447|NCT03374761|child discipline|child discipline
132448|NCT03374761|Indonesia|indonesia
132449|NCT03374696|Chlamydia infections|chlamydia infections
132450|NCT03374696|condoms|condoms
132451|NCT03374696|theater,|theater,
132452|NCT03374696|sex education|sex education
132453|NCT03374683|Risky play|risky play
132454|NCT03374683|Physical activity|physical activity
132455|NCT03374683|Injury prevention|injury prevention
132456|NCT03374683|Outdoor play|outdoor play
132457|NCT03374670|Zimura|zimura
132458|NCT03374670|ARC1905|arc1905
132459|NCT03374670|Eylea|eylea
132460|NCT03374670|aflibercept|aflibercept
132461|NCT03374670|IPCV|ipcv
132462|NCT03374670|avacincaptad pegol|avacincaptad pegol
132463|NCT03374670|complement factor C5 inhibitor|complement factor c5 inhibitor
132464|NCT03374657|Clinical trials, dark adaptation, gene therapy, RLBP1 mutation, retinitis pigmentosa.|clinical trials, dark adaptation, gene therapy, rlbp1 mutation, retinitis pigmentosa.
132465|NCT03374644|Correlation|correlation
132466|NCT03374644|ETCO2|etco2
132467|NCT03374644|PaCO2|paco2
132468|NCT03374644|nasal cannula|nasal cannula
132469|NCT03374644|Sentri Nasal Cannula|sentri nasal cannula
132470|NCT03374592|Intensity-modulated radiation therapy|intensity-modulated radiation therapy
132471|NCT03374592|Volumetric intensity-modulated arc therapy|volumetric intensity-modulated arc therapy
132472|NCT03374592|Radiotherapy|radiotherapy
132473|NCT03374592|Pain|pain
132474|NCT03374592|Metastasis|metastasis
132475|NCT03374592|Quality of Life|quality of life
132476|NCT03374592|Acute Toxicity|acute toxicity
132477|NCT03374566|Epstein-Barr Virus Infections|epstein-barr virus infections
132478|NCT03374566|Immunodeficiency|immunodeficiency
132479|NCT03374566|Screening|screening
132480|NCT03374566|Immunologic Function|immunologic function
132481|NCT03374527|T-cells|t-cells
132482|NCT03374527|circulation|circulation
132483|NCT03374527|synovial fluid|synovial fluid
132484|NCT03374527|psoriasis|psoriasis
132485|NCT03374527|psoriatic arthritis|psoriatic arthritis
132486|NCT03374514|corticosteroids|corticosteroids
132487|NCT03374514|Electric impedance|electric impedance
132488|NCT03374501|Sugardown™|sugardown™
132489|NCT03374501|Galactomannan|galactomannan
132490|NCT03374501|Postprandial blood glucose|postprandial blood glucose
132491|NCT03374501|Insulin|insulin
132492|NCT03374488|Urothelial carcinoma|urothelial carcinoma
132493|NCT03374488|programmed cell death protein 1 (PD-1) inhibitor|programmed cell death protein 1 (pd-1) inhibitor
132494|NCT03374488|indoleamine 2,3-dioxygenase (IDO) inhibitor|indoleamine 2,3-dioxygenase (ido) inhibitor
132495|NCT03374462|Pediatrics|pediatrics
132496|NCT03374449|Major surgery|major surgery
132497|NCT03374449|Postoperative morbidity and mortality|postoperative morbidity and mortality
132498|NCT03374449|Renin angiotensin system inhibitors|renin angiotensin system inhibitors
132499|NCT03374397|Laparoscopic unilateral ovarian cystectomy|laparoscopic unilateral ovarian cystectomy
132500|NCT03374397|SurgiGuard|surgiguard
132501|NCT03374397|Hemostasis|hemostasis
132502|NCT03374397|Ovarian function preservation|ovarian function preservation
132503|NCT03374397|Bipolar electrocauterization|bipolar electrocauterization
132504|NCT03374371|Staphylococcus epidermidis Infection|staphylococcus epidermidis infection
132505|NCT03374371|Staphylococcus epidermidis Contamination|staphylococcus epidermidis contamination
132506|NCT03374371|intravascular device|intravascular device
132507|NCT03374371|implanted material|implanted material
132508|NCT03374345|Cold Hypersensitivity|cold hypersensitivity
132509|NCT03374345|Korean medicine|korean medicine
132510|NCT03374345|Sipjeondaebo-tang|sipjeondaebo-tang
132511|NCT03374345|Cold intolerance|cold intolerance
132512|NCT03374332|Refractory|refractory
132513|NCT03374332|progression|progression
132514|NCT03374332|recurrence|recurrence
132515|NCT03374306|Myopia|myopia
132516|NCT03374306|Myopia control|myopia control
132517|NCT03374306|Atropine|atropine
132518|NCT03374306|Electroretinogram|electroretinogram
132519|NCT03374306|Multifocal Electroretinogram|multifocal electroretinogram
132520|NCT03374293|pancreatic cancer|pancreatic cancer
132521|NCT03374293|Radiation|radiation
132522|NCT03374293|Anti-PD-1 Antibody|anti-pd-1 antibody
132523|NCT03374280|non small cell lung cancer|non small cell lung cancer
132524|NCT03374280|Gefitinib|gefitinib
132525|NCT03374280|EGFR negative|egfr negative
132526|NCT03374280|Pemetrexed|pemetrexed
132527|NCT03374254|CRC, MSS, non-MSI-H, PD-1, anti-PD-1, anti PD-1, MEK, MEK inhibitor|crc, mss, non-msi-h, pd-1, anti-pd-1, anti pd-1, mek, mek inhibitor
132528|NCT03374215|Adrenal Adenoma|adrenal adenoma
132529|NCT03374215|Molecular Genetics|molecular genetics
132530|NCT03374215|African-American|african-american
132531|NCT03374215|Biomarkers|biomarkers
132532|NCT03374215|Primary Aldosteronism|primary aldosteronism
132533|NCT03374202|ARV Therapy|arv therapy
132534|NCT03374202|Broadly Neutralizing|broadly neutralizing
132535|NCT03374202|Gene Transfer|gene transfer
132536|NCT03374202|Monoclonal Antibody|monoclonal antibody
132537|NCT03374202|AAV8|aav8
132538|NCT03374176|periodontitis|periodontitis
132539|NCT03374176|diabetes mellitus|diabetes mellitus
132540|NCT03374176|systemic antimicrobials|systemic antimicrobials
132541|NCT03374163|infertility , implantion failure, intracytoplasmic sperm injection|infertility , implantion failure, intracytoplasmic sperm injection
132542|NCT03374150|Low-Calorie Diet|low-calorie diet
132543|NCT03374150|Diet, High-Protein|diet, high-protein
132544|NCT03374150|Obesity|obesity
132545|NCT03374150|weight cycling|weight cycling
132546|NCT03374150|body composition|body composition
132547|NCT03374150|high-sensitivity C-Reactive protein|high-sensitivity c-reactive protein
132548|NCT03374150|malondialdehyde|malondialdehyde
132549|NCT03374150|glutathione|glutathione
132550|NCT03374124|Chronic rhinosinusitis|chronic rhinosinusitis
132551|NCT03374124|Eosinophil|eosinophil
132552|NCT03374124|Surgery|surgery
132553|NCT03374124|Diagnosis|diagnosis
132554|NCT03374111|Thalassemia;|thalassemia;
132555|NCT03374111|the Syndrome of Blood Deficiency|the syndrome of blood deficiency
132556|NCT03374111|Anemia|anemia
132557|NCT03374111|Colla Corii Asini|colla corii asini
132558|NCT03374098|Medicaid|medicaid
132559|NCT03374098|Mississippi|mississippi
132560|NCT03374085|Multiple Myeloma|multiple myeloma
132561|NCT03374085|Safety|safety
132562|NCT03374085|Efficacy|efficacy
132563|NCT03374085|CC-92480|cc-92480
132564|NCT03374085|Relapsed|relapsed
132565|NCT03374085|Refractory|refractory
132566|NCT03374033|Preterm infants, growth, nutrition, physical activity|preterm infants, growth, nutrition, physical activity
132567|NCT03373994|FDG, perfusion, hypoxia, tumor, PET|fdg, perfusion, hypoxia, tumor, pet
132568|NCT03373955|T Cell repertoire|t cell repertoire
132569|NCT03373955|lung cancer|lung cancer
132570|NCT03373955|tumor mutation burden|tumor mutation burden
132571|NCT03373955|Circulating tumour DNA|circulating tumour dna
132572|NCT03373942|glaucoma|glaucoma
132573|NCT03373942|EDI OCT|edi oct
132574|NCT03373942|pseudoexfoliation|pseudoexfoliation
132575|NCT03373942|choroidal thickness|choroidal thickness
132576|NCT03373916|Peer Mentorship|peer mentorship
132577|NCT03373916|Psychiatric Hospitalization|psychiatric hospitalization
132578|NCT03373916|Suicide Risk|suicide risk
132579|NCT03373864|Unilateral spinal anesthesia|unilateral spinal anesthesia
132580|NCT03373864|general anesthesia|general anesthesia
132581|NCT03373864|hemodynamic stability|hemodynamic stability
132582|NCT03373864|MINS|mins
132583|NCT03373864|hip fracture|hip fracture
132584|NCT03373864|elderly|elderly
132585|NCT03373864|AKI|aki
132586|NCT03373825|overdose prevention|overdose prevention
132587|NCT03373825|opioid overdose|opioid overdose
132588|NCT03373825|risk behavior|risk behavior
132589|NCT03373825|harm reduction|harm reduction
132590|NCT03373799|rotator cuff|rotator cuff
132591|NCT03373799|physiotherapy|physiotherapy
132592|NCT03373799|video-based rehabilitation|video-based rehabilitation
132593|NCT03373799|exercise|exercise
132594|NCT03373786|Kidney disease|kidney disease
132595|NCT03373786|Nephritis|nephritis
132596|NCT03373786|Hereditary kidney disease|hereditary kidney disease
132597|NCT03373786|Hereditary nephritis|hereditary nephritis
132598|NCT03373773|pelvic reconstructive surgery|pelvic reconstructive surgery
132599|NCT03373773|foley catheter|foley catheter
132600|NCT03373773|Foley removal|foley removal
132601|NCT03373773|Urogynecology|urogynecology
132602|NCT03373773|Urinary Retention|urinary retention
132603|NCT03373773|Gynecologic surgery|gynecologic surgery
132604|NCT03373734|Online Cognitive Behavioural Therapy|online cognitive behavioural therapy
132605|NCT03373734|Pregnancy|pregnancy
132606|NCT03373734|Self-help|self-help
132607|NCT03373669|oral cholera vaccine|oral cholera vaccine
132608|NCT03373669|OCV|ocv
132609|NCT03373669|dose interval|dose interval
132610|NCT03373656|Vaccination|vaccination
132611|NCT03373656|Childhood|childhood
132612|NCT03373656|Hematologic Malignancy|hematologic malignancy
132613|NCT03373656|Solid Tumor|solid tumor
132614|NCT03373656|Immune Deficiency|immune deficiency
132616|NCT03373604|Cognitive Impairment|cognitive impairment
132617|NCT03373604|Alzheimer's|alzheimer's
132618|NCT03373591|bariatric surgery|bariatric surgery
132619|NCT03373591|liposomal bupivacaine|liposomal bupivacaine
132621|NCT03373578|Infant, Premature;|infant, premature;
132622|NCT03373578|Polysomnography;|polysomnography;
132623|NCT03373578|Ear Protective Devices|ear protective devices
132624|NCT03373552|Coronary Artery Disease; Clopidogrel; Polymorphism, genetic|coronary artery disease; clopidogrel; polymorphism, genetic
132625|NCT03373539|Biomarkers|biomarkers
132626|NCT03373539|Neurotrophins|neurotrophins
400591|NCT01866098|antipsychotic|antipsychotic
132627|NCT03373526|Hematopoietic Stem Cell Transplantation|hematopoietic stem cell transplantation
132628|NCT03373526|Aerobic Exercise|aerobic exercise
132629|NCT03373526|Breathing Exercises|breathing exercises
132630|NCT03373526|Inspiratory Capacity|inspiratory capacity
132631|NCT03373526|Muscle Strength|muscle strength
132632|NCT03373526|Exercise Tolerance|exercise tolerance
132633|NCT03373526|Autonomic Nervous System|autonomic nervous system
132634|NCT03373513|Return-to-work, Visual analogue pain score, Cosmesis|return-to-work, visual analogue pain score, cosmesis
132635|NCT03373461|glomerunephritis, complement driven, chronic kidney disease|glomerunephritis, complement driven, chronic kidney disease
132636|NCT03373409|Dry Powder Inhaler|dry powder inhaler
132637|NCT03373396|Chlordecone|chlordecone
132638|NCT03373396|fibrosis|fibrosis
132639|NCT03373396|cirrhosis|cirrhosis
132640|NCT03373396|chronic hepatitis B, C|chronic hepatitis b, c
132641|NCT03373396|alcohol|alcohol
132642|NCT03373396|viral hepatitis|viral hepatitis
132643|NCT03373396|transaminases|transaminases
132644|NCT03373396|fibroscan|fibroscan
132645|NCT03373383|Epilepsy|epilepsy
132646|NCT03373383|Padsevonil|padsevonil
132647|NCT03373357|sleep apnea|sleep apnea
132648|NCT03373357|arterial hypertension|arterial hypertension
132649|NCT03373357|cardiovascular risk|cardiovascular risk
132650|NCT03373344|emotional processing|emotional processing
132651|NCT03373344|multiple sclerosis|multiple sclerosis
132652|NCT03373344|cognition|cognition
132653|NCT03373331|Emotional Processing|emotional processing
132654|NCT03373331|Cognition|cognition
132655|NCT03373331|Traumatic Brain Injury|traumatic brain injury
132656|NCT03373331|Intervention|intervention
132657|NCT03373292|Stenting|stenting
132658|NCT03373292|Jugular vein stenosis|jugular vein stenosis
132659|NCT03373292|Intracranial hypertension|intracranial hypertension
132660|NCT03373292|Headache|headache
132661|NCT03373292|Tinnitus|tinnitus
132662|NCT03373292|Papilledema|papilledema
132663|NCT03373292|Visual impairment|visual impairment
132664|NCT03373279|Heart Transplant|heart transplant
132665|NCT03373240|Drug use Disorders|drug use disorders
132666|NCT03373240|Cognitive Remediation|cognitive remediation
132667|NCT03373227|Heart Transplant|heart transplant
132668|NCT03373214|Human Hookworm|human hookworm
132669|NCT03373214|Necator americanus|necator americanus
132670|NCT03373214|Hookworm|hookworm
132671|NCT03373214|Hookworm Disease|hookworm disease
132672|NCT03373214|Iron-deficiency anemia|iron-deficiency anemia
132673|NCT03373214|Soil-transmitted helminth infection|soil-transmitted helminth infection
132674|NCT03373214|Neglected Tropical Disease|neglected tropical disease
132675|NCT03373214|Na-GST-1|na-gst-1
132676|NCT03373214|CpG|cpg
132677|NCT03373175|Monitoring NIV, inspiratory muscular unloading, EMG|monitoring niv, inspiratory muscular unloading, emg
132678|NCT03373149|IVF|ivf
132679|NCT03373149|Growth hormone|growth hormone
132680|NCT03373149|Poor responders|poor responders
132681|NCT03373123|Esophageal Varices|esophageal varices
132682|NCT03373123|Variceal Hemorrhage|variceal hemorrhage
132683|NCT03373123|Endoscopy|endoscopy
132684|NCT03373123|Radiomics|radiomics
132685|NCT03373123|Hepatitis B Virus|hepatitis b virus
132686|NCT03373110|Online Therapy|online therapy
132687|NCT03373110|Fitbit|fitbit
132688|NCT03373110|Depression|depression
132689|NCT03373110|Cardiovascular Disease|cardiovascular disease
132690|NCT03373097|Neuroblastoma|neuroblastoma
132691|NCT03373097|GD2 CAR T cell|gd2 car t cell
132692|NCT03373097|CAR T|car t
132693|NCT03373084|Magnetic Resonance Imaging (MRI)|magnetic resonance imaging (mri)
132694|NCT03373084|Ultrasound|ultrasound
132695|NCT03373084|Sport|sport
132696|NCT03373084|Hamstring muscle|hamstring muscle
132697|NCT03373084|Injury|injury
132698|NCT03373071|CD19-CAR T cell|cd19-car t cell
132699|NCT03373071|CD19-malignancy|cd19-malignancy
132700|NCT03373071|CAR T cell|car t cell
132701|NCT03373071|CD19-ALL|cd19-all
132702|NCT03373071|CD19-LNH|cd19-lnh
132703|NCT03373058|Hyperthermic Intraperitoneal Chemotherapy|hyperthermic intraperitoneal chemotherapy
132704|NCT03373058|Advanced-Stage Epithelial Ovarian Cancer|advanced-stage epithelial ovarian cancer
132705|NCT03373058|Cytoreductive surgery|cytoreductive surgery
132706|NCT03373058|Postoperative Chemotherapy|postoperative chemotherapy
132707|NCT03373045|Severe asthma|severe asthma
132708|NCT03373045|Monoclonal antibody|monoclonal antibody
132709|NCT03373045|Corticosteroid|corticosteroid
132710|NCT03373045|Non-interventional|non-interventional
132711|NCT03373032|Physical Activity|physical activity
132712|NCT03373032|Sensory Neuropathy|sensory neuropathy
132715|NCT03373019|R-GDP|r-gdp
132716|NCT03373019|diffuse large B-cell lymphoma|diffuse large b-cell lymphoma
132717|NCT03372980|Biomarkers|biomarkers
132718|NCT03372967|preventable disease|preventable disease
132719|NCT03372967|vaccine|vaccine
132720|NCT03372967|public health|public health
132721|NCT03372967|vaccine history|vaccine history
132722|NCT03372967|point-of-care|point-of-care
132723|NCT03372941|Acute bacterial skin and skin structure infections|acute bacterial skin and skin structure infections
132724|NCT03372941|Hospital avoidance|hospital avoidance
132725|NCT03372941|Antibiotic therapy|antibiotic therapy
132726|NCT03372941|Dalbavancin|dalbavancin
132727|NCT03372941|Emergency department|emergency department
132728|NCT03372902|Breast imaging|breast imaging
132729|NCT03372902|17-598|17-598
132730|NCT03372889|Anterior Cruciate Ligament|anterior cruciate ligament
132731|NCT03372889|On-Q Catheter|on-q catheter
132732|NCT03372889|nerve block|nerve block
132733|NCT03372889|ACL reconstruction|acl reconstruction
132734|NCT03372889|patient education materials|patient education materials
132735|NCT03372837|Diffuse large B-cell lymphoma, rituximab, SyB L-0501, combination therapy|diffuse large b-cell lymphoma, rituximab, syb l-0501, combination therapy
132736|NCT03372824|mass screening|mass screening
132737|NCT03372798|catheter ablation|catheter ablation
132738|NCT03372798|intraprocedural left atrial wall thickness imaging|intraprocedural left atrial wall thickness imaging
132739|NCT03372785|coronary artery disease|coronary artery disease
132740|NCT03372785|Cardiac magnetic resonance (CMR) imaging|cardiac magnetic resonance (cmr) imaging
132741|NCT03372785|Myocardial Stunning|myocardial stunning
132742|NCT03372785|Percutaneous Coronary Intervention|percutaneous coronary intervention
132743|NCT03372785|Chronic Total Occlusion of Coronary Artery|chronic total occlusion of coronary artery
132744|NCT03372772|Fatigue, Levocarnitine,|fatigue, levocarnitine,
132745|NCT03372746|Biopsy|biopsy
132746|NCT03372733|Omega-7|omega-7
132747|NCT03372733|Palmitoleic Acid|palmitoleic acid
132748|NCT03372733|Monounsaturated Fatty Acids|monounsaturated fatty acids
132749|NCT03372733|Lipoproteins|lipoproteins
132750|NCT03372733|Satiety|satiety
132751|NCT03372707|Cuff leak test|cuff leak test
132752|NCT03372707|Post-extubation airway obstruction|post-extubation airway obstruction
132753|NCT03372707|Laryngeal edema|laryngeal edema
132754|NCT03372681|Distal Gastrectomy|distal gastrectomy
132755|NCT03372681|Postoperative Reflux Rate|postoperative reflux rate
132756|NCT03372681|Gastric Cance|gastric cance
132757|NCT03372681|Laparoscopic Surgery|laparoscopic surgery
132758|NCT03372668|lower limb amputation|lower limb amputation
132759|NCT03372668|PLP|plp
132760|NCT03372616|aortic blood pressure|aortic blood pressure
132761|NCT03372616|diastolic dysfuntion|diastolic dysfuntion
132762|NCT03372616|echocardiography|echocardiography
132763|NCT03372616|left ventricular ejection fraction|left ventricular ejection fraction
132764|NCT03372603|GSK2798745, efficacy, safety, chronic cough, crossover study|gsk2798745, efficacy, safety, chronic cough, crossover study
132765|NCT03372590|general movement assessment|general movement assessment
132766|NCT03372538|placenta accreta|placenta accreta
132767|NCT03372499|Hepatic Encephalopathy|hepatic encephalopathy
132768|NCT03372499|Diet Management|diet management
132769|NCT03372499|Transjugular Intrahepatic Portosystemic Shunt|transjugular intrahepatic portosystemic shunt
132770|NCT03372460|Transcranial Direct Current Stimulation|transcranial direct current stimulation
132771|NCT03372460|Stress Disorders, Post-Traumatic|stress disorders, post-traumatic
132772|NCT03372460|Virtual Reality|virtual reality
132773|NCT03372460|Prefrontal Cortex|prefrontal cortex
132774|NCT03372460|Veterans|veterans
132775|NCT03372460|Quality of Life|quality of life
132776|NCT03372395|probiotics implementation|probiotics implementation
132777|NCT03372395|HPV infection|hpv infection
132778|NCT03372395|vaginosis|vaginosis
132779|NCT03372395|yeast vaginitis|yeast vaginitis
132780|NCT03372382|postpartum|postpartum
132781|NCT03372369|contraceptive knowledge|contraceptive knowledge
132782|NCT03372369|contraceptive use|contraceptive use
132783|NCT03372369|educational intervention|educational intervention
132784|NCT03372369|poster|poster
132785|NCT03372369|online survey|online survey
132786|NCT03372356|DT|dt
132787|NCT03372356|HADS|hads
132788|NCT03372356|SPBS|spbs
132789|NCT03372356|CD-RISC|cd-risc
132790|NCT03372356|Psychosocial Screening|psychosocial screening
132791|NCT03372330|peripheral artery disease|peripheral artery disease
132792|NCT03372330|sepsis|sepsis
132793|NCT03372317|Tau|tau
132794|NCT03372317|MK-6240|mk-6240
132795|NCT03372317|Cognition|cognition
132796|NCT03372304|Peripheral regional anesthesia|peripheral regional anesthesia
132797|NCT03372291|Acute Myeloid Leukemia|acute myeloid leukemia
132798|NCT03372278|Total hip arthroplasty|total hip arthroplasty
132799|NCT03372278|Medical Device|medical device
132800|NCT03372278|Safety|safety
132801|NCT03372278|Prothesis|prothesis
132802|NCT03372265|Peripheral regional anesthesia|peripheral regional anesthesia
132803|NCT03372239|Indoximod|indoximod
132804|NCT03372226|Gambling|gambling
132805|NCT03372226|Problematic Gambling|problematic gambling
132806|NCT03372226|Pathological Gambling|pathological gambling
132807|NCT03372187|diet|diet
132808|NCT03372187|MS|ms
132809|NCT03372187|Telehealth|telehealth
132810|NCT03372174|cardiac surgery|cardiac surgery
132811|NCT03372174|mechanical ventilation|mechanical ventilation
132812|NCT03372174|postoperative infections|postoperative infections
132813|NCT03372161|lumbosacral radicular pain|lumbosacral radicular pain
132814|NCT03372161|sciatica|sciatica
132815|NCT03372161|leg pain|leg pain
132816|NCT03372135|POCD|pocd
132817|NCT03372135|RARC|rarc
132818|NCT03372135|Trendelenburg Position|trendelenburg position
132819|NCT03372096|embolization|embolization
132820|NCT03372096|prostate|prostate
132821|NCT03372083|Iron Chelation Therapy|iron chelation therapy
132822|NCT03372083|Deferasirox|deferasirox
132823|NCT03372083|Asunra|asunra
132824|NCT03372083|Jadenu|jadenu
132825|NCT03372083|Exjade|exjade
132826|NCT03372083|ICL 670|icl 670
132827|NCT03372083|Pediatric|pediatric
132828|NCT03372070|primary snoring|primary snoring
132829|NCT03372070|bed partner|bed partner
132830|NCT03372070|home sleep testing|home sleep testing
132831|NCT03372057|Lymphoma|lymphoma
132832|NCT03372057|T-cell Lymphoma|t-cell lymphoma
132833|NCT03372057|Relapse|relapse
132834|NCT03372057|Refractory|refractory
132835|NCT03372057|PI3K-δ,γ|pi3k-δ,γ
132836|NCT03372044|Relative bioavailability|relative bioavailability
132837|NCT03372044|Modified release|modified release
132838|NCT03372044|Pharmacokinetics|pharmacokinetics
132839|NCT03372031|Music Supported Therapy|music supported therapy
132840|NCT03372031|plasticity|plasticity
132841|NCT03372031|multisensory integration|multisensory integration
132842|NCT03372031|bimanual coupling|bimanual coupling
132843|NCT03372031|auditory feedback|auditory feedback
132844|NCT03372031|dexterity|dexterity
132845|NCT03372031|piano therapy|piano therapy
132846|NCT03371992|immunotherapy|immunotherapy
132847|NCT03371992|anti-PD1|anti-pd1
132848|NCT03371992|anti-PDL1|anti-pdl1
132849|NCT03371992|biomarker|biomarker
132850|NCT03371992|drug mechanism|drug mechanism
132851|NCT03371966|Beetroot Juice|beetroot juice
132852|NCT03371966|Older Adults|older adults
132853|NCT03371966|Nitrate|nitrate
132854|NCT03371966|Nitrite|nitrite
132855|NCT03371966|Nitric Oxide|nitric oxide
132856|NCT03371953|vecuronium|vecuronium
132857|NCT03371953|atracurium|atracurium
132858|NCT03371953|combination|combination
132859|NCT03371927|Premature Infants|premature infants
132860|NCT03371927|SINC feeding protocol|sinc feeding protocol
132861|NCT03371914|costing|costing
132862|NCT03371914|behavioral intervention|behavioral intervention
132863|NCT03371914|management|management
132864|NCT03371901|Menisci, Tibial|menisci, tibial
132865|NCT03371901|Cartilage, Articular|cartilage, articular
132866|NCT03371901|Blood Flow Restriction Training|blood flow restriction training
132867|NCT03371901|Resistance training|resistance training
132868|NCT03371901|Physical Therapy Modalities|physical therapy modalities
132869|NCT03371901|Feasibility Studies|feasibility studies
132870|NCT03371862|Liraglutide|liraglutide
132871|NCT03371862|Victoza|victoza
132872|NCT03371836|pediatrics|pediatrics
132873|NCT03371823|Hypertension|hypertension
132874|NCT03371823|Endothelin-1 receptor|endothelin-1 receptor
132875|NCT03371810|attention-deficit / hyperactivity disorder|attention-deficit / hyperactivity disorder
132876|NCT03371810|depression|depression
132877|NCT03371810|obesity|obesity
132878|NCT03371810|prevention|prevention
132879|NCT03371810|bright light therapy|bright light therapy
132880|NCT03371810|exercise|exercise
132881|NCT03371810|mobile healthy system|mobile healthy system
132882|NCT03371797|ALERT, MSSBP, MSDBP|alert, mssbp, msdbp
132883|NCT03371784|Acute myocardial infarction|acute myocardial infarction
132884|NCT03371784|Left ventricular remodeling|left ventricular remodeling
132885|NCT03371784|Coronary wedge pressure|coronary wedge pressure
132886|NCT03371784|Glucocorticoid therapy|glucocorticoid therapy
132887|NCT03371732|Psychological intervention Alcohol|psychological intervention alcohol
132888|NCT03371732|Tobacco consumption|tobacco consumption
132889|NCT03371732|Substance use|substance use
132890|NCT03371732|Health risk behavior|health risk behavior
132891|NCT03371732|Oncology setting|oncology setting
132892|NCT03371732|Women|women
132893|NCT03371732|Supportive care|supportive care
132894|NCT03371706|aphasia|aphasia
132895|NCT03371706|primary progressive aphasia|primary progressive aphasia
132896|NCT03371706|dementia|dementia
132897|NCT03371706|communication|communication
132898|NCT03371706|frontotemporal dementia|frontotemporal dementia
132899|NCT03371706|Alzheimer's disease|alzheimer's disease
132900|NCT03371693|hyperthermic intraperitoneal chemotherapy|hyperthermic intraperitoneal chemotherapy
132901|NCT03371693|epithelial ovarian cancer|epithelial ovarian cancer
132902|NCT03371667|Hematopoietic Stem Cell|hematopoietic stem cell
132903|NCT03371667|Methotrexate|methotrexate
132904|NCT03371667|Corticosteroids therapy|corticosteroids therapy
132905|NCT03371667|Acute GVHD|acute gvhd
132906|NCT03371667|Allogenic stem cell transplantation|allogenic stem cell transplantation
132907|NCT03371641|Fetal Alcohol Syndrome|fetal alcohol syndrome
132908|NCT03371641|Pregnancy|pregnancy
132909|NCT03371641|Biomarker|biomarker
132910|NCT03371641|PlGF|plgf
132911|NCT03371641|Cognitive development|cognitive development
132912|NCT03371641|Behavior troubles|behavior troubles
132913|NCT03371576|toric IOL|toric iol
132914|NCT03371550|Concurrent 3-D chemoradiotherapy,Docetaxel,Cisplatin,Chemotherapy ·|concurrent 3-d chemoradiotherapy,docetaxel,cisplatin,chemotherapy ·
132915|NCT03371511|Microbiota|microbiota
132916|NCT03371511|Microbiome|microbiome
132917|NCT03371485|Non-small cell lung cancer|non-small cell lung cancer
132918|NCT03371485|Immunotherapy|immunotherapy
132919|NCT03371485|Cancer vaccine|cancer vaccine
132920|NCT03371485|Dendritic cell vaccine|dendritic cell vaccine
132921|NCT03371485|Allogeneic vaccine|allogeneic vaccine
132922|NCT03371446|DNA Methylation. Smoking. SOCS-1 gene.|dna methylation. smoking. socs-1 gene.
132923|NCT03371433|Osteoporosis|osteoporosis
132924|NCT03371433|Hip Fractures|hip fractures
132925|NCT03371433|Soft Drinks|soft drinks
132926|NCT03371368|Obesity|obesity
132927|NCT03371368|Insulin Resistance|insulin resistance
132928|NCT03371368|Bariatric Surgery|bariatric surgery
132929|NCT03371368|Gastric Bypass|gastric bypass
132930|NCT03371368|Sleeve Gastrectomy|sleeve gastrectomy
132931|NCT03371355|Type 2 Diabetes|type 2 diabetes
132932|NCT03371355|Hepatic Steatosis|hepatic steatosis
132933|NCT03371355|Triglycerides|triglycerides
132934|NCT03371355|AKCEA-ANGPTL3-Lrx|akcea-angptl3-lrx
132935|NCT03371355|IONIS-ANGPTL3-Lrx|ionis-angptl3-lrx
132936|NCT03371355|Fatty Liver|fatty liver
132937|NCT03371355|Fatty Liver Without Mention of Alcohol|fatty liver without mention of alcohol
132938|NCT03371355|Liver Fat|liver fat
132939|NCT03371355|Liver Diseases|liver diseases
132940|NCT03371355|Diabetes Mellitus Type 2 in Nonobese|diabetes mellitus type 2 in nonobese
132941|NCT03371355|Diabetes Mellitus|diabetes mellitus
132942|NCT03371355|Triglycerides High|triglycerides high
132943|NCT03371355|High Triglycerides|high triglycerides
132944|NCT03371355|Metabolic Disease|metabolic disease
132945|NCT03371355|Endocrine System Diseases|endocrine system diseases
132946|NCT03371355|Digestive System Disease|digestive system disease
132947|NCT03371355|Glucose Metabolism Disorders|glucose metabolism disorders
132948|NCT03371329|mesenchymal stem cell|mesenchymal stem cell
132949|NCT03371329|stroke|stroke
132950|NCT03371329|intracerebral hemorrhage|intracerebral hemorrhage
132951|NCT03371329|cell therapy|cell therapy
132952|NCT03371264|Liver transplantation|liver transplantation
132953|NCT03371264|Allocation process|allocation process
132954|NCT03371264|Extended-criteria donors|extended-criteria donors
132955|NCT03371264|Survival|survival
132956|NCT03371251|Adults|adults
132957|NCT03371251|BOS161721|bos161721
132958|NCT03371251|standard of care|standard of care
132959|NCT03371251|moderately to severely active Systemic Lupus Erythematosus|moderately to severely active systemic lupus erythematosus
132960|NCT03371212|Dual Mobility|dual mobility
132961|NCT03371212|Serum metal levels|serum metal levels
132962|NCT03371186|Implementation Research|implementation research
132963|NCT03371186|Maternal Mortality and Morbidity|maternal mortality and morbidity
132964|NCT03371186|Neonatal Mortality and Morbidity|neonatal mortality and morbidity
132965|NCT03371186|Infant Mortality and Morbidity|infant mortality and morbidity
132966|NCT03371186|Child Mortality and Morbidity|child mortality and morbidity
132967|NCT03371186|Community Health Workers|community health workers
132968|NCT03371186|Health Systems Strengthening|health systems strengthening
132969|NCT03371173|Pulmonary Hypertension|pulmonary hypertension
132970|NCT03371173|Iron Deficiency|iron deficiency
132971|NCT03371108|Diabetes|diabetes
132972|NCT03371108|Diabetes Type 2|diabetes type 2
132973|NCT03371108|Type 2|type 2
132974|NCT03371108|Basal|basal
132975|NCT03371108|Insulin|insulin
132976|NCT03371108|Glargine|glargine
132977|NCT03371108|T2DM|t2dm
132978|NCT03371108|Diabetes Mellitus|diabetes mellitus
132979|NCT03371095|Behcet's Disease|behcet's disease
132980|NCT03371095|Vasculitis|vasculitis
132981|NCT03371095|Biotherapy|biotherapy
132982|NCT03371095|immunosuppressant|immunosuppressant
132983|NCT03371095|Infliximab|infliximab
132984|NCT03371082|Diabetes|diabetes
132985|NCT03371082|Diabetes Type 1|diabetes type 1
132986|NCT03371082|Type 1|type 1
132987|NCT03371082|Basal|basal
132988|NCT03371082|Insulin|insulin
132989|NCT03371082|Glargine|glargine
132990|NCT03371082|T1DM|t1dm
132991|NCT03371082|Diabetes Mellitus|diabetes mellitus
132992|NCT03371082|Insulin Dependent Diabetes|insulin dependent diabetes
132993|NCT03371069|methylphenidate|methylphenidate
132994|NCT03371069|drug utilisation study|drug utilisation study
132995|NCT03371069|pediatrics|pediatrics
132996|NCT03371056|Neonatal infections|neonatal infections
132997|NCT03371056|maternal-fetal infection|maternal-fetal infection
132998|NCT03371056|group B streptococcus|group b streptococcus
132999|NCT03371056|vaginal sample|vaginal sample
133000|NCT03371056|antibiotic prophylaxis|antibiotic prophylaxis
133001|NCT03371056|bacterial resistance|bacterial resistance
133002|NCT03371043|analgesics|analgesics
133003|NCT03371043|opioids|opioids
133004|NCT03371043|outpatient drug use|outpatient drug use
133005|NCT03371043|pediatrics|pediatrics
133006|NCT03371030|distal radius fractures|distal radius fractures
133007|NCT03371030|pronator quadratus|pronator quadratus
133008|NCT03371030|osteosynthesis|osteosynthesis
133009|NCT03371004|DM-CHOC-PEN|dm-choc-pen
133010|NCT03371004|Radiation|radiation
133011|NCT03371004|Cancer|cancer
133012|NCT03370991|Blueberries|blueberries
133013|NCT03370991|Polyphenols|polyphenols
133014|NCT03370991|Cardiovascular Disease|cardiovascular disease
133015|NCT03370991|Atherosclerosis|atherosclerosis
133016|NCT03370991|Oxidative Stress|oxidative stress
133017|NCT03370991|Inflammmation|inflammmation
133018|NCT03370991|Endothelium|endothelium
133019|NCT03370991|Vasodilation|vasodilation
133020|NCT03370991|Blood Pressure|blood pressure
133021|NCT03370991|Menopause|menopause
133022|NCT03370991|Women's Health|women's health
133023|NCT03370991|Functional Food|functional food
133024|NCT03370991|Bioactive Compounds|bioactive compounds
133025|NCT03370991|Dietary Supplements|dietary supplements
133026|NCT03370991|Aging|aging
133027|NCT03370965|optic neuritis|optic neuritis
133028|NCT03370965|neuromyelitis optica|neuromyelitis optica
133029|NCT03370965|multiple sclerosis|multiple sclerosis
133030|NCT03370965|emergent treatment of optic neuritis|emergent treatment of optic neuritis
133031|NCT03370965|optic neuritis disease modifying therapy|optic neuritis disease modifying therapy
133032|NCT03370965|optic neuritis treatment trial|optic neuritis treatment trial
133033|NCT03370965|plasma exchange|plasma exchange
133034|NCT03370939|ischemic stroke|ischemic stroke
133035|NCT03370939|endovascular treatment|endovascular treatment
133036|NCT03370939|workflow|workflow
133037|NCT03370913|Gene Therapy|gene therapy
133038|NCT03370913|Clotting Disorders|clotting disorders
133039|NCT03370913|Blood Disorder|blood disorder
133040|NCT03370913|Blood Coagulation Disorders|blood coagulation disorders
133041|NCT03370913|Inherited Blood Coagulation disorders|inherited blood coagulation disorders
133042|NCT03370913|Hematologic Diseases|hematologic diseases
133043|NCT03370913|Coagulation Protein Disorders|coagulation protein disorders
133044|NCT03370913|Hemorrhagic Disorders|hemorrhagic disorders
133045|NCT03370913|Genetic Diseases|genetic diseases
133046|NCT03370913|Inborn|inborn
133047|NCT03370913|Factor VIII|factor viii
133048|NCT03370913|Coagulants|coagulants
133049|NCT03370900|Education (Medical); Retention;|education (medical); retention;
133050|NCT03370848|Niacin|niacin
133051|NCT03370848|Psyllium|psyllium
133052|NCT03370848|Dietary fiber|dietary fiber
133053|NCT03370835|Beta-Blocker|beta-blocker
133054|NCT03370835|Chronic Obstructive Pulmonary Disease|chronic obstructive pulmonary disease
133055|NCT03370835|COPD|copd
133056|NCT03370835|Cardioselective|cardioselective
133057|NCT03370822|Fetal monitoring|fetal monitoring
133058|NCT03370822|Acceptability|acceptability
133059|NCT03370822|Fetal Heart Rate|fetal heart rate
133060|NCT03370809|Frailty|frailty
133061|NCT03370809|Oncogeriatric|oncogeriatric
133062|NCT03370809|PET 18F-FDG|pet 18f-fdg
133063|NCT03370809|SPM (Statistical Parametric Mapping)|spm (statistical parametric mapping)
133064|NCT03370809|Neurology|neurology
133065|NCT03370796|dementia|dementia
133066|NCT03370796|cognitive impairment|cognitive impairment
133067|NCT03370796|cognition|cognition
133068|NCT03370796|quality of life|quality of life
133069|NCT03370796|depressive symptoms|depressive symptoms
133070|NCT03370796|Reminiscence Therapy|reminiscence therapy
133071|NCT03370744|subjective cognitive decline|subjective cognitive decline
133072|NCT03370744|brain network|brain network
133073|NCT03370744|multi-modality|multi-modality
133074|NCT03370744|magnetic resonance imaging|magnetic resonance imaging
133075|NCT03370731|pediatric|pediatric
133076|NCT03370731|obstructive sleep apnea|obstructive sleep apnea
133077|NCT03370731|polysomnography|polysomnography
133078|NCT03370731|quality of life|quality of life
133079|NCT03370731|adenotonsillectomy|adenotonsillectomy
133080|NCT03370692|Outcome|outcome
133081|NCT03370692|Survival|survival
133082|NCT03370692|Prognostication|prognostication
133083|NCT03370679|Premature|premature
133084|NCT03370679|Ventricular|ventricular
133085|NCT03370679|Complexes|complexes
133086|NCT03370679|Beats|beats
133087|NCT03370679|Prognosis|prognosis
133088|NCT03370653|MPS VI|mps vi
133089|NCT03370653|Lysosomal disease|lysosomal disease
133090|NCT03370653|Glycoaminoglycans (GAG)|glycoaminoglycans (gag)
133091|NCT03370653|Odiparcil|odiparcil
133092|NCT03370627|Autoimmune Diseases|autoimmune diseases
133093|NCT03370627|Plasmacytoid Dendritic Cells|plasmacytoid dendritic cells
133094|NCT03370627|Type I Interferons|type i interferons
133095|NCT03370627|Antibodies|antibodies
133096|NCT03370627|Anti-CD303|anti-cd303
133097|NCT03370614|PET|pet
133098|NCT03370614|MRI|mri
133099|NCT03370614|Irritable Bowel Syndrome|irritable bowel syndrome
133100|NCT03370614|Irritable Bowel|irritable bowel
133101|NCT03370614|Positron emission tomography|positron emission tomography
133102|NCT03370614|Magnetic resonance imaging|magnetic resonance imaging
133103|NCT03370614|FDG|fdg
133104|NCT03370614|Fluorodeoxyglucose|fluorodeoxyglucose
133105|NCT03370601|crohn's disease|crohn's disease
133106|NCT03370601|ulcerative colitis|ulcerative colitis
133107|NCT03370601|infliximab|infliximab
133108|NCT03370601|loss of response|loss of response
133109|NCT03370562|dexmedetomidine|dexmedetomidine
133110|NCT03370562|cesarean|cesarean
133111|NCT03370562|spinal anesthesia|spinal anesthesia
133112|NCT03370549|Mental health|mental health
133113|NCT03370549|Suicide|suicide
133114|NCT03370549|Sexual risk behaviors|sexual risk behaviors
133115|NCT03370536|Atrial Fibrillation|atrial fibrillation
133116|NCT03370536|Persistent Atrial Fibrillation|persistent atrial fibrillation
133117|NCT03370536|AFIB|afib
133118|NCT03370536|Arrhythmia|arrhythmia
133119|NCT03370471|aerobic exercise|aerobic exercise
133120|NCT03370471|learning|learning
133121|NCT03370471|language|language
133122|NCT03370471|cognition|cognition
133123|NCT03370432|Vitamin D|vitamin d
133125|NCT03370432|CYP2R1|cyp2r1
133126|NCT03370432|Gene-environment interaction|gene-environment interaction
133127|NCT03370432|prospective case-cohort study|prospective case-cohort study
133128|NCT03370432|single nucleotide polymorphisms|single nucleotide polymorphisms
133129|NCT03370432|colorectal cancer|colorectal cancer
133130|NCT03370419|Metabolic syndrome|metabolic syndrome
133131|NCT03370419|Habits|habits
133132|NCT03370419|African American|african american
133133|NCT03370419|Emergency Medicine|emergency medicine
133134|NCT03370406|Squamous Cell|squamous cell
133135|NCT03370406|Carcinoma|carcinoma
133136|NCT03370406|Lower Extremities|lower extremities
133137|NCT03370406|5-Fluorouracil|5-fluorouracil
133138|NCT03370406|Imiquimod|imiquimod
133139|NCT03370393|Reward-drive|reward-drive
133140|NCT03370393|Cogntiive-control|cogntiive-control
133141|NCT03370315|Parkinsonian Disorders|parkinsonian disorders
133142|NCT03370315|Dance Therapy|dance therapy
133143|NCT03370315|Rehabilitation|rehabilitation
133144|NCT03370315|Kinematics|kinematics
133145|NCT03370315|Locomotion|locomotion
133146|NCT03370315|Quality of Life|quality of life
133147|NCT03370302|Drug therapy|drug therapy
133148|NCT03370263|Benlysta, systemic lupus erythematosus, safety, efficacy|benlysta, systemic lupus erythematosus, safety, efficacy
133149|NCT03370250|immediate breast reconstruction|immediate breast reconstruction
133150|NCT03370250|free greater omentum|free greater omentum
133151|NCT03370250|breast-conserving surgery|breast-conserving surgery
133152|NCT03370250|luminal breast cancer|luminal breast cancer
133153|NCT03370237|Diabetic foot ulcer|diabetic foot ulcer
133154|NCT03370237|type 2 diabetes|type 2 diabetes
133155|NCT03370237|foot ulcer risk|foot ulcer risk
133156|NCT03370224|Memory|memory
133157|NCT03370224|Learning|learning
133158|NCT03370224|Cognition|cognition
133159|NCT03370224|Treatment|treatment
133160|NCT03370211|resistance training|resistance training
133161|NCT03370211|inflammatory markers|inflammatory markers
133162|NCT03370211|functional capacity|functional capacity
133163|NCT03370185|Leukemia|leukemia
133164|NCT03370185|Lymphoma|lymphoma
133165|NCT03370185|Refractory|refractory
133166|NCT03370185|Relapse|relapse
133167|NCT03370133|Bimekizumab|bimekizumab
133168|NCT03370133|PSO|pso
133169|NCT03370133|Psoriasis|psoriasis
133170|NCT03370120|Drug-Resistant Epilepsy|drug-resistant epilepsy
133171|NCT03370120|Padsevonil|padsevonil
133172|NCT03370081|Capnometry|capnometry
133173|NCT03370081|Capnography|capnography
133174|NCT03370081|ETCO2|etco2
133175|NCT03370081|Recovery room|recovery room
133176|NCT03370081|Post-anesthesia care unit|post-anesthesia care unit
133177|NCT03370068|ICSI|icsi
133178|NCT03370068|IVF|ivf
133179|NCT03370068|Infertility|infertility
133180|NCT03370068|non-male factor|non-male factor
133181|NCT03370068|intracytoplasmic sperm injection|intracytoplasmic sperm injection
133182|NCT03370068|In vitro fertilization|in vitro fertilization
133183|NCT03370055|Exposed tendon or bone|exposed tendon or bone
133184|NCT03370055|LeucoPatch|leucopatch
133185|NCT03370055|Plastic Surgery|plastic surgery
133186|NCT03370055|Granulation tissue|granulation tissue
133187|NCT03370055|Wound|wound
133188|NCT03370042|aesthetics|aesthetics
133189|NCT03370042|root coverage|root coverage
133190|NCT03370042|semilunar coronally positioned flap|semilunar coronally positioned flap
133191|NCT03370042|free gingival graft|free gingival graft
133192|NCT03370042|width of keratinised tissue|width of keratinised tissue
133193|NCT03370029|Exercise capacity|exercise capacity
133194|NCT03370029|Respiratory muscle strength|respiratory muscle strength
133195|NCT03370029|Physical inactivity|physical inactivity
133196|NCT03370029|Quality of life|quality of life
133197|NCT03370016|Radical Prostatectomy|radical prostatectomy
133198|NCT03370016|Robotic Assisted Radical Prostatectomy|robotic assisted radical prostatectomy
133199|NCT03369977|BioGlue Surgical Adhesive|bioglue surgical adhesive
133200|NCT03369977|Type A Aortic Dissection|type a aortic dissection
133201|NCT03369951|ACUMIN|acumin
133202|NCT03369951|Infusion|infusion
133203|NCT03369951|Injection|injection
133204|NCT03369951|Minocycline|minocycline
133205|NCT03369951|Pharmacokinetic|pharmacokinetic
133206|NCT03369951|PK|pk
133207|NCT03369938|left ventricular assist device|left ventricular assist device
133208|NCT03369938|exercise training|exercise training
133209|NCT03369912|Safety, efficacy|safety, efficacy
133210|NCT03369912|pregnant women|pregnant women
133211|NCT03369912|CSJ148|csj148
133212|NCT03369912|HCMV infection|hcmv infection
133213|NCT03369912|congenital HCMV|congenital hcmv
133215|NCT03369886|Angiography|angiography
133216|NCT03369886|Artificial neural network|artificial neural network
133217|NCT03369873|cardiac catheterization|cardiac catheterization
133218|NCT03369873|anxiety|anxiety
133219|NCT03369873|stress|stress
133220|NCT03369873|nursing orientation|nursing orientation
133221|NCT03369847|inhaled corticosteroids|inhaled corticosteroids
133222|NCT03369847|budesonide|budesonide
133223|NCT03369847|beclomethasone|beclomethasone
133224|NCT03369834|phototherapy|phototherapy
133225|NCT03369834|diabetes mellitus|diabetes mellitus
133226|NCT03369834|exercise|exercise
133227|NCT03369821|type 1 diabetes|type 1 diabetes
133228|NCT03369821|monogenic diabetes|monogenic diabetes
133229|NCT03369821|autoimmune diabetes|autoimmune diabetes
133230|NCT03369821|early-onset autoimmune diabetes|early-onset autoimmune diabetes
133231|NCT03369821|beta cell (β-cell) destruction|beta cell (β-cell) destruction
133232|NCT03369821|type 1 diabetes genetic risk|type 1 diabetes genetic risk
133233|NCT03369821|extremely early-onset Type 1 diabetes|extremely early-onset type 1 diabetes
133234|NCT03369821|neonatal diabetes|neonatal diabetes
133235|NCT03369808|H7N9|h7n9
133236|NCT03369795|methotrexate|methotrexate
133237|NCT03369795|add-on|add-on
133238|NCT03369795|schizophrenia|schizophrenia
133239|NCT03369795|schizoaffective|schizoaffective
133240|NCT03369782|Muscle Tension|muscle tension
133241|NCT03369782|Skeletal Muscle Relaxants|skeletal muscle relaxants
133242|NCT03369782|Arthroplasties, Hip Replacement|arthroplasties, hip replacement
133243|NCT03369782|Rocuronium|rocuronium
133244|NCT03369782|sugammadex|sugammadex
133245|NCT03369730|Screening|screening
133246|NCT03369730|Duration of Untreated Psychosis (DUP)|duration of untreated psychosis (dup)
133247|NCT03369730|Coordinated Specialty Care (CSC)|coordinated specialty care (csc)
133248|NCT03369730|First Episode Psychosis (FEP)|first episode psychosis (fep)
133249|NCT03369730|At Risk Mental State (ARMS)|at risk mental state (arms)
133250|NCT03369730|Clinical High Risk for Psychosis (CHR)|clinical high risk for psychosis (chr)
133251|NCT03369717|endoscopic sinus surgery|endoscopic sinus surgery
133252|NCT03369717|antibiotics|antibiotics
133253|NCT03369704|cryptomeria, omalizumab, seasonal allergic rhinitis|cryptomeria, omalizumab, seasonal allergic rhinitis
133254|NCT03369678|Cultural Safety|cultural safety
133255|NCT03369678|Discrimination|discrimination
133256|NCT03369678|Emergency Departments|emergency departments
133257|NCT03369678|Health Equity|health equity
133258|NCT03369678|Indigenous Populations|indigenous populations
133259|NCT03369678|Marginalized Populations|marginalized populations
133260|NCT03369678|Patient Experiences of Care|patient experiences of care
133261|NCT03369678|Trauma- and Violence-Informed Care|trauma- and violence-informed care
133262|NCT03369678|Staff Engagement|staff engagement
133263|NCT03369678|Harm Reduction|harm reduction
133264|NCT03369665|Multiple sclerosis|multiple sclerosis
133265|NCT03369665|Mavenclad®|mavenclad®
133266|NCT03369665|Cladribine|cladribine
133267|NCT03369665|Health-related Quality of Life|health-related quality of life
133268|NCT03369639|late life|late life
133269|NCT03369639|THC|thc
133270|NCT03369639|depression|depression
133271|NCT03369639|anxiety|anxiety
133272|NCT03369639|dronabinol|dronabinol
133273|NCT03369600|elastography|elastography
133274|NCT03369587|Handwriting, Micrographia|handwriting, micrographia
133275|NCT03369548|Bile acids|bile acids
133276|NCT03369548|Lipid metabolism|lipid metabolism
133277|NCT03369548|Cholesterol|cholesterol
133278|NCT03369548|Probiotics|probiotics
133279|NCT03369548|Polyphenols|polyphenols
133280|NCT03369548|Prebiotics|prebiotics
133281|NCT03369548|Gut bacteria|gut bacteria
133282|NCT03369548|Gut microbiota|gut microbiota
133283|NCT03369535|hypertension|hypertension
133284|NCT03369522|seizure detection|seizure detection
133285|NCT03369509|Drug hypersensitivity, drug allergy, cross reaction|drug hypersensitivity, drug allergy, cross reaction
133286|NCT03369496|Social Capital|social capital
133287|NCT03369496|Social Support|social support
133288|NCT03369496|Neighborhood|neighborhood
133289|NCT03369496|Population Health|population health
133290|NCT03369496|Healthy Aging|healthy aging
133291|NCT03369496|Adult|adult
133292|NCT03369496|Canada|canada
133293|NCT03369431|Autism|autism
133294|NCT03369431|Gastrointestinal|gastrointestinal
133295|NCT03369431|behaviour|behaviour
133296|NCT03369431|constipation|constipation
133297|NCT03369431|diarrhoea|diarrhoea
133298|NCT03369431|probiotic|probiotic
133299|NCT03369431|sociability|sociability
133300|NCT03369405|periodontitis|periodontitis
133301|NCT03369405|hypothyroidism|hypothyroidism
133302|NCT03369379|Fibromyalgia|fibromyalgia
133303|NCT03369379|D Vitamin|d vitamin
133304|NCT03369366|Maxillofacial Defects|maxillofacial defects
133305|NCT03369366|Benign, large tumors requiring surgical resection|benign, large tumors requiring surgical resection
133306|NCT03369353|Bone Marrow Transplantation|bone marrow transplantation
133307|NCT03369353|Graft Vs Host Disease|graft vs host disease
133308|NCT03369353|Inflammatory Bowel Diseases|inflammatory bowel diseases
133309|NCT03369353|Functional Gastrointestinal Disorders|functional gastrointestinal disorders
133315|NCT03369275|Mesenchymal Stromal Cells|mesenchymal stromal cells
133316|NCT03369275|Randomized Controlled Trial|randomized controlled trial
133317|NCT03369275|Cryopreserved|cryopreserved
133318|NCT03369275|Allogeneic|allogeneic
133319|NCT03369275|Phase II|phase ii
133320|NCT03369262|preterm labor|preterm labor
133321|NCT03369262|preterm birth|preterm birth
133322|NCT03369262|premature birth|premature birth
133323|NCT03369262|tocolysis|tocolysis
133324|NCT03369262|prostaglandin F2α antagonist|prostaglandin f2α antagonist
133326|NCT03369262|tocolytic|tocolytic
133327|NCT03369236|factor D|factor d
133328|NCT03369236|fD|fd
133329|NCT03369236|alternative pathway|alternative pathway
133330|NCT03369236|complement mediated disease|complement mediated disease
133331|NCT03369236|Membranoproliferative Glomerulonephritis|membranoproliferative glomerulonephritis
133332|NCT03369236|Primary MPGN|primary mpgn
133333|NCT03369236|MPGN|mpgn
133334|NCT03369236|Mesangiocapillary Glomerulonephritis|mesangiocapillary glomerulonephritis
133335|NCT03369236|idiopathic MPGN|idiopathic mpgn
133336|NCT03369236|DDD|ddd
133337|NCT03369236|C3GN|c3gn
133344|NCT03369197|procedural sedation|procedural sedation
133345|NCT03369197|monitored anesthesia care|monitored anesthesia care
133346|NCT03369197|endoscopy|endoscopy
133347|NCT03369184|Coronary flow|coronary flow
133348|NCT03369184|Coronary vascular resistance|coronary vascular resistance
133349|NCT03369184|Supplemental oxygen|supplemental oxygen
133350|NCT03369145|Hepatokines|hepatokines
133351|NCT03369145|High Fat Diet|high fat diet
133352|NCT03369145|Glycaemic Control|glycaemic control
133353|NCT03369145|Fibroblast Growth Factor 21|fibroblast growth factor 21
133354|NCT03369145|Leukocyte Cell-derived Chemotaxin 2|leukocyte cell-derived chemotaxin 2
133355|NCT03369145|Fetuin-A|fetuin-a
133356|NCT03369145|Appetite|appetite
133357|NCT03369145|Ghrelin|ghrelin
133358|NCT03369145|Peptide YY|peptide yy
133359|NCT03369119|Acute asthma|acute asthma
133360|NCT03369119|Montelukast|montelukast
133361|NCT03369119|Hospitalized children|hospitalized children
133362|NCT03369119|Preschool children|preschool children
133363|NCT03369093|RCT|rct
133364|NCT03369093|severe pneumonia|severe pneumonia
133365|NCT03369093|amoxicillin|amoxicillin
133366|NCT03369093|under five|under five
133367|NCT03369080|Body Mass Index|body mass index
133368|NCT03369067|Artificial Pancreas (AP)|artificial pancreas (ap)
133369|NCT03369067|Continuous Glucose Monitor (CGM)|continuous glucose monitor (cgm)
133370|NCT03369067|Closed Loop Control (CLC)|closed loop control (clc)
133371|NCT03369067|Insulin Pump|insulin pump
133372|NCT03369041|chemoembolization|chemoembolization
133373|NCT03369015|Reward Learning|reward learning
133374|NCT03369015|Decision Making|decision making
133375|NCT03369002|Hepatic Impairment|hepatic impairment
133376|NCT03368950|Anxiety|anxiety
133377|NCT03368950|Depression|depression
133378|NCT03368950|Stress|stress
133379|NCT03368937|Artificial Pancreas (AP)|artificial pancreas (ap)
133380|NCT03368937|Closed Loop Control (CLC)|closed loop control (clc)
133381|NCT03368937|Continuous Glucose Monitor (CGM)|continuous glucose monitor (cgm)
133382|NCT03368937|Insulin Pump|insulin pump
133383|NCT03368924|sickle cell anemia red blood cell oxidation|sickle cell anemia red blood cell oxidation
133384|NCT03368924|vaso-occlusive crises|vaso-occlusive crises
133385|NCT03368924|anti bande 3 antibodies|anti bande 3 antibodies
133386|NCT03368924|red blood cell oxidation|red blood cell oxidation
133387|NCT03368911|Hoarseness|hoarseness
133388|NCT03368911|Sore Throat|sore throat
133389|NCT03368911|Thyroidectomy|thyroidectomy
133390|NCT03368885|MIYCN -Maternal Infant Young Child Nutrition|miycn -maternal infant young child nutrition
133391|NCT03368885|CGPP - Core Group Polio Project|cgpp - core group polio project
133392|NCT03368885|A&T- Alive and Thrive|a&t- alive and thrive
133393|NCT03368885|PCI- Project Concern International|pci- project concern international
133394|NCT03368885|UP- Uttar Pradesh|up- uttar pradesh
133395|NCT03368885|VHSNC -Village Health, Sanitation and Nutrition Committee|vhsnc -village health, sanitation and nutrition committee
133396|NCT03368885|CMC- Community Mobilization Coordinator|cmc- community mobilization coordinator
133397|NCT03368872|Sarcopenia, muscle function, muscle endurance, fatigue|sarcopenia, muscle function, muscle endurance, fatigue
133398|NCT03368859|cancer|cancer
133399|NCT03368859|colorectal cancer|colorectal cancer
133400|NCT03368859|ABT-165|abt-165
133401|NCT03368859|FOLFIRI|folfiri
133402|NCT03368859|Bevacizumab|bevacizumab
133403|NCT03368859|bowel cancer|bowel cancer
133404|NCT03368859|metastatic colorectal cancer|metastatic colorectal cancer
133593|NCT03367676|trastuzumab|trastuzumab
133405|NCT03368859|metastatic colorectal|metastatic colorectal
133406|NCT03368820|lung neoplasms|lung neoplasms
133407|NCT03368820|cardiovascular co-morbidity|cardiovascular co-morbidity
133408|NCT03368781|Atrial Fibrillation|atrial fibrillation
133409|NCT03368768|Antimicrobial-resistant bacterial infection|antimicrobial-resistant bacterial infection
133410|NCT03368768|Questionaire|questionaire
133411|NCT03368729|metastatic breast cancer|metastatic breast cancer
133412|NCT03368729|HER2 positive|her2 positive
133413|NCT03368729|Poly (ADP-Ribose) polymerase (PARP)|poly (adp-ribose) polymerase (parp)
133414|NCT03368729|Niraparib|niraparib
133415|NCT03368729|Trastuzumab|trastuzumab
133416|NCT03368716|Pediatric Obesity|pediatric obesity
170232|NCT03131544|BPH|bph
133417|NCT03368716|Executive Function|executive function
133418|NCT03368716|Behavioral Intervention|behavioral intervention
133420|NCT03368703|Transcranial direct-current stimulation|transcranial direct-current stimulation
133421|NCT03368703|Transcranial magnetic stimulation|transcranial magnetic stimulation
133422|NCT03368703|Motor-evoked potentials|motor-evoked potentials
133423|NCT03368703|Inhibition|inhibition
133424|NCT03368703|Muscle weakness|muscle weakness
133425|NCT03368690|pine barkextract, antioxidant, ADHD, catecholamine|pine barkextract, antioxidant, adhd, catecholamine
133426|NCT03368638|Degenerative lumbar spinal stenosis|degenerative lumbar spinal stenosis
133427|NCT03368638|Neural mobilization|neural mobilization
133428|NCT03368638|Hip extension mobilization|hip extension mobilization
133429|NCT03368638|Case series|case series
133430|NCT03368638|Neurogenic claudication|neurogenic claudication
133431|NCT03368625|Stereotactic Radiosurgery|stereotactic radiosurgery
133432|NCT03368625|Radiation|radiation
133433|NCT03368625|Surgery|surgery
133434|NCT03368586|Flash Glucose Monitoring|flash glucose monitoring
133435|NCT03368586|Children|children
133436|NCT03368586|Adolescents|adolescents
133437|NCT03368573|ADHD|adhd
133438|NCT03368573|Cognitive Assessment|cognitive assessment
133439|NCT03368573|QbTest|qbtest
133440|NCT03368573|Medication|medication
133441|NCT03368573|Feasibility|feasibility
133442|NCT03368560|Treatment-resistant Late Life Depression|treatment-resistant late life depression
133443|NCT03368560|Sudarshan Kriya Yoga|sudarshan kriya yoga
133444|NCT03368560|Glutathione|glutathione
133445|NCT03368508|Simulation|simulation
133446|NCT03368508|Physiotherapy training|physiotherapy training
133447|NCT03368508|360-degree video|360-degree video
133448|NCT03368495|yellow fever vaccine|yellow fever vaccine
133449|NCT03368495|MMR vaccine|mmr vaccine
133450|NCT03368495|immunogenicity|immunogenicity
133451|NCT03368482|cognition disorders|cognition disorders
133452|NCT03368482|frail elderly|frail elderly
133453|NCT03368482|human physical conditioning|human physical conditioning
133454|NCT03368482|institutionalization|institutionalization
133455|NCT03368482|physical activity|physical activity
133456|NCT03368469|Transcranial|transcranial
133457|NCT03368469|Stimulation|stimulation
133458|NCT03368456|mhealth|mhealth
133459|NCT03368456|preventive intervention|preventive intervention
133460|NCT03368456|primary health care|primary health care
133461|NCT03368443|Parkinson's disease|parkinson's disease
133462|NCT03368443|context-dependent learning|context-dependent learning
133463|NCT03368443|transcranial magnetic stimulation|transcranial magnetic stimulation
133464|NCT03368443|cognitive function|cognitive function
133465|NCT03368430|Melatonin; Chronic periodontitis; Host modulation therapy|melatonin; chronic periodontitis; host modulation therapy
133466|NCT03368417|Hypertension|hypertension
133467|NCT03368417|Wireless Home Blood Pressure Monitoring|wireless home blood pressure monitoring
133468|NCT03368417|Medication Adherence|medication adherence
133469|NCT03368417|Medication Titration|medication titration
133470|NCT03368417|Financial Incentives|financial incentives
133471|NCT03368417|Ambulatory Blood Pressure Monitoring|ambulatory blood pressure monitoring
133472|NCT03368378|prostate cancer|prostate cancer
133473|NCT03368378|radical prostatectomy|radical prostatectomy
133474|NCT03368378|deep venous complex ligation|deep venous complex ligation
133475|NCT03368365|Monitoring|monitoring
133476|NCT03368365|Home|home
133477|NCT03368365|Lung|lung
133478|NCT03368365|Transplant|transplant
133479|NCT03368365|Hospitalization|hospitalization
133480|NCT03368365|Respiratory function at rest|respiratory function at rest
133481|NCT03368365|Monitoring modem|monitoring modem
133482|NCT03368352|Melatonin|melatonin
133483|NCT03368352|Altitude|altitude
133484|NCT03368352|Sleep|sleep
133485|NCT03368352|Ventilation|ventilation
133486|NCT03368352|Cognition|cognition
133487|NCT03368313|Nonelastic compression theraphy|nonelastic compression theraphy
133488|NCT03368313|Compression theraphy|compression theraphy
133489|NCT03368313|Compression stockings|compression stockings
133490|NCT03368300|progressive supranuclear palsy|progressive supranuclear palsy
133491|NCT03368300|Caribbean atypical Parkinsonism|caribbean atypical parkinsonism
133492|NCT03368300|Annona Muricata|annona muricata
133493|NCT03368287|Total Knee Arthroplasty|total knee arthroplasty
133494|NCT03368287|steps|steps
133495|NCT03368287|rehabilitation|rehabilitation
133496|NCT03368287|activity tracker|activity tracker
133497|NCT03368261|Pulmonary arterial hypertension|pulmonary arterial hypertension
133498|NCT03368261|SCD|scd
133499|NCT03368261|Epidemiology|epidemiology
133500|NCT03368248|Palliative care|palliative care
133501|NCT03368248|Collegial meetings|collegial meetings
133502|NCT03368248|Neonatal resuscitation services|neonatal resuscitation services
133503|NCT03368248|Survey|survey
133504|NCT03368248|Medico-caring staff of the NICUs|medico-caring staff of the nicus
133505|NCT03368235|rheumatoid arthritis, swollen joints, tender joints, autoimmunity|rheumatoid arthritis, swollen joints, tender joints, autoimmunity
133506|NCT03368209|Non-invasive glucose monitoring|non-invasive glucose monitoring
133507|NCT03368196|Stomach cancer|stomach cancer
133508|NCT03368196|Cancer where the esophagus meets the stomach|cancer where the esophagus meets the stomach
133509|NCT03368196|Human epidermal growth factor 2|human epidermal growth factor 2
133510|NCT03368196|HER2|her2
133511|NCT03368196|Breast Cancer|breast cancer
133512|NCT03368196|Adenocarcinoma, Gastroesophageal Junction (GEJ)|adenocarcinoma, gastroesophageal junction (gej)
133513|NCT03368196|Gastric Cancer|gastric cancer
133514|NCT03368196|Antibody drug conjugate (ADC)|antibody drug conjugate (adc)
133515|NCT03368196|Oncology|oncology
133516|NCT03368170|Levodopa induced dyskinesia|levodopa induced dyskinesia
133517|NCT03368118|ABX464|abx464
133518|NCT03368118|Ulcerative Colitis|ulcerative colitis
133519|NCT03368105|Clostridium difficile Infection|clostridium difficile infection
133520|NCT03368105|Lactobacillus plantarum 299v|lactobacillus plantarum 299v
133521|NCT03368105|organ transplantation|organ transplantation
133522|NCT03368105|antibiotic-associated diarrhoea|antibiotic-associated diarrhoea
133523|NCT03368092|severe trauma|severe trauma
133524|NCT03368092|acute respiratory distress syndrome|acute respiratory distress syndrome
133525|NCT03368092|damage-associated molecular patterns|damage-associated molecular patterns
133526|NCT03368092|neutrophil extracellular traps|neutrophil extracellular traps
133527|NCT03368092|dornase alfa|dornase alfa
133528|NCT03368079|Dysphagia|dysphagia
133529|NCT03368079|Oropharyngeal dysphagia|oropharyngeal dysphagia
133530|NCT03368079|Video Fluoroscopic Swallowing Exam (VFSE)|video fluoroscopic swallowing exam (vfse)
133531|NCT03368053|gp120|gp120
133532|NCT03368053|HIV infections|hiv infections
133533|NCT03368053|RV144|rv144
133534|NCT03368053|gp120-NefTat/AS01B vaccine candidate|gp120-neftat/as01b vaccine candidate
133535|NCT03368053|V1V2|v1v2
133536|NCT03368040|body core temperature|body core temperature
133537|NCT03368027|Vision Disorders; Stress, Psychological|vision disorders; stress, psychological
133538|NCT03368014|Sharing|sharing
133539|NCT03368014|Mind|mind
133540|NCT03368014|Enjoyment|enjoyment
133541|NCT03368001|Autism|autism
133542|NCT03367988|Opioid Dependence|opioid dependence
133543|NCT03367988|Analagesia|analagesia
133544|NCT03367988|Opioid-free Anesthesia|opioid-free anesthesia
133545|NCT03367962|PET-CT scan|pet-ct scan
133546|NCT03367962|[18F]F-AraG|[18f]f-arag
133547|NCT03367949|Surgical guide|surgical guide
133548|NCT03367949|impression inversion|impression inversion
133549|NCT03367949|stereolithographic surgical guides|stereolithographic surgical guides
133550|NCT03367936|mobile technology|mobile technology
133551|NCT03367936|feedback message|feedback message
133552|NCT03367936|self-monitoring|self-monitoring
133553|NCT03367910|Urinary tract infection|urinary tract infection
133554|NCT03367910|Multidrug resistant organism|multidrug resistant organism
133555|NCT03367910|Fecal microbiota transplantation|fecal microbiota transplantation
133556|NCT03367897|Helicobacter pylori|helicobacter pylori
133557|NCT03367897|peptic ulcer|peptic ulcer
133558|NCT03367897|erosions|erosions
133559|NCT03367897|bleeding|bleeding
133560|NCT03367897|Nsaids|nsaids
133561|NCT03367897|Noac|noac
133562|NCT03367884|Hypopharyngeal cancer|hypopharyngeal cancer
133563|NCT03367884|Neck dissection|neck dissection
133564|NCT03367884|Induction chemotherapy|induction chemotherapy
133565|NCT03367884|Cervical lymph node metastasis|cervical lymph node metastasis
133566|NCT03367884|definitive radiotherapy|definitive radiotherapy
133567|NCT03367871|Recurrent Cervical Cancer|recurrent cervical cancer
133568|NCT03367871|Persistent Cervical Cancer|persistent cervical cancer
133569|NCT03367871|Metastatic Cervical Cancer|metastatic cervical cancer
133570|NCT03367845|Parent sensitivity|parent sensitivity
133571|NCT03367845|Fathers|fathers
133572|NCT03367845|Attachment|attachment
133573|NCT03367845|Marital communication|marital communication
133574|NCT03367780|Head-neck tumours|head-neck tumours
133575|NCT03367780|Radiotherapy|radiotherapy
133576|NCT03367780|Salivary gland toxicity|salivary gland toxicity
133577|NCT03367780|PSMA PET/CT|psma pet/ct
133578|NCT03367767|Blood Sample|blood sample
133579|NCT03367767|Medical History|medical history
133580|NCT03367767|Optical Imaging|optical imaging
133581|NCT03367754|Immunotherapy|immunotherapy
133582|NCT03367754|Immunologic Non-Responder|immunologic non-responder
133583|NCT03367754|Immunologic Response|immunologic response
133584|NCT03367754|Randomized|randomized
133585|NCT03367754|PD-1|pd-1
133586|NCT03367728|Bariatric Surgery|bariatric surgery
133587|NCT03367728|Bariatrics|bariatrics
133588|NCT03367728|Ropivacaine|ropivacaine
133589|NCT03367728|Randomized Controlled Trial|randomized controlled trial
133590|NCT03367728|Enhanced Recovery After Bariatric Surgery|enhanced recovery after bariatric surgery
133591|NCT03367728|TAP Block|tap block
133592|NCT03367728|Rectus Sheath Block|rectus sheath block
133602|NCT03367624|Pneumonia|pneumonia
133603|NCT03367624|PV leukocidin|pv leukocidin
133604|NCT03367624|ICU|icu
133605|NCT03367611|Immunochemical faecal occult blood test|immunochemical faecal occult blood test
133606|NCT03367611|iFOBT|ifobt
133607|NCT03367611|Cancer patient pathway|cancer patient pathway
133608|NCT03367611|Colonoscopy|colonoscopy
133609|NCT03367611|Colorectal cancer|colorectal cancer
133610|NCT03367585|Supplementary Feeding|supplementary feeding
133611|NCT03367585|vitamin D|vitamin d
133612|NCT03367585|Muscle Strength|muscle strength
133613|NCT03367585|postural balance|postural balance
133614|NCT03367585|exercise|exercise
133615|NCT03367585|aged|aged
133616|NCT03367559|Rotavirus|rotavirus
133617|NCT03367559|ROTAVAC|rotavac
133618|NCT03367559|Vaccine|vaccine
133619|NCT03367559|Vietnam|vietnam
133620|NCT03367546|SCD|scd
133621|NCT03367546|cALD|cald
133622|NCT03367481|Gingival fissures|gingival fissures
133623|NCT03367481|Gingival recession|gingival recession
133624|NCT03367481|Risk factors|risk factors
133625|NCT03367481|Traumatic toothbrusing|traumatic toothbrusing
133626|NCT03367468|Plantar fascitis|plantar fascitis
133627|NCT03367468|Pain|pain
133628|NCT03367468|Exercise|exercise
133629|NCT03367468|Physiotherapy|physiotherapy
133630|NCT03367468|Quality of life|quality of life
133631|NCT03367455|Potassium|potassium
133632|NCT03367455|Genetic Variants|genetic variants
133633|NCT03367442|Thoracic trauma|thoracic trauma
133634|NCT03367442|mechanical ventilation|mechanical ventilation
133635|NCT03367442|Acute respiratory distress syndrome|acute respiratory distress syndrome
133636|NCT03367442|Esophageal pressure|esophageal pressure
133637|NCT03367442|Pleural pressure|pleural pressure
133638|NCT03367429|stroke|stroke
133639|NCT03367429|spasticity|spasticity
133640|NCT03367403|TRAILBLAZER-ALZ|trailblazer-alz
133641|NCT03367364|Venous Thromboembolism, Deep Venous Thrombosis, Clots|venous thromboembolism, deep venous thrombosis, clots
133642|NCT03367325|non-valvular atrial fibrillation|non-valvular atrial fibrillation
133643|NCT03367325|time in therapeutic range|time in therapeutic range
133644|NCT03367325|primary care|primary care
133645|NCT03367299|Acute Lymphoid Leukemia|acute lymphoid leukemia
133646|NCT03367299|Philadelphia Chromosome-Negative B-Cell Precursor|philadelphia chromosome-negative b-cell precursor
133647|NCT03367299|Adults|adults
133648|NCT03367299|Minimal residual disease|minimal residual disease
133649|NCT03367299|Blinatumomab|blinatumomab
133650|NCT03367260|patient preferences|patient preferences
133661|NCT03367234|Federally Qualified Health Center|federally qualified health center
133662|NCT03367234|Contingency Management|contingency management
133663|NCT03367234|Cognitive Behavioral Therapy|cognitive behavioral therapy
133664|NCT03367234|Cognitive Behavioral / Relapse Prevention|cognitive behavioral / relapse prevention
133665|NCT03367234|Medication Assisted Treatment|medication assisted treatment
133666|NCT03367234|Behavioral Health Consultant|behavioral health consultant
133667|NCT03367234|Integrated Care|integrated care
133668|NCT03367208|metabolomic|metabolomic
133669|NCT03367195|GERD|gerd
133670|NCT03367195|DLBS2411|dlbs2411
133671|NCT03367195|omeprazole|omeprazole
133672|NCT03367169|Pilon fractures|pilon fractures
133673|NCT03367169|Osteosynthesis|osteosynthesis
133674|NCT03367169|Mini invasive plate osteosynthesis|mini invasive plate osteosynthesis
133675|NCT03367169|Locked plate|locked plate
133676|NCT03367169|Open reduction|open reduction
133677|NCT03367130|Antiretroviral therapy, clinic attendance, Nepal|antiretroviral therapy, clinic attendance, nepal
133678|NCT03367091|Wearable Exoskeleton|wearable exoskeleton
133679|NCT03367091|Stroke|stroke
133680|NCT03367091|Energy Consumption|energy consumption
133681|NCT03367091|Cardiorespiratory Load|cardiorespiratory load
133682|NCT03367078|tDCS|tdcs
133683|NCT03367078|transcranial direct current stimulation|transcranial direct current stimulation
133684|NCT03367078|acquired brain injury|acquired brain injury
133685|NCT03367078|coma|coma
133686|NCT03367078|vigilance|vigilance
133687|NCT03367052|ProDisc-C vivo|prodisc-c vivo
133688|NCT03367052|Hybrid|hybrid
133689|NCT03367052|Cervical degenerative disc disease|cervical degenerative disc disease
133690|NCT03367039|ProDisc-C vivo|prodisc-c vivo
133691|NCT03367039|ACDF|acdf
133692|NCT03367039|Cervical degenerative disc disease|cervical degenerative disc disease
133693|NCT03367026|ivabradine|ivabradine
133694|NCT03367026|sepsis|sepsis
133695|NCT03367026|heart rate|heart rate
133696|NCT03366935|labor analgesia|labor analgesia
133697|NCT03366935|dural puncture epidural (DPE)|dural puncture epidural (dpe)
133698|NCT03366935|standard Epidural (EPL)|standard epidural (epl)
133699|NCT03366935|continuous epidural infusion (CEI)|continuous epidural infusion (cei)
133700|NCT03366935|programmed intermittent epidural bolus (PIEB)|programmed intermittent epidural bolus (pieb)
133701|NCT03366909|mindfulness|mindfulness
133702|NCT03366909|cannabis use|cannabis use
133703|NCT03366883|preoperative chemotherapy|preoperative chemotherapy
133704|NCT03366883|preoperative chemoradiotherapy|preoperative chemoradiotherapy
133705|NCT03366883|clinical trial|clinical trial
133706|NCT03366883|phase III|phase iii
133707|NCT03366883|Esophageal squamous cancer|esophageal squamous cancer
133708|NCT03366870|CBT-I|cbt-i
133709|NCT03366870|Insomnia|insomnia
133710|NCT03366844|invasive adenocarcinoma of the breast|invasive adenocarcinoma of the breast
133711|NCT03366844|ER-positive and HER2-negative breast cancer|er-positive and her2-negative breast cancer
133712|NCT03366844|Triple negative breast cancer (TNBC)|triple negative breast cancer (tnbc)
133713|NCT03366844|immunotherapy|immunotherapy
170550|NCT03129178|Nitrate|nitrate
133714|NCT03366844|checkpoint inhibitor|checkpoint inhibitor
133715|NCT03366844|HR-positive|hr-positive
133716|NCT03366805|opioid|opioid
133717|NCT03366805|analgesic|analgesic
133718|NCT03366805|ambulatory|ambulatory
133719|NCT03366805|orthopedic|orthopedic
133720|NCT03366805|surgery|surgery
133721|NCT03366805|patient education|patient education
133722|NCT03366805|video|video
133723|NCT03366805|medication diary|medication diary
133724|NCT03366779|Lumbar disc herniation, reherniation|lumbar disc herniation, reherniation
133725|NCT03366753|acute normovolemic hemodilution|acute normovolemic hemodilution
133726|NCT03366753|coronary artery bypass graft surgery|coronary artery bypass graft surgery
133727|NCT03366753|hydroxyethyl starch|hydroxyethyl starch
133728|NCT03366753|blood viscosity|blood viscosity
133729|NCT03366740|Persistent diarrhea|persistent diarrhea
133730|NCT03366740|> 6 to 36 months aged children|> 6 to 36 months aged children
133731|NCT03366740|green banana|green banana
133732|NCT03366740|rice suji|rice suji
133733|NCT03366740|milk suji|milk suji
133734|NCT03366740|comminuted chicken|comminuted chicken
133735|NCT03366727|drug eluting balloon|drug eluting balloon
133736|NCT03366714|Noninvasive ventilation, respiratory distress syndrome|noninvasive ventilation, respiratory distress syndrome
133737|NCT03366701|physical activity|physical activity
133738|NCT03366701|sedentary behavior|sedentary behavior
133739|NCT03366701|implicit attitudes|implicit attitudes
133740|NCT03366701|self regulation|self regulation
133741|NCT03366701|intention|intention
133742|NCT03366701|chronic diseases|chronic diseases
133743|NCT03366662|Electromyography|electromyography
133744|NCT03366649|Bypass Surgery|bypass surgery
133745|NCT03366649|Cardiology|cardiology
133746|NCT03366649|Coronary Artery Bypass Surgery|coronary artery bypass surgery
133747|NCT03366649|Mitral Valve Repair|mitral valve repair
133748|NCT03366649|Mitral Valve Surgery|mitral valve surgery
133749|NCT03366649|Coronary Revascularization|coronary revascularization
133750|NCT03366636|Pregnancy|pregnancy
133751|NCT03366636|Adolescents|adolescents
133752|NCT03366636|STIs/STDs|stis/stds
133753|NCT03366636|Self-sufficiency|self-sufficiency
133754|NCT03366623|Pain assessment|pain assessment
133755|NCT03366623|Self report|self report
133756|NCT03366623|Hospital clown intervention|hospital clown intervention
133757|NCT03366597|sevoflurane|sevoflurane
133758|NCT03366597|S100β protein|s100β protein
133759|NCT03366597|regional cerebral oxygen saturation|regional cerebral oxygen saturation
133760|NCT03366597|infant|infant
133761|NCT03366571|Liver Cirrhosis|liver cirrhosis
133762|NCT03366558|motion detectors|motion detectors
133763|NCT03366558|early stage Parkinson's disease|early stage parkinson's disease
133764|NCT03366558|advanced Parkinson's disease|advanced parkinson's disease
133765|NCT03366558|UPDRS|updrs
133766|NCT03366558|observational study with non-diseased controls|observational study with non-diseased controls
133767|NCT03366545|cardiac resynchronization therapy|cardiac resynchronization therapy
133768|NCT03366545|CRT|crt
133769|NCT03366545|clinical routine|clinical routine
133770|NCT03366532|diet|diet
133771|NCT03366532|food frequency questionnaire|food frequency questionnaire
133772|NCT03366532|nutrient|nutrient
133773|NCT03366519|Embolism, Pulmonary|embolism, pulmonary
133774|NCT03366519|echocardiography|echocardiography
133775|NCT03366519|emergency|emergency
133776|NCT03366519|prognosis|prognosis
133777|NCT03366467|dental treatment|dental treatment
133778|NCT03366467|sensory adapted environment|sensory adapted environment
133779|NCT03366428|HER2|her2
133780|NCT03366428|Breast cancer|breast cancer
133781|NCT03366428|Oncology|oncology
133782|NCT03366428|Antibody drug conjugate|antibody drug conjugate
133784|NCT03366415|Nasopharyngeal Carcinoma|nasopharyngeal carcinoma
133785|NCT03366415|concurrent chemoradiotherapy|concurrent chemoradiotherapy
133786|NCT03366415|sequential chemoradiotherapy|sequential chemoradiotherapy
133787|NCT03366376|hippocampus|hippocampus
133788|NCT03366376|radiotherapy|radiotherapy
133789|NCT03366363|Knee osteoarthritis|knee osteoarthritis
133790|NCT03366363|acupuncture|acupuncture
133791|NCT03366363|electroacupuncture|electroacupuncture
133792|NCT03366363|sham acupuncture|sham acupuncture
133793|NCT03366337|IgA Nephropathy|iga nephropathy
133794|NCT03366337|CKD associated with type 1 diabetes|ckd associated with type 1 diabetes
133795|NCT03366337|Focal segmental glomerulosclerosis|focal segmental glomerulosclerosis
133796|NCT03366337|Autosomal dominant polycystic kidney disease|autosomal dominant polycystic kidney disease
133797|NCT03366337|IgAN|igan
133798|NCT03366337|FSGS|fsgs
133799|NCT03366337|ADPKD|adpkd
133800|NCT03366337|Bardoxolone methyl|bardoxolone methyl
133801|NCT03366337|CDDO-ME|cddo-me
133802|NCT03366337|RTA 402|rta 402
133803|NCT03366311|intubation|intubation
133804|NCT03366311|epiglottis lift|epiglottis lift
133805|NCT03366311|hold high position|hold high position
133806|NCT03366285|Bonding|bonding
133807|NCT03366285|Gene expression|gene expression
133808|NCT03366285|Stress response|stress response
133809|NCT03366285|Neurodevelopment|neurodevelopment
133810|NCT03366246|topical anesthetic|topical anesthetic
133811|NCT03366246|nanocapsules|nanocapsules
133812|NCT03366246|nanotechnology|nanotechnology
133813|NCT03366246|lidocaine|lidocaine
133814|NCT03366246|prilocaine|prilocaine
133815|NCT03366246|fractional CO2 laser resurfacing|fractional co2 laser resurfacing
133816|NCT03366168|Diabetes|diabetes
133817|NCT03366168|Fungiform Papillae|fungiform papillae
133818|NCT03366168|Insulin|insulin
133819|NCT03366155|Unresectable Liver Tumor|unresectable liver tumor
133820|NCT03366155|Response Rates|response rates
133821|NCT03366155|Progression-Free Survival|progression-free survival
133822|NCT03366155|Patient Survival|patient survival
133823|NCT03366142|Autosomal Recessive Disorder|autosomal recessive disorder
133824|NCT03366142|Immune|immune
133825|NCT03366142|Gingival|gingival
133826|NCT03366142|Oral Ulcer|oral ulcer
133827|NCT03366142|Cytokine Expression|cytokine expression
133828|NCT03366129|CEREBROVASCULAR DISEASE|cerebrovascular disease
133829|NCT03366129|Vascular Cognitive Impairment|vascular cognitive impairment
133830|NCT03366129|Stroke|stroke
133831|NCT03366129|Permeability Imaging|permeability imaging
133832|NCT03366116|Pharmacodynamics|pharmacodynamics
133833|NCT03366116|DNA Methylation|dna methylation
133834|NCT03366116|Pharmacokinetics|pharmacokinetics
133835|NCT03366116|Nucleoside Analog|nucleoside analog
133836|NCT03366116|Epigenetics|epigenetics
133837|NCT03366064|Non-small cell lung cancer|non-small cell lung cancer
133838|NCT03366064|Natural killer cells|natural killer cells
133839|NCT03366064|HLA-haploidentical family donor|hla-haploidentical family donor
133840|NCT03366051|Endometrial Cancer|endometrial cancer
133841|NCT03366051|Sentinel Lymph Node|sentinel lymph node
133842|NCT03366051|Lymphadenectomy|lymphadenectomy
133843|NCT03366038|pancreaticoduodenectomy|pancreaticoduodenectomy
133844|NCT03366038|pancreaticojejunostomy|pancreaticojejunostomy
133845|NCT03366038|pancreatic fistula|pancreatic fistula
133846|NCT03366012|Cytosponge|cytosponge
133847|NCT03366012|GERD|gerd
133848|NCT03365986|hereditary|hereditary
133849|NCT03365986|colorectal cancer|colorectal cancer
133850|NCT03365986|screening|screening
133851|NCT03365973|Pathological Fracture|pathological fracture
133852|NCT03365973|Indeterminate Instability|indeterminate instability
133853|NCT03365973|Spinal Metastases|spinal metastases
133854|NCT03365973|Breast Cancer|breast cancer
133855|NCT03365960|Watermelon|watermelon
133856|NCT03365960|Watermelon phytochemicals bioavailability|watermelon phytochemicals bioavailability
133857|NCT03365960|Flow Mediated Vasodilation|flow mediated vasodilation
133858|NCT03365960|Pharmacokinetics|pharmacokinetics
133859|NCT03365934|Microflora|microflora
133860|NCT03365934|Microbiome|microbiome
133861|NCT03365934|skin physiology|skin physiology
133862|NCT03365934|Fitzpatrick Skin Types I-III|fitzpatrick skin types i-iii
133863|NCT03365934|Tape-stripped wounds|tape-stripped wounds
133864|NCT03365908|ACL|acl
133865|NCT03365895|diffusion|diffusion
133866|NCT03365895|tensor|tensor
133867|NCT03365895|imaging|imaging
133868|NCT03365895|chemotherapy|chemotherapy
133869|NCT03365895|peripheral neuropathy|peripheral neuropathy
133870|NCT03365895|breast cancer|breast cancer
133871|NCT03365895|MRI|mri
133872|NCT03365895|Magnetic Resonance Imaging|magnetic resonance imaging
133873|NCT03365895|Diffusion Tensor Imaging|diffusion tensor imaging
133874|NCT03365843|Cardiac surgery|cardiac surgery
133875|NCT03365843|Sternal closure|sternal closure
133876|NCT03365817|cognitive function|cognitive function
133877|NCT03365817|opioid dependence|opioid dependence
133878|NCT03365817|opioid withdrawal|opioid withdrawal
133879|NCT03365817|quality of life|quality of life
133880|NCT03365817|side effect|side effect
133881|NCT03365804|Ultrasound|ultrasound
133882|NCT03365804|Scoliosis|scoliosis
133883|NCT03365804|Orthoses|orthoses
133884|NCT03365804|3D Printing|3d printing
133885|NCT03365791|PDR001|pdr001
133886|NCT03365791|LAG525|lag525
133887|NCT03365791|Immune checkpoint blockade|immune checkpoint blockade
133888|NCT03365791|Solid tumor malignancy|solid tumor malignancy
133889|NCT03365791|lymphoma|lymphoma
133890|NCT03365791|Small cell lung cancer (SCLC)|small cell lung cancer (sclc)
133891|NCT03365791|Gastric/esophageal adenocarcinoma|gastric/esophageal adenocarcinoma
133892|NCT03365791|Castration resistant prostate adenocarcinoma (CRPC)|castration resistant prostate adenocarcinoma (crpc)
133893|NCT03365791|Soft tissue sarcoma|soft tissue sarcoma
133894|NCT03365791|Ovarian adenocarcinoma|ovarian adenocarcinoma
133895|NCT03365791|Advanced well-differentiated neuroendocrine tumors (NETs)|advanced well-differentiated neuroendocrine tumors (nets)
133896|NCT03365791|Diffuse large B cell lymphoma (DLBCL)|diffuse large b cell lymphoma (dlbcl)
133897|NCT03365778|educational intervention|educational intervention
133899|NCT03365778|selective laser trabeculoplasty|selective laser trabeculoplasty
133900|NCT03365739|Mango|mango
133901|NCT03365739|Mango pulp phytochemicals bioavailability|mango pulp phytochemicals bioavailability
133902|NCT03365739|Pharmacokinetics|pharmacokinetics
133903|NCT03365713|COPD|copd
133904|NCT03365713|Spirometry|spirometry
133905|NCT03365713|COPD Diagnosis|copd diagnosis
133906|NCT03365713|PEF|pef
133907|NCT03365713|Case Finding|case finding
133908|NCT03365713|LMIC|lmic
133909|NCT03365700|Persistent atrial fibrillation|persistent atrial fibrillation
133910|NCT03365700|Catheter ablation|catheter ablation
133911|NCT03365687|Children|children
133912|NCT03365687|Vitamin D|vitamin d
133913|NCT03365687|Respiratory viral infection|respiratory viral infection
133914|NCT03365687|Randomized controlled trial|randomized controlled trial
133915|NCT03365687|Asthma exacerbations|asthma exacerbations
133916|NCT03365674|Myofascial Pain Syndromes, Gastrocnemius, Trigger points, Injections, Vibration|myofascial pain syndromes, gastrocnemius, trigger points, injections, vibration
133917|NCT03365661|AML|aml
133918|NCT03365661|MDS|mds
133919|NCT03365596|Brain connectivity|brain connectivity
133920|NCT03365596|Magnetic resonance imaging|magnetic resonance imaging
133921|NCT03365596|Recovery prediction|recovery prediction
133922|NCT03365583|Vitamin B12|vitamin b12
133923|NCT03365583|Microbiome|microbiome
133924|NCT03365583|infant|infant
133925|NCT03365570|hemoglobin, iron, oral lesions, oral manifestations,cross-sectional study|hemoglobin, iron, oral lesions, oral manifestations,cross-sectional study
133926|NCT03365531|fasting|fasting
133927|NCT03365518|Psychological Treatment|psychological treatment
133928|NCT03365518|Intimacy|intimacy
133929|NCT03365518|Cognitive Behavioural Therapy|cognitive behavioural therapy
133930|NCT03365518|Cognitive Behavioral Therapy|cognitive behavioral therapy
133931|NCT03365518|Mindfulness|mindfulness
133932|NCT03365518|Group Therapy|group therapy
133933|NCT03365518|Couples Therapy|couples therapy
133934|NCT03365479|pulmonary hypertension|pulmonary hypertension
133935|NCT03365479|iloprost|iloprost
133936|NCT03365479|inhaled|inhaled
133937|NCT03365479|breelib|breelib
133938|NCT03365479|nebulizer|nebulizer
133939|NCT03365479|pulmonary arterial hypertension|pulmonary arterial hypertension
133940|NCT03365466|recurrent implantation failure|recurrent implantation failure
133941|NCT03365466|aspirin|aspirin
133942|NCT03365466|low molecular weight heparin|low molecular weight heparin
133943|NCT03365440|ECG|ecg
133944|NCT03365440|cardiac arrhythmia|cardiac arrhythmia
133945|NCT03365440|heart rhythm|heart rhythm
133946|NCT03365440|esophageal ECG|esophageal ecg
133947|NCT03365440|non-invasive mapping|non-invasive mapping
133948|NCT03365440|supraventricular tachycardia|supraventricular tachycardia
133949|NCT03365440|atrial fibrillation|atrial fibrillation
133950|NCT03365440|atrial flutter|atrial flutter
133951|NCT03365440|extrasystole|extrasystole
133952|NCT03365427|rehabilitation|rehabilitation
133953|NCT03365427|application on smart phones|application on smart phones
133954|NCT03365414|Postural Orthostatic Tachycardia Syndrome|postural orthostatic tachycardia syndrome
133955|NCT03365414|POTS|pots
133956|NCT03365414|Syncope|syncope
133957|NCT03365414|Vasovagal|vasovagal
133958|NCT03365414|Hypotension|hypotension
133959|NCT03365414|Tachycardia|tachycardia
133960|NCT03365401|surgery|surgery
133961|NCT03365401|decompression|decompression
133962|NCT03365375|Chest Pain|chest pain
133963|NCT03365375|Anxiety|anxiety
133964|NCT03365375|Mindfulness|mindfulness
133965|NCT03365375|Emergency Service, Hospital|emergency service, hospital
133966|NCT03365362|directly observed therapy|directly observed therapy
133967|NCT03365362|varenicline|varenicline
133968|NCT03365362|long-term pharmacotherapy|long-term pharmacotherapy
133969|NCT03365323|Periprosthetic Joint Infection|periprosthetic joint infection
133970|NCT03365284|total knee arthroplasty|total knee arthroplasty
133971|NCT03365284|rehabilitation|rehabilitation
133972|NCT03365284|Smart Kneebrace|smart kneebrace
133973|NCT03365219|Surgical Site Infection|surgical site infection
133974|NCT03365219|Cesarean delivery infection|cesarean delivery infection
133975|NCT03365167|LANAP|lanap
133976|NCT03365167|Periodontitis|periodontitis
133977|NCT03365154|Peripheral Artery Disease|peripheral artery disease
133978|NCT03365154|Atherectomy|atherectomy
133979|NCT03365154|Orbital Atherectomy|orbital atherectomy
133980|NCT03365141|vitiligo|vitiligo
133981|NCT03365141|intralesional injection|intralesional injection
133982|NCT03365141|corticosteroid|corticosteroid
133983|NCT03365141|triamcinolone|triamcinolone
133990|NCT03365089|Failure to mature|failure to mature
133991|NCT03365089|Collateral vein|collateral vein
133992|NCT03365063|Knowledge Translation|knowledge translation
133993|NCT03365063|Chronic Kidney Disease|chronic kidney disease
133994|NCT03365063|Matched Cluster Randomized Trial|matched cluster randomized trial
133996|NCT03365024|Insomnia|insomnia
133997|NCT03365011|Nitrous Oxide|nitrous oxide
133998|NCT03364972|cataract|cataract
133999|NCT03364972|cataract extraction|cataract extraction
134000|NCT03364972|interocular lens implant|interocular lens implant
134001|NCT03364972|glistenings|glistenings
134002|NCT03364972|phacoemulsification|phacoemulsification
134003|NCT03364972|hydrophobic acrylic|hydrophobic acrylic
134004|NCT03364972|light scatter|light scatter
134005|NCT03364972|patient related outcome measures|patient related outcome measures
134006|NCT03364933|Child|child
134007|NCT03364933|Critical Illness|critical illness
134008|NCT03364933|Length of Stay|length of stay
134009|NCT03364933|Satisfaction|satisfaction
134010|NCT03364920|Maresin-1|maresin-1
134011|NCT03364920|SAP|sap
134012|NCT03364920|IPN|ipn
134013|NCT03364920|MODS|mods
134014|NCT03364920|Mortality|mortality
134015|NCT03364907|HIPEC|hipec
134016|NCT03364907|oxaliplatin|oxaliplatin
134017|NCT03364907|flushing|flushing
134018|NCT03364907|peritoneal carcinomatosis|peritoneal carcinomatosis
134019|NCT03364894|Parkinson's Disease|parkinson's disease
134020|NCT03364894|Biomarkers|biomarkers
134021|NCT03364894|Wearable sensors|wearable sensors
134022|NCT03364894|Imaging|imaging
134023|NCT03364894|Disease progression|disease progression
134024|NCT03364868|Type 1 diabetes|type 1 diabetes
134025|NCT03364868|T1D|t1d
134026|NCT03364868|diabetes mellitus|diabetes mellitus
134027|NCT03364868|oral insulin|oral insulin
134028|NCT03364868|oral tolerance|oral tolerance
134029|NCT03364868|autoantigen|autoantigen
134030|NCT03364868|self tolerance|self tolerance
134031|NCT03364868|prevention|prevention
134032|NCT03364868|at risk for developing type 1 diabetes|at risk for developing type 1 diabetes
134033|NCT03364868|juvenile diabetes|juvenile diabetes
134034|NCT03364868|autoimmune diabetes|autoimmune diabetes
134035|NCT03364855|Balance|balance
134036|NCT03364855|Patellofemoral pain syndrome|patellofemoral pain syndrome
134037|NCT03364855|Star excursion balance test|star excursion balance test
134038|NCT03364855|Kinesthetic Ability Trainer 2000|kinesthetic ability trainer 2000
134039|NCT03364816|cervical spondylosis|cervical spondylosis
134040|NCT03364816|artificial disc replacement|artificial disc replacement
134041|NCT03364816|complications|complications
134042|NCT03364816|photographic indicators|photographic indicators
134043|NCT03364816|functional efficacy|functional efficacy
134044|NCT03364803|Cushing Syndrome|cushing syndrome
134045|NCT03364803|Cushing's Disease|cushing's disease
134046|NCT03364803|Cushing Disease|cushing disease
134047|NCT03364803|17-592|17-592
134048|NCT03364803|Memorial Sloan Kettering Cancer Center|memorial sloan kettering cancer center
134049|NCT03364790|knee - spine syndrome|knee - spine syndrome
134050|NCT03364790|PLIF|plif
134051|NCT03364790|TKA|tka
134052|NCT03364790|sagittal parameters|sagittal parameters
134053|NCT03364790|neuroelectrophysiology|neuroelectrophysiology
134054|NCT03364777|lumbar surgery, emotional state|lumbar surgery, emotional state
134055|NCT03364764|sirolimus|sirolimus
134056|NCT03364764|refractory pure red cell aplasia|refractory pure red cell aplasia
134057|NCT03364764|prospective study|prospective study
134058|NCT03364751|Oral Health|oral health
134059|NCT03364751|Smoking|smoking
134060|NCT03364751|Cigarette|cigarette
134061|NCT03364751|Reduced risk product|reduced risk product
134062|NCT03364751|Tobacco heating system|tobacco heating system
134063|NCT03364751|THS|ths
134064|NCT03364751|Modified risk tobacco product|modified risk tobacco product
134065|NCT03364751|Clinical attachment level|clinical attachment level
134066|NCT03364699|strenuous exercise|strenuous exercise
134067|NCT03364699|dietary supplementation|dietary supplementation
134068|NCT03364699|immune system|immune system
134069|NCT03364699|leucocyte function|leucocyte function
134070|NCT03364699|inflammation|inflammation
134071|NCT03364686|BioRBCs|biorbcs
134072|NCT03364686|Biotin labeled red blood cells|biotin labeled red blood cells
134079|NCT03364660|Epidural Stimulation|epidural stimulation
134080|NCT03364660|Spinal Cord Injury|spinal cord injury
134081|NCT03364660|Task-Specific|task-specific
134082|NCT03364634|decompressive craniectomy|decompressive craniectomy
134083|NCT03364634|intracranial pressure|intracranial pressure
134084|NCT03364634|icp|icp
134085|NCT03364634|telemetry|telemetry
134086|NCT03364634|telemetric|telemetric
134087|NCT03364621|Liver resection|liver resection
134088|NCT03364621|Metastasis|metastasis
134089|NCT03364621|Molecular profiling|molecular profiling
134090|NCT03364621|Epigenetic analysis|epigenetic analysis
134091|NCT03364621|Genomic analysis|genomic analysis
134092|NCT03364621|Sequencing|sequencing
134093|NCT03364595|radial head fracture|radial head fracture
134094|NCT03364595|replacement|replacement
134095|NCT03364595|plate|plate
134096|NCT03364582|Dietary patterns|dietary patterns
134097|NCT03364582|Metabolomics|metabolomics
134098|NCT03364582|Mortaltiy|mortaltiy
134099|NCT03364582|Colorectal cancer|colorectal cancer
134100|NCT03364569|Drainage|drainage
134101|NCT03364569|Breast augmentation|breast augmentation
134102|NCT03364569|Tranexamic acid|tranexamic acid
134103|NCT03364517|Medical regulation|medical regulation
134104|NCT03364517|SPIA|spia
134105|NCT03364517|Imminent delivery|imminent delivery
134106|NCT03364504|PXE|pxe
134107|NCT03364504|renal cells|renal cells
134108|NCT03364504|urine|urine
134109|NCT03364504|calcification|calcification
134110|NCT03364504|omics|omics
134111|NCT03364504|drug screening|drug screening
134112|NCT03364491|Tranexamic Acid|tranexamic acid
134113|NCT03364491|Hemorrhage|hemorrhage
134114|NCT03364491|Cesarean|cesarean
134115|NCT03364478|Surgical approach|surgical approach
134116|NCT03364478|Laparoscopic right hemicolectomy|laparoscopic right hemicolectomy
134117|NCT03364452|Dietary Assessment Methodology|dietary assessment methodology
134118|NCT03364452|beverages|beverages
134119|NCT03364452|non-nutritive sweeteners|non-nutritive sweeteners
134120|NCT03364439|DLBCL|dlbcl
134121|NCT03364387|Acute Coronary Syndrome|acute coronary syndrome
134122|NCT03364387|MINOCA|minoca
134123|NCT03364387|Myocardial Infarction|myocardial infarction
134124|NCT03364387|Atrial Fibrillation|atrial fibrillation
134125|NCT03364374|Stroke rehabilitation|stroke rehabilitation
134126|NCT03364374|Upper extremity|upper extremity
134127|NCT03364374|Posture|posture
134128|NCT03364309|plaque psoriasis|plaque psoriasis
134129|NCT03364309|ixekizumab|ixekizumab
134130|NCT03364309|skin condition|skin condition
134131|NCT03364309|skin disease|skin disease
134132|NCT03364309|itching|itching
134133|NCT03364309|psoriasis vulgaris|psoriasis vulgaris
134134|NCT03364309|immune-mediated systemic disease|immune-mediated systemic disease
134135|NCT03364309|skin lesions|skin lesions
134136|NCT03364309|scaly patches|scaly patches
134137|NCT03364309|papules|papules
134138|NCT03364296|Acute stroke, Biomarkers|acute stroke, biomarkers
134139|NCT03364283|Posterior fossa|posterior fossa
134140|NCT03364283|Pineal region|pineal region
134141|NCT03364270|atherosclerosis|atherosclerosis
134142|NCT03364257|metagenomic|metagenomic
134143|NCT03364257|infection|infection
134144|NCT03364257|diagnosis|diagnosis
134145|NCT03364244|Revatio|revatio
134146|NCT03364244|Pulmonary arterial hypertension|pulmonary arterial hypertension
134147|NCT03364244|Pediatric patients|pediatric patients
134148|NCT03364205|SFA interview technique|sfa interview technique
134149|NCT03364205|adolescence|adolescence
134150|NCT03364205|obesity|obesity
134151|NCT03364205|nutrition|nutrition
134152|NCT03364205|exercise|exercise
134153|NCT03364192|Whole Health Coaching|whole health coaching
134154|NCT03364192|Integrative Health Coaching|integrative health coaching
134155|NCT03364192|Peer Support Specialist|peer support specialist
134156|NCT03364192|Personalized Health Plan|personalized health plan
134157|NCT03364179|dementia|dementia
134158|NCT03364179|young onset dementia|young onset dementia
134159|NCT03364179|quality of death|quality of death
134160|NCT03364179|late onset dementia|late onset dementia
134161|NCT03364179|palliative care|palliative care
134162|NCT03364166|buccal squamous cell carcinoma|buccal squamous cell carcinoma
134163|NCT03364153|Zimura|zimura
134164|NCT03364153|ARC1905|arc1905
134165|NCT03364153|complement factor C5 inhibitor|complement factor c5 inhibitor
134166|NCT03364153|avacincaptad pegol|avacincaptad pegol
134167|NCT03364153|STGD1|stgd1
134168|NCT03364140|Peripartum Cardiomyopathy|peripartum cardiomyopathy
134169|NCT03364140|Heart Failure|heart failure
134170|NCT03364127|Vulvar Pain, Dyspareunia|vulvar pain, dyspareunia
134171|NCT03364088|Total knee arthroplasty|total knee arthroplasty
134172|NCT03364088|Anesthesia|anesthesia
134173|NCT03364088|Surgical tourniquet|surgical tourniquet
134174|NCT03364088|Pain|pain
134175|NCT03364088|Postoperative nausea and vomiting|postoperative nausea and vomiting
134176|NCT03364088|Quality of life|quality of life
134177|NCT03364088|Length of stay|length of stay
134178|NCT03364088|Knee function|knee function
134179|NCT03364088|Bioelectrical impedance|bioelectrical impedance
134180|NCT03364088|Knee endoprosthesis|knee endoprosthesis
134181|NCT03364062|Blood Pressure|blood pressure
134182|NCT03364062|shoulder replacement|shoulder replacement
134183|NCT03364062|proximal humeral fracture|proximal humeral fracture
134184|NCT03364036|Multiple sclerosis|multiple sclerosis
134185|NCT03364036|Mavenclad ®|mavenclad ®
134186|NCT03364036|Cladribine|cladribine
134187|NCT03364010|Motor control|motor control
134188|NCT03364010|Proprioception|proprioception
134189|NCT03363997|estriol|estriol
134190|NCT03363997|pharmacokinetic|pharmacokinetic
134191|NCT03363997|pharmacodynamic|pharmacodynamic
134192|NCT03363997|hormone replacement therapy|hormone replacement therapy
134193|NCT03363997|vaginal ring administration|vaginal ring administration
134194|NCT03363971|soft tissue, pain|soft tissue, pain
134195|NCT03363958|myocardial protection|myocardial protection
134196|NCT03363958|remote ischemic preconditioning|remote ischemic preconditioning
134197|NCT03363958|remote ischemic postconditioning|remote ischemic postconditioning
134198|NCT03363958|cardiac surgery|cardiac surgery
134199|NCT03363945|kidney transplant|kidney transplant
134200|NCT03363945|cellular therapy|cellular therapy
134201|NCT03363945|anti-rejection therapy|anti-rejection therapy
134202|NCT03363945|living donor|living donor
134203|NCT03363945|HLA-matched|hla-matched
134204|NCT03363945|hematopoietic stem cells (HSC)|hematopoietic stem cells (hsc)
134205|NCT03363945|CD34+|cd34+
134206|NCT03363945|CD3+|cd3+
134207|NCT03363945|T cells|t cells
134208|NCT03363932|Ventricular septal defect|ventricular septal defect
134209|NCT03363932|Congenital heart disease|congenital heart disease
134210|NCT03363932|Outcome|outcome
134211|NCT03363919|adolescent|adolescent
134212|NCT03363919|biomarkers|biomarkers
134213|NCT03363893|Neoplasms|neoplasms
134214|NCT03363880|Severe trauma|severe trauma
134215|NCT03363880|Multiple trauma|multiple trauma
134216|NCT03363880|Regional Trauma management system|regional trauma management system
134217|NCT03363880|Trauma management team|trauma management team
134218|NCT03363867|High grade serous|high grade serous
134219|NCT03363867|C1 molecular subtype|c1 molecular subtype
134220|NCT03363841|Candida auris|candida auris
134221|NCT03363815|Healthy Volunteer|healthy volunteer
134222|NCT03363815|CC-90001|cc-90001
134223|NCT03363815|Pharmacokinetics|pharmacokinetics
134224|NCT03363815|Omeprazole|omeprazole
134225|NCT03363815|Midazolam|midazolam
134226|NCT03363815|Warfarin|warfarin
134227|NCT03363815|Rosuvastatin|rosuvastatin
134228|NCT03363815|Metformin|metformin
134229|NCT03363815|Digoxin|digoxin
134230|NCT03363815|Nintedanib|nintedanib
134231|NCT03363763|rash|rash
134232|NCT03363763|fibroma|fibroma
134233|NCT03363763|skin|skin
134234|NCT03363763|facial|facial
134235|NCT03363763|face|face
134236|NCT03363763|bumps|bumps
134237|NCT03363763|redness|redness
134238|NCT03363763|erythema|erythema
134239|NCT03363763|lesions|lesions
134240|NCT03363763|papules|papules
134241|NCT03363763|blood vessel|blood vessel
134242|NCT03363763|cheeks|cheeks
134243|NCT03363750|Depression|depression
134244|NCT03363750|Adolescent|adolescent
134245|NCT03363750|mind-body-skills|mind-body-skills
134246|NCT03363750|group therapy|group therapy
134247|NCT03363750|primary care|primary care
134248|NCT03363724|Parkinson Disease|parkinson disease
134249|NCT03363724|Deep Brain Stimulation|deep brain stimulation
134250|NCT03363724|Microelectrodes recording|microelectrodes recording
134251|NCT03363724|HaGuide|haguide
134252|NCT03363724|Alpha Omega Engineering Ltd.|alpha omega engineering ltd.
134253|NCT03363698|Chronic Cough|chronic cough
134254|NCT03363698|Upper-Airway Cough Syndrome|upper-airway cough syndrome
134255|NCT03363698|GERD|gerd
134256|NCT03363698|Allergic Rhinitis|allergic rhinitis
134257|NCT03363698|Methacholine Challenge Test|methacholine challenge test
134258|NCT03363698|Cough Challenge|cough challenge
134259|NCT03363698|Capsaicin|capsaicin
134260|NCT03363685|Survival Prediction|survival prediction
134261|NCT03363685|Spinal Metastases|spinal metastases
134262|NCT03363685|Non Small Cell Lung Cancer Metastatic|non small cell lung cancer metastatic
134263|NCT03363672|Chronic Postoperative Pain|chronic postoperative pain
134264|NCT03363672|Daily Life|daily life
134265|NCT03363672|Risk Factor|risk factor
134266|NCT03363659|Glioblastoma|glioblastoma
134267|NCT03363659|Glioblastoma Multiforme|glioblastoma multiforme
134268|NCT03363659|Anaplastic Glioma|anaplastic glioma
134269|NCT03363659|Unmethylated|unmethylated
134270|NCT03363633|Venous Ulceration|venous ulceration
134271|NCT03363633|Refluxing Perforator Veins|refluxing perforator veins
134272|NCT03363620|maxillary expansion|maxillary expansion
134273|NCT03363620|self ligating|self ligating
134274|NCT03363620|arch form|arch form
134275|NCT03363594|Diabetes, T2D|diabetes, t2d
134276|NCT03363581|Food preferences|food preferences
134277|NCT03363581|Fat|fat
134278|NCT03363581|Weight loss|weight loss
134279|NCT03363529|Dynamic lighting, ipRGC|dynamic lighting, iprgc
134280|NCT03363503|COPD|copd
134281|NCT03363503|Salmeterol/Fluticasone|salmeterol/fluticasone
134282|NCT03363503|Discair|discair
134283|NCT03363503|Diskus|diskus
134284|NCT03363503|Spirometry|spirometry
134285|NCT03363490|Self-Management|self-management
134286|NCT03363490|Neuromuscular Exercise Therapy|neuromuscular exercise therapy
134287|NCT03363490|Knee osteoarthritis|knee osteoarthritis
134288|NCT03363477|antithrombotic|antithrombotic
134289|NCT03363477|heparin|heparin
134290|NCT03363477|anticoagulant|anticoagulant
134291|NCT03363477|low molecular weight heparin|low molecular weight heparin
134292|NCT03363477|pharmacodynamic equivalence|pharmacodynamic equivalence
134293|NCT03363425|Dexmedetomidine|dexmedetomidine
134294|NCT03363425|Lidocaine|lidocaine
134295|NCT03363425|Postoperative Pain|postoperative pain
134296|NCT03363425|Analgesic Consumption|analgesic consumption
134297|NCT03363425|Recovery|recovery
134298|NCT03363425|Abdominal Gynaecological Surgery|abdominal gynaecological surgery
134299|NCT03363399|Diagnostic accuracy study|diagnostic accuracy study
134300|NCT03363399|Flow cytometry analysis|flow cytometry analysis
134301|NCT03363399|Myeloperoxidase|myeloperoxidase
134302|NCT03363399|Peripheral blood sample|peripheral blood sample
134303|NCT03363386|aerobic exercise|aerobic exercise
134304|NCT03363386|dynamic balance|dynamic balance
134305|NCT03363386|functional capacity|functional capacity
134306|NCT03363386|HbA1c|hba1c
134307|NCT03363386|proprioceptive exercise training|proprioceptive exercise training
134308|NCT03363373|Antibody, Neuroblastoma, Pediatric, Adult|antibody, neuroblastoma, pediatric, adult
134309|NCT03363334|ITP|itp
134310|NCT03363334|Immune Thrombocytopenia|immune thrombocytopenia
134311|NCT03363321|hemophilia|hemophilia
134312|NCT03363295|endophthalmitis|endophthalmitis
134313|NCT03363282|Crosslinking|crosslinking
134314|NCT03363256|Digital therapeutics|digital therapeutics
134315|NCT03363256|Adaptation|adaptation
134316|NCT03363230|mindfulness|mindfulness
134317|NCT03363230|emotion regulation|emotion regulation
134318|NCT03363230|impulsivity|impulsivity
134319|NCT03363217|Glioma|glioma
134320|NCT03363217|Optic Pathway Glioma|optic pathway glioma
134321|NCT03363217|Low grade glioma|low grade glioma
134322|NCT03363217|MAPK/ERK|mapk/erk
134323|NCT03363217|Plexiform Neurofibroma|plexiform neurofibroma
134324|NCT03363217|Neurofibromatosis Type 1|neurofibromatosis type 1
134325|NCT03363217|Central Nervous System|central nervous system
134326|NCT03363217|CNS|cns
134327|NCT03363217|Brain Tumor|brain tumor
134328|NCT03363217|LGG|lgg
134329|NCT03363217|NF1|nf1
134330|NCT03363217|KIAA1549-BRAF|kiaa1549-braf
134331|NCT03363217|Mitogen-activated Protein Kinase (MEK) inhibitor|mitogen-activated protein kinase (mek) inhibitor
134332|NCT03363217|Trametinib|trametinib
134333|NCT03363191|fluticasone furoate/vilanterol, efficacy, asthma, Chronic obstructive pulmonary disease|fluticasone furoate/vilanterol, efficacy, asthma, chronic obstructive pulmonary disease
134334|NCT03363165|PAD|pad
134335|NCT03363087|Atrial Scar|atrial scar
134336|NCT03363087|Atrial Fibrillation Ablation|atrial fibrillation ablation
134337|NCT03363087|Mapping|mapping
134338|NCT03363087|Persistent Atrial Fibrillation|persistent atrial fibrillation
134339|NCT03363087|Catheter Ablation|catheter ablation
134340|NCT03363074|Low-Level Laser Therapy, Orthotic Insoles|low-level laser therapy, orthotic insoles
134341|NCT03363048|Food restrictions/incentives|food restrictions/incentives
134342|NCT03363048|Food Stamp program|food stamp program
134343|NCT03363048|Policy change|policy change
134344|NCT03363048|Supplemental Nutrition Assistance Program (SNAP)|supplemental nutrition assistance program (snap)
134345|NCT03363009|prehabilitation|prehabilitation
134346|NCT03363009|connected devices|connected devices
134347|NCT03362996|extra virgin olive oil|extra virgin olive oil
134348|NCT03362996|mild cognitive impairment|mild cognitive impairment
134349|NCT03362996|randomized double blind clinical trial|randomized double blind clinical trial
134350|NCT03362970|Bloody Diarrhea|bloody diarrhea
134351|NCT03362970|STEC|stec
134352|NCT03362970|Hematochezia|hematochezia
134353|NCT03362970|BioFire FilmArray|biofire filmarray
134354|NCT03362970|Child|child
134355|NCT03362957|embolization|embolization
134356|NCT03362957|vascular|vascular
134357|NCT03362905|Lidocaine|lidocaine
134358|NCT03362905|Dosage forms|dosage forms
134359|NCT03362905|Pain scores|pain scores
134360|NCT03362879|Advanced Parkinson's Disease|advanced parkinson's disease
134361|NCT03362879|Levodopa-Carbidopa Intestinal Gel (LCIG)|levodopa-carbidopa intestinal gel (lcig)
134362|NCT03362827|Low back pain|low back pain
134363|NCT03362827|Long-term potentiation|long-term potentiation
134364|NCT03362827|Hyperalgesia|hyperalgesia
134365|NCT03362827|Allodynia|allodynia
134366|NCT03362814|HCV|hcv
134367|NCT03362814|Ravidasvir|ravidasvir
134368|NCT03362814|SVR12|svr12
134369|NCT03362801|physical activity|physical activity
134370|NCT03362801|elderly|elderly
134371|NCT03362788|Antithrombotics Antiplatelets Stents Angioplasty|antithrombotics antiplatelets stents angioplasty
134372|NCT03362762|Type 2 diabetes|type 2 diabetes
134373|NCT03362762|insulin|insulin
134374|NCT03362762|Hb1Ac|hb1ac
134375|NCT03362762|glycemia|glycemia
134376|NCT03362762|Guadeloupe|guadeloupe
134377|NCT03362671|OSA|osa
134378|NCT03362671|Mandibular Advancement Splint|mandibular advancement splint
134379|NCT03362671|Oral Appliance|oral appliance
134380|NCT03362671|Treatment|treatment
134381|NCT03362671|Orthodontic Implants|orthodontic implants
134382|NCT03362658|Magnetic Resonance Imaging|magnetic resonance imaging
134383|NCT03362658|MRI|mri
134384|NCT03362658|Biomarker|biomarker
134385|NCT03362619|Cervical cancer|cervical cancer
134386|NCT03362619|Cytotoxic lymphocyte|cytotoxic lymphocyte
134387|NCT03362619|CC-CTL|cc-ctl
134388|NCT03362606|Ovarian cancer|ovarian cancer
134389|NCT03362606|Cytotoxic lymphocyte|cytotoxic lymphocyte
134390|NCT03362606|OC-CTL|oc-ctl
134391|NCT03362580|Epiretinal Membrane|epiretinal membrane
134392|NCT03362580|Diabetes|diabetes
134393|NCT03362567|Cervical Radiculopathy|cervical radiculopathy
134394|NCT03362567|Sustained Natural Apophyseal Glides|sustained natural apophyseal glides
134395|NCT03362567|Mechanical Cervical Traction|mechanical cervical traction
134396|NCT03362567|Pain Intensity|pain intensity
134397|NCT03362567|Neck Disability|neck disability
134398|NCT03362554|Insulin|insulin
134399|NCT03362554|Glucose|glucose
134400|NCT03362554|Rab3|rab3
134401|NCT03362541|multiple sclerosis|multiple sclerosis
134402|NCT03362541|fatigue|fatigue
134403|NCT03362541|self-management|self-management
134404|NCT03362541|rehabilitation|rehabilitation
134405|NCT03362502|gene therapy, mini-dystrophin, AAV|gene therapy, mini-dystrophin, aav
134406|NCT03362489|In Vitro Fertilization|in vitro fertilization
134407|NCT03362489|Intra-Uterine Insemination|intra-uterine insemination
134408|NCT03362489|Poor responders|poor responders
134409|NCT03362476|Human Immunodeficiency Virus|human immunodeficiency virus
134410|NCT03362476|Hepatitis C|hepatitis c
134411|NCT03362476|Computer Intervention|computer intervention
134412|NCT03362476|Alcoholism|alcoholism
134413|NCT03362476|Women|women
134414|NCT03362476|Russia|russia
134415|NCT03362450|Midgut volvulus|midgut volvulus
134416|NCT03362450|Fetal volvulus|fetal volvulus
171424|NCT03123172|co2 gap|co2 gap
134417|NCT03362450|Whirlpool sign|whirlpool sign
134418|NCT03362450|Pregnant women|pregnant women
134419|NCT03362450|Position of mesenteric vessels|position of mesenteric vessels
134420|NCT03362450|Post natal surgery|post natal surgery
134421|NCT03362450|Foetopathology if performed|foetopathology if performed
134422|NCT03362450|Hydro-meconium level in the dilated loops|hydro-meconium level in the dilated loops
134423|NCT03362411|Healthy participants|healthy participants
134424|NCT03362411|Healthy subjects|healthy subjects
134425|NCT03362385|Obstructive sleep apnea|obstructive sleep apnea
134426|NCT03362385|Acute coronary syndrome|acute coronary syndrome
134427|NCT03362385|Continuous positive airway pressure|continuous positive airway pressure
134428|NCT03362385|Outcome|outcome
134429|NCT03362359|prostatectomy|prostatectomy
134430|NCT03362359|68Ga-PSMA-11|68ga-psma-11
134431|NCT03362359|EPLND|eplnd
134432|NCT03362346|Wavelet transform|wavelet transform
134433|NCT03362346|Deep learning|deep learning
134434|NCT03362307|Low-Level Light Therapy, Osseointegration|low-level light therapy, osseointegration
134435|NCT03362281|Peptic ulcer hemorrhage|peptic ulcer hemorrhage
134436|NCT03362281|Proton Pump Inhibitor|proton pump inhibitor
134437|NCT03362255|Optic Nerve Sheath Diameter Injection Speed|optic nerve sheath diameter injection speed
134438|NCT03362216|soft tissue, pain|soft tissue, pain
134439|NCT03362203|Conditioned pain modulation, neck pain|conditioned pain modulation, neck pain
134440|NCT03362190|Zimura|zimura
134441|NCT03362190|ARC1905|arc1905
134442|NCT03362190|Lucentis|lucentis
134443|NCT03362190|ranibizumab|ranibizumab
134444|NCT03362190|Wet AMD|wet amd
134445|NCT03362190|avacincaptad pegol|avacincaptad pegol
134446|NCT03362190|complement factor C5 inhibitor|complement factor c5 inhibitor
134447|NCT03362177|Chemotherapy Induced Thrombocytopenia|chemotherapy induced thrombocytopenia
134448|NCT03362177|Gastrointestinal Cancer|gastrointestinal cancer
134449|NCT03362177|Colorectal Cancer|colorectal cancer
134450|NCT03362164|Fabry|fabry
134451|NCT03362164|Fibrosis|fibrosis
134452|NCT03362164|Dialysis|dialysis
134453|NCT03362164|Stroke|stroke
134454|NCT03362164|Chronic kidney disease|chronic kidney disease
134455|NCT03362151|type 1 diabetes|type 1 diabetes
134456|NCT03362151|pasta|pasta
134457|NCT03362151|rice|rice
134458|NCT03362151|protein|protein
134459|NCT03362151|carbohydrate|carbohydrate
134460|NCT03362138|melanoma|melanoma
134461|NCT03362138|dysplastic nevus|dysplastic nevus
134462|NCT03362138|artificial intelligence|artificial intelligence
134463|NCT03362138|early diagnosis|early diagnosis
134464|NCT03362112|lipoprotein-associated phospholipase A2|lipoprotein-associated phospholipase a2
134465|NCT03362099|varenicline|varenicline
134466|NCT03362099|bupropion|bupropion
134467|NCT03362086|bone tumor osteosarcoma|bone tumor osteosarcoma
134468|NCT03362073|Ketamine|ketamine
134469|NCT03362073|Refractory cancer pain|refractory cancer pain
134470|NCT03362073|Terminally ill cancer patients|terminally ill cancer patients
134471|NCT03362073|Palliative care|palliative care
134472|NCT03362060|Triple Negative Breast Cancer|triple negative breast cancer
134473|NCT03362060|Vaccine|vaccine
134474|NCT03362060|Immunotherapy|immunotherapy
134475|NCT03362060|PD-1 Inhibitor|pd-1 inhibitor
134476|NCT03362060|Metastatic Breast Cancer|metastatic breast cancer
134477|NCT03362021|transvaginal oocyte retrieval|transvaginal oocyte retrieval
134478|NCT03362021|sedation|sedation
134479|NCT03362021|dexmedetomidine|dexmedetomidine
134480|NCT03362021|fentanyl|fentanyl
134481|NCT03362021|remifentanil|remifentanil
134482|NCT03362021|midazolam|midazolam
134483|NCT03361995|STEMI|stemi
134484|NCT03361969|quality of life|quality of life
134485|NCT03361969|hot flushes|hot flushes
134486|NCT03361969|prostate cancer|prostate cancer
134487|NCT03361969|testosterone|testosterone
134582|NCT03361345|Postinflammatory hyperpigmentation|postinflammatory hyperpigmentation
134488|NCT03361930|spastic unilateral cerebral palsy, ankle-foot orthosis, AFO, muscle activity, muscular activity, electromyography, EMG,|spastic unilateral cerebral palsy, ankle-foot orthosis, afo, muscle activity, muscular activity, electromyography, emg,
134489|NCT03361917|Colonoscopy screening|colonoscopy screening
134490|NCT03361917|Colonscopy procedure|colonscopy procedure
134491|NCT03361878|Metformin|metformin
134492|NCT03361878|Intolerance|intolerance
134493|NCT03361878|Pharmacokinetics|pharmacokinetics
134494|NCT03361865|Urothelial cancer, programmed cell death 1 (PD-1) inhibitor|urothelial cancer, programmed cell death 1 (pd-1) inhibitor
134495|NCT03361865|indoleamine 2,3-dioxygenase (IDO) inhibitor|indoleamine 2,3-dioxygenase (ido) inhibitor
134496|NCT03361852|Follicular Lymphoma|follicular lymphoma
134497|NCT03361826|Magnetic seizure therapy (MST)|magnetic seizure therapy (mst)
134498|NCT03361826|Treatment resistance|treatment resistance
134499|NCT03361826|Open-label trial|open-label trial
134500|NCT03361826|Borderline Personality Disorder|borderline personality disorder
134501|NCT03361826|Suicidal Ideation|suicidal ideation
134502|NCT03361826|Treatment-resistant depression|treatment-resistant depression
134503|NCT03361826|Dialectical behavior therapy (DBT)|dialectical behavior therapy (dbt)
134504|NCT03361826|MST + DBT|mst + dbt
134505|NCT03361826|Neuroimaging-based biomarkers|neuroimaging-based biomarkers
134506|NCT03361800|Breast Cancer|breast cancer
134507|NCT03361800|ER Negative Breast Cancer|er negative breast cancer
134508|NCT03361800|Triple Negative Breast Cancer|triple negative breast cancer
134509|NCT03361800|PR Negative Breast Cancer|pr negative breast cancer
134510|NCT03361800|ER Positive PR Positive Breast Cancer|er positive pr positive breast cancer
134511|NCT03361787|adolescents|adolescents
134512|NCT03361787|parents|parents
134513|NCT03361787|coaching|coaching
134514|NCT03361761|Chronic disease|chronic disease
134515|NCT03361761|precariousness and vulnerability|precariousness and vulnerability
134516|NCT03361761|Health education|health education
134517|NCT03361748|Multiple Myeloma|multiple myeloma
134518|NCT03361748|Efficacy and Safety|efficacy and safety
134519|NCT03361748|BB2121|bb2121
134520|NCT03361748|CAR T Cell|car t cell
134521|NCT03361748|BCMA|bcma
134522|NCT03361748|Relapsed and Refractory|relapsed and refractory
134523|NCT03361735|PSA Level Greater than or Equal to 0.2|psa level greater than or equal to 0.2
134524|NCT03361735|Stage IV Prostate Adenocarcinoma AJCC v7|stage iv prostate adenocarcinoma ajcc v7
134525|NCT03361683|High-Flow nasal oxygen|high-flow nasal oxygen
134526|NCT03361618|Uric acid|uric acid
134527|NCT03361618|Adenosine deaminase|adenosine deaminase
134528|NCT03361618|Zinc Sulfate|zinc sulfate
134529|NCT03361618|5'-nucleotidase|5'-nucleotidase
134530|NCT03361618|Asthenospermia.|asthenospermia.
134531|NCT03361618|Xanthine oxidase|xanthine oxidase
134532|NCT03361592|symmetry index, functional performance tests, SMT|symmetry index, functional performance tests, smt
134533|NCT03361579|Placebo|placebo
134534|NCT03361566|physical activity|physical activity
134535|NCT03361566|energy balance|energy balance
134536|NCT03361566|caloric restriction|caloric restriction
134537|NCT03361566|overfeeding|overfeeding
134538|NCT03361566|appetite regulation|appetite regulation
134539|NCT03361540|Pharmacokinetics|pharmacokinetics
134540|NCT03361540|Safety|safety
134541|NCT03361540|ASP8302|asp8302
134542|NCT03361514|antidepressants, discontinuation, primary care, MBCT|antidepressants, discontinuation, primary care, mbct
134543|NCT03361501|Omega-3 Fatty acids|omega-3 fatty acids
134544|NCT03361501|Triglycerides|triglycerides
134545|NCT03361475|Sharing|sharing
134546|NCT03361475|Mind|mind
134547|NCT03361475|Enjoyment|enjoyment
134548|NCT03361462|Sharing|sharing
134549|NCT03361462|Mind|mind
134550|NCT03361462|Enjoyment|enjoyment
134551|NCT03361410|Mild Decline in Cognition|mild decline in cognition
134552|NCT03361410|Mild Cognitive Decline|mild cognitive decline
134553|NCT03361410|Mild Cognitive Impairment|mild cognitive impairment
134554|NCT03361410|Dementia|dementia
134555|NCT03361410|Positron Emission Tomography (PET)|positron emission tomography (pet)
134556|NCT03361410|F-18 Fluorodeoxyglucose (FDG)|f-18 fluorodeoxyglucose (fdg)
134557|NCT03361410|Cerebral Metabolism|cerebral metabolism
134558|NCT03361410|Dietary Supplement|dietary supplement
134559|NCT03361410|MCI|mci
134560|NCT03361410|MDC|mdc
134561|NCT03361410|Grape|grape
134562|NCT03361410|Memory|memory
134563|NCT03361410|Randomized|randomized
134564|NCT03361410|Non-Drug|non-drug
134565|NCT03361410|Supplement|supplement
134566|NCT03361410|Non-Pharmacologic|non-pharmacologic
134567|NCT03361410|Natural|natural
134568|NCT03361410|Red Wine|red wine
134569|NCT03361410|Free|free
134570|NCT03361410|UCLA|ucla
134571|NCT03361410|Brain Scan|brain scan
134572|NCT03361410|Alzheimer's Disease|alzheimer's disease
134573|NCT03361410|Brain Diseases|brain diseases
134574|NCT03361410|Central Nervous System Diseases|central nervous system diseases
134575|NCT03361410|Cognition|cognition
134576|NCT03361410|Cognitive|cognitive
134577|NCT03361410|Neurocognitive|neurocognitive
134578|NCT03361410|Neurodegenerative|neurodegenerative
134579|NCT03361384|men who have sex with men|men who have sex with men
134580|NCT03361371|Nose suctioning|nose suctioning
134581|NCT03361371|Pediatric|pediatric
134583|NCT03361345|Acne|acne
134584|NCT03361319|NSCLC|nsclc
134585|NCT03361319|Non-Small Cell Lung Cancer|non-small cell lung cancer
134586|NCT03361319|Adenocarcinoma of lung|adenocarcinoma of lung
134587|NCT03361306|Relapsed|relapsed
134588|NCT03361280|hemodialysis|hemodialysis
134589|NCT03361280|dialytic clearance|dialytic clearance
134590|NCT03361280|pharmacokinetics|pharmacokinetics
134591|NCT03361241|Stroke|stroke
134592|NCT03361241|Postural Balance|postural balance
134593|NCT03361241|Motor Function|motor function
134594|NCT03361241|Gait|gait
134595|NCT03361241|Virtual Reality Exposure Therapy|virtual reality exposure therapy
134596|NCT03361241|Physiotherapist|physiotherapist
134597|NCT03361228|Non-small cell lung cancer (NSCLC)|non-small cell lung cancer (nsclc)
134598|NCT03361228|melanoma|melanoma
134599|NCT03361228|urothelial carcinoma|urothelial carcinoma
134600|NCT03361228|squamous cell carcinoma of the head and neck (SCCHN)|squamous cell carcinoma of the head and neck (scchn)
134601|NCT03361228|small cell lung cancer (SCLC)|small cell lung cancer (sclc)
134602|NCT03361228|colorectal cancer (CRC)|colorectal cancer (crc)
134603|NCT03361228|arginase 1 inhibitor|arginase 1 inhibitor
134604|NCT03361228|indoleamine 2,3-dioxygenase 1 inhibitor|indoleamine 2,3-dioxygenase 1 inhibitor
134605|NCT03361228|programmed death-1 receptor (PD-1) inhibitor|programmed death-1 receptor (pd-1) inhibitor
134606|NCT03361215|Disease progression|disease progression
134607|NCT03361215|Disease course|disease course
134608|NCT03361215|Immunological characterization|immunological characterization
134609|NCT03361189|Congenital heart disease|congenital heart disease
134610|NCT03361189|Pacemaker|pacemaker
134611|NCT03361189|Sinus node dysfunction|sinus node dysfunction
134612|NCT03361163|Streptococcus pyogenes pharyngitis|streptococcus pyogenes pharyngitis
134613|NCT03361163|Streptococcus Pharyngitis|streptococcus pharyngitis
134614|NCT03361163|Strep Throat|strep throat
134615|NCT03361163|Streptococcus pyogenes Infection|streptococcus pyogenes infection
134616|NCT03361163|Group A Streptococcus: B Hemolytic Pharyngitis|group a streptococcus: b hemolytic pharyngitis
134617|NCT03361163|Group A Streptococcal Infection|group a streptococcal infection
134618|NCT03361163|Controlled human infection model|controlled human infection model
134619|NCT03361163|Challenge study|challenge study
134620|NCT03361150|prehabilitation|prehabilitation
134621|NCT03361111|severe asthma|severe asthma
134622|NCT03361111|anti-IgE|anti-ige
134623|NCT03361111|periostin|periostin
134624|NCT03361111|induced sputum,|induced sputum,
134625|NCT03361111|exhaled breath condensate|exhaled breath condensate
134626|NCT03361098|SGLT2 inhibition; dapagliflozin|sglt2 inhibition; dapagliflozin
134627|NCT03361098|GLP-1 receptor agonist; exenatide|glp-1 receptor agonist; exenatide
134628|NCT03361098|Central satiety and reward circuits|central satiety and reward circuits
134629|NCT03361098|bodyweight|bodyweight
134630|NCT03361098|brain|brain
134631|NCT03361085|non-ventilator-associated hospital acquired pneumonia|non-ventilator-associated hospital acquired pneumonia
134632|NCT03361085|Hospital-acquired Pneumonia|hospital-acquired pneumonia
134633|NCT03361085|Healthcare Associated Infection|healthcare associated infection
134634|NCT03361085|Adherence|adherence
134635|NCT03361085|infection prevention|infection prevention
134636|NCT03361085|implementation|implementation
134637|NCT03361072|oral immunotherapy|oral immunotherapy
134638|NCT03361072|milk|milk
134639|NCT03361072|peanut|peanut
134640|NCT03361072|egg|egg
134641|NCT03361072|adult|adult
134642|NCT03361059|risk factors|risk factors
134643|NCT03361059|elderly patients|elderly patients
134644|NCT03361059|risk of falling|risk of falling
134645|NCT03361046|TAVI|tavi
134646|NCT03361046|valve-in-valve|valve-in-valve
134647|NCT03361046|aortic stenosis|aortic stenosis
134648|NCT03361033|Survivorship|survivorship
134649|NCT03361033|Social Functioning|social functioning
134650|NCT03361033|Social Outcomes|social outcomes
134651|NCT03361007|TAVI|tavi
134652|NCT03361007|common carotid artery|common carotid artery
134653|NCT03360955|Extubation|extubation
134654|NCT03360955|Cardiac Surgery|cardiac surgery
134655|NCT03360929|Lung Cancer|lung cancer
134656|NCT03360916|high cholesterol|high cholesterol
134657|NCT03360916|exercise|exercise
134658|NCT03360916|statins|statins
134659|NCT03360890|thyroid cancer|thyroid cancer
134660|NCT03360890|salivary gland cancer|salivary gland cancer
134661|NCT03360890|pembrolizumab|pembrolizumab
134662|NCT03360890|docetaxel|docetaxel
134663|NCT03360864|Therapeutic education|therapeutic education
134664|NCT03360812|Medical Students|medical students
134665|NCT03360812|Education|education
134666|NCT03360812|Prognosis|prognosis
134667|NCT03360812|Online training resource|online training resource
134668|NCT03360786|sport concussion|sport concussion
134669|NCT03360786|cervical spine|cervical spine
134670|NCT03360786|youth|youth
134671|NCT03360760|osteosarcoma|osteosarcoma
134672|NCT03360760|pelvis|pelvis
134673|NCT03360760|sacrum|sacrum
134674|NCT03360747|Familial Lipoprotein Lipase Deficiency|familial lipoprotein lipase deficiency
134675|NCT03360747|Hyperlipoproteinemias|hyperlipoproteinemias
134676|NCT03360747|Familial Hyperlipoproteinemia Type 1|familial hyperlipoproteinemia type 1
134677|NCT03360747|Hyperlipoproteinemia Type I|hyperlipoproteinemia type i
135162|NCT03357783|Pregnancy|pregnancy
134678|NCT03360747|Hyperchylomicronemia, Familial|hyperchylomicronemia, familial
134679|NCT03360747|Lipoprotein Lipase Deficiency, Familial|lipoprotein lipase deficiency, familial
134680|NCT03360747|Hyperlipidemias|hyperlipidemias
134681|NCT03360747|Dyslipidemias|dyslipidemias
134682|NCT03360747|Lipid Metabolism Disorders|lipid metabolism disorders
134683|NCT03360747|Lipid Metabolism, Inborn Errors|lipid metabolism, inborn errors
134684|NCT03360747|Metabolic Diseases|metabolic diseases
134685|NCT03360747|Metabolism, Inborn Errors|metabolism, inborn errors
134686|NCT03360747|Genetic Diseases, Inborn|genetic diseases, inborn
134687|NCT03360721|mCRPC|mcrpc
134688|NCT03360721|metastatic castration resistant prostate cancer|metastatic castration resistant prostate cancer
134689|NCT03360721|nonsteroidal antiandrogen|nonsteroidal antiandrogen
134690|NCT03360721|androgen signaling|androgen signaling
134691|NCT03360695|Cancer Care|cancer care
134692|NCT03360695|Major Depression and Cancer|major depression and cancer
134693|NCT03360695|Schizophrenia and Cancer|schizophrenia and cancer
134694|NCT03360695|Bipolar Disorder and Cancer|bipolar disorder and cancer
134695|NCT03360695|Lung Cancer|lung cancer
134696|NCT03360695|Breast Cancer|breast cancer
134697|NCT03360695|Head and Neck Cancer|head and neck cancer
134698|NCT03360695|Gastrointestinal Cancer|gastrointestinal cancer
134699|NCT03360695|Schizophrenia|schizophrenia
134700|NCT03360695|Bipolar Disorder|bipolar disorder
134701|NCT03360695|Major Depression|major depression
134702|NCT03360669|hypertension, blood pressure, systolic, diastolic, AOBP, Omron HEM-907, research, clinical|hypertension, blood pressure, systolic, diastolic, aobp, omron hem-907, research, clinical
134703|NCT03360656|shivering, fever, normothermia|shivering, fever, normothermia
134704|NCT03360643|Point-of-care ultrasound|point-of-care ultrasound
134705|NCT03360643|Intussusception|intussusception
134706|NCT03360643|Pediatric Emergency Medicine|pediatric emergency medicine
134707|NCT03360643|Ultrasound|ultrasound
134708|NCT03360617|IV|iv
134709|NCT03360617|Intravenous|intravenous
134710|NCT03360617|IV Push|iv push
134711|NCT03360617|Piggyback|piggyback
134712|NCT03360617|Antibiotics|antibiotics
134713|NCT03360617|Beta Lactam|beta lactam
134714|NCT03360617|Infection|infection
134715|NCT03360604|glycaemic index|glycaemic index
134716|NCT03360604|glycaemia|glycaemia
134717|NCT03360604|diabetes mellitus|diabetes mellitus
134718|NCT03360604|type 2 diabetes|type 2 diabetes
134719|NCT03360565|Obstructive Sleep Apnea Syndrome (OSAS)|obstructive sleep apnea syndrome (osas)
134720|NCT03360526|PICSI|picsi
134721|NCT03360526|ORP|orp
134722|NCT03360526|TESA|tesa
134723|NCT03360526|seminal oxidation reduction potential|seminal oxidation reduction potential
134724|NCT03360513|Orthodontics|orthodontics
134725|NCT03360513|Dental arch|dental arch
134726|NCT03360513|Orthodontic appliance design.|orthodontic appliance design.
134727|NCT03360500|Osteoarthritis, Knee|osteoarthritis, knee
134728|NCT03360500|Cryotherapy|cryotherapy
134729|NCT03360500|Exercise|exercise
134730|NCT03360500|Physiotherapy|physiotherapy
134731|NCT03360500|Knee|knee
134732|NCT03360448|Gene Transfer|gene transfer
134733|NCT03360422|MSM, young adult|msm, young adult
134734|NCT03360409|Cervical Disc Degeneration|cervical disc degeneration
134735|NCT03360409|cervical anterior discectomy|cervical anterior discectomy
134736|NCT03360409|Spinal alignment|spinal alignment
134737|NCT03360396|severe heterogeneous emphysema|severe heterogeneous emphysema
134738|NCT03360396|severe homogeneous emphysema|severe homogeneous emphysema
134739|NCT03360383|Spinal Fractures/surgery|spinal fractures/surgery
134740|NCT03360383|Vertebroplasty|vertebroplasty
134741|NCT03360383|Quality-Adjusted Life Years|quality-adjusted life years
134742|NCT03360370|Neurodevelopmental disorders,|neurodevelopmental disorders,
134743|NCT03360370|Congenital heart disease|congenital heart disease
134744|NCT03360370|Children|children
134745|NCT03360344|carpal tunnel syndrome, forearm wrist hand pain, kinesio tape|carpal tunnel syndrome, forearm wrist hand pain, kinesio tape
134746|NCT03360318|pediatric|pediatric
134747|NCT03360318|elbow fractures|elbow fractures
134748|NCT03360318|management|management
134749|NCT03360305|emergency department|emergency department
134750|NCT03360305|prevention|prevention
134751|NCT03360305|transitions of care|transitions of care
134752|NCT03360292|Neonatology|neonatology
134753|NCT03360266|remineralization|remineralization
134754|NCT03360266|fluoride varnish|fluoride varnish
134755|NCT03360227|syncope|syncope
134756|NCT03360227|bradycardia|bradycardia
134757|NCT03360227|tachycardia|tachycardia
134758|NCT03360227|sudden cardiac death|sudden cardiac death
134759|NCT03360227|implantable cardioverter-defibrillator|implantable cardioverter-defibrillator
134760|NCT03360227|ventricular tachycardia|ventricular tachycardia
134761|NCT03360227|ventricular fibrillation|ventricular fibrillation
134762|NCT03360227|biomarker|biomarker
134763|NCT03360227|thyroid hormone|thyroid hormone
134764|NCT03360214|Mastectomy|mastectomy
134765|NCT03360214|Tissue expander|tissue expander
134766|NCT03360214|PEMF|pemf
134767|NCT03360214|PIB|pib
134768|NCT03360201|Africa|africa
134769|NCT03360201|Kenya|kenya
134770|NCT03360201|Family relations|family relations
134771|NCT03360201|Child mental health|child mental health
134772|NCT03360201|Adolescent mental health|adolescent mental health
134773|NCT03360201|Family therapy|family therapy
134774|NCT03360201|Program evaluation|program evaluation
134775|NCT03360201|Family Conflict|family conflict
134776|NCT03360201|Marital Conflict|marital conflict
134777|NCT03360201|Domestic Violence|domestic violence
134778|NCT03360201|Parenting|parenting
134779|NCT03360201|Parent-Child Relations|parent-child relations
134780|NCT03360201|child abuse|child abuse
134781|NCT03360201|low- and middle-income country|low- and middle-income country
134782|NCT03360149|Hemophilia pregnant|hemophilia pregnant
134783|NCT03360149|Hemophilia delivery|hemophilia delivery
134784|NCT03360149|Hemophilia children|hemophilia children
134785|NCT03360136|Exhaustion Disorder|exhaustion disorder
134786|NCT03360136|Burnout|burnout
134787|NCT03360136|Clinical Burnout|clinical burnout
134788|NCT03360097|In vitro Fertilization|in vitro fertilization
134789|NCT03360097|Slow Developing Blastocyst|slow developing blastocyst
134790|NCT03360097|Fresh Embryo Transfer|fresh embryo transfer
134791|NCT03360097|Frozen Embryo Transfer|frozen embryo transfer
134792|NCT03360097|Live Birth Rate|live birth rate
134793|NCT03360084|CT|ct
134794|NCT03360084|Interventional radiology|interventional radiology
134795|NCT03360084|Lung biopsy|lung biopsy
134796|NCT03360084|Transthoracic biopsy|transthoracic biopsy
134797|NCT03360084|Systemic air embolism|systemic air embolism
134798|NCT03360058|motivational techniques|motivational techniques
134799|NCT03360058|primary care|primary care
134800|NCT03360032|Incremental shuttle walk test|incremental shuttle walk test
134801|NCT03360032|Cardiopulmonary exercise test|cardiopulmonary exercise test
134802|NCT03360032|VO2 peak|vo2 peak
134803|NCT03360006|Castrate-Resistant Prostate Cancer (CRPC)|castrate-resistant prostate cancer (crpc)
134804|NCT03360006|Metastatic Castrate-Resistant Prostate Cancer (CRPC)|metastatic castrate-resistant prostate cancer (crpc)
134805|NCT03360006|Acute Myeloid Leukemia (AML)|acute myeloid leukemia (aml)
134806|NCT03360006|Relapsing acute myeloid leukemia|relapsing acute myeloid leukemia
134807|NCT03360006|Remitting acute myeloid leukemia|remitting acute myeloid leukemia
134808|NCT03360006|Dose-limiting toxicity|dose-limiting toxicity
134809|NCT03360006|Recommended phase two dose|recommended phase two dose
134810|NCT03360006|Pharmacokinetics|pharmacokinetics
134811|NCT03359993|Endotracheal intubation|endotracheal intubation
134812|NCT03359993|Neonatal premedication|neonatal premedication
134813|NCT03359993|Delivery room|delivery room
134814|NCT03359941|Integrative Treatments|integrative treatments
134815|NCT03359941|Korean Traditional medicine|korean traditional medicine
134816|NCT03359915|COPD|copd
134817|NCT03359915|Self-Management|self-management
134818|NCT03359915|Action Plan|action plan
134819|NCT03359915|SGRQ|sgrq
134820|NCT03359915|LMIC|lmic
134821|NCT03359915|COPD Diagnosis|copd diagnosis
134822|NCT03359902|Mild Cognitive Impairment|mild cognitive impairment
134823|NCT03359902|Vagal Nerve Stimulation|vagal nerve stimulation
134824|NCT03359902|tVNS|tvns
134825|NCT03359902|Alzheimer's disease|alzheimer's disease
134826|NCT03359876|Real-world study|real-world study
134827|NCT03359876|Atrial fibrillation|atrial fibrillation
134828|NCT03359876|Renal dysfunction|renal dysfunction
134829|NCT03359876|Rivaroxaban|rivaroxaban
134830|NCT03359876|Warfarin|warfarin
134831|NCT03359824|exercise, brown adipose tissue|exercise, brown adipose tissue
134832|NCT03359811|Local Anesthetic Solution|local anesthetic solution
134833|NCT03359811|Bupivacaine HCl|bupivacaine hcl
134834|NCT03359811|Liposomal Bupivacaine|liposomal bupivacaine
134835|NCT03359811|Peritoneal Cancer|peritoneal cancer
134836|NCT03359785|Drug therapy|drug therapy
134837|NCT03359772|Neuropathic Pain|neuropathic pain
134838|NCT03359772|Balance|balance
134839|NCT03359772|Kinesthetic Ability Trainer|kinesthetic ability trainer
134840|NCT03359772|Quality of Life|quality of life
134841|NCT03359759|Telemedicine|telemedicine
134842|NCT03359759|Connected watches|connected watches
134843|NCT03359759|Patient-Reported symptom monitoring|patient-reported symptom monitoring
134844|NCT03359759|Secure Platform|secure platform
134845|NCT03359733|Drug therapy|drug therapy
134846|NCT03359694|breast cancer, neoadjuvant chemotherapy,susceptible gene|breast cancer, neoadjuvant chemotherapy,susceptible gene
134847|NCT03359655|misoprostol|misoprostol
134848|NCT03359655|hyoscine butyl bromide|hyoscine butyl bromide
134849|NCT03359655|cervical dilatation|cervical dilatation
134850|NCT03359655|cervical ripening|cervical ripening
134851|NCT03359655|hysteroscopy|hysteroscopy
134852|NCT03359655|pain|pain
134853|NCT03359642|Microbiota|microbiota
134854|NCT03359642|inflammatory bowel disease|inflammatory bowel disease
134855|NCT03359642|inflammation|inflammation
134856|NCT03359642|anti-TNF alpha|anti-tnf alpha
134857|NCT03359629|Spectrophon|spectrophon
134858|NCT03359629|Glucose|glucose
134859|NCT03359629|Biosensor|biosensor
134860|NCT03359629|Non-invasive testing|non-invasive testing
134861|NCT03359616|rectal cancer|rectal cancer
134862|NCT03359616|laparoscopic surgery|laparoscopic surgery
134863|NCT03359616|total mesorectal excision|total mesorectal excision
134864|NCT03359616|transanal surgery|transanal surgery
134865|NCT03359603|Electro-acupuncture|electro-acupuncture
134866|NCT03359603|Knee osteoarthritis|knee osteoarthritis
134867|NCT03359603|Treatment frequency|treatment frequency
134868|NCT03359577|Chronic plaque psoriasis|chronic plaque psoriasis
134869|NCT03359577|Inflammation|inflammation
134870|NCT03359577|Cardiovascular diseases|cardiovascular diseases
134871|NCT03359564|Lumbar Disc Herniation|lumbar disc herniation
134872|NCT03359564|Micro Endoscopic Discectomy|micro endoscopic discectomy
134873|NCT03359551|Choroideremia|choroideremia
134874|NCT03359551|REP1|rep1
134875|NCT03359551|Retina|retina
134876|NCT03359551|Retinal Degeneration|retinal degeneration
134877|NCT03359551|Retinal Dystrophy|retinal dystrophy
134878|NCT03359551|Natural History|natural history
134879|NCT03359538|Amyotrophic Lateral Sclerosis|amyotrophic lateral sclerosis
134880|NCT03359538|Motor Neuron Disease|motor neuron disease
134881|NCT03359538|Rapamycin|rapamycin
134882|NCT03359512|anesthesia monitoring|anesthesia monitoring
134883|NCT03359473|GSK2881078|gsk2881078
134884|NCT03359473|COPD|copd
134885|NCT03359473|muscle weakness|muscle weakness
134886|NCT03359473|post-menopausal|post-menopausal
134887|NCT03359473|selective androgen receptor modulator|selective androgen receptor modulator
134888|NCT03359447|infant|infant
134889|NCT03359447|primary prevention|primary prevention
134890|NCT03359434|Acute Stroke|acute stroke
134891|NCT03359434|Blood Pressure|blood pressure
134892|NCT03359434|Cerebral Hemorrhage|cerebral hemorrhage
134893|NCT03359421|prehospital|prehospital
134894|NCT03359421|aeromedical|aeromedical
134895|NCT03359421|trauma|trauma
134896|NCT03359421|ems|ems
134897|NCT03359421|helicopter|helicopter
134898|NCT03359408|Health care|health care
134899|NCT03359408|Dementia care|dementia care
134900|NCT03359408|Collaborative care|collaborative care
134901|NCT03359408|Discharge management|discharge management
134902|NCT03359408|Hospital|hospital
134903|NCT03359408|Primary care|primary care
134904|NCT03359395|Anesthesia|anesthesia
134905|NCT03359356|alopecia|alopecia
134906|NCT03359356|alopecia areata|alopecia areata
134907|NCT03359356|alopecia universalis|alopecia universalis
134908|NCT03359356|alopecia totalis|alopecia totalis
134909|NCT03359356|dupixent|dupixent
134910|NCT03359356|dupilumab|dupilumab
134911|NCT03359330|Peripheral nervous system diseases|peripheral nervous system diseases
134912|NCT03359330|Wounds and injuries|wounds and injuries
134913|NCT03359330|Nerve regeneration|nerve regeneration
134914|NCT03359330|Biocompatible materials|biocompatible materials
134915|NCT03359330|Surgical procedures|surgical procedures
134916|NCT03359317|Osteoporosis|osteoporosis
134917|NCT03359317|Bone Diseases|bone diseases
134918|NCT03359304|bone tumor|bone tumor
134919|NCT03359291|macitentan|macitentan
134920|NCT03359291|rosuvastatin|rosuvastatin
134921|NCT03359291|pharmacokinetics|pharmacokinetics
134922|NCT03359278|distal radius fracture, sigmoid notch|distal radius fracture, sigmoid notch
134923|NCT03359252|coil embolization|coil embolization
134924|NCT03359252|headache|headache
134925|NCT03359252|stent|stent
134926|NCT03359239|PGV001|pgv001
134927|NCT03359239|atezolizumab|atezolizumab
134928|NCT03359239|urothelial cancer|urothelial cancer
134929|NCT03359239|personalized neoantigen vaccine|personalized neoantigen vaccine
134930|NCT03359187|Radiation- induced mucositis|radiation- induced mucositis
134931|NCT03359187|Head and Neck Cancer|head and neck cancer
134932|NCT03359187|Radiation therapy side effect|radiation therapy side effect
134933|NCT03359161|ambulatory|ambulatory
134934|NCT03359161|Subcutaneous|subcutaneous
134935|NCT03359161|furosemide|furosemide
134936|NCT03359148|Nosocomial infection|nosocomial infection
134937|NCT03359148|Ventilator system|ventilator system
134938|NCT03359148|Closed suction system|closed suction system
134939|NCT03359148|Open suction system|open suction system
134940|NCT03359148|Bacterial contamination|bacterial contamination
134941|NCT03359135|Compression garment|compression garment
134942|NCT03359096|Sleep apnea|sleep apnea
134943|NCT03359096|Tongue stimulation|tongue stimulation
134944|NCT03359096|Cardiovascular function|cardiovascular function
134945|NCT03359083|foot-ankle characteristic|foot-ankle characteristic
134946|NCT03359083|lumbopelvic control|lumbopelvic control
134947|NCT03359083|balance|balance
134948|NCT03359083|physical performance|physical performance
134949|NCT03359070|Tinea cruris|tinea cruris
134950|NCT03359070|dapaconazole|dapaconazole
134951|NCT03359070|topical antifungal|topical antifungal
134952|NCT03359070|dermatophytoses|dermatophytoses
134953|NCT03359057|Folic acid|folic acid
134954|NCT03359057|Supplementation|supplementation
134955|NCT03359057|Ethinyl estradiol|ethinyl estradiol
134956|NCT03359057|Levonorgestrel|levonorgestrel
134957|NCT03359057|Oral contraceptive|oral contraceptive
134958|NCT03359044|Fiberoptic bronchoscopy|fiberoptic bronchoscopy
134959|NCT03359044|Neuropsychological Development|neuropsychological development
134960|NCT03359044|general anesthesia|general anesthesia
134961|NCT03359018|osteosarcoma|osteosarcoma
134962|NCT03359018|advanced|advanced
134963|NCT03359018|apatinib|apatinib
134964|NCT03359018|PD-1|pd-1
134965|NCT03359005|Ewing Sarcoma|ewing sarcoma
134966|NCT03359005|Irinotecan|irinotecan
134967|NCT03359005|Temozolomide|temozolomide
134968|NCT03358992|CESOFB|cesofb
135857|NCT03352869|Metformin|metformin
134969|NCT03358992|clinical evaluation|clinical evaluation
134970|NCT03358992|RECIST|recist
134971|NCT03358992|histological response|histological response
134972|NCT03358992|survival|survival
134973|NCT03358992|osteosarcoma|osteosarcoma
134974|NCT03358992|Ewing sarcoma|ewing sarcoma
134975|NCT03358979|Conjunctival Diseases|conjunctival diseases
134976|NCT03358979|Dry Eye Syndromes|dry eye syndromes
134977|NCT03358979|Antigens|antigens
134978|NCT03358979|CD147|cd147
134979|NCT03358966|chronic kidney disease|chronic kidney disease
134980|NCT03358966|energy expenditure|energy expenditure
134981|NCT03358966|metabolic rate|metabolic rate
134982|NCT03358953|electronic cigarettes|electronic cigarettes
134983|NCT03358953|cardiovascular|cardiovascular
134984|NCT03358953|nicotine replacement patches|nicotine replacement patches
134985|NCT03358940|Non-medical abortion|non-medical abortion
134986|NCT03358940|Misoprostol|misoprostol
134987|NCT03358940|miscarriage complications|miscarriage complications
134988|NCT03358940|Guadeloupe|guadeloupe
134989|NCT03358927|HIV/AIDS|hiv/aids
134990|NCT03358927|Fast-track care|fast-track care
134991|NCT03358927|Behavioral economics|behavioral economics
134992|NCT03358927|Differentiated care|differentiated care
134993|NCT03358914|psoriasis, adolescents, quality of life, PRO (patient-reported outcome), validation|psoriasis, adolescents, quality of life, pro (patient-reported outcome), validation
134994|NCT03358862|myopia|myopia
134995|NCT03358862|progressive myopia|progressive myopia
134996|NCT03358862|contact lenses|contact lenses
134997|NCT03358862|extended depth of focus|extended depth of focus
134998|NCT03358862|retrospective clinical series|retrospective clinical series
134999|NCT03358862|axial length|axial length
135000|NCT03358862|refractive error|refractive error
135001|NCT03358836|Hemophilia B|hemophilia b
135002|NCT03358836|FIX|fix
135003|NCT03358836|Factor IX|factor ix
135004|NCT03358836|Factor 9|factor 9
135005|NCT03358823|AS database ; Brain Image;Neural-EEG Data|as database ; brain image;neural-eeg data
135006|NCT03358797|Community-based Intervention|community-based intervention
135007|NCT03358797|Lifestyle intervention|lifestyle intervention
135008|NCT03358797|Women in East Jerusalem|women in east jerusalem
135009|NCT03358797|Diabetes prevention|diabetes prevention
135010|NCT03358797|Leadership|leadership
135011|NCT03358784|Humeral Fractures, Proximal|humeral fractures, proximal
135012|NCT03358784|Arthroplasty, Shoulder Replacement|arthroplasty, shoulder replacement
135013|NCT03358784|Bone Plates|bone plates
135014|NCT03358771|COPD|copd
135015|NCT03358771|AECOPD|aecopd
135016|NCT03358771|Discharge care bundle|discharge care bundle
135017|NCT03358771|Patient Care Bundles|patient care bundles
135018|NCT03358758|Trauma|trauma
135019|NCT03358758|War-Related Injuries|war-related injuries
135020|NCT03358758|Firearm|firearm
135021|NCT03358758|Explosion|explosion
135022|NCT03358758|Bomb|bomb
135023|NCT03358758|Ordnance|ordnance
135024|NCT03358758|IED|ied
135025|NCT03358758|Epidemiology|epidemiology
135026|NCT03358758|Public Health|public health
135027|NCT03358745|Type 2 diabetes risk|type 2 diabetes risk
135028|NCT03358745|Cardiovascular disease risk|cardiovascular disease risk
135029|NCT03358732|embryo transfer, mock embryo transfer, endometrial receptivity, endometrial scratching, IVF|embryo transfer, mock embryo transfer, endometrial receptivity, endometrial scratching, ivf
135030|NCT03358667|peri-implant soft tissue augmentation|peri-implant soft tissue augmentation
135031|NCT03358654|Umbilical Cord Bleeding|umbilical cord bleeding
135032|NCT03358654|Knee Osteoarthritis|knee osteoarthritis
135033|NCT03358654|stem cells|stem cells
135034|NCT03358641|exercise|exercise
135035|NCT03358641|physical activity|physical activity
135036|NCT03358641|radiographic osteoarthritis|radiographic osteoarthritis
135037|NCT03358628|Osteosarcoma|osteosarcoma
135038|NCT03358628|Patient-derived xenograft|patient-derived xenograft
135039|NCT03358615|robson classification|robson classification
135040|NCT03358615|Egypt|egypt
135041|NCT03358602|Supraglottic cancer|supraglottic cancer
135042|NCT03358602|Laryngeal cancer|laryngeal cancer
135043|NCT03358602|Cervical lymph node|cervical lymph node
135044|NCT03358602|Neck dissection|neck dissection
135045|NCT03358563|Prostate Cancer|prostate cancer
135046|NCT03358563|Prostatectomy|prostatectomy
135047|NCT03358563|Chemohormonal therapy|chemohormonal therapy
135048|NCT03358563|Androgen deprivation therapy|androgen deprivation therapy
135049|NCT03358563|docetaxel chemotherapy|docetaxel chemotherapy
135050|NCT03358550|accommodation|accommodation
135051|NCT03358550|dark focus|dark focus
135052|NCT03358550|night myopia|night myopia
135053|NCT03358537|Dietary fiber|dietary fiber
135054|NCT03358472|Head and neck squamous cell carcinoma|head and neck squamous cell carcinoma
135055|NCT03358472|programmed cell death 1 (PD-1) inhibitor|programmed cell death 1 (pd-1) inhibitor
135056|NCT03358472|indoleamine 2,3-dioxygenase 1 (IDO1) inhibitor|indoleamine 2,3-dioxygenase 1 (ido1) inhibitor
135057|NCT03358459|phenotype; genotype|phenotype; genotype
135058|NCT03358446|central catheterization|central catheterization
135059|NCT03358446|femoral vein central catheterization|femoral vein central catheterization
135060|NCT03358446|leg angulation|leg angulation
135061|NCT03358407|Inflammatory Bowel disease|inflammatory bowel disease
135062|NCT03358407|Pro-drug|pro-drug
135065|NCT03358381|total knee arthroplasty|total knee arthroplasty
135066|NCT03358381|CT scan|ct scan
135067|NCT03358355|PAD|pad
135068|NCT03358355|unacylated ghrelin|unacylated ghrelin
135069|NCT03358355|Peripheral Artery Disease|peripheral artery disease
135072|NCT03358316|Rotator Cuff Tear|rotator cuff tear
135073|NCT03358316|Magnetic Resonance Imaging|magnetic resonance imaging
135074|NCT03358316|humeral migration|humeral migration
135075|NCT03358303|telemonitoring|telemonitoring
135076|NCT03358303|smartphone application|smartphone application
135077|NCT03358290|JTE-051|jte-051
135078|NCT03358290|Psoriasis|psoriasis
135079|NCT03358264|Vascular dysfunction, L-citrulline, arginase|vascular dysfunction, l-citrulline, arginase
135080|NCT03358225|Hybrid surgery,ACDF,C-ADR,bi-level cervical spondylosis|hybrid surgery,acdf,c-adr,bi-level cervical spondylosis
135081|NCT03358212|giant cell tumor of bone|giant cell tumor of bone
135082|NCT03358212|Denosumab|denosumab
135083|NCT03358212|post-operative|post-operative
135084|NCT03358199|LOD|lod
135085|NCT03358199|PCOS|pcos
135086|NCT03358199|AMH|amh
135087|NCT03358199|OHSS|ohss
135088|NCT03358186|Periprosthetic Fractures|periprosthetic fractures
135089|NCT03358186|Arthroplasty|arthroplasty
135090|NCT03358186|Surgical procedures|surgical procedures
135091|NCT03358173|Humeral Fractures|humeral fractures
135092|NCT03358173|plate|plate
135093|NCT03358173|Conservative Treatment|conservative treatment
135094|NCT03358134|Peripheral Spondylarthropathies|peripheral spondylarthropathies
135095|NCT03358134|Psoriatic arthritis|psoriatic arthritis
135096|NCT03358134|Reactive arthritis|reactive arthritis
135097|NCT03358056|Mindfulness|mindfulness
135098|NCT03358056|Emotion|emotion
135099|NCT03358056|Mindfulenss-based cognitive therapy|mindfulenss-based cognitive therapy
135100|NCT03358043|respiratory failure|respiratory failure
135101|NCT03358043|mechanical ventilation|mechanical ventilation
135102|NCT03358043|prevalence|prevalence
135103|NCT03358017|Triple negative breast cancer|triple negative breast cancer
135104|NCT03358017|Neoadjuvant chemotherapy|neoadjuvant chemotherapy
135105|NCT03358017|p53|p53
135106|NCT03358017|Zoledronate|zoledronate
135107|NCT03358017|Atorvastatin|atorvastatin
135108|NCT03358017|Mevalonate pathway inhibitors|mevalonate pathway inhibitors
135109|NCT03358017|Hippo pathway|hippo pathway
135110|NCT03358004|TNBC|tnbc
135111|NCT03358004|metronomic chemotherapy|metronomic chemotherapy
135112|NCT03358004|vinorelbine|vinorelbine
135113|NCT03358004|capecitabine|capecitabine
135114|NCT03357991|E6/E7 mRNA|e6/e7 mrna
135115|NCT03357991|anal cancer screening|anal cancer screening
135116|NCT03357991|men who have sex with men|men who have sex with men
135117|NCT03357991|cost-effectiveness analysis|cost-effectiveness analysis
135118|NCT03357991|High resolution anoscopy|high resolution anoscopy
135119|NCT03357978|immunodeficiency|immunodeficiency
135120|NCT03357978|liver disease|liver disease
135121|NCT03357978|cancer risk|cancer risk
135122|NCT03357965|maternal infant bonding|maternal infant bonding
135123|NCT03357965|depression|depression
135124|NCT03357965|anxiety|anxiety
135125|NCT03357939|HLX03|hlx03
135126|NCT03357939|adalimumab|adalimumab
135127|NCT03357939|pharmacokinetics|pharmacokinetics
135128|NCT03357939|biosimilar|biosimilar
135129|NCT03357900|Consciousness Monitor|consciousness monitor
135130|NCT03357900|Clinical Pharmacology|clinical pharmacology
135131|NCT03357861|cancer|cancer
135132|NCT03357861|intensive care unit|intensive care unit
135133|NCT03357861|checkpoint inhibitors|checkpoint inhibitors
135134|NCT03357861|adverse event|adverse event
135135|NCT03357835|trauma|trauma
135136|NCT03357835|triage|triage
135137|NCT03357835|software|software
135138|NCT03357835|emergency|emergency
135139|NCT03357822|Chronic hepatitis B|chronic hepatitis b
135140|NCT03357822|Nucleoside analog|nucleoside analog
135141|NCT03357822|Pegylated Interferon|pegylated interferon
135142|NCT03357822|Sequential combination therapy|sequential combination therapy
135143|NCT03357822|HBsAg loss|hbsag loss
135144|NCT03357796|Depressive Disorder, Major|depressive disorder, major
135145|NCT03357796|Depressive Disorder|depressive disorder
135146|NCT03357796|Mood Disorders|mood disorders
135147|NCT03357796|Mental Disorders|mental disorders
135148|NCT03357796|Desvenlafaxine Succinate|desvenlafaxine succinate
135149|NCT03357796|Serotonin and Noradrenaline Reuptake Inhibitors|serotonin and noradrenaline reuptake inhibitors
135150|NCT03357796|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors
135151|NCT03357796|Membrane Transport Modulators|membrane transport modulators
135152|NCT03357796|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action
135153|NCT03357796|Neurotransmitter Agents|neurotransmitter agents
135154|NCT03357796|Physiological Effects of Drugs|physiological effects of drugs
135155|NCT03357796|Antidepressive Agents|antidepressive agents
135156|NCT03357796|Psychotropic Drugs|psychotropic drugs
135157|NCT03357783|Frequency|frequency
135158|NCT03357783|Macroscopic|macroscopic
135159|NCT03357783|Deciduosis|deciduosis
135161|NCT03357783|Neoplasm|neoplasm
135163|NCT03357770|mesenchymal stem cells|mesenchymal stem cells
135164|NCT03357770|Knee Osteoarthritis|knee osteoarthritis
135165|NCT03357770|Umbilical Cord|umbilical cord
135166|NCT03357744|distress|distress
135167|NCT03357744|assessment methods|assessment methods
135168|NCT03357718|premedication|premedication
135169|NCT03357705|alveolar ridge preservation|alveolar ridge preservation
135170|NCT03357692|all on four; piezoelectric; implant; trans-sinusal|all on four; piezoelectric; implant; trans-sinusal
135171|NCT03357679|Bed up head elevated position|bed up head elevated position
135172|NCT03357679|Glidescope assisted tracheal intubation|glidescope assisted tracheal intubation
135173|NCT03357679|Laryngeal exposure|laryngeal exposure
135174|NCT03357679|Time to intubation|time to intubation
135175|NCT03357653|proteinuria|proteinuria
135176|NCT03357653|progression|progression
135177|NCT03357653|early immunoglobulin A (IgA) nephropathy|early immunoglobulin a (iga) nephropathy
135178|NCT03357627|Drug therapy|drug therapy
135179|NCT03357601|High Intensity Interval|high intensity interval
135180|NCT03357601|Moderate Endurance Exercise|moderate endurance exercise
135181|NCT03357601|Fat Loss|fat loss
135182|NCT03357601|Endurance Capacity|endurance capacity
135183|NCT03357575|Knee Osteoarthritis|knee osteoarthritis
135184|NCT03357575|adipose|adipose
135185|NCT03357575|mesenchymal stem cells|mesenchymal stem cells
135186|NCT03357562|Cystic fibrosis|cystic fibrosis
135187|NCT03357562|CT|ct
135188|NCT03357562|MRI|mri
135189|NCT03357562|radiation dose|radiation dose
135190|NCT03357562|contrast agent|contrast agent
135191|NCT03357549|Breast Feeding|breast feeding
135192|NCT03357549|Motivational Interviewing|motivational interviewing
135193|NCT03357549|Self Efficacy|self efficacy
135194|NCT03357497|colorectal surgery, early mobilization, postoperative care|colorectal surgery, early mobilization, postoperative care
135195|NCT03357484|impacted tooth|impacted tooth
135196|NCT03357484|pain|pain
135197|NCT03357484|platelet-rich fibrin|platelet-rich fibrin
135198|NCT03357484|third molar|third molar
135199|NCT03357484|tooth extraction|tooth extraction
135200|NCT03357484|wound healing|wound healing
135201|NCT03357471|Certolizumab Pegol|certolizumab pegol
135202|NCT03357471|E-Device|e-device
135203|NCT03357458|Family Integrated Care|family integrated care
135204|NCT03357458|Parenting education|parenting education
135205|NCT03357458|Nursing|nursing
135206|NCT03357458|Cost effectiveness|cost effectiveness
135207|NCT03357458|Patient engagement|patient engagement
135208|NCT03357458|Randomized controlled trial|randomized controlled trial
135209|NCT03357458|Neonatal intensive care unit|neonatal intensive care unit
135210|NCT03357445|Total hip Arthroplasty|total hip arthroplasty
135211|NCT03357445|Hip implant|hip implant
135212|NCT03357432|collagen|collagen
135213|NCT03357432|gelatin|gelatin
135214|NCT03357432|PINP|pinp
135215|NCT03357406|implant|implant
135216|NCT03357406|piezoelectric|piezoelectric
135217|NCT03357406|drills|drills
135218|NCT03357406|immediate loading|immediate loading
135219|NCT03357341|electronic health record|electronic health record
135220|NCT03357341|Pilot|pilot
135221|NCT03357341|COPD|copd
135222|NCT03357341|Sensor|sensor
135223|NCT03357341|Asthma|asthma
135224|NCT03357328|Phototherapy|phototherapy
135225|NCT03357328|Nursing home|nursing home
135226|NCT03357328|Light therapy|light therapy
135227|NCT03357250|biomarkers|biomarkers
135228|NCT03357185|Femoral bifurcation|femoral bifurcation
135229|NCT03357185|Peripheral arterial disease|peripheral arterial disease
135230|NCT03357185|Vascular surgery|vascular surgery
135231|NCT03357185|Eversion|eversion
135232|NCT03357185|Open surgery|open surgery
135233|NCT03357172|Immune recovery|immune recovery
135234|NCT03357172|Immunomodulatory cells|immunomodulatory cells
135235|NCT03357172|GVHD|gvhd
135236|NCT03357172|GVL|gvl
135237|NCT03357159|anti thymocyte globulin|anti thymocyte globulin
135238|NCT03357159|cyclophospamide|cyclophospamide
135239|NCT03357159|graft-versus-host disease|graft-versus-host disease
135240|NCT03357159|stem cell transplantation|stem cell transplantation
135241|NCT03357120|Breast Cancer|breast cancer
135242|NCT03357120|Neoadjuvant chemotherapy|neoadjuvant chemotherapy
135243|NCT03357120|Circulating tumor DNA|circulating tumor dna
135244|NCT03357094|Pulmonary ventilation|pulmonary ventilation
135245|NCT03357094|Pulmonary perfusion|pulmonary perfusion
135246|NCT03357094|Single Photon Emission Computed Tomography|single photon emission computed tomography
135247|NCT03357055|tourniquet, pain, ketamine|tourniquet, pain, ketamine
135248|NCT03357029|Chronic pancreatitis|chronic pancreatitis
135249|NCT03357029|Vagal nerve stimulation|vagal nerve stimulation
135250|NCT03357029|Visceral Pain|visceral pain
135251|NCT03357016|interval training|interval training
135252|NCT03357016|abdominal fat mass|abdominal fat mass
135253|NCT03357016|postmenopausal women|postmenopausal women
135254|NCT03357016|lipids oxidation|lipids oxidation
135255|NCT03356964|endometrial receptivity progesterone elevation|endometrial receptivity progesterone elevation
135256|NCT03356925|Xpert®MTB/RIF|xpert®mtb/rif
135257|NCT03356925|Xpert®MTB/RIF Ultra|xpert®mtb/rif ultra
135258|NCT03356886|Chronic Low Back Pain|chronic low back pain
135259|NCT03356886|Pain Neuroscience Education|pain neuroscience education
135260|NCT03356886|Spinal Manipulative Techniques|spinal manipulative techniques
135261|NCT03356886|Psychosocial Factors|psychosocial factors
135262|NCT03356860|breast cancer|breast cancer
135263|NCT03356860|immunotherapy|immunotherapy
135264|NCT03356860|anti-PD-L1|anti-pd-l1
135265|NCT03356834|Chronic hepatitis B|chronic hepatitis b
135266|NCT03356834|Efficacy, safety, and tolerability|efficacy, safety, and tolerability
135267|NCT03356834|Tenofovir alafenamide|tenofovir alafenamide
135268|NCT03356808|Lung cancer|lung cancer
135269|NCT03356808|CAR-T|car-t
135270|NCT03356808|mesothelin|mesothelin
135271|NCT03356808|Muc1|muc1
135272|NCT03356808|GD2|gd2
135273|NCT03356808|MAGE-A4|mage-a4
135274|NCT03356795|Cervical cancer|cervical cancer
135275|NCT03356795|CAR-T|car-t
135276|NCT03356795|GD2|gd2
135277|NCT03356795|PSMA|psma
135278|NCT03356795|Muc1|muc1
135279|NCT03356795|Mesothelin|mesothelin
135280|NCT03356795|HPV|hpv
135281|NCT03356795|solid tumor|solid tumor
135282|NCT03356782|CART|cart
135283|NCT03356782|PD-1|pd-1
135284|NCT03356782|PDL-1|pdl-1
135285|NCT03356782|CTLA-4|ctla-4
135286|NCT03356782|sarcoma|sarcoma
135287|NCT03356782|solid tumor|solid tumor
135288|NCT03356769|refractory seizure|refractory seizure
135289|NCT03356769|cognitive impairment|cognitive impairment
135290|NCT03356769|electroencephalography improvement|electroencephalography improvement
135291|NCT03356769|seizure reduction|seizure reduction
135292|NCT03356769|seizure free|seizure free
135293|NCT03356769|aspirin|aspirin
135294|NCT03356743|lobectomy|lobectomy
135295|NCT03356730|Implants|implants
135296|NCT03356730|Vitamin D|vitamin d
135297|NCT03356730|Osseointegration|osseointegration
135298|NCT03356730|Histomorphometric|histomorphometric
135299|NCT03356717|simulation, high-fidelity, observer tool; learning outcomes|simulation, high-fidelity, observer tool; learning outcomes
135300|NCT03356704|adults|adults
135301|NCT03356691|Spiritist pass|spiritist pass
135302|NCT03356691|adult|adult
135303|NCT03356691|laying of hands|laying of hands
135304|NCT03356665|diagnosis|diagnosis
135305|NCT03356665|sensitivity|sensitivity
135306|NCT03356665|specificity|specificity
135307|NCT03356665|rapid diagnostic test|rapid diagnostic test
135308|NCT03356665|molecular biology|molecular biology
135309|NCT03356665|LAMP|lamp
135310|NCT03356665|RT-PCR|rt-pcr
135311|NCT03356665|serology|serology
135312|NCT03356665|ELISA|elisa
135313|NCT03356665|immune trypanolysis|immune trypanolysis
135314|NCT03356665|clinical symptom|clinical symptom
135315|NCT03356652|Cardiac resynchronizaton therapy|cardiac resynchronizaton therapy
135316|NCT03356652|Electrical activation mapping|electrical activation mapping
135317|NCT03356652|Noninvasive|noninvasive
135318|NCT03356652|Electrical dyssynchrony|electrical dyssynchrony
135319|NCT03356639|Schizophrenia|schizophrenia
135320|NCT03356639|ASP6981|asp6981
135321|NCT03356639|Safety|safety
135322|NCT03356639|Phase 1|phase 1
135323|NCT03356626|fever, inflammation|fever, inflammation
135324|NCT03356600|Brain Metastases|brain metastases
135325|NCT03356587|NGS|ngs
135326|NCT03356587|Nanostring|nanostring
135327|NCT03356587|Biomarker Driven Umbrella Trial|biomarker driven umbrella trial
135328|NCT03356587|abemaciclib|abemaciclib
135329|NCT03356535|targeted metabolomics|targeted metabolomics
135330|NCT03356535|multivariate statistics|multivariate statistics
135331|NCT03356535|metabolic signatures|metabolic signatures
135332|NCT03356535|partial least squares|partial least squares
135333|NCT03356535|healthy lifestyle index|healthy lifestyle index
135334|NCT03356535|EPIC|epic
135335|NCT03356483|Psilocybin|psilocybin
135336|NCT03356470|melanoma|melanoma
135337|NCT03356470|antimelanoma T cells|antimelanoma t cells
135338|NCT03356444|abiraterone|abiraterone
135339|NCT03356444|docetaxel|docetaxel
135340|NCT03356444|Castration-resistant Prostate Cancer|castration-resistant prostate cancer
135341|NCT03356431|Exercise therapy|exercise therapy
135342|NCT03356431|Physical Therapy|physical therapy
135343|NCT03356418|Exercise|exercise
135344|NCT03356418|Vibration|vibration
135345|NCT03356418|Torque|torque
135346|NCT03356418|Aging|aging
135347|NCT03356392|acute stroke, thrombectomy, endovascular treatment|acute stroke, thrombectomy, endovascular treatment
135348|NCT03356379|Diagnosis|diagnosis
135349|NCT03356379|Peripheral artery disease|peripheral artery disease
135350|NCT03356379|sports|sports
135351|NCT03356314|superior mesenteric artery|superior mesenteric artery
135352|NCT03356314|superior mesenteric vein|superior mesenteric vein
135353|NCT03356314|intestinal malrotation|intestinal malrotation
135354|NCT03356314|volvulus|volvulus
135355|NCT03356314|pregnant women|pregnant women
135356|NCT03356314|mesenteric vessels position|mesenteric vessels position
135357|NCT03356314|postnatal diagnosis|postnatal diagnosis
135358|NCT03356314|prophylactic surgery|prophylactic surgery
135359|NCT03356301|Aortic compliance|aortic compliance
135360|NCT03356301|Aortic distensibility|aortic distensibility
135361|NCT03356301|CMR|cmr
135362|NCT03356301|Triathletes|triathletes
135363|NCT03356301|Ventriculo-atrial coupling|ventriculo-atrial coupling
136745|NCT03347110|Bimekizumab|bimekizumab
135364|NCT03356288|Capnography, Diagnosis. Breathlessness, Exacerbations, Device|capnography, diagnosis. breathlessness, exacerbations, device
135365|NCT03356262|Cohort study|cohort study
135366|NCT03356249|Sepsis|sepsis
135367|NCT03356249|Septic shock|septic shock
135368|NCT03356249|Next-Generation Sequencing|next-generation sequencing
135369|NCT03356249|Bacteremia|bacteremia
135370|NCT03356223|Clinical Trial|clinical trial
135371|NCT03356223|Phase II|phase ii
135372|NCT03356223|Monotherapy|monotherapy
135373|NCT03356223|Abemaciclib|abemaciclib
135374|NCT03356223|Homozygous deletion of CDKN2A|homozygous deletion of cdkn2a
135375|NCT03356223|Amplification of CCND1|amplification of ccnd1
135376|NCT03356223|Amplification of CDK6|amplification of cdk6
135377|NCT03356223|Multicenter Trial|multicenter trial
135378|NCT03356158|Metastatic Colorectal Cancer,|metastatic colorectal cancer,
135379|NCT03356158|Recombinant Anti-EGFR Monoclonal Antibody|recombinant anti-egfr monoclonal antibody
135380|NCT03356145|paracervical block|paracervical block
135381|NCT03356145|abortion|abortion
135382|NCT03356145|dilation and evacuation|dilation and evacuation
135383|NCT03356145|cervical preparation|cervical preparation
135384|NCT03356132|breast implant|breast implant
135385|NCT03356132|complication|complication
135386|NCT03356132|satisfaction|satisfaction
135387|NCT03356132|quality of life|quality of life
135388|NCT03356132|augmentation|augmentation
135389|NCT03356132|textured|textured
135390|NCT03356132|polyurethane|polyurethane
135391|NCT03356119|Contraceptive Implant|contraceptive implant
135392|NCT03356106|Obstructive sleep apnea|obstructive sleep apnea
135393|NCT03356106|Pre-Eclampsia|pre-eclampsia
135394|NCT03356093|head and neck cancer, symptom cluster, change, radiotherapy|head and neck cancer, symptom cluster, change, radiotherapy
135395|NCT03356080|decitabine|decitabine
135396|NCT03356080|retinoid acid|retinoid acid
135397|NCT03356080|cytarabine C|cytarabine c
135398|NCT03356080|Granulocyte Colony Stimulating Factor|granulocyte colony stimulating factor
135399|NCT03356080|acute myeloid leukemia|acute myeloid leukemia
135400|NCT03356080|Myelodysplastic Syndrome|myelodysplastic syndrome
135401|NCT03356028|Trauma|trauma
135402|NCT03356028|Psychiatric Disorder|psychiatric disorder
135403|NCT03356028|mass trauma|mass trauma
135404|NCT03356015|Polyp detection rate|polyp detection rate
135405|NCT03356015|Adenoma detection rate|adenoma detection rate
135406|NCT03356015|Boston Bowel Preparation Scale|boston bowel preparation scale
135407|NCT03355989|Conditional Cash Transfer|conditional cash transfer
135408|NCT03355989|Immunization coverage|immunization coverage
135409|NCT03355989|Immunization reminder|immunization reminder
135410|NCT03355976|recurrent|recurrent
135411|NCT03355976|advanced|advanced
135412|NCT03355976|metastatitic|metastatitic
135413|NCT03355937|unexplained infertility|unexplained infertility
135414|NCT03355937|recurrent implantation failure|recurrent implantation failure
135415|NCT03355885|early onset pneumonia|early onset pneumonia
135416|NCT03355885|out-of-hospital cardiac arrest|out-of-hospital cardiac arrest
135417|NCT03355885|prognosis|prognosis
135418|NCT03355885|antibiotic|antibiotic
135419|NCT03355859|Non Hodgkin Lymphoma|non hodgkin lymphoma
135420|NCT03355859|CD19-targeted chimeric antigen receptor|cd19-targeted chimeric antigen receptor
135421|NCT03355859|JWCAR029|jwcar029
135422|NCT03355846|Anal Fissure|anal fissure
135423|NCT03355846|local therapy|local therapy
135424|NCT03355846|pain|pain
135425|NCT03355846|defecation|defecation
135426|NCT03355846|bleeding|bleeding
135427|NCT03355820|Immune response|immune response
135428|NCT03355820|Cervarix|cervarix
135429|NCT03355820|Persistence|persistence
135430|NCT03355820|Chinese|chinese
135431|NCT03355820|Human papillomavirus|human papillomavirus
135432|NCT03355807|sleeve gastrectomy|sleeve gastrectomy
135433|NCT03355807|magnesium sulfate|magnesium sulfate
135434|NCT03355807|postoperative pain|postoperative pain
135435|NCT03355807|bariatric surgery|bariatric surgery
135436|NCT03355794|DIPG|dipg
135437|NCT03355794|High Grade Glioma|high grade glioma
135438|NCT03355794|ribociclib|ribociclib
135439|NCT03355794|everolimus|everolimus
135440|NCT03355781|childhood trauma|childhood trauma
135441|NCT03355781|candidate gene expression|candidate gene expression
135442|NCT03355781|cerebral morphology|cerebral morphology
135443|NCT03355781|schizophrenic symptomatology|schizophrenic symptomatology
135444|NCT03355781|conceptual framework of stress vulnerability|conceptual framework of stress vulnerability
135445|NCT03355768|Romidepsin|romidepsin
135446|NCT03355768|Pralatrexate|pralatrexate
135447|NCT03355768|PTCL|ptcl
135448|NCT03355768|Peripheral T-cell Lymphoma|peripheral t-cell lymphoma
135449|NCT03355742|XIENCE|xience
135450|NCT03355742|High bleeding risk (HBR)|high bleeding risk (hbr)
135451|NCT03355742|Dual antiplatelet therapy (DAPT)|dual antiplatelet therapy (dapt)
135452|NCT03355742|Coronary Artery Disease|coronary artery disease
135453|NCT03355742|Drug eluting stent (DES)|drug eluting stent (des)
135454|NCT03355690|thrombectomy|thrombectomy
135455|NCT03355690|thrombolysis|thrombolysis
135456|NCT03355690|Health-economic status|health-economic status
135457|NCT03355690|Outcome after stroke|outcome after stroke
135458|NCT03355677|Case finding|case finding
135459|NCT03355677|complex case management|complex case management
135460|NCT03355664|Malaria, Falciparum|malaria, falciparum
135461|NCT03355664|Malaria|malaria
135462|NCT03355664|Protozoan Infections|protozoan infections
135463|NCT03355664|Lumefantrine|lumefantrine
135464|NCT03355664|Artemether|artemether
135465|NCT03355664|Amodiaquine|amodiaquine
135466|NCT03355664|Piperaquine|piperaquine
135467|NCT03355664|Artemether-lumefantrine combination|artemether-lumefantrine combination
135468|NCT03355664|Artemisinins|artemisinins
135469|NCT03355664|Dihydroartemisinin|dihydroartemisinin
135470|NCT03355664|Mefloquine|mefloquine
135471|NCT03355664|Artemisinin|artemisinin
135472|NCT03355664|Antimalarials|antimalarials
135473|NCT03355664|Antiparasitic Agents|antiparasitic agents
135474|NCT03355664|Anti-Infective Agents|anti-infective agents
135475|NCT03355664|ACT|act
135476|NCT03355664|TACT|tact
135477|NCT03355664|Triple ACT(s)|triple act(s)
135478|NCT03355664|Resistance|resistance
135479|NCT03355664|Antimalarial resistance|antimalarial resistance
135480|NCT03355664|Cardiotoxicity|cardiotoxicity
135481|NCT03355664|Safety|safety
135482|NCT03355664|Tolerability|tolerability
135483|NCT03355664|Efficacy|efficacy
135484|NCT03355651|Anterior Cruciate Ligament Tears|anterior cruciate ligament tears
135485|NCT03355651|Dietary Supplementations|dietary supplementations
135486|NCT03355651|Plasma Rich Proteins|plasma rich proteins
135487|NCT03355651|Collagen|collagen
135488|NCT03355651|Chondroitin Sulfate|chondroitin sulfate
135489|NCT03355651|Hyaluronic Acid|hyaluronic acid
135490|NCT03355625|Flow Cytometry|flow cytometry
135491|NCT03355625|eCPR|ecpr
135492|NCT03355625|Extracorporeal Life Support|extracorporeal life support
135493|NCT03355586|Lung diseases|lung diseases
135494|NCT03355586|Cancer|cancer
135495|NCT03355586|Interventional pulmonology|interventional pulmonology
135496|NCT03355586|Peripheral nodule|peripheral nodule
135497|NCT03355573|Bimekizumab|bimekizumab
135498|NCT03355573|Ankylosing Spondylitis|ankylosing spondylitis
135499|NCT03355573|AS|as
135500|NCT03355534|dexmedetomidine|dexmedetomidine
135501|NCT03355534|general anesthesia|general anesthesia
135502|NCT03355534|cerebral aneurysm|cerebral aneurysm
135503|NCT03355521|functionality|functionality
135504|NCT03355521|gait|gait
135505|NCT03355521|kinematics|kinematics
135506|NCT03355521|electromyographic activity|electromyographic activity
135507|NCT03355521|depressive symptoms|depressive symptoms
135508|NCT03355521|quality of life|quality of life
135509|NCT03355495|Colonoscopy|colonoscopy
135510|NCT03355495|Cecal Intubation Rate|cecal intubation rate
135511|NCT03355456|Persistent atrial fibrillation|persistent atrial fibrillation
135512|NCT03355456|Medication refractory atrial fibrillation|medication refractory atrial fibrillation
135513|NCT03355456|Pulmonary vein isolation procedure|pulmonary vein isolation procedure
135514|NCT03355456|Low voltage directed ablation|low voltage directed ablation
135515|NCT03355443|Colonoscopy|colonoscopy
135516|NCT03355443|Lower Gastrointestinal Tract|lower gastrointestinal tract
135517|NCT03355443|Re-examination|re-examination
135518|NCT03355443|Retroflexion|retroflexion
135519|NCT03355391|SCREENING|screening
135520|NCT03355391|RISK FACTOR|risk factor
135521|NCT03355365|Mesenchymal Stem Cells|mesenchymal stem cells
135522|NCT03355365|Neural Progenitors|neural progenitors
135523|NCT03355365|Autologous|autologous
135524|NCT03355365|Bone Marrow|bone marrow
135525|NCT03355365|Multiple Sclerosis|multiple sclerosis
135526|NCT03355352|Zalviso|zalviso
135527|NCT03355352|sufentanyl|sufentanyl
135528|NCT03355352|PCA|pca
135529|NCT03355352|Dipidolor|dipidolor
135530|NCT03355339|Balance|balance
135531|NCT03355339|Dual-task|dual-task
135532|NCT03355339|King-Devick Test|king-devick test
135533|NCT03355339|Saccades|saccades
135534|NCT03355339|Binasal Occlusion|binasal occlusion
135535|NCT03355313|saliva|saliva
135536|NCT03355313|Low-level light therapy|low-level light therapy
135537|NCT03355313|salivary glands|salivary glands
135538|NCT03355274|Transcutaneous Oximetry|transcutaneous oximetry
135539|NCT03355248|postpartum|postpartum
135540|NCT03355248|postoperative cesarean pain management|postoperative cesarean pain management
135541|NCT03355248|opioid requirements|opioid requirements
135542|NCT03355222|complementary feeding|complementary feeding
135543|NCT03355222|calcium|calcium
135544|NCT03355209|LGS|lgs
135545|NCT03355196|Osteoarthritic patients|osteoarthritic patients
135546|NCT03355196|Cartilage|cartilage
135547|NCT03355196|Safety|safety
135548|NCT03355183|isokinetics|isokinetics
135549|NCT03355183|knee|knee
135550|NCT03355157|Palbociclib|palbociclib
135551|NCT03355157|Endocrine Therapy|endocrine therapy
135552|NCT03355157|Chemotherapy|chemotherapy
135553|NCT03355157|Real world setting|real world setting
135554|NCT03355157|Electronic patient-reported outcome|electronic patient-reported outcome
135555|NCT03355157|Daily Monitoring Treatment Impact|daily monitoring treatment impact
135556|NCT03355157|Health care utilization (call tracking, geofencing)|health care utilization (call tracking, geofencing)
135557|NCT03355105|Neuromuscular disease|neuromuscular disease
135558|NCT03355066|Wnt pathway|wnt pathway
135559|NCT03355066|Wnt inhibition|wnt inhibition
135560|NCT03355066|SM08502|sm08502
135561|NCT03355040|shoulder dystocia|shoulder dystocia
135562|NCT03355040|maternal and neonatal morbidity|maternal and neonatal morbidity
135563|NCT03355027|Low Density Lipoprotein Cholesterol (LDL)|low density lipoprotein cholesterol (ldl)
135564|NCT03355027|PCSK9|pcsk9
135565|NCT03355027|Alirocumab|alirocumab
135566|NCT03355027|Flow Mediated Dilatation|flow mediated dilatation
135567|NCT03355027|Arterial Stiffness|arterial stiffness
135568|NCT03355027|Carotid Intima Media Thickness|carotid intima media thickness
135569|NCT03355027|Inflammation|inflammation
135570|NCT03355027|Endothelial function|endothelial function
135571|NCT03355027|FDG PET-CT|fdg pet-ct
135572|NCT03355027|PET-MR|pet-mr
135573|NCT03355027|Ezetimibe|ezetimibe
135574|NCT03354962|Melanoma|melanoma
135575|NCT03354962|Immune checkpoint|immune checkpoint
135576|NCT03354962|Nivolumab|nivolumab
135577|NCT03354962|Ipilimumab|ipilimumab
135578|NCT03354962|Abscopal effect|abscopal effect
135579|NCT03354962|Stereotactic radiotherapy|stereotactic radiotherapy
135580|NCT03354962|PD-1|pd-1
135581|NCT03354962|CTLA-4|ctla-4
135582|NCT03354949|Wheelchair|wheelchair
135583|NCT03354949|Hemiplegia|hemiplegia
135584|NCT03354949|Stroke|stroke
135585|NCT03354949|Postural control|postural control
135586|NCT03354949|Pain|pain
135587|NCT03354910|Live Donor Kidney Transplantation|live donor kidney transplantation
135588|NCT03354910|LDKT|ldkt
135589|NCT03354910|Disparity|disparity
135590|NCT03354910|African American|african american
135591|NCT03354910|Education|education
135592|NCT03354910|Patient Support|patient support
135593|NCT03354897|stratified medicine, UMOD, torasemide|stratified medicine, umod, torasemide
135594|NCT03354858|follicle flushing|follicle flushing
135595|NCT03354858|direct follicle aspiration|direct follicle aspiration
135596|NCT03354858|fertilization rate|fertilization rate
135597|NCT03354858|maturation|maturation
135598|NCT03354754|Intra-abdominal infection|intra-abdominal infection
135599|NCT03354754|LYS228|lys228
135600|NCT03354754|beta-lactam antibiotics|beta-lactam antibiotics
135601|NCT03354754|creatinine clearance|creatinine clearance
135602|NCT03354754|enterobacteriaceae|enterobacteriaceae
135603|NCT03354676|adipokines, metabolic syndrome, obese children|adipokines, metabolic syndrome, obese children
135604|NCT03354663|paroxysmal atrial fibrillation|paroxysmal atrial fibrillation
135605|NCT03354663|PAF|paf
135606|NCT03354663|ablation|ablation
135607|NCT03354585|Mindfulness|mindfulness
135608|NCT03354585|fMRI|fmri
135609|NCT03354585|Pain|pain
135610|NCT03354585|Low Back|low back
135611|NCT03354585|Radicular|radicular
135612|NCT03354559|coagulopathy|coagulopathy
135613|NCT03354559|trauma|trauma
135614|NCT03354559|bleeding|bleeding
135615|NCT03354559|fibrinogen|fibrinogen
135616|NCT03354559|transfusion|transfusion
135617|NCT03354507|topiramate|topiramate
135618|NCT03354507|epilepsy|epilepsy
135619|NCT03354507|sodium bicarbonate|sodium bicarbonate
135620|NCT03354507|urine alkalinization|urine alkalinization
135621|NCT03354494|Oocyte donors|oocyte donors
135622|NCT03354494|Ovarian stimulation|ovarian stimulation
135623|NCT03354494|Desogestrel|desogestrel
135624|NCT03354494|Corifolitropina alfa|corifolitropina alfa
135625|NCT03354494|Gonadotropins|gonadotropins
135626|NCT03354481|Dyscalculia|dyscalculia
135627|NCT03354468|Prevention and Control|prevention and control
135628|NCT03354468|Patient Safety|patient safety
135629|NCT03354468|Aged|aged
135630|NCT03354468|Risk Management|risk management
135631|NCT03354442|Class III treatment|class iii treatment
135632|NCT03354442|Modified Fixed Mandibular Retractor Appliance|modified fixed mandibular retractor appliance
135633|NCT03354442|RCT|rct
135634|NCT03354429|Acute ischaemic stroke; Transient Ischaemic Attack (TIA); Stroke|acute ischaemic stroke; transient ischaemic attack (tia); stroke
135635|NCT03354416|Imaging-Based Prognostic Markers|imaging-based prognostic markers
135636|NCT03354416|Multiparametric MRI (mpMRI)|multiparametric mri (mpmri)
135637|NCT03354416|Translation of Imaging into Treatment Decisions|translation of imaging into treatment decisions
135638|NCT03354416|Decision-Support System|decision-support system
135639|NCT03354416|Artificial Intelligence Research|artificial intelligence research
135640|NCT03354403|XLRS|xlrs
135641|NCT03354403|RS1|rs1
135642|NCT03354403|Carrier|carrier
135643|NCT03354390|genetically modified lymphocytes|genetically modified lymphocytes
135644|NCT03354390|tumor antigens|tumor antigens
135645|NCT03354390|T cell receptor immunotherapy|t cell receptor immunotherapy
135646|NCT03354390|genomic retroviral elements|genomic retroviral elements
135647|NCT03354351|Stepped-care model|stepped-care model
135648|NCT03354351|Men's health|men's health
135649|NCT03354351|Prevention|prevention
135650|NCT03354351|Early treatment|early treatment
135651|NCT03354351|Psychotherapy|psychotherapy
135652|NCT03354338|Periodontal disease|periodontal disease
135653|NCT03354338|Bacteremia|bacteremia
135654|NCT03354338|Amoxicilline|amoxicilline
135655|NCT03354338|Inflamatory markers|inflamatory markers
135656|NCT03354325|Office Visits|office visits
135657|NCT03354312|scaling and root planing|scaling and root planing
135658|NCT03354312|topical anesthesia|topical anesthesia
135659|NCT03354299|malnutrition|malnutrition
135660|NCT03354299|liver cirrhosis|liver cirrhosis
135661|NCT03354299|coconut milk|coconut milk
135662|NCT03354286|670G|670g
135663|NCT03354286|Hybrid closed-loop system|hybrid closed-loop system
135664|NCT03354286|pediatric|pediatric
135665|NCT03354234|Gz accelerations|gz accelerations
135666|NCT03354234|Head up tilt (HUT) test|head up tilt (hut) test
135667|NCT03354234|Lower body negative pressure (LBNP) method|lower body negative pressure (lbnp) method
135668|NCT03354234|Physiological parameters|physiological parameters
135669|NCT03354234|Variable gravitational stimuli|variable gravitational stimuli
135670|NCT03354221|EoE|eoe
135671|NCT03354208|biomarkers|biomarkers
135672|NCT03354182|Mandibular type II furcations|mandibular type ii furcations
135673|NCT03354182|Periodontal treatment|periodontal treatment
135674|NCT03354182|Demineralized bovine bone mineral|demineralized bovine bone mineral
135675|NCT03354182|Collagen membrane|collagen membrane
135676|NCT03354169|Metabolism|metabolism
135677|NCT03354169|Eating|eating
135678|NCT03354169|Circadian Rhythms|circadian rhythms
135679|NCT03354143|Dementia|dementia
135680|NCT03354143|Alzheimer's Disease|alzheimer's disease
135681|NCT03354143|Blood Pressure|blood pressure
135682|NCT03354143|Cognitive Function|cognitive function
135683|NCT03354143|Magnetic Resonance Imaging|magnetic resonance imaging
135684|NCT03354078|Cesarean section|cesarean section
135685|NCT03354078|Wound infection|wound infection
135686|NCT03354078|Gapping|gapping
135687|NCT03354065|pancreatitis|pancreatitis
135688|NCT03354065|mild|mild
135689|NCT03354065|biliary|biliary
135690|NCT03354065|referring|referring
135691|NCT03354052|Pain|pain
135692|NCT03354052|rTMS|rtms
135693|NCT03354052|Rehabilitation|rehabilitation
135694|NCT03354039|DMD|dmd
135695|NCT03354026|Blood-breaking Decotion|blood-breaking decotion
135696|NCT03354013|AOA|aoa
135697|NCT03354013|embryo developmental problems|embryo developmental problems
135698|NCT03354013|genetic screening|genetic screening
135699|NCT03354013|calcium pattern analysis|calcium pattern analysis
135700|NCT03354000|Patient Portal|patient portal
135701|NCT03354000|Healthcare disparities|healthcare disparities
135702|NCT03354000|Safety net healthcare system|safety net healthcare system
135703|NCT03353987|Post-op cognitive dysfunction|post-op cognitive dysfunction
135704|NCT03353987|Cognitive training|cognitive training
135705|NCT03353987|Logbook|logbook
135706|NCT03353987|Elderly|elderly
135707|NCT03353974|Multiple Sclerosis|multiple sclerosis
135708|NCT03353974|Video game therapy|video game therapy
135709|NCT03353974|Balance|balance
135710|NCT03353974|Cognitive functions|cognitive functions
135711|NCT03353961|NSSI|nssi
135712|NCT03353948|Polycystic Ovary Syndrome|polycystic ovary syndrome
135713|NCT03353948|Obesity|obesity
135714|NCT03353948|Infertility|infertility
135715|NCT03353948|IVF|ivf
135716|NCT03353935|surgery|surgery
135717|NCT03353935|pelvic function|pelvic function
135718|NCT03353922|cognitive function|cognitive function
135719|NCT03353909|Intrauterine adhesion|intrauterine adhesion
135720|NCT03353909|Delayed miscarriage|delayed miscarriage
135721|NCT03353909|hyaluronan gel|hyaluronan gel
135722|NCT03353831|Recurrent Ovarian Cancer|recurrent ovarian cancer
135723|NCT03353831|Atezolizumab|atezolizumab
135724|NCT03353831|Bevacizumab|bevacizumab
135725|NCT03353779|Percutaneous coronary intervention|percutaneous coronary intervention
135726|NCT03353779|antiplatelet|antiplatelet
135727|NCT03353779|platelet function|platelet function
135728|NCT03353779|prognosis|prognosis
135729|NCT03353766|Early Orthodontic treatment|early orthodontic treatment
135730|NCT03353766|Orthodontic treatment outcome|orthodontic treatment outcome
135731|NCT03353766|Crossbite treatment|crossbite treatment
135732|NCT03353727|Orthoptic rehabilitation|orthoptic rehabilitation
135733|NCT03353727|low vision|low vision
135734|NCT03353727|eye tracker|eye tracker
135735|NCT03353727|tactile device|tactile device
135736|NCT03353688|Parkinson's|parkinson's
135737|NCT03353688|Parkinson Disease|parkinson disease
135738|NCT03353675|Nivolumab|nivolumab
135739|NCT03353675|Therapeutic Vaccine|therapeutic vaccine
135740|NCT03353662|bio fortification|bio fortification
135741|NCT03353623|Immersive Virtual Environments|immersive virtual environments
135742|NCT03353623|Wearable Haptic Devices|wearable haptic devices
135743|NCT03353623|Neuromotor Impairments|neuromotor impairments
135744|NCT03353623|Rehabilitation|rehabilitation
135745|NCT03353623|Serious Game|serious game
135746|NCT03353623|Randomized Controlled Trial|randomized controlled trial
135747|NCT03353610|Tachycardia|tachycardia
135748|NCT03353610|PSVT episodes|psvt episodes
135749|NCT03353584|Virtual reality|virtual reality
135750|NCT03353584|Pain|pain
135751|NCT03353584|Nonpharmacological|nonpharmacological
135752|NCT03353493|Mindfulness-Based Cognitive Therapy|mindfulness-based cognitive therapy
135753|NCT03353493|Neural, psychological and molecular mechanisms|neural, psychological and molecular mechanisms
135754|NCT03353480|Azithromycin tablet, Bioequivalence, Phase I, Chinese, Healthy Subjects|azithromycin tablet, bioequivalence, phase i, chinese, healthy subjects
135755|NCT03353454|Cholestasis|cholestasis
135756|NCT03353454|Maralixibat|maralixibat
135757|NCT03353454|Mutation|mutation
135958|NCT03352154|cochlear implant|cochlear implant
135758|NCT03353441|Verbal Learning and Memory Test (VLMT)|verbal learning and memory test (vlmt)
135759|NCT03353441|Stroop Test|stroop test
135760|NCT03353441|Attention|attention
135761|NCT03353441|Working Memory|working memory
135762|NCT03353441|Learning and recognition|learning and recognition
135763|NCT03353441|CogTrack|cogtrack
135764|NCT03353428|Lung cancer|lung cancer
135765|NCT03353428|Cytotoxic lymphocyte|cytotoxic lymphocyte
135766|NCT03353428|LC-CTL|lc-ctl
135767|NCT03353428|NSCLC|nsclc
135768|NCT03353415|Post-bariatric Hypoglycemia;|post-bariatric hypoglycemia;
135769|NCT03353402|Melanoma|melanoma
135770|NCT03353402|Fecal Microbiota Transplantation|fecal microbiota transplantation
135771|NCT03353402|Immunotherapy|immunotherapy
135772|NCT03353389|Acute Kidney Injury|acute kidney injury
135773|NCT03353389|Hospital-acquired Acute Kidney Injury|hospital-acquired acute kidney injury
135774|NCT03353389|Community-acquired Acute Kidney Injury|community-acquired acute kidney injury
135775|NCT03353389|Acute Renal Failure|acute renal failure
135776|NCT03353363|cesarean delivery|cesarean delivery
135777|NCT03353363|liposomal bupivacaine|liposomal bupivacaine
135778|NCT03353363|Exparel|exparel
135779|NCT03353363|bupivacaine|bupivacaine
135780|NCT03353363|wound infiltration|wound infiltration
135781|NCT03353337|neurocognition|neurocognition
135782|NCT03353337|prognosis|prognosis
135783|NCT03353337|aerobic exercise|aerobic exercise
135784|NCT03353311|ERAS|eras
135785|NCT03353311|Fast-track|fast-track
135786|NCT03353311|colorectal surgery|colorectal surgery
135787|NCT03353311|immuno-nutrition|immuno-nutrition
135788|NCT03353298|Uric acid|uric acid
135789|NCT03353298|Left ventricular mass|left ventricular mass
135790|NCT03353298|Nephrectomy|nephrectomy
135791|NCT03353298|Allopurinol|allopurinol
135792|NCT03353298|Magnetic resonance imaging|magnetic resonance imaging
135793|NCT03353233|iPACK|ipack
135794|NCT03353233|Interspace between the Popliteal Artery and Capsule of the Knee|interspace between the popliteal artery and capsule of the knee
135795|NCT03353233|Posterior Capsule block|posterior capsule block
135796|NCT03353233|Nerve Block|nerve block
135797|NCT03353220|Overweight|overweight
135798|NCT03353220|Obesity|obesity
135799|NCT03353220|Weight Loss|weight loss
135800|NCT03353220|Lorcaserin|lorcaserin
135801|NCT03353220|Healthy Volunteers|healthy volunteers
135802|NCT03353207|REM Sleep Without Atonia|rem sleep without atonia
135803|NCT03353207|Dopamine transmission|dopamine transmission
135804|NCT03353207|Neurodegeneration|neurodegeneration
135805|NCT03353194|Cerebral Palsy|cerebral palsy
135806|NCT03353194|Canada|canada
135807|NCT03353194|Registry|registry
135808|NCT03353181|Endoscopic Retrograde Cholangiopancreatography|endoscopic retrograde cholangiopancreatography
135809|NCT03353181|endoscopic drainage|endoscopic drainage
135810|NCT03353181|endoscopic nasobiliary drainage|endoscopic nasobiliary drainage
135811|NCT03353181|stent|stent
135812|NCT03353168|fear|fear
135813|NCT03353168|anxiety|anxiety
135814|NCT03353168|childbirth|childbirth
135815|NCT03353168|pregnancy|pregnancy
135816|NCT03353129|Quality Improvement|quality improvement
135817|NCT03353129|Patient Safety|patient safety
135818|NCT03353129|Outcome Improvements|outcome improvements
135819|NCT03353077|Skin SCC|skin scc
135820|NCT03353077|Skin Carcinoma, Squamous|skin carcinoma, squamous
135821|NCT03353038|assistive technology|assistive technology
135822|NCT03353038|3 Dimensional Printing|3 dimensional printing
135823|NCT03353038|Self-Management|self-management
135824|NCT03353025|non-invasive prolactinoma|non-invasive prolactinoma
135825|NCT03353012|Immediate postpartum implant|immediate postpartum implant
135826|NCT03353012|postpartum implant|postpartum implant
135827|NCT03353012|implant contraception|implant contraception
135828|NCT03353012|Etonogestrel|etonogestrel
135829|NCT03353012|Levonorgestrel|levonorgestrel
135830|NCT03352999|Refractory out-hospital cardiac arrest|refractory out-hospital cardiac arrest
135831|NCT03352999|Extracorporeal Life Support|extracorporeal life support
135832|NCT03352986|Sickle cell disease|sickle cell disease
135833|NCT03352986|anemia|anemia
135834|NCT03352986|Africa|africa
135835|NCT03352934|avelumab|avelumab
135836|NCT03352934|anti-PD-L1|anti-pd-l1
135837|NCT03352934|neuroendocrine tumor|neuroendocrine tumor
135838|NCT03352934|NET G3|net g3
135839|NCT03352934|neuroendocrine carcinoma|neuroendocrine carcinoma
135840|NCT03352934|NEC G3|nec g3
135841|NCT03352921|clinical pilates|clinical pilates
135842|NCT03352921|exercise|exercise
135843|NCT03352921|Sagital Cervical Disorientation|sagital cervical disorientation
135844|NCT03352921|Disorientation|disorientation
135845|NCT03352921|Forward Head Posture|forward head posture
135846|NCT03352908|Dysphagia|dysphagia
135847|NCT03352908|Aspiration|aspiration
135849|NCT03352908|FEES|fees
135850|NCT03352908|Swallow Problems|swallow problems
135851|NCT03352895|Resveratrol|resveratrol
135852|NCT03352895|chronic kidney disease|chronic kidney disease
135853|NCT03352869|Polycystic Ovary Syndrome|polycystic ovary syndrome
135854|NCT03352869|Overweight and Obesity|overweight and obesity
135855|NCT03352869|Impaired Glucose Regulation|impaired glucose regulation
135856|NCT03352869|Exenatide|exenatide
135858|NCT03352856|Cereal allergy; barley starch, DBPC|cereal allergy; barley starch, dbpc
135859|NCT03352830|household air pollution|household air pollution
135860|NCT03352830|health promotion|health promotion
135861|NCT03352830|clean cookstove adoption|clean cookstove adoption
135862|NCT03352830|clean cookstove sustained use|clean cookstove sustained use
173322|NCT03111394|MS|ms
135863|NCT03352765|Rituximab|rituximab
135864|NCT03352765|Bendamustine|bendamustine
135865|NCT03352765|Melphalan|melphalan
135866|NCT03352765|Autologous Stem Cell Transplantation (ASCT)|autologous stem cell transplantation (asct)
135867|NCT03352765|17-373|17-373
135868|NCT03352752|virtual reality|virtual reality
135869|NCT03352752|fractional laser|fractional laser
135870|NCT03352752|scars|scars
135871|NCT03352752|acute pain|acute pain
135872|NCT03352752|anxiety score|anxiety score
135873|NCT03352726|EPIT|epit
135874|NCT03352726|Epicutaneous|epicutaneous
135875|NCT03352726|Immunotherapy|immunotherapy
135876|NCT03352726|Viaskin|viaskin
135877|NCT03352713|self-regulation|self-regulation
135878|NCT03352713|binge eating|binge eating
135879|NCT03352713|smoking|smoking
135880|NCT03352713|ecological momentary assessment|ecological momentary assessment
135881|NCT03352713|mobile sensing|mobile sensing
135882|NCT03352713|mHealth|mhealth
135883|NCT03352687|Shoulder surgery|shoulder surgery
135884|NCT03352687|Local regional anesthesia|local regional anesthesia
135885|NCT03352674|insulin glargine|insulin glargine
135886|NCT03352674|diabetes mellitus|diabetes mellitus
135887|NCT03352674|immunogenicity|immunogenicity
135888|NCT03352635|Ethnic Differences|ethnic differences
135889|NCT03352622|PHARMACOGENOMICS|pharmacogenomics
135890|NCT03352622|POLYMORPHISM|polymorphism
135892|NCT03352609|rTMS|rtms
135893|NCT03352609|Transcranial Magnetic Stimulation|transcranial magnetic stimulation
135894|NCT03352609|Smoking|smoking
135895|NCT03352609|Nicotine|nicotine
135896|NCT03352570|anastomotic leakage|anastomotic leakage
135897|NCT03352570|fistula|fistula
135898|NCT03352557|Mild cognitive impairment|mild cognitive impairment
135899|NCT03352557|Alzheimer's disease|alzheimer's disease
135900|NCT03352531|Anti-PD-1 monoclonal antibody|anti-pd-1 monoclonal antibody
135901|NCT03352531|immunotherapy|immunotherapy
135902|NCT03352531|immuno-oncology|immuno-oncology
135903|NCT03352531|advanced solid tumors|advanced solid tumors
135904|NCT03352466|Anthrax|anthrax
135905|NCT03352440|Cerebral Palsy|cerebral palsy
135906|NCT03352440|Virtual Reality Exposure Therapy|virtual reality exposure therapy
135907|NCT03352440|Learning|learning
135908|NCT03352440|Motor Activity|motor activity
135909|NCT03352440|Motor Skills|motor skills
135910|NCT03352414|HIPEC|hipec
135911|NCT03352414|peritoneal carcinomatosis|peritoneal carcinomatosis
135912|NCT03352401|Pulmonary aspiration, full stomach, gastric content inhalation, Mendelson syndrom|pulmonary aspiration, full stomach, gastric content inhalation, mendelson syndrom
135913|NCT03352388|Older people|older people
135914|NCT03352388|Nutrition|nutrition
135915|NCT03352388|Snack|snack
135916|NCT03352388|Dairy|dairy
135917|NCT03352388|Protein|protein
135918|NCT03352388|Berries|berries
135919|NCT03352349|Terlipressinum|terlipressinum
135920|NCT03352349|Portal Vein Pressure|portal vein pressure
135921|NCT03352349|Liver Tumor Resection|liver tumor resection
135922|NCT03352336|Atelectasis|atelectasis
135923|NCT03352336|Oxygenation|oxygenation
135924|NCT03352336|Venous admixture|venous admixture
135925|NCT03352336|Computed Tomography|computed tomography
135926|NCT03352336|Oxygenation test|oxygenation test
135927|NCT03352310|umbilical cord blood|umbilical cord blood
135928|NCT03352297|Post burn scar face|post burn scar face
135929|NCT03352297|Unfiltered nanofat|unfiltered nanofat
135930|NCT03352297|Adipose tissue growth factors|adipose tissue growth factors
135931|NCT03352297|Adipose stem cells|adipose stem cells
135932|NCT03352297|POSAS|posas
135933|NCT03352297|Image J|image j
135934|NCT03352297|Face|face
135935|NCT03352284|Zirconia implant|zirconia implant
135936|NCT03352284|One-piece|one-piece
135937|NCT03352284|Monoblock|monoblock
135938|NCT03352284|Single tooth|single tooth
135939|NCT03352271|Incremental hemodialysis|incremental hemodialysis
135940|NCT03352271|Precision medicine|precision medicine
135941|NCT03352271|Individualized care|individualized care
135942|NCT03352258|Alzheimer's Disease|alzheimer's disease
135943|NCT03352258|Amyloid|amyloid
135944|NCT03352258|Radiotherapy|radiotherapy
135945|NCT03352219|Human immunodeficiency virus|human immunodeficiency virus
135946|NCT03352219|Sexually transmitted disease|sexually transmitted disease
135947|NCT03352219|African Americans|african americans
135948|NCT03352219|Young adults|young adults
135949|NCT03352219|Behavioral intervention|behavioral intervention
135950|NCT03352219|Entertainment-Education|entertainment-education
135951|NCT03352219|Serial drama|serial drama
135952|NCT03352219|Sexual behavior|sexual behavior
135953|NCT03352219|HIV testing|hiv testing
135954|NCT03352219|Homophobia|homophobia
135955|NCT03352219|Social cognitive theory|social cognitive theory
135956|NCT03352206|Mass drug administration|mass drug administration
135957|NCT03352206|Effectiveness|effectiveness
135959|NCT03352154|Evoked Potential P300|evoked potential p300
135960|NCT03352102|Electric Stimulation|electric stimulation
135961|NCT03352102|Intensive Care Units|intensive care units
135962|NCT03352102|Mechanical Ventilation|mechanical ventilation
135963|NCT03352102|Ventilator Weaning|ventilator weaning
135964|NCT03352089|Magnetic resonance imaging|magnetic resonance imaging
135965|NCT03352089|Positron emission tomography|positron emission tomography
135966|NCT03352076|Danazol|danazol
135967|NCT03352024|neuro degenerative diseases|neuro degenerative diseases
135968|NCT03352024|Alzheimer's disease|alzheimer's disease
135969|NCT03352024|lumbar puncture|lumbar puncture
135970|NCT03352024|CSF|csf
135971|NCT03352024|hypno analgesia|hypno analgesia
135972|NCT03352024|no drug care|no drug care
135973|NCT03352024|pain|pain
135974|NCT03352024|anxiety|anxiety
135975|NCT03352024|counseling|counseling
135976|NCT03351998|insulin sensitivity|insulin sensitivity
135977|NCT03351998|cardiorespiratory fitness|cardiorespiratory fitness
135978|NCT03351998|skeletal muscle mitochondrial function|skeletal muscle mitochondrial function
135979|NCT03351959|ypT0|ypt0
135980|NCT03351946|Atelectasis|atelectasis
135981|NCT03351946|Oxygenation|oxygenation
135982|NCT03351946|Positive end-expiratory pressure|positive end-expiratory pressure
135983|NCT03351946|Mechanical ventilation|mechanical ventilation
135984|NCT03351946|General anesthesia|general anesthesia
135985|NCT03351946|Computed tomography|computed tomography
135986|NCT03351868|Fanconi anemia|fanconi anemia
135987|NCT03351868|Lentiviral vector|lentiviral vector
135988|NCT03351868|FANCA|fanca
135989|NCT03351868|Gene|gene
135990|NCT03351855|Human papilloma virus|human papilloma virus
135991|NCT03351855|Cytotoxic lymphocyte|cytotoxic lymphocyte
135992|NCT03351855|HPV-CTL|hpv-ctl
135993|NCT03351842|Adjuvant chemotherapy|adjuvant chemotherapy
135994|NCT03351842|Micropapillary Component|micropapillary component
135995|NCT03351842|Early stage lung cancer|early stage lung cancer
135996|NCT03351829|Beta Thalassemia|beta thalassemia
135997|NCT03351829|Lentiviral vector|lentiviral vector
135998|NCT03351829|Gene|gene
135999|NCT03351803|BRCA|brca
136000|NCT03351803|BFOR|bfor
136001|NCT03351803|Ashkenazi|ashkenazi
136002|NCT03351803|17-568|17-568
136003|NCT03351764|Non-Invasive Brain Stimulation|non-invasive brain stimulation
136004|NCT03351764|fMRI|fmri
136005|NCT03351764|TMS-Evoked Potential|tms-evoked potential
136006|NCT03351764|Transcranial Magnetic Stimulation (TMS)|transcranial magnetic stimulation (tms)
136007|NCT03351764|EEG|eeg
136008|NCT03351751|PF-06372865|pf-06372865
136009|NCT03351751|Safety|safety
136010|NCT03351751|Tolerability|tolerability
136011|NCT03351751|Pharmacokinetics|pharmacokinetics
136012|NCT03351751|Multiple dose|multiple dose
136013|NCT03351751|Healthy subjects|healthy subjects
136014|NCT03351738|coronary heart disease pharmacokinetic pharmacodynamics|coronary heart disease pharmacokinetic pharmacodynamics
136015|NCT03351725|peripheral venous catheter|peripheral venous catheter
136016|NCT03351725|catheter colonization|catheter colonization
136017|NCT03351712|Wearables|wearables
136018|NCT03351712|Activity Trackers|activity trackers
136019|NCT03351712|ACT|act
136020|NCT03351712|Health promotion|health promotion
136021|NCT03351712|Obesity|obesity
136022|NCT03351712|Chronic Health Condition|chronic health condition
136023|NCT03351712|Psychological well-being|psychological well-being
136024|NCT03351712|Quality of life|quality of life
136025|NCT03351712|Behavior modification|behavior modification
136026|NCT03351712|RCT|rct
136027|NCT03351686|tranexamic acid|tranexamic acid
136028|NCT03351647|Crohn Disease|crohn disease
136029|NCT03351647|Ustekinumab|ustekinumab
136030|NCT03351647|Vedolizumab|vedolizumab
136031|NCT03351647|anti-TNF|anti-tnf
136032|NCT03351647|CRP|crp
136033|NCT03351647|calprotectin|calprotectin
136034|NCT03351647|cohort|cohort
136035|NCT03351595|Growth pattern|growth pattern
136036|NCT03351595|Environmental and prenatal exposure|environmental and prenatal exposure
136037|NCT03351582|family therapy|family therapy
136038|NCT03351582|psychological health|psychological health
136039|NCT03351569|Unverricht-Lundborg disease|unverricht-lundborg disease
136040|NCT03351569|progressive myoclonus epilepsy|progressive myoclonus epilepsy
136041|NCT03351569|pharmacoresistant epilepsy|pharmacoresistant epilepsy
136042|NCT03351543|vaccine response|vaccine response
136043|NCT03351543|immune system activity|immune system activity
136044|NCT03351504|household air pollution|household air pollution
136045|NCT03351504|fine particulate matter|fine particulate matter
136046|NCT03351504|kerosene|kerosene
136047|NCT03351491|Health mobile applications|health mobile applications
136048|NCT03351491|Apps|apps
136049|NCT03351491|mhealth|mhealth
136050|NCT03351491|ehealth|ehealth
136051|NCT03351491|France|france
136052|NCT03351491|msanté|msanté
136053|NCT03351491|applications mobiles|applications mobiles
136054|NCT03351439|Hip Arthroscopy|hip arthroscopy
136055|NCT03351426|obesity|obesity
136056|NCT03351426|overweight|overweight
136057|NCT03351426|neuromodulation|neuromodulation
136058|NCT03351426|transcranial direct current stimulation (tDCS)|transcranial direct current stimulation (tdcs)
136059|NCT03351413|Fall Prevention|fall prevention
136060|NCT03351413|Older Adults|older adults
136061|NCT03351400|cardiac stem cells|cardiac stem cells
136062|NCT03351400|c-kit|c-kit
136063|NCT03351387|amputation|amputation
136064|NCT03351387|necrosis|necrosis
136065|NCT03351387|high risk lower extremity wound|high risk lower extremity wound
136066|NCT03351374|behavioral health|behavioral health
136067|NCT03351374|software|software
136068|NCT03351374|integration|integration
136069|NCT03351348|Bupivacaine|bupivacaine
136070|NCT03351348|Mastectomy|mastectomy
136071|NCT03351348|Sentinel lymph node biopsy SLNB|sentinel lymph node biopsy slnb
136072|NCT03351348|17-576|17-576
136073|NCT03351322|Alopecia|alopecia
136074|NCT03351322|Hair Loss|hair loss
136075|NCT03351322|Female Pattern Baldness|female pattern baldness
136077|NCT03351270|XLMTM|xlmtm
136078|NCT03351270|Myotubular myopathy|myotubular myopathy
136079|NCT03351205|Asherman syndrome|asherman syndrome
136080|NCT03351205|hysteroscopy|hysteroscopy
136081|NCT03351205|uterine stent|uterine stent
136082|NCT03351205|Estrogen|estrogen
136083|NCT03351205|Amnion|amnion
136084|NCT03351205|Hysteroscopic Adhesiolysis|hysteroscopic adhesiolysis
136085|NCT03351179|Heart Failure with Preserved Ejection Fraction|heart failure with preserved ejection fraction
136086|NCT03351179|Acute MyocAcute Myocardial Infarction|acute myocacute myocardial infarction
136087|NCT03351179|Predictive factors|predictive factors
136088|NCT03351140|Multiple Myeloma|multiple myeloma
136089|NCT03351140|Patient‐Reported Outcome Measurement Information System (PROMIS)|patient‐reported outcome measurement information system (promis)
136090|NCT03351140|Non‐Small Cell Lung Cancer (NSCLC)|non‐small cell lung cancer (nsclc)
136091|NCT03351140|Breast cancer|breast cancer
136092|NCT03351140|Diffuse Large B‐Cell (DLBCL)|diffuse large b‐cell (dlbcl)
136093|NCT03351140|Follicular Lymphoma|follicular lymphoma
136094|NCT03351140|Prostate Cancer|prostate cancer
136095|NCT03351140|Qualitative interview|qualitative interview
136096|NCT03351114|Morphea, Localized Scleroderma|morphea, localized scleroderma
136097|NCT03351062|premenopausal|premenopausal
136098|NCT03351062|early breast cancer|early breast cancer
136099|NCT03351062|estrogen receptor positive|estrogen receptor positive
136100|NCT03351049|Acute care, support surface|acute care, support surface
136101|NCT03351036|Hypothermia|hypothermia
136102|NCT03351010|Mindfulness, Cancer, Pain Management|mindfulness, cancer, pain management
136103|NCT03350997|Exercise|exercise
136104|NCT03350971|virtual reality|virtual reality
136105|NCT03350971|physical therapy|physical therapy
136106|NCT03350971|myocardial revascualrization|myocardial revascualrization
136107|NCT03350932|sensory imagination; foods|sensory imagination; foods
136108|NCT03350906|Exercise|exercise
136109|NCT03350906|muscle function|muscle function
136110|NCT03350880|Passive|passive
136111|NCT03350880|Stretching|stretching
136112|NCT03350880|Water|water
136113|NCT03350880|Proprioceptive Neuromuscular Facilitation (PNF)|proprioceptive neuromuscular facilitation (pnf)
136114|NCT03350867|Posture|posture
136115|NCT03350867|Orthosis|orthosis
136116|NCT03350867|Foot|foot
136117|NCT03350867|Biomechanical Phenomena|biomechanical phenomena
136118|NCT03350854|early stage breast cancer;|early stage breast cancer;
136119|NCT03350854|treatment decision making|treatment decision making
136120|NCT03350854|newly diagnosed breast cancer|newly diagnosed breast cancer
136121|NCT03350828|CF|cf
136122|NCT03350828|Cystic Fibrosis|cystic fibrosis
136123|NCT03350828|Sweat|sweat
136124|NCT03350828|Sweat chloride|sweat chloride
136125|NCT03350828|CFTR Modulator|cftr modulator
136126|NCT03350815|Ankylosing spondylitis, ASDAS inactive disease, secukinumab|ankylosing spondylitis, asdas inactive disease, secukinumab
136127|NCT03350789|acupuncture|acupuncture
136128|NCT03350789|sciatica|sciatica
136129|NCT03350789|MRI, functional|mri, functional
136130|NCT03350776|Neoplasm|neoplasm
136131|NCT03350776|Chronic disease|chronic disease
136132|NCT03350776|Complex cases|complex cases
136133|NCT03350776|Care coordination|care coordination
136134|NCT03350776|Oncologic nursing|oncologic nursing
136135|NCT03350776|Theoretical model|theoretical model
136136|NCT03350763|Pancreatic Cancer|pancreatic cancer
136137|NCT03350763|Biliary decompression|biliary decompression
136138|NCT03350737|No-option patients|no-option patients
136139|NCT03350711|Microbiota composition|microbiota composition
136140|NCT03350711|Microbiota Enrichment Program|microbiota enrichment program
136141|NCT03350711|Fecal microbiota transplant (FMT)|fecal microbiota transplant (fmt)
136142|NCT03350698|Human papilloma virus|human papilloma virus
136143|NCT03350672|HIV prevention|hiv prevention
136144|NCT03350672|PrEP|prep
136145|NCT03350672|Descovy|descovy
136146|NCT03350659|orthostatic hypotension|orthostatic hypotension
136147|NCT03350659|midodrine|midodrine
136148|NCT03350659|atomoxetine|atomoxetine
136149|NCT03350659|treatment|treatment
136150|NCT03350646|embryo transfer|embryo transfer
136151|NCT03350646|volume|volume
136152|NCT03350646|culture medium|culture medium
136153|NCT03350646|loading the catheter|loading the catheter
136154|NCT03350646|clinical pregnancy rate|clinical pregnancy rate
136155|NCT03350620|child, myopia, nearsightedness|child, myopia, nearsightedness
136248|NCT03349840|Ramadan|ramadan
136156|NCT03350607|Epiretinal membrane, sweeper, forceps, microperimetry|epiretinal membrane, sweeper, forceps, microperimetry
136157|NCT03350594|Anorexia Nervosa|anorexia nervosa
136158|NCT03350594|Multiple Family Therapy|multiple family therapy
136159|NCT03350594|Systemic Family Therapy|systemic family therapy
136160|NCT03350594|Adolescence|adolescence
136161|NCT03350594|Randomised controled trial|randomised controled trial
136162|NCT03350581|Catheter ablation|catheter ablation
136163|NCT03350581|Fast anatomical mapping (FAM)|fast anatomical mapping (fam)
136164|NCT03350581|Computed tomography (CT)|computed tomography (ct)
136165|NCT03350581|Magnetic resonance image (MRI)|magnetic resonance image (mri)
136166|NCT03350581|Contact force|contact force
136167|NCT03350581|Atrial fibrillation|atrial fibrillation
136168|NCT03350568|Antioxidants|antioxidants
136169|NCT03350568|Oxidative Stress|oxidative stress
136170|NCT03350568|Atherosclerosis|atherosclerosis
136171|NCT03350568|Epidemiology|epidemiology
136172|NCT03350542|Drug-Eluting Stents|drug-eluting stents
136173|NCT03350529|prostate cancer|prostate cancer
136174|NCT03350529|benign prostatic hyperplasia|benign prostatic hyperplasia
136175|NCT03350529|benign prostatic obstruction|benign prostatic obstruction
136176|NCT03350529|high intensity focused ultrasound|high intensity focused ultrasound
136177|NCT03350529|real-time temperature feedback control|real-time temperature feedback control
136178|NCT03350529|magnetic resonance imaging|magnetic resonance imaging
136179|NCT03350503|phacoemulsification|phacoemulsification
136180|NCT03350503|intraocular lens|intraocular lens
136181|NCT03350503|vision|vision
136182|NCT03350503|toric|toric
136183|NCT03350490|Cancer ablation|cancer ablation
136184|NCT03350490|Life information rehabilitation therapy|life information rehabilitation therapy
136185|NCT03350477|Cancer ablation|cancer ablation
136186|NCT03350477|Life information rehabilitation therapy|life information rehabilitation therapy
136187|NCT03350451|Hyperoxaluria, Primary|hyperoxaluria, primary
136188|NCT03350451|Hyperoxaluria|hyperoxaluria
136189|NCT03350451|Kidney Diseases|kidney diseases
136190|NCT03350451|Urologic Diseases|urologic diseases
136191|NCT03350451|Metabolism, Inborn Errors|metabolism, inborn errors
136192|NCT03350451|Genetic Diseases, Inborn|genetic diseases, inborn
136193|NCT03350451|Metabolic Diseases|metabolic diseases
136194|NCT03350438|participation|participation
136195|NCT03350438|quality of life|quality of life
136196|NCT03350438|occupational therapy|occupational therapy
136197|NCT03350425|hemodialysis|hemodialysis
136198|NCT03350425|pneumococcal vaccination|pneumococcal vaccination
136199|NCT03350347|Renal anemia|renal anemia
136200|NCT03350334|Duloxetine|duloxetine
136201|NCT03350334|laparoscopic hysterectomy|laparoscopic hysterectomy
136202|NCT03350334|postoperative pain|postoperative pain
136203|NCT03350334|postoperative recovery|postoperative recovery
136204|NCT03350295|Relative bioavailability|relative bioavailability
136205|NCT03350295|In vitro dissolution|in vitro dissolution
136206|NCT03350269|Living kidney donation|living kidney donation
136207|NCT03350269|Kidney transplant|kidney transplant
136208|NCT03350269|Lost Wage Reimbursement|lost wage reimbursement
136209|NCT03350243|Neonatal Intensive Care Unit|neonatal intensive care unit
136210|NCT03350243|Mindfulness|mindfulness
136211|NCT03350243|Care coordination|care coordination
136212|NCT03350243|Anticipatory guidance|anticipatory guidance
136213|NCT03350243|Parental support|parental support
136214|NCT03350243|Neonatal follow-up|neonatal follow-up
136215|NCT03350152|Chemotherapy, Low-intensity therapy, elderly, prognosis,|chemotherapy, low-intensity therapy, elderly, prognosis,
136216|NCT03350126|MSI or MMR|msi or mmr
136217|NCT03350113|prognosis|prognosis
136218|NCT03350113|diagnosis|diagnosis
136219|NCT03350087|repetitive transcranial magnetic stimulation|repetitive transcranial magnetic stimulation
136220|NCT03350087|stroke|stroke
136221|NCT03350087|optimal treatment protocol|optimal treatment protocol
136222|NCT03350087|VR-based cycling training (VCT)|vr-based cycling training (vct)
136223|NCT03350087|randomized controlled trial|randomized controlled trial
136224|NCT03350087|motor control|motor control
136225|NCT03350087|clinical predictors|clinical predictors
136226|NCT03350074|Hepatitis B virus|hepatitis b virus
136227|NCT03350074|PreS/S variability|pres/s variability
136228|NCT03350074|Anti-HBV treatment|anti-hbv treatment
136229|NCT03350048|Tuberculosis|tuberculosis
136230|NCT03350048|Point-of-care test|point-of-care test
136231|NCT03350048|Diagnostics|diagnostics
136232|NCT03350048|Biomarkers|biomarkers
136233|NCT03349957|TACE|tace
136234|NCT03349944|exercise|exercise
136235|NCT03349931|Aspergillosis,|aspergillosis,
136236|NCT03349931|qPCR|qpcr
136237|NCT03349931|allogenic haemopoietic stem-cell transplantation|allogenic haemopoietic stem-cell transplantation
136238|NCT03349931|leukemia|leukemia
136239|NCT03349905|Freeze all|freeze all
136240|NCT03349905|IVF|ivf
136241|NCT03349905|deferred embryo transfer|deferred embryo transfer
136242|NCT03349905|endometriosis|endometriosis
136243|NCT03349853|Palliative care; Acetaminophen; Subcutaneous route; Pain treatment|palliative care; acetaminophen; subcutaneous route; pain treatment
136244|NCT03349840|type 2 diabetes|type 2 diabetes
136245|NCT03349840|insulin|insulin
136246|NCT03349840|glargine u100|glargine u100
136247|NCT03349840|degludec|degludec
136249|NCT03349814|appendicitis|appendicitis
136250|NCT03349814|appendectomy|appendectomy
136251|NCT03349814|yersinia|yersinia
136252|NCT03349801|iAMD|iamd
136253|NCT03349801|biomarker|biomarker
136254|NCT03349801|clinical endpoint|clinical endpoint
136255|NCT03349788|Left colic artery|left colic artery
136256|NCT03349788|Laparoscopic Surgery|laparoscopic surgery
136257|NCT03349788|Anterior resection of rectum|anterior resection of rectum
136258|NCT03349788|Rectum cancer|rectum cancer
136259|NCT03349775|Pulmonary Hypertension|pulmonary hypertension
136260|NCT03349775|BMI|bmi
136261|NCT03349775|Echocardiography|echocardiography
136262|NCT03349775|CPET|cpet
136263|NCT03349775|6-minute walk test|6-minute walk test
136264|NCT03349775|Cardio Metabolic disease|cardio metabolic disease
136265|NCT03349762|Huaier Granule|huaier granule
136266|NCT03349762|multisite|multisite
136267|NCT03349762|open-label|open-label
136268|NCT03349762|prospective|prospective
136269|NCT03349749|intensive care units|intensive care units
136270|NCT03349749|resuscitation|resuscitation
136271|NCT03349749|fluid therapy|fluid therapy
136272|NCT03349749|Vascular Access Devices|vascular access devices
136273|NCT03349749|cardiac output|cardiac output
136274|NCT03349749|monitoring, physiologic|monitoring, physiologic
136275|NCT03349736|Pelvic floor muscle|pelvic floor muscle
136276|NCT03349697|Liver Health|liver health
136277|NCT03349697|Hangover|hangover
136278|NCT03349697|Herbal supplement|herbal supplement
136279|NCT03349697|Liver function|liver function
136280|NCT03349658|total hip arthroplasty|total hip arthroplasty
136281|NCT03349658|cerebral oxygen saturation|cerebral oxygen saturation
136282|NCT03349658|general anesthesia|general anesthesia
136283|NCT03349658|spinal anesthesia|spinal anesthesia
136284|NCT03349632|Contact lenses|contact lenses
136285|NCT03349632|Myopia|myopia
136286|NCT03349632|Near-sighted|near-sighted
136287|NCT03349632|Daily disposable|daily disposable
136288|NCT03349593|Heart failure, diastolic dysfunction, venous return|heart failure, diastolic dysfunction, venous return
136289|NCT03349593|Left ventricular filling pressures|left ventricular filling pressures
136290|NCT03349580|rehabilitation|rehabilitation
136291|NCT03349580|randomized controlled trial|randomized controlled trial
136292|NCT03349580|strength training|strength training
136293|NCT03349580|early initiation|early initiation
136294|NCT03349580|intra-abdominal pressure|intra-abdominal pressure
136295|NCT03349554|Parkinson's disease|parkinson's disease
136296|NCT03349554|anxiety|anxiety
136297|NCT03349554|meditation|meditation
136298|NCT03349554|in-patients|in-patients
136299|NCT03349528|bipolar disorder|bipolar disorder
136300|NCT03349528|bipolar depression|bipolar depression
136301|NCT03349528|depressive episode|depressive episode
136302|NCT03349528|probiotic supplement|probiotic supplement
136303|NCT03349528|probiotics|probiotics
136304|NCT03349528|relapse prevention|relapse prevention
136305|NCT03349528|rehospitalization|rehospitalization
136306|NCT03349502|Allogeneic natural killer cell, MG4101|allogeneic natural killer cell, mg4101
136307|NCT03349489|Type 1 diabetes|type 1 diabetes
136308|NCT03349489|Exercise|exercise
136309|NCT03349489|Hypoglycemia|hypoglycemia
136310|NCT03349489|Insulin pump|insulin pump
136311|NCT03349476|Atrial Fibrillation|atrial fibrillation
136312|NCT03349476|AFIB|afib
136313|NCT03349476|Ablation|ablation
136314|NCT03349476|Paroxysmal|paroxysmal
136315|NCT03349476|Persistent|persistent
136316|NCT03349450|Lymphoma|lymphoma
136317|NCT03349450|DLBCL|dlbcl
136318|NCT03349450|Lymphoma, B-Cell|lymphoma, b-cell
136319|NCT03349450|Lymphoma, Large B-Cell, Diffuse|lymphoma, large b-cell, diffuse
136320|NCT03349450|Neoplasms by Histologic Type|neoplasms by histologic type
136321|NCT03349450|Neoplasms|neoplasms
136322|NCT03349450|Lymphoproliferative Disorders|lymphoproliferative disorders
136323|NCT03349450|Lymphatic Diseases|lymphatic diseases
136324|NCT03349450|Immunoproliferative Disorders|immunoproliferative disorders
136325|NCT03349450|Immune System Diseases|immune system diseases
136326|NCT03349450|Lymphoma, Non-Hodgkin|lymphoma, non-hodgkin
136327|NCT03349450|Cyclophosphamide|cyclophosphamide
136328|NCT03349450|Pembrolizumab|pembrolizumab
136329|NCT03349450|Immunosuppressive Agents|immunosuppressive agents
136330|NCT03349450|Immunologic Factors|immunologic factors
136331|NCT03349450|Physiological Effects of Drugs|physiological effects of drugs
136332|NCT03349450|Antirheumatic Agents|antirheumatic agents
136333|NCT03349450|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating
136334|NCT03349450|Alkylating Agents|alkylating agents
136335|NCT03349450|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action
136336|NCT03349450|Antineoplastic Agents|antineoplastic agents
136337|NCT03349450|Myeloablative Agonists|myeloablative agonists
136338|NCT03349450|Canada|canada
136339|NCT03349450|Ontario|ontario
136340|NCT03349450|Diffuse Large B Cell Lymphoma|diffuse large b cell lymphoma
136341|NCT03349450|refractory|refractory
136342|NCT03349450|relapsed|relapsed
136343|NCT03349450|checkpoint inhibitor|checkpoint inhibitor
136344|NCT03349450|vaccine|vaccine
136345|NCT03349450|DPX-Survivac|dpx-survivac
136346|NCT03349450|Survivin|survivin
136347|NCT03349450|Immunotherapy|immunotherapy
136348|NCT03349450|Transformed Lymphoma|transformed lymphoma
136349|NCT03349450|Double Hit|double hit
136350|NCT03349450|Large Cell Lymphoma|large cell lymphoma
136351|NCT03349450|Keytruda|keytruda
136352|NCT03349424|Somatostatin|somatostatin
136353|NCT03349424|Pancreatic Fistula|pancreatic fistula
136354|NCT03349424|Intermediate Risk|intermediate risk
136355|NCT03349424|Pancreaticoduodenectomy|pancreaticoduodenectomy
136356|NCT03349398|Uncut Roux-en-Y|uncut roux-en-y
136357|NCT03349398|Roux-en-Y|roux-en-y
136358|NCT03349385|Secondary revascularization|secondary revascularization
136359|NCT03349385|Repeat revascularization|repeat revascularization
136360|NCT03349385|Coronary revascularization|coronary revascularization
136361|NCT03349385|Coronary artery bypass graft|coronary artery bypass graft
136362|NCT03349333|FOT12-CN-301|fot12-cn-301
136363|NCT03349333|PTCL (peripheral T-cell lymphoma)|ptcl (peripheral t-cell lymphoma)
136364|NCT03349333|pralatrexate|pralatrexate
136365|NCT03349333|vitamin B12|vitamin b12
136366|NCT03349333|folic acid|folic acid
136367|NCT03349320|Alzheimer|alzheimer
136368|NCT03349320|APOE|apoe
136369|NCT03349320|CYP2D6|cyp2d6
136370|NCT03349320|Donepezil|donepezil
136371|NCT03349320|Genetics|genetics
136372|NCT03349307|lobectomy|lobectomy
136373|NCT03349294|Thyroid|thyroid
136374|NCT03349294|Thyroidectomy|thyroidectomy
136375|NCT03349294|Iodine|iodine
136376|NCT03349294|Biokinetic|biokinetic
136377|NCT03349294|Ablation|ablation
136378|NCT03349255|alpha-fetoprotein|alpha-fetoprotein
136379|NCT03349255|AFP|afp
136380|NCT03349255|HCC|hcc
136381|NCT03349255|CAR T cell therapy|car t cell therapy
136382|NCT03349229|care practices|care practices
136383|NCT03349229|geriatry|geriatry
136384|NCT03349229|oncology|oncology
136385|NCT03349151|Postoperative maternal feeding, cesarean section|postoperative maternal feeding, cesarean section
136386|NCT03349138|rehabilitation|rehabilitation
136387|NCT03349138|functional electrical stimulation|functional electrical stimulation
136388|NCT03349138|electrode array|electrode array
136389|NCT03349138|upper limb|upper limb
136390|NCT03349138|chronic|chronic
136391|NCT03349138|motor relearning|motor relearning
136392|NCT03349125|Cervical Brace|cervical brace
136393|NCT03349125|Elderly|elderly
136394|NCT03349125|Dysphagia|dysphagia
136395|NCT03349125|VFSS|vfss
136396|NCT03349125|Videoflouroscopy|videoflouroscopy
136397|NCT03349125|Swallow Problems|swallow problems
136398|NCT03349112|Manometry|manometry
136399|NCT03349112|Lidocaine|lidocaine
136400|NCT03349112|Pharyngeal|pharyngeal
136401|NCT03349112|High Resolution Pharyngeal Manometry (HRPM)|high resolution pharyngeal manometry (hrpm)
136402|NCT03349112|Pressure|pressure
136403|NCT03349086|Botox Injection|botox injection
136404|NCT03349086|Spasmodic|spasmodic
136405|NCT03349086|Dysphonia|dysphonia
136406|NCT03349086|Voice Therapy|voice therapy
136407|NCT03349086|Speech Therapy|speech therapy
136408|NCT03349086|Voice Rest|voice rest
136409|NCT03349060|atopic dermatitis|atopic dermatitis
136410|NCT03349060|atopic eczema|atopic eczema
136411|NCT03349060|eczema|eczema
136412|NCT03349060|JAK|jak
136413|NCT03349060|janus kinase|janus kinase
136414|NCT03349047|Food Allergy|food allergy
136415|NCT03349047|Anxiety|anxiety
136416|NCT03349047|Casual Exposure|casual exposure
136417|NCT03349047|Peanut Hypersensitivity|peanut hypersensitivity
136418|NCT03349047|Tree nut Hypersensitivity|tree nut hypersensitivity
136419|NCT03349047|Adolescents|adolescents
136420|NCT03349034|Local anesthetics|local anesthetics
136421|NCT03349034|Randomized Control Trial|randomized control trial
136422|NCT03349034|Free tissue transfer|free tissue transfer
136423|NCT03349034|Head and neck|head and neck
136424|NCT03349034|Microvascular|microvascular
136425|NCT03349034|Postoperative Pain|postoperative pain
136426|NCT03349021|esophagus|esophagus
136427|NCT03349021|stenosis|stenosis
136428|NCT03349021|bougienage|bougienage
136429|NCT03349008|necro-inflammatory|necro-inflammatory
136430|NCT03349008|glycyrrhizin|glycyrrhizin
136431|NCT03349008|entecavir|entecavir
136432|NCT03349008|hepatic biological parameters|hepatic biological parameters
136433|NCT03349008|liver fibrosis|liver fibrosis
136434|NCT03348982|Physical activity|physical activity
136435|NCT03348982|Sleep|sleep
136436|NCT03348982|Children|children
136437|NCT03348982|Autism Spectrum Disorder|autism spectrum disorder
136438|NCT03348982|Melatonin|melatonin
136439|NCT03348969|Mitomycin C|mitomycin c
136440|NCT03348969|Neoadjuvant|neoadjuvant
136441|NCT03348904|Non-small cell lung cancer|non-small cell lung cancer
136442|NCT03348904|programmed cell death protein 1 (PD-1) antibody|programmed cell death protein 1 (pd-1) antibody
136443|NCT03348904|indoleamine 2,3-dioxygenase (IDO) inhibitor|indoleamine 2,3-dioxygenase (ido) inhibitor
136444|NCT03348891|Melanoma|melanoma
136445|NCT03348891|TNF|tnf
136446|NCT03348891|Immune checkpoints|immune checkpoints
136447|NCT03348891|Tumor-infiltrating lymphocytes|tumor-infiltrating lymphocytes
136448|NCT03348891|Cytokines|cytokines
136449|NCT03348891|Circulating leukocytes|circulating leukocytes
136450|NCT03348878|drug compliance|drug compliance
136451|NCT03348878|hypertension|hypertension
136452|NCT03348878|anti-hypertensive agents|anti-hypertensive agents
136453|NCT03348865|Cognitive Behavioural Therapy|cognitive behavioural therapy
136454|NCT03348839|telemedicine|telemedicine
136455|NCT03348839|telemonitoring|telemonitoring
136456|NCT03348839|educational therapy|educational therapy
136457|NCT03348813|Black|black
136458|NCT03348813|Adolescents|adolescents
136459|NCT03348813|Community-based research|community-based research
136460|NCT03348813|Randomized controlled trial|randomized controlled trial
136461|NCT03348813|Intervention|intervention
136462|NCT03348813|Behavioral science|behavioral science
136463|NCT03348800|Child|child
136464|NCT03348800|RCT|rct
136465|NCT03348800|Anesthesia|anesthesia
136466|NCT03348800|Tooth extraction|tooth extraction
136467|NCT03348787|Behavioral and Cognitive Therapies|behavioral and cognitive therapies
136468|NCT03348774|Disease Course|disease course
136469|NCT03348761|Repetitive Transcranial Magnetic Stimulation|repetitive transcranial magnetic stimulation
136470|NCT03348761|resting-state Functional magnetic resonance imaging|resting-state functional magnetic resonance imaging
136471|NCT03348761|treatment response trajectories|treatment response trajectories
136472|NCT03348722|Active surveillance|active surveillance
136473|NCT03348722|Low risk prostate cancer|low risk prostate cancer
136474|NCT03348722|Prostatic neoplasm/therapy (MESH)|prostatic neoplasm/therapy (mesh)
136475|NCT03348722|Prostatic neoplasm/surgery (MESH)|prostatic neoplasm/surgery (mesh)
136476|NCT03348722|Prostatic neoplasm/radiotherapy (MESH)|prostatic neoplasm/radiotherapy (mesh)
136477|NCT03348722|Prostatectomy (MESH)|prostatectomy (mesh)
136478|NCT03348722|Quality of life (MESH)|quality of life (mesh)
136479|NCT03348722|Costs and Cost Analysis (MESH)|costs and cost analysis (mesh)
136480|NCT03348683|Induction|induction
136481|NCT03348683|Labor|labor
136482|NCT03348683|Propranolol|propranolol
136483|NCT03348670|SCLC|sclc
136484|NCT03348670|SNP|snp
136485|NCT03348670|Oncology|oncology
136486|NCT03348670|Drug|drug
136487|NCT03348670|Etoposide|etoposide
136488|NCT03348670|Methotrexate|methotrexate
136489|NCT03348670|Lung|lung
136490|NCT03348670|Cancer|cancer
136491|NCT03348670|Topotecan|topotecan
136492|NCT03348670|Everolimus|everolimus
136493|NCT03348618|Obsessive-Compulsive Disorder|obsessive-compulsive disorder
136494|NCT03348618|Anxiety|anxiety
136495|NCT03348618|PANS|pans
136496|NCT03348618|PANDAS|pandas
136497|NCT03348618|Children|children
136498|NCT03348605|Amputation|amputation
136499|NCT03348605|Phantom Pain|phantom pain
136500|NCT03348605|Gait analysis|gait analysis
136501|NCT03348592|Microbiome, p-inulin|microbiome, p-inulin
136502|NCT03348579|Intensive care unit|intensive care unit
136503|NCT03348579|Pneumonia|pneumonia
136504|NCT03348579|Ventilator associated|ventilator associated
136505|NCT03348579|Hospital acquired pneumonia|hospital acquired pneumonia
136506|NCT03348579|Guidelines|guidelines
136507|NCT03348553|Omega-fatty-acids|omega-fatty-acids
136508|NCT03348553|Absorption|absorption
136509|NCT03348553|Bioavailability|bioavailability
136510|NCT03348553|Fruit & Vegetable concentrate|fruit & vegetable concentrate
136511|NCT03348553|Lipid Metabolism|lipid metabolism
136512|NCT03348475|Guided self-help|guided self-help
136513|NCT03348475|Group-based intervention|group-based intervention
136514|NCT03348475|Binge Focused Therapy|binge focused therapy
136515|NCT03348475|Brain Over Binge|brain over binge
136516|NCT03348475|Non-expert guided|non-expert guided
136517|NCT03348475|Minimally intensive|minimally intensive
136518|NCT03348462|psoriasis|psoriasis
136519|NCT03348462|anthralin|anthralin
136520|NCT03348462|ethosome|ethosome
136521|NCT03348462|liposome|liposome
136522|NCT03348449|HIV|hiv
136523|NCT03348449|Dual therapy|dual therapy
136524|NCT03348449|Comorbidities|comorbidities
136525|NCT03348449|Nucleoside analogues sparing-regimens|nucleoside analogues sparing-regimens
136526|NCT03348436|paroxysmal supraventricular tachycardia|paroxysmal supraventricular tachycardia
136527|NCT03348436|Left Atrial Function|left atrial function
136528|NCT03348423|Peri-procedural pain|peri-procedural pain
136529|NCT03348423|Pain|pain
136530|NCT03348423|Anxiety|anxiety
136531|NCT03348423|Analgesia|analgesia
136532|NCT03348423|Anxiolysis|anxiolysis
136533|NCT03348371|Incretin effect|incretin effect
136534|NCT03348371|Ethanol|ethanol
136535|NCT03348345|eating disorders|eating disorders
136536|NCT03348345|prevention|prevention
136537|NCT03348345|yoga|yoga
136538|NCT03348345|mindfulness|mindfulness
136539|NCT03348345|embodiment|embodiment
136540|NCT03348345|self-regulation|self-regulation
136541|NCT03348345|functional action|functional action
136542|NCT03348345|interoceptive awareness|interoceptive awareness
136543|NCT03348332|exercise|exercise
136544|NCT03348332|intrapartum|intrapartum
136545|NCT03348332|aerobic exercise|aerobic exercise
136546|NCT03348332|resistance exercise|resistance exercise
136547|NCT03348332|wellbeing|wellbeing
136548|NCT03348293|biodegradable scaffold|biodegradable scaffold
136549|NCT03348293|immediate breast reconstruction|immediate breast reconstruction
136550|NCT03348293|3D printing|3d printing
136551|NCT03348241|Gum Arabic|gum arabic
136552|NCT03348241|Cancer patients|cancer patients
136553|NCT03348241|Chemotherapy|chemotherapy
136554|NCT03348241|Oral mucositis|oral mucositis
136555|NCT03348228|Hydroxycitrate Supplements|hydroxycitrate supplements
136556|NCT03348215|Gait rehabilitation|gait rehabilitation
136557|NCT03348163|Transgender women|transgender women
136558|NCT03348163|Bictegravir|bictegravir
136559|NCT03348150|HIPEC|hipec
136560|NCT03348150|Hyperthermic Intraperitoneal Chemotherapy|hyperthermic intraperitoneal chemotherapy
136561|NCT03348150|gastrectomy|gastrectomy
136562|NCT03348150|cytoreductive surgery|cytoreductive surgery
136563|NCT03348150|oxaliplatin|oxaliplatin
136564|NCT03348150|docetaxel|docetaxel
136565|NCT03348124|Intellectual disability|intellectual disability
136566|NCT03348124|Parenthood|parenthood
136567|NCT03348124|Reproduction|reproduction
136568|NCT03348124|Intervention|intervention
136569|NCT03348124|Adolescents|adolescents
136570|NCT03348111|Mucositis|mucositis
136571|NCT03348111|Peri-Implantitis|peri-implantitis
136572|NCT03348111|Air-Flow Master Piezon®|air-flow master piezon®
136573|NCT03348098|Triple negative breast cancer|triple negative breast cancer
136574|NCT03348046|Infliximab|infliximab
136575|NCT03348046|Remsima|remsima
136576|NCT03348046|Biosimilar|biosimilar
136577|NCT03348046|Autoimmune Disease|autoimmune disease
136578|NCT03348046|Rheumatoid Arthritis|rheumatoid arthritis
136579|NCT03348046|Cohort Study|cohort study
136580|NCT03348046|Disease modifying anti-rheumatic drugs|disease modifying anti-rheumatic drugs
136581|NCT03348046|Tumor necrosis factor-alpha inhibitors|tumor necrosis factor-alpha inhibitors
136582|NCT03347994|Acute Myeloid Leukemia|acute myeloid leukemia
136583|NCT03347994|AML|aml
136584|NCT03347994|Refractory AML|refractory aml
136585|NCT03347994|Relapsed AML|relapsed aml
136586|NCT03347994|Refractory Acute Myeloid Leukemia|refractory acute myeloid leukemia
136587|NCT03347994|Relapsed Acute Myeloid Leukemia|relapsed acute myeloid leukemia
136588|NCT03347981|Intraocular Lens|intraocular lens
136589|NCT03347981|trifocal|trifocal
136590|NCT03347981|hydrophobic|hydrophobic
136591|NCT03347981|hydrophilic|hydrophilic
136592|NCT03347968|type 2 Diabetes Mellitus, MEDI0382|type 2 diabetes mellitus, medi0382
136593|NCT03347955|placebo effect|placebo effect
136594|NCT03347942|Overweight|overweight
136595|NCT03347942|Obesity|obesity
136596|NCT03347942|Satiety|satiety
136597|NCT03347942|Cardiovascular risk|cardiovascular risk
136598|NCT03347903|esophagus|esophagus
136599|NCT03347903|motility|motility
136600|NCT03347890|GLP-1|glp-1
136601|NCT03347890|fMRI|fmri
136602|NCT03347877|autologous osteo-periosteal cylinder graft|autologous osteo-periosteal cylinder graft
136603|NCT03347877|autologous osteochondral graft|autologous osteochondral graft
136604|NCT03347877|randomized controlled trial|randomized controlled trial
136605|NCT03347877|Hepple V osteochondral lesions of the talus|hepple v osteochondral lesions of the talus
136606|NCT03347851|mechanical heart valve|mechanical heart valve
136607|NCT03347851|On-X|on-x
136608|NCT03347838|PD-1|pd-1
136609|NCT03347838|Precancerous Conditions|precancerous conditions
136610|NCT03347838|Nivolumab|nivolumab
136611|NCT03347838|Lung Cancer Immunoprevention|lung cancer immunoprevention
136612|NCT03347812|Aortic Arch|aortic arch
136613|NCT03347812|Endovascular Treatment|endovascular treatment
136614|NCT03347812|Traditional Open Surgery|traditional open surgery
136615|NCT03347812|Chimney Technique|chimney technique
136616|NCT03347812|Fenestration Technique|fenestration technique
136617|NCT03347812|Branched Stent-grafts Technique|branched stent-grafts technique
136618|NCT03347799|very premature infants|very premature infants
136619|NCT03347799|screening|screening
136620|NCT03347799|retinopathy|retinopathy
136621|NCT03347773|Oral nutritional supplement|oral nutritional supplement
136622|NCT03347773|Sarcopenic obesity|sarcopenic obesity
136623|NCT03347773|Body composition|body composition
136624|NCT03347760|68-Ga-DOTATOC PET|68-ga-dotatoc pet
136625|NCT03347760|Myocarditis|myocarditis
136626|NCT03347734|eye exercises|eye exercises
136627|NCT03347734|convergence exercise|convergence exercise
136628|NCT03347734|hyperopia|hyperopia
136629|NCT03347734|oculomotor exercise|oculomotor exercise
136630|NCT03347734|school-age children|school-age children
136631|NCT03347708|Lumbar disc degeneration|lumbar disc degeneration
136632|NCT03347708|Low back pain|low back pain
136633|NCT03347708|Intervertebral disc degeneration|intervertebral disc degeneration
136634|NCT03347695|modified Cox-Maze|modified cox-maze
136635|NCT03347695|atrial fibrillation|atrial fibrillation
136636|NCT03347695|surgery|surgery
136637|NCT03347682|Amputation, prosthesis,psychometrics, questionnaires|amputation, prosthesis,psychometrics, questionnaires
136638|NCT03347669|Fibromyalgia|fibromyalgia
136639|NCT03347669|Small fiber neuropathy|small fiber neuropathy
136640|NCT03347669|Sudoscan®|sudoscan®
136641|NCT03347656|Mobilization Therapy|mobilization therapy
136642|NCT03347656|Clitical Illness|clitical illness
136643|NCT03347656|Stroke|stroke
136644|NCT03347656|Intensive Care|intensive care
136645|NCT03347656|Functional Mobility|functional mobility
136646|NCT03347656|Quality of Life|quality of life
136647|NCT03347643|Internet game addiction|internet game addiction
136648|NCT03347643|Internet gaming disorder|internet gaming disorder
136649|NCT03347643|transcranial direct current stimulation|transcranial direct current stimulation
136651|NCT03347643|craving|craving
136652|NCT03347643|cue reactivity|cue reactivity
136654|NCT03347630|oesophagus cancer|oesophagus cancer
136655|NCT03347630|Staging|staging
136656|NCT03347591|Fibrinogen|fibrinogen
136657|NCT03347591|Factor II|factor ii
136658|NCT03347591|Factor V|factor v
136659|NCT03347591|Factor V & VIII|factor v & viii
136660|NCT03347591|Factor VII|factor vii
136661|NCT03347591|Factor X|factor x
136662|NCT03347591|Factor XI|factor xi
136663|NCT03347591|Factor XIII|factor xiii
136664|NCT03347591|α2-antiplasmin|α2-antiplasmin
136665|NCT03347591|Plasminogen activator inhibitor 1|plasminogen activator inhibitor 1
136666|NCT03347591|Epidemiology|epidemiology
136667|NCT03347591|Genetics|genetics
136668|NCT03347591|Phenotype|phenotype
136669|NCT03347565|adolescents, healthy controls|adolescents, healthy controls
136670|NCT03347552|treatment engagement|treatment engagement
136671|NCT03347526|Vigabatrin|vigabatrin
136672|NCT03347526|Cosyntropin|cosyntropin
136673|NCT03347513|H-pylori|h-pylori
136674|NCT03347513|iron deficiency anemia|iron deficiency anemia
136675|NCT03347513|Pregnancy|pregnancy
136676|NCT03347513|iron therapy|iron therapy
136677|NCT03347487|Bilateral Habenula|bilateral habenula
136678|NCT03347487|Treatment Resistant Major Depressive Disorder|treatment resistant major depressive disorder
136679|NCT03347474|Bilateral Nucleus Accumbens|bilateral nucleus accumbens
136680|NCT03347474|Methamphetamine Addiction|methamphetamine addiction
136681|NCT03347461|Tympanostomy tube placement|tympanostomy tube placement
136682|NCT03347461|Otiprio|otiprio
136683|NCT03347461|Ciprodex drops|ciprodex drops
136684|NCT03347461|Ear drops|ear drops
136685|NCT03347461|Middle ear|middle ear
136686|NCT03347448|Psychology|psychology
136687|NCT03347448|Skin|skin
136688|NCT03347435|clopidogrel|clopidogrel
136689|NCT03347435|pharmacogenetics|pharmacogenetics
136690|NCT03347435|antiplatelet therapy|antiplatelet therapy
136691|NCT03347435|acute coronary syndromes|acute coronary syndromes
136692|NCT03347409|ERAS, Fast-track surgery, gynecology|eras, fast-track surgery, gynecology
136693|NCT03347370|subcutaneous interferon beta therapy multiple sclerosis (MS)|subcutaneous interferon beta therapy multiple sclerosis (ms)
136694|NCT03347370|injection site reactions (ISR)|injection site reactions (isr)
136695|NCT03347370|flu-like symptoms (FLS)|flu-like symptoms (fls)
136696|NCT03347370|non-interventional study (NIS)|non-interventional study (nis)
136697|NCT03347370|SC Peginterferon beta-1a|sc peginterferon beta-1a
136698|NCT03347370|SC interferon beta-1a|sc interferon beta-1a
136699|NCT03347370|SC interferon beta-1b|sc interferon beta-1b
136700|NCT03347370|Plegridy®|plegridy®
136701|NCT03347370|Betaferon®|betaferon®
136702|NCT03347370|Extavia®|extavia®
136703|NCT03347370|Rebif®|rebif®
136704|NCT03347344|Spinocerebellar ataxia-SCA2|spinocerebellar ataxia-sca2
136705|NCT03347344|SARA (Scale for the Assessment and Rating of Ataxia) score|sara (scale for the assessment and rating of ataxia) score
136706|NCT03347344|Riluzole (Rilutek)|riluzole (rilutek)
136707|NCT03347331|PET imaging- Serotonin-Radiotracer|pet imaging- serotonin-radiotracer
136708|NCT03347305|Energy expenditure|energy expenditure
136709|NCT03347305|Peritoneal dialysis|peritoneal dialysis
136710|NCT03347292|Liver cell carcinoma|liver cell carcinoma
136711|NCT03347292|Liver cancer|liver cancer
136712|NCT03347279|Asthma, Uncontrolled Asthma, Severe Uncontrolled Asthma|asthma, uncontrolled asthma, severe uncontrolled asthma
136713|NCT03347227|AF ablation|af ablation
136714|NCT03347227|Pulmonary vein isolation|pulmonary vein isolation
136715|NCT03347227|Atrial scar ablation|atrial scar ablation
136717|NCT03347201|Cardiopulmonary bypass, Heparin, Protamine|cardiopulmonary bypass, heparin, protamine
136718|NCT03347188|posttraumatic headache (PTH)|posttraumatic headache (pth)
136719|NCT03347175|Respiration, Artificial|respiration, artificial
136720|NCT03347175|Advanced Cardiac Life Support|advanced cardiac life support
136721|NCT03347175|Heart Massage|heart massage
136722|NCT03347175|Emergency Service, Hospital|emergency service, hospital
136723|NCT03347162|Cancer|cancer
136724|NCT03347162|Muscle mass|muscle mass
136725|NCT03347162|Muscle strength|muscle strength
136726|NCT03347162|Complications|complications
136727|NCT03347162|Patient reported outcomes|patient reported outcomes
136728|NCT03347162|PRO|pro
136729|NCT03347162|Physical function|physical function
136730|NCT03347149|Alarms|alarms
136731|NCT03347149|Alarm Fatigue|alarm fatigue
136732|NCT03347149|Alarm Nuisance|alarm nuisance
136733|NCT03347149|Alarm Reduction|alarm reduction
136734|NCT03347149|Patient Monitoring|patient monitoring
136735|NCT03347149|Intensive Care|intensive care
136736|NCT03347123|Epacadostat|epacadostat
136737|NCT03347123|nivolumab|nivolumab
136738|NCT03347123|ipilimumab|ipilimumab
174450|NCT03104517|Bladder|bladder
136739|NCT03347123|lirilumab|lirilumab
136740|NCT03347123|solid tumor|solid tumor
136741|NCT03347123|melanoma|melanoma
136742|NCT03347123|non-small cell lung cancer (NSCLC)|non-small cell lung cancer (nsclc)
136743|NCT03347123|squamous cell carcinoma of the head and neck (SCCHN)|squamous cell carcinoma of the head and neck (scchn)
136744|NCT03347123|IDO inhibitor|ido inhibitor
136747|NCT03347110|PsA|psa
136748|NCT03347097|glioma|glioma
136749|NCT03347097|TIL|til
136750|NCT03347097|immunotherapy|immunotherapy
136751|NCT03347084|DBS|dbs
136752|NCT03347084|brain imaging|brain imaging
136753|NCT03347084|Memory|memory
136754|NCT03347084|fMRI|fmri
136755|NCT03347071|prevention|prevention
136756|NCT03347071|collegiate athletes|collegiate athletes
136757|NCT03347071|yoga|yoga
136759|NCT03347045|cystectomy|cystectomy
136760|NCT03347045|nutrition|nutrition
136761|NCT03347045|physiotherapy|physiotherapy
136762|NCT03347045|prehabilitation|prehabilitation
136763|NCT03347045|enhanced recovery after surgery|enhanced recovery after surgery
136764|NCT03347019|bankart repair|bankart repair
136765|NCT03347019|accelerated rehabilitation|accelerated rehabilitation
136766|NCT03347019|shoulder|shoulder
136767|NCT03346993|Bupivacaine|bupivacaine
136768|NCT03346993|Brachial Plexus Block|brachial plexus block
136769|NCT03346993|Ultrasound|ultrasound
136770|NCT03346980|Spigelman|spigelman
136771|NCT03346967|AD mesenchymal stem cells;sexual hormone deficiency|ad mesenchymal stem cells;sexual hormone deficiency
136772|NCT03346954|: Cushing's disease, [11C]-Methionine PET/MRI, Sensitivity|: cushing's disease, [11c]-methionine pet/mri, sensitivity
136773|NCT03346915|HPV vaccinaton|hpv vaccinaton
136774|NCT03346915|Cervical cancer screening|cervical cancer screening
136775|NCT03346915|Web-based mobile health education|web-based mobile health education
136776|NCT03346915|brief negotiated interview (BNI|brief negotiated interview (bni
136777|NCT03346889|vestibular evoked myogenic potentials|vestibular evoked myogenic potentials
136778|NCT03346889|head impulse testing|head impulse testing
136779|NCT03346889|quality of life|quality of life
136780|NCT03346876|Pectus excavatum, heart rate variability|pectus excavatum, heart rate variability
136781|NCT03346863|Electrical Cardioversion|electrical cardioversion
136782|NCT03346824|Levosimendan|levosimendan
136783|NCT03346824|Veno-arterial ECMO|veno-arterial ecmo
136784|NCT03346824|Weaning|weaning
136785|NCT03346798|External eating|external eating
136786|NCT03346798|Technology|technology
136787|NCT03346798|Photography|photography
136788|NCT03346798|Social media|social media
136789|NCT03346785|External eating|external eating
136790|NCT03346785|Technology|technology
136791|NCT03346785|Photography|photography
136792|NCT03346785|Social media|social media
136793|NCT03346759|tampon|tampon
136794|NCT03346759|menstruation|menstruation
136795|NCT03346759|menstrual period|menstrual period
136796|NCT03346746|cognition|cognition
136797|NCT03346746|glycaemic|glycaemic
136798|NCT03346746|mood|mood
136799|NCT03346746|diet|diet
136800|NCT03346733|psyllium|psyllium
136801|NCT03346733|viscous fibre|viscous fibre
136802|NCT03346720|Data Sharing|data sharing
136803|NCT03346655|Treatment|treatment
136804|NCT03346642|Relapsed/Refractory|relapsed/refractory
136805|NCT03346642|primary mediastinal large B-cell lymphoma|primary mediastinal large b-cell lymphoma
136806|NCT03346642|PD-1 antibody|pd-1 antibody
136807|NCT03346642|Decitabine|decitabine
136808|NCT03346642|GVD chemotherapy|gvd chemotherapy
136809|NCT03346564|Head and neck cancer|head and neck cancer
136810|NCT03346564|Ritual training|ritual training
136811|NCT03346564|disfigurement|disfigurement
136812|NCT03346564|body image|body image
136813|NCT03346551|Postnatal depression|postnatal depression
136814|NCT03346551|Attachment|attachment
136815|NCT03346551|Self-defining memories|self-defining memories
136816|NCT03346525|echocardiography|echocardiography
136817|NCT03346525|penicillin prophylaxis|penicillin prophylaxis
136818|NCT03346525|intramuscular benzathine penicillin G|intramuscular benzathine penicillin g
136819|NCT03346525|benzathine penicillin G|benzathine penicillin g
136820|NCT03346525|low-resource setting|low-resource setting
136821|NCT03346499|HIV|hiv
136822|NCT03346486|Diet|diet
136823|NCT03346486|Metabolites|metabolites
136824|NCT03346486|Cognitive function|cognitive function
136825|NCT03346486|Physiology|physiology
136826|NCT03346486|LDL|ldl
136827|NCT03346486|Diet Habit|diet habit
136828|NCT03346486|Diet Modification|diet modification
136829|NCT03346434|Eczema|eczema
136830|NCT03346408|Analgesics|analgesics
136831|NCT03346395|Adjustment disorders|adjustment disorders
136832|NCT03346395|Anxiety disorders|anxiety disorders
136833|NCT03346395|Depression|depression
136834|NCT03346395|Mental disorders|mental disorders
136835|NCT03346395|Interventional study|interventional study
136836|NCT03346395|Primary health care|primary health care
136837|NCT03346395|Problem solving|problem solving
136838|NCT03346395|Randomized controlled trial|randomized controlled trial
136839|NCT03346395|Return to work|return to work
136840|NCT03346395|Sick leave|sick leave
136841|NCT03346382|Epilepsy|epilepsy
136842|NCT03346382|Emergency medical services|emergency medical services
136843|NCT03346369|Nephrolithiasis|nephrolithiasis
136844|NCT03346369|Urolithiasis|urolithiasis
136845|NCT03346369|Secondary Hyperoxaluria|secondary hyperoxaluria
136846|NCT03346369|Hyperoxaluria|hyperoxaluria
136847|NCT03346369|Lanthanum Carbonate|lanthanum carbonate
136851|NCT03346317|Asherman syndrome|asherman syndrome
136852|NCT03346317|hysteroscopy|hysteroscopy
136853|NCT03346317|Uterine stent|uterine stent
136854|NCT03346317|Estrogen|estrogen
136855|NCT03346317|Amnion|amnion
136856|NCT03346317|Hysteroscopic Adhesiolysis|hysteroscopic adhesiolysis
136857|NCT03346304|Autofluorescence Broncoscopy (AFB)|autofluorescence broncoscopy (afb)
136858|NCT03346304|Photodynamic Therapy (PDT)|photodynamic therapy (pdt)
136859|NCT03346304|High Grade Lesions (HGLs)|high grade lesions (hgls)
136860|NCT03346304|lung cancer|lung cancer
136861|NCT03346304|photosensitiser|photosensitiser
136862|NCT03346304|Fotolon|fotolon
136863|NCT03346278|Cardiac Rehabilitation|cardiac rehabilitation
136864|NCT03346278|Text Messaging|text messaging
136865|NCT03346265|progressive modular rebalancing|progressive modular rebalancing
136866|NCT03346265|PMR|pmr
136867|NCT03346265|visual sensory cues|visual sensory cues
136868|NCT03346265|SC|sc
136869|NCT03346265|Parkinson Disease|parkinson disease
136870|NCT03346265|Movement Disorders|movement disorders
136871|NCT03346265|Parkinson rehabilitation|parkinson rehabilitation
136872|NCT03346265|neurocognitive method|neurocognitive method
136873|NCT03346265|motor performance|motor performance
136874|NCT03346265|improving gait|improving gait
136875|NCT03346265|physiotherapy|physiotherapy
136876|NCT03346265|3D motion analysis system|3d motion analysis system
136877|NCT03346265|improvements|improvements
136878|NCT03346226|Delirium Dexmedetomidine elderly|delirium dexmedetomidine elderly
136879|NCT03346213|Cardiopulmonary exercise testing|cardiopulmonary exercise testing
136880|NCT03346213|Intravenous iron|intravenous iron
136881|NCT03346213|Total haemoglobin mass|total haemoglobin mass
136882|NCT03346148|Food Allergy, Restaurant staff|food allergy, restaurant staff
136883|NCT03346109|Nasopharyngeal Carcinoma|nasopharyngeal carcinoma
136884|NCT03346109|medial group retropharyngeal node|medial group retropharyngeal node
136885|NCT03346096|TEAM (Thiotepa, Etoposide, Cytosar, Melphalan )|team (thiotepa, etoposide, cytosar, melphalan )
136886|NCT03346096|autologous stem-cell transplantation (ASCT)|autologous stem-cell transplantation (asct)
136887|NCT03346096|malignant lymphoma|malignant lymphoma
136888|NCT03346057|arrhythmia, bradycardia, neuromuscular blocking agents, surgery, tachycardia|arrhythmia, bradycardia, neuromuscular blocking agents, surgery, tachycardia
136889|NCT03346031|music therapy, pain, oxidative stress parameters|music therapy, pain, oxidative stress parameters
136890|NCT03345992|Macrolides|macrolides
136891|NCT03345979|Alkermes|alkermes
136892|NCT03345979|schizophrenia|schizophrenia
136893|NCT03345979|aripiprazole lauroxil|aripiprazole lauroxil
136894|NCT03345979|ARISTADA|aristada
136895|NCT03345979|ARISTADA INITIO|aristada initio
136896|NCT03345940|Multiple Sclerosis|multiple sclerosis
136897|NCT03345927|S-adenosylhomocysteine|s-adenosylhomocysteine
136898|NCT03345927|Endothelial function|endothelial function
136900|NCT03345901|pemafibrate|pemafibrate
136901|NCT03345875|human papillomavirus|human papillomavirus
136902|NCT03345875|cervical cancer|cervical cancer
136903|NCT03345875|self-collection|self-collection
136904|NCT03345862|Social isolation, Loneliness, Health Related Quality of Life|social isolation, loneliness, health related quality of life
136905|NCT03345849|Upadacitinib|upadacitinib
136906|NCT03345849|ABT-494|abt-494
136907|NCT03345849|Efficacy|efficacy
136908|NCT03345849|Safety|safety
136909|NCT03345849|Crohn's Disease|crohn's disease
136914|NCT03345823|Upadacitinib|upadacitinib
136915|NCT03345823|ABT-494|abt-494
136916|NCT03345823|Extension Study|extension study
136917|NCT03345823|Efficacy|efficacy
136918|NCT03345823|Safety|safety
136919|NCT03345823|Crohn's Disease|crohn's disease
136920|NCT03345823|Maintenance Study|maintenance study
136921|NCT03345810|NSCLC|nsclc
136922|NCT03345810|Non small cell lung cancer|non small cell lung cancer
136923|NCT03345797|Paediatric|paediatric
136924|NCT03345758|respiratory failure, circulatory failure|respiratory failure, circulatory failure
136925|NCT03345745|Fetuin-A|fetuin-a
136926|NCT03345745|S100A12|s100a12
136927|NCT03345745|C-Reactive Protein|c-reactive protein
136928|NCT03345745|Chronic Periodontitis|chronic periodontitis
136929|NCT03345706|Hypothermia,ECPR|hypothermia,ecpr
136930|NCT03345693|Rehabilitation|rehabilitation
136931|NCT03345693|MoTrack Therapy|motrack therapy
136932|NCT03345693|Telemedicine|telemedicine
136933|NCT03345693|Computer Vision|computer vision
136934|NCT03345693|Compliance|compliance
136935|NCT03345680|Dental visits|dental visits
136936|NCT03345680|School-based program|school-based program
136937|NCT03345680|Dental screening|dental screening
136938|NCT03345680|Dental Caries|dental caries
136939|NCT03345641|premature birth|premature birth
136940|NCT03345641|mother's post-traumatic reaction|mother's post-traumatic reaction
136941|NCT03345641|mother-infant interactions|mother-infant interactions
136942|NCT03345628|sedation|sedation
136943|NCT03345628|critical care|critical care
136944|NCT03345628|infant|infant
136945|NCT03345628|neurodevelopment|neurodevelopment
136946|NCT03345615|atrial fibrillation|atrial fibrillation
136947|NCT03345615|myocardial infarction|myocardial infarction
136948|NCT03345615|intensive monitoring|intensive monitoring
136949|NCT03345615|oral anticoagulation|oral anticoagulation
136950|NCT03345615|hospitalization|hospitalization
136951|NCT03345589|Ursodeoxycholic Acid|ursodeoxycholic acid
136952|NCT03345576|Electric Stimulation|electric stimulation
136953|NCT03345576|Spinal Cord Injuries|spinal cord injuries
136954|NCT03345576|Muscle Denervation|muscle denervation
136955|NCT03345576|carbohydrate metabolism|carbohydrate metabolism
136956|NCT03345576|Lipids metabolism|lipids metabolism
136957|NCT03345576|Basal Metabolic Rate|basal metabolic rate
136958|NCT03345576|Muscle Proteins|muscle proteins
136959|NCT03345576|Mitochondria, Muscle|mitochondria, muscle
136960|NCT03345576|RNA|rna
136961|NCT03345576|Rehabilitation|rehabilitation
136962|NCT03345563|Prostate Cancer|prostate cancer
136963|NCT03345563|Fatigue|fatigue
136964|NCT03345563|Elderly|elderly
136965|NCT03345563|Supportive Care|supportive care
136966|NCT03345563|Light Exercise|light exercise
136967|NCT03345563|Quality of Life|quality of life
136968|NCT03345537|Inflammatory|inflammatory
136969|NCT03345537|Optic neuritis|optic neuritis
136970|NCT03345537|autoantibodies anti MOG|autoantibodies anti mog
136971|NCT03345524|Obstructive Sleep Apnea|obstructive sleep apnea
136972|NCT03345524|OSA|osa
136973|NCT03345524|Peer-Buddies|peer-buddies
136974|NCT03345524|CPAP|cpap
136975|NCT03345524|CPAP Adherence|cpap adherence
136976|NCT03345511|ultrasound guided caudal block|ultrasound guided caudal block
136977|NCT03345511|anal surgery|anal surgery
136978|NCT03345485|Phase 1 clinical trial|phase 1 clinical trial
136979|NCT03345485|Solid Tumor|solid tumor
136980|NCT03345485|Small Cell Lung Cancer|small cell lung cancer
136981|NCT03345485|Breast Cancer|breast cancer
136982|NCT03345485|Ovarian Cancer|ovarian cancer
136983|NCT03345485|Soft Tissue Sarcoma|soft tissue sarcoma
136984|NCT03345485|Relapsed/Refractory|relapsed/refractory
136985|NCT03345485|Triple Negative|triple negative
136986|NCT03345485|GIST|gist
136987|NCT03345485|Epithelial cancer|epithelial cancer
136988|NCT03345485|Peritoneal cancer|peritoneal cancer
136989|NCT03345485|Fallopian tube cancer|fallopian tube cancer
136990|NCT03345485|Metastatic|metastatic
136991|NCT03345485|Advanced|advanced
136992|NCT03345485|Endometrial|endometrial
136993|NCT03345485|Phase 2 clinical trial|phase 2 clinical trial
136994|NCT03345459|Internet-based treatment|internet-based treatment
136995|NCT03345407|Nemiralisib|nemiralisib
136996|NCT03345407|Dose-Finding|dose-finding
136997|NCT03345407|GSK2269557|gsk2269557
136998|NCT03345407|Acute Moderate or Severe Exacerbation of Chronic Obstructive Pulmonary Disease|acute moderate or severe exacerbation of chronic obstructive pulmonary disease
136999|NCT03345394|crack cocaine|crack cocaine
137000|NCT03345394|contingency management|contingency management
137001|NCT03345394|ambulatory treatment|ambulatory treatment
137002|NCT03345394|Brazil|brazil
137003|NCT03345368|transcranial magnetic stimulation|transcranial magnetic stimulation
137004|NCT03345368|obesity|obesity
137005|NCT03345368|diet|diet
137006|NCT03345303|Bortezomib|bortezomib
137007|NCT03345290|Aging|aging
137008|NCT03345290|Central pressure|central pressure
137009|NCT03345290|FDG PET|fdg pet
137010|NCT03345290|Quantita|quantita
137011|NCT03345277|Termperature|termperature
137012|NCT03345277|Fever|fever
137013|NCT03345277|Vital Signs|vital signs
137014|NCT03345264|Sexual Dysfunction|sexual dysfunction
137015|NCT03345264|Fertility Disorders|fertility disorders
137016|NCT03345264|Cancer|cancer
137017|NCT03345251|ICSI - physical - Manipulation - scratching|icsi - physical - manipulation - scratching
137018|NCT03345238|Dry Needling|dry needling
137019|NCT03345238|Myofascial Pain Syndrome|myofascial pain syndrome
137020|NCT03345238|Neurophysiological effects|neurophysiological effects
137021|NCT03345238|Autonomic Nervous System|autonomic nervous system
137022|NCT03345225|Chemoembolization (TACE)|chemoembolization (tace)
137023|NCT03345225|HCC|hcc
137024|NCT03345225|Liver Cancer|liver cancer
137025|NCT03345199|Multiple Sclerosis, Inspiratory Muscle Training|multiple sclerosis, inspiratory muscle training
137026|NCT03345186|Outcome|outcome
137027|NCT03345186|Gout|gout
137028|NCT03345147|Vitamin A|vitamin a
137029|NCT03345147|Isotopic dilution|isotopic dilution
137030|NCT03345147|dietary assessment|dietary assessment
137031|NCT03345095|Marizomib|marizomib
137032|NCT03345095|Temozolomide|temozolomide
137033|NCT03345095|Glioblastoma|glioblastoma
137034|NCT03345095|Phase III|phase iii
137035|NCT03345069|Premature|premature
137036|NCT03345069|Magnetic resonance imaging (MRI)|magnetic resonance imaging (mri)
137037|NCT03345069|Neurodevelopmental impairment|neurodevelopmental impairment
137038|NCT03345069|Cerebral Palsy|cerebral palsy
137039|NCT03345069|Cognitive Impairment|cognitive impairment
137040|NCT03345069|Diffusion MRI|diffusion mri
137041|NCT03345069|Functional MRI|functional mri
137042|NCT03345069|Infant|infant
137043|NCT03345069|Magnetic resonance spectroscopy|magnetic resonance spectroscopy
137044|NCT03345043|VAL-339851|val-339851
137045|NCT03345043|H7N9 antigen mRNA|h7n9 antigen mrna
137046|NCT03345043|Influenza vaccine|influenza vaccine
137047|NCT03345043|Moderna|moderna
137048|NCT03345030|comet assay|comet assay
137049|NCT03345030|DNA damage|dna damage
137050|NCT03345030|granulosa|granulosa
137051|NCT03345030|IVF outcome|ivf outcome
137052|NCT03345004|Diamyd|diamyd
137053|NCT03345004|Diabetes|diabetes
137054|NCT03345004|Juvenile Diabetes|juvenile diabetes
137055|NCT03345004|Diabetes Type 1|diabetes type 1
137056|NCT03345004|Type 1 Diabetes|type 1 diabetes
137057|NCT03345004|Autoimmune Diabetes|autoimmune diabetes
137058|NCT03345004|Insulin Dependent Diabetes|insulin dependent diabetes
137059|NCT03345004|Type 1 Diabetes Mellitus|type 1 diabetes mellitus
137060|NCT03345004|rhGAD65|rhgad65
137061|NCT03345004|GAD65|gad65
137062|NCT03345004|GAD-Alum|gad-alum
137063|NCT03345004|Diabetes Mellitus|diabetes mellitus
137064|NCT03345004|Diabetes Mellitus Type 1|diabetes mellitus type 1
137065|NCT03345004|Glucose Metabolism Disorders|glucose metabolism disorders
137066|NCT03345004|Metabolic Diseases|metabolic diseases
137067|NCT03345004|Vitamin D|vitamin d
137068|NCT03345004|Vitamins|vitamins
137069|NCT03345004|Micronutrients|micronutrients
137070|NCT03345004|Cholecalciferol|cholecalciferol
137071|NCT03345004|Ergocalciferols|ergocalciferols
137072|NCT03344991|Hypothermia|hypothermia
137073|NCT03344991|Newborn|newborn
137074|NCT03344978|Neonate|neonate
137075|NCT03344978|Premature|premature
137076|NCT03344978|Hypothermia|hypothermia
137077|NCT03344978|Cardboard|cardboard
137078|NCT03344978|Cot|cot
137079|NCT03344965|Metastatic Breast Cancer|metastatic breast cancer
137080|NCT03344965|Invasive Breast Cancer|invasive breast cancer
137081|NCT03344965|Somatic Mutation Breast Cancer (BRCA1)|somatic mutation breast cancer (brca1)
137082|NCT03344965|Somatic Mutation Breast Cancer (BRCA2)|somatic mutation breast cancer (brca2)
137083|NCT03344926|Acceptance and Commitment therapy|acceptance and commitment therapy
137084|NCT03344926|ACT|act
137085|NCT03344926|CBT|cbt
137086|NCT03344926|Smart phone|smart phone
137087|NCT03344926|Internet|internet
137088|NCT03344926|Intervention|intervention
137089|NCT03344900|mHealth|mhealth
137090|NCT03344900|Medication adherence|medication adherence
137091|NCT03344900|Barriers to adherence|barriers to adherence
137092|NCT03344887|anemia|anemia
137093|NCT03344887|donor sex|donor sex
137094|NCT03344887|prospective blinded pragmatic randomized|prospective blinded pragmatic randomized
137095|NCT03344874|heart sounds|heart sounds
137096|NCT03344874|Stethee|stethee
137097|NCT03344874|electronic stethoscope|electronic stethoscope
137098|NCT03344861|lung cancer|lung cancer
137099|NCT03344861|lung carcinoma|lung carcinoma
137100|NCT03344861|lung metastases|lung metastases
137101|NCT03344835|Prostate Cancer|prostate cancer
137102|NCT03344835|Disease Outcome|disease outcome
137103|NCT03344822|68Ga-PSMA PET|68ga-psma pet
137104|NCT03344809|lymphoma|lymphoma
137105|NCT03344809|unclassifiable|unclassifiable
137106|NCT03344809|next|next
137107|NCT03344809|generation|generation
137108|NCT03344809|sequencing|sequencing
137109|NCT03344796|Skin Cancer|skin cancer
137110|NCT03344796|Sunburn, erythema|sunburn, erythema
137111|NCT03344796|UV Exposure, Sunburn|uv exposure, sunburn
137112|NCT03344796|Wearable UV Device|wearable uv device
137113|NCT03344757|prostate cancer|prostate cancer
137114|NCT03344757|localized prostate cancer|localized prostate cancer
137115|NCT03344757|spanish|spanish
137116|NCT03344757|latino|latino
137117|NCT03344757|hispanic|hispanic
137118|NCT03344757|stress management|stress management
137119|NCT03344744|Subarachnoid Haemorrhage|subarachnoid haemorrhage
137120|NCT03344679|Pectoral nerve block|pectoral nerve block
137121|NCT03344679|Adenosine|adenosine
137122|NCT03344679|Magnesium sulphate|magnesium sulphate
137123|NCT03344640|Overuse tendinopathy|overuse tendinopathy
137124|NCT03344640|shoulder|shoulder
137125|NCT03344640|rotator cuff|rotator cuff
137126|NCT03344640|IL-17A-Ab|il-17a-ab
137127|NCT03344640|AIN457X|ain457x
137128|NCT03344614|third-line treatment|third-line treatment
137129|NCT03344614|apatinib|apatinib
137130|NCT03344614|raltitrexed|raltitrexed
137131|NCT03344549|eHealth|ehealth
137132|NCT03344549|Nutrition Therapy|nutrition therapy
137133|NCT03344549|Telehealth|telehealth
137134|NCT03344549|Diabetic Kidney Disease|diabetic kidney disease
137135|NCT03344549|Chronic Kidney Disease|chronic kidney disease
137136|NCT03344536|Debio 1347|debio 1347
137137|NCT03344536|Fulvestrant|fulvestrant
137138|NCT03344536|17-379|17-379
137139|NCT03344510|lidocaine|lidocaine
137140|NCT03344510|vibration|vibration
137141|NCT03344510|anesthesia|anesthesia
137142|NCT03344510|injection|injection
137143|NCT03344510|pain|pain
137144|NCT03344510|discomfort|discomfort
137145|NCT03344510|dermatology|dermatology
137146|NCT03344510|dermatologic surgery|dermatologic surgery
137147|NCT03344510|local|local
137148|NCT03344510|device|device
137149|NCT03344471|preterm delivery|preterm delivery
137150|NCT03344471|PTSD|ptsd
137151|NCT03344471|prematurity|prematurity
137152|NCT03344471|birth|birth
137153|NCT03344471|personality|personality
137154|NCT03344458|Human Growth Hormone|human growth hormone
137155|NCT03344458|hGH|hgh
137156|NCT03344458|GHD|ghd
137157|NCT03344458|rhGH|rhgh
137158|NCT03344458|Pediatric Growth Hormone Deficiency|pediatric growth hormone deficiency
137159|NCT03344458|Long Acting Growth Hormone|long acting growth hormone
137160|NCT03344458|Somatropin|somatropin
137161|NCT03344458|Prodrug|prodrug
137162|NCT03344458|Growth Failure|growth failure
137163|NCT03344458|Growth Hormone Replacement Therapy|growth hormone replacement therapy
137164|NCT03344458|Sustained Release Growth Hormone|sustained release growth hormone
137165|NCT03344458|Growth Hormone Deficiency|growth hormone deficiency
137166|NCT03344458|TransCon GH|transcon gh
137167|NCT03344419|cocaine|cocaine
137168|NCT03344419|mindfulness based relapse prevention|mindfulness based relapse prevention
137169|NCT03344419|motivational enhancement therapy|motivational enhancement therapy
137170|NCT03344406|Asthma|asthma
137171|NCT03344406|Telephone interview|telephone interview
137172|NCT03344406|Cross-sectional|cross-sectional
137173|NCT03344406|Qualitative research|qualitative research
137174|NCT03344406|E-RS: COPD|e-rs: copd
137175|NCT03344380|Gene polymorphism|gene polymorphism
137176|NCT03344380|acute kidney injury|acute kidney injury
137177|NCT03344380|liver transplantation|liver transplantation
137178|NCT03344367|Non Hodgkin Lymphoma|non hodgkin lymphoma
137179|NCT03344367|CD19-targeted chimeric antigen receptor|cd19-targeted chimeric antigen receptor
137180|NCT03344367|JWCAR029|jwcar029
137181|NCT03344341|T2DM|t2dm
137182|NCT03344328|Chemotherapy|chemotherapy
137183|NCT03344328|Bortezomib|bortezomib
137184|NCT03344328|Multiple myeloma|multiple myeloma
137185|NCT03344315|Gingival recession|gingival recession
137186|NCT03344315|Collagen matrix|collagen matrix
137187|NCT03344315|Connective tissue graft|connective tissue graft
137188|NCT03344315|Coronally advanced flap|coronally advanced flap
137189|NCT03344315|Root coverage|root coverage
137190|NCT03344315|keratinized tissue|keratinized tissue
137191|NCT03344315|Periodontal disease|periodontal disease
137192|NCT03344289|Linked-color-imaging|linked-color-imaging
137193|NCT03344289|Advanced Imaging Techniques|advanced imaging techniques
137194|NCT03344276|carotid stenosis|carotid stenosis
137195|NCT03344276|neurocognition|neurocognition
137196|NCT03344276|carotid stenting|carotid stenting
137197|NCT03344276|circle of willis|circle of willis
137198|NCT03344250|Adoptive Cell Therapy|adoptive cell therapy
137199|NCT03344250|Armed Activated T-cells|armed activated t-cells
137200|NCT03344250|Bispecific Antibodies|bispecific antibodies
137201|NCT03344250|Immunotherapy|immunotherapy
137202|NCT03344198|Cardiovascular Disease|cardiovascular disease
137203|NCT03344198|Mediterranean Diet|mediterranean diet
137204|NCT03344198|Exercise Training|exercise training
137205|NCT03344198|Blood Pressure|blood pressure
137206|NCT03344185|glycaemic index|glycaemic index
137207|NCT03344185|mood|mood
137208|NCT03344185|glucose|glucose
137209|NCT03344185|diet|diet
137210|NCT03344159|Mineralocorticoid receptor antagonist|mineralocorticoid receptor antagonist
137211|NCT03344159|Brain natriuretic peptide (BNP)|brain natriuretic peptide (bnp)
137212|NCT03344159|Sympathetic Nervous System|sympathetic nervous system
137213|NCT03344159|Positron Emissions Tomography|positron emissions tomography
137214|NCT03344146|ischemic stroke, direct oral anticoagulants, adherence, electronic monitoring, adherence-improving intervention, polypharmacy|ischemic stroke, direct oral anticoagulants, adherence, electronic monitoring, adherence-improving intervention, polypharmacy
137215|NCT03344133|Obesity|obesity
137216|NCT03344133|Exercise|exercise
137217|NCT03344133|CVD risk factors|cvd risk factors
137218|NCT03344133|Appetite Regulation|appetite regulation
137219|NCT03344133|Gut Microbiota|gut microbiota
137220|NCT03344120|Symptoms and Signs|symptoms and signs
137221|NCT03344120|Pain|pain
137222|NCT03344120|Ureteral Calculi|ureteral calculi
137223|NCT03344120|Ureteroscopy|ureteroscopy
137224|NCT03344120|Ureteral Stents|ureteral stents
137225|NCT03344107|Symptoms and Signs|symptoms and signs
137226|NCT03344107|Pain|pain
137227|NCT03344107|Renal Calculi|renal calculi
137228|NCT03344107|Ureteral Stent|ureteral stent
137229|NCT03344107|Ureteroscopy|ureteroscopy
137230|NCT03344081|attention|attention
137231|NCT03344081|interoception|interoception
137232|NCT03344081|meditation|meditation
137233|NCT03344081|mind wandering|mind wandering
137234|NCT03344068|nasopharyngeal carcinoma|nasopharyngeal carcinoma
137235|NCT03344068|nutritional support|nutritional support
137236|NCT03344068|early and whole course|early and whole course
137237|NCT03344068|efficacy and safety|efficacy and safety
137238|NCT03344055|Adenoma Detection Rate|adenoma detection rate
137239|NCT03344055|Endocuff|endocuff
137240|NCT03344055|Colonoscopy|colonoscopy
137241|NCT03344029|Influenza|influenza
137242|NCT03344029|Flu|flu
137243|NCT03343964|aEEG, cEEG|aeeg, ceeg
137244|NCT03343951|Physical Therapists|physical therapists
137245|NCT03343951|Diagnosis|diagnosis
137246|NCT03343951|Clinical Competence|clinical competence
137247|NCT03343951|Interprofessional Relations|interprofessional relations
137248|NCT03343951|Cost Analysis|cost analysis
137249|NCT03343938|Group embryo culture|group embryo culture
137250|NCT03343938|Low oxygen tension|low oxygen tension
137251|NCT03343938|Closed station|closed station
137252|NCT03343938|Embryo handling|embryo handling
137253|NCT03343925|Reinfection|reinfection
137254|NCT03343912|Estriol|estriol
137255|NCT03343912|Trimegestone|trimegestone
137256|NCT03343912|Vaginal Ring|vaginal ring
137257|NCT03343886|Health Status|health status
137258|NCT03343886|Well-being|well-being
137259|NCT03343886|Mental Health|mental health
137260|NCT03343886|Risk Factors|risk factors
137261|NCT03343886|Aging|aging
137262|NCT03343873|anesthetics; fMRI; EEG; functional connectivity|anesthetics; fmri; eeg; functional connectivity
137263|NCT03343834|Allogenic cell stem transplant (HSCT)|allogenic cell stem transplant (hsct)
137264|NCT03343834|EBV-induced lymphoproliferation|ebv-induced lymphoproliferation
137265|NCT03343834|Epigenetic|epigenetic
137266|NCT03343808|Cooled radiofrequency|cooled radiofrequency
137267|NCT03343808|chronic knee pain|chronic knee pain
137268|NCT03343808|knee arthroplasty|knee arthroplasty
137269|NCT03343808|genicular nerve|genicular nerve
137270|NCT03343782|Diabetes|diabetes
137271|NCT03343782|BM mesenchymal stem cell|bm mesenchymal stem cell
137272|NCT03343717|Pneumonia, Ventilator-Associated|pneumonia, ventilator-associated
137273|NCT03343717|Mechanical ventilation|mechanical ventilation
137274|NCT03343717|Physical therapy|physical therapy
137275|NCT03343665|Nivolumab|nivolumab
137276|NCT03343652|Hodgkin's Lymphoma|hodgkin's lymphoma
137277|NCT03343652|Nivolumab|nivolumab
137278|NCT03343652|Bendamustine Hydrochloride|bendamustine hydrochloride
137279|NCT03343626|Drug therapy|drug therapy
137280|NCT03343613|IDO-1 Inhibitor|ido-1 inhibitor
137281|NCT03343613|IDO1 Inhibitor|ido1 inhibitor
137282|NCT03343613|IDO Inhibitor|ido inhibitor
137283|NCT03343574|Parkinson's Disease|parkinson's disease
137284|NCT03343574|Neurogenic orthostatic hypotension|neurogenic orthostatic hypotension
137285|NCT03343574|Orthostatic intolerance|orthostatic intolerance
137286|NCT03343574|Exercise|exercise
137287|NCT03343574|Abdominal binder|abdominal binder
137288|NCT03343574|Autonomic dysfunction|autonomic dysfunction
137289|NCT03343574|Dizziness|dizziness
137290|NCT03343574|Physical Therapy|physical therapy
137291|NCT03343574|Blood pressure|blood pressure
137292|NCT03343574|Heart rate|heart rate
137293|NCT03343574|Autonomic function testing|autonomic function testing
137294|NCT03343574|Neurology|neurology
137295|NCT03343574|Falls risk|falls risk
137296|NCT03343574|Autonomic Nervous System|autonomic nervous system
137297|NCT03343574|Autonomic reflex screening|autonomic reflex screening
137298|NCT03343574|Cerebral blood flow|cerebral blood flow
137299|NCT03343574|Cerebral perfusion|cerebral perfusion
137300|NCT03343574|Activities of Daily Living|activities of daily living
137301|NCT03343535|portable ex-vivo lung perfusion|portable ex-vivo lung perfusion
137302|NCT03343535|breathing lung transplant|breathing lung transplant
137303|NCT03343535|portable OCS Lung System|portable ocs lung system
137304|NCT03343522|Vascular function|vascular function
137305|NCT03343522|Physical training|physical training
137306|NCT03343522|Laser Speckle Contrast Imaging|laser speckle contrast imaging
137307|NCT03343509|Hemorrhoidectomy|hemorrhoidectomy
137308|NCT03343509|Metronidazole|metronidazole
137309|NCT03343509|Postoperative analgesia|postoperative analgesia
137310|NCT03343496|Awake fiberoptic intubation|awake fiberoptic intubation
137311|NCT03343483|Volunteerism|volunteerism
137312|NCT03343483|Aged|aged
137313|NCT03343483|Loneliness|loneliness
137314|NCT03343483|Quality of Life|quality of life
137315|NCT03343470|Cushing Syndrome|cushing syndrome
137316|NCT03343470|Adrenal Insufficiency|adrenal insufficiency
137317|NCT03343470|Peripheral blood mononuclear cells|peripheral blood mononuclear cells
137318|NCT03343470|Melatonin|melatonin
137319|NCT03343470|Cortisol|cortisol
137320|NCT03343470|Immunological profile|immunological profile
137321|NCT03343470|Cushing Disease|cushing disease
137322|NCT03343457|Anxiety|anxiety
137323|NCT03343457|Chronic Pain|chronic pain
137324|NCT03343431|Hepatitis B|hepatitis b
137325|NCT03343431|Hepatitis B eAg|hepatitis b eag
137326|NCT03343431|Pregnancy|pregnancy
137327|NCT03343418|Bleeding|bleeding
137328|NCT03343418|Valve Cardiac Surgery|valve cardiac surgery
137329|NCT03343418|Desmopressin|desmopressin
137330|NCT03343405|Mind/Body|mind/body
137331|NCT03343392|Hydrogen Peroxide|hydrogen peroxide
137332|NCT03343392|Analgesics|analgesics
137333|NCT03343392|Tooth Bleaching|tooth bleaching
137334|NCT03343379|Abdominal muscles|abdominal muscles
137335|NCT03343379|Back muscles|back muscles
137336|NCT03343379|Core stability|core stability
137337|NCT03343379|Field test|field test
137338|NCT03343379|Muscle strength dynamometer|muscle strength dynamometer
137339|NCT03343379|Lower extremity injury|lower extremity injury
137340|NCT03343379|Risk assessment|risk assessment
137341|NCT03343379|Prospective studies|prospective studies
137342|NCT03343366|fasting plasma glucose|fasting plasma glucose
137343|NCT03343366|fasting plasma insulin|fasting plasma insulin
137344|NCT03343366|HOMA-IR insulin resistance|homa-ir insulin resistance
137345|NCT03343366|clinical attachment loss|clinical attachment loss
137346|NCT03343353|burn injury, phototherapy, wound healing|burn injury, phototherapy, wound healing
137351|NCT03343275|Stent, incrustation, pH Control|stent, incrustation, ph control
137352|NCT03343236|Head and neck cancer|head and neck cancer
137353|NCT03343236|Observational study|observational study
137354|NCT03343236|Three tertiary hospitals|three tertiary hospitals
137355|NCT03343236|Long-term follow-up|long-term follow-up
137356|NCT03343236|Survival|survival
137357|NCT03343236|Immune response|immune response
137358|NCT03343236|Metabolomics|metabolomics
137360|NCT03343197|IDH1|idh1
137361|NCT03343197|AG-120|ag-120
137362|NCT03343197|AG-881|ag-881
137363|NCT03343184|dentin bonding agents|dentin bonding agents
137364|NCT03343184|tooth sensitivity|tooth sensitivity
137365|NCT03343184|composite resin restoration|composite resin restoration
137366|NCT03343171|total hip arthroplasty|total hip arthroplasty
137367|NCT03343145|Neutropenia|neutropenia
137368|NCT03343106|Acceptance and Commitment Therapy|acceptance and commitment therapy
137369|NCT03343106|Exposure and Response Prevention|exposure and response prevention
137370|NCT03343106|Psychotherapy|psychotherapy
137371|NCT03343106|Obsessive-Compulsive Disorder|obsessive-compulsive disorder
137372|NCT03343106|Treatment Acceptability|treatment acceptability
137373|NCT03343106|Treatment Adherence|treatment adherence
137374|NCT03343093|Erectile Dysfunction|erectile dysfunction
137375|NCT03343080|Cardiac Surgery|cardiac surgery
137380|NCT03343054|Phase 1|phase 1
137381|NCT03343054|talazoparib|talazoparib
137382|NCT03343054|PF-06944076|pf-06944076
137383|NCT03343054|MDV3800|mdv3800
137384|NCT03343054|BMN673|bmn673
137385|NCT03343054|PARP inhibitor|parp inhibitor
137386|NCT03343054|Japanese|japanese
137387|NCT03343054|solid tumors|solid tumors
137388|NCT03343054|breast cancer|breast cancer
137389|NCT03343054|C3441030|c3441030
137390|NCT03343028|veterans|veterans
137391|NCT03343028|post traumatic stress disorder|post traumatic stress disorder
137392|NCT03343028|depression|depression
137393|NCT03343015|TMD, centric relation, complete dentures|tmd, centric relation, complete dentures
137394|NCT03342989|delirium|delirium
137395|NCT03342989|speed of processing|speed of processing
137396|NCT03342989|cognitive decline|cognitive decline
137397|NCT03342976|Frailty|frailty
137398|NCT03342976|Physical impairment|physical impairment
137399|NCT03342976|Cognitive decline|cognitive decline
137400|NCT03342976|ICT|ict
137401|NCT03342937|pembrolizumab|pembrolizumab
137402|NCT03342937|XELOX|xelox
137403|NCT03342937|gastric cancer|gastric cancer
137404|NCT03342924|cognitive control|cognitive control
137405|NCT03342924|physical fitness|physical fitness
137406|NCT03342924|minority|minority
137407|NCT03342898|Drug Therapy|drug therapy
137408|NCT03342885|Low Back Pain|low back pain
137409|NCT03342885|Sleep ergonomics|sleep ergonomics
137410|NCT03342872|Adolescents|adolescents
137411|NCT03342872|Substance Use Disorders|substance use disorders
137412|NCT03342859|Uterine fibroids|uterine fibroids
137413|NCT03342859|Bleeding reduction|bleeding reduction
137414|NCT03342859|Vilaprisan|vilaprisan
137415|NCT03342859|Mode of action|mode of action
137416|NCT03342859|Hysterectomy|hysterectomy
137417|NCT03342859|Myomectomy|myomectomy
137418|NCT03342859|Pharmacodynamic|pharmacodynamic
137419|NCT03342807|Hypertriglyceridemia-induced acute pancreatitis|hypertriglyceridemia-induced acute pancreatitis
137420|NCT03342807|insulin|insulin
137421|NCT03342807|triglyceride|triglyceride
137422|NCT03342807|treatment|treatment
137423|NCT03342781|bronchiolitis|bronchiolitis
137424|NCT03342781|diffuser mask|diffuser mask
137425|NCT03342781|high-flow nasal oxygen|high-flow nasal oxygen
137426|NCT03342781|pediatric intensive-care unit|pediatric intensive-care unit
137427|NCT03342716|Pancreatitis|pancreatitis
137428|NCT03342716|Multiple Organ Dysfunction Syndrome|multiple organ dysfunction syndrome
137429|NCT03342690|Selara|selara
137430|NCT03342690|Chronic Heart Failure|chronic heart failure
137431|NCT03342677|Cirrhosis|cirrhosis
137432|NCT03342677|HCC|hcc
137433|NCT03342677|Primovist|primovist
137434|NCT03342664|ICH|ich
137435|NCT03342651|Vitamin D|vitamin d
137436|NCT03342651|general anesthesia|general anesthesia
137437|NCT03342651|respiratory complications|respiratory complications
137438|NCT03342638|Autologous Stem Cell Transplantation|autologous stem cell transplantation
137439|NCT03342638|Stem Cells|stem cells
137440|NCT03342638|Hematopoietic Stem Cell Transplantation|hematopoietic stem cell transplantation
137441|NCT03342625|High intensity focused ultrasound|high intensity focused ultrasound
137442|NCT03342599|Alpha Lipoic Acid|alpha lipoic acid
137443|NCT03342586|resting state functional Magnetic Resonance Imaging|resting state functional magnetic resonance imaging
137444|NCT03342586|rsfMRI|rsfmri
175354|NCT03098758|CEA|cea
137445|NCT03342586|17-403|17-403
137446|NCT03342560|Liver Fibrosis|liver fibrosis
137447|NCT03342560|Ultrasound Elastography|ultrasound elastography
137448|NCT03342560|Shear wave speed|shear wave speed
137449|NCT03342560|Stiffness|stiffness
137450|NCT03342560|Liver Biopsy|liver biopsy
137451|NCT03342547|Norovirus|norovirus
137452|NCT03342521|myocardial infarction|myocardial infarction
137453|NCT03342521|optical coherence tomography|optical coherence tomography
137454|NCT03342521|intracoronary thrombus|intracoronary thrombus
137455|NCT03342521|VerifyNow|verifynow
137456|NCT03342508|Maternal outcomes|maternal outcomes
137457|NCT03342508|Neonatal Outcomes|neonatal outcomes
137458|NCT03342495|transition, young adults, transfer|transition, young adults, transfer
137459|NCT03342482|MSG|msg
137460|NCT03342482|Gulf War Syndrome|gulf war syndrome
137461|NCT03342482|Diet|diet
137462|NCT03342482|Glutamate|glutamate
137463|NCT03342469|ADHD|adhd
137464|NCT03342469|Food Additives|food additives
137465|NCT03342469|Artificial Food Coloring|artificial food coloring
137466|NCT03342469|Diet|diet
137467|NCT03342456|Helicobacter pylori eradication|helicobacter pylori eradication
137468|NCT03342456|Duodenal Ulcer|duodenal ulcer
137469|NCT03342456|Ilaprazole/Doxycycline-based Bismuth-containing quadruple therapy|ilaprazole/doxycycline-based bismuth-containing quadruple therapy
137470|NCT03342443|memantine|memantine
137471|NCT03342443|radiotherapy-related cognitive impairment|radiotherapy-related cognitive impairment
137472|NCT03342417|breast cancer|breast cancer
137473|NCT03342417|ovarian cancer|ovarian cancer
137474|NCT03342417|gastric cancer|gastric cancer
137475|NCT03342404|(β)-Thalassemia|(β)-thalassemia
137476|NCT03342404|Beta-Thalassemia|beta-thalassemia
137477|NCT03342404|Phase 2|phase 2
137478|NCT03342404|Luspatercept|luspatercept
137479|NCT03342404|ACE-536|ace-536
137480|NCT03342404|Safety|safety
137481|NCT03342404|Efficacy|efficacy
137482|NCT03342404|Placebo|placebo
137483|NCT03342404|Red Blood Cell Transfusions|red blood cell transfusions
137484|NCT03342404|Erythrocyte transfusion|erythrocyte transfusion
137485|NCT03342404|Hb increase|hb increase
137486|NCT03342404|NTDT|ntdt
137487|NCT03342378|HPV|hpv
137488|NCT03342378|HPV-positive|hpv-positive
137489|NCT03342378|Oropharynx Cancer|oropharynx cancer
137490|NCT03342352|Squamous cell carcinoma of the head and neck|squamous cell carcinoma of the head and neck
137491|NCT03342352|programmed cell death protein 1 (PD-1) antibody|programmed cell death protein 1 (pd-1) antibody
137492|NCT03342352|indoleamine 2,3-dioxygenase (IDO) inhibitor|indoleamine 2,3-dioxygenase (ido) inhibitor
137493|NCT03342339|influence of emotions|influence of emotions
137494|NCT03342339|positif emotional induction|positif emotional induction
137495|NCT03342339|decision making|decision making
137496|NCT03342339|Iowa Gambling Task|iowa gambling task
137497|NCT03342326|Lexical priming|lexical priming
137498|NCT03342326|Healthy Aging|healthy aging
137499|NCT03342300|soft tissue sarcoma|soft tissue sarcoma
137500|NCT03342300|pegylated liposomal doxorubicin|pegylated liposomal doxorubicin
137501|NCT03342300|pirarubicin|pirarubicin
137502|NCT03342300|toxicity for heart|toxicity for heart
137503|NCT03342300|cumulative dose|cumulative dose
137504|NCT03342287|gut microbiome|gut microbiome
137505|NCT03342287|anxiety|anxiety
137506|NCT03342287|depression|depression
137507|NCT03342287|cognition|cognition
137508|NCT03342235|Excimer Laser Surgery|excimer laser surgery
137509|NCT03342235|Photorefractive Keratectomy|photorefractive keratectomy
137510|NCT03342235|Anisometropic Amblyopia|anisometropic amblyopia
137511|NCT03342235|Visual Acuity|visual acuity
137512|NCT03342235|Refractive Surgical Procedures|refractive surgical procedures
137513|NCT03342235|PRK|prk
137514|NCT03342222|PEEK Interference Screw; Fixation; Anterior Cruciate Ligament Reconstruction|peek interference screw; fixation; anterior cruciate ligament reconstruction
137515|NCT03342209|carbon monoxide toxicity|carbon monoxide toxicity
137516|NCT03342209|high flow nasal cannula|high flow nasal cannula
137517|NCT03342209|emergency department|emergency department
137518|NCT03342196|Thiotepa|thiotepa
137519|NCT03342196|Fludarabine|fludarabine
137520|NCT03342196|Melphalan|melphalan
137521|NCT03342183|Dialysis|dialysis
137522|NCT03342183|Hemodialysis|hemodialysis
137523|NCT03342183|Remote Ischemic Preconditioning|remote ischemic preconditioning
137524|NCT03342144|Chronic Lymphocytic Leukemia (CLL)|chronic lymphocytic leukemia (cll)
137525|NCT03342144|Cancer|cancer
137526|NCT03342144|Leukemia|leukemia
137527|NCT03342144|venetoclax|venetoclax
137528|NCT03342131|Wnt signaling|wnt signaling
137529|NCT03342105|Rhinitis, Allergic|rhinitis, allergic
137530|NCT03342105|Moxibustion|moxibustion
137531|NCT03342040|TAP block|tap block
137532|NCT03342040|laparoscopic IPOM|laparoscopic ipom
137533|NCT03342040|post operative pain|post operative pain
137534|NCT03341962|Ulcerative Colitis|ulcerative colitis
137535|NCT03341962|IMU-838|imu-838
137536|NCT03341962|vidofludimus calcium|vidofludimus calcium
137537|NCT03341936|Squamous Cell Carcinoma|squamous cell carcinoma
137538|NCT03341923|contact lenses|contact lenses
137539|NCT03341923|lens centration|lens centration
137540|NCT03341923|multifocal|multifocal
137541|NCT03341897|embolization|embolization
137542|NCT03341897|coiling|coiling
137543|NCT03341897|varicocele|varicocele
137544|NCT03341871|chronic hepatitis C virus (HCV)|chronic hepatitis c virus (hcv)
137545|NCT03341871|Genotype|genotype
137546|NCT03341871|glecaprevir|glecaprevir
137547|NCT03341871|pibrentasvir|pibrentasvir
137548|NCT03341871|sustained virologic response|sustained virologic response
137549|NCT03341871|chronic hepatitis C virus genotype 1|chronic hepatitis c virus genotype 1
137550|NCT03341871|chronic hepatitis C virus genotype 2|chronic hepatitis c virus genotype 2
137551|NCT03341871|chronic hepatitis C virus genotype 3|chronic hepatitis c virus genotype 3
137552|NCT03341871|chronic hepatitis C virus genotype 4|chronic hepatitis c virus genotype 4
137553|NCT03341871|chronic hepatitis C virus genotype 5|chronic hepatitis c virus genotype 5
137554|NCT03341871|chronic hepatitis C virus genotype 6|chronic hepatitis c virus genotype 6
137556|NCT03341806|LITT|litt
137557|NCT03341806|Laser Interstitial Thermal Therapy|laser interstitial thermal therapy
137558|NCT03341806|Bavencio|bavencio
137559|NCT03341806|immunotherapy|immunotherapy
137560|NCT03341767|HIV|hiv
137561|NCT03341767|Cryptosporidium|cryptosporidium
137562|NCT03341767|Clofazimine|clofazimine
137563|NCT03341754|Malaria Infection|malaria infection
137564|NCT03341741|chronic pulmonary infection|chronic pulmonary infection
137565|NCT03341702|jail|jail
137566|NCT03341702|violence|violence
137567|NCT03341702|predictive factors|predictive factors
137568|NCT03341702|prevention|prevention
137569|NCT03341689|Psilocybin|psilocybin
137570|NCT03341663|Stable Angina Pectoris|stable angina pectoris
137571|NCT03341663|Acupoint sensitization|acupoint sensitization
137572|NCT03341663|Correlation analysis|correlation analysis
137573|NCT03341663|Diagnostic value|diagnostic value
137574|NCT03341650|Mediterranean Diet|mediterranean diet
137575|NCT03341650|BMI|bmi
137576|NCT03341650|weight loss|weight loss
137577|NCT03341650|pasta|pasta
137578|NCT03341650|obesity|obesity
137579|NCT03341637|Drug Therapy|drug therapy
137580|NCT03341624|persistent fetal vasculature|persistent fetal vasculature
137581|NCT03341624|congenital cataract|congenital cataract
137582|NCT03341533|Analgesia|analgesia
137583|NCT03341533|Laparoscopy|laparoscopy
137584|NCT03341533|Pain|pain
137585|NCT03341507|laryngoscopy|laryngoscopy
137586|NCT03341507|retromolar|retromolar
137587|NCT03341481|galactagogues, lactogenesis, preterm labor|galactagogues, lactogenesis, preterm labor
137588|NCT03341468|Urethral catheter discomfort|urethral catheter discomfort
137589|NCT03341468|Urethral catheter pain|urethral catheter pain
137590|NCT03341468|Urethral catheter immobilization device|urethral catheter immobilization device
137591|NCT03341468|Prolonged urethral catheterization|prolonged urethral catheterization
137592|NCT03341468|Foley catheter|foley catheter
137593|NCT03341468|Urinary catheter|urinary catheter
137594|NCT03341468|Indwelling urethral catheter support|indwelling urethral catheter support
137595|NCT03341455|Sri Lanka|sri lanka
137596|NCT03341455|preschool|preschool
137597|NCT03341455|randomized control trial|randomized control trial
137598|NCT03341429|obesity|obesity
137599|NCT03341429|GLP-1|glp-1
137600|NCT03341429|liraglutide|liraglutide
137601|NCT03341429|diabetes|diabetes
137602|NCT03341429|bariatric surgery|bariatric surgery
137603|NCT03341416|cerebellar ataxia|cerebellar ataxia
137604|NCT03341416|stroke|stroke
137605|NCT03341416|Spinocerebellar ataxia|spinocerebellar ataxia
137606|NCT03341416|deep brain stimulation|deep brain stimulation
137607|NCT03341416|dentate nucleus|dentate nucleus
137608|NCT03341403|severe asthma|severe asthma
137609|NCT03341403|synbiotic|synbiotic
137610|NCT03341403|immunomodulation|immunomodulation
137611|NCT03341403|sputum|sputum
137612|NCT03341390|Healthy participants|healthy participants
137613|NCT03341390|Healthy subjects|healthy subjects
137614|NCT03341390|Strokes|strokes
137615|NCT03341377|utility parameter|utility parameter
137616|NCT03341377|patient-reported outcome|patient-reported outcome
137617|NCT03341377|perioperative symptom management|perioperative symptom management
137618|NCT03341377|lung cancer|lung cancer
137619|NCT03341351|Fourth-degree laceration|fourth-degree laceration
137620|NCT03341351|Beef tongue model|beef tongue model
137621|NCT03341325|animal-assisted therapy|animal-assisted therapy
137622|NCT03341273|Antibiotic Therapy|antibiotic therapy
137623|NCT03341273|Lower Respiratory Tract Infection|lower respiratory tract infection
137624|NCT03341273|Procalcitonin|procalcitonin
137625|NCT03341260|Pulpitis, irreversible Pulpitis,|pulpitis, irreversible pulpitis,
137626|NCT03341260|Diclofenac Potassium|diclofenac potassium
137627|NCT03341260|Premedication, Preoperative Analgesic|premedication, preoperative analgesic
137628|NCT03341260|Postoperative pain|postoperative pain
137629|NCT03341247|Obesity|obesity
137630|NCT03341247|Portion Size Effect|portion size effect
137631|NCT03341247|fMRI|fmri
137632|NCT03341247|Functional Magnetic Resonance Imaging|functional magnetic resonance imaging
137633|NCT03341247|Inhibition|inhibition
137634|NCT03341247|Decision Making|decision making
175613|NCT03097315|UME|ume
137635|NCT03341247|Satiety Responsiveness|satiety responsiveness
137636|NCT03341247|Anthropometrics|anthropometrics
137637|NCT03341247|DXA|dxa
137638|NCT03341247|Reward Processing|reward processing
137639|NCT03341247|Working Memory|working memory
137640|NCT03341234|Superficial Serratus Plane Block|superficial serratus plane block
137641|NCT03341234|Modified Radical Mastectomy|modified radical mastectomy
137642|NCT03341234|Axillary Lymph Node Disection|axillary lymph node disection
137643|NCT03341234|bupivacaine|bupivacaine
137644|NCT03341195|SMS|sms
137645|NCT03341195|Automated calls|automated calls
137646|NCT03341195|Routine immunization|routine immunization
137647|NCT03341195|mHealth|mhealth
137648|NCT03341182|epidural steroid injection|epidural steroid injection
137649|NCT03341182|radiation exposure|radiation exposure
137650|NCT03341182|mirror|mirror
137651|NCT03341156|Heart transplantation|heart transplantation
137652|NCT03341143|Unresectable|unresectable
137653|NCT03341143|Stage III|stage iii
137654|NCT03341143|Stage IV|stage iv
137655|NCT03341130|OSA|osa
137656|NCT03341130|Mandibular Advancement Splint|mandibular advancement splint
137657|NCT03341130|Oral Appliance|oral appliance
137658|NCT03341130|Treatment|treatment
137659|NCT03341130|Repositioning Splint|repositioning splint
137660|NCT03341117|acetylsalicylic acid|acetylsalicylic acid
137661|NCT03341117|antioxidant enzyme system|antioxidant enzyme system
137662|NCT03341117|stress oxidative|stress oxidative
137663|NCT03341117|type 2 diabetes mellitus.|type 2 diabetes mellitus.
137664|NCT03341091|Tai-chi|tai-chi
137665|NCT03341091|Dementia|dementia
137666|NCT03341091|Dyad approach|dyad approach
137667|NCT03341091|Fall prevention|fall prevention
137668|NCT03341091|Mobility|mobility
137669|NCT03341078|Ibudilast|ibudilast
137670|NCT03341078|Methamphetamine|methamphetamine
137671|NCT03341078|Neuroinflammation|neuroinflammation
137672|NCT03341013|Type 2 Diabetes Mellitus|type 2 diabetes mellitus
137673|NCT03341013|GLP-1 receptor agonists|glp-1 receptor agonists
137674|NCT03340987|vestibular incision subperiosteal tunnel access|vestibular incision subperiosteal tunnel access
137675|NCT03340987|coronally advanced flap|coronally advanced flap
137676|NCT03340987|subepithelial connective tissue graft|subepithelial connective tissue graft
137677|NCT03340987|multiple gingival recessions|multiple gingival recessions
137678|NCT03340974|Super Oxide Dismutase|super oxide dismutase
137679|NCT03340948|Mindfulness Based Stress Reduction|mindfulness based stress reduction
137680|NCT03340948|Depressive symptoms|depressive symptoms
137681|NCT03340948|Coronary Artery Disease|coronary artery disease
137682|NCT03340948|Mastery|mastery
137683|NCT03340935|fasting mimicking diet|fasting mimicking diet
137684|NCT03340935|malignant neoplasm|malignant neoplasm
137685|NCT03340935|metabolism|metabolism
137686|NCT03340935|metabolic effects|metabolic effects
137687|NCT03340935|adjuvant treatment|adjuvant treatment
137688|NCT03340935|metastatic setting|metastatic setting
137689|NCT03340922|premature ventricular complex|premature ventricular complex
137690|NCT03340922|catheter ablation|catheter ablation
137691|NCT03340922|activation mapping|activation mapping
137692|NCT03340922|wavefront|wavefront
137693|NCT03340896|Larynx, hypopharynx|larynx, hypopharynx
137694|NCT03340857|Post-cancer retraining|post-cancer retraining
137695|NCT03340857|Physical activity|physical activity
137696|NCT03340857|Intelligent electric bicycle|intelligent electric bicycle
137697|NCT03340818|Low back pain, bone marrow concentrate, disc degeneration|low back pain, bone marrow concentrate, disc degeneration
137698|NCT03340805|Sepsis|sepsis
137699|NCT03340805|Septic shock|septic shock
137700|NCT03340805|Pediatric|pediatric
137701|NCT03340805|Fluid resuscitation|fluid resuscitation
137702|NCT03340805|Saline|saline
137703|NCT03340805|Lactated Ringer's|lactated ringer's
137704|NCT03340805|Crystalloid|crystalloid
137705|NCT03340805|Mortality|mortality
137706|NCT03340805|Pragmatic trial|pragmatic trial
137707|NCT03340805|Feasibility|feasibility
137708|NCT03340792|Exoskeleton Device|exoskeleton device
137709|NCT03340792|Rehabilitation|rehabilitation
137710|NCT03340792|Body composition|body composition
137711|NCT03340792|Quality of Life|quality of life
137712|NCT03340779|Norepinephrine|norepinephrine
137713|NCT03340779|Dobutamine|dobutamine
137714|NCT03340779|Shock|shock
137715|NCT03340766|DLBCL Relapsed post-autologous or allogeneic hematopoietic stem cell transplantation (HSCT)|dlbcl relapsed post-autologous or allogeneic hematopoietic stem cell transplantation (hsct)
137716|NCT03340766|Antibodies|antibodies
137717|NCT03340766|Bispecific in combination with PD-1/PD-L1 inhibitor|bispecific in combination with pd-1/pd-l1 inhibitor
137718|NCT03340727|Moderate preterm infant|moderate preterm infant
137719|NCT03340727|Caffeine citrate|caffeine citrate
137720|NCT03340701|progesterone|progesterone
137721|NCT03340701|pharmacology|pharmacology
137722|NCT03340701|pharmacokinetics|pharmacokinetics
137723|NCT03340662|Healthy Volunteer|healthy volunteer
137724|NCT03340662|CC-122|cc-122
137725|NCT03340662|Adult|adult
137726|NCT03340662|Phase 1|phase 1
137727|NCT03340662|CYTOCHROME P450|cytochrome p450
137728|NCT03340623|DIEP|diep
137729|NCT03340623|Venous coupler|venous coupler
137730|NCT03340584|Total Knee Replacement|total knee replacement
137731|NCT03340584|Taping|taping
137732|NCT03340584|Rehabilitation|rehabilitation
137733|NCT03340584|Edema|edema
137734|NCT03340584|Pain|pain
137735|NCT03340571|Alzheimer's Disease|alzheimer's disease
137736|NCT03340571|biomarkers|biomarkers
137737|NCT03340571|blood|blood
137738|NCT03340519|Crohn|crohn
137739|NCT03340519|MRI|mri
137740|NCT03340506|Tafinlar|tafinlar
137741|NCT03340506|Mekinist|mekinist
137742|NCT03340506|Dabrafenib|dabrafenib
137743|NCT03340506|Trametinib|trametinib
137744|NCT03340506|Adult|adult
137745|NCT03340506|Pediatric|pediatric
137746|NCT03340506|Melanoma|melanoma
137747|NCT03340506|Melanoma Stage IV|melanoma stage iv
137748|NCT03340506|Metastatic Melanoma|metastatic melanoma
137749|NCT03340506|Advanced Melanoma|advanced melanoma
137750|NCT03340506|Lung Cancer|lung cancer
137751|NCT03340506|NSLC|nslc
137752|NCT03340506|Non Small Cell Lung Cancer|non small cell lung cancer
137753|NCT03340506|BRAF V600 Mutation|braf v600 mutation
137754|NCT03340506|BRAF Gene Mutation|braf gene mutation
137755|NCT03340506|Solid tumor|solid tumor
137756|NCT03340506|Rare cancers|rare cancers
137757|NCT03340506|High Grade Glioma|high grade glioma
137758|NCT03340493|Stroke|stroke
137759|NCT03340493|Ischemia|ischemia
137760|NCT03340493|Cerebral Infarction|cerebral infarction
137761|NCT03340493|Cerebrovascular Disorders|cerebrovascular disorders
137762|NCT03340493|Brain Diseases|brain diseases
137763|NCT03340493|Central Nervous System Diseases|central nervous system diseases
137764|NCT03340493|Nervous System Diseases|nervous system diseases
137765|NCT03340493|Vascular Diseases|vascular diseases
137766|NCT03340493|Cardiovascular Diseases|cardiovascular diseases
137767|NCT03340493|Pathologic Processes|pathologic processes
137768|NCT03340493|Brain Infarction|brain infarction
137769|NCT03340493|Brain Ischemia|brain ischemia
137770|NCT03340493|Tenecteplase|tenecteplase
137771|NCT03340493|Fibrinolytic agents|fibrinolytic agents
137772|NCT03340493|Fibrin Modulating agents|fibrin modulating agents
137773|NCT03340493|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action
137774|NCT03340493|Plasminogen|plasminogen
137775|NCT03340493|Tissue Plasminogen Activator|tissue plasminogen activator
137776|NCT03340454|H. pylori|h. pylori
137777|NCT03340454|H. pylori infection|h. pylori infection
137778|NCT03340428|incarceration|incarceration
137779|NCT03340428|linkage to care|linkage to care
137780|NCT03340428|retention in care|retention in care
137781|NCT03340415|Hallux Valgus|hallux valgus
137782|NCT03340415|Bunion|bunion
137783|NCT03340415|Post-operative|post-operative
137784|NCT03340415|Rehabilitation|rehabilitation
137785|NCT03340415|Weight Bearing Status|weight bearing status
137786|NCT03340402|Breast Cancer|breast cancer
137787|NCT03340350|Minocycline|minocycline
137788|NCT03340350|PTSD|ptsd
137789|NCT03340337|electrical stimulation|electrical stimulation
137790|NCT03340337|Muscle Strength|muscle strength
137791|NCT03340337|Fatigue|fatigue
137792|NCT03340337|assessments, pain|assessments, pain
137793|NCT03340324|inflammation|inflammation
137794|NCT03340324|autoimmunity|autoimmunity
137795|NCT03340324|immunotherapy|immunotherapy
137796|NCT03340324|infertility|infertility
137797|NCT03340324|pelvic pain|pelvic pain
137798|NCT03340311|M-Health, GDM, Bluetooth, SMBG|m-health, gdm, bluetooth, smbg
137799|NCT03340272|prostate cancer|prostate cancer
137800|NCT03340272|pelvic irradiation|pelvic irradiation
137801|NCT03340272|hormonal treatment|hormonal treatment
137802|NCT03340259|Congenital malformations of the gastrointestinal tract|congenital malformations of the gastrointestinal tract
137803|NCT03340259|Enterostomy|enterostomy
137804|NCT03340259|Microbiota|microbiota
137805|NCT03340259|Necrotizing enterocolitis|necrotizing enterocolitis
137806|NCT03340259|Newborn Infants|newborn infants
137807|NCT03340259|Spontaneous intestinal perforation|spontaneous intestinal perforation
137808|NCT03340246|Varicose veins, phlebectomy|varicose veins, phlebectomy
137809|NCT03340233|diastolic dysfunction|diastolic dysfunction
137810|NCT03340233|mechanism|mechanism
137811|NCT03340233|MRI magnetic resonance imaging|mri magnetic resonance imaging
137812|NCT03340233|ejection fraction|ejection fraction
137813|NCT03340220|Transcranial Magnetic Stimulation|transcranial magnetic stimulation
137814|NCT03340207|intubation|intubation
137815|NCT03340207|anesthesiology|anesthesiology
137816|NCT03340194|Systemic sclerosis|systemic sclerosis
137817|NCT03340194|Calcinosis cutis|calcinosis cutis
137818|NCT03340181|RIPC, myocardial protective effect|ripc, myocardial protective effect
137819|NCT03340168|Bisphenol S, toxicokinetics|bisphenol s, toxicokinetics
137820|NCT03340129|Immunotherapy|immunotherapy
137821|NCT03340129|Radiotherapy|radiotherapy
137822|NCT03340129|Brain metastases|brain metastases
137823|NCT03340129|Stereotactic radiotherapy|stereotactic radiotherapy
137824|NCT03340129|Stereotactic radiosurgery|stereotactic radiosurgery
137825|NCT03340103|Lutein/Zeaxanthin|lutein/zeaxanthin
137826|NCT03340103|Antioxidant|antioxidant
137827|NCT03340103|Oxidative stress|oxidative stress
137828|NCT03340103|Carotenoid|carotenoid
137829|NCT03340103|Preterm newborn|preterm newborn
137830|NCT03340064|Epilepsy|epilepsy
137831|NCT03340064|Partial Seizures|partial seizures
137832|NCT03340064|Levetiracetam|levetiracetam
137833|NCT03340064|Monotherapy|monotherapy
137834|NCT03340064|Adjunctive Treatment|adjunctive treatment
137835|NCT03340038|Free Flap Reconstructive Surgery|free flap reconstructive surgery
137836|NCT03340038|Head and Neck|head and neck
137837|NCT03340025|negative pressure wound therapy|negative pressure wound therapy
137838|NCT03340025|split thickness skin graft|split thickness skin graft
137839|NCT03339986|Portion Size|portion size
137840|NCT03339986|Feasibility|feasibility
137841|NCT03339986|Acceptability|acceptability
137842|NCT03339986|Snacking|snacking
137843|NCT03339986|Preschool children|preschool children
137844|NCT03339973|Peripheral Arterial Occlusive Disease|peripheral arterial occlusive disease
137845|NCT03339973|ABCB5|abcb5
137846|NCT03339973|allogeneic|allogeneic
137847|NCT03339973|mesenchymal stem cells|mesenchymal stem cells
137848|NCT03339973|advanced therapy medicinal product|advanced therapy medicinal product
137849|NCT03339973|somatic cell therapy|somatic cell therapy
137850|NCT03339973|phase I/IIa|phase i/iia
137851|NCT03339973|non-healing ulcers|non-healing ulcers
137852|NCT03339947|Multidrug-resistant Enterobacteriaceae acquisition|multidrug-resistant enterobacteriaceae acquisition
137853|NCT03339947|travellers' diarrhoea|travellers' diarrhoea
137854|NCT03339947|international travel|international travel
137855|NCT03339895|COLORECTAL SURGERY|colorectal surgery
137856|NCT03339895|PVI GUIDED FLUID MANAGEMENT|pvi guided fluid management
137857|NCT03339895|GOAL DIRECTED THERAPY|goal directed therapy
137858|NCT03339882|remifemin|remifemin
137859|NCT03339882|preventive effect|preventive effect
137860|NCT03339882|LHRH-a|lhrh-a
137861|NCT03339882|breast cancer|breast cancer
137862|NCT03339843|cancer|cancer
137863|NCT03339830|SMA|sma
137864|NCT03339830|Spinal Muscular Atrophy|spinal muscular atrophy
137865|NCT03339830|Neuromuscular disease|neuromuscular disease
137866|NCT03339830|Spinraza|spinraza
137867|NCT03339804|Chemotherapy|chemotherapy
137868|NCT03339804|Muscle sympathetic nervous activity|muscle sympathetic nervous activity
137869|NCT03339804|Blood flow|blood flow
137870|NCT03339804|Endothelial microparticles|endothelial microparticles
137871|NCT03339765|Self-advocacy|self-advocacy
137872|NCT03339765|Advanced cancer|advanced cancer
137873|NCT03339765|Serious games|serious games
137874|NCT03339765|Self-management|self-management
137875|NCT03339739|Musculoskeletal Pain|musculoskeletal pain
137876|NCT03339739|Orofacial Pain|orofacial pain
137877|NCT03339739|Physical Therapy Modalities|physical therapy modalities
137878|NCT03339739|Oral Contraceptives|oral contraceptives
137879|NCT03339739|Mandibular Diseases|mandibular diseases
137880|NCT03339739|Muscular Diseases|muscular diseases
137881|NCT03339739|Risk factors|risk factors
137882|NCT03339739|Contraceptive Usage|contraceptive usage
137883|NCT03339739|Pain, Chronic|pain, chronic
137884|NCT03339739|Craniomandibular Disorders|craniomandibular disorders
137885|NCT03339661|CMV infection|cmv infection
137886|NCT03339661|kidney transplant|kidney transplant
137887|NCT03339661|γδ T cells monitoring|γδ t cells monitoring
137888|NCT03339648|School Resource Officer|school resource officer
137889|NCT03339648|Trauma Informed Care|trauma informed care
137890|NCT03339648|Cultural Competency|cultural competency
137891|NCT03339648|Restorative Problem Solving|restorative problem solving
137892|NCT03339648|Social Emotional Learning|social emotional learning
137893|NCT03339648|Professional Development|professional development
137894|NCT03339648|School Violence|school violence
137895|NCT03339622|uncontrollable cancer pain|uncontrollable cancer pain
137896|NCT03339622|incurable malignancy,|incurable malignancy,
137897|NCT03339596|electroconvulsive therapy|electroconvulsive therapy
137898|NCT03339596|depression|depression
137899|NCT03339596|cognition|cognition
137900|NCT03339596|cognitive side-effects|cognitive side-effects
137901|NCT03339596|erythropoietin|erythropoietin
137902|NCT03339596|functional magnetic resonance imaging|functional magnetic resonance imaging
137903|NCT03339583|chronic insomnia|chronic insomnia
137904|NCT03339583|brief behavioral treatment|brief behavioral treatment
137905|NCT03339583|behavioral treatment|behavioral treatment
137906|NCT03339583|insomnia severity index|insomnia severity index
137907|NCT03339583|predictors|predictors
137908|NCT03339583|treatment response|treatment response
137909|NCT03339531|2D|2d
137910|NCT03339531|prostate neoplasms|prostate neoplasms
137911|NCT03339531|radiotherapy|radiotherapy
137912|NCT03339531|simulation|simulation
137913|NCT03339492|rotator cuff|rotator cuff
137914|NCT03339492|PEMF|pemf
137915|NCT03339492|Pulsed Electromagnetic Field|pulsed electromagnetic field
137916|NCT03339492|Rotator Cuff Repair|rotator cuff repair
137917|NCT03339492|adjunctive therapy|adjunctive therapy
137918|NCT03339479|dielectric property|dielectric property
137919|NCT03339479|lung nodules|lung nodules
137920|NCT03339479|differential diagnosis|differential diagnosis
137921|NCT03339479|frozen pathological examination|frozen pathological examination
137922|NCT03339427|vitamin D|vitamin d
137923|NCT03339427|cardiovascular|cardiovascular
137924|NCT03339427|muscle power|muscle power
137925|NCT03339362|low back pain|low back pain
137926|NCT03339362|lumbar facet joint pain|lumbar facet joint pain
137927|NCT03339362|feasibility|feasibility
137928|NCT03339362|lumbar facet joint injection|lumbar facet joint injection
137929|NCT03339310|CCM Therapy|ccm therapy
137930|NCT03339310|2-Lead|2-lead
137931|NCT03339310|FIX-HF-5C2|fix-hf-5c2
137932|NCT03339310|Optimizer|optimizer
138132|NCT03338270|MRI|mri
137933|NCT03339258|Posttraumatic Stress Disorder|posttraumatic stress disorder
137934|NCT03339258|Post-traumatic Stress Disorder|post-traumatic stress disorder
137935|NCT03339258|PTSD|ptsd
137936|NCT03339258|Doxazosin|doxazosin
137937|NCT03339258|Nightmares|nightmares
137938|NCT03339258|Sleep Disturbance|sleep disturbance
137939|NCT03339245|obesity|obesity
137940|NCT03339245|fructose|fructose
137941|NCT03339245|glucose|glucose
137942|NCT03339245|fecal microbiota|fecal microbiota
137943|NCT03339245|intestinal permiability|intestinal permiability
137944|NCT03339245|fecal metabolites|fecal metabolites
137945|NCT03339193|atrial fibrillation|atrial fibrillation
137946|NCT03339193|stroke|stroke
137947|NCT03339193|atrial appendage|atrial appendage
137948|NCT03339180|cardiac troponin|cardiac troponin
137949|NCT03339167|Lysine, Adult, Protein Quality|lysine, adult, protein quality
137950|NCT03339154|Healthy|healthy
137951|NCT03339154|Men|men
137952|NCT03339154|Adults|adults
137953|NCT03339154|Methionine|methionine
137954|NCT03339141|Intubation conditions|intubation conditions
137955|NCT03339141|Anaesthetic techniques|anaesthetic techniques
137956|NCT03339141|Laryngoscopy|laryngoscopy
137957|NCT03339128|Irritable Bowel Syndrome with Diarrhea|irritable bowel syndrome with diarrhea
137958|NCT03339128|IBSD|ibsd
137959|NCT03339128|IBS-D|ibs-d
137960|NCT03339128|Irritable Bowel Syndrome|irritable bowel syndrome
137961|NCT03339128|Pediatric|pediatric
137962|NCT03339115|Mitral Insufficiency|mitral insufficiency
137963|NCT03339115|Heart Failure|heart failure
137964|NCT03339115|Mitral Valve|mitral valve
137965|NCT03339115|Heart Diseases|heart diseases
137966|NCT03339115|Valvular Heart Disease|valvular heart disease
137967|NCT03339102|Non-infectious intermediate, posterior and panuveitis|non-infectious intermediate, posterior and panuveitis
137968|NCT03339102|Post-Marketing Surveillance|post-marketing surveillance
137969|NCT03339102|Humira®|humira®
137970|NCT03339089|rheumatoid arthritis|rheumatoid arthritis
137971|NCT03339089|plaque psoriasis|plaque psoriasis
137972|NCT03339089|ankylosing spondylitis|ankylosing spondylitis
137973|NCT03339089|Immune-Mediated Inflammatory Diseases|immune-mediated inflammatory diseases
137974|NCT03339089|Chinese Patients|chinese patients
137975|NCT03339063|Nontuberculous Mycobacteria|nontuberculous mycobacteria
137976|NCT03339063|Non-tuberculous mycobacteria|non-tuberculous mycobacteria
137977|NCT03339063|NTM-PD|ntm-pd
137978|NCT03339063|NTM-LD|ntm-ld
137979|NCT03339063|MAC|mac
137980|NCT03339063|M. avium|m. avium
137981|NCT03339063|M. intracellulare|m. intracellulare
137982|NCT03339063|M. abscessus|m. abscessus
137983|NCT03339063|Atypical mycobacteria|atypical mycobacteria
137984|NCT03339063|NTM|ntm
137985|NCT03339050|church-based health promotion|church-based health promotion
137986|NCT03339050|African Americans|african americans
137987|NCT03339037|HBOT|hbot
137988|NCT03339037|TBI|tbi
137989|NCT03339037|pediatrics|pediatrics
137990|NCT03339037|PCS|pcs
137991|NCT03339037|PPCS|ppcs
137992|NCT03339037|concussion|concussion
137993|NCT03339037|traumatic brain injury|traumatic brain injury
137994|NCT03339037|hyperbaric oxygen|hyperbaric oxygen
137995|NCT03339024|Oxytocin|oxytocin
137996|NCT03339024|Administration, Intranasal|administration, intranasal
137997|NCT03339024|Ethanol|ethanol
137998|NCT03339024|Follow-up Studies|follow-up studies
137999|NCT03338998|stroke|stroke
138000|NCT03338998|intracerebral hemorrhage|intracerebral hemorrhage
138001|NCT03338998|ICH|ich
138002|NCT03338998|BAF312|baf312
138003|NCT03338998|siponimod|siponimod
138004|NCT03338998|sphingosine-1-phosphate receptor|sphingosine-1-phosphate receptor
138005|NCT03338946|Remote monitoring|remote monitoring
138006|NCT03338920|acute migraine|acute migraine
138007|NCT03338920|aura|aura
138008|NCT03338920|sumatriptan nasal powder|sumatriptan nasal powder
138009|NCT03338920|AVP-825|avp-825
138010|NCT03338920|adolescents|adolescents
138011|NCT03338907|cerebral hypoxia|cerebral hypoxia
138012|NCT03338907|CO2|co2
138013|NCT03338907|cerebral perfusion|cerebral perfusion
138014|NCT03338907|hypoxia|hypoxia
138015|NCT03338881|Drug therapy|drug therapy
138016|NCT03338868|physical activity|physical activity
138017|NCT03338868|pain|pain
138018|NCT03338868|uric acid|uric acid
138019|NCT03338855|T2DM, insulin resistance, skeletal muscle, mitochondria, dapagliflozin|t2dm, insulin resistance, skeletal muscle, mitochondria, dapagliflozin
138020|NCT03338816|Acute Intermittent Porphyria (AIP)|acute intermittent porphyria (aip)
138021|NCT03338816|Acute Hepatic Porphyria (AHP)|acute hepatic porphyria (ahp)
138022|NCT03338816|Hereditary Coproporphyria (HCP)|hereditary coproporphyria (hcp)
138023|NCT03338816|Variegate Porphyria (VP)|variegate porphyria (vp)
138024|NCT03338816|ALA dehydratase deficient porphyria (ADP) (ALAD)|ala dehydratase deficient porphyria (adp) (alad)
138025|NCT03338816|RNAi therapeutic|rnai therapeutic
138026|NCT03338816|Porphyria|porphyria
138027|NCT03338777|melanoma|melanoma
138028|NCT03338777|lipoplexes|lipoplexes
138029|NCT03338777|plasmid|plasmid
138030|NCT03338777|herpes simplex thymidine kinase|herpes simplex thymidine kinase
138031|NCT03338777|interleukin-2|interleukin-2
138131|NCT03338296|lifestyle modification|lifestyle modification
138032|NCT03338777|granulocyte-macrophage colony-stimulating factor|granulocyte-macrophage colony-stimulating factor
138033|NCT03338777|tumor vaccine|tumor vaccine
138034|NCT03338777|suicide gene|suicide gene
138035|NCT03338764|Transient insomnia|transient insomnia
138036|NCT03338764|Insomnia|insomnia
138037|NCT03338764|Sleep initiation and maintenance disorder|sleep initiation and maintenance disorder
138038|NCT03338699|Early infant male circumcision|early infant male circumcision
138039|NCT03338699|ShangRing|shangring
138040|NCT03338699|sub-Saharan Africa|sub-saharan africa
138042|NCT03338699|WHO|who
138043|NCT03338686|Keratinized tissue|keratinized tissue
138044|NCT03338686|Keratinized mucosa|keratinized mucosa
138045|NCT03338686|Attached mucosa|attached mucosa
138046|NCT03338686|Dental implants|dental implants
138047|NCT03338686|Free gingival graft|free gingival graft
138048|NCT03338686|Connective tissue graft|connective tissue graft
138049|NCT03338686|Patient-centered outcomes|patient-centered outcomes
138050|NCT03338647|Stereotactic body radiation therapy|stereotactic body radiation therapy
138051|NCT03338647|transarterial chemoembolization|transarterial chemoembolization
138052|NCT03338647|SBRT|sbrt
138053|NCT03338647|TACE|tace
138054|NCT03338634|Portion Size Effect|portion size effect
138055|NCT03338634|Childhood Obesity|childhood obesity
138056|NCT03338634|fMRI|fmri
138057|NCT03338621|tuberculosis|tuberculosis
138058|NCT03338621|drug-resistant tuberculosis|drug-resistant tuberculosis
138059|NCT03338621|TB|tb
138060|NCT03338621|DR-TB|dr-tb
138061|NCT03338621|pretomanid|pretomanid
138062|NCT03338621|PA-824|pa-824
138063|NCT03338621|bedaquiline|bedaquiline
138064|NCT03338621|TMC207|tmc207
138065|NCT03338621|moxifloxacin|moxifloxacin
138066|NCT03338621|pyrazinamide|pyrazinamide
138067|NCT03338621|HRZE|hrze
138068|NCT03338621|TB Alliance|tb alliance
138069|NCT03338621|NC-008|nc-008
138070|NCT03338621|drug-sensitive tuberculosis|drug-sensitive tuberculosis
138071|NCT03338621|DS-TB|ds-tb
138072|NCT03338608|Cosmesis|cosmesis
138073|NCT03338608|Wound Healing|wound healing
138074|NCT03338608|Anterior Cervical Decompression and Fusion|anterior cervical decompression and fusion
138075|NCT03338608|ACDF|acdf
138076|NCT03338608|Platysma|platysma
138077|NCT03338595|arterial stiffness|arterial stiffness
138078|NCT03338595|flow-mediated dilation|flow-mediated dilation
138079|NCT03338595|endothelial function|endothelial function
138080|NCT03338595|Orkambi|orkambi
138081|NCT03338595|exercise capacity|exercise capacity
138082|NCT03338582|Pacemaker|pacemaker
138083|NCT03338582|Conduction disturbance|conduction disturbance
138084|NCT03338582|TAVI|tavi
138085|NCT03338556|Rhinovirus|rhinovirus
138086|NCT03338556|Healthy volunteer|healthy volunteer
138087|NCT03338556|Outpatient|outpatient
138088|NCT03338556|Cold virus|cold virus
138089|NCT03338556|HRV-16|hrv-16
138090|NCT03338543|percutaneous electrical nerve stimulation|percutaneous electrical nerve stimulation
138091|NCT03338543|transcutaneous electrical nerve stimulation|transcutaneous electrical nerve stimulation
138092|NCT03338543|pain|pain
138093|NCT03338543|liver cancer|liver cancer
138094|NCT03338543|hepatocellular carcinoma|hepatocellular carcinoma
138095|NCT03338530|Psychosocial treatment|psychosocial treatment
138096|NCT03338530|School intervention|school intervention
138097|NCT03338530|Autism Spectrum Disorder|autism spectrum disorder
138098|NCT03338504|type 2 myocardial infarction|type 2 myocardial infarction
138099|NCT03338465|Greater Trochanteric Pain Syndrome,|greater trochanteric pain syndrome,
138100|NCT03338465|Gluteal|gluteal
138101|NCT03338465|Tendinopathy|tendinopathy
138102|NCT03338465|ESWT|eswt
138103|NCT03338465|shockwave|shockwave
138104|NCT03338452|ketogenic diet|ketogenic diet
138105|NCT03338452|body composition|body composition
138106|NCT03338452|metabolism|metabolism
138107|NCT03338452|body dissatisfaction|body dissatisfaction
138108|NCT03338452|cognition|cognition
138109|NCT03338413|Rehabilitation|rehabilitation
138110|NCT03338400|Quality of Recovery, Dexamethasone, Same day surgery|quality of recovery, dexamethasone, same day surgery
138111|NCT03338387|neuropeptides|neuropeptides
138112|NCT03338387|microdialysis|microdialysis
138113|NCT03338374|Cardiac chronotropy|cardiac chronotropy
138114|NCT03338374|Cardiac resynchronisation therapy|cardiac resynchronisation therapy
138115|NCT03338374|Rate responsive pacemaker|rate responsive pacemaker
138116|NCT03338374|Heart failure with preserved ejection fraction|heart failure with preserved ejection fraction
138117|NCT03338361|approach avoidance training|approach avoidance training
138118|NCT03338361|attentional bias training|attentional bias training
138119|NCT03338361|alcohol depencence|alcohol depencence
138120|NCT03338361|relapse|relapse
138121|NCT03338348|Vosaroxin|vosaroxin
138122|NCT03338322|postoperative pain|postoperative pain
138123|NCT03338322|reciproc|reciproc
138124|NCT03338322|twisted file adaptive|twisted file adaptive
138125|NCT03338309|Fractional flow reserve|fractional flow reserve
138126|NCT03338309|Instantaneous wave-free ratio|instantaneous wave-free ratio
138127|NCT03338309|Ischemic heart disease|ischemic heart disease
138128|NCT03338296|body mass index|body mass index
138129|NCT03338296|weight loss|weight loss
138130|NCT03338296|adolescents|adolescents
138133|NCT03338270|Neuroradiology|neuroradiology
138134|NCT03338270|minute-MRI|minute-mri
138135|NCT03338270|multi EPI-mix|multi epi-mix
138136|NCT03338270|Clinical Validation|clinical validation
138137|NCT03338257|Pre-school children|pre-school children
138138|NCT03338257|fruit and vegetable acceptance|fruit and vegetable acceptance
138139|NCT03338257|service-learning|service-learning
138140|NCT03338257|pre-school nutrition education|pre-school nutrition education
138141|NCT03338257|childhood obesity|childhood obesity
138142|NCT03338244|Childhood mortality|childhood mortality
138143|NCT03338244|Mass treatment|mass treatment
138144|NCT03338244|Azithromycin|azithromycin
138145|NCT03338244|Infection|infection
138146|NCT03338231|Immunity duration|immunity duration
138147|NCT03338218|Hydroxyethylstarch (HES)|hydroxyethylstarch (hes)
138148|NCT03338205|ketamine|ketamine
138149|NCT03338205|pediatric status asthmaticus|pediatric status asthmaticus
138150|NCT03338192|Low back pain|low back pain
138151|NCT03338192|Chronic pain|chronic pain
138152|NCT03338192|Health disparities in chronic low back pain|health disparities in chronic low back pain
138153|NCT03338179|Metamemory|metamemory
138154|NCT03338179|Schizophrenia|schizophrenia
138155|NCT03338114|ALS|als
138156|NCT03338114|Amyotrophic Lateral Sclerosis|amyotrophic lateral sclerosis
138157|NCT03338114|Fasciculation|fasciculation
138158|NCT03338114|FLX-787|flx-787
138159|NCT03338062|Radiation Treatment|radiation treatment
138160|NCT03338036|Concussion|concussion
138161|NCT03338036|Post-Concussion Syndrome|post-concussion syndrome
138162|NCT03338036|Biofeedback|biofeedback
138163|NCT03338036|Heart Rate Variability|heart rate variability
138164|NCT03338036|Neurofeedback|neurofeedback
138165|NCT03338023|Insulin Glargine|insulin glargine
138166|NCT03338010|Insulin glargine|insulin glargine
138167|NCT03337997|Irreversible Electroporation|irreversible electroporation
138168|NCT03337997|Pancreatic Adenocarcinoma|pancreatic adenocarcinoma
138169|NCT03337984|Diverticulitis|diverticulitis
138170|NCT03337984|Damage Control Surgery|damage control surgery
138171|NCT03337971|Post-menopausal|post-menopausal
138172|NCT03337971|Osteoporosis|osteoporosis
138173|NCT03337971|Bone Turnover Markers|bone turnover markers
138174|NCT03337971|Dairy Products|dairy products
138175|NCT03337958|Education|education
138176|NCT03337958|Dry Powder Inhalers|dry powder inhalers
138177|NCT03337958|Metered Dose Inhalers|metered dose inhalers
138178|NCT03337958|Pulmonary Disease|pulmonary disease
138179|NCT03337958|Chronic Obstructive|chronic obstructive
138180|NCT03337945|CYP450 phenotyping in patients with liver cirrhosis|cyp450 phenotyping in patients with liver cirrhosis
138181|NCT03337906|HIV|hiv
138182|NCT03337867|Recurrent stroke|recurrent stroke
138183|NCT03337867|Stroke|stroke
138184|NCT03337867|Transcranial Magnetic Stimulation|transcranial magnetic stimulation
138185|NCT03337867|Theta-Burst-Stimulation|theta-burst-stimulation
138186|NCT03337854|prognostic|prognostic
138187|NCT03337854|phenotype|phenotype
138188|NCT03337854|Computed tomography|computed tomography
138189|NCT03337854|Chronic Obstructive Pulmonary Disease|chronic obstructive pulmonary disease
138190|NCT03337841|Hepatocellular carcinoma|hepatocellular carcinoma
138191|NCT03337841|Neo adjuvant chemotherapy|neo adjuvant chemotherapy
138192|NCT03337841|Adjuvant chemotherapy|adjuvant chemotherapy
138193|NCT03337841|Immune checkpoint inhibitor|immune checkpoint inhibitor
138194|NCT03337841|Pembrolizumab|pembrolizumab
138195|NCT03337828|Alcohol-free beer|alcohol-free beer
138196|NCT03337828|Carbohydrates|carbohydrates
138197|NCT03337828|Overweight|overweight
138198|NCT03337828|Obesity|obesity
138199|NCT03337828|Diabetes mellitus type 2|diabetes mellitus type 2
138200|NCT03337828|Microbiota|microbiota
138201|NCT03337828|Glucose metabolism|glucose metabolism
138202|NCT03337776|WhatsApp messenger|whatsapp messenger
138203|NCT03337776|crc screening|crc screening
138204|NCT03337776|screening update rate|screening update rate
138205|NCT03337763|LV-LV conduction delay|lv-lv conduction delay
138206|NCT03337750|Combat|combat
138207|NCT03337750|Psychological Treatment|psychological treatment
138208|NCT03337750|Military|military
138209|NCT03337750|Psychotherapy|psychotherapy
138210|NCT03337750|Trauma|trauma
138211|NCT03337750|Posttraumatic Stress|posttraumatic stress
138212|NCT03337750|Posttraumatic Stress Disorder|posttraumatic stress disorder
138213|NCT03337711|NSCLC;ctDNA;IIA-IIIA|nsclc;ctdna;iia-iiia
138214|NCT03337659|Family-integrated care|family-integrated care
138215|NCT03337659|neonatal intensive care unit|neonatal intensive care unit
138216|NCT03337659|premature|premature
138217|NCT03337659|infant development|infant development
138218|NCT03337646|vyvanse|vyvanse
138219|NCT03337646|executive function|executive function
138220|NCT03337646|safety|safety
138221|NCT03337633|cognitive load|cognitive load
138222|NCT03337633|galvanic skin response|galvanic skin response
138223|NCT03337633|meal size|meal size
138224|NCT03337633|kilocalories|kilocalories
138225|NCT03337633|menu design|menu design
138226|NCT03337620|chronic|chronic
138227|NCT03337607|Extracorporeal shock wave therapy|extracorporeal shock wave therapy
138228|NCT03337607|ESWT|eswt
138229|NCT03337607|Radial extracorporeal shock wave therapy|radial extracorporeal shock wave therapy
138230|NCT03337607|rESWT|reswt
138231|NCT03337607|Chronic non-specific low back pain|chronic non-specific low back pain
138232|NCT03337607|Non-steroidal anti-inflammatory drug|non-steroidal anti-inflammatory drug
138233|NCT03337594|Gadolinium|gadolinium
138234|NCT03337594|MultiHance|multihance
138235|NCT03337594|Dotarem|dotarem
138236|NCT03337594|Contrast agents|contrast agents
138237|NCT03337594|Magnetic Resonance Imaging|magnetic resonance imaging
138238|NCT03337594|Gadolinium retention|gadolinium retention
138239|NCT03337594|Pediatric|pediatric
138240|NCT03337594|Bone|bone
138241|NCT03337581|Dexmedetomidine|dexmedetomidine
138242|NCT03337581|pediatrics|pediatrics
138243|NCT03337581|Pharmacodynamics|pharmacodynamics
138244|NCT03337581|Pharmacokinetics|pharmacokinetics
138245|NCT03337568|AML CR|aml cr
138246|NCT03337568|allogeneic hematopoietic cell transplantation|allogeneic hematopoietic cell transplantation
138247|NCT03337568|busulfan|busulfan
138248|NCT03337568|fludarabine|fludarabine
138249|NCT03337568|ATG|atg
138250|NCT03337542|AR101|ar101
138251|NCT03337542|Characterized Peanut Allergen|characterized peanut allergen
138252|NCT03337542|CPNA (Characterized Peanut Allergen)|cpna (characterized peanut allergen)
138253|NCT03337542|OIT (oral immunotherapy)|oit (oral immunotherapy)
138254|NCT03337542|Peanut Allergy|peanut allergy
138255|NCT03337542|Peanut-Allergic Children|peanut-allergic children
138256|NCT03337542|Desensitization|desensitization
138257|NCT03337542|Food Allergy|food allergy
138258|NCT03337464|exercise|exercise
138259|NCT03337464|EEG|eeg
138260|NCT03337464|EMG|emg
138261|NCT03337464|Motor function|motor function
138262|NCT03337464|Mood|mood
138263|NCT03337464|Cognition|cognition
138264|NCT03337425|Psychotherapy, group|psychotherapy, group
138265|NCT03337425|Adults|adults
138266|NCT03337412|Therapeutic Education|therapeutic education
138267|NCT03337412|physical activity|physical activity
138268|NCT03337412|overweight|overweight
138269|NCT03337412|obesity|obesity
138270|NCT03337399|Lung Cancer|lung cancer
138271|NCT03337373|Critical care|critical care
138272|NCT03337373|Neuromuscular Blocking Agents|neuromuscular blocking agents
138273|NCT03337373|Pharmacodynamics|pharmacodynamics
138274|NCT03337373|Pharmacokinetics|pharmacokinetics
138275|NCT03337373|Physiological Effects of Drugs|physiological effects of drugs
138276|NCT03337360|fertility|fertility
138277|NCT03337360|male subfertility|male subfertility
138278|NCT03337360|foodsupplement|foodsupplement
138279|NCT03337360|oxidative stress|oxidative stress
138280|NCT03337347|Prognostic significance|prognostic significance
138281|NCT03337321|pregnancy|pregnancy
138282|NCT03337321|emotions|emotions
138283|NCT03337321|patient experience|patient experience
138284|NCT03337321|maternal care|maternal care
138285|NCT03337308|hyperlipidemia|hyperlipidemia
138286|NCT03337308|heterozygous familial hypercholesterolemia|heterozygous familial hypercholesterolemia
138287|NCT03337308|atherosclerotic cardiovascular disease|atherosclerotic cardiovascular disease
138288|NCT03337308|high cholesterol|high cholesterol
138289|NCT03337308|ASCVD|ascvd
138290|NCT03337308|HeFH|hefh
138291|NCT03337308|LDL|ldl
138292|NCT03337295|Meibomian Gland Dysfunction|meibomian gland dysfunction
138293|NCT03337295|Lipid Layer Thickness|lipid layer thickness
138294|NCT03337282|anesthesia|anesthesia
138295|NCT03337282|noncardiac surgery|noncardiac surgery
138296|NCT03337282|major surgery|major surgery
138297|NCT03337282|POCD|pocd
138298|NCT03337243|Stem Cell Injection|stem cell injection
138299|NCT03337243|Cytokine|cytokine
138300|NCT03337243|Wharton's Jelly|wharton's jelly
138301|NCT03337243|Stem Cells|stem cells
138302|NCT03337230|Cancer|cancer
138303|NCT03337230|Weight-Loss|weight-loss
138304|NCT03337230|Social Media|social media
138305|NCT03337217|colonoscopy|colonoscopy
138306|NCT03337191|ultrasound guided caudal injection|ultrasound guided caudal injection
138307|NCT03337191|sacral hiatus|sacral hiatus
138308|NCT03337191|sacral canal|sacral canal
138309|NCT03337165|Rheumatoid arthritis|rheumatoid arthritis
138310|NCT03337165|Auto-immune disorders|auto-immune disorders
138311|NCT03337165|Tolerogenic Dendritic Cells|tolerogenic dendritic cells
138312|NCT03337139|Weight Loss|weight loss
138313|NCT03337139|Obesity|obesity
138314|NCT03337139|Overweight|overweight
138315|NCT03337139|Behavioral Weight Loss|behavioral weight loss
138316|NCT03337100|Opioids|opioids
138317|NCT03337100|Naloxone|naloxone
138318|NCT03337100|Co-dispensing|co-dispensing
138319|NCT03337100|Cluster randomized trial|cluster randomized trial
138320|NCT03337100|Opioid antagonist|opioid antagonist
138321|NCT03337035|Probiotics, Oxytocin|probiotics, oxytocin
138322|NCT03337022|Psoriasis|psoriasis
138323|NCT03337022|CC-90006|cc-90006
138324|NCT03337022|Mild to moderate plaque-type psoriasis|mild to moderate plaque-type psoriasis
138325|NCT03337022|Safety|safety
138326|NCT03337022|Pharmacokinetics|pharmacokinetics
138327|NCT03337022|Pharmacodynamics|pharmacodynamics
138328|NCT03337009|Opioid antagonist|opioid antagonist
138329|NCT03337009|Naloxone|naloxone
138330|NCT03337009|Opioids|opioids
138331|NCT03337009|Web-based intervention|web-based intervention
138332|NCT03336996|Motor nerve injury|motor nerve injury
138333|NCT03336996|umbilical cord interstitial stem cell|umbilical cord interstitial stem cell
138334|NCT03336996|bold-DTI|bold-dti
138335|NCT03336996|reconstruction of motor circuits|reconstruction of motor circuits
138336|NCT03336983|prostate cancer|prostate cancer
138337|NCT03336983|bone metastasis|bone metastasis
138338|NCT03336983|enzalutamide|enzalutamide
138339|NCT03336983|zoledronic acid|zoledronic acid
138340|NCT03336970|single visit root canal treatment, chlorhexidine|single visit root canal treatment, chlorhexidine
138341|NCT03336957|chromogranin A, stress, gingivitis, pregnancy|chromogranin a, stress, gingivitis, pregnancy
138342|NCT03336931|children|children
138343|NCT03336931|precision medicine|precision medicine
138344|NCT03336931|personalised medicine|personalised medicine
138345|NCT03336931|high-risk cancer|high-risk cancer
138346|NCT03336931|refractory|refractory
138347|NCT03336931|recurrent|recurrent
138348|NCT03336931|sequencing|sequencing
138349|NCT03336931|patient derived xenograft|patient derived xenograft
138350|NCT03336931|molecular profiling|molecular profiling
138351|NCT03336931|paediatric|paediatric
138352|NCT03336918|Bipolar Disorder|bipolar disorder
138353|NCT03336918|Bipolar I and II Depression|bipolar i and ii depression
138354|NCT03336918|Lithium|lithium
138355|NCT03336918|Depression|depression
138356|NCT03336905|Adolescent and young adult|adolescent and young adult
138357|NCT03336892|Care Coordination|care coordination
138358|NCT03336879|Gambling Disorder|gambling disorder
138359|NCT03336879|Mental Disorder|mental disorder
138360|NCT03336879|Behavioral Addiction|behavioral addiction
138361|NCT03336827|Emotion Regulation|emotion regulation
138362|NCT03336827|Post-Treatment Breast Cancer Care|post-treatment breast cancer care
138363|NCT03336827|Cognitive-Behavioral Therapy|cognitive-behavioral therapy
138364|NCT03336827|CBT|cbt
138365|NCT03336827|Hypnosis|hypnosis
138366|NCT03336814|Terlipressin|terlipressin
138367|NCT03336814|norepinephrine|norepinephrine
138368|NCT03336801|sevoflurane|sevoflurane
138369|NCT03336801|propofol|propofol
138370|NCT03336775|acupuncure|acupuncure
138371|NCT03336775|dysphagia|dysphagia
138372|NCT03336775|radiation|radiation
138373|NCT03336749|Stroke, upper limb, sensory training, rehabilitation|stroke, upper limb, sensory training, rehabilitation
138374|NCT03336736|Physical Activity|physical activity
138375|NCT03336736|Diet|diet
138376|NCT03336736|Exercise|exercise
138377|NCT03336736|Sarcoidosis|sarcoidosis
138378|NCT03336736|Pulmonary sarcoidosis|pulmonary sarcoidosis
138379|NCT03336736|Lung Function|lung function
138380|NCT03336736|Fitness|fitness
138381|NCT03336736|Strength|strength
138382|NCT03336736|Endurance|endurance
138383|NCT03336710|Self-control|self-control
138384|NCT03336710|Ecological Momentary Assessment|ecological momentary assessment
138385|NCT03336710|Attentional bias|attentional bias
138386|NCT03336710|Respiratory Sinus Arrhythmia|respiratory sinus arrhythmia
138387|NCT03336710|Affect|affect
138388|NCT03336710|Emotion Regulation|emotion regulation
138389|NCT03336710|Well-being|well-being
138390|NCT03336710|Decentering|decentering
138391|NCT03336710|Affective disorders|affective disorders
138392|NCT03336684|Patient education|patient education
138393|NCT03336684|Rheumatoid arthritis|rheumatoid arthritis
138394|NCT03336684|Knowledge|knowledge
138395|NCT03336684|Attitudes|attitudes
138396|NCT03336684|Practice|practice
138397|NCT03336671|Pediatric|pediatric
138398|NCT03336671|Chronic Sinusitis|chronic sinusitis
138399|NCT03336645|Seizure|seizure
138400|NCT03336645|Midazolam hydrochloride|midazolam hydrochloride
138401|NCT03336645|Convulsive|convulsive
138402|NCT03336632|PBSCT|pbsct
138403|NCT03336632|myeloablative conditioning|myeloablative conditioning
138404|NCT03336632|HDACi|hdaci
138405|NCT03336632|chidamide|chidamide
138406|NCT03336619|Influenza|influenza
138407|NCT03336606|immunotherapy|immunotherapy
138408|NCT03336606|OX40|ox40
138409|NCT03336606|antibodies|antibodies
138410|NCT03336606|HNSCC|hnscc
138411|NCT03336606|melanoma|melanoma
138412|NCT03336606|phase 1|phase 1
138413|NCT03336606|squamous cell|squamous cell
138414|NCT03336567|telephonic interview|telephonic interview
138415|NCT03336567|TCR Therapy|tcr therapy
138416|NCT03336567|cross-sectional|cross-sectional
138417|NCT03336567|CGT|cgt
138418|NCT03336567|qualitative|qualitative
138419|NCT03336554|osteosarcoma|osteosarcoma
138420|NCT03336554|epigenetic biomarker|epigenetic biomarker
138421|NCT03336554|hMe-Seal technique|hme-seal technique
138422|NCT03336541|Prenatal depression|prenatal depression
138423|NCT03336541|Ketamine|ketamine
138424|NCT03336541|Cesarean delivery|cesarean delivery
138425|NCT03336541|Postpartum depression|postpartum depression
138426|NCT03336528|Long-acting insulin analog|long-acting insulin analog
138427|NCT03336515|Positional Obstructive Sleep Apnea|positional obstructive sleep apnea
138428|NCT03336515|Postural Device|postural device
138429|NCT03336515|Treatment|treatment
138430|NCT03336476|Direct laryngoscopy|direct laryngoscopy
138431|NCT03336476|Videolaryngoscopy|videolaryngoscopy
138432|NCT03336476|Diabetes Mellitus|diabetes mellitus
138433|NCT03336476|Intubation|intubation
138434|NCT03336476|Anesthesia|anesthesia
138435|NCT03336463|Thrombophilia screening|thrombophilia screening
138436|NCT03336463|Genetic risk score|genetic risk score
138437|NCT03336437|Menopause|menopause
138438|NCT03336437|Vaginal dryness|vaginal dryness
138439|NCT03336437|Vaginal atrophy|vaginal atrophy
138440|NCT03336437|Postmenopause|postmenopause
138441|NCT03336437|Estrogen|estrogen
138442|NCT03336437|Urinary microbiome|urinary microbiome
138443|NCT03336437|Estradiol vaginal ring|estradiol vaginal ring
138444|NCT03336437|Genitourinary Syndrome of Menopause|genitourinary syndrome of menopause
138445|NCT03336437|Vaginal microbiome|vaginal microbiome
138446|NCT03336424|MS|ms
138447|NCT03336424|Multiple sclerosis|multiple sclerosis
138448|NCT03336424|urinary Bladder, Neurogenic|urinary bladder, neurogenic
138449|NCT03336424|Urodynamics|urodynamics
138450|NCT03336424|Randomized controlled trial|randomized controlled trial
138451|NCT03336385|Older adults|older adults
138452|NCT03336385|Prebiotics|prebiotics
138453|NCT03336385|Intestinal permeability|intestinal permeability
138454|NCT03336385|NSAIDS|nsaids
138455|NCT03336359|colonoscopy|colonoscopy
138456|NCT03336359|image enhanced endoscopy|image enhanced endoscopy
138457|NCT03336346|DTG|dtg
138458|NCT03336346|Dolutegravir|dolutegravir
138459|NCT03336346|Efavirenz|efavirenz
138460|NCT03336346|Etonogestrel|etonogestrel
138461|NCT03336333|zanubrutinib|zanubrutinib
138462|NCT03336333|BTK inhibitor|btk inhibitor
138463|NCT03336333|bendamustine|bendamustine
138464|NCT03336333|rituximab|rituximab
138465|NCT03336333|venetoclax|venetoclax
138466|NCT03336333|BGB-3111|bgb-3111
138467|NCT03336333|Phase 3|phase 3
138468|NCT03336307|Parkinson disease|parkinson disease
138469|NCT03336307|movement Disorders|movement disorders
138470|NCT03336307|gait disturbance|gait disturbance
138471|NCT03336307|Parkinson|parkinson
138472|NCT03336307|Parkinson gait|parkinson gait
138473|NCT03336307|3D motion analysis systems|3d motion analysis systems
138474|NCT03336307|motion analysis|motion analysis
138475|NCT03336307|Parkinson rehabilitation|parkinson rehabilitation
138476|NCT03336307|rehabilitation gait improvement|rehabilitation gait improvement
138477|NCT03336307|gait improvement|gait improvement
138478|NCT03336307|SMART Capture|smart capture
138479|NCT03336307|MATLAB software|matlab software
138480|NCT03336294|Sarcopenia|sarcopenia
138481|NCT03336294|Muscle strength|muscle strength
138482|NCT03336294|SRM P31|srm p31
138483|NCT03336294|Phosphocreatine|phosphocreatine
138484|NCT03336268|Opioid Use Disorder|opioid use disorder
138485|NCT03336268|Peer Recovery Coach|peer recovery coach
138486|NCT03336229|cancer|cancer
138487|NCT03336229|colorectal|colorectal
138488|NCT03336229|exercise|exercise
138489|NCT03336229|physical fitness|physical fitness
138490|NCT03336203|eGFR, gout, CKD, uric acid, uric acid lowering therapy, hyperuricemia, allopurinol, febuxostat|egfr, gout, ckd, uric acid, uric acid lowering therapy, hyperuricemia, allopurinol, febuxostat
138491|NCT03336190|military|military
138492|NCT03336190|caregiver|caregiver
138493|NCT03336177|gynecology|gynecology
138494|NCT03336177|cancer|cancer
138495|NCT03336177|aged|aged
138496|NCT03336177|delay|delay
138497|NCT03336177|help-seeking behavior|help-seeking behavior
138498|NCT03336177|qualitative research|qualitative research
138499|NCT03336177|semiopragmatic analysis|semiopragmatic analysis
138500|NCT03336177|psychodynamic analysis|psychodynamic analysis
138501|NCT03336112|Non-cardiac chest pain|non-cardiac chest pain
138502|NCT03336112|Psychological distress|psychological distress
138503|NCT03336112|I-CBT|i-cbt
138504|NCT03336047|Exercise|exercise
138505|NCT03336047|Actigraphy|actigraphy
138506|NCT03336047|Prevention and Control|prevention and control
138507|NCT03336047|Cardiorespiratory Fitness|cardiorespiratory fitness
138508|NCT03336034|IBS-C|ibs-c
138509|NCT03336034|Experience sampling method|experience sampling method
138510|NCT03336034|Ecological momentary assessment|ecological momentary assessment
138511|NCT03336034|Abdominal pain|abdominal pain
138512|NCT03336034|Constipation|constipation
138513|NCT03335995|mechanical invasive ventilation|mechanical invasive ventilation
138514|NCT03335995|course of the care|course of the care
138515|NCT03335995|prognosis|prognosis
138516|NCT03335995|stroke|stroke
138517|NCT03335982|transendoscopic enteral tubing|transendoscopic enteral tubing
138518|NCT03335982|mid-gut|mid-gut
138519|NCT03335982|endoscopy|endoscopy
138520|NCT03335982|nasal-jejunal tube|nasal-jejunal tube
138521|NCT03335982|fecal microbiota transplantation|fecal microbiota transplantation
138522|NCT03335982|enteral nutrition|enteral nutrition
138523|NCT03335956|Glucocorticoid receptor; antagonist|glucocorticoid receptor; antagonist
138524|NCT03335943|CDA-2, MDS|cda-2, mds
138525|NCT03335930|exercise|exercise
138526|NCT03335930|blood glucose response|blood glucose response
138527|NCT03335930|metabolic control|metabolic control
138528|NCT03335930|type 2 diabetes.|type 2 diabetes.
138529|NCT03335904|Angiotensin receptor blockade|angiotensin receptor blockade
138530|NCT03335904|control of breathing|control of breathing
138531|NCT03335904|breath-holding|breath-holding
138532|NCT03335891|asthma education program|asthma education program
138533|NCT03335891|balance|balance
138534|NCT03335891|core stabilization exercises|core stabilization exercises
138536|NCT03335826|Elderly|elderly
138537|NCT03335826|Cancer surgery|cancer surgery
138538|NCT03335826|Epidural anesthesia and analgesia|epidural anesthesia and analgesia
138539|NCT03335826|Long-term survival|long-term survival
138540|NCT03335826|Quality of life|quality of life
138541|NCT03335813|brachytherapy|brachytherapy
138542|NCT03335813|multichannel balloon applicator|multichannel balloon applicator
138543|NCT03335787|Athletic Tape|athletic tape
138544|NCT03335787|Proprioception|proprioception
138545|NCT03335787|Hemiplegia|hemiplegia
138546|NCT03335787|Gait|gait
138547|NCT03335761|Urinary|urinary
138548|NCT03335761|Incontinence|incontinence
138549|NCT03335748|ADHD|adhd
138550|NCT03335748|Combined type|combined type
138551|NCT03335748|Cognitive training|cognitive training
138552|NCT03335748|Intervention|intervention
138553|NCT03335748|Youths|youths
138554|NCT03335735|alcohol|alcohol
138555|NCT03335735|driving|driving
138556|NCT03335735|breathalyzers|breathalyzers
138557|NCT03335735|smartphone|smartphone
138558|NCT03335722|stammering|stammering
138559|NCT03335722|speech motor disorder|speech motor disorder
138560|NCT03335722|electrical current stimulation|electrical current stimulation
138561|NCT03335722|metronome-timed speech|metronome-timed speech
138562|NCT03335709|Occupational therapy|occupational therapy
138563|NCT03335696|Epidemiology|epidemiology
138564|NCT03335696|Magnetic resonance imaging|magnetic resonance imaging
138565|NCT03335696|Diffusion tensor imaging|diffusion tensor imaging
138566|NCT03335696|White matter|white matter
138567|NCT03335696|Functional MRI|functional mri
138568|NCT03335696|Connectome|connectome
138569|NCT03335696|Resting state brain networks|resting state brain networks
138570|NCT03335696|Neuropsychology|neuropsychology
138571|NCT03335670|68Ga-pentixafor|68ga-pentixafor
138572|NCT03335670|(68Ga)pentixafor|(68ga)pentixafor
138573|NCT03335670|Gallium Radioisotopes|gallium radioisotopes
138574|NCT03335670|CXCR4|cxcr4
138575|NCT03335644|determinants of dietary patterns and nutritional status|determinants of dietary patterns and nutritional status
138576|NCT03335618|Activity|activity
138577|NCT03335618|Mood|mood
138578|NCT03335605|primary immunodeficiency|primary immunodeficiency
138579|NCT03335527|Aged|aged
138580|NCT03335527|Postoperative period|postoperative period
138581|NCT03335527|Intensive Care Unit|intensive care unit
138582|NCT03335527|Mechanical ventilation|mechanical ventilation
138583|NCT03335527|Sleep quality|sleep quality
138584|NCT03335527|Dexmedetomidine|dexmedetomidine
138585|NCT03335514|GALNT4|galnt4
138586|NCT03335501|Closed-loop control|closed-loop control
138587|NCT03335501|Artificial pancreas|artificial pancreas
138588|NCT03335501|Postprandial glucose control|postprandial glucose control
138589|NCT03335501|Insulin|insulin
138590|NCT03335488|Urea|urea
138591|NCT03335488|Hyperammonemic crisis (HAC)|hyperammonemic crisis (hac)
138592|NCT03335475|congenital heart disease|congenital heart disease
138593|NCT03335475|physical activity|physical activity
138594|NCT03335436|buprenorphine maintenance|buprenorphine maintenance
138595|NCT03335397|education|education
138596|NCT03335397|health science|health science
138597|NCT03335397|app|app
138598|NCT03335397|m-learning|m-learning
138599|NCT03335358|couples|couples
138600|NCT03335358|positive psychology|positive psychology
138601|NCT03335358|behavioral intervention|behavioral intervention
138602|NCT03335358|stroke|stroke
138603|NCT03335358|depression|depression
138604|NCT03335358|wellbeing|wellbeing
138605|NCT03335358|caregiver|caregiver
138606|NCT03335345|Airway Extubation/adverse effects/ Methods|airway extubation/adverse effects/ methods
138607|NCT03335345|Nutrition|nutrition
138608|NCT03335345|Ventilator Weaning/methods|ventilator weaning/methods
138609|NCT03335345|Intensive care Unit|intensive care unit
138610|NCT03335345|Enteral Nutrition|enteral nutrition
138611|NCT03335332|High intensity exercise|high intensity exercise
138612|NCT03335332|Cardiorespiratory fitness|cardiorespiratory fitness
138613|NCT03335332|Stroke volume reserve|stroke volume reserve
138614|NCT03335332|Arrhythmia burden|arrhythmia burden
138615|NCT03335319|Cardiovascular Disease|cardiovascular disease
138616|NCT03335319|Coronary Artery Disease|coronary artery disease
138617|NCT03335319|Cardiopulmonary Exercise Testing|cardiopulmonary exercise testing
138618|NCT03335319|Oxygen Uptake Kinetics|oxygen uptake kinetics
138619|NCT03335319|Skeletal Muscle Oxygenation|skeletal muscle oxygenation
138620|NCT03335319|Exercise Training|exercise training
138621|NCT03335319|Periodized Exercise|periodized exercise
138622|NCT03335306|Body constitution|body constitution
138623|NCT03335306|Chinese Medicine|chinese medicine
138624|NCT03335306|Validation|validation
138625|NCT03335293|pregnancy|pregnancy
138626|NCT03335293|repeat cesarean section|repeat cesarean section
138627|NCT03335293|spinal anesthesia|spinal anesthesia
138628|NCT03335293|bupivacaine|bupivacaine
138629|NCT03335293|epinephrine|epinephrine
138630|NCT03335293|intrathecal|intrathecal
138631|NCT03335293|analgesia|analgesia
138632|NCT03335254|Hypogonadism|hypogonadism
138633|NCT03335254|Testosterone|testosterone
138634|NCT03335254|Testosterone undecanoate|testosterone undecanoate
138635|NCT03335241|Ovarian Cancer|ovarian cancer
138636|NCT03335241|Fludarabine|fludarabine
138637|NCT03335241|Pegylated Liposomal Doxorubicin|pegylated liposomal doxorubicin
138638|NCT03335241|Chemotherapy|chemotherapy
138639|NCT03335228|platelet rich plasma, frontal fibrosing alopecia|platelet rich plasma, frontal fibrosing alopecia
138640|NCT03335202|respiratory and intestinal microbiome|respiratory and intestinal microbiome
138641|NCT03335202|antibiotic therapy|antibiotic therapy
138642|NCT03335202|cftr modifier|cftr modifier
138643|NCT03335202|diversity|diversity
138644|NCT03335189|E-Health|e-health
138645|NCT03335189|Smartphone technology|smartphone technology
138646|NCT03335189|Real-time symptom assessment|real-time symptom assessment
138647|NCT03335189|Self-care|self-care
138648|NCT03335189|Symptom management|symptom management
138649|NCT03335150|Parkinson's disease|parkinson's disease
138650|NCT03335150|Rehabilitation|rehabilitation
138651|NCT03335150|Cognition|cognition
138652|NCT03335124|Sepsis|sepsis
138653|NCT03335124|Vitamin C|vitamin c
138654|NCT03335124|Hydrocortisone|hydrocortisone
138655|NCT03335124|Thiamine|thiamine
138656|NCT03335124|Critical Illness|critical illness
138657|NCT03335124|Fluid Responsiveness|fluid responsiveness
138658|NCT03335124|Hemodynamics|hemodynamics
138659|NCT03335111|Remote Ischemic Postconditioning|remote ischemic postconditioning
138660|NCT03335111|Peripheral Immunity|peripheral immunity
138661|NCT03335098|Waldenstrom's macroglobulinemia|waldenstrom's macroglobulinemia
138662|NCT03335098|Lymphoplasmacytic lymphoma|lymphoplasmacytic lymphoma
138663|NCT03335098|Bortezomib|bortezomib
138664|NCT03335098|Thalidomide|thalidomide
138665|NCT03335072|Azithromycin|azithromycin
138666|NCT03335072|Mass Drug Administration|mass drug administration
138667|NCT03335072|Antibiotic Resistance|antibiotic resistance
138668|NCT03335059|BCG|bcg
138669|NCT03335059|Bacillus Calmette-Guérin|bacillus calmette-guérin
138670|NCT03335059|CIS|cis
138671|NCT03335059|BCG-unresponsive|bcg-unresponsive
138672|NCT03335059|Synergo|synergo
138673|NCT03335059|chemohyperthermia|chemohyperthermia
138674|NCT03335059|thermochemotherapy|thermochemotherapy
138675|NCT03335059|RF|rf
138676|NCT03335059|radio frequency|radio frequency
138677|NCT03335059|RITE|rite
138678|NCT03335046|Home Visit|home visit
138679|NCT03335046|School Absenteeism|school absenteeism
138680|NCT03335033|Carotid Plaque|carotid plaque
138681|NCT03335033|Contrast Enhanced Ultrasound|contrast enhanced ultrasound
138682|NCT03335033|Shear Wave Elastography|shear wave elastography
138683|NCT03335033|Endarterectomy|endarterectomy
138684|NCT03335033|Stenosis|stenosis
138685|NCT03335020|Ultrasound|ultrasound
138686|NCT03335020|3D ultrasonography|3d ultrasonography
138687|NCT03335020|Contrast-enhanced ultrasound|contrast-enhanced ultrasound
138688|NCT03335020|Shear wave elastography|shear wave elastography
138689|NCT03335007|Aceclofenac|aceclofenac
138690|NCT03335007|pain|pain
138691|NCT03335007|irreversible pulpitis|irreversible pulpitis
138692|NCT03334994|Immediate dental implant, Connective tissue graft, Esthetic zone.|immediate dental implant, connective tissue graft, esthetic zone.
138693|NCT03334981|meconium concentration|meconium concentration
138694|NCT03334981|buprenorphine|buprenorphine
138695|NCT03334981|methadone|methadone
138696|NCT03334981|pregnant|pregnant
138697|NCT03334981|liquid chromatography-tandem mass spectrometry|liquid chromatography-tandem mass spectrometry
138698|NCT03334981|opioid-dependant woman|opioid-dependant woman
138699|NCT03334968|Stroke|stroke
138700|NCT03334968|prolidase|prolidase
138701|NCT03334968|prognosis|prognosis
138702|NCT03334968|biomarker|biomarker
138703|NCT03334955|Polycystic Ovary Syndrome|polycystic ovary syndrome
138704|NCT03334955|Laparoscopic ovarian drilling|laparoscopic ovarian drilling
138705|NCT03334955|subendometrial blood flow|subendometrial blood flow
138706|NCT03334942|youth|youth
138707|NCT03334942|parents|parents
138708|NCT03334942|posttraumatic stress|posttraumatic stress
138709|NCT03334942|violence|violence
138710|NCT03334942|violent injuries|violent injuries
138711|NCT03334929|virtual reality|virtual reality
138712|NCT03334929|trigger point injections|trigger point injections
138713|NCT03334903|Total Knee Arthroplasty|total knee arthroplasty
138714|NCT03334903|Neurontin|neurontin
138715|NCT03334903|Gabapentin|gabapentin
138716|NCT03334903|Opioid Tapering|opioid tapering
138717|NCT03334890|colorectal cancer|colorectal cancer
138718|NCT03334890|septin 9|septin 9
138719|NCT03334890|SEPT9|sept9
138720|NCT03334890|methylation|methylation
138721|NCT03334890|CEA|cea
138722|NCT03334864|Advanced non-small cell lung cancer|advanced non-small cell lung cancer
138723|NCT03334838|Food effect|food effect
138724|NCT03334838|Dose proportionality|dose proportionality
138725|NCT03334825|HIV|hiv
138726|NCT03334825|housing|housing
138727|NCT03334825|homelessness|homelessness
138728|NCT03334812|cartilage lesion, ACI|cartilage lesion, aci
138729|NCT03334799|sacroiliac belt|sacroiliac belt
138730|NCT03334799|kinematics|kinematics
138731|NCT03334799|stability|stability
138732|NCT03334799|pelvic girdle pain|pelvic girdle pain
138733|NCT03334799|sacroiliac instability|sacroiliac instability
138734|NCT03334786|ALS|als
138735|NCT03334786|Amyotrophic Lateral Sclerosis|amyotrophic lateral sclerosis
138736|NCT03334786|Fasciculation|fasciculation
138737|NCT03334786|FLX-787|flx-787
138738|NCT03334773|Type 2 diabetes, nutrition education programme, intervention, South Africa|type 2 diabetes, nutrition education programme, intervention, south africa
138739|NCT03334760|Cohort study|cohort study
138740|NCT03334760|Infant feeding|infant feeding
138741|NCT03334760|Overweight|overweight
138742|NCT03334760|Child BMI|child bmi
138743|NCT03334760|Breastfeeding|breastfeeding
138744|NCT03334760|Intake of protein|intake of protein
138745|NCT03334747|uncomplicated Plasmodium falciparum Malaria.|uncomplicated plasmodium falciparum malaria.
138746|NCT03334734|Tuberculosis|tuberculosis
138747|NCT03334734|PBTZ169|pbtz169
138748|NCT03334734|antimycobacterial|antimycobacterial
138749|NCT03334708|17-257|17-257
138750|NCT03334669|Childhood obesity|childhood obesity
138751|NCT03334669|Preschool|preschool
138752|NCT03334669|Head Start|head start
138753|NCT03334669|Family Interventions|family interventions
138754|NCT03334669|Community Based Participatory Research (CBPR)|community based participatory research (cbpr)
138755|NCT03334669|Empowerment Theory|empowerment theory
138756|NCT03334669|Family Ecological Theory|family ecological theory
138757|NCT03334669|Step Wedge Design|step wedge design
138758|NCT03334669|Low Income|low income
138759|NCT03334656|Split thickness skin graft donor site|split thickness skin graft donor site
138760|NCT03334656|wound healing|wound healing
138761|NCT03334656|Fetal skin bioconstruct|fetal skin bioconstruct
138762|NCT03334656|Fibroblasts|fibroblasts
138763|NCT03334656|Keratinocytes|keratinocytes
138764|NCT03334643|Type 2 Diabetes|type 2 diabetes
138765|NCT03334643|Dietary fiber|dietary fiber
138766|NCT03334643|Glycemic response|glycemic response
138767|NCT03334630|ablation|ablation
138768|NCT03334630|electrophysiology|electrophysiology
138769|NCT03334630|atrial fibrillation|atrial fibrillation
138770|NCT03334630|catheter|catheter
138771|NCT03334630|paroxysmal|paroxysmal
138772|NCT03334617|Non-small cell lung cancer|non-small cell lung cancer
138773|NCT03334617|NSCLC|nsclc
138774|NCT03334617|anti-PD-1/PD-L1|anti-pd-1/pd-l1
138775|NCT03334617|umbrella study|umbrella study
138776|NCT03334617|Durvalumab|durvalumab
138777|NCT03334617|MEDI4736|medi4736
138778|NCT03334617|Olaparib|olaparib
138779|NCT03334617|AZD2281|azd2281
138780|NCT03334617|AZD9150|azd9150
138781|NCT03334617|AZD6738|azd6738
138782|NCT03334617|Vistusertib|vistusertib
138783|NCT03334617|AZD2014|azd2014
138784|NCT03334617|Oleclumab|oleclumab
138785|NCT03334617|MEDI9447|medi9447
138786|NCT03334604|antibiotic-associated diarrhea|antibiotic-associated diarrhea
138787|NCT03334604|probiotics|probiotics
138788|NCT03334513|Bevacizumab|bevacizumab
138789|NCT03334513|Biometry|biometry
138790|NCT03334513|Ranibizumab|ranibizumab
138791|NCT03334513|Refractive error|refractive error
138792|NCT03334513|Retinopathy of prematurity|retinopathy of prematurity
138793|NCT03334487|Cancer|cancer
138794|NCT03334487|Small Cell Lung Cancer|small cell lung cancer
138795|NCT03334487|Relapsed Small Cell Lung Cancer|relapsed small cell lung cancer
138796|NCT03334487|Remitting Small Cell Lung Cancer|remitting small cell lung cancer
138797|NCT03334487|Delta-like protein 3 (DLL3)|delta-like protein 3 (dll3)
138798|NCT03334487|DLL3 Expressing Small Cell Lung Cancer|dll3 expressing small cell lung cancer
138799|NCT03334487|Rovalpituzumab Tesirine|rovalpituzumab tesirine
138800|NCT03334461|Oral antiseptics|oral antiseptics
138801|NCT03334461|remineralisation agents|remineralisation agents
138802|NCT03334435|eczema|eczema
138803|NCT03334435|atopic eczema|atopic eczema
138804|NCT03334422|eczema|eczema
138805|NCT03334422|atopic eczema|atopic eczema
138806|NCT03334396|eczema|eczema
138807|NCT03334396|atopic eczema|atopic eczema
138808|NCT03334383|Laparoscopic colorectal surgery|laparoscopic colorectal surgery
138809|NCT03334383|Retractor sponge|retractor sponge
138810|NCT03334383|Trendelenburg position|trendelenburg position
138811|NCT03334383|Postoperative complications|postoperative complications
138812|NCT03334370|Diabetes mellitus|diabetes mellitus
138813|NCT03334357|Physical fitness|physical fitness
138814|NCT03334357|Klotho|klotho
138815|NCT03334357|Training|training
138816|NCT03334357|HIIT|hiit
138817|NCT03334357|WB-EMS|wb-ems
138818|NCT03334292|Wilson Disease|wilson disease
138819|NCT03334266|sugar|sugar
138820|NCT03334266|sweetened|sweetened
138821|NCT03334266|beverages|beverages
138822|NCT03334266|responsive|responsive
138823|NCT03334253|Myopia|myopia
138824|NCT03334253|atropine|atropine
138825|NCT03334240|HPV|hpv
138826|NCT03334240|Digoxin|digoxin
138827|NCT03334240|Furosemide|furosemide
138828|NCT03334240|Vulvar HSIL|vulvar hsil
138829|NCT03334227|High-Flow Nasal Cannula|high-flow nasal cannula
138830|NCT03334227|Severe Sepsis|severe sepsis
138831|NCT03334227|qSOFA|qsofa
138832|NCT03334214|Hepatic Steatosis|hepatic steatosis
138833|NCT03334214|IONIS-DGAT2Rx|ionis-dgat2rx
138834|NCT03334214|Type 2 Diabetes|type 2 diabetes
138835|NCT03334162|Children|children
138836|NCT03334162|Adolescents|adolescents
138837|NCT03334162|Cancer|cancer
138838|NCT03334162|brain Tumor|brain tumor
138839|NCT03334162|exercise|exercise
138840|NCT03334162|Chemotherapy-induced Peripheral Neuropathy|chemotherapy-induced peripheral neuropathy
138841|NCT03334162|CIPN|cipn
138842|NCT03334162|Sensorimotor Training|sensorimotor training
138843|NCT03334123|exercise|exercise
138844|NCT03334123|aerobic exercise|aerobic exercise
138845|NCT03334123|functional training|functional training
138846|NCT03334123|strength training|strength training
138847|NCT03334123|resistance training|resistance training
138848|NCT03334123|kidney failure|kidney failure
138849|NCT03334123|rehabilitation|rehabilitation
138850|NCT03334123|physical activity|physical activity
138851|NCT03334123|hemodialysis|hemodialysis
138852|NCT03334123|dialysis patients|dialysis patients
138853|NCT03334123|chronic renal failure|chronic renal failure
138854|NCT03334123|chronic kidney disease|chronic kidney disease
138855|NCT03334123|end-stage renal disease|end-stage renal disease
138856|NCT03334123|intradialytic exercise|intradialytic exercise
138857|NCT03334097|Pregnancy|pregnancy
138858|NCT03334097|fear|fear
138859|NCT03334097|Parturition|parturition
138860|NCT03334097|Prenatal Education|prenatal education
138861|NCT03334045|Neurobiology|neurobiology
138862|NCT03334045|Occupational Stress|occupational stress
138863|NCT03334045|Dopamine|dopamine
138864|NCT03334032|Body composition|body composition
138865|NCT03334032|Total body protein|total body protein
138866|NCT03334032|nutritional recovery|nutritional recovery
138867|NCT03334032|Exercise status|exercise status
138868|NCT03334032|In-vivo neutron activation analysis|in-vivo neutron activation analysis
138869|NCT03334032|Protein depletion|protein depletion
138870|NCT03334006|Pentaglobin®|pentaglobin®
138871|NCT03334006|Personalised Medicine|personalised medicine
138872|NCT03333993|Pilates exercise|pilates exercise
138873|NCT03333993|Fatigue|fatigue
138874|NCT03333993|Quality of Life|quality of life
138875|NCT03333967|apatinib|apatinib
138876|NCT03333954|atrophic macular degeneration|atrophic macular degeneration
138877|NCT03333954|geographic atrophy|geographic atrophy
138878|NCT03333954|macular degeneration|macular degeneration
138879|NCT03333954|dry macular degeneration|dry macular degeneration
138880|NCT03333954|AMD|amd
138881|NCT03333954|retina implant|retina implant
138882|NCT03333954|retinal prosthesis|retinal prosthesis
138883|NCT03333954|visual prosthesis|visual prosthesis
138884|NCT03333902|quadratus lumborum block|quadratus lumborum block
138885|NCT03333902|anesthesia|anesthesia
138886|NCT03333902|pain, postoperative|pain, postoperative
138887|NCT03333837|Improvisation|improvisation
138888|NCT03333837|Memory loss|memory loss
138889|NCT03333837|Caregivers|caregivers
138890|NCT03333837|Quality of Life|quality of life
138891|NCT03333837|Dance|dance
138892|NCT03333837|Social Group|social group
138893|NCT03333837|MRI|mri
138894|NCT03333837|mild cognitive impairment|mild cognitive impairment
138895|NCT03333837|MCI|mci
138896|NCT03333837|Social engagement|social engagement
138897|NCT03333824|Pharmacokinetics, Cardiac Conduction, Mitotic Checkpoint inhibitor, QTc interval|pharmacokinetics, cardiac conduction, mitotic checkpoint inhibitor, qtc interval
138898|NCT03333798|Intimate Partner Violence|intimate partner violence
138899|NCT03333798|Domestic Violence|domestic violence
138900|NCT03333798|Mental Health|mental health
138901|NCT03333798|Cognitive- Behavioral Therapy|cognitive- behavioral therapy
138902|NCT03333798|Community Lay Workers|community lay workers
138903|NCT03333785|Primary Care|primary care
138904|NCT03333785|Oncology|oncology
138905|NCT03333785|Continuity of care|continuity of care
138906|NCT03333785|Integration of care|integration of care
138907|NCT03333785|Communication|communication
138908|NCT03333759|laser|laser
138909|NCT03333759|Er:YAG laser|er:yag laser
138910|NCT03333759|acne|acne
138911|NCT03333759|acne vulgaris|acne vulgaris
138912|NCT03333759|optical coherence tomography|optical coherence tomography
138913|NCT03333720|Phenylketonuria|phenylketonuria
138914|NCT03333720|Inherited Metabolic Disorders|inherited metabolic disorders
138915|NCT03333694|Cutaneous Squamous Cell Carcinoma (cSCC) in situ, mTOR kinase inhibitors, PI3K inhibitor.|cutaneous squamous cell carcinoma (cscc) in situ, mtor kinase inhibitors, pi3k inhibitor.
138916|NCT03333681|Rheumatoid arthritis|rheumatoid arthritis
138917|NCT03333681|Stem Cells|stem cells
138918|NCT03333681|Cellular immunity|cellular immunity
138919|NCT03333681|Humoral immunity|humoral immunity
138920|NCT03333681|chemokines|chemokines
138921|NCT03333681|homing of immune cells|homing of immune cells
138922|NCT03333668|Lisdexamfetamine|lisdexamfetamine
138923|NCT03333668|Guanfacine|guanfacine
138924|NCT03333668|functional Magnetic Resonance Imaging|functional magnetic resonance imaging
138925|NCT03333668|Attention Deficit Hyperactivity Disorder|attention deficit hyperactivity disorder
138926|NCT03333655|Metastatic Cancer|metastatic cancer
138927|NCT03333642|diabetes|diabetes
138928|NCT03333642|metabolic surgery|metabolic surgery
138929|NCT03333642|ileal interposition|ileal interposition
138930|NCT03333629|Autistic Disorder|autistic disorder
138931|NCT03333629|Early Detection|early detection
138932|NCT03333629|Early Intervention|early intervention
138933|NCT03333616|Genitourinary Cancer|genitourinary cancer
138934|NCT03333603|Schizophrenia|schizophrenia
138935|NCT03333590|DMD|dmd
138936|NCT03333590|Duchenne Muscular Dystrophy|duchenne muscular dystrophy
138937|NCT03333564|Vitamin D3|vitamin d3
138938|NCT03333564|Vitamin D deficiency|vitamin d deficiency
138939|NCT03333564|estradiol|estradiol
138940|NCT03333564|omega-3 fatty acids|omega-3 fatty acids
138941|NCT03333564|menopausal|menopausal
138942|NCT03333551|AL Cardiac Amyloidosis|al cardiac amyloidosis
138943|NCT03333551|18F-Florbetapir (Amyvid)|18f-florbetapir (amyvid)
138944|NCT03333538|Hemorrhagic Fever, Ebola|hemorrhagic fever, ebola
138945|NCT03333538|Ebola Virus Disease|ebola virus disease
138946|NCT03333538|Ebola Virus Vaccines|ebola virus vaccines
138947|NCT03333538|Hemorrhagic Fevers, Viral|hemorrhagic fevers, viral
138948|NCT03333538|GP protein, Ebola virus|gp protein, ebola virus
138949|NCT03333538|Filoviridae Infections|filoviridae infections
138950|NCT03333538|RNA Virus Infections|rna virus infections
138951|NCT03333525|Fat-protein counting|fat-protein counting
138952|NCT03333525|Type 1 diabetes|type 1 diabetes
138953|NCT03333525|Postprandial glucose level|postprandial glucose level
138954|NCT03333512|Nap|nap
138955|NCT03333512|Recovery Sleep|recovery sleep
138956|NCT03333512|Cognitive Functions|cognitive functions
138957|NCT03333512|Glucose Metabolism|glucose metabolism
138958|NCT03333512|Neurobehavioral Functions|neurobehavioral functions
138959|NCT03333512|Mood|mood
138960|NCT03333512|Subjective Sleepiness|subjective sleepiness
138961|NCT03333460|cocaine|cocaine
138962|NCT03333460|addiction|addiction
138963|NCT03333460|transcranial magnetic stimulation|transcranial magnetic stimulation
138964|NCT03333460|neuromodulation|neuromodulation
138965|NCT03333460|neuroimaging|neuroimaging
138966|NCT03333460|brain stimulation|brain stimulation
138967|NCT03333395|Mechanical ventilation|mechanical ventilation
138968|NCT03333395|Acute Exacerbation of chronic obstructive airway disease (AECOPD)|acute exacerbation of chronic obstructive airway disease (aecopd)
138969|NCT03333395|Nebulized heparin|nebulized heparin
138970|NCT03333395|C-Reactive Protein (CRP|c-reactive protein (crp
138971|NCT03333369|resting-state functional MRI|resting-state functional mri
138972|NCT03333369|Dopamine|dopamine
138973|NCT03333369|functional connectivity|functional connectivity
138974|NCT03333343|EGFR-mutant NSCLC|egfr-mutant nsclc
138975|NCT03333343|EGF816|egf816
138976|NCT03333343|LXH254|lxh254
138977|NCT03333343|INC280|inc280
138978|NCT03333343|ribociclib|ribociclib
138979|NCT03333343|trametinib|trametinib
138980|NCT03333343|gefitinib|gefitinib
138981|NCT03333343|EGFR T790M|egfr t790m
138982|NCT03333343|BRAF mutation|braf mutation
138983|NCT03333343|BRAF fusion|braf fusion
138984|NCT03333343|BRAF rearrangement|braf rearrangement
138985|NCT03333343|MET amplification|met amplification
138986|NCT03333330|Carotid atherosclerosis|carotid atherosclerosis
138987|NCT03333330|Carotid plaque|carotid plaque
138988|NCT03333330|Brain magnetic resonance imaging|brain magnetic resonance imaging
138989|NCT03333330|Contrast enhanced ultrasound|contrast enhanced ultrasound
138990|NCT03333330|Carotid CT angiography|carotid ct angiography
138991|NCT03333330|Silent brain ischemia|silent brain ischemia
138992|NCT03333330|Vascular cognitive impairment|vascular cognitive impairment
138993|NCT03333304|Procalcitonin|procalcitonin
138994|NCT03333278|Critical Care|critical care
138995|NCT03333278|Shock, Septic|shock, septic
138996|NCT03333278|Ascorbic Acid|ascorbic acid
138997|NCT03333278|Adult|adult
138998|NCT03333252|Caregiver|caregiver
138999|NCT03333252|Psycho-social intervention|psycho-social intervention
139000|NCT03333252|Cognitive training|cognitive training
139001|NCT03333252|Quality of life|quality of life
139002|NCT03333252|Early on-set Alzheimer's Disease|early on-set alzheimer's disease
139003|NCT03333239|childhood and adolescence|childhood and adolescence
139004|NCT03333226|Breast Neoplasms|breast neoplasms
139005|NCT03333226|Sentinel Lymph Node Biopsy|sentinel lymph node biopsy
139006|NCT03333226|Lymph Node Excision|lymph node excision
139007|NCT03333226|Technetium Tc 99m|technetium tc 99m
139008|NCT03333226|Indocyanine Green|indocyanine green
139009|NCT03333226|Lymphatic System|lymphatic system
139010|NCT03333226|Secondary Prevention|secondary prevention
139011|NCT03333200|Pediatric|pediatric
139012|NCT03333200|Rare|rare
139013|NCT03333200|Neurodegenerative|neurodegenerative
139014|NCT03333200|Genetic|genetic
139015|NCT03333200|Neurodevelopment|neurodevelopment
139016|NCT03333200|Brain|brain
139017|NCT03333200|MRI|mri
139018|NCT03333200|Biorepository|biorepository
139019|NCT03333200|NDRD|ndrd
139020|NCT03333200|Longitudinal|longitudinal
139021|NCT03333200|Cognitive|cognitive
139022|NCT03333200|Motor|motor
139023|NCT03333200|Language|language
139024|NCT03333200|Adaptive behavior|adaptive behavior
139025|NCT03333187|Myelofibrosis, Myeloproliferative Disease|myelofibrosis, myeloproliferative disease
139026|NCT03333174|apnea of prematurity|apnea of prematurity
139027|NCT03333174|bradycardia|bradycardia
139028|NCT03333174|hypoxemic episode|hypoxemic episode
139029|NCT03333174|oxygen delivery|oxygen delivery
139030|NCT03333161|apnea of prematurity|apnea of prematurity
139031|NCT03333161|bradycardia|bradycardia
140216|NCT03325881|SHP465|shp465
139032|NCT03333161|hypoxemic episode|hypoxemic episode
139033|NCT03333161|permissive hypercapnia|permissive hypercapnia
139034|NCT03333148|Colorectal Surgery|colorectal surgery
139035|NCT03333148|Immunonutrition|immunonutrition
139036|NCT03333148|Complications|complications
139037|NCT03333148|Microbiome|microbiome
139038|NCT03333148|Preoperative nutrition|preoperative nutrition
139039|NCT03333135|Ultramarathons|ultramarathons
139040|NCT03333135|Electromagnetic field therapy|electromagnetic field therapy
139041|NCT03333135|Endurance|endurance
139042|NCT03333135|Exercise|exercise
139043|NCT03333135|Environmental conditions|environmental conditions
139044|NCT03333109|AMG 334, erenumab, migraine, episodic, headache, CGRP|amg 334, erenumab, migraine, episodic, headache, cgrp
139045|NCT03333096|Glaucoma|glaucoma
139046|NCT03333096|Mild Cognitive Impairment|mild cognitive impairment
139047|NCT03333096|Ocusweep|ocusweep
139048|NCT03333096|Reaction Time|reaction time
139049|NCT03333096|Neuropsychology|neuropsychology
139050|NCT03333096|Dementia|dementia
139051|NCT03333096|Alzheimer's Disease|alzheimer's disease
139052|NCT03333096|Brain Diseases|brain diseases
139053|NCT03333083|Lamivudine|lamivudine
139054|NCT03333083|Raltegravir|raltegravir
139055|NCT03333031|cancer|cancer
139056|NCT03333031|imaging agent|imaging agent
139057|NCT03333031|HSP90|hsp90
139058|NCT03333018|COPD|copd
139059|NCT03332979|pre-death grief|pre-death grief
139060|NCT03332979|palliative care|palliative care
139061|NCT03332979|dementia|dementia
139062|NCT03332979|caregiver|caregiver
139063|NCT03332979|preparation for end of life|preparation for end of life
139064|NCT03332966|adolescent|adolescent
139065|NCT03332966|outpatients|outpatients
139066|NCT03332966|questionnaire|questionnaire
139067|NCT03332966|psychotic-like symptoms|psychotic-like symptoms
139068|NCT03332966|psychosis risk|psychosis risk
139069|NCT03332940|Tc99m-tilmanocept|tc99m-tilmanocept
139070|NCT03332940|Tilmanocept|tilmanocept
139071|NCT03332940|NASH|nash
139072|NCT03332940|Nonalcoholic Steatohepatitis|nonalcoholic steatohepatitis
139073|NCT03332914|Osteoarthritis|osteoarthritis
139074|NCT03332914|microcurrent|microcurrent
139075|NCT03332914|knee|knee
139076|NCT03332914|electrotherapy|electrotherapy
139077|NCT03332875|OurRelationship|ourrelationship
139078|NCT03332875|Couple therapy|couple therapy
139079|NCT03332875|Internet|internet
139080|NCT03332875|Marriage Counseling|marriage counseling
139081|NCT03332862|Catheter Ablation|catheter ablation
139082|NCT03332862|Atrial Fibrillation|atrial fibrillation
139083|NCT03332862|Contact Force|contact force
139084|NCT03332862|Continuous Ablation|continuous ablation
139085|NCT03332823|Mental health|mental health
139086|NCT03332823|Mental well-being|mental well-being
139087|NCT03332823|Community-based engagement|community-based engagement
139088|NCT03332823|Positive psychology|positive psychology
139089|NCT03332823|Public health approach|public health approach
139090|NCT03332810|Mental health|mental health
139091|NCT03332810|Mental well-being|mental well-being
139092|NCT03332810|Community-based engagement|community-based engagement
139093|NCT03332810|Positive psychology|positive psychology
139094|NCT03332810|Public health approach|public health approach
139095|NCT03332758|retinal detachment|retinal detachment
139096|NCT03332758|inflammasome|inflammasome
139097|NCT03332758|macular hole|macular hole
139098|NCT03332745|Troponin|troponin
139099|NCT03332732|Healthy Volunteers|healthy volunteers
139100|NCT03332732|Pharmacokinetics|pharmacokinetics
139101|NCT03332654|Urinary Incontinence, Stress|urinary incontinence, stress
139102|NCT03332654|Multiple Sclerosis|multiple sclerosis
139103|NCT03332654|Lower Urinary Tract Symptoms|lower urinary tract symptoms
139104|NCT03332628|Peer Reviewed Research|peer reviewed research
139105|NCT03332615|Palliative Care|palliative care
139106|NCT03332602|Iron deficiency|iron deficiency
139107|NCT03332602|Iron fortification|iron fortification
139108|NCT03332602|Iron encapsulation|iron encapsulation
139109|NCT03332589|Melanoma|melanoma
139110|NCT03332589|CNS metastases|cns metastases
139111|NCT03332589|BRAF mutation|braf mutation
139112|NCT03332589|MEK mutation|mek mutation
139113|NCT03332589|E6201|e6201
139114|NCT03332576|vaccine|vaccine
139115|NCT03332576|immunotherapy|immunotherapy
139116|NCT03332576|combination therapy|combination therapy
139117|NCT03332563|Adolescent|adolescent
139118|NCT03332563|Cognitive Behavioral Therapy|cognitive behavioral therapy
139119|NCT03332563|Chronic Pain|chronic pain
139120|NCT03332563|smartphone application|smartphone application
139121|NCT03332563|internet-delivered|internet-delivered
139122|NCT03332550|laparoscopic lavage|laparoscopic lavage
139123|NCT03332537|Young Adults|young adults
139125|NCT03332537|Self Management|self management
139126|NCT03332537|Pain|pain
139127|NCT03332537|Gut microbiome|gut microbiome
139128|NCT03332537|Genetics|genetics
139129|NCT03332537|Online education|online education
139130|NCT03332524|1st degree burn|1st degree burn
139131|NCT03332498|colon|colon
139132|NCT03332498|rectum|rectum
139133|NCT03332498|advanced|advanced
139134|NCT03332498|refractory|refractory
139135|NCT03332472|type 1 diabetes|type 1 diabetes
139136|NCT03332446|cold water immersion, strength training, training effect|cold water immersion, strength training, training effect
139137|NCT03332433|Hypoxia|hypoxia
139138|NCT03332433|Gastroscope|gastroscope
139139|NCT03332433|High-flow nasal cannula|high-flow nasal cannula
139140|NCT03332420|Huaiqihuang granule|huaiqihuang granule
139141|NCT03332420|primary nephrotic syndrome|primary nephrotic syndrome
139142|NCT03332420|multisite|multisite
139143|NCT03332420|prospective|prospective
139144|NCT03332420|open-label|open-label
139145|NCT03332407|Postoperative delirium|postoperative delirium
139146|NCT03332407|Sleep quality|sleep quality
139147|NCT03332407|Pediatric anesthesia|pediatric anesthesia
139148|NCT03332407|Strabismus surgery|strabismus surgery
139149|NCT03332394|Care Model|care model
139150|NCT03332394|COPD|copd
139151|NCT03332394|Exacerbations|exacerbations
139152|NCT03332394|Health Confidence Score|health confidence score
139153|NCT03332368|Triple-negative breast cancer|triple-negative breast cancer
139154|NCT03332368|Traditional Chinese Medicine|traditional chinese medicine
139155|NCT03332355|glioblastoma multiforme|glioblastoma multiforme
139156|NCT03332355|anaplastic astrocytoma|anaplastic astrocytoma
139157|NCT03332355|high grade glioma|high grade glioma
139158|NCT03332355|temozolomide|temozolomide
139159|NCT03332355|PROCASPASE ACTIVATING COMPOUND-1 (PAC-1)|procaspase activating compound-1 (pac-1)
139160|NCT03332355|advanced malignancy|advanced malignancy
139161|NCT03332355|maximal tolerated dose (MTD)|maximal tolerated dose (mtd)
139162|NCT03332342|dry eye disease|dry eye disease
139163|NCT03332342|tears|tears
139164|NCT03332342|inflammation|inflammation
139165|NCT03332342|ocular surface|ocular surface
139166|NCT03332329|HBsAg|hbsag
139167|NCT03332329|PegIFN|pegifn
139168|NCT03332329|ETV|etv
139169|NCT03332329|Chronic Hepatitis B (CHB)|chronic hepatitis b (chb)
139170|NCT03332329|HBV|hbv
139171|NCT03332329|GMCSF|gmcsf
139172|NCT03332303|Vaginal Dryness|vaginal dryness
139173|NCT03332303|Vaginal and/or Vulvar Irritation/Itching|vaginal and/or vulvar irritation/itching
139174|NCT03332303|Dysuria|dysuria
139175|NCT03332303|Vaginal Pain and Bleeding|vaginal pain and bleeding
139176|NCT03332277|Active Bodysuits|active bodysuits
139177|NCT03332264|PAOD|paod
139178|NCT03332264|drug coated balloon|drug coated balloon
139179|NCT03332264|drug coated stent|drug coated stent
139180|NCT03332264|percutaneous transluminal angioplasty (PTA)|percutaneous transluminal angioplasty (pta)
139181|NCT03332251|Posture Correction Girdle|posture correction girdle
139182|NCT03332225|sepsis|sepsis
139183|NCT03332225|macrophage activation syndrome|macrophage activation syndrome
139184|NCT03332225|immunoparalysis|immunoparalysis
139185|NCT03332225|anakinra|anakinra
139186|NCT03332225|recombinant human interferon-gamma|recombinant human interferon-gamma
139187|NCT03332225|HLA-DR|hla-dr
139188|NCT03332199|symptom cluster|symptom cluster
139189|NCT03332199|oncology|oncology
139190|NCT03332199|psychoeducation|psychoeducation
139191|NCT03332199|symptom management|symptom management
139192|NCT03332199|fatigue|fatigue
139193|NCT03332199|pain|pain
139194|NCT03332199|sleep disturbance|sleep disturbance
139195|NCT03332160|Lymphedema|lymphedema
139196|NCT03332160|Cancer|cancer
139197|NCT03332160|Head Cancer|head cancer
139198|NCT03332160|Neck Cancer|neck cancer
139199|NCT03332160|Head and Neck Cancer|head and neck cancer
139200|NCT03332108|mobile health (mHealth)|mobile health (mhealth)
139201|NCT03332108|electronic health (eHealth)|electronic health (ehealth)
139202|NCT03332108|breastfeeding|breastfeeding
139203|NCT03332108|infant nutrition|infant nutrition
139204|NCT03332108|text messaging intervention|text messaging intervention
139205|NCT03332069|Hyperthermia|hyperthermia
139206|NCT03332069|cervix|cervix
139207|NCT03332069|HIV|hiv
139208|NCT03332056|Ureteral stent pain|ureteral stent pain
139209|NCT03332056|nephrolithiasis|nephrolithiasis
139210|NCT03332056|kidney stone|kidney stone
139211|NCT03332043|HIRREM|hirrem
139212|NCT03332043|Neurotechnology|neurotechnology
139213|NCT03332043|Closed-loop|closed-loop
139214|NCT03332043|Acoustic stimulation|acoustic stimulation
139215|NCT03332043|Allostatic|allostatic
139216|NCT03332043|Heart rate variability|heart rate variability
139217|NCT03332043|Baroreflex sensitivity|baroreflex sensitivity
139218|NCT03332043|Blood pressure management|blood pressure management
139219|NCT03332043|Autocalibration|autocalibration
139220|NCT03332043|Neural oscillations|neural oscillations
139221|NCT03332043|Relaxation|relaxation
139222|NCT03332043|Electroencephalic|electroencephalic
139223|NCT03332017|Relapsed/Refractory Follicular non-Hodgkin Lymphoma|relapsed/refractory follicular non-hodgkin lymphoma
139224|NCT03332004|Indocyanine Green|indocyanine green
139225|NCT03332004|Deep Infiltrating Endometriosis|deep infiltrating endometriosis
139226|NCT03332004|Near-Infrared Vision|near-infrared vision
139227|NCT03332004|Occult endometriosis|occult endometriosis
139228|NCT03332004|Invisible endometriosis|invisible endometriosis
139229|NCT03331978|Adherence|adherence
139230|NCT03331978|Antiretroviral treatment|antiretroviral treatment
139231|NCT03331978|Black/ AfricanAmerican|black/ africanamerican
139232|NCT03331965|Interventional Radiology|interventional radiology
139233|NCT03331965|Metoclopramide|metoclopramide
139234|NCT03331965|Gastrojejenostomy|gastrojejenostomy
139235|NCT03331952|Streptococcal Pneumonia|streptococcal pneumonia
139236|NCT03331952|Pneumococcal Conjugate Vaccine|pneumococcal conjugate vaccine
139237|NCT03331887|endodontically treate teeth|endodontically treate teeth
139238|NCT03331887|Emax crowns|emax crowns
139239|NCT03331887|Fiber reinforced composite post|fiber reinforced composite post
139240|NCT03331887|Endocrowns|endocrowns
139241|NCT03331874|confocal|confocal
139242|NCT03331874|basal|basal
139243|NCT03331874|carcinoma|carcinoma
139244|NCT03331848|Levodopa-Induced Dyskinesia (LID)|levodopa-induced dyskinesia (lid)
139245|NCT03331848|Foliglurax|foliglurax
139246|NCT03331848|Parkinson's Disease|parkinson's disease
139247|NCT03331848|mGlu4 PAM|mglu4 pam
139248|NCT03331822|circadian|circadian
139249|NCT03331822|light therapy|light therapy
139250|NCT03331822|ICU nurse|icu nurse
139251|NCT03331809|intubation|intubation
139252|NCT03331809|pharyngitis|pharyngitis
139253|NCT03331796|mild cognitive impairment|mild cognitive impairment
139254|NCT03331796|tms|tms
139255|NCT03331796|rtms|rtms
139256|NCT03331796|transcranial magnetic stimulation|transcranial magnetic stimulation
139257|NCT03331796|noninvasive brain stimulation|noninvasive brain stimulation
139258|NCT03331796|non-pharmacological|non-pharmacological
139259|NCT03331770|Benzalkonium Chloride|benzalkonium chloride
139260|NCT03331770|Latanoprost|latanoprost
139261|NCT03331770|BAK-free|bak-free
139262|NCT03331770|Glaucoma|glaucoma
139263|NCT03331770|Ocular hypertension|ocular hypertension
139264|NCT03331770|conjunctival hyperemia|conjunctival hyperemia
139265|NCT03331770|BUT|but
139266|NCT03331770|OSDI|osdi
139267|NCT03331770|Schirmer I|schirmer i
139268|NCT03331770|Corneal staining|corneal staining
139269|NCT03331770|Tear meniscus height|tear meniscus height
139270|NCT03331744|Infantile hemanioma|infantile hemanioma
139271|NCT03331744|Infantile hepatic hemangioma|infantile hepatic hemangioma
139272|NCT03331744|Ulcerated infantile hemangioma|ulcerated infantile hemangioma
139273|NCT03331744|Clinical characteristics|clinical characteristics
139274|NCT03331744|Demographic characteristics|demographic characteristics
139275|NCT03331718|pancreatoduodenectomy|pancreatoduodenectomy
139276|NCT03331718|pancreaticojejunostomy|pancreaticojejunostomy
139277|NCT03331718|polyglycolic acid|polyglycolic acid
139278|NCT03331718|Neoveil|neoveil
139279|NCT03331718|pancreatic fistula|pancreatic fistula
139280|NCT03331718|pancreas|pancreas
139281|NCT03331666|Hyperlipidemia, Hypercholesterolemia, atherothrombosis|hyperlipidemia, hypercholesterolemia, atherothrombosis
139282|NCT03331653|Cervical Pain|cervical pain
139283|NCT03331653|Motor Control|motor control
139284|NCT03331653|Sternocleidomastoid|sternocleidomastoid
139285|NCT03331653|Dry Needling|dry needling
139286|NCT03331601|Brain metastasis|brain metastasis
139287|NCT03331601|HER2|her2
139288|NCT03331588|Lung cancer|lung cancer
139289|NCT03331588|Pain|pain
139290|NCT03331588|Quality of life|quality of life
139291|NCT03331562|Pembrolizumab|pembrolizumab
139292|NCT03331562|Paricalcitol|paricalcitol
139293|NCT03331562|Pancreatic cancer|pancreatic cancer
139294|NCT03331562|Metastatic Pancreatic Cancer|metastatic pancreatic cancer
139295|NCT03331562|Vitamin D|vitamin d
139296|NCT03331562|Immune Checkpoint Inhibitor|immune checkpoint inhibitor
139297|NCT03331562|VDR agonist|vdr agonist
139298|NCT03331562|PD1 Inhibitor|pd1 inhibitor
139299|NCT03331510|Shoulder, Instability, Latarjet, Dislocation, Strength|shoulder, instability, latarjet, dislocation, strength
139300|NCT03331484|percutaneous coronary intervention|percutaneous coronary intervention
139301|NCT03331484|bleeding|bleeding
139302|NCT03331484|atrial fibrillation|atrial fibrillation
139303|NCT03331484|Ticagrelor|ticagrelor
139304|NCT03331484|Rivaroxaban|rivaroxaban
139305|NCT03331458|physical activity|physical activity
139306|NCT03331445|inhaled nitric oxide|inhaled nitric oxide
139307|NCT03331445|non tuberculous mycobacteria|non tuberculous mycobacteria
139308|NCT03331445|drug resistant pneumonia|drug resistant pneumonia
139309|NCT03331406|Metastatic gastrointestinal cancer|metastatic gastrointestinal cancer
139310|NCT03331406|Physical Activity|physical activity
139311|NCT03331380|1.5 T CMR|1.5 t cmr
139312|NCT03331380|Low SAR CMR|low sar cmr
139313|NCT03331380|Gadolinium|gadolinium
139314|NCT03331380|Regadenoson|regadenoson
139315|NCT03331380|Adenosine|adenosine
139316|NCT03331367|Cryotherapy|cryotherapy
139317|NCT03331367|Radiation|radiation
139318|NCT03331367|Prostatectomy|prostatectomy
139319|NCT03331367|Immune Response|immune response
139320|NCT03331354|employment|employment
139321|NCT03331354|distance learning|distance learning
139322|NCT03331354|incarceration|incarceration
139323|NCT03331328|MonaLisa|monalisa
139324|NCT03331328|Genitourinary syndrome of menopause (GSM)|genitourinary syndrome of menopause (gsm)
139325|NCT03331250|Epithelioid hemangioendothelioma (EHE)|epithelioid hemangioendothelioma (ehe)
139326|NCT03331250|Angiosarcoma|angiosarcoma
139327|NCT03331211|Leukemia, Lymphoblastic, Acute|leukemia, lymphoblastic, acute
139328|NCT03331198|JCAR017|jcar017
139329|NCT03331198|chimeric antigen receptor|chimeric antigen receptor
139330|NCT03331198|CLL|cll
139331|NCT03331198|SLL|sll
140413|NCT03324815|Morphine|morphine
139332|NCT03331198|chronic lymphocytic leukemia|chronic lymphocytic leukemia
139333|NCT03331198|small lymphocytic lymphoma|small lymphocytic lymphoma
139334|NCT03331198|CAR|car
139335|NCT03331198|CAR T cells|car t cells
139336|NCT03331198|autologous T cell therapy|autologous t cell therapy
139337|NCT03331198|immunotherapy|immunotherapy
139338|NCT03331185|Extraction|extraction
139339|NCT03331185|Alveolar Ridge Augmentation|alveolar ridge augmentation
139340|NCT03331185|Freeze Dried Bone Allograft|freeze dried bone allograft
139341|NCT03331185|Leukocytic Platelet Rich Fibrin|leukocytic platelet rich fibrin
139342|NCT03331185|Volumetric Changes|volumetric changes
139343|NCT03331185|Dense Polytetrafluoroethylene Membrane|dense polytetrafluoroethylene membrane
139344|NCT03331172|HIFU|hifu
139345|NCT03331172|thyroid nodule|thyroid nodule
139346|NCT03331172|Benign|benign
139347|NCT03331172|Reapplication|reapplication
139348|NCT03331159|Lumbar Fusion|lumbar fusion
139349|NCT03331159|Hydroxyapatite|hydroxyapatite
139350|NCT03331146|Nitric Oxide|nitric oxide
139351|NCT03331146|Sodium Nitrite|sodium nitrite
139352|NCT03331146|Cardiopulmonary bypass|cardiopulmonary bypass
139353|NCT03331146|cardioplegic cardiac arrest|cardioplegic cardiac arrest
139354|NCT03331146|coronary revacularization|coronary revacularization
139355|NCT03331133|Twin|twin
139356|NCT03331133|Early Development|early development
139357|NCT03331133|Cohort|cohort
139358|NCT03331120|Neck pain|neck pain
139359|NCT03331120|Ambulatory|ambulatory
139360|NCT03331120|Orthotic|orthotic
139361|NCT03331081|Overactive Bladder Syndrome|overactive bladder syndrome
139362|NCT03331055|percutaneous electrical nerve stimulation|percutaneous electrical nerve stimulation
139363|NCT03331055|transcutaneous electrical nerve stimulation|transcutaneous electrical nerve stimulation
139364|NCT03331055|pain|pain
139365|NCT03331055|pancreatic cancer|pancreatic cancer
139366|NCT03331042|Insomnia|insomnia
139367|NCT03331042|Transient Insomnia|transient insomnia
139368|NCT03331042|Sleep initiation and maintenance disorder|sleep initiation and maintenance disorder
139369|NCT03331029|3 D Ultrasound, left atrium, Mitral inflow velocity, systolic and diastolic ventricular function|3 d ultrasound, left atrium, mitral inflow velocity, systolic and diastolic ventricular function
139370|NCT03331016|Foster caregiver|foster caregiver
139371|NCT03331016|Kinship caregiver|kinship caregiver
139372|NCT03331016|Foster youth|foster youth
139373|NCT03331016|Unintended pregnancy|unintended pregnancy
139374|NCT03331016|Curriculum|curriculum
139375|NCT03331016|Intervention|intervention
139376|NCT03331016|sexually transmitted infections|sexually transmitted infections
139377|NCT03331016|Behaviorism|behaviorism
139378|NCT03331016|Monitoring|monitoring
139379|NCT03331016|Communication|communication
139380|NCT03331016|Adolescent development|adolescent development
139381|NCT03331016|sexually transmitted diseases|sexually transmitted diseases
139382|NCT03330951|HbA1c|hba1c
139383|NCT03330951|Glycated albumin|glycated albumin
139384|NCT03330938|Hemodialysis|hemodialysis
139385|NCT03330938|Resilience|resilience
139386|NCT03330938|Cognitive Behavioral Therapy|cognitive behavioral therapy
139387|NCT03330873|Asherman syndrome|asherman syndrome
139388|NCT03330873|disposable balloon uterine stent|disposable balloon uterine stent
139389|NCT03330873|hysteroscopy|hysteroscopy
139390|NCT03330873|Foley catheter|foley catheter
139391|NCT03330847|Germline BRCA mutation|germline brca mutation
139392|NCT03330847|Human epidermal growth factor receptor 2|human epidermal growth factor receptor 2
139393|NCT03330847|Olaparib|olaparib
139394|NCT03330847|Homologous Recombinant Repair (HRR)-related Genes|homologous recombinant repair (hrr)-related genes
139395|NCT03330834|CAR-T|car-t
139396|NCT03330834|advanced lung cancer|advanced lung cancer
139397|NCT03330834|single-arm|single-arm
139398|NCT03330834|phase I clinical study|phase i clinical study
139399|NCT03330795|end-stage lung disease|end-stage lung disease
139400|NCT03330795|Bilateral Orthotopic Lung Transplant (BOLT) candidate|bilateral orthotopic lung transplant (bolt) candidate
139401|NCT03330795|CD3/CD19 negative allogeneic hematopoietic stem cells (HSCT)|cd3/cd19 negative allogeneic hematopoietic stem cells (hsct)
139402|NCT03330795|CD3+/CD19+ depleted Bone Marrow Transplant (BMT)|cd3+/cd19+ depleted bone marrow transplant (bmt)
139403|NCT03330795|Cadaveric (Deceased) Donor|cadaveric (deceased) donor
139404|NCT03330795|Unrelated (Deceased) Donor|unrelated (deceased) donor
139405|NCT03330782|pain|pain
139406|NCT03330782|propofol|propofol
139407|NCT03330782|remifentanil|remifentanil
139408|NCT03330769|Psoriatic Arthritis|psoriatic arthritis
139409|NCT03330769|Ultrasonography|ultrasonography
139410|NCT03330769|Minimal disease activity|minimal disease activity
139411|NCT03330756|Roux-en-Y gastric bypass|roux-en-y gastric bypass
139412|NCT03330756|Mini gastric bypass|mini gastric bypass
139413|NCT03330756|Type 2 diabetes mellitus|type 2 diabetes mellitus
139414|NCT03330756|Morbid Obesity|morbid obesity
139415|NCT03330691|CD19|cd19
139416|NCT03330691|CD22|cd22
139417|NCT03330691|CAR T-cell|car t-cell
139418|NCT03330678|Probiotic|probiotic
139419|NCT03330678|Gut microbiome|gut microbiome
139420|NCT03330678|VSL#3|vsl#3
139421|NCT03330652|Quality of life|quality of life
139422|NCT03330652|Cognitive function|cognitive function
139423|NCT03330652|Mental state|mental state
139424|NCT03330652|Functional capacity|functional capacity
139425|NCT03330652|EQ5D|eq5d
139426|NCT03330652|HADS|hads
139427|NCT03330652|Barthel Index|barthel index
139428|NCT03330652|mRS|mrs
139429|NCT03330626|Fluid management|fluid management
139430|NCT03330626|conventional method|conventional method
139431|NCT03330626|InBody S10|inbody s10
139432|NCT03330626|CRRT|crrt
139433|NCT03330574|Glaucoma|glaucoma
139434|NCT03330561|HER2-positive breast cancer|her2-positive breast cancer
139435|NCT03330561|HER2 -positive gastric cancer|her2 -positive gastric cancer
139436|NCT03330561|HER2-positive bladder cancer|her2-positive bladder cancer
139437|NCT03330561|Pieris|pieris
139438|NCT03330561|PRS-343|prs-343
139439|NCT03330561|Anticalin|anticalin
139440|NCT03330561|Bi-specific|bi-specific
139441|NCT03330561|4-1BB|4-1bb
139442|NCT03330561|CD137|cd137
139443|NCT03330561|HER2|her2
139444|NCT03330548|Plant-based diet|plant-based diet
139445|NCT03330548|Hyperlipidemia|hyperlipidemia
139446|NCT03330548|Diabetes|diabetes
139447|NCT03330548|Overweight|overweight
139448|NCT03330548|Veterans|veterans
139449|NCT03330509|Palliative care|palliative care
139450|NCT03330509|Consultation model|consultation model
139451|NCT03330496|infant-newborn|infant-newborn
139452|NCT03330496|infant-premature|infant-premature
139453|NCT03330496|pain|pain
139454|NCT03330496|acute pain|acute pain
139455|NCT03330496|repetitive pain|repetitive pain
139456|NCT03330483|pain|pain
139457|NCT03330483|discomfort|discomfort
139458|NCT03330483|hydrophylic catheter|hydrophylic catheter
139459|NCT03330483|urodynamic study|urodynamic study
139460|NCT03330444|Endometrial microbiota|endometrial microbiota
139461|NCT03330444|Bacterial pathogens|bacterial pathogens
139462|NCT03330444|Assisted reproductive techniques|assisted reproductive techniques
139463|NCT03330444|Dysbiosis|dysbiosis
139464|NCT03330444|Endometrial receptivity|endometrial receptivity
139465|NCT03330444|Endometrial diagnosis|endometrial diagnosis
139466|NCT03330405|NSCLC, TNBC, hormone receptor positive (HR+) breast cancer, recurrent epithelial ovarian cancer, UC, and castration resistant prostate cancer (CRPC).|nsclc, tnbc, hormone receptor positive (hr+) breast cancer, recurrent epithelial ovarian cancer, uc, and castration resistant prostate cancer (crpc).
139467|NCT03330379|Endotracheal tube|endotracheal tube
139468|NCT03330379|ventilator's associated pneumonia|ventilator's associated pneumonia
139469|NCT03330379|intensive care unit|intensive care unit
139470|NCT03330379|orotracheal intubation|orotracheal intubation
139471|NCT03330340|vertebral compression fracture|vertebral compression fracture
139472|NCT03330340|osteoporosis|osteoporosis
139473|NCT03330340|glucocorticoids|glucocorticoids
139474|NCT03330340|vertebroplasty|vertebroplasty
139475|NCT03330262|Postural Instability|postural instability
139476|NCT03330262|Balance Disorder|balance disorder
139477|NCT03330262|Balance Prosthesis|balance prosthesis
139478|NCT03330262|Dizziness|dizziness
139479|NCT03330236|Electroencephalography|electroencephalography
139480|NCT03330236|Spectral edge frequency|spectral edge frequency
139481|NCT03330236|Patient state index|patient state index
139482|NCT03330236|Anesthesia|anesthesia
139483|NCT03330236|Laparoscopic surgery|laparoscopic surgery
139484|NCT03330236|Postoperative delirium|postoperative delirium
139485|NCT03330236|Emergence delirium|emergence delirium
139486|NCT03330210|LAAC|laac
139487|NCT03330210|3D printing|3d printing
139488|NCT03330210|Procedure success|procedure success
139489|NCT03330210|Procedure-related complications|procedure-related complications
139490|NCT03330197|DIPG|dipg
139491|NCT03330197|Glioblastoma|glioblastoma
139492|NCT03330197|Anaplastic Astrocytoma|anaplastic astrocytoma
139493|NCT03330197|High Grade Glioma (HGG) Not Otherwise Specified (NOS)|high grade glioma (hgg) not otherwise specified (nos)
139494|NCT03330197|Supratentorial Tumor NOS|supratentorial tumor nos
139495|NCT03330184|Bifidobacterium|bifidobacterium
139496|NCT03330184|People With Abnormal Glucose Level|people with abnormal glucose level
139497|NCT03330171|Immunogenicity|immunogenicity
139498|NCT03330171|Safety|safety
139499|NCT03330171|Vaccine|vaccine
139500|NCT03330145|Complicated Grief|complicated grief
139501|NCT03330145|Risk Factors|risk factors
139502|NCT03330145|Cancer|cancer
139503|NCT03330145|Children|children
139504|NCT03330119|Pregnancy|pregnancy
139505|NCT03330119|cesarean section|cesarean section
139506|NCT03330119|enhanced recovery|enhanced recovery
139507|NCT03330119|narcotic use|narcotic use
139508|NCT03330106|Drug therapy|drug therapy
139509|NCT03330093|Children|children
139510|NCT03330080|Ecological momentary assessment|ecological momentary assessment
139511|NCT03330080|Sleepiness|sleepiness
139512|NCT03330080|Fatigue|fatigue
139513|NCT03330080|Endocrinopathy|endocrinopathy
139514|NCT03330080|Family functioning|family functioning
139515|NCT03330067|laparoscope|laparoscope
139516|NCT03330041|Cutaneous Sutures|cutaneous sutures
139517|NCT03330041|Scar Cosmesis|scar cosmesis
139518|NCT03330041|Linear Wound Closure|linear wound closure
139519|NCT03330041|Wound Cosmesis|wound cosmesis
139520|NCT03330028|Diseases of oesophagus stomach and duodenum|diseases of oesophagus stomach and duodenum
139521|NCT03330028|Gastric cancer|gastric cancer
139522|NCT03330028|Gastroesophageal cancer|gastroesophageal cancer
139523|NCT03330028|Adenocarcinoma of the stomach or gastroesophageal junction|adenocarcinoma of the stomach or gastroesophageal junction
139524|NCT03330028|Hyperthermic intraperitoneal chemotherapy|hyperthermic intraperitoneal chemotherapy
139525|NCT03330028|HIPEC|hipec
139526|NCT03330028|Paclitaxel|paclitaxel
139527|NCT03330028|Taxol|taxol
139528|NCT03330028|Dexamethasone|dexamethasone
139529|NCT03330028|Decadron|decadron
139530|NCT03330028|Diphenhydramine|diphenhydramine
139531|NCT03330028|Benadryl|benadryl
139532|NCT03330028|Cisplatin|cisplatin
139533|NCT03330028|Platinol-AQ|platinol-aq
139534|NCT03330028|Platinol|platinol
139535|NCT03330028|CDDP|cddp
139536|NCT03330028|Mitomycin-C|mitomycin-c
139537|NCT03330028|Mitomycin|mitomycin
139538|NCT03330028|Famotidine|famotidine
139539|NCT03330028|Pepcid|pepcid
139540|NCT03330015|postmenopausal bleeding|postmenopausal bleeding
139541|NCT03330015|endometrial cancer|endometrial cancer
139542|NCT03330015|Patient's experience|patient's experience
139543|NCT03330015|Patient's choice|patient's choice
139544|NCT03330002|Arterial Closure Device|arterial closure device
139545|NCT03330002|Large Bore Closure Device|large bore closure device
139546|NCT03329950|CDX-1140|cdx-1140
139547|NCT03329950|Solid Tumors|solid tumors
139548|NCT03329950|Liver Cancer|liver cancer
139549|NCT03329950|GI Cancer|gi cancer
139550|NCT03329950|Kidney Cancer|kidney cancer
139551|NCT03329950|Celldex|celldex
139552|NCT03329950|Monoclonal|monoclonal
139553|NCT03329950|Antibody|antibody
139554|NCT03329950|CD40|cd40
139555|NCT03329950|CD-40|cd-40
139556|NCT03329950|Flt3l|flt3l
139557|NCT03329950|CDX-301|cdx-301
139558|NCT03329950|Lung Cancer|lung cancer
139559|NCT03329950|Bile duct cancer|bile duct cancer
139560|NCT03329950|TNBC|tnbc
139561|NCT03329950|RCC|rcc
139562|NCT03329950|Non-Hodgkin Lymphoma|non-hodgkin lymphoma
139563|NCT03329950|Follicular Lymphoma|follicular lymphoma
139564|NCT03329950|Dendritic cell|dendritic cell
139565|NCT03329898|Asherman syndrome|asherman syndrome
139566|NCT03329898|uterine stent|uterine stent
139567|NCT03329898|hysteroscopy|hysteroscopy
139568|NCT03329872|Neuro-Orthopedics|neuro-orthopedics
139569|NCT03329872|Register|register
139570|NCT03329833|Parkinson's Disease|parkinson's disease
139571|NCT03329833|Parkinson's|parkinson's
139572|NCT03329833|Motivational Interviewing|motivational interviewing
139573|NCT03329833|Exercise|exercise
139574|NCT03329833|Motivation|motivation
139575|NCT03329820|Chronic hepatitis B infection|chronic hepatitis b infection
139576|NCT03329820|Health-related quality of life|health-related quality of life
139577|NCT03329820|Cost-effectiveness|cost-effectiveness
139578|NCT03329820|Treatment|treatment
139579|NCT03329820|Chinese|chinese
139580|NCT03329781|Endotoxaemia, Curcumin.|endotoxaemia, curcumin.
139581|NCT03329755|Advanced melanoma|advanced melanoma
139582|NCT03329755|Immune checkpoint|immune checkpoint
139583|NCT03329755|E-follow-up|e-follow-up
139584|NCT03329716|brace-weaning, cost-effectiveness|brace-weaning, cost-effectiveness
139585|NCT03329703|PNES|pnes
139586|NCT03329703|UPLIFT|uplift
139587|NCT03329703|Depression|depression
139588|NCT03329703|Mindfulness|mindfulness
139589|NCT03329703|CBT|cbt
139590|NCT03329703|Managing Epilepsy Well (MEW) Network|managing epilepsy well (mew) network
139591|NCT03329703|Psychogenic Seizures|psychogenic seizures
139592|NCT03329703|Non-Epileptic Seizures|non-epileptic seizures
139593|NCT03329690|Adenocarcinoma Metastatic|adenocarcinoma metastatic
139594|NCT03329690|Adenocarcinoma of the Stomach|adenocarcinoma of the stomach
139595|NCT03329690|Adenocarcinoma of the Gastroesophageal Junction|adenocarcinoma of the gastroesophageal junction
139596|NCT03329690|HER2 Overexpression|her2 overexpression
139597|NCT03329690|Adenocarcinoma, Locally Advanced|adenocarcinoma, locally advanced
139598|NCT03329690|DESTINY - Gastric 01|destiny - gastric 01
139599|NCT03329625|Triple P|triple p
139600|NCT03329625|RCT|rct
139601|NCT03329625|parent management training|parent management training
139602|NCT03329625|Child welfare|child welfare
139603|NCT03329625|child behavior problems|child behavior problems
139604|NCT03329586|maximum oxygen consumption|maximum oxygen consumption
139605|NCT03329586|organ transplantation|organ transplantation
139606|NCT03329586|physical fitness|physical fitness
139607|NCT03329586|rehabilitation|rehabilitation
139608|NCT03329573|Cross-over|cross-over
139609|NCT03329573|Chinese|chinese
139610|NCT03329573|GSKT|gskt
139611|NCT03329573|Mississauga|mississauga
139612|NCT03329573|Healthy|healthy
139613|NCT03329573|Bioequivalence|bioequivalence
139614|NCT03329573|Paroxetine|paroxetine
139615|NCT03329547|Bioequivalence|bioequivalence
139616|NCT03329547|Pharmacokinetics|pharmacokinetics
139617|NCT03329547|SKF101804|skf101804
139618|NCT03329547|Crossover|crossover
139619|NCT03329547|Cefixime|cefixime
139620|NCT03329521|Cluster Randomized Controlled Trial|cluster randomized controlled trial
139621|NCT03329521|Kidney Transplant|kidney transplant
139622|NCT03329521|Living Kidney Donation|living kidney donation
139623|NCT03329521|Kidney Disease|kidney disease
140414|NCT03324815|Methadone|methadone
139624|NCT03329508|Parkinson disease|parkinson disease
139625|NCT03329495|right colon cancer|right colon cancer
139626|NCT03329495|superior mesenteric artery|superior mesenteric artery
139627|NCT03329495|superior mesenteric vein|superior mesenteric vein
139628|NCT03329482|Ultrasound|ultrasound
139629|NCT03329482|kneading-massage|kneading-massage
139630|NCT03329482|low back pain|low back pain
139631|NCT03329482|pain intensity|pain intensity
139632|NCT03329482|disability|disability
139633|NCT03329469|Computed Tomography Fractional Flow Reserve (CT-FFR),|computed tomography fractional flow reserve (ct-ffr),
139634|NCT03329469|Computed Coronary Tomography Angiography (CCTA)|computed coronary tomography angiography (ccta)
139635|NCT03329469|Invasive Fractional Flow Reserve (iFFR)|invasive fractional flow reserve (iffr)
139636|NCT03329469|Fractional Flow Reserve (FFR)|fractional flow reserve (ffr)
139637|NCT03329469|Emergency Department (ED)|emergency department (ed)
139638|NCT03329469|Emergency Room (ER)|emergency room (er)
139639|NCT03329443|spironolactone|spironolactone
139640|NCT03329404|Thalassemia|thalassemia
139641|NCT03329404|pathogen reduction therapy|pathogen reduction therapy
139642|NCT03329391|Psychosocial model,nursing intervention|psychosocial model,nursing intervention
139769|NCT03328637|Smartphone Addiction|smartphone addiction
139643|NCT03329378|Neoadjuvant chemotherapy|neoadjuvant chemotherapy
139644|NCT03329378|locally advanced breast cancer|locally advanced breast cancer
139645|NCT03329378|Her2neu|her2neu
139646|NCT03329365|Flow cytometry|flow cytometry
139647|NCT03329365|Lactate dehydrogenase (LDH) release|lactate dehydrogenase (ldh) release
139648|NCT03329365|Anemia|anemia
139649|NCT03329365|Cytopenia|cytopenia
139650|NCT03329339|diet|diet
139651|NCT03329326|standardized test|standardized test
139652|NCT03329326|prosthesis|prosthesis
139653|NCT03329326|upper limb amputation|upper limb amputation
139654|NCT03329326|rehabilitation outcome|rehabilitation outcome
139655|NCT03329313|Intensive care unit|intensive care unit
139656|NCT03329313|SLEDD-f|sledd-f
139657|NCT03329313|intermittent hemodialysis/diafiltration|intermittent hemodialysis/diafiltration
139658|NCT03329300|Pediatric Obesity|pediatric obesity
139659|NCT03329300|Executive Function|executive function
139660|NCT03329300|Behavioral Intervention|behavioral intervention
139661|NCT03329287|Simplified Cognitive Behavioral Therapy (SCBT)|simplified cognitive behavioral therapy (scbt)
139662|NCT03329287|Generalized Anxiety Disorder|generalized anxiety disorder
139663|NCT03329287|Depression|depression
139664|NCT03329287|Operating manual|operating manual
139665|NCT03329287|Efficacy|efficacy
139666|NCT03329274|registry|registry
139667|NCT03329209|Drug therapy|drug therapy
139668|NCT03329183|Irinotecan|irinotecan
139669|NCT03329183|UGT1A1|ugt1a1
139670|NCT03329183|Advanced Colorectal Cancer|advanced colorectal cancer
139671|NCT03329170|Oral health|oral health
139672|NCT03329170|Dental caries|dental caries
139673|NCT03329170|Heart Defects|heart defects
139674|NCT03329170|Congenital|congenital
139675|NCT03329144|Young mother|young mother
139676|NCT03329144|Depression|depression
139677|NCT03329144|Anxiety|anxiety
139678|NCT03329144|Resilience|resilience
139679|NCT03329144|Emotion regulation|emotion regulation
139680|NCT03329144|Parenting|parenting
139681|NCT03329144|CBT|cbt
139682|NCT03329118|SHR3824,simvastatin, drug-drug interaction|shr3824,simvastatin, drug-drug interaction
139683|NCT03329105|Gingival Health|gingival health
139684|NCT03329105|Biofilm Formation|biofilm formation
139685|NCT03329092|Complicated intra-abdominal infection|complicated intra-abdominal infection
139686|NCT03329092|Hosptial acquired pneumonia|hosptial acquired pneumonia
139687|NCT03329092|Ventilator associated pneumonia|ventilator associated pneumonia
139688|NCT03329092|Gram negative infections|gram negative infections
139689|NCT03329092|Metallo-beta lactamase|metallo-beta lactamase
139690|NCT03329092|Multi drug resistant pathogens|multi drug resistant pathogens
139691|NCT03329079|rural|rural
139692|NCT03329079|men|men
139693|NCT03329079|community-based participatory research|community-based participatory research
139694|NCT03329079|weight loss|weight loss
139695|NCT03329079|mobile applications|mobile applications
139696|NCT03329079|text messaging|text messaging
139697|NCT03329066|Asthma|asthma
139698|NCT03329066|Sleep|sleep
139699|NCT03329066|Adolescents|adolescents
139700|NCT03329066|Urban|urban
139701|NCT03329066|Intervention|intervention
139702|NCT03329066|High school|high school
139703|NCT03329053|exercise prescription|exercise prescription
139704|NCT03329053|digital exercise prescription tool|digital exercise prescription tool
139705|NCT03329040|Hyperbilirubinemia|hyperbilirubinemia
139706|NCT03329040|Primiparity|primiparity
139707|NCT03329040|multiparity|multiparity
139708|NCT03329001|PARP inhibitor|parp inhibitor
139709|NCT03329001|niraparib|niraparib
139710|NCT03329001|Zejula|zejula
139711|NCT03328988|bladder cancer|bladder cancer
139712|NCT03328988|radical cystectomy|radical cystectomy
139713|NCT03328988|epidural analgesia|epidural analgesia
139714|NCT03328988|quadratus lumborum block|quadratus lumborum block
139715|NCT03328988|postoperative pain|postoperative pain
139716|NCT03328923|post-prandial cognition|post-prandial cognition
139717|NCT03328923|brown seaweed|brown seaweed
139718|NCT03328910|Emergence Delirium|emergence delirium
139719|NCT03328910|pulse oximetry|pulse oximetry
139720|NCT03328910|Children, Preschool|children, preschool
139721|NCT03328897|Chronic spontaneous urticarial|chronic spontaneous urticarial
139722|NCT03328897|ISS7|iss7
139723|NCT03328897|UAS7|uas7
139724|NCT03328897|omalizumab|omalizumab
139725|NCT03328897|China|china
139726|NCT03328871|Striae Gravidarum|striae gravidarum
139727|NCT03328871|Fractional Laser|fractional laser
139728|NCT03328871|Platelet-Rich Plasma (PRP)|platelet-rich plasma (prp)
139729|NCT03328871|Nanofat Graft|nanofat graft
139730|NCT03328871|Combination Therapy|combination therapy
139731|NCT03328858|Ketogenic Diet, brain tumors|ketogenic diet, brain tumors
139732|NCT03328845|Oxidation|oxidation
139733|NCT03328845|Insulin analogues|insulin analogues
139734|NCT03328845|Type 1 diabetes mellitus|type 1 diabetes mellitus
139735|NCT03328832|Thrombin-gelatin matrix|thrombin-gelatin matrix
139736|NCT03328832|Floseal|floseal
139737|NCT03328832|Tranexamic Acid|tranexamic acid
139738|NCT03328832|Total Knee Arthroplasty|total knee arthroplasty
139739|NCT03328819|Acupuncture|acupuncture
139740|NCT03328819|Chronic pain|chronic pain
139741|NCT03328819|Major depressive disorder|major depressive disorder
139742|NCT03328819|Biomarkers|biomarkers
139743|NCT03328819|Gene|gene
139744|NCT03328819|Comorbidity|comorbidity
139745|NCT03328806|low back pain|low back pain
139746|NCT03328806|outcome measures|outcome measures
139747|NCT03328806|cross culture adaptation|cross culture adaptation
139748|NCT03328806|Core Outcome Measure Index|core outcome measure index
139749|NCT03328793|music|music
139750|NCT03328793|gait|gait
139751|NCT03328793|emotions|emotions
139752|NCT03328793|communication|communication
139753|NCT03328780|preoperative|preoperative
139754|NCT03328780|orthopedic surgery|orthopedic surgery
139755|NCT03328754|Pitchfork|pitchfork
139756|NCT03328754|Class II malocclusion|class ii malocclusion
139757|NCT03328754|PowerScope|powerscope
139758|NCT03328741|Clinical Trials, Randomized|clinical trials, randomized
139759|NCT03328741|Telemedicine|telemedicine
139760|NCT03328702|Dysphagia|dysphagia
139761|NCT03328702|Oropharyngeal dysphagia|oropharyngeal dysphagia
139762|NCT03328702|Total Laryngectomy|total laryngectomy
139763|NCT03328702|Video Fluoroscopic Swallowing Exam (VFSE)|video fluoroscopic swallowing exam (vfse)
139764|NCT03328689|prevention|prevention
139765|NCT03328689|exercise|exercise
139766|NCT03328689|randomized controlled trial|randomized controlled trial
139767|NCT03328689|physical activity|physical activity
139768|NCT03328663|Cancer Care|cancer care
139771|NCT03328637|Evidence based intervention|evidence based intervention
139772|NCT03328585|CBT-I|cbt-i
139773|NCT03328585|Telemedicine|telemedicine
139774|NCT03328494|Paclitaxel|paclitaxel
139775|NCT03328494|BOS172722|bos172722
139776|NCT03328494|triple-negative breast cancer|triple-negative breast cancer
139777|NCT03328468|Stroke|stroke
139778|NCT03328429|bartholin|bartholin
139779|NCT03328429|marsupialisation|marsupialisation
139780|NCT03328429|abscess|abscess
139781|NCT03328416|Image-Guided Biopsy|image-guided biopsy
139782|NCT03328416|Multidetector Computed Tomography|multidetector computed tomography
139783|NCT03328416|Diagnostic Imaging|diagnostic imaging
139784|NCT03328416|Cryosurgery|cryosurgery
139785|NCT03328416|Ablation Techniques|ablation techniques
139786|NCT03328403|Endovascular therapy|endovascular therapy
139787|NCT03328403|Mechanical thrombectomy|mechanical thrombectomy
139788|NCT03328403|Acute ischaemic stroke treatment|acute ischaemic stroke treatment
139789|NCT03328364|enzalutamide|enzalutamide
139790|NCT03328364|metastatic castration-resistant prostate cancer|metastatic castration-resistant prostate cancer
139791|NCT03328364|Xtandi|xtandi
139792|NCT03328364|registry based study|registry based study
139793|NCT03328364|MDV3100|mdv3100
139794|NCT03328364|mCRPC|mcrpc
139795|NCT03328351|Manual therapy|manual therapy
139796|NCT03328351|cervical radiculopathy|cervical radiculopathy
139797|NCT03328351|pressure pain threshold|pressure pain threshold
139798|NCT03328351|physiotherapy|physiotherapy
139799|NCT03328338|Mitochondria|mitochondria
139800|NCT03328338|Oxidative phosphorylation (mitochondrial respiration)|oxidative phosphorylation (mitochondrial respiration)
139801|NCT03328338|Subcutaneous abdominal adipose tissue|subcutaneous abdominal adipose tissue
139802|NCT03328338|Heart.|heart.
139803|NCT03328325|Influenza|influenza
139804|NCT03328325|PCR|pcr
139805|NCT03328325|Seasonal Vaccination|seasonal vaccination
139806|NCT03328221|Heart rate variability|heart rate variability
139807|NCT03328221|Observational study|observational study
139808|NCT03328221|Physical activity|physical activity
139809|NCT03328221|Rehabilitation|rehabilitation
139810|NCT03328208|Nonpharmacologic analgesia|nonpharmacologic analgesia
139811|NCT03328208|Medical app|medical app
139812|NCT03328208|Relaxation|relaxation
139813|NCT03328143|Craniotomy, anxiety, malignant, cancer, brain tumor|craniotomy, anxiety, malignant, cancer, brain tumor
139814|NCT03328130|Adeno-associated virus|adeno-associated virus
139815|NCT03328130|AAV|aav
139816|NCT03328130|Retinitis Pigmentosa|retinitis pigmentosa
139817|NCT03328130|PDE6B|pde6b
139818|NCT03328130|Gene Therapy|gene therapy
139819|NCT03328130|Gene Transfer|gene transfer
139820|NCT03328130|Retinal Dystrophy|retinal dystrophy
139821|NCT03328130|Eye Diseases|eye diseases
139822|NCT03328130|Vision Disorders|vision disorders
139823|NCT03328130|Eye Diseases, Hereditary|eye diseases, hereditary
139824|NCT03328130|Retinal Diseases|retinal diseases
139825|NCT03328130|Retinal Degeneration|retinal degeneration
139826|NCT03328104|T- cell acute lymphoblastic leukemia|t- cell acute lymphoblastic leukemia
139827|NCT03328104|T-ALL|t-all
139828|NCT03328104|T-cell lymphoblastic lymphoma|t-cell lymphoblastic lymphoma
139829|NCT03328104|T-LLy|t-lly
139830|NCT03328104|Everolimus|everolimus
139831|NCT03328104|Maximum tolerated dose|maximum tolerated dose
139832|NCT03328091|Prostate Cancer|prostate cancer
139833|NCT03328091|Genetics|genetics
139834|NCT03328078|DLBCL|dlbcl
139835|NCT03328078|MCL|mcl
139836|NCT03328078|WM|wm
139837|NCT03328078|LPL|lpl
139838|NCT03328078|MYD88|myd88
139839|NCT03328078|IRAK4|irak4
139840|NCT03328078|NHL|nhl
139841|NCT03328078|AML|aml
139842|NCT03327987|vaccine immunogenicity|vaccine immunogenicity
139843|NCT03327987|vaccine safety|vaccine safety
139844|NCT03327974|Aged between 18 and 65|aged between 18 and 65
139845|NCT03327974|Major depressive disorder|major depressive disorder
139846|NCT03327974|Suicide|suicide
139847|NCT03327974|Ecological momentary assessment|ecological momentary assessment
139848|NCT03327974|Smartphone application|smartphone application
139849|NCT03327948|Sacral neuromodulation (SNM)|sacral neuromodulation (snm)
139850|NCT03327948|SNM|snm
139851|NCT03327922|Subdermal|subdermal
139852|NCT03327922|Suture|suture
139853|NCT03327922|Wound Closure|wound closure
139854|NCT03327922|Wound Cosmesis|wound cosmesis
139855|NCT03327909|Intradialytic Hypotension, Hypertension, Ambulatory Blood Pressure|intradialytic hypotension, hypertension, ambulatory blood pressure
139856|NCT03327896|Quality Measures, Social Determinants of Health|quality measures, social determinants of health
139857|NCT03327883|Diagnostic Imaging|diagnostic imaging
139858|NCT03327883|Review of Patients Records|review of patients records
139859|NCT03327883|PET MRI|pet mri
139860|NCT03327883|Treatment Responses|treatment responses
139861|NCT03327870|Sjogren's Syndrome|sjogren's syndrome
139862|NCT03327870|Sicca|sicca
139863|NCT03327844|Regenerative Endodontic Therapy|regenerative endodontic therapy
139864|NCT03327844|Infected immature permanent teeth|infected immature permanent teeth
139865|NCT03327831|aminolevulinic acid|aminolevulinic acid
139866|NCT03327831|pdt|pdt
139867|NCT03327831|photodynamic therapy|photodynamic therapy
139868|NCT03327831|Photochemotherapy|photochemotherapy
139869|NCT03327805|Choline|choline
139870|NCT03327805|Trimethylamine N-Oxide|trimethylamine n-oxide
139871|NCT03327805|Vascular health|vascular health
139872|NCT03327766|vitamin D and recurrent pregnancy loss|vitamin d and recurrent pregnancy loss
139873|NCT03327753|exercise|exercise
139874|NCT03327753|mobility|mobility
139875|NCT03327753|physiotherapy|physiotherapy
139876|NCT03327753|validation|validation
139877|NCT03327740|Hypersensitivity reactions (HSR)|hypersensitivity reactions (hsr)
139878|NCT03327740|HIV|hiv
139879|NCT03327740|Dolutegravir|dolutegravir
139880|NCT03327727|IA|ia
139881|NCT03327714|mindfulness|mindfulness
139882|NCT03327714|children|children
139883|NCT03327714|anxiety|anxiety
139884|NCT03327714|depression|depression
139885|NCT03327714|mental disorder|mental disorder
139886|NCT03327714|risk factor|risk factor
139887|NCT03327701|Exercise-induced bronchoconstriction|exercise-induced bronchoconstriction
139888|NCT03327701|Benralizumab|benralizumab
139889|NCT03327701|Antiinterleukin 5 receptor α monoclonal antibody|antiinterleukin 5 receptor α monoclonal antibody
139890|NCT03327688|Focus assesment with sonography for trauma|focus assesment with sonography for trauma
139891|NCT03327688|POCUS|pocus
139892|NCT03327688|LOS|los
139893|NCT03327688|Point-of-care ultrasound|point-of-care ultrasound
139894|NCT03327688|length of stay|length of stay
139895|NCT03327688|cost-minimization|cost-minimization
139896|NCT03327688|primary health care|primary health care
139897|NCT03327688|Ultrasound|ultrasound
139898|NCT03327688|Emergency department|emergency department
139899|NCT03327675|prostate-specific membrane antigen|prostate-specific membrane antigen
139900|NCT03327675|Lymph Node Dissection|lymph node dissection
139901|NCT03327675|Prostatectomy|prostatectomy
139902|NCT03327675|Positron-Emission Tomography|positron-emission tomography
139903|NCT03327662|Cabazitaxel|cabazitaxel
139904|NCT03327662|Docetaxel|docetaxel
139905|NCT03327662|Circulating Tumour Cells|circulating tumour cells
139906|NCT03327649|heart failure with preserved ejection fraction|heart failure with preserved ejection fraction
139907|NCT03327649|inflammation|inflammation
139908|NCT03327636|Papillary Thyroid Microcarcinoma|papillary thyroid microcarcinoma
139909|NCT03327636|High intensity focused ultrasound|high intensity focused ultrasound
139910|NCT03327636|Active surveillance|active surveillance
139911|NCT03327623|sleep apnea|sleep apnea
139912|NCT03327623|arrhythmia|arrhythmia
139913|NCT03327610|Respiratory Therapy|respiratory therapy
139914|NCT03327610|Positive Pressure Respiration|positive pressure respiration
139915|NCT03327610|Physical Therapy Modalities|physical therapy modalities
139916|NCT03327597|MGUS|mgus
139917|NCT03327597|Screening|screening
139918|NCT03327597|Population-based|population-based
139919|NCT03327571|Drug therapy|drug therapy
139920|NCT03327545|Trigger points|trigger points
139921|NCT03327545|Trigegeminal nerve|trigegeminal nerve
139922|NCT03327545|Pain|pain
139923|NCT03327532|Acute Heart Failure|acute heart failure
139924|NCT03327532|Congestion|congestion
139925|NCT03327532|Ultrasound|ultrasound
139926|NCT03327519|Asthma|asthma
139927|NCT03327519|Insomnia|insomnia
139928|NCT03327506|Premedication/ Hypnosis/ Anxiety/Surgery|premedication/ hypnosis/ anxiety/surgery
139929|NCT03327493|Cardiogenic shock|cardiogenic shock
139930|NCT03327493|Extra-Corporeal-Life-Support (ECLS)|extra-corporeal-life-support (ecls)
139931|NCT03327493|inflammation|inflammation
139932|NCT03327493|adrenergic system|adrenergic system
139933|NCT03327480|osteoarthritis thumb|osteoarthritis thumb
139934|NCT03327480|orthosis|orthosis
139935|NCT03327480|functioning|functioning
139936|NCT03327454|Ankylosing spondylitis|ankylosing spondylitis
139937|NCT03327454|Axial spondyloarthritis|axial spondyloarthritis
139938|NCT03327454|Benepali pen|benepali pen
139939|NCT03327454|Etanercept|etanercept
139940|NCT03327454|Patient questionnaire|patient questionnaire
139941|NCT03327454|Pre-filled pen|pre-filled pen
139942|NCT03327454|Biological DMARDs|biological dmards
139943|NCT03327454|Antirheumatic drug|antirheumatic drug
139944|NCT03327428|Anemia, Sickle Cell|anemia, sickle cell
139945|NCT03327428|Sickle Cell disease|sickle cell disease
139946|NCT03327415|Children|children
139947|NCT03327415|Food practice|food practice
139948|NCT03327415|Food consumption|food consumption
139949|NCT03327415|Nutrient intake|nutrient intake
139950|NCT03327402|SHP465|shp465
139951|NCT03327402|ADHD|adhd
139952|NCT03327402|Hyperactivity|hyperactivity
139953|NCT03327376|central venous catheters|central venous catheters
139954|NCT03327376|venous thrombosis|venous thrombosis
139955|NCT03327376|ultrasound|ultrasound
139956|NCT03327376|critical care|critical care
139957|NCT03327363|ICT based clinical trial,|ict based clinical trial,
139958|NCT03327363|eCRF|ecrf
139959|NCT03327363|electronic -institutional review board (eIRB),|electronic -institutional review board (eirb),
139960|NCT03327363|Centralized monitoring|centralized monitoring
139961|NCT03327363|contract research organization (CRO)|contract research organization (cro)
139962|NCT03327311|No condition|no condition
139963|NCT03327298|Pedicle screw. Free hand. Lumbar fixation|pedicle screw. free hand. lumbar fixation
139964|NCT03327285|Acute lymphoblastic leukemia|acute lymphoblastic leukemia
139965|NCT03327285|Hematopoietic stem cell transplantation|hematopoietic stem cell transplantation
139966|NCT03327285|Anti-CD19 chimeric antigen receptor T-cell|anti-cd19 chimeric antigen receptor t-cell
139967|NCT03327181|short chain fatty acid metabolism|short chain fatty acid metabolism
139968|NCT03327168|Adipose Tissue, Brown|adipose tissue, brown
139969|NCT03327155|HIV prevention|hiv prevention
139970|NCT03327155|PrEP|prep
139971|NCT03327142|Adrenal Gland|adrenal gland
139972|NCT03327142|Endoscopic Ultrasound Guided FNA|endoscopic ultrasound guided fna
139973|NCT03327116|atopic dermatitis|atopic dermatitis
139974|NCT03327116|pruritus|pruritus
139975|NCT03327116|methotrexate|methotrexate
139976|NCT03327116|inflamation|inflamation
139977|NCT03327116|IL-31|il-31
139978|NCT03327103|decision making|decision making
139979|NCT03327103|advanced prostate cancer|advanced prostate cancer
139980|NCT03327103|decision aid|decision aid
139981|NCT03327103|minorities|minorities
139982|NCT03327103|mHealth|mhealth
139983|NCT03327103|community patient navigator|community patient navigator
139984|NCT03327090|Olympic Weightlifting|olympic weightlifting
139985|NCT03327090|Taping|taping
139986|NCT03327090|Muscles Facilitation|muscles facilitation
139987|NCT03327090|Jumps|jumps
139988|NCT03326999|adductor canal regional block|adductor canal regional block
139989|NCT03326999|obturator nerve regional block|obturator nerve regional block
139990|NCT03326999|total knee arthroplasty|total knee arthroplasty
139991|NCT03326999|knee replacement surgery|knee replacement surgery
139992|NCT03326999|Knee rheumatoid arthritis|knee rheumatoid arthritis
139993|NCT03326973|Quality of Life (QoL)|quality of life (qol)
139994|NCT03326973|17-518|17-518
139995|NCT03326960|general anesthesia|general anesthesia
139996|NCT03326960|postoperative delirium|postoperative delirium
139997|NCT03326960|postoperative cognitive dysfunction|postoperative cognitive dysfunction
139998|NCT03326960|retinal nerve fiber layer|retinal nerve fiber layer
139999|NCT03326960|biomarker|biomarker
140000|NCT03326947|TPF induction chemotherapy, randomized, trial,OSCC|tpf induction chemotherapy, randomized, trial,oscc
140001|NCT03326921|HA-1|ha-1
140002|NCT03326921|TCR|tcr
140003|NCT03326921|Immunotherapy|immunotherapy
140004|NCT03326921|Leukemia|leukemia
140005|NCT03326843|low platelet count|low platelet count
140006|NCT03326843|ITP|itp
140007|NCT03326830|Respiratory Insufficiency|respiratory insufficiency
140008|NCT03326830|Oxygen Inhalation Therapy|oxygen inhalation therapy
140009|NCT03326817|Degenerative Arthritis, Rheumatic Diseases|degenerative arthritis, rheumatic diseases
140010|NCT03326804|Hip Resurfacing Arthroplasty|hip resurfacing arthroplasty
140011|NCT03326804|Ceramic|ceramic
140012|NCT03326804|H1|h1
140415|NCT03324815|Pain|pain
140013|NCT03326791|Acetylsalicylic acid|acetylsalicylic acid
140014|NCT03326791|Aspirin|aspirin
140015|NCT03326791|Trombyl|trombyl
140016|NCT03326791|Secondary prevention|secondary prevention
140017|NCT03326778|Aortic Valve Stenosis|aortic valve stenosis
140018|NCT03326778|Rapid deployment Valve|rapid deployment valve
140019|NCT03326778|CABG|cabg
140020|NCT03326778|Edwards Intuity Elite|edwards intuity elite
140021|NCT03326765|tuberous sclerosis complex (TSC)|tuberous sclerosis complex (tsc)
140022|NCT03326765|Children|children
140023|NCT03326765|Adults|adults
140024|NCT03326752|Cancer|cancer
140025|NCT03326752|Lung Cancer|lung cancer
140026|NCT03326752|NSCLC|nsclc
140027|NCT03326752|Anti-PD-1 inhibitor|anti-pd-1 inhibitor
140028|NCT03326752|Immuno-oncology|immuno-oncology
140029|NCT03326752|Toll-Like Receptor (TLR) agonist|toll-like receptor (tlr) agonist
140030|NCT03326713|Genetic Testing|genetic testing
140031|NCT03326713|Prevention|prevention
140032|NCT03326687|Language|language
140033|NCT03326687|Anomia|anomia
140034|NCT03326687|Therapy|therapy
140035|NCT03326674|Tesetaxel|tesetaxel
140036|NCT03326674|Capecitabine|capecitabine
140037|NCT03326674|HER2 negative|her2 negative
140038|NCT03326674|Hormone Receptor positive|hormone receptor positive
140039|NCT03326674|Locally advanced or metastatic breast cancer|locally advanced or metastatic breast cancer
140040|NCT03326674|Combination of tesetaxel and capecitabine|combination of tesetaxel and capecitabine
140041|NCT03326674|Taxanes|taxanes
140042|NCT03326674|Metastatic breast cancer|metastatic breast cancer
140043|NCT03326674|Breast cancer|breast cancer
140044|NCT03326674|Central nervous system (CNS) metastases|central nervous system (cns) metastases
140045|NCT03326661|Tonsillectomy|tonsillectomy
140046|NCT03326661|Aspiration|aspiration
140047|NCT03326661|Quinsy|quinsy
140048|NCT03326648|Sarcopenia|sarcopenia
140049|NCT03326648|Frailty|frailty
140050|NCT03326648|Strength training|strength training
140051|NCT03326648|Autophagy|autophagy
140052|NCT03326635|Resuscitation|resuscitation
140053|NCT03326635|Frailty|frailty
140054|NCT03326635|ICU|icu
140055|NCT03326635|Ageing|ageing
140056|NCT03326635|Rehabilitation|rehabilitation
140057|NCT03326635|Elderly|elderly
140058|NCT03326622|Amyotrophic Lateral Sclerosis|amyotrophic lateral sclerosis
140059|NCT03326622|aerobic exercise|aerobic exercise
140060|NCT03326622|functional outcome|functional outcome
140061|NCT03326622|non-invasive ventilation|non-invasive ventilation
140062|NCT03326622|oxygen uptake|oxygen uptake
140063|NCT03326596|Hemorrhage|hemorrhage
140064|NCT03326596|Tranexamic acid (TXA)|tranexamic acid (txa)
140065|NCT03326596|Estimated Blood Loss (EBL)|estimated blood loss (ebl)
140066|NCT03326583|End Stage Renal Disease|end stage renal disease
140067|NCT03326583|ESRD|esrd
140068|NCT03326583|Hyperkalemia|hyperkalemia
140069|NCT03326570|Lung cancer|lung cancer
140070|NCT03326570|Data collection post bronchoscopy|data collection post bronchoscopy
140071|NCT03326557|Induction of Labour|induction of labour
140072|NCT03326557|Previous Caesarean delivery|previous caesarean delivery
140073|NCT03326557|Foley|foley
140074|NCT03326557|Membrane sweeping|membrane sweeping
140075|NCT03326557|Vaginal delivery|vaginal delivery
140076|NCT03326505|Umbilical Cord Mesenchymal Stem Cells|umbilical cord mesenchymal stem cells
140077|NCT03326505|Multiple Sclerosis|multiple sclerosis
140078|NCT03326505|Neuroimmunology|neuroimmunology
140079|NCT03326505|Autoimmune disease|autoimmune disease
140080|NCT03326505|Physical therapy|physical therapy
140081|NCT03326492|Snake bites|snake bites
140082|NCT03326492|Antivenom serum|antivenom serum
140083|NCT03326492|Snake venoms|snake venoms
140084|NCT03326479|Molecular Profiling|molecular profiling
140085|NCT03326479|Biomarker Analysis|biomarker analysis
140086|NCT03326479|Outcomes Database|outcomes database
140087|NCT03326466|Subacromial Impingement Syndrome|subacromial impingement syndrome
140088|NCT03326466|Central Nervous System Sensitization|central nervous system sensitization
140089|NCT03326466|Muscle Function|muscle function
140090|NCT03326466|EMG|emg
140091|NCT03326466|Force Steadiness|force steadiness
140092|NCT03326466|CUFF Algometry|cuff algometry
140093|NCT03326466|Manual Algometry|manual algometry
140094|NCT03326466|Pain|pain
140095|NCT03326466|Maximal Voluntary Isometric Contraction|maximal voluntary isometric contraction
140096|NCT03326453|mini dental implant|mini dental implant
140097|NCT03326453|overdenture|overdenture
140098|NCT03326453|Patient satisfaction|patient satisfaction
140099|NCT03326427|Attention Deficit Hyperactive Disorder|attention deficit hyperactive disorder
140100|NCT03326427|Skill Training Group|skill training group
140101|NCT03326427|Dialectical Behavior Therapy|dialectical behavior therapy
140102|NCT03326401|dietary total antioxidant activity|dietary total antioxidant activity
140103|NCT03326401|nutritional status|nutritional status
140104|NCT03326401|macular degeneration|macular degeneration
140105|NCT03326401|glycemic load|glycemic load
140106|NCT03326401|glycemic index|glycemic index
140107|NCT03326401|nutrient intake|nutrient intake
140108|NCT03326375|TACE|tace
140109|NCT03326375|SBRT|sbrt
140110|NCT03326362|chronic low back pain|chronic low back pain
140111|NCT03326362|strength training|strength training
140112|NCT03326362|biomechanics|biomechanics
140113|NCT03326362|inflammatory biomarkers|inflammatory biomarkers
140114|NCT03326349|computerized cognitive rehabilitation|computerized cognitive rehabilitation
140115|NCT03326336|Eye Diseases|eye diseases
140116|NCT03326336|Hereditary Eye Diseases|hereditary eye diseases
140117|NCT03326336|Retinal degeneration|retinal degeneration
140118|NCT03326336|Inherited retinal diseases|inherited retinal diseases
140119|NCT03326336|Rod & cone dystrophies|rod & cone dystrophies
140120|NCT03326336|Retinitis Pigmentosa|retinitis pigmentosa
140121|NCT03326336|Gene Therapy|gene therapy
140122|NCT03326336|Optogenetic|optogenetic
140123|NCT03326336|Intravitreal Injections|intravitreal injections
140124|NCT03326336|AAV Vectors|aav vectors
140125|NCT03326336|Medical device|medical device
140126|NCT03326336|Visual Interface|visual interface
140127|NCT03326323|acute normovolemic hemodilution|acute normovolemic hemodilution
140128|NCT03326310|Chronic Myeloid Leukemia|chronic myeloid leukemia
140129|NCT03326310|Myelofibrosis|myelofibrosis
140130|NCT03326310|selumetinib|selumetinib
140131|NCT03326310|azacitidine|azacitidine
140132|NCT03326297|Infant Colic|infant colic
140133|NCT03326297|Osteopathy|osteopathy
140134|NCT03326297|Stress|stress
140135|NCT03326297|Physiotherapy|physiotherapy
140136|NCT03326284|Hypocaloric diet|hypocaloric diet
140137|NCT03326284|Dietary protein|dietary protein
140138|NCT03326245|Pharmacological MRI|pharmacological mri
140139|NCT03326245|C-11 Raclopride|c-11 raclopride
140140|NCT03326245|PET Imaging|pet imaging
140141|NCT03326245|Neuropsychological Testing|neuropsychological testing
140142|NCT03326219|MOCA|moca
140143|NCT03326219|VSM|vsm
140144|NCT03326219|Clarivein|clarivein
140145|NCT03326219|Histological|histological
140146|NCT03326206|Navajo|navajo
140147|NCT03326206|Community Health Workers|community health workers
140148|NCT03326206|Community Health Representatives|community health representatives
140149|NCT03326206|Tribal health systems|tribal health systems
140150|NCT03326206|American Indian|american indian
140151|NCT03326206|Rural|rural
140152|NCT03326206|Health disparities|health disparities
140153|NCT03326193|Stage IIIb - IV|stage iiib - iv
140154|NCT03326193|gBRCAmut|gbrcamut
140155|NCT03326193|BRCA|brca
140156|NCT03326193|PARP inhibitor|parp inhibitor
140157|NCT03326193|Ovarian|ovarian
140158|NCT03326193|Primary Peritoneal|primary peritoneal
140159|NCT03326193|Fallopian Tube|fallopian tube
140160|NCT03326193|VEGF inhibitor|vegf inhibitor
140161|NCT03326193|Bevacizumab|bevacizumab
140162|NCT03326193|Niraparib|niraparib
140163|NCT03326193|Angiogenesis Inhibitors|angiogenesis inhibitors
140164|NCT03326193|Angiogenesis Modulating Agents|angiogenesis modulating agents
140165|NCT03326193|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors
140166|NCT03326154|cholecystectomy|cholecystectomy
140167|NCT03326154|quality of life|quality of life
140168|NCT03326128|Bupropion XL|bupropion xl
140169|NCT03326128|Anhedonia|anhedonia
140170|NCT03326128|Heavy Smokers|heavy smokers
140171|NCT03326128|Smoking cessation|smoking cessation
140172|NCT03326115|patient activation|patient activation
140173|NCT03326115|peer visitation|peer visitation
140174|NCT03326115|amputee|amputee
140175|NCT03326102|Breast Cancer|breast cancer
140176|NCT03326102|DHP107|dhp107
140177|NCT03326102|Paclitaxel|paclitaxel
140178|NCT03326102|Liporaxel|liporaxel
140179|NCT03326089|pulmonary rehabilitation|pulmonary rehabilitation
140180|NCT03326050|Rhinoscleroma|rhinoscleroma
140181|NCT03326050|Gemifloxacin|gemifloxacin
140182|NCT03326050|Ciprofloxacin|ciprofloxacin
140183|NCT03326037|Nephrotic Syndrome|nephrotic syndrome
140184|NCT03326037|NPHS2 gene mutation|nphs2 gene mutation
140185|NCT03326037|disease association|disease association
140186|NCT03326011|Exoskeleton Device|exoskeleton device
140187|NCT03326011|Gait rehabilitation|gait rehabilitation
140188|NCT03326011|Chronic storke|chronic storke
140189|NCT03325998|Exoskeleton Device|exoskeleton device
140190|NCT03325998|Elderly|elderly
140191|NCT03325998|Gait rehabilitation|gait rehabilitation
140192|NCT03325959|hyperbaric oxygen|hyperbaric oxygen
140193|NCT03325959|HBOT|hbot
140194|NCT03325959|fibromyalgia|fibromyalgia
140195|NCT03325959|pain|pain
140196|NCT03325933|insulin sensitivity|insulin sensitivity
140197|NCT03325933|muscle|muscle
140198|NCT03325933|strength|strength
140199|NCT03325933|resistance training|resistance training
140200|NCT03325933|strength training|strength training
140201|NCT03325933|vascular function|vascular function
140202|NCT03325933|arterial stiffness|arterial stiffness
140203|NCT03325933|glucose tolerance|glucose tolerance
140204|NCT03325920|sleep bruxism|sleep bruxism
140205|NCT03325920|diagnosis|diagnosis
140206|NCT03325920|validation study|validation study
140207|NCT03325920|assessment|assessment
140208|NCT03325907|Biopsy, Needle|biopsy, needle
140209|NCT03325907|Printing, Three-Dimensional|printing, three-dimensional
140210|NCT03325907|Image-Guided Biopsy|image-guided biopsy
140211|NCT03325894|ADHD|adhd
140212|NCT03325894|SHP465|shp465
140213|NCT03325894|Hyperactivity|hyperactivity
140214|NCT03325881|ADHD|adhd
140215|NCT03325881|Hyperactivity|hyperactivity
140217|NCT03325868|heavy periods, painful periods, adenomyosis|heavy periods, painful periods, adenomyosis
140218|NCT03325855|FMT|fmt
140219|NCT03325855|CDI|cdi
140220|NCT03325855|Fecal Matter Transplant|fecal matter transplant
140221|NCT03325842|Cross-cultural comparison|cross-cultural comparison
140222|NCT03325842|Disability evaluation|disability evaluation
140223|NCT03325842|Self-assessment|self-assessment
140224|NCT03325842|Child|child
140225|NCT03325842|Adolescent|adolescent
140226|NCT03325829|Registry|registry
140227|NCT03325829|Diverticular Disease|diverticular disease
140228|NCT03325829|Diverticulitis|diverticulitis
140229|NCT03325829|Uncomplicated Diverticular Disease|uncomplicated diverticular disease
140230|NCT03325816|nivolumab|nivolumab
140231|NCT03325816|177Lu-DOTA0-Tyr3-Octreotate|177lu-dota0-tyr3-octreotate
140232|NCT03325816|Lutathera|lutathera
140233|NCT03325803|actinic keratosis|actinic keratosis
140234|NCT03325803|ablative fractional laser|ablative fractional laser
140235|NCT03325803|photodynamic therapy|photodynamic therapy
140236|NCT03325803|ablative depth|ablative depth
140237|NCT03325803|protoporphyrin IX|protoporphyrin ix
140238|NCT03325790|Meniere's disease|meniere's disease
140239|NCT03325790|Hearing Loss|hearing loss
140240|NCT03325790|Vertigo|vertigo
140241|NCT03325790|Tinnitus|tinnitus
140242|NCT03325790|Ebselen|ebselen
140243|NCT03325790|Pharmacokinetics|pharmacokinetics
140244|NCT03325790|Safety|safety
140245|NCT03325790|Efficacy|efficacy
140246|NCT03325790|Speech|speech
140247|NCT03325777|Cigarettes|cigarettes
140248|NCT03325777|Tobacco Use|tobacco use
140249|NCT03325764|Obesity|obesity
140250|NCT03325764|bariatric surgery|bariatric surgery
140251|NCT03325764|sleeve gastrectomy|sleeve gastrectomy
140252|NCT03325764|physical activity|physical activity
140253|NCT03325764|movement analysis|movement analysis
140254|NCT03325725|severe aspiration|severe aspiration
140255|NCT03325699|Mild dementia|mild dementia
140256|NCT03325699|Cognitive impairment|cognitive impairment
140257|NCT03325699|Informal caregiver|informal caregiver
140258|NCT03325699|Aging|aging
140259|NCT03325699|Quality of life|quality of life
140260|NCT03325699|Health application|health application
140261|NCT03325699|Information and communication technology (ICT)|information and communication technology (ict)
140262|NCT03325686|vitamin D|vitamin d
140263|NCT03325686|atletes|atletes
140264|NCT03325686|physical performance|physical performance
140265|NCT03325660|Whole body vibration, Pelvic floor muscle|whole body vibration, pelvic floor muscle
140266|NCT03325647|body composition|body composition
140267|NCT03325647|klinefelter syndrome|klinefelter syndrome
140268|NCT03325647|XXY|xxy
140269|NCT03325647|sex chromosome variation|sex chromosome variation
140270|NCT03325647|sex chromosome aneuploidy|sex chromosome aneuploidy
140271|NCT03325647|testosterone|testosterone
140272|NCT03325621|Hepcidin|hepcidin
140273|NCT03325621|Hemoglobin|hemoglobin
178956|NCT03077399|stroke|stroke
140274|NCT03325621|Iron|iron
140275|NCT03325621|Anemia of chronic disease|anemia of chronic disease
140276|NCT03325582|Perianal Fistula Crohn's disease, MRI|perianal fistula crohn's disease, mri
140277|NCT03325556|Dementia|dementia
140278|NCT03325556|Dementia-related psychosis|dementia-related psychosis
140279|NCT03325556|Dementia associated with Parkinson's disease|dementia associated with parkinson's disease
140280|NCT03325556|Dementia with Lewy bodies|dementia with lewy bodies
140281|NCT03325556|Alzheimer's disease|alzheimer's disease
140282|NCT03325556|Behavioral variant frontotemporal dementia|behavioral variant frontotemporal dementia
140283|NCT03325556|Progressive supranuclear palsy|progressive supranuclear palsy
140284|NCT03325556|Corticobasal degeneration|corticobasal degeneration
140285|NCT03325556|Vascular dementia|vascular dementia
140286|NCT03325556|Hallucinations|hallucinations
140287|NCT03325556|Delusions|delusions
140288|NCT03325556|Psychosis|psychosis
140289|NCT03325543|Urinary Incontinence, Stress|urinary incontinence, stress
140290|NCT03325543|Pelvic Floor|pelvic floor
140291|NCT03325543|Exercise|exercise
140292|NCT03325530|Adolescent|adolescent
140293|NCT03325530|Nutrition|nutrition
140294|NCT03325530|Physical Activity|physical activity
140295|NCT03325504|Non-union|non-union
140296|NCT03325504|Advanced therapies|advanced therapies
140297|NCT03325504|Mesenchymal stem cells|mesenchymal stem cells
140298|NCT03325504|Long bone|long bone
140299|NCT03325465|squamous cell carcinoma of the head and neck|squamous cell carcinoma of the head and neck
140300|NCT03325465|head and neck cancer|head and neck cancer
140301|NCT03325465|neoadjuvant pembrolizumab|neoadjuvant pembrolizumab
140302|NCT03325465|epacadostat|epacadostat
140303|NCT03325439|Electroencephalographic neonatal seizures|electroencephalographic neonatal seizures
140304|NCT03325439|Brivaracetam|brivaracetam
140305|NCT03325439|Epilepsy|epilepsy
140306|NCT03325439|ENS|ens
140307|NCT03325439|Newborns|newborns
140308|NCT03325439|Pharmacokinetic|pharmacokinetic
140309|NCT03325413|Perioperative geriatric care|perioperative geriatric care
140310|NCT03325413|Geriatric assessment|geriatric assessment
140311|NCT03325413|Postoperative cognitive dysfunction|postoperative cognitive dysfunction
140312|NCT03325413|POCD|pocd
140313|NCT03325413|Frailty|frailty
140314|NCT03325413|Depression|depression
140315|NCT03325413|Physical fitness|physical fitness
140316|NCT03325413|Geriatric anesthesia|geriatric anesthesia
140317|NCT03325413|IADL|iadl
140318|NCT03325413|Postoperative functional status|postoperative functional status
140319|NCT03325413|Quality of life|quality of life
140320|NCT03325400|Fluoride toothpaste|fluoride toothpaste
140321|NCT03325400|Cytogenetic damage|cytogenetic damage
140322|NCT03325400|Exfoliated buccal cells|exfoliated buccal cells
140323|NCT03325400|Micronucleus assay|micronucleus assay
140324|NCT03325348|Severe Pre eclampsia|severe pre eclampsia
140325|NCT03325348|Nifidepine|nifidepine
140326|NCT03325348|Labetalol|labetalol
140327|NCT03325335|midazolam premedication|midazolam premedication
140328|NCT03325322|Frailty|frailty
140329|NCT03325322|Inflammation|inflammation
140330|NCT03325322|Mesenchymal stem cell|mesenchymal stem cell
140331|NCT03325322|Mesenchymal stromal cell|mesenchymal stromal cell
140332|NCT03325309|Lumbar spinal stenosis|lumbar spinal stenosis
140333|NCT03325309|Cycling|cycling
140334|NCT03325309|Lumbar-flexion-based training|lumbar-flexion-based training
140335|NCT03325283|stroke prevention|stroke prevention
140336|NCT03325283|embolic protection|embolic protection
140337|NCT03325283|cognition|cognition
140338|NCT03325270|prebiotics|prebiotics
140339|NCT03325270|Galacto-oligosaccharides|galacto-oligosaccharides
140340|NCT03325270|Iron-deficiency|iron-deficiency
140341|NCT03325257|Unresectable melanoma|unresectable melanoma
140342|NCT03325257|metastatic melanoma|metastatic melanoma
140343|NCT03325257|Immunotherapy|immunotherapy
140344|NCT03325257|Nivolumab|nivolumab
140345|NCT03325257|Temporary Auhorization for Use (ATU)|temporary auhorization for use (atu)
140346|NCT03325205|Transcranial direct current stimulation|transcranial direct current stimulation
140347|NCT03325205|Neuromodulation|neuromodulation
140348|NCT03325205|Individualizing brain stimulation|individualizing brain stimulation
140349|NCT03325205|Neuropsychology|neuropsychology
140350|NCT03325192|Indwelling Pleural Catheter|indwelling pleural catheter
140351|NCT03325192|Pleurodesis|pleurodesis
140352|NCT03325192|Iodopovidone|iodopovidone
140353|NCT03325192|Pleural Effusion, Malignant|pleural effusion, malignant
140354|NCT03325179|Simple Obesity|simple obesity
140355|NCT03325179|Thread-embedding Therapy|thread-embedding therapy
140356|NCT03325179|Acupuncture|acupuncture
140357|NCT03325153|Obstructive Sleep Apnea|obstructive sleep apnea
140358|NCT03325153|Bronchoscopy|bronchoscopy
140359|NCT03325153|STOP-Bang questionnaire|stop-bang questionnaire
140360|NCT03325153|Cardiopulmonary events|cardiopulmonary events
140361|NCT03325127|Prostate Cancer, Bone metastases, Xofigo, Zytiga, Xtandi.|prostate cancer, bone metastases, xofigo, zytiga, xtandi.
140362|NCT03325114|type 1 diabetes|type 1 diabetes
140363|NCT03325114|hypercalciuria|hypercalciuria
140364|NCT03325088|Severe Asthma|severe asthma
140365|NCT03325088|airway smooth muscle cells|airway smooth muscle cells
140366|NCT03325088|Rac1 protein|rac1 protein
140367|NCT03325075|VAL-181388|val-181388
140368|NCT03325075|Chikungunya vaccine|chikungunya vaccine
140369|NCT03325049|Family Relations|family relations
140370|NCT03325049|Family Health|family health
140371|NCT03325049|Intervention study|intervention study
140372|NCT03325049|Social support|social support
140373|NCT03325049|Intensive care unit|intensive care unit
140374|NCT03325023|PCOS, microbiota, probiotic,obesity|pcos, microbiota, probiotic,obesity
140375|NCT03324984|Spinal anesthesia|spinal anesthesia
140376|NCT03324984|Pain|pain
140377|NCT03324984|Chloroprocaine|chloroprocaine
140378|NCT03324958|Endometrial cancer|endometrial cancer
140379|NCT03324958|Brachytherapy|brachytherapy
140380|NCT03324958|Virtual reality|virtual reality
140381|NCT03324958|Pain|pain
140382|NCT03324958|Anxiety|anxiety
140383|NCT03324932|bone health|bone health
140384|NCT03324932|hormone-sensitive breast cancer|hormone-sensitive breast cancer
140385|NCT03324932|postmenopausal|postmenopausal
140386|NCT03324932|aromatase inhibitor|aromatase inhibitor
140387|NCT03324932|bone mineral density|bone mineral density
140388|NCT03324919|Psoriasis|psoriasis
140389|NCT03324919|Urticaria|urticaria
140390|NCT03324919|Lupus erythematodes|lupus erythematodes
140391|NCT03324919|qualtiy of life|qualtiy of life
140392|NCT03324906|Prader-Willi Syndrome|prader-willi syndrome
140393|NCT03324906|Obesity|obesity
140394|NCT03324906|Depressive disorder|depressive disorder
140395|NCT03324906|Obsessive-compulsive disorder|obsessive-compulsive disorder
140396|NCT03324906|noninvasive brain stimulation|noninvasive brain stimulation
140397|NCT03324880|rhPTH[1-84)|rhpth[1-84)
140398|NCT03324880|Parathyroid hormone|parathyroid hormone
140399|NCT03324880|Hypocalcemia|hypocalcemia
140400|NCT03324880|Hypoparathyroidism|hypoparathyroidism
140401|NCT03324854|Mosquito net|mosquito net
140402|NCT03324854|Mesh|mesh
140403|NCT03324854|Polypropylene mesh|polypropylene mesh
140404|NCT03324854|Prolene mesh|prolene mesh
140405|NCT03324854|ventral hernia|ventral hernia
140406|NCT03324854|hernia|hernia
140407|NCT03324841|Molecular Profiling|molecular profiling
140408|NCT03324841|Biomarker Analysis|biomarker analysis
140409|NCT03324841|Next Generation Sequencing|next generation sequencing
140410|NCT03324828|anxiety|anxiety
140411|NCT03324828|surgery|surgery
140412|NCT03324828|clown|clown
140416|NCT03324789|Single implant|single implant
140417|NCT03324789|Anterior edentulism|anterior edentulism
140418|NCT03324789|partial denture|partial denture
140419|NCT03324776|inhaled insulin|inhaled insulin
140420|NCT03324750|corticotherapy|corticotherapy
140421|NCT03324750|qualitative study|qualitative study
140422|NCT03324750|therapeutic education|therapeutic education
140423|NCT03324750|lifestyle change|lifestyle change
140424|NCT03324750|diet|diet
140425|NCT03324737|Prevention|prevention
140426|NCT03324737|Smartphone application|smartphone application
140427|NCT03324737|Randomized control trial|randomized control trial
140428|NCT03324711|Cognitive disorders|cognitive disorders
140429|NCT03324711|Alzheimer's disease|alzheimer's disease
140430|NCT03324711|Mini Mental State Examination|mini mental state examination
140431|NCT03324711|Geriatry|geriatry
140432|NCT03324685|Oral Contraceptive, Healthy Volunteers, Ethinyl Estradiol,|oral contraceptive, healthy volunteers, ethinyl estradiol,
140433|NCT03324685|Levonorgestrel|levonorgestrel
140434|NCT03324672|lumbar pain; pregnancy;|lumbar pain; pregnancy;
140435|NCT03324659|Mindfulness|mindfulness
140436|NCT03324659|Exercise|exercise
140437|NCT03324659|Meditation|meditation
140438|NCT03324659|Back pain|back pain
140439|NCT03324646|Research|research
140440|NCT03324646|Brain|brain
140441|NCT03324646|Inflammation|inflammation
140442|NCT03324633|HIV|hiv
140443|NCT03324633|HCV|hcv
140444|NCT03324633|cohort|cohort
140445|NCT03324633|natural history|natural history
140446|NCT03324633|cure|cure
140447|NCT03324620|physiotherapy|physiotherapy
140448|NCT03324620|nurse|nurse
140449|NCT03324620|Cost effectiveness|cost effectiveness
140450|NCT03324620|Activities of Daily Living|activities of daily living
140451|NCT03324620|exercise tolerance|exercise tolerance
140452|NCT03324620|Allogeneic|allogeneic
140453|NCT03324620|Quality of Life|quality of life
140454|NCT03324620|Rehabilitation|rehabilitation
140455|NCT03324620|Physical Activity|physical activity
140456|NCT03324594|functional performance|functional performance
140457|NCT03324594|synthetic male condom|synthetic male condom
140458|NCT03324581|ADHD|adhd
140459|NCT03324581|ADD|add
140460|NCT03324516|pterional incision|pterional incision
140461|NCT03324516|Temporal hollowing|temporal hollowing
140462|NCT03324503|Pulmonary Sarcoidosis|pulmonary sarcoidosis
140463|NCT03324503|HRCT|hrct
140464|NCT03324503|Glucocorticoid|glucocorticoid
140465|NCT03324503|Prednisone|prednisone
140466|NCT03324503|FRI|fri
140467|NCT03324503|Prednisolone|prednisolone
140468|NCT03324490|Mid-thoracic spinal anesthesia|mid-thoracic spinal anesthesia
140469|NCT03324490|Mid-thoracic epidural anesthesia|mid-thoracic epidural anesthesia
140470|NCT03324490|Nephrectomy|nephrectomy
140471|NCT03324490|Lung disease|lung disease
140472|NCT03324438|pediatrics|pediatrics
140473|NCT03324425|breast cancer|breast cancer
140474|NCT03324425|metastatic breast cancer|metastatic breast cancer
140475|NCT03324399|ALS|als
140476|NCT03324399|Amyotrophic Lateral Sclerosis|amyotrophic lateral sclerosis
140477|NCT03324386|Hypertension|hypertension
140478|NCT03324386|Tecnology|tecnology
140479|NCT03324386|Nursing|nursing
140480|NCT03324386|Education|education
140481|NCT03324347|Animal-Assisted Intervention|animal-assisted intervention
140482|NCT03324347|Dog-Assisted Intervention|dog-assisted intervention
140483|NCT03324347|Dental Care|dental care
140484|NCT03324347|Questionnaire|questionnaire
140485|NCT03324347|Pilot Project|pilot project
140486|NCT03324347|Dental Clinic|dental clinic
140487|NCT03324321|Cerebral Haemodynamics|cerebral haemodynamics
140488|NCT03324321|Carbon Dioxide|carbon dioxide
140489|NCT03324321|Cerebral Autoregulation|cerebral autoregulation
140490|NCT03324308|Coronary Artery Disease|coronary artery disease
140491|NCT03324308|Ischemia|ischemia
140492|NCT03324308|Computed Tomography|computed tomography
140493|NCT03324308|Myocardial perfusion|myocardial perfusion
140494|NCT03324308|Dynamic Imaging|dynamic imaging
140495|NCT03324282|Anti PD1|anti pd1
140496|NCT03324282|Bladder carcinoma|bladder carcinoma
140497|NCT03324282|Chemotherapy|chemotherapy
140498|NCT03324282|Immunological monitoring|immunological monitoring
140499|NCT03324256|Energy drink consumption|energy drink consumption
140500|NCT03324230|Monoclonal antibody|monoclonal antibody
140501|NCT03324230|Mepolizumab|mepolizumab
140502|NCT03324230|Eosinophil|eosinophil
140503|NCT03324217|motor imagery|motor imagery
140504|NCT03324217|action observation|action observation
140505|NCT03324191|Tea extract|tea extract
140506|NCT03324191|Triglycerides|triglycerides
140507|NCT03324191|Energy metabolism|energy metabolism
140508|NCT03324178|Neurofeedback|neurofeedback
140509|NCT03324178|Attention|attention
140510|NCT03324165|Computed Tomography|computed tomography
140511|NCT03324165|Algorithm|algorithm
140512|NCT03324165|Alvarado Score|alvarado score
140513|NCT03324152|High-intensity interval training|high-intensity interval training
140514|NCT03324152|Exercise|exercise
140515|NCT03324152|Muscle function|muscle function
140516|NCT03324152|Inflammation|inflammation
140517|NCT03324126|Preterm infants|preterm infants
140518|NCT03324126|very low birth weight|very low birth weight
140519|NCT03324126|breast milk|breast milk
140520|NCT03324126|individualized fortification|individualized fortification
140521|NCT03324126|targeted protein fortification|targeted protein fortification
140522|NCT03324126|adjustable protein fortification|adjustable protein fortification
140523|NCT03324126|growth|growth
140524|NCT03324087|HRQoL|hrqol
140525|NCT03324087|Immune Thrombocytopenia|immune thrombocytopenia
140526|NCT03324048|Preoperative anxiety|preoperative anxiety
140527|NCT03324048|Relaxation|relaxation
140528|NCT03324048|Autonomous nervous system|autonomous nervous system
140529|NCT03324048|Surgery|surgery
140530|NCT03324048|Visual Analogue Scale (VAS)|visual analogue scale (vas)
140531|NCT03324048|State-Trait Anxiety Inventory (STAI-Y)|state-trait anxiety inventory (stai-y)
140532|NCT03324022|Fibroblast growth factors|fibroblast growth factors
140533|NCT03324022|Fibroblast growth factors receptors|fibroblast growth factors receptors
140534|NCT03324022|Thyroid orbitopathy|thyroid orbitopathy
140535|NCT03323944|metastatic adenocarcinoma, pancreas|metastatic adenocarcinoma, pancreas
140536|NCT03323931|autism spectrum disorder|autism spectrum disorder
140537|NCT03323931|robot-enhanced intervention|robot-enhanced intervention
140538|NCT03323931|imitation|imitation
140539|NCT03323931|joint attention|joint attention
140540|NCT03323931|turn-taking|turn-taking
140541|NCT03323892|preimplantation development|preimplantation development
140542|NCT03323892|DNA fragmentation|dna fragmentation
140543|NCT03323892|abstinence duration|abstinence duration
140544|NCT03323879|brachytherapy|brachytherapy
140545|NCT03323879|LDR|ldr
140546|NCT03323879|HDR|hdr
140547|NCT03323879|monotherapy|monotherapy
140548|NCT03323879|focal|focal
140549|NCT03323801|Infertility|infertility
140550|NCT03323762|Pre-Eclampsia; Mild|pre-eclampsia; mild
140551|NCT03323762|Pre-Eclampsia; Moderate|pre-eclampsia; moderate
140552|NCT03323762|Gestational Hypertension|gestational hypertension
140553|NCT03323762|Remote ischemic conditioning|remote ischemic conditioning
140554|NCT03323749|Myopathy|myopathy
140555|NCT03323749|PMD|pmd
140556|NCT03323749|Primary Mitochondrial Disease|primary mitochondrial disease
140557|NCT03323749|MTP-131|mtp-131
140558|NCT03323749|elamipretide|elamipretide
140559|NCT03323710|Metastatic|metastatic
140560|NCT03323710|Renal Cell Carcinoma|renal cell carcinoma
140561|NCT03323710|Kidney Cancer|kidney cancer
140562|NCT03323710|Sunitinib|sunitinib
140563|NCT03323710|Sutent|sutent
140564|NCT03323710|Tyrosine Kinase Inhibitor|tyrosine kinase inhibitor
140565|NCT03323710|Angiogenesis Inhibitor|angiogenesis inhibitor
140566|NCT03323710|Propranolol|propranolol
140567|NCT03323710|Beta-blocker|beta-blocker
140568|NCT03323710|First-line|first-line
140569|NCT03323697|Depression|depression
140570|NCT03323697|Anxiety|anxiety
140571|NCT03323697|Herbal Medicine|herbal medicine
140572|NCT03323697|Chinese Medicine|chinese medicine
140573|NCT03323697|Hamilton Scale|hamilton scale
140574|NCT03323697|SSRI|ssri
140575|NCT03323671|primary dysmenorrhea|primary dysmenorrhea
140576|NCT03323671|preemptive analgesia|preemptive analgesia
140577|NCT03323645|prostate cancer|prostate cancer
140578|NCT03323645|erectile dysfunction|erectile dysfunction
140579|NCT03323645|penile prosthesis|penile prosthesis
140580|NCT03323632|Stroke|stroke
140581|NCT03323632|Cerebrovascular accident|cerebrovascular accident
140582|NCT03323632|Upper extremity|upper extremity
140583|NCT03323632|Cerebral Infarction|cerebral infarction
140584|NCT03323632|Brain Infarction|brain infarction
140585|NCT03323632|Brain Ischemia|brain ischemia
140586|NCT03323632|Cerebrovascular Disorders|cerebrovascular disorders
140587|NCT03323632|Cardiovascular Diseases|cardiovascular diseases
140588|NCT03323632|Nervous System Diseases|nervous system diseases
140589|NCT03323632|Central Nervous System Diseases|central nervous system diseases
140590|NCT03323619|Transcatheter aortic valve replacement|transcatheter aortic valve replacement
140591|NCT03323619|Anesthesia technique|anesthesia technique
140592|NCT03323619|Delirium|delirium
140593|NCT03323567|TMD, collagen, intramuscular injection, trigger point|tmd, collagen, intramuscular injection, trigger point
140594|NCT03323554|radical prostatectomy , Device,|radical prostatectomy , device,
140595|NCT03323541|biosimilars|biosimilars
140596|NCT03323541|filgrastim|filgrastim
140597|NCT03323541|Stem cell transplantation|stem cell transplantation
140598|NCT03323541|lymphoma|lymphoma
140599|NCT03323541|multiple myeloma|multiple myeloma
140600|NCT03323528|Dorithricin|dorithricin
140601|NCT03323528|Tyrothricin|tyrothricin
140602|NCT03323528|Benzalkonium chloride|benzalkonium chloride
140603|NCT03323528|Benzocaine|benzocaine
140604|NCT03323528|placebo-controlled|placebo-controlled
140605|NCT03323528|Pharyngitis|pharyngitis
140606|NCT03323528|sore throat|sore throat
140607|NCT03323528|throat pain|throat pain
140608|NCT03323528|difficulty swallowing|difficulty swallowing
140609|NCT03323528|complete responder|complete responder
140610|NCT03323528|lozenge|lozenge
140611|NCT03323528|Non-streptococcal Infections|non-streptococcal infections
140612|NCT03323502|Nursing Homes|nursing homes
140613|NCT03323502|Skilled Nursing Facilities|skilled nursing facilities
140614|NCT03323502|Advance Care Planning|advance care planning
140615|NCT03323502|Advance Directives|advance directives
141396|NCT03318588|Cytokine|cytokine
140616|NCT03323502|Alzheimer Disease|alzheimer disease
140617|NCT03323502|Dementia|dementia
140618|NCT03323502|Do Not Resuscitate Orders|do not resuscitate orders
140619|NCT03323502|Physician Orders for Life-Sustaining Treatment|physician orders for life-sustaining treatment
140620|NCT03323502|Artificial Nutrition|artificial nutrition
140621|NCT03323502|Hospitalization|hospitalization
140622|NCT03323502|Intubation|intubation
140623|NCT03323502|Pragmatic Clinical Trials|pragmatic clinical trials
140624|NCT03323502|Randomized Controlled Trials|randomized controlled trials
140625|NCT03323502|Patient Preferences|patient preferences
140626|NCT03323502|Resuscitation Orders|resuscitation orders
140627|NCT03323489|celiac|celiac
140628|NCT03323489|radiosurgery|radiosurgery
140629|NCT03323489|sbrt|sbrt
140630|NCT03323489|radiotherapy|radiotherapy
140631|NCT03323489|pain|pain
140632|NCT03323463|squamous cell carcinoma of the neck of unknown primary|squamous cell carcinoma of the neck of unknown primary
140633|NCT03323463|HPV-Associated Oropharyngeal Squamous Cell Carcinoma|hpv-associated oropharyngeal squamous cell carcinoma
140634|NCT03323463|Oropharyngeal Squamous Cell Carcinoma|oropharyngeal squamous cell carcinoma
140635|NCT03323463|17-409|17-409
140636|NCT03323463|Hypoxia negative|hypoxia negative
140637|NCT03323463|T1-2n1-2b oropharyngeal squamous cell carcinoma|t1-2n1-2b oropharyngeal squamous cell carcinoma
140638|NCT03323450|High grade gliomas (WHO grade III or IV)|high grade gliomas (who grade iii or iv)
140639|NCT03323450|Low grade gliomas (WHO Grade II)|low grade gliomas (who grade ii)
140640|NCT03323424|Metastatic cancer|metastatic cancer
140641|NCT03323424|Abscopal effect|abscopal effect
140642|NCT03323424|Ionizing radiation|ionizing radiation
140769|NCT03322644|Pain|pain
140643|NCT03323424|Antibody-Dependant Cell Cytotoxicity (ADCC)|antibody-dependant cell cytotoxicity (adcc)
140644|NCT03323424|Immuno-Radiation effect|immuno-radiation effect
140645|NCT03323424|Stereotactic Body Radio-Therapy (SBRT)|stereotactic body radio-therapy (sbrt)
140646|NCT03323424|Targeted therapies|targeted therapies
140647|NCT03323398|mRNA-2416|mrna-2416
140648|NCT03323398|OX40 ligand|ox40 ligand
140649|NCT03323398|OX40L|ox40l
140650|NCT03323398|Moderna|moderna
140651|NCT03323385|Colorectal surgery|colorectal surgery
140652|NCT03323385|Pain|pain
140653|NCT03323385|Analgesia|analgesia
140654|NCT03323385|N1539|n1539
140655|NCT03323385|Phase 3b|phase 3b
140656|NCT03323359|Hemopatch|hemopatch
140657|NCT03323359|Hepatic resection|hepatic resection
140658|NCT03323359|Hemostasis|hemostasis
140659|NCT03323359|Surgery|surgery
140660|NCT03323346|metastatic breast cancer|metastatic breast cancer
140661|NCT03323346|disulfiram|disulfiram
140662|NCT03323346|cooper|cooper
140663|NCT03323294|Obesity|obesity
140664|NCT03323294|Pediatric Health|pediatric health
140665|NCT03323294|Type 2 Diabetes|type 2 diabetes
140666|NCT03323294|Insulin Resistance|insulin resistance
140667|NCT03323294|Metformin Therapy|metformin therapy
140668|NCT03323281|Diabetic foot|diabetic foot
140669|NCT03323281|Cognitive functions|cognitive functions
140670|NCT03323281|Psychiatric disorders|psychiatric disorders
140671|NCT03323281|Neurology|neurology
140672|NCT03323281|Psychiatry|psychiatry
140673|NCT03323268|Intensive care|intensive care
140674|NCT03323268|Cardiogenic shock|cardiogenic shock
140675|NCT03323268|Peripheral veno-arterial extracorporeal membrane oxygenation|peripheral veno-arterial extracorporeal membrane oxygenation
140676|NCT03323268|Left ventricular overload|left ventricular overload
140677|NCT03323268|Native cardiac output|native cardiac output
140678|NCT03323268|Pulmonary artery blood flow|pulmonary artery blood flow
140679|NCT03323268|End-tidal carbon dioxide|end-tidal carbon dioxide
140680|NCT03323268|Swan Ganz catheter|swan ganz catheter
140681|NCT03323268|Blood gaz|blood gaz
140682|NCT03323242|Vessel Sealing Devices|vessel sealing devices
140683|NCT03323242|Liver Transplantation|liver transplantation
140684|NCT03323229|Ultrasonography|ultrasonography
140685|NCT03323229|Ambulances|ambulances
140686|NCT03323229|Satellite Communications|satellite communications
140687|NCT03323229|Telemedicine|telemedicine
140688|NCT03323151|Relapsed Mantle-Cell Lymphoma|relapsed mantle-cell lymphoma
140689|NCT03323151|Refractory Mantle-Cell Lymphoma|refractory mantle-cell lymphoma
140690|NCT03323151|Ixazomib|ixazomib
140691|NCT03323151|Ibrutinib|ibrutinib
140692|NCT03323151|Proteasome Inhibitor|proteasome inhibitor
140693|NCT03323151|Bruton's Tyrosine Kinase Inhibitor|bruton's tyrosine kinase inhibitor
140694|NCT03323138|Ex-PRESS|ex-press
140695|NCT03323138|glaucoma|glaucoma
140696|NCT03323138|filtration surgery|filtration surgery
140697|NCT03323138|phacoemulsification|phacoemulsification
140698|NCT03323112|influenza|influenza
140699|NCT03323112|vaccination|vaccination
140700|NCT03323112|health care workers|health care workers
140701|NCT03323112|immune responses|immune responses
140702|NCT03323112|humoral immunity|humoral immunity
140703|NCT03323112|cellular immunity|cellular immunity
140704|NCT03323073|unipolar|unipolar
140705|NCT03323073|bipolar|bipolar
140706|NCT03323073|depression|depression
140707|NCT03323073|resting state fMRI|resting state fmri
140708|NCT03323073|neural network|neural network
140709|NCT03323073|connectivity|connectivity
140710|NCT03323047|tonsillectomy|tonsillectomy
140711|NCT03323047|acetaminophen|acetaminophen
140712|NCT03323047|dexamethasone|dexamethasone
140713|NCT03323008|Prisoners|prisoners
140714|NCT03323008|End-of-life Care|end-of-life care
140715|NCT03323008|Geriatric Care|geriatric care
140716|NCT03323008|Palliative Care|palliative care
140717|NCT03323008|Hospice Care|hospice care
140718|NCT03323008|Prison|prison
140719|NCT03323008|Corrections|corrections
140720|NCT03323008|Inmates|inmates
140721|NCT03322995|Neoadjuvant Therapy|neoadjuvant therapy
140722|NCT03322982|diet, low-fat|diet, low-fat
140723|NCT03322956|Low back/lumbar spine|low back/lumbar spine
140724|NCT03322956|Multimodal Physical therapy|multimodal physical therapy
140725|NCT03322956|Quality of life|quality of life
140726|NCT03322956|Range of Motion|range of motion
140727|NCT03322956|Pain|pain
140728|NCT03322943|Ursodeoxycholic Acid|ursodeoxycholic acid
140729|NCT03322943|Response|response
140730|NCT03322930|microperimetry|microperimetry
140731|NCT03322930|rod visual fields|rod visual fields
140732|NCT03322917|dry eye|dry eye
140734|NCT03322917|autologous|autologous
140735|NCT03322917|after LASIK|after lasik
140736|NCT03322917|ocular surface|ocular surface
140737|NCT03322904|iris collarette; autonomous nervous system|iris collarette; autonomous nervous system
140738|NCT03322891|Urology|urology
140739|NCT03322878|postoperative pain , pediatrics , magnesium sulfate|postoperative pain , pediatrics , magnesium sulfate
140740|NCT03322839|Guideline-adherence|guideline-adherence
140741|NCT03322839|Implementation|implementation
140742|NCT03322839|Implementation-strategies|implementation-strategies
140743|NCT03322839|Randomized-controlled-trial|randomized-controlled-trial
140744|NCT03322839|Organisational risk-factors|organisational risk-factors
140745|NCT03322839|Schools|schools
140746|NCT03322839|Social risk-factors|social risk-factors
140747|NCT03322813|Glioblastoma|glioblastoma
140748|NCT03322813|Blood Brain Barrier|blood brain barrier
140749|NCT03322813|BBB|bbb
140750|NCT03322813|ExAblate|exablate
140751|NCT03322813|Blood Brain Barrier Disruption|blood brain barrier disruption
140752|NCT03322813|Infiltrating glioma|infiltrating glioma
140753|NCT03322774|Stepped Care|stepped care
140754|NCT03322761|Multiple sclerosis|multiple sclerosis
140755|NCT03322761|Exercise|exercise
140756|NCT03322761|Disease-modifying treatment|disease-modifying treatment
140757|NCT03322761|Early treatment|early treatment
140758|NCT03322683|Neck Pain|neck pain
140759|NCT03322683|Physical Therapy Modalities|physical therapy modalities
140760|NCT03322683|Massage|massage
140761|NCT03322683|Manual Therapy|manual therapy
140762|NCT03322670|community-acquired pneumonia|community-acquired pneumonia
140763|NCT03322670|family practice|family practice
140764|NCT03322670|streptococcus pneumoniae|streptococcus pneumoniae
140765|NCT03322657|Sugammadex|sugammadex
140766|NCT03322657|Neostigmine|neostigmine
140767|NCT03322657|Reversal of neuromuscular block|reversal of neuromuscular block
140768|NCT03322644|Pancreatitis|pancreatitis
140770|NCT03322644|Internet Intervention|internet intervention
140771|NCT03322644|Behavioral Intervention|behavioral intervention
140772|NCT03322566|Non-small cell lung cancer|non-small cell lung cancer
140773|NCT03322566|programmed cell death 1 (PD-1) inhibitor|programmed cell death 1 (pd-1) inhibitor
140774|NCT03322566|indoleamine 2|indoleamine 2
140775|NCT03322566|3-dioxygenase 1 (IDO1) inhibitor|3-dioxygenase 1 (ido1) inhibitor
140776|NCT03322566|chemotherapy|chemotherapy
140777|NCT03322540|non-small cell lung cancer|non-small cell lung cancer
140778|NCT03322540|programmed cell death 1 (PD-1) inhibitor|programmed cell death 1 (pd-1) inhibitor
140779|NCT03322540|indoleamine 2|indoleamine 2
140780|NCT03322540|3-dioxygenase 1 (IDO1) inhibitor|3-dioxygenase 1 (ido1) inhibitor
140781|NCT03322514|gut hormones|gut hormones
140782|NCT03322514|obesity|obesity
140783|NCT03322514|appetite|appetite
140784|NCT03322514|propionate|propionate
140785|NCT03322514|fermentation|fermentation
140786|NCT03322449|APOA2|apoa2
140787|NCT03322449|Inflammation|inflammation
140788|NCT03322449|gene|gene
140789|NCT03322449|diet|diet
140790|NCT03322410|Fluid overload|fluid overload
140791|NCT03322410|Hydratation statud|hydratation statud
140792|NCT03322410|Peritoneal hypepermeability|peritoneal hypepermeability
140793|NCT03322410|Peritoneal dialysis|peritoneal dialysis
140794|NCT03322410|Impedancemetry|impedancemetry
140795|NCT03322397|adolescence|adolescence
140796|NCT03322397|immune function|immune function
140797|NCT03322397|gene expression|gene expression
140798|NCT03322397|psychological well-being|psychological well-being
140799|NCT03322397|social connection|social connection
140800|NCT03322397|kindness|kindness
140801|NCT03322345|lymph flow|lymph flow
140802|NCT03322345|Fontan|fontan
140803|NCT03322332|adiponectin|adiponectin
140804|NCT03322332|omentin-1|omentin-1
140805|NCT03322332|resistin|resistin
140806|NCT03322332|RBP4|rbp4
140807|NCT03322332|epicardial fat|epicardial fat
140808|NCT03322332|Coronary artery disease|coronary artery disease
140809|NCT03322319|Cardiac amyloidosis|cardiac amyloidosis
140810|NCT03322319|Caribbean|caribbean
140811|NCT03322319|Diagnosis|diagnosis
140812|NCT03322319|Transthyretin|transthyretin
140813|NCT03322306|genetic screening|genetic screening
140814|NCT03322306|neuro-degenerative disease|neuro-degenerative disease
140815|NCT03322293|Actinic Keratoses|actinic keratoses
140816|NCT03322293|photodynamic therapy|photodynamic therapy
140817|NCT03322293|aminolevulinic acid|aminolevulinic acid
140818|NCT03322293|precancerous skin lesion|precancerous skin lesion
140819|NCT03322280|Hepatocellular carcinoma|hepatocellular carcinoma
140820|NCT03322280|Portal vein tumor thrombus|portal vein tumor thrombus
140821|NCT03322280|Transcatheter arterial chemoembolization|transcatheter arterial chemoembolization
140822|NCT03322280|iodine-125 seed|iodine-125 seed
140823|NCT03322267|Adjuvant pembrolizumab|adjuvant pembrolizumab
140824|NCT03322267|Chemoradiotherapy|chemoradiotherapy
140825|NCT03322228|Hospice|hospice
140826|NCT03322228|Palliative Care|palliative care
140827|NCT03322228|Integrative Medicine|integrative medicine
140828|NCT03322228|Music Therapy|music therapy
140829|NCT03322228|Inpatient|inpatient
140830|NCT03322228|Caregiver|caregiver
140831|NCT03322215|palbociclib|palbociclib
140832|NCT03322215|fulvestrant|fulvestrant
140833|NCT03322215|capecitabine|capecitabine
140834|NCT03322202|Spinal Cord Injury|spinal cord injury
140835|NCT03322202|Motivational Interviewing|motivational interviewing
140836|NCT03322150|Atropine|atropine
140837|NCT03322150|glycopyrrolate|glycopyrrolate
140838|NCT03322150|bradycardia|bradycardia
140839|NCT03322150|dexmedetomidine|dexmedetomidine
140840|NCT03322150|spinal anesthesia|spinal anesthesia
140841|NCT03322098|Atropine|atropine
140842|NCT03322098|glycopyrrolate|glycopyrrolate
140843|NCT03322098|bradycardia|bradycardia
140844|NCT03322098|dexmedetomidine|dexmedetomidine
140845|NCT03322098|spinal anesthesia|spinal anesthesia
140846|NCT03322085|atrial fibrillation|atrial fibrillation
140847|NCT03322085|atrial electrical remodeling|atrial electrical remodeling
140848|NCT03322046|Therapeutic Lifestyle Change|therapeutic lifestyle change
140849|NCT03322046|Cardiovascular Disease|cardiovascular disease
140850|NCT03322046|First Responders|first responders
140851|NCT03322046|Firefighters|firefighters
140852|NCT03322046|CVD|cvd
140853|NCT03321981|Bispecific Antibody IgG1, HER2 HER3|bispecific antibody igg1, her2 her3
140854|NCT03321981|MCLA-128|mcla-128
140855|NCT03321981|Antibodies, bispecific|antibodies, bispecific
140856|NCT03321981|Immunologic Factors|immunologic factors
140857|NCT03321981|Cytokines|cytokines
140858|NCT03321981|combination Trastuzumab with and without Vinorelbine|combination trastuzumab with and without vinorelbine
140859|NCT03321968|Influenza|influenza
140860|NCT03321968|Human|human
140861|NCT03321968|RNA Virus Infections|rna virus infections
140862|NCT03321968|Lot Consistency|lot consistency
140863|NCT03321968|Immunologic|immunologic
140864|NCT03321968|Orthomyxoviridae Infections|orthomyxoviridae infections
140865|NCT03321968|Infection|infection
140866|NCT03321968|Virus Diseases|virus diseases
140867|NCT03321942|Adipose Tissue-derived Mesenchymal Stem Cells|adipose tissue-derived mesenchymal stem cells
140868|NCT03321942|Chronic Kidney Diseases|chronic kidney diseases
140869|NCT03321916|MacTel|mactel
140870|NCT03321903|Oxygen|oxygen
140871|NCT03321903|Oximetry|oximetry
140872|NCT03321903|Electron Spin Resonance Spectroscopy|electron spin resonance spectroscopy
140873|NCT03321903|Carbon|carbon
140874|NCT03321903|Charcoal|charcoal
140875|NCT03321903|Radiotherapy|radiotherapy
140876|NCT03321903|India Ink|india ink
140877|NCT03321903|EPR|epr
140878|NCT03321903|ESR|esr
140879|NCT03321903|Immunotherapy|immunotherapy
140880|NCT03321890|relapsed or refractory|relapsed or refractory
140881|NCT03321890|peripheral T-cell lymphoma|peripheral t-cell lymphoma
140882|NCT03321890|Combination therapy|combination therapy
140883|NCT03321864|Transperineal biopsy|transperineal biopsy
140884|NCT03321864|Prostate cancer|prostate cancer
140885|NCT03321864|Transrectal ultrasound|transrectal ultrasound
140886|NCT03321864|Fusion biopsy techniques|fusion biopsy techniques
140887|NCT03321812|decalcification bone scaffold|decalcification bone scaffold
140888|NCT03321812|microfracture|microfracture
140889|NCT03321812|randomized controlled trial|randomized controlled trial
140890|NCT03321812|cartilage lesions of the knee|cartilage lesions of the knee
140891|NCT03321773|Helicobacter pylori|helicobacter pylori
140892|NCT03321773|Eradication rate|eradication rate
140893|NCT03321734|Caffeine|caffeine
140894|NCT03321734|Prematurity|prematurity
140895|NCT03321721|hand|hand
140896|NCT03321721|feet lacerations|feet lacerations
140897|NCT03321721|children|children
140898|NCT03321721|conservative management|conservative management
140899|NCT03321682|Cardiopulmonary Capacity|cardiopulmonary capacity
140900|NCT03321682|Quality of Life|quality of life
140901|NCT03321682|Functional Capacity|functional capacity
140902|NCT03321682|Functional Training|functional training
140903|NCT03321630|Pebrolizumab|pebrolizumab
140904|NCT03321630|Lenvatinib|lenvatinib
140905|NCT03321604|Hemodialysis|hemodialysis
140906|NCT03321604|Kidney|kidney
140907|NCT03321604|Dialysis|dialysis
140908|NCT03321604|Kindred|kindred
140909|NCT03321604|Fabry|fabry
140910|NCT03321604|Massachusetts General Hospital|massachusetts general hospital
140911|NCT03321578|nosocomial|nosocomial
140912|NCT03321578|hospital acquired|hospital acquired
140913|NCT03321578|clostridium difficile|clostridium difficile
140914|NCT03321565|obesity|obesity
140915|NCT03321552|Desert foot|desert foot
140916|NCT03321552|No-option patients|no-option patients
140917|NCT03321552|Venous arterialization|venous arterialization
140918|NCT03321539|Nasopharyngeal carcinoma;adjuvant chemotherapy|nasopharyngeal carcinoma;adjuvant chemotherapy
140919|NCT03321513|Diabetic Macular Edema|diabetic macular edema
140920|NCT03321513|anti-vascular endothelial growth factor|anti-vascular endothelial growth factor
140921|NCT03321487|Blood-Brain Barrier disruption|blood-brain barrier disruption
140922|NCT03321487|Blood-Brain Barrier opening|blood-brain barrier opening
140923|NCT03321487|magnetic resonance-guided focused ultrasound|magnetic resonance-guided focused ultrasound
140924|NCT03321409|Somatic symptom|somatic symptom
140925|NCT03321409|SSS-CN|sss-cn
140926|NCT03321409|PHQ-15|phq-15
140927|NCT03321409|Suspected CAD|suspected cad
140928|NCT03321409|Coronary angiography|coronary angiography
140929|NCT03321396|Sodium Alginate|sodium alginate
140930|NCT03321396|Calcium Lactate|calcium lactate
140932|NCT03321383|dyspepsia|dyspepsia
140933|NCT03321383|health related quality of life|health related quality of life
140934|NCT03321331|Mobile Health|mobile health
140935|NCT03321331|mobile apps|mobile apps
140936|NCT03321331|weight control|weight control
140937|NCT03321331|weight management|weight management
140938|NCT03321331|self-directed intervention|self-directed intervention
140939|NCT03321331|behavioral intervention|behavioral intervention
140940|NCT03321266|Fistula plug|fistula plug
140941|NCT03321253|Posterior Capsule Opacification|posterior capsule opacification
140942|NCT03321253|Macular Pigment Optical Density|macular pigment optical density
140943|NCT03321253|Anterior Chamber Parameters|anterior chamber parameters
140944|NCT03321253|Nd: YAG Laser Posterior Capsulotomy|nd: yag laser posterior capsulotomy
140945|NCT03321253|Posterior Capsulotomy|posterior capsulotomy
140946|NCT03321253|Cystoid Macular Edema|cystoid macular edema
140947|NCT03321253|Choroidal Thickness|choroidal thickness
140948|NCT03321240|focal cortical dysplasia|focal cortical dysplasia
140949|NCT03321240|Pronostic|pronostic
140950|NCT03321240|Epilepsy surgery|epilepsy surgery
140951|NCT03321240|Epiletogenicity index|epiletogenicity index
140952|NCT03321240|SEEG|seeg
140953|NCT03321227|Children|children
140954|NCT03321227|Nutrition|nutrition
140955|NCT03321227|Eggs|eggs
140956|NCT03321227|Cognitive performance|cognitive performance
140957|NCT03321227|Glycemic response|glycemic response
140958|NCT03321227|Appetite|appetite
140959|NCT03321227|Emotion|emotion
140960|NCT03321214|Gluten Free diet|gluten free diet
140961|NCT03321188|Heated intraperitoneal chemotherapy|heated intraperitoneal chemotherapy
140962|NCT03321188|HIPEC|hipec
140963|NCT03321188|cisplatin|cisplatin
140964|NCT03321188|paclitaxel|paclitaxel
140965|NCT03321188|carboplatin|carboplatin
140966|NCT03321188|adjuvant IV chemotherapy|adjuvant iv chemotherapy
140967|NCT03321175|Wound|wound
140968|NCT03321175|infection|infection
140969|NCT03321175|cesarean section|cesarean section
140970|NCT03321162|surgical guide , double scan , triple scan protocol|surgical guide , double scan , triple scan protocol
140971|NCT03321149|Web-based intervention|web-based intervention
140972|NCT03321149|Sedentary behavior|sedentary behavior
140973|NCT03321149|Lifestyle intervention|lifestyle intervention
140974|NCT03321149|Feasibility|feasibility
140975|NCT03321123|B cell Acute Lymphoblastic Leukemia|b cell acute lymphoblastic leukemia
140976|NCT03321123|relapsed or refractory|relapsed or refractory
140977|NCT03321123|CD-19 Positive|cd-19 positive
140978|NCT03321097|stroke rehabilitation|stroke rehabilitation
140979|NCT03321097|spasticity|spasticity
140980|NCT03321097|Botulinum toxin type A injection|botulinum toxin type a injection
140981|NCT03321097|robot-assisted therapy|robot-assisted therapy
140982|NCT03321097|massed therapy|massed therapy
140983|NCT03321097|distributed therapy|distributed therapy
140984|NCT03321084|Osteoarthrosis|osteoarthrosis
140985|NCT03321084|Exercise Movement Techniques|exercise movement techniques
140986|NCT03321084|Pilates|pilates
140987|NCT03321084|Elderly|elderly
140988|NCT03321084|Physiotherapy|physiotherapy
140989|NCT03321058|Drug Substitution|drug substitution
140990|NCT03321058|Multicompartment Compliance Aid|multicompartment compliance aid
140991|NCT03321045|89Zr-Trastuzumab, HER2 Imaging|89zr-trastuzumab, her2 imaging
140992|NCT03321032|Coronary Artery Disease|coronary artery disease
140993|NCT03321032|Diabetes Mellitus|diabetes mellitus
140994|NCT03321032|Drug-eluting stents|drug-eluting stents
140995|NCT03321032|Restenosis|restenosis
140996|NCT03320993|post-prandial glucose control|post-prandial glucose control
140997|NCT03320993|alcohol|alcohol
140998|NCT03320980|ALPPS|alpps
140999|NCT03320980|RALPPS|ralpps
141000|NCT03320980|Portal Vein Embolization|portal vein embolization
141001|NCT03320980|Hilar Cholangiocarcinoma|hilar cholangiocarcinoma
141002|NCT03320980|Intrahepatic Cholangiocarcinoma|intrahepatic cholangiocarcinoma
141003|NCT03320954|Language|language
141004|NCT03320954|Anomia|anomia
141005|NCT03320941|Obesity disease|obesity disease
141006|NCT03320941|Over weight|over weight
141007|NCT03320941|T2DM|t2dm
141008|NCT03320941|interventional study|interventional study
141009|NCT03320941|Weight loss|weight loss
141010|NCT03320902|Family members|family members
141011|NCT03320902|sudden death|sudden death
141012|NCT03320902|sudden death counseling|sudden death counseling
141013|NCT03320902|depression|depression
141014|NCT03320837|metabolomics|metabolomics
141015|NCT03320837|microbiome|microbiome
141016|NCT03320837|infant formula|infant formula
141017|NCT03320837|synbiotics|synbiotics
141018|NCT03320837|urine samples|urine samples
141019|NCT03320837|NMR analysis|nmr analysis
141020|NCT03320811|Celiac disease|celiac disease
141021|NCT03320811|serological tests|serological tests
141022|NCT03320811|anti-deamidated gliadin peptide antibodies|anti-deamidated gliadin peptide antibodies
141023|NCT03320798|Bullous pemphigoid|bullous pemphigoid
141024|NCT03320798|neurologic disorders|neurologic disorders
141025|NCT03320785|preterm infants|preterm infants
141026|NCT03320785|sepsis|sepsis
141027|NCT03320785|chorioamnionitis|chorioamnionitis
141028|NCT03320785|circulating markers|circulating markers
141029|NCT03320746|Physical activity|physical activity
141030|NCT03320746|Sedentary time|sedentary time
141031|NCT03320746|Intervention|intervention
141032|NCT03320746|Retiree|retiree
141033|NCT03320733|dual energy CT|dual energy ct
141034|NCT03320694|Gestational Diabetes Mellitus, Metformin, Insulin|gestational diabetes mellitus, metformin, insulin
141035|NCT03320681|Neurostimulator|neurostimulator
141036|NCT03320668|Falls Prevention|falls prevention
141037|NCT03320668|Otago Program|otago program
141038|NCT03320668|Community-Dwelling|community-dwelling
141039|NCT03320655|Chronic Heart Failure|chronic heart failure
141040|NCT03320655|Fragility|fragility
141041|NCT03320642|Acute leukemia|acute leukemia
141042|NCT03320642|chronic myelogenous leukemia|chronic myelogenous leukemia
141043|NCT03320642|myelodysplasia|myelodysplasia
141044|NCT03320642|chronic lymphocytic leukemia/small lymphocytic lymphoma|chronic lymphocytic leukemia/small lymphocytic lymphoma
141045|NCT03320642|follicular|follicular
141046|NCT03320642|marginal zone|marginal zone
141047|NCT03320642|diffuse large B-cell|diffuse large b-cell
141048|NCT03320642|Hodgkin's lymphoma|hodgkin's lymphoma
141049|NCT03320642|mantle cell lymphoma|mantle cell lymphoma
141050|NCT03320642|Janus kinase inhibitor|janus kinase inhibitor
141051|NCT03320642|graft-versus-host disease|graft-versus-host disease
141052|NCT03320590|Time lapse Primovision|time lapse primovision
141053|NCT03320590|Spermatic nuclear quality|spermatic nuclear quality
141054|NCT03320590|intracytoplasmic sperm injection (ICSI)|intracytoplasmic sperm injection (icsi)
141055|NCT03320590|Embryonic kinetics|embryonic kinetics
141056|NCT03320564|injections, intravenous|injections, intravenous
141057|NCT03320564|fluorodeoxyglucose F-18|fluorodeoxyglucose f-18
141058|NCT03320551|Education|education
141059|NCT03320538|Hou Gu Mi Xi|hou gu mi xi
141060|NCT03320538|peptic ulcer disease|peptic ulcer disease
141061|NCT03320538|traditional Chinese medicine|traditional chinese medicine
141062|NCT03320538|randomized controlled trial|randomized controlled trial
141063|NCT03320538|dietary therapy|dietary therapy
141064|NCT03320525|YKL-40|ykl-40
141065|NCT03320525|Pharmacokinetic|pharmacokinetic
141066|NCT03320525|Solid tumors|solid tumors
141067|NCT03320525|T-ChOS|t-chos
141068|NCT03320525|Benecta|benecta
141069|NCT03320525|chitinase 3 like-1 protein (CHI3L1)|chitinase 3 like-1 protein (chi3l1)
141070|NCT03320512|PrEP|prep
141071|NCT03320512|gamification|gamification
141072|NCT03320512|mHealth|mhealth
141073|NCT03320512|HIV prevention|hiv prevention
141074|NCT03320512|truvada|truvada
141075|NCT03320512|eHealth|ehealth
141076|NCT03320512|app|app
141077|NCT03320512|adherence|adherence
141078|NCT03320512|ymsm|ymsm
141079|NCT03320512|transgender women|transgender women
141080|NCT03320486|Mycoses|mycoses
141081|NCT03320486|Dermatomycoses|dermatomycoses
141082|NCT03320486|Antifugal Agents|antifugal agents
141083|NCT03320486|Dapaconazole|dapaconazole
141084|NCT03320460|oral lichen planus; photobiomodulation; inflammation|oral lichen planus; photobiomodulation; inflammation
141085|NCT03320447|ablative fractional laser|ablative fractional laser
141086|NCT03320447|photodynamic therapy|photodynamic therapy
141087|NCT03320447|protoporphyrin IX|protoporphyrin ix
141088|NCT03320447|methy-aminolevulinate|methy-aminolevulinate
141089|NCT03320421|hypofractionated radiation|hypofractionated radiation
141090|NCT03320421|breast cancer|breast cancer
141091|NCT03320421|breast conserving surgery|breast conserving surgery
141092|NCT03320421|simultaneous boost radiation|simultaneous boost radiation
141093|NCT03320408|biobank|biobank
141094|NCT03320408|pathogenesis|pathogenesis
141095|NCT03320408|Aortic Aneurysm|aortic aneurysm
141096|NCT03320304|Difficult to Treat Depression|difficult to treat depression
141097|NCT03320304|TRD|trd
141098|NCT03320304|VNS Therapy|vns therapy
141099|NCT03320304|Vagus Nerve Stimulation|vagus nerve stimulation
141100|NCT03320304|VNS|vns
141101|NCT03320291|Rhizarthrosis|rhizarthrosis
141102|NCT03320291|Regjoint|regjoint
141103|NCT03320291|Trapeziectomy|trapeziectomy
141104|NCT03320278|endotracheal intubation|endotracheal intubation
141105|NCT03320278|airway management|airway management
141780|NCT03315884|TASC C, D|tasc c, d
141106|NCT03320265|Phosphorylcholine human monoclonal antibody|phosphorylcholine human monoclonal antibody
141107|NCT03320265|Lipoprotein a|lipoprotein a
141108|NCT03320252|CHEVAR|chevar
141109|NCT03320252|Chimney|chimney
141110|NCT03320252|Juxtarenal|juxtarenal
141111|NCT03320252|Short Infrarenal /neck|short infrarenal /neck
141112|NCT03320252|Endurant|endurant
141113|NCT03320239|HIV|hiv
141114|NCT03320239|risk assessment|risk assessment
141115|NCT03320239|HIV testing|hiv testing
141116|NCT03320239|unprotected anal intercourse|unprotected anal intercourse
141117|NCT03320239|Social medica|social medica
141118|NCT03320213|CA125|ca125
141119|NCT03320213|Yolk sac morphology|yolk sac morphology
141120|NCT03320213|Threatened miscarriage|threatened miscarriage
141121|NCT03320174|tafenoquine|tafenoquine
141122|NCT03320174|australia|australia
141123|NCT03320161|Supportive care|supportive care
141124|NCT03320161|Cancer|cancer
141125|NCT03320161|Health-related quality of life|health-related quality of life
141126|NCT03320161|Consensus|consensus
141127|NCT03320161|Participative approach|participative approach
141128|NCT03320161|Patient involvement|patient involvement
141129|NCT03320161|DELPHI method|delphi method
141130|NCT03320135|enamel matrix derivative|enamel matrix derivative
141131|NCT03320135|proximal furcation|proximal furcation
141132|NCT03320135|randomized clinical trial|randomized clinical trial
141133|NCT03320122|Telemedicine|telemedicine
141134|NCT03320083|sleep, infants, behavioural insomnia, breastfeeding|sleep, infants, behavioural insomnia, breastfeeding
141135|NCT03320057|medication abortion|medication abortion
141136|NCT03320057|mifepristone|mifepristone
141137|NCT03320044|Circulating Tumor DNA|circulating tumor dna
141138|NCT03320044|Lung cancer Surgery|lung cancer surgery
141139|NCT03320044|early diagnosis|early diagnosis
141140|NCT03320044|immuno-sequencing|immuno-sequencing
141141|NCT03320031|Linagliptin|linagliptin
141142|NCT03320031|premixedinsulin therapy|premixedinsulin therapy
141143|NCT03320031|peritoneal dialysis|peritoneal dialysis
141144|NCT03320031|glycemic variability|glycemic variability
141145|NCT03320018|neuroprotection|neuroprotection
141146|NCT03320018|antioxidant|antioxidant
141147|NCT03320005|respiratory performance|respiratory performance
141148|NCT03320005|quality of life|quality of life
141149|NCT03320005|physical performance|physical performance
141150|NCT03319992|Robotics [H01.671.293.643]|robotics [h01.671.293.643]
141151|NCT03319992|Exoskeleton Device [E07.341]|exoskeleton device [e07.341]
141152|NCT03319992|Rehabilitation Research [H01.770.644.145.472]|rehabilitation research [h01.770.644.145.472]
141153|NCT03319992|Physical and Rehabilitation Medicine [H02.403.680]|physical and rehabilitation medicine [h02.403.680]
141154|NCT03319992|Exercise Therapy [E02.779.483]|exercise therapy [e02.779.483]
141155|NCT03319992|Patient Outcome Assessment [N05.715.360.575.575.399]|patient outcome assessment [n05.715.360.575.575.399]
141156|NCT03319979|Folate, DHFR|folate, dhfr
141157|NCT03319953|Drug therapy|drug therapy
141158|NCT03319940|Half Life Extended (HLE) Bispecific T cell engager (BiTE®)|half life extended (hle) bispecific t cell engager (bite®)
141159|NCT03319940|Delta-like protein 3 (DLL3)|delta-like protein 3 (dll3)
141160|NCT03319927|integrated pest management|integrated pest management
141161|NCT03319927|environmental health|environmental health
141162|NCT03319927|child care|child care
141163|NCT03319927|preschool children|preschool children
141164|NCT03319927|pesticides|pesticides
141165|NCT03319914|calciphylaxis, calcific uremic arteriolopathy,|calciphylaxis, calcific uremic arteriolopathy,
141166|NCT03319914|calcium metabolism disorders|calcium metabolism disorders
141167|NCT03319914|metabolic diseases|metabolic diseases
141168|NCT03319914|sodium thiosulfate|sodium thiosulfate
141169|NCT03319901|Leukemia|leukemia
141170|NCT03319888|CPAP, Chronic kidney disease, sleep apnea|cpap, chronic kidney disease, sleep apnea
141171|NCT03319875|Epiduroscopy|epiduroscopy
141172|NCT03319875|Discectomy|discectomy
141173|NCT03319875|Holmium Yag laser|holmium yag laser
141174|NCT03319875|Lumbar disc herniation|lumbar disc herniation
141175|NCT03319875|Minimally invasive treatment|minimally invasive treatment
141176|NCT03319849|Ciliary Neurotrophic Factor (CNTF)|ciliary neurotrophic factor (cntf)
141177|NCT03319849|Macular Telangiectasia (MacTel)|macular telangiectasia (mactel)
141178|NCT03319810|MCI, Alzheimer Disease, AD|mci, alzheimer disease, ad
141179|NCT03319797|Autologous chondrocyte transplantation ACT|autologous chondrocyte transplantation act
141180|NCT03319771|exercise|exercise
141181|NCT03319771|neuroimaging|neuroimaging
141182|NCT03319771|walking|walking
141183|NCT03319771|multiple sclerosis|multiple sclerosis
141184|NCT03319758|bone augmentation|bone augmentation
141185|NCT03319758|esthetics|esthetics
141186|NCT03319758|immediate implant|immediate implant
141187|NCT03319758|buccal bone defects|buccal bone defects
141188|NCT03319654|Unexplained Infertility|unexplained infertility
141189|NCT03319654|Idiopathic Infertility|idiopathic infertility
141190|NCT03319654|DNA damage|dna damage
141191|NCT03319654|DNA fragmentation|dna fragmentation
141192|NCT03319654|Insemination|insemination
141193|NCT03319641|68Ga-PSMA|68ga-psma
141194|NCT03319641|Positron-Emission Tomography|positron-emission tomography
141195|NCT03319641|Immunohistochemistry|immunohistochemistry
141196|NCT03319615|Appetite|appetite
141197|NCT03319615|Energy Intake|energy intake
141198|NCT03319615|Body Composition|body composition
141199|NCT03319615|Energy Expenditure|energy expenditure
141200|NCT03319602|oxygen mask|oxygen mask
141201|NCT03319602|high-flow oxygen therapy|high-flow oxygen therapy
141202|NCT03319602|acute respiratory failure|acute respiratory failure
141203|NCT03319576|Gastrostomy|gastrostomy
141204|NCT03319576|Feeding|feeding
141205|NCT03319576|G-tube|g-tube
141206|NCT03319550|milk protein, endotoxemia, muscle protein synthesis, whey, casein|milk protein, endotoxemia, muscle protein synthesis, whey, casein
141207|NCT03319537|Pevonedistat|pevonedistat
141208|NCT03319537|Pemetrexed|pemetrexed
141209|NCT03319537|Cisplatin|cisplatin
141210|NCT03319537|17-361|17-361
141211|NCT03319511|thoracic spinal|thoracic spinal
141212|NCT03319511|awake mastectomy|awake mastectomy
141213|NCT03319511|paravertebral block|paravertebral block
141214|NCT03319511|analgesia|analgesia
141215|NCT03319511|ultrasound|ultrasound
141216|NCT03319511|breast cancer|breast cancer
141217|NCT03319485|ExAblate|exablate
141218|NCT03319485|MRgFUS|mrgfus
141219|NCT03319485|Pallidotomy|pallidotomy
141220|NCT03319472|malignant|malignant
141221|NCT03319472|cancer|cancer
141222|NCT03319472|simple bedside test|simple bedside test
141223|NCT03319472|rapid|rapid
141224|NCT03319472|score|score
141225|NCT03319472|widely available|widely available
141226|NCT03319472|feasible|feasible
141227|NCT03319459|Solid Tumor|solid tumor
141228|NCT03319459|HER2|her2
141229|NCT03319459|EGFR|egfr
141230|NCT03319459|Advanced Solid Tumor|advanced solid tumor
141231|NCT03319459|Breast Cancer|breast cancer
141232|NCT03319459|Head and Neck Cancer|head and neck cancer
141233|NCT03319459|Head and Neck Squamous Cell Carcinoma|head and neck squamous cell carcinoma
141234|NCT03319459|Colorectal Cancer|colorectal cancer
141235|NCT03319459|Gastric Cancer|gastric cancer
141236|NCT03319459|HER2 Positive|her2 positive
141237|NCT03319459|EGFR Positive|egfr positive
141238|NCT03319459|EGFR+|egfr+
141239|NCT03319459|HER2+|her2+
141240|NCT03319459|Immunotherapy|immunotherapy
141241|NCT03319459|NK cell therapy|nk cell therapy
141242|NCT03319459|Natural killer cell therapy|natural killer cell therapy
141243|NCT03319459|antibody-dependent cell-mediated cytotoxicity|antibody-dependent cell-mediated cytotoxicity
141244|NCT03319459|ADCC|adcc
141245|NCT03319459|Non small cell lung cancer|non small cell lung cancer
141246|NCT03319459|Renal cancer|renal cancer
141247|NCT03319433|spinal hypotension|spinal hypotension
141248|NCT03319433|perfusion index|perfusion index
141249|NCT03319433|caesarean section|caesarean section
141250|NCT03319394|Firefighters|firefighters
141251|NCT03319394|Exercise Training|exercise training
141252|NCT03319394|Resistance Training|resistance training
141253|NCT03319394|Exercise Test|exercise test
141254|NCT03319394|High-Intensity Interval Training|high-intensity interval training
141255|NCT03319381|Algorithm|algorithm
141256|NCT03319381|In-hospital mortality|in-hospital mortality
141257|NCT03319381|Multiple trauma|multiple trauma
141258|NCT03319381|Standard of care|standard of care
141259|NCT03319355|multicomponent therapy|multicomponent therapy
141260|NCT03319264|Spondylarthropathy|spondylarthropathy
141261|NCT03319264|Sarcopenia|sarcopenia
141262|NCT03319264|lean mass|lean mass
141263|NCT03319264|fat mass|fat mass
141264|NCT03319238|Chronic pain|chronic pain
141265|NCT03319238|Neuropathic pain|neuropathic pain
141266|NCT03319238|Ketamine|ketamine
141267|NCT03319238|Concomitant treatment|concomitant treatment
141268|NCT03319238|Adverse effect|adverse effect
141269|NCT03319173|Mild Cognitive Impairment|mild cognitive impairment
141270|NCT03319173|AMPK activation|ampk activation
141271|NCT03319173|DNA global hypo-methylation|dna global hypo-methylation
141272|NCT03319173|Metabolic Syndrome|metabolic syndrome
141273|NCT03319173|Ketogenic diet|ketogenic diet
141274|NCT03319173|SAM/SAH Index|sam/sah index
141275|NCT03319173|S-adenosylmethionine (SAM)|s-adenosylmethionine (sam)
141276|NCT03319173|S-adenosylhomocysteine (SAH)|s-adenosylhomocysteine (sah)
141277|NCT03319173|Region-Specific hyper-methylation|region-specific hyper-methylation
141278|NCT03319173|mTOR kinase pathway|mtor kinase pathway
141279|NCT03319173|AMP/ATP ratio|amp/atp ratio
141280|NCT03319173|Low Reduction Potential|low reduction potential
141281|NCT03319173|High Reduction Potential|high reduction potential
141282|NCT03319173|Delta G|delta g
141283|NCT03319173|Exergonic|exergonic
141284|NCT03319173|Endergonic|endergonic
141285|NCT03319173|Epigenetic Histone Modification|epigenetic histone modification
141286|NCT03319173|Montreal Cognitive Assessment (MoCA)|montreal cognitive assessment (moca)
141287|NCT03319173|Brief Visual Memory Test-Revised (BVMT-R)|brief visual memory test-revised (bvmt-r)
141288|NCT03319173|Rey Auditory Verbal Learning Task (RAVLT)|rey auditory verbal learning task (ravlt)
141289|NCT03319173|HOMA-IR|homa-ir
141290|NCT03319147|exercise|exercise
141291|NCT03319147|recovery|recovery
141292|NCT03319147|muscle|muscle
141293|NCT03319147|protein|protein
141294|NCT03319121|Non cardiac chest pain|non cardiac chest pain
141295|NCT03319121|Empirical therapy|empirical therapy
141296|NCT03319121|Guided therapy|guided therapy
141395|NCT03318588|Photoreceptor apoptosis|photoreceptor apoptosis
141297|NCT03319095|pelvic floor, muscle, electrical stimulation, physiotherapy|pelvic floor, muscle, electrical stimulation, physiotherapy
141298|NCT03319043|Cough Variant Asthma|cough variant asthma
141299|NCT03319043|impedance|impedance
141300|NCT03319043|inflammation|inflammation
141301|NCT03319043|Chanqin granules|chanqin granules
141302|NCT03319030|exercise|exercise
141303|NCT03319030|Aerobic Exercise|aerobic exercise
141304|NCT03319017|Hypoxia|hypoxia
141305|NCT03319017|Hyperinflammatory|hyperinflammatory
141306|NCT03319017|Hyperoxia|hyperoxia
141307|NCT03319017|Apoptosis|apoptosis
141308|NCT03319017|Oxygenation|oxygenation
141309|NCT03319017|Polymorphonuclear Cells|polymorphonuclear cells
141310|NCT03319017|Tumor necrosis factor(TNF)-α|tumor necrosis factor(tnf)-α
141311|NCT03319017|Cytokine|cytokine
141312|NCT03318991|thulium laser|thulium laser
141313|NCT03318991|GreenLight laser|greenlight laser
141314|NCT03318991|laser therapy|laser therapy
141315|NCT03318991|resection of the prostate|resection of the prostate
141316|NCT03318991|prostate hyperplasia|prostate hyperplasia
141317|NCT03318978|Benzo[a]pyrene|benzo[a]pyrene
141318|NCT03318978|Accelerator Mass Spectrometry|accelerator mass spectrometry
141319|NCT03318978|Polycyclic Aromatic Hydrocarbons|polycyclic aromatic hydrocarbons
141320|NCT03318965|Mortality|mortality
141321|NCT03318965|Anthropometry|anthropometry
141322|NCT03318965|Nutrition Assessment|nutrition assessment
141323|NCT03318965|Caliper|caliper
141324|NCT03318952|lidocaine injection|lidocaine injection
141325|NCT03318952|articaine injections|articaine injections
141326|NCT03318952|pediatric dental anesthesia|pediatric dental anesthesia
141327|NCT03318952|post dental procedure pain|post dental procedure pain
141328|NCT03318939|EGFR|egfr
141329|NCT03318939|HER2|her2
141330|NCT03318939|Exon 20 insertion mutation|exon 20 insertion mutation
141331|NCT03318926|tea, cup-year, renal stone disease|tea, cup-year, renal stone disease
141332|NCT03318913|Vascular function|vascular function
141333|NCT03318913|Type 2 diabetes mellitus|type 2 diabetes mellitus
141334|NCT03318913|Fish protein hydrolysates|fish protein hydrolysates
141335|NCT03318887|Cirrhosis|cirrhosis
141336|NCT03318887|Direct acting antiviral agents|direct acting antiviral agents
141337|NCT03318887|Hepatitis C|hepatitis c
141338|NCT03318887|Pharmacological monitoring|pharmacological monitoring
141339|NCT03318874|Dry Eye Disease|dry eye disease
141340|NCT03318874|Meibomian Gland Dysfunction|meibomian gland dysfunction
141341|NCT03318874|Blephasteam|blephasteam
141342|NCT03318874|THERA°PEARL Eye Mask|thera°pearl eye mask
141343|NCT03318848|students, nursing|students, nursing
141344|NCT03318848|simulation training|simulation training
141345|NCT03318848|Instructional Films and Videos|instructional films and videos
141346|NCT03318848|Aptitude|aptitude
141347|NCT03318835|Thalidomide|thalidomide
141348|NCT03318835|R-CHOP|r-chop
141349|NCT03318835|diffuse large B-cell lymphoma|diffuse large b-cell lymphoma
141350|NCT03318822|brain injury|brain injury
141351|NCT03318809|Cardiovascular Diseases|cardiovascular diseases
141352|NCT03318809|Renal Impairment|renal impairment
141353|NCT03318809|Heart Diseases|heart diseases
141354|NCT03318796|Bifurcation lesions|bifurcation lesions
141355|NCT03318783|Eicosanoids|eicosanoids
141356|NCT03318783|Epoxyeicosatrienoic Acids|epoxyeicosatrienoic acids
141357|NCT03318770|Acute Lymphoblastic Leukemia|acute lymphoblastic leukemia
141358|NCT03318770|adult|adult
141359|NCT03318770|dasatinib|dasatinib
141360|NCT03318770|blinatumomab|blinatumomab
141361|NCT03318770|LAL2116|lal2116
141362|NCT03318757|bupivacaine liposomal injectable|bupivacaine liposomal injectable
141363|NCT03318757|post operative pain|post operative pain
141364|NCT03318757|post operative narcotic use|post operative narcotic use
141365|NCT03318757|bupivacaine hydrochloride|bupivacaine hydrochloride
141366|NCT03318744|Silent Brain Infarction|silent brain infarction
141367|NCT03318744|Antithrombotics|antithrombotics
141368|NCT03318744|Antiplatelet|antiplatelet
141369|NCT03318744|Aspirin|aspirin
141370|NCT03318744|Asymptomatic|asymptomatic
141371|NCT03318731|fenugreek extract|fenugreek extract
141372|NCT03318731|non-resistance trained|non-resistance trained
141373|NCT03318666|Adolescent|adolescent
141374|NCT03318666|Adolescent Medicine|adolescent medicine
141375|NCT03318666|Mental Health Services|mental health services
141376|NCT03318666|eHealth|ehealth
141377|NCT03318666|Online systems|online systems
141378|NCT03318666|Primary Health Care|primary health care
141379|NCT03318666|Social media|social media
141380|NCT03318666|Social support|social support
141381|NCT03318653|Blood pressure|blood pressure
141382|NCT03318653|Dialysis|dialysis
141383|NCT03318640|schizophrenia|schizophrenia
141384|NCT03318640|mindfulness|mindfulness
141385|NCT03318640|parasympathetic system|parasympathetic system
141386|NCT03318614|Gut Microbiota|gut microbiota
141387|NCT03318614|Probiotics|probiotics
141388|NCT03318614|Abdominal Pain|abdominal pain
141389|NCT03318614|Small Intestinal Bacterial Overgrowth|small intestinal bacterial overgrowth
141390|NCT03318614|Mental|mental
141391|NCT03318601|cirrhotic|cirrhotic
141392|NCT03318601|ascite|ascite
141393|NCT03318601|copeptin|copeptin
141394|NCT03318588|Retinal detachment|retinal detachment
141397|NCT03318575|remote ischemic conditioning (RIC)|remote ischemic conditioning (ric)
141398|NCT03318575|percutaneous coronary intervention|percutaneous coronary intervention
141399|NCT03318575|PCI|pci
141400|NCT03318575|cardiac troponin I|cardiac troponin i
141401|NCT03318575|cardiac catheterization|cardiac catheterization
141402|NCT03318575|myocardial injury|myocardial injury
141403|NCT03318575|myocardial necrosis|myocardial necrosis
141404|NCT03318575|autoRIC|autoric
141405|NCT03318575|Ischemia-Reperfusion Injury (IRI)|ischemia-reperfusion injury (iri)
141406|NCT03318575|Automated Remote Ischemic Conditioning|automated remote ischemic conditioning
141407|NCT03318549|virtual reality|virtual reality
141408|NCT03318549|glaucoma|glaucoma
141409|NCT03318549|age related macular degeneration|age related macular degeneration
141410|NCT03318549|quality of life|quality of life
141411|NCT03318549|visual field|visual field
141412|NCT03318549|optical coherence tomography|optical coherence tomography
141413|NCT03318536|Serotonin Antagonists|serotonin antagonists
141414|NCT03318536|Sympathomimetics|sympathomimetics
141415|NCT03318523|BIIB054|biib054
141416|NCT03318523|Alpha-synuclein|alpha-synuclein
141417|NCT03318497|Pancreatic adenocarcinoma|pancreatic adenocarcinoma
141418|NCT03318497|18F-FLT|18f-flt
141419|NCT03318497|FLT|flt
141420|NCT03318497|Locally advanced pancreatic adenocarcinoma|locally advanced pancreatic adenocarcinoma
141421|NCT03318497|Borderline resectable pancreatic adenocarcinoma|borderline resectable pancreatic adenocarcinoma
141422|NCT03318497|resectable pancreatic adenocarcinoma|resectable pancreatic adenocarcinoma
141423|NCT03318471|MgSo4, Mayfield clamp, pressor effect|mgso4, mayfield clamp, pressor effect
141424|NCT03318445|DNA repair mutation|dna repair mutation
141425|NCT03318432|Stroke|stroke
141426|NCT03318432|Acute Stroke|acute stroke
141427|NCT03318432|Ischemic Stroke|ischemic stroke
141428|NCT03318432|Hemorrhagic Stroke|hemorrhagic stroke
141429|NCT03318432|Cerebral Ischemia|cerebral ischemia
141430|NCT03318432|Cerebral Infarction|cerebral infarction
141431|NCT03318432|Cerebral Stroke|cerebral stroke
141432|NCT03318432|Cerebral Vascular Accident|cerebral vascular accident
141433|NCT03318432|Stroke Recovery|stroke recovery
141434|NCT03318406|registry|registry
141435|NCT03318406|vapor ablation|vapor ablation
141436|NCT03318406|InterVapor|intervapor
141437|NCT03318406|BTVA|btva
141438|NCT03318341|physical stimulation|physical stimulation
141439|NCT03318341|Subliminal stimulation|subliminal stimulation
141440|NCT03318341|stroke rehabilitation|stroke rehabilitation
141441|NCT03318341|upper extremity|upper extremity
141442|NCT03318341|paresis|paresis
141443|NCT03318341|patient safety|patient safety
141444|NCT03318315|AS03-adjuvanted Inactivated Influenza Vaccine|as03-adjuvanted inactivated influenza vaccine
141445|NCT03318315|Co-Administered|co-administered
141446|NCT03318315|Healthy Adults|healthy adults
141447|NCT03318315|Immunogenicity|immunogenicity
141448|NCT03318315|Inactivated Seasonal Influenza Vaccine|inactivated seasonal influenza vaccine
141449|NCT03318315|Phase II|phase ii
141450|NCT03318315|Safety|safety
141451|NCT03318263|Estrogen-receptor-positive breast cancer|estrogen-receptor-positive breast cancer
141452|NCT03318263|aromatase inhibitor,|aromatase inhibitor,
141453|NCT03318263|ESR1,|esr1,
141454|NCT03318263|PIK3CA|pik3ca
141455|NCT03318263|AKT|akt
141456|NCT03318263|endocrine resistance|endocrine resistance
141457|NCT03318263|circulating tumor DNA|circulating tumor dna
141458|NCT03318250|DRG Stimulation|drg stimulation
141459|NCT03318211|preeclampsia|preeclampsia
141460|NCT03318211|Magnisium sulfate|magnisium sulfate
141461|NCT03318198|Graduate Medical Education|graduate medical education
141462|NCT03318198|Attending Supervision of Residents|attending supervision of residents
141463|NCT03318198|Patient Safety|patient safety
141464|NCT03318185|gasless single-port laparoscopic surgery;rectal carcinoma|gasless single-port laparoscopic surgery;rectal carcinoma
141465|NCT03318172|Spinal Cord Stimulation|spinal cord stimulation
141466|NCT03318172|High Density Stimulation|high density stimulation
141467|NCT03318146|Plugged Tear Duct|plugged tear duct
141468|NCT03318133|general anesthesia|general anesthesia
141469|NCT03318133|sacral plexus block|sacral plexus block
141470|NCT03318133|lumbar plexus block|lumbar plexus block
141471|NCT03318133|hip fracture|hip fracture
141472|NCT03318133|elderly|elderly
141473|NCT03318094|insulin resistance|insulin resistance
141474|NCT03318094|phentolamine|phentolamine
141475|NCT03318094|microvascular recruitment|microvascular recruitment
141476|NCT03318094|autonomic nervous system|autonomic nervous system
141477|NCT03318081|Amphetamine-type stimulants|amphetamine-type stimulants
141478|NCT03318081|prefrontal-striatal circuits|prefrontal-striatal circuits
141479|NCT03318081|cognitive rehabilitation therapy|cognitive rehabilitation therapy
141480|NCT03318068|Cancer|cancer
141481|NCT03318068|Pediatric cancer|pediatric cancer
141482|NCT03318068|Yoga|yoga
141483|NCT03318068|Psychological distress|psychological distress
141484|NCT03318068|Outpatient chemotherapy|outpatient chemotherapy
141485|NCT03318029|Vitamin D|vitamin d
141486|NCT03318029|Supplementation|supplementation
141487|NCT03318029|Sunlight|sunlight
141488|NCT03318016|Arsenic Trioxide|arsenic trioxide
141489|NCT03318016|Cyclophosphamide|cyclophosphamide
141490|NCT03317990|Prostate Cancer|prostate cancer
141491|NCT03317990|Nerve sparing|nerve sparing
141492|NCT03317990|NeuroSAFE|neurosafe
141493|NCT03317990|Frozen section|frozen section
141494|NCT03317977|Asthma management, adolescents|asthma management, adolescents
141495|NCT03317925|Pediatric Renal Transplant|pediatric renal transplant
141496|NCT03317925|Renal Allograft|renal allograft
141497|NCT03317925|Angiotensin II|angiotensin ii
141498|NCT03317925|Angiotensin-(1-7)|angiotensin-(1-7)
141500|NCT03317925|ACE2|ace2
141501|NCT03317860|perceptual disorders|perceptual disorders
141502|NCT03317860|cerebrovascular disorders|cerebrovascular disorders
141503|NCT03317860|neurobehavioral manifestations|neurobehavioral manifestations
141504|NCT03317860|neurologic manifestations|neurologic manifestations
141505|NCT03317860|neglect|neglect
141506|NCT03317860|non-invasive brain stimulation|non-invasive brain stimulation
141507|NCT03317860|rehabilitation|rehabilitation
141508|NCT03317860|tDCS|tdcs
141509|NCT03317860|paresis|paresis
141510|NCT03317795|Menorrhagia|menorrhagia
141511|NCT03317795|FIbroids|fibroids
141512|NCT03317795|Menstrual Bleeding|menstrual bleeding
141513|NCT03317795|Heavy Bleeding|heavy bleeding
141514|NCT03317795|Menses|menses
141515|NCT03317795|Uterine Fibroids|uterine fibroids
141516|NCT03317730|Xtampza ER|xtampza er
141517|NCT03317730|LAHNC|lahnc
141518|NCT03317730|Head and neck cancer|head and neck cancer
141519|NCT03317730|Pain management|pain management
141520|NCT03317691|myocardial infarction|myocardial infarction
141521|NCT03317691|artificial Intelligence|artificial intelligence
141522|NCT03317691|12 lead electrocardiogram|12 lead electrocardiogram
141523|NCT03317665|biologic|biologic
141524|NCT03317665|prosthetic|prosthetic
141525|NCT03317665|mesh|mesh
141526|NCT03317613|Neuropathic Pain|neuropathic pain
141527|NCT03317613|Qutenza|qutenza
141528|NCT03317613|Capsaicin|capsaicin
141529|NCT03317613|Cancer patient|cancer patient
141530|NCT03317561|troponin|troponin
141531|NCT03317561|major surgery|major surgery
141532|NCT03317535|Anesthesia Methods|anesthesia methods
141533|NCT03317535|Acute Ischemic Stroke|acute ischemic stroke
141534|NCT03317535|Endovascular Treatment|endovascular treatment
141535|NCT03317522|Pregnancy|pregnancy
141536|NCT03317522|teratogenesis|teratogenesis
141537|NCT03317496|Avelumab, immunotherapy, PD-L1 inhibitor, non-small cell lung cancer (NSCLC), urothelial cancer (UC), carboplatin, pemetrexed, gemcitabine, cisplatin|avelumab, immunotherapy, pd-l1 inhibitor, non-small cell lung cancer (nsclc), urothelial cancer (uc), carboplatin, pemetrexed, gemcitabine, cisplatin
141538|NCT03317444|blood bicarbonate, kidney disease|blood bicarbonate, kidney disease
141539|NCT03317431|dopamine,mechanical ventilation,lung injury|dopamine,mechanical ventilation,lung injury
141540|NCT03317366|ARQ 092|arq 092
141541|NCT03317366|ArQule|arqule
141542|NCT03317366|AKT|akt
141543|NCT03317366|PIK3CA|pik3ca
141544|NCT03317366|Overgrowth|overgrowth
141545|NCT03317366|Congenital malformations|congenital malformations
141546|NCT03317353|Vestibular Rehabilitation|vestibular rehabilitation
141547|NCT03317353|Falls in elderly|falls in elderly
141548|NCT03317353|Computerized Dynamic Posturography|computerized dynamic posturography
141549|NCT03317353|Optokinetic stimuli|optokinetic stimuli
141550|NCT03317327|HNSCC|hnscc
141551|NCT03317327|Nivolumab|nivolumab
141552|NCT03317327|immunotherapy|immunotherapy
141553|NCT03317301|Pruritus cutaneus|pruritus cutaneus
141554|NCT03317288|spinal cord injury|spinal cord injury
141555|NCT03317288|pressure ulcer|pressure ulcer
141556|NCT03317288|laser Doppler flowmetry|laser doppler flowmetry
141557|NCT03317262|quality of life, citalopram, quetiapine, pregabalin|quality of life, citalopram, quetiapine, pregabalin
141558|NCT03317249|Inappropriate Sinus Tachycardia|inappropriate sinus tachycardia
141559|NCT03317249|Pregnancy Related|pregnancy related
141560|NCT03317249|IST|ist
141561|NCT03317236|Bioequivalence|bioequivalence
141562|NCT03317236|Quetiapine|quetiapine
141563|NCT03317197|Out-of-Hospital Cardiac Arrest|out-of-hospital cardiac arrest
141564|NCT03317197|Vasopressin-steroid-epinephrine (VSE)|vasopressin-steroid-epinephrine (vse)
141565|NCT03317197|Treatment Outcome|treatment outcome
141566|NCT03317197|prognosis|prognosis
141567|NCT03317197|Return of spontaneous circulation|return of spontaneous circulation
141568|NCT03317184|Physical Activity|physical activity
141569|NCT03317184|Pfannenstiel incision|pfannenstiel incision
141570|NCT03317184|Periumbilical incision|periumbilical incision
141571|NCT03317171|dietary supplementation|dietary supplementation
141572|NCT03317171|flavonoids|flavonoids
141573|NCT03317171|omega 3|omega 3
141574|NCT03317158|non-muscle invasive bladder cancer|non-muscle invasive bladder cancer
141575|NCT03317158|BCG|bcg
141576|NCT03317158|immunotherapy|immunotherapy
141577|NCT03317145|venous thromboembolism|venous thromboembolism
141578|NCT03317145|deep vein thrombosis|deep vein thrombosis
141579|NCT03317145|pulmonary embolism|pulmonary embolism
141580|NCT03317145|neuromuscular electrostimulation|neuromuscular electrostimulation
141581|NCT03317145|foot compression|foot compression
141582|NCT03317145|hip replacement|hip replacement
141583|NCT03317132|Vocational, First-episode psychosis|vocational, first-episode psychosis
141584|NCT03317080|lung cancer|lung cancer
141585|NCT03317080|circulating tumor DNA|circulating tumor dna
141586|NCT03317080|molecular classification|molecular classification
141587|NCT03317080|dynamic monitoring|dynamic monitoring
141588|NCT03317080|next generation sequencing|next generation sequencing
141589|NCT03317080|diagnosis|diagnosis
141590|NCT03317080|postoperative relapse|postoperative relapse
141591|NCT03317067|Dexmdetomidine|dexmdetomidine
141592|NCT03317067|Haloperidol|haloperidol
141593|NCT03317067|Delirium|delirium
141594|NCT03317067|Productive Delirium|productive delirium
141595|NCT03317067|Agitation|agitation
141596|NCT03317067|Intubation|intubation
141597|NCT03317067|Ventilatory free days|ventilatory free days
141598|NCT03317067|Sedation|sedation
141599|NCT03317067|ICU patients|icu patients
141600|NCT03317067|Mechanical Ventilation|mechanical ventilation
141601|NCT03317054|Gambing|gambing
141602|NCT03317054|occupational health services|occupational health services
141603|NCT03317054|psychosocial risks|psychosocial risks
141604|NCT03317041|Capacitive-resistive electric transfer therapy|capacitive-resistive electric transfer therapy
141605|NCT03317041|Radiofrequency therapy|radiofrequency therapy
141606|NCT03317041|Recovery intervention|recovery intervention
141607|NCT03317041|Fatigue|fatigue
141608|NCT03317041|Running|running
141609|NCT03316976|Drug therapy|drug therapy
141610|NCT03316963|Neostigmine|neostigmine
141611|NCT03316963|Nerve stimulant medication|nerve stimulant medication
141612|NCT03316963|Treatments for snoring|treatments for snoring
141613|NCT03316950|postmenopause|postmenopause
141614|NCT03316950|rejuvenation|rejuvenation
141615|NCT03316950|radiofrequency|radiofrequency
141616|NCT03316950|diva|diva
141617|NCT03316859|opioid-induced constipation (OIC)|opioid-induced constipation (oic)
141618|NCT03316846|Chronic Pain|chronic pain
141619|NCT03316846|Depression|depression
141620|NCT03316846|Anxiety|anxiety
141621|NCT03316846|Stress|stress
141622|NCT03316846|iCBT|icbt
141623|NCT03316846|Cognitive behavioral therapy|cognitive behavioral therapy
141624|NCT03316846|Internet delivered|internet delivered
141625|NCT03316846|Tailored treatment|tailored treatment
141626|NCT03316807|Hepatitis B, Vaccine|hepatitis b, vaccine
141627|NCT03316807|Randomized Controlled Trial|randomized controlled trial
141628|NCT03316807|HIV|hiv
141629|NCT03316807|Immunogenicity|immunogenicity
141630|NCT03316794|Triple Negative Breast Cancer|triple negative breast cancer
141631|NCT03316794|Cancer|cancer
141632|NCT03316794|Breast Cancer|breast cancer
141633|NCT03316794|Maximum tolerated dose (MTD)|maximum tolerated dose (mtd)
141634|NCT03316794|Pharmacokinetics|pharmacokinetics
141635|NCT03316768|grip|grip
141636|NCT03316768|pinch|pinch
141637|NCT03316768|forces|forces
141638|NCT03316768|pressure|pressure
141639|NCT03316768|Tekscan|tekscan
141640|NCT03316768|sensor|sensor
141641|NCT03316768|ADL|adl
141642|NCT03316768|activities of daily living|activities of daily living
141643|NCT03316768|work requirements|work requirements
141644|NCT03316768|hand biomechanics|hand biomechanics
141645|NCT03316768|forceful precision grip|forceful precision grip
141646|NCT03316768|power grip|power grip
141647|NCT03316768|hominid|hominid
141648|NCT03316768|hominin|hominin
141649|NCT03316768|prehistoric|prehistoric
141650|NCT03316742|Obese|obese
141651|NCT03316742|Overweight|overweight
141652|NCT03316742|Weight loss|weight loss
141653|NCT03316742|West Africa|west africa
141654|NCT03316729|Sub-massive acute pulmonary embolism|sub-massive acute pulmonary embolism
141655|NCT03316716|caesarean section|caesarean section
141656|NCT03316716|neonatal hypothermia|neonatal hypothermia
141657|NCT03316716|maternal hypothermia|maternal hypothermia
141658|NCT03316716|active warming|active warming
141659|NCT03316716|skin-to-skin contact|skin-to-skin contact
141660|NCT03316703|Spine, Spinal injuries, Fractures, Bone|spine, spinal injuries, fractures, bone
141661|NCT03316677|anastomotic leak|anastomotic leak
141662|NCT03316677|colorectal|colorectal
141663|NCT03316677|anastomosis testing|anastomosis testing
141664|NCT03316677|Intraoperative testing|intraoperative testing
141665|NCT03316664|cognitive behavioural therapy|cognitive behavioural therapy
141666|NCT03316664|psychotic disorder|psychotic disorder
141667|NCT03316664|schizophrenia|schizophrenia
141668|NCT03316664|schizoaffective disorder|schizoaffective disorder
141669|NCT03316664|psychological intervention|psychological intervention
141670|NCT03316651|pulmonary alveolar proteinosis|pulmonary alveolar proteinosis
141671|NCT03316651|granulocyte-macrophage colony-stimulating factor|granulocyte-macrophage colony-stimulating factor
141672|NCT03316651|whole lung lavage|whole lung lavage
141673|NCT03316612|Advanced Glycation End Products, Metabolites, Gut Microbiota|advanced glycation end products, metabolites, gut microbiota
141674|NCT03316599|Pancreatic Cancer|pancreatic cancer
141675|NCT03316586|Breast Cancer|breast cancer
141676|NCT03316573|Lymphoma|lymphoma
141677|NCT03316573|Histiocyte sarcoma|histiocyte sarcoma
141678|NCT03316573|Follicular Dendritic Cell Saroma|follicular dendritic cell saroma
141679|NCT03316573|Interdigitating dendritic cell sarcoma|interdigitating dendritic cell sarcoma
141680|NCT03316560|XLRP|xlrp
141681|NCT03316560|retinal degeneration|retinal degeneration
141682|NCT03316560|RPGR|rpgr
141683|NCT03316560|adeno-associated virus|adeno-associated virus
141684|NCT03316560|gene therapy|gene therapy
141685|NCT03316560|AAV|aav
141686|NCT03316547|preterm|preterm
141687|NCT03316521|complement inhibition|complement inhibition
141688|NCT03316521|C3 complement inhibitor|c3 complement inhibitor
141689|NCT03316521|AMY-101|amy-101
141690|NCT03316521|Compstatin Cp40|compstatin cp40
141691|NCT03316521|Paroxysmal Nocturnal Hemoglobinuria (PNH)|paroxysmal nocturnal hemoglobinuria (pnh)
141692|NCT03316521|C3 glomerulopathy (C3G)|c3 glomerulopathy (c3g)
141693|NCT03316521|Periodontal disease|periodontal disease
141694|NCT03316521|Age-related macular degeneration (AMD)|age-related macular degeneration (amd)
141695|NCT03316521|ABO incompatible kidney transplantation|abo incompatible kidney transplantation
141696|NCT03316508|copeptin|copeptin
141697|NCT03316508|pediatric cardiac surgery|pediatric cardiac surgery
141698|NCT03316508|heart lung machine|heart lung machine
141699|NCT03316469|Anti-mullerian hormone|anti-mullerian hormone
141700|NCT03316456|AL|al
141701|NCT03316443|Glidescope,Macintosh, Laryngscope, intubation,Hypertension.|glidescope,macintosh, laryngscope, intubation,hypertension.
141702|NCT03316404|Multiple Sclerosis|multiple sclerosis
141703|NCT03316404|MS|ms
141704|NCT03316378|Human|human
141705|NCT03316378|Pain|pain
141706|NCT03316378|Biomechanics|biomechanics
141707|NCT03316378|Anesthetics|anesthetics
141708|NCT03316313|Public Health|public health
141709|NCT03316313|Patient Education as Topic|patient education as topic
141710|NCT03316313|Hepatitis C|hepatitis c
141711|NCT03316300|Ciliary Neurotrophic Factor (CNTF)|ciliary neurotrophic factor (cntf)
141712|NCT03316300|Macular Telangiectasia (MacTel)|macular telangiectasia (mactel)
141713|NCT03316261|infants|infants
141714|NCT03316261|type 1 diabetes|type 1 diabetes
141715|NCT03316261|Freder1k|freder1k
141716|NCT03316248|Transtibial amputation|transtibial amputation
141717|NCT03316248|visual feedback|visual feedback
141718|NCT03316248|rehabilitation|rehabilitation
141719|NCT03316196|trauma|trauma
141720|NCT03316196|PTSD|ptsd
141721|NCT03316196|cognition|cognition
141722|NCT03316183|cerebral oximetry|cerebral oximetry
141723|NCT03316183|near-infrared spectroscopy (NIRS)|near-infrared spectroscopy (nirs)
141724|NCT03316183|metabolomic profiling|metabolomic profiling
141725|NCT03316183|neurocognitive outcomes|neurocognitive outcomes
141726|NCT03316183|Cerebral protection|cerebral protection
141727|NCT03316144|immunotherapy|immunotherapy
141728|NCT03316144|check point inhibitor|check point inhibitor
141729|NCT03316144|PD-1 antibody|pd-1 antibody
141730|NCT03316144|phase 1 trial|phase 1 trial
141731|NCT03316144|Malignant Lymphoma|malignant lymphoma
141732|NCT03316131|Gout|gout
141733|NCT03316131|Uric acid|uric acid
141734|NCT03316131|Hyperuricemia|hyperuricemia
141735|NCT03316131|Asymptomatic gout|asymptomatic gout
141736|NCT03316131|Febuxostat|febuxostat
141737|NCT03316131|Dapagliflozin|dapagliflozin
141738|NCT03316131|Uric acid transporter 1 (URAT1) Inhibitor|uric acid transporter 1 (urat1) inhibitor
141739|NCT03316131|Xanthine Oxidase Inhibitor|xanthine oxidase inhibitor
141740|NCT03316131|Sodium-glucose cotransporter 2 (SGLT2) Inhibitor|sodium-glucose cotransporter 2 (sglt2) inhibitor
141741|NCT03316118|anesthesiology|anesthesiology
141742|NCT03316118|pain|pain
141743|NCT03316118|arthroplasty|arthroplasty
141744|NCT03316079|intensive care|intensive care
141745|NCT03316079|invasive mechanical ventilation|invasive mechanical ventilation
141746|NCT03316079|mechanical insufflation-exsufflation|mechanical insufflation-exsufflation
141747|NCT03316079|airway mucus clearance|airway mucus clearance
141748|NCT03316079|chest physiotherapy|chest physiotherapy
141749|NCT03316079|peak expiratory flow|peak expiratory flow
141750|NCT03316079|pulmonary mechanics|pulmonary mechanics
141751|NCT03316066|Stellate Ganglion|stellate ganglion
141752|NCT03316066|Local Anesthetic|local anesthetic
141753|NCT03316040|HIV/AIDS|hiv/aids
141754|NCT03316040|Join-in-Circuit|join-in-circuit
141755|NCT03316014|Pediatry; Adverse drug reactions; Pharmacovigilance|pediatry; adverse drug reactions; pharmacovigilance
141756|NCT03315988|type 2 diabetes|type 2 diabetes
141757|NCT03315988|vegan diet|vegan diet
141758|NCT03315988|TMAO|tmao
141759|NCT03315988|cardiovascular disease|cardiovascular disease
141760|NCT03315975|Influenza vaccine|influenza vaccine
141761|NCT03315923|Active secondary progressive Multiple Sclerosis|active secondary progressive multiple sclerosis
141762|NCT03315923|Glatiramer acetate|glatiramer acetate
141763|NCT03315923|Rituximab|rituximab
141764|NCT03315923|Comparative study|comparative study
141765|NCT03315923|Disability|disability
141766|NCT03315923|Randomized clinical trial|randomized clinical trial
141767|NCT03315923|Annualized relapse rate|annualized relapse rate
141768|NCT03315910|Tobacco Treatment|tobacco treatment
141769|NCT03315910|Lung CT|lung ct
141770|NCT03315910|Cancer Screening|cancer screening
141771|NCT03315910|17-500|17-500
141772|NCT03315897|bipolar disorder|bipolar disorder
141773|NCT03315897|cognition|cognition
141774|NCT03315897|cognitive dysfunction|cognitive dysfunction
141775|NCT03315897|erythropoietin|erythropoietin
141776|NCT03315897|pro-cognitive efficacy|pro-cognitive efficacy
141777|NCT03315897|prefrontal cortex|prefrontal cortex
141778|NCT03315897|functional magnetic resonance imaging|functional magnetic resonance imaging
141779|NCT03315897|biomarker|biomarker
141781|NCT03315884|CFA|cfa
141782|NCT03315884|Supera|supera
141783|NCT03315884|iliac arteries|iliac arteries
141784|NCT03315884|common femoral artery|common femoral artery
141785|NCT03315884|plasty of the common femoral artery|plasty of the common femoral artery
141786|NCT03315884|stenting Supera|stenting supera
141787|NCT03315871|Vaccine|vaccine
141788|NCT03315871|PSA|psa
141789|NCT03315871|Immunotherapy|immunotherapy
141790|NCT03315871|Immune Response|immune response
141791|NCT03315871|Checkpoint Inhibitor|checkpoint inhibitor
141792|NCT03315858|NFAT|nfat
141793|NCT03315858|gene expression|gene expression
141794|NCT03315858|tacrolimus|tacrolimus
141795|NCT03315845|BMI|bmi
141796|NCT03315845|obstetric anaesthesia|obstetric anaesthesia
141797|NCT03315845|neuraxial anaesthesia|neuraxial anaesthesia
141798|NCT03315845|neuraxial ultrasound|neuraxial ultrasound
141799|NCT03315845|difficult neuraxial anaesthesia|difficult neuraxial anaesthesia
141800|NCT03315832|Aortic Valve Stenosis|aortic valve stenosis
141801|NCT03315832|Valsartan|valsartan
141802|NCT03315832|Angiotensin Receptor Antagonists|angiotensin receptor antagonists
141803|NCT03315832|Transcatheter Aortic Valve Replacement|transcatheter aortic valve replacement
141804|NCT03315832|Heart Valve Prosthesis Implantation|heart valve prosthesis implantation
141805|NCT03315832|double-blind phase II study|double-blind phase ii study
141806|NCT03315832|left ventricular mass|left ventricular mass
141807|NCT03315819|glenohumeral dislocation|glenohumeral dislocation
141808|NCT03315819|Arthroscopic|arthroscopic
141809|NCT03315819|capsular lesions|capsular lesions
141810|NCT03315806|Dietary nitrate|dietary nitrate
141811|NCT03315806|Nitrate|nitrate
141812|NCT03315806|Flow-mediated dilation|flow-mediated dilation
141813|NCT03315806|Tissue oxygen saturation|tissue oxygen saturation
141814|NCT03315767|HVPG|hvpg
141815|NCT03315767|portal hypertension|portal hypertension
141816|NCT03315767|ARFI|arfi
141817|NCT03315767|portal vein flow|portal vein flow
141818|NCT03315767|advanced liver chronic disease (ACLD)|advanced liver chronic disease (acld)
141819|NCT03315741|Bronchiolitis obliterans syndrome|bronchiolitis obliterans syndrome
141820|NCT03315728|Quality improvement|quality improvement
141821|NCT03315728|Indigenous|indigenous
141822|NCT03315728|First Nation|first nation
141823|NCT03315728|Participatory|participatory
141824|NCT03315728|Diabetes|diabetes
141825|NCT03315728|Chronic Disease|chronic disease
141826|NCT03315702|R-spondin proteins, mechanical ventilation, lung injury|r-spondin proteins, mechanical ventilation, lung injury
141827|NCT03315663|Mobile Health|mobile health
141828|NCT03315650|Non-valvular AF|non-valvular af
141829|NCT03315650|ACS|acs
141830|NCT03315650|PCI|pci
141831|NCT03315650|NOAC|noac
141832|NCT03315650|Rivaroxaban|rivaroxaban
141833|NCT03315624|Hemodialysis|hemodialysis
141834|NCT03315624|Hemodiafiltration|hemodiafiltration
141835|NCT03315624|Renal replacement therapy|renal replacement therapy
141836|NCT03315598|Neuralgia, Acupuncture Treatment|neuralgia, acupuncture treatment
141837|NCT03315585|focal therapy|focal therapy
141838|NCT03315585|IRE|ire
141839|NCT03315585|Composite Steep-pulse Treatment Apparatus|composite steep-pulse treatment apparatus
141840|NCT03315585|prostate cancer|prostate cancer
141841|NCT03315572|caregiver|caregiver
141842|NCT03315572|ELLIPTA|ellipta
141843|NCT03315572|Asthma|asthma
141844|NCT03315572|Dry Powder Inhaler|dry powder inhaler
141845|NCT03315572|pediatric|pediatric
141846|NCT03315559|GSK2269557|gsk2269557
141847|NCT03315559|Pharmacokinetics|pharmacokinetics
141848|NCT03315559|Radiolabel|radiolabel
141849|NCT03315559|Healthy|healthy
141850|NCT03315559|Excretion|excretion
141851|NCT03315559|Bioavailability|bioavailability
141852|NCT03315546|deep inspiration breath-hold|deep inspiration breath-hold
141853|NCT03315546|radiotherapy|radiotherapy
141854|NCT03315546|late effects|late effects
141855|NCT03315546|pediatric cancer|pediatric cancer
141856|NCT03315520|Hodgkin Lymphoma|hodgkin lymphoma
141857|NCT03315520|Non-Hodgkin lymphoma|non-hodgkin lymphoma
141858|NCT03315520|autologous hematopoietic stem-cell transplantation|autologous hematopoietic stem-cell transplantation
141859|NCT03315520|conditioning regimen|conditioning regimen
141860|NCT03315494|rheumatoid arthritis|rheumatoid arthritis
141861|NCT03315494|healthy volunteers|healthy volunteers
141862|NCT03315494|moderate to severe|moderate to severe
141863|NCT03315468|melanoma|melanoma
141864|NCT03315468|database|database
141865|NCT03315468|cohort|cohort
141866|NCT03315442|Fluid|fluid
141867|NCT03315442|Balance|balance
141868|NCT03315416|Speech Disorder|speech disorder
141869|NCT03315416|Breast Feeding|breast feeding
141870|NCT03315416|Infant Feeding|infant feeding
141871|NCT03315416|Bottle Feeding|bottle feeding
141872|NCT03315416|Speech Development|speech development
141873|NCT03315416|Speech Sound Development|speech sound development
141874|NCT03315416|Speech Sound Disorder|speech sound disorder
141875|NCT03315416|Non-nutritive Sucking|non-nutritive sucking
141876|NCT03315403|quantitative polymerase chain reaction|quantitative polymerase chain reaction
141877|NCT03315403|qPCR|qpcr
141878|NCT03315403|autolysin|autolysin
141879|NCT03315403|lytA|lyta
141880|NCT03315403|Pneumococcal pneumonia|pneumococcal pneumonia
141881|NCT03315403|Diagnostics|diagnostics
141882|NCT03315403|Community-acquired Pneumonia|community-acquired pneumonia
141883|NCT03315403|Antibiotic resistance|antibiotic resistance
141884|NCT03315390|post-traumatic stress, primary health care, stress disorder|post-traumatic stress, primary health care, stress disorder
141885|NCT03315364|Recurrent breast cancer|recurrent breast cancer
141886|NCT03315364|Metastatic breast cancer|metastatic breast cancer
141887|NCT03315364|MBC|mbc
141888|NCT03315364|Firstline chemotherapy|firstline chemotherapy
141889|NCT03315364|Paclitaxel|paclitaxel
141890|NCT03315364|Liporaxel|liporaxel
141891|NCT03315364|Taxol|taxol
141892|NCT03315351|PET-scan|pet-scan
141893|NCT03315351|Brachytherapy|brachytherapy
141894|NCT03315351|Cervical Cancer|cervical cancer
141895|NCT03315325|Aging|aging
141896|NCT03315286|ultraviolet light|ultraviolet light
141897|NCT03315286|dosimetry|dosimetry
141898|NCT03315286|actinic keratosis|actinic keratosis
141899|NCT03315286|skin cancer|skin cancer
141900|NCT03315286|sun counseling|sun counseling
141901|NCT03315286|wearable device|wearable device
141902|NCT03315273|Traumatic brain injury, motor imagery ability, validation|traumatic brain injury, motor imagery ability, validation
141903|NCT03315260|Castration resistant prostate cancer|castration resistant prostate cancer
141904|NCT03315260|Patient reported outcome|patient reported outcome
141905|NCT03315247|Obesity|obesity
141906|NCT03315247|Bariatric Surgery|bariatric surgery
141907|NCT03315247|Bariatrics|bariatrics
141908|NCT03315247|Cognitive Therapy|cognitive therapy
141909|NCT03315247|Binge Eating|binge eating
141910|NCT03315234|SYNTAX score|syntax score
141911|NCT03315234|Coronary Atherosclerosis|coronary atherosclerosis
141912|NCT03315234|Coronary Artery Disease|coronary artery disease
141913|NCT03315234|SNPs|snps
141914|NCT03315234|Genetics|genetics
141915|NCT03315234|Genetic Risk Score|genetic risk score
141916|NCT03315234|Personalized Medicine|personalized medicine
141917|NCT03315208|transdiagnostic treatment|transdiagnostic treatment
141918|NCT03315208|cognitive-behavioral therapy|cognitive-behavioral therapy
141919|NCT03315208|Unified Protocol|unified protocol
141920|NCT03315208|young adults|young adults
141921|NCT03315208|substance use disorder|substance use disorder
141922|NCT03315208|emotional disorder|emotional disorder
141923|NCT03315208|depression|depression
141924|NCT03315208|anxiety|anxiety
141925|NCT03315208|emotion dysregulation|emotion dysregulation
141926|NCT03315208|self-injurious thoughts and behaviors|self-injurious thoughts and behaviors
141927|NCT03315182|MPS IIIB|mps iiib
141928|NCT03315182|Sanfilippo Syndrome B|sanfilippo syndrome b
141929|NCT03315169|Incision and Drainage|incision and drainage
141930|NCT03315169|Packing|packing
141931|NCT03315156|Acute otitis media|acute otitis media
141932|NCT03315156|AOM|aom
141933|NCT03315156|Electrogustometer|electrogustometer
141934|NCT03315156|EGM|egm
141935|NCT03315156|Taste threshold|taste threshold
141936|NCT03315104|influenza A|influenza a
141937|NCT03315104|hospitalized|hospitalized
141938|NCT03315104|H1N1|h1n1
141939|NCT03315104|H3N2|h3n2
141940|NCT03315104|human flu|human flu
141941|NCT03315104|respiratory tract infection|respiratory tract infection
141942|NCT03315104|serious illness|serious illness
141943|NCT03315104|flu|flu
141944|NCT03315091|Pharmacokinetics, WEE1 inhibitor, food effect, safety assessments|pharmacokinetics, wee1 inhibitor, food effect, safety assessments
141945|NCT03315065|thoracic Radiation therapy|thoracic radiation therapy
141946|NCT03315065|Lung Function|lung function
141947|NCT03315052|Graft loss|graft loss
141948|NCT03315052|Renal failure|renal failure
141949|NCT03315052|Infection|infection
141950|NCT03315052|Diabetes|diabetes
141951|NCT03315052|Hypertension|hypertension
141952|NCT03315026|Siltuximab|siltuximab
141953|NCT03315026|Autologous Stem Cell Transplantation (AST)|autologous stem cell transplantation (ast)
141954|NCT03315026|17-365|17-365
141955|NCT03315013|Antiretroviral therapy initiation|antiretroviral therapy initiation
141956|NCT03315013|Sub-Sahara Africa|sub-sahara africa
141957|NCT03315013|ART|art
141958|NCT03315000|methacholine|methacholine
141959|NCT03315000|airway hyperresponsiveness|airway hyperresponsiveness
141960|NCT03314987|air pollution|air pollution
141961|NCT03314987|oxidative stress|oxidative stress
141962|NCT03314987|intervention|intervention
141963|NCT03314974|AML|aml
141964|NCT03314974|ALL|all
141965|NCT03314974|MDS|mds
141966|NCT03314974|NHL|nhl
141967|NCT03314974|CLL|cll
141968|NCT03314974|CML|cml
141969|NCT03314974|SLL|sll
141970|NCT03314961|rectal cancer|rectal cancer
141971|NCT03314935|INCB001158|incb001158
141972|NCT03314935|arginase inhibitor|arginase inhibitor
141973|NCT03314935|oxaliplatin|oxaliplatin
141974|NCT03314935|leucovorin|leucovorin
141975|NCT03314935|5 fluorouracil|5 fluorouracil
141976|NCT03314935|gemcitabine|gemcitabine
141977|NCT03314935|cisplatin|cisplatin
141978|NCT03314935|paclitaxel|paclitaxel
141979|NCT03314935|solid tumors|solid tumors
141980|NCT03314935|colorectal cancer|colorectal cancer
141981|NCT03314935|biliary tract cancer|biliary tract cancer
141982|NCT03314935|gastroesophageal cancer|gastroesophageal cancer
141983|NCT03314935|endometrial cancer|endometrial cancer
141984|NCT03314935|ovarian cancer|ovarian cancer
141985|NCT03314922|Diffuse large B-cell lymphoma (DLBCL)|diffuse large b-cell lymphoma (dlbcl)
141986|NCT03314922|follicular lymphoma (FL)|follicular lymphoma (fl)
141987|NCT03314922|marginal zone lymphoma (MZL)|marginal zone lymphoma (mzl)
141988|NCT03314922|mantle cell lymphoma (MCL)|mantle cell lymphoma (mcl)
141989|NCT03314922|phosphatidylinositol 3-kinase (PI3K)|phosphatidylinositol 3-kinase (pi3k)
141990|NCT03314909|Renal Dialysis|renal dialysis
141991|NCT03314909|Hemoperfusion|hemoperfusion
141992|NCT03314909|Paraquat|paraquat
141993|NCT03314896|Colonic Neoplasms|colonic neoplasms
141994|NCT03314896|Laparoscopic Surgery|laparoscopic surgery
141995|NCT03314896|T4|t4
141996|NCT03314883|Ultrasound|ultrasound
141997|NCT03314883|Diaphragm|diaphragm
141998|NCT03314883|Non Invasive Ventilation|non invasive ventilation
141999|NCT03314857|TAVI|tavi
142000|NCT03314857|TAVR|tavr
142001|NCT03314857|CHINA|china
142002|NCT03314857|SAPIEN XT|sapien xt
142003|NCT03314857|High Risk|high risk
142004|NCT03314857|Transcatheter aortic valve implantation|transcatheter aortic valve implantation
142005|NCT03314857|Transcatheter aortic valve replacement|transcatheter aortic valve replacement
142006|NCT03314831|sepsis|sepsis
142007|NCT03314831|septic shock|septic shock
142008|NCT03314831|systemic inflammatory response syndrome|systemic inflammatory response syndrome
142009|NCT03314831|tetradecanoic acid|tetradecanoic acid
142010|NCT03314831|myristic acid|myristic acid
142011|NCT03314818|carotid atherosclerosis|carotid atherosclerosis
142012|NCT03314818|plaque progression|plaque progression
142013|NCT03314818|Framingham Risk Score|framingham risk score
142014|NCT03314805|astragalus polysaccharides|astragalus polysaccharides
142015|NCT03314805|breast cancer|breast cancer
142016|NCT03314805|adjuvant chemotherapy|adjuvant chemotherapy
142017|NCT03314792|pain|pain
142018|NCT03314792|postoperative pain|postoperative pain
142019|NCT03314792|postoperative pain management|postoperative pain management
142020|NCT03314792|opioid|opioid
142021|NCT03314792|analgesia|analgesia
142022|NCT03314792|oxycodone|oxycodone
142023|NCT03314792|tapentadol|tapentadol
142024|NCT03314792|hysterectomy|hysterectomy
142025|NCT03314792|respiratory depression|respiratory depression
142026|NCT03314727|Osmolar Concentration|osmolar concentration
142027|NCT03314727|Oxidative Stress|oxidative stress
142028|NCT03314727|Salt|salt
142029|NCT03314727|Inflammation|inflammation
142030|NCT03314727|Endothelial Function|endothelial function
142031|NCT03314727|Hypertension|hypertension
142032|NCT03314701|Resting Energy Expenditure|resting energy expenditure
142033|NCT03314701|Multiple Fracture Ribs|multiple fracture ribs
142034|NCT03314701|Ventilation|ventilation
142035|NCT03314675|CRT-D, LV Latency|crt-d, lv latency
142036|NCT03314649|Peritoneal Lavage, Gene Mutation, Peritoneal Metastasis,Gastric Cancer|peritoneal lavage, gene mutation, peritoneal metastasis,gastric cancer
142037|NCT03314584|TBI|tbi
142038|NCT03314584|traumatic brain injury|traumatic brain injury
142039|NCT03314584|transcranial magnetic stimulation|transcranial magnetic stimulation
142040|NCT03314584|headache|headache
142041|NCT03314571|Epidural analgesia|epidural analgesia
142042|NCT03314571|Labor pain|labor pain
142043|NCT03314571|Satisfaction|satisfaction
142044|NCT03314571|Care assessment|care assessment
142045|NCT03314571|Psychometry|psychometry
142046|NCT03314558|COPD|copd
142047|NCT03314558|pulmonary rehabilitation|pulmonary rehabilitation
142048|NCT03314558|insomnia|insomnia
142049|NCT03314558|sleep quality|sleep quality
142050|NCT03314558|physical activity|physical activity
142051|NCT03314545|endocrown|endocrown
142052|NCT03314545|laminate veneer with coronal post|laminate veneer with coronal post
142053|NCT03314545|post and core|post and core
142054|NCT03314545|crown|crown
142055|NCT03314532|Surgical Resection|surgical resection
142056|NCT03314532|TILA-TACE|tila-tace
142057|NCT03314532|Hepatocellular carcinoma|hepatocellular carcinoma
142058|NCT03314519|Lung ultrasonography|lung ultrasonography
142059|NCT03314519|Lung collapse|lung collapse
142060|NCT03314519|fiberoptic bronchoscopy|fiberoptic bronchoscopy
142061|NCT03314519|double lumen tube|double lumen tube
142062|NCT03314506|exercise|exercise
142063|NCT03314493|Vascular calcification|vascular calcification
142064|NCT03314493|Coronary calcification|coronary calcification
142065|NCT03314493|Peritoneal Dialysis|peritoneal dialysis
142066|NCT03314493|Spironolactone|spironolactone
142067|NCT03314480|Multidetector Computed Tomography|multidetector computed tomography
142068|NCT03314480|Cone Beam Computed Tomography|cone beam computed tomography
142069|NCT03314480|Maxillofacial fractures|maxillofacial fractures
142070|NCT03314480|zygomaticomaxillary fractures|zygomaticomaxillary fractures
142071|NCT03314467|diabetic retinopathy|diabetic retinopathy
142072|NCT03314467|diabetes|diabetes
142073|NCT03314467|arterial hypertension|arterial hypertension
142074|NCT03314467|obstructive sleep apnea syndrome|obstructive sleep apnea syndrome
142075|NCT03314441|yoga|yoga
142076|NCT03314441|sleep quality|sleep quality
142077|NCT03314441|sleep quantity|sleep quantity
142078|NCT03314441|sleep efficiency|sleep efficiency
142079|NCT03314441|insomnia|insomnia
142080|NCT03314415|overweight|overweight
142081|NCT03314415|obesity|obesity
142082|NCT03314415|weight loss|weight loss
142083|NCT03314415|robot|robot
142084|NCT03314402|JAK2 inhibitor|jak2 inhibitor
142085|NCT03314402|Tolerance|tolerance
142086|NCT03314402|Pharmacokinetics|pharmacokinetics
142087|NCT03314402|Dose-escalated|dose-escalated
142088|NCT03314389|Cochet bonnet esthesiometer|cochet bonnet esthesiometer
142089|NCT03314376|prehabilitation|prehabilitation
142090|NCT03314376|surgery|surgery
142091|NCT03314376|exercise program|exercise program
142092|NCT03314376|transplant|transplant
142093|NCT03314376|postoperative|postoperative
142094|NCT03314363|Calorimetry, Indirect|calorimetry, indirect
142095|NCT03314363|respiratory dialysis|respiratory dialysis
142096|NCT03314350|Geriatrics|geriatrics
142097|NCT03314350|Frailty|frailty
142098|NCT03314337|Distal Pancreatectomy|distal pancreatectomy
142099|NCT03314337|Pancreatic stent|pancreatic stent
142100|NCT03314337|Post-operative pancreatic fistula|post-operative pancreatic fistula
142101|NCT03314311|Rehabilitation|rehabilitation
142102|NCT03314311|Exercise|exercise
142103|NCT03314311|Nutrition Therapy|nutrition therapy
142104|NCT03314311|Patient Education as Topic|patient education as topic
142105|NCT03314285|Cervicalgia|cervicalgia
142106|NCT03314246|Diabetes Mellitus, Type 2|diabetes mellitus, type 2
142107|NCT03314246|Ramadan Fasting|ramadan fasting
142108|NCT03314246|Randomized controlled trial|randomized controlled trial
142109|NCT03314207|XLRP|xlrp
142110|NCT03314207|retinal degeneration|retinal degeneration
142111|NCT03314207|RPGR|rpgr
142112|NCT03314207|ORF15|orf15
142113|NCT03314181|t(11,14) positive relapsed/refractory (R/R) multiple myeloma|t(11,14) positive relapsed/refractory (r/r) multiple myeloma
142114|NCT03314181|Non-refractory Relapsed Multiple Myeloma|non-refractory relapsed multiple myeloma
142115|NCT03314181|Non-refractory Refractory Multiple Myeloma|non-refractory refractory multiple myeloma
142116|NCT03314181|Relapsed Multiple Myeloma|relapsed multiple myeloma
142117|NCT03314181|Refractory Multiple Myeloma|refractory multiple myeloma
142118|NCT03314181|Multiple Myeloma|multiple myeloma
142119|NCT03314181|Cancer|cancer
142120|NCT03314168|Breast Cancer|breast cancer
142121|NCT03314168|Combined training|combined training
142122|NCT03314168|Fatigue|fatigue
142123|NCT03314155|Depressive disorder|depressive disorder
142124|NCT03314155|Treatment Resistant Depression|treatment resistant depression
142125|NCT03314155|[18 F ] DPA- 714|[18 f ] dpa- 714
142126|NCT03314155|PET|pet
142127|NCT03314155|MRI|mri
142128|NCT03314155|Inflammation|inflammation
142129|NCT03314142|blood glucose|blood glucose
142130|NCT03314142|bran particle size|bran particle size
142131|NCT03314142|glucemic index|glucemic index
142132|NCT03314116|hearing loss During basic training, otoacoustic emission|hearing loss during basic training, otoacoustic emission
142133|NCT03314090|Cleft lip|cleft lip
142134|NCT03314090|Scar|scar
142135|NCT03314090|Silicone sheet|silicone sheet
142136|NCT03314090|Silicone gel|silicone gel
142137|NCT03314064|Phase 4|phase 4
142138|NCT03314064|Russian Federation|russian federation
142139|NCT03314064|dolutegravir|dolutegravir
142140|NCT03314064|long-term safety|long-term safety
142141|NCT03314064|Human Immunodeficiency Virus|human immunodeficiency virus
142142|NCT03314051|Nasopharyngeal Carcinoma|nasopharyngeal carcinoma
142143|NCT03314051|plasma EBV DNA|plasma ebv dna
142144|NCT03314038|Chronic Atrophic Gastritis|chronic atrophic gastritis
142145|NCT03314038|Malignant Transformation|malignant transformation
142146|NCT03314038|Syndrome|syndrome
142147|NCT03314038|Traditional Chinese Medicine|traditional chinese medicine
142148|NCT03314038|Cross-sectional Study|cross-sectional study
142149|NCT03313999|Lymphedema indentometer|lymphedema indentometer
142150|NCT03313999|Durometer|durometer
142151|NCT03313986|penile curvature|penile curvature
142152|NCT03313986|Peyronie's disease|peyronie's disease
142153|NCT03313986|Nesbit|nesbit
142154|NCT03313960|Diabetes Mellitus, Type 2|diabetes mellitus, type 2
142155|NCT03313960|Afrezza|afrezza
142156|NCT03313934|Hyaluronic Acid Filler|hyaluronic acid filler
142157|NCT03313934|Platelet Rich Fibrin (PRF)|platelet rich fibrin (prf)
142158|NCT03313934|Tear Trough Filler|tear trough filler
142159|NCT03313921|myopia|myopia
142160|NCT03313921|astigmatism|astigmatism
142161|NCT03313921|online assessment|online assessment
142162|NCT03313921|refractive error|refractive error
142163|NCT03313895|cognitive impairment, Alzheimer's disease, exercise, cognitive training, imaging|cognitive impairment, alzheimer's disease, exercise, cognitive training, imaging
142164|NCT03313882|RNA Stability|rna stability
142165|NCT03313882|HuR protein|hur protein
142166|NCT03313882|SCN5A|scn5a
142167|NCT03313869|Metabolism|metabolism
142168|NCT03313869|Lipid oxidation|lipid oxidation
142169|NCT03313869|micronutrient cocktail supplementation|micronutrient cocktail supplementation
142170|NCT03313869|physical inactivity|physical inactivity
142171|NCT03313869|glucose intolerance|glucose intolerance
142172|NCT03313869|oxidative stress|oxidative stress
142173|NCT03313843|Optical Coherence Tomography|optical coherence tomography
142174|NCT03313830|Whey|whey
142175|NCT03313830|Muscle Protein Synthesis|muscle protein synthesis
142176|NCT03313778|mRNA-4157|mrna-4157
142177|NCT03313778|Personalized cancer vaccine|personalized cancer vaccine
142179|NCT03313778|pembrolizumab|pembrolizumab
142180|NCT03313752|diabetes, heart, dapagliflozin,|diabetes, heart, dapagliflozin,
142181|NCT03313726|PSMA-PET|psma-pet
142182|NCT03313700|Stomach Neoplasm|stomach neoplasm
142183|NCT03313700|Robotic Surgery|robotic surgery
142184|NCT03313700|Distal Gastrectomy|distal gastrectomy
142185|NCT03313648|Recurrent HCC|recurrent hcc
142186|NCT03313648|Laparoscopic Hepatectomy|laparoscopic hepatectomy
142187|NCT03313648|RFA|rfa
142188|NCT03313648|RCT|rct
142189|NCT03313635|Prealbumin|prealbumin
142190|NCT03313622|OCD|ocd
142191|NCT03313622|Obsessive Compulsive Disorder|obsessive compulsive disorder
142192|NCT03313557|Continued access, safety assessments|continued access, safety assessments
142193|NCT03313531|Thrombin generation|thrombin generation
142194|NCT03313531|variability|variability
142195|NCT03313531|level of agreement|level of agreement
142196|NCT03313531|hemophilia|hemophilia
142197|NCT03313518|tDCS, Alzheimer Disease|tdcs, alzheimer disease
142198|NCT03313479|Nausea, vomiting|nausea, vomiting
142199|NCT03313440|Fibre|fibre
142200|NCT03313440|diet|diet
142201|NCT03313440|fecal bulk|fecal bulk
181480|NCT03062358|PD1|pd1
142202|NCT03313414|HCV|hcv
142203|NCT03313414|Needlestick|needlestick
142204|NCT03313375|hemodynamics|hemodynamics
142205|NCT03313375|exercise|exercise
142206|NCT03313349|ADHD, Behavioral Problems, Children and Adolescents|adhd, behavioral problems, children and adolescents
142207|NCT03313336|Dermal anesthesia.|dermal anesthesia.
142208|NCT03313336|Venipuncture and intravenous cannulation.|venipuncture and intravenous cannulation.
142209|NCT03313336|Skin blanching or erythema.|skin blanching or erythema.
142210|NCT03313336|Phase I.|phase i.
142211|NCT03313336|Therapeutic equivalence.|therapeutic equivalence.
142212|NCT03313336|Eutectic Mixture of Local anaesthetics (EMLA)|eutectic mixture of local anaesthetics (emla)
142213|NCT03313323|Immuno-PET|immuno-pet
142214|NCT03313323|Ipilimumab|ipilimumab
142215|NCT03313323|Immunotherapy|immunotherapy
142216|NCT03313310|Youth Empowerment|youth empowerment
142217|NCT03313310|Employment Intervention|employment intervention
142218|NCT03313310|Young Men Who Have Sex With Men|young men who have sex with men
142219|NCT03313310|Young Transgender Women|young transgender women
142220|NCT03313297|skin|skin
142221|NCT03313297|wound healing|wound healing
142222|NCT03313297|11 beta-hydroxysteroid dehydrogenase type 1|11 beta-hydroxysteroid dehydrogenase type 1
142223|NCT03313271|lymphoma|lymphoma
142224|NCT03313271|CLAP|clap
142225|NCT03313271|China|china
142226|NCT03313271|patient registry|patient registry
142227|NCT03313193|nausea|nausea
142228|NCT03313193|vomiting|vomiting
142229|NCT03313193|pain|pain
142230|NCT03313193|fatigue|fatigue
142231|NCT03313193|depression|depression
142232|NCT03313193|anxiety|anxiety
142233|NCT03313193|PTSD-parent|ptsd-parent
142234|NCT03313193|caregiver self efficacy-parent|caregiver self efficacy-parent
142235|NCT03313154|Quality of Life|quality of life
142236|NCT03313154|Psychiatric comorbidity|psychiatric comorbidity
142237|NCT03313154|Cognitive impairment|cognitive impairment
142238|NCT03313154|Chronic Hepatitis HCV-related|chronic hepatitis hcv-related
142239|NCT03313089|micronutrient powders|micronutrient powders
142240|NCT03313089|spinkles|spinkles
142241|NCT03313089|nutrition|nutrition
142242|NCT03313089|food security program|food security program
142243|NCT03313089|nutritional program|nutritional program
142244|NCT03313089|hemoglobin|hemoglobin
142245|NCT03313089|anemia|anemia
142246|NCT03313076|burn injury|burn injury
142247|NCT03313076|thermal burn injury|thermal burn injury
142248|NCT03313076|omega 3 fatty acids|omega 3 fatty acids
142249|NCT03313076|vitamin D|vitamin d
142250|NCT03313076|fish oil|fish oil
142251|NCT03313076|chronic pain|chronic pain
142252|NCT03313076|chronic pain due to trauma|chronic pain due to trauma
142253|NCT03313063|magnetic resonance imaging|magnetic resonance imaging
142254|NCT03313063|myocard|myocard
142255|NCT03313063|preeclampsia|preeclampsia
142256|NCT03313011|apraxia of speech|apraxia of speech
142257|NCT03312972|Cancer|cancer
142258|NCT03312972|HDR Brachytherapy|hdr brachytherapy
142259|NCT03312972|Prostate Cancer|prostate cancer
142260|NCT03312920|tDCS, accelerated learning, memory|tdcs, accelerated learning, memory
142261|NCT03312907|immunosuppressants|immunosuppressants
142262|NCT03312907|Systemic Lupus Erythematosus Disease Activity Index|systemic lupus erythematosus disease activity index
142263|NCT03312907|Belimumab|belimumab
142264|NCT03312907|Lupus Low Disease Activity State|lupus low disease activity state
142265|NCT03312907|Systemic Lupus Erythematosus|systemic lupus erythematosus
142266|NCT03312894|Drug therapy|drug therapy
142268|NCT03312881|neuropathic|neuropathic
142269|NCT03312881|children|children
142270|NCT03312881|QST|qst
142271|NCT03312868|Stereotactic Body Radiotherapy|stereotactic body radiotherapy
142272|NCT03312855|coronary artery disease|coronary artery disease
142273|NCT03312855|platelet inhibition|platelet inhibition
142274|NCT03312790|augmented reality|augmented reality
142275|NCT03312790|fatigue|fatigue
142276|NCT03312790|muscle|muscle
142277|NCT03312790|heart rate|heart rate
142278|NCT03312790|mental function|mental function
142279|NCT03312777|analgesia, Cytochrome P450 2D6|analgesia, cytochrome p450 2d6
142280|NCT03312764|Prediabetes|prediabetes
142281|NCT03312764|Obesity|obesity
142282|NCT03312764|Intensive behavioral counseling|intensive behavioral counseling
142283|NCT03312764|Type 2 Diabetes|type 2 diabetes
142284|NCT03312751|Interferon-gamma|interferon-gamma
142285|NCT03312751|NI-0501|ni-0501
142286|NCT03312751|primary HLH|primary hlh
142287|NCT03312751|emapalumab|emapalumab
142288|NCT03312738|everolimus|everolimus
142289|NCT03312738|exemestane|exemestane
142290|NCT03312738|advanced Breast Cancer|advanced breast cancer
142291|NCT03312738|non-steroidal aromatase inhibitors|non-steroidal aromatase inhibitors
142292|NCT03312738|breast carcinoma|breast carcinoma
142293|NCT03312738|breast cancer|breast cancer
142294|NCT03312738|breast lump|breast lump
142295|NCT03312738|HER2 negative|her2 negative
142296|NCT03312738|breast cancer progression|breast cancer progression
142297|NCT03312712|FDG|fdg
142298|NCT03312712|PET|pet
142299|NCT03312712|CT|ct
142300|NCT03312712|Sarcoidosis|sarcoidosis
181636|NCT03061435|HPV|hpv
142301|NCT03312699|Inactivated, quadrivalent influenza vaccine|inactivated, quadrivalent influenza vaccine
142302|NCT03312699|Inactivated Hepatitis A vaccine|inactivated hepatitis a vaccine
142303|NCT03312699|Inactivated, trivalent high-dose influenza vaccine|inactivated, trivalent high-dose influenza vaccine
142304|NCT03312699|Typhoid Vi Polysaccharide Vaccine|typhoid vi polysaccharide vaccine
142305|NCT03312699|Typhoid Vaccine Live Oral Ty21a|typhoid vaccine live oral ty21a
142306|NCT03312699|Influenza Vaccine, Adjuvanted|influenza vaccine, adjuvanted
142307|NCT03312686|endoflip|endoflip
142308|NCT03312660|Prebiotics|prebiotics
142309|NCT03312660|kefir|kefir
142310|NCT03312647|Adverse Drug Reaction|adverse drug reaction
142311|NCT03312647|Latent Tuberculosis Infection|latent tuberculosis infection
142312|NCT03312647|Tuberculosis|tuberculosis
142313|NCT03312634|Interventional study|interventional study
142314|NCT03312634|Clinical trial phase 3|clinical trial phase 3
142315|NCT03312634|Efficacy and safety|efficacy and safety
142316|NCT03312634|Heterotopic ossification|heterotopic ossification
142317|NCT03312634|Flare-up|flare-up
142318|NCT03312634|Palovarotene|palovarotene
142319|NCT03312634|Retinoic acid receptor agonist|retinoic acid receptor agonist
142320|NCT03312634|Retinoic acid receptor gamma agonist|retinoic acid receptor gamma agonist
142321|NCT03312634|Clementia|clementia
142322|NCT03312634|Myositis Ossificans Progressiva|myositis ossificans progressiva
142323|NCT03312634|Munchmeyer's Disease|munchmeyer's disease
142324|NCT03312634|FOP|fop
142325|NCT03312634|FOP variants|fop variants
142326|NCT03312621|Adolescent Health|adolescent health
142327|NCT03312608|cerebral reorganization, TMS|cerebral reorganization, tms
142328|NCT03312556|hypertension|hypertension
142329|NCT03312556|supine hypertension|supine hypertension
142330|NCT03312556|autonomic failure|autonomic failure
142331|NCT03312556|pure autonomic failure|pure autonomic failure
142332|NCT03312556|multiple system atrophy|multiple system atrophy
142333|NCT03312556|cpap|cpap
142334|NCT03312543|Photoaging of Skin, Skin Wrinkling, Solar Aging of Skin, light therapy|photoaging of skin, skin wrinkling, solar aging of skin, light therapy
142335|NCT03312517|insomnia|insomnia
142336|NCT03312517|belsomra|belsomra
142337|NCT03312517|suvorexant|suvorexant
142338|NCT03312504|sport injury|sport injury
142339|NCT03312504|injury prevention|injury prevention
142340|NCT03312504|fitness|fitness
142341|NCT03312504|neuromuscular training|neuromuscular training
142342|NCT03312504|implementation|implementation
142343|NCT03312465|Total Shoulder Arthroplasty|total shoulder arthroplasty
142344|NCT03312465|Hemi Shoulder Arthroplasty|hemi shoulder arthroplasty
142345|NCT03312452|Pediatric|pediatric
142346|NCT03312452|Perioperative|perioperative
142347|NCT03312452|Intravenous fluid|intravenous fluid
142348|NCT03312439|Myocardial infarction|myocardial infarction
142349|NCT03312439|Stroke|stroke
142350|NCT03312439|Diabetes|diabetes
142351|NCT03312439|Depression|depression
142352|NCT03312439|Dementia|dementia
142353|NCT03312439|Fractures|fractures
142354|NCT03312426|Cancer|cancer
142355|NCT03312426|Tumor|tumor
142356|NCT03312426|Healthy Participants|healthy participants
142357|NCT03312426|Healthy Subjects|healthy subjects
142358|NCT03312426|Neoplasm|neoplasm
142359|NCT03312413|dexmedetomidine|dexmedetomidine
142360|NCT03312413|coughing during anesthetic emergence|coughing during anesthetic emergence
142361|NCT03312413|thyroid surgery|thyroid surgery
142362|NCT03312400|Telomeres|telomeres
142363|NCT03312400|Aplastic Anemia|aplastic anemia
142364|NCT03312400|Pulmonary Fibrosis|pulmonary fibrosis
142365|NCT03312400|Androgens|androgens
142366|NCT03312400|Hepatic Fibrosis|hepatic fibrosis
142367|NCT03312335|Lupus Erythematosus, Systemic|lupus erythematosus, systemic
142368|NCT03312335|SLE|sle
142369|NCT03312335|Interleukin-2|interleukin-2
142370|NCT03312335|IL-2|il-2
142371|NCT03312335|T-Lymphocytes, Regulatory|t-lymphocytes, regulatory
142372|NCT03312335|Treg|treg
142373|NCT03312296|Stent Thrombosis|stent thrombosis
142374|NCT03312270|aphasia|aphasia
142375|NCT03312270|comprehension|comprehension
142376|NCT03312270|text-to-speech|text-to-speech
142377|NCT03312270|social validity|social validity
142378|NCT03312231|A/H7N9|a/h7n9
142379|NCT03312231|Immunogenicity|immunogenicity
142380|NCT03312231|Influenza|influenza
142381|NCT03312231|Safety|safety
142382|NCT03312231|Sanofi Pasteur|sanofi pasteur
142383|NCT03312231|Vaccine|vaccine
142384|NCT03312192|Anterior Cervical Discectomy and Fusion|anterior cervical discectomy and fusion
142385|NCT03312192|Stand-Alone Cage|stand-alone cage
142386|NCT03312192|Anterior Plating|anterior plating
142387|NCT03312166|ear lobe|ear lobe
142388|NCT03312166|compression|compression
142389|NCT03312166|medical device|medical device
142390|NCT03312166|recurrence|recurrence
142391|NCT03312101|exercise program|exercise program
142392|NCT03312062|elbow|elbow
142393|NCT03312062|foam rolling|foam rolling
142394|NCT03312062|proprioception|proprioception
142395|NCT03312062|motor performance|motor performance
142396|NCT03312062|strength|strength
142397|NCT03312049|Aflatoxin B1|aflatoxin b1
142398|NCT03312049|Aflatoxin M1|aflatoxin m1
142399|NCT03312049|Aflatoxin|aflatoxin
142400|NCT03312049|Mycotoxin|mycotoxin
142401|NCT03312049|Stunting|stunting
142402|NCT03312049|Linear growth|linear growth
142403|NCT03312049|Pregnancy|pregnancy
142404|NCT03312049|Birth outcomes|birth outcomes
142405|NCT03312049|Nepal|nepal
142406|NCT03312036|CPFA|cpfa
142407|NCT03312036|Liver failure|liver failure
142408|NCT03312036|Resin|resin
142409|NCT03312036|detoxification|detoxification
142410|NCT03312023|Hepatitis B|hepatitis b
142411|NCT03312023|HBsAg|hbsag
142412|NCT03312023|Ledipasvir/Sofosbuvir|ledipasvir/sofosbuvir
142413|NCT03312023|Hepatitis B treatment|hepatitis b treatment
142415|NCT03311997|Hamstring|hamstring
142416|NCT03311997|Suture|suture
142417|NCT03311945|Raltegravir|raltegravir
142418|NCT03311945|Lamivudine|lamivudine
142419|NCT03311776|Pancreatic cancer|pancreatic cancer
142420|NCT03311776|Biomarkers|biomarkers
142421|NCT03311776|Biobank|biobank
142422|NCT03311776|Diagnostic biomarkers|diagnostic biomarkers
142423|NCT03311776|Predictive biomarkers|predictive biomarkers
142424|NCT03311776|Prognostic biomarkers|prognostic biomarkers
142425|NCT03311763|implementation|implementation
142426|NCT03311711|Alzheimer's Disease|alzheimer's disease
142427|NCT03311711|Aging|aging
142428|NCT03311711|Behavioral Research|behavioral research
142429|NCT03311659|Diphtheria|diphtheria
142430|NCT03311659|Pertussis|pertussis
142431|NCT03311659|Tetanus|tetanus
142432|NCT03311659|Immunogenicity|immunogenicity
142433|NCT03311633|Radius Fracture Distal|radius fracture distal
142434|NCT03311633|Radius Fracture Distal Therapy|radius fracture distal therapy
142435|NCT03311633|Fracture fixation|fracture fixation
142436|NCT03311633|Closed Fracture Reduction|closed fracture reduction
142437|NCT03311607|Post-kala-azar Dermal Leishmaniasis|post-kala-azar dermal leishmaniasis
142438|NCT03311607|Visceral Leishmaniasis|visceral leishmaniasis
142439|NCT03311607|AmBisome|ambisome
142440|NCT03311607|Liposomal amphotericin B|liposomal amphotericin b
142441|NCT03311607|Bangladesh|bangladesh
142442|NCT03311607|Kala azar|kala azar
142443|NCT03311594|Alcohol|alcohol
142444|NCT03311594|Pain|pain
142445|NCT03311568|Ultrasonography|ultrasonography
142446|NCT03311568|Microvessels|microvessels
142447|NCT03311568|Physiopathology|physiopathology
142448|NCT03311568|Diagnostic Imaging|diagnostic imaging
142449|NCT03311568|Critical Care|critical care
142450|NCT03311555|Recurrent PSA-only prostate cancer following prostatectomy|recurrent psa-only prostate cancer following prostatectomy
142451|NCT03311542|GBM|gbm
142452|NCT03311542|Glioma|glioma
142453|NCT03311516|insulin therapy|insulin therapy
142454|NCT03311503|lentiviral|lentiviral
142455|NCT03311503|Gene therapy|gene therapy
142456|NCT03311503|busulfan|busulfan
142457|NCT03311490|Ankle Sprain|ankle sprain
142458|NCT03311490|Prophylaxis|prophylaxis
142459|NCT03311490|Indoor Sports|indoor sports
142460|NCT03311490|Ligamentous sprain|ligamentous sprain
142461|NCT03311490|Prevention|prevention
142462|NCT03311477|ABBV-399|abbv-399
142463|NCT03311477|Maximum tolerated dose (MTD)|maximum tolerated dose (mtd)
142464|NCT03311477|Maximally administered dose (MAD)|maximally administered dose (mad)
142465|NCT03311477|Dose escalation|dose escalation
142466|NCT03311477|Pharmacokinetics|pharmacokinetics
142467|NCT03311477|Advanced solid tumors|advanced solid tumors
142468|NCT03311477|Cancer|cancer
142469|NCT03311477|Solid tumors|solid tumors
142470|NCT03311464|Pyoderma Gangrenosum|pyoderma gangrenosum
142471|NCT03311464|Ulcer|ulcer
142472|NCT03311464|Efficacy|efficacy
142473|NCT03311464|Safety|safety
142474|NCT03311464|Adalimumab|adalimumab
142475|NCT03311464|Humira®|humira®
142476|NCT03311464|Japan|japan
142477|NCT03311425|Anterior cervical discectomy and fusion|anterior cervical discectomy and fusion
142478|NCT03311425|prevertebral swelling|prevertebral swelling
142479|NCT03311425|swallowing|swallowing
142480|NCT03311425|methylprednisolone|methylprednisolone
142481|NCT03311425|intraoperative steroid|intraoperative steroid
142687|NCT03310450|predictors|predictors
142482|NCT03311412|Locally advanced/unresectable|locally advanced/unresectable
142483|NCT03311412|Metastatic solid tumor|metastatic solid tumor
142484|NCT03311412|Lymphoma|lymphoma
142485|NCT03311412|Anti-PD-1|anti-pd-1
142486|NCT03311412|PD-1|pd-1
142487|NCT03311412|PD1|pd1
142488|NCT03311412|Anti-LAG-3|anti-lag-3
142489|NCT03311412|LAG-3|lag-3
142490|NCT03311412|LAG3|lag3
142491|NCT03311412|Anti-TIM-3|anti-tim-3
142492|NCT03311412|TIM-3|tim-3
142493|NCT03311412|TIM3|tim3
142494|NCT03311399|Surgical Site Infection|surgical site infection
142495|NCT03311399|mHealth|mhealth
142496|NCT03311399|Cesarean Section|cesarean section
142497|NCT03311373|COPD|copd
142498|NCT03311360|vertebral artery origin stenosis|vertebral artery origin stenosis
142499|NCT03311360|drug-coated balloon|drug-coated balloon
142500|NCT03311360|stenting|stenting
142501|NCT03311360|medical treatment|medical treatment
142502|NCT03311347|pulmonary ultrasound|pulmonary ultrasound
142503|NCT03311347|hypergravity|hypergravity
142504|NCT03311347|human physiology|human physiology
142505|NCT03311347|oxygen|oxygen
142506|NCT03311347|lung ventilation|lung ventilation
142507|NCT03311347|lung perfusion|lung perfusion
142508|NCT03311347|computed tomography|computed tomography
142509|NCT03311347|electrical impedance tomography|electrical impedance tomography
142510|NCT03311347|altitude chamber|altitude chamber
142511|NCT03311334|DSP-7888|dsp-7888
142512|NCT03311334|nivolumab|nivolumab
142513|NCT03311334|Pembrolizumab|pembrolizumab
142514|NCT03311334|immune checkpoint inhibitor|immune checkpoint inhibitor
142515|NCT03311334|cancer vaccine|cancer vaccine
142516|NCT03311334|WT1|wt1
142517|NCT03311334|ICI|ici
142518|NCT03311334|Wilms Tumor 1|wilms tumor 1
142519|NCT03311321|Arterial Stiffness|arterial stiffness
142520|NCT03311321|Endothelial Function|endothelial function
142521|NCT03311321|Vitamin K|vitamin k
142522|NCT03311308|Melanoma|melanoma
142523|NCT03311308|Unresectable|unresectable
142524|NCT03311308|Stage III|stage iii
142525|NCT03311308|Stage IV|stage iv
142526|NCT03311282|breastfeeding|breastfeeding
142527|NCT03311282|infants|infants
142528|NCT03311282|squeezing|squeezing
142529|NCT03311282|breathing|breathing
142530|NCT03311256|Tissue Transit Time|tissue transit time
142531|NCT03311243|cytokines|cytokines
142532|NCT03311243|scaling root planing|scaling root planing
142533|NCT03311243|oral hygiene|oral hygiene
142534|NCT03311243|systemic inflammation|systemic inflammation
142535|NCT03311204|Eyelid margin|eyelid margin
142536|NCT03311204|tear film|tear film
142537|NCT03311204|debridement|debridement
142538|NCT03311204|contact lens and ocular discomfort|contact lens and ocular discomfort
142539|NCT03311178|Shock|shock
142540|NCT03311178|Preterm infant|preterm infant
142541|NCT03311178|Dobutamine|dobutamine
142542|NCT03311165|neonate|neonate
142543|NCT03311165|Acute Respiratory Distress Syndrome|acute respiratory distress syndrome
142544|NCT03311165|prognosis|prognosis
142545|NCT03311165|risk factor|risk factor
142546|NCT03311165|clinical course|clinical course
142547|NCT03311152|Hepatocellular carcinoma|hepatocellular carcinoma
142548|NCT03311152|Cirrhosis|cirrhosis
142549|NCT03311152|Circulating epigenetic biomarker|circulating epigenetic biomarker
142550|NCT03311152|Plasma biomarker|plasma biomarker
142551|NCT03311152|SEPT9|sept9
142552|NCT03311152|Septin9|septin9
142553|NCT03311152|DNA methylation biomarker|dna methylation biomarker
142554|NCT03311152|Circulating DNA methylation biomarker|circulating dna methylation biomarker
142555|NCT03311152|Alpha-fetoprotein|alpha-fetoprotein
142556|NCT03311139|Atrial Fibrillation|atrial fibrillation
142557|NCT03311139|Acute Coronary Syndrome|acute coronary syndrome
142558|NCT03311139|Anticoagulation|anticoagulation
142559|NCT03311087|high flow nasal oxygen|high flow nasal oxygen
142560|NCT03311087|acute hypoxemic respiratory failure|acute hypoxemic respiratory failure
142561|NCT03311087|adults|adults
142562|NCT03311087|intensive care unit|intensive care unit
142563|NCT03311074|Sonication Linker Medicated Polymerase Chain Reaction|sonication linker medicated polymerase chain reaction
142564|NCT03311074|Previously GSK2696273|previously gsk2696273
142565|NCT03311074|Gene therapy|gene therapy
142566|NCT03311074|Adenosine deaminase deficiency|adenosine deaminase deficiency
142567|NCT03311074|Retroviral insertion site|retroviral insertion site
142568|NCT03311074|Severe combined immunodeficiency|severe combined immunodeficiency
142569|NCT03311074|Strimvelis|strimvelis
142570|NCT03311061|Teen Pregnancy|teen pregnancy
142571|NCT03311061|Prevention|prevention
142572|NCT03311061|Positive Youth Development|positive youth development
142573|NCT03311061|Financial Literacy|financial literacy
142574|NCT03311061|College and Career Readiness|college and career readiness
142575|NCT03311061|School Based Intervention|school based intervention
142576|NCT03311061|Age 13-19|age 13-19
142577|NCT03311061|Behavior Modification|behavior modification
142578|NCT03311048|Cleaning workers|cleaning workers
142579|NCT03311048|Work-related asthma|work-related asthma
142580|NCT03311048|Work-related rhinitis|work-related rhinitis
142581|NCT03311048|Respiratory symptoms|respiratory symptoms
142582|NCT03311048|Nasal swab|nasal swab
142583|NCT03310996|working memory|working memory
142584|NCT03310983|Fat mass|fat mass
142585|NCT03310983|Gestational weight gain|gestational weight gain
142586|NCT03310983|Fetal adipose tissue|fetal adipose tissue
142587|NCT03310970|Peer Reviewed Research|peer reviewed research
142588|NCT03310957|Breast cancer|breast cancer
142589|NCT03310957|Breast carcinoma|breast carcinoma
142590|NCT03310957|Triple negative breast cancer|triple negative breast cancer
142591|NCT03310957|Locally-advanced breast cancer|locally-advanced breast cancer
142592|NCT03310957|Metastatic breast cancer|metastatic breast cancer
142593|NCT03310957|Tumors, breast|tumors, breast
142594|NCT03310957|Breast tumors|breast tumors
142595|NCT03310957|pembrolizumab|pembrolizumab
142596|NCT03310957|LIV-1 protein, human|liv-1 protein, human
142597|NCT03310957|Ladiratuzumab vedotin|ladiratuzumab vedotin
142598|NCT03310957|hLIV22-vcMMAE|hliv22-vcmmae
181973|NCT03058900|RCT|rct
142599|NCT03310918|AML|aml
142600|NCT03310905|Research|research
142601|NCT03310905|Transplant|transplant
142602|NCT03310905|Abdominal Wall|abdominal wall
142603|NCT03310905|Hernia|hernia
142604|NCT03310892|Colorectal cancer screening|colorectal cancer screening
142605|NCT03310879|Cancer|cancer
142606|NCT03310853|probiotics|probiotics
142607|NCT03310853|infections|infections
142608|NCT03310853|bacterial vaginosis|bacterial vaginosis
142609|NCT03310827|Nutrition|nutrition
142610|NCT03310827|Nutrigenomics|nutrigenomics
142611|NCT03310801|left atrial appendage occlusion|left atrial appendage occlusion
142612|NCT03310801|antithrombotic therapy|antithrombotic therapy
142613|NCT03310801|atrial fibrillation|atrial fibrillation
142614|NCT03310801|percutaneous coronary intervention|percutaneous coronary intervention
142615|NCT03310801|drug eluting stent|drug eluting stent
142616|NCT03310788|IOP fluctuations|iop fluctuations
142617|NCT03310788|iCare Home|icare home
142618|NCT03310788|SLT|slt
142619|NCT03310788|self-tonometry|self-tonometry
142620|NCT03310775|Social skill training|social skill training
142621|NCT03310775|PEERS|peers
142622|NCT03310762|immunization coverage|immunization coverage
142623|NCT03310762|silicon bracelet|silicon bracelet
142624|NCT03310762|immunization reminders|immunization reminders
142625|NCT03310749|Type 2 Diabetes Mellitus|type 2 diabetes mellitus
142626|NCT03310749|DPP-IV inhibitor|dpp-iv inhibitor
142627|NCT03310749|Drug-Drug Interactions|drug-drug interactions
142628|NCT03310749|Ethnicity|ethnicity
142629|NCT03310736|iron deficiency|iron deficiency
142630|NCT03310736|anemia|anemia
142631|NCT03310736|hepcidin|hepcidin
142632|NCT03310697|Afebrile seizure|afebrile seizure
142633|NCT03310697|Toxicological screening|toxicological screening
142634|NCT03310697|Chromatography|chromatography
142635|NCT03310697|Mass spectrometry|mass spectrometry
142636|NCT03310697|Children|children
142637|NCT03310684|Renin-Angiotensin system|renin-angiotensin system
142638|NCT03310684|Hypertension|hypertension
142639|NCT03310684|Obesity|obesity
142640|NCT03310684|Angiotensin-(1-7)|angiotensin-(1-7)
142641|NCT03310684|Angiotensin II|angiotensin ii
142642|NCT03310684|FGF23|fgf23
142643|NCT03310684|Klotho|klotho
142644|NCT03310684|Uric acid|uric acid
142645|NCT03310684|Left ventricular hypertrophy|left ventricular hypertrophy
142646|NCT03310645|Refractory chronic cough|refractory chronic cough
142647|NCT03310645|healthy volunteers|healthy volunteers
142648|NCT03310632|Antroquinonol|antroquinonol
142649|NCT03310632|Hocena|hocena
142650|NCT03310632|metastatic pancreatic cancer|metastatic pancreatic cancer
142651|NCT03310619|JCAR017|jcar017
142652|NCT03310619|B-Cell Malignancies|b-cell malignancies
142653|NCT03310619|NHL|nhl
142654|NCT03310619|non-Hodgkin lymphoma|non-hodgkin lymphoma
142655|NCT03310619|CAR T cells|car t cells
142656|NCT03310619|chimeric antigen receptor|chimeric antigen receptor
142657|NCT03310606|Therapeutic drug monitoring|therapeutic drug monitoring
142658|NCT03310593|bipolar disorder|bipolar disorder
142659|NCT03310593|bipolar depression|bipolar depression
142660|NCT03310593|cannabidiol|cannabidiol
142661|NCT03310593|endocannabinoids|endocannabinoids
142662|NCT03310541|AZD5363|azd5363
142663|NCT03310541|AKT Mutations|akt mutations
142664|NCT03310541|17-322|17-322
142665|NCT03310528|Aspiration risk|aspiration risk
142666|NCT03310528|GI Endoscopy|gi endoscopy
142667|NCT03310528|Fasting guidelines|fasting guidelines
142668|NCT03310528|Delayed gastric emptying|delayed gastric emptying
142669|NCT03310515|PrEP|prep
142670|NCT03310515|MSM|msm
142671|NCT03310515|seroincidence|seroincidence
142672|NCT03310515|HIV-1|hiv-1
142673|NCT03310515|TGW|tgw
142674|NCT03310515|STIs|stis
142675|NCT03310502|positron emission tomography|positron emission tomography
142676|NCT03310502|skeletal muscle|skeletal muscle
142677|NCT03310502|liver|liver
142678|NCT03310502|adipose tissue|adipose tissue
142679|NCT03310502|brain|brain
142680|NCT03310502|genetics|genetics
142681|NCT03310463|infection|infection
142682|NCT03310463|gram-negative bacterium|gram-negative bacterium
142683|NCT03310463|renal impairment|renal impairment
142684|NCT03310450|troponin-I|troponin-i
142685|NCT03310450|hs-CRP|hs-crp
142686|NCT03310450|Malondialdehyde|malondialdehyde
142688|NCT03310385|Acute Bronchitis, Herbal Medicine|acute bronchitis, herbal medicine
142689|NCT03310333|PROM|prom
142690|NCT03310333|Dinoprostone|dinoprostone
142691|NCT03310333|cervical ripening device|cervical ripening device
142692|NCT03310333|oxytocin|oxytocin
142693|NCT03310320|Plaque psoriasis|plaque psoriasis
142694|NCT03310320|PASI|pasi
142695|NCT03310320|BSA|bsa
142696|NCT03310320|sPGA|spga
142697|NCT03310320|P-VAS|p-vas
142698|NCT03310320|IL17A-|il17a-
142699|NCT03310320|CCL20|ccl20
142700|NCT03310320|PK|pk
142701|NCT03310307|Homocysteine|homocysteine
142702|NCT03310307|Overweight|overweight
142703|NCT03310307|vitamin D3|vitamin d3
142704|NCT03310307|Reproductive women|reproductive women
142705|NCT03310307|RCT|rct
142706|NCT03310294|Lactobacillus|lactobacillus
142707|NCT03310294|Herpes Labial|herpes labial
142708|NCT03310294|Immune repsonse|immune repsonse
142709|NCT03310281|Depression|depression
142710|NCT03310229|cardiovascular complications|cardiovascular complications
142711|NCT03310216|artificial intelligent|artificial intelligent
142712|NCT03310216|visual inspection|visual inspection
142713|NCT03310190|Chronic Lymphocytic Leukemia (CLL)|chronic lymphocytic leukemia (cll)
142714|NCT03310190|Deletion of the short arm of chromosome 17 (Del[17p])|deletion of the short arm of chromosome 17 (del[17p])
142715|NCT03310190|Relapse Chronic Lymphocytic Leukemia|relapse chronic lymphocytic leukemia
142716|NCT03310190|Refractory Chronic Lymphocytic Leukemia|refractory chronic lymphocytic leukemia
142717|NCT03310190|Chronic Lymphocytic Leukemia with deletion of the short arm of chromosome 17|chronic lymphocytic leukemia with deletion of the short arm of chromosome 17
142718|NCT03310190|Cancer|cancer
142719|NCT03310177|Chronic Obstructive Pulmonary Disease|chronic obstructive pulmonary disease
142720|NCT03310177|Metabolomics|metabolomics
142721|NCT03310138|treatment|treatment
142722|NCT03310138|brain stimulation|brain stimulation
142723|NCT03310125|Atrial Fibrillation|atrial fibrillation
142724|NCT03310125|Inflammation|inflammation
142725|NCT03310125|Thoracic Surgery|thoracic surgery
142726|NCT03310125|Randomized|randomized
142727|NCT03310125|Colchicine|colchicine
142728|NCT03310099|Obesity|obesity
142729|NCT03310099|Heart failure with preserved ejection fraction|heart failure with preserved ejection fraction
142730|NCT03310099|HFpEF|hfpef
142731|NCT03310099|unsaturated fatty acids|unsaturated fatty acids
142732|NCT03310099|cardiorespiratory fitness|cardiorespiratory fitness
142733|NCT03310099|dietary intervention|dietary intervention
142734|NCT03310086|corticision|corticision
142735|NCT03310086|CBCT|cbct
142736|NCT03310086|Crowding|crowding
142737|NCT03309995|Cough|cough
142738|NCT03309995|Laryngitis|laryngitis
142739|NCT03309995|Pharyngitis|pharyngitis
142740|NCT03309995|Rhinitis|rhinitis
142741|NCT03309995|Zinc Acetate|zinc acetate
142742|NCT03309995|Zinc Lozenge|zinc lozenge
142743|NCT03309956|Ambulatory Electrocardiography|ambulatory electrocardiography
142744|NCT03309956|Holter Monitor|holter monitor
142745|NCT03309956|Zio Patch Monitor|zio patch monitor
142746|NCT03309956|Pediatrics|pediatrics
142747|NCT03309930|comprehension|comprehension
142748|NCT03309930|Strategies|strategies
142749|NCT03309930|repeated exposure|repeated exposure
142750|NCT03309865|semi-vegetarian diet|semi-vegetarian diet
142751|NCT03309865|vedolizumab|vedolizumab
142752|NCT03309865|ulcerative colitis|ulcerative colitis
142753|NCT03309839|HLA-DR expression|hla-dr expression
142754|NCT03309839|cardiopulmonary bypass|cardiopulmonary bypass
142755|NCT03309839|neonate|neonate
142756|NCT03309826|gestational hypertension|gestational hypertension
142757|NCT03309826|pre-eclampsia|pre-eclampsia
142758|NCT03309826|eclampsia|eclampsia
142759|NCT03309826|obstructive sleep apnea-hypopnea|obstructive sleep apnea-hypopnea
142760|NCT03309826|positive airway pressure|positive airway pressure
142761|NCT03309826|polysomnography|polysomnography
142762|NCT03309826|blood pressure|blood pressure
142763|NCT03309826|arterial stiffness|arterial stiffness
142764|NCT03309813|ExAblate|exablate
142765|NCT03309813|TcMRgFUS|tcmrgfus
142766|NCT03309813|Thalamotomy|thalamotomy
142767|NCT03309800|Acute Bronchitis|acute bronchitis
142768|NCT03309774|Children|children
142769|NCT03309774|Complex Regional Pain Syndrome|complex regional pain syndrome
142770|NCT03309774|Relaxation|relaxation
142771|NCT03309774|Bergès relaxation|bergès relaxation
142772|NCT03309774|Pain|pain
142773|NCT03309748|photodynamic therapy|photodynamic therapy
142774|NCT03309748|black-stain|black-stain
142775|NCT03309748|Pigmented bacteria|pigmented bacteria
142776|NCT03309748|Tannerella forsythia|tannerella forsythia
142777|NCT03309735|threatened miscarriage|threatened miscarriage
142778|NCT03309735|miscarriage|miscarriage
142779|NCT03309735|micronized progesterone|micronized progesterone
142780|NCT03309735|dydrogesterone|dydrogesterone
142781|NCT03309670|psychiatric outcome|psychiatric outcome
142782|NCT03309670|psychosocial outcome|psychosocial outcome
142783|NCT03309670|young|young
142784|NCT03309644|Unplanned admissions|unplanned admissions
142785|NCT03309644|Visits to the ED|visits to the ed
142786|NCT03309644|Readmissions|readmissions
142787|NCT03309644|Death|death
142788|NCT03309631|Gene classifier|gene classifier
142789|NCT03309618|myocardial infarction|myocardial infarction
142790|NCT03309618|arterial stiffness|arterial stiffness
142791|NCT03309618|pulse wave velocity|pulse wave velocity
142792|NCT03309618|flow mediated dilatation|flow mediated dilatation
142793|NCT03309618|fluvastatin|fluvastatin
142794|NCT03309618|valsartan|valsartan
142795|NCT03309605|Translational read through|translational read through
142796|NCT03309579|Aneurysmal subarachnoid hemorrhage (aSAH)|aneurysmal subarachnoid hemorrhage (asah)
142797|NCT03309579|Red Blood Cell Transfusion (RBC)|red blood cell transfusion (rbc)
142798|NCT03309579|Vasospasm|vasospasm
142799|NCT03309579|Intracranial Hemorrhages|intracranial hemorrhages
142800|NCT03309579|Cardiovascular Diseases|cardiovascular diseases
142801|NCT03309540|Low back/lumbar spine|low back/lumbar spine
142802|NCT03309540|Multimodal Physical therapy|multimodal physical therapy
142803|NCT03309540|Quality of life|quality of life
142804|NCT03309540|Range of Motion|range of motion
142805|NCT03309540|Pain|pain
142806|NCT03309527|insomia|insomia
142807|NCT03309527|Depression|depression
142808|NCT03309527|Self Harm|self harm
142809|NCT03309527|Suicide|suicide
142810|NCT03309527|guided self-help|guided self-help
142811|NCT03309527|psychological treatment|psychological treatment
142812|NCT03309527|eCBTI|ecbti
142813|NCT03309527|internet|internet
142814|NCT03309527|Psychotherapy|psychotherapy
142815|NCT03309501|Knee osteoarthritis|knee osteoarthritis
142816|NCT03309501|Randomised Double-blind Controlled trial|randomised double-blind controlled trial
142817|NCT03309501|Tong-Luo-Qu-Tong Plaster|tong-luo-qu-tong plaster
142818|NCT03309488|Food allergy|food allergy
142819|NCT03309488|Milk allergy|milk allergy
142820|NCT03309488|Egg allergy|egg allergy
142821|NCT03309488|Nut allergy|nut allergy
142822|NCT03309488|Basophil activation test|basophil activation test
142823|NCT03309488|Diagnosis|diagnosis
142824|NCT03309488|Specific IgE|specific ige
142825|NCT03309488|Skin prick test|skin prick test
142826|NCT03309475|first episode psychosis|first episode psychosis
142827|NCT03309475|early psychosis|early psychosis
142828|NCT03309475|schizophrenia|schizophrenia
142829|NCT03309475|mindfulness|mindfulness
142830|NCT03309475|social cognition|social cognition
142831|NCT03309475|social functioning|social functioning
142832|NCT03309475|AGES-Mind|ages-mind
142833|NCT03309475|SocialMind|socialmind
142834|NCT03309462|Next generation sequencing|next generation sequencing
142835|NCT03309462|Re-biopsy|re-biopsy
142836|NCT03309462|Acquired resistance|acquired resistance
142837|NCT03309462|Tissue sample|tissue sample
142838|NCT03309462|Peripheral blood|peripheral blood
142839|NCT03309423|Blood gas analysis|blood gas analysis
142840|NCT03309423|Critical care|critical care
142841|NCT03309423|venus to arterial conversion|venus to arterial conversion
142842|NCT03309410|Blood Gas Analysis|blood gas analysis
142843|NCT03309410|Emergency Service, Hospital|emergency service, hospital
142844|NCT03309410|Venous to arterial conversion|venous to arterial conversion
142845|NCT03309410|Matched-Pair Analysis|matched-pair analysis
142846|NCT03309397|adolescent sports|adolescent sports
142847|NCT03309358|Cystic Fibrosis|cystic fibrosis
142848|NCT03309358|Pulmonary exacerbation|pulmonary exacerbation
142849|NCT03309358|Pulmonary inflammation|pulmonary inflammation
142850|NCT03309358|Respiratory tract disease|respiratory tract disease
142851|NCT03309358|Pulmonary disease|pulmonary disease
142852|NCT03309358|Biofilms|biofilms
142853|NCT03309267|pain, thoracotomy|pain, thoracotomy
142854|NCT03309228|elderly people|elderly people
142855|NCT03309228|polymedication,|polymedication,
142856|NCT03309228|ethics|ethics
142857|NCT03309228|qualitative research|qualitative research
142858|NCT03309150|Ataxia telangiectasia mutated and Rad3-related protein inhibitor (ATRi)|ataxia telangiectasia mutated and rad3-related protein inhibitor (atri)
142859|NCT03309150|M6620|m6620
142860|NCT03309150|Solid tumors|solid tumors
142861|NCT03309137|Blood stream infections|blood stream infections
142862|NCT03309137|Prospective|prospective
142863|NCT03309137|Preventative|preventative
142864|NCT03309137|Randomized|randomized
142865|NCT03309124|White potatoes|white potatoes
142866|NCT03309124|Older adults|older adults
142867|NCT03309124|Satiety|satiety
142868|NCT03309124|Glycaemia|glycaemia
142869|NCT03309072|transcranial Direct Current Stimulation (tDCS)|transcranial direct current stimulation (tdcs)
142870|NCT03309072|accelerated learning|accelerated learning
142871|NCT03309072|memory|memory
142872|NCT03309059|Nursing care|nursing care
142873|NCT03309059|diaper rash|diaper rash
142874|NCT03309059|fecal incontinence|fecal incontinence
142875|NCT03309059|urinary incontinence|urinary incontinence
142876|NCT03309046|Parents|parents
142877|NCT03309046|Caregivers|caregivers
142878|NCT03309046|Veterans|veterans
142879|NCT03309033|Vaccine Efficacy|vaccine efficacy
142880|NCT03309033|Immune Response|immune response
142881|NCT03309033|Long-Term Protection|long-term protection
142882|NCT03309020|OCT|oct
142883|NCT03309020|Cataracts|cataracts
142884|NCT03309020|Visual Acuity|visual acuity
142885|NCT03309007|Autophagy|autophagy
142886|NCT03308994|Multiple sclerosis|multiple sclerosis
142887|NCT03308994|Epidemiology|epidemiology
142888|NCT03308994|Oral disease modifying treatments|oral disease modifying treatments
142889|NCT03308994|Therapeutical delays|therapeutical delays
142890|NCT03308994|Socio-Economic Status|socio-economic status
142891|NCT03308981|therapeutic online game|therapeutic online game
142892|NCT03308981|resilience|resilience
142893|NCT03308981|prevention|prevention
142894|NCT03308981|emotional disorders|emotional disorders
142895|NCT03308981|child|child
142896|NCT03308981|adolescent|adolescent
142897|NCT03308942|Niraparib|niraparib
142898|NCT03308942|Zejula|zejula
142899|NCT03308942|PARP Inhibitor|parp inhibitor
142900|NCT03308942|PD-1 Inhibitor|pd-1 inhibitor
142901|NCT03308916|elastography|elastography
142902|NCT03308916|screening|screening
142903|NCT03308916|non-invasive markers|non-invasive markers
142904|NCT03308916|microbiome|microbiome
142905|NCT03308916|gut-liver-axis|gut-liver-axis
142906|NCT03308916|cost-benefit|cost-benefit
142907|NCT03308916|fibroscan|fibroscan
142908|NCT03308916|aixplorer|aixplorer
142909|NCT03308916|ultrasound elastography|ultrasound elastography
142910|NCT03308916|liver fibrosis|liver fibrosis
142911|NCT03308916|alcoholic liver disease|alcoholic liver disease
142912|NCT03308916|advanced fibrosis|advanced fibrosis
142913|NCT03308916|enhanced liver fibrosis test|enhanced liver fibrosis test
142914|NCT03308916|direct liver fibrosis markers|direct liver fibrosis markers
142915|NCT03308916|ELF|elf
142916|NCT03308916|cytokeratin-18|cytokeratin-18
142917|NCT03308916|neoepitopes|neoepitopes
142918|NCT03308916|collagen|collagen
142919|NCT03308916|NAFLD|nafld
142920|NCT03308916|ALD|ald
142921|NCT03308916|metabolomics|metabolomics
142922|NCT03308916|non-alcoholic fatty liver disease|non-alcoholic fatty liver disease
142923|NCT03308825|Influenza|influenza
142924|NCT03308825|Flu|flu
142925|NCT03308812|Cardiovascular health|cardiovascular health
142926|NCT03308812|Health coach|health coach
142927|NCT03308812|Cardiovascular risk factors|cardiovascular risk factors
142928|NCT03308812|Ethnic disparities|ethnic disparities
142929|NCT03308812|Behavioral intervention|behavioral intervention
142930|NCT03308812|E-health lifestyle intervention|e-health lifestyle intervention
142931|NCT03308812|Health360x|health360x
142932|NCT03308812|eHealthyStrides|ehealthystrides
142933|NCT03308773|Prediabetes|prediabetes
142934|NCT03308773|insulin resistance|insulin resistance
142935|NCT03308773|T2DM|t2dm
142936|NCT03308773|Carotid IMT/Plaque|carotid imt/plaque
142937|NCT03308747|Low-grade systemic inflammation|low-grade systemic inflammation
142938|NCT03308747|Muscle protein synthesis|muscle protein synthesis
142939|NCT03308747|Proteasome activation|proteasome activation
142940|NCT03308747|Anabolic signaling|anabolic signaling
142941|NCT03308747|Aging|aging
142942|NCT03308747|Sarcopenia|sarcopenia
142943|NCT03308734|High-intensity interval training|high-intensity interval training
142944|NCT03308734|REHIT|rehit
142945|NCT03308734|Prostate cancer|prostate cancer
142946|NCT03308734|cardiorespiratory fitness|cardiorespiratory fitness
142947|NCT03308656|uterocervical angle, labor induction|uterocervical angle, labor induction
142948|NCT03308643|myomectomy|myomectomy
142949|NCT03308643|oxytocin|oxytocin
142950|NCT03308643|blood loss|blood loss
142951|NCT03308617|sonication|sonication
142952|NCT03308578|Obsructive sleep apnea|obsructive sleep apnea
142953|NCT03308578|Adipose tissue|adipose tissue
142954|NCT03308565|AIS grade A or B|ais grade a or b
142955|NCT03308513|Prolonged acute mechanical ventilation|prolonged acute mechanical ventilation
142956|NCT03308500|HIIT|hiit
142957|NCT03308500|Children|children
142958|NCT03308500|Cardiorespiratory fitness|cardiorespiratory fitness
142959|NCT03308500|Body composition|body composition
142960|NCT03308487|Vitamin D|vitamin d
142961|NCT03308487|pregnancy|pregnancy
142962|NCT03308461|difficult defecation|difficult defecation
142963|NCT03308461|fecal microbiota transplantation|fecal microbiota transplantation
142964|NCT03308461|stool pattern|stool pattern
142965|NCT03308448|Traumatic optic neuropathy|traumatic optic neuropathy
142966|NCT03308448|Erythropoietin|erythropoietin
142967|NCT03308448|EPO|epo
142968|NCT03308448|Eprex|eprex
142969|NCT03308422|screens|screens
142970|NCT03308422|preschool children|preschool children
142971|NCT03308422|parenting education|parenting education
142972|NCT03308422|social perceptions|social perceptions
142973|NCT03308396|Durvalumab|durvalumab
142974|NCT03308396|Guadecitabine|guadecitabine
142975|NCT03308357|drug monitoring|drug monitoring
142976|NCT03308331|HIV|hiv
142977|NCT03308331|nicotine|nicotine
142978|NCT03308331|brain|brain
142979|NCT03308331|smoking|smoking
142980|NCT03308318|Deep temporal fascia|deep temporal fascia
142981|NCT03308318|Deep layer of the deep temporal fascia|deep layer of the deep temporal fascia
142982|NCT03308318|Superficial layer of the deep temporal fascia|superficial layer of the deep temporal fascia
142983|NCT03308318|Temporal fascial layers|temporal fascial layers
142984|NCT03308318|Temporal anatomy|temporal anatomy
142985|NCT03308305|Coma|coma
142986|NCT03308305|Cardiac arrest|cardiac arrest
142987|NCT03308305|Prognosis|prognosis
142988|NCT03308305|MRI|mri
142989|NCT03308279|dry needling|dry needling
142990|NCT03308279|median nerve|median nerve
142991|NCT03308279|Pronator Teres|pronator teres
142992|NCT03308253|Vascular Surgery|vascular surgery
142993|NCT03308253|Surgical Site Infection|surgical site infection
142994|NCT03308253|Prophylactic Antibiotics|prophylactic antibiotics
142995|NCT03308253|Implantable Beads|implantable beads
142996|NCT03308240|Magic|magic
142997|NCT03308240|Anxiety|anxiety
142998|NCT03308240|Pediatric|pediatric
142999|NCT03308227|Linezolid; PK/PD; Septic shock|linezolid; pk/pd; septic shock
143000|NCT03308214|septic shock; imipenem; VD ;pharmacokinetics|septic shock; imipenem; vd ;pharmacokinetics
143001|NCT03308188|Opioid therapy|opioid therapy
143002|NCT03308188|web-based intervention|web-based intervention
143003|NCT03308188|self-management|self-management
143004|NCT03308162|Integrated Behavioral Health Care|integrated behavioral health care
143005|NCT03308136|epidural steroid injection|epidural steroid injection
143006|NCT03308136|procedural pain|procedural pain
143007|NCT03308136|local Anesthetic Injection|local anesthetic injection
143008|NCT03308097|PrEP|prep
143009|NCT03308097|Uptake|uptake
143010|NCT03308097|MSM|msm
143011|NCT03308097|Black|black
143012|NCT03308084|transforaminal lumbar interbody fusion, methylprednisolone|transforaminal lumbar interbody fusion, methylprednisolone
143013|NCT03308071|Hypnosis|hypnosis
143014|NCT03308071|Hypnotherapy|hypnotherapy
143015|NCT03308071|Perioperative Pain Management|perioperative pain management
143016|NCT03308071|Narcotic reduction|narcotic reduction
143017|NCT03308071|Perioperative Outcomes|perioperative outcomes
143018|NCT03308071|Total knee replacement|total knee replacement
143019|NCT03308071|Total knee arthroplasty|total knee arthroplasty
143020|NCT03308058|Breastfeeding Rural Hispanic Pregnant|breastfeeding rural hispanic pregnant
143022|NCT03308045|electrotransfer|electrotransfer
143023|NCT03308045|ciliary muscle|ciliary muscle
143024|NCT03308045|uveitis|uveitis
143025|NCT03307993|Lu AE58054|lu ae58054
143026|NCT03307980|gene therapy|gene therapy
143027|NCT03307928|Obstructive Sleep Apnea Syndrome|obstructive sleep apnea syndrome
143028|NCT03307928|Aged|aged
143029|NCT03307928|Hypertension|hypertension
143030|NCT03307928|Oxygen Consumption|oxygen consumption
143031|NCT03307928|Exercise|exercise
143032|NCT03307902|Vaccination|vaccination
143033|NCT03307889|perioperative monitoring|perioperative monitoring
143034|NCT03307876|biologic,|biologic,
143035|NCT03307876|Alpha 2 Macroglobulin|alpha 2 macroglobulin
143036|NCT03307876|A2M|a2m
143037|NCT03307876|back pain|back pain
143038|NCT03307876|APIC|apic
143039|NCT03307876|FAC|fac
143040|NCT03307876|FACT|fact
143041|NCT03307863|etonogestrel implant|etonogestrel implant
143042|NCT03307863|anti-epileptic drugs|anti-epileptic drugs
143043|NCT03307863|pharmacokinetics|pharmacokinetics
143044|NCT03307850|type 1 diabetes|type 1 diabetes
143045|NCT03307850|hypoglycemia|hypoglycemia
143046|NCT03307850|exercise|exercise
143047|NCT03307850|stress|stress
143048|NCT03307850|artificial pancreas|artificial pancreas
143049|NCT03307850|cortisol|cortisol
143050|NCT03307837|nilateral Transpositional First Metatarsal Osteotomy|nilateral transpositional first metatarsal osteotomy
143051|NCT03307824|Laparoscopic Surgery|laparoscopic surgery
143052|NCT03307824|synthetic glue IFABONDTM|synthetic glue ifabondtm
143053|NCT03307824|time of surgery|time of surgery
143054|NCT03307811|liver|liver
143055|NCT03307811|biopsy|biopsy
143056|NCT03307811|hepatic|hepatic
143057|NCT03307811|EUS|eus
143058|NCT03307811|fine needle biopsy|fine needle biopsy
143059|NCT03307798|dental implant,bone quality,tactile sensation|dental implant,bone quality,tactile sensation
143060|NCT03307772|lactobacillus|lactobacillus
143061|NCT03307772|Herpes Labialis|herpes labialis
143062|NCT03307772|immune response|immune response
143063|NCT03307720|agonist trigger|agonist trigger
143064|NCT03307720|Ovulation induction|ovulation induction
143065|NCT03307720|Controlled ovarian stimulation (COS)|controlled ovarian stimulation (cos)
143066|NCT03307720|Poor responder|poor responder
143067|NCT03307707|FGF23|fgf23
143068|NCT03307707|klotho|klotho
143069|NCT03307707|Mineral Bone Disorder|mineral bone disorder
143070|NCT03307694|Cancer|cancer
143071|NCT03307694|Thyroid nodule|thyroid nodule
143072|NCT03307694|Imaging|imaging
143073|NCT03307694|Radiology|radiology
143074|NCT03307681|White potatoes|white potatoes
143075|NCT03307681|Children|children
143076|NCT03307681|Satiety|satiety
143077|NCT03307681|Glycaemia|glycaemia
143078|NCT03307655|nitric oxide|nitric oxide
143079|NCT03307655|follicular fluid|follicular fluid
143080|NCT03307655|sperm|sperm
143081|NCT03307655|capacitation|capacitation
143082|NCT03307655|fertilization|fertilization
143083|NCT03307655|phosphorylation|phosphorylation
143084|NCT03307655|nitrosylation|nitrosylation
143085|NCT03307642|Influenza vaccination rates|influenza vaccination rates
143086|NCT03307642|Respiratory Tract Diseases|respiratory tract diseases
143087|NCT03307603|Yttrium-90 radioembolization|yttrium-90 radioembolization
143088|NCT03307603|Nivolumab|nivolumab
143089|NCT03307551|propofol, automated, manual|propofol, automated, manual
143298|NCT03306303|melatonin|melatonin
143090|NCT03307538|Perihilar cholangiocarcinoma|perihilar cholangiocarcinoma
143091|NCT03307538|Klatskin tumor|klatskin tumor
143092|NCT03307538|Stereotactic body radiation therapy|stereotactic body radiation therapy
143093|NCT03307512|inhaled insulin|inhaled insulin
143094|NCT03307512|asthma|asthma
143095|NCT03307512|COPD|copd
143096|NCT03307486|Gestational diabetes|gestational diabetes
143097|NCT03307486|Type 2 DM after GDM|type 2 dm after gdm
143098|NCT03307473|Physical activity|physical activity
143099|NCT03307473|Bicycling|bicycling
143100|NCT03307473|Transportation|transportation
143101|NCT03307473|Public health|public health
143102|NCT03307447|optical coherence tomography|optical coherence tomography
143103|NCT03307434|Program|program
143104|NCT03307434|Prevention|prevention
143105|NCT03307434|Injury|injury
143106|NCT03307434|Athletics|athletics
143107|NCT03307421|simulation|simulation
143108|NCT03307421|debriefing|debriefing
143109|NCT03307421|team score|team score
143110|NCT03307421|multidisciplinarity|multidisciplinarity
143111|NCT03307421|DEBRIEF sim II|debrief sim ii
143112|NCT03307395|Chronic Subdural Hematoma|chronic subdural hematoma
143113|NCT03307395|Embolization|embolization
143114|NCT03307395|Middle meningeal artery|middle meningeal artery
143115|NCT03307382|Biliary stricture, cholangioscopy|biliary stricture, cholangioscopy
143116|NCT03307369|Severe malaria|severe malaria
143117|NCT03307369|plasmodium vivax|plasmodium vivax
143118|NCT03307356|Uterine Transplant|uterine transplant
143119|NCT03307356|MRKH|mrkh
143120|NCT03307343|sedentary behavior|sedentary behavior
143121|NCT03307343|light intensity physical activity|light intensity physical activity
143122|NCT03307343|behavioral intervention|behavioral intervention
143123|NCT03307343|office workers|office workers
143124|NCT03307343|blood pressure|blood pressure
143125|NCT03307343|pulse wave velocity|pulse wave velocity
143126|NCT03307343|randomized clinical trial|randomized clinical trial
143127|NCT03307330|Obstructive Sleep Apnea|obstructive sleep apnea
143128|NCT03307330|Adipose Tissue|adipose tissue
143129|NCT03307317|Near Infrared Spectroscopy|near infrared spectroscopy
143130|NCT03307317|EEG|eeg
143131|NCT03307317|Functional Brain Activity|functional brain activity
143132|NCT03307317|Neurodevelopment|neurodevelopment
143133|NCT03307304|Batten Disease|batten disease
143134|NCT03307304|Neurodegenerative|neurodegenerative
143135|NCT03307304|Lysosomal Storage|lysosomal storage
143136|NCT03307304|Biomarkers|biomarkers
143137|NCT03307304|Longitudinal Study|longitudinal study
143138|NCT03307265|Weighted Jacket|weighted jacket
143139|NCT03307265|Balance disorder|balance disorder
143140|NCT03307265|Equilibrium disorder|equilibrium disorder
143141|NCT03307226|Suubi|suubi
143142|NCT03307226|Adolescent Girls|adolescent girls
143143|NCT03307226|Poverty|poverty
143144|NCT03307226|Economic Empowement Interventions|economic empowement interventions
143145|NCT03307226|Adherence to HIV antiretroviral therapy|adherence to hiv antiretroviral therapy
143146|NCT03307226|HIV/AIDS-impacted girls|hiv/aids-impacted girls
143147|NCT03307226|Uganda|uganda
143148|NCT03307226|Cost-effectiveness|cost-effectiveness
143149|NCT03307200|Supportive care|supportive care
143150|NCT03307200|Prospective observational study|prospective observational study
143151|NCT03307161|manual therapy|manual therapy
143152|NCT03307161|heart rate|heart rate
143153|NCT03307148|Locally Advanced or Metastatic|locally advanced or metastatic
143154|NCT03307135|Spasticity|spasticity
143155|NCT03307135|electrophysiology|electrophysiology
143156|NCT03307135|biomechanics|biomechanics
143157|NCT03307135|objective assessment|objective assessment
143158|NCT03307096|FURS|furs
143159|NCT03307096|microperc|microperc
143160|NCT03307096|renal calculus|renal calculus
143161|NCT03307096|Randomized Controlled Trial|randomized controlled trial
143162|NCT03307096|Retrograde Intrarenal Surgery|retrograde intrarenal surgery
143163|NCT03307057|Pediatrics|pediatrics
143164|NCT03307057|Behavioral Research|behavioral research
143165|NCT03307031|training volume|training volume
143166|NCT03307031|elderly|elderly
143167|NCT03307031|lipid profile|lipid profile
143168|NCT03307031|postmenopausal|postmenopausal
143169|NCT03307018|Bronchoscopy|bronchoscopy
143170|NCT03307018|Respiratory Complications|respiratory complications
143171|NCT03307018|Anatomical Lung Resection|anatomical lung resection
143172|NCT03306992|Exercise|exercise
143173|NCT03306966|Ascending colon|ascending colon
143174|NCT03306940|botulinum toxin A|botulinum toxin a
143175|NCT03306927|blood sugar|blood sugar
143176|NCT03306927|insulin|insulin
143177|NCT03306927|appetite|appetite
143178|NCT03306927|peas|peas
143179|NCT03306875|multiple sclerosis|multiple sclerosis
143180|NCT03306875|cognitive training|cognitive training
143181|NCT03306875|telerehabilitation|telerehabilitation
143182|NCT03306875|personality|personality
143183|NCT03306875|Conscientiousness|conscientiousness
143184|NCT03306875|predict|predict
143185|NCT03306862|blood sugar|blood sugar
143186|NCT03306862|insulin|insulin
143187|NCT03306862|peas|peas
143188|NCT03306836|Hybrid operation|hybrid operation
143189|NCT03306836|Cerebral Aneurysm|cerebral aneurysm
143190|NCT03306836|Arteriovenous Malformations|arteriovenous malformations
143191|NCT03306836|Anticoagulation|anticoagulation
143192|NCT03306823|Cerebral Aneurysm|cerebral aneurysm
143193|NCT03306823|Arteriovenous Malformations|arteriovenous malformations
143194|NCT03306823|Hybrid operation|hybrid operation
143195|NCT03306823|Anticoagulation|anticoagulation
143196|NCT03306810|Perioperative complications|perioperative complications
143197|NCT03306810|Dysglycemia management team|dysglycemia management team
143198|NCT03306810|Nurse Practitioner|nurse practitioner
143199|NCT03306810|Hospital|hospital
143200|NCT03306797|Music therapy|music therapy
143201|NCT03306797|Sonification technique|sonification technique
143202|NCT03306797|Rehabilitation|rehabilitation
143203|NCT03306784|RAPID3|rapid3
143204|NCT03306784|pain catastrophizing|pain catastrophizing
143205|NCT03306771|Morbid Obesity|morbid obesity
143206|NCT03306771|Carotid Stenosis|carotid stenosis
143207|NCT03306771|Metabolic Syndrome|metabolic syndrome
143208|NCT03306745|Polycystic Ovary Syndrome|polycystic ovary syndrome
143209|NCT03306745|Anti-Mullerian Hormone|anti-mullerian hormone
143210|NCT03306745|Androgens|androgens
143211|NCT03306745|Micronutrient Supplementation|micronutrient supplementation
143212|NCT03306732|Thiamine|thiamine
143213|NCT03306732|Thiamine Supplementation|thiamine supplementation
143214|NCT03306732|Vasoplegia Syndrome|vasoplegia syndrome
143215|NCT03306732|Inotropic support|inotropic support
143216|NCT03306732|Cardiac surgery|cardiac surgery
143217|NCT03306732|Renal Failure|renal failure
143218|NCT03306706|blood sugar|blood sugar
143219|NCT03306706|insulin|insulin
143220|NCT03306706|appetite|appetite
143221|NCT03306706|peas|peas
143222|NCT03306693|Emotional Intelligence|emotional intelligence
143223|NCT03306693|Quality of Life|quality of life
143224|NCT03306628|Skin Scarring|skin scarring
143225|NCT03306628|keloids|keloids
143226|NCT03306628|hypertrophic scars|hypertrophic scars
143227|NCT03306628|CO2 laser therapy|co2 laser therapy
143228|NCT03306615|Muscle Stiffness|muscle stiffness
143229|NCT03306615|Muscle Spasticity|muscle spasticity
143230|NCT03306615|Stroke|stroke
143231|NCT03306615|Cerebral Palsy|cerebral palsy
143232|NCT03306615|Hyperreflexia|hyperreflexia
143233|NCT03306602|Composite Resins|composite resins
143234|NCT03306602|Dental Restorations|dental restorations
143235|NCT03306589|Inflammation|inflammation
143236|NCT03306589|GM-CSF|gm-csf
143237|NCT03306589|LPS|lps
143238|NCT03306589|Skin blisters|skin blisters
143239|NCT03306589|Healthy subjects|healthy subjects
143240|NCT03306589|cantharidin|cantharidin
143241|NCT03306576|composite restoration|composite restoration
143242|NCT03306563|TBI|tbi
143243|NCT03306563|Mild traumatic brain injury|mild traumatic brain injury
143244|NCT03306563|Concussion|concussion
143245|NCT03306563|Diagnostics|diagnostics
143246|NCT03306563|Rapid test|rapid test
143247|NCT03306563|Traumatic Brain Injury|traumatic brain injury
143248|NCT03306563|mTBI|mtbi
143249|NCT03306550|drug-drug interaction|drug-drug interaction
143250|NCT03306550|Asprin|asprin
143251|NCT03306550|salvianolate injection|salvianolate injection
143252|NCT03306550|PK-PD model|pk-pd model
143253|NCT03306550|metabolic enzymes|metabolic enzymes
143254|NCT03306524|mechanical ventilation|mechanical ventilation
143255|NCT03306524|SIPPV|sippv
143256|NCT03306524|PSV|psv
143257|NCT03306524|Device flow|device flow
143258|NCT03306524|Circuit flow|circuit flow
143259|NCT03306524|Slope time|slope time
143260|NCT03306524|neonatal intensive care|neonatal intensive care
143261|NCT03306498|plasma free amino acids|plasma free amino acids
143262|NCT03306459|PCOS|pcos
143263|NCT03306459|Quality of life|quality of life
143264|NCT03306459|Sexuality|sexuality
143265|NCT03306459|Psychological traits|psychological traits
143266|NCT03306433|dental caries|dental caries
143267|NCT03306433|white spot lesion|white spot lesion
143268|NCT03306433|prevention|prevention
143269|NCT03306433|smooth surface sealant|smooth surface sealant
143270|NCT03306420|MS201408-0005A|ms201408-0005a
143271|NCT03306420|MS201408-0005B|ms201408-0005b
143272|NCT03306420|MS201408-0005C|ms201408-0005c
143273|NCT03306420|First-in-Human|first-in-human
143274|NCT03306420|Advanced solid tumors|advanced solid tumors
143275|NCT03306394|metastatic|metastatic
143276|NCT03306394|colorectal|colorectal
143277|NCT03306394|cancer|cancer
143278|NCT03306394|trifluridine/tipiracil|trifluridine/tipiracil
143279|NCT03306394|early access|early access
143281|NCT03306381|Epigenetics|epigenetics
143282|NCT03306381|Dietary intervention|dietary intervention
143283|NCT03306381|Gut Microbiota|gut microbiota
143284|NCT03306381|Inflammation|inflammation
143285|NCT03306381|Genetics|genetics
143286|NCT03306368|OUD|oud
143287|NCT03306368|XR-NTX|xr-ntx
143288|NCT03306368|assertive outreach|assertive outreach
143289|NCT03306368|youth|youth
143290|NCT03306355|Intraocular Lens|intraocular lens
143291|NCT03306355|trifocal|trifocal
143292|NCT03306355|hydrophobic|hydrophobic
143293|NCT03306355|hydrophilic|hydrophilic
143294|NCT03306342|Intraocular Lens|intraocular lens
143295|NCT03306342|trifocal|trifocal
143296|NCT03306342|hydrophobic|hydrophobic
143297|NCT03306342|hydrophilic|hydrophilic
143299|NCT03306303|STEMI|stemi
143300|NCT03306303|No-reflow|no-reflow
143301|NCT03306290|Obese|obese
143302|NCT03306290|Bariatric surgery|bariatric surgery
143303|NCT03306290|Antibiotic prophylaxis|antibiotic prophylaxis
143304|NCT03306290|Cefoxitin|cefoxitin
143305|NCT03306264|MDS|mds
143306|NCT03306264|CMML|cmml
143307|NCT03306264|decitabine|decitabine
143308|NCT03306264|Myelodysplastic Syndromes|myelodysplastic syndromes
143309|NCT03306264|Chronic Myelomonocytic Leukemia|chronic myelomonocytic leukemia
143310|NCT03306264|Acute Myeloid Leukemia|acute myeloid leukemia
143311|NCT03306264|AML|aml
143312|NCT03306251|HIV|hiv
143313|NCT03306251|Pregnancy|pregnancy
143314|NCT03306251|Prevention of mother-to-child transmission|prevention of mother-to-child transmission
143315|NCT03306238|laparoscopy/ key-hole|laparoscopy/ key-hole
143316|NCT03306238|renal surgery|renal surgery
143317|NCT03306238|open/hasson|open/hasson
143318|NCT03306238|closed/veress|closed/veress
143319|NCT03306212|cerebral palsy|cerebral palsy
143320|NCT03306212|casting|casting
143321|NCT03306212|Botulinum toxin A|botulinum toxin a
143322|NCT03306186|diagnosis|diagnosis
143323|NCT03306186|prognosis|prognosis
143324|NCT03306160|central blood pressure|central blood pressure
143325|NCT03306160|ambulatory blood pressure monitoring|ambulatory blood pressure monitoring
143326|NCT03306160|blood pressure variability|blood pressure variability
143327|NCT03306147|Pain|pain
143328|NCT03306147|Opioid|opioid
143329|NCT03306147|Drug monitoring|drug monitoring
143330|NCT03306147|Pain education|pain education
143331|NCT03306121|Nasopharyngeal carcinoma;Induction chemotherapy|nasopharyngeal carcinoma;induction chemotherapy
143332|NCT03306069|Aerobic exercise|aerobic exercise
143333|NCT03306069|Interval training|interval training
143334|NCT03306069|VO2max|vo2max
143335|NCT03306069|Health Promotion|health promotion
143336|NCT03306069|Inflammation|inflammation
143337|NCT03306069|Body Composition|body composition
143338|NCT03306056|Exercise|exercise
143339|NCT03306056|Strength Training|strength training
143340|NCT03306056|Health Promotion|health promotion
143341|NCT03306056|Inflammation|inflammation
143342|NCT03306056|Body Composition|body composition
143343|NCT03306043|hypereosinophilic syndrome|hypereosinophilic syndrome
143344|NCT03306043|hypereosinophilic syndrome flare|hypereosinophilic syndrome flare
143345|NCT03306043|open-label extension study|open-label extension study
143346|NCT03306043|Mepolizumab|mepolizumab
143347|NCT03306043|SB240563|sb240563
143348|NCT03306043|Long-term safety|long-term safety
143349|NCT03306030|PEG|peg
143350|NCT03306030|Bowel preparation|bowel preparation
143351|NCT03306030|Colonoscopy|colonoscopy
143352|NCT03306030|split-does|split-does
143353|NCT03306017|left ventricular assist device|left ventricular assist device
143354|NCT03306017|platelet-leukocyte conjugates|platelet-leukocyte conjugates
143355|NCT03306017|lipo-oxygenase products|lipo-oxygenase products
143356|NCT03305991|tuberculosis|tuberculosis
143357|NCT03305991|pregnancy|pregnancy
143358|NCT03305991|ethiopia|ethiopia
143359|NCT03305978|Ultra low dose chest CT|ultra low dose chest ct
143360|NCT03305978|lung cancer screening|lung cancer screening
143361|NCT03305939|Gestational Diabetes,Lifestyle,Type 2 DM|gestational diabetes,lifestyle,type 2 dm
143362|NCT03305913|mCRC|mcrc
143363|NCT03305900|formate|formate
143364|NCT03305900|one-carbon metabolism|one-carbon metabolism
143365|NCT03305887|TKA|tka
143366|NCT03305887|Barbed suture|barbed suture
143367|NCT03305887|Surgical time|surgical time
143368|NCT03305874|contrast-induced nephropathy (CIN)|contrast-induced nephropathy (cin)
143369|NCT03305874|percutaneous coronary intervention (PCI)|percutaneous coronary intervention (pci)
143370|NCT03305874|computer-based risk tool|computer-based risk tool
143371|NCT03305861|Thulium Laser Enucleation of the Prostate (ThuLEP)|thulium laser enucleation of the prostate (thulep)
143372|NCT03305861|Greenlight Laser Enucleation of the Prostate (Green LEP)|greenlight laser enucleation of the prostate (green lep)
143373|NCT03305835|Primary Hyperoxaluria (PH)|primary hyperoxaluria (ph)
143374|NCT03305835|Hyperoxaluria|hyperoxaluria
143375|NCT03305835|PH|ph
143376|NCT03305835|PH 1|ph 1
143377|NCT03305835|PH 2|ph 2
143378|NCT03305835|PH 3|ph 3
143379|NCT03305835|Dent Disease|dent disease
143380|NCT03305835|Dent 1|dent 1
143381|NCT03305835|Dent 2|dent 2
143382|NCT03305835|Cystinuria|cystinuria
143383|NCT03305835|APRT Deficiency|aprt deficiency
143384|NCT03305835|24-Hydroxylase Deficiency|24-hydroxylase deficiency
143385|NCT03305835|CYP24A1|cyp24a1
143386|NCT03305809|Parkinson Disease Dementia|parkinson disease dementia
143387|NCT03305809|Parkinson Disease|parkinson disease
143388|NCT03305809|Dopamine|dopamine
143389|NCT03305809|Cognition|cognition
143390|NCT03305809|Lewy Body Dementia|lewy body dementia
143391|NCT03305809|Dementia with Lewy Bodies|dementia with lewy bodies
143392|NCT03305770|soft contact lenses|soft contact lenses
143393|NCT03305770|vision|vision
143394|NCT03305770|eyesight|eyesight
143395|NCT03305744|Athlete|athlete
143396|NCT03305744|Middle-aged|middle-aged
143397|NCT03305744|Endurance training|endurance training
143398|NCT03305744|Cardiac Function|cardiac function
143399|NCT03305744|Atrial Fibrillation|atrial fibrillation
143400|NCT03305731|Rehabilitation|rehabilitation
143401|NCT03305731|Disability|disability
143402|NCT03305692|cardiac resynchronization therapy|cardiac resynchronization therapy
143403|NCT03305692|pacing|pacing
143404|NCT03305692|echocardiography|echocardiography
143405|NCT03305692|optimization|optimization
143406|NCT03305692|heart failure|heart failure
143407|NCT03305653|Pediatrics|pediatrics
143408|NCT03305588|essential tremor (ET)|essential tremor (et)
143409|NCT03305588|stereotactic radiosurgery (SRS)|stereotactic radiosurgery (srs)
143410|NCT03305588|radiosurgery (RS)|radiosurgery (rs)
143411|NCT03305588|deep brain stimulation (DBS)|deep brain stimulation (dbs)
143412|NCT03305588|Parkinson's Disease (PD)|parkinson's disease (pd)
143413|NCT03305588|tremor-dominant Parkinson's disease (TDPD)|tremor-dominant parkinson's disease (tdpd)
143414|NCT03305575|Cervical Cerclage|cervical cerclage
143415|NCT03305575|Bupivacaine|bupivacaine
143416|NCT03305575|Chloroprocaine|chloroprocaine
143417|NCT03305575|spinal anesthesia|spinal anesthesia
143418|NCT03305562|Hypertension|hypertension
143419|NCT03305549|Dialysis-requiring Acute Kidney Injury|dialysis-requiring acute kidney injury
143420|NCT03305549|Renal Recovery|renal recovery
143422|NCT03305523|circumcision; Thermocautery; Complication|circumcision; thermocautery; complication
143423|NCT03305497|Opioid Overdose; Naloxone|opioid overdose; naloxone
143424|NCT03305484|contact lenses|contact lenses
143425|NCT03305484|red eye|red eye
143426|NCT03305484|corneal infiltrate|corneal infiltrate
143427|NCT03305471|Chronic hemodialysis|chronic hemodialysis
143428|NCT03305471|Investigational drug|investigational drug
143429|NCT03305445|Immunotransplant|immunotransplant
143430|NCT03305445|Relapsed Diffuse Large B-Cell Lymphoma|relapsed diffuse large b-cell lymphoma
143431|NCT03305445|Refractory Diffuse Large B-Cell Lymphoma|refractory diffuse large b-cell lymphoma
143432|NCT03305445|Nivolumab|nivolumab
143433|NCT03305445|Ipilimumab|ipilimumab
143434|NCT03305419|Crossover|crossover
143435|NCT03305419|Sequential|sequential
143436|NCT03305419|GSK2982772|gsk2982772
143437|NCT03305419|Safety|safety
143438|NCT03305419|Pharmacokinetics|pharmacokinetics
143439|NCT03305419|Healthy subjects|healthy subjects
143440|NCT03305393|Heart Failure|heart failure
143441|NCT03305393|CRT|crt
143442|NCT03305393|Cardiac Recynchronization Therapy|cardiac recynchronization therapy
143443|NCT03305393|left bundle branch block|left bundle branch block
143444|NCT03305393|atrio-ventricular conduction|atrio-ventricular conduction
143445|NCT03305380|anti-PD1|anti-pd1
143446|NCT03305380|anti-PD-L1|anti-pd-l1
143447|NCT03305354|mobile health|mobile health
143448|NCT03305354|physical activity|physical activity
143449|NCT03305341|SCLC|sclc
143450|NCT03305341|SNP|snp
143451|NCT03305341|Oncology|oncology
143452|NCT03305341|Drug|drug
143453|NCT03305341|Etoposide|etoposide
143454|NCT03305341|Methotrexate|methotrexate
143455|NCT03305341|Lung|lung
143456|NCT03305341|Cancer|cancer
143457|NCT03305328|Oscillations|oscillations
143458|NCT03305328|Non-invasive Brain Stimulation|non-invasive brain stimulation
143459|NCT03305328|Transcranial Alternating Current Stimulation|transcranial alternating current stimulation
143460|NCT03305276|diet;|diet;
143461|NCT03305276|exercise;|exercise;
143462|NCT03305276|hypertension;|hypertension;
143463|NCT03305276|vitamin d|vitamin d
143464|NCT03305237|Weight loss|weight loss
143465|NCT03305237|Chrono-nutrition|chrono-nutrition
143466|NCT03305237|Diet|diet
143467|NCT03305237|energy expenditure|energy expenditure
143468|NCT03305224|castration-resistant prostate cancer|castration-resistant prostate cancer
143469|NCT03305224|bone metastasis|bone metastasis
143470|NCT03305185|AIS|ais
143471|NCT03305107|Child|child
143472|NCT03305107|Exercise|exercise
143473|NCT03305107|Chocolate milk|chocolate milk
143474|NCT03305107|Blood glucose|blood glucose
143475|NCT03305107|Cognition|cognition
143476|NCT03305107|Appetite|appetite
143477|NCT03305107|Emotions|emotions
143478|NCT03305107|Cortisol|cortisol
143479|NCT03305094|Remote ischemic preconditioning|remote ischemic preconditioning
143480|NCT03305094|Myocardial infarction|myocardial infarction
143481|NCT03305094|Cardiac surgery|cardiac surgery
143482|NCT03305055|opioid|opioid
143483|NCT03305055|ketamine|ketamine
143484|NCT03305042|aging|aging
143485|NCT03305042|alpha-retinol|alpha-retinol
143486|NCT03305042|hypervitaminosis A|hypervitaminosis a
143487|NCT03305042|vitamin A biomarkers|vitamin a biomarkers
143488|NCT03305042|serum retinol|serum retinol
143489|NCT03305029|Age related macular degeneration|age related macular degeneration
143490|NCT03305029|embryonic stem cells|embryonic stem cells
143491|NCT03305029|somatic cell nuclear transfer|somatic cell nuclear transfer
143492|NCT03305016|Human Growth Hormone|human growth hormone
143493|NCT03305016|hGH|hgh
143494|NCT03305016|GHD|ghd
143495|NCT03305016|rhGH|rhgh
143496|NCT03305016|Pediatric Growth Hormone Deficiency|pediatric growth hormone deficiency
143497|NCT03305016|Long Acting Growth Hormone|long acting growth hormone
143498|NCT03305016|Somatropin|somatropin
143499|NCT03305016|Prodrug|prodrug
143500|NCT03305016|Growth Failure|growth failure
143501|NCT03305016|Growth Hormone Replacement Therapy|growth hormone replacement therapy
143502|NCT03305016|Sustained Release Growth Hormone|sustained release growth hormone
143503|NCT03305016|Growth Hormone Deficiency|growth hormone deficiency
143504|NCT03305016|TransCon GH|transcon gh
143505|NCT03304964|FP-025, MMP-12 inhibitor|fp-025, mmp-12 inhibitor
143506|NCT03304912|Pre-Exposure Prophylaxis|pre-exposure prophylaxis
143507|NCT03304912|Injection Drug Use|injection drug use
143508|NCT03304873|rectal MRSA|rectal mrsa
143509|NCT03304873|mupirocin-resistant nasal MRSA|mupirocin-resistant nasal mrsa
143510|NCT03304834|HIFU|hifu
143511|NCT03304834|High intensity focused ultrasound|high intensity focused ultrasound
143512|NCT03304821|Atherosclerotic peripheral artery disease|atherosclerotic peripheral artery disease
143513|NCT03304821|Granulocyte-macrophage colony stimulating factor (GM-CSF)|granulocyte-macrophage colony stimulating factor (gm-csf)
143514|NCT03304821|Atherosclerosis|atherosclerosis
143515|NCT03304821|Cardiology|cardiology
143516|NCT03304821|Vascular disease|vascular disease
143517|NCT03304808|premature ejaculation|premature ejaculation
143518|NCT03304808|cognitive-behavior|cognitive-behavior
143519|NCT03304808|treatment|treatment
143520|NCT03304808|device|device
143521|NCT03304795|Vitamin D|vitamin d
143522|NCT03304795|Asia|asia
143523|NCT03304795|Trend|trend
143524|NCT03304795|KNHANES|knhanes
143525|NCT03304795|Temporal change|temporal change
143526|NCT03304782|Preterm Birth|preterm birth
143527|NCT03304782|Fitbit|fitbit
143528|NCT03304782|Preterm Delivery|preterm delivery
143529|NCT03304769|Virtual Reality Distraction|virtual reality distraction
143530|NCT03304769|Pediatric IV placement|pediatric iv placement
143531|NCT03304756|locally advanced breast cancer|locally advanced breast cancer
143532|NCT03304756|triple negative|triple negative
143533|NCT03304756|cisplatin|cisplatin
143534|NCT03304743|dental panoramic radiographs|dental panoramic radiographs
143535|NCT03304743|osteoporosis|osteoporosis
143536|NCT03304743|feasibility study|feasibility study
143537|NCT03304730|Zygapophyseal Joint|zygapophyseal joint
143538|NCT03304730|Low Back Pain|low back pain
143539|NCT03304730|Spine Osteoarthritis|spine osteoarthritis
143540|NCT03304717|Leukodystrophy|leukodystrophy
143541|NCT03304717|Antiretroviral Drugs|antiretroviral drugs
143542|NCT03304704|Assays|assays
143543|NCT03304704|Direct Skin Feeds|direct skin feeds
143544|NCT03304704|Infection|infection
143545|NCT03304704|Parasite|parasite
143546|NCT03304704|Gametocyte|gametocyte
143547|NCT03304691|Malaria|malaria
143548|NCT03304691|Parasitemia|parasitemia
143549|NCT03304691|Anemia|anemia
143550|NCT03304691|Ligand|ligand
143551|NCT03304691|Anopheles gambiae|anopheles gambiae
143552|NCT03304678|mTORC1 Inhibition|mtorc1 inhibition
143553|NCT03304678|VEGF-D|vegf-d
143554|NCT03304678|MicroRNA|microrna
143555|NCT03304665|Healthy Volunteers|healthy volunteers
143556|NCT03304665|Mental Health|mental health
143557|NCT03304665|Common Data Elements|common data elements
143558|NCT03304600|OCD|ocd
143559|NCT03304600|tDCS|tdcs
143560|NCT03304561|knee|knee
143561|NCT03304561|rehabilitation|rehabilitation
143562|NCT03304561|ACL|acl
143563|NCT03304561|Contralateral training|contralateral training
143564|NCT03304548|Telephone interviews|telephone interviews
143565|NCT03304548|Subcutaneous|subcutaneous
143566|NCT03304548|Low-interventional|low-interventional
143567|NCT03304548|Qualitative research|qualitative research
143568|NCT03304548|PAH|pah
143569|NCT03304535|Glaucoma|glaucoma
143570|NCT03304535|Social Worker|social worker
143571|NCT03304496|Nitroglycerin|nitroglycerin
143572|NCT03304496|Vasodilator Agents|vasodilator agents
143573|NCT03304496|Subcutaneous Injection|subcutaneous injection
143574|NCT03304496|Radial Artery|radial artery
143575|NCT03304496|Coronary Angiography|coronary angiography
143576|NCT03304496|Cardiac Catheterization|cardiac catheterization
143577|NCT03304496|Coronary Angioplasty|coronary angioplasty
143578|NCT03304496|Percutaneous Coronary Intervention|percutaneous coronary intervention
143579|NCT03304457|Lurasidone|lurasidone
143580|NCT03304457|Olanzapine|olanzapine
143581|NCT03304457|Brain derived neurotrophic factor|brain derived neurotrophic factor
143582|NCT03304457|Nerve growth factor|nerve growth factor
143583|NCT03304457|Neurotrophin 3|neurotrophin 3
143584|NCT03304431|QT dispersion|qt dispersion
143585|NCT03304431|topical lidocaine|topical lidocaine
143586|NCT03304431|P-wave values|p-wave values
143587|NCT03304405|ASD|asd
143588|NCT03304392|anxiety|anxiety
143589|NCT03304392|depression|depression
143590|NCT03304392|internet-delivered cognitive behaviour therapy|internet-delivered cognitive behaviour therapy
143591|NCT03304392|randomized controlled trial|randomized controlled trial
143592|NCT03304392|patient-centered|patient-centered
143593|NCT03304392|knowledge implementation|knowledge implementation
143594|NCT03304392|mental health system|mental health system
143595|NCT03304392|therapist-assistance|therapist-assistance
143596|NCT03304353|Plantar heel pain|plantar heel pain
143597|NCT03304353|Resistance training|resistance training
144293|NCT03299855|MoCA|moca
143598|NCT03304340|acute stroke,TENS ,posture stability, function|acute stroke,tens ,posture stability, function
143599|NCT03304327|Yoga|yoga
143600|NCT03304327|Mindfulness|mindfulness
143601|NCT03304314|PTC|ptc
143602|NCT03304314|EYES|eyes
143603|NCT03304314|Pseudotumor cerebri|pseudotumor cerebri
143604|NCT03304314|increased Intracranial pressure|increased intracranial pressure
143605|NCT03304314|ICP|icp
143606|NCT03304301|sunlight exposure|sunlight exposure
143607|NCT03304301|institutionalized elderly|institutionalized elderly
143608|NCT03304301|depression|depression
143609|NCT03304301|quality of life|quality of life
143610|NCT03304301|cognition function|cognition function
143611|NCT03304288|all-trans retinoid acid|all-trans retinoid acid
143612|NCT03304288|rituximab|rituximab
143613|NCT03304288|steroid-resistant|steroid-resistant
143614|NCT03304288|refractory|refractory
143615|NCT03304288|low-dose|low-dose
143616|NCT03304275|Pertussis|pertussis
143617|NCT03304275|Vaccination|vaccination
143618|NCT03304275|Emergency Department|emergency department
143619|NCT03304262|Metaplasticity|metaplasticity
143620|NCT03304262|Motor excitability|motor excitability
143621|NCT03304262|rTMS|rtms
143622|NCT03304262|tDCS|tdcs
143623|NCT03304236|Cervical Myelopathy|cervical myelopathy
143624|NCT03304236|sEMG|semg
143625|NCT03304236|Motion capture analysis|motion capture analysis
143626|NCT03304210|PIPAC|pipac
143627|NCT03304210|Peritoneal carcinomatosis|peritoneal carcinomatosis
143628|NCT03304210|Ovarian cancer|ovarian cancer
143629|NCT03304210|Pharmacokinetics|pharmacokinetics
143630|NCT03304210|Pharmacodynamics|pharmacodynamics
143631|NCT03304210|Safety and efficacy|safety and efficacy
143632|NCT03304210|Abraxane|abraxane
143633|NCT03304210|Breast cancer|breast cancer
143634|NCT03304210|Pancreas cancer|pancreas cancer
143635|NCT03304210|Stomach cancer|stomach cancer
143636|NCT03304158|Diabetes|diabetes
143637|NCT03304158|Non-communicable disease|non-communicable disease
143638|NCT03304158|Primary health care|primary health care
143639|NCT03304158|Nepal|nepal
143640|NCT03304145|Treatment Care Planning|treatment care planning
143641|NCT03304132|Oral Microbiome|oral microbiome
143642|NCT03304132|reflux disorders|reflux disorders
143643|NCT03304132|esophageal microbiome|esophageal microbiome
143644|NCT03304132|Alcohol Use|alcohol use
143645|NCT03304132|Tobacco Use|tobacco use
143646|NCT03304119|Torsion of tibial tuberosity|torsion of tibial tuberosity
143647|NCT03304119|Recurrent patellar dislocation|recurrent patellar dislocation
143648|NCT03304119|MRI Measurements|mri measurements
143649|NCT03304119|Patellar instability|patellar instability
143650|NCT03304119|Patellar dislocation|patellar dislocation
143651|NCT03304119|Tibial tubercle position|tibial tubercle position
143652|NCT03304119|Tibial tubercle torsion|tibial tubercle torsion
143653|NCT03304093|IFCT|ifct
143654|NCT03304093|VIH|vih
143655|NCT03304093|Nivolumab|nivolumab
143656|NCT03304093|NSCLC|nsclc
143657|NCT03304080|Breast Neoplasms|breast neoplasms
143658|NCT03304080|Breast Diseases|breast diseases
143659|NCT03304080|Palbociclib|palbociclib
143660|NCT03304080|Trastuzumab|trastuzumab
143661|NCT03304080|Pertuzumab|pertuzumab
143662|NCT03304080|Hormone Antagonists|hormone antagonists
143663|NCT03304080|Anastrozole|anastrozole
143664|NCT03304080|Arimidex|arimidex
143665|NCT03304080|Ibrance|ibrance
143666|NCT03304080|Perjeta|perjeta
143667|NCT03304054|MuSK antibody positive|musk antibody positive
143668|NCT03304041|low-FODMAP|low-fodmap
143669|NCT03304041|Irritable Bowel Syndrome|irritable bowel syndrome
143670|NCT03304041|stool fermentation|stool fermentation
143671|NCT03304041|Breath test|breath test
143672|NCT03304028|Connected Devices|connected devices
143673|NCT03304028|Pulmonary Exacerbations|pulmonary exacerbations
143674|NCT03304028|Cumulative Sum (CUSUM) Chart|cumulative sum (cusum) chart
143675|NCT03304015|Intervention|intervention
143676|NCT03304015|Violence against Women|violence against women
143677|NCT03304015|Female Garment Workers|female garment workers
143678|NCT03304015|Bangladesh|bangladesh
143679|NCT03303976|pneumococcal vaccine|pneumococcal vaccine
143680|NCT03303976|bioconjugate|bioconjugate
143681|NCT03303963|culture-free|culture-free
143682|NCT03303963|tuberculosis|tuberculosis
143683|NCT03303963|multidrug resistant|multidrug resistant
143684|NCT03303963|diagnosis|diagnosis
143685|NCT03303963|follow-up|follow-up
143686|NCT03303963|africa|africa
143687|NCT03303963|molecular tools|molecular tools
143688|NCT03303937|virulence factor genes;|virulence factor genes;
143689|NCT03303937|phenotyping|phenotyping
143690|NCT03303937|genotyping|genotyping
143691|NCT03303937|antimicrobial susceptibility|antimicrobial susceptibility
143692|NCT03303924|Pharmacokinetic|pharmacokinetic
143693|NCT03303924|Bronchoalveolar Lavage|bronchoalveolar lavage
143694|NCT03303924|Epithelial Lining Fluid|epithelial lining fluid
143695|NCT03303924|Alveolar Macrophage|alveolar macrophage
143696|NCT03303924|Gram-negative bacterium|gram-negative bacterium
143697|NCT03303924|Acinetobacter baumannii|acinetobacter baumannii
143698|NCT03303872|atrial high rate episode|atrial high rate episode
143699|NCT03303872|pacemaker|pacemaker
144294|NCT03299842|seizure|seizure
143700|NCT03303872|atrial fibrillation|atrial fibrillation
143701|NCT03303872|stroke|stroke
143702|NCT03303859|Bacterial vaginosis, preterm delivery, Martinique, stress|bacterial vaginosis, preterm delivery, martinique, stress
143703|NCT03303833|Lifestyle|lifestyle
143704|NCT03303833|Nutrition|nutrition
143705|NCT03303807|Extracorporeal CO2 removal (ECCO2-R)|extracorporeal co2 removal (ecco2-r)
143706|NCT03303807|ARDS|ards
143707|NCT03303794|Total Knee arthroplasty|total knee arthroplasty
143708|NCT03303794|bupivacaine|bupivacaine
143709|NCT03303794|anesthesia|anesthesia
143710|NCT03303729|Carbohydrate|carbohydrate
143711|NCT03303729|Cluster Dextrin|cluster dextrin
143712|NCT03303729|Exercise training|exercise training
143713|NCT03303729|Protein supplement|protein supplement
143714|NCT03303703|cardiac rehabilitation|cardiac rehabilitation
143715|NCT03303677|endoscopic sinus surgery|endoscopic sinus surgery
143716|NCT03303677|topical nasal therapy|topical nasal therapy
143717|NCT03303664|opioid|opioid
143718|NCT03303664|inpatient|inpatient
143719|NCT03303664|pain|pain
143720|NCT03303664|multimodal|multimodal
143721|NCT03303651|Analgesia, Monitoring, Opioid, Sufentanil, Sevoflurane|analgesia, monitoring, opioid, sufentanil, sevoflurane
143722|NCT03303638|Multi-sensory environment|multi-sensory environment
143723|NCT03303638|Snoezelen|snoezelen
143724|NCT03303638|Bathing|bathing
143725|NCT03303638|Showering|showering
143726|NCT03303638|Tub Bathing|tub bathing
143727|NCT03303599|Chronic Hepatitis C|chronic hepatitis c
143728|NCT03303599|Sustained Virological Response|sustained virological response
143729|NCT03303599|Chronic Hepatitis C genotype 1|chronic hepatitis c genotype 1
143730|NCT03303599|Chronic Hepatitis C genotype 2|chronic hepatitis c genotype 2
143731|NCT03303599|Chronic Hepatitis C genotype 3|chronic hepatitis c genotype 3
143732|NCT03303599|Chronic Hepatitis C genotype 4|chronic hepatitis c genotype 4
143733|NCT03303599|Chronic Hepatitis C genotype 5|chronic hepatitis c genotype 5
143734|NCT03303599|Chronic Hepatitis C genotype 6|chronic hepatitis c genotype 6
143735|NCT03303599|Hepatitis C|hepatitis c
143736|NCT03303586|Asthma|asthma
143737|NCT03303586|Fluid Shift|fluid shift
143738|NCT03303586|Compression stockings|compression stockings
143739|NCT03303586|intrathoracic airway narrowing|intrathoracic airway narrowing
143740|NCT03303573|Erythropoeitin|erythropoeitin
143741|NCT03303547|MRI|mri
143742|NCT03303547|Tissue|tissue
143743|NCT03303547|Imaging|imaging
143744|NCT03303547|Pathology|pathology
143745|NCT03303547|Rectal|rectal
143746|NCT03303547|Cancer|cancer
143747|NCT03303534|inflammation|inflammation
143748|NCT03303534|hydrogen sulfide|hydrogen sulfide
143749|NCT03303534|caloric restriction|caloric restriction
143750|NCT03303534|vascular surgery|vascular surgery
143751|NCT03303495|FOLFIRI|folfiri
143752|NCT03303495|CPT-11|cpt-11
143753|NCT03303495|Bevacizumab|bevacizumab
143754|NCT03303495|2nd-line metastatic colorectal cancer|2nd-line metastatic colorectal cancer
143755|NCT03303456|early psychosis|early psychosis
143756|NCT03303456|clinical high risk|clinical high risk
143757|NCT03303456|mobile health|mobile health
143758|NCT03303430|cerebral microembolisation|cerebral microembolisation
143759|NCT03303430|plaque characteristics|plaque characteristics
143760|NCT03303417|Kiwifruit|kiwifruit
143761|NCT03303378|melatonin|melatonin
143762|NCT03303378|Reperfusion Injury|reperfusion injury
143763|NCT03303378|myocardial infarction|myocardial infarction
143764|NCT03303365|Brain Metastases|brain metastases
143765|NCT03303365|WBRT (whole brain radiotherapy)|wbrt (whole brain radiotherapy)
143766|NCT03303365|SRS (stereotactic radiosurgery)|srs (stereotactic radiosurgery)
143767|NCT03303365|CYBER-Knife|cyber-knife
143768|NCT03303339|PLK1|plk1
143769|NCT03303339|PLK Inhibitor|plk inhibitor
143770|NCT03303339|Onvansertib|onvansertib
143771|NCT03303326|sexual health|sexual health
143772|NCT03303313|RNAi therapeutic|rnai therapeutic
143773|NCT03303313|Atypical Hemolytic Uremic Syndrome|atypical hemolytic uremic syndrome
143774|NCT03303313|Hemolysis|hemolysis
143775|NCT03303313|Thrombocytopenia|thrombocytopenia
143776|NCT03303313|Renal insufficiency|renal insufficiency
143777|NCT03303313|Thrombotic Microangiopathy|thrombotic microangiopathy
143778|NCT03303313|aHUS|ahus
143779|NCT03303313|TMA|tma
143780|NCT03303287|health education|health education
143781|NCT03303235|methylergonovine|methylergonovine
143782|NCT03303209|opioid|opioid
143783|NCT03303209|opioids|opioids
143784|NCT03303209|taper|taper
143785|NCT03303209|chronic pain|chronic pain
143786|NCT03303196|Post-Pancreatectomy Diabetes|post-pancreatectomy diabetes
143787|NCT03303196|Insulin Therapy|insulin therapy
143788|NCT03303144|Pharmacokinetics|pharmacokinetics
143789|NCT03303144|Equivalence|equivalence
143790|NCT03303118|Hypoxia|hypoxia
143791|NCT03303118|Brain|brain
143792|NCT03303118|Cerebral vaso-reactivity|cerebral vaso-reactivity
143793|NCT03303118|EEG|eeg
143794|NCT03303118|Concentration performance|concentration performance
143795|NCT03303118|Cerebral oxygenation|cerebral oxygenation
143796|NCT03303118|Cerebral blood-flow|cerebral blood-flow
143797|NCT03303118|Heart rate variability|heart rate variability
143798|NCT03303066|Myelodysplastic Syndromes|myelodysplastic syndromes
143799|NCT03303066|Anemia|anemia
183479|NCT03049176|ART|art
143800|NCT03303066|Hemoglobin (Hb)|hemoglobin (hb)
143801|NCT03303066|Low Risk Myelodysplastic Syndrome|low risk myelodysplastic syndrome
143802|NCT03303053|Hyperthyroidism,Graves disease,Cholestyramine,Prednisolone|hyperthyroidism,graves disease,cholestyramine,prednisolone
143803|NCT03303040|Mechanical ventilation|mechanical ventilation
143804|NCT03303040|Diaphragm weakness|diaphragm weakness
143805|NCT03303040|Difficulty weaning from mechanical ventilation|difficulty weaning from mechanical ventilation
143806|NCT03303040|Diaphragm stimulation|diaphragm stimulation
143807|NCT03303027|Cosmesis|cosmesis
143808|NCT03303027|Surgical Wound|surgical wound
143809|NCT03303027|Fast Absorbing Gut|fast absorbing gut
143810|NCT03303027|Linear Cutaneous Wound|linear cutaneous wound
143811|NCT03303014|Suture|suture
143812|NCT03303014|Absorbable|absorbable
143813|NCT03303014|Non-absorbable|non-absorbable
143814|NCT03303014|Split wound|split wound
143815|NCT03303014|Cutaneous Wound|cutaneous wound
143816|NCT03303001|subacromial infiltration|subacromial infiltration
143817|NCT03303001|high volumen|high volumen
143818|NCT03303001|shoulder pain|shoulder pain
143819|NCT03302988|Wound Edge Eversion|wound edge eversion
143820|NCT03302988|Dermal Sutures|dermal sutures
143821|NCT03302975|Running|running
143822|NCT03302975|Biomechanics|biomechanics
143823|NCT03302975|Kinetics|kinetics
143824|NCT03302962|asthma|asthma
143825|NCT03302962|pediatric|pediatric
143826|NCT03302962|american indian|american indian
143827|NCT03302962|children|children
143828|NCT03302949|Nutritional Supplement|nutritional supplement
143829|NCT03302949|Health-related Quality of Life|health-related quality of life
143830|NCT03302949|Dietary Intake|dietary intake
143831|NCT03302936|Midurethral sling|midurethral sling
143832|NCT03302936|Pyridium|pyridium
143833|NCT03302923|Nursing home residents|nursing home residents
143834|NCT03302923|Brisk walking|brisk walking
143835|NCT03302910|Acute Heart Failure, Chronic Heart Failure, Heart Failure, Heart conditions, nitroglycerin|acute heart failure, chronic heart failure, heart failure, heart conditions, nitroglycerin
143836|NCT03302897|Leprosy, vaccine, adjuvant, GLA, GLA-SE|leprosy, vaccine, adjuvant, gla, gla-se
143837|NCT03302871|cerebral palsy|cerebral palsy
143838|NCT03302871|botulinum toxin A|botulinum toxin a
143839|NCT03302871|constraint induced movement therapy|constraint induced movement therapy
143840|NCT03302871|transcranial direct current stimulation|transcranial direct current stimulation
143841|NCT03302832|Total Knee Arthroplasty|total knee arthroplasty
143842|NCT03302832|Total Knee Replacement|total knee replacement
143843|NCT03302806|disability|disability
143844|NCT03302806|EDSS|edss
143845|NCT03302767|Oncology|oncology
143846|NCT03302767|Work Keeping|work keeping
143847|NCT03302767|Social difficulties|social difficulties
143848|NCT03302767|Cognitive Disorders|cognitive disorders
143849|NCT03302741|stroke|stroke
143850|NCT03302728|CD 30 positive, relapsed, refractory|cd 30 positive, relapsed, refractory
143851|NCT03302702|exercise|exercise
143852|NCT03302702|duration|duration
143853|NCT03302689|TAP-block|tap-block
143854|NCT03302689|VAS of pain|vas of pain
143855|NCT03302689|Cesarean section|cesarean section
143856|NCT03302689|Postoperative analgesia|postoperative analgesia
143857|NCT03302676|Saliva substitute|saliva substitute
143858|NCT03302663|Fetal bone heart abnormality|fetal bone heart abnormality
143859|NCT03302624|acute kidney injury|acute kidney injury
143860|NCT03302624|quality of life|quality of life
143861|NCT03302624|Renal replacement therapy|renal replacement therapy
143862|NCT03302624|Intensive care unit|intensive care unit
143863|NCT03302611|major depressive disorder|major depressive disorder
143864|NCT03302611|military|military
143865|NCT03302611|surf therapy|surf therapy
143866|NCT03302611|hike therapy|hike therapy
143867|NCT03302611|randomized controlled trial|randomized controlled trial
143868|NCT03302598|enterocutaneous fistula - C-reactive protein- surgical repair|enterocutaneous fistula - c-reactive protein- surgical repair
143869|NCT03302585|Optic Neuritis|optic neuritis
143870|NCT03302585|Vitamin D|vitamin d
143871|NCT03302572|primary care|primary care
143872|NCT03302572|advance directives|advance directives
143873|NCT03302572|randomized controlled trial|randomized controlled trial
143874|NCT03302533|distal humerus fracture|distal humerus fracture
143875|NCT03302533|total elbow arthroplasty|total elbow arthroplasty
143876|NCT03302533|elbow prosthesis|elbow prosthesis
143877|NCT03302533|delayed arthroplasty|delayed arthroplasty
143878|NCT03302533|revision surgery|revision surgery
143879|NCT03302494|Non-valvular Atrial Fibrillation|non-valvular atrial fibrillation
143880|NCT03302494|Left Atrial Appendage|left atrial appendage
143881|NCT03302481|Obesity surgery|obesity surgery
143882|NCT03302481|liver|liver
143883|NCT03302481|mitochondria|mitochondria
143884|NCT03302481|steatosis|steatosis
143885|NCT03302455|insomia|insomia
143886|NCT03302455|eCBTI|ecbti
143887|NCT03302455|internet|internet
143888|NCT03302455|psychotherapy|psychotherapy
143889|NCT03302455|guided self-help|guided self-help
143890|NCT03302455|psychological treatment|psychological treatment
143891|NCT03302429|Alveolar cleft -Platelet rich fibrin- calcium phosphate|alveolar cleft -platelet rich fibrin- calcium phosphate
143892|NCT03302377|Feasibility|feasibility
143893|NCT03302338|Feeding intolerance|feeding intolerance
143894|NCT03302338|Simulated amniotic fluid like solution|simulated amniotic fluid like solution
143895|NCT03302338|Necrotizing enterocolitis|necrotizing enterocolitis
143896|NCT03302325|stage IV solid tumor|stage iv solid tumor
143897|NCT03302312|Posttraumatic Stress Disorder|posttraumatic stress disorder
143898|NCT03302312|Generalized Anxiety Disorder|generalized anxiety disorder
143899|NCT03302312|Depression|depression
143900|NCT03302312|Distress|distress
143901|NCT03302312|Alcohol Use|alcohol use
143902|NCT03302312|Pain|pain
143903|NCT03302299|Adherence|adherence
143904|NCT03302299|Hepatotoxicity|hepatotoxicity
143905|NCT03302299|Phosphatidtylethanol|phosphatidtylethanol
143906|NCT03302286|Heart-Lung Machine|heart-lung machine
143907|NCT03302286|Cardiopulmonary Bypass|cardiopulmonary bypass
143908|NCT03302273|stem cell therapy|stem cell therapy
143909|NCT03302273|dry eye disease|dry eye disease
143910|NCT03302260|maternal health|maternal health
143911|NCT03302260|pregnancy|pregnancy
143912|NCT03302260|pre-eclampsia|pre-eclampsia
143913|NCT03302234|Programmed Cell Death Receptor 1 (PD-1)|programmed cell death receptor 1 (pd-1)
143914|NCT03302234|Programmed Cell Death Receptor Ligand 1 (PD-L1)|programmed cell death receptor ligand 1 (pd-l1)
143915|NCT03302234|Cytotoxic T-lymphocyte-associated protein 4 (CTLA4)|cytotoxic t-lymphocyte-associated protein 4 (ctla4)
143916|NCT03302234|PD1|pd1
143917|NCT03302234|PD-1|pd-1
143918|NCT03302234|PDL1|pdl1
143919|NCT03302234|PD-L1|pd-l1
143920|NCT03302234|CTLA4|ctla4
143921|NCT03302208|General Anesthesia|general anesthesia
143922|NCT03302195|Heparin|heparin
143923|NCT03302195|Allogeneic blood product transfusions|allogeneic blood product transfusions
143924|NCT03302195|Bleeding|bleeding
143925|NCT03302195|Cardiac surgery|cardiac surgery
143926|NCT03302195|Obesity|obesity
143927|NCT03302169|Prostate Cancer|prostate cancer
143928|NCT03302169|Urinary incontinence|urinary incontinence
143929|NCT03302169|Radical prostatectomy|radical prostatectomy
143930|NCT03302169|Rhabdosphincter|rhabdosphincter
143931|NCT03302169|Robotic Surgery|robotic surgery
143932|NCT03302156|Uterine cancer|uterine cancer
143933|NCT03302156|Ovarian cancer|ovarian cancer
143934|NCT03302156|Hysterectomy|hysterectomy
143935|NCT03302156|Salpingo-oophorectomy|salpingo-oophorectomy
143936|NCT03302143|Dental Implant|dental implant
143937|NCT03302143|Guided Bone Regeneration|guided bone regeneration
143938|NCT03302143|Contour Augmentation|contour augmentation
143939|NCT03302117|Wood smoke|wood smoke
143940|NCT03302117|Bronchoscopy|bronchoscopy
143941|NCT03302065|inhalation|inhalation
143942|NCT03302065|anticholinergic|anticholinergic
143943|NCT03302026|nicotine treatment|nicotine treatment
143944|NCT03302026|real time fMRI|real time fmri
143945|NCT03302013|Arthroplasty|arthroplasty
143946|NCT03302013|Knee|knee
143947|NCT03302013|Bicruciate retaining|bicruciate retaining
143948|NCT03302013|Vanguard XP|vanguard xp
143949|NCT03302013|Vanguard CR|vanguard cr
143950|NCT03302013|Surgery|surgery
143951|NCT03302013|Zimmer Biomet|zimmer biomet
143952|NCT03302013|Joint Replacement|joint replacement
143953|NCT03302013|Osteoarthritis|osteoarthritis
143954|NCT03302000|prematurity|prematurity
143955|NCT03302000|sensory stimulation|sensory stimulation
143956|NCT03302000|rehabilitation|rehabilitation
143957|NCT03302000|infant|infant
143958|NCT03301961|Circulating Tumor DNA|circulating tumor dna
143959|NCT03301961|Early diagnosis|early diagnosis
143960|NCT03301961|Surveillance|surveillance
143961|NCT03301961|Methylation|methylation
143962|NCT03301961|Somatic mutation|somatic mutation
143963|NCT03301935|Risk assessment|risk assessment
143964|NCT03301922|Occupational Health Services|occupational health services
143965|NCT03301922|Metacognitive therapy|metacognitive therapy
143966|NCT03301922|Work focused therapy|work focused therapy
143967|NCT03301922|Sick leave|sick leave
143968|NCT03301896|Phase I|phase i
143969|NCT03301896|LHC165|lhc165
143970|NCT03301896|PDR001|pdr001
143971|NCT03301896|intratumoral injection|intratumoral injection
143972|NCT03301896|abscopal|abscopal
143973|NCT03301896|checkpoint inhibitor|checkpoint inhibitor
143974|NCT03301896|programmed cell death|programmed cell death
143975|NCT03301896|PD-1|pd-1
143976|NCT03301896|TLR-7|tlr-7
143977|NCT03301896|toll-like receptor|toll-like receptor
143978|NCT03301896|melanoma|melanoma
143979|NCT03301896|head and neck|head and neck
143980|NCT03301831|Parents|parents
143981|NCT03301831|Technology-Dependent Child|technology-dependent child
143982|NCT03301831|Resourcefulness|resourcefulness
143983|NCT03301792|Group prenatal care|group prenatal care
143984|NCT03301792|Diabetes|diabetes
143985|NCT03301779|Red Blood Cells|red blood cells
143986|NCT03301766|lidocaine|lidocaine
143987|NCT03301740|Ultrafiltration profiling|ultrafiltration profiling
143988|NCT03301740|Hemodialysis|hemodialysis
143989|NCT03301740|Dialysis|dialysis
143990|NCT03301740|Cardiovascular outcomes|cardiovascular outcomes
143991|NCT03301740|Patient-reported outcomes|patient-reported outcomes
143992|NCT03301740|Crossover study design|crossover study design
143993|NCT03301740|End Stage Renal Disease|end stage renal disease
143994|NCT03301740|Ultrafiltration|ultrafiltration
143995|NCT03301740|Echocardiogram|echocardiogram
143996|NCT03301740|Blood pressure|blood pressure
143997|NCT03301740|Hypotension|hypotension
143998|NCT03301740|Symptoms|symptoms
143999|NCT03301714|motivational interviewing|motivational interviewing
144000|NCT03301714|elderly|elderly
144001|NCT03301714|oral health|oral health
144002|NCT03301688|PD-1 antibody|pd-1 antibody
144003|NCT03301688|phase 1 trial|phase 1 trial
144004|NCT03301675|Orange juice|orange juice
144005|NCT03301675|Healthy diet|healthy diet
144006|NCT03301675|Metabolic syndrome|metabolic syndrome
144007|NCT03301675|Cardiometabolic risk factors|cardiometabolic risk factors
144008|NCT03301675|Body composition|body composition
144009|NCT03301662|atrial fibrillation|atrial fibrillation
144010|NCT03301662|cryptogenic stroke|cryptogenic stroke
144011|NCT03301662|ECG screening|ecg screening
144012|NCT03301662|health-related quality of life|health-related quality of life
144013|NCT03301662|Short Form-36|short form-36
144014|NCT03301662|stroke|stroke
144015|NCT03301662|thumb-ECG|thumb-ecg
144016|NCT03301636|Melanoma, Metastaic Melanoma|melanoma, metastaic melanoma
144017|NCT03301623|Clinical Decision Support|clinical decision support
144018|NCT03301623|Patient Education Materials|patient education materials
144019|NCT03301623|Opioid Use|opioid use
144020|NCT03301623|Chronic Noncancer Pain|chronic noncancer pain
144021|NCT03301610|Pain Education|pain education
144022|NCT03301610|Information Delivery|information delivery
144023|NCT03301610|Mobile Application|mobile application
144024|NCT03301597|Chemotherapy-induced Neutropenia|chemotherapy-induced neutropenia
144025|NCT03301597|Bacterial Infections|bacterial infections
144026|NCT03301597|Fungal Infections|fungal infections
144027|NCT03301584|Hip fracture|hip fracture
144028|NCT03301584|ADL|adl
144029|NCT03301584|patient participation|patient participation
144030|NCT03301584|functional balance|functional balance
144031|NCT03301584|physical performance|physical performance
144032|NCT03301571|Coronary artery bypass graft|coronary artery bypass graft
144033|NCT03301571|Echocardiography|echocardiography
144034|NCT03301545|Bariatric surgery|bariatric surgery
144035|NCT03301545|Obesity|obesity
144036|NCT03301545|Type 2 Diabetes Mellitus|type 2 diabetes mellitus
144037|NCT03301545|Indigenous Population|indigenous population
144038|NCT03301545|Randomized Control Trial|randomized control trial
144039|NCT03301545|Glycoslyated Hemoglobin A1C|glycoslyated hemoglobin a1c
144040|NCT03301545|Anthropometric measurements|anthropometric measurements
144041|NCT03301545|Medication Use|medication use
144042|NCT03301532|G1D, glucose, transporter|g1d, glucose, transporter
144043|NCT03301506|PBC|pbc
144044|NCT03301506|Primary Biliary Cholangitis (PBC)|primary biliary cholangitis (pbc)
144045|NCT03301467|C3 Glomerulonephritis|c3 glomerulonephritis
144046|NCT03301467|C3 glomerulopathy|c3 glomerulopathy
144047|NCT03301467|C3G|c3g
144048|NCT03301467|DDD|ddd
144049|NCT03301467|dense deposit disease|dense deposit disease
144050|NCT03301467|membranoproliferative glomerulonephritis|membranoproliferative glomerulonephritis
144051|NCT03301467|MPGN|mpgn
144052|NCT03301467|C3GN|c3gn
144053|NCT03301467|idiopathic MPGN|idiopathic mpgn
144054|NCT03301441|migraine|migraine
144055|NCT03301441|migraine with aura|migraine with aura
144056|NCT03301441|migraine without aura|migraine without aura
144057|NCT03301441|ischemic stroke|ischemic stroke
144058|NCT03301441|Mismatch|mismatch
144059|NCT03301415|Asymptomatic|asymptomatic
144060|NCT03301415|Congenital CMV Infection|congenital cmv infection
144061|NCT03301415|Valganciclovir Therapy|valganciclovir therapy
144062|NCT03301337|Amino acid uptake|amino acid uptake
144063|NCT03301337|Aging|aging
144064|NCT03301337|Meat protein|meat protein
144065|NCT03301324|intubation|intubation
144066|NCT03301272|Parkinson, Botox, Tremor|parkinson, botox, tremor
144067|NCT03301259|Necrotic pulp|necrotic pulp
144068|NCT03301259|wave-one|wave-one
144069|NCT03301259|one-shape|one-shape
144070|NCT03301259|periapical lesion|periapical lesion
144071|NCT03301194|Hypertension|hypertension
144072|NCT03301194|Effectiveness|effectiveness
144073|NCT03301194|Cost Effectiveness|cost effectiveness
144074|NCT03301194|Cost|cost
144075|NCT03301194|Multi-disciplinary|multi-disciplinary
144076|NCT03301194|Risk Stratification|risk stratification
144077|NCT03301168|ALL|all
144078|NCT03301168|AML|aml
144079|NCT03301168|hematologic neoplasms|hematologic neoplasms
144080|NCT03301168|hematologic malignancies|hematologic malignancies
144081|NCT03301168|primary immune deficiences|primary immune deficiences
144082|NCT03301168|allogeneic stem cell transplant|allogeneic stem cell transplant
144083|NCT03301142|urinary stress incontinence|urinary stress incontinence
144084|NCT03301142|urinary incontinence,stress|urinary incontinence,stress
144085|NCT03301142|laser|laser
144086|NCT03301142|physiotherapy|physiotherapy
144087|NCT03301142|kinesiotherapy|kinesiotherapy
144088|NCT03301116|Exercise|exercise
144089|NCT03301116|Frail Elderly|frail elderly
144090|NCT03301116|Homebound Persons|homebound persons
144091|NCT03301116|Activities of Daily Living|activities of daily living
144092|NCT03301116|Mobility Limitation|mobility limitation
144093|NCT03301116|Home Care Services|home care services
144094|NCT03301116|Long-Term Care|long-term care
144095|NCT03301116|Dual MEDICAID MEDICARE Eligibility|dual medicaid medicare eligibility
144096|NCT03301103|Nutrition|nutrition
144097|NCT03301103|Gastroenteritis|gastroenteritis
144098|NCT03301103|Traveler's diarrhea|traveler's diarrhea
144099|NCT03301103|E. coli|e. coli
144100|NCT03301090|Adults|adults
144101|NCT03301090|Evaluate|evaluate
144102|NCT03301090|Healthy|healthy
144103|NCT03301090|Immunogenicity|immunogenicity
144104|NCT03301090|MERS-CoV|mers-cov
144105|NCT03301090|Pharmacokinetics|pharmacokinetics
144106|NCT03301090|Phase I|phase i
144107|NCT03301090|Placebo|placebo
144108|NCT03301090|REGN MERS|regn mers
144109|NCT03301090|Safety|safety
144110|NCT03301090|Tolerability|tolerability
144111|NCT03301077|children and adolescents|children and adolescents
144112|NCT03301077|mental health|mental health
144113|NCT03301077|epidemiology|epidemiology
144114|NCT03301077|psychiatric disorders|psychiatric disorders
144115|NCT03301064|alcohol, intervention, Latino, community|alcohol, intervention, latino, community
144116|NCT03301051|Influenza|influenza
144117|NCT03301051|Human|human
144118|NCT03301051|RNA Virus Infections|rna virus infections
144119|NCT03301051|Efficacy|efficacy
144120|NCT03301051|Immunologic|immunologic
144121|NCT03301051|Immunogenic Factors|immunogenic factors
144122|NCT03301051|Physiological Effects of Drug|physiological effects of drug
144123|NCT03301051|Virus Diseases|virus diseases
144124|NCT03301051|Orthomyxoviridae Infections|orthomyxoviridae infections
144125|NCT03301051|Infection|infection
144126|NCT03301038|hypercalcemia|hypercalcemia
144127|NCT03301038|nephrocalcinosis|nephrocalcinosis
144128|NCT03301038|CYP24A1|cyp24a1
144129|NCT03301038|hypercalciuria|hypercalciuria
144130|NCT03301025|Pregabalin, hypotensive anesthesia, blood loss, analgesia|pregabalin, hypotensive anesthesia, blood loss, analgesia
144131|NCT03301012|Adolescent|adolescent
144132|NCT03301012|Relapse Prevention|relapse prevention
144133|NCT03301012|Smartphone|smartphone
144134|NCT03301012|Recovery Support|recovery support
144135|NCT03300999|ginger tea|ginger tea
144136|NCT03300973|urodynamic study|urodynamic study
144137|NCT03300973|stress urinary incontinence|stress urinary incontinence
144138|NCT03300882|Study co-enrollment (CTOT-20 and CTOT-22)|study co-enrollment (ctot-20 and ctot-22)
144139|NCT03300882|cytomegalovirus (CMV)|cytomegalovirus (cmv)
144140|NCT03300882|CMV seropositive positive recipient|cmv seropositive positive recipient
144141|NCT03300882|CMV infection|cmv infection
144142|NCT03300882|CMV-specific immunity|cmv-specific immunity
144143|NCT03300882|immunologic monitoring|immunologic monitoring
144144|NCT03300869|Spinal Muscular Atrophy|spinal muscular atrophy
144145|NCT03300869|Natural History|natural history
144146|NCT03300856|Transcranial Magnetic Stimulation (TMS)|transcranial magnetic stimulation (tms)
144147|NCT03300856|Electrophysiology|electrophysiology
144148|NCT03300843|Cell Therapy|cell therapy
144149|NCT03300843|Immunotherapy|immunotherapy
144150|NCT03300843|Vaccines|vaccines
144151|NCT03300830|Immunodeficiency|immunodeficiency
144152|NCT03300830|Viral-Associated Cancer|viral-associated cancer
144153|NCT03300830|Kaposi Sarcoma Herpes Virus|kaposi sarcoma herpes virus
144154|NCT03300830|Idiopathic Castleman Disease|idiopathic castleman disease
144155|NCT03300830|Endogenous Retroviruses|endogenous retroviruses
144157|NCT03300791|heart failure|heart failure
144158|NCT03300791|readmission|readmission
144159|NCT03300791|predictive models|predictive models
144160|NCT03300778|neurocognition|neurocognition
144161|NCT03300778|high-risk|high-risk
144162|NCT03300778|prognosis|prognosis
144163|NCT03300765|Thyroid Cancer|thyroid cancer
144164|NCT03300765|Apatinib|apatinib
144165|NCT03300765|Intensity modulated radiation therapy|intensity modulated radiation therapy
144166|NCT03300726|Synaptic injury|synaptic injury
144167|NCT03300713|Mass screening|mass screening
144168|NCT03300713|Pediatrician training|pediatrician training
144169|NCT03300648|coma|coma
144170|NCT03300648|pediatrics|pediatrics
144171|NCT03300583|Interstitial lung disease|interstitial lung disease
144172|NCT03300583|Self-Management|self-management
144173|NCT03300583|Service provision|service provision
144174|NCT03300531|Pure Platelet-rich Plasma|pure platelet-rich plasma
144175|NCT03300531|Randomized Controlled Trial|randomized controlled trial
144176|NCT03300518|GnRH antagonist|gnrh antagonist
144177|NCT03300518|Estrogen pretreatment|estrogen pretreatment
144178|NCT03300518|Poor response patient|poor response patient
144179|NCT03300492|Natural Killer cells|natural killer cells
144180|NCT03300492|NK cells|nk cells
144181|NCT03300492|Immunotherapy|immunotherapy
144182|NCT03300492|haploidentical hematopoietic stem cell transplantation|haploidentical hematopoietic stem cell transplantation
144183|NCT03300479|nontraumatic intracerebral hemorrhage|nontraumatic intracerebral hemorrhage
183972|NCT03045718|Elderly|elderly
144184|NCT03300479|Cleviprex®|cleviprex®
144185|NCT03300479|Ebrantil®|ebrantil®
144186|NCT03300479|Systolic blood pressure|systolic blood pressure
144187|NCT03300466|Hyaluronic Acid, Lidocaine|hyaluronic acid, lidocaine
144188|NCT03300427|Heart failure with reduced left ventricular ejection fraction|heart failure with reduced left ventricular ejection fraction
144189|NCT03300427|LVEF|lvef
144190|NCT03300427|Cardiac dysfunction|cardiac dysfunction
144191|NCT03300427|Heart muscle dysfunction|heart muscle dysfunction
144192|NCT03300427|Left ventricular (LV) dilation|left ventricular (lv) dilation
144193|NCT03300427|Left ventricular hypertrophy|left ventricular hypertrophy
144194|NCT03300427|HF|hf
144195|NCT03300427|AHF|ahf
144196|NCT03300427|CHF|chf
144197|NCT03300427|CCF|ccf
144198|NCT03300427|acute heart failure|acute heart failure
144199|NCT03300427|chronic heart failure|chronic heart failure
144200|NCT03300427|congestive heart failure|congestive heart failure
144201|NCT03300427|congestive cardiac failure|congestive cardiac failure
144202|NCT03300388|Insulin resistance|insulin resistance
144203|NCT03300388|Exercise|exercise
144204|NCT03300388|Omega-3 fatty acids|omega-3 fatty acids
144205|NCT03300388|Adipose tissue|adipose tissue
144206|NCT03300349|Breast cancer|breast cancer
144207|NCT03300349|Breast cancer-related lymphedema|breast cancer-related lymphedema
144208|NCT03300349|Shoulder injury|shoulder injury
144209|NCT03300349|Prevention|prevention
144210|NCT03300349|Educational activity|educational activity
144211|NCT03300349|Physiotherapy|physiotherapy
144212|NCT03300336|Walking|walking
144213|NCT03300336|Inpatients|inpatients
144214|NCT03300336|Veterans|veterans
144215|NCT03300336|Early Ambulation|early ambulation
144216|NCT03300336|Quality of Life|quality of life
144217|NCT03300323|peri-operative|peri-operative
144218|NCT03300323|fluid|fluid
144219|NCT03300323|microcirculation|microcirculation
144220|NCT03300297|Temporomandibular joint|temporomandibular joint
144221|NCT03300297|Physical Therapy|physical therapy
144222|NCT03300297|Cervical spine thrust joint manipulation|cervical spine thrust joint manipulation
144223|NCT03300297|therapy, exercise|therapy, exercise
144224|NCT03300297|Temporomandibular Disorders|temporomandibular disorders
144225|NCT03300284|Quality of Life|quality of life
144226|NCT03300284|Decision Making|decision making
144227|NCT03300284|17-382|17-382
144228|NCT03300219|telerehabilitation|telerehabilitation
144229|NCT03300219|occupational therapy|occupational therapy
144230|NCT03300219|rct|rct
144231|NCT03300219|participation|participation
144232|NCT03300219|quality of life|quality of life
144233|NCT03300219|intervention|intervention
144234|NCT03300219|older adults|older adults
144235|NCT03300206|Breast Biopsy|breast biopsy
144236|NCT03300206|Breast Biopsy Imaging|breast biopsy imaging
144237|NCT03300206|Stereotactic Biopsy|stereotactic biopsy
144238|NCT03300193|Magnetic Resonance guided Focused Ultrasound|magnetic resonance guided focused ultrasound
144239|NCT03300193|Tremor|tremor
144240|NCT03300193|Essential Tremor|essential tremor
144241|NCT03300193|Parkinson's Disease|parkinson's disease
144242|NCT03300154|Cardiovascular risk|cardiovascular risk
144243|NCT03300154|Behavioral economics|behavioral economics
144244|NCT03300154|Text messages|text messages
144245|NCT03300154|Financial incentives|financial incentives
144246|NCT03300141|Upper Extremity|upper extremity
144247|NCT03300141|Rehabilitation|rehabilitation
144248|NCT03300141|Arm|arm
144249|NCT03300141|Robotics|robotics
144250|NCT03300141|Stroke Rehabilitation|stroke rehabilitation
144251|NCT03300141|Virtual Reality Thearpy|virtual reality thearpy
144252|NCT03300128|autism|autism
144253|NCT03300128|parenting|parenting
144254|NCT03300128|Incredible Years|incredible years
144255|NCT03300102|personalised medicine|personalised medicine
144256|NCT03300050|live attenuated influenza vaccine|live attenuated influenza vaccine
144257|NCT03300050|inactivated influenza vaccine|inactivated influenza vaccine
144258|NCT03300024|Hemodialysis|hemodialysis
144259|NCT03300024|Arteriovenous|arteriovenous
144260|NCT03300024|Graft|graft
144261|NCT03300024|polytetrafluoroethylene|polytetrafluoroethylene
144262|NCT03300024|Bovine|bovine
144263|NCT03300011|ultrasonic|ultrasonic
144264|NCT03300011|chronic total occlusion|chronic total occlusion
144265|NCT03300011|heart function|heart function
144266|NCT03299985|Gastroesophageal reflux Disease|gastroesophageal reflux disease
144267|NCT03299985|Myofascial release|myofascial release
144268|NCT03299985|Diaphragm|diaphragm
144269|NCT03299972|Sarcopenia|sarcopenia
144270|NCT03299972|Resistance exercise|resistance exercise
144271|NCT03299972|Protein|protein
144272|NCT03299946|Nivolumab|nivolumab
144273|NCT03299946|Cabozantinib|cabozantinib
144274|NCT03299946|Neoadjuvant|neoadjuvant
144275|NCT03299946|Immunotherapy|immunotherapy
144276|NCT03299946|Liver Cancer|liver cancer
144277|NCT03299946|Borderline Resectable|borderline resectable
144278|NCT03299946|Advance Resectable|advance resectable
144279|NCT03299946|Neoplasms|neoplasms
144280|NCT03299946|Hepatocellular Carcinoma|hepatocellular carcinoma
144281|NCT03299946|HCC|hcc
144282|NCT03299946|Resection|resection
144283|NCT03299894|Sepsis|sepsis
144284|NCT03299894|Shock, septic|shock, septic
144285|NCT03299894|Emergency service, hospital|emergency service, hospital
144286|NCT03299894|Anti-infective agents|anti-infective agents
144287|NCT03299894|Outcome assessment|outcome assessment
144288|NCT03299868|Peripherally inserted central catheter|peripherally inserted central catheter
144289|NCT03299868|Terminally ill cancer patients|terminally ill cancer patients
144290|NCT03299868|Palliative care|palliative care
144291|NCT03299855|oncogeriatric|oncogeriatric
144292|NCT03299855|MMS|mms
144295|NCT03299842|tonic clonic|tonic clonic
144296|NCT03299842|epilepsy|epilepsy
144297|NCT03299842|myoclonic|myoclonic
144298|NCT03299842|encephalopathy|encephalopathy
144299|NCT03299829|trientine|trientine
144300|NCT03299829|Wilson's disease|wilson's disease
144301|NCT03299816|Chronic Kidney Disease|chronic kidney disease
144302|NCT03299816|Hypertension|hypertension
144303|NCT03299816|Albuminuria|albuminuria
144304|NCT03299816|African Americans|african americans
144305|NCT03299790|Type 2 diabetes|type 2 diabetes
144306|NCT03299790|Diabetic cardiomyopathy|diabetic cardiomyopathy
144307|NCT03299790|Cardiac function|cardiac function
144308|NCT03299790|Exercise echocardiography|exercise echocardiography
144309|NCT03299790|Exercise training|exercise training
144310|NCT03299751|neonatal sepsis|neonatal sepsis
144311|NCT03299751|biomarker combination|biomarker combination
144312|NCT03299751|diagnostic|diagnostic
144313|NCT03299751|antibiotic use|antibiotic use
144314|NCT03299751|newborn|newborn
144315|NCT03299751|preterm neonates|preterm neonates
144316|NCT03299751|NICU|nicu
144317|NCT03299686|Asthma, allergic, eosinophilic, non-T2 high|asthma, allergic, eosinophilic, non-t2 high
144318|NCT03299647|Attention-deficit/hyperactivity disorder|attention-deficit/hyperactivity disorder
144319|NCT03299647|behavioral deficits|behavioral deficits
144320|NCT03299647|cognitive function|cognitive function
144321|NCT03299647|polyunsaturated fatty acids|polyunsaturated fatty acids
144322|NCT03299647|visual memory|visual memory
144323|NCT03299582|paclitaxel|paclitaxel
144324|NCT03299582|neuropathy|neuropathy
144325|NCT03299582|hypothermia|hypothermia
144326|NCT03299582|cryocompression|cryocompression
144327|NCT03299556|Wearable Health Technology|wearable health technology
144328|NCT03299556|iPhone|iphone
144329|NCT03299556|Apple Watch|apple watch
144330|NCT03299556|Pain Medication|pain medication
144331|NCT03299543|beta-hydroxybutyrate|beta-hydroxybutyrate
144332|NCT03299543|breath acetone|breath acetone
144333|NCT03299530|Corneal Astigmatism|corneal astigmatism
144334|NCT03299530|Scheimpflug|scheimpflug
144335|NCT03299530|pupil size|pupil size
144336|NCT03299530|Toric|toric
144337|NCT03299517|lidocaine|lidocaine
144338|NCT03299517|amiodarone|amiodarone
144339|NCT03299491|Maternity Waiting Area|maternity waiting area
144340|NCT03299491|Ethiopia|ethiopia
144341|NCT03299491|Community Leader|community leader
144342|NCT03299491|Religious Leader|religious leader
144343|NCT03299491|Skilled birth attendance|skilled birth attendance
144344|NCT03299491|Postnatal care|postnatal care
144345|NCT03299491|Information, Education, Communication|information, education, communication
144346|NCT03299491|Safe Motherhood|safe motherhood
144347|NCT03299491|Health Extension Worker|health extension worker
144348|NCT03299491|Antenatal Care|antenatal care
144349|NCT03299465|bone marrow transplantation|bone marrow transplantation
144350|NCT03299465|yoga|yoga
144351|NCT03299452|ex vivo high-throughput drug screening assay|ex vivo high-throughput drug screening assay
144352|NCT03299426|Typhoid|typhoid
144353|NCT03299426|Typhoid in Malawi|typhoid in malawi
144354|NCT03299426|Typhoid Vaccine|typhoid vaccine
144355|NCT03299413|Inflammatory Bowel Disease|inflammatory bowel disease
144356|NCT03299413|Mesenchymal stem cells|mesenchymal stem cells
144357|NCT03299413|Ulcerative colitis|ulcerative colitis
144358|NCT03299413|Neutrophils|neutrophils
144359|NCT03299400|IOP|iop
144360|NCT03299387|urinary tract|urinary tract
144361|NCT03299387|infection|infection
144362|NCT03299387|recurrent|recurrent
144363|NCT03299387|women|women
144364|NCT03299374|Pilates|pilates
144365|NCT03299374|Balance|balance
144366|NCT03299374|Falls|falls
144367|NCT03299374|Older people|older people
144368|NCT03299361|Carpal tunnel syndrome|carpal tunnel syndrome
144369|NCT03299361|Corticosteroid|corticosteroid
144370|NCT03299361|Diffusion tensor imaging|diffusion tensor imaging
144371|NCT03299361|Injection|injection
144372|NCT03299361|Magnetic resonance image|magnetic resonance image
144373|NCT03299361|Ultrasound|ultrasound
144374|NCT03299348|Psychological Mechanisms|psychological mechanisms
144375|NCT03299348|Social-Cognitive Mechanisms|social-cognitive mechanisms
144376|NCT03299322|Bronchial Asthma，TCM，microorganism|bronchial asthma，tcm，microorganism
144377|NCT03299309|Glioma|glioma
144378|NCT03299309|Medulloblastoma|medulloblastoma
144379|NCT03299309|PRiME|prime
144380|NCT03299309|Pro00079843|pro00079843
144381|NCT03299309|Thompson|thompson
144382|NCT03299309|Pediatric|pediatric
144383|NCT03299309|Landi|landi
144384|NCT03299296|Thromboprophylaxis|thromboprophylaxis
144385|NCT03299296|orthopedic|orthopedic
144386|NCT03299296|rivaroxaban|rivaroxaban
144387|NCT03299296|enoxaparin|enoxaparin
144388|NCT03299270|Surgery|surgery
144389|NCT03299270|Solid malignancy|solid malignancy
144390|NCT03299270|Elderly|elderly
144391|NCT03299270|Functional recovery|functional recovery
144392|NCT03299257|OSA|osa
144393|NCT03299257|CPAP|cpap
144394|NCT03299257|sleepiness|sleepiness
144395|NCT03299257|donepezil|donepezil
144396|NCT03299231|COPD|copd
144397|NCT03299231|acute exacerbation|acute exacerbation
144398|NCT03299231|OPEP|opep
144399|NCT03299218|Specialized Nutritious Food (SNF)|specialized nutritious food (snf)
144400|NCT03299218|Social and Behaviour change communication (SBCC)|social and behaviour change communication (sbcc)
144401|NCT03299218|Cash-based transfers|cash-based transfers
144402|NCT03299140|Bipolar disorder|bipolar disorder
144403|NCT03299140|Children|children
144404|NCT03299140|Family Focused Therapy|family focused therapy
144405|NCT03299140|CBT|cbt
144406|NCT03299114|Neuropathic Pain|neuropathic pain
144407|NCT03299114|Whirlpool|whirlpool
144408|NCT03299114|Osteoarthritis|osteoarthritis
144409|NCT03299114|Sleep|sleep
144410|NCT03299101|Frailty|frailty
144411|NCT03299101|Prehabilitation|prehabilitation
144412|NCT03299101|Exercise therapy|exercise therapy
144413|NCT03299101|Surgery|surgery
144414|NCT03299101|Nutrition support|nutrition support
144415|NCT03299075|External eating|external eating
144416|NCT03299075|Technology|technology
144417|NCT03299075|Photography|photography
144418|NCT03299075|Social media|social media
144419|NCT03299049|Long acting Cabotegravir|long acting cabotegravir
144420|NCT03299049|Safety|safety
144421|NCT03299049|HIV-1|hiv-1
144422|NCT03299049|Efficacy|efficacy
144423|NCT03299049|Tolerability|tolerability
144424|NCT03299049|ATLAS-2M|atlas-2m
144425|NCT03299049|Long acting Rilpivirine|long acting rilpivirine
144426|NCT03299036|Hepatoma|hepatoma
144427|NCT03299036|Transcatheter Arterial chemo-embolization|transcatheter arterial chemo-embolization
144428|NCT03299036|Microsphere|microsphere
144429|NCT03299036|Doxorubicin|doxorubicin
144430|NCT03299023|Obstructive Sleep Apnea|obstructive sleep apnea
144431|NCT03299023|Orthodontics|orthodontics
144432|NCT03299023|Tooth Movement|tooth movement
144433|NCT03299023|Medibyte|medibyte
144434|NCT03299023|Apnea|apnea
144435|NCT03299023|Hypopnea|hypopnea
144436|NCT03299023|Sleep|sleep
144437|NCT03299023|Disturbed Breathing|disturbed breathing
144438|NCT03299010|Diabetes Mellitus|diabetes mellitus
144439|NCT03299010|Risk|risk
144440|NCT03299010|Complications|complications
144441|NCT03299010|Mortality|mortality
144442|NCT03299010|Cardiovascular Diseases|cardiovascular diseases
144443|NCT03299010|Chinese|chinese
144444|NCT03299010|Prediction|prediction
144445|NCT03298997|Hemorrhoids|hemorrhoids
144446|NCT03298997|Ligation|ligation
144447|NCT03298997|Ultrasound|ultrasound
144448|NCT03298997|Prospective|prospective
144449|NCT03298997|Randomized Controlled Trial|randomized controlled trial
144450|NCT03298945|colonoscopy|colonoscopy
144451|NCT03298945|colorectal cancer|colorectal cancer
144452|NCT03298945|bowel preparation regimen|bowel preparation regimen
144453|NCT03298945|pragmatic trial|pragmatic trial
144454|NCT03298932|Transesophageal echography|transesophageal echography
144455|NCT03298932|Perioperative cardiac surgery|perioperative cardiac surgery
144456|NCT03298932|Aortic valve replacement|aortic valve replacement
144457|NCT03298932|2D strain of right ventricle|2d strain of right ventricle
144458|NCT03298893|cervical cancer|cervical cancer
144459|NCT03298893|nivolumab|nivolumab
144460|NCT03298893|cisplatin|cisplatin
144461|NCT03298893|radiotherapy|radiotherapy
144462|NCT03298880|Valsalva manoeuvre|valsalva manoeuvre
144463|NCT03298880|Vagal tone|vagal tone
144464|NCT03298880|Modified Valsalva|modified valsalva
144465|NCT03298880|Valsalva Assist Device|valsalva assist device
144466|NCT03298867|Proptosis|proptosis
144467|NCT03298867|Human monoclonal antibody|human monoclonal antibody
144468|NCT03298867|insulin-like growth factor-1 receptor|insulin-like growth factor-1 receptor
144469|NCT03298867|Thyroid-Associated Ophthalmopathy|thyroid-associated ophthalmopathy
144470|NCT03298867|Hyperthyroidism|hyperthyroidism
144471|NCT03298867|Autoimmune Thyroid Disease|autoimmune thyroid disease
144472|NCT03298802|readmission|readmission
144473|NCT03298802|triage visit for pregnancy related hypertension|triage visit for pregnancy related hypertension
144474|NCT03298802|hydrochlorothiazide|hydrochlorothiazide
144475|NCT03298789|static stretching|static stretching
144476|NCT03298789|muscle power|muscle power
144477|NCT03298789|countermovement jump|countermovement jump
144478|NCT03298789|dynamometry|dynamometry
144479|NCT03298789|warm up|warm up
144480|NCT03298789|force plate|force plate
144481|NCT03298750|Mechanical Laboratory Ovarian Stimulation Poor responders|mechanical laboratory ovarian stimulation poor responders
144482|NCT03298711|Central Nervous System Sensitization|central nervous system sensitization
144483|NCT03298711|Neuropeptides|neuropeptides
144484|NCT03298698|Idiopathic nephrotic syndrome|idiopathic nephrotic syndrome
144485|NCT03298698|Minimal change disease|minimal change disease
144486|NCT03298698|Focal segmental glomerulosclerosis|focal segmental glomerulosclerosis
144487|NCT03298698|Rituximab|rituximab
144488|NCT03298698|Randomized clinical trial|randomized clinical trial
144489|NCT03298685|transition|transition
144490|NCT03298685|care program|care program
144491|NCT03298685|needs|needs
144492|NCT03298672|Alzheimer's Disease|alzheimer's disease
144493|NCT03298672|Dementia|dementia
144494|NCT03298672|Brain Diseases|brain diseases
144495|NCT03298672|Central Nervous System Diseases|central nervous system diseases
144496|NCT03298672|Cognition|cognition
144497|NCT03298672|Neurodegenerative Diseases|neurodegenerative diseases
144498|NCT03298672|Neurocognitive Disorders|neurocognitive disorders
144499|NCT03298672|Mental Disorders|mental disorders
144500|NCT03298633|Male infertility|male infertility
144501|NCT03298633|In vitro fertilization|in vitro fertilization
144502|NCT03298633|Intracytoplasmic sperm injection|intracytoplasmic sperm injection
144503|NCT03298620|nursing home|nursing home
144504|NCT03298620|gerodontology|gerodontology
144505|NCT03298620|oral hygiene|oral hygiene
144506|NCT03298568|food intolerance|food intolerance
144507|NCT03298568|histamine intolerance|histamine intolerance
144508|NCT03298568|diamine oxidase|diamine oxidase
144510|NCT03298568|DAOsin|daosin
144511|NCT03298529|Glycemic index|glycemic index
144512|NCT03298529|Insulinemic index|insulinemic index
144513|NCT03298529|Traditional egg pasta|traditional egg pasta
144514|NCT03298503|Parkinson's disease|parkinson's disease
144515|NCT03298503|posture balance|posture balance
144516|NCT03298503|attention|attention
144517|NCT03298490|validity|validity
144518|NCT03298490|reliability|reliability
144519|NCT03298490|low back pain|low back pain
144520|NCT03298451|Hepatocellular Carcinoma Non-Resectable|hepatocellular carcinoma non-resectable
144521|NCT03298399|Hematopoietic cell transplantation (HCT)|hematopoietic cell transplantation (hct)
144522|NCT03298399|Haploidentical|haploidentical
144523|NCT03298399|Mesenchymal stromal cells|mesenchymal stromal cells
144524|NCT03298386|Elderly|elderly
144525|NCT03298386|Multimorbidity|multimorbidity
144526|NCT03298386|Polypharmacy|polypharmacy
144527|NCT03298373|Healthy Men|healthy men
144528|NCT03298373|Male Contraception|male contraception
144529|NCT03298373|Androgen|androgen
144530|NCT03298360|HIV cell reservoir|hiv cell reservoir
144531|NCT03298295|Diabetes Mellitus|diabetes mellitus
144532|NCT03298295|Insulin Pump Therapy|insulin pump therapy
144533|NCT03298295|Continuous Subcutaneous Insulin Infusion|continuous subcutaneous insulin infusion
144534|NCT03298256|AIS|ais
144535|NCT03298243|stroke|stroke
144536|NCT03298243|proprioception|proprioception
144537|NCT03298243|sensory substitution|sensory substitution
144538|NCT03298217|Inspiratory flow|inspiratory flow
144539|NCT03298217|High flow nasal cannula, spirometry|high flow nasal cannula, spirometry
144540|NCT03298217|spirometry|spirometry
144541|NCT03298217|physiologic study|physiologic study
144542|NCT03298217|Bronchiolitis patients sverity score mWCAS/ 3-5.|bronchiolitis patients sverity score mwcas/ 3-5.
144543|NCT03298178|TAVR|tavr
144544|NCT03298178|TAVI|tavi
144545|NCT03298178|SAVR|savr
144546|NCT03298152|lithium disilicate endocrowns|lithium disilicate endocrowns
144547|NCT03298152|cerasmart endocrowns|cerasmart endocrowns
144548|NCT03298126|Radial artery occlusion|radial artery occlusion
144549|NCT03298126|TR band|tr band
144550|NCT03298126|Transradial catheterization|transradial catheterization
144551|NCT03298087|oligometastatic|oligometastatic
144552|NCT03298087|SBRT|sbrt
144553|NCT03298087|abiraterone|abiraterone
144554|NCT03298087|apalutamide|apalutamide
144555|NCT03298074|platinum-resistant|platinum-resistant
144556|NCT03298074|recurrent|recurrent
144557|NCT03298061|Eosinophilic Granulomatosis|eosinophilic granulomatosis
144558|NCT03298061|MEA115921|mea115921
144559|NCT03298061|Polyangiitis|polyangiitis
144560|NCT03298061|Long-term access program|long-term access program
144561|NCT03298061|mepolizumab|mepolizumab
144562|NCT03298022|Ulcerative Colitis|ulcerative colitis
144563|NCT03297983|M7583|m7583
144564|NCT03297983|Healthy Subjects|healthy subjects
144565|NCT03297983|Cross-over|cross-over
144566|NCT03297931|Pulse|pulse
144567|NCT03297931|Snack|snack
144568|NCT03297931|Post-prandial glycemia|post-prandial glycemia
144569|NCT03297931|Appetite|appetite
144570|NCT03297931|Food intake|food intake
144571|NCT03297931|Young adults|young adults
144572|NCT03297931|Satiety|satiety
144573|NCT03297905|Chronic Pain|chronic pain
144574|NCT03297905|Military|military
144575|NCT03297853|Descriptive|descriptive
144576|NCT03297853|Support|support
144577|NCT03297853|Retrospective|retrospective
144578|NCT03297853|survey|survey
144579|NCT03297827|diagnosis|diagnosis
144580|NCT03297827|inflammatory biomarkers|inflammatory biomarkers
144581|NCT03297827|cytokines|cytokines
144582|NCT03297827|interleukin|interleukin
144583|NCT03297827|interferons|interferons
144584|NCT03297814|Peripheral arterial disease|peripheral arterial disease
184476|NCT03042858|PPV|ppv
144585|NCT03297814|Platelet lysate|platelet lysate
144586|NCT03297788|SCLC|sclc
144587|NCT03297788|Brain Metastases|brain metastases
144588|NCT03297788|SRS (stereotactic radiosurgery)|srs (stereotactic radiosurgery)
144589|NCT03297788|WBRT (whole brain radiotherapy)|wbrt (whole brain radiotherapy)
144590|NCT03297775|Rheumatoid Arthritis|rheumatoid arthritis
144591|NCT03297775|RA|ra
144592|NCT03297775|Interstitial Lung Disease|interstitial lung disease
144593|NCT03297775|ILD|ild
144594|NCT03297775|lung disease|lung disease
144595|NCT03297775|connective tissue disease|connective tissue disease
144596|NCT03297775|CTD|ctd
144597|NCT03297775|idiopathic pulmonary fibrosis|idiopathic pulmonary fibrosis
144598|NCT03297775|IPF|ipf
144599|NCT03297775|airways disease|airways disease
144600|NCT03297593|renal cell carcinoma|renal cell carcinoma
144601|NCT03297593|Nivolumab|nivolumab
144602|NCT03297593|Ipilimumab|ipilimumab
144603|NCT03297593|metastatic renal cell carcinoma|metastatic renal cell carcinoma
144604|NCT03297593|immunotherapy|immunotherapy
144605|NCT03297593|Opdivo|opdivo
144606|NCT03297593|Yervoy|yervoy
144607|NCT03297567|Elderly|elderly
144608|NCT03297567|Hospitalization|hospitalization
144609|NCT03297567|Immobilization|immobilization
144610|NCT03297567|Exercise|exercise
144611|NCT03297567|Accelerometry|accelerometry
144612|NCT03297515|Omega-3|omega-3
144613|NCT03297515|dry AMD|dry amd
144614|NCT03297515|Stargardt|stargardt
144615|NCT03297515|visual acuity|visual acuity
144616|NCT03297424|PLX2853|plx2853
144617|NCT03297424|Small cell lung cancer (SCLC)|small cell lung cancer (sclc)
144618|NCT03297424|Uveal Melanoma|uveal melanoma
144619|NCT03297424|Ovarian Clear Cell Carcinoma|ovarian clear cell carcinoma
144620|NCT03297424|Non-Hodgkin Lymphoma|non-hodgkin lymphoma
144621|NCT03297424|Advanced Malignancies|advanced malignancies
144622|NCT03297424|Solid Tumor|solid tumor
144623|NCT03297424|Diffuse Large B Cell Lymphoma (DLBCL)|diffuse large b cell lymphoma (dlbcl)
144624|NCT03297424|Follicular Lymphoma (FL)|follicular lymphoma (fl)
144625|NCT03297424|ARID1A|arid1a
144626|NCT03297411|electroconvulsive therapy|electroconvulsive therapy
144627|NCT03297411|computer modelling|computer modelling
144628|NCT03297385|Prostate Cancer|prostate cancer
144629|NCT03297385|Androgen Receptor Genomics|androgen receptor genomics
144630|NCT03297385|Enzalutamide|enzalutamide
144631|NCT03297385|Prostatectomy|prostatectomy
144632|NCT03297385|Neoadjuvant androgen ablation|neoadjuvant androgen ablation
144633|NCT03297372|Intraocular lens|intraocular lens
144634|NCT03297372|monofocal|monofocal
144635|NCT03297372|cataract|cataract
144636|NCT03297372|PhysIOL|physiol
144637|NCT03297359|Dalteparin|dalteparin
144638|NCT03297359|Fragmin|fragmin
144639|NCT03297346|radiotherapy|radiotherapy
144640|NCT03297346|cardiovascular changes|cardiovascular changes
144641|NCT03297346|cardiac imaging|cardiac imaging
144642|NCT03297346|circulating biomarkers|circulating biomarkers
144643|NCT03297346|dosimetry|dosimetry
144644|NCT03297333|Obesity|obesity
144645|NCT03297333|Exercise|exercise
144646|NCT03297333|Cardiac Fat|cardiac fat
144647|NCT03297333|Cardiac Magnetic Resonance|cardiac magnetic resonance
144648|NCT03297333|Vascular Health|vascular health
144649|NCT03297320|Advance Care Planning, End of life, CPR|advance care planning, end of life, cpr
144650|NCT03297294|Painful diabetic neuropathy|painful diabetic neuropathy
144651|NCT03297294|Neuropathic pain|neuropathic pain
144652|NCT03297294|Angiotensin II type 2 receptor antagonist|angiotensin ii type 2 receptor antagonist
144653|NCT03297281|Photovaporization|photovaporization
144654|NCT03297281|Laser|laser
144655|NCT03297281|Benign prostatic hyperplasia|benign prostatic hyperplasia
144656|NCT03297281|Oral anticoagulation|oral anticoagulation
144657|NCT03297281|Complication|complication
144658|NCT03297268|Dementia Caregiver Empowerment|dementia caregiver empowerment
144659|NCT03297268|Caregiver Burden|caregiver burden
144660|NCT03297268|Agitation in Dementia|agitation in dementia
144661|NCT03297268|Environmental Sensors|environmental sensors
144662|NCT03297268|Wearable Technology|wearable technology
144663|NCT03297255|Primary Liver Cancer; Cohort Study|primary liver cancer; cohort study
144664|NCT03297242|Helicobacter Pylori eradication|helicobacter pylori eradication
144665|NCT03297229|Peer mentoring|peer mentoring
144666|NCT03297229|Self-monitoring|self-monitoring
144667|NCT03297229|Behavioral economics|behavioral economics
144668|NCT03297229|Hypertension|hypertension
144669|NCT03297216|PreTerm Birth|preterm birth
144670|NCT03297216|HIV-1-infection|hiv-1-infection
144671|NCT03297216|Antiretroviral Treatment|antiretroviral treatment
144672|NCT03297164|acute myocardial infarction|acute myocardial infarction
144673|NCT03297164|heart failure|heart failure
144674|NCT03297164|optimized treatment|optimized treatment
144675|NCT03297151|Resistance Training|resistance training
144676|NCT03297151|Muscle Function|muscle function
144677|NCT03297151|Protein Synthesis|protein synthesis
144678|NCT03297125|Optune Therapy|optune therapy
144680|NCT03297125|NovoCure-TTF-200A|novocure-ttf-200a
144681|NCT03297099|robot-assisted laparosocpic|robot-assisted laparosocpic
144682|NCT03297099|hepatectomy|hepatectomy
144683|NCT03297086|multifocal intraocular lens, angle kappa, presbyopia|multifocal intraocular lens, angle kappa, presbyopia
144684|NCT03297060|Alcohol Screening|alcohol screening
144685|NCT03297047|cast, fracture, immobilization, displacement, child|cast, fracture, immobilization, displacement, child
144686|NCT03297034|Late effects|late effects
144687|NCT03297034|Childhood cancer survivors|childhood cancer survivors
144688|NCT03297034|Swiss Childhood Cancer Registry|swiss childhood cancer registry
144689|NCT03297034|Europe|europe
144690|NCT03297021|ambulatory surgery|ambulatory surgery
144691|NCT03297021|post-operative nausea and vomiting|post-operative nausea and vomiting
144692|NCT03297021|general anesthesia|general anesthesia
144693|NCT03297008|healthy|healthy
144694|NCT03297008|saliva|saliva
144695|NCT03297008|stool|stool
144696|NCT03297008|biomarkers|biomarkers
144697|NCT03297008|Respiratory Syncytial Virus|respiratory syncytial virus
144698|NCT03297008|Rotavirus|rotavirus
144699|NCT03297008|Immunoglobulin|immunoglobulin
144700|NCT03297008|Antibody|antibody
144701|NCT03296995|glucose|glucose
144702|NCT03296995|systemic lupus erythematosus|systemic lupus erythematosus
144703|NCT03296982|Whole blood clotting time|whole blood clotting time
144704|NCT03296956|Postpartum|postpartum
144705|NCT03296956|Dietary Supplement|dietary supplement
144706|NCT03296956|Mood Symptoms|mood symptoms
144707|NCT03296930|Direct Acting Antiviral Agents (DAAs)|direct acting antiviral agents (daas)
144708|NCT03296904|Lower limb amputation|lower limb amputation
144709|NCT03296904|Wearable robotics|wearable robotics
144710|NCT03296891|Ultrasonography|ultrasonography
144711|NCT03296891|Point-of-care ultrasound|point-of-care ultrasound
144712|NCT03296891|Resuscitation|resuscitation
144713|NCT03296891|Critical Care|critical care
144714|NCT03296878|low income|low income
144715|NCT03296865|taping|taping
144716|NCT03296865|functionality|functionality
144717|NCT03296865|rehabilitation|rehabilitation
144718|NCT03296865|muscle activity|muscle activity
144719|NCT03296865|electromyography|electromyography
144720|NCT03296813|loop diuretic|loop diuretic
144721|NCT03296787|Drug therapy|drug therapy
144722|NCT03296748|asymptomatic cystocele.|asymptomatic cystocele.
144723|NCT03296748|stress urinary incontinence|stress urinary incontinence
144724|NCT03296696|Phase 1|phase 1
144725|NCT03296696|EGFRvIII-positive glioblastoma or malignant glioma|egfrviii-positive glioblastoma or malignant glioma
144726|NCT03296696|safety and tolerability|safety and tolerability
144727|NCT03296696|AMG 596|amg 596
144728|NCT03296670|STEMI|stemi
144729|NCT03296670|CSFP|csfp
144730|NCT03296670|Alprostadil|alprostadil
144731|NCT03296670|targeted perfusion microcatheter|targeted perfusion microcatheter
144732|NCT03296631|microbiome|microbiome
144733|NCT03296631|gut|gut
144734|NCT03296631|infant gut|infant gut
144735|NCT03296631|phages|phages
144736|NCT03296631|phages-bacteria interactions|phages-bacteria interactions
144737|NCT03296631|microbiome development|microbiome development
144738|NCT03296618|chronic stroke|chronic stroke
144739|NCT03296618|neural stem cell|neural stem cell
144740|NCT03296618|transplant|transplant
144741|NCT03296618|paralysis|paralysis
144742|NCT03296605|Obesity|obesity
144743|NCT03296592|myelopathy|myelopathy
144744|NCT03296592|diffusion MRI|diffusion mri
144745|NCT03296592|spinal cord injury|spinal cord injury
144746|NCT03296592|spinal cord compression|spinal cord compression
144747|NCT03296592|spondylosis|spondylosis
144748|NCT03296592|cervical|cervical
144749|NCT03296540|STEMI|stemi
144750|NCT03296501|ALS|als
144751|NCT03296501|ADRC|adrc
144752|NCT03296501|adipose derived regenerative cells|adipose derived regenerative cells
144753|NCT03296501|intraspinal transplantation|intraspinal transplantation
144754|NCT03296501|mesenchymal cells|mesenchymal cells
144755|NCT03296488|post-laparotomy wound pain|post-laparotomy wound pain
144756|NCT03296488|NALDEBAIN (150 mg Nalbuphine Sebacate)|naldebain (150 mg nalbuphine sebacate)
144757|NCT03296488|PCA (patient-control-ed alagesia)|pca (patient-control-ed alagesia)
144758|NCT03296449|Hypoxia|hypoxia
144759|NCT03296449|High-Frequency Jet Ventilation|high-frequency jet ventilation
144760|NCT03296449|Continuous Positive Airway Pressure|continuous positive airway pressure
144761|NCT03296423|BCG vaccination|bcg vaccination
144762|NCT03296410|Hand, Foot and Mouth Disease (HFMD)|hand, foot and mouth disease (hfmd)
144763|NCT03296410|immunogenicity|immunogenicity
144764|NCT03296410|safety|safety
144765|NCT03296397|Genital warts|genital warts
144766|NCT03296397|HPV vaccine|hpv vaccine
144767|NCT03296397|Relapse|relapse
144768|NCT03296384|schizophrenia|schizophrenia
144769|NCT03296384|environmental factors|environmental factors
144770|NCT03296358|Acute urticaria|acute urticaria
144771|NCT03296358|Emergency department|emergency department
144772|NCT03296358|Acute allergic syndrome|acute allergic syndrome
144773|NCT03296358|Corticosteroid|corticosteroid
144774|NCT03296358|H1-Antihistamines|h1-antihistamines
144775|NCT03296358|Chronic urticaria|chronic urticaria
144776|NCT03296345|Ketamine|ketamine
144777|NCT03296345|Sickle Cell Disease|sickle cell disease
144778|NCT03296345|Vaso-Occlusive Crisis|vaso-occlusive crisis
144779|NCT03296332|Evaluation|evaluation
144780|NCT03296332|Population-based Intervention|population-based intervention
144781|NCT03296332|Salt intake|salt intake
144782|NCT03296332|Hypertension|hypertension
144783|NCT03296306|urothelial carcinoma|urothelial carcinoma
144784|NCT03296306|cisplatin|cisplatin
144785|NCT03296306|first-line chemotherapy|first-line chemotherapy
144786|NCT03296293|Positive end-expiratory pressure(PEEP)|positive end-expiratory pressure(peep)
144787|NCT03296293|intracranial pressure(ICP)|intracranial pressure(icp)
144788|NCT03296293|central venous pressure(CVP)|central venous pressure(cvp)
144789|NCT03296293|intracranial central venous pressure difference(IVPD)|intracranial central venous pressure difference(ivpd)
144790|NCT03296280|ultrasound|ultrasound
144791|NCT03296280|ultrasonography|ultrasonography
144792|NCT03296280|point of care|point of care
144793|NCT03296280|Doppler ultrasound|doppler ultrasound
144794|NCT03296280|ultrasound imaging|ultrasound imaging
144795|NCT03296280|diagnostic ultrasound|diagnostic ultrasound
144796|NCT03296267|bile acid|bile acid
144797|NCT03296267|bacterial uptake|bacterial uptake
144798|NCT03296254|mindfulness|mindfulness
144799|NCT03296254|meditation|meditation
144800|NCT03296254|stress|stress
144801|NCT03296254|burn-out|burn-out
144802|NCT03296254|personality|personality
144803|NCT03296254|randomized controlled trial|randomized controlled trial
144804|NCT03296241|stress urinary incontinence|stress urinary incontinence
144805|NCT03296241|sexual dysfunction|sexual dysfunction
144806|NCT03296241|laser|laser
144807|NCT03296241|Er:YAG|er:yag
144808|NCT03296241|vaginal laser|vaginal laser
144809|NCT03296241|vaginal tightening|vaginal tightening
144810|NCT03296241|non-ablative|non-ablative
144811|NCT03296241|minimally-invasive|minimally-invasive
144812|NCT03296228|AIS|ais
144813|NCT03296202|HIV|hiv
144814|NCT03296202|cohort studies|cohort studies
144815|NCT03296202|antiretroviral treatment|antiretroviral treatment
144816|NCT03296189|ureteroscopy|ureteroscopy
144817|NCT03296189|ureteric stent|ureteric stent
144818|NCT03296189|intraluminal|intraluminal
144819|NCT03296189|local anaesthetic/anesthetic|local anaesthetic/anesthetic
144820|NCT03296189|steroid/glucocorticoid|steroid/glucocorticoid
144821|NCT03296150|therapeutic educational program|therapeutic educational program
144822|NCT03296150|adherence|adherence
144823|NCT03296150|quality of life|quality of life
144824|NCT03296150|elderly|elderly
144825|NCT03296150|cancer|cancer
144826|NCT03296137|immune therapy|immune therapy
144827|NCT03296137|TILs|tils
144828|NCT03296137|Adoptive cell therapy|adoptive cell therapy
144829|NCT03296124|Prostate Cancer|prostate cancer
144830|NCT03296124|Proton Radiation|proton radiation
144831|NCT03296098|Contraception|contraception
144832|NCT03296098|Healthy Female|healthy female
144833|NCT03296098|Progestin|progestin
144834|NCT03296098|ulipristal acetate|ulipristal acetate
144835|NCT03296033|enoxaparin|enoxaparin
144836|NCT03296033|thromboembolism|thromboembolism
144837|NCT03296033|coagulation|coagulation
144838|NCT03296033|factor Xa|factor xa
144839|NCT03295994|arthroscopy|arthroscopy
144840|NCT03295994|physical therapy|physical therapy
144841|NCT03295994|rehabilitation|rehabilitation
144842|NCT03295994|surgery|surgery
144843|NCT03295994|rotator cuff tear|rotator cuff tear
144844|NCT03295929|3D model|3d model
144845|NCT03295929|Inner ear|inner ear
144846|NCT03295903|Vascular function|vascular function
144847|NCT03295903|Cannabidiol supplementation|cannabidiol supplementation
144848|NCT03295890|myofascial trigger point, tinnitus, dry needling|myofascial trigger point, tinnitus, dry needling
144849|NCT03295864|Arnold-Chiari Malformation, Type 1|arnold-chiari malformation, type 1
144850|NCT03295864|Multifrequency tympanometry|multifrequency tympanometry
144851|NCT03295864|Inner ear pressure|inner ear pressure
144852|NCT03295851|Anemia|anemia
144853|NCT03295851|Pre-operative|pre-operative
144854|NCT03295851|Intravenous Iron|intravenous iron
144855|NCT03295851|Ferric carboxymaltose|ferric carboxymaltose
144856|NCT03295851|abdominal surgery|abdominal surgery
144857|NCT03295838|Borderline personality disorder|borderline personality disorder
144858|NCT03295838|Psychotherapy|psychotherapy
144859|NCT03295838|Treatment outcome|treatment outcome
144860|NCT03295838|Pragmatic clinical trials as topic|pragmatic clinical trials as topic
144861|NCT03295838|Mentalization-based treatment|mentalization-based treatment
144862|NCT03295838|Alexithymia|alexithymia
144863|NCT03295825|Heparin binding protein|heparin binding protein
144864|NCT03295825|Mortality|mortality
144865|NCT03295786|Parkinson|parkinson
144866|NCT03295786|CDNF|cdnf
144867|NCT03295786|Drug Delivery System|drug delivery system
144868|NCT03295786|Intracerebral|intracerebral
144869|NCT03295773|Ischemic Stroke|ischemic stroke
144870|NCT03295773|3D-rotational angiography|3d-rotational angiography
144871|NCT03295773|Morphology|morphology
144872|NCT03295773|Atherosclerosis|atherosclerosis
144873|NCT03295721|bunion|bunion
144874|NCT03295721|bunionectomy|bunionectomy
144875|NCT03295721|bunion surgery|bunion surgery
144876|NCT03295721|postoperative pain|postoperative pain
144877|NCT03295708|Major depressive disorder,Fish Oil|major depressive disorder,fish oil
144878|NCT03295695|Chemotherapy induced cardiotoxicity|chemotherapy induced cardiotoxicity
144879|NCT03295695|Tumor blood perfusion|tumor blood perfusion
144880|NCT03295630|Accelerometry|accelerometry
144881|NCT03295630|Validity|validity
144882|NCT03295617|spinal thoracic herniation|spinal thoracic herniation
144883|NCT03295617|surgery|surgery
144884|NCT03295617|endoscopic approach|endoscopic approach
144885|NCT03295617|thoracic spine|thoracic spine
144886|NCT03295617|minimal invasive access|minimal invasive access
144887|NCT03295604|Gingival recession|gingival recession
144888|NCT03295604|Subepithelial connective tissue grafts|subepithelial connective tissue grafts
144889|NCT03295604|CAD/CAM|cad/cam
144890|NCT03295591|Metastatic colorectal cancer|metastatic colorectal cancer
144891|NCT03295591|Liver resection|liver resection
144892|NCT03295591|Circulating tumor cells|circulating tumor cells
144893|NCT03295578|employees|employees
144894|NCT03295578|continuous glucose monitoring|continuous glucose monitoring
144895|NCT03295578|personalized feedback|personalized feedback
144896|NCT03295578|cognition|cognition
144897|NCT03295578|wellbeing|wellbeing
144898|NCT03295565|Sequencing|sequencing
144899|NCT03295565|cabazitaxel|cabazitaxel
144900|NCT03295565|abiraterone|abiraterone
144901|NCT03295565|enzalutamide|enzalutamide
144902|NCT03295565|clinical benefit rate|clinical benefit rate
144903|NCT03295565|docetaxel|docetaxel
144904|NCT03295565|second line treatment|second line treatment
144905|NCT03295552|decitabine|decitabine
144906|NCT03295552|triple negative breast cancer|triple negative breast cancer
144907|NCT03295552|carboplatin|carboplatin
144908|NCT03295552|metastatic|metastatic
144909|NCT03295526|Cervical Cancer, Lymph nodes debulking surgery|cervical cancer, lymph nodes debulking surgery
144910|NCT03295513|mutilated, root canal treated teeth, and coronal fracture|mutilated, root canal treated teeth, and coronal fracture
144911|NCT03295500|CyberKnife|cyberknife
144912|NCT03295500|hepatocellular|hepatocellular
144913|NCT03295500|dose fraction|dose fraction
144914|NCT03295500|ICG R15|icg r15
144915|NCT03295487|post menopausal stress incontinence|post menopausal stress incontinence
144916|NCT03295487|local estrogen|local estrogen
144917|NCT03295448|fatty acids|fatty acids
144918|NCT03295448|biomarker|biomarker
144919|NCT03295448|carbohydrate|carbohydrate
144920|NCT03295448|lipogenesis|lipogenesis
144921|NCT03295435|Diet|diet
144922|NCT03295435|Oral Health|oral health
144923|NCT03295435|Nutrition|nutrition
144924|NCT03295435|Dentition|dentition
144925|NCT03295422|Persistent Atrial Fibrillation|persistent atrial fibrillation
144926|NCT03295422|Radiofrequency ablation|radiofrequency ablation
144927|NCT03295422|Catheter ablation|catheter ablation
144928|NCT03295383|cyclophosphamide|cyclophosphamide
144929|NCT03295383|Rituximab|rituximab
144930|NCT03295370|Pain mechanisms|pain mechanisms
144931|NCT03295370|Cortical activation|cortical activation
144932|NCT03295370|fNIRS|fnirs
144933|NCT03295370|Accessory spinal nerve|accessory spinal nerve
144934|NCT03295370|Autonomic response|autonomic response
144935|NCT03295370|Muscular perfusion|muscular perfusion
144936|NCT03295318|Neisseria meningitidis|neisseria meningitidis
144937|NCT03295318|conjugate meningococcal vaccine|conjugate meningococcal vaccine
144938|NCT03295318|meningococcal serogroup X|meningococcal serogroup x
144939|NCT03295305|Biomarker|biomarker
144940|NCT03295305|Bipolar Disorder|bipolar disorder
144941|NCT03295305|Cognition|cognition
144942|NCT03295305|Cognitive Impairment|cognitive impairment
144943|NCT03295305|cognitive remediation|cognitive remediation
144944|NCT03295305|functional magnetic resonance imaging|functional magnetic resonance imaging
144945|NCT03295305|pro-cognitive effect|pro-cognitive effect
144946|NCT03295292|Phototherapeutic Keratectomy (PTK)|phototherapeutic keratectomy (ptk)
144947|NCT03295292|photorefractive Keratectomy (PRK)|photorefractive keratectomy (prk)
144948|NCT03295292|Collagen Cross-linking (CXL)|collagen cross-linking (cxl)
144949|NCT03295292|Stem Cell Therapy|stem cell therapy
144950|NCT03295279|World Trade Center|world trade center
144951|NCT03295279|Quantitative computerized tomography|quantitative computerized tomography
144952|NCT03295279|Qualitative computerized tomography of the chest|qualitative computerized tomography of the chest
144953|NCT03295279|Chronic airway disease|chronic airway disease
144954|NCT03295279|Interstitial lung disease|interstitial lung disease
144955|NCT03295279|Occupational pulmonology|occupational pulmonology
144956|NCT03295253|urinary incontinence|urinary incontinence
144957|NCT03295253|stress urinary incontinence|stress urinary incontinence
144958|NCT03295253|stress incontinence|stress incontinence
144959|NCT03295240|Mantle Cell Lymphoma|mantle cell lymphoma
144960|NCT03295240|MCL|mcl
144961|NCT03295240|Lymphoma|lymphoma
144962|NCT03295240|Venetoclax|venetoclax
144963|NCT03295240|17-216|17-216
144964|NCT03295227|Thymoma|thymoma
144965|NCT03295227|Thymic cancer|thymic cancer
144966|NCT03295227|Pembrolizumab|pembrolizumab
144967|NCT03295227|Keytruda|keytruda
144968|NCT03295227|MK-3475|mk-3475
144969|NCT03295227|SCH-900475|sch-900475
144970|NCT03295214|Acetaminophen|acetaminophen
144971|NCT03295214|Functional Endoscopic Sinus Surgery|functional endoscopic sinus surgery
144972|NCT03295201|Cystic Fibrosis|cystic fibrosis
144973|NCT03295201|Postural exercise|postural exercise
144974|NCT03295201|Pulmonary rehabilitation|pulmonary rehabilitation
144975|NCT03295175|Congenital Abnormalities|congenital abnormalities
144976|NCT03295175|Hypospadias|hypospadias
144977|NCT03295175|Congenital megaprepuce|congenital megaprepuce
144978|NCT03295175|Histology|histology
144979|NCT03295110|Alzheimer's disease and Related Disorders (ADRD)|alzheimer's disease and related disorders (adrd)
144980|NCT03295110|natural caregiver|natural caregiver
144981|NCT03295110|non-medical connected device|non-medical connected device
144982|NCT03295110|caregiver's burden|caregiver's burden
144983|NCT03295110|anxiety|anxiety
144984|NCT03295110|costs|costs
144985|NCT03295110|quality of life|quality of life
144986|NCT03295110|depressive symptoms|depressive symptoms
144987|NCT03295110|independence|independence
144988|NCT03295097|pharmacogenomics|pharmacogenomics
144989|NCT03295071|Heredity Optic Atrophy|heredity optic atrophy
144990|NCT03295071|Leber Hereditary Optic Atrophy|leber hereditary optic atrophy
145280|NCT03293355|Vietnam|vietnam
144991|NCT03295071|Leber Hereditary Optic Neuropathy|leber hereditary optic neuropathy
144992|NCT03295071|Eye Diseases|eye diseases
144993|NCT03295071|Hereditary Eye Diseases|hereditary eye diseases
144994|NCT03295071|Inherited retinal dystrophies or degeneration|inherited retinal dystrophies or degeneration
144995|NCT03295071|Inborn Genetic Disease|inborn genetic disease
144996|NCT03295071|Gene Therapy|gene therapy
144997|NCT03295071|Intravitreal Injections|intravitreal injections
144998|NCT03295071|Mitochondrial Disease|mitochondrial disease
144999|NCT03295071|AAV2 Vectors|aav2 vectors
145000|NCT03295071|Nervous System Diseases|nervous system diseases
145001|NCT03295071|Neurodegenerative Disease|neurodegenerative disease
145002|NCT03295071|Heredodegenerative Disorders of the Nervous System|heredodegenerative disorders of the nervous system
145003|NCT03295006|TheraSphere, hepatocellular carcinoma, dosimetry|therasphere, hepatocellular carcinoma, dosimetry
145004|NCT03294980|Chronic lymphocytic leukemia|chronic lymphocytic leukemia
145005|NCT03294980|Observational study|observational study
145006|NCT03294967|High Myopia|high myopia
145007|NCT03294967|Caffeine|caffeine
145008|NCT03294967|Choroidal Thickness|choroidal thickness
145009|NCT03294967|Choroidal Volume|choroidal volume
145010|NCT03294967|Optical Coherence Tomography|optical coherence tomography
145011|NCT03294967|Optical Coherence Tomography Angiography|optical coherence tomography angiography
145012|NCT03294954|Neuroblastoma|neuroblastoma
145013|NCT03294954|Natural Killer T-Cells|natural killer t-cells
145014|NCT03294954|Chimerical Antigen Receptor|chimerical antigen receptor
145015|NCT03294915|prediabetes|prediabetes
145016|NCT03294915|resistant starch|resistant starch
145017|NCT03294915|insulin sensitivity|insulin sensitivity
145018|NCT03294889|Prostate cancer|prostate cancer
145019|NCT03294889|Stereotactic body radiation therapy|stereotactic body radiation therapy
145020|NCT03294889|Calypso® beacon system|calypso® beacon system
145021|NCT03294876|Glucocorticoid|glucocorticoid
145022|NCT03294876|HPA axis|hpa axis
145023|NCT03294863|Scar|scar
145024|NCT03294863|Cosmesis|cosmesis
145025|NCT03294863|Embrace Device|embrace device
145026|NCT03294863|Split Wound|split wound
145027|NCT03294863|Wound Closure|wound closure
145028|NCT03294863|Cutaneous Wound|cutaneous wound
145029|NCT03294824|NK cells|nk cells
145030|NCT03294824|Cytomegalovirus|cytomegalovirus
145031|NCT03294824|adenovirus|adenovirus
145032|NCT03294824|Allogeneic transplantation|allogeneic transplantation
145033|NCT03294772|Respiratory Tract Infections|respiratory tract infections
145034|NCT03294772|gastroenteritis|gastroenteritis
145035|NCT03294772|hand sanitizer|hand sanitizer
145036|NCT03294772|handwashing|handwashing
145037|NCT03294772|day care|day care
145038|NCT03294759|amion|amion
145039|NCT03294759|stem cell|stem cell
145040|NCT03294759|acl|acl
145041|NCT03294746|Drug induced interstitial lung disease (DIILD)|drug induced interstitial lung disease (diild)
145042|NCT03294694|Metastatic Hormone-Receptor-Positive (HR+) Breast Cancer|metastatic hormone-receptor-positive (hr+) breast cancer
145043|NCT03294694|HER2-Negative Breast Cancer|her2-negative breast cancer
145044|NCT03294694|Metastatic Epithelial Ovarian Cancer|metastatic epithelial ovarian cancer
145045|NCT03294668|social skills group training|social skills group training
145046|NCT03294668|Adolescents|adolescents
145047|NCT03294668|Active control group|active control group
145048|NCT03294668|Australian|australian
145049|NCT03294642|exercise|exercise
145050|NCT03294642|FODMAP|fodmap
145051|NCT03294642|gastrointestinal|gastrointestinal
145052|NCT03294642|endurance|endurance
145053|NCT03294642|cycling|cycling
145054|NCT03294629|cPAP|cpap
145055|NCT03294629|SenseAwake|senseawake
145056|NCT03294616|transcutaneous electroacupuncture|transcutaneous electroacupuncture
145057|NCT03294603|Healthy Volunteer|healthy volunteer
145058|NCT03294603|CC-220|cc-220
145059|NCT03294603|Male|male
145060|NCT03294590|Child oral health behaviors|child oral health behaviors
145061|NCT03294590|Text messages|text messages
145062|NCT03294590|Motivation|motivation
145063|NCT03294590|Self efficacy|self efficacy
145064|NCT03294590|Outcome Expectations|outcome expectations
145065|NCT03294590|Bottle/sippy cup use|bottle/sippy cup use
145066|NCT03294590|Sugar sweetened beverage consumption|sugar sweetened beverage consumption
145067|NCT03294590|Fluoride varnish|fluoride varnish
145068|NCT03294590|Healthy eating|healthy eating
145069|NCT03294590|Parent oral health behaviors|parent oral health behaviors
145070|NCT03294590|Parent oral health attitudes|parent oral health attitudes
145071|NCT03294590|Fluoride|fluoride
145072|NCT03294577|Plinabulin|plinabulin
145073|NCT03294577|Pegfilgrastim|pegfilgrastim
145074|NCT03294577|bone pain|bone pain
145075|NCT03294577|Chemotherapy induced neutropenia|chemotherapy induced neutropenia
145076|NCT03294564|Inflammation|inflammation
145077|NCT03294564|Threat sensitivity|threat sensitivity
145078|NCT03294564|Reward sensitivity|reward sensitivity
145079|NCT03294551|HPV Vaccine|hpv vaccine
145080|NCT03294551|immunization registry|immunization registry
145081|NCT03294551|Reminder recall (R/R)|reminder recall (r/r)
145082|NCT03294486|Glioblastoma|glioblastoma
145083|NCT03294486|Oncolytic viruses|oncolytic viruses
145084|NCT03294473|reminder recall (R/R), influenza vaccines|reminder recall (r/r), influenza vaccines
145085|NCT03294460|Functional Magnetic Resonance Imaging (fMRI)|functional magnetic resonance imaging (fmri)
145086|NCT03294460|Alcohol Use|alcohol use
145087|NCT03294460|Polymorphism, Genetic|polymorphism, genetic
145088|NCT03294460|Magnetic Resonance Imaging (MRI)|magnetic resonance imaging (mri)
145089|NCT03294447|Fear of falling|fear of falling
145090|NCT03294408|fractal analysis|fractal analysis
145091|NCT03294408|trabecular bone texture|trabecular bone texture
145092|NCT03294408|knee osteoarthritis|knee osteoarthritis
145093|NCT03294408|subchondral bone|subchondral bone
145094|NCT03294408|Medical Resonnance Imaging|medical resonnance imaging
145095|NCT03294395|Antimicrobial resistance|antimicrobial resistance
145096|NCT03294395|Antibiotics|antibiotics
145097|NCT03294395|Fosfomycin|fosfomycin
145098|NCT03294395|Ertapenem|ertapenem
145099|NCT03294395|Gentamicin|gentamicin
145100|NCT03294395|Neisseria Gonorrhoeae|neisseria gonorrhoeae
145101|NCT03294382|epicanthoplasty|epicanthoplasty
145102|NCT03294382|Botulinum Toxins|botulinum toxins
145103|NCT03294382|scar|scar
145104|NCT03294382|intercanthal distance|intercanthal distance
145105|NCT03294382|blepharoplasty|blepharoplasty
145106|NCT03294369|Hypertension|hypertension
145107|NCT03294369|Diabetes|diabetes
145108|NCT03294369|Dyslipidemia|dyslipidemia
145109|NCT03294369|Smoking|smoking
145110|NCT03294369|Cardiovascular|cardiovascular
145111|NCT03294369|Toledo|toledo
145112|NCT03294317|His bundle pacing|his bundle pacing
145113|NCT03294317|Pacemaker|pacemaker
145114|NCT03294304|MIBC|mibc
145115|NCT03294304|UC|uc
145116|NCT03294304|Immunotherapy|immunotherapy
145117|NCT03294304|Bladder Cancer|bladder cancer
145118|NCT03294304|Neoadjuvant|neoadjuvant
145119|NCT03294304|Nivolumab|nivolumab
145120|NCT03294304|Cisplatin|cisplatin
145121|NCT03294304|Gemcitabine|gemcitabine
145122|NCT03294265|Diabetes|diabetes
145123|NCT03294265|Peer support|peer support
145124|NCT03294265|WhatsApp|whatsapp
145125|NCT03294252|PIPAC|pipac
145126|NCT03294252|oxaliplatin|oxaliplatin
145127|NCT03294252|peritoneal metastases|peritoneal metastases
145128|NCT03294187|Upper Extremity|upper extremity
145129|NCT03294187|Feedback|feedback
145130|NCT03294187|Rehabilitation|rehabilitation
145131|NCT03294187|Randomized Controlled Trial|randomized controlled trial
145132|NCT03294161|Meglumine antimoniate|meglumine antimoniate
145133|NCT03294161|L.Braziliensis|l.braziliensis
145134|NCT03294161|Immunotherapy|immunotherapy
145135|NCT03294161|Immucillin|immucillin
145136|NCT03294148|Placebo|placebo
145137|NCT03294148|Back|back
145138|NCT03294148|Pain|pain
145139|NCT03294148|Chronic|chronic
145140|NCT03294148|Mind-Body|mind-body
145141|NCT03294135|Encepur|encepur
145142|NCT03294135|Adults|adults
145143|NCT03294135|Long term immunogenicity|long term immunogenicity
145144|NCT03294135|Tick-borne Encephalitis vaccine|tick-borne encephalitis vaccine
145145|NCT03294135|Booster|booster
145146|NCT03294122|Radiotherapy|radiotherapy
145147|NCT03294122|Adverse effects|adverse effects
145148|NCT03294122|Prostate cancer|prostate cancer
145149|NCT03294122|Head and neck cancer|head and neck cancer
145150|NCT03294122|Patient risk stratification|patient risk stratification
145151|NCT03294122|Mathematical models|mathematical models
145152|NCT03294122|Microbiome|microbiome
145153|NCT03294122|Inflammatory cytokines|inflammatory cytokines
145154|NCT03294122|Magnetic Resonance Imaging|magnetic resonance imaging
145155|NCT03294109|TQL block, TAP block, donor nephrectomy, pain, patient satisfaction|tql block, tap block, donor nephrectomy, pain, patient satisfaction
145156|NCT03294083|Cancer|cancer
145157|NCT03294083|Renal cell carcinoma|renal cell carcinoma
145158|NCT03294083|Clear cell renal cell carcinoma|clear cell renal cell carcinoma
145159|NCT03294070|hemodynamic parameters|hemodynamic parameters
145160|NCT03294070|arterial stiffness|arterial stiffness
185225|NCT03037645|CLL|cll
145161|NCT03294057|Self-Management IT Program|self-management it program
145162|NCT03294044|Self-Management IT Program|self-management it program
145163|NCT03294031|Parkinson Disease|parkinson disease
145164|NCT03294031|Neurodegenerative Disorder|neurodegenerative disorder
145165|NCT03294031|Physical Activity|physical activity
145166|NCT03294031|Pilates Method|pilates method
145167|NCT03294031|Stabilometer|stabilometer
145168|NCT03293953|HCV|hcv
145169|NCT03293953|HIV|hiv
145170|NCT03293953|Liver Fibrosis|liver fibrosis
145171|NCT03293953|Liver Iron Overload|liver iron overload
145172|NCT03293940|Breast Pain|breast pain
145173|NCT03293940|Nerve Pain|nerve pain
145174|NCT03293940|Mastectomy|mastectomy
145175|NCT03293940|Lumpectomy|lumpectomy
145176|NCT03293940|Breast Reconstruction|breast reconstruction
145177|NCT03293927|children, mechanically ventilated, fentanyl, dexmedetomidine, delirium, polypharmacy|children, mechanically ventilated, fentanyl, dexmedetomidine, delirium, polypharmacy
145178|NCT03293888|Spectral Diagnosis Probe|spectral diagnosis probe
145179|NCT03293888|Chaos Wand|chaos wand
145180|NCT03293888|Spectral Analysis|spectral analysis
145181|NCT03293888|Optical Spectroscopy|optical spectroscopy
145182|NCT03293862|laparotomy|laparotomy
145183|NCT03293862|emergency surgery|emergency surgery
145184|NCT03293862|abdominal wound dehiscence|abdominal wound dehiscence
145580|NCT03291301|Insomnia|insomnia
145185|NCT03293862|prophylactic mesh|prophylactic mesh
145186|NCT03293836|Varicose ulcer|varicose ulcer
145187|NCT03293836|Venous ulcer|venous ulcer
145188|NCT03293836|Radiofrequency ablation|radiofrequency ablation
145189|NCT03293836|Perforating veins insufficiency|perforating veins insufficiency
145190|NCT03293836|Varicose veins treatment|varicose veins treatment
145191|NCT03293797|Mindfulness-based Therapy|mindfulness-based therapy
145192|NCT03293797|Wellbeing|wellbeing
145193|NCT03293797|Treatment|treatment
145194|NCT03293784|Melanoma|melanoma
145195|NCT03293784|Immune checkpoint|immune checkpoint
145196|NCT03293784|Nivolumab|nivolumab
145197|NCT03293784|Ipilimumab|ipilimumab
145198|NCT03293784|Infliximab|infliximab
145199|NCT03293784|Certolizumab|certolizumab
145200|NCT03293784|PD-1|pd-1
145201|NCT03293784|TNFa|tnfa
145202|NCT03293784|CTLA-4|ctla-4
145203|NCT03293771|Transgender women|transgender women
145204|NCT03293771|Male-to-female|male-to-female
145205|NCT03293771|Gender confirmation surgery|gender confirmation surgery
145206|NCT03293771|Voiding disorder|voiding disorder
145207|NCT03293771|Vaginal dysfunction|vaginal dysfunction
145208|NCT03293693|beta-glucan|beta-glucan
145209|NCT03293693|Blood glucose|blood glucose
145210|NCT03293693|Gut microbiota|gut microbiota
145211|NCT03293693|Satiety|satiety
145212|NCT03293693|Dietary intervention|dietary intervention
145213|NCT03293667|Rheumatoid Arthritis|rheumatoid arthritis
145214|NCT03293667|Regulatory T Cells|regulatory t cells
145215|NCT03293641|Children, Sickle Cell Disease, Zinc|children, sickle cell disease, zinc
145216|NCT03293628|cervical intraepithelial neoplasia|cervical intraepithelial neoplasia
145217|NCT03293628|haemostasis|haemostasis
145218|NCT03293628|vaginal pack|vaginal pack
145219|NCT03293628|Loop electrical excision procedure|loop electrical excision procedure
145220|NCT03293628|randomized clinical trials|randomized clinical trials
145221|NCT03293628|uterine cervical neoplasm|uterine cervical neoplasm
145222|NCT03293602|prostate cancer|prostate cancer
145224|NCT03293602|BOLD|bold
145225|NCT03293602|18F-MISO|18f-miso
145226|NCT03293602|PET|pet
145227|NCT03293589|end-stage renal disease|end-stage renal disease
145228|NCT03293589|critical limb ischemia|critical limb ischemia
145229|NCT03293589|surgical revascularisation|surgical revascularisation
145230|NCT03293589|endovascular therapy|endovascular therapy
145231|NCT03293576|Behavioural Medicine|behavioural medicine
145232|NCT03293576|Health Psychology|health psychology
145233|NCT03293576|Psychosocial Intervention|psychosocial intervention
145234|NCT03293576|People Who Inject Drugs|people who inject drugs
145235|NCT03293563|Kidney cancer|kidney cancer
145236|NCT03293563|Surgical approaches|surgical approaches
145237|NCT03293563|Medical treatment|medical treatment
145238|NCT03293563|Multicentric and multidisciplinary network|multicentric and multidisciplinary network
145239|NCT03293537|Dementia|dementia
145240|NCT03293537|Aphathy|aphathy
145241|NCT03293537|Emotion|emotion
145242|NCT03293537|Images|images
145243|NCT03293537|Skin conductance|skin conductance
145244|NCT03293537|Heart rate|heart rate
145245|NCT03293524|Heredity Optic Atrophy|heredity optic atrophy
145246|NCT03293524|Leber Hereditary Optic Atrophy|leber hereditary optic atrophy
145247|NCT03293524|Leber Hereditary Optic Neuropathy|leber hereditary optic neuropathy
145248|NCT03293524|LHON|lhon
145249|NCT03293524|Eye Diseases|eye diseases
145250|NCT03293524|Hereditary Eye Diseases|hereditary eye diseases
145251|NCT03293524|Inherited retinal dystrophies or degeneration|inherited retinal dystrophies or degeneration
145252|NCT03293524|Inborn Genetic Disease|inborn genetic disease
145253|NCT03293524|Gene Therapy|gene therapy
145254|NCT03293524|Intravitreal Injections|intravitreal injections
145255|NCT03293524|Mitochondrial Disease|mitochondrial disease
145256|NCT03293524|AAV2 Vectors|aav2 vectors
145257|NCT03293524|Nervous System Diseases|nervous system diseases
145258|NCT03293524|Neurodegenerative Disease|neurodegenerative disease
145259|NCT03293524|Heredodegenerative Disorders of the Nervous System|heredodegenerative disorders of the nervous system
145260|NCT03293524|Atrophy|atrophy
145261|NCT03293524|Pathological Conditions, Anatomical|pathological conditions, anatomical
145262|NCT03293524|Anesthetics|anesthetics
145263|NCT03293524|Central Nervous System Depressants|central nervous system depressants
145264|NCT03293524|Physiological Effects of Drugs|physiological effects of drugs
145265|NCT03293511|Oxytocin|oxytocin
145266|NCT03293511|Eye tracking|eye tracking
145267|NCT03293511|Autistic trait|autistic trait
145268|NCT03293407|Pulmonary arterial hypertension|pulmonary arterial hypertension
145269|NCT03293407|PAH|pah
145270|NCT03293394|Amyotrophic Lateral Sclerosis|amyotrophic lateral sclerosis
145271|NCT03293394|Motor Neuron Disease|motor neuron disease
145272|NCT03293394|Transcranial Direct Current Stimulation|transcranial direct current stimulation
145273|NCT03293368|Oral|oral
145274|NCT03293368|Lichen planus|lichen planus
145275|NCT03293368|PRP|prp
145276|NCT03293355|People Living with HIV Who Use Drugs (PLHWUD)|people living with hiv who use drugs (plhwud)
145277|NCT03293355|Community Health Workers (CHW)|community health workers (chw)
145278|NCT03293355|Multilevel Service Integration|multilevel service integration
145279|NCT03293355|HIV/AIDS|hiv/aids
145281|NCT03293329|rotator cuff injury|rotator cuff injury
145282|NCT03293329|diaphragm|diaphragm
145283|NCT03293329|physical therapy|physical therapy
145284|NCT03293329|manual therapy|manual therapy
145285|NCT03293316|Transcranial electrical stimulation; random noise;|transcranial electrical stimulation; random noise;
145286|NCT03293316|cognitive interventions; electroencephalography;|cognitive interventions; electroencephalography;
145287|NCT03293316|inter-individual variability; stochastic resonance;|inter-individual variability; stochastic resonance;
145288|NCT03293303|Prevention|prevention
145289|NCT03293303|Physical activity|physical activity
145290|NCT03293303|Sedentary behaviour|sedentary behaviour
145291|NCT03293303|Daily activities|daily activities
145292|NCT03293303|Homecare|homecare
145293|NCT03293303|Nursing|nursing
145294|NCT03293303|Primary care|primary care
145295|NCT03293303|Older adults|older adults
145296|NCT03293303|Function Focused Care|function focused care
145297|NCT03293303|Reablement|reablement
145298|NCT03293303|Restorative Care|restorative care
145299|NCT03293290|HIV pre-exposure prophylaxis|hiv pre-exposure prophylaxis
145300|NCT03293290|criminal justice|criminal justice
145301|NCT03293290|women|women
145302|NCT03293290|risk networks|risk networks
145303|NCT03293264|metabolic syndrome|metabolic syndrome
145304|NCT03293264|exercise training|exercise training
145305|NCT03293264|employees|employees
145306|NCT03293264|workplace|workplace
145307|NCT03293264|operational health service|operational health service
145308|NCT03293238|knee|knee
145309|NCT03293238|osteoarthritis|osteoarthritis
145310|NCT03293238|ultrasound|ultrasound
145311|NCT03293238|sonography|sonography
145312|NCT03293238|injection|injection
145313|NCT03293225|cu|cu
145314|NCT03293212|Postoperative pain|postoperative pain
145315|NCT03293212|Failed back surgery syndrome|failed back surgery syndrome
145316|NCT03293212|Korean medicine|korean medicine
145317|NCT03293173|DLBCL|dlbcl
145318|NCT03293173|Chemoimmunotherapy|chemoimmunotherapy
145319|NCT03293173|High risk|high risk
145320|NCT03293173|CNS prophylaxis|cns prophylaxis
145321|NCT03293173|Biomarker-driven|biomarker-driven
145322|NCT03293147|Blood pressure|blood pressure
145323|NCT03293147|Antihypertensive treatment|antihypertensive treatment
145324|NCT03293147|Adherence|adherence
145325|NCT03293147|Biomarker|biomarker
145326|NCT03293147|Urine|urine
145327|NCT03293147|HPLC-MS/MS|hplc-ms/ms
145328|NCT03293134|Fowler syndrome|fowler syndrome
145329|NCT03293121|running related injuries|running related injuries
145330|NCT03293108|Osteoporosis|osteoporosis
145331|NCT03293108|Denosumab|denosumab
145332|NCT03293095|musculoskeletal pathology|musculoskeletal pathology
145333|NCT03293095|motion sensor|motion sensor
145334|NCT03293095|motion capture|motion capture
145335|NCT03293095|functional task|functional task
145336|NCT03293095|biomarker|biomarker
145337|NCT03293069|Conservative Iron Chelation|conservative iron chelation
145338|NCT03293069|Disease-modifying Strategy|disease-modifying strategy
145339|NCT03293056|aerobic exercises|aerobic exercises
145340|NCT03293056|training|training
145341|NCT03293056|aquatic|aquatic
145342|NCT03293030|atopic dermatitis|atopic dermatitis
145343|NCT03293030|eczema|eczema
145344|NCT03293030|dupilumab|dupilumab
145345|NCT03293030|atopic eczema|atopic eczema
145346|NCT03293004|collagen|collagen
145347|NCT03293004|tendon|tendon
145348|NCT03293004|procollagen type I N-terminal|procollagen type i n-terminal
145349|NCT03293004|athletes|athletes
145350|NCT03293004|vitamin C|vitamin c
145351|NCT03293004|hydrolyzed collagen|hydrolyzed collagen
145352|NCT03292991|Hepatocellular Carcinoma|hepatocellular carcinoma
145353|NCT03292991|SIR Spheres|sir spheres
145354|NCT03292991|SIRT|sirt
145355|NCT03292939|progestrone|progestrone
145356|NCT03292939|doppler indices|doppler indices
145357|NCT03292913|HIV|hiv
145358|NCT03292887|Mucopolysaccharidosis II|mucopolysaccharidosis ii
145359|NCT03292887|Hunter Syndrome|hunter syndrome
145360|NCT03292887|Enzyme Replacement Therapy|enzyme replacement therapy
145361|NCT03292887|Lysosomal|lysosomal
145362|NCT03292887|Glycosaminoglycans|glycosaminoglycans
145363|NCT03292874|prostate cancer|prostate cancer
145364|NCT03292874|MRI|mri
145365|NCT03292848|CNS Disorders|cns disorders
145366|NCT03292848|Brexpiprazole|brexpiprazole
145367|NCT03292835|complex|complex
145368|NCT03292835|zoonotic|zoonotic
145369|NCT03292835|medical device|medical device
145370|NCT03292796|Open Angle Glaucoma|open angle glaucoma
145371|NCT03292796|Cataract|cataract
145372|NCT03292796|Phacoemulsification,|phacoemulsification,
145373|NCT03292796|Cystoid Macular Oedema,|cystoid macular oedema,
145374|NCT03292796|Prostaglandin Analogues|prostaglandin analogues
145375|NCT03292783|VEGF|vegf
145376|NCT03292783|DLL4|dll4
145377|NCT03292783|Solid Tumors|solid tumors
145378|NCT03292783|bispecific antibody|bispecific antibody
145379|NCT03292783|anti-angiogenic|anti-angiogenic
145380|NCT03292770|Embryo Transfer|embryo transfer
145381|NCT03292770|Flushing catheter|flushing catheter
145382|NCT03292770|Pregnancy rate|pregnancy rate
145383|NCT03292770|Frozen Embryo Tranfer|frozen embryo tranfer
145384|NCT03292757|Fluorescence|fluorescence
145385|NCT03292744|immunosenescence|immunosenescence
145386|NCT03292718|PERT|pert
145387|NCT03292718|mobile application|mobile application
145388|NCT03292705|cognitive training|cognitive training
145389|NCT03292705|person-centered approach|person-centered approach
145390|NCT03292614|Multifocal Intraocular Lens|multifocal intraocular lens
145391|NCT03292614|Postoperative Measurements of refraction|postoperative measurements of refraction
145392|NCT03292601|Spinal Orthosis|spinal orthosis
145393|NCT03292601|Spinal Brace|spinal brace
145394|NCT03292588|urban setting|urban setting
145395|NCT03292588|children and adolescents|children and adolescents
145396|NCT03292588|double-masked, placebo-controlled randomized trial|double-masked, placebo-controlled randomized trial
145397|NCT03292588|asthma exacerbations (attacks)|asthma exacerbations (attacks)
145398|NCT03292588|mepolizumab adjunctive therapy|mepolizumab adjunctive therapy
145399|NCT03292588|asthma exacerbations prevention|asthma exacerbations prevention
145400|NCT03292588|difficult-to-control exacerbation-prone asthma|difficult-to-control exacerbation-prone asthma
145401|NCT03292549|Urology|urology
145402|NCT03292549|Robotic surgery|robotic surgery
145403|NCT03292549|Haemostasis|haemostasis
145404|NCT03292549|Partial Nephrectomy|partial nephrectomy
145405|NCT03292523|Hyperventilation syndrome|hyperventilation syndrome
145406|NCT03292523|Work productivity|work productivity
145407|NCT03292523|Absenteeism|absenteeism
145408|NCT03292523|Presenteeism|presenteeism
145409|NCT03292484|AR101|ar101
145410|NCT03292484|Characterized Peanut Allergen|characterized peanut allergen
145411|NCT03292484|OIT (oral immunotherapy)|oit (oral immunotherapy)
145412|NCT03292484|Peanut Allergy|peanut allergy
145413|NCT03292484|Allergy|allergy
145414|NCT03292484|Peanut-Allergic Children|peanut-allergic children
145415|NCT03292484|Peanut-Allergic Adults|peanut-allergic adults
145416|NCT03292484|Desensitization|desensitization
145417|NCT03292484|CPNA (Characterized Peanut Allergen)|cpna (characterized peanut allergen)
145418|NCT03292471|Aphasia|aphasia
145419|NCT03292471|Rehabilitation|rehabilitation
145420|NCT03292471|Stroke|stroke
145421|NCT03292458|spasmodic dysphonia|spasmodic dysphonia
145422|NCT03292458|laryngeal dystonia|laryngeal dystonia
145423|NCT03292458|functional MRI|functional mri
145424|NCT03292458|Xyrem|xyrem
145425|NCT03292432|Adherence, Medication|adherence, medication
145426|NCT03292406|T-Cell|t-cell
145427|NCT03292406|Lymphoma|lymphoma
145428|NCT03292406|Cutaneous|cutaneous
145429|NCT03292406|CTCL|ctcl
145430|NCT03292393|Hypertension|hypertension
145431|NCT03292393|Medication|medication
145432|NCT03292393|Adherence|adherence
145433|NCT03292380|Caffeine|caffeine
145434|NCT03292380|Dietary intake|dietary intake
145435|NCT03292380|Validation|validation
145436|NCT03292380|Dietary methods|dietary methods
145437|NCT03292354|Coronary Computed Tomography Angiography|coronary computed tomography angiography
145438|NCT03292354|Image Quality|image quality
145439|NCT03292354|Contrast Media Reduction|contrast media reduction
145440|NCT03292354|Personalised Injection Protocols|personalised injection protocols
145441|NCT03292328|breast cancer|breast cancer
145442|NCT03292328|neuropathy|neuropathy
145443|NCT03292328|peripheral neuropathy|peripheral neuropathy
145444|NCT03292328|yoga|yoga
145445|NCT03292328|17-449|17-449
145446|NCT03292315|Glucagon-Like Peptide-1|glucagon-like peptide-1
145447|NCT03292302|Translational read through|translational read through
145448|NCT03292289|proctectomy|proctectomy
145449|NCT03292289|coloanal continuity reconstruction|coloanal continuity reconstruction
185710|NCT03034941|IVF|ivf
145450|NCT03292263|Multiple Myeloma|multiple myeloma
145451|NCT03292263|Nivolumab|nivolumab
145452|NCT03292263|Melphalan|melphalan
145453|NCT03292263|Autologous hematopoietic stem cell transplantation|autologous hematopoietic stem cell transplantation
145454|NCT03292250|NGS|ngs
145455|NCT03292250|Nanostring|nanostring
145456|NCT03292250|Biomarker Driven Umbrella Trial|biomarker driven umbrella trial
145457|NCT03292250|BYL719,poziotinib, abemaciclib, nintedanib|byl719,poziotinib, abemaciclib, nintedanib
145458|NCT03292250|Durvalumab + Tremelimumab Combination Treatment|durvalumab + tremelimumab combination treatment
145459|NCT03292237|Energy|energy
145460|NCT03292237|Nutrition|nutrition
145461|NCT03292237|Critical illness|critical illness
145462|NCT03292237|Parenteral nutrition|parenteral nutrition
145463|NCT03292237|Intensive care unit|intensive care unit
145464|NCT03292237|Ward|ward
145465|NCT03292237|Randomised Controlled Trial|randomised controlled trial
145466|NCT03292237|Intensive Nutrition|intensive nutrition
145467|NCT03292211|Early mobilization|early mobilization
145468|NCT03292211|Acute stroke|acute stroke
145469|NCT03292211|Early intervention|early intervention
145470|NCT03292211|Early mobilization therapy|early mobilization therapy
145471|NCT03292198|Subclinical lymphedema|subclinical lymphedema
145472|NCT03292198|bioimpedance|bioimpedance
145473|NCT03292198|breast cancer|breast cancer
145474|NCT03292159|stroke|stroke
145475|NCT03292159|vagus nerve stimulation|vagus nerve stimulation
145476|NCT03292159|upper extremity paresis|upper extremity paresis
145477|NCT03292133|Lung Cancer|lung cancer
145478|NCT03292094|Young|young
145479|NCT03292094|Healthy|healthy
145480|NCT03292094|African|african
145481|NCT03292094|Longitudinal|longitudinal
145482|NCT03292094|Hypertension|hypertension
145483|NCT03292094|Salt intake|salt intake
145484|NCT03292094|Obesity|obesity
145485|NCT03292094|Organ damage|organ damage
145486|NCT03292081|Intracoronary Imaging|intracoronary imaging
145487|NCT03292081|Optical Frequency Domain Imaging|optical frequency domain imaging
145488|NCT03292081|Intravascular Ultrasound|intravascular ultrasound
145489|NCT03292081|Percutaneous Coronary Intervention|percutaneous coronary intervention
145490|NCT03292081|Drug Eluting Stent|drug eluting stent
145491|NCT03292055|food frequency questionnaire; psychometric properties|food frequency questionnaire; psychometric properties
145492|NCT03292042|metabolic syndrome|metabolic syndrome
145493|NCT03292042|lifestyle intervention|lifestyle intervention
145494|NCT03292042|health promotion|health promotion
145495|NCT03292042|mental health nurse|mental health nurse
145496|NCT03292042|serious mental illness|serious mental illness
145497|NCT03292029|Renal replacement therapy|renal replacement therapy
145498|NCT03292029|Haemodialsysis|haemodialsysis
145499|NCT03292029|Calcification Inhibition Test|calcification inhibition test
145500|NCT03292016|Off Episodes|off episodes
145501|NCT03292016|Parkinson Disease|parkinson disease
145502|NCT03292003|rheumatoid arthritis|rheumatoid arthritis
145503|NCT03292003|post-traumatic arthritis|post-traumatic arthritis
145504|NCT03292003|osteoarthritis|osteoarthritis
145505|NCT03292003|degenerative arthritis|degenerative arthritis
145506|NCT03292003|failed osteotomy|failed osteotomy
145507|NCT03291977|surgery - glioblastoma - fluorescein|surgery - glioblastoma - fluorescein
145508|NCT03291847|maternal opioid use|maternal opioid use
145509|NCT03291847|neonatal abstinence syndrome|neonatal abstinence syndrome
145510|NCT03291847|buprenorphine-naloxone|buprenorphine-naloxone
145511|NCT03291834|type 1 diabetes mellitus|type 1 diabetes mellitus
145512|NCT03291834|sports|sports
145513|NCT03291834|child|child
145514|NCT03291834|adolescent|adolescent
145515|NCT03291821|DuoStim|duostim
145516|NCT03291821|MitoScore|mitoscore
145517|NCT03291821|Preimplantation genetic diagnosis|preimplantation genetic diagnosis
145518|NCT03291821|MII oocyte|mii oocyte
145519|NCT03291808|Obesity|obesity
145520|NCT03291808|Asthma|asthma
145521|NCT03291808|Weight loss|weight loss
145522|NCT03291743|Crohn's|crohn's
145523|NCT03291743|Capsule endoscopy|capsule endoscopy
145524|NCT03291743|IBD|ibd
145525|NCT03291730|Anxiety|anxiety
145526|NCT03291717|Mental Illness|mental illness
145527|NCT03291717|Community Participation|community participation
145528|NCT03291717|Stigma|stigma
145529|NCT03291717|Photovoice|photovoice
145530|NCT03291704|Dry Eye|dry eye
145531|NCT03291704|Thermal Therapy|thermal therapy
145532|NCT03291704|Meibomian Gland Dysfunction|meibomian gland dysfunction
145533|NCT03291691|Protective Nerve Stimulation|protective nerve stimulation
145534|NCT03291691|Regional Anesthesia|regional anesthesia
145535|NCT03291691|Sciatic nerve block|sciatic nerve block
145536|NCT03291691|femoral nerve block|femoral nerve block
145537|NCT03291691|brachial plexus block|brachial plexus block
145538|NCT03291665|Plantar Fasciitis|plantar fasciitis
145539|NCT03291665|Plantar heel pain|plantar heel pain
145540|NCT03291652|Ischemic Stroke|ischemic stroke
145541|NCT03291652|atherosclerosis|atherosclerosis
145542|NCT03291652|Plaque morphology|plaque morphology
145543|NCT03291652|DSA/3DRA|dsa/3dra
145544|NCT03291613|Sickle Cell Disease|sickle cell disease
145545|NCT03291613|Adolescence|adolescence
145546|NCT03291613|Pain Assessment|pain assessment
145547|NCT03291613|Tablet Application|tablet application
145548|NCT03291613|Pain|pain
145549|NCT03291613|mHealth|mhealth
145550|NCT03291587|lung cancer|lung cancer
145551|NCT03291587|cancer screening|cancer screening
145552|NCT03291587|tobacco use|tobacco use
145553|NCT03291548|Quinoa|quinoa
145554|NCT03291548|Functional food|functional food
145555|NCT03291548|Cardiovascular disease|cardiovascular disease
145556|NCT03291548|Cholesterol|cholesterol
145557|NCT03291548|Lipid profile|lipid profile
145558|NCT03291548|Randomised Control Trial|randomised control trial
145559|NCT03291522|Testicular sperm extraction|testicular sperm extraction
145560|NCT03291509|weight loss|weight loss
145561|NCT03291509|weight management|weight management
145562|NCT03291483|Whole body vibration|whole body vibration
145563|NCT03291483|mesh id D000072797|mesh id d000072797
145564|NCT03291483|Plyometric exercise|plyometric exercise
145565|NCT03291483|Muscle strength|muscle strength
145566|NCT03291483|Physical fitness|physical fitness
145567|NCT03291483|Balance|balance
145568|NCT03291470|knee|knee
145569|NCT03291431|alcohol use disorder|alcohol use disorder
145570|NCT03291431|intermittent theta burst|intermittent theta burst
145571|NCT03291431|Veterans|veterans
145572|NCT03291431|depressive disorder|depressive disorder
145573|NCT03291431|cigarette smoking|cigarette smoking
145574|NCT03291418|Healthy Volunteers, ATB-346, Naproxen sodium, GI safety|healthy volunteers, atb-346, naproxen sodium, gi safety
145575|NCT03291392|Genetics|genetics
145576|NCT03291392|Stroke|stroke
145577|NCT03291392|Biobank|biobank
145578|NCT03291392|Atherosclerosis|atherosclerosis
145579|NCT03291379|mCRC, HCC, radiopaque beads, vandetanib|mcrc, hcc, radiopaque beads, vandetanib
145581|NCT03291301|Cognitive Behavioral Therapy|cognitive behavioral therapy
145582|NCT03291301|CBT-I|cbt-i
145583|NCT03291301|Acupressure|acupressure
145584|NCT03291301|Traditional Chinese Medicine|traditional chinese medicine
145585|NCT03291288|Tenosynovial Giant Cell Tumors (TGCT)|tenosynovial giant cell tumors (tgct)
145586|NCT03291288|Kit-mutant melanoma|kit-mutant melanoma
145587|NCT03291288|Kit-mutant gastrointestinal stromal tumor (GIST)|kit-mutant gastrointestinal stromal tumor (gist)
145588|NCT03291288|Cocktail drug-drug interaction (DDI)|cocktail drug-drug interaction (ddi)
145589|NCT03291210|hyperoxemia|hyperoxemia
145590|NCT03291210|myocardial injury|myocardial injury
145591|NCT03291210|transcatheter aortic valve replacement|transcatheter aortic valve replacement
145592|NCT03291197|Suprascapular nerve block|suprascapular nerve block
145593|NCT03291197|Median nerve block|median nerve block
145594|NCT03291197|CRPS|crps
145595|NCT03291197|Shoulder hand syndrome|shoulder hand syndrome
145596|NCT03291184|neuromuscular blockade|neuromuscular blockade
145597|NCT03291184|neuromuscular monitoring|neuromuscular monitoring
145598|NCT03291171|physical activity|physical activity
145599|NCT03291171|sedentary behaviour|sedentary behaviour
145600|NCT03291171|type 2 diabetes|type 2 diabetes
145601|NCT03291171|eHealth|ehealth
145602|NCT03291171|mHealth|mhealth
145603|NCT03291171|self-regulation|self-regulation
145604|NCT03291171|behaviour change techniques|behaviour change techniques
145605|NCT03291158|Bacterial Infections|bacterial infections
145606|NCT03291145|Long QT Syndrome|long qt syndrome
145607|NCT03291132|Smoke-free|smoke-free
145608|NCT03291132|Teens|teens
145609|NCT03291119|Cervico-medullary, Extubation Failure, Risk Predictors|cervico-medullary, extubation failure, risk predictors
145610|NCT03291093|PET/MRI|pet/mri
145611|NCT03291093|Amyloid|amyloid
145612|NCT03291093|Flutemetamol|flutemetamol
145613|NCT03291054|Gastrointestinal Stromal Tumors|gastrointestinal stromal tumors
145614|NCT03291054|GIST|gist
145615|NCT03291054|Pembrolizumab|pembrolizumab
145616|NCT03291054|Epacadostat|epacadostat
145617|NCT03291054|Columbia|columbia
145618|NCT03291015|arthroscopy|arthroscopy
145619|NCT03291015|radiographic(plain X ray)|radiographic(plain x ray)
145620|NCT03290963|depression|depression
145621|NCT03290963|bipolar I disorder|bipolar i disorder
145622|NCT03290963|bipolar II disorder|bipolar ii disorder
145623|NCT03290950|Daratumumab|daratumumab
145624|NCT03290950|Carfilzomib|carfilzomib
145625|NCT03290950|Lenalidomide|lenalidomide
145626|NCT03290950|Dexamethasone|dexamethasone
145627|NCT03290950|17-352|17-352
145628|NCT03290924|institutional delivery|institutional delivery
145629|NCT03290911|low responders|low responders
145630|NCT03290898|Asthma|asthma
145631|NCT03290898|Exercise|exercise
145632|NCT03290898|Asthma treatment|asthma treatment
145633|NCT03290898|Inhaled corticosteroid|inhaled corticosteroid
145634|NCT03290898|Rehabilitation|rehabilitation
145635|NCT03290859|Procedural Sedation|procedural sedation
145636|NCT03290833|Robotics|robotics
145637|NCT03290833|Stroke|stroke
145638|NCT03290833|Hand|hand
145639|NCT03290833|neurorehabilitation|neurorehabilitation
145640|NCT03290820|nasopharyngeal carcinoma|nasopharyngeal carcinoma
145641|NCT03290820|N2-3 disease|n2-3 disease
145642|NCT03290820|distant metastasis|distant metastasis
145643|NCT03290820|aspirin|aspirin
145644|NCT03290820|survival|survival
145645|NCT03290781|Ulcerative colitis|ulcerative colitis
145646|NCT03290755|Hepatitis C|hepatitis c
145647|NCT03290755|sexual network|sexual network
145648|NCT03290755|sexual transmitted|sexual transmitted
145649|NCT03290755|men who have sex with men|men who have sex with men
145650|NCT03290755|HIV positive|hiv positive
145651|NCT03290755|sexual behaviour|sexual behaviour
145652|NCT03290729|wedge implants; atrophic bone|wedge implants; atrophic bone
145653|NCT03290664|AML|aml
145654|NCT03290638|Guided Bone Regeneration|guided bone regeneration
145655|NCT03290638|Dehydrated Human Amnion Chorion Membrane|dehydrated human amnion chorion membrane
145656|NCT03290638|Type I Bovine Collagen Membrane|type i bovine collagen membrane
145657|NCT03290638|Ridge Preservation|ridge preservation
145658|NCT03290638|Ridge Healing|ridge healing
145659|NCT03290638|Teeth Extraction|teeth extraction
145660|NCT03290612|Sleep|sleep
145661|NCT03290612|Vitamin C|vitamin c
145662|NCT03290599|Cognitive dysfunction|cognitive dysfunction
145663|NCT03290599|Hip Surgery|hip surgery
145664|NCT03290599|Mini mental Test,|mini mental test,
145665|NCT03290599|Preoperative Hospitalisation|preoperative hospitalisation
145666|NCT03290599|Spinal Anesthesia|spinal anesthesia
145667|NCT03290534|wedge resection|wedge resection
145668|NCT03290534|sublobar resection|sublobar resection
145669|NCT03290534|brachytherapy|brachytherapy
145670|NCT03290534|CivaSheet|civasheet
145671|NCT03290534|Pd-103|pd-103
145672|NCT03290534|CivaTech Oncology|civatech oncology
145673|NCT03290534|lung cancer|lung cancer
145674|NCT03290534|lung|lung
145675|NCT03290521|pain|pain
145676|NCT03290521|laparoscopy|laparoscopy
145677|NCT03290521|washing|washing
145678|NCT03290521|intraperitoneal irrigation|intraperitoneal irrigation
145679|NCT03290508|Prolaris|prolaris
145680|NCT03290508|Prostate Cancer|prostate cancer
145681|NCT03290508|Cell Cycle Progression Test|cell cycle progression test
145682|NCT03290495|ketamine|ketamine
145683|NCT03290495|isoflurane|isoflurane
145684|NCT03290495|electroencephalography|electroencephalography
145685|NCT03290495|maintenance|maintenance
145686|NCT03290495|recovery|recovery
145687|NCT03290495|anesthesia|anesthesia
145688|NCT03290469|ICU|icu
145689|NCT03290469|Intensive Care Unit|intensive care unit
145690|NCT03290456|Vasculitis|vasculitis
145691|NCT03290456|GPA|gpa
145692|NCT03290456|Granulomatosis with Polyangitis|granulomatosis with polyangitis
145693|NCT03290456|MPA|mpa
145694|NCT03290456|Microscopic Polyangitis|microscopic polyangitis
145695|NCT03290456|Systemic anti-neutrophil cytoplasmic antibodies (ANCA)|systemic anti-neutrophil cytoplasmic antibodies (anca)
145696|NCT03290456|Prednisone|prednisone
145697|NCT03290456|glucocorticoids|glucocorticoids
145698|NCT03290456|Remission Maintenance|remission maintenance
145699|NCT03290456|Rituximab|rituximab
145700|NCT03290456|Cyclophosphamide|cyclophosphamide
145701|NCT03290443|Hepatic|hepatic
145702|NCT03290443|Pharmacokinetics|pharmacokinetics
145703|NCT03290443|Phase 1|phase 1
145704|NCT03290443|Enasidenib|enasidenib
145705|NCT03290443|CC-90007|cc-90007
145706|NCT03290430|Nicotine Dependence|nicotine dependence
145707|NCT03290430|applied behavioral research|applied behavioral research
145708|NCT03290417|Active Surveillance|active surveillance
145709|NCT03290417|Vitamin D|vitamin d
145710|NCT03290417|Omega-3 Fatty Acid|omega-3 fatty acid
145711|NCT03290417|tumeric curcumin|tumeric curcumin
145712|NCT03290404|Axillary Block|axillary block
145713|NCT03290404|LidocaÏne 1% adrenaliné|lidocaïne 1% adrenaliné
145714|NCT03290391|Russia|russia
145715|NCT03290391|Substance use|substance use
145716|NCT03290391|Peer case managers|peer case managers
145717|NCT03290391|ART|art
145718|NCT03290391|HIV|hiv
145719|NCT03290365|Platelet rich plasma|platelet rich plasma
145720|NCT03290365|Osteoarthritis of knee|osteoarthritis of knee
145721|NCT03290365|Hyaluronic acid|hyaluronic acid
145722|NCT03290339|one-day surgery|one-day surgery
145723|NCT03290339|hysterectomy|hysterectomy
145724|NCT03290339|ambulatory|ambulatory
145725|NCT03290326|Alzheimer|alzheimer
145726|NCT03290326|Memory Problems|memory problems
145727|NCT03290313|Depression|depression
145728|NCT03290313|erectile dysfunction|erectile dysfunction
145729|NCT03290313|shu gan yi yang|shu gan yi yang
145730|NCT03290300|Nasal valve|nasal valve
145731|NCT03290300|Nasal airway obstruction|nasal airway obstruction
145732|NCT03290300|Quality of Life|quality of life
145733|NCT03290287|COPD|copd
145734|NCT03290274|Deep brain stimulation|deep brain stimulation
145735|NCT03290274|Alzheimer´s Disease|alzheimer´s disease
145736|NCT03290274|Fornix|fornix
145737|NCT03290274|Basal nucleus of Meynert|basal nucleus of meynert
145738|NCT03290222|Respiratory symptoms|respiratory symptoms
145739|NCT03290222|Children|children
145740|NCT03290209|Stomach Neoplasm|stomach neoplasm
145741|NCT03290209|Elderly Patients|elderly patients
145742|NCT03290209|Laparoscopic D1 Lymphadenectomy|laparoscopic d1 lymphadenectomy
145743|NCT03290196|Shoulder|shoulder
145744|NCT03290196|Rotator cuff|rotator cuff
145745|NCT03290183|Confocal laser endomicroscopy|confocal laser endomicroscopy
145746|NCT03290157|Colonoscopy|colonoscopy
145747|NCT03290157|preparation|preparation
145748|NCT03290157|new media|new media
145749|NCT03290157|SPA|spa
145750|NCT03290157|APP|app
145751|NCT03290144|Cystic fibrosis - Pregnancy - Diabetes|cystic fibrosis - pregnancy - diabetes
145752|NCT03290105|oropharyngeal colonization|oropharyngeal colonization
145753|NCT03290079|metastatic progressive high-grade neuroendocrine|metastatic progressive high-grade neuroendocrine
145754|NCT03290079|progressive high-grade neuroendocrine|progressive high-grade neuroendocrine
145755|NCT03290079|high grade neuroendocrine|high grade neuroendocrine
145756|NCT03290079|carcinoma originating outside of the lung|carcinoma originating outside of the lung
145757|NCT03290079|poorly differentiated neuroendocrine|poorly differentiated neuroendocrine
145758|NCT03290066|Primary Dysmenorrhea|primary dysmenorrhea
145759|NCT03290066|Kinesio Taping|kinesio taping
145760|NCT03289962|Cancer vaccine|cancer vaccine
145761|NCT03289962|Neoantigen|neoantigen
145762|NCT03289962|Personalized|personalized
145763|NCT03289962|Atezolizumab|atezolizumab
145764|NCT03289962|Vaccine|vaccine
145765|NCT03289962|Immunotherapy|immunotherapy
145766|NCT03289962|Anti-PDL1|anti-pdl1
145767|NCT03289962|Checkpoint Inhibitor|checkpoint inhibitor
145768|NCT03289962|Personalized vaccine|personalized vaccine
145769|NCT03289936|preterm|preterm
145770|NCT03289936|ventilation|ventilation
145771|NCT03289936|nasal intermittent positive pressure ventilation|nasal intermittent positive pressure ventilation
145772|NCT03289936|synchronization|synchronization
145773|NCT03289936|cardio-respiratory events|cardio-respiratory events
145774|NCT03289936|newborn|newborn
145775|NCT03289923|Transcranial Magnetic Stimulation (TMS)|transcranial magnetic stimulation (tms)
145776|NCT03289923|Major Depressive Disorder|major depressive disorder
145777|NCT03289923|Cognitive Therapy|cognitive therapy
145778|NCT03289832|Sulforaphane|sulforaphane
145779|NCT03289832|Curcumin|curcumin
145780|NCT03289832|Crucera-SGS|crucera-sgs
145781|NCT03289832|Meriva-SF|meriva-sf
145782|NCT03289832|Skin|skin
145783|NCT03289832|erythema|erythema
145784|NCT03289832|UV|uv
145785|NCT03289832|Sunburn|sunburn
145786|NCT03289832|Inflammation|inflammation
145787|NCT03289832|Redness|redness
145788|NCT03289832|ultra-violet|ultra-violet
145789|NCT03289832|sunlight|sunlight
145790|NCT03289819|TNBC|tnbc
145791|NCT03289819|neoadjuvant chemotherapy|neoadjuvant chemotherapy
145792|NCT03289819|triple negative breast cancer|triple negative breast cancer
145793|NCT03289793|Attention Deficit Disorder with Hyperactivity|attention deficit disorder with hyperactivity
145794|NCT03289793|ADHD|adhd
145795|NCT03289793|Children|children
145796|NCT03289793|Inattention|inattention
145797|NCT03289793|Hyperactivity|hyperactivity
145798|NCT03289793|Neurofeedback|neurofeedback
145799|NCT03289793|Neuropsychology|neuropsychology
145800|NCT03289754|knee implant|knee implant
145801|NCT03289754|osteoarthritis|osteoarthritis
145802|NCT03289754|patient-specific|patient-specific
145803|NCT03289754|knee osteoarthritis|knee osteoarthritis
145804|NCT03289741|Octreotide|octreotide
145805|NCT03289741|Lanreotide|lanreotide
145806|NCT03289741|17-422|17-422
145807|NCT03289728|elderly patients|elderly patients
145808|NCT03289728|myocardial infarction|myocardial infarction
145809|NCT03289728|myocardial revascularization strategy|myocardial revascularization strategy
145810|NCT03289728|ischemia imaging|ischemia imaging
145811|NCT03289728|coronary artery disease|coronary artery disease
145812|NCT03289663|synergistic combination|synergistic combination
145813|NCT03289663|insecticide resistance|insecticide resistance
145814|NCT03289663|vectors|vectors
145815|NCT03289650|immunosuppression|immunosuppression
145816|NCT03289624|Care Planning|care planning
145817|NCT03289624|Care Values and Preferences|care values and preferences
145818|NCT03289611|Preeclampsia|preeclampsia
145819|NCT03289611|pregnancy|pregnancy
145820|NCT03289611|biomarkers|biomarkers
145821|NCT03289611|prediction|prediction
145822|NCT03289611|safety|safety
145823|NCT03289611|cost|cost
145824|NCT03289585|Hidradenitis Suppurativa|hidradenitis suppurativa
145825|NCT03289585|Registry|registry
145826|NCT03289546|mindfulness|mindfulness
145827|NCT03289546|exercise|exercise
145828|NCT03289546|cognitive function|cognitive function
145829|NCT03289533|Cancer|cancer
145830|NCT03289533|Hepatocellular carcinoma|hepatocellular carcinoma
145831|NCT03289533|Liver disease|liver disease
145832|NCT03289533|Avelumab|avelumab
145833|NCT03289533|Axitinib|axitinib
145834|NCT03289520|Access Blood Flow Monitoring|access blood flow monitoring
145835|NCT03289520|Clinical Trial Vascular Access|clinical trial vascular access
145836|NCT03289520|Fistula Failure|fistula failure
145837|NCT03289520|Hemodialysis|hemodialysis
145838|NCT03289520|Vascular Access|vascular access
145839|NCT03289507|Longvida Curcumin|longvida curcumin
145840|NCT03289507|Pharmacokinetics|pharmacokinetics
145841|NCT03289494|Slowly Digestible Starch|slowly digestible starch
145842|NCT03289494|SDS|sds
145843|NCT03289494|Type 2 diabetes|type 2 diabetes
145844|NCT03289494|T2D|t2d
145845|NCT03289494|Glycemic response|glycemic response
145846|NCT03289494|Continuous Glucose Monitoring System|continuous glucose monitoring system
145847|NCT03289494|CGMS|cgms
145848|NCT03289481|Heart failure|heart failure
145849|NCT03289481|HFpEF|hfpef
145850|NCT03289481|Nitrate supplement|nitrate supplement
145851|NCT03289455|Acute Lymphoblastic Leukaemia|acute lymphoblastic leukaemia
145852|NCT03289455|CD19 Positive|cd19 positive
145853|NCT03289455|CD22 Positive|cd22 positive
145854|NCT03289455|Relapsed Acute Lymphoblastic Leukaemia|relapsed acute lymphoblastic leukaemia
145855|NCT03289455|Refractory Acute Lymphoblastic Leukaemia|refractory acute lymphoblastic leukaemia
145856|NCT03289455|AUTO3|auto3
145857|NCT03289429|Atorvastatin|atorvastatin
145858|NCT03289429|Magnesium sulfate|magnesium sulfate
145859|NCT03289429|POAF|poaf
145860|NCT03289429|Cardiac|cardiac
145861|NCT03289429|Valve|valve
145862|NCT03289416|knee|knee
145863|NCT03289416|osteoarthritis|osteoarthritis
145864|NCT03289416|platelet rich plasma (PRP)|platelet rich plasma (prp)
145865|NCT03289416|bone marrow concentrate (BMC)|bone marrow concentrate (bmc)
145866|NCT03289364|Breast Cancer|breast cancer
145867|NCT03289364|Alopecia|alopecia
145868|NCT03289364|Hair Loss|hair loss
145869|NCT03289364|Scalp Cooling|scalp cooling
145870|NCT03289364|Penguin Cold Caps|penguin cold caps
145871|NCT03289338|Zoledronic acid|zoledronic acid
145872|NCT03289338|Methylprednisolone|methylprednisolone
145873|NCT03289338|Active Charcot's disease|active charcot's disease
145874|NCT03289325|Cardiac surgery|cardiac surgery
145875|NCT03289325|Dexmedetomidine|dexmedetomidine
145876|NCT03289325|Long-term outcome|long-term outcome
145877|NCT03289325|Mortality|mortality
145878|NCT03289325|Quality of life|quality of life
145879|NCT03289312|sepsis, lymphocyte|sepsis, lymphocyte
145880|NCT03289299|myeloma|myeloma
145881|NCT03289299|MRD|mrd
145882|NCT03289299|smoldering|smoldering
145883|NCT03289286|Breast Cancer|breast cancer
145884|NCT03289286|Ambulatory surgery|ambulatory surgery
145885|NCT03289286|Electronic tool|electronic tool
145886|NCT03289286|e-follow-up|e-follow-up
145887|NCT03289273|Liver cancer|liver cancer
145888|NCT03289273|unresectable hepatocellular carcinoma|unresectable hepatocellular carcinoma
145889|NCT03289273|real-world practice conditions|real-world practice conditions
145890|NCT03289273|safety and effectiveness|safety and effectiveness
145891|NCT03289273|management and treatment of liver cancer|management and treatment of liver cancer
145892|NCT03289260|Condylomata acuminata, Fulguration, Imiquimod|condylomata acuminata, fulguration, imiquimod
145893|NCT03289195|MRI|mri
145894|NCT03289195|Biopsy|biopsy
145895|NCT03289195|17-390|17-390
145896|NCT03289143|Alzheimer Disease|alzheimer disease
145897|NCT03289143|Brain Diseases|brain diseases
145898|NCT03289143|Dementia|dementia
145899|NCT03289143|Neurodegenerative Diseases|neurodegenerative diseases
145900|NCT03289143|Neurocognitive Disorders|neurocognitive disorders
145901|NCT03289117|Urinary catheterization|urinary catheterization
145902|NCT03289117|Gel installation|gel installation
145903|NCT03289117|Novel medical device|novel medical device
145904|NCT03289117|Indwelling urinary catheter|indwelling urinary catheter
145905|NCT03289117|Long-term urinary catheter|long-term urinary catheter
145906|NCT03289117|Male patients|male patients
145907|NCT03289091|aerobic training|aerobic training
145908|NCT03289091|aquatic exercise|aquatic exercise
145909|NCT03289091|aging|aging
145910|NCT03289065|Genetic|genetic
145911|NCT03289065|Fabry Disease|fabry disease
145912|NCT03289065|Glycolipid|glycolipid
145913|NCT03289065|lysosomal|lysosomal
145914|NCT03289052|Hyaluronic acid, midface|hyaluronic acid, midface
145915|NCT03289039|Breast Cancer|breast cancer
145916|NCT03289026|Aripiprazole; Acute schizophrenia episode; positive symptoms|aripiprazole; acute schizophrenia episode; positive symptoms
145917|NCT03289000|osteoarthritis|osteoarthritis
145918|NCT03289000|knee arthroplasty|knee arthroplasty
145919|NCT03289000|knee replacement|knee replacement
145920|NCT03289000|patient specific|patient specific
145921|NCT03288974|Multiple Myeloma|multiple myeloma
145922|NCT03288974|POMALYST®|pomalyst®
145923|NCT03288974|Pomalidomide|pomalidomide
145924|NCT03288974|Observational|observational
145925|NCT03288974|Korea|korea
145926|NCT03288974|Post Marketing Surveillance[PMS]|post marketing surveillance[pms]
145927|NCT03288974|Relapsed and Refractory Multiple Myeloma|relapsed and refractory multiple myeloma
145928|NCT03288935|refugee|refugee
145929|NCT03288935|trauma-informed case management (TICM)|trauma-informed case management (ticm)
145930|NCT03288935|trauma-informed cultural orientation (TICO)|trauma-informed cultural orientation (tico)
145931|NCT03288935|PTSD|ptsd
145932|NCT03288935|depression|depression
145933|NCT03288935|refugee resettlement|refugee resettlement
145934|NCT03288922|Online Hemodiafiltration|online hemodiafiltration
145935|NCT03288922|Super high-flux dialyzer|super high-flux dialyzer
145936|NCT03288922|Protein-bound uremic toxin|protein-bound uremic toxin
145937|NCT03288922|P-cresol|p-cresol
145938|NCT03288896|Adolescence|adolescence
145939|NCT03288896|Alcohol Drinking|alcohol drinking
145940|NCT03288896|Binge Drinking|binge drinking
145941|NCT03288896|I-Change model|i-change model
145942|NCT03288896|Web-based interventions|web-based interventions
145943|NCT03288896|Computer-tailoring|computer-tailoring
145944|NCT03288857|Naspira|naspira
145945|NCT03288857|Suctioning|suctioning
145946|NCT03288857|Nasal suction device|nasal suction device
145947|NCT03288857|Children|children
145948|NCT03288844|LSCD, Holoclar, follow-up|lscd, holoclar, follow-up
145949|NCT03288831|Randomized, double-blinded, placebo-controlled trial|randomized, double-blinded, placebo-controlled trial
145950|NCT03288831|Oral food challenge|oral food challenge
145951|NCT03288753|Cochlear implant|cochlear implant
145952|NCT03288714|Transcranial Magnetic Stimulation|transcranial magnetic stimulation
145953|NCT03288714|TMS|tms
145954|NCT03288714|sTMS|stms
145955|NCT03288701|heart failure|heart failure
145956|NCT03288701|cardial decompensation|cardial decompensation
145957|NCT03288701|smart scale|smart scale
145958|NCT03288701|bioimpedance analysis|bioimpedance analysis
145959|NCT03288701|whole body water|whole body water
145960|NCT03288675|Major depressive disorder|major depressive disorder
145961|NCT03288675|Treatment resistant depression|treatment resistant depression
145962|NCT03288675|Accelerated intermittent thetaburst stimulation|accelerated intermittent thetaburst stimulation
145963|NCT03288675|Cognitive control training|cognitive control training
145964|NCT03288675|Neuroimaging|neuroimaging
145965|NCT03288662|Computed tomography|computed tomography
145966|NCT03288662|thymic epithelial tumors|thymic epithelial tumors
145967|NCT03288610|Copeptin|copeptin
145968|NCT03288610|Vasopressin|vasopressin
145969|NCT03288610|Microcirculation|microcirculation
145970|NCT03288610|Inflammation|inflammation
145971|NCT03288610|Vasodilation|vasodilation
145972|NCT03288610|Cardiopulmonary bypass|cardiopulmonary bypass
145973|NCT03288597|positive rate|positive rate
145974|NCT03288597|SUVmax|suvmax
145975|NCT03288597|relationship|relationship
145976|NCT03288584|Arterial stiffness|arterial stiffness
145977|NCT03288584|Endothelial function|endothelial function
145978|NCT03288584|Endothelial glycocalyx|endothelial glycocalyx
145979|NCT03288584|Left ventricular function|left ventricular function
145980|NCT03288584|Apoptosis|apoptosis
145981|NCT03288584|Oxidative stress|oxidative stress
145982|NCT03288571|Diabetes|diabetes
145983|NCT03288571|nephropathy|nephropathy
145984|NCT03288571|Kidney|kidney
145985|NCT03288571|parenchyma|parenchyma
145986|NCT03288571|Wharton Jelly|wharton jelly
145987|NCT03288571|Mesenchymal stem cells|mesenchymal stem cells
145988|NCT03288545|MIUC|miuc
145989|NCT03288545|ASG-22ME|asg-22me
145990|NCT03288545|ASG-22CE|asg-22ce
145991|NCT03288545|Antibody-drug conjugate|antibody-drug conjugate
145992|NCT03288545|Antineoplastic agents|antineoplastic agents
145993|NCT03288545|CPI|cpi
145994|NCT03288545|Enfortumab vedotin|enfortumab vedotin
145995|NCT03288545|MIBC|mibc
145996|NCT03288545|Locally advanced urothelial cancer|locally advanced urothelial cancer
145997|NCT03288545|Cisplatin|cisplatin
145998|NCT03288545|Drug therapy|drug therapy
145999|NCT03288545|Carboplatin|carboplatin
146000|NCT03288545|Metastatic urothelial cancer|metastatic urothelial cancer
146001|NCT03288545|Nectin-4|nectin-4
146002|NCT03288545|Gemcitabine|gemcitabine
146003|NCT03288545|Muscle invasive urothelial cancer|muscle invasive urothelial cancer
146004|NCT03288545|Muscle invasive bladder cancer|muscle invasive bladder cancer
146005|NCT03288545|Checkpoint Inhibitors|checkpoint inhibitors
146006|NCT03288545|Pembrolizumab|pembrolizumab
146007|NCT03288532|Renal Cell Carcinoma|renal cell carcinoma
146008|NCT03288532|Immunotherapy|immunotherapy
146009|NCT03288532|Multi-Arm Multi-Stage|multi-arm multi-stage
146010|NCT03288519|Cerebral aneurysm|cerebral aneurysm
146011|NCT03288519|Endovascular therapy|endovascular therapy
146012|NCT03288519|Classic laryngeal mask airway|classic laryngeal mask airway
146013|NCT03288519|Hemodynamic changes|hemodynamic changes
146014|NCT03288493|CAR-T cells|car-t cells
146015|NCT03288454|Ciraparantag|ciraparantag
146016|NCT03288454|PER977|per977
146017|NCT03288454|Apixaban|apixaban
146018|NCT03288454|Whole Blood Clotting Time (WBCT)|whole blood clotting time (wbct)
146019|NCT03288441|Hematologic Neoplasms|hematologic neoplasms
146020|NCT03288441|Thrombocytopenia|thrombocytopenia
146021|NCT03288441|Anticoagulants|anticoagulants
146022|NCT03288441|Platelet Aggregation Inhibitors|platelet aggregation inhibitors
146023|NCT03288415|Integrated prognostic model|integrated prognostic model
146024|NCT03288389|Membrane Lipid Replacement|membrane lipid replacement
146025|NCT03288389|NTFactor Lipids|ntfactor lipids
146026|NCT03288389|Fibromyalgia|fibromyalgia
146027|NCT03288389|Pain|pain
146028|NCT03288389|Faigue|faigue
146029|NCT03288389|Gastrointestinal symptoms|gastrointestinal symptoms
146030|NCT03288376|obstructive sleep apnea|obstructive sleep apnea
146031|NCT03288376|polysomnography|polysomnography
146032|NCT03288363|tDCS|tdcs
146033|NCT03288363|cognition|cognition
146034|NCT03288350|Phase II Trial|phase ii trial
146035|NCT03288350|Esophago-Gastric Adenocarcinoma|esophago-gastric adenocarcinoma
146036|NCT03288350|Avelumab|avelumab
146037|NCT03288337|Hidradenitis Suppurativa|hidradenitis suppurativa
146038|NCT03288337|Quality of Life|quality of life
146039|NCT03288298|TSCC|tscc
146040|NCT03288298|OSCC|oscc
146041|NCT03288298|luteolin|luteolin
146042|NCT03288298|nanoluteolin|nanoluteolin
146043|NCT03288298|nanotechnology|nanotechnology
146044|NCT03288298|oral cancer|oral cancer
146045|NCT03288298|apoptosis|apoptosis
146046|NCT03288298|PCR|pcr
146047|NCT03288298|MTT|mtt
146048|NCT03288298|ELISA reader|elisa reader
146049|NCT03288285|hemodiafiltration|hemodiafiltration
146050|NCT03288285|pre-dilution|pre-dilution
146051|NCT03288285|post-dilution|post-dilution
146052|NCT03288285|uremic toxins|uremic toxins
146053|NCT03288259|Transnasal endoscopy - Obesity - endoscopy without sedation|transnasal endoscopy - obesity - endoscopy without sedation
146054|NCT03288246|adolescent|adolescent
146055|NCT03288246|HIV|hiv
146056|NCT03288246|point-of-care|point-of-care
146057|NCT03288246|viral load|viral load
146058|NCT03288233|Hemoglobin A1c|hemoglobin a1c
146059|NCT03288233|HbA1c|hba1c
146060|NCT03288233|End tidal carbon monoxide|end tidal carbon monoxide
146061|NCT03288220|Stroke|stroke
146062|NCT03288207|Community-Based Participatory Research|community-based participatory research
146063|NCT03288207|Obesity|obesity
146064|NCT03288207|Cardiovascular Disease Risk|cardiovascular disease risk
146065|NCT03288207|Social Determinants of Health|social determinants of health
146066|NCT03288168|Observation|observation
146067|NCT03288168|Molecular Subgroup|molecular subgroup
146068|NCT03288168|NanoString|nanostring
146069|NCT03288155|Parkinson's|parkinson's
146070|NCT03288155|Fatigue|fatigue
146071|NCT03288155|Flavonoid|flavonoid
146072|NCT03288155|Cocoa|cocoa
146073|NCT03288129|monotherapy|monotherapy
146074|NCT03288129|adjunctive therapy|adjunctive therapy
146075|NCT03288129|open-label|open-label
146076|NCT03288129|multicenter|multicenter
146077|NCT03288064|raisins|raisins
146078|NCT03288064|carbohydrates|carbohydrates
146079|NCT03288064|antioxidant capacity|antioxidant capacity
146080|NCT03288064|substrate oxidation|substrate oxidation
146081|NCT03288064|prolonged cycling|prolonged cycling
146082|NCT03288025|Insulin Resistance|insulin resistance
146083|NCT03288025|Inflammation|inflammation
146084|NCT03288025|Right Ventricular Function|right ventricular function
146085|NCT03288025|Metabolism|metabolism
146086|NCT03288025|Glucose|glucose
146087|NCT03287986|Elderly|elderly
146088|NCT03287986|MRI|mri
146089|NCT03287960|LEPR deficiency obesity|lepr deficiency obesity
146090|NCT03287960|setmelanotide|setmelanotide
146091|NCT03287960|RM-493|rm-493
146092|NCT03287960|Leptin receptor|leptin receptor
146093|NCT03287960|Obesity|obesity
146094|NCT03287960|Melanocortin 4 receptor|melanocortin 4 receptor
146095|NCT03287934|selective laser sintering, stereolithography stents|selective laser sintering, stereolithography stents
146096|NCT03287921|pulmonary care|pulmonary care
146097|NCT03287921|COPD|copd
146098|NCT03287921|small airway disease|small airway disease
146099|NCT03287921|hyperinflation|hyperinflation
146100|NCT03287908|Amgen|amgen
146101|NCT03287908|Phase 1|phase 1
146102|NCT03287908|Clinical Trial|clinical trial
146103|NCT03287908|Oncology/Hematology|oncology/hematology
146104|NCT03287908|Relapsed/Refractory Multiple Myeloma|relapsed/refractory multiple myeloma
146105|NCT03287908|Immunotherapy|immunotherapy
146106|NCT03287895|Cardio-pulmonary resuscitation|cardio-pulmonary resuscitation
146107|NCT03287895|CPR|cpr
146108|NCT03287895|Decision-making|decision-making
146109|NCT03287895|Advance Care Planning|advance care planning
146110|NCT03287895|End of life|end of life
146111|NCT03287895|Code Status|code status
146112|NCT03287895|Goals of Care|goals of care
146113|NCT03287895|Communication|communication
146114|NCT03287882|preconception supplementation|preconception supplementation
146115|NCT03287882|multiple micronutrients|multiple micronutrients
146116|NCT03287882|low birth weight|low birth weight
146117|NCT03287869|Bipolar|bipolar
146118|NCT03287869|Mania|mania
146119|NCT03287869|Brexpiprazole|brexpiprazole
146120|NCT03287856|Valve-in-valve|valve-in-valve
146121|NCT03287856|TAVI|tavi
146122|NCT03287843|Locally advanced rectal cancer|locally advanced rectal cancer
146123|NCT03287843|Neoadjuvant chemoradiation|neoadjuvant chemoradiation
146124|NCT03287830|text message|text message
146125|NCT03287830|Short message service (SMS)|short message service (sms)
146126|NCT03287830|mHealth|mhealth
146127|NCT03287817|Diffuse Large B Cell Lymphoma|diffuse large b cell lymphoma
146128|NCT03287817|Relapsed Diffuse Large B Cell Lymphoma|relapsed diffuse large b cell lymphoma
146129|NCT03287817|Refractory Diffuse Large B Cell Lymphoma|refractory diffuse large b cell lymphoma
146130|NCT03287817|AUTO3|auto3
146131|NCT03287817|PD-1|pd-1
146132|NCT03287817|Anti PD-1 antibody|anti pd-1 antibody
146133|NCT03287804|Multiple Myeloma|multiple myeloma
146134|NCT03287804|Relapsed Multiple Myeloma|relapsed multiple myeloma
146135|NCT03287804|Refractory Multiple Myeloma|refractory multiple myeloma
146136|NCT03287804|AUTO2|auto2
146137|NCT03287778|Pyridoxine|pyridoxine
146138|NCT03287778|Vitamin B6|vitamin b6
146139|NCT03287778|Neurologic Manifestations|neurologic manifestations
146140|NCT03287778|Involuntary Movements|involuntary movements
146141|NCT03287778|Movement Disorder|movement disorder
146142|NCT03287778|Dyskinesias|dyskinesias
146143|NCT03287778|Physiological Effects of Drugs|physiological effects of drugs
146144|NCT03287778|Psychotic Disorders|psychotic disorders
146145|NCT03287778|Schizophrenia Spectrum and Other Psychotic Disorders|schizophrenia spectrum and other psychotic disorders
146146|NCT03287778|Signs and Symptoms|signs and symptoms
146147|NCT03287765|Dementia|dementia
146148|NCT03287765|Tauopathies|tauopathies
146149|NCT03287765|cognitive impairment|cognitive impairment
146150|NCT03287765|CNS Diseases|cns diseases
146151|NCT03287765|neurodegenerative disease|neurodegenerative disease
146152|NCT03287739|Upper Extremity|upper extremity
146153|NCT03287739|Cohort Studies|cohort studies
146154|NCT03287739|Prognosis|prognosis
146155|NCT03287726|Probiotics|probiotics
146156|NCT03287726|Appetite Regulation|appetite regulation
146157|NCT03287726|Gastrointestinal microbiome|gastrointestinal microbiome
146158|NCT03287726|Caloric Restriction|caloric restriction
146159|NCT03287726|Body weight maintenance|body weight maintenance
146160|NCT03287726|Body composition|body composition
146161|NCT03287661|chronic pain|chronic pain
146162|NCT03287661|online treatment|online treatment
146163|NCT03287661|acceptance-based therapy|acceptance-based therapy
146164|NCT03287648|optical coherence tomography|optical coherence tomography
146165|NCT03287648|blue fundus autofluorescence|blue fundus autofluorescence
146166|NCT03287596|Spondylarthropathy|spondylarthropathy
146167|NCT03287596|Tendinopathy|tendinopathy
146168|NCT03287596|MRI|mri
146169|NCT03287596|Healthy Volunteer|healthy volunteer
146170|NCT03287570|Osteoarthritis, Knee|osteoarthritis, knee
146171|NCT03287570|Moxibustion|moxibustion
146172|NCT03287544|Aphasia|aphasia
146173|NCT03287544|Rehabilitation|rehabilitation
146174|NCT03287544|Communication|communication
146175|NCT03287544|Linguistics|linguistics
146176|NCT03287531|conventional therapy|conventional therapy
146177|NCT03287518|Endothelial function|endothelial function
146178|NCT03287518|Blood pressure|blood pressure
146179|NCT03287518|Lipid metabolism|lipid metabolism
146180|NCT03287518|EndoPAT score RHI|endopat score rhi
146181|NCT03287479|vitrification|vitrification
146182|NCT03287479|semi-automated|semi-automated
146183|NCT03287479|manual|manual
146184|NCT03287466|oxygen|oxygen
146185|NCT03287466|oxygen saturation|oxygen saturation
146186|NCT03287466|oxygen concentration|oxygen concentration
146187|NCT03287440|Health Disparities|health disparities
146188|NCT03287440|Lung Diseases|lung diseases
146189|NCT03287440|Self-management|self-management
146190|NCT03287440|Chronic Disease|chronic disease
146191|NCT03287440|Socio-economic status|socio-economic status
146192|NCT03287427|Advanced|advanced
146193|NCT03287427|Metastatic|metastatic
146194|NCT03287401|EEG|eeg
146195|NCT03287401|PACU Delirium|pacu delirium
146196|NCT03287388|Laparoscopic surgery|laparoscopic surgery
146197|NCT03287388|Abdominal working space|abdominal working space
146198|NCT03287388|Moderate neuromuscular blockade|moderate neuromuscular blockade
146199|NCT03287388|Deep neuromuscular blockade|deep neuromuscular blockade
146200|NCT03287388|MRI measurement|mri measurement
146201|NCT03287362|major depressive disorder|major depressive disorder
146202|NCT03287362|cognitive behavioral therapy|cognitive behavioral therapy
146203|NCT03287362|supportive therapy|supportive therapy
146204|NCT03287362|schema therapy|schema therapy
146205|NCT03287362|biomarkers|biomarkers
146206|NCT03287362|neuropsychology|neuropsychology
146207|NCT03287362|circadian rhythm|circadian rhythm
146208|NCT03287336|tranexamic acid|tranexamic acid
146209|NCT03287336|postpartum hemorrhage|postpartum hemorrhage
146210|NCT03287323|palliative care|palliative care
146211|NCT03287323|surgical intensive care|surgical intensive care
146212|NCT03287323|family satisfaction|family satisfaction
146213|NCT03287323|ICU decision-making|icu decision-making
146214|NCT03287323|end-of-life care|end-of-life care
146215|NCT03287310|eosinophils|eosinophils
146216|NCT03287310|pharmacokinetics|pharmacokinetics
146217|NCT03287310|First time in Human|first time in human
146218|NCT03287310|GSK3511294|gsk3511294
146219|NCT03287310|pharmacodynamics|pharmacodynamics
146220|NCT03287310|asthma|asthma
146221|NCT03287271|ovarian cancer|ovarian cancer
146222|NCT03287271|cancer|cancer
146223|NCT03287271|ovary|ovary
146224|NCT03287271|carboplatin|carboplatin
146225|NCT03287271|paclitaxel|paclitaxel
146226|NCT03287271|VS-6063|vs-6063
146227|NCT03287271|primary peritoneal carcinoma|primary peritoneal carcinoma
146228|NCT03287271|fallopian tube|fallopian tube
146229|NCT03287271|defactinib|defactinib
146230|NCT03287258|perineal massage|perineal massage
146231|NCT03287258|health education|health education
146232|NCT03287258|perineal tear|perineal tear
146233|NCT03287258|episiotomy|episiotomy
146234|NCT03287258|pelvic floor muscle exercise|pelvic floor muscle exercise
146235|NCT03287245|polycythemia vera|polycythemia vera
146236|NCT03287245|PV|pv
146237|NCT03287245|P vera|p vera
146238|NCT03287245|myeloproliferative diseases|myeloproliferative diseases
146239|NCT03287245|hematologic diseases|hematologic diseases
146240|NCT03287245|myeloproliferative neoplasm|myeloproliferative neoplasm
146241|NCT03287245|MPN|mpn
146242|NCT03287232|Prasterone|prasterone
146243|NCT03287232|DHEA|dhea
146244|NCT03287232|Menopause|menopause
146245|NCT03287232|Sexual Disorder|sexual disorder
146246|NCT03287180|Adolescent Community Reinforcement Approach|adolescent community reinforcement approach
146247|NCT03287180|A-CRA|a-cra
146248|NCT03287180|Opioid-Related Disorders|opioid-related disorders
146249|NCT03287180|Behavior|behavior
146250|NCT03287180|Psychosocial treatment|psychosocial treatment
146251|NCT03287180|Pharmacotherapy|pharmacotherapy
146252|NCT03287180|Randomized controlled|randomized controlled
146253|NCT03287180|Adolescent|adolescent
146254|NCT03287180|Young adult|young adult
146255|NCT03287154|Alcohol Abstinence|alcohol abstinence
146256|NCT03287154|Alcohol Addiction|alcohol addiction
146257|NCT03287154|Alcohol Consumption|alcohol consumption
146258|NCT03287154|Alcohol Dependence|alcohol dependence
146259|NCT03287141|noninvasive ventilation|noninvasive ventilation
146260|NCT03287141|continuous positive airway pressure|continuous positive airway pressure
146261|NCT03287141|intermittent positive-pressure breathing|intermittent positive-pressure breathing
146262|NCT03287141|exercise test|exercise test
146263|NCT03287141|physical endurance|physical endurance
146264|NCT03287141|physical fitness|physical fitness
146265|NCT03287089|Nitrofurantoin|nitrofurantoin
146266|NCT03287089|Prolapse|prolapse
146267|NCT03287089|Pelvic Organ Prolapse|pelvic organ prolapse
146268|NCT03287089|Anti-incontinence procedure|anti-incontinence procedure
146269|NCT03287089|Urinary retention|urinary retention
146270|NCT03287089|Urinary Tract Infection|urinary tract infection
146271|NCT03287089|Short-term catheterization|short-term catheterization
146272|NCT03287076|stroke|stroke
146273|NCT03287076|glucose|glucose
146274|NCT03287076|exenatide|exenatide
146275|NCT03287037|Unipolar depression|unipolar depression
146276|NCT03287037|bipolar depression|bipolar depression
146277|NCT03287037|Transcranial direct current stimulation|transcranial direct current stimulation
146278|NCT03287011|dental plaque|dental plaque
146279|NCT03287011|tooth pastes|tooth pastes
146280|NCT03287011|oral hygiene|oral hygiene
146281|NCT03286998|placenta previa|placenta previa
146282|NCT03286998|color doppler|color doppler
146283|NCT03286998|placenta accreta|placenta accreta
146284|NCT03286998|ultrasonography|ultrasonography
146285|NCT03286933|yoga therapy|yoga therapy
146286|NCT03286933|JIA|jia
146287|NCT03286933|quality of life|quality of life
146288|NCT03286933|pain management|pain management
146289|NCT03286920|home nutrition|home nutrition
146290|NCT03286920|BMI|bmi
146291|NCT03286920|postoperative|postoperative
146292|NCT03286920|body weight|body weight
146293|NCT03286907|Uptake of HPV vaccination|uptake of hpv vaccination
146294|NCT03286881|Common Mental Disorders|common mental disorders
146295|NCT03286881|Brief Psychological Treatments|brief psychological treatments
146296|NCT03286881|Primary Care|primary care
146297|NCT03286881|Randomized Clinical Trial|randomized clinical trial
146298|NCT03286842|HER2-ve metastatic breast cancer|her2-ve metastatic breast cancer
146299|NCT03286842|Germline BRCA1/2 mutations|germline brca1/2 mutations
146300|NCT03286842|Somatic BRCA1/2 mutations|somatic brca1/2 mutations
146301|NCT03286842|BRCA1|brca1
146302|NCT03286842|BRCA2|brca2
146303|NCT03286816|type 1 diabetes mellitus|type 1 diabetes mellitus
146304|NCT03286816|impaired awareness of hypoglycemia|impaired awareness of hypoglycemia
146305|NCT03286816|lactate|lactate
146306|NCT03286816|MR spectroscopy|mr spectroscopy
146307|NCT03286790|elderly|elderly
146308|NCT03286777|6-prenylnaringenin|6-prenylnaringenin
146309|NCT03286777|Bioavailability|bioavailability
146310|NCT03286777|Pharmacokinetics|pharmacokinetics
146311|NCT03286777|PBMC|pbmc
146312|NCT03286712|Flow mediated dilatation|flow mediated dilatation
146313|NCT03286712|Brachial artery|brachial artery
146314|NCT03286712|Anemia|anemia
146315|NCT03286712|Chronic kidney disease|chronic kidney disease
146316|NCT03286712|Renogen|renogen
146317|NCT03286712|Erythropoietin Alpha|erythropoietin alpha
146318|NCT03286686|optic ataxia|optic ataxia
146319|NCT03286686|posterior parietal cortex functions|posterior parietal cortex functions
146320|NCT03286686|multisensory integration|multisensory integration
146321|NCT03286673|calcium carbonate|calcium carbonate
146322|NCT03286673|calcium phosphate|calcium phosphate
146323|NCT03286673|metabolic effects|metabolic effects
146324|NCT03286673|human study|human study
146325|NCT03286673|calcium and phosphorus metabolism|calcium and phosphorus metabolism
146326|NCT03286660|Exercise tests|exercise tests
146327|NCT03286660|COPD|copd
146328|NCT03286660|Rehabilitation|rehabilitation
146329|NCT03286647|grief, periodontal disease|grief, periodontal disease
146330|NCT03286621|eye tracking|eye tracking
146331|NCT03286621|visual preference|visual preference
146332|NCT03286595|early psychosis|early psychosis
146333|NCT03286595|clinical high risk|clinical high risk
146334|NCT03286595|mobile health|mobile health
146335|NCT03286556|Acute Exacerbation of Idiopathic Pulmonary Fibrosis|acute exacerbation of idiopathic pulmonary fibrosis
146336|NCT03286543|electrical stimulation|electrical stimulation
146337|NCT03286543|neurostimulation|neurostimulation
146338|NCT03286543|TKA pain|tka pain
146339|NCT03286543|pain following total knee replacement|pain following total knee replacement
146340|NCT03286543|total knee arthroplasty|total knee arthroplasty
146341|NCT03286530|Acute Myeloid Leukemia|acute myeloid leukemia
146342|NCT03286530|Acute Myeloid Leukemia in Remission|acute myeloid leukemia in remission
146343|NCT03286530|Allogenic Stem Cell Transplantation|allogenic stem cell transplantation
146344|NCT03286517|Puberty, Sexuality|puberty, sexuality
146345|NCT03286491|acute coronary syndrome, risk classification, 30 day adverse event, clinical decision support system|acute coronary syndrome, risk classification, 30 day adverse event, clinical decision support system
146346|NCT03286478|body image|body image
146347|NCT03286478|school|school
146348|NCT03286478|adolescence|adolescence
146349|NCT03286478|intervention|intervention
146350|NCT03286478|task-shifting|task-shifting
146351|NCT03286465|blood transfusion|blood transfusion
146352|NCT03286452|Antimicrobial|antimicrobial
146353|NCT03286452|Collagen|collagen
146354|NCT03286452|Bioburden|bioburden
146355|NCT03286452|Biofilm|biofilm
146356|NCT03286452|PHMB|phmb
146357|NCT03286452|Chronic wounds|chronic wounds
146358|NCT03286452|Acute wounds|acute wounds
146359|NCT03286426|vision screening|vision screening
146360|NCT03286426|portable fundus camera|portable fundus camera
146361|NCT03286426|acne medication|acne medication
146362|NCT03286400|CTAG|ctag
146363|NCT03286400|TEVAR|tevar
146364|NCT03286387|Memory|memory
146365|NCT03286387|naturalistic|naturalistic
146366|NCT03286387|context|context
146367|NCT03286387|fMRI|fmri
146368|NCT03286387|Attention|attention
146369|NCT03286374|Obesity|obesity
146370|NCT03286374|Occupational rehabilitation|occupational rehabilitation
146371|NCT03286374|Sick leave|sick leave
146372|NCT03286374|Life style treatment|life style treatment
146373|NCT03286335|Brain Tumor|brain tumor
146374|NCT03286283|Rhytides|rhytides
146375|NCT03286283|Wrinkle Reduction|wrinkle reduction
146376|NCT03286283|J-Plasma|j-plasma
146377|NCT03286283|Dermal Resurfacing|dermal resurfacing
146378|NCT03286270|mRUS|mrus
146379|NCT03286270|validation tool|validation tool
146380|NCT03286270|Impaired fractures|impaired fractures
146381|NCT03286257|Vascular function|vascular function
146382|NCT03286257|Vascular structure|vascular structure
146383|NCT03286257|Thermoregulation|thermoregulation
146384|NCT03286257|Hot flushes|hot flushes
146385|NCT03286257|Cerebral blood flow|cerebral blood flow
146386|NCT03286257|Exercise training|exercise training
146387|NCT03286231|gluteal venous vasculature|gluteal venous vasculature
146388|NCT03286231|prone position|prone position
146389|NCT03286231|jackknife position|jackknife position
146390|NCT03286153|Hemophilia A|hemophilia a
146391|NCT03286153|FVIII|fviii
146392|NCT03286153|Ideal body weight|ideal body weight
146393|NCT03286153|Actual body weight|actual body weight
146394|NCT03286140|endovenous ablation|endovenous ablation
146395|NCT03286075|DLPFC, tDCS, emotional processing|dlpfc, tdcs, emotional processing
146396|NCT03286036|Biomarkers, early detection|biomarkers, early detection
146397|NCT03286023|brain metastases|brain metastases
146398|NCT03286023|stereotactic radiation|stereotactic radiation
146399|NCT03286023|cyberknife|cyberknife
146400|NCT03285997|Quadrivalent Influenza Vaccines|quadrivalent influenza vaccines
146401|NCT03285945|Positron-Emission Tomography|positron-emission tomography
146402|NCT03285932|Brain Metastase|brain metastase
146403|NCT03285932|Radiation of resection cavity|radiation of resection cavity
146404|NCT03285932|WBRT (whole brain radiotherapy)|wbrt (whole brain radiotherapy)
146405|NCT03285932|SRS (stereotactic radiosurgery)|srs (stereotactic radiosurgery)
146406|NCT03285919|perturbed walking|perturbed walking
146407|NCT03285919|stepping response|stepping response
146409|NCT03285854|Dialysis|dialysis
146410|NCT03285854|calcium|calcium
146411|NCT03285854|mineral and bone disorder (MBD)|mineral and bone disorder (mbd)
146412|NCT03285854|calcification|calcification
146413|NCT03285854|DEXA|dexa
146414|NCT03285854|peripheral quantitative CT scan (pqCT)|peripheral quantitative ct scan (pqct)
146415|NCT03285841|cervical cancer|cervical cancer
146416|NCT03285841|vulvar cancer|vulvar cancer
146417|NCT03285841|optical coherence tomography|optical coherence tomography
146418|NCT03285841|autofluorescence imaging|autofluorescence imaging
146419|NCT03285828|medical education, motivational interviewing, medical empathy|medical education, motivational interviewing, medical empathy
146420|NCT03285789|Dyslexia|dyslexia
146421|NCT03285789|Visual Fields|visual fields
146422|NCT03285789|visual attention span|visual attention span
146423|NCT03285789|visual search|visual search
146424|NCT03285789|visual attention field|visual attention field
146425|NCT03285750|GRP120|grp120
146426|NCT03285750|Adipose tissue|adipose tissue
146427|NCT03285750|Type 2 diabetes|type 2 diabetes
146428|NCT03285737|Protein ingestion|protein ingestion
146429|NCT03285737|Muscle protein synthesis|muscle protein synthesis
146430|NCT03285724|Mitral Valve Repair|mitral valve repair
146431|NCT03285724|Transapical|transapical
146432|NCT03285724|artificial chordae|artificial chordae
146433|NCT03285724|bi-leaflet prolapse|bi-leaflet prolapse
146434|NCT03285724|anterior prolapse|anterior prolapse
146435|NCT03285724|posterior prolapse|posterior prolapse
146436|NCT03285685|Analgesia|analgesia
146437|NCT03285685|Facial pain|facial pain
146438|NCT03285685|Transcranial Direct Current Stimulation|transcranial direct current stimulation
146439|NCT03285685|Temporomandibular disorders|temporomandibular disorders
146440|NCT03285672|Hot Flashes, vasomotor symptoms, postmenopausal|hot flashes, vasomotor symptoms, postmenopausal
146441|NCT03285659|depression|depression
146442|NCT03285659|Primary Health Care|primary health care
146443|NCT03285659|Health Plan Implementation|health plan implementation
146444|NCT03285659|Collaborative care|collaborative care
146445|NCT03285659|Patient-Centered Care|patient-centered care
146446|NCT03285646|Knee|knee
146447|NCT03285646|Hip|hip
146448|NCT03285555|barbed suture|barbed suture
146449|NCT03285555|knoteless suture|knoteless suture
146450|NCT03285555|closure|closure
146451|NCT03285555|wound|wound
146452|NCT03285555|time|time
146453|NCT03285555|total hip arthroplasty|total hip arthroplasty
146454|NCT03285542|adhesive|adhesive
146455|NCT03285542|total knee arthroplasty|total knee arthroplasty
146456|NCT03285542|wound|wound
146457|NCT03285542|closure|closure
146458|NCT03285542|time|time
146459|NCT03285542|barbed suture|barbed suture
146460|NCT03285542|knoteless suture|knoteless suture
146461|NCT03285529|barbed suture|barbed suture
146462|NCT03285529|knoteless suture|knoteless suture
146463|NCT03285529|total knee arthroplasty|total knee arthroplasty
146464|NCT03285529|wound|wound
146465|NCT03285529|closure|closure
146466|NCT03285529|time|time
146467|NCT03285516|transdiagnostic treatment|transdiagnostic treatment
146468|NCT03285516|emotional disorders|emotional disorders
146469|NCT03285516|veterans|veterans
146470|NCT03285516|rural|rural
146471|NCT03285490|Actinic Keratosis|actinic keratosis
146472|NCT03285490|Keratosis|keratosis
146473|NCT03285490|Keratosis, Actinic|keratosis, actinic
146474|NCT03285490|Precancerous Conditions|precancerous conditions
146475|NCT03285490|Neoplasms|neoplasms
146476|NCT03285490|Sun Damaged Skin|sun damaged skin
146477|NCT03285490|Actinic Keratoses|actinic keratoses
146478|NCT03285477|Actinic Keratosis|actinic keratosis
146479|NCT03285477|Keratosis|keratosis
146480|NCT03285477|Keratosis, Actinic|keratosis, actinic
146481|NCT03285477|Skin Diseases|skin diseases
146482|NCT03285477|Actinic Keratoses|actinic keratoses
146483|NCT03285477|Precancerous Conditions|precancerous conditions
146484|NCT03285477|Neoplasms|neoplasms
146485|NCT03285464|knee|knee
146487|NCT03285464|exercise|exercise
146488|NCT03285464|proximal control|proximal control
146489|NCT03285464|PFPS|pfps
146490|NCT03285451|Submental ultrasound, Obstructive sleep apnea|submental ultrasound, obstructive sleep apnea
146491|NCT03285438|Venous Thromboembolism|venous thromboembolism
146492|NCT03285438|Anticoagulant|anticoagulant
146493|NCT03285438|Direct oral anticoagulant|direct oral anticoagulant
146494|NCT03285438|risk of recurrent venous thromboembolism|risk of recurrent venous thromboembolism
146495|NCT03285438|anticoagulant-related bleeding|anticoagulant-related bleeding
146496|NCT03285425|Batten's disease|batten's disease
146497|NCT03285425|Neuronal Ceroid Lipofuscinosis|neuronal ceroid lipofuscinosis
146498|NCT03285412|Breast Cancer|breast cancer
146499|NCT03285399|Nepal|nepal
146500|NCT03285399|Breastfeeding|breastfeeding
146501|NCT03285399|Micronutrients|micronutrients
146502|NCT03285399|Women|women
146503|NCT03285399|Infants|infants
146504|NCT03285360|Bifluoride, sylc, hypersensitivity,|bifluoride, sylc, hypersensitivity,
146505|NCT03285347|parkinson|parkinson
146506|NCT03285347|executive dysfunction|executive dysfunction
146507|NCT03285347|attention|attention
146508|NCT03285347|computer-based cognitive training|computer-based cognitive training
146509|NCT03285321|Nivolumab|nivolumab
146510|NCT03285321|Ipilimumab|ipilimumab
146511|NCT03285321|immunotherapy|immunotherapy
146512|NCT03285269|shock|shock
146513|NCT03285269|ultrasound|ultrasound
146514|NCT03285256|Prospective memory, working memory, substance abuse|prospective memory, working memory, substance abuse
146515|NCT03285243|Delirium, anesthesia, pediatrics|delirium, anesthesia, pediatrics
146516|NCT03285217|HMB|hmb
146517|NCT03285204|optical coherence tomography|optical coherence tomography
146518|NCT03285204|amyotrophic lateral sclerosis|amyotrophic lateral sclerosis
146519|NCT03285191|NRS|nrs
146520|NCT03285191|Concept elicitation|concept elicitation
146521|NCT03285191|Real-time data capture|real-time data capture
146522|NCT03285191|Rheumatoid arthritis|rheumatoid arthritis
146523|NCT03285191|GSK3196165|gsk3196165
146524|NCT03285178|Sickle Cell Disease|sickle cell disease
146525|NCT03285178|SCD|scd
146526|NCT03285178|Olinciguat|olinciguat
146527|NCT03285178|IW-1701|iw-1701
146528|NCT03285152|Ketogenic Diet|ketogenic diet
146529|NCT03285152|17-396|17-396
146530|NCT03285139|Postpartum depression|postpartum depression
146531|NCT03285139|CBT|cbt
146532|NCT03285139|Lay Peer|lay peer
146533|NCT03285074|Diagnostic discordance of obesity|diagnostic discordance of obesity
146534|NCT03285074|all-cause mortality|all-cause mortality
146535|NCT03285048|cognitive impairment|cognitive impairment
146536|NCT03285035|Cryotherapy|cryotherapy
146537|NCT03285035|Palliation|palliation
146538|NCT03285035|Dysphagia|dysphagia
146539|NCT03285022|Incomplete caries removel|incomplete caries removel
146540|NCT03285022|Partial caries removel|partial caries removel
146541|NCT03284970|Interferon beta-1a|interferon beta-1a
146542|NCT03284970|Dimethyl fumarate|dimethyl fumarate
146543|NCT03284970|Rebif|rebif
146544|NCT03284970|Tecfidera|tecfidera
146545|NCT03284970|Relapsing-Remitting Multiple Sclerosis|relapsing-remitting multiple sclerosis
146546|NCT03284892|postextubation dysphagia|postextubation dysphagia
146547|NCT03284892|endotracheal intubation|endotracheal intubation
146548|NCT03284892|randomized controlled trial|randomized controlled trial
146549|NCT03284892|dysphagia intervention|dysphagia intervention
146550|NCT03284892|dysphagia screening|dysphagia screening
146551|NCT03284879|Psoriasis vulgaris|psoriasis vulgaris
146552|NCT03284879|Psoriasis arthropathica|psoriasis arthropathica
146553|NCT03284879|Serious infections|serious infections
146554|NCT03284879|Gastrointestinal Disorders|gastrointestinal disorders
146555|NCT03284879|Serious Hypersensitivity|serious hypersensitivity
146556|NCT03284879|Weight Decrease|weight decrease
146557|NCT03284879|Vasculitis|vasculitis
146558|NCT03284879|Malignancies|malignancies
146559|NCT03284879|Depression and Suicidal Ideation|depression and suicidal ideation
146560|NCT03284840|dietary intake|dietary intake
146561|NCT03284840|nutritional status|nutritional status
146562|NCT03284840|micronutrients|micronutrients
146563|NCT03284840|thyroid health|thyroid health
146564|NCT03284827|edoxaban|edoxaban
146565|NCT03284827|dual antiplatelet therapy|dual antiplatelet therapy
146566|NCT03284827|cerebral embolization|cerebral embolization
146567|NCT03284827|leaflet thrombosis|leaflet thrombosis
146568|NCT03284814|coenzyme q10|coenzyme q10
146569|NCT03284814|single dose bioavailability|single dose bioavailability
146570|NCT03284814|multiple dose bioavailability|multiple dose bioavailability
146571|NCT03284788|acceptance-based therapy|acceptance-based therapy
146572|NCT03284788|adolescents|adolescents
146573|NCT03284788|weight|weight
146574|NCT03284788|weight loss|weight loss
146575|NCT03284788|obesity|obesity
146576|NCT03284788|overweight|overweight
146577|NCT03284749|Copper Oxide|copper oxide
146578|NCT03284749|Antibiotic Resistance|antibiotic resistance
146579|NCT03284723|HER2|her2
146580|NCT03284723|PF-06804103|pf-06804103
146582|NCT03284723|breast cancer|breast cancer
146583|NCT03284723|gastric cancer|gastric cancer
146584|NCT03284723|esophagogastric cancer|esophagogastric cancer
146585|NCT03284723|non-small cell lung cancer|non-small cell lung cancer
146586|NCT03284723|neoplasms|neoplasms
146587|NCT03284723|solid tumors|solid tumors
146588|NCT03284723|human epidermal growth receptor 2|human epidermal growth receptor 2
146589|NCT03284723|NSCLC|nsclc
146590|NCT03284710|HIV|hiv
146591|NCT03284671|Transcranial Direct Current Stimulation|transcranial direct current stimulation
146592|NCT03284671|Supplementary motor area|supplementary motor area
146593|NCT03284671|Orbitofrontal cortex|orbitofrontal cortex
146594|NCT03284658|Tyrosinemia Type 1|tyrosinemia type 1
146595|NCT03284658|Biomarker|biomarker
146596|NCT03284632|Tobacco|tobacco
146597|NCT03284632|E-Cigarettes|e-cigarettes
146598|NCT03284632|Toxicants|toxicants
146599|NCT03284632|Formaldehyde DNA Adducts|formaldehyde dna adducts
146600|NCT03284632|Oxidative Damage|oxidative damage
146601|NCT03284567|Breast cancer|breast cancer
146602|NCT03284567|Football|football
146603|NCT03284567|Late effects|late effects
146604|NCT03284567|Physical exercise|physical exercise
146605|NCT03284567|Soccer training|soccer training
146606|NCT03284567|Rehabilitation|rehabilitation
146607|NCT03284567|Bone mineralization|bone mineralization
146608|NCT03284567|Body composition|body composition
146609|NCT03284567|Fitness|fitness
146610|NCT03284567|Aerobic capacity|aerobic capacity
146611|NCT03284554|Satiety|satiety
146612|NCT03284554|Nutrients|nutrients
146613|NCT03284554|Appetite|appetite
146614|NCT03284554|Encapsulation|encapsulation
146615|NCT03284554|Lipid|lipid
146616|NCT03284554|Amino acid|amino acid
146617|NCT03284554|Probiotic bacteria|probiotic bacteria
146618|NCT03284489|Pancreatitis|pancreatitis
146619|NCT03284476|Nosocomial Peritonitis|nosocomial peritonitis
146620|NCT03284476|Community-acquired Peritonitis|community-acquired peritonitis
146621|NCT03284476|Post-operative Peritonitis|post-operative peritonitis
146622|NCT03284463|acute ischemic stroke|acute ischemic stroke
146623|NCT03284463|glibenclamide|glibenclamide
146624|NCT03284463|rt-PA|rt-pa
146625|NCT03284463|blood-brain barrier|blood-brain barrier
146626|NCT03284463|brain edema|brain edema
146627|NCT03284450|Dance|dance
146628|NCT03284450|Sprint|sprint
146629|NCT03284450|Females|females
146630|NCT03284450|Recovery|recovery
146631|NCT03284424|PD1|pd1
146632|NCT03284424|PD-1|pd-1
146633|NCT03284424|PDL1|pdl1
146634|NCT03284424|PD-L1|pd-l1
146635|NCT03284398|parenteral nutrition|parenteral nutrition
146636|NCT03284398|ICU|icu
146637|NCT03284398|3-chamber bags|3-chamber bags
146638|NCT03284398|ICD-9-CM|icd-9-cm
146639|NCT03284398|BSI|bsi
146640|NCT03284398|Medical records system|medical records system
146641|NCT03284398|computerized|computerized
146642|NCT03284359|Critical Illness|critical illness
146643|NCT03284359|Mechanical Ventilation|mechanical ventilation
146644|NCT03284359|Economics, Behavioral|economics, behavioral
146645|NCT03284359|Surrogate decision maker|surrogate decision maker
146646|NCT03284307|Sedation|sedation
146647|NCT03284307|Propofol|propofol
146648|NCT03284307|Dexmedetomidine|dexmedetomidine
146649|NCT03284307|Ketamine|ketamine
146650|NCT03284307|Sevoflurane|sevoflurane
146651|NCT03284307|Electroencephalogram|electroencephalogram
146652|NCT03284268|Gene therapy|gene therapy
146653|NCT03284255|Bioresorbable Vascular Scaffold System|bioresorbable vascular scaffold system
146654|NCT03284255|Percutaneous Coronary Intervention|percutaneous coronary intervention
146655|NCT03284255|Cardiac Catheterization|cardiac catheterization
146656|NCT03284255|Tomography, Optical Coherence|tomography, optical coherence
146657|NCT03284242|Kidney|kidney
146658|NCT03284242|Transplant|transplant
146659|NCT03284229|ELCA|elca
146660|NCT03284229|Coronary Artery Disease|coronary artery disease
146661|NCT03284229|India|india
146662|NCT03284151|prostate cancer|prostate cancer
146663|NCT03284151|good prognosis|good prognosis
146664|NCT03284151|focused treatment|focused treatment
146665|NCT03284151|Cyberknife|cyberknife
146666|NCT03284138|Schizophrenia|schizophrenia
146667|NCT03284138|rTMS|rtms
146668|NCT03284138|first rank symptoms|first rank symptoms
146669|NCT03284112|Dementia, Schools, Nutrition, Health|dementia, schools, nutrition, health
146670|NCT03284086|Oxygen consumption|oxygen consumption
146671|NCT03284086|Physical endurance|physical endurance
146672|NCT03284073|uterus|uterus
146673|NCT03284073|transplantation|transplantation
146674|NCT03284073|infertility|infertility
146675|NCT03284060|Cognitive remediation, 22q11.2 deletion syndrome|cognitive remediation, 22q11.2 deletion syndrome
146676|NCT03284008|Breast Neoplasm|breast neoplasm
146677|NCT03284008|Physiotherapy|physiotherapy
146678|NCT03284008|Rehabilitation|rehabilitation
146679|NCT03283982|Ventral Hernia|ventral hernia
146680|NCT03283982|Robotic|robotic
146681|NCT03283982|Laparoscopic|laparoscopic
146682|NCT03283982|Pain scores|pain scores
146683|NCT03283930|anxiety, cbt, abmt|anxiety, cbt, abmt
146684|NCT03283904|Children|children
146685|NCT03283904|Schools|schools
146686|NCT03283891|Educational intervention|educational intervention
146687|NCT03283891|Watson's theory of human caring|watson's theory of human caring
146688|NCT03283891|Quality of working life of haemodialysis nurses|quality of working life of haemodialysis nurses
146689|NCT03283891|Quality of life of haemodialysis patients|quality of life of haemodialysis patients
146690|NCT03283839|Temporo-mandibular dysfunction|temporo-mandibular dysfunction
146691|NCT03283839|Balance control|balance control
146692|NCT03283839|Orientation function|orientation function
146693|NCT03283826|Multiple Sclerosis (MS)|multiple sclerosis (ms)
146694|NCT03283826|Primary Progressive Multiple Sclerosis|primary progressive multiple sclerosis
146695|NCT03283826|Secondary Progressive Multiple Sclerosis|secondary progressive multiple sclerosis
146696|NCT03283826|Epstein-Barr Virus (EBV)|epstein-barr virus (ebv)
146697|NCT03283826|EBV-associated Multiple Sclerosis|ebv-associated multiple sclerosis
146698|NCT03283826|Inflammation|inflammation
146699|NCT03283826|Central Nervous System|central nervous system
146700|NCT03283826|Autoimmune Disease|autoimmune disease
146701|NCT03283826|Autoimmunity|autoimmunity
146702|NCT03283826|Demyelination|demyelination
146703|NCT03283826|Cell Therapy|cell therapy
146704|NCT03283826|T-cell|t-cell
146705|NCT03283826|Allogeneic|allogeneic
146706|NCT03283826|EBV viremia|ebv viremia
146707|NCT03283826|Off-the-shelf (T cells)|off-the-shelf (t cells)
146708|NCT03283813|Paediatric Obesity|paediatric obesity
146709|NCT03283813|Insulin resistance|insulin resistance
146710|NCT03283813|Zinc|zinc
146711|NCT03283813|Myo-inositol|myo-inositol
146712|NCT03283800|Copper Oxide|copper oxide
146713|NCT03283800|Compression Therapy|compression therapy
146714|NCT03283800|Chronic Venous Disease|chronic venous disease
146715|NCT03283800|Randomised Controlled Trial|randomised controlled trial
146716|NCT03283800|Lipodermatosclerosis|lipodermatosclerosis
146717|NCT03283787|Pressure Ulcer|pressure ulcer
146718|NCT03283787|ACell|acell
146719|NCT03283787|ACell MicroMatrix®|acell micromatrix®
146720|NCT03283787|ACell Cytal™|acell cytal™
146721|NCT03283787|Extracellular Matrix|extracellular matrix
146722|NCT03283787|Urinary Bladder Matrix|urinary bladder matrix
146723|NCT03283787|Wound|wound
146724|NCT03283761|FOLFOX|folfox
146725|NCT03283761|Nab-Paclitaxel|nab-paclitaxel
146726|NCT03283735|Deprescribing|deprescribing
146727|NCT03283735|Polypharmacy|polypharmacy
146728|NCT03283735|Elderly|elderly
146729|NCT03283735|Enablement|enablement
146730|NCT03283735|Quality of Life|quality of life
146731|NCT03283683|rest-activity rhythm|rest-activity rhythm
146732|NCT03283683|survival|survival
146733|NCT03283683|actigraphy|actigraphy
146734|NCT03283670|Depression|depression
146735|NCT03283670|treatment-resistant|treatment-resistant
146736|NCT03283644|gastric bypass|gastric bypass
146737|NCT03283644|Obesity|obesity
146738|NCT03283644|Morbid obesity|morbid obesity
146739|NCT03283644|Matched Healthy Controls|matched healthy controls
146740|NCT03283631|Malignant Glioma|malignant glioma
146741|NCT03283631|INTERCEPT|intercept
146742|NCT03283631|Pro00083828|pro00083828
146743|NCT03283631|Adult|adult
146744|NCT03283631|Chimeric Antigen Receptor|chimeric antigen receptor
146745|NCT03283631|CAR T cell|car t cell
146746|NCT03283631|EGFRvIII|egfrviii
146747|NCT03283618|Weight loss|weight loss
146748|NCT03283618|Video conferencing|video conferencing
146749|NCT03283618|Health coaching|health coaching
146750|NCT03283618|Telemedicine|telemedicine
146751|NCT03283618|mHealth|mhealth
146752|NCT03283618|Obesity|obesity
146753|NCT03283566|Pancreatectomy|pancreatectomy
146754|NCT03283566|Autologous Islet Transplantation|autologous islet transplantation
146755|NCT03283566|Pancreatitis|pancreatitis
146756|NCT03283566|Diabetes|diabetes
146757|NCT03283566|Hydroxychloroquine|hydroxychloroquine
146758|NCT03283553|breast cancer|breast cancer
146759|NCT03283540|Low Anterior Resection|low anterior resection
146760|NCT03283501|TAVI|tavi
146761|NCT03283501|PCI|pci
146762|NCT03283488|anorexia|anorexia
146763|NCT03283488|cachexia|cachexia
146764|NCT03283488|mirtazapine|mirtazapine
146765|NCT03283488|megestrol|megestrol
146766|NCT03283488|palliative care|palliative care
146767|NCT03283436|Laparoscopy|laparoscopy
146768|NCT03283436|Superior hypogastric plexus block|superior hypogastric plexus block
146769|NCT03283410|propofol|propofol
146770|NCT03283410|dose-response|dose-response
146771|NCT03283410|elderly|elderly
146772|NCT03283410|young adults|young adults
146773|NCT03283384|Breast cancer|breast cancer
146774|NCT03283384|Ribociclib|ribociclib
146775|NCT03283384|Letrozole|letrozole
146776|NCT03283384|Chemotherapy|chemotherapy
146777|NCT03283384|CDK4|cdk4
146778|NCT03283384|CDK6|cdk6
146779|NCT03283384|Ki67|ki67
146780|NCT03283384|NEOLBC|neolbc
146781|NCT03283371|Drug Resistant Focal Epilepsy, Natalizumab, Seizure|drug resistant focal epilepsy, natalizumab, seizure
146782|NCT03283358|Prevention and control|prevention and control
146783|NCT03283345|breast cancer|breast cancer
146784|NCT03283345|menstrual cycle|menstrual cycle
146785|NCT03283345|breast surgery|breast surgery
146786|NCT03283345|systemic responses to trauma|systemic responses to trauma
146787|NCT03283332|Ethnicity|ethnicity
146788|NCT03283332|adolescents|adolescents
146789|NCT03283332|cohort|cohort
146790|NCT03283332|longitudinal|longitudinal
146791|NCT03283332|health inequalities|health inequalities
146792|NCT03283319|Influenza|influenza
146793|NCT03283319|human|human
146794|NCT03283319|Influenza in Birds|influenza in birds
146795|NCT03283319|Orthomyxoviridae Infections|orthomyxoviridae infections
146796|NCT03283319|RNA Virus Infections|rna virus infections
146797|NCT03283319|Virus Diseases|virus diseases
146798|NCT03283319|Respiratory Tract Infections|respiratory tract infections
146799|NCT03283319|Respiratory Tract Diseases|respiratory tract diseases
146800|NCT03283319|MF59|mf59
146801|NCT03283319|AS03|as03
146802|NCT03283319|Adjuvants|adjuvants
146803|NCT03283319|Immunologic|immunologic
146804|NCT03283293|Neoadjuvant Chemotherapy|neoadjuvant chemotherapy
146805|NCT03283293|Intensity-modulated Radiation Therapy|intensity-modulated radiation therapy
146806|NCT03283293|Target Volume Delineation|target volume delineation
146807|NCT03283293|Locoregional Failure Pattern|locoregional failure pattern
146808|NCT03283293|Nasopharyngeal Carcinoma|nasopharyngeal carcinoma
146809|NCT03283280|Short fiber reinforced resin composite|short fiber reinforced resin composite
146810|NCT03283280|Nanohybrid resin composite|nanohybrid resin composite
146811|NCT03283280|Indirect resin composite restoration|indirect resin composite restoration
146812|NCT03283267|Healthy Chinese Subjects, Pharmacodynamic Study|healthy chinese subjects, pharmacodynamic study
146813|NCT03283254|Postpartum Depression Treatment|postpartum depression treatment
146814|NCT03283202|Diffuse B-Cell Lymphoma|diffuse b-cell lymphoma
146815|NCT03283202|R-CHOP-21|r-chop-21
146816|NCT03283202|International Prognostic Index (IPI)|international prognostic index (ipi)
146817|NCT03283189|Use of cosmetics|use of cosmetics
146818|NCT03283189|Pregnant women|pregnant women
146819|NCT03283189|Risk perception|risk perception
146820|NCT03283189|Preventive attitude|preventive attitude
146821|NCT03283189|Qualitative study|qualitative study
146822|NCT03283150|Deep Brain Stimulation(DBS)|deep brain stimulation(dbs)
146823|NCT03283150|Sedation|sedation
146824|NCT03283150|DBS Implantation|dbs implantation
146825|NCT03283150|Microelectrode recording(MER)|microelectrode recording(mer)
146826|NCT03283137|CLL|cll
146827|NCT03283137|B-cell Non Hodgkin Lymphoma|b-cell non hodgkin lymphoma
146828|NCT03283137|pembrolizumab|pembrolizumab
146829|NCT03283137|TGR-1202|tgr-1202
146830|NCT03283098|Secondary hyperparathyroidism|secondary hyperparathyroidism
146831|NCT03283098|Chronic kidney disease CKD|chronic kidney disease ckd
146832|NCT03283098|Intact parathyroid hormone iPTH|intact parathyroid hormone ipth
146833|NCT03283098|Hemodialysis|hemodialysis
146834|NCT03283085|Immunosuppressants|immunosuppressants
146835|NCT03283085|Mesalamine|mesalamine
146836|NCT03283085|Ulcerative Colitis|ulcerative colitis
146837|NCT03283085|Crohn's disease|crohn's disease
146838|NCT03283085|Gastroenteritis|gastroenteritis
146839|NCT03283072|thermal threshold|thermal threshold
146840|NCT03283072|pressure pain threshold|pressure pain threshold
146841|NCT03283072|temporal summation|temporal summation
146842|NCT03283046|Multiple myeloma|multiple myeloma
146843|NCT03283046|Newly diagnosed|newly diagnosed
146844|NCT03283046|Nivolumab|nivolumab
146845|NCT03283046|BMS-936558|bms-936558
146846|NCT03283046|Opdivo|opdivo
146847|NCT03283046|Lenalidomide|lenalidomide
146848|NCT03283046|CC-5013|cc-5013
146849|NCT03283046|Revlimid|revlimid
146850|NCT03283046|Dexamethasone|dexamethasone
146851|NCT03283046|Decadron|decadron
146852|NCT03283046|Ipilimumab|ipilimumab
146853|NCT03283046|Yervoy|yervoy
146854|NCT03283046|BMS-734016|bms-734016
146855|NCT03283046|MDX010|mdx010
146856|NCT03283033|Children|children
146857|NCT03283033|Plate Waste|plate waste
146858|NCT03283033|Fruit and vegetable intake|fruit and vegetable intake
146859|NCT03283033|School lunch|school lunch
146860|NCT03283033|social marketing|social marketing
146861|NCT03283020|Remifentanil|remifentanil
146862|NCT03283020|Methylnaltrexone|methylnaltrexone
146863|NCT03283020|Pharyngeal dysfunction|pharyngeal dysfunction
146864|NCT03283020|Anesthetic sedation|anesthetic sedation
146865|NCT03283007|Nintedanib, lung transplantation, bronchiolitis obliterans syndrome|nintedanib, lung transplantation, bronchiolitis obliterans syndrome
146866|NCT03282968|exergaming|exergaming
146867|NCT03282968|physiotherapy|physiotherapy
146868|NCT03282968|balance|balance
146869|NCT03282942|hypertension|hypertension
146870|NCT03282942|Aerobic training|aerobic training
146871|NCT03282942|Strength training|strength training
146872|NCT03282916|Valacyclovir|valacyclovir
146873|NCT03282916|Anti-viral treatment|anti-viral treatment
146874|NCT03282890|HIV|hiv
146875|NCT03282890|Substance Abuse|substance abuse
146876|NCT03282890|Pre-Exposure Prophylaxis|pre-exposure prophylaxis
146877|NCT03282890|HIV Risk Behavior|hiv risk behavior
146878|NCT03282890|Methadone Maintenance|methadone maintenance
146879|NCT03282864|asthma|asthma
146982|NCT03282175|BDNF|bdnf
146880|NCT03282864|air pollution|air pollution
146881|NCT03282864|air filtration|air filtration
146882|NCT03282864|indoor air quality|indoor air quality
146883|NCT03282864|respiratory health|respiratory health
146884|NCT03282851|MSB11456|msb11456
146885|NCT03282851|Actemra®|actemra®
146886|NCT03282851|RoActemra®|roactemra®
146887|NCT03282799|etonogestrel|etonogestrel
146888|NCT03282799|efavirenz|efavirenz
146889|NCT03282799|antiretroviral therapy|antiretroviral therapy
146891|NCT03282786|Inflammatory Bowel Disease|inflammatory bowel disease
146892|NCT03282786|Crohn's Disease|crohn's disease
146893|NCT03282786|Ulcerative Colitis|ulcerative colitis
146894|NCT03282786|Carbon Dioxide (CO2)|carbon dioxide (co2)
146895|NCT03282786|Colonoscopy|colonoscopy
146896|NCT03282773|acute myocardial infarction|acute myocardial infarction
146897|NCT03282773|percutaneous coronary intervention|percutaneous coronary intervention
146898|NCT03282773|deferred stent implantation|deferred stent implantation
146899|NCT03282760|Cell Transplantation|cell transplantation
146900|NCT03282760|Neural Stem Cells|neural stem cells
146901|NCT03282708|intestinal microbiome|intestinal microbiome
146902|NCT03282708|captive great apes|captive great apes
146903|NCT03282708|human beings|human beings
146904|NCT03282695|Disc Herniation|disc herniation
146905|NCT03282695|Lumbar Herniated Disc|lumbar herniated disc
146906|NCT03282695|Ozone Therapy|ozone therapy
146907|NCT03282682|hypogonadism|hypogonadism
146908|NCT03282682|aging male|aging male
146909|NCT03282682|strength training|strength training
146910|NCT03282682|physical activity|physical activity
146911|NCT03282682|testosterone|testosterone
146912|NCT03282669|Pregnancy|pregnancy
146913|NCT03282669|Transcutaneous Carbon Dioxide Monitoring|transcutaneous carbon dioxide monitoring
146914|NCT03282669|Pulse Oximetry|pulse oximetry
146915|NCT03282669|Cesarean Section|cesarean section
146916|NCT03282669|Postoperative pain control|postoperative pain control
146917|NCT03282669|High BMI|high bmi
146918|NCT03282669|Hypercarbia|hypercarbia
146919|NCT03282669|Hypoxemia|hypoxemia
146920|NCT03282656|Gene therapy|gene therapy
146921|NCT03282656|lentivirus vector|lentivirus vector
146922|NCT03282656|BCL11A|bcl11a
146923|NCT03282656|Fetal Hemoglobin|fetal hemoglobin
146924|NCT03282630|Acupuncture|acupuncture
146925|NCT03282630|Sphenopalatine ganglion|sphenopalatine ganglion
146926|NCT03282630|Allergic rhinitis|allergic rhinitis
146927|NCT03282630|Randomized Trial|randomized trial
146928|NCT03282604|Intubation|intubation
146929|NCT03282604|Intratracheal|intratracheal
146930|NCT03282604|Nasopharynx|nasopharynx
146931|NCT03282578|sternum|sternum
146932|NCT03282578|bone healing|bone healing
146933|NCT03282578|recovery|recovery
146934|NCT03282565|ACL|acl
146935|NCT03282565|Quadriceps|quadriceps
146936|NCT03282565|Muscle|muscle
146937|NCT03282565|Resistance Training|resistance training
146938|NCT03282539|Lumen apposing metal stents|lumen apposing metal stents
146939|NCT03282539|Double pigtail stents|double pigtail stents
146940|NCT03282539|Endoscopic ultrasonography|endoscopic ultrasonography
146941|NCT03282513|AG-120|ag-120
146942|NCT03282513|Healthy Volunteer|healthy volunteer
146943|NCT03282513|Clinical Pharmacology|clinical pharmacology
146944|NCT03282513|Hepatic Impairment|hepatic impairment
146945|NCT03282487|cortisol|cortisol
146946|NCT03282487|adrenal insufficiency|adrenal insufficiency
146947|NCT03282487|hypopituitarism|hypopituitarism
146948|NCT03282487|hydrocortisone|hydrocortisone
146949|NCT03282474|Hepatitis E|hepatitis e
146950|NCT03282422|Cerebral palsy|cerebral palsy
146951|NCT03282422|Hemiplegia|hemiplegia
146952|NCT03282422|Upper-limb splint|upper-limb splint
146953|NCT03282422|Home-based|home-based
146954|NCT03282422|Social Participation|social participation
146955|NCT03282409|Prediction|prediction
146956|NCT03282409|Chronic Renal Disease|chronic renal disease
146957|NCT03282409|Acute Kidney Injury|acute kidney injury
146958|NCT03282383|biomarkers pneumonia severity|biomarkers pneumonia severity
146959|NCT03282370|Japanese Encephalitis|japanese encephalitis
146960|NCT03282370|JECEVAX|jecevax
146961|NCT03282370|Vietnam|vietnam
146962|NCT03282344|NKTR-214|nktr-214
146963|NCT03282344|NIVOLUMAB|nivolumab
146964|NCT03282344|17-366|17-366
146965|NCT03282331|Preoxygenation|preoxygenation
146966|NCT03282331|Intubation|intubation
146967|NCT03282331|Electrical Impedance Tomography|electrical impedance tomography
146968|NCT03282331|Lung aeration|lung aeration
146969|NCT03282331|Alveolar recruitment|alveolar recruitment
146970|NCT03282318|Bladder Pain Syndrome|bladder pain syndrome
146971|NCT03282318|Interstitial Cystitis|interstitial cystitis
146972|NCT03282318|ASP6294|asp6294
146973|NCT03282279|oocyte retrieval|oocyte retrieval
146974|NCT03282279|surgical complications|surgical complications
146975|NCT03282240|Influenza|influenza
146976|NCT03282227|migraine|migraine
146977|NCT03282227|migraine headache|migraine headache
146978|NCT03282227|acute migraine|acute migraine
146979|NCT03282227|acute migraine headache|acute migraine headache
146980|NCT03282214|Energy conservation|energy conservation
146981|NCT03282214|Self management|self management
146983|NCT03282175|interleukin-15|interleukin-15
146984|NCT03282175|interleukin-8|interleukin-8
146985|NCT03282175|resistin|resistin
146986|NCT03282175|SPPB|sppb
146987|NCT03282162|Oxytocin|oxytocin
146988|NCT03282162|affective touch|affective touch
146989|NCT03282162|trait autism|trait autism
146990|NCT03282149|inflammation|inflammation
146991|NCT03282149|cytokine|cytokine
146992|NCT03282149|anti-inflammatory|anti-inflammatory
146993|NCT03282149|pain|pain
146994|NCT03282123|MDMA|mdma
146995|NCT03282123|methylenedioxymethamphetamine|methylenedioxymethamphetamine
146996|NCT03282123|psychotherapy|psychotherapy
146997|NCT03282071|Mental health|mental health
146998|NCT03282071|Mental well-being|mental well-being
146999|NCT03282071|Community-based engagement|community-based engagement
147000|NCT03282071|Positive psychology|positive psychology
147001|NCT03282071|Public health approach|public health approach
147002|NCT03282058|Silastic Stenting|silastic stenting
147003|NCT03282058|Trans-nasal Endoscopic Surgery|trans-nasal endoscopic surgery
147004|NCT03282058|Post-operative Intra-nasal Re-mucosalization|post-operative intra-nasal re-mucosalization
147005|NCT03282045|acute sore throat|acute sore throat
147006|NCT03282045|lysobact|lysobact
147007|NCT03282019|myAIRVO2|myairvo2
147008|NCT03282019|high-flow nasal cannula therapy|high-flow nasal cannula therapy
147009|NCT03282019|home oxygen therapy|home oxygen therapy
147010|NCT03282019|HOT|hot
147011|NCT03282019|COPD|copd
147012|NCT03282006|Pivmecillinam|pivmecillinam
147013|NCT03281993|apnea test, brain death, pupillometry|apnea test, brain death, pupillometry
147014|NCT03281980|Bangladesh|bangladesh
147015|NCT03281980|Child development|child development
147016|NCT03281980|Poor mothers|poor mothers
147017|NCT03281980|Psycho social stimulation|psycho social stimulation
147018|NCT03281980|Unconditional cash transfer|unconditional cash transfer
147019|NCT03281954|anti-PD-L1 antibody|anti-pd-l1 antibody
147020|NCT03281954|TNBC|tnbc
147021|NCT03281915|infertility|infertility
147022|NCT03281915|pain|pain
147023|NCT03281915|pregnancy|pregnancy
147024|NCT03281889|Brain Tumor|brain tumor
147025|NCT03281876|Immunogenicity|immunogenicity
147026|NCT03281876|Vaccination|vaccination
147027|NCT03281876|Chronic Obstructive Pulmonary Disease|chronic obstructive pulmonary disease
147028|NCT03281876|Non-typeable Haemophilus influenzae|non-typeable haemophilus influenzae
147029|NCT03281876|Acute exacerbation of COPD|acute exacerbation of copd
147030|NCT03281876|Moraxella catarrhalis|moraxella catarrhalis
147031|NCT03281876|Efficacy|efficacy
147032|NCT03281876|Safety|safety
147033|NCT03281837|osteoarthritis|osteoarthritis
147034|NCT03281837|knee osteoarthritis|knee osteoarthritis
147035|NCT03281837|patellofemoral osteoarthritis|patellofemoral osteoarthritis
147036|NCT03281837|tibiofemoral osteoarthritis|tibiofemoral osteoarthritis
147037|NCT03281837|hyaluronan|hyaluronan
147038|NCT03281837|hyaluronic acid|hyaluronic acid
147039|NCT03281837|intra-articular|intra-articular
147040|NCT03281837|arthritis|arthritis
147041|NCT03281837|joint disease|joint disease
147042|NCT03281837|active|active
147043|NCT03281837|viscosupplements|viscosupplements
147044|NCT03281837|Hymovis|hymovis
147045|NCT03281824|HER2 Positive Breast Cancer|her2 positive breast cancer
147046|NCT03281824|ALT-P7|alt-p7
147047|NCT03281824|Antibody-Drug Conjugate|antibody-drug conjugate
147048|NCT03281772|hypertension|hypertension
147049|NCT03281772|clinical decision support software|clinical decision support software
147050|NCT03281772|renin|renin
147051|NCT03281772|aldosterone|aldosterone
147052|NCT03281759|Brain Injuries, Traumatic;|brain injuries, traumatic;
147053|NCT03281759|Diffuse Axonal Injury|diffuse axonal injury
147054|NCT03281759|Low-Level Light Therapy|low-level light therapy
147055|NCT03281759|Neurologic Manifestations|neurologic manifestations
147056|NCT03281759|Quality of Life|quality of life
147057|NCT03281759|Rehabilitation|rehabilitation
147058|NCT03281733|malnutrition|malnutrition
147059|NCT03281733|adult|adult
147060|NCT03281733|hospitalized patients|hospitalized patients
147061|NCT03281733|dietitian|dietitian
147062|NCT03281733|communication|communication
147063|NCT03281733|discharge|discharge
147064|NCT03281733|nutrition|nutrition
147065|NCT03281707|NIRS|nirs
147066|NCT03281707|DO2|do2
147067|NCT03281694|nicotine|nicotine
147068|NCT03281694|positive allosteric modulator|positive allosteric modulator
147069|NCT03281694|attention|attention
147070|NCT03281694|cognition|cognition
147071|NCT03281681|adenocarcinoma of the ovary|adenocarcinoma of the ovary
147072|NCT03281681|ovarian adenocarcinoma|ovarian adenocarcinoma
147073|NCT03281681|ovarian cancer|ovarian cancer
147074|NCT03281681|cancer of the ovary|cancer of the ovary
147075|NCT03281681|ovarian neoplasm|ovarian neoplasm
147076|NCT03281681|AO|ao
147077|NCT03281681|ovarian carcinoma|ovarian carcinoma
147078|NCT03281668|Knee osteoarthritis|knee osteoarthritis
147079|NCT03281655|Visnadine|visnadine
147080|NCT03281655|Prenylflavonoids|prenylflavonoids
147081|NCT03281655|Bovine colostrum|bovine colostrum
147082|NCT03281655|Sexual wellbeing|sexual wellbeing
147083|NCT03281629|Transcranial magnetic stimulation|transcranial magnetic stimulation
147084|NCT03281629|schizophrenia|schizophrenia
147085|NCT03281629|MRI|mri
147086|NCT03281629|smoking|smoking
147087|NCT03281603|Patient satisfaction|patient satisfaction
147088|NCT03281603|Retention|retention
147089|NCT03281590|identification|identification
147090|NCT03281590|diagnosis|diagnosis
147091|NCT03281590|management|management
147092|NCT03281590|investigation|investigation
147093|NCT03281590|prevalence|prevalence
147094|NCT03281590|incidence|incidence
147095|NCT03281590|quality of care|quality of care
147096|NCT03281590|hospitalization|hospitalization
147097|NCT03281590|morbidity|morbidity
147098|NCT03281590|disability|disability
147099|NCT03281577|Drug Therapy|drug therapy
147100|NCT03281538|CR845|cr845
147101|NCT03281538|difelikefalin|difelikefalin
147102|NCT03281538|Pruritus|pruritus
147103|NCT03281538|Chronic Itch|chronic itch
147104|NCT03281538|Itch|itch
147105|NCT03281538|Itching|itching
147106|NCT03281538|hemodialysis|hemodialysis
147107|NCT03281538|Uremic Pruritus|uremic pruritus
147108|NCT03281538|Dialysis|dialysis
147109|NCT03281538|CKD|ckd
147110|NCT03281538|CKD-associated pruritus|ckd-associated pruritus
147111|NCT03281538|CKD-aP|ckd-ap
147112|NCT03281538|ESRD (end stage renal disease)|esrd (end stage renal disease)
147113|NCT03281538|Chronic Kidney Disease|chronic kidney disease
147114|NCT03281538|Kidney failure, chronic|kidney failure, chronic
147115|NCT03281538|Kidney dysfunction|kidney dysfunction
147116|NCT03281538|Generalized pruritus|generalized pruritus
147117|NCT03281525|cardiotransplant|cardiotransplant
147118|NCT03281512|Saturated fatty acids|saturated fatty acids
147119|NCT03281512|CHNS|chns
147120|NCT03281473|ARDS|ards
147121|NCT03281473|Esophageal pressure|esophageal pressure
147122|NCT03281473|Mechanical ventilation|mechanical ventilation
147123|NCT03281460|Hysterectomy, Vaginal|hysterectomy, vaginal
147124|NCT03281460|Uterine Myomatosis|uterine myomatosis
147125|NCT03281460|Morcellation|morcellation
147126|NCT03281460|Laparoscopy|laparoscopy
147127|NCT03281460|in-bag morcellation|in-bag morcellation
147128|NCT03281447|Nurse navigation|nurse navigation
147129|NCT03281447|Family|family
147130|NCT03281447|Self Efficacy|self efficacy
147131|NCT03281447|Needs assessment|needs assessment
147132|NCT03281447|Quality of Life|quality of life
147133|NCT03281447|Colorectal Neoplasms|colorectal neoplasms
147134|NCT03281447|Case Management|case management
147135|NCT03281434|Skeletal muscle|skeletal muscle
147136|NCT03281434|Protein synthesis|protein synthesis
147137|NCT03281434|Protein ingestion|protein ingestion
147138|NCT03281434|Resistance exercise|resistance exercise
147139|NCT03281356|Pilot Study|pilot study
147140|NCT03281356|Early childhood development|early childhood development
147141|NCT03281343|PrEP|prep
147142|NCT03281343|Women|women
147143|NCT03281343|Linkage to Care|linkage to care
147144|NCT03281317|vasoplegicsyndrome|vasoplegicsyndrome
147145|NCT03281317|cardiac surgery|cardiac surgery
147146|NCT03281317|predictive risk score|predictive risk score
147147|NCT03281304|ulcerative colitis|ulcerative colitis
147148|NCT03281304|inflammatory bowel disease|inflammatory bowel disease
147149|NCT03281291|malaria vaccine|malaria vaccine
147150|NCT03281291|infants|infants
147151|NCT03281291|Malaria|malaria
147152|NCT03281291|RTS,S/AS01|rts,s/as01
147153|NCT03281291|falciparum|falciparum
147154|NCT03281291|genomics|genomics
147155|NCT03281291|efficacy|efficacy
147156|NCT03281278|Thrombelastography,acute on chronic liver failure, platelet|thrombelastography,acute on chronic liver failure, platelet
147157|NCT03281265|pre-acute-on-chronic liver failure|pre-acute-on-chronic liver failure
147158|NCT03281265|hepatitis B|hepatitis b
147159|NCT03281252|liver failure|liver failure
147160|NCT03281239|welder, airport agent, Welding fumes|welder, airport agent, welding fumes
147161|NCT03281226|Pulmonary tuberculosis|pulmonary tuberculosis
147162|NCT03281226|HIV/AIDS|hiv/aids
147163|NCT03281226|Glutathione|glutathione
147164|NCT03281226|N-acetylcysteine|n-acetylcysteine
147165|NCT03281226|Oxidative stress|oxidative stress
147166|NCT03281187|Hormonal reposition, Testosterone nasal, Nasotestt|hormonal reposition, testosterone nasal, nasotestt
147167|NCT03281174|Inactivated Enterovirus Type 71 (EV71) Vaccine|inactivated enterovirus type 71 (ev71) vaccine
147168|NCT03281174|5-year Immune Persistence|5-year immune persistence
147169|NCT03281161|skin cancer|skin cancer
147170|NCT03281161|prevention|prevention
147171|NCT03281161|worksite|worksite
147172|NCT03281161|policy|policy
147173|NCT03281161|cost and effectiveness|cost and effectiveness
147174|NCT03281161|implementation|implementation
147175|NCT03281148|immediate implants, accuracy,extraction sockets|immediate implants, accuracy,extraction sockets
147176|NCT03281135|Cervical cancer screening|cervical cancer screening
147177|NCT03281135|Adherance|adherance
147178|NCT03281135|HPV typing|hpv typing
147179|NCT03281135|HDSS|hdss
147180|NCT03281135|Ethiopia|ethiopia
147181|NCT03281109|menstrual cycle|menstrual cycle
147182|NCT03281109|gingivitis|gingivitis
147183|NCT03281109|interleukin 1|interleukin 1
147184|NCT03281109|tumor necrosis factor alpha|tumor necrosis factor alpha
147185|NCT03281083|Non-Alcoholic Fatty Liver Disease|non-alcoholic fatty liver disease
147186|NCT03281083|Diabetes Mellitus, type 2|diabetes mellitus, type 2
147187|NCT03281083|Thyroid hormone|thyroid hormone
147188|NCT03281083|Levothyroxine|levothyroxine
147189|NCT03281070|Anastomotic leakage|anastomotic leakage
147190|NCT03281070|Anterior resection|anterior resection
147191|NCT03281070|Risk factors|risk factors
147192|NCT03281070|Incidence|incidence
147193|NCT03281070|Rectal Cancer|rectal cancer
147195|NCT03281031|Acute abdominal pain|acute abdominal pain
147196|NCT03281031|Pelvic pain|pelvic pain
147197|NCT03281031|Diagnostic performance|diagnostic performance
147198|NCT03281031|Young women|young women
147199|NCT03281018|hypnosis|hypnosis
147200|NCT03281018|preoperative anxiety|preoperative anxiety
147201|NCT03281018|hysterectomy|hysterectomy
147202|NCT03281018|hospitalisation|hospitalisation
147203|NCT03281005|Retinitis pigmentosa|retinitis pigmentosa
147204|NCT03281005|Visual function evaluation|visual function evaluation
147205|NCT03280940|Inflammation|inflammation
147206|NCT03280940|Immune activation|immune activation
147207|NCT03280940|Integrase Inhibitors|integrase inhibitors
147208|NCT03280940|Naive patients|naive patients
147209|NCT03280927|Onychomycosis|onychomycosis
147210|NCT03280914|obstructive sleep apnea|obstructive sleep apnea
147211|NCT03280914|real world|real world
147212|NCT03280914|community|community
147213|NCT03280901|renal replacement therapy|renal replacement therapy
147214|NCT03280901|haemodialysis|haemodialysis
147215|NCT03280901|haemodiafiltration|haemodiafiltration
147216|NCT03280862|Heart Failure|heart failure
147217|NCT03280862|Branch Block|branch block
147218|NCT03280862|Cardiac Resynchronization Therapy|cardiac resynchronization therapy
147219|NCT03280849|chitosan|chitosan
147220|NCT03280849|endoscopic|endoscopic
147221|NCT03280849|sellar tumor|sellar tumor
147222|NCT03280849|biomaterials|biomaterials
147223|NCT03280849|transphenoidal|transphenoidal
147224|NCT03280823|complement system|complement system
147225|NCT03280810|Schizophrenia|schizophrenia
147226|NCT03280810|Postural|postural
147227|NCT03280810|Cognitive|cognitive
147229|NCT03280758|Resistance training|resistance training
147230|NCT03280758|Diabetes Mellitus|diabetes mellitus
147231|NCT03280758|blood-glucose control|blood-glucose control
147232|NCT03280758|Muscle|muscle
147233|NCT03280758|Function|function
147234|NCT03280732|Lung Ultrasound|lung ultrasound
147235|NCT03280732|Chest X-Ray|chest x-ray
147236|NCT03280732|Pneumonia|pneumonia
147237|NCT03280732|Pneumothorax|pneumothorax
147238|NCT03280732|Pleural effusion|pleural effusion
147239|NCT03280719|Prone position|prone position
147240|NCT03280719|Supine position|supine position
147241|NCT03280719|Hypofractionation|hypofractionation
147242|NCT03280719|Accelerated radiotherapy|accelerated radiotherapy
147243|NCT03280719|Regional nodal irradiation|regional nodal irradiation
147244|NCT03280706|Gastric Emptying|gastric emptying
147245|NCT03280706|labor|labor
147246|NCT03280706|maltodextrin|maltodextrin
147247|NCT03280706|orange juice|orange juice
147248|NCT03280706|coffee|coffee
147249|NCT03280706|ultrasound|ultrasound
147250|NCT03280693|Body mass index,|body mass index,
147251|NCT03280693|Bone density|bone density
147252|NCT03280693|Balance|balance
147253|NCT03280693|Postmenopause|postmenopause
147254|NCT03280680|Violence against young women and girls|violence against young women and girls
147255|NCT03280680|Sexual and reproductive health and rights|sexual and reproductive health and rights
147256|NCT03280680|Consent|consent
147257|NCT03280680|Health services|health services
147258|NCT03280680|Legal services|legal services
147259|NCT03280680|Awareness raising|awareness raising
147260|NCT03280680|Community mobilization|community mobilization
147261|NCT03280654|Obesity|obesity
147262|NCT03280654|Overactive Bladder|overactive bladder
147263|NCT03280654|Urinary incontinence|urinary incontinence
147264|NCT03280654|Visceral Adiposity Index|visceral adiposity index
147265|NCT03280654|Waist Circumference|waist circumference
147266|NCT03280615|Albuminuria|albuminuria
147267|NCT03280615|Carotid Intima-Media Thickness|carotid intima-media thickness
147268|NCT03280615|Pulse Wave Velocity|pulse wave velocity
147269|NCT03280615|Inflammation|inflammation
147270|NCT03280589|Heart Rate Variability|heart rate variability
147271|NCT03280589|EEG|eeg
147272|NCT03280589|Respiration|respiration
147273|NCT03280576|Postoperative|postoperative
147274|NCT03280576|Dysfunction Following Cardiac Surgery|dysfunction following cardiac surgery
147275|NCT03280524|Reflexology,diabetes, quality of life|reflexology,diabetes, quality of life
147276|NCT03280485|TBI|tbi
147277|NCT03280485|management|management
147278|NCT03280485|S100B|s100b
147279|NCT03280485|biomarkers|biomarkers
147280|NCT03280485|mild head injury|mild head injury
147281|NCT03280485|intracranial complication|intracranial complication
147282|NCT03280472|Interpretation Bias|interpretation bias
147283|NCT03280472|Interpretation Modification Program|interpretation modification program
147284|NCT03280433|Epicardial adipose tissue|epicardial adipose tissue
147285|NCT03280433|Coronary artery disease|coronary artery disease
147286|NCT03280433|Atrial fibrillation|atrial fibrillation
147287|NCT03280433|Severe aortic stenosis|severe aortic stenosis
147288|NCT03280433|Proteome|proteome
147289|NCT03280433|Mass spectrometry|mass spectrometry
147290|NCT03280433|Computed tomography|computed tomography
147291|NCT03280420|Acute urinary retention|acute urinary retention
147292|NCT03280420|BPH|bph
147293|NCT03280420|TWOC|twoc
147294|NCT03280420|Tamsulosin|tamsulosin
147295|NCT03280407|Neoadjuvant chemotherapy,|neoadjuvant chemotherapy,
147296|NCT03280407|locally advanced rectal cancer,|locally advanced rectal cancer,
147297|NCT03280407|chemotherapy|chemotherapy
147298|NCT03280407|CAPOX (oxaliplatin/capecitabine)|capox (oxaliplatin/capecitabine)
147299|NCT03280407|FOLFOX (oxaliplatin/leucovorin/5FU)|folfox (oxaliplatin/leucovorin/5fu)
147300|NCT03280394|Liquid biopsy|liquid biopsy
147301|NCT03280394|Classical Hodgkin Lymphoma|classical hodgkin lymphoma
147302|NCT03280394|Diffuse Large B Cell Lymphoma|diffuse large b cell lymphoma
147303|NCT03280394|Follicular Lymphoma|follicular lymphoma
147304|NCT03280394|Mantle Cell Lymphoma|mantle cell lymphoma
147305|NCT03280394|Mutations|mutations
147306|NCT03280381|Nifty Cup|nifty cup
147307|NCT03280381|breastfeeding difficulties|breastfeeding difficulties
147308|NCT03280381|preterm infant|preterm infant
147309|NCT03280381|cup feeding|cup feeding
147310|NCT03280355|COPD|copd
147311|NCT03280355|Chronic Obstructive Pulmonary Disease|chronic obstructive pulmonary disease
147312|NCT03280355|Randomised controlled trial (RCT)|randomised controlled trial (rct)
147313|NCT03280355|Rehabilitation|rehabilitation
147314|NCT03280355|Singing Training|singing training
147315|NCT03280342|Migraine|migraine
147316|NCT03280342|Headache|headache
147317|NCT03280316|Spinal Vascular Disorder|spinal vascular disorder
147318|NCT03280316|Overactive Bladder|overactive bladder
147319|NCT03280290|Lymphocytes CD4|lymphocytes cd4
147320|NCT03280290|Lymphocytes CCR7|lymphocytes ccr7
147321|NCT03280290|ALLOGRAFT|allograft
147322|NCT03280290|Hematopoietic Stem Cells|hematopoietic stem cells
147323|NCT03280251|Cognitive disorders|cognitive disorders
147324|NCT03280251|cognitive training|cognitive training
147325|NCT03280251|symptomatic treatment|symptomatic treatment
147326|NCT03280251|Methylphenidate|methylphenidate
147327|NCT03280251|elderly|elderly
147328|NCT03280225|Suicide|suicide
147329|NCT03280225|Prevention|prevention
147330|NCT03280225|Implementation|implementation
147331|NCT03280225|Facilitation|facilitation
147332|NCT03280212|Chronic subdural hematoma|chronic subdural hematoma
147333|NCT03280212|Tranexamic acid|tranexamic acid
147334|NCT03280212|TXA|txa
147335|NCT03280186|Spinal Vascular Malformations|spinal vascular malformations
147336|NCT03280186|Bladder|bladder
147337|NCT03280186|Surgical intervention|surgical intervention
147338|NCT03280186|Urodynamics|urodynamics
147339|NCT03280147|Neonate|neonate
147340|NCT03280147|Sepsis|sepsis
147341|NCT03280147|Antibiotics|antibiotics
147342|NCT03280147|Duration|duration
147343|NCT03280134|non-sentinel lymph node|non-sentinel lymph node
147344|NCT03280134|breast cancer|breast cancer
147345|NCT03280134|prediction|prediction
147346|NCT03280134|CK19|ck19
147347|NCT03280134|contrast-enhanced ultrasound|contrast-enhanced ultrasound
147348|NCT03280121|transoral incisionless|transoral incisionless
147349|NCT03280108|Intraocular lens|intraocular lens
147350|NCT03280108|IOL|iol
147351|NCT03280056|MSC|msc
147352|NCT03280056|Autologous|autologous
147353|NCT03280056|Neurotrophic factors|neurotrophic factors
147354|NCT03280043|Breast reduction|breast reduction
147355|NCT03280043|Reduction mammoplasty|reduction mammoplasty
147356|NCT03280043|Hematoma|hematoma
147357|NCT03280043|Hemorrhage|hemorrhage
147358|NCT03280043|Ketorolac|ketorolac
147359|NCT03280043|Toradol|toradol
147360|NCT03280030|midostaurin|midostaurin
147361|NCT03280030|PKC412|pkc412
147362|NCT03280030|cytarabine|cytarabine
147363|NCT03280030|daunorubicin|daunorubicin
147364|NCT03280030|acute myeloid leukemia|acute myeloid leukemia
147365|NCT03280030|combination treatment|combination treatment
147366|NCT03280030|FLT3|flt3
147367|NCT03280030|acute myeloid leukemia (AML)|acute myeloid leukemia (aml)
147368|NCT03280030|acute myelogenous leukemia (AML)|acute myelogenous leukemia (aml)
147369|NCT03280017|anesthesia|anesthesia
147370|NCT03280017|thoracic surgery|thoracic surgery
147371|NCT03280017|thoracic paravertebral block|thoracic paravertebral block
147372|NCT03280017|ketamine|ketamine
147373|NCT03279991|biobank|biobank
147374|NCT03279991|chronic disease|chronic disease
147375|NCT03279991|omics|omics
147376|NCT03279991|big data|big data
147377|NCT03279991|4 P medicine|4 p medicine
147378|NCT03279965|Lung MRI cystic fibrosis primary ciliary dyskinesia|lung mri cystic fibrosis primary ciliary dyskinesia
147379|NCT03279913|Depression, neurofeedback, TMS|depression, neurofeedback, tms
147380|NCT03279874|decision-making|decision-making
147381|NCT03279874|repair behavior|repair behavior
147382|NCT03279874|interviews|interviews
147383|NCT03279796|Adipose-drived mesenchymal stem cells|adipose-drived mesenchymal stem cells
147384|NCT03279796|Rotator cuff injury|rotator cuff injury
147385|NCT03279796|Lateral Epicondylitis|lateral epicondylitis
147386|NCT03279796|Randomized controlled trials|randomized controlled trials
147387|NCT03279770|lnRNA|lnrna
147388|NCT03279770|CV disease|cv disease
147389|NCT03279757|Fractional laser|fractional laser
147390|NCT03279757|Topical anesthesia|topical anesthesia
147391|NCT03279757|Drug delivery|drug delivery
147392|NCT03279757|CO2 laser|co2 laser
147393|NCT03279744|Oral Verrucous Hyperplasia|oral verrucous hyperplasia
147394|NCT03279744|Oral Erythroleukoplakia|oral erythroleukoplakia
147395|NCT03279731|eating disorder, pharmacotherapy|eating disorder, pharmacotherapy
147396|NCT03279705|water exchange|water exchange
147397|NCT03279705|water jet channel colonoscopy|water jet channel colonoscopy
147398|NCT03279705|colonoscopy|colonoscopy
147399|NCT03279705|cecal insertion time|cecal insertion time
147400|NCT03279705|adenoma detection rate|adenoma detection rate
147401|NCT03279692|Meningioma|meningioma
147402|NCT03279679|costoclavicular|costoclavicular
147403|NCT03279679|paracoracoid|paracoracoid
147404|NCT03279679|brachial plexus|brachial plexus
147405|NCT03279640|Motor Network|motor network
147406|NCT03279640|Resting-state fMRI|resting-state fmri
147407|NCT03279640|Repetitive Transcranial Magnetic Stimulation|repetitive transcranial magnetic stimulation
147408|NCT03279640|Transcranial Direct Current Stimulation|transcranial direct current stimulation
147409|NCT03279627|inpatient|inpatient
147410|NCT03279627|hypoglycemia|hypoglycemia
147411|NCT03279627|hyperglycemia|hyperglycemia
147412|NCT03279627|hospital readmission|hospital readmission
147413|NCT03279627|discharge planning|discharge planning
147414|NCT03279614|ORR|orr
147415|NCT03279614|OS|os
147416|NCT03279614|PFS|pfs
147417|NCT03279614|safety|safety
147418|NCT03279601|chemotherapy|chemotherapy
147419|NCT03279601|OS|os
147420|NCT03279601|ORR|orr
147421|NCT03279601|PFS|pfs
147422|NCT03279601|safety|safety
147423|NCT03279588|Ultrasound diagnosis|ultrasound diagnosis
147424|NCT03279588|Abdominal Ultrasound|abdominal ultrasound
147425|NCT03279588|Emergency Department|emergency department
147426|NCT03279523|Dementia|dementia
147427|NCT03279523|HIV|hiv
147428|NCT03279523|Brain Disease|brain disease
147429|NCT03279523|CNS Diseases|cns diseases
147430|NCT03279523|Mild Cognitive Impairment|mild cognitive impairment
147431|NCT03279523|Neurodegenerative Disease|neurodegenerative disease
147432|NCT03279523|Tauopathies|tauopathies
147433|NCT03279510|auditory perception|auditory perception
147434|NCT03279510|hearing|hearing
147435|NCT03279484|safety , electrical performance|safety , electrical performance
147436|NCT03279471|autism spectrum disorder|autism spectrum disorder
147437|NCT03279471|anxiety|anxiety
147438|NCT03279471|cognitive behavior therapy|cognitive behavior therapy
147439|NCT03279471|functional neuroimaging|functional neuroimaging
147440|NCT03279458|Capnography|capnography
147441|NCT03279432|VDR, MEGALIN, haplotypes, obesity, metabolic syndrome|vdr, megalin, haplotypes, obesity, metabolic syndrome
147442|NCT03279406|Atrial fibrillation|atrial fibrillation
147443|NCT03279406|Stroke|stroke
147444|NCT03279406|Thrombus|thrombus
147445|NCT03279406|Left atrial appendage|left atrial appendage
147446|NCT03279406|Bleeding|bleeding
147447|NCT03279393|Post-Traumatic Stress Disorder|post-traumatic stress disorder
147448|NCT03279393|PTSD|ptsd
147449|NCT03279393|trauma|trauma
147450|NCT03279393|stress|stress
147451|NCT03279393|atherosclerosis|atherosclerosis
147452|NCT03279393|macrophage|macrophage
147453|NCT03279393|plaque burden|plaque burden
147454|NCT03279393|vascular inflammation|vascular inflammation
147455|NCT03279393|atherosclerotic inflammation|atherosclerotic inflammation
147456|NCT03279393|PET/MRI|pet/mri
147457|NCT03279393|18F-FDG-PET|18f-fdg-pet
147458|NCT03279380|genetic polymorphism|genetic polymorphism
147459|NCT03279380|sport performance|sport performance
147460|NCT03279380|myokines|myokines
147461|NCT03279354|Health-related quality of life|health-related quality of life
147462|NCT03279354|Physical activity|physical activity
147463|NCT03279354|Smartphone application|smartphone application
147464|NCT03279341|laxatives|laxatives
147465|NCT03279341|constipation|constipation
147466|NCT03279315|Iodine|iodine
147467|NCT03279315|Balance experiment|balance experiment
147468|NCT03279315|EAR|ear
147469|NCT03279315|Chinese women|chinese women
147470|NCT03279315|Euthyroid|euthyroid
147471|NCT03279289|FOLFIRI|folfiri
147472|NCT03279289|aflibercept|aflibercept
147473|NCT03279289|5-FU|5-fu
147474|NCT03279289|oxaliplatin|oxaliplatin
147475|NCT03279289|elderly|elderly
147476|NCT03279289|metastatic colorectal cancer|metastatic colorectal cancer
147477|NCT03279276|Hip arthroplasty|hip arthroplasty
147478|NCT03279237|GastroEsophageal Cancer|gastroesophageal cancer
147479|NCT03279224|Bipolar, Depression, FMT, Microbiome|bipolar, depression, fmt, microbiome
147480|NCT03279211|digestibility|digestibility
147481|NCT03279211|whey protein|whey protein
147482|NCT03279211|zein|zein
147483|NCT03279211|bioavailability|bioavailability
147484|NCT03279198|breast cancer screening|breast cancer screening
147485|NCT03279198|colorectal cancer screening|colorectal cancer screening
147486|NCT03279198|cervical cancer screening|cervical cancer screening
147487|NCT03279198|cancer screening beliefs|cancer screening beliefs
147488|NCT03279198|cost-effectiveness|cost-effectiveness
147489|NCT03279198|demographics|demographics
147490|NCT03279198|tailored intervention|tailored intervention
147491|NCT03279185|HIV/AIDS, perinatal HIV infection|hiv/aids, perinatal hiv infection
147492|NCT03279172|videolaryngoscope|videolaryngoscope
147493|NCT03279172|intraocular pressure|intraocular pressure
147494|NCT03279172|Direct laryngoscope|direct laryngoscope
147495|NCT03279120|HIV|hiv
147496|NCT03279120|LNG|lng
147497|NCT03279120|TFV|tfv
147498|NCT03279120|IVR|ivr
147499|NCT03279120|Contraception|contraception
147500|NCT03279120|Prevention|prevention
147501|NCT03279094|Sickle Cell Disease|sickle cell disease
147502|NCT03279094|Hematopoietic stem cell transplantation|hematopoietic stem cell transplantation
147503|NCT03279094|Haploidentical stem cell transplantation|haploidentical stem cell transplantation
147504|NCT03279094|Post-transplant Cytoxan|post-transplant cytoxan
147505|NCT03279081|Crohn's disease|crohn's disease
147506|NCT03279081|complex perianal fistula(s)|complex perianal fistula(s)
147507|NCT03279068|electronic fetal monitoring|electronic fetal monitoring
147508|NCT03279055|Insomnia|insomnia
147509|NCT03279042|En masse retraction|en masse retraction
147510|NCT03279042|Corticotomy|corticotomy
147511|NCT03279042|Acceleration of tooth movement|acceleration of tooth movement
147512|NCT03279042|Piezocision|piezocision
147513|NCT03279042|Flapless corticotomy|flapless corticotomy
147514|NCT03279042|Class II division 1 malocclusion|class ii division 1 malocclusion
147515|NCT03279042|Protrusion of upper incisors|protrusion of upper incisors
147516|NCT03279042|Sliding mechanics|sliding mechanics
147517|NCT03279042|mini-implant based anchorage|mini-implant based anchorage
147518|NCT03279042|temporary anchorage devices|temporary anchorage devices
147519|NCT03278990|PrEP|prep
147520|NCT03278990|Prevention|prevention
147521|NCT03278990|Value Affirmation|value affirmation
147522|NCT03278990|Future Selves|future selves
147523|NCT03278990|Behavioral Intervention|behavioral intervention
147524|NCT03278977|Apparent Life-Threatening Event|apparent life-threatening event
147525|NCT03278977|ALTE|alte
147526|NCT03278977|Sudden Infant Death|sudden infant death
147527|NCT03278964|Graves Disease|graves disease
147528|NCT03278964|Orbital decompression|orbital decompression
147529|NCT03278964|Graves Orbitopathy|graves orbitopathy
147530|NCT03278964|Exophthalmos|exophthalmos
147531|NCT03278964|Diplopia|diplopia
147532|NCT03278964|Restrictive Strabismus|restrictive strabismus
147533|NCT03278951|Weight loss|weight loss
147534|NCT03278951|video conferencing|video conferencing
147535|NCT03278951|mHealth|mhealth
147536|NCT03278951|Telemedicine|telemedicine
147537|NCT03278951|glycemic control|glycemic control
147538|NCT03278938|depression|depression
147539|NCT03278938|citalopram|citalopram
147540|NCT03278938|bupropion|bupropion
147541|NCT03278938|combination therapy|combination therapy
147542|NCT03278912|Inflammatory Bowel Disease|inflammatory bowel disease
147543|NCT03278912|Chronic Granulomatous Disease|chronic granulomatous disease
147544|NCT03278912|Dysbiosis|dysbiosis
147545|NCT03278912|Microbiome|microbiome
147546|NCT03278912|Immunodeficiency|immunodeficiency
147547|NCT03278899|Adrenoleukodystropy|adrenoleukodystropy
147548|NCT03278899|X-ALD|x-ald
147549|NCT03278899|ALD|ald
147550|NCT03278886|Alcohol Use|alcohol use
147551|NCT03278886|Pain|pain
147552|NCT03278886|HIV|hiv
147553|NCT03278886|Low-dose naltrexone|low-dose naltrexone
147554|NCT03278886|Nalmefene|nalmefene
147555|NCT03278873|Achromatopsia|achromatopsia
147556|NCT03278873|CNGB3|cngb3
147557|NCT03278873|CNGA3|cnga3
147558|NCT03278860|Oxytocin|oxytocin
147559|NCT03278860|social touch|social touch
147560|NCT03278847|NNRD|nnrd
147561|NCT03278847|matching|matching
147562|NCT03278847|propensity score|propensity score
147563|NCT03278821|Informed choice|informed choice
147564|NCT03278821|Alcohol use disorder|alcohol use disorder
147565|NCT03278821|Addiction treatment|addiction treatment
147566|NCT03278795|Weaning, ventilatory support, assisted ventilation modes|weaning, ventilatory support, assisted ventilation modes
147567|NCT03278756|Depression|depression
147568|NCT03278756|Remission|remission
147569|NCT03278756|Relapse prevention|relapse prevention
147570|NCT03278756|Cognitive control training|cognitive control training
147571|NCT03278756|Internet intervention|internet intervention
147572|NCT03278743|tea|tea
147573|NCT03278743|cognition|cognition
147574|NCT03278743|very old|very old
147575|NCT03278743|Newcastle 85+|newcastle 85+
147576|NCT03278743|epidemiology|epidemiology
147577|NCT03278730|sepsis|sepsis
147578|NCT03278730|para-Tyrosine|para-tyrosine
147579|NCT03278730|ortho-Tyrosine|ortho-tyrosine
147580|NCT03278730|meta-Tyrosine|meta-tyrosine
147581|NCT03278704|Concurrent training|concurrent training
147582|NCT03278704|Type 2 Diabetes Mellitus|type 2 diabetes mellitus
147583|NCT03278704|Resistance exercise|resistance exercise
147584|NCT03278704|High-Intensity Interval Training (HIIT)|high-intensity interval training (hiit)
147585|NCT03278704|Muscle hypertrophy|muscle hypertrophy
147586|NCT03278704|Interference effect|interference effect
147587|NCT03278678|Nutritional screening MNA-SF malnutrition Case Management|nutritional screening mna-sf malnutrition case management
147588|NCT03278665|Cutaneous melanoma|cutaneous melanoma
147589|NCT03278639|gait disorders|gait disorders
147590|NCT03278639|balance disorders|balance disorders
147591|NCT03278639|music|music
147592|NCT03278639|tango|tango
147593|NCT03278639|rhythmic auditory stimulation|rhythmic auditory stimulation
147594|NCT03278639|health-related quality of life|health-related quality of life
147595|NCT03278626|Locally Advanced Esophageal Squamous Cell Carcinoma|locally advanced esophageal squamous cell carcinoma
147596|NCT03278561|asthma|asthma
147597|NCT03278561|age of onset|age of onset
147598|NCT03278561|inflammation|inflammation
147599|NCT03278561|comorbidity|comorbidity
147600|NCT03278561|microbiome|microbiome
147601|NCT03278548|HES|hes
147602|NCT03278548|Hydroxyethylstarch|hydroxyethylstarch
147603|NCT03278522|ramosetron|ramosetron
147604|NCT03278496|addiction|addiction
147605|NCT03278496|substance abuse treatment|substance abuse treatment
147606|NCT03278496|aftercare|aftercare
147607|NCT03278496|outpatient counseling|outpatient counseling
147608|NCT03278496|opiates|opiates
147609|NCT03278496|cocaine|cocaine
147610|NCT03278483|Latent tuberculosis, ,|latent tuberculosis, ,
147611|NCT03278483|isoniazid, rifampin,|isoniazid, rifampin,
147612|NCT03278483|rifampin,|rifampin,
147613|NCT03278483|adverse,|adverse,
147614|NCT03278483|diabetes mellitus|diabetes mellitus
147615|NCT03278457|hypertrophic cardiomyopathy|hypertrophic cardiomyopathy
147616|NCT03278457|implantable cardioverter defibrillator|implantable cardioverter defibrillator
147617|NCT03278457|positron emission tomography|positron emission tomography
147618|NCT03278392|pregnancy|pregnancy
147619|NCT03278392|metabolism|metabolism
147620|NCT03278392|stress|stress
147621|NCT03278392|emotional state|emotional state
147622|NCT03278392|diet|diet
147623|NCT03278392|glycemic response|glycemic response
147624|NCT03278353|Expectation|expectation
147625|NCT03278353|Conservative Intervention|conservative intervention
147626|NCT03278340|Skin Cancer|skin cancer
147627|NCT03278340|Prevention|prevention
147628|NCT03278340|Policy|policy
147629|NCT03278340|Worksite|worksite
147630|NCT03278340|Scale-up|scale-up
147631|NCT03278340|Cost and Effectiveness|cost and effectiveness
147632|NCT03278275|urokinase plasminogen activator receptor|urokinase plasminogen activator receptor
147633|NCT03278275|uPAR PET/CT|upar pet/ct
147634|NCT03278275|positron emission tomography|positron emission tomography
147635|NCT03278275|neuroendocrine tumors|neuroendocrine tumors
147636|NCT03278249|brain tumor|brain tumor
147637|NCT03278223|Multipurpose Contact Lens Care System|multipurpose contact lens care system
147638|NCT03278210|EEG-fMRI|eeg-fmri
147639|NCT03278210|brain imaging|brain imaging
147640|NCT03278210|presurgical evaluation|presurgical evaluation
147641|NCT03278210|epilepsy surgery|epilepsy surgery
147642|NCT03278158|safety|safety
147643|NCT03278158|tolerability|tolerability
147644|NCT03278132|Inactivated Enterovirus Type 71 (EV71) Vaccine|inactivated enterovirus type 71 (ev71) vaccine
147645|NCT03278132|Safety|safety
147646|NCT03278132|Immunogenicity|immunogenicity
147647|NCT03278132|Infant|infant
147648|NCT03278093|Physiotherapy|physiotherapy
147649|NCT03278093|Physical therapy|physical therapy
147650|NCT03278093|Balance|balance
147651|NCT03278093|Posturography|posturography
147652|NCT03278067|England|england
147653|NCT03278067|Adverse Event of Interest|adverse event of interest
147654|NCT03278067|Seasonal influenza vaccines|seasonal influenza vaccines
147655|NCT03278067|Pilot study|pilot study
147656|NCT03278067|Prospective passive enhanced safety surveillance|prospective passive enhanced safety surveillance
147657|NCT03278054|apical periodontitis|apical periodontitis
147658|NCT03278054|hybrid|hybrid
147659|NCT03278054|ProTaper|protaper
147660|NCT03278054|rotary|rotary
147661|NCT03278015|S-1|s-1
147662|NCT03278015|nab-paclitaxel|nab-paclitaxel
147663|NCT03277976|atrial fibrillation;|atrial fibrillation;
147664|NCT03277976|catheter ablation;|catheter ablation;
147665|NCT03277976|pulmonary vein isolation|pulmonary vein isolation
147666|NCT03277976|ablation index|ablation index
147667|NCT03277963|Obesity|obesity
147668|NCT03277963|Obstructive sleep apnea syndrome|obstructive sleep apnea syndrome
147669|NCT03277950|virtual reality|virtual reality
147670|NCT03277950|feedback|feedback
147671|NCT03277937|gastric varices|gastric varices
147672|NCT03277937|endoscopic ultrasound|endoscopic ultrasound
147673|NCT03277937|coils|coils
147674|NCT03277937|cyanoacrylate|cyanoacrylate
147675|NCT03277898|Breast Neoplasms|breast neoplasms
147676|NCT03277898|"Exercis* OR Aerobic Exercise"|"exercis* or aerobic exercise"
147677|NCT03277898|Cognitive Function*|cognitive function*
147678|NCT03277898|"Antineoplastic therapy OR Antineoplastic agent"|"antineoplastic therapy or antineoplastic agent"
147679|NCT03277898|Chemotherapy, Adjuvant|chemotherapy, adjuvant
147680|NCT03277885|Work related chronic pain|work related chronic pain
147681|NCT03277885|Preventive care|preventive care
147682|NCT03277859|Yoga|yoga
147683|NCT03277859|Veterans|veterans
147684|NCT03277859|Traumatic Brain Injury|traumatic brain injury
147685|NCT03277859|Post-concussive Headaches|post-concussive headaches
147686|NCT03277859|Post-concussive Symptoms|post-concussive symptoms
147687|NCT03277768|Premature infant|premature infant
147688|NCT03277768|Tissue Oxygenation|tissue oxygenation
147689|NCT03277768|Patent Ductus Arteriosus|patent ductus arteriosus
147690|NCT03277716|Huge hepatocellular carcinoma|huge hepatocellular carcinoma
147691|NCT03277716|Microwave ablation|microwave ablation
147693|NCT03277716|Safety|safety
147694|NCT03277716|Non-resectable|non-resectable
147695|NCT03277716|Treatment|treatment
147696|NCT03277703|Influenza vaccine|influenza vaccine
147697|NCT03277703|Booster dose|booster dose
147698|NCT03277703|immunocompromised|immunocompromised
147699|NCT03277703|Biologic therapy|biologic therapy
147700|NCT03277703|Rheumatologic disease|rheumatologic disease
147701|NCT03277703|inflammatory bowel disease|inflammatory bowel disease
147702|NCT03277690|Cushing Syndrome, Adrenocortical Hyperfunction|cushing syndrome, adrenocortical hyperfunction
147703|NCT03277664|pediatric|pediatric
147704|NCT03277664|asthma adherence|asthma adherence
147705|NCT03277664|electronic device|electronic device
147706|NCT03277651|noninvasive|noninvasive
147707|NCT03277651|Hemodynamics|hemodynamics
147708|NCT03277638|recurrent glioblastoma|recurrent glioblastoma
147709|NCT03277638|brain cancer|brain cancer
147710|NCT03277625|pancreaticoduodenectomy|pancreaticoduodenectomy
147711|NCT03277573|Salsalate|salsalate
147712|NCT03277560|Major Trauma Centre|major trauma centre
147713|NCT03277560|ISS|iss
147714|NCT03277560|Outcome Measures|outcome measures
147715|NCT03277534|electrical stimulation|electrical stimulation
147716|NCT03277508|Brain-computer integration|brain-computer integration
147717|NCT03277482|Recurrent gynecological cancer|recurrent gynecological cancer
147718|NCT03277482|Metastatic Cervical Cancer|metastatic cervical cancer
147719|NCT03277482|Metastatic Ovarian Cancer|metastatic ovarian cancer
147720|NCT03277482|Metastatic Vaginal Cancer|metastatic vaginal cancer
147721|NCT03277482|Metastatic Vulvar Cancer|metastatic vulvar cancer
147722|NCT03277482|Metastatic Endometrial Cancer|metastatic endometrial cancer
147723|NCT03277482|Recurrent Cervical Carcinoma|recurrent cervical carcinoma
147724|NCT03277482|Recurrent Ovarian Carcinoma|recurrent ovarian carcinoma
147725|NCT03277482|Recurrent Vaginal Cancer|recurrent vaginal cancer
147726|NCT03277482|Recurrent Vulvar Cancer|recurrent vulvar cancer
147727|NCT03277482|Recurrent Endometrial Cancer|recurrent endometrial cancer
147728|NCT03277469|Gynecologic Cancer|gynecologic cancer
147729|NCT03277443|Skeletal open bite|skeletal open bite
147730|NCT03277430|uterus transplantation, absolute uterine factor infertility|uterus transplantation, absolute uterine factor infertility
147731|NCT03277404|EDTA|edta
147732|NCT03277404|Postoperative pain|postoperative pain
147733|NCT03277404|Pulp necrosis|pulp necrosis
147734|NCT03277404|Smear layer|smear layer
147735|NCT03277352|cervical cancer|cervical cancer
147736|NCT03277352|endometrial cancer|endometrial cancer
147737|NCT03277352|gastric cancer (including stomach and gastroesophageal junction (GEJ))|gastric cancer (including stomach and gastroesophageal junction (gej))
147738|NCT03277352|esophageal cancer|esophageal cancer
147739|NCT03277352|hepatocellular carcinoma (HCC)|hepatocellular carcinoma (hcc)
147740|NCT03277352|melanoma (mucosal or cutaneous)|melanoma (mucosal or cutaneous)
147741|NCT03277352|Merkel cell carcinoma|merkel cell carcinoma
147742|NCT03277352|mesothelioma|mesothelioma
147743|NCT03277352|microsatellite instability-high (MSI-H)|microsatellite instability-high (msi-h)
147744|NCT03277352|solid tumors|solid tumors
147745|NCT03277352|non-small cell lung cancer (NSCLC)|non-small cell lung cancer (nsclc)
147746|NCT03277352|ovarian cancer|ovarian cancer
147747|NCT03277352|squamous cell carcinoma of the head and neck (SCCHN)|squamous cell carcinoma of the head and neck (scchn)
147748|NCT03277352|small cell lung cancer (SCLC)|small cell lung cancer (sclc)
147749|NCT03277352|renal cell carcinoma (RCC)|renal cell carcinoma (rcc)
147750|NCT03277352|triple-negative breast cancer (TNBC)|triple-negative breast cancer (tnbc)
147751|NCT03277352|urothelial carcinoma|urothelial carcinoma
147752|NCT03277352|glucocorticoid-induced tumor necrosis factor receptor (GITR)|glucocorticoid-induced tumor necrosis factor receptor (gitr)
147753|NCT03277339|Generalized anxious disorders|generalized anxious disorders
147754|NCT03277339|Thermal cure|thermal cure
147755|NCT03277339|paroxetine|paroxetine
147756|NCT03277274|Drug Therapy|drug therapy
147757|NCT03277235|fatigue|fatigue
147758|NCT03277235|colon cancer|colon cancer
147759|NCT03277235|quality of life|quality of life
147760|NCT03277222|Neurocognitive impairment|neurocognitive impairment
147761|NCT03277222|HIV-1|hiv-1
147762|NCT03277222|Intranasal insulin|intranasal insulin
147763|NCT03277222|Neurocognitive Disorder|neurocognitive disorder
147764|NCT03277222|Cognition|cognition
147765|NCT03277222|Memory|memory
147766|NCT03277183|erythropoietin|erythropoietin
147767|NCT03277170|acute asthma exacerbation|acute asthma exacerbation
147768|NCT03277170|pediatric asthma|pediatric asthma
147769|NCT03277170|leukotriene receptor antagonist|leukotriene receptor antagonist
147770|NCT03277170|montelukast|montelukast
147771|NCT03277144|linear stapler|linear stapler
147772|NCT03277092|Child, blood drawing procedure, near Infrared light|child, blood drawing procedure, near infrared light
147773|NCT03277079|coronary artery disease|coronary artery disease
147774|NCT03277079|LDL cholesterol|ldl cholesterol
147775|NCT03277079|therapeutic target|therapeutic target
147776|NCT03277053|colorectal|colorectal
147777|NCT03277053|laparoscopic|laparoscopic
147778|NCT03277053|application|application
147779|NCT03277053|ERP|erp
147780|NCT03277053|adherence|adherence
147781|NCT03277053|mobile|mobile
147782|NCT03277027|cerebral palsy|cerebral palsy
147783|NCT03277027|Health-Related Quality Of Life|health-related quality of life
147784|NCT03277027|Physical Activity|physical activity
147785|NCT03277014|Nutritional monitoring|nutritional monitoring
147786|NCT03277014|insulin-like growth factor-1|insulin-like growth factor-1
147787|NCT03277001|AECOPD|aecopd
147788|NCT03277001|VTE prevention|vte prevention
147789|NCT03277001|Rivaroxaban|rivaroxaban
147790|NCT03277001|LMWHs|lmwhs
147791|NCT03276988|Thyroid cancer|thyroid cancer
147792|NCT03276988|Thyroidectomy|thyroidectomy
147793|NCT03276988|rhTSH|rhtsh
147794|NCT03276988|GX-30|gx-30
147795|NCT03276975|CT fluoroscopy|ct fluoroscopy
147796|NCT03276975|epidural patching|epidural patching
147797|NCT03276975|spontaneous intracranial hypotension|spontaneous intracranial hypotension
147798|NCT03276962|falciparum, efficacy|falciparum, efficacy
147799|NCT03276962|RTS,S/AS01|rts,s/as01
147800|NCT03276962|malaria vaccine|malaria vaccine
147801|NCT03276962|safety|safety
147802|NCT03276962|Malaria|malaria
147803|NCT03276962|immunogenicity|immunogenicity
147804|NCT03276962|infants|infants
147805|NCT03276949|Blood glucose|blood glucose
147806|NCT03276949|non-invasive|non-invasive
147807|NCT03276949|Raman spectroscopy|raman spectroscopy
147808|NCT03276910|antidoping|antidoping
147809|NCT03276871|Balloon dissection|balloon dissection
147810|NCT03276871|Telescopic dissection|telescopic dissection
147811|NCT03276871|Inguinal hernia|inguinal hernia
147812|NCT03276871|TEP|tep
147813|NCT03276845|Ultrasound|ultrasound
147814|NCT03276845|Elastography|elastography
147815|NCT03276845|Doppler Ultrasound|doppler ultrasound
147816|NCT03276845|Contrast enhanced Ultrasound|contrast enhanced ultrasound
147817|NCT03276845|Three-dimensional Ultrasound|three-dimensional ultrasound
147818|NCT03276819|Oral potentially malignant lesions (OPML)|oral potentially malignant lesions (opml)
147819|NCT03276819|Head and neck squamous cell carcinoma (HNSCC)|head and neck squamous cell carcinoma (hnscc)
147820|NCT03276819|Biomarkers|biomarkers
147821|NCT03276819|Smoking cessation program|smoking cessation program
147822|NCT03276819|Loss of heterozigoty (LOH)|loss of heterozigoty (loh)
147823|NCT03276819|Medico-economics|medico-economics
147824|NCT03276819|Sociology|sociology
147825|NCT03276819|Psychology|psychology
147826|NCT03276806|CT low dose|ct low dose
147827|NCT03276806|nurse led intervention|nurse led intervention
147828|NCT03276806|safety net hospital|safety net hospital
147829|NCT03276806|lung cancer screening with CTLD|lung cancer screening with ctld
147830|NCT03276767|online intervention|online intervention
147831|NCT03276767|e-Health|e-health
147832|NCT03276767|reminder|reminder
147833|NCT03276767|SMS-textmessage|sms-textmessage
147834|NCT03276767|e-mail|e-mail
147835|NCT03276767|mobile phone|mobile phone
147836|NCT03276767|cell phone|cell phone
147837|NCT03276754|Pneumococcal infections|pneumococcal infections
147838|NCT03276754|COPD exacerbations|copd exacerbations
147839|NCT03276741|labor|labor
147840|NCT03276741|anesthesia|anesthesia
147841|NCT03276741|oral intake|oral intake
147842|NCT03276741|maternal satisfaction|maternal satisfaction
147843|NCT03276741|newborn complications|newborn complications
147844|NCT03276728|Heart Failure|heart failure
147845|NCT03276728|Cardiovascular Diseases|cardiovascular diseases
147846|NCT03276728|Heart Diseases|heart diseases
147847|NCT03276728|Ejection fraction|ejection fraction
147848|NCT03276728|Heart Failure with reduced ejection fraction|heart failure with reduced ejection fraction
147849|NCT03276728|Heart Failure with preserved ejection fraction|heart failure with preserved ejection fraction
147850|NCT03276715|malignant pleural effusion|malignant pleural effusion
147851|NCT03276715|lung cancer|lung cancer
147852|NCT03276637|Genome Sequencing|genome sequencing
147853|NCT03276637|Exome Sequencing|exome sequencing
147854|NCT03276637|Military|military
147855|NCT03276637|Air Force|air force
147856|NCT03276611|Assessment|assessment
147857|NCT03276611|pulmonary|pulmonary
147858|NCT03276611|artery|artery
147859|NCT03276611|right|right
147860|NCT03276611|sided|sided
147861|NCT03276611|hemodynamics|hemodynamics
147862|NCT03276611|patients|patients
147863|NCT03276611|sleep|sleep
147864|NCT03276611|apnea|apnea
147865|NCT03276611|syndrome|syndrome
147866|NCT03276611|contionous|contionous
147867|NCT03276611|positive|positive
147868|NCT03276611|air|air
147869|NCT03276611|way|way
147870|NCT03276611|pressure|pressure
147871|NCT03276611|treatment|treatment
147872|NCT03276585|home sleep monitor|home sleep monitor
147873|NCT03276585|Sleep Apnea Syndromes|sleep apnea syndromes
147874|NCT03276585|questionnaire|questionnaire
147875|NCT03276559|critically ill|critically ill
147876|NCT03276559|ICU|icu
147877|NCT03276559|uncommunicative|uncommunicative
147878|NCT03276559|caregivers|caregivers
147879|NCT03276559|surrogate|surrogate
147880|NCT03276559|decision-making|decision-making
148179|NCT03274310|Influenza|influenza
147881|NCT03276533|dexmedetomidine; lidocaine; cytokine|dexmedetomidine; lidocaine; cytokine
147882|NCT03276520|ethyl glucuronide, biomarker, diagnostic randomized trial|ethyl glucuronide, biomarker, diagnostic randomized trial
147883|NCT03276481|melphalan|melphalan
147884|NCT03276481|stem cell transplantation|stem cell transplantation
147885|NCT03276481|17-404|17-404
147886|NCT03276481|hematopoietic cell transplantation|hematopoietic cell transplantation
147887|NCT03276481|HCT|hct
147888|NCT03276468|venetoclax; obinutuzumab; atezolizumab; lymphoma|venetoclax; obinutuzumab; atezolizumab; lymphoma
147889|NCT03276455|Beta thalassemia|beta thalassemia
147890|NCT03276455|Gene therapy|gene therapy
147891|NCT03276455|Beta-globin|beta-globin
147892|NCT03276455|Hematopoietic stem cells|hematopoietic stem cells
147893|NCT03276455|Lentiviral vector|lentiviral vector
147894|NCT03276429|NSCLC|nsclc
147895|NCT03276429|SCLC|sclc
147896|NCT03276429|MOLECULAR BIOMARKERS|molecular biomarkers
147897|NCT03276390|health disparities|health disparities
147898|NCT03276390|living donation|living donation
147899|NCT03276312|Lipogems|lipogems
147900|NCT03276312|Adipose-derived Mesenchymal Stem Cells|adipose-derived mesenchymal stem cells
147901|NCT03276312|Lipofilling|lipofilling
147902|NCT03276312|Diabetic foot|diabetic foot
147903|NCT03276208|Pregnancy|pregnancy
147904|NCT03276208|Tobacco|tobacco
147905|NCT03276208|Massage Therapy|massage therapy
147906|NCT03276208|Mindfulness|mindfulness
147907|NCT03276195|Neurodevelopmental Disorder|neurodevelopmental disorder
147908|NCT03276195|Genomics|genomics
147909|NCT03276195|Genetics|genetics
147910|NCT03276169|atrial fibrillation|atrial fibrillation
147911|NCT03276169|left atrial appendage closure|left atrial appendage closure
147912|NCT03276169|left atrial function|left atrial function
147913|NCT03276130|Blood coagulation disorder|blood coagulation disorder
147914|NCT03276130|Haematologic diseases|haematologic diseases
147915|NCT03276130|Coagulation protein disorder|coagulation protein disorder
147916|NCT03276130|Hemorrhagic disorder|hemorrhagic disorder
147917|NCT03276130|Genetic diseases, inborn|genetic diseases, inborn
147918|NCT03276130|Pain|pain
147919|NCT03276130|Anxiety|anxiety
147920|NCT03276130|Pain medication|pain medication
147921|NCT03276130|Anxiety medication|anxiety medication
147922|NCT03276117|pregnancy.obstructed labour|pregnancy.obstructed labour
147923|NCT03276104|IOL dislocation|iol dislocation
147924|NCT03276104|Cataract|cataract
147925|NCT03276104|Cataract surgery|cataract surgery
147926|NCT03276104|Scleral suturing|scleral suturing
147927|NCT03276104|Verisyse|verisyse
147928|NCT03276104|Iris-claw|iris-claw
147929|NCT03276104|Late in-the-bag IOL dislocation|late in-the-bag iol dislocation
147930|NCT03276091|colonoscopy|colonoscopy
147931|NCT03276091|immunochemical fecal test|immunochemical fecal test
147932|NCT03276091|screening|screening
147933|NCT03276078|COPD|copd
147934|NCT03276052|COPD, Pharmacokinetics|copd, pharmacokinetics
147935|NCT03276026|sugammadex|sugammadex
147936|NCT03276026|post anesthesia care unit recovery|post anesthesia care unit recovery
147937|NCT03276013|Oncology|oncology
147938|NCT03276013|Endometrial Cancer|endometrial cancer
147939|NCT03276013|Pembrolizumab|pembrolizumab
147940|NCT03276013|Doxorubicin|doxorubicin
147941|NCT03276013|Metastatic Endometrial Cancer|metastatic endometrial cancer
147942|NCT03276000|Misoprostol ,office hysteroscopy|misoprostol ,office hysteroscopy
147943|NCT03275987|cancer screening|cancer screening
147944|NCT03275935|ACOS|acos
147945|NCT03275935|Asthma|asthma
147946|NCT03275935|COPD|copd
147947|NCT03275935|inhalation technique|inhalation technique
147948|NCT03275922|Migraine|migraine
147949|NCT03275922|Headache|headache
147950|NCT03275922|Pain|pain
147951|NCT03275922|Efficacy|efficacy
147952|NCT03275922|Pediatric|pediatric
147953|NCT03275909|Chronic schizophrenia|chronic schizophrenia
147954|NCT03275909|Emotional Management Therapy|emotional management therapy
147955|NCT03275909|Integrated Psychological Therapy|integrated psychological therapy
147956|NCT03275844|Physical activity|physical activity
147957|NCT03275844|Physical capacity|physical capacity
147958|NCT03275844|Children|children
147959|NCT03275818|sarcoma|sarcoma
147960|NCT03275818|Desmoid tumor|desmoid tumor
147961|NCT03275818|Desmoplastic small round cell tumor|desmoplastic small round cell tumor
147962|NCT03275818|Ewing sarcoma|ewing sarcoma
147963|NCT03275818|relapsed|relapsed
147964|NCT03275818|refractory|refractory
147965|NCT03275805|Residual dysplasia|residual dysplasia
147966|NCT03275805|Pavlik Harness|pavlik harness
147967|NCT03275792|Shiga-Toxigenic Escherichia coli|shiga-toxigenic escherichia coli
147968|NCT03275792|Child|child
147969|NCT03275753|Visual function|visual function
147970|NCT03275753|Critical flicker fusion|critical flicker fusion
147971|NCT03275753|Dark adaptation|dark adaptation
147972|NCT03275753|Reading test|reading test
147973|NCT03275727|Breast Cancer|breast cancer
147974|NCT03275727|Survivors|survivors
147975|NCT03275727|Internet intervention|internet intervention
147976|NCT03275727|Psychosocial intervention|psychosocial intervention
147977|NCT03275727|Acceptance and Commitment Therapy (ACT)|acceptance and commitment therapy (act)
148780|NCT03270241|Short-term|short-term
147978|NCT03275727|Randomized controlled trial|randomized controlled trial
147979|NCT03275688|lung cancer|lung cancer
147980|NCT03275688|volatile organic compound|volatile organic compound
147981|NCT03275688|screening|screening
147982|NCT03275688|VOC|voc
147983|NCT03275688|clinical trial|clinical trial
147984|NCT03275675|Cancer|cancer
147985|NCT03275675|Oral chemotherapy|oral chemotherapy
147986|NCT03275675|Community Pharmacy|community pharmacy
147987|NCT03275675|Satisfaction|satisfaction
147988|NCT03275636|Haploidentical|haploidentical
147989|NCT03275636|mismatched unrelated donor|mismatched unrelated donor
147990|NCT03275636|hematopoietic stem cell transplantation|hematopoietic stem cell transplantation
147991|NCT03275636|donor comparison|donor comparison
147992|NCT03275584|positron emission tomography|positron emission tomography
147993|NCT03275584|NH3|nh3
147994|NCT03275571|Cognition|cognition
147995|NCT03275571|Intervention|intervention
147996|NCT03275571|Therapy|therapy
147997|NCT03275558|Nasal Spray|nasal spray
147998|NCT03275558|Gliosarcoma|gliosarcoma
147999|NCT03275558|Glioblastoma|glioblastoma
148000|NCT03275558|Gliomas|gliomas
148001|NCT03275519|distal hypospadias repair|distal hypospadias repair
148002|NCT03275519|urinary tract infection|urinary tract infection
148003|NCT03275519|prophylactic antibiotic use|prophylactic antibiotic use
148004|NCT03275506|neoadjuvant|neoadjuvant
148005|NCT03275506|debulking surgery|debulking surgery
148006|NCT03275493|CD19+ ,CAR-T, CRS|cd19+ ,car-t, crs
148007|NCT03275454|Autoimmune Diseases|autoimmune diseases
148008|NCT03275454|Hematologic Diseases|hematologic diseases
148009|NCT03275454|Immune System Diseases|immune system diseases
148010|NCT03275454|Blood Platelet Disorders|blood platelet disorders
148011|NCT03275441|electroretinogram|electroretinogram
148012|NCT03275441|ERG|erg
148013|NCT03275441|dark-adaptation|dark-adaptation
148014|NCT03275441|ophthalmology|ophthalmology
148015|NCT03275441|electrophysiology|electrophysiology
148016|NCT03275441|ISCEV|iscev
148017|NCT03275441|electroretinography|electroretinography
148018|NCT03275441|scotopic|scotopic
148019|NCT03275428|THRIVE|thrive
148020|NCT03275428|Non-intubated thoracic surgery|non-intubated thoracic surgery
148021|NCT03275415|BPD|bpd
148022|NCT03275415|surfactant|surfactant
148023|NCT03275415|budesonide|budesonide
148024|NCT03275415|respiratory distress syndrome|respiratory distress syndrome
148025|NCT03275402|Radioimmunotherapy|radioimmunotherapy
148026|NCT03275402|Neuroblastoma|neuroblastoma
148027|NCT03275402|CNS Metastases|cns metastases
148028|NCT03275402|Leptomeningeal Metastases|leptomeningeal metastases
148029|NCT03275402|Pediatric|pediatric
148030|NCT03275389|Safety|safety
148031|NCT03275389|Healthy adults|healthy adults
148032|NCT03275389|Immunogenicity|immunogenicity
148033|NCT03275389|Supra-seasonal universal influenza vaccines - inactivated (SUIVs)|supra-seasonal universal influenza vaccines - inactivated (suivs)
148034|NCT03275363|Subjective cognitive decline|subjective cognitive decline
148035|NCT03275363|Mild Cognitive Impairment|mild cognitive impairment
148036|NCT03275363|Dementia|dementia
148037|NCT03275363|Cerebral aging|cerebral aging
148038|NCT03275337|Social Phobia|social phobia
148039|NCT03275337|Anxiety|anxiety
148040|NCT03275337|Cerebellum|cerebellum
148041|NCT03275337|tDCS|tdcs
148042|NCT03275337|Neuromodulation|neuromodulation
148043|NCT03275337|Fear Extinction|fear extinction
148044|NCT03275311|metastatic breast cancer|metastatic breast cancer
148045|NCT03275311|observational study|observational study
148046|NCT03275311|survival|survival
148047|NCT03275311|real world data|real world data
148048|NCT03275311|real life setting|real life setting
148049|NCT03275298|ovarian cancer|ovarian cancer
148050|NCT03275298|observational study|observational study
148051|NCT03275298|survival|survival
148052|NCT03275298|real world data|real world data
148053|NCT03275298|real life setting|real life setting
148054|NCT03275259|Shock wave|shock wave
148055|NCT03275259|Gynoid lipodystrophy|gynoid lipodystrophy
148056|NCT03275259|Cellulits|cellulits
148057|NCT03275246|Primary total knee replacement|primary total knee replacement
148058|NCT03275207|Chronic pain|chronic pain
148059|NCT03275207|CPSP|cpsp
148060|NCT03275207|Dexmedetomidine|dexmedetomidine
148061|NCT03275207|Surgery|surgery
148062|NCT03275155|Autonomic Dysfunction|autonomic dysfunction
148063|NCT03275155|Inflammation|inflammation
148064|NCT03275155|Cognitive impairment|cognitive impairment
148065|NCT03275155|Interoception|interoception
148066|NCT03275155|Gait impairment|gait impairment
148067|NCT03275129|ultrasound assessment|ultrasound assessment
148068|NCT03275116|Bronchodilation|bronchodilation
148069|NCT03275116|Hyperinflation|hyperinflation
148070|NCT03275116|Physical activity|physical activity
148071|NCT03275116|Sleep quality|sleep quality
148072|NCT03275090|lipid emulsions; preterm; sepsis|lipid emulsions; preterm; sepsis
148073|NCT03275077|End stage renal disease|end stage renal disease
148074|NCT03275077|ESRD|esrd
148075|NCT03275077|Thromboelastography|thromboelastography
148076|NCT03275077|Fibrinogen|fibrinogen
148077|NCT03275064|Articular cartilage, partial thickness cartilage lesion, knee, cartilage|articular cartilage, partial thickness cartilage lesion, knee, cartilage
148078|NCT03275064|regeneration|regeneration
148079|NCT03275051|Beta Thalassaemia|beta thalassaemia
148080|NCT03275051|previously GSK2696277|previously gsk2696277
148081|NCT03275051|Lentiviral vector|lentiviral vector
148082|NCT03275051|TIGET-BTHAL|tiget-bthal
148083|NCT03275051|Gene therapy|gene therapy
148084|NCT03275038|Neuroimage|neuroimage
148085|NCT03275038|Training|training
148086|NCT03275038|Aging|aging
148087|NCT03275038|Brain|brain
148088|NCT03275038|Cardiovascular risks|cardiovascular risks
148089|NCT03274960|asymptomati bacteriuria, Griess nitrite test, preterm birth|asymptomati bacteriuria, griess nitrite test, preterm birth
148090|NCT03274947|Oropharyngeal Dysphagia|oropharyngeal dysphagia
148091|NCT03274947|Stroke|stroke
148092|NCT03274934|Adolescents|adolescents
148093|NCT03274934|Web- and mobile-based intervention|web- and mobile-based intervention
148094|NCT03274934|Acceptance and Commitment therapy|acceptance and commitment therapy
148095|NCT03274934|Psychological well-being|psychological well-being
148096|NCT03274934|Career preparation|career preparation
148097|NCT03274934|Lifecontrol|lifecontrol
148098|NCT03274934|Successful educational transitions|successful educational transitions
148099|NCT03274934|Learning difficulties|learning difficulties
148100|NCT03274934|Psychological flexibility and mindfulness skills|psychological flexibility and mindfulness skills
148101|NCT03274921|cardiovascular complications|cardiovascular complications
148102|NCT03274921|biomarkers|biomarkers
148103|NCT03274882|metastatic|metastatic
148104|NCT03274882|colorectal|colorectal
148105|NCT03274882|cancer|cancer
148106|NCT03274882|Lonsurf|lonsurf
148107|NCT03274882|S95005|s95005
148108|NCT03274882|Russia|russia
148109|NCT03274869|Scrub typhus|scrub typhus
148110|NCT03274869|Cardiovascular Complication|cardiovascular complication
189015|NCT03014258|Pf|pf
148111|NCT03274830|primary osteoarthritis|primary osteoarthritis
148112|NCT03274830|secondary osteoarthritis|secondary osteoarthritis
148113|NCT03274830|femoral head fracture|femoral head fracture
148114|NCT03274830|necrosis|necrosis
148115|NCT03274817|Alzheimer's Disease|alzheimer's disease
148116|NCT03274817|Depression|depression
148117|NCT03274817|Escitalopram|escitalopram
148118|NCT03274817|Venlafaxine|venlafaxine
148119|NCT03274791|COPD|copd
148120|NCT03274791|smoking|smoking
148121|NCT03274791|induced sputum|induced sputum
148122|NCT03274791|clinical features|clinical features
148123|NCT03274765|ovarian stimulation|ovarian stimulation
148124|NCT03274765|blood test|blood test
148125|NCT03274765|Medically Assisted Procreation|medically assisted procreation
148126|NCT03274752|Paroxetine|paroxetine
148128|NCT03274674|I-PRF|i-prf
148129|NCT03274674|Microneedle|microneedle
148130|NCT03274674|Gingival Thickness|gingival thickness
148131|NCT03274674|Injectable-Platelet-Rich-Fibrin|injectable-platelet-rich-fibrin
148132|NCT03274674|Platelet Rich Fibrin|platelet rich fibrin
148133|NCT03274661|solid tumor, Pembrolizumab,|solid tumor, pembrolizumab,
148134|NCT03274609|Lung diseases|lung diseases
148135|NCT03274609|cancer|cancer
148136|NCT03274609|Interventional pulmonology|interventional pulmonology
148137|NCT03274609|peripheral nodule|peripheral nodule
148138|NCT03274596|Oxidative Damage|oxidative damage
148139|NCT03274596|Vitamin E|vitamin e
148140|NCT03274596|Total Antioxidant Capacity|total antioxidant capacity
148141|NCT03274596|Retinopathy of Prematurity|retinopathy of prematurity
148142|NCT03274583|atrial fibrillation|atrial fibrillation
148143|NCT03274583|smartphone|smartphone
148144|NCT03274583|detection|detection
148145|NCT03274557|Achilles, tendinose, tendinopathy, pain|achilles, tendinose, tendinopathy, pain
148146|NCT03274544|Idiopathic Pulmonary Fibrosis|idiopathic pulmonary fibrosis
148147|NCT03274544|Chinese Medicine|chinese medicine
148148|NCT03274544|Herbal Medicine|herbal medicine
148149|NCT03274518|Hemodialysis|hemodialysis
148150|NCT03274518|Hemodiafiltration|hemodiafiltration
148151|NCT03274518|fluid status|fluid status
148152|NCT03274518|hemodynamics|hemodynamics
148153|NCT03274479|adenosine receptors|adenosine receptors
148154|NCT03274479|checkpoint inhibitors|checkpoint inhibitors
148155|NCT03274479|immune system activator|immune system activator
148156|NCT03274440|OCD|ocd
148157|NCT03274440|Marijuana|marijuana
148158|NCT03274440|THC|thc
148159|NCT03274440|Cannabis|cannabis
148160|NCT03274440|CBD|cbd
148161|NCT03274440|Cannabinoid|cannabinoid
148162|NCT03274414|squamous cell carcinoma|squamous cell carcinoma
148163|NCT03274414|esthesioneuroblastoma|esthesioneuroblastoma
148164|NCT03274414|adenoid cystic carcinoma|adenoid cystic carcinoma
148165|NCT03274414|adenocarcinoma|adenocarcinoma
148166|NCT03274414|cisplatin|cisplatin
148167|NCT03274414|17-442|17-442
148168|NCT03274401|Atrial fibrillation|atrial fibrillation
148169|NCT03274401|Pulmonary embolism|pulmonary embolism
148170|NCT03274401|Screening|screening
148171|NCT03274375|Anti-NMDAR encephalitis|anti-nmdar encephalitis
148172|NCT03274375|IA adsorption|ia adsorption
148173|NCT03274375|Paediatric|paediatric
148174|NCT03274336|patient satisfaction|patient satisfaction
148175|NCT03274336|preanesthesia|preanesthesia
148176|NCT03274336|movie|movie
148177|NCT03274336|brochure|brochure
148178|NCT03274336|face-to-face interview|face-to-face interview
148180|NCT03274310|Text message|text message
148181|NCT03274310|Influenza-like Illness|influenza-like illness
148182|NCT03274310|Acute Respiratory Infection|acute respiratory infection
148183|NCT03274284|chemoradiation for|chemoradiation for
148184|NCT03274284|T1G3 BC|t1g3 bc
148185|NCT03274271|physical activity|physical activity
148186|NCT03274271|sedentary behaviour|sedentary behaviour
148187|NCT03274271|eHealth|ehealth
148188|NCT03274271|mHealth|mhealth
148189|NCT03274271|self-regulation|self-regulation
148190|NCT03274271|behaviour change techniques|behaviour change techniques
148191|NCT03274271|action planning|action planning
148192|NCT03274271|coping planning|coping planning
148193|NCT03274271|self-monitoring|self-monitoring
148194|NCT03274271|prevention|prevention
148195|NCT03274245|Public Health|public health
148196|NCT03274206|Cervical Intraepithelian Neoplasia Grade 2/3|cervical intraepithelian neoplasia grade 2/3
148197|NCT03274206|CIN 2/3|cin 2/3
148198|NCT03274206|HPV|hpv
148199|NCT03274180|Travel consultation|travel consultation
148200|NCT03274102|Inactivated Enterovirus Type 71 (EV71) Vaccine|inactivated enterovirus type 71 (ev71) vaccine
148201|NCT03274102|Concomitant vaccination|concomitant vaccination
148202|NCT03274102|Safety|safety
148203|NCT03274102|Immunogenicity|immunogenicity
148204|NCT03274102|Infant|infant
148205|NCT03274076|diffuse|diffuse
148206|NCT03274076|scleroderma|scleroderma
148207|NCT03274076|systemic sclerosis|systemic sclerosis
148208|NCT03274050|robot|robot
148209|NCT03274050|surgery|surgery
148210|NCT03274050|pediatry|pediatry
148211|NCT03273998|coagulation|coagulation
148212|NCT03273998|bleeding|bleeding
148213|NCT03273972|Healthy Volunteers|healthy volunteers
148214|NCT03273972|Low Density Lipoprotein Cholesterol (LDL)|low density lipoprotein cholesterol (ldl)
148215|NCT03273972|PCSK9|pcsk9
148216|NCT03273972|Alirocumab|alirocumab
148217|NCT03273972|Forearm Blood Flow|forearm blood flow
148218|NCT03273972|Arterial Stiffness|arterial stiffness
148219|NCT03273972|Carotid Intima Media Thickness|carotid intima media thickness
148220|NCT03273972|Inflammation|inflammation
148221|NCT03273972|Endothelial function|endothelial function
148222|NCT03273959|Physiotherapy|physiotherapy
148223|NCT03273959|Physical Therapy|physical therapy
148224|NCT03273959|Exercise|exercise
148225|NCT03273959|Hospitalization|hospitalization
148226|NCT03273959|Pediatric|pediatric
148227|NCT03273959|Adolescents|adolescents
148228|NCT03273946|CCI18781|cci18781
148229|NCT03273946|Observational|observational
148230|NCT03273946|Post-marketing|post-marketing
148231|NCT03273946|Fluticasone propionate|fluticasone propionate
148232|NCT03273946|Asthma|asthma
148233|NCT03273920|laparoscopy-assisted gastrectomy|laparoscopy-assisted gastrectomy
148234|NCT03273920|robot-assisted gastrectomy|robot-assisted gastrectomy
148235|NCT03273920|advanced gastric cancer|advanced gastric cancer
148236|NCT03273920|D2 Lymphadenectomy|d2 lymphadenectomy
148237|NCT03273907|CyPass Micro-Stent|cypass micro-stent
148238|NCT03273894|Hypothermia, temperature management|hypothermia, temperature management
148239|NCT03273881|Gestational diabetes mellitus|gestational diabetes mellitus
148240|NCT03273881|Pre-gestational diabetes mellitus|pre-gestational diabetes mellitus
148241|NCT03273881|Treatment|treatment
148242|NCT03273881|Neonatal hypoglycemia|neonatal hypoglycemia
148243|NCT03273803|Heart sounds, smartphone, application|heart sounds, smartphone, application
148244|NCT03273777|Cesarean section|cesarean section
148245|NCT03273777|Skin incision|skin incision
148246|NCT03273777|Skewness|skewness
148247|NCT03273777|Line drawing|line drawing
148248|NCT03273764|Preterm, RDS, Surfactant, CPAP|preterm, rds, surfactant, cpap
148249|NCT03273751|Remote Ischemic Preconditioning|remote ischemic preconditioning
148250|NCT03273751|Partial nephrectomy|partial nephrectomy
148251|NCT03273751|Acute kidney injury|acute kidney injury
148252|NCT03273738|type 2 diabetes|type 2 diabetes
148253|NCT03273738|postmenopausal|postmenopausal
148254|NCT03273725|Oral Health|oral health
148255|NCT03273725|Vitamin D|vitamin d
148256|NCT03273686|Esophageal Cancer|esophageal cancer
148257|NCT03273686|Nasogastric Tube|nasogastric tube
148258|NCT03273673|Secondary ACL Injury Prevention|secondary acl injury prevention
148259|NCT03273673|Visual Biofeedback|visual biofeedback
148260|NCT03273673|Tactile Biofeedback|tactile biofeedback
148261|NCT03273634|Palpitations|palpitations
148262|NCT03273608|Hepatocellular Carcinoma|hepatocellular carcinoma
148263|NCT03273608|Advanced HCC|advanced hcc
148264|NCT03273608|Unresectable|unresectable
148265|NCT03273608|deTACE|detace
148266|NCT03273608|HepaSphere|hepasphere
148267|NCT03273517|Glycemia|glycemia
148268|NCT03273517|Preoperative fasting|preoperative fasting
148269|NCT03273517|Pediatric patients|pediatric patients
148270|NCT03273517|Anesthesia|anesthesia
148271|NCT03273517|Knowledge of the resident|knowledge of the resident
148272|NCT03273491|self-weighing|self-weighing
148273|NCT03273491|weight gain|weight gain
148274|NCT03273491|Ecological Momentary Assessment|ecological momentary assessment
148275|NCT03273491|mood|mood
148276|NCT03273491|emerging adulthood|emerging adulthood
148277|NCT03273491|obesity|obesity
148278|NCT03273491|eating disorders|eating disorders
148279|NCT03273478|Bifurcation aneurysm|bifurcation aneurysm
148280|NCT03273478|Unruptured bifurcation aneurysm|unruptured bifurcation aneurysm
148281|NCT03273478|Ruptured bifurcation aneurysm|ruptured bifurcation aneurysm
148282|NCT03273478|Stent-assisted coiling|stent-assisted coiling
148283|NCT03273478|pCONUS2 Bifurcation Aneurysm Implant|pconus2 bifurcation aneurysm implant
148284|NCT03273465|IBD|ibd
148285|NCT03273465|Colitis|colitis
148286|NCT03273465|fecal|fecal
148287|NCT03273465|FMT|fmt
148288|NCT03273465|microbiota|microbiota
148289|NCT03273465|transplantation|transplantation
148290|NCT03273439|Repetitive transcranial magnetic stimulation|repetitive transcranial magnetic stimulation
148291|NCT03273439|Negative symptoms|negative symptoms
148292|NCT03273439|randomized controlled trial|randomized controlled trial
148293|NCT03273439|Schizophrenia|schizophrenia
148294|NCT03273439|cognition|cognition
148295|NCT03273413|Pravastatin|pravastatin
148296|NCT03273413|Statin|statin
148297|NCT03273400|Lumbar, Hamstring, Mobilisation|lumbar, hamstring, mobilisation
148298|NCT03273322|Left atrial appendage closure|left atrial appendage closure
148299|NCT03273322|Rivaroxaban|rivaroxaban
148300|NCT03273322|Dual antiplatelet therapy|dual antiplatelet therapy
148301|NCT03273322|Anticoagulation|anticoagulation
148302|NCT03273322|Stroke prevention|stroke prevention
148303|NCT03273296|microbiota|microbiota
148304|NCT03273296|metabolize|metabolize
148305|NCT03273257|Pulmonary endarterectomy|pulmonary endarterectomy
148306|NCT03273257|PEA|pea
148307|NCT03273257|Medical therapy|medical therapy
148308|NCT03273218|coronary angiography|coronary angiography
189243|NCT03012971|Surgery|surgery
148309|NCT03273218|diagnosctic transradial catheter|diagnosctic transradial catheter
148310|NCT03273218|transradial catheter|transradial catheter
148311|NCT03273205|Transcranial direct current stimulation (tDCS)|transcranial direct current stimulation (tdcs)
148312|NCT03273192|healthy subjects|healthy subjects
148313|NCT03273192|adalimumab|adalimumab
148314|NCT03273192|single dose|single dose
148315|NCT03273192|Phase 1|phase 1
148316|NCT03273192|PK|pk
148317|NCT03273179|cerebral venous sinus thrombosis|cerebral venous sinus thrombosis
148318|NCT03273179|CSF pressure|csf pressure
148319|NCT03273179|modified Rankin Scale|modified rankin scale
148320|NCT03273179|papilledema|papilledema
148321|NCT03273179|NIHSS|nihss
148322|NCT03273127|Asthma, placebo, abediterol, DPI, corticosteroids|asthma, placebo, abediterol, dpi, corticosteroids
148323|NCT03273114|back pain|back pain
148324|NCT03273114|physiotherapy|physiotherapy
148325|NCT03273114|exercise therapy|exercise therapy
148326|NCT03273114|cognitive functional therapy|cognitive functional therapy
148327|NCT03273114|low back pain|low back pain
148328|NCT03273114|backache|backache
148329|NCT03273114|lower back pain|lower back pain
148330|NCT03273114|lumbago|lumbago
148331|NCT03273114|multidimensional|multidimensional
148332|NCT03273114|biopsychosocial|biopsychosocial
148333|NCT03273088|healthy subjects|healthy subjects
148334|NCT03273088|Pharmacokinetics|pharmacokinetics
148335|NCT03273088|etanercept|etanercept
148336|NCT03273088|single dose|single dose
148337|NCT03273088|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal
148338|NCT03273075|P2Y12r inhibitor|p2y12r inhibitor
148339|NCT03273075|Cardiac Arrest|cardiac arrest
148340|NCT03273075|STEMI|stemi
148341|NCT03273075|HTPR|htpr
148342|NCT03273062|Brain Injury|brain injury
148343|NCT03273062|Traumatic Brain Injury|traumatic brain injury
148344|NCT03273062|Acquired Brain Injury|acquired brain injury
148345|NCT03273062|Cognition|cognition
148346|NCT03273062|Neuropsychiatric Symptopms|neuropsychiatric symptopms
148347|NCT03273062|COMT|comt
148348|NCT03272997|Positron emission thomography|positron emission thomography
148349|NCT03272997|Computed tomography|computed tomography
148350|NCT03272997|Sensitivity|sensitivity
148351|NCT03272997|Specificity|specificity
148352|NCT03272971|lung cancer|lung cancer
148353|NCT03272971|radiofrequency ablation|radiofrequency ablation
148354|NCT03272971|bronchoscopy|bronchoscopy
148355|NCT03272971|NSCLC|nsclc
148356|NCT03272958|Pruritus|pruritus
148357|NCT03272958|Bullous pemphigoid|bullous pemphigoid
148358|NCT03272919|Breast Cancer, Peripheral neuropathy, Taxol, carboplatin|breast cancer, peripheral neuropathy, taxol, carboplatin
148359|NCT03272906|aphasia|aphasia
148360|NCT03272906|stroke|stroke
148361|NCT03272906|tDCS|tdcs
148362|NCT03272906|language|language
148363|NCT03272906|stimulation|stimulation
148364|NCT03272906|brain|brain
148365|NCT03272906|speech therapy|speech therapy
148366|NCT03272893|psychoneuroimmunology|psychoneuroimmunology
148367|NCT03272880|Art Therapy|art therapy
148368|NCT03272880|Music Therapy|music therapy
148369|NCT03272815|pneumothorax|pneumothorax
148370|NCT03272815|chest tube removal|chest tube removal
148371|NCT03272815|percussion|percussion
148372|NCT03272802|Amyotrophic Lateral Sclerosis|amyotrophic lateral sclerosis
148373|NCT03272802|Edaravone|edaravone
148374|NCT03272776|LMA Protector|lma protector
148375|NCT03272776|Second Generation Laryngeal Masks|second generation laryngeal masks
148376|NCT03272776|Airway|airway
148377|NCT03272776|Dual Gastric Acces|dual gastric acces
148378|NCT03272776|Teleflex|teleflex
148379|NCT03272776|Supraglottic Devices|supraglottic devices
148380|NCT03272776|Ambulatory Surgery|ambulatory surgery
148381|NCT03272737|KAATSU|kaatsu
148382|NCT03272737|Cardiovascular system|cardiovascular system
148383|NCT03272737|Elderly|elderly
148384|NCT03272711|Vortioxetine|vortioxetine
148385|NCT03272711|Elderly|elderly
148386|NCT03272711|Online cognitive training|online cognitive training
148387|NCT03272698|ketamine|ketamine
148388|NCT03272698|treatment-resistant depression|treatment-resistant depression
148389|NCT03272698|electroconvulsive therapy|electroconvulsive therapy
148390|NCT03272685|Reduced nicotine cigarettes|reduced nicotine cigarettes
148391|NCT03272685|Alternative nicotine products|alternative nicotine products
148392|NCT03272685|Biomarkers of tobacco exposure|biomarkers of tobacco exposure
148393|NCT03272659|Fluorescence Sigmoidoscopy|fluorescence sigmoidoscopy
148394|NCT03272659|PDD|pdd
148395|NCT03272659|Photodynamic Diagnosis|photodynamic diagnosis
148396|NCT03272646|Gastric Cancer|gastric cancer
148397|NCT03272607|Adverse Drug Event|adverse drug event
148398|NCT03272607|Choosing Wisely Canada|choosing wisely canada
148399|NCT03272607|Deprescribing|deprescribing
148400|NCT03272607|Elderly|elderly
148401|NCT03272607|Frailty|frailty
148402|NCT03272607|High value healthcare|high value healthcare
148403|NCT03272607|Medication rationalization|medication rationalization
148404|NCT03272607|Medication stewardship|medication stewardship
148405|NCT03272607|Polypharmacy|polypharmacy
148406|NCT03272594|Neonatal pain|neonatal pain
148407|NCT03272594|Pediatric pain|pediatric pain
148408|NCT03272594|Pain assessment|pain assessment
148409|NCT03272594|Breastfeeding|breastfeeding
148410|NCT03272594|Sucrose|sucrose
148411|NCT03272594|Randomized controlled trial|randomized controlled trial
148412|NCT03272594|Behavioural pain response|behavioural pain response
148413|NCT03272594|Neurophysiological pain response|neurophysiological pain response
148414|NCT03272581|Functional|functional
148415|NCT03272581|Training|training
148416|NCT03272581|Performance|performance
148417|NCT03272568|Extended Life Plasma Derived Factor Products|extended life plasma derived factor products
148418|NCT03272568|Female hemophilia A and B carriers|female hemophilia a and b carriers
148419|NCT03272568|Menorrhagia|menorrhagia
148420|NCT03272542|gastric bypass|gastric bypass
148421|NCT03272542|calcium absorption|calcium absorption
148422|NCT03272542|postmenopausal women|postmenopausal women
148423|NCT03272516|Mild to moderate Depression|mild to moderate depression
148424|NCT03272516|Mild to moderate Anxiety|mild to moderate anxiety
148425|NCT03272516|Mindfulness based cognitive therapy|mindfulness based cognitive therapy
148426|NCT03272516|Primary care|primary care
148427|NCT03272516|PHQ-9|phq-9
148428|NCT03272516|GAD-7|gad-7
148429|NCT03272516|Antidepressants|antidepressants
148430|NCT03272516|Anxiolytica|anxiolytica
148431|NCT03272516|Subjective wellbeing|subjective wellbeing
148432|NCT03272503|Pimozide|pimozide
148433|NCT03272490|locking plate|locking plate
148434|NCT03272490|anatomical preshaped|anatomical preshaped
148435|NCT03272490|polyaxial|polyaxial
148436|NCT03272490|outcome|outcome
148437|NCT03272477|hormone receptor positive|hormone receptor positive
148438|NCT03272477|human epidermal growth factor receptor 2 positive|human epidermal growth factor receptor 2 positive
148439|NCT03272477|Early breast cancer|early breast cancer
148440|NCT03272477|HR+/HER2+|hr+/her2+
148441|NCT03272464|Melanoma|melanoma
148442|NCT03272438|steps|steps
148443|NCT03272438|goals|goals
148444|NCT03272386|pelvic floor muscles|pelvic floor muscles
148445|NCT03272386|instruction|instruction
148446|NCT03272386|assessment|assessment
148447|NCT03272386|acceptability|acceptability
148448|NCT03272386|understanding|understanding
148449|NCT03272334|Metastatic Breast Cancer|metastatic breast cancer
148450|NCT03272334|Adoptive Cell Therapy|adoptive cell therapy
148451|NCT03272334|Armed Activated T-cells|armed activated t-cells
148452|NCT03272334|Bispecific Antibodies|bispecific antibodies
148453|NCT03272334|Immunotherapy|immunotherapy
148454|NCT03272321|biomedical intervention|biomedical intervention
148455|NCT03272321|oxytocin|oxytocin
148456|NCT03272321|EEG|eeg
148457|NCT03272321|skin conductance response|skin conductance response
148458|NCT03272321|heart rate|heart rate
148459|NCT03272321|gaze direction|gaze direction
148460|NCT03272321|eye contact|eye contact
148461|NCT03272282|WHO PARTOGRAPG.OBSTRUCTED LABOUR. managment of labour|who partograpg.obstructed labour. managment of labour
148462|NCT03272269|Diabetes Mellitus type 1|diabetes mellitus type 1
148463|NCT03272269|Autoimmune disease|autoimmune disease
148464|NCT03272269|Immunotherapy|immunotherapy
148465|NCT03272269|Diabetes treatment|diabetes treatment
148466|NCT03272269|Residual beta cell function|residual beta cell function
148467|NCT03272269|Adult patients|adult patients
148468|NCT03272243|thoracolumbar fracture|thoracolumbar fracture
148469|NCT03272243|short segment fixation|short segment fixation
148470|NCT03272243|long segment fixation|long segment fixation
148471|NCT03272243|index level|index level
148472|NCT03272230|Apathy|apathy
148473|NCT03272230|Goal-directed behavior|goal-directed behavior
148474|NCT03272230|Assessment|assessment
148475|NCT03272230|Diagnosis|diagnosis
148476|NCT03272230|Sensor|sensor
148477|NCT03272230|Ecological condition|ecological condition
148478|NCT03272230|Neurological disease|neurological disease
148479|NCT03272217|Atezolizumab|atezolizumab
148480|NCT03272217|MPDL3280A|mpdl3280a
148481|NCT03272217|Bevacizumab|bevacizumab
148482|NCT03272217|Avastin|avastin
148483|NCT03272217|Cisplatin-Ineligible|cisplatin-ineligible
148484|NCT03272217|Anti-PD-L1 Antibodies|anti-pd-l1 antibodies
148485|NCT03272204|pubic hair; grooming; urinary tract symptoms; vaginitis|pubic hair; grooming; urinary tract symptoms; vaginitis
148487|NCT03272191|Infarction|infarction
148488|NCT03272191|Infarct|infarct
148489|NCT03272191|Subacute MI|subacute mi
148490|NCT03272191|stem cell|stem cell
148491|NCT03272165|Healthy Volunteers|healthy volunteers
148492|NCT03272165|Safety|safety
148493|NCT03272165|Tolerability|tolerability
148494|NCT03272165|Pharmacokinetics|pharmacokinetics
148495|NCT03272165|Pharmacodynamics|pharmacodynamics
148496|NCT03272165|Immunogenicity|immunogenicity
148497|NCT03272126|vitamin D|vitamin d
148498|NCT03272100|lateral approach|lateral approach
148499|NCT03272100|bone augmentation|bone augmentation
148500|NCT03272100|sinus lift|sinus lift
148501|NCT03272100|flap|flap
148502|NCT03272087|Thoracoscopy|thoracoscopy
148503|NCT03272048|Firearms|firearms
148504|NCT03272035|General practice|general practice
148505|NCT03272035|death|death
148506|NCT03272035|bereavement|bereavement
148507|NCT03272022|cobalamin, folate|cobalamin, folate
148508|NCT03271996|Pilonidal sinus|pilonidal sinus
148509|NCT03271996|Bascom|bascom
148510|NCT03271996|Cleft lift|cleft lift
148511|NCT03271996|Fistulectomy|fistulectomy
148512|NCT03271996|Karydakis|karydakis
148513|NCT03271918|Pituitary Adenoma|pituitary adenoma
148514|NCT03271918|Dopaminergic Agonist|dopaminergic agonist
148515|NCT03271918|Nonfunctioning Pituitary Adenoma|nonfunctioning pituitary adenoma
148516|NCT03271918|Cabergoline|cabergoline
148517|NCT03271879|Diabetes|diabetes
148518|NCT03271879|Heart|heart
148519|NCT03271879|Arrhythmia|arrhythmia
148520|NCT03271866|Schizophrenia|schizophrenia
148521|NCT03271866|Metabolic syndrome|metabolic syndrome
148522|NCT03271866|Metformin|metformin
148523|NCT03271866|Cognitive impairment|cognitive impairment
148524|NCT03271866|Clinical trial|clinical trial
148525|NCT03271827|Apnoeic oxygenation|apnoeic oxygenation
148526|NCT03271827|Airway management|airway management
148527|NCT03271827|Oxygen insufflation|oxygen insufflation
148528|NCT03271827|Paediatric general anaesthesia|paediatric general anaesthesia
148529|NCT03271775|Dizziness|dizziness
148530|NCT03271775|Instability|instability
148531|NCT03271762|MITRACLIP|mitraclip
148532|NCT03271762|primary Mitral Regurgitation|primary mitral regurgitation
148533|NCT03271762|high surgical risks|high surgical risks
148534|NCT03271749|Fast Track surgical recovery|fast track surgical recovery
148535|NCT03271749|Surgical recovery|surgical recovery
148536|NCT03271749|Thoracic surgery|thoracic surgery
148537|NCT03271736|Parkinson's disease|parkinson's disease
148538|NCT03271736|Auditory cues|auditory cues
148539|NCT03271736|step in place|step in place
148540|NCT03271736|transcranial magnetic stimulation|transcranial magnetic stimulation
148541|NCT03271736|cortical excitability|cortical excitability
148542|NCT03271723|cohort studies|cohort studies
148543|NCT03271723|infant development|infant development
148544|NCT03271723|pregnancy|pregnancy
148545|NCT03271723|Brazil|brazil
148546|NCT03271723|observational studies|observational studies
148547|NCT03271723|epidemiology|epidemiology
148548|NCT03271723|maternal health|maternal health
148549|NCT03271710|Distal embolization|distal embolization
148550|NCT03271710|Percutaneous transluminal angioplasty|percutaneous transluminal angioplasty
148551|NCT03271710|Integrated embolic protection|integrated embolic protection
148552|NCT03271684|stroke, self-management, Bridges, participation, function, self-efficacy|stroke, self-management, bridges, participation, function, self-efficacy
148553|NCT03271671|neurally adjusted ventilator assist|neurally adjusted ventilator assist
148554|NCT03271671|Pressure support ventilation|pressure support ventilation
148555|NCT03271671|non invasive ventilation|non invasive ventilation
148556|NCT03271671|niv|niv
148557|NCT03271658|patient decision aid|patient decision aid
148558|NCT03271658|end-of-life care|end-of-life care
148559|NCT03271658|shared decision making|shared decision making
148560|NCT03271658|informed decision|informed decision
148561|NCT03271658|decision-making|decision-making
148562|NCT03271658|clinical decision-making|clinical decision-making
148563|NCT03271658|web-based decision aid|web-based decision aid
148564|NCT03271658|palliative|palliative
148565|NCT03271658|critical care|critical care
148566|NCT03271658|nursing|nursing
148567|NCT03271645|Depression|depression
148568|NCT03271645|Anxiety|anxiety
148569|NCT03271645|Stress|stress
148570|NCT03271645|Internet-delivered interventions|internet-delivered interventions
148571|NCT03271632|multiple myeloma|multiple myeloma
148572|NCT03271632|chimeric antigen receptor|chimeric antigen receptor
148573|NCT03271632|BCMA|bcma
148574|NCT03271632|CD38|cd38
148575|NCT03271632|CD56|cd56
148576|NCT03271632|CD138|cd138
148577|NCT03271619|Safety Issues|safety issues
148578|NCT03271580|Wound healing|wound healing
148579|NCT03271580|Diabetes|diabetes
148580|NCT03271580|Inflammatory cells|inflammatory cells
148581|NCT03271580|Macrophage|macrophage
148582|NCT03271528|Lacosamide|lacosamide
148583|NCT03271528|Alcohol craving|alcohol craving
148584|NCT03271528|Alcohol Urge Questionnaire|alcohol urge questionnaire
148585|NCT03271528|Obsessive-Compulsive Drinking Scale|obsessive-compulsive drinking scale
148586|NCT03271515|leukemia|leukemia
148587|NCT03271515|lymphoma|lymphoma
148588|NCT03271515|CAR-T|car-t
148589|NCT03271515|bispecific|bispecific
148590|NCT03271515|CD20|cd20
148591|NCT03271515|CD19|cd19
148592|NCT03271489|Elagolix Sodium|elagolix sodium
148593|NCT03271489|Heavy Menstrual Bleeding (HMB)|heavy menstrual bleeding (hmb)
148594|NCT03271489|Heavy Uterine Bleeding|heavy uterine bleeding
148595|NCT03271489|Leiomyomata|leiomyomata
148596|NCT03271489|Menorrhagia|menorrhagia
148597|NCT03271489|Elagolix + Norethindrone Acetate|elagolix + norethindrone acetate
148598|NCT03271489|Elagolix + E2/NETA|elagolix + e2/neta
148599|NCT03271489|Elagolix|elagolix
148600|NCT03271489|Safety|safety
148601|NCT03271489|Efficacy|efficacy
148602|NCT03271489|ABT-620|abt-620
148603|NCT03271476|Breast Cancer|breast cancer
148604|NCT03271476|EMDR|emdr
148605|NCT03271463|stroke|stroke
148606|NCT03271463|selective voluntary motor control|selective voluntary motor control
148607|NCT03271450|dabigatran|dabigatran
148608|NCT03271450|warfarin|warfarin
148609|NCT03271450|apixaban|apixaban
148610|NCT03271450|edoxaban|edoxaban
148611|NCT03271450|extended treatment|extended treatment
148612|NCT03271450|oral anticoagulant|oral anticoagulant
148613|NCT03271450|rivaroxaban|rivaroxaban
148614|NCT03271450|comparative safety|comparative safety
148615|NCT03271450|comparative effectiveness|comparative effectiveness
148616|NCT03271385|hypertrophic Cardiomyopathy|hypertrophic cardiomyopathy
148617|NCT03271385|hypertensive Heart Disease|hypertensive heart disease
148618|NCT03271385|cardiac magnetic resonance|cardiac magnetic resonance
148619|NCT03271307|self-test|self-test
148620|NCT03271307|testing|testing
148621|NCT03271307|cost-effectiveness|cost-effectiveness
148622|NCT03271294|pelvic organ prolapse|pelvic organ prolapse
148623|NCT03271294|Exair|exair
148624|NCT03271294|Transvaginal mesh|transvaginal mesh
148625|NCT03271281|68Ga-NODAGA-E[c(RGDyK)]2|68ga-nodaga-e[c(rgdyk)]2
148626|NCT03271281|Angiogenesis PET/CT|angiogenesis pet/ct
148627|NCT03271281|Neuroendocrine tumors|neuroendocrine tumors
148628|NCT03271268|Vascular filling|vascular filling
148629|NCT03271268|Fluid overload|fluid overload
148630|NCT03271268|Biomarkers|biomarkers
148631|NCT03271268|Lung edema|lung edema
148632|NCT03271255|apatinib|apatinib
148633|NCT03271255|bevacizumab|bevacizumab
148634|NCT03271255|FOLFIRI|folfiri
148635|NCT03271255|colorectal cancer|colorectal cancer
148636|NCT03271229|Platelet rich plasma|platelet rich plasma
148637|NCT03271229|bone marrow|bone marrow
148638|NCT03271229|stem cell|stem cell
148639|NCT03271203|Michigan Hand Outcomes Questionnaire|michigan hand outcomes questionnaire
148640|NCT03271203|Real-time data capture|real-time data capture
148641|NCT03271203|Cognitive debriefing|cognitive debriefing
148642|NCT03271203|Hand Osteoarthritis|hand osteoarthritis
148643|NCT03271203|Concept elicitation|concept elicitation
148644|NCT03271190|aging|aging
148645|NCT03271190|memory complaint|memory complaint
148646|NCT03271177|transradial percutaneous coronary intervention|transradial percutaneous coronary intervention
148647|NCT03271138|Celiac Disease|celiac disease
148648|NCT03271138|Gluten-Free Diet|gluten-free diet
148649|NCT03271138|Bifidobacterium infantis NLS super strain|bifidobacterium infantis nls super strain
148650|NCT03271138|gastrointestinal symptoms|gastrointestinal symptoms
148651|NCT03271138|quality of life|quality of life
148652|NCT03271138|microbiota|microbiota
148653|NCT03271138|IgA TTG|iga ttg
148654|NCT03271138|IgA DGP|iga dgp
148655|NCT03271125|Intervention|intervention
148656|NCT03271125|Multiple sclerosis|multiple sclerosis
148657|NCT03271125|Treadmill|treadmill
148658|NCT03271125|Mobility|mobility
148659|NCT03271099|survivorship; navigation|survivorship; navigation
148660|NCT03271086|Relaxation training|relaxation training
148661|NCT03271086|Pediatric clinic|pediatric clinic
148662|NCT03271086|Children 6-11 years|children 6-11 years
148663|NCT03271086|Text messaging|text messaging
148664|NCT03271073|gastric cancer|gastric cancer
148665|NCT03271073|gastroesophageal junction cancer|gastroesophageal junction cancer
148666|NCT03271073|Apatinib|apatinib
148667|NCT03271073|S1|s1
148668|NCT03271047|cancer|cancer
148669|NCT03271034|Lipedema|lipedema
148670|NCT03271034|Metabolism|metabolism
148671|NCT03271034|Body Composition|body composition
148672|NCT03271034|Fat Distribution|fat distribution
148673|NCT03271034|Immunology|immunology
148674|NCT03270995|breast cancer|breast cancer
148675|NCT03270995|gynecological cancer|gynecological cancer
148676|NCT03270995|fear of cancer recurrence|fear of cancer recurrence
148677|NCT03270995|clinical trial|clinical trial
148678|NCT03270995|randomized controlled trial|randomized controlled trial
148679|NCT03270995|group therapy|group therapy
148680|NCT03270995|intervention|intervention
148681|NCT03270995|cognitive-existential|cognitive-existential
148682|NCT03270982|Non Inflammatory Degenerative Joint Disease|non inflammatory degenerative joint disease
148683|NCT03270982|Rheumatoid Arthritis|rheumatoid arthritis
148684|NCT03270982|Revision where other devices have failed|revision where other devices have failed
148685|NCT03270982|Correction of functional deformity|correction of functional deformity
148686|NCT03270982|Oncology Applications|oncology applications
148687|NCT03270982|Treatment of acute or Chronic fractures|treatment of acute or chronic fractures
148688|NCT03270930|Operative duration|operative duration
148689|NCT03270930|Pediatric surgery|pediatric surgery
148690|NCT03270930|Emergency laparotomy|emergency laparotomy
148691|NCT03270930|Mortality rate|mortality rate
148692|NCT03270930|Survival|survival
148693|NCT03270930|Kaplan-Meier analysis|kaplan-meier analysis
148694|NCT03270930|ROC curve analysis|roc curve analysis
148695|NCT03270930|Senior resident|senior resident
148696|NCT03270917|Parenchymal preserving|parenchymal preserving
148697|NCT03270917|Postero-superior|postero-superior
148698|NCT03270917|Laparoscopy|laparoscopy
148699|NCT03270917|Hepatectomy|hepatectomy
148700|NCT03270891|Pharmacogenomics|pharmacogenomics
148701|NCT03270891|Primary care physicians|primary care physicians
148702|NCT03270878|Glasdegib|glasdegib
148703|NCT03270878|PF-04449913|pf-04449913
148704|NCT03270878|Pharmacokinetics|pharmacokinetics
148705|NCT03270878|Bioavailability|bioavailability
148706|NCT03270813|Child|child
148707|NCT03270813|Adolescent|adolescent
148708|NCT03270787|Acute Mountain sickness|acute mountain sickness
148709|NCT03270787|Compound Danshen Dripping Pills|compound danshen dripping pills
148710|NCT03270748|Allogeneic hematopoietic stem cell transplantation|allogeneic hematopoietic stem cell transplantation
148711|NCT03270748|acute graft-versus-host disease|acute graft-versus-host disease
148712|NCT03270748|Unrelated donors|unrelated donors
148713|NCT03270748|Post-transplant cyclophosphamide|post-transplant cyclophosphamide
148714|NCT03270748|Myeloid Malignancies|myeloid malignancies
148715|NCT03270748|unrelated hematopoietic cell transplantation|unrelated hematopoietic cell transplantation
148716|NCT03270748|GITMO|gitmo
148717|NCT03270709|Vitamin D3|vitamin d3
148718|NCT03270709|Pulmonary disease|pulmonary disease
148719|NCT03270709|Immunosuppression|immunosuppression
148721|NCT03270709|Smoking|smoking
148722|NCT03270683|Out-of-hospital cardiac arrest|out-of-hospital cardiac arrest
148723|NCT03270683|transcranial Doppler sonography|transcranial doppler sonography
148724|NCT03270683|cerebrovascular circulation|cerebrovascular circulation
148725|NCT03270683|prognosis|prognosis
148726|NCT03270657|Deep Brain Stimulation|deep brain stimulation
148727|NCT03270592|Service dogs|service dogs
148728|NCT03270592|Alert dogs|alert dogs
148729|NCT03270592|Costs|costs
148730|NCT03270592|Quality of Life|quality of life
148731|NCT03270592|Cost-effectiveness|cost-effectiveness
148732|NCT03270566|Water hardness|water hardness
148733|NCT03270566|Atopic eczema prevention|atopic eczema prevention
148734|NCT03270566|Skin barrier function|skin barrier function
148735|NCT03270566|Skin microbiome|skin microbiome
148736|NCT03270527|Dietary fat modification|dietary fat modification
148737|NCT03270527|Lipids|lipids
148738|NCT03270527|LDL cholesterol|ldl cholesterol
148739|NCT03270527|Dietary fatty acids|dietary fatty acids
148740|NCT03270527|Saturated fat|saturated fat
148741|NCT03270514|cardiac surgery|cardiac surgery
148742|NCT03270514|sternotomy|sternotomy
148743|NCT03270514|post-operative pain|post-operative pain
148744|NCT03270514|sternal wound infiltration|sternal wound infiltration
148745|NCT03270488|Thumb|thumb
148746|NCT03270488|Osteoarthritis|osteoarthritis
148747|NCT03270488|Physical Therapy|physical therapy
148748|NCT03270488|Pain|pain
148749|NCT03270449|fibromyalgia|fibromyalgia
148750|NCT03270449|community-based|community-based
148751|NCT03270449|multidisciplinary|multidisciplinary
148752|NCT03270410|neonates|neonates
148753|NCT03270410|non invasive monitoring|non invasive monitoring
148754|NCT03270397|Self Esteem|self esteem
148755|NCT03270397|Body Image|body image
148756|NCT03270397|Eating disorders|eating disorders
148757|NCT03270384|early feasibility|early feasibility
148758|NCT03270384|non-randomized|non-randomized
148759|NCT03270345|Decubitus|decubitus
148760|NCT03270345|Pressure|pressure
148761|NCT03270345|Ulcer|ulcer
148762|NCT03270345|Injuries|injuries
148763|NCT03270345|Sores|sores
148764|NCT03270345|Intensive care|intensive care
148765|NCT03270319|Measurement of cardiac output|measurement of cardiac output
148766|NCT03270280|Chronic Periodontitis|chronic periodontitis
148767|NCT03270280|Phytomedicines|phytomedicines
148768|NCT03270280|Nigella sativa|nigella sativa
148769|NCT03270241|Vitiligo|vitiligo
148770|NCT03270241|Dermatology|dermatology
148771|NCT03270241|Johns Hopkins|johns hopkins
148772|NCT03270241|Compensation|compensation
148773|NCT03270241|Paid|paid
148774|NCT03270241|Phototherapy|phototherapy
148775|NCT03270241|NB-UVB|nb-uvb
148776|NCT03270241|Light treatment|light treatment
148777|NCT03270241|Skin|skin
148778|NCT03270241|Biopsies|biopsies
148779|NCT03270241|Money|money
148781|NCT03270228|Incidence of cancer|incidence of cancer
148782|NCT03270228|Survival|survival
148783|NCT03270215|Computed Tomography|computed tomography
148784|NCT03270215|Specificity|specificity
148785|NCT03270215|Sensitivity|sensitivity
148786|NCT03270202|Exercise|exercise
148787|NCT03270202|Cardiorespiratory fitness|cardiorespiratory fitness
148788|NCT03270202|Risk factors|risk factors
148789|NCT03270202|Monitoring, physiologic|monitoring, physiologic
148790|NCT03270202|Monitoring, ambulatory|monitoring, ambulatory
148791|NCT03270202|Prognosis|prognosis
148792|NCT03270202|Norway|norway
148793|NCT03270163|Intensive care unit acquired muscle weakness|intensive care unit acquired muscle weakness
148794|NCT03270163|Transcutaneous electrical stimulation|transcutaneous electrical stimulation
148795|NCT03270137|Alzheimer Disease|alzheimer disease
148796|NCT03270137|rTMS|rtms
148797|NCT03270137|Cognition|cognition
148798|NCT03270137|Behavioral Symptoms|behavioral symptoms
148799|NCT03270137|Functionality|functionality
148800|NCT03270124|Aortic Valve Stenosis|aortic valve stenosis
148801|NCT03270124|Fitbit|fitbit
148802|NCT03270124|iPAD|ipad
148803|NCT03270124|Physical Exercises|physical exercises
148804|NCT03270124|Quality of Life|quality of life
148805|NCT03270111|breast cancer survivor|breast cancer survivor
148806|NCT03270111|weight loss program|weight loss program
148807|NCT03270098|Schizophrenia|schizophrenia
148808|NCT03270098|Aerobic Exercise|aerobic exercise
148809|NCT03270098|Cognition|cognition
148810|NCT03270098|Daily Functioning|daily functioning
148811|NCT03270098|Biomarkers|biomarkers
148812|NCT03270098|Brain Derived Neurotrophic Factor|brain derived neurotrophic factor
148813|NCT03270046|Bowel preparation|bowel preparation
148814|NCT03270046|CRC screening|crc screening
148815|NCT03270033|Shoulder Joint|shoulder joint
148816|NCT03270033|Arthroscopy|arthroscopy
148817|NCT03270033|Ambulatory surgical procedures|ambulatory surgical procedures
148818|NCT03270033|Pain, Postoperative|pain, postoperative
148819|NCT03270033|Brachial Plexus Block|brachial plexus block
148820|NCT03270033|Corticosteroid|corticosteroid
148821|NCT03270033|Dexamethasone|dexamethasone
148822|NCT03270033|Dexmedetomidine|dexmedetomidine
148823|NCT03270033|Bupivacaine|bupivacaine
148824|NCT03270033|Alpha 2 agonist|alpha 2 agonist
148825|NCT03270033|Postoperative analgesia|postoperative analgesia
148826|NCT03270020|treatment|treatment
148827|NCT03270020|denosumab|denosumab
148828|NCT03270020|Positron Emission Tomography (PET) CT scan|positron emission tomography (pet) ct scan
148829|NCT03269994|pancreatoduodenectomy|pancreatoduodenectomy
148830|NCT03269994|17-418|17-418
148831|NCT03269994|cefoxitin|cefoxitin
148832|NCT03269994|piperacillin-tazobactam|piperacillin-tazobactam
148833|NCT03269981|Adjuvant radiotherapy|adjuvant radiotherapy
148834|NCT03269981|Lymphatic irradiation|lymphatic irradiation
148835|NCT03269981|Taxane|taxane
148836|NCT03269981|Anthracycline|anthracycline
148837|NCT03269981|Prospective study|prospective study
148838|NCT03269942|Intracranial Aneurysm|intracranial aneurysm
148839|NCT03269942|Flow Diverter|flow diverter
148840|NCT03269942|Cerebral Revascularization|cerebral revascularization
148841|NCT03269851|neurological deficit|neurological deficit
148842|NCT03269799|uncontrolled type 2 diabetes mellitus|uncontrolled type 2 diabetes mellitus
148843|NCT03269799|periodontitis|periodontitis
148844|NCT03269799|non surgical periodontal treatment|non surgical periodontal treatment
148845|NCT03269799|vitamin C|vitamin c
148846|NCT03269773|Atopic Dermatitis|atopic dermatitis
148847|NCT03269773|Stem cell|stem cell
148848|NCT03269773|Cell therapy|cell therapy
148849|NCT03269773|skin disease|skin disease
148850|NCT03269773|Umbilical cord Blood|umbilical cord blood
148851|NCT03269773|UCB-MSC|ucb-msc
148852|NCT03269773|hUCB-MSC|hucb-msc
148854|NCT03269773|furestem|furestem
148855|NCT03269773|dermatitis|dermatitis
148856|NCT03269773|eczema|eczema
148857|NCT03269747|glucocorticoids|glucocorticoids
148858|NCT03269747|brown adipose tissue|brown adipose tissue
148859|NCT03269747|cold induced thermogenesis|cold induced thermogenesis
148860|NCT03269734|Vascular Diseases|vascular diseases
148861|NCT03269734|Cerebrovascular Diseases|cerebrovascular diseases
148862|NCT03269734|Cardiovascular Diseases|cardiovascular diseases
148863|NCT03269734|Aortic aneurysm|aortic aneurysm
148864|NCT03269734|Arteriovenous malformations|arteriovenous malformations
148865|NCT03269734|Catheterization|catheterization
148866|NCT03269721|Cognition|cognition
148867|NCT03269721|Pulmonary|pulmonary
148868|NCT03269721|COPD|copd
148869|NCT03269721|Lung|lung
148870|NCT03269656|Vitamin D|vitamin d
148871|NCT03269656|Cancer|cancer
148872|NCT03269656|Survival|survival
148873|NCT03269643|Vital Sign|vital sign
148874|NCT03269643|Vigilance System|vigilance system
148875|NCT03269643|Heart Rate|heart rate
148876|NCT03269617|dysbiosis|dysbiosis
148877|NCT03269617|gut microbiota|gut microbiota
148878|NCT03269617|bacteriophage|bacteriophage
148879|NCT03269617|irritable bowel syndrome|irritable bowel syndrome
148880|NCT03269617|gastrointestinal distress|gastrointestinal distress
148881|NCT03269617|prebiotic|prebiotic
148882|NCT03269604|Urological Surgery|urological surgery
148883|NCT03269604|Bacterial resistance|bacterial resistance
148884|NCT03269591|Dysmenorrhea|dysmenorrhea
148885|NCT03269591|Pulsed electromagnetic field|pulsed electromagnetic field
148886|NCT03269591|Diclofenac|diclofenac
148887|NCT03269578|Pharmacodynamics|pharmacodynamics
148888|NCT03269578|Tissue Collection|tissue collection
148889|NCT03269578|Tissue Biopsies|tissue biopsies
148890|NCT03269578|Biospecimen|biospecimen
148891|NCT03269578|Assay Development|assay development
148892|NCT03269526|Pancreatic Cancer|pancreatic cancer
148893|NCT03269526|Pancreatic Adenocarcinoma|pancreatic adenocarcinoma
148894|NCT03269526|Adoptive cell therapy|adoptive cell therapy
148895|NCT03269526|Armed activated T-cells|armed activated t-cells
148896|NCT03269526|Bispecific antibody|bispecific antibody
148897|NCT03269526|Immunotherapy|immunotherapy
148898|NCT03269474|epidermolysis bullosa simplex|epidermolysis bullosa simplex
148899|NCT03269474|genetic expression|genetic expression
148900|NCT03269474|drug repurposing|drug repurposing
148901|NCT03269474|computational approaches|computational approaches
148902|NCT03269474|drug discovery|drug discovery
148903|NCT03269461|stent, DES, INSPIRON, OCT, tissue repair|stent, des, inspiron, oct, tissue repair
148904|NCT03269448|partial pressure of carbon dioxide|partial pressure of carbon dioxide
148905|NCT03269448|carbon dioxide|carbon dioxide
148906|NCT03269448|peripheral venous blood|peripheral venous blood
148907|NCT03269448|central venous blood|central venous blood
148908|NCT03269448|venous blood gas|venous blood gas
148909|NCT03269448|blood gas analysis|blood gas analysis
148910|NCT03269422|17-407|17-407
148911|NCT03269422|Intermediate Risk Prostate Cancer|intermediate risk prostate cancer
148912|NCT03269422|DIL|dil
148913|NCT03269422|Dominant Intra-Prostatic Lesion|dominant intra-prostatic lesion
148914|NCT03269396|severe laryngotracheal dysfunction|severe laryngotracheal dysfunction
148915|NCT03269383|stellate ganglion block|stellate ganglion block
148916|NCT03269383|cardiac surgery|cardiac surgery
148917|NCT03269383|atrial fibrillation|atrial fibrillation
148918|NCT03269370|CBT|cbt
148919|NCT03269370|Self-Help|self-help
148920|NCT03269370|Family|family
148921|NCT03269357|LARC|larc
148922|NCT03269357|contraception|contraception
148923|NCT03269357|counselling|counselling
148924|NCT03269357|unplanned pregnancy|unplanned pregnancy
148925|NCT03269331|nursing practice|nursing practice
148926|NCT03269331|evidence-based practice models|evidence-based practice models
148927|NCT03269331|military nursing|military nursing
148928|NCT03269331|clinical inquiry|clinical inquiry
148929|NCT03269266|Scrub Typhus|scrub typhus
148930|NCT03269266|Positive Rapid Diagnostic Test|positive rapid diagnostic test
148931|NCT03269253|ALSPAC|alspac
148932|NCT03269253|longitudinal|longitudinal
148933|NCT03269227|Malignant Pleural Mesothelioma|malignant pleural mesothelioma
148934|NCT03269227|Radiotherapy|radiotherapy
148935|NCT03269227|Tomotherapy|tomotherapy
148936|NCT03269227|Hypofractionation|hypofractionation
148937|NCT03269214|osteonecrosis|osteonecrosis
148938|NCT03269214|mandible|mandible
148939|NCT03269201|parkinsonism|parkinsonism
148940|NCT03269201|ataxia|ataxia
148941|NCT03269201|tremor|tremor
148942|NCT03269201|dystonia|dystonia
148943|NCT03269175|Clinically Isolated Syndrome suggestive of Multiple Sclerosis or Multiple Sclerosis|clinically isolated syndrome suggestive of multiple sclerosis or multiple sclerosis
148944|NCT03269149|Alzheimer's disease|alzheimer's disease
148945|NCT03269149|African-American Women|african-american women
148946|NCT03269149|Caregivers|caregivers
148947|NCT03269149|Tango|tango
148948|NCT03269149|Dance-based intervention|dance-based intervention
148949|NCT03269136|Multiple Myeloma|multiple myeloma
148950|NCT03269136|relapse/ refractory multiple myeloma|relapse/ refractory multiple myeloma
148951|NCT03269136|bispecific antibody|bispecific antibody
148952|NCT03269136|bispecific|bispecific
148953|NCT03269136|BCMA|bcma
148954|NCT03269136|BCMA- CD3 bispecific|bcma- cd3 bispecific
148955|NCT03269136|Phase 1|phase 1
148956|NCT03269136|PF-06863135|pf-06863135
148957|NCT03269123|Sensory trick|sensory trick
148958|NCT03269123|Geste Antagoniste|geste antagoniste
148959|NCT03269110|neurological|neurological
148960|NCT03269110|autism|autism
148961|NCT03269110|ASD|asd
148962|NCT03269110|behaviour|behaviour
148963|NCT03269110|folic acid|folic acid
148964|NCT03269110|pre-eclampsia|pre-eclampsia
148965|NCT03269110|asthma|asthma
148966|NCT03269110|executive function|executive function
148967|NCT03269071|Multiple Sclerosis|multiple sclerosis
148968|NCT03269071|Cell Therapy|cell therapy
148969|NCT03269071|Human Neural Stem Cells|human neural stem cells
148970|NCT03269032|Mediterranean diet|mediterranean diet
148971|NCT03269032|gut microbiome|gut microbiome
148972|NCT03269032|gastrointestinal|gastrointestinal
148973|NCT03269019|Heparin-induced thrombocytopenia|heparin-induced thrombocytopenia
148974|NCT03269019|Thrombosis|thrombosis
148975|NCT03269019|thrombin-antithrombin|thrombin-antithrombin
148976|NCT03269019|d-dimer|d-dimer
148977|NCT03269019|Thrombelastograghy|thrombelastograghy
148978|NCT03269006|Visceral leishmaniasis|visceral leishmaniasis
148979|NCT03269006|Vector control|vector control
148980|NCT03269006|Sand fly,|sand fly,
148981|NCT03269006|Bangladesh|bangladesh
148982|NCT03268993|prevention|prevention
148983|NCT03268993|dietary supplement|dietary supplement
148984|NCT03268993|broccoli|broccoli
148985|NCT03268993|avmacol|avmacol
148986|NCT03268967|intensive care|intensive care
148987|NCT03268967|crisis resource management|crisis resource management
148988|NCT03268967|simulation training|simulation training
148989|NCT03268967|before and after study|before and after study
148990|NCT03268954|Drug therapy|drug therapy
148991|NCT03268941|Drug therapy|drug therapy
148992|NCT03268928|Shared Book Reading|shared book reading
148993|NCT03268928|Language Development|language development
148994|NCT03268928|Syntax|syntax
148995|NCT03268928|Vocabulary|vocabulary
148996|NCT03268928|Phonological Awareness|phonological awareness
148997|NCT03268928|Young Children|young children
148998|NCT03268928|Randomised Control Trial|randomised control trial
148999|NCT03268928|Language Intervention|language intervention
149000|NCT03268915|Idiopathic pulmonary fibrosis|idiopathic pulmonary fibrosis
149001|NCT03268915|3 minutes sit-to-stand test|3 minutes sit-to-stand test
149002|NCT03268915|Interindividual reproductibility|interindividual reproductibility
149003|NCT03268889|Chidamide, CHOP regimen|chidamide, chop regimen
149004|NCT03268876|Epithelial ovarian cancer|epithelial ovarian cancer
149005|NCT03268876|Surgery|surgery
149006|NCT03268876|Quality of life|quality of life
149007|NCT03268863|pain tolerance|pain tolerance
149008|NCT03268863|perioperative pain|perioperative pain
149009|NCT03268863|virtual reality therapy|virtual reality therapy
149010|NCT03268850|LDKT|ldkt
149011|NCT03268850|Live donor transplantation|live donor transplantation
149012|NCT03268850|Kidney transplantation|kidney transplantation
149013|NCT03268798|stroke|stroke
149014|NCT03268798|strength training|strength training
149015|NCT03268798|rehabilitation|rehabilitation
149016|NCT03268785|Parathyroid glands|parathyroid glands
149017|NCT03268785|Needle puncture|needle puncture
149018|NCT03268785|Diff-quik staining|diff-quik staining
149019|NCT03268785|PTH test assay|pth test assay
149020|NCT03268785|Thyroid cancer|thyroid cancer
149021|NCT03268759|substance abuse|substance abuse
149022|NCT03268746|Korea|korea
149023|NCT03268746|Trifocal|trifocal
149024|NCT03268746|PanOptix|panoptix
149025|NCT03268746|Bilateral implantation|bilateral implantation
149026|NCT03268746|Cataract|cataract
149027|NCT03268746|Prospective|prospective
149028|NCT03268746|Single Arm|single arm
149029|NCT03268746|ACRYSOF|acrysof
149030|NCT03268746|Model TFNT00|model tfnt00
149031|NCT03268733|Folic acid|folic acid
149032|NCT03268733|PCOS|pcos
149033|NCT03268733|Insulin resistance|insulin resistance
149034|NCT03268733|Infertility|infertility
149035|NCT03268720|gluten sensitivity|gluten sensitivity
149036|NCT03268720|gluten-free diet|gluten-free diet
149037|NCT03268720|FODMAP diet|fodmap diet
149038|NCT03268720|microbiome|microbiome
149039|NCT03268707|Paroxysmal Atrial Fibrillation|paroxysmal atrial fibrillation
149040|NCT03268707|Pulmonary Vein Isolation|pulmonary vein isolation
149041|NCT03268707|Telemetry Monitoring|telemetry monitoring
149042|NCT03268707|Cryoballoon ablation|cryoballoon ablation
149043|NCT03268655|gingerol|gingerol
149044|NCT03268655|microbiome|microbiome
149045|NCT03268655|gut|gut
149046|NCT03268655|ginger|ginger
149047|NCT03268642|Fulminant Myocarditis|fulminant myocarditis
149048|NCT03268642|Retrospective cohort study|retrospective cohort study
149049|NCT03268629|Insomnia|insomnia
149050|NCT03268629|Mindfulness-based Intervention|mindfulness-based intervention
149051|NCT03268629|Mindfulness Meditation|mindfulness meditation
149052|NCT03268629|Tai Chi|tai chi
149053|NCT03268629|Inflammation|inflammation
149054|NCT03268629|NF-κB|nf-κb
149055|NCT03268616|neural respiratory drive|neural respiratory drive
149056|NCT03268616|noninvasive positive pressure ventilation|noninvasive positive pressure ventilation
149057|NCT03268616|electromyography|electromyography
149058|NCT03268590|Hyperoxia|hyperoxia
149059|NCT03268590|Hypoxia, Brain|hypoxia, brain
149060|NCT03268512|leucocyte- and platelet rich fibrin|leucocyte- and platelet rich fibrin
149061|NCT03268512|ridge preservation|ridge preservation
149062|NCT03268512|growth factors|growth factors
149063|NCT03268512|platelet concentrates|platelet concentrates
149064|NCT03268486|Fetal monitoring|fetal monitoring
149065|NCT03268486|cardiotocography|cardiotocography
149066|NCT03268473|OSAS|osas
149067|NCT03268473|Obstructive Sleep Apnea|obstructive sleep apnea
149068|NCT03268473|Periodontitis|periodontitis
149069|NCT03268434|Depression|depression
149070|NCT03268434|Metacognition|metacognition
149071|NCT03268434|CBT|cbt
149072|NCT03268434|D-MCT|d-mct
149073|NCT03268434|cognitive bias|cognitive bias
149074|NCT03268421|juvenile fibromyalgia|juvenile fibromyalgia
149075|NCT03268421|pain in children|pain in children
149076|NCT03268421|musculoskeletal pain|musculoskeletal pain
149077|NCT03268421|cognitive behavioral therapy|cognitive behavioral therapy
149078|NCT03268421|coping skills training|coping skills training
149079|NCT03268421|neuromuscular exercise|neuromuscular exercise
149080|NCT03268421|graded aerobic exercise|graded aerobic exercise
149081|NCT03268408|community intervention|community intervention
149082|NCT03268408|newsletter|newsletter
149083|NCT03268382|Ovarian Cancer|ovarian cancer
149084|NCT03268382|Ovarian Carcinoma|ovarian carcinoma
149085|NCT03268382|High Grade Serous Ovarian Cancer|high grade serous ovarian cancer
149086|NCT03268382|Recurrent Cancer|recurrent cancer
149087|NCT03268382|Resistant Cancer|resistant cancer
149088|NCT03268304|Upper Limb Motor Function Deficit|upper limb motor function deficit
149089|NCT03268304|Neurorehabilitation|neurorehabilitation
149090|NCT03268304|Virtual Reality|virtual reality
149091|NCT03268304|Action Research Arm Test|action research arm test
149092|NCT03268291|Adherence to therapy|adherence to therapy
149093|NCT03268291|Myocardial Infarction|myocardial infarction
149094|NCT03268291|Coronary Artery Disease|coronary artery disease
149095|NCT03268291|Communicational program|communicational program
149096|NCT03268278|analgesia|analgesia
149097|NCT03268278|endodontic|endodontic
190267|NCT03005873|DSP|dsp
149098|NCT03268278|postoperative|postoperative
149099|NCT03268187|Cognitive Fatigue|cognitive fatigue
149100|NCT03268187|Multiple Sclerosis|multiple sclerosis
149101|NCT03268187|Biofeedback|biofeedback
149102|NCT03268187|Self-Alert Training|self-alert training
149103|NCT03268187|Vigilance|vigilance
149104|NCT03268187|Autonomic potentials|autonomic potentials
149105|NCT03268161|anti-MAG neuropathy|anti-mag neuropathy
149106|NCT03268161|Waldenström disease|waldenström disease
149107|NCT03268161|Mutational analysis|mutational analysis
149108|NCT03268148|neonates|neonates
149109|NCT03268148|pain|pain
149110|NCT03268148|low level laser|low level laser
149111|NCT03268135|miRNA|mirna
149112|NCT03268135|lncRNAs|lncrnas
149113|NCT03268135|transcriptome|transcriptome
149114|NCT03268135|heart failure|heart failure
149115|NCT03268135|aortic stenosis|aortic stenosis
149116|NCT03268135|biomarkers|biomarkers
149117|NCT03268122|Patient Isolation|patient isolation
149118|NCT03268122|Methicillin-Resistant Staphylococcus aureus|methicillin-resistant staphylococcus aureus
149119|NCT03268122|Vancomycin-Resistant Enterococci|vancomycin-resistant enterococci
149120|NCT03268083|Foot-and-Mouth Disease|foot-and-mouth disease
149121|NCT03268083|Vaccines|vaccines
149122|NCT03268083|Hand, Foot and Mouth Disease|hand, foot and mouth disease
149123|NCT03268083|EV71 vaccine|ev71 vaccine
149124|NCT03268070|Transcranial Magnetic Stimulation|transcranial magnetic stimulation
149125|NCT03268070|Neurophysiology|neurophysiology
149126|NCT03268070|Neuroscience|neuroscience
149127|NCT03268070|Stroke Rehabilitation|stroke rehabilitation
149128|NCT03268057|Non-Small-Cell Lung|non-small-cell lung
149129|NCT03268057|Carcinoma|carcinoma
149130|NCT03268057|Advanced|advanced
149131|NCT03268057|VX15/2503|vx15/2503
149132|NCT03268057|Semaphorin 4D|semaphorin 4d
149133|NCT03268057|SEMA4D|sema4d
149134|NCT03268057|safety tolerability|safety tolerability
149135|NCT03268057|pharmacokinetics|pharmacokinetics
149136|NCT03268057|monoclonal antibody|monoclonal antibody
149137|NCT03268057|IO Failure|io failure
149138|NCT03268057|Immunotherapy Failure|immunotherapy failure
149139|NCT03268057|Decline Chemo|decline chemo
149140|NCT03268031|artificial intelligence|artificial intelligence
149141|NCT03268031|glaucoma|glaucoma
149142|NCT03268018|calcium|calcium
149143|NCT03268018|peripheral arterial disease|peripheral arterial disease
149144|NCT03267992|COPD|copd
149145|NCT03267992|Coils|coils
149146|NCT03267992|App|app
149147|NCT03267979|pain assessment|pain assessment
149148|NCT03267979|pupillary diameter|pupillary diameter
149149|NCT03267979|variation coefficient of pupillary diameter|variation coefficient of pupillary diameter
149150|NCT03267979|pain self assessment|pain self assessment
149151|NCT03267979|video-pupillometer|video-pupillometer
149152|NCT03267979|electrocardiogram|electrocardiogram
149153|NCT03267979|analgesic treatment|analgesic treatment
149154|NCT03267966|periampullary cancer|periampullary cancer
149155|NCT03267966|margin status|margin status
149156|NCT03267966|R1 resection|r1 resection
149157|NCT03267966|clearance margin|clearance margin
149158|NCT03267953|Stress management, e-Health, cardiovascular disease, adaptive design, lay coaching, motivational interviewing|stress management, e-health, cardiovascular disease, adaptive design, lay coaching, motivational interviewing
149159|NCT03267940|Extrahepatic Cholangiocarcinoma|extrahepatic cholangiocarcinoma
149160|NCT03267940|Intrahepatic Cholangiocarcinoma|intrahepatic cholangiocarcinoma
149161|NCT03267940|Gallbladder Adenocarcinoma|gallbladder adenocarcinoma
149162|NCT03267940|PEGylated Recombinant Human Hyaluronidase|pegylated recombinant human hyaluronidase
149163|NCT03267940|PEGylated Recombinant Human Hyaluronidase with atezolizumab|pegylated recombinant human hyaluronidase with atezolizumab
149164|NCT03267927|OSA|osa
149165|NCT03267927|Polysomnography|polysomnography
149166|NCT03267927|Rapid palatal expansion|rapid palatal expansion
149167|NCT03267927|Mandibular advancement|mandibular advancement
149168|NCT03267927|Sleep position|sleep position
149169|NCT03267862|biomarker|biomarker
149170|NCT03267849|biomarker|biomarker
149171|NCT03267823|Bleeding|bleeding
149172|NCT03267823|heart surgery|heart surgery
149173|NCT03267823|coagulation|coagulation
149174|NCT03267823|coagulopathy|coagulopathy
149175|NCT03267823|INR|inr
149176|NCT03267810|Neuropathic Pain|neuropathic pain
149177|NCT03267810|Transcutaneous Electrical Nerve Stimulation|transcutaneous electrical nerve stimulation
149178|NCT03267797|Recurrent Implantation Failure|recurrent implantation failure
149179|NCT03267797|Peripheral blood mononuclear cell|peripheral blood mononuclear cell
149180|NCT03267797|Human chorionic gonadotropin|human chorionic gonadotropin
149181|NCT03267784|diabetic neuropathic ulcer|diabetic neuropathic ulcer
149182|NCT03267784|ABCB5|abcb5
149183|NCT03267784|allogeneic|allogeneic
149184|NCT03267784|mesenchymal stem cells|mesenchymal stem cells
149185|NCT03267784|skin ulcer|skin ulcer
149186|NCT03267784|advanced therapy medicinal product|advanced therapy medicinal product
149187|NCT03267784|somatic cell therapy|somatic cell therapy
149188|NCT03267784|phase I/IIa|phase i/iia
149189|NCT03267784|Diabetic Foot Ulcer|diabetic foot ulcer
149190|NCT03267745|protein|protein
149191|NCT03267745|skeletal muscle|skeletal muscle
149192|NCT03267745|immobilization|immobilization
149193|NCT03267706|Primary care|primary care
149194|NCT03267706|Palliative care|palliative care
149195|NCT03267641|Intra-tumour heterogeneity|intra-tumour heterogeneity
149196|NCT03267641|Cancer immunotherapy|cancer immunotherapy
149197|NCT03267641|Tumour microenvironment|tumour microenvironment
149198|NCT03267641|Driver mutations|driver mutations
149199|NCT03267641|Precision Medicine|precision medicine
149200|NCT03267628|intrathecal morphine|intrathecal morphine
149201|NCT03267628|quadratus lumborum type 2 block|quadratus lumborum type 2 block
149202|NCT03267628|cesarean section|cesarean section
149203|NCT03267628|pain|pain
149204|NCT03267615|Liver Cirrhosis|liver cirrhosis
149205|NCT03267615|Portal Hypertension|portal hypertension
149206|NCT03267589|immunotherapy|immunotherapy
149207|NCT03267589|ovarian cancer|ovarian cancer
149208|NCT03267589|durvalumab|durvalumab
149209|NCT03267589|tremelilumab|tremelilumab
149210|NCT03267589|MEDI 9447|medi 9447
149211|NCT03267589|MEDI 0562|medi 0562
149212|NCT03267563|prevention|prevention
149213|NCT03267563|implementation|implementation
149214|NCT03267563|sustainment|sustainment
149215|NCT03267563|perinatal|perinatal
149216|NCT03267563|pregnancy|pregnancy
149217|NCT03267563|postpartum|postpartum
149218|NCT03267537|Insomnia|insomnia
149219|NCT03267537|Sleep|sleep
149220|NCT03267537|Telemedicine|telemedicine
149221|NCT03267368|Comprehensive Care Program|comprehensive care program
149222|NCT03267368|Stereotactic Radiotherapy|stereotactic radiotherapy
149223|NCT03267316|First-in-Human|first-in-human
149224|NCT03267316|Phase 1|phase 1
149225|NCT03267316|Phase 2|phase 2
149226|NCT03267316|Antibody, Monoclonal|antibody, monoclonal
149227|NCT03267316|IL1RAP|il1rap
149228|NCT03267316|Safety|safety
149229|NCT03267316|Tolerability|tolerability
149230|NCT03267316|Cancer|cancer
149231|NCT03267316|Solid tumor|solid tumor
149232|NCT03267316|Malignant|malignant
149233|NCT03267316|Dose escalation|dose escalation
149234|NCT03267316|Dose expansion|dose expansion
149235|NCT03267316|CAN04|can04
149236|NCT03267316|Immunoglobulin|immunoglobulin
149237|NCT03267316|Clinical Trial|clinical trial
149238|NCT03267316|Infusion|infusion
149239|NCT03267316|Antineoplastic|antineoplastic
149240|NCT03267316|Anticancer|anticancer
149241|NCT03267303|Narcolepsy|narcolepsy
149242|NCT03267277|Calcinosis|calcinosis
149243|NCT03267277|Dermatomyositis|dermatomyositis
149244|NCT03267277|Juvenile Dermatomyositis|juvenile dermatomyositis
149245|NCT03267277|Idiopathic Inflammatory Myopathies|idiopathic inflammatory myopathies
149246|NCT03267277|Sodium Thiosulfate|sodium thiosulfate
149247|NCT03267251|Vaccine Decision Making|vaccine decision making
149248|NCT03267251|Public Health|public health
149249|NCT03267251|Health Communication|health communication
149250|NCT03267251|Digital Interventions|digital interventions
149251|NCT03267225|drug interaction|drug interaction
149252|NCT03267225|genetic polymorphism|genetic polymorphism
149253|NCT03267212|Functional Electrical Stimulation (FES)-Rowing|functional electrical stimulation (fes)-rowing
149254|NCT03267212|Ventilatory support|ventilatory support
149255|NCT03267173|Pancreatic Cancer|pancreatic cancer
149256|NCT03267173|CAR-T|car-t
149257|NCT03267173|Mesothelin|mesothelin
149259|NCT03267173|HER2|her2
149260|NCT03267147|Anti-CCP|anti-ccp
149261|NCT03267147|rheumatoid arthritis|rheumatoid arthritis
149262|NCT03267121|head and neck cancer|head and neck cancer
149263|NCT03267121|Apatinib|apatinib
149264|NCT03267121|Tegafur Gimeracil Oteracil|tegafur gimeracil oteracil
149265|NCT03267121|induction chemotherapy|induction chemotherapy
149266|NCT03267108|Pulmonary Fibrosis|pulmonary fibrosis
149267|NCT03267108|PF|pf
149268|NCT03267108|Pulmonary Hypertension|pulmonary hypertension
149269|NCT03267108|Inhaled Nitric Oxide|inhaled nitric oxide
149270|NCT03267108|iNO|ino
149271|NCT03267108|Long Term Oxygen Therapy|long term oxygen therapy
149272|NCT03267108|Oxygen|oxygen
149273|NCT03267056|drug-coated balloon|drug-coated balloon
149274|NCT03267043|preterm birth|preterm birth
149275|NCT03267043|NICU|nicu
149276|NCT03267043|neonatal|neonatal
149277|NCT03267043|skin to skin|skin to skin
149278|NCT03267043|kangaroo care|kangaroo care
149279|NCT03267043|separation stress|separation stress
149280|NCT03267043|family nurture|family nurture
149281|NCT03267043|maternal confidence|maternal confidence
149282|NCT03267043|maternal competence|maternal competence
149283|NCT03267043|calming cycle|calming cycle
149284|NCT03267043|infant neurodevelopment|infant neurodevelopment
149285|NCT03267043|infant psychological development|infant psychological development
149286|NCT03267043|mother-infant co-regulation|mother-infant co-regulation
149287|NCT03267043|postpartum depression|postpartum depression
149288|NCT03267030|Hypersensitivity to PEG-asparaginase|hypersensitivity to peg-asparaginase
149289|NCT03266965|Fatigue|fatigue
149290|NCT03266965|Histamine|histamine
149291|NCT03266952|stroke|stroke
149292|NCT03266952|race|race
149293|NCT03266952|diet|diet
149294|NCT03266952|diabetes|diabetes
149295|NCT03266952|ethnicity|ethnicity
149296|NCT03266952|myocardial infarction|myocardial infarction
149297|NCT03266874|total hip arthroplasty|total hip arthroplasty
149298|NCT03266848|Magnetic Resonance Imaging|magnetic resonance imaging
149299|NCT03266848|Ferumoxytol|ferumoxytol
149300|NCT03266835|Chronic Total Occlusion|chronic total occlusion
149301|NCT03266835|Peripheral|peripheral
149431|NCT03266146|Short-term|short-term
149302|NCT03266835|SoundBite™ Crossing System|soundbite™ crossing system
149303|NCT03266835|CTO|cto
149304|NCT03266835|intra-luminal|intra-luminal
149305|NCT03266835|Active wire|active wire
149306|NCT03266835|Device|device
149307|NCT03266835|Procedure|procedure
149308|NCT03266809|Cardiac function|cardiac function
149309|NCT03266809|Cardio-toxicity|cardio-toxicity
149310|NCT03266770|ureteral stent|ureteral stent
149311|NCT03266744|Metastatic Breast Cancer|metastatic breast cancer
149312|NCT03266744|Whole Body MRI|whole body mri
149313|NCT03266744|Computerised Tomography|computerised tomography
149314|NCT03266744|Bone scan|bone scan
149315|NCT03266718|cancer survivor|cancer survivor
149316|NCT03266718|breast cancer|breast cancer
149317|NCT03266718|prostate cancer|prostate cancer
149318|NCT03266718|couples|couples
149319|NCT03266692|BCMA|bcma
149320|NCT03266692|SEA-BCMA|sea-bcma
149321|NCT03266692|B Cell Maturation Antigen|b cell maturation antigen
149322|NCT03266692|ACTR|actr
149323|NCT03266692|ACTR087|actr087
149324|NCT03266692|T cell|t cell
149325|NCT03266692|T cell product|t cell product
149326|NCT03266692|relapsed|relapsed
149327|NCT03266692|refractory|refractory
149328|NCT03266692|multiple myeloma|multiple myeloma
149329|NCT03266692|adoptive T cells|adoptive t cells
149330|NCT03266692|autologous|autologous
149331|NCT03266692|gene therapy|gene therapy
149332|NCT03266692|cell therapy|cell therapy
149333|NCT03266679|bipolar disorder|bipolar disorder
149334|NCT03266679|metacognition|metacognition
149335|NCT03266679|reflective functioning|reflective functioning
149336|NCT03266679|metacognition-based intervention|metacognition-based intervention
149337|NCT03266679|sense of self|sense of self
149338|NCT03266679|insight|insight
149339|NCT03266666|grocery|grocery
149340|NCT03266666|lifestyle|lifestyle
149341|NCT03266666|lifestyle change|lifestyle change
149342|NCT03266666|behavior|behavior
149343|NCT03266666|nutrition|nutrition
149344|NCT03266640|Cytomegalovirus|cytomegalovirus
149345|NCT03266640|CMV|cmv
149346|NCT03266640|cytotoxic t-lymphocytes|cytotoxic t-lymphocytes
149347|NCT03266627|adenovirus|adenovirus
149348|NCT03266627|primary immune deficiency disorder|primary immune deficiency disorder
149349|NCT03266627|cytotoxic t-lymphocytes|cytotoxic t-lymphocytes
149350|NCT03266614|Mental Illness|mental illness
149351|NCT03266614|Loneliness|loneliness
149352|NCT03266614|Hope|hope
149353|NCT03266614|Community|community
149354|NCT03266614|Social Media|social media
149355|NCT03266601|Aged 1-7 years old, within 72 hours of onset patients with herpangina|aged 1-7 years old, within 72 hours of onset patients with herpangina
149356|NCT03266588|migraine|migraine
149357|NCT03266588|acute|acute
149358|NCT03266575|Frailty|frailty
149359|NCT03266575|Sarcopenia|sarcopenia
149360|NCT03266575|Pulmonary Rehabilitation|pulmonary rehabilitation
149361|NCT03266562|Positron Emission Mammography|positron emission mammography
149362|NCT03266549|botulinum toxin|botulinum toxin
149363|NCT03266549|infantile esotropia|infantile esotropia
149364|NCT03266536|Gut microbiota|gut microbiota
149365|NCT03266523|CT|ct
149366|NCT03266523|MRI|mri
149367|NCT03266523|Anxiety-state|anxiety-state
149368|NCT03266523|Anxiety State-Trait|anxiety state-trait
149369|NCT03266510|Inspiratory muscle strength training|inspiratory muscle strength training
149370|NCT03266497|diet quality|diet quality
149371|NCT03266497|health disparities|health disparities
149372|NCT03266497|immigrants|immigrants
149373|NCT03266497|foreign-born|foreign-born
149374|NCT03266497|Blacks/African Americans|blacks/african americans
149375|NCT03266497|place of birth/nativity|place of birth/nativity
149376|NCT03266497|length of residency|length of residency
149377|NCT03266497|NHANES|nhanes
149378|NCT03266497|acculturation|acculturation
149379|NCT03266484|Microbiome|microbiome
149380|NCT03266484|Fatigue|fatigue
149381|NCT03266484|Probiotics|probiotics
149382|NCT03266471|Cytokines|cytokines
149383|NCT03266471|Pharmacogenetics|pharmacogenetics
149384|NCT03266445|relapse|relapse
149385|NCT03266445|buprenorphine/naloxone|buprenorphine/naloxone
149386|NCT03266445|opioids|opioids
149387|NCT03266445|narcotics|narcotics
149388|NCT03266445|post-surgical pain|post-surgical pain
149389|NCT03266393|Envarsus XR|envarsus xr
149390|NCT03266393|Kidney transplantation|kidney transplantation
149391|NCT03266393|Grafting, Kidney|grafting, kidney
149392|NCT03266393|Tacrolimus|tacrolimus
149393|NCT03266393|Rejection|rejection
149394|NCT03266393|Adherence|adherence
149395|NCT03266393|Quality of Life|quality of life
149396|NCT03266393|post-transplant immunosuppression|post-transplant immunosuppression
149397|NCT03266354|Artisan|artisan
149398|NCT03266302|vasodilatory shock|vasodilatory shock
149399|NCT03266302|hemoadsorption|hemoadsorption
149400|NCT03266302|cardiac surgery|cardiac surgery
149401|NCT03266302|cytokines|cytokines
149402|NCT03266250|inferior vena caca ultrasound|inferior vena caca ultrasound
149403|NCT03266237|Influenza|influenza
149404|NCT03266237|Influenza Virus Vaccines|influenza virus vaccines
149405|NCT03266237|Vaxigrip|vaxigrip
149406|NCT03266237|Respiratory Tract Infections|respiratory tract infections
149407|NCT03266237|Orthomyxoviridae Infections|orthomyxoviridae infections
149408|NCT03266237|Frailty|frailty
149409|NCT03266237|Aging|aging
149410|NCT03266237|Safety|safety
149411|NCT03266237|Immunogenicity|immunogenicity
149412|NCT03266224|congenital muscular torticollis|congenital muscular torticollis
149413|NCT03266224|wryneck|wryneck
149414|NCT03266224|sternocleidomastoid|sternocleidomastoid
149415|NCT03266224|ultrasonography|ultrasonography
149416|NCT03266224|digital analysis|digital analysis
149417|NCT03266185|paclitaxel-containing chemotherapy|paclitaxel-containing chemotherapy
149418|NCT03266172|immediate release tablet|immediate release tablet
149419|NCT03266172|GSK2982772|gsk2982772
149420|NCT03266172|Modified release|modified release
149421|NCT03266172|minitablet|minitablet
149422|NCT03266159|Dose escalation|dose escalation
149423|NCT03266159|Small cell lung cancer|small cell lung cancer
149424|NCT03266159|Trametinib|trametinib
149425|NCT03266159|GSK525762|gsk525762
149426|NCT03266159|Ras-mutations|ras-mutations
149427|NCT03266159|BET inhibitor|bet inhibitor
149428|NCT03266146|Drug-induced Liver Injury|drug-induced liver injury
149429|NCT03266146|Recurrence|recurrence
149430|NCT03266146|Methylprednisolone|methylprednisolone
149432|NCT03266133|Gestational Diabetes Mellitus|gestational diabetes mellitus
149433|NCT03266133|Sleep education|sleep education
149434|NCT03266120|Gardening|gardening
149435|NCT03266120|Therapeutic Arts|therapeutic arts
149436|NCT03266120|Therapeutic Horticulture|therapeutic horticulture
149437|NCT03266120|Anxiety|anxiety
149438|NCT03266120|Depression|depression
149439|NCT03266120|Mood States|mood states
149440|NCT03266120|Quality of Life|quality of life
149441|NCT03266120|Social Interactions|social interactions
149442|NCT03266120|Stress|stress
149443|NCT03266120|Wellness|wellness
149444|NCT03266055|Blueberry|blueberry
149445|NCT03266055|Diet|diet
149446|NCT03266003|Tuberculosis|tuberculosis
149447|NCT03266003|Directly observed therapy|directly observed therapy
149448|NCT03266003|Adherence|adherence
149449|NCT03266003|Video assisted directly observed therapy|video assisted directly observed therapy
149450|NCT03266003|Electronic directly observed therapy|electronic directly observed therapy
149451|NCT03266003|Mobile health|mobile health
149452|NCT03265964|Suicidal Ideation|suicidal ideation
149453|NCT03265964|Veteran|veteran
149454|NCT03265964|Uridine|uridine
149455|NCT03265964|Neuroimaging|neuroimaging
149456|NCT03265951|sleep apnea, PTSD|sleep apnea, ptsd
149457|NCT03265938|Head and Neck cancer|head and neck cancer
149458|NCT03265938|Cancer of oral cavity|cancer of oral cavity
149459|NCT03265938|Ear, Nose and Throat|ear, nose and throat
149460|NCT03265938|Indirect laryngoscopy|indirect laryngoscopy
149461|NCT03265938|Awake intubation|awake intubation
149462|NCT03265938|Expected difficult intubation|expected difficult intubation
149463|NCT03265847|intimate partner violence|intimate partner violence
149464|NCT03265847|safety planning|safety planning
149465|NCT03265847|immigrant, refugee|immigrant, refugee
149466|NCT03265847|Native American|native american
149467|NCT03265847|risk for future violence|risk for future violence
149468|NCT03265847|risk for intimate partner homicide|risk for intimate partner homicide
149469|NCT03265821|Smoking|smoking
149470|NCT03265821|Periodontal treatment|periodontal treatment
149471|NCT03265821|Periodontal disease|periodontal disease
149472|NCT03265821|Healing|healing
149473|NCT03265808|stem cells|stem cells
149474|NCT03265782|efficacy|efficacy
149475|NCT03265782|safety|safety
149476|NCT03265782|paracetamol|paracetamol
149477|NCT03265782|ibuprofen|ibuprofen
149479|NCT03265782|preterms|preterms
149480|NCT03265769|Femoral approach|femoral approach
149481|NCT03265769|Radial approach|radial approach
149482|NCT03265769|Chronic total occlusion|chronic total occlusion
149483|NCT03265730|Outpatient clinics|outpatient clinics
149484|NCT03265730|oral antibiotics|oral antibiotics
149485|NCT03265730|diarrhea|diarrhea
149486|NCT03265717|telomerase, tert, cancer vaccine|telomerase, tert, cancer vaccine
149487|NCT03265704|Maternal PIH|maternal pih
149488|NCT03265704|Neonatal thrombocytopenia|neonatal thrombocytopenia
149489|NCT03265704|Neonatal neutropenia|neonatal neutropenia
149490|NCT03265691|Accidental Falls|accidental falls
149491|NCT03265691|Hyponatremia|hyponatremia
149492|NCT03265691|Elderly|elderly
149493|NCT03265691|Risk factors|risk factors
149494|NCT03265691|Nurse|nurse
149495|NCT03265665|walking|walking
149496|NCT03265665|African American women|african american women
149497|NCT03265665|community-based|community-based
149498|NCT03265652|Intense Pulsed Light|intense pulsed light
149499|NCT03265652|Meibomian Gland Dysfunction|meibomian gland dysfunction
149500|NCT03265652|Dry Eye Disease|dry eye disease
149501|NCT03265587|Feng Shui|feng shui
149502|NCT03265587|Inner harmony|inner harmony
149503|NCT03265587|Chi|chi
149504|NCT03265522|Mediterranean diet|mediterranean diet
149505|NCT03265522|Lifestyle|lifestyle
149506|NCT03265483|Personalized prevention trial|personalized prevention trial
149507|NCT03265483|Magnesium|magnesium
149508|NCT03265483|Vitamin D metabolism and synthesis|vitamin d metabolism and synthesis
149509|NCT03265483|Magnesium-vitamin D interaction|magnesium-vitamin d interaction
149510|NCT03265444|MSA|msa
149511|NCT03265405|pulmonary sarcoidosis|pulmonary sarcoidosis
149512|NCT03265405|corticosteroids|corticosteroids
149513|NCT03265405|glucocorticoids|glucocorticoids
149514|NCT03265405|relapse|relapse
149515|NCT03265405|interstitial lung disease|interstitial lung disease
149516|NCT03265405|diffuse parenchymal lung disease|diffuse parenchymal lung disease
149517|NCT03265405|immunosuppression|immunosuppression
149518|NCT03265405|mediastinal lymphadenopathy|mediastinal lymphadenopathy
149519|NCT03265366|Ultrashort echo time magnetic resonance imaging|ultrashort echo time magnetic resonance imaging
149520|NCT03265353|Potassium|potassium
149521|NCT03265353|Sodium|sodium
149522|NCT03265353|Vascular function|vascular function
149523|NCT03265340|Transcranial Magnetic Stimulation|transcranial magnetic stimulation
149524|NCT03265288|Inflammation|inflammation
149525|NCT03265288|Essential Fatty Acids|essential fatty acids
149526|NCT03265288|Inflammation resolution|inflammation resolution
149527|NCT03265288|Docosahexaenoic acid|docosahexaenoic acid
149528|NCT03265288|Lung function|lung function
149529|NCT03265275|Fast track|fast track
149530|NCT03265223|Ropivacaine|ropivacaine
149531|NCT03265223|local anesthesia|local anesthesia
149532|NCT03265223|intraincisional infiltration|intraincisional infiltration
149533|NCT03265223|intraperitoneal instillation|intraperitoneal instillation
149534|NCT03265223|post-laparoscopic cholecystectomy pain|post-laparoscopic cholecystectomy pain
149535|NCT03265223|shoulder pain|shoulder pain
149536|NCT03265223|rescue analgesia|rescue analgesia
149537|NCT03265223|triple blinding|triple blinding
149538|NCT03265210|Middle-aged and Older Adults|middle-aged and older adults
149539|NCT03265210|Primary Care|primary care
149540|NCT03265197|Tinnitus|tinnitus
149541|NCT03265197|Intra-tympanic|intra-tympanic
149542|NCT03265197|Lidocaine|lidocaine
149543|NCT03265197|Dexamethasone|dexamethasone
149544|NCT03265132|Interleukin 1 receptor antagonist|interleukin 1 receptor antagonist
149545|NCT03265132|IL-1 receptor antagonist|il-1 receptor antagonist
149546|NCT03265132|Kineret|kineret
149547|NCT03265132|anakinra|anakinra
149548|NCT03265132|Adult-Onset Still's Disease|adult-onset still's disease
149549|NCT03265132|Systemic Juvenile Idiopathic Arthritis|systemic juvenile idiopathic arthritis
149550|NCT03265093|Pain Measurement|pain measurement
149551|NCT03265093|Platelet Activation|platelet activation
149552|NCT03265093|Quality of Life|quality of life
149553|NCT03265028|primary care|primary care
149554|NCT03265028|antibiotics|antibiotics
149555|NCT03265028|communication skills|communication skills
149556|NCT03265028|general practice|general practice
149557|NCT03265028|outpatient|outpatient
149558|NCT03265028|ambulatory care|ambulatory care
149559|NCT03265028|anti-bacterial agents|anti-bacterial agents
149560|NCT03265002|fibre|fibre
149561|NCT03265002|inulin|inulin
149562|NCT03265002|psyllium|psyllium
149563|NCT03265002|small bowel MRI|small bowel mri
149564|NCT03264989|Sickle cell disease|sickle cell disease
149565|NCT03264989|sickle cell anemia|sickle cell anemia
149566|NCT03264989|vaso-occlusive crisis|vaso-occlusive crisis
149567|NCT03264989|P-selectin|p-selectin
149568|NCT03264989|SEG101|seg101
149569|NCT03264989|crizanlizumab|crizanlizumab
149570|NCT03264989|monoclonal antibody|monoclonal antibody
149571|NCT03264989|Anemia, Sickle Cell|anemia, sickle cell
149572|NCT03264989|HbS Disease|hbs disease
149573|NCT03264989|Hemoglobin SC Disease|hemoglobin sc disease
149574|NCT03264989|Sickle Cell Disorders|sickle cell disorders
149575|NCT03264989|Sickling Disorder Due to Hemoglobin S|sickling disorder due to hemoglobin s
149576|NCT03264976|diabetic retinopathy|diabetic retinopathy
149577|NCT03264976|miRNA|mirna
149578|NCT03264976|serum exosomes|serum exosomes
149579|NCT03264976|prognostic biomarker|prognostic biomarker
149580|NCT03264963|Upper airway exercises|upper airway exercises
149581|NCT03264963|Smart phone application|smart phone application
149582|NCT03264937|TTR|ttr
149583|NCT03264937|INR|inr
149584|NCT03264937|Warfarin|warfarin
149585|NCT03264937|social software|social software
149586|NCT03264924|physical activity|physical activity
149587|NCT03264924|motivation|motivation
149588|NCT03264924|behaviour change|behaviour change
149589|NCT03264911|pharyngitis|pharyngitis
149590|NCT03264911|amoxicillin|amoxicillin
149591|NCT03264872|Motivational Interviewing|motivational interviewing
149592|NCT03264859|NGAL|ngal
149593|NCT03264859|STEMI|stemi
149594|NCT03264859|no-reflow|no-reflow
149595|NCT03264859|PCI (Percutaneous Coronary Intervention)|pci (percutaneous coronary intervention)
149596|NCT03264820|digital obstructive arterial disease, DOAD|digital obstructive arterial disease, doad
149597|NCT03264807|Lymph Node 14v|lymph node 14v
149598|NCT03264807|D2 lymphadenectomy|d2 lymphadenectomy
149599|NCT03264781|Cyclofem®|cyclofem®
149600|NCT03264781|Implant|implant
149601|NCT03264781|Jadelle|jadelle
149602|NCT03264781|Implanon|implanon
149603|NCT03264781|irregular uterine bleeding|irregular uterine bleeding
149604|NCT03264781|randomized controlled trial|randomized controlled trial
149605|NCT03264768|valves|valves
149606|NCT03264768|Chronic Obstructive Pulmonary Disease|chronic obstructive pulmonary disease
149607|NCT03264768|endoscopic long volume reduction|endoscopic long volume reduction
149608|NCT03264742|ghreline, stroke|ghreline, stroke
149609|NCT03264729|plantar heel pain|plantar heel pain
149610|NCT03264716|TACE (transarterial chemoembolization)|tace (transarterial chemoembolization)
149611|NCT03264716|colorectal liver metastasis|colorectal liver metastasis
149612|NCT03264703|Joint pain|joint pain
149613|NCT03264703|Joint stiffness|joint stiffness
149614|NCT03264703|Joint redness|joint redness
149615|NCT03264703|Loss of joint function|loss of joint function
149616|NCT03264703|Swollen joints|swollen joints
149617|NCT03264690|Crohn's disease|crohn's disease
149618|NCT03264690|Ulcerative colitis|ulcerative colitis
149619|NCT03264677|8-week HUT|8-week hut
149620|NCT03264677|Hydro Boost|hydro boost
149621|NCT03264677|Skin healthy signs|skin healthy signs
149622|NCT03264677|Environmental aggressors|environmental aggressors
149623|NCT03264677|Cosmetic|cosmetic
149624|NCT03264664|E7386|e7386
149625|NCT03264664|dose escalation|dose escalation
149626|NCT03264664|advanced or recurrent neoplasms|advanced or recurrent neoplasms
149627|NCT03264651|Selective androgen receptor modulator|selective androgen receptor modulator
149628|NCT03264651|Aromatase inhibitor|aromatase inhibitor
149629|NCT03264638|PCOS|pcos
149630|NCT03264638|Dingkundan|dingkundan
149631|NCT03264638|Diane-35|diane-35
149632|NCT03264625|Cholecalciferol|cholecalciferol
149633|NCT03264625|Peritoneal dialysis|peritoneal dialysis
149634|NCT03264625|Peritonitis|peritonitis
149635|NCT03264573|Atrophic scar|atrophic scar
149636|NCT03264573|PRP|prp
149637|NCT03264573|ADSCs|adscs
149638|NCT03264560|Telepsychiatry|telepsychiatry
149639|NCT03264560|Synchronous|synchronous
149640|NCT03264560|Asynchronous|asynchronous
149641|NCT03264560|SNF|snf
149642|NCT03264521|Crowdsourcing|crowdsourcing
149643|NCT03264521|Patient Engagement|patient engagement
149644|NCT03264521|Chiropractic|chiropractic
149645|NCT03264508|endothelial function|endothelial function
149646|NCT03264508|arterial stiffness|arterial stiffness
149647|NCT03264508|heat|heat
149648|NCT03264508|hot water immersion|hot water immersion
149649|NCT03264443|physical activity|physical activity
149650|NCT03264443|exercise|exercise
149651|NCT03264443|aging|aging
149652|NCT03264443|older|older
149653|NCT03264430|Perianal fistula|perianal fistula
149654|NCT03264430|Hemorrhoids|hemorrhoids
149655|NCT03264404|Pancreas|pancreas
149656|NCT03264404|pembrolizumab|pembrolizumab
149657|NCT03264404|azacitidine|azacitidine
149658|NCT03264404|metastatic pancreatic cancer|metastatic pancreatic cancer
149659|NCT03264404|first-line|first-line
149660|NCT03264391|OCT-A|oct-a
149661|NCT03264391|Retinal vasculitis|retinal vasculitis
149662|NCT03264391|Behcet's disease|behcet's disease
149663|NCT03264365|Health-related quality of life|health-related quality of life
149664|NCT03264365|Anxiety|anxiety
149665|NCT03264365|Depression|depression
149666|NCT03264365|Post-traumatic stress disorder|post-traumatic stress disorder
149667|NCT03264365|Recovery programme|recovery programme
149668|NCT03264365|Rehabilitation|rehabilitation
149669|NCT03264365|Follow-up programme|follow-up programme
149670|NCT03264365|Aftercare|aftercare
149671|NCT03264365|Randomized controlled Trial|randomized controlled trial
149672|NCT03264365|Multicentre|multicentre
149673|NCT03264339|Infant|infant
149674|NCT03264339|Hand/Growth & Development|hand/growth & development
149675|NCT03264339|Motor activity|motor activity
149676|NCT03264339|Exercise|exercise
149677|NCT03264339|Communication|communication
149678|NCT03264313|tobacco|tobacco
149679|NCT03264313|Smoking Cessation|smoking cessation
149680|NCT03264313|TMS|tms
149681|NCT03264313|Neuromodulation|neuromodulation
149682|NCT03264313|transcranial magnetic stimulation|transcranial magnetic stimulation
149683|NCT03264300|brain tumor, MRI|brain tumor, mri
149684|NCT03264287|acne vulgaris|acne vulgaris
149685|NCT03264287|acupuncture|acupuncture
149686|NCT03264287|cupping|cupping
149687|NCT03264287|ear point tapping|ear point tapping
149688|NCT03264287|randomized controlled trial|randomized controlled trial
149689|NCT03264274|Colorectal|colorectal
149690|NCT03264274|Metastatic|metastatic
149691|NCT03264274|Chemorefractory|chemorefractory
149692|NCT03264274|Ultrasound|ultrasound
149693|NCT03264274|Aflibercept|aflibercept
149694|NCT03264261|stroke, locomotion|stroke, locomotion
149695|NCT03264248|obesity|obesity
149696|NCT03264248|overweight|overweight
149697|NCT03264248|wheelchair|wheelchair
149698|NCT03264235|Powered-Knee Exoskeleton|powered-knee exoskeleton
149699|NCT03264235|Stair Training|stair training
149700|NCT03264235|Keeogo|keeogo
149701|NCT03264196|condylar hear|condylar hear
149702|NCT03264196|fracture|fracture
149703|NCT03264196|randomised controlled trial|randomised controlled trial
149704|NCT03264144|Social norms|social norms
149705|NCT03264144|Adolescent|adolescent
149706|NCT03264144|Smoking|smoking
149707|NCT03264144|Randomised controlled trial|randomised controlled trial
149708|NCT03264131|Brentuximab Vedotin|brentuximab vedotin
149709|NCT03264131|Adcetris|adcetris
149710|NCT03264131|Lymphoma|lymphoma
149711|NCT03264131|Leukemia|leukemia
149712|NCT03264131|CD30|cd30
149713|NCT03264118|Periodontal Guided Tissue Regeneration|periodontal guided tissue regeneration
149714|NCT03264118|Photochemotherapy|photochemotherapy
149715|NCT03264079|RTA 402|rta 402
149716|NCT03264079|Bardoxolone methyl|bardoxolone methyl
149717|NCT03264079|Itraconazole|itraconazole
149718|NCT03264079|Sporanox|sporanox
149719|NCT03264079|CYP3A4|cyp3a4
149720|NCT03264053|socket shield technique|socket shield technique
149721|NCT03264053|crestal bone loss|crestal bone loss
149722|NCT03264053|immediate implanation|immediate implanation
149723|NCT03264040|Mannosidosis|mannosidosis
149724|NCT03264040|Biomarker|biomarker
149725|NCT03263988|pulse contour analysis|pulse contour analysis
149726|NCT03263988|capton|capton
149727|NCT03263988|intraoperative monitoring|intraoperative monitoring
149728|NCT03263962|CHF|chf
149729|NCT03263962|Canrenone|canrenone
149730|NCT03263949|risk prediction|risk prediction
149731|NCT03263949|ventricular arrhythmia|ventricular arrhythmia
149732|NCT03263949|myocardial infarction|myocardial infarction
149733|NCT03263936|Relapse|relapse
149734|NCT03263936|Myelogenous|myelogenous
149735|NCT03263936|Leukemia|leukemia
149736|NCT03263936|Refractory|refractory
149737|NCT03263936|Acute|acute
149738|NCT03263936|Pediatric|pediatric
149739|NCT03263923|grandmother caregivers|grandmother caregivers
149740|NCT03263923|grandfamily|grandfamily
149741|NCT03263923|grandfamilies|grandfamilies
149742|NCT03263923|custodial grandparent|custodial grandparent
149743|NCT03263923|custodial grandmother|custodial grandmother
149744|NCT03263923|multigenerational family|multigenerational family
149745|NCT03263923|Grandmothers raising or living with grandchildren|grandmothers raising or living with grandchildren
149746|NCT03263897|abortive effect|abortive effect
149747|NCT03263897|mobile interface|mobile interface
149748|NCT03263884|nerve growth factor|nerve growth factor
149749|NCT03263884|repetitive transcranial magnetic stimulation|repetitive transcranial magnetic stimulation
149750|NCT03263884|dorsolateral prefrontal cortex|dorsolateral prefrontal cortex
149751|NCT03263871|nutrition|nutrition
149752|NCT03263832|Antibiogramme|antibiogramme
149753|NCT03263832|Antibiofilmogramme|antibiofilmogramme
149754|NCT03263819|Postural Orthostatic Tachycardia Syndrome, gastrointestinal hormones|postural orthostatic tachycardia syndrome, gastrointestinal hormones
149755|NCT03263806|angina|angina
149756|NCT03263806|coronary artery disease|coronary artery disease
149757|NCT03263806|coronary artery catheterization|coronary artery catheterization
149758|NCT03263806|coronary CT angiography|coronary ct angiography
149759|NCT03263806|fractional flow reserve CT|fractional flow reserve ct
149760|NCT03263806|emergency department|emergency department
149761|NCT03263793|singing|singing
149762|NCT03263780|Diagnostic imaging|diagnostic imaging
149763|NCT03263780|High-Intensity Focused Ultrasound|high-intensity focused ultrasound
149764|NCT03263780|HIFU|hifu
149765|NCT03263780|18F-Fluciclovine|18f-fluciclovine
149766|NCT03263780|high resolution diffusion-weighted imaging|high resolution diffusion-weighted imaging
149767|NCT03263767|Peripheral haemopoietic stem cell transplant|peripheral haemopoietic stem cell transplant
149768|NCT03263767|High dose cyclophosphamide|high dose cyclophosphamide
149769|NCT03263767|acute GVHD|acute gvhd
149770|NCT03263767|allogenic transplantation|allogenic transplantation
149771|NCT03263767|RIC (reduced-intensity conditioning)|ric (reduced-intensity conditioning)
149772|NCT03263741|Paclitaxel|paclitaxel
149773|NCT03263741|S-1|s-1
149774|NCT03263741|Oxaliplatin|oxaliplatin
149775|NCT03263741|Efficiency|efficiency
149776|NCT03263741|safety|safety
149777|NCT03263728|Stress Cardiac Magnetic Resonance|stress cardiac magnetic resonance
149778|NCT03263715|Polymyalgia Rheumatica|polymyalgia rheumatica
149779|NCT03263715|Tocilizumab|tocilizumab
149780|NCT03263715|Glucocorticoid|glucocorticoid
149781|NCT03263715|Glucocorticoid-Sparing|glucocorticoid-sparing
149782|NCT03263702|Persistent Atrial Fibrillation|persistent atrial fibrillation
149783|NCT03263702|mapping|mapping
149784|NCT03263663|colorectal cancer|colorectal cancer
149785|NCT03263663|adjuvant|adjuvant
149786|NCT03263650|prostate cancer|prostate cancer
149787|NCT03263650|genomic alterations|genomic alterations
149788|NCT03263650|DNA damage repair|dna damage repair
149789|NCT03263650|DDR pathway gene expression|ddr pathway gene expression
149790|NCT03263650|aggressive-variant prostate carcinomas|aggressive-variant prostate carcinomas
149791|NCT03263650|small cell prostate carcinoma|small cell prostate carcinoma
149792|NCT03263650|neuroendocrine prostate carcinoma|neuroendocrine prostate carcinoma
149793|NCT03263637|Relapsed or refractory haematological malignancies|relapsed or refractory haematological malignancies
149794|NCT03263637|AZD4573|azd4573
149795|NCT03263637|CDK9i|cdk9i
149796|NCT03263637|Acute Myeloid Leukemia (AML)|acute myeloid leukemia (aml)
149797|NCT03263637|Acute Lymphocytic Leukemia (ALL)|acute lymphocytic leukemia (all)
149798|NCT03263637|Chronic lymphocytic Leukemia (CLL)|chronic lymphocytic leukemia (cll)
149799|NCT03263637|High risk Myelodysplastic syndrome (MDS)|high risk myelodysplastic syndrome (mds)
149800|NCT03263637|Chronic Myelomonocytic Leukemia (CML)|chronic myelomonocytic leukemia (cml)
149801|NCT03263637|Richter's syndrome|richter's syndrome
149802|NCT03263637|B-cell Non-Hodgkin Lymphoma (B-cell NHL)|b-cell non-hodgkin lymphoma (b-cell nhl)
149803|NCT03263637|T-cell Non-Hodgkin Lymphoma (T-cell NHL)|t-cell non-hodgkin lymphoma (t-cell nhl)
149804|NCT03263637|Small lymphocytic Lymphoma (SLL)|small lymphocytic lymphoma (sll)
149805|NCT03263637|Multiple Myeloma (MM)|multiple myeloma (mm)
149806|NCT03263624|psoriasis|psoriasis
149807|NCT03263624|laser|laser
149808|NCT03263624|nail|nail
149809|NCT03263611|disc degeneration|disc degeneration
149810|NCT03263611|Intervertebral disc|intervertebral disc
149811|NCT03263611|discogenic pain|discogenic pain
149812|NCT03263611|chronic discogenic lumbar back pain|chronic discogenic lumbar back pain
149813|NCT03263598|liver cirrhosis|liver cirrhosis
149814|NCT03263598|ascites|ascites
149815|NCT03263585|Osteoporosis|osteoporosis
149816|NCT03263585|Vertebral Fracture|vertebral fracture
149817|NCT03263585|Back Pain|back pain
149818|NCT03263585|Spinal orthosis|spinal orthosis
149819|NCT03263585|Elderly women|elderly women
149820|NCT03263559|Reduced Intensity Conditioning|reduced intensity conditioning
149821|NCT03263559|Haploidentical|haploidentical
149822|NCT03263559|Bone Marrow|bone marrow
149823|NCT03263559|Transplant|transplant
149824|NCT03263559|Sickle Cell Disease|sickle cell disease
149825|NCT03263533|schizophrenia|schizophrenia
149826|NCT03263533|clozapine|clozapine
149827|NCT03263533|vorinostat|vorinostat
149828|NCT03263533|HDAC|hdac
149829|NCT03263533|histone deacetylase inhibitor|histone deacetylase inhibitor
149830|NCT03263507|IONIS PKK-LRx|ionis pkk-lrx
149831|NCT03263455|neglect,|neglect,
149832|NCT03263455|stroke,|stroke,
149833|NCT03263455|rehabilitation,|rehabilitation,
149834|NCT03263455|range of motion|range of motion
149835|NCT03263416|Metastatic solid tumor|metastatic solid tumor
149836|NCT03263416|Oral Targeted Therapy|oral targeted therapy
149837|NCT03263416|Treatment adherence|treatment adherence
149838|NCT03263403|Meningococcal Vaccine|meningococcal vaccine
149839|NCT03263403|Ingovax ACWY|ingovax acwy
149840|NCT03263403|adults|adults
149841|NCT03263403|Bangladeshi|bangladeshi
149842|NCT03263403|immunogenicity|immunogenicity
149843|NCT03263390|Obesity|obesity
149844|NCT03263390|Bariatric Surgery|bariatric surgery
149845|NCT03263390|Anti Obesity Medications|anti obesity medications
149846|NCT03263390|Weight Regulation|weight regulation
149847|NCT03263390|Pluripotent Stem Cells|pluripotent stem cells
149848|NCT03263377|School feeding|school feeding
149849|NCT03263377|Fortified Biscuits|fortified biscuits
149850|NCT03263377|Bangladesh|bangladesh
149851|NCT03263312|myocardial fibrosis|myocardial fibrosis
149852|NCT03263312|exercise training|exercise training
149853|NCT03263312|Fontan|fontan
149854|NCT03263273|Minocycline|minocycline
149855|NCT03263273|Topical|topical
149856|NCT03263273|Tetracycline|tetracycline
149857|NCT03263273|Doxycycline|doxycycline
149858|NCT03263273|Rosacea|rosacea
149859|NCT03263273|Skin Disease|skin disease
149860|NCT03263273|Anti-Bacterial Agent|anti-bacterial agent
149861|NCT03263273|Anti-Inflammatory Agent|anti-inflammatory agent
149862|NCT03263260|stent, DES, Inspiron|stent, des, inspiron
149863|NCT03263195|HIV|hiv
149864|NCT03263195|Zika Virus|zika virus
149865|NCT03263195|Pregnancy|pregnancy
149866|NCT03263195|MTCT|mtct
149867|NCT03263182|childbirth|childbirth
149868|NCT03263182|delivery|delivery
149869|NCT03263169|e-health, community networks, pragmatic RCT|e-health, community networks, pragmatic rct
149870|NCT03263156|sleep|sleep
149871|NCT03263156|ADHD|adhd
149872|NCT03263156|behavioural intervention|behavioural intervention
149873|NCT03263156|insomnia|insomnia
149874|NCT03263130|COPD, Emphysema, Asthma COPD Overlap|copd, emphysema, asthma copd overlap
149875|NCT03263117|Acute stroke|acute stroke
149876|NCT03263117|Cerebral Stroke|cerebral stroke
149877|NCT03263091|Myelodysplastic Syndromes|myelodysplastic syndromes
149878|NCT03263091|Anemia|anemia
149879|NCT03263091|Hemoglobin (Hb)|hemoglobin (hb)
149880|NCT03263091|Low Risk Myelodysplastic Syndrome|low risk myelodysplastic syndrome
149881|NCT03263091|Low Risk MDS|low risk mds
149983|NCT03262376|Vitamins|vitamins
149882|NCT03263078|inhalation,intravenous anesthesia|inhalation,intravenous anesthesia
149883|NCT03263065|Nopal|nopal
149884|NCT03263065|Bran|bran
149885|NCT03263065|Psyllium|psyllium
149886|NCT03263052|kidney transplant|kidney transplant
149887|NCT03263052|immunosuppression|immunosuppression
149888|NCT03263052|tacrolimus XR|tacrolimus xr
149889|NCT03263052|elderly|elderly
149890|NCT03263052|quality of life|quality of life
149891|NCT03263052|neurological adverse events|neurological adverse events
149892|NCT03263039|Programmed Cell Death 1 Receptor|programmed cell death 1 receptor
149893|NCT03263039|Pembrolizumab|pembrolizumab
149894|NCT03263039|Keytruda|keytruda
149895|NCT03263039|MK-3475|mk-3475
149896|NCT03263039|Urothelial Carcinoma|urothelial carcinoma
149897|NCT03263026|Lymphoma|lymphoma
149898|NCT03263026|Non-Hodgkin's Lymphoma|non-hodgkin's lymphoma
149899|NCT03263026|enzastaurin|enzastaurin
149900|NCT03263013|Functional (BOLD) MRI|functional (bold) mri
149901|NCT03263000|Belpharospasm|belpharospasm
149902|NCT03263000|Blink Reflex|blink reflex
149903|NCT03263000|Eyeblink|eyeblink
149904|NCT03262974|Imatinib|imatinib
149905|NCT03262974|Pharmacogenetics|pharmacogenetics
149906|NCT03262974|CML|cml
149907|NCT03262974|Plasma level|plasma level
149908|NCT03262961|Mild pre-eclampsia Sildenafil Citrate|mild pre-eclampsia sildenafil citrate
149909|NCT03262922|systemic scleroderma|systemic scleroderma
149910|NCT03262922|environmental and professional toxics|environmental and professional toxics
149911|NCT03262909|cartilage damage|cartilage damage
149912|NCT03262909|cartilage defect|cartilage defect
149913|NCT03262909|chondral lesion|chondral lesion
149914|NCT03262909|osteochondral lesion|osteochondral lesion
149915|NCT03262909|femur|femur
149916|NCT03262909|condyle|condyle
149917|NCT03262896|Brain Death|brain death
149918|NCT03262896|Spinal Reflex|spinal reflex
149919|NCT03262896|Electromyography|electromyography
149920|NCT03262883|Prolonged akut mechanical ventilation|prolonged akut mechanical ventilation
149921|NCT03262883|Tracheotomy|tracheotomy
149922|NCT03262857|magnesium sulfate|magnesium sulfate
149923|NCT03262857|pulpitis|pulpitis
149924|NCT03262857|anesthesia|anesthesia
149925|NCT03262805|Knee OA|knee oa
149926|NCT03262805|Joint Pain|joint pain
149927|NCT03262805|Dietary supplement|dietary supplement
149928|NCT03262805|WOMAC|womac
149929|NCT03262805|Lequesne index|lequesne index
149930|NCT03262805|hs-CRP|hs-crp
149931|NCT03262766|Acute Intermittent Hypoxia|acute intermittent hypoxia
149932|NCT03262766|Upper Extremity Training|upper extremity training
150059|NCT03261856|SIBO|sibo
149933|NCT03262714|Dance, walking, cardiovascular risk, functional capacity.|dance, walking, cardiovascular risk, functional capacity.
149934|NCT03262688|INL-001|inl-001
149935|NCT03262688|Bupivacaine|bupivacaine
149936|NCT03262688|Collagen|collagen
149937|NCT03262688|Children|children
149938|NCT03262688|Pediatric|pediatric
149939|NCT03262688|Inguinal hernia|inguinal hernia
149940|NCT03262675|Heart Failure|heart failure
149941|NCT03262675|Acute Heart Failure|acute heart failure
149942|NCT03262675|Chronic Heat Failure|chronic heat failure
149943|NCT03262675|Cardiovascular diseases|cardiovascular diseases
149944|NCT03262675|Heart diseases|heart diseases
149945|NCT03262675|Registry|registry
149946|NCT03262675|Tunisia|tunisia
149947|NCT03262597|fluid balance|fluid balance
149948|NCT03262597|dehydration|dehydration
149949|NCT03262597|rehydration|rehydration
149950|NCT03262597|electrolytes|electrolytes
149951|NCT03262597|urine|urine
149952|NCT03262571|Heart failure|heart failure
149953|NCT03262571|Lung ultrasound|lung ultrasound
149954|NCT03262571|B-lines|b-lines
149955|NCT03262558|staphylococcus aureus|staphylococcus aureus
149956|NCT03262558|nosocomial infection|nosocomial infection
149957|NCT03262532|Interactive web-base simulation|interactive web-base simulation
149958|NCT03262493|intubation, gastrointestinal|intubation, gastrointestinal
149959|NCT03262493|nursing|nursing
149960|NCT03262493|clinical trial|clinical trial
149961|NCT03262493|enteral nutrition|enteral nutrition
149962|NCT03262441|HIV|hiv
149963|NCT03262441|Antiretroviral treatment|antiretroviral treatment
149964|NCT03262441|Mycophenolate mofetil|mycophenolate mofetil
149965|NCT03262441|Cure|cure
149966|NCT03262441|Latency|latency
149967|NCT03262441|Reservoir|reservoir
149968|NCT03262441|CD4 T cell|cd4 t cell
149969|NCT03262441|Anti-proliferation|anti-proliferation
149970|NCT03262415|LabPatch Continuous Glucose Monitoring (CGM)|labpatch continuous glucose monitoring (cgm)
149971|NCT03262402|Chronic periodontitis|chronic periodontitis
149972|NCT03262402|Candida spp|candida spp
149973|NCT03262402|Histatin-5|histatin-5
149974|NCT03262402|Lactoferrin|lactoferrin
149975|NCT03262389|positron emission tomography (PET)|positron emission tomography (pet)
149976|NCT03262389|computerized tomography (CT)|computerized tomography (ct)
149977|NCT03262389|Magnetic resonance imaging (MRI)|magnetic resonance imaging (mri)
149978|NCT03262389|Fludeoxyglucose (F-18 FDG)|fludeoxyglucose (f-18 fdg)
149979|NCT03262389|C-11 acetate|c-11 acetate
149980|NCT03262376|Stress|stress
149981|NCT03262376|Anxiety|anxiety
149982|NCT03262376|Cortisol|cortisol
149984|NCT03262376|Botanicals|botanicals
149985|NCT03262376|Minerals|minerals
149986|NCT03262363|nutrigenomics|nutrigenomics
149987|NCT03262363|Diet-gene interaction,|diet-gene interaction,
149988|NCT03262363|Curcumin,|curcumin,
149989|NCT03262363|Antioxidants,|antioxidants,
149990|NCT03262363|Human NFE2L2 protein,|human nfe2l2 protein,
149991|NCT03262363|Polymorphism,|polymorphism,
149992|NCT03262363|Diabetes,|diabetes,
149993|NCT03262363|Chronic kidney disease|chronic kidney disease
149994|NCT03262324|Foot and Ankle|foot and ankle
149995|NCT03262324|Disorders|disorders
149996|NCT03262324|Outcome Measure|outcome measure
149997|NCT03262298|CD22|cd22
149998|NCT03262298|CAR-T|car-t
149999|NCT03262298|Leukemia|leukemia
150000|NCT03262298|Lymphoma|lymphoma
150001|NCT03262220|Haematological malignancy|haematological malignancy
150002|NCT03262220|Total Marrow Irradiation|total marrow irradiation
150003|NCT03262220|Volumetric Arc Therapy|volumetric arc therapy
150004|NCT03262181|Exercise|exercise
150005|NCT03262181|Physical Activity|physical activity
150006|NCT03262181|Biomechanics|biomechanics
150007|NCT03262168|Exercise|exercise
150008|NCT03262168|Physical Activity|physical activity
150009|NCT03262142|COPD|copd
150010|NCT03262142|Pseudomonas Aeruginosa|pseudomonas aeruginosa
150011|NCT03262116|bionic pancreas|bionic pancreas
150012|NCT03262116|insulin|insulin
150013|NCT03262116|continuous glucose monitor|continuous glucose monitor
150014|NCT03262116|type 1 diabetes|type 1 diabetes
150015|NCT03262116|insulin pharmacokinetics|insulin pharmacokinetics
150016|NCT03262103|Prostate Cancer|prostate cancer
150017|NCT03262103|Gleason 8-10|gleason 8-10
150018|NCT03262103|Immunotherapy|immunotherapy
150019|NCT03262103|Neoadjuvant|neoadjuvant
150020|NCT03262090|Emergence Delirium|emergence delirium
150021|NCT03262090|desoflurane|desoflurane
150022|NCT03262090|general anesthesia|general anesthesia
150023|NCT03262077|photodynamic therapy|photodynamic therapy
150024|NCT03262077|periodontal disease|periodontal disease
150025|NCT03262077|dosimetry|dosimetry
150026|NCT03262077|methylene blue|methylene blue
150027|NCT03262051|cytochrome|cytochrome
150028|NCT03262051|chronic inflammation|chronic inflammation
150029|NCT03262051|genotyping|genotyping
150030|NCT03262051|phenotyping|phenotyping
150031|NCT03262051|acute inflammation|acute inflammation
150032|NCT03262051|rheumatoid arthritis|rheumatoid arthritis
150033|NCT03262038|intrathecal morphine|intrathecal morphine
150034|NCT03262025|Primary cecal pathology|primary cecal pathology
150035|NCT03262025|Emergency laparotomy|emergency laparotomy
150036|NCT03262025|Ruptured liver abscess|ruptured liver abscess
150037|NCT03262025|Right hemicolectomy|right hemicolectomy
150038|NCT03262025|Conservative colonic resection|conservative colonic resection
150039|NCT03262025|Fulminant amoebic colitis|fulminant amoebic colitis
150040|NCT03262025|Ileocecal resection|ileocecal resection
150041|NCT03262025|Ileoascending anastomosis|ileoascending anastomosis
150042|NCT03262025|Ileotransverse anastomosis|ileotransverse anastomosis
150043|NCT03262025|Cecal diverticulitis|cecal diverticulitis
150044|NCT03262025|Amoebic typhilitis|amoebic typhilitis
150045|NCT03262025|Idiopathic typhilitis|idiopathic typhilitis
150046|NCT03261999|Prostate Neoplasm Cancer Carcinoma|prostate neoplasm cancer carcinoma
150047|NCT03261986|Trident|trident
150048|NCT03261986|RSA|rsa
150049|NCT03261986|THA|tha
150050|NCT03261947|Drug therapy|drug therapy
150051|NCT03261934|Chronic Atrophic Gastritis|chronic atrophic gastritis
150052|NCT03261934|Malignant Transformation|malignant transformation
150053|NCT03261934|Risk Assessment|risk assessment
150054|NCT03261934|Syndrome Evolution|syndrome evolution
150055|NCT03261934|Traditional Chinese Medicine|traditional chinese medicine
150056|NCT03261934|Registry Study|registry study
150057|NCT03261869|Ice pack therapy, third molar surgery, swelling, pain, trismus|ice pack therapy, third molar surgery, swelling, pain, trismus
150058|NCT03261856|Breath test|breath test
150060|NCT03261856|GI|gi
150061|NCT03261843|platelet rich plasma , posterior lumbar interbody fusion|platelet rich plasma , posterior lumbar interbody fusion
150062|NCT03261830|Antibiotic|antibiotic
150063|NCT03261830|Pediatric|pediatric
150064|NCT03261817|web|web
150065|NCT03261817|brain imaging|brain imaging
150066|NCT03261817|heart rate variability|heart rate variability
150067|NCT03261817|circadian cycles|circadian cycles
150068|NCT03261817|cognition|cognition
150069|NCT03261817|well-being|well-being
150070|NCT03261817|hippocampus|hippocampus
150071|NCT03261817|N acetyl aspartate|n acetyl aspartate
150072|NCT03261817|white matter|white matter
150073|NCT03261817|physical activity|physical activity
150074|NCT03261791|hepatocellular carcinoma|hepatocellular carcinoma
150075|NCT03261791|apatinib|apatinib
150076|NCT03261791|portal vein invasion|portal vein invasion
150077|NCT03261791|adjuvant therapy|adjuvant therapy
150078|NCT03261791|resection|resection
150079|NCT03261739|NAFLD, CB1 receptor blockade, anti-CB1 monoclonal antibody|nafld, cb1 receptor blockade, anti-cb1 monoclonal antibody
150080|NCT03261726|unilateral deafness|unilateral deafness
150081|NCT03261726|acoustic neuroma|acoustic neuroma
150082|NCT03261726|cochlear implant|cochlear implant
150562|NCT03258775|hydration|hydration
150083|NCT03261713|rehabilitation|rehabilitation
150084|NCT03261713|telerehabilitation|telerehabilitation
150085|NCT03261713|feasibility studies|feasibility studies
191504|NCT02998853|FFR|ffr
150086|NCT03261713|virtual reality|virtual reality
150087|NCT03261700|women Veterans|women veterans
150088|NCT03261700|interpersonal violence|interpersonal violence
150089|NCT03261687|pregnancy|pregnancy
150090|NCT03261687|pelvic girdle pain|pelvic girdle pain
150091|NCT03261687|hydrotherapy|hydrotherapy
150092|NCT03261687|quality of life|quality of life
150093|NCT03261687|physical therapy|physical therapy
150094|NCT03261674|Insomnia|insomnia
150095|NCT03261674|Traumatic Brain Injury|traumatic brain injury
150096|NCT03261674|Cognitive Behavioral Therapy|cognitive behavioral therapy
150097|NCT03261674|Veterans|veterans
150098|NCT03261622|Sacral Nerve Stimulation|sacral nerve stimulation
150099|NCT03261622|Sacral Nerve Modulation|sacral nerve modulation
150100|NCT03261609|extremely preterm|extremely preterm
150101|NCT03261609|young adults|young adults
150102|NCT03261609|CVD risks factors|cvd risks factors
150103|NCT03261609|inflammation|inflammation
150104|NCT03261609|chronic health conditions|chronic health conditions
150106|NCT03261596|Soil-transmitted helminth|soil-transmitted helminth
150107|NCT03261596|hookworm|hookworm
150108|NCT03261596|hookworm infections|hookworm infections
150109|NCT03261596|necator americanus|necator americanus
150110|NCT03261596|ancylostoma duodenale|ancylostoma duodenale
150111|NCT03261570|Postural Orthostatic Tachycardia Syndrome (POTS)|postural orthostatic tachycardia syndrome (pots)
150112|NCT03261570|POTS|pots
150113|NCT03261570|Orthostatic Intolerance|orthostatic intolerance
150114|NCT03261570|Digoxin|digoxin
150115|NCT03261570|Pyridostigmine|pyridostigmine
150116|NCT03261570|Mestinon|mestinon
150117|NCT03261531|Overweight|overweight
150118|NCT03261531|Class I Obesity|class i obesity
150119|NCT03261518|ileus|ileus
150120|NCT03261518|Contrast-induced Nephropathy|contrast-induced nephropathy
150121|NCT03261518|vena cava inferior|vena cava inferior
150122|NCT03261505|fMRI|fmri
150123|NCT03261505|acupuncture|acupuncture
150124|NCT03261505|osteoarthritis|osteoarthritis
150125|NCT03261479|pneumonia|pneumonia
150126|NCT03261479|thermal imaging|thermal imaging
150127|NCT03261479|respiratory distress|respiratory distress
150128|NCT03261479|x-ray|x-ray
150129|NCT03261479|thermal|thermal
150130|NCT03261466|obesity|obesity
150131|NCT03261466|paediatric|paediatric
150132|NCT03261466|probiotic|probiotic
150133|NCT03261401|Healthy Subjects|healthy subjects
150134|NCT03261401|M5717|m5717
150135|NCT03261401|Malaria|malaria
150136|NCT03261401|Plasmodium falciparum|plasmodium falciparum
150137|NCT03261349|Follicular lymphoma|follicular lymphoma
150138|NCT03261349|MALT lymphoma|malt lymphoma
150139|NCT03261349|Waldenström's macroglobulinemia|waldenström's macroglobulinemia
150140|NCT03261349|Hepatitis C virus|hepatitis c virus
150141|NCT03261323|Breast Reconstruction|breast reconstruction
150142|NCT03261323|Mastectomy|mastectomy
150143|NCT03261310|acetaminophen|acetaminophen
150144|NCT03261310|pain|pain
150145|NCT03261310|laminectomy|laminectomy
150146|NCT03261310|craniotomy|craniotomy
150147|NCT03261284|D-dimer|d-dimer
150148|NCT03261284|Nonvalvular atrial fibrillation|nonvalvular atrial fibrillation
150149|NCT03261284|Direct thrombin inhibitor|direct thrombin inhibitor
150150|NCT03261284|INR|inr
150151|NCT03261193|quadratus lumborum block|quadratus lumborum block
150152|NCT03261193|post-operative pain|post-operative pain
150153|NCT03261193|cesarean section pain|cesarean section pain
150154|NCT03261193|analgesia|analgesia
150155|NCT03261193|nerve block|nerve block
150156|NCT03261167|Botulinum toxin A|botulinum toxin a
150157|NCT03261167|Safety|safety
150158|NCT03261167|post-stroke upper limb spasticity|post-stroke upper limb spasticity
150159|NCT03261167|Efficacy|efficacy
150160|NCT03261167|GSK1358820|gsk1358820
150161|NCT03261167|double blind|double blind
150162|NCT03261154|Serum iPTH|serum ipth
150163|NCT03261154|Calcium|calcium
150164|NCT03261154|Phosphate|phosphate
150165|NCT03261128|cancer|cancer
150166|NCT03261128|chemotherapy|chemotherapy
150167|NCT03261115|Pain, Benzocaine, Clinical trial|pain, benzocaine, clinical trial
150168|NCT03261102|IBD|ibd
150169|NCT03261102|Crohn|crohn
150170|NCT03261102|adalimumab|adalimumab
150171|NCT03261102|ADAL|adal
150172|NCT03261089|coma, prognosis, cardiac arrest|coma, prognosis, cardiac arrest
150173|NCT03261076|Specific Learning Disorder|specific learning disorder
150174|NCT03261076|Learning Disorders|learning disorders
150175|NCT03261076|Neurodevelopmental Disorders|neurodevelopmental disorders
150176|NCT03261076|Mental Disorders|mental disorders
150177|NCT03261076|Developmental Reading Disability|developmental reading disability
150178|NCT03261076|Reading Disorder|reading disorder
150179|NCT03261076|Conduct Disorder|conduct disorder
150180|NCT03261050|Eating disorder|eating disorder
150181|NCT03261050|Counter attitudinal therapy|counter attitudinal therapy
150182|NCT03261050|fMRI|fmri
150183|NCT03261024|En-masse retraction , Class I bimaxillary protrusion|en-masse retraction , class i bimaxillary protrusion
150184|NCT03261011|immunotherapy|immunotherapy
150185|NCT03261011|immuno-oncology|immuno-oncology
150186|NCT03261011|advanced solid tumors|advanced solid tumors
150187|NCT03260920|oxytocin|oxytocin
150188|NCT03260920|frontotemporal dementia|frontotemporal dementia
150189|NCT03260920|apathy|apathy
150190|NCT03260920|empathy|empathy
150191|NCT03260907|Overactive bladder|overactive bladder
150192|NCT03260907|menopause|menopause
150193|NCT03260907|Postmenopausal overactive bladder|postmenopausal overactive bladder
150194|NCT03260907|Electroacupuncture|electroacupuncture
150195|NCT03260894|Renal cell carcinoma|renal cell carcinoma
150196|NCT03260894|programmed cell death 1 (PD-1) inhibitor|programmed cell death 1 (pd-1) inhibitor
150197|NCT03260894|indoleamine 2|indoleamine 2
150198|NCT03260894|3-dioxygenase 1 (IDO1) inhibitor|3-dioxygenase 1 (ido1) inhibitor
150199|NCT03260881|Epicardial Fat|epicardial fat
150200|NCT03260855|Lymphoma|lymphoma
150201|NCT03260855|Cancer survivorship|cancer survivorship
150202|NCT03260855|Fear|fear
150203|NCT03260842|early detection|early detection
150204|NCT03260842|biomarkers|biomarkers
150205|NCT03260842|pancreas cancer|pancreas cancer
150206|NCT03260829|vitamin C|vitamin c
150207|NCT03260829|palatally impacted canines|palatally impacted canines
150208|NCT03260829|intraepidermal injection|intraepidermal injection
150209|NCT03260816|Preschoolers|preschoolers
150210|NCT03260816|Developmental Delay|developmental delay
150211|NCT03260816|Disruptive Behavior|disruptive behavior
150212|NCT03260816|Early Intervention|early intervention
150213|NCT03260816|Parent-Child Interaction Therapy (PCIT)|parent-child interaction therapy (pcit)
150214|NCT03260816|Telehealth|telehealth
150215|NCT03260816|Telemental Health|telemental health
150216|NCT03260816|Telepsychiatry|telepsychiatry
150217|NCT03260803|osteopenia|osteopenia
150218|NCT03260803|oligopin|oligopin
150219|NCT03260803|postmenopause|postmenopause
150220|NCT03260803|antioxidant|antioxidant
150221|NCT03260803|bone|bone
150222|NCT03260790|Vaccine|vaccine
150223|NCT03260790|Pneumococcal|pneumococcal
150224|NCT03260790|Pneumonia|pneumonia
150225|NCT03260764|Multifocal Contact Lenses|multifocal contact lenses
150226|NCT03260764|Bifocal Spectacles|bifocal spectacles
150227|NCT03260764|Congenital Cataracts|congenital cataracts
150228|NCT03260738|Chronic Low Back Pain|chronic low back pain
150229|NCT03260738|Rehabilitation|rehabilitation
150230|NCT03260738|Robot Poppy|robot poppy
150231|NCT03260712|biliary tract cancer|biliary tract cancer
150232|NCT03260712|metastitic cancer|metastitic cancer
150233|NCT03260712|advanced cancer|advanced cancer
150234|NCT03260712|pembrolizumab|pembrolizumab
150235|NCT03260712|cisplatin|cisplatin
150236|NCT03260712|gemcitabine|gemcitabine
150237|NCT03260712|gallbladder cancer|gallbladder cancer
150238|NCT03260673|cataract|cataract
150239|NCT03260673|phacoemulsification|phacoemulsification
150240|NCT03260673|type 2 diabetes mellitus|type 2 diabetes mellitus
150241|NCT03260673|corneal endothelial cells|corneal endothelial cells
150242|NCT03260634|voriconazole|voriconazole
150243|NCT03260634|therapeutic drug monitoring|therapeutic drug monitoring
150244|NCT03260608|dementia, deficits, burden, caregivers, telemedicine.|dementia, deficits, burden, caregivers, telemedicine.
150245|NCT03260582|cardiac rehabilitation|cardiac rehabilitation
150246|NCT03260582|eHealth|ehealth
150247|NCT03260582|smartphone application|smartphone application
150248|NCT03260569|Mechanical ventilation|mechanical ventilation
150249|NCT03260569|Inhaled nitric oxide|inhaled nitric oxide
150250|NCT03260556|pulmonary fibrosis|pulmonary fibrosis
150251|NCT03260543|ginseng powder|ginseng powder
150252|NCT03260543|Fatty Liver|fatty liver
150253|NCT03260543|Clinical Trial|clinical trial
150254|NCT03260491|Oncology|oncology
150255|NCT03260491|Advanced Non-small Cell Lung Cancer|advanced non-small cell lung cancer
150256|NCT03260491|Inoperable Non-small Cell Lung Cancer|inoperable non-small cell lung cancer
150257|NCT03260491|Metastatic|metastatic
150258|NCT03260491|Unresectable|unresectable
150259|NCT03260491|Epidermal growth factor receptor|epidermal growth factor receptor
150260|NCT03260491|EGFR|egfr
150261|NCT03260478|Traumatic Brain Injury (TBI)|traumatic brain injury (tbi)
150262|NCT03260478|Red Blood Cells (RBC) Transfusion|red blood cells (rbc) transfusion
150263|NCT03260478|Intensive Care Unit (ICU)|intensive care unit (icu)
150264|NCT03260478|Transfusion Threshold|transfusion threshold
150265|NCT03260478|Anemia|anemia
150266|NCT03260478|Oxygen Delivery|oxygen delivery
150267|NCT03260478|Neurocritical Care|neurocritical care
150268|NCT03260478|Critical Care Neurology and Trauma|critical care neurology and trauma
150269|NCT03260465|total hip replacement|total hip replacement
150270|NCT03260465|roentgen stereophotogrammetric analysis|roentgen stereophotogrammetric analysis
150271|NCT03260452|Type 2 diabetes|type 2 diabetes
150272|NCT03260452|Adipose tissue|adipose tissue
150273|NCT03260452|Hematopoiesis|hematopoiesis
150274|NCT03260452|Inflammation|inflammation
150275|NCT03260452|Macrophages|macrophages
150276|NCT03260439|tramadol-penile block -circumcision surgery-anesthesia-child|tramadol-penile block -circumcision surgery-anesthesia-child
150277|NCT03260426|Tolerability diet after surgery|tolerability diet after surgery
150278|NCT03260400|RPNI|rpni
150565|NCT03258762|Caucasian|caucasian
150279|NCT03260400|Regenerative Peripheral Nerve Interface|regenerative peripheral nerve interface
150280|NCT03260387|pediatric|pediatric
150281|NCT03260387|total pancreatectomy|total pancreatectomy
150282|NCT03260387|acute pancreatitis|acute pancreatitis
150283|NCT03260387|chronic pancreatitis|chronic pancreatitis
150284|NCT03260387|islet transplant|islet transplant
150285|NCT03260387|islet autotransplant|islet autotransplant
150286|NCT03260335|Challenging behaviour|challenging behaviour
150287|NCT03260335|Biofeedback|biofeedback
150288|NCT03260335|Anxiety management|anxiety management
150289|NCT03260322|Pembrolizumab|pembrolizumab
150290|NCT03260322|Oncology|oncology
150291|NCT03260322|Tumors|tumors
150292|NCT03260322|ASP8374|asp8374
150293|NCT03260322|Locally advanced or metastatic solid tumor malignancies|locally advanced or metastatic solid tumor malignancies
150294|NCT03260296|smartphones addiction|smartphones addiction
150295|NCT03260283|pethidine|pethidine
150296|NCT03260257|Neurofeedback, Gamma band response|neurofeedback, gamma band response
150297|NCT03260244|atrial fibrillation|atrial fibrillation
150298|NCT03260244|atrial flutter|atrial flutter
150299|NCT03260244|supraventricular tachycardia|supraventricular tachycardia
150300|NCT03260244|ventricular tachycardia|ventricular tachycardia
150301|NCT03260244|premature ventricular contractions|premature ventricular contractions
150302|NCT03260244|cardiac mapping system|cardiac mapping system
150303|NCT03260218|postoperative delirium|postoperative delirium
150304|NCT03260218|elderly|elderly
150305|NCT03260218|total joint replacement|total joint replacement
150306|NCT03260218|risk factors for delirium|risk factors for delirium
150307|NCT03260218|postoperative confusion|postoperative confusion
150308|NCT03260205|SPD489|spd489
150309|NCT03260205|Lisdexamfetamine dimesylate|lisdexamfetamine dimesylate
150310|NCT03260205|ADHD|adhd
150311|NCT03260205|hyperactivity|hyperactivity
150312|NCT03260205|Neurobehavioral disorder|neurobehavioral disorder
150313|NCT03260192|circulating tumor DNA|circulating tumor dna
150314|NCT03260166|nicotinamide|nicotinamide
150315|NCT03260166|lupus-associated skin lesion|lupus-associated skin lesion
150316|NCT03260166|lupus erythematosus|lupus erythematosus
150317|NCT03260153|Intracerebral Hemorrhage|intracerebral hemorrhage
150318|NCT03260153|Perihematomal edema|perihematomal edema
150319|NCT03260153|Deproteinised Calf Blood Serum Injection|deproteinised calf blood serum injection
150320|NCT03260140|weight loss|weight loss
150321|NCT03260140|lifestyle|lifestyle
150322|NCT03260140|diet|diet
150323|NCT03260140|exercise|exercise
150324|NCT03260140|randomized controlled trial|randomized controlled trial
150325|NCT03260127|PTSD|ptsd
150326|NCT03260127|treatment|treatment
150327|NCT03260127|posttraumatic stress disorder|posttraumatic stress disorder
150328|NCT03260127|therapy|therapy
150329|NCT03260127|cognition|cognition
150330|NCT03260127|thinking|thinking
150331|NCT03260127|executive function|executive function
150332|NCT03260127|computer|computer
150333|NCT03260127|training|training
150334|NCT03260114|Physical activity|physical activity
150335|NCT03260114|Body weight|body weight
150336|NCT03260114|Obesity|obesity
150337|NCT03260062|cochlear implants|cochlear implants
150338|NCT03260062|language development|language development
150339|NCT03260062|parenting intervention|parenting intervention
150340|NCT03260062|maternal sensitivity|maternal sensitivity
150341|NCT03260062|facilitative language techniques|facilitative language techniques
150342|NCT03260036|Urea synthesis|urea synthesis
150343|NCT03260036|Ammonia|ammonia
150344|NCT03260036|Bariatric surgery|bariatric surgery
150345|NCT03260023|Avelumab|avelumab
150346|NCT03260023|Cancer|cancer
150347|NCT03260023|Anti PD-L1|anti pd-l1
150348|NCT03260023|Therapeutic Vaccine|therapeutic vaccine
150349|NCT03259971|Rett syndrome|rett syndrome
150350|NCT03259971|Tourette syndrome|tourette syndrome
150351|NCT03259971|Probiotic|probiotic
150352|NCT03259919|Metformin|metformin
150353|NCT03259919|Pregnancy outcome|pregnancy outcome
150354|NCT03259919|Androgens|androgens
150355|NCT03259893|Proctor Conceptual Model of Implementation Research|proctor conceptual model of implementation research
150356|NCT03259893|Prevention|prevention
150357|NCT03259893|Safety net hospital|safety net hospital
150358|NCT03259893|Diverse inner city patients|diverse inner city patients
150359|NCT03259880|evaluation|evaluation
150360|NCT03259867|Hepatocellular carcinoma|hepatocellular carcinoma
150361|NCT03259867|Colorectal cancer|colorectal cancer
150362|NCT03259867|Immune checkpoint inhibitor|immune checkpoint inhibitor
150363|NCT03259867|Gastric cancer|gastric cancer
150364|NCT03259867|Non-small cell lung cancer|non-small cell lung cancer
150365|NCT03259828|Sigmoid colon cancer|sigmoid colon cancer
150366|NCT03259828|Internal organ motion|internal organ motion
150367|NCT03259828|Radiotherapy|radiotherapy
150368|NCT03259815|FFR Targeted PCI|ffr targeted pci
150369|NCT03259815|Post-PCI FFR|post-pci ffr
150370|NCT03259815|Physiology-guided PCI Optimisation|physiology-guided pci optimisation
150371|NCT03259776|Intensive Care|intensive care
150372|NCT03259776|Patient- and Family-Centred Care|patient- and family-centred care
150373|NCT03259776|Patient and Public Involvement|patient and public involvement
150563|NCT03258775|substrate oxidation|substrate oxidation
150374|NCT03259776|South West London Major Trauma Network|south west london major trauma network
150375|NCT03259776|Service Improvement|service improvement
150376|NCT03259776|Survey Questionnaire|survey questionnaire
150377|NCT03259776|Visitor Experiences|visitor experiences
150378|NCT03259763|Gastroenterostomy|gastroenterostomy
150379|NCT03259763|Gastric Outlet Obstruction|gastric outlet obstruction
150381|NCT03259763|Endosonography|endosonography
150382|NCT03259750|Self-reported outcome instrument|self-reported outcome instrument
150383|NCT03259750|Sport|sport
150384|NCT03259750|Ankle and foot|ankle and foot
150385|NCT03259750|Injury|injury
150386|NCT03259711|Cardiotoxicity|cardiotoxicity
150387|NCT03259711|selective estrogen receptor modulators|selective estrogen receptor modulators
150388|NCT03259711|aromatase inhibitors|aromatase inhibitors
150389|NCT03259711|hormone replacement therapy|hormone replacement therapy
150390|NCT03259711|estrogen|estrogen
150391|NCT03259685|Non-nutritive sweeteners|non-nutritive sweeteners
150392|NCT03259685|High Sugar Sweetened Beverages|high sugar sweetened beverages
150393|NCT03259685|Diet|diet
150394|NCT03259672|intubation|intubation
150395|NCT03259672|pharyngitis|pharyngitis
150396|NCT03259672|remifentanil|remifentanil
150397|NCT03259633|Neurofibromatosis type1,|neurofibromatosis type1,
150398|NCT03259633|Plexiform Neurofibromas|plexiform neurofibromas
150399|NCT03259633|inoperable, progressive/symptomatic plexiform neurofibromas (PN) without any alternative therapeutic options|inoperable, progressive/symptomatic plexiform neurofibromas (pn) without any alternative therapeutic options
150400|NCT03259633|mutation in the NF1 gene|mutation in the nf1 gene
150401|NCT03259633|Selumetinib|selumetinib
150402|NCT03259633|Early Access|early access
150403|NCT03259633|Intermediate Access Protocol|intermediate access protocol
150404|NCT03259607|Bioequivalence|bioequivalence
150405|NCT03259594|Renal functional reserve|renal functional reserve
150406|NCT03259594|Simple renal cysts|simple renal cysts
150407|NCT03259594|Laparoscopic deroofing|laparoscopic deroofing
150408|NCT03259581|transarterial chemoembolization|transarterial chemoembolization
150409|NCT03259568|TMS|tms
150410|NCT03259555|Brexpiprazole|brexpiprazole
150411|NCT03259555|Bipolar|bipolar
150412|NCT03259555|Manic episode|manic episode
150413|NCT03259529|Diffuse Large B-cell Lymphoma|diffuse large b-cell lymphoma
150414|NCT03259529|Nivolumab|nivolumab
150415|NCT03259529|Bendamustine Hydrochloride|bendamustine hydrochloride
150416|NCT03259529|Gemcitabine|gemcitabine
150417|NCT03259529|Rituximab|rituximab
150418|NCT03259516|myelodysplastic syndrome|myelodysplastic syndrome
150419|NCT03259516|nivolumab|nivolumab
150420|NCT03259516|5-azacitidine|5-azacitidine
150421|NCT03259516|cytarabine|cytarabine
150422|NCT03259516|melphalan|melphalan
150423|NCT03259516|all-trans retinoic acid|all-trans retinoic acid
150424|NCT03259516|lymphodepletion|lymphodepletion
150425|NCT03259477|laparoscopic partial nephrectomy|laparoscopic partial nephrectomy
150426|NCT03259477|precise segmental renal arterial clamping|precise segmental renal arterial clamping
150427|NCT03259477|renal cell carcinoma|renal cell carcinoma
150428|NCT03259477|renal functional reserve|renal functional reserve
150429|NCT03259438|Qigong|qigong
150430|NCT03259438|Comprehensive Health Improvement Program (CHIP)|comprehensive health improvement program (chip)
150431|NCT03259438|Pre-Train Injury Prevention Program|pre-train injury prevention program
150432|NCT03259438|Cancer Related Fatigue|cancer related fatigue
150433|NCT03259438|Cancer Survivorship|cancer survivorship
150434|NCT03259438|Inflammation|inflammation
150435|NCT03259438|Flowmetry|flowmetry
150436|NCT03259438|Corticomuscular coherence|corticomuscular coherence
150437|NCT03259438|Heart Rate Variability|heart rate variability
150438|NCT03259438|Neuroimmune Interactions|neuroimmune interactions
150439|NCT03259438|Complex Systems Analysis|complex systems analysis
150440|NCT03259438|Female|female
150441|NCT03259425|Resectable Stage IIIB, IIIC, and IVM1a|resectable stage iiib, iiic, and ivm1a
150442|NCT03259373|AF|af
150443|NCT03259373|AFib|afib
150444|NCT03259373|OAC|oac
150445|NCT03259373|Atrial fibrillation|atrial fibrillation
150446|NCT03259373|Oral anticoagulant|oral anticoagulant
150447|NCT03259373|Education|education
150448|NCT03259360|Tobacco|tobacco
150449|NCT03259360|Gender Identity Minority|gender identity minority
150450|NCT03259360|Sexual Identity Minority|sexual identity minority
150451|NCT03259360|Cessation|cessation
150452|NCT03259360|Intervention|intervention
150453|NCT03259360|Young Adults|young adults
150454|NCT03259360|Social Media|social media
150455|NCT03259360|Internet|internet
150456|NCT03259360|Cigarette|cigarette
150457|NCT03259321|Fish|fish
150458|NCT03259321|Polyunsaturated fatty acids|polyunsaturated fatty acids
150459|NCT03259321|CHNS|chns
150460|NCT03259295|skin tag|skin tag
150461|NCT03259243|Bupivacaine, Port site infiltration ,Postoperative pain ,Gynecologic laparoscopy|bupivacaine, port site infiltration ,postoperative pain ,gynecologic laparoscopy
150462|NCT03259230|Hemophagocytic Lymphohistiocytosis|hemophagocytic lymphohistiocytosis
150463|NCT03259230|Malignancy-Associated Hemophagocytic Lymphohistiocytosis|malignancy-associated hemophagocytic lymphohistiocytosis
150464|NCT03259230|M-HLH|m-hlh
150564|NCT03258762|Japanese|japanese
150465|NCT03259230|Patients with known diagnosis of malignancy without HLH|patients with known diagnosis of malignancy without hlh
150466|NCT03259230|Interferon Gamma|interferon gamma
150467|NCT03259230|IFNγ|ifnγ
150468|NCT03259230|Biomarkers|biomarkers
150469|NCT03259230|Inflammatory Markers|inflammatory markers
150470|NCT03259230|Blood draws|blood draws
150471|NCT03259230|Data collection|data collection
150472|NCT03259204|Achilles tendon|achilles tendon
150473|NCT03259204|Microdialysis|microdialysis
150474|NCT03259204|Immobilization|immobilization
150475|NCT03259204|Wound healing|wound healing
150476|NCT03259204|Intermittent Pneumatic Compression|intermittent pneumatic compression
150477|NCT03259204|Ultrasonography|ultrasonography
150478|NCT03259191|Anti-reflux mucosectomy,refractory gastroesophageal reflux disease,safety,efficacy|anti-reflux mucosectomy,refractory gastroesophageal reflux disease,safety,efficacy
150479|NCT03259178|Binocular vision test|binocular vision test
150480|NCT03259165|Heart Failure|heart failure
150481|NCT03259165|Acute Heart Failure|acute heart failure
150482|NCT03259165|Pulmonary Edema|pulmonary edema
150483|NCT03259165|Lung Ultrasound|lung ultrasound
150484|NCT03259165|Extra vascular lung water|extra vascular lung water
150485|NCT03259165|B-lines|b-lines
150486|NCT03259165|Diuretics|diuretics
150487|NCT03259165|Nitrates|nitrates
150488|NCT03259152|Giant cell tumor of bone|giant cell tumor of bone
150489|NCT03259152|Denousmab|denousmab
150490|NCT03259152|Pathologic|pathologic
150491|NCT03259152|Clinical|clinical
150492|NCT03259152|Mechansim|mechansim
150493|NCT03259139|adolescent|adolescent
150494|NCT03259139|gun|gun
150495|NCT03259139|violence|violence
150496|NCT03259139|media|media
150497|NCT03259126|Transradial|transradial
150498|NCT03259126|Coronary|coronary
150499|NCT03259126|X-ray|x-ray
150500|NCT03259126|Radiation|radiation
150501|NCT03259126|Curtain|curtain
150502|NCT03259113|insertable cardiac monitor|insertable cardiac monitor
150503|NCT03259113|atrial fibrillation|atrial fibrillation
150504|NCT03259113|non-sustained ventricular tachycardia|non-sustained ventricular tachycardia
150505|NCT03259074|ankylosing spondylitis, AS, secukinumab, GP2017, adalimumab biosimilar, mSASSS, ASAS20|ankylosing spondylitis, as, secukinumab, gp2017, adalimumab biosimilar, msasss, asas20
150506|NCT03259009|colorectal cancer|colorectal cancer
150507|NCT03259009|anti-EGFR therapy|anti-egfr therapy
150508|NCT03259009|rechallenge|rechallenge
150509|NCT03259009|circulating tumor DNA|circulating tumor dna
150510|NCT03259009|biomarker|biomarker
150511|NCT03259009|RAS mutations|ras mutations
150512|NCT03258996|Gingival recession|gingival recession
150513|NCT03258996|Class III gingival recession|class iii gingival recession
150514|NCT03258996|Multiples gingival recessions|multiples gingival recessions
150515|NCT03258996|Periodontitis|periodontitis
150516|NCT03258996|Mucogingival surgery|mucogingival surgery
150517|NCT03258996|Modified vestibular incision subperiosteal tunnel access|modified vestibular incision subperiosteal tunnel access
150518|NCT03258996|Coronally advanced flap|coronally advanced flap
150519|NCT03258996|Connective tissue graft|connective tissue graft
150520|NCT03258996|Post-surgical pain|post-surgical pain
150521|NCT03258983|Alpha-linolenic acid|alpha-linolenic acid
150522|NCT03258983|Dietary intake|dietary intake
150523|NCT03258983|Adipose tissue|adipose tissue
150524|NCT03258983|Nutritional epidemiology|nutritional epidemiology
150525|NCT03258970|vitamin supplement|vitamin supplement
150526|NCT03258970|Vitamin C|vitamin c
150527|NCT03258970|Vitamin E|vitamin e
150528|NCT03258905|transition-age youth|transition-age youth
150529|NCT03258905|mobile app|mobile app
150530|NCT03258905|grounding|grounding
150531|NCT03258905|Seeking Safety|seeking safety
150532|NCT03258879|Combined spinal epidural analgesia, dural puncture epidural|combined spinal epidural analgesia, dural puncture epidural
150533|NCT03258866|thrombocytopenia|thrombocytopenia
150534|NCT03258866|Immune Thrombocytopenia|immune thrombocytopenia
150535|NCT03258866|purpura|purpura
150536|NCT03258853|cystic fibrosis|cystic fibrosis
150537|NCT03258853|insulin|insulin
150538|NCT03258853|glucagon|glucagon
150539|NCT03258853|continuous glucose monitor|continuous glucose monitor
150540|NCT03258853|bionic pancreas|bionic pancreas
150541|NCT03258840|EPA|epa
150542|NCT03258840|Paraoxonase 1|paraoxonase 1
150543|NCT03258840|Paraoxonase 2|paraoxonase 2
150544|NCT03258840|Type 2 diabetes|type 2 diabetes
150545|NCT03258827|elderly|elderly
150546|NCT03258827|sarcopenia|sarcopenia
150547|NCT03258827|strengthening exercise|strengthening exercise
150548|NCT03258814|axial spondyloarthritis|axial spondyloarthritis
150549|NCT03258814|active supervised training|active supervised training
150550|NCT03258814|physical training|physical training
150551|NCT03258814|adalimumab|adalimumab
150552|NCT03258814|spinal mobility|spinal mobility
150553|NCT03258814|physiotherapy|physiotherapy
150554|NCT03258814|physical function|physical function
150555|NCT03258814|health-related quality of life|health-related quality of life
192132|NCT02994381|14C|14c
150557|NCT03258814|disease activity|disease activity
150558|NCT03258814|psychosocial risk factors|psychosocial risk factors
150559|NCT03258814|workability|workability
150560|NCT03258814|Bath Ankylosing Spondylitis Metrology Index (BASMI)|bath ankylosing spondylitis metrology index (basmi)
150561|NCT03258775|RMR|rmr
150566|NCT03258762|pharmacokinetics|pharmacokinetics
150567|NCT03258762|pyrimethamine|pyrimethamine
150568|NCT03258762|toxoplasmosis|toxoplasmosis
150569|NCT03258749|COPD|copd
150570|NCT03258749|GOLD|gold
150571|NCT03258749|formoterol|formoterol
150572|NCT03258749|tiotropium|tiotropium
150573|NCT03258736|pediatric, inguinal hernia, caudal, ilioinguinal/ilioihypogastric|pediatric, inguinal hernia, caudal, ilioinguinal/ilioihypogastric
150574|NCT03258710|Tenofovir Disoproxil Fumarate|tenofovir disoproxil fumarate
150575|NCT03258710|safety|safety
150576|NCT03258710|chronic hepatitis B|chronic hepatitis b
150577|NCT03258710|virological effect|virological effect
150578|NCT03258697|Local analgesia, Pharmacokinetics, Total joint replacement|local analgesia, pharmacokinetics, total joint replacement
150579|NCT03258684|corticosteroid|corticosteroid
150580|NCT03258684|hydrocortisone|hydrocortisone
150581|NCT03258684|septic shock|septic shock
150582|NCT03258684|thiamine|thiamine
150583|NCT03258684|vitamin C|vitamin c
150584|NCT03258658|Urethral Stricture|urethral stricture
150585|NCT03258632|Alcohol Use Disorder|alcohol use disorder
150586|NCT03258606|Surrogate|surrogate
150587|NCT03258606|Decision Making|decision making
150588|NCT03258606|Capacity to Consent|capacity to consent
150589|NCT03258606|Cognitive Impairment|cognitive impairment
150590|NCT03258606|Enrollment|enrollment
150591|NCT03258593|Carcinoma-in-situ|carcinoma-in-situ
150592|NCT03258593|High-grade Ta or T1 disease|high-grade ta or t1 disease
150593|NCT03258593|Papillary Tumors|papillary tumors
150594|NCT03258580|Pain|pain
150595|NCT03258580|Visual Analogue Pain Scale|visual analogue pain scale
150596|NCT03258580|Healthy Volunteer|healthy volunteer
150597|NCT03258580|Social Cognition|social cognition
150598|NCT03258580|Eye Movement|eye movement
150599|NCT03258567|Monoclonal Antibody|monoclonal antibody
150600|NCT03258541|TraceIT®|traceit®
150601|NCT03258541|Hydrogel spacer|hydrogel spacer
150602|NCT03258541|Rectal cancer|rectal cancer
150603|NCT03258515|Mesenchymal epithelial transition (MET) receptor|mesenchymal epithelial transition (met) receptor
150604|NCT03258515|Small molecule kinase inhibitors|small molecule kinase inhibitors
150605|NCT03258515|Moxifloxacin (Avelox)|moxifloxacin (avelox)
150606|NCT03258515|QT prolongation|qt prolongation
150607|NCT03258437|sperm motility, Clinical Trial , DA-9401|sperm motility, clinical trial , da-9401
150608|NCT03258385|Vitamin B12, Fortified milk, Immunity, Child development|vitamin b12, fortified milk, immunity, child development
150609|NCT03258359|MDS|mds
150610|NCT03258346|Pomegranate Juice|pomegranate juice
150611|NCT03258346|Functional Tasks of Living|functional tasks of living
150612|NCT03258333|aortic stenosis, aortic valve replacement, pericardium|aortic stenosis, aortic valve replacement, pericardium
150613|NCT03258320|Cabazitaxel|cabazitaxel
150614|NCT03258320|Docetaxel|docetaxel
150615|NCT03258320|Mitoxantrone|mitoxantrone
150616|NCT03258320|Satraplatin|satraplatin
150617|NCT03258320|Surgery|surgery
150618|NCT03258320|Prostate Cancer|prostate cancer
150619|NCT03258320|Localized|localized
150620|NCT03258320|High Risk|high risk
150621|NCT03258294|melatonin|melatonin
150622|NCT03258294|sleep disturbances|sleep disturbances
150623|NCT03258229|Angelica gigas N. extract|angelica gigas n. extract
150624|NCT03258229|Glucose|glucose
150625|NCT03258229|Clinical Trial|clinical trial
150626|NCT03258216|Upper gastrointestinal disorders|upper gastrointestinal disorders
150627|NCT03258216|Automatic tongue diagnosis system|automatic tongue diagnosis system
150628|NCT03258216|Panendoscopy|panendoscopy
150629|NCT03258190|Urolithiasis|urolithiasis
150630|NCT03258190|Recurrence|recurrence
150631|NCT03258190|Citrate|citrate
150632|NCT03258190|Antioxidants|antioxidants
150633|NCT03258190|Lime Powder Regimen|lime powder regimen
150634|NCT03258177|Virtual Visits|virtual visits
150635|NCT03258177|Telehealth|telehealth
150636|NCT03258138|Pragmatic|pragmatic
150637|NCT03258138|Pilot study|pilot study
150638|NCT03258138|Mixed methods|mixed methods
150639|NCT03258138|Randomized controlled trial|randomized controlled trial
150640|NCT03258138|Implementation research|implementation research
150641|NCT03258138|Person-centered care|person-centered care
150642|NCT03258138|Multidisciplinary|multidisciplinary
150643|NCT03258138|Ecological approach|ecological approach
150644|NCT03258073|maternal|maternal
150645|NCT03258073|newborn|newborn
150646|NCT03258073|resuscitation|resuscitation
150647|NCT03258073|emergencies|emergencies
150648|NCT03258073|medical simulation|medical simulation
150649|NCT03258060|Heart Failure|heart failure
150650|NCT03258060|Pacing|pacing
150651|NCT03258060|Resynchronization|resynchronization
150652|NCT03258060|Electrophysiology|electrophysiology
150653|NCT03258060|Imaging|imaging
150654|NCT03258060|Cardiac Resynchronization Therapy|cardiac resynchronization therapy
150655|NCT03258034|Conversion therapy|conversion therapy
150656|NCT03258021|Glioblastoma|glioblastoma
150657|NCT03258021|GBM|gbm
150658|NCT03258021|Tumor-treating fields|tumor-treating fields
150659|NCT03258021|TTFields|ttfields
150660|NCT03258008|Malignant neoplasms of lip oral cavity and pharynx|malignant neoplasms of lip oral cavity and pharynx
150661|NCT03258008|Malignant neoplasms of ill-defined secondary and unspecified sites|malignant neoplasms of ill-defined secondary and unspecified sites
150662|NCT03258008|Oropharyngeal Cancer|oropharyngeal cancer
150663|NCT03258008|Oropharyngeal squamous cell carcinoma|oropharyngeal squamous cell carcinoma
150664|NCT03258008|OPSCC|opscc
150665|NCT03258008|Human Papillomavirus - positive (HPV+)|human papillomavirus - positive (hpv+)
150666|NCT03258008|Utomilumab|utomilumab
150667|NCT03258008|PF-05082566|pf-05082566
150668|NCT03258008|Anti-CD137|anti-cd137
150669|NCT03258008|ISA101b|isa101b
150670|NCT03257995|asthma, asthma attack, difficulty breathing, bronchial diseases, lung, lung diseases, inhaled drugs, bronchodilator, inhaled corticosteriod|asthma, asthma attack, difficulty breathing, bronchial diseases, lung, lung diseases, inhaled drugs, bronchodilator, inhaled corticosteriod
150671|NCT03257982|Brain-computer interface|brain-computer interface
150672|NCT03257982|Functional electrical stimulation|functional electrical stimulation
150673|NCT03257969|Oral chemotherapy|oral chemotherapy
150674|NCT03257969|Health related program|health related program
150675|NCT03257969|Secured drug intake|secured drug intake
150676|NCT03257969|Pharmacist intervention|pharmacist intervention
150677|NCT03257969|Cancer outpatient|cancer outpatient
150678|NCT03257956|Vital Sign|vital sign
150679|NCT03257956|Vigilance System|vigilance system
150680|NCT03257956|Heart Rate|heart rate
150681|NCT03257956|Respiratory Rate|respiratory rate
150682|NCT03257917|Financial Burden|financial burden
150683|NCT03257917|Out of Pocket expenses|out of pocket expenses
150684|NCT03257917|Time spent on Healthcare|time spent on healthcare
150685|NCT03257917|Metastatic Breast Cancer|metastatic breast cancer
150686|NCT03257904|intracranial pressure|intracranial pressure
150687|NCT03257891|Adrenocortical Carcinoma|adrenocortical carcinoma
150688|NCT03257891|Cabazitaxel|cabazitaxel
150689|NCT03257865|Brexpiprazole|brexpiprazole
150690|NCT03257865|Bipolar|bipolar
150691|NCT03257865|Manic episode|manic episode
150692|NCT03257852|Methotrexate|methotrexate
150693|NCT03257852|Arthritis, Rheumatoid|arthritis, rheumatoid
150694|NCT03257852|ASP5094|asp5094
150695|NCT03257839|SoftVue|softvue
150696|NCT03257839|Dense Breast Tissue|dense breast tissue
150697|NCT03257839|Breast Screening|breast screening
150698|NCT03257839|Abnormal Breast|abnormal breast
150699|NCT03257839|Normal Breast|normal breast
150700|NCT03257839|Breast Imaging|breast imaging
150701|NCT03257839|Breast Biopsy|breast biopsy
150702|NCT03257839|Mammography|mammography
150703|NCT03257839|Tomosynthesis|tomosynthesis
150704|NCT03257839|Automated Breast Ultrasound|automated breast ultrasound
150705|NCT03257839|Breast Cancer|breast cancer
150706|NCT03257839|Breast Carcinoma|breast carcinoma
150707|NCT03257839|Breast Tumors|breast tumors
150708|NCT03257839|Mammary Carcinoma|mammary carcinoma
150709|NCT03257839|Malignant Breast Tumor|malignant breast tumor
150710|NCT03257839|Mammary Neoplasm|mammary neoplasm
150711|NCT03257839|Mammary Cancer|mammary cancer
150712|NCT03257839|ABUS|abus
150713|NCT03257839|AWBUS|awbus
150714|NCT03257839|Breast Tomography|breast tomography
150715|NCT03257839|ATUS|atus
150716|NCT03257839|ABTUS|abtus
150717|NCT03257839|Mammogram|mammogram
150718|NCT03257839|3D Mammogram|3d mammogram
150719|NCT03257839|3D ABUS|3d abus
150720|NCT03257839|3D Breast Ultrasound|3d breast ultrasound
150721|NCT03257839|DBT|dbt
150722|NCT03257839|FFDM|ffdm
150723|NCT03257839|Digital Mammography|digital mammography
150724|NCT03257839|Breast Ultrasound|breast ultrasound
150725|NCT03257839|Dense Breasts|dense breasts
150726|NCT03257839|Breast Density|breast density
150727|NCT03257839|Dense Parenchyma|dense parenchyma
150728|NCT03257839|Asymptomatic|asymptomatic
150729|NCT03257839|Delphinus|delphinus
150730|NCT03257839|Delphinus Medical Technologies|delphinus medical technologies
150731|NCT03257839|Screening Breast Ultrasound|screening breast ultrasound
150732|NCT03257826|congenital pseudarthrosis of the tibia|congenital pseudarthrosis of the tibia
150733|NCT03257826|age of surgery|age of surgery
150734|NCT03257826|Percutaneous Kirschner wire|percutaneous kirschner wire
150735|NCT03257813|timolol|timolol
150736|NCT03257813|dorzolamide|dorzolamide
150737|NCT03257813|brimonidine|brimonidine
150738|NCT03257813|Glaucoma|glaucoma
150739|NCT03257813|Ocular hypertension|ocular hypertension
150740|NCT03257800|ketamine|ketamine
150741|NCT03257800|Propofol|propofol
150742|NCT03257800|laryngeal masks|laryngeal masks
150743|NCT03257800|anesthesia|anesthesia
150744|NCT03257800|child|child
150745|NCT03257722|Non Small Cell Lung Cancer|non small cell lung cancer
150746|NCT03257722|Metastasis|metastasis
150747|NCT03257722|Recurrence|recurrence
150748|NCT03257722|Immunotherapy|immunotherapy
150749|NCT03257670|Dyspareunia|dyspareunia
150750|NCT03257670|Laser|laser
150751|NCT03257670|CO2|co2
150752|NCT03257670|Breast Cancer|breast cancer
150753|NCT03257670|Vaginal Atrophy|vaginal atrophy
150754|NCT03257670|Lidocaine|lidocaine
150755|NCT03257644|Atopic dermatitis|atopic dermatitis
150756|NCT03257644|Janus kinase (JAK) inhibitor|janus kinase (jak) inhibitor
150757|NCT03257644|pediatric|pediatric
150758|NCT03257644|inflammation|inflammation
150759|NCT03257631|Pediatric|pediatric
150760|NCT03257631|Brain Tumor|brain tumor
150761|NCT03257631|Central Nervous System Neoplasms|central nervous system neoplasms
150762|NCT03257631|Glioma|glioma
150763|NCT03257631|High-grade glioma|high-grade glioma
150764|NCT03257631|HGG|hgg
150765|NCT03257631|Ependymoma|ependymoma
150766|NCT03257631|Medulloblastoma|medulloblastoma
150767|NCT03257631|DIPG|dipg
150768|NCT03257631|Diffuse intrinsic pontine gliomaProgressive|diffuse intrinsic pontine gliomaprogressive
150769|NCT03257631|RecurrentPomalidomide|recurrentpomalidomide
150770|NCT03257631|PomalystImnovid|pomalystimnovid
150771|NCT03257631|CC-4047|cc-4047
150772|NCT03257631|Children|children
150773|NCT03257605|Pharmacogenomics|pharmacogenomics
150774|NCT03257605|Medication Therapy Management|medication therapy management
150775|NCT03257579|Myocardial Infarction|myocardial infarction
150776|NCT03257579|Adherence|adherence
150777|NCT03257579|Medication|medication
150778|NCT03257540|bunion|bunion
150779|NCT03257540|early weight-bearing|early weight-bearing
150780|NCT03257540|Lapidus|lapidus
150781|NCT03257540|arthrodesis|arthrodesis
150782|NCT03257540|intramedullary nail|intramedullary nail
150783|NCT03257540|Hallux Valgus|hallux valgus
150784|NCT03257527|Well-being|well-being
150785|NCT03257527|Comparative Clinical Trial|comparative clinical trial
150786|NCT03257527|Positive Psychology Intervention|positive psychology intervention
150787|NCT03257527|Mindfulness Based Stress Reduction (MBSR)|mindfulness based stress reduction (mbsr)
150788|NCT03257527|Group Therapy|group therapy
150789|NCT03257527|Happiness|happiness
150790|NCT03257527|Bibliotherapy|bibliotherapy
150791|NCT03257475|cervical cance|cervical cance
150792|NCT03257475|vaginal radiation injury|vaginal radiation injury
150793|NCT03257475|PIBS|pibs
150794|NCT03257475|R-V|r-v
150795|NCT03257475|VRL|vrl
150796|NCT03257462|17-hydroxyprogesterone|17-hydroxyprogesterone
150797|NCT03257449|Body Weight|body weight
150798|NCT03257449|Weight loss|weight loss
150799|NCT03257449|BMI|bmi
150800|NCT03257449|Waist Circumference|waist circumference
150801|NCT03257449|Body Fat Percentage|body fat percentage
150802|NCT03257449|Viscofiber|viscofiber
150803|NCT03257449|Viscous Fibres|viscous fibres
150804|NCT03257449|supplement|supplement
150805|NCT03257436|Pacing|pacing
150806|NCT03257423|Uncomplicated acute appendicitis|uncomplicated acute appendicitis
150807|NCT03257423|Complicated acute appendicitis|complicated acute appendicitis
150808|NCT03257423|Antibiotic therapy|antibiotic therapy
150809|NCT03257423|Microbiological etiology|microbiological etiology
150810|NCT03257358|Relapsing Multiple Sclerosis|relapsing multiple sclerosis
150811|NCT03257358|RMS|rms
150812|NCT03257358|Relapsing Multiple Sclerosis (RMS)|relapsing multiple sclerosis (rms)
150813|NCT03257358|Multiple Sclerosis|multiple sclerosis
150814|NCT03257358|MS|ms
150815|NCT03257358|Multiple Sclerosis (MS)|multiple sclerosis (ms)
150816|NCT03257358|Fingolimod|fingolimod
150817|NCT03257358|FLUENT|fluent
150818|NCT03257358|Immune Phenotype|immune phenotype
150819|NCT03257345|Real world outcomes|real world outcomes
150820|NCT03257332|Rectum cancer|rectum cancer
150821|NCT03257332|Low Anterior Rectal Syndrome|low anterior rectal syndrome
150822|NCT03257332|Anorectal muscle function|anorectal muscle function
150823|NCT03257306|Urinary tract stone|urinary tract stone
150824|NCT03257306|ureter double-J stent|ureter double-j stent
150825|NCT03257254|GSV|gsv
150826|NCT03257254|AASV|aasv
150827|NCT03257254|Vein|vein
150828|NCT03257254|Venous|venous
150829|NCT03257254|Ulcer|ulcer
150830|NCT03257254|Varicose Vein|varicose vein
150831|NCT03257254|VLU|vlu
150832|NCT03257254|venous insufficiency|venous insufficiency
150833|NCT03257254|venous disease|venous disease
150834|NCT03257254|chronic VLU|chronic vlu
150835|NCT03257241|aml|aml
150836|NCT03257241|acute myeloid leukemia|acute myeloid leukemia
150837|NCT03257241|DAC|dac
150838|NCT03257241|DA-90|da-90
150839|NCT03257241|FLAG-IDA|flag-ida
150840|NCT03257241|CLAG-M|clag-m
150841|NCT03257241|Ara-C|ara-c
150842|NCT03257241|HiDAC|hidac
150843|NCT03257215|Vitamin D|vitamin d
150844|NCT03257202|Propionibacterium Acnes|propionibacterium acnes
150845|NCT03257202|Surgical Site Infection|surgical site infection
150846|NCT03257202|Shoulder|shoulder
150847|NCT03257137|sleep|sleep
150848|NCT03257137|macronutrients|macronutrients
150849|NCT03257137|dietary patterns|dietary patterns
150850|NCT03257137|sleep quality|sleep quality
150851|NCT03257137|diet quality|diet quality
150852|NCT03257137|polysomnography|polysomnography
150853|NCT03257137|appetite|appetite
150854|NCT03257137|mood|mood
150855|NCT03257137|hunger|hunger
150856|NCT03257111|rehabilitation outcomes|rehabilitation outcomes
150857|NCT03257111|activity level|activity level
150858|NCT03257098|Chronic Venous Ulcer|chronic venous ulcer
150859|NCT03257098|ABCB5|abcb5
150860|NCT03257098|Allogeneic|allogeneic
150861|NCT03257098|Mesenchymal stem cells|mesenchymal stem cells
150862|NCT03257098|varicose ulcer|varicose ulcer
150863|NCT03257098|skin ulcer|skin ulcer
150864|NCT03257098|advanced therapy medicinal product|advanced therapy medicinal product
150865|NCT03257098|somatic cell therapy|somatic cell therapy
150866|NCT03257098|phase I/IIa|phase i/iia
150867|NCT03257072|hookworm|hookworm
150868|NCT03257072|controlled human infection model|controlled human infection model
150869|NCT03257020|OCT|oct
150870|NCT03257020|RNFL|rnfl
150871|NCT03257020|BMO-MRW|bmo-mrw
150872|NCT03257020|Glaucoma|glaucoma
150873|NCT03256981|SBRT|sbrt
150874|NCT03256981|Oligoprogressive disease|oligoprogressive disease
150875|NCT03256981|NSCLC|nsclc
150876|NCT03256981|TKI|tki
150877|NCT03256955|Validation study for a neuromuscular monitoring device|validation study for a neuromuscular monitoring device
150878|NCT03256929|Personalized Diet|personalized diet
150879|NCT03256929|Microbiota|microbiota
150880|NCT03256929|Depression|depression
150881|NCT03256929|Elderly|elderly
150882|NCT03256929|Gut flora|gut flora
150883|NCT03256916|Cervical cancer|cervical cancer
150884|NCT03256903|Methoxyflurane|methoxyflurane
150885|NCT03256903|emergency|emergency
150886|NCT03256903|trauma pain|trauma pain
150887|NCT03256903|inhaled analgesia|inhaled analgesia
150888|NCT03256890|mindfulness|mindfulness
150889|NCT03256890|blood pressure|blood pressure
150890|NCT03256890|hypertension|hypertension
150891|NCT03256890|prehypertension|prehypertension
150892|NCT03256890|self regulation|self regulation
150893|NCT03256890|Science of Behavior Change|science of behavior change
150894|NCT03256890|attention control|attention control
150895|NCT03256890|self awareness|self awareness
150896|NCT03256890|emotion regulation|emotion regulation
150897|NCT03256838|Citric Acid|citric acid
150898|NCT03256838|Ferric Compounds|ferric compounds
150899|NCT03256838|Renal Insufficiency|renal insufficiency
150900|NCT03256838|Anticoagulants|anticoagulants
150901|NCT03256838|Calcium Chelating Agents|calcium chelating agents
150902|NCT03256838|Chelating Agents|chelating agents
150903|NCT03256838|Sequestering Agents|sequestering agents
150904|NCT03256838|Hemodialysis|hemodialysis
150905|NCT03256838|Dialysis|dialysis
150906|NCT03256838|Renal Failure|renal failure
150907|NCT03256838|Kidney Failure|kidney failure
150908|NCT03256838|Urologic Diseases|urologic diseases
150909|NCT03256838|Metabolic Disease|metabolic disease
150910|NCT03256838|Kidney Diseases|kidney diseases
150911|NCT03256838|Renal Insufficiency, Chronic|renal insufficiency, chronic
150912|NCT03256825|Diagnostic accuracy|diagnostic accuracy
150913|NCT03256825|Anti-bacterial agents|anti-bacterial agents
150914|NCT03256825|Decision support systems, clinical|decision support systems, clinical
150915|NCT03256812|Arrhythmias, Atrial Fibrillation|arrhythmias, atrial fibrillation
150916|NCT03256786|cesarean delivery with spinal anesthesia|cesarean delivery with spinal anesthesia
150917|NCT03256786|Hypothermia and shivering|hypothermia and shivering
150918|NCT03256786|Active warming|active warming
150919|NCT03256760|Insomnia, depression|insomnia, depression
150920|NCT03256747|Diabetes Mellitus|diabetes mellitus
150921|NCT03256747|Diabetes Mellitus, Type 2|diabetes mellitus, type 2
150922|NCT03256747|Glucose Metabolism Disorders|glucose metabolism disorders
150923|NCT03256747|Metabolic Diseases|metabolic diseases
150924|NCT03256747|Endocrine System Diseases|endocrine system diseases
150925|NCT03256721|apatinib docetaxel pemetrexed|apatinib docetaxel pemetrexed
150926|NCT03256708|antibiotic-associated diarrhea|antibiotic-associated diarrhea
150927|NCT03256708|probiotic|probiotic
150928|NCT03256708|prebiotic|prebiotic
150929|NCT03256708|placebo|placebo
150930|NCT03256708|synbiotic|synbiotic
150931|NCT03256682|Resilience|resilience
150932|NCT03256682|Mobile video counseling|mobile video counseling
150933|NCT03256682|Emotiona labor|emotiona labor
150934|NCT03256643|traumatic brain injury|traumatic brain injury
150935|NCT03256643|brain contusion|brain contusion
150936|NCT03256643|craniocerebral trauma|craniocerebral trauma
150937|NCT03256643|exercise therapy|exercise therapy
150938|NCT03256643|chronic brain injury|chronic brain injury
150939|NCT03256643|environment impact|environment impact
150940|NCT03256643|cognitive therapy|cognitive therapy
150941|NCT03256643|health facility environment|health facility environment
150942|NCT03256630|Active Surveillance|active surveillance
150943|NCT03256630|Radical Prostatectomy|radical prostatectomy
150944|NCT03256617|low back pain|low back pain
150945|NCT03256617|cognitive reassurance|cognitive reassurance
150946|NCT03256617|physical therapist training|physical therapist training
150947|NCT03256604|point of care, HGF, innate immunity|point of care, hgf, innate immunity
150948|NCT03256578|Resuscitation|resuscitation
150949|NCT03256578|Neonatal Prematurity|neonatal prematurity
150950|NCT03256578|Positive-Pressure Ventilation|positive-pressure ventilation
150951|NCT03256578|Respiratory Function Monitor|respiratory function monitor
150952|NCT03256461|sepsis|sepsis
150953|NCT03256461|lactate clearance|lactate clearance
150954|NCT03256461|protocolized resuscitation|protocolized resuscitation
150955|NCT03256422|Controlled, virological and therapeutic success, treatment discontinution, 4 days per week|controlled, virological and therapeutic success, treatment discontinution, 4 days per week
150956|NCT03256409|biomaterials|biomaterials
150957|NCT03256409|methacrylates|methacrylates
150958|NCT03256409|microbiology|microbiology
150959|NCT03256409|implant dentistry/implantology|implant dentistry/implantology
150960|NCT03256409|removable prosthodontics|removable prosthodontics
150961|NCT03256409|clinical studies/trials|clinical studies/trials
151149|NCT03255148|oxytocin|oxytocin
150962|NCT03256396|Intraoperative mechanical ventilation|intraoperative mechanical ventilation
150963|NCT03256396|Positive-end expiratory pressure|positive-end expiratory pressure
150964|NCT03256396|Esophageal pressure|esophageal pressure
150965|NCT03256396|Transpulmonary pressure|transpulmonary pressure
150966|NCT03256396|Laparoscopic gynecologic surgery|laparoscopic gynecologic surgery
150967|NCT03256370|Allergic manifestation, Human milk oligosaccharides, Breast Milk|allergic manifestation, human milk oligosaccharides, breast milk
150968|NCT03256357|unilateral cerebral palsy|unilateral cerebral palsy
150969|NCT03256357|upper limb rehabilitation|upper limb rehabilitation
150970|NCT03256344|Liver Metastases|liver metastases
150971|NCT03256305|Repetitive transcranial magnetic stimulation|repetitive transcranial magnetic stimulation
150972|NCT03256279|Orthodontic Wires|orthodontic wires
150973|NCT03256279|Alloys/therapeutic use|alloys/therapeutic use
150974|NCT03256279|Orthodontics, corrective|orthodontics, corrective
150975|NCT03256253|alcohol use disorder|alcohol use disorder
150976|NCT03256253|alcohol abuse|alcohol abuse
150977|NCT03256253|treatment|treatment
150978|NCT03256253|lyrica|lyrica
150979|NCT03256240|Crohn's recurrence|crohn's recurrence
150980|NCT03256227|Posttraumatic Stress Disorder|posttraumatic stress disorder
150981|NCT03256227|family therapy|family therapy
150982|NCT03256227|patient adherence|patient adherence
150983|NCT03256227|Prolonged Exposure Therapy|prolonged exposure therapy
150984|NCT03256201|Cancer|cancer
150985|NCT03256201|prehabilitation|prehabilitation
150986|NCT03256201|sarcopenia|sarcopenia
150987|NCT03256188|classroom|classroom
150988|NCT03256188|prolonged sitting|prolonged sitting
150989|NCT03256188|sedentary time|sedentary time
150990|NCT03256188|time-on-task|time-on-task
150991|NCT03256188|children|children
150992|NCT03256175|Myocardial Protection|myocardial protection
150993|NCT03256175|Oxygen|oxygen
150994|NCT03256175|Exercise Test|exercise test
150995|NCT03256162|ketamine|ketamine
150996|NCT03256162|glutamate|glutamate
150997|NCT03256136|Lung Cancer|lung cancer
150998|NCT03256123|Vitamin A Deficiency|vitamin a deficiency
150999|NCT03256123|Iron Deficiency|iron deficiency
151000|NCT03256123|Parasite|parasite
151001|NCT03256123|Gut Microbiota|gut microbiota
151002|NCT03256123|Red palm oil|red palm oil
151003|NCT03256110|Advance Care Planning|advance care planning
151004|NCT03256110|Palliative Care|palliative care
151005|NCT03256110|Indians, North American|indians, north american
151006|NCT03256110|Alaska Natives|alaska natives
151007|NCT03256110|Health Communication|health communication
151008|NCT03256110|Primary Health Care|primary health care
151009|NCT03256097|Sound processing strategy|sound processing strategy
151010|NCT03256019|intubation|intubation
151011|NCT03256019|Cardiopulmonary Resuscitation|cardiopulmonary resuscitation
151012|NCT03256006|sport exercise|sport exercise
151013|NCT03256006|ultra endurance|ultra endurance
151014|NCT03255954|Interpersonal Counseling|interpersonal counseling
151015|NCT03255941|LHV (Lady Health Visitor)|lhv (lady health visitor)
151016|NCT03255941|LHW (Lady Health Worker|lhw (lady health worker
151017|NCT03255941|DMPA (Depot medroxyprogesterone acetate or Depo Provera)|dmpa (depot medroxyprogesterone acetate or depo provera)
151018|NCT03255941|DMPA IM (Depo Provera intramuscular injection)|dmpa im (depo provera intramuscular injection)
151019|NCT03255941|SP (Sayana Press subcutaneous injection)|sp (sayana press subcutaneous injection)
151020|NCT03255941|Contraception|contraception
151021|NCT03255941|CBA2I (Community-based access to injectables)|cba2i (community-based access to injectables)
151022|NCT03255941|Sayana (Sayana Press)|sayana (sayana press)
151023|NCT03255941|JHPIEGO (Johns Hopkins Program for International Education in Gynaecology and Obstetrics)|jhpiego (johns hopkins program for international education in gynaecology and obstetrics)
151024|NCT03255941|Sayana|sayana
151025|NCT03255928|Platelet activation|platelet activation
151026|NCT03255928|Ventricular Assist Device|ventricular assist device
151027|NCT03255928|Thrombosis|thrombosis
151028|NCT03255928|Bleeding|bleeding
151029|NCT03255928|Antithrombotic Pharmacological Therapy|antithrombotic pharmacological therapy
151030|NCT03255928|Mechanical Circulatory Support|mechanical circulatory support
151031|NCT03255915|HIV Prevention|hiv prevention
151032|NCT03255915|Intravaginal Ring|intravaginal ring
151033|NCT03255915|Tenofovir Disoproxil Fumarate|tenofovir disoproxil fumarate
151034|NCT03255915|Emtricitabine|emtricitabine
151035|NCT03255902|Diabetes|diabetes
151036|NCT03255889|Safety|safety
151037|NCT03255889|Tolerability|tolerability
151038|NCT03255889|Pharmacokinetics|pharmacokinetics
151039|NCT03255889|Absorption|absorption
151040|NCT03255876|Polyphenols|polyphenols
151041|NCT03255876|Hyperglycemia|hyperglycemia
151042|NCT03255876|Postprandial|postprandial
151043|NCT03255876|Starch|starch
151044|NCT03255876|Alpha-amylase|alpha-amylase
151045|NCT03255863|Psychological Theory|psychological theory
151046|NCT03255850|adolescents|adolescents
151047|NCT03255850|quality of life|quality of life
151048|NCT03255850|psychological well-being|psychological well-being
151049|NCT03255837|Transcranial Stimulation|transcranial stimulation
151050|NCT03255837|Memory|memory
151051|NCT03255824|Oral Surgery|oral surgery
151052|NCT03255824|Third Molars|third molars
151053|NCT03255824|Intravenous Sedation|intravenous sedation
151054|NCT03255824|Dexmedetomidine|dexmedetomidine
151055|NCT03255811|Advanced gastric cancer apatinib Maintenance therapy|advanced gastric cancer apatinib maintenance therapy
151056|NCT03255772|Magnetocardiography|magnetocardiography
151057|NCT03255772|Chest pain|chest pain
151058|NCT03255733|Chronic Lateral Epicondylitis|chronic lateral epicondylitis
151059|NCT03255733|Tennis Elbow|tennis elbow
151060|NCT03255733|Intense Therapeutic Ultrasound (ITU)|intense therapeutic ultrasound (itu)
151061|NCT03255733|Guided Therapy Systems (GTS)|guided therapy systems (gts)
151062|NCT03255733|Ardent Sound, Inc.|ardent sound, inc.
151063|NCT03255733|Actisound|actisound
151064|NCT03255707|Amblyopia|amblyopia
151065|NCT03255707|Interactive Binocular Treatment|interactive binocular treatment
151066|NCT03255707|Dissociative Treatment|dissociative treatment
151067|NCT03255707|Occlusion|occlusion
151068|NCT03255707|Patching|patching
151069|NCT03255681|Cosmetics|cosmetics
151070|NCT03255681|Filler|filler
151071|NCT03255668|Mercaptopurine, acute lymphoblastic leukemia, hematotoxicity|mercaptopurine, acute lymphoblastic leukemia, hematotoxicity
151072|NCT03255655|Chronic Plantar Fasciitis|chronic plantar fasciitis
151073|NCT03255655|Plantar Fascia Pain|plantar fascia pain
151074|NCT03255655|Intense Therapeutic Ultrasound (ITU)|intense therapeutic ultrasound (itu)
151075|NCT03255655|Guided Therapy Systems (GTS)|guided therapy systems (gts)
151076|NCT03255655|Ardent Sound, Inc.|ardent sound, inc.
151077|NCT03255655|Actisound|actisound
151078|NCT03255642|Clonazepam|clonazepam
151079|NCT03255642|Melatonin|melatonin
151080|NCT03255642|Treatment|treatment
151081|NCT03255642|REM Sleep Behavior Disorder|rem sleep behavior disorder
151082|NCT03255603|Resistant Starch|resistant starch
151083|NCT03255603|Dietary Fiber|dietary fiber
151084|NCT03255603|Gastrointestinal Microbiome|gastrointestinal microbiome
151085|NCT03255603|Gastrointestinal Tolerance|gastrointestinal tolerance
151086|NCT03255590|motor recovery|motor recovery
151087|NCT03255590|transcranial magnetic stimulation|transcranial magnetic stimulation
151088|NCT03255590|motor learning|motor learning
151089|NCT03255590|ischemic Stroke|ischemic stroke
151090|NCT03255577|Sentinel Lymph Node Biopsy|sentinel lymph node biopsy
151091|NCT03255577|17-384|17-384
151092|NCT03255538|patellar tendon|patellar tendon
151093|NCT03255499|cognitive training|cognitive training
151094|NCT03255499|physical exercise|physical exercise
151095|NCT03255499|brain dynamics|brain dynamics
151096|NCT03255499|cognitive abilities|cognitive abilities
151097|NCT03255499|physiological markers|physiological markers
151098|NCT03255460|Multiple Sclerosis|multiple sclerosis
151099|NCT03255460|Fatigue|fatigue
151100|NCT03255460|Physical Activity|physical activity
151101|NCT03255460|Exercise|exercise
151102|NCT03255447|Idiopathic Membranous Nephropathy|idiopathic membranous nephropathy
151103|NCT03255447|Primary Membranous Nephropathy|primary membranous nephropathy
151104|NCT03255447|Immunoadsorption|immunoadsorption
151105|NCT03255447|Apharesis|apharesis
151106|NCT03255421|urodynamic|urodynamic
151107|NCT03255421|backwards cystometry|backwards cystometry
151108|NCT03255421|reverse cystometry|reverse cystometry
151109|NCT03255421|follow-up|follow-up
151110|NCT03255395|MRI|mri
151111|NCT03255395|Ultrasound|ultrasound
151112|NCT03255395|Phantom Limb Pain|phantom limb pain
151113|NCT03255395|Residual Limb Pain|residual limb pain
151114|NCT03255395|Neuroma|neuroma
151115|NCT03255382|ABBV-0066|abbv-0066
151116|NCT03255382|BI 655066|bi 655066
151117|NCT03255382|risankizumab|risankizumab
151118|NCT03255369|Zika virus|zika virus
151119|NCT03255369|Microcephaly|microcephaly
151120|NCT03255369|Child|child
151121|NCT03255369|pregnancy|pregnancy
151122|NCT03255356|Postoperative pulmonary complications|postoperative pulmonary complications
151123|NCT03255356|Protective mechanical ventilation|protective mechanical ventilation
151124|NCT03255356|Alveolar lung recruitment manoeuvres|alveolar lung recruitment manoeuvres
151125|NCT03255356|Cardiac Surgery Procedures|cardiac surgery procedures
151126|NCT03255317|Substance use, youth, mobile health, data collection adherence, user engagement|substance use, youth, mobile health, data collection adherence, user engagement
151127|NCT03255278|Tuberculosis|tuberculosis
151128|NCT03255278|Recombinant vaccine|recombinant vaccine
151129|NCT03255278|Mycobacterium tuberculosis|mycobacterium tuberculosis
151130|NCT03255265|organ transplantation|organ transplantation
151131|NCT03255265|cfDNA|cfdna
151132|NCT03255265|microchimerism|microchimerism
151133|NCT03255265|acute rejection|acute rejection
151134|NCT03255239|ventral hernia|ventral hernia
151135|NCT03255239|Open mesh repair|open mesh repair
151136|NCT03255239|Polyester mesh|polyester mesh
151137|NCT03255239|Preperitoneal|preperitoneal
151138|NCT03255239|Retromuscular|retromuscular
151139|NCT03255187|Biomarker|biomarker
151140|NCT03255187|Fish oil|fish oil
151141|NCT03255187|Oxidative stress|oxidative stress
151142|NCT03255187|Air pollution|air pollution
151143|NCT03255187|Cardiopulmonary system|cardiopulmonary system
151144|NCT03255174|Bleeding, hemostasis, re-bleeding, hemostatic|bleeding, hemostasis, re-bleeding, hemostatic
151145|NCT03255148|resting state|resting state
151146|NCT03255148|EEG|eeg
151147|NCT03255148|skin conductance|skin conductance
151148|NCT03255148|heart rate|heart rate
151150|NCT03255109|Lung|lung
151151|NCT03255109|acute|acute
151152|NCT03255109|respiratory|respiratory
151153|NCT03255109|distress|distress
151154|NCT03255109|weaning|weaning
151155|NCT03255109|mechanical ventilation|mechanical ventilation
151156|NCT03255109|respiratory infection|respiratory infection
151157|NCT03255083|Oncology|oncology
151158|NCT03255083|Advanced Non-small Cell Lung Cancer|advanced non-small cell lung cancer
151159|NCT03255083|Inoperable Non-small Cell Lung Cancer|inoperable non-small cell lung cancer
151160|NCT03255083|Metastatic|metastatic
151161|NCT03255083|Non-resectable|non-resectable
151162|NCT03255083|Epidermal growth factor receptor|epidermal growth factor receptor
151163|NCT03255083|EGFR|egfr
151164|NCT03255070|HER2|her2
151165|NCT03255070|Breast Cancer|breast cancer
151166|NCT03255070|ADC|adc
151167|NCT03255070|antibody drug conjugate|antibody drug conjugate
151168|NCT03255070|elevated HER2 expression|elevated her2 expression
151169|NCT03255070|breast neoplasm|breast neoplasm
151170|NCT03255070|stomach neoplasm|stomach neoplasm
151171|NCT03255070|gastrointestinal neoplasm|gastrointestinal neoplasm
151172|NCT03255070|digestive system|digestive system
151173|NCT03255070|breast diseases|breast diseases
151174|NCT03255070|digestive system neoplasm|digestive system neoplasm
151175|NCT03255070|digestive system diseases|digestive system diseases
151176|NCT03255070|stomach diseases|stomach diseases
151177|NCT03255044|statin|statin
151178|NCT03255044|hydrophilic|hydrophilic
151179|NCT03255044|lipophilic|lipophilic
151180|NCT03255031|Ketogenic Diet|ketogenic diet
151181|NCT03255031|Detoxification|detoxification
151182|NCT03255031|Functional MRI|functional mri
151183|NCT03255031|MRI/MRS|mri/mrs
151184|NCT03255031|Alcoholism|alcoholism
151185|NCT03255018|Monoclonal Antibody|monoclonal antibody
151186|NCT03255018|PD-1 Receptor|pd-1 receptor
151187|NCT03255005|obesity|obesity
151188|NCT03255005|endoscopy|endoscopy
151189|NCT03255005|endoscopic sleeve gastroplasty|endoscopic sleeve gastroplasty
151190|NCT03254953|digital health|digital health
151191|NCT03254953|eHealth|ehealth
151192|NCT03254953|technology|technology
151193|NCT03254953|smartphone|smartphone
151194|NCT03254953|obesity|obesity
151195|NCT03254953|overweight|overweight
151196|NCT03254953|weight loss|weight loss
151197|NCT03254953|behavioral intervention|behavioral intervention
151198|NCT03254953|self-monitoring|self-monitoring
151199|NCT03254953|tracking|tracking
151200|NCT03254953|engagement|engagement
151201|NCT03254953|adherence|adherence
151202|NCT03254953|weight change|weight change
151203|NCT03254953|e-mail|e-mail
151204|NCT03254953|mobile application|mobile application
151205|NCT03254953|goal setting|goal setting
151206|NCT03254953|action plan|action plan
151207|NCT03254953|feedback|feedback
151208|NCT03254953|electronic health|electronic health
151209|NCT03254940|text message|text message
151210|NCT03254940|digital health|digital health
151211|NCT03254940|weight loss|weight loss
151212|NCT03254940|personalized|personalized
151213|NCT03254927|Erbitux|erbitux
151214|NCT03254927|Cetuximab|cetuximab
151215|NCT03254927|Oral Cancer|oral cancer
151216|NCT03254927|Oropharyngeal cancer|oropharyngeal cancer
151217|NCT03254927|Laryngeal cancer|laryngeal cancer
151218|NCT03254927|Head and Neck Squamous Cell Carcinoma|head and neck squamous cell carcinoma
151219|NCT03254914|Home Blood Pressure|home blood pressure
151220|NCT03254914|Fimasartan|fimasartan
151221|NCT03254875|Breast cancer, Psychosocial intervention|breast cancer, psychosocial intervention
151222|NCT03254862|Functional electrical stimulation|functional electrical stimulation
151223|NCT03254836|Actigraphy|actigraphy
151224|NCT03254836|Major Depression Inventory (MDI)|major depression inventory (mdi)
151225|NCT03254836|Insomnia Severity Index (ISI)|insomnia severity index (isi)
151226|NCT03254797|Rehabilitation|rehabilitation
151227|NCT03254797|Neurological condition|neurological condition
151228|NCT03254797|Walking ability|walking ability
151229|NCT03254797|Feedback|feedback
151230|NCT03254797|External information|external information
151231|NCT03254771|Knee ostheoartritis|knee ostheoartritis
151232|NCT03254771|Arthroplasty|arthroplasty
151233|NCT03254771|Clinical trial|clinical trial
151234|NCT03254771|Decision aids|decision aids
151235|NCT03254745|Rheumatoid Arthritis|rheumatoid arthritis
151236|NCT03254745|Pakistan|pakistan
151237|NCT03254745|Pharmacist|pharmacist
151238|NCT03254745|Intervention|intervention
151239|NCT03254745|Treatment outcome|treatment outcome
151240|NCT03254719|Low Back Pain|low back pain
151241|NCT03254719|Chiropractic|chiropractic
151242|NCT03254719|Veterans|veterans
151243|NCT03254719|PTSD|ptsd
151244|NCT03254719|Depression|depression
151245|NCT03254719|Anxiety|anxiety
151246|NCT03254706|Dentin adhesive; Non-carious cervical lesions; Longevity.|dentin adhesive; non-carious cervical lesions; longevity.
151247|NCT03254693|Non-carious cervical lesions; Universal system; Longevity.|non-carious cervical lesions; universal system; longevity.
151248|NCT03254680|Turmeric Oil|turmeric oil
151249|NCT03254680|antiseizure medications|antiseizure medications
151250|NCT03254680|ar-turmerone|ar-turmerone
151251|NCT03254615|Plain water|plain water
151252|NCT03254615|Educative strategies|educative strategies
151253|NCT03254615|Effectiveness|effectiveness
151254|NCT03254589|Methotrexate|methotrexate
151255|NCT03254589|Rheumatoid arthritis|rheumatoid arthritis
151256|NCT03254589|Blood pressure|blood pressure
151257|NCT03254589|Arterial stiffness|arterial stiffness
151258|NCT03254589|Cardiovascular risk|cardiovascular risk
151259|NCT03254576|Overweight|overweight
151260|NCT03254576|Obesity|obesity
151261|NCT03254576|Body Mass Index|body mass index
151262|NCT03254576|Weight|weight
151263|NCT03254576|Brain imaging|brain imaging
151264|NCT03254576|Child|child
151265|NCT03254576|Learning|learning
151266|NCT03254550|PrEP|prep
151267|NCT03254524|Epidemiology Research|epidemiology research
151268|NCT03254511|neoadjuvant chemoradiation|neoadjuvant chemoradiation
151269|NCT03254511|pathologic response|pathologic response
151270|NCT03254511|low molecular weight heparin|low molecular weight heparin
151271|NCT03254498|colonic adenoma|colonic adenoma
151272|NCT03254498|serrated polyps|serrated polyps
151273|NCT03254498|caecal intubation time|caecal intubation time
151274|NCT03254498|withdrawal time|withdrawal time
151275|NCT03254498|polyp miss rate|polyp miss rate
151276|NCT03254485|Heart Failure|heart failure
151277|NCT03254485|Cardiovascular|cardiovascular
151278|NCT03254485|HF|hf
151279|NCT03254485|HFpEF|hfpef
151280|NCT03254472|Biological markers|biological markers
151281|NCT03254472|Professional practice|professional practice
151282|NCT03254472|Big data analysis|big data analysis
151283|NCT03254472|Measured concentrations|measured concentrations
151284|NCT03254472|Cardiac markers|cardiac markers
151285|NCT03254472|Troponin|troponin
151286|NCT03254472|NTproBNP|ntprobnp
151287|NCT03254472|Creatinin|creatinin
151288|NCT03254472|INR|inr
151289|NCT03254472|Hemogram|hemogram
151290|NCT03254472|Lipid profile|lipid profile
151291|NCT03254446|Diabetes|diabetes
151292|NCT03254446|Hypertension|hypertension
151293|NCT03254446|Dyslipidemia|dyslipidemia
151294|NCT03254446|Cardiovascular Risk|cardiovascular risk
151295|NCT03254433|Neuroimaging|neuroimaging
151296|NCT03254433|Smoking Cessation|smoking cessation
151297|NCT03254433|Weight Loss|weight loss
151298|NCT03254407|bioequivalent|bioequivalent
151299|NCT03254407|IV/PO switch|iv/po switch
151300|NCT03254407|appropriateness|appropriateness
151301|NCT03254407|clinical pharmacy|clinical pharmacy
151302|NCT03254394|Oxaliplatin|oxaliplatin
151303|NCT03254394|Cold hypersensitivity|cold hypersensitivity
151304|NCT03254394|Neuropathy|neuropathy
151305|NCT03254394|Colorectal cancer|colorectal cancer
151306|NCT03254394|CIPN|cipn
151307|NCT03254394|Neuropathic Pain|neuropathic pain
151308|NCT03254381|cognitive assessment|cognitive assessment
151309|NCT03254381|cognitive function|cognitive function
151310|NCT03254381|community dwelling older people|community dwelling older people
151311|NCT03254381|pre-diabetes|pre-diabetes
151312|NCT03254381|randomized control trial|randomized control trial
151313|NCT03254381|exercise|exercise
151314|NCT03254381|pilot study|pilot study
151315|NCT03254381|feasibility study|feasibility study
151316|NCT03254368|Methionine Aminopeptidase 2 Inhibitor|methionine aminopeptidase 2 inhibitor
151317|NCT03254368|Diabetes Mellitus, Type 2|diabetes mellitus, type 2
151318|NCT03254368|Blood Glucose|blood glucose
151319|NCT03254368|Overweight|overweight
151320|NCT03254368|Obesity|obesity
151321|NCT03254355|avulsion injury|avulsion injury
151322|NCT03254355|urinary incontinence|urinary incontinence
151323|NCT03254355|multimodal physiotherapy|multimodal physiotherapy
151324|NCT03254329|human milk|human milk
151325|NCT03254329|micronutrients|micronutrients
151326|NCT03254329|lactation|lactation
151327|NCT03254329|milk volume|milk volume
151328|NCT03254329|milk composition|milk composition
151329|NCT03254329|reference values|reference values
151330|NCT03254303|Sevoflurane, Catheterization, Anesthetics Inhalation, child|sevoflurane, catheterization, anesthetics inhalation, child
151331|NCT03254277|Broadly Neutralizing Antibody|broadly neutralizing antibody
151332|NCT03254277|3BNC117-LS|3bnc117-ls
151333|NCT03254277|First in Human|first in human
151334|NCT03254277|Dose Escalation|dose escalation
151335|NCT03254225|Hypertension|hypertension
151336|NCT03254225|Elderly|elderly
151337|NCT03254225|Resistance training|resistance training
151338|NCT03254225|Heart rate variability|heart rate variability
151339|NCT03254212|Heart failure|heart failure
151340|NCT03254212|Central sleep apnea|central sleep apnea
151341|NCT03254212|oxygen therapy|oxygen therapy
151342|NCT03254199|Charcot-Marie-Tooth|charcot-marie-tooth
151343|NCT03254199|CMT|cmt
151344|NCT03254199|Muscle Cramps|muscle cramps
151345|NCT03254199|Muscle Cramping|muscle cramping
151346|NCT03254199|FLX-787|flx-787
151347|NCT03254199|Hereditary Sensory and Motor Neuropathy|hereditary sensory and motor neuropathy
151348|NCT03254199|Neurogenetic disorder|neurogenetic disorder
151349|NCT03254199|Nervous System Malformations|nervous system malformations
151350|NCT03254199|Nervous System Diseases|nervous system diseases
151351|NCT03254199|Neurodegenerative Diseases|neurodegenerative diseases
151352|NCT03254199|Neuromuscular Diseases|neuromuscular diseases
151353|NCT03254186|Propranolol|propranolol
151354|NCT03254186|Safety|safety
151355|NCT03254186|Efficacy|efficacy
151356|NCT03254186|Tardive Dyskinesia treatment|tardive dyskinesia treatment
151357|NCT03254173|Mirtazapine|mirtazapine
151358|NCT03254173|Anorexia - Cachexia|anorexia - cachexia
151359|NCT03254173|Advanced Cancer|advanced cancer
151360|NCT03254173|Appetite|appetite
151361|NCT03254160|Stroke|stroke
151362|NCT03254160|Rehabilitation|rehabilitation
151363|NCT03254160|Ischemic|ischemic
151364|NCT03254121|Sustained virological response|sustained virological response
151365|NCT03254121|Whole genome sequencing|whole genome sequencing
151366|NCT03254095|Skin temperature|skin temperature
151367|NCT03254095|Plantar pressure|plantar pressure
151368|NCT03254095|Diabetic foot|diabetic foot
151369|NCT03254095|Tissue hardness|tissue hardness
151370|NCT03254095|Neuropathy|neuropathy
151371|NCT03254095|Peripheral artery disease|peripheral artery disease
151372|NCT03254082|sorghum health|sorghum health
151373|NCT03254056|fascial closure device|fascial closure device
151374|NCT03254056|laparoscopic surgery|laparoscopic surgery
151375|NCT03254056|postoperative pain|postoperative pain
151376|NCT03254030|Adenoma|adenoma
151377|NCT03254030|Sessile serrated adenoma|sessile serrated adenoma
151378|NCT03254017|Bilateral Habeluna|bilateral habeluna
151379|NCT03254017|Remote Deep Brain Stimulation|remote deep brain stimulation
151380|NCT03254017|Treatment Resistant Major Depressive Disorder|treatment resistant major depressive disorder
151381|NCT03253900|wobble board|wobble board
151382|NCT03253900|slides|slides
151383|NCT03253900|rowing stroke|rowing stroke
151384|NCT03253900|rowing biomechanics|rowing biomechanics
151385|NCT03253900|power output|power output
151386|NCT03253887|Central Venous Catheters|central venous catheters
151387|NCT03253887|Child|child
151388|NCT03253887|ethanol therapy|ethanol therapy
151389|NCT03253887|CLABSI|clabsi
151390|NCT03253874|Pre-operative Testing|pre-operative testing
151391|NCT03253874|Cataract Surgery|cataract surgery
151392|NCT03253874|Health Service Research|health service research
151393|NCT03253874|Low-Value Care|low-value care
151394|NCT03253874|Safety-Net Hospital|safety-net hospital
151395|NCT03253861|Acute necrotizing pancreatitis|acute necrotizing pancreatitis
151396|NCT03253861|Acute pancreatitis|acute pancreatitis
151397|NCT03253861|Sepsis/complications|sepsis/complications
151398|NCT03253861|Infection|infection
151399|NCT03253861|Organ Dysfunction Scores|organ dysfunction scores
151400|NCT03253861|Drainage|drainage
151401|NCT03253861|Catheters|catheters
151402|NCT03253861|Antibiotics|antibiotics
151403|NCT03253861|Multiresistant organism|multiresistant organism
151404|NCT03253861|Pancreatitis/complications|pancreatitis/complications
151405|NCT03253861|Pancreatitis/diagnosis|pancreatitis/diagnosis
151406|NCT03253861|Pancreatitis/surgery|pancreatitis/surgery
151407|NCT03253861|Pancreatitis/therapy|pancreatitis/therapy
151408|NCT03253861|Pancreatitis, Acute Necrotizing/complications|pancreatitis, acute necrotizing/complications
151409|NCT03253861|Pancreatitis, Acute Necrotizing/surgery|pancreatitis, acute necrotizing/surgery
151410|NCT03253861|Pancreatitis, Acute Necrotizing/therapy|pancreatitis, acute necrotizing/therapy
151411|NCT03253822|Colorectal Neoplasms|colorectal neoplasms
151412|NCT03253822|Decision Support Techniques|decision support techniques
151413|NCT03253822|Early Detection of Cancer|early detection of cancer
151414|NCT03253822|Educational Status|educational status
151415|NCT03253822|Decision Making|decision making
151416|NCT03253822|Knowledge, Attitudes, Practice|knowledge, attitudes, practice
151417|NCT03253770|Cognitive Aid|cognitive aid
151418|NCT03253757|PrEP|prep
151419|NCT03253757|HIV|hiv
151420|NCT03253744|Image Guidance|image guidance
151421|NCT03253744|Dose Escalation|dose escalation
151422|NCT03253744|Radiotherapy|radiotherapy
151423|NCT03253744|Re-irradiation|re-irradiation
151424|NCT03253744|Quality of Life|quality of life
151425|NCT03253731|Brain Plasticity|brain plasticity
151426|NCT03253731|Healthy Volunteers|healthy volunteers
151427|NCT03253718|Healthy Volunteers|healthy volunteers
151428|NCT03253705|Assay Development|assay development
151429|NCT03253705|Gene Expression|gene expression
193333|NCT02986672|ADD|add
151430|NCT03253705|Metabolomics|metabolomics
151431|NCT03253705|Induced Pluripotent Stem Cell (iPS)|induced pluripotent stem cell (ips)
151432|NCT03253705|PBMCs/DNA/RNA|pbmcs/dna/rna
151433|NCT03253692|Cardiac Computed Tomography|cardiac computed tomography
151434|NCT03253692|Radiation|radiation
151435|NCT03253692|Iterative Reconstruction|iterative reconstruction
151436|NCT03253653|waterpipe|waterpipe
151437|NCT03253653|hookah|hookah
151438|NCT03253653|NNAL|nnal
151439|NCT03253653|SPMA|spma
151440|NCT03253653|1-HOP|1-hop
151441|NCT03253653|Furan-BDA-NAL|furan-bda-nal
151442|NCT03253653|Carbon monoxide|carbon monoxide
151443|NCT03253653|Pulmonary Function|pulmonary function
151444|NCT03253640|Costs and Cost Analysis|costs and cost analysis
151445|NCT03253640|Quality of Life|quality of life
151446|NCT03253640|Length of Stay|length of stay
151447|NCT03253640|Cohort study|cohort study
151448|NCT03253601|Rehabilitation|rehabilitation
151449|NCT03253601|Disability|disability
151450|NCT03253601|Mobile Health Technology|mobile health technology
151643|NCT03252080|type 2 diabetes|type 2 diabetes
151451|NCT03253575|Head and Neck Squamous Cell Carcinoma|head and neck squamous cell carcinoma
151452|NCT03253575|Breast Cancer|breast cancer
151453|NCT03253575|Non-Small Cell Lung Cancer|non-small cell lung cancer
151454|NCT03253575|Epithelial Ovarian Cancer|epithelial ovarian cancer
151455|NCT03253575|Colorectal Cancer|colorectal cancer
151456|NCT03253575|Local Recurrent Cancer|local recurrent cancer
151457|NCT03253575|Late Stage Cancer|late stage cancer
151458|NCT03253575|Clinical Utility|clinical utility
151459|NCT03253575|Outcomes Study|outcomes study
151460|NCT03253562|diabetes|diabetes
151461|NCT03253562|Metformin|metformin
151462|NCT03253562|vildagliptin|vildagliptin
151463|NCT03253562|hypertension|hypertension
151464|NCT03253562|cardiovascular risk|cardiovascular risk
151465|NCT03253549|remote automated monitoring|remote automated monitoring
151466|NCT03253549|hospital to home virtual care|hospital to home virtual care
151467|NCT03253549|cardiac surgery|cardiac surgery
151468|NCT03253549|major vascular surgery|major vascular surgery
151469|NCT03253549|self-management|self-management
151470|NCT03253536|Hepatocellular Cancer|hepatocellular cancer
151471|NCT03253536|Quality of Life|quality of life
151472|NCT03253536|stereotactic body radiation therapy|stereotactic body radiation therapy
151473|NCT03253536|observational|observational
151474|NCT03253497|chlorhexidine, benzidamine, laryngeal mask|chlorhexidine, benzidamine, laryngeal mask
151475|NCT03253484|scar NAFL laser|scar nafl laser
151476|NCT03253458|Optical coherence tomography|optical coherence tomography
151477|NCT03253458|Confocal Laser Endomicroscopy|confocal laser endomicroscopy
151478|NCT03253458|Histology|histology
151479|NCT03253445|smoking cessation|smoking cessation
151480|NCT03253445|acceptance and commitment therapy|acceptance and commitment therapy
151482|NCT03253445|schizophrenic patients|schizophrenic patients
151483|NCT03253445|hostel setting|hostel setting
151484|NCT03253445|randomised controlled trial|randomised controlled trial
151485|NCT03253419|Falls|falls
151486|NCT03253419|Hip Replacement|hip replacement
151487|NCT03253419|Home Safety|home safety
151488|NCT03253367|Schizophrenia Spectrum and Other Psychotic Disorders|schizophrenia spectrum and other psychotic disorders
151489|NCT03253341|exercise program|exercise program
151490|NCT03253341|lifestyle changes|lifestyle changes
151491|NCT03253341|fitness program|fitness program
151492|NCT03253341|lifestyle intervention|lifestyle intervention
151493|NCT03253302|transanal surgery|transanal surgery
151494|NCT03253302|total mesorectal excision|total mesorectal excision
151495|NCT03253302|rectal cancer|rectal cancer
151496|NCT03253289|Hepatocellular carcinoma, HCC, Liver cancer|hepatocellular carcinoma, hcc, liver cancer
151497|NCT03253276|Bile Acid Transporter|bile acid transporter
151498|NCT03253237|Glycemic variability|glycemic variability
151499|NCT03253237|Hypoglycemia|hypoglycemia
151500|NCT03253211|Co-management model of care|co-management model of care
151501|NCT03253211|Primary Care|primary care
151502|NCT03253211|Specialty Care|specialty care
151503|NCT03253211|Decision support tools|decision support tools
151504|NCT03253211|Emergency Department Clinicians|emergency department clinicians
151505|NCT03253211|Co-management|co-management
151506|NCT03253185|Cancer|cancer
151507|NCT03253185|Advanced cancer|advanced cancer
151508|NCT03253185|Esophagogastric junction (EGJ) cancers|esophagogastric junction (egj) cancers
151509|NCT03253185|Maximum tolerated dose (MTD)|maximum tolerated dose (mtd)
151510|NCT03253185|Maximum Tolerated Dose|maximum tolerated dose
151511|NCT03253185|Pharmacokinetics|pharmacokinetics
151512|NCT03253146|Vimentin|vimentin
151513|NCT03253146|sepsis|sepsis
151514|NCT03253146|immune cells|immune cells
151515|NCT03253146|apoptosis|apoptosis
151516|NCT03253107|gastric cancer|gastric cancer
151517|NCT03253107|RNA sequencing|rna sequencing
151518|NCT03253107|chemotherapy response|chemotherapy response
151519|NCT03253107|miRNA sequencing|mirna sequencing
151520|NCT03253055|Physical Performance|physical performance
151521|NCT03253055|Bone|bone
151522|NCT03253055|Illness|illness
151523|NCT03253055|Injury|injury
151524|NCT03253042|Exercise|exercise
151525|NCT03253042|Vibration|vibration
151526|NCT03253042|Torque|torque
151527|NCT03253042|Aging|aging
151528|NCT03253029|oncology, cancer cachexia, cachexia anorexia,|oncology, cancer cachexia, cachexia anorexia,
151529|NCT03252977|fentanyl|fentanyl
151530|NCT03252977|Pain Threshold|pain threshold
151531|NCT03252977|predicted|predicted
151532|NCT03252938|solid tumor|solid tumor
151533|NCT03252938|peritoneal carcinomatosis|peritoneal carcinomatosis
151534|NCT03252886|intubation|intubation
151535|NCT03252886|Cardiopulmonary Resuscitation|cardiopulmonary resuscitation
151536|NCT03252886|neck injury|neck injury
151537|NCT03252873|adherence|adherence
151538|NCT03252873|pulmonary rehabilitation|pulmonary rehabilitation
151539|NCT03252873|copd|copd
151540|NCT03252847|XLRP RPGR|xlrp rpgr
151541|NCT03252808|Unresectable pancreatic cancer|unresectable pancreatic cancer
151542|NCT03252808|Metastatic pancreatic cancer|metastatic pancreatic cancer
151543|NCT03252808|Pancreatic adenocarcinoma|pancreatic adenocarcinoma
151544|NCT03252808|TBI-1401(HF10)|tbi-1401(hf10)
151545|NCT03252808|HF10|hf10
151546|NCT03252808|Oncolytic virus|oncolytic virus
152128|NCT03249064|TREGS|tregs
151547|NCT03252808|Oncolytic viral immunotherapy|oncolytic viral immunotherapy
151548|NCT03252808|Gemcitabine|gemcitabine
151549|NCT03252808|Nab-paclitaxel|nab-paclitaxel
151550|NCT03252808|Albumin-bound paclitaxel|albumin-bound paclitaxel
151551|NCT03252808|Abraxane|abraxane
151552|NCT03252808|Tegafur-gimeracil-oteracil potassium|tegafur-gimeracil-oteracil potassium
151553|NCT03252808|TS-1|ts-1
151554|NCT03252808|canerpaturev|canerpaturev
151555|NCT03252795|Infertility, female|infertility, female
151556|NCT03252795|Mayer Rokitansky Kuster Hauser Syndrome|mayer rokitansky kuster hauser syndrome
151557|NCT03252795|Transplantation; Deceased donor|transplantation; deceased donor
151558|NCT03252782|Soft Tissue|soft tissue
151559|NCT03252782|Functional Appliance|functional appliance
151560|NCT03252782|Maxillary Molar Distalization|maxillary molar distalization
151561|NCT03252756|Cannabidiol|cannabidiol
151562|NCT03252756|Alcohol Use Disorder|alcohol use disorder
151563|NCT03252730|Dry scalp|dry scalp
151564|NCT03252730|Itchy scalp|itchy scalp
151565|NCT03252704|postprandial glucose insulin|postprandial glucose insulin
151566|NCT03252678|Advanced Care Planning|advanced care planning
151567|NCT03252665|STEMI|stemi
151568|NCT03252665|myocardial perfusion|myocardial perfusion
151569|NCT03252665|TMPFC|tmpfc
151570|NCT03252665|Nicorandil|nicorandil
151571|NCT03252665|Alprostadil|alprostadil
151572|NCT03252652|Cranial vessels|cranial vessels
151573|NCT03252652|Normal parameters|normal parameters
151574|NCT03252652|Carotid Duplex|carotid duplex
151575|NCT03252652|Egyptian|egyptian
151576|NCT03252639|Renal Artery Stenosis|renal artery stenosis
151577|NCT03252639|Renal Blood Perfusion|renal blood perfusion
151578|NCT03252613|septic cardiomyopathy|septic cardiomyopathy
151579|NCT03252613|cytokine|cytokine
151580|NCT03252613|iPSC|ipsc
151581|NCT03252613|Inducible pluripotent stem cell|inducible pluripotent stem cell
151582|NCT03252561|TAP block|tap block
151583|NCT03252561|Acute Appendicitis|acute appendicitis
151584|NCT03252561|Post-operative analgesia|post-operative analgesia
151585|NCT03252535|Huntington disease|huntington disease
151586|NCT03252535|Stem cell therapy|stem cell therapy
151587|NCT03252535|Dental pulp stem cell|dental pulp stem cell
151588|NCT03252522|ADHD|adhd
151589|NCT03252522|ODD|odd
151590|NCT03252522|DMDD|dmdd
151591|NCT03252522|Inattention|inattention
151592|NCT03252522|Impulsivity|impulsivity
151593|NCT03252522|Irritability|irritability
151594|NCT03252522|Anger|anger
151595|NCT03252522|Micronutrients|micronutrients
151596|NCT03252509|percutaneous radiologic gastrostomy|percutaneous radiologic gastrostomy
151597|NCT03252509|Head and Neck Neoplasms|head and neck neoplasms
151598|NCT03252470|2D laparoscopic surgery|2d laparoscopic surgery
151599|NCT03252470|3D laparascopic surgery|3d laparascopic surgery
151600|NCT03252470|laparoscopic roux-en-y gastric bypass|laparoscopic roux-en-y gastric bypass
151601|NCT03252457|Purpura|purpura
151602|NCT03252457|Thrombocytopenia|thrombocytopenia
151603|NCT03252457|immune throbocytopenia|immune throbocytopenia
151604|NCT03252444|Shoulder dyskinesis|shoulder dyskinesis
151605|NCT03252444|EMG biofeedback training|emg biofeedback training
151606|NCT03252444|Intensive Scapula-focused intervention|intensive scapula-focused intervention
151607|NCT03252418|ascorbic acid|ascorbic acid
151608|NCT03252418|diode laser|diode laser
151609|NCT03252418|gingival hyperpigmentation|gingival hyperpigmentation
151610|NCT03252392|hearing and communication abnormalities|hearing and communication abnormalities
151611|NCT03252366|MAXILLARY SINUS ELEVATION ,Simultaneous implant placement|maxillary sinus elevation ,simultaneous implant placement
151612|NCT03252353|Octreotide Capsules, Acromegaly, OPTIMAL, MYCAPSSA|octreotide capsules, acromegaly, optimal, mycapssa
151613|NCT03252301|pain|pain
151614|NCT03252301|post operative|post operative
151615|NCT03252301|surgery|surgery
151616|NCT03252301|objective|objective
151617|NCT03252236|Stroke|stroke
151618|NCT03252236|Tai Chi|tai chi
151619|NCT03252236|Dual-tasking|dual-tasking
151620|NCT03252236|Arterial compliance|arterial compliance
151621|NCT03252236|Arterial stiffness|arterial stiffness
151622|NCT03252236|Autonomic nervous system|autonomic nervous system
151623|NCT03252236|Heart rate variability|heart rate variability
151624|NCT03252223|polycystic ovary syndrome|polycystic ovary syndrome
151625|NCT03252223|anovulation|anovulation
151626|NCT03252223|hyperandrogenism|hyperandrogenism
151627|NCT03252210|Preoperative localization|preoperative localization
151628|NCT03252210|Stereoscopic Localization|stereoscopic localization
151629|NCT03252210|Wedge Resection|wedge resection
151630|NCT03252210|Ground Glass Opacity|ground glass opacity
151631|NCT03252197|Ultrasound guided central venous cannulation|ultrasound guided central venous cannulation
151632|NCT03252197|new device|new device
151633|NCT03252197|first attempt success|first attempt success
151634|NCT03252184|Phototherapy|phototherapy
151635|NCT03252184|Laser Therapy|laser therapy
151636|NCT03252184|Endothelium-Dependent|endothelium-dependent
151637|NCT03252184|Vascular Endothelium|vascular endothelium
151638|NCT03252184|Low Intensity Light Therapy|low intensity light therapy
151639|NCT03252184|Relaxing Factors|relaxing factors
151640|NCT03252171|CAR-T cell immunotherapy|car-t cell immunotherapy
151641|NCT03252171|GD2|gd2
151642|NCT03252171|glioma|glioma
151644|NCT03252080|holistic management|holistic management
151645|NCT03252067|Azithromycin eyedrops, pharmacokinetics, tears|azithromycin eyedrops, pharmacokinetics, tears
151646|NCT03252041|PCS|pcs
151647|NCT03252028|Hepatocyte growth factor, Nosocomial infections, VAP, Meningitis, In vitro, point of care, rapid test|hepatocyte growth factor, nosocomial infections, vap, meningitis, in vitro, point of care, rapid test
151648|NCT03252002|Chronic kidney disease|chronic kidney disease
151649|NCT03251989|Brain Tumor|brain tumor
151650|NCT03251989|Central Nervous System Tumors|central nervous system tumors
151651|NCT03251989|Choroid Plexus Tumors|choroid plexus tumors
151652|NCT03251989|Gliomas|gliomas
151653|NCT03251989|Atypical Teratoid Rhabdoid Tumor|atypical teratoid rhabdoid tumor
151654|NCT03251976|ovarian cancer|ovarian cancer
151655|NCT03251976|cardiopulmonary resuscitation|cardiopulmonary resuscitation
151656|NCT03251976|end of life care|end of life care
151657|NCT03251976|endometrial cancer|endometrial cancer
151658|NCT03251976|cervical cancer|cervical cancer
151659|NCT03251950|Vegetable and fruit intake|vegetable and fruit intake
151660|NCT03251937|Chronic Pain|chronic pain
151661|NCT03251937|Back Pain|back pain
151662|NCT03251937|Leg Pain|leg pain
151663|NCT03251937|Pain|pain
151664|NCT03251937|Stimulation|stimulation
151665|NCT03251937|Spinal Cord Stimulator|spinal cord stimulator
151666|NCT03251937|Implantable Pulse Generator|implantable pulse generator
151791|NCT03251040|Sealing|sealing
151667|NCT03251872|pulmonary arterial hypertension|pulmonary arterial hypertension
151668|NCT03251872|PAH|pah
151669|NCT03251872|poly (ADP-ribose) polymerases inhibition|poly (adp-ribose) polymerases inhibition
151670|NCT03251872|PARP-1 inhibition|parp-1 inhibition
151671|NCT03251872|DNA damage|dna damage
151672|NCT03251872|Early-phase clinical trial pilot study|early-phase clinical trial pilot study
151673|NCT03251872|Olaparib|olaparib
151674|NCT03251872|Safety and efficacy|safety and efficacy
151675|NCT03251859|platelet reactivity|platelet reactivity
151676|NCT03251859|ticagrelor|ticagrelor
151677|NCT03251859|myocardial infarction|myocardial infarction
151678|NCT03251859|pharmacodynamics|pharmacodynamics
151679|NCT03251859|antiplatelet therapy|antiplatelet therapy
151680|NCT03251846|Diabetes Mellitus, Type 1|diabetes mellitus, type 1
151681|NCT03251846|self-monitoring blood glucose|self-monitoring blood glucose
151682|NCT03251846|diabetes mobile application|diabetes mobile application
151683|NCT03251846|diabetes management device|diabetes management device
151684|NCT03251820|electrical status epilepticus during slow wave sleep|electrical status epilepticus during slow wave sleep
151685|NCT03251820|seizure|seizure
151686|NCT03251820|cognition|cognition
151687|NCT03251820|continuous spikes and waves during sleep|continuous spikes and waves during sleep
151688|NCT03251807|Low-intensity pulsed ultrasound|low-intensity pulsed ultrasound
151689|NCT03251807|Twin-block|twin-block
151690|NCT03251807|Functional treatment|functional treatment
151691|NCT03251781|Minimal Clinically Important Difference|minimal clinically important difference
151692|NCT03251781|Exercise Test|exercise test
151693|NCT03251781|Rehabilitation|rehabilitation
151694|NCT03251781|Disability Evaluation|disability evaluation
151695|NCT03251768|Chemotherapy|chemotherapy
151696|NCT03251768|Neutropenia|neutropenia
151697|NCT03251768|breast cancer|breast cancer
151698|NCT03251755|type 2 diabetes mellitus|type 2 diabetes mellitus
151699|NCT03251755|insomnia|insomnia
151700|NCT03251755|Dao-in|dao-in
151701|NCT03251742|Fontan operation|fontan operation
151702|NCT03251742|Negative pressure ventilation|negative pressure ventilation
151703|NCT03251742|MRI|mri
151704|NCT03251729|cerclage, preterm birth, short cervix|cerclage, preterm birth, short cervix
151705|NCT03251716|Metabolic syndrome|metabolic syndrome
151706|NCT03251716|Schizophrenia|schizophrenia
151707|NCT03251716|Efficacy|efficacy
151708|NCT03251716|Female|female
151709|NCT03251716|Berberine|berberine
151710|NCT03251638|NHS( newborn hearing screening )|nhs( newborn hearing screening )
151711|NCT03251599|peak temperature|peak temperature
151712|NCT03251599|rewarming rate|rewarming rate
151713|NCT03251599|surgical outcomes|surgical outcomes
151714|NCT03251560|Fuke Qianjin capsule|fuke qianjin capsule
151715|NCT03251560|chronic pelvic pain|chronic pelvic pain
151716|NCT03251547|rFVIIa|rfviia
151717|NCT03251547|Massive Hemorrhage|massive hemorrhage
151718|NCT03251547|non-hemophilia|non-hemophilia
151719|NCT03251534|Eos imaging stereography|eos imaging stereography
151720|NCT03251534|Centromedullary nailing|centromedullary nailing
151721|NCT03251534|Quantification of malunions|quantification of malunions
151722|NCT03251521|pain|pain
151723|NCT03251521|spasticity|spasticity
151724|NCT03251521|stroke|stroke
151725|NCT03251521|injection|injection
151726|NCT03251521|botulinum toxin A|botulinum toxin a
151727|NCT03251508|Peanut|peanut
151728|NCT03251495|Vaccination|vaccination
151729|NCT03251495|Contagious Diseases|contagious diseases
151730|NCT03251495|Tropical Medicine|tropical medicine
151731|NCT03251495|Infectious Diseases|infectious diseases
151732|NCT03251469|tranexamic acid|tranexamic acid
151733|NCT03251469|blood tranfusion|blood tranfusion
151734|NCT03251469|hip fractures|hip fractures
151735|NCT03251469|elderly|elderly
151736|NCT03251469|blood loss|blood loss
151737|NCT03251456|myopia|myopia
151738|NCT03251456|Tertiary Care|tertiary care
151739|NCT03251456|Pre-school Children|pre-school children
151740|NCT03251417|Irinotecan|irinotecan
151741|NCT03251417|Apatinib|apatinib
151742|NCT03251391|revascularization|revascularization
151743|NCT03251391|blocked arteries|blocked arteries
151744|NCT03251391|leg arteries|leg arteries
151745|NCT03251391|leg pain|leg pain
151746|NCT03251378|VEGF|vegf
151747|NCT03251378|colorectal|colorectal
151748|NCT03251365|Pancreatic cancer|pancreatic cancer
151749|NCT03251365|Gemcitabine|gemcitabine
151750|NCT03251365|Pancreatic carcinomatosis|pancreatic carcinomatosis
151751|NCT03251365|Intrabdominal hyperthermic chemotherapy|intrabdominal hyperthermic chemotherapy
151752|NCT03251352|TKI, CML, discontinuation|tki, cml, discontinuation
151753|NCT03251339|Healthy Participants|healthy participants
151754|NCT03251339|MSB11455|msb11455
151755|NCT03251274|bath machine|bath machine
151756|NCT03251274|sleep quality|sleep quality
151757|NCT03251274|nursing home|nursing home
151758|NCT03251274|heart rate variability|heart rate variability
151759|NCT03251248|MSB11455|msb11455
151760|NCT03251248|Healthy subjects|healthy subjects
151761|NCT03251235|cognitive behaviour therapy|cognitive behaviour therapy
151762|NCT03251222|conscious sedation, vitroretinal procedures|conscious sedation, vitroretinal procedures
151763|NCT03251157|Asthma|asthma
151764|NCT03251157|Adults|adults
151765|NCT03251157|Europe|europe
151766|NCT03251157|Lung function|lung function
151767|NCT03251157|Allergy|allergy
151768|NCT03251157|Atopy|atopy
151769|NCT03251157|IgE|ige
151770|NCT03251157|Sensitisation|sensitisation
151771|NCT03251157|Diet|diet
151772|NCT03251157|Dietary patterns|dietary patterns
151773|NCT03251157|Dietary antioxidants|dietary antioxidants
151774|NCT03251157|Flavonoids|flavonoids
151775|NCT03251157|Fruits and vegetables|fruits and vegetables
151776|NCT03251157|Food frequency questionnaire (FFQ)|food frequency questionnaire (ffq)
151777|NCT03251157|Fatty acids|fatty acids
151778|NCT03251144|HIV/AIDS|hiv/aids
151779|NCT03251144|Tenofovir disoproxil fumarate (TDF)|tenofovir disoproxil fumarate (tdf)
151780|NCT03251144|Tenofovir alafenamide (TAF)|tenofovir alafenamide (taf)
151781|NCT03251144|mitochondria|mitochondria
151782|NCT03251144|toxicity|toxicity
151783|NCT03251118|Crohn's Disease|crohn's disease
151784|NCT03251118|Ulcerative colitis|ulcerative colitis
151785|NCT03251118|Indeterminate colitis|indeterminate colitis
151786|NCT03251118|Digestive System Diseases|digestive system diseases
151787|NCT03251066|Nose Saline Solution Irrigation Nasal Spray|nose saline solution irrigation nasal spray
151788|NCT03251066|Sodium propionate Locke-Ringer Solution|sodium propionate locke-ringer solution
151789|NCT03251040|Esophagogastric anastomosis|esophagogastric anastomosis
151790|NCT03251040|Fibrin sealant|fibrin sealant
151792|NCT03251014|Thrombosis|thrombosis
151793|NCT03251014|Yellowstripe scad|yellowstripe scad
151794|NCT03251014|Salmon|salmon
151795|NCT03251014|Healthy overweight subjects|healthy overweight subjects
151796|NCT03251014|Randomized crossover trial|randomized crossover trial
151797|NCT03251001|gingiva|gingiva
151798|NCT03251001|keratinized mucosa|keratinized mucosa
151799|NCT03251001|gingival graft|gingival graft
151800|NCT03250975|Intubation injury|intubation injury
151801|NCT03250975|Acute laryngeal injury|acute laryngeal injury
151802|NCT03250975|Chronic Laryngeal Injury|chronic laryngeal injury
151803|NCT03250962|Relapsed/Refractory; Hodgkin Lymphoma；Decitabine; SHR-1210|relapsed/refractory; hodgkin lymphoma；decitabine; shr-1210
151804|NCT03250936|trampoline|trampoline
151805|NCT03250923|Oral Candidiasis, Thrush, Oral Moniliasis|oral candidiasis, thrush, oral moniliasis
151806|NCT03250910|hepatitis C virus|hepatitis c virus
151807|NCT03250910|human immunodeficiency virus|human immunodeficiency virus
151808|NCT03250910|Direct acting antiviral agent|direct acting antiviral agent
151809|NCT03250897|Alveolar macrophages|alveolar macrophages
151810|NCT03250897|Blood monocyte-derived macrophages|blood monocyte-derived macrophages
151811|NCT03250897|FACS analysis|facs analysis
151812|NCT03250897|Broncho-alveolar lavage fluids|broncho-alveolar lavage fluids
151813|NCT03250897|Non-infectious lung diseases|non-infectious lung diseases
151814|NCT03250858|Personalised nutrition|personalised nutrition
151815|NCT03250858|Mobile web application|mobile web application
151816|NCT03250845|Multigam|multigam
151817|NCT03250845|Immunoglobulin|immunoglobulin
151818|NCT03250845|Secondary immunodeficiency|secondary immunodeficiency
151819|NCT03250832|advanced solid tumors|advanced solid tumors
151820|NCT03250832|endometrioid ovarian cancer|endometrioid ovarian cancer
151821|NCT03250832|fallopian tube cancer|fallopian tube cancer
151822|NCT03250832|primary peritoneal cancer|primary peritoneal cancer
151823|NCT03250832|breast cancer|breast cancer
151824|NCT03250832|bladder cancer|bladder cancer
151825|NCT03250832|urothelial carcinoma|urothelial carcinoma
151826|NCT03250832|TNBC|tnbc
151827|NCT03250832|triple-negative breast cancer|triple-negative breast cancer
151828|NCT03250832|LAG-3|lag-3
151829|NCT03250832|colorectal cancer|colorectal cancer
151830|NCT03250832|lung cancer|lung cancer
151831|NCT03250806|aortic stenosis, auscultation, target echocardiography|aortic stenosis, auscultation, target echocardiography
151832|NCT03250793|Hernia, DIaphragmatic, Congenital|hernia, diaphragmatic, congenital
151833|NCT03250793|Respiration, Artificial|respiration, artificial
151834|NCT03250793|physiologic pilot study|physiologic pilot study
151836|NCT03250793|Neurally Adjusted Ventilatory Assist|neurally adjusted ventilatory assist
151837|NCT03250793|esophageal transducer|esophageal transducer
151838|NCT03250793|Work of Breathing|work of breathing
151839|NCT03250754|Acupuncture|acupuncture
151840|NCT03250754|Migraine|migraine
151841|NCT03250754|Tension-type headache|tension-type headache
151842|NCT03250741|Rotigotine|rotigotine
151843|NCT03250741|Dopamine|dopamine
151844|NCT03250728|CDG|cdg
151845|NCT03250728|Stroke-like|stroke-like
151846|NCT03250728|Endothelial progenitor cells (EPCs)|endothelial progenitor cells (epcs)
151847|NCT03250728|Protein C|protein c
151848|NCT03250728|Congenital Disorders og Glycosylation|congenital disorders og glycosylation
151849|NCT03250702|Tanzania|tanzania
151850|NCT03250702|Observational|observational
151851|NCT03250702|Sub-Saharan Africa|sub-saharan africa
151852|NCT03250702|Treatment|treatment
151853|NCT03250689|Danirixin|danirixin
151854|NCT03250689|CXCR2|cxcr2
151855|NCT03250689|NETs|nets
151856|NCT03250689|GSK1325756|gsk1325756
151857|NCT03250689|COPD|copd
151858|NCT03250689|HBr|hbr
151859|NCT03250676|HER2|her2
151860|NCT03250676|estrogen receptor|estrogen receptor
151861|NCT03250676|H3B-6545|h3b-6545
151862|NCT03250676|breast cancer|breast cancer
151863|NCT03250676|Endocrine Therapy|endocrine therapy
151864|NCT03250663|topical therapy, atopic dermatitis,|topical therapy, atopic dermatitis,
151865|NCT03250650|Overactive Bladder|overactive bladder
151866|NCT03250650|Electric Stimulation|electric stimulation
151867|NCT03250650|Physical Therapy Modalities|physical therapy modalities
151868|NCT03250637|Gene-environment interaction|gene-environment interaction
151869|NCT03250637|Candidate gene|candidate gene
151870|NCT03250637|Western style diet|western style diet
151871|NCT03250637|Toll-like receptors|toll-like receptors
151872|NCT03250637|Prospective study|prospective study
151873|NCT03250637|Nested case-cohort|nested case-cohort
151874|NCT03250611|Occipital condyle|occipital condyle
151875|NCT03250611|Occipital condyle screw|occipital condyle screw
151876|NCT03250598|Healthy|healthy
151877|NCT03250598|Japanese|japanese
151878|NCT03250585|acute chest syndrome|acute chest syndrome
151879|NCT03250585|secretory phospholipases A2|secretory phospholipases a2
151880|NCT03250585|exhaled breath condensate|exhaled breath condensate
151881|NCT03250585|sickle cell disease|sickle cell disease
151882|NCT03250559|Stone disease|stone disease
151883|NCT03250533|Wound healing|wound healing
151884|NCT03250533|Phototherapy|phototherapy
151885|NCT03250533|Electrotherapy|electrotherapy
151886|NCT03250507|TAP block|tap block
151887|NCT03250507|Liposomal bupivicaine|liposomal bupivicaine
151888|NCT03250494|Duloxetine, Dexamethasone, Postoperative pain, side effects.|duloxetine, dexamethasone, postoperative pain, side effects.
151889|NCT03250481|Sedation, Responsiveness Index, Electromyogram|sedation, responsiveness index, electromyogram
151890|NCT03250390|Lung cancer|lung cancer
151891|NCT03250390|diagnosis|diagnosis
151892|NCT03250390|volatile organic compounds|volatile organic compounds
151893|NCT03250377|Brivaracetam|brivaracetam
151894|NCT03250377|Epilepsy|epilepsy
151895|NCT03250377|Partial seizures with or without secondary generalization|partial seizures with or without secondary generalization
151896|NCT03250377|Briviact|briviact
151897|NCT03250325|Adoptive cell transfer|adoptive cell transfer
151898|NCT03250325|Cell therapy|cell therapy
151899|NCT03250325|Immunotherapy|immunotherapy
151900|NCT03250325|NY-ESO-1|ny-eso-1
151901|NCT03250325|T cell receptor gene therapy|t cell receptor gene therapy
151902|NCT03250325|Synovial sarcoma|synovial sarcoma
151903|NCT03250312|Osteopathic manipulation|osteopathic manipulation
151904|NCT03250312|low back pain|low back pain
151905|NCT03250312|immune cells|immune cells
151906|NCT03250273|Immunotherapy|immunotherapy
151907|NCT03250273|Nivolumab|nivolumab
151908|NCT03250273|Entinostat|entinostat
151909|NCT03250273|Pancreatic Adenocarcinoma|pancreatic adenocarcinoma
151910|NCT03250273|Cholangiocarcinoma|cholangiocarcinoma
151911|NCT03250273|Unresectable|unresectable
151912|NCT03250273|Metastatic|metastatic
151913|NCT03250273|PD-1|pd-1
151914|NCT03250273|Antibody|antibody
151915|NCT03250260|3-dimensional imaging|3-dimensional imaging
151916|NCT03250260|Breast Conserving Treatment|breast conserving treatment
151917|NCT03250260|Simulation|simulation
151918|NCT03250247|deep vein thrombosis|deep vein thrombosis
151919|NCT03250247|superficial venous reflux|superficial venous reflux
151920|NCT03250247|blood clot|blood clot
151921|NCT03250247|post thrombotic syndrome|post thrombotic syndrome
151922|NCT03250247|iliac vein obstruction|iliac vein obstruction
151923|NCT03250234|microRNA, carbohydrate oxidation|microrna, carbohydrate oxidation
151924|NCT03250208|Microbiome|microbiome
151925|NCT03250208|Lactobacillus|lactobacillus
151926|NCT03250208|Probiotic|probiotic
151927|NCT03250208|Fem-Dophilus|fem-dophilus
151928|NCT03250156|Mindfulness|mindfulness
151929|NCT03250156|Attention|attention
151930|NCT03250156|Working Memory|working memory
151931|NCT03250156|Psychological Well-Being|psychological well-being
151932|NCT03250156|Proctored Practice|proctored practice
151933|NCT03250117|Parkinson Disease|parkinson disease
151934|NCT03250117|Dyskinesia|dyskinesia
151935|NCT03250117|ropinirole|ropinirole
151937|NCT03250117|ProNeura|proneura
151938|NCT03250117|movement disorders|movement disorders
151939|NCT03250117|dopamine agonist|dopamine agonist
151940|NCT03250117|extended-release|extended-release
151941|NCT03250117|Parkinsonian disorders|parkinsonian disorders
151942|NCT03250117|brain diseases|brain diseases
151943|NCT03250117|central nervous system diseases|central nervous system diseases
151944|NCT03250117|Neurodegenerative Diseases|neurodegenerative diseases
151945|NCT03250117|Antiparkinson agents|antiparkinson agents
151946|NCT03250117|Anti-dyskinesia agents|anti-dyskinesia agents
151947|NCT03250117|dopamine agents|dopamine agents
151948|NCT03250117|neurotransmitter agents|neurotransmitter agents
151949|NCT03250117|REQUIP|requip
151950|NCT03250117|subdermal|subdermal
151951|NCT03250104|antimicrobial stewardship|antimicrobial stewardship
151952|NCT03250104|infection control|infection control
151953|NCT03250104|nosocomial infection|nosocomial infection
151954|NCT03250104|clostridium difficile|clostridium difficile
151955|NCT03250104|MRGN bacteria|mrgn bacteria
151956|NCT03250104|health-care associated pathogens|health-care associated pathogens
151957|NCT03250104|VRE|vre
151958|NCT03250091|gastric precancerous lesions|gastric precancerous lesions
151959|NCT03250091|gastric cancer|gastric cancer
151960|NCT03250091|gastric intestinal Metaplasia|gastric intestinal metaplasia
151961|NCT03250091|gastric atrophy|gastric atrophy
151962|NCT03250091|gastric dysplasia|gastric dysplasia
151963|NCT03250078|Pancreas|pancreas
151964|NCT03250078|Cancer|cancer
151965|NCT03250078|MRI|mri
151966|NCT03250078|BRCA|brca
151967|NCT03250078|Early Detection|early detection
151968|NCT03250078|Genetics|genetics
151969|NCT03250052|Fimasartan|fimasartan
151970|NCT03250039|Absorption, Metabolism, Excretion, Absolute Bioavailability|absorption, metabolism, excretion, absolute bioavailability
151971|NCT03250026|primary care|primary care
151972|NCT03250026|convergence dialogue|convergence dialogue
151973|NCT03250026|sick leave|sick leave
151974|NCT03250026|care manager|care manager
151975|NCT03249974|Enlite glucose monitoring|enlite glucose monitoring
151976|NCT03249974|accuracy|accuracy
151977|NCT03249974|usability|usability
151978|NCT03249974|skin reactions|skin reactions
151979|NCT03249974|type 1 diabetes mellitus|type 1 diabetes mellitus
151980|NCT03249961|motor|motor
151981|NCT03249961|transcranial direct current stimulation|transcranial direct current stimulation
151982|NCT03249961|transcranial magnetic stimulation|transcranial magnetic stimulation
151983|NCT03249935|Azithromycin|azithromycin
151984|NCT03249935|Chlamydia|chlamydia
151985|NCT03249935|Correctional|correctional
151986|NCT03249935|Facilities|facilities
151987|NCT03249935|Symptoms|symptoms
151988|NCT03249935|Urethral|urethral
151989|NCT03249935|Urogenital|urogenital
151990|NCT03249935|Youth|youth
151991|NCT03249922|spinal cord stimulation|spinal cord stimulation
151992|NCT03249896|Gestational Diabetes|gestational diabetes
151993|NCT03249896|RCT|rct
151994|NCT03249896|Lifestyle coaching program|lifestyle coaching program
151995|NCT03249896|Smartphone app|smartphone app
151996|NCT03249896|Gestational weight gain|gestational weight gain
151997|NCT03249883|prosthetic feet|prosthetic feet
151998|NCT03249883|double blind study|double blind study
151999|NCT03249883|limited ambulators|limited ambulators
152000|NCT03249883|SACH foot|sach foot
152001|NCT03249883|prosthetic components comparison|prosthetic components comparison
152002|NCT03249857|Bipolar affective disorders|bipolar affective disorders
152003|NCT03249857|Cognition|cognition
152004|NCT03249857|Emotion|emotion
152005|NCT03249857|Embodiment|embodiment
152006|NCT03249857|Sensorimotor|sensorimotor
152007|NCT03249857|Simulation|simulation
152008|NCT03249844|arterial ischemic stroke|arterial ischemic stroke
152009|NCT03249844|children|children
152010|NCT03249844|steroids|steroids
152011|NCT03249844|aspirin|aspirin
152012|NCT03249844|Methylprednisolone|methylprednisolone
152013|NCT03249844|Prednisolone|prednisolone
152014|NCT03249831|Sickle Cell Disease|sickle cell disease
152015|NCT03249831|Sickle Cell Disorders|sickle cell disorders
152016|NCT03249831|Hemoglobinopathies|hemoglobinopathies
152017|NCT03249831|Thalassemia|thalassemia
152018|NCT03249831|Anemia, Sickle Cell|anemia, sickle cell
152019|NCT03249831|Haploidentical Transplant|haploidentical transplant
152020|NCT03249831|Nonmyeloablative Conditioning|nonmyeloablative conditioning
152021|NCT03249831|CD4+ T cell|cd4+ t cell
152022|NCT03249831|CD4+ T cell-depleted Hematopoietic Cell Transplant|cd4+ t cell-depleted hematopoietic cell transplant
152023|NCT03249831|Mixed Chimerism|mixed chimerism
152024|NCT03249805|LMIC|lmic
152025|NCT03249805|Medical device efficacy|medical device efficacy
152026|NCT03249740|Age-related macular degeneration|age-related macular degeneration
152027|NCT03249740|Choroidal neovascularization|choroidal neovascularization
152028|NCT03249727|natural killer cells|natural killer cells
152029|NCT03249727|natural killer cell activity|natural killer cell activity
152030|NCT03249714|double-blind, placebo controlled, ofatumumab, relapsing multiple sclerosis, Japanese patients|double-blind, placebo controlled, ofatumumab, relapsing multiple sclerosis, japanese patients
152031|NCT03249701|Acupoint Stimulation|acupoint stimulation
152032|NCT03249701|postoperative recovery|postoperative recovery
152033|NCT03249701|Postoperative Complications|postoperative complications
152034|NCT03249701|Peri-operation|peri-operation
152035|NCT03249688|Lifestyle intervention|lifestyle intervention
152036|NCT03249688|Medical food|medical food
152037|NCT03249688|Randomized controlled trial|randomized controlled trial
152038|NCT03249688|Prodromal Alzheimer's disease|prodromal alzheimer's disease
152039|NCT03249688|Prevention|prevention
152040|NCT03249688|Intervention|intervention
152041|NCT03249688|Multidomain|multidomain
152042|NCT03249688|Multimodal|multimodal
152043|NCT03249675|mild Traumatic Brain Injury|mild traumatic brain injury
152044|NCT03249675|Concussion|concussion
152045|NCT03249662|periarticular infiltration|periarticular infiltration
152046|NCT03249662|postoperative pain management|postoperative pain management
152047|NCT03249662|plasma level of bupivacaine|plasma level of bupivacaine
152048|NCT03249649|defibulation|defibulation
152049|NCT03249649|healthcare needs assessment|healthcare needs assessment
152051|NCT03249623|Weaning|weaning
152052|NCT03249623|Intensive Care|intensive care
152053|NCT03249623|Individualised Care|individualised care
152054|NCT03249623|Open-Loop Decision Support System|open-loop decision support system
152055|NCT03249623|Respiratory Failure|respiratory failure
152056|NCT03249623|Mechanical Ventilation|mechanical ventilation
152057|NCT03249623|Spontaneous breathing Tests|spontaneous breathing tests
152058|NCT03249623|Extubation|extubation
152059|NCT03249597|Sepsis|sepsis
152060|NCT03249597|Emergency Medical Services|emergency medical services
152061|NCT03249597|Prehospital|prehospital
152062|NCT03249597|Emergency Care|emergency care
152063|NCT03249597|Emergency Medicine|emergency medicine
152064|NCT03249571|exercise|exercise
152065|NCT03249571|flavonoids|flavonoids
152066|NCT03249571|gut permeability|gut permeability
152067|NCT03249571|gut-derived phenolics|gut-derived phenolics
152068|NCT03249558|Pain|pain
152069|NCT03249558|Pain Management|pain management
152070|NCT03249519|Radiation therapy|radiation therapy
152071|NCT03249519|Chemoradiation|chemoradiation
152072|NCT03249519|Brachytherapy|brachytherapy
152073|NCT03249519|Hyperthermia|hyperthermia
152074|NCT03249519|Cervical cancer|cervical cancer
152075|NCT03249519|Multimodality treatment of advanced cervical cancer|multimodality treatment of advanced cervical cancer
152076|NCT03249493|Decentralised Area|decentralised area
152077|NCT03249467|HAQ-II|haq-ii
152078|NCT03249467|Rheumatoid arthritis|rheumatoid arthritis
152079|NCT03249454|Incomplete SCI|incomplete sci
152080|NCT03249415|Platelet-Rich Plasma|platelet-rich plasma
152081|NCT03249415|Cell therapy|cell therapy
152082|NCT03249415|Regenerative factors|regenerative factors
152083|NCT03249415|Autologous treatment|autologous treatment
152084|NCT03249415|Paracrine factors|paracrine factors
152085|NCT03249363|Pulse Irrigation Povidone Iodine Spine Surgery|pulse irrigation povidone iodine spine surgery
152086|NCT03249350|Substance Use Disorders|substance use disorders
152087|NCT03249350|Adolescents|adolescents
152088|NCT03249350|Treatment|treatment
152089|NCT03249350|Mediation|mediation
152090|NCT03249324|Pregnancy|pregnancy
152091|NCT03249324|Overweight|overweight
152092|NCT03249324|Obesity|obesity
152093|NCT03249324|Prevention|prevention
152094|NCT03249324|Positive-gain counseling|positive-gain counseling
152095|NCT03249311|Levomilnacipran|levomilnacipran
152096|NCT03249311|Antidepressant|antidepressant
152097|NCT03249311|Ottawa|ottawa
152098|NCT03249311|Selective Norepinephrine Reuptake Inhibitor|selective norepinephrine reuptake inhibitor
152099|NCT03249311|Healthy males|healthy males
152100|NCT03249311|Tyramine response|tyramine response
152101|NCT03249311|Serotonin|serotonin
152102|NCT03249311|Norepinephrine|norepinephrine
152103|NCT03249285|hypertension|hypertension
152104|NCT03249285|pharmacogenomics|pharmacogenomics
152105|NCT03249285|anti-hypertensive therapy|anti-hypertensive therapy
152106|NCT03249246|Sepsis|sepsis
152107|NCT03249246|ICU|icu
152108|NCT03249246|Point prevalence|point prevalence
152109|NCT03249207|Aneurysmal|aneurysmal
152110|NCT03249181|MTCT|mtct
152111|NCT03249181|Antiretroviral|antiretroviral
152112|NCT03249181|Pregnancy|pregnancy
152113|NCT03249181|Africa|africa
152114|NCT03249155|Freezing of Gait, Action Observation|freezing of gait, action observation
152115|NCT03249142|Ovarian Cancer|ovarian cancer
152116|NCT03249142|Anti-PD-L1|anti-pd-l1
152117|NCT03249142|Anti-CLA-4|anti-cla-4
152118|NCT03249142|Neo-adjuvant|neo-adjuvant
152119|NCT03249129|Trauma|trauma
152120|NCT03249129|spinal cord|spinal cord
152121|NCT03249129|autoimmunity|autoimmunity
152122|NCT03249129|antibody|antibody
152123|NCT03249116|human-animal interaction|human-animal interaction
152124|NCT03249116|animal-assisted intervention|animal-assisted intervention
152125|NCT03249103|Fibromyalgia|fibromyalgia
152126|NCT03249077|Prevention|prevention
152127|NCT03249077|Medicare|medicare
152129|NCT03249064|CD91|cd91
152130|NCT03249064|LRP1|lrp1
152131|NCT03249025|lidocaine|lidocaine
152132|NCT03249025|ketamine|ketamine
152133|NCT03249025|infusion|infusion
152134|NCT03248999|multidrug resistance|multidrug resistance
152135|NCT03248999|nursing home|nursing home
152136|NCT03248999|ESBL|esbl
152137|NCT03248999|CRE|cre
152138|NCT03248947|opioid use disorder|opioid use disorder
152139|NCT03248947|Medication-assisted treatment|medication-assisted treatment
152140|NCT03248947|Buprenorphine treatment|buprenorphine treatment
152141|NCT03248947|Collaborative care model|collaborative care model
152142|NCT03248908|pupillary reflex|pupillary reflex
152143|NCT03248908|nociception|nociception
152144|NCT03248908|heart rate|heart rate
152145|NCT03248908|intraoperative monitoring|intraoperative monitoring
152146|NCT03248895|Inhaler assessment|inhaler assessment
152147|NCT03248895|Direct observation of therapy|direct observation of therapy
152148|NCT03248882|PF-05221304|pf-05221304
152149|NCT03248882|NAFLD|nafld
152150|NCT03248882|NASH|nash
152151|NCT03248882|features of metabolic syndrome|features of metabolic syndrome
152152|NCT03248882|Dose-Ranging Study|dose-ranging study
152153|NCT03248869|asthma|asthma
152154|NCT03248869|mobile application|mobile application
152155|NCT03248869|mobile app|mobile app
152156|NCT03248869|mobile health applications|mobile health applications
152157|NCT03248869|asthma mobile health application|asthma mobile health application
152158|NCT03248843|KN035|kn035
152159|NCT03248843|Solid tumors|solid tumors
152160|NCT03248843|Phase 1|phase 1
152161|NCT03248804|Obesity|obesity
152162|NCT03248804|Weight Loss|weight loss
152163|NCT03248804|body composition|body composition
152164|NCT03248804|dietary protein|dietary protein
152165|NCT03248778|disclosure|disclosure
152166|NCT03248752|Behavioural|behavioural
152167|NCT03248739|Catheter|catheter
152168|NCT03248739|Ventricular|ventricular
152169|NCT03248739|External Ventricular Drain Catheter|external ventricular drain catheter
152170|NCT03248739|EVD Catheter|evd catheter
152171|NCT03248739|Occlusion|occlusion
152172|NCT03248739|Ventriculostomy|ventriculostomy
152173|NCT03248739|Clear Bactiseal catheter|clear bactiseal catheter
152174|NCT03248739|Orange Bactiseal catheter|orange bactiseal catheter
152175|NCT03248739|Ventriculostomy Occlusion|ventriculostomy occlusion
152176|NCT03248739|Neurosurgery|neurosurgery
152177|NCT03248726|Polyethylene Glycol|polyethylene glycol
152178|NCT03248726|Bisacodyl|bisacodyl
152179|NCT03248726|Colonoscopy|colonoscopy
152180|NCT03248726|Bowel preparation|bowel preparation
152181|NCT03248726|Ottawa bowel preparation scale|ottawa bowel preparation scale
152182|NCT03248635|Survey|survey
152183|NCT03248635|Pre-Test|pre-test
152184|NCT03248622|Incidence|incidence
152185|NCT03248622|Hepatitis B Surface Antigen|hepatitis b surface antigen
152186|NCT03248622|Decompensation|decompensation
152187|NCT03248596|Extracorporeal Membrane Oxygenation (ECMO)|extracorporeal membrane oxygenation (ecmo)
152188|NCT03248596|Primary hemostasis|primary hemostasis
152189|NCT03248583|Proof-of-principle|proof-of-principle
152190|NCT03248583|Feasibility|feasibility
152191|NCT03248557|resuscitation|resuscitation
152192|NCT03248557|wavelet analysis|wavelet analysis
152193|NCT03248557|spectral analysis|spectral analysis
152194|NCT03248557|post-cardiac arrest syndrome|post-cardiac arrest syndrome
152195|NCT03248544|vitamin D|vitamin d
152196|NCT03248544|Brain Neoplasms|brain neoplasms
152197|NCT03248544|perioperative complications|perioperative complications
152198|NCT03248544|clinical outcomes|clinical outcomes
152199|NCT03248544|craniotomy|craniotomy
152200|NCT03248544|Immune System|immune system
152201|NCT03248531|Hidradenitis Suppurativa|hidradenitis suppurativa
152202|NCT03248531|Bimekizumab|bimekizumab
152203|NCT03248531|HS|hs
152204|NCT03248531|Moderate to Severe HS|moderate to severe hs
152205|NCT03248518|Inflammatory Rheumatic Disease|inflammatory rheumatic disease
152206|NCT03248518|Fatigue|fatigue
152207|NCT03248518|Exercise|exercise
152208|NCT03248518|Behavioural Intervention|behavioural intervention
152209|NCT03248518|Rheumatoid Arthritis|rheumatoid arthritis
152210|NCT03248518|Systemic Lupus Erythematosus|systemic lupus erythematosus
152211|NCT03248518|Axial Spondyloarthritis|axial spondyloarthritis
152212|NCT03248492|HER-2 positive breast cancer|her-2 positive breast cancer
152213|NCT03248492|Metastatic or Unresectable|metastatic or unresectable
152214|NCT03248492|Resistant or refractory to T-DM1|resistant or refractory to t-dm1
152215|NCT03248492|DESTINY - Breast 01|destiny - breast 01
152216|NCT03248479|Hu5F9-G4|hu5f9-g4
152217|NCT03248479|CD47|cd47
152218|NCT03248479|azacitidine|azacitidine
152219|NCT03248466|platelet rich gel|platelet rich gel
152220|NCT03248466|BMMSCs|bmmscs
152221|NCT03248466|diabetic foot ulcer|diabetic foot ulcer
152222|NCT03248453|Simulated colonoscopy|simulated colonoscopy
152223|NCT03248453|Self-regulated learning|self-regulated learning
152224|NCT03248427|Breast Cancer|breast cancer
152225|NCT03248427|Neoadjuvant|neoadjuvant
152226|NCT03248427|Luminal B tumors|luminal b tumors
152227|NCT03248427|Ribociclib|ribociclib
152228|NCT03248375|Unresectable Hepatocellular Carcinoma|unresectable hepatocellular carcinoma
152229|NCT03248375|Radioembolization|radioembolization
152230|NCT03248375|Radiation Segmentectomy|radiation segmentectomy
152231|NCT03248349|Critically ill children|critically ill children
152232|NCT03248349|Pharmacokinetics|pharmacokinetics
152233|NCT03248349|Anti-Bacterial agents|anti-bacterial agents
152234|NCT03248310|Quality of Life (QoL)|quality of life (qol)
152235|NCT03248310|17-377|17-377
152236|NCT03248271|Diabetes|diabetes
152237|NCT03248271|Sarcopenia|sarcopenia
152238|NCT03248271|Hypotension|hypotension
152239|NCT03248271|Tilt Table Test|tilt table test
152240|NCT03248258|Metastatic Breast Cancer|metastatic breast cancer
152241|NCT03248258|Treatment Decision Making|treatment decision making
152242|NCT03248258|Shared Decision Making|shared decision making
152243|NCT03248245|interprofessional team collaboration|interprofessional team collaboration
152244|NCT03248245|primary school|primary school
152245|NCT03248245|learning environment|learning environment
152246|NCT03248245|teacher's self-efficacy|teacher's self-efficacy
152247|NCT03248245|teachers working ours|teachers working ours
152248|NCT03248245|pupils learning outcome|pupils learning outcome
152249|NCT03248245|cluster-randomized|cluster-randomized
152250|NCT03248232|Transcatheter aortic valve implantation|transcatheter aortic valve implantation
152251|NCT03248193|paclitaxel|paclitaxel
152252|NCT03248193|neuropathy|neuropathy
152253|NCT03248193|hypothermia|hypothermia
152254|NCT03248193|cryocompression|cryocompression
152255|NCT03248193|alopecia|alopecia
152256|NCT03248180|antipsychotic|antipsychotic
152257|NCT03248180|guided dose reduction|guided dose reduction
152258|NCT03248180|maintenance treatment|maintenance treatment
152259|NCT03248180|remitted psychosis|remitted psychosis
152260|NCT03248180|relapse|relapse
152261|NCT03248167|Cannabidiol|cannabidiol
152262|NCT03248154|Biofilm|biofilm
152263|NCT03248154|Procellera|procellera
152264|NCT03248141|Hemophilia A Factor VIII|hemophilia a factor viii
152265|NCT03248141|Hemophilia B Factor IX|hemophilia b factor ix
152266|NCT03248141|Cross-sectional|cross-sectional
152267|NCT03248141|Epidemiological|epidemiological
152268|NCT03248141|Clinical practice|clinical practice
152269|NCT03248141|United States|united states
152270|NCT03248128|Fluticasone furoate|fluticasone furoate
152271|NCT03248128|Efficacy|efficacy
152272|NCT03248128|Vilanterol|vilanterol
152273|NCT03248128|Asthma|asthma
152274|NCT03248128|Safety|safety
152275|NCT03248128|GW642444|gw642444
152276|NCT03248128|GW685698|gw685698
152277|NCT03248115|polyphenols|polyphenols
152278|NCT03248115|green tea catechins|green tea catechins
152279|NCT03248115|coffee caffeoylquinic acids|coffee caffeoylquinic acids
152280|NCT03248115|metabolism|metabolism
152281|NCT03248115|inter-individual variability|inter-individual variability
152282|NCT03248115|colonic microbiota|colonic microbiota
152283|NCT03248102|paediatric|paediatric
152284|NCT03248063|Staphylococcus aureus|staphylococcus aureus
152285|NCT03248063|bacteremia|bacteremia
152286|NCT03248063|cloxacillin|cloxacillin
152287|NCT03248063|cefazolin|cefazolin
152288|NCT03248024|Chronic Disease|chronic disease
152289|NCT03248024|Ulcerative Colitis|ulcerative colitis
152290|NCT03248011|hamstring|hamstring
152291|NCT03248011|ultrasound|ultrasound
152292|NCT03248011|intervention|intervention
152293|NCT03247998|Stroke|stroke
152294|NCT03247998|endovascular repair|endovascular repair
152295|NCT03247998|general anesthesia|general anesthesia
152296|NCT03247998|conscious sedation|conscious sedation
152297|NCT03247985|Mesh|mesh
152298|NCT03247985|Repair|repair
152299|NCT03247985|Peritoneal|peritoneal
152300|NCT03247959|oral health education, distraction, videogame|oral health education, distraction, videogame
152301|NCT03247946|infant|infant
152302|NCT03247946|feeding position|feeding position
152303|NCT03247946|respiratory|respiratory
152304|NCT03247946|ear|ear
152305|NCT03247933|COPD|copd
152306|NCT03247933|RESPIRATORY REHABILITATION TELEMEDICINE|respiratory rehabilitation telemedicine
152307|NCT03247920|Antibiotic switch therapy|antibiotic switch therapy
152308|NCT03247920|Amoxicillin/clavulanic acid|amoxicillin/clavulanic acid
152309|NCT03247894|Multiple sclerosis, anesthesia|multiple sclerosis, anesthesia
152310|NCT03247842|post mastectomy pain|post mastectomy pain
152311|NCT03247829|CardioMEMS|cardiomems
152312|NCT03247829|Left Ventricular Assist Device|left ventricular assist device
152313|NCT03247829|Hemodynamic Management|hemodynamic management
152314|NCT03247803|Air-Q® SP|air-q® sp
152315|NCT03247803|Williams Airway Intubator (WA)|williams airway intubator (wa)
152316|NCT03247803|Flexible Bronchoscopic intubation (FBI)|flexible bronchoscopic intubation (fbi)
152317|NCT03247803|Fiberoptic Intubation (FOI)|fiberoptic intubation (foi)
152318|NCT03247803|Fiberoptic Intubating Airway(FIA)|fiberoptic intubating airway(fia)
152319|NCT03247803|Laryngeal Mask Airway|laryngeal mask airway
152320|NCT03247777|golf|golf
152321|NCT03247777|strength training|strength training
152322|NCT03247777|physical performance tests|physical performance tests
152323|NCT03247777|body composition|body composition
152324|NCT03247738|ticagrelor|ticagrelor
152325|NCT03247738|cangrelor|cangrelor
152326|NCT03247712|HNSCC|hnscc
152327|NCT03247712|radiation|radiation
152328|NCT03247712|surgery|surgery
152329|NCT03247712|phase 1|phase 1
152330|NCT03247712|immunotherapy|immunotherapy
152331|NCT03247712|nivolumab|nivolumab
152332|NCT03247712|antibodies|antibodies
152333|NCT03247673|safety|safety
152334|NCT03247673|Pharmacokinetics|pharmacokinetics
152335|NCT03247673|Immunogenicity|immunogenicity
152336|NCT03247647|Alcohol Intervention|alcohol intervention
152337|NCT03247647|College Students|college students
152338|NCT03247634|getting ahead|getting ahead
152339|NCT03247634|vulnerable population|vulnerable population
152340|NCT03247634|safety net practice network|safety net practice network
152341|NCT03247621|external eating, technology|external eating, technology
152342|NCT03247608|Ambio Health|ambio health
152343|NCT03247595|Colonoscopy preparation|colonoscopy preparation
152344|NCT03247595|Magnesium Citrate Capsules|magnesium citrate capsules
152345|NCT03247582|Real World Evidence|real world evidence
152346|NCT03247582|Non-valvular Atrial Fibrillation|non-valvular atrial fibrillation
152347|NCT03247582|Observational Safety|observational safety
152348|NCT03247569|Non-valvular Atrial Fibrillation|non-valvular atrial fibrillation
152349|NCT03247569|Real World Evidence|real world evidence
152350|NCT03247569|Observational Safety|observational safety
152351|NCT03247491|Mindfulness|mindfulness
152352|NCT03247491|Compassion|compassion
152353|NCT03247491|Depression during Pregnancy and Postpartum|depression during pregnancy and postpartum
152354|NCT03247491|Prevention|prevention
152355|NCT03247491|Stress|stress
152356|NCT03247478|Computed tomography (CT) reconstruction|computed tomography (ct) reconstruction
152357|NCT03247478|axillary lymph node status|axillary lymph node status
152358|NCT03247452|Low fiber diet|low fiber diet
152359|NCT03247452|Colonoscopy|colonoscopy
152360|NCT03247452|Bowel Cleansing|bowel cleansing
152361|NCT03247439|CMC Joint|cmc joint
152362|NCT03247439|Osteoarthritis|osteoarthritis
152363|NCT03247439|Cartilage Replacement|cartilage replacement
152364|NCT03247439|First CMC Joint Osteoarthritis|first cmc joint osteoarthritis
152365|NCT03247439|Damaged Articular Surface|damaged articular surface
152366|NCT03247439|LRTI|lrti
152367|NCT03247439|Ligament Reconstruction Tendon Interposition|ligament reconstruction tendon interposition
152368|NCT03247387|Wearable device|wearable device
152369|NCT03247387|Patient monitor|patient monitor
152370|NCT03247374|rehabilitation|rehabilitation
152371|NCT03247374|treatment|treatment
152372|NCT03247374|biofeedback|biofeedback
152373|NCT03247374|bio-feedback|bio-feedback
152374|NCT03247374|dysphagia|dysphagia
152375|NCT03247374|swallowing disorders|swallowing disorders
152376|NCT03247374|post-stroke|post-stroke
152377|NCT03247374|deglutition disorders|deglutition disorders
152378|NCT03247361|Heart Failure; Rehabilitation|heart failure; rehabilitation
152379|NCT03247322|Medication Safety|medication safety
152380|NCT03247322|Mobile Health Technology|mobile health technology
152381|NCT03247309|T-cell therapy|t-cell therapy
152382|NCT03247309|immunotherapy|immunotherapy
152383|NCT03247309|adoptive cellular therapy|adoptive cellular therapy
152384|NCT03247309|T-Cell Receptor|t-cell receptor
152385|NCT03247309|IMA201|ima201
152386|NCT03247309|Cytotherapy|cytotherapy
152387|NCT03247309|Cell Therapy|cell therapy
152388|NCT03247309|Gene Therapy|gene therapy
152389|NCT03247296|Daclatasvir|daclatasvir
152390|NCT03247296|HCC|hcc
152391|NCT03247296|HCV|hcv
152392|NCT03247296|Sofosbuvir|sofosbuvir
194500|NCT02979847|hybrid|hybrid
152393|NCT03247244|Cannabis|cannabis
152394|NCT03247244|Tics|tics
152395|NCT03247244|Tourette Syndrome|tourette syndrome
152396|NCT03247231|Subepithelial tumors|subepithelial tumors
152397|NCT03247231|Submucosal tumors|submucosal tumors
152398|NCT03247231|Endoscopic band ligation|endoscopic band ligation
152399|NCT03247205|hip fracture|hip fracture
152400|NCT03247205|cognitive impairment|cognitive impairment
152401|NCT03247205|physical therapy|physical therapy
152402|NCT03247192|resistance training|resistance training
152403|NCT03247192|protein supplementation|protein supplementation
152404|NCT03247192|aging|aging
152405|NCT03247192|Randomized Controlled Trial|randomized controlled trial
152406|NCT03247127|hippocampal avoidance whole brain radiotherapy (HA-WBRT)|hippocampal avoidance whole brain radiotherapy (ha-wbrt)
152407|NCT03247127|brain metastases|brain metastases
152408|NCT03247127|memory preservation|memory preservation
152409|NCT03247127|neurocognitive function|neurocognitive function
152410|NCT03247075|Social anxiety disorder|social anxiety disorder
152411|NCT03247075|Cognitive Behavior Therapy|cognitive behavior therapy
152412|NCT03247075|Internet-delivered treatments|internet-delivered treatments
152413|NCT03247075|Children and adolescents|children and adolescents
152414|NCT03247075|Randomized controlled trial|randomized controlled trial
152415|NCT03247062|agitation, sleep deprivation, bundle|agitation, sleep deprivation, bundle
152416|NCT03246997|Food Insecure|food insecure
152417|NCT03246958|Thyroid Cancer|thyroid cancer
152418|NCT03246932|peer expert or specialist|peer expert or specialist
152419|NCT03246932|psycho-education|psycho-education
152420|NCT03246932|schizophrenia|schizophrenia
152421|NCT03246932|outpatients|outpatients
152422|NCT03246893|Sepsis|sepsis
152423|NCT03246893|Septic shock|septic shock
152424|NCT03246893|Severe sepsis|severe sepsis
152425|NCT03246893|Extubation|extubation
152426|NCT03246893|Reintubation|reintubation
152427|NCT03246893|Noninvasive positive pressure ventilation|noninvasive positive pressure ventilation
152428|NCT03246893|High flow oxygen nasal cannula|high flow oxygen nasal cannula
152429|NCT03246867|isolytic stretching|isolytic stretching
152430|NCT03246867|static stretching|static stretching
152431|NCT03246867|Glenohumeral Internal Rotation Deficit|glenohumeral internal rotation deficit
152432|NCT03246854|DBPR112|dbpr112
152433|NCT03246854|EGFR mutated NSCLC|egfr mutated nsclc
152434|NCT03246854|squamous cell cancer of head and neck|squamous cell cancer of head and neck
152435|NCT03246854|maximum tolerated dose|maximum tolerated dose
152436|NCT03246854|recommended Phase 2 dose|recommended phase 2 dose
152437|NCT03246841|Oncogeneticists|oncogeneticists
152438|NCT03246841|Mutations|mutations
152439|NCT03246841|Breast Cancer|breast cancer
152440|NCT03246841|Ovarian cancer|ovarian cancer
152441|NCT03246828|gliclazide|gliclazide
152442|NCT03246828|glucagon|glucagon
152443|NCT03246828|diabetes|diabetes
152444|NCT03246802|recurrent prostate cancer|recurrent prostate cancer
152445|NCT03246802|mpMRI|mpmri
152446|NCT03246802|salvage HDR brachytherapy|salvage hdr brachytherapy
152447|NCT03246763|childhood obesity|childhood obesity
152448|NCT03246750|Brentuximab Vedotin|brentuximab vedotin
152449|NCT03246724|Ocular surgery|ocular surgery
152450|NCT03246724|Intravenous sedation|intravenous sedation
152451|NCT03246724|Oral sedation|oral sedation
152452|NCT03246698|Stretching|stretching
152453|NCT03246698|Subacromial Impingement Syndrome|subacromial impingement syndrome
152454|NCT03246698|Glenohumeral Internal Rotation Deficit|glenohumeral internal rotation deficit
152455|NCT03246672|obesity, morbid|obesity, morbid
152456|NCT03246659|medullary thyroid carcinoma|medullary thyroid carcinoma
152457|NCT03246659|MTC|mtc
152458|NCT03246659|new gastrin analog|new gastrin analog
152459|NCT03246659|111In-CP04|111in-cp04
152460|NCT03246659|CP04 indium|cp04 indium
152461|NCT03246659|personalised diagnostics|personalised diagnostics
152462|NCT03246659|personalised therapy|personalised therapy
152463|NCT03246659|theranostics|theranostics
152464|NCT03246659|advanced MTC|advanced mtc
152465|NCT03246659|CCK-2/gastrin receptor|cck-2/gastrin receptor
152466|NCT03246646|Substance Abuse|substance abuse
152467|NCT03246646|Alcohol Abuse|alcohol abuse
152468|NCT03246620|emergency|emergency
152469|NCT03246620|emergency medicine|emergency medicine
152470|NCT03246620|sedation|sedation
152471|NCT03246620|acute agitation|acute agitation
152472|NCT03246594|atrial fibrillation|atrial fibrillation
152473|NCT03246594|esophageal probe|esophageal probe
152474|NCT03246594|thermolesion|thermolesion
152475|NCT03246581|inhalation|inhalation
152476|NCT03246581|anticholinergic|anticholinergic
152477|NCT03246568|Ablation|ablation
152478|NCT03246568|Renal Denervation|renal denervation
152479|NCT03246568|Cryoballoon|cryoballoon
152480|NCT03246477|maxillomandibular advancement osteotomy|maxillomandibular advancement osteotomy
152481|NCT03246477|long-term results|long-term results
152482|NCT03246477|quality of life|quality of life
152483|NCT03246477|polysomnographic measurements|polysomnographic measurements
152484|NCT03246477|skeletal stability|skeletal stability
152485|NCT03246464|Contact lenses|contact lenses
152486|NCT03246464|Children|children
152487|NCT03246464|Myopia|myopia
152488|NCT03246451|GLP-1|glp-1
152489|NCT03246451|glucagon-like peptide-1|glucagon-like peptide-1
152490|NCT03246451|Metformin|metformin
152491|NCT03246451|Exendin(9-39)|exendin(9-39)
152492|NCT03246399|SM04690|sm04690
152493|NCT03246399|Wnt pathway|wnt pathway
152494|NCT03246399|Samumed|samumed
152495|NCT03246373|cognitive impairment|cognitive impairment
152496|NCT03246334|Cohort study|cohort study
152497|NCT03246334|Critical Care|critical care
152498|NCT03246334|Follow-up study|follow-up study
152499|NCT03246334|Intensive care units|intensive care units
152500|NCT03246334|Long-term outcome|long-term outcome
152501|NCT03246334|Outcome assessment|outcome assessment
152502|NCT03246334|Quality of life|quality of life
152503|NCT03246321|Colorectal Neoplasms|colorectal neoplasms
152504|NCT03246321|Peritoneal Neoplasms|peritoneal neoplasms
152505|NCT03246321|Intraperitoneal Injections|intraperitoneal injections
152506|NCT03246321|Laparoscopy|laparoscopy
152507|NCT03246321|Aerosols|aerosols
152508|NCT03246321|Chemotherapy, Cancer, Regional Perfusion|chemotherapy, cancer, regional perfusion
152509|NCT03246321|Antineoplastic Agents|antineoplastic agents
152510|NCT03246321|Leucovorin|leucovorin
152511|NCT03246321|Fluorouracil|fluorouracil
152512|NCT03246321|Platinum|platinum
152513|NCT03246321|Intraoperative Complications|intraoperative complications
152514|NCT03246321|Postoperative Complications|postoperative complications
152515|NCT03246321|Drug-Related Side Effects and Adverse Reactions|drug-related side effects and adverse reactions
152516|NCT03246321|Disease-free survival|disease-free survival
152517|NCT03246321|Survival|survival
152518|NCT03246321|Mortality|mortality
152519|NCT03246321|Quality of Life|quality of life
152520|NCT03246321|Costs and Cost Analysis|costs and cost analysis
152521|NCT03246321|Translational Medical Research|translational medical research
152522|NCT03246321|Clinical Trials, Phase II as topic|clinical trials, phase ii as topic
152523|NCT03246321|PIPAC|pipac
152524|NCT03246321|Pressurized Intraperitoneal Aerosol Chemotherapy|pressurized intraperitoneal aerosol chemotherapy
152525|NCT03246321|Pressurised Intraperitoneal Aerosol Chemotherapy|pressurised intraperitoneal aerosol chemotherapy
152526|NCT03246321|Peritoneum|peritoneum
152527|NCT03246321|Cecal Neoplasms|cecal neoplasms
152528|NCT03246321|Oxaliplatin|oxaliplatin
152529|NCT03246295|Proteomics|proteomics
152530|NCT03246295|Metabolomics|metabolomics
152531|NCT03246256|acute|acute
152532|NCT03246256|informed consent|informed consent
152533|NCT03246256|thrombolysis|thrombolysis
152534|NCT03246243|Hypoxic Ischemic Encephalopathy|hypoxic ischemic encephalopathy
152535|NCT03246243|Bottle Feeding|bottle feeding
152536|NCT03246230|newborn vaccine responses|newborn vaccine responses
152537|NCT03246178|Haploidentical|haploidentical
152538|NCT03246178|Hematopoietic stem cell transplantation|hematopoietic stem cell transplantation
152539|NCT03246178|Severe aplastic anemia|severe aplastic anemia
152540|NCT03246152|Anti-VEGF safety|anti-vegf safety
152541|NCT03246152|Ischemic Maculopathy|ischemic maculopathy
152542|NCT03246152|Diabetic Macular Edema|diabetic macular edema
152543|NCT03246152|OCTA|octa
152544|NCT03246139|stroke|stroke
152545|NCT03246139|neurorehabilitation|neurorehabilitation
152546|NCT03246139|mirror neuron system|mirror neuron system
152547|NCT03246139|action observation|action observation
152548|NCT03246139|motor imagery|motor imagery
152549|NCT03246139|MEG|meg
152550|NCT03246113|GBM WHO Grade IV|gbm who grade iv
152551|NCT03246100|centralized reminder/recall|centralized reminder/recall
152552|NCT03246100|influenza vaccine reminders|influenza vaccine reminders
152553|NCT03246100|childhood influenza vaccines|childhood influenza vaccines
152554|NCT03246087|acupuncture|acupuncture
152555|NCT03246087|plantar fasiosis|plantar fasiosis
152556|NCT03246074|Phase I|phase i
152557|NCT03246074|Ovarian Cancer|ovarian cancer
152558|NCT03246074|Fostamatinib and Paclitaxel|fostamatinib and paclitaxel
152559|NCT03246035|Acute Decompensated Heart Failure|acute decompensated heart failure
152560|NCT03246035|Heart Failure|heart failure
152561|NCT03246035|Frailty|frailty
152562|NCT03246035|Geriatrics|geriatrics
152563|NCT03246035|Self-care|self-care
152564|NCT03246035|Emergency Medicine|emergency medicine
152565|NCT03246035|Cardiology|cardiology
152566|NCT03246035|Patient Oriented Research|patient oriented research
152567|NCT03246022|blood pressure fluctuation|blood pressure fluctuation
152568|NCT03246022|hypertension|hypertension
152569|NCT03246022|continuous positive airway pressure|continuous positive airway pressure
152570|NCT03246022|intermittent hypixa|intermittent hypixa
152571|NCT03246022|oxygen desaturation|oxygen desaturation
152572|NCT03246009|Neutropenia|neutropenia
152573|NCT03246009|Chemotherapy|chemotherapy
152574|NCT03246009|rHSA/GCSF|rhsa/gcsf
152575|NCT03245996|sick sinus syndrome|sick sinus syndrome
152576|NCT03245996|heart rate|heart rate
152577|NCT03245996|aortic blood pressure|aortic blood pressure
152578|NCT03245996|artificial pacemaker|artificial pacemaker
152579|NCT03245996|beta-blockers|beta-blockers
152580|NCT03245996|ivabradine|ivabradine
152581|NCT03245944|immature AVF|immature avf
152582|NCT03245944|percutaneous intervention|percutaneous intervention
152583|NCT03245892|Nivolumab|nivolumab
152584|NCT03245892|Paclitaxel|paclitaxel
152585|NCT03245892|Carboplatin|carboplatin
152586|NCT03245892|17-182|17-182
152587|NCT03245866|Subarachnoid Hemorrhage|subarachnoid hemorrhage
152588|NCT03245866|Intracranial Aneurysm|intracranial aneurysm
152589|NCT03245866|Ruptured Intracranial Aneurysm|ruptured intracranial aneurysm
152590|NCT03245866|Neurosurgery|neurosurgery
152591|NCT03245866|Interventional Neuroradiology|interventional neuroradiology
152592|NCT03245866|Neurointensive Care Medicine|neurointensive care medicine
152593|NCT03245866|Switzerland|switzerland
152594|NCT03245853|Keratoconus|keratoconus
152595|NCT03245853|Corneal Crosslinking|corneal crosslinking
152596|NCT03245853|CXL|cxl
152597|NCT03245814|service dogs|service dogs
152598|NCT03245814|human-animal interaction|human-animal interaction
152599|NCT03245801|Juvenile idiopathic arthritis|juvenile idiopathic arthritis
152600|NCT03245801|Canada|canada
152601|NCT03245801|Registry|registry
152602|NCT03245801|Clinical outcomes|clinical outcomes
152603|NCT03245801|Adverse events|adverse events
152604|NCT03245801|CAPRI|capri
152605|NCT03245788|Lay Navigator|lay navigator
152606|NCT03245788|Quality of Care|quality of care
152607|NCT03245788|High-Need Cancer Treatment Regimen|high-need cancer treatment regimen
152608|NCT03245775|health disparities|health disparities
152609|NCT03245775|community-based participatory research|community-based participatory research
152610|NCT03245749|omega-3 status|omega-3 status
152611|NCT03245749|blood lipids|blood lipids
152612|NCT03245749|Eicosapentaenoic acid (EPA)|eicosapentaenoic acid (epa)
152613|NCT03245749|Docosahexaenoic acid (DHA)|docosahexaenoic acid (dha)
152614|NCT03245723|premature adults|premature adults
152615|NCT03245723|premature|premature
152616|NCT03245723|premature lung function|premature lung function
152617|NCT03245723|premature cardiac function|premature cardiac function
152618|NCT03245723|MRI|mri
152619|NCT03245723|PET|pet
152620|NCT03245697|breast milk|breast milk
152621|NCT03245697|composition|composition
152622|NCT03245697|Galicia|galicia
152623|NCT03245697|diet|diet
152624|NCT03245697|lactation|lactation
152625|NCT03245684|ARDS|ards
152626|NCT03245684|Ventilator-induced Lung Injury|ventilator-induced lung injury
152627|NCT03245684|cytokines|cytokines
152628|NCT03245684|mechanical ventilation|mechanical ventilation
152629|NCT03245645|FODMAP|fodmap
152630|NCT03245645|IBS|ibs
152631|NCT03245645|Diet|diet
152632|NCT03245645|Re-introduction|re-introduction
152633|NCT03245645|Fructose|fructose
152634|NCT03245619|3-hydroxykynurenine|3-hydroxykynurenine
152635|NCT03245619|Acute pancreatitis|acute pancreatitis
152636|NCT03245619|Dose-escalation|dose-escalation
152637|NCT03245619|Healthy subjects|healthy subjects
152638|NCT03245619|GSK3335065|gsk3335065
152639|NCT03245606|NAFLD|nafld
152640|NCT03245606|steatosis|steatosis
152641|NCT03245606|fibrosis|fibrosis
152642|NCT03245606|transient elastography|transient elastography
152643|NCT03245554|Gastrointestinal Cancer|gastrointestinal cancer
152644|NCT03245554|Propranolol|propranolol
152645|NCT03245541|SBRT/SABR; Durvalumab; Locally advanced; Borderline resectable|sbrt/sabr; durvalumab; locally advanced; borderline resectable
152646|NCT03245502|tissue oxygenation|tissue oxygenation
152647|NCT03245450|eribulin mesilate|eribulin mesilate
152648|NCT03245450|irinotecan|irinotecan
152649|NCT03245450|combination therapy|combination therapy
152650|NCT03245450|children|children
152651|NCT03245437|Social Cognition|social cognition
152652|NCT03245437|Oxytocin|oxytocin
152653|NCT03245372|cardiac output|cardiac output
152654|NCT03245372|perioperative care|perioperative care
152655|NCT03245372|postoperative complications|postoperative complications
152656|NCT03245359|Total Knee Arthroplasty|total knee arthroplasty
152657|NCT03245359|Intra-articular Analgesia|intra-articular analgesia
152658|NCT03245359|Bupivacaine Hydrochloride|bupivacaine hydrochloride
152659|NCT03245294|cervical epidural space|cervical epidural space
152660|NCT03245294|abrupt pressure decrease|abrupt pressure decrease
152661|NCT03245281|Heart Failure|heart failure
152662|NCT03245268|Balloon pulmonary angioplasty|balloon pulmonary angioplasty
152663|NCT03245268|BPA|bpa
152664|NCT03245255|pressure measurements|pressure measurements
152665|NCT03245255|blood pressure|blood pressure
152666|NCT03245255|contrast echocardiography|contrast echocardiography
152667|NCT03245255|ventricular pressures|ventricular pressures
152668|NCT03245255|catheterization|catheterization
152669|NCT03245242|enhanced recovery after surgery|enhanced recovery after surgery
152670|NCT03245242|urologic reconstruction|urologic reconstruction
152671|NCT03245242|pediatric urology|pediatric urology
152672|NCT03245242|bladder augmentation|bladder augmentation
152673|NCT03245242|Mitrofanoff|mitrofanoff
152674|NCT03245242|Malone antegrade continence enema channel|malone antegrade continence enema channel
152675|NCT03245242|appendicovesicostomy|appendicovesicostomy
152676|NCT03245242|ileovesicostomy|ileovesicostomy
152677|NCT03245242|appendicocecostomy|appendicocecostomy
152678|NCT03245216|Parkinson's Disease|parkinson's disease
152679|NCT03245216|motor learning|motor learning
152680|NCT03245216|aerobic exercise|aerobic exercise
152681|NCT03245216|cardiovascular exercise|cardiovascular exercise
152682|NCT03245216|balance|balance
152683|NCT03245216|postural instability|postural instability
152684|NCT03245216|motor skill|motor skill
152685|NCT03245203|neoadjuvant chemotherapy|neoadjuvant chemotherapy
152686|NCT03245164|obese children|obese children
152687|NCT03245164|motor skills|motor skills
152688|NCT03245164|physiotherapy|physiotherapy
152689|NCT03245164|basketball|basketball
152690|NCT03245151|pediatrics|pediatrics
152691|NCT03245151|central nervous system tumors|central nervous system tumors
152692|NCT03245151|lenvatinib|lenvatinib
152693|NCT03245151|E7080|e7080
152694|NCT03245151|everolimus|everolimus
152695|NCT03245151|Ewing sarcoma/peripheral primitive neuroectodermal tumor|ewing sarcoma/peripheral primitive neuroectodermal tumor
152696|NCT03245151|rhabdomyosarcoma|rhabdomyosarcoma
152697|NCT03245151|high grade glioma|high grade glioma
152698|NCT03245151|solid tumors|solid tumors
152699|NCT03245138|endoscopic third ventriculostomy|endoscopic third ventriculostomy
152700|NCT03245138|ventricular peritoneal shunt|ventricular peritoneal shunt
152701|NCT03245138|communicating hydrocephalus|communicating hydrocephalus
152702|NCT03245060|psychosocial well-being|psychosocial well-being
152703|NCT03245060|solution focused brief therapy|solution focused brief therapy
152704|NCT03245034|Medical Residents|medical residents
152705|NCT03245034|Well-Being|well-being
152706|NCT03245034|Stress/Burnout in Medical Residents|stress/burnout in medical residents
152707|NCT03244982|fluorescein|fluorescein
152708|NCT03244982|angiography|angiography
152709|NCT03244969|Hematoma fracture, angiogenesis, bone formation|hematoma fracture, angiogenesis, bone formation
152710|NCT03244917|Nursing home|nursing home
152711|NCT03244917|Palliative Care|palliative care
152712|NCT03244917|Dementia|dementia
152713|NCT03244917|Infection|infection
152714|NCT03244917|Antimicrobials|antimicrobials
152715|NCT03244904|NGS,SCLC, ctDNA|ngs,sclc, ctdna
152716|NCT03244878|Cognitive Behavior Therapy|cognitive behavior therapy
152717|NCT03244852|OCD|ocd
153213|NCT03241277|DSM-IV TR|dsm-iv tr
152718|NCT03244852|deep brain stimulation|deep brain stimulation
152719|NCT03244852|treatment-resistant OCD|treatment-resistant ocd
152720|NCT03244826|Cancer|cancer
152721|NCT03244800|0382, T2DM|0382, t2dm
152722|NCT03244761|high flow tracheal oxygen|high flow tracheal oxygen
152723|NCT03244761|modified interface|modified interface
152724|NCT03244735|Ketogenic Diet|ketogenic diet
152725|NCT03244709|Giant cell arteritis,|giant cell arteritis,
152726|NCT03244709|Tocilizumab|tocilizumab
152727|NCT03244709|Aortitis|aortitis
152728|NCT03244709|Remission|remission
152729|NCT03244696|Multiple Sclerosis|multiple sclerosis
152730|NCT03244696|Sclerosis|sclerosis
152731|NCT03244696|Demyelinating Autoimmune Diseases, Central Nervous System|demyelinating autoimmune diseases, central nervous system
152732|NCT03244696|Autoimmune Diseases of the Nervous System|autoimmune diseases of the nervous system
152733|NCT03244696|Nervous System Diseases|nervous system diseases
152734|NCT03244696|Demyelinating Diseases|demyelinating diseases
152735|NCT03244696|Immune System Diseases|immune system diseases
152736|NCT03244696|Physical Activity|physical activity
152737|NCT03244696|Walking|walking
152738|NCT03244696|Hydration|hydration
152739|NCT03244696|Lifestyle Intervention|lifestyle intervention
152740|NCT03244696|Health Behavior Tracking|health behavior tracking
152741|NCT03244696|Inflammatory Biomarkers|inflammatory biomarkers
152742|NCT03244696|Neurodegenerative Disease|neurodegenerative disease
152743|NCT03244670|Myopia|myopia
152744|NCT03244644|C Difficile Colitis|c difficile colitis
152745|NCT03244644|Clostridium Difficile|clostridium difficile
152746|NCT03244644|CDI|cdi
152747|NCT03244644|C.Difficile Diarrhea|c.difficile diarrhea
152748|NCT03244644|Fecal Transplant|fecal transplant
152749|NCT03244644|Fecal Microbiota Transplant|fecal microbiota transplant
152750|NCT03244644|Microbiota Restoration Therapy|microbiota restoration therapy
152751|NCT03244644|Diarrhea|diarrhea
152752|NCT03244644|FMT|fmt
152753|NCT03244644|Microbial Suspension|microbial suspension
152754|NCT03244592|Minocycline|minocycline
152755|NCT03244566|positron emission tomography|positron emission tomography
152756|NCT03244566|cervical lymphatic metastasis|cervical lymphatic metastasis
152757|NCT03244540|postoperative pain|postoperative pain
152758|NCT03244540|transversus abdominis plane block|transversus abdominis plane block
152759|NCT03244540|quadratus lumborum block|quadratus lumborum block
152760|NCT03244540|neuropathic pain|neuropathic pain
152761|NCT03244527|BCAA|bcaa
152762|NCT03244527|stroke|stroke
152763|NCT03244527|mobility|mobility
152764|NCT03244514|cardiac surgery|cardiac surgery
152765|NCT03244514|KDIGO-Guideline|kdigo-guideline
152766|NCT03244501|tSMS|tsms
152767|NCT03244501|Transcranial Static Magnetic Field Stimulation|transcranial static magnetic field stimulation
152768|NCT03244501|healthy control|healthy control
152769|NCT03244475|mild Traumatic Brain Injury|mild traumatic brain injury
152770|NCT03244475|transcranial electrical stimulation|transcranial electrical stimulation
152771|NCT03244475|neurofeedback|neurofeedback
152772|NCT03244475|magnetoencephalography|magnetoencephalography
152773|NCT03244475|post-traumatic stress disorder|post-traumatic stress disorder
152774|NCT03244449|biomarker|biomarker
152775|NCT03244449|insulin resistance|insulin resistance
152776|NCT03244449|myokine|myokine
152777|NCT03244449|clamp|clamp
152778|NCT03244423|Pediatric|pediatric
152779|NCT03244423|Cyanotic heart disease|cyanotic heart disease
152780|NCT03244423|Tranexamic acid|tranexamic acid
152781|NCT03244423|Postoperative blood loss|postoperative blood loss
152782|NCT03244358|Triple Negative Breast Cancer|triple negative breast cancer
152783|NCT03244358|Epalrestat|epalrestat
152784|NCT03244306|leukemia|leukemia
152785|NCT03244306|CD 22|cd 22
152786|NCT03244306|CAR T cell|car t cell
152787|NCT03244306|pediatric|pediatric
152788|NCT03244306|young adult|young adult
152789|NCT03244306|chimeric antigen receptor|chimeric antigen receptor
152790|NCT03244267|Orthopedics|orthopedics
152791|NCT03244254|Celiac Disease|celiac disease
152792|NCT03244254|Children|children
152793|NCT03244254|I-FABP|i-fabp
152794|NCT03244241|Type 2 diabetes, inpatient diabetes management, basal-bolus insulin|type 2 diabetes, inpatient diabetes management, basal-bolus insulin
152795|NCT03244228|First in human|first in human
152796|NCT03244228|Multiple ascending dose|multiple ascending dose
152797|NCT03244228|Single ascending dose|single ascending dose
152798|NCT03244215|Recurrence of stroke|recurrence of stroke
152799|NCT03244215|Corneal Confocal Microscopy|corneal confocal microscopy
152800|NCT03244215|High performance liquid chromatography,|high performance liquid chromatography,
152801|NCT03244215|Inflammatory biomarkers|inflammatory biomarkers
152802|NCT03244215|modified Rankin scale ( mRS)|modified rankin scale ( mrs)
152803|NCT03244202|Incidental Findings|incidental findings
152804|NCT03244202|Decision Aids|decision aids
152805|NCT03244202|Genomic Sequencing|genomic sequencing
152806|NCT03244202|Randomized Controlled Trail|randomized controlled trail
152807|NCT03244202|Genetic Counselling|genetic counselling
152808|NCT03244189|Urinary Stone Disease|urinary stone disease
152809|NCT03244189|Kidney Stone|kidney stone
152810|NCT03244189|Urinary Calculi|urinary calculi
152811|NCT03244176|DLBCL|dlbcl
152812|NCT03244163|Spyglass DS|spyglass ds
154575|NCT03233490|willingness|willingness
152813|NCT03244163|Laser lithotripsy|laser lithotripsy
152814|NCT03244163|Endoscopic retrograde cholangiopancreatography|endoscopic retrograde cholangiopancreatography
152815|NCT03244150|Physical activity|physical activity
152816|NCT03244150|Obesity|obesity
152817|NCT03244150|Overweight|overweight
152818|NCT03244150|Lifestyle|lifestyle
152819|NCT03244150|Diet|diet
152820|NCT03244124|dentin bonding agents|dentin bonding agents
152821|NCT03244124|tooth sensitivity|tooth sensitivity
152822|NCT03244124|composite resin restoration|composite resin restoration
152823|NCT03244059|COPD|copd
152824|NCT03244059|belimumab|belimumab
152825|NCT03244059|biologic agent|biologic agent
152826|NCT03244059|GRP78|grp78
152827|NCT03244046|Low Back pain|low back pain
152828|NCT03244046|Pain|pain
152829|NCT03244046|Posttraumatic Stress Disorder|posttraumatic stress disorder
152830|NCT03244046|PTSD|ptsd
152831|NCT03244046|Somatic Experiencing|somatic experiencing
152832|NCT03244046|SE|se
152833|NCT03244033|context|context
152834|NCT03244033|contextual error|contextual error
152835|NCT03244033|contextual care|contextual care
152836|NCT03244033|electronic medical record|electronic medical record
152837|NCT03244033|clinical decision support|clinical decision support
152838|NCT03244007|macular hole|macular hole
152839|NCT03244007|lamellar macular hole|lamellar macular hole
152840|NCT03243994|Cor pulmonale|cor pulmonale
152841|NCT03243994|COPD|copd
152842|NCT03243994|Malabsorption|malabsorption
152843|NCT03243994|D-xylose|d-xylose
152844|NCT03243994|Zinc|zinc
152845|NCT03243955|acupuncture|acupuncture
152846|NCT03243955|TENS|tens
152847|NCT03243955|TEAS|teas
152848|NCT03243955|constipation|constipation
152849|NCT03243955|transcutaneous|transcutaneous
152850|NCT03243942|pressure measurements|pressure measurements
152851|NCT03243942|blood pressure|blood pressure
152852|NCT03243942|contrast echocardiography|contrast echocardiography
152853|NCT03243942|ventricular pressures|ventricular pressures
152854|NCT03243942|catheterization|catheterization
152855|NCT03243916|interventional therapy|interventional therapy
152856|NCT03243916|TACE|tace
152857|NCT03243916|Cyberknife|cyberknife
152858|NCT03243903|T2DM|t2dm
152859|NCT03243903|QS-M needle free injector|qs-m needle free injector
152860|NCT03243903|insulin pen|insulin pen
152861|NCT03243903|effective|effective
152862|NCT03243903|safety|safety
152863|NCT03243877|Screening|screening
152864|NCT03243877|Mammography|mammography
152865|NCT03243851|Glioblastoma|glioblastoma
152866|NCT03243838|Triple-Negative Breast Cancer|triple-negative breast cancer
152867|NCT03243838|apatinib|apatinib
152868|NCT03243838|pCR|pcr
152869|NCT03243838|OS|os
152870|NCT03243838|Neoadjuvant chemotherapy|neoadjuvant chemotherapy
152871|NCT03243825|neoadjuvant chemotherapy|neoadjuvant chemotherapy
152872|NCT03243825|brachytherapy|brachytherapy
152873|NCT03243825|radiotherapy|radiotherapy
152874|NCT03243812|Sickle Cell Disease|sickle cell disease
152875|NCT03243812|Muscle function|muscle function
152876|NCT03243812|Hemorheological disorders|hemorheological disorders
152877|NCT03243760|CCI15106|cci15106
152878|NCT03243760|pharmacokinetics|pharmacokinetics
152879|NCT03243760|BAL|bal
152880|NCT03243760|COPD|copd
152881|NCT03243734|spray cryotherapy|spray cryotherapy
152882|NCT03243734|quality of life|quality of life
152883|NCT03243734|symptom reduction|symptom reduction
152884|NCT03243734|esophageal malignancies|esophageal malignancies
152885|NCT03243734|liquid nitrogen|liquid nitrogen
152886|NCT03243734|ablation|ablation
152887|NCT03243721|multiple sclerosis|multiple sclerosis
152888|NCT03243721|thalamus|thalamus
152889|NCT03243721|high field MRI|high field mri
152890|NCT03243721|cognition|cognition
152891|NCT03243708|Venous Thromboembolism Risk Calculator|venous thromboembolism risk calculator
152892|NCT03243695|immediate implants, implant failure, angled abutments|immediate implants, implant failure, angled abutments
152893|NCT03243682|Shock wave lithotripsy|shock wave lithotripsy
152894|NCT03243682|Bidirectional|bidirectional
152895|NCT03243682|Stones|stones
152896|NCT03243669|Colonoscopy|colonoscopy
152897|NCT03243669|High-definition endoscopy|high-definition endoscopy
152898|NCT03243669|Virtual chromoendoscopy|virtual chromoendoscopy
152899|NCT03243669|Adenoma detection rate (ADR)|adenoma detection rate (adr)
152900|NCT03243604|Cardiotoxicity|cardiotoxicity
152901|NCT03243604|abiraterone acetate|abiraterone acetate
152902|NCT03243604|androgen antagonist|androgen antagonist
152903|NCT03243565|adenoid hypertrophy|adenoid hypertrophy
152904|NCT03243565|Adenoid Hyperplasia|adenoid hyperplasia
152905|NCT03243565|children|children
152906|NCT03243565|respiratory tract infection|respiratory tract infection
152907|NCT03243565|adenotonsillectomy|adenotonsillectomy
152908|NCT03243565|OM-85|om-85
152909|NCT03243539|lung protective ventilation|lung protective ventilation
152910|NCT03243500|atracurium|atracurium
152911|NCT03243500|high myopes|high myopes
152912|NCT03243500|percaruncular|percaruncular
152913|NCT03243500|phacoemulsification|phacoemulsification
152914|NCT03243500|medial canthal|medial canthal
152915|NCT03243500|ophthalmic regional anesthesia|ophthalmic regional anesthesia
152916|NCT03243461|Glioblastoma|glioblastoma
152917|NCT03243461|high grade glioma|high grade glioma
152918|NCT03243461|brain tumor|brain tumor
152919|NCT03243461|Anaplastic astrocytoma|anaplastic astrocytoma
152920|NCT03243461|DIPG|dipg
152921|NCT03243461|Gliomatosis cerebri|gliomatosis cerebri
152922|NCT03243461|Diffuse midline glioma|diffuse midline glioma
152923|NCT03243409|reversed shoulder arthroplasties|reversed shoulder arthroplasties
152924|NCT03243409|clinical complications|clinical complications
152925|NCT03243409|complex proximal humeral fractures|complex proximal humeral fractures
152926|NCT03243396|Mental health|mental health
152927|NCT03243396|Cognitive behavioral therapy|cognitive behavioral therapy
152928|NCT03243396|Task-shifting|task-shifting
152929|NCT03243396|Global health|global health
152930|NCT03243396|Teacher|teacher
152931|NCT03243396|Community health volunteer|community health volunteer
152932|NCT03243396|Children|children
152933|NCT03243396|Orphans|orphans
152934|NCT03243396|Abandoned children|abandoned children
152935|NCT03243396|TF-CBT|tf-cbt
152936|NCT03243396|Mental health policy|mental health policy
152937|NCT03243396|Ministry of Education|ministry of education
152938|NCT03243396|Ministry of Health|ministry of health
152939|NCT03243396|Delivery|delivery
152940|NCT03243396|Implementation science|implementation science
152941|NCT03243396|Qualitative comparative analysis|qualitative comparative analysis
152942|NCT03243396|Implementation practices and policies|implementation practices and policies
152943|NCT03243396|Youth|youth
152944|NCT03243396|Adoption|adoption
152945|NCT03243396|Fidelity|fidelity
152946|NCT03243396|Kenya|kenya
152947|NCT03243396|Bungoma|bungoma
152948|NCT03243396|Kanduyi|kanduyi
152949|NCT03243396|East Africa|east africa
152950|NCT03243396|Posttraumatic stress|posttraumatic stress
152951|NCT03243396|Childhood traumatic grief|childhood traumatic grief
152952|NCT03243396|Grief|grief
152953|NCT03243396|Trauma|trauma
152954|NCT03243383|readmission|readmission
152955|NCT03243370|Validate the Clock'nTest|validate the clock'ntest
152956|NCT03243357|Endodontics, molars, instrumentation, obturation, anatomy|endodontics, molars, instrumentation, obturation, anatomy
152957|NCT03243331|Breast Cancer|breast cancer
152958|NCT03243292|Bronchial Thermoplasty|bronchial thermoplasty
152959|NCT03243292|Alair|alair
152960|NCT03243292|Registry|registry
152961|NCT03243227|carpal tunnel syndrome|carpal tunnel syndrome
152962|NCT03243227|neurodynamics|neurodynamics
152963|NCT03243227|median nerve gliding exercise|median nerve gliding exercise
152964|NCT03243214|Transcranial Magnetic Stimulation|transcranial magnetic stimulation
152965|NCT03243188|Palliative Care|palliative care
152966|NCT03243175|intracerebral hemorrhage|intracerebral hemorrhage
152967|NCT03243175|atrial fibrillation|atrial fibrillation
152968|NCT03243175|microhemorrhage|microhemorrhage
152969|NCT03243175|oral anticoagulation|oral anticoagulation
152970|NCT03243175|left atrial appendage closure|left atrial appendage closure
152971|NCT03243084|tACS|tacs
152972|NCT03243084|transcranial alternating current stimulation|transcranial alternating current stimulation
152973|NCT03243084|low back pain|low back pain
152974|NCT03243084|chronic pain|chronic pain
152975|NCT03243084|alpha oscillations|alpha oscillations
152976|NCT03243084|heart rate variability|heart rate variability
152977|NCT03243071|Medical Care|medical care
152978|NCT03243071|Racial Discrimination|racial discrimination
152979|NCT03243071|Poor Health Literacy|poor health literacy
152980|NCT03243071|Medical Care Disparities|medical care disparities
152981|NCT03243045|Arterial hypertension|arterial hypertension
152982|NCT03243045|Microcirculation|microcirculation
152983|NCT03243045|Sympathetic nervous system|sympathetic nervous system
152984|NCT03243019|cervico-facial|cervico-facial
152985|NCT03243019|rapamycin|rapamycin
152986|NCT03243006|acute pain|acute pain
152987|NCT03243006|emergency department|emergency department
152988|NCT03243006|opioid consumption|opioid consumption
152989|NCT03242980|HIV|hiv
152990|NCT03242980|Adherence|adherence
152991|NCT03242980|Viral re-suppression|viral re-suppression
152992|NCT03242980|Step-wedgged randomized trial|step-wedgged randomized trial
152993|NCT03242967|Anemia|anemia
152994|NCT03242967|hemoglobin|hemoglobin
152995|NCT03242967|darbepoetin alfa|darbepoetin alfa
152996|NCT03242967|TIW|tiw
152997|NCT03242967|hypoxia-inducible factor prolyl-hydroxylase inhibitor|hypoxia-inducible factor prolyl-hydroxylase inhibitor
152998|NCT03242967|HIF-PHI|hif-phi
152999|NCT03242967|AKB-6548|akb-6548
153000|NCT03242967|vadadustat|vadadustat
153001|NCT03242967|renal|renal
153002|NCT03242967|hypoxia-inducible factor|hypoxia-inducible factor
153003|NCT03242967|HIF|hif
153004|NCT03242967|dialysis-dependent chronic kidney disease|dialysis-dependent chronic kidney disease
153005|NCT03242967|CKD|ckd
153006|NCT03242967|DD-CKD|dd-ckd
153007|NCT03242967|kidney|kidney
153008|NCT03242967|erythropoiesis stimulating agent|erythropoiesis stimulating agent
153009|NCT03242967|ESA|esa
153010|NCT03242928|Cocaine Use Disorder; cocaine dependence|cocaine use disorder; cocaine dependence
153011|NCT03242902|light therapy|light therapy
153012|NCT03242902|cancer related fatigue|cancer related fatigue
155162|NCT03229291|SM04755|sm04755
153013|NCT03242902|sleep quality|sleep quality
153014|NCT03242902|biological rhythms|biological rhythms
153015|NCT03242850|Reading|reading
153016|NCT03242850|Text Messages|text messages
153017|NCT03242850|Video|video
153018|NCT03242850|Cognitive Development|cognitive development
153019|NCT03242850|Child Development|child development
153020|NCT03242850|Infants|infants
153021|NCT03242811|Medical age assessment|medical age assessment
153022|NCT03242798|liver cirrhosis|liver cirrhosis
153023|NCT03242798|malnutrition|malnutrition
153024|NCT03242798|nutritional status|nutritional status
153025|NCT03242798|nutritional assessment|nutritional assessment
153026|NCT03242785|Self-monitoring|self-monitoring
153027|NCT03242785|Education|education
153028|NCT03242785|Self-titration|self-titration
153029|NCT03242785|antihypertensives|antihypertensives
153030|NCT03242746|LEEP|leep
153031|NCT03242746|Loop Electrosurgical Excision Procedure|loop electrosurgical excision procedure
153032|NCT03242746|Cervical Intraepithelial Neoplasia|cervical intraepithelial neoplasia
153033|NCT03242746|pregnancy outcome|pregnancy outcome
153034|NCT03242733|Gastroparesis|gastroparesis
153035|NCT03242694|persistent atrial fibrillation|persistent atrial fibrillation
153036|NCT03242694|pulmonary vein isolation|pulmonary vein isolation
153037|NCT03242694|catheter ablation|catheter ablation
153038|NCT03242694|left atrial function|left atrial function
153039|NCT03242694|left atrial pressure|left atrial pressure
153040|NCT03242694|voltage map|voltage map
153041|NCT03242694|strain|strain
153042|NCT03242694|scar|scar
153043|NCT03242694|success|success
153044|NCT03242694|biomarker|biomarker
153045|NCT03242668|paravertebral block,PVC,PCA|paravertebral block,pvc,pca
153046|NCT03242642|Heart disease|heart disease
153047|NCT03242642|valve disease|valve disease
153048|NCT03242642|heart valve disease|heart valve disease
153049|NCT03242642|mitral regurgitation|mitral regurgitation
153050|NCT03242642|cardiovascular disease|cardiovascular disease
153051|NCT03242642|mitral insufficiency|mitral insufficiency
153052|NCT03242629|pediatric ophthalmic examination|pediatric ophthalmic examination
153053|NCT03242629|chloral hydrate|chloral hydrate
153054|NCT03242629|Effects Comparison|effects comparison
153055|NCT03242603|Relapsed, Refractory, Neuroblastoma|relapsed, refractory, neuroblastoma
153056|NCT03242603|Anti-GD2|anti-gd2
153057|NCT03242603|Natural Killer (NK) Cells|natural killer (nk) cells
153058|NCT03242603|Immunotherapy|immunotherapy
153059|NCT03242538|Exercise|exercise
153060|NCT03242512|RANKL|rankl
153061|NCT03242512|osteoporosis|osteoporosis
153062|NCT03242512|bone resorption|bone resorption
153063|NCT03242512|post-menopausal women|post-menopausal women
153064|NCT03242512|TK006|tk006
153065|NCT03242434|Mannitol|mannitol
153066|NCT03242434|Intestinal permeability|intestinal permeability
153067|NCT03242434|Thermal injury|thermal injury
153068|NCT03242434|HESTIA|hestia
153069|NCT03242434|Sucralose|sucralose
153070|NCT03242434|Lactulose|lactulose
153071|NCT03242421|test-retest reliability|test-retest reliability
153072|NCT03242421|Binocular vision tests|binocular vision tests
153073|NCT03242395|Neuroinflammation|neuroinflammation
153074|NCT03242395|fMRI|fmri
153075|NCT03242395|Post-operative cognitive dysfunction|post-operative cognitive dysfunction
153076|NCT03242395|Systemic inflammation|systemic inflammation
153077|NCT03242395|Severe burns|severe burns
153078|NCT03242382|advanced|advanced
153079|NCT03242382|sarcoma|sarcoma
153080|NCT03242382|cdk4|cdk4
153081|NCT03242369|colorectal neoplasia|colorectal neoplasia
153082|NCT03242369|colonoscopy|colonoscopy
153083|NCT03242369|quality of bowel cleansing|quality of bowel cleansing
153084|NCT03242369|bowel preparation|bowel preparation
153085|NCT03242330|Implant survival|implant survival
153086|NCT03242330|Patient satisfaction|patient satisfaction
153087|NCT03242278|Non-valvular atrial fibrillation (NVAF)|non-valvular atrial fibrillation (nvaf)
153088|NCT03242278|Prevention|prevention
153089|NCT03242278|Stroke|stroke
153090|NCT03242239|HER2 Positive Breast Cancer|her2 positive breast cancer
153091|NCT03242239|Trastuzumab|trastuzumab
153092|NCT03242239|Biosimilar|biosimilar
153093|NCT03242226|+3.00ADD|+3.00add
153094|NCT03242226|single vision spectacle|single vision spectacle
153095|NCT03242200|survivors of childhood cancer|survivors of childhood cancer
153096|NCT03242200|young adult female|young adult female
153097|NCT03242200|mobile app|mobile app
153098|NCT03242200|questionnaire|questionnaire
153099|NCT03242200|health tracking|health tracking
153100|NCT03242187|Minimally invasive surgery|minimally invasive surgery
153101|NCT03242187|trans-anal total mesorectal excision|trans-anal total mesorectal excision
153102|NCT03242187|Laparoscopic total mesoretal excision|laparoscopic total mesoretal excision
153103|NCT03242070|Patient Portals|patient portals
153104|NCT03242070|Chronic Disease|chronic disease
153105|NCT03242070|Older Adults|older adults
153106|NCT03242057|NAVA|nava
153107|NCT03242057|Extubation|extubation
153108|NCT03242057|NIPPV|nippv
153109|NCT03241992|Inflammatory Bowel Disease|inflammatory bowel disease
153110|NCT03241992|IBD|ibd
153111|NCT03241992|Electronic Health Record|electronic health record
153112|NCT03241992|Patient Portal|patient portal
153113|NCT03241992|Quality of Life|quality of life
153114|NCT03241966|Parkinson's Disease|parkinson's disease
153115|NCT03241966|Online Study|online study
153116|NCT03241966|Quality of Life|quality of life
153117|NCT03241966|Activities of Daily Living|activities of daily living
153118|NCT03241966|Perception|perception
153119|NCT03241966|Cognition|cognition
153120|NCT03241966|Gait|gait
153121|NCT03241927|Pembrolizumab|pembrolizumab
153122|NCT03241927|NK Cell Exhaustion|nk cell exhaustion
153123|NCT03241927|PD-1|pd-1
153124|NCT03241927|Unresectable|unresectable
153125|NCT03241927|Stage III|stage iii
153126|NCT03241927|Stage IV|stage iv
153127|NCT03241901|Artemether-Lumefantrine, Primaquine|artemether-lumefantrine, primaquine
153128|NCT03241888|Levonorgestrel-releasing intrauterine system|levonorgestrel-releasing intrauterine system
153129|NCT03241888|megestrol acetate|megestrol acetate
153130|NCT03241888|Atypical Endometrial Hyperplasia|atypical endometrial hyperplasia
153131|NCT03241875|pregabalin|pregabalin
153132|NCT03241875|gabapentin|gabapentin
153133|NCT03241875|post operative pain|post operative pain
153134|NCT03241875|laparoscopic cholecystectomy|laparoscopic cholecystectomy
153135|NCT03241810|Breast Cancer, HER2 Negative, Hormone receptor positive, heregulin|breast cancer, her2 negative, hormone receptor positive, heregulin
153136|NCT03241797|AIP|aip
153137|NCT03241797|EUS-FNA|eus-fna
153138|NCT03241784|ALS|als
153139|NCT03241784|T-Regulatory Cells|t-regulatory cells
153140|NCT03241745|Nivolumab|nivolumab
153141|NCT03241745|17-180|17-180
153142|NCT03241732|Traumatic Brain Injury|traumatic brain injury
153143|NCT03241732|TBI|tbi
153144|NCT03241732|Brain Trauma|brain trauma
153145|NCT03241732|N-acetyl cysteine|n-acetyl cysteine
153146|NCT03241732|Concussion|concussion
153147|NCT03241732|NAC|nac
153148|NCT03241732|Integrative Medicine|integrative medicine
153149|NCT03241732|EEG|eeg
153150|NCT03241732|electroencephalogram|electroencephalogram
153151|NCT03241732|Functional magnetic resonance imaging or functional MRI|functional magnetic resonance imaging or functional mri
153152|NCT03241732|fMRI|fmri
153153|NCT03241732|PET|pet
153154|NCT03241732|Positron emission tomography|positron emission tomography
153155|NCT03241732|MRI|mri
153156|NCT03241732|magnetic resonance imaging|magnetic resonance imaging
153157|NCT03241706|hypoglycemia|hypoglycemia
153158|NCT03241706|type 1 diabetes|type 1 diabetes
153159|NCT03241706|liver glucose metabolism|liver glucose metabolism
153160|NCT03241628|Skin blisters|skin blisters
153161|NCT03241628|Finger webbing|finger webbing
153162|NCT03241628|Finger contracture|finger contracture
153163|NCT03241628|Hand contracture|hand contracture
153164|NCT03241589|Teledermatology|teledermatology
153165|NCT03241589|Telehealth|telehealth
153166|NCT03241589|Dermatology|dermatology
153167|NCT03241589|Telemedicine|telemedicine
153168|NCT03241589|Mobile Application|mobile application
153169|NCT03241550|invasive fungal disease|invasive fungal disease
153170|NCT03241550|Cresemba®|cresemba®
153171|NCT03241550|Hematological malignancy|hematological malignancy
153172|NCT03241550|isavuconazonium sulfate|isavuconazonium sulfate
153173|NCT03241550|ASP9766|asp9766
153174|NCT03241550|isavuconazole|isavuconazole
153175|NCT03241550|pediatric population|pediatric population
153176|NCT03241524|Pelvic Floor muscles|pelvic floor muscles
153177|NCT03241524|Physical Therapy|physical therapy
153178|NCT03241524|Sexual function evaluation|sexual function evaluation
153179|NCT03241511|Periodontitis, End Stage Renal Disease, Periodontal treatment|periodontitis, end stage renal disease, periodontal treatment
153180|NCT03241498|Medicines optimisation|medicines optimisation
153181|NCT03241498|Healthcare resource utilisation|healthcare resource utilisation
153182|NCT03241498|HRQOL|hrqol
153183|NCT03241498|Pharmacist-led|pharmacist-led
153184|NCT03241498|GP based|gp based
153185|NCT03241459|Percutaneous Transluminal Angioplasty|percutaneous transluminal angioplasty
153186|NCT03241459|PTA|pta
153187|NCT03241459|Peripheral Artery Disease|peripheral artery disease
153188|NCT03241459|PAD|pad
153189|NCT03241459|Paclitaxel|paclitaxel
153190|NCT03241433|Exercise|exercise
153191|NCT03241394|Monocyte subsets|monocyte subsets
153192|NCT03241394|Obesity|obesity
153193|NCT03241394|Metabolic Syndrome|metabolic syndrome
153194|NCT03241381|observational sample|observational sample
153195|NCT03241368|Irritable Bowel Disease|irritable bowel disease
153196|NCT03241368|IBD|ibd
153197|NCT03241368|Mucosal Disease|mucosal disease
153198|NCT03241329|Endometriosis|endometriosis
153199|NCT03241329|Metabolomics|metabolomics
153200|NCT03241329|Transcriptomics|transcriptomics
153201|NCT03241329|Follicular fluid|follicular fluid
153202|NCT03241329|Cumulus cells|cumulus cells
153203|NCT03241329|Oocyte quality|oocyte quality
153204|NCT03241316|qualitative and survey research|qualitative and survey research
153205|NCT03241303|Glp-1|glp-1
153206|NCT03241303|alpha-glucosidase inhibitor|alpha-glucosidase inhibitor
153207|NCT03241303|acarbose|acarbose
153208|NCT03241290|C-arm|c-arm
153209|NCT03241290|Medical Imaging Device|medical imaging device
153210|NCT03241290|Radiological|radiological
153211|NCT03241277|social phobia|social phobia
153212|NCT03241277|anxiety disorders|anxiety disorders
153214|NCT03241277|periodontal disease|periodontal disease
153215|NCT03241277|non surgical periodontal treatment|non surgical periodontal treatment
153216|NCT03241251|psychosocial risk|psychosocial risk
153217|NCT03241225|Elder abuse|elder abuse
153218|NCT03241225|Depression|depression
153219|NCT03241225|Mental health|mental health
153220|NCT03241212|adolescent|adolescent
153221|NCT03241212|young adult|young adult
153222|NCT03241212|knowledge|knowledge
153223|NCT03241212|self-care|self-care
153224|NCT03241186|Ipilimumab|ipilimumab
153225|NCT03241186|Nivolumab|nivolumab
153226|NCT03241186|OPDIVO|opdivo
153227|NCT03241186|IgG4 kappa immunoglobulin|igg4 kappa immunoglobulin
153228|NCT03241173|advanced or metastatic cervical cancer|advanced or metastatic cervical cancer
153229|NCT03241173|endometrial cancer|endometrial cancer
153230|NCT03241173|esophageal cancer|esophageal cancer
153231|NCT03241173|hepatocellular carcinoma (HCC)|hepatocellular carcinoma (hcc)
153232|NCT03241173|melanoma|melanoma
153233|NCT03241173|Merkel cell carcinoma|merkel cell carcinoma
153234|NCT03241173|mesothelioma|mesothelioma
153235|NCT03241173|microsatellite instability-high colorectal cancer|microsatellite instability-high colorectal cancer
153236|NCT03241173|non-small cell lung cancer (NSCLC)|non-small cell lung cancer (nsclc)
153237|NCT03241173|ovarian cancer|ovarian cancer
153238|NCT03241173|squamous cell carcinoma of the head and neck|squamous cell carcinoma of the head and neck
153239|NCT03241173|small cell lung cancer (SLCL)|small cell lung cancer (slcl)
153240|NCT03241173|renal cell carcinoma (RCC)|renal cell carcinoma (rcc)
153241|NCT03241173|triple-negative breast cancer|triple-negative breast cancer
153242|NCT03241173|TNBC|tnbc
153243|NCT03241173|urothelial carcinoma|urothelial carcinoma
153244|NCT03241173|OX40 ligand (OX40)|ox40 ligand (ox40)
153245|NCT03241173|SCCHN|scchn
153246|NCT03241173|MSI-H CRC|msi-h crc
153247|NCT03241173|gastric cancer (including stomach and gastroesophageal junction [GEJ])|gastric cancer (including stomach and gastroesophageal junction [gej])
153248|NCT03241134|Dry needling|dry needling
153249|NCT03241134|Sham needling|sham needling
153250|NCT03241134|Office workers|office workers
153251|NCT03241134|Myofascial pain|myofascial pain
153252|NCT03241134|Surface electromyography|surface electromyography
153253|NCT03241121|Time Restricted Feeding|time restricted feeding
153254|NCT03241121|Eating patterns|eating patterns
153255|NCT03241095|Osteopathic Manipulation Treatment|osteopathic manipulation treatment
153256|NCT03241095|Golf|golf
153257|NCT03241069|bio-impedance|bio-impedance
153258|NCT03241069|BIOPAC system|biopac system
195624|NCT02973542|IBS|ibs
153259|NCT03241069|dyspnea|dyspnea
153260|NCT03241069|acute heart failure|acute heart failure
153261|NCT03241043|Pharmacokinetic study|pharmacokinetic study
153262|NCT03241043|Comparing Envarsus versus Advagraf|comparing envarsus versus advagraf
153263|NCT03241017|Diffuse Large B-Cell Lymphoma|diffuse large b-cell lymphoma
153264|NCT03241017|Double-hit Lymphomas|double-hit lymphomas
153265|NCT03241017|Grey Zone Lymphomas|grey zone lymphomas
153266|NCT03241017|Double or Triple Expressor Lymphomas|double or triple expressor lymphomas
153267|NCT03241017|Unclassifiable Aggressive Lymphoma types|unclassifiable aggressive lymphoma types
153268|NCT03241017|Aggressive Lymphomas|aggressive lymphomas
153269|NCT03240991|bradykinin-mediated angiodema|bradykinin-mediated angiodema
153270|NCT03240991|quality of life|quality of life
153271|NCT03240939|Dutasteride|dutasteride
153272|NCT03240939|Tadalafil|tadalafil
153273|NCT03240926|COPD|copd
153274|NCT03240926|COPD Exacerbation|copd exacerbation
153275|NCT03240926|COPD Asthma|copd asthma
153276|NCT03240926|COPD Bronchitis|copd bronchitis
153277|NCT03240926|COPD, Severe Early-Onset|copd, severe early-onset
153278|NCT03240887|Teen pregnancy prevention|teen pregnancy prevention
153279|NCT03240874|Gestational Diabetes|gestational diabetes
153280|NCT03240874|Diabetes Type 2 in Pregnancy|diabetes type 2 in pregnancy
153281|NCT03240861|T cells|t cells
153282|NCT03240861|stem cells|stem cells
153283|NCT03240861|gene therapy|gene therapy
153284|NCT03240861|NYESO|nyeso
153285|NCT03240861|Sarcoma|sarcoma
153286|NCT03240848|congenital cataract|congenital cataract
153287|NCT03240848|artificial intelligent clinic|artificial intelligent clinic
153288|NCT03240835|pre-Albumin|pre-albumin
153289|NCT03240835|Retinol Conjugated Protein|retinol conjugated protein
153290|NCT03240835|Transferrin|transferrin
153291|NCT03240835|Locoregionally Advanced Nasopharyngeal Carcinoma|locoregionally advanced nasopharyngeal carcinoma
153292|NCT03240835|nutrition|nutrition
153293|NCT03240822|Penile Trauma|penile trauma
153294|NCT03240822|Allotransplantation|allotransplantation
153295|NCT03240822|Vascularized Composite Allotransplantation|vascularized composite allotransplantation
153296|NCT03240822|VCA|vca
153297|NCT03240822|Genital Trauma|genital trauma
153298|NCT03240822|Penile Transplantation|penile transplantation
153299|NCT03240822|Amputation|amputation
153300|NCT03240822|Penile Injury|penile injury
153301|NCT03240796|congenital cataract|congenital cataract
153302|NCT03240796|intra-capsular IOL implantation|intra-capsular iol implantation
153303|NCT03240796|ciliary sulcus fixation|ciliary sulcus fixation
153304|NCT03240783|CT-Fluoroscopic Selective Transforaminal Epidural Steroid|ct-fluoroscopic selective transforaminal epidural steroid
153305|NCT03240783|Oral Dexamethasone|oral dexamethasone
155163|NCT03229291|topical|topical
153306|NCT03240783|Acute Lumbar Radiculopathy|acute lumbar radiculopathy
153307|NCT03240783|Sciatic Neuropathy|sciatic neuropathy
153308|NCT03240783|Betamethasone injectable|betamethasone injectable
153309|NCT03240783|Dexamethasone injectable|dexamethasone injectable
153310|NCT03240783|Acute Lumbar radicular pain|acute lumbar radicular pain
153311|NCT03240783|Randomized Controlled Trial (RCT)|randomized controlled trial (rct)
153312|NCT03240783|Comparative Effectiveness Controlled Trial|comparative effectiveness controlled trial
153313|NCT03240770|HFV|hfv
153314|NCT03240770|HFA|hfa
153315|NCT03240770|High Frequency Vibration|high frequency vibration
153316|NCT03240757|meal absorption|meal absorption
153317|NCT03240757|exercise|exercise
153318|NCT03240757|energy balance|energy balance
153319|NCT03240757|lipolysis|lipolysis
153320|NCT03240744|immunogenicity|immunogenicity
153321|NCT03240744|safety|safety
153322|NCT03240744|Hand, Foot and Mouth Disease (HFMD)|hand, foot and mouth disease (hfmd)
153323|NCT03240731|sickle cell disease|sickle cell disease
153324|NCT03240731|haploidentical|haploidentical
153325|NCT03240731|graft|graft
153326|NCT03240731|marrow|marrow
153327|NCT03240705|Stress|stress
153328|NCT03240705|Medical education|medical education
153329|NCT03240692|Major Depressive Disorder|major depressive disorder
153330|NCT03240692|Treatment-Resistant Depression|treatment-resistant depression
153331|NCT03240692|Transcranial Magnetic Stimulation (TMS)|transcranial magnetic stimulation (tms)
153332|NCT03240692|Theta-Burst Stimulation|theta-burst stimulation
153333|NCT03240679|Barrett's esophagus|barrett's esophagus
153334|NCT03240679|Endoscopic Mucosal Resection|endoscopic mucosal resection
153335|NCT03240640|Inspiratory muscle training|inspiratory muscle training
153336|NCT03240640|COPD|copd
153337|NCT03240640|Dyspnea|dyspnea
153338|NCT03240640|Balance|balance
153339|NCT03240562|serratus anterior plane block|serratus anterior plane block
153340|NCT03240562|ultrasound-guided|ultrasound-guided
153341|NCT03240562|regional anesthesia|regional anesthesia
153342|NCT03240562|thoracic surgery|thoracic surgery
153343|NCT03240562|postoperative pain|postoperative pain
153344|NCT03240549|advanced pulmonary adenocarcinoma|advanced pulmonary adenocarcinoma
153345|NCT03240549|Bevacizumab|bevacizumab
153346|NCT03240549|First line chemotherapy|first line chemotherapy
153347|NCT03240549|Stable disease|stable disease
153348|NCT03240536|Rheumatology Referral|rheumatology referral
153349|NCT03240536|Choosing Wisely|choosing wisely
153350|NCT03240510|Breast cancer|breast cancer
153351|NCT03240510|Male|male
153352|NCT03240471|Distal radius fracture|distal radius fracture
153353|NCT03240471|Conservative treatment|conservative treatment
153354|NCT03240471|Patient rated outcome (PRO)|patient rated outcome (pro)
153355|NCT03240419|Obesity|obesity
153356|NCT03240419|Inflammation|inflammation
153357|NCT03240419|Pregnancy|pregnancy
153358|NCT03240419|Programming|programming
153359|NCT03240393|Non Small Cell Lung Cancer|non small cell lung cancer
153360|NCT03240393|NSCLC|nsclc
153361|NCT03240393|INC280|inc280
153362|NCT03240393|EGFR wild-type (wt)|egfr wild-type (wt)
153363|NCT03240393|advanced non-small cell lung cancer|advanced non-small cell lung cancer
153364|NCT03240393|advanced/metastatic disease|advanced/metastatic disease
153365|NCT03240393|Non-small cell lung carcinoma (NSCLC)|non-small cell lung carcinoma (nsclc)
153366|NCT03240393|treatment of lung cancer after first metastasis|treatment of lung cancer after first metastasis
153367|NCT03240393|lung cancer|lung cancer
153368|NCT03240393|lung adenocarcinoma|lung adenocarcinoma
153369|NCT03240393|Non small cell lung carcinoma|non small cell lung carcinoma
153370|NCT03240393|Non-small cell lung cancer|non-small cell lung cancer
153371|NCT03240393|MET exon 14 deletion|met exon 14 deletion
153372|NCT03240393|MET exon 14 skipping|met exon 14 skipping
153373|NCT03240393|MET exon 14 mutation|met exon 14 mutation
153374|NCT03240393|MET mutation|met mutation
153375|NCT03240393|MET amplification|met amplification
153376|NCT03240393|MET inhibitor|met inhibitor
153377|NCT03240393|MET dysregulation|met dysregulation
153378|NCT03240393|MET activation|met activation
153379|NCT03240393|MET signaling|met signaling
153380|NCT03240393|MET pathway|met pathway
153381|NCT03240393|MET|met
153382|NCT03240393|cMET|cmet
153383|NCT03240328|CAR-T HIV therapy|car-t hiv therapy
153384|NCT03240328|immunotherapy|immunotherapy
153385|NCT03240328|function cure|function cure
153386|NCT03240263|Difficult to wean patients|difficult to wean patients
153387|NCT03240263|ICU aquired muscle weakness|icu aquired muscle weakness
153388|NCT03240263|Cerebral perfusion|cerebral perfusion
153389|NCT03240263|Respiratroy muscles|respiratroy muscles
153390|NCT03240263|IMT|imt
153391|NCT03240263|Cerebral oxygenation|cerebral oxygenation
153392|NCT03240263|Weaning outcomes|weaning outcomes
153393|NCT03240250|VATS|vats
153394|NCT03240250|Pulmonary lobectomy|pulmonary lobectomy
153395|NCT03240250|Uniportal|uniportal
153396|NCT03240250|Postoperative pain|postoperative pain
153397|NCT03240250|Thoracic surgery|thoracic surgery
153398|NCT03240237|HFpEF|hfpef
153399|NCT03240224|Cancer ablation|cancer ablation
153400|NCT03240224|Life information rehabilitation therapy|life information rehabilitation therapy
153401|NCT03240211|Pembrolizumab|pembrolizumab
153402|NCT03240211|Decitabine|decitabine
153403|NCT03240211|Pralatrexate|pralatrexate
153404|NCT03240211|T-cell lymphoma|t-cell lymphoma
153405|NCT03240198|occupational|occupational
153406|NCT03240198|cohort|cohort
153407|NCT03240198|biomarkers|biomarkers
153408|NCT03240185|hemorrhoid|hemorrhoid
153409|NCT03240185|pain|pain
153410|NCT03240185|deep breathing|deep breathing
153411|NCT03240185|multimodal pain control|multimodal pain control
153413|NCT03240133|hereditary angioedema|hereditary angioedema
153414|NCT03240133|kallikrein inhibitor|kallikrein inhibitor
153415|NCT03240133|plasma kallikrein|plasma kallikrein
153416|NCT03240107|levator resection|levator resection
153417|NCT03240107|levator tucking|levator tucking
153418|NCT03240107|Fair levator function|fair levator function
153419|NCT03240107|Eyelid contour|eyelid contour
153420|NCT03240094|Ehealth|ehealth
153421|NCT03240094|Older adults|older adults
153422|NCT03240094|Undernutrition|undernutrition
153423|NCT03240081|Post-menopause dyspareunia|post-menopause dyspareunia
153424|NCT03240081|Vulvar vestibular pain|vulvar vestibular pain
153425|NCT03240081|Genitourinary syndrome of menopause|genitourinary syndrome of menopause
153426|NCT03240081|Sexual pain|sexual pain
153427|NCT03240068|Renin-Angiotensin System|renin-angiotensin system
153428|NCT03240068|Inflammation|inflammation
153429|NCT03240068|Cardiovascular|cardiovascular
153430|NCT03240068|Atherosclerosis|atherosclerosis
153431|NCT03240055|spinal anesthesia|spinal anesthesia
153432|NCT03240055|etomidate|etomidate
153433|NCT03240055|median effective dose|median effective dose
153434|NCT03240055|BIS50|bis50
153435|NCT03240042|anterior cervical spine surgery|anterior cervical spine surgery
153436|NCT03240042|endotracheal cuff pressure|endotracheal cuff pressure
153437|NCT03240042|endotracheal tracheal intubation|endotracheal tracheal intubation
153438|NCT03240042|dysphonia|dysphonia
153439|NCT03240029|children|children
153440|NCT03240029|life quality|life quality
153441|NCT03240029|school reintegration|school reintegration
153442|NCT03240003|Social Anxiety|social anxiety
153443|NCT03240003|Social Anxiety Disorder|social anxiety disorder
153444|NCT03240003|SAD|sad
153445|NCT03239990|Children's mental health|children's mental health
153446|NCT03239990|Conduct disorders|conduct disorders
153447|NCT03239990|Conduct problems|conduct problems
153448|NCT03239990|Externalizing problems|externalizing problems
153449|NCT03239990|Parental Intervention|parental intervention
153450|NCT03239990|Groups based intervention|groups based intervention
153451|NCT03239990|Finland|finland
153452|NCT03239990|Social learning theory|social learning theory
153453|NCT03239990|Cognitive-behavioral theory|cognitive-behavioral theory
153454|NCT03239977|social intelligence|social intelligence
153455|NCT03239977|quality of life|quality of life
153456|NCT03239977|social competence|social competence
153457|NCT03239964|recurrent keloid|recurrent keloid
153458|NCT03239964|surgical excision|surgical excision
153459|NCT03239964|steroids injection|steroids injection
153460|NCT03239938|chronic whiplash associated disorders|chronic whiplash associated disorders
153461|NCT03239938|central sensitization|central sensitization
153462|NCT03239938|electroencephalography|electroencephalography
153463|NCT03239938|physiotherapy|physiotherapy
153464|NCT03239938|chronic pain|chronic pain
153465|NCT03239938|functionality|functionality
153466|NCT03239938|quality of life|quality of life
153467|NCT03239938|stress management|stress management
153468|NCT03239938|randomized controlled trial|randomized controlled trial
153469|NCT03239938|modern neuroscience approach|modern neuroscience approach
153470|NCT03239938|pain neuroscience education|pain neuroscience education
153471|NCT03239938|neck school|neck school
153472|NCT03239938|exercise therapy|exercise therapy
153473|NCT03239938|pain cognitions|pain cognitions
153474|NCT03239925|Cell phones, Electromagnetic Radiation|cell phones, electromagnetic radiation
153475|NCT03239912|Low-level laser|low-level laser
153476|NCT03239912|functional treatment|functional treatment
153477|NCT03239912|twin-block|twin-block
153478|NCT03239912|RCT|rct
153479|NCT03239899|HIV|hiv
153480|NCT03239899|Brain|brain
153481|NCT03239899|Immunotherapy|immunotherapy
153482|NCT03239860|Multiple Sclerosis|multiple sclerosis
153483|NCT03239860|Multiple Sclerosis Relapsing-Remitting|multiple sclerosis relapsing-remitting
153484|NCT03239860|GNbAC1|gnbac1
153485|NCT03239860|MRI|mri
153486|NCT03239860|Monoclonal antibody|monoclonal antibody
153487|NCT03239860|Multiple Sclerosis associated retrovirus MSRV|multiple sclerosis associated retrovirus msrv
153488|NCT03239860|MS|ms
153489|NCT03239860|RRMS|rrms
153490|NCT03239860|HERV-W|herv-w
153491|NCT03239808|once-weekly haemodialysis|once-weekly haemodialysis
153492|NCT03239808|incremental haemodialysis|incremental haemodialysis
153493|NCT03239808|randomized clinical trial|randomized clinical trial
153494|NCT03239795|Posters|posters
153495|NCT03239795|Pamphlets|pamphlets
153496|NCT03239795|Primary Health Care|primary health care
153497|NCT03239795|Health Facilities|health facilities
153498|NCT03239769|Thyroid surgery|thyroid surgery
153499|NCT03239769|Thyroidectomy|thyroidectomy
153500|NCT03239769|Minimally invasive access|minimally invasive access
153501|NCT03239769|Aesthetic principle|aesthetic principle
153502|NCT03239769|POSAS|posas
153503|NCT03239743|virtual reality|virtual reality
153504|NCT03239743|adenoidectomy|adenoidectomy
153505|NCT03239743|induction of anesthesia|induction of anesthesia
153506|NCT03239743|pre-operative anxiety|pre-operative anxiety
153507|NCT03239730|dyspnea|dyspnea
153509|NCT03239730|blood gas analysis|blood gas analysis
153510|NCT03239730|emergency department|emergency department
153511|NCT03239730|Intensive care unit|intensive care unit
153512|NCT03239704|Inflammatory Bowel Disease|inflammatory bowel disease
153513|NCT03239704|Ulcerative Colitis|ulcerative colitis
153514|NCT03239704|Crohn Disease|crohn disease
153515|NCT03239704|Quality Improvement|quality improvement
153516|NCT03239704|Telemedicine|telemedicine
153517|NCT03239678|Preoxygenation|preoxygenation
153518|NCT03239678|Oxygen Concentration|oxygen concentration
153519|NCT03239665|Vaccine|vaccine
153520|NCT03239665|Educational intervention|educational intervention
153521|NCT03239665|Senior Center Model of Care|senior center model of care
153522|NCT03239665|Older adults|older adults
153523|NCT03239652|Microsphere|microsphere
153524|NCT03239652|Transcatheter Arterial chemo-embolization|transcatheter arterial chemo-embolization
153525|NCT03239639|Substitute decision makers of patient|substitute decision makers of patient
153526|NCT03239600|Anti-IL-7 Receptor-alpha Monoclonal Antibody|anti-il-7 receptor-alpha monoclonal antibody
153527|NCT03239600|Safety|safety
153528|NCT03239600|GSK2618960|gsk2618960
153529|NCT03239600|Primary Sjögren's Syndrome|primary sjögren's syndrome
153530|NCT03239587|Symptoms and signs involving cognition perception emotion & behaviour|symptoms and signs involving cognition perception emotion & behaviour
153531|NCT03239587|Abdominal cancer patients|abdominal cancer patients
153532|NCT03239587|Musical preop intervention|musical preop intervention
153533|NCT03239587|Surveys|surveys
153534|NCT03239587|Questionnaires|questionnaires
153535|NCT03239587|Blood draws|blood draws
153536|NCT03239548|Opinion,|opinion,
153537|NCT03239548|Doctors,|doctors,
153538|NCT03239548|Nurses,|nurses,
153539|NCT03239548|Key informants,|key informants,
153540|NCT03239548|Independent Nurse Midwifery Practitioner|independent nurse midwifery practitioner
153541|NCT03239522|GSK1278863|gsk1278863
153542|NCT03239522|pharmacokinetics|pharmacokinetics
153543|NCT03239522|mass balance|mass balance
153544|NCT03239522|daprodustat|daprodustat
153545|NCT03239509|long-term survival|long-term survival
153546|NCT03239509|bioprosthesis|bioprosthesis
153547|NCT03239509|complications|complications
153548|NCT03239509|anticoagulation|anticoagulation
153549|NCT03239509|mechanichal prosthesis|mechanichal prosthesis
153550|NCT03239470|autologous polyclonal regulatory T cell therapy|autologous polyclonal regulatory t cell therapy
153551|NCT03239470|PolyTregs|polytregs
153552|NCT03239470|open-label|open-label
153553|NCT03239470|Phase 1 (safety)|phase 1 (safety)
153554|NCT03239444|ICE|ice
153555|NCT03239444|Ablation|ablation
153556|NCT03239444|Trans-septal|trans-septal
153557|NCT03239444|Septum|septum
153558|NCT03239444|Echocardiography|echocardiography
153559|NCT03239431|asthma|asthma
153560|NCT03239431|lung function|lung function
153561|NCT03239431|forced oscillometry technique|forced oscillometry technique
153562|NCT03239431|exacerbation|exacerbation
153563|NCT03239418|NMES|nmes
153564|NCT03239405|laparoscopic|laparoscopic
153565|NCT03239405|sleeve|sleeve
153566|NCT03239405|gastrectomy|gastrectomy
153567|NCT03239392|BNZ-1|bnz-1
153568|NCT03239392|Cytokine|cytokine
153569|NCT03239392|IL-2|il-2
153570|NCT03239392|IL-15|il-15
153571|NCT03239379|cytokine inhibitor|cytokine inhibitor
153572|NCT03239379|IL-2|il-2
153573|NCT03239379|IL-9|il-9
153574|NCT03239379|IL-15|il-15
153575|NCT03239366|T2D|t2d
153576|NCT03239340|EGFR, NSCLC, Lung Cancer, Biopsy, Molecular Profiling|egfr, nsclc, lung cancer, biopsy, molecular profiling
153577|NCT03239327|Misoprostol|misoprostol
153578|NCT03239327|neonatal|neonatal
153579|NCT03239327|respiratory distress|respiratory distress
153580|NCT03239327|cesarean section|cesarean section
153581|NCT03239288|Fiber|fiber
153582|NCT03239288|Postprandial glucose|postprandial glucose
153583|NCT03239288|Insulin|insulin
153584|NCT03239288|Resistant Starch Type 4|resistant starch type 4
153585|NCT03239275|en masse retraction|en masse retraction
153586|NCT03239275|biocreative therapy|biocreative therapy
153587|NCT03239275|class II|class ii
153588|NCT03239275|skeletal anchorage|skeletal anchorage
153589|NCT03239262|Atrial Fibrillation|atrial fibrillation
153590|NCT03239262|Left Atrial Cryoablation|left atrial cryoablation
153591|NCT03239262|Ganglionated Plexi|ganglionated plexi
153592|NCT03239262|Open-Heart Surgery|open-heart surgery
153593|NCT03239249|school dropout prevention|school dropout prevention
153594|NCT03239249|intervention study|intervention study
153595|NCT03239249|cluster-randomized|cluster-randomized
153596|NCT03239210|Brain Function|brain function
153597|NCT03239210|functional magnetic resonance imaging (fMRI)|functional magnetic resonance imaging (fmri)
153598|NCT03239210|Sensory processing|sensory processing
153599|NCT03239210|Obsessive-Compulsive Disorder|obsessive-compulsive disorder
153600|NCT03239210|OCD|ocd
153601|NCT03239184|Cancer ablation|cancer ablation
153602|NCT03239184|Life information rehabilitation therapy|life information rehabilitation therapy
153603|NCT03239171|Cancer ablation|cancer ablation
153604|NCT03239171|Life information rehabilitation therapy|life information rehabilitation therapy
153605|NCT03239158|Cancer ablation|cancer ablation
153606|NCT03239158|Life information rehabilitation therapy|life information rehabilitation therapy
153607|NCT03239145|Advanced Solid Tumor|advanced solid tumor
153608|NCT03239145|Melanoma|melanoma
153609|NCT03239145|Ovarian Cancer|ovarian cancer
153610|NCT03239145|Renal Cancer|renal cancer
153611|NCT03239145|Colorectal Cancer|colorectal cancer
153612|NCT03239119|rE-4|re-4
153613|NCT03239119|Exenatide|exenatide
153614|NCT03239119|Metformin|metformin
153615|NCT03239119|Sulfonylurea|sulfonylurea
153616|NCT03239106|itch|itch
153617|NCT03239106|pruritus|pruritus
153618|NCT03239106|CIP|cip
153619|NCT03239080|Rheumatoid Arthritis|rheumatoid arthritis
153620|NCT03239080|HR-pQCT|hr-pqct
153621|NCT03239080|erosion|erosion
153622|NCT03239080|denosumab|denosumab
153623|NCT03239067|Ticagrelor|ticagrelor
153624|NCT03239067|Clopidogrel|clopidogrel
153625|NCT03239067|Acute Coronary Syndrome|acute coronary syndrome
153626|NCT03239067|Percutaneous Coronary Intervention|percutaneous coronary intervention
153627|NCT03239028|diet quality|diet quality
153628|NCT03239028|pregnancy|pregnancy
153629|NCT03239028|adolescence|adolescence
153630|NCT03239028|longitudinal study|longitudinal study
153631|NCT03239028|food frequency questionnaire|food frequency questionnaire
153632|NCT03238989|Interstitial lung disease|interstitial lung disease
153633|NCT03238976|breast core biopsy|breast core biopsy
153634|NCT03238976|core needle biopsies|core needle biopsies
153635|NCT03238924|posttraumatic stress disorder|posttraumatic stress disorder
153636|NCT03238924|oxytocin|oxytocin
153637|NCT03238924|Prolonged Exposure|prolonged exposure
153638|NCT03238898|muscle cramps|muscle cramps
153639|NCT03238898|diabetic neuropathy|diabetic neuropathy
153640|NCT03238898|botulinum toxin|botulinum toxin
153641|NCT03238872|Anxiety|anxiety
153642|NCT03238872|Depression|depression
153643|NCT03238872|CBT|cbt
153644|NCT03238872|Outcome monitoring|outcome monitoring
153645|NCT03238872|Dissemination|dissemination
153646|NCT03238872|Routine services|routine services
153647|NCT03238833|In vitro fertilization|in vitro fertilization
153648|NCT03238833|Poor ovarian responder|poor ovarian responder
153649|NCT03238833|Luteal ovarian stimulation|luteal ovarian stimulation
153650|NCT03238833|Antagonist protocol|antagonist protocol
153651|NCT03238833|Cumulus cells|cumulus cells
153652|NCT03238820|Gastrointestinal stromal tumors|gastrointestinal stromal tumors
153653|NCT03238820|Robot|robot
153654|NCT03238820|manual suture|manual suture
153655|NCT03238807|hCG|hcg
153656|NCT03238807|Intrauterine hCG|intrauterine hcg
153657|NCT03238807|IVF|ivf
153658|NCT03238807|ICSI|icsi
153659|NCT03238794|Body Mass Index|body mass index
153660|NCT03238794|gastric|gastric
153661|NCT03238794|bypass|bypass
153662|NCT03238794|bariatric surgery|bariatric surgery
153663|NCT03238794|bile acid|bile acid
153664|NCT03238794|weight loss|weight loss
153665|NCT03238794|diet|diet
153666|NCT03238794|low calorie|low calorie
153667|NCT03238781|Migraine|migraine
153668|NCT03238781|Headache|headache
153669|NCT03238781|Prevention|prevention
153670|NCT03238781|Prophylaxis|prophylaxis
153671|NCT03238768|Nutrition|nutrition
153672|NCT03238768|Body Composition|body composition
153673|NCT03238768|Preterm|preterm
153674|NCT03238768|Neonate|neonate
153675|NCT03238755|HIV|hiv
153676|NCT03238755|Diastolic Dysfunction|diastolic dysfunction
153677|NCT03238755|Myocardial fibrosis|myocardial fibrosis
153678|NCT03238755|Statin|statin
153679|NCT03238742|Xuebijing Injection, morality, sepsis|xuebijing injection, morality, sepsis
153680|NCT03238690|LVAD|lvad
153681|NCT03238690|Cardiac Recovery|cardiac recovery
153682|NCT03238677|speech sound disorder|speech sound disorder
153683|NCT03238651|Drug therapy|drug therapy
153684|NCT03238638|Epacadostat|epacadostat
153685|NCT03238638|Pembrolizumab|pembrolizumab
153686|NCT03238638|PD-1|pd-1
153687|NCT03238638|PD-L1|pd-l1
153688|NCT03238612|influenza|influenza
153689|NCT03238612|FFA|ffa
153690|NCT03238612|clarithromycin|clarithromycin
153691|NCT03238612|mortality|mortality
153692|NCT03238612|hospitalisation|hospitalisation
153693|NCT03238586|hiv|hiv
153694|NCT03238586|aids|aids
153695|NCT03238586|alcohol|alcohol
153696|NCT03238586|health|health
153697|NCT03238586|knowledge|knowledge
153698|NCT03238586|motivation|motivation
153699|NCT03238586|skills|skills
153700|NCT03238586|behavior|behavior
153701|NCT03238573|Colorectal Sessile Serrated Adenomas/Polyps optical enhancement endoscopy|colorectal sessile serrated adenomas/polyps optical enhancement endoscopy
153702|NCT03238508|Deferred stenting|deferred stenting
153703|NCT03238508|Microvascular dysfunction|microvascular dysfunction
153704|NCT03238495|Operable breast cancer|operable breast cancer
153705|NCT03238495|Neo-adjuvant chemotherapy|neo-adjuvant chemotherapy
153706|NCT03238469|Microwave Ablation|microwave ablation
155164|NCT03229291|Samumed|samumed
153707|NCT03238469|Hair Follicle|hair follicle
153708|NCT03238469|Sweat gland|sweat gland
153709|NCT03238456|Pacific Islander|pacific islander
153710|NCT03238456|Native Hawaiian|native hawaiian
153711|NCT03238456|NHPI|nhpi
153712|NCT03238456|Tobacco Health|tobacco health
153713|NCT03238456|Tobacco Use|tobacco use
153714|NCT03238456|Tobacco Smoking|tobacco smoking
153715|NCT03238456|Tobacco Use Cessation|tobacco use cessation
153716|NCT03238456|Smoking Cessation|smoking cessation
153717|NCT03238456|Smoking|smoking
153718|NCT03238456|Cigarette Use|cigarette use
153719|NCT03238456|Young Adult|young adult
153720|NCT03238443|DSA|dsa
153721|NCT03238430|Intrathecal morphine, continuous wound infiltration|intrathecal morphine, continuous wound infiltration
153722|NCT03238417|women's health|women's health
153723|NCT03238417|primary health care|primary health care
153724|NCT03238417|mental health|mental health
153725|NCT03238417|Veterans|veterans
153726|NCT03238417|quality improvement|quality improvement
153727|NCT03238404|gastric cancer|gastric cancer
153728|NCT03238404|neoadjuvant chemotherapy|neoadjuvant chemotherapy
153729|NCT03238404|enhanced recovery after surgery|enhanced recovery after surgery
153730|NCT03238404|gastrectomy|gastrectomy
153731|NCT03238391|Contrast-induced nephropathy|contrast-induced nephropathy
153732|NCT03238391|Ischemic preconditioning|ischemic preconditioning
153733|NCT03238378|head and neck cancer|head and neck cancer
153734|NCT03238378|Locally recurrent head and neck cancer|locally recurrent head and neck cancer
153735|NCT03238378|Brachytherapy|brachytherapy
153736|NCT03238378|Hyperthermia|hyperthermia
153737|NCT03238339|Pulmonary Disease, Chronic Obstructive|pulmonary disease, chronic obstructive
153738|NCT03238339|Respiratory Insufficiency|respiratory insufficiency
153739|NCT03238339|Oxygen Inhalation Therapy|oxygen inhalation therapy
153740|NCT03238339|Noninvasive Ventilation|noninvasive ventilation
153741|NCT03238326|Brexpiprazole|brexpiprazole
153742|NCT03238326|Schizophrenia|schizophrenia
153743|NCT03238300|adolescent|adolescent
153744|NCT03238287|Emergency|emergency
196288|NCT02969577|ADT|adt
153745|NCT03238287|Mechanical chest compression|mechanical chest compression
153746|NCT03238287|Cerebral oximetry|cerebral oximetry
153747|NCT03238222|Walking|walking
153748|NCT03238222|Six-Minute Walk Distance|six-minute walk distance
153749|NCT03238222|Illness Perceptions|illness perceptions
153750|NCT03238222|Theory of Planned Behaviour|theory of planned behaviour
153751|NCT03238209|neural respiratory drive|neural respiratory drive
153752|NCT03238209|transesophageal diaphragmatic EMG|transesophageal diaphragmatic emg
153753|NCT03238209|surface diaphragmatic EMG|surface diaphragmatic emg
153754|NCT03238209|surface sternocleidomastoid EMG|surface sternocleidomastoid emg
153755|NCT03238209|surface parasternal intercostal muscle EMG|surface parasternal intercostal muscle emg
153756|NCT03238196|FGFR inhibitor|fgfr inhibitor
153757|NCT03238196|ER+ metastatic breast cancer|er+ metastatic breast cancer
153758|NCT03238196|CDK4/6 inhibitor|cdk4/6 inhibitor
153759|NCT03238196|Endocrine therapy|endocrine therapy
153760|NCT03238183|knee osteoarthritis|knee osteoarthritis
153761|NCT03238183|hyaluronic acid|hyaluronic acid
153762|NCT03238183|dextrose|dextrose
153763|NCT03238183|therapeutic effects|therapeutic effects
153764|NCT03238118|irritability|irritability
153765|NCT03238118|severe mood dysregulation|severe mood dysregulation
153766|NCT03238118|disruptive mood dysregulation disorder|disruptive mood dysregulation disorder
153767|NCT03238105|Dark circles|dark circles
153768|NCT03238105|Periorbital hyperchromia|periorbital hyperchromia
153769|NCT03238105|Facial aesthetics|facial aesthetics
153770|NCT03238092|in vitro fertilization|in vitro fertilization
153771|NCT03238092|estradiol|estradiol
153772|NCT03238092|gnrh antagonist|gnrh antagonist
153773|NCT03238092|testosterone|testosterone
153774|NCT03238053|laser treatment, randomized trial, menopause, vaginal symptoms, overactive bladder|laser treatment, randomized trial, menopause, vaginal symptoms, overactive bladder
153775|NCT03238040|Critical illness|critical illness
153776|NCT03238040|PICU|picu
153777|NCT03238040|biomarkers|biomarkers
153778|NCT03238027|SNDX-6352|sndx-6352
153779|NCT03238027|CSF-1R inhibitor|csf-1r inhibitor
153780|NCT03238027|Colony Stimulating factor 1 receptor inhibitor|colony stimulating factor 1 receptor inhibitor
153781|NCT03238027|Solid Tumor|solid tumor
153782|NCT03238027|Recurrent locally advanced tumor|recurrent locally advanced tumor
153783|NCT03238027|unresectable solid tumor|unresectable solid tumor
153784|NCT03238027|Metastatic tumor|metastatic tumor
153785|NCT03238027|durvalumab|durvalumab
153786|NCT03238001|Cognitive assessment|cognitive assessment
153787|NCT03238001|Cognition|cognition
153788|NCT03238001|Clock Test|clock test
153789|NCT03237975|type 2 diabetes|type 2 diabetes
153790|NCT03237975|sense of coherence|sense of coherence
153791|NCT03237975|self-care|self-care
153792|NCT03237975|strengths-based intervention|strengths-based intervention
153793|NCT03237962|High flow nasal cannula|high flow nasal cannula
153794|NCT03237962|Pulmonary rehab|pulmonary rehab
153795|NCT03237962|Pulmonary rehabilitation|pulmonary rehabilitation
153796|NCT03237962|Nasal cannula|nasal cannula
153797|NCT03237962|Exercise endurance|exercise endurance
153798|NCT03237962|Oxygen Therapy|oxygen therapy
153799|NCT03237962|COPD|copd
155260|NCT03228576|Tacrolimus|tacrolimus
153800|NCT03237962|Chronic Obstructive Pulmonary Disease|chronic obstructive pulmonary disease
153801|NCT03237949|Tobacco Use Disorder|tobacco use disorder
153802|NCT03237949|Hospitalized patients|hospitalized patients
153803|NCT03237949|Text message|text message
153804|NCT03237949|Motivational Interview|motivational interview
153805|NCT03237949|Substance-Related Disorders|substance-related disorders
153806|NCT03237949|Behaviors and Mental Disorders|behaviors and mental disorders
153807|NCT03237923|fluid|fluid
153808|NCT03237910|amplitude spectrum area|amplitude spectrum area
153809|NCT03237910|defibrillation|defibrillation
153810|NCT03237910|waveform analysis|waveform analysis
153811|NCT03237910|cardiopulmonary resuscitation|cardiopulmonary resuscitation
153812|NCT03237910|cardiac arrest|cardiac arrest
153813|NCT03237897|ERAS|eras
153814|NCT03237897|Enhanced recovery after surgery|enhanced recovery after surgery
153815|NCT03237884|Palliative Care|palliative care
153816|NCT03237884|Oncology|oncology
153817|NCT03237884|advanced incurable cancer (any type)|advanced incurable cancer (any type)
153818|NCT03237884|integration|integration
153819|NCT03237884|development|development
153820|NCT03237884|palliative care interventions|palliative care interventions
153821|NCT03237884|process indicators|process indicators
153822|NCT03237884|Romania|romania
153823|NCT03237858|heart failure|heart failure
153824|NCT03237858|diagnostics|diagnostics
153825|NCT03237858|heart sounds|heart sounds
153826|NCT03237858|CRT-D|crt-d
153827|NCT03237858|ICD|icd
153828|NCT03237858|remote monitoring|remote monitoring
153829|NCT03237819|Thrombotic Thrombocytopenic Purpura|thrombotic thrombocytopenic purpura
153830|NCT03237819|Intensive care|intensive care
153831|NCT03237806|ARDS,|ards,
153832|NCT03237806|Transpulmonary pressure,|transpulmonary pressure,
153833|NCT03237806|Sedation|sedation
153834|NCT03237754|migraine|migraine
153835|NCT03237754|neurostimulation|neurostimulation
153836|NCT03237754|neuroimaging|neuroimaging
153837|NCT03237754|tDCS|tdcs
153838|NCT03237754|MRI|mri
153839|NCT03237702|prostate cancer|prostate cancer
153840|NCT03237702|prostate biopsy|prostate biopsy
153841|NCT03237702|biomarkers|biomarkers
153842|NCT03237702|metabolomics|metabolomics
153843|NCT03237702|overtreatment|overtreatment
153844|NCT03237702|cancer screening|cancer screening
153845|NCT03237702|urine|urine
153846|NCT03237702|lycopene|lycopene
153847|NCT03237676|cognitive rehabilitation|cognitive rehabilitation
153848|NCT03237676|diffusion tensor imaging|diffusion tensor imaging
153849|NCT03237676|neuropsychology|neuropsychology
153850|NCT03237676|functional outcome|functional outcome
153851|NCT03237650|Painful cutaneous electrical stimulation|painful cutaneous electrical stimulation
153852|NCT03237650|Conditioned Pain Modulation|conditioned pain modulation
153853|NCT03237624|gingivitis|gingivitis
153854|NCT03237611|emesis|emesis
153855|NCT03237611|aprepitant|aprepitant
153856|NCT03237611|carboplatin|carboplatin
153857|NCT03237611|chemotherapy-induced nausea and vomiting|chemotherapy-induced nausea and vomiting
153858|NCT03237585|gender based violence|gender based violence
153859|NCT03237585|violence against women|violence against women
153860|NCT03237585|intimate partner violence|intimate partner violence
153861|NCT03237585|impact assessment|impact assessment
153862|NCT03237585|rural response system|rural response system
153863|NCT03237585|cluster randomised controlled trial|cluster randomised controlled trial
153864|NCT03237572|breast cancer|breast cancer
153865|NCT03237572|pembrolizumab|pembrolizumab
153866|NCT03237572|focused ultrasound|focused ultrasound
153867|NCT03237572|immunotherapy|immunotherapy
153868|NCT03237559|Eugenics|eugenics
153869|NCT03237559|Eligible Couples|eligible couples
153870|NCT03237559|Knowledge|knowledge
153871|NCT03237559|Attitude|attitude
153872|NCT03237559|Practice|practice
153873|NCT03237546|Robotic Cardiac Surgery|robotic cardiac surgery
153874|NCT03237494|Peripheral Nervous System Diseases|peripheral nervous system diseases
153875|NCT03237494|Transthyretin Amyloidosis|transthyretin amyloidosis
153876|NCT03237494|Transthyretin-related familial amyloid polyneuropathy|transthyretin-related familial amyloid polyneuropathy
153877|NCT03237494|Transthyretin-related familial amyloid cardiomyopathy|transthyretin-related familial amyloid cardiomyopathy
153878|NCT03237481|inguinal hernia|inguinal hernia
153879|NCT03237481|hernia|hernia
153880|NCT03237481|hernia surgery|hernia surgery
153881|NCT03237481|postoperative pain|postoperative pain
153882|NCT03237481|herniorrhaphy|herniorrhaphy
153883|NCT03237468|concussion|concussion
153884|NCT03237468|football|football
153885|NCT03237468|student|student
153886|NCT03237468|athlete|athlete
153887|NCT03237468|sports|sports
153888|NCT03237429|bioimpedance spectroscopy|bioimpedance spectroscopy
153889|NCT03237429|arterial stiffness|arterial stiffness
153890|NCT03237416|Drug-drug interaction|drug-drug interaction
153891|NCT03237403|Sepsis|sepsis
153892|NCT03237403|Adults|adults
153893|NCT03237403|Pre hospital settings|pre hospital settings
153894|NCT03237403|Triage|triage
153895|NCT03237403|Hospital orientation|hospital orientation
153896|NCT03237403|Outcome|outcome
153897|NCT03237364|deployed in Iraq and/or Afghanistan|deployed in iraq and/or afghanistan
153898|NCT03237351|goal-directed fluid therapy|goal-directed fluid therapy
153899|NCT03237351|thoracic surgery, video-assisted|thoracic surgery, video-assisted
153900|NCT03237351|acute lung injury|acute lung injury
153901|NCT03237325|OM|om
153902|NCT03237325|Head and Neck Cancer|head and neck cancer
153903|NCT03237325|SGX942|sgx942
153904|NCT03237325|Dusquetide|dusquetide
153905|NCT03237325|Squamous Cell Carcinoma|squamous cell carcinoma
153906|NCT03237299|Pharyngitis|pharyngitis
153907|NCT03237299|case-control study|case-control study
153908|NCT03237299|loco-regional complications of pharyngitis|loco-regional complications of pharyngitis
153909|NCT03237286|depression|depression
153910|NCT03237286|ketamine|ketamine
153911|NCT03237286|neurocognitive|neurocognitive
153912|NCT03237286|fMRI|fmri
153913|NCT03237286|cognitive training|cognitive training
153914|NCT03237247|extrahepatic cholestasis, CBC|extrahepatic cholestasis, cbc
153915|NCT03237208|Transcutaneous electrical nerve stimulation|transcutaneous electrical nerve stimulation
153916|NCT03237208|emergency medicine|emergency medicine
153917|NCT03237182|whole genome sequencing;|whole genome sequencing;
153918|NCT03237156|Drug therapy|drug therapy
153919|NCT03237130|esophagus cancer; radiomics; computed tomograpy|esophagus cancer; radiomics; computed tomograpy
153920|NCT03237104|Adolescent|adolescent
153921|NCT03237104|Athlete|athlete
153922|NCT03237091|non-invasive brain stimulation|non-invasive brain stimulation
153923|NCT03237078|probiotics|probiotics
153924|NCT03237078|major depressive disorder|major depressive disorder
153925|NCT03237078|gut-brain axis|gut-brain axis
153926|NCT03237078|inflammation|inflammation
153927|NCT03237039|Roussouly type|roussouly type
153928|NCT03237039|spine alignment|spine alignment
153929|NCT03237039|fall-risk|fall-risk
153930|NCT03237039|gait cycle analysis|gait cycle analysis
153931|NCT03237026|prostate cancer, prostatectomy, prostate radiotherapy, chemotherapy, immunotherapy, biomarkers, metabolomics, urine|prostate cancer, prostatectomy, prostate radiotherapy, chemotherapy, immunotherapy, biomarkers, metabolomics, urine
153932|NCT03237013|Sunbathing|sunbathing
153933|NCT03237013|Indoor Tanning|indoor tanning
153934|NCT03237013|Facial Morphing|facial morphing
153935|NCT03237013|Skin Cancer Risk|skin cancer risk
153936|NCT03237000|Preeclampsia|preeclampsia
153937|NCT03237000|MgSO4|mgso4
153938|NCT03236987|MAC|mac
153939|NCT03236987|Clarithromycin|clarithromycin
153940|NCT03236987|Azithromycin|azithromycin
153941|NCT03236987|Efficacy|efficacy
153942|NCT03236987|Safety|safety
153943|NCT03236961|uncomplicated acute appendicitis|uncomplicated acute appendicitis
153944|NCT03236961|complicated acute appendicitis|complicated acute appendicitis
153945|NCT03236961|antibiotic therapy|antibiotic therapy
153946|NCT03236922|obstetric fistula, anti-incontinence techniques|obstetric fistula, anti-incontinence techniques
153947|NCT03236896|Menopause|menopause
153948|NCT03236896|Hot Flash|hot flash
153949|NCT03236896|MENQOL|menqol
153950|NCT03236896|Mobile exercise device|mobile exercise device
153951|NCT03236870|psoriasis|psoriasis
153952|NCT03236870|effectiveness|effectiveness
153953|NCT03236870|safety|safety
153954|NCT03236870|adalimumab|adalimumab
153955|NCT03236857|Cancer|cancer
153956|NCT03236857|Venetoclax|venetoclax
153957|NCT03236857|pediatric|pediatric
153958|NCT03236857|relapsed or refractory|relapsed or refractory
153959|NCT03236831|Ventricular Assist Device|ventricular assist device
153960|NCT03236818|pulmonary arterial hypertension|pulmonary arterial hypertension
153961|NCT03236818|right ventricle|right ventricle
153962|NCT03236818|MRI|mri
153963|NCT03236818|medical combination therapy|medical combination therapy
153964|NCT03236805|Morphine|morphine
153965|NCT03236805|Ketamine|ketamine
153966|NCT03236805|Acute pain|acute pain
153967|NCT03236805|prehospital|prehospital
153968|NCT03236792|Newly Diagnosed|newly diagnosed
153969|NCT03236792|AL Amyloidosis|al amyloidosis
153970|NCT03236792|Amyloid|amyloid
153971|NCT03236792|Light chain Amyloidosis|light chain amyloidosis
153972|NCT03236753|Thread-Embedding Acupuncture|thread-embedding acupuncture
153973|NCT03236753|Herniated Intervertebral Disc of Lumbar Spine|herniated intervertebral disc of lumbar spine
153974|NCT03236753|Low Back Pain|low back pain
153975|NCT03236753|Radiculopathy|radiculopathy
153976|NCT03236727|Dexmedetomidine, spinal fusion, SSEP|dexmedetomidine, spinal fusion, ssep
153977|NCT03236701|hyperphosphatemia|hyperphosphatemia
153978|NCT03236701|hemodialysis|hemodialysis
153979|NCT03236701|dietary treatment|dietary treatment
153980|NCT03236701|egg white|egg white
153981|NCT03236701|protein energy wasting|protein energy wasting
153982|NCT03236662|BMD|bmd
153983|NCT03236662|Becker muscular dystrophy|becker muscular dystrophy
153984|NCT03236662|epicatechin|epicatechin
153985|NCT03236662|clinical trial|clinical trial
153986|NCT03236662|neuromuscular disease|neuromuscular disease
153987|NCT03236623|Surgical Patient|surgical patient
153988|NCT03236623|Menthol|menthol
153989|NCT03236623|Clinical Study|clinical study
153990|NCT03236571|Marfan syndrome|marfan syndrome
153991|NCT03236571|Personal Training Program|personal training program
153992|NCT03236571|Cardiorespiratory rehabilitation|cardiorespiratory rehabilitation
153993|NCT03236571|Muscular rehabilitation|muscular rehabilitation
153994|NCT03236558|Type 1 diabetes|type 1 diabetes
153995|NCT03236558|Juvenile diabetes|juvenile diabetes
153996|NCT03236558|Immune-tolerance|immune-tolerance
153997|NCT03236558|Regulatory T lymphocyte|regulatory t lymphocyte
153999|NCT03236558|TCR|tcr
154000|NCT03236558|Repertoire|repertoire
154001|NCT03236532|HIV/AIDS; Resistance training, supplementation|hiv/aids; resistance training, supplementation
154002|NCT03236506|Illicit drug|illicit drug
154003|NCT03236506|Injecting drug|injecting drug
154004|NCT03236467|Fibromyalgia and PTSD|fibromyalgia and ptsd
154005|NCT03236454|brain stimulation|brain stimulation
154006|NCT03236454|cognitive training|cognitive training
154007|NCT03236454|cognition|cognition
154008|NCT03236454|treatment|treatment
154009|NCT03236441|remote ischemic conditioning|remote ischemic conditioning
154010|NCT03236441|contrast-induced nephropathy|contrast-induced nephropathy
154011|NCT03236441|cardiac catheterization|cardiac catheterization
154012|NCT03236441|coronary artery disease|coronary artery disease
154013|NCT03236428|Smoldering Multiple Myeloma|smoldering multiple myeloma
154014|NCT03236428|Monoclonal Gammopathy|monoclonal gammopathy
154015|NCT03236402|Knowledge|knowledge
154016|NCT03236402|Opinion|opinion
154017|NCT03236402|Adoption|adoption
154018|NCT03236402|Adults|adults
154019|NCT03236402|Cross-Sectional|cross-sectional
154020|NCT03236363|Physical activity|physical activity
154021|NCT03236363|Obesity|obesity
154022|NCT03236363|Children|children
154023|NCT03236363|Cognitive function|cognitive function
154024|NCT03236363|Academic achievement|academic achievement
154025|NCT03236363|Cardiorespiratory fitness|cardiorespiratory fitness
154026|NCT03236363|Adiposity|adiposity
154027|NCT03236363|Cardiovascular fitness|cardiovascular fitness
154028|NCT03236363|Aerobic capacity|aerobic capacity
154029|NCT03236350|Chronic Kidney Disease|chronic kidney disease
154030|NCT03236350|Hypertension|hypertension
154031|NCT03236350|Cardiovascular Disease|cardiovascular disease
154032|NCT03236350|Central Aortic Systolic Pressure|central aortic systolic pressure
154033|NCT03236350|Proteinuria|proteinuria
154034|NCT03236350|Remote Ischemic Conditioning|remote ischemic conditioning
154035|NCT03236350|Left Ventricular Hypertrophy|left ventricular hypertrophy
154036|NCT03236337|Physical activity|physical activity
154037|NCT03236337|Obesity|obesity
154038|NCT03236337|Children|children
154039|NCT03236337|Cognitive function|cognitive function
154040|NCT03236337|Academic achievement|academic achievement
154041|NCT03236337|Cardiorespiratory fitness|cardiorespiratory fitness
154042|NCT03236337|Adiposity|adiposity
154043|NCT03236337|Cardiovascular fitness|cardiovascular fitness
154044|NCT03236337|Atherosclerosis|atherosclerosis
154045|NCT03236337|Aerobic capacity|aerobic capacity
154046|NCT03236298|Epidural|epidural
154047|NCT03236298|Labor analgesia|labor analgesia
154048|NCT03236298|Programmed intermittent epidural bolus|programmed intermittent epidural bolus
154049|NCT03236285|Obesity|obesity
154050|NCT03236285|Microcirculation|microcirculation
154051|NCT03236285|Endothelial function|endothelial function
154052|NCT03236285|Laser speckle imaging|laser speckle imaging
154053|NCT03236285|Capillary density|capillary density
154054|NCT03236272|Biomarkers|biomarkers
154055|NCT03236272|High-Throughput Screening Assays|high-throughput screening assays
154056|NCT03236272|Respiratory Distress Syndrome, Adult|respiratory distress syndrome, adult
154057|NCT03236220|haploidentical hematopoietic stem cell transplantation|haploidentical hematopoietic stem cell transplantation
154058|NCT03236220|poor graft function|poor graft function
154059|NCT03236220|prolonged isolated thrombocytopenia|prolonged isolated thrombocytopenia
154060|NCT03236220|bone marrow endothelial cells|bone marrow endothelial cells
154061|NCT03236220|N-acetyl-L-cysteine|n-acetyl-l-cysteine
154062|NCT03236220|Acute leukemia|acute leukemia
154063|NCT03236181|Energy Expenditure|energy expenditure
154064|NCT03236181|Appetite|appetite
154065|NCT03236181|Satiety|satiety
154066|NCT03236155|Opioids|opioids
154067|NCT03236142|bariatric|bariatric
154068|NCT03236142|duodenal switch|duodenal switch
154069|NCT03236142|DS|ds
154070|NCT03236142|weight loss surgery|weight loss surgery
154071|NCT03236142|SIPS|sips
154072|NCT03236142|Single Anastomosis|single anastomosis
154073|NCT03236129|DLI|dli
154074|NCT03236129|Regulatory T cells depletion|regulatory t cells depletion
154075|NCT03236129|Hematological malignancies|hematological malignancies
154076|NCT03236129|Relapse|relapse
154077|NCT03236103|Ventricular assist device|ventricular assist device
154078|NCT03236090|Cirrhosis|cirrhosis
154079|NCT03236090|Probiotics|probiotics
154080|NCT03236090|Systemic inflammation|systemic inflammation
154081|NCT03236090|neuroinflammation|neuroinflammation
154082|NCT03236090|Cognitive function|cognitive function
154083|NCT03236090|Bacterial translocation|bacterial translocation
154084|NCT03236077|obesity, women, exercise, physical activity,|obesity, women, exercise, physical activity,
154085|NCT03236051|gastric cancer|gastric cancer
154086|NCT03236051|gastrectomy|gastrectomy
154087|NCT03236051|multimodal analgesia|multimodal analgesia
154088|NCT03236051|parecoxib|parecoxib
154089|NCT03236038|exocrine pancreatic insufficiency|exocrine pancreatic insufficiency
154090|NCT03236038|liver cirrhosis|liver cirrhosis
154091|NCT03236038|decompensated cirrhosis|decompensated cirrhosis
154092|NCT03236038|malnutrition|malnutrition
154093|NCT03236038|prevalence|prevalence
154094|NCT03236025|smoking cessation|smoking cessation
154095|NCT03236025|video|video
154096|NCT03236025|male smoker|male smoker
154097|NCT03236012|amputation, amputations, sweating, residual limb,|amputation, amputations, sweating, residual limb,
154098|NCT03235986|RDS|rds
154099|NCT03235973|refractory acute leukemia|refractory acute leukemia
154100|NCT03235973|refractory myelodysplastic syndrome|refractory myelodysplastic syndrome
154101|NCT03235973|cladribine dose escalation|cladribine dose escalation
154102|NCT03235947|Renal transplant|renal transplant
154103|NCT03235947|Antimicrobian prophylaxis|antimicrobian prophylaxis
154104|NCT03235947|Fosfomycin|fosfomycin
154105|NCT03235947|Urinary tract infection|urinary tract infection
154106|NCT03235947|Asymptomatic bacteriuria|asymptomatic bacteriuria
154107|NCT03235934|glucose monitoring|glucose monitoring
154108|NCT03235921|hemorrhagic shock|hemorrhagic shock
154109|NCT03235921|perfusion index|perfusion index
154110|NCT03235921|lactate|lactate
154111|NCT03235921|nitroglycerin|nitroglycerin
154112|NCT03235908|Copeptin|copeptin
154113|NCT03235908|Outcome prediction|outcome prediction
154114|NCT03235882|Lung surfactant|lung surfactant
154115|NCT03235882|Mid-infrared spectroscopy|mid-infrared spectroscopy
154116|NCT03235882|Prematurity|prematurity
154117|NCT03235882|Respiratory distress syndrome|respiratory distress syndrome
154118|NCT03235882|gastric aspirate|gastric aspirate
154119|NCT03235843|Chronotropic Incompetence|chronotropic incompetence
154120|NCT03235843|Rate Adaptive Pacing|rate adaptive pacing
154121|NCT03235843|Minute Ventilation Sensor|minute ventilation sensor
154122|NCT03235843|Primary Prevention ICD Therapy|primary prevention icd therapy
154123|NCT03235843|Implantable Cardioverter Defibrillator|implantable cardioverter defibrillator
154124|NCT03235843|Heart Failure|heart failure
154125|NCT03235843|Exercise Intolerance|exercise intolerance
154126|NCT03235830|Healthcare utilization|healthcare utilization
154127|NCT03235830|Health literacy|health literacy
154128|NCT03235817|Proseal™ LMA|proseal™ lma
154129|NCT03235817|infants|infants
154130|NCT03235817|ventilation|ventilation
154131|NCT03235817|general anesthesia|general anesthesia
154132|NCT03235817|outpatient surgery|outpatient surgery
154133|NCT03235804|High-protein diet|high-protein diet
154134|NCT03235804|Inflammation|inflammation
154135|NCT03235804|Gut microbiota|gut microbiota
154136|NCT03235804|Energy metabolism|energy metabolism
154137|NCT03235804|Body composition|body composition
154138|NCT03235778|Tolerance; Pharmacokinetic characteristics|tolerance; pharmacokinetic characteristics
154139|NCT03235765|NSCLC|nsclc
154140|NCT03235765|Cancer panel|cancer panel
154141|NCT03235765|NGS|ngs
154142|NCT03235765|Actionable mutation|actionable mutation
154143|NCT03235765|Immune checkpoint inhibitor|immune checkpoint inhibitor
154144|NCT03235752|Randomized|randomized
154145|NCT03235752|Double-blind|double-blind
154146|NCT03235752|Placebo-controlled|placebo-controlled
154147|NCT03235752|Safety|safety
154148|NCT03235752|Efficacy|efficacy
154149|NCT03235752|Active Ulcerative Colitis|active ulcerative colitis
154150|NCT03235726|bystander|bystander
154151|NCT03235726|inhalation powder|inhalation powder
154152|NCT03235726|monodose device|monodose device
154153|NCT03235726|COPD|copd
154154|NCT03235726|pharmacokinetics|pharmacokinetics
154155|NCT03235726|safety|safety
154156|NCT03235726|Healthy|healthy
154157|NCT03235726|CCI15106|cci15106
154158|NCT03235726|tolerability|tolerability
154159|NCT03235713|Ecological momentary assessments|ecological momentary assessments
154160|NCT03235700|heart failure with reduced ejection fraction|heart failure with reduced ejection fraction
154161|NCT03235700|intermediate coronary stenosis|intermediate coronary stenosis
154162|NCT03235700|adenosine|adenosine
154163|NCT03235700|hyperemia|hyperemia
154164|NCT03235674|Cardiac rehabilitation|cardiac rehabilitation
154165|NCT03235674|interval exercise|interval exercise
154166|NCT03235635|microbiome|microbiome
154167|NCT03235635|preterm|preterm
154168|NCT03235635|newborn|newborn
154169|NCT03235635|gut microbiome|gut microbiome
154170|NCT03235635|allergic predisposition|allergic predisposition
154171|NCT03235596|executive functions|executive functions
154172|NCT03235596|tDCS|tdcs
154173|NCT03235583|Energy expenditure|energy expenditure
154174|NCT03235583|physical activity|physical activity
154175|NCT03235583|accelerometer|accelerometer
154176|NCT03235583|magnetometer|magnetometer
154177|NCT03235583|monitoring|monitoring
154178|NCT03235583|free-living conditions|free-living conditions
154179|NCT03235583|doubly labelled water|doubly labelled water
154180|NCT03235570|Solid tumor|solid tumor
154181|NCT03235570|malignancy|malignancy
154182|NCT03235570|fibroblast growth factor receptor (FGFR)|fibroblast growth factor receptor (fgfr)
154183|NCT03235570|fibroblast growth factor (FGF)/FGFR alteration|fibroblast growth factor (fgf)/fgfr alteration
154184|NCT03235557|prostate|prostate
154185|NCT03235557|cancer|cancer
154186|NCT03235557|radiation|radiation
154187|NCT03235557|stereotactic|stereotactic
154188|NCT03235557|CyberKnife|cyberknife
154189|NCT03235557|elderly|elderly
154190|NCT03235544|Mantle cell lymphoma|mantle cell lymphoma
154191|NCT03235544|non-Hodgkin lymphoma|non-hodgkin lymphoma
154192|NCT03235544|Bruton's tyrosine kinase (BTK)|bruton's tyrosine kinase (btk)
154193|NCT03235544|phosphatidylinositol 3-kinase (PI3K)|phosphatidylinositol 3-kinase (pi3k)
154194|NCT03235531|alcohol withdrawal syndrome|alcohol withdrawal syndrome
154195|NCT03235531|trauma|trauma
154196|NCT03235531|alcohol use disorder|alcohol use disorder
154197|NCT03235531|alcohol|alcohol
154198|NCT03235531|lorazepam|lorazepam
154199|NCT03235531|benzodiazepine|benzodiazepine
154200|NCT03235531|valproate|valproate
154201|NCT03235518|HIV Prevention|hiv prevention
154202|NCT03235518|Female sex workers|female sex workers
154203|NCT03235505|Smoking Cessation|smoking cessation
154204|NCT03235505|Electronic cigarette|electronic cigarette
154205|NCT03235505|Adults|adults
154206|NCT03235492|diabetes|diabetes
154207|NCT03235492|salivary glycated albumin|salivary glycated albumin
154208|NCT03235492|HbA1c|hba1c
154209|NCT03235453|Parkinson|parkinson
154210|NCT03235453|Quality of Life|quality of life
154211|NCT03235453|Sleep Disorder|sleep disorder
154212|NCT03235453|Gait Disorders|gait disorders
154213|NCT03235453|Mobility|mobility
154214|NCT03235427|Coronary|coronary
154215|NCT03235427|Coronary Disease|coronary disease
154216|NCT03235427|Coronary Arteriosclerosis|coronary arteriosclerosis
154217|NCT03235427|Heart Disease|heart disease
154218|NCT03235427|Cardiotoxicity|cardiotoxicity
154219|NCT03235427|Breast Cancer|breast cancer
154220|NCT03235427|Carcinoma|carcinoma
154221|NCT03235427|Coronary Vessels|coronary vessels
154222|NCT03235427|Radiation|radiation
154223|NCT03235427|Radiation Therapy|radiation therapy
154224|NCT03235427|Coronary Artery Disease|coronary artery disease
154225|NCT03235427|CAD|cad
154226|NCT03235427|RT|rt
154227|NCT03235427|CT|ct
154228|NCT03235427|Cardiac toxicity|cardiac toxicity
154229|NCT03235427|Cardiac calcium score|cardiac calcium score
154230|NCT03235427|Chest RT|chest rt
154231|NCT03235427|Lung Cancer|lung cancer
154232|NCT03235427|Lymphoma|lymphoma
154233|NCT03235427|Cardiac CT Scan|cardiac ct scan
154234|NCT03235427|Coronary Artery|coronary artery
154235|NCT03235427|Coronary arteries|coronary arteries
154236|NCT03235427|Cardiac Side Effect|cardiac side effect
154237|NCT03235427|Cardiac tissue|cardiac tissue
154238|NCT03235427|Cardiac|cardiac
154239|NCT03235401|Questionnaire|questionnaire
154240|NCT03235401|Disability assessment|disability assessment
154241|NCT03235401|Bothersomeness|bothersomeness
154242|NCT03235401|Pulmonary Arterial Hypertension|pulmonary arterial hypertension
154243|NCT03235401|patient-reported outcome measure|patient-reported outcome measure
154244|NCT03235401|New York Heart Association (NYHA) functional class|new york heart association (nyha) functional class
154245|NCT03235388|Trauma|trauma
154246|NCT03235388|Injury|injury
154247|NCT03235388|Audit filter|audit filter
154248|NCT03235388|Quality improvement|quality improvement
154249|NCT03235388|India|india
154250|NCT03235375|Kidney Failure, Kidney Insufficiency, Renal Failure, Renal Insufficiency, MEDI0382|kidney failure, kidney insufficiency, renal failure, renal insufficiency, medi0382
154251|NCT03235349|Chronic Hepatitis C Virus (HCV)|chronic hepatitis c virus (hcv)
154252|NCT03235349|Genotype 1 to 6|genotype 1 to 6
154253|NCT03235349|Cirrhosis|cirrhosis
154254|NCT03235349|Compensated Cirrhosis|compensated cirrhosis
154255|NCT03235349|Human Immunodeficiency Virus|human immunodeficiency virus
154256|NCT03235349|co-infection|co-infection
154257|NCT03235349|Treatment-naïve|treatment-naïve
154258|NCT03235349|treatment-experienced|treatment-experienced
154259|NCT03235349|interferon|interferon
154260|NCT03235349|Asian|asian
154261|NCT03235323|Vein Graft Failure|vein graft failure
154262|NCT03235323|Coronary Artery Bypass|coronary artery bypass
154263|NCT03235323|External Counterpulsation|external counterpulsation
154264|NCT03235310|HIV|hiv
154265|NCT03235310|Pregnancy|pregnancy
154266|NCT03235310|Prevention of mother-to-child transmission|prevention of mother-to-child transmission
154267|NCT03235297|Altitude|altitude
154268|NCT03235297|Diffusing capacity for carbon monoxide|diffusing capacity for carbon monoxide
154269|NCT03235297|COPD|copd
154270|NCT03235297|Pulmonary function testing|pulmonary function testing
154271|NCT03235284|Parkinson's Disease ande Video Games|parkinson's disease ande video games
154272|NCT03235258|HIV Infection|hiv infection
154273|NCT03235258|Adolescent|adolescent
154274|NCT03235245|cutaneous melanoma|cutaneous melanoma
154275|NCT03235245|mucosal melanoma|mucosal melanoma
154276|NCT03235245|BRAF mutation|braf mutation
154277|NCT03235206|Police Officers|police officers
154278|NCT03235154|HCV|hcv
154279|NCT03235154|suboxone|suboxone
154280|NCT03235154|epclusa|epclusa
154281|NCT03235154|psychiatrist|psychiatrist
154282|NCT03235141|Azithromycin eye drops|azithromycin eye drops
154283|NCT03235141|Local Pharmacokinetics|local pharmacokinetics
154284|NCT03235063|Dilated cardiomyopathy|dilated cardiomyopathy
154285|NCT03235063|registry|registry
154286|NCT03235063|heart failure|heart failure
154287|NCT03235063|pregnancy|pregnancy
154288|NCT03234959|Early Intervention|early intervention
154289|NCT03234959|Cerebral Palsy|cerebral palsy
154290|NCT03234959|CareToy Intervention|caretoy intervention
154291|NCT03234959|Infant Massage|infant massage
154292|NCT03234959|Information Communication Technology|information communication technology
154293|NCT03234946|Diabetes|diabetes
154294|NCT03234946|Family|family
154295|NCT03234946|Impaired fasting-glucose|impaired fasting-glucose
154296|NCT03234946|Carbohydrate intolerance|carbohydrate intolerance
154297|NCT03234933|Cancer|cancer
154298|NCT03234920|cirrhosis|cirrhosis
154299|NCT03234920|liver transplantation|liver transplantation
154300|NCT03234920|HMB|hmb
154301|NCT03234907|Drug therapy|drug therapy
154302|NCT03234881|Binge Eating|binge eating
154303|NCT03234881|Cognitive Behavioral Therapy|cognitive behavioral therapy
154304|NCT03234881|Weight Management|weight management
154305|NCT03234881|Veterans|veterans
154306|NCT03234842|Esophagus|esophagus
154307|NCT03234842|Proton|proton
154308|NCT03234842|Radiation|radiation
154309|NCT03234829|arch lengths, space analysis, arch prediction|arch lengths, space analysis, arch prediction
154310|NCT03234790|Diesel Exhaust|diesel exhaust
154311|NCT03234790|Air Pollution|air pollution
154312|NCT03234790|Airway Responsiveness|airway responsiveness
154313|NCT03234790|Proteomics|proteomics
154314|NCT03234790|Urine PAH Metabolites|urine pah metabolites
154315|NCT03234764|IgE|ige
154316|NCT03234764|Allergy|allergy
154317|NCT03234764|Tolerance|tolerance
154318|NCT03234764|Immunotherapy|immunotherapy
154319|NCT03234764|Desensitization|desensitization
154320|NCT03234751|human B-type natriuretic peptide|human b-type natriuretic peptide
154321|NCT03234725|Blue light imaging|blue light imaging
154322|NCT03234725|Linked color imaging|linked color imaging
154323|NCT03234725|Optical histology|optical histology
154324|NCT03234725|Adenoma detection rate|adenoma detection rate
154325|NCT03234725|Variable stiffness|variable stiffness
154326|NCT03234725|Deep learning|deep learning
154327|NCT03234712|Advanced Solid Tumors|advanced solid tumors
154328|NCT03234712|Epidermal Growth Factor Receptor (EGFR)|epidermal growth factor receptor (egfr)
154329|NCT03234712|Squamous cell carcinoma of the head and neck (HNSCC)|squamous cell carcinoma of the head and neck (hnscc)
154330|NCT03234712|non-small cell lung cancer (NSCLC)|non-small cell lung cancer (nsclc)
154331|NCT03234712|Glioblastoma (GBM)|glioblastoma (gbm)
154332|NCT03234712|Cancer|cancer
154333|NCT03234712|overexpression of Epidermal Growth Factor Receptor (EGFR)|overexpression of epidermal growth factor receptor (egfr)
154334|NCT03234686|Dementia|dementia
154335|NCT03234686|Alzheimer's Disease|alzheimer's disease
154336|NCT03234621|protective ventilation strategy|protective ventilation strategy
154337|NCT03234608|Healthcare services|healthcare services
154338|NCT03234608|Adults|adults
154339|NCT03234595|Cerebraca wafer|cerebraca wafer
154340|NCT03234595|Recurrent high grade glioma|recurrent high grade glioma
154341|NCT03234595|anaplastic astrocytoma|anaplastic astrocytoma
154342|NCT03234595|glioblastoma multiforme|glioblastoma multiforme
154343|NCT03234569|sonohysterosalpingography|sonohysterosalpingography
154344|NCT03234569|hysterosalpingography|hysterosalpingography
154345|NCT03234543|Abdominal Surgery|abdominal surgery
154346|NCT03234543|Pre-conditioning|pre-conditioning
154347|NCT03234543|Remote Ischemic Conditioning|remote ischemic conditioning
154348|NCT03234543|Post-Operative Complications|post-operative complications
154349|NCT03234543|Acute Phase Response|acute phase response
154350|NCT03234530|albuminuria|albuminuria
154351|NCT03234530|sleep apnea|sleep apnea
154352|NCT03234530|particulate matter|particulate matter
154353|NCT03234530|renal injury|renal injury
154354|NCT03234491|Diabetes|diabetes
154355|NCT03234491|Insulin|insulin
154356|NCT03234478|deep brain stimulation|deep brain stimulation
154357|NCT03234478|cognition|cognition
154358|NCT03234478|young onset Parkinson disease|young onset parkinson disease
154359|NCT03234452|Lactoflorene plus|lactoflorene plus
154360|NCT03234452|Bifidobacterium animalis subsp. lactis, BB-12®|bifidobacterium animalis subsp. lactis, bb-12®
154361|NCT03234452|Lactobacillus acidophilus, LA-5®|lactobacillus acidophilus, la-5®
154362|NCT03234452|Lactobacillus paracasei subsp. paracasei, L. CASEI 431®|lactobacillus paracasei subsp. paracasei, l. casei 431®
154363|NCT03234452|Inflammation|inflammation
154364|NCT03234452|gut permeability|gut permeability
154365|NCT03234452|disbiosis|disbiosis
154366|NCT03234452|probiotic|probiotic
154367|NCT03234452|IgA|iga
154368|NCT03234452|IL10|il10
154369|NCT03234439|digital behavioral health|digital behavioral health
154370|NCT03234413|Botulinum Toxin-A|botulinum toxin-a
154371|NCT03234374|Pharmacokinetics|pharmacokinetics
154372|NCT03234374|Bioavailability|bioavailability
154373|NCT03234374|Safety|safety
154374|NCT03234374|Bupivacaine|bupivacaine
154375|NCT03234374|Collagen|collagen
154376|NCT03234374|Implant|implant
154377|NCT03234374|Marcaine|marcaine
154378|NCT03234374|Hernioplasty|hernioplasty
154379|NCT03234361|Hypertension|hypertension
154380|NCT03234361|High phosphorus diet|high phosphorus diet
154381|NCT03234361|FGF 23|fgf 23
154382|NCT03234361|24 hour ambulatory blood pressure|24 hour ambulatory blood pressure
154383|NCT03234361|Muscle sympathetic nerve|muscle sympathetic nerve
154384|NCT03234348|biodegradable stent|biodegradable stent
154385|NCT03234348|STEMI|stemi
154386|NCT03234348|Magnesium bioresorbable|magnesium bioresorbable
154387|NCT03234348|Vasomotion|vasomotion
154388|NCT03234335|Multiple Myeloma|multiple myeloma
154389|NCT03234335|Renal Failure|renal failure
154390|NCT03234335|Autologous Hematopoietic Stem Cell Transplantation (ASCT)|autologous hematopoietic stem cell transplantation (asct)
154391|NCT03234335|Melphalan|melphalan
154392|NCT03234322|prevention|prevention
154393|NCT03234322|risk score|risk score
154394|NCT03234322|behaviour|behaviour
154395|NCT03234322|physical activity|physical activity
154396|NCT03234296|uncomplicated acute appendicitis|uncomplicated acute appendicitis
154397|NCT03234296|complicated acute appendicitis|complicated acute appendicitis
154398|NCT03234296|antibiotic therapy|antibiotic therapy
154399|NCT03234296|spontaneous resolution|spontaneous resolution
154400|NCT03234283|Intubation|intubation
154401|NCT03234270|Heat stress, pilots|heat stress, pilots
154402|NCT03234257|Carotid stenosis|carotid stenosis
154403|NCT03234257|stiffness|stiffness
154404|NCT03234257|ultrafast ultrasound imaging|ultrafast ultrasound imaging
154405|NCT03234257|Plaque stability|plaque stability
154406|NCT03234218|vitamin D, liver transplantation|vitamin d, liver transplantation
154407|NCT03234192|extensor carpi radialis brevis|extensor carpi radialis brevis
154408|NCT03234192|Therapeutic Ultrasound|therapeutic ultrasound
154409|NCT03234192|Astym Treatment Technique|astym treatment technique
154410|NCT03234192|Graston Treatment Technique|graston treatment technique
154411|NCT03234179|Non small cell lung cancer|non small cell lung cancer
154412|NCT03234179|Genetic study|genetic study
154413|NCT03234166|Acute necrotizing pancreatitis Acute pancreatitis Pancreas disease Sepsis Infection Drainage Catheters Antibiotics Multiresistant organism|acute necrotizing pancreatitis acute pancreatitis pancreas disease sepsis infection drainage catheters antibiotics multiresistant organism
154414|NCT03234153|Muscle-invasive Bladder Cancer|muscle-invasive bladder cancer
154415|NCT03234153|Ineligible for Cisplatin-based Chemotherapy|ineligible for cisplatin-based chemotherapy
154416|NCT03234153|Durvalumab|durvalumab
154417|NCT03234153|Tremelimumab|tremelimumab
154418|NCT03234114|new generation drug eluting stent (DES)|new generation drug eluting stent (des)
154419|NCT03234114|antithrombotic therapy|antithrombotic therapy
154420|NCT03234114|randomized clinical trial (RCT)|randomized clinical trial (rct)
154421|NCT03234101|Systematic review and meta-analysis|systematic review and meta-analysis
154422|NCT03234101|Evidence-based medicine (EBM)|evidence-based medicine (ebm)
154423|NCT03234101|Evidence-based nutrition (EBN)|evidence-based nutrition (ebn)
154424|NCT03234101|Clinical practice guidelines|clinical practice guidelines
154425|NCT03234101|Prospective cohort studies|prospective cohort studies
154426|NCT03234101|Low-risk lifestyle behaviours|low-risk lifestyle behaviours
154427|NCT03234101|Healthy Diet|healthy diet
154428|NCT03234101|Exercise|exercise
154429|NCT03234101|Physical activity|physical activity
154430|NCT03234101|Body weight|body weight
154431|NCT03234101|Sleep|sleep
154432|NCT03234101|alcohol|alcohol
154433|NCT03234101|Smoking|smoking
154434|NCT03234101|Cardiovascular disease|cardiovascular disease
154435|NCT03234101|Coronary heart disease|coronary heart disease
154436|NCT03234101|Stroke|stroke
154437|NCT03234101|Diabetes|diabetes
154438|NCT03234101|Cancer|cancer
154439|NCT03234101|Cardiovascular disease mortality|cardiovascular disease mortality
154440|NCT03234101|Coronary heart disease mortality|coronary heart disease mortality
154441|NCT03234101|Stroke mortality|stroke mortality
154442|NCT03234101|All-cause mortality|all-cause mortality
154443|NCT03234088|Congestive Heart Failure|congestive heart failure
154444|NCT03234088|Heart Failure|heart failure
154445|NCT03234088|Home telemonitoring|home telemonitoring
154446|NCT03234088|Telehealth|telehealth
154447|NCT03234088|HF Disease Management|hf disease management
154448|NCT03234088|Heart failure remote self management|heart failure remote self management
154449|NCT03234049|pediatric|pediatric
154450|NCT03234049|checklist|checklist
154451|NCT03234049|cognitive aid|cognitive aid
154452|NCT03234036|GSK2838232|gsk2838232
154453|NCT03234036|safety|safety
154454|NCT03234036|food effect|food effect
154455|NCT03234036|capsule|capsule
154456|NCT03234036|healthy|healthy
154458|NCT03234036|tablet|tablet
154459|NCT03233984|bisphenol-A|bisphenol-a
154460|NCT03233984|prevention|prevention
154461|NCT03233984|endocrine disruptors|endocrine disruptors
154462|NCT03233932|CKD-841|ckd-841
154463|NCT03233932|Leuplin|leuplin
154464|NCT03233932|Postmenopausal|postmenopausal
154465|NCT03233919|Remote Ischemic Conditioning|remote ischemic conditioning
154466|NCT03233893|based dentin substitute|based dentin substitute
154467|NCT03233893|dentin bridge|dentin bridge
154468|NCT03233893|tertiary dentin|tertiary dentin
154469|NCT03233893|indirect pulp treatment|indirect pulp treatment
154470|NCT03233880|chlamydia|chlamydia
154471|NCT03233880|prevention|prevention
154472|NCT03233841|Natural History Study|natural history study
154473|NCT03233841|Observational Study|observational study
154474|NCT03233841|Prospective Study|prospective study
154475|NCT03233841|Retrospective Study|retrospective study
154476|NCT03233841|Farber Disease|farber disease
154477|NCT03233841|Farber's Disease|farber's disease
154478|NCT03233841|ASAH1|asah1
154479|NCT03233841|Subcutaneous Nodules|subcutaneous nodules
154480|NCT03233841|Lysosomal Storage Disease|lysosomal storage disease
154481|NCT03233841|Lysosomal Storage Disease, Nervous System|lysosomal storage disease, nervous system
154482|NCT03233841|Metabolic Diseases|metabolic diseases
154483|NCT03233841|Lipid Metabolism Disorders|lipid metabolism disorders
154484|NCT03233841|Lipidoses|lipidoses
154485|NCT03233841|Sphingolipidoses|sphingolipidoses
154486|NCT03233841|Genetic Disease, Inborn|genetic disease, inborn
154487|NCT03233841|Musculoskeletal Diseases|musculoskeletal diseases
154488|NCT03233841|Connective Tissue Diseases|connective tissue diseases
154489|NCT03233841|Central Nervous System Diseases|central nervous system diseases
154490|NCT03233841|Brain Diseases, Metabolic, Inborn|brain diseases, metabolic, inborn
154491|NCT03233841|Brain Diseases, Metabolic|brain diseases, metabolic
154492|NCT03233841|Brain Diseases, Inborn|brain diseases, inborn
154493|NCT03233841|Brain Diseases|brain diseases
154494|NCT03233841|Infant, Newborn Diseases|infant, newborn diseases
154495|NCT03233841|Inborn Errors of Metabolism|inborn errors of metabolism
154496|NCT03233841|Inherited Metabolic Disease|inherited metabolic disease
154497|NCT03233828|Intralesional Injection|intralesional injection
154498|NCT03233828|Immunotherapy|immunotherapy
154499|NCT03233828|Immune Response|immune response
154500|NCT03233828|Interleukin-2 (Aldesleukin)|interleukin-2 (aldesleukin)
154501|NCT03233828|Tumor Infiltration|tumor infiltration
154502|NCT03233828|Metastasis Prevention|metastasis prevention
154503|NCT03233815|Inhaled anesthesia|inhaled anesthesia
154504|NCT03233815|Total intravenous anesthesia|total intravenous anesthesia
154505|NCT03233802|Alcohol Use Disorder|alcohol use disorder
154506|NCT03233802|Treatment|treatment
154507|NCT03233802|Cognitive-Behavioral Treatment|cognitive-behavioral treatment
154508|NCT03233802|Individualized Treatment|individualized treatment
154509|NCT03233776|Anakinra|anakinra
154510|NCT03233776|Mucositis|mucositis
154511|NCT03233776|Hematopoietic stem cell transplantation|hematopoietic stem cell transplantation
154512|NCT03233776|Febrile neutropenia|febrile neutropenia
154513|NCT03233737|local anesthesia|local anesthesia
154514|NCT03233737|pain tolerance|pain tolerance
154515|NCT03233737|experimental pain|experimental pain
154516|NCT03233724|PD-L1|pd-l1
154517|NCT03233724|Demethylating Agents and Histone Deacetylase (HDAC) Inhibitors|demethylating agents and histone deacetylase (hdac) inhibitors
154518|NCT03233724|DNA Hypomethylating Agent|dna hypomethylating agent
154519|NCT03233724|Cytidine Deaminase|cytidine deaminase
154520|NCT03233724|Checkpoint Inhibitor|checkpoint inhibitor
154521|NCT03233685|Tennis|tennis
154522|NCT03233685|Reaction Time|reaction time
154523|NCT03233685|Visual training|visual training
154524|NCT03233672|adjuvant|adjuvant
154525|NCT03233672|hypofractionation|hypofractionation
154526|NCT03233672|IMRT|imrt
154527|NCT03233672|phase I-II|phase i-ii
154528|NCT03233672|prostate neoplasms|prostate neoplasms
154529|NCT03233672|radiotherapy|radiotherapy
154530|NCT03233659|Allogeneic Stem Cell Transplantation, APCs, GVHD|allogeneic stem cell transplantation, apcs, gvhd
154531|NCT03233646|OCT angiography|oct angiography
154532|NCT03233646|Optical Coherence Tomography|optical coherence tomography
154533|NCT03233646|Vessel Density|vessel density
154534|NCT03233646|Superficial Capillary Plexus|superficial capillary plexus
154535|NCT03233646|retinal microvasculature|retinal microvasculature
154536|NCT03233646|OCTA|octa
154537|NCT03233633|pain management|pain management
154538|NCT03233633|terminally ill|terminally ill
154539|NCT03233620|knee arthroplasty|knee arthroplasty
154540|NCT03233620|working-age|working-age
154541|NCT03233620|patient related outcome measures|patient related outcome measures
154542|NCT03233607|Postpartum|postpartum
154543|NCT03233607|Hemoglobin|hemoglobin
154544|NCT03233594|Chronic Pain Syndrome|chronic pain syndrome
154545|NCT03233594|Chronic Pain|chronic pain
154546|NCT03233594|Chiropractic|chiropractic
154547|NCT03233594|PET|pet
154548|NCT03233594|MRI|mri
154549|NCT03233594|Positron emission tomography|positron emission tomography
154550|NCT03233594|Magnetic resonance imaging|magnetic resonance imaging
154551|NCT03233542|Cognitive biases|cognitive biases
154552|NCT03233542|Associations|associations
154553|NCT03233542|Interpretations|interpretations
154554|NCT03233542|Physiological and biological markers|physiological and biological markers
154555|NCT03233529|atopic dermatitis|atopic dermatitis
154556|NCT03233529|atopic eczema|atopic eczema
154557|NCT03233529|eczema|eczema
154558|NCT03233529|topical treatment|topical treatment
154559|NCT03233529|skin diseases|skin diseases
154560|NCT03233529|phosphodiesterase-4 inhibitor|phosphodiesterase-4 inhibitor
154561|NCT03233529|PDE-4 inhibitor|pde-4 inhibitor
154562|NCT03233529|crisaborole|crisaborole
154563|NCT03233516|Community-acquired pneumonia|community-acquired pneumonia
154564|NCT03233516|Pediatrics|pediatrics
154565|NCT03233516|Etiology|etiology
154566|NCT03233516|Point-of-care test|point-of-care test
154567|NCT03233516|MxA|mxa
154568|NCT03233516|CRP|crp
154569|NCT03233516|Procalcitonin|procalcitonin
154570|NCT03233516|Infectious diseases|infectious diseases
154571|NCT03233516|Respiratory viruses|respiratory viruses
154572|NCT03233516|Pediatric asthma|pediatric asthma
154573|NCT03233490|CPR training|cpr training
154574|NCT03233490|students|students
154576|NCT03233477|Posner Schlossman Syndrome|posner schlossman syndrome
154577|NCT03233477|cytokine expression|cytokine expression
154578|NCT03233477|cytomegalovirus|cytomegalovirus
154579|NCT03233438|Critical Pathways|critical pathways
154580|NCT03233438|Health Facilities|health facilities
154581|NCT03233438|Clinical Protocols|clinical protocols
154582|NCT03233438|Patient Satisfaction|patient satisfaction
154583|NCT03233438|Absenteeism|absenteeism
154584|NCT03233438|Anti-Bacterial Agents|anti-bacterial agents
154585|NCT03233438|Quality of Life|quality of life
154586|NCT03233438|Economics, Medical|economics, medical
154587|NCT03233438|Health Resources|health resources
154588|NCT03233438|Health resource utilization|health resource utilization
154589|NCT03233438|Acute bacterial skin and skin structure infection (ABSSSI)|acute bacterial skin and skin structure infection (absssi)
154590|NCT03233425|Child|child
154591|NCT03233425|adolescent|adolescent
154592|NCT03233425|co-morbidity|co-morbidity
154593|NCT03233425|psychology|psychology
154594|NCT03233425|motivation|motivation
154595|NCT03233425|physical activity|physical activity
154596|NCT03233425|eating disorders|eating disorders
154597|NCT03233425|quality of life|quality of life
154598|NCT03233425|therapy|therapy
154599|NCT03233425|predictors|predictors
154600|NCT03233412|high grade cervical intraepithelial neoplasia|high grade cervical intraepithelial neoplasia
154601|NCT03233412|Immunomodulatory treatment|immunomodulatory treatment
154602|NCT03233399|Electroencephalography|electroencephalography
154603|NCT03233399|Magnetoencephalography|magnetoencephalography
154604|NCT03233399|Transcranial Magnetic Stimulation|transcranial magnetic stimulation
154605|NCT03233373|Nasal Airway Obstruction|nasal airway obstruction
154606|NCT03233373|Devices|devices
154607|NCT03233373|Imaging, Diagnostic|imaging, diagnostic
154608|NCT03233373|Computer-Assisted Image Processing|computer-assisted image processing
154609|NCT03233373|Thermal Analysis, Differential|thermal analysis, differential
154610|NCT03233321|Dry cold application|dry cold application
154611|NCT03233321|Pain|pain
154612|NCT03233321|Bruise|bruise
154613|NCT03233321|Subcutaneous injection|subcutaneous injection
154614|NCT03233308|Aqueous Humor Dynamics|aqueous humor dynamics
154615|NCT03233308|Trabecular Outflow|trabecular outflow
154616|NCT03233308|Netarsudil|netarsudil
154617|NCT03233243|Rosuvastatin|rosuvastatin
154618|NCT03233243|Sodium fluoride|sodium fluoride
154619|NCT03233243|Positron-emission tomography|positron-emission tomography
154620|NCT03233230|Rheumatoid Arthritis|rheumatoid arthritis
154621|NCT03233230|American College of Rheumatology|american college of rheumatology
154622|NCT03233230|High-sensitivity C-reactive protein|high-sensitivity c-reactive protein
154623|NCT03233230|Bruton's tyrosine kinase|bruton's tyrosine kinase
154624|NCT03233217|Influenza|influenza
154625|NCT03233191|Digital Mammography|digital mammography
154626|NCT03233191|Breast Tomography|breast tomography
154627|NCT03233191|Screening Mammography|screening mammography
154628|NCT03233191|TMIST|tmist
154629|NCT03233165|laser therapy|laser therapy
154630|NCT03233165|recurrence|recurrence
154631|NCT03233165|leukoplakia|leukoplakia
154632|NCT03233165|precancerous lesion|precancerous lesion
154633|NCT03233152|recurrence|recurrence
154634|NCT03233139|Japanese patients|japanese patients
154635|NCT03233113|Exposure therapy|exposure therapy
154636|NCT03233113|Cognitive-behavioral therapy|cognitive-behavioral therapy
154637|NCT03233113|Anxiety disorders|anxiety disorders
154638|NCT03233100|FMT|fmt
154639|NCT03233100|gut microbiota|gut microbiota
154640|NCT03233100|gut-brain disorder|gut-brain disorder
154641|NCT03233100|constipation|constipation
154642|NCT03233100|depression|depression
154643|NCT03233100|anxiety|anxiety
154644|NCT03233074|Myelodysplastic Syndromes|myelodysplastic syndromes
154645|NCT03233074|Acute Myeloid Leukemia|acute myeloid leukemia
154646|NCT03233074|Bone Marrow|bone marrow
154647|NCT03233074|Mesenchymal stromal cell|mesenchymal stromal cell
154648|NCT03233074|Healthy donor|healthy donor
154649|NCT03233061|Obesity; cardiorespiratory fitness; oxygen uptake; household activities; physical activity; sedentary; intensity; obese women|obesity; cardiorespiratory fitness; oxygen uptake; household activities; physical activity; sedentary; intensity; obese women
154650|NCT03233035|Ketamine-Intranasal-Acute pain-Emergency departement|ketamine-intranasal-acute pain-emergency departement
154651|NCT03232996|Balance|balance
154652|NCT03232996|Gait|gait
154653|NCT03232957|Intrathecal morphine, total knee arthroplasty|intrathecal morphine, total knee arthroplasty
154654|NCT03232931|auditory|auditory
154655|NCT03232931|tactile|tactile
154656|NCT03232931|mother's voice|mother's voice
154657|NCT03232931|multisensory|multisensory
154658|NCT03232892|NSCLC|nsclc
154659|NCT03232892|NF-1 mutant|nf-1 mutant
154660|NCT03232879|Motor Imagery|motor imagery
154661|NCT03232879|Action Observation|action observation
154662|NCT03232879|Heart Rate|heart rate
154663|NCT03232879|Respiration Rate|respiration rate
154664|NCT03232879|Electrodermal Activity|electrodermal activity
154665|NCT03232866|Exercise Movement Techniques|exercise movement techniques
154666|NCT03232866|Exercise|exercise
154667|NCT03232866|Monitoring, Physiologic|monitoring, physiologic
154668|NCT03232866|Heart Rate|heart rate
154669|NCT03232866|Autonomic Nervous System|autonomic nervous system
154670|NCT03232866|Heart rate variability|heart rate variability
154671|NCT03232853|medical error in anesthesia|medical error in anesthesia
154672|NCT03232853|drug error in anesthesia|drug error in anesthesia
154673|NCT03232840|wrong site surgery in regional anesthesia|wrong site surgery in regional anesthesia
154674|NCT03232801|hypoactive sexual desire disorder|hypoactive sexual desire disorder
154675|NCT03232801|female sexual dysfunction|female sexual dysfunction
154676|NCT03232801|low libido|low libido
154677|NCT03232801|female sexual interest-arousal disorder|female sexual interest-arousal disorder
154678|NCT03232801|low desire|low desire
154679|NCT03232801|sexual dysfunction|sexual dysfunction
154680|NCT03232788|Periodontal disease|periodontal disease
154681|NCT03232788|Recession|recession
154682|NCT03232788|Black space|black space
154683|NCT03232775|visual pedagogy|visual pedagogy
154684|NCT03232723|Magnetoencephalography|magnetoencephalography
154685|NCT03232723|Whole-cortex MEG System (with optional EEG)|whole-cortex meg system (with optional eeg)
154686|NCT03232554|Iron-Deficiency Anemia|iron-deficiency anemia
154687|NCT03232554|Buxue Yimu Pills|buxue yimu pills
154688|NCT03232554|Ferrous Sulfate|ferrous sulfate
154689|NCT03232554|clinical observations|clinical observations
154690|NCT03232554|adult women|adult women
154691|NCT03232554|Metabonomics|metabonomics
154692|NCT03232515|Bioimpedance Vector Analysis (BIVA)|bioimpedance vector analysis (biva)
154693|NCT03232515|Chronic Renal Failure|chronic renal failure
154694|NCT03232515|Dialysis|dialysis
154695|NCT03232515|Dry weight|dry weight
154696|NCT03232515|Blood Pressure|blood pressure
154697|NCT03232437|HbA1c|hba1c
154698|NCT03232411|prostate disease|prostate disease
154699|NCT03232411|prostatic neoplasm|prostatic neoplasm
154700|NCT03232411|biobank|biobank
154701|NCT03232411|prostate cancer in black males|prostate cancer in black males
154702|NCT03232411|biospecimen|biospecimen
154703|NCT03232411|smoking and the aggressiveness of prostate cancer|smoking and the aggressiveness of prostate cancer
154704|NCT03232372|Bone loss, dental implant desing|bone loss, dental implant desing
154705|NCT03232346|buprenorphine|buprenorphine
154706|NCT03232346|naltrexone|naltrexone
154707|NCT03232346|Vivitrol|vivitrol
154708|NCT03232346|opioid dependence|opioid dependence
154709|NCT03232294|fetal macrosomia|fetal macrosomia
154710|NCT03232294|fetal abdominal wall thickness|fetal abdominal wall thickness
154711|NCT03232294|subcutaneous adipose tissue|subcutaneous adipose tissue
154712|NCT03232268|Microtransplantation|microtransplantation
154713|NCT03232268|Myeloid Hemopathy|myeloid hemopathy
154714|NCT03232203|Human leukocyte antigen|human leukocyte antigen
154715|NCT03232203|Key Risk Message|key risk message
154716|NCT03232203|ADA-SCID|ada-scid
154717|NCT03232203|Health care providers|health care providers
154718|NCT03232190|prematurity|prematurity
154719|NCT03232190|psychomotor development|psychomotor development
154720|NCT03232190|parent empowerment|parent empowerment
154721|NCT03232190|e-health|e-health
154722|NCT03232190|parental support|parental support
154723|NCT03232190|post discharge follow-up|post discharge follow-up
154724|NCT03232164|Prostate Cancer|prostate cancer
154725|NCT03232164|Prostate neoplasm|prostate neoplasm
154726|NCT03232151|Stroke|stroke
154727|NCT03232138|Sulforaphane|sulforaphane
154728|NCT03232138|Chemoprevention|chemoprevention
154729|NCT03232138|Former Smokers|former smokers
154730|NCT03232112|Alcohol|alcohol
154731|NCT03232112|Addiction|addiction
154732|NCT03232112|Glucagon Like Peptide-1|glucagon like peptide-1
154733|NCT03232112|GLP-1|glp-1
154734|NCT03232099|trimethylamine-N-oxide|trimethylamine-n-oxide
154735|NCT03232099|TMAO|tmao
154736|NCT03232099|Gut Microbiota|gut microbiota
154737|NCT03232099|Gut Flora|gut flora
154738|NCT03232099|Atherosclerosis|atherosclerosis
154739|NCT03232099|Wine|wine
154740|NCT03232099|Red Wine|red wine
154741|NCT03232086|Controlled Human Exposure Study|controlled human exposure study
154742|NCT03232086|Cardiovascular|cardiovascular
154743|NCT03232047|Computerized, Executive function, memory, cognitive training|computerized, executive function, memory, cognitive training
154744|NCT03232047|Mild Cognitive Impairment|mild cognitive impairment
154745|NCT03232034|Calcium citrate, dairy product, whey protein, appetite, metabolism|calcium citrate, dairy product, whey protein, appetite, metabolism
154746|NCT03232021|urinary bladder|urinary bladder
154747|NCT03232021|urinary catheters|urinary catheters
154748|NCT03232021|pregabalin|pregabalin
154749|NCT03232008|Blood glucose|blood glucose
154750|NCT03232008|Appetite|appetite
154751|NCT03231995|Severe influenza|severe influenza
154752|NCT03231995|biomarkers|biomarkers
154753|NCT03231995|respiratory microbiome|respiratory microbiome
154754|NCT03231995|prognosis|prognosis
154755|NCT03231943|FTIH|ftih
154756|NCT03231943|Healthy|healthy
154757|NCT03231943|Tolerability|tolerability
154758|NCT03231943|Dose-escalation|dose-escalation
154759|NCT03231943|HIV-1|hiv-1
154760|NCT03231943|Safety|safety
154761|NCT03231943|PK|pk
154762|NCT03231943|GSK3640254|gsk3640254
154763|NCT03231943|Maturation inhibitor|maturation inhibitor
154764|NCT03231930|Diagnosis|diagnosis
154765|NCT03231930|Point of Care Diagnostics|point of care diagnostics
154766|NCT03231930|Hepatitis|hepatitis
154767|NCT03231826|Home monitoring|home monitoring
154768|NCT03231826|ECG|ecg
154769|NCT03231826|Myocardial Infarction|myocardial infarction
154770|NCT03231826|Arrythmia|arrythmia
154771|NCT03231813|irritant contact dermatitis|irritant contact dermatitis
154772|NCT03231813|sodium lauryl sulphate|sodium lauryl sulphate
154773|NCT03231813|emollients|emollients
154774|NCT03231813|transepidermal water loss|transepidermal water loss
154775|NCT03231800|Attention-Deficit Hyperactivity Disorder (ADHD)|attention-deficit hyperactivity disorder (adhd)
154776|NCT03231774|Echocardiography|echocardiography
154777|NCT03231774|Right heart catheterization|right heart catheterization
154778|NCT03231722|mFOLFOXIRI + Panitumumab|mfolfoxiri + panitumumab
154779|NCT03231722|RAS and BRAF wt|ras and braf wt
154780|NCT03231696|nerve block|nerve block
154781|NCT03231696|peripheral nerve stimulation|peripheral nerve stimulation
154782|NCT03231657|preeclampsia|preeclampsia
154783|NCT03231657|intrauterine growth restriction|intrauterine growth restriction
154784|NCT03231657|angiogenic factors|angiogenic factors
154785|NCT03231644|Fibrous Dysplasia|fibrous dysplasia
154786|NCT03231644|McCune-Albright Syndrome|mccune-albright syndrome
154787|NCT03231644|Mazabrauds|mazabrauds
154788|NCT03231644|FD/MAS|fd/mas
154789|NCT03231631|Exercise|exercise
154790|NCT03231631|Education|education
154791|NCT03231631|Stents|stents
154792|NCT03231631|Angioplasty|angioplasty
154793|NCT03231631|Cardiac Rehabilitation|cardiac rehabilitation
154794|NCT03231631|Cholesterol, HDL|cholesterol, hdl
154795|NCT03231631|Metabolic Equivalent|metabolic equivalent
154796|NCT03231618|dietary intake|dietary intake
154797|NCT03231618|cross-over intervention|cross-over intervention
154798|NCT03231618|energy expenditure|energy expenditure
154799|NCT03231540|Critical care|critical care
154800|NCT03231540|nutrition|nutrition
154801|NCT03231540|whey protein|whey protein
154802|NCT03231540|mechanical ventilation|mechanical ventilation
154803|NCT03231540|muscle function|muscle function
154804|NCT03231514|body composition|body composition
154805|NCT03231514|exercise performance|exercise performance
154806|NCT03231514|keto-adaptation|keto-adaptation
154807|NCT03231475|NSCLC|nsclc
154808|NCT03231475|EGFR-TKI|egfr-tki
154809|NCT03231449|routine care, evaluation, Africa, observatory|routine care, evaluation, africa, observatory
154810|NCT03231436|intrathecal bupivacaine|intrathecal bupivacaine
154811|NCT03231436|hyperbaric bupivacaine|hyperbaric bupivacaine
154812|NCT03231436|failed spinal|failed spinal
154813|NCT03231423|Obesity|obesity
154814|NCT03231423|VAS|vas
154815|NCT03231423|Pain|pain
154816|NCT03231423|Laparoscopy|laparoscopy
154817|NCT03231423|Bypass|bypass
154818|NCT03231410|arteriovenous fistula|arteriovenous fistula
154819|NCT03231410|maturation|maturation
154820|NCT03231410|monocyte adhesion|monocyte adhesion
154821|NCT03231410|vascular access|vascular access
154822|NCT03231397|Abdominal Aortic Aneurysm (AAA)|abdominal aortic aneurysm (aaa)
154823|NCT03231371|Orthotopic Heart Transplant|orthotopic heart transplant
154824|NCT03231345|Peripheral IV|peripheral iv
154825|NCT03231345|Internal jugular vein|internal jugular vein
154826|NCT03231345|IJ|ij
154827|NCT03231345|Peripheral IJ|peripheral ij
154828|NCT03231345|Ultrasound-guided IJ|ultrasound-guided ij
154829|NCT03231332|Helicobacter pylori|helicobacter pylori
154830|NCT03231332|Eradication|eradication
154831|NCT03231332|Microbiome|microbiome
154832|NCT03231332|ESBL|esbl
154833|NCT03231332|GIT|git
154834|NCT03231306|Neurofibroma, Plexiform|neurofibroma, plexiform
154835|NCT03231306|Genes, Neurofibromatosis|genes, neurofibromatosis
154836|NCT03231306|Peripheral nerve tumors|peripheral nerve tumors
154837|NCT03231306|Neurofibromatosis 1|neurofibromatosis 1
154838|NCT03231306|Neurofibromas|neurofibromas
154839|NCT03231280|knee|knee
154840|NCT03231267|Multiresistant enterobacteriaceae|multiresistant enterobacteriaceae
154841|NCT03231267|digestive colonization|digestive colonization
154842|NCT03231267|bacteriophages|bacteriophages
154843|NCT03231267|Admission in intensive care unit >72h|admission in intensive care unit >72h
154844|NCT03231267|Presence of at least 2 consecutive stools|presence of at least 2 consecutive stools
154845|NCT03231241|Headaches|headaches
154846|NCT03231241|Tension-Type Headache|tension-type headache
154847|NCT03231241|New Daily Persistent Headache (NDPH)|new daily persistent headache (ndph)
154848|NCT03231241|Migraine|migraine
154849|NCT03231202|Non-operative management|non-operative management
154850|NCT03231202|Splenic Injury|splenic injury
154851|NCT03231202|Blunt|blunt
154852|NCT03231202|Splenic artery embolization|splenic artery embolization
154853|NCT03231202|Trauma|trauma
154854|NCT03231189|Coronary artery disease|coronary artery disease
154855|NCT03231189|cardiac MRI|cardiac mri
154856|NCT03231189|heart failure|heart failure
154857|NCT03231176|Biliary Tract Neoplasms|biliary tract neoplasms
154858|NCT03231176|Bile Duct Neoplasms|bile duct neoplasms
154859|NCT03231176|Gallbladder Neoplasms|gallbladder neoplasms
154860|NCT03231085|Craniosynostosis|craniosynostosis
154861|NCT03231085|hemoglobin|hemoglobin
154862|NCT03231085|iron peros|iron peros
154863|NCT03231085|iron intravenous|iron intravenous
154864|NCT03231072|mechanical ventilation|mechanical ventilation
155261|NCT03228576|Envarsus|envarsus
154865|NCT03231072|pleural effusion|pleural effusion
154866|NCT03231072|EIT|eit
154867|NCT03231059|Coronary artery disease|coronary artery disease
154868|NCT03231059|Percutaneous coronary intervention|percutaneous coronary intervention
154869|NCT03231059|Drug-eluting stent|drug-eluting stent
154870|NCT03231059|Antiplatelet drugs|antiplatelet drugs
154871|NCT03231059|Clinical event committee|clinical event committee
154872|NCT03231020|single ventricle|single ventricle
154873|NCT03231020|pediatric cardiology|pediatric cardiology
154874|NCT03231020|interstage|interstage
154875|NCT03231020|home monitoring|home monitoring
154876|NCT03231020|mHealth|mhealth
154877|NCT03230994|adenomyosis|adenomyosis
154878|NCT03230994|diagnosis|diagnosis
154879|NCT03230994|treatment|treatment
154880|NCT03230994|epidemiology|epidemiology
197780|NCT02959723|BMPR2|bmpr2
154881|NCT03230994|Complications|complications
154882|NCT03230981|biomechanics|biomechanics
154883|NCT03230981|cornea|cornea
154884|NCT03230981|optical coherence tomography|optical coherence tomography
154885|NCT03230981|vibrography|vibrography
154886|NCT03230981|brillouin microscopy|brillouin microscopy
154887|NCT03230968|Practical Approach to Lung Health|practical approach to lung health
154888|NCT03230968|Respiratory diseases|respiratory diseases
154889|NCT03230968|Mexico|mexico
154890|NCT03230955|Randomized clinical trial|randomized clinical trial
154891|NCT03230955|Hotlines|hotlines
154892|NCT03230942|patient education|patient education
154893|NCT03230942|arthritis|arthritis
154894|NCT03230942|knee|knee
154895|NCT03230942|arthroplasty|arthroplasty
154896|NCT03230942|gait|gait
154897|NCT03230929|EMG, BIS, phase lag entropy|emg, bis, phase lag entropy
154898|NCT03230903|Multiple Sclerosis|multiple sclerosis
154899|NCT03230903|Telerehabilitation|telerehabilitation
154900|NCT03230903|Physical rehabilitation|physical rehabilitation
154901|NCT03230890|PTSD|ptsd
154902|NCT03230890|military|military
154903|NCT03230890|neurotechnology|neurotechnology
154904|NCT03230890|HIRREM|hirrem
154905|NCT03230890|allostasis|allostasis
154906|NCT03230890|heart rate variability|heart rate variability
154907|NCT03230890|baroreflex sensitivity|baroreflex sensitivity
154908|NCT03230890|closed loop|closed loop
154909|NCT03230890|acoustic stimulation|acoustic stimulation
154910|NCT03230890|neural oscillations|neural oscillations
154911|NCT03230890|autonomic|autonomic
154912|NCT03230890|hyperarousal|hyperarousal
154913|NCT03230864|Treatment-resistant schizophrenia|treatment-resistant schizophrenia
154914|NCT03230864|Lu AF35700|lu af35700
154915|NCT03230851|Light Transmittance Aggregometry|light transmittance aggregometry
154916|NCT03230851|Indobufen|indobufen
154917|NCT03230851|Aspirin|aspirin
154918|NCT03230851|Plasma Thromboxane|plasma thromboxane
154919|NCT03230851|Urine 11-dehydro thromboxane|urine 11-dehydro thromboxane
154920|NCT03230825|incomplete abortion|incomplete abortion
154921|NCT03230825|retained products of conception|retained products of conception
154922|NCT03230825|combined oral contraceptives|combined oral contraceptives
154923|NCT03230825|ultrasound|ultrasound
154924|NCT03230812|Insulin sensitivity|insulin sensitivity
154925|NCT03230812|Metabolic flexibility|metabolic flexibility
154926|NCT03230799|congenital cataract|congenital cataract
154927|NCT03230799|minimal invasive surgery|minimal invasive surgery
154928|NCT03230799|secondary intraocular lens implantation|secondary intraocular lens implantation
154929|NCT03230786|Type 2 Diabetes Mellitus|type 2 diabetes mellitus
154930|NCT03230786|KBP-042|kbp-042
154931|NCT03230760|acupuncture|acupuncture
154932|NCT03230760|breast engorgement|breast engorgement
154933|NCT03230760|lactation|lactation
154934|NCT03230734|prostate cancer|prostate cancer
154935|NCT03230734|castration-resistant prostate cancer|castration-resistant prostate cancer
154936|NCT03230734|metastatic prostate cancer|metastatic prostate cancer
154937|NCT03230734|bone only metastatic prostate cancer|bone only metastatic prostate cancer
154938|NCT03230734|radium-223|radium-223
154939|NCT03230734|Docetaxel|docetaxel
154940|NCT03230721|laser|laser
154941|NCT03230721|HoLEP|holep
154942|NCT03230721|ThuLEP|thulep
154943|NCT03230721|Thulium|thulium
154944|NCT03230721|Thulium-fiber|thulium-fiber
154945|NCT03230721|BPH|bph
154946|NCT03230721|EEP|eep
154947|NCT03230721|monopolar enucleation|monopolar enucleation
154948|NCT03230708|Microparticles|microparticles
154949|NCT03230708|Erythrocytes|erythrocytes
154950|NCT03230708|Methotrexate|methotrexate
154951|NCT03230695|stroke|stroke
154952|NCT03230695|robotic therapy|robotic therapy
154953|NCT03230695|transcranial direct current stimulation|transcranial direct current stimulation
154954|NCT03230682|early improvement|early improvement
154955|NCT03230682|antidepressants|antidepressants
154956|NCT03230682|major depression diorder|major depression diorder
154957|NCT03230682|resting-state fMRI|resting-state fmri
154958|NCT03230669|substance abuse|substance abuse
154959|NCT03230669|addiction|addiction
154960|NCT03230669|etherapy|etherapy
154961|NCT03230591|Fabry's disease|fabry's disease
154962|NCT03230591|Agalsidase Alfa|agalsidase alfa
154963|NCT03230591|Cardiomyopathy|cardiomyopathy
154964|NCT03230591|Enzyme replacement therapy|enzyme replacement therapy
155262|NCT03228576|Everolimus|everolimus
154965|NCT03230591|Diastolic stress echocardiography|diastolic stress echocardiography
154966|NCT03230591|LV vortex flow|lv vortex flow
154967|NCT03230591|Cardiac MRI|cardiac mri
154968|NCT03230578|Pharmacists|pharmacists
154969|NCT03230578|Prescriptions|prescriptions
154970|NCT03230513|vertigo|vertigo
154971|NCT03230513|benign paroxysmal positional vertigo|benign paroxysmal positional vertigo
154972|NCT03230513|particle repositioning manoeuvre|particle repositioning manoeuvre
154973|NCT03230500|computer guided|computer guided
154974|NCT03230500|immediate implant|immediate implant
154975|NCT03230500|patient satisfaction|patient satisfaction
154976|NCT03230461|CPR|cpr
197884|NCT02958852|Statins|statins
154977|NCT03230461|Basic life support|basic life support
154978|NCT03230448|Acute alcoholism|acute alcoholism
154979|NCT03230435|anorexia nervosa, health-related quality of life|anorexia nervosa, health-related quality of life
154980|NCT03230422|infant, laryngoscopes, pediatrics|infant, laryngoscopes, pediatrics
154981|NCT03230409|Tuberculosis, Latent Tuberculosis Infection, Adherence, Nursing, Pediatrics, Public Health.|tuberculosis, latent tuberculosis infection, adherence, nursing, pediatrics, public health.
154982|NCT03230396|vitamins|vitamins
154983|NCT03230396|dietary supplements|dietary supplements
154984|NCT03230396|chewing gum|chewing gum
154985|NCT03230396|pharmacokinetics|pharmacokinetics
154986|NCT03230396|healthy human subjects|healthy human subjects
154987|NCT03230370|intensity|intensity
154988|NCT03230370|rehabilitation|rehabilitation
154989|NCT03230318|iCCA|icca
154990|NCT03230318|intrahepatic cholangiocarcinoma|intrahepatic cholangiocarcinoma
154991|NCT03230318|FGFR2 gene fusion or FGFR2 gene mutation or amplification|fgfr2 gene fusion or fgfr2 gene mutation or amplification
154992|NCT03230318|biliary cancer|biliary cancer
154993|NCT03230318|bile duct cancer|bile duct cancer
154994|NCT03230318|FGFR2 gene rearrangement|fgfr2 gene rearrangement
154995|NCT03230318|liver cancer|liver cancer
154996|NCT03230318|targeted therapy|targeted therapy
154997|NCT03230318|combined hepatocellular and cholangiocarcinoma|combined hepatocellular and cholangiocarcinoma
154998|NCT03230318|cHCC-CCA|chcc-cca
154999|NCT03230318|derazantinib|derazantinib
155000|NCT03230305|Elderly|elderly
155001|NCT03230305|Cancer|cancer
155002|NCT03230305|Ethnographic interview|ethnographic interview
155003|NCT03230305|Social representation|social representation
155004|NCT03230305|Clinical trials|clinical trials
155005|NCT03230305|Reasons of non-participation|reasons of non-participation
155006|NCT03230305|Qualitative method|qualitative method
155007|NCT03230292|Psoriasis|psoriasis
155008|NCT03230292|Chronic Plaque Psoriasis|chronic plaque psoriasis
155009|NCT03230292|Bimekizumab|bimekizumab
155010|NCT03230279|Sacroiliac pain|sacroiliac pain
155011|NCT03230279|Low back pain|low back pain
155012|NCT03230188|asthma|asthma
155013|NCT03230188|neurocircuitry|neurocircuitry
155014|NCT03230188|severe asthma|severe asthma
155015|NCT03230188|mild to moderate asthma|mild to moderate asthma
155016|NCT03230188|neurocircuitry patterns|neurocircuitry patterns
155017|NCT03230149|Fabry|fabry
155018|NCT03230149|Stroke|stroke
155019|NCT03230149|Cerebrovascular Accident|cerebrovascular accident
155020|NCT03230149|small fiber neuropathy|small fiber neuropathy
155021|NCT03230136|Myocardial injury|myocardial injury
155022|NCT03230136|Ischemia reperfusion|ischemia reperfusion
155023|NCT03230136|cardiac surgery|cardiac surgery
155024|NCT03230136|cardioprotection|cardioprotection
155025|NCT03230123|Diabetes Mellitus|diabetes mellitus
155026|NCT03230123|green banana|green banana
155027|NCT03230123|resistant starch|resistant starch
155028|NCT03230123|glucose|glucose
155029|NCT03230123|prebiotics|prebiotics
155030|NCT03230123|insulin|insulin
155031|NCT03230123|incretins|incretins
155032|NCT03230110|Sleep disordered breathing|sleep disordered breathing
155033|NCT03230110|Obstructive sleep apnea|obstructive sleep apnea
155034|NCT03230110|Hypertension|hypertension
155035|NCT03230110|Pregnancy|pregnancy
155036|NCT03230084|Infertility|infertility
155037|NCT03230084|Ovulation|ovulation
155038|NCT03230084|Pregnanediol 3-glucuronide|pregnanediol 3-glucuronide
155039|NCT03230084|Progesterone|progesterone
155040|NCT03230084|Urine dipstick test|urine dipstick test
155041|NCT03230084|Feasibility study|feasibility study
155042|NCT03230084|Fertile period|fertile period
155043|NCT03230084|Menstrual cycle|menstrual cycle
155044|NCT03230084|Natural family planning|natural family planning
155045|NCT03230084|Fertility awareness methods|fertility awareness methods
155046|NCT03230071|Herbal therapy|herbal therapy
155047|NCT03230071|Randomized controlled trial|randomized controlled trial
155048|NCT03230071|Vascular Dementia|vascular dementia
155049|NCT03230045|acupoint stimulation|acupoint stimulation
155050|NCT03230045|elderly patients|elderly patients
155051|NCT03230045|postoperative pulmonary complications|postoperative pulmonary complications
155052|NCT03230019|wedge resection|wedge resection
155053|NCT03230019|tubeless|tubeless
155054|NCT03229980|myocardial protection|myocardial protection
155055|NCT03229980|potassium cardioplegia|potassium cardioplegia
155056|NCT03229980|tropinin|tropinin
155057|NCT03229980|Custodiol|custodiol
155058|NCT03229967|Bronchopulmonary dysplasia|bronchopulmonary dysplasia
155059|NCT03229967|Microbiome|microbiome
155060|NCT03229967|Microbiota|microbiota
155061|NCT03229967|Premature infant|premature infant
155062|NCT03229967|Observational cohort study|observational cohort study
155063|NCT03229928|Behavior|behavior
155064|NCT03229928|Outcome Measures|outcome measures
155065|NCT03229928|Intellectual/Developmental Disabilities|intellectual/developmental disabilities
155066|NCT03229902|stroke|stroke
155067|NCT03229889|Access Sheath|access sheath
155068|NCT03229889|PCNL|pcnl
198007|NCT02958098|stroke|stroke
155069|NCT03229889|Percutaneous Nephrolithotomy|percutaneous nephrolithotomy
155070|NCT03229889|Ureteroscopy|ureteroscopy
155071|NCT03229889|Alpha Blocker|alpha blocker
155072|NCT03229889|Flomax|flomax
155073|NCT03229889|PDE-5 Inhibitor|pde-5 inhibitor
155074|NCT03229889|Cialis|cialis
155075|NCT03229889|Phosphodiesterase Inhibitor|phosphodiesterase inhibitor
155076|NCT03229863|Breastfeeding|breastfeeding
155077|NCT03229863|First foods|first foods
155078|NCT03229850|Diabetes|diabetes
155079|NCT03229850|Insulin|insulin
155080|NCT03229850|Lipohypertrophy|lipohypertrophy
155081|NCT03229850|Euglycemic Clamp|euglycemic clamp
155082|NCT03229837|Construct validity|construct validity
155083|NCT03229837|Minimally important differences|minimally important differences
155084|NCT03229837|Patient-reported outcomes|patient-reported outcomes
155085|NCT03229837|Pediatric cancer survivors|pediatric cancer survivors
155086|NCT03229837|PROMIS pediatric measures|promis pediatric measures
155087|NCT03229824|Drain antisepsis|drain antisepsis
155088|NCT03229824|Bacterial colonization|bacterial colonization
155089|NCT03229824|Surgical site infection|surgical site infection
155090|NCT03229733|Stroke|stroke
155091|NCT03229733|Kinect|kinect
155092|NCT03229733|Rehabilitation|rehabilitation
155093|NCT03229733|Upper limbs|upper limbs
155094|NCT03229720|Audio Visual Distraction|audio visual distraction
155095|NCT03229681|Baduanjin; CHF; 6MWT; CPET|baduanjin; chf; 6mwt; cpet
155096|NCT03229668|urinary bladder|urinary bladder
155097|NCT03229668|urinary catheters|urinary catheters
155098|NCT03229668|pregabalin|pregabalin
155099|NCT03229642|repetitive transcranial magnetic stimulation|repetitive transcranial magnetic stimulation
155100|NCT03229642|opioid use disorder|opioid use disorder
155101|NCT03229642|craving|craving
155102|NCT03229642|functional magnetic resonance imaging|functional magnetic resonance imaging
155103|NCT03229642|neuropsychological tests|neuropsychological tests
155104|NCT03229629|Behavior change communication|behavior change communication
155105|NCT03229629|Ethiopia|ethiopia
155106|NCT03229629|Food voucher|food voucher
155107|NCT03229629|complementary feeding practice|complementary feeding practice
155108|NCT03229629|affordability|affordability
155109|NCT03229629|accessibility|accessibility
155110|NCT03229629|gender|gender
155111|NCT03229603|HPV infection and Cervical cancer|hpv infection and cervical cancer
155112|NCT03229564|Burns|burns
155113|NCT03229564|Scar|scar
155114|NCT03229564|Skin|skin
155115|NCT03229564|Wound healing|wound healing
155116|NCT03229564|Tissue Engineering|tissue engineering
155117|NCT03229564|Dermis|dermis
155118|NCT03229564|Epidermis|epidermis
155119|NCT03229564|Thermal Injuries|thermal injuries
155120|NCT03229551|chronic rhinosinusitis|chronic rhinosinusitis
155121|NCT03229551|chronically draining sinus|chronically draining sinus
155122|NCT03229551|condemned sinus|condemned sinus
155123|NCT03229551|post-endoscopic sinus surgery|post-endoscopic sinus surgery
155124|NCT03229512|Hand Foot Skin Reaction|hand foot skin reaction
155125|NCT03229512|Sildenafil|sildenafil
155126|NCT03229499|Randomized Controlled Trial|randomized controlled trial
155127|NCT03229499|clinical trial|clinical trial
155128|NCT03229499|anastrozole|anastrozole
155129|NCT03229499|pulmonary hypertension|pulmonary hypertension
155130|NCT03229499|pulmonary arterial hypertension|pulmonary arterial hypertension
155131|NCT03229499|PAH|pah
155132|NCT03229486|emergence delirium|emergence delirium
155133|NCT03229486|tonsillectomy|tonsillectomy
155134|NCT03229473|Balance|balance
155135|NCT03229473|Falls|falls
155136|NCT03229473|Screening|screening
155137|NCT03229473|COPD|copd
155138|NCT03229434|affective responses|affective responses
155139|NCT03229434|stress-related parameters|stress-related parameters
155140|NCT03229434|green exercise|green exercise
155141|NCT03229421|Zika Virus|zika virus
155142|NCT03229408|Inflammation|inflammation
155143|NCT03229408|Hyperandrogenism|hyperandrogenism
155144|NCT03229408|Anovulation|anovulation
155145|NCT03229408|Insulin Resistance|insulin resistance
155146|NCT03229395|skeletal muscle|skeletal muscle
155147|NCT03229395|muscle mass|muscle mass
155148|NCT03229395|glucocorticoids|glucocorticoids
155149|NCT03229395|biomarkers|biomarkers
155150|NCT03229382|MCL, obinutuzumab|mcl, obinutuzumab
155151|NCT03229369|ACL|acl
155152|NCT03229369|ALL|all
155153|NCT03229369|Ligament injury|ligament injury
155154|NCT03229369|Reconstruction|reconstruction
155155|NCT03229343|idiopathic pulmonary fibrosis, palliative care|idiopathic pulmonary fibrosis, palliative care
155156|NCT03229330|Wound Healing|wound healing
155157|NCT03229330|Outcome Assessment (Health Care)|outcome assessment (health care)
155158|NCT03229317|Lung function|lung function
155159|NCT03229317|Children|children
155160|NCT03229317|Vitamin D|vitamin d
155161|NCT03229317|COPD|copd
155165|NCT03229291|Wnt inhibitor|wnt inhibitor
155166|NCT03229226|Simulation|simulation
155167|NCT03229226|Task Trainer|task trainer
155168|NCT03229213|cystic fibrosis|cystic fibrosis
155169|NCT03229213|video games|video games
155170|NCT03229213|exercise|exercise
155171|NCT03229213|maximal oxygen consumption|maximal oxygen consumption
155172|NCT03229148|Anesthesia or Conscious sedation for Thrombectomy for Stroke|anesthesia or conscious sedation for thrombectomy for stroke
155173|NCT03229148|Thrombectomy|thrombectomy
155174|NCT03229148|Anesthesia|anesthesia
155175|NCT03229148|Conscious sedation|conscious sedation
155176|NCT03229148|Stroke|stroke
155177|NCT03229122|ovarian cancer, gBRCAm|ovarian cancer, gbrcam
155178|NCT03229109|dehydration|dehydration
155179|NCT03229109|spectrophon|spectrophon
155180|NCT03229109|device|device
155181|NCT03229109|perspiration|perspiration
155182|NCT03229096|gastric cancer|gastric cancer
155183|NCT03229096|neoadjuvant chemotherapy|neoadjuvant chemotherapy
155184|NCT03229096|apatinib|apatinib
155185|NCT03229070|Thoracic Surgery|thoracic surgery
155186|NCT03229070|Postoperative Period|postoperative period
155187|NCT03229070|Rehabilitation|rehabilitation
155188|NCT03229070|Early mobilization|early mobilization
155189|NCT03229070|Cycle-ergometer|cycle-ergometer
155190|NCT03229044|adipokine, tetranectin, lipid metabolism, body mass index|adipokine, tetranectin, lipid metabolism, body mass index
155191|NCT03229031|spinal cord, spinal cord injury|spinal cord, spinal cord injury
155192|NCT03229005|soft tissue; implant; abutment;|soft tissue; implant; abutment;
155193|NCT03228966|Pediatric|pediatric
155194|NCT03228953|Pharmacogenomic testing|pharmacogenomic testing
155195|NCT03228953|Depression|depression
155196|NCT03228940|Cardiovascular Disease, Renal Disease|cardiovascular disease, renal disease
155197|NCT03228901|Oxytocin|oxytocin
155198|NCT03228901|Affiliation|affiliation
155199|NCT03228888|Rhythm|rhythm
155200|NCT03228888|Ecological sounds|ecological sounds
155201|NCT03228888|Auditory stimuli|auditory stimuli
155202|NCT03228888|rhythmic auditory stimulation|rhythmic auditory stimulation
155203|NCT03228888|Parkinson's Disease|parkinson's disease
155204|NCT03228888|Gait|gait
155205|NCT03228888|Gait analysis|gait analysis
155206|NCT03228888|Spatio-temporal parameters|spatio-temporal parameters
155207|NCT03228875|pregnancy outcomes, birth outcomes|pregnancy outcomes, birth outcomes
155208|NCT03228849|Bony mallet injury|bony mallet injury
155209|NCT03228849|Anchor suture|anchor suture
155210|NCT03228849|Conservative treatment|conservative treatment
155211|NCT03228849|DIP joint|dip joint
155212|NCT03228823|Premature Ventricular contractions|premature ventricular contractions
155213|NCT03228823|Cardiomyopathy|cardiomyopathy
155214|NCT03228797|pain|pain
155215|NCT03228771|PRGF|prgf
155216|NCT03228771|Statins|statins
155217|NCT03228771|socket augmentation|socket augmentation
155218|NCT03228758|POEM|poem
155219|NCT03228745|mindfulness based stress reduction|mindfulness based stress reduction
155220|NCT03228745|total knee arthroplasty|total knee arthroplasty
155221|NCT03228745|pre-operative|pre-operative
155222|NCT03228719|Total Knee Replacement|total knee replacement
155223|NCT03228719|Physical Therapy|physical therapy
155224|NCT03228706|Type 2 Diabetes Mellitus|type 2 diabetes mellitus
155225|NCT03228706|Medication Adherence|medication adherence
155226|NCT03228706|Malay patients|malay patients
155227|NCT03228706|Structured Group-Based Intervention|structured group-based intervention
155228|NCT03228706|Randomised controlled trial|randomised controlled trial
155229|NCT03228693|Keloid|keloid
155230|NCT03228667|Pembrolizumab|pembrolizumab
155231|NCT03228667|Nivolumab|nivolumab
155232|NCT03228667|Non-Small Cell Lung Cancer (NSCLC)|non-small cell lung cancer (nsclc)
155233|NCT03228667|Immunotherapy|immunotherapy
155234|NCT03228667|Interleukin-15|interleukin-15
155235|NCT03228667|PD-1 Checkpoint Inhibitor|pd-1 checkpoint inhibitor
155236|NCT03228667|ALT-803|alt-803
155237|NCT03228667|Atezolizumab|atezolizumab
155238|NCT03228667|Avelumab|avelumab
155239|NCT03228667|Small Cell Lung Cancer (SCLC)|small cell lung cancer (sclc)
155240|NCT03228667|Urothelial Carcinoma|urothelial carcinoma
155241|NCT03228667|Head and Neck Squamous Cell Carcinoma (HNSCC)|head and neck squamous cell carcinoma (hnscc)
155242|NCT03228667|Merkel Cell Carcinoma (MCC)|merkel cell carcinoma (mcc)
155243|NCT03228667|Melanoma|melanoma
155244|NCT03228667|Renal Cell Carcinoma (RCC)|renal cell carcinoma (rcc)
155245|NCT03228667|Gastric Cancer|gastric cancer
155246|NCT03228667|Cervical Cancer|cervical cancer
155247|NCT03228667|Hepatocellular Carcinoma (HCC)|hepatocellular carcinoma (hcc)
155248|NCT03228667|Microsatellite Instability-High (MSI-H)|microsatellite instability-high (msi-h)
155249|NCT03228667|PD-L1 Checkpoint Inhibitor|pd-l1 checkpoint inhibitor
155250|NCT03228667|Mismatch Repair Deficient (dMMR) Solid Tumor Cancer|mismatch repair deficient (dmmr) solid tumor cancer
155251|NCT03228667|Colorectal Cancer (CRC)|colorectal cancer (crc)
155252|NCT03228641|skin rejuvenation|skin rejuvenation
155253|NCT03228641|wrinkle removal|wrinkle removal
155254|NCT03228641|skin laxity reduction|skin laxity reduction
155255|NCT03228628|Spinal puncture|spinal puncture
155256|NCT03228628|Pain|pain
155257|NCT03228628|Anxiety|anxiety
155258|NCT03228628|Nitrous oxyde|nitrous oxyde
155259|NCT03228615|shared decision making|shared decision making
155263|NCT03228576|kidney|kidney
155264|NCT03228576|Transplant|transplant
155265|NCT03228550|omega-3 fatty acid|omega-3 fatty acid
155266|NCT03228550|B vitamins|b vitamins
155267|NCT03228550|vitamin E|vitamin e
155268|NCT03228550|Phosphatidylserine|phosphatidylserine
155269|NCT03228550|Gingko biloba|gingko biloba
155270|NCT03228550|Gait|gait
155271|NCT03228550|Aerobic Exercise|aerobic exercise
155272|NCT03228550|Memory|memory
155273|NCT03228550|Cognitive function|cognitive function
155274|NCT03228485|Smartphone|smartphone
155275|NCT03228485|Application|application
155276|NCT03228485|Pilot|pilot
155277|NCT03228485|mhealth|mhealth
155278|NCT03228459|Kidney Diseases|kidney diseases
155279|NCT03228459|Subclinical Disease and/or Syndrome|subclinical disease and/or syndrome
155280|NCT03228459|Atherosclerosis|atherosclerosis
155281|NCT03228459|Biomarkers|biomarkers
155282|NCT03228459|Prevention|prevention
155283|NCT03228459|Lung capacity|lung capacity
155284|NCT03228459|Early diagnosis|early diagnosis
155285|NCT03228459|Advanced glycation-end products|advanced glycation-end products
155286|NCT03228459|Atrial fibrillation|atrial fibrillation
155287|NCT03228459|Diabetes|diabetes
155288|NCT03228459|Arterial ultrasound|arterial ultrasound
155289|NCT03228446|training intervention|training intervention
155290|NCT03228446|filter training|filter training
155291|NCT03228446|distractor inhibition|distractor inhibition
155292|NCT03228433|Drug Therapy|drug therapy
155293|NCT03228394|Postpartum Care|postpartum care
155294|NCT03228394|Postpartum Depression|postpartum depression
155295|NCT03228381|Functional Mitral Regurgitation|functional mitral regurgitation
155296|NCT03228381|Heart Failure|heart failure
155297|NCT03228355|Levcromakalim|levcromakalim
155298|NCT03228342|Rheumatoid Arthritis|rheumatoid arthritis
155299|NCT03228342|Ultrasound|ultrasound
155300|NCT03228342|Impact|impact
155301|NCT03228329|cardiometry|cardiometry
155302|NCT03228329|stroke volume|stroke volume
155303|NCT03228329|liver transplantation|liver transplantation
155304|NCT03228290|Cirrhosis|cirrhosis
155305|NCT03228290|Liver|liver
155306|NCT03228290|Liver Transplant|liver transplant
155307|NCT03228290|Frailty|frailty
155308|NCT03228290|end stage|end stage
155309|NCT03228277|Extracellular vesicles|extracellular vesicles
155310|NCT03228277|Bronchoalveolar lavage fluid|bronchoalveolar lavage fluid
155311|NCT03228277|Liquid biopsy|liquid biopsy
155312|NCT03228277|T790M|t790m
155313|NCT03228277|NSCLC|nsclc
155314|NCT03228277|Exosomes|exosomes
155315|NCT03228277|EGFR mutation testing|egfr mutation testing
155316|NCT03228199|Randomised Control Trial|randomised control trial
155317|NCT03228199|Productivity|productivity
155318|NCT03228199|Agricultural workers|agricultural workers
155319|NCT03228199|India|india
155320|NCT03228199|Vision correction|vision correction
155321|NCT03228173|Cognition|cognition
155322|NCT03228173|Executive functioning|executive functioning
155323|NCT03228173|Depression|depression
155324|NCT03228173|Affect|affect
155325|NCT03228173|adult females|adult females
155326|NCT03228160|Sympathetically Maintained Pain|sympathetically maintained pain
155327|NCT03228160|Linear-Polarized Near-Infrared Irradiation|linear-polarized near-infrared irradiation
155328|NCT03228160|Stellate Ganglion|stellate ganglion
155329|NCT03228160|Heart Rate Variability|heart rate variability
155330|NCT03228160|Autonomic Dysfunction Outcome|autonomic dysfunction outcome
155331|NCT03228134|treatment； bronchial asthma|treatment； bronchial asthma
155332|NCT03228108|Culture-guided|culture-guided
155333|NCT03228108|Targeted prophylaxis|targeted prophylaxis
155334|NCT03228108|Prostate biopsy|prostate biopsy
155335|NCT03228108|Antibiotic prophylaxis|antibiotic prophylaxis
155336|NCT03228095|Volatile Organic Compounds|volatile organic compounds
155337|NCT03228095|Tuberculosis|tuberculosis
155338|NCT03228095|Nano-sensors|nano-sensors
155339|NCT03228095|Electronic nose|electronic nose
155340|NCT03228095|Digestive cancers|digestive cancers
155341|NCT03228082|Patient empowerment|patient empowerment
155342|NCT03228082|Women's Health|women's health
155343|NCT03228082|Home Blood Pressure Monitoring|home blood pressure monitoring
155344|NCT03228069|rabies vaccination|rabies vaccination
155345|NCT03228056|postoperative pain|postoperative pain
155346|NCT03228056|videothoracoscopic surgery|videothoracoscopic surgery
155347|NCT03228056|thoracic epidural analgesia|thoracic epidural analgesia
155348|NCT03228056|lung lobectomy|lung lobectomy
155349|NCT03228043|Apatinib|apatinib
155350|NCT03228043|Outcome, Fatal|outcome, fatal
155351|NCT03228043|Colorectal Cancer|colorectal cancer
155352|NCT03228043|surgery|surgery
155353|NCT03228043|adjuvant chemotherapy|adjuvant chemotherapy
155354|NCT03228030|thiamine|thiamine
155355|NCT03228030|heart failure|heart failure
155356|NCT03228030|heart failure with reduced ejection fraction|heart failure with reduced ejection fraction
155357|NCT03228030|geriatric|geriatric
155358|NCT03228030|thiamin|thiamin
155359|NCT03228030|vitamin b1|vitamin b1
155360|NCT03228030|congestive heart failure|congestive heart failure
155361|NCT03228017|cardiovascular disease|cardiovascular disease
155362|NCT03228017|CVD|cvd
155363|NCT03227991|Suicide|suicide
155364|NCT03227978|pleurodesis|pleurodesis
155365|NCT03227978|PCL|pcl
155366|NCT03227965|cancer|cancer
155367|NCT03227926|RAS|ras
155368|NCT03227926|Panitumumab|panitumumab
155369|NCT03227926|EGFR|egfr
155370|NCT03227926|Clonal evolution|clonal evolution
155371|NCT03227835|contrast-induced nephropathy|contrast-induced nephropathy
155372|NCT03227835|contrast-induced acute kidney injury|contrast-induced acute kidney injury
155373|NCT03227835|prophylaxis|prophylaxis
155374|NCT03227835|intravenous hydration|intravenous hydration
155375|NCT03227809|College student risk behavior prevention|college student risk behavior prevention
155376|NCT03227809|Substance use|substance use
155377|NCT03227809|Alcohol|alcohol
155378|NCT03227809|Marijuana|marijuana
155379|NCT03227809|Illicit drugs|illicit drugs
155380|NCT03227809|Prescription drug misuse|prescription drug misuse
155381|NCT03227809|Risky sexual behaviors|risky sexual behaviors
155382|NCT03227796|osteoarthritis|osteoarthritis
155383|NCT03227796|knee|knee
155384|NCT03227796|healthy|healthy
155385|NCT03227796|volunteer|volunteer
155386|NCT03227796|LEVI-04|levi-04
155387|NCT03227770|Hemoperfusion|hemoperfusion
155388|NCT03227770|Hemodialysis|hemodialysis
155389|NCT03227770|Mortality|mortality
155390|NCT03227757|TRILUMINATE|triluminate
155391|NCT03227757|Percutaneous transcatheter intervention|percutaneous transcatheter intervention
155392|NCT03227757|Tricuspid regurgitation|tricuspid regurgitation
155393|NCT03227757|Tricuspid Valve Repair System|tricuspid valve repair system
155394|NCT03227744|Prostate Cancer, Anxiety|prostate cancer, anxiety
155395|NCT03227731|Preexposure prophylaxis|preexposure prophylaxis
155396|NCT03227731|safety|safety
155397|NCT03227731|HIV prevention|hiv prevention
155398|NCT03227731|pregnant women|pregnant women
155399|NCT03227731|lactating women|lactating women
155400|NCT03227718|VOR|vor
155401|NCT03227705|Preterm birth|preterm birth
155402|NCT03227705|Short cervix|short cervix
155403|NCT03227705|Pessary|pessary
155404|NCT03227705|Progesterone|progesterone
155405|NCT03227679|Personalized Medicine|personalized medicine
155406|NCT03227679|Nicotine Metabolite Ratio (NMR)|nicotine metabolite ratio (nmr)
155407|NCT03227679|Varenicline|varenicline
155408|NCT03227679|Nicotine Replacement Therapy (NRT)|nicotine replacement therapy (nrt)
155409|NCT03227679|Smoking Cessation|smoking cessation
155410|NCT03227679|Pharmacotherapy|pharmacotherapy
155411|NCT03227666|Postural sway|postural sway
155412|NCT03227666|Progressive balance exercise|progressive balance exercise
155413|NCT03227666|RCT|rct
155414|NCT03227666|Functional balance|functional balance
155415|NCT03227653|Efavirenz|efavirenz
155416|NCT03227653|Child Behavior|child behavior
155417|NCT03227653|Cognition|cognition
155418|NCT03227653|Medication Adherence|medication adherence
155419|NCT03227653|Drug-Related Side Effects|drug-related side effects
155420|NCT03227614|abortion|abortion
155421|NCT03227614|social support|social support
155422|NCT03227614|Anxiety|anxiety
155423|NCT03227614|Pain|pain
155424|NCT03227588|Fractional Flow Reserve|fractional flow reserve
155425|NCT03227588|Percutaneous Coronary Intervention|percutaneous coronary intervention
155426|NCT03227562|risperidone|risperidone
155427|NCT03227562|anxiety|anxiety
155428|NCT03227562|cognition|cognition
155429|NCT03227562|stress|stress
155430|NCT03227536|Neonatal asphyxia|neonatal asphyxia
155431|NCT03227536|neonatal acidosis|neonatal acidosis
155432|NCT03227536|fetal ECG|fetal ecg
155433|NCT03227536|umbilical cord acid-base status|umbilical cord acid-base status
155434|NCT03227523|low back pain|low back pain
155435|NCT03227523|respiratory disorders|respiratory disorders
155436|NCT03227523|pulmonary disease, chronic obstructive|pulmonary disease, chronic obstructive
155437|NCT03227523|postural balance|postural balance
155438|NCT03227523|functional laterality|functional laterality
155439|NCT03227523|diaphragm|diaphragm
155440|NCT03227510|Hepatocellular Carcinoma , MicroRNAs, Somalia|hepatocellular carcinoma , micrornas, somalia
155441|NCT03227497|Blood Pressure|blood pressure
155442|NCT03227497|Cholesterol|cholesterol
155443|NCT03227497|Triglycerides|triglycerides
155444|NCT03227497|Walnuts|walnuts
155445|NCT03227458|areal bone mineral density|areal bone mineral density
155446|NCT03227458|dehydroepiandrosterone (DHEA)|dehydroepiandrosterone (dhea)
155447|NCT03227458|postmenopause|postmenopause
155448|NCT03227458|exercise|exercise
155449|NCT03227458|sex hormones|sex hormones
155450|NCT03227445|DISKUS|diskus
155451|NCT03227445|HandiHaler|handihaler
155452|NCT03227445|COPD|copd
155453|NCT03227445|Placebo|placebo
155454|NCT03227445|Cross-over|cross-over
155455|NCT03227445|Dry powder inhaler|dry powder inhaler
155456|NCT03227445|ELLIPTA|ellipta
155457|NCT03227432|Multiple Myeloma|multiple myeloma
155458|NCT03227406|sleep|sleep
155459|NCT03227406|memory|memory
155460|NCT03227406|REM sleep|rem sleep
155461|NCT03227406|slow wave sleep|slow wave sleep
155462|NCT03227406|cognition|cognition
155463|NCT03227406|sleep spindles|sleep spindles
155464|NCT03227393|Heart Failure, Systolic|heart failure, systolic
155465|NCT03227393|Defibrillators, Implantable|defibrillators, implantable
155466|NCT03227393|Pacemaker, Artificial|pacemaker, artificial
155467|NCT03227367|biomaterials|biomaterials
155468|NCT03227367|apoptosis|apoptosis
155469|NCT03227367|bone regeneration|bone regeneration
155470|NCT03227354|Medical Device|medical device
155471|NCT03227341|asthma control|asthma control
155472|NCT03227341|pulmonary rehabilitation|pulmonary rehabilitation
155473|NCT03227328|HR-positive Breast Cancer|hr-positive breast cancer
155474|NCT03227328|metastatic breast cancer|metastatic breast cancer
155475|NCT03227328|First line treatment|first line treatment
155476|NCT03227328|endocrine therapy|endocrine therapy
155477|NCT03227328|chemotherapy|chemotherapy
155478|NCT03227328|randomized phase III trial|randomized phase iii trial
155479|NCT03227328|aromatase inhibitor|aromatase inhibitor
155480|NCT03227328|HR-negative Breast Cancer|hr-negative breast cancer
155481|NCT03227328|CDK4/6 inhibitor|cdk4/6 inhibitor
155482|NCT03227276|Litramine|litramine
155483|NCT03227276|Opuntia ficus-indica|opuntia ficus-indica
155484|NCT03227276|weight loss|weight loss
155485|NCT03227263|Hemorrhagic Hereditary Telangiectasia (HHT)|hemorrhagic hereditary telangiectasia (hht)
155486|NCT03227263|VEGF therapy|vegf therapy
155487|NCT03227263|Bevacizumab|bevacizumab
155488|NCT03227250|freezing of gait|freezing of gait
155489|NCT03227250|Parkinson disease|parkinson disease
155490|NCT03227250|GPi|gpi
155491|NCT03227237|Impact, Interpersonal Relationship, Juvenile delinquency|impact, interpersonal relationship, juvenile delinquency
155492|NCT03227211|COPD exacerbated|copd exacerbated
155493|NCT03227211|Readmission|readmission
155494|NCT03227211|Prospective cohort study|prospective cohort study
155495|NCT03227211|Nested case control study|nested case control study
155496|NCT03227211|Clinical prediction rules|clinical prediction rules
155497|NCT03227159|Acute Myocardial Infarction|acute myocardial infarction
155498|NCT03227159|Troponin|troponin
155499|NCT03227159|Emergency department|emergency department
155500|NCT03227146|Burns|burns
155501|NCT03227146|Scar|scar
155502|NCT03227146|Skin|skin
155503|NCT03227146|Wound healing|wound healing
155504|NCT03227146|Tissue Engineering|tissue engineering
155505|NCT03227146|Dermis|dermis
155506|NCT03227146|Epidermis|epidermis
155507|NCT03227146|Thermal Injuries|thermal injuries
155508|NCT03227120|Exercise Therapy|exercise therapy
155509|NCT03227094|Diabetes|diabetes
155510|NCT03227094|Screening test|screening test
155511|NCT03227094|Continuous glucose monitoring|continuous glucose monitoring
155512|NCT03227094|Oral glucose tolerance test|oral glucose tolerance test
155513|NCT03227068|pediatric oncology|pediatric oncology
155514|NCT03227068|parent|parent
155515|NCT03227055|Arterial stiffness, children, chronic kidney disease, hypertension, microRNA|arterial stiffness, children, chronic kidney disease, hypertension, microrna
155516|NCT03227042|Sanfilippo Syndrome Type B|sanfilippo syndrome type b
155517|NCT03227042|MPS IIIB|mps iiib
155518|NCT03227042|MPS 3 B|mps 3 b
155519|NCT03226990|pressure area|pressure area
155520|NCT03226990|polyether elastomeric impression|polyether elastomeric impression
155521|NCT03226990|wax spacer|wax spacer
155522|NCT03226964|endobronchial ultrasound|endobronchial ultrasound
155523|NCT03226964|high flow nasal oxygen|high flow nasal oxygen
155524|NCT03226938|dietary patterns|dietary patterns
155525|NCT03226938|dietary adherence|dietary adherence
155526|NCT03226938|popular diets|popular diets
155527|NCT03226938|Paleo|paleo
155528|NCT03226938|vegan|vegan
155529|NCT03226938|behavior change|behavior change
155530|NCT03226938|adherence|adherence
155531|NCT03226938|compliance|compliance
155532|NCT03226938|vegetarian|vegetarian
155533|NCT03226938|low carb|low carb
155534|NCT03226938|low-carb|low-carb
155535|NCT03226938|whole food plant-based|whole food plant-based
155536|NCT03226938|social ecological model|social ecological model
155537|NCT03226925|thoracic tumors|thoracic tumors
155538|NCT03226925|motion management|motion management
155539|NCT03226925|radiotherapy|radiotherapy
155540|NCT03226925|ventilator|ventilator
155541|NCT03226873|HIV prevention|hiv prevention
155542|NCT03226873|PrEP|prep
155543|NCT03226873|peer navigation|peer navigation
155544|NCT03226873|women|women
155545|NCT03226847|Atrial Fibrillation, Athletes, Pulmonary Vein Isolation|atrial fibrillation, athletes, pulmonary vein isolation
155546|NCT03226821|HIV Lipodystrophy|hiv lipodystrophy
155547|NCT03226821|Tesamorelin|tesamorelin
155548|NCT03226821|Body Composition|body composition
155549|NCT03226821|Visceral Adiposity|visceral adiposity
155550|NCT03226795|Cystic fibrosis|cystic fibrosis
155551|NCT03226795|Therapeutic adherence|therapeutic adherence
155552|NCT03226795|Co-constructed intervention|co-constructed intervention
155553|NCT03226795|Patient involvement|patient involvement
155554|NCT03226743|stepped and collaborative care|stepped and collaborative care
155555|NCT03226743|cluster-randomized controlled trial|cluster-randomized controlled trial
155556|NCT03226743|health services research|health services research
155557|NCT03226743|evidence-based medicine|evidence-based medicine
155558|NCT03226743|complex intervention|complex intervention
155559|NCT03226743|guideline implementation|guideline implementation
155560|NCT03226743|collaborative network|collaborative network
155561|NCT03226730|Female Adolescent|female adolescent
155562|NCT03226730|Married|married
198655|NCT02954354|Flu|flu
155563|NCT03226730|West Africa|west africa
155564|NCT03226730|Family Planning|family planning
155565|NCT03226730|Contraceptive Use|contraceptive use
155566|NCT03226730|Birth Spacing|birth spacing
155567|NCT03226704|CD19|cd19
155568|NCT03226704|CD22|cd22
155569|NCT03226704|CD19/22|cd19/22
155570|NCT03226704|Immunotherapy|immunotherapy
155571|NCT03226704|Apheresis|apheresis
155572|NCT03226691|Plerixafor|plerixafor
155573|NCT03226691|Leukapheresis|leukapheresis
155574|NCT03226691|Mobilization|mobilization
155575|NCT03226691|Stem Cells|stem cells
155576|NCT03226691|Sickle Cell Disease|sickle cell disease
155577|NCT03226665|obstruction|obstruction
155578|NCT03226665|small bowel|small bowel
155579|NCT03226665|ultrasound|ultrasound
155580|NCT03226639|Atrial Fibrillation|atrial fibrillation
155581|NCT03226639|First Ablation|first ablation
155582|NCT03226626|Tumescent|tumescent
155583|NCT03226626|Lidocaine|lidocaine
155584|NCT03226626|Epinephrine|epinephrine
155585|NCT03226626|Cefazolin|cefazolin
155586|NCT03226626|Metronidazole|metronidazole
155587|NCT03226626|Surgical Site Infection|surgical site infection
155588|NCT03226626|Thrombosis|thrombosis
155589|NCT03226626|Sepsis|sepsis
155590|NCT03226626|Prevention|prevention
155591|NCT03226626|Prophylaxis|prophylaxis
155592|NCT03226613|Human Papillomavirus|human papillomavirus
155593|NCT03226613|Oropharyngeal Cancer|oropharyngeal cancer
155594|NCT03226613|Base of Tongue Cancer|base of tongue cancer
155595|NCT03226613|Tonsil Cancer|tonsil cancer
155596|NCT03226600|Gingival Recession|gingival recession
155597|NCT03226600|Connective Tissue Graft|connective tissue graft
155598|NCT03226600|OrACELL|oracell
155599|NCT03226600|Decellularized Dermis|decellularized dermis
155600|NCT03226600|Periodontics|periodontics
155601|NCT03226587|blue light|blue light
155602|NCT03226587|blood pressure|blood pressure
155603|NCT03226587|vascular function|vascular function
155604|NCT03226587|endothelial function|endothelial function
155605|NCT03226587|health volunteers|health volunteers
155606|NCT03226574|Resiniferatoxin|resiniferatoxin
155607|NCT03226574|RTX|rtx
155608|NCT03226574|Cancer pain|cancer pain
155609|NCT03226548|Earned Income Tax Credit (EITC)|earned income tax credit (eitc)
155610|NCT03226548|Tax Credit|tax credit
155611|NCT03226548|Paycheck Plus|paycheck plus
155612|NCT03226535|Computer Assisted Instrument Guidance (CAIG)|computer assisted instrument guidance (caig)
155613|NCT03226535|Ultrasound-CT Fusion|ultrasound-ct fusion
155614|NCT03226535|Image Fusion|image fusion
155615|NCT03226535|Clear Guide SCENERGY|clear guide scenergy
155616|NCT03226535|Needle path|needle path
155617|NCT03226535|Needle Guidance|needle guidance
155618|NCT03226535|CT|ct
155619|NCT03226535|Ultrasound|ultrasound
155620|NCT03226509|cascade of care|cascade of care
155621|NCT03226483|Brain Metastases|brain metastases
155622|NCT03226483|Intraoperative Radiotherapy|intraoperative radiotherapy
155623|NCT03226483|Neurosurgery|neurosurgery
155624|NCT03226470|Transcription Activator-like Effector Nucleases|transcription activator-like effector nucleases
155625|NCT03226470|Human papillomavirus|human papillomavirus
155626|NCT03226470|cervical intraepithelial neoplasia|cervical intraepithelial neoplasia
155627|NCT03226457|Heart Failure|heart failure
155628|NCT03226457|Type 2 Diabetes Mellitus|type 2 diabetes mellitus
155629|NCT03226457|Sodium-Glucose co-Transporter 2 (SGLT2) inhibitors|sodium-glucose co-transporter 2 (sglt2) inhibitors
155630|NCT03226457|Natriuresis|natriuresis
155631|NCT03226457|Diuresis|diuresis
155632|NCT03226444|Dry Eye|dry eye
155633|NCT03226444|Primary Sjogren's Syndrome|primary sjogren's syndrome
155634|NCT03226444|Sjogren's Syndrome|sjogren's syndrome
155635|NCT03226405|Cancer|cancer
155636|NCT03226392|QAW039, uncontrolled asthma|qaw039, uncontrolled asthma
155637|NCT03226366|door-to-antibiotic time|door-to-antibiotic time
155638|NCT03226366|emergency department care|emergency department care
155639|NCT03226366|antimicrobial|antimicrobial
155640|NCT03226366|care reorganization|care reorganization
155641|NCT03226366|severe sepsis|severe sepsis
155642|NCT03226366|swarming|swarming
155643|NCT03226314|bacterial multi-resitance|bacterial multi-resitance
155644|NCT03226288|Plantar Fascitis|plantar fascitis
155645|NCT03226288|orthopedic|orthopedic
155646|NCT03226288|3D surface scanning|3d surface scanning
155647|NCT03226275|Concor AM®|concor am®
155648|NCT03226275|Concor®|concor®
155649|NCT03226275|Norvasc®|norvasc®
155650|NCT03226275|Bisoprolol|bisoprolol
155651|NCT03226275|Amlodipine|amlodipine
155652|NCT03226275|Bisoprolol-Amlodipine fixed dose combination|bisoprolol-amlodipine fixed dose combination
155653|NCT03226275|Chinese Participants|chinese participants
155654|NCT03226236|Carcinoma, Renal Cell|carcinoma, renal cell
155655|NCT03226236|vaccination|vaccination
155656|NCT03226236|dendritic cells|dendritic cells
155657|NCT03226236|autologous tumor homogenate|autologous tumor homogenate
155658|NCT03226236|High Dose -IL2|high dose -il2
155659|NCT03226236|immunomodulating radiotherapy|immunomodulating radiotherapy
155660|NCT03226236|secondary|secondary
155661|NCT03226210|Diabetes Mellitus|diabetes mellitus
155662|NCT03226210|Rapid-acting insulin analogues|rapid-acting insulin analogues
155663|NCT03226210|Continuous glucose monitoring system (CGMS)|continuous glucose monitoring system (cgms)
155664|NCT03226210|Continuous subcutaneous insulin infusion (CSII)|continuous subcutaneous insulin infusion (csii)
155665|NCT03226184|Er:YAG laser, laser, biofilm removal, biofilm, disinfection, septic revision surgery|er:yag laser, laser, biofilm removal, biofilm, disinfection, septic revision surgery
155666|NCT03226158|Next generation pathogen sequencing (NGPS)|next generation pathogen sequencing (ngps)
155667|NCT03226158|Pediatric|pediatric
155668|NCT03226158|Cancer|cancer
155669|NCT03226158|Bloodstream infection (BSI)|bloodstream infection (bsi)
155670|NCT03226119|HTLV|htlv
155671|NCT03226119|Confirmatory|confirmatory
155672|NCT03226119|Supplemental|supplemental
155673|NCT03226119|Blot|blot
155674|NCT03226119|HTLV-I|htlv-i
155675|NCT03226119|HTLV-II|htlv-ii
155676|NCT03226106|Rehabilitation|rehabilitation
155677|NCT03226106|Total Knee Arthroplasty|total knee arthroplasty
155678|NCT03226106|Telemedicine|telemedicine
155679|NCT03226106|Physical Activity|physical activity
155680|NCT03226054|Proton Pump Inhibitor|proton pump inhibitor
155681|NCT03226041|transcutaneous carbon dioxide|transcutaneous carbon dioxide
155682|NCT03226041|retroperitoneoscopic|retroperitoneoscopic
155683|NCT03226041|urologic surgery|urologic surgery
155684|NCT03226041|anesthesia|anesthesia
155685|NCT03226015|Limbal Stem-cell Deficiency|limbal stem-cell deficiency
155686|NCT03226015|Oral mucosa transplantation|oral mucosa transplantation
155687|NCT03226015|Amniotic membrane|amniotic membrane
155688|NCT03226015|Mesenchymal stem cells|mesenchymal stem cells
155689|NCT03226002|Airtraq NT|airtraq nt
155690|NCT03226002|nasotracheal intubation|nasotracheal intubation
155691|NCT03226002|right|right
155692|NCT03226002|left|left
155693|NCT03225976|Phototherapy|phototherapy
155694|NCT03225976|Athletic Performance|athletic performance
155695|NCT03225976|Muscle Strength|muscle strength
155696|NCT03225976|Fatigue|fatigue
155697|NCT03225963|Glioblastoma|glioblastoma
155698|NCT03225963|Bevacizumab|bevacizumab
155699|NCT03225950|Periodontal disease|periodontal disease
155700|NCT03225950|Periodontitis|periodontitis
155701|NCT03225950|Aggressive periodontitis|aggressive periodontitis
155702|NCT03225950|Dysbiosis|dysbiosis
155703|NCT03225950|Inflammation|inflammation
155704|NCT03225950|Regulation|regulation
155705|NCT03225950|Cytokines|cytokines
155706|NCT03225950|Bacteria|bacteria
155707|NCT03225950|Porphyromonas gingivalis|porphyromonas gingivalis
155708|NCT03225950|Saliva|saliva
155709|NCT03225950|Anti-CCP|anti-ccp
155710|NCT03225950|Peptidyl arginine deiminases|peptidyl arginine deiminases
155711|NCT03225950|Single nucleotide polymorphisms|single nucleotide polymorphisms
155712|NCT03225898|blood flow restriction|blood flow restriction
155713|NCT03225898|resistance exercise|resistance exercise
155714|NCT03225885|gestational age|gestational age
155715|NCT03225885|multi-media|multi-media
155716|NCT03225885|mobile application|mobile application
155717|NCT03225885|anxiety|anxiety
155718|NCT03225885|clinical trial|clinical trial
155719|NCT03225885|random allocation|random allocation
155720|NCT03225872|Osteosarcoma|osteosarcoma
155721|NCT03225872|Bone cancer|bone cancer
155722|NCT03225872|Family-based study|family-based study
155723|NCT03225859|Stress Disorders, Posttraumatic|stress disorders, posttraumatic
155724|NCT03225859|Self-Management|self-management
155725|NCT03225820|pharmacogenomic information|pharmacogenomic information
155726|NCT03225807|Intubated|intubated
155727|NCT03225807|Intubation|intubation
155728|NCT03225807|Ventilator|ventilator
155729|NCT03225807|Ventilator-free days|ventilator-free days
155730|NCT03225807|Ventilator free days|ventilator free days
155731|NCT03225807|Mechanical Ventilation|mechanical ventilation
155732|NCT03225807|Meta-Analysis|meta-analysis
155733|NCT03225807|Tidal Volume|tidal volume
155734|NCT03225807|Tidal Volumes|tidal volumes
155735|NCT03225807|inflammation|inflammation
155736|NCT03225807|cytokines|cytokines
155737|NCT03225807|Pulmonary Infiltrate|pulmonary infiltrate
155738|NCT03225807|Pulmonary Infiltrates|pulmonary infiltrates
155739|NCT03225807|Low Tidal Volumes|low tidal volumes
155740|NCT03225807|Protective Ventilation|protective ventilation
155741|NCT03225794|Retrovirus|retrovirus
155742|NCT03225794|Viral emergence|viral emergence
155743|NCT03225755|Growth Hormone Deficiency|growth hormone deficiency
155744|NCT03225755|Adipose Tissue|adipose tissue
155745|NCT03225755|Inflammation|inflammation
155746|NCT03225716|Waldenstrom's Macroglobulinemia|waldenstrom's macroglobulinemia
155747|NCT03225703|Exercise|exercise
155748|NCT03225703|Osteoporosis|osteoporosis
155749|NCT03225703|Osteoarthritis|osteoarthritis
155750|NCT03225703|MRI|mri
155751|NCT03225703|DXA|dxa
155752|NCT03225703|High Impact|high impact
155753|NCT03225703|Cartilage|cartilage
155754|NCT03225703|Bone|bone
155755|NCT03225651|Stem cell|stem cell
155756|NCT03225651|Autism|autism
155757|NCT03225651|Psychological|psychological
155758|NCT03225651|Rehabilitation|rehabilitation
198882|NCT02953106|Asthma|asthma
155759|NCT03225625|spinal cord injury|spinal cord injury
155760|NCT03225625|spinal cord compression|spinal cord compression
155761|NCT03225625|spinal cord ischemia|spinal cord ischemia
155762|NCT03225625|spinal cord diseases|spinal cord diseases
155763|NCT03225625|spinal paralysis|spinal paralysis
155764|NCT03225625|paraplegia|paraplegia
155765|NCT03225625|paraparesis|paraparesis
155766|NCT03225625|SCI|sci
155767|NCT03225586|Non-communicable Diseases, Risk Factors|non-communicable diseases, risk factors
155768|NCT03225573|second mesiobuccal canal CBCT prevalence population|second mesiobuccal canal cbct prevalence population
155769|NCT03225560|Smart Phone Application|smart phone application
155770|NCT03225560|Bowel Preparation|bowel preparation
155771|NCT03225560|Colorectal Cancer Screening|colorectal cancer screening
155772|NCT03225547|HER-2 negative breast cancer|her-2 negative breast cancer
155773|NCT03225547|breast cancer|breast cancer
155774|NCT03225547|pembrolizumab|pembrolizumab
155775|NCT03225547|mifepristone|mifepristone
155776|NCT03225534|Asthma|asthma
155777|NCT03225534|Allergy|allergy
155778|NCT03225534|Epidemiology|epidemiology
155779|NCT03225534|Environment|environment
155780|NCT03225534|Exposures|exposures
155781|NCT03225521|Physical Activity|physical activity
155782|NCT03225521|Mobile Health|mobile health
155783|NCT03225521|Self Monitoring|self monitoring
155784|NCT03225521|Wearable Sensors|wearable sensors
155785|NCT03225521|Tailored Health Communication|tailored health communication
155786|NCT03225521|Implementation Intentions|implementation intentions
155787|NCT03225521|Mobile Apps|mobile apps
155788|NCT03225521|Anti-Sedentary Behavior|anti-sedentary behavior
155789|NCT03225521|Opportunistic Physical Activity|opportunistic physical activity
155790|NCT03225521|Health Belief Model|health belief model
155791|NCT03225482|Mild Cognitive Impairment|mild cognitive impairment
155792|NCT03225482|Cognitive rehabilitation|cognitive rehabilitation
155793|NCT03225482|Cognitive training|cognitive training
155794|NCT03225482|Cognitive remediation|cognitive remediation
155795|NCT03225469|Bowel Preparation|bowel preparation
155796|NCT03225469|Colonoscopy|colonoscopy
155797|NCT03225469|Quality|quality
155798|NCT03225469|Family Support|family support
155799|NCT03225469|Education|education
155800|NCT03225456|appetite regulation|appetite regulation
155801|NCT03225456|obesity|obesity
155802|NCT03225456|oxytocin|oxytocin
155803|NCT03225443|Locally advanced cervical cancer|locally advanced cervical cancer
155804|NCT03225443|Particle radiotherapy|particle radiotherapy
155805|NCT03225443|Neoadjuvant Chemotherapy|neoadjuvant chemotherapy
155806|NCT03225417|Ixazomib|ixazomib
155807|NCT03225404|Tendinopathy|tendinopathy
155808|NCT03225404|Electrolysis|electrolysis
155809|NCT03225404|Exercise|exercise
155810|NCT03225404|Dry needing|dry needing
155811|NCT03225391|Residents|residents
155812|NCT03225391|Naps|naps
155813|NCT03225391|decision making|decision making
155814|NCT03225378|Fluid responsiveness|fluid responsiveness
155815|NCT03225378|Passive leg raising|passive leg raising
155816|NCT03225378|Pulse pressure variation|pulse pressure variation
155817|NCT03225365|Melanoma|melanoma
155818|NCT03225365|Nivolumab|nivolumab
155819|NCT03225365|Ipilimumab|ipilimumab
155820|NCT03225365|Immune modulation|immune modulation
155821|NCT03225326|articaine|articaine
155822|NCT03225326|local anesthesia|local anesthesia
155823|NCT03225326|AMSA|amsa
155824|NCT03225300|Glioblastoma|glioblastoma
155825|NCT03225300|Chemoradiation|chemoradiation
155826|NCT03225300|Simultaneous integrated boost|simultaneous integrated boost
155827|NCT03225274|Breathing exercises|breathing exercises
155828|NCT03225274|Respiratory status|respiratory status
155829|NCT03225274|Nebulization therapy|nebulization therapy
155830|NCT03225274|lower respiratory tract disorders|lower respiratory tract disorders
155831|NCT03225235|Prostate cancer, SBRT, Ultrafractionation, CyberKnife|prostate cancer, sbrt, ultrafractionation, cyberknife
155832|NCT03225222|Prostate cancer|prostate cancer
155833|NCT03225222|multivariate risk assessment|multivariate risk assessment
155834|NCT03225222|MRI|mri
155835|NCT03225222|biopsy|biopsy
155836|NCT03225222|screening|screening
155837|NCT03225222|multicenter|multicenter
155838|NCT03225209|Roux-en-y gastric bypass|roux-en-y gastric bypass
155839|NCT03225209|GLP-1|glp-1
155840|NCT03225209|Liraglutide|liraglutide
155841|NCT03225209|OPTIFAST|optifast
155842|NCT03225196|Extracellular RNA|extracellular rna
155843|NCT03225196|MicroRNA|microrna
155844|NCT03225183|TOPMed|topmed
155845|NCT03225183|Blood Pressure|blood pressure
155846|NCT03225183|Long Noncoding RNA|long noncoding rna
155847|NCT03225183|Gene Expression|gene expression
155848|NCT03225183|MicroRNA|microrna
155849|NCT03225170|Decision-Making|decision-making
155850|NCT03225170|BRCA1|brca1
155851|NCT03225170|BRCA2|brca2
155852|NCT03225170|Generic Counseling|generic counseling
155853|NCT03225170|HBOC|hboc
155854|NCT03225157|Audiogram|audiogram
155855|NCT03225157|Statins|statins
155856|NCT03225157|Drug Response|drug response
155857|NCT03225157|Cancer Treatment|cancer treatment
155858|NCT03225157|Head and Neck Cancer|head and neck cancer
155859|NCT03225144|Motor Neuron Disease|motor neuron disease
155860|NCT03225144|Frontotemporal Dementia|frontotemporal dementia
155861|NCT03225144|Corticobasal Syndrome|corticobasal syndrome
155862|NCT03225131|Age Related Macular Degeneration|age related macular degeneration
155863|NCT03225131|Dark Adaptation|dark adaptation
155864|NCT03225118|Rebound|rebound
155865|NCT03225118|Reinitiation|reinitiation
155866|NCT03225118|ART|art
155867|NCT03225118|Reservoirs|reservoirs
155868|NCT03225118|Immune Exhaustion|immune exhaustion
155869|NCT03225105|Solid Tumors|solid tumors
155870|NCT03225105|M3541|m3541
155871|NCT03225105|Palliative radiotherapy|palliative radiotherapy
155872|NCT03225105|Adenosine triphosphate-competitive inhibitor|adenosine triphosphate-competitive inhibitor
155873|NCT03225092|Chronic Knee Pain|chronic knee pain
155874|NCT03225092|Status-Post Total Knee Arthroplasty|status-post total knee arthroplasty
155875|NCT03225092|Platelet Rich Plasma|platelet rich plasma
155876|NCT03225079|Pentaglobin® use|pentaglobin® use
155877|NCT03225079|severe bacterial infection|severe bacterial infection
155878|NCT03225053|Percutaneous microelectrolysis|percutaneous microelectrolysis
155879|NCT03225053|Physiotherapy|physiotherapy
155880|NCT03225040|Acromegaly|acromegaly
155881|NCT03225040|Pegvisomant|pegvisomant
155882|NCT03225040|Osteoporosis|osteoporosis
155883|NCT03225027|Emotional prosody, schizophrenia|emotional prosody, schizophrenia
155884|NCT03225001|Sapien XT|sapien xt
155885|NCT03225001|Partner II|partner ii
155886|NCT03225001|cardiovascular disease|cardiovascular disease
155887|NCT03225001|heart disease|heart disease
155888|NCT03225001|aortic disease|aortic disease
155889|NCT03225001|SAVR|savr
155890|NCT03225001|TAVR|tavr
155891|NCT03225001|failing surgical valve|failing surgical valve
155892|NCT03225001|failing valve|failing valve
155893|NCT03225001|failing bioprosthetic valve|failing bioprosthetic valve
155894|NCT03224988|Alzheimer's Disease|alzheimer's disease
155895|NCT03224988|AD|ad
155896|NCT03224988|MCI-AD|mci-ad
155898|NCT03224988|Memory|memory
155899|NCT03224988|TMS|tms
155900|NCT03224988|Transcranial Magnetic Stimulation|transcranial magnetic stimulation
155901|NCT03224988|Neuropsychological evaluation|neuropsychological evaluation
155902|NCT03224988|MRI|mri
155903|NCT03224988|DTI|dti
155904|NCT03224988|EEG|eeg
155905|NCT03224975|Pain|pain
155906|NCT03224975|Brain responses|brain responses
155907|NCT03224975|Neuroimaging|neuroimaging
155908|NCT03224975|fMRI|fmri
155909|NCT03224975|Burn|burn
155910|NCT03224975|Memory|memory
155911|NCT03224962|pit and fissure caries|pit and fissure caries
155912|NCT03224936|DISE|dise
155913|NCT03224936|OSAS|osas
155914|NCT03224936|PSI|psi
155915|NCT03224910|FNA, smears, imprints, ROSE|fna, smears, imprints, rose
155916|NCT03224897|Reappraisal|reappraisal
155917|NCT03224897|Emotion Regulation|emotion regulation
155918|NCT03224897|tDCS|tdcs
155919|NCT03224897|Reinterpretation|reinterpretation
155920|NCT03224858|Patient-Centered Care|patient-centered care
155921|NCT03224858|Comorbidity|comorbidity
155922|NCT03224754|Atypia, thyroid, malignancy|atypia, thyroid, malignancy
155923|NCT03224741|Behavioral Economics|behavioral economics
155924|NCT03224702|M6495|m6495
155925|NCT03224702|anti-A disintegrin and metalloproteinase with thrombospondin motifs-5 nanobody|anti-a disintegrin and metalloproteinase with thrombospondin motifs-5 nanobody
155926|NCT03224702|Osteoarthritis|osteoarthritis
155927|NCT03224676|Quality of sleep|quality of sleep
155928|NCT03224676|Perceived sleep distractors|perceived sleep distractors
155929|NCT03224676|Adult patients|adult patients
155930|NCT03224663|Effectiveness|effectiveness
155931|NCT03224663|Module based learning|module based learning
155932|NCT03224663|Mobile application based learning|mobile application based learning
155933|NCT03224663|Facility based newborn care|facility based newborn care
155934|NCT03224663|Knowledge|knowledge
155935|NCT03224663|Practices|practices
155936|NCT03224663|Nursing students|nursing students
155937|NCT03224585|anakinra|anakinra
155938|NCT03224585|Kineret|kineret
155939|NCT03224585|pericarditis|pericarditis
155940|NCT03224572|vitamin C|vitamin c
155941|NCT03224572|quality of life|quality of life
155942|NCT03224572|terminal cancer|terminal cancer
155943|NCT03224533|nut consumption|nut consumption
155944|NCT03224533|NHANES|nhanes
155945|NCT03224533|epidemiology|epidemiology
155946|NCT03224533|plasma glucose|plasma glucose
155947|NCT03224533|hemoglobin A1c|hemoglobin a1c
155948|NCT03224507|multiple myeloma|multiple myeloma
155949|NCT03224507|induction therapy|induction therapy
155950|NCT03224507|autologous hematopoietic cell transplantation|autologous hematopoietic cell transplantation
155951|NCT03224507|KRdD|krdd
155952|NCT03224507|Daratumumab|daratumumab
155953|NCT03224507|Carfilzomib|carfilzomib
155954|NCT03224507|Lenalidomide|lenalidomide
155955|NCT03224468|medical marijuana|medical marijuana
155956|NCT03224468|cannabis|cannabis
155957|NCT03224468|pain|pain
155958|NCT03224468|insomnia|insomnia
199134|NCT02951130|HRF|hrf
155959|NCT03224468|depression|depression
155960|NCT03224468|anxiety|anxiety
155961|NCT03224468|addiction|addiction
155962|NCT03224468|dependence|dependence
155963|NCT03224468|neurocognition|neurocognition
155964|NCT03224468|MRI|mri
155965|NCT03224455|sleep|sleep
155966|NCT03224455|sleep in children|sleep in children
155967|NCT03224455|children and sleep|children and sleep
155968|NCT03224455|environment|environment
155969|NCT03224455|environment and sleep|environment and sleep
155970|NCT03224455|environment and children|environment and children
155971|NCT03224416|Alcohol|alcohol
155972|NCT03224416|Delay Discounting|delay discounting
155973|NCT03224416|Risky Sexual Behavior|risky sexual behavior
155974|NCT03224416|Decision Making|decision making
155975|NCT03224416|MSM|msm
155976|NCT03224390|Contraception|contraception
155977|NCT03224390|Family Planning|family planning
155978|NCT03224390|Digital Health|digital health
155979|NCT03224390|Kenya|kenya
155980|NCT03224390|Unmet Need|unmet need
155981|NCT03224364|Solo surgery|solo surgery
155982|NCT03224364|Camera holder|camera holder
155983|NCT03224364|Laparoscopic Appendectomy|laparoscopic appendectomy
155984|NCT03224325|Drug therapy|drug therapy
155985|NCT03224312|Primary aldosteronism|primary aldosteronism
155986|NCT03224312|cardiovascular events|cardiovascular events
155987|NCT03224312|cerebrovascular events|cerebrovascular events
155988|NCT03224286|Pressure sensitive mat|pressure sensitive mat
155989|NCT03224273|proximal box design preparation|proximal box design preparation
155990|NCT03224247|vertical splitting|vertical splitting
155991|NCT03224247|Cesarean Section Complications|cesarean section complications
155992|NCT03224247|uterine vessels|uterine vessels
155993|NCT03224247|injury|injury
155994|NCT03224234|Uncontrolled Type 2 Diabetes|uncontrolled type 2 diabetes
155995|NCT03224234|Insulclock|insulclock
155996|NCT03224234|Electronic device|electronic device
155997|NCT03224234|Alarm system|alarm system
155998|NCT03224221|esophageal squamous cell carcinoma|esophageal squamous cell carcinoma
155999|NCT03224221|apatinib|apatinib
156000|NCT03224208|melanoma|melanoma
156001|NCT03224208|advanced|advanced
156002|NCT03224208|vemurafenib|vemurafenib
156003|NCT03224208|cobimetinib|cobimetinib
156004|NCT03224195|rehabilitation|rehabilitation
156005|NCT03224195|patient perspective|patient perspective
156006|NCT03224195|semi-structured interview|semi-structured interview
156007|NCT03224143|dementia|dementia
156008|NCT03224143|doll therapy|doll therapy
156009|NCT03224143|attachment|attachment
156010|NCT03224130|transitions of care|transitions of care
156011|NCT03224130|reutilization|reutilization
156012|NCT03224130|nurse phone call|nurse phone call
156013|NCT03224104|elderly|elderly
156014|NCT03224104|TG02|tg02
156015|NCT03224104|newly diagnosed|newly diagnosed
156016|NCT03224104|first relapse|first relapse
156017|NCT03224091|Eating disorders|eating disorders
156018|NCT03224091|psychopathology|psychopathology
156019|NCT03224091|pathophysiology|pathophysiology
156020|NCT03224091|prospective|prospective
156021|NCT03224091|longitudinal|longitudinal
156022|NCT03224052|Anti-Bacterial Agents|anti-bacterial agents
156023|NCT03224052|Falciparum|falciparum
156024|NCT03224052|Vivax|vivax
156025|NCT03224000|Malignant neoplasms of lip oral cavity and pharynx|malignant neoplasms of lip oral cavity and pharynx
156026|NCT03224000|Oropharyngeal Cancer|oropharyngeal cancer
156027|NCT03224000|Human papilloma virus positive|human papilloma virus positive
156028|NCT03224000|HPV+|hpv+
156029|NCT03224000|Squamous cell carcinoma of the oropharynx|squamous cell carcinoma of the oropharynx
156030|NCT03224000|Squamous cell carcinoma of the tonsil|squamous cell carcinoma of the tonsil
156031|NCT03224000|Squamous cell carcinoma of the base of tongue|squamous cell carcinoma of the base of tongue
156032|NCT03224000|Squamous cell carcinoma of the soft palate|squamous cell carcinoma of the soft palate
156033|NCT03224000|Squamous cell carcinoma of the oropharyngeal walls|squamous cell carcinoma of the oropharyngeal walls
156034|NCT03224000|Magnetic Resonance Imaging Guided Radiotherapy|magnetic resonance imaging guided radiotherapy
156035|NCT03224000|Standard of Care Radiotherapy Planning|standard of care radiotherapy planning
156036|NCT03224000|Radiation Therapy|radiation therapy
156037|NCT03224000|Intensity modulated radiotherapy|intensity modulated radiotherapy
156038|NCT03224000|IMRT|imrt
156039|NCT03224000|Modified Barium Swallow|modified barium swallow
156040|NCT03224000|MBS|mbs
156041|NCT03224000|Swallowing questionnaire|swallowing questionnaire
156042|NCT03224000|The M.D. Anderson Dysphagia Inventory (MDADI)|the m.d. anderson dysphagia inventory (mdadi)
156043|NCT03224000|Symptom questionnaire|symptom questionnaire
156044|NCT03224000|The M.D. Anderson Symptom Inventory for Head and Neck Cancer (MDASI-HN)|the m.d. anderson symptom inventory for head and neck cancer (mdasi-hn)
156045|NCT03224000|Video-Strobe Procedure|video-strobe procedure
156046|NCT03223987|16S rRNA|16s rrna
156047|NCT03223987|Microbiome|microbiome
156048|NCT03223987|Strath Herbal Yeast Preparation|strath herbal yeast preparation
156049|NCT03223974|Angioplasty|angioplasty
156050|NCT03223974|drug-coated balloon|drug-coated balloon
156051|NCT03223974|bifurcation|bifurcation
199332|NCT02950051|CLL|cll
156052|NCT03223961|myelodysplastic syndrome|myelodysplastic syndrome
156053|NCT03223961|erythropoetin|erythropoetin
156054|NCT03223922|whole brain radiation therapy|whole brain radiation therapy
156055|NCT03223922|genu of corpus callosum|genu of corpus callosum
156056|NCT03223922|cognitive function|cognitive function
156057|NCT03223909|dry eye|dry eye
156058|NCT03223909|Chondroitin sulfate|chondroitin sulfate
156059|NCT03223909|Ocular lubricants|ocular lubricants
156060|NCT03223896|antagonist|antagonist
156061|NCT03223896|nasal|nasal
156062|NCT03223857|visual outcomes|visual outcomes
156063|NCT03223857|multifocal intraocular lens|multifocal intraocular lens
156064|NCT03223857|patient satisfaction|patient satisfaction
156065|NCT03223857|spectacle independence|spectacle independence
156066|NCT03223844|Dopamine|dopamine
156067|NCT03223844|Amphetamine|amphetamine
156068|NCT03223844|Positron Emission Tomography|positron emission tomography
156069|NCT03223844|Magnetic Resonance Imaging|magnetic resonance imaging
156070|NCT03223844|Schizophrenia|schizophrenia
156071|NCT03223844|Psychosis|psychosis
156072|NCT03223844|[18F]FDOPA|[18f]fdopa
156073|NCT03223844|[11C]-(+)-PHNO|[11c]-(+)-phno
156074|NCT03223831|unresectable malignant gastric outlet obstruction|unresectable malignant gastric outlet obstruction
156075|NCT03223831|Partially covered pyloro-duodenal stents|partially covered pyloro-duodenal stents
156076|NCT03223831|uncovered pyloro-duodenal stents|uncovered pyloro-duodenal stents
156077|NCT03223818|Liver|liver
156078|NCT03223818|Digestive system|digestive system
156079|NCT03223779|Colorectal Cancer|colorectal cancer
156080|NCT03223766|Proton therapy|proton therapy
156081|NCT03223766|Long-term effects|long-term effects
156082|NCT03223727|Radium-223|radium-223
156083|NCT03223714|Conbercept ophthalmic injection|conbercept ophthalmic injection
156084|NCT03223714|ME|me
156085|NCT03223714|CRVO|crvo
156086|NCT03223662|Neoadjuvant Chemoradiotherapy (nCRT)|neoadjuvant chemoradiotherapy (ncrt)
156087|NCT03223662|Esophagectomy|esophagectomy
156088|NCT03223662|Tissue or serologic biomarkers|tissue or serologic biomarkers
156089|NCT03223649|Metabolism|metabolism
156090|NCT03223649|Children|children
156091|NCT03223649|Walking Bouts|walking bouts
156092|NCT03223649|Glucose|glucose
156093|NCT03223649|Insulin|insulin
156094|NCT03223636|Transcranial Magnetic Stimulation (TMS)|transcranial magnetic stimulation (tms)
156095|NCT03223636|Magnetic Resonance Imaging (MRI)|magnetic resonance imaging (mri)
156096|NCT03223636|Electroencephalogram (EEG)|electroencephalogram (eeg)
156097|NCT03223636|Magnetoencephalogram|magnetoencephalogram
156098|NCT03223636|Transcranial Electrical Stimulation (TES)|transcranial electrical stimulation (tes)
156099|NCT03223623|Complex Regional Pain Syndrome|complex regional pain syndrome
156100|NCT03223623|CRPS|crps
156101|NCT03223623|Dystonia|dystonia
156102|NCT03223610|Monoclonal Antibody|monoclonal antibody
156103|NCT03223610|Dose-Finding|dose-finding
156104|NCT03223597|Radium-223|radium-223
156105|NCT03223597|quality of life|quality of life
156106|NCT03223597|Pain|pain
156107|NCT03223571|stroke|stroke
156108|NCT03223571|Upper arm|upper arm
156109|NCT03223571|Cerebral plasticity|cerebral plasticity
156110|NCT03223571|Functional connectivity|functional connectivity
156111|NCT03223571|Rehabilitation|rehabilitation
156112|NCT03223558|cardiac rehabilitation|cardiac rehabilitation
156113|NCT03223545|mindfulness-based cognitive therapy|mindfulness-based cognitive therapy
156114|NCT03223545|Meditation|meditation
156115|NCT03223519|DOMS|doms
156116|NCT03223519|Exercise|exercise
156117|NCT03223519|Ibuprofen|ibuprofen
156118|NCT03223519|Magnesium|magnesium
156119|NCT03223519|Vitamin C|vitamin c
156120|NCT03223519|Muscle pain|muscle pain
156121|NCT03223467|Obesity|obesity
156122|NCT03223467|Obstructive sleep apnea|obstructive sleep apnea
156123|NCT03223467|Bariatric surgery candidate|bariatric surgery candidate
156124|NCT03223467|Metabolic syndrome|metabolic syndrome
156125|NCT03223441|Pulse wave velocity|pulse wave velocity
156126|NCT03223441|anesthesia|anesthesia
156127|NCT03223415|Clostridium difficile infection|clostridium difficile infection
156128|NCT03223415|Infection Control|infection control
156129|NCT03223415|Prevention|prevention
156130|NCT03223415|Asymptomatic carriage|asymptomatic carriage
156131|NCT03223415|Colonization|colonization
156132|NCT03223415|Pilot Study|pilot study
156133|NCT03223415|Contact Precaution|contact precaution
156134|NCT03223415|Detection|detection
156135|NCT03223363|Birth weight Prediction|birth weight prediction
156136|NCT03223363|Two-dimensional Ultrasonography|two-dimensional ultrasonography
156137|NCT03223363|Three-dimensional Ultrasonography|three-dimensional ultrasonography
156138|NCT03223337|GSK1278863|gsk1278863
156139|NCT03223337|Daprodustat|daprodustat
156140|NCT03223337|Healthy control|healthy control
156141|NCT03223337|Single dose|single dose
156142|NCT03223337|Hepatic Impairment|hepatic impairment
156143|NCT03223324|Threatened Premature Labor|threatened premature labor
156144|NCT03223324|Abdominal Fetal ECG|abdominal fetal ecg
156145|NCT03223298|Myofascial Pain|myofascial pain
156146|NCT03223298|Myofascial Pain Disorder|myofascial pain disorder
156147|NCT03223298|Maxillofacial Pain|maxillofacial pain
156148|NCT03223298|Masseter Muscle|masseter muscle
156149|NCT03223298|Temporalis Muscle|temporalis muscle
156150|NCT03223298|Botulinum Toxin|botulinum toxin
156151|NCT03223285|Cervical spine;|cervical spine;
156152|NCT03223285|Diaphragm;|diaphragm;
156153|NCT03223285|Manual Therapy|manual therapy
156154|NCT03223285|Pain|pain
156155|NCT03223285|Range of Motion|range of motion
156156|NCT03223272|hypertension|hypertension
156157|NCT03223272|sympathetic tone|sympathetic tone
156158|NCT03223272|resperpine|resperpine
156159|NCT03223259|Dance Injuries|dance injuries
156160|NCT03223259|Injury Prevention Workshops|injury prevention workshops
156161|NCT03223259|Motor Skill Theory|motor skill theory
156658|NCT03219814|body-image|body-image
156162|NCT03223259|Gross Motor Skills|gross motor skills
156163|NCT03223220|Stroke, Neuroprotection, Ketamine|stroke, neuroprotection, ketamine
156164|NCT03223194|Crigler-Najjar|crigler-najjar
156166|NCT03223194|AAV8 Delivered Gene Transfer|aav8 delivered gene transfer
156167|NCT03223194|Adeno Associated Virus|adeno associated virus
156168|NCT03223181|Comiss|comiss
156169|NCT03223155|Small cell lung cancer|small cell lung cancer
156170|NCT03223155|ipilimumab|ipilimumab
156171|NCT03223155|nivolumab|nivolumab
156172|NCT03223155|stereotactic body radiotherapy|stereotactic body radiotherapy
156173|NCT03223129|Type 2 Diabetes Mellitus|type 2 diabetes mellitus
156174|NCT03223129|Impaired glucose tolerance|impaired glucose tolerance
156175|NCT03223129|Metabolomics|metabolomics
156176|NCT03223116|heartburn|heartburn
156177|NCT03223116|regurgitation|regurgitation
156178|NCT03223103|Brain cancer|brain cancer
156179|NCT03223103|Glioblastoma|glioblastoma
156180|NCT03223103|Personalized vaccine|personalized vaccine
156181|NCT03223103|Poly-ICLC|poly-iclc
156182|NCT03223103|Immunotherapy|immunotherapy
156183|NCT03223103|Cancer|cancer
156184|NCT03223103|NovoTTF-200A|novottf-200a
156185|NCT03223103|Optune|optune
156186|NCT03223103|GBM|gbm
156187|NCT03223103|immunogenicity|immunogenicity
156188|NCT03223090|Language|language
156189|NCT03223090|learning|learning
156190|NCT03223090|plasticity|plasticity
156191|NCT03223077|Post infectious|post infectious
156192|NCT03223051|Spinal Muscular Atrophy|spinal muscular atrophy
156193|NCT03223051|Children|children
156194|NCT03223051|Motor assessment|motor assessment
156195|NCT03223051|Space exploration|space exploration
156196|NCT03223051|Upper limbs|upper limbs
156197|NCT03223038|Nutrition|nutrition
156198|NCT03223025|IGHD|ighd
156199|NCT03223025|somatropin|somatropin
156200|NCT03223012|Adalimumab|adalimumab
156201|NCT03223012|Humira®|humira®
156202|NCT03223012|AbbVie patient care support program|abbvie patient care support program
156203|NCT03223012|Psoriasis|psoriasis
156204|NCT03223012|Axial Spondyloarthritis|axial spondyloarthritis
156205|NCT03223012|Rheumatoid Arthritis|rheumatoid arthritis
156206|NCT03223012|Ulcerative Colitis|ulcerative colitis
156207|NCT03222999|Out-of-Hospital Cardiac Arrest|out-of-hospital cardiac arrest
156208|NCT03222986|sepsis, nanoparticle tracking analysis|sepsis, nanoparticle tracking analysis
156209|NCT03222973|Remyelination|remyelination
156210|NCT03222973|Re-myelination|re-myelination
156211|NCT03222973|DMT|dmt
156212|NCT03222973|LINGO-1|lingo-1
156213|NCT03222973|Anti-LINGO-1|anti-lingo-1
156214|NCT03222973|Opicinumab|opicinumab
156215|NCT03222921|high tibial osteotomy|high tibial osteotomy
156216|NCT03222908|Behavior|behavior
156217|NCT03222908|Perioperative/Postoperative Complications|perioperative/postoperative complications
156218|NCT03222908|contract agreement|contract agreement
156219|NCT03222908|implementation intentions|implementation intentions
156220|NCT03222908|precommitment|precommitment
156221|NCT03222908|smoking cessation|smoking cessation
156222|NCT03222895|Esophageal Neoplasms|esophageal neoplasms
156223|NCT03222895|Lymph node metastases|lymph node metastases
156224|NCT03222895|Esophagectomy|esophagectomy
156225|NCT03222843|ITP|itp
156226|NCT03222804|Infants|infants
156227|NCT03222804|Probiotic|probiotic
156228|NCT03222804|B. Infantis|b. infantis
156229|NCT03222791|Diabetes|diabetes
156230|NCT03222778|fluid responsiveness|fluid responsiveness
156231|NCT03222778|tissue doppler|tissue doppler
156232|NCT03222778|off-pump coronary bypass surgery|off-pump coronary bypass surgery
156233|NCT03222765|prediabetes lifestyle drugs microvascular complications|prediabetes lifestyle drugs microvascular complications
156234|NCT03222752|Alpha-Stim|alpha-stim
156235|NCT03222752|Cranial Electrotherapy Stimulation|cranial electrotherapy stimulation
156236|NCT03222752|CES|ces
156237|NCT03222726|exercise, diabetic kidney disease, complications|exercise, diabetic kidney disease, complications
156238|NCT03222687|tacrolimus, Henoch-Schönlein purpura nephritis, children|tacrolimus, henoch-schönlein purpura nephritis, children
156239|NCT03222674|AML|aml
156240|NCT03222674|CAR T|car t
156241|NCT03222674|Muc1,CLL1, CD33, CD38, CD56, and/or CD123|muc1,cll1, cd33, cd38, cd56, and/or cd123
156242|NCT03222648|Idiopathic Pulmonary Fibrosis|idiopathic pulmonary fibrosis
156243|NCT03222648|Exercise training|exercise training
156244|NCT03222648|Health related quality of life|health related quality of life
156245|NCT03222648|Biomarkers|biomarkers
156246|NCT03222635|Barrett's esophagus|barrett's esophagus
156247|NCT03222635|Submucosal esophageal adenocarcinoma|submucosal esophageal adenocarcinoma
156248|NCT03222635|Endoscopic treatment|endoscopic treatment
156249|NCT03222635|Endoscopic follow-up|endoscopic follow-up
156250|NCT03222622|EGFR inhibitor, topical agent, psoriasis, phase 2|egfr inhibitor, topical agent, psoriasis, phase 2
156251|NCT03222609|Post-polycythemia vera MF (PPV-MF)|post-polycythemia vera mf (ppv-mf)
156252|NCT03222609|Post-essential thrombocythemia (PET-MF)|post-essential thrombocythemia (pet-mf)
156253|NCT03222609|ruxolitinib|ruxolitinib
156254|NCT03222609|navitoclax|navitoclax
156255|NCT03222609|splenic volume|splenic volume
156256|NCT03222609|Primary Myelofibrosis|primary myelofibrosis
156257|NCT03222609|Jakafi|jakafi
156258|NCT03222609|enlarged spleen|enlarged spleen
156259|NCT03222609|splenomegaly|splenomegaly
156260|NCT03222609|ABT 263|abt 263
156261|NCT03222609|bone marrow fibrosis|bone marrow fibrosis
156262|NCT03222596|Quality of Life|quality of life
156263|NCT03222596|Fatigue|fatigue
156264|NCT03222596|Physical Disability|physical disability
156265|NCT03222596|Disabilities Psychological|disabilities psychological
156266|NCT03222596|Pain|pain
156267|NCT03222596|Motivation|motivation
156268|NCT03222596|Multiple sclerosis|multiple sclerosis
156269|NCT03222583|Chronic Hepatitis C Virus (HCV)|chronic hepatitis c virus (hcv)
156270|NCT03222583|Genotype 1 to 6|genotype 1 to 6
156271|NCT03222583|Asian|asian
156272|NCT03222583|non-cirrhotic|non-cirrhotic
156273|NCT03222583|Human Immunodeficiency Virus|human immunodeficiency virus
156274|NCT03222583|co-infection|co-infection
156275|NCT03222583|Treatment-naïve|treatment-naïve
156276|NCT03222583|Treatment-experienced|treatment-experienced
156277|NCT03222583|interferon|interferon
156278|NCT03222544|methylene blue|methylene blue
156279|NCT03222544|Photodynamics Therapy|photodynamics therapy
156280|NCT03222518|acute pain, trauma, paracetamol, NSAID|acute pain, trauma, paracetamol, nsaid
156281|NCT03222505|Stroke|stroke
156282|NCT03222505|Gait Stride Management Assist|gait stride management assist
156283|NCT03222505|Stroke, post 1 year or longer|stroke, post 1 year or longer
156284|NCT03222492|Diffuse Cutaneous Systemic Sclerosis (dcSSc)|diffuse cutaneous systemic sclerosis (dcssc)
156285|NCT03222492|Phase 1/2 clinical trial|phase 1/2 clinical trial
156286|NCT03222492|dose escalation randomized trial|dose escalation randomized trial
156287|NCT03222492|Brentuximab vedotin|brentuximab vedotin
156288|NCT03222466|Patient educational materials; prostate cancer; co-creation|patient educational materials; prostate cancer; co-creation
156289|NCT03222453|thalassemia|thalassemia
156290|NCT03222453|stem cell|stem cell
156291|NCT03222388|IIEF|iief
156292|NCT03222388|electronic validation|electronic validation
156293|NCT03222375|Yaroshuk's MEGA-DISCOVERY · DIAGNOSTICS · TREATMENT|yaroshuk's mega-discovery · diagnostics · treatment
156294|NCT03222375|Yaroshuk's Scientific Medical School|yaroshuk's scientific medical school
156295|NCT03222375|Center of Synergetics|center of synergetics
156296|NCT03222375|Controlling spatiotemporal chaos/Dr. Synergetic|controlling spatiotemporal chaos/dr. synergetic
156297|NCT03222375|Autowave processes in Medicine|autowave processes in medicine
156298|NCT03222375|Autowave Reverberator|autowave reverberator
156299|NCT03222375|Bifurcation of Dynamic systems on a plane|bifurcation of dynamic systems on a plane
156300|NCT03222375|Spiral Autowaves|spiral autowaves
156301|NCT03222375|Drift of Spiral Autowaves|drift of spiral autowaves
156302|NCT03222375|Excitable medium and Cellular Automata|excitable medium and cellular automata
156303|NCT03222375|Stochastic Resonance and Coherence Resonance|stochastic resonance and coherence resonance
156304|NCT03222375|Autowaves/SQUED|autowaves/squed
156305|NCT03222375|Theory of Semiconducting QUantum Excitonic Device|theory of semiconducting quantum excitonic device
156306|NCT03222362|retinal detachment|retinal detachment
156307|NCT03222362|trauma|trauma
156308|NCT03222362|age related macular degeneration|age related macular degeneration
156309|NCT03222349|interictal state|interictal state
156310|NCT03222349|ictal/peri-ictal state|ictal/peri-ictal state
156311|NCT03222323|volunteers|volunteers
156312|NCT03222284|diabetes|diabetes
156313|NCT03222284|type 2 diabetes|type 2 diabetes
156314|NCT03222284|type ii diabetes|type ii diabetes
156315|NCT03222284|insulin|insulin
156316|NCT03222284|mobile applications|mobile applications
156317|NCT03222284|Diabetes Mellitus|diabetes mellitus
156318|NCT03222284|Diabetes Mellitus, Type 2|diabetes mellitus, type 2
156319|NCT03222284|smartphone application|smartphone application
156320|NCT03222284|health application|health application
156321|NCT03222271|NIV weaning strategy|niv weaning strategy
156322|NCT03222258|Palliative Care|palliative care
156323|NCT03222258|Quality of Life|quality of life
156324|NCT03222258|Prospective Cohort Study|prospective cohort study
156325|NCT03222258|Treatment decision|treatment decision
156326|NCT03222258|Utilization of health care|utilization of health care
156327|NCT03222232|intestinal failure|intestinal failure
156328|NCT03222232|catheter-related bloodstream infections|catheter-related bloodstream infections
156329|NCT03222232|catheter salvage|catheter salvage
199655|NCT02948062|ALD|ald
156330|NCT03222232|recurrent infections|recurrent infections
156331|NCT03222232|home parenteral support|home parenteral support
156332|NCT03222219|dental implant insertional torque stability|dental implant insertional torque stability
156333|NCT03222206|Hepatokine|hepatokine
156334|NCT03222206|Adipokine|adipokine
156335|NCT03222206|Saccharometabolism|saccharometabolism
156336|NCT03222206|Lipid metabolism|lipid metabolism
156337|NCT03222193|Medical device|medical device
156338|NCT03222193|Retraining|retraining
156339|NCT03222193|Snoring|snoring
156340|NCT03222193|TRP|trp
156341|NCT03222193|Tongue|tongue
156342|NCT03222167|Elbasvir|elbasvir
156343|NCT03222167|Grazoprevir|grazoprevir
156344|NCT03222167|SVR12|svr12
156345|NCT03222167|hepatitis C|hepatitis c
156346|NCT03222167|metabolic syndrome|metabolic syndrome
156347|NCT03222154|High Energy Shock Waves|high energy shock waves
156348|NCT03222154|physiotherapy|physiotherapy
156349|NCT03222141|Sapien 3|sapien 3
156350|NCT03222141|Transfemoral|transfemoral
156351|NCT03222141|Transapical|transapical
156352|NCT03222141|Transaortic|transaortic
156353|NCT03222141|TAVI|tavi
156354|NCT03222141|Aortic Stenosis|aortic stenosis
156355|NCT03222141|THV|thv
156356|NCT03222141|Aortic Valve|aortic valve
156357|NCT03222141|Transcatheter Heart Valve|transcatheter heart valve
156358|NCT03222141|TAVR|tavr
156359|NCT03222128|SAPIEN 3|sapien 3
156360|NCT03222128|Transfemoral|transfemoral
156361|NCT03222128|Transapical|transapical
156362|NCT03222128|Transaortic|transaortic
156363|NCT03222128|NovaFlex|novaflex
156364|NCT03222128|TAVI|tavi
156365|NCT03222128|Aortic Stenosis|aortic stenosis
156366|NCT03222128|THV|thv
156367|NCT03222128|Aortic Valve|aortic valve
156368|NCT03222128|Transcatheter Heart Valve|transcatheter heart valve
156369|NCT03222128|TAVR|tavr
156370|NCT03222063|Play interventions, anxiety|play interventions, anxiety
156371|NCT03222024|ischaemic stroke|ischaemic stroke
156372|NCT03222024|severe|severe
156373|NCT03222024|malignant|malignant
156374|NCT03222024|courses|courses
156375|NCT03222024|risk factors|risk factors
156376|NCT03222024|clinical course|clinical course
156377|NCT03222024|management|management
156378|NCT03222024|prognosis|prognosis
156379|NCT03222011|Crohn Disease|crohn disease
156380|NCT03222011|Inflammatory Bowel Disease|inflammatory bowel disease
156381|NCT03222011|Intestinal stricture|intestinal stricture
156382|NCT03221998|morbidly obese|morbidly obese
156383|NCT03221998|,elective sleeve|,elective sleeve
156384|NCT03221998|gastrectomy|gastrectomy
156385|NCT03221998|paracetamol|paracetamol
156386|NCT03221998|IV Perfelgan|iv perfelgan
156387|NCT03221985|experience sampling method|experience sampling method
156388|NCT03221972|25 hydroxyvitamin D|25 hydroxyvitamin d
156389|NCT03221972|6-17 years old|6-17 years old
156390|NCT03221972|vitamin D deficiency|vitamin d deficiency
156391|NCT03221959|malignant middle cerebral artery infarction|malignant middle cerebral artery infarction
156392|NCT03221920|Very Low Carbohydrate Diet|very low carbohydrate diet
156393|NCT03221920|Colorectal Adenocarcinoma|colorectal adenocarcinoma
156394|NCT03221894|Complementary therapies|complementary therapies
156395|NCT03221868|motor activity|motor activity
156396|NCT03221868|women|women
156397|NCT03221842|Antibody-mediated kidney transplant rejection|antibody-mediated kidney transplant rejection
156398|NCT03221842|Renal|renal
156399|NCT03221829|spinal anaesthesia|spinal anaesthesia
156400|NCT03221829|elderly patients|elderly patients
156401|NCT03221829|transurethral resection of bladder tumour|transurethral resection of bladder tumour
156402|NCT03221816|Menopause|menopause
156403|NCT03221816|homocysteine|homocysteine
156404|NCT03221816|lipid profile|lipid profile
156405|NCT03221790|Irritable bowel syndrome|irritable bowel syndrome
156406|NCT03221790|Low FODMAP diet|low fodmap diet
156407|NCT03221790|Mucosal Inflammation|mucosal inflammation
156408|NCT03221751|randomized controlled trial|randomized controlled trial
156409|NCT03221738|BDD|bdd
156410|NCT03221725|sacrospinous ligament fixation|sacrospinous ligament fixation
156411|NCT03221725|stress urinary incontinence|stress urinary incontinence
156412|NCT03221712|cardiopulmonary exercise test|cardiopulmonary exercise test
156413|NCT03221712|chronic total occlusion|chronic total occlusion
156414|NCT03221712|cardiac rehabilitation|cardiac rehabilitation
156415|NCT03221673|Exercise|exercise
156416|NCT03221673|Children|children
156417|NCT03221673|Arkansas|arkansas
156418|NCT03221673|Physical activity|physical activity
156419|NCT03221673|Sedentary|sedentary
156420|NCT03221660|filling material, polymerization|filling material, polymerization
156421|NCT03221647|Celiac Disease; P31-43; Loxorubine; TLR7.|celiac disease; p31-43; loxorubine; tlr7.
156422|NCT03221634|Programmed cell death 1 receptor (PD1)|programmed cell death 1 receptor (pd1)
156423|NCT03221634|PD-1|pd-1
156424|NCT03221634|Programmed cell death ligand 1 receptor (PDL1)|programmed cell death ligand 1 receptor (pdl1)
156425|NCT03221634|PD-L1|pd-l1
156426|NCT03221621|Acne inversa|acne inversa
156427|NCT03221621|Adalimumab|adalimumab
156428|NCT03221621|Cost-effectiveness|cost-effectiveness
156429|NCT03221608|Colorectal Cancer|colorectal cancer
156430|NCT03221608|HIPEC|hipec
156431|NCT03221608|Peritoneal Carcinomatosis|peritoneal carcinomatosis
156432|NCT03221608|Lobaplatin|lobaplatin
156433|NCT03221556|Comparative effectiveness research|comparative effectiveness research
156434|NCT03221556|Patient-centered medical home|patient-centered medical home
156435|NCT03221556|Shared decision-making|shared decision-making
156436|NCT03221530|suicidal ideation|suicidal ideation
156437|NCT03221530|mental health|mental health
156438|NCT03221530|adolescent|adolescent
156439|NCT03221530|Latino|latino
156440|NCT03221530|immigrant|immigrant
156441|NCT03221504|urinary tract infections|urinary tract infections
156442|NCT03221504|pyelonephritis|pyelonephritis
156443|NCT03221504|cefuroxime|cefuroxime
156444|NCT03221504|children|children
156445|NCT03221491|Analgesia|analgesia
156446|NCT03221491|Colorectal Surgery|colorectal surgery
156447|NCT03221491|Background Infusion|background infusion
156448|NCT03221439|back pain|back pain
156449|NCT03221439|physiotherapy|physiotherapy
156450|NCT03221439|exercise therapy|exercise therapy
156451|NCT03221439|cognitive functional therapy|cognitive functional therapy
156452|NCT03221439|low back pain|low back pain
156453|NCT03221439|backache|backache
156454|NCT03221439|lower back pain|lower back pain
156455|NCT03221439|lumbago|lumbago
156456|NCT03221439|multidimensional|multidimensional
156457|NCT03221439|biopsychosocial|biopsychosocial
156458|NCT03221426|PD1|pd1
156459|NCT03221426|PD-1|pd-1
156460|NCT03221426|PDL1|pdl1
156461|NCT03221426|PD-L1|pd-l1
156462|NCT03221413|transcranial alternating current stimulation|transcranial alternating current stimulation
156463|NCT03221413|Neuroimaging|neuroimaging
156464|NCT03221413|EEG|eeg
156465|NCT03221387|Therapy|therapy
156466|NCT03221387|Noninvasive Ventilation|noninvasive ventilation
156467|NCT03221335|EUS-guided RFA|eus-guided rfa
156468|NCT03221335|liver|liver
156469|NCT03221335|stomach|stomach
156470|NCT03221335|adrenal|adrenal
156471|NCT03221335|kidney tumour|kidney tumour
156472|NCT03221283|Music therapy|music therapy
156473|NCT03221283|Depression|depression
156474|NCT03221283|Emotion|emotion
156475|NCT03221283|Motivation|motivation
156476|NCT03221270|tACS|tacs
156477|NCT03221270|Sham|sham
156478|NCT03221270|Auditory Hallucinations|auditory hallucinations
156479|NCT03221270|Schizophrenia|schizophrenia
156480|NCT03221270|Schizo Affective Disorder|schizo affective disorder
156481|NCT03221270|EEG|eeg
156482|NCT03221244|Distractibility|distractibility
156483|NCT03221244|Virtual Reality|virtual reality
156484|NCT03221244|Attention|attention
156485|NCT03221244|Child|child
156486|NCT03221244|Pediatric|pediatric
156487|NCT03221205|sleep apnea, obstructive|sleep apnea, obstructive
156488|NCT03221205|obesity|obesity
156489|NCT03221205|DM2|dm2
156490|NCT03221205|TEI index|tei index
156491|NCT03221205|CPAP|cpap
156492|NCT03221192|Real-time data capture|real-time data capture
156493|NCT03221192|Concept elicitation|concept elicitation
156494|NCT03221192|Nasal polyps|nasal polyps
156495|NCT03221192|Cognitive debriefing|cognitive debriefing
156496|NCT03221192|Patient-reported outcomes|patient-reported outcomes
156497|NCT03221192|HRQoL|hrqol
156498|NCT03221166|Children|children
156499|NCT03221166|Crohn disease|crohn disease
156500|NCT03221166|Thalidomide|thalidomide
156501|NCT03221166|Mucosal healing|mucosal healing
156502|NCT03221153|Patient Safety|patient safety
156503|NCT03221153|Quality|quality
156504|NCT03221153|Simulation|simulation
156505|NCT03221153|Undergraduate|undergraduate
156506|NCT03221153|Medical Student|medical student
156507|NCT03221114|Hispanics/Latinos|hispanics/latinos
156508|NCT03221114|Underserved Population|underserved population
156509|NCT03221075|Invasive Aspergillosis|invasive aspergillosis
156510|NCT03221075|Azole resistance|azole resistance
156511|NCT03221075|Aspergillus fumigatus|aspergillus fumigatus
156512|NCT03221075|Efficacy of antifungal therapy|efficacy of antifungal therapy
156513|NCT03221075|Patient registry|patient registry
156514|NCT03221049|diagnosis performance|diagnosis performance
156515|NCT03221049|hepatocellular carcinoma|hepatocellular carcinoma
156516|NCT03221049|liver fibrosis|liver fibrosis
156517|NCT03221049|progression|progression
156518|NCT03221036|Drug therapy|drug therapy
156519|NCT03221023|Vancomycin|vancomycin
156520|NCT03221023|Implantable Neural Stimulator|implantable neural stimulator
156521|NCT03221023|Deep Brain Stimulation|deep brain stimulation
156522|NCT03221023|Surgical Site Infection|surgical site infection
156523|NCT03221010|Smoking|smoking
156524|NCT03221010|Smoking cessation|smoking cessation
156525|NCT03221010|Motivational Interviewing|motivational interviewing
156526|NCT03221010|Primary health care|primary health care
156527|NCT03221010|Randomized clinical trial|randomized clinical trial
156528|NCT03220997|Sequela|sequela
156529|NCT03220997|Ketosis|ketosis
156530|NCT03220971|Lipoprotein and Apolipoproteins metabolism|lipoprotein and apolipoproteins metabolism
156531|NCT03220932|Epithelial Ovarian Cancer - Platinum-resistant - Cytoreductive surgery - HIPEC - Quality of Life|epithelial ovarian cancer - platinum-resistant - cytoreductive surgery - hipec - quality of life
156532|NCT03220919|Insulin|insulin
156533|NCT03220919|Type 2 diabetes|type 2 diabetes
156534|NCT03220880|Dexmedetomidine|dexmedetomidine
156535|NCT03220880|Sedation|sedation
156536|NCT03220880|Pediatric|pediatric
156537|NCT03220841|Crohn Disease|crohn disease
156538|NCT03220841|Inflammatory Bowel Disease|inflammatory bowel disease
156539|NCT03220841|Intestinal stricture|intestinal stricture
156540|NCT03220698|endotracheal intubation|endotracheal intubation
156541|NCT03220698|confirmation|confirmation
156542|NCT03220698|ultrasonography|ultrasonography
156543|NCT03220685|Microbiota|microbiota
156544|NCT03220672|Pelvic floor muscles|pelvic floor muscles
156545|NCT03220672|pelvic floor muscle training|pelvic floor muscle training
156546|NCT03220672|motor control|motor control
156547|NCT03220672|Educational intervention|educational intervention
156548|NCT03220672|menopause|menopause
156549|NCT03220646|Abemaciclib (LY2835219)|abemaciclib (ly2835219)
156550|NCT03220646|meningioma|meningioma
156551|NCT03220646|Astrocytoma|astrocytoma
156552|NCT03220646|ependymoma|ependymoma
156553|NCT03220646|Oligodendroglioma|oligodendroglioma
156554|NCT03220646|CNS lymphoma|cns lymphoma
156555|NCT03220646|17-261|17-261
156556|NCT03220620|fluid therapy|fluid therapy
156557|NCT03220620|perioperative|perioperative
156558|NCT03220620|hemodilution|hemodilution
156559|NCT03220607|uterocervical angle, second trimester abortion|uterocervical angle, second trimester abortion
156560|NCT03220594|hypogastric artery|hypogastric artery
156561|NCT03220594|anti-mullerian hormone|anti-mullerian hormone
156562|NCT03220594|ovarian reserve|ovarian reserve
156563|NCT03220594|postpartum|postpartum
156564|NCT03220555|Buzzy|buzzy
156565|NCT03220555|anesthetic cream|anesthetic cream
156566|NCT03220555|pediatric|pediatric
156567|NCT03220555|pain|pain
156568|NCT03220555|venipuncture|venipuncture
156569|NCT03220555|vaccination|vaccination
156570|NCT03220555|vibration|vibration
156571|NCT03220555|cold|cold
156572|NCT03220555|distraction|distraction
156573|NCT03220555|vaccination center|vaccination center
156574|NCT03220542|Helicobacter Pylori|helicobacter pylori
156575|NCT03220542|Probiotics|probiotics
156576|NCT03220542|Sulforaphane|sulforaphane
156577|NCT03220477|Pembrolizumab|pembrolizumab
156578|NCT03220477|guadecitabine|guadecitabine
156579|NCT03220477|mocetinostat|mocetinostat
156580|NCT03220477|17-241|17-241
156581|NCT03220451|pressure ulcer|pressure ulcer
156582|NCT03220451|pressure sore|pressure sore
156583|NCT03220451|decubitus ulcer|decubitus ulcer
156584|NCT03220451|spinal cord injury|spinal cord injury
156585|NCT03220451|adhesive elastic bandage|adhesive elastic bandage
156586|NCT03220451|taping|taping
156587|NCT03220451|kinesio taping|kinesio taping
156588|NCT03220451|neuro taping|neuro taping
156589|NCT03220412|adolescent|adolescent
156590|NCT03220412|gun|gun
156591|NCT03220412|violence|violence
156592|NCT03220412|media|media
156593|NCT03220386|staphylococcus aureus|staphylococcus aureus
156594|NCT03220386|nosocomial infection|nosocomial infection
156595|NCT03220386|decolonization|decolonization
156596|NCT03220386|emergency department|emergency department
156597|NCT03220373|Neuropsychology|neuropsychology
156598|NCT03220373|Cognition|cognition
156599|NCT03220373|Drop-out|drop-out
156600|NCT03220373|Follow-up|follow-up
156601|NCT03220347|Non-Hodgkin's Lymphomas|non-hodgkin's lymphomas
156602|NCT03220347|Safety|safety
156603|NCT03220347|Efficacy|efficacy
156604|NCT03220347|CC-90010|cc-90010
156605|NCT03220347|Solid Tumors|solid tumors
156606|NCT03220347|Relapsed/Refractory|relapsed/refractory
156607|NCT03220308|Self-control|self-control
156608|NCT03220308|Well-being|well-being
156609|NCT03220269|Utstein|utstein
156610|NCT03220269|Resuscitation|resuscitation
156611|NCT03220269|Epidemiology|epidemiology
156612|NCT03220269|Emergency medicine|emergency medicine
156613|NCT03220269|Resuscitation Registry|resuscitation registry
156614|NCT03220230|Next generation sequencing|next generation sequencing
156615|NCT03220230|Lung cancer|lung cancer
156616|NCT03220230|target therapies|target therapies
156617|NCT03220204|Heart Failure|heart failure
156618|NCT03220204|Positive Psychology|positive psychology
156619|NCT03220204|Adherence to Health Behaviors|adherence to health behaviors
156620|NCT03220178|breast cancer|breast cancer
156621|NCT03220178|HER2 negative|her2 negative
156622|NCT03220178|hormone receptor positive|hormone receptor positive
156623|NCT03220178|advanced|advanced
156624|NCT03220178|metastatic|metastatic
156625|NCT03220113|Migraine|migraine
156626|NCT03220113|Craniofacial Neuralgia|craniofacial neuralgia
156627|NCT03220100|Lung Cancer|lung cancer
156628|NCT03219983|interscalene block|interscalene block
156629|NCT03219983|liposomal bupivacaine|liposomal bupivacaine
156630|NCT03219957|HCV|hcv
156631|NCT03219957|Hepatitis C Virus|hepatitis c virus
156632|NCT03219957|RNA Viruses|rna viruses
200027|NCT02945631|HPV|hpv
156633|NCT03219957|Flavivirus|flavivirus
156634|NCT03219957|Liver Diseases|liver diseases
156635|NCT03219957|Hepatitis, Viral, Human|hepatitis, viral, human
156636|NCT03219957|Flaviviridae Infections|flaviviridae infections
156637|NCT03219931|infant colics|infant colics
156638|NCT03219931|probiotic|probiotic
156639|NCT03219931|gut microbiome|gut microbiome
156640|NCT03219931|bifidobacterium breve|bifidobacterium breve
156641|NCT03219931|crying time|crying time
156642|NCT03219918|Colorectal adenoma|colorectal adenoma
156643|NCT03219918|Colonoscopy|colonoscopy
156644|NCT03219918|Caps|caps
156645|NCT03219918|Adenoma detection rate|adenoma detection rate
156646|NCT03219892|freezing of gait|freezing of gait
156647|NCT03219892|rTMS|rtms
156648|NCT03219892|fMRI|fmri
156649|NCT03219879|Relapse prevention|relapse prevention
156650|NCT03219879|Persistent depressive disorder|persistent depressive disorder
156651|NCT03219879|Recurrent depressive disorder|recurrent depressive disorder
156652|NCT03219879|Telephone-based intervention|telephone-based intervention
156653|NCT03219879|Cognitive behavioral therapy|cognitive behavioral therapy
156654|NCT03219866|Nebulizer|nebulizer
156655|NCT03219866|Inhaler|inhaler
156656|NCT03219840|Cetylpyridium Chloride (CPC)|cetylpyridium chloride (cpc)
156657|NCT03219840|Chewing Gum|chewing gum
156659|NCT03219814|attention|attention
156660|NCT03219814|cognitive dissonance|cognitive dissonance
156661|NCT03219814|eating disorder prevention|eating disorder prevention
156662|NCT03219788|emergence|emergence
156663|NCT03219788|remifentanil|remifentanil
156664|NCT03219788|recovery|recovery
156665|NCT03219788|desflurene|desflurene
156666|NCT03219775|tailored immuno therapy|tailored immuno therapy
156667|NCT03219775|Nivolumab|nivolumab
156668|NCT03219775|Ipilimumab|ipilimumab
156669|NCT03219775|boost|boost
156670|NCT03219749|obstructive sleep apnea|obstructive sleep apnea
156671|NCT03219749|exercise training|exercise training
156672|NCT03219749|vascular function|vascular function
156673|NCT03219710|Chemotherapy induced nausea and vomiting|chemotherapy induced nausea and vomiting
156674|NCT03219710|olanzapine|olanzapine
156675|NCT03219697|Childhood obesity prevention;|childhood obesity prevention;
156676|NCT03219658|Parenting|parenting
156677|NCT03219658|Home visiting|home visiting
156678|NCT03219658|Childhood obesity treatment|childhood obesity treatment
156679|NCT03219606|Systemic sclerosis|systemic sclerosis
156680|NCT03219606|Education|education
156681|NCT03219606|Modified Rodnan skin score|modified rodnan skin score
156682|NCT03219528|Irritable Bowel Syndrome|irritable bowel syndrome
156683|NCT03219528|Diarrhea|diarrhea
156684|NCT03219528|Small Intestinal Bacterial Overgrowth|small intestinal bacterial overgrowth
156685|NCT03219528|Gut Microbiota|gut microbiota
156686|NCT03219489|Electronic Medical Record|electronic medical record
156687|NCT03219489|Progesterone|progesterone
156688|NCT03219476|aromatase inhibitor|aromatase inhibitor
156689|NCT03219476|breast cancer|breast cancer
156690|NCT03219476|estrogen receptor|estrogen receptor
156691|NCT03219476|progesterone receptor|progesterone receptor
156692|NCT03219476|endocrine-targeted therapy|endocrine-targeted therapy
156693|NCT03219476|Anti-estrogen therapy|anti-estrogen therapy
156694|NCT03219476|HR+|hr+
156695|NCT03219476|HER2-negative|her2-negative
156696|NCT03219476|Neoadjuvant Treatment|neoadjuvant treatment
156697|NCT03219450|Leukemia|leukemia
156698|NCT03219450|Lymphocytic Leukemia|lymphocytic leukemia
156699|NCT03219437|ABBV-066|abbv-066
156700|NCT03219437|BI 655066|bi 655066
156701|NCT03219424|Return to work status|return to work status
156702|NCT03219424|Functional outcome|functional outcome
156703|NCT03219424|Quality of life|quality of life
156704|NCT03219398|Living donor laparoscopic nephrectomy|living donor laparoscopic nephrectomy
156705|NCT03219398|Pneumoperitoneum|pneumoperitoneum
156706|NCT03219398|Renal resistive index|renal resistive index
156707|NCT03219398|Syndecan-1|syndecan-1
156708|NCT03219398|soluble VEGF-R2|soluble vegf-r2
156709|NCT03219398|Occludin|occludin
156710|NCT03219398|KIM-1|kim-1
156711|NCT03219398|Interleukin-6|interleukin-6
156712|NCT03219385|uterine leiomyoma|uterine leiomyoma
156713|NCT03219385|uterine fibroid|uterine fibroid
156714|NCT03219385|uterine myoma|uterine myoma
156715|NCT03219385|abnormal menstrual bleeding|abnormal menstrual bleeding
156716|NCT03219385|heavy menstrual bleeding|heavy menstrual bleeding
156717|NCT03219385|menorrhagia|menorrhagia
156718|NCT03219385|high-intensity focused ultrasound|high-intensity focused ultrasound
156719|NCT03219385|ultrasound imaging|ultrasound imaging
156720|NCT03219359|IBD|ibd
156721|NCT03219359|Inflammatory Bowel Diseases|inflammatory bowel diseases
156722|NCT03219359|Gastroenteritis|gastroenteritis
156723|NCT03219359|Crohn's disease|crohn's disease
156724|NCT03219359|Colitis|colitis
156725|NCT03219359|Vedolizumab|vedolizumab
156726|NCT03219346|stroke , swallowing function ,oral health quality of life|stroke , swallowing function ,oral health quality of life
156727|NCT03219333|Enfortumab vedotin|enfortumab vedotin
156728|NCT03219333|Metastatic Urothelial Cancer|metastatic urothelial cancer
156729|NCT03219333|ASG-22CE|asg-22ce
156730|NCT03219333|Locally Advanced Urothelial Cancer|locally advanced urothelial cancer
156731|NCT03219333|Antibody-Drug Conjugate|antibody-drug conjugate
156732|NCT03219333|Nectin-4|nectin-4
156733|NCT03219333|Platinum-naïve|platinum-naïve
156734|NCT03219333|Cisplatin-ineligible|cisplatin-ineligible
156735|NCT03219333|Antineoplastic Agents|antineoplastic agents
156736|NCT03219333|Drug Therapy|drug therapy
156737|NCT03219333|ASG-22ME|asg-22me
156738|NCT03219320|Type 2 Diabetes|type 2 diabetes
156739|NCT03219320|Neuropathic Pain|neuropathic pain
156740|NCT03219320|Peripheral Nervous System|peripheral nervous system
156741|NCT03219307|cartilage repair|cartilage repair
156742|NCT03219307|cartilage regeneration|cartilage regeneration
156743|NCT03219307|cartilage reconstruction|cartilage reconstruction
156744|NCT03219307|cartilage restoration|cartilage restoration
156745|NCT03219307|autologous chondrocyte implantation|autologous chondrocyte implantation
156746|NCT03219307|matrix associated chondrocyte implantation|matrix associated chondrocyte implantation
156747|NCT03219294|neuromuscular blockade|neuromuscular blockade
156748|NCT03219294|sugammadex|sugammadex
156749|NCT03219255|Post-marketing|post-marketing
156750|NCT03219255|Chronic obstructive pulmonary disease|chronic obstructive pulmonary disease
156751|NCT03219255|Drug use investigation|drug use investigation
156752|NCT03219255|RELVAR 100 ELLIPTA|relvar 100 ellipta
156753|NCT03219242|Advanced ovarian cancer|advanced ovarian cancer
156754|NCT03219229|Fat-free mass|fat-free mass
156755|NCT03219229|Tanner stage 1|tanner stage 1
156756|NCT03219229|Pre-pubertal|pre-pubertal
156757|NCT03219216|Chronic Hepatitis C Virus (HCV)|chronic hepatitis c virus (hcv)
156758|NCT03219216|Genotype 1 - 6|genotype 1 - 6
156759|NCT03219216|Metavir System Fibrosis Score|metavir system fibrosis score
156760|NCT03219216|Glecaprevir|glecaprevir
156761|NCT03219216|Pibrentasvir|pibrentasvir
156762|NCT03219216|Treatment naïve|treatment naïve
156763|NCT03219216|Cirrhosis|cirrhosis
156764|NCT03219216|Compensated cirrhosis|compensated cirrhosis
156765|NCT03219203|HBV vaccination|hbv vaccination
156766|NCT03219203|immunity|immunity
156767|NCT03219138|muscle function tests|muscle function tests
156768|NCT03219125|marrow adipose tissue|marrow adipose tissue
156769|NCT03219125|bone marrow adiposity|bone marrow adiposity
156770|NCT03219112|balance|balance
156771|NCT03219112|rehabilitation|rehabilitation
156772|NCT03219112|exergaming|exergaming
156773|NCT03219112|virtual reality|virtual reality
156774|NCT03219086|combined spinal epidural anesthesia|combined spinal epidural anesthesia
156775|NCT03219086|caesarian section|caesarian section
156776|NCT03219086|prilocaine|prilocaine
156777|NCT03219086|bupivacaine|bupivacaine
156778|NCT03219073|multiple sclerosis|multiple sclerosis
156779|NCT03219073|neuropathic pain|neuropathic pain
156780|NCT03219073|[18F] FDG-PET CT|[18f] fdg-pet ct
156781|NCT03219073|tDCS|tdcs
156782|NCT03219073|transcranial direct current stimulation|transcranial direct current stimulation
156783|NCT03219060|Cognitive dissonance|cognitive dissonance
156784|NCT03219060|Motivational interviewing|motivational interviewing
156785|NCT03219060|Health Professional role|health professional role
156786|NCT03219060|Nurses|nurses
156787|NCT03219060|Health Promotion|health promotion
156788|NCT03219060|Lifestyle|lifestyle
156789|NCT03219060|Smoking cessation|smoking cessation
156790|NCT03219034|oral appliance|oral appliance
156791|NCT03219034|sleep quality|sleep quality
156792|NCT03219034|sleep apnea|sleep apnea
156793|NCT03219021|Cleft lip and Palate|cleft lip and palate
156794|NCT03219021|unilateral cleft lip and palate|unilateral cleft lip and palate
156795|NCT03219021|surgically repaired cleft lip and palate|surgically repaired cleft lip and palate
156796|NCT03219021|arch dimensions|arch dimensions
156797|NCT03219021|arch discrepancies|arch discrepancies
156798|NCT03219021|dental arch dimensions|dental arch dimensions
156799|NCT03219021|arch parameter|arch parameter
156800|NCT03219021|arch circumference|arch circumference
156801|NCT03219021|intercanine width|intercanine width
156802|NCT03219021|first deciduous molar width|first deciduous molar width
156803|NCT03219021|second deciduous molar width|second deciduous molar width
156804|NCT03219021|permanent first molar width|permanent first molar width
156805|NCT03219008|depressive disorder|depressive disorder
156806|NCT03219008|multi-dimensional diagnosis technique|multi-dimensional diagnosis technique
156807|NCT03219008|individualized therapy|individualized therapy
156808|NCT03219008|management technique|management technique
156809|NCT03219008|e-MBC|e-mbc
156810|NCT03219008|MBC|mbc
156811|NCT03218995|DMD|dmd
156812|NCT03218995|Duchenne|duchenne
156813|NCT03218995|Eteplirsen|eteplirsen
156814|NCT03218995|dystrophy|dystrophy
156815|NCT03218995|dystrophin|dystrophin
156816|NCT03218995|exon 51|exon 51
156817|NCT03218982|Caregiver|caregiver
156818|NCT03218982|Vietnamese|vietnamese
156819|NCT03218982|Alzheimer's Disease|alzheimer's disease
156820|NCT03218956|Protein requirement|protein requirement
156821|NCT03218943|BiPAP|bipap
156822|NCT03218943|APRV|aprv
156823|NCT03218943|Physiological dead space|physiological dead space
156824|NCT03218943|volumetric capnography|volumetric capnography
156825|NCT03218943|ARDS|ards
156826|NCT03218943|impaired oxygenation|impaired oxygenation
156827|NCT03218943|ICU|icu
156828|NCT03218943|Mechanical ventilation|mechanical ventilation
156829|NCT03218930|General Practice|general practice
156830|NCT03218930|Social Marketing|social marketing
156831|NCT03218930|Behavior Change|behavior change
156832|NCT03218930|Antibiotic Prescribing|antibiotic prescribing
156833|NCT03218917|P aeruginosa|p aeruginosa
156834|NCT03218917|bronchiectasis|bronchiectasis
156835|NCT03218917|active neutrophil elastase|active neutrophil elastase
156836|NCT03218904|Glucose Breath Test|glucose breath test
156837|NCT03218891|Refractory Angina|refractory angina
156838|NCT03218891|Rehabilitation|rehabilitation
156839|NCT03218839|PrePex|prepex
156840|NCT03218839|HIV Seropositivity|hiv seropositivity
156841|NCT03218800|subcutaneous|subcutaneous
156842|NCT03218800|ertapenem|ertapenem
156843|NCT03218800|urinary tract infection|urinary tract infection
156844|NCT03218800|advanced cancer|advanced cancer
156845|NCT03218800|palliative care|palliative care
156846|NCT03218787|Coronary Artery Lesions|coronary artery lesions
156847|NCT03218787|XIENCE|xience
156848|NCT03218787|Dual Antiplatelet Therapy (DAPT)|dual antiplatelet therapy (dapt)
156849|NCT03218787|Reduced DAPT|reduced dapt
156850|NCT03218787|Risk of bleeding|risk of bleeding
156851|NCT03218787|Drug-eluting stents|drug-eluting stents
156852|NCT03218761|norepinephrine|norepinephrine
157049|NCT03217526|Burn injury|burn injury
156853|NCT03218761|norepinephrine transporter|norepinephrine transporter
156854|NCT03218748|Mental illness|mental illness
156855|NCT03218748|Disclosure|disclosure
156856|NCT03218748|stigma|stigma
156857|NCT03218748|soldiers|soldiers
156858|NCT03218748|secrecy|secrecy
156859|NCT03218735|large for gestational age fetal growth|large for gestational age fetal growth
156860|NCT03218722|Acute traumatic coagulopathy|acute traumatic coagulopathy
156861|NCT03218722|Hemostasis|hemostasis
156862|NCT03218722|Severe hemorrhage|severe hemorrhage
156863|NCT03218696|cough|cough
156864|NCT03218696|children|children
156865|NCT03218696|Acute Upper Respiratory Tract Infection|acute upper respiratory tract infection
156866|NCT03218683|relapsed|relapsed
156867|NCT03218683|refractory|refractory
156868|NCT03218683|AZD5991|azd5991
156869|NCT03218683|Non-Hodgkin lymphoma|non-hodgkin lymphoma
156870|NCT03218683|Richter syndrome|richter syndrome
156871|NCT03218683|Chronic lymphocytic leukemia|chronic lymphocytic leukemia
156872|NCT03218683|Small lymphocytic lymphoma|small lymphocytic lymphoma
156873|NCT03218683|T-cell lymphoma, Multiple myeloma|t-cell lymphoma, multiple myeloma
156874|NCT03218683|Acute Myeloid Leukemia (AML)|acute myeloid leukemia (aml)
156875|NCT03218683|Acute Lymphocytic Leukemia (ALL)|acute lymphocytic leukemia (all)
156876|NCT03218683|Myelodysplastic Syndrome (MDS)|myelodysplastic syndrome (mds)
156877|NCT03218683|Cutaneous T-cell Lymphoma|cutaneous t-cell lymphoma
156878|NCT03218657|Aplastic Anemia|aplastic anemia
156879|NCT03218657|levamisole hydrochloride|levamisole hydrochloride
156880|NCT03218657|clinical study|clinical study
156881|NCT03218644|Proprioception|proprioception
156882|NCT03218631|oxandrolone, cardiac|oxandrolone, cardiac
156883|NCT03218605|Achilles tendon|achilles tendon
156884|NCT03218605|Warming-up|warming-up
156885|NCT03218605|Vascularisation|vascularisation
156886|NCT03218605|Physical activity|physical activity
156887|NCT03218605|Oxygen-to-See (O2C)|oxygen-to-see (o2c)
156888|NCT03218592|Adherence|adherence
156889|NCT03218592|Hair|hair
156890|NCT03218579|microbiome|microbiome
156891|NCT03218579|intestinal bacteria|intestinal bacteria
156892|NCT03218566|pulmonary embolism|pulmonary embolism
156893|NCT03218566|clot|clot
156894|NCT03218540|stroke volume variation|stroke volume variation
156895|NCT03218540|central venous pressure|central venous pressure
156896|NCT03218540|serum lactate|serum lactate
156897|NCT03218540|serum creatinine|serum creatinine
156898|NCT03218514|Obesity|obesity
156899|NCT03218514|Venous thromboembolism|venous thromboembolism
156900|NCT03218514|Heparin, Low-Molecular-Weight|heparin, low-molecular-weight
156901|NCT03218514|Body Composition|body composition
156902|NCT03218514|Glomerular filtration rate|glomerular filtration rate
156903|NCT03218514|Bariatric Surgery|bariatric surgery
156904|NCT03218501|Uremic Pruritus|uremic pruritus
156905|NCT03218462|sensory adapted environment|sensory adapted environment
156906|NCT03218462|pediatric dentistry|pediatric dentistry
156907|NCT03218462|oral health|oral health
156908|NCT03218462|Developmental Disability|developmental disability
156909|NCT03218462|Intellectual Disability|intellectual disability
156910|NCT03218462|dental anxiety|dental anxiety
156911|NCT03218462|autism spectrum|autism spectrum
156912|NCT03218423|screening|screening
156913|NCT03218423|plasma|plasma
156914|NCT03218423|DNA methylation|dna methylation
156915|NCT03218410|surgical embolectomy|surgical embolectomy
156916|NCT03218410|catheter-directed therapy|catheter-directed therapy
156917|NCT03218397|Gram-negative Bacteremia|gram-negative bacteremia
156918|NCT03218397|ICU|icu
156919|NCT03218397|Critically ill|critically ill
200406|NCT02943252|S1|s1
156920|NCT03218397|Intensive Care Unit|intensive care unit
156921|NCT03218397|Rapid identification|rapid identification
156922|NCT03218397|Rapid susceptibility|rapid susceptibility
156923|NCT03218397|Accelerate PhenoTest™ BC Kit|accelerate phenotest™ bc kit
156924|NCT03218397|Accelerate Pheno™ System (AXDX)|accelerate pheno™ system (axdx)
156925|NCT03218397|Antimicrobial stewardship|antimicrobial stewardship
156926|NCT03218397|Antimicrobial use|antimicrobial use
156927|NCT03218384|Injectafer|injectafer
156928|NCT03218384|ferric carboxymaltose|ferric carboxymaltose
156929|NCT03218384|Supplemental Iron|supplemental iron
156930|NCT03218371|scleral indentation|scleral indentation
156931|NCT03218371|chandelier light|chandelier light
156932|NCT03218371|air vitrectomy|air vitrectomy
156933|NCT03218371|rhegmatogenous retinal detachment|rhegmatogenous retinal detachment
156934|NCT03218345|EUS-guided RFA|eus-guided rfa
156935|NCT03218345|pancreatic ca|pancreatic ca
156936|NCT03218345|interventional EUS|interventional eus
156937|NCT03218306|SPI|spi
156938|NCT03218306|Remifentanil|remifentanil
156939|NCT03218306|Target controlled infusion|target controlled infusion
156940|NCT03218280|trauma|trauma
156941|NCT03218280|antioxidant|antioxidant
156942|NCT03218280|oxidative stress|oxidative stress
156943|NCT03218280|Vitamin C|vitamin c
156944|NCT03218280|Ascorbic Acid|ascorbic acid
156945|NCT03218267|total hip replacement|total hip replacement
156946|NCT03218267|static disbalance|static disbalance
156947|NCT03218254|hematological cancer, fatigue, quality of life|hematological cancer, fatigue, quality of life
156948|NCT03218241|Healthy Volunteers|healthy volunteers
157050|NCT03217526|Gait|gait
156949|NCT03218228|aggressive periodontitis|aggressive periodontitis
156950|NCT03218215|cough assits|cough assits
156951|NCT03218202|Inflammatory Bowel Disease|inflammatory bowel disease
156952|NCT03218202|Crohn Disease|crohn disease
156953|NCT03218202|Ulcerative Colitis|ulcerative colitis
156954|NCT03218202|Intestinal stricture|intestinal stricture
156955|NCT03218189|Essential medicines lists|essential medicines lists
156956|NCT03218163|bone marrow|bone marrow
156957|NCT03218163|bone marrow transplant|bone marrow transplant
156958|NCT03218163|allogeneic|allogeneic
156959|NCT03218163|Medi-551|medi-551
156960|NCT03218137|Subjects|subjects
156961|NCT03218137|diagnosed|diagnosed
156962|NCT03218124|Thyroidectomy|thyroidectomy
156963|NCT03218124|Remifentanil|remifentanil
156964|NCT03218124|Extubation|extubation
156965|NCT03218124|Cough|cough
156966|NCT03218124|Target controlled infusion|target controlled infusion
156967|NCT03218111|Glymphatic network|glymphatic network
156968|NCT03218111|healthy|healthy
156969|NCT03218111|central nervous system|central nervous system
156970|NCT03218085|tenofovir|tenofovir
156971|NCT03218085|prevention|prevention
156972|NCT03218085|microbiome|microbiome
156973|NCT03218085|cervicovaginal|cervicovaginal
156974|NCT03218085|biopsy|biopsy
156975|NCT03218085|swab|swab
156976|NCT03218085|cytokines|cytokines
156977|NCT03218085|inflammation|inflammation
156978|NCT03218085|pharmacology|pharmacology
156979|NCT03218059|Cesarean Scar Pregnancy|cesarean scar pregnancy
156980|NCT03218033|systemic lupus|systemic lupus
156981|NCT03218033|self-management|self-management
156982|NCT03218033|social media|social media
156983|NCT03217942|Muscle soreness|muscle soreness
156984|NCT03217942|NGF-induced pain|ngf-induced pain
156985|NCT03217942|Pain model|pain model
156986|NCT03217942|Long-lasting sensitization|long-lasting sensitization
156987|NCT03217929|vagus nerve|vagus nerve
156988|NCT03217929|obesity|obesity
156989|NCT03217929|craving|craving
156990|NCT03217929|food|food
156991|NCT03217916|podocyte glycoprotein|podocyte glycoprotein
156992|NCT03217916|kidney injury|kidney injury
156993|NCT03217916|preeclampsia|preeclampsia
156994|NCT03217903|Myelodysplastic syndromes|myelodysplastic syndromes
156995|NCT03217877|noninvasive stress testing|noninvasive stress testing
156996|NCT03217877|high risk|high risk
156997|NCT03217877|unstable angina|unstable angina
156998|NCT03217877|PCI|pci
156999|NCT03217864|Cancer|cancer
157000|NCT03217864|palliative care|palliative care
157001|NCT03217864|hospitalization at home|hospitalization at home
157002|NCT03217864|home health care provider|home health care provider
157003|NCT03217851|Plasmodium falciparum|plasmodium falciparum
157004|NCT03217851|Prevalence Survey|prevalence survey
157005|NCT03217851|Antimalarial Drug|antimalarial drug
157006|NCT03217838|AML|aml
157007|NCT03217838|Acute Myeloid Leukaemia|acute myeloid leukaemia
157008|NCT03217838|AZD2811|azd2811
157009|NCT03217838|AZD1152|azd1152
157010|NCT03217838|AZD1152 hQPA|azd1152 hqpa
157011|NCT03217838|barasertib|barasertib
157012|NCT03217838|azacitidine|azacitidine
157013|NCT03217838|Vidaza|vidaza
157014|NCT03217786|Macrovascular Disease|macrovascular disease
157015|NCT03217786|Microvascular Coronary Artery Disease|microvascular coronary artery disease
157016|NCT03217786|Cardiac Transplant Rejection|cardiac transplant rejection
157017|NCT03217786|Transplant; Failure, Heart|transplant; failure, heart
157018|NCT03217786|Intravascular ultrasound (IVUS)|intravascular ultrasound (ivus)
157019|NCT03217786|Optical Coherence Tomography|optical coherence tomography
157020|NCT03217786|Index of Microcirculatory Resistance|index of microcirculatory resistance
157021|NCT03217786|Fractional Flow Reserve|fractional flow reserve
157022|NCT03217786|Coronary Flow Reserve|coronary flow reserve
157023|NCT03217786|Positron Emission Tomography|positron emission tomography
157024|NCT03217786|Endomyocardial Biopsies|endomyocardial biopsies
157025|NCT03217760|Induced stress, dental anxiety, endodontic treatment, salivary cortisol, cardiovascular parameters, pain, discomfort.|induced stress, dental anxiety, endodontic treatment, salivary cortisol, cardiovascular parameters, pain, discomfort.
157026|NCT03217695|Heart rate variability|heart rate variability
157027|NCT03217695|Self-efficacy|self-efficacy
157028|NCT03217695|Pediatrics|pediatrics
157029|NCT03217695|Mindfulness-based yoga|mindfulness-based yoga
157030|NCT03217695|Symptoms|symptoms
157031|NCT03217682|Hospice|hospice
157032|NCT03217682|Palliative Care|palliative care
157033|NCT03217682|Integrative Medicine|integrative medicine
157034|NCT03217682|Massage Therapy|massage therapy
157035|NCT03217682|Music Therapy|music therapy
157036|NCT03217682|Caregivers|caregivers
157037|NCT03217669|epacadostat|epacadostat
157038|NCT03217669|sirolimus|sirolimus
157039|NCT03217617|SCID-X1|scid-x1
157040|NCT03217617|lentiviral vector|lentiviral vector
157041|NCT03217604|PF-06852231|pf-06852231
157042|NCT03217604|Safety|safety
157043|NCT03217604|Tolerability|tolerability
157044|NCT03217604|Pharmacokinetics|pharmacokinetics
157045|NCT03217604|First-in-human|first-in-human
157046|NCT03217604|Healthy subjects|healthy subjects
157047|NCT03217578|Spinal Muscular Atrophy|spinal muscular atrophy
157048|NCT03217578|Newborn Screening|newborn screening
157051|NCT03217526|Physical Function|physical function
157052|NCT03217513|osteoporosis|osteoporosis
157053|NCT03217513|osteoarthritis|osteoarthritis
157054|NCT03217513|knee|knee
157055|NCT03217422|Type 1, Type 2, autoimmune hepatitis, AIH,|type 1, type 2, autoimmune hepatitis, aih,
157056|NCT03217396|synaptic plasticity|synaptic plasticity
157057|NCT03217396|neuroinflammation|neuroinflammation
157058|NCT03217396|neurodegeneration|neurodegeneration
157059|NCT03217383|Oral appliance therapy|oral appliance therapy
157060|NCT03217383|mandibular protrusion|mandibular protrusion
157061|NCT03217370|patient blood management|patient blood management
157062|NCT03217370|restrictive transfusion|restrictive transfusion
157063|NCT03217357|tDCS, non invasive brain stimulation|tdcs, non invasive brain stimulation
157064|NCT03217318|ureteral stent|ureteral stent
157065|NCT03217305|EIT. NAVA. Endexpiratory Lung Impedance.|eit. nava. endexpiratory lung impedance.
157066|NCT03217279|stroke-participation|stroke-participation
157067|NCT03217279|restriction-needs-cohort-patients-caregivers|restriction-needs-cohort-patients-caregivers
157068|NCT03217201|Breast Cancer|breast cancer
157069|NCT03217201|Oncology|oncology
157070|NCT03217201|Circadian Rhythm|circadian rhythm
157071|NCT03217201|Light Therapy|light therapy
157072|NCT03217201|Chemotherapy side effects|chemotherapy side effects
157073|NCT03217188|Proton Re-Irradiation|proton re-irradiation
157074|NCT03217188|17-300|17-300
157075|NCT03217175|bionic pancreas|bionic pancreas
157076|NCT03217175|type 1 diabetes|type 1 diabetes
157077|NCT03217123|OCD, DBS, fMRI, Y-BOCS, tractography|ocd, dbs, fmri, y-bocs, tractography
157078|NCT03217110|Cerebellum|cerebellum
157079|NCT03217097|Neuroendocrine tumors|neuroendocrine tumors
157080|NCT03217097|Methylation MGMT status|methylation mgmt status
157081|NCT03217097|Alkylating agents|alkylating agents
157082|NCT03217097|Oxaliplatin|oxaliplatin
157083|NCT03217084|White spot lesion ,fluoride varnish|white spot lesion ,fluoride varnish
157084|NCT03217071|non small cell lung cancer, resectable|non small cell lung cancer, resectable
157085|NCT03217058|digital health|digital health
157086|NCT03217058|implementation|implementation
157087|NCT03217058|primary care|primary care
157088|NCT03217032|Hemophilia A|hemophilia a
157089|NCT03217032|factor VIII|factor viii
157090|NCT03217032|Gene therapy|gene therapy
157091|NCT03217032|lentiviral vector|lentiviral vector
157092|NCT03217019|Radial Artery|radial artery
157093|NCT03217019|Vascular Catheters|vascular catheters
157094|NCT03217006|coronary artery bypass surgery|coronary artery bypass surgery
157095|NCT03217006|multiple arterial graft|multiple arterial graft
157096|NCT03217006|radial artery graft|radial artery graft
157097|NCT03216993|feeding protocol|feeding protocol
157098|NCT03216980|cardiovascular disease|cardiovascular disease
157099|NCT03216980|vascular function|vascular function
157100|NCT03216980|PTSD|ptsd
157102|NCT03216941|Psychomotor agitation; Tranquilizing agents|psychomotor agitation; tranquilizing agents
157103|NCT03216928|Reverse Signaling|reverse signaling
157104|NCT03216928|Anti-TNF|anti-tnf
157105|NCT03216915|Heart Rhythm|heart rhythm
157106|NCT03216915|Fingolimod|fingolimod
157107|NCT03216915|autonomic nervous system|autonomic nervous system
157108|NCT03216915|Effects of Medicinal Substance|effects of medicinal substance
157109|NCT03216902|Glaucoma|glaucoma
157110|NCT03216889|Multiple Sclerosis|multiple sclerosis
157111|NCT03216837|Perinatal stroke|perinatal stroke
157112|NCT03216837|hemiplegia|hemiplegia
157113|NCT03216837|hemiplegic cerebral palsy|hemiplegic cerebral palsy
157114|NCT03216772|Gynecologic Surgery|gynecologic surgery
157115|NCT03216772|larscopy|larscopy
157116|NCT03216772|morcellation|morcellation
157117|NCT03216759|Comprehensive intestinal protection strategy|comprehensive intestinal protection strategy
157118|NCT03216759|Intestinal complications|intestinal complications
157119|NCT03216759|laparotomy|laparotomy
157120|NCT03216746|oral health|oral health
157121|NCT03216746|knowledge|knowledge
157122|NCT03216746|adolescent|adolescent
157123|NCT03216733|DES|des
157124|NCT03216733|Angina pectoris|angina pectoris
157125|NCT03216733|Stent|stent
157126|NCT03216720|Coronary artery bypass grafting|coronary artery bypass grafting
157127|NCT03216720|Miniaturized extracorporeal circulation|miniaturized extracorporeal circulation
157128|NCT03216720|Thrombin generation|thrombin generation
157129|NCT03216655|congenital cataract|congenital cataract
157130|NCT03216655|anxiety|anxiety
157131|NCT03216655|guardian|guardian
157132|NCT03216642|Dacryocystitis|dacryocystitis
157133|NCT03216642|Bacteriology|bacteriology
157134|NCT03216642|Microbial Sensitivity Tests|microbial sensitivity tests
157135|NCT03216629|Pain|pain
157136|NCT03216629|Empathy|empathy
157137|NCT03216629|Dressing change|dressing change
157138|NCT03216616|fatigue|fatigue
157139|NCT03216616|Inflammatory Rheumatism|inflammatory rheumatism
157140|NCT03216616|Coping|coping
157141|NCT03216616|self-efficacy|self-efficacy
157142|NCT03216603|Health literacy|health literacy
157143|NCT03216590|Shoulder Arthroscopy|shoulder arthroscopy
157144|NCT03216590|Soft Tissue Swelling|soft tissue swelling
157145|NCT03216590|Rotator Cuff Repair|rotator cuff repair
157146|NCT03216590|Shoulder Arthroscopy Complications|shoulder arthroscopy complications
157842|NCT03212092|Aggression|aggression
157147|NCT03216577|health-related quality of life|health-related quality of life
157148|NCT03216551|selective mediastinal lymphadenectomy|selective mediastinal lymphadenectomy
157149|NCT03216551|minimally invasive surgery|minimally invasive surgery
157150|NCT03216460|T1D, Omnipod|t1d, omnipod
157151|NCT03216447|adherence|adherence
157152|NCT03216447|conversion|conversion
157153|NCT03216447|advagraf|advagraf
157154|NCT03216447|prograf|prograf
157155|NCT03216434|post-traumatic stress disorder|post-traumatic stress disorder
157156|NCT03216434|dopamine|dopamine
157157|NCT03216434|biomarker|biomarker
157158|NCT03216421|DCIS|dcis
157159|NCT03216421|Intraoperative Radiation (IORT)|intraoperative radiation (iort)
157160|NCT03216421|Lumpectomy|lumpectomy
157161|NCT03216421|Breast Conserving Surgery|breast conserving surgery
157162|NCT03216382|High worry|high worry
157163|NCT03216382|Anxiety|anxiety
157164|NCT03216382|Attention Training Technique|attention training technique
157165|NCT03216382|Attention Control|attention control
157166|NCT03216382|Attention|attention
157167|NCT03216382|Mindfulness|mindfulness
157168|NCT03216382|Attention Bias|attention bias
157169|NCT03216382|Worry|worry
157170|NCT03216382|Pathological Worry|pathological worry
157171|NCT03216382|Anxiety Disorder|anxiety disorder
157172|NCT03216369|Arterial Spin Labeling|arterial spin labeling
157173|NCT03216369|MRI|mri
157174|NCT03216369|Perfusion|perfusion
157175|NCT03216369|Carotid artery stenting|carotid artery stenting
157176|NCT03216369|Carotid endarterectomy|carotid endarterectomy
157177|NCT03216330|Quantitative sensory test (QST)|quantitative sensory test (qst)
157178|NCT03216330|Deep dyspareunia|deep dyspareunia
157179|NCT03216330|Electronic Thimble Algometer|electronic thimble algometer
157180|NCT03216317|Hypertension|hypertension
157181|NCT03216317|Hypotension|hypotension
157182|NCT03216317|Cardiovascular system|cardiovascular system
157183|NCT03216278|healthy,|healthy,
157184|NCT03216278|fasted,|fasted,
157185|NCT03216278|fed|fed
157186|NCT03216226|Glucagon|glucagon
157187|NCT03216148|FET PET|fet pet
157188|NCT03216135|Microbiome|microbiome
157189|NCT03216109|Supportive Care|supportive care
157190|NCT03216109|Quality of Life|quality of life
157191|NCT03216083|colpocleisis|colpocleisis
157192|NCT03216083|vaginectomy|vaginectomy
157193|NCT03216083|tranexamic acid|tranexamic acid
157194|NCT03216070|Dasatinib|dasatinib
157195|NCT03216057|hypertriglyceridemia|hypertriglyceridemia
157196|NCT03216057|pediatric obesity|pediatric obesity
157197|NCT03216057|omega 3|omega 3
157198|NCT03216044|childbirth|childbirth
157199|NCT03216044|caesarean delivery|caesarean delivery
157200|NCT03216044|vaginal delivery|vaginal delivery
157201|NCT03216044|chronic pain|chronic pain
157202|NCT03216044|painful sexual intercourse|painful sexual intercourse
157203|NCT03216031|Falls prevention|falls prevention
157204|NCT03216031|Gardening|gardening
157205|NCT03216018|resilience|resilience
157206|NCT03216018|prevention program|prevention program
157207|NCT03216018|body-image|body-image
157208|NCT03216018|self-esteem|self-esteem
157209|NCT03215992|Diffuse Optical Tomography|diffuse optical tomography
157210|NCT03215966|bioequivalence|bioequivalence
157211|NCT03215953|offloading|offloading
157212|NCT03215953|plantar pressure|plantar pressure
157213|NCT03215953|Diabetic Foot Ulcer|diabetic foot ulcer
157214|NCT03215953|cast shoe|cast shoe
157215|NCT03215953|forefoot offloading shoe|forefoot offloading shoe
157216|NCT03215927|ILD|ild
157217|NCT03215914|Closed loop insulin delivery system|closed loop insulin delivery system
157218|NCT03215914|Insulin Pump|insulin pump
157219|NCT03215914|Glycemic control|glycemic control
157220|NCT03215914|Glucose Counterregulation|glucose counterregulation
157221|NCT03215901|Population-based survey|population-based survey
157222|NCT03215901|HIV treatment|hiv treatment
157223|NCT03215901|HIV testing|hiv testing
157224|NCT03215901|Survival expectations|survival expectations
157225|NCT03215901|Condom use|condom use
157226|NCT03215901|Life plans|life plans
157227|NCT03215901|South African young adults|south african young adults
157228|NCT03215862|Post-ERCP Acute Pancreatitis|post-ercp acute pancreatitis
157229|NCT03215862|Normal Saline|normal saline
157230|NCT03215862|Lactated Ringer's|lactated ringer's
157231|NCT03215823|Intubation|intubation
157232|NCT03215823|videolaryngoscope|videolaryngoscope
157233|NCT03215810|Stage IV|stage iv
157234|NCT03215810|NSCLC|nsclc
157235|NCT03215810|Recurrent|recurrent
157236|NCT03215810|TIL|til
157237|NCT03215810|Tumor-infiltrating Lymphocyte Therapy (TIL)|tumor-infiltrating lymphocyte therapy (til)
157238|NCT03215797|svv|svv
157239|NCT03215797|norepinephrine|norepinephrine
157240|NCT03215797|phenylephrine|phenylephrine
157241|NCT03215797|elderly|elderly
157242|NCT03215784|obesity|obesity
157243|NCT03215784|placenta|placenta
157244|NCT03215784|inflammation|inflammation
157245|NCT03215784|fish oil|fish oil
157246|NCT03215784|probiotics|probiotics
157247|NCT03215758|QAW039, uncontrolled asthma|qaw039, uncontrolled asthma
157248|NCT03215745|Delirium|delirium
157249|NCT03215745|Critical Care|critical care
157250|NCT03215745|Prevention & control|prevention & control
157251|NCT03215745|Clinical Trial|clinical trial
157252|NCT03215732|prevalence|prevalence
157253|NCT03215732|vaccine coverage|vaccine coverage
157254|NCT03215732|risk factors|risk factors
157255|NCT03215732|morbidity|morbidity
157256|NCT03215732|mortality|mortality
157257|NCT03215732|quality of life|quality of life
157258|NCT03215732|economic vulnerability|economic vulnerability
157259|NCT03215732|food security|food security
157260|NCT03215732|treatment needs|treatment needs
157261|NCT03215732|decentralized care|decentralized care
157262|NCT03215732|health costs|health costs
157263|NCT03215732|caregivers training|caregivers training
157264|NCT03215719|Radiation Therapy|radiation therapy
157265|NCT03215680|Urinary iodine concentration|urinary iodine concentration
157266|NCT03215654|mental health|mental health
157267|NCT03215654|promotion|promotion
157268|NCT03215654|prevention|prevention
157269|NCT03215654|adolescence|adolescence
157270|NCT03215654|school programs|school programs
157271|NCT03215654|intervention|intervention
157272|NCT03215641|obesity|obesity
157273|NCT03215641|pediatrics|pediatrics
157274|NCT03215641|weight management program|weight management program
157275|NCT03215641|Fitbit|fitbit
157276|NCT03215641|personal activity tracker|personal activity tracker
157277|NCT03215628|CEUS|ceus
157278|NCT03215628|TCEUS|tceus
157279|NCT03215628|contrast enhanced ultrasound|contrast enhanced ultrasound
157280|NCT03215628|perfusion|perfusion
157281|NCT03215628|cerebral perfusion|cerebral perfusion
157282|NCT03215628|sulphur hexafluoride|sulphur hexafluoride
157283|NCT03215628|SonoVue|sonovue
157284|NCT03215602|knee|knee
157285|NCT03215602|osteoarthritis|osteoarthritis
157286|NCT03215602|exercise|exercise
157287|NCT03215602|quadriceps|quadriceps
157288|NCT03215602|strength|strength
157289|NCT03215602|activities of daily living|activities of daily living
157290|NCT03215602|treatment outcome|treatment outcome
157291|NCT03215589|Near-infrared spectroscopy-derived cerebral oximetry|near-infrared spectroscopy-derived cerebral oximetry
157292|NCT03215563|atherosclerosis, imaging|atherosclerosis, imaging
157293|NCT03215550|atherosclerosis, imaging|atherosclerosis, imaging
157294|NCT03215537|physical activity|physical activity
157295|NCT03215537|cardiopulmonary function|cardiopulmonary function
157296|NCT03215537|quality of life|quality of life
157297|NCT03215537|Perioperative management|perioperative management
157298|NCT03215537|comprehensive intervention|comprehensive intervention
157299|NCT03215537|health behavior model|health behavior model
157300|NCT03215511|Solid Tumor|solid tumor
157301|NCT03215511|Metastatic cancer|metastatic cancer
157302|NCT03215511|Advanced cancer|advanced cancer
157303|NCT03215511|Neurotrophic tyrosine receptor kinase (NTRK)|neurotrophic tyrosine receptor kinase (ntrk)
157304|NCT03215511|NTRK1|ntrk1
157305|NCT03215511|NTRK2|ntrk2
157306|NCT03215511|NTRK3|ntrk3
157307|NCT03215511|Fusion Positive|fusion positive
157308|NCT03215511|Children|children
157309|NCT03215485|adolescent|adolescent
157310|NCT03215485|sports|sports
157311|NCT03215485|nutrition|nutrition
157312|NCT03215485|physical activity|physical activity
157313|NCT03215485|body mass index|body mass index
157314|NCT03215485|virtual world|virtual world
157315|NCT03215459|Cardiopulmonary Exercise Testing|cardiopulmonary exercise testing
157316|NCT03215394|Social ABCs|social abcs
157317|NCT03215394|autism|autism
157318|NCT03215394|autism spectrum disorder|autism spectrum disorder
157319|NCT03215394|Early Intervention|early intervention
157320|NCT03215394|Toddler|toddler
157321|NCT03215394|Early Identification|early identification
157322|NCT03215394|Pivotal Response Treatment|pivotal response treatment
157323|NCT03215394|ASD|asd
157324|NCT03215394|PRT|prt
157325|NCT03215394|Control Group|control group
157326|NCT03215394|treatment Group|treatment group
157327|NCT03215394|At Risk|at risk
157328|NCT03215394|Social Communication|social communication
157329|NCT03215394|Positive Affect|positive affect
157330|NCT03215394|Smiling|smiling
157331|NCT03215394|Social Orienting|social orienting
157332|NCT03215394|Attentional Control|attentional control
157333|NCT03215394|Attentional Disengagement|attentional disengagement
157334|NCT03215394|Naturalistic Developmental Behaviour Intervention|naturalistic developmental behaviour intervention
157335|NCT03215394|NDBI|ndbi
157336|NCT03215381|Healthy Volunteer Male Subjects|healthy volunteer male subjects
157337|NCT03215355|Adaptive radiotherapy|adaptive radiotherapy
157338|NCT03215355|Contrast media|contrast media
157339|NCT03215355|Cone-beam computed tomography|cone-beam computed tomography
157340|NCT03215355|Stereotactic body radiation therapy|stereotactic body radiation therapy
157341|NCT03215342|Child|child
157342|NCT03215342|Rehabilitation|rehabilitation
157343|NCT03215342|Psychotherapy, groups|psychotherapy, groups
157344|NCT03215303|Asthma|asthma
157345|NCT03215303|Continuous positive airway pressure|continuous positive airway pressure
157346|NCT03215303|Oxygen consumption|oxygen consumption
157347|NCT03215277|Ankylosing Spondylitis|ankylosing spondylitis
157348|NCT03215277|Bimekizumab|bimekizumab
157349|NCT03215277|AS|as
157350|NCT03215277|Certolizumab Pegol|certolizumab pegol
157351|NCT03215277|Cimzia|cimzia
157352|NCT03215251|Thirst, Dry Mouth, Intervention Bundle|thirst, dry mouth, intervention bundle
157353|NCT03215225|Endodontology|endodontology
157354|NCT03215225|Endodontics|endodontics
157355|NCT03215212|ear plug|ear plug
157356|NCT03215212|eye mask|eye mask
157357|NCT03215212|ocean sound|ocean sound
157358|NCT03215212|sleep quality|sleep quality
157359|NCT03215212|intensive care unit|intensive care unit
157360|NCT03215186|congenital cataract|congenital cataract
157361|NCT03215186|risk factor|risk factor
157362|NCT03215186|mathematic model|mathematic model
157363|NCT03215160|Mobilization|mobilization
157364|NCT03215160|Manual Therapies|manual therapies
157365|NCT03215160|Exercise|exercise
157366|NCT03215147|Idiopathic Pulmonary Fibrosis|idiopathic pulmonary fibrosis
157367|NCT03215147|Airway Disease|airway disease
157368|NCT03215134|Improving Access to Psychological Therapies (IAPT)|improving access to psychological therapies (iapt)
157369|NCT03215134|Primary mental health service|primary mental health service
157370|NCT03215134|Compassion Focused Therapy (CFT)|compassion focused therapy (cft)
157371|NCT03215095|Radioiodine (RAI)|radioiodine (rai)
157372|NCT03215095|Durvalumab (Medi4736)|durvalumab (medi4736)
157373|NCT03215095|RAI-avid|rai-avid
157374|NCT03215095|17-218|17-218
157375|NCT03215069|gestational diabetes, SGLT-2 inhibitor, empagliflozin|gestational diabetes, sglt-2 inhibitor, empagliflozin
157376|NCT03215043|Eriocitrin|eriocitrin
157377|NCT03215043|Intermediate hyperglycemia|intermediate hyperglycemia
157378|NCT03215043|Citrus bioflavonoids|citrus bioflavonoids
157379|NCT03215030|Drug Therapy|drug therapy
157380|NCT03215004|Volunteer|volunteer
157381|NCT03215004|HIV|hiv
157382|NCT03215004|Leukapheresis|leukapheresis
157383|NCT03214978|thyroid|thyroid
157384|NCT03214965|Kidney transplantation|kidney transplantation
157385|NCT03214965|Facebook|facebook
157386|NCT03214965|Education|education
157387|NCT03214965|Adolescent|adolescent
157388|NCT03214965|Social Networking|social networking
157389|NCT03214939|dendritic cell, IL-12, IL-18, cytotoxicity|dendritic cell, il-12, il-18, cytotoxicity
157390|NCT03214926|Parkinson's disease|parkinson's disease
157391|NCT03214926|Dance|dance
157392|NCT03214926|Google Glass|google glass
157393|NCT03214926|Mobility|mobility
157394|NCT03214926|Balance|balance
157395|NCT03214913|resuscitation|resuscitation
157396|NCT03214913|fluid therapy|fluid therapy
157397|NCT03214887|Hyaluronan|hyaluronan
157398|NCT03214887|Bone marrow mononuclear cells|bone marrow mononuclear cells
157399|NCT03214848|Long-acting reversible contraceptive|long-acting reversible contraceptive
157400|NCT03214848|Post Abortion|post abortion
157401|NCT03214848|Iintrauterine device|iintrauterine device
157402|NCT03214848|Contraceptive implant|contraceptive implant
157403|NCT03214848|LARC|larc
157404|NCT03214848|IUD|iud
157405|NCT03214835|Larynx|larynx
157406|NCT03214835|reflux|reflux
157407|NCT03214835|LPR|lpr
157408|NCT03214835|tumor|tumor
157409|NCT03214835|lesion|lesion
157410|NCT03214822|Microbiome|microbiome
157411|NCT03214809|ultrasound|ultrasound
157412|NCT03214809|MET team|met team
157413|NCT03214809|Concordance|concordance
157414|NCT03214783|artificial intelligence|artificial intelligence
157415|NCT03214783|facial recognition|facial recognition
157416|NCT03214783|facial characteristic|facial characteristic
157417|NCT03214731|artesunate|artesunate
157418|NCT03214705|CT perfusion|ct perfusion
157419|NCT03214705|Subarachnoid hemorrhage|subarachnoid hemorrhage
157420|NCT03214705|Vasospasm|vasospasm
157421|NCT03214705|Delayed cerebral ischemia|delayed cerebral ischemia
157422|NCT03214692|Gum Arabic|gum arabic
157423|NCT03214692|Renal failure|renal failure
157424|NCT03214692|Hemodialysis|hemodialysis
157425|NCT03214692|Antioxidant and anti-inflammatory|antioxidant and anti-inflammatory
157426|NCT03214679|Hepatitis C|hepatitis c
157427|NCT03214679|HCV|hcv
157428|NCT03214679|People who inject drugs|people who inject drugs
157429|NCT03214666|MDS|mds
157430|NCT03214666|AML|aml
157431|NCT03214640|neuraxial analgesia|neuraxial analgesia
157432|NCT03214640|spinal block|spinal block
157433|NCT03214640|epidural block|epidural block
157434|NCT03214588|Drug Therapy|drug therapy
157435|NCT03214575|Central Venous Vascular Access|central venous vascular access
157436|NCT03214575|Intensive Care Unit|intensive care unit
157437|NCT03214575|Needle Navigation Technology|needle navigation technology
157438|NCT03214536|spine surgery|spine surgery
157439|NCT03214536|regional anaesthesia|regional anaesthesia
157440|NCT03214536|opioid consumption|opioid consumption
157441|NCT03214536|acute postoperative pain|acute postoperative pain
157442|NCT03214523|sleep|sleep
157443|NCT03214523|actigraphy|actigraphy
157444|NCT03214497|laryngeal mask|laryngeal mask
157445|NCT03214497|Supreme|supreme
157446|NCT03214497|Protector|protector
157447|NCT03214471|bariatric surgery|bariatric surgery
157448|NCT03214471|healthy lifestyle|healthy lifestyle
157449|NCT03214458|Therapy|therapy
157450|NCT03214458|Noninvasive Ventilation|noninvasive ventilation
157451|NCT03214432|Mild traumatic brain injury|mild traumatic brain injury
157452|NCT03214432|Concussion|concussion
157453|NCT03214432|Labour market affiliation|labour market affiliation
157454|NCT03214432|Return to work|return to work
157455|NCT03214432|Sickness absence|sickness absence
157456|NCT03214432|Long-term sickness absence|long-term sickness absence
157457|NCT03214432|Disability pension|disability pension
157458|NCT03214419|Breast cancer|breast cancer
157459|NCT03214419|3D Optical scanning|3d optical scanning
157460|NCT03214419|Preoperative MRI|preoperative mri
157461|NCT03214419|Tumor localization|tumor localization
157462|NCT03214354|sickle cell disease|sickle cell disease
157463|NCT03214354|stem cell transplant|stem cell transplant
157464|NCT03214354|red blood cell engraftment|red blood cell engraftment
157465|NCT03214354|nonmyeloablative|nonmyeloablative
157466|NCT03214354|pure red cell aplasia|pure red cell aplasia
157467|NCT03214341|mediastinal masses|mediastinal masses
157468|NCT03214341|MRI diffusion|mri diffusion
157469|NCT03214315|Prostatectomy|prostatectomy
157470|NCT03214302|antiviral treatment|antiviral treatment
157471|NCT03214302|hepatitis B virus|hepatitis b virus
157472|NCT03214302|pregnant woman|pregnant woman
157473|NCT03214302|Postpartum hepatitis|postpartum hepatitis
157474|NCT03214289|Fecal Microbiota Transplantation|fecal microbiota transplantation
157475|NCT03214289|Intestinal Acute Graft Versus Host Disease|intestinal acute graft versus host disease
157476|NCT03214289|Hematopoietic Stem Cell Transplantation|hematopoietic stem cell transplantation
157477|NCT03214276|polyphenols|polyphenols
157478|NCT03214276|cycling|cycling
157479|NCT03214276|endurance|endurance
157480|NCT03214276|aerobic|aerobic
157481|NCT03214276|pain|pain
157482|NCT03214263|Inflammatory rheumatic diseases|inflammatory rheumatic diseases
157483|NCT03214263|Biomarkers|biomarkers
157484|NCT03214263|Tailored treatment|tailored treatment
157485|NCT03214263|Personalised medicine|personalised medicine
157486|NCT03214263|DANBIO|danbio
157487|NCT03214263|Danish Rheumatologic Biobank|danish rheumatologic biobank
157488|NCT03214263|clinical data|clinical data
157489|NCT03214250|Nivolumab|nivolumab
157490|NCT03214250|APX005M|apx005m
157491|NCT03214250|previously untreated metastatic pancreatic adenocarcinoma|previously untreated metastatic pancreatic adenocarcinoma
157492|NCT03214250|Gemcitabine|gemcitabine
157493|NCT03214250|nab-Paclitaxel|nab-paclitaxel
157494|NCT03214224|Telemedicine|telemedicine
157495|NCT03214224|Pulmonary Function Testing|pulmonary function testing
157496|NCT03214224|Telehealth|telehealth
157497|NCT03214185|unexplained recurrent pregnancy loss|unexplained recurrent pregnancy loss
157498|NCT03214185|infertility, female|infertility, female
157499|NCT03214185|preimplantation genetic screening|preimplantation genetic screening
157500|NCT03214185|in vitro fertilization|in vitro fertilization
157501|NCT03214185|intracytoplasmic sperm injection|intracytoplasmic sperm injection
157502|NCT03214146|ALS|als
157503|NCT03214146|Motor Neuron Disease|motor neuron disease
157504|NCT03214146|Neuromuscular Disease|neuromuscular disease
157505|NCT03214146|Neurodegenerative Disease|neurodegenerative disease
157506|NCT03214146|Central Nervous System Disease|central nervous system disease
400592|NCT01866098|severe mental illness|severe mental illness
157507|NCT03214146|HLA-haplo matched allogenic bone marrow derived stem cells|hla-haplo matched allogenic bone marrow derived stem cells
157508|NCT03214120|thromboelastography, modified ultrafiltration|thromboelastography, modified ultrafiltration
157509|NCT03214107|Exercise|exercise
157510|NCT03214107|Hypoglycemia|hypoglycemia
157511|NCT03214107|Carbohydrates|carbohydrates
157512|NCT03214029|troponin|troponin
157513|NCT03214029|high-sensitivity cardiac troponin|high-sensitivity cardiac troponin
157514|NCT03214029|acute myocardial infarction|acute myocardial infarction
157515|NCT03214016|Pilates Training|pilates training
157516|NCT03214016|Aerobic Exercises|aerobic exercises
157517|NCT03214016|Hypertension|hypertension
157518|NCT03214016|Clinical trial|clinical trial
157519|NCT03214003|small cell lung cancer limited stage|small cell lung cancer limited stage
157520|NCT03214003|twice-daily radiotherapy|twice-daily radiotherapy
157521|NCT03214003|simultaneous integrated boosting technique|simultaneous integrated boosting technique
157522|NCT03213990|Sepsis|sepsis
157523|NCT03213990|Beta-lactam antibiotics|beta-lactam antibiotics
157524|NCT03213977|DLBCL, R-DA-EPOCH, R-CEOP90, auto-HSCT|dlbcl, r-da-epoch, r-ceop90, auto-hsct
157525|NCT03213964|Recurrent|recurrent
157526|NCT03213964|Platinum Resistant|platinum resistant
157527|NCT03213964|Platinum Sensitive|platinum sensitive
157528|NCT03213951|Surgical resection|surgical resection
157529|NCT03213951|Margins of resection|margins of resection
157530|NCT03213951|Beta radiopharmaceutical|beta radiopharmaceutical
157531|NCT03213951|Beta probe device|beta probe device
157532|NCT03213951|Ex-vivo|ex-vivo
157533|NCT03213938|Chronic prostatitis|chronic prostatitis
157534|NCT03213938|chronic pelvic pain syndrome|chronic pelvic pain syndrome
157535|NCT03213938|acupuncture|acupuncture
157536|NCT03213938|randomized controlled trial|randomized controlled trial
157537|NCT03213912|effective concentration|effective concentration
157538|NCT03213899|Subjective Global Assessment|subjective global assessment
157539|NCT03213899|Nutritional Status|nutritional status
157540|NCT03213899|Hospital Mortality|hospital mortality
157541|NCT03213899|Length of Stay|length of stay
157542|NCT03213899|Malnutrition|malnutrition
157543|NCT03213886|hip fracture|hip fracture
157544|NCT03213886|elderly|elderly
157545|NCT03213886|vitamin D|vitamin d
157546|NCT03213886|rehabilitation|rehabilitation
157547|NCT03213873|Balance control|balance control
157548|NCT03213873|Exercise|exercise
157549|NCT03213873|Magnetic Resonance Imaging|magnetic resonance imaging
157550|NCT03213873|Functional Magnetic Resonance Imaging|functional magnetic resonance imaging
157551|NCT03213847|Carpal Tunnel Syndrome|carpal tunnel syndrome
157552|NCT03213847|Superb microvascular imaging|superb microvascular imaging
157553|NCT03213847|Doppler ultrasound|doppler ultrasound
157554|NCT03213847|Ultrasound|ultrasound
157555|NCT03213847|Median Nerve Entrapment|median nerve entrapment
157556|NCT03213847|Diagnoses Disease|diagnoses disease
157557|NCT03213808|Allergic diseases|allergic diseases
157558|NCT03213808|hypersensitivity|hypersensitivity
157559|NCT03213808|International Classification of Diseases (ICD)|international classification of diseases (icd)
157560|NCT03213808|World Health Organization (WHO)|world health organization (who)
157561|NCT03213782|Nature Based Sounds|nature based sounds
157562|NCT03213782|Agitation|agitation
157564|NCT03213782|Patients|patients
157565|NCT03213782|Intensive Care Units|intensive care units
157566|NCT03213769|oral minor aphthous ulcer|oral minor aphthous ulcer
157567|NCT03213769|topical Q10 gel|topical q10 gel
157568|NCT03213769|topical antioxidant|topical antioxidant
157569|NCT03213769|oral recurrent aphthous ulcer|oral recurrent aphthous ulcer
157570|NCT03213769|oral aphthous stomatitis|oral aphthous stomatitis
157571|NCT03213756|doppler ultrasound|doppler ultrasound
157572|NCT03213756|physical exercise|physical exercise
157573|NCT03213756|arteriovenous fistula maturation|arteriovenous fistula maturation
157574|NCT03213717|Obesity|obesity
157575|NCT03213717|Loading|loading
157576|NCT03213717|Edema|edema
157577|NCT03213717|Urine|urine
157578|NCT03213613|Teen health|teen health
157579|NCT03213613|Teen development|teen development
157580|NCT03213613|Adolescent development|adolescent development
157581|NCT03213613|Memory|memory
157582|NCT03213613|Attention|attention
157583|NCT03213613|Reward processing|reward processing
157584|NCT03213574|Goal directed fluid therapy|goal directed fluid therapy
157585|NCT03213548|alar base reduction|alar base reduction
157586|NCT03213548|alar facial groove|alar facial groove
157587|NCT03213548|alectomy|alectomy
157588|NCT03213548|Flare|flare
157589|NCT03213548|Nose|nose
157590|NCT03213535|PROM|prom
157591|NCT03213496|clinical trial, non cardiac surgery, walking.|clinical trial, non cardiac surgery, walking.
157592|NCT03213483|gingival recession|gingival recession
157593|NCT03213483|connective tissue graft|connective tissue graft
157594|NCT03213483|deepithelialized free gingival graft|deepithelialized free gingival graft
157595|NCT03213483|free gingival graft|free gingival graft
157596|NCT03213457|Elagolix|elagolix
157597|NCT03213457|Endometriosis associated pain|endometriosis associated pain
157598|NCT03213457|Dysmenorrhea (DYS)|dysmenorrhea (dys)
400593|NCT01866098|weight loss|weight loss
201348|NCT02936713|gas|gas
157599|NCT03213457|Non-menstrual pelvic pain (NMPP)|non-menstrual pelvic pain (nmpp)
157600|NCT03213444|Colon cancer|colon cancer
157601|NCT03213444|adjuvant chemotherapy|adjuvant chemotherapy
157602|NCT03213444|sympathetic nerve activity|sympathetic nerve activity
157603|NCT03213444|peripheral vascular function|peripheral vascular function
157604|NCT03213431|Cancer survivors|cancer survivors
157605|NCT03213431|Instrument development|instrument development
157606|NCT03213431|Neurocognitive functioning|neurocognitive functioning
157607|NCT03213431|Patient-reported outcomes|patient-reported outcomes
157608|NCT03213431|Qualitative interview|qualitative interview
157609|NCT03213418|tobacco|tobacco
157610|NCT03213418|smoking|smoking
157611|NCT03213418|Tobacco Use|tobacco use
157612|NCT03213418|Tobacco Dependence|tobacco dependence
157613|NCT03213418|Smoking, Tobacco|smoking, tobacco
157614|NCT03213418|Cigarette Smoking|cigarette smoking
157615|NCT03213418|Cigarette|cigarette
157616|NCT03213418|Nicotine|nicotine
157617|NCT03213405|human Respiratory Syncytial Virus|human respiratory syncytial virus
157618|NCT03213405|Phase I|phase i
157619|NCT03213405|Recombinant BCG vaccine|recombinant bcg vaccine
157620|NCT03213379|actimeter|actimeter
157621|NCT03213379|apomorphin pump|apomorphin pump
157622|NCT03213366|PrEP|prep
157623|NCT03213366|HIV prevention|hiv prevention
157624|NCT03213366|Public Health Social Media Campaign|public health social media campaign
157625|NCT03213366|Peer Intervention|peer intervention
157626|NCT03213327|mental health|mental health
157627|NCT03213327|assessment|assessment
157628|NCT03213327|health promotion|health promotion
157629|NCT03213327|case management|case management
157630|NCT03213327|health insurance|health insurance
157631|NCT03213314|LiverMultiScan|livermultiscan
157632|NCT03213314|multiparameter MRI|multiparameter mri
157633|NCT03213314|functional liver remnant|functional liver remnant
157634|NCT03213314|liver resection|liver resection
157635|NCT03213314|hepatic resection|hepatic resection
157636|NCT03213314|portal vein embolisation|portal vein embolisation
157637|NCT03213314|preoperative liver function|preoperative liver function
157638|NCT03213314|postoperative liver failure|postoperative liver failure
157639|NCT03213301|Progressive Malignant Pleural Mesothelioma|progressive malignant pleural mesothelioma
157640|NCT03213301|Lurbinectedin|lurbinectedin
157641|NCT03213301|Mesothelioma|mesothelioma
157642|NCT03213301|Phase II Trial|phase ii trial
157643|NCT03213275|Extremely premature infants|extremely premature infants
157644|NCT03213275|gut-immune-brain axis|gut-immune-brain axis
157645|NCT03213275|neonatal brain injury|neonatal brain injury
157646|NCT03213275|gut microbiome|gut microbiome
157647|NCT03213275|neurodevelopmental outcome|neurodevelopmental outcome
157648|NCT03213275|neonatal immunity|neonatal immunity
157649|NCT03213223|retention|retention
157650|NCT03213223|attrition|attrition
157651|NCT03213223|PMTCT|pmtct
157652|NCT03213223|elimination of mother to child transmission of HIV|elimination of mother to child transmission of hiv
157653|NCT03213184|Birth cohort|birth cohort
157654|NCT03213184|asthma|asthma
157655|NCT03213184|allergies|allergies
157656|NCT03213171|organ donation|organ donation
157657|NCT03213171|family physician|family physician
157658|NCT03213171|primary care|primary care
157659|NCT03213171|clinical trial|clinical trial
157660|NCT03213171|registry trial|registry trial
157661|NCT03213171|cluster trial|cluster trial
157662|NCT03213171|stepped-wedge|stepped-wedge
157663|NCT03213145|drug-drug interaction|drug-drug interaction
157664|NCT03213132|sleep|sleep
157665|NCT03213132|insomnia|insomnia
157666|NCT03213132|CBT|cbt
157667|NCT03213119|Caloric Vestibular Stimulation Reward|caloric vestibular stimulation reward
157668|NCT03213119|Brain Stimulation|brain stimulation
157669|NCT03213119|Reward|reward
157670|NCT03213119|Vestibular System|vestibular system
157671|NCT03213119|Cingulate Cortex|cingulate cortex
157672|NCT03213119|Cancellation Tasks|cancellation tasks
157673|NCT03213106|TMS|tms
157674|NCT03213106|Transcranial Magnetic Stimulation|transcranial magnetic stimulation
157675|NCT03213106|Cerebellar Ataxia|cerebellar ataxia
157676|NCT03213093|Diabetes|diabetes
157677|NCT03213093|Diabetic Foot Ulcer|diabetic foot ulcer
157678|NCT03213093|Plantar pressure|plantar pressure
157679|NCT03213080|Targeted Lung Denervation|targeted lung denervation
157680|NCT03213080|TLD|tld
157681|NCT03213054|esophageal cancer|esophageal cancer
157682|NCT03213054|OBP-301|obp-301
157683|NCT03213054|radiation|radiation
157684|NCT03213054|Telomelysin|telomelysin
157685|NCT03213054|radiotherapy|radiotherapy
157686|NCT03213054|oncolytic|oncolytic
157687|NCT03213054|virotherapy|virotherapy
157688|NCT03213054|loco regional|loco regional
157689|NCT03213015|confiability|confiability
157690|NCT03213015|ankle|ankle
157691|NCT03213015|patellofemoral pain syndrome|patellofemoral pain syndrome
157692|NCT03212989|HIV|hiv
157693|NCT03212989|HXTC|hxtc
157694|NCT03212989|Antiretroviral Therapy|antiretroviral therapy
157695|NCT03212989|HIV-Infected|hiv-infected
157696|NCT03212989|Vorinostat|vorinostat
157697|NCT03212989|AIDS|aids
157698|NCT03212976|Non-Invasive|non-invasive
157699|NCT03212976|Magnetic Resonance Imaging|magnetic resonance imaging
157700|NCT03212976|Ventricular catheters|ventricular catheters
157701|NCT03212924|cochlear implant|cochlear implant
157702|NCT03212924|Listening effort|listening effort
157703|NCT03212924|pupillometry|pupillometry
157704|NCT03212911|HBV vaccination, HIV, isolated anti-HBc|hbv vaccination, hiv, isolated anti-hbc
157705|NCT03212898|pharmacist interventions, warfarin, elderly rural patients|pharmacist interventions, warfarin, elderly rural patients
157706|NCT03212885|Deep Brain Stimulation|deep brain stimulation
157707|NCT03212872|Ammonia|ammonia
157708|NCT03212872|bleeding risk factors|bleeding risk factors
157709|NCT03212872|endoscopic risk signs for bleeding|endoscopic risk signs for bleeding
157710|NCT03212872|esophageal varices|esophageal varices
157711|NCT03212859|older adults|older adults
157712|NCT03212859|physiotherapy|physiotherapy
157713|NCT03212859|physical activity|physical activity
157714|NCT03212846|hippotherapy|hippotherapy
157715|NCT03212846|cerebral palsy|cerebral palsy
157716|NCT03212846|spasticity|spasticity
157717|NCT03212807|Checkpoint inhibition|checkpoint inhibition
157718|NCT03212807|PDL1|pdl1
157719|NCT03212807|EBV DLBCL|ebv dlbcl
157720|NCT03212807|PCNSL|pcnsl
157721|NCT03212716|Infectiology|infectiology
157722|NCT03212716|Biology of infectious agents|biology of infectious agents
157723|NCT03212716|Flu|flu
157724|NCT03212716|Intensive care|intensive care
157725|NCT03212703|Mindfulness training|mindfulness training
157726|NCT03212703|Parents and families|parents and families
157727|NCT03212703|Pediatric OCD|pediatric ocd
157728|NCT03212690|mechanical ventilation|mechanical ventilation
157729|NCT03212690|echocardiography|echocardiography
157730|NCT03212690|right ventricular function|right ventricular function
157731|NCT03212690|Ang (1-7)|ang (1-7)
157732|NCT03212690|Ang II|ang ii
157733|NCT03212690|Renin-angiotensin system|renin-angiotensin system
157734|NCT03212625|Urea Cream|urea cream
157735|NCT03212625|Sorafenib|sorafenib
157736|NCT03212612|Galectin-3 ,endometrosis|galectin-3 ,endometrosis
157737|NCT03212599|APP-processing|app-processing
157738|NCT03212599|Disulfiram|disulfiram
157739|NCT03212599|ADAM10|adam10
157740|NCT03212599|Alzheimer's disease|alzheimer's disease
157741|NCT03212599|blood|blood
157742|NCT03212560|Exercise capacity|exercise capacity
157743|NCT03212560|Physical activity|physical activity
157744|NCT03212560|Quality of life|quality of life
157745|NCT03212560|Pulmonary functions|pulmonary functions
157746|NCT03212560|Muscle strength|muscle strength
157747|NCT03212560|Respiratory muscle strength|respiratory muscle strength
157748|NCT03212560|Respiratory muscle endurance|respiratory muscle endurance
157749|NCT03212560|Dyspnea|dyspnea
157750|NCT03212560|Anxiety|anxiety
157751|NCT03212560|Fatigue|fatigue
157752|NCT03212547|ADBB|adbb
157753|NCT03212547|social withdrawal behavior|social withdrawal behavior
157754|NCT03212547|preterm|preterm
157755|NCT03212547|posttraumatic stress|posttraumatic stress
157756|NCT03212547|postpartum depression|postpartum depression
157757|NCT03212547|early detection|early detection
157758|NCT03212547|interactional guidance|interactional guidance
157759|NCT03212547|synchronization within parent infant interaction|synchronization within parent infant interaction
157760|NCT03212534|Dascena|dascena
157761|NCT03212534|patient mortality|patient mortality
157762|NCT03212534|machine learning|machine learning
157763|NCT03212534|algorithm|algorithm
157764|NCT03212534|diagnostic|diagnostic
157765|NCT03212521|chronic hepatitis C virus (HCV)|chronic hepatitis c virus (hcv)
157766|NCT03212521|Hepatitis|hepatitis
157767|NCT03212521|HCV genotype|hcv genotype
157768|NCT03212521|aspartate aminotransferase|aspartate aminotransferase
157769|NCT03212521|platelet|platelet
157770|NCT03212521|Aspartate aminotransferase to Platelet Ratio Index (APRI)|aspartate aminotransferase to platelet ratio index (apri)
157771|NCT03212521|glecaprevir|glecaprevir
157772|NCT03212521|pibrentasvir|pibrentasvir
157773|NCT03212521|Sustained Virologic Response 12 weeks post dosing (SVR12)|sustained virologic response 12 weeks post dosing (svr12)
157774|NCT03212508|Continuous positive airway pressure, preterm|continuous positive airway pressure, preterm
157775|NCT03212495|knee arthroscopy|knee arthroscopy
157776|NCT03212495|dexmedetomidine|dexmedetomidine
157777|NCT03212495|neostigmine|neostigmine
157778|NCT03212482|brain-injured patients, patient-ventilator asychrony|brain-injured patients, patient-ventilator asychrony
157779|NCT03212456|general anesthesia|general anesthesia
157780|NCT03212456|cancer recurrence|cancer recurrence
157781|NCT03212456|opioids analgesics|opioids analgesics
157782|NCT03212456|neoplasm|neoplasm
157783|NCT03212430|L-kynurenine|l-kynurenine
157784|NCT03212430|Cerebral hemodynamic|cerebral hemodynamic
157785|NCT03212430|Headache|headache
157786|NCT03212430|Mohammad Al-Mahdi Al-Karagholi|mohammad al-mahdi al-karagholi
157787|NCT03212404|Cancer|cancer
157788|NCT03212404|PD-L1|pd-l1
157789|NCT03212404|PDL1|pdl1
157790|NCT03212404|PD-1|pd-1
157791|NCT03212404|PD1|pd1
201593|NCT02935088|FFR|ffr
157792|NCT03212404|Solid tumors|solid tumors
157793|NCT03212404|Anti PD-L1|anti pd-l1
157794|NCT03212404|MSI-High|msi-high
157795|NCT03212404|Endometrial|endometrial
157796|NCT03212404|Non-small cell lung cancer, NSCLC|non-small cell lung cancer, nsclc
157797|NCT03212404|CK-301|ck-301
157798|NCT03212352|miscarriage|miscarriage
157799|NCT03212352|mifepristone|mifepristone
157800|NCT03212352|misoprostol|misoprostol
157801|NCT03212352|medical treatment|medical treatment
157802|NCT03212352|patient satisfaction|patient satisfaction
157803|NCT03212352|abortifacient agents|abortifacient agents
157804|NCT03212339|parent-child interactions|parent-child interactions
157805|NCT03212339|mental health care|mental health care
157806|NCT03212339|child health services|child health services
157807|NCT03212339|parenting confidence|parenting confidence
157808|NCT03212339|adverse childhood events|adverse childhood events
157809|NCT03212339|dyadic care model|dyadic care model
157810|NCT03212313|Adults|adults
157811|NCT03212313|Liver Disease|liver disease
157812|NCT03212300|aerobic exercise training|aerobic exercise training
157813|NCT03212300|delirium|delirium
157814|NCT03212261|Lymphoma|lymphoma
157815|NCT03212222|screening|screening
157816|NCT03212222|cell phone application|cell phone application
157817|NCT03212209|Sleep Apnea|sleep apnea
157818|NCT03212209|CPAP|cpap
157819|NCT03212196|Pancreaticoduodenectomy|pancreaticoduodenectomy
157820|NCT03212196|Pancreaticogastrostomy|pancreaticogastrostomy
157821|NCT03212196|Pancreaticojejunostomy|pancreaticojejunostomy
157822|NCT03212196|Stent|stent
157823|NCT03212196|Transanastomotic drain|transanastomotic drain
157824|NCT03212183|web-based intervention|web-based intervention
157825|NCT03212183|self-management|self-management
157826|NCT03212183|nursing|nursing
157827|NCT03212183|epilepsy|epilepsy
157828|NCT03212183|seizures|seizures
157829|NCT03212170|Invasive Breast Cancer|invasive breast cancer
157830|NCT03212170|Metastatic Breast Cancer|metastatic breast cancer
157831|NCT03212170|PR Positive Breast Cancer|pr positive breast cancer
157832|NCT03212144|nuts|nuts
157833|NCT03212144|exercise|exercise
157834|NCT03212144|vagal activity|vagal activity
157835|NCT03212144|peanuts|peanuts
157836|NCT03212144|heart rate variability|heart rate variability
157837|NCT03212118|Sick Leave|sick leave
157838|NCT03212118|Return to work|return to work
157839|NCT03212118|Motivational interviewing|motivational interviewing
157840|NCT03212118|Absenteeism|absenteeism
157841|NCT03212118|Occupational Health|occupational health
157843|NCT03212092|aggressive behavior|aggressive behavior
157844|NCT03212092|nutritional supplements|nutritional supplements
157845|NCT03212092|dietary supplements|dietary supplements
157846|NCT03212092|vitamin, mineral|vitamin, mineral
157847|NCT03212092|omega-3|omega-3
157848|NCT03212092|n-3 fatty acids|n-3 fatty acids
157849|NCT03212092|intellectual disability|intellectual disability
157850|NCT03212079|Cancer Survivors|cancer survivors
157851|NCT03212079|Physical Activities|physical activities
157852|NCT03212079|Baltimore|baltimore
157853|NCT03212079|State of Maryland|state of maryland
157854|NCT03212053|Essential thrombocythemia|essential thrombocythemia
157855|NCT03212053|Multiplate|multiplate
157856|NCT03212053|ROTEM|rotem
157857|NCT03212053|haemorrhage|haemorrhage
157858|NCT03212053|thrombosis|thrombosis
157859|NCT03212053|Vasodilatator Stimulated Phosphoprotein (VASP)|vasodilatator stimulated phosphoprotein (vasp)
157860|NCT03212027|apparent diffusion coefficient|apparent diffusion coefficient
157861|NCT03212027|aquaporins|aquaporins
157862|NCT03212014|Parkinson Disease|parkinson disease
157863|NCT03212014|intelligent|intelligent
157864|NCT03212014|Rehabilitaion|rehabilitaion
157865|NCT03211988|abdominal|abdominal
157866|NCT03211988|neuroendocrine tumor|neuroendocrine tumor
157867|NCT03211988|columbia|columbia
157868|NCT03211988|relapsed|relapsed
157869|NCT03211988|refractory|refractory
157870|NCT03211949|axillary nerve block|axillary nerve block
157871|NCT03211923|muscle relaxation|muscle relaxation
157872|NCT03211923|transcranial magnetic stimulation|transcranial magnetic stimulation
157873|NCT03211923|myopathy|myopathy
157874|NCT03211910|Sacral and trochenteric pressure ulcers|sacral and trochenteric pressure ulcers
157875|NCT03211884|Problem solving therapy|problem solving therapy
157876|NCT03211884|Military family caregivers|military family caregivers
157877|NCT03211884|Cognitive impariment|cognitive impariment
157878|NCT03211884|Traumatic brain injury|traumatic brain injury
157879|NCT03211871|pain management, dexmedetomidine|pain management, dexmedetomidine
157880|NCT03211845|Ehealth|ehealth
157881|NCT03211845|Older adults|older adults
157882|NCT03211845|Undernutrition|undernutrition
157883|NCT03211845|Feasibility study|feasibility study
157884|NCT03211832|Dissemination research|dissemination research
157885|NCT03211832|Public health workforce|public health workforce
157886|NCT03211832|Diabetes prevention|diabetes prevention
157887|NCT03211832|Diabetes control|diabetes control
157888|NCT03211832|Chronic disease prevention|chronic disease prevention
201674|NCT02934620|HIV|hiv
157889|NCT03211832|Evidence-based public health|evidence-based public health
157890|NCT03211832|Public health accreditation|public health accreditation
157891|NCT03211819|immediate|immediate
157892|NCT03211819|esthetics|esthetics
157893|NCT03211793|systemic sclerosis|systemic sclerosis
157894|NCT03211793|scleroderma|scleroderma
157895|NCT03211793|digital ulcer|digital ulcer
157896|NCT03211793|vasculopathy|vasculopathy
157897|NCT03211793|mesenchymal stromal cell|mesenchymal stromal cell
157898|NCT03211793|mesenchymal stem cell|mesenchymal stem cell
157899|NCT03211754|Walnuts|walnuts
157900|NCT03211754|almonds|almonds
157901|NCT03211754|adiponectin|adiponectin
157902|NCT03211754|lipocalin-2|lipocalin-2
157903|NCT03211754|obesity|obesity
157904|NCT03211741|Bevacizumab|bevacizumab
157905|NCT03211702|geriatric assessments|geriatric assessments
157906|NCT03211702|diffuse large B-cell lymphoma|diffuse large b-cell lymphoma
157907|NCT03211702|activity of daily living|activity of daily living
157908|NCT03211702|instrumental activity of daily living|instrumental activity of daily living
157909|NCT03211702|Charlson's comorbidity index|charlson's comorbidity index
157910|NCT03211689|Exercise|exercise
157911|NCT03211689|Stress|stress
157912|NCT03211689|Fatigue|fatigue
157913|NCT03211689|Quality of Life|quality of life
157914|NCT03211676|dialyzer|dialyzer
157915|NCT03211676|beta2-microglobilin|beta2-microglobilin
157916|NCT03211676|myoglobin|myoglobin
157917|NCT03211637|nursing care|nursing care
157918|NCT03211637|skin lesions|skin lesions
157919|NCT03211637|wound healing|wound healing
157920|NCT03211637|varicose ulcers|varicose ulcers
157921|NCT03211611|BRCA1/2 Mutation|brca1/2 mutation
157922|NCT03211611|Breast cancer|breast cancer
157923|NCT03211611|General practitionner|general practitionner
157924|NCT03211572|breast|breast
157925|NCT03211559|ankylosing spondylitis|ankylosing spondylitis
157926|NCT03211559|clinical pilates exercise|clinical pilates exercise
157927|NCT03211559|aerobic exercise|aerobic exercise
157928|NCT03211559|functional exercise capacity|functional exercise capacity
157929|NCT03211559|pulmonary function|pulmonary function
157930|NCT03211546|Pediatric femur fracture|pediatric femur fracture
157931|NCT03211546|Spica casting|spica casting
157932|NCT03211546|Traction|traction
157933|NCT03211546|Intramedullary nailing|intramedullary nailing
157934|NCT03211546|Children|children
157935|NCT03211546|Internal fixation|internal fixation
157936|NCT03211546|External fixation|external fixation
157937|NCT03211533|infants at risk of cerebral palsy|infants at risk of cerebral palsy
157938|NCT03211533|MRI|mri
157939|NCT03211533|general movements|general movements
157940|NCT03211520|Cancer treatment|cancer treatment
157941|NCT03211520|Anthracyclines|anthracyclines
157942|NCT03211520|Cardiac MRI|cardiac mri
157943|NCT03211507|Idiopathic Pulmonary Fibrosis|idiopathic pulmonary fibrosis
157944|NCT03211494|Mechanical ventilation|mechanical ventilation
157945|NCT03211494|Driving pressure|driving pressure
157946|NCT03211494|Closed-loop ventilation|closed-loop ventilation
157947|NCT03211494|Esophageal catheter|esophageal catheter
157948|NCT03211455|bariatric surgery|bariatric surgery
157949|NCT03211455|rehabilitation|rehabilitation
157950|NCT03211455|lidocaine|lidocaine
157951|NCT03211442|Breast cancer|breast cancer
157952|NCT03211442|Radiotherapy|radiotherapy
157953|NCT03211442|Cardiac complications|cardiac complications
157954|NCT03211442|Acute coronary events|acute coronary events
157955|NCT03211442|NTCP model|ntcp model
157956|NCT03211325|Transient Receptor Potential Channels|transient receptor potential channels
157957|NCT03211325|Raynaud's Phenomenon Isolated Primary|raynaud's phenomenon isolated primary
157958|NCT03211325|Raynaud's Phenomenon (Secondary)|raynaud's phenomenon (secondary)
157959|NCT03211312|Cardiovascular diseases|cardiovascular diseases
157960|NCT03211312|Prediction model|prediction model
157961|NCT03211312|Dental extraction|dental extraction
157962|NCT03211312|Elderly patients|elderly patients
157963|NCT03211286|Hip fracture|hip fracture
157964|NCT03211286|Tranexamic acid|tranexamic acid
157965|NCT03211286|Perioperative blood loss|perioperative blood loss
157966|NCT03211286|Blood Transfusion|blood transfusion
157967|NCT03211260|Parkinson Disease|parkinson disease
157968|NCT03211260|Freezing of gait|freezing of gait
157969|NCT03211260|Equistasi|equistasi
157970|NCT03211247|EPIT|epit
157971|NCT03211247|Epicutaneous|epicutaneous
157972|NCT03211247|Immunotherapy|immunotherapy
157973|NCT03211247|Viaskin|viaskin
157974|NCT03211221|OCD|ocd
157975|NCT03211221|TMS|tms
157976|NCT03211182|lifestyle intervention|lifestyle intervention
157977|NCT03211182|prediabetes|prediabetes
157978|NCT03211156|Amoxicillin|amoxicillin
157979|NCT03211156|Gardnerella vaginalis|gardnerella vaginalis
157980|NCT03211156|Vaginal Colonization|vaginal colonization
157981|NCT03211143|GERD|gerd
157982|NCT03211143|CKD-381|ckd-381
157983|NCT03211143|Nexium|nexium
157984|NCT03211143|Bioequivalence|bioequivalence
157985|NCT03211130|medication adherence|medication adherence
157986|NCT03211130|self-management|self-management
157987|NCT03211130|antithrombotic|antithrombotic
157988|NCT03211104|intermittent androgen deprivation therapy|intermittent androgen deprivation therapy
157989|NCT03211104|curcumin|curcumin
157990|NCT03211078|Early lung cancer|early lung cancer
157991|NCT03211078|Photodynamic therapy|photodynamic therapy
157992|NCT03211078|ENB|enb
157993|NCT03211065|Rituximab|rituximab
157994|NCT03211065|Non Hodgkin's Lymphoma|non hodgkin's lymphoma
157995|NCT03211065|Subcutaneous Immunoglobulin|subcutaneous immunoglobulin
157996|NCT03211039|Rady Children's|rady children's
157997|NCT03211039|Pediatric|pediatric
157998|NCT03211039|Genomic|genomic
157999|NCT03211039|Precision Medicine|precision medicine
158000|NCT03211039|Neonate|neonate
158001|NCT03211026|Urinary tract infection|urinary tract infection
158002|NCT03211026|Multidrug resistant bacteria|multidrug resistant bacteria
158003|NCT03211026|Candiduria|candiduria
158004|NCT03211026|Epidemiology|epidemiology
158005|NCT03211026|Graft rejection|graft rejection
158006|NCT03211026|Solid organ transplantation|solid organ transplantation
158007|NCT03211013|oxytocin|oxytocin
158008|NCT03211013|PTSD|ptsd
158009|NCT03211013|attention bias|attention bias
158010|NCT03211013|startle|startle
158011|NCT03211000|aortic aneurysm|aortic aneurysm
158012|NCT03211000|autophagy|autophagy
158013|NCT03211000|oxidative stress|oxidative stress
158014|NCT03211000|Hippo pathway|hippo pathway
158015|NCT03210987|ward round|ward round
158016|NCT03210987|patient case presentation|patient case presentation
158017|NCT03210987|communication|communication
158018|NCT03210987|patient-centered care|patient-centered care
158019|NCT03210935|Adnexal cutaneous carcinoma|adnexal cutaneous carcinoma
158020|NCT03210935|Merkel cell carcinoma|merkel cell carcinoma
158021|NCT03210935|Advanced basal cell carcinoma requiring systemic treatment|advanced basal cell carcinoma requiring systemic treatment
158022|NCT03210922|cervical collar, nasoendotracheal intubation, glidescope|cervical collar, nasoendotracheal intubation, glidescope
158023|NCT03210870|Maternal health|maternal health
158024|NCT03210870|maternal nutrition|maternal nutrition
158025|NCT03210870|fetal health related to maternal nutrition|fetal health related to maternal nutrition
158026|NCT03210857|apnea|apnea
158027|NCT03210857|neck extension|neck extension
158028|NCT03210857|syncope|syncope
158029|NCT03210857|diving blackout|diving blackout
158030|NCT03210857|right internal carotid arteria|right internal carotid arteria
158031|NCT03210857|pulsatility index|pulsatility index
158032|NCT03210857|healthy trained apnoea divers|healthy trained apnoea divers
158033|NCT03210857|doppler ultrasonography|doppler ultrasonography
158034|NCT03210844|total hip arthroplasty|total hip arthroplasty
158035|NCT03210844|direct anterior|direct anterior
158036|NCT03210844|posterior approach|posterior approach
158037|NCT03210831|NEC, tissue oxygenation, gut inflammation|nec, tissue oxygenation, gut inflammation
158038|NCT03210779|oral wound healing|oral wound healing
158039|NCT03210779|probiotics|probiotics
158040|NCT03210766|Cannabinoids, nabilone, FBSS, THC/CBD, refractory pain|cannabinoids, nabilone, fbss, thc/cbd, refractory pain
158041|NCT03210753|Multiple Myeloma|multiple myeloma
158042|NCT03210753|Peripheral neuropathy|peripheral neuropathy
158043|NCT03210753|Subcutaneous injection|subcutaneous injection
158044|NCT03210753|Bortezomib|bortezomib
158045|NCT03210753|Risk factors|risk factors
158046|NCT03210701|pharmacy|pharmacy
158047|NCT03210701|pharmacist|pharmacist
158048|NCT03210701|POCT|poct
158049|NCT03210701|Implementation science|implementation science
158050|NCT03210688|Prednisolone|prednisolone
158051|NCT03210688|alfacalcidol|alfacalcidol
158052|NCT03210688|Minimal change nephropathy|minimal change nephropathy
158053|NCT03210649|Dyslipidemia|dyslipidemia
158054|NCT03210597|water-base exercise|water-base exercise
158055|NCT03210584|Knee joint|knee joint
158056|NCT03210584|Cartilage degeneration|cartilage degeneration
158057|NCT03210584|Ultrasound imaging|ultrasound imaging
158058|NCT03210584|Full-Field Optical Coherence Tomography|full-field optical coherence tomography
158059|NCT03210584|9,4 Tesla MRI|9,4 tesla mri
158060|NCT03210584|Multimodal evaluation|multimodal evaluation
158061|NCT03210558|female athletes, testosterone, physical performance, body composition|female athletes, testosterone, physical performance, body composition
158062|NCT03210545|Biomarker|biomarker
158063|NCT03210545|Glucocorticoids|glucocorticoids
158064|NCT03210545|Metabolism|metabolism
158065|NCT03210506|chronic hepatitis B|chronic hepatitis b
158066|NCT03210506|hepatitis B virus|hepatitis b virus
158067|NCT03210506|Cytokines|cytokines
158068|NCT03210506|Pegylated Interferon α-2a|pegylated interferon α-2a
158069|NCT03210506|Nucleoside Analogues|nucleoside analogues
158070|NCT03210493|chronic hepatitis B|chronic hepatitis b
158071|NCT03210493|hepatitis B virus|hepatitis b virus
158072|NCT03210493|Treg Cells|treg cells
158073|NCT03210493|Pegylated Interferon α-2a|pegylated interferon α-2a
158074|NCT03210493|Nucleoside Analogues|nucleoside analogues
158075|NCT03210480|Lithium Sulphate|lithium sulphate
158076|NCT03210480|Prolonged release formulation|prolonged release formulation
158077|NCT03210480|Lithium carbonate|lithium carbonate
158078|NCT03210480|Immediate release formulation|immediate release formulation
158079|NCT03210480|Bipolar Disorder|bipolar disorder
158080|NCT03210480|Tremor|tremor
158081|NCT03210467|chronic hepatitis B|chronic hepatitis b
158082|NCT03210467|hepatitis B virus|hepatitis b virus
158083|NCT03210467|Pegylated Interferon α-2a|pegylated interferon α-2a
158084|NCT03210467|entecavir|entecavir
158085|NCT03210467|Plasmacytoid Dendritic Cells|plasmacytoid dendritic cells
158086|NCT03210415|Preterm Labor|preterm labor
158087|NCT03210415|China|china
158088|NCT03210415|Pregnant Women|pregnant women
158089|NCT03210415|≥35 Years Old|≥35 years old
158090|NCT03210389|Recurrent Nasopharyngeal Carcinoma|recurrent nasopharyngeal carcinoma
158091|NCT03210389|lobaptin|lobaptin
158092|NCT03210376|Malignant neoplasms of digestive organs|malignant neoplasms of digestive organs
158093|NCT03210376|Malignant neoplasms of female genital organs|malignant neoplasms of female genital organs
158094|NCT03210376|Malignant neoplasms of male genital organs|malignant neoplasms of male genital organs
158095|NCT03210376|Malignant neoplasms of urinary tract|malignant neoplasms of urinary tract
158096|NCT03210376|Neuromuscular blockade|neuromuscular blockade
158098|NCT03210376|Sugammadex|sugammadex
158099|NCT03210376|Neostigmine|neostigmine
158100|NCT03210376|Pain Assessment|pain assessment
158101|NCT03210376|Survey|survey
158102|NCT03210324|mifepristone antiprogestins|mifepristone antiprogestins
158103|NCT03210298|Pressurized IntraPeritoneal Aerosol Chemotherapy|pressurized intraperitoneal aerosol chemotherapy
158104|NCT03210298|PIPAC|pipac
158105|NCT03210298|Pressurized IntraThoracic Aerosol Chemotherapy|pressurized intrathoracic aerosol chemotherapy
158106|NCT03210298|PITAC|pitac
158107|NCT03210298|Cisplatin|cisplatin
158108|NCT03210298|Oxaliplatin|oxaliplatin
158109|NCT03210298|Gemcitabine|gemcitabine
158110|NCT03210298|Paclitaxel|paclitaxel
158111|NCT03210298|nab-Paclitaxel|nab-paclitaxel
158112|NCT03210298|Doxorubicine|doxorubicine
158113|NCT03210298|Mitomycin|mitomycin
158114|NCT03210285|Whole exome sequencing|whole exome sequencing
158115|NCT03210285|Neurofibromatosis Type 2|neurofibromatosis type 2
158116|NCT03210285|Acoustic Neuroma|acoustic neuroma
158117|NCT03210285|Vestibular schwannoma|vestibular schwannoma
158118|NCT03210194|Inservice Training|inservice training
158119|NCT03210194|Neonatal Resuscitation|neonatal resuscitation
158120|NCT03210194|Randomized Cluster Trial|randomized cluster trial
158121|NCT03210155|Cranial Electrotherapy Stimulation (CES)|cranial electrotherapy stimulation (ces)
158122|NCT03210155|Efficacy|efficacy
158123|NCT03210155|Post Partum|post partum
158124|NCT03210155|Anxiety|anxiety
158125|NCT03210155|Depression|depression
158126|NCT03210155|Insomnia|insomnia
158127|NCT03210155|Sleep Quality|sleep quality
158128|NCT03210155|Maternal Functioning|maternal functioning
158129|NCT03210142|Sleep Apnea, Neural Stimulation|sleep apnea, neural stimulation
158130|NCT03210129|Motivation|motivation
158131|NCT03210129|Behavior|behavior
158132|NCT03210129|Exercise|exercise
158133|NCT03210129|Motivational interview|motivational interview
158134|NCT03210129|Cancer|cancer
158135|NCT03210129|economic evaluation|economic evaluation
158136|NCT03210103|Transoral Surgery|transoral surgery
158137|NCT03210103|Head and Neck Cancer|head and neck cancer
158138|NCT03210090|Stem cells transplantation|stem cells transplantation
158139|NCT03210090|Cytomegalovirus infection|cytomegalovirus infection
158140|NCT03210090|CMV-Specific Immune response|cmv-specific immune response
158141|NCT03210090|Immune reconstitution|immune reconstitution
158142|NCT03210090|Humoral/Cellular mismatch|humoral/cellular mismatch
158143|NCT03210090|Interferon-gamma|interferon-gamma
158144|NCT03210077|general anesthesia|general anesthesia
158145|NCT03210077|Entropy|entropy
158146|NCT03210077|Hypnosis|hypnosis
158147|NCT03210064|Apatinib|apatinib
158148|NCT03210051|Acute ischemic stroke|acute ischemic stroke
158149|NCT03210051|Endovascular treatment|endovascular treatment
158150|NCT03210051|Remote ischemic conditioning|remote ischemic conditioning
158151|NCT03210051|Reperfusion therapy|reperfusion therapy
158152|NCT03210051|Neuroprotection|neuroprotection
158153|NCT03210038|Cystoscopy|cystoscopy
158154|NCT03209986|Liver Cirrhosis|liver cirrhosis
158155|NCT03209986|Mesenchymal Sem Cells|mesenchymal sem cells
158156|NCT03209947|Ulnar Neuropathies|ulnar neuropathies
158157|NCT03209947|Ultrasound|ultrasound
158158|NCT03209934|Bone and Joint Infection|bone and joint infection
158159|NCT03209934|Daptomycin|daptomycin
158160|NCT03209934|Eosinophilic pneumonia|eosinophilic pneumonia
158161|NCT03209921|Bone and Joint Infection|bone and joint infection
158162|NCT03209921|Daptomycin|daptomycin
158163|NCT03209908|antiviral treatment|antiviral treatment
158164|NCT03209908|hepatitis B virus|hepatitis b virus
158165|NCT03209908|mother-to-child transmission|mother-to-child transmission
158166|NCT03209908|Tenofovir Disoproxil Fumarate|tenofovir disoproxil fumarate
158167|NCT03209882|Transcranial infrared laser stimulation (TILS)|transcranial infrared laser stimulation (tils)
158168|NCT03209882|Near-infrared spectroscopy (NIRS)|near-infrared spectroscopy (nirs)
158169|NCT03209830|mental fatigue|mental fatigue
158170|NCT03209830|drug therapy|drug therapy
158171|NCT03209830|subarachnoid hemorrhage|subarachnoid hemorrhage
158172|NCT03209830|stroke|stroke
158173|NCT03209804|Intracranial Arteriovenous Malformations|intracranial arteriovenous malformations
158174|NCT03209752|3D analysis|3d analysis
158175|NCT03209752|Brace|brace
158176|NCT03209752|EOS imagind system|eos imagind system
158177|NCT03209752|Anatomical transfer|anatomical transfer
158178|NCT03209713|Mexican|mexican
158179|NCT03209713|Mexican-American|mexican-american
158180|NCT03209713|17-336|17-336
158181|NCT03209674|Cardiac surgery|cardiac surgery
158182|NCT03209674|Thoracic surgery|thoracic surgery
158183|NCT03209661|vascular function|vascular function
158184|NCT03209622|Smoking Cessation|smoking cessation
158185|NCT03209622|Acute Coronary Syndrome|acute coronary syndrome
158186|NCT03209622|Cardiology|cardiology
158187|NCT03209609|Coronary artery bypass|coronary artery bypass
158188|NCT03209596|Athletes|athletes
158189|NCT03209596|Food intake|food intake
158190|NCT03209596|Supplementation|supplementation
158191|NCT03209596|Biochemical biomarkers|biochemical biomarkers
158192|NCT03209596|Soccer Players|soccer players
158193|NCT03209570|urinary incontinence, nursing home|urinary incontinence, nursing home
158194|NCT03209557|Mobile Technology|mobile technology
158195|NCT03209557|Sociobehavioral|sociobehavioral
158196|NCT03209544|Suicidal ideation|suicidal ideation
158197|NCT03209544|Suicide|suicide
158198|NCT03209544|Cognitive behavioral therapy|cognitive behavioral therapy
158199|NCT03209544|Online intervention|online intervention
158200|NCT03209531|Quadriceps activation deficits|quadriceps activation deficits
158201|NCT03209531|ACL|acl
158202|NCT03209531|Surgery|surgery
158203|NCT03209531|Quadrcieps weakness|quadrcieps weakness
158204|NCT03209531|Operant conditioning|operant conditioning
158205|NCT03209531|Cortical excitability|cortical excitability
158206|NCT03209505|Lid Wiper Epitheliopahty|lid wiper epitheliopahty
158207|NCT03209505|Coefficient of Friction|coefficient of friction
158208|NCT03209466|Chlorhexidine gluconate|chlorhexidine gluconate
158209|NCT03209466|Diabetic foot ulcer syndrome|diabetic foot ulcer syndrome
158210|NCT03209466|Wound healing|wound healing
158211|NCT03209453|family work shop|family work shop
158212|NCT03209427|morphine, pruritus, serotonin|morphine, pruritus, serotonin
158213|NCT03209414|Frailty syndrome|frailty syndrome
158214|NCT03209414|Coronary heart disease|coronary heart disease
158215|NCT03209414|Coronary revascularization|coronary revascularization
158216|NCT03209414|Major adverse cardiovascular events|major adverse cardiovascular events
158217|NCT03209414|Arterial stiffness|arterial stiffness
158218|NCT03209414|Applanation tonometry|applanation tonometry
158219|NCT03209414|Lean body mass|lean body mass
158220|NCT03209414|ST2 biomarker|st2 biomarker
158221|NCT03209401|Niraparib|niraparib
158222|NCT03209401|Carboplatin|carboplatin
158223|NCT03209375|triage|triage
158224|NCT03209375|early warning system|early warning system
158225|NCT03209362|Knee|knee
158226|NCT03209362|Osteoarthritis|osteoarthritis
158227|NCT03209362|Intra-articular injection|intra-articular injection
158228|NCT03209349|Sigmoidoscopy|sigmoidoscopy
158229|NCT03209336|Ultra-low rectal cancer|ultra-low rectal cancer
158230|NCT03209336|Intersphincteric resection|intersphincteric resection
158231|NCT03209336|IORT|iort
158232|NCT03209323|Epileptiform patterns|epileptiform patterns
158233|NCT03209323|sevoflurane|sevoflurane
158234|NCT03209323|propofol|propofol
158235|NCT03209323|bispectral index|bispectral index
158236|NCT03209323|state entropy|state entropy
158237|NCT03209323|response entropy|response entropy
158238|NCT03209323|A-line Auto Regressive Index|a-line auto regressive index
158239|NCT03209323|middle latency auditory evoked potentials|middle latency auditory evoked potentials
158240|NCT03209284|maxillary atrophy|maxillary atrophy
158241|NCT03209284|transcrestal sinus floor elevation|transcrestal sinus floor elevation
158242|NCT03209271|Fluid therapy|fluid therapy
158243|NCT03209258|Stroke|stroke
158244|NCT03209258|Intracerebral Hemorrhage|intracerebral hemorrhage
158245|NCT03209258|Care Bundle|care bundle
158246|NCT03209258|Clinical Trial|clinical trial
158247|NCT03209258|Stepped-wedge Cluster|stepped-wedge cluster
158248|NCT03209258|Management|management
158249|NCT03209258|Blood Pressure|blood pressure
158250|NCT03209219|effectiveness, safety|effectiveness, safety
158251|NCT03209206|Intravesical Chemotherapy|intravesical chemotherapy
158252|NCT03209206|Docetaxel|docetaxel
158253|NCT03209206|Radical Nephroureterectomy|radical nephroureterectomy
158254|NCT03209193|off-pump coronary artery bypass|off-pump coronary artery bypass
158255|NCT03209193|sevoflurane|sevoflurane
158256|NCT03209193|desflurane|desflurane
158257|NCT03209193|tissue oxygen saturation|tissue oxygen saturation
158258|NCT03209180|HFrEF|hfref
158259|NCT03209180|Carvedilol|carvedilol
158260|NCT03209180|Slow Release|slow release
158261|NCT03209180|NT-proBNP|nt-probnp
158512|NCT03207490|Rehabilitation|rehabilitation
158262|NCT03209167|Breast reconstruction; abdominoplasty; patient satisfaction|breast reconstruction; abdominoplasty; patient satisfaction
158263|NCT03209154|Adherence|adherence
158264|NCT03209154|Therapeutic Drug Monitoring|therapeutic drug monitoring
158265|NCT03209154|Patient perspective|patient perspective
158266|NCT03209141|hypertension|hypertension
158267|NCT03209141|Diastolic Dysfunction|diastolic dysfunction
158268|NCT03209141|impedance cardiography|impedance cardiography
158269|NCT03209141|echocardiography|echocardiography
158270|NCT03209076|rectal neoplasms|rectal neoplasms
158271|NCT03209076|sexual dysfunctions|sexual dysfunctions
158272|NCT03209076|Urinary incontinence|urinary incontinence
158273|NCT03209076|Quality of life|quality of life
158274|NCT03209076|robotic surgical procedures|robotic surgical procedures
158275|NCT03209076|laparoscopy|laparoscopy
158276|NCT03209037|chronic hepatitis B|chronic hepatitis b
158277|NCT03209037|hepatitis B virus|hepatitis b virus
158278|NCT03209037|CD8+T Cells|cd8+t cells
158279|NCT03209037|Pegylated Interferon α-2a|pegylated interferon α-2a
158280|NCT03209037|Nucleoside Analogues|nucleoside analogues
158281|NCT03209024|hypertension|hypertension
158282|NCT03209024|home blood pressure monitoring|home blood pressure monitoring
158283|NCT03209024|self blood pressure monitoring|self blood pressure monitoring
158284|NCT03209024|telemedicine|telemedicine
158285|NCT03209024|health apps|health apps
158286|NCT03209024|informatics|informatics
158287|NCT03209024|data collection|data collection
158288|NCT03209024|personal health records|personal health records
158289|NCT03209024|smartphone|smartphone
158290|NCT03209024|self care|self care
158291|NCT03209024|blood pressure monitors|blood pressure monitors
158292|NCT03209011|chronic hepatitis B|chronic hepatitis b
158293|NCT03209011|hepatitis B virus|hepatitis b virus
158294|NCT03209011|CD4+T Cells|cd4+t cells
158295|NCT03209011|Pegylated Interferon α-2a|pegylated interferon α-2a
158296|NCT03209011|Nucleoside Analogues|nucleoside analogues
158297|NCT03208998|hepatitis B virus|hepatitis b virus
158298|NCT03208998|Chronic Hepatitis B Infection|chronic hepatitis b infection
158299|NCT03208998|Pegylated Interferon α-2a|pegylated interferon α-2a
158300|NCT03208998|Nucleoside Analogues|nucleoside analogues
158301|NCT03208998|Natural Killer Cells|natural killer cells
158302|NCT03208985|Emergency contraception|emergency contraception
158303|NCT03208972|IVF|ivf
158304|NCT03208972|ovarian stimulation|ovarian stimulation
158305|NCT03208972|low dose hCG|low dose hcg
158306|NCT03208972|hp-FSH|hp-fsh
158307|NCT03208972|Corifollitropin Alfa|corifollitropin alfa
158308|NCT03208972|costs of IVF|costs of ivf
158309|NCT03208946|Advanced glycation end products|advanced glycation end products
158310|NCT03208946|Absorption|absorption
158311|NCT03208946|Excretion|excretion
158312|NCT03208933|Pirfenidone, UIP, IPF, FVC|pirfenidone, uip, ipf, fvc
158313|NCT03208907|Vivax malaria|vivax malaria
158314|NCT03208907|Radical cure|radical cure
158315|NCT03208907|Elimination|elimination
158316|NCT03208881|Osteoarthritis, Obesity, Liraglutide, Ultrasound|osteoarthritis, obesity, liraglutide, ultrasound
158317|NCT03208855|Cognitive Behavioral Therapy|cognitive behavioral therapy
158318|NCT03208816|pain|pain
158319|NCT03208816|constipation|constipation
158320|NCT03208803|Myelofibrosis|myelofibrosis
158321|NCT03208803|Erythropoiesis-stimulating Agents|erythropoiesis-stimulating agents
158625|NCT03206840|hypnosis|hypnosis
158322|NCT03208803|Janus Kinase 2 inhibitors|janus kinase 2 inhibitors
158323|NCT03208803|Ruxolitinib|ruxolitinib
158324|NCT03208725|Malnutrition|malnutrition
158325|NCT03208725|Hospitalization|hospitalization
158326|NCT03208725|Acute Illness|acute illness
158327|NCT03208725|Pediatric|pediatric
158328|NCT03208725|Post-discharge mortality|post-discharge mortality
158329|NCT03208725|Mortality|mortality
158330|NCT03208725|Cohort|cohort
158331|NCT03208725|Nested case control|nested case control
158332|NCT03208725|Antimicrobial resistance|antimicrobial resistance
158333|NCT03208725|Antibiotic|antibiotic
158334|NCT03208725|Feeding|feeding
158335|NCT03208725|Undernutrition|undernutrition
158336|NCT03208699|anorexia|anorexia
158337|NCT03208699|bulimia|bulimia
158338|NCT03208686|Gender|gender
158339|NCT03208686|Men|men
158340|NCT03208686|Black/African American|black/african american
158341|NCT03208686|Self-management|self-management
158342|NCT03208660|seizure|seizure
158343|NCT03208660|Fycompa|fycompa
158344|NCT03208647|case-control study|case-control study
158345|NCT03208647|Multiple risk factors|multiple risk factors
158346|NCT03208634|robotics|robotics
158347|NCT03208634|motor performance|motor performance
158348|NCT03208634|stroke patient|stroke patient
158349|NCT03208634|upper limb|upper limb
158350|NCT03208634|rehabilitation|rehabilitation
158351|NCT03208608|RBANS-H|rbans-h
158352|NCT03208608|Older adults|older adults
158353|NCT03208608|Normal hearing|normal hearing
158354|NCT03208608|Cognition|cognition
158355|NCT03208608|Age-related hearing loss|age-related hearing loss
158356|NCT03208569|anticholinergic|anticholinergic
158357|NCT03208569|alzheimer|alzheimer
158358|NCT03208569|cognition|cognition
158359|NCT03208569|MMSE|mmse
158360|NCT03208569|anticholinergic cognitive burden scale|anticholinergic cognitive burden scale
158361|NCT03208543|thermotherapy|thermotherapy
158362|NCT03208543|Pakistan|pakistan
158363|NCT03208504|Thoracic Aortic Disease|thoracic aortic disease
158364|NCT03208504|Thoracic Aneurysm|thoracic aneurysm
158365|NCT03208465|Empagliflozin|empagliflozin
158366|NCT03208465|Sitagliptin|sitagliptin
158367|NCT03208465|Myocardial perfusion reserve|myocardial perfusion reserve
158368|NCT03208426|Efficacy, Self|efficacy, self
158369|NCT03208413|thalidomide|thalidomide
158370|NCT03208413|radiation-induced brain injury|radiation-induced brain injury
158371|NCT03208387|17-338|17-338
158372|NCT03208387|Cognitive function|cognitive function
158373|NCT03208387|Behavioral function|behavioral function
158374|NCT03208374|Histologically confirmed cancer|histologically confirmed cancer
158375|NCT03208374|IMPACT testing|impact testing
158376|NCT03208374|17-327|17-327
158377|NCT03208335|rh-endostatin|rh-endostatin
158378|NCT03208335|radiotherapy|radiotherapy
158379|NCT03208296|Basal Cell Nevus Syndrome|basal cell nevus syndrome
158380|NCT03208296|Basal Cell Carcinoma|basal cell carcinoma
158381|NCT03208257|esmolol|esmolol
158382|NCT03208257|adrenergic storm|adrenergic storm
158383|NCT03208257|septic shock|septic shock
158384|NCT03208244|Heart Disease|heart disease
158385|NCT03208244|Heart Transplant|heart transplant
158386|NCT03208244|HCV|hcv
158387|NCT03208244|Hepatitis C|hepatitis c
158388|NCT03208218|Evaluation of the pharmacokinetics equivalence|evaluation of the pharmacokinetics equivalence
158389|NCT03208218|Healthy volunteers|healthy volunteers
158390|NCT03208218|Single dose over the period I and II(crossover)|single dose over the period i and ii(crossover)
158391|NCT03208218|Healthy male volunteers|healthy male volunteers
158392|NCT03208192|colorectal liver metastases|colorectal liver metastases
158393|NCT03208192|hepatocellular carcinoma|hepatocellular carcinoma
158394|NCT03208192|intrahepatic cholangiocellular carcinoma|intrahepatic cholangiocellular carcinoma
158395|NCT03208192|tumor of liver|tumor of liver
158396|NCT03208192|focal nodular hyperplasia liver|focal nodular hyperplasia liver
158397|NCT03208192|hemangioma liver|hemangioma liver
158398|NCT03208140|intubation to supraglottic devices|intubation to supraglottic devices
158399|NCT03208140|intubation device|intubation device
158400|NCT03208140|laryngeal vision|laryngeal vision
158401|NCT03208140|success intubation|success intubation
158402|NCT03208140|videolaryngoscope|videolaryngoscope
158403|NCT03208140|direct intubation|direct intubation
158404|NCT03208127|HCV|hcv
158405|NCT03208127|Epclusa|epclusa
158406|NCT03208127|ESLD|esld
158407|NCT03208114|breastfeeding, support, promotion|breastfeeding, support, promotion
158408|NCT03208075|phosphorus,diet|phosphorus,diet
158409|NCT03208075|phosphorus|phosphorus
158410|NCT03208075|healthy subject|healthy subject
158411|NCT03208062|Biobank|biobank
158412|NCT03208062|Waste material|waste material
158413|NCT03208062|Orthopaedic|orthopaedic
158414|NCT03208049|Insomnia|insomnia
158415|NCT03208049|CBT|cbt
158416|NCT03208049|Gulf War Veterans|gulf war veterans
158417|NCT03208049|Sleep|sleep
158418|NCT03208036|schizophrenia|schizophrenia
158419|NCT03208036|tdcs|tdcs
158420|NCT03208036|working memory|working memory
158421|NCT03208036|cognitive remediation|cognitive remediation
158422|NCT03208036|cognition|cognition
158423|NCT03208010|health disparities|health disparities
159524|NCT03201081|elderly|elderly
158424|NCT03208010|lifestyle behaviors|lifestyle behaviors
158425|NCT03208010|diabetes prevention|diabetes prevention
158426|NCT03208010|Hispanic health|hispanic health
158427|NCT03207997|Scleroderma|scleroderma
158428|NCT03207997|Pulmonary fibrosis|pulmonary fibrosis
158429|NCT03207997|MRI|mri
158430|NCT03207997|quantification|quantification
158431|NCT03207984|Gingival Recession|gingival recession
158432|NCT03207984|Collagen Matrix|collagen matrix
158433|NCT03207984|Periodontics|periodontics
158434|NCT03207971|Gingival recession|gingival recession
158435|NCT03207971|Laser-Doppler Flowmetry|laser-doppler flowmetry
158436|NCT03207971|Periodontics|periodontics
158437|NCT03207919|maternal-fetal attachment|maternal-fetal attachment
158438|NCT03207919|maternal health|maternal health
158439|NCT03207919|maternal stress|maternal stress
158440|NCT03207919|Lullaby Project|lullaby project
158441|NCT03207880|pregnancy test|pregnancy test
158442|NCT03207867|Immunotherapy, A2aR, PDR001, NIR178, NSCLC, solid tumors|immunotherapy, a2ar, pdr001, nir178, nsclc, solid tumors
158443|NCT03207841|SCI|sci
158444|NCT03207841|High Protein|high protein
158445|NCT03207841|Low Carbohydrate|low carbohydrate
158446|NCT03207841|Metabolic Health|metabolic health
158447|NCT03207841|Microbiome|microbiome
158448|NCT03207828|Behavioral activation|behavioral activation
158449|NCT03207763|Safety|safety
158450|NCT03207763|Reactogenicity|reactogenicity
158451|NCT03207763|Acceptability|acceptability
158452|NCT03207763|Microneedle patch|microneedle patch
158453|NCT03207750|Immunogenicity|immunogenicity
158454|NCT03207750|lyophilized formulation|lyophilized formulation
158455|NCT03207750|United States|united states
158456|NCT03207750|Reactogenicity|reactogenicity
158457|NCT03207750|Safety|safety
158458|NCT03207750|Porcine circovirus -free|porcine circovirus -free
158459|NCT03207750|Human rotavirus vaccine|human rotavirus vaccine
202463|NCT02929927|PDT|pdt
158460|NCT03207750|liquid formulation|liquid formulation
158461|NCT03207750|Healthy infants|healthy infants
158462|NCT03207737|Spinal Cord Injuries|spinal cord injuries
158463|NCT03207737|SCI|sci
158464|NCT03207737|Telehealth|telehealth
158465|NCT03207737|Mindfulness|mindfulness
158466|NCT03207737|Nutrition|nutrition
158467|NCT03207737|Exercise|exercise
158468|NCT03207724|advanced pancreatic cancer|advanced pancreatic cancer
158469|NCT03207724|locally advanced pancreatic cancer|locally advanced pancreatic cancer
158470|NCT03207724|recurrent diagnosis|recurrent diagnosis
158471|NCT03207724|new diagnosis|new diagnosis
158472|NCT03207724|adenocarcinoma|adenocarcinoma
158473|NCT03207685|Epilepsy|epilepsy
158474|NCT03207685|Epilepsy Monitoring Unit|epilepsy monitoring unit
158475|NCT03207685|EMU|emu
158476|NCT03207685|Seizure|seizure
158477|NCT03207685|Seizure Detection|seizure detection
158478|NCT03207672|E7389 liposomal formulation|e7389 liposomal formulation
158479|NCT03207672|dose escalation|dose escalation
158480|NCT03207672|maximum tolerated dose|maximum tolerated dose
158481|NCT03207672|pharmacokinetics|pharmacokinetics
158482|NCT03207659|RIRS|rirs
158483|NCT03207659|Renal stones|renal stones
158484|NCT03207659|Efficacy|efficacy
158485|NCT03207659|Safety|safety
158486|NCT03207646|Cardiac Rehabiliation|cardiac rehabiliation
158487|NCT03207646|Percutaneous Coronary Intervention|percutaneous coronary intervention
158488|NCT03207646|Cardiovascular Risk Factor|cardiovascular risk factor
158489|NCT03207646|Digital Health Solution|digital health solution
158490|NCT03207646|Medication Adherence|medication adherence
158491|NCT03207633|OCD, rTMS, right orbitofrontal cortex|ocd, rtms, right orbitofrontal cortex
158492|NCT03207607|Adults|adults
158493|NCT03207607|Snacks|snacks
158494|NCT03207607|Appetite|appetite
158495|NCT03207607|Blood glucose|blood glucose
158496|NCT03207607|Insulin|insulin
158497|NCT03207555|Malignant neoplasms stated as primary lymphoid haematopoietic|malignant neoplasms stated as primary lymphoid haematopoietic
158498|NCT03207555|Chronic Lymphocytic Leukemia|chronic lymphocytic leukemia
158499|NCT03207555|CLL|cll
158500|NCT03207555|Small Lymphocytic Leukemia|small lymphocytic leukemia
158501|NCT03207555|SLL|sll
158502|NCT03207555|Ibrutinib|ibrutinib
158503|NCT03207555|PCI-32765|pci-32765
158504|NCT03207555|Imbruvica|imbruvica
158505|NCT03207542|Malignant neoplasms stated as primary lymphoid haematopoietic|malignant neoplasms stated as primary lymphoid haematopoietic
158506|NCT03207542|B-Cell Precursor Acute Lymphoblastic Leukemia|b-cell precursor acute lymphoblastic leukemia
158507|NCT03207542|T-Cell Precursor Acute Lymphoblastic Leukemia|t-cell precursor acute lymphoblastic leukemia
158508|NCT03207542|ALL|all
158509|NCT03207542|Daratumumab|daratumumab
158510|NCT03207516|sourdough; leavening process; fermentation; brewer's yeast|sourdough; leavening process; fermentation; brewer's yeast
158511|NCT03207490|Hand|hand
158513|NCT03207490|sEMG|semg
158514|NCT03207477|Infant|infant
158515|NCT03207477|Prematurely born|prematurely born
158516|NCT03207477|maturation|maturation
158517|NCT03207451|Anti-Platelet Therapy|anti-platelet therapy
158518|NCT03207425|Hepatic Impairment|hepatic impairment
158519|NCT03207386|Sexual Violence|sexual violence
158520|NCT03207386|Prevention|prevention
158521|NCT03207386|Mixed-Methods|mixed-methods
158522|NCT03207386|Outcome Evaluation|outcome evaluation
159525|NCT03201081|motivation|motivation
158523|NCT03207386|Process Evaluation|process evaluation
158524|NCT03207386|Adolescence|adolescence
158525|NCT03207347|BAP1|bap1
158526|NCT03207347|niraparib|niraparib
158527|NCT03207347|DNA repair|dna repair
158528|NCT03207347|PARP inhibitor|parp inhibitor
158529|NCT03207347|homologous repair deficiency|homologous repair deficiency
158530|NCT03207347|renal cell carcinoma|renal cell carcinoma
158531|NCT03207347|cholangiocarcinoma|cholangiocarcinoma
158532|NCT03207347|mesothelioma|mesothelioma
158533|NCT03207347|uveal melanoma|uveal melanoma
158534|NCT03207334|acute myeloid leukemia|acute myeloid leukemia
158535|NCT03207334|genomic signatures|genomic signatures
158536|NCT03207334|midostaurin|midostaurin
158537|NCT03207334|relapsed|relapsed
158538|NCT03207334|refractory|refractory
158539|NCT03207334|PKC412|pkc412
158540|NCT03207308|Vitamin A Status|vitamin a status
158541|NCT03207308|Retinol Isotope dilution|retinol isotope dilution
158542|NCT03207308|Total body vitamin A stores|total body vitamin a stores
158543|NCT03207308|Children|children
158544|NCT03207308|Senegal|senegal
158545|NCT03207295|Nesiritide|nesiritide
158546|NCT03207295|Total Cavo-Pulmonary Connection|total cavo-pulmonary connection
158547|NCT03207295|Congenital Heart Disease|congenital heart disease
158548|NCT03207243|Severe asthma|severe asthma
158549|NCT03207243|Safety|safety
158550|NCT03207243|GSK3772847|gsk3772847
158551|NCT03207243|Efficacy|efficacy
158552|NCT03207217|Safety Planning|safety planning
158553|NCT03207217|Access to Lethal Means|access to lethal means
158554|NCT03207217|Zero Suicide|zero suicide
158555|NCT03207204|Dental bleaching|dental bleaching
158556|NCT03207204|Color|color
158557|NCT03207204|Sensitivity|sensitivity
158558|NCT03207204|violet LED|violet led
158559|NCT03207204|Quality of life|quality of life
158560|NCT03207165|Cardiogenic shock|cardiogenic shock
158561|NCT03207165|Inotropes|inotropes
158562|NCT03207165|Low cardiac output syndrome|low cardiac output syndrome
158563|NCT03207139|cancer prostate|cancer prostate
158564|NCT03207139|Ga-68 PSMA Ligand|ga-68 psma ligand
158565|NCT03207139|staging|staging
158566|NCT03207139|biochemical failure|biochemical failure
158567|NCT03207126|Ultrasound|ultrasound
158568|NCT03207126|Biopsy|biopsy
158569|NCT03207126|Endometrial cancer|endometrial cancer
158570|NCT03207113|prostate-specific antigen|prostate-specific antigen
158571|NCT03207113|prostate cancer survivorship|prostate cancer survivorship
158572|NCT03207113|mobile health|mobile health
158573|NCT03207113|realist evaluation|realist evaluation
158574|NCT03207113|case study|case study
158575|NCT03207100|Intracerebral hemorrhage|intracerebral hemorrhage
158576|NCT03207100|Early antihypertensive treatment|early antihypertensive treatment
158577|NCT03207100|Analgesia-first|analgesia-first
158578|NCT03207100|Sedation|sedation
158579|NCT03207074|iKnife|iknife
158580|NCT03207074|Mass Spectrometry|mass spectrometry
158581|NCT03207074|Point-of-care|point-of-care
158582|NCT03207074|Diagnosis|diagnosis
158583|NCT03207074|Endometrial Cancer|endometrial cancer
158584|NCT03207061|endometrial cancer|endometrial cancer
158585|NCT03207061|staging|staging
158586|NCT03207061|3 Dimensional|3 dimensional
158587|NCT03207061|Ultrasound|ultrasound
158588|NCT03207061|Myometrial invasion|myometrial invasion
158589|NCT03206996|autism|autism
158590|NCT03206996|sensory over-responsiveness|sensory over-responsiveness
158591|NCT03206996|auditory hyper-sensitivity|auditory hyper-sensitivity
158592|NCT03206996|auditory processing|auditory processing
158593|NCT03206996|exposure therapy|exposure therapy
158594|NCT03206996|exposure and response prevention|exposure and response prevention
158595|NCT03206996|cognitive behavior therapy|cognitive behavior therapy
158596|NCT03206996|occupational therapy|occupational therapy
158597|NCT03206983|Small pupil|small pupil
158598|NCT03206944|standardized tomato extract|standardized tomato extract
158599|NCT03206944|anti-aggregation|anti-aggregation
158600|NCT03206944|high cardiovascular risk|high cardiovascular risk
158601|NCT03206944|diet supplement|diet supplement
158602|NCT03206931|Metastatic cancer|metastatic cancer
158603|NCT03206931|Advanced cancer|advanced cancer
158604|NCT03206931|Neurotrophic tyrosine receptor kinase (NTRK)|neurotrophic tyrosine receptor kinase (ntrk)
158605|NCT03206931|NTRK1|ntrk1
158606|NCT03206931|NTRK2|ntrk2
158607|NCT03206931|NTRK3|ntrk3
158608|NCT03206931|Fusion Positive|fusion positive
158609|NCT03206931|Children|children
158610|NCT03206931|Loxo-195|loxo-195
158611|NCT03206892|LESS surgery|less surgery
158612|NCT03206892|conventional multi-port laparoscopy|conventional multi-port laparoscopy
158613|NCT03206892|SILS|sils
158614|NCT03206892|Single-site surgery|single-site surgery
158615|NCT03206892|Covidien|covidien
158616|NCT03206892|laparoscopy|laparoscopy
158617|NCT03206892|minimally invasive surgery|minimally invasive surgery
158618|NCT03206892|ovarian drilling|ovarian drilling
158619|NCT03206892|PCOS|pcos
158620|NCT03206892|Diagnostic laparoscopy|diagnostic laparoscopy
158621|NCT03206879|ESBL|esbl
158622|NCT03206879|Enterobacteriaceae|enterobacteriaceae
158623|NCT03206879|multidrug-resistance|multidrug-resistance
158624|NCT03206840|mindfulness meditation|mindfulness meditation
158626|NCT03206840|meta-awareness|meta-awareness
158627|NCT03206840|absorption|absorption
158628|NCT03206840|consciousness|consciousness
158629|NCT03206840|self|self
158630|NCT03206827|colorectal cancer|colorectal cancer
158631|NCT03206827|type 2 diabetes|type 2 diabetes
158632|NCT03206827|diet|diet
158633|NCT03206827|plant protein|plant protein
158634|NCT03206827|animal protein|animal protein
158635|NCT03206814|Hypertension|hypertension
158636|NCT03206814|Ambulatory Systolic Blood Pressure|ambulatory systolic blood pressure
158637|NCT03206814|Home Blood Pressure|home blood pressure
158638|NCT03206814|ESH-CARE APP|esh-care app
158639|NCT03206801|Urine biomarker|urine biomarker
158640|NCT03206801|CXCL10 chemokine|cxcl10 chemokine
158641|NCT03206801|Post-transplant monitoring|post-transplant monitoring
158642|NCT03206801|Protocol biopsy|protocol biopsy
158643|NCT03206775|cognitive training|cognitive training
158644|NCT03206775|Self-report assessments|self-report assessments
158645|NCT03206775|Normative Data|normative data
158646|NCT03206723|corneal abrasion|corneal abrasion
158647|NCT03206723|contact lens|contact lens
158648|NCT03206723|eye trauma|eye trauma
158649|NCT03206710|vitamin C|vitamin c
158650|NCT03206710|ascorbic acid|ascorbic acid
158651|NCT03206710|wheeze|wheeze
158652|NCT03206710|nicotine|nicotine
158653|NCT03206710|smoke exposure|smoke exposure
158654|NCT03206710|long term follow up|long term follow up
158655|NCT03206710|pulmonary function testing|pulmonary function testing
158656|NCT03206710|forced expiratory flows|forced expiratory flows
158657|NCT03206697|mitochondrial copy, number and energy|mitochondrial copy, number and energy
158658|NCT03206658|acute kidney injury|acute kidney injury
158659|NCT03206658|prevention|prevention
158660|NCT03206658|severity|severity
158661|NCT03206658|biomarker|biomarker
158662|NCT03206619|smoking|smoking
158663|NCT03206619|habit|habit
158664|NCT03206619|preference|preference
158665|NCT03206619|behavior|behavior
158666|NCT03206619|tailoring|tailoring
158667|NCT03206619|cessation|cessation
158668|NCT03206619|engagement|engagement
158669|NCT03206619|digital|digital
158670|NCT03206619|mobile app|mobile app
158671|NCT03206619|recommender system|recommender system
158672|NCT03206606|COPD|copd
158673|NCT03206606|Spirometry|spirometry
158674|NCT03206606|Mobile application|mobile application
158675|NCT03206580|aging|aging
158676|NCT03206580|strength training|strength training
158677|NCT03206580|functionality|functionality
158678|NCT03206567|Hair thinning, Hair loss, Women, Nutraceutical supplement|hair thinning, hair loss, women, nutraceutical supplement
158679|NCT03206541|Neurological syndromes|neurological syndromes
158680|NCT03206541|Arbovirus infection|arbovirus infection
158681|NCT03206515|Renal Pelvic Pressure|renal pelvic pressure
158682|NCT03206476|Food Habits|food habits
158683|NCT03206476|Adolescents|adolescents
158684|NCT03206476|Educative Intervention|educative intervention
158685|NCT03206476|Nutrition Assessment|nutrition assessment
158686|NCT03206476|Behavior Modifications|behavior modifications
158687|NCT03206437|mindfulness|mindfulness
158688|NCT03206437|meditation|meditation
158689|NCT03206359|Unfolded Protein Response|unfolded protein response
158690|NCT03206359|GADD34|gadd34
158691|NCT03206359|Type I IFN|type i ifn
158692|NCT03206359|IFN response genes|ifn response genes
158693|NCT03206359|Type II IFN|type ii ifn
158694|NCT03206359|anti-DNA autoantibodies|anti-dna autoantibodies
158695|NCT03206333|Breast cancer|breast cancer
158696|NCT03206333|Cardiovascular diseases|cardiovascular diseases
158697|NCT03206333|Coronary artery calcium|coronary artery calcium
158698|NCT03206333|Prediction|prediction
158699|NCT03206333|Risk stratification|risk stratification
158700|NCT03206333|Deep learning technique|deep learning technique
158701|NCT03206333|Software development|software development
158702|NCT03206333|Computed tomography scan|computed tomography scan
158703|NCT03206307|Return to work|return to work
158704|NCT03206307|medical rehabilitation|medical rehabilitation
158705|NCT03206281|clinical weight estimation|clinical weight estimation
158706|NCT03206268|retinal nerve fiber layer thickness|retinal nerve fiber layer thickness
158707|NCT03206268|uveitis|uveitis
158708|NCT03206268|SD-OCT|sd-oct
158709|NCT03206268|GDx VCC|gdx vcc
158710|NCT03206255|Human Papilloma Virus 16|human papilloma virus 16
158711|NCT03206255|Human Papilloma Virus 18|human papilloma virus 18
158712|NCT03206255|adolescent girl|adolescent girl
158713|NCT03206255|non-inferiority|non-inferiority
158714|NCT03206255|immuno-persistence|immuno-persistence
158715|NCT03206242|Rehabilitation|rehabilitation
158716|NCT03206242|Physiotherapy|physiotherapy
158717|NCT03206242|Trismus|trismus
158718|NCT03206242|Pain|pain
158719|NCT03206242|Return to work|return to work
158720|NCT03206242|Quality of life|quality of life
158721|NCT03206190|SPG4|spg4
158722|NCT03206190|presymptomatic|presymptomatic
158723|NCT03206190|at risk|at risk
158724|NCT03206190|mutation carriers|mutation carriers
158725|NCT03206190|biomarkers|biomarkers
158726|NCT03206190|longitudinal progression|longitudinal progression
158727|NCT03206164|Health Services Research|health services research
158728|NCT03206138|Investigator trial|investigator trial
158729|NCT03206138|Cervical Intraepithelial Neoplasia|cervical intraepithelial neoplasia
158730|NCT03206125|Esophageal Squamous Cell Carcinoma|esophageal squamous cell carcinoma
158731|NCT03206125|Case-Control Study|case-control study
158732|NCT03206125|Risk Factors|risk factors
158733|NCT03206125|Epidemiology|epidemiology
158734|NCT03206112|Focal Dystonia|focal dystonia
158735|NCT03206112|Healthy Volunteers|healthy volunteers
158736|NCT03206112|Paired Associative Stimulation (PAS)|paired associative stimulation (pas)
158737|NCT03206099|Phenotyping|phenotyping
158738|NCT03206099|Genetics|genetics
158739|NCT03206099|Sequencing|sequencing
158740|NCT03206099|Inborn Errors of Immunity|inborn errors of immunity
158741|NCT03206099|Genomics|genomics
158742|NCT03206086|DNA Repair|dna repair
158743|NCT03206086|Inflammation|inflammation
158744|NCT03206086|Hematopoiesis|hematopoiesis
158745|NCT03206086|Pancytopenia|pancytopenia
158746|NCT03206073|Oncolytic Vaccinia Virus|oncolytic vaccinia virus
158747|NCT03206073|Tumor Cell Death|tumor cell death
158748|NCT03206073|Viral Therapy|viral therapy
158749|NCT03206073|Anti-Tumor Immunity|anti-tumor immunity
158750|NCT03206060|Hypertension|hypertension
158751|NCT03206060|Catecholamine|catecholamine
158752|NCT03206060|Familial Syndromes|familial syndromes
158753|NCT03206060|Somatostatin Receptors|somatostatin receptors
158754|NCT03206060|Ionizing Radiation|ionizing radiation
158755|NCT03206034|Memory|memory
158756|NCT03206034|Cognition|cognition
158757|NCT03205995|TMA|tma
158758|NCT03205995|aHUS|ahus
158759|NCT03205982|Wisepill|wisepill
158760|NCT03205982|ART|art
158761|NCT03205982|PLWH|plwh
158762|NCT03205969|Breast Cancer|breast cancer
158763|NCT03205969|chemotherapy side effect|chemotherapy side effect
158764|NCT03205969|mobile game|mobile game
158765|NCT03205956|Parkinson's disease|parkinson's disease
158766|NCT03205956|PD|pd
158767|NCT03205956|levodopa|levodopa
158768|NCT03205943|ICON|icon
158769|NCT03205904|cystic fibrosis related diabetes|cystic fibrosis related diabetes
158770|NCT03205891|Malignant neoplasms stated as primary lymphoid haematopoietic|malignant neoplasms stated as primary lymphoid haematopoietic
158771|NCT03205891|Anaplastic Large Cell Lymphoma|anaplastic large cell lymphoma
158772|NCT03205891|Classical Hodgkin Lymphoma|classical hodgkin lymphoma
158773|NCT03205891|CD30+ peripheral T-cell lymphoma|cd30+ peripheral t-cell lymphoma
158774|NCT03205891|Brentuximab Vedotin|brentuximab vedotin
158775|NCT03205891|SGN-35|sgn-35
158776|NCT03205891|Adcetris|adcetris
158777|NCT03205891|TAK228|tak228
158778|NCT03205891|TAK-228|tak-228
158779|NCT03205891|MLN0128|mln0128
158780|NCT03205891|Glucose Monitor|glucose monitor
158781|NCT03205891|Glucometer|glucometer
158782|NCT03205826|Emphysema|emphysema
158783|NCT03205826|Bronchoscopic intervention|bronchoscopic intervention
158784|NCT03205826|CHARTIS measurement|chartis measurement
158785|NCT03205813|Pain, Postoperative|pain, postoperative
158786|NCT03205813|Cesarean delivery|cesarean delivery
158787|NCT03205813|Intrathecal morphine|intrathecal morphine
158788|NCT03205761|Advanced Breast Cancer|advanced breast cancer
158789|NCT03205761|Triple Negative|triple negative
158790|NCT03205761|olaparib|olaparib
158791|NCT03205761|lynparza|lynparza
158792|NCT03205761|BRCA|brca
158793|NCT03205761|Methylation|methylation
158794|NCT03205709|memory|memory
158795|NCT03205709|computerized training|computerized training
158796|NCT03205709|cognition|cognition
158797|NCT03205709|MRI|mri
158798|NCT03205709|mci|mci
158799|NCT03205709|memory problems|memory problems
158800|NCT03205709|memory complaints|memory complaints
158801|NCT03205670|Autologous Cells|autologous cells
158802|NCT03205670|Buccal Mucosa|buccal mucosa
158803|NCT03205670|Urethroplasty|urethroplasty
158804|NCT03205670|Tissue-engineered Construct|tissue-engineered construct
158805|NCT03205670|Hybrid matrix|hybrid matrix
158806|NCT03205670|Collagen|collagen
158807|NCT03205670|Polylactoglycolide Fibers|polylactoglycolide fibers
158808|NCT03205540|Continuous epidural analgesia|continuous epidural analgesia
158809|NCT03205540|Bilateral single-shot adductor canal blocks|bilateral single-shot adductor canal blocks
158810|NCT03205527|Fall risk|fall risk
158811|NCT03205527|Stroke survivors|stroke survivors
158812|NCT03205527|Perturbation training|perturbation training
158813|NCT03205501|BE|be
158814|NCT03205501|EAC|eac
158815|NCT03205501|HGD|hgd
158816|NCT03205501|Esophagus|esophagus
158817|NCT03205488|Northwestern|northwestern
158818|NCT03205488|Nilotinib|nilotinib
158819|NCT03205488|USA|usa
158820|NCT03205488|NILO-PD|nilo-pd
158821|NCT03205488|Parkinson Disease|parkinson disease
158822|NCT03205475|Training|training
158823|NCT03205475|Intervention|intervention
158824|NCT03205475|Social Communication|social communication
158825|NCT03205475|Play|play
158826|NCT03205462|Pseudomanas Aeruginosa|pseudomanas aeruginosa
158827|NCT03205462|antibiotic resistance|antibiotic resistance
158828|NCT03205462|nosocomial infection|nosocomial infection
158829|NCT03205462|factors of pathogenicity of bacteria|factors of pathogenicity of bacteria
158830|NCT03205462|the system of secretion of type III pathogenic bacteria|the system of secretion of type iii pathogenic bacteria
158831|NCT03205462|chronic infection|chronic infection
158832|NCT03205410|remote ischemic preconditioning|remote ischemic preconditioning
158833|NCT03205410|cardiac surgery-associated acute kidney injury|cardiac surgery-associated acute kidney injury
158834|NCT03205410|neutrophil gelatinase-associated lipocalin|neutrophil gelatinase-associated lipocalin
158835|NCT03205384|Urgent abdominal surgery|urgent abdominal surgery
158836|NCT03205371|Meningitis|meningitis
158837|NCT03205371|Meningococcal Meningitis|meningococcal meningitis
158838|NCT03205371|Meningococcal Infections|meningococcal infections
158839|NCT03205371|MenACYW Conjugate vaccine|menacyw conjugate vaccine
158840|NCT03205358|Meningitis|meningitis
158841|NCT03205358|Meningococcal Meningitis|meningococcal meningitis
158842|NCT03205358|MenACYW conjugate vaccine|menacyw conjugate vaccine
158843|NCT03205358|NIMENRIX®|nimenrix®
158844|NCT03205345|Cirrhosis|cirrhosis
158845|NCT03205345|NASH Cirrhosis|nash cirrhosis
158846|NCT03205345|Decompensated NASH cirrhosis|decompensated nash cirrhosis
158847|NCT03205345|Cirrhosis, Liver|cirrhosis, liver
158848|NCT03205345|Non-Alcoholic Fatty Liver Disease|non-alcoholic fatty liver disease
158849|NCT03205332|Worry|worry
158850|NCT03205332|Anxiety|anxiety
158851|NCT03205319|Oesophagoduodenoscopy|oesophagoduodenoscopy
158852|NCT03205319|E-learning|e-learning
158853|NCT03205319|Appropriate use of healthcare|appropriate use of healthcare
158854|NCT03205319|Deimplementation|deimplementation
158855|NCT03205306|Myasthenia Gravis|myasthenia gravis
158856|NCT03205306|Psyche|psyche
158857|NCT03205306|Depression|depression
158858|NCT03205306|Anxiety Disorder|anxiety disorder
158859|NCT03205306|Posttraumatic Stress Disorder|posttraumatic stress disorder
158860|NCT03205306|Disease Processing|disease processing
158861|NCT03205293|School-Based Intervention|school-based intervention
158862|NCT03205293|Ecological Model|ecological model
158863|NCT03205293|Participatory Approach|participatory approach
158864|NCT03205293|Palestinian Female Schoolchildren|palestinian female schoolchildren
158865|NCT03205280|Multiple Sclerosis, Relapsing-Remitting, Computer-Assisted Diagnosis, MRI, Diagnosis, Treatment Efficacy|multiple sclerosis, relapsing-remitting, computer-assisted diagnosis, mri, diagnosis, treatment efficacy
158866|NCT03205254|Mediterranean diet|mediterranean diet
158867|NCT03205254|HDL|hdl
158868|NCT03205254|Fast food|fast food
158869|NCT03205254|Gut microbiota|gut microbiota
158870|NCT03205254|Inflammation|inflammation
158871|NCT03205241|Exercise|exercise
158872|NCT03205241|Fish Oil|fish oil
158873|NCT03205241|Cycling|cycling
158874|NCT03205241|Inflammation|inflammation
158875|NCT03205241|Oxidative stress|oxidative stress
158876|NCT03205215|Hyperbaric oxygen|hyperbaric oxygen
158877|NCT03205215|Pressurized oxygen|pressurized oxygen
158878|NCT03205215|Concussion|concussion
158879|NCT03205215|Post concussive syndrome|post concussive syndrome
158880|NCT03205215|Oxygen therapy|oxygen therapy
158881|NCT03205189|postoperative pain|postoperative pain
158882|NCT03205189|ambulatory surgery|ambulatory surgery
158883|NCT03205189|general anesthesia|general anesthesia
158884|NCT03205189|anesthesia consultation|anesthesia consultation
158885|NCT03205189|post-op prescription|post-op prescription
158886|NCT03205176|AZD5153|azd5153
158887|NCT03205176|Olaparib|olaparib
158888|NCT03205176|Malignant solid tumors|malignant solid tumors
158889|NCT03205176|Lymphoma|lymphoma
158890|NCT03205176|Ovarian Cancer|ovarian cancer
158891|NCT03205176|BRD4|brd4
158892|NCT03205150|non-alcoholic steatohepatitis|non-alcoholic steatohepatitis
158893|NCT03205150|NASH|nash
158894|NCT03205150|Obese|obese
158895|NCT03205150|Type 2 diabetes mellitus|type 2 diabetes mellitus
158896|NCT03205150|non-alcoholic fatty liver disease|non-alcoholic fatty liver disease
158897|NCT03205098|biological markers|biological markers
158898|NCT03205098|mesenteric ischemia|mesenteric ischemia
158899|NCT03205098|ultratrail|ultratrail
158900|NCT03205072|ERCP|ercp
158901|NCT03205072|Per-Oral Cholangioscopy|per-oral cholangioscopy
158902|NCT03205072|Liver Transplantation|liver transplantation
158903|NCT03205072|Spy Glass|spy glass
158904|NCT03205033|Melatonin|melatonin
158905|NCT03205033|Breast cancer|breast cancer
158906|NCT03205033|Chemotherapy|chemotherapy
158907|NCT03205033|Sleep-wake rhytms|sleep-wake rhytms
158908|NCT03205033|Circadian rhythms|circadian rhythms
158909|NCT03205007|Health Promotion|health promotion
158910|NCT03205007|Nutrition|nutrition
158911|NCT03205007|Older Adults|older adults
158912|NCT03204994|Colorectal surgery|colorectal surgery
158913|NCT03204994|Fluorescence guided surgery|fluorescence guided surgery
158914|NCT03204981|intramural needle ablation|intramural needle ablation
158915|NCT03204981|ventricular arrhythmia|ventricular arrhythmia
158916|NCT03204968|vagus nerve|vagus nerve
158917|NCT03204968|Lung lobectomy|lung lobectomy
158918|NCT03204955|Osmolar therapy|osmolar therapy
158919|NCT03204955|Acetate|acetate
158920|NCT03204942|Bone metastasis,Thoracic secondary, Cancer Pain,|bone metastasis,thoracic secondary, cancer pain,
158921|NCT03204903|Dry eye|dry eye
158922|NCT03204903|Laser acupuncture|laser acupuncture
158923|NCT03204903|Traditional Chinese medicine|traditional chinese medicine
158924|NCT03204877|Melatonin|melatonin
158925|NCT03204877|Insulin sensitivity|insulin sensitivity
158926|NCT03204877|Insulin secretion|insulin secretion
158927|NCT03204877|Incretin response|incretin response
158928|NCT03204838|IDH1, IDH2, MUTATION, AML|idh1, idh2, mutation, aml
158929|NCT03204825|Patient education|patient education
158930|NCT03204825|Pain management|pain management
158931|NCT03204825|Transcutaneous electrical nerve stimulation|transcutaneous electrical nerve stimulation
158932|NCT03204825|Physical activity|physical activity
158933|NCT03204825|Feasibility|feasibility
158934|NCT03204786|Autism Spectrum Disorder (ASD)|autism spectrum disorder (asd)
158935|NCT03204786|Autism|autism
158936|NCT03204747|Gait speed|gait speed
158937|NCT03204747|multiple sclerosis|multiple sclerosis
158938|NCT03204747|lower urinary tract symptoms|lower urinary tract symptoms
158939|NCT03204747|overactive bladder|overactive bladder
158940|NCT03204734|therapy|therapy
158941|NCT03204734|Capecitabine|capecitabine
158942|NCT03204734|breast cancer|breast cancer
158943|NCT03204708|postoperative analgsia|postoperative analgsia
158944|NCT03204708|peripheral block catheter|peripheral block catheter
158945|NCT03204708|modified radical mastectomy|modified radical mastectomy
158946|NCT03204695|Non-valvular atrial fibrillation|non-valvular atrial fibrillation
158947|NCT03204695|Atrial Fibrillation|atrial fibrillation
158948|NCT03204695|Stroke|stroke
158949|NCT03204695|Left Atrial Appendage (LAA)|left atrial appendage (laa)
158950|NCT03204695|LAA Closure|laa closure
158951|NCT03204695|LAA Occlusion|laa occlusion
158952|NCT03204695|WaveCrest|wavecrest
158953|NCT03204682|Endometriosis|endometriosis
158954|NCT03204682|Magnetic transcranial stimulation|magnetic transcranial stimulation
158955|NCT03204682|Chronic pain|chronic pain
158956|NCT03204682|Analgesic|analgesic
158957|NCT03204669|Copper|copper
158958|NCT03204669|Selenium|selenium
158959|NCT03204669|Zinc|zinc
158960|NCT03204669|Continuous renal replacement therapy|continuous renal replacement therapy
158961|NCT03204656|difficult orotracheal intubation|difficult orotracheal intubation
158962|NCT03204656|selective lung intubation|selective lung intubation
158963|NCT03204656|unexpected difficult selective lung intubation|unexpected difficult selective lung intubation
158964|NCT03204630|infant nutrition|infant nutrition
158965|NCT03204630|probiotic|probiotic
158966|NCT03204617|HIV infection|hiv infection
158967|NCT03204617|First in Human|first in human
158968|NCT03204617|Therapeutic Vaccines|therapeutic vaccines
158970|NCT03204617|HIV reservoir|hiv reservoir
158971|NCT03204604|Memory|memory
158972|NCT03204604|Dietary Treatment|dietary treatment
158973|NCT03204565|gingival recession, clinical trial(s).|gingival recession, clinical trial(s).
158974|NCT03204539|inhibitor|inhibitor
158975|NCT03204539|Factor VIII inhibitor|factor viii inhibitor
158976|NCT03204513|Prosthesis|prosthesis
158977|NCT03204513|Powered Prosthesis|powered prosthesis
158978|NCT03204500|Amyotrophic lateral sclerosis|amyotrophic lateral sclerosis
158979|NCT03204500|Dual therapy|dual therapy
158980|NCT03204500|Randomized controlled trial|randomized controlled trial
158981|NCT03204500|ALSFRS-R|alsfrs-r
158982|NCT03204487|tear film thickness|tear film thickness
158983|NCT03204487|ocular surface disease|ocular surface disease
158984|NCT03204487|OCT|oct
158985|NCT03204474|Lacosamide|lacosamide
158986|NCT03204474|Bioequivalence|bioequivalence
158987|NCT03204474|Intravenous solution|intravenous solution
158988|NCT03204474|Tablet|tablet
158989|NCT03204422|urinary sodium excretion|urinary sodium excretion
158990|NCT03204422|24-hout urine|24-hout urine
158991|NCT03204422|salt intakes|salt intakes
158992|NCT03204422|hypertension|hypertension
158993|NCT03204409|CHIKV|chikv
158994|NCT03204409|DENGUE|dengue
158995|NCT03204409|Chikungunya|chikungunya
158996|NCT03204409|DENV|denv
158997|NCT03204357|Cardiac surgery|cardiac surgery
158998|NCT03204344|Gastrointestinal surgery|gastrointestinal surgery
158999|NCT03204344|Preoperative oral carbohydrate|preoperative oral carbohydrate
159000|NCT03204344|Diabetic patients|diabetic patients
159001|NCT03204344|Postoperative recovery|postoperative recovery
159002|NCT03204331|Endometriosis|endometriosis
159003|NCT03204331|Pain|pain
159004|NCT03204331|Dysmenorrhea|dysmenorrhea
159005|NCT03204318|Endometriosis|endometriosis
159006|NCT03204318|Pain|pain
159007|NCT03204318|Dysmenorrhea|dysmenorrhea
159008|NCT03204305|Marijuana|marijuana
159009|NCT03204305|cannabis|cannabis
159010|NCT03204305|cannabinoid receptor|cannabinoid receptor
159011|NCT03204292|Inferior vena cava|inferior vena cava
159012|NCT03204292|Fluid responsiveness|fluid responsiveness
159013|NCT03204292|Central venous pressure|central venous pressure
159014|NCT03204266|urinary tract|urinary tract
159015|NCT03204266|Bladder cancer|bladder cancer
159016|NCT03204266|Radical cystectomy|radical cystectomy
159017|NCT03204266|Omega-3 Fatty Acids|omega-3 fatty acids
159018|NCT03204240|Spinal Cord Injury|spinal cord injury
159019|NCT03204240|Skeletal Muscle|skeletal muscle
159020|NCT03204240|Functional Electrical Stimulation|functional electrical stimulation
159021|NCT03204240|Diabetes|diabetes
159022|NCT03204227|Japanese Encephalitis|japanese encephalitis
159023|NCT03204227|JECEVAX|jecevax
159024|NCT03204227|Vietnam|vietnam
159025|NCT03204214|binge drinking|binge drinking
159026|NCT03204201|Fluorescence|fluorescence
159027|NCT03204188|Deletion 17p|deletion 17p
159028|NCT03204188|Bruton's Tyrosine Kinase Inhibitor|bruton's tyrosine kinase inhibitor
159029|NCT03204188|TP53 Mutation|tp53 mutation
159030|NCT03204188|NOTCH1 mutation|notch1 mutation
159031|NCT03204188|Complex Cytogenics|complex cytogenics
159032|NCT03204123|prostate cancer|prostate cancer
159033|NCT03204123|prostatectomy|prostatectomy
159034|NCT03204123|biochemical recurrence|biochemical recurrence
159035|NCT03204123|Ga-HBED-iPSMA|ga-hbed-ipsma
159036|NCT03204123|16-306|16-306
159037|NCT03204110|Reversible cerebral vasoconstriction syndrome|reversible cerebral vasoconstriction syndrome
159038|NCT03204110|Anatomic and morphological retinal network analysis|anatomic and morphological retinal network analysis
159039|NCT03204110|Retinal vessel analyser|retinal vessel analyser
159040|NCT03204110|retinography|retinography
159041|NCT03204110|Prospective analysis|prospective analysis
159042|NCT03204084|pterygium,Low temperature plasma|pterygium,low temperature plasma
159043|NCT03204045|oxycodone, fentanyl, tracheal extubation|oxycodone, fentanyl, tracheal extubation
159044|NCT03204032|Tegafur|tegafur
159045|NCT03204032|Temozolomide|temozolomide
159046|NCT03204032|Thalidomide|thalidomide
159047|NCT03204032|Extrapancreatic Neuroendocrine Tumor|extrapancreatic neuroendocrine tumor
159048|NCT03204019|Tegafur|tegafur
159049|NCT03204019|Temozolomide|temozolomide
159050|NCT03204019|Thalidomide|thalidomide
159051|NCT03204019|Pancreatic Neuroendocrine Tumor|pancreatic neuroendocrine tumor
159052|NCT03203993|BRCA mutation|brca mutation
159053|NCT03203967|Adults|adults
159054|NCT03203967|Unilateral TKA|unilateral tka
159055|NCT03203967|Single femoral nerve block|single femoral nerve block
159056|NCT03203967|Low-dose epidural morphine|low-dose epidural morphine
159057|NCT03203967|Effect of postoperative analgesia|effect of postoperative analgesia
159058|NCT03203967|Quality of life|quality of life
159059|NCT03203941|Autologous Cord Blood Stem Cells|autologous cord blood stem cells
159060|NCT03203928|ADHD|adhd
159061|NCT03203928|Occupational Therapy|occupational therapy
159062|NCT03203915|cholesterol|cholesterol
159063|NCT03203915|triglyceride|triglyceride
159064|NCT03203915|grape seed extract|grape seed extract
159065|NCT03203915|chardonnay pomace powder|chardonnay pomace powder
159066|NCT03203915|polyphenol|polyphenol
159067|NCT03203915|gut microbiome|gut microbiome
159068|NCT03203902|Therapeutic touch|therapeutic touch
159069|NCT03203902|Post-traumatic Stress Disorder|post-traumatic stress disorder
159070|NCT03203902|Homeless|homeless
159071|NCT03203889|American Indians|american indians
159072|NCT03203889|Native Americans|native americans
159073|NCT03203889|Community Reinforcement Approach and Family Training|community reinforcement approach and family training
159074|NCT03203889|Nar-Anonymous Facilitation|nar-anonymous facilitation
159075|NCT03203889|Treatment Entry|treatment entry
159076|NCT03203889|Cultural adaptations|cultural adaptations
159077|NCT03203889|Spirituality|spirituality
159078|NCT03203850|hereditary hemochromatosis|hereditary hemochromatosis
159079|NCT03203850|ICL670|icl670
159080|NCT03203850|deferasirox FCT|deferasirox fct
159081|NCT03203850|iron overload|iron overload
159082|NCT03203837|Radioembolization|radioembolization
159083|NCT03203837|Y90|y90
159084|NCT03203837|TheraSphere|therasphere
159085|NCT03203837|HCC|hcc
159086|NCT03203837|Biomarker|biomarker
159087|NCT03203837|Prognostic factor|prognostic factor
159088|NCT03203837|Angiogenesis|angiogenesis
159089|NCT03203837|Inflammatory|inflammatory
159090|NCT03203837|Liver|liver
159091|NCT03203811|Healthy Subjects|healthy subjects
159092|NCT03203746|Lycopene|lycopene
159093|NCT03203746|Chronic periodontitis|chronic periodontitis
159094|NCT03203746|Protein carbonyl|protein carbonyl
159095|NCT03203733|Oral Mucositis , cooling, cryotherapy|oral mucositis , cooling, cryotherapy
159096|NCT03203720|adherence|adherence
159097|NCT03203720|adolescent|adolescent
159098|NCT03203720|Motivational Intervention|motivational intervention
159099|NCT03203707|IPSRT|ipsrt
159100|NCT03203707|early intervention|early intervention
159101|NCT03203707|bipolar disorder|bipolar disorder
159102|NCT03203668|Hyperparathyroidism|hyperparathyroidism
159103|NCT03203668|Imaging|imaging
159104|NCT03203668|Scintigraphy|scintigraphy
159105|NCT03203668|18F-choline|18f-choline
159106|NCT03203668|18F-fluorocholine|18f-fluorocholine
159107|NCT03203668|PET|pet
159108|NCT03203668|PET/CT|pet/ct
159109|NCT03203655|Mobile text|mobile text
159110|NCT03203655|Obesity|obesity
159111|NCT03203655|Hispanic|hispanic
159112|NCT03203655|Women|women
159113|NCT03203642|ADPKD|adpkd
159114|NCT03203642|Autosomal Dominant Polycystic Kidney Disease|autosomal dominant polycystic kidney disease
159115|NCT03203642|Polycystic Kidney|polycystic kidney
159116|NCT03203642|Tesevatinib|tesevatinib
159117|NCT03203642|Polycystic Kidney Disease|polycystic kidney disease
159118|NCT03203642|PKD|pkd
159119|NCT03203603|asthma|asthma
159120|NCT03203603|pulmonary function testing|pulmonary function testing
159121|NCT03203603|wheeze|wheeze
159122|NCT03203603|vitamin C|vitamin c
159123|NCT03203603|antioxidants|antioxidants
159124|NCT03203603|forced expiratory flows|forced expiratory flows
159125|NCT03203551|Dentures|dentures
159126|NCT03203551|Biofilms|biofilms
159127|NCT03203551|Disinfection|disinfection
159128|NCT03203551|Candidiasis|candidiasis
159129|NCT03203551|Candida|candida
159130|NCT03203538|night work|night work
159131|NCT03203538|shift work|shift work
159132|NCT03203538|light|light
159133|NCT03203538|bright light|bright light
159134|NCT03203538|sleep|sleep
159135|NCT03203538|cognitive performance|cognitive performance
159136|NCT03203538|circadian rhythm|circadian rhythm
159137|NCT03203525|Liver Cancer|liver cancer
159138|NCT03203525|Hepatic metastases|hepatic metastases
159139|NCT03203525|Advanced liver cancer|advanced liver cancer
159140|NCT03203525|Eloxatin|eloxatin
159141|NCT03203525|Oxaliplatin|oxaliplatin
159142|NCT03203525|Leucovorin|leucovorin
159143|NCT03203525|Citrovorum|citrovorum
159144|NCT03203525|Wellcovorin|wellcovorin
159145|NCT03203525|5-fluorouracil|5-fluorouracil
159146|NCT03203525|Fluorouracil|fluorouracil
159147|NCT03203525|5-FU|5-fu
159148|NCT03203525|Adrucil|adrucil
159149|NCT03203525|Efudex|efudex
159150|NCT03203525|Bevacizumab|bevacizumab
159151|NCT03203525|Avastin|avastin
159152|NCT03203525|Anti-VEGF monoclonal antibody|anti-vegf monoclonal antibody
159153|NCT03203525|rhuMab-VEGF|rhumab-vegf
159154|NCT03203525|Liposomal Doxorubicin|liposomal doxorubicin
159155|NCT03203525|Doxil|doxil
159156|NCT03203525|Doxorubicin Hydrochloride (Liposomal)|doxorubicin hydrochloride (liposomal)
159157|NCT03203525|Temsirolimus|temsirolimus
159158|NCT03203525|CCI-779|cci-779
159159|NCT03203525|Torisel|torisel
159160|NCT03203525|NovoTTF-100L System|novottf-100l system
159161|NCT03203512|Fish oil; N-3 polyunsaturated fatty acids|fish oil; n-3 polyunsaturated fatty acids
159162|NCT03203499|Substance abuse disorder|substance abuse disorder
159163|NCT03203486|NAFLD|nafld
159164|NCT03203486|no fibrosis|no fibrosis
159165|NCT03203486|Mediterranean diet|mediterranean diet
159166|NCT03203486|STAT3|stat3
159167|NCT03203486|GCKR|gckr
159168|NCT03203486|visfatin|visfatin
159169|NCT03203486|oxidized LDL|oxidized ldl
159170|NCT03203486|fasting glucose|fasting glucose
159171|NCT03203486|inflammation|inflammation
159172|NCT03203473|Renal Cancer|renal cancer
159173|NCT03203460|Prostate Cancer|prostate cancer
159174|NCT03203460|Active Surveillance|active surveillance
159175|NCT03203460|Exercise|exercise
159176|NCT03203460|High-Intensity Interval Training|high-intensity interval training
159177|NCT03203460|Randomized Controlled Trial|randomized controlled trial
159178|NCT03203447|RVO|rvo
159179|NCT03203447|ME|me
159180|NCT03203447|Microneedle|microneedle
159181|NCT03203447|Microinjection|microinjection
159182|NCT03203447|Triamcinolone|triamcinolone
159183|NCT03203447|Choroid|choroid
159184|NCT03203447|Choroid injection|choroid injection
159185|NCT03203447|Suprachoroidal|suprachoroidal
159186|NCT03203447|Anti-VEGF|anti-vegf
159187|NCT03203447|Subretinal Fluid|subretinal fluid
159188|NCT03203447|Cystoid Macular Edema|cystoid macular edema
159189|NCT03203447|Optical Coherence Tomography|optical coherence tomography
159190|NCT03203447|OCT|oct
159191|NCT03203447|Central Subfield Thickness|central subfield thickness
159192|NCT03203447|Lucentis|lucentis
159193|NCT03203447|Avastin|avastin
159194|NCT03203447|Ranibizumab|ranibizumab
159195|NCT03203447|Bevacizumab|bevacizumab
159196|NCT03203434|Pancreatic cancer|pancreatic cancer
159197|NCT03203434|Esophageal cancer|esophageal cancer
159198|NCT03203434|volatile organic compounds|volatile organic compounds
159199|NCT03203434|Field asymmetric ion mobility spectrometry|field asymmetric ion mobility spectrometry
159200|NCT03203395|Depression|depression
159201|NCT03203395|Anxiety|anxiety
159202|NCT03203395|Panic Attacks|panic attacks
159203|NCT03203395|Collaborative Care|collaborative care
159204|NCT03203395|Heart disease and depression|heart disease and depression
159205|NCT03203395|Heart disease and anxiety|heart disease and anxiety
159206|NCT03203395|Heart disease and panic attacks|heart disease and panic attacks
159207|NCT03203369|Blastic plasmacytoid dendritic cell neoplasm|blastic plasmacytoid dendritic cell neoplasm
159208|NCT03203369|Natural Killer (NK) cell blastic lymphoma|natural killer (nk) cell blastic lymphoma
159209|NCT03203369|Hematologic malignancies|hematologic malignancies
159210|NCT03203369|Cluster of differentiation (CD) CD4+CD56+ hematodermic tumor|cluster of differentiation (cd) cd4+cd56+ hematodermic tumor
159211|NCT03203369|Acute leukemia and myeloid neoplasms|acute leukemia and myeloid neoplasms
159212|NCT03203369|Chimeric Antigen Receptor T-cell (CAR-T) therapy|chimeric antigen receptor t-cell (car-t) therapy
159213|NCT03203369|Allogeneic|allogeneic
159214|NCT03203369|Cluster of differentiation 4 (CD4)|cluster of differentiation 4 (cd4)
159215|NCT03203369|Cluster of differentiation 56 (CD56)|cluster of differentiation 56 (cd56)
159216|NCT03203356|growth hormone|growth hormone
159217|NCT03203356|children|children
159218|NCT03203356|adrenal function|adrenal function
159219|NCT03203343|Inguinal Hernia, Indirect|inguinal hernia, indirect
159220|NCT03203343|Children, Only|children, only
159221|NCT03203343|Inflammatory Response|inflammatory response
159222|NCT03203343|Surgery|surgery
159526|NCT03201081|adherence|adherence
159223|NCT03203343|Interleukin-6|interleukin-6
159224|NCT03203343|Tumor necrosis factor alpha|tumor necrosis factor alpha
159225|NCT03203343|C reactive protein|c reactive protein
159226|NCT03203343|Leukocytes|leukocytes
159227|NCT03203304|hepatocellular carcinoma|hepatocellular carcinoma
159228|NCT03203304|nivolumab|nivolumab
159229|NCT03203304|ipilimumab|ipilimumab
159230|NCT03203304|stereotactic body radiotherapy|stereotactic body radiotherapy
159231|NCT03203304|SBRT|sbrt
159232|NCT03203291|stroke|stroke
159233|NCT03203291|robotic training|robotic training
159234|NCT03203291|gait|gait
159235|NCT03203278|South Asian|south asian
159236|NCT03203265|HIV home testing|hiv home testing
159237|NCT03203239|red light|red light
159238|NCT03203239|vasodilation|vasodilation
159239|NCT03203239|nitric oxide|nitric oxide
159240|NCT03203226|Intellectual Disability|intellectual disability
159241|NCT03203226|Feldenkrais Method|feldenkrais method
159242|NCT03203226|Short Physical Performance Battery|short physical performance battery
159243|NCT03203226|Stabilometry|stabilometry
159244|NCT03203226|Supported employment|supported employment
159245|NCT03203213|Poisoning|poisoning
159246|NCT03203213|Psychoactive substances|psychoactive substances
159247|NCT03203174|microneedle|microneedle
159248|NCT03203174|botulinum toxin|botulinum toxin
159249|NCT03203174|botox|botox
159250|NCT03203174|palmar hyperhidrosis|palmar hyperhidrosis
159251|NCT03203174|sweating|sweating
159252|NCT03203174|hyperhidrosis|hyperhidrosis
159253|NCT03203148|Cardiopulmonary Bypass|cardiopulmonary bypass
159254|NCT03203148|Blood Coagulation Testing|blood coagulation testing
159255|NCT03203148|Point-of-Care Testing|point-of-care testing
159256|NCT03203109|lateropulsion|lateropulsion
159257|NCT03203109|pusher syndrome|pusher syndrome
159258|NCT03203109|posture|posture
159259|NCT03203109|balance|balance
159260|NCT03203109|PASS|pass
159261|NCT03203109|verticality perception|verticality perception
159262|NCT03203109|gait|gait
159263|NCT03203096|magnesium, stress, metabolomics, heart rate variability|magnesium, stress, metabolomics, heart rate variability
159264|NCT03203083|Reproducibility of Results|reproducibility of results
159265|NCT03203083|Clinical Assessment|clinical assessment
159266|NCT03203044|Dietary Intervention|dietary intervention
159267|NCT03203031|pain|pain
159268|NCT03203031|neonate|neonate
159269|NCT03203031|regional anesthesia|regional anesthesia
159270|NCT03203031|postoperative|postoperative
159271|NCT03203018|Cardiovascular Diseases (CVD)|cardiovascular diseases (cvd)
159272|NCT03203018|Community-based intervention|community-based intervention
159273|NCT03203018|Socio-economic status (SES)|socio-economic status (ses)
159274|NCT03203018|Health literacy (HL)|health literacy (hl)
159275|NCT03202979|Trazodone|trazodone
159276|NCT03202979|Placebo|placebo
159277|NCT03202979|Gabapentin|gabapentin
159278|NCT03202979|Neuropathic pain|neuropathic pain
159279|NCT03202940|Lung Cancer|lung cancer
159280|NCT03202901|knee-pain, curcuma, inflammation|knee-pain, curcuma, inflammation
159281|NCT03202862|fulvestrant|fulvestrant
159282|NCT03202862|ESR1|esr1
159283|NCT03202849|hematopoietic stem cell transplant|hematopoietic stem cell transplant
159284|NCT03202849|vitamin a|vitamin a
159285|NCT03202849|vitamin d|vitamin d
159286|NCT03202810|optical imaging technology, loss of heterozygosity, prevention, miRNA, cost-effectiveness|optical imaging technology, loss of heterozygosity, prevention, mirna, cost-effectiveness
159287|NCT03202758|Durvalumab|durvalumab
159288|NCT03202758|Tremelimumab|tremelimumab
159289|NCT03202758|FOLFOX|folfox
159290|NCT03202758|metastatic colorectal cancer|metastatic colorectal cancer
159291|NCT03202732|Self-management|self-management
159292|NCT03202732|Patient Activeted measure|patient activeted measure
159293|NCT03202732|Patient-reported outcome|patient-reported outcome
159294|NCT03202732|Type 1 diabetes Mellitus|type 1 diabetes mellitus
159295|NCT03202732|Non-inferiority study|non-inferiority study
159296|NCT03202719|Inactivated polio vaccine|inactivated polio vaccine
159297|NCT03202719|Polio|polio
159298|NCT03202719|oral polio vaccine|oral polio vaccine
159299|NCT03202693|Tuberculosis, PA-824|tuberculosis, pa-824
159300|NCT03202667|SGLT2-inhibitor|sglt2-inhibitor
159301|NCT03202667|Treatment|treatment
159302|NCT03202641|ARDS|ards
159303|NCT03202641|PEEP titration|peep titration
159304|NCT03202641|Open Lung Strategy|open lung strategy
159305|NCT03202641|Right heart function|right heart function
159306|NCT03202641|Lung recruitment maneuver|lung recruitment maneuver
159307|NCT03202641|Esophageal Pressure|esophageal pressure
159308|NCT03202641|Respiratory system compliance|respiratory system compliance
159309|NCT03202615|lactoferrin|lactoferrin
159310|NCT03202615|iron deficiency anemia in pregnancy|iron deficiency anemia in pregnancy
159311|NCT03202602|Obstructive sleep apnea|obstructive sleep apnea
159312|NCT03202602|Continuous positive airway pressure|continuous positive airway pressure
159313|NCT03202602|Telemoedicine|telemoedicine
159314|NCT03202589|Preoperative assessement for geriatric patients|preoperative assessement for geriatric patients
159315|NCT03202589|FOCUS Echocardiography|focus echocardiography
159316|NCT03202589|Orthopedic|orthopedic
159317|NCT03202589|Surgery|surgery
159318|NCT03202589|Geriatric|geriatric
159528|NCT03201081|health|health
159319|NCT03202576|nasogastric tube|nasogastric tube
159320|NCT03202576|microbridle|microbridle
159321|NCT03202550|Oral Sedation|oral sedation
159322|NCT03202550|Lorazepam|lorazepam
159323|NCT03202550|Oxycodone|oxycodone
159324|NCT03202524|Paracentesis|paracentesis
159325|NCT03202524|Albumin|albumin
159326|NCT03202524|Plasma|plasma
159327|NCT03202498|Cirrhosis, Liver|cirrhosis, liver
159328|NCT03202498|Fibrosis, Liver|fibrosis, liver
159329|NCT03202498|Hepatic Cirrhosis|hepatic cirrhosis
159330|NCT03202498|Liver Fibrosis|liver fibrosis
159331|NCT03202485|astigmatism|astigmatism
159332|NCT03202485|high myopia|high myopia
159333|NCT03202485|phakic intraocular lens|phakic intraocular lens
159334|NCT03202485|astigmatic keratotomy|astigmatic keratotomy
159335|NCT03202485|toric|toric
159336|NCT03202459|Anesthesia|anesthesia
159337|NCT03202459|Complications|complications
159338|NCT03202459|Nausea|nausea
159339|NCT03202459|Vomiting|vomiting
159340|NCT03202433|Virtual Reality|virtual reality
159341|NCT03202433|Stress Reduction|stress reduction
159342|NCT03202433|Needle Aspiration|needle aspiration
159343|NCT03202433|Blood Donors|blood donors
159344|NCT03202433|Intervention|intervention
159345|NCT03202394|intubation|intubation
159346|NCT03202394|aerosol|aerosol
159347|NCT03202394|sepsis|sepsis
159348|NCT03202394|edema|edema
159349|NCT03202381|Androgen deprivation therapy|androgen deprivation therapy
159350|NCT03202381|GnRH antagonist|gnrh antagonist
159351|NCT03202355|Alignment phase|alignment phase
159352|NCT03202355|Photobiomodulation|photobiomodulation
159353|NCT03202355|Orthodontic treatment|orthodontic treatment
159354|NCT03202355|Malocclusion|malocclusion
159355|NCT03202355|OrthoPulse™|orthopulse™
159356|NCT03202303|Autism|autism
159357|NCT03202303|Irritability|irritability
159358|NCT03202303|Cannabinoids|cannabinoids
159359|NCT03202277|physical activity, sleep, sedentary behavior, dietary intake, smartphone|physical activity, sleep, sedentary behavior, dietary intake, smartphone
159360|NCT03202264|Polypharmacy|polypharmacy
159361|NCT03202264|Mobility|mobility
159362|NCT03202264|Multimorbidity|multimorbidity
159363|NCT03202264|Drug Discontinuation|drug discontinuation
159364|NCT03202264|Patient Preference|patient preference
159365|NCT03202264|eHealth|ehealth
159366|NCT03202251|overactive bladder|overactive bladder
159367|NCT03202251|underactive bladder|underactive bladder
159368|NCT03202251|urinary incontinence|urinary incontinence
159369|NCT03202199|Adenocarcinoma, pancreas, PET/MRI|adenocarcinoma, pancreas, pet/mri
159370|NCT03202173|Probe-based confocal laser endomicroscopy|probe-based confocal laser endomicroscopy
159371|NCT03202173|Optical biopsy|optical biopsy
159372|NCT03202160|Goiter|goiter
159373|NCT03202147|Ischemic stroke, post-stroke cognitive impairment, PSCI|ischemic stroke, post-stroke cognitive impairment, psci
159374|NCT03202108|Ketogenic|ketogenic
159375|NCT03202108|Diet|diet
159376|NCT03202108|Epilepsy|epilepsy
159377|NCT03202108|Glut-1 DS|glut-1 ds
159378|NCT03202108|Krio|krio
159379|NCT03202095|Depression|depression
159380|NCT03202095|Type 2 Diabetes|type 2 diabetes
159381|NCT03202095|Creatine|creatine
159382|NCT03202095|Diabetes|diabetes
159383|NCT03202069|Protein|protein
159384|NCT03202069|Weight Loss|weight loss
159385|NCT03202056|hip osteoarthritis|hip osteoarthritis
159386|NCT03202056|physiotherapy|physiotherapy
159387|NCT03202056|manual therapy|manual therapy
159388|NCT03202030|immediate dentoalveolar restoration|immediate dentoalveolar restoration
159389|NCT03202030|bio-oss|bio-oss
159390|NCT03202030|immediate dental implant|immediate dental implant
159391|NCT03202030|bovine bone|bovine bone
159393|NCT03202004|efficacy|efficacy
159394|NCT03202004|PASI|pasi
159395|NCT03202004|GSK2894512|gsk2894512
159396|NCT03202004|NRS|nrs
159397|NCT03202004|Topical|topical
159398|NCT03202004|psoriasis|psoriasis
159399|NCT03201991|ALS|als
159400|NCT03201978|Healthy adults|healthy adults
159401|NCT03201978|GSK2894512|gsk2894512
159402|NCT03201978|Topical|topical
159403|NCT03201978|Psoriasis|psoriasis
159404|NCT03201978|Pharmacokinetics|pharmacokinetics
159405|NCT03201952|Glucose|glucose
159406|NCT03201952|Ileostomy|ileostomy
159407|NCT03201939|HIV/AIDS|hiv/aids
159408|NCT03201939|sub-Saharan Africa|sub-saharan africa
159409|NCT03201939|Kidney disease|kidney disease
159410|NCT03201939|Albuminuria|albuminuria
159411|NCT03201939|Genetic risk|genetic risk
159412|NCT03201900|perampanel|perampanel
159413|NCT03201848|Huaiqihuang granule|huaiqihuang granule
159414|NCT03201848|immune thrombocytopenia|immune thrombocytopenia
159415|NCT03201848|randomized|randomized
159416|NCT03201848|double-blind|double-blind
159417|NCT03201848|placebo-controlled,|placebo-controlled,
159418|NCT03201822|flavanol|flavanol
159419|NCT03201822|ADME|adme
159420|NCT03201822|cocoa flavanols|cocoa flavanols
159421|NCT03201822|polyphenols|polyphenols
159422|NCT03201796|Bacterial prostatitis|bacterial prostatitis
159423|NCT03201796|CBP|cbp
159424|NCT03201796|Levofloxacin|levofloxacin
159425|NCT03201796|Prulifloxacin|prulifloxacin
159527|NCT03201081|resistance-training|resistance-training
159426|NCT03201783|frozen-thawed embryo transfer|frozen-thawed embryo transfer
159427|NCT03201783|time interval|time interval
159428|NCT03201770|Uncomplicated Malaria|uncomplicated malaria
159429|NCT03201770|Pyramax|pyramax
159430|NCT03201770|Pyronaridine artesunate|pyronaridine artesunate
159431|NCT03201757|Alkermes|alkermes
159432|NCT03201757|ALKS 3831|alks 3831
159433|NCT03201757|Olanzapine|olanzapine
159434|NCT03201757|Samidorphan|samidorphan
159435|NCT03201757|Schizophrenia|schizophrenia
159436|NCT03201757|Schizophreniform|schizophreniform
159437|NCT03201757|Bipolar I|bipolar i
159438|NCT03201718|Hepatitis C|hepatitis c
159439|NCT03201718|Paritaprevir|paritaprevir
159440|NCT03201718|Ritonavir|ritonavir
159441|NCT03201718|Ombitasvir|ombitasvir
159442|NCT03201718|Dasabuvir|dasabuvir
159443|NCT03201705|Failed Back Surgery Syndrome|failed back surgery syndrome
159444|NCT03201705|Spinal Cord Stimulation|spinal cord stimulation
159445|NCT03201705|Pain Management|pain management
159446|NCT03201705|Implantable Neurostimulator|implantable neurostimulator
159447|NCT03201679|SIRS, systemic inflammatory response syndrome|sirs, systemic inflammatory response syndrome
159448|NCT03201679|Hip Fracture Surgery|hip fracture surgery
159449|NCT03201679|Sepsis|sepsis
159450|NCT03201679|Mortality|mortality
159451|NCT03201666|prenatal diagnosis|prenatal diagnosis
159452|NCT03201666|non-invasive prenatal tests|non-invasive prenatal tests
159453|NCT03201666|chromosome microarray analysis|chromosome microarray analysis
159454|NCT03201653|Distal Pancreatectomy|distal pancreatectomy
159455|NCT03201653|Pancreatic Fistula|pancreatic fistula
159456|NCT03201653|Oxidized Regenerated Cellulose|oxidized regenerated cellulose
159457|NCT03201653|Pancreatectomy|pancreatectomy
159458|NCT03201614|platelet-rich plasma, hyaluronic acid, knee osteroarthritis|platelet-rich plasma, hyaluronic acid, knee osteroarthritis
159459|NCT03201601|Polycystic ovarian syndrome|polycystic ovarian syndrome
159460|NCT03201601|D-chiro-inositol|d-chiro-inositol
159461|NCT03201601|Fertility|fertility
159462|NCT03201588|Retinopathy of Prematurity|retinopathy of prematurity
159463|NCT03201575|Intensive care|intensive care
159464|NCT03201575|septic shock|septic shock
159465|NCT03201575|multiple organ failure|multiple organ failure
159466|NCT03201575|Ischemia-reperfusion|ischemia-reperfusion
159467|NCT03201575|ischemic conditioning|ischemic conditioning
159468|NCT03201575|remote conditioning|remote conditioning
159469|NCT03201575|SOFA score|sofa score
159470|NCT03201536|ZipLine3 device vs. conventional sutures|zipline3 device vs. conventional sutures
159471|NCT03201523|Community-based Intervention|community-based intervention
159472|NCT03201523|Socio-ecological Model|socio-ecological model
159473|NCT03201523|Participatory Approach|participatory approach
159474|NCT03201523|Ultra-Orthodox Jewish women|ultra-orthodox jewish women
159475|NCT03201432|Vertebral Artery Stenosis|vertebral artery stenosis
159476|NCT03201432|Ischemic Stroke|ischemic stroke
159477|NCT03201432|Stent|stent
159478|NCT03201406|Renal biopsy, Chronic kidney disease,Diabetic nephropathy,Lupus Nephritis|renal biopsy, chronic kidney disease,diabetic nephropathy,lupus nephritis
159479|NCT03201393|Back pain|back pain
159480|NCT03201393|Neuropathic Pain|neuropathic pain
159481|NCT03201393|Radiculopathy|radiculopathy
159482|NCT03201393|Allodynia|allodynia
159483|NCT03201367|Portal vein|portal vein
159484|NCT03201367|thrombosis|thrombosis
159485|NCT03201367|acute|acute
159486|NCT03201367|rivaroxaban|rivaroxaban
159487|NCT03201354|Glaucoma|glaucoma
159488|NCT03201354|Ocular hypertension|ocular hypertension
159489|NCT03201354|Filtration surgery|filtration surgery
159490|NCT03201354|Trabeculectomy with Ex-PRESS|trabeculectomy with ex-press
159491|NCT03201354|Non penetrating deep sclerectomy|non penetrating deep sclerectomy
159492|NCT03201354|Phacoemulsification|phacoemulsification
159493|NCT03201354|Combined surgery|combined surgery
159494|NCT03201341|Stroke|stroke
159495|NCT03201341|Multisensory|multisensory
159496|NCT03201341|Plasticity|plasticity
159497|NCT03201341|Body|body
159498|NCT03201341|Space|space
159499|NCT03201341|MRI|mri
159500|NCT03201315|Fentanyl, opioids|fentanyl, opioids
159501|NCT03201302|bone|bone
159502|NCT03201302|childhood|childhood
159503|NCT03201302|pre-adolescence|pre-adolescence
159504|NCT03201302|bone turnover markers|bone turnover markers
159505|NCT03201302|sclerostin|sclerostin
159506|NCT03201302|sports|sports
159507|NCT03201302|physical activity|physical activity
159508|NCT03201302|nutrition|nutrition
159509|NCT03201276|glucosamine sulfate|glucosamine sulfate
159510|NCT03201276|individual differences|individual differences
159511|NCT03201276|gene polymorphism|gene polymorphism
159512|NCT03201250|carfilzomib|carfilzomib
159513|NCT03201250|cabozantinib|cabozantinib
159514|NCT03201250|proteasome inhibitor|proteasome inhibitor
159515|NCT03201250|resistance|resistance
159516|NCT03201237|Cerebral palsy|cerebral palsy
159517|NCT03201211|Safety|safety
159518|NCT03201211|Immunogenicity|immunogenicity
159519|NCT03201198|physical activity|physical activity
159520|NCT03201198|Chronic Obstructive Pulmonary Disease|chronic obstructive pulmonary disease
159521|NCT03201185|Cardiovascular events|cardiovascular events
159522|NCT03201185|Ventricular remodeling|ventricular remodeling
159523|NCT03201159|ASH|ash
159529|NCT03201029|center for ethnic skin|center for ethnic skin
159530|NCT03201029|skin of color clinic|skin of color clinic
159531|NCT03201029|ethnic skin center|ethnic skin center
159532|NCT03201016|cirrhosis|cirrhosis
159533|NCT03201003|AR101|ar101
159534|NCT03201003|Characterized Peanut Allergen|characterized peanut allergen
159535|NCT03201003|CPNA (Characterized Peanut Allergen)|cpna (characterized peanut allergen)
159536|NCT03201003|OIT (oral immunotherapy)|oit (oral immunotherapy)
159537|NCT03201003|Peanut Allergy|peanut allergy
159538|NCT03201003|Peanut-Allergic Children|peanut-allergic children
159539|NCT03201003|Desensitization|desensitization
159540|NCT03201003|ARTEMIS|artemis
159541|NCT03201003|Allergy|allergy
159542|NCT03200990|pressure-volume loops|pressure-volume loops
159543|NCT03200990|cardiac mechanics|cardiac mechanics
159544|NCT03200990|high-risk PCI|high-risk pci
159545|NCT03200938|pulpotomy|pulpotomy
159546|NCT03200938|Biological cement|biological cement
159547|NCT03200938|Deciduous tooth|deciduous tooth
159548|NCT03200925|video|video
159549|NCT03200925|skin-to-skin|skin-to-skin
159550|NCT03200925|kangaroo care|kangaroo care
159551|NCT03200925|prenatal education|prenatal education
159552|NCT03200899|cognitive rehabilitation|cognitive rehabilitation
159553|NCT03200886|hyaluronic acid|hyaluronic acid
159554|NCT03200886|intra-articular injections|intra-articular injections
159555|NCT03200886|triamcinolone|triamcinolone
159556|NCT03200886|osteoarthritis of the thumb|osteoarthritis of the thumb
159557|NCT03200873|transcranial magnetic stimulation|transcranial magnetic stimulation
159558|NCT03200873|theta burst stimulation|theta burst stimulation
159559|NCT03200873|impulsivity|impulsivity
159560|NCT03200860|heart failure|heart failure
159561|NCT03200860|diuretic response|diuretic response
159562|NCT03200860|empagliflozin|empagliflozin
159563|NCT03200847|Pembrolizumab|pembrolizumab
159564|NCT03200847|All-Trans Retinoic Acid|all-trans retinoic acid
159565|NCT03200834|Right colon cancer|right colon cancer
159566|NCT03200834|D3 dissection|d3 dissection
159567|NCT03200834|complete mesocolic excision|complete mesocolic excision
159568|NCT03200834|Hemicolectomy|hemicolectomy
159569|NCT03200808|Nonneoplastic Epithelial Disorders|nonneoplastic epithelial disorders
159570|NCT03200808|methylene blue|methylene blue
159571|NCT03200808|treatment|treatment
159572|NCT03200795|Diabetes|diabetes
159573|NCT03200795|Musculoskelatal pain|musculoskelatal pain
159574|NCT03200795|Rebound exercises|rebound exercises
159575|NCT03200795|Depression|depression
159576|NCT03200795|Glucose|glucose
159577|NCT03200795|Quality of life|quality of life
159578|NCT03200782|postprandial hypoglycemia|postprandial hypoglycemia
159579|NCT03200782|bariatric surgery|bariatric surgery
159580|NCT03200782|late dumping syndrome|late dumping syndrome
159581|NCT03200782|anakinra|anakinra
159582|NCT03200782|empagliflozin|empagliflozin
159583|NCT03200782|SGLT2 inhibitor|sglt2 inhibitor
159584|NCT03200782|IL-1Beta|il-1beta
159585|NCT03200782|IL1|il1
159586|NCT03200769|CPAP|cpap
159587|NCT03200769|Sleep Apnea Syndrome|sleep apnea syndrome
159588|NCT03200769|Pharmacoresistant Epilepsy|pharmacoresistant epilepsy
159589|NCT03200769|Apnea Hypopnea-Index|apnea hypopnea-index
159590|NCT03200756|sedentary behavior|sedentary behavior
159591|NCT03200743|Hypertension|hypertension
159592|NCT03200743|Pregnancy|pregnancy
159593|NCT03200743|Catestatin|catestatin
159594|NCT03200730|Family Dignity Intervention|family dignity intervention
159595|NCT03200730|Multicentre Randomized Control Trial|multicentre randomized control trial
159596|NCT03200730|Palliative Care|palliative care
159597|NCT03200730|End-of-Life Care|end-of-life care
159598|NCT03200717|renal cell carcinoma|renal cell carcinoma
159599|NCT03200717|metastatic renal cell|metastatic renal cell
159600|NCT03200717|pazopanib|pazopanib
159601|NCT03200717|checkpoint inhibitor therapy|checkpoint inhibitor therapy
159602|NCT03200717|RCC|rcc
159603|NCT03200717|hypernephroma|hypernephroma
159604|NCT03200717|renal adenocarcinoma|renal adenocarcinoma
159605|NCT03200717|kidney cancer|kidney cancer
159606|NCT03200717|renal cancer|renal cancer
159607|NCT03200717|adult|adult
159608|NCT03200691|Esophageal Squamous Cell Carcinoma|esophageal squamous cell carcinoma
159609|NCT03200691|PD-1|pd-1
159610|NCT03200691|Neoadjuvant treatment|neoadjuvant treatment
159611|NCT03200678|knee muscle|knee muscle
159612|NCT03200678|strength|strength
159613|NCT03200678|fatigue|fatigue
159614|NCT03200678|MRI|mri
159615|NCT03200678|ACL|acl
159616|NCT03200652|Lysine|lysine
159617|NCT03200652|Adult|adult
159618|NCT03200652|Protein Quality|protein quality
159619|NCT03200639|Breast Cancer Female|breast cancer female
159620|NCT03200639|Gynecologic Cancer|gynecologic cancer
159621|NCT03200639|Menopause|menopause
159622|NCT03200639|Physical Activity|physical activity
159623|NCT03200613|Spinal cord injury|spinal cord injury
159624|NCT03200613|Venous thromboembolism|venous thromboembolism
159625|NCT03200613|Hemorrhage|hemorrhage
159626|NCT03200600|Carcinoma, Non-Small-Cell Lung|carcinoma, non-small-cell lung
159627|NCT03200600|Surgery|surgery
159628|NCT03200600|Dexamethasone|dexamethasone
159629|NCT03200600|Flubiprofen Axetil|flubiprofen axetil
159630|NCT03200600|Delirium|delirium
159631|NCT03200587|Metastatic|metastatic
159632|NCT03200574|Perceval|perceval
159633|NCT03200522|Asthma, Diet|asthma, diet
159634|NCT03200509|nonspecific low back pain|nonspecific low back pain
159635|NCT03200509|chronic pain|chronic pain
159636|NCT03200483|Autonomic Nervous System|autonomic nervous system
159637|NCT03200483|Aerobic exercise|aerobic exercise
159638|NCT03200483|Recuperation|recuperation
159639|NCT03200483|Music|music
159640|NCT03200457|Liver iron|liver iron
159641|NCT03200457|Liver steatosis|liver steatosis
159642|NCT03200457|MRI|mri
159643|NCT03200405|umbilical hernia|umbilical hernia
159644|NCT03200405|mesh repair|mesh repair
159645|NCT03200405|MRI-visibility|mri-visibility
159646|NCT03200405|underlay|underlay
159647|NCT03200405|NANEP|nanep
159648|NCT03200405|DynaMeshCICAT|dynameshcicat
159649|NCT03200405|DynaMeshVisible|dynameshvisible
159650|NCT03200405|preperitoneal|preperitoneal
159651|NCT03200392|Er,Cr:YSGG laser|er,cr:ysgg laser
159652|NCT03200392|connective tissue graft|connective tissue graft
159653|NCT03200392|root coverage|root coverage
159654|NCT03200392|mucogingival surgery|mucogingival surgery
159655|NCT03200392|gingival recession|gingival recession
159656|NCT03200366|Cancer Screening Tests|cancer screening tests
159657|NCT03200366|Colonoscopy|colonoscopy
159658|NCT03200275|Legionella urine antigen test|legionella urine antigen test
159659|NCT03200249|dose escalation, chemo-radiation, rectum cancer, phase 2|dose escalation, chemo-radiation, rectum cancer, phase 2
159660|NCT03200236|Lung Cancer Screening|lung cancer screening
159661|NCT03200236|Smoking Cessation|smoking cessation
159662|NCT03200236|Tobacco Use|tobacco use
159663|NCT03200210|Continuous Ambulatory Peritoneal Dialysis (CAPD)|continuous ambulatory peritoneal dialysis (capd)
159664|NCT03200210|Hyperuricemia|hyperuricemia
159665|NCT03200210|Cardiovascular events|cardiovascular events
159666|NCT03200210|Treatment|treatment
159667|NCT03200197|Chewing gum|chewing gum
159668|NCT03200197|Artificial saliva|artificial saliva
159670|NCT03200197|Mastication|mastication
159671|NCT03200197|Salivary glands|salivary glands
159672|NCT03200197|Xerostomia|xerostomia
159673|NCT03200184|Hepatitis C|hepatitis c
159674|NCT03200184|sofosbuvir|sofosbuvir
159675|NCT03200184|daclatasvir|daclatasvir
159676|NCT03200171|Carcinoma, Hepatocellular|carcinoma, hepatocellular
159677|NCT03200171|Hepatitis C|hepatitis c
159678|NCT03200158|Stress related mucosal disease (SRMD)|stress related mucosal disease (srmd)
159679|NCT03200158|APACHEII score|apacheii score
159680|NCT03200158|C-reactive protein|c-reactive protein
159681|NCT03200158|Malondialdehyde (MDA)|malondialdehyde (mda)
159682|NCT03200158|transforming growth factor (TGF)|transforming growth factor (tgf)
159683|NCT03200158|interleukin (IL)|interleukin (il)
159684|NCT03200093|Clostridium difficile|clostridium difficile
159685|NCT03200093|C diff|c diff
159686|NCT03200093|Oral Vancomycin|oral vancomycin
159687|NCT03200093|Prophylaxis|prophylaxis
159688|NCT03200054|therapy|therapy
159689|NCT03200054|postnatal|postnatal
159690|NCT03200002|Lupus Nephritis, cyclophosphamide, Mycophenolate mofetil|lupus nephritis, cyclophosphamide, mycophenolate mofetil
159691|NCT03199989|colon cancer|colon cancer
159692|NCT03199989|adjuvant chemotherapy|adjuvant chemotherapy
159693|NCT03199989|high risk|high risk
159694|NCT03199976|wheeze|wheeze
159695|NCT03199976|shortness of breath|shortness of breath
159696|NCT03199963|Mammographic|mammographic
159697|NCT03199963|Breast|breast
159698|NCT03199963|Density|density
159699|NCT03199963|BIRADS C or D|birads c or d
159700|NCT03199950|Delirium|delirium
159701|NCT03199950|Haloperidol|haloperidol
159702|NCT03199950|Prophylactic|prophylactic
159703|NCT03199950|High-risk|high-risk
159704|NCT03199937|Autism Spectrum Disorder|autism spectrum disorder
159705|NCT03199937|Executive Functioning|executive functioning
159706|NCT03199937|Intervention|intervention
159707|NCT03199937|Flexible|flexible
159708|NCT03199937|Unstuck|unstuck
159709|NCT03199937|Transition|transition
159710|NCT03199937|Behavior|behavior
159711|NCT03199937|High school|high school
159712|NCT03199937|Problem Solving|problem solving
159713|NCT03199937|Self-Control|self-control
159714|NCT03199937|Coping|coping
159715|NCT03199924|acute pain|acute pain
159716|NCT03199924|Renal colic|renal colic
159717|NCT03199924|Diclofenac|diclofenac
159718|NCT03199924|Lidocain|lidocain
159719|NCT03199924|Magnesium sulfate|magnesium sulfate
159720|NCT03199898|Lung/Growth & Development|lung/growth & development
159721|NCT03199898|Respiration, artificial|respiration, artificial
159722|NCT03199898|Reproducibility of Results|reproducibility of results
159723|NCT03199898|Observer Variation|observer variation
159724|NCT03199859|gastric cancer|gastric cancer
159725|NCT03199859|postoperative|postoperative
159726|NCT03199859|subsyndromal delirium|subsyndromal delirium
159727|NCT03199859|quality of life|quality of life
159728|NCT03199833|rehabilitation|rehabilitation
159729|NCT03199833|orthosis|orthosis
159730|NCT03199833|functional electrical stimulation|functional electrical stimulation
159731|NCT03199833|electrode array|electrode array
159732|NCT03199833|upper limb|upper limb
159733|NCT03199833|sub-acute|sub-acute
159734|NCT03199833|motor relearning|motor relearning
159735|NCT03199807|HCC|hcc
159736|NCT03199807|NRT|nrt
159737|NCT03199807|TOMO radiotherapy|tomo radiotherapy
159738|NCT03199781|cellulits of leg|cellulits of leg
159739|NCT03199781|Motorized power massage|motorized power massage
159740|NCT03199781|massage|massage
159741|NCT03199768|architecture|architecture
159742|NCT03199768|delirium|delirium
159743|NCT03199768|environment|environment
159744|NCT03199768|hospital design and construction|hospital design and construction
159745|NCT03199755|therapeutic|therapeutic
159746|NCT03199755|ACT|act
159747|NCT03199755|gametocyte|gametocyte
159748|NCT03199729|Overground training|overground training
159749|NCT03199729|Dynamic Stability|dynamic stability
159750|NCT03199729|Fall risk|fall risk
159751|NCT03199703|PVI Ablation|pvi ablation
159752|NCT03199703|Cryoballoon|cryoballoon
159753|NCT03199677|apatinib,refractory thyroid cancer|apatinib,refractory thyroid cancer
159754|NCT03199638|Continuous Glucose Monitoring|continuous glucose monitoring
159755|NCT03199638|Children|children
159756|NCT03199638|Exercise|exercise
159757|NCT03199638|Glycated hemoglobin|glycated hemoglobin
159758|NCT03199638|Adolescents|adolescents
159759|NCT03199638|Insulin sensitivity|insulin sensitivity
159760|NCT03199638|Glutamine|glutamine
159761|NCT03199625|cognitive-behavior therapy|cognitive-behavior therapy
159762|NCT03199625|magnetic resonance imaging|magnetic resonance imaging
159763|NCT03199625|Panic Disorder|panic disorder
159764|NCT03199612|Thrombosis during Continuous Flow Pump Support|thrombosis during continuous flow pump support
159765|NCT03199599|PET/CT|pet/ct
159766|NCT03199599|image processing|image processing
159767|NCT03199599|outcome|outcome
159768|NCT03199586|Advanced or metastatic treatment-refractory solid tumor malignancies|advanced or metastatic treatment-refractory solid tumor malignancies
159769|NCT03199573|sunscreen|sunscreen
159770|NCT03199534|Pelvic Pain|pelvic pain
159771|NCT03199534|Dyspareunia|dyspareunia
159772|NCT03199534|Pelvic Floor Dysfunction|pelvic floor dysfunction
159773|NCT03199534|Pelvic Floor Physical Therapy|pelvic floor physical therapy
159774|NCT03199534|Chemodenervation|chemodenervation
159775|NCT03199534|Botulinum Toxin A|botulinum toxin a
159776|NCT03199534|Vaginismus|vaginismus
159777|NCT03199521|apixaban|apixaban
159778|NCT03199521|endogenous fibrinolysis|endogenous fibrinolysis
159779|NCT03199521|warfarin|warfarin
159780|NCT03199521|aspirin|aspirin
159781|NCT03199521|thrombotic status|thrombotic status
159782|NCT03199508|Nocturnal Enuresis|nocturnal enuresis
159783|NCT03199508|Voiding Diary|voiding diary
159784|NCT03199495|traditional Chinese medicine|traditional chinese medicine
159785|NCT03199495|electroacupuncture|electroacupuncture
159786|NCT03199495|abdominal pain|abdominal pain
159787|NCT03199469|AAV8-Delivered Gene Therapy|aav8-delivered gene therapy
159788|NCT03199469|XLMTM|xlmtm
159789|NCT03199469|Adeno Associated Virus|adeno associated virus
159790|NCT03199443|Sacral neuromodulation|sacral neuromodulation
159791|NCT03199443|Electromyography|electromyography
159792|NCT03199443|Pelvic floor|pelvic floor
159793|NCT03199430|catecholamines|catecholamines
159794|NCT03199430|Exercise|exercise
159795|NCT03199430|lipid metabolism|lipid metabolism
159796|NCT03199339|tuberculosis|tuberculosis
159797|NCT03199339|TBA7371|tba7371
159798|NCT03199339|TBA-7371|tba-7371
159799|NCT03199339|TB Alliance|tb alliance
159800|NCT03199339|TB|tb
159801|NCT03199339|Pulmonary Tuberculosis|pulmonary tuberculosis
159802|NCT03199313|tuberculosis|tuberculosis
159803|NCT03199313|TB|tb
159804|NCT03199313|Sutezolid|sutezolid
159805|NCT03199313|pulmonary tuberculosis|pulmonary tuberculosis
159806|NCT03199300|bleomycin|bleomycin
159807|NCT03199300|cisplatin|cisplatin
159808|NCT03199300|trastuzumab|trastuzumab
159809|NCT03199300|anthracyclines|anthracyclines
159810|NCT03199300|toxicity|toxicity
159811|NCT03199287|metagenomics|metagenomics
159812|NCT03199287|next-generation sequencing|next-generation sequencing
159813|NCT03199287|bioinformatics|bioinformatics
159814|NCT03199287|antibiotic susceptibility|antibiotic susceptibility
159815|NCT03199248|Digital Mucous Cyst|digital mucous cyst
159816|NCT03199248|capsulotomy|capsulotomy
159817|NCT03199235|iron intake|iron intake
159818|NCT03199235|iron bioavailability|iron bioavailability
159819|NCT03199222|amputation|amputation
159820|NCT03199222|transtibial|transtibial
159821|NCT03199222|socket|socket
159822|NCT03199222|pressure|pressure
159823|NCT03199209|physical activity|physical activity
159824|NCT03199209|healthy eating|healthy eating
159825|NCT03199209|behavioral intervention|behavioral intervention
159826|NCT03199209|community health worker|community health worker
159827|NCT03199209|Hispanic/Latino|hispanic/latino
159828|NCT03199196|Cancer Prevention|cancer prevention
159829|NCT03199196|African-American woman|african-american woman
159830|NCT03199196|Hispanic woman|hispanic woman
159831|NCT03199196|Sedentary|sedentary
159832|NCT03199196|Activity Tracker|activity tracker
159833|NCT03199196|Smartphone Application|smartphone application
159834|NCT03199196|Questionnaires|questionnaires
159835|NCT03199196|Surveys|surveys
159836|NCT03199196|Focus Group|focus group
159837|NCT03199196|Electronic Newsletters|electronic newsletters
159838|NCT03199196|Telephone Counseling|telephone counseling
159839|NCT03199183|Takayasu Arteritis|takayasu arteritis
159840|NCT03199183|registry|registry
159841|NCT03199170|Caesarean Section|caesarean section
159842|NCT03199170|Spinal anesthesia|spinal anesthesia
159843|NCT03199170|Quadratus lumborum block|quadratus lumborum block
159844|NCT03199170|Postoperative pain|postoperative pain
159845|NCT03199170|Intrathecal morphine|intrathecal morphine
159846|NCT03199144|Pancreatic Neoplasms|pancreatic neoplasms
159847|NCT03199144|Borderline resectable|borderline resectable
159848|NCT03199144|Neoadjuvant treatment|neoadjuvant treatment
159849|NCT03199144|Chemotherapy|chemotherapy
159850|NCT03199144|Stereotactic radiation|stereotactic radiation
159851|NCT03199118|root coverage|root coverage
159852|NCT03199092|Reading|reading
159853|NCT03199092|Developmental Dyslexia|developmental dyslexia
159854|NCT03199092|Music|music
159855|NCT03199092|Rhythm|rhythm
159856|NCT03199092|Intervention|intervention
159857|NCT03199066|survival|survival
159858|NCT03199066|therapy|therapy
159859|NCT03199066|epidemiology|epidemiology
159860|NCT03199053|Type 2 Diabetes Mellitus|type 2 diabetes mellitus
159861|NCT03199027|Adherence|adherence
159862|NCT03199001|Fabry Disease|fabry disease
159863|NCT03199001|T1 Mapping|t1 mapping
159864|NCT03199001|Cardiovascular Magnetic Resonance|cardiovascular magnetic resonance
159865|NCT03198975|magnetic resonance image features|magnetic resonance image features
159866|NCT03198975|pathological differentiation|pathological differentiation
159867|NCT03198975|machine learning-based model|machine learning-based model
159868|NCT03198962|ATS, Thai MSM TG, Use of amphetamine-type stimulants, HIV, adherence|ats, thai msm tg, use of amphetamine-type stimulants, hiv, adherence
159869|NCT03198923|Non-small Cell Lung Cancer|non-small cell lung cancer
159870|NCT03198897|familial hypercholesterolaemia|familial hypercholesterolaemia
159871|NCT03198897|Biomarker|biomarker
159872|NCT03198871|Post-operative pain|post-operative pain
159873|NCT03198871|Major abdominal surgery|major abdominal surgery
159874|NCT03198871|Colorectal surgery|colorectal surgery
159875|NCT03198871|Gastric surgery|gastric surgery
159876|NCT03198858|Paroxysmal Atrial Fibrillation|paroxysmal atrial fibrillation
159877|NCT03198845|knee osteoarthritis|knee osteoarthritis
159878|NCT03198845|video game|video game
159879|NCT03198845|therapeutic effects|therapeutic effects
159880|NCT03198832|Periodontal Disease|periodontal disease
159881|NCT03198832|Type 2 Diabetes Mellitus|type 2 diabetes mellitus
159882|NCT03198832|Z-scan|z-scan
159883|NCT03198832|Atherosclerosis|atherosclerosis
159884|NCT03198819|Topical rifampicin, neural tube defects, infection, newborn|topical rifampicin, neural tube defects, infection, newborn
159885|NCT03198806|Autonomic Nervous System|autonomic nervous system
159886|NCT03198806|Fluid Therapy|fluid therapy
159887|NCT03198806|Heart Rate|heart rate
159888|NCT03198806|Exercise|exercise
159889|NCT03198767|obesity|obesity
159890|NCT03198767|overweight|overweight
159891|NCT03198767|body mass index|body mass index
159892|NCT03198767|BMI|bmi
159893|NCT03198767|diarrhea|diarrhea
159894|NCT03198754|Autologous Stem Cell Transplant|autologous stem cell transplant
159895|NCT03198754|Multiple Myeloma|multiple myeloma
159896|NCT03198754|oncology|oncology
159897|NCT03198754|circadian rhythms|circadian rhythms
159898|NCT03198754|light therapy|light therapy
159899|NCT03198754|Hematopoietic stem cell transplantation|hematopoietic stem cell transplantation
159900|NCT03198715|Fibrinolysis enhancer|fibrinolysis enhancer
159901|NCT03198715|TAFIa inhibitor|tafia inhibitor
159902|NCT03198715|Developmental Phase I|developmental phase i
159903|NCT03198702|physiotherapy|physiotherapy
159904|NCT03198702|children|children
159905|NCT03198702|shoulder deformation|shoulder deformation
159906|NCT03198702|obstetrical brachial plexus palsy|obstetrical brachial plexus palsy
159907|NCT03198689|systemic sclerosis|systemic sclerosis
159908|NCT03198689|scleroderma|scleroderma
159909|NCT03198689|brentuximab vedotin|brentuximab vedotin
159910|NCT03198689|CD30-directed antibody-drug conjugate|cd30-directed antibody-drug conjugate
159911|NCT03198689|antirheumatic agents|antirheumatic agents
159912|NCT03198689|antineoplastic agents|antineoplastic agents
159913|NCT03198689|connective tissue diseases|connective tissue diseases
159914|NCT03198689|skin diseases|skin diseases
159915|NCT03198689|immunologic factors|immunologic factors
159916|NCT03198637|efficient|efficient
159917|NCT03198637|neuromuscular|neuromuscular
159918|NCT03198637|blockade|blockade
159919|NCT03198572|Non-alcoholic steatohepatitis|non-alcoholic steatohepatitis
159920|NCT03198559|HIV latency|hiv latency
159921|NCT03198559|Disulfiram|disulfiram
159922|NCT03198559|Vorinostat|vorinostat
159923|NCT03198559|Latency Reversing Agents|latency reversing agents
159924|NCT03198559|Histone Deacetylase Inhibitors (HDACi)|histone deacetylase inhibitors (hdaci)
159925|NCT03198546|Hepatocellular carcinoma|hepatocellular carcinoma
159926|NCT03198546|immunotherapy|immunotherapy
159927|NCT03198546|CAR-T cell therapy|car-t cell therapy
159928|NCT03198546|GPC3 or TGFβ targeting|gpc3 or tgfβ targeting
159929|NCT03198546|Phase I clinical study|phase i clinical study
160227|NCT03196713|Autism|autism
159930|NCT03198546|squamous cell lung cancer|squamous cell lung cancer
159931|NCT03198546|interventional radiology|interventional radiology
159932|NCT03198546|IL7-CCL19-secreting|il7-ccl19-secreting
159934|NCT03198533|Arthrosis|arthrosis
159935|NCT03198533|Implant|implant
159936|NCT03198481|midurethral sling|midurethral sling
159937|NCT03198481|movie|movie
159938|NCT03198481|preparedness|preparedness
159939|NCT03198481|Video Counseling|video counseling
159940|NCT03198468|Non Small Cell Lung Cancer|non small cell lung cancer
159941|NCT03198468|Metastatic Lung Cancer|metastatic lung cancer
204274|NCT02919163|affect|affect
159942|NCT03198468|Lung Cancer|lung cancer
159943|NCT03198468|Vapor Ablation|vapor ablation
159944|NCT03198468|BTVA|btva
159945|NCT03198429|domestic violence|domestic violence
159946|NCT03198429|dyadic mother-child intervention|dyadic mother-child intervention
159947|NCT03198429|fathers|fathers
159948|NCT03198429|parenting|parenting
159949|NCT03198429|young children|young children
159950|NCT03198377|Pain Threshold|pain threshold
159951|NCT03198377|Transcutaneous Electrical Nerve Stimulation|transcutaneous electrical nerve stimulation
159952|NCT03198377|Habituation|habituation
159953|NCT03198325|HIV-1|hiv-1
159954|NCT03198299|therapeutic effects|therapeutic effects
159955|NCT03198299|insoles|insoles
159956|NCT03198299|children|children
159957|NCT03198273|clinical pilates|clinical pilates
159958|NCT03198273|exercise|exercise
159959|NCT03198273|lumbar disc herniation|lumbar disc herniation
159960|NCT03198273|chronic low back pain|chronic low back pain
159961|NCT03198234|Pediatric|pediatric
159962|NCT03198234|GvHD|gvhd
159963|NCT03198234|Hematopoietic Stem Cell Transplantation|hematopoietic stem cell transplantation
159964|NCT03198234|Stem Cells|stem cells
159965|NCT03198234|Transplant|transplant
159966|NCT03198234|BMT - bone marrow transplant|bmt - bone marrow transplant
159967|NCT03198221|Golytely, Clenpiq, bowel prep|golytely, clenpiq, bowel prep
159968|NCT03198156|Transcranial Direct Current Stimulation|transcranial direct current stimulation
159969|NCT03198156|Without Cataplexy|without cataplexy
159970|NCT03198143|Decision-making|decision-making
159971|NCT03198143|Ghrelin|ghrelin
159972|NCT03198143|Healthy Volunteers|healthy volunteers
159973|NCT03198143|Obese|obese
159974|NCT03198104|Multiparametric MR Imaging|multiparametric mr imaging
159975|NCT03198104|Paediatric|paediatric
159976|NCT03198091|stable angina pectoris|stable angina pectoris
159977|NCT03198091|Dun Ye Guan Xin Ning|dun ye guan xin ning
159978|NCT03198078|Brexpiprazole|brexpiprazole
159979|NCT03198078|Schizophrenia|schizophrenia
159980|NCT03198078|Adolescent|adolescent
159981|NCT03198065|Laparoscopic appendectomy|laparoscopic appendectomy
159982|NCT03198065|Single-incision laparoscopic appendectomy|single-incision laparoscopic appendectomy
159983|NCT03198065|Single-incision laparoscopic surgery setting|single-incision laparoscopic surgery setting
159984|NCT03198065|Simple appendicitis|simple appendicitis
159985|NCT03198065|Complicated appendicitis|complicated appendicitis
159986|NCT03198052|Lung Cancer|lung cancer
159987|NCT03198052|CAR-T Cell Therapy|car-t cell therapy
159988|NCT03198052|PSCA|psca
159989|NCT03198052|MUC1|muc1
159990|NCT03198052|HER2|her2
159991|NCT03198052|Mesothelin|mesothelin
159992|NCT03198052|Lewis-Y, PD-L1|lewis-y, pd-l1
159993|NCT03198039|Meditation|meditation
159994|NCT03198039|Cognitive Dysfunction|cognitive dysfunction
159995|NCT03198039|Postoperative Period|postoperative period
159996|NCT03198039|Cardiac Surgery|cardiac surgery
159997|NCT03198000|Eye Redness|eye redness
159998|NCT03198000|Eye Comfort|eye comfort
159999|NCT03198000|Red Eyes|red eyes
160000|NCT03197987|adenoma detection rate|adenoma detection rate
160001|NCT03197987|cap-assisted colonoscopy|cap-assisted colonoscopy
160002|NCT03197987|endocuff|endocuff
160003|NCT03197974|stage|stage
160004|NCT03197974|online|online
160005|NCT03197974|self-help|self-help
160006|NCT03197974|coaching support|coaching support
160007|NCT03197974|quality of life|quality of life
160008|NCT03197974|mindfulness|mindfulness
160009|NCT03197974|psychoeducation|psychoeducation
160010|NCT03197974|persuasive systems design|persuasive systems design
160011|NCT03197974|psychosocial|psychosocial
160012|NCT03197922|Autism Spectrum Disorder|autism spectrum disorder
160013|NCT03197922|Constipation|constipation
160014|NCT03197909|COPD (Chronic Obstructive Pulmonary Patients)|copd (chronic obstructive pulmonary patients)
160015|NCT03197909|Atrophy|atrophy
160016|NCT03197909|cell cultur|cell cultur
160017|NCT03197909|systemic inflammation|systemic inflammation
160018|NCT03197909|Catabolism|catabolism
160019|NCT03197857|Bariatric surgery|bariatric surgery
160020|NCT03197857|Morbid obesity|morbid obesity
160021|NCT03197857|Physical condition|physical condition
160022|NCT03197857|Muscle|muscle
160023|NCT03197857|6-minute walking test|6-minute walking test
160024|NCT03197857|Protein supplementation|protein supplementation
160025|NCT03197857|Physical activity program|physical activity program
160026|NCT03197831|Medicaid Expansion, Affordable Care Act, Health Care Reform|medicaid expansion, affordable care act, health care reform
160027|NCT03197818|COPD|copd
160028|NCT03197818|Anticholinergics|anticholinergics
160029|NCT03197818|Triple Combination|triple combination
160030|NCT03197805|Equivocal Her 2|equivocal her 2
160031|NCT03197805|Genomic test|genomic test
160032|NCT03197792|Transesophageal ultrasound|transesophageal ultrasound
160033|NCT03197792|TEE|tee
160034|NCT03197792|Portal vein pulsatility|portal vein pulsatility
160035|NCT03197792|Splenic vein pulsatility|splenic vein pulsatility
160036|NCT03197792|Venous congestion|venous congestion
160037|NCT03197792|Strain|strain
160038|NCT03197792|Right ventricular dysfunction|right ventricular dysfunction
160039|NCT03197792|Pulmonary hypertension|pulmonary hypertension
160040|NCT03197792|Venous hypertension|venous hypertension
160041|NCT03197766|Achondroplasia|achondroplasia
160042|NCT03197766|Dwarfism|dwarfism
160043|NCT03197766|Bone Diseases|bone diseases
160044|NCT03197766|Bone Diseases, Developmental|bone diseases, developmental
160045|NCT03197766|ACH|ach
160046|NCT03197766|Natriuretic Peptide, C-Type|natriuretic peptide, c-type
160047|NCT03197766|Musculoskeletal Diseases|musculoskeletal diseases
160048|NCT03197766|Natriuretic Agents|natriuretic agents
160049|NCT03197766|Physiological Effects of Drugs|physiological effects of drugs
160050|NCT03197766|Skeletal Dysplasias|skeletal dysplasias
160051|NCT03197766|Genetic Diseases, Inborn|genetic diseases, inborn
160052|NCT03197766|Osteochondrodysplasias|osteochondrodysplasias
160053|NCT03197753|laryngeal mask airway|laryngeal mask airway
160054|NCT03197753|nasotracheal intubation|nasotracheal intubation
160055|NCT03197753|dental treatment|dental treatment
160056|NCT03197727|Tooth wear, risk factors, saliva, diet, oral hygiene|tooth wear, risk factors, saliva, diet, oral hygiene
160057|NCT03197714|Myeloid Leukemia|myeloid leukemia
160058|NCT03197701|Lung function|lung function
160059|NCT03197701|Inspiratory flow rates|inspiratory flow rates
160060|NCT03197675|Chronic pain|chronic pain
160061|NCT03197675|Acupuncture|acupuncture
160062|NCT03197662|Prader-Willi Syndrome|prader-willi syndrome
160063|NCT03197662|Hyperphagia|hyperphagia
160064|NCT03197636|Vitamin D|vitamin d
160065|NCT03197636|Soluble PD-1|soluble pd-1
160066|NCT03197623|Glucocorticoids|glucocorticoids
160067|NCT03197610|gingival recession|gingival recession
160068|NCT03197610|sub epithelial connective tissue graft|sub epithelial connective tissue graft
160069|NCT03197610|enamel matrix derivatives|enamel matrix derivatives
160070|NCT03197610|root coverage aesthetic score|root coverage aesthetic score
160071|NCT03197597|B. pertussis|b. pertussis
160072|NCT03197597|Acellular vaccination|acellular vaccination
160073|NCT03197597|Strain variation|strain variation
160074|NCT03197532|fertility|fertility
160075|NCT03197532|hormones|hormones
160076|NCT03197532|healthy|healthy
160077|NCT03197532|chemotherapy|chemotherapy
160078|NCT03197532|oncofertility|oncofertility
160079|NCT03197532|alkylating agent|alkylating agent
160080|NCT03197532|fertility after cancer|fertility after cancer
160081|NCT03197532|late effects|late effects
160082|NCT03197532|survivorship|survivorship
160083|NCT03197532|healthy volunteers|healthy volunteers
160084|NCT03197532|perimenopause|perimenopause
160085|NCT03197532|middle age|middle age
160086|NCT03197519|mHealth|mhealth
160087|NCT03197519|Eating Disorders|eating disorders
160088|NCT03197519|Randomised Controlled Trial|randomised controlled trial
160089|NCT03197519|Cognitive Behavioural Therapy|cognitive behavioural therapy
160090|NCT03197519|cost effectiveness|cost effectiveness
160091|NCT03197480|Anti-Vascular Endothelial Growth Factor|anti-vascular endothelial growth factor
160092|NCT03197480|Aflibercept|aflibercept
160093|NCT03197480|Intravitreal injection|intravitreal injection
160094|NCT03197480|Diabetic Macular Edema|diabetic macular edema
160095|NCT03197441|Platelet-rich plasma|platelet-rich plasma
160096|NCT03197441|Osteoarthritis Knee|osteoarthritis knee
160097|NCT03197428|Platelet-Rich Plasma|platelet-rich plasma
160098|NCT03197428|Ankle Injuries|ankle injuries
160099|NCT03197428|Lateral Ligament, Ankle|lateral ligament, ankle
160100|NCT03197415|Platelet-rich plasma|platelet-rich plasma
160101|NCT03197415|Intervertebral Disc Degeneration|intervertebral disc degeneration
160102|NCT03197415|Low Back Pain|low back pain
160103|NCT03197402|Leucine|leucine
160104|NCT03197402|Protein|protein
160105|NCT03197402|Supplementation|supplementation
160106|NCT03197389|Biomarker|biomarker
160107|NCT03197363|Civilization diseases|civilization diseases
160108|NCT03197363|Cardiovascular Risk Factor|cardiovascular risk factor
160109|NCT03197363|Population study|population study
160110|NCT03197363|Intestinal microbiome|intestinal microbiome
160111|NCT03197363|Oral microbiome|oral microbiome
160112|NCT03197350|heart failure with preserved ejection fraction|heart failure with preserved ejection fraction
160113|NCT03197350|Imaging|imaging
160114|NCT03197350|Prognosis|prognosis
160115|NCT03197337|Vulvodynia|vulvodynia
160116|NCT03197337|Localized Provoked Vulvodynia (LPV)|localized provoked vulvodynia (lpv)
160117|NCT03197337|Referred pain|referred pain
160118|NCT03197337|Utero-Sacral ligaments laxity|utero-sacral ligaments laxity
160119|NCT03197311|Oral surgery|oral surgery
160120|NCT03197311|Medication adherence|medication adherence
160121|NCT03197298|Acute Coronary Syndrome|acute coronary syndrome
160122|NCT03197298|Percutaneous Coronary Intervention|percutaneous coronary intervention
160123|NCT03197298|Drug-Eluting Stents|drug-eluting stents
161326|NCT03190057|BioFreedom|biofreedom
160124|NCT03197298|Platelet Aggregation Inhibitors|platelet aggregation inhibitors
160125|NCT03197298|Ticagrelor|ticagrelor
160126|NCT03197298|clopidogrel|clopidogrel
160127|NCT03197298|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists
160128|NCT03197285|neck pain|neck pain
160129|NCT03197285|eye|eye
160130|NCT03197285|propioception|propioception
160131|NCT03197285|range of motion|range of motion
160132|NCT03197285|pain|pain
160133|NCT03197272|Myopia|myopia
160134|NCT03197272|corneal Crosslinking|corneal crosslinking
160135|NCT03197259|CLL, del(17p)|cll, del(17p)
160136|NCT03197246|PICC line|picc line
160137|NCT03197246|ECG|ecg
160138|NCT03197246|chest x-ray|chest x-ray
160139|NCT03197246|IVECG|ivecg
160140|NCT03197246|ICECG|icecg
160141|NCT03197194|Central retinal artery occlusion|central retinal artery occlusion
160142|NCT03197194|visual acuity|visual acuity
160143|NCT03197194|visual field|visual field
160144|NCT03197194|mRs|mrs
160145|NCT03197194|NEI-VFQ-25|nei-vfq-25
160146|NCT03197168|stigma|stigma
160147|NCT03197168|psychosocial intervention|psychosocial intervention
160148|NCT03197168|low-and-middle income countries|low-and-middle income countries
160149|NCT03197142|cardiac arrest|cardiac arrest
160150|NCT03197142|resuscitation|resuscitation
160151|NCT03197142|Out-Of-Hospital Cardiac Arrest|out-of-hospital cardiac arrest
160152|NCT03197142|CPR|cpr
160153|NCT03197103|Autologous fat grafting|autologous fat grafting
160154|NCT03197103|Breast|breast
160155|NCT03197103|Deformity|deformity
160156|NCT03197103|Asymmetry|asymmetry
160157|NCT03197103|Tuberous breast|tuberous breast
160158|NCT03197103|Acetylcysteine|acetylcysteine
160159|NCT03197090|Screening|screening
160160|NCT03197090|Zenicor|zenicor
160161|NCT03197051|Endothelial glycocalyx|endothelial glycocalyx
160162|NCT03197051|Acute kidney injury|acute kidney injury
160163|NCT03197051|Valvular heart disease|valvular heart disease
160164|NCT03197038|Cognitive function|cognitive function
160165|NCT03197038|Kidney Disease|kidney disease
160166|NCT03197038|Exercise|exercise
160167|NCT03197038|Older adults|older adults
160168|NCT03197025|HPV-16|hpv-16
160169|NCT03197025|Premalignancy|premalignancy
160170|NCT03197025|T Cell Therapy|t cell therapy
160171|NCT03197012|neuroendocrine tumor (NET)|neuroendocrine tumor (net)
160172|NCT03197012|Peptide Receptor Radionuclide Therapy (PRRT)|peptide receptor radionuclide therapy (prrt)
160173|NCT03197012|somatostatin receptor (SSTR)|somatostatin receptor (sstr)
160174|NCT03196999|PTSD|ptsd
160175|NCT03196999|Attention bias modification|attention bias modification
160176|NCT03196999|Remote app-based study|remote app-based study
160177|NCT03196999|Digital Health|digital health
160178|NCT03196960|Mobilization Therapy|mobilization therapy
160179|NCT03196960|Critical Illness|critical illness
160180|NCT03196960|Muscle Strength|muscle strength
160181|NCT03196960|Functional Mobility|functional mobility
160182|NCT03196960|Outcome|outcome
160183|NCT03196960|Intensive Care Unit|intensive care unit
160184|NCT03196960|Quality of Life|quality of life
160185|NCT03196947|multiple myeloma|multiple myeloma
160186|NCT03196947|APO010|apo010
160187|NCT03196947|Drug Response Predictor|drug response predictor
160188|NCT03196947|DRP|drp
160189|NCT03196921|amphotericin B|amphotericin b
160190|NCT03196921|cryptococcal|cryptococcal
160191|NCT03196908|ECG|ecg
160192|NCT03196908|Blood Pressure|blood pressure
160193|NCT03196908|Energy Drinks|energy drinks
160194|NCT03196895|Diabetes Mellitus, Type 2|diabetes mellitus, type 2
160195|NCT03196895|Continuous Glucose Monitoring|continuous glucose monitoring
160196|NCT03196895|Lifestyle Modification|lifestyle modification
160197|NCT03196882|pregnancy|pregnancy
160198|NCT03196882|iron|iron
160199|NCT03196882|hemoglobin|hemoglobin
160200|NCT03196882|supplementation|supplementation
160201|NCT03196882|neurodevelopment|neurodevelopment
160202|NCT03196882|newborn|newborn
160203|NCT03196882|anemia|anemia
160204|NCT03196882|clinical trial|clinical trial
160205|NCT03196869|NPC peripheral blood dendritic cell chronic-chemotherap|npc peripheral blood dendritic cell chronic-chemotherap
160206|NCT03196856|Greek Yogurt|greek yogurt
160207|NCT03196856|Muscle Size|muscle size
160208|NCT03196856|Bone Health|bone health
160209|NCT03196856|Body Composition|body composition
160210|NCT03196856|Exercise|exercise
160211|NCT03196843|raltitrexed|raltitrexed
160212|NCT03196843|radiotherapy|radiotherapy
160213|NCT03196843|older patient|older patient
160214|NCT03196843|head and neck squamous cell carcinoma|head and neck squamous cell carcinoma
160215|NCT03196830|Relapse/refractory non-Hodgkin lymphoma|relapse/refractory non-hodgkin lymphoma
160216|NCT03196830|CAR - T CD19/CD20/CD22/CD30|car - t cd19/cd20/cd22/cd30
160217|NCT03196817|Random Allocation|random allocation
160218|NCT03196817|Injections|injections
160219|NCT03196817|Orthotic Devices|orthotic devices
160220|NCT03196765|X-ALD|x-ald
160221|NCT03196752|cricothyroid membrane|cricothyroid membrane
160222|NCT03196726|cognitive-behavioral therapy|cognitive-behavioral therapy
160223|NCT03196713|Allegiance|allegiance
160224|NCT03196713|Knowledge|knowledge
160225|NCT03196713|Supervision|supervision
160226|NCT03196713|Early intervention|early intervention
160228|NCT03196700|palliative care|palliative care
160229|NCT03196700|head and neck cancer|head and neck cancer
160230|NCT03196700|radiotherapy|radiotherapy
160232|NCT03196700|quality of life|quality of life
160233|NCT03196687|diastolic dysfunction|diastolic dysfunction
160234|NCT03196661|safety investigation|safety investigation
160235|NCT03196648|Gingivitis|gingivitis
160236|NCT03196648|Periodontal disease|periodontal disease
160237|NCT03196648|Inflammation|inflammation
160238|NCT03196648|Teeth whitening|teeth whitening
160239|NCT03196648|Breath freshening|breath freshening
160240|NCT03196648|Periodontal pathogens|periodontal pathogens
160241|NCT03196648|Bleeding on probing|bleeding on probing
160242|NCT03196622|Sarcopenia|sarcopenia
160243|NCT03196622|Elderly people|elderly people
160244|NCT03196622|Hospitalization|hospitalization
160245|NCT03196609|Intestinal microbiota, microbial genes, oncology|intestinal microbiota, microbial genes, oncology
160246|NCT03196596|TAVI|tavi
160247|NCT03196596|Computer simulation|computer simulation
160248|NCT03196583|obstructive sleep apnea syndrome|obstructive sleep apnea syndrome
160249|NCT03196583|video-polysomnography|video-polysomnography
160250|NCT03196583|mandibular advancement device|mandibular advancement device
160251|NCT03196583|oral device|oral device
160252|NCT03196583|cephalometry|cephalometry
160253|NCT03196518|PET Imaging|pet imaging
160254|NCT03196518|18F-TFB|18f-tfb
160255|NCT03196518|17-315|17-315
160256|NCT03196505|Anesthetics, Local|anesthetics, local
160257|NCT03196505|Liposomal Bupivacaine|liposomal bupivacaine
160258|NCT03196505|Bupivacaine|bupivacaine
160259|NCT03196505|Postoperative Complications|postoperative complications
160260|NCT03196505|Roux-en-Y Gastric Bypass|roux-en-y gastric bypass
160261|NCT03196505|Sleeve Gastrectomy|sleeve gastrectomy
160262|NCT03196505|Laparoscopic Bariatric Surgery|laparoscopic bariatric surgery
160263|NCT03196466|antiepileptics|antiepileptics
160264|NCT03196466|pharmacokinetics|pharmacokinetics
160265|NCT03196466|children|children
160266|NCT03196453|overweight|overweight
160267|NCT03196453|probiotic|probiotic
160268|NCT03196453|weight management|weight management
160269|NCT03196440|elderly|elderly
160270|NCT03196440|taste|taste
160271|NCT03196440|thresholds|thresholds
160272|NCT03196427|Drug Therapy|drug therapy
160273|NCT03196401|Durvalumb|durvalumb
160274|NCT03196401|Radiation Therapy|radiation therapy
160275|NCT03196401|Clonal Bone Marrow Plasmacytosis|clonal bone marrow plasmacytosis
160276|NCT03196401|MEDI4736|medi4736
160277|NCT03196401|17-269|17-269
160278|NCT03196388|ENZALUTAMIDE|enzalutamide
160279|NCT03196388|External Beam Hypofractionated Radiotherapy Intermediate Risk Prostate Cancer|external beam hypofractionated radiotherapy intermediate risk prostate cancer
160280|NCT03196375|Motor Neuron Disease|motor neuron disease
160281|NCT03196375|Neurodegenerative Diseases|neurodegenerative diseases
160282|NCT03196375|Nervous System Diseases|nervous system diseases
160283|NCT03196375|Neuromuscular Diseases|neuromuscular diseases
160284|NCT03196375|Amyotrophic Lateral Sclerosis|amyotrophic lateral sclerosis
160285|NCT03196375|Primary Lateral Sclerosis|primary lateral sclerosis
160286|NCT03196375|Progressive Muscular Atrophy|progressive muscular atrophy
160287|NCT03196375|Muscle cramps|muscle cramps
160288|NCT03196375|Muscle cramping|muscle cramping
160289|NCT03196375|ALS|als
160290|NCT03196375|MND|mnd
160291|NCT03196375|PMA|pma
160292|NCT03196375|PLS|pls
160293|NCT03196375|FLX-787|flx-787
160294|NCT03196362|short-term intensive insulin therapy|short-term intensive insulin therapy
160295|NCT03196362|pioglitazone|pioglitazone
160296|NCT03196362|metformin|metformin
160297|NCT03196362|remission|remission
160298|NCT03196362|sequential therapy|sequential therapy
160299|NCT03196258|fracture|fracture
160300|NCT03196258|persistent pain|persistent pain
160301|NCT03196258|cognitive behavioural therapy|cognitive behavioural therapy
160302|NCT03196258|post surgical pain|post surgical pain
160303|NCT03196258|health-related quality of life|health-related quality of life
160304|NCT03196167|sugammadex|sugammadex
160305|NCT03196167|extubation|extubation
160306|NCT03196167|CABG, AVR, CABG/AVR combination|cabg, avr, cabg/avr combination
160307|NCT03196154|Homeostasis Model Assessment|homeostasis model assessment
160308|NCT03196154|Insulin Resistance|insulin resistance
160309|NCT03196154|Beta Cell Function|beta cell function
160310|NCT03196154|Liquid Chromatography Tandem Mass Spectrometry|liquid chromatography tandem mass spectrometry
160311|NCT03196115|Hyaline Fibromatosis Syndrome|hyaline fibromatosis syndrome
160312|NCT03196115|Biomarker|biomarker
160313|NCT03196102|tobacco prevention; tobacco intervention; military; brief intervention|tobacco prevention; tobacco intervention; military; brief intervention
160314|NCT03196063|Exercise Therapy|exercise therapy
160315|NCT03196063|Heavy Slow Resistance Program|heavy slow resistance program
160316|NCT03196063|Rehabilitation|rehabilitation
160317|NCT03196024|Diabetes; CVD; Lifestyle; Hispanic; Promotora|diabetes; cvd; lifestyle; hispanic; promotora
160318|NCT03196024|Diabetes Mellitus, Type 2|diabetes mellitus, type 2
160319|NCT03196024|Cardiovascular Diseases|cardiovascular diseases
160320|NCT03196024|Risk Reduction Behavior|risk reduction behavior
160321|NCT03196024|Hispanic Americans; Latinos|hispanic americans; latinos
160322|NCT03196024|Community Health Workers|community health workers
160323|NCT03195972|Adherence, Patient, oncology, oral therapy|adherence, patient, oncology, oral therapy
160324|NCT03195959|Pulmonary arterial hypertension|pulmonary arterial hypertension
160325|NCT03195959|Chronic thromboembolic pulmonary hypertension|chronic thromboembolic pulmonary hypertension
160326|NCT03195959|Hypoxia|hypoxia
160327|NCT03195959|Hyperoxia|hyperoxia
160328|NCT03195933|Depression|depression
160329|NCT03195933|Childhood Adversity|childhood adversity
160330|NCT03195933|Childhood Abuse|childhood abuse
160331|NCT03195933|Cortisol|cortisol
160332|NCT03195933|Emotional Memory|emotional memory
160333|NCT03195933|Magnetic Resonance Imaging (MRI)|magnetic resonance imaging (mri)
160334|NCT03195907|Stroke|stroke
160335|NCT03195907|Mortality|mortality
160336|NCT03195907|Intensive care unit|intensive care unit
160337|NCT03195907|Pulmonary rehabilitation|pulmonary rehabilitation
160338|NCT03195894|Alcohol abuse, Alcoholometer, Medical Device, App|alcohol abuse, alcoholometer, medical device, app
160339|NCT03195868|chemotherapy|chemotherapy
160340|NCT03195868|chemo-induced|chemo-induced
160341|NCT03195868|CIPN|cipn
160342|NCT03195829|Mild Cognitive Impairment|mild cognitive impairment
160343|NCT03195829|Computerized Cognitive Stimulation|computerized cognitive stimulation
160344|NCT03195829|Cognition|cognition
160345|NCT03195829|Psychosocial factors|psychosocial factors
160346|NCT03195816|Mild Cognitive Impairment|mild cognitive impairment
160347|NCT03195816|white matter hyperintensities|white matter hyperintensities
160348|NCT03195816|computerized cognitive training|computerized cognitive training
160349|NCT03195816|brain plasticity|brain plasticity
160350|NCT03195751|telemonitoring|telemonitoring
160351|NCT03195738|pediatrics|pediatrics
160352|NCT03195738|case series|case series
160353|NCT03195738|feasibility|feasibility
160354|NCT03195712|BMI|bmi
160355|NCT03195712|Obesity|obesity
160356|NCT03195699|STAT3, cancer, inhibitor, advanced cancer|stat3, cancer, inhibitor, advanced cancer
160357|NCT03195673|Carotid artery stenting|carotid artery stenting
160358|NCT03195673|Silent embolism|silent embolism
160359|NCT03195673|Terazosin|terazosin
160360|NCT03195660|adaptive servo-ventilation|adaptive servo-ventilation
160361|NCT03195660|ASV|asv
160362|NCT03195660|HFpEF|hfpef
160363|NCT03195647|cardiovascular|cardiovascular
160364|NCT03195647|potassium supplementation|potassium supplementation
160365|NCT03195647|coronary artery by pass surgery|coronary artery by pass surgery
160366|NCT03195634|Cirrhosis|cirrhosis
160367|NCT03195634|Portal Hypertension|portal hypertension
160368|NCT03195621|Coronary Artery Disease|coronary artery disease
160369|NCT03195621|Critical lesion|critical lesion
160370|NCT03195608|In-vehicle technologies|in-vehicle technologies
160371|NCT03195608|Parkinson's disease|parkinson's disease
160372|NCT03195608|Driving performance|driving performance
160373|NCT03195569|QL1101 Avastin® Non Small Cell Lung Cancer|ql1101 avastin® non small cell lung cancer
160374|NCT03195543|Blood coagulation disorders|blood coagulation disorders
160375|NCT03195543|Platelets|platelets
160376|NCT03195543|Thrombin|thrombin
160377|NCT03195543|Treatment|treatment
160378|NCT03195517|Osteopenia|osteopenia
160379|NCT03195517|Physical activity|physical activity
160380|NCT03195517|Bone turnover markers|bone turnover markers
160381|NCT03195517|Osteoprogenitor cells|osteoprogenitor cells
160382|NCT03195517|Quality of life|quality of life
160383|NCT03195452|HIV|hiv
160384|NCT03195452|Antiretrovirals|antiretrovirals
160385|NCT03195452|Raltegravir|raltegravir
160386|NCT03195413|Hand blast injury|hand blast injury
160387|NCT03195413|Nerve block|nerve block
160388|NCT03195413|Hand injury|hand injury
160389|NCT03195413|Forearm nerve block|forearm nerve block
160390|NCT03195413|Ultrasound guided nerve block|ultrasound guided nerve block
160391|NCT03195413|Ultrasound nerve block|ultrasound nerve block
160392|NCT03195413|Emergency department|emergency department
160393|NCT03195413|Emergency physician|emergency physician
160394|NCT03195413|Emergency room|emergency room
160395|NCT03195387|malaria, P. falciparum, chemoprotection, Phase Ib|malaria, p. falciparum, chemoprotection, phase ib
160396|NCT03195374|Analgesic opioids|analgesic opioids
160397|NCT03195374|Misuse|misuse
160398|NCT03195374|Use disorder|use disorder
160399|NCT03195374|Pain|pain
160400|NCT03195335|Cerebral Palsy|cerebral palsy
160401|NCT03195335|Participation|participation
160402|NCT03195335|LIFE Habits (life-H)|life habits (life-h)
160403|NCT03195335|Validity|validity
160404|NCT03195335|Reliability|reliability
160405|NCT03195322|Immediate Breast Reconstruction|immediate breast reconstruction
160406|NCT03195322|Pain Control|pain control
160407|NCT03195322|Post Mastectomy Pain Control|post mastectomy pain control
160408|NCT03195322|Acellular Dermal Matrix|acellular dermal matrix
160409|NCT03195309|Cesarean Delivery|cesarean delivery
160410|NCT03195309|Ropivacaine|ropivacaine
160411|NCT03195309|Fentanyl|fentanyl
160412|NCT03195309|Patient-controlled Epidural Analgesia|patient-controlled epidural analgesia
160413|NCT03195283|meal service|meal service
160414|NCT03195283|protein intake|protein intake
160415|NCT03195283|satisfaction|satisfaction
160416|NCT03195283|hospitalized patients|hospitalized patients
160417|NCT03195270|Positron emission tomography|positron emission tomography
160418|NCT03195270|Magnetic Resonance Imaging|magnetic resonance imaging
160419|NCT03195270|PET/MRI|pet/mri
160420|NCT03195270|Fluorodeoxyglucose|fluorodeoxyglucose
160421|NCT03195270|FDG|fdg
160422|NCT03195270|Pain|pain
160423|NCT03195270|Chronic Pain|chronic pain
160424|NCT03195270|Neuropathic Pain|neuropathic pain
160425|NCT03195270|Inflammatory Pain|inflammatory pain
160426|NCT03195270|Nociceptive Pain|nociceptive pain
160427|NCT03195244|aquatic therapy, hydrotherapy|aquatic therapy, hydrotherapy
160428|NCT03195231|Parkinson`s disease|parkinson`s disease
160429|NCT03195231|Depression|depression
160430|NCT03195231|Wuling Powder|wuling powder
160431|NCT03195218|Cancer prevention|cancer prevention
160432|NCT03195218|Diagnosis|diagnosis
160433|NCT03195218|Microendoscope|microendoscope
160434|NCT03195218|High Resolution Microendoscope|high resolution microendoscope
160435|NCT03195179|pelvic fracture urethral injury|pelvic fracture urethral injury
160436|NCT03195179|urethra|urethra
160437|NCT03195179|disruption|disruption
160438|NCT03195179|trauma|trauma
160439|NCT03195166|elderly spinal anesthesia|elderly spinal anesthesia
160440|NCT03195140|Diabetes Mellitus|diabetes mellitus
160441|NCT03195140|Diabetes|diabetes
160442|NCT03195140|Sensor Augmented Pump|sensor augmented pump
160443|NCT03195140|Hypoglycemia|hypoglycemia
160444|NCT03195127|Physical Therapy Modalities|physical therapy modalities
160445|NCT03195127|Rehabilitation|rehabilitation
160446|NCT03195127|Exercise Therapy|exercise therapy
160447|NCT03195127|Critical Illness|critical illness
160448|NCT03195127|Respiration, Artificial|respiration, artificial
160449|NCT03195127|Chronic Disease|chronic disease
160450|NCT03195114|post TAVR quantification|post tavr quantification
160451|NCT03195114|cardiac MRI|cardiac mri
160452|NCT03195114|echocardiography|echocardiography
160453|NCT03195114|biomarkers|biomarkers
160454|NCT03195101|orbital tumors|orbital tumors
160455|NCT03195101|transconjunctival approach|transconjunctival approach
160456|NCT03195062|Fructose|fructose
160457|NCT03195062|Obesity|obesity
160458|NCT03195062|Metabolism|metabolism
160459|NCT03195062|Post-prandial kinetics|post-prandial kinetics
160460|NCT03195049|hyperbilirubinemia|hyperbilirubinemia
160461|NCT03195049|kernicterus|kernicterus
160462|NCT03195036|HIV-exposed|hiv-exposed
160463|NCT03195036|Early Childhood Development|early childhood development
160464|NCT03195036|Cameroon|cameroon
160465|NCT03195023|Renal insufficiency, Chronic|renal insufficiency, chronic
160466|NCT03194997|Breast Cancer|breast cancer
160467|NCT03194997|Quality of life|quality of life
160468|NCT03194997|Lymphedema|lymphedema
160469|NCT03194997|Fatigue|fatigue
160470|NCT03194997|Depressive symptoms|depressive symptoms
160471|NCT03194997|Body image|body image
160472|NCT03194997|Self Esteem|self esteem
160473|NCT03194997|Optimism|optimism
160474|NCT03194997|Sexual function|sexual function
160475|NCT03194997|Stress|stress
160476|NCT03194997|Sleep quality|sleep quality
160477|NCT03194997|Pain|pain
160478|NCT03194997|Muscular strength|muscular strength
160479|NCT03194997|Postural|postural
160480|NCT03194997|Balance|balance
160481|NCT03194997|Range of motion|range of motion
160482|NCT03194997|Cardiorespiratory fitness|cardiorespiratory fitness
160483|NCT03194984|dental whitening|dental whitening
160484|NCT03194984|Dental office whitening|dental office whitening
160485|NCT03194971|glioblastoma|glioblastoma
160486|NCT03194971|brain tumor autopsy|brain tumor autopsy
160487|NCT03194971|autopsy|autopsy
160488|NCT03194971|Optune therapy|optune therapy
160489|NCT03194971|tumor treatment fields|tumor treatment fields
160490|NCT03194971|TTFields|ttfields
160491|NCT03194971|Recurrent glioblastoma|recurrent glioblastoma
160492|NCT03194971|grade IV|grade iv
160493|NCT03194971|brain tumor|brain tumor
160494|NCT03194971|newly diagnosed glioblastoma|newly diagnosed glioblastoma
160495|NCT03194945|Type 2 diabetes mellitus|type 2 diabetes mellitus
160496|NCT03194945|Continuous subcutaneous insulin infusion|continuous subcutaneous insulin infusion
160497|NCT03194945|Metformin|metformin
160498|NCT03194945|Linagliptin|linagliptin
160499|NCT03194919|online intervention|online intervention
160500|NCT03194919|e-Health|e-health
160501|NCT03194919|negotiating quit date|negotiating quit date
160502|NCT03194906|Pediatric oncology|pediatric oncology
160503|NCT03194906|Brain tumor|brain tumor
160504|NCT03194906|Low grade glioma|low grade glioma
160505|NCT03194906|Cognitive late effects|cognitive late effects
160506|NCT03194906|Radiation therapy|radiation therapy
160507|NCT03194906|Neuroprotection|neuroprotection
160508|NCT03194906|Memantine|memantine
160509|NCT03194893|Non−small cell lung cancer (NSCLC)|non−small cell lung cancer (nsclc)
160510|NCT03194893|Anaplastic lymphoma kinase (ALK)|anaplastic lymphoma kinase (alk)
160511|NCT03194893|Rearranged during transfection (RET)|rearranged during transfection (ret)
160512|NCT03194893|Alectinib|alectinib
160513|NCT03194893|Crizotinib|crizotinib
160514|NCT03194854|e-Health|e-health
160515|NCT03194854|self-efficacy theory|self-efficacy theory
160516|NCT03194854|mixture modeling|mixture modeling
160517|NCT03194854|mobile health|mobile health
160618|NCT03194308|Pre-exposure prophylaxis|pre-exposure prophylaxis
160518|NCT03194854|complier average causal effect estimation|complier average causal effect estimation
160519|NCT03194828|Adherence|adherence
160520|NCT03194828|Mobile health|mobile health
160521|NCT03194828|Real-time data|real-time data
160522|NCT03194815|Psychosis|psychosis
160523|NCT03194815|Immunotherapy|immunotherapy
160524|NCT03194815|Autoantibodies|autoantibodies
160525|NCT03194789|FGBMM|fgbmm
160526|NCT03194789|LPSE|lpse
160527|NCT03194789|UDI - 6|udi - 6
160528|NCT03194789|UIQ - 7|uiq - 7
160529|NCT03194776|PAD|pad
160530|NCT03194776|peripheral artery/arterial disease|peripheral artery/arterial disease
160531|NCT03194776|peripheral vascular disease|peripheral vascular disease
160532|NCT03194776|leg pain|leg pain
160533|NCT03194776|claudication|claudication
160534|NCT03194776|leg pain with exercise|leg pain with exercise
160535|NCT03194776|exercise test|exercise test
160536|NCT03194776|walk test|walk test
160537|NCT03194737|Benign prostatic hyperplasia|benign prostatic hyperplasia
160538|NCT03194737|BPH|bph
160539|NCT03194737|Urinary retention|urinary retention
160540|NCT03194737|prostate|prostate
160541|NCT03194737|hypertrophy|hypertrophy
160542|NCT03194711|Percutaneous Coronary Revascularization|percutaneous coronary revascularization
160543|NCT03194711|Optical Coherence Tomography|optical coherence tomography
160544|NCT03194711|Stents, Drug-Eluting|stents, drug-eluting
160545|NCT03194698|Intense Pulsed Light|intense pulsed light
160546|NCT03194685|Acute Myeloid Leukemia|acute myeloid leukemia
160547|NCT03194659|Nutrition|nutrition
160548|NCT03194659|choline|choline
160549|NCT03194659|pregnancy|pregnancy
160550|NCT03194659|docosahexaenoic acid|docosahexaenoic acid
160551|NCT03194659|DHA|dha
160552|NCT03194659|fatty acids|fatty acids
160553|NCT03194646|Uterine Fibroid|uterine fibroid
160554|NCT03194620|Flavanols|flavanols
160555|NCT03194620|Cocoa Flavanols|cocoa flavanols
160556|NCT03194620|Epicatechins|epicatechins
160557|NCT03194620|Polyphenols|polyphenols
160558|NCT03194620|Procyanidins|procyanidins
160559|NCT03194620|EGCG|egcg
160560|NCT03194620|EGC|egc
160561|NCT03194620|ECG|ecg
160562|NCT03194620|Theaflavins|theaflavins
160563|NCT03194620|Thearubigins|thearubigins
160564|NCT03194594|Ketamine, dexamethasone, mood|ketamine, dexamethasone, mood
160565|NCT03194568|Scoliosis|scoliosis
160566|NCT03194568|Idiopathic Scoliosis|idiopathic scoliosis
160567|NCT03194568|Adolescent Idiopathic Scoliosis|adolescent idiopathic scoliosis
160568|NCT03194555|Innate Immune System|innate immune system
160569|NCT03194555|Cytokines|cytokines
160570|NCT03194555|Cox-2|cox-2
160571|NCT03194555|Headache|headache
160572|NCT03194555|Migraine|migraine
160573|NCT03194555|Migraine Prevention|migraine prevention
160574|NCT03194542|Luspatercept|luspatercept
160575|NCT03194542|ACE-536|ace-536
160576|NCT03194542|Myeloproliferative Neoplasm-Associated Myelofibrosis|myeloproliferative neoplasm-associated myelofibrosis
160577|NCT03194542|Primary Myelofibrosis|primary myelofibrosis
160578|NCT03194542|Post-Polycythemia Vera Myelofibrosis|post-polycythemia vera myelofibrosis
160579|NCT03194542|Post-Essential Thrombocythemia|post-essential thrombocythemia
160580|NCT03194542|Anemia|anemia
160581|NCT03194542|Red Blood Cell (RBC) Transfusion|red blood cell (rbc) transfusion
160582|NCT03194542|Ruxolitinib|ruxolitinib
160583|NCT03194529|Crohn's Disease|crohn's disease
160584|NCT03194529|PCDAI|pcdai
160585|NCT03194529|16s rRNA|16s rrna
160586|NCT03194529|Fecal Microbiota Transplantation|fecal microbiota transplantation
160587|NCT03194529|Gut Microbiome|gut microbiome
160588|NCT03194529|FMT|fmt
160589|NCT03194516|prostate cancer|prostate cancer
160590|NCT03194516|ketogenic diet|ketogenic diet
160591|NCT03194516|overweight, obese|overweight, obese
160592|NCT03194503|Intubation|intubation
160593|NCT03194503|Video Laryngoscope|video laryngoscope
160594|NCT03194503|Coaching/training|coaching/training
160595|NCT03194477|HIV young Black men who have sex with men substance use|hiv young black men who have sex with men substance use
160596|NCT03194464|hemiparesis|hemiparesis
160597|NCT03194451|bone tissue engineering, dental stem cell differentiation|bone tissue engineering, dental stem cell differentiation
160598|NCT03194438|Pulmonary Hypertension|pulmonary hypertension
160599|NCT03194438|Symptom Management|symptom management
160600|NCT03194438|Behavioral Intervention|behavioral intervention
160601|NCT03194438|Integrative Therapy|integrative therapy
160602|NCT03194438|Quality of Life|quality of life
160603|NCT03194425|Sacral neuromodulation|sacral neuromodulation
160604|NCT03194425|Electromyography|electromyography
160605|NCT03194425|Pelvic floor|pelvic floor
160606|NCT03194412|Frail Elderly|frail elderly
160607|NCT03194412|Geriatric Assessment|geriatric assessment
160608|NCT03194412|Humans|humans
160609|NCT03194412|Aged|aged
160610|NCT03194386|Post-Traumatic Syndrome|post-traumatic syndrome
160611|NCT03194386|Eye-Movement Desensitization and Reprocessing|eye-movement desensitization and reprocessing
160612|NCT03194334|vegetarianism|vegetarianism
160613|NCT03194334|creatine|creatine
160614|NCT03194334|carnosine|carnosine
160615|NCT03194334|carnitine|carnitine
160616|NCT03194308|HIV risk reduction|hiv risk reduction
160617|NCT03194308|Safer Conception|safer conception
160619|NCT03194308|South Africa|south africa
160620|NCT03194308|Women|women
160621|NCT03194308|Reproductive Health|reproductive health
160622|NCT03194295|Drug-free community support|drug-free community support
160623|NCT03194295|Methadone maintenance|methadone maintenance
160624|NCT03194295|Social networks|social networks
160625|NCT03194282|stroke|stroke
160626|NCT03194282|balance|balance
160627|NCT03194282|insole|insole
160628|NCT03194256|Smoking|smoking
160629|NCT03194256|Cigarettes|cigarettes
160630|NCT03194256|E-Cigarettes|e-cigarettes
160631|NCT03194243|acute dyspnea|acute dyspnea
160632|NCT03194243|acute heart failure|acute heart failure
160633|NCT03194243|emergency|emergency
160634|NCT03194230|Cervical dilators|cervical dilators
160635|NCT03194230|induction of labor|induction of labor
160636|NCT03194230|cervical ripening|cervical ripening
160637|NCT03194230|medical termination of pregnancy|medical termination of pregnancy
160638|NCT03194230|second-trimester of pregnancy.|second-trimester of pregnancy.
160639|NCT03194191|Insomnia|insomnia
160640|NCT03194191|Pregnancy|pregnancy
160641|NCT03194191|Acupuncture|acupuncture
160642|NCT03194191|Insomnia severity index|insomnia severity index
160643|NCT03194191|Pittsburgh Sleep Quality Index|pittsburgh sleep quality index
160644|NCT03194191|Anxiety|anxiety
160645|NCT03194191|Depression|depression
160646|NCT03194165|antiretroviral|antiretroviral
160647|NCT03194165|children|children
160648|NCT03194165|pharmacokinetics|pharmacokinetics
160649|NCT03194139|Healthy Adult|healthy adult
160650|NCT03194139|Superoxide Dismutase|superoxide dismutase
160651|NCT03194139|First in Human|first in human
160652|NCT03194139|Free Radical Dismutase|free radical dismutase
160653|NCT03194087|Secondary Hyperparathyroidism|secondary hyperparathyroidism
160654|NCT03194087|Low parathyroid hormone|low parathyroid hormone
160655|NCT03194087|Hemodialysis|hemodialysis
160656|NCT03194074|Laser Laryngeal Surgery|laser laryngeal surgery
160657|NCT03194074|Desflurane|desflurane
160658|NCT03194074|Propofol|propofol
160659|NCT03194061|chemotherapy|chemotherapy
160660|NCT03194061|complication|complication
160661|NCT03194048|drooling|drooling
160662|NCT03194048|tongue thrust|tongue thrust
160663|NCT03194035|inflammation|inflammation
160664|NCT03194035|exercise|exercise
160665|NCT03194035|ultra endurance|ultra endurance
160666|NCT03194009|diabetes|diabetes
160667|NCT03194009|prevention|prevention
160668|NCT03194009|metformin|metformin
160669|NCT03194009|Mexico City|mexico city
160670|NCT03193983|occlusive dressing|occlusive dressing
160671|NCT03193970|Bladder Cancer|bladder cancer
160672|NCT03193970|Registry|registry
160673|NCT03193970|Post‐surgical outcomes|post‐surgical outcomes
160674|NCT03193970|Radical cystectomy|radical cystectomy
160675|NCT03193970|MD Anderson Symptom inventory|md anderson symptom inventory
160676|NCT03193970|MDASI|mdasi
160677|NCT03193892|registry|registry
160678|NCT03193892|China|china
160679|NCT03193892|lymphangioleiomyomatosis|lymphangioleiomyomatosis
160680|NCT03193879|Pulmonary function|pulmonary function
160681|NCT03193879|Particulate matter|particulate matter
160682|NCT03193879|COPD|copd
160683|NCT03193879|Asthma|asthma
160684|NCT03193866|Immunomodulating treatment|immunomodulating treatment
160685|NCT03193866|Cohort study|cohort study
160686|NCT03193866|Dimethyl fumarate|dimethyl fumarate
160687|NCT03193866|Fingolimod|fingolimod
160688|NCT03193866|Interferon-beta|interferon-beta
160689|NCT03193866|Natalizumab|natalizumab
160690|NCT03193866|Rituximab|rituximab
160691|NCT03193866|Glatiramer acetate|glatiramer acetate
160692|NCT03193840|old acetabular fracture; posterior wall osteotomy|old acetabular fracture; posterior wall osteotomy
160693|NCT03193827|vip score|vip score
160694|NCT03193827|peripheral venous cannulation|peripheral venous cannulation
160695|NCT03193827|particles|particles
160696|NCT03193801|SAPIEN 3|sapien 3
160697|NCT03193801|PARTNER 3|partner 3
160698|NCT03193801|cardiovascular disease|cardiovascular disease
160699|NCT03193801|TMVR|tmvr
160700|NCT03193801|failing valve|failing valve
160701|NCT03193801|failing bioprosthetic valve|failing bioprosthetic valve
160702|NCT03193775|HBV vaccine|hbv vaccine
160703|NCT03193775|persistent|persistent
160704|NCT03193775|HBsAg|hbsag
160705|NCT03193775|IP-10|ip-10
160706|NCT03193762|pain|pain
160707|NCT03193762|pain management|pain management
160708|NCT03193762|anxiety|anxiety
160709|NCT03193749|Chagas disease, cardiomyopathy, amiodarone, clinical trial|chagas disease, cardiomyopathy, amiodarone, clinical trial
160710|NCT03193723|Hernia|hernia
160711|NCT03193723|Local anesthesia|local anesthesia
160712|NCT03193723|ultrasound|ultrasound
160713|NCT03193710|Intravenous anesthesia|intravenous anesthesia
160714|NCT03193710|Inhalational anesthesia|inhalational anesthesia
160715|NCT03193710|Colorectal cancer resection|colorectal cancer resection
160716|NCT03193710|Lymphocytes|lymphocytes
160717|NCT03193710|Metastasis|metastasis
160718|NCT03193710|Survival|survival
160719|NCT03193710|Molecular mechanism|molecular mechanism
160720|NCT03193671|HE4|he4
160721|NCT03193671|CA125|ca125
160722|NCT03193671|RMI|rmi
160723|NCT03193671|ROMA|roma
160724|NCT03193658|spine surgery|spine surgery
160725|NCT03193658|Thoracolumbar Interfascial Plane block|thoracolumbar interfascial plane block
160726|NCT03193658|regional anesthesia|regional anesthesia
160727|NCT03193658|postoperative analgesia|postoperative analgesia
160728|NCT03193658|opioid consumption|opioid consumption
160729|NCT03193632|lean body mass|lean body mass
160730|NCT03193632|resting energy expenditure|resting energy expenditure
160731|NCT03193632|oxygen consumption|oxygen consumption
160732|NCT03193632|Indirect calorimetry|indirect calorimetry
160733|NCT03193632|carbon dioxide excretion|carbon dioxide excretion
160734|NCT03193632|respiratory quotient|respiratory quotient
160735|NCT03193580|Anodal Stimulation Transcranial Direct Current Stimulation|anodal stimulation transcranial direct current stimulation
160736|NCT03193580|High-Definition Transcranial Direct Current Stimulation|high-definition transcranial direct current stimulation
160737|NCT03193580|tDCS|tdcs
160738|NCT03193580|Non-invasive brain stimulation|non-invasive brain stimulation
160739|NCT03193580|Pediatrics|pediatrics
160740|NCT03193489|Balance|balance
160741|NCT03193489|Posturograpy|posturograpy
160742|NCT03193489|quality of life|quality of life
160743|NCT03193463|Topotecan|topotecan
160744|NCT03193463|Convection-Enhanced Delivery|convection-enhanced delivery
160745|NCT03193450|helicobactor pylori|helicobactor pylori
160746|NCT03193437|Thymus|thymus
160747|NCT03193437|Selinexor|selinexor
160748|NCT03193437|KPT-330|kpt-330
160749|NCT03193398|Major Depressive Disorder|major depressive disorder
160750|NCT03193398|Anhedonia|anhedonia
160751|NCT03193398|antidepressant|antidepressant
160752|NCT03193398|Nociceptin|nociceptin
160753|NCT03193398|NOPR|nopr
160754|NCT03193333|glaucoma|glaucoma
160755|NCT03193333|primary open-angle glaucoma|primary open-angle glaucoma
160756|NCT03193333|Ophthalmic antihypertensives|ophthalmic antihypertensives
160757|NCT03193333|Krytantek Ofteno®.|krytantek ofteno®.
160758|NCT03193333|timolol|timolol
160759|NCT03193333|brimonidine|brimonidine
160760|NCT03193333|dorzolamide|dorzolamide
160761|NCT03193320|plethysmographic variability index|plethysmographic variability index
160762|NCT03193320|PVI|pvi
160763|NCT03193281|Dasatinib|dasatinib
160764|NCT03193281|Imatinib|imatinib
160765|NCT03193268|sensorimotor training|sensorimotor training
160766|NCT03193268|quality of life|quality of life
160767|NCT03193268|posture|posture
160768|NCT03193242|Asthma|asthma
160769|NCT03193242|Asthma Action Plan|asthma action plan
160770|NCT03193216|Barrett's|barrett's
160771|NCT03193216|GERD|gerd
160772|NCT03193216|reflux|reflux
160773|NCT03193216|alginate solution|alginate solution
160774|NCT03193216|proton pump inhibitor|proton pump inhibitor
160775|NCT03193177|fasting-like diet|fasting-like diet
160776|NCT03193177|chronic diseases|chronic diseases
160777|NCT03193177|autoimmune diseases|autoimmune diseases
160778|NCT03193177|metabolic disorder|metabolic disorder
160779|NCT03193164|Electric Stimulation Therapy; Endothelial Progenitor Cells.|electric stimulation therapy; endothelial progenitor cells.
160780|NCT03193151|Liver transplant|liver transplant
160781|NCT03193151|global gene expression|global gene expression
160782|NCT03193151|molecular diagnostics|molecular diagnostics
160783|NCT03193138|Cardiotoxicity|cardiotoxicity
160784|NCT03193138|Androgens|androgens
160785|NCT03193138|Hormone Replacement Therapy|hormone replacement therapy
160786|NCT03193138|Testosterone|testosterone
160787|NCT03193138|Androgen Antagonists|androgen antagonists
160788|NCT03193112|Agomelatine|agomelatine
160789|NCT03193112|Depression|depression
160790|NCT03193112|Intraocular pressure|intraocular pressure
160791|NCT03193086|Multiple Sclerosis|multiple sclerosis
160792|NCT03193086|Blood-Brain-Barrier|blood-brain-barrier
160793|NCT03193086|Treatment response|treatment response
160794|NCT03193086|Metabolism|metabolism
160795|NCT03193086|Alemtuzumab|alemtuzumab
160796|NCT03193086|Perfusion|perfusion
160797|NCT03193086|Oxygen consumption|oxygen consumption
160798|NCT03193047|Cholesterol|cholesterol
160799|NCT03193047|PCSK9|pcsk9
160800|NCT03193047|Repatha|repatha
160801|NCT03193047|evolocumab|evolocumab
160802|NCT03193047|LDL-C|ldl-c
160803|NCT03193034|Arthroplasty|arthroplasty
160804|NCT03193034|replacement|replacement
160805|NCT03193034|Knee|knee
160806|NCT03193034|function|function
160807|NCT03193034|radiographic|radiographic
160808|NCT03193034|survivorship|survivorship
160809|NCT03193021|vessel closure|vessel closure
160810|NCT03193021|venous access site|venous access site
160811|NCT03193021|femoral venotomy|femoral venotomy
160812|NCT03193021|medium bore|medium bore
160813|NCT03193021|multiple access sites|multiple access sites
160814|NCT03193008|Breast Cancer|breast cancer
160815|NCT03193008|Axillary ultrasound|axillary ultrasound
160816|NCT03193008|Sentinel lymph node biopsy|sentinel lymph node biopsy
160817|NCT03193008|Axillary management|axillary management
160818|NCT03192995|HIV|hiv
160819|NCT03192995|sexual behavior|sexual behavior
160820|NCT03192956|Hyperbaric|hyperbaric
160821|NCT03192956|Decompression sickness|decompression sickness
160822|NCT03192956|Decompression injury|decompression injury
160823|NCT03192956|Inflammation|inflammation
161227|NCT03190824|telomerase|telomerase
160824|NCT03192956|Central nervous injury|central nervous injury
160825|NCT03192956|Hybervaric oxygen therapy|hybervaric oxygen therapy
160826|NCT03192930|Hyperbaric|hyperbaric
160827|NCT03192930|Saturation|saturation
160828|NCT03192930|Decompression injury|decompression injury
160829|NCT03192930|Decompression sickness|decompression sickness
160830|NCT03192930|Inflammation|inflammation
160831|NCT03192930|Central nervous system injury|central nervous system injury
160832|NCT03192930|Diving medicine|diving medicine
160833|NCT03192917|Shock wave therapy|shock wave therapy
160834|NCT03192917|erectile dysfunction|erectile dysfunction
160835|NCT03192904|Lung cancer|lung cancer
160836|NCT03192904|Segmentectomy|segmentectomy
160837|NCT03192904|Postoperative Complication|postoperative complication
160838|NCT03192904|Stapling Device|stapling device
160839|NCT03192904|Energy Device|energy device
160840|NCT03192878|infliximab|infliximab
160841|NCT03192878|biosimilars|biosimilars
160842|NCT03192878|treatment|treatment
160843|NCT03192852|Tooth bleaching color|tooth bleaching color
160844|NCT03192852|dental esthetic|dental esthetic
160845|NCT03192852|Clinical Trial|clinical trial
160846|NCT03192852|Violet LED light|violet led light
160847|NCT03192852|Violet LED|violet led
160848|NCT03192852|color|color
160849|NCT03192852|sensibility|sensibility
160850|NCT03192852|dental aesthetic|dental aesthetic
160851|NCT03192826|Nd-YAG capsulotomy|nd-yag capsulotomy
160852|NCT03192826|ocular hypertension|ocular hypertension
160853|NCT03192826|brimonidine|brimonidine
160854|NCT03192826|brinzolamide|brinzolamide
160855|NCT03192800|clinical outcome|clinical outcome
160856|NCT03192800|prognositic factor|prognositic factor
160857|NCT03192800|spinal dural arteriovenous fistula|spinal dural arteriovenous fistula
160858|NCT03192722|Filters|filters
160859|NCT03192722|Illumination|illumination
160860|NCT03192722|Low vision|low vision
160861|NCT03192722|Reading|reading
160862|NCT03192709|Sildenafil IVF ICI failure|sildenafil ivf ici failure
160863|NCT03192631|financial incentive|financial incentive
160864|NCT03192579|neoatherosclerosis|neoatherosclerosis
160865|NCT03192566|Acetaminophen|acetaminophen
160866|NCT03192566|Anesthesia|anesthesia
160867|NCT03192566|Adolescent|adolescent
160868|NCT03192566|Obesity|obesity
160869|NCT03192553|donning|donning
160870|NCT03192553|doffing|doffing
160871|NCT03192553|self-contamination|self-contamination
160872|NCT03192553|healthcare workers|healthcare workers
160873|NCT03192540|Exercise|exercise
160874|NCT03192527|KN015|kn015
160875|NCT03192527|Long-acting FSH|long-acting fsh
160876|NCT03192514|Polypharmacy|polypharmacy
160877|NCT03192514|Benzodiazepine use|benzodiazepine use
160878|NCT03192501|lung cancer|lung cancer
160879|NCT03192501|iCAGES|icages
160880|NCT03192501|gene mutation|gene mutation
160881|NCT03192501|precision medicine|precision medicine
160882|NCT03192501|advanced cancers|advanced cancers
160883|NCT03192462|Pancreatic Cancer|pancreatic cancer
160884|NCT03192462|Immune-based therapies|immune-based therapies
160885|NCT03192462|CytotoxicT Lymphocytes|cytotoxict lymphocytes
160886|NCT03192423|Stress|stress
160887|NCT03192423|Performance of procedures|performance of procedures
160888|NCT03192423|Lumbar Puncture|lumbar puncture
160889|NCT03192410|myocardial infarction|myocardial infarction
160890|NCT03192410|cardiovascular diseases|cardiovascular diseases
160891|NCT03192410|mortality|mortality
160892|NCT03192410|post-myocardial infarction patients|post-myocardial infarction patients
160893|NCT03192410|risk prediction|risk prediction
160894|NCT03192410|kidney function|kidney function
160895|NCT03192410|mental well-being|mental well-being
160896|NCT03192410|cardiovascular drug treatment|cardiovascular drug treatment
160897|NCT03192384|Hospital falls|hospital falls
160898|NCT03192371|Zagreb regimen|zagreb regimen
160899|NCT03192371|Encephalitis|encephalitis
160900|NCT03192371|Antibody persistence|antibody persistence
160901|NCT03192371|Essen regimen|essen regimen
160902|NCT03192371|Post-Exposure Prophylaxis (PEP)|post-exposure prophylaxis (pep)
160903|NCT03192371|Rabies|rabies
160904|NCT03192358|Thickened Liquids|thickened liquids
160905|NCT03192358|Dysphagia Management|dysphagia management
160906|NCT03192358|Videofluoroscopy|videofluoroscopy
160907|NCT03192358|Swallowing Physiology|swallowing physiology
160908|NCT03192332|Intravenous thrombolysis|intravenous thrombolysis
160909|NCT03192332|Endovascular treatment|endovascular treatment
160910|NCT03192332|Mechanical thrombectomy|mechanical thrombectomy
160911|NCT03192332|Bridging thrombolysis|bridging thrombolysis
160912|NCT03192332|Acute ischemic stroke|acute ischemic stroke
160913|NCT03192319|Herpes zoster vaccine|herpes zoster vaccine
160914|NCT03192319|Cell-mediated immunity|cell-mediated immunity
160915|NCT03192319|hematopoietic stem cell transplantation|hematopoietic stem cell transplantation
160916|NCT03192306|Herpes Labialis|herpes labialis
160917|NCT03192306|Cold Sore|cold sore
160918|NCT03192267|newly diagnosed rheumatoid arthritis|newly diagnosed rheumatoid arthritis
160919|NCT03192267|lung disease|lung disease
160920|NCT03192241|reading|reading
160921|NCT03192228|Diabetes Mellitus, Type 2 +|diabetes mellitus, type 2 +
160922|NCT03192228|Patient Education|patient education
160923|NCT03192215|Atrial Cardiopathy|atrial cardiopathy
160924|NCT03192215|Cryptogenic stroke|cryptogenic stroke
160925|NCT03192215|Ischemic stroke|ischemic stroke
160926|NCT03192215|Apixaban|apixaban
160927|NCT03192215|Aspirin|aspirin
160928|NCT03192202|Lymphoma|lymphoma
160929|NCT03192202|Cutaneous Lymphoma|cutaneous lymphoma
160930|NCT03192202|cutaneous T-cell lymphoma (CTCL)|cutaneous t-cell lymphoma (ctcl)
160931|NCT03192202|CD30-Positive Cutaneous Lymphoma|cd30-positive cutaneous lymphoma
160932|NCT03192202|T-cell lymphoma|t-cell lymphoma
160933|NCT03192202|PTCL|ptcl
160934|NCT03192202|CTCL|ctcl
160935|NCT03192202|CD30|cd30
160936|NCT03192202|immunotherapy|immunotherapy
160937|NCT03192176|Vasomotor symptoms|vasomotor symptoms
160938|NCT03192176|Menopause|menopause
160939|NCT03192176|Hot flashes|hot flashes
160940|NCT03192176|Perimenopause|perimenopause
160941|NCT03192124|primary total knee|primary total knee
160942|NCT03192124|infection|infection
160943|NCT03192111|Healthy Volunteers|healthy volunteers
160944|NCT03192111|Mild Renal Impairment|mild renal impairment
160945|NCT03192111|Moderate Renal Impairment|moderate renal impairment
160946|NCT03192111|Severe Renal Impairment|severe renal impairment
160947|NCT03192111|Entinostat|entinostat
160948|NCT03192111|Histone Deacetylase Inhibitor|histone deacetylase inhibitor
160949|NCT03192111|HDAC|hdac
160950|NCT03192059|Immunotherapy|immunotherapy
160951|NCT03192059|Radiotherapy|radiotherapy
160952|NCT03192059|Immune-modulatory cocktail|immune-modulatory cocktail
160953|NCT03192020|Hand dysfunction|hand dysfunction
160954|NCT03192020|Xiapex|xiapex
160955|NCT03192020|Xiaflex|xiaflex
160956|NCT03192020|Aponeurectomy|aponeurectomy
160957|NCT03192020|Aponeurotomy|aponeurotomy
160958|NCT03192020|Dupuytren disease|dupuytren disease
160959|NCT03192020|Joint contracture|joint contracture
160960|NCT03192020|Surgery|surgery
160961|NCT03191968|Behavior change|behavior change
160962|NCT03191968|Prostate cancer|prostate cancer
160963|NCT03191968|Behavioral counseling|behavioral counseling
160964|NCT03191968|Physical Activity|physical activity
160965|NCT03191968|Randomized controlled trial|randomized controlled trial
160966|NCT03191942|Myopia control|myopia control
160967|NCT03191942|Orthokeratology|orthokeratology
160968|NCT03191942|Children|children
160969|NCT03191942|Treatment zone|treatment zone
160970|NCT03191929|Depression|depression
160971|NCT03191929|Post-traumatic Stress Disorder|post-traumatic stress disorder
160972|NCT03191929|Health Information Technology (HIT)|health information technology (hit)
160973|NCT03191929|Primary Care Provider|primary care provider
160974|NCT03191929|Mental Health Screening|mental health screening
160975|NCT03191916|Parkinson's Disease|parkinson's disease
160976|NCT03191916|Mild Cognitive Impairment|mild cognitive impairment
160977|NCT03191916|tDCS|tdcs
160978|NCT03191916|Cognitive function|cognitive function
160979|NCT03191890|in vivo culture|in vivo culture
160980|NCT03191877|coffee consumption|coffee consumption
160981|NCT03191877|Cesarean section|cesarean section
160982|NCT03191877|intestinal motility|intestinal motility
160983|NCT03191864|Esophagitis|esophagitis
160984|NCT03191864|Eosinophilic Esophagitis|eosinophilic esophagitis
160985|NCT03191864|Fluticasone|fluticasone
160986|NCT03191864|Dysphagia|dysphagia
160987|NCT03191864|Safety|safety
160988|NCT03191864|Efficacy|efficacy
160989|NCT03191864|Pharmacokinetics|pharmacokinetics
160990|NCT03191864|Esophageal Diseases|esophageal diseases
160991|NCT03191864|Gastrointestinal Diseases|gastrointestinal diseases
160992|NCT03191864|Digestive System Diseases|digestive system diseases
160993|NCT03191864|Glucocorticoids|glucocorticoids
160994|NCT03191864|Orally Disintegrating Tablet|orally disintegrating tablet
160995|NCT03191825|online intervention|online intervention
160996|NCT03191825|mHealth m-Health|mhealth m-health
160997|NCT03191825|eHealth e-Health|ehealth e-health
160998|NCT03191825|smoking cessation|smoking cessation
160999|NCT03191825|lapse management|lapse management
161000|NCT03191825|relapse prevention|relapse prevention
161001|NCT03191812|Falls|falls
161002|NCT03191812|transcranial Direct Current Stimulation|transcranial direct current stimulation
161003|NCT03191812|Mobility|mobility
161004|NCT03191812|Dual Task|dual task
161005|NCT03191760|Posttraumatic Stress Disorder|posttraumatic stress disorder
161006|NCT03191760|Social Support|social support
161007|NCT03191760|Primary Care|primary care
161008|NCT03191747|Masculine Norms|masculine norms
161009|NCT03191747|Skin Care|skin care
161010|NCT03191747|Gender|gender
161011|NCT03191734|Lower Urinary Tract Symptoms (LUTS)|lower urinary tract symptoms (luts)
161012|NCT03191734|Benign Prostatic Hyperplasia (BPH)|benign prostatic hyperplasia (bph)
161013|NCT03191734|AQUABEAM|aquabeam
161014|NCT03191734|Aquablation|aquablation
161015|NCT03191721|Peri-implantitis|peri-implantitis
161016|NCT03191721|Triclosan|triclosan
161017|NCT03191721|Toothpastes|toothpastes
161018|NCT03191721|Therapeutics|therapeutics
161019|NCT03191721|Periodontal Diseases|periodontal diseases
161020|NCT03191721|Periodontitis|periodontitis
161021|NCT03191721|Dentifrices|dentifrices
161022|NCT03191708|Fractional Flow Reserve|fractional flow reserve
161023|NCT03191708|Quantitative Coronary Angiography|quantitative coronary angiography
161024|NCT03191708|Coronary artery disease|coronary artery disease
161025|NCT03191708|Angina pectoris|angina pectoris
161026|NCT03191708|Quantitative Flow Ratio|quantitative flow ratio
161027|NCT03191695|Participation|participation
161028|NCT03191695|Activity|activity
161029|NCT03191695|Cerebral Palsy|cerebral palsy
161030|NCT03191695|LIFE Habits (life-H)|life habits (life-h)
161031|NCT03191695|Gross Motor Function|gross motor function
161032|NCT03191695|Health-related Quality of Life|health-related quality of life
161033|NCT03191695|Family|family
161034|NCT03191630|Kidney transplant|kidney transplant
161035|NCT03191630|SystemCHANGE|systemchange
161036|NCT03191630|physical activity|physical activity
161037|NCT03191630|smart phone|smart phone
161038|NCT03191630|Fitbit|fitbit
161039|NCT03191630|activity monitor|activity monitor
161040|NCT03191630|step count|step count
161041|NCT03191630|post-surgery|post-surgery
161042|NCT03191630|quality of life|quality of life
161043|NCT03191630|cardiovascular|cardiovascular
161044|NCT03191604|Endoscopy|endoscopy
161045|NCT03191604|Narrow band imaging|narrow band imaging
161046|NCT03191604|Dysplasia|dysplasia
161047|NCT03191591|Overweight|overweight
161048|NCT03191591|Obesity|obesity
161049|NCT03191591|Maternal-child|maternal-child
161050|NCT03191591|Social Determinants of Health|social determinants of health
161051|NCT03191578|NMIBC|nmibc
161052|NCT03191578|Immunotherapy|immunotherapy
161053|NCT03191578|RUTI|ruti
161054|NCT03191578|Non-muscle invasive bladder cancer|non-muscle invasive bladder cancer
161055|NCT03191565|mhealth|mhealth
161056|NCT03191565|self-monitoring|self-monitoring
161057|NCT03191565|Outcome monitoring|outcome monitoring
161058|NCT03191552|Cerebral palsy|cerebral palsy
161059|NCT03191552|lycra garments|lycra garments
161060|NCT03191552|orthosis|orthosis
161061|NCT03191552|suit therapy|suit therapy
161062|NCT03191552|trunk control|trunk control
161063|NCT03191513|Interesterified|interesterified
161064|NCT03191513|Postprandial|postprandial
161065|NCT03191513|Lipid|lipid
161066|NCT03191474|PrEP|prep
161067|NCT03191474|Pre-exposure Prophylaxis|pre-exposure prophylaxis
161068|NCT03191474|Truvada|truvada
161069|NCT03191474|Client-centered case management|client-centered case management
161070|NCT03191474|Transgender|transgender
161071|NCT03191474|Gender non-conforming|gender non-conforming
161072|NCT03191461|Anthracycline-based chemotherapy|anthracycline-based chemotherapy
161073|NCT03191461|Anth-bC|anth-bc
161074|NCT03191461|Chemotherapy|chemotherapy
161075|NCT03191461|Myocardial Perfusion|myocardial perfusion
161076|NCT03191435|Diabetes mellitus, type 2|diabetes mellitus, type 2
161077|NCT03191435|Inspiratory muscle training|inspiratory muscle training
161078|NCT03191435|Glycemic control|glycemic control
161079|NCT03191435|Glucose|glucose
161080|NCT03191435|Exercise|exercise
161081|NCT03191435|Diaphragm exercise|diaphragm exercise
161082|NCT03191435|Inspiratory loading|inspiratory loading
161083|NCT03191422|Rehabilitation|rehabilitation
161084|NCT03191422|Occupational Performance|occupational performance
161085|NCT03191409|cognitive impairment|cognitive impairment
161086|NCT03191409|ESRD|esrd
161087|NCT03191409|functional MRI|functional mri
161088|NCT03191383|Maternal immunization|maternal immunization
161089|NCT03191383|Immunogenicity|immunogenicity
161090|NCT03191383|Vaccines|vaccines
161091|NCT03191383|Safety|safety
161092|NCT03191383|Reactogenicity|reactogenicity
161093|NCT03191383|Respiratory Syncytial Virus|respiratory syncytial virus
161094|NCT03191370|pain during laryngoscopy, Flexible nasal endoscopy|pain during laryngoscopy, flexible nasal endoscopy
161095|NCT03191357|traumatic brain injury,posttraumatic stress,service member|traumatic brain injury,posttraumatic stress,service member
161096|NCT03191344|Intraoperative Parathyroid Scores System|intraoperative parathyroid scores system
161097|NCT03191344|total thyroidectomy|total thyroidectomy
161098|NCT03191344|thyroid cancer|thyroid cancer
161099|NCT03191344|hypoparathyroidism|hypoparathyroidism
161100|NCT03191344|prediction|prediction
161101|NCT03191331|dietary intervention|dietary intervention
161102|NCT03191331|gestational weight gain|gestational weight gain
161103|NCT03191331|gestational diabetes|gestational diabetes
161104|NCT03191331|overweight|overweight
161105|NCT03191331|obesity|obesity
161106|NCT03191318|ERAS|eras
161107|NCT03191318|Enhanced recovery after sugery in bariatric surgery|enhanced recovery after sugery in bariatric surgery
161108|NCT03191318|sleeve gastrectomy|sleeve gastrectomy
161109|NCT03191292|probabilistic antibiotherapy|probabilistic antibiotherapy
161110|NCT03191292|prosthetic joint infection|prosthetic joint infection
161111|NCT03191292|treatment failure|treatment failure
161112|NCT03191279|Wounds and injury|wounds and injury
205801|NCT02909764|Age|age
161113|NCT03191279|Trauma|trauma
161114|NCT03191279|First aid|first aid
161115|NCT03191279|Bystander|bystander
161116|NCT03191279|Laypersons|laypersons
161117|NCT03191266|repetitive transcranial magnetic stimulation|repetitive transcranial magnetic stimulation
161118|NCT03191266|alcohol use disorder|alcohol use disorder
161119|NCT03191266|neuroimaging|neuroimaging
161120|NCT03191266|relapse|relapse
161121|NCT03191266|Veterans|veterans
161122|NCT03191253|food insecurity|food insecurity
161123|NCT03191253|community-based|community-based
161124|NCT03191253|food assistance|food assistance
161125|NCT03191253|food support|food support
161126|NCT03191253|intervention|intervention
161127|NCT03191253|medically tailored|medically tailored
161128|NCT03191253|nutrition|nutrition
161129|NCT03191240|Out-of-Hospital Cardiac Arrest|out-of-hospital cardiac arrest
161130|NCT03191240|Vasopressin|vasopressin
161131|NCT03191214|Infra-red thermography|infra-red thermography
161132|NCT03191201|Metabolomics, Transcriptomics, Ironomics|metabolomics, transcriptomics, ironomics
161134|NCT03191175|Inflammasome|inflammasome
161135|NCT03191162|Benznidazole|benznidazole
161136|NCT03191162|PCR|pcr
161137|NCT03191123|Hepatocellular Carcinoma|hepatocellular carcinoma
161138|NCT03191123|Hepatic Resection|hepatic resection
161139|NCT03191123|TACE|tace
161140|NCT03191123|Solitary Huge Tumor|solitary huge tumor
161141|NCT03191123|Overall Survival|overall survival
161142|NCT03191110|COLON|colon
161143|NCT03191110|colorectal cancer|colorectal cancer
161144|NCT03191110|nutrition|nutrition
161145|NCT03191110|lifestyle|lifestyle
161146|NCT03191110|survival|survival
161147|NCT03191110|recurrence|recurrence
161148|NCT03191110|quality of life|quality of life
161149|NCT03191084|marijuana|marijuana
161150|NCT03191084|THC|thc
161151|NCT03191084|cannabis|cannabis
161152|NCT03191084|driving|driving
161153|NCT03191084|impairment|impairment
161154|NCT03191084|intoxication|intoxication
161155|NCT03191071|pneumonia|pneumonia
161156|NCT03191071|procalcitonin|procalcitonin
161157|NCT03191071|lung ultrasound|lung ultrasound
161158|NCT03191071|point of care testing|point of care testing
161159|NCT03191071|antibiotic prescription|antibiotic prescription
161160|NCT03191071|respiratory pathogens|respiratory pathogens
161161|NCT03191071|host biomarkers|host biomarkers
161162|NCT03191058|Depression|depression
161163|NCT03191058|Unipolar Depression|unipolar depression
161164|NCT03191058|Treatment Resistant Depression|treatment resistant depression
161165|NCT03191058|Magnetic Seizure Therapy|magnetic seizure therapy
161166|NCT03191058|Suicidal Ideation|suicidal ideation
161167|NCT03191058|Electroconvulsive Therapy|electroconvulsive therapy
161169|NCT03191045|motility|motility
161170|NCT03191045|perfused manometry|perfused manometry
161171|NCT03191045|stomach|stomach
161172|NCT03191045|bowel|bowel
161173|NCT03191045|water|water
161174|NCT03191032|Peripheral nerves/lesions; hands; rehabilitation; fMRI|peripheral nerves/lesions; hands; rehabilitation; fmri
161175|NCT03191019|Cell phones|cell phones
161176|NCT03191019|Women|women
161177|NCT03191006|effect|effect
161178|NCT03191006|insoles|insoles
161179|NCT03191006|children|children
161180|NCT03190967|Ado-trastuzumab Emtansine|ado-trastuzumab emtansine
161181|NCT03190967|Systemic Control of Disease|systemic control of disease
161182|NCT03190967|Maximum Tolerated Dose|maximum tolerated dose
161183|NCT03190967|Preventing the Formation of a Metastasis|preventing the formation of a metastasis
161184|NCT03190954|Raclopride|raclopride
161185|NCT03190954|[11C] NNC-112|[11c] nnc-112
161186|NCT03190954|Functional Magnetic Resonance Imaging (fMRI)|functional magnetic resonance imaging (fmri)
161187|NCT03190954|Dopamine D1 Receptor|dopamine d1 receptor
161188|NCT03190954|D2 Receptors|d2 receptors
161189|NCT03190941|KRAS|kras
161190|NCT03190941|HRAS|hras
161191|NCT03190941|NRAS|nras
161192|NCT03190941|Cell Therapy|cell therapy
161193|NCT03190941|Immunotherapy|immunotherapy
161194|NCT03190928|Disease Monitoring|disease monitoring
161195|NCT03190928|Molecular Monitoring|molecular monitoring
161196|NCT03190928|Novel Biomarker Identification|novel biomarker identification
161197|NCT03190928|Gene Expression Analyses|gene expression analyses
161198|NCT03190928|Watchful-Waiting|watchful-waiting
161199|NCT03190889|ACL Reconstruction|acl reconstruction
161200|NCT03190889|Rehabilitation|rehabilitation
161201|NCT03190889|Sports Injury|sports injury
161202|NCT03190889|Neuromuscular Intervention|neuromuscular intervention
161203|NCT03190889|Knee Injury|knee injury
161204|NCT03190876|Drain usage|drain usage
161205|NCT03190863|Tenodesis grasp|tenodesis grasp
161206|NCT03190863|Neurofeedback|neurofeedback
161207|NCT03190863|Motor imagery|motor imagery
161208|NCT03190863|Reach-to-grasp|reach-to-grasp
161209|NCT03190863|Rehabilitation|rehabilitation
161210|NCT03190863|Physical therapy|physical therapy
161211|NCT03190863|Cervical spinal cord injury|cervical spinal cord injury
161212|NCT03190863|Tetraplegia|tetraplegia
161213|NCT03190863|AIS A|ais a
161214|NCT03190863|AIS B|ais b
161215|NCT03190850|Sleep Apnea|sleep apnea
161216|NCT03190850|Elderly|elderly
161217|NCT03190850|Inspiratory training|inspiratory training
161218|NCT03190837|gaucher|gaucher
161219|NCT03190837|gaucher disease|gaucher disease
161220|NCT03190824|melanoma|melanoma
161221|NCT03190824|immunotherapy|immunotherapy
161222|NCT03190824|immune oncology|immune oncology
161223|NCT03190824|loco regional therapy|loco regional therapy
161224|NCT03190824|adenovirus|adenovirus
161225|NCT03190824|oncolytic virus|oncolytic virus
161226|NCT03190824|unresectable|unresectable
161228|NCT03190811|advanced solid tumor|advanced solid tumor
161229|NCT03190811|DC-CIK|dc-cik
161230|NCT03190811|anti-PD-1 antibody|anti-pd-1 antibody
161231|NCT03190811|immunotherapy|immunotherapy
161232|NCT03190785|benzoic acid|benzoic acid
161233|NCT03190785|endocrine disrupting chemicals|endocrine disrupting chemicals
161234|NCT03190785|leptin|leptin
161235|NCT03190785|metabolic rate|metabolic rate
161236|NCT03190733|Hematopoietic Stem Cell Transplantation|hematopoietic stem cell transplantation
161237|NCT03190733|ATG|atg
161238|NCT03190733|chronic GVHD|chronic gvhd
161239|NCT03190733|leukemia relapse|leukemia relapse
161240|NCT03190694|chronic kidney disease|chronic kidney disease
161241|NCT03190694|non diabetic|non diabetic
161242|NCT03190668|tissue microdialysis|tissue microdialysis
161243|NCT03190668|spinal fusion|spinal fusion
161244|NCT03190668|surgical site infection|surgical site infection
161245|NCT03190642|Orthognathic Surgery|orthognathic surgery
161246|NCT03190642|Swelling|swelling
161247|NCT03190629|body composition|body composition
161248|NCT03190629|bioimpedance|bioimpedance
161249|NCT03190629|hemodialysis|hemodialysis
161250|NCT03190629|hemodiafiltration|hemodiafiltration
161251|NCT03190629|nutritional status|nutritional status
161252|NCT03190629|protein energy wasting|protein energy wasting
161253|NCT03190590|transcranial magnetic stimulation|transcranial magnetic stimulation
161254|NCT03190577|Transthyretin mutation|transthyretin mutation
161255|NCT03190551|infraclavicular brachial plexus block|infraclavicular brachial plexus block
161256|NCT03190551|retroclavicular approach|retroclavicular approach
161257|NCT03190551|costoclavicular approach|costoclavicular approach
161258|NCT03190551|upper limb surgery|upper limb surgery
161259|NCT03190551|needle shaft visibility|needle shaft visibility
161260|NCT03190512|Periodontal disease|periodontal disease
161261|NCT03190512|depression|depression
161262|NCT03190512|body image|body image
161263|NCT03190512|self-esteem|self-esteem
161264|NCT03190499|Cancer|cancer
161265|NCT03190499|Leukemia|leukemia
161266|NCT03190486|Baby cries|baby cries
161267|NCT03190486|pain|pain
161268|NCT03190486|brain responses|brain responses
161269|NCT03190486|neuroimaging|neuroimaging
161270|NCT03190486|fMRI|fmri
161271|NCT03190395|Paroxysmal Atrial Fibrillation|paroxysmal atrial fibrillation
161272|NCT03190395|Circumferential Pulmonary Vein Isolation(CPVI)|circumferential pulmonary vein isolation(cpvi)
161273|NCT03190395|Leftatrium Roofline Ablation(LARA)|leftatrium roofline ablation(lara)
161274|NCT03190395|Longterm success rate|longterm success rate
161275|NCT03190317|electronic medical record|electronic medical record
161276|NCT03190317|personal health record|personal health record
161277|NCT03190317|Veteran|veteran
161278|NCT03190317|self-management|self-management
161279|NCT03190278|Acute Myeloid Leukemia|acute myeloid leukemia
161280|NCT03190278|Relapsed/Refractory Acute Myeloid Leukemia|relapsed/refractory acute myeloid leukemia
161281|NCT03190278|Newly diagnosed AML|newly diagnosed aml
161282|NCT03190278|ELN adverse genetic risk group|eln adverse genetic risk group
161283|NCT03190278|Chimeric Antigen Receptor T-Cell (CAR-T) therapy|chimeric antigen receptor t-cell (car-t) therapy
161284|NCT03190278|Allogeneic|allogeneic
161285|NCT03190278|Transcription Activator-Like Effector Nuclease (TALEN)|transcription activator-like effector nuclease (talen)
161286|NCT03190265|cy|cy
161287|NCT03190265|Cyclophosphamide|cyclophosphamide
161288|NCT03190265|Pancreatic Vaccine|pancreatic vaccine
161289|NCT03190265|GVAX|gvax
161290|NCT03190265|Nivolumab|nivolumab
161291|NCT03190265|Vaccine|vaccine
161292|NCT03190265|Ipilimumab|ipilimumab
161293|NCT03190265|CRS-207|crs-207
161294|NCT03190265|Immunotherapy|immunotherapy
161295|NCT03190265|PD-1|pd-1
161296|NCT03190265|Adenocarcinoma|adenocarcinoma
161297|NCT03190265|Carcinoma|carcinoma
161298|NCT03190265|Neoplasms|neoplasms
161299|NCT03190252|Diving medicine|diving medicine
161300|NCT03190252|Inflammation|inflammation
161301|NCT03190252|Central nervous system injury|central nervous system injury
161302|NCT03190252|Trimix|trimix
161303|NCT03190252|Decompression sickness|decompression sickness
161304|NCT03190252|Venous gas emboli|venous gas emboli
161305|NCT03190226|L-PRF|l-prf
161306|NCT03190226|keratinised tissues|keratinised tissues
161307|NCT03190226|implant|implant
161308|NCT03190226|free gingival graft|free gingival graft
161309|NCT03190213|high grade|high grade
161310|NCT03190161|Schizophrenia|schizophrenia
161311|NCT03190148|GLP-1|glp-1
161312|NCT03190148|Ectopic Lipids|ectopic lipids
161313|NCT03190135|Overweight|overweight
161314|NCT03190135|Obesity|obesity
161315|NCT03190135|School|school
161316|NCT03190135|Physical Activity|physical activity
161317|NCT03190109|bone age measurement|bone age measurement
161318|NCT03190109|skeletal age measurement|skeletal age measurement
161319|NCT03190109|ultrasound|ultrasound
161320|NCT03190109|x-Ray|x-ray
161321|NCT03190083|mastectomy|mastectomy
161322|NCT03190083|lumpectomy|lumpectomy
161323|NCT03190083|3-Dimensional Mammogram|3-dimensional mammogram
161324|NCT03190083|digital breast tomosynthesis|digital breast tomosynthesis
161325|NCT03190070|Renal reserve, physiological study, diagnostic testing|renal reserve, physiological study, diagnostic testing
161327|NCT03190057|Drug Eluting Stent|drug eluting stent
161328|NCT03190057|Coronary Artery Disease|coronary artery disease
161329|NCT03190031|training|training
161330|NCT03190031|exercise|exercise
161331|NCT03190031|quality of life|quality of life
161332|NCT03190005|PRU|pru
161333|NCT03190005|P2Y12 receptor|p2y12 receptor
161334|NCT03189979|community based participatory research|community based participatory research
161335|NCT03189979|Childhood obesity|childhood obesity
161336|NCT03189966|transversalis fascia plane block|transversalis fascia plane block
161337|NCT03189966|quadratus lumborum block|quadratus lumborum block
161338|NCT03189966|ultrasound-guided|ultrasound-guided
161339|NCT03189966|Developmental Dysplasia of the Hip|developmental dysplasia of the hip
161340|NCT03189966|postoperative analgesia|postoperative analgesia
161341|NCT03189914|pancreatic cancer|pancreatic cancer
161342|NCT03189914|Abraxane|abraxane
161343|NCT03189914|first line|first line
161344|NCT03189875|Systemic Lupus Erythematosus Disease|systemic lupus erythematosus disease
161345|NCT03189849|Farming environment|farming environment
161346|NCT03189836|CD20+|cd20+
161347|NCT03189836|B cell|b cell
161348|NCT03189836|ACTR|actr
161349|NCT03189836|ACTR707|actr707
161350|NCT03189836|relapsed|relapsed
161351|NCT03189836|refractory|refractory
161352|NCT03189836|T cell|t cell
161353|NCT03189836|T cell product|t cell product
161354|NCT03189836|adoptive T cells|adoptive t cells
161355|NCT03189836|gene therapy|gene therapy
161356|NCT03189810|Sham Repetitive Transcranial Magnetic Stimulation (rTMS)|sham repetitive transcranial magnetic stimulation (rtms)
161357|NCT03189810|Schizophrenia|schizophrenia
161358|NCT03189810|Cannabis Use Disorder|cannabis use disorder
161359|NCT03189810|Cognitive Function|cognitive function
161360|NCT03189758|chronic kidney disease|chronic kidney disease
161361|NCT03189758|hemodialysis|hemodialysis
161362|NCT03189758|sodium restriction|sodium restriction
161363|NCT03189758|MRI|mri
161364|NCT03189732|lipolysis|lipolysis
161365|NCT03189732|adipose tissue|adipose tissue
161366|NCT03189732|exercise|exercise
161367|NCT03189719|PD1|pd1
161368|NCT03189719|PD-1|pd-1
161369|NCT03189719|PDL1|pdl1
161370|NCT03189719|PD-L1|pd-l1
161371|NCT03189706|Hu3F8|hu3f8
161372|NCT03189706|Irinotecan|irinotecan
161373|NCT03189706|Temozolomide|temozolomide
161374|NCT03189706|Sargramostim|sargramostim
161375|NCT03189706|Chemoimmunotherapy|chemoimmunotherapy
161376|NCT03189706|17-251|17-251
161377|NCT03189680|sensorimotor training|sensorimotor training
161378|NCT03189680|exergaming|exergaming
161379|NCT03189680|posture|posture
161380|NCT03189680|quality of life|quality of life
161381|NCT03189641|Drug eluting stents|drug eluting stents
161382|NCT03189641|Coronary artery disease|coronary artery disease
161383|NCT03189641|Coronary artery stenosis|coronary artery stenosis
161384|NCT03189641|Myocardial ischemia|myocardial ischemia
161385|NCT03189641|Angioplasty|angioplasty
161386|NCT03189628|stromal vascular fraction|stromal vascular fraction
161387|NCT03189628|skin regeneration|skin regeneration
161388|NCT03189628|skin texture|skin texture
161389|NCT03189628|anti-aging|anti-aging
161390|NCT03189602|Takayasu Arteritis|takayasu arteritis
161391|NCT03189602|Pulmonary artery hypertension|pulmonary artery hypertension
161392|NCT03189589|Pharmacokinetics|pharmacokinetics
161393|NCT03189589|Healthy|healthy
161394|NCT03189589|ELLIPTA|ellipta
161395|NCT03189589|Safety|safety
161396|NCT03189589|GSK2269557|gsk2269557
161397|NCT03189589|Inhalation|inhalation
161398|NCT03189589|Tolerability|tolerability
161399|NCT03189537|Profilaxis|profilaxis
161400|NCT03189537|Ingavirin|ingavirin
161401|NCT03189511|Brown Adipose Tissue|brown adipose tissue
161402|NCT03189511|Brown Fat|brown fat
161403|NCT03189511|Fluvastatin|fluvastatin
161404|NCT03189511|Prospective Clinical Trial|prospective clinical trial
161405|NCT03189446|Endometrial Cancer|endometrial cancer
161406|NCT03189446|Gynecologic Cancer|gynecologic cancer
161407|NCT03189420|glioma|glioma
161408|NCT03189420|glioblastoma|glioblastoma
161409|NCT03189420|low grade tumor|low grade tumor
161410|NCT03189407|Moringa Oleifera tea|moringa oleifera tea
161411|NCT03189407|Type 2 Diabetes Mellitus|type 2 diabetes mellitus
161412|NCT03189407|Metformin Steady state concentrations|metformin steady state concentrations
161413|NCT03189407|Herb-drug interaction|herb-drug interaction
161414|NCT03189394|HIV|hiv
161415|NCT03189394|gay couples|gay couples
161416|NCT03189394|relationships|relationships
161417|NCT03189394|dyads|dyads
161418|NCT03189381|Whole Brain Radiation|whole brain radiation
161419|NCT03189381|Simultaneous Integrated Boost|simultaneous integrated boost
161420|NCT03189368|Cardiac Resynchronization Therapy|cardiac resynchronization therapy
161421|NCT03189368|Multi-site Pacing|multi-site pacing
161422|NCT03189368|Ventriculoarterial Coupling|ventriculoarterial coupling
161423|NCT03189368|Energy Efficiency|energy efficiency
161424|NCT03189342|Balance|balance
161425|NCT03189342|Dual-task interference|dual-task interference
161426|NCT03189342|Falls|falls
161427|NCT03189342|Gait|gait
161428|NCT03189342|Older Adults|older adults
162421|NCT03183193|miRNAs|mirnas
161429|NCT03189329|NIR spectroscopy, cognitive function, eye, nerve block|nir spectroscopy, cognitive function, eye, nerve block
161430|NCT03189316|Peritoneal fluid|peritoneal fluid
161431|NCT03189316|B cells|b cells
161432|NCT03189316|Regulatory B cells|regulatory b cells
161433|NCT03189316|Human|human
161434|NCT03189264|Percutaneous Nephrolithotomy|percutaneous nephrolithotomy
161435|NCT03189264|Postoperative Complications|postoperative complications
161436|NCT03189264|Renal Stone|renal stone
161437|NCT03189264|Surgical Success|surgical success
161438|NCT03189264|Surgical Complications|surgical complications
161439|NCT03189264|Pneumatic Dilation|pneumatic dilation
161440|NCT03189212|Telemedicine|telemedicine
161441|NCT03189186|Kidney Cancer|kidney cancer
161442|NCT03189186|Immunotherapy|immunotherapy
161443|NCT03189186|Renal Cell Carcinoma|renal cell carcinoma
161444|NCT03189186|Cryoablation|cryoablation
161445|NCT03189186|Metastatic Renal Cancer|metastatic renal cancer
161446|NCT03189173|Obstructive Sleep Apnea|obstructive sleep apnea
161447|NCT03189173|Ventilatory Control Instability|ventilatory control instability
161448|NCT03189173|Complex Sleep Apnea|complex sleep apnea
161449|NCT03189121|Metabolism|metabolism
161450|NCT03189121|Macronutrients|macronutrients
161451|NCT03189121|Obesity|obesity
161452|NCT03189121|Energy Expenditure|energy expenditure
161453|NCT03189121|Glucose|glucose
161454|NCT03189108|Malignant Effusion Composition|malignant effusion composition
161455|NCT03189108|Paracentesis|paracentesis
161456|NCT03189108|Thoracentesis|thoracentesis
161457|NCT03189095|exercise|exercise
161458|NCT03189095|physical activity|physical activity
161459|NCT03189095|SCI|sci
161460|NCT03189095|spinal cord injury|spinal cord injury
161461|NCT03189095|online|online
161462|NCT03189056|chronic Chagas disease|chronic chagas disease
161463|NCT03189056|bladder|bladder
161464|NCT03189056|lower urinary tract|lower urinary tract
161465|NCT03189056|urodynamic|urodynamic
161466|NCT03189030|metastatic|metastatic
161467|NCT03189030|microsatellite stable (MSS)|microsatellite stable (mss)
161468|NCT03189004|mHealth, health services, technology, smartphones, Bangladesh|mhealth, health services, technology, smartphones, bangladesh
161469|NCT03188991|pancreatic cystic neoplasm|pancreatic cystic neoplasm
161470|NCT03188991|pancreatic cyst|pancreatic cyst
161471|NCT03188991|pancreatic mucinous cyst|pancreatic mucinous cyst
161472|NCT03188991|pancreatic neoplasms|pancreatic neoplasms
161473|NCT03188991|digestive system neoplasms|digestive system neoplasms
161474|NCT03188991|pancreatic diseases|pancreatic diseases
161475|NCT03188991|mucinous cystic neoplasm|mucinous cystic neoplasm
161476|NCT03188965|First in human|first in human
161477|NCT03188965|Solid tumors|solid tumors
161478|NCT03188965|Lymphomas|lymphomas
161479|NCT03188965|Dose escalation|dose escalation
161480|NCT03188965|Dose expansion|dose expansion
161481|NCT03188913|Burns|burns
161482|NCT03188913|Coagulation|coagulation
161483|NCT03188913|Factor XIII|factor xiii
161484|NCT03188913|Glycocalix|glycocalix
161485|NCT03188913|Cicatrization|cicatrization
161486|NCT03188900|Preeclampsia|preeclampsia
161487|NCT03188900|apheresis|apheresis
161488|NCT03188900|sflt-1|sflt-1
161489|NCT03188887|NIgA|niga
161490|NCT03188887|Kidney biopsy|kidney biopsy
161491|NCT03188887|GFR|gfr
161492|NCT03188887|Corticotherapy|corticotherapy
161493|NCT03188861|mental health conditions in ACSC patients|mental health conditions in acsc patients
161494|NCT03188861|multimorbidity|multimorbidity
161495|NCT03188861|health care utilization|health care utilization
161496|NCT03188809|Postoperative Pain|postoperative pain
161497|NCT03188809|Functional Outcomes|functional outcomes
161498|NCT03188809|Total Knee Arthroplasty|total knee arthroplasty
161499|NCT03188809|Adductor Canal Block|adductor canal block
161500|NCT03188809|Femoral Nerve Block|femoral nerve block
161501|NCT03188796|vitamin D|vitamin d
161502|NCT03188796|critical care|critical care
161503|NCT03188770|Middle-income countries|middle-income countries
161504|NCT03188744|Cervical cancer|cervical cancer
161505|NCT03188744|Pelvic floor muscles|pelvic floor muscles
161506|NCT03188744|Physiotherapy|physiotherapy
161507|NCT03188744|Quality of life|quality of life
161508|NCT03188731|ZIKA|zika
161509|NCT03188731|Dengue|dengue
161510|NCT03188731|Chikungunya|chikungunya
161511|NCT03188731|Pregnant Women|pregnant women
161512|NCT03188731|Pregnant Woman|pregnant woman
161513|NCT03188731|ZIKV|zikv
161514|NCT03188718|Polysomnogram|polysomnogram
161515|NCT03188718|Sleep Disordered Breathing|sleep disordered breathing
161516|NCT03188705|pharmacogenetics|pharmacogenetics
161517|NCT03188705|carboxylesterase|carboxylesterase
161518|NCT03188705|Personalized Medicine|personalized medicine
161519|NCT03188692|Haemophilus influenza type b|haemophilus influenza type b
161520|NCT03188692|Adsorbed Diphtheria-Purified Pertussis-Tetanus-Inactivate|adsorbed diphtheria-purified pertussis-tetanus-inactivate
161521|NCT03188692|poliovirus combined vaccine|poliovirus combined vaccine
161522|NCT03188692|Hib|hib
161523|NCT03188692|DPT-IPV|dpt-ipv
161524|NCT03188692|Intramuscular|intramuscular
161525|NCT03188679|CMV|cmv
161526|NCT03188679|neurological impairment|neurological impairment
161527|NCT03188679|outcome prediction|outcome prediction
162422|NCT03183193|Lipidomics|lipidomics
161528|NCT03188679|amniotic fluid biomarkers|amniotic fluid biomarkers
161529|NCT03188640|Bariatric surgery|bariatric surgery
161530|NCT03188640|Sex hormones|sex hormones
161531|NCT03188640|Women|women
161532|NCT03188640|Quality of life|quality of life
161533|NCT03188614|shock|shock
161534|NCT03188614|crystalloid|crystalloid
161535|NCT03188614|acute kidney injury|acute kidney injury
161536|NCT03188601|Graft vs Host Disease|graft vs host disease
161537|NCT03188601|Immune System Diseases|immune system diseases
161538|NCT03188601|Protease Inhibitors|protease inhibitors
161539|NCT03188601|Alpha 1-Antitrypsin|alpha 1-antitrypsin
161540|NCT03188601|Enzyme Inhibitors|enzyme inhibitors
161541|NCT03188601|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action
161542|NCT03188601|Trypsin Inhibitors|trypsin inhibitors
161543|NCT03188601|Serine Proteinase Inhibitors|serine proteinase inhibitors
161544|NCT03188484|Atrial Fibrillation|atrial fibrillation
161545|NCT03188484|Electrocardiography|electrocardiography
161546|NCT03188484|Biological Markers|biological markers
161547|NCT03188484|Risk Assessment|risk assessment
161548|NCT03188458|Infants|infants
161549|NCT03188458|Cord blood sample|cord blood sample
161550|NCT03188458|Acellular pertussis|acellular pertussis
161551|NCT03188458|Boostrix|boostrix
161552|NCT03188458|Colombia|colombia
161553|NCT03188458|Pregnant women|pregnant women
161554|NCT03188419|Prospective Donors|prospective donors
161555|NCT03188419|Immunodeficiency|immunodeficiency
161556|NCT03188406|Gastric Intestinal Metaplasia|gastric intestinal metaplasia
161557|NCT03188406|Epidemiology|epidemiology
161558|NCT03188406|Risk Stratification|risk stratification
161559|NCT03188406|Helicobacter Pylori|helicobacter pylori
161561|NCT03188380|abdominal ultrasound|abdominal ultrasound
161562|NCT03188380|abdominal radiograph|abdominal radiograph
161563|NCT03188380|preterm|preterm
161564|NCT03188367|dose-finding|dose-finding
161565|NCT03188367|extraintestinal symptoms|extraintestinal symptoms
161566|NCT03188367|gluten|gluten
161567|NCT03188367|intestinal symptoms|intestinal symptoms
161568|NCT03188367|placebo|placebo
161569|NCT03188354|Positron-Emission Tomography|positron-emission tomography
161570|NCT03188354|Magnetic Resonance Imaging|magnetic resonance imaging
161571|NCT03188341|vascular surgery|vascular surgery
161572|NCT03188341|repolarization disturbances|repolarization disturbances
161573|NCT03188341|cardiac complications|cardiac complications
161574|NCT03188341|high risk patient|high risk patient
161575|NCT03188341|high risk procedure|high risk procedure
161576|NCT03188302|Stool consistency|stool consistency
161577|NCT03188302|Texture Analyser|texture analyser
161578|NCT03188302|Bristol Stool Form Scale|bristol stool form scale
161579|NCT03188289|chitosan|chitosan
161580|NCT03188289|clorhexidine|clorhexidine
161581|NCT03188289|suture|suture
161582|NCT03188289|bacteria|bacteria
161583|NCT03188289|wisdom|wisdom
161584|NCT03188276|Chronic Hepatitis C|chronic hepatitis c
161585|NCT03188276|direct-acting antiviral agents|direct-acting antiviral agents
161586|NCT03188276|Myeloid-Derived Suppressor Cells|myeloid-derived suppressor cells
161587|NCT03188276|NK cells|nk cells
161588|NCT03188263|diabetes|diabetes
161589|NCT03188263|sleep|sleep
161590|NCT03188263|circadian rhythm|circadian rhythm
161591|NCT03188263|light treatment|light treatment
161592|NCT03188224|Transition|transition
161593|NCT03188224|Improved patient outcomes|improved patient outcomes
161594|NCT03188224|RCT|rct
161595|NCT03188224|Child health|child health
161596|NCT03188224|Empower youth|empower youth
161597|NCT03188185|Alkermes|alkermes
161598|NCT03188185|Major Depressive Disorder|major depressive disorder
161599|NCT03188185|Treatment Refractory MDD|treatment refractory mdd
161600|NCT03188185|ALKS 5461|alks 5461
161601|NCT03188133|Schizophrenia|schizophrenia
161602|NCT03188133|Visual Hallucination|visual hallucination
161603|NCT03188133|False Perception|false perception
161604|NCT03188133|emotional priming|emotional priming
161605|NCT03188107|Risky Infant|risky infant
161606|NCT03188107|Cerebral Palsy|cerebral palsy
161607|NCT03188107|Down Syndrome|down syndrome
161608|NCT03188107|Spina Bifida|spina bifida
161609|NCT03188107|Infant Motor Profile|infant motor profile
161610|NCT03188068|Kaposiform Hemangioendothelioma|kaposiform hemangioendothelioma
161611|NCT03188068|Kasabach Merritt Phenomenon|kasabach merritt phenomenon
161612|NCT03188068|Sirolimus|sirolimus
161613|NCT03188068|Prednisolone|prednisolone
161614|NCT03188055|patient decision making|patient decision making
161615|NCT03188055|surgical decision making|surgical decision making
161616|NCT03188055|shared decision making|shared decision making
161617|NCT03188055|decision support techniques|decision support techniques
161618|NCT03188042|Transorbital Alternating Current Stimulation|transorbital alternating current stimulation
161619|NCT03188042|Glaucoma|glaucoma
161620|NCT03188029|ethomidate adrenocortical insufficiency|ethomidate adrenocortical insufficiency
161621|NCT03188016|"music therapy"|"music therapy"
161622|NCT03188016|"Intensive Interaction"|"intensive interaction"
161623|NCT03188016|"non-verbal communication"|"non-verbal communication"
161624|NCT03188016|"musical improvisation"|"musical improvisation"
161625|NCT03188016|"feasibility study"|"feasibility study"
161626|NCT03188016|"randomised controlled trial"|"randomised controlled trial"
161627|NCT03188003|Exercise Movement Techniques|exercise movement techniques
161628|NCT03188003|Low Back Pain|low back pain
161629|NCT03188003|Exercise|exercise
161630|NCT03187990|PSMA PET/MRI|psma pet/mri
161631|NCT03187990|Guided Biopsy|guided biopsy
161632|NCT03187990|Prostate Cancer|prostate cancer
161633|NCT03187977|Cognitive intervention|cognitive intervention
161634|NCT03187977|Survivors|survivors
161635|NCT03187977|Childhood ALL|childhood all
161636|NCT03187964|People Living with HIV (PLHIV)|people living with hiv (plhiv)
161637|NCT03187964|Xpert HIV-1 Viral Load (Xpert VL)|xpert hiv-1 viral load (xpert vl)
161638|NCT03187964|Xpert Ultra|xpert ultra
161639|NCT03187964|Antiretroviral treatment (ART)|antiretroviral treatment (art)
161640|NCT03187951|Other disorders of glucose regulation and pancreatic internal secretion|other disorders of glucose regulation and pancreatic internal secretion
161641|NCT03187951|Pancreatic cancer|pancreatic cancer
161642|NCT03187951|Questionnaires|questionnaires
161643|NCT03187951|Surveys|surveys
161644|NCT03187951|Nutritional Questionnaire|nutritional questionnaire
161645|NCT03187951|Nutritional Counseling|nutritional counseling
161646|NCT03187951|Booklet|booklet
161647|NCT03187951|Pamphlet|pamphlet
161648|NCT03187951|Educational materials|educational materials
161649|NCT03187951|Aerobic Exercise|aerobic exercise
161650|NCT03187951|Strength Training Exercises|strength training exercises
161651|NCT03187951|Physical Assessments|physical assessments
161652|NCT03187951|Walk Test|walk test
161653|NCT03187938|Alkaline Phosphatase|alkaline phosphatase
161654|NCT03187938|Pregnancy|pregnancy
161655|NCT03187938|Suboptimal fetal growth|suboptimal fetal growth
161656|NCT03187938|Placental insufficiency|placental insufficiency
161657|NCT03187938|Low birth weight|low birth weight
161658|NCT03187938|IUGR|iugr
161659|NCT03187899|cervical plexus block|cervical plexus block
161660|NCT03187899|clavicle fracture|clavicle fracture
161661|NCT03187899|interscalene brachial plexus block|interscalene brachial plexus block
161662|NCT03187886|Cerebral amyloid angiopathy|cerebral amyloid angiopathy
161663|NCT03187886|CAA-RI|caa-ri
161664|NCT03187886|MRI|mri
161665|NCT03187886|Intracerebral hemorrhage|intracerebral hemorrhage
161666|NCT03187873|community participation|community participation
161667|NCT03187873|Maternal and child health|maternal and child health
161668|NCT03187873|Kenya|kenya
161669|NCT03187860|Bronchial epithelial cell|bronchial epithelial cell
161670|NCT03187860|mucus|mucus
161671|NCT03187860|Air Liquid Interface|air liquid interface
161672|NCT03187847|Physical Activity|physical activity
161673|NCT03187847|Fatigue|fatigue
161674|NCT03187847|Rehabilitation|rehabilitation
161675|NCT03187834|infection|infection
161676|NCT03187834|azithromycin|azithromycin
161677|NCT03187834|amoxicillin|amoxicillin
161678|NCT03187834|co-trimoxazole|co-trimoxazole
161679|NCT03187834|trachoma|trachoma
161680|NCT03187834|mass treatment|mass treatment
161681|NCT03187808|Neck pain, Thoracic manipulation, special massage|neck pain, thoracic manipulation, special massage
161682|NCT03187795|Spinal Cord Injuries|spinal cord injuries
161683|NCT03187795|Randomized Controlled Trial|randomized controlled trial
161684|NCT03187795|Neurogenic Bladder|neurogenic bladder
161685|NCT03187795|Rehabilitation|rehabilitation
161686|NCT03187769|Alkermes|alkermes
161687|NCT03187769|ALKS 3831|alks 3831
161688|NCT03187769|Olanzapine|olanzapine
161689|NCT03187769|Samidorphan|samidorphan
161690|NCT03187769|Schizophrenia|schizophrenia
161691|NCT03187769|Schizophreniform|schizophreniform
161692|NCT03187769|Bipolar I|bipolar i
161693|NCT03187756|Hematopoietic Malignancies|hematopoietic malignancies
161694|NCT03187756|Nonmyeloablative Peripheral Blood Stem Cell Transplant|nonmyeloablative peripheral blood stem cell transplant
161695|NCT03187756|Posttransplantation|posttransplantation
161696|NCT03187743|Lupus erythematosus|lupus erythematosus
161697|NCT03187743|Systemic|systemic
161698|NCT03187743|Corticosteroid|corticosteroid
161699|NCT03187743|Prednisone|prednisone
161700|NCT03187743|Pharmacokinetics|pharmacokinetics
161701|NCT03187730|Smoking Cassation|smoking cassation
161702|NCT03187730|Immigrants|immigrants
161703|NCT03187730|Economic Disparity|economic disparity
161704|NCT03187717|Postoperative pain|postoperative pain
161705|NCT03187717|Recovery period|recovery period
161706|NCT03187717|Total intravenous anesthesia|total intravenous anesthesia
161707|NCT03187717|Inhalation anesthesia|inhalation anesthesia
161708|NCT03187704|air filtration, HEPA, In-home,|air filtration, hepa, in-home,
161709|NCT03187678|switch|switch
161710|NCT03187678|intravenous|intravenous
161711|NCT03187678|selexipag|selexipag
161712|NCT03187665|Pediatric|pediatric
161713|NCT03187665|Pulse Oximeter|pulse oximeter
161714|NCT03187665|Wireless|wireless
161715|NCT03187665|Motion|motion
161716|NCT03187665|False Alarm|false alarm
161717|NCT03187639|Coronary artery disease|coronary artery disease
161718|NCT03187639|CT coronary angiography|ct coronary angiography
161719|NCT03187639|FFRct|ffrct
161720|NCT03187639|Rapid access chest pain clinic|rapid access chest pain clinic
161721|NCT03187639|Stable chest pain|stable chest pain
161722|NCT03187639|Resource utilisation|resource utilisation
161723|NCT03187639|Quality of life|quality of life
161724|NCT03187626|Base-of-thumb osteoarthritis|base-of-thumb osteoarthritis
161725|NCT03187626|Botulinum toxin A|botulinum toxin a
161726|NCT03187626|Intra-articular therapy|intra-articular therapy
161727|NCT03187626|Randomized trial|randomized trial
161728|NCT03187613|Retinal shift|retinal shift
161729|NCT03187613|Aniseikonia|aniseikonia
161730|NCT03187613|Metamorphopsia|metamorphopsia
161731|NCT03187613|Autofluorescence|autofluorescence
161732|NCT03187587|Hyperthermia, Induced|hyperthermia, induced
161733|NCT03187587|Laser Coagulation|laser coagulation
161734|NCT03187587|Laser Therapy|laser therapy
161735|NCT03187574|vaginal prolapse, mesh kit, anatomic assessment, quality of life|vaginal prolapse, mesh kit, anatomic assessment, quality of life
161736|NCT03187561|Sleep|sleep
161737|NCT03187561|Parenting|parenting
161738|NCT03187561|Marital relationship|marital relationship
161739|NCT03187561|Parent-child relations|parent-child relations
161741|NCT03187548|CPP-ACP|cpp-acp
161742|NCT03187535|Transcutaneous Electrical Acupoint Stimulation|transcutaneous electrical acupoint stimulation
161743|NCT03187522|AAA|aaa
161744|NCT03187522|Abdominal Aortic Aneurysms|abdominal aortic aneurysms
161745|NCT03187509|Torsemide, loop diuretics, weight-based|torsemide, loop diuretics, weight-based
161746|NCT03187496|drug-drug interaction|drug-drug interaction
161747|NCT03187444|Cardiovascular risk|cardiovascular risk
161748|NCT03187444|Chronic inflammatory rheumatism|chronic inflammatory rheumatism
161749|NCT03187444|Rheumatoid arthritis|rheumatoid arthritis
161750|NCT03187444|Spondyloarthritis|spondyloarthritis
161751|NCT03187444|Inflammation|inflammation
161752|NCT03187431|Stem cell|stem cell
161753|NCT03187431|Therapy|therapy
161754|NCT03187431|IPF|ipf
161755|NCT03187418|Cyclophotocoagulation|cyclophotocoagulation
161756|NCT03187418|Micropulse TSCPC|micropulse tscpc
161757|NCT03187418|Laser ablation|laser ablation
161758|NCT03187418|Laser therapy|laser therapy
161759|NCT03187405|Subarachnoid Hemorrhage|subarachnoid hemorrhage
161760|NCT03187405|Intracranial Aneurysm|intracranial aneurysm
161761|NCT03187405|Cerebral Ischemia|cerebral ischemia
161762|NCT03187405|Ventriculostomy|ventriculostomy
161763|NCT03187405|Tissue Plasminogen Activator|tissue plasminogen activator
161764|NCT03187353|Cognitive complaints|cognitive complaints
161765|NCT03187353|RRSO|rrso
161766|NCT03187353|Oophorectomy|oophorectomy
161767|NCT03187353|Memory|memory
161768|NCT03187353|Cognition|cognition
161769|NCT03187353|Early menopause|early menopause
161770|NCT03187327|prophylactic salpingectomy|prophylactic salpingectomy
161771|NCT03187327|vaginal hysterectomy|vaginal hysterectomy
161772|NCT03187327|p53 expression|p53 expression
161773|NCT03187327|ovarian cancers|ovarian cancers
161774|NCT03187314|Esophageal cancer|esophageal cancer
161775|NCT03187314|Radiation|radiation
161776|NCT03187314|Anti-PD-1 Antibody|anti-pd-1 antibody
161777|NCT03187301|Parkinson's Disease|parkinson's disease
161778|NCT03187301|Off episodes|off episodes
162154|NCT03184857|augmentation|augmentation
161779|NCT03187275|Cancer Related Fatigue (CRF)|cancer related fatigue (crf)
161780|NCT03187275|Prostate Cancer|prostate cancer
161781|NCT03187275|Swedish Massage Therapy (SMT)|swedish massage therapy (smt)
161782|NCT03187275|Cancer|cancer
161783|NCT03187275|Quality of Life (QOL)|quality of life (qol)
161784|NCT03187262|Waldenström Macroglobulinemia|waldenström macroglobulinemia
161785|NCT03187223|Multiple Myeloma|multiple myeloma
161786|NCT03187223|Bendamustine|bendamustine
161787|NCT03187223|Melphalan|melphalan
161788|NCT03187223|ASCT|asct
161789|NCT03187210|CD30+ Lymphoma|cd30+ lymphoma
161790|NCT03187210|ASCT|asct
161791|NCT03187210|Brentuximab Vedotin|brentuximab vedotin
161792|NCT03187171|Anterior Cervical Spine Fusion|anterior cervical spine fusion
161793|NCT03187132|virtual reality|virtual reality
161794|NCT03187132|transcutaneous electrical nerve stimulation|transcutaneous electrical nerve stimulation
161795|NCT03187132|analgesia|analgesia
161796|NCT03187119|Pediatric|pediatric
161797|NCT03187119|Education|education
161798|NCT03187119|Technology-supported intervention|technology-supported intervention
161799|NCT03187119|Asthma Action Plan|asthma action plan
161800|NCT03187119|Health literacy|health literacy
161801|NCT03187093|MDD|mdd
161802|NCT03187093|Vortioxetine|vortioxetine
161803|NCT03187093|Cognitive dysfunction|cognitive dysfunction
161804|NCT03187093|IGF-1|igf-1
161805|NCT03187093|BDNF|bdnf
161806|NCT03187093|Functioning|functioning
161807|NCT03187067|pneumonia|pneumonia
161808|NCT03187067|diagnostic|diagnostic
161809|NCT03187067|ultrasound|ultrasound
161810|NCT03187067|Pakistan|pakistan
161811|NCT03187067|Mozambique|mozambique
161812|NCT03187041|blood draw tourniquets|blood draw tourniquets
161813|NCT03187041|skin surface pressure|skin surface pressure
161814|NCT03187041|blood draw band|blood draw band
161815|NCT03187041|elastic tourniquet|elastic tourniquet
161816|NCT03187041|phlebotomy|phlebotomy
161817|NCT03187041|tourniquet pressure|tourniquet pressure
161818|NCT03187028|Cancer of Pancreas|cancer of pancreas
161819|NCT03187028|Neoplasms, Pancreatic|neoplasms, pancreatic
161820|NCT03187028|Pancreas Cancer|pancreas cancer
161821|NCT03187028|Pancreas Neoplasms|pancreas neoplasms
161822|NCT03187028|Cancer of the Pancreas|cancer of the pancreas
161823|NCT03187028|Pancreatic Cancer|pancreatic cancer
161824|NCT03187015|Healthy Volunteers|healthy volunteers
161825|NCT03187015|Entinostat|entinostat
161826|NCT03187015|Histone Deacetylase Inhibitor|histone deacetylase inhibitor
161827|NCT03187015|HDAC|hdac
161828|NCT03186989|Mild Alzheimer's Disease|mild alzheimer's disease
161829|NCT03186989|ISIS 814907|isis 814907
161830|NCT03186989|Memory Loss|memory loss
161831|NCT03186989|Alzheimers|alzheimers
161832|NCT03186989|MAPT|mapt
161833|NCT03186976|Risk Factor Modification|risk factor modification
161834|NCT03186976|Catheter ablation|catheter ablation
161835|NCT03186963|distal radius fracture|distal radius fracture
161836|NCT03186963|volar plate|volar plate
161837|NCT03186963|immobilization|immobilization
161838|NCT03186898|hepatocellular carcinoma|hepatocellular carcinoma
161839|NCT03186898|HCC|hcc
161840|NCT03186898|Proton Therapy|proton therapy
161841|NCT03186898|Photon Therapy|photon therapy
161842|NCT03186898|Liver cancer|liver cancer
161843|NCT03186859|non-alcoholic fatty liver disease|non-alcoholic fatty liver disease
161844|NCT03186859|bariatric surgery|bariatric surgery
161845|NCT03186846|cognitive decline|cognitive decline
161846|NCT03186846|hemodynamic monitoring|hemodynamic monitoring
161847|NCT03186846|LIDCO|lidco
161848|NCT03186846|INVOS|invos
161849|NCT03186846|BIS|bis
161850|NCT03186846|brain injury biomarkers|brain injury biomarkers
161851|NCT03186820|Endometriosis|endometriosis
161852|NCT03186820|Magnetic resonance imaging (MRI)|magnetic resonance imaging (mri)
161853|NCT03186820|Susceptibility-weighted imaging (SWI)|susceptibility-weighted imaging (swi)
161854|NCT03186807|normogram|normogram
161855|NCT03186807|brain lumination|brain lumination
161856|NCT03186807|fetal cortex|fetal cortex
161857|NCT03186807|ultrasound|ultrasound
161858|NCT03186794|Rehabilitation|rehabilitation
161859|NCT03186794|Fatigue|fatigue
161860|NCT03186781|Flu Virus|flu virus
161861|NCT03186781|Flu Shot|flu shot
161862|NCT03186781|H2N2|h2n2
161863|NCT03186781|Protein|protein
161864|NCT03186781|Immune Response|immune response
161865|NCT03186742|Eplerenone|eplerenone
161866|NCT03186742|Concentric hypertrophy|concentric hypertrophy
161867|NCT03186729|Intracerebral hemorrhage|intracerebral hemorrhage
161868|NCT03186716|Colostrum|colostrum
161869|NCT03186716|Enteral Nutrition|enteral nutrition
161870|NCT03186716|Intestinal Permeability|intestinal permeability
161871|NCT03186716|Intensive Care Unit|intensive care unit
161872|NCT03186703|Cancer prevention|cancer prevention
161873|NCT03186703|Knowledge translation|knowledge translation
161874|NCT03186703|Physical activity|physical activity
161875|NCT03186703|Diet|diet
161876|NCT03186703|Alcohol|alcohol
161877|NCT03186703|Smoking|smoking
161878|NCT03186690|vital pulp therapy|vital pulp therapy
161879|NCT03186690|Biodentine|biodentine
161880|NCT03186690|Mineral Trioxide Aggregate|mineral trioxide aggregate
161881|NCT03186677|ISU304|isu304
161882|NCT03186677|previously treated hemophilia B patients|previously treated hemophilia b patients
161883|NCT03186677|FIX|fix
161884|NCT03186677|Factor IX|factor ix
161885|NCT03186677|CB2679d|cb2679d
161886|NCT03186651|Vaginal|vaginal
161887|NCT03186651|Medical Device|medical device
161888|NCT03186651|Female Stress Urinary Incontinence|female stress urinary incontinence
161889|NCT03186625|acute coronary syndrome|acute coronary syndrome
161890|NCT03186625|gut microbiota|gut microbiota
161891|NCT03186625|Trimethylamine N-oxide|trimethylamine n-oxide
161892|NCT03186625|percutaneous coronary intervention|percutaneous coronary intervention
161893|NCT03186612|Video games; Virtual reality; Occupational therapy, Manual dexterity; Multiple sclerosis.|video games; virtual reality; occupational therapy, manual dexterity; multiple sclerosis.
161894|NCT03186599|Medication Event Monitoring System|medication event monitoring system
161895|NCT03186599|adherence|adherence
161896|NCT03186586|Heavy Menstrual Bleeding|heavy menstrual bleeding
161897|NCT03186586|Levonorgestrel relesing intrauterine system|levonorgestrel relesing intrauterine system
161898|NCT03186560|Leg ulcers and use of geko device|leg ulcers and use of geko device
161899|NCT03186508|obesity prevention|obesity prevention
161900|NCT03186508|sleep|sleep
161901|NCT03186508|behavioral intervention|behavioral intervention
161902|NCT03186456|acute cerebral infarction|acute cerebral infarction
162155|NCT03184857|bovine bone|bovine bone
161903|NCT03186456|umbilical cord mesenchymal stem cells|umbilical cord mesenchymal stem cells
161904|NCT03186443|herpetic neuralgia|herpetic neuralgia
161905|NCT03186443|post-herpetic neuralgia|post-herpetic neuralgia
161906|NCT03186443|pregabalin|pregabalin
161907|NCT03186430|Vaccine|vaccine
161908|NCT03186430|Vaccination|vaccination
161909|NCT03186430|Behavioral Research|behavioral research
161910|NCT03186430|Adolescent|adolescent
161911|NCT03186430|Health Promotion|health promotion
161912|NCT03186430|Public Health|public health
161913|NCT03186417|Arthritis, Rheumatoid, Stem Cells, Mesenchymal, Autoimmune|arthritis, rheumatoid, stem cells, mesenchymal, autoimmune
161914|NCT03186352|photodynamic therapy|photodynamic therapy
161915|NCT03186352|photoactivated disinfection|photoactivated disinfection
162520|NCT03182699|FGF 23|fgf 23
161916|NCT03186352|primary root caries lesion|primary root caries lesion
161917|NCT03186352|cavity disinfection|cavity disinfection
161918|NCT03186352|lasers|lasers
161919|NCT03186352|root caries|root caries
161920|NCT03186339|QoL|qol
161921|NCT03186339|TAVI|tavi
161922|NCT03186339|surgical aortic valve replacement|surgical aortic valve replacement
161923|NCT03186339|Aortic stenosis|aortic stenosis
161924|NCT03186326|immunotherapy|immunotherapy
161925|NCT03186326|second line|second line
161926|NCT03186313|HCV|hcv
161927|NCT03186313|Sofosbuvir|sofosbuvir
161928|NCT03186313|Ribavirin|ribavirin
161929|NCT03186300|bolus advisor|bolus advisor
161930|NCT03186248|Achalasia cardia|achalasia cardia
161931|NCT03186248|myotomy|myotomy
161932|NCT03186248|Per oral endoscopic myotomy|per oral endoscopic myotomy
161933|NCT03186248|laparoscopic fundoplication|laparoscopic fundoplication
161934|NCT03186209|Asthma,|asthma,
161935|NCT03186209|Bronchial Diseases,|bronchial diseases,
161936|NCT03186209|Respiratory Tract Diseases,|respiratory tract diseases,
161937|NCT03186209|Lung Diseases,|lung diseases,
161938|NCT03186209|Obstructive Lung Diseases|obstructive lung diseases
161939|NCT03186196|Folate|folate
161940|NCT03186196|Polymorphism|polymorphism
161941|NCT03186196|Overweight and Obesity|overweight and obesity
161942|NCT03186196|Inflammatory markers|inflammatory markers
161943|NCT03186183|HIV prevention|hiv prevention
161944|NCT03186183|Sexual health|sexual health
161945|NCT03186183|Motivational interviewing|motivational interviewing
161946|NCT03186183|Information-Motivation-Behavioural skills model|information-motivation-behavioural skills model
161947|NCT03186183|Health promotion|health promotion
161948|NCT03186157|trephined syndrome|trephined syndrome
161949|NCT03186157|sinking skin flap syndrome|sinking skin flap syndrome
161950|NCT03186157|craniectomy|craniectomy
161951|NCT03186157|decompressive craniectomy|decompressive craniectomy
161952|NCT03186157|neurosurgical complications|neurosurgical complications
161953|NCT03186118|pediatric|pediatric
161954|NCT03186118|young adult|young adult
161955|NCT03186118|acute lymphoblastic leukemia|acute lymphoblastic leukemia
161956|NCT03186118|CD 19|cd 19
161957|NCT03186118|leukemia|leukemia
161958|NCT03186118|chimeric antigen receptor|chimeric antigen receptor
161959|NCT03186118|T cell|t cell
161960|NCT03186105|Appendicitis Acute|appendicitis acute
161961|NCT03186105|AMBULATORY|ambulatory
161962|NCT03186092|Respiratory muscle strength|respiratory muscle strength
161963|NCT03186092|Pulmonary hypertension|pulmonary hypertension
161964|NCT03186092|Respiratory muscle training|respiratory muscle training
161965|NCT03186027|chronic fatigue|chronic fatigue
161966|NCT03186027|Sleep problems|sleep problems
161967|NCT03186027|Autonomic dysfunction|autonomic dysfunction
161968|NCT03186027|Health-Related Quality of Life|health-related quality of life
161969|NCT03186027|Coenzyme Q10|coenzyme q10
161970|NCT03186027|NADH|nadh
161971|NCT03186014|Malignant dysphagia|malignant dysphagia
161972|NCT03186014|Stent|stent
161973|NCT03186014|Esophageal neoplasms|esophageal neoplasms
161974|NCT03186014|Brachytherapy|brachytherapy
161975|NCT03186001|frontalis|frontalis
161976|NCT03186001|frontal line|frontal line
161977|NCT03186001|glabellar line|glabellar line
161978|NCT03186001|botulinum toxin|botulinum toxin
161979|NCT03186001|abobotulinum|abobotulinum
161980|NCT03185988|Human epidermal growth factor receptor 2|human epidermal growth factor receptor 2
161981|NCT03185988|Biliary tract cancer|biliary tract cancer
161982|NCT03185988|Esophageal squamous cell carcinoma|esophageal squamous cell carcinoma
161983|NCT03185988|Targeted therapy|targeted therapy
161984|NCT03185988|colorectal cancer|colorectal cancer
161985|NCT03185975|HIV|hiv
161986|NCT03185975|transgender|transgender
161987|NCT03185975|trans|trans
161988|NCT03185975|youth|youth
161989|NCT03185975|home testing|home testing
161990|NCT03185936|optic disc pit|optic disc pit
161991|NCT03185936|retinal detachment|retinal detachment
161992|NCT03185936|maculopathy|maculopathy
161993|NCT03185923|Community-Acquired Infections|community-acquired infections
161994|NCT03185923|Humans|humans
161995|NCT03185923|Medicine, Chinese Traditional|medicine, chinese traditional
161996|NCT03185871|Invasive breast carcinoma|invasive breast carcinoma
161997|NCT03185871|breast carcinoma stage T1cN0 to N3N0|breast carcinoma stage t1cn0 to n3n0
161998|NCT03185858|secondary prevention|secondary prevention
161999|NCT03185858|primary healthcare|primary healthcare
162000|NCT03185858|village doctors|village doctors
162001|NCT03185858|rural China|rural china
162002|NCT03185858|medication adherence|medication adherence
162003|NCT03185858|physical activity|physical activity
162004|NCT03185832|Hear failure|hear failure
162005|NCT03185832|Sudden Cardiac Death|sudden cardiac death
162006|NCT03185832|Arrhythmia|arrhythmia
162007|NCT03185832|Implanted device|implanted device
162008|NCT03185832|ICD|icd
162009|NCT03185832|CRT|crt
162010|NCT03185806|severe acute pancreatitis|severe acute pancreatitis
162011|NCT03185806|sterile acute peripancreatic fluid collections|sterile acute peripancreatic fluid collections
162012|NCT03185806|percutaneous catheter drainage|percutaneous catheter drainage
162013|NCT03185793|SHR4640, Phase II, monotherapy, dose-finding|shr4640, phase ii, monotherapy, dose-finding
162014|NCT03185780|complementary/integrative medicine|complementary/integrative medicine
162015|NCT03185780|glioblastoma|glioblastoma
162016|NCT03185780|quality of life|quality of life
162017|NCT03185780|adherence|adherence
162018|NCT03185754|lung cancer|lung cancer
162020|NCT03185754|lobectomy|lobectomy
162021|NCT03185754|sublobar resection|sublobar resection
162022|NCT03185728|Child Abuse|child abuse
162023|NCT03185728|Mandated Reporting|mandated reporting
162024|NCT03185728|Online Learning|online learning
162025|NCT03185728|Child Protection|child protection
162026|NCT03185728|GAMIFICATION|gamification
162027|NCT03185728|Early Childhood Education|early childhood education
162028|NCT03185715|oocyte donation|oocyte donation
162029|NCT03185715|recipient counselling|recipient counselling
162030|NCT03185715|single embryo transfer (SET)|single embryo transfer (set)
162031|NCT03185715|double embryo transfer (DET)|double embryo transfer (det)
162032|NCT03185715|decision-making|decision-making
162033|NCT03185689|Glycemic control|glycemic control
162034|NCT03185689|Diabetes self-management education|diabetes self-management education
162035|NCT03185650|Healthy Volunteers|healthy volunteers
162036|NCT03185637|Outcomes|outcomes
162037|NCT03185637|Mortality|mortality
162038|NCT03185637|Complications|complications
162039|NCT03185637|Neonatal surgery|neonatal surgery
162040|NCT03185637|Paediatric surgery|paediatric surgery
162041|NCT03185637|Childrens surgery|childrens surgery
162042|NCT03185637|Sub-Saharan Africa|sub-saharan africa
162043|NCT03185637|Research Collaboration|research collaboration
162044|NCT03185637|Gastroschisis|gastroschisis
162045|NCT03185637|Anorectal malformation|anorectal malformation
162046|NCT03185637|Appendicitis|appendicitis
162047|NCT03185637|Intussuception|intussuception
162048|NCT03185637|Inguinal hernia|inguinal hernia
162049|NCT03185585|Nutritional screenings|nutritional screenings
162050|NCT03185546|smoking|smoking
162051|NCT03185546|vaping|vaping
162052|NCT03185520|Stroke|stroke
162053|NCT03185520|Ischemic Stroke|ischemic stroke
162054|NCT03185520|Cryptogenic Stroke|cryptogenic stroke
162055|NCT03185520|Embolic stroke of undetermined source|embolic stroke of undetermined source
162056|NCT03185520|ESUS|esus
162057|NCT03185520|Cerebrovascular Disease|cerebrovascular disease
162058|NCT03185481|Parkinson's Disease|parkinson's disease
162059|NCT03185481|Motor Fluctuations|motor fluctuations
162060|NCT03185481|D1 partial agonist|d1 partial agonist
162061|NCT03185468|CAR T|car t
162062|NCT03185468|Bladder|bladder
162063|NCT03185455|Hypertension|hypertension
162064|NCT03185455|Pregnancy|pregnancy
162065|NCT03185455|Text|text
162066|NCT03185442|fMRI|fmri
162067|NCT03185442|PRF|prf
162068|NCT03185416|Quality of Life|quality of life
162069|NCT03185416|Caregiver|caregiver
162070|NCT03185416|Quality Improvement|quality improvement
162071|NCT03185403|hemodynamic effect|hemodynamic effect
162072|NCT03185403|para vertebral block|para vertebral block
162073|NCT03185390|periampullary lesions|periampullary lesions
162074|NCT03185351|midazolam|midazolam
162075|NCT03185351|brachial plexus block|brachial plexus block
162076|NCT03185338|physical activity, promotion, school|physical activity, promotion, school
162077|NCT03185299|Polyp detection rate|polyp detection rate
162078|NCT03185299|Adenoma detection rate|adenoma detection rate
162079|NCT03185299|Boston Bowel Preparation Scale|boston bowel preparation scale
162080|NCT03185286|3D printing, metal implant, bone defect|3d printing, metal implant, bone defect
162081|NCT03185260|Cardio-Pulmonary Resuscitation|cardio-pulmonary resuscitation
162082|NCT03185260|Cardiac Arrest|cardiac arrest
162083|NCT03185260|Training|training
162084|NCT03185247|Transdiagnostic|transdiagnostic
162085|NCT03185247|POTS (Postural Orthostatic Tachycardia Syndrome)|pots (postural orthostatic tachycardia syndrome)
162086|NCT03185247|Therapy|therapy
162087|NCT03185234|tDCS|tdcs
162088|NCT03185221|Stents Coronary Artery Disease|stents coronary artery disease
162089|NCT03185208|Lithium|lithium
162090|NCT03185208|Mild Cognitive Impairment|mild cognitive impairment
162091|NCT03185208|MCI|mci
162092|NCT03185208|Dementia|dementia
162093|NCT03185208|Alzheimer|alzheimer
162094|NCT03185208|Alzheimer's Disease|alzheimer's disease
162095|NCT03185208|Cognition|cognition
162096|NCT03185208|Memory|memory
162097|NCT03185208|Thinking|thinking
162098|NCT03185208|Prevention|prevention
162099|NCT03185208|amyloid|amyloid
162100|NCT03185208|imaging|imaging
162101|NCT03185208|MRI|mri
162102|NCT03185208|PET|pet
162103|NCT03185208|tau|tau
162104|NCT03185208|plaques|plaques
162105|NCT03185208|tangles|tangles
162106|NCT03185182|Diagnosis|diagnosis
162107|NCT03185182|Imaging|imaging
162108|NCT03185169|breast cancer survivor|breast cancer survivor
162109|NCT03185169|postmenopausal|postmenopausal
162110|NCT03185169|dysuria|dysuria
162111|NCT03185169|dyspareunia|dyspareunia
162112|NCT03185169|vaginal dryness|vaginal dryness
162113|NCT03185169|urinary tract infections|urinary tract infections
162114|NCT03185169|urinary frequency|urinary frequency
162115|NCT03185169|urinary urgency|urinary urgency
162116|NCT03185169|genital burning|genital burning
162117|NCT03185169|genital itching|genital itching
162118|NCT03185169|genital dryness|genital dryness
162119|NCT03185156|nausea and vomiting|nausea and vomiting
162120|NCT03185156|hemabate|hemabate
162121|NCT03185156|propofol|propofol
162122|NCT03185130|Headache|headache
162123|NCT03185130|Benign Headache|benign headache
162124|NCT03185117|opioid consumption|opioid consumption
162125|NCT03185117|postdischarge|postdischarge
162126|NCT03185117|major orthopedic surgery|major orthopedic surgery
162127|NCT03185104|removable partial denture|removable partial denture
162128|NCT03185104|silver diamine fluoride|silver diamine fluoride
162129|NCT03185078|physical therapy|physical therapy
162130|NCT03185078|ESWT|eswt
162131|NCT03185026|Psychiatry|psychiatry
162132|NCT03185026|Suicide|suicide
162133|NCT03185026|Psychoeducation|psychoeducation
162134|NCT03185026|Randomized controlled trial|randomized controlled trial
162135|NCT03185026|current suicidal behavior disorder|current suicidal behavior disorder
162136|NCT03185026|DSM-5|dsm-5
162137|NCT03185013|Cervical intraepithelial neoplasia (CIN)|cervical intraepithelial neoplasia (cin)
162138|NCT03185013|Human papillomavirus (HPV)|human papillomavirus (hpv)
162139|NCT03185013|High grade squamous intraepithelial lesion (HSIL)|high grade squamous intraepithelial lesion (hsil)
162140|NCT03185013|CIN 2|cin 2
162141|NCT03185013|CIN 3|cin 3
162142|NCT03185013|papillomavirus|papillomavirus
162143|NCT03184987|fluticasone furoate|fluticasone furoate
162144|NCT03184987|fixed dose combination|fixed dose combination
162145|NCT03184987|Japanese subjects|japanese subjects
162146|NCT03184987|vilanterol|vilanterol
162147|NCT03184987|asthma|asthma
162148|NCT03184987|umeclidinium bromide|umeclidinium bromide
162149|NCT03184987|closed triple therapy|closed triple therapy
162150|NCT03184935|Myelodysplastic Syndromes|myelodysplastic syndromes
162151|NCT03184935|mesenchymal stem cells|mesenchymal stem cells
162152|NCT03184922|femoral suspensory loops|femoral suspensory loops
162153|NCT03184857|maxillary sinus|maxillary sinus
162156|NCT03184857|Nano hydroxy appatite|nano hydroxy appatite
162157|NCT03184844|Thalidomide TI|thalidomide ti
162158|NCT03184831|sinus lift, injectable platelet rich fibrin, sticky bone, bovine bone|sinus lift, injectable platelet rich fibrin, sticky bone, bovine bone
162159|NCT03184792|Spinal electrical stimulation|spinal electrical stimulation
162160|NCT03184779|Ski|ski
162161|NCT03184779|Snowboard|snowboard
162162|NCT03184779|Snow Sport|snow sport
162163|NCT03184779|Injury|injury
162164|NCT03184779|Injury Prevention|injury prevention
162165|NCT03184779|Safety|safety
162166|NCT03184779|Safety Video|safety video
162167|NCT03184779|Video Intervention|video intervention
162168|NCT03184779|Youth|youth
162169|NCT03184779|Children|children
162170|NCT03184779|Adolescent|adolescent
162171|NCT03184779|Education|education
162172|NCT03184779|Knowledge|knowledge
162173|NCT03184753|Autologous|autologous
162174|NCT03184753|IgT|igt
162175|NCT03184753|Ovarian Cancer|ovarian cancer
162176|NCT03184753|CART|cart
162177|NCT03184701|Telehealth|telehealth
162178|NCT03184701|Quality of Life|quality of life
162179|NCT03184688|platelet rich plasma|platelet rich plasma
162180|NCT03184688|Perineural injection therapy|perineural injection therapy
162181|NCT03184688|hydrodissection|hydrodissection
162182|NCT03184662|High-intensity physical activity|high-intensity physical activity
162183|NCT03184662|Diabetes|diabetes
162184|NCT03184662|Renal function decline|renal function decline
162185|NCT03184636|ACLF|aclf
162186|NCT03184636|SOFA|sofa
162187|NCT03184636|Zagazig university|zagazig university
162188|NCT03184610|Keratoconus|keratoconus
162189|NCT03184610|Optical Coherence Tomography|optical coherence tomography
162190|NCT03184610|Corneal Epithelium Thickness Maps|corneal epithelium thickness maps
162191|NCT03184597|HLA screening|hla screening
162192|NCT03184597|SJS/TEN|sjs/ten
162193|NCT03184597|MPE|mpe
162194|NCT03184597|AEDs|aeds
207168|NCT02900924|PAD|pad
162195|NCT03184571|bemcentinib|bemcentinib
162196|NCT03184571|NSCLC|nsclc
162197|NCT03184571|pembrolizumab|pembrolizumab
162198|NCT03184571|Keytruda|keytruda
162199|NCT03184571|BGB324|bgb324
162200|NCT03184558|bemcentinib|bemcentinib
162201|NCT03184558|TNBC|tnbc
162202|NCT03184558|pembrolizumab|pembrolizumab
162203|NCT03184558|Keytruda|keytruda
162204|NCT03184558|BGB324|bgb324
162205|NCT03184545|anterior knee pain|anterior knee pain
162206|NCT03184480|Drug Use Investigation|drug use investigation
162207|NCT03184480|GW685698|gw685698
162208|NCT03184480|asthma|asthma
162209|NCT03184480|Post-marketing surveillance|post-marketing surveillance
162210|NCT03184480|ARNUITY ELLIPTA|arnuity ellipta
162211|NCT03184467|GV1001|gv1001
162212|NCT03184467|Alzheimer Disease|alzheimer disease
162213|NCT03184454|OCD|ocd
162214|NCT03184454|deep brain stimulation|deep brain stimulation
162215|NCT03184454|treatment-resistant OCD|treatment-resistant ocd
162216|NCT03184428|YAG-Laser Capsulotomy|yag-laser capsulotomy
162217|NCT03184389|Behavioral Counseling|behavioral counseling
162218|NCT03184389|Cigarette Smoking|cigarette smoking
162219|NCT03184389|Mobile Health|mobile health
162220|NCT03184389|Heart Rate Variability Monitoring|heart rate variability monitoring
162221|NCT03184389|Mindfulness-Based Exercises|mindfulness-based exercises
162222|NCT03184389|Mobile Apps|mobile apps
162223|NCT03184389|Physiological Monitoring|physiological monitoring
162224|NCT03184389|Respiratory Pattern Monitoring|respiratory pattern monitoring
162225|NCT03184389|Stress-Management Interventions|stress-management interventions
162226|NCT03184389|Sensor-Triggered Stress Intervention|sensor-triggered stress intervention
162227|NCT03184389|Smartphone Apps|smartphone apps
162228|NCT03184389|Smoking Cessation|smoking cessation
162229|NCT03184389|Wearable Sensors|wearable sensors
162230|NCT03184389|Eating Behavior|eating behavior
162231|NCT03184389|Stress-Related Eating|stress-related eating
162232|NCT03184376|Gut microbiota|gut microbiota
162233|NCT03184376|Prebiotic|prebiotic
162234|NCT03184376|Liver biopsy|liver biopsy
162235|NCT03184376|Oligofructose|oligofructose
162236|NCT03184350|cervical cancer|cervical cancer
162237|NCT03184350|endometrial cancer|endometrial cancer
162238|NCT03184350|proton therapy|proton therapy
162239|NCT03184337|Weight loss|weight loss
162240|NCT03184337|Women|women
162241|NCT03184337|Sleep|sleep
162242|NCT03184337|Intervention|intervention
162243|NCT03184337|Diet|diet
162244|NCT03184337|Physical activity|physical activity
162245|NCT03184337|Fitbit|fitbit
162246|NCT03184311|Therapy response prediction|therapy response prediction
162247|NCT03184311|Exercise tolerance|exercise tolerance
162248|NCT03184311|High-intensity interval training|high-intensity interval training
162249|NCT03184298|Military Personnel|military personnel
162250|NCT03184298|Sexual Assault|sexual assault
162251|NCT03184298|Military Sexual Trauma|military sexual trauma
162252|NCT03184298|Alcohol and Substance Abuse|alcohol and substance abuse
162253|NCT03184285|limitation in conventional monitoring|limitation in conventional monitoring
162254|NCT03184272|limitation in conventional monitoring|limitation in conventional monitoring
162255|NCT03184259|Stroke|stroke
162256|NCT03184259|Exoskeleton Robot|exoskeleton robot
162257|NCT03184259|Rehabilitation|rehabilitation
162258|NCT03184259|Ankle Foot Orthosis|ankle foot orthosis
162259|NCT03184259|Knee Brace|knee brace
162260|NCT03184259|Foot Drop|foot drop
162261|NCT03184246|Videolaryngoscopy (GlideScope)|videolaryngoscopy (glidescope)
162262|NCT03184246|Direct laryngoscopy|direct laryngoscopy
162263|NCT03184220|Neck Pain|neck pain
162264|NCT03184220|Physical Therapy Modalities|physical therapy modalities
162265|NCT03184220|Fascia|fascia
162266|NCT03184220|Manual Therapy|manual therapy
162267|NCT03184220|Massage|massage
162268|NCT03184194|daratumumab|daratumumab
162269|NCT03184194|nivolumab|nivolumab
162270|NCT03184194|cyclophosphamide|cyclophosphamide
162271|NCT03184181|tendinopathy|tendinopathy
162272|NCT03184181|electrolysis|electrolysis
162273|NCT03184181|exercise|exercise
162274|NCT03184181|dry needling|dry needling
162275|NCT03184168|healthy volunteers, lorlatinib, PF-06463922, ADME, NSCLC, radiolabel, metabolism|healthy volunteers, lorlatinib, pf-06463922, adme, nsclc, radiolabel, metabolism
162276|NCT03184155|Nicardipine|nicardipine
162277|NCT03184155|Percutaneous Coronary Intervention|percutaneous coronary intervention
162278|NCT03184155|Coronary Artery Disease|coronary artery disease
162279|NCT03184142|Intimidation|intimidation
162280|NCT03184142|Simulation|simulation
162281|NCT03184142|Medical education|medical education
162282|NCT03184142|Surgical education|surgical education
162283|NCT03184077|Postpartum dyspareunia|postpartum dyspareunia
162284|NCT03184077|Obestric laceration|obestric laceration
162285|NCT03184064|Blackcurrant|blackcurrant
162286|NCT03184064|Citrus|citrus
162287|NCT03184064|Polyphenols|polyphenols
162288|NCT03184064|Glucose|glucose
162289|NCT03184064|Postprandial|postprandial
162290|NCT03184064|Metabolism|metabolism
162291|NCT03184051|Knee|knee
162292|NCT03184051|Osteoarthritis|osteoarthritis
162293|NCT03184051|Ultrasonography evaluation/ultrasound|ultrasonography evaluation/ultrasound
162294|NCT03184051|Articular cartilage|articular cartilage
162295|NCT03184051|UltraSound Speed Of Sound (US-SOS)|ultrasound speed of sound (us-sos)
162296|NCT03184051|UltraSound Time of Flight (US-TOF)|ultrasound time of flight (us-tof)
162297|NCT03184012|caries|caries
162298|NCT03184012|full coverage|full coverage
162299|NCT03184012|strip crown|strip crown
162300|NCT03184012|Zirconia crown|zirconia crown
162301|NCT03184012|primary anterior teeth|primary anterior teeth
162302|NCT03184012|crown|crown
162303|NCT03183960|Self-management|self-management
162304|NCT03183960|Quality of Life|quality of life
162305|NCT03183960|Self-efficacy|self-efficacy
162306|NCT03183960|Support|support
162307|NCT03183960|Stroke|stroke
162308|NCT03183960|Older adults|older adults
162309|NCT03183947|fMRI|fmri
162310|NCT03183947|neurofeedback|neurofeedback
162311|NCT03183947|emotion regulation|emotion regulation
162312|NCT03183947|schizophrenia|schizophrenia
162313|NCT03183947|cognitive reappraisal|cognitive reappraisal
162314|NCT03183947|depression|depression
162315|NCT03183934|Epidermolysis Bullosa|epidermolysis bullosa
162316|NCT03183934|Stem cell|stem cell
162317|NCT03183908|influenza vaccine|influenza vaccine
162318|NCT03183908|fever following vaccination|fever following vaccination
162319|NCT03183908|pain following vaccination|pain following vaccination
162320|NCT03183908|quality of life|quality of life
162321|NCT03183869|microbiome|microbiome
162322|NCT03183869|multiple sclerosis|multiple sclerosis
162323|NCT03183869|microbiota|microbiota
162324|NCT03183869|gut|gut
162325|NCT03183843|Atrial Fibrillation|atrial fibrillation
162326|NCT03183843|Mitral Valve Stenosis|mitral valve stenosis
162327|NCT03183843|Mitral Valve Insufficiency|mitral valve insufficiency
162328|NCT03183843|Dabigatran|dabigatran
162329|NCT03183843|Biological Prosthesis|biological prosthesis
162330|NCT03183843|Mitral Valve Replacement|mitral valve replacement
162331|NCT03183843|Cox-Maze Procedure|cox-maze procedure
162332|NCT03183830|Cardiovascular Disease|cardiovascular disease
162333|NCT03183830|Inorganic nitrate|inorganic nitrate
162334|NCT03183830|Nitric Oxide|nitric oxide
162335|NCT03183830|Inflammation|inflammation
162336|NCT03183817|Person-centred care|person-centred care
162337|NCT03183778|Chronic kidney disease, stages 3B-4|chronic kidney disease, stages 3b-4
162338|NCT03183752|thyroid|thyroid
162339|NCT03183752|insulin|insulin
162340|NCT03183752|thyroid nodule|thyroid nodule
162341|NCT03183752|insulin resistance|insulin resistance
162342|NCT03183752|thyroid volume|thyroid volume
162343|NCT03183752|metformin|metformin
162344|NCT03183739|ASP8062|asp8062
162345|NCT03183739|Pharmacokinetics|pharmacokinetics
162346|NCT03183739|Safety|safety
162347|NCT03183700|Screening HPV|screening hpv
162348|NCT03183700|Self sampling|self sampling
162349|NCT03183700|DNA Methylation|dna methylation
162350|NCT03183687|neurosurgery|neurosurgery
162351|NCT03183687|resident wellness|resident wellness
162352|NCT03183687|health|health
162353|NCT03183687|mental health|mental health
162354|NCT03183687|physical activity|physical activity
162355|NCT03183687|physician health|physician health
162356|NCT03183622|Deep Second-Degree Burn Wound|deep second-degree burn wound
162357|NCT03183596|Deep Serratus Block|deep serratus block
162358|NCT03183596|Reconstructive Breast Surgery|reconstructive breast surgery
162359|NCT03183596|Superficial Serratus block|superficial serratus block
162360|NCT03183583|Tissue Adhesive|tissue adhesive
162361|NCT03183492|Israel|israel
162362|NCT03183492|Universal Mass Vaccination|universal mass vaccination
162363|NCT03183492|Havrix®|havrix®
162364|NCT03183492|Hepatitis A|hepatitis a
162365|NCT03183492|Healthy adults|healthy adults
162366|NCT03183492|Long term persistence|long term persistence
162367|NCT03183492|Toddlers|toddlers
162368|NCT03183479|adolescent idiopathic scoliosis|adolescent idiopathic scoliosis
162369|NCT03183479|fibrinogen concentrate|fibrinogen concentrate
162370|NCT03183479|perioperative blood loss|perioperative blood loss
162371|NCT03183479|transfusion|transfusion
162372|NCT03183453|Confabulations|confabulations
162373|NCT03183453|Neuropsychological rehabilitation|neuropsychological rehabilitation
162374|NCT03183453|Memory|memory
162375|NCT03183440|Atopic dermatitis|atopic dermatitis
162376|NCT03183440|Prevention|prevention
162377|NCT03183440|Prebiotics|prebiotics
162378|NCT03183440|Pregnancy|pregnancy
162379|NCT03183414|cardiac surgery|cardiac surgery
162380|NCT03183414|transoesophageal echocardiography|transoesophageal echocardiography
162381|NCT03183401|childhood cancer survivor|childhood cancer survivor
162382|NCT03183388|psychotherapy|psychotherapy
162383|NCT03183362|Barbed sutures,Cesarean Section, adhesions|barbed sutures,cesarean section, adhesions
162384|NCT03183323|hfpef|hfpef
162385|NCT03183323|hfref|hfref
162386|NCT03183323|cardiorenal syndrome|cardiorenal syndrome
162387|NCT03183323|exercise|exercise
162388|NCT03183323|telerehabilitation|telerehabilitation
162389|NCT03183323|rehabilitation|rehabilitation
162390|NCT03183284|dexamethazone|dexamethazone
162391|NCT03183284|prednislone|prednislone
162392|NCT03183284|severe ITP|severe itp
162393|NCT03183232|Immunotherapy, γδ T Cell, Lung Cancer|immunotherapy, γδ t cell, lung cancer
162394|NCT03183219|Immunotherapy, γδ T Cell, Liver Cancer|immunotherapy, γδ t cell, liver cancer
162395|NCT03183206|Immunotherapy, γδ T Cell, Breast Cancer|immunotherapy, γδ t cell, breast cancer
162396|NCT03183193|NAFLD|nafld
162397|NCT03183193|NASH|nash
162398|NCT03183193|Obesity|obesity
162399|NCT03183193|AASLD|aasld
162400|NCT03183193|AHA|aha
162401|NCT03183193|Energy-restricted diet|energy-restricted diet
162402|NCT03183193|Lifestyle intervention|lifestyle intervention
162403|NCT03183193|Mediterranean diet|mediterranean diet
162404|NCT03183193|Weight loss|weight loss
162405|NCT03183193|Liver damage|liver damage
162406|NCT03183193|Inflammation|inflammation
162407|NCT03183193|Oxidative stress|oxidative stress
162408|NCT03183193|Microbiota composition|microbiota composition
162409|NCT03183193|Eating behaviour|eating behaviour
162410|NCT03183193|Satiety|satiety
162411|NCT03183193|Physical activity|physical activity
162412|NCT03183193|Sedentary behaviours|sedentary behaviours
162413|NCT03183193|Sleep quality|sleep quality
162414|NCT03183193|Sleep duration|sleep duration
162415|NCT03183193|Psychological factors|psychological factors
162416|NCT03183193|Nutrigenomics|nutrigenomics
162417|NCT03183193|Nutrigenetics|nutrigenetics
162418|NCT03183193|Transcriptomics|transcriptomics
162419|NCT03183193|Epigenetics|epigenetics
162420|NCT03183193|Metabolomics|metabolomics
162423|NCT03183115|Early esophageal squamous cell neoplasm|early esophageal squamous cell neoplasm
162424|NCT03183115|Radiofrequency ablation|radiofrequency ablation
162425|NCT03183115|Endoscopic submucosal dissection|endoscopic submucosal dissection
162426|NCT03183115|Esophageal cancer|esophageal cancer
162427|NCT03183115|Recurrence|recurrence
162428|NCT03183115|Field cancerization|field cancerization
162429|NCT03183076|epilepsy|epilepsy
162430|NCT03183076|Diet, Carbohydrate-Restricted|diet, carbohydrate-restricted
162431|NCT03183076|Drug Resistance|drug resistance
162432|NCT03183037|Acupuncture|acupuncture
162433|NCT03183037|17-298|17-298
162434|NCT03183011|cardiac resynchronization therapy|cardiac resynchronization therapy
162435|NCT03183011|implantable cardioverter defibrillator|implantable cardioverter defibrillator
162436|NCT03183011|heart failure|heart failure
162437|NCT03183011|magnetic resonance imaging|magnetic resonance imaging
162438|NCT03182972|intervention study|intervention study
162439|NCT03182972|medication reconciliation|medication reconciliation
162440|NCT03182972|pharmacists|pharmacists
162441|NCT03182972|Nigeria|nigeria
162442|NCT03182972|Diabetes|diabetes
162443|NCT03182972|Hypertension|hypertension
162444|NCT03182959|Nrf2 pathway|nrf2 pathway
162445|NCT03182959|Oral mucosa|oral mucosa
162446|NCT03182959|HNSCC|hnscc
162447|NCT03182959|Head and Neck Cancer|head and neck cancer
162448|NCT03182959|Head and Neck Squamous Cell Carcinoma|head and neck squamous cell carcinoma
162449|NCT03182959|Avmacol|avmacol
162450|NCT03182959|Tobacco-related Head and Neck Cancer|tobacco-related head and neck cancer
162451|NCT03182959|broccoli sprout powder|broccoli sprout powder
162452|NCT03182959|broccoli seed extract powder|broccoli seed extract powder
162453|NCT03182933|10 meter walk test|10 meter walk test
162454|NCT03182933|Opioid consumption|opioid consumption
162455|NCT03182894|chemo-refractory|chemo-refractory
162456|NCT03182894|pembrolizumab|pembrolizumab
162457|NCT03182894|epacadostat|epacadostat
162458|NCT03182894|azacitidine|azacitidine
162459|NCT03182894|recommended phase 2 dose (RP2D)|recommended phase 2 dose (rp2d)
162460|NCT03182894|microsatellite-stable (MSS) Metastatic Colorectal Cancer|microsatellite-stable (mss) metastatic colorectal cancer
162461|NCT03182881|Myofascial-reléase|myofascial-reléase
162462|NCT03182881|Fibromyalgia|fibromyalgia
162463|NCT03182881|Lymphatic drainage|lymphatic drainage
162464|NCT03182881|Breast cancer|breast cancer
162465|NCT03182855|Acute Coronary Syndrome|acute coronary syndrome
162466|NCT03182855|STEMI|stemi
162467|NCT03182855|Platelet reactivity|platelet reactivity
162468|NCT03182855|Anti-thrombotic therapy|anti-thrombotic therapy
162469|NCT03182829|direct oral anticoagulants|direct oral anticoagulants
162470|NCT03182829|apixaban|apixaban
162471|NCT03182829|dabigatran|dabigatran
162472|NCT03182829|edoxaban|edoxaban
162473|NCT03182829|rivaroxaban|rivaroxaban
162474|NCT03182829|urine|urine
162475|NCT03182829|LC-MS/MS|lc-ms/ms
162476|NCT03182829|evaluation study|evaluation study
162477|NCT03182829|point of care test|point of care test
162478|NCT03182829|blood coagulation|blood coagulation
162479|NCT03182829|coagulation test|coagulation test
162480|NCT03182829|anticoagulant|anticoagulant
162481|NCT03182829|thrombosis|thrombosis
162482|NCT03182829|pulmonary embolism|pulmonary embolism
162483|NCT03182829|atrial fibrillation|atrial fibrillation
162484|NCT03182829|anticoagulation|anticoagulation
162485|NCT03182829|mass spectrometry|mass spectrometry
162486|NCT03182829|POC test|poc test
162487|NCT03182816|epidermal growth factor receptor|epidermal growth factor receptor
162488|NCT03182816|CTLA-4|ctla-4
162489|NCT03182816|PD-1|pd-1
207632|NCT02897232|HPV|hpv
162490|NCT03182816|chimeric antigen receptor T cells|chimeric antigen receptor t cells
162491|NCT03182816|solid tumor|solid tumor
162492|NCT03182803|mesothelin|mesothelin
162493|NCT03182803|CTLA-4|ctla-4
162494|NCT03182803|PD-1|pd-1
162495|NCT03182803|chimeric antigen receptor T cells|chimeric antigen receptor t cells
162496|NCT03182803|solid tumor|solid tumor
162497|NCT03182790|Smoking Cessation|smoking cessation
162498|NCT03182790|Quit to Win|quit to win
162499|NCT03182790|Brief intervention|brief intervention
162500|NCT03182790|Semi-personalized Instant messaging|semi-personalized instant messaging
162501|NCT03182790|Incentives|incentives
162502|NCT03182790|AWARD model|award model
162503|NCT03182790|Smoking Cessation Intervention|smoking cessation intervention
162504|NCT03182790|Regular messages|regular messages
162505|NCT03182777|arrhythmias, cardiac|arrhythmias, cardiac
162506|NCT03182777|channelopathies|channelopathies
162507|NCT03182777|death, sudden|death, sudden
162508|NCT03182777|genetic testing|genetic testing
162509|NCT03182777|electrocardiography, ambulatory|electrocardiography, ambulatory
162510|NCT03182777|anesthesia, local|anesthesia, local
162511|NCT03182777|dentistry|dentistry
162512|NCT03182738|HIV/AIDS Health Management App|hiv/aids health management app
162513|NCT03182738|HIV/AIDS symptoms|hiv/aids symptoms
162514|NCT03182725|POTS|pots
162515|NCT03182725|tachycardia|tachycardia
162516|NCT03182725|ivabradine|ivabradine
162517|NCT03182699|Secondary Hyperparathyroidism|secondary hyperparathyroidism
162518|NCT03182699|Hemodialysis|hemodialysis
162519|NCT03182699|Left Ventricular Hypertrophy|left ventricular hypertrophy
162521|NCT03182699|Etelcalcetide|etelcalcetide
162522|NCT03182699|Alfacalcidol|alfacalcidol
162523|NCT03182686|osteoarthritis|osteoarthritis
162524|NCT03182686|osteoarthritis of the knee|osteoarthritis of the knee
162525|NCT03182686|OA|oa
162526|NCT03182686|OAK|oak
162527|NCT03182686|Kellgren Lawrence (KL)|kellgren lawrence (kl)
162528|NCT03182673|advanced solid tumor|advanced solid tumor
162529|NCT03182673|Protein Kinase MEK inhibitor (MEKi)|protein kinase mek inhibitor (meki)
162530|NCT03182673|Programmed Death 1(PD-1)|programmed death 1(pd-1)
162531|NCT03182673|Safety|safety
162532|NCT03182673|Pharmacokinetics|pharmacokinetics
162533|NCT03182673|PARP inhibitor|parp inhibitor
162534|NCT03182621|Physical Fitness|physical fitness
162535|NCT03182621|Body Composition|body composition
162536|NCT03182621|Executive Cognitive Function|executive cognitive function
162537|NCT03182582|Laser Debridement|laser debridement
162538|NCT03182582|Debridement|debridement
162539|NCT03182556|Dance Therapy|dance therapy
162540|NCT03182556|Exercise|exercise
162541|NCT03182556|Myofeedback|myofeedback
162542|NCT03182556|Fibromyalgia|fibromyalgia
162543|NCT03182543|Exercise|exercise
162544|NCT03182543|Oxidative stress|oxidative stress
162545|NCT03182543|Antioxidant|antioxidant
162546|NCT03182491|Platelet activating factor|platelet activating factor
162547|NCT03182491|Basophil activation test|basophil activation test
162548|NCT03182491|Anaphylatoxins|anaphylatoxins
162549|NCT03182478|skin picking|skin picking
162550|NCT03182478|SPD|spd
162551|NCT03182478|Cognitive-Behavioral Therapy|cognitive-behavioral therapy
162552|NCT03182478|CBT|cbt
162553|NCT03182478|Group treatment|group treatment
162554|NCT03182478|Rothbaum protocol|rothbaum protocol
162555|NCT03182452|Alarms|alarms
162556|NCT03182452|Alarm Fatigue|alarm fatigue
162557|NCT03182452|Alarm Nuisance|alarm nuisance
162558|NCT03182452|Alarm Reduction|alarm reduction
162559|NCT03182452|Patient Monitoring|patient monitoring
162560|NCT03182452|Intensive Care|intensive care
162561|NCT03182439|WEARABLE HEART RATE MONITORS, ACCURACY|wearable heart rate monitors, accuracy
162562|NCT03182413|modafinil|modafinil
162563|NCT03182413|connexin|connexin
162564|NCT03182413|sleep deprivation|sleep deprivation
162565|NCT03182413|cognitive performance|cognitive performance
162566|NCT03182387|Bronchoalveolar lavage|bronchoalveolar lavage
162567|NCT03182387|amylase assay|amylase assay
162568|NCT03182387|aspiration pneumonia|aspiration pneumonia
162569|NCT03182374|Autologous Protein Solution (APS)|autologous protein solution (aps)
162570|NCT03182374|Intra-articular Injection|intra-articular injection
162571|NCT03182374|Osteoarthritis|osteoarthritis
162572|NCT03182361|Auricular, nasal, orbital, extraoral prostheses, extraoral implants, peri-implant reactions, Holgers|auricular, nasal, orbital, extraoral prostheses, extraoral implants, peri-implant reactions, holgers
162573|NCT03182348|Microvessels|microvessels
162574|NCT03182348|Cardiovascular disease|cardiovascular disease
162575|NCT03182348|OCT|oct
162576|NCT03182322|Type 1 diabetes|type 1 diabetes
162577|NCT03182322|T1D|t1d
162578|NCT03182322|diabetes mellitus|diabetes mellitus
162579|NCT03182322|intranasal insulin|intranasal insulin
162580|NCT03182322|mucosal tolerance|mucosal tolerance
162581|NCT03182322|autoantigen|autoantigen
162582|NCT03182322|self tolerance|self tolerance
162583|NCT03182322|prevention|prevention
162584|NCT03182322|at risk for developing type 1 diabetes|at risk for developing type 1 diabetes
162585|NCT03182322|juvenile diabetes|juvenile diabetes
207695|NCT02896777|pH|ph
162586|NCT03182296|beta cell mass|beta cell mass
162587|NCT03182296|exendin|exendin
162588|NCT03182296|GLP-1 PET|glp-1 pet
162589|NCT03182283|Person-centered care|person-centered care
162590|NCT03182283|Psychosis care|psychosis care
162591|NCT03182283|Integrated care|integrated care
162592|NCT03182257|TRK|trk
162593|NCT03182257|TRKA|trka
162594|NCT03182257|TRKB|trkb
162595|NCT03182257|TRKC|trkc
162596|NCT03182257|NTRK1|ntrk1
162597|NCT03182257|NTRK2|ntrk2
162598|NCT03182257|NTRK3|ntrk3
162599|NCT03182257|NTRK fusion positive|ntrk fusion positive
162600|NCT03182257|NTRK1 fusion|ntrk1 fusion
162601|NCT03182257|NTRK2 fusion|ntrk2 fusion
162602|NCT03182257|NTRK3 fusion|ntrk3 fusion
162603|NCT03182257|NTRK1 gene rearrangement|ntrk1 gene rearrangement
162604|NCT03182257|NTRK2 gene rearrangement|ntrk2 gene rearrangement
162605|NCT03182257|NTRK3 gene fusion|ntrk3 gene fusion
162606|NCT03182257|ETV6-NTRK3|etv6-ntrk3
162607|NCT03182257|fusion|fusion
162608|NCT03182257|tumors|tumors
162609|NCT03182257|solid tumors|solid tumors
162610|NCT03182257|CNS tumors|cns tumors
162611|NCT03182257|central nervous system tumors|central nervous system tumors
162612|NCT03182257|TRK fusion|trk fusion
162613|NCT03182257|ETV6|etv6
162614|NCT03182257|ETV6 fusion|etv6 fusion
162615|NCT03182257|solid CNS tumor|solid cns tumor
162616|NCT03182257|advanced CNS tumor|advanced cns tumor
162617|NCT03182257|primary CNS tumor|primary cns tumor
162618|NCT03182244|gilteritinib|gilteritinib
162619|NCT03182244|Acute Myeloid Leukemia (AML)|acute myeloid leukemia (aml)
162620|NCT03182244|ASP2215|asp2215
162621|NCT03182231|exendin|exendin
162622|NCT03182231|GLP1|glp1
162623|NCT03182231|beta cell mass|beta cell mass
162624|NCT03182218|Periprocedural|periprocedural
162625|NCT03182218|Anticoagulation|anticoagulation
162626|NCT03182218|Dabigatran|dabigatran
162627|NCT03182218|Rivaroxaban|rivaroxaban
162628|NCT03182218|Apixaban|apixaban
162629|NCT03182218|Edoxaban|edoxaban
162630|NCT03182218|Direct oral anticoagulant|direct oral anticoagulant
162631|NCT03182218|Surgery|surgery
162632|NCT03182218|Anaesthesia|anaesthesia
162633|NCT03182218|Novel oral anticoagulant|novel oral anticoagulant
162634|NCT03182218|Perioperative medicine|perioperative medicine
162635|NCT03182205|Breathing Exercises|breathing exercises
162636|NCT03182205|Autonomic Nervous System|autonomic nervous system
162637|NCT03182205|Hemodynamics|hemodynamics
162638|NCT03182192|Betal cells|betal cells
162639|NCT03182192|Roux- and Y gastic bypass|roux- and y gastic bypass
162640|NCT03182192|exendin|exendin
162641|NCT03182192|GLP1|glp1
162642|NCT03182166|golimumab|golimumab
162643|NCT03182166|clinical response|clinical response
162644|NCT03182166|mayo score|mayo score
162645|NCT03182166|rectosigmoidoscopy|rectosigmoidoscopy
162646|NCT03182166|ulcerative colitis|ulcerative colitis
162647|NCT03182140|long-acting contraception,|long-acting contraception,
162648|NCT03182140|unintended pregnancy|unintended pregnancy
162649|NCT03182140|satisfaction|satisfaction
162650|NCT03182140|bleeding profile|bleeding profile
162651|NCT03182140|amenorrhea|amenorrhea
162652|NCT03182075|Obsessive-Compulsive Disorder|obsessive-compulsive disorder
162653|NCT03182075|OCD|ocd
162654|NCT03182075|Obsessive Personality Disorder|obsessive personality disorder
162655|NCT03182075|Compulsive Behavior|compulsive behavior
162656|NCT03182075|Personality Disorders|personality disorders
162657|NCT03182075|Mental Disorders|mental disorders
162658|NCT03182075|Anxiety Disorders|anxiety disorders
162659|NCT03182075|Impulsive Behavior|impulsive behavior
162660|NCT03182075|Cognition|cognition
162661|NCT03182075|Emotion|emotion
162662|NCT03182075|Emotional Regulation|emotional regulation
162663|NCT03182062|one lung ventilation|one lung ventilation
162664|NCT03182062|postoperative pulmonary complication|postoperative pulmonary complication
162665|NCT03182062|perioperative lung protective ventilation|perioperative lung protective ventilation
162666|NCT03182049|GPA|gpa
162667|NCT03182049|Granulomatosis with polyangiitis|granulomatosis with polyangiitis
162668|NCT03182049|Wegener's granulomatosis|wegener's granulomatosis
162669|NCT03182049|Subglottic Stenosis|subglottic stenosis
162670|NCT03182049|Bronchial Stenosis|bronchial stenosis
162671|NCT03182023|outcome,ECMO,Respiratory Failure,Circulatory Failure|outcome,ecmo,respiratory failure,circulatory failure
162672|NCT03182010|Cesarean section scar, Barbed suture, Conventional suture|cesarean section scar, barbed suture, conventional suture
162673|NCT03181997|Aortic Valve Stenosis|aortic valve stenosis
162674|NCT03181997|Transcatheter Aortic Valve Implantation|transcatheter aortic valve implantation
162675|NCT03181997|Cancer|cancer
162676|NCT03181997|Malignancy|malignancy
162677|NCT03181971|water|water
162678|NCT03181971|sugar-sweetened beverages|sugar-sweetened beverages
162679|NCT03181971|schools|schools
162680|NCT03181958|nasal high frequency oscillation ventilation(NHFOV)|nasal high frequency oscillation ventilation(nhfov)
162681|NCT03181958|nasal continuous positive airway pressure(NCPAP)|nasal continuous positive airway pressure(ncpap)
162682|NCT03181958|nasal intermittent positive pressure ventilation（NIPPV）|nasal intermittent positive pressure ventilation（nippv）
162683|NCT03181958|neonatal respiratory distress syndrome(NRDS)|neonatal respiratory distress syndrome(nrds)
162684|NCT03181958|preterm infants|preterm infants
162685|NCT03181906|medication discrepancy|medication discrepancy
162686|NCT03181906|primary care|primary care
162687|NCT03181906|transition of care|transition of care
162688|NCT03181880|ASTUTE|astute
162689|NCT03181880|Chronic Obstructive Pulmonary Disease|chronic obstructive pulmonary disease
162690|NCT03181880|Randomised|randomised
162691|NCT03181880|Pragmatic|pragmatic
162692|NCT03181880|Standard of Care|standard of care
162693|NCT03181880|Aclidinium bromide/formoterol fumarate fixed-dose combination|aclidinium bromide/formoterol fumarate fixed-dose combination
162694|NCT03181880|Duaklir|duaklir
162695|NCT03181880|Genuair|genuair
162696|NCT03181867|PET/ CT|pet/ ct
162697|NCT03181867|Endorectal MRI|endorectal mri
162698|NCT03181867|Imaging|imaging
162699|NCT03181867|PSMA|psma
162700|NCT03181867|Prostate Cancer Relapse|prostate cancer relapse
162701|NCT03181854|Integrated Early Palliative Care|integrated early palliative care
162702|NCT03181828|CPSI deficiency|cpsi deficiency
162703|NCT03181828|OTC Deficiency|otc deficiency
162704|NCT03181828|AS Deficiency|as deficiency
162705|NCT03181828|AL Deficiency|al deficiency
162706|NCT03181815|CLADRIBINE|cladribine
162707|NCT03181815|ACUTE MYELOID LEUKEMIA|acute myeloid leukemia
162708|NCT03181789|HIV vaccine|hiv vaccine
162709|NCT03181789|DNA vaccine|dna vaccine
162710|NCT03181789|IL-12|il-12
162711|NCT03181789|Electroporation|electroporation
162712|NCT03181789|p24|p24
162713|NCT03181789|Gag|gag
162714|NCT03181789|Adjuvant|adjuvant
162715|NCT03181789|Healthy|healthy
162716|NCT03181763|MDMA|mdma
162717|NCT03181763|Startle response|startle response
162718|NCT03181763|sleep|sleep
162719|NCT03181763|Oxytocin|oxytocin
162720|NCT03181750|Palliative Care|palliative care
162721|NCT03181750|Latino|latino
162722|NCT03181750|Patient Navigation|patient navigation
162723|NCT03181737|diabetes mellitus typ 2, adherence, psychological online-intervention, randomized controlled study|diabetes mellitus typ 2, adherence, psychological online-intervention, randomized controlled study
162724|NCT03181711|Dental caries|dental caries
162725|NCT03181711|Tooth, deciduous|tooth, deciduous
162726|NCT03181711|Children|children
162727|NCT03181711|Radiography/bitewing|radiography/bitewing
162728|NCT03181711|diagnostic imaging|diagnostic imaging
162729|NCT03181685|Progesterone supplementation|progesterone supplementation
162730|NCT03181685|IVF|ivf
162731|NCT03181685|Preference expressed by the patient|preference expressed by the patient
162732|NCT03181672|Stellate ganglion block Tourniquet reaction|stellate ganglion block tourniquet reaction
162733|NCT03181659|Musculoskeletal Manipulations|musculoskeletal manipulations
162734|NCT03181659|Exercise|exercise
162735|NCT03181659|Patient Education|patient education
162736|NCT03181659|Low back pain|low back pain
162737|NCT03181633|PNH|pnh
162738|NCT03181633|Paroxysmal|paroxysmal
162739|NCT03181633|Hemoglobinuria|hemoglobinuria
162740|NCT03181633|ACH-0144471|ach-0144471
162741|NCT03181594|Cryotherapy|cryotherapy
162742|NCT03181594|Cryoablation|cryoablation
162743|NCT03181581|ultrasonography|ultrasonography
162744|NCT03181581|ultrasonics|ultrasonics
162745|NCT03181581|brain|brain
162746|NCT03181581|surgery|surgery
162747|NCT03181555|Pregnant|pregnant
162748|NCT03181555|Obese|obese
162749|NCT03181555|Omic|omic
162750|NCT03181490|Pulmonary Nodule|pulmonary nodule
162751|NCT03181490|Solitary|solitary
162752|NCT03181477|Phase II|phase ii
162753|NCT03181477|Radiotherapy with SIB-IMRT|radiotherapy with sib-imrt
162754|NCT03181477|Tomozolomide|tomozolomide
162755|NCT03181438|Renal Transplantation|renal transplantation
162756|NCT03181438|Acute pain|acute pain
162757|NCT03181438|Regional Anesthesia|regional anesthesia
162758|NCT03181438|TAP Block|tap block
162759|NCT03181425|Knee cartilage|knee cartilage
162760|NCT03181425|Early Osteoarthritis|early osteoarthritis
162761|NCT03181425|MRI tractography|mri tractography
162762|NCT03181425|Diffusion Tensor Imaging|diffusion tensor imaging
162763|NCT03181386|Dabigatran|dabigatran
162764|NCT03181386|Rivaroxaban|rivaroxaban
162765|NCT03181386|Apixaban|apixaban
162766|NCT03181386|Warfarin|warfarin
162767|NCT03181386|Tooth Extraction|tooth extraction
162768|NCT03181373|Craniocerebral injury|craniocerebral injury
162769|NCT03181373|Mild and severe brain traumatic injury|mild and severe brain traumatic injury
162770|NCT03181373|Neuropsychological abilities|neuropsychological abilities
162771|NCT03181373|Clinical assessment|clinical assessment
162772|NCT03181373|Anatomical and functional imaging|anatomical and functional imaging
162773|NCT03181360|ischemic stroke|ischemic stroke
162774|NCT03181360|wake-up|wake-up
162775|NCT03181360|thrombolysis|thrombolysis
162776|NCT03181360|tenecteplase|tenecteplase
162777|NCT03181360|computed tomography|computed tomography
162778|NCT03181347|Bariatrics|bariatrics
162779|NCT03181347|Microbiology|microbiology
162780|NCT03181334|colorectal|colorectal
207906|NCT02895334|CHD|chd
162781|NCT03181334|cancer|cancer
162782|NCT03181334|neoplasm|neoplasm
162783|NCT03181334|CRC screening|crc screening
162784|NCT03181334|FIT|fit
162785|NCT03181334|Fecal Immunochemical Test|fecal immunochemical test
162786|NCT03181321|nutrition|nutrition
162787|NCT03181321|fitness|fitness
162788|NCT03181321|cardiovascular disease|cardiovascular disease
162789|NCT03181321|firefighters|firefighters
162790|NCT03181321|obesity|obesity
162791|NCT03181321|injury|injury
162792|NCT03181295|Family Medicine|family medicine
162793|NCT03181295|Primary Care|primary care
162794|NCT03181295|Exercise prescriptions|exercise prescriptions
162795|NCT03181295|Technology|technology
162796|NCT03181282|Deep brain stimulation|deep brain stimulation
162797|NCT03181282|Balance|balance
162798|NCT03181282|Gait|gait
162799|NCT03181282|Physical Therapy|physical therapy
162800|NCT03181282|Parkinson disease|parkinson disease
162801|NCT03181230|Turner syndrome|turner syndrome
162802|NCT03181230|45,XO|45,xo
162803|NCT03181230|body composition|body composition
162804|NCT03181230|cardiometabolism|cardiometabolism
162805|NCT03181230|quality of life|quality of life
162806|NCT03181230|fitness|fitness
162807|NCT03181178|Complementary food supplement|complementary food supplement
162808|NCT03181178|Protein quality and linear growth|protein quality and linear growth
162809|NCT03181178|Intervention targeting complementary foods and growth|intervention targeting complementary foods and growth
162810|NCT03181165|Low-carbohydrate|low-carbohydrate
162811|NCT03181165|Low calorie|low calorie
162812|NCT03181165|Energy restricted|energy restricted
162813|NCT03181139|Enhanced Recovery after Surgery (ERAS)|enhanced recovery after surgery (eras)
162814|NCT03181139|Fast-track surgery|fast-track surgery
162815|NCT03181139|Pec Blocks|pec blocks
162816|NCT03181139|Mastectomy|mastectomy
162817|NCT03181126|Relapsed of Refractory Acute Lymphoblastic Leukemia|relapsed of refractory acute lymphoblastic leukemia
162818|NCT03181126|Cancer|cancer
162819|NCT03181126|Venetoclax|venetoclax
162820|NCT03181126|Navitoclax|navitoclax
162821|NCT03181113|peginterferon alpha|peginterferon alpha
162822|NCT03181113|HBeAg seroconversion|hbeag seroconversion
162823|NCT03181113|immune control|immune control
162824|NCT03181087|Mesenchymal Stem Cells|mesenchymal stem cells
162825|NCT03181087|Cesarean Section|cesarean section
162826|NCT03181087|Uterine Scar|uterine scar
162827|NCT03181035|Oral Tongue Cancer|oral tongue cancer
162828|NCT03181035|Tumor Hypoxia|tumor hypoxia
162829|NCT03181022|Patient-Provider Communication|patient-provider communication
162830|NCT03181022|Motivational Interviewing|motivational interviewing
162831|NCT03181022|Medication Adherence|medication adherence
162832|NCT03181009|Oral Immunotherapy|oral immunotherapy
162833|NCT03181009|Omalizumab|omalizumab
162834|NCT03181009|OIT|oit
162835|NCT03181009|Xolair|xolair
162836|NCT03180996|FEVAR|fevar
162837|NCT03180996|Fenestrated|fenestrated
162838|NCT03180996|Endovascular|endovascular
162839|NCT03180996|AAA|aaa
162840|NCT03180996|Custom device|custom device
162841|NCT03180957|Dupuytren|dupuytren
162842|NCT03180957|adalimumab|adalimumab
162843|NCT03180957|anti TNF|anti tnf
162844|NCT03180957|phase II clinical trial|phase ii clinical trial
162845|NCT03180957|randomized controlled trial|randomized controlled trial
162846|NCT03180957|double-blind method|double-blind method
162847|NCT03180957|Dupuytren's|dupuytren's
162848|NCT03180957|Dupuytren's contracture|dupuytren's contracture
162849|NCT03180892|Iodine|iodine
162850|NCT03180892|thyroid peroxidase antibody|thyroid peroxidase antibody
162851|NCT03180840|Enzyme-Replacement Therapy|enzyme-replacement therapy
162852|NCT03180840|pegunigalsidase alfa|pegunigalsidase alfa
162853|NCT03180840|Fabry Disease|fabry disease
162854|NCT03180801|broad|broad
162855|NCT03180801|universal|universal
162856|NCT03180801|vaccine|vaccine
162857|NCT03180801|influenza|influenza
162858|NCT03180801|peptide|peptide
162859|NCT03180801|T cell|t cell
162860|NCT03180801|H1N1|h1n1
162861|NCT03180801|human challenge|human challenge
162862|NCT03180788|ESD|esd
162863|NCT03180788|Traction assisted ESD|traction assisted esd
162864|NCT03180788|Polypectomy|polypectomy
162865|NCT03180788|Clip and thread ESD|clip and thread esd
162866|NCT03180775|Amino acids|amino acids
162867|NCT03180775|Macrophage atherogenicity|macrophage atherogenicity
162868|NCT03180775|Triglycerides|triglycerides
162869|NCT03180775|Cholesterol|cholesterol
162870|NCT03180775|Lipoproteins|lipoproteins
162871|NCT03180697|Amide Proton Transfer|amide proton transfer
162872|NCT03180697|bevacizumab|bevacizumab
162873|NCT03180697|recurrent malignant gliomas|recurrent malignant gliomas
162874|NCT03180697|efficacy|efficacy
162875|NCT03180684|HPV-16|hpv-16
162876|NCT03180684|HPV-18|hpv-18
162877|NCT03180671|anterior deprogrammer|anterior deprogrammer
162878|NCT03180671|muscle pain|muscle pain
162879|NCT03180671|centric relation|centric relation
162880|NCT03180606|Elderly|elderly
162881|NCT03180606|Frail|frail
162882|NCT03180606|Primary care|primary care
162883|NCT03180580|Childhood, Overweight, Obesity|childhood, overweight, obesity
162884|NCT03180554|chronic widespread pain|chronic widespread pain
162885|NCT03180554|heart rate variability|heart rate variability
162886|NCT03180554|pain intensity|pain intensity
162887|NCT03180554|diaphragmatic breathing|diaphragmatic breathing
162888|NCT03180554|vagus nerve stimulation|vagus nerve stimulation
162889|NCT03180463|Osteonecrosis of Femoral Head|osteonecrosis of femoral head
162890|NCT03180463|umbilical cord mesenchymal stem cells|umbilical cord mesenchymal stem cells
162891|NCT03180450|Heart Failure|heart failure
162892|NCT03180450|Human Umbilical Cord Mesenchymal Stem Cells|human umbilical cord mesenchymal stem cells
162893|NCT03180437|Immunotherapy|immunotherapy
162894|NCT03180437|γδ T Cell|γδ t cell
162895|NCT03180437|Pancreatic Cancer|pancreatic cancer
162896|NCT03180424|carnitine|carnitine
162897|NCT03180424|elderly|elderly
162898|NCT03180424|functional status|functional status
162899|NCT03180411|Colorectal Cancer|colorectal cancer
162900|NCT03180411|CRC|crc
162901|NCT03180411|Colorectal cancer surveillance|colorectal cancer surveillance
162902|NCT03180411|Decision support tool|decision support tool
162903|NCT03180411|Interviews|interviews
162904|NCT03180411|Questionnaire|questionnaire
162905|NCT03180411|Survey|survey
162906|NCT03180385|NAVA|nava
162907|NCT03180385|BiPAP|bipap
162908|NCT03180385|Pediatrics|pediatrics
162909|NCT03180385|Cardiac Surgery|cardiac surgery
162910|NCT03180359|solid transplant|solid transplant
162911|NCT03180359|grafted children|grafted children
162912|NCT03180359|vaccine recommendation|vaccine recommendation
162913|NCT03180359|immunization efficacy|immunization efficacy
162914|NCT03180359|solid grafted children|solid grafted children
162915|NCT03180359|solid transplant candidate children|solid transplant candidate children
162916|NCT03180333|Chronic Hepatitis B|chronic hepatitis b
162917|NCT03180320|chronic heart failure|chronic heart failure
162918|NCT03180320|exercise-based cardiac rehabilitation|exercise-based cardiac rehabilitation
162919|NCT03180320|Baduanjin|baduanjin
162920|NCT03180203|INTELLiVENT-ASV|intellivent-asv
163118|NCT03179007|PD-1|pd-1
162921|NCT03180203|Fully closed-loop ventilation|fully closed-loop ventilation
162923|NCT03180177|Hyperthermic Intraperitoneal Chemotherapy|hyperthermic intraperitoneal chemotherapy
162924|NCT03180177|Neoadjuvant Chemotherapy|neoadjuvant chemotherapy
162925|NCT03180177|Interval Debulking Surgery|interval debulking surgery
162926|NCT03180177|Advanced-Stage Epithelial Ovarian Cancer|advanced-stage epithelial ovarian cancer
162927|NCT03180177|Postoperative Chemotherapy|postoperative chemotherapy
162928|NCT03180151|corticotomy|corticotomy
162929|NCT03180151|enmass retraction|enmass retraction
162930|NCT03180151|mini implant|mini implant
162931|NCT03180138|mobile phone|mobile phone
162932|NCT03180138|Children's Health|children's health
162933|NCT03180125|hydrodissection|hydrodissection
162934|NCT03180125|sodium hyaluorinate|sodium hyaluorinate
162935|NCT03180099|Lumbar Disk Hernia|lumbar disk hernia
162936|NCT03180099|Thoracolumbar Interfascial Plane Block|thoracolumbar interfascial plane block
162937|NCT03180099|Lumbar Disk Surgery|lumbar disk surgery
162938|NCT03180086|Breast cancer risk|breast cancer risk
162939|NCT03180086|Primary Care|primary care
162940|NCT03180086|Women|women
162941|NCT03180060|Likelihood Ratio|likelihood ratio
162942|NCT03180060|Cardiovascular Magnetic Resonance|cardiovascular magnetic resonance
162943|NCT03180060|CMR|cmr
162944|NCT03180060|Myocardial Perfusion|myocardial perfusion
162945|NCT03180060|Predictive Values|predictive values
162946|NCT03180060|Computed Tomography Perfusion|computed tomography perfusion
162947|NCT03180060|CTP|ctp
162948|NCT03180060|SPECT|spect
162949|NCT03180060|PET|pet
162950|NCT03180060|Diagnostic Accuracy|diagnostic accuracy
162951|NCT03180060|Quantitative Coronary Angiography|quantitative coronary angiography
162952|NCT03180060|Area Under the Curve|area under the curve
162953|NCT03180060|ROC Curve|roc curve
162954|NCT03180034|Human Papillomavirus|human papillomavirus
162955|NCT03180034|Cervical Cancer|cervical cancer
162956|NCT03180034|Costa Rica|costa rica
162957|NCT03180034|Fewer Doses|fewer doses
162958|NCT03180034|HPV-Associated Cancers|hpv-associated cancers
162959|NCT03179995|Octreotide, Major Liver Resection|octreotide, major liver resection
162960|NCT03179943|bladder cancer|bladder cancer
162961|NCT03179943|Ureteral Cancer|ureteral cancer
162962|NCT03179943|Urothelial cancer|urothelial cancer
162963|NCT03179943|Urethral cancer|urethral cancer
162964|NCT03179930|Entinostat|entinostat
162965|NCT03179930|Pembrolizumab|pembrolizumab
162966|NCT03179930|17-073|17-073
162967|NCT03179917|Pembrolizumab|pembrolizumab
162968|NCT03179917|Radiation Therapy|radiation therapy
162969|NCT03179917|17-054|17-054
162970|NCT03179891|Interictal Period A|interictal period a
162971|NCT03179891|Icta/peri-ictal Period B|icta/peri-ictal period b
162972|NCT03179839|Mindfulness-Based Cognitive Therapy|mindfulness-based cognitive therapy
162973|NCT03179813|hydrocortisone|hydrocortisone
162974|NCT03179813|third molar|third molar
162975|NCT03179813|oral surgery|oral surgery
162976|NCT03179813|postoperative pain|postoperative pain
162977|NCT03179813|edema|edema
162978|NCT03179800|Hypertension|hypertension
162979|NCT03179800|Resistant Hypertension|resistant hypertension
162980|NCT03179800|Baroreceptor|baroreceptor
162981|NCT03179800|BAT|bat
162982|NCT03179722|Aging|aging
162983|NCT03179722|Drug-related problems|drug-related problems
162984|NCT03179722|Medication review|medication review
162985|NCT03179722|Community pharmacist|community pharmacist
162986|NCT03179722|Medication use|medication use
162987|NCT03179709|Acute Respiratory Distress Syndrome|acute respiratory distress syndrome
162988|NCT03179709|Neuromuscular Blockade|neuromuscular blockade
162989|NCT03179709|Interviews|interviews
162990|NCT03179709|Implementation Science|implementation science
162991|NCT03179696|Schizophrenia|schizophrenia
162992|NCT03179696|CBSST|cbsst
162993|NCT03179696|mobile CBT|mobile cbt
162994|NCT03179696|negative symptoms|negative symptoms
162995|NCT03179683|aluminum step-wedge|aluminum step-wedge
162996|NCT03179683|demineralized bone matrix|demineralized bone matrix
162997|NCT03179683|dental implant|dental implant
162998|NCT03179683|digital densitometry|digital densitometry
162999|NCT03179683|low level laser therapy|low level laser therapy
163000|NCT03179683|maxillary sinus augmentation.|maxillary sinus augmentation.
163001|NCT03179657|Prospective Cohort study|prospective cohort study
163002|NCT03179657|Nutrition|nutrition
163003|NCT03179657|Diet|diet
163004|NCT03179657|Guangzhou|guangzhou
163005|NCT03179657|Chinese|chinese
163006|NCT03179631|Duchenne Muscular Dystrophy|duchenne muscular dystrophy
163007|NCT03179631|Dystrophinopathy|dystrophinopathy
163008|NCT03179631|Nonsense Mutation|nonsense mutation
163009|NCT03179631|Premature Stop Codon|premature stop codon
163010|NCT03179631|Becker Muscular Dystrophy|becker muscular dystrophy
163011|NCT03179631|DMD/BMD|dmd/bmd
163012|NCT03179631|PTC124|ptc124
163013|NCT03179631|Ataluren|ataluren
163014|NCT03179618|Unstable Angina|unstable angina
163015|NCT03179618|Xuefu Zhuyu Decoction|xuefu zhuyu decoction
163016|NCT03179592|Computed Tomography|computed tomography
163017|NCT03179579|Gastric Cancer|gastric cancer
163018|NCT03179579|Peritoneal Carcinomatosis|peritoneal carcinomatosis
163019|NCT03179579|Hyperthermic Intraperitoneal Chemotherapy|hyperthermic intraperitoneal chemotherapy
163020|NCT03179579|Systemic Chemotherapy|systemic chemotherapy
163021|NCT03179579|Cytoreductive Surgery|cytoreductive surgery
163022|NCT03179566|drug disposal|drug disposal
163023|NCT03179540|Low Rectal Cancer|low rectal cancer
163024|NCT03179540|Complete Clinical Response|complete clinical response
163025|NCT03179540|Non-operative Management|non-operative management
163026|NCT03179527|Unstable Angina|unstable angina
163027|NCT03179527|Shuanghe Decoction|shuanghe decoction
163028|NCT03179514|Unstable Angina|unstable angina
163029|NCT03179514|Gualou Xiebai Banxia Decoction|gualou xiebai banxia decoction
163030|NCT03179514|Danshen Decoction|danshen decoction
163031|NCT03179475|Spinal Cord Injury|spinal cord injury
163032|NCT03179475|Traumatic Spinal Cord Injury|traumatic spinal cord injury
163033|NCT03179475|Targin®|targin®
163034|NCT03179475|Opioids|opioids
163035|NCT03179475|Naloxone|naloxone
163036|NCT03179475|Opioid Induced Constipation|opioid induced constipation
163037|NCT03179475|Oxycodone-Naloxone|oxycodone-naloxone
163038|NCT03179436|Programmed Death-1 (PD-1, PD1),|programmed death-1 (pd-1, pd1),
163039|NCT03179436|Programmed Death-Ligand 1 (PD-L1, PDL1)|programmed death-ligand 1 (pd-l1, pdl1)
163040|NCT03179423|Diabetes Mellitus, Type 1|diabetes mellitus, type 1
163041|NCT03179423|T1D|t1d
163042|NCT03179423|Monoclonal antibody|monoclonal antibody
163043|NCT03179423|Multiple Sclerosis associated retrovirus MSRV|multiple sclerosis associated retrovirus msrv
163044|NCT03179423|Human Endogenous Retrovirus Type W (HERV-W)|human endogenous retrovirus type w (herv-w)
163045|NCT03179423|GNbAC1|gnbac1
163046|NCT03179410|metastatic castrate-resistant prostate cancer (mCRPC)|metastatic castrate-resistant prostate cancer (mcrpc)
163047|NCT03179410|neuroendocrine prostate cancer (NEPC)|neuroendocrine prostate cancer (nepc)
163048|NCT03179345|Volunteer|volunteer
163049|NCT03179345|Pharmacodynamics|pharmacodynamics
163050|NCT03179345|Pharmacokinetics|pharmacokinetics
163051|NCT03179319|PrEP|prep
163052|NCT03179319|HIV testing|hiv testing
163053|NCT03179319|Sexually transmitted disease (STD) testing|sexually transmitted disease (std) testing
163054|NCT03179319|Mobile app|mobile app
163055|NCT03179319|Young men who have sex with men|young men who have sex with men
163056|NCT03179319|Technology|technology
163057|NCT03179306|Cervix|cervix
163058|NCT03179306|HPV|hpv
163059|NCT03179306|Imaging|imaging
163060|NCT03179306|Costa Rica|costa rica
163061|NCT03179280|Type 1 diabetes|type 1 diabetes
163062|NCT03179280|Dual-wave bolus|dual-wave bolus
163063|NCT03179280|Postprandial euglycaemia|postprandial euglycaemia
163064|NCT03179267|vital signs|vital signs
163065|NCT03179267|monitoring|monitoring
163066|NCT03179267|early warning score|early warning score
163067|NCT03179202|Electrical Stimulation|electrical stimulation
163068|NCT03179202|Neurostimulation|neurostimulation
163069|NCT03179202|Neuromodulation|neuromodulation
163070|NCT03179202|Back Pain|back pain
163071|NCT03179202|Low Back Pain|low back pain
163072|NCT03179163|Hypertension|hypertension
163073|NCT03179163|Blood Pressure|blood pressure
163074|NCT03179163|Cardiovascular Disease|cardiovascular disease
163075|NCT03179163|ACE Inhibitor|ace inhibitor
163076|NCT03179163|Diuretic|diuretic
163077|NCT03179163|Nitric Oxide|nitric oxide
163078|NCT03179163|Hydrogen Sulfide|hydrogen sulfide
163079|NCT03179163|Captopril|captopril
163080|NCT03179163|Enalapril|enalapril
163081|NCT03179163|Hydrochlorothiazide|hydrochlorothiazide
163082|NCT03179163|Microcirculation|microcirculation
163083|NCT03179163|Skin|skin
163084|NCT03179150|computer-aided diagnosis|computer-aided diagnosis
163085|NCT03179150|Web|web
163086|NCT03179150|Cloud computing|cloud computing
163087|NCT03179150|lung cancer|lung cancer
163088|NCT03179124|cerebral palsy|cerebral palsy
163089|NCT03179124|trunk control|trunk control
163090|NCT03179124|upper extremity|upper extremity
163091|NCT03179098|Elbow|elbow
163092|NCT03179098|Stretching|stretching
163093|NCT03179098|Joint amplitude|joint amplitude
163094|NCT03179098|Electromyography|electromyography
163095|NCT03179098|Surface heat|surface heat
163096|NCT03179098|Orthosis|orthosis
163097|NCT03179098|Posttraumatic|posttraumatic
163098|NCT03179085|Diabetes|diabetes
163099|NCT03179085|American Indians|american indians
163100|NCT03179085|Disparity|disparity
163101|NCT03179085|microalbuminuria|microalbuminuria
163102|NCT03179085|Telemedicine|telemedicine
163103|NCT03179085|Community health representative (CHR)|community health representative (chr)
163104|NCT03179085|Patient Activation Measure (PAM)|patient activation measure (pam)
163105|NCT03179085|Home base kidney care|home base kidney care
163106|NCT03179059|Reproductive Health|reproductive health
163107|NCT03179059|Family Planning|family planning
163108|NCT03179059|Randomization Trial|randomization trial
163109|NCT03179059|Uganda|uganda
163110|NCT03179033|LVAD|lvad
163111|NCT03179033|Passive leg raising|passive leg raising
163112|NCT03179020|Intensive Care Units|intensive care units
163113|NCT03179020|Brain Death|brain death
163114|NCT03179020|Organ Donation|organ donation
163115|NCT03179020|Family interview|family interview
163116|NCT03179007|MUC1|muc1
163117|NCT03179007|CTLA-4|ctla-4
163119|NCT03179007|chimeric antigen receptor T cells|chimeric antigen receptor t cells
163120|NCT03179007|solid tumor|solid tumor
163121|NCT03178994|Post - adolescence acne|post - adolescence acne
163122|NCT03178994|Topical 2% ketoconazole cream|topical 2% ketoconazole cream
163123|NCT03178877|IBS, Rome IV criteria, anxiety|ibs, rome iv criteria, anxiety
163124|NCT03178864|cerebral venous thrombosis|cerebral venous thrombosis
163125|NCT03178864|anticoagulation|anticoagulation
163126|NCT03178799|Fractures|fractures
163127|NCT03178799|Osteoporosis|osteoporosis
163128|NCT03178799|Care management|care management
163129|NCT03178799|cost-effeciveness|cost-effeciveness
163130|NCT03178799|Randomized controlled trial|randomized controlled trial
163131|NCT03178786|Art Therapy|art therapy
163132|NCT03178773|mobile health|mobile health
163133|NCT03178773|social support|social support
163134|NCT03178773|health disparity|health disparity
163136|NCT03178760|Optic nerve sheath diameter|optic nerve sheath diameter
163137|NCT03178760|average optic nerve sheath diameter for healthy children|average optic nerve sheath diameter for healthy children
163138|NCT03178747|Methylene blue|methylene blue
163139|NCT03178747|Giemsa|giemsa
163140|NCT03178747|Tzanck smear|tzanck smear
163141|NCT03178695|Infertility|infertility
163142|NCT03178695|Pregnancy|pregnancy
163143|NCT03178695|Menopause|menopause
163144|NCT03178695|Perimenopause|perimenopause
163145|NCT03178695|Premature Ovarian Failure|premature ovarian failure
163146|NCT03178669|Colitis, Ulcerative|colitis, ulcerative
163147|NCT03178669|Gastrointestinal Diseases|gastrointestinal diseases
163148|NCT03178669|Inflammatory Bowel Disease|inflammatory bowel disease
163149|NCT03178669|Immunomodulator Therapy|immunomodulator therapy
163150|NCT03178669|Glucocorticoids|glucocorticoids
163151|NCT03178669|Anti-Inflammatory Agents|anti-inflammatory agents
163152|NCT03178669|Therapeutic uses|therapeutic uses
163153|NCT03178669|Kappaproct|kappaproct
163154|NCT03178669|IDX0150|idx0150
163155|NCT03178669|DIMS0150|dims0150
163156|NCT03178656|sorafenib, operation|sorafenib, operation
163157|NCT03178578|Fluid therapy|fluid therapy
163158|NCT03178565|Respiratory Failure|respiratory failure
163159|NCT03178565|Mechanical Ventilation|mechanical ventilation
163160|NCT03178565|Mechanical insufflation-exsufflation|mechanical insufflation-exsufflation
163161|NCT03178565|Airway mucus clearance|airway mucus clearance
163162|NCT03178539|tonsillectomy|tonsillectomy
163163|NCT03178539|post operative analgesia|post operative analgesia
163164|NCT03178539|diklofanic|diklofanic
163165|NCT03178539|ketorolac|ketorolac
163166|NCT03178500|clomiphene citrate|clomiphene citrate
163167|NCT03178500|stair- step|stair- step
163168|NCT03178500|poly cystic ovary|poly cystic ovary
163169|NCT03178487|Upadacitinib|upadacitinib
163170|NCT03178487|ABT-494|abt-494
163171|NCT03178487|Ankylosing Spondylitis (AS)|ankylosing spondylitis (as)
163172|NCT03178487|Safety|safety
163173|NCT03178487|Efficacy|efficacy
163174|NCT03178474|infant formula|infant formula
163175|NCT03178474|Clinical trial|clinical trial
163176|NCT03178474|Chinese infant|chinese infant
163177|NCT03178474|body growth|body growth
163178|NCT03178474|gut microbiota|gut microbiota
163179|NCT03178474|Stool characteristics|stool characteristics
163180|NCT03178461|Caesarean Section|caesarean section
163181|NCT03178461|Delivery|delivery
163182|NCT03178435|risk score|risk score
163183|NCT03178435|Acute kidney injury|acute kidney injury
163184|NCT03178435|critical care|critical care
163185|NCT03178422|tobacco use cessation|tobacco use cessation
163186|NCT03178422|smoking prevention|smoking prevention
163187|NCT03178422|NRT|nrt
163188|NCT03178370|Gastroparesis|gastroparesis
163189|NCT03178370|Nausea and Vomiting|nausea and vomiting
163190|NCT03178370|Abdominal Pain|abdominal pain
163191|NCT03178370|Gastric Emptying|gastric emptying
163192|NCT03178370|Electrophysiology|electrophysiology
163193|NCT03178370|Hormones|hormones
163194|NCT03178370|Inflammation|inflammation
163195|NCT03178370|Enteric Nervous System|enteric nervous system
163196|NCT03178370|Autonomic Nervous System|autonomic nervous system
163197|NCT03178331|Children|children
163198|NCT03178331|Student|student
163199|NCT03178331|Questionnaires|questionnaires
163200|NCT03178331|Screening|screening
163201|NCT03178331|Health check|health check
163202|NCT03178331|School health services|school health services
163203|NCT03178279|physical health|physical health
163204|NCT03178201|Relapsed follicular lymphoma|relapsed follicular lymphoma
163205|NCT03178201|Refractory follicular lymphoma|refractory follicular lymphoma
163206|NCT03178188|lupus erythematosus, Discoid|lupus erythematosus, discoid
163207|NCT03178188|Pulsed-dye Laser|pulsed-dye laser
163208|NCT03178175|Scalp acupuncture|scalp acupuncture
163209|NCT03178175|Parkinson's disease|parkinson's disease
163210|NCT03178175|Balance|balance
163211|NCT03178162|limitation in conventional monitoring|limitation in conventional monitoring
163212|NCT03178149|Age-related Macular Degeneration|age-related macular degeneration
163213|NCT03178149|ASP7317|asp7317
163214|NCT03178136|HR-HPV opportunistic screening|hr-hpv opportunistic screening
163215|NCT03178136|virus load|virus load
163216|NCT03178136|multi-site|multi-site
163217|NCT03178123|anti-PD-1 monoclonal antibody|anti-pd-1 monoclonal antibody
163218|NCT03178123|Mucosal Melanoma|mucosal melanoma
163219|NCT03178123|Interferons|interferons
163220|NCT03178110|physical therapy|physical therapy
163221|NCT03178110|cancer rehabilitation|cancer rehabilitation
163222|NCT03178097|limitation in conventional monitoring|limitation in conventional monitoring
163223|NCT03178084|HIV|hiv
163224|NCT03178084|CD4/CD8 ratio|cd4/cd8 ratio
163225|NCT03178084|immune recovery|immune recovery
163226|NCT03178084|maraviroc|maraviroc
163227|NCT03178084|efavirenz|efavirenz
163228|NCT03178071|NSCLC|nsclc
163229|NCT03178032|Diffuse intrinsic pontine gliomas|diffuse intrinsic pontine gliomas
163230|NCT03178032|Oncolytic adenovirus|oncolytic adenovirus
163231|NCT03177980|Term infants|term infants
163232|NCT03177980|Analgesia|analgesia
163233|NCT03177980|fentanyl|fentanyl
163234|NCT03177980|clonidine|clonidine
163235|NCT03177980|pharmacokinetics|pharmacokinetics
163236|NCT03177980|sedation|sedation
163237|NCT03177980|pharmacodynamics|pharmacodynamics
163238|NCT03177980|neurophysiology|neurophysiology
163239|NCT03177980|pharmacogenetics|pharmacogenetics
163240|NCT03177980|asphyxia|asphyxia
163241|NCT03177980|hypothermia|hypothermia
163242|NCT03177967|Insomnia|insomnia
163243|NCT03177967|Cognitive behavioral treatment for insomnia (CBT-I)|cognitive behavioral treatment for insomnia (cbt-i)
163244|NCT03177941|Melanoma|melanoma
163245|NCT03177941|Skin Self-Examination|skin self-examination
163246|NCT03177941|First-degree Relative|first-degree relative
163247|NCT03177941|Mobile Application|mobile application
163248|NCT03177876|tenting Hydroxyapetite nano particles implant immediate|tenting hydroxyapetite nano particles implant immediate
163249|NCT03177863|neoplasm|neoplasm
163250|NCT03177863|uterine cervix|uterine cervix
163251|NCT03177850|sleep related breathing disturbances|sleep related breathing disturbances
163252|NCT03177850|respiratory polygraphy|respiratory polygraphy
163253|NCT03177850|airway disease|airway disease
163254|NCT03177850|emphysema|emphysema
163255|NCT03177850|acetazolamide|acetazolamide
163256|NCT03177850|altitude|altitude
163257|NCT03177850|nocturnal pulse oxymetry|nocturnal pulse oxymetry
163258|NCT03177837|exercise performance|exercise performance
163259|NCT03177837|maximal spiroergometry|maximal spiroergometry
163260|NCT03177837|airway disease|airway disease
163261|NCT03177837|emphysema|emphysema
163262|NCT03177837|prevention|prevention
163263|NCT03177837|acetazolamide|acetazolamide
163264|NCT03177837|altitude|altitude
163265|NCT03177811|postural control|postural control
163266|NCT03177811|balance performance|balance performance
163267|NCT03177811|airway disease|airway disease
163268|NCT03177811|altitude|altitude
163269|NCT03177811|prevention|prevention
163270|NCT03177811|acetazolamide|acetazolamide
163271|NCT03177772|caregivers|caregivers
163272|NCT03177772|grief|grief
163273|NCT03177772|dementia|dementia
163274|NCT03177772|long-term care|long-term care
163275|NCT03177772|psychotherapy group|psychotherapy group
163276|NCT03177733|breast surgery|breast surgery
163277|NCT03177733|acute pain|acute pain
163278|NCT03177733|regional anesthesia|regional anesthesia
163279|NCT03177694|cough|cough
163280|NCT03177694|exacerbation|exacerbation
163281|NCT03177694|connected device|connected device
163282|NCT03177681|Malignant neoplasms of independent (primary) multiple sites|malignant neoplasms of independent (primary) multiple sites
163283|NCT03177681|Gastrointestinal symptoms|gastrointestinal symptoms
163284|NCT03177681|Probiotics|probiotics
163285|NCT03177681|Yogurt|yogurt
163286|NCT03177681|Stool sample|stool sample
163287|NCT03177681|Questionnaires|questionnaires
163288|NCT03177681|Surveys|surveys
163289|NCT03177681|Holter monitor|holter monitor
163290|NCT03177629|Immune Thrombocytopenic Purpura|immune thrombocytopenic purpura
163291|NCT03177629|Helicobacter pylori|helicobacter pylori
163292|NCT03177616|Migraine|migraine
163293|NCT03177616|Women|women
163294|NCT03177616|Adult|adult
163295|NCT03177616|Feasibility|feasibility
163296|NCT03177616|Safety|safety
163297|NCT03177616|Pilot Randomized Trial|pilot randomized trial
163298|NCT03177616|Randomized Control Trial|randomized control trial
163299|NCT03177616|Chiropractic|chiropractic
163300|NCT03177603|Pulmonary Arterial Hypertension|pulmonary arterial hypertension
163301|NCT03177603|Dose-escalation|dose-escalation
163302|NCT03177603|Safety|safety
163303|NCT03177603|Tolerability|tolerability
163304|NCT03177603|GSK2586881|gsk2586881
163305|NCT03177590|autism|autism
163306|NCT03177590|Pervasive Developmental Disorder|pervasive developmental disorder
163307|NCT03177564|driving pressure|driving pressure
163308|NCT03177564|one-lung ventilation|one-lung ventilation
163309|NCT03177551|Prostatic Neoplasms|prostatic neoplasms
163310|NCT03177551|Nomograms|nomograms
163311|NCT03177551|Drug Resistance, Neoplasm|drug resistance, neoplasm
163312|NCT03177538|suboptimal response|suboptimal response
163313|NCT03177538|Corifollitropin alfa|corifollitropin alfa
163314|NCT03177538|IVF|ivf
163315|NCT03177538|Ovarian stimulation|ovarian stimulation
163316|NCT03177525|parent training|parent training
163317|NCT03177525|social skills|social skills
163318|NCT03177512|PrEP|prep
163319|NCT03177512|HIV Testing|hiv testing
163320|NCT03177512|STI Testing|sti testing
163321|NCT03177512|Mobile app|mobile app
163322|NCT03177512|Technology|technology
163323|NCT03177512|Young men who have sex with men|young men who have sex with men
163324|NCT03177499|Portal pressure gradient|portal pressure gradient
163325|NCT03177499|Transjugular intrahepatic portosystemic shunt|transjugular intrahepatic portosystemic shunt
163326|NCT03177499|Virtual imaging-based portal pressure gradient|virtual imaging-based portal pressure gradient
163327|NCT03177486|Syntax score|syntax score
163328|NCT03177486|Frank sign|frank sign
163329|NCT03177486|Coronary angiography|coronary angiography
163330|NCT03177473|degenerative disc disease|degenerative disc disease
163331|NCT03177473|CervicalStim devic|cervicalstim devic
163332|NCT03177473|cervical|cervical
163333|NCT03177473|cervical fusion|cervical fusion
163334|NCT03177447|Cardiac Failure|cardiac failure
163335|NCT03177447|Congestive Heart Failure|congestive heart failure
163336|NCT03177447|Heart Decompensation|heart decompensation
163337|NCT03177447|Heart Failure, Congestive|heart failure, congestive
163338|NCT03177434|constipation|constipation
163339|NCT03177434|children|children
163340|NCT03177434|polyethylene glycols (PEG)|polyethylene glycols (peg)
163341|NCT03177434|lactulose|lactulose
163342|NCT03177408|Diastolic Dysfunction|diastolic dysfunction
163343|NCT03177408|Hypertension|hypertension
163344|NCT03177408|HMGB1|hmgb1
163345|NCT03177382|Total Neoadjuvant Treatment|total neoadjuvant treatment
163346|NCT03177382|Rectal Cancer|rectal cancer
163347|NCT03177382|High Risk Factors|high risk factors
163348|NCT03177382|Chemoradiotherapy|chemoradiotherapy
163349|NCT03177369|Bone and joint infection|bone and joint infection
163350|NCT03177369|Staphylococcus aureus|staphylococcus aureus
163351|NCT03177369|Teicoplanin|teicoplanin
163352|NCT03177369|Subcutaneous administration|subcutaneous administration
163353|NCT03177356|Platelet rich fibrin,xenograft|platelet rich fibrin,xenograft
163354|NCT03177343|Pristinamycin|pristinamycin
163355|NCT03177343|Staphylococcus aureus|staphylococcus aureus
163356|NCT03177343|Bone and joint infection|bone and joint infection
163357|NCT03177304|Interpersonal Psychotherapy|interpersonal psychotherapy
163358|NCT03177304|Internet|internet
163359|NCT03177304|Training|training
163360|NCT03177304|Depression|depression
163361|NCT03177304|Dissemination|dissemination
163362|NCT03177291|NSCLC|nsclc
163363|NCT03177291|SCLC|sclc
163364|NCT03177265|nicotine dependence|nicotine dependence
163365|NCT03177265|tobacco cessation|tobacco cessation
163366|NCT03177174|locally advanced nasopharyngeal carcinoma|locally advanced nasopharyngeal carcinoma
163367|NCT03177174|Concurrent chemoradiotherapy|concurrent chemoradiotherapy
163368|NCT03177174|Toxic reaction|toxic reaction
163369|NCT03177161|PROM|prom
163370|NCT03177161|Patient Reported Outcome Measure|patient reported outcome measure
163371|NCT03177161|PROMIS|promis
163372|NCT03177161|PROMIS-10|promis-10
163373|NCT03177161|PROMIS Global Health|promis global health
163374|NCT03177161|RiksStroke|riksstroke
163375|NCT03177161|ICHOM|ichom
163376|NCT03177161|International Consortium for Health Outcomes Measurement|international consortium for health outcomes measurement
163377|NCT03177161|Wales|wales
163378|NCT03177161|Administration|administration
163379|NCT03177161|Method|method
163380|NCT03177161|Delivery|delivery
163381|NCT03177122|Polycystic Ovary Syndrome|polycystic ovary syndrome
163382|NCT03177122|Myo-Inositol|myo-inositol
163383|NCT03177122|Assisted Reproductive Technology|assisted reproductive technology
163384|NCT03177122|oocyte performance|oocyte performance
163385|NCT03177122|pregnancy|pregnancy
163386|NCT03177109|Dentine Hypersensitivity|dentine hypersensitivity
163387|NCT03177109|Fluoride varnish|fluoride varnish
163388|NCT03177109|Desensitizing agents|desensitizing agents
163389|NCT03177096|Type 1 diabetes children,School,Childcare facilities,Sensor|type 1 diabetes children,school,childcare facilities,sensor
163390|NCT03177070|Ureteric injury|ureteric injury
163391|NCT03177070|Colorectal Surgery|colorectal surgery
163392|NCT03177044|Inflammatory bowel disease, pelvic floor exercise|inflammatory bowel disease, pelvic floor exercise
163393|NCT03176992|ablation|ablation
163394|NCT03176992|surgicel|surgicel
163395|NCT03176953|PTSD|ptsd
163396|NCT03176953|alcohol use disorder|alcohol use disorder
163397|NCT03176953|Veterans|veterans
163398|NCT03176940|Escalating Dosage|escalating dosage
163399|NCT03176927|magnetogastrogram|magnetogastrogram
163400|NCT03176927|gastroparesis|gastroparesis
163401|NCT03176927|electrogastrogram|electrogastrogram
163402|NCT03176927|gastric slow wave|gastric slow wave
163403|NCT03176914|Community mobilisation|community mobilisation
163404|NCT03176901|urinary urge incontinence|urinary urge incontinence
163405|NCT03176901|urinary incontinence|urinary incontinence
163406|NCT03176901|older adult women|older adult women
163407|NCT03176901|older adults|older adults
163408|NCT03176901|mindfulness-based stress reduction|mindfulness-based stress reduction
163409|NCT03176901|health enhancement program|health enhancement program
163410|NCT03176901|feasibility|feasibility
163411|NCT03176901|randomized controlled trial|randomized controlled trial
163511|NCT03176264|PDR001|pdr001
163412|NCT03176901|complementary|complementary
163413|NCT03176901|integrative|integrative
163414|NCT03176901|therapies|therapies
163415|NCT03176888|Exercise|exercise
163416|NCT03176888|Aerobic capacity|aerobic capacity
163417|NCT03176888|Rehabilitation|rehabilitation
163418|NCT03176810|percutaneous coronary intervention|percutaneous coronary intervention
163419|NCT03176810|optical coherence tomography|optical coherence tomography
163420|NCT03176797|Liver Fibrosis, multiparametric magnetic resonance imaging|liver fibrosis, multiparametric magnetic resonance imaging
163421|NCT03176784|Varenicline|varenicline
163422|NCT03176784|Nicotine Patch|nicotine patch
163423|NCT03176784|Quit Smoking|quit smoking
163424|NCT03176784|Tobacco|tobacco
163425|NCT03176784|Cigarettes|cigarettes
163426|NCT03176732|Sleep Apnea|sleep apnea
163427|NCT03176732|Hypertension|hypertension
163428|NCT03176732|Positive Airway Pressure|positive airway pressure
163429|NCT03176732|Blood Pressure|blood pressure
163430|NCT03176680|Anesthesia,Esophagectomy,Esophageal cancer,Treatment outcome|anesthesia,esophagectomy,esophageal cancer,treatment outcome
163431|NCT03176667|regional, erector spinae block, lobectomy, video-assisted|regional, erector spinae block, lobectomy, video-assisted
163432|NCT03176641|Platelet-Rich Plasma|platelet-rich plasma
163433|NCT03176641|Meniscus|meniscus
163434|NCT03176641|Knee Injuries|knee injuries
163435|NCT03176628|Pharmacokinetics|pharmacokinetics
163436|NCT03176628|Pharmacodynamics|pharmacodynamics
163437|NCT03176615|Gastric Bypass|gastric bypass
163438|NCT03176602|Subjective Global Assessment|subjective global assessment
163439|NCT03176602|Nutrition Risk in Critically ill Score|nutrition risk in critically ill score
163440|NCT03176602|Critical Illness|critical illness
163441|NCT03176589|positive expiratory pressure|positive expiratory pressure
163442|NCT03176589|oxygen saturation|oxygen saturation
163443|NCT03176589|abdominal surgery|abdominal surgery
163444|NCT03176589|carbon dioxide|carbon dioxide
163445|NCT03176576|cancer among adolescents|cancer among adolescents
163446|NCT03176576|cancer among young adults|cancer among young adults
163447|NCT03176576|adolescents and young adults (AYA)|adolescents and young adults (aya)
163448|NCT03176576|quality of life|quality of life
163449|NCT03176576|reduce stress|reduce stress
163450|NCT03176576|patient navigation|patient navigation
163451|NCT03176576|questionnaire|questionnaire
163452|NCT03176576|supportive care|supportive care
163453|NCT03176576|distress levels|distress levels
163454|NCT03176576|support resources|support resources
163455|NCT03176576|satisfaction survey|satisfaction survey
163456|NCT03176576|teen cancer|teen cancer
163457|NCT03176563|herbal treatment|herbal treatment
163458|NCT03176563|antibiotics|antibiotics
163459|NCT03176563|uncomplicated urinary tract infection|uncomplicated urinary tract infection
163460|NCT03176511|older adults|older adults
163461|NCT03176511|dual task|dual task
163462|NCT03176511|A Matter of Balance|a matter of balance
163463|NCT03176498|cerebral Infarction|cerebral infarction
163464|NCT03176498|umbilical cord mesenchymal stem cells|umbilical cord mesenchymal stem cells
163465|NCT03176485|metastatic|metastatic
163466|NCT03176485|melanoma|melanoma
163467|NCT03176485|cancer|cancer
163468|NCT03176485|colon|colon
163469|NCT03176485|thyroid|thyroid
163470|NCT03176485|Differentiated|differentiated
163471|NCT03176485|Hepatocellular Carcinoma|hepatocellular carcinoma
163472|NCT03176485|HCC|hcc
163473|NCT03176485|RCC|rcc
163474|NCT03176485|Renal Cell Carcinoma|renal cell carcinoma
163475|NCT03176472|Diabetic Neuropathic Pain|diabetic neuropathic pain
163476|NCT03176472|Neuropathic Pain|neuropathic pain
163477|NCT03176472|HDAC6|hdac6
163478|NCT03176472|ricolinostat|ricolinostat
163479|NCT03176459|bupvacaine|bupvacaine
163480|NCT03176459|exparel|exparel
163481|NCT03176459|analgesic|analgesic
163482|NCT03176459|TAP Block|tap block
163483|NCT03176407|sensor capsule|sensor capsule
163484|NCT03176394|Foley, UTI, Biofilm, DNA|foley, uti, biofilm, dna
163485|NCT03176381|Prostatic Neoplasms|prostatic neoplasms
163486|NCT03176381|Abiraterone Acetate|abiraterone acetate
163487|NCT03176381|FK506 binding protein 5|fk506 binding protein 5
163488|NCT03176381|Neurotensin|neurotensin
163489|NCT03176381|yes-associated protein 1|yes-associated protein 1
163490|NCT03176381|AKR1C3 protein|akr1c3 protein
163491|NCT03176381|Proliferating Cell Nuclear Antigen|proliferating cell nuclear antigen
163492|NCT03176368|dry mouth|dry mouth
163493|NCT03176368|coconut oil|coconut oil
163494|NCT03176368|radiation|radiation
163495|NCT03176342|Drug patch tests|drug patch tests
163496|NCT03176329|Full closed-loop ventilation control|full closed-loop ventilation control
163497|NCT03176329|Critical care|critical care
163498|NCT03176316|ileus|ileus
163499|NCT03176316|fusion of spine|fusion of spine
163500|NCT03176277|Leukemia|leukemia
163501|NCT03176277|Leukemia, Myeloid|leukemia, myeloid
163502|NCT03176277|Leukemia, Myeloid, Acute|leukemia, myeloid, acute
163503|NCT03176277|MER|mer
163504|NCT03176277|MERTK|mertk
163505|NCT03176277|TYRO3|tyro3
163506|NCT03176277|AXL|axl
163507|NCT03176277|AML|aml
163508|NCT03176277|de novo AML|de novo aml
163509|NCT03176277|Relapsed/ Refractory AML|relapsed/ refractory aml
163510|NCT03176277|TAM|tam
163512|NCT03176264|immunotherapy|immunotherapy
163513|NCT03176264|bevacizumab|bevacizumab
163514|NCT03176264|mFOLFOX6|mfolfox6
163515|NCT03176264|CRC|crc
163516|NCT03176264|MMS|mms
163517|NCT03176264|CMS4|cms4
163518|NCT03176264|ElevatION;CRC-101|elevation;crc-101
163519|NCT03176238|post menopausal|post menopausal
163520|NCT03176238|advanced breast cancer|advanced breast cancer
163521|NCT03176238|metastatic breast cancer|metastatic breast cancer
163522|NCT03176238|everolimus|everolimus
163523|NCT03176238|exemestane|exemestane
163524|NCT03176238|mTor inhibitor|mtor inhibitor
163525|NCT03176238|endocrine therapy|endocrine therapy
163526|NCT03176212|Gut permeability|gut permeability
163527|NCT03176212|Cytokine|cytokine
163528|NCT03176212|Endotoxin|endotoxin
163529|NCT03176199|control-released oxycodone|control-released oxycodone
163530|NCT03176199|immediate-released oxycodone|immediate-released oxycodone
163531|NCT03176199|cancer pain|cancer pain
163532|NCT03176199|opioid-naive|opioid-naive
163533|NCT03176186|ischemic-reperfusion injury|ischemic-reperfusion injury
163534|NCT03176186|out of hospital cardiac arrest|out of hospital cardiac arrest
163535|NCT03176160|LITT|litt
163536|NCT03176160|Fecci|fecci
163537|NCT03176160|Pro00079623|pro00079623
163538|NCT03176160|Glioblastoma|glioblastoma
163539|NCT03176160|Laser Interstitial Thermal Therapy|laser interstitial thermal therapy
163540|NCT03176160|Palliative|palliative
163541|NCT03176147|Anemia|anemia
163542|NCT03176147|Pregnancy|pregnancy
163543|NCT03176147|Hepcidine|hepcidine
163544|NCT03176147|Iron|iron
163545|NCT03176121|Oxycodone|oxycodone
163546|NCT03176121|Cancer Pain|cancer pain
163547|NCT03176121|Long-term use|long-term use
163548|NCT03176082|colorectal cancer screening|colorectal cancer screening
163549|NCT03176082|colorectal cancer|colorectal cancer
163550|NCT03176069|Vaginismus|vaginismus
163551|NCT03176069|Muscle Tone|muscle tone
163552|NCT03176069|Sexual dysfunctions|sexual dysfunctions
163553|NCT03176056|Type 2 Diabetes Mellitus|type 2 diabetes mellitus
163554|NCT03176056|Low carbohydrate diet|low carbohydrate diet
163555|NCT03176017|Transurethral Incision Of The Prostate|transurethral incision of the prostate
163556|NCT03176017|Prostate|prostate
163557|NCT03176017|Holmium Laser|holmium laser
163558|NCT03176017|Ejaculatory Sparing|ejaculatory sparing
163559|NCT03175965|Heart arrest, hypothermia, SEP, prognosis|heart arrest, hypothermia, sep, prognosis
163560|NCT03175939|adjuvant chemotherapy|adjuvant chemotherapy
163562|NCT03175926|Asthma|asthma
163563|NCT03175926|inhaler device|inhaler device
163564|NCT03175926|handling|handling
163565|NCT03175900|Migraine|migraine
163566|NCT03175900|Naoan dripping pills|naoan dripping pills
163567|NCT03175900|Traditional Chinese Medicine|traditional chinese medicine
163568|NCT03175900|fMRI|fmri
163569|NCT03175900|Randomized Controlled trial|randomized controlled trial
163570|NCT03175887|depression|depression
163571|NCT03175887|trd|trd
163572|NCT03175887|treatment-resistant depression|treatment-resistant depression
163573|NCT03175887|TMS|tms
163574|NCT03175874|Osteoporosis|osteoporosis
163575|NCT03175874|Alzheimer Disease|alzheimer disease
163576|NCT03175848|Cervical Cancer|cervical cancer
163577|NCT03175848|Radiotherapy|radiotherapy
163578|NCT03175848|Chemotherapy|chemotherapy
163579|NCT03175848|stage IVB cervical cancer|stage ivb cervical cancer
163580|NCT03175835|Dyslipidemia|dyslipidemia
163581|NCT03175835|CKD-519|ckd-519
163582|NCT03175835|Rosuvastatin|rosuvastatin
163583|NCT03175835|Drug-Drug Interaction|drug-drug interaction
163584|NCT03175809|Chronic pelvic pain|chronic pelvic pain
163585|NCT03175809|Pain|pain
163586|NCT03175809|Dry needling|dry needling
163587|NCT03175809|Biofeedback|biofeedback
163588|NCT03175809|Pelvic pain|pelvic pain
163589|NCT03175731|Esophageal and gastric varices|esophageal and gastric varices
163590|NCT03175731|Hemorrhage|hemorrhage
163591|NCT03175718|Sarcoma|sarcoma
163592|NCT03175718|Wound|wound
163593|NCT03175718|Therapy|therapy
163594|NCT03175627|Dental caries|dental caries
163595|NCT03175627|Proximal surfaces|proximal surfaces
163596|NCT03175627|Posterior teeth|posterior teeth
163597|NCT03175627|Carious lesions|carious lesions
163598|NCT03175627|Tooth diseases|tooth diseases
163599|NCT03175627|Dental restorations|dental restorations
163600|NCT03175627|Composite resin|composite resin
163601|NCT03175614|Physical activity|physical activity
163602|NCT03175614|Food Habits|food habits
163603|NCT03175614|Information and communiation Technology|information and communiation technology
163604|NCT03175614|Health education|health education
163605|NCT03175601|Sleep disturbances|sleep disturbances
163606|NCT03175601|Biomarkers|biomarkers
163607|NCT03175601|Prefrailty|prefrailty
163608|NCT03175601|Insulin resistance|insulin resistance
163609|NCT03175601|Olfactory impairment|olfactory impairment
163610|NCT03175601|Multiplex array|multiplex array
163611|NCT03175601|Gait speed|gait speed
163612|NCT03175536|high-deductible health plan|high-deductible health plan
163613|NCT03175536|medication adherence|medication adherence
163614|NCT03175536|out-of-pocket costs|out-of-pocket costs
163615|NCT03175536|preventive drug list|preventive drug list
163616|NCT03175536|value-based insurance design|value-based insurance design
163617|NCT03175523|BioResorbable Scaffold|bioresorbable scaffold
163618|NCT03175523|Quantitative Coronary Angiography|quantitative coronary angiography
163619|NCT03175523|Intravascular Imaging|intravascular imaging
163620|NCT03175510|validity, reliability, low back pain|validity, reliability, low back pain
163621|NCT03175497|Gastric Cancer, VEGFR inhibitor|gastric cancer, vegfr inhibitor
163622|NCT03175484|High Fidelity Simulation|high fidelity simulation
163623|NCT03175484|Cognitive Load|cognitive load
163624|NCT03175484|Simulation Training/methods*|simulation training/methods*
163625|NCT03175484|Task Performance and Analysis*|task performance and analysis*
163626|NCT03175484|Students, Medical|students, medical
163627|NCT03175484|Prospective Studies|prospective studies
163628|NCT03175458|tenting|tenting
163629|NCT03175458|grafting|grafting
163630|NCT03175458|implant placement|implant placement
163631|NCT03175419|laparoscopic liver resection|laparoscopic liver resection
163632|NCT03175341|breast cancer|breast cancer
163633|NCT03175341|ascorbic acid|ascorbic acid
163634|NCT03175341|vitamin C|vitamin c
163635|NCT03175341|vitamin supplementation|vitamin supplementation
163636|NCT03175341|quality of life|quality of life
163637|NCT03175315|psychoeducation|psychoeducation
163638|NCT03175315|treatment and education programme|treatment and education programme
163639|NCT03175315|self-management|self-management
163640|NCT03175315|diabetes education|diabetes education
163641|NCT03175315|flash glucose monitoring|flash glucose monitoring
163642|NCT03175302|cognitive processes|cognitive processes
163643|NCT03175302|perioperative cognition|perioperative cognition
163644|NCT03175302|neurocognitive impairment|neurocognitive impairment
163645|NCT03175276|Delirium|delirium
163646|NCT03175276|Cognitive decline|cognitive decline
163647|NCT03175276|IQCODE|iqcode
163648|NCT03175263|onabotulinumtoxinA, chronic migraine, myofascial pain|onabotulinumtoxina, chronic migraine, myofascial pain
163649|NCT03175224|Advanced Solid Tumor|advanced solid tumor
163650|NCT03175224|Relapsed Solid Tumor|relapsed solid tumor
163651|NCT03175224|Recurrent Solid Tumor|recurrent solid tumor
163652|NCT03175159|Risk Reduction|risk reduction
163653|NCT03175159|Crystal Methamphetamine|crystal methamphetamine
163654|NCT03175159|Cocaine|cocaine
163655|NCT03175159|Stimulant Abuse|stimulant abuse
163656|NCT03175159|HIV|hiv
163657|NCT03175159|Behavioral Activation|behavioral activation
163658|NCT03175133|rehabilitation|rehabilitation
163659|NCT03175133|physical therapy|physical therapy
209048|NCT02888652|PCI|pci
163660|NCT03175107|exergaming|exergaming
163661|NCT03175107|physiotherapy|physiotherapy
163662|NCT03175107|upper extremities|upper extremities
163663|NCT03175107|telerehabilitation|telerehabilitation
163664|NCT03175094|women|women
163665|NCT03175094|HIV prevention|hiv prevention
163666|NCT03175094|criminal justice|criminal justice
163667|NCT03175081|Intraperitoneal local anesthetic|intraperitoneal local anesthetic
163668|NCT03175081|Ropivacaine|ropivacaine
163669|NCT03175081|Postoperative pain|postoperative pain
163670|NCT03175081|Bariatric surgery|bariatric surgery
163671|NCT03175068|Functional magnetic resonance imaging|functional magnetic resonance imaging
163672|NCT03175068|Electroencephalography|electroencephalography
163673|NCT03175068|Cognitive Behavioral Therapy|cognitive behavioral therapy
163674|NCT03175068|Supportive Therapy|supportive therapy
163675|NCT03175029|Lower Urinary Tract Symptoms|lower urinary tract symptoms
163676|NCT03174990|aspirin|aspirin
163677|NCT03174990|clopidogrel|clopidogrel
163678|NCT03174990|peripheral arterial disease|peripheral arterial disease
163679|NCT03174990|genetics|genetics
163680|NCT03174964|Recurrent Implantation Failure|recurrent implantation failure
163681|NCT03174964|IVIg|ivig
163682|NCT03174964|Pregnancy Rate|pregnancy rate
163683|NCT03174951|Recurrent Pregnancy Loss|recurrent pregnancy loss
163684|NCT03174951|IVIg|ivig
163685|NCT03174951|Pregnancy Rate|pregnancy rate
163686|NCT03174938|Early diagnosis, biomarker, PET, MRI, β-amyloid, tau, CSF, cognitive test|early diagnosis, biomarker, pet, mri, β-amyloid, tau, csf, cognitive test
163687|NCT03174912|EORTC|eortc
163688|NCT03174912|CUETO|cueto
163689|NCT03174912|bladder neoplasm|bladder neoplasm
163690|NCT03174912|disease progression|disease progression
163691|NCT03174912|recurrence|recurrence
163692|NCT03174886|tau|tau
163693|NCT03174886|neurofibrillary|neurofibrillary
163694|NCT03174886|degeneration|degeneration
163695|NCT03174886|primary progressive aphasia|primary progressive aphasia
163696|NCT03174886|agrammatic|agrammatic
163697|NCT03174886|tauopathy|tauopathy
163698|NCT03174886|immunotherapy|immunotherapy
163699|NCT03174886|immunization|immunization
163700|NCT03174860|Pulpitis, irreversible Pulpitis, Hot tooth|pulpitis, irreversible pulpitis, hot tooth
163701|NCT03174860|Cataflam, Diclofenac Potassium, Preoperative, Premedication, Analgesic|cataflam, diclofenac potassium, preoperative, premedication, analgesic
163702|NCT03174860|Local anesthesia, Articaine, Buccal infiltration|local anesthesia, articaine, buccal infiltration
163703|NCT03174847|Primary aldosteronism|primary aldosteronism
163704|NCT03174847|Blood pressure|blood pressure
163705|NCT03174847|Adrenalectomy|adrenalectomy
163706|NCT03174847|Mineralocorticoid-receptor Antagonists|mineralocorticoid-receptor antagonists
163707|NCT03174847|Cardiovascular|cardiovascular
163708|NCT03174847|Endothelial|endothelial
163709|NCT03174847|Renal|renal
163710|NCT03174834|Bladder Stimulation Technique|bladder stimulation technique
163711|NCT03174834|Clean Catch Urine|clean catch urine
163712|NCT03174834|UTI in infants less than 6 months|uti in infants less than 6 months
163713|NCT03174821|Diabetic nephropathy|diabetic nephropathy
163714|NCT03174821|Insulin pump intensive therapy|insulin pump intensive therapy
163715|NCT03174808|cutaneous T-cell lymphoma|cutaneous t-cell lymphoma
163716|NCT03174756|Hypochlorous Acid|hypochlorous acid
163717|NCT03174756|Chlorhexidine|chlorhexidine
163718|NCT03174756|Antiplaque agents|antiplaque agents
163719|NCT03174756|Substantivity|substantivity
163720|NCT03174730|smoking|smoking
163721|NCT03174730|smartphone|smartphone
163722|NCT03174730|technology|technology
163723|NCT03174730|addiction|addiction
163724|NCT03174678|Dexmedetomidine|dexmedetomidine
163725|NCT03174678|child|child
163726|NCT03174678|premedication|premedication
163727|NCT03174678|emergence delirium|emergence delirium
163728|NCT03174678|dental treatment|dental treatment
163729|NCT03174626|caregiver|caregiver
163730|NCT03174626|stress management|stress management
163731|NCT03174600|Stroke|stroke
163732|NCT03174600|Lower urinary tract dysfunction|lower urinary tract dysfunction
163733|NCT03174600|Functional status|functional status
163734|NCT03174600|Mini mental test|mini mental test
163735|NCT03174587|Systemic lupus erythematosus|systemic lupus erythematosus
163736|NCT03174587|HLA-haplo-matching|hla-haplo-matching
163737|NCT03174587|allogenic bone marrow derived mesenchymal stem cell|allogenic bone marrow derived mesenchymal stem cell
163738|NCT03174587|Phase 1 clinical trial|phase 1 clinical trial
163739|NCT03174535|Ischemic Stroke|ischemic stroke
163740|NCT03174535|Secondary Prevention|secondary prevention
163741|NCT03174535|Endpoint Events|endpoint events
163742|NCT03174535|Risk Assessment|risk assessment
163743|NCT03174535|Traditional Chinese Medicine|traditional chinese medicine
163744|NCT03174535|Registry Study|registry study
163745|NCT03174522|Autologous|autologous
163746|NCT03174522|Bone Marrow-derived Mononuclear Cells (BM-MNCs)|bone marrow-derived mononuclear cells (bm-mncs)
163747|NCT03174522|Advanced Therapy Medicinal Product (ATMP)|advanced therapy medicinal product (atmp)
163748|NCT03174522|Tissue-engineered Medicinal Product|tissue-engineered medicinal product
163749|NCT03174522|Revascularization|revascularization
209165|NCT02887690|MPL|mpl
163750|NCT03174522|Angiogenesis|angiogenesis
163751|NCT03174522|Vasculogenesis|vasculogenesis
163752|NCT03174522|Arteriogenesis|arteriogenesis
163753|NCT03174509|airway extubation|airway extubation
163754|NCT03174509|positive-pressure respiration|positive-pressure respiration
163755|NCT03174509|suction|suction
163756|NCT03174509|ventilator weaning|ventilator weaning
163757|NCT03174457|Oesophageal Candidiasis|oesophageal candidiasis
163758|NCT03174457|Paediatric|paediatric
163759|NCT03174457|Invasive Candidiasis|invasive candidiasis
163760|NCT03174457|Prophylaxis of Candida Infections|prophylaxis of candida infections
163761|NCT03174457|Candidemia|candidemia
163762|NCT03174457|Aspergillosis|aspergillosis
163763|NCT03174457|Micafungin|micafungin
163764|NCT03174444|Chinese American|chinese american
163765|NCT03174444|Asian American|asian american
163766|NCT03174444|Colorectal cancer screening|colorectal cancer screening
163767|NCT03174444|Print materials|print materials
163768|NCT03174418|Optical coherence tomography|optical coherence tomography
163769|NCT03174418|Percutaneous coronary interventions|percutaneous coronary interventions
163770|NCT03174418|Coronary atherosclerosis in bifurcations|coronary atherosclerosis in bifurcations
163771|NCT03174392|Exercise|exercise
163772|NCT03174392|Multimodal|multimodal
163773|NCT03174392|Balance|balance
163774|NCT03174392|Resistance|resistance
163775|NCT03174392|Mobility|mobility
163776|NCT03174314|Visual Impairment|visual impairment
163777|NCT03174275|squamous cell carcinoma of the head and neck (SCCHN)|squamous cell carcinoma of the head and neck (scchn)
163778|NCT03174275|durvalumab|durvalumab
163779|NCT03174275|neoadjuvant induction|neoadjuvant induction
163780|NCT03174275|post-operative treatment|post-operative treatment
163781|NCT03174262|Ergonomics|ergonomics
163782|NCT03174262|Computer Workstation|computer workstation
163783|NCT03174262|Habit|habit
163784|NCT03174262|Self-efficacy|self-efficacy
163785|NCT03174262|Knowledge|knowledge
163786|NCT03174249|Behavioural therapy|behavioural therapy
163787|NCT03174249|Exposure in vivo|exposure in vivo
163788|NCT03174249|Cortical reorganisation|cortical reorganisation
163789|NCT03174249|Mirror therapy|mirror therapy
163790|NCT03174210|COPD|copd
163791|NCT03174210|supplemental oxygen|supplemental oxygen
163792|NCT03174210|oxygen concentrator|oxygen concentrator
163793|NCT03174171|Everolimus, mTor inhibitor|everolimus, mtor inhibitor
163794|NCT03174158|text messaging|text messaging
163795|NCT03174093|Mobile Health|mobile health
163796|NCT03174080|Positron-Emission|positron-emission
163797|NCT03174080|PET Scan Tomography|pet scan tomography
163798|NCT03174067|buprenorphine|buprenorphine
163799|NCT03174067|emergency department|emergency department
163800|NCT03174054|Men aged 40 and over|men aged 40 and over
163801|NCT03174054|multi parametric MRI|multi parametric mri
163802|NCT03174015|Sanitation|sanitation
163803|NCT03174015|Demand|demand
163804|NCT03174015|Peri-urban|peri-urban
163805|NCT03174015|Behavior Change|behavior change
163807|NCT03174015|Zambia|zambia
163808|NCT03174002|Oxygenation|oxygenation
163809|NCT03174002|Acute Respiratory Distress Syndrome|acute respiratory distress syndrome
163810|NCT03174002|Mechanical ventilation|mechanical ventilation
163811|NCT03174002|Critical illness|critical illness
163812|NCT03174002|Critical care|critical care
163813|NCT03173989|osteoarthritis|osteoarthritis
163814|NCT03173989|hand deformities|hand deformities
163815|NCT03173989|hand strength|hand strength
163816|NCT03173989|assistive technology|assistive technology
163817|NCT03173989|exercise|exercise
163818|NCT03173989|health education|health education
163819|NCT03173963|Sodium Glucose Co-Transporter 2 (SGLT2) Inhibitor|sodium glucose co-transporter 2 (sglt2) inhibitor
163820|NCT03173963|Kidney Biopsy|kidney biopsy
163821|NCT03173963|Morphometry|morphometry
163822|NCT03173963|American Indians|american indians
163823|NCT03173963|Glomerular Filtration Rate|glomerular filtration rate
163824|NCT03173950|Immunotherapy|immunotherapy
163825|NCT03173950|Anti-PD-1 Antibody|anti-pd-1 antibody
163826|NCT03173950|Brain Tumors|brain tumors
163827|NCT03173950|MDASI-BT|mdasi-bt
163828|NCT03173950|Spinal Cord Tumors|spinal cord tumors
163829|NCT03173937|Haploidentical|haploidentical
163830|NCT03173937|Nonmyeloablative|nonmyeloablative
163831|NCT03173924|Small Molecule|small molecule
163832|NCT03173924|Radiolabeled|radiolabeled
163833|NCT03173924|PSA|psa
163834|NCT03173924|Diagnostic|diagnostic
163835|NCT03173924|PMSA|pmsa
163836|NCT03173911|Balance|balance
163837|NCT03173911|Postural control|postural control
163838|NCT03173911|Elastic Bandages|elastic bandages
163839|NCT03173911|Force plate|force plate
163840|NCT03173898|PDL Injection; Infiltration; Anesthesia; Extraction|pdl injection; infiltration; anesthesia; extraction
163841|NCT03173872|Reiki|reiki
163842|NCT03173872|Chronic Pain|chronic pain
163843|NCT03173872|Military|military
163844|NCT03173859|prostate cancer, abiraterone, apalutamide|prostate cancer, abiraterone, apalutamide
163845|NCT03173846|neurofeedback|neurofeedback
163846|NCT03173846|episodic memory|episodic memory
163847|NCT03173846|real-time functional MRI|real-time functional mri
163848|NCT03173833|cancer patients, quality of life|cancer patients, quality of life
163849|NCT03173820|tacrolimus|tacrolimus
163850|NCT03173820|transplantation|transplantation
163851|NCT03173820|CYP3A5|cyp3a5
163852|NCT03173820|genotype|genotype
163853|NCT03173768|intravenous antibiotics|intravenous antibiotics
163854|NCT03173768|appropriateness|appropriateness
163855|NCT03173768|outpatient antimicrobial therapy|outpatient antimicrobial therapy
163856|NCT03173716|DEFINITY contrast|definity contrast
163857|NCT03173677|Mononuclear cells|mononuclear cells
163858|NCT03173677|Whey proteins|whey proteins
163859|NCT03173677|Metabolically-Activated Macrophage|metabolically-activated macrophage
163860|NCT03173677|Macrophage Polarization|macrophage polarization
163861|NCT03173677|Macronutrients|macronutrients
163862|NCT03173638|acute non arteritic anterior ischemic optic neuropathy|acute non arteritic anterior ischemic optic neuropathy
163863|NCT03173638|mesenchymal stem cells|mesenchymal stem cells
163864|NCT03173638|intravitreal injection|intravitreal injection
163865|NCT03173638|safety|safety
163866|NCT03173599|Chronic Hepatitis B|chronic hepatitis b
163867|NCT03173586|Sugar sweetened beverage, biomarker|sugar sweetened beverage, biomarker
163868|NCT03173573|Cystic Fibrosis|cystic fibrosis
163869|NCT03173560|Renal Cell Carcinoma|renal cell carcinoma
163870|NCT03173560|lenvatinib|lenvatinib
163871|NCT03173560|everolimus|everolimus
163872|NCT03173560|E7080|e7080
163873|NCT03173560|VEGF-targeted treatment|vegf-targeted treatment
163874|NCT03173508|right ventricular function|right ventricular function
163875|NCT03173508|echocardiography|echocardiography
163876|NCT03173508|obstructive airway disease|obstructive airway disease
163877|NCT03173508|emphysema|emphysema
163878|NCT03173508|acetazolamide|acetazolamide
163879|NCT03173508|altitude|altitude
163880|NCT03173495|fat metabolism|fat metabolism
163881|NCT03173495|fructose|fructose
163882|NCT03173495|exercise|exercise
163883|NCT03173456|acute pain|acute pain
163884|NCT03173456|musculoskeletal pain|musculoskeletal pain
163885|NCT03173456|emergency medicine|emergency medicine
163886|NCT03173456|Emergency Service, Hospital|emergency service, hospital
163887|NCT03173456|analgesics|analgesics
163888|NCT03173456|Acetaminophen|acetaminophen
163889|NCT03173456|Ibuprofen|ibuprofen
163890|NCT03173456|oxycodone|oxycodone
163891|NCT03173456|hydrocodone|hydrocodone
163892|NCT03173456|codeine|codeine
163893|NCT03173456|adult|adult
163894|NCT03173443|Fiberoptic intubation|fiberoptic intubation
163895|NCT03173443|double lumen tube|double lumen tube
163896|NCT03173391|GKA|gka
163897|NCT03173391|T2DM|t2dm
163898|NCT03173391|HMS5552|hms5552
163899|NCT03173391|monotherapy|monotherapy
163900|NCT03173365|Hand-foot Syndrome|hand-foot syndrome
163901|NCT03173365|Brimonidine|brimonidine
163902|NCT03173365|Mirvaso|mirvaso
163903|NCT03173365|palmar-plantar erythrodysesthesia syndrome|palmar-plantar erythrodysesthesia syndrome
163904|NCT03173365|Brimonidine Tartrate|brimonidine tartrate
163905|NCT03173352|Hemangioma|hemangioma
163906|NCT03173339|intubation|intubation
163907|NCT03173339|pharyngitis|pharyngitis
163908|NCT03173339|remifentanil|remifentanil
163909|NCT03173313|Hypothermia|hypothermia
163910|NCT03173313|Acute Myocardial Infarction|acute myocardial infarction
163911|NCT03173313|AMI|ami
163912|NCT03173313|PCI|pci
163913|NCT03173313|Therapeutic Hypothermia|therapeutic hypothermia
163914|NCT03173300|PMM2-CDG|pmm2-cdg
163915|NCT03173300|CDG-Ia|cdg-ia
163916|NCT03173287|Hepatic fibrosis|hepatic fibrosis
163917|NCT03173287|IVIM|ivim
163918|NCT03173287|1.5T MRI|1.5t mri
163919|NCT03173248|Acute Myeloid Leukemia|acute myeloid leukemia
163920|NCT03173248|Leukemia|leukemia
163921|NCT03173248|Azacitidine|azacitidine
163922|NCT03173248|AG-120|ag-120
163923|NCT03173248|ivosidenib|ivosidenib
163924|NCT03173209|school|school
163925|NCT03173196|severe sepsis|severe sepsis
163926|NCT03173196|encephalopathy|encephalopathy
163927|NCT03173170|Drug Therapy|drug therapy
163928|NCT03173144|Life Style|life style
163929|NCT03173144|Diet|diet
163930|NCT03173144|Food|food
163931|NCT03173144|Exercise|exercise
163932|NCT03173144|Treatment Outcome|treatment outcome
163933|NCT03173144|Biomarkers|biomarkers
163934|NCT03173144|Smoking|smoking
163935|NCT03173105|Visually Impaired Persons|visually impaired persons
163936|NCT03173105|Postural Balance|postural balance
163937|NCT03173105|Rehabilitation|rehabilitation
163938|NCT03173105|Transcranial Direct Current Stimulation|transcranial direct current stimulation
163939|NCT03173092|Drug therapy|drug therapy
163940|NCT03173053|S. aureus|s. aureus
163941|NCT03173053|Home Parenteral Nutrition|home parenteral nutrition
163942|NCT03173053|Intestinal failure|intestinal failure
163943|NCT03173053|Eradication|eradication
163944|NCT03173053|Decolonization|decolonization
163945|NCT03173040|Traditional Chinese medicine|traditional chinese medicine
163946|NCT03173040|Niu Bang Zi pill|niu bang zi pill
163947|NCT03173040|methotrexate|methotrexate
163948|NCT03173040|active rheumatoid arthritis|active rheumatoid arthritis
163949|NCT03173001|intestinal helminths; protozoan infections;|intestinal helminths; protozoan infections;
163950|NCT03173001|colorectal cancer; chemotherapy; cancer pathogenesis;|colorectal cancer; chemotherapy; cancer pathogenesis;
163951|NCT03172988|Carcinoma, Non-Small-Cell Lung|carcinoma, non-small-cell lung
163952|NCT03172988|Surgery|surgery
163953|NCT03172988|Dexamethasone|dexamethasone
163954|NCT03172988|Flurbiprofen axetil|flurbiprofen axetil
163955|NCT03172988|Long-term survival|long-term survival
163956|NCT03172975|Controlled infection|controlled infection
163957|NCT03172975|Na-GST-1|na-gst-1
163958|NCT03172975|Hookworm vaccine|hookworm vaccine
163959|NCT03172936|injected lesion|injected lesion
163960|NCT03172936|distal lesion|distal lesion
163961|NCT03172936|abscopal activity|abscopal activity
163962|NCT03172936|intratumoral|intratumoral
163963|NCT03172936|checkpoint inhibitor|checkpoint inhibitor
163964|NCT03172936|cyclic dinucleotide|cyclic dinucleotide
163965|NCT03172936|programmed cell death|programmed cell death
163966|NCT03172910|PER977|per977
163967|NCT03172910|Ciraparantag|ciraparantag
163968|NCT03172910|Whole Blood Clotting Time (WBCT)|whole blood clotting time (wbct)
163969|NCT03172910|Rivaroxaban|rivaroxaban
163970|NCT03172897|Adult|adult
163971|NCT03172897|Intensive care unit|intensive care unit
163972|NCT03172897|Mechanical ventilation|mechanical ventilation
163973|NCT03172897|Delirium|delirium
163974|NCT03172897|Dexmedetomidine|dexmedetomidine
163975|NCT03172884|Renal Impairment|renal impairment
163976|NCT03172884|Pharmacokinetics|pharmacokinetics
163977|NCT03172884|Hepatic impairment|hepatic impairment
163978|NCT03172871|Schizophrenia|schizophrenia
163979|NCT03172871|Aripiprazole Intramuscular Depot|aripiprazole intramuscular depot
163980|NCT03172871|Acute treatment|acute treatment
163981|NCT03172858|cervical ripening|cervical ripening
163982|NCT03172858|term premature rupture of membrane|term premature rupture of membrane
163983|NCT03172858|intracervical balloon catheter|intracervical balloon catheter
163984|NCT03172845|coronary bifurcation lesion|coronary bifurcation lesion
163985|NCT03172845|optical coherence tomography|optical coherence tomography
163986|NCT03172845|vulnerable plaque|vulnerable plaque
163987|NCT03172793|telavancin|telavancin
163988|NCT03172793|lipoglycopeptide|lipoglycopeptide
163989|NCT03172793|MRSA|mrsa
163990|NCT03172793|pharmacokinetics|pharmacokinetics
163991|NCT03172767|Preterm|preterm
163992|NCT03172767|Sensory processing|sensory processing
163993|NCT03172767|School Readiness|school readiness
163994|NCT03172741|Cannabis|cannabis
163995|NCT03172715|Open reduction internal fixation|open reduction internal fixation
163996|NCT03172715|Arthroplasty|arthroplasty
163997|NCT03172715|Surgery|surgery
163998|NCT03172715|Randomized controlled trial|randomized controlled trial
163999|NCT03172663|obesity|obesity
164000|NCT03172624|Nivolumab|nivolumab
164001|NCT03172624|Ipilimumab|ipilimumab
164002|NCT03172624|17-219|17-219
164003|NCT03172572|minimally invasive surgical procedures|minimally invasive surgical procedures
164004|NCT03172572|pancreas surgery|pancreas surgery
164005|NCT03172572|pancreatoduodenectomy|pancreatoduodenectomy
164006|NCT03172559|Stereotactic body radiotherapy|stereotactic body radiotherapy
164007|NCT03172559|SBRT|sbrt
164008|NCT03172559|Radiotherapy|radiotherapy
164009|NCT03172559|Bridging therapy|bridging therapy
164010|NCT03172559|Transplant|transplant
164011|NCT03172546|direct oral anticoagulant|direct oral anticoagulant
164012|NCT03172546|hemorrhagic complication|hemorrhagic complication
164013|NCT03172546|thrombotic complication|thrombotic complication
164014|NCT03172546|genetic polymorphisms|genetic polymorphisms
164015|NCT03172533|anorexia nervosa|anorexia nervosa
164016|NCT03172533|estrogen|estrogen
164017|NCT03172533|psychotherapy|psychotherapy
164018|NCT03172533|cortisol|cortisol
164019|NCT03172533|appetite regulation|appetite regulation
164020|NCT03172533|neurocognitive performance|neurocognitive performance
164021|NCT03172533|eating disorder|eating disorder
164022|NCT03172533|sexual hormone|sexual hormone
164023|NCT03172520|Parotidectomy|parotidectomy
164024|NCT03172507|Hematopoietic Stem Cells|hematopoietic stem cells
164025|NCT03172442|Class III treatment|class iii treatment
164026|NCT03172442|orthodontic removable traction appliance|orthodontic removable traction appliance
164027|NCT03172442|RCT|rct
164028|NCT03172429|pulmonary hypertension|pulmonary hypertension
164029|NCT03172429|cerebral tissue oxygenation|cerebral tissue oxygenation
164030|NCT03172429|disease progression|disease progression
164031|NCT03172429|hypoxia|hypoxia
164032|NCT03172416|Gastric Cancer|gastric cancer
164033|NCT03172416|Unresectable Peritoneal Carcinomatosis|unresectable peritoneal carcinomatosis
164034|NCT03172416|Oxaliplatin|oxaliplatin
164035|NCT03172416|Pressurized intraperitoneal aerosol chemotherapy|pressurized intraperitoneal aerosol chemotherapy
164036|NCT03172403|Cachexia|cachexia
164037|NCT03172403|Cancer of Digestive System|cancer of digestive system
164038|NCT03172403|Myostatin|myostatin
164039|NCT03172403|Skeletal muscle|skeletal muscle
164040|NCT03172390|Ascending aorta aneurysm|ascending aorta aneurysm
164041|NCT03172390|Aortic wall shear stress|aortic wall shear stress
164042|NCT03172390|4D phase contrast Cardiovascular Magnetic Resonance|4d phase contrast cardiovascular magnetic resonance
164043|NCT03172390|Aortic dissection|aortic dissection
164044|NCT03172377|adalimumab|adalimumab
164045|NCT03172377|anti-TNF|anti-tnf
164046|NCT03172377|Humira|humira
164047|NCT03172377|interval lengthening|interval lengthening
164048|NCT03172377|dosing interval|dosing interval
164049|NCT03172377|inflammatory bowel disease|inflammatory bowel disease
164050|NCT03172377|antidrug antibodies|antidrug antibodies
164051|NCT03172377|trough levels|trough levels
164052|NCT03172377|pharmacokinetics|pharmacokinetics
164053|NCT03172377|immunogenicity|immunogenicity
164054|NCT03172377|cost-effectiveness|cost-effectiveness
164055|NCT03172377|dose reduction|dose reduction
164056|NCT03172312|Intraoperative Parathyroid Scores System|intraoperative parathyroid scores system
164057|NCT03172312|total thyroidectomy|total thyroidectomy
164058|NCT03172312|thyroid cancer|thyroid cancer
164059|NCT03172312|hypoparathyroidism|hypoparathyroidism
164060|NCT03172312|prediction|prediction
164061|NCT03172273|Liver Cirrhosis|liver cirrhosis
164062|NCT03172273|Transjugular Intrahepatic Portosystemic shunt|transjugular intrahepatic portosystemic shunt
164063|NCT03172273|Refractory ascites|refractory ascites
164064|NCT03172247|cardiology diabetes|cardiology diabetes
164065|NCT03172234|β-endorphins,laryngoscopy and tracheal intubation|β-endorphins,laryngoscopy and tracheal intubation
164066|NCT03172221|malaria|malaria
164067|NCT03172221|pregnancy|pregnancy
164068|NCT03172221|diagnosis|diagnosis
164069|NCT03172221|low-transmission|low-transmission
164070|NCT03172221|Plasmodium falciparum|plasmodium falciparum
164071|NCT03172221|rapid diagnostic test|rapid diagnostic test
164072|NCT03172195|ulcerative colitis|ulcerative colitis
164073|NCT03172195|inflammation|inflammation
164074|NCT03172195|immunosuppressive drugs|immunosuppressive drugs
164075|NCT03172195|herpesvirus|herpesvirus
164076|NCT03172195|qPCR|qpcr
164077|NCT03172195|colonic mucosa|colonic mucosa
164078|NCT03172156|NSCLC|nsclc
164079|NCT03172156|stage I|stage i
164080|NCT03172156|The next generation of high-throughput gene sequencing (NGS)|the next generation of high-throughput gene sequencing (ngs)
164081|NCT03172156|ctDNA|ctdna
164082|NCT03172143|Ileocolic|ileocolic
164083|NCT03172143|Crohn's|crohn's
164084|NCT03172143|Terminal ilium|terminal ilium
164085|NCT03172143|Ileocecal|ileocecal
164086|NCT03172130|Obstructive Sleep Apnea|obstructive sleep apnea
164087|NCT03172130|CPAP|cpap
164088|NCT03172091|Lung transplant|lung transplant
164089|NCT03172091|Acute resection|acute resection
164090|NCT03172091|Volatile Organic Compounds|volatile organic compounds
164091|NCT03172078|advanced endoscopic procedure|advanced endoscopic procedure
164092|NCT03172078|ERCP|ercp
164093|NCT03172078|EUS|eus
164094|NCT03172078|target-controlled infusion|target-controlled infusion
164095|NCT03172078|sedation|sedation
164096|NCT03172078|propofol|propofol
164097|NCT03172039|hemodialysis|hemodialysis
164098|NCT03172039|antimicrobial stewardship|antimicrobial stewardship
164099|NCT03172039|antimicrobial agents|antimicrobial agents
164100|NCT03172039|bacterial infections|bacterial infections
164101|NCT03172039|ambulatory care|ambulatory care
164102|NCT03172026|Telerehabilitation|telerehabilitation
164103|NCT03172026|Maraviroc|maraviroc
164104|NCT03171987|lidocaine patch|lidocaine patch
164105|NCT03171987|flurbiprofen patch|flurbiprofen patch
164106|NCT03171987|acute back pain|acute back pain
164107|NCT03171974|breast capsular contructure|breast capsular contructure
164108|NCT03171961|weight loss|weight loss
164109|NCT03171961|Diet|diet
164110|NCT03171961|online visit|online visit
164111|NCT03171961|clinic visit|clinic visit
164112|NCT03171948|almond|almond
164113|NCT03171948|weight loss|weight loss
164114|NCT03171948|Weight maintenance|weight maintenance
164115|NCT03171948|hypoenergetic diet|hypoenergetic diet
164116|NCT03171922|weight loss|weight loss
164117|NCT03171922|internet-based diet|internet-based diet
164118|NCT03171922|online dietary coach|online dietary coach
164119|NCT03171922|clinic visit approach|clinic visit approach
164120|NCT03171922|Diet|diet
164121|NCT03171792|Musculoskeletal pain|musculoskeletal pain
164122|NCT03171792|Adolescent|adolescent
164123|NCT03171792|Qualitative research|qualitative research
164124|NCT03171792|Attitude|attitude
164125|NCT03171792|Health professionals|health professionals
164126|NCT03171740|Emergence Delirium|emergence delirium
164127|NCT03171740|Emergence Agitation|emergence agitation
164128|NCT03171740|premedication|premedication
164129|NCT03171740|dexmedetomidine|dexmedetomidine
164130|NCT03171740|midazolam|midazolam
164131|NCT03171714|Drainage Catheter|drainage catheter
164132|NCT03171688|Postoperative Nausea and Vomiting|postoperative nausea and vomiting
164133|NCT03171688|cesarean|cesarean
164134|NCT03171688|risk factors|risk factors
164135|NCT03171675|Chronic Periodontitis|chronic periodontitis
164136|NCT03171675|Preterm Labor|preterm labor
164137|NCT03171675|Preterm Birth|preterm birth
164138|NCT03171675|Interleukin-17|interleukin-17
164139|NCT03171675|IL-17|il-17
164140|NCT03171675|Periodontal Disease|periodontal disease
164141|NCT03171675|Periodontitis|periodontitis
164142|NCT03171675|Periodontal risk factors|periodontal risk factors
164143|NCT03171675|Medical risk factors|medical risk factors
164144|NCT03171649|rehabilitation|rehabilitation
164145|NCT03171649|exoskeleton|exoskeleton
164146|NCT03171649|functional electrical stimulation|functional electrical stimulation
164147|NCT03171649|upper limb|upper limb
164148|NCT03171649|sub-acute|sub-acute
164149|NCT03171649|motor re-learning|motor re-learning
164150|NCT03171623|T2DM|t2dm
164151|NCT03171623|Diabetes|diabetes
164152|NCT03171623|GKA|gka
164153|NCT03171610|laparoscopic nephrectomy|laparoscopic nephrectomy
164154|NCT03171610|Patient-controlled analgesia (PCA)|patient-controlled analgesia (pca)
164155|NCT03171610|sufentanil|sufentanil
164156|NCT03171610|fentanyl|fentanyl
164157|NCT03171597|Unstable Angina|unstable angina
164158|NCT03171597|Traditional Chinese Medicine|traditional chinese medicine
164159|NCT03171571|eating Behavior|eating behavior
164160|NCT03171571|Volunteers|volunteers
164161|NCT03171545|Peer Mentoring|peer mentoring
164162|NCT03171545|Team Training|team training
164163|NCT03171545|Checklist|checklist
164164|NCT03171532|ACL|acl
164165|NCT03171519|Physical activity|physical activity
164166|NCT03171519|Disorders of onset and maintenance of sleep|disorders of onset and maintenance of sleep
164167|NCT03171519|non-pharmacological treatment|non-pharmacological treatment
164168|NCT03171519|Acupuncture|acupuncture
164169|NCT03171506|ketogenic diet|ketogenic diet
164170|NCT03171506|carbohydrate-restricted diet|carbohydrate-restricted diet
164171|NCT03171493|Bladder cancer, Radical cystectomy|bladder cancer, radical cystectomy
164172|NCT03171480|Preeclampsia|preeclampsia
164173|NCT03171480|Induction|induction
164174|NCT03171454|hysteroscopic operation|hysteroscopic operation
164175|NCT03171454|intrauterine balloon|intrauterine balloon
164176|NCT03171454|adhesions|adhesions
164177|NCT03171415|Obesity|obesity
164178|NCT03171415|Overweight|overweight
164179|NCT03171415|Thermogenesis|thermogenesis
164180|NCT03171415|Fat reduction|fat reduction
164181|NCT03171389|GIST|gist
164182|NCT03171389|KIT secondary mutation|kit secondary mutation
164183|NCT03171389|ponatinib|ponatinib
164184|NCT03171376|Root canal treatment|root canal treatment
164185|NCT03171376|Coronal leakage|coronal leakage
164186|NCT03171376|Intraorifice barrier|intraorifice barrier
164187|NCT03171363|Attention bias modification treatment|attention bias modification treatment
164188|NCT03171363|Anxiety disorders|anxiety disorders
164189|NCT03171363|Attention training|attention training
164190|NCT03171337|Chronic tension-type headache|chronic tension-type headache
164191|NCT03171337|Acupuncture|acupuncture
164192|NCT03171337|Fu's subcutaneous needling(FSN)|fu's subcutaneous needling(fsn)
164193|NCT03171337|fMRI|fmri
164194|NCT03171337|Regional homogeneity (ReHo)|regional homogeneity (reho)
164195|NCT03171246|dietary intervention|dietary intervention
164196|NCT03171220|Neoantigen|neoantigen
164197|NCT03171220|Neoantigen Reactive T cells (NRTs)|neoantigen reactive t cells (nrts)
164198|NCT03171220|PD-1 Inhibitor|pd-1 inhibitor
164199|NCT03171220|Advanced Solid Tumor|advanced solid tumor
164200|NCT03171220|Adoptive Cell Therapy(ACT)|adoptive cell therapy(act)
164201|NCT03171220|PD-1 antibody|pd-1 antibody
164203|NCT03171207|Gait Therapy|gait therapy
164204|NCT03171194|Lupus|lupus
164205|NCT03171194|Stem Cell|stem cell
164206|NCT03171194|Systemic Lupus Erythematosus|systemic lupus erythematosus
164207|NCT03171181|Spatial cognition, vestibular system, motor control|spatial cognition, vestibular system, motor control
164208|NCT03171168|Gait Analysis|gait analysis
164209|NCT03171168|WOMAC|womac
164210|NCT03171168|SF-36|sf-36
164211|NCT03171142|Heliox|heliox
164212|NCT03171129|Respiratory Distress|respiratory distress
164213|NCT03171129|Nasal CPAP|nasal cpap
164214|NCT03171129|high flow nasal canula|high flow nasal canula
164215|NCT03171116|ghrelin|ghrelin
164216|NCT03171116|obestatin|obestatin
164217|NCT03171116|children|children
164218|NCT03171064|Exercise|exercise
164219|NCT03171064|Cancer|cancer
164220|NCT03171064|Melanoma|melanoma
164221|NCT03171064|Feasibility|feasibility
164222|NCT03171064|PD-1 antibodies|pd-1 antibodies
164223|NCT03171064|Checkpoint inhibitors|checkpoint inhibitors
164224|NCT03171064|Immune system|immune system
164225|NCT03171038|Telemonitoring|telemonitoring
164226|NCT03171038|Chronic Heart Failure|chronic heart failure
164227|NCT03171038|eHealth|ehealth
164228|NCT03171038|Mortality|mortality
164229|NCT03171025|Muscle Invasive|muscle invasive
164230|NCT03171012|Muscle Stretching Exercises|muscle stretching exercises
164231|NCT03170999|China|china
164232|NCT03170999|Cognitive testing|cognitive testing
164233|NCT03170999|COPD exacerbation|copd exacerbation
164234|NCT03170999|CERT|cert
164235|NCT03170973|Obesity|obesity
164236|NCT03170973|Motor Activity|motor activity
164237|NCT03170973|Fatty acids|fatty acids
164238|NCT03170973|Lipid|lipid
164239|NCT03170960|Kidney|kidney
164240|NCT03170960|Bladder|bladder
164241|NCT03170960|Renal pelvis|renal pelvis
164242|NCT03170960|Ureter|ureter
164243|NCT03170960|Urethra|urethra
164244|NCT03170960|Cancer|cancer
164245|NCT03170960|Prostate|prostate
164246|NCT03170960|Castration-resistant|castration-resistant
164247|NCT03170960|Lung|lung
164248|NCT03170960|Breast|breast
164249|NCT03170960|Ovarian|ovarian
164250|NCT03170960|Endometrial|endometrial
164251|NCT03170960|Liver|liver
164252|NCT03170960|Stomach|stomach
164253|NCT03170947|Rheumatoid arthritis|rheumatoid arthritis
164254|NCT03170947|Foot|foot
164255|NCT03170947|Insoles|insoles
164256|NCT03170947|Quality of life|quality of life
164257|NCT03170947|Physical Activity|physical activity
164258|NCT03170895|FLT3-ITD (+) Acute Myeloid Leukemia (AML)|flt3-itd (+) acute myeloid leukemia (aml)
164259|NCT03170882|Drug therapy|drug therapy
164260|NCT03170778|Congenital Heart Disease|congenital heart disease
164261|NCT03170778|CHD|chd
164262|NCT03170778|Fontan|fontan
164263|NCT03170752|RCT, Cardiovascular Risk Factors, Screening|rct, cardiovascular risk factors, screening
164264|NCT03170739|dexmedetomidine|dexmedetomidine
164265|NCT03170739|dopamine|dopamine
164266|NCT03170739|surgery|surgery
164267|NCT03170726|Preemptive intravenous ibuprofen|preemptive intravenous ibuprofen
164268|NCT03170726|Intraoperative analgesia|intraoperative analgesia
164269|NCT03170726|Third molar tooth surgery|third molar tooth surgery
164270|NCT03170713|Preemptive intravenous ibuprofen|preemptive intravenous ibuprofen
164271|NCT03170713|trismus|trismus
164272|NCT03170713|edema|edema
164273|NCT03170713|Third molar tooth extraction|third molar tooth extraction
164274|NCT03170713|Antiinflammatory effect|antiinflammatory effect
164275|NCT03170700|preschool|preschool
164276|NCT03170700|eating behaviors|eating behaviors
164277|NCT03170700|family|family
164278|NCT03170648|Acupuncture|acupuncture
164279|NCT03170648|Breast Cancer|breast cancer
164280|NCT03170635|recess, occupational therapy|recess, occupational therapy
164281|NCT03170622|children|children
164282|NCT03170622|paediatrics|paediatrics
164283|NCT03170622|faecal volitile organic compounds|faecal volitile organic compounds
164284|NCT03170622|diagnosis|diagnosis
164285|NCT03170622|pathogenesis|pathogenesis
164286|NCT03170583|bradycardia, pacemaker, MRI scan|bradycardia, pacemaker, mri scan
164287|NCT03170570|recurrent cervical cancer|recurrent cervical cancer
164288|NCT03170570|re-irradiation|re-irradiation
164289|NCT03170570|intensity-modulated radiotherapy|intensity-modulated radiotherapy
164290|NCT03170557|Persistent pain|persistent pain
164291|NCT03170557|Spinal cord injury|spinal cord injury
164292|NCT03170557|Acupuncture|acupuncture
164293|NCT03170557|Randomized Controlled Trial|randomized controlled trial
164294|NCT03170557|RCT|rct
164295|NCT03170531|MRI|mri
164296|NCT03170531|MR imaging|mr imaging
164297|NCT03170531|17-267|17-267
164298|NCT03170505|cleft palate|cleft palate
164299|NCT03170466|Palliative care|palliative care
164300|NCT03170453|Autism|autism
164301|NCT03170453|Autism Spectrum Disorder|autism spectrum disorder
164302|NCT03170453|Asperger's Syndrome|asperger's syndrome
164303|NCT03170453|Pervasive Developmental Disorder|pervasive developmental disorder
164304|NCT03170453|Cognition|cognition
164305|NCT03170453|Social Cognition|social cognition
164306|NCT03170453|Psychosocial Treatment|psychosocial treatment
164307|NCT03170453|Cognitive Enhancement Therapy|cognitive enhancement therapy
164308|NCT03170453|Enriched Supportive Therapy|enriched supportive therapy
164309|NCT03170453|Therapy|therapy
164310|NCT03170453|Psychotherapy|psychotherapy
164311|NCT03170440|Nerve stimulation|nerve stimulation
164312|NCT03170414|HIV|hiv
164313|NCT03170414|Kidney Transplant|kidney transplant
164314|NCT03170414|Liver Transplant|liver transplant
164315|NCT03170414|Transplant|transplant
164316|NCT03170414|HOPE Act|hope act
164317|NCT03170375|obesity|obesity
164318|NCT03170375|sodium|sodium
164319|NCT03170375|DASH diet|dash diet
164320|NCT03170375|hypertension|hypertension
164321|NCT03170375|vascular stiffness|vascular stiffness
164322|NCT03170375|diastolic function|diastolic function
164323|NCT03170362|Treatment|treatment
164324|NCT03170362|Pharmacogenetics|pharmacogenetics
164325|NCT03170362|Depression|depression
164326|NCT03170271|Asthma, Bronchial Diseases, Respiratory Tract Diseases, Lung Diseases, Obstructive Lung Diseases|asthma, bronchial diseases, respiratory tract diseases, lung diseases, obstructive lung diseases
164327|NCT03170271|Additional relevant MeSH terms:|additional relevant mesh terms:
164328|NCT03170271|Asthma|asthma
164329|NCT03170271|Inflammation|inflammation
164330|NCT03170271|Bronchial Diseases|bronchial diseases
164331|NCT03170271|Respiratory Tract Diseases|respiratory tract diseases
164332|NCT03170271|Lung Diseases, Obstructive|lung diseases, obstructive
164333|NCT03170271|Lung Diseases Respiratory Hypersensitivity|lung diseases respiratory hypersensitivity
164334|NCT03170271|Hypersensitivity, Immediate|hypersensitivity, immediate
164335|NCT03170271|Hypersensitivity|hypersensitivity
164336|NCT03170271|Immune System Diseases|immune system diseases
164337|NCT03170271|Pathologic Processes|pathologic processes
164338|NCT03170258|real-time fMRI|real-time fmri
164339|NCT03170258|reward|reward
164340|NCT03170258|motivation|motivation
164341|NCT03170258|dopamine|dopamine
164342|NCT03170258|EEG|eeg
164343|NCT03170232|HRQoL|hrqol
164344|NCT03170232|Disease Progression|disease progression
164345|NCT03170232|Danirixin|danirixin
164346|NCT03170232|COPD|copd
164347|NCT03170206|Lung Cancer|lung cancer
164348|NCT03170141|CAR T|car t
164349|NCT03170141|Gene Therapy|gene therapy
164350|NCT03170141|GBM|gbm
164351|NCT03170141|PD-L1|pd-l1
164352|NCT03170141|PD1|pd1
164353|NCT03170115|Rectal Cancer|rectal cancer
164354|NCT03170115|Total neoadjuvant therapy|total neoadjuvant therapy
164355|NCT03170115|Induction chemotherapy|induction chemotherapy
164356|NCT03170115|Aspirin colorectal cancer|aspirin colorectal cancer
164357|NCT03170102|occupational therapy|occupational therapy
164358|NCT03170089|oral-health-awareness, Diabetes|oral-health-awareness, diabetes
164359|NCT03170076|skin manifestations - hepatitis c virus|skin manifestations - hepatitis c virus
164360|NCT03170063|Parkinson's Disease|parkinson's disease
164361|NCT03170063|Alpha-Synuclein|alpha-synuclein
164362|NCT03170063|Biomarker|biomarker
164363|NCT03170011|Cardiac rehabilitation|cardiac rehabilitation
164364|NCT03170011|Sit to Stand|sit to stand
164365|NCT03170011|Function|function
164366|NCT03169985|Rosuvastatin|rosuvastatin
164367|NCT03169985|Ezetimibe|ezetimibe
164368|NCT03169985|Atherosclerotic plaque|atherosclerotic plaque
164369|NCT03169985|Intravascular ultrasound|intravascular ultrasound
164370|NCT03169959|Anti-diabetic|anti-diabetic
164371|NCT03169959|Anti-hyperglycemic agents|anti-hyperglycemic agents
164372|NCT03169959|Bioequivalence|bioequivalence
164373|NCT03169959|Fixed-Combination Drug Product (FCDP) of saxagliptin / dapagliflozin / metformin extended-release (XR).|fixed-combination drug product (fcdp) of saxagliptin / dapagliflozin / metformin extended-release (xr).
164374|NCT03169959|Fed-state bioequivalence (BE)|fed-state bioequivalence (be)
164375|NCT03169959|XIGDUO® XR|xigduo® xr
164376|NCT03169959|ONGLYZA®|onglyza®
164377|NCT03169933|adjuvant|adjuvant
164378|NCT03169933|androgen suppressive therapy|androgen suppressive therapy
164379|NCT03169933|literature review|literature review
164380|NCT03169933|phase II|phase ii
164381|NCT03169933|prostate neoplasms|prostate neoplasms
164382|NCT03169933|radiotherapy|radiotherapy
164383|NCT03169907|Cardiac functions|cardiac functions
164384|NCT03169907|Intrauterine fetal anemia|intrauterine fetal anemia
164385|NCT03169907|Intrauterine Fetal blood transfusion|intrauterine fetal blood transfusion
164386|NCT03169907|Myocardial performance index|myocardial performance index
164387|NCT03169907|spatiotemporal imaging correlation|spatiotemporal imaging correlation
164388|NCT03169868|clinical decision support|clinical decision support
164389|NCT03169868|drug levels in blood|drug levels in blood
164390|NCT03169868|therapeutic drug monitoring|therapeutic drug monitoring
164391|NCT03169868|medication adherence|medication adherence
164392|NCT03169868|medication therapy management|medication therapy management
164393|NCT03169855|Traffic Ophthalmology|traffic ophthalmology
164394|NCT03169855|Glare|glare
164395|NCT03169855|Cataract|cataract
164396|NCT03169855|Nighttime driving|nighttime driving
164397|NCT03169855|contrast sensitivity|contrast sensitivity
164398|NCT03169855|mesopic vision|mesopic vision
164399|NCT03169829|Hemodialysis|hemodialysis
164400|NCT03169829|Renal Disease|renal disease
164401|NCT03169803|Electrical Stimulation Therapy|electrical stimulation therapy
164402|NCT03169803|Electrodes|electrodes
164403|NCT03169803|Parasympathetic Nervous System|parasympathetic nervous system
164404|NCT03169803|Sympathetic Fibers|sympathetic fibers
164405|NCT03169803|Post Ganglionic|post ganglionic
164406|NCT03169803|Congestive Heart Failure|congestive heart failure
164407|NCT03169803|Heart Failure|heart failure
164408|NCT03169673|Magnetic Resonance Imaging|magnetic resonance imaging
164409|NCT03169673|Pulmonary Function|pulmonary function
164410|NCT03169634|Failed knee replacement|failed knee replacement
164411|NCT03169634|loosening|loosening
164413|NCT03169634|reoperation|reoperation
164414|NCT03169621|Chronic Endometritis|chronic endometritis
164415|NCT03169621|Endometrial pathogens|endometrial pathogens
164416|NCT03169621|Microbiological diagnosis|microbiological diagnosis
164417|NCT03169621|Next Generation Sequencing|next generation sequencing
164418|NCT03169621|Metagenomics|metagenomics
164419|NCT03169621|Endometrial receptivity|endometrial receptivity
164420|NCT03169608|autonomic nervous system|autonomic nervous system
164421|NCT03169608|atrial fibrillation|atrial fibrillation
164422|NCT03169608|acute kidney injury|acute kidney injury
164423|NCT03169608|baroreflex sensitivity|baroreflex sensitivity
164424|NCT03169608|microcirculation|microcirculation
164425|NCT03169608|coronary artery bypass graft|coronary artery bypass graft
164426|NCT03169569|hemostatic powder|hemostatic powder
164427|NCT03169569|post-ESD bleeding|post-esd bleeding
164428|NCT03169569|antithrombotic therapy|antithrombotic therapy
164429|NCT03169569|high risk of bleeding|high risk of bleeding
164430|NCT03169569|endoscopic submucosal dissection|endoscopic submucosal dissection
164431|NCT03169569|adverse event|adverse event
164432|NCT03169556|Intubation|intubation
164433|NCT03169556|light wand|light wand
164434|NCT03169556|video laryngoscopy|video laryngoscopy
164435|NCT03169556|cervical spine immobilization|cervical spine immobilization
164436|NCT03169530|cardiovascular, alcohol, diabetes|cardiovascular, alcohol, diabetes
164437|NCT03169517|Peripheral nerve block|peripheral nerve block
164438|NCT03169517|laser speckle contrast imaging|laser speckle contrast imaging
164439|NCT03169517|blood flow index|blood flow index
164440|NCT03169504|Pulmonary Disease, Chronic Obstructive|pulmonary disease, chronic obstructive
164441|NCT03169504|Acupuncture Therapy|acupuncture therapy
164442|NCT03169504|Humans|humans
164443|NCT03169491|Sleep Apnea, Obstructive|sleep apnea, obstructive
164444|NCT03169491|Child|child
164445|NCT03169491|Continuous Positive Airway Pressure|continuous positive airway pressure
164446|NCT03169491|Perioperative management|perioperative management
164447|NCT03169491|Adenotonsillectomy|adenotonsillectomy
164448|NCT03169491|Acoustic pharyngometry|acoustic pharyngometry
164449|NCT03169478|hysteroscopic myomectomy|hysteroscopic myomectomy
164450|NCT03169478|balloon dilatation|balloon dilatation
164451|NCT03169478|adhesions|adhesions
164452|NCT03169426|remote ischemic conditioning|remote ischemic conditioning
164453|NCT03169426|beta-blocker|beta-blocker
164454|NCT03169400|vascular calcification|vascular calcification
164455|NCT03169400|haemodialysis|haemodialysis
164456|NCT03169400|dialysis membrane|dialysis membrane
164457|NCT03169387|Virtual Reality Exposure Therapy|virtual reality exposure therapy
164458|NCT03169374|Virtual Reality|virtual reality
164459|NCT03169374|Mechanical Ventilation|mechanical ventilation
164460|NCT03169374|Anxiety|anxiety
164461|NCT03169309|complementary and alternative medicine|complementary and alternative medicine
164462|NCT03169309|military|military
164463|NCT03169309|binaural beat technology|binaural beat technology
164464|NCT03169309|brain entrainment technology|brain entrainment technology
164465|NCT03169309|sleep|sleep
164466|NCT03169296|Myelodysplastic syndrome|myelodysplastic syndrome
164467|NCT03169296|Mutations|mutations
164468|NCT03169296|Next-generation sequencing|next-generation sequencing
164469|NCT03169270|Exercise training|exercise training
164470|NCT03169270|Muscle dysfunction|muscle dysfunction
164471|NCT03169270|COPD|copd
164472|NCT03169257|paediatric obesity|paediatric obesity
164473|NCT03169257|cardiovascular dysfunction|cardiovascular dysfunction
164474|NCT03169257|metabolic syndrome|metabolic syndrome
164475|NCT03169257|adipokines|adipokines
164476|NCT03169257|inflammation|inflammation
164477|NCT03169257|oxidative stress|oxidative stress
164478|NCT03169218|Adult|adult
164479|NCT03169218|Chronic pain|chronic pain
164480|NCT03169218|Entrapment neuropathy. Carpal tunnel|entrapment neuropathy. carpal tunnel
164481|NCT03169218|Exercise therapy|exercise therapy
164482|NCT03169218|Humans|humans
164483|NCT03169218|Neuronal plasticity|neuronal plasticity
164484|NCT03169218|Mirror neurons|mirror neurons
164485|NCT03169218|Pain/cognitive aspects|pain/cognitive aspects
164486|NCT03169218|Physiotherapy|physiotherapy
164487|NCT03169218|Somatosensory cortex|somatosensory cortex
164488|NCT03169179|Physical activity|physical activity
164489|NCT03169179|Mobile health|mobile health
164490|NCT03169179|Wearable fitness technology|wearable fitness technology
164491|NCT03169179|Organisational wellness|organisational wellness
164492|NCT03169179|Occupational health|occupational health
164493|NCT03169179|Police force|police force
164494|NCT03169166|GnRH agonist|gnrh agonist
164495|NCT03169166|In Vitro fertilization|in vitro fertilization
164496|NCT03169166|Assisted Reproductive Technology|assisted reproductive technology
164497|NCT03169166|Follicule Maturation|follicule maturation
164498|NCT03169166|Pregnancy|pregnancy
164499|NCT03169153|contact lenses|contact lenses
164500|NCT03169153|lipids|lipids
164501|NCT03169153|deposits|deposits
164502|NCT03169140|pain management|pain management
164503|NCT03169140|topical analgesic|topical analgesic
164504|NCT03169140|acute low back pain|acute low back pain
164505|NCT03169140|kinesiology tape|kinesiology tape
164506|NCT03169127|Ibuprofen|ibuprofen
164507|NCT03169127|Lower third molar|lower third molar
164508|NCT03169127|Oral Surgery|oral surgery
164509|NCT03169114|Appendicitis|appendicitis
164510|NCT03169114|Surgery|surgery
164511|NCT03169114|Antibiotic therapy|antibiotic therapy
164512|NCT03169114|RIPASA Score|ripasa score
164513|NCT03169101|Smoking Cessation|smoking cessation
164514|NCT03169101|HIV|hiv
164515|NCT03169101|Cognition|cognition
164516|NCT03169088|eating Behavior|eating behavior
164517|NCT03169088|Volunteers|volunteers
164518|NCT03169075|Adapted physical activity|adapted physical activity
164519|NCT03169075|Oral targeted therapy|oral targeted therapy
164520|NCT03169075|Advanced cancer|advanced cancer
164521|NCT03169075|Fatigue|fatigue
164522|NCT03169075|Quality of life|quality of life
164523|NCT03169075|Randomized Study|randomized study
164524|NCT03169049|nerve conduction block|nerve conduction block
164525|NCT03169049|high frequency stimulation|high frequency stimulation
164526|NCT03169049|handgrip|handgrip
164527|NCT03169010|registry|registry
164528|NCT03169010|pulmonary hypertension|pulmonary hypertension
164529|NCT03169010|survival|survival
164530|NCT03169010|biomarker|biomarker
164531|NCT03169010|whole genome sequencing|whole genome sequencing
164532|NCT03168997|Alzheimer Disease Memantine|alzheimer disease memantine
164533|NCT03168984|Healthy Japanese subjects|healthy japanese subjects
164534|NCT03168984|Healthy Caucasian subjects|healthy caucasian subjects
164535|NCT03168984|UCB0942|ucb0942
164536|NCT03168971|Cancer|cancer
164537|NCT03168971|Anxiety|anxiety
164538|NCT03168971|Cognitive behavior therapy|cognitive behavior therapy
164539|NCT03168971|Elderly|elderly
164540|NCT03168971|Caregivers|caregivers
164541|NCT03168971|18-542|18-542
164542|NCT03168945|Active Case Finding|active case finding
164543|NCT03168906|Amyloidosis|amyloidosis
164544|NCT03168906|NEOD001|neod001
164545|NCT03168906|RAIN|rain
164546|NCT03168893|deep brain stimulation|deep brain stimulation
164547|NCT03168867|insulin dependent diabetes mellitus|insulin dependent diabetes mellitus
164548|NCT03168867|adolescents/young adults|adolescents/young adults
164549|NCT03168867|e-health intervention|e-health intervention
164550|NCT03168867|parental monitoring|parental monitoring
164551|NCT03168854|Anopheles stephensi Mosquitoes|anopheles stephensi mosquitoes
164552|NCT03168854|GAP3KO|gap3ko
164553|NCT03168854|Genetically-attenuated|genetically-attenuated
164554|NCT03168854|Malaria-Naïve Adults|malaria-naïve adults
164555|NCT03168854|Phase 1|phase 1
164556|NCT03168854|Plasmodium falciparum|plasmodium falciparum
164557|NCT03168815|HFNC|hfnc
164558|NCT03168815|Bronchoscopy|bronchoscopy
164559|NCT03168815|Hypoxia|hypoxia
164560|NCT03168815|Immunocompromised|immunocompromised
164561|NCT03168815|Hematological malignancy|hematological malignancy
164562|NCT03168802|Focused ultrasound Ablation|focused ultrasound ablation
164563|NCT03168802|Radiofrequency Ablation|radiofrequency ablation
164564|NCT03168802|Facet joint syndrome|facet joint syndrome
164565|NCT03168802|Chronic low back pain|chronic low back pain
164566|NCT03168789|Breathing Awareness Meditation,|breathing awareness meditation,
164567|NCT03168776|Drug-eluting stent|drug-eluting stent
164568|NCT03168763|Malignant neoplasms of independent (primary) multiple sites|malignant neoplasms of independent (primary) multiple sites
164569|NCT03168763|Advanced Cancer|advanced cancer
164570|NCT03168763|Videos|videos
164571|NCT03168763|Questionnaires|questionnaires
164572|NCT03168763|Surveys|surveys
164573|NCT03168724|Cognition|cognition
164574|NCT03168724|Intervention|intervention
164575|NCT03168724|Self-management|self-management
164576|NCT03168724|Rehabilitation|rehabilitation
164577|NCT03168711|ALS|als
164578|NCT03168711|Inosine|inosine
164579|NCT03168711|Uric acid|uric acid
164580|NCT03168711|Urate|urate
164581|NCT03168711|Glutathione|glutathione
164582|NCT03168711|Biomarker|biomarker
164583|NCT03168711|Oxidative stress|oxidative stress
164584|NCT03168711|Oxidative damage|oxidative damage
164585|NCT03168698|pregnancy|pregnancy
164586|NCT03168698|postpartum hemorrhage|postpartum hemorrhage
164587|NCT03168698|cesarean delivery|cesarean delivery
164588|NCT03168698|carbetocin|carbetocin
164589|NCT03168698|duratocin|duratocin
164590|NCT03168698|oxytocin|oxytocin
164591|NCT03168685|smartphones|smartphones
164592|NCT03168685|clinical trials|clinical trials
164593|NCT03168685|weight|weight
164594|NCT03168685|actigraph|actigraph
164595|NCT03168685|tracking|tracking
164596|NCT03168685|hemophilia|hemophilia
165779|NCT03160846|Dobutamine|dobutamine
164597|NCT03168633|: Type 2 Diabetes Mellitus|: type 2 diabetes mellitus
164598|NCT03168633|Web-based intervention|web-based intervention
164599|NCT03168633|medication adherence|medication adherence
164600|NCT03168633|lifestyle changes|lifestyle changes
164601|NCT03168607|ORR|orr
164602|NCT03168607|OS|os
164603|NCT03168607|PFS|pfs
164604|NCT03168607|safety|safety
164605|NCT03168594|chemotherapy|chemotherapy
164606|NCT03168594|OS|os
164607|NCT03168594|ORR|orr
164608|NCT03168594|PFS|pfs
164609|NCT03168594|safety|safety
164610|NCT03168529|Acute Heart Failure|acute heart failure
164611|NCT03168529|Observation|observation
164612|NCT03168529|Ivabradine|ivabradine
164613|NCT03168516|Oxygen|oxygen
164614|NCT03168516|closed-loop automatic control|closed-loop automatic control
164615|NCT03168516|Oxygen saturation|oxygen saturation
164616|NCT03168516|preterm infants|preterm infants
164617|NCT03168451|text messaging|text messaging
164618|NCT03168438|Metastatic|metastatic
164619|NCT03168438|Multiple Myeloma|multiple myeloma
164620|NCT03168438|Previously Treated|previously treated
164621|NCT03168438|T Cell Receptor|t cell receptor
164622|NCT03168438|Cell Therapy|cell therapy
164623|NCT03168438|Immuno-oncology|immuno-oncology
164624|NCT03168438|SPEAR T Cell|spear t cell
164625|NCT03168438|T Cell Therapy|t cell therapy
164626|NCT03168438|NY-ESO-1|ny-eso-1
164627|NCT03168425|safe opioid prescribing|safe opioid prescribing
164628|NCT03168412|Hepatitis E|hepatitis e
164629|NCT03168399|Phenylketonuria|phenylketonuria
164630|NCT03168399|PKU|pku
164631|NCT03168399|Metabolism|metabolism
164632|NCT03168399|Metabolic|metabolic
164633|NCT03168399|Control|control
164634|NCT03168399|Acceptability|acceptability
164635|NCT03168347|Decision making|decision making
164636|NCT03168269|CCTA interpretation|ccta interpretation
164637|NCT03168269|technicians|technicians
164638|NCT03168269|experts|experts
164639|NCT03168269|comparison|comparison
164640|NCT03168243|nutrition support, home enteral feeding|nutrition support, home enteral feeding
164641|NCT03168217|Periodontitis|periodontitis
164642|NCT03168217|classification|classification
164643|NCT03168217|Cluster analysis|cluster analysis
164644|NCT03168139|Metastatic colorectal cancer|metastatic colorectal cancer
164645|NCT03168139|Metastatic pancreatic cancer|metastatic pancreatic cancer
164646|NCT03168139|NOX-A12|nox-a12
164647|NCT03168139|Olaptesed pegol|olaptesed pegol
164648|NCT03168139|Spiegelmer|spiegelmer
164649|NCT03168139|Pembrolizumab|pembrolizumab
164650|NCT03168139|PD-1 inhibitor|pd-1 inhibitor
164651|NCT03168139|Stromal cell-derived factor-1 (SDF-1)|stromal cell-derived factor-1 (sdf-1)
164652|NCT03168139|CXCL12|cxcl12
164653|NCT03168139|Tumor microenvironment|tumor microenvironment
164654|NCT03168139|Immunotherapy|immunotherapy
164655|NCT03168139|Checkpoint inhibition|checkpoint inhibition
164656|NCT03168113|skin barrier function|skin barrier function
164657|NCT03168113|microbiome|microbiome
164658|NCT03168113|transepidermal water loss (TEWL)|transepidermal water loss (tewl)
164659|NCT03168113|epidermal transcriptome|epidermal transcriptome
164660|NCT03168113|epidermal lipid composition|epidermal lipid composition
164661|NCT03168061|advanced solid tumor|advanced solid tumor
164662|NCT03168061|unresectable soft tissue sarcoma|unresectable soft tissue sarcoma
164663|NCT03168048|mobile application|mobile application
164664|NCT03168048|radiotherapy|radiotherapy
164665|NCT03168048|patient-care|patient-care
164667|NCT03168048|follow-up|follow-up
164668|NCT03168048|patient satisfaction|patient satisfaction
164669|NCT03168048|quality of life|quality of life
164670|NCT03168009|BAT|bat
164671|NCT03168009|Bariatric Surgery|bariatric surgery
164672|NCT03168009|Energy Metabolism|energy metabolism
164673|NCT03167996|South Asian|south asian
164674|NCT03167996|Cardiovascular Risk Reduction|cardiovascular risk reduction
164675|NCT03167996|Metabolic Disorders|metabolic disorders
164676|NCT03167996|Lifestyle modifications|lifestyle modifications
164677|NCT03167957|fluconazole|fluconazole
164678|NCT03167957|fluconazole-resistant|fluconazole-resistant
164679|NCT03167944|Mastectomy|mastectomy
164680|NCT03167944|Seroma|seroma
164681|NCT03167931|non-invasive brain stimulation|non-invasive brain stimulation
164682|NCT03167931|neuromodulation|neuromodulation
164683|NCT03167931|semantic tasks|semantic tasks
164684|NCT03167918|calcium dobesilate|calcium dobesilate
164685|NCT03167918|Xuefuzhuyu Decoction|xuefuzhuyu decoction
164686|NCT03167918|pulmonary function|pulmonary function
164687|NCT03167905|Anesthesia, Obstetrical|anesthesia, obstetrical
164688|NCT03167905|Epidural anesthesia|epidural anesthesia
164689|NCT03167905|Postnatal depression|postnatal depression
164690|NCT03167905|Persistent pain|persistent pain
164691|NCT03167879|family planning|family planning
164692|NCT03167879|safer conception|safer conception
164693|NCT03167879|HIV|hiv
164694|NCT03167879|serodiscordant couples|serodiscordant couples
164695|NCT03167879|Uganda|uganda
164696|NCT03167879|contraception|contraception
164697|NCT03167840|falls prevention, older adults, mild cognitive impairment|falls prevention, older adults, mild cognitive impairment
164698|NCT03167827|pelvic floor|pelvic floor
164699|NCT03167827|climateric|climateric
164700|NCT03167827|exercise|exercise
164701|NCT03167827|Supplementation of Isoflavone|supplementation of isoflavone
164702|NCT03167801|tetraplegia|tetraplegia
164703|NCT03167801|spinal cord injury|spinal cord injury
164704|NCT03167801|melatonin|melatonin
164705|NCT03167801|sleep quality|sleep quality
164706|NCT03167801|sleepiness|sleepiness
164707|NCT03167723|Chest tube size|chest tube size
164708|NCT03167723|Hemothorax|hemothorax
164709|NCT03167723|Empyema|empyema
164710|NCT03167697|Phenylketonuria|phenylketonuria
164711|NCT03167697|Hyperphenylalaninaemia|hyperphenylalaninaemia
164712|NCT03167697|Inherited Metabolic Disorders|inherited metabolic disorders
164713|NCT03167671|Oswestry|oswestry
164714|NCT03167671|SF 36|sf 36
164715|NCT03167671|Promis Pain and Function|promis pain and function
164716|NCT03167671|Berg Balance|berg balance
164717|NCT03167658|Wellness|wellness
164718|NCT03167658|Prevention|prevention
164719|NCT03167619|Mestastic|mestastic
164720|NCT03167619|Platinum Sensitive|platinum sensitive
164721|NCT03167619|Advanced|advanced
164722|NCT03167619|PARP inhibitor|parp inhibitor
164723|NCT03167606|myPEEPS|mypeeps
164724|NCT03167606|Mobile Intervention|mobile intervention
164725|NCT03167606|Human Immunodeficiency Virus (HIV)|human immunodeficiency virus (hiv)
164726|NCT03167606|Men who have sex with men (MSM)|men who have sex with men (msm)
164727|NCT03167593|Lactobacillus coryniformis|lactobacillus coryniformis
164728|NCT03167593|Flu|flu
164729|NCT03167593|Vaccine|vaccine
164730|NCT03167528|Pain|pain
164731|NCT03167528|Quality of life|quality of life
164732|NCT03167476|miRNA|mirna
164733|NCT03167476|biomarker|biomarker
164734|NCT03167450|CRISPR|crispr
164735|NCT03167450|Gene Editing|gene editing
164736|NCT03167450|Qualitative|qualitative
164737|NCT03167450|Participation Clinical Trials|participation clinical trials
164738|NCT03167450|Genetic Literacy|genetic literacy
164739|NCT03167437|Reduce Symptoms of Crohn's Disease|reduce symptoms of crohn's disease
164740|NCT03167437|HDAC Inhibitors|hdac inhibitors
164741|NCT03167424|In-stent restenosis|in-stent restenosis
164742|NCT03167424|Bioresorbable vascular scaffold|bioresorbable vascular scaffold
164743|NCT03167424|Coronary angiography|coronary angiography
164744|NCT03167398|fecal microbiota transplantation|fecal microbiota transplantation
164745|NCT03167398|carbapenem-resistant enterobacteriaceae|carbapenem-resistant enterobacteriaceae
164746|NCT03167398|multidrug resistant bacteria|multidrug resistant bacteria
164747|NCT03167398|carrier|carrier
164748|NCT03167385|locally advanced differentiated thyroid carcinoma|locally advanced differentiated thyroid carcinoma
164749|NCT03167385|radioiodine refractory thyroid carcinoma|radioiodine refractory thyroid carcinoma
164750|NCT03167372|Light Therapy|light therapy
164751|NCT03167372|N-of-1|n-of-1
164752|NCT03167359|Psychiatry|psychiatry
164753|NCT03167359|Radiation Therapy|radiation therapy
164754|NCT03167346|stroke|stroke
164755|NCT03167346|core symptoms|core symptoms
164756|NCT03167346|public awareness|public awareness
164757|NCT03167346|FAST|fast
164758|NCT03167307|omega-3 fatty acids|omega-3 fatty acids
164759|NCT03167307|eicosapentaenoic acid|eicosapentaenoic acid
164760|NCT03167307|docosahexaenoic acid|docosahexaenoic acid
164761|NCT03167307|antidepressants|antidepressants
164762|NCT03167307|suicidality|suicidality
164763|NCT03167307|cognition|cognition
164764|NCT03167307|childhood depression|childhood depression
164765|NCT03167307|pediatric depression|pediatric depression
164766|NCT03167294|Aquablation|aquablation
164767|NCT03167294|AQUABEAM|aquabeam
164768|NCT03167294|BPH|bph
164769|NCT03167294|LUTS|luts
164770|NCT03167281|Chest tube|chest tube
164771|NCT03167281|Thoracostomy|thoracostomy
164772|NCT03167281|Pleural Diseases|pleural diseases
164773|NCT03167281|Lung Neoplasms|lung neoplasms
164774|NCT03167281|Pulmonary Embolism|pulmonary embolism
164775|NCT03167281|Pneumothorax|pneumothorax
164776|NCT03167281|Thoracic Surgery|thoracic surgery
164777|NCT03167281|Deoxyribonucleases|deoxyribonucleases
164778|NCT03167281|Fibrinolytic Agents|fibrinolytic agents
164779|NCT03167281|Drainage|drainage
164780|NCT03167281|Pleural Effusion|pleural effusion
164781|NCT03167268|Lycopene|lycopene
164782|NCT03167268|Anti EGFR therapy|anti egfr therapy
164783|NCT03167216|chronic pain|chronic pain
164784|NCT03167216|prostatitis|prostatitis
164785|NCT03167216|pelvic pain|pelvic pain
164786|NCT03167203|hESC-RPE|hesc-rpe
164787|NCT03167203|Macular Degenerative Disease|macular degenerative disease
164788|NCT03167190|Point of Care Ultrasound|point of care ultrasound
164789|NCT03167151|Recurrent intermediate risk NMIBC|recurrent intermediate risk nmibc
164790|NCT03167151|Intravesical Pembrolizumab|intravesical pembrolizumab
164791|NCT03167151|Intravenous Pembrolizumab|intravenous pembrolizumab
164792|NCT03167151|Phase I/II|phase i/ii
164793|NCT03167151|Marker-lesion|marker-lesion
164794|NCT03167151|Non-muscle invasive bladder cancer (NMIBC)|non-muscle invasive bladder cancer (nmibc)
164795|NCT03167138|Shoulder pain|shoulder pain
164796|NCT03167138|Rotator cuff disease|rotator cuff disease
164797|NCT03167138|Spinal cord injuries|spinal cord injuries
164798|NCT03167138|Mesenchymal stromal cells|mesenchymal stromal cells
164799|NCT03167138|Regenerative medicine|regenerative medicine
164800|NCT03167138|Rehabilitation|rehabilitation
164801|NCT03167125|colorectal cancer screening|colorectal cancer screening
164802|NCT03167125|cancer screening|cancer screening
164803|NCT03167125|pragmatic trial|pragmatic trial
164804|NCT03167125|boot camp translation|boot camp translation
164805|NCT03167112|Potentially Curable|potentially curable
164806|NCT03167112|Preoperative|preoperative
164807|NCT03167112|FOLFIRINOX|folfirinox
164808|NCT03167073|smartphone application|smartphone application
164809|NCT03167073|low-income women|low-income women
164810|NCT03167073|breastfeeding|breastfeeding
164811|NCT03167073|health education|health education
164812|NCT03167073|health disparities|health disparities
164813|NCT03167073|postpartum weight loss|postpartum weight loss
164814|NCT03167034|exercise|exercise
164815|NCT03167034|echocardiography|echocardiography
164816|NCT03167034|right ventricular function|right ventricular function
164817|NCT03167034|obstructive airway disease|obstructive airway disease
164818|NCT03167034|emphysema|emphysema
164819|NCT03167034|acetazolamide|acetazolamide
164820|NCT03167034|altitude|altitude
164821|NCT03167021|Cannabis|cannabis
164822|NCT03167021|Community pharmacy|community pharmacy
164823|NCT03167021|Prevention|prevention
164824|NCT03167021|Students|students
164825|NCT03166995|Fibromyalgia,postural exercises|fibromyalgia,postural exercises
164826|NCT03166982|Tubo-ovarian abscess|tubo-ovarian abscess
164827|NCT03166982|Transvaginal drainage|transvaginal drainage
164828|NCT03166982|Laparoscopic treatment|laparoscopic treatment
164829|NCT03166956|Vitamin C|vitamin c
164830|NCT03166956|Glutamine|glutamine
164831|NCT03166956|Interleukin-6|interleukin-6
164832|NCT03166956|Clinical outcomes|clinical outcomes
164833|NCT03166930|Muscle Spasticity|muscle spasticity
164834|NCT03166930|Muscle Stretching Exercises|muscle stretching exercises
164835|NCT03166891|ovarian cancer, relapsed or refractory,chiauranib|ovarian cancer, relapsed or refractory,chiauranib
164836|NCT03166878|CAR-T|car-t
164837|NCT03166878|Cancer treatment|cancer treatment
164838|NCT03166878|Immunotherapy|immunotherapy
164839|NCT03166878|Adoptive cell therapy|adoptive cell therapy
164840|NCT03166878|Chimeric antigen receptor|chimeric antigen receptor
164841|NCT03166878|Universal CAR-T|universal car-t
164842|NCT03166865|osteoarthritis (OA)|osteoarthritis (oa)
164843|NCT03166865|mesenchymal stem cells(MSC)|mesenchymal stem cells(msc)
164844|NCT03166839|maternal health|maternal health
164845|NCT03166839|statistical analysis plan|statistical analysis plan
164846|NCT03166813|remote ischaemic preconditioning|remote ischaemic preconditioning
164847|NCT03166813|childhood cancer|childhood cancer
164848|NCT03166813|cardio-oncology|cardio-oncology
164849|NCT03166813|anthracycline|anthracycline
164850|NCT03166813|myocardial reperfusion injury|myocardial reperfusion injury
164851|NCT03166800|mitoquinone|mitoquinone
164852|NCT03166800|Fatigue|fatigue
164853|NCT03166800|Multiple Sclerosis|multiple sclerosis
164854|NCT03166748|Incomplete lower first molar|incomplete lower first molar
164855|NCT03166748|Immature permanent molar|immature permanent molar
164856|NCT03166748|Potassium nitrate in polycarboxylate|potassium nitrate in polycarboxylate
164857|NCT03166748|Mineral trioxide aggregate .Mineral trioxid|mineral trioxide aggregate .mineral trioxid
164858|NCT03166644|Analgesia Nociception Index (ANI)|analgesia nociception index (ani)
164859|NCT03166644|Postoperative Analgesia|postoperative analgesia
164860|NCT03166644|Postoperative Hypoxemia|postoperative hypoxemia
164861|NCT03166566|glaucoma|glaucoma
164862|NCT03166566|glaucoma surgery|glaucoma surgery
164863|NCT03166566|glaucoma drainage device|glaucoma drainage device
164864|NCT03166566|glaucoma implant|glaucoma implant
164865|NCT03166566|blindness|blindness
164866|NCT03166540|coffee|coffee
164867|NCT03166540|cocoa|cocoa
164868|NCT03166540|bioavailability|bioavailability
164869|NCT03166540|pharmacokinetics|pharmacokinetics
164870|NCT03166540|cardiometabolic risk factors|cardiometabolic risk factors
164871|NCT03166540|caffeoylquinic acids|caffeoylquinic acids
164872|NCT03166540|flavan-3-ol|flavan-3-ol
164873|NCT03166540|caffeine|caffeine
164874|NCT03166540|trigonelline|trigonelline
164875|NCT03166540|diterpene|diterpene
164876|NCT03166449|Traumatic Brain injury|traumatic brain injury
164877|NCT03166449|Immunonutrition|immunonutrition
164878|NCT03166384|electrosurgical bipolar sealing devices, breast cancer|electrosurgical bipolar sealing devices, breast cancer
164879|NCT03166371|Endocrinology|endocrinology
164880|NCT03166371|Nutrition|nutrition
164881|NCT03166371|Aging|aging
164882|NCT03166332|Mindfulness|mindfulness
164883|NCT03166332|Mediterranean diet|mediterranean diet
164884|NCT03166332|Neurodevelopment|neurodevelopment
164885|NCT03166332|Epigenetics|epigenetics
164886|NCT03166332|Fetal growth restriction|fetal growth restriction
164887|NCT03166306|pulmonary vascular disease|pulmonary vascular disease
164888|NCT03166306|pulmonary vascular imaging|pulmonary vascular imaging
164889|NCT03166293|Cerebral Palsy|cerebral palsy
164890|NCT03166293|Physical Therapy|physical therapy
164891|NCT03166293|Rehabilitation|rehabilitation
164892|NCT03166280|hepatitis C|hepatitis c
164893|NCT03166280|vitamin D|vitamin d
164894|NCT03166280|iron|iron
164895|NCT03166280|hepcidin|hepcidin
164896|NCT03166215|Drug therapy|drug therapy
164897|NCT03166202|age-related macular degeneration|age-related macular degeneration
164898|NCT03166189|Repeated IVF failure|repeated ivf failure
164899|NCT03166189|Stem cell|stem cell
164900|NCT03166163|bleeding on brushing|bleeding on brushing
164901|NCT03166150|Urinary Incontinence|urinary incontinence
164902|NCT03166150|Pelvic Floor Disorder|pelvic floor disorder
164903|NCT03166150|Pelvic Floor Muscle|pelvic floor muscle
164904|NCT03166150|Strength|strength
164905|NCT03166150|Disability|disability
164906|NCT03166150|Aging|aging
164907|NCT03166150|Atrophy|atrophy
164908|NCT03166150|Exercise|exercise
164909|NCT03166150|Magnetic Resonance Imaging|magnetic resonance imaging
164910|NCT03166150|Fatty Infiltration|fatty infiltration
164911|NCT03166150|Physical Therapy|physical therapy
164912|NCT03166150|Multi-modal Rehabilitation|multi-modal rehabilitation
164913|NCT03166150|Stress Urinary Incontinence|stress urinary incontinence
164914|NCT03166150|Urge Urinary Incontinence|urge urinary incontinence
164915|NCT03166150|Mixed Urinary Incontinence|mixed urinary incontinence
164916|NCT03166137|Warts,Laser,Cryotherapy|warts,laser,cryotherapy
164917|NCT03166098|Psychotic Spectrum Disorders|psychotic spectrum disorders
164918|NCT03166085|HER2-Negative|her2-negative
164920|NCT03166085|Nab-paclitaxel (Abraxane)|nab-paclitaxel (abraxane)
164921|NCT03166085|17-093|17-093
164922|NCT03166072|Low-vision|low-vision
164923|NCT03166072|health related quality of life|health related quality of life
164924|NCT03166072|visual aids|visual aids
164925|NCT03166072|randomized controlled trial|randomized controlled trial
164926|NCT03166059|Catheter directed thrombolysis (CDT)|catheter directed thrombolysis (cdt)
164927|NCT03166033|Carpal Tunnel Syndrome|carpal tunnel syndrome
164928|NCT03166033|etiology|etiology
164929|NCT03166033|risk factor|risk factor
164930|NCT03166020|Serious Game|serious game
164931|NCT03166020|Stroke|stroke
164932|NCT03166020|Rehabilitation|rehabilitation
164933|NCT03166020|Connected objects|connected objects
164934|NCT03166007|Multiple Sclerosis|multiple sclerosis
164935|NCT03166007|Neurogenic Bowel Dysfunction|neurogenic bowel dysfunction
164936|NCT03166007|Abdominal massage|abdominal massage
164937|NCT03165994|esophagus|esophagus
164938|NCT03165994|gastroesophageal (GE) junction|gastroesophageal (ge) junction
164939|NCT03165994|T1-3N0-1|t1-3n0-1
164940|NCT03165981|Influenza vaccine|influenza vaccine
164941|NCT03165981|fever following vaccination|fever following vaccination
164942|NCT03165981|PCV13 vaccine|pcv13 vaccine
164943|NCT03165981|DTaP vaccine|dtap vaccine
164944|NCT03165981|pneumococcal vaccine|pneumococcal vaccine
164945|NCT03165955|breast cancer|breast cancer
164946|NCT03165955|paclitaxel|paclitaxel
164947|NCT03165929|free gingival grafts|free gingival grafts
164948|NCT03165929|connective tissue grafts|connective tissue grafts
164949|NCT03165929|flurbiprofen|flurbiprofen
164950|NCT03165890|cognition|cognition
164951|NCT03165890|visuomotor learning|visuomotor learning
164952|NCT03165890|airway disease|airway disease
164953|NCT03165890|altitude|altitude
164954|NCT03165890|prevention|prevention
164955|NCT03165890|acetazolamide|acetazolamide
164956|NCT03165877|GLYCEMIC INDEX|glycemic index
164957|NCT03165877|NAFLD|nafld
164958|NCT03165877|METABOLIC PARAMETERS|metabolic parameters
164959|NCT03165877|SATIETY|satiety
164960|NCT03165864|Thalassaemia, IONIS TMPRSS6-Lrx|thalassaemia, ionis tmprss6-lrx
164961|NCT03165838|postpartum|postpartum
164962|NCT03165838|pregnancy|pregnancy
164963|NCT03165838|contraception|contraception
164964|NCT03165838|RROP|rrop
164965|NCT03165812|Sleeve Gastrectomy|sleeve gastrectomy
164966|NCT03165812|Duodeno Jejunal Bypass|duodeno jejunal bypass
164967|NCT03165812|Single Anastomosis|single anastomosis
164968|NCT03165812|Intensive Medical Therapy|intensive medical therapy
164969|NCT03165812|Diabetes Mellitus|diabetes mellitus
164970|NCT03165786|fear of hypoglycemia|fear of hypoglycemia
164971|NCT03165786|self-management|self-management
164972|NCT03165786|glycemic control|glycemic control
164973|NCT03165786|glycemic variability|glycemic variability
164974|NCT03165760|protective mechanical ventilation|protective mechanical ventilation
164975|NCT03165747|Probiotics|probiotics
164976|NCT03165747|Menopausal Osteoporosis|menopausal osteoporosis
164977|NCT03165734|myelofibrosis|myelofibrosis
164978|NCT03165734|pacritinib|pacritinib
164979|NCT03165734|Post-polycythemia Vera Myelofibrosis|post-polycythemia vera myelofibrosis
164980|NCT03165734|Post-essential Thrombocythemia Myelofibrosis|post-essential thrombocythemia myelofibrosis
164981|NCT03165734|Ruxolitinib|ruxolitinib
164982|NCT03165734|Bone Marrow Disease|bone marrow disease
164983|NCT03165734|Hematologic Diseases|hematologic diseases
164984|NCT03165734|Blood Platelet Disorders|blood platelet disorders
164985|NCT03165734|Hemorrhagic Disorders|hemorrhagic disorders
164986|NCT03165734|Splenomegaly|splenomegaly
164987|NCT03165734|Anemia|anemia
164988|NCT03165734|Spleen volume|spleen volume
164989|NCT03165734|Spleen|spleen
164990|NCT03165721|Renal Cancer|renal cancer
164991|NCT03165721|DNA Hypermethylation|dna hypermethylation
164992|NCT03165721|Gastrointestinal Stromal Tumors|gastrointestinal stromal tumors
165092|NCT03164980|ovarian cancer|ovarian cancer
164993|NCT03165721|DNA Methyltransferase (DNMT) Inhibitor|dna methyltransferase (dnmt) inhibitor
164994|NCT03165721|Succinate Dehydrogenase (SDH) Deficiency|succinate dehydrogenase (sdh) deficiency
164995|NCT03165708|Epidural technique|epidural technique
164996|NCT03165695|Delirium|delirium
164997|NCT03165695|Insomnia|insomnia
164998|NCT03165695|Ramelteon|ramelteon
164999|NCT03165682|fatigue|fatigue
165000|NCT03165682|depression|depression
165001|NCT03165682|cortical excitability|cortical excitability
165002|NCT03165669|education|education
165003|NCT03165669|sleep|sleep
165004|NCT03165669|pillow|pillow
165005|NCT03165669|neck|neck
165006|NCT03165656|Echocardiography|echocardiography
165007|NCT03165656|right ventricular function|right ventricular function
165008|NCT03165656|pulmonary hypertension|pulmonary hypertension
165009|NCT03165656|disease progression|disease progression
165010|NCT03165656|hypoxia|hypoxia
165011|NCT03165617|Influenza vaccine|influenza vaccine
165012|NCT03165604|Physical fitness|physical fitness
165013|NCT03165604|Exercise|exercise
165014|NCT03165604|Childhood Obesity|childhood obesity
165015|NCT03165604|Information|information
165016|NCT03165539|Postoperative|postoperative
165017|NCT03165539|One-lung ventilation|one-lung ventilation
165018|NCT03165539|Cerebral oximetry|cerebral oximetry
165019|NCT03165539|Cerebral desaturation|cerebral desaturation
165020|NCT03165513|Traditional healer|traditional healer
165021|NCT03165513|faith healer|faith healer
165022|NCT03165513|depression|depression
165023|NCT03165513|mhGAP|mhgap
165024|NCT03165513|Kenya|kenya
165025|NCT03165500|Exodontia|exodontia
165026|NCT03165500|Sedation|sedation
165027|NCT03165500|Nitrous Oxide|nitrous oxide
165028|NCT03165500|Benzodiazepines|benzodiazepines
165029|NCT03165487|Triple Negative Breast Cancer|triple negative breast cancer
165030|NCT03165487|microenvironment|microenvironment
165031|NCT03165487|IORT|iort
165032|NCT03165487|Hormone Receptor Positive, HER 2 negative|hormone receptor positive, her 2 negative
165033|NCT03165474|childhood obesity|childhood obesity
165034|NCT03165474|mhealth|mhealth
165035|NCT03165474|digital health|digital health
165036|NCT03165474|nutrition|nutrition
165037|NCT03165474|intervention|intervention
165038|NCT03165461|intubation to supraglottic devices|intubation to supraglottic devices
165039|NCT03165461|intubating laryngeal tube|intubating laryngeal tube
165040|NCT03165448|oral surgery|oral surgery
165041|NCT03165448|psychology|psychology
165042|NCT03165448|fear|fear
165043|NCT03165448|pain|pain
165044|NCT03165448|dentistry|dentistry
165045|NCT03165396|mild cognitive impairment|mild cognitive impairment
165046|NCT03165383|Transverse Abdominis Plane (TAP) Block|transverse abdominis plane (tap) block
165047|NCT03165383|Patient Control Analgesia (PCA)|patient control analgesia (pca)
165048|NCT03165357|Crossfit|crossfit
165049|NCT03165357|Sodium bicarbonate|sodium bicarbonate
165050|NCT03165357|Physical capacity|physical capacity
165051|NCT03165318|Pulsed electromagnetic field|pulsed electromagnetic field
165052|NCT03165318|Anterior cruciate ligament reconstruction|anterior cruciate ligament reconstruction
165053|NCT03165318|Muscle|muscle
165054|NCT03165253|Helicobacter pylori infection|helicobacter pylori infection
165055|NCT03165253|Children|children
165056|NCT03165253|Synbiotic|synbiotic
165057|NCT03165253|Standard Triple Therapy|standard triple therapy
165058|NCT03165201|Liver transplantation and Biopsy|liver transplantation and biopsy
165059|NCT03165201|Liver transplantation and LiverMultiScan|liver transplantation and livermultiscan
165060|NCT03165175|prescription drug abuse|prescription drug abuse
165061|NCT03165175|prescription drug misuse|prescription drug misuse
165062|NCT03165175|risk reduction|risk reduction
165063|NCT03165175|education|education
165064|NCT03165175|military|military
165065|NCT03165175|mobile application|mobile application
165066|NCT03165175|substance misuse|substance misuse
165067|NCT03165175|substance abuse|substance abuse
165068|NCT03165162|natural|natural
165069|NCT03165162|Food Label Choices|food label choices
165070|NCT03165136|Unexplained Recurrent Miscarriage|unexplained recurrent miscarriage
165071|NCT03165136|First trimester abortion|first trimester abortion
165072|NCT03165136|Hydroxychloroquine|hydroxychloroquine
165073|NCT03165136|Antiphospholipid antibody|antiphospholipid antibody
165074|NCT03165097|tolerability|tolerability
165075|NCT03165097|safety|safety
165076|NCT03165084|Self-management|self-management
165077|NCT03165084|Primary Health Care|primary health care
165078|NCT03165084|eHealth|ehealth
165079|NCT03165032|exercise|exercise
165080|NCT03165032|echocardiography|echocardiography
165081|NCT03165032|right ventricular function|right ventricular function
165082|NCT03165032|pulmonary hypertension|pulmonary hypertension
165083|NCT03165032|hypoxia|hypoxia
165084|NCT03165019|high altitude illness|high altitude illness
165085|NCT03165019|pulmonary hypertension|pulmonary hypertension
165086|NCT03165019|sleep apnea|sleep apnea
165087|NCT03165019|disease progression|disease progression
165088|NCT03165019|hypoxia|hypoxia
165089|NCT03165006|Breast cancer, screening, survival|breast cancer, screening, survival
165090|NCT03164993|Neoplasms|neoplasms
165091|NCT03164980|Quality of life|quality of life
165093|NCT03164980|platinum sensitive|platinum sensitive
165094|NCT03164980|recurrent|recurrent
165095|NCT03164941|selective laser trabeculoplasty|selective laser trabeculoplasty
165096|NCT03164941|practice|practice
165097|NCT03164941|treatment|treatment
165098|NCT03164941|intraocular pressure|intraocular pressure
165099|NCT03164928|Denosumab|denosumab
165100|NCT03164928|Pediatric GIOP|pediatric giop
165101|NCT03164928|Glucocorticoid-induced|glucocorticoid-induced
165102|NCT03164928|Osteoporosis|osteoporosis
165103|NCT03164889|Chronic hepatitis B, antiviral treatment|chronic hepatitis b, antiviral treatment
165104|NCT03164863|Neoadjuvant Chemotherapy, Triple Negative Breast Cancer|neoadjuvant chemotherapy, triple negative breast cancer
165105|NCT03164824|Questionnaire|questionnaire
165106|NCT03164824|Functional Rating Index|functional rating index
165107|NCT03164824|Cross-cultural adaptation|cross-cultural adaptation
165108|NCT03164824|Psychometric properties testing|psychometric properties testing
165109|NCT03164772|mRNA Vaccine|mrna vaccine
165110|NCT03164772|Durvalumab|durvalumab
165111|NCT03164772|MEDI4736|medi4736
165112|NCT03164772|anti-PD-L1|anti-pd-l1
165113|NCT03164772|tremelimumab|tremelimumab
165114|NCT03164772|anti-CTLA-4|anti-ctla-4
165115|NCT03164772|BI 1361849|bi 1361849
165116|NCT03164746|Autism|autism
165117|NCT03164746|Therapeutic body wraps|therapeutic body wraps
165118|NCT03164681|sheerly|sheerly
165119|NCT03164642|Depressive Symptoms|depressive symptoms
165120|NCT03164642|Developmental Disabilities|developmental disabilities
165121|NCT03164642|Early Intervention|early intervention
165122|NCT03164642|Language Development|language development
165123|NCT03164642|Communication|communication
165124|NCT03164642|Maternal Empowerment|maternal empowerment
165125|NCT03164629|BPH|bph
165126|NCT03164629|Lower Urinary Track Infection|lower urinary track infection
165127|NCT03164629|Urine Retention|urine retention
165128|NCT03164616|NSCLC|nsclc
165129|NCT03164616|PD-L1|pd-l1
165130|NCT03164616|Durvalumab|durvalumab
165131|NCT03164616|Tremelimumab|tremelimumab
165132|NCT03164616|PFS|pfs
165133|NCT03164616|Overall survival (OS)|overall survival (os)
165134|NCT03164616|Tumor Mutational Burden (TMB)|tumor mutational burden (tmb)
165135|NCT03164551|GERI+|geri+
165136|NCT03164551|TICON|ticon
165137|NCT03164551|EEVA|eeva
165138|NCT03164551|Embryo culture|embryo culture
165139|NCT03164551|In Vitro Fertilization|in vitro fertilization
165140|NCT03164551|Intracytoplasmic Sperm Injection|intracytoplasmic sperm injection
165141|NCT03164525|Thai version|thai version
165142|NCT03164525|validated|validated
165143|NCT03164525|Critical Care Pain Observation Tool|critical care pain observation tool
165144|NCT03164525|Behavioral Pain Scale|behavioral pain scale
165145|NCT03164525|adult ICU patients|adult icu patients
165146|NCT03164499|Health education|health education
165147|NCT03164499|Life style|life style
165148|NCT03164499|Risk factors|risk factors
165149|NCT03164499|Cardiovascular diseases|cardiovascular diseases
165150|NCT03164499|Cognitive performance|cognitive performance
165151|NCT03164499|Quality of life|quality of life
165152|NCT03164473|Eosinophilic granulomatosis with polyangiitis in remission|eosinophilic granulomatosis with polyangiitis in remission
165153|NCT03164473|double-blind randomized controlled trial|double-blind randomized controlled trial
165154|NCT03164473|maintenance therapy|maintenance therapy
165155|NCT03164473|rituximab versus azathioprine|rituximab versus azathioprine
165156|NCT03164473|vasculitis remission|vasculitis remission
165157|NCT03164473|asthma control|asthma control
165158|NCT03164473|rhinosinusal manifestations control|rhinosinusal manifestations control
165159|NCT03164473|glucocorticoid therapy reduction/withdrawal|glucocorticoid therapy reduction/withdrawal
165160|NCT03164473|steroid sparing effect|steroid sparing effect
165161|NCT03164473|damage|damage
165162|NCT03164434|intracranial pressure|intracranial pressure
165163|NCT03164434|cerebrospinal fluid drainage|cerebrospinal fluid drainage
165164|NCT03164434|waveform analysis|waveform analysis
165165|NCT03164395|atrial fibrillation|atrial fibrillation
165166|NCT03164395|implantable cardiac defibrillator|implantable cardiac defibrillator
165167|NCT03164395|cardioversion|cardioversion
165168|NCT03164369|epidural block, ultrasound|epidural block, ultrasound
165169|NCT03164356|Limb Fluid Volume Management|limb fluid volume management
165170|NCT03164356|Prosthetic Socket Modification|prosthetic socket modification
165171|NCT03164343|Pain Neuroscience Education|pain neuroscience education
165172|NCT03164330|Health Care|health care
165173|NCT03164330|Workplace Wellness|workplace wellness
165174|NCT03164330|Preventative Health Care|preventative health care
165175|NCT03164330|Health Costs|health costs
165176|NCT03164317|Hypertension|hypertension
165177|NCT03164317|High blood pressure|high blood pressure
165178|NCT03164317|Task shifting|task shifting
165179|NCT03164317|Decision support system|decision support system
165180|NCT03164291|MAC and NTM|mac and ntm
165181|NCT03164278|Wheelchair|wheelchair
165182|NCT03164278|Biomechanics|biomechanics
165183|NCT03164278|Transfer|transfer
165184|NCT03164278|Participation|participation
165185|NCT03164278|Training|training
165186|NCT03164265|Regulatory Dendritic Cells|regulatory dendritic cells
165187|NCT03164252|Third molar;|third molar;
165188|NCT03164252|Third molar surgery;|third molar surgery;
165189|NCT03164252|Laser;|laser;
165190|NCT03164252|Tissue Repair.|tissue repair.
165191|NCT03164226|endothelial function|endothelial function
165192|NCT03164226|acute coronary syndrome|acute coronary syndrome
165193|NCT03164213|tDCS|tdcs
165194|NCT03164213|aphasia|aphasia
165195|NCT03164161|Pain Sensitivity|pain sensitivity
165196|NCT03164161|Measurement|measurement
165197|NCT03164161|Cold Pressor|cold pressor
165198|NCT03164161|β-endorphins|β-endorphins
165199|NCT03164161|saliva|saliva
165200|NCT03164161|oral surgery|oral surgery
165201|NCT03164109|Healthy Adult|healthy adult
165202|NCT03164109|Superoxide Dismutase|superoxide dismutase
165203|NCT03164109|Free Radical Dismutase|free radical dismutase
165204|NCT03164109|Cardiodynamic Assessment|cardiodynamic assessment
165205|NCT03164083|Joint Diseases|joint diseases
165206|NCT03164083|Musculoskeletal Diseases|musculoskeletal diseases
165207|NCT03164083|Arthritis|arthritis
165208|NCT03164070|Osteoarthritis|osteoarthritis
165209|NCT03164070|Flow cytometry|flow cytometry
165210|NCT03164070|Synovial fluid|synovial fluid
165211|NCT03164057|DNA methyltransferase inhibitors|dna methyltransferase inhibitors
165212|NCT03164057|Acute myeloid leukemia|acute myeloid leukemia
165213|NCT03164044|Allergy|allergy
165214|NCT03164044|Drug allergy|drug allergy
165215|NCT03164044|Basophil activation test|basophil activation test
165216|NCT03164044|Flow cytometry|flow cytometry
165217|NCT03164005|VEGF-B|vegf-b
165218|NCT03163979|locally advanced cervical cancer; radiotherapy|locally advanced cervical cancer; radiotherapy
165219|NCT03163953|Physical Activity|physical activity
165220|NCT03163953|Sedentary Lifestyle|sedentary lifestyle
165221|NCT03163953|Office Workers|office workers
165222|NCT03163940|Laughter Yoga|laughter yoga
165223|NCT03163940|Major Depressive Disorder|major depressive disorder
165224|NCT03163940|Anxiety|anxiety
165225|NCT03163940|Stress|stress
165226|NCT03163940|Depression|depression
165227|NCT03163940|Quality of Life|quality of life
165228|NCT03163940|Mood Disorder|mood disorder
165229|NCT03163914|vasopressor|vasopressor
165230|NCT03163914|spinal anaesthesia|spinal anaesthesia
165231|NCT03163901|traumatic brain injury|traumatic brain injury
165232|NCT03163875|erythema|erythema
165233|NCT03163875|wheal formation|wheal formation
165234|NCT03163875|vascular reaction of the skin|vascular reaction of the skin
165235|NCT03163862|IVF|ivf
165236|NCT03163836|Double Valve Replacement|double valve replacement
165237|NCT03163836|Atrial Fibrillation Ablation|atrial fibrillation ablation
165238|NCT03163797|Oropharyngeal cancer|oropharyngeal cancer
165239|NCT03163797|integrated PET/MR|integrated pet/mr
165240|NCT03163797|diffusion-weighted imaging|diffusion-weighted imaging
165241|NCT03163797|perfusion-weighted imaging|perfusion-weighted imaging
165242|NCT03163758|Ischemic stroke|ischemic stroke
165243|NCT03163758|Functional magnetic resonance imaging (fMRI)|functional magnetic resonance imaging (fmri)
165244|NCT03163758|Repetitive transcranial magnetic stimulation (rTMS)|repetitive transcranial magnetic stimulation (rtms)
165245|NCT03163758|Brain Reorganization|brain reorganization
165246|NCT03163732|Solid tumor|solid tumor
165247|NCT03163732|Advanced tumor|advanced tumor
165248|NCT03163732|Profiling panel|profiling panel
165249|NCT03163719|Seizure|seizure
165250|NCT03163719|Generalized convulsive seizure|generalized convulsive seizure
165251|NCT03163719|Convulsions|convulsions
165252|NCT03163719|Creatine Kinase|creatine kinase
165253|NCT03163719|Lactate|lactate
165254|NCT03163719|Lactacidaemia|lactacidaemia
165255|NCT03163719|Diagnostic|diagnostic
165256|NCT03163719|Losing consciousness|losing consciousness
165257|NCT03163719|Epilepsy|epilepsy
165258|NCT03163719|Epileptic generalized tonic-clonic seizure|epileptic generalized tonic-clonic seizure
165259|NCT03163706|Schizophrenia|schizophrenia
165260|NCT03163706|Stroop effect|stroop effect
165261|NCT03163706|Semantic conflict|semantic conflict
165262|NCT03163706|Response conflict|response conflict
165263|NCT03163693|Dexmedetomidine|dexmedetomidine
165264|NCT03163693|Cardiac Troponin I|cardiac troponin i
165265|NCT03163693|Glycogen Phosphorylase Isoenzyme BB|glycogen phosphorylase isoenzyme bb
165266|NCT03163680|Gastroduodenal Ulcer|gastroduodenal ulcer
165267|NCT03163680|Marginal Ulcer|marginal ulcer
165268|NCT03163680|Peptic Ulcer Hemorrhage|peptic ulcer hemorrhage
165269|NCT03163680|Peptic Ulcer|peptic ulcer
165270|NCT03163667|advanced, metastatic RCC|advanced, metastatic rcc
165271|NCT03163667|RCC|rcc
165272|NCT03163667|CB-839|cb-839
165273|NCT03163667|Everolimus|everolimus
165274|NCT03163667|CBE|cbe
165275|NCT03163667|Glutaminase Inhibitor|glutaminase inhibitor
165276|NCT03163667|Glutaminase|glutaminase
165277|NCT03163667|Tumor Metabolism|tumor metabolism
165278|NCT03163667|Glutamine|glutamine
165279|NCT03163654|multiple gingival recessions|multiple gingival recessions
165280|NCT03163654|collagen matrix|collagen matrix
165281|NCT03163654|connective tissue graft|connective tissue graft
165282|NCT03163654|tunnel technique|tunnel technique
165283|NCT03163641|Photorefractive Keratectomy, Corneal Defect|photorefractive keratectomy, corneal defect
165284|NCT03163628|severe bacterial infection|severe bacterial infection
165285|NCT03163628|acute infection|acute infection
165286|NCT03163628|infection viral|infection viral
165287|NCT03163628|biomarker combination|biomarker combination
165288|NCT03163628|diagnostic|diagnostic
165289|NCT03163628|child|child
165290|NCT03163602|Peri-Implantitis|peri-implantitis
165291|NCT03163602|Infection|infection
165292|NCT03163602|Bone substitutes|bone substitutes
165293|NCT03163524|family planning|family planning
165294|NCT03163524|reproductive health|reproductive health
165295|NCT03163524|m-health|m-health
165296|NCT03163498|Hypertension|hypertension
165297|NCT03163498|Exercise|exercise
165298|NCT03163498|Sleep|sleep
165299|NCT03163485|epilepsy|epilepsy
165300|NCT03163485|multimodal neuromonitoring|multimodal neuromonitoring
165301|NCT03163485|depth EEG|depth eeg
165302|NCT03163485|microdialysis|microdialysis
165303|NCT03163485|brain injury|brain injury
165304|NCT03163485|brain tissue at risk|brain tissue at risk
165305|NCT03163485|NCSE|ncse
165306|NCT03163485|short time monitoring|short time monitoring
165307|NCT03163485|neurologic ICU|neurologic icu
165308|NCT03163459|mechanical thrombectomy|mechanical thrombectomy
165309|NCT03163459|selective brain cooling|selective brain cooling
165310|NCT03163446|Staphylococcus aureus|staphylococcus aureus
165311|NCT03163446|bacteremia|bacteremia
165312|NCT03163446|staphylococcal endocarditis|staphylococcal endocarditis
165313|NCT03163433|Patient activation measure|patient activation measure
165314|NCT03163433|Self-efficacy|self-efficacy
165315|NCT03163433|Patient participation in research|patient participation in research
165316|NCT03163433|Patient reported outcome measures|patient reported outcome measures
165317|NCT03163420|Anesthetic efficacy|anesthetic efficacy
165318|NCT03163420|Diclofenac|diclofenac
165319|NCT03163420|Irreversible pulpitis|irreversible pulpitis
165320|NCT03163381|first-line treatment failure|first-line treatment failure
165321|NCT03163381|one measurable lesion|one measurable lesion
165322|NCT03163368|metastatic tumor|metastatic tumor
165323|NCT03163368|brain lesion|brain lesion
165324|NCT03163368|stereotactic radiosurgery|stereotactic radiosurgery
165325|NCT03163368|neoadjuvant|neoadjuvant
165326|NCT03163368|maximum tolerated dose|maximum tolerated dose
165327|NCT03163368|dose escalation|dose escalation
165328|NCT03163368|neurosurgical resection|neurosurgical resection
165329|NCT03163355|pureed diet|pureed diet
165330|NCT03163355|dysphasia|dysphasia
165331|NCT03163342|Seasonal|seasonal
165332|NCT03163303|Tobacco|tobacco
165333|NCT03163303|Cigarettes|cigarettes
165334|NCT03163303|Alcohol|alcohol
165335|NCT03163303|Cessation|cessation
165336|NCT03163303|Intervention|intervention
165337|NCT03163303|Young adults|young adults
165338|NCT03163303|Internet|internet
165339|NCT03163303|Social media|social media
165340|NCT03163264|obesity|obesity
165341|NCT03163264|weight loss|weight loss
165342|NCT03163264|weight gain|weight gain
165343|NCT03163264|weight management|weight management
165344|NCT03163264|primary care|primary care
165345|NCT03163264|health coach|health coach
165346|NCT03163251|READ-SG|read-sg
165347|NCT03163251|Burnout|burnout
165348|NCT03163251|Professional identity|professional identity
165349|NCT03163251|Empathy|empathy
165350|NCT03163251|Emotional intelligence|emotional intelligence
165351|NCT03163238|Dexmedetomidine|dexmedetomidine
165352|NCT03163238|Congenital Heart Disease|congenital heart disease
165353|NCT03163238|Cardiopulmonary Bypass|cardiopulmonary bypass
165354|NCT03163238|Interleukin|interleukin
165355|NCT03163225|outpatient care|outpatient care
165356|NCT03163225|emergency department visits|emergency department visits
165357|NCT03163212|Lactoferrin/FOS Supplementation|lactoferrin/fos supplementation
165358|NCT03163173|Healthy Adult|healthy adult
165359|NCT03163173|Superoxide Dismutase|superoxide dismutase
165360|NCT03163173|Absorption|absorption
165361|NCT03163173|Metabolism|metabolism
165362|NCT03163173|Elimination|elimination
165363|NCT03163173|Mass Balance|mass balance
165364|NCT03163173|Male Subjects|male subjects
165365|NCT03163160|pelvic floor muscles|pelvic floor muscles
165366|NCT03163160|pelvic floor myalgia|pelvic floor myalgia
165367|NCT03163160|manual therapy|manual therapy
165368|NCT03163160|electrolysis|electrolysis
165369|NCT03163160|galvanic|galvanic
165370|NCT03163147|frequency|frequency
165371|NCT03163134|Lumbar Drain, CSF Leak|lumbar drain, csf leak
165372|NCT03163121|Plasmodium falciparum|plasmodium falciparum
165373|NCT03163121|PfSPZ Vaccine|pfspz vaccine
165374|NCT03163121|PfSPZ-GA1 Vaccine|pfspz-ga1 vaccine
165375|NCT03163121|Controlled human malaria infection (CHMI)|controlled human malaria infection (chmi)
165376|NCT03163121|Genetically attenuated sporozoites|genetically attenuated sporozoites
165377|NCT03163121|Plasmodium falciparum sporozoites (PfSPZ)|plasmodium falciparum sporozoites (pfspz)
165378|NCT03163108|controller|controller
165379|NCT03163108|hyperoxia|hyperoxia
165380|NCT03163108|hypoxia|hypoxia
165381|NCT03163108|ventilation|ventilation
165382|NCT03163108|cerebral oxygenation|cerebral oxygenation
165383|NCT03163095|sepsis|sepsis
165384|NCT03163095|abdominal infection|abdominal infection
165385|NCT03163095|open abdomen management|open abdomen management
165386|NCT03163095|Negative pressure peritoneal therapy|negative pressure peritoneal therapy
165387|NCT03163082|Coercion theory|coercion theory
165388|NCT03163082|Corrosive Couple Coercion|corrosive couple coercion
165389|NCT03163069|tooth bleaching|tooth bleaching
165390|NCT03163069|dentifrice|dentifrice
165391|NCT03163056|Smoking cessation|smoking cessation
165392|NCT03163056|Depression|depression
165393|NCT03163056|Clinical trial|clinical trial
165394|NCT03163030|Heart Failure|heart failure
165395|NCT03163030|Preserved Ejection Fraction|preserved ejection fraction
165396|NCT03163030|VNS|vns
165397|NCT03163030|Vagus Nerve|vagus nerve
165398|NCT03163030|Autonomic Regulation Therapy|autonomic regulation therapy
165399|NCT03163017|3D Fluoroscopy|3d fluoroscopy
165400|NCT03163004|Sedentary behavior|sedentary behavior
165401|NCT03162978|Exercise|exercise
165402|NCT03162978|behavior economics|behavior economics
165403|NCT03162952|Chronic pain|chronic pain
165404|NCT03162913|Strawberry|strawberry
165405|NCT03162913|Cognition|cognition
165406|NCT03162913|Gait|gait
165407|NCT03162913|Posture|posture
165408|NCT03162900|Glasdegib|glasdegib
211291|NCT02873325|ADV|adv
165409|NCT03162900|PF-04449913|pf-04449913
165410|NCT03162900|Pharmacokinetics|pharmacokinetics
165411|NCT03162900|QTc|qtc
165412|NCT03162900|TQT|tqt
165413|NCT03162874|Levodopa-Induced Dyskinesia (LID)|levodopa-induced dyskinesia (lid)
165414|NCT03162874|Wearing-off|wearing-off
165415|NCT03162874|Foliglurax|foliglurax
165416|NCT03162874|Parkinson's Disease|parkinson's disease
165417|NCT03162874|mGluR4 PAM|mglur4 pam
165418|NCT03162835|Pain Neuroscience Education|pain neuroscience education
165419|NCT03162822|Caregiver-Child Coercion|caregiver-child coercion
165420|NCT03162822|Early Childhood Caries|early childhood caries
165421|NCT03162809|infertility|infertility
165422|NCT03162809|in vitro fertilization|in vitro fertilization
165423|NCT03162809|Estradiol|estradiol
165424|NCT03162809|Progesterone|progesterone
165425|NCT03162783|Aldeyra|aldeyra
165426|NCT03162770|mindfulness meditation|mindfulness meditation
165427|NCT03162770|hemodialysis|hemodialysis
165428|NCT03162770|quality of life|quality of life
165429|NCT03162770|stress|stress
165430|NCT03162718|lung cancer|lung cancer
165431|NCT03162718|exercise|exercise
165432|NCT03162718|pre-operative exercise program|pre-operative exercise program
165433|NCT03162679|trauma treatment|trauma treatment
165434|NCT03162679|Refugees|refugees
165435|NCT03162679|Emotion regulation|emotion regulation
165436|NCT03162679|Group therapy|group therapy
165437|NCT03162679|randomized controlled|randomized controlled
165438|NCT03162679|PTSD|ptsd
165439|NCT03162653|Allopurinol|allopurinol
165440|NCT03162653|hypothermia therapy|hypothermia therapy
165441|NCT03162653|hypoxic-ischemic encephalopathy|hypoxic-ischemic encephalopathy
165442|NCT03162653|neonatal oxygen deficiency|neonatal oxygen deficiency
165443|NCT03162653|childbirth outcome|childbirth outcome
165444|NCT03162653|perinatal asphyxia|perinatal asphyxia
165445|NCT03162640|Early onset of cannabis use|early onset of cannabis use
165446|NCT03162640|Addiction|addiction
165447|NCT03162640|Time perception|time perception
165448|NCT03162627|Malignant neoplasm of breast|malignant neoplasm of breast
165449|NCT03162627|Malignant neoplasms of digestive organs|malignant neoplasms of digestive organs
165450|NCT03162627|Malignant neoplasms of female genital organs|malignant neoplasms of female genital organs
165451|NCT03162627|Malignant neoplasms of male genital organs|malignant neoplasms of male genital organs
165452|NCT03162627|Malignant neoplasms of thyroid and other endocrine glands|malignant neoplasms of thyroid and other endocrine glands
165453|NCT03162627|Solid tumors|solid tumors
165454|NCT03162627|Ras Pathway Alterations|ras pathway alterations
165455|NCT03162627|Ovarian Tumors with PARP Resistance|ovarian tumors with parp resistance
165456|NCT03162627|Selumetinib|selumetinib
165457|NCT03162627|AZD6244|azd6244
165458|NCT03162627|Olaparib|olaparib
165459|NCT03162627|Lynparza|lynparza
165460|NCT03162614|healthy volunteers|healthy volunteers
165461|NCT03162614|Malaria|malaria
165462|NCT03162614|malaria vaccine|malaria vaccine
165463|NCT03162614|controlled human challenge|controlled human challenge
165464|NCT03162614|RTS,S/AS01|rts,s/as01
165465|NCT03162536|ARQ 531|arq 531
165466|NCT03162536|Hematologic Malignancies|hematologic malignancies
165467|NCT03162536|SLL|sll
165468|NCT03162536|CLL|cll
165469|NCT03162536|B-cell NHL|b-cell nhl
165470|NCT03162536|WM|wm
165471|NCT03162536|BTK (Bruton's tyrosine kinase)|btk (bruton's tyrosine kinase)
165472|NCT03162536|cancer|cancer
165473|NCT03162536|refractory|refractory
165474|NCT03162536|relapsed|relapsed
165475|NCT03162536|Acalabrutinib|acalabrutinib
165476|NCT03162536|ArQule|arqule
165477|NCT03162536|BGB-3111|bgb-3111
165478|NCT03162536|Blood Protein Disorders|blood protein disorders
165479|NCT03162536|Follicular Lymphoma|follicular lymphoma
165480|NCT03162536|BTK Intolerant|btk intolerant
165481|NCT03162536|C481|c481
165482|NCT03162536|C481S|c481s
165483|NCT03162536|C481S Mutation|c481s mutation
165484|NCT03162536|Cardiovascular Diseases|cardiovascular diseases
165485|NCT03162536|Chronic Lymphocytic Leukemia|chronic lymphocytic leukemia
165486|NCT03162536|DLBCL (Diffuse Large B-cell lymphoma)|dlbcl (diffuse large b-cell lymphoma)
165487|NCT03162536|GS-4059|gs-4059
165778|NCT03160846|Dopamine|dopamine
165488|NCT03162536|Hemorrhagic Disorders|hemorrhagic disorders
165489|NCT03162536|Hemostatic Disorders|hemostatic disorders
165490|NCT03162536|Ibrutinib|ibrutinib
165491|NCT03162536|Immune System Diseases|immune system diseases
165492|NCT03162536|Immunoproliferative Disorders|immunoproliferative disorders
165493|NCT03162536|Leukemia|leukemia
165494|NCT03162536|Leukemia, B-Cell|leukemia, b-cell
165495|NCT03162536|Leukemia, Lymphocytic, Chronic, B-Cell|leukemia, lymphocytic, chronic, b-cell
165496|NCT03162536|Leukemia, Lymphoid|leukemia, lymphoid
165497|NCT03162536|Lymphatic Diseases|lymphatic diseases
165498|NCT03162536|Lymphoma|lymphoma
165499|NCT03162536|Lymphoma, B-Cell|lymphoma, b-cell
165500|NCT03162536|Lymphoma, B-Cell, Marginal Zone|lymphoma, b-cell, marginal zone
165501|NCT03162536|Lymphoma, Mantle-Cell|lymphoma, mantle-cell
165502|NCT03162536|Lymphoma, Non-Hodgkin|lymphoma, non-hodgkin
165503|NCT03162536|Lymphoproliferative Disorders|lymphoproliferative disorders
165504|NCT03162536|Mantle Cell Lymphoma|mantle cell lymphoma
165505|NCT03162536|Marginal zone lymphoma|marginal zone lymphoma
165506|NCT03162536|Neoplasms|neoplasms
165507|NCT03162536|Neoplasms by Histologic Type|neoplasms by histologic type
165508|NCT03162536|Neoplasms, Plasma Cell|neoplasms, plasma cell
165509|NCT03162536|NHL (Non-Hodgkin's Lymphoma)|nhl (non-hodgkin's lymphoma)
165510|NCT03162536|ONO-4059|ono-4059
165511|NCT03162536|Paraproteinemias|paraproteinemias
165512|NCT03162536|Small Lymphocytic Lymphoma|small lymphocytic lymphoma
165513|NCT03162536|Tirabrutinib|tirabrutinib
165514|NCT03162536|Vascular Diseases|vascular diseases
165515|NCT03162536|Waldenstrom Macroglobulinemia|waldenstrom macroglobulinemia
165516|NCT03162536|Zanubrutinib|zanubrutinib
165517|NCT03162510|SOLAR regimen|solar regimen
165518|NCT03162471|Corneal astigmatism|corneal astigmatism
165519|NCT03162471|Cataract surgery|cataract surgery
165520|NCT03162471|Corneal hysteresis|corneal hysteresis
165521|NCT03162471|Corneal resistance factor|corneal resistance factor
165522|NCT03162471|Intraocular pressure|intraocular pressure
165523|NCT03162445|bone mineral density|bone mineral density
165524|NCT03162445|Autism Spectrum Disorder|autism spectrum disorder
165525|NCT03162445|Autism|autism
165526|NCT03162432|IBD|ibd
165527|NCT03162393|brachial plexus; avulsion injury|brachial plexus; avulsion injury
165528|NCT03162380|Bipolar Disorder|bipolar disorder
165529|NCT03162380|occupational stress|occupational stress
165530|NCT03162367|Burn|burn
165531|NCT03162367|Epidermal cell suspension|epidermal cell suspension
165532|NCT03162341|Dual-Energy Computed Tomography|dual-energy computed tomography
165533|NCT03162341|UltraSonography|ultrasonography
165534|NCT03162341|Gout|gout
165535|NCT03162341|Urate deposition|urate deposition
165536|NCT03162302|MRI|mri
165537|NCT03162302|magnetic resonance imaging|magnetic resonance imaging
165538|NCT03162302|fat quantification|fat quantification
165539|NCT03162302|iron quantification|iron quantification
165540|NCT03162289|Fasting|fasting
165541|NCT03162289|Vegan|vegan
165542|NCT03162276|BRCA 1/2 Carriers|brca 1/2 carriers
165543|NCT03162276|The Work|the work
165544|NCT03162276|RCT|rct
165545|NCT03162276|IBSR|ibsr
165546|NCT03162263|Ekso|ekso
165547|NCT03162263|neuroplasticity|neuroplasticity
165548|NCT03162263|functional recovery|functional recovery
165549|NCT03162237|Type1 diabetes|type1 diabetes
165550|NCT03162237|porcine islets|porcine islets
165551|NCT03162237|treg cells|treg cells
165552|NCT03162237|immunosuppress|immunosuppress
165553|NCT03162237|xenotransplantation|xenotransplantation
165554|NCT03162224|Head and Neck Squamous Cell Carcinoma|head and neck squamous cell carcinoma
165555|NCT03162224|Oropharyngeal Cancer|oropharyngeal cancer
165556|NCT03162224|HPV|hpv
165557|NCT03162224|Human Papilloma Virus|human papilloma virus
165558|NCT03162224|Cancer Immunotherapy|cancer immunotherapy
165559|NCT03162224|Check point inhibitors|check point inhibitors
165560|NCT03162224|PD-L1 inhibitor|pd-l1 inhibitor
165561|NCT03162224|Recurrent or Metastatic Cancer|recurrent or metastatic cancer
165562|NCT03162224|Durvalumab|durvalumab
165563|NCT03162224|MEDI0457|medi0457
165564|NCT03162224|Antineoplastic agents|antineoplastic agents
165565|NCT03162224|Neoplasms|neoplasms
165566|NCT03162185|Neuroplasticity|neuroplasticity
165567|NCT03162185|SSRI|ssri
165568|NCT03162185|Motor Learning|motor learning
165569|NCT03162172|congenital adrenal hyperplasia|congenital adrenal hyperplasia
165570|NCT03162172|short stature|short stature
165571|NCT03162172|growth hormone treatment|growth hormone treatment
165572|NCT03162133|Breast Cancer|breast cancer
165573|NCT03162133|Aromatase Inhibitor Therapy|aromatase inhibitor therapy
165574|NCT03162133|Baduanjin Exercise|baduanjin exercise
165575|NCT03162107|adherence|adherence
165576|NCT03162107|HIV|hiv
165577|NCT03162107|MDR/XDR TB|mdr/xdr tb
165578|NCT03162107|Health Care Worker|health care worker
165579|NCT03162081|addiction|addiction
165580|NCT03162081|cognition|cognition
165581|NCT03162081|impulsivity|impulsivity
165582|NCT03162081|neuropsychology|neuropsychology
165583|NCT03162081|prescription drug misuse|prescription drug misuse
165584|NCT03162081|dependence|dependence
165585|NCT03162068|Cushing's syndrome|cushing's syndrome
165586|NCT03162068|Osteoporosis|osteoporosis
165587|NCT03162068|peripheral Quantitative Computed|peripheral quantitative computed
165588|NCT03162068|volumetric Bone Mineral Density|volumetric bone mineral density
165589|NCT03162068|Cortical and trabecular bone|cortical and trabecular bone
165590|NCT03162068|Bone Strength|bone strength
165591|NCT03162055|COPD|copd
165592|NCT03162042|Activin A|activin a
165593|NCT03162042|Myostatin|myostatin
165594|NCT03162042|Follistatin|follistatin
165595|NCT03162042|Cachexia|cachexia
165596|NCT03162042|Squamous cell carcinoma|squamous cell carcinoma
165597|NCT03162029|CBCT|cbct
165598|NCT03162029|Bone quality|bone quality
165599|NCT03162029|Renal failure|renal failure
165600|NCT03161990|DAIR|dair
165601|NCT03161990|Transgluteal approach|transgluteal approach
165602|NCT03161990|Posterior approach|posterior approach
165603|NCT03161964|Hypoglycemia|hypoglycemia
165604|NCT03161964|Impaired Awareness of Hypoglycemia|impaired awareness of hypoglycemia
165605|NCT03161964|Propranolol|propranolol
165606|NCT03161951|acute Infections, flow cytometry, cell activation|acute infections, flow cytometry, cell activation
165607|NCT03161912|Diabetes|diabetes
165608|NCT03161912|Retinal Diseases|retinal diseases
165609|NCT03161912|Diabetic Retinopathy|diabetic retinopathy
165610|NCT03161912|Diabetic macular edema|diabetic macular edema
165611|NCT03161912|Retinal vein occlusion|retinal vein occlusion
165612|NCT03161912|Macular edema secondary to retinal vein occlusion|macular edema secondary to retinal vein occlusion
165613|NCT03161912|Intravitreal anti-VEGF (vascular endothelial growth factor)|intravitreal anti-vegf (vascular endothelial growth factor)
165614|NCT03161912|VEGF inhibitor|vegf inhibitor
165615|NCT03161912|aflibercept|aflibercept
165616|NCT03161912|real world data|real world data
165617|NCT03161912|treatment pattern|treatment pattern
165618|NCT03161899|thalassemia - nutrition -growth|thalassemia - nutrition -growth
165619|NCT03161886|colon capsule endoscopy|colon capsule endoscopy
165620|NCT03161860|Program evaluation|program evaluation
165621|NCT03161860|Cost-effectiveness|cost-effectiveness
165622|NCT03161860|Community participation|community participation
165623|NCT03161860|empowerment|empowerment
165624|NCT03161847|OPMD|opmd
165625|NCT03161834|DNA|dna
165626|NCT03161834|Circulating tumor cells|circulating tumor cells
165627|NCT03161795|Chemical coping|chemical coping
165628|NCT03161795|Long-term opioid therapy|long-term opioid therapy
165629|NCT03161795|Risk factors|risk factors
165630|NCT03161795|Predictive tools|predictive tools
165631|NCT03161795|Frequency|frequency
165632|NCT03161782|pain|pain
165633|NCT03161782|exercise|exercise
165634|NCT03161782|proprioceptive neuromuscular facilitation stretching|proprioceptive neuromuscular facilitation stretching
165635|NCT03161782|static stretching|static stretching
165636|NCT03161743|platelet-rich plasma|platelet-rich plasma
165637|NCT03161743|platelet|platelet
165638|NCT03161730|videolaryngoscope, novice|videolaryngoscope, novice
165639|NCT03161717|electrical stimulation|electrical stimulation
165640|NCT03161717|vaginal delivery|vaginal delivery
165641|NCT03161678|Pharmacogenetics|pharmacogenetics
165642|NCT03161678|Carboxylesterase 1 (CES1)|carboxylesterase 1 (ces1)
165643|NCT03161678|Antiplatelet therapy|antiplatelet therapy
165644|NCT03161652|diabetic retinopathy|diabetic retinopathy
165645|NCT03161652|blindness|blindness
165646|NCT03161652|eye|eye
165647|NCT03161652|macular edema|macular edema
165648|NCT03161652|prolactin|prolactin
165649|NCT03161652|dopamine antagonists|dopamine antagonists
165650|NCT03161652|peptide hormones|peptide hormones
165651|NCT03161639|Pulpectomy|pulpectomy
165652|NCT03161639|Primary teeth|primary teeth
165653|NCT03161639|Working length|working length
165654|NCT03161639|Apex locator|apex locator
165655|NCT03161587|FEV1|fev1
165656|NCT03161587|COPD|copd
165657|NCT03161587|CAT|cat
165658|NCT03161587|treatment modality|treatment modality
165659|NCT03161587|FVC|fvc
165660|NCT03161587|GOLD 2016|gold 2016
165661|NCT03161587|mMRC|mmrc
165662|NCT03161574|neochemotherapy|neochemotherapy
165663|NCT03161574|CRM|crm
165664|NCT03161483|CC-220|cc-220
165665|NCT03161483|Safety|safety
165666|NCT03161483|Efficacy|efficacy
165667|NCT03161483|Active Systemic Lupus Erythematosus|active systemic lupus erythematosus
165668|NCT03161457|RA|ra
165669|NCT03161457|Moderate RA|moderate ra
165670|NCT03161457|Moderate Rheumatoid Arthritis|moderate rheumatoid arthritis
165671|NCT03161457|Severe RA|severe ra
165672|NCT03161457|Severe Rheumatoid Arthritis|severe rheumatoid arthritis
165673|NCT03161457|Moderate to Severe RA|moderate to severe ra
165674|NCT03161457|Moderate to Severe Rheumatoid Arthritis|moderate to severe rheumatoid arthritis
165675|NCT03161431|Immunotherapy|immunotherapy
165676|NCT03161431|Chemokine receptor blockade|chemokine receptor blockade
165677|NCT03161431|Myeloid-derived suppressor cells|myeloid-derived suppressor cells
165678|NCT03161405|Drug Therapy|drug therapy
165679|NCT03161392|mammography|mammography
165680|NCT03161392|ductal ectasia|ductal ectasia
165681|NCT03161392|breast neoplasm/diagnostic imaging|breast neoplasm/diagnostic imaging
165682|NCT03161392|mammary Glands, Human/pathology|mammary glands, human/pathology
165683|NCT03161392|female|female
165684|NCT03161379|Neoadjuvant therapy|neoadjuvant therapy
165685|NCT03161379|immunotherapy|immunotherapy
165686|NCT03161379|Cytoxan|cytoxan
165687|NCT03161379|Cyclophosphamide|cyclophosphamide
165688|NCT03161379|Pancreatic Vaccine|pancreatic vaccine
165689|NCT03161379|SBRT|sbrt
165690|NCT03161379|GVAX|gvax
165691|NCT03161379|Nivolumab|nivolumab
165692|NCT03161379|borderline resectable|borderline resectable
165693|NCT03161379|Radioimmunotherapy|radioimmunotherapy
165694|NCT03161379|Vaccine|vaccine
165695|NCT03161379|Antibody|antibody
165696|NCT03161379|Anti-PD-1|anti-pd-1
165697|NCT03161366|Ebola Zaire Outbreak|ebola zaire outbreak
165698|NCT03161366|Safety of rVSVΔG-ZEBOV-GP vaccine|safety of rvsvδg-zebov-gp vaccine
400594|NCT01866085|stress urinary incontinence|stress urinary incontinence
165699|NCT03161366|Effectiveness of rVSVΔG-ZEBOV-GP vaccine|effectiveness of rvsvδg-zebov-gp vaccine
165700|NCT03161340|Recurrent Implantation Failure|recurrent implantation failure
165701|NCT03161340|Rapamycin|rapamycin
165702|NCT03161340|Pregnancy Rate|pregnancy rate
165703|NCT03161327|ankle brachial index|ankle brachial index
165704|NCT03161327|peripheral arterial disease|peripheral arterial disease
165705|NCT03161314|Plantar Fasciitis|plantar fasciitis
165706|NCT03161314|Plantar Heel Pain|plantar heel pain
165707|NCT03161314|Multisegment Foot Motion|multisegment foot motion
165708|NCT03161314|EMG|emg
165709|NCT03161314|Gait|gait
165710|NCT03161314|treatment|treatment
165711|NCT03161314|strengthening|strengthening
165712|NCT03161314|stretching|stretching
165713|NCT03161314|exercise|exercise
165714|NCT03161275|cerebral saturation|cerebral saturation
165715|NCT03161275|epidural anaesthesia|epidural anaesthesia
165716|NCT03161275|Near Infrared Spectroscopy (NIRS)|near infrared spectroscopy (nirs)
165717|NCT03161275|Regional cerebral oxygen saturation|regional cerebral oxygen saturation
165718|NCT03161262|Text-message reminder|text-message reminder
165719|NCT03161262|Post-operative medication|post-operative medication
165720|NCT03161262|Behavioral Research|behavioral research
165721|NCT03161262|Social Research|social research
165722|NCT03161262|Short Message Service (SMS)|short message service (sms)
165723|NCT03161249|first psychotic episode, mobile app intervention|first psychotic episode, mobile app intervention
165724|NCT03161197|CKD, Dialysis, ESRD|ckd, dialysis, esrd
165725|NCT03161197|Mindfulness-Based Stress Reduction (MBSR)|mindfulness-based stress reduction (mbsr)
165726|NCT03161184|maternal health|maternal health
165727|NCT03161184|community health|community health
165728|NCT03161184|health services|health services
165729|NCT03161184|Tanzania|tanzania
165730|NCT03161184|evaluation|evaluation
165731|NCT03161184|cluster randomized trial|cluster randomized trial
165732|NCT03161158|Cardio-Renal Syndrome type 1|cardio-renal syndrome type 1
165733|NCT03161158|Acutely decompensated chronic heart failure|acutely decompensated chronic heart failure
165734|NCT03161158|Ultrafiltration|ultrafiltration
165735|NCT03161067|Tetraplegia|tetraplegia
165736|NCT03161067|Rehabilitation|rehabilitation
165737|NCT03161067|Brain Computer Interface|brain computer interface
165738|NCT03161067|Intracortical Microstimulation|intracortical microstimulation
165739|NCT03161067|Upper extremity prosthetics|upper extremity prosthetics
165740|NCT03161054|Metronomic Chemotherapy|metronomic chemotherapy
165741|NCT03161054|Elderly non-fit patients|elderly non-fit patients
165742|NCT03161054|Aggressive B-Cell lymphomas|aggressive b-cell lymphomas
165743|NCT03161041|Cytoreductive surgery, HIPEC, perioperative chemotherapy, peritoneal carcinomatosis, bevacizumab, colorectal surgery|cytoreductive surgery, hipec, perioperative chemotherapy, peritoneal carcinomatosis, bevacizumab, colorectal surgery
165744|NCT03161028|multiple sclerosis|multiple sclerosis
165745|NCT03161028|magnetic resonance imaging|magnetic resonance imaging
165746|NCT03161028|gait|gait
165747|NCT03161028|neuroprotective agents|neuroprotective agents
165748|NCT03161028|thioctic acid|thioctic acid
165749|NCT03161028|alpha-lipoic acid|alpha-lipoic acid
165750|NCT03161028|mobility|mobility
165751|NCT03161028|chronic progressive multiple sclerosis|chronic progressive multiple sclerosis
165752|NCT03160989|Blood pressure variability|blood pressure variability
165753|NCT03160989|Combined physical exercise|combined physical exercise
165754|NCT03160989|Hypertension|hypertension
165755|NCT03160963|elderly|elderly
165756|NCT03160937|pain|pain
165757|NCT03160924|Enhanced recovery after surgery|enhanced recovery after surgery
165758|NCT03160924|ERAS|eras
165759|NCT03160924|Fast track recovery|fast track recovery
165760|NCT03160924|Laparoscopic gastrectomy|laparoscopic gastrectomy
165761|NCT03160924|Gastric Cancer|gastric cancer
165762|NCT03160911|Over-the-scope clip|over-the-scope clip
165763|NCT03160911|endoscopic haemostasis|endoscopic haemostasis
165764|NCT03160898|Amyotrophic Lateral Sclerosis|amyotrophic lateral sclerosis
165765|NCT03160898|ALS|als
165766|NCT03160898|CK-2127107|ck-2127107
165767|NCT03160898|Reldesemtiv|reldesemtiv
165768|NCT03160872|Donor sperm insemination|donor sperm insemination
165769|NCT03160872|Anti Mullerian Hormone|anti mullerian hormone
165770|NCT03160872|Ovarian reserve|ovarian reserve
165771|NCT03160872|Antral follicle count|antral follicle count
165772|NCT03160859|unsedated colonoscopy|unsedated colonoscopy
165773|NCT03160859|water exchange colonoscopy|water exchange colonoscopy
165774|NCT03160859|cap|cap
165775|NCT03160859|colonoscopy pain|colonoscopy pain
165776|NCT03160846|Inotrope|inotrope
165777|NCT03160846|Milrinone|milrinone
165780|NCT03160833|HMPL453|hmpl453
165781|NCT03160833|solid tumor|solid tumor
165782|NCT03160833|dose escalation|dose escalation
165783|NCT03160794|Prostate cancer|prostate cancer
165784|NCT03160794|stereotactic ablative radiotherpy|stereotactic ablative radiotherpy
165785|NCT03160794|PET/MR|pet/mr
165787|NCT03160768|T cell isolation|t cell isolation
165788|NCT03160768|physiologic age|physiologic age
165789|NCT03160703|Dental stain, stannous fluoride, dentifrice|dental stain, stannous fluoride, dentifrice
165790|NCT03160690|Choroidal thickness|choroidal thickness
165791|NCT03160690|Open Angle Glaucoma|open angle glaucoma
165792|NCT03160690|Non penetrating deep sclerectomy|non penetrating deep sclerectomy
165793|NCT03160677|Acute Stroke|acute stroke
165794|NCT03160677|Blood Pressure|blood pressure
165795|NCT03160677|Cerebral Hemorrhage|cerebral hemorrhage
165796|NCT03160664|magnetic seizure therapy|magnetic seizure therapy
165797|NCT03160664|electroconvulsive therapy|electroconvulsive therapy
165798|NCT03160664|bipolar mania|bipolar mania
165799|NCT03160664|cognition|cognition
165800|NCT03160664|randomized controlled trial|randomized controlled trial
165801|NCT03160651|alcoholic hepatitis|alcoholic hepatitis
165802|NCT03160651|spontaneous improvement|spontaneous improvement
165803|NCT03160651|corticosteroids|corticosteroids
165804|NCT03160638|Azithromycin|azithromycin
165805|NCT03160638|Immunomodulation|immunomodulation
165806|NCT03160638|Pharmacokinetics|pharmacokinetics
165807|NCT03160638|Tissue degradation|tissue degradation
165808|NCT03160638|Tissue remodelling|tissue remodelling
165809|NCT03160612|Wheelchair|wheelchair
165810|NCT03160612|Biomechanics|biomechanics
165811|NCT03160612|Transfer|transfer
165812|NCT03160612|Training|training
165813|NCT03160586|Stuttering|stuttering
165814|NCT03160586|Anxiety|anxiety
165815|NCT03160495|PET/MR|pet/mr
165816|NCT03160495|Squamous cell carcinoma|squamous cell carcinoma
165817|NCT03160495|Heterogeneity|heterogeneity
165818|NCT03160482|Thyroid Neoplasm|thyroid neoplasm
165819|NCT03160482|Thyroid Cancer|thyroid cancer
165820|NCT03160482|Bethesda Classification|bethesda classification
165821|NCT03160482|Biomarkers|biomarkers
165822|NCT03160482|Protein convertase|protein convertase
165823|NCT03160469|obesity|obesity
165824|NCT03160456|upper airway|upper airway
165825|NCT03160456|genioglossus|genioglossus
165826|NCT03160456|CPAP|cpap
165827|NCT03160456|electrical stimulation|electrical stimulation
165828|NCT03160456|sleep|sleep
165829|NCT03160456|sleep disordered breathing|sleep disordered breathing
165830|NCT03160443|Anorexia nervosa|anorexia nervosa
165831|NCT03160443|Bulimia|bulimia
165832|NCT03160443|Binge eating disorders|binge eating disorders
165833|NCT03160443|Neuropsychology|neuropsychology
165834|NCT03160443|Neurocognition|neurocognition
165835|NCT03160443|Daily functioning|daily functioning
165836|NCT03160430|Chronic Kidney Failure|chronic kidney failure
165837|NCT03160430|ESRD|esrd
165838|NCT03160430|End-Stage Kidney Disease|end-stage kidney disease
165839|NCT03160430|End-Stage Renal Disease|end-stage renal disease
165840|NCT03160430|Renal Disease, End-Stage|renal disease, end-stage
165841|NCT03160430|Renal Failure, Chronic|renal failure, chronic
165842|NCT03160430|Renal Failure, End-Stage|renal failure, end-stage
165843|NCT03160404|Exercise|exercise
165844|NCT03160404|Zolpidem|zolpidem
165845|NCT03160404|Sleep|sleep
165846|NCT03160326|chronic kidney disease|chronic kidney disease
165847|NCT03160326|ultrasound|ultrasound
165848|NCT03160326|muscle loss|muscle loss
165849|NCT03160313|Social engagement|social engagement
165850|NCT03160313|Physical Activity|physical activity
165851|NCT03160313|Sleep Quality|sleep quality
165852|NCT03160313|Traumatic Brain Injury|traumatic brain injury
165853|NCT03160313|Veteran|veteran
165854|NCT03160287|mobile, sleep, physical activity, older adults|mobile, sleep, physical activity, older adults
165855|NCT03160274|tumor suppressor gene|tumor suppressor gene
165856|NCT03160274|oncogene|oncogene
165857|NCT03160274|mutation|mutation
165858|NCT03160274|susceptibility gene|susceptibility gene
165859|NCT03160222|reliability|reliability
165860|NCT03160222|bioelectrical impedance analysis|bioelectrical impedance analysis
165861|NCT03160222|computed tomography|computed tomography
165862|NCT03160222|strength|strength
165863|NCT03160222|mobility|mobility
165864|NCT03160209|risk factors|risk factors
165865|NCT03160209|case-control study|case-control study
165866|NCT03160196|Diabetes Mellitus, Type 2|diabetes mellitus, type 2
165867|NCT03160196|Hemoglobin A, Glycosylated|hemoglobin a, glycosylated
165868|NCT03160183|initiating chemotherapy|initiating chemotherapy
165869|NCT03160183|prospective, open label, single arm, cohort|prospective, open label, single arm, cohort
165870|NCT03160183|non randomized, non interventional|non randomized, non interventional
165871|NCT03160170|open lumbar spine surgery|open lumbar spine surgery
165872|NCT03160170|operative time and efficiency|operative time and efficiency
165873|NCT03160170|Suction-Integrated Surgical Tissue Elevator and Retractor|suction-integrated surgical tissue elevator and retractor
165874|NCT03160144|laparoscopic resection of colorectal cancer|laparoscopic resection of colorectal cancer
165875|NCT03160144|open lung approach|open lung approach
165876|NCT03160131|Stroke|stroke
165877|NCT03160131|Visual impairment|visual impairment
165878|NCT03160131|Hemianopia|hemianopia
165879|NCT03160131|Neuro Vision Technology|neuro vision technology
165880|NCT03160131|Rehabilitation|rehabilitation
165881|NCT03160079|blinatumomab|blinatumomab
165882|NCT03160079|pembrolizumab|pembrolizumab
165883|NCT03160079|MK-3475|mk-3475
165884|NCT03160079|relapsed|relapsed
165885|NCT03160079|refractory|refractory
165886|NCT03160079|B-lineage acute lymphoblastic leukemia|b-lineage acute lymphoblastic leukemia
165887|NCT03160079|ALL|all
165888|NCT03160066|Psychobiotic|psychobiotic
165889|NCT03160066|Brain-gut axis|brain-gut axis
165890|NCT03160066|Stress|stress
165891|NCT03160066|Cognition|cognition
165892|NCT03160066|EEG|eeg
165893|NCT03160001|Niclosamide|niclosamide
165894|NCT03160001|Rheumatoid arthritis|rheumatoid arthritis
165895|NCT03160001|diseases activity|diseases activity
165896|NCT03160001|Efficacy|efficacy
165897|NCT03160001|Safety|safety
165898|NCT03159975|Tuberculosis|tuberculosis
165899|NCT03159975|DNA vaccine|dna vaccine
165900|NCT03159975|Electroporation|electroporation
165901|NCT03159975|GX-70|gx-70
165902|NCT03159962|Rapid maxillary expansion|rapid maxillary expansion
165903|NCT03159962|Mandibular response|mandibular response
165904|NCT03159962|Class II malocclusion|class ii malocclusion
165905|NCT03159962|Growing subjects|growing subjects
165906|NCT03159949|VO2max, maximal oxygen uptake|vo2max, maximal oxygen uptake
165907|NCT03159910|Shoulder Pain|shoulder pain
165908|NCT03159910|Occupational Exposure|occupational exposure
165909|NCT03159910|Clinical Trial|clinical trial
165910|NCT03159897|advanced stage (IIB-IV)|advanced stage (iib-iv)
165911|NCT03159897|ABVD DD-DI|abvd dd-di
165912|NCT03159897|PET|pet
165913|NCT03159871|Cesarean section|cesarean section
165914|NCT03159871|C- section|c- section
165915|NCT03159871|Suture|suture
165916|NCT03159858|Complex Abdominal Aortic Aneurysm|complex abdominal aortic aneurysm
165917|NCT03159845|zinc|zinc
165918|NCT03159832|Efficacy|efficacy
165919|NCT03159832|PK/PD study|pk/pd study
165920|NCT03159832|Renal Insufficiency|renal insufficiency
165921|NCT03159832|Type 2 Diabetes|type 2 diabetes
165922|NCT03159728|Ability Care|ability care
165923|NCT03159728|Caregiver overload|caregiver overload
165924|NCT03159728|Family caregiver|family caregiver
165925|NCT03159715|Internet, Behavioral Activation, Positive Psychology|internet, behavioral activation, positive psychology
165926|NCT03159702|hematological malignancy|hematological malignancy
165927|NCT03159702|EVOMELA|evomela
165928|NCT03159702|Melphalan HCl|melphalan hcl
165929|NCT03159702|Total Body Irradiation|total body irradiation
165930|NCT03159702|Reduced Intensity Conditioning|reduced intensity conditioning
165931|NCT03159702|Haploidentical Transplantation|haploidentical transplantation
165932|NCT03159702|Fludarabine|fludarabine
165933|NCT03159702|Hematologic Diseases|hematologic diseases
165934|NCT03159702|Neoplasms, Plasma Cell|neoplasms, plasma cell
165935|NCT03159702|Neoplasms by Histologic Type|neoplasms by histologic type
165936|NCT03159702|Lymphoproliferative Disorders|lymphoproliferative disorders
165937|NCT03159676|Prostate cancer|prostate cancer
165938|NCT03159676|Radiation therapy|radiation therapy
165939|NCT03159676|Radiotherapy|radiotherapy
165940|NCT03159676|Proton|proton
165941|NCT03159676|Proton beam|proton beam
165942|NCT03159676|Stereotactic ablative body radiotherapy|stereotactic ablative body radiotherapy
165943|NCT03159676|Stereotactic body radiotherapy|stereotactic body radiotherapy
165944|NCT03159676|SABR|sabr
165945|NCT03159676|SBRT|sbrt
165946|NCT03159676|Localized|localized
165947|NCT03159676|Low risk|low risk
165948|NCT03159676|Intermediate risk|intermediate risk
165949|NCT03159637|Pneumoperitoneum|pneumoperitoneum
165950|NCT03159637|Trendelenburg position|trendelenburg position
165951|NCT03159637|intra-abdominal pressure|intra-abdominal pressure
165952|NCT03159624|nasoseptal flap|nasoseptal flap
165953|NCT03159624|tissue repair|tissue repair
165954|NCT03159624|wound healing|wound healing
165955|NCT03159624|remucosalization|remucosalization
165956|NCT03159624|upper airway|upper airway
165957|NCT03159624|granulation tissue|granulation tissue
165958|NCT03159624|tissue graft|tissue graft
165959|NCT03159598|A-BR|a-br
165960|NCT03159598|Abdominal-based breast reconstruction|abdominal-based breast reconstruction
165961|NCT03159598|Seroma|seroma
165962|NCT03159585|TAEST16001|taest16001
165963|NCT03159572|Ovarian cancer|ovarian cancer
165964|NCT03159572|Fallopian tube cancer|fallopian tube cancer
165965|NCT03159572|Primary peritoneal cancer|primary peritoneal cancer
165966|NCT03159572|Germline Breast Cancer Susceptibility Gene (BRCA1/2 gene)|germline breast cancer susceptibility gene (brca1/2 gene)
165967|NCT03159572|Homologous Recombination Deficiency (HRD)|homologous recombination deficiency (hrd)
165968|NCT03159520|Pain|pain
165969|NCT03159507|Omega-3 Index|omega-3 index
165970|NCT03159507|Cellular metabolism|cellular metabolism
165971|NCT03159507|EPA Monoglyceride|epa monoglyceride
165972|NCT03159507|Quality of life|quality of life
165973|NCT03159442|Chronic obstructive pulmonary disease (COPD)|chronic obstructive pulmonary disease (copd)
165974|NCT03159442|Asthma|asthma
165975|NCT03159442|AZD8871|azd8871
166177|NCT03158116|Pseudomonas aeruginosa|pseudomonas aeruginosa
165976|NCT03159442|muscarinic receptor antagonist and β2 adrenoceptor agonist (MABA)|muscarinic receptor antagonist and β2 adrenoceptor agonist (maba)
165977|NCT03159442|Phase I|phase i
165978|NCT03159442|Safety|safety
165979|NCT03159442|Tolerability|tolerability
165980|NCT03159442|Pharmacokinetics|pharmacokinetics
165981|NCT03159442|long-acting muscarinic antagonist (LAMA)|long-acting muscarinic antagonist (lama)
165982|NCT03159442|long-acting β2-agonist (LABA)|long-acting β2-agonist (laba)
165983|NCT03159442|Japanese|japanese
165984|NCT03159429|Dyspnea|dyspnea
165985|NCT03159429|Rehabilitation of olfaction|rehabilitation of olfaction
165986|NCT03159429|Hyperventilation syndrome|hyperventilation syndrome
165987|NCT03159390|dietary supplements|dietary supplements
165988|NCT03159377|pulmonary nodule, CT, low dose|pulmonary nodule, ct, low dose
165989|NCT03159364|CTL|ctl
165990|NCT03159364|Virus CTL|virus ctl
165991|NCT03159364|Fungus CTL|fungus ctl
165992|NCT03159364|TB CTL|tb ctl
165993|NCT03159325|internet|internet
165994|NCT03159325|chronic disease management|chronic disease management
165995|NCT03159325|technology|technology
165996|NCT03159325|telehealth|telehealth
165997|NCT03159325|application|application
165998|NCT03159312|obesity,bariatric surgery,physical activity|obesity,bariatric surgery,physical activity
165999|NCT03159299|mHealth|mhealth
166000|NCT03159299|Hispanic/Latinos|hispanic/latinos
166001|NCT03159299|Diabetes Self-Management Education|diabetes self-management education
166002|NCT03159273|Dietary nitrate supplementation|dietary nitrate supplementation
166003|NCT03159273|Cold symptoms|cold symptoms
166004|NCT03159273|Stress|stress
166005|NCT03159273|Immunity|immunity
166006|NCT03159273|Exhaled nitric oxide|exhaled nitric oxide
166007|NCT03159273|Lung function|lung function
166008|NCT03159273|Cardiovascular activity|cardiovascular activity
166009|NCT03159260|night-time leg cramps|night-time leg cramps
166010|NCT03159260|topical|topical
166011|NCT03159260|spasm|spasm
166012|NCT03159247|education|education
166013|NCT03159247|counseling|counseling
166014|NCT03159247|motivational interviewing|motivational interviewing
166015|NCT03159247|tailoring|tailoring
166016|NCT03159221|type 2 diabetes in adolescents|type 2 diabetes in adolescents
166017|NCT03159221|obesity in adolescents|obesity in adolescents
166018|NCT03159221|behavioral family systems therapy|behavioral family systems therapy
166019|NCT03159208|Prognosis|prognosis
166020|NCT03159208|Critical Illness|critical illness
166021|NCT03159208|Ventilation, Mechanical|ventilation, mechanical
166022|NCT03159208|Disease Attributes|disease attributes
166023|NCT03159208|Socioeconomic Factors|socioeconomic factors
166024|NCT03159208|Activities of Daily LIving|activities of daily living
166025|NCT03159208|Cognition|cognition
166026|NCT03159195|metastatic breast cancer|metastatic breast cancer
166027|NCT03159195|advanced breast cancer|advanced breast cancer
166028|NCT03159195|HR+/ HER2-|hr+/ her2-
166029|NCT03159182|Hypertrophic scarring|hypertrophic scarring
166030|NCT03159182|Silicone Material|silicone material
166031|NCT03159182|Pressure garments|pressure garments
166032|NCT03159169|Neck Pain|neck pain
166033|NCT03159169|Upper Limb Pain|upper limb pain
166034|NCT03159130|Pain pump catheters|pain pump catheters
166035|NCT03159130|bariatric surgery|bariatric surgery
166036|NCT03159130|OnQ pump|onq pump
166037|NCT03159130|sleeve gastrectomy|sleeve gastrectomy
166038|NCT03159130|continuous infusion catheter|continuous infusion catheter
166039|NCT03159117|GD3 ADC (Pfizer PF-06688992)|gd3 adc (pfizer pf-06688992)
166040|NCT03159117|Stage III Melanoma|stage iii melanoma
166041|NCT03159117|Stage IV Melanoma|stage iv melanoma
166042|NCT03159117|17-165|17-165
166043|NCT03159078|Acinetobacter|acinetobacter
166044|NCT03159078|Polymyxins|polymyxins
166045|NCT03159078|Imipenem|imipenem
166046|NCT03159078|Pseudomona|pseudomona
166047|NCT03159078|Klebsiella|klebsiella
166048|NCT03159026|Amish/Mennonite variant|amish/mennonite variant
166049|NCT03159013|Pyrethroids|pyrethroids
166050|NCT03159013|Lambda-cyhalothrin|lambda-cyhalothrin
166051|NCT03159013|Biomarkers|biomarkers
166052|NCT03159013|Toxicokinetics|toxicokinetics
166053|NCT03158974|External Genital Warts|external genital warts
166054|NCT03158961|Thyroid|thyroid
166055|NCT03158961|Thyroidectomy|thyroidectomy
166056|NCT03158961|Transoral|transoral
166057|NCT03158961|Endoscopic|endoscopic
166058|NCT03158961|Surgery|surgery
166059|NCT03158948|Sepsis|sepsis
166060|NCT03158948|LR12|lr12
166061|NCT03158948|TREM1|trem1
166062|NCT03158948|TREM-1|trem-1
166063|NCT03158935|adoptive cell therapy|adoptive cell therapy
166064|NCT03158935|melanoma|melanoma
166065|NCT03158935|ovarian|ovarian
166066|NCT03158935|cyclophosphamide|cyclophosphamide
166067|NCT03158935|fludarabine|fludarabine
166068|NCT03158935|tumor-infiltrating lymphocytes (TILs)|tumor-infiltrating lymphocytes (tils)
166069|NCT03158935|pembrolizumab|pembrolizumab
166070|NCT03158935|interleukin-2|interleukin-2
166071|NCT03158935|anti-PD-1|anti-pd-1
166072|NCT03158935|immune checkpoint|immune checkpoint
166073|NCT03158909|Eyemask|eyemask
166074|NCT03158909|Earplugs|earplugs
166075|NCT03158896|mesenchymal stem cell|mesenchymal stem cell
166390|NCT03157128|C611G|c611g
166076|NCT03158896|hematopoietic stem cell transplant|hematopoietic stem cell transplant
166077|NCT03158896|Allogeneic hematopoietic stem cell transplant|allogeneic hematopoietic stem cell transplant
166078|NCT03158896|Autologous hematopoietic stem cell transplant|autologous hematopoietic stem cell transplant
166079|NCT03158896|Wharton's jelly|wharton's jelly
212203|NCT02867085|MDS|mds
166080|NCT03158896|umbilical cord blood|umbilical cord blood
166081|NCT03158896|steroid refractory graft versus host disease|steroid refractory graft versus host disease
166082|NCT03158883|Avelumab|avelumab
166083|NCT03158883|NSCLC|nsclc
166084|NCT03158883|Stereotactic ablative radiotherapy (SAR)|stereotactic ablative radiotherapy (sar)
166085|NCT03158857|Myanmar|myanmar
166087|NCT03158831|Drug Allergy|drug allergy
166088|NCT03158831|Penicillin Allergy|penicillin allergy
166089|NCT03158831|Antibiotic Allergy|antibiotic allergy
166090|NCT03158831|Graded Drug Challenge|graded drug challenge
166091|NCT03158792|Anticoagulation|anticoagulation
166092|NCT03158792|Thromboprophylaxis|thromboprophylaxis
166093|NCT03158792|Anti-Xa levels|anti-xa levels
166094|NCT03158792|Elderly|elderly
166095|NCT03158792|Prevention|prevention
166096|NCT03158792|Enoxaparin|enoxaparin
166097|NCT03158792|Low molecular weight heparin|low molecular weight heparin
166098|NCT03158766|infection|infection
166099|NCT03158766|intervertebral disc|intervertebral disc
166100|NCT03158766|Propionibacterium acnes|propionibacterium acnes
166101|NCT03158766|spine|spine
166102|NCT03158727|intensive care|intensive care
166103|NCT03158701|evaluation|evaluation
166104|NCT03158675|fractional co2 laser, topical steroid,UVB narrow band|fractional co2 laser, topical steroid,uvb narrow band
166105|NCT03158662|Epidermolysis Bullosa|epidermolysis bullosa
166106|NCT03158662|Recessive Dystrophic|recessive dystrophic
166107|NCT03158662|Simplex|simplex
166108|NCT03158662|Junctional Non-Herlitz|junctional non-herlitz
166109|NCT03158649|Pregnancy|pregnancy
166110|NCT03158649|Prenatal well-being|prenatal well-being
166111|NCT03158649|Mental maternal prenatal well-being|mental maternal prenatal well-being
166112|NCT03158649|Positive Psychology|positive psychology
166113|NCT03158649|Positive Psychology Intervention|positive psychology intervention
166114|NCT03158649|Web-based intervention|web-based intervention
166115|NCT03158623|total joint arthroplasty|total joint arthroplasty
166116|NCT03158623|platelet-rich plasma|platelet-rich plasma
166117|NCT03158623|activated collagen|activated collagen
166118|NCT03158571|Gastric Cancer|gastric cancer
166119|NCT03158571|gastric adenocarcinoma|gastric adenocarcinoma
166120|NCT03158571|cancer subtypes|cancer subtypes
166121|NCT03158571|prognosis|prognosis
166122|NCT03158571|survival|survival
166123|NCT03158571|molecular classification|molecular classification
166124|NCT03158571|chemotherapy|chemotherapy
166125|NCT03158571|immunotherapy|immunotherapy
166126|NCT03158519|Physical activity|physical activity
166127|NCT03158480|DC-CIK|dc-cik
166128|NCT03158480|interferon|interferon
166129|NCT03158441|MRI|mri
166130|NCT03158441|Diffusion|diffusion
166131|NCT03158441|DTI|dti
166132|NCT03158415|mHealth|mhealth
166133|NCT03158402|Inspiratory muscle training|inspiratory muscle training
166134|NCT03158402|Systemic Inflammatory Response Syndrome|systemic inflammatory response syndrome
166135|NCT03158389|MGMT methylation|mgmt methylation
166136|NCT03158389|targeted therapy|targeted therapy
166137|NCT03158389|umbrella protocol|umbrella protocol
166138|NCT03158376|gabapentin|gabapentin
166139|NCT03158376|thoracotomy|thoracotomy
166140|NCT03158376|chronic post-thoracotomy pain|chronic post-thoracotomy pain
166141|NCT03158376|acute post-thoracotomy pain|acute post-thoracotomy pain
166142|NCT03158376|quality of life|quality of life
166143|NCT03158376|neuropathic pain|neuropathic pain
166144|NCT03158363|immobilization|immobilization
166145|NCT03158363|fasting|fasting
166146|NCT03158363|endotoxemia|endotoxemia
166147|NCT03158363|LPS|lps
166148|NCT03158363|metabolism|metabolism
166149|NCT03158363|model of disease|model of disease
166150|NCT03158337|Exercise|exercise
166151|NCT03158337|Physical Activity|physical activity
166152|NCT03158337|Brain blood flow|brain blood flow
166153|NCT03158337|Cognition|cognition
166154|NCT03158337|Fitness|fitness
166155|NCT03158311|QVM149|qvm149
166156|NCT03158311|asthma|asthma
166157|NCT03158311|adult|adult
166158|NCT03158259|IS|is
166159|NCT03158259|ICH|ich
166160|NCT03158259|rtPa|rtpa
166161|NCT03158259|Prehospital|prehospital
166162|NCT03158259|MSU|msu
166163|NCT03158246|zoledronic acid|zoledronic acid
166164|NCT03158246|Yigu|yigu
166165|NCT03158246|Aclasta|aclasta
166166|NCT03158246|Osteoporosis|osteoporosis
166167|NCT03158246|Postmenopausal|postmenopausal
166168|NCT03158246|BMD|bmd
166169|NCT03158246|fracture|fracture
166170|NCT03158246|Biochemical markers|biochemical markers
166171|NCT03158233|Zika virus disease|zika virus disease
166172|NCT03158194|Anxiety|anxiety
166173|NCT03158194|Stress|stress
166174|NCT03158194|Asthma|asthma
166175|NCT03158181|Behavior; Operational block; Monitoring; Social Sciences ; New technologies|behavior; operational block; monitoring; social sciences ; new technologies
166176|NCT03158116|tracheostomy tube|tracheostomy tube
166178|NCT03158103|MEK162 (Binimetinib)|mek162 (binimetinib)
166179|NCT03158103|Pexidartinib|pexidartinib
166180|NCT03158103|17-056|17-056
166181|NCT03158090|Acromegaly|acromegaly
166182|NCT03158064|17-160|17-160
166183|NCT03158064|durvalumab|durvalumab
166184|NCT03158064|tremelimumab|tremelimumab
166185|NCT03158064|MEDI4736|medi4736
166186|NCT03158051|Hypertension|hypertension
166187|NCT03158051|Young Adult|young adult
166188|NCT03158051|Self-Management|self-management
166189|NCT03158051|Health coach|health coach
166190|NCT03158038|Trivalent|trivalent
166191|NCT03158038|Influenza|influenza
166192|NCT03158038|FluMist Quadrivalent|flumist quadrivalent
166193|NCT03158038|Vaccine|vaccine
166194|NCT03158038|Prevention|prevention
166195|NCT03158038|Healthy|healthy
166196|NCT03158038|Monovalent|monovalent
166197|NCT03158025|Recreational sedatives|recreational sedatives
166198|NCT03158025|Healthy participants|healthy participants
166199|NCT03158025|Lemborexant|lemborexant
166200|NCT03158025|E2006|e2006
166201|NCT03158025|Zolpidem|zolpidem
166202|NCT03158025|Suvorexant|suvorexant
166203|NCT03157999|Older Adults|older adults
166204|NCT03157999|Transitional Care|transitional care
166205|NCT03157999|Caregiver|caregiver
166206|NCT03157999|Intervention|intervention
166207|NCT03157986|COPD|copd
166208|NCT03157986|Balance|balance
166209|NCT03157986|Whole Body Vibration Training|whole body vibration training
166210|NCT03157986|pulmonary rehabilitation|pulmonary rehabilitation
166211|NCT03157986|exercise|exercise
166212|NCT03157973|Information Literacy|information literacy
166213|NCT03157973|Nursing Care|nursing care
166214|NCT03157973|Social Support|social support
166215|NCT03157960|Fructose|fructose
166216|NCT03157960|Uric acid|uric acid
166217|NCT03157960|Oxidised LDL|oxidised ldl
166218|NCT03157960|Interleukin 6|interleukin 6
166219|NCT03157947|decision aid|decision aid
166220|NCT03157947|focus group|focus group
166221|NCT03157934|stroke network|stroke network
166222|NCT03157934|acute stroke care|acute stroke care
166223|NCT03157934|emergency medical services|emergency medical services
166224|NCT03157934|integrated care|integrated care
166225|NCT03157908|South Africa|south africa
166226|NCT03157908|Retention in care|retention in care
166227|NCT03157908|Pregnancy|pregnancy
166228|NCT03157908|Mobile health|mobile health
166229|NCT03157895|Foster Families|foster families
166230|NCT03157882|pediatric|pediatric
166231|NCT03157882|children|children
166232|NCT03157882|Faces Pain Scale Revised|faces pain scale revised
166233|NCT03157882|Wong Baker FACES|wong baker faces
166234|NCT03157882|pain scales|pain scales
166235|NCT03157882|BRIGANCE|brigance
166236|NCT03157869|Learning, Automatism, Motor Activity, Electric Stimulation|learning, automatism, motor activity, electric stimulation
166237|NCT03157856|Fluorescence imaging technique|fluorescence imaging technique
166238|NCT03157856|Biopsies from resected prostate|biopsies from resected prostate
166239|NCT03157856|Medical device|medical device
166240|NCT03157830|Multiple Sclerosis|multiple sclerosis
166241|NCT03157830|MS|ms
166242|NCT03157830|ocrelizumab|ocrelizumab
166243|NCT03157830|OCREVUS|ocrevus
166244|NCT03157830|Natalizumab|natalizumab
166245|NCT03157830|Tysabri|tysabri
166246|NCT03157791|simethicone|simethicone
166247|NCT03157778|pregnenolone|pregnenolone
166248|NCT03157778|endocannabinoid|endocannabinoid
166249|NCT03157778|food intake|food intake
166250|NCT03157778|type-1 cannabinoid receptor|type-1 cannabinoid receptor
166251|NCT03157765|recurrent implantation failure|recurrent implantation failure
166252|NCT03157765|frozen embryo transfer|frozen embryo transfer
166253|NCT03157765|IVF|ivf
166254|NCT03157765|endometrial scratch|endometrial scratch
166255|NCT03157765|endometrial injury|endometrial injury
166256|NCT03157739|Migraine|migraine
166257|NCT03157726|benign prostatic hyperplasia|benign prostatic hyperplasia
166258|NCT03157726|multicenter randomized control clinical trial|multicenter randomized control clinical trial
166259|NCT03157726|transurethral plasmakinetic enucleation of prostate|transurethral plasmakinetic enucleation of prostate
166260|NCT03157726|transurethral resection of prostate|transurethral resection of prostate
166261|NCT03157713|Obesity|obesity
166262|NCT03157713|Weight-loss|weight-loss
166263|NCT03157713|Financial Incentives|financial incentives
166264|NCT03157713|Behavioral Economics|behavioral economics
166265|NCT03157648|Shivering temperature|shivering temperature
166266|NCT03157622|Chronic Low Back Pain|chronic low back pain
166267|NCT03157622|Cognitive-Behavioural Therapy|cognitive-behavioural therapy
166268|NCT03157622|Exposure|exposure
166269|NCT03157622|Therapeutic processes|therapeutic processes
166270|NCT03157622|Single-case study|single-case study
166271|NCT03157609|Thermometry|thermometry
166272|NCT03157609|SpotOn|spoton
166273|NCT03157596|disability|disability
166274|NCT03157596|developmental disability|developmental disability
166275|NCT03157596|special healthcare needs|special healthcare needs
166276|NCT03157557|Treatment|treatment
166277|NCT03157557|Sheltered Housing|sheltered housing
166278|NCT03157544|Chronic Neck Pain|chronic neck pain
166279|NCT03157544|Chronic Back Pain|chronic back pain
166280|NCT03157544|non-pharmacological|non-pharmacological
166281|NCT03157544|pain relief|pain relief
166282|NCT03157518|Asthma|asthma
166283|NCT03157518|obesity|obesity
166284|NCT03157518|micorbiome|micorbiome
166285|NCT03157518|probiotics|probiotics
166286|NCT03157492|Adult|adult
166287|NCT03157492|Post-lingual|post-lingual
166288|NCT03157492|Auditory training|auditory training
166289|NCT03157492|Communication strategies|communication strategies
166290|NCT03157492|Speech tracking|speech tracking
166291|NCT03157492|Speech recognition|speech recognition
166292|NCT03157492|Quality of Life|quality of life
166293|NCT03157479|Mechanical ventilation|mechanical ventilation
166294|NCT03157453|Evaluation scale|evaluation scale
166295|NCT03157453|Brain injury|brain injury
166296|NCT03157453|Severity of Brain Injury|severity of brain injury
166297|NCT03157453|Initial Evaluation|initial evaluation
166298|NCT03157427|Solar Lentigo, Cryotherapy, Difluoroethane|solar lentigo, cryotherapy, difluoroethane
166299|NCT03157388|inflammation|inflammation
166300|NCT03157388|Macrophages|macrophages
166301|NCT03157388|CD163|cd163
166302|NCT03157375|IOL, IOL Rotation, Axial Rotation|iol, iol rotation, axial rotation
166303|NCT03157349|Biofreeze|biofreeze
166304|NCT03157349|Acute Neck Pain|acute neck pain
166305|NCT03157349|Placebo|placebo
166306|NCT03157349|chiropractic|chiropractic
166307|NCT03157336|Cassava|cassava
166308|NCT03157336|Konzo|konzo
166309|NCT03157336|Cyanide|cyanide
166310|NCT03157336|Cyanate|cyanate
166311|NCT03157336|Thiocyanate|thiocyanate
166312|NCT03157336|Carbamoylation|carbamoylation
166313|NCT03157336|Isoprostanes|isoprostanes
166314|NCT03157336|Oxidative Damage|oxidative damage
166315|NCT03157323|Glycemic Index|glycemic index
166316|NCT03157323|Acute Lymphoblastic Leukemia|acute lymphoblastic leukemia
166317|NCT03157323|Dietary Change|dietary change
166318|NCT03157323|Pediatric Oncology|pediatric oncology
166319|NCT03157284|Lactobacillus, Probiotics|lactobacillus, probiotics
166320|NCT03157219|Heart failure|heart failure
166321|NCT03157219|Institutional level registry|institutional level registry
166322|NCT03157219|Systolic heart failure|systolic heart failure
166323|NCT03157219|Acute heart failure|acute heart failure
166324|NCT03157219|Heart failure India|heart failure india
166325|NCT03157193|Peri-Implantitis|peri-implantitis
166326|NCT03157193|Dental Implants|dental implants
166327|NCT03157193|Hyaluronic Acid|hyaluronic acid
166328|NCT03157193|Clinical Trial|clinical trial
166329|NCT03157167|Kaposi Sarcoma, KS, HIV|kaposi sarcoma, ks, hiv
166330|NCT03157154|Haemophilia|haemophilia
166331|NCT03157154|Atherosclerosis|atherosclerosis
166332|NCT03157154|Atrial fibrillation|atrial fibrillation
166333|NCT03157154|Antiplatelets|antiplatelets
166334|NCT03157154|Anticoagulant|anticoagulant
166335|NCT03157141|Ankle osteoarthritis|ankle osteoarthritis
166336|NCT03157141|total ankle replacement|total ankle replacement
166337|NCT03157141|ankle arthrodesis|ankle arthrodesis
166338|NCT03157141|kinematics|kinematics
166339|NCT03157141|kinetics|kinetics
166340|NCT03157141|plantar pressure measurements|plantar pressure measurements
166341|NCT03157141|functional compensatory adaptations|functional compensatory adaptations
166342|NCT03157128|LOXO-292|loxo-292
166343|NCT03157128|KIF5B-RET|kif5b-ret
166344|NCT03157128|M918T|m918t
166345|NCT03157128|CCDC6-RET|ccdc6-ret
166346|NCT03157128|RET-PTC1|ret-ptc1
166347|NCT03157128|NCOA4-RET|ncoa4-ret
166348|NCT03157128|RET-PTC|ret-ptc
166349|NCT03157128|RET-PTC3|ret-ptc3
166350|NCT03157128|RET-PTC4|ret-ptc4
166351|NCT03157128|PRKAR1A-RET|prkar1a-ret
166352|NCT03157128|RET-PTC2|ret-ptc2
166353|NCT03157128|GOLGA5-RET|golga5-ret
166354|NCT03157128|RET-PTC5|ret-ptc5
166355|NCT03157128|ERC1-RET|erc1-ret
166356|NCT03157128|KTN1-RET|ktn1-ret
166357|NCT03157128|RET-PTC8|ret-ptc8
166358|NCT03157128|HOOK3-RET|hook3-ret
166359|NCT03157128|PCM1-RET|pcm1-ret
166360|NCT03157128|TRIM24-RET|trim24-ret
166361|NCT03157128|RET-PTC6|ret-ptc6
166362|NCT03157128|TRIM27-RET|trim27-ret
166363|NCT03157128|TRIM33-RET|trim33-ret
166364|NCT03157128|RET-PTC7|ret-ptc7
166365|NCT03157128|AKAP13-RET|akap13-ret
166366|NCT03157128|FKBP15-RET|fkbp15-ret
166367|NCT03157128|SPECC1L-RET|specc1l-ret
166368|NCT03157128|TBL1XR1-RET|tbl1xr1-ret
166369|NCT03157128|BCR-RET|bcr-ret
166370|NCT03157128|FGRF1OP-RET|fgrf1op-ret
166371|NCT03157128|RFG8-RET|rfg8-ret
166372|NCT03157128|RET-PTC9|ret-ptc9
166373|NCT03157128|ACBD5-RET|acbd5-ret
166374|NCT03157128|MYH13-RET|myh13-ret
166375|NCT03157128|CUX1-RET|cux1-ret
166376|NCT03157128|KIAA1468-RET|kiaa1468-ret
166377|NCT03157128|FRMD4A-RET|frmd4a-ret
166378|NCT03157128|SQSTM1-RET|sqstm1-ret
166379|NCT03157128|AFAP1L2-RET|afap1l2-ret
166380|NCT03157128|PPFIBP2-RET|ppfibp2-ret
166381|NCT03157128|EML4-RET|eml4-ret
166382|NCT03157128|PARD3-RET|pard3-ret
166383|NCT03157128|G533C|g533c
166384|NCT03157128|C609F|c609f
166385|NCT03157128|C609G|c609g
166386|NCT03157128|C609R|c609r
166387|NCT03157128|C609S|c609s
166388|NCT03157128|C609Y|c609y
166389|NCT03157128|C611F|c611f
166391|NCT03157128|C611S|c611s
166392|NCT03157128|C611Y|c611y
166393|NCT03157128|C611W|c611w
166394|NCT03157128|C618F|c618f
166395|NCT03157128|C618R|c618r
166396|NCT03157128|C618S|c618s
166397|NCT03157128|C620F|c620f
166398|NCT03157128|C620R|c620r
166399|NCT03157128|C620S|c620s
166400|NCT03157128|C630R|c630r
166401|NCT03157128|C630Y|c630y
166402|NCT03157128|D631Y|d631y
166403|NCT03157128|C634F|c634f
166404|NCT03157128|C634G|c634g
166405|NCT03157128|C634R|c634r
166406|NCT03157128|C634S|c634s
166407|NCT03157128|C634W|c634w
166408|NCT03157128|C634Y|c634y
166409|NCT03157128|K666E|k666e
166410|NCT03157128|E768D|e768d
166411|NCT03157128|L790F|l790f
166412|NCT03157128|V804L|v804l
166413|NCT03157128|V804M|v804m
166414|NCT03157128|A883F|a883f
166415|NCT03157128|S891A|s891a
166416|NCT03157128|R912P|r912p
166417|NCT03157128|CLIP1-RET|clip1-ret
166418|NCT03157128|Y806C|y806c
166419|NCT03157128|RET fusion|ret fusion
166420|NCT03157128|RET alteration|ret alteration
166421|NCT03157128|RET mutation|ret mutation
166422|NCT03157128|RET rearrangement|ret rearrangement
166423|NCT03157128|RET translocation|ret translocation
166424|NCT03157128|Neoplasms by Site|neoplasms by site
166425|NCT03157128|Neoplasms|neoplasms
166426|NCT03157128|Non-Small Cell Lung Cancer|non-small cell lung cancer
166427|NCT03157128|Lung Neoplasms|lung neoplasms
166428|NCT03157128|Carcinoma, Non-Small-Cell Lung|carcinoma, non-small-cell lung
166429|NCT03157128|Cancer of Lung|cancer of lung
166430|NCT03157128|Cancer of the Lung|cancer of the lung
166431|NCT03157128|Lung Cancer|lung cancer
166432|NCT03157128|Neoplasms, Lung|neoplasms, lung
166433|NCT03157128|Neoplasms, Pulmonary|neoplasms, pulmonary
166434|NCT03157128|Pulmonary Cancer|pulmonary cancer
166435|NCT03157128|Pulmonary Neoplasms|pulmonary neoplasms
166436|NCT03157128|Respiratory Tract Neoplasms|respiratory tract neoplasms
166437|NCT03157128|Lung Diseases|lung diseases
166438|NCT03157128|Respiratory Tract Diseases|respiratory tract diseases
166439|NCT03157128|Carcinoma, Bronchogenic|carcinoma, bronchogenic
166440|NCT03157128|Bronchial Neoplasms|bronchial neoplasms
166441|NCT03157128|Medullary Thyroid Cancer|medullary thyroid cancer
166442|NCT03157128|Papillary Thyroid Cancer|papillary thyroid cancer
166443|NCT03157128|Thyroid Diseases|thyroid diseases
166444|NCT03157128|Thyroid Neoplasms|thyroid neoplasms
166445|NCT03157128|Cancer of the Thyroid|cancer of the thyroid
166446|NCT03157128|Cancer of Thyroid|cancer of thyroid
166447|NCT03157128|Neoplasms, Thyroid|neoplasms, thyroid
166448|NCT03157128|Thyroid Ademona|thyroid ademona
166449|NCT03157128|Thyroid Cancer|thyroid cancer
166450|NCT03157128|Thyroid Carcinoma|thyroid carcinoma
166451|NCT03157128|Endocrine System Diseases|endocrine system diseases
166452|NCT03157128|Endocrine Gland Neoplasms|endocrine gland neoplasms
166453|NCT03157128|Head and Neck Neoplasms|head and neck neoplasms
166454|NCT03157128|Thoracic Neoplasms|thoracic neoplasms
166455|NCT03157128|CNS tumor|cns tumor
166456|NCT03157128|Primary CNS tumor|primary cns tumor
166457|NCT03157128|Cancer of Colon|cancer of colon
166458|NCT03157128|Cancer of the Colon|cancer of the colon
166459|NCT03157128|Colon Cancer|colon cancer
166460|NCT03157128|Colon Neoplasms|colon neoplasms
166461|NCT03157128|Colonic Cancer|colonic cancer
166462|NCT03157128|Neoplasms, Colonic|neoplasms, colonic
166463|NCT03157128|Malignant tumor of Breast|malignant tumor of breast
166464|NCT03157128|Mammary Cancer|mammary cancer
166465|NCT03157128|Mammary Carcinoma, Human|mammary carcinoma, human
166466|NCT03157128|Mammary Neoplasm, Human|mammary neoplasm, human
166467|NCT03157128|Neoplasms, Breast|neoplasms, breast
166468|NCT03157128|Tumors, Breast|tumors, breast
166469|NCT03157128|Human Mammary Carcinoma|human mammary carcinoma
166470|NCT03157128|Malignant Neoplasm of Breast|malignant neoplasm of breast
166471|NCT03157128|Breast Carcinoma|breast carcinoma
166472|NCT03157128|Breast Tumors|breast tumors
166473|NCT03157128|Cancer of the Breast|cancer of the breast
166474|NCT03157128|Breast Neoplasms|breast neoplasms
166475|NCT03157128|Breast Cancer|breast cancer
166476|NCT03157128|RET Inhibitor|ret inhibitor
166477|NCT03157128|MTC|mtc
166478|NCT03157128|NSCLC|nsclc
166479|NCT03157115|Kinocardiography|kinocardiography
166480|NCT03157115|Cardiac contractility|cardiac contractility
166481|NCT03157115|Heart kinetic energy|heart kinetic energy
166482|NCT03157102|children|children
166483|NCT03157102|status asthmaticus|status asthmaticus
166484|NCT03157102|HFNC|hfnc
166485|NCT03157011|Primary Sjögren syndrome - Digestive symptoms|primary sjögren syndrome - digestive symptoms
166486|NCT03156998|CARE|care
166487|NCT03156998|Paediatric asthma|paediatric asthma
166488|NCT03156998|Compliance|compliance
166489|NCT03156998|Home nebulizer|home nebulizer
166490|NCT03156959|Eating disorders|eating disorders
166491|NCT03156959|Cognitive Behavioral Therapy|cognitive behavioral therapy
166492|NCT03156959|Eye Movement Desensitization and Processing|eye movement desensitization and processing
166493|NCT03156946|breastfeeding|breastfeeding
166494|NCT03156946|mother-to-mother support|mother-to-mother support
166495|NCT03156946|lactation consultant|lactation consultant
166496|NCT03156946|stepped wedge cluster randomized trial|stepped wedge cluster randomized trial
166497|NCT03156946|peer counseling|peer counseling
166498|NCT03156907|High dosage Buprenorphine (HDB)|high dosage buprenorphine (hdb)
166499|NCT03156907|Chronic pain|chronic pain
166500|NCT03156907|Analgesics opioids|analgesics opioids
166501|NCT03156907|Withdrawal symptoms|withdrawal symptoms
166502|NCT03156894|Graft Dysfunction|graft dysfunction
166503|NCT03156894|Primary Graft Dysfunction|primary graft dysfunction
166504|NCT03156894|heart transplant|heart transplant
166505|NCT03156894|heart failure|heart failure
166506|NCT03156894|Hemodynamic parameters|hemodynamic parameters
166507|NCT03156894|Incidence of PDG|incidence of pdg
166508|NCT03156855|efficacy|efficacy
166509|NCT03156855|safety|safety
166510|NCT03156855|H. pylori eradication|h. pylori eradication
166511|NCT03156842|Hypertension|hypertension
166512|NCT03156842|Dyslipidemia|dyslipidemia
166513|NCT03156842|Fimasartan|fimasartan
166514|NCT03156842|Rosuvastatin|rosuvastatin
166515|NCT03156829|splinting|splinting
166516|NCT03156829|steroid|steroid
166517|NCT03156829|cortisone|cortisone
166518|NCT03156829|trigger digit|trigger digit
166519|NCT03156816|Myocardial Infarction|myocardial infarction
166520|NCT03156816|STEMI|stemi
166521|NCT03156816|Inflammation|inflammation
166522|NCT03156816|Left ventricular remodeling|left ventricular remodeling
166523|NCT03156816|Colchicine|colchicine
166524|NCT03156816|CMR|cmr
166525|NCT03156790|recombinant L-Asparaginase|recombinant l-asparaginase
166526|NCT03156790|Spectrila®|spectrila®
166527|NCT03156790|Lymphoblastic Leukaemia|lymphoblastic leukaemia
166528|NCT03156790|BRALL 2014|brall 2014
166529|NCT03156777|Gastric cancer; Circulating tumor cells; Prognosis|gastric cancer; circulating tumor cells; prognosis
166530|NCT03156764|Qp/Qs ratio|qp/qs ratio
166531|NCT03156764|Pediatric congenital heart disease|pediatric congenital heart disease
166532|NCT03156751|Syphilis screening|syphilis screening
166533|NCT03156751|antenatal care|antenatal care
166534|NCT03156751|prenatal diagnosis|prenatal diagnosis
166535|NCT03156751|rapid diagnosis test|rapid diagnosis test
166536|NCT03156751|Burkina Faso|burkina faso
166537|NCT03156751|feasibility|feasibility
166538|NCT03156725|Iron Bioavailability|iron bioavailability
166539|NCT03156725|hepcidin|hepcidin
166540|NCT03156725|ferritin|ferritin
166541|NCT03156725|iron absorption|iron absorption
166542|NCT03156725|iron status|iron status
166543|NCT03156712|Anemia|anemia
166544|NCT03156712|Iron deficiency anemia|iron deficiency anemia
166545|NCT03156712|Iron fortification|iron fortification
166546|NCT03156712|ferrous sulfate|ferrous sulfate
166547|NCT03156712|aspergillus oryzae|aspergillus oryzae
166548|NCT03156712|iron supplementation|iron supplementation
166549|NCT03156712|AUC|auc
166550|NCT03156686|Acute Heart Failure|acute heart failure
166551|NCT03156686|Chronic Heart Failure|chronic heart failure
166552|NCT03156686|Home care services|home care services
166553|NCT03156686|Cost-Benefit Analysis|cost-benefit analysis
166554|NCT03156686|Quality of life|quality of life
166555|NCT03156634|Patient education|patient education
166556|NCT03156634|Internet|internet
166557|NCT03156608|External Fetal Heart Rate Monitor|external fetal heart rate monitor
166558|NCT03156608|Fetal Heart Rate Monitor|fetal heart rate monitor
166559|NCT03156582|liver transplantation, hepatocellular carcinoma, alpha-foetoproteins, AFP|liver transplantation, hepatocellular carcinoma, alpha-foetoproteins, afp
166560|NCT03156569|saliva , dental , oral health|saliva , dental , oral health
166561|NCT03156530|Acupunture|acupunture
166562|NCT03156530|Acupunture Therapy|acupunture therapy
166563|NCT03156530|Acupunture Points|acupunture points
166564|NCT03156530|Acupunture Ear|acupunture ear
166565|NCT03156530|Postural Balance|postural balance
166566|NCT03156517|Treatment|treatment
166567|NCT03156517|Deep Brain Stimulation|deep brain stimulation
166568|NCT03156517|VIM Nucleus of the Thalamus|vim nucleus of the thalamus
166569|NCT03156517|Posterior Subthalamic Area|posterior subthalamic area
166570|NCT03156517|Zona Incerta|zona incerta
166571|NCT03156517|Efficacy|efficacy
166572|NCT03156517|Safety|safety
166573|NCT03156491|recurrent miscarriages (RM)|recurrent miscarriages (rm)
166574|NCT03156491|recurrent pregnancy loss (RPL)|recurrent pregnancy loss (rpl)
166575|NCT03156491|fetal-maternal interface|fetal-maternal interface
166576|NCT03156491|decidualization|decidualization
166577|NCT03156491|co-culture|co-culture
166578|NCT03156491|implantation|implantation
166579|NCT03156491|immune regulation|immune regulation
166580|NCT03156478|Prevention|prevention
166581|NCT03156478|Digital solutions|digital solutions
166582|NCT03156478|Type 2 diabetes|type 2 diabetes
166583|NCT03156478|Life style modification|life style modification
166584|NCT03156478|Physical activity|physical activity
166585|NCT03156478|Healthy diet|healthy diet
166586|NCT03156478|Health economics|health economics
166587|NCT03156478|Environmental choice architecture|environmental choice architecture
166588|NCT03156478|Socio-economic facilitators|socio-economic facilitators
166589|NCT03156478|Socio-economic barriers|socio-economic barriers
166590|NCT03156478|Wellbeing|wellbeing
166591|NCT03156387|diode laser|diode laser
166592|NCT03156387|scalpel surgery|scalpel surgery
166593|NCT03156387|frenectomy|frenectomy
166594|NCT03156387|postoperative complications|postoperative complications
166595|NCT03156348|Pharmaceutical intervention|pharmaceutical intervention
166596|NCT03156348|Older adult|older adult
166597|NCT03156348|Internal medicine|internal medicine
166598|NCT03156348|Adverse drug event|adverse drug event
166599|NCT03156322|cesarean section|cesarean section
166600|NCT03156322|combined spinal epidural anesthesia|combined spinal epidural anesthesia
166601|NCT03156322|patient controlled epidural analgesia|patient controlled epidural analgesia
166602|NCT03156322|postoperative pain|postoperative pain
166603|NCT03156296|transversus abdominis plane block , Dexmedetomidine|transversus abdominis plane block , dexmedetomidine
166604|NCT03156283|smartphone|smartphone
166605|NCT03156283|obstructive sleep apnea|obstructive sleep apnea
166606|NCT03156283|adherence|adherence
166607|NCT03156270|nasal valve|nasal valve
166608|NCT03156270|nasal airway obstruction|nasal airway obstruction
166609|NCT03156257|Microgravity Effects on Vascular Cells|microgravity effects on vascular cells
166611|NCT03156231|airway disease|airway disease
166612|NCT03156231|bronchitis|bronchitis
166613|NCT03156231|emphysema|emphysema
166614|NCT03156231|altitude|altitude
166615|NCT03156231|prevention|prevention
166616|NCT03156231|acetazolamide|acetazolamide
166617|NCT03156218|PaO2/FiO2 ratio, hyperoxia, mechanical ventilation, ARDS|pao2/fio2 ratio, hyperoxia, mechanical ventilation, ards
166618|NCT03156205|critically ill patients|critically ill patients
166619|NCT03156205|music therapy|music therapy
166620|NCT03156205|sleep|sleep
166621|NCT03156205|delirium|delirium
166622|NCT03156205|melatonin|melatonin
166623|NCT03156205|elderly|elderly
166624|NCT03156192|Caregivers|caregivers
166625|NCT03156192|Family-centered care|family-centered care
166626|NCT03156192|Music use|music use
166627|NCT03156192|Psycho-social benefits of music|psycho-social benefits of music
166628|NCT03156088|Predictors|predictors
166629|NCT03156088|Sacral neuromodulation|sacral neuromodulation
166630|NCT03156088|Outcomes|outcomes
166631|NCT03156088|Overactive bladder|overactive bladder
166632|NCT03156075|hip fracture, intervention, mortality, mobility|hip fracture, intervention, mortality, mobility
166633|NCT03156036|Temozolomide|temozolomide
166634|NCT03156036|Capecitabine|capecitabine
166635|NCT03156036|MGMT|mgmt
166636|NCT03156010|oculomotor testing|oculomotor testing
166637|NCT03155997|early stage breast cancer|early stage breast cancer
166638|NCT03155997|cyclin-dependent kinase (CDK)|cyclin-dependent kinase (cdk)
166639|NCT03155971|Drug-Coated Balloon|drug-coated balloon
166640|NCT03155971|Main Coronary Artery|main coronary artery
166641|NCT03155971|De Novo Lesion|de novo lesion
166642|NCT03155919|taurine|taurine
166643|NCT03155919|triathletes|triathletes
166644|NCT03155919|oxidative stress|oxidative stress
166645|NCT03155919|chocolate milk|chocolate milk
166646|NCT03155906|Chronic hepatitis C|chronic hepatitis c
166647|NCT03155906|Opiate Substitution Treatment|opiate substitution treatment
166648|NCT03155906|Integrated Delivery of Health Care|integrated delivery of health care
166649|NCT03155906|Substance Abuse Treatment Centers|substance abuse treatment centers
166650|NCT03155841|Prevention|prevention
166651|NCT03155841|Internet|internet
166652|NCT03155841|Adolescence|adolescence
166653|NCT03155841|LGBT|lgbt
166654|NCT03155841|Sexuality|sexuality
166655|NCT03155828|PCOS, OSA, CPAP|pcos, osa, cpap
166656|NCT03155763|kidney transplantation|kidney transplantation
166657|NCT03155763|implantation biopsy|implantation biopsy
166658|NCT03155763|histology|histology
166659|NCT03155763|allograft function|allograft function
166660|NCT03155763|allograft survival|allograft survival
166661|NCT03155750|insomnia|insomnia
166662|NCT03155737|Knee Osteoarthritis|knee osteoarthritis
166663|NCT03155685|antipsychotic|antipsychotic
166664|NCT03155685|palliative care|palliative care
166665|NCT03155659|Fish|fish
166666|NCT03155659|Polyunsaturated fatty acids|polyunsaturated fatty acids
166667|NCT03155659|Mortality|mortality
166668|NCT03155659|CHNS|chns
166669|NCT03155659|NHANES|nhanes
166670|NCT03155646|TAP block|tap block
166671|NCT03155646|Dexmedetomidine|dexmedetomidine
166672|NCT03155646|Clonidine|clonidine
166673|NCT03155633|Marathon, runners, biomarkers, recovery|marathon, runners, biomarkers, recovery
166674|NCT03155594|Diabetes|diabetes
166675|NCT03155594|Diabetes Mellitus|diabetes mellitus
166676|NCT03155594|Diabetes Type 1|diabetes type 1
166677|NCT03155594|Diabetes Type 2|diabetes type 2
166678|NCT03155594|CGM|cgm
166679|NCT03155594|Continuous Glucose Monitoring|continuous glucose monitoring
166680|NCT03155594|Inpatient|inpatient
166681|NCT03155594|Outpatient|outpatient
166682|NCT03155594|Transition of care|transition of care
166683|NCT03155594|DM-1|dm-1
166684|NCT03155594|DM-2|dm-2
166685|NCT03155594|Freestyle Libre|freestyle libre
166686|NCT03155555|Fluid Responsiveness|fluid responsiveness
166687|NCT03155555|Pediatric surgery|pediatric surgery
166688|NCT03155555|General endotracheal anaesthesia|general endotracheal anaesthesia
166689|NCT03155542|alcohol|alcohol
166690|NCT03155542|gene polymorphisms|gene polymorphisms
166691|NCT03155542|Colorectal cancer|colorectal cancer
166692|NCT03155529|cervical cancer|cervical cancer
166693|NCT03155529|radical hysterectomy|radical hysterectomy
166694|NCT03155529|Postoperative pelvic floor dysfunction|postoperative pelvic floor dysfunction
166695|NCT03155529|the injure of pelvic floor|the injure of pelvic floor
166696|NCT03155529|Three-dimensional reconstruction|three-dimensional reconstruction
166697|NCT03155529|structural destruction of pelvic organs|structural destruction of pelvic organs
166698|NCT03155529|structural destruction of pelvoic floor|structural destruction of pelvoic floor
166699|NCT03155516|Cancer pain|cancer pain
166700|NCT03155516|GPM|gpm
166701|NCT03155516|pain assessment|pain assessment
166702|NCT03155503|SUVN-911|suvn-911
166703|NCT03155503|Depression|depression
166704|NCT03155503|single dose|single dose
166705|NCT03155503|multiple dose|multiple dose
166706|NCT03155503|alpha4 beta2 receptor|alpha4 beta2 receptor
166707|NCT03155503|first in human|first in human
166708|NCT03155503|safety|safety
166709|NCT03155503|pharmacokinetics|pharmacokinetics
166710|NCT03155503|tolerability|tolerability
166711|NCT03155490|Hospital medical emergency team|hospital medical emergency team
166712|NCT03155490|Leadership|leadership
166713|NCT03155490|Simulation training|simulation training
166714|NCT03155477|SLE, vitamin D, SLEDAI, IL-6, TGF- β1|sle, vitamin d, sledai, il-6, tgf- β1
166715|NCT03155464|indocyanine-green|indocyanine-green
166716|NCT03155464|systemic scerlosis|systemic scerlosis
166717|NCT03155438|Oxidative stress|oxidative stress
166718|NCT03155438|Cumulus cell|cumulus cell
166719|NCT03155438|Controlled ovarian hyperstimulation|controlled ovarian hyperstimulation
166720|NCT03155438|In vitro fertilization|in vitro fertilization
166721|NCT03155438|Low responder|low responder
166722|NCT03155412|Type 2 Diabetes|type 2 diabetes
166723|NCT03155412|adipose tissue|adipose tissue
166724|NCT03155412|preadipocytes|preadipocytes
166725|NCT03155412|expandability|expandability
166726|NCT03155412|hypertrophy|hypertrophy
166727|NCT03155412|hyperplasia|hyperplasia
166728|NCT03155412|lipogenesis|lipogenesis
166729|NCT03155412|adipogenesis|adipogenesis
166730|NCT03155412|insulin sensitivity|insulin sensitivity
166731|NCT03155399|Stroke|stroke
166732|NCT03155399|Neurorehabilitation|neurorehabilitation
166733|NCT03155399|Proprioceptive Training|proprioceptive training
166734|NCT03155399|Bilateral Arm Training|bilateral arm training
166735|NCT03155399|Intracortical Inhibition|intracortical inhibition
166736|NCT03155373|Cardiopulmonary exercise testing|cardiopulmonary exercise testing
166737|NCT03155360|Colics|colics
166738|NCT03155360|infant colics|infant colics
166739|NCT03155360|Migraine equivalent|migraine equivalent
166740|NCT03155360|Migraine|migraine
166741|NCT03155360|Episodic symptoms associated to migraine|episodic symptoms associated to migraine
166742|NCT03155360|Colic|colic
166743|NCT03155334|Multiple Sclerosis; Patient Information Sheet; User Testing|multiple sclerosis; patient information sheet; user testing
166744|NCT03155256|EUS, cyanoacrylate, coils, gastric varices|eus, cyanoacrylate, coils, gastric varices
166745|NCT03155243|Humira®|humira®
166746|NCT03155243|Adalimumab|adalimumab
166747|NCT03155243|Ocular inflammation|ocular inflammation
166748|NCT03155243|Active non-infectious intermediate, posterior and panuveitis|active non-infectious intermediate, posterior and panuveitis
166749|NCT03155230|Inguinal hernia|inguinal hernia
166750|NCT03155217|melanoma|melanoma
166751|NCT03155217|elderly|elderly
166752|NCT03155217|tolerance|tolerance
166753|NCT03155217|adverse effects|adverse effects
166754|NCT03155217|targeted therapies|targeted therapies
166755|NCT03155204|inhalation|inhalation
166756|NCT03155204|LABA|laba
166757|NCT03155204|corticosteroid|corticosteroid
166758|NCT03155191|Acute lymphoblastic leukemia|acute lymphoblastic leukemia
166759|NCT03155191|Leukemia|leukemia
166760|NCT03155191|Lymphoblastic|lymphoblastic
166761|NCT03155191|TBI-1501|tbi-1501
166762|NCT03155191|Anti-CD19 CAR Expressing T cells Therapy|anti-cd19 car expressing t cells therapy
166763|NCT03155191|CD19 CAR Gene-Transduced Lymphocyte|cd19 car gene-transduced lymphocyte
166764|NCT03155191|Adoptive Immunotherapy|adoptive immunotherapy
166765|NCT03155191|Genetically Engineered Lymphocyte Therapy|genetically engineered lymphocyte therapy
166766|NCT03155191|Retroviral Vector|retroviral vector
166767|NCT03155191|Neoplasms by Histologic Type|neoplasms by histologic type
166768|NCT03155191|Neoplasms|neoplasms
166769|NCT03155191|Neoplasms, Experimental|neoplasms, experimental
166770|NCT03155191|Immune System Diseases|immune system diseases
166771|NCT03155191|Chimeric antigen receptor|chimeric antigen receptor
166772|NCT03155165|Colonoscopy, Retroview™ colonoscope, retrofex colonoscopy|colonoscopy, retroview™ colonoscope, retrofex colonoscopy
166773|NCT03155139|prevalence|prevalence
166774|NCT03155139|primary aldosteronism|primary aldosteronism
166775|NCT03155139|hypertension|hypertension
166776|NCT03155139|nationwide|nationwide
166777|NCT03155126|shock|shock
166778|NCT03155126|acute kidney injury|acute kidney injury
166779|NCT03155126|crystalloid|crystalloid
166780|NCT03155113|Chronic infection|chronic infection
166781|NCT03155113|HCV|hcv
166782|NCT03155113|DAA therapy|daa therapy
166783|NCT03155113|immune response|immune response
166784|NCT03155087|T2DM|t2dm
166785|NCT03155087|genetic polymorphism|genetic polymorphism
166786|NCT03155087|diabetic nephropathy|diabetic nephropathy
166787|NCT03155035|deworming|deworming
166788|NCT03155035|STH|sth
166789|NCT03155022|ST-elevation myocardial infarction|st-elevation myocardial infarction
166790|NCT03154996|Gliomas|gliomas
166791|NCT03154996|Recurrent|recurrent
166792|NCT03154996|Chronic Convection|chronic convection
166793|NCT03154996|High Grade Gliomas|high grade gliomas
166794|NCT03154983|Mesylate Apatinib|mesylate apatinib
166795|NCT03154983|The First-line Treatment|the first-line treatment
166796|NCT03154983|Metastatic Gastric Cancer|metastatic gastric cancer
166797|NCT03154970|Physical Therapy Specialty|physical therapy specialty
166798|NCT03154931|PTSD|ptsd
166799|NCT03154931|CBT|cbt
166800|NCT03154931|CFT|cft
166801|NCT03154931|compassion|compassion
166802|NCT03154931|shame|shame
166803|NCT03154931|guilty|guilty
166804|NCT03154931|self-criticism|self-criticism
166805|NCT03154879|Heart arrest|heart arrest
166806|NCT03154879|Hypothermia|hypothermia
166807|NCT03154879|EEG|eeg
166808|NCT03154879|Prognosis|prognosis
166809|NCT03154866|Lactobacillus kefiri LKF01 DSM32079|lactobacillus kefiri lkf01 dsm32079
166810|NCT03154866|Microbial Colonization|microbial colonization
166811|NCT03154853|Electromyography,Excessive Foot Pronation,exercise,neurology,physical therapy|electromyography,excessive foot pronation,exercise,neurology,physical therapy
166812|NCT03154814|ulinastatin|ulinastatin
166813|NCT03154814|cardiopulmonary bypass|cardiopulmonary bypass
166814|NCT03154814|cardiac surgery|cardiac surgery
166815|NCT03154788|Falls prevention|falls prevention
166816|NCT03154788|Community-Based Participatory Research|community-based participatory research
166817|NCT03154749|Neoadjuvant chemotherapy|neoadjuvant chemotherapy
166818|NCT03154749|Triple-Negative Breast Cancer|triple-negative breast cancer
166819|NCT03154736|CVD|cvd
166820|NCT03154736|FDRCV|fdrcv
166821|NCT03154736|Developing countries|developing countries
166822|NCT03154736|Rcih countries|rcih countries
166823|NCT03154710|Web-mediated follow up|web-mediated follow up
166824|NCT03154710|Lymphoma|lymphoma
166825|NCT03154710|Personalized medicine|personalized medicine
166826|NCT03154684|Autonomy|autonomy
166827|NCT03154684|Rehabilitation|rehabilitation
166828|NCT03154684|Falls|falls
166829|NCT03154684|Quality of life|quality of life
166830|NCT03154684|Senior|senior
166831|NCT03154671|older adult;|older adult;
166832|NCT03154671|comprehensive geriatric assessment|comprehensive geriatric assessment
166833|NCT03154671|chemotherapy|chemotherapy
166834|NCT03154671|integrated care|integrated care
166835|NCT03154671|randomized controlled trial|randomized controlled trial
166836|NCT03154632|Myofascial trigger point|myofascial trigger point
166837|NCT03154632|Trapezius Muscle|trapezius muscle
166838|NCT03154632|Diathermy|diathermy
166839|NCT03154632|Ultrasound|ultrasound
166840|NCT03154593|Prevalence|prevalence
166841|NCT03154541|Chronic Rhinosinusitis (CRS), Cystic Fibrosis related CRS|chronic rhinosinusitis (crs), cystic fibrosis related crs
166842|NCT03154515|Respiratory Tract Infections|respiratory tract infections
166843|NCT03154515|Acute Respiratory Viral Infection|acute respiratory viral infection
166844|NCT03154502|Sodium intake|sodium intake
166845|NCT03154502|Urinary sodium excretion|urinary sodium excretion
166846|NCT03154411|ABY-029|aby-029
166847|NCT03154411|Affibody|affibody
166848|NCT03154411|molecular fluorescence-guided surgery|molecular fluorescence-guided surgery
166849|NCT03154411|Epidermal Growth Factor Receptor (EGFR)|epidermal growth factor receptor (egfr)
166850|NCT03154398|evaluation of thyroid function in diabetes patients|evaluation of thyroid function in diabetes patients
166851|NCT03154385|ITP|itp
166852|NCT03154346|Baseline|baseline
166853|NCT03154346|Project Baseline|project baseline
166854|NCT03154346|Baseline Study|baseline study
166855|NCT03154346|Project Baseline Study|project baseline study
166856|NCT03154333|Epidermolysis|epidermolysis
166857|NCT03154333|bullosa|bullosa
166858|NCT03154333|simplex|simplex
166859|NCT03154333|EBS|ebs
166860|NCT03154281|Breast|breast
166861|NCT03154281|Ovarian|ovarian
166862|NCT03154268|Gestational weight gain|gestational weight gain
166863|NCT03154268|Chinese pregnant women|chinese pregnant women
166864|NCT03154268|Retrospective longitudinal study|retrospective longitudinal study
166865|NCT03154268|China|china
166866|NCT03154268|IOM guideline|iom guideline
166867|NCT03154268|Adverse outcome|adverse outcome
166868|NCT03154268|Model|model
166869|NCT03154255|Obesity|obesity
166870|NCT03154255|Paediatric|paediatric
166871|NCT03154255|Mediterranean diet|mediterranean diet
166872|NCT03154255|Gamification|gamification
166873|NCT03154255|Insulin-resistance|insulin-resistance
166874|NCT03154242|non small cell lung cancer|non small cell lung cancer
166875|NCT03154242|NSCLC|nsclc
166876|NCT03154242|Platinum|platinum
166877|NCT03154151|PTSD|ptsd
166878|NCT03154151|Post-Traumatic Stress Disorder|post-traumatic stress disorder
166879|NCT03154151|Post-Traumatic Stress Disorder symptoms|post-traumatic stress disorder symptoms
166880|NCT03154151|World Trade Center|world trade center
166881|NCT03154151|9/11|9/11
166882|NCT03154151|first responder|first responder
166883|NCT03154151|rescue/recovery/clean-up worker|rescue/recovery/clean-up worker
166884|NCT03154151|trauma|trauma
166885|NCT03154151|9/11 survivor|9/11 survivor
166886|NCT03154138|Stroke|stroke
166887|NCT03154138|hemiplegia|hemiplegia
166888|NCT03154138|rehabilitation|rehabilitation
166889|NCT03154138|prismatic adaptation|prismatic adaptation
166890|NCT03154138|postural imbalance|postural imbalance
166891|NCT03154138|posture|posture
166892|NCT03154138|spatial cognition|spatial cognition
166893|NCT03154099|CIRCI|circi
166894|NCT03154086|REarranged during Transfection|rearranged during transfection
166895|NCT03154073|Exercise|exercise
166896|NCT03154073|Physical activity|physical activity
166897|NCT03154073|Blood glucose|blood glucose
166898|NCT03154073|Sleep|sleep
166899|NCT03154060|Flash glucose monitoring|flash glucose monitoring
166900|NCT03154060|Accuracy|accuracy
166901|NCT03154060|Precision|precision
166902|NCT03154034|Stress echocardiography|stress echocardiography
166903|NCT03154034|Cardiopulmonary exercise testing|cardiopulmonary exercise testing
166904|NCT03154034|ergospirometry|ergospirometry
166905|NCT03154021|Gingival Index|gingival index
166906|NCT03154021|Plaque Index|plaque index
166907|NCT03154021|Bleeding|bleeding
166908|NCT03154021|Pocket Depth|pocket depth
166909|NCT03154008|reward|reward
166910|NCT03154008|emotion regulation|emotion regulation
166911|NCT03154008|electroencephalogram|electroencephalogram
166912|NCT03154008|event-related potentials|event-related potentials
166913|NCT03154008|cognitive behavior therapy|cognitive behavior therapy
166914|NCT03153995|expander|expander
166915|NCT03153982|HNSCC|hnscc
166916|NCT03153956|AposTherapy® System|apostherapy® system
166917|NCT03153956|Osteoarthritis|osteoarthritis
166918|NCT03153956|Total knee arthroplasties|total knee arthroplasties
166919|NCT03153956|Degenerative joint disease|degenerative joint disease
166920|NCT03153930|sedentary behavior|sedentary behavior
166921|NCT03153930|youth|youth
166922|NCT03153930|moderating factors|moderating factors
166923|NCT03153930|metabolic outcomes|metabolic outcomes
166924|NCT03153917|shift work|shift work
166925|NCT03153917|melatonin|melatonin
166926|NCT03153917|sleep|sleep
166927|NCT03153904|anxiety|anxiety
166928|NCT03153904|depression|depression
166929|NCT03153904|trauma|trauma
166930|NCT03153904|behavior problems|behavior problems
166931|NCT03153904|evidence-based treatments|evidence-based treatments
166932|NCT03153904|manualized treatments|manualized treatments
166933|NCT03153904|cognitive-behavioral therapy|cognitive-behavioral therapy
166934|NCT03153904|youth|youth
166935|NCT03153904|mental health|mental health
166936|NCT03153891|environment|environment
166937|NCT03153891|nature|nature
166938|NCT03153878|Unruptured Intracranial Aneurysm|unruptured intracranial aneurysm
166939|NCT03153878|Benefit-risk|benefit-risk
166940|NCT03153878|Ischemic heart disease|ischemic heart disease
166941|NCT03153878|Ischemic cerebrovascular disease|ischemic cerebrovascular disease
166942|NCT03153878|Antithrombotic|antithrombotic
166943|NCT03153878|Anticoagulant|anticoagulant
166944|NCT03153878|People's Republic of China|people's republic of china
166945|NCT03153878|Multicenter Studies|multicenter studies
166946|NCT03153839|Children|children
166947|NCT03153839|Babies|babies
166948|NCT03153839|Infant|infant
166949|NCT03153839|Swimming pool|swimming pool
166950|NCT03153839|Aquatic physical activity|aquatic physical activity
166951|NCT03153839|Motor development|motor development
166952|NCT03153839|Neurodevelopment|neurodevelopment
166953|NCT03153826|COPD Exacerbation|copd exacerbation
166954|NCT03153826|Muscle atrophy|muscle atrophy
166955|NCT03153826|Inflammation|inflammation
166956|NCT03153826|Oxidative stress|oxidative stress
166957|NCT03153813|pain|pain
166958|NCT03153813|knee osteoarthritis|knee osteoarthritis
166959|NCT03153813|obesity|obesity
166960|NCT03153813|capsaicin|capsaicin
166961|NCT03153787|implantation failure|implantation failure
166962|NCT03153787|fertility|fertility
166963|NCT03153787|microbiome|microbiome
166964|NCT03153787|Assisted reproduction|assisted reproduction
166965|NCT03153774|Sarcopenia|sarcopenia
166966|NCT03153774|Heart failure (HF)|heart failure (hf)
166967|NCT03153774|The trans aortic valvular implantation (TAVI)|the trans aortic valvular implantation (tavi)
166968|NCT03153748|Treatment strategy|treatment strategy
166969|NCT03153735|Hyaluronic acid|hyaluronic acid
166970|NCT03153735|Small Penis|small penis
166971|NCT03153735|Penile Enhancement|penile enhancement
166972|NCT03153722|pediatric|pediatric
166973|NCT03153722|hospital discharge|hospital discharge
166974|NCT03153722|quality improvement|quality improvement
166975|NCT03153722|transition of care|transition of care
166976|NCT03153709|Pregnancy rates|pregnancy rates
166977|NCT03153709|pharmacokinetic interactions|pharmacokinetic interactions
166978|NCT03153709|Women on efavirenz|women on efavirenz
166979|NCT03153709|initiating the Levonorgestrel Implant|initiating the levonorgestrel implant
400595|NCT01866085|post prostatectomy|post prostatectomy
400596|NCT01866072|ACLF|aclf
166980|NCT03153709|initiating the Depot Medroxyprogesterone Acetate Injectable|initiating the depot medroxyprogesterone acetate injectable
166981|NCT03153683|Acute|acute
166982|NCT03153683|Ischemic|ischemic
166983|NCT03153683|Stroke|stroke
166984|NCT03153683|Biomarkers|biomarkers
166985|NCT03153683|Proteins|proteins
166986|NCT03153683|Leukocyte|leukocyte
166987|NCT03153683|Inflammatory Cells|inflammatory cells
166988|NCT03153683|Acid/Base Balance|acid/base balance
166989|NCT03153657|Tooth Bleaching|tooth bleaching
166990|NCT03153644|Qualitative Research|qualitative research
166991|NCT03153644|Medical conditions|medical conditions
166992|NCT03153644|Birth control methods|birth control methods
166993|NCT03153644|Intrauterine Devices|intrauterine devices
166994|NCT03153644|Physicians, Primary Care|physicians, primary care
166995|NCT03153644|Long-acting reversible contraceptives (LARC)|long-acting reversible contraceptives (larc)
166996|NCT03153540|Aphasia|aphasia
166997|NCT03153540|Agrammatism|agrammatism
166998|NCT03153540|Frontotemporal Dementia|frontotemporal dementia
166999|NCT03153540|Tauopathies|tauopathies
167000|NCT03153540|Neurodegenerative Diseases|neurodegenerative diseases
167001|NCT03153540|Language Disorders|language disorders
167002|NCT03153540|Frontotemporal Lobar Degeneration|frontotemporal lobar degeneration
167003|NCT03153514|CLL|cll
167004|NCT03153488|ADHD|adhd
167005|NCT03153488|Methylphenidate|methylphenidate
167006|NCT03153488|Amphetamine|amphetamine
167007|NCT03153488|Attention Deficit Hyperactivity Disorder|attention deficit hyperactivity disorder
167008|NCT03153488|Treatment|treatment
167009|NCT03153475|Revision knee surgery, implant replacement|revision knee surgery, implant replacement
167010|NCT03153449|complex primary, deformity, ligamentous laxity|complex primary, deformity, ligamentous laxity
167011|NCT03153410|Pancreas vaccine|pancreas vaccine
167012|NCT03153410|immunotherapy|immunotherapy
167013|NCT03153410|antibody|antibody
167014|NCT03153410|PD-1|pd-1
167015|NCT03153410|IMC-CS4|imc-cs4
167016|NCT03153410|Pembrolizumab|pembrolizumab
167017|NCT03153410|GVAX|gvax
167018|NCT03153410|Borderline Resectable|borderline resectable
167019|NCT03153397|trauma|trauma
167020|NCT03153397|brain|brain
167021|NCT03153397|neurological|neurological
167022|NCT03153397|injury|injury
167023|NCT03153397|enteral|enteral
167024|NCT03153397|tube|tube
167025|NCT03153397|feeding|feeding
167026|NCT03153397|nutrition|nutrition
167027|NCT03153384|Diagnosis|diagnosis
167028|NCT03153384|Blood Culture|blood culture
167029|NCT03153371|Alzheimer's disease|alzheimer's disease
167030|NCT03153371|Young-onset|young-onset
167031|NCT03153371|variant|variant
167032|NCT03153371|visuospatial|visuospatial
167033|NCT03153371|language|language
167034|NCT03153371|apraxia|apraxia
167035|NCT03153371|control|control
167036|NCT03153371|dementia|dementia
167037|NCT03153371|memory|memory
167038|NCT03153371|MRI|mri
167039|NCT03153371|neurology|neurology
167040|NCT03153371|neuropsychology|neuropsychology
167041|NCT03153371|brain|brain
167042|NCT03153358|EGFR mutation icotinib SBRT|egfr mutation icotinib sbrt
167043|NCT03153306|Albumin|albumin
167044|NCT03153293|LHON,G11778A mutation, rAAV2-ND4，gene therapy|lhon,g11778a mutation, raav2-nd4，gene therapy
167045|NCT03153254|Upper extremity|upper extremity
167046|NCT03153254|Rehabilitation|rehabilitation
167047|NCT03153254|Robot assisted therapy|robot assisted therapy
167048|NCT03153254|Robotics|robotics
167049|NCT03153254|Devices|devices
167050|NCT03153254|Orthosis|orthosis
167051|NCT03153228|E-cigarettes|e-cigarettes
167052|NCT03153202|Ibrutinib|ibrutinib
167053|NCT03153202|Pembrolizumab|pembrolizumab
167054|NCT03153202|Chronic Lymphocytic Leukemia|chronic lymphocytic leukemia
167055|NCT03153202|Mantle Cell Lymphoma|mantle cell lymphoma
167056|NCT03153189|PA,menatal health,QOL|pa,menatal health,qol
167057|NCT03153176|physical activity|physical activity
167058|NCT03153176|physical fitness|physical fitness
167059|NCT03153176|eating habits|eating habits
167060|NCT03153176|sedentary behavior|sedentary behavior
167061|NCT03153176|sleep quality|sleep quality
167062|NCT03153176|satisfaction personal|satisfaction personal
167063|NCT03153176|school health|school health
167064|NCT03153176|adolescent|adolescent
167065|NCT03153150|Oral anticoagulant|oral anticoagulant
167066|NCT03153150|Factor Xa inhibitors|factor xa inhibitors
167067|NCT03153150|Direct thrombin inhibitor|direct thrombin inhibitor
167068|NCT03153150|Vitamin K antagonist|vitamin k antagonist
167069|NCT03153150|Antiplatelet drug|antiplatelet drug
167070|NCT03153124|Respiratory muscle strength|respiratory muscle strength
167071|NCT03153124|Renal insufficiency|renal insufficiency
167072|NCT03153124|Respiratory muscle training|respiratory muscle training
167073|NCT03153098|physical activity|physical activity
167074|NCT03153098|intervention|intervention
167075|NCT03153098|behaviour change|behaviour change
167076|NCT03153098|inactive adults|inactive adults
167077|NCT03153098|behaviour change techniques|behaviour change techniques
167078|NCT03153098|well-being|well-being
167079|NCT03153085|Unresectable melanoma|unresectable melanoma
400597|NCT01866072|AVH|avh
213447|NCT02859415|Sarcoma|sarcoma
167080|NCT03153085|Metastatic melanoma|metastatic melanoma
167081|NCT03153085|Recurrent Melanoma|recurrent melanoma
167082|NCT03153085|TBI-1401(HF10)|tbi-1401(hf10)
167083|NCT03153085|HF10|hf10
167084|NCT03153085|HSV-1|hsv-1
167085|NCT03153085|Oncolytic virus|oncolytic virus
167086|NCT03153085|Oncolytic viral immunotherapy|oncolytic viral immunotherapy
167087|NCT03153085|Ipilimumab|ipilimumab
167088|NCT03153085|Intratumoral administration|intratumoral administration
167089|NCT03153085|canerpaturev|canerpaturev
167090|NCT03153059|gut microbiota|gut microbiota
167091|NCT03153059|stool frequency|stool frequency
167092|NCT03153046|prebiotics|prebiotics
167093|NCT03153046|cognitive impairment|cognitive impairment
167094|NCT03153046|weight gain|weight gain
167095|NCT03153033|Wheelchair propulsion|wheelchair propulsion
167096|NCT03153033|Shoulder|shoulder
167097|NCT03153033|Biomechanics|biomechanics
167098|NCT03152994|Chronic Obstructive Pulmonary Disease|chronic obstructive pulmonary disease
167099|NCT03152994|Type 2 Diabetes Mellitus|type 2 diabetes mellitus
167100|NCT03152994|neutrophil-lymphocyte ratio|neutrophil-lymphocyte ratio
167101|NCT03152994|platelet-lymphocyte ratio|platelet-lymphocyte ratio
167102|NCT03152994|lymphocyte-monocyte ratio|lymphocyte-monocyte ratio
167103|NCT03152968|FMS|fms
167104|NCT03152955|trigeminal neuralgia|trigeminal neuralgia
167105|NCT03152955|nerve block|nerve block
167106|NCT03152929|Surgery|surgery
167107|NCT03152929|Breast|breast
167108|NCT03152929|Pectoral Never Block|pectoral never block
167109|NCT03152929|Paravertebral Block|paravertebral block
167110|NCT03152929|Analgesia|analgesia
167111|NCT03152929|Mastectomy|mastectomy
167112|NCT03152916|subtalar joint|subtalar joint
167113|NCT03152916|arthrodesis|arthrodesis
167114|NCT03152916|3d printing|3d printing
167115|NCT03152903|Recombinant BCG vaccine|recombinant bcg vaccine
167116|NCT03152903|Category 1 pulmonary tuberculosis|category 1 pulmonary tuberculosis
167117|NCT03152903|Recurrence|recurrence
167118|NCT03152903|Efficacy|efficacy
167119|NCT03152890|Insulin|insulin
167120|NCT03152890|Liver transplantation|liver transplantation
167121|NCT03152890|Hyperglycemia|hyperglycemia
167122|NCT03152825|myocardial ischaemia|myocardial ischaemia
167123|NCT03152825|myocardial viability|myocardial viability
167124|NCT03152825|coronary chronic total occlusions|coronary chronic total occlusions
167125|NCT03152825|cardiac magnetic resonance|cardiac magnetic resonance
167126|NCT03152825|stress CMR|stress cmr
167127|NCT03152799|remote ischaemic conditioning|remote ischaemic conditioning
167128|NCT03152799|remote ischemic conditioning|remote ischemic conditioning
167129|NCT03152799|cerebral infarction|cerebral infarction
167130|NCT03152799|ischaemia reperfusion injury|ischaemia reperfusion injury
167131|NCT03152799|ischemia reperfusion injury|ischemia reperfusion injury
167132|NCT03152799|anterior circulation stroke|anterior circulation stroke
167133|NCT03152799|mechanical thrombectomy|mechanical thrombectomy
167134|NCT03152773|MRI Catheterization|mri catheterization
167135|NCT03152773|Real-time MRI|real-time mri
167136|NCT03152760|Alcoholism|alcoholism
167137|NCT03152760|Healthy Volunteers|healthy volunteers
167138|NCT03152760|Craving|craving
167139|NCT03152760|Gut|gut
167140|NCT03152734|Elderly patients, Mortality, morbidity, post-intervention|elderly patients, mortality, morbidity, post-intervention
167141|NCT03152721|accelerometry|accelerometry
167142|NCT03152721|home based|home based
167143|NCT03152721|motor complications|motor complications
167144|NCT03152721|Parkinson KinetiGraph|parkinson kinetigraph
167145|NCT03152721|Registry|registry
167146|NCT03152682|glucose|glucose
167147|NCT03152682|glucose homeostasis|glucose homeostasis
167148|NCT03152669|asthma|asthma
167149|NCT03152669|Chronic obstructive pulmonary disease|chronic obstructive pulmonary disease
167150|NCT03152669|Salford Lung Study|salford lung study
167151|NCT03152656|Familial hypercholesterolemia|familial hypercholesterolemia
167152|NCT03152656|total cholesterol|total cholesterol
167153|NCT03152656|low-density lipoprotein cholesterol|low-density lipoprotein cholesterol
167154|NCT03152656|tendon xanthomas|tendon xanthomas
167155|NCT03152656|premature atherosclerosis|premature atherosclerosis
167156|NCT03152643|Cumulative live birth rates|cumulative live birth rates
167157|NCT03152643|cleavage-stage embryo transfer|cleavage-stage embryo transfer
167158|NCT03152643|blastocyst transfer|blastocyst transfer
167159|NCT03152630|lncRNAs|lncrnas
167160|NCT03152630|Alzheimer's disease|alzheimer's disease
167161|NCT03152630|vascular dementia|vascular dementia
167162|NCT03152617|bariatric surgery|bariatric surgery
167163|NCT03152617|gastric bypass|gastric bypass
167164|NCT03152617|malnutrition|malnutrition
167165|NCT03152617|bone disease|bone disease
167166|NCT03152617|oral health|oral health
167167|NCT03152591|Polycystic ovary syndrome|polycystic ovary syndrome
167168|NCT03152591|PCOS|pcos
167169|NCT03152591|hyperandrogenism|hyperandrogenism
167170|NCT03152591|insulin resistance|insulin resistance
167171|NCT03152591|overweight|overweight
167172|NCT03152591|obesity|obesity
167173|NCT03152552|Diabetes mellitus|diabetes mellitus
167174|NCT03152552|LIK066|lik066
167175|NCT03152552|Obesity|obesity
167176|NCT03152552|Type 2 diabetes mellitus (T2DM)|type 2 diabetes mellitus (t2dm)
167177|NCT03152552|Heart Failure (HF)|heart failure (hf)
167178|NCT03152552|Hypertension|hypertension
167179|NCT03152552|Renal dysfunction|renal dysfunction
167180|NCT03152552|Adult-onset diabetes|adult-onset diabetes
167181|NCT03152552|Noninsulin-dependent diabetes mellitus (NIDDM)|noninsulin-dependent diabetes mellitus (niddm)
167182|NCT03152552|High blood sugar|high blood sugar
167183|NCT03152500|IOL|iol
167184|NCT03152500|Stability|stability
167185|NCT03152500|FEMTIS IOL|femtis iol
167186|NCT03152500|Acrysof IOL|acrysof iol
167187|NCT03152500|FLACS|flacs
167188|NCT03152500|Capsulotomy|capsulotomy
167189|NCT03152487|endoscopic ultrasound|endoscopic ultrasound
167190|NCT03152487|celiac plexus neurolysis|celiac plexus neurolysis
167191|NCT03152487|radiofrequency ablation|radiofrequency ablation
167192|NCT03152487|pancreatic cancer|pancreatic cancer
167193|NCT03152461|Viscoelastic testing|viscoelastic testing
167194|NCT03152461|Coagulation|coagulation
167195|NCT03152461|Quantra|quantra
167196|NCT03152461|Hemostasis|hemostasis
167197|NCT03152448|Prolaris|prolaris
167198|NCT03152448|Prostate Cancer|prostate cancer
167199|NCT03152409|Aspirin|aspirin
167200|NCT03152409|Treatment|treatment
167201|NCT03152409|Salicylic acid|salicylic acid
167202|NCT03152409|anti-inflammatory|anti-inflammatory
167203|NCT03152396|modifiable cardiovascular risk factors|modifiable cardiovascular risk factors
167204|NCT03152396|cardiovascular risk factors|cardiovascular risk factors
167205|NCT03152396|blood pressure|blood pressure
167206|NCT03152396|LDL-cholesterol|ldl-cholesterol
167207|NCT03152396|total-cholesterol|total-cholesterol
167208|NCT03152396|HDL-cholesterol|hdl-cholesterol
167209|NCT03152396|hemoglobin A1C|hemoglobin a1c
167210|NCT03152396|tobacco cessation|tobacco cessation
167211|NCT03152396|patient satisfaction|patient satisfaction
167212|NCT03152383|Autism Spectrum Disorder|autism spectrum disorder
167213|NCT03152383|Behavioral Research|behavioral research
167214|NCT03152383|Psychology|psychology
167215|NCT03152383|Cognitive Disorders|cognitive disorders
167216|NCT03152370|E7046|e7046
167217|NCT03152370|Radiotherapy/Chemoradiotherapy|radiotherapy/chemoradiotherapy
167218|NCT03152370|Neoadjuvant therapy|neoadjuvant therapy
167219|NCT03152370|Rectal cancer|rectal cancer
167220|NCT03152357|osteoarthritis|osteoarthritis
167221|NCT03152357|total knee arthroplasty|total knee arthroplasty
167222|NCT03152357|TKA|tka
167223|NCT03152357|TKR|tkr
167224|NCT03152357|patient specific|patient specific
167225|NCT03152357|Conformis|conformis
167226|NCT03152344|Fall|fall
167227|NCT03152344|Balance control|balance control
167228|NCT03152344|Screening test|screening test
167229|NCT03152344|Oxygen|oxygen
167230|NCT03152344|Skeletal muscle mass|skeletal muscle mass
167231|NCT03152331|Neurofeedback|neurofeedback
167232|NCT03152318|Malignant Glioma|malignant glioma
167233|NCT03152318|Brain Tumor|brain tumor
167234|NCT03152318|Glioblastoma|glioblastoma
167235|NCT03152305|Migraine|migraine
167236|NCT03152305|Intracranial pressure|intracranial pressure
167237|NCT03152305|Headache|headache
167238|NCT03152253|Tobacco, Smoking, Text Message|tobacco, smoking, text message
167239|NCT03152240|Acute Coronary Syndrome|acute coronary syndrome
167240|NCT03152240|Primary Angioplasty|primary angioplasty
167241|NCT03152240|Gender|gender
167242|NCT03152214|Transition out of military|transition out of military
167243|NCT03152188|Hepatic Encephalopathy|hepatic encephalopathy
167244|NCT03152188|Cirrhosis|cirrhosis
167245|NCT03152188|Liver|liver
167246|NCT03152188|Openbiome|openbiome
167247|NCT03152188|FMT Capsule|fmt capsule
167248|NCT03152188|Placebo|placebo
167249|NCT03152175|Memory Reconsolidation|memory reconsolidation
167250|NCT03152175|Propranolol|propranolol
167251|NCT03152175|Police officers|police officers
167252|NCT03152175|911 operators|911 operators
167253|NCT03152175|Efficacy|efficacy
167254|NCT03152175|Cost-effectiveness|cost-effectiveness
167255|NCT03152162|osteoarthritis|osteoarthritis
167256|NCT03152162|patient-specific|patient-specific
167257|NCT03152162|knee replacement|knee replacement
167258|NCT03152162|TKA|tka
167259|NCT03152162|knee arthroplasty|knee arthroplasty
167260|NCT03152162|total knee replacement|total knee replacement
167261|NCT03152162|posterior stabilized|posterior stabilized
167262|NCT03152149|Chronic Obstructive Pulmonary Disease|chronic obstructive pulmonary disease
167263|NCT03152110|High Intensity Interval Training|high intensity interval training
167264|NCT03152110|HIIT|hiit
167265|NCT03152110|Physical Activity|physical activity
167266|NCT03152071|thoracoscopic surgery|thoracoscopic surgery
167267|NCT03152071|RATS|rats
167268|NCT03152071|VATS|vats
167269|NCT03152071|Robot|robot
167270|NCT03152045|communication between adolescent patients and their clinician|communication between adolescent patients and their clinician
167271|NCT03152032|employment service|employment service
167272|NCT03152032|vocational counseling|vocational counseling
167273|NCT03152032|employment outcome|employment outcome
167274|NCT03152032|schizophrenia|schizophrenia
167275|NCT03152032|bipolar|bipolar
167276|NCT03152032|occupational therapy in mental health|occupational therapy in mental health
167277|NCT03152019|Hemorrhagic Hereditary Telangiectasia (HHT)|hemorrhagic hereditary telangiectasia (hht)
167278|NCT03152019|Antiangiogenic therapy|antiangiogenic therapy
167279|NCT03152019|Tacrolimus|tacrolimus
167280|NCT03152006|Healthcare transition|healthcare transition
167281|NCT03152006|Adolescents|adolescents
167282|NCT03152006|Nigeria|nigeria
167283|NCT03151993|Ischemic Stroke|ischemic stroke
167284|NCT03151993|Fibrinolysis|fibrinolysis
167285|NCT03151993|Fortelyzin|fortelyzin
167483|NCT03150810|BGB-290|bgb-290
167286|NCT03151954|nasal epithelium stem cells|nasal epithelium stem cells
167287|NCT03151954|Hippo-YAP pathway|hippo-yap pathway
167288|NCT03151954|proliferation|proliferation
167289|NCT03151954|differentiation|differentiation
167290|NCT03151863|Dexmedetomidine|dexmedetomidine
167291|NCT03151863|Opioids|opioids
167292|NCT03151863|Palliative Care|palliative care
167293|NCT03151863|Elderly people|elderly people
167294|NCT03151863|Nursing care|nursing care
167295|NCT03151863|Analgesia|analgesia
167296|NCT03151863|Sedation|sedation
167297|NCT03151863|Anxiolysis|anxiolysis
167298|NCT03151863|Intranasal|intranasal
167299|NCT03151850|fungal|fungal
167300|NCT03151850|mucosa|mucosa
167301|NCT03151850|diversity|diversity
167302|NCT03151850|Basidiomycete|basidiomycete
167303|NCT03151837|Diabetes|diabetes
167304|NCT03151837|Bitter melon(Momordica charantia)|bitter melon(momordica charantia)
167305|NCT03151837|Insulin sensitivity|insulin sensitivity
167306|NCT03151811|Refractory Multiple Myeloma|refractory multiple myeloma
167307|NCT03151811|Relapsed Multiple Myeloma|relapsed multiple myeloma
167308|NCT03151811|Melflufen|melflufen
167309|NCT03151811|Pomalidomide|pomalidomide
167310|NCT03151811|Dexamethasone|dexamethasone
167311|NCT03151798|Nonalcoholic fatty liver|nonalcoholic fatty liver
167312|NCT03151798|Exercise|exercise
167313|NCT03151798|Weight loss diet|weight loss diet
167314|NCT03151785|CPR|cpr
167315|NCT03151785|Schools|schools
167316|NCT03151785|Education|education
167317|NCT03151785|Lifesaver|lifesaver
167318|NCT03151733|SILS|sils
167319|NCT03151733|colorectal cancer|colorectal cancer
167320|NCT03151694|childhood obesity|childhood obesity
167321|NCT03151694|body weight|body weight
167322|NCT03151694|nutritional risk|nutritional risk
167323|NCT03151681|Reconsolidation|reconsolidation
167324|NCT03151681|Propranolol|propranolol
167325|NCT03151681|Infidelity|infidelity
167326|NCT03151681|Attachment injury|attachment injury
167327|NCT03151681|Romantic relationships|romantic relationships
167328|NCT03151603|Uva Ursi|uva ursi
167329|NCT03151603|fosfomycin|fosfomycin
167330|NCT03151603|uncomplicated urinary tract infection of women|uncomplicated urinary tract infection of women
167331|NCT03151564|Diseases of liver|diseases of liver
167332|NCT03151564|Colon carcinoma|colon carcinoma
167333|NCT03151564|Colorectal carcinoma|colorectal carcinoma
167334|NCT03151564|Liver metastases|liver metastases
167335|NCT03151564|Computed tomography|computed tomography
167336|NCT03151564|CT|ct
167337|NCT03151564|Reduced radiation doses|reduced radiation doses
167338|NCT03151538|Pedography|pedography
167339|NCT03151538|Exercise|exercise
167340|NCT03151538|Play Training|play training
167341|NCT03151538|Pes Planus|pes planus
167342|NCT03151538|Femoral Anteversion|femoral anteversion
167343|NCT03151512|MRI|mri
167344|NCT03151512|distortion correction|distortion correction
167345|NCT03151512|Magnetic Resonance Imaging|magnetic resonance imaging
167346|NCT03151512|prostheses|prostheses
167347|NCT03151447|Breast Cancer|breast cancer
167348|NCT03151447|Anti-PD1 Antibody|anti-pd1 antibody
167349|NCT03151447|Stereotactic Body Radiation Therapy|stereotactic body radiation therapy
167350|NCT03151434|VATS|vats
167351|NCT03151434|pain|pain
167352|NCT03151421|air quality feedback|air quality feedback
167353|NCT03151421|second-hand smoke|second-hand smoke
167354|NCT03151421|passive smoking|passive smoking
167355|NCT03151421|exposure to second-hand smoke|exposure to second-hand smoke
167356|NCT03151421|second-hand smoke exposure prevention|second-hand smoke exposure prevention
167357|NCT03151408|AML|aml
167358|NCT03151395|COPD|copd
167359|NCT03151395|AECOPD|aecopd
167360|NCT03151395|GOLD (Global Initiative for Chronic Obstructive Lung Disease)|gold (global initiative for chronic obstructive lung disease)
167361|NCT03151395|Asia Pacific|asia pacific
167362|NCT03151382|Alzheimer Disease|alzheimer disease
167363|NCT03151382|Cognitive Function|cognitive function
167364|NCT03151382|tandospirone|tandospirone
167365|NCT03151304|MDS|mds
167366|NCT03151291|cancer cachexia|cancer cachexia
167367|NCT03151291|WB-EMS|wb-ems
167368|NCT03151291|skeletal muscle mass|skeletal muscle mass
167369|NCT03151291|exercise|exercise
167370|NCT03151291|nutrition|nutrition
167371|NCT03151291|dietary supplements|dietary supplements
167372|NCT03151278|Fluoroscopy|fluoroscopy
167373|NCT03151278|Ablation|ablation
167374|NCT03151278|Three dimensional|three dimensional
167375|NCT03151278|Atrial arrhythmia|atrial arrhythmia
167376|NCT03151278|Radiation|radiation
167377|NCT03151265|Functional Outcome Measures|functional outcome measures
167378|NCT03151265|Wearable Sensors|wearable sensors
167379|NCT03151265|ViMove|vimove
167380|NCT03151265|Low Back Pain|low back pain
167381|NCT03151265|Range of Movement|range of movement
167382|NCT03151265|Muscle Activity|muscle activity
167383|NCT03151265|ThermaCare|thermacare
167384|NCT03151226|obstructive sleep apnea screen negative|obstructive sleep apnea screen negative
167385|NCT03151226|respiratory depression|respiratory depression
167386|NCT03151226|cesarean section|cesarean section
167387|NCT03151200|Amblyopia treatment|amblyopia treatment
167388|NCT03151161|chemotherapy|chemotherapy
167389|NCT03151161|maintenance therapy|maintenance therapy
167390|NCT03151161|icotinib|icotinib
167391|NCT03151148|allogeneic targeted microbiome transplant (TMT)|allogeneic targeted microbiome transplant (tmt)
167392|NCT03151148|dysbiosis in AD|dysbiosis in ad
167393|NCT03151148|Staphylococcus aureus colonized skin|staphylococcus aureus colonized skin
167394|NCT03151148|antimicrobial peptides (AMPs)|antimicrobial peptides (amps)
167395|NCT03151148|randomized trial|randomized trial
167396|NCT03151135|Energy metabolism|energy metabolism
167397|NCT03151109|reverse total shoulder arthroplasty|reverse total shoulder arthroplasty
167398|NCT03151109|glenoid bone loss|glenoid bone loss
167399|NCT03151083|Health Technology|health technology
167400|NCT03151083|Internet-Based Psychotherapy|internet-based psychotherapy
167401|NCT03151083|self-care|self-care
167402|NCT03151083|Primary Care|primary care
167403|NCT03151083|Mental Health|mental health
167404|NCT03151057|Idelalisib|idelalisib
167405|NCT03151057|Zydelig|zydelig
167406|NCT03151057|allo transplant|allo transplant
167407|NCT03151057|PI3K inhibitor|pi3k inhibitor
167408|NCT03151057|post transplant maintenance therapy|post transplant maintenance therapy
167409|NCT03151044|epirubicin|epirubicin
167410|NCT03151044|high-dose|high-dose
167411|NCT03151044|Diffuse Large B-cell Lymphoma|diffuse large b-cell lymphoma
167412|NCT03151044|medium/high-risk|medium/high-risk
167413|NCT03151031|balance|balance
167414|NCT03151031|college students|college students
167415|NCT03151031|star excursion balance test|star excursion balance test
167416|NCT03151018|coronary artery disease|coronary artery disease
167541|NCT03150446|laparoscopy|laparoscopy
167417|NCT03151018|percutaneous coronary intervention|percutaneous coronary intervention
167418|NCT03151018|zotarolimus-eluting stents|zotarolimus-eluting stents
167419|NCT03151005|Polycystic Ovary Syndrome (PCOS)|polycystic ovary syndrome (pcos)
167420|NCT03151005|Overweight|overweight
167421|NCT03151005|Obesity|obesity
167422|NCT03151005|GLP-1 Agonist|glp-1 agonist
167423|NCT03151005|Oral contraceptives (OCs)|oral contraceptives (ocs)
167424|NCT03151005|Metformin|metformin
167425|NCT03151005|Reproductive Disorders|reproductive disorders
167426|NCT03151005|Cardiovascular risk factor|cardiovascular risk factor
167427|NCT03151005|Lipid Metabolism|lipid metabolism
167428|NCT03150992|Feasibility|feasibility
167429|NCT03150992|Elemental Diet|elemental diet
167430|NCT03150992|Quality of life|quality of life
167431|NCT03150992|Palliative|palliative
167432|NCT03150992|Nutrition|nutrition
167433|NCT03150992|Ovarian|ovarian
167434|NCT03150992|Peritoneal|peritoneal
167435|NCT03150992|Advanced|advanced
167436|NCT03150992|Metastatic|metastatic
167437|NCT03150992|Bowel obstruction|bowel obstruction
167438|NCT03150992|Inoperable|inoperable
167439|NCT03150979|Stroke|stroke
167440|NCT03150979|Assistive devices|assistive devices
167441|NCT03150979|Gait|gait
167442|NCT03150979|Rehabilitation|rehabilitation
167443|NCT03150979|Clinical trial|clinical trial
167444|NCT03150966|Multiple sclerosis|multiple sclerosis
167445|NCT03150966|Nanocurcumin|nanocurcumin
167446|NCT03150966|MicroRNAs|micrornas
167447|NCT03150966|Th17 cells|th17 cells
167448|NCT03150966|Treg cells|treg cells
167449|NCT03150953|anesthesia|anesthesia
167450|NCT03150953|MRI|mri
167451|NCT03150953|thermoregulation|thermoregulation
167452|NCT03150862|Adult glioblastoma, adult gian cell glioblastoma, adult gliosarcoma, glioma neoplasms|adult glioblastoma, adult gian cell glioblastoma, adult gliosarcoma, glioma neoplasms
167453|NCT03150862|recurrent adult brain tumor|recurrent adult brain tumor
167454|NCT03150862|neoplasms, central nervous system neoplasms, neoplasms by histologic type, neoplasms by site|neoplasms, central nervous system neoplasms, neoplasms by histologic type, neoplasms by site
167455|NCT03150862|astrocytoma|astrocytoma
167456|NCT03150862|neuroepithelial|neuroepithelial
167457|NCT03150862|neuroectodermal tumors|neuroectodermal tumors
167458|NCT03150862|germ cell and embryonal|germ cell and embryonal
167459|NCT03150862|antineoplastic agents|antineoplastic agents
167460|NCT03150862|glandular and epithelial|glandular and epithelial
167461|NCT03150862|nerve tissue, nervous system diseases|nerve tissue, nervous system diseases
167462|NCT03150862|temozolomide|temozolomide
167463|NCT03150862|BGB-290|bgb-290
167464|NCT03150862|alkylating, alkylating agents|alkylating, alkylating agents
167465|NCT03150862|molecular mechanisms of pharmacological action|molecular mechanisms of pharmacological action
167466|NCT03150862|Poly(ADP-ribose) polymerase inhibitors|poly(adp-ribose) polymerase inhibitors
167467|NCT03150862|enzyme inhibitors|enzyme inhibitors
167468|NCT03150836|bladder cancer|bladder cancer
167469|NCT03150836|urothelial|urothelial
167470|NCT03150823|Direct current|direct current
167471|NCT03150823|Galvanic current|galvanic current
167472|NCT03150823|Handgrip Force|handgrip force
167473|NCT03150823|Palmar Grip|palmar grip
167474|NCT03150823|Dynamometry|dynamometry
167475|NCT03150823|Miofeedback|miofeedback
167476|NCT03150810|Ovarian cancer|ovarian cancer
167477|NCT03150810|Triple negative breast cancer|triple negative breast cancer
167478|NCT03150810|Small cell lung cancer|small cell lung cancer
167479|NCT03150810|Prostate cancer,|prostate cancer,
167480|NCT03150810|Gastric cancer|gastric cancer
167481|NCT03150810|neoplasms|neoplasms
167482|NCT03150810|temozolomide|temozolomide
167484|NCT03150810|antineoplastic agents|antineoplastic agents
167485|NCT03150810|alkylating, alkylating agents,|alkylating, alkylating agents,
167486|NCT03150810|Poly (ADP-ribose) polymerase inhibitors|poly (adp-ribose) polymerase inhibitors
167487|NCT03150810|enzyme inhibitors|enzyme inhibitors
167488|NCT03150797|UCSF|ucsf
167489|NCT03150797|UCLA|ucla
167490|NCT03150797|melatonin|melatonin
167491|NCT03150797|migraine|migraine
167492|NCT03150797|headache|headache
167493|NCT03150784|Motor Learning|motor learning
167494|NCT03150784|Coordination|coordination
167495|NCT03150784|Children|children
167496|NCT03150784|Motor Skills Disorders|motor skills disorders
167497|NCT03150784|Movement|movement
167498|NCT03150758|Erectile Disfunction|erectile disfunction
167499|NCT03150758|Urinary Function|urinary function
167500|NCT03150706|POLE mutation|pole mutation
167501|NCT03150706|mismatch repair deficient|mismatch repair deficient
167502|NCT03150706|Avelumab|avelumab
167503|NCT03150680|SYNTAX score|syntax score
167504|NCT03150680|SNPs|snps
167505|NCT03150680|Genetics|genetics
167506|NCT03150680|Pharmacogenetics|pharmacogenetics
167507|NCT03150680|Genetic Risk Score|genetic risk score
167508|NCT03150680|Precision Medicine|precision medicine
167509|NCT03150654|macular pigment|macular pigment
167510|NCT03150654|macular pigment optical density|macular pigment optical density
167511|NCT03150654|diabetic retinopathy|diabetic retinopathy
167512|NCT03150654|laser pan-retinal photocoagulation|laser pan-retinal photocoagulation
167513|NCT03150641|Maternal blood loss|maternal blood loss
167514|NCT03150641|Cesarean delivery|cesarean delivery
167515|NCT03150641|Delayed cord clamping|delayed cord clamping
167516|NCT03150641|Neonatal health|neonatal health
167517|NCT03150576|Triple negative breast cancer|triple negative breast cancer
167518|NCT03150576|germline BRCA|germline brca
167519|NCT03150576|platinum and PARP inhibitor|platinum and parp inhibitor
167520|NCT03150576|neoadjuvant chemotherapy|neoadjuvant chemotherapy
167521|NCT03150576|olaparib|olaparib
167522|NCT03150563|Stretching|stretching
167523|NCT03150563|Stretching sensation|stretching sensation
167524|NCT03150563|Isokinetic dynamometry|isokinetic dynamometry
167525|NCT03150563|Stretching load.|stretching load.
167526|NCT03150550|Mindfulness|mindfulness
167527|NCT03150550|Alcohol|alcohol
167528|NCT03150550|Alcohol Use Disorder|alcohol use disorder
167529|NCT03150550|Relapse|relapse
167530|NCT03150550|Relapse Prevention|relapse prevention
167531|NCT03150550|Cognitive-behavioral therapy|cognitive-behavioral therapy
167532|NCT03150537|jet injector|jet injector
167533|NCT03150537|influenza vaccine|influenza vaccine
167534|NCT03150537|immune response|immune response
167535|NCT03150524|stroke|stroke
167536|NCT03150524|RCVS|rcvs
167537|NCT03150498|Food Effect|food effect
167538|NCT03150498|Pharmacokinetics|pharmacokinetics
167539|NCT03150472|Dental Instruments|dental instruments
167540|NCT03150472|Dental Technology|dental technology
167542|NCT03150446|ureteral catheterization|ureteral catheterization
167543|NCT03150420|calciphylaxis|calciphylaxis
167544|NCT03150420|calcific uremic arteriolopathy, calcinosis|calcific uremic arteriolopathy, calcinosis
167545|NCT03150420|calcium metabolism disorders|calcium metabolism disorders
167546|NCT03150420|metabolic diseases|metabolic diseases
167547|NCT03150420|sodium thiosulfate|sodium thiosulfate
167548|NCT03150342|CZT scanner|czt scanner
167549|NCT03150342|myocardial perfusion imaging|myocardial perfusion imaging
167550|NCT03150342|Hypertrophic Cardiomyopathy|hypertrophic cardiomyopathy
167551|NCT03150303|Periprocedural period|periprocedural period
167552|NCT03150303|Anticoagulant treatment|anticoagulant treatment
167553|NCT03150303|Thromboembolic events|thromboembolic events
167554|NCT03150303|Bleeding events|bleeding events
167555|NCT03150264|lung protective ventilation strategies|lung protective ventilation strategies
167556|NCT03150264|obesity|obesity
167557|NCT03150225|andropause|andropause
167558|NCT03150225|depressive symptoms|depressive symptoms
167559|NCT03150225|stress|stress
167560|NCT03150225|abdominal Obesity|abdominal obesity
167561|NCT03150225|testosterone|testosterone
167562|NCT03150225|erectile dysfunction|erectile dysfunction
167563|NCT03150186|second hand smoke|second hand smoke
167564|NCT03150186|passive smoking|passive smoking
167565|NCT03150186|airborne nicotine|airborne nicotine
214048|NCT02855515|AHI|ahi
167566|NCT03150186|private settings|private settings
167567|NCT03150186|outdoors|outdoors
167568|NCT03150173|opioid use disorder, syringe exchange, HIV risk reduction|opioid use disorder, syringe exchange, hiv risk reduction
167569|NCT03150160|travoprost|travoprost
167570|NCT03150160|brinzolamide 1%/brimonidine 0.2%|brinzolamide 1%/brimonidine 0.2%
167571|NCT03150160|normal tension glaucoma|normal tension glaucoma
167572|NCT03150160|intraocular pressure|intraocular pressure
167573|NCT03150160|efficacy|efficacy
167574|NCT03150160|safety|safety
167575|NCT03150147|Organ preservation|organ preservation
167576|NCT03150147|Survival|survival
167577|NCT03150147|Graft function|graft function
167578|NCT03150147|Reperfusion injury|reperfusion injury
167579|NCT03150147|Heart transplantation|heart transplantation
167580|NCT03150134|Acute Myeloid Leukemia|acute myeloid leukemia
167581|NCT03150134|transplantation|transplantation
167582|NCT03150134|allogeneic transplantation|allogeneic transplantation
167583|NCT03150134|immunosuppressive agents|immunosuppressive agents
167584|NCT03150082|GR37547|gr37547
167585|NCT03150082|Cross-over|cross-over
167586|NCT03150082|Bioequivalence|bioequivalence
167587|NCT03150082|Ciprofloxacin|ciprofloxacin
167588|NCT03150069|Pregnancy|pregnancy
167589|NCT03150056|abiraterone|abiraterone
167590|NCT03150056|castrate-resistant prostate cancer|castrate-resistant prostate cancer
167591|NCT03150056|androgen receptor targeted therapy|androgen receptor targeted therapy
167592|NCT03150056|RP2D|rp2d
167593|NCT03150056|enzalutamide|enzalutamide
167594|NCT03150056|GSK525762|gsk525762
167595|NCT03150043|Hemoglobin|hemoglobin
167596|NCT03150043|Cesarean delivery|cesarean delivery
167597|NCT03150004|Acute myeloid leukemia|acute myeloid leukemia
167599|NCT03150004|salvage chemotherapy|salvage chemotherapy
167600|NCT03150004|CLAG-M|clag-m
167601|NCT03150004|relapse acute myeloid leukemia|relapse acute myeloid leukemia
167602|NCT03150004|secondary acute myeloid leukemia|secondary acute myeloid leukemia
167603|NCT03150004|phase II|phase ii
167604|NCT03150004|pharmacogenomics|pharmacogenomics
167605|NCT03149991|treatment resistant|treatment resistant
167606|NCT03149991|inadequate response|inadequate response
167607|NCT03149978|Neoadjuvant Chemoradiation|neoadjuvant chemoradiation
167608|NCT03149978|treatment effect prediction|treatment effect prediction
167609|NCT03149978|metabonomics|metabonomics
167610|NCT03149913|below the knee artery|below the knee artery
167611|NCT03149913|endovascular|endovascular
167612|NCT03149913|drug coated balloon|drug coated balloon
167613|NCT03149913|critical limb ischemia|critical limb ischemia
167614|NCT03149848|Tuberculosis|tuberculosis
167615|NCT03149848|Human Immunodeficiency Virus|human immunodeficiency virus
167616|NCT03149848|Rifabutin|rifabutin
167617|NCT03149848|Drug-drug interaction|drug-drug interaction
167618|NCT03149848|Cabotegravir|cabotegravir
167619|NCT03149809|Urinary incontinence|urinary incontinence
167620|NCT03149809|Parkinson disease|parkinson disease
167621|NCT03149809|Overactive urinary bladder|overactive urinary bladder
167622|NCT03149809|Nocturia|nocturia
167623|NCT03149757|Treatment Adherence|treatment adherence
167624|NCT03149757|Alcohol or Drugs|alcohol or drugs
167625|NCT03149757|Behavioral|behavioral
167626|NCT03149757|Internet|internet
167627|NCT03149757|Adolescents|adolescents
167628|NCT03149757|Young Adults|young adults
167629|NCT03149757|Social Support|social support
167630|NCT03149718|Pharmacy|pharmacy
167631|NCT03149718|Intervention|intervention
167632|NCT03149718|Medication Adherence|medication adherence
167633|NCT03149705|Ischemic stroke, stroke, bio-collection, Imaging markers, biomarkers, clinical outcomes|ischemic stroke, stroke, bio-collection, imaging markers, biomarkers, clinical outcomes
167634|NCT03149679|Cyclophosphamide|cyclophosphamide
167635|NCT03149679|Colorectal Cancer Metastatic|colorectal cancer metastatic
167636|NCT03149679|TP53 Gene Mutation|tp53 gene mutation
167637|NCT03149653|lipid emulsion|lipid emulsion
167638|NCT03149653|olive oil|olive oil
167639|NCT03149653|fish oil|fish oil
167640|NCT03149653|intestinal failure|intestinal failure
167641|NCT03149653|home parenteral nutrition|home parenteral nutrition
167642|NCT03149640|Prevention|prevention
167643|NCT03149640|inhaled amikacin|inhaled amikacin
167644|NCT03149640|placebo|placebo
167645|NCT03149614|mobilization|mobilization
167646|NCT03149614|resonant oscillation|resonant oscillation
167647|NCT03149575|Glioma|glioma
167648|NCT03149575|Glioblastoma|glioblastoma
167649|NCT03149575|Glioblastoma multiforme|glioblastoma multiforme
167651|NCT03149575|brain tumor|brain tumor
167652|NCT03149575|brain cancer|brain cancer
167653|NCT03149575|recurrent brain tumor|recurrent brain tumor
167654|NCT03149575|recurrent brain cancer|recurrent brain cancer
167655|NCT03149575|refractory brain tumor|refractory brain tumor
167656|NCT03149575|refractory brain cancer|refractory brain cancer
167657|NCT03149575|recurrent GBM|recurrent gbm
167658|NCT03149575|refractory GBM|refractory gbm
167659|NCT03149575|recurrent glioma|recurrent glioma
167660|NCT03149575|refractory glioma|refractory glioma
400598|NCT01866072|Fibroscan|fibroscan
167661|NCT03149575|recurrent glioblastoma|recurrent glioblastoma
167662|NCT03149575|refractory glioblastoma|refractory glioblastoma
167663|NCT03149575|recurrent glioblastoma multiforme|recurrent glioblastoma multiforme
167664|NCT03149575|refractory glioblastoma multiforme|refractory glioblastoma multiforme
167665|NCT03149575|failed temodar|failed temodar
167666|NCT03149575|failed temozolomide|failed temozolomide
167667|NCT03149575|temodar refractory|temodar refractory
167668|NCT03149575|temozolomide refractory|temozolomide refractory
167669|NCT03149575|failed avastin|failed avastin
167670|NCT03149575|avastin refractory|avastin refractory
167671|NCT03149575|failed bevacizumab|failed bevacizumab
167672|NCT03149575|bevacizumab refractory|bevacizumab refractory
167673|NCT03149575|avastin failure|avastin failure
167674|NCT03149575|bevacizumab failure|bevacizumab failure
167676|NCT03149549|cancer|cancer
167677|NCT03149549|solid tumor|solid tumor
167678|NCT03149549|PROCLAIM|proclaim
167679|NCT03149549|CX-2009|cx-2009
167680|NCT03149549|PROBODY™ Therapeutic|probody™ therapeutic
167681|NCT03149549|Drug Conjugate|drug conjugate
167682|NCT03149549|Antibody drug conjugate|antibody drug conjugate
167683|NCT03149549|CD166|cd166
167684|NCT03149536|pharmacogenetic|pharmacogenetic
167685|NCT03149536|pharmacogenomic|pharmacogenomic
167686|NCT03149536|polymorphism|polymorphism
167687|NCT03149536|individualized controlled ovarian stimulation|individualized controlled ovarian stimulation
167688|NCT03149536|algorithm|algorithm
167689|NCT03149536|assisted reproduction|assisted reproduction
167690|NCT03149523|exhaustive genetic and immunological analyses|exhaustive genetic and immunological analyses
167691|NCT03149523|targeted therapies|targeted therapies
167692|NCT03149523|colon cancer|colon cancer
167693|NCT03149523|kidney cancer|kidney cancer
167694|NCT03149523|liver cancer|liver cancer
167695|NCT03149523|immunological tumor microenvironment|immunological tumor microenvironment
167696|NCT03149523|tumor microenvironment heterogeneity|tumor microenvironment heterogeneity
167697|NCT03149510|mobile application|mobile application
167698|NCT03149510|mHealth|mhealth
167699|NCT03149458|stroke|stroke
167700|NCT03149458|balance|balance
167701|NCT03149458|dance|dance
167702|NCT03149432|mirror therapy|mirror therapy
167703|NCT03149432|amputation|amputation
167704|NCT03149432|phantom pain|phantom pain
167705|NCT03149419|postmenopause|postmenopause
167706|NCT03149419|paroxetine|paroxetine
167707|NCT03149419|endothelial dysfunction|endothelial dysfunction
167708|NCT03149419|blood pressure|blood pressure
167709|NCT03149419|heart rate variability|heart rate variability
167710|NCT03149419|sleep quality|sleep quality
167711|NCT03149419|perceived stress|perceived stress
167712|NCT03149419|sleepiness|sleepiness
167713|NCT03149393|Functional Dyspepsia|functional dyspepsia
167714|NCT03149393|Qizhi Weitong Granules|qizhi weitong granules
167715|NCT03149393|Traditional Chinese Medicine|traditional chinese medicine
167716|NCT03149328|Home Dialysis|home dialysis
167717|NCT03149328|Person-Centred Care|person-centred care
167718|NCT03149328|Patient-Reported Outcome Measures|patient-reported outcome measures
167719|NCT03149328|Process Evaluation|process evaluation
167720|NCT03149328|Educational Support|educational support
167721|NCT03149328|Electronic Patient-Reported Outcome Measures|electronic patient-reported outcome measures
167722|NCT03149328|Patient-Reported Experience Measures|patient-reported experience measures
167723|NCT03149302|Manual therapy|manual therapy
167724|NCT03149302|Sensorimotor exercises|sensorimotor exercises
167725|NCT03149302|Balance exercises|balance exercises
167726|NCT03149302|Cervical mobilization|cervical mobilization
167727|NCT03149302|Specific neck muscle exercises|specific neck muscle exercises
167728|NCT03149263|botulinum toxin|botulinum toxin
167729|NCT03149263|anxiety reduction|anxiety reduction
167730|NCT03149263|pain reduction|pain reduction
167731|NCT03149263|medical clowns|medical clowns
167732|NCT03149263|distraction|distraction
167733|NCT03149250|Aggregometry|aggregometry
167734|NCT03149237|Mozambique|mozambique
167735|NCT03149237|Couples-based services|couples-based services
167736|NCT03149237|HIV/AIDS|hiv/aids
167737|NCT03149237|Ante-natal Care|ante-natal care
167738|NCT03149198|Fibromyalgia, pilates, exercises|fibromyalgia, pilates, exercises
167739|NCT03149185|prostate cancer|prostate cancer
167740|NCT03149185|advanced prostate cancer|advanced prostate cancer
167741|NCT03149185|technology based|technology based
167742|NCT03149146|Clinical Decision Making|clinical decision making
167743|NCT03149146|Myanmar Physical therapists|myanmar physical therapists
167744|NCT03149146|Educational workshop|educational workshop
167745|NCT03149133|Biomechanics|biomechanics
167746|NCT03149133|Strength training|strength training
167747|NCT03149133|Elastography|elastography
167748|NCT03149133|Ultrasound|ultrasound
167749|NCT03149120|Metastatic|metastatic
167750|NCT03149120|Unresectable|unresectable
167751|NCT03149120|anthracycline|anthracycline
167752|NCT03149120|chemotherapy|chemotherapy
167753|NCT03149120|systemic therapy|systemic therapy
167754|NCT03149107|Prodrome, CHR, Schizophrenia, prevention, N-acetylcysteine|prodrome, chr, schizophrenia, prevention, n-acetylcysteine
167755|NCT03149094|Self-Management|self-management
167756|NCT03149094|mHealth|mhealth
167757|NCT03149042|FFR|ffr
167758|NCT03149042|Fractional Flow Reserve|fractional flow reserve
167759|NCT03149042|Atherosclerosis|atherosclerosis
167760|NCT03149042|Coronary|coronary
167761|NCT03149042|stenosis|stenosis
167762|NCT03149029|Metastatic Melanoma|metastatic melanoma
167763|NCT03149003|Glioblastoma (GBM)|glioblastoma (gbm)
167764|NCT03149003|Wilms Tumor 1 (WT1)|wilms tumor 1 (wt1)
167765|NCT03149003|Cancer Vaccines|cancer vaccines
167766|NCT03149003|Neoplasms|neoplasms
167767|NCT03149003|Astrocytoma|astrocytoma
167768|NCT03149003|Glioma|glioma
167769|NCT03149003|Brain Cancer|brain cancer
167770|NCT03149003|Brain Tumor|brain tumor
167771|NCT03149003|Bevacizumab|bevacizumab
167772|NCT03148990|Double Viral Vaccine Measles and Rubella|double viral vaccine measles and rubella
167773|NCT03148990|Safety Efficacy Imunogenicity|safety efficacy imunogenicity
167774|NCT03148977|Matrix Metalloproteinases|matrix metalloproteinases
167775|NCT03148951|MPV|mpv
167776|NCT03148951|NLR|nlr
167777|NCT03148951|Postoperative pain|postoperative pain
167778|NCT03148938|DAM|dam
167779|NCT03148938|multiple sclerosis|multiple sclerosis
167780|NCT03148938|MSFC|msfc
167781|NCT03148938|application|application
167782|NCT03148938|mobile|mobile
167783|NCT03148925|nicotine vaccine|nicotine vaccine
167784|NCT03148925|smoking vaccine|smoking vaccine
167785|NCT03148925|smoking cessation|smoking cessation
167786|NCT03148925|SELA-070|sela-070
167787|NCT03148899|Sleep Apnea|sleep apnea
167788|NCT03148899|Oxytocin Nasal Spray|oxytocin nasal spray
167789|NCT03148886|Physical activity|physical activity
167790|NCT03148860|Psoriatic Arthritis|psoriatic arthritis
167791|NCT03148860|Ustekinumab|ustekinumab
167792|NCT03148860|Methotrexate|methotrexate
167793|NCT03148860|DAS28|das28
167794|NCT03148834|Acute Myocardial Infarction Reperfusion Injury|acute myocardial infarction reperfusion injury
167795|NCT03148821|pressure ulcer|pressure ulcer
167796|NCT03148821|pressure sore|pressure sore
167797|NCT03148821|patient positioning|patient positioning
167798|NCT03148769|Bloodstream infections, epidemiology|bloodstream infections, epidemiology
167799|NCT03148678|Emotional reactivity|emotional reactivity
167800|NCT03148678|Cognitive flexibility|cognitive flexibility
167801|NCT03148665|Oral Cancer|oral cancer
167802|NCT03148665|Head and Neck Cancer|head and neck cancer
167803|NCT03148639|auditory hallucination|auditory hallucination
167804|NCT03148639|schizophrenia|schizophrenia
167805|NCT03148639|treatment-resistant|treatment-resistant
167806|NCT03148639|psychotherapy|psychotherapy
167807|NCT03148639|virtual reality|virtual reality
167808|NCT03148639|avatar|avatar
167809|NCT03148626|mindfulness curriculum|mindfulness curriculum
167810|NCT03148600|Ileoanal pouch, pelvic floor exercise|ileoanal pouch, pelvic floor exercise
167811|NCT03148587|abortion|abortion
167812|NCT03148587|medical abortion|medical abortion
167813|NCT03148587|mifepristone|mifepristone
167814|NCT03148587|pregnancy test|pregnancy test
167815|NCT03148548|VTE|vte
167816|NCT03148548|thrombophilia screening|thrombophilia screening
167817|NCT03148548|patients|patients
167818|NCT03148548|risk factors|risk factors
167819|NCT03148548|post-thrombotic syndrome|post-thrombotic syndrome
167820|NCT03148496|abdominal surgery|abdominal surgery
167821|NCT03148496|wound complication|wound complication
167822|NCT03148483|Pregnancy outcome|pregnancy outcome
167823|NCT03148483|Feasibility|feasibility
167824|NCT03148483|Milk Fortification|milk fortification
167825|NCT03148483|Periodontitis|periodontitis
167826|NCT03148483|Pregnant women|pregnant women
167827|NCT03148483|Periodontal Therapy|periodontal therapy
167828|NCT03148470|theta burst stimulation|theta burst stimulation
167829|NCT03148470|Language switching|language switching
167830|NCT03148470|dorsolateral prefrontal cortex|dorsolateral prefrontal cortex
167831|NCT03148457|Stroke|stroke
167832|NCT03148457|Direct oral anticoagulation|direct oral anticoagulation
167833|NCT03148457|Apixaban|apixaban
167834|NCT03148457|Dabigatran|dabigatran
167835|NCT03148457|Rivaroxaban|rivaroxaban
167836|NCT03148457|Edoxaban|edoxaban
167837|NCT03148457|Therapy initiation|therapy initiation
167838|NCT03148457|Major bleeding|major bleeding
167839|NCT03148457|Atrial fibrillation|atrial fibrillation
167840|NCT03148379|Total Knee Replacement|total knee replacement
167841|NCT03148366|Self Efficacy|self efficacy
167842|NCT03148353|ultrasonography, corticosteroid, subacromial impingement syndrome, shoulder pain|ultrasonography, corticosteroid, subacromial impingement syndrome, shoulder pain
167843|NCT03148249|Randomized control trial|randomized control trial
167844|NCT03148249|Charles Bonnet syndrome|charles bonnet syndrome
167845|NCT03148249|visual hallucinations|visual hallucinations
167846|NCT03148249|age related macular degeneration|age related macular degeneration
167847|NCT03148249|patient education|patient education
167848|NCT03148223|Dysmenorrhea|dysmenorrhea
167849|NCT03148223|acupuncture|acupuncture
167850|NCT03148223|auriculotherapy|auriculotherapy
167851|NCT03148197|Allogeneic hematopoietic stem cell transplantation|allogeneic hematopoietic stem cell transplantation
167852|NCT03148197|Graft-versus-host-disease|graft-versus-host-disease
167853|NCT03148197|Acute Myeloid Leukemia|acute myeloid leukemia
167854|NCT03148184|reverse total shoulder arthroplasty|reverse total shoulder arthroplasty
167855|NCT03148184|60 years old or younger|60 years old or younger
167856|NCT03148184|outcomes|outcomes
167857|NCT03148171|Pre-Exposure Prophylaxis (PrEP); Retention in PrEP Care|pre-exposure prophylaxis (prep); retention in prep care
167858|NCT03148158|Bladder Cancer|bladder cancer
167859|NCT03148158|Flexible cystoscopy|flexible cystoscopy
167860|NCT03148158|Diagnosis|diagnosis
167861|NCT03148132|Retinopathy of Prematurity|retinopathy of prematurity
167862|NCT03148132|VEGF|vegf
167863|NCT03148132|Bevacizumab|bevacizumab
167864|NCT03148132|Ranibizumab|ranibizumab
167865|NCT03148093|Metastatic Colorectal Cancer|metastatic colorectal cancer
167866|NCT03148093|Registry|registry
167867|NCT03148093|Patient Reported Outcomes|patient reported outcomes
167868|NCT03148093|Treatment Patterns|treatment patterns
167869|NCT03148093|Prescription Use|prescription use
167870|NCT03148067|Risk Factors|risk factors
167871|NCT03148067|Incidence|incidence
167872|NCT03148067|Epidemiology|epidemiology
167873|NCT03148054|Anastomosis|anastomosis
167874|NCT03148054|Colon|colon
167875|NCT03148054|CT|ct
167876|NCT03148054|Endoscopy|endoscopy
167877|NCT03148054|Enema|enema
167878|NCT03148054|Detection leak|detection leak
167879|NCT03148054|Anastomotic leak|anastomotic leak
167880|NCT03147989|MultiHance|multihance
167881|NCT03147989|MRI|mri
167882|NCT03147989|CNS|cns
167883|NCT03147989|Gadobenate Dimeglumine|gadobenate dimeglumine
167884|NCT03147963|therapy|therapy
167885|NCT03147963|breast cancer|breast cancer
167886|NCT03147963|docetaxel|docetaxel
167887|NCT03147963|metastasis|metastasis
167888|NCT03147950|Prone-Flexed Position|prone-flexed position
167889|NCT03147950|Percutaneous Nephrolithotomy (PCNL)|percutaneous nephrolithotomy (pcnl)
167890|NCT03147950|Clavien-Dindo Classification Score|clavien-dindo classification score
167891|NCT03147911|Stroke or systemic embolism|stroke or systemic embolism
167892|NCT03147911|CHA2DS2-VASc score|cha2ds2-vasc score
167893|NCT03147898|Whooping cough|whooping cough
167894|NCT03147898|Pertussis|pertussis
167895|NCT03147807|Carbapenems de-escalation, rapid diagnostic test,|carbapenems de-escalation, rapid diagnostic test,
167896|NCT03147807|Carbapenem-antimicrobial de-escalation-rapid diagnostic test|carbapenem-antimicrobial de-escalation-rapid diagnostic test
167897|NCT03147781|auriculotherapy, human milk, breastfeeding, lactogenesis|auriculotherapy, human milk, breastfeeding, lactogenesis
167898|NCT03147768|Laser Tissue Welding|laser tissue welding
167899|NCT03147768|Pancreatic Sealing|pancreatic sealing
167900|NCT03147768|Hemostasis|hemostasis
167901|NCT03147768|Pancreatic Tumors|pancreatic tumors
167902|NCT03147768|Pancreatic Resection|pancreatic resection
167903|NCT03147768|Pancreatic leakage|pancreatic leakage
167904|NCT03147768|LTW|ltw
167905|NCT03147755|stroke|stroke
167906|NCT03147742|ruxolitinib|ruxolitinib
167907|NCT03147742|acute or chronic steroid-refractory GVHD|acute or chronic steroid-refractory gvhd
167908|NCT03147742|hematopoietic stem cell transplantation (allo-HSCT)|hematopoietic stem cell transplantation (allo-hsct)
167909|NCT03147729|Radiofrequency|radiofrequency
167910|NCT03147729|Anal incontinence|anal incontinence
167911|NCT03147729|Fecal incontinence|fecal incontinence
167912|NCT03147729|Women sexual function|women sexual function
167913|NCT03147729|Sexuality|sexuality
167914|NCT03147703|Microbiota|microbiota
167915|NCT03147703|Food timing|food timing
167917|NCT03147690|Solid Organ Injury|solid organ injury
167918|NCT03147677|Type 2 diabetic nephropathy|type 2 diabetic nephropathy
167919|NCT03147677|Alfacalcidol|alfacalcidol
167920|NCT03147664|pompe disease|pompe disease
167921|NCT03147664|exercise capacity|exercise capacity
167922|NCT03147664|cardiopulmonary exercise testing|cardiopulmonary exercise testing
167923|NCT03147651|Cystic fibrosis|cystic fibrosis
167924|NCT03147651|exercise capacity|exercise capacity
167925|NCT03147651|non-cystic fibrosis|non-cystic fibrosis
167926|NCT03147651|bronchiectasis|bronchiectasis
167927|NCT03147625|Aged|aged
167928|NCT03147625|Independent living|independent living
167929|NCT03147625|Health Promotion|health promotion
167930|NCT03147625|Residence Characteristics|residence characteristics
167931|NCT03147625|Elderly-only household|elderly-only household
167932|NCT03147599|Mebeverine|mebeverine
167933|NCT03147599|Incontinence|incontinence
167934|NCT03147599|Orthotopic Neobladder|orthotopic neobladder
167935|NCT03147586|Immune Nutrition|immune nutrition
167936|NCT03147586|Morbidity|morbidity
167937|NCT03147573|Hypertension|hypertension
167938|NCT03147573|Blood pressure monitoring|blood pressure monitoring
167939|NCT03147560|Immunogenicity|immunogenicity
167940|NCT03147560|Safety|safety
167941|NCT03147560|Sabin IPV|sabin ipv
167942|NCT03147560|bOPV|bopv
167943|NCT03147508|Diagnostics, clinical criteria, clincal reasoning, neck pain|diagnostics, clinical criteria, clincal reasoning, neck pain
167944|NCT03147456|bariatric|bariatric
167945|NCT03147456|obesity|obesity
167946|NCT03147456|protein supplements|protein supplements
400599|NCT01866072|Transient elastography|transient elastography
167947|NCT03147443|traditional Chinese medicine|traditional chinese medicine
167948|NCT03147443|Drugs, Chinese Herbal|drugs, chinese herbal
167949|NCT03147443|N-of-1 trials|n-of-1 trials
167950|NCT03147443|sputum|sputum
167951|NCT03147443|symptoms|symptoms
167952|NCT03147443|individualized treatment|individualized treatment
167953|NCT03147443|stable bronchiectasis|stable bronchiectasis
167954|NCT03147391|Atrial Fibrillation|atrial fibrillation
167955|NCT03147391|Left Atrial Appendage Closure|left atrial appendage closure
167956|NCT03147391|LAmbre device|lambre device
167957|NCT03147391|Stroke|stroke
167958|NCT03147352|Fasciitis|fasciitis
167959|NCT03147352|Gangrene|gangrene
167960|NCT03147352|Fasciitis, Necrotizing|fasciitis, necrotizing
167961|NCT03147352|Soft Tissue Infections|soft tissue infections
167962|NCT03147352|Fournier's Gangrene|fournier's gangrene
167963|NCT03147352|Streptococcal septic shock syndrome|streptococcal septic shock syndrome
167964|NCT03147352|Flesh eating bacteria|flesh eating bacteria
167965|NCT03147352|Meleneys ulcer|meleneys ulcer
167966|NCT03147352|Wounds and Injuries|wounds and injuries
167967|NCT03147352|Streptococcus pyogenes|streptococcus pyogenes
167968|NCT03147352|Staphylococcus aureus|staphylococcus aureus
167969|NCT03147352|Soft Tissue Infections/blood|soft tissue infections/blood
167970|NCT03147352|Necrosis/blood|necrosis/blood
167971|NCT03147352|Necrosis/diagnosis|necrosis/diagnosis
168068|NCT03146689|NSAID|nsaid
167972|NCT03147352|Necrosis/mortality|necrosis/mortality
167973|NCT03147352|Necrosis/surgery|necrosis/surgery
167974|NCT03147352|Prognosis|prognosis
167975|NCT03147352|Risk Factors|risk factors
167976|NCT03147352|Bacterial Infections|bacterial infections
167977|NCT03147352|Infection|infection
167978|NCT03147352|Skin Diseases, Bacterial|skin diseases, bacterial
167979|NCT03147352|Observational study|observational study
167980|NCT03147352|Biological markers|biological markers
167981|NCT03147352|Endothelium|endothelium
167982|NCT03147352|suPAR|supar
167983|NCT03147352|sTM|stm
167984|NCT03147352|syndecan-1|syndecan-1
167985|NCT03147352|sE-selectin|se-selectin
167986|NCT03147352|VE-cadherin|ve-cadherin
167987|NCT03147352|protein C|protein c
167988|NCT03147352|Hyperbaric oxygen therapy|hyperbaric oxygen therapy
167989|NCT03147352|HBOT|hbot
167990|NCT03147339|AGEs( Advanced glycation end products)|ages( advanced glycation end products)
167991|NCT03147313|extracorporeal shock wave|extracorporeal shock wave
167992|NCT03147313|microsurgical nerve coaptation|microsurgical nerve coaptation
167993|NCT03147313|nerve regeneration|nerve regeneration
167994|NCT03147300|Low back pain|low back pain
167995|NCT03147300|Model of care|model of care
167996|NCT03147300|Primary health care|primary health care
167997|NCT03147300|Implementation|implementation
167998|NCT03147300|Patient-rated outcome|patient-rated outcome
167999|NCT03147300|Clinician-rated outcome|clinician-rated outcome
168000|NCT03147300|Cost-effectiveness|cost-effectiveness
168001|NCT03147287|Breast Cancer|breast cancer
168002|NCT03147274|Diabetes Mellitus, Type 1|diabetes mellitus, type 1
168003|NCT03147274|Adolescence|adolescence
168004|NCT03147222|fragility fracture|fragility fracture
168005|NCT03147222|dementia|dementia
168006|NCT03147222|intervention|intervention
168007|NCT03147157|tacrolimus|tacrolimus
168008|NCT03147157|histocompatibility antigens|histocompatibility antigens
168009|NCT03147131|Total Hip Arthroplasty|total hip arthroplasty
168010|NCT03147131|Short Stem|short stem
168011|NCT03147131|DEXA|dexa
168012|NCT03147118|trapeziometacarpal arthritis|trapeziometacarpal arthritis
168013|NCT03147105|chronic progressive multiple sclerosis, mobility, arm ergometry, rehabilitation|chronic progressive multiple sclerosis, mobility, arm ergometry, rehabilitation
168014|NCT03147079|obesity|obesity
168015|NCT03147079|pregnancy|pregnancy
168016|NCT03147079|lifestyle|lifestyle
168017|NCT03147079|gestational weight gain|gestational weight gain
168018|NCT03147079|weight of offspring|weight of offspring
168019|NCT03147079|antenatal care|antenatal care
168020|NCT03147079|health behavior|health behavior
168021|NCT03147079|physical activity|physical activity
168022|NCT03147079|diet|diet
168023|NCT03147079|programme evaluation|programme evaluation
168024|NCT03147079|costs and costs analysis|costs and costs analysis
168025|NCT03147066|Dezocine|dezocine
168026|NCT03147066|CRBD|crbd
168027|NCT03147066|General anesthesia|general anesthesia
168028|NCT03147066|Urinary catheter|urinary catheter
168029|NCT03147040|Lobular|lobular
168030|NCT03147040|Metastatic or incurable locally advanced cancer|metastatic or incurable locally advanced cancer
168031|NCT03147040|Disease progression on endocrine therapy in advanced setting|disease progression on endocrine therapy in advanced setting
168032|NCT03147027|ischemic cardiomyopathy|ischemic cardiomyopathy
168033|NCT03147027|prophylactic ablation|prophylactic ablation
168034|NCT03147014|Echocardiography|echocardiography
168035|NCT03147014|Congenital Heart Disease|congenital heart disease
168036|NCT03147014|Maternal hyperoxygenation|maternal hyperoxygenation
168037|NCT03147001|Endurance exercise|endurance exercise
168038|NCT03147001|Dietary protein|dietary protein
168039|NCT03146975|Beta-defensins|beta-defensins
400600|NCT01866059|root caries|root caries
168040|NCT03146975|Chronic periodontitis|chronic periodontitis
168041|NCT03146975|Diabetes mellitus|diabetes mellitus
168042|NCT03146975|Non-surgical periodontal therapy|non-surgical periodontal therapy
168043|NCT03146897|Food Aid, Malnutrition, RUSF, FBF, Supplementary Food|food aid, malnutrition, rusf, fbf, supplementary food
168044|NCT03146845|Diabetic Foot Ulcer|diabetic foot ulcer
168045|NCT03146845|Pressure Ulcer|pressure ulcer
168046|NCT03146845|Leg Ulcer|leg ulcer
168047|NCT03146819|osteoarthritis|osteoarthritis
168048|NCT03146819|osteoarthritis knee|osteoarthritis knee
168049|NCT03146819|total knee replacement|total knee replacement
168050|NCT03146819|patient specific|patient specific
168051|NCT03146819|total knee arthroplasty|total knee arthroplasty
168052|NCT03146819|orthopedics|orthopedics
168053|NCT03146806|Cancer pain|cancer pain
168054|NCT03146806|Anesthesiology|anesthesiology
168055|NCT03146806|Opiates|opiates
168056|NCT03146806|Intranasal ketamine|intranasal ketamine
168057|NCT03146793|Calciphylaxis/complications|calciphylaxis/complications
168058|NCT03146793|Kidney Failure, Chronic/complications|kidney failure, chronic/complications
168059|NCT03146793|Renal Dialysis|renal dialysis
168060|NCT03146793|Thiosulfates/therapeutic use|thiosulfates/therapeutic use
168061|NCT03146793|Time Factors|time factors
168062|NCT03146741|Heart Failure|heart failure
168063|NCT03146702|Quality of Life|quality of life
168064|NCT03146689|osteoarthritis|osteoarthritis
168065|NCT03146689|n-of-1|n-of-1
168066|NCT03146689|ibuprofen|ibuprofen
168067|NCT03146689|capsaicin|capsaicin
168069|NCT03146689|topical|topical
168070|NCT03146663|Platinum-resistant|platinum-resistant
168071|NCT03146663|ovarian neoplasm|ovarian neoplasm
168072|NCT03146663|antineoplastic agents|antineoplastic agents
168073|NCT03146663|ovarian diseases|ovarian diseases
168074|NCT03146663|cancer of the ovary|cancer of the ovary
168075|NCT03146637|Activated CIK|activated cik
168076|NCT03146637|MUC1/CEA/EpCAM/GPC3|muc1/cea/epcam/gpc3
168077|NCT03146637|Bispecfic antibody|bispecfic antibody
168078|NCT03146637|liver cancer|liver cancer
168079|NCT03146598|Foot deformity|foot deformity
168080|NCT03146598|Orthopaedic management|orthopaedic management
168081|NCT03146598|prevention|prevention
168082|NCT03146598|side pole static ankle foot orthosis|side pole static ankle foot orthosis
168083|NCT03146585|Glycocalyx|glycocalyx
168084|NCT03146559|Cross education|cross education
168086|NCT03146520|Syndecan 2|syndecan 2
168087|NCT03146520|Methylation biomarker|methylation biomarker
168088|NCT03146520|Colorectal cancer|colorectal cancer
168089|NCT03146520|EarlyTect Colon Cancer test|earlytect colon cancer test
168090|NCT03146481|Anesthetic efficacy, Irriversible pulpitis, Aceclofenac|anesthetic efficacy, irriversible pulpitis, aceclofenac
168091|NCT03146455|Thrombelastograghy|thrombelastograghy
168092|NCT03146455|reference ranges|reference ranges
168093|NCT03146455|racial|racial
168094|NCT03146455|geographic|geographic
168095|NCT03146455|Blood Transfusion|blood transfusion
168096|NCT03146442|increased dietary protein|increased dietary protein
168097|NCT03146442|breakfast|breakfast
168098|NCT03146442|weight management|weight management
168099|NCT03146442|satiety|satiety
168100|NCT03146442|glucose control|glucose control
168101|NCT03146442|fMRI|fmri
168102|NCT03146442|cognitive performance|cognitive performance
168103|NCT03146442|memory|memory
168104|NCT03146442|attention|attention
168105|NCT03146442|executive function|executive function
168106|NCT03146442|structural MRI|structural mri
168107|NCT03146442|sleep quality|sleep quality
168108|NCT03146403|HSV|hsv
168109|NCT03146403|Herpes|herpes
168110|NCT03146403|Genital Herpes|genital herpes
168111|NCT03146403|Vaccine|vaccine
168112|NCT03146390|biofilms|biofilms
168113|NCT03146390|essential oils|essential oils
168114|NCT03146390|microscopy, confocal|microscopy, confocal
168115|NCT03146390|mouthwashes|mouthwashes
168116|NCT03146364|Virtual Reality|virtual reality
168117|NCT03146351|preterm|preterm
168118|NCT03146351|infant|infant
168119|NCT03146351|physiotherapy|physiotherapy
168120|NCT03146338|Anti-EGFR|anti-egfr
168121|NCT03146338|Hypomagnesemia|hypomagnesemia
168122|NCT03146338|Magnesium-rich mineral water|magnesium-rich mineral water
168123|NCT03146338|Metastatic colorectal or head and neck cancers|metastatic colorectal or head and neck cancers
168124|NCT03146325|H. pylori infection|h. pylori infection
168125|NCT03146312|gene expression|gene expression
168126|NCT03146312|gene array|gene array
168127|NCT03146312|epigenetics|epigenetics
168128|NCT03146312|DNA methylation|dna methylation
168129|NCT03146260|TESE|tese
168130|NCT03146260|Sperm retreival|sperm retreival
168131|NCT03146260|Azoospermia|azoospermia
168132|NCT03146260|FSH|fsh
168133|NCT03146260|LH|lh
168134|NCT03146208|Growth differentiation factor-15|growth differentiation factor-15
168135|NCT03146208|Dipeptidyl-peptidase inhibitors (DPP4 -I)|dipeptidyl-peptidase inhibitors (dpp4 -i)
168136|NCT03146208|Coronroy artery diseases|coronroy artery diseases
168137|NCT03146195|pelvic organ prolapse|pelvic organ prolapse
168138|NCT03146195|dynamic magnetic resonance imaging|dynamic magnetic resonance imaging
168139|NCT03146195|three-dimensional reconstruction|three-dimensional reconstruction
168140|NCT03146195|space coordinates|space coordinates
168141|NCT03146182|C-reactive protein|c-reactive protein
168142|NCT03146182|Procalcitonin|procalcitonin
168143|NCT03146182|Community-acquired pneumonia|community-acquired pneumonia
168144|NCT03146182|Antibiotic stewardship|antibiotic stewardship
168145|NCT03146156|obesity|obesity
168146|NCT03146156|overweight|overweight
168147|NCT03146156|lifestyle intervention|lifestyle intervention
168148|NCT03146156|fetal growth/adiposity|fetal growth/adiposity
168149|NCT03146156|Mediterranean diet|mediterranean diet
168150|NCT03146117|PET CT|pet ct
168151|NCT03146091|Antibiotics|antibiotics
168152|NCT03146052|Colon cleansing|colon cleansing
168153|NCT03146013|HTLV|htlv
168154|NCT03146013|Confirmatory|confirmatory
168155|NCT03146013|Supplemental|supplemental
168156|NCT03146013|Blot|blot
168157|NCT03146013|HTLV-I|htlv-i
168158|NCT03146013|HTLV-II|htlv-ii
168159|NCT03145987|Cognitive functioning|cognitive functioning
168160|NCT03145987|Neuropsychological status|neuropsychological status
168161|NCT03145987|Vitis vinifera|vitis vinifera
168162|NCT03145974|respiratory failure|respiratory failure
168163|NCT03145974|mechanical ventilation|mechanical ventilation
168164|NCT03145961|Breast cancer early stage|breast cancer early stage
168165|NCT03145961|circulating tumour DNA|circulating tumour dna
168166|NCT03145961|pembrolizumab|pembrolizumab
168167|NCT03145961|targeted therapy|targeted therapy
168168|NCT03145961|randomised clinical trial|randomised clinical trial
168169|NCT03145961|phase II|phase ii
168170|NCT03145961|mutation screening|mutation screening
168171|NCT03145961|intermediate endpoint|intermediate endpoint
168172|NCT03145948|Tolerability|tolerability
168173|NCT03145948|Psoriasis|psoriasis
168174|NCT03145948|Pharmacokinetics|pharmacokinetics
168175|NCT03145948|Safety|safety
168176|NCT03145948|Healthy Volunteers|healthy volunteers
168177|NCT03145909|Cancer|cancer
168178|NCT03145909|Metastatic|metastatic
168179|NCT03145909|Prolactin Receptor (PRLR)|prolactin receptor (prlr)
168180|NCT03145909|Breast cancer|breast cancer
168181|NCT03145909|Colorectal cancer|colorectal cancer
168182|NCT03145909|Adrenocortical carcinoma,|adrenocortical carcinoma,
168183|NCT03145909|Chromophobe renal cell carcinoma|chromophobe renal cell carcinoma
168184|NCT03145909|Hepatocellular carcinoma|hepatocellular carcinoma
168185|NCT03145896|vitamin D|vitamin d
168186|NCT03145896|Anemia|anemia
168187|NCT03145896|IBD|ibd
168188|NCT03145857|Gallium-68|gallium-68
168189|NCT03145857|Positron Emission Tomography|positron emission tomography
168190|NCT03145857|68Ga-HA-DOTATATE|68ga-ha-dotatate
168191|NCT03145844|DAA|daa
168192|NCT03145844|Hepatitis|hepatitis
168193|NCT03145831|Pediatrics|pediatrics
168194|NCT03145818|dissemination|dissemination
168195|NCT03145805|blood chemical analysis|blood chemical analysis
168196|NCT03145805|bupivacaine|bupivacaine
168197|NCT03145805|local anesthetic toxicity|local anesthetic toxicity
168198|NCT03145805|Drug-Related Side Effects and Adverse Reactions|drug-related side effects and adverse reactions
168199|NCT03145766|Rabies virus|rabies virus
168200|NCT03145753|HIV testing program|hiv testing program
168201|NCT03145753|HCV testing program|hcv testing program
168202|NCT03145753|education|education
168203|NCT03145727|Chemotherapy|chemotherapy
168204|NCT03145727|nausea|nausea
168205|NCT03145727|vomiting|vomiting
168206|NCT03145727|transcutaneous electrical acupoint stimulation|transcutaneous electrical acupoint stimulation
168207|NCT03145714|POCD|pocd
168208|NCT03145714|Elderly|elderly
168209|NCT03145688|Behavioural|behavioural
168210|NCT03145688|Family physical activity habit|family physical activity habit
168211|NCT03145675|Anticoagulation|anticoagulation
168212|NCT03145675|Enoxaparin|enoxaparin
168213|NCT03145675|Dose|dose
168214|NCT03145649|Breast milk|breast milk
168215|NCT03145649|Hormone|hormone
168216|NCT03145649|Infant growth|infant growth
168217|NCT03145649|Gestational diabetes mellitus|gestational diabetes mellitus
168218|NCT03145636|Obesity|obesity
168219|NCT03145636|Bariatric surgery|bariatric surgery
168220|NCT03145636|Vagal blocking|vagal blocking
168221|NCT03145636|vBloc therapy|vbloc therapy
168222|NCT03145636|Vagus Nerve|vagus nerve
168223|NCT03145636|Percent excess weight loss|percent excess weight loss
168224|NCT03145636|Percent total body weight loss|percent total body weight loss
168225|NCT03145597|facings|facings
168226|NCT03145597|veneers|veneers
168227|NCT03145597|laminates|laminates
168228|NCT03145597|existing|existing
168229|NCT03145597|restorations|restorations
168230|NCT03145597|esthetics|esthetics
168231|NCT03145597|dental|dental
168232|NCT03145584|Total Knee Arthroplasty|total knee arthroplasty
168233|NCT03145584|Physiotherapy|physiotherapy
168234|NCT03145558|Tirapazamine, embolization, TACE, Hepatocellular carcinoma|tirapazamine, embolization, tace, hepatocellular carcinoma
168235|NCT03145493|Drainage, Suction|drainage, suction
168236|NCT03145493|tranexamic acid|tranexamic acid
168237|NCT03145480|leukemia|leukemia
168238|NCT03145480|richter|richter
168239|NCT03145467|Migraine|migraine
168240|NCT03145467|Paracetamol|paracetamol
214930|NCT02849886|GvHD|gvhd
168241|NCT03145467|Zolmitriptan|zolmitriptan
168242|NCT03145467|Emergency services|emergency services
168243|NCT03145454|Pain|pain
168244|NCT03145454|children|children
168245|NCT03145454|emergency|emergency
168246|NCT03145454|electroencephalography|electroencephalography
168247|NCT03145454|heart rate|heart rate
168248|NCT03145454|skin conductance|skin conductance
168249|NCT03145454|pupillary diameter|pupillary diameter
168250|NCT03145415|pudendal nerve block|pudendal nerve block
168251|NCT03145415|hypospadias|hypospadias
168252|NCT03145415|caudal block|caudal block
168253|NCT03145376|TAVI|tavi
168254|NCT03145376|MitraClip|mitraclip
168255|NCT03145376|geriatric assessment|geriatric assessment
168256|NCT03145376|heart rate variability|heart rate variability
168257|NCT03145376|elderly|elderly
168258|NCT03145350|NAFLD|nafld
168259|NCT03145350|Fat intake|fat intake
168260|NCT03145350|Sugar intake|sugar intake
168261|NCT03145311|Repetitive transcranial magnetic stimulation, Drug Induced Tardive Syndrome|repetitive transcranial magnetic stimulation, drug induced tardive syndrome
168262|NCT03145298|HPAH (heritable)|hpah (heritable)
168263|NCT03145298|IPAH (idiopathic)|ipah (idiopathic)
168264|NCT03145298|PAH-CTD (connective tissue diseases)|pah-ctd (connective tissue diseases)
168265|NCT03145298|PAH-HIV (human immunodeficiency virus)|pah-hiv (human immunodeficiency virus)
168266|NCT03145285|Abiraterone Acetate|abiraterone acetate
168267|NCT03145285|Cushing Syndrome|cushing syndrome
168268|NCT03145285|Adrenocortical Carcinoma|adrenocortical carcinoma
168269|NCT03145272|Pharmacogenomics|pharmacogenomics
168270|NCT03145272|Pharmacokinetics|pharmacokinetics
168271|NCT03145272|Oxycodone|oxycodone
168272|NCT03145246|intrabony defect|intrabony defect
168273|NCT03145246|periodontal regeneration|periodontal regeneration
168274|NCT03145233|physiotherapy|physiotherapy
168275|NCT03145220|EA-230|ea-230
168276|NCT03145220|Systemic Inflammatory Response Syndrome|systemic inflammatory response syndrome
168277|NCT03145220|Acute Kidney Injury|acute kidney injury
168278|NCT03145220|Interleukin-6|interleukin-6
168279|NCT03145220|Safety|safety
168280|NCT03145220|Tolerability|tolerability
168281|NCT03145220|Phase II|phase ii
168282|NCT03145220|Randomized clinical trial|randomized clinical trial
168283|NCT03145155|continuum of care|continuum of care
168284|NCT03145155|maternal|maternal
168285|NCT03145155|newborn|newborn
168286|NCT03145155|child health|child health
168287|NCT03145155|noncommunicable diseases|noncommunicable diseases
168288|NCT03145142|Near-Infrared Spectroscopy|near-infrared spectroscopy
168289|NCT03145129|Intraocular pressure|intraocular pressure
168290|NCT03145129|IOP|iop
168291|NCT03145129|CPAP|cpap
168292|NCT03145090|bone scintigraphy|bone scintigraphy
168293|NCT03145090|knee arthroplasty|knee arthroplasty
168294|NCT03145090|spect-ct|spect-ct
168295|NCT03145090|quantification|quantification
168296|NCT03145077|Head and Neck Cancer|head and neck cancer
168297|NCT03145077|Osteoradionecrosis|osteoradionecrosis
168298|NCT03145077|ORN|orn
168299|NCT03145077|Dynamic contrast-enhanced magnetic resonance imaging|dynamic contrast-enhanced magnetic resonance imaging
168300|NCT03145077|DCE-MRI|dce-mri
168301|NCT03145077|Questionnaires|questionnaires
168302|NCT03145077|Surveys|surveys
168303|NCT03145064|relapsed/refractory non-GCB type|relapsed/refractory non-gcb type
168304|NCT03145051|saline solution|saline solution
168305|NCT03145051|minerals|minerals
168306|NCT03145051|cystic fibrosis|cystic fibrosis
168307|NCT03145051|chronic rhinosinusitis|chronic rhinosinusitis
168308|NCT03145051|nasal irrigation|nasal irrigation
168309|NCT03145012|Cancer|cancer
168310|NCT03145012|Immunity|immunity
168311|NCT03145012|Peripheral Blood Mononuclear Cells|peripheral blood mononuclear cells
168312|NCT03145012|Ranitidine|ranitidine
168313|NCT03144999|Dry AMD|dry amd
168314|NCT03144999|Dry Age-related Macular Degeneration|dry age-related macular degeneration
168315|NCT03144999|Gene Therapy|gene therapy
168316|NCT03144999|Complement|complement
168317|NCT03144999|Intravitreal Injection|intravitreal injection
168318|NCT03144999|Geographic Atrophy|geographic atrophy
168319|NCT03144999|Drusen|drusen
168320|NCT03144999|Membrane Attack Complex|membrane attack complex
168321|NCT03144999|CD59|cd59
168322|NCT03144934|HPV|hpv
168323|NCT03144921|Early-stage Dementia|early-stage dementia
168324|NCT03144921|Early-stage Alzheimer's disease|early-stage alzheimer's disease
168325|NCT03144921|Care partner|care partner
168326|NCT03144921|Caregivers|caregivers
168327|NCT03144921|Caregiving|caregiving
168328|NCT03144869|type 1 diabetes mellitus|type 1 diabetes mellitus
168329|NCT03144869|physical activity|physical activity
168330|NCT03144869|children|children
168331|NCT03144869|constant glucose monitoring|constant glucose monitoring
168332|NCT03144856|Biliary Tract Cancer|biliary tract cancer
168333|NCT03144856|Second line thrapy|second line thrapy
168334|NCT03144856|Apatinib|apatinib
168335|NCT03144843|Gastric cancer|gastric cancer
168336|NCT03144843|Peritoneal metastasis|peritoneal metastasis
168337|NCT03144843|Paclitaxol|paclitaxol
215056|NCT02849249|allergy|allergy
168338|NCT03144843|Apatinib|apatinib
168339|NCT03144843|Second-line chemotherapy|second-line chemotherapy
168340|NCT03144817|hemodialysis|hemodialysis
168341|NCT03144817|fluid overload|fluid overload
168342|NCT03144817|dialysis disequilibrium|dialysis disequilibrium
168343|NCT03144817|intra-dialytic hypotension|intra-dialytic hypotension
168344|NCT03144817|dialysate sodium lowering|dialysate sodium lowering
168345|NCT03144804|Colorectal Cancer|colorectal cancer
168346|NCT03144765|taTME|tatme
168347|NCT03144765|Transanal|transanal
168348|NCT03144765|Rectal cancer|rectal cancer
168349|NCT03144765|Colorectal|colorectal
168350|NCT03144765|Total mesorectal excision|total mesorectal excision
168351|NCT03144765|TME|tme
168352|NCT03144687|Myelofibrosis|myelofibrosis
168353|NCT03144687|Janus kinase (JAK) inhibitor|janus kinase (jak) inhibitor
168354|NCT03144687|itacitinib|itacitinib
168355|NCT03144687|ruxolitinib|ruxolitinib
168356|NCT03144674|Marginal zone lymphoma|marginal zone lymphoma
168357|NCT03144674|phosphatidylinositol 3-kinase (PI3K)δ inhibitor|phosphatidylinositol 3-kinase (pi3k)δ inhibitor
168358|NCT03144674|indolent (slow-growing) non-Hodgkin lymphoma B-cell lymphoma|indolent (slow-growing) non-hodgkin lymphoma b-cell lymphoma
168359|NCT03144661|hepatocellular carcinoma|hepatocellular carcinoma
168360|NCT03144661|cholangiocarcinoma|cholangiocarcinoma
168361|NCT03144661|esophageal|esophageal
168362|NCT03144661|nasopharyngeal|nasopharyngeal
168363|NCT03144661|serous ovarian|serous ovarian
168364|NCT03144661|solid tumors|solid tumors
168365|NCT03144661|fibroblast growth factor (FGF)|fibroblast growth factor (fgf)
168366|NCT03144661|fibroblast growth factor receptor (FGFR)|fibroblast growth factor receptor (fgfr)
168367|NCT03144635|Direct Acting Antivirals|direct acting antivirals
168368|NCT03144635|Grazoprevir|grazoprevir
168369|NCT03144635|Elbasvir|elbasvir
168370|NCT03144622|(4S)-4-(3-[18F]fluoropropyl-)-L-glutamate|(4s)-4-(3-[18f]fluoropropyl-)-l-glutamate
168371|NCT03144622|18F-FSPG|18f-fspg
168372|NCT03144622|PET/CT|pet/ct
168373|NCT03144622|system xC-transporter|system xc-transporter
168374|NCT03144609|mechanical ventilation, obesity, oral-surgical procedures|mechanical ventilation, obesity, oral-surgical procedures
168375|NCT03144583|CART19|cart19
168376|NCT03144570|ICU, encephalitis, meningo-encephalitis, seizures|icu, encephalitis, meningo-encephalitis, seizures
168377|NCT03144557|Education|education
168378|NCT03144557|COPD|copd
168379|NCT03144557|Inhalation Devices|inhalation devices
168380|NCT03144544|Similarity|similarity
168381|NCT03144544|Diversity|diversity
168382|NCT03144531|School-age child|school-age child
168383|NCT03144518|Positive Affect|positive affect
168384|NCT03144518|Positive Mood|positive mood
168385|NCT03144518|Influenza Vaccination|influenza vaccination
168386|NCT03144518|Vaccination|vaccination
168387|NCT03144518|Randomised Controlled Trial|randomised controlled trial
168388|NCT03144505|Type 2 Diabetes|type 2 diabetes
168389|NCT03144505|Exercise|exercise
168390|NCT03144505|High Intensity Interval Training|high intensity interval training
168391|NCT03144505|Glycemic Control|glycemic control
168392|NCT03144492|Cell Culture|cell culture
168393|NCT03144492|Microgravity co-culture|microgravity co-culture
168394|NCT03144453|Curare|curare
168395|NCT03144453|Robotic surgery|robotic surgery
168396|NCT03144440|ZEPATIER|zepatier
168397|NCT03144427|albumin|albumin
168398|NCT03144427|resuscitation|resuscitation
168399|NCT03144427|burns|burns
168400|NCT03144427|shock|shock
168401|NCT03144427|fluid creep|fluid creep
168402|NCT03144401|cesarean section|cesarean section
168403|NCT03144401|Misoprostol|misoprostol
168404|NCT03144401|sublingual|sublingual
168405|NCT03144401|uterotonics|uterotonics
168406|NCT03144323|Intraoral elastics|intraoral elastics
168407|NCT03144258|congenital heart defects|congenital heart defects
168408|NCT03144258|systemic microcirculation|systemic microcirculation
168409|NCT03144258|laser Doppler perfusion imaging|laser doppler perfusion imaging
168410|NCT03144258|cardiac corrective surgery|cardiac corrective surgery
168411|NCT03144245|AML|aml
168412|NCT03144245|treatment|treatment
168413|NCT03144245|relapsed|relapsed
168414|NCT03144245|refractory|refractory
168415|NCT03144245|phase 1|phase 1
168416|NCT03144219|intracranial pressure|intracranial pressure
168417|NCT03144219|transcranial Doppler|transcranial doppler
168418|NCT03144219|jugular compression|jugular compression
168419|NCT03144219|cerebral compliance|cerebral compliance
168420|NCT03144193|topical treatment|topical treatment
168421|NCT03144193|wrinkles|wrinkles
168422|NCT03144193|extracellular matrix|extracellular matrix
168423|NCT03144180|pregnant|pregnant
168424|NCT03144180|third trimester|third trimester
168425|NCT03144180|umbilical cord blood collection|umbilical cord blood collection
168426|NCT03144154|Cancer|cancer
168427|NCT03144154|Fatigue|fatigue
168428|NCT03144154|Hypnosis|hypnosis
168429|NCT03144154|Self-hypnosis|self-hypnosis
168430|NCT03144154|Self-care|self-care
168431|NCT03144154|Emotional distress|emotional distress
168432|NCT03144154|Cancer survivors|cancer survivors
168433|NCT03144128|vitamin D|vitamin d
168434|NCT03144128|muscle|muscle
168435|NCT03144128|metabolism|metabolism
168436|NCT03144128|cancer cachexia|cancer cachexia
168437|NCT03144115|oxytocin|oxytocin
168438|NCT03144115|sex hormone|sex hormone
168439|NCT03144115|verbal reward|verbal reward
168440|NCT03144115|mate selection|mate selection
168441|NCT03144115|metaphorical language|metaphorical language
168442|NCT03144089|Morbid obesity|morbid obesity
168443|NCT03144089|Obstructive sleep apnea|obstructive sleep apnea
168444|NCT03144089|Mask ventilation|mask ventilation
168445|NCT03144089|Upper airway obstruction|upper airway obstruction
168446|NCT03144076|healthcare|healthcare
168447|NCT03144076|India|india
168448|NCT03144076|health insurance|health insurance
168449|NCT03144076|RSBY|rsby
168450|NCT03144076|free health insurance|free health insurance
168451|NCT03144076|inpatient insurance|inpatient insurance
168452|NCT03144076|wealth transfer|wealth transfer
168453|NCT03144063|Disease Activity|disease activity
168454|NCT03144063|SLEDAI-2K|sledai-2k
168455|NCT03144024|Tricuspid Regurgitation|tricuspid regurgitation
168456|NCT03144024|Insufficiency, Tricuspid Valve|insufficiency, tricuspid valve
168457|NCT03144024|Valvular Annuloplasty|valvular annuloplasty
168458|NCT03144024|Cardiac Valve Annulus Repair|cardiac valve annulus repair
168459|NCT03144011|acute kidney injury, cardiosurgery|acute kidney injury, cardiosurgery
168460|NCT03143985|TEW-7197|tew-7197
168461|NCT03143985|Pomalidomide|pomalidomide
168462|NCT03143972|Dexmedetomidine|dexmedetomidine
168463|NCT03143972|Remifentanil|remifentanil
168464|NCT03143972|Pharmacodynamics|pharmacodynamics
168465|NCT03143972|Interaction|interaction
168466|NCT03143946|neuroendocrine tumor|neuroendocrine tumor
168467|NCT03143946|vitamin|vitamin
168468|NCT03143946|diet|diet
168469|NCT03143933|propofol, BIS, general anesthesia|propofol, bis, general anesthesia
168570|NCT03143283|suicidal|suicidal
168470|NCT03143920|hyperbaric oxygen|hyperbaric oxygen
168471|NCT03143920|inflammation|inflammation
168472|NCT03143920|chronic disease|chronic disease
168473|NCT03143920|urinary bladder|urinary bladder
168474|NCT03143920|urinary tract infection|urinary tract infection
168475|NCT03143920|recurrent urinary tract infection|recurrent urinary tract infection
168476|NCT03143920|painful bladder syndrome|painful bladder syndrome
168477|NCT03143920|chronic pain|chronic pain
168478|NCT03143920|hypoxia|hypoxia
168479|NCT03143920|bacterial infection|bacterial infection
168480|NCT03143907|Mindfulness|mindfulness
168481|NCT03143907|Group Therapy|group therapy
168482|NCT03143894|Breast Cancer|breast cancer
168483|NCT03143894|Cognition|cognition
168484|NCT03143894|Fatigue|fatigue
168485|NCT03143894|Cancer-related Cognitive Impairment|cancer-related cognitive impairment
168486|NCT03143894|Transcranial Direct Current Stimulation|transcranial direct current stimulation
168487|NCT03143868|acute exercise|acute exercise
168488|NCT03143868|resistance exercise|resistance exercise
168489|NCT03143868|aerobic exercise|aerobic exercise
168490|NCT03143868|appetite|appetite
168491|NCT03143868|energy intake|energy intake
168492|NCT03143855|oxycodone|oxycodone
168493|NCT03143855|lorcaserin|lorcaserin
168494|NCT03143855|Belviq|belviq
168495|NCT03143842|VNS|vns
168496|NCT03143842|accelerate learning|accelerate learning
168497|NCT03143842|memory|memory
168498|NCT03143829|gerontology|gerontology
168499|NCT03143829|symptom self-management|symptom self-management
168500|NCT03143829|Chemotherapy-induced Nausea and Vomiting|chemotherapy-induced nausea and vomiting
168501|NCT03143816|diabetes|diabetes
168502|NCT03143816|time in range|time in range
168503|NCT03143816|inhaled insulin|inhaled insulin
168504|NCT03143816|continuous glucose monitoring|continuous glucose monitoring
168505|NCT03143816|type 1 diabetes|type 1 diabetes
168506|NCT03143816|hypoglycemia|hypoglycemia
168507|NCT03143816|post prandial hypergylcemia|post prandial hypergylcemia
168508|NCT03143790|Erectile Function|erectile function
168509|NCT03143790|Prostatectomy|prostatectomy
168510|NCT03143790|Extracorporeal Shock Wave Therapy|extracorporeal shock wave therapy
168511|NCT03143790|IIEF-5|iief-5
168512|NCT03143777|physiotherapy|physiotherapy
168513|NCT03143777|rehabilitation|rehabilitation
168514|NCT03143777|critical care|critical care
168515|NCT03143777|seating|seating
168516|NCT03143738|regional anesthesia|regional anesthesia
168517|NCT03143738|knee replacement|knee replacement
168518|NCT03143738|pain treatment|pain treatment
168519|NCT03143738|rehabilitation|rehabilitation
168520|NCT03143686|Severe symptomatic Aortic Stenosis|severe symptomatic aortic stenosis
168521|NCT03143673|Severe Symptomatic Aortic Valve Stenosis|severe symptomatic aortic valve stenosis
168522|NCT03143660|obesity|obesity
168523|NCT03143608|GERD|gerd
168524|NCT03143608|Hiatal hernia repair|hiatal hernia repair
168525|NCT03143608|Transoral Incision less fundoplication|transoral incision less fundoplication
168526|NCT03143595|Preexisting cognitive impairment|preexisting cognitive impairment
168527|NCT03143595|Elderly|elderly
168528|NCT03143595|Outcomes|outcomes
168529|NCT03143556|renal transplant|renal transplant
168530|NCT03143556|magnetic ureteral stent|magnetic ureteral stent
168531|NCT03143556|Black-Star®|black-star®
168532|NCT03143543|cocaine disorder|cocaine disorder
168533|NCT03143543|opioid disorder|opioid disorder
168534|NCT03143543|lorcaserin|lorcaserin
168535|NCT03143543|MRI|mri
168536|NCT03143543|fMRI|fmri
168537|NCT03143530|Ropivacaine|ropivacaine
168538|NCT03143517|Inflammatory Bowel Diseases|inflammatory bowel diseases
168539|NCT03143517|Irritable Bowel Syndrome|irritable bowel syndrome
168540|NCT03143517|Ulcerative Colitis|ulcerative colitis
168541|NCT03143517|Crohn Disease|crohn disease
168542|NCT03143517|Indeterminate Colitis|indeterminate colitis
168543|NCT03143426|3D laparoscopic cholecystectomy|3d laparoscopic cholecystectomy
168544|NCT03143426|Junior surgeons|junior surgeons
168545|NCT03143426|Complication|complication
168546|NCT03143426|Conversion|conversion
168547|NCT03143413|Salivary glands ultrasonography|salivary glands ultrasonography
168548|NCT03143413|Systemic sclerosis|systemic sclerosis
168549|NCT03143413|Gougerot Sjogren syndrome|gougerot sjogren syndrome
168550|NCT03143413|Sicca syndrome|sicca syndrome
168551|NCT03143400|Probiotics|probiotics
168552|NCT03143400|Galenic form|galenic form
168553|NCT03143400|Digestive tract|digestive tract
168554|NCT03143400|Intestinal microbiota|intestinal microbiota
168555|NCT03143400|Lactobacillus salivarius|lactobacillus salivarius
168556|NCT03143361|aortic valve stenosis|aortic valve stenosis
168557|NCT03143361|heart valves|heart valves
168558|NCT03143361|heart surgery|heart surgery
168559|NCT03143335|Breast; Reconstruction; BAD; Implant; ADM|breast; reconstruction; bad; implant; adm
168560|NCT03143322|Bone-only metastases|bone-only metastases
168561|NCT03143322|solid tumors|solid tumors
168562|NCT03143322|SBRT|sbrt
168563|NCT03143283|suicide|suicide
168564|NCT03143283|lethal means|lethal means
168565|NCT03143283|counseling|counseling
168566|NCT03143283|youth|youth
168567|NCT03143283|parents|parents
168568|NCT03143283|firearms|firearms
168569|NCT03143283|medication|medication
168571|NCT03143283|emergency department|emergency department
168572|NCT03143270|nivolumab|nivolumab
168573|NCT03143270|deb-TACE|deb-tace
168574|NCT03143270|17-087|17-087
168575|NCT03143218|Malaria|malaria
168576|NCT03143218|Seasonal vaccination|seasonal vaccination
168577|NCT03143218|Seasonal chemoprevention|seasonal chemoprevention
168578|NCT03143192|DME, Micropulse Laser, Anti-VEGF|dme, micropulse laser, anti-vegf
168579|NCT03143140|Ablation Techniques|ablation techniques
168580|NCT03143101|FluMist Quadrivalent|flumist quadrivalent
168581|NCT03143101|Trivalent|trivalent
168582|NCT03143101|Influenza|influenza
168583|NCT03143101|Vaccine|vaccine
168584|NCT03143101|Prevention|prevention
168585|NCT03143088|Blood pressure|blood pressure
168586|NCT03143088|Medical clown|medical clown
168587|NCT03143088|Pediatric|pediatric
168588|NCT03143062|National Early Warning Score|national early warning score
168589|NCT03143062|Rapid response system|rapid response system
168590|NCT03143049|Pomalidomide|pomalidomide
168591|NCT03143036|daratumumab|daratumumab
168592|NCT03142971|Shock waves|shock waves
168593|NCT03142971|Greater trochanteric pain syndrome|greater trochanteric pain syndrome
168594|NCT03142932|smoking|smoking
168595|NCT03142919|Mood Disorder|mood disorder
168596|NCT03142919|MDD|mdd
168597|NCT03142919|Endotoxin|endotoxin
168598|NCT03142919|MRI|mri
168599|NCT03142919|CRP|crp
168600|NCT03142906|preoperative, perioperative, point-of-care ultrasound|preoperative, perioperative, point-of-care ultrasound
168601|NCT03142893|testosterone|testosterone
168602|NCT03142893|cortisol|cortisol
168603|NCT03142880|marginally hyperbaric|marginally hyperbaric
168604|NCT03142880|ropivacaine|ropivacaine
168605|NCT03142880|cesarean|cesarean
168606|NCT03142867|Non-Alcoholic Fatty Liver Disease|non-alcoholic fatty liver disease
168607|NCT03142867|Non Alcoholic Steatohepatitis|non alcoholic steatohepatitis
168608|NCT03142867|Prevalence|prevalence
168609|NCT03142867|Coronary Artery Disease|coronary artery disease
168610|NCT03142867|PDFF|pdff
168611|NCT03142854|bowel preparation|bowel preparation
168612|NCT03142854|colonoscopy|colonoscopy
168613|NCT03142854|predictive model|predictive model
168614|NCT03142841|Depression|depression
168615|NCT03142841|Burden|burden
168616|NCT03142841|Problem Solving Ability|problem solving ability
168617|NCT03142841|Caregivers|caregivers
168618|NCT03142841|Stroke|stroke
168619|NCT03142841|Veterans|veterans
168620|NCT03142828|chlorhexidine, dental implant, in-situ drug delivery,|chlorhexidine, dental implant, in-situ drug delivery,
168621|NCT03142815|Coronary Artery Bypass Graft (CABG), Arterial stiffness|coronary artery bypass graft (cabg), arterial stiffness
168622|NCT03142802|Testicular cancer|testicular cancer
168623|NCT03142802|low-dose CT|low-dose ct
168624|NCT03142802|CT scan|ct scan
168625|NCT03142789|Pain|pain
168626|NCT03142789|Total knee arthroplasty|total knee arthroplasty
168627|NCT03142789|Regional anesthesia|regional anesthesia
168628|NCT03142776|clarithromycin|clarithromycin
168629|NCT03142776|photodynamic therapy|photodynamic therapy
168630|NCT03142776|Antimicrobial therapy|antimicrobial therapy
168631|NCT03142776|Periodontal pocket|periodontal pocket
168632|NCT03142724|HV|hv
168633|NCT03142698|hepatic steatosis|hepatic steatosis
168634|NCT03142698|MRImaging|mrimaging
168635|NCT03142685|NEC|nec
168636|NCT03142685|Bowel Ultrasound|bowel ultrasound
168637|NCT03142685|CHD|chd
168638|NCT03142672|Postoperative pain|postoperative pain
168639|NCT03142672|child|child
168640|NCT03142672|pulpotomy|pulpotomy
168641|NCT03142672|general anesthesia|general anesthesia
168642|NCT03142620|Drug resistant H.pylori infection|drug resistant h.pylori infection
168643|NCT03142620|vitamin D|vitamin d
168644|NCT03142620|gastritis|gastritis
168645|NCT03142529|Non dialysis|non dialysis
168646|NCT03142516|Clinical Trial, Phase II|clinical trial, phase ii
168647|NCT03142516|Elderly|elderly
168648|NCT03142516|Aged|aged
168649|NCT03142516|Disease-Free Survival|disease-free survival
168650|NCT03142516|Safety|safety
168651|NCT03142516|Tolerability|tolerability
168652|NCT03142516|Chemotherapy regimen|chemotherapy regimen
168653|NCT03142516|Monoclonal antibody|monoclonal antibody
168654|NCT03142516|FOLFIRI|folfiri
168655|NCT03142516|Panitumumab|panitumumab
168656|NCT03142516|RAS/BRAF Wild-type|ras/braf wild-type
168657|NCT03142503|psoriatic arthritis|psoriatic arthritis
168658|NCT03142503|psoriasis|psoriasis
168659|NCT03142503|body composition|body composition
168660|NCT03142503|DXA measurements|dxa measurements
168661|NCT03142503|spondyloarthritis|spondyloarthritis
168662|NCT03142503|diet therapy|diet therapy
168663|NCT03142503|adipose tissue|adipose tissue
168664|NCT03142490|Acupuncture|acupuncture
168665|NCT03142490|Infertility|infertility
168666|NCT03142490|In vitro fertilization|in vitro fertilization
168667|NCT03142490|Quality of life|quality of life
168668|NCT03142490|Stress|stress
168669|NCT03142490|Anxiety|anxiety
168670|NCT03142477|Therapeutic touch|therapeutic touch
168671|NCT03142477|Reiki|reiki
168672|NCT03142477|Laying-on-of-Hands|laying-on-of-hands
168673|NCT03142477|Spiritual Therapies|spiritual therapies
168674|NCT03142464|saline solution|saline solution
168675|NCT03142464|laparoscopy|laparoscopy
168676|NCT03142464|cholecystectomy|cholecystectomy
168677|NCT03142464|outcomes|outcomes
168678|NCT03142412|Lupus|lupus
168679|NCT03142412|SLE|sle
168680|NCT03142412|Systemic Lupus Erythematosus|systemic lupus erythematosus
168681|NCT03142399|heart failure|heart failure
168682|NCT03142399|cardiac reabilitation|cardiac reabilitation
168683|NCT03142399|nutritional status|nutritional status
168684|NCT03142399|quality of life|quality of life
168685|NCT03142399|milk protein|milk protein
168686|NCT03142386|geriatric oncology|geriatric oncology
168687|NCT03142386|pain|pain
168688|NCT03142386|osteopathic manipulative treatment|osteopathic manipulative treatment
168689|NCT03142386|quality of life|quality of life
168690|NCT03142373|heart rate variability|heart rate variability
168691|NCT03142373|autonomic nervous system|autonomic nervous system
168692|NCT03142373|osteopathic manipulative treatment|osteopathic manipulative treatment
168693|NCT03142373|skin conductance|skin conductance
168694|NCT03142347|remote endarterectomy|remote endarterectomy
168695|NCT03142347|DCB balloon|dcb balloon
168696|NCT03142334|Programmed Cell Death-1 (PD1, PD-1)|programmed cell death-1 (pd1, pd-1)
168697|NCT03142334|Programmed Death-Ligand 1 (PDL1, PD-L1)|programmed death-ligand 1 (pdl1, pd-l1)
168698|NCT03142334|Adjuvant|adjuvant
168699|NCT03142308|Satisfaction|satisfaction
168700|NCT03142308|Training program|training program
168701|NCT03142308|Egypt|egypt
168702|NCT03142308|Cross-sectional|cross-sectional
168703|NCT03142308|Multi-center|multi-center
168704|NCT03142295|Urine transfusion|urine transfusion
168705|NCT03142295|Recurrent urinary tract infection|recurrent urinary tract infection
168706|NCT03142295|Urinary microbiota|urinary microbiota
168707|NCT03142282|maintenance treatment|maintenance treatment
168708|NCT03142243|Tennis|tennis
168709|NCT03142243|Asymmetry|asymmetry
168710|NCT03142243|Morphological|morphological
168711|NCT03142230|feeding tube|feeding tube
168712|NCT03142230|gastric|gastric
168713|NCT03142230|newborn infant|newborn infant
168714|NCT03142230|nursing|nursing
168715|NCT03142230|pain|pain
168716|NCT03142191|Idiopathic Pulmonary Fibrosis (IPF)|idiopathic pulmonary fibrosis (ipf)
168717|NCT03142191|Pulmonary Fibrosis|pulmonary fibrosis
168718|NCT03142191|CC-90001|cc-90001
168719|NCT03142191|Safety|safety
168720|NCT03142191|Efficacy|efficacy
168721|NCT03142191|IPF|ipf
168722|NCT03142191|idiopathic pulmonary fibrosis|idiopathic pulmonary fibrosis
168723|NCT03142178|osteoarthritis|osteoarthritis
168724|NCT03142178|pain|pain
168725|NCT03142178|knee|knee
168726|NCT03142152|Functional Mitral Regurgitation|functional mitral regurgitation
168727|NCT03142152|Percutaneous Mitral Valve Repair|percutaneous mitral valve repair
168728|NCT03142152|Percutaneous Mitral Valve Annuloplasty|percutaneous mitral valve annuloplasty
168729|NCT03142152|Coronary Sinus Annuloplasty|coronary sinus annuloplasty
168730|NCT03142152|Secondary Mitral Regurgitation|secondary mitral regurgitation
168731|NCT03142152|Functional MR|functional mr
168732|NCT03142152|FMR|fmr
400601|NCT01866059|GIC|gic
168733|NCT03142139|Observational study; DTaP-IPV-Hib; Atopic Dermatitis; AD; Heterologous immunity; Non-specific effects; Non-targeted effects; Immunization;|observational study; dtap-ipv-hib; atopic dermatitis; ad; heterologous immunity; non-specific effects; non-targeted effects; immunization;
168734|NCT03142113|optimization|optimization
168735|NCT03142113|adalimumab|adalimumab
168736|NCT03142087|balance|balance
168737|NCT03142087|brain tumor|brain tumor
168738|NCT03142087|virtual reality|virtual reality
168739|NCT03142074|Improve diagnosis|improve diagnosis
168740|NCT03142009|Community-Based Participatory Research|community-based participatory research
168741|NCT03141996|vibration|vibration
168742|NCT03141996|stroke|stroke
168743|NCT03141996|activities of daily living|activities of daily living
168744|NCT03141983|ESRD|esrd
168745|NCT03141983|End-Stage Kidney Disease|end-stage kidney disease
168746|NCT03141970|Proteinuria Hypoproteinemia Edema Hypoalbuminemia Prednisone|proteinuria hypoproteinemia edema hypoalbuminemia prednisone
168747|NCT03141957|Aging|aging
168748|NCT03141957|Hypermetabolism|hypermetabolism
168749|NCT03141944|non motor symptoms|non motor symptoms
168750|NCT03141931|Nutraceutical supplement|nutraceutical supplement
168751|NCT03141905|patient safety|patient safety
168752|NCT03141905|self-management|self-management
168753|NCT03141905|remote monitoring|remote monitoring
168754|NCT03141879|Frailty|frailty
168755|NCT03141879|Physical Activity|physical activity
168756|NCT03141879|Resistance training|resistance training
168757|NCT03141853|Randomized Controlled Trial|randomized controlled trial
168758|NCT03141853|Intervention Study|intervention study
168759|NCT03141827|Lipoprotein|lipoprotein
168760|NCT03141827|Apolipoprotein|apolipoprotein
168761|NCT03141827|Pancreatic clamp|pancreatic clamp
168762|NCT03141827|Insulin|insulin
168763|NCT03141827|Nasal|nasal
168764|NCT03141801|ACL|acl
168765|NCT03141801|Knee|knee
168766|NCT03141801|Muscle|muscle
168767|NCT03141788|Aligners|aligners
168768|NCT03141775|Clostridium difficile associated diarrhea (CDAD)|clostridium difficile associated diarrhea (cdad)
168769|NCT03141762|Falls|falls
168770|NCT03141762|Intensive care|intensive care
168771|NCT03141736|Infant|infant
168772|NCT03141736|Newborn|newborn
168773|NCT03141736|Preterm|preterm
168774|NCT03141736|Hypothermia|hypothermia
168775|NCT03141736|Kangaroo|kangaroo
168776|NCT03141736|Plastic|plastic
168777|NCT03141736|Bag|bag
168778|NCT03141723|Infant|infant
168779|NCT03141723|Newborn|newborn
168780|NCT03141723|Preterm|preterm
168781|NCT03141723|Hypothermia|hypothermia
168782|NCT03141723|Kangaroo|kangaroo
168783|NCT03141723|Plastic|plastic
168784|NCT03141723|Bag|bag
168785|NCT03141697|Carbon Dioxide|carbon dioxide
168786|NCT03141697|Coloboscopy|coloboscopy
168787|NCT03141671|Prostate Cancer|prostate cancer
168788|NCT03141658|TS-134|ts-134
168789|NCT03141658|ketamine|ketamine
168790|NCT03141658|fMRI|fmri
168791|NCT03141619|cerebral oximetry|cerebral oximetry
168792|NCT03141619|near-infrared spectroscopy|near-infrared spectroscopy
168793|NCT03141619|neurocognitive|neurocognitive
168794|NCT03141619|post-ICU syndrome|post-icu syndrome
168795|NCT03141593|adherence to medication|adherence to medication
168796|NCT03141593|electronic monitoring|electronic monitoring
168797|NCT03141567|Lymphangiogenesis|lymphangiogenesis
168798|NCT03141567|Heart Failure|heart failure
168799|NCT03141541|low back pain|low back pain
168800|NCT03141541|cognitive behavioural therapy|cognitive behavioural therapy
168801|NCT03141541|randomised controlled trial|randomised controlled trial
168802|NCT03141528|Self-learning|self-learning
168803|NCT03141528|Instructor-led learning|instructor-led learning
168804|NCT03141528|Long-term retention|long-term retention
168805|NCT03141515|lung ultrasound|lung ultrasound
168806|NCT03141515|recruitment maneuver|recruitment maneuver
168807|NCT03141515|atelectasis|atelectasis
168808|NCT03141515|children|children
168809|NCT03141502|tension wound|tension wound
168810|NCT03141502|skin stretching device|skin stretching device
168811|NCT03141502|skin grafting|skin grafting
168812|NCT03141476|Surgery|surgery
168813|NCT03141476|Obesity|obesity
168814|NCT03141476|Drug|drug
168815|NCT03141476|Antibiotics|antibiotics
168816|NCT03141476|Cefuroxime|cefuroxime
168817|NCT03141463|Therapeutic vaccination|therapeutic vaccination
168818|NCT03141372|Total Laparoscopic Hysterectomy|total laparoscopic hysterectomy
168819|NCT03141372|Urinary Retention|urinary retention
168820|NCT03141372|Backfill Void Trial|backfill void trial
168821|NCT03141372|Autofill Void Trial|autofill void trial
168822|NCT03141346|mother|mother
168823|NCT03141346|infant|infant
168824|NCT03141346|nutrition|nutrition
168825|NCT03141346|sugar|sugar
168826|NCT03141346|obesity|obesity
168827|NCT03141346|growth|growth
168828|NCT03141307|Neonatal screening|neonatal screening
168829|NCT03141307|Biobank|biobank
168830|NCT03141307|Broad Consent|broad consent
168831|NCT03141294|tracheostomy，fascia，force gauge|tracheostomy，fascia，force gauge
168832|NCT03141281|aging|aging
168833|NCT03141281|cognitive ability|cognitive ability
168834|NCT03141281|IADL|iadl
168835|NCT03141281|driving|driving
168836|NCT03141281|financial fraud|financial fraud
168837|NCT03141281|perception|perception
168838|NCT03141281|attention|attention
168839|NCT03141281|memory|memory
168840|NCT03141255|Therapeutic Hypothermia (TH)|therapeutic hypothermia (th)
168841|NCT03141242|Advance Care Planning|advance care planning
168842|NCT03141242|Group Medial Visit|group medial visit
168843|NCT03141242|Shared Medical Appointment|shared medical appointment
168844|NCT03141229|MBSR|mbsr
168845|NCT03141229|Children|children
168846|NCT03141229|Teacher|teacher
168847|NCT03141229|School|school
168848|NCT03141229|Burnout|burnout
168849|NCT03141229|Classroom behavior|classroom behavior
168850|NCT03141190|stress, surgery, mindfulness, feasibility|stress, surgery, mindfulness, feasibility
168851|NCT03141125|Erythrocyte sedimentation rate|erythrocyte sedimentation rate
168852|NCT03141125|Modified Rodnan Skin Score|modified rodnan skin score
168853|NCT03141125|B-cell Activating Factor|b-cell activating factor
168854|NCT03141125|soluble-CD40Ligand|soluble-cd40ligand
168855|NCT03141125|Procollagen Type-1 N-terminal Propeptide|procollagen type-1 n-terminal propeptide
168856|NCT03141125|Scleroderma|scleroderma
168857|NCT03141099|OHCA|ohca
168858|NCT03141099|Hemodynamic|hemodynamic
168859|NCT03141099|TTM|ttm
168860|NCT03141099|post-rescusitation care|post-rescusitation care
168861|NCT03141099|Blood pressure targets|blood pressure targets
168862|NCT03141099|Oxygenation targets|oxygenation targets
168863|NCT03141086|shift work disorder|shift work disorder
168864|NCT03141073|GKA|gka
168865|NCT03141073|T2DM|t2dm
168866|NCT03141073|HMS5552|hms5552
168867|NCT03141073|Add-on therapy|add-on therapy
168868|NCT03141073|Metformin|metformin
168869|NCT03141047|Sexual trauma, Lifespan Integration|sexual trauma, lifespan integration
168870|NCT03141008|Ketosis|ketosis
168871|NCT03141008|NAFLD|nafld
168872|NCT03141008|Obesity|obesity
168873|NCT03140995|Exercise|exercise
168874|NCT03140995|Sleep|sleep
168875|NCT03140982|propofol|propofol
168876|NCT03140982|pharmacology|pharmacology
168877|NCT03140982|anesthesic induction|anesthesic induction
168878|NCT03140982|drug titration|drug titration
168879|NCT03140969|CEP290|cep290
168880|NCT03140969|p.Cys998X|p.cys998x
168881|NCT03140969|c.2991+1655A>G|c.2991+1655a>g
168882|NCT03140969|RNA therapy|rna therapy
168883|NCT03140969|Antisense oligonucleotide|antisense oligonucleotide
168884|NCT03140969|Leber's congenital amaurosis|leber's congenital amaurosis
168885|NCT03140943|carfilzomib|carfilzomib
168886|NCT03140917|Liver function|liver function
168887|NCT03140917|Future liver remnant|future liver remnant
168888|NCT03140917|Chemotherapy|chemotherapy
168889|NCT03140891|preterm infant|preterm infant
168890|NCT03140891|respiratory distress syndrome|respiratory distress syndrome
168891|NCT03140891|nasal high frequence oscillation ventilation|nasal high frequence oscillation ventilation
168892|NCT03140865|Alzheimer's|alzheimer's
168893|NCT03140865|observational|observational
168894|NCT03140865|prediabetes|prediabetes
168895|NCT03140865|mild cognitive impairment|mild cognitive impairment
168896|NCT03140774|Ebola vaccine|ebola vaccine
168897|NCT03140774|immunogenicity|immunogenicity
168898|NCT03140774|persistence|persistence
168899|NCT03140722|anemia|anemia
168900|NCT03140722|kidney|kidney
168901|NCT03140722|dialysis-dependent chronic kidney disease|dialysis-dependent chronic kidney disease
168902|NCT03140722|CKD|ckd
168903|NCT03140722|DD-CKD|dd-ckd
168904|NCT03140722|renal|renal
168905|NCT03140722|vadadustat|vadadustat
168906|NCT03140722|AKB-6548|akb-6548
168907|NCT03140722|hypoxia-inducible factor|hypoxia-inducible factor
168908|NCT03140722|HIF|hif
168909|NCT03140722|hypoxia-inducible factor prolyl-hydroxylase inhibitor|hypoxia-inducible factor prolyl-hydroxylase inhibitor
168910|NCT03140722|HIF-PHI|hif-phi
168911|NCT03140722|hyporesponder|hyporesponder
168912|NCT03140722|hyporesponsive|hyporesponsive
168913|NCT03140722|epoetin alfa|epoetin alfa
168914|NCT03140722|hemoglobin|hemoglobin
168915|NCT03140722|erythropoiesis stimulating agent|erythropoiesis stimulating agent
168916|NCT03140722|ESA|esa
168917|NCT03140709|Salivary|salivary
168918|NCT03140709|Oxytocin|oxytocin
168919|NCT03140709|Induction|induction
168920|NCT03140709|Labor|labor
168921|NCT03140657|Ankylosing spondylitis, Nanocurcumin, MicroRNA, Th17 cells|ankylosing spondylitis, nanocurcumin, microrna, th17 cells
168922|NCT03140644|thoracic sarcoidosis|thoracic sarcoidosis
168923|NCT03140644|ultra-low dose computed tomography|ultra-low dose computed tomography
168924|NCT03140644|Magnetic resonance imaging using Ultrashort echo time|magnetic resonance imaging using ultrashort echo time
168925|NCT03140631|atrial fibrillation|atrial fibrillation
168926|NCT03140631|catheter ablation|catheter ablation
168927|NCT03140631|protamine sulfate|protamine sulfate
168928|NCT03140631|anticoagulation reversal|anticoagulation reversal
168929|NCT03140618|single-system-design|single-system-design
168930|NCT03140618|mixed methods|mixed methods
168931|NCT03140618|psychiatric inpatient care|psychiatric inpatient care
168932|NCT03140618|work environment|work environment
168933|NCT03140618|rebuilding|rebuilding
168934|NCT03140579|recruitment|recruitment
168935|NCT03140579|lung homogeneity|lung homogeneity
168936|NCT03140579|airway pressure release ventilation|airway pressure release ventilation
168937|NCT03140566|heart failure|heart failure
168938|NCT03140566|acute decompensated heart failure|acute decompensated heart failure
168939|NCT03140566|congestion|congestion
168940|NCT03140566|inferior vena cava|inferior vena cava
168941|NCT03140553|Neoadjuvant Treatment|neoadjuvant treatment
168942|NCT03140553|HER2-Positive Breast Cancer|her2-positive breast cancer
168943|NCT03140540|Fluid management|fluid management
168944|NCT03140540|goal-directed therapy|goal-directed therapy
168945|NCT03140540|transesophageal echocardiography|transesophageal echocardiography
168946|NCT03140514|Urine chemokine monitoring|urine chemokine monitoring
168947|NCT03140488|Induction of labor|induction of labor
168948|NCT03140488|Pitocin|pitocin
168950|NCT03140475|Metacognition|metacognition
168951|NCT03140475|Mousetracking|mousetracking
168952|NCT03140475|EEG|eeg
168953|NCT03140475|Event related potentials|event related potentials
168954|NCT03140475|Frequency analysis|frequency analysis
168955|NCT03140475|Depression|depression
168956|NCT03140462|Tacrolimus|tacrolimus
168957|NCT03140462|Pharmacokinetics|pharmacokinetics
168958|NCT03140462|Genetic polymorphisms|genetic polymorphisms
168959|NCT03140449|Tuberous sclerosis complex|tuberous sclerosis complex
168960|NCT03140449|facial angiofibroma|facial angiofibroma
168961|NCT03140449|rapamycin|rapamycin
168962|NCT03140449|calcitriol|calcitriol
168963|NCT03140436|stain removal efficacy, air polishing powder|stain removal efficacy, air polishing powder
168964|NCT03140423|MRSA|mrsa
168965|NCT03140423|healthcare-associated infections|healthcare-associated infections
168966|NCT03140423|mupirocin|mupirocin
168967|NCT03140423|iodophor|iodophor
168968|NCT03140423|resistance|resistance
168969|NCT03140410|Staphylococci|staphylococci
168970|NCT03140410|Blood-stream infections|blood-stream infections
168971|NCT03140410|Linezolid|linezolid
168972|NCT03140397|Bioavailability|bioavailability
168973|NCT03140397|Pharmacokinetics|pharmacokinetics
168974|NCT03140397|8-prenylnaringenin|8-prenylnaringenin
168975|NCT03140397|6-prenylnaringenin|6-prenylnaringenin
168976|NCT03140397|Prenylflavonoids|prenylflavonoids
168977|NCT03140397|PBMC|pbmc
168978|NCT03140371|Enteral feeding|enteral feeding
168979|NCT03140371|Oral nutritional supplements|oral nutritional supplements
168980|NCT03140371|Peptide-based feed|peptide-based feed
168981|NCT03140371|Hydrolysed feed|hydrolysed feed
168982|NCT03140371|Semi-elemental feed|semi-elemental feed
168983|NCT03140345|Hemodialysis|hemodialysis
168984|NCT03140345|Microcirculation|microcirculation
168985|NCT03140345|Traditional Chinese Medicine|traditional chinese medicine
168986|NCT03140345|Hemodialysis vascular access|hemodialysis vascular access
168987|NCT03140319|Fibroblast|fibroblast
168988|NCT03140319|Cell transplantation|cell transplantation
168989|NCT03140306|Computed tomography|computed tomography
168990|NCT03140306|Model based iterative reconstruction|model based iterative reconstruction
168991|NCT03140306|Low dose CT|low dose ct
168992|NCT03140293|Chorionic villus sampling|chorionic villus sampling
168993|NCT03140293|Pain|pain
168994|NCT03140293|Anxiety|anxiety
168995|NCT03140280|Black raspberries|black raspberries
168996|NCT03140280|MDS|mds
168997|NCT03140280|Myelodysplastic Syndromes|myelodysplastic syndromes
168998|NCT03140280|hypomethylating effects|hypomethylating effects
168999|NCT03140280|chemopreventive agent|chemopreventive agent
169000|NCT03140280|BRB|brb
169001|NCT03140280|pharmokinetics|pharmokinetics
169002|NCT03140267|Ventilated induced diaphragmatic dysfunction|ventilated induced diaphragmatic dysfunction
169003|NCT03140267|Weaning|weaning
169004|NCT03140267|Inspiratory muscle training|inspiratory muscle training
169005|NCT03140215|Baska|baska
169006|NCT03140215|seal pressure|seal pressure
169007|NCT03140215|I-Gel|i-gel
169008|NCT03140215|Supraglottic airway device|supraglottic airway device
169009|NCT03140189|Esophageal cancer|esophageal cancer
169010|NCT03140189|Robotic|robotic
169011|NCT03140189|Ivor-Lewis esophagectomy|ivor-lewis esophagectomy
169012|NCT03140176|Sunitinib|sunitinib
169013|NCT03140176|Metastatic Renal Cell Carcinoma|metastatic renal cell carcinoma
169014|NCT03140176|Africa Middle East|africa middle east
169015|NCT03140098|Collagen membrane|collagen membrane
169016|NCT03140098|Cardiac surgery|cardiac surgery
169017|NCT03140098|Postoperative complication|postoperative complication
169018|NCT03140072|Asthma, Single Ascending Dose (SAD), Multiple Ascending Dose (MAD), AZD9898|asthma, single ascending dose (sad), multiple ascending dose (mad), azd9898
169019|NCT03140059|surgical procedure|surgical procedure
169020|NCT03140059|residual pockets|residual pockets
169021|NCT03140059|agressive periodontitis|agressive periodontitis
169022|NCT03140059|antimicrobial photodynamic therapy|antimicrobial photodynamic therapy
169023|NCT03140020|aneurysm|aneurysm
169024|NCT03140020|cognition|cognition
169025|NCT03140020|functional connectivity|functional connectivity
169026|NCT03140020|frontal lobe function|frontal lobe function
169027|NCT03140020|neuropsychological testing|neuropsychological testing
169028|NCT03140020|coiling|coiling
169029|NCT03140020|clipping|clipping
215952|NCT02844205|neonate|neonate
169030|NCT03140007|ERCP|ercp
169031|NCT03140007|cholangioscopy|cholangioscopy
169032|NCT03139994|occlusion|occlusion
169033|NCT03139994|pain|pain
169034|NCT03139981|eczema|eczema
169035|NCT03139955|Feasibility Study|feasibility study
169036|NCT03139955|Pre/Post-Operative Patient Monitoring|pre/post-operative patient monitoring
169037|NCT03139955|Continuous Patient Monitoring|continuous patient monitoring
169038|NCT03139955|Patient Deterioration Identification|patient deterioration identification
169039|NCT03139955|Bodytrak|bodytrak
169040|NCT03139955|National Early Warning System|national early warning system
169041|NCT03139955|Patient Safety|patient safety
169042|NCT03139942|Endoscopy|endoscopy
169043|NCT03139942|Colonoscopy|colonoscopy
169044|NCT03139942|Hyperspectral imaging|hyperspectral imaging
169045|NCT03139942|Tissue classification|tissue classification
169046|NCT03139942|Tissue autofluorescence|tissue autofluorescence
169047|NCT03139942|Advanced imaging techniques|advanced imaging techniques
169048|NCT03139916|Glioblastoma|glioblastoma
169049|NCT03139903|Seckel Syndrome|seckel syndrome
169050|NCT03139903|Microcephalic Osteodysplastic Primordial Dwarfism Type II|microcephalic osteodysplastic primordial dwarfism type ii
169051|NCT03139864|Type 1 diabetes|type 1 diabetes
169052|NCT03139864|Control|control
169053|NCT03139864|Physical activity|physical activity
169054|NCT03139864|Substrate utilization|substrate utilization
169055|NCT03139864|Hormonal regulation|hormonal regulation
169056|NCT03139851|Solid tumor|solid tumor
169057|NCT03139851|Breast cancer|breast cancer
169058|NCT03139851|Metastatic cancer|metastatic cancer
169059|NCT03139851|Pembrolizumab|pembrolizumab
169060|NCT03139851|Metronomic cyclophosphamide|metronomic cyclophosphamide
169061|NCT03139838|Palliative Care|palliative care
169062|NCT03139838|Pragmatic Clinical Trial|pragmatic clinical trial
169063|NCT03139838|Electronic Health Records|electronic health records
169064|NCT03139838|Economics, Behavioral|economics, behavioral
169065|NCT03139812|continuous contact lens wear|continuous contact lens wear
169066|NCT03139812|silicone hydrogel contact lenses|silicone hydrogel contact lenses
169067|NCT03139812|irrigation|irrigation
169068|NCT03139812|corneal epithelial permeability|corneal epithelial permeability
169069|NCT03139812|contact lens-related adverse events|contact lens-related adverse events
169070|NCT03139734|Sacral Nerve Modulation|sacral nerve modulation
169071|NCT03139708|Mydriasis|mydriasis
169463|NCT03136861|spinal pain|spinal pain
169072|NCT03139708|Cycloplegics|cycloplegics
169073|NCT03139630|HIV, Dyslipidemia|hiv, dyslipidemia
169074|NCT03139630|Dyslipidemia|dyslipidemia
169075|NCT03139630|Protease Inhibitor|protease inhibitor
169076|NCT03139630|Ritonavir|ritonavir
169077|NCT03139630|PCSK9|pcsk9
169078|NCT03139630|Observational|observational
169079|NCT03139617|Fascia Iliaca Block|fascia iliaca block
169080|NCT03139617|Femoral 3-in-1 block|femoral 3-in-1 block
169081|NCT03139617|Fracture femur|fracture femur
169082|NCT03139617|Spinal anesthesia|spinal anesthesia
169083|NCT03139604|Acute graft-versus-host disease|acute graft-versus-host disease
169084|NCT03139604|Janus kinase (JAK) inhibitor|janus kinase (jak) inhibitor
169085|NCT03139604|itacitinib|itacitinib
169086|NCT03139604|corticosteroids|corticosteroids
169087|NCT03139604|allogeneic hematopoietic stem cell transplant (allo-HSCT)|allogeneic hematopoietic stem cell transplant (allo-hsct)
169088|NCT03139565|Influenza|influenza
169089|NCT03139565|Solid Organ Transplant|solid organ transplant
169090|NCT03139565|Infection|infection
169091|NCT03139565|Vaccine|vaccine
169092|NCT03139565|Immunogenicity|immunogenicity
169093|NCT03139552|Taste Test|taste test
169094|NCT03139552|Spices|spices
169095|NCT03139552|Reduced sugar|reduced sugar
169096|NCT03139552|Food liking|food liking
169097|NCT03139526|Craniopharyngioma|craniopharyngioma
169098|NCT03139526|Children|children
169099|NCT03139526|Social participation|social participation
169100|NCT03139526|Life-H questionnaire|life-h questionnaire
169101|NCT03139487|Anticoagulant Adverse Reaction|anticoagulant adverse reaction
169102|NCT03139487|Cancer-associated Thrombosis|cancer-associated thrombosis
169103|NCT03139487|Low molecular weight heparin|low molecular weight heparin
169104|NCT03139487|Direct oral anticoagulant|direct oral anticoagulant
169105|NCT03139461|Physical Therapy|physical therapy
169106|NCT03139461|Capacity Building|capacity building
169107|NCT03139461|Clinical-Community Linkages|clinical-community linkages
169108|NCT03139396|inlay bridge, tub shaped design|inlay bridge, tub shaped design
169109|NCT03139383|postoperative nausea|postoperative nausea
169110|NCT03139383|postoperative vomiting|postoperative vomiting
169111|NCT03139383|gynecologic laparoscopic surgery|gynecologic laparoscopic surgery
169112|NCT03139344|metabolism|metabolism
169113|NCT03139344|exercise|exercise
169114|NCT03139344|glucose|glucose
169115|NCT03139344|secondary health conditions|secondary health conditions
169116|NCT03139344|quality of life|quality of life
169117|NCT03139305|glucagon|glucagon
169118|NCT03139266|cystic fibrosis|cystic fibrosis
169119|NCT03139266|mindfulness|mindfulness
169120|NCT03139266|cognitive behavioral therapy|cognitive behavioral therapy
169121|NCT03139266|UPLIFT|uplift
169122|NCT03139266|anxiety|anxiety
169123|NCT03139266|depression|depression
169124|NCT03139266|web based intervention|web based intervention
169125|NCT03139253|Helicobacter Pylori Infection|helicobacter pylori infection
169126|NCT03139253|Antimicrobial susceptibility testing (AST)|antimicrobial susceptibility testing (ast)
169127|NCT03139253|Triple Therapy|triple therapy
169128|NCT03139201|silicone hydrogel soft contact lens|silicone hydrogel soft contact lens
169129|NCT03139188|Cancer|cancer
169130|NCT03139188|incurable pathologies|incurable pathologies
169131|NCT03139188|palliative care|palliative care
169132|NCT03139162|Home Care Services|home care services
169133|NCT03139162|Aging|aging
169134|NCT03139162|Frailty|frailty
169135|NCT03139162|Complexity|complexity
169136|NCT03139162|Nursing|nursing
169137|NCT03139149|conservative treatment|conservative treatment
169138|NCT03139149|laparoscopic adhesiolysis|laparoscopic adhesiolysis
169139|NCT03139149|strangulation|strangulation
169140|NCT03139071|coffee consumption|coffee consumption
169141|NCT03139071|cardiovascular diseases|cardiovascular diseases
169142|NCT03139071|coronary artery calcium|coronary artery calcium
169143|NCT03139071|subclinical atherosclerosis|subclinical atherosclerosis
169144|NCT03139019|Diabetes prevention|diabetes prevention
169145|NCT03139019|Weight loss|weight loss
169146|NCT03139019|Lifestyle change|lifestyle change
169147|NCT03138967|Malignant neoplasms of urinary tract|malignant neoplasms of urinary tract
169148|NCT03138967|Bladder cancer|bladder cancer
169149|NCT03138967|Outpatient bladder procedures|outpatient bladder procedures
169150|NCT03138967|Outpatient cystoscopy procedure|outpatient cystoscopy procedure
169151|NCT03138967|Transurethral resection of the bladder|transurethral resection of the bladder
169152|NCT03138967|TURB|turb
169153|NCT03138967|Rocuronium|rocuronium
169154|NCT03138967|Rocuronium Bromide|rocuronium bromide
169155|NCT03138967|Zemuron|zemuron
169156|NCT03138967|Sugammadex|sugammadex
169157|NCT03138967|Neostigmine|neostigmine
169158|NCT03138967|Glycopyrrolate|glycopyrrolate
169159|NCT03138928|glaucoma|glaucoma
169160|NCT03138928|trabeculectomy|trabeculectomy
169161|NCT03138928|minimally invasive glaucoma surgery|minimally invasive glaucoma surgery
169162|NCT03138928|XEN45 gel stent|xen45 gel stent
169163|NCT03138915|clinically significant portal hypertension|clinically significant portal hypertension
169164|NCT03138915|hepatic venous pressure gradient|hepatic venous pressure gradient
169165|NCT03138915|radiomics|radiomics
169166|NCT03138889|NKTR-214|nktr-214
169167|NCT03138889|Metastatic Urothelial Bladder Cancer|metastatic urothelial bladder cancer
169168|NCT03138889|Metastatic Non-Small Cell Lung Cancer|metastatic non-small cell lung cancer
169169|NCT03138889|Pembrolizumab|pembrolizumab
169170|NCT03138889|Keytruda®|keytruda®
169171|NCT03138889|Melanoma|melanoma
169172|NCT03138889|Bladder|bladder
169173|NCT03138889|NSCLC|nsclc
169174|NCT03138889|HCC|hcc
169175|NCT03138889|HNSCC|hnscc
169176|NCT03138889|Bempegaldesleukin|bempegaldesleukin
169177|NCT03138889|bempeg|bempeg
169178|NCT03138850|intravenous sedation|intravenous sedation
169179|NCT03138850|esophagogastroduodenalscopy|esophagogastroduodenalscopy
169180|NCT03138850|upper airway|upper airway
169181|NCT03138850|mandibular advancement device|mandibular advancement device
169182|NCT03138850|high flow nasal cannula|high flow nasal cannula
169183|NCT03138837|Bladder cancer|bladder cancer
169184|NCT03138837|Magnetic Resonance Imaging|magnetic resonance imaging
169185|NCT03138837|Bladder Cancer Superficial|bladder cancer superficial
169186|NCT03138824|Bladder Urothelial Carcinoma|bladder urothelial carcinoma
169187|NCT03138824|TURBT|turbt
169188|NCT03138824|Recurrence|recurrence
169189|NCT03138824|Progression|progression
169190|NCT03138811|asthma|asthma
169191|NCT03138811|allergen bronchoprovocation|allergen bronchoprovocation
169192|NCT03138811|pharmacodynamics|pharmacodynamics
169193|NCT03138811|pharmacokinetics|pharmacokinetics
169194|NCT03138811|safety|safety
169195|NCT03138811|tolerability|tolerability
169196|NCT03138798|Labor|labor
169197|NCT03138798|Second stage|second stage
169198|NCT03138798|Dental device|dental device
169199|NCT03138746|hyperbaric oxygenation|hyperbaric oxygenation
169200|NCT03138746|insulin sensitivity|insulin sensitivity
169201|NCT03138746|human|human
169202|NCT03138746|inflammation|inflammation
169203|NCT03138655|Drug therapy|drug therapy
169204|NCT03138642|mucosal melanoma|mucosal melanoma
169205|NCT03138642|radiotherapy|radiotherapy
169206|NCT03138616|Gestational diabetes mellitus|gestational diabetes mellitus
169207|NCT03138616|vitamin D|vitamin d
169208|NCT03138616|postpartum|postpartum
169209|NCT03138603|surgery|surgery
169210|NCT03138603|heart disease|heart disease
169211|NCT03138603|metoprolol|metoprolol
169212|NCT03138603|myocardial injury|myocardial injury
169213|NCT03138590|transcranial Direct Current Stimulation (tDCS)|transcranial direct current stimulation (tdcs)
169214|NCT03138590|accelerate learning|accelerate learning
169215|NCT03138590|memory|memory
169216|NCT03138564|Nursing|nursing
169217|NCT03138564|Nephrology|nephrology
169218|NCT03138564|Behavioral Research|behavioral research
169219|NCT03138564|Social Research|social research
169220|NCT03138551|Sensory Food Aversions|sensory food aversions
169221|NCT03138538|Advanced Solid Tumors|advanced solid tumors
169222|NCT03138538|M8891|m8891
169223|NCT03138538|Methionine Aminopeptidase 2 Inhibitor|methionine aminopeptidase 2 inhibitor
169224|NCT03138512|localized; resected; adjuvant|localized; resected; adjuvant
169225|NCT03138473|SYNTAX Score|syntax score
169226|NCT03138473|residual SYNTAX score|residual syntax score
169227|NCT03138473|SYNTAX Revascularization Index|syntax revascularization index
169228|NCT03138447|insulin|insulin
169229|NCT03138447|basal|basal
169230|NCT03138447|titration|titration
169231|NCT03138447|digital health|digital health
169232|NCT03138434|Abdominal Aortic Aneurysm|abdominal aortic aneurysm
169233|NCT03138434|4D flow MRI|4d flow mri
169234|NCT03138434|DCE-MRI|dce-mri
169235|NCT03138434|T1 and T2 mapping|t1 and t2 mapping
169236|NCT03138408|Ovarian cancer|ovarian cancer
169237|NCT03138408|Endometrial cancer|endometrial cancer
169238|NCT03138408|SC-004|sc-004
169239|NCT03138408|Maximum tolerated dose (MTD)|maximum tolerated dose (mtd)
169240|NCT03138408|ABBV-181|abbv-181
169241|NCT03138395|acute myeloid leukemia|acute myeloid leukemia
169242|NCT03138395|myelodysplastic syndrome|myelodysplastic syndrome
169243|NCT03138395|relapse|relapse
169244|NCT03138395|PCR|pcr
169245|NCT03138395|droplet digital|droplet digital
169246|NCT03138395|polymerase chain reaction|polymerase chain reaction
169247|NCT03138382|obesity|obesity
169248|NCT03138382|metabolic syndrome|metabolic syndrome
169249|NCT03138356|Type 2 diabetes mellitus, saxagliptin, dapagliflozin, metformin XR, fixed-dose combination, healthy subjects, crossover, cohorts.|type 2 diabetes mellitus, saxagliptin, dapagliflozin, metformin xr, fixed-dose combination, healthy subjects, crossover, cohorts.
169250|NCT03138304|decision making|decision making
169251|NCT03138304|heuristics|heuristics
169252|NCT03138226|uterus, transplantation, infertility, twin|uterus, transplantation, infertility, twin
169253|NCT03138213|pancreaticoduodenectomy|pancreaticoduodenectomy
169254|NCT03138213|surgical outcome|surgical outcome
169255|NCT03138200|Transfusion|transfusion
169256|NCT03138200|ScvO2|scvo2
169257|NCT03138200|Hemoglobin|hemoglobin
169258|NCT03138187|spontaneous physical activity|spontaneous physical activity
169259|NCT03138187|caloric intake|caloric intake
169260|NCT03138174|Blood Glucose Monitor System Accuracy|blood glucose monitor system accuracy
169261|NCT03138161|cancer immunotherapy, combination chemo-/immunotherapy|cancer immunotherapy, combination chemo-/immunotherapy
169262|NCT03138148|intensive care|intensive care
169263|NCT03138135|PrEP|prep
169264|NCT03138135|HIV prevention|hiv prevention
169265|NCT03138135|Risk reduction|risk reduction
169266|NCT03138135|STI prevention|sti prevention
169267|NCT03138135|Home HIV testing|home hiv testing
169268|NCT03138135|HIV testing|hiv testing
169269|NCT03138135|STI testing|sti testing
169270|NCT03138109|non-cardiac surgery|non-cardiac surgery
169271|NCT03138109|major adverse cardiac event|major adverse cardiac event
169272|NCT03138083|Mesenchymal-epithelial transition factor (MET) inhibitor|mesenchymal-epithelial transition factor (met) inhibitor
169273|NCT03138044|Hepatocellular Carcinoma|hepatocellular carcinoma
169274|NCT03138044|Ipsilateral Liver Lobe Devascularization|ipsilateral liver lobe devascularization
169275|NCT03138044|Alcohol Treatment|alcohol treatment
169276|NCT03138044|CILDAT|cildat
169277|NCT03138031|Percutaneuos Ethanol alcohol injection|percutaneuos ethanol alcohol injection
169278|NCT03138005|Emergency Care, Prehospital|emergency care, prehospital
169279|NCT03138005|Resuscitation|resuscitation
169280|NCT03138005|Oxygen|oxygen
169281|NCT03138005|Cardiac Arrest|cardiac arrest
169282|NCT03138005|Heart Arrest|heart arrest
169283|NCT03137992|COPD|copd
169284|NCT03137979|Periodontitis|periodontitis
169285|NCT03137979|Gingiva mesenchymal stem cells|gingiva mesenchymal stem cells
169286|NCT03137966|Diabetes mellitus, foot ulcer, deferoxamine|diabetes mellitus, foot ulcer, deferoxamine
169287|NCT03137940|Unilateral Cerebral Palsy|unilateral cerebral palsy
169288|NCT03137940|tDCS|tdcs
169289|NCT03137940|Safety|safety
169290|NCT03137940|Upper Limb functions|upper limb functions
169291|NCT03137927|bordetella pertussis|bordetella pertussis
169292|NCT03137927|vaccine|vaccine
169293|NCT03137927|Immunologic Factors|immunologic factors
169294|NCT03137927|whooping cough|whooping cough
169295|NCT03137914|orthognathic surgery|orthognathic surgery
169296|NCT03137914|TMJ|tmj
169297|NCT03137914|osteoarthritis|osteoarthritis
169298|NCT03137875|Tuberculosis|tuberculosis
169299|NCT03137875|TB|tb
169300|NCT03137875|MDR-TB|mdr-tb
169301|NCT03137875|LIPA|lipa
169302|NCT03137875|filter paper|filter paper
169303|NCT03137875|slides|slides
169304|NCT03137875|MTBDR Plus|mtbdr plus
169305|NCT03137849|Yoga|yoga
169306|NCT03137849|Hypertension|hypertension
169307|NCT03137849|Post-Menopausal Women|post-menopausal women
169308|NCT03137849|Heart Rate Variability|heart rate variability
169309|NCT03137823|diagnosis, tonsillitis, streptococcus, GABHS|diagnosis, tonsillitis, streptococcus, gabhs
169310|NCT03137784|asthma,|asthma,
169311|NCT03137784|NVA237,|nva237,
169312|NCT03137784|glycopyrronium bromide|glycopyrronium bromide
216361|NCT02841696|GLS|gls
169313|NCT03137784|allergic asthma,|allergic asthma,
169314|NCT03137784|allergy triggered asthma,|allergy triggered asthma,
169315|NCT03137784|reactive asthma,|reactive asthma,
169316|NCT03137784|asthma attack,|asthma attack,
169317|NCT03137784|difficulty breathing|difficulty breathing
169318|NCT03137745|Thromboelastography, chemotherapy,hyperthermic|thromboelastography, chemotherapy,hyperthermic
169319|NCT03137693|histologically proven|histologically proven
169320|NCT03137693|invasive adenocarcinoma of breast|invasive adenocarcinoma of breast
169321|NCT03137693|node negative (N0)|node negative (n0)
169322|NCT03137693|breast-conserving surgery|breast-conserving surgery
169323|NCT03137693|negative for Her-2 amplification|negative for her-2 amplification
169324|NCT03137693|estrogen receptor (ER) positive|estrogen receptor (er) positive
169325|NCT03137693|progesterone receptor (PR) positive|progesterone receptor (pr) positive
169326|NCT03137680|Arteriovenous Fistula|arteriovenous fistula
169327|NCT03137680|Pre-operative Exercise|pre-operative exercise
169328|NCT03137680|Fistula Maturation|fistula maturation
169329|NCT03137667|Influenza Vaccination Rates|influenza vaccination rates
169330|NCT03137654|Cognitive Training|cognitive training
169331|NCT03137654|Emotion Processing|emotion processing
169332|NCT03137641|occupational exposure|occupational exposure
169333|NCT03137641|antineoplastic drugs|antineoplastic drugs
169334|NCT03137641|biomonitoring|biomonitoring
169335|NCT03137628|general anesthesia,mechanical ventilation,colectomy|general anesthesia,mechanical ventilation,colectomy
169336|NCT03137589|Telemedicine|telemedicine
169337|NCT03137576|Awake Thoracic Surgery, Erector Spinae Plane Block|awake thoracic surgery, erector spinae plane block
169338|NCT03137563|Women|women
169339|NCT03137563|25-65 years|25-65 years
169340|NCT03137537|Lymphoma|lymphoma
169341|NCT03137537|Abnormal resting heart rate|abnormal resting heart rate
169342|NCT03137537|Autonomic imbalance|autonomic imbalance
169343|NCT03137537|Cancer survivorship|cancer survivorship
169344|NCT03137524|Fan or Air Therapy|fan or air therapy
169345|NCT03137511|Public Health|public health
169346|NCT03137511|General Medicine|general medicine
169347|NCT03137511|Dermatology|dermatology
169348|NCT03137498|renal colic|renal colic
169349|NCT03137498|lidocaine|lidocaine
169350|NCT03137498|ketorolac|ketorolac
169351|NCT03137498|acute pain|acute pain
169352|NCT03137485|lumbar disc herniation|lumbar disc herniation
169353|NCT03137485|endoscopic discectomy|endoscopic discectomy
169354|NCT03137485|open discectomy|open discectomy
169355|NCT03137485|comparative study|comparative study
169356|NCT03137485|Translaminar|translaminar
169357|NCT03137485|surgery|surgery
169358|NCT03137472|TMS, CRPS, Sham|tms, crps, sham
169359|NCT03137459|Transtheoretical Model (TTM)|transtheoretical model (ttm)
169462|NCT03136861|inflammatory back pain|inflammatory back pain
169360|NCT03137446|Intravenous fluid resuscitation|intravenous fluid resuscitation
169361|NCT03137446|Septic shock|septic shock
169362|NCT03137446|Severe sepsis|severe sepsis
169363|NCT03137446|Fluid restriction|fluid restriction
169364|NCT03137433|Weight loss|weight loss
169365|NCT03137433|Cardiometabolic|cardiometabolic
169366|NCT03137433|Meal-replacement therapy|meal-replacement therapy
169367|NCT03137407|heel pain|heel pain
169368|NCT03137394|spinal cord injury|spinal cord injury
169369|NCT03137394|shoulder pain|shoulder pain
169370|NCT03137394|psychosocial|psychosocial
169371|NCT03137368|ovarian function suppression/ablation|ovarian function suppression/ablation
169372|NCT03137368|breast cancer|breast cancer
169373|NCT03137368|Exemestane|exemestane
169374|NCT03137368|Tamoxifen|tamoxifen
169375|NCT03137368|CYP2D6*10 mutations|cyp2d6*10 mutations
169376|NCT03137355|Leigh Syndrome|leigh syndrome
169377|NCT03137355|Leigh Disease|leigh disease
169378|NCT03137355|Leigh's Necrotizing Encephalopathy|leigh's necrotizing encephalopathy
169379|NCT03137355|Subacute Necrotizing Encephalomyelopathy|subacute necrotizing encephalomyelopathy
169380|NCT03137355|Subacute Necrotizing Encephalomyopathy|subacute necrotizing encephalomyopathy
169381|NCT03137342|PrEP|prep
169382|NCT03137342|Adherence|adherence
169383|NCT03137342|Risk Reduction|risk reduction
169384|NCT03137342|Stimulant Use|stimulant use
169385|NCT03137290|Paediatric general anaesthesia|paediatric general anaesthesia
169386|NCT03137290|Rocuronium|rocuronium
169387|NCT03137290|Neostigmine|neostigmine
169388|NCT03137290|Sugammadex|sugammadex
169389|NCT03137277|Colonoscopy|colonoscopy
169391|NCT03137277|Adenoma detection rate|adenoma detection rate
169392|NCT03137277|colonoscopic imaging feature improvement|colonoscopic imaging feature improvement
169393|NCT03137277|Olympus colonoscopes|olympus colonoscopes
169394|NCT03137264|T790M mutation|t790m mutation
169395|NCT03137264|EGFR epidermal growth factor receptor|egfr epidermal growth factor receptor
169396|NCT03137264|non-invasive testing|non-invasive testing
169397|NCT03137264|lung cancer|lung cancer
169398|NCT03137251|Transcutaneous electrical nerve stimulation|transcutaneous electrical nerve stimulation
169399|NCT03137251|TENS|tens
169400|NCT03137251|Analgesia|analgesia
169401|NCT03137251|Labour pain|labour pain
169402|NCT03137251|Physical therapy modality|physical therapy modality
216446|NCT02841085|Genetic|genetic
169403|NCT03137238|Self-motion perception|self-motion perception
169404|NCT03137238|Optic flow|optic flow
169405|NCT03137238|Vestibular system|vestibular system
169406|NCT03137238|Multisensory integration|multisensory integration
169407|NCT03137238|Parkinson's disease|parkinson's disease
169408|NCT03137212|Percutaneous Coronary Intervention|percutaneous coronary intervention
169409|NCT03137212|STEMI|stemi
169410|NCT03137212|Thrombosis|thrombosis
169411|NCT03137199|stem cell|stem cell
169412|NCT03137199|mesenchymal stem cell|mesenchymal stem cell
169413|NCT03137199|lung|lung
169414|NCT03137199|asthma|asthma
169415|NCT03137186|Metformin, prostate cancer|metformin, prostate cancer
169416|NCT03137147|pediatric|pediatric
169417|NCT03137147|children|children
169418|NCT03137147|adolescent|adolescent
169419|NCT03137147|sleep|sleep
169420|NCT03137147|pain|pain
169421|NCT03137147|cognitive-behavioral therapy|cognitive-behavioral therapy
169422|NCT03137121|nausea|nausea
169423|NCT03137121|vomiting|vomiting
169424|NCT03137121|olanzapine|olanzapine
169425|NCT03137082|Alcohol Use Disorder|alcohol use disorder
169426|NCT03137082|Guanfacine|guanfacine
169427|NCT03137082|Stress|stress
169428|NCT03137082|Craving|craving
169429|NCT03137082|Gender|gender
169430|NCT03137082|Relapse|relapse
169431|NCT03137056|Hemodialysis|hemodialysis
169432|NCT03137056|Membrane|membrane
169433|NCT03137056|Albumin|albumin
169434|NCT03137056|Proteomics|proteomics
169435|NCT03137043|GINA guidelines|gina guidelines
169436|NCT03137043|Prevalence|prevalence
169437|NCT03137043|Mepolizumab|mepolizumab
169438|NCT03137043|severe asthma|severe asthma
169439|NCT03137043|Spain|spain
169440|NCT03137030|Abuse deterrent formulation|abuse deterrent formulation
169441|NCT03137030|Hydrocodone|hydrocodone
169442|NCT03137030|Analgesics, Opioid|analgesics, opioid
169443|NCT03137030|Narcotics|narcotics
169444|NCT03137017|Abuse deterrent formulation|abuse deterrent formulation
169445|NCT03137017|Hydrocodone|hydrocodone
169446|NCT03137017|Analgesics, Opioid|analgesics, opioid
169447|NCT03137017|Narcotics|narcotics
169448|NCT03136991|Oral myeloperoxidase inhibitor|oral myeloperoxidase inhibitor
169449|NCT03136978|Macrophages|macrophages
169450|NCT03136978|Macrophages, Peritoneal|macrophages, peritoneal
169451|NCT03136978|Endometriosis|endometriosis
169452|NCT03136952|NIRS|nirs
169453|NCT03136952|Monitoring|monitoring
169454|NCT03136952|Pediatric|pediatric
169455|NCT03136874|donors|donors
169456|NCT03136874|gametes|gametes
169457|NCT03136874|motivation|motivation
169458|NCT03136874|psychological|psychological
169459|NCT03136861|axial spondyloarthritis|axial spondyloarthritis
169460|NCT03136861|ankylosing spondylitis|ankylosing spondylitis
169461|NCT03136861|non-radiographic axial spondyloarthritis|non-radiographic axial spondyloarthritis
169464|NCT03136861|secukinumab|secukinumab
169465|NCT03136861|AIN457|ain457
169466|NCT03136848|perfusion|perfusion
169467|NCT03136822|Diabetic Foot|diabetic foot
169468|NCT03136744|Sedentary behaviour|sedentary behaviour
169469|NCT03136744|Co-morbidity|co-morbidity
169470|NCT03136744|Intervention|intervention
169471|NCT03136731|Celiac disease, Gluten, Microbiome, Genetic|celiac disease, gluten, microbiome, genetic
169472|NCT03136718|mHealth|mhealth
169473|NCT03136718|Hearing aids|hearing aids
169474|NCT03136718|Auditory rehabilitation|auditory rehabilitation
169475|NCT03136718|Adult|adult
169476|NCT03136718|Reusable Learning Object|reusable learning object
169477|NCT03136718|Education|education
169478|NCT03136718|Personalised|personalised
169479|NCT03136718|Telehealth|telehealth
169480|NCT03136718|Teleaudiology|teleaudiology
169481|NCT03136705|Phosphorus Homeostasis|phosphorus homeostasis
169482|NCT03136705|FGF23|fgf23
169483|NCT03136705|Vitamin D|vitamin d
169484|NCT03136692|app|app
169485|NCT03136692|weight loss|weight loss
169486|NCT03136692|diet|diet
169487|NCT03136692|behavior|behavior
169488|NCT03136653|DARPin|darpin
169489|NCT03136653|MP0250|mp0250
169490|NCT03136653|VEGF|vegf
169491|NCT03136653|HGF|hgf
169492|NCT03136653|RRMM|rrmm
169493|NCT03136627|RCC, Tivozanib, Nivolumab, Metastatic Renal Cell Cancer|rcc, tivozanib, nivolumab, metastatic renal cell cancer
169494|NCT03136588|Information and Communication Technology|information and communication technology
169495|NCT03136588|Adherence|adherence
169496|NCT03136588|Kidney transplantation|kidney transplantation
169497|NCT03136523|NSCLC|nsclc
169498|NCT03136523|SCLC|sclc
169499|NCT03136523|MOLECULAR BIOMARKERS|molecular biomarkers
169500|NCT03136523|EGFR|egfr
169501|NCT03136523|PD-L1|pd-l1
169502|NCT03136523|ALK|alk
169503|NCT03136523|KRAS|kras
169504|NCT03136458|contrast media|contrast media
169505|NCT03136458|nephropathy|nephropathy
169506|NCT03136458|ischemic preconditioning|ischemic preconditioning
169507|NCT03136445|Tranexamic acid|tranexamic acid
169508|NCT03136445|Platelet transfusion|platelet transfusion
169509|NCT03136432|Cerebral Palsy|cerebral palsy
169510|NCT03136432|Functional Exercise Capacity|functional exercise capacity
169511|NCT03136432|Quality of Life|quality of life
169512|NCT03136419|microbiota|microbiota
169513|NCT03136419|innate immunity|innate immunity
169514|NCT03136393|nutrition|nutrition
169515|NCT03136393|pregnancy|pregnancy
169516|NCT03136393|birth weight|birth weight
169517|NCT03136380|healthy Japanese subjects|healthy japanese subjects
169518|NCT03136380|CXCR2 inhibitor|cxcr2 inhibitor
169519|NCT03136380|Danirixin|danirixin
169520|NCT03136367|encounter decision aids|encounter decision aids
169521|NCT03136367|shared decision making|shared decision making
169522|NCT03136367|socioeconomic status|socioeconomic status
169523|NCT03136367|disparities|disparities
169524|NCT03136367|decision quality|decision quality
169525|NCT03136341|Upper Limb|upper limb
169526|NCT03136341|Tremor|tremor
169527|NCT03136341|task-dependent|task-dependent
169528|NCT03136315|Renal failure|renal failure
169529|NCT03136315|athlete|athlete
169530|NCT03136315|ultra endurance|ultra endurance
169531|NCT03136263|Attention|attention
169532|NCT03136263|Attention deficit/hyperactivity disorder|attention deficit/hyperactivity disorder
169533|NCT03136263|Cognitive control|cognitive control
169534|NCT03136263|Executive control|executive control
169535|NCT03136263|Executive functions|executive functions
169536|NCT03136263|Impulse control|impulse control
169537|NCT03136263|Impulsivity|impulsivity
169538|NCT03136263|Oxytocin|oxytocin
169539|NCT03136250|Muscle Energy Techniques|muscle energy techniques
169540|NCT03136250|Autogenic Inhibition|autogenic inhibition
169541|NCT03136250|Reciprocal Inhibition|reciprocal inhibition
169542|NCT03136250|Stretching|stretching
169543|NCT03136250|Range of Motion|range of motion
169544|NCT03136250|Muscle Strength|muscle strength
169545|NCT03136250|VAS|vas
169546|NCT03136250|Neck Disability Index|neck disability index
169547|NCT03136250|NDI|ndi
169548|NCT03136224|circumcision|circumcision
169549|NCT03136224|Thermocautery|thermocautery
169550|NCT03136224|Clamp|clamp
169551|NCT03136224|Surgical Circumcision|surgical circumcision
169552|NCT03136198|Heart Failure|heart failure
169553|NCT03136198|Acute Heart Failure|acute heart failure
169554|NCT03136198|Pulmonary Edema|pulmonary edema
169555|NCT03136198|Lung ultrasound|lung ultrasound
169556|NCT03136198|Extra vascular lung water|extra vascular lung water
169557|NCT03136198|B-lines|b-lines
169558|NCT03136185|LSD1|lsd1
169559|NCT03136159|pregnancy|pregnancy
169560|NCT03136159|delivery|delivery
169561|NCT03136159|cesarean section|cesarean section
169562|NCT03136159|wound healing|wound healing
169563|NCT03136159|silver-containing dressing|silver-containing dressing
169564|NCT03136120|Ipratropium bromide|ipratropium bromide
169565|NCT03136120|Cryobiopsy|cryobiopsy
169566|NCT03136120|TBCB|tbcb
169567|NCT03136120|IPF|ipf
169568|NCT03136120|Transbronchial cryobiopsy|transbronchial cryobiopsy
169569|NCT03136120|Interstitial lung disease|interstitial lung disease
169570|NCT03136094|American Indian|american indian
169571|NCT03136094|Alaska Native|alaska native
169572|NCT03136094|Youth and Young Adult|youth and young adult
169574|NCT03136081|Septic shock|septic shock
169575|NCT03136081|Candidiasis|candidiasis
169576|NCT03136081|Candidemia|candidemia
169577|NCT03136081|Bacteremia|bacteremia
169578|NCT03136081|Immunoparalysis|immunoparalysis
169579|NCT03136055|NEC|nec
169580|NCT03136029|HFrEF|hfref
169581|NCT03136029|Exercise Intolerance|exercise intolerance
169582|NCT03136029|Nitric Oxide|nitric oxide
169583|NCT03135990|Virtual Reality|virtual reality
169584|NCT03135990|Exposure Therapy|exposure therapy
169585|NCT03135990|Cognitive Behavioral Therapy|cognitive behavioral therapy
169586|NCT03135990|Extinction Learning|extinction learning
169587|NCT03135964|NPWT|npwt
169588|NCT03135964|foam|foam
169589|NCT03135964|gauze|gauze
169590|NCT03135951|Breast Cancer|breast cancer
169591|NCT03135951|Pharmacokinetics|pharmacokinetics
169592|NCT03135951|Long-acting Myeloid Growth Factor|long-acting myeloid growth factor
169593|NCT03135951|Early Stage Breast Cancer|early stage breast cancer
169594|NCT03135951|Docetaxel + Cyclophosphamide (TC) Chemotherapy|docetaxel + cyclophosphamide (tc) chemotherapy
169595|NCT03135912|Tinea Pedis|tinea pedis
169596|NCT03135912|Athlete's Foot|athlete's foot
169597|NCT03135886|HIV|hiv
169598|NCT03135886|HIV Testing|hiv testing
169599|NCT03135886|Hepatitis C Virus Testing|hepatitis c virus testing
169600|NCT03135886|Opioid Use Disorder Treatment|opioid use disorder treatment
169601|NCT03135886|Substance Use Disorders Treatment|substance use disorders treatment
169602|NCT03135886|Hepatitis C Virus|hepatitis c virus
169603|NCT03135886|Practice Coaching|practice coaching
169604|NCT03135860|Inhaled Nitric Oxide|inhaled nitric oxide
169605|NCT03135860|COPD|copd
169606|NCT03135860|Chronic Obstructive Pulmonary Disease|chronic obstructive pulmonary disease
169607|NCT03135860|Idopathic Pulmonary Fibrosis|idopathic pulmonary fibrosis
169608|NCT03135860|Long Term Oxygen Therapy (LTOT)|long term oxygen therapy (ltot)
169609|NCT03135808|MRI|mri
169610|NCT03135808|Imaging,|imaging,
169611|NCT03135808|Anatomy|anatomy
216711|NCT02839330|Flu|flu
169612|NCT03135808|Tissue|tissue
169613|NCT03135808|Colorectal|colorectal
169614|NCT03135808|Sigmoid|sigmoid
169615|NCT03135808|Colon|colon
169616|NCT03135808|Pathology|pathology
169617|NCT03135795|sufentanil|sufentanil
169618|NCT03135795|DNA methylation|dna methylation
169619|NCT03135769|avelumab|avelumab
169620|NCT03135769|PDL1|pdl1
169621|NCT03135769|Gestational Trophoblastic Neoplasias|gestational trophoblastic neoplasias
169622|NCT03135769|GTN|gtn
169623|NCT03135769|Hydatiform mole|hydatiform mole
169624|NCT03135769|hCG|hcg
169625|NCT03135717|Chronic kidney disease|chronic kidney disease
169626|NCT03135717|Enteral nutrition|enteral nutrition
169627|NCT03135717|Oral nutritional supplements|oral nutritional supplements
169628|NCT03135717|Parenteral nutrition|parenteral nutrition
169629|NCT03135717|Refeeding|refeeding
169630|NCT03135717|Wasting|wasting
169631|NCT03135652|Radiotherapy|radiotherapy
169632|NCT03135652|Colorectal Cancer|colorectal cancer
169633|NCT03135652|Liver Metastases|liver metastases
169634|NCT03135639|tACS|tacs
169635|NCT03135639|transcranial alternating current stimulation|transcranial alternating current stimulation
169636|NCT03135639|stimulation|stimulation
169637|NCT03135639|healthy control|healthy control
169638|NCT03135639|alpha oscillations|alpha oscillations
169639|NCT03135639|heart rate variability|heart rate variability
169640|NCT03135626|Pulpotomy|pulpotomy
169641|NCT03135626|Primary molars|primary molars
169642|NCT03135613|Knee tumor|knee tumor
169643|NCT03135613|Microwave|microwave
169644|NCT03135613|Gait|gait
169645|NCT03135600|Knee|knee
169646|NCT03135600|ACL Injury|acl injury
169647|NCT03135600|Kinematics|kinematics
169648|NCT03135587|Knee|knee
169649|NCT03135587|Loading|loading
169650|NCT03135587|Kinematics|kinematics
169651|NCT03135522|Chronic cough|chronic cough
169652|NCT03135522|Refractory cough|refractory cough
169653|NCT03135522|Chronic refractory cough|chronic refractory cough
169654|NCT03135522|Zinc|zinc
169655|NCT03135522|Zinc acetate|zinc acetate
169656|NCT03135509|Healthy Subjects|healthy subjects
169657|NCT03135509|CC-220 Capsules|cc-220 capsules
169658|NCT03135509|Relative Bioavailability|relative bioavailability
169659|NCT03135509|Phase 1|phase 1
169660|NCT03135470|pain|pain
169661|NCT03135470|ambulatory surgery|ambulatory surgery
169662|NCT03135470|oxycodone|oxycodone
169663|NCT03135470|adverse effect|adverse effect
169664|NCT03135444|Screening|screening
169665|NCT03135444|Shared Decision Making|shared decision making
169666|NCT03135418|Virtual Reality|virtual reality
169667|NCT03135392|Breast Cancer|breast cancer
169668|NCT03135392|sensation recovery|sensation recovery
169669|NCT03135392|Neurotization|neurotization
169670|NCT03135366|Tuberculosis|tuberculosis
169671|NCT03135366|TB|tb
169672|NCT03135366|Adherence|adherence
169673|NCT03135366|Mobile Health|mobile health
169674|NCT03135366|mHealth|mhealth
169675|NCT03135366|Behavior change|behavior change
169676|NCT03135366|Social and Behavior Change Communication (SBCC)|social and behavior change communication (sbcc)
169677|NCT03135366|Drug-Resistance|drug-resistance
169678|NCT03135366|Keheala|keheala
169679|NCT03135275|ST-elevation Myocardial Infarction|st-elevation myocardial infarction
169680|NCT03135275|Multivessel coronary disease|multivessel coronary disease
169681|NCT03135275|Immediate complete coronary revascularization|immediate complete coronary revascularization
169682|NCT03135275|Staged complete coronary revascularization|staged complete coronary revascularization
169683|NCT03135275|Percutaneous coronary intervention|percutaneous coronary intervention
169684|NCT03135275|Biodegradable-polymer everolimus-eluting stent|biodegradable-polymer everolimus-eluting stent
169685|NCT03135236|Parent training|parent training
169686|NCT03135236|Family education|family education
169687|NCT03135236|Young adults|young adults
169688|NCT03135236|Down syndrome|down syndrome
169689|NCT03135236|sexuality|sexuality
169690|NCT03135223|Physical activity|physical activity
169691|NCT03135145|Single Event Multilevel Lower Extremity Orthopedic Surgery (SEMLS)|single event multilevel lower extremity orthopedic surgery (semls)
169692|NCT03135145|Physical Therapy|physical therapy
169693|NCT03135145|Gait Training|gait training
169694|NCT03135145|Functional Walking|functional walking
169695|NCT03135145|Selective Dorsal Rhizotomy (SDR)|selective dorsal rhizotomy (sdr)
169696|NCT03135132|High visceral fat|high visceral fat
169697|NCT03135132|Low calorie diet|low calorie diet
169698|NCT03135132|Mild weight loss|mild weight loss
169699|NCT03135132|Metabolomics|metabolomics
169700|NCT03135132|Metabolites|metabolites
169701|NCT03135132|Acylcarnitines|acylcarnitines
169702|NCT03135093|synergies|synergies
169703|NCT03135093|upper limb|upper limb
169704|NCT03135093|vision|vision
169705|NCT03135067|HIV self-testing|hiv self-testing
169706|NCT03135067|female sex workers|female sex workers
169707|NCT03135067|partner testing|partner testing
169708|NCT03135067|couples testing|couples testing
169709|NCT03135067|transactional sex|transactional sex
400602|NCT01866059|RMGIC|rmgic
216833|NCT02838498|EMS|ems
169710|NCT03135054|FLT3-ITD (+) AML; Quizartinib, Omacetaxine mepesuccinate|flt3-itd (+) aml; quizartinib, omacetaxine mepesuccinate
169711|NCT03135041|Prebiotics|prebiotics
169712|NCT03135041|Microbiome|microbiome
169713|NCT03135041|Glucose metabolism|glucose metabolism
169714|NCT03134976|Salvage surgery|salvage surgery
169715|NCT03134976|Head and neck cancer|head and neck cancer
169716|NCT03134976|Wound healing|wound healing
169717|NCT03134976|Hypothyroidism|hypothyroidism
169718|NCT03134976|Levothyroxine|levothyroxine
169719|NCT03134937|Gastric Ultrasound|gastric ultrasound
169720|NCT03134937|Gastric Distension|gastric distension
169721|NCT03134937|Gastric Volume|gastric volume
169722|NCT03134937|Gastric Fluid Volume|gastric fluid volume
169723|NCT03134937|High-flow oxygen therapy|high-flow oxygen therapy
169724|NCT03134937|HFHHNO|hfhhno
169725|NCT03134937|Healthy volunteer|healthy volunteer
169726|NCT03134924|Bacterial Vaginosis|bacterial vaginosis
169727|NCT03134885|suicide|suicide
169728|NCT03134885|suicidal conducts|suicidal conducts
169729|NCT03134885|post discharge monitoring system|post discharge monitoring system
169730|NCT03134872|PD-1|pd-1
169731|NCT03134872|PD-L1|pd-l1
169732|NCT03134872|SHR-1210|shr-1210
169733|NCT03134872|Carboplatin|carboplatin
169734|NCT03134872|Pemetrexed|pemetrexed
169735|NCT03134859|motor development|motor development
169736|NCT03134846|Intraoperative fluorescence imaging|intraoperative fluorescence imaging
169737|NCT03134846|Cetuximab-IRDye800CW|cetuximab-irdye800cw
169738|NCT03134846|Molecular imaging|molecular imaging
169739|NCT03134833|HIV|hiv
169740|NCT03134833|STI|sti
169741|NCT03134833|Mental Health|mental health
169742|NCT03134833|Substance Use|substance use
169743|NCT03134833|Peer Support|peer support
169744|NCT03134820|Low molecular weight heparins|low molecular weight heparins
169745|NCT03134820|Procoagulants|procoagulants
169746|NCT03134820|Phospholipid-dependent Microparticles|phospholipid-dependent microparticles
169747|NCT03134794|neuroeconomics|neuroeconomics
169748|NCT03134794|multiple sclerosis|multiple sclerosis
169749|NCT03134794|educational intervention|educational intervention
169750|NCT03134794|traffic light system|traffic light system
169751|NCT03134794|aversion to ambiguity|aversion to ambiguity
169752|NCT03134794|risk|risk
169753|NCT03134794|outcomes|outcomes
169754|NCT03134794|knowledge|knowledge
169755|NCT03134794|action|action
169756|NCT03134794|gaps|gaps
169757|NCT03134794|disease modifying agents|disease modifying agents
169758|NCT03134755|Asthma|asthma
169759|NCT03134755|Children|children
169760|NCT03134755|Stress|stress
169761|NCT03134755|Puerto Rican|puerto rican
169762|NCT03134755|Health disparities|health disparities
169763|NCT03134755|Treatment response|treatment response
169764|NCT03134742|soft tissue sarcoma extremities|soft tissue sarcoma extremities
169765|NCT03134729|Serratus Block, Pain Management, lung lobectomy|serratus block, pain management, lung lobectomy
169766|NCT03134690|Poor ovarian response gonadotropins antagonist|poor ovarian response gonadotropins antagonist
169767|NCT03134677|Spinal anesthesia|spinal anesthesia
169768|NCT03134677|General anesthesia|general anesthesia
169769|NCT03134677|P wave dispersion|p wave dispersion
169770|NCT03134651|Anxiety|anxiety
169771|NCT03134651|Oocyte retrieval|oocyte retrieval
169772|NCT03134651|Monitoring of brain function|monitoring of brain function
169773|NCT03134625|metabolomics|metabolomics
169774|NCT03134625|biomarker|biomarker
169775|NCT03134625|acute rejection|acute rejection
169776|NCT03134612|lidocain|lidocain
169777|NCT03134612|ondansetron|ondansetron
169778|NCT03134612|pain|pain
169779|NCT03134612|propofol|propofol
169780|NCT03134586|Capsule endoscopy|capsule endoscopy
169781|NCT03134586|Crohn's disease|crohn's disease
169782|NCT03134586|Magnetic resonance enterography|magnetic resonance enterography
169783|NCT03134586|Ileocolonoscopy|ileocolonoscopy
169784|NCT03134586|Bowel Ultrasound|bowel ultrasound
169785|NCT03134586|diagnostic imaging|diagnostic imaging
169786|NCT03134573|Relapsing Remitting Multiple Sclerosis (RRMS),|relapsing remitting multiple sclerosis (rrms),
169787|NCT03134573|Clinically isolated Syndrome (CIS),|clinically isolated syndrome (cis),
169788|NCT03134573|Secondary Progressive Multiple Sclerosis (SPMS)|secondary progressive multiple sclerosis (spms)
169789|NCT03134560|vein display instrument|vein display instrument
169790|NCT03134560|pediatric|pediatric
169791|NCT03134560|vein access|vein access
169792|NCT03134560|vein cannulation|vein cannulation
169793|NCT03134547|emergence agitation|emergence agitation
169794|NCT03134547|sevoflurane|sevoflurane
169795|NCT03134547|children|children
169796|NCT03134534|lobectomy|lobectomy
169797|NCT03134534|robot-assisted thoracoscopic surgery|robot-assisted thoracoscopic surgery
169798|NCT03134534|lung cancer|lung cancer
169799|NCT03134521|bone and joint infection|bone and joint infection
169800|NCT03134521|daptomycin|daptomycin
169801|NCT03134521|population pharmacokinetics|population pharmacokinetics
169802|NCT03134521|Glycoprotein-P (PgP)|glycoprotein-p (pgp)
169803|NCT03134482|in vitro maturation (IVM)|in vitro maturation (ivm)
400603|NCT01866059|Biodentine|biodentine
169804|NCT03134482|polycystic ovarian syndrome (PCOS)|polycystic ovarian syndrome (pcos)
169805|NCT03134482|ovarian hyperstimulation syndrome (OHSS)|ovarian hyperstimulation syndrome (ohss)
169806|NCT03134482|assisted reproductive technology (ART)|assisted reproductive technology (art)
169807|NCT03134430|Regional nerve block|regional nerve block
169808|NCT03134430|cancer recurrence|cancer recurrence
169809|NCT03134404|RAMP|ramp
169810|NCT03134404|Rapid Access|rapid access
169811|NCT03134404|Metastasis to Bone|metastasis to bone
169812|NCT03134404|Cancer|cancer
169813|NCT03134378|Helicobacter pylori|helicobacter pylori
169814|NCT03134378|triple therapy|triple therapy
169815|NCT03134378|eradication|eradication
169816|NCT03134365|meal ingestion|meal ingestion
169817|NCT03134365|palatability|palatability
169818|NCT03134365|postprandial responses|postprandial responses
169819|NCT03134365|hedonic response|hedonic response
169820|NCT03134352|subacute|subacute
169821|NCT03134339|nicotine, smoking|nicotine, smoking
169822|NCT03134209|Monocryl|monocryl
169823|NCT03134209|Dermabond|dermabond
169824|NCT03134209|Polyester mesh|polyester mesh
169825|NCT03134209|Joint Disease|joint disease
169826|NCT03134209|Arthropathy|arthropathy
169827|NCT03134209|Joint Replacement|joint replacement
169828|NCT03134196|Herpes Zoster Ophthalmicus|herpes zoster ophthalmicus
169829|NCT03134196|Zoster Eye Disease Study|zoster eye disease study
169830|NCT03134196|Varicella Zoster Virus|varicella zoster virus
169831|NCT03134196|Zoster|zoster
169832|NCT03134196|Shingles|shingles
169833|NCT03134183|D&E|d&e
169834|NCT03134183|dilation and evacuation|dilation and evacuation
169835|NCT03134183|abortion|abortion
169836|NCT03134183|second trimester|second trimester
169837|NCT03134183|mifepristone|mifepristone
169838|NCT03134183|misoprostol|misoprostol
169839|NCT03134170|pharmacist|pharmacist
169840|NCT03134170|diabetes|diabetes
169841|NCT03134170|Preventative Care|preventative care
169842|NCT03134170|Quality of Life|quality of life
169843|NCT03134157|Leiomyoma simvastatin infertility|leiomyoma simvastatin infertility
169844|NCT03134144|Exoskeleton|exoskeleton
169845|NCT03134144|Manual materials handling|manual materials handling
169846|NCT03134144|Musculoskeletal disorders|musculoskeletal disorders
169847|NCT03134144|Posture|posture
169848|NCT03134144|Standing work|standing work
169849|NCT03134144|Muscle activity|muscle activity
169850|NCT03134118|Thymoma|thymoma
169851|NCT03134118|Phase II|phase ii
169852|NCT03134118|nivolumab|nivolumab
169853|NCT03134118|Thymic carcinoma|thymic carcinoma
169854|NCT03134079|Taste Test|taste test
169855|NCT03134079|Spices|spices
169856|NCT03134079|Reduced sugar|reduced sugar
169857|NCT03134079|Food liking|food liking
169858|NCT03134053|hypertrophy scar|hypertrophy scar
169859|NCT03134053|burn|burn
169860|NCT03134040|Incentives|incentives
169861|NCT03134040|Motivation|motivation
169862|NCT03133975|high dose vitamin D|high dose vitamin d
169863|NCT03133975|dyslipidemia|dyslipidemia
169864|NCT03133975|premenopausal women|premenopausal women
169865|NCT03133923|Attenuated Mumps Vaccine(F-genotype，Human Diploid Cell, KMB-17), safety, immunogenecity|attenuated mumps vaccine(f-genotype，human diploid cell, kmb-17), safety, immunogenecity
169866|NCT03133910|Pharmacokinetics|pharmacokinetics
169867|NCT03133910|Ceftazidime|ceftazidime
169868|NCT03133897|dexamethasone|dexamethasone
169869|NCT03133897|prednisone|prednisone
169870|NCT03133897|inpatient|inpatient
169871|NCT03133897|paediatrics|paediatrics
169872|NCT03133884|chronic tension-type headache|chronic tension-type headache
169873|NCT03133884|acupuncture|acupuncture
169874|NCT03133884|Deqi|deqi
169875|NCT03133845|delirium|delirium
169876|NCT03133845|elderly|elderly
169877|NCT03133845|lumbar|lumbar
169878|NCT03133845|surgery|surgery
169879|NCT03133832|Schistosomiasis haematobium|schistosomiasis haematobium
169880|NCT03133832|Praziquantel|praziquantel
169881|NCT03133832|A randomized controlled trial|a randomized controlled trial
169882|NCT03133806|Percutaneous Occlusion|percutaneous occlusion
169883|NCT03133793|heart failure with preserved ejection fraction|heart failure with preserved ejection fraction
169884|NCT03133767|Normal saline|normal saline
169885|NCT03133767|Lactated ringers|lactated ringers
169886|NCT03133767|Emergency department|emergency department
169887|NCT03133741|GIP|gip
169888|NCT03133741|GIP receptor antagonist|gip receptor antagonist
169889|NCT03133728|EID HIV|eid hiv
169890|NCT03133728|Early Infant Diagnosis|early infant diagnosis
169891|NCT03133728|Point of Care|point of care
169892|NCT03133728|Infant|infant
169893|NCT03133728|HIV|hiv
169894|NCT03133715|robot-assisted|robot-assisted
169895|NCT03133689|Alcohol|alcohol
169896|NCT03133689|Coronary heart disease|coronary heart disease
169897|NCT03133689|Ischemic heart disease|ischemic heart disease
169898|NCT03133689|Cardiovascular health|cardiovascular health
169899|NCT03133689|Individual participant data meta-analysis|individual participant data meta-analysis
169900|NCT03133689|Longitudinal|longitudinal
169901|NCT03133676|Osteoarthritis|osteoarthritis
169902|NCT03133676|Arthritis|arthritis
169903|NCT03133676|Joint Disease|joint disease
169904|NCT03133676|Osteoarthritis, Knee|osteoarthritis, knee
169905|NCT03133663|electrocardiogram|electrocardiogram
169906|NCT03133663|premature|premature
169907|NCT03133663|resuscitation|resuscitation
169908|NCT03133650|Vascular-Targeted Photodynamic Therapy (VTP)|vascular-targeted photodynamic therapy (vtp)
169909|NCT03133650|15-319|15-319
169910|NCT03133624|unruptured intracranial aneurysms|unruptured intracranial aneurysms
169911|NCT03133624|rupture risk|rupture risk
169912|NCT03133624|computational fluid dynamic|computational fluid dynamic
169913|NCT03133624|high resolution magnetic resonance images|high resolution magnetic resonance images
169914|NCT03133624|gene|gene
169915|NCT03133624|multi dimensional prediction model|multi dimensional prediction model
169916|NCT03133624|clinical features|clinical features
169917|NCT03133624|risk factors|risk factors
169918|NCT03133624|registry study|registry study
169919|NCT03133624|china|china
169920|NCT03133624|biomarkers|biomarkers
169921|NCT03133611|Speech disorder|speech disorder
169922|NCT03133611|Acoustic analysis|acoustic analysis
169923|NCT03133611|Dysarthria|dysarthria
169924|NCT03133598|Un-ruptured intracranial aneurysm|un-ruptured intracranial aneurysm
169925|NCT03133598|Interventional therapy and craniotomy|interventional therapy and craniotomy
169926|NCT03133598|Prospective cohort study|prospective cohort study
169927|NCT03133598|China|china
169928|NCT03133546|NSCLC|nsclc
169929|NCT03133546|EGFR|egfr
169930|NCT03133546|TKI|tki
169931|NCT03133546|EGFRm|egfrm
169932|NCT03133546|T790M|t790m
169933|NCT03133533|robot-assisted|robot-assisted
169934|NCT03133520|Respiratory failure|respiratory failure
169935|NCT03133520|immuncompromise patients|immuncompromise patients
169936|NCT03133520|high flow oxygen|high flow oxygen
169937|NCT03133507|cancer|cancer
169938|NCT03133507|salivary alpha amylase|salivary alpha amylase
169939|NCT03133507|pain|pain
169940|NCT03133507|positive affect|positive affect
169941|NCT03133507|emotion regulation strategies|emotion regulation strategies
169942|NCT03133481|Adductor Canal Block|adductor canal block
169943|NCT03133481|Femoral Canal Block|femoral canal block
169944|NCT03133468|AJM347|ajm347
169945|NCT03133468|pharmacokinetics|pharmacokinetics
169946|NCT03133468|food effect study|food effect study
169947|NCT03133468|pharmacodynamics|pharmacodynamics
169948|NCT03133455|Rumination|rumination
169949|NCT03133429|carotid artery|carotid artery
169950|NCT03133429|stroke|stroke
169951|NCT03133429|stent|stent
169952|NCT03133416|rotator cuff tendinopathy|rotator cuff tendinopathy
169953|NCT03133416|rotator cuff tear|rotator cuff tear
169954|NCT03133416|platelet-rich plasma|platelet-rich plasma
169955|NCT03133416|physiotherapy|physiotherapy
169956|NCT03133416|exercise|exercise
169957|NCT03133377|Early activity and mobilization, rehabilitation, intensive care|early activity and mobilization, rehabilitation, intensive care
169958|NCT03133325|Hyaluronic Acid, Lidocaine|hyaluronic acid, lidocaine
169959|NCT03133286|Anal Cancer|anal cancer
169960|NCT03133286|Bladder|bladder
169961|NCT03133286|Cervical|cervical
169962|NCT03133286|Colorectal|colorectal
169963|NCT03133286|Esophageal|esophageal
169964|NCT03133286|Gallbladder|gallbladder
169965|NCT03133286|Liver|liver
169966|NCT03133286|Ovarian|ovarian
169967|NCT03133286|Pancreas|pancreas
169968|NCT03133286|Pancreatic|pancreatic
169969|NCT03133286|Prostate|prostate
169970|NCT03133286|Rectal|rectal
169972|NCT03133286|Kidney|kidney
169973|NCT03133286|Stomach|stomach
169974|NCT03133286|Testicular|testicular
169975|NCT03133286|Uterine|uterine
169976|NCT03133286|Cancer|cancer
169977|NCT03133286|Radiation Therapy|radiation therapy
169978|NCT03133286|Radiation Treatment|radiation treatment
169979|NCT03133273|Colorectal Cancer Metastatic|colorectal cancer metastatic
169980|NCT03133273|Chemosensitivity|chemosensitivity
169981|NCT03133221|NHL|nhl
169982|NCT03133221|indolent NHL|indolent nhl
169983|NCT03133221|Zydelig|zydelig
169984|NCT03133221|Idelalisib|idelalisib
169985|NCT03133221|B-cell NHL|b-cell nhl
169986|NCT03133221|Non-Hodgkin Lymphoma|non-hodgkin lymphoma
169987|NCT03133221|Maintenance|maintenance
169988|NCT03133221|Transformed B-cell Non-Hodgkin's lymphoma|transformed b-cell non-hodgkin's lymphoma
169989|NCT03133221|Autologous Stem Cell Transplantation|autologous stem cell transplantation
169990|NCT03133208|sepsis|sepsis
169991|NCT03133208|sepsis associated encephalopathy|sepsis associated encephalopathy
169992|NCT03133208|sepsis associated delirium|sepsis associated delirium
169993|NCT03133208|altered mental status|altered mental status
169994|NCT03133195|Terriparatide, bone fracture healing, PFNA|terriparatide, bone fracture healing, pfna
169995|NCT03133169|Thalassemia|thalassemia
169996|NCT03133169|Glutamine/glutamate ratio|glutamine/glutamate ratio
169997|NCT03133169|Pulmonary hypertension|pulmonary hypertension
169998|NCT03133156|Exercise|exercise
169999|NCT03133156|Training|training
170000|NCT03133156|Type 2 Diabetes|type 2 diabetes
170001|NCT03133156|Mellitus|mellitus
170002|NCT03133143|Cognitive Function|cognitive function
170003|NCT03133143|Schizophrenia and Disorders with Psychotic Features|schizophrenia and disorders with psychotic features
170004|NCT03133143|Computers, Digital|computers, digital
170005|NCT03133130|Scar|scar
170006|NCT03133130|Scar prevention|scar prevention
170007|NCT03133130|siRNA|sirna
170008|NCT03133091|PIEB|pieb
170009|NCT03133091|PCEA|pcea
170010|NCT03133091|LEVOBUPIVACAINE|levobupivacaine
170011|NCT03133078|Side Hop|side hop
170012|NCT03133078|Forward Hop|forward hop
170013|NCT03133078|Step test|step test
170014|NCT03133078|Vertical Jump|vertical jump
170015|NCT03133052|cognitive control training|cognitive control training
170016|NCT03133052|aMCI|amci
170017|NCT03133052|MRI|mri
170018|NCT03133052|RCT|rct
170019|NCT03133026|obstructive Jaundice|obstructive jaundice
170020|NCT03133026|Self Expandable Metal Stents (SEMS)|self expandable metal stents (sems)
170021|NCT03133026|Cholangitis|cholangitis
170022|NCT03133000|Recurrent abdominal wall hernia|recurrent abdominal wall hernia
170023|NCT03133000|Incisional hernia|incisional hernia
170024|NCT03132987|quadriceps strength|quadriceps strength
170025|NCT03132987|quadriceps voluntary activation|quadriceps voluntary activation
170026|NCT03132987|progressive strength program|progressive strength program
170027|NCT03132961|Vestibular evoked myogenic potentials|vestibular evoked myogenic potentials
170028|NCT03132961|Electrocochleography|electrocochleography
170029|NCT03132961|Infrasound|infrasound
170030|NCT03132948|ALL Cancer Patients|all cancer patients
170031|NCT03132948|Quality of Life|quality of life
170032|NCT03132948|Fitness|fitness
170033|NCT03132935|Non-STEMI Acute Coronary Syndrome|non-stemi acute coronary syndrome
170034|NCT03132935|ST-segment elevation myocardial infarction|st-segment elevation myocardial infarction
170035|NCT03132935|Telemedicine|telemedicine
170036|NCT03132922|Cell Therapy|cell therapy
170037|NCT03132922|T Cell Therapy|t cell therapy
170038|NCT03132922|SPEAR T Cell|spear t cell
170039|NCT03132922|MAGE-A4|mage-a4
170040|NCT03132922|Immuno-oncology|immuno-oncology
170041|NCT03132922|Metastatic|metastatic
170042|NCT03132922|Urothelial Cancer|urothelial cancer
170043|NCT03132922|Previously Treated|previously treated
170044|NCT03132922|T Cell Receptor|t cell receptor
170045|NCT03132922|Squamous, adenosquamous, adenocarcinoma or large cell NSCLC|squamous, adenosquamous, adenocarcinoma or large cell nsclc
170046|NCT03132922|Squamous or adenocarcinoma esophageal cancer|squamous or adenocarcinoma esophageal cancer
170047|NCT03132922|Sarcoma|sarcoma
170048|NCT03132922|Melanoma|melanoma
170049|NCT03132922|Bladder|bladder
170050|NCT03132922|Ovarian|ovarian
170051|NCT03132818|Procreation with donation|procreation with donation
170052|NCT03132792|Alpha-fetoprotein|alpha-fetoprotein
170053|NCT03132792|Cell Therapy|cell therapy
170054|NCT03132792|T Cell Therapy|t cell therapy
170055|NCT03132792|SPEAR T Cell|spear t cell
170056|NCT03132792|Immuno-oncology|immuno-oncology
170057|NCT03132792|Metastatic|metastatic
170058|NCT03132792|Previously treated|previously treated
170059|NCT03132792|T Cell Receptor|t cell receptor
170060|NCT03132779|Intralipid|intralipid
170061|NCT03132779|NK cells|nk cells
170062|NCT03132779|Recurrent miscarriage|recurrent miscarriage
170063|NCT03132740|Hepatic Carcinoma,Three-dimensional Visualization|hepatic carcinoma,three-dimensional visualization
170064|NCT03132714|Full-mouth ultrasonic debridement|full-mouth ultrasonic debridement
170065|NCT03132714|Clarithromycin|clarithromycin
170066|NCT03132714|Amoxicillin|amoxicillin
170067|NCT03132714|Metronidazole|metronidazole
170068|NCT03132714|Antimicrobial therapy|antimicrobial therapy
170069|NCT03132714|Photodynamic therapy|photodynamic therapy
170070|NCT03132714|Low-level laser therapy|low-level laser therapy
170071|NCT03132675|Melanoma|melanoma
170072|NCT03132675|pIL-12|pil-12
170073|NCT03132675|pembrolizumab|pembrolizumab
170074|NCT03132675|tavokinogene telseplasmid|tavokinogene telseplasmid
170075|NCT03132649|Three dimensional visualization|three dimensional visualization
170076|NCT03132649|Operation strategy|operation strategy
170077|NCT03132597|stress|stress
170078|NCT03132597|anxiety|anxiety
170079|NCT03132597|depression|depression
170080|NCT03132597|quality of life|quality of life
170081|NCT03132597|Mindfulness|mindfulness
170082|NCT03132584|Non Hodgkin Lymphoma|non hodgkin lymphoma
170083|NCT03132571|Schizophrenia|schizophrenia
170084|NCT03132571|Diabetes|diabetes
170085|NCT03132571|Obesity|obesity
170086|NCT03132519|Cough|cough
170087|NCT03132519|Hypertension|hypertension
170088|NCT03132519|Remifentanil|remifentanil
170089|NCT03132519|Sevoflurane|sevoflurane
170090|NCT03132519|Desflurane|desflurane
170091|NCT03132441|advanced heart failure|advanced heart failure
170092|NCT03132441|NYHA Class III-IV|nyha class iii-iv
170093|NCT03132441|frailty|frailty
170094|NCT03132441|cardiac rehabilitation|cardiac rehabilitation
170095|NCT03132415|Prevention & Control|prevention & control
170096|NCT03132415|Internet|internet
170097|NCT03132415|Adolescents|adolescents
170098|NCT03132415|Young adults|young adults
170099|NCT03132402|Elisa|elisa
170100|NCT03132402|Plasmodium Falciparum|plasmodium falciparum
170101|NCT03132389|Sexual assault|sexual assault
170102|NCT03132389|Sexually transmitted diseases|sexually transmitted diseases
217329|NCT02835066|Stage I|stage i
170103|NCT03132389|Chlamydia trachomatis|chlamydia trachomatis
170104|NCT03132389|Mycoplasma genitalium|mycoplasma genitalium
170105|NCT03132389|Neisseria gonorrhoeae|neisseria gonorrhoeae
170106|NCT03132389|Hepatitis B and C|hepatitis b and c
170107|NCT03132389|HIV|hiv
170108|NCT03132389|Syphilis|syphilis
170109|NCT03132389|Follow up visits after sexual assault|follow up visits after sexual assault
170110|NCT03132324|Sickle cell disease (SCD)|sickle cell disease (scd)
170111|NCT03132324|sickle cell SS|sickle cell ss
170112|NCT03132324|lysine demethylase 1 (LSD1) inhibition|lysine demethylase 1 (lsd1) inhibition
170113|NCT03132311|yellow fever vaccine|yellow fever vaccine
170114|NCT03132311|hiv|hiv
170115|NCT03132272|ADAsorb apheresis|adasorb apheresis
170116|NCT03132272|Globaffin adsorber|globaffin adsorber
170117|NCT03132272|Agonistic Autoantibodies|agonistic autoantibodies
170118|NCT03132272|Immunoadsorption|immunoadsorption
170119|NCT03132272|Alzheimer Dementia|alzheimer dementia
170120|NCT03132259|Dexmedethomidine|dexmedethomidine
170121|NCT03132246|Methicillin-resistant Staphylococcus aureus (MRSA)|methicillin-resistant staphylococcus aureus (mrsa)
170122|NCT03132246|Infection|infection
170123|NCT03132246|Biofilm Assay|biofilm assay
170124|NCT03132233|Migraine|migraine
170125|NCT03132233|Prevention|prevention
170126|NCT03132233|Prophylaxis|prophylaxis
170127|NCT03132233|Ketone bodies|ketone bodies
170128|NCT03132233|Beta-hydroxybutyrate|beta-hydroxybutyrate
170129|NCT03132233|Double-blind|double-blind
170130|NCT03132233|Randomised|randomised
170131|NCT03132233|Placebo controlled|placebo controlled
170132|NCT03132233|Mitochondrial functioning|mitochondrial functioning
170133|NCT03132233|Energy metabolism|energy metabolism
170134|NCT03132233|Intervention|intervention
170135|NCT03132233|Dietary Supplement|dietary supplement
170136|NCT03132220|critical care nurses|critical care nurses
170137|NCT03132220|mindfulness-based cognitive therapy|mindfulness-based cognitive therapy
170138|NCT03132220|Burn-out Syndrome|burn-out syndrome
170139|NCT03132220|Post-traumatic Stress Disorder|post-traumatic stress disorder
170140|NCT03132220|Cognitive Behavioral Therapy|cognitive behavioral therapy
170141|NCT03132207|Oral Health|oral health
170142|NCT03132207|Pregnancy|pregnancy
170143|NCT03132207|Prevention|prevention
170144|NCT03132207|adverse pregnancy outcomes|adverse pregnancy outcomes
170145|NCT03132181|Empagliflozin|empagliflozin
170146|NCT03132181|Diabetes|diabetes
170147|NCT03132181|Systemic vascular resistance|systemic vascular resistance
170148|NCT03132181|Cardiac output|cardiac output
170149|NCT03132181|Blood pressure|blood pressure
170150|NCT03132168|cystectomy|cystectomy
170151|NCT03132168|urology|urology
170152|NCT03132168|surgery|surgery
170153|NCT03132129|Type 2 diabetes|type 2 diabetes
170154|NCT03132129|Diabetic cardiomyopathy|diabetic cardiomyopathy
170155|NCT03132129|Cardiovascular magnetic resonance|cardiovascular magnetic resonance
170156|NCT03132116|Cat Scratch Disease's lymphadenitis|cat scratch disease's lymphadenitis
170157|NCT03132116|Infectious Diseases|infectious diseases
170158|NCT03132103|Vitamin D deficiency|vitamin d deficiency
170159|NCT03132103|Simulated sunlight radiation|simulated sunlight radiation
170160|NCT03132103|Oral vitamin D3|oral vitamin d3
170161|NCT03132051|carpal tunnel syndrome|carpal tunnel syndrome
170162|NCT03132025|Metastatic Colorectal Cancer|metastatic colorectal cancer
170163|NCT03132025|Apatinib|apatinib
170164|NCT03132025|Capecitabine|capecitabine
170165|NCT03131999|VEGF-D|vegf-d
170166|NCT03131999|Imatinib mesylate|imatinib mesylate
170167|NCT03131999|Sirolimus|sirolimus
170168|NCT03131921|Energy expenditure|energy expenditure
170169|NCT03131921|Nutrition|nutrition
170170|NCT03131921|Colorectal cancer|colorectal cancer
170171|NCT03131921|Dietary needs|dietary needs
170172|NCT03131908|Melanoma and other malignant neoplasms of skin|melanoma and other malignant neoplasms of skin
170173|NCT03131908|Metastatic Melanoma|metastatic melanoma
170174|NCT03131908|GSK2633771|gsk2633771
170175|NCT03131908|Pembrolizumab|pembrolizumab
170176|NCT03131908|Keytruda|keytruda
170177|NCT03131908|MK-3475|mk-3475
170178|NCT03131908|SCH-900475|sch-900475
170179|NCT03131895|Drug therapy|drug therapy
170180|NCT03131882|trigger finger|trigger finger
170181|NCT03131882|trigger thumb|trigger thumb
170182|NCT03131882|ultrasound guided|ultrasound guided
170183|NCT03131882|hyaluronic acid|hyaluronic acid
170184|NCT03131856|Geriatrics|geriatrics
170185|NCT03131856|Nutritional risk|nutritional risk
170186|NCT03131856|Multi-disciplinary intervention|multi-disciplinary intervention
170187|NCT03131856|Randomized Controlled Trial|randomized controlled trial
170188|NCT03131843|skin infection|skin infection
170189|NCT03131843|vaccination|vaccination
170190|NCT03131843|children|children
170191|NCT03131843|alcohol swab|alcohol swab
170192|NCT03131843|skin preparation|skin preparation
170193|NCT03131804|Aerobic|aerobic
170194|NCT03131804|Intradialytic|intradialytic
170195|NCT03131804|Cardio-metabolic markers|cardio-metabolic markers
170196|NCT03131804|Dialysis Adequacy|dialysis adequacy
170197|NCT03131804|Quality of Life|quality of life
170198|NCT03131804|Cost Effectiveness|cost effectiveness
170199|NCT03131791|Extracorporeal Shock Wave|extracorporeal shock wave
170200|NCT03131791|Spasticity in stokes|spasticity in stokes
170201|NCT03131791|Botulinum toxin|botulinum toxin
170202|NCT03131752|chronic obstructive pulmonary disease|chronic obstructive pulmonary disease
170203|NCT03131752|muscle strength|muscle strength
170204|NCT03131752|physical activity|physical activity
170205|NCT03131739|Resilience|resilience
170206|NCT03131739|Alaska Native|alaska native
170207|NCT03131739|Community Based Participatory Research|community based participatory research
170208|NCT03131739|Culture and Community Factors|culture and community factors
170209|NCT03131739|Protective Factors|protective factors
170210|NCT03131739|Risk Factors|risk factors
170211|NCT03131726|simvastatin|simvastatin
170212|NCT03131726|diclofenac|diclofenac
170213|NCT03131713|Mohs micrographic surgery|mohs micrographic surgery
170214|NCT03131713|pain|pain
170215|NCT03131713|functional status|functional status
170216|NCT03131700|RPH101|rph101
170217|NCT03131700|RPH-101|rph-101
170218|NCT03131700|Biosimilar|biosimilar
170219|NCT03131700|Bevacizumab|bevacizumab
170220|NCT03131700|Safety|safety
170221|NCT03131674|Somatic tinnitus|somatic tinnitus
170222|NCT03131635|Developmental|developmental
170223|NCT03131596|Intrauterine Adhesion|intrauterine adhesion
170224|NCT03131596|Hysteroscopy|hysteroscopy
170225|NCT03131596|Intrauterine balloon|intrauterine balloon
170226|NCT03131596|Reformation|reformation
170227|NCT03131596|Prevention|prevention
170228|NCT03131583|SHR4640 Febuxostat Colchicine pharmacodynamics|shr4640 febuxostat colchicine pharmacodynamics
170229|NCT03131570|Psoriasis|psoriasis
170230|NCT03131570|Chronic Plaque Psoriasis|chronic plaque psoriasis
170231|NCT03131570|Secukinumab|secukinumab
170233|NCT03131544|Benign Prostatic Hypertrophy|benign prostatic hypertrophy
170235|NCT03131544|Prostate|prostate
170236|NCT03131544|Lower Urinary Tract Symptoms|lower urinary tract symptoms
170237|NCT03131544|Nocturia|nocturia
170238|NCT03131544|Incomplete bladder emptying|incomplete bladder emptying
170239|NCT03131479|renal function|renal function
170240|NCT03131479|sodium-glucose co-transporter|sodium-glucose co-transporter
170241|NCT03131479|pharmacokinetics|pharmacokinetics
170242|NCT03131479|decreased renal function|decreased renal function
170243|NCT03131479|decreased kidney function|decreased kidney function
170244|NCT03131479|kidney disease|kidney disease
170245|NCT03131479|urinary glucose excretion|urinary glucose excretion
170246|NCT03131479|UGE|uge
170247|NCT03131466|Trigeminal Neuralgia|trigeminal neuralgia
170248|NCT03131466|Pulsed Radiofrequency|pulsed radiofrequency
170249|NCT03131466|Gasserian Ganglion|gasserian ganglion
170250|NCT03131453|Placebo controlled,|placebo controlled,
170251|NCT03131453|APOE4 carriers,|apoe4 carriers,
170252|NCT03131453|Homozygotes,|homozygotes,
170253|NCT03131453|Heterozygotes,|heterozygotes,
170254|NCT03131453|Brain Amyloid,|brain amyloid,
170255|NCT03131453|Preclinical Alzheimer's Disease (AD),|preclinical alzheimer's disease (ad),
170256|NCT03131453|Aβ lowering,|aβ lowering,
170257|NCT03131453|BACE-1 inhibitor|bace-1 inhibitor
170258|NCT03131427|Wilson's Disease|wilson's disease
170259|NCT03131427|Hereditary Hemochromatosis|hereditary hemochromatosis
170260|NCT03131427|Hereditary Hyperbilirubinemias|hereditary hyperbilirubinemias
170261|NCT03131427|Inherited Cholestatic Liver Disease|inherited cholestatic liver disease
170262|NCT03131427|Genetic Testing|genetic testing
170263|NCT03131375|dexmedetomidine|dexmedetomidine
170264|NCT03131375|emergence delirium|emergence delirium
170265|NCT03131375|anesthesia|anesthesia
170266|NCT03131375|propofol|propofol
170267|NCT03131375|children|children
170268|NCT03131362|COPD|copd
170269|NCT03131323|delineate the prevalence of abnormal nasal finding in wheezy child|delineate the prevalence of abnormal nasal finding in wheezy child
170270|NCT03131297|anal fistulas|anal fistulas
170271|NCT03131297|evaluation of radiofrequency|evaluation of radiofrequency
170272|NCT03131271|Percutaneous coronary intervention|percutaneous coronary intervention
170273|NCT03131271|Femoral arterial catheter|femoral arterial catheter
170274|NCT03131271|Pain|pain
170275|NCT03131271|Cold application|cold application
170276|NCT03131271|Nursing|nursing
170277|NCT03131206|Non-small cell lung cancer|non-small cell lung cancer
170278|NCT03131206|NSCLC|nsclc
170279|NCT03131206|ALK|alk
170280|NCT03131206|RET|ret
170281|NCT03131206|alectinib|alectinib
170282|NCT03131206|Thyroid cancer|thyroid cancer
170283|NCT03131154|reproxalap|reproxalap
170284|NCT03131128|Mindfulness-based intervention|mindfulness-based intervention
170285|NCT03131128|Weight loss|weight loss
170286|NCT03131128|Workplace health promotion|workplace health promotion
170287|NCT03131128|Obesity|obesity
170288|NCT03131063|Extracorporeal Membrane Oxygenation|extracorporeal membrane oxygenation
170289|NCT03131063|Sepsis|sepsis
170290|NCT03131063|Antibiotics|antibiotics
170291|NCT03131063|Pharmacokinetic|pharmacokinetic
170292|NCT03131063|Intensive Care Unit|intensive care unit
170293|NCT03131050|Scopolamine|scopolamine
170294|NCT03131037|immunotherapy|immunotherapy
170295|NCT03131037|immuno-oncology|immuno-oncology
217606|NCT02833298|SVR|svr
170296|NCT03131037|tumor vaccine|tumor vaccine
170297|NCT03131024|anthracyclines|anthracyclines
170298|NCT03130998|smoking cessation|smoking cessation
170299|NCT03130998|depression|depression
170300|NCT03130998|mental health|mental health
170301|NCT03130998|mood management|mood management
170302|NCT03130998|primary care|primary care
170303|NCT03130998|screening|screening
170304|NCT03130998|brief intervention|brief intervention
170305|NCT03130998|referral to treatment|referral to treatment
170306|NCT03130985|microRNA|microrna
170307|NCT03130985|biomarker|biomarker
170308|NCT03130946|breast neoplasms|breast neoplasms
170309|NCT03130946|Ultrasonography, Interventional|ultrasonography, interventional
170310|NCT03130946|Biopsy, Large-Core Needle|biopsy, large-core needle
170311|NCT03130946|Biopsy, Fine-Needle|biopsy, fine-needle
170312|NCT03130933|third molar|third molar
170313|NCT03130933|oral surgical procedures|oral surgical procedures
170314|NCT03130933|antibiotic prophylaxis|antibiotic prophylaxis
170315|NCT03130933|placebo effect|placebo effect
170316|NCT03130920|preconditioning, resection|preconditioning, resection
170317|NCT03130894|trimethylamine-N-oxide|trimethylamine-n-oxide
170318|NCT03130894|type2 Diabetes|type2 diabetes
170319|NCT03130894|enzyme flavin monooxygenase 3 polymorphisms|enzyme flavin monooxygenase 3 polymorphisms
170320|NCT03130855|pediatric patients|pediatric patients
170321|NCT03130855|articaine local anesthesia|articaine local anesthesia
170322|NCT03130829|NSCLC|nsclc
170323|NCT03130829|QoL|qol
170324|NCT03130829|Fucoidan|fucoidan
170325|NCT03130816|Umbilical cord blood transplantation|umbilical cord blood transplantation
170326|NCT03130816|Cytokine changes|cytokine changes
170327|NCT03130764|Non-small Cell Lung Cancer|non-small cell lung cancer
170328|NCT03130712|immunotherapy|immunotherapy
170329|NCT03130712|GPC3-CART|gpc3-cart
170330|NCT03130712|HCC|hcc
170331|NCT03130699|Diabetes|diabetes
170332|NCT03130699|mHealth|mhealth
170333|NCT03130699|Medical Assistant|medical assistant
170334|NCT03130699|Automated|automated
170335|NCT03130699|Adaptive Feedback|adaptive feedback
170336|NCT03130699|Self-Management Support|self-management support
170337|NCT03130699|Hispanics|hispanics
170338|NCT03130699|HbA1c|hba1c
170339|NCT03130699|Cyberinfrastructure|cyberinfrastructure
170340|NCT03130699|Federally-Qualified Health Centers|federally-qualified health centers
170341|NCT03130699|Cost-Effectiveness|cost-effectiveness
170342|NCT03130699|T2DM|t2dm
170343|NCT03130699|Pay-for-Performance|pay-for-performance
170344|NCT03130699|Medication Adherence|medication adherence
170345|NCT03130699|LDL-C|ldl-c
170346|NCT03130699|Systolic Blood Pressure|systolic blood pressure
170347|NCT03130699|Text Messaging|text messaging
170348|NCT03130673|hip fracture|hip fracture
170349|NCT03130673|trochanteric fracure|trochanteric fracure
170350|NCT03130673|subtrocantheric fracture|subtrocantheric fracture
170351|NCT03130673|femoral head fracture|femoral head fracture
170352|NCT03130673|epidemiology|epidemiology
170353|NCT03130660|central line|central line
170354|NCT03130660|Central Line Complication|central line complication
170355|NCT03130634|CPT-11(irinotecan)|cpt-11(irinotecan)
170356|NCT03130634|silymarin|silymarin
170357|NCT03130634|GI toxicity|gi toxicity
170358|NCT03130608|liver disease|liver disease
170359|NCT03130608|transplant|transplant
170360|NCT03130608|muscle wasting|muscle wasting
170361|NCT03130608|breathing exercise|breathing exercise
170362|NCT03130595|accelerometry|accelerometry
170363|NCT03130595|Parkinson Kinetigraph|parkinson kinetigraph
170364|NCT03130582|high-dose etoposide,autologous peripheral blood stem cell transplantation|high-dose etoposide,autologous peripheral blood stem cell transplantation
170365|NCT03130569|Risk Assessment|risk assessment
170366|NCT03130569|Personal Genomic Testing|personal genomic testing
170367|NCT03130569|Skin Cancer|skin cancer
170368|NCT03130569|Primary Care|primary care
170369|NCT03130556|Glasdegib|glasdegib
170370|NCT03130556|PF-04449913|pf-04449913
170371|NCT03130556|Pharmacokinetics|pharmacokinetics
170372|NCT03130556|Bioavailability|bioavailability
170373|NCT03130543|Brief resolved unexplained event|brief resolved unexplained event
170374|NCT03130530|robotic|robotic
170375|NCT03130530|colorectal|colorectal
170376|NCT03130530|surgery|surgery
170377|NCT03130517|hemolysis,newborn|hemolysis,newborn
170378|NCT03130478|long-acting injectable antipsychotic|long-acting injectable antipsychotic
170379|NCT03130478|persistence|persistence
170380|NCT03130465|adherence|adherence
170381|NCT03130465|long-acting injectable antipsychotic|long-acting injectable antipsychotic
170382|NCT03130465|all-cause treatment discontinuation|all-cause treatment discontinuation
170383|NCT03130465|recent-onset schizophrenia|recent-onset schizophrenia
170384|NCT03130465|daily oral atypical antipsychotic|daily oral atypical antipsychotic
170385|NCT03130439|Breast Cancer|breast cancer
170386|NCT03130426|Diabetes|diabetes
170387|NCT03130426|iGlarLixi|iglarlixi
170388|NCT03130426|Metformin|metformin
170389|NCT03130426|Insulin|insulin
170390|NCT03130426|Diet|diet
170391|NCT03130426|Exercise|exercise
170392|NCT03130426|Lifestyle|lifestyle
170393|NCT03130413|Ambu Aura Gain|ambu aura gain
170394|NCT03130413|Air-Q intubating laryngeal airway|air-q intubating laryngeal airway
170395|NCT03130413|Paediatric surgery|paediatric surgery
170396|NCT03130400|Knee|knee
170397|NCT03130400|Gait|gait
170398|NCT03130400|Injuries|injuries
170399|NCT03130400|Arthritis|arthritis
170400|NCT03130387|Hytsteroscopy|hytsteroscopy
170401|NCT03130374|mesenchymal stem cells|mesenchymal stem cells
170402|NCT03130374|Tracheal Stenosis|tracheal stenosis
170403|NCT03130374|Laryngeal Stenosis|laryngeal stenosis
170404|NCT03130374|cell therapy|cell therapy
170405|NCT03130309|Knee|knee
170406|NCT03130309|Replacement|replacement
170407|NCT03130309|Mobile-bearing|mobile-bearing
170408|NCT03130309|unicompartmental prosthesis|unicompartmental prosthesis
170409|NCT03130296|HIV infection|hiv infection
170410|NCT03130296|Fc receptor polymorphism (FcR)|fc receptor polymorphism (fcr)
170411|NCT03130283|Acute patients|acute patients
170412|NCT03130283|Exacerbated chronic patients|exacerbated chronic patients
170413|NCT03130270|nasopharyngeal carcinoma|nasopharyngeal carcinoma
170414|NCT03130270|disease-free survival|disease-free survival
170415|NCT03130270|adverse reaction|adverse reaction
170416|NCT03130257|blood pressure measurement|blood pressure measurement
170417|NCT03130231|Delirium β2-microspheres|delirium β2-microspheres
170418|NCT03130179|Bioequivalence|bioequivalence
170419|NCT03130166|Postoperative pain|postoperative pain
170420|NCT03130166|Postoperative recovery|postoperative recovery
170421|NCT03130166|Intracorporeal anastomosis|intracorporeal anastomosis
170422|NCT03130166|Robotic right colectomy|robotic right colectomy
170423|NCT03130114|Mortality|mortality
170424|NCT03130114|Infant|infant
170425|NCT03130114|Antibiotics|antibiotics
170426|NCT03130114|Linear Growth|linear growth
170427|NCT03130101|Type 1 Diabetes|type 1 diabetes
170428|NCT03130101|Exercise|exercise
170429|NCT03130101|Basal insulin|basal insulin
170430|NCT03130101|CSII|csii
170431|NCT03130101|OmniPod|omnipod
170432|NCT03130101|CGM|cgm
170433|NCT03130088|Out-Of-Hospital Cardiac Arrest|out-of-hospital cardiac arrest
170434|NCT03130088|Resuscitation Registry|resuscitation registry
170435|NCT03130088|EuReCa TWO|eureca two
170436|NCT03130062|Resistance Exercise|resistance exercise
170437|NCT03130062|Functional Fitness|functional fitness
170438|NCT03130062|Actigraphy|actigraphy
170439|NCT03130062|Primary Sjögren Syndrome|primary sjögren syndrome
170440|NCT03130049|Peripheral nerve block|peripheral nerve block
170441|NCT03130049|Ultrasound|ultrasound
170442|NCT03130036|Memory|memory
170443|NCT03130036|Cognitive|cognitive
170444|NCT03129984|mandibular movements|mandibular movements
170445|NCT03129958|NECK PAIN, OFFICE WORKERS|neck pain, office workers
170446|NCT03129945|Obstetric Labor, Premature|obstetric labor, premature
170447|NCT03129945|Tocolytic Agents|tocolytic agents
170448|NCT03129932|gluten|gluten
170449|NCT03129932|adipokine|adipokine
170450|NCT03129932|obesity|obesity
170451|NCT03129932|diet|diet
170452|NCT03129906|Fibromyalgia; non-celiac gluten sensitivity|fibromyalgia; non-celiac gluten sensitivity
170453|NCT03129880|Voice disorder|voice disorder
170454|NCT03129880|Hoarseness|hoarseness
170455|NCT03129880|Phonation Disorders|phonation disorders
170456|NCT03129880|Speech Disorders|speech disorders
170457|NCT03129854|prostate cancer|prostate cancer
170458|NCT03129854|metastatic|metastatic
170459|NCT03129854|cryotherapy|cryotherapy
170460|NCT03129854|ADT|adt
170461|NCT03129841|weight loss|weight loss
170462|NCT03129841|dietary pattern|dietary pattern
170463|NCT03129841|late dinner|late dinner
170464|NCT03129841|early dinner|early dinner
170465|NCT03129828|Diffuse Large B Cell Lymphoma|diffuse large b cell lymphoma
170466|NCT03129828|Ibrutinib|ibrutinib
170467|NCT03129828|Bortezomib|bortezomib
170468|NCT03129815|extubation|extubation
170469|NCT03129815|pediatric resuscitation|pediatric resuscitation
170470|NCT03129815|reintubation|reintubation
170471|NCT03129815|failures of extubation.|failures of extubation.
170472|NCT03129802|extubation|extubation
170473|NCT03129802|pediatric resuscitation|pediatric resuscitation
170474|NCT03129802|reintubation|reintubation
170475|NCT03129802|failures of extubation.|failures of extubation.
170476|NCT03129802|Respiratory Insufficiency|respiratory insufficiency
170477|NCT03129763|SPY-ICG Angiography|spy-icg angiography
170478|NCT03129763|Tissue Expander|tissue expander
170479|NCT03129763|Capsule Pressure|capsule pressure
170480|NCT03129763|Blood Supply|blood supply
170481|NCT03129724|Kidney Neoplasms|kidney neoplasms
170482|NCT03129724|Kidney|kidney
170483|NCT03129724|Neoplasms|neoplasms
170484|NCT03129724|TKI|tki
170485|NCT03129724|Axitinib|axitinib
170486|NCT03129724|VEGF|vegf
170487|NCT03129724|mTORi|mtori
170488|NCT03129685|Hepatocellular carcinoma|hepatocellular carcinoma
170489|NCT03129685|Devascularization|devascularization
170490|NCT03129672|allograft|allograft
170491|NCT03129672|distal tibia sarcoma|distal tibia sarcoma
170492|NCT03129659|Coronary CT Angiography|coronary ct angiography
170493|NCT03129659|High-sensitivity Troponin|high-sensitivity troponin
170494|NCT03129659|Diagnosis|diagnosis
170495|NCT03129620|Ampicillin|ampicillin
170496|NCT03129607|POPF|popf
170497|NCT03129607|Classification system|classification system
170498|NCT03129581|obesity, diet, sleep activity|obesity, diet, sleep activity
170499|NCT03129555|Non-vitamin K antagonist oral anticoagulation|non-vitamin k antagonist oral anticoagulation
170500|NCT03129555|Non-vitamin K Antagonist Oral Anticoagulants|non-vitamin k antagonist oral anticoagulants
170501|NCT03129555|Direct-acting Oral Anticoagulants|direct-acting oral anticoagulants
170502|NCT03129555|Novel oral anticoagulant drugs|novel oral anticoagulant drugs
170503|NCT03129516|imaginary|imaginary
170504|NCT03129516|Turkish version|turkish version
170505|NCT03129516|motor imagery|motor imagery
170506|NCT03129516|reliability|reliability
170507|NCT03129503|Optical coherence tomography (OCT)|optical coherence tomography (oct)
170508|NCT03129490|Atrial Fibrillation|atrial fibrillation
170509|NCT03129490|Non-vitamin K antagonist oral anticoagulation|non-vitamin k antagonist oral anticoagulation
170510|NCT03129490|Direct-acting oral anticoagulants|direct-acting oral anticoagulants
170511|NCT03129490|Novel oral anticoagulant drugs|novel oral anticoagulant drugs
170512|NCT03129490|Non-vitamin K antagonist oral anticoagulants|non-vitamin k antagonist oral anticoagulants
170513|NCT03129477|Non invasive ventilation in COPD|non invasive ventilation in copd
170514|NCT03129477|Noninvasive ventilation|noninvasive ventilation
170515|NCT03129477|Tele-monitoring|tele-monitoring
170516|NCT03129438|continuous EEG|continuous eeg
170517|NCT03129438|routine EEG|routine eeg
170518|NCT03129438|prognosis|prognosis
170519|NCT03129425|Patient|patient
170520|NCT03129425|Caregiver|caregiver
170521|NCT03129425|Coping|coping
170522|NCT03129425|Psychosocial adaptation|psychosocial adaptation
170523|NCT03129399|anesthesia|anesthesia
170524|NCT03129399|King Vision|king vision
170525|NCT03129399|videolaryngoscope|videolaryngoscope
170526|NCT03129399|nasotracheal|nasotracheal
170527|NCT03129360|Early Psychosis|early psychosis
170528|NCT03129360|Levetiracetam|levetiracetam
170529|NCT03129308|HIV|hiv
170530|NCT03129308|Cutaneous Autoantibodies|cutaneous autoantibodies
170531|NCT03129308|Indirect Immunofluorescence|indirect immunofluorescence
170532|NCT03129269|Cognitive decline|cognitive decline
170533|NCT03129269|frailty|frailty
170534|NCT03129269|mild cognitive impairment|mild cognitive impairment
170535|NCT03129269|Positron Emission Tomography, PET|positron emission tomography, pet
170536|NCT03129269|Alzheimer disease|alzheimer disease
170537|NCT03129269|amyloid load|amyloid load
170538|NCT03129269|Magnetic resonance imaging, MRI|magnetic resonance imaging, mri
170539|NCT03129256|non-small cell lung cancer|non-small cell lung cancer
170540|NCT03129256|Apatinib|apatinib
170541|NCT03129256|S1|s1
170542|NCT03129217|Diaphragm function|diaphragm function
170543|NCT03129217|Acute respiratory failure|acute respiratory failure
170544|NCT03129217|Weaning|weaning
170545|NCT03129204|intensive care unit|intensive care unit
170546|NCT03129204|critical care|critical care
170547|NCT03129204|family|family
170548|NCT03129204|caregiver|caregiver
170549|NCT03129204|actigraphy|actigraphy
170551|NCT03129178|Nitric oxide|nitric oxide
170552|NCT03129178|Microvascular|microvascular
170553|NCT03129165|Cardiovascular diseases|cardiovascular diseases
170554|NCT03129165|Public Health|public health
170555|NCT03129165|Hypertension|hypertension
170556|NCT03129165|Smoking|smoking
170557|NCT03129165|Hypercholesterolemia|hypercholesterolemia
170558|NCT03129165|Food Habits|food habits
170559|NCT03129165|Exercise|exercise
170560|NCT03129165|Anxiety|anxiety
170561|NCT03129165|Depression|depression
170562|NCT03129165|Obesity|obesity
170563|NCT03129165|Diabetes|diabetes
170564|NCT03129139|Metastatic|metastatic
170565|NCT03128996|Bone marrow transplant|bone marrow transplant
170566|NCT03128996|Transplant|transplant
170567|NCT03128996|Transplantation|transplantation
170568|NCT03128996|Reduced Intensity|reduced intensity
170569|NCT03128996|Familial HLA mismatched|familial hla mismatched
170570|NCT03128905|Colchicine|colchicine
170571|NCT03128905|Corticoids|corticoids
170572|NCT03128905|Prednisone|prednisone
170574|NCT03128905|Calcium Pyrophosphate Deposition Disease|calcium pyrophosphate deposition disease
170575|NCT03128814|Tennis|tennis
170576|NCT03128814|Asymmetry|asymmetry
170577|NCT03128814|Structural|structural
170578|NCT03128814|Functional|functional
170579|NCT03128801|Low Back Pain|low back pain
170580|NCT03128801|Back Pain|back pain
170581|NCT03128801|Muscle Stretching Exercises|muscle stretching exercises
170582|NCT03128801|Stabilization Exercise|stabilization exercise
170583|NCT03128801|Exercise Therapy|exercise therapy
170584|NCT03128801|Exercise Movement|exercise movement
170585|NCT03128801|Exercise Movement Tecniques|exercise movement tecniques
170586|NCT03128801|Pain|pain
170587|NCT03128801|Disability|disability
170588|NCT03128788|epidurography epidural pressure patient posture|epidurography epidural pressure patient posture
170589|NCT03128749|Obsessive-Compulsive Disorder|obsessive-compulsive disorder
170590|NCT03128749|Mindfulness Based Intervention|mindfulness based intervention
170591|NCT03128749|Cognitive-Behavioral Therapy|cognitive-behavioral therapy
170592|NCT03128749|Functional Magnetic Resonance Imaging|functional magnetic resonance imaging
170593|NCT03128749|Neuropsychology|neuropsychology
170594|NCT03128749|Childhood Maltreatment|childhood maltreatment
170595|NCT03128723|Acne|acne
170596|NCT03128710|Survey|survey
170597|NCT03128710|Focus Group|focus group
170598|NCT03128710|Treatment Preferences|treatment preferences
170599|NCT03128697|Obesity|obesity
170600|NCT03128697|Satiety quotient|satiety quotient
170601|NCT03128697|Appetite control|appetite control
170602|NCT03128697|Weight loss|weight loss
170603|NCT03128697|Satiety phenotype|satiety phenotype
170604|NCT03128697|Functional food|functional food
170605|NCT03128684|lentils|lentils
170606|NCT03128684|satiety|satiety
170607|NCT03128684|appetite|appetite
170608|NCT03128684|food intake|food intake
170609|NCT03128684|24-hour energy intake|24-hour energy intake
170610|NCT03128671|intensive care unit|intensive care unit
170611|NCT03128671|critical care|critical care
170612|NCT03128671|mechanical ventilation|mechanical ventilation
170613|NCT03128671|confusion|confusion
170614|NCT03128671|polysomnography|polysomnography
170615|NCT03128671|delirium|delirium
170616|NCT03128671|adult|adult
170617|NCT03128658|Trauma induced coagulopathy|trauma induced coagulopathy
170618|NCT03128554|Not Ready to Quit|not ready to quit
170619|NCT03128554|Primary Care|primary care
170620|NCT03128554|Tobacco|tobacco
170621|NCT03128554|Reduce to Quit|reduce to quit
170622|NCT03128554|Smoking Reduction|smoking reduction
170623|NCT03128528|SGLT-2 inhibitor, Chronic heart failure, tissue sodium,|sglt-2 inhibitor, chronic heart failure, tissue sodium,
170624|NCT03128515|Hydroxyurea|hydroxyurea
170625|NCT03128502|saliva|saliva
170626|NCT03128502|GCF|gcf
170627|NCT03128502|pentraxin-3|pentraxin-3
170628|NCT03128489|Safety|safety
170629|NCT03128489|Infanrix™-IPV/Hib|infanrix™-ipv/hib
170630|NCT03128489|Immunogenicity|immunogenicity
170631|NCT03128489|Indian infants|indian infants
170632|NCT03128489|Combined vaccine|combined vaccine
170633|NCT03128463|Age-Related Macular Degeneration|age-related macular degeneration
170634|NCT03128463|Polypoidal Choroidal Vasculopathy|polypoidal choroidal vasculopathy
170635|NCT03128463|Pathological Myopia|pathological myopia
170636|NCT03128463|Conbercept|conbercept
170637|NCT03128450|Parkinson Disease|parkinson disease
170638|NCT03128450|Neural stem cell|neural stem cell
170639|NCT03128450|Nasal delivery|nasal delivery
170640|NCT03128437|Anxiety|anxiety
170641|NCT03128437|Young Adults|young adults
170642|NCT03128437|Health Behaviors|health behaviors
170643|NCT03128411|Leukemia, Chronic Myelogenous|leukemia, chronic myelogenous
170644|NCT03128398|Gastroparesis|gastroparesis
170645|NCT03128385|Upper limb neurorehabilitation|upper limb neurorehabilitation
170646|NCT03128385|Neurological rehabilitation|neurological rehabilitation
170647|NCT03128385|Upper extremity|upper extremity
170648|NCT03128281|Malignant Neoplasms of Female Genital Organs|malignant neoplasms of female genital organs
170649|NCT03128281|Laparoscopic gynecologic surgery|laparoscopic gynecologic surgery
170650|NCT03128281|Robotic gynecologic surgery|robotic gynecologic surgery
170651|NCT03128281|AirSeal® Insufflation System|airseal® insufflation system
170652|NCT03128281|AIS|ais
170653|NCT03128281|Conventional Insufflation System|conventional insufflation system
170654|NCT03128281|CIS|cis
170655|NCT03128281|Questionnaires|questionnaires
170656|NCT03128281|Surveys|surveys
170657|NCT03128255|Fusion|fusion
170658|NCT03128255|Hybrid Imaging|hybrid imaging
170659|NCT03128255|Mapping|mapping
170660|NCT03128255|Iodine|iodine
170661|NCT03128255|Ultrasound|ultrasound
170662|NCT03128242|oxytocin|oxytocin
170663|NCT03128242|attention bias|attention bias
170664|NCT03128242|attention training|attention training
170665|NCT03128242|eye-tracking|eye-tracking
170666|NCT03128203|Oxytocin|oxytocin
170667|NCT03128203|Resting-state|resting-state
170668|NCT03128203|Functional connectivity|functional connectivity
170669|NCT03128203|BOLD|bold
170670|NCT03128190|high-risk surgery|high-risk surgery
170671|NCT03128190|pulse-pressure variation|pulse-pressure variation
170672|NCT03128190|monitoring|monitoring
170673|NCT03128190|Postoperative Complications|postoperative complications
170674|NCT03128177|nocturnal hypertension|nocturnal hypertension
170675|NCT03128177|non-dipping blood pressure|non-dipping blood pressure
170676|NCT03128177|obstructive sleep apnea|obstructive sleep apnea
170677|NCT03128151|NMB (Neuromuscular Blockade)|nmb (neuromuscular blockade)
170678|NCT03128151|Anesthesia|anesthesia
170679|NCT03128151|Curarization|curarization
170680|NCT03128151|TOFr (train of four)|tofr (train of four)
170681|NCT03128151|PACU (postanesthesia care unit)|pacu (postanesthesia care unit)
170682|NCT03128151|Monitorization|monitorization
170683|NCT03128112|Parental perception, obesity, overweight|parental perception, obesity, overweight
170684|NCT03128099|Social Skills|social skills
170685|NCT03128099|Social attention|social attention
170686|NCT03128099|Virtual reality|virtual reality
170687|NCT03128099|Eye tracking|eye tracking
400604|NCT01866059|Calcium silicate|calcium silicate
170688|NCT03128073|Heart failure, Cardio-Renal Syndrome|heart failure, cardio-renal syndrome
170689|NCT03128047|pediatric cancer|pediatric cancer
170690|NCT03128047|brain tumor|brain tumor
170691|NCT03128047|glioblastoma|glioblastoma
170692|NCT03128047|high grade brain tumor|high grade brain tumor
170693|NCT03128047|malignant brain tumor|malignant brain tumor
170694|NCT03128047|recurrent brain tumor|recurrent brain tumor
170695|NCT03128021|Depression|depression
170696|NCT03128021|fMRI|fmri
170697|NCT03128021|Escitalopram|escitalopram
170698|NCT03128021|Lexapro|lexapro
170699|NCT03128021|Randomized Clinical Trial|randomized clinical trial
170700|NCT03128021|Levomilnacipran|levomilnacipran
170701|NCT03128021|Fetzima|fetzima
170702|NCT03127995|Breast Cancer pT1-3, pN0-N3, M0|breast cancer pt1-3, pn0-n3, m0
170703|NCT03127995|Lymph Node Irradiation|lymph node irradiation
170704|NCT03127982|Anxiety Depression Emotion PTSD Randomized Clinical Trial|anxiety depression emotion ptsd randomized clinical trial
170705|NCT03127969|Rheumatoid hand|rheumatoid hand
170706|NCT03127969|Fluidotherapy|fluidotherapy
170707|NCT03127969|Rehabilitation|rehabilitation
170708|NCT03127943|lidocaine, mandible|lidocaine, mandible
170709|NCT03127930|Cognitive Impairment|cognitive impairment
170710|NCT03127930|Memory loss|memory loss
170711|NCT03127930|Caregivers|caregivers
170712|NCT03127930|Medication adherence|medication adherence
170713|NCT03127930|Medication compliance|medication compliance
170714|NCT03127930|Medication management|medication management
170715|NCT03127930|Problem solving|problem solving
170716|NCT03127930|Quality of Life|quality of life
170717|NCT03127930|Health resource utilization|health resource utilization
170718|NCT03127930|Community dwelling|community dwelling
170719|NCT03127917|Gait Speed|gait speed
170720|NCT03127917|Cognitive Function|cognitive function
170721|NCT03127904|Varicose ulcer|varicose ulcer
170722|NCT03127904|Compressive therapy|compressive therapy
170723|NCT03127904|Venous ulcer|venous ulcer
170724|NCT03127904|Chronic venous disease|chronic venous disease
170725|NCT03127891|pranayama yoga|pranayama yoga
170726|NCT03127878|Exercise|exercise
170727|NCT03127878|Pulmonary Disease, Chronic Obstructive|pulmonary disease, chronic obstructive
170728|NCT03127878|Activities of Daily Living|activities of daily living
170729|NCT03127878|Upper Extremity|upper extremity
170730|NCT03127878|Motor Activity|motor activity
170731|NCT03127839|Exercise|exercise
170732|NCT03127839|Pain Neuroscience Education|pain neuroscience education
170733|NCT03127839|Physical Therapy|physical therapy
170734|NCT03127839|Subacromial Pain|subacromial pain
170735|NCT03127839|Rotator Cuff|rotator cuff
170736|NCT03127826|Low Back Pain|low back pain
170737|NCT03127826|Risk-Stratified Care|risk-stratified care
170738|NCT03127813|glaucoma|glaucoma
170739|NCT03127813|OSA|osa
170740|NCT03127813|apnoea|apnoea
170741|NCT03127813|intraocular|intraocular
170742|NCT03127813|CPAP|cpap
170743|NCT03127813|airway|airway
170744|NCT03127813|pressure|pressure
170745|NCT03127813|blindness|blindness
170746|NCT03127800|Obstructive Sleep Apnoea|obstructive sleep apnoea
170747|NCT03127800|Morphine sulphate|morphine sulphate
170748|NCT03127800|Sleep Disordered Breathing|sleep disordered breathing
170749|NCT03127800|Central Sleep Apnoea|central sleep apnoea
170750|NCT03127800|Hypoxaemia|hypoxaemia
170751|NCT03127800|Hypercapnia|hypercapnia
170752|NCT03127800|Cheyne-Stokes Respiration|cheyne-stokes respiration
170753|NCT03127800|Analgesia|analgesia
170754|NCT03127800|Respiration|respiration
170755|NCT03127800|Apnoea-Hypopnea Index|apnoea-hypopnea index
170756|NCT03127800|Oxygen Desaturation Index|oxygen desaturation index
170757|NCT03127800|Oximetry|oximetry
170758|NCT03127800|Respiratory Polygraphy|respiratory polygraphy
170759|NCT03127800|Polysomnography|polysomnography
170760|NCT03127774|Cisplatin|cisplatin
170761|NCT03127774|Heated Cisplatin|heated cisplatin
170762|NCT03127761|Multiple Myeloma|multiple myeloma
170763|NCT03127748|ventricular septal defect,transcatheter closure|ventricular septal defect,transcatheter closure
170764|NCT03127735|Phase 1|phase 1
170765|NCT03127735|mIDH1|midh1
170766|NCT03127735|IDH1 mutation|idh1 mutation
170767|NCT03127735|mIDH1 inhibitor|midh1 inhibitor
170768|NCT03127709|17-199|17-199
170769|NCT03127709|histiocytosis|histiocytosis
170770|NCT03127696|Fecal Microbiota Transplant|fecal microbiota transplant
170771|NCT03127631|Androgen Deprivation Therapy|androgen deprivation therapy
170772|NCT03127553|salt intake|salt intake
170773|NCT03127553|functional food|functional food
170774|NCT03127553|low-salt bread|low-salt bread
170775|NCT03127553|blood pressure|blood pressure
170776|NCT03127514|Randomized|randomized
170777|NCT03127514|Double-blind|double-blind
170778|NCT03127514|Placebo-controlled|placebo-controlled
170779|NCT03127514|Amyotrophic Lateral Sclerosis|amyotrophic lateral sclerosis
170780|NCT03127514|Sodium Phenylbutyrate|sodium phenylbutyrate
170781|NCT03127514|Tauroursodeoxycholic Acid|tauroursodeoxycholic acid
170782|NCT03127475|Parkinson's disease|parkinson's disease
170783|NCT03127475|freezing of gait|freezing of gait
170784|NCT03127475|electrophysiology|electrophysiology
218200|NCT02829879|RCT|rct
170785|NCT03127475|magnetic resonance image|magnetic resonance image
170786|NCT03127475|direct current stimulation|direct current stimulation
170787|NCT03127423|Hybrid ablation|hybrid ablation
170788|NCT03127423|Thoracoscope|thoracoscope
170789|NCT03127397|antiretroviral therapy|antiretroviral therapy
170790|NCT03127397|HIV/AIDS|hiv/aids
170791|NCT03127397|ART adherence|art adherence
170792|NCT03127371|Nitrous Oxide|nitrous oxide
170793|NCT03127371|Abscess|abscess
170794|NCT03127371|Incision and drainage|incision and drainage
170795|NCT03127358|Addiction|addiction
170796|NCT03127358|Sustained Viral Response|sustained viral response
170797|NCT03127358|Adherence|adherence
170798|NCT03127358|Adverse Effects|adverse effects
170799|NCT03127358|Direct Acting Antiviral Agent|direct acting antiviral agent
170800|NCT03127358|Chronic Hepatitis C|chronic hepatitis c
170801|NCT03127358|Resistance Development|resistance development
170802|NCT03127358|Methadone Clinic|methadone clinic
170803|NCT03127358|Primary Care|primary care
170804|NCT03127358|Directly Observed Therapy|directly observed therapy
170805|NCT03127358|Randomized Controlled Trial|randomized controlled trial
170806|NCT03127358|Resistance|resistance
170807|NCT03127358|Reinfection|reinfection
170808|NCT03127358|Treatment Outcome|treatment outcome
170809|NCT03127358|Patient Navigation|patient navigation
170810|NCT03127358|Multi-Site|multi-site
170811|NCT03127358|Liver Disease|liver disease
170812|NCT03127358|Intervention|intervention
170813|NCT03127332|Treatment care planning|treatment care planning
170814|NCT03127306|Pain|pain
170815|NCT03127306|Behavioural Pain Scale|behavioural pain scale
170816|NCT03127306|BPS|bps
170817|NCT03127306|NRS|nrs
170818|NCT03127306|Delirium|delirium
170819|NCT03127306|CAM-ICU|cam-icu
170820|NCT03127280|urinary tract infections|urinary tract infections
170821|NCT03127280|postoperative voiding dysfunction|postoperative voiding dysfunction
170822|NCT03127280|foley removal|foley removal
170823|NCT03127280|patient satisfaction|patient satisfaction
170824|NCT03127267|Amyotrophic Lateral Sclerosis|amyotrophic lateral sclerosis
170825|NCT03127267|ALS|als
170826|NCT03127267|Tyrosine kinase inhibitor|tyrosine kinase inhibitor
170827|NCT03127267|Lou Gehrig's disease|lou gehrig's disease
170828|NCT03127267|Charcot's disease|charcot's disease
170829|NCT03127267|Motor Neuron disease|motor neuron disease
170830|NCT03127267|MND|mnd
170831|NCT03127254|Video Narrative|video narrative
170832|NCT03127241|Assistive devices|assistive devices
170833|NCT03127241|Randomized controlled trial (RCT)|randomized controlled trial (rct)
170834|NCT03127241|Upper limbs|upper limbs
170835|NCT03127241|Robotic devices|robotic devices
170836|NCT03127228|Laser|laser
170837|NCT03127202|Cardiac Resynchronization Therapy|cardiac resynchronization therapy
170838|NCT03127150|Chylous leakage|chylous leakage
170839|NCT03127150|Diagnostic criteria|diagnostic criteria
170840|NCT03127150|Pancreas surgery|pancreas surgery
170841|NCT03127150|Therapy|therapy
170842|NCT03127098|locally advanced or metastatic|locally advanced or metastatic
170843|NCT03127098|carcinoembryonic antigen (CEA)-expressing|carcinoembryonic antigen (cea)-expressing
170844|NCT03127098|CEA|cea
170845|NCT03127098|carcinoembryonic antigen|carcinoembryonic antigen
170846|NCT03127072|colorectal cancer|colorectal cancer
170847|NCT03127072|liver metastasis|liver metastasis
170848|NCT03127072|Radiofrequency Ablation|radiofrequency ablation
170849|NCT03127072|chemotherapy|chemotherapy
170850|NCT03127072|target therapy|target therapy
170851|NCT03127059|Dysfunctional Breathing|dysfunctional breathing
170852|NCT03127059|Uncontrolled Asthma|uncontrolled asthma
170853|NCT03127059|Breathing Exercises|breathing exercises
170854|NCT03127059|Adults|adults
170855|NCT03127007|immunotherapy|immunotherapy
170856|NCT03127007|anti-PD-L1|anti-pd-l1
170857|NCT03126955|microvascular decompression, Xth nerve|microvascular decompression, xth nerve
170858|NCT03126942|Aged patients|aged patients
170859|NCT03126942|Cost Estimates|cost estimates
170860|NCT03126942|Complete Denture|complete denture
170861|NCT03126942|Dental Economics|dental economics
170862|NCT03126942|Dental Implants|dental implants
170863|NCT03126942|Dental Prosthesis, Implant-Supported|dental prosthesis, implant-supported
170864|NCT03126942|Denture Retention|denture retention
170865|NCT03126942|Minimally Invasive Surgical Procedures|minimally invasive surgical procedures
170866|NCT03126942|Oral Health-Related Quality of Life|oral health-related quality of life
170867|NCT03126942|Overdenture|overdenture
170868|NCT03126942|Patient Acceptance of Health Care|patient acceptance of health care
170869|NCT03126942|Quality of Healthcare|quality of healthcare
170870|NCT03126942|Quality of Life|quality of life
170871|NCT03126942|Patient Satisfaction|patient satisfaction
170872|NCT03126942|Single implant overdenture|single implant overdenture
170873|NCT03126929|disorders of consciousness|disorders of consciousness
170874|NCT03126929|Vegetative state|vegetative state
170875|NCT03126929|Minimally conscious state|minimally conscious state
170876|NCT03126929|Emergence from MCS|emergence from mcs
170877|NCT03126929|Coma Recovery Scale-Revised|coma recovery scale-revised
218340|NCT02829268|Ataxia|ataxia
170878|NCT03126890|Pharmacokinetics,adverse events|pharmacokinetics,adverse events
170879|NCT03126890|Linezolid|linezolid
170880|NCT03126890|Therapeutic drug monitoring|therapeutic drug monitoring
170881|NCT03126890|Myelosuppression|myelosuppression
170882|NCT03126890|Lactic acidosis|lactic acidosis
170883|NCT03126890|Peripheral neuropathy|peripheral neuropathy
170884|NCT03126864|Hematopoietic/Lymphoid Cancer|hematopoietic/lymphoid cancer
170885|NCT03126864|Acute Myeloid Leukemia|acute myeloid leukemia
170886|NCT03126864|AML|aml
170887|NCT03126864|Relapsed or Refractory CD33-Positive|relapsed or refractory cd33-positive
170888|NCT03126864|CD33-CAR-T cells|cd33-car-t cells
170889|NCT03126864|Fludarabine|fludarabine
170890|NCT03126864|Fludarabine phosphate|fludarabine phosphate
170891|NCT03126864|Fludara|fludara
170892|NCT03126864|Cyclophosphamide|cyclophosphamide
170893|NCT03126864|Cytoxan|cytoxan
170894|NCT03126864|Neosar|neosar
170895|NCT03126838|diaphragm|diaphragm
170896|NCT03126838|ultrasound|ultrasound
170897|NCT03126838|dysfunction|dysfunction
170898|NCT03126838|cardiac surgery|cardiac surgery
170899|NCT03126838|weaning|weaning
170900|NCT03126812|Primary stage 4|primary stage 4
170901|NCT03126812|Neo adjuvant|neo adjuvant
170902|NCT03126786|Diabetes Mellitus|diabetes mellitus
170903|NCT03126786|Diabetic Retinopathy|diabetic retinopathy
170904|NCT03126786|Microneedle|microneedle
170905|NCT03126786|Mircoinjection|mircoinjection
170906|NCT03126786|Triamcinolone|triamcinolone
170907|NCT03126786|Choroid|choroid
170908|NCT03126786|Choroid Injection|choroid injection
170909|NCT03126786|Aflibercept|aflibercept
170910|NCT03126786|Suprachoroidal|suprachoroidal
170911|NCT03126773|non-interventional|non-interventional
170912|NCT03126773|cohort|cohort
170913|NCT03126773|Angeliq Micro|angeliq micro
170914|NCT03126773|menopause|menopause
170915|NCT03126773|Russia|russia
170916|NCT03126734|Down Syndrome|down syndrome
170917|NCT03126734|Acceptance|acceptance
170918|NCT03126734|Commitment|commitment
170919|NCT03126734|Concience of influence|concience of influence
170920|NCT03126721|drug interaction|drug interaction
170921|NCT03126721|PF-06751979|pf-06751979
170922|NCT03126721|oral midazolam|oral midazolam
170923|NCT03126695|Abnormal hemoglobin (called hemoglobin S or sickle hemoglobin) in the red blood cells|abnormal hemoglobin (called hemoglobin s or sickle hemoglobin) in the red blood cells
170924|NCT03126695|Thrombotic cardiovascular events|thrombotic cardiovascular events
170925|NCT03126695|Acute coronary syndrome|acute coronary syndrome
170926|NCT03126695|P2Y12 platelet inhibitor|p2y12 platelet inhibitor
170927|NCT03126695|Brilinta|brilinta
170928|NCT03126682|Wellbutrin|wellbutrin
170929|NCT03126682|Electroconvulsive therapy|electroconvulsive therapy
170930|NCT03126682|Right Unilateral Ultra Brief|right unilateral ultra brief
170931|NCT03126669|Hyperbaric oxygen|hyperbaric oxygen
170932|NCT03126669|multitasking performance|multitasking performance
170933|NCT03126669|cognitive funcitons|cognitive funcitons
170934|NCT03126656|testosterone|testosterone
170935|NCT03126656|chronic heart failure|chronic heart failure
170936|NCT03126552|hookworm|hookworm
170937|NCT03126552|controlled human infection model|controlled human infection model
170938|NCT03126539|aging|aging
170939|NCT03126539|ultraviolet exposure|ultraviolet exposure
170940|NCT03126539|skin fragility|skin fragility
170941|NCT03126539|sulforaphane|sulforaphane
170942|NCT03126513|G-POEM|g-poem
170943|NCT03126513|Safety|safety
170944|NCT03126513|Efficacy|efficacy
170945|NCT03126500|Malnutrition|malnutrition
170946|NCT03126500|Disease-related malnutrition|disease-related malnutrition
170947|NCT03126500|Frailty|frailty
170948|NCT03126500|Sarcopenia|sarcopenia
170949|NCT03126500|Hospital discharge|hospital discharge
170950|NCT03126500|Geriatrics|geriatrics
170951|NCT03126461|metastatic melanoma|metastatic melanoma
170952|NCT03126448|Infection|infection
170953|NCT03126448|Nonunion|nonunion
170954|NCT03126448|Fracture healing|fracture healing
170955|NCT03126435|FOLFIRINOX|folfirinox
170956|NCT03126435|5-Fluorouracil|5-fluorouracil
170957|NCT03126435|folinic acid|folinic acid
170958|NCT03126435|irinotecan|irinotecan
170959|NCT03126435|oxaliplatin|oxaliplatin
170960|NCT03126435|Gemcitabine|gemcitabine
170961|NCT03126409|coronary artery disease|coronary artery disease
171053|NCT03125850|knowledge|knowledge
170962|NCT03126409|coronary artery bypass graft|coronary artery bypass graft
170963|NCT03126344|King Vision|king vision
170964|NCT03126331|Kidney Cancer|kidney cancer
170965|NCT03126331|Metastatic|metastatic
170966|NCT03126331|Nivolumab|nivolumab
170967|NCT03126305|exposure|exposure
170968|NCT03126305|response prevention|response prevention
170969|NCT03126305|web-based application|web-based application
170970|NCT03126292|Medical home|medical home
170971|NCT03126292|Primary care|primary care
170972|NCT03126292|Children|children
170973|NCT03126292|Development|development
170974|NCT03126279|Osteoarthritis|osteoarthritis
170976|NCT03126279|Postoperative Pain|postoperative pain
170977|NCT03126253|childhood anemia, socioeconomic status|childhood anemia, socioeconomic status
170978|NCT03126227|AR101|ar101
170979|NCT03126227|Characterized Peanut Allergen|characterized peanut allergen
170980|NCT03126227|CPNA (Characterized Peanut Allergen)|cpna (characterized peanut allergen)
170981|NCT03126227|OIT (oral immunotherapy)|oit (oral immunotherapy)
170982|NCT03126227|Peanut Allergy|peanut allergy
170983|NCT03126227|Peanut-Allergic Children|peanut-allergic children
170984|NCT03126227|Desensitization|desensitization
170985|NCT03126227|ARC007|arc007
170986|NCT03126227|Characterized Oral Desensitization Immunotherapy (CODIT™)|characterized oral desensitization immunotherapy (codit™)
170987|NCT03126214|atrial fibrillation|atrial fibrillation
170988|NCT03126214|stroke|stroke
170989|NCT03126214|oral anticoagulation therapy|oral anticoagulation therapy
170990|NCT03126214|pharmacist case management|pharmacist case management
170991|NCT03126201|focal segmental glomerulosclerosis|focal segmental glomerulosclerosis
170992|NCT03126201|disease progression|disease progression
170993|NCT03126175|conservative treatment, treatment outcome|conservative treatment, treatment outcome
170994|NCT03126162|minimally invasive gynecologic surgery|minimally invasive gynecologic surgery
170995|NCT03126162|same-day discharge|same-day discharge
170996|NCT03126162|bladder testing|bladder testing
170997|NCT03126136|Fetal heart rate abnormalities|fetal heart rate abnormalities
170998|NCT03126136|Pregnancy|pregnancy
170999|NCT03126136|Epidural analgesia|epidural analgesia
171000|NCT03126136|Pulse pressure|pulse pressure
171001|NCT03126123|Anal condylomatosis|anal condylomatosis
171002|NCT03126123|surgery|surgery
171003|NCT03126123|acetic acid|acetic acid
171004|NCT03126123|dysplastic areas|dysplastic areas
171005|NCT03126110|cervical cancer|cervical cancer
171006|NCT03126110|endometrial cancer|endometrial cancer
171007|NCT03126110|gastric cancer (stomach, esophageal, and gastroesophageal junction [GEJ])|gastric cancer (stomach, esophageal, and gastroesophageal junction [gej])
171008|NCT03126110|hepatocellular carcinoma (HCC)|hepatocellular carcinoma (hcc)
171009|NCT03126110|melanoma|melanoma
171010|NCT03126110|Merkel cell carcinoma|merkel cell carcinoma
171011|NCT03126110|mesothelioma|mesothelioma
171012|NCT03126110|microsatellite instability-high (MSI-H) colorectal cancer (CRC)|microsatellite instability-high (msi-h) colorectal cancer (crc)
171013|NCT03126110|non-small cell lung cancer (NSCLC)|non-small cell lung cancer (nsclc)
171014|NCT03126110|ovarian cancer|ovarian cancer
171015|NCT03126110|squamous cell carcinoma of the head and neck (SCCHN)|squamous cell carcinoma of the head and neck (scchn)
171016|NCT03126110|small cell lung cancer (SCLC)|small cell lung cancer (sclc)
171017|NCT03126110|renal cell carcinoma (RCC)|renal cell carcinoma (rcc)
171018|NCT03126110|triple-negative breast cancer (TNBC)|triple-negative breast cancer (tnbc)
171019|NCT03126110|urothelial carcinoma|urothelial carcinoma
171020|NCT03126110|glucocorticoid-induced tumor necrosis factor receptor (GITR)|glucocorticoid-induced tumor necrosis factor receptor (gitr)
171021|NCT03126058|enhanced recovery after surgery|enhanced recovery after surgery
171022|NCT03126058|colorectal cancer|colorectal cancer
171023|NCT03126045|Lumbar puncture|lumbar puncture
171024|NCT03126045|Post lumbar puncture headache|post lumbar puncture headache
171025|NCT03126045|Atraumatic needle|atraumatic needle
171026|NCT03126045|Haematology|haematology
171027|NCT03126032|Sepsis|sepsis
171028|NCT03126032|SIRS|sirs
171029|NCT03126032|Glycocalyx|glycocalyx
171030|NCT03126032|Glycocheck™-System|glycocheck™-system
171031|NCT03126032|Infection|infection
171032|NCT03126019|Follicular lymphoma|follicular lymphoma
171033|NCT03126019|non-Hodgkin lymphoma (NHL)|non-hodgkin lymphoma (nhl)
171034|NCT03126019|phosphatidylinositol 3-kinase (PI3K) δ inhibitor|phosphatidylinositol 3-kinase (pi3k) δ inhibitor
171035|NCT03125993|obesity; brisk walking|obesity; brisk walking
171036|NCT03125928|Atezolizumab|atezolizumab
171037|NCT03125928|PD-L1|pd-l1
171038|NCT03125915|couples HIV testing; drug intervention; communication skills|couples hiv testing; drug intervention; communication skills
171039|NCT03125889|Image-guided|image-guided
171040|NCT03125889|BPH|bph
171041|NCT03125889|Aquablation|aquablation
171042|NCT03125889|AQUABEAM|aquabeam
171043|NCT03125889|LUTS|luts
171044|NCT03125889|Tissue resection|tissue resection
171045|NCT03125889|Robotics|robotics
171046|NCT03125863|Image-guided|image-guided
171047|NCT03125863|BPH|bph
171048|NCT03125863|Aquablation|aquablation
171049|NCT03125863|AQUABEAM|aquabeam
171050|NCT03125863|LUTS|luts
171051|NCT03125863|Tissue resection|tissue resection
171052|NCT03125863|Robotics|robotics
171054|NCT03125850|psychology|psychology
171055|NCT03125811|Isopropyl alcohol|isopropyl alcohol
171056|NCT03125811|Zofran|zofran
171057|NCT03125811|antiemetics|antiemetics
171058|NCT03125798|video-assisted thoracic surgery|video-assisted thoracic surgery
171059|NCT03125798|LigaSure|ligasure
171060|NCT03125798|mediastinal lymph node dissection|mediastinal lymph node dissection
171061|NCT03125785|congenital cataract, contact lens|congenital cataract, contact lens
171062|NCT03125772|coronary artery disease|coronary artery disease
171063|NCT03125772|diabetes mellitus|diabetes mellitus
171064|NCT03125772|everolimus|everolimus
171065|NCT03125772|paclitaxel stents|paclitaxel stents
171066|NCT03125759|Ischemic Stroke|ischemic stroke
171067|NCT03125759|Omentin|omentin
171068|NCT03125733|Endoscopy, Digestive system|endoscopy, digestive system
171069|NCT03125733|Natural orifice transluminal endoscopic surgery|natural orifice transluminal endoscopic surgery
171070|NCT03125733|Therapeutic|therapeutic
171071|NCT03125733|Complications|complications
171072|NCT03125720|cardiac resynchronization therapy|cardiac resynchronization therapy
171073|NCT03125720|chronic heart failure|chronic heart failure
171074|NCT03125720|image fusion-guided implantation|image fusion-guided implantation
171075|NCT03125720|SPECT|spect
171076|NCT03125720|venogram|venogram
171077|NCT03125681|remote ischemic conditioning|remote ischemic conditioning
171078|NCT03125681|off-pump coronary artery bypass surgery|off-pump coronary artery bypass surgery
171079|NCT03125655|cytokines|cytokines
171080|NCT03125642|Lymphoblastic Lymphoma|lymphoblastic lymphoma
171081|NCT03125642|Mature B-cell Lymphomas|mature b-cell lymphomas
171082|NCT03125642|Follicular Lymphoma|follicular lymphoma
171083|NCT03125642|Diffuse Large B-Cell Lymphoma|diffuse large b-cell lymphoma
171084|NCT03125642|Mantle Cell Lymphoma|mantle cell lymphoma
171085|NCT03125642|Burkitt's/Burkitt's like|burkitt's/burkitt's like
171086|NCT03125642|Mature T-Cell Lymphoma|mature t-cell lymphoma
171087|NCT03125616|Prematurity|prematurity
171088|NCT03125616|Vaccination|vaccination
171089|NCT03125603|Immunotherapy|immunotherapy
171090|NCT03125603|Anti-PD-(L)-1|anti-pd-(l)-1
171091|NCT03125603|Anti-CTLA-4|anti-ctla-4
171092|NCT03125590|Osteoporosis, osteopenia, test-retest, validity, PEQ, questionnaire, facilitators, barriers, exercise, physical activity|osteoporosis, osteopenia, test-retest, validity, peq, questionnaire, facilitators, barriers, exercise, physical activity
171093|NCT03125577|4S CAR-T|4s car-t
171094|NCT03125577|CD19|cd19
171095|NCT03125577|CD20|cd20
171096|NCT03125577|CD22|cd22
171097|NCT03125577|CD38|cd38
171098|NCT03125577|CD123|cd123
171099|NCT03125577|B cell leukemia|b cell leukemia
171100|NCT03125577|B-ALL|b-all
171101|NCT03125577|CD70|cd70
171102|NCT03125577|CD30|cd30
171103|NCT03125551|Dietary supplements|dietary supplements
171104|NCT03125551|Bleeding tendency|bleeding tendency
171105|NCT03125538|Motor Imagery|motor imagery
171106|NCT03125538|Amputation|amputation
171107|NCT03125538|Functional rehabilitation|functional rehabilitation
171108|NCT03125538|Locomotion|locomotion
171109|NCT03125538|Phantom-limb pain|phantom-limb pain
171110|NCT03125525|migraine|migraine
171111|NCT03125525|transcutaneous|transcutaneous
171112|NCT03125525|supraorbital|supraorbital
171113|NCT03125525|nerve|nerve
171114|NCT03125525|stimulation|stimulation
171115|NCT03125512|Sleep Apnea Syndromes|sleep apnea syndromes
171116|NCT03125512|Positional sleep apnea|positional sleep apnea
171117|NCT03125512|CPAP|cpap
171118|NCT03125512|Night Shift|night shift
171119|NCT03125486|subcutaneous Belimumab|subcutaneous belimumab
171120|NCT03125486|Individual Patient Compassionate Use|individual patient compassionate use
171121|NCT03125486|SLE|sle
171122|NCT03125486|GSK1550188|gsk1550188
171123|NCT03125447|Prematurely born children|prematurely born children
171124|NCT03125447|Attention function|attention function
171125|NCT03125447|Posture|posture
171126|NCT03125447|Mobility|mobility
171127|NCT03125356|diet soda|diet soda
171128|NCT03125356|low-calorie sweeteners|low-calorie sweeteners
171129|NCT03125356|obesity|obesity
171130|NCT03125343|radiotherapy|radiotherapy
171131|NCT03125343|chemotherapy|chemotherapy
171132|NCT03125343|complete response|complete response
171133|NCT03125330|Coaching|coaching
171134|NCT03125330|Professional coaching|professional coaching
171135|NCT03125330|Emergency physicians|emergency physicians
171136|NCT03125330|Emergency medicine|emergency medicine
171137|NCT03125330|Goal attainment|goal attainment
171138|NCT03125330|Leadership strengths|leadership strengths
171139|NCT03125330|Well-being|well-being
171140|NCT03125330|Burnout|burnout
171141|NCT03125330|Adult level of development|adult level of development
171142|NCT03125330|Group coaching|group coaching
171143|NCT03125330|Instructor|instructor
171144|NCT03125330|Assistant professor|assistant professor
171145|NCT03125330|Academic faculty|academic faculty
171146|NCT03125330|Subject-Object Interview|subject-object interview
171147|NCT03125304|Endometriosis|endometriosis
171148|NCT03125304|acupuncture|acupuncture
171149|NCT03125304|pain|pain
171150|NCT03125304|dysmenorrhea|dysmenorrhea
171151|NCT03125291|Substance Use and Abuse|substance use and abuse
171152|NCT03125291|Risky Sexual Behavior|risky sexual behavior
171153|NCT03125291|Behavior Problems|behavior problems
171154|NCT03125291|Academic Achievement|academic achievement
171155|NCT03125265|nutrition|nutrition
171156|NCT03125265|hemodialysis|hemodialysis
171157|NCT03125265|mortality|mortality
171159|NCT03125252|Delirium|delirium
171160|NCT03125252|Reanimation|reanimation
171161|NCT03125252|Conversational hypnosis|conversational hypnosis
171162|NCT03125239|Refractory Adult Acute Myeloid Leukemia|refractory adult acute myeloid leukemia
171163|NCT03125239|Relapsed Adult Acute Myeloid Leukemia|relapsed adult acute myeloid leukemia
218709|NCT02826655|WF-OCT|wf-oct
171164|NCT03125187|Sodium Heparin|sodium heparin
171165|NCT03125187|Intravenous administration|intravenous administration
171166|NCT03125187|Pharmacokinetics|pharmacokinetics
171167|NCT03125187|Coagulation factor|coagulation factor
171168|NCT03125174|sputum|sputum
171169|NCT03125174|bronchiectasis|bronchiectasis
171170|NCT03125174|lung disease|lung disease
171171|NCT03125161|colorectal cancer|colorectal cancer
171172|NCT03125161|liver metastasis|liver metastasis
171173|NCT03125161|hepatic arterial infusion|hepatic arterial infusion
171174|NCT03125161|chemotherapy|chemotherapy
171175|NCT03125161|target therapy|target therapy
171176|NCT03125161|conversional resection rates|conversional resection rates
171177|NCT03125083|Skin restricted lupus|skin restricted lupus
171178|NCT03125083|Psychiatric disorders|psychiatric disorders
171179|NCT03125083|Inflammation|inflammation
171180|NCT03125083|Kynurenine pathway|kynurenine pathway
171181|NCT03124667|adherence|adherence
171182|NCT03124667|cognition|cognition
171183|NCT03124667|exercise|exercise
171184|NCT03124667|aging|aging
171185|NCT03124667|brain training|brain training
171186|NCT03124667|cognitive training|cognitive training
171187|NCT03124667|executive function|executive function
171188|NCT03124641|Hypothermic oxygenated machine perfusion|hypothermic oxygenated machine perfusion
171189|NCT03124641|Orthotopic liver transplantation|orthotopic liver transplantation
171190|NCT03124641|Extended criteria donation|extended criteria donation
171191|NCT03124641|Donation after brain death|donation after brain death
171192|NCT03124641|HOPE|hope
171193|NCT03124563|Exercise|exercise
171194|NCT03124563|Health Behavior|health behavior
171195|NCT03124563|Aging|aging
171196|NCT03124550|Caregivers|caregivers
171197|NCT03124550|Exercise|exercise
171198|NCT03124550|Behavior Change|behavior change
171199|NCT03124537|Physical Exercise|physical exercise
171200|NCT03124537|Behavior Change|behavior change
171201|NCT03124524|estradiol valerate/dienogest|estradiol valerate/dienogest
171202|NCT03124524|ethinylestradiol/ drospirenone|ethinylestradiol/ drospirenone
171203|NCT03124524|pelvic pain|pelvic pain
171204|NCT03124524|primary dysmenorrhea|primary dysmenorrhea
171205|NCT03124524|uterine artery doppler indices|uterine artery doppler indices
171206|NCT03124498|Hepatocellular Carcinoma, Autologous Cytokine-Induced Killer|hepatocellular carcinoma, autologous cytokine-induced killer
171207|NCT03124459|CMT1 / CMTX|cmt1 / cmtx
171208|NCT03124446|mindfulness, meditation, emerging adults, young adults, undergraduate students, stress, health|mindfulness, meditation, emerging adults, young adults, undergraduate students, stress, health
171209|NCT03124433|prostate cancer|prostate cancer
171210|NCT03124433|prostatectomy, retropubic|prostatectomy, retropubic
171211|NCT03124433|Androgen Receptor Antagonists|androgen receptor antagonists
171212|NCT03124420|Helicobacter Infection|helicobacter infection
171213|NCT03124420|Eradication therapy|eradication therapy
171214|NCT03124420|Antibiotics|antibiotics
171215|NCT03124381|Acne|acne
171216|NCT03124368|factor D|factor d
171217|NCT03124368|fD|fd
171218|NCT03124368|alternative pathway|alternative pathway
171219|NCT03124368|complement mediated disease|complement mediated disease
171220|NCT03124368|idiopathic MPGN|idiopathic mpgn
171221|NCT03124368|MPGN Type I|mpgn type i
171222|NCT03124368|MPGN Type II|mpgn type ii
171223|NCT03124368|MPGN Type III|mpgn type iii
171224|NCT03124368|Primary MPGN|primary mpgn
171225|NCT03124368|MCGN|mcgn
171226|NCT03124368|Mesangiocapillary Glomerulonephritis|mesangiocapillary glomerulonephritis
171227|NCT03124355|vagal stimulation|vagal stimulation
171228|NCT03124355|POTS|pots
171229|NCT03124355|galantamine|galantamine
171230|NCT03124355|pyridostigmine|pyridostigmine
171231|NCT03124238|massage|massage
171232|NCT03124212|mutation carrier|mutation carrier
171233|NCT03124212|blood relative|blood relative
171234|NCT03124212|genetic testing|genetic testing
171235|NCT03124212|family-based cohort|family-based cohort
171236|NCT03124199|Eradication|eradication
171237|NCT03124199|Helicobacter pylori|helicobacter pylori
171238|NCT03124199|rifaximin|rifaximin
171239|NCT03124199|therapy|therapy
171240|NCT03124199|standard triple therapy|standard triple therapy
171241|NCT03124186|motor recovery|motor recovery
171242|NCT03124186|neuroplasticity|neuroplasticity
171243|NCT03124186|subacute|subacute
171244|NCT03124186|human|human
171245|NCT03124186|sensory|sensory
171246|NCT03124186|nerve stimulation|nerve stimulation
171247|NCT03124173|fMRI|fmri
171248|NCT03124173|cingulate cortex|cingulate cortex
171249|NCT03124173|adaptation|adaptation
171250|NCT03124173|frontal cortex|frontal cortex
171251|NCT03124160|Healthy Women|healthy women
171252|NCT03124160|Female Contraception|female contraception
171253|NCT03124160|IUD|iud
171254|NCT03124147|motor recovery|motor recovery
171255|NCT03124147|neuroplasticity|neuroplasticity
171256|NCT03124147|chronic|chronic
171257|NCT03124147|human|human
171258|NCT03124147|noninvasive brain stimulation|noninvasive brain stimulation
171259|NCT03124147|neuromodulation|neuromodulation
171260|NCT03124108|Elafibranor|elafibranor
171261|NCT03124108|Primary Biliary Cholangitis|primary biliary cholangitis
171262|NCT03124108|Alkaline phosphatase|alkaline phosphatase
171263|NCT03124095|physical exercise|physical exercise
171264|NCT03124095|combined training|combined training
171265|NCT03124095|physical activity|physical activity
171266|NCT03124095|physical fitness|physical fitness
171267|NCT03124056|Extracorporeal photopheresis|extracorporeal photopheresis
171268|NCT03124056|Biomarker of response|biomarker of response
171269|NCT03124056|Steroid resistant|steroid resistant
171270|NCT03124030|direct oral anticoagulant|direct oral anticoagulant
171271|NCT03124030|oral anticoagulant therapy|oral anticoagulant therapy
171272|NCT03124030|dental extraction|dental extraction
171273|NCT03124030|bleeding complication|bleeding complication
171274|NCT03124030|atrial fibrillation|atrial fibrillation
171275|NCT03124030|deep venous thrombosis|deep venous thrombosis
171276|NCT03124004|direct oral anticoagulant|direct oral anticoagulant
171277|NCT03124004|oral anticoagulant therapy|oral anticoagulant therapy
171278|NCT03124004|periodontal disease|periodontal disease
171279|NCT03124004|periodontal debridement|periodontal debridement
171280|NCT03124004|ultrasonic periodontal debridement|ultrasonic periodontal debridement
171281|NCT03124004|ultrasonic scaling|ultrasonic scaling
171282|NCT03124004|periodontal scaling|periodontal scaling
171283|NCT03124004|subgingival scaling|subgingival scaling
171284|NCT03123978|castration resistant prostate cancer|castration resistant prostate cancer
171285|NCT03123965|Special Access Scheme|special access scheme
171286|NCT03123965|Expanded Access|expanded access
171287|NCT03123965|Pre-approval Access|pre-approval access
171288|NCT03123965|Compassionate Use|compassionate use
171289|NCT03123965|Special Access Program|special access program
171290|NCT03123965|Named Patient Basis|named patient basis
171291|NCT03123952|Expanded Access|expanded access
171292|NCT03123952|Pre-approval Access|pre-approval access
171293|NCT03123952|Compassionate Use|compassionate use
171294|NCT03123952|Special Access Program|special access program
171295|NCT03123952|Named Patient Basis|named patient basis
171296|NCT03123952|Special Access Scheme|special access scheme
171297|NCT03123939|ALL|all
171298|NCT03123939|Acute Lymphoblastic Leukemia|acute lymphoblastic leukemia
171299|NCT03123939|CTL019|ctl019
171300|NCT03123939|relapsed/refractory pediatric/young adult|relapsed/refractory pediatric/young adult
171301|NCT03123926|spontaneous preterm birth|spontaneous preterm birth
171302|NCT03123926|lipids|lipids
171303|NCT03123926|biomarkers|biomarkers
171304|NCT03123874|human milk|human milk
171305|NCT03123874|breast milk|breast milk
171306|NCT03123874|expressed human milk|expressed human milk
171307|NCT03123874|bacterial communities|bacterial communities
171308|NCT03123874|microbiome|microbiome
171309|NCT03123874|breast pump|breast pump
171310|NCT03123874|bacterial growth|bacterial growth
171311|NCT03123861|Pelvic Organ Prolapse|pelvic organ prolapse
171312|NCT03123861|postoperative gluteal pain|postoperative gluteal pain
171313|NCT03123861|opioid use|opioid use
171314|NCT03123835|Achalasia|achalasia
171315|NCT03123835|Fistula|fistula
171316|NCT03123835|Obesity|obesity
171317|NCT03123835|POEM|poem
171318|NCT03123835|GERD|gerd
171319|NCT03123835|endoscopic|endoscopic
171320|NCT03123835|treatments|treatments
171321|NCT03123835|post bariatric surger weight gain|post bariatric surger weight gain
171322|NCT03123835|endoluminal|endoluminal
171323|NCT03123835|Bariatric Surgery|bariatric surgery
171324|NCT03123835|Barretts|barretts
171325|NCT03123809|Diabetes Mellitus|diabetes mellitus
171326|NCT03123809|gastroparesis|gastroparesis
171327|NCT03123809|gastric electrical stimulation|gastric electrical stimulation
171328|NCT03123809|pyloroplasty|pyloroplasty
171329|NCT03123809|Idiopathic -unknown etiology|idiopathic -unknown etiology
171330|NCT03123796|chronic rejection|chronic rejection
171331|NCT03123796|transplant outcome|transplant outcome
171332|NCT03123783|CD40|cd40
171333|NCT03123783|Immunotherapy|immunotherapy
171334|NCT03123783|Nivolumab|nivolumab
171335|NCT03123783|APX005M|apx005m
171336|NCT03123783|PD-1|pd-1
171337|NCT03123770|Breast cancer|breast cancer
171338|NCT03123770|Neoadjuvant Chemotherapy|neoadjuvant chemotherapy
171339|NCT03123770|Pegylated liposomal doxorubicin|pegylated liposomal doxorubicin
171340|NCT03123770|PLD|pld
171341|NCT03123744|Palbociclib|palbociclib
171342|NCT03123744|Cyclin Pathway|cyclin pathway
171343|NCT03123744|kinase inhibitor|kinase inhibitor
171344|NCT03123731|physical activity|physical activity
171345|NCT03123731|diet|diet
171346|NCT03123731|mHealth|mhealth
171347|NCT03123731|Fitbit|fitbit
171348|NCT03123731|neurocognition|neurocognition
171349|NCT03123731|text messaging|text messaging
171350|NCT03123718|methotrexate|methotrexate
171351|NCT03123640|Medication reconciliation|medication reconciliation
171352|NCT03123640|Medication review|medication review
171353|NCT03123640|Drug related admission|drug related admission
171354|NCT03123627|Cytomegalovirus, Seropositive|cytomegalovirus, seropositive
171355|NCT03123614|Photorefractive keratectomy|photorefractive keratectomy
171356|NCT03123601|Nursing home|nursing home
171358|NCT03123601|Dysphasia|dysphasia
171359|NCT03123601|Choking|choking
171360|NCT03123601|Dehydration|dehydration
171361|NCT03123588|Essential thrombocythemia|essential thrombocythemia
171362|NCT03123588|hydroxyurea-resistant|hydroxyurea-resistant
171363|NCT03123588|hydroxyurea-intolerant|hydroxyurea-intolerant
171364|NCT03123588|ruxolitinib|ruxolitinib
171365|NCT03123588|anagrelide|anagrelide
171366|NCT03123562|Cerebral palsy|cerebral palsy
171367|NCT03123562|Stem cells|stem cells
171368|NCT03123562|Neonatal icterus|neonatal icterus
171369|NCT03123536|high risk|high risk
171370|NCT03123536|complication|complication
171371|NCT03123536|Ultrasonography|ultrasonography
171372|NCT03123510|probiotics|probiotics
171373|NCT03123510|prebiotics|prebiotics
171374|NCT03123510|synbiotics|synbiotics
171375|NCT03123510|obesity|obesity
171376|NCT03123497|Idiopathic Thrombocytopenic Purpura|idiopathic thrombocytopenic purpura
171377|NCT03123484|beta-elemene|beta-elemene
171378|NCT03123471|Plaque Psoriasis|plaque psoriasis
171379|NCT03123471|Scalp|scalp
171380|NCT03123471|Double-Blind|double-blind
171381|NCT03123471|Efficacy|efficacy
171382|NCT03123471|Safety|safety
171383|NCT03123471|CC-10004|cc-10004
171384|NCT03123471|Apremilast|apremilast
171385|NCT03123471|Otezla|otezla
171386|NCT03123471|Itch|itch
171387|NCT03123471|Head|head
171388|NCT03123458|MSC|msc
171389|NCT03123458|GVHDs|gvhds
171390|NCT03123458|transplantation|transplantation
171391|NCT03123445|endostar|endostar
171392|NCT03123432|immunomodulating nutrients|immunomodulating nutrients
171393|NCT03123406|cinacalcet|cinacalcet
171394|NCT03123406|secondary hyperparathyroidism|secondary hyperparathyroidism
171395|NCT03123406|calcimimetics|calcimimetics
171396|NCT03123406|CKD-MBD|ckd-mbd
171397|NCT03123393|Drug therapy|drug therapy
171398|NCT03123315|hysterectomy|hysterectomy
171399|NCT03123315|ureter|ureter
171400|NCT03123302|MRI scan, sedation, epilepsia|mri scan, sedation, epilepsia
171401|NCT03123289|PET/CT|pet/ct
171402|NCT03123289|68Gallium Citrate|68gallium citrate
171403|NCT03123289|Orthopedic Hardware infection|orthopedic hardware infection
171404|NCT03123250|Lower Urinary Tract Symptoms (LUTS)|lower urinary tract symptoms (luts)
171405|NCT03123250|AQUABEAM|aquabeam
171406|NCT03123250|Aquablation|aquablation
171407|NCT03123250|Benign Prostatic Hyperplasia (BPH)|benign prostatic hyperplasia (bph)
171408|NCT03123224|Caregiver|caregiver
171409|NCT03123224|Caregiving|caregiving
171410|NCT03123224|TBI|tbi
171411|NCT03123224|dementia|dementia
171412|NCT03123224|Alzheimer's disease|alzheimer's disease
171413|NCT03123224|physical exercise|physical exercise
171414|NCT03123224|physical activity|physical activity
171415|NCT03123224|psychosocial|psychosocial
171416|NCT03123224|caregiver skills training|caregiver skills training
171417|NCT03123211|Expanded Access|expanded access
171418|NCT03123211|Pre-approval Access|pre-approval access
171419|NCT03123211|Compassionate Use|compassionate use
171420|NCT03123211|Special Access Program|special access program
171421|NCT03123211|Named Patient Basis|named patient basis
171422|NCT03123211|Special Access Scheme|special access scheme
171423|NCT03123198|borderline personality disorder, dialectical behavior therapy, suicidal behaviors|borderline personality disorder, dialectical behavior therapy, suicidal behaviors
171425|NCT03123172|PPV|ppv
171426|NCT03123172|resuscitation|resuscitation
171427|NCT03123172|liver transplantation|liver transplantation
171428|NCT03123146|Cognitive Behavioral Therapy|cognitive behavioral therapy
171429|NCT03123107|Vitamin C|vitamin c
171430|NCT03123107|Postoperative atrial fibrillation|postoperative atrial fibrillation
171431|NCT03123107|coronary artery bypass graft|coronary artery bypass graft
171432|NCT03123107|ascorbic acid|ascorbic acid
171433|NCT03123055|Urothelial Cell Carcinoma|urothelial cell carcinoma
171434|NCT03123055|UCC|ucc
171435|NCT03123055|bladder cancer|bladder cancer
171436|NCT03123055|B-701|b-701
171437|NCT03123055|FGFR3|fgfr3
171438|NCT03123055|invasive bladder cancer|invasive bladder cancer
171439|NCT03123055|Transitional Cell Carcinoma|transitional cell carcinoma
171440|NCT03123055|TCC|tcc
171441|NCT03123055|second line therapy|second line therapy
171442|NCT03123055|monoclonal antibody|monoclonal antibody
171443|NCT03123055|combination therapy|combination therapy
171444|NCT03123055|Phase 1b|phase 1b
171445|NCT03123055|pembrolizumab|pembrolizumab
171446|NCT03123055|checkpoint inhibitor|checkpoint inhibitor
171447|NCT03123055|Phase 2|phase 2
171448|NCT03123055|Urothelial Carcinoma|urothelial carcinoma
171449|NCT03123055|Vofatamab|vofatamab
171450|NCT03123042|Sentinel lymph node|sentinel lymph node
171451|NCT03123042|Early gastric cancer|early gastric cancer
171452|NCT03123042|Non-curative endoscopic resection|non-curative endoscopic resection
171453|NCT03123029|Expanded Access|expanded access
171454|NCT03123029|Pre-approval Access|pre-approval access
171455|NCT03123029|Compassionate Use|compassionate use
171456|NCT03123029|Special Access Program|special access program
171457|NCT03123029|Named Patient Basis|named patient basis
171458|NCT03123029|Special Access Scheme|special access scheme
171459|NCT03123016|Vitiligo|vitiligo
171460|NCT03123003|Bone age,|bone age,
171461|NCT03123003|Height prediction|height prediction
171462|NCT03123003|Growth|growth
171463|NCT03122938|lactoferrin|lactoferrin
171464|NCT03122938|Iron Metabolism|iron metabolism
171465|NCT03122938|iron-deficiency anemia|iron-deficiency anemia
171466|NCT03122938|pregnant women|pregnant women
171467|NCT03122938|fetal development|fetal development
171468|NCT03122912|fish oil|fish oil
171469|NCT03122899|SI-BONE|si-bone
171470|NCT03122899|sacroiliac joint|sacroiliac joint
171471|NCT03122899|degenerative sacroiliitis|degenerative sacroiliitis
171472|NCT03122899|sacroiliac joint disruption|sacroiliac joint disruption
171473|NCT03122899|iFuse|ifuse
171474|NCT03122860|SM04690|sm04690
171475|NCT03122860|Wnt pathway inhibitor|wnt pathway inhibitor
171476|NCT03122860|osteoarthritis|osteoarthritis
171477|NCT03122860|Samumed|samumed
171478|NCT03122834|Heart Failure|heart failure
171479|NCT03122834|Genetic Polymorphism|genetic polymorphism
171480|NCT03122834|RAAS|raas
171481|NCT03122834|Cardiac Fibrosis|cardiac fibrosis
171482|NCT03122834|Remodeling|remodeling
171483|NCT03122808|Tachysystole|tachysystole
171484|NCT03122808|Excessive Uterine Activity|excessive uterine activity
171485|NCT03122769|Metformin|metformin
171486|NCT03122769|Heart Failure|heart failure
171487|NCT03122769|Organic cation transporter|organic cation transporter
171488|NCT03122769|Pharmacogenetics|pharmacogenetics
171489|NCT03122769|Pharmacokinetics|pharmacokinetics
171490|NCT03122769|Positron Emission Tomography|positron emission tomography
171491|NCT03122756|Intravenous Dexamethasone|intravenous dexamethasone
171492|NCT03122756|Spinal Anesthesia|spinal anesthesia
171493|NCT03122756|Post-cesarean Section Pain|post-cesarean section pain
171494|NCT03122730|Cardiac surgery|cardiac surgery
171495|NCT03122730|Cardiopulmonary bypass|cardiopulmonary bypass
171496|NCT03122730|Epoprostenol|epoprostenol
171497|NCT03122717|Non-Small Cell Lung Cancer|non-small cell lung cancer
171498|NCT03122665|Nefopam|nefopam
171499|NCT03122665|Pharmacokinetics|pharmacokinetics
171500|NCT03122665|Shivering,|shivering,
171501|NCT03122665|Thermoregulation|thermoregulation
171502|NCT03122665|Anesthesia|anesthesia
171503|NCT03122652|Radiologically Isolated Syndrome|radiologically isolated syndrome
171504|NCT03122626|stroke|stroke
171505|NCT03122626|community-based exercise program|community-based exercise program
171506|NCT03122626|task-oriented exercise|task-oriented exercise
171507|NCT03122626|group exercise program|group exercise program
171508|NCT03122626|healthcare-recreation partnership|healthcare-recreation partnership
171509|NCT03122626|randomized controlled pilot trial|randomized controlled pilot trial
171510|NCT03122626|mixed methods|mixed methods
171511|NCT03122587|tACS|tacs
171512|NCT03122587|Brain Stimulation|brain stimulation
171513|NCT03122587|Transcranial Alternating Current Stimulation|transcranial alternating current stimulation
171514|NCT03122587|Substance Use|substance use
171515|NCT03122574|aromatherapy|aromatherapy
171516|NCT03122574|pediatric|pediatric
171517|NCT03122574|venipuncture|venipuncture
171518|NCT03122574|lavender|lavender
171519|NCT03122574|pain management|pain management
171520|NCT03122548|stomach cancer|stomach cancer
171521|NCT03122548|gastric cancer|gastric cancer
171522|NCT03122548|esophageal cancer|esophageal cancer
171523|NCT03122548|digestive system diseases|digestive system diseases
171524|NCT03122548|gastrointestinal diseases|gastrointestinal diseases
171525|NCT03122548|stomach diseases|stomach diseases
171526|NCT03122535|Femtosecond LASIK (FS--LASIK)|femtosecond lasik (fs--lasik)
171527|NCT03122535|Visual acuity|visual acuity
171528|NCT03122535|Refractive errors|refractive errors
171529|NCT03122535|Side-cut angles|side-cut angles
171530|NCT03122522|unresectable|unresectable
171531|NCT03122522|III or stage IV|iii or stage iv
171532|NCT03122522|Ipilimumab|ipilimumab
171533|NCT03122522|Nivolumab|nivolumab
171534|NCT03122522|17-162|17-162
171535|NCT03122509|Durvalumab|durvalumab
171536|NCT03122509|Tremelimumab|tremelimumab
171537|NCT03122509|Radiation Therapy|radiation therapy
171538|NCT03122509|Ablation|ablation
171539|NCT03122509|17-139|17-139
171540|NCT03122496|Durvalumab (Medi4736)|durvalumab (medi4736)
171541|NCT03122496|Tremelimumab|tremelimumab
171542|NCT03122496|Image Guided Stereotactic Body Radiotherapy (SBRT)|image guided stereotactic body radiotherapy (sbrt)
171543|NCT03122496|17-108|17-108
171544|NCT03122470|TRUS biopsy|trus biopsy
171545|NCT03122470|Pelvic MRI|pelvic mri
171546|NCT03122457|Actinic Keratosis|actinic keratosis
171547|NCT03122366|single nucleotide polymorphisms|single nucleotide polymorphisms
171548|NCT03122366|Toll-like receptor-4|toll-like receptor-4
171549|NCT03122340|Acute Coronary Syndrome|acute coronary syndrome
171550|NCT03122340|Polyprenols|polyprenols
171551|NCT03122340|Cholesterol|cholesterol
171552|NCT03122314|paracetamol|paracetamol
171553|NCT03122314|dexketoprofen|dexketoprofen
171554|NCT03122314|emergency department|emergency department
171555|NCT03122314|musculoskeletal pain|musculoskeletal pain
171556|NCT03122275|Adherence|adherence
171557|NCT03122275|Directive Counseling|directive counseling
171558|NCT03122262|Antiretroviral Agents, first-line antiretroviral therapy|antiretroviral agents, first-line antiretroviral therapy
171559|NCT03122262|dolutegravir|dolutegravir
171560|NCT03122262|Tenofovir alafenamide|tenofovir alafenamide
171561|NCT03122249|Palliative care|palliative care
171562|NCT03122249|Symptom management|symptom management
171563|NCT03122249|Self-management|self-management
171564|NCT03122249|Rural area|rural area
171565|NCT03122249|eHealth|ehealth
171566|NCT03122249|telehealth|telehealth
171567|NCT03122223|HIV|hiv
171568|NCT03122158|major depressive disorder|major depressive disorder
171569|NCT03122158|anxiety disorders|anxiety disorders
171570|NCT03122158|adolescent|adolescent
171571|NCT03122158|child|child
171572|NCT03122145|healthy|healthy
171573|NCT03122145|volunteer|volunteer
171574|NCT03122132|Hepatitis C Infection|hepatitis c infection
171575|NCT03122132|Ombitasvir/Paritaprevir/Ritonavir+dasabuvir|ombitasvir/paritaprevir/ritonavir+dasabuvir
171576|NCT03122119|Sacroiliac|sacroiliac
171577|NCT03122119|Joint Injection|joint injection
171578|NCT03122119|Platelet Rich Plasma|platelet rich plasma
171579|NCT03122119|Ultrasound|ultrasound
171580|NCT03122119|Low Back Pain|low back pain
171581|NCT03122093|pediatric|pediatric
171582|NCT03122093|dietary treatment|dietary treatment
171583|NCT03122093|celiac disease|celiac disease
171584|NCT03122093|T1D|t1d
171585|NCT03122080|acupuncture|acupuncture
171586|NCT03122080|insomnia|insomnia
171587|NCT03122080|depression|depression
171588|NCT03122080|antidepressants|antidepressants
171589|NCT03122067|oxytocin|oxytocin
171590|NCT03122067|social cognition|social cognition
171591|NCT03122067|fMRI|fmri
171592|NCT03122067|empathy|empathy
171593|NCT03122054|Laparoscopic Cholecystectomy, Delayed Cholecystectomy|laparoscopic cholecystectomy, delayed cholecystectomy
171594|NCT03122041|metformin intolerance|metformin intolerance
171595|NCT03122041|PCOS|pcos
171596|NCT03122041|Sitagliptin|sitagliptin
171597|NCT03122041|beta cell function|beta cell function
171598|NCT03122028|LAmbre|lambre
171599|NCT03122002|Ischemic Stroke|ischemic stroke
171600|NCT03122002|Cerebral Infarction|cerebral infarction
171601|NCT03122002|Cerebrovascular Disorders|cerebrovascular disorders
171602|NCT03121950|dementia|dementia
171603|NCT03121924|oocyte denudation|oocyte denudation
171604|NCT03121924|preincubation|preincubation
171605|NCT03121924|icsi|icsi
171606|NCT03121924|oocyte donation|oocyte donation
171607|NCT03121911|Recent Myocardial Infarction|recent myocardial infarction
171608|NCT03121911|Interval Physical Training|interval physical training
171609|NCT03121911|Inspiratory Muscle Training|inspiratory muscle training
171610|NCT03121911|Expiratory Flow Limitation|expiratory flow limitation
171611|NCT03121911|Ventilatory Efficiency|ventilatory efficiency
171612|NCT03121911|Inflammatory Markers|inflammatory markers
171613|NCT03121911|Heart Rate Variability|heart rate variability
171614|NCT03121859|TENS|tens
171615|NCT03121859|interferential current therapy|interferential current therapy
171616|NCT03121859|Chronic neck pain|chronic neck pain
171617|NCT03121846|Apatinib|apatinib
171618|NCT03121846|Soft Tissue Sarcoma|soft tissue sarcoma
171619|NCT03121833|Endostar|endostar
171620|NCT03121833|Soft Tissue Sarcoma|soft tissue sarcoma
171621|NCT03121833|Chemotherapy|chemotherapy
171622|NCT03121807|home parenteral nutrition|home parenteral nutrition
171623|NCT03121794|ultrasonography|ultrasonography
171624|NCT03121794|Intraosseous Vascular access|intraosseous vascular access
171625|NCT03121794|humerus|humerus
171626|NCT03121794|anatomic landmark|anatomic landmark
171627|NCT03121768|Prognostic Model|prognostic model
171628|NCT03121768|Bladder Cancer|bladder cancer
171629|NCT03121768|Superficial Bladder Cancer|superficial bladder cancer
171630|NCT03121768|Recurrence|recurrence
171631|NCT03121768|Progression|progression
171632|NCT03121768|BCG|bcg
171633|NCT03121742|Suicide|suicide
171634|NCT03121729|enhanced recovery after surgery|enhanced recovery after surgery
171635|NCT03121729|gastric cancer|gastric cancer
171636|NCT03121664|Drug drug interaction, CYP3A4, itraconazole|drug drug interaction, cyp3a4, itraconazole
171637|NCT03121651|Mobile technology|mobile technology
171638|NCT03121651|Reinforcement-learning|reinforcement-learning
171639|NCT03121651|Medication management|medication management
171640|NCT03121638|Varicella Vaccine|varicella vaccine
171641|NCT03121638|Herpes Zoster Vaccine|herpes zoster vaccine
171642|NCT03121612|RDS|rds
171643|NCT03121573|near infrared spectroscopy, NIRS, duloxetine|near infrared spectroscopy, nirs, duloxetine
171644|NCT03121560|Hysteroscopy|hysteroscopy
171645|NCT03121560|Saline infusion hysterosonography|saline infusion hysterosonography
171646|NCT03121534|Hematopoietic/Lymphoid Cancer|hematopoietic/lymphoid cancer
171647|NCT03121534|Richter's transformation|richter's transformation
171648|NCT03121534|RT|rt
171649|NCT03121534|Blinatumomab|blinatumomab
171650|NCT03121534|Dexamethasone|dexamethasone
171651|NCT03121534|Decadron|decadron
171652|NCT03121521|statins liver enzymes melatonin|statins liver enzymes melatonin
171653|NCT03121430|peripheral arterial disease|peripheral arterial disease
400605|NCT01866046|battered women|battered women
171654|NCT03121430|Drug eluting peripheral vascular stent system|drug eluting peripheral vascular stent system
171655|NCT03121430|primary patency|primary patency
171656|NCT03121378|Hip Joint Alloplasty|hip joint alloplasty
171657|NCT03121378|Bone Cements|bone cements
171658|NCT03121378|Impedance Aggregometry|impedance aggregometry
171659|NCT03121378|Platelet Activation|platelet activation
171660|NCT03121365|Digital literacy|digital literacy
171661|NCT03121365|Reading|reading
171662|NCT03121352|Carboplatin|carboplatin
171663|NCT03121352|Nab-Paclitaxel|nab-paclitaxel
171664|NCT03121352|Pembrolizumab|pembrolizumab
171665|NCT03121326|Sarcopenia|sarcopenia
171666|NCT03121326|Aging|aging
171667|NCT03121326|Biomarkers|biomarkers
171668|NCT03121326|Metabolomics|metabolomics
171669|NCT03121313|Tegafur-uracil|tegafur-uracil
171670|NCT03121313|distant metastasis|distant metastasis
171671|NCT03121313|oral cavity cancer|oral cavity cancer
171672|NCT03121261|levobupivacaine|levobupivacaine
171673|NCT03121261|nerve fibers|nerve fibers
171674|NCT03121261|clonidine|clonidine
171675|NCT03121248|Accelerated radiotherapy|accelerated radiotherapy
171676|NCT03121248|Older women|older women
171677|NCT03121248|Hypo-fractonation|hypo-fractonation
171678|NCT03121235|aspergillosis|aspergillosis
171679|NCT03121235|mycosis|mycosis
171680|NCT03121235|neutropenia|neutropenia
171681|NCT03121235|hematologic diseases|hematologic diseases
171682|NCT03121235|AsperGenius PCR|aspergenius pcr
171683|NCT03121235|Ambisome|ambisome
171684|NCT03121235|Voriconazole|voriconazole
171685|NCT03121196|Social deprivation|social deprivation
171686|NCT03121196|Adverse perinatal outcomes|adverse perinatal outcomes
171687|NCT03121183|Cardiology|cardiology
171688|NCT03121183|Device Removal|device removal
171689|NCT03121183|Pacemaker|pacemaker
171690|NCT03121183|Defibrillators|defibrillators
171691|NCT03121183|Catheterization|catheterization
171692|NCT03121183|Laser Therapy|laser therapy
171693|NCT03121183|Cost-Benefit Analysis|cost-benefit analysis
171694|NCT03121170|primary dysmenorrhea|primary dysmenorrhea
171695|NCT03121170|extracorporeal shock wave therapy|extracorporeal shock wave therapy
171696|NCT03121170|traditional Chinese medicine|traditional chinese medicine
171697|NCT03121157|African Americans|african americans
171698|NCT03121157|Emerging adults|emerging adults
171699|NCT03121157|Medication adherence|medication adherence
171700|NCT03121157|eHealth|ehealth
171701|NCT03121118|Mild Cognitive Impairment|mild cognitive impairment
171702|NCT03121118|Amyvid|amyvid
171703|NCT03121118|Amyloid Imaging|amyloid imaging
171704|NCT03121118|PET Brain Scan|pet brain scan
171705|NCT03121118|Amyloid Plaque|amyloid plaque
171706|NCT03121118|Ethics|ethics
171707|NCT03121118|Results disclosure|results disclosure
171708|NCT03121105|Idiopathic Inflammatory demyelinating disorders of the central nervous system|idiopathic inflammatory demyelinating disorders of the central nervous system
171709|NCT03121105|Multiple Sclerosis|multiple sclerosis
171710|NCT03121105|Neuromyelitis Optica|neuromyelitis optica
171711|NCT03121105|MRI|mri
171712|NCT03121105|pahtological|pahtological
171713|NCT03121079|Interferon-alpha|interferon-alpha
171714|NCT03121079|Relapse|relapse
171715|NCT03121079|prevention|prevention
171716|NCT03121079|hematopietic stem cell transplantation|hematopietic stem cell transplantation
171717|NCT03121079|acute myeloid leukemia|acute myeloid leukemia
171718|NCT03121066|Transcranial Magnetic Stimulation|transcranial magnetic stimulation
171719|NCT03121066|Non invasive brain stimulation|non invasive brain stimulation
171720|NCT03121066|Theta Burst Protocol|theta burst protocol
171721|NCT03121066|Brain connectivity|brain connectivity
171722|NCT03121066|Dorsolateral prefrontal cortex|dorsolateral prefrontal cortex
171723|NCT03121066|Parietal cortex|parietal cortex
171724|NCT03121053|transcatheter aortic valve implantation|transcatheter aortic valve implantation
171725|NCT03121053|transcatheter aortic valve replacement|transcatheter aortic valve replacement
171726|NCT03121040|Vespa amino acid mixture (VAAM®)|vespa amino acid mixture (vaam®)
171727|NCT03121040|Young athletes|young athletes
171728|NCT03121040|Nutrition|nutrition
171729|NCT03121040|lactic acid accumulation|lactic acid accumulation
171730|NCT03121040|Anaerobic metabolism|anaerobic metabolism
171731|NCT03121040|ATP|atp
171732|NCT03121040|Sports damage|sports damage
171733|NCT03121027|Anemia|anemia
171734|NCT03121027|Ever married women|ever married women
171735|NCT03121027|Economic inequality|economic inequality
171736|NCT03121027|Diabetes|diabetes
171737|NCT03121027|Maternity|maternity
171738|NCT03121027|BMI|bmi
171739|NCT03120988|Knee OA|knee oa
171740|NCT03120988|lavage|lavage
171741|NCT03120988|Platelet Poor Plasma (PPP)|platelet poor plasma (ppp)
171742|NCT03120975|Anti-Infective Agents|anti-infective agents
171743|NCT03120975|Decision Support Systems, Clinical|decision support systems, clinical
171744|NCT03120975|Quality Improvement|quality improvement
171745|NCT03120949|Rheumatoid Arthritis|rheumatoid arthritis
171746|NCT03120949|moderate|moderate
171747|NCT03120949|severe|severe
171748|NCT03120949|subcutaneous|subcutaneous
171749|NCT03120949|Olokizumab|olokizumab
171750|NCT03120949|open-label|open-label
171751|NCT03120936|Adherence|adherence
171752|NCT03120936|Transgender|transgender
171753|NCT03120936|PrEP|prep
171754|NCT03120936|HIV Prevention|hiv prevention
171755|NCT03120936|Truvada|truvada
171756|NCT03120936|HIV Risk Reduction|hiv risk reduction
171757|NCT03120923|subacromial injection|subacromial injection
171758|NCT03120871|Beta cell failure|beta cell failure
171759|NCT03120871|Puberty|puberty
171760|NCT03120871|Microbiome|microbiome
171761|NCT03120871|Insulin Sensitivity|insulin sensitivity
171762|NCT03120858|motor imagery|motor imagery
171763|NCT03120858|kinesthetic imagery|kinesthetic imagery
171764|NCT03120858|reliability|reliability
171765|NCT03120858|Turkish version|turkish version
171766|NCT03120845|Pain,|pain,
171767|NCT03120845|one-visit|one-visit
171768|NCT03120845|two visits|two visits
171769|NCT03120819|exercise|exercise
171770|NCT03120819|fatigue|fatigue
171771|NCT03120819|physical activity|physical activity
171772|NCT03120754|ERAS|eras
171773|NCT03120754|Peritoneal drainage|peritoneal drainage
171774|NCT03120754|Primary Closure|primary closure
171775|NCT03120741|Healthcare Quality|healthcare quality
171776|NCT03120728|Emergency contraception|emergency contraception
171777|NCT03120728|Contraceptive vaginal ring|contraceptive vaginal ring
171778|NCT03120728|NuvaRing|nuvaring
171779|NCT03120728|Contraception|contraception
171780|NCT03120715|low molecular weight heparin (LMWH)|low molecular weight heparin (lmwh)
171781|NCT03120715|frozen embryo transfer (FET)|frozen embryo transfer (fet)
171782|NCT03120715|pregnancy|pregnancy
171783|NCT03120689|VITOM|vitom
171784|NCT03120689|Adult learners|adult learners
171785|NCT03120689|Medical students|medical students
171786|NCT03120689|Residents|residents
171787|NCT03120689|Vaginal surgery|vaginal surgery
171788|NCT03120689|Medical education|medical education
171789|NCT03120676|Relapsed|relapsed
171790|NCT03120676|Refractory|refractory
171791|NCT03120676|Atezolizumab|atezolizumab
171792|NCT03120676|17-191|17-191
171793|NCT03120663|antimicrobials|antimicrobials
171794|NCT03120663|pharmacokinetics|pharmacokinetics
171795|NCT03120663|augmented renal clearance|augmented renal clearance
171796|NCT03120663|non critically ill|non critically ill
171797|NCT03120637|Methylene Blue|methylene blue
171798|NCT03120637|Septic Shock|septic shock
171799|NCT03120637|Vasoplegia|vasoplegia
171800|NCT03120637|Cirrhosis|cirrhosis
171801|NCT03120611|Exercise|exercise
171802|NCT03120611|Hemodialysis|hemodialysis
171803|NCT03120611|Virtual Reality|virtual reality
171804|NCT03120598|preparation strategies|preparation strategies
171805|NCT03120598|implementation strategies|implementation strategies
171806|NCT03120598|sustainment strategies|sustainment strategies
171807|NCT03120585|Respiratory Distress Syndrome, Newborn|respiratory distress syndrome, newborn
171808|NCT03120585|fluid restriction|fluid restriction
171809|NCT03120572|Respiratory muscle strength|respiratory muscle strength
171810|NCT03120572|Diaphragmatic surface electromyography|diaphragmatic surface electromyography
171811|NCT03120572|Functional capacity|functional capacity
171812|NCT03120559|Gingivitis|gingivitis
171813|NCT03120559|SMS|sms
171814|NCT03120559|Dental floss|dental floss
171815|NCT03120559|behavior change|behavior change
171816|NCT03120559|HAPA|hapa
171817|NCT03120546|cervical spine motion|cervical spine motion
171818|NCT03120546|video laryngoscope|video laryngoscope
171819|NCT03120546|rigid video stylet|rigid video stylet
171820|NCT03120533|iontophoresis|iontophoresis
171821|NCT03120533|treprostinil|treprostinil
171822|NCT03120507|in-hospital cardiac arrest|in-hospital cardiac arrest
171823|NCT03120507|IHCA|ihca
171824|NCT03120507|quality of life|quality of life
171825|NCT03120507|QoL|qol
171826|NCT03120507|patient-reported outcomes|patient-reported outcomes
171827|NCT03120494|HIV prevention, high risk MSM, sero-discordant couples, PrEP|hiv prevention, high risk msm, sero-discordant couples, prep
171828|NCT03120468|alcohol, alcohol dependence, addiction, alcohol use disorder|alcohol, alcohol dependence, addiction, alcohol use disorder
171829|NCT03120455|weight loss|weight loss
171830|NCT03120455|Almond|almond
171831|NCT03120455|Pistachio|pistachio
171832|NCT03120455|hypoenergetic diet|hypoenergetic diet
171833|NCT03120455|Nut|nut
171834|NCT03120442|postoperative delirium|postoperative delirium
171835|NCT03120442|total knee arthroplasty|total knee arthroplasty
171836|NCT03120442|propofol|propofol
171837|NCT03120442|dexmedetomidine|dexmedetomidine
171838|NCT03120442|fentanyl|fentanyl
171839|NCT03120442|inflammatory response|inflammatory response
171840|NCT03120442|interleukins|interleukins
171841|NCT03120442|CAM-ICU|cam-icu
171842|NCT03120429|lean fish|lean fish
171843|NCT03120429|weight loss|weight loss
171844|NCT03120429|Diet|diet
171845|NCT03120364|Herpes Zoster Vaccine|herpes zoster vaccine
171846|NCT03120364|Prevention of Herpes Zoster|prevention of herpes zoster
171847|NCT03120338|Child and Adolescent|child and adolescent
171848|NCT03120338|Randomised Controlled Trial|randomised controlled trial
171849|NCT03120338|Paediatrics|paediatrics
171850|NCT03120338|DAWBA|dawba
171953|NCT03119792|Prevention|prevention
171851|NCT03120338|eHealth Services|ehealth services
171852|NCT03120312|outcome|outcome
171853|NCT03120286|OBESITY|obesity
171854|NCT03120286|In Vitro Fertilization (IVF)|in vitro fertilization (ivf)
171855|NCT03120286|Polycystic ovary syndrome (PCOS)|polycystic ovary syndrome (pcos)
171856|NCT03120260|Caloric Restriction|caloric restriction
171857|NCT03120260|weight loss|weight loss
171858|NCT03120260|sleep|sleep
171859|NCT03120221|Pregnancy|pregnancy
171860|NCT03120221|Iodine deficiency|iodine deficiency
171861|NCT03120221|Thyroid|thyroid
171862|NCT03120208|Postpartum psychological disorders|postpartum psychological disorders
171863|NCT03120208|immediate postpartum hemorrhage.|immediate postpartum hemorrhage.
171864|NCT03120182|aspirin|aspirin
171865|NCT03120182|bleeding risk|bleeding risk
171866|NCT03120182|intracranial bleeding|intracranial bleeding
171867|NCT03120182|burr-hole drainage|burr-hole drainage
171868|NCT03120182|chronic subdural hematoma|chronic subdural hematoma
171869|NCT03120182|anticoagulation|anticoagulation
171870|NCT03120169|COPD|copd
171871|NCT03120169|exercise|exercise
171872|NCT03120169|training|training
171873|NCT03120169|cycling|cycling
171874|NCT03120169|treadmill|treadmill
171875|NCT03120169|walking|walking
171876|NCT03120169|pulmonary rehabilitation|pulmonary rehabilitation
171877|NCT03120156|sensomotoric insoles|sensomotoric insoles
171878|NCT03120156|postural control|postural control
171879|NCT03120156|proprioceptive insoles|proprioceptive insoles
171880|NCT03120156|insoles|insoles
171881|NCT03120143|Small-sided ball games|small-sided ball games
171882|NCT03120143|Aging|aging
171883|NCT03120143|Muscle mass|muscle mass
171884|NCT03120143|Health|health
171885|NCT03120143|Training|training
171886|NCT03120143|Protein intake|protein intake
171887|NCT03120143|Physical function|physical function
171888|NCT03120143|Physiological adaptations|physiological adaptations
171889|NCT03120130|Phase I,|phase i,
171890|NCT03120117|Midurethral Slings|midurethral slings
171891|NCT03120078|Ultrasound|ultrasound
171892|NCT03120065|adherence|adherence
171893|NCT03120013|Transcranial direct current stimulation|transcranial direct current stimulation
171894|NCT03120013|Transcranial magnetic stimulation|transcranial magnetic stimulation
171895|NCT03120013|Spinocerebellar ataxia|spinocerebellar ataxia
171896|NCT03120013|Cerebellar ataxia|cerebellar ataxia
171897|NCT03120000|DLBCL|dlbcl
171898|NCT03119987|Red cell Distribution Width|red cell distribution width
171899|NCT03119987|Risk|risk
171900|NCT03119987|Mortality|mortality
171901|NCT03119987|Hemorrhage|hemorrhage
171903|NCT03119974|TPO-RAS|tpo-ras
171904|NCT03119974|Thrombopoietin-receptor agonists|thrombopoietin-receptor agonists
171905|NCT03119961|Amyloid Amyloid Plaque|amyloid amyloid plaque
171906|NCT03119961|Tau Protein|tau protein
171907|NCT03119961|Sonication|sonication
171908|NCT03119948|Muscle spasticity|muscle spasticity
171909|NCT03119948|Botulinum toxin|botulinum toxin
171910|NCT03119935|ambu bag, ventilation, tidal volume|ambu bag, ventilation, tidal volume
171911|NCT03119922|major sickle cell disease (SCD)|major sickle cell disease (scd)
171912|NCT03119922|children|children
171913|NCT03119922|pneumococcal preventive measures|pneumococcal preventive measures
171914|NCT03119909|fMRI|fmri
171915|NCT03119909|cingulate cortex|cingulate cortex
171916|NCT03119909|adaptation|adaptation
171917|NCT03119909|frontal cortex|frontal cortex
171918|NCT03119896|chronic pain|chronic pain
171919|NCT03119896|self-management|self-management
171920|NCT03119896|pain management|pain management
171921|NCT03119896|doctor patient communication|doctor patient communication
171922|NCT03119896|primary care|primary care
171923|NCT03119883|Myeloma|myeloma
171924|NCT03119883|Metabolism|metabolism
171925|NCT03119883|Glutamine|glutamine
171926|NCT03119870|fMRI|fmri
171927|NCT03119870|EEG|eeg
171928|NCT03119870|behavior|behavior
171929|NCT03119870|cingulate cortex|cingulate cortex
171930|NCT03119857|Non-metastatic Prostate Cancer|non-metastatic prostate cancer
171931|NCT03119831|chlorhexidine|chlorhexidine
171932|NCT03119831|alcohol|alcohol
171933|NCT03119831|C31G|c31g
171934|NCT03119831|Mouthrinses|mouthrinses
171935|NCT03119831|Early postsurgical wound healing|early postsurgical wound healing
171936|NCT03119818|ESRD|esrd
171937|NCT03119818|hemodialysis|hemodialysis
171938|NCT03119818|phosphate|phosphate
171939|NCT03119818|ATP|atp
171940|NCT03119818|magnetic resonance spectroscopy|magnetic resonance spectroscopy
171941|NCT03119805|composite scores|composite scores
171942|NCT03119805|patient reported outcomes|patient reported outcomes
171943|NCT03119805|patient perpective|patient perpective
171944|NCT03119805|physician perspective|physician perspective
171945|NCT03119805|cut-off values|cut-off values
171946|NCT03119805|flare|flare
171947|NCT03119805|remission|remission
171948|NCT03119805|minimal disease activity|minimal disease activity
171949|NCT03119805|low disease activity|low disease activity
171950|NCT03119792|Behavioral Modification|behavioral modification
171951|NCT03119792|Health Community|health community
171952|NCT03119792|Community Intervention|community intervention
171954|NCT03119792|Cardiovascular Health|cardiovascular health
171955|NCT03119792|Education Intervention|education intervention
171956|NCT03119792|Colombia|colombia
171957|NCT03119779|pulpotomy|pulpotomy
171958|NCT03119779|deep caries|deep caries
171959|NCT03119779|permanent molars|permanent molars
171960|NCT03119779|MTA|mta
171961|NCT03119753|Rapid Prototyping technique|rapid prototyping technique
171962|NCT03119753|complete denture|complete denture
171963|NCT03119714|bronchoprovocation|bronchoprovocation
171964|NCT03119714|early-late asthmatic reaction|early-late asthmatic reaction
171965|NCT03119714|mast cell stabilizer|mast cell stabilizer
171966|NCT03119714|mast cell mediators|mast cell mediators
171967|NCT03119714|sputum eosinophils|sputum eosinophils
171968|NCT03119701|Patients Surviving Open Surgery|patients surviving open surgery
171969|NCT03119701|Ruptured Abdominal Aortic Aneurysm|ruptured abdominal aortic aneurysm
171970|NCT03119675|Myopia|myopia
171971|NCT03119675|Hyperopia|hyperopia
171972|NCT03119675|Anisometropia|anisometropia
171973|NCT03119675|Amblyopia Risk Factors|amblyopia risk factors
171974|NCT03119675|Risk Factors|risk factors
171975|NCT03119675|Smartphone Application (App)|smartphone application (app)
171976|NCT03119675|Photoscreening|photoscreening
171977|NCT03119675|Vision Screening|vision screening
171978|NCT03119675|Mobile Vision Screening|mobile vision screening
171979|NCT03119662|Acute kidney injury (AKI)|acute kidney injury (aki)
171980|NCT03119662|Acute kidney injury network (AKIN)|acute kidney injury network (akin)
171981|NCT03119662|Chronic kidney disease (CKD)|chronic kidney disease (ckd)
171982|NCT03119662|Contrast-enhanced computed tomography (CECT)|contrast-enhanced computed tomography (cect)
171983|NCT03119662|Endovascular Aneurysm Repair (EVAR)|endovascular aneurysm repair (evar)
171984|NCT03119662|Iodixanol|iodixanol
171985|NCT03119662|Non-enhanced computed tomography (NECT)|non-enhanced computed tomography (nect)
171986|NCT03119662|Serum creatinine (SCr)|serum creatinine (scr)
171987|NCT03119623|Heart Failure|heart failure
171988|NCT03119623|Endothelial function|endothelial function
171989|NCT03119623|Brachial Artery Reactivity Test|brachial artery reactivity test
171990|NCT03119623|Sacubitril/Valsartan|sacubitril/valsartan
171991|NCT03119623|Enalapril|enalapril
171992|NCT03119623|HFREF|hfref
171993|NCT03119597|low mood, depression|low mood, depression
171994|NCT03119584|chronic constipation|chronic constipation
171995|NCT03119584|diabetes|diabetes
171996|NCT03119571|Cardiac arrest|cardiac arrest
171997|NCT03119571|Ventricular fibrillation|ventricular fibrillation
171998|NCT03119571|coronary artery disease|coronary artery disease
171999|NCT03119545|intervention|intervention
172000|NCT03119545|support program|support program
172001|NCT03119545|family centered|family centered
172002|NCT03119545|parental death|parental death
172003|NCT03119519|NSCLC|nsclc
172004|NCT03119519|Oligometastases|oligometastases
172005|NCT03119519|radiotherapy|radiotherapy
172006|NCT03119493|Metabolic syndrome X|metabolic syndrome x
172007|NCT03119493|Autonomic nervous system|autonomic nervous system
172008|NCT03119493|Aerobic exercise|aerobic exercise
172009|NCT03119493|Exercise|exercise
172010|NCT03119493|Heart rate|heart rate
172011|NCT03119480|Acute Kidney Injury|acute kidney injury
172012|NCT03119480|Electronic alerts|electronic alerts
172013|NCT03119402|Reading|reading
172014|NCT03119402|Developmental Dyslexia|developmental dyslexia
172015|NCT03119402|Music|music
172016|NCT03119402|Rhythm|rhythm
172017|NCT03119402|transcranial electrical stimulation|transcranial electrical stimulation
172018|NCT03119402|transcranial direct current stimulation|transcranial direct current stimulation
172019|NCT03119389|Hand Hygiene|hand hygiene
172020|NCT03119389|Non-sterile glove use|non-sterile glove use
172021|NCT03119376|peer review|peer review
172022|NCT03119376|online tool|online tool
172023|NCT03119376|Randomized Controlled Trial|randomized controlled trial
172024|NCT03119363|cancer-related fatigue|cancer-related fatigue
172025|NCT03119363|circadian rhythms|circadian rhythms
172026|NCT03119363|light therapy|light therapy
172027|NCT03119363|systematic light exposure|systematic light exposure
172028|NCT03119363|cancer survivors|cancer survivors
172029|NCT03119363|oncology|oncology
172030|NCT03119363|Multiple Myeloma|multiple myeloma
172031|NCT03119363|Hematopoietic stem cell transplantation|hematopoietic stem cell transplantation
172032|NCT03119363|Autologous stem cell transplantation|autologous stem cell transplantation
172033|NCT03119337|male circumcision, text-based follow-up, Zimbabwe,|male circumcision, text-based follow-up, zimbabwe,
172034|NCT03119324|Biomodulation|biomodulation
172035|NCT03119324|LLLT|lllt
172036|NCT03119324|Temporomandibular Joint Disorders|temporomandibular joint disorders
172037|NCT03119324|Pain management|pain management
172038|NCT03119285|ovarian cancer|ovarian cancer
172039|NCT03119285|BRCA1|brca1
172040|NCT03119285|BRCA2|brca2
172041|NCT03119285|BROCA|broca
172042|NCT03119246|beta testing|beta testing
172043|NCT03119246|assessment battery|assessment battery
172044|NCT03119246|HD|hd
172045|NCT03119207|ICU|icu
172046|NCT03119168|screening|screening
172047|NCT03119168|adenoma detection rate|adenoma detection rate
172048|NCT03119168|simethicone|simethicone
172049|NCT03119155|Congenital Heart Disease|congenital heart disease
172050|NCT03119155|Echocardiography|echocardiography
172051|NCT03119155|Diagnosis|diagnosis
172052|NCT03119129|prevention|prevention
172053|NCT03119129|health disparities|health disparities
172054|NCT03119129|Native Hawaiians and other Pacific Islanders|native hawaiians and other pacific islanders
172055|NCT03119116|Stroke Prevention in NVAF patients|stroke prevention in nvaf patients
172056|NCT03119103|respiratory pattern|respiratory pattern
172057|NCT03119103|sensor data|sensor data
172058|NCT03119103|bed sheet|bed sheet
172059|NCT03119103|pressure|pressure
172060|NCT03119103|respiration rate|respiration rate
172061|NCT03119090|biomarkers|biomarkers
172062|NCT03119090|Fontan operation|fontan operation
172063|NCT03119090|Single ventricle|single ventricle
172064|NCT03119090|congenital heart disease|congenital heart disease
172065|NCT03119077|PCOS|pcos
172066|NCT03119051|mild cognitive impairment|mild cognitive impairment
172067|NCT03119038|total hip|total hip
172068|NCT03119038|degenerative joint disease|degenerative joint disease
172069|NCT03119038|osteoarthritis|osteoarthritis
172070|NCT03119025|Dendritic Cells|dendritic cells
172071|NCT03119025|DC-based Vaccines|dc-based vaccines
172072|NCT03119025|Chronic HCV Infection|chronic hcv infection
172073|NCT03119025|Antigen-Specific T cell response|antigen-specific t cell response
172074|NCT03119025|Recombinant HCV-Core antigen|recombinant hcv-core antigen
172075|NCT03119025|Recombinant HCV-NS3 antigen|recombinant hcv-ns3 antigen
172076|NCT03119012|Bioresorbable scaffold|bioresorbable scaffold
172077|NCT03119012|Dual antiplatelet therapy|dual antiplatelet therapy
172078|NCT03119012|P2Y12 receptor inhibitor|p2y12 receptor inhibitor
172079|NCT03119012|Coronary artery disease|coronary artery disease
172080|NCT03118986|olanzapine|olanzapine
172081|NCT03118986|vomiting|vomiting
172082|NCT03118986|children|children
172083|NCT03118986|adolescents|adolescents
172084|NCT03118986|bone marrow transplant|bone marrow transplant
172085|NCT03118986|supportive care|supportive care
172086|NCT03118934|contact lenses|contact lenses
172087|NCT03118934|presbyopia|presbyopia
172088|NCT03118934|multifocal|multifocal
172089|NCT03118908|Succinate|succinate
172090|NCT03118908|B complex vitamins|b complex vitamins
172091|NCT03118908|menopause|menopause
172092|NCT03118882|Breast cancer screening|breast cancer screening
172093|NCT03118882|Colorectal Cancer screening|colorectal cancer screening
172094|NCT03118882|Primary prevention|primary prevention
172095|NCT03118882|Lifestyles|lifestyles
172096|NCT03118882|Teachable moment|teachable moment
172097|NCT03118869|Asthma|asthma
172098|NCT03118869|B2 adrenergic receptors|b2 adrenergic receptors
172099|NCT03118869|Polymorphism|polymorphism
172100|NCT03118804|Weaning|weaning
172101|NCT03118804|Mechanical ventilation|mechanical ventilation
172102|NCT03118804|Electrical impedance tomography|electrical impedance tomography
172103|NCT03118804|Tidal distribution|tidal distribution
172104|NCT03118778|Stress Ulcer Prevention|stress ulcer prevention
172105|NCT03118726|LARC|larc
172106|NCT03118726|New Mexico|new mexico
172107|NCT03118726|Contraception|contraception
172108|NCT03118713|Glimepride|glimepride
172109|NCT03118713|Metformin|metformin
172110|NCT03118713|Ipragliflozin|ipragliflozin
172111|NCT03118713|Type 2 Diabetes Mellitus|type 2 diabetes mellitus
172112|NCT03118713|ASP1941|asp1941
172113|NCT03118687|Immune system|immune system
172114|NCT03118674|Interventional, Open-label, PCT, Hepatitis C|interventional, open-label, pct, hepatitis c
172115|NCT03118648|upper limb|upper limb
172116|NCT03118648|functional recovery|functional recovery
172117|NCT03118648|activities of daily living|activities of daily living
172118|NCT03118635|Summer|summer
172119|NCT03118635|Diet|diet
172120|NCT03118635|Physical Activity|physical activity
172121|NCT03118635|Sedentary behavior|sedentary behavior
172122|NCT03118635|Low-income|low-income
172123|NCT03118609|Caregivers|caregivers
172124|NCT03118609|Chronic Pain|chronic pain
172125|NCT03118596|intubation|intubation
172126|NCT03118596|tracheal|tracheal
172127|NCT03118596|airway device|airway device
172128|NCT03118596|supra-glottic airway device|supra-glottic airway device
172129|NCT03118596|fibreoptic scope|fibreoptic scope
172130|NCT03118570|Osteogenesis Imperfecta|osteogenesis imperfecta
172131|NCT03118570|Brittle Bone Disease|brittle bone disease
172132|NCT03118557|pelvic floor|pelvic floor
172133|NCT03118557|strengthening|strengthening
172134|NCT03118557|Stress|stress
172135|NCT03118557|urinary|urinary
172136|NCT03118557|incontinence|incontinence
172137|NCT03118544|Chronic Total Occlusion|chronic total occlusion
172138|NCT03118544|Coronary Artery Disease|coronary artery disease
172139|NCT03118544|Percutaneous Coronary Intervention|percutaneous coronary intervention
172141|NCT03118544|PCI|pci
172142|NCT03118531|Long Lesion|long lesion
172143|NCT03118531|In-stent Late Lumen Loss (LLL)|in-stent late lumen loss (lll)
172144|NCT03118531|Major Adverse Cardiac Events (MACE)|major adverse cardiac events (mace)
172145|NCT03118531|MYOCARDIAL INFARCTION (MI)|myocardial infarction (mi)
172146|NCT03118531|TARGET VESSEL REVASCULARIZATION (TVR)|target vessel revascularization (tvr)
172147|NCT03118531|TARGET LESION REVASCULARIZATION (TLR)|target lesion revascularization (tlr)
172148|NCT03118531|Target Vessel Failure (TVF)|target vessel failure (tvf)
172149|NCT03118531|Target Lesion Failure (TLF)|target lesion failure (tlf)
172150|NCT03118531|Stent Thrombosis (ST)|stent thrombosis (st)
172151|NCT03118479|IHH|ihh
172152|NCT03118479|KS|ks
172153|NCT03118479|Idiopathic hypogonadotropic hypogonadism|idiopathic hypogonadotropic hypogonadism
172154|NCT03118479|GnRH deficiency|gnrh deficiency
172155|NCT03118466|AML|aml
172156|NCT03118453|Musculoskeletal pain/*therapy|musculoskeletal pain/*therapy
172157|NCT03118453|Behavioral medicine|behavioral medicine
172158|NCT03118453|Physical therapy|physical therapy
172159|NCT03118453|Cost-benefit analyses|cost-benefit analyses
172160|NCT03118453|Treatment outcome|treatment outcome
172161|NCT03118453|Adults|adults
172162|NCT03118440|Fluoroscopy|fluoroscopy
172163|NCT03118440|Pacemaker|pacemaker
172164|NCT03118440|Three dimensional|three dimensional
172165|NCT03118440|Radiation|radiation
172166|NCT03118440|Imaging|imaging
172167|NCT03118427|Fluoroscopy|fluoroscopy
172168|NCT03118427|Pacemaker|pacemaker
172169|NCT03118427|Three dimensional|three dimensional
172170|NCT03118427|Radiation|radiation
172171|NCT03118427|Imaging|imaging
172172|NCT03118414|Balance|balance
172173|NCT03118414|Cognition|cognition
172174|NCT03118414|Exercise|exercise
172175|NCT03118362|Burns|burns
172176|NCT03118362|Critically ill|critically ill
172177|NCT03118362|Acid-Base status|acid-base status
172178|NCT03118349|CA19-9 Positive Malignancies|ca19-9 positive malignancies
172179|NCT03118323|willingness topay|willingness topay
172180|NCT03118323|WTP|wtp
172181|NCT03118323|health economic|health economic
172182|NCT03118323|preference-based measures|preference-based measures
172183|NCT03118310|Reduction of liver fat|reduction of liver fat
172184|NCT03118297|Etonogestrel Implant|etonogestrel implant
172185|NCT03118284|Foley catheter|foley catheter
172186|NCT03118271|lumbar disc herniation|lumbar disc herniation
172187|NCT03118271|lumbar traction|lumbar traction
172188|NCT03118271|spinal manipulation|spinal manipulation
172189|NCT03118271|lumbar surgery|lumbar surgery
172190|NCT03118258|Vaginal HPV self-sampling|vaginal hpv self-sampling
172191|NCT03118258|Pap test smear|pap test smear
172192|NCT03118258|cervical cancer screening|cervical cancer screening
172193|NCT03118258|deprivation|deprivation
172194|NCT03118258|sexual and reproductive health|sexual and reproductive health
172195|NCT03118258|Precariousness|precariousness
172196|NCT03118232|Nursing Homes|nursing homes
172197|NCT03118232|Health Facilities|health facilities
172198|NCT03118232|Infections|infections
172199|NCT03118232|Readmissions|readmissions
172200|NCT03118232|Multi-Drug resistance|multi-drug resistance
172201|NCT03118232|Antibiotic Use|antibiotic use
172202|NCT03118219|assisted reproductive technology|assisted reproductive technology
172203|NCT03118219|embryo transfer|embryo transfer
172204|NCT03118219|online intervention|online intervention
172205|NCT03118219|rct|rct
172206|NCT03118206|Lumbar spinal stenosis|lumbar spinal stenosis
172207|NCT03118206|spinal manipulation|spinal manipulation
172208|NCT03118206|physical therapy|physical therapy
172209|NCT03118206|surgery|surgery
172210|NCT03118193|depression|depression
172211|NCT03118193|antidepressant|antidepressant
172212|NCT03118193|resistance|resistance
172213|NCT03118167|Acrylamide|acrylamide
172214|NCT03118167|Tea polyphenols|tea polyphenols
172215|NCT03118167|Water-soluble antioxidant of bamboo leaves|water-soluble antioxidant of bamboo leaves
172216|NCT03118154|endometriosis|endometriosis
172217|NCT03118154|pelvic pain|pelvic pain
172218|NCT03118154|dysmenorrhea|dysmenorrhea
172219|NCT03118141|preimplantation genetic screening|preimplantation genetic screening
172220|NCT03118141|single embryo transfer|single embryo transfer
172221|NCT03118141|frozen embryo transfer|frozen embryo transfer
172222|NCT03118141|cumulative live birth rate|cumulative live birth rate
172223|NCT03118128|Acute Lymphoblastic Leukemia (ALL), ABCB1, Metformin|acute lymphoblastic leukemia (all), abcb1, metformin
172224|NCT03118115|bioimpedance|bioimpedance
172225|NCT03118115|thrombosis|thrombosis
172226|NCT03118115|free flap|free flap
172227|NCT03118115|microsurgerie|microsurgerie
172228|NCT03118115|breast reconstruction|breast reconstruction
172229|NCT03118089|Oral nutritional supplements|oral nutritional supplements
172230|NCT03118050|exercise|exercise
172231|NCT03118050|bed rest|bed rest
172232|NCT03118050|muscle|muscle
172233|NCT03118050|nutrition|nutrition
172234|NCT03118050|amino acids|amino acids
172235|NCT03118037|Radiofrequency Ablation|radiofrequency ablation
172236|NCT03118024|deep inferior epigastric perforator flap|deep inferior epigastric perforator flap
172237|NCT03118024|fluid restriction|fluid restriction
172238|NCT03118024|catecholamine restriction|catecholamine restriction
172239|NCT03118011|Tobacco use, withdrawal symptoms|tobacco use, withdrawal symptoms
172240|NCT03117985|HIV reservoirs|hiv reservoirs
172241|NCT03117985|HIV persistence|hiv persistence
172242|NCT03117985|Viral rebound|viral rebound
172243|NCT03117972|Metastatic colorectal cancer|metastatic colorectal cancer
172244|NCT03117972|Biomarker|biomarker
172245|NCT03117972|Chemotherapy intensification|chemotherapy intensification
172246|NCT03117972|Syndecan1|syndecan1
172248|NCT03117972|CD138|cd138
172249|NCT03117946|immunomonitoring|immunomonitoring
172250|NCT03117946|immune checkpoint|immune checkpoint
172251|NCT03117946|chemoradiation|chemoradiation
172252|NCT03117946|T cells|t cells
172253|NCT03117933|BRCA1/2 mutation|brca1/2 mutation
172254|NCT03117933|Platinum resistance|platinum resistance
172255|NCT03117920|Refractory pancreatic cancer|refractory pancreatic cancer
172256|NCT03117920|Minnelide|minnelide
172257|NCT03117920|Minnelide002|minnelide002
172258|NCT03117920|2017-000126-36|2017-000126-36
172259|NCT03117881|Multiple Sclerosis|multiple sclerosis
172260|NCT03117881|Yoga|yoga
172261|NCT03117881|Pilates|pilates
172262|NCT03117881|Telerehabilitation|telerehabilitation
172263|NCT03117881|Physical activity|physical activity
172264|NCT03117842|Female entertainment workers|female entertainment workers
172265|NCT03117842|mHealth|mhealth
172266|NCT03117842|HIV testing|hiv testing
172267|NCT03117842|Cambodia|cambodia
172268|NCT03117816|deep molecular remission of MR4 or better|deep molecular remission of mr4 or better
172269|NCT03117803|Aneurysm, Intracranial|aneurysm, intracranial
172270|NCT03117803|Registries|registries
172271|NCT03117803|Multicenter Studies|multicenter studies
172272|NCT03117803|People's Republic of China|people's republic of china
172273|NCT03117790|elderly|elderly
172274|NCT03117790|surgery|surgery
172275|NCT03117790|analgesia|analgesia
172276|NCT03117790|dexmedetomidine|dexmedetomidine
172277|NCT03117790|sleep quality|sleep quality
172278|NCT03117751|Leukemia|leukemia
172279|NCT03117751|Lymphoma|lymphoma
172280|NCT03117751|Pediatric|pediatric
172281|NCT03117751|B-Cell|b-cell
172282|NCT03117751|T-Cell|t-cell
172283|NCT03117725|oxidative stress|oxidative stress
172284|NCT03117725|antioxidants|antioxidants
172285|NCT03117725|diminished ovarian reserve|diminished ovarian reserve
172286|NCT03117712|cerebral blood supply|cerebral blood supply
172287|NCT03117712|cardiopulmonary bypass|cardiopulmonary bypass
172288|NCT03117712|open-heart cardiac surgery|open-heart cardiac surgery
172289|NCT03117699|Hemiplegia|hemiplegia
172290|NCT03117699|transport device|transport device
172291|NCT03117673|right ventricular systolic pressure (RVSP)|right ventricular systolic pressure (rvsp)
172292|NCT03117673|Transesophageal echocardiography|transesophageal echocardiography
172293|NCT03117634|anti vegf|anti vegf
172294|NCT03117634|aflibercept|aflibercept
172295|NCT03117634|treat and extend|treat and extend
172296|NCT03117621|Blincyto|blincyto
172297|NCT03117608|OA|oa
172298|NCT03117608|aMAT|amat
172299|NCT03117608|PRP|prp
172300|NCT03117595|Single Shot Spinal|single shot spinal
172301|NCT03117595|Intrathecal narcotics|intrathecal narcotics
172302|NCT03117595|Morphine|morphine
172303|NCT03117595|Fentanyl|fentanyl
172304|NCT03117595|Labour Analgesia|labour analgesia
172305|NCT03117582|C. diff|c. diff
172306|NCT03117582|CDI|cdi
172307|NCT03117582|Clostridium Difficile Infection|clostridium difficile infection
172308|NCT03117582|Diarrhea|diarrhea
172309|NCT03117582|Fecal microbiota transplantation|fecal microbiota transplantation
172310|NCT03117582|FMT|fmt
172311|NCT03117543|Screening|screening
172312|NCT03117530|minocycline|minocycline
172313|NCT03117530|brain inflammation|brain inflammation
172314|NCT03117530|microglia|microglia
172315|NCT03117530|cognition|cognition
172316|NCT03117517|PCOS|pcos
172317|NCT03117504|Stress urinary incontinence|stress urinary incontinence
172318|NCT03117504|SUI|sui
172319|NCT03117491|Gow-Gates nerve block|gow-gates nerve block
172320|NCT03117491|Inferior alveolar nerve block|inferior alveolar nerve block
172321|NCT03117491|local anesthesia|local anesthesia
172322|NCT03117491|molar|molar
172323|NCT03117491|pulpitis|pulpitis
172324|NCT03117452|schizophrenia|schizophrenia
172325|NCT03117452|visual processing|visual processing
172326|NCT03117452|cognitive training|cognitive training
172327|NCT03117452|visual training|visual training
172328|NCT03117426|Symfony Extended Range of Vision IOL|symfony extended range of vision iol
172329|NCT03117426|AT LISA tri 839MP IOL|at lisa tri 839mp iol
172330|NCT03117426|Trifocal IOL|trifocal iol
172331|NCT03117426|Extended depth of focus IOLs|extended depth of focus iols
172332|NCT03117413|Cochlear implantation|cochlear implantation
172333|NCT03117413|Deafness|deafness
172334|NCT03117413|Auditory cortex|auditory cortex
172335|NCT03117413|Auditory plasticity|auditory plasticity
172336|NCT03117413|Tinnitus|tinnitus
172337|NCT03117361|multiple myeloma|multiple myeloma
172338|NCT03117361|plitidepsin|plitidepsin
172339|NCT03117361|Aplidin|aplidin
172340|NCT03117348|Enteral Nutrition|enteral nutrition
172341|NCT03117348|Digestive System Neoplasms|digestive system neoplasms
172342|NCT03117348|Randomized Controlled Trial|randomized controlled trial
172343|NCT03117348|Clinical Outcomes|clinical outcomes
172344|NCT03117335|Non-small Cell Lung Cancer|non-small cell lung cancer
172345|NCT03117335|Sulijia|sulijia
400606|NCT01866046|HIV risk|hiv risk
172346|NCT03117335|Recombinant endostatin|recombinant endostatin
172347|NCT03117335|Vinorelbine|vinorelbine
172348|NCT03117335|Cisplatin|cisplatin
172349|NCT03117322|cerebral palsy|cerebral palsy
172350|NCT03117322|children|children
172351|NCT03117322|chronic constipation|chronic constipation
172352|NCT03117322|synbiotic|synbiotic
172353|NCT03117322|prebiotics|prebiotics
172354|NCT03117322|probiotics|probiotics
172355|NCT03117322|agave inulin|agave inulin
172356|NCT03117322|microbiota|microbiota
172357|NCT03117309|Nivolumab|nivolumab
172358|NCT03117309|Ipilimumab|ipilimumab
172359|NCT03117309|OPDIVO|opdivo
172360|NCT03117309|IgG1 kappa immunoglobulin|igg1 kappa immunoglobulin
172361|NCT03117296|physical therapy|physical therapy
172362|NCT03117296|occupational therapy|occupational therapy
172363|NCT03117296|tAVR|tavr
172364|NCT03117283|Laparoscopic surgery|laparoscopic surgery
172365|NCT03117283|Radical total gastrectomy|radical total gastrectomy
172366|NCT03117283|Bursectomy|bursectomy
172367|NCT03117283|Advanced posterior gastric wall cancer|advanced posterior gastric wall cancer
172368|NCT03117257|Lobaplatin|lobaplatin
172369|NCT03117257|head and neck cancer|head and neck cancer
172370|NCT03117257|chronic-chemotherapy|chronic-chemotherapy
172371|NCT03117231|osteoarthritis|osteoarthritis
172372|NCT03117231|elderly|elderly
172373|NCT03117231|musculoskeletal pain|musculoskeletal pain
172374|NCT03117231|transcranial direct current stimulation|transcranial direct current stimulation
172375|NCT03117192|zinc supplementation|zinc supplementation
172376|NCT03117192|immunity|immunity
172377|NCT03117192|thalassemia|thalassemia
172378|NCT03117166|lidocaine implantation ICD|lidocaine implantation icd
172379|NCT03117140|Brachial Plexus Block|brachial plexus block
172380|NCT03117140|Clonidine|clonidine
172381|NCT03117140|Dexamethasone|dexamethasone
172382|NCT03117140|Buprenorphine|buprenorphine
172383|NCT03117114|colonoscopy|colonoscopy
172384|NCT03117114|polyp|polyp
172385|NCT03117114|resection|resection
172386|NCT03117101|Tolerability Pharmacokinetics|tolerability pharmacokinetics
172387|NCT03117088|Standardized handover|standardized handover
172388|NCT03117088|Online-based|online-based
172389|NCT03117088|SOFA-Score|sofa-score
172390|NCT03117088|ICU|icu
172391|NCT03117088|ISBAR3|isbar3
172392|NCT03117075|cancer pain, wearable device|cancer pain, wearable device
172393|NCT03117036|lymphoma|lymphoma
172394|NCT03117036|cohort|cohort
172395|NCT03117036|serum|serum
172396|NCT03117036|cell-free DNA|cell-free dna
172397|NCT03117023|dexmedetomidine|dexmedetomidine
172398|NCT03117023|sleep deprivation|sleep deprivation
172399|NCT03117023|gastric cancer|gastric cancer
172400|NCT03117023|middle-aged and elderly patient|middle-aged and elderly patient
172401|NCT03117010|Hemophagocytic lymphohistiocytosis|hemophagocytic lymphohistiocytosis
172402|NCT03116997|neuromuscular blockade|neuromuscular blockade
172403|NCT03116997|sugammadex|sugammadex
172404|NCT03116997|SUG|sug
172405|NCT03116997|neostigmine|neostigmine
172406|NCT03116997|NEO/GLYCO|neo/glyco
172407|NCT03116997|17-207|17-207
172408|NCT03116984|Hepatocellular Carcinoma|hepatocellular carcinoma
172409|NCT03116984|external- beam radiotherapy (EBRT)|external- beam radiotherapy (ebrt)
172410|NCT03116984|transarterial chemoembolization (TACE)|transarterial chemoembolization (tace)
172411|NCT03116971|M3814, Small Cell Lung Cancer (SCLC), Deoxyribonucleic acid-dependent protein kinase inhibitor, Chemotherapy|m3814, small cell lung cancer (sclc), deoxyribonucleic acid-dependent protein kinase inhibitor, chemotherapy
172412|NCT03116958|CPAP compliance|cpap compliance
172413|NCT03116958|Telemedicine integrated platform|telemedicine integrated platform
172414|NCT03116958|Standard management|standard management
172415|NCT03116958|Cost-effectiveness|cost-effectiveness
172416|NCT03116945|PET/CT|pet/ct
172417|NCT03116945|68Gallium Citrate|68gallium citrate
172418|NCT03116945|Hepatocellular carcinoma|hepatocellular carcinoma
172419|NCT03116932|HIV prevention, high risk MSM, PrEP|hiv prevention, high risk msm, prep
172420|NCT03116919|nutrition|nutrition
172421|NCT03116919|Potatoes|potatoes
172422|NCT03116919|endothelial function|endothelial function
172423|NCT03116919|feeding trial|feeding trial
172424|NCT03116880|Aorta, Abdominal/surgery|aorta, abdominal/surgery
172425|NCT03116880|Endovascular Procedures|endovascular procedures
172426|NCT03116854|Acute Coronary Syndrome|acute coronary syndrome
172427|NCT03116854|Beta Blockers|beta blockers
172428|NCT03116854|Prognosis|prognosis
172429|NCT03116828|epilepsy|epilepsy
172430|NCT03116828|seizures|seizures
172431|NCT03116828|partial on-set seizures|partial on-set seizures
172432|NCT03116815|blood pressure|blood pressure
172433|NCT03116815|monitoring|monitoring
172434|NCT03116815|hypertension|hypertension
172435|NCT03116815|patient reported outcomes|patient reported outcomes
172436|NCT03116776|walnut shell glasses moxibustion|walnut shell glasses moxibustion
172437|NCT03116776|dry eye|dry eye
172438|NCT03116776|randomized controlled trial|randomized controlled trial
172439|NCT03116750|mechanical thrombectomy|mechanical thrombectomy
172440|NCT03116737|AOM|aom
172441|NCT03116724|catheterization, central venous|catheterization, central venous
400607|NCT01866046|STI risk|sti risk
172442|NCT03116724|jugular veins|jugular veins
172443|NCT03116724|echocardiography, transesophageal|echocardiography, transesophageal
172444|NCT03116672|pain|pain
172445|NCT03116672|Diclofenac|diclofenac
172446|NCT03116672|NSAID|nsaid
172447|NCT03116672|Ketorolac|ketorolac
172448|NCT03116646|mastication|mastication
172449|NCT03116646|cerebral palsy|cerebral palsy
172450|NCT03116646|family|family
172451|NCT03116633|lung cancer|lung cancer
172452|NCT03116633|biopsy|biopsy
172453|NCT03116620|mastication|mastication
172454|NCT03116620|children with neuromuscular disorders|children with neuromuscular disorders
172455|NCT03116607|User satisfaction|user satisfaction
172456|NCT03116607|Readmission|readmission
172457|NCT03116607|Emergency department|emergency department
172458|NCT03116607|Pharmaceutical intervention|pharmaceutical intervention
172459|NCT03116594|Herpes Zoster Vaccine|herpes zoster vaccine
172460|NCT03116594|Prevention of Herpes Zoster|prevention of herpes zoster
172461|NCT03116581|Perceptual Decision|perceptual decision
172462|NCT03116581|Social Cognition|social cognition
172463|NCT03116581|Motivation|motivation
172464|NCT03116568|IBD|ibd
172465|NCT03116568|Meconium|meconium
172466|NCT03116568|Pregnancy|pregnancy
172467|NCT03116568|Microbiota|microbiota
172468|NCT03116568|Newborn|newborn
172469|NCT03116555|Apatinib|apatinib
172470|NCT03116555|Irinotecan|irinotecan
172471|NCT03116555|Second-line|second-line
172472|NCT03116555|Metastatic Gastric Adenocarcinoma|metastatic gastric adenocarcinoma
172473|NCT03116529|Neoadjuvant|neoadjuvant
172474|NCT03116529|Soft Tissue Sarcoma|soft tissue sarcoma
172475|NCT03116529|Immunotherapy|immunotherapy
172476|NCT03116529|Checkpoint Inhibitor|checkpoint inhibitor
172477|NCT03116529|PD-1 (Programmed Cell Death Protein 1)|pd-1 (programmed cell death protein 1)
172478|NCT03116529|PD-L1 (Programmed Death Ligand 1)|pd-l1 (programmed death ligand 1)
172479|NCT03116529|CTLA-4 (Cytotoxic T-Lymphocyte-Associated Protein 4)|ctla-4 (cytotoxic t-lymphocyte-associated protein 4)
172480|NCT03116529|Radiotherapy|radiotherapy
172481|NCT03116529|Durvalumab|durvalumab
172482|NCT03116529|Tremelimumab|tremelimumab
172483|NCT03116529|Surgery|surgery
172484|NCT03116529|Radiation|radiation
172485|NCT03116529|Combined|combined
172486|NCT03116529|Preoperative|preoperative
172487|NCT03116503|Suicide|suicide
172488|NCT03116490|morbidity|morbidity
172489|NCT03116490|mortality|mortality
172490|NCT03116490|hip fracture|hip fracture
172491|NCT03116490|anesthesia type|anesthesia type
172492|NCT03116490|POSSUM|possum
172493|NCT03116451|foot health|foot health
172494|NCT03116451|nurses|nurses
172495|NCT03116451|work well-being|work well-being
172496|NCT03116438|Coronary Artery Disease|coronary artery disease
172497|NCT03116438|Nuclear Stress Test|nuclear stress test
172498|NCT03116438|CT Angiography|ct angiography
172499|NCT03116438|Angiography|angiography
172500|NCT03116425|Precision Medicine|precision medicine
172501|NCT03116425|Functional Neuroimaging|functional neuroimaging
172502|NCT03116425|Transcranial Magnetic Stimulation, Repetitive|transcranial magnetic stimulation, repetitive
172503|NCT03116425|Transcranial Direct Current Stimulation|transcranial direct current stimulation
172504|NCT03116425|Monocentric|monocentric
172505|NCT03116425|Comparative balanced, randomized|comparative balanced, randomized
172506|NCT03116425|double-blind cross-over 3 Arms Study|double-blind cross-over 3 arms study
172507|NCT03116412|Malignant melanoma|malignant melanoma
172508|NCT03116412|Follow up|follow up
172509|NCT03116412|Radiology|radiology
172510|NCT03116412|Survival|survival
172511|NCT03116399|Older adults|older adults
172512|NCT03116399|Social Support|social support
172513|NCT03116399|Technology uptake|technology uptake
172514|NCT03116373|Posture|posture
172515|NCT03116373|Physiology|physiology
172516|NCT03116373|Head|head
172517|NCT03116373|Intubation|intubation
172518|NCT03116373|Intratracheal methods|intratracheal methods
172519|NCT03116334|Obesity|obesity
172520|NCT03116334|BMI|bmi
172521|NCT03116334|executive functioning|executive functioning
172522|NCT03116334|general cognitive ability|general cognitive ability
172523|NCT03116334|twin study|twin study
172524|NCT03116334|heritability|heritability
172525|NCT03116334|cognition|cognition
172526|NCT03116334|GCTA|gcta
172527|NCT03116243|migrant and seasonal head start|migrant and seasonal head start
172528|NCT03116243|early childhood education|early childhood education
172529|NCT03116243|head start|head start
172530|NCT03116230|Knee pathology|knee pathology
172531|NCT03116217|renal function|renal function
172532|NCT03116217|post natal|post natal
172533|NCT03116217|peptidome|peptidome
172534|NCT03116204|Dependency|dependency
172535|NCT03116204|FRC department|frc department
172536|NCT03116204|scale validation|scale validation
172537|NCT03116204|validity|validity
172538|NCT03116204|reliability|reliability
172539|NCT03116178|Fluid therapy|fluid therapy
172540|NCT03116178|oximetry|oximetry
172541|NCT03116178|thromboelastography|thromboelastography
172542|NCT03116178|intraoperative/method|intraoperative/method
172543|NCT03116178|monitoring|monitoring
172544|NCT03116139|Computed tomography scan|computed tomography scan
172545|NCT03116139|Ventilation-perfusion lung scan|ventilation-perfusion lung scan
172546|NCT03116139|Acute kidney injury|acute kidney injury
172547|NCT03116139|Pulmonary embolism|pulmonary embolism
172548|NCT03116139|Contrast-induced nephropathy|contrast-induced nephropathy
172549|NCT03116113|XLRP|xlrp
172550|NCT03116113|Ophthalmology|ophthalmology
172551|NCT03116113|Gene Therapy|gene therapy
172552|NCT03116113|Retinitis Pigmentosa GTPase Regulator (RPGR)|retinitis pigmentosa gtpase regulator (rpgr)
172553|NCT03116113|AAV8|aav8
172554|NCT03116087|Postmenopausal women|postmenopausal women
172555|NCT03116061|Multimorbidity|multimorbidity
172556|NCT03116061|Family Medicine|family medicine
172557|NCT03116061|decompensation|decompensation
172558|NCT03116061|predictive value|predictive value
172559|NCT03116022|menopause|menopause
172560|NCT03116022|sexual dysfunction|sexual dysfunction
172561|NCT03116022|coital pain|coital pain
172562|NCT03116022|vagina|vagina
172563|NCT03116009|Obesity|obesity
172564|NCT03116009|Pregnancy|pregnancy
172565|NCT03116009|Diabetes Mellitus|diabetes mellitus
172566|NCT03116009|Perinatal Outcomes|perinatal outcomes
172567|NCT03115957|Parenteral Nutrition|parenteral nutrition
172568|NCT03115957|Digestive System Neoplasms|digestive system neoplasms
172569|NCT03115957|Randomized Controlled Trials|randomized controlled trials
172570|NCT03115957|Clinical Outcomes|clinical outcomes
172571|NCT03115957|Postoperative Period|postoperative period
172572|NCT03115905|Aneurysmal Subarachnoid Hemorrhage|aneurysmal subarachnoid hemorrhage
172573|NCT03115905|Emergency Medical Services|emergency medical services
172574|NCT03115905|Registry Study|registry study
172575|NCT03115905|China|china
172576|NCT03115866|Healthy Diet|healthy diet
172577|NCT03115866|Fruits and Vegetables|fruits and vegetables
172578|NCT03115866|Metabolome|metabolome
172579|NCT03115866|Microbiome|microbiome
172580|NCT03115866|Young Adults|young adults
172581|NCT03115788|Thermal|thermal
172582|NCT03115788|ipad|ipad
172583|NCT03115788|game|game
172584|NCT03115762|ASKB1202|askb1202
172585|NCT03115749|Crohn's disease|crohn's disease
172586|NCT03115749|ulcerative colitis|ulcerative colitis
172587|NCT03115749|mesenchymal stem cells|mesenchymal stem cells
172588|NCT03115749|intestinal inflammation|intestinal inflammation
172589|NCT03115736|HIV|hiv
172590|NCT03115736|Hepatitis B|hepatitis b
172591|NCT03115736|Renal dysfunction|renal dysfunction
172592|NCT03115736|tenofovir alafenamide|tenofovir alafenamide
172593|NCT03115723|Hospitalization|hospitalization
172594|NCT03115723|Health Care Economics and Organizations|health care economics and organizations
172595|NCT03115710|Keratoconus|keratoconus
172596|NCT03115710|Prevalence|prevalence
172597|NCT03115671|Phosphatidylserine|phosphatidylserine
172598|NCT03115671|Omega-3|omega-3
172599|NCT03115606|videolaryngoscope|videolaryngoscope
172600|NCT03115606|Fastrach LMA|fastrach lma
172601|NCT03115606|cervical motion|cervical motion
172602|NCT03115593|hysteroscopy|hysteroscopy
172603|NCT03115593|pipette|pipette
172604|NCT03115593|biopsy|biopsy
172605|NCT03115593|endometrial cancer|endometrial cancer
172606|NCT03115541|venous thromboembolism prophylaxis|venous thromboembolism prophylaxis
172607|NCT03115541|deep vein thrombosis|deep vein thrombosis
172608|NCT03115541|pulmonary embolus|pulmonary embolus
172609|NCT03115541|esophageal resection|esophageal resection
172610|NCT03115541|incidence|incidence
172611|NCT03115528|Malignant neoplasms of independent (primary) multiple sites|malignant neoplasms of independent (primary) multiple sites
172612|NCT03115528|Medical oncologists|medical oncologists
172613|NCT03115528|Palliative care physicians|palliative care physicians
172614|NCT03115528|Questionnaire|questionnaire
172615|NCT03115528|Survey|survey
172616|NCT03115515|Thyroid Stimulating Hormone|thyroid stimulating hormone
172617|NCT03115489|seizure|seizure
172618|NCT03115489|glutamate activation|glutamate activation
172619|NCT03115489|N-Methyl D-Aspartate|n-methyl d-aspartate
172620|NCT03115489|gamma-aminobutyric acid receptor|gamma-aminobutyric acid receptor
172621|NCT03115489|Ketamine|ketamine
172622|NCT03115463|Neonatal Resuscitation|neonatal resuscitation
172623|NCT03115463|Prematurity|prematurity
172624|NCT03115463|Oxygen|oxygen
172625|NCT03115450|External ventricular drain (EVD)|external ventricular drain (evd)
172626|NCT03115450|Placement of Bolt|placement of bolt
172627|NCT03115437|Body mass|body mass
172628|NCT03115437|Running-related injury|running-related injury
172629|NCT03115437|Sports injury prevention|sports injury prevention
172630|NCT03115437|Impact forces|impact forces
172631|NCT03115437|Epidemiology|epidemiology
172632|NCT03115437|Running biomechanics|running biomechanics
172633|NCT03115437|Sports footwear|sports footwear
172634|NCT03115437|Shoe cushioning|shoe cushioning
172635|NCT03115424|Weight Loss|weight loss
172636|NCT03115424|Bariatric Surgery|bariatric surgery
172637|NCT03115398|Fitness Tracker|fitness tracker
172638|NCT03115398|Activity Monitoring|activity monitoring
172639|NCT03115398|Chemotherapy|chemotherapy
172640|NCT03115398|Radiation Therapy|radiation therapy
172641|NCT03115398|Chemoradiotherapy|chemoradiotherapy
172642|NCT03115359|Chronic Low Back Pain|chronic low back pain
172643|NCT03115359|Opioid Therapy|opioid therapy
172644|NCT03115359|Chronic Pain|chronic pain
172645|NCT03115359|Mindfulness Meditation|mindfulness meditation
172646|NCT03115359|Cognitive Behavioral Therapy|cognitive behavioral therapy
172647|NCT03115359|Opioid-treated Chronic Low Back Pain|opioid-treated chronic low back pain
172648|NCT03115359|CLBP|clbp
172649|NCT03115307|Insemination|insemination
172650|NCT03115307|Luteal phase support|luteal phase support
172651|NCT03115307|Gonadotropin-releasing hormone agonist|gonadotropin-releasing hormone agonist
172652|NCT03115307|Triptorelin|triptorelin
172653|NCT03115268|social support|social support
172654|NCT03115255|retinopathy of prematurity|retinopathy of prematurity
172655|NCT03115255|ranibizumab|ranibizumab
172656|NCT03115255|vascular endothelial growth factor|vascular endothelial growth factor
172657|NCT03115229|Obesity|obesity
172658|NCT03115229|Overweight|overweight
172659|NCT03115229|Physical Activity|physical activity
172660|NCT03115229|Nutrition|nutrition
172661|NCT03115229|Nursing|nursing
172662|NCT03115203|muscle skin|muscle skin
172663|NCT03115203|IRM 3 tesla|irm 3 tesla
172664|NCT03115138|Biopsy|biopsy
172665|NCT03115125|B lymphocyte|b lymphocyte
172666|NCT03115086|Bile Acid Synthesis Disorder|bile acid synthesis disorder
172667|NCT03115086|Zellweger Spectrum Disorder|zellweger spectrum disorder
172668|NCT03115086|Peroxisomal Disorder|peroxisomal disorder
172669|NCT03115086|Cholic Acid|cholic acid
172670|NCT03115086|Cholbam|cholbam
172671|NCT03115086|Kolbam|kolbam
172672|NCT03115086|The Replace Registry|the replace registry
172673|NCT03115073|Vulvovaginal candidiasis|vulvovaginal candidiasis
172674|NCT03115073|Candiplus|candiplus
172675|NCT03115073|Clotrimazole|clotrimazole
172676|NCT03115073|Safety|safety
172677|NCT03115073|Tolerability|tolerability
172678|NCT03115073|Clinical efficacy|clinical efficacy
172679|NCT03115034|carotid stenosis|carotid stenosis
172680|NCT03115034|melatonin|melatonin
172681|NCT03115034|vascular injury|vascular injury
172682|NCT03115034|ischemia reperfusion|ischemia reperfusion
172683|NCT03114995|Tirofiban|tirofiban
172684|NCT03114995|Resistance to antiplatelet agents|resistance to antiplatelet agents
172685|NCT03114982|Prevention of varicella|prevention of varicella
172686|NCT03114982|Varicella-zoster vaccine|varicella-zoster vaccine
172687|NCT03114969|Overall error|overall error
172688|NCT03114969|Error rate|error rate
172689|NCT03114969|Critical error|critical error
172690|NCT03114969|COPD|copd
172691|NCT03114969|ELLIPTA|ellipta
172692|NCT03114969|Dry powder inhaler|dry powder inhaler
172693|NCT03114943|prevention of varicella|prevention of varicella
172694|NCT03114943|Varicella-zoster vaccine|varicella-zoster vaccine
172695|NCT03114917|Suicide|suicide
172696|NCT03114917|Self-harm|self-harm
172697|NCT03114917|Psychosis|psychosis
172698|NCT03114917|Community|community
172699|NCT03114917|Suicide Prevention|suicide prevention
172700|NCT03114917|CBT|cbt
172701|NCT03114917|CARMS|carms
172702|NCT03114917|Randomised controlled trial|randomised controlled trial
172703|NCT03114891|post-traumatic stress|post-traumatic stress
172704|NCT03114891|depression|depression
172705|NCT03114865|bone marrow|bone marrow
172706|NCT03114865|bone marrow transplant|bone marrow transplant
172707|NCT03114865|allogeneic|allogeneic
172708|NCT03114865|tacrolimus|tacrolimus
172709|NCT03114865|cyclophosphamide|cyclophosphamide
172710|NCT03114865|Blinatumomab|blinatumomab
172711|NCT03114839|Lactobacillus casei strain Shirota|lactobacillus casei strain shirota
172712|NCT03114839|Yakult|yakult
172713|NCT03114839|IntelliCap|intellicap
172714|NCT03114761|Roux-en-Y Gastric Bypass|roux-en-y gastric bypass
172715|NCT03114761|Internal Herniation|internal herniation
172716|NCT03114761|Computed Tomography|computed tomography
172717|NCT03114748|deep brain stimulation|deep brain stimulation
172718|NCT03114748|EEG|eeg
172719|NCT03114709|Mindfulness|mindfulness
172720|NCT03114709|Exercise|exercise
172721|NCT03114709|Physical activity|physical activity
172722|NCT03114709|Behavior change|behavior change
172723|NCT03114709|Aging|aging
172724|NCT03114709|Randomized controlled trial|randomized controlled trial
172725|NCT03114709|Pilot|pilot
172726|NCT03114670|Leukemia|leukemia
172727|NCT03114670|Leukemia, Myeloid|leukemia, myeloid
172728|NCT03114670|Recurrence|recurrence
172729|NCT03114670|Neoplasms by Histologic Type|neoplasms by histologic type
172730|NCT03114670|Disease Attributes|disease attributes
172731|NCT03114670|Cyclophosphamide|cyclophosphamide
172732|NCT03114670|Fludarabine|fludarabine
172733|NCT03114670|CD123|cd123
172734|NCT03114670|Chimeric Antigen Receptor modified T-cells|chimeric antigen receptor modified t-cells
172735|NCT03114631|dendritic cells, pancreatic cancer, immunotherapy|dendritic cells, pancreatic cancer, immunotherapy
172736|NCT03114566|transplant donor|transplant donor
172737|NCT03114566|HLA typed|hla typed
172738|NCT03114566|17-211|17-211
172739|NCT03114553|family health history|family health history
172740|NCT03114553|prevention|prevention
220718|NCT02814578|OCT|oct
172741|NCT03114553|genetic risk|genetic risk
172742|NCT03114553|clinical decision support|clinical decision support
172743|NCT03114527|Dedifferentiated liposarcoma|dedifferentiated liposarcoma
172744|NCT03114527|DDL|ddl
172745|NCT03114527|Leiomyosarcoma|leiomyosarcoma
172746|NCT03114527|LMS|lms
172747|NCT03114527|Ribociclib|ribociclib
172748|NCT03114501|Malignant neoplasms of lip oral cavity and pharynx|malignant neoplasms of lip oral cavity and pharynx
172749|NCT03114501|Head and Neck Cancer|head and neck cancer
172750|NCT03114501|Yoga|yoga
172751|NCT03114501|Questionnaires|questionnaires
172752|NCT03114501|Surveys|surveys
172753|NCT03114462|Malignant neoplasms of respiratory and intrathoracic organs|malignant neoplasms of respiratory and intrathoracic organs
172754|NCT03114462|Squamous cell carcinoma of the larynx|squamous cell carcinoma of the larynx
172755|NCT03114462|Stereotactic hypofractionated radioablation|stereotactic hypofractionated radioablation
172756|NCT03114462|HYDRA|hydra
172757|NCT03114462|Questionnaires|questionnaires
172758|NCT03114462|Surveys|surveys
172759|NCT03114423|EMDR|emdr
172760|NCT03114423|Psychotherapy|psychotherapy
172761|NCT03114423|Substance Use Disorders|substance use disorders
172762|NCT03114423|Eye Movement Desensitization and Reprocessing|eye movement desensitization and reprocessing
172763|NCT03114371|Prader-Willi syndrome|prader-willi syndrome
172764|NCT03114371|Oxytocin|oxytocin
172765|NCT03114371|Behavioural troubles|behavioural troubles
172766|NCT03114358|De-escalation|de-escalation
172767|NCT03114358|Carbapenems|carbapenems
172768|NCT03114358|Antimicrobial stewardship|antimicrobial stewardship
172769|NCT03114345|Pressure ulcer|pressure ulcer
172770|NCT03114345|Interface pressure|interface pressure
172771|NCT03114345|Pressure mapping device|pressure mapping device
172772|NCT03114345|Monitoring|monitoring
172773|NCT03114345|Microvascularization|microvascularization
172774|NCT03114319|TNO155|tno155
172775|NCT03114319|SHP2|shp2
172776|NCT03114319|advanced solid tumor|advanced solid tumor
172777|NCT03114319|NSCLC|nsclc
172778|NCT03114319|HNSCC|hnscc
172779|NCT03114319|Colorectal cancer (CRC)|colorectal cancer (crc)
172780|NCT03114319|Esophageal SCC|esophageal scc
172781|NCT03114319|EGFR|egfr
172782|NCT03114319|GIST|gist
172783|NCT03114319|PTPN11|ptpn11
172784|NCT03114319|cancers with a mass|cancers with a mass
172785|NCT03114319|bulky tumor|bulky tumor
172786|NCT03114319|nodule|nodule
172787|NCT03114319|lump|lump
172788|NCT03114319|advanced solid malignancies|advanced solid malignancies
172789|NCT03114306|ERAS|eras
172790|NCT03114306|pain|pain
172791|NCT03114306|knee arthroplasty|knee arthroplasty
172792|NCT03114306|joint pain|joint pain
172793|NCT03114306|regional anaesthesia|regional anaesthesia
172794|NCT03114293|Physical activity|physical activity
172795|NCT03114293|Mobility|mobility
172796|NCT03114254|Recurrent|recurrent
172797|NCT03114254|Locally advanced|locally advanced
172798|NCT03114254|Metastatic|metastatic
172799|NCT03114241|COPD|copd
172800|NCT03114241|Physical activity|physical activity
172801|NCT03114241|Endothelial function|endothelial function
172802|NCT03114228|myeloid|myeloid
172803|NCT03114228|leukemia|leukemia
172804|NCT03114228|FLT3-mutated|flt3-mutated
172805|NCT03114228|PKC412|pkc412
172806|NCT03114228|midostaurin|midostaurin
172807|NCT03114228|adult|adult
172808|NCT03114228|AML|aml
172809|NCT03114228|ETP|etp
172810|NCT03114228|FMS-like tyrosine kinase receptor|fms-like tyrosine kinase receptor
172811|NCT03114228|Acute myeloid leukemia|acute myeloid leukemia
172812|NCT03114215|Biotin|biotin
172813|NCT03114215|MD1003|md1003
172814|NCT03114215|ALSFRS-R|alsfrs-r
172815|NCT03114189|Sleep disturbance|sleep disturbance
172816|NCT03114189|footbath|footbath
172817|NCT03114189|Kneipp|kneipp
172818|NCT03114189|care of sleep|care of sleep
172819|NCT03114189|sleep|sleep
172820|NCT03114150|physical activity|physical activity
172821|NCT03114150|aging|aging
172822|NCT03114150|learning and memory|learning and memory
172823|NCT03114150|exercise|exercise
172824|NCT03114150|brain|brain
172825|NCT03114137|Sub-Saharan Africa|sub-saharan africa
172826|NCT03114137|Sickle Cell Disease|sickle cell disease
172827|NCT03114137|Vasculopathy|vasculopathy
172828|NCT03114137|Nephropathy|nephropathy
172829|NCT03114137|Pulmonary hypertension|pulmonary hypertension
172830|NCT03114137|cardiac disease|cardiac disease
172831|NCT03114137|hemolysis|hemolysis
172832|NCT03114137|pulse wave velocity|pulse wave velocity
172833|NCT03114137|blood viscosity|blood viscosity
172834|NCT03114124|ablation|ablation
172835|NCT03114124|atrioventricular node|atrioventricular node
172836|NCT03114124|microfidelity|microfidelity
172837|NCT03114098|Drug Resistance|drug resistance
172838|NCT03114098|CYP2D6|cyp2d6
172839|NCT03114098|cytochrom P450|cytochrom p450
172840|NCT03114072|Pregnancy|pregnancy
172841|NCT03114072|Blue-blockers|blue-blockers
172842|NCT03114072|Sleep quality|sleep quality
172843|NCT03114072|Melatonin|melatonin
172844|NCT03114059|Late Effects of Surgery|late effects of surgery
172845|NCT03114033|Cardiac Arrest|cardiac arrest
172846|NCT03114033|Intensive Care Unit|intensive care unit
172847|NCT03114033|Therapeutic Mild Hypercapnia|therapeutic mild hypercapnia
172848|NCT03114033|Normocapnia|normocapnia
172849|NCT03114033|Mortality|mortality
172850|NCT03114033|Neurological function|neurological function
172851|NCT03114020|Emphysema|emphysema
172852|NCT03114020|COPD|copd
172853|NCT03114020|Alpha-1 Antitrypsin Deficiency|alpha-1 antitrypsin deficiency
172854|NCT03114007|Mental health problems|mental health problems
172855|NCT03114007|Substance misuse|substance misuse
173253|NCT03111901|MK-3475|mk-3475
172856|NCT03114007|Psychosocial difficulties|psychosocial difficulties
172857|NCT03114007|Youth|youth
172858|NCT03113994|Spinal Cord Injury|spinal cord injury
172859|NCT03113994|Osteoporosis|osteoporosis
172860|NCT03113994|Cardiometabolic Syndrome|cardiometabolic syndrome
172861|NCT03113916|Culturally-tailored|culturally-tailored
172862|NCT03113916|Weight Loss|weight loss
172863|NCT03113916|Diabetes|diabetes
172864|NCT03113916|Women|women
172865|NCT03113916|Hispanic|hispanic
172866|NCT03113916|Obesity|obesity
172867|NCT03113903|Pain|pain
172868|NCT03113903|psychophysics|psychophysics
172869|NCT03113903|Nociception|nociception
172870|NCT03113903|Sensitivity|sensitivity
172871|NCT03113903|Senses|senses
172872|NCT03113903|Phenotyping|phenotyping
172873|NCT03113903|Questionnaire|questionnaire
172874|NCT03113903|Anxiety|anxiety
172875|NCT03113903|Depression|depression
172876|NCT03113903|Catastrophizing|catastrophizing
172877|NCT03113890|pharmacogenetic testing|pharmacogenetic testing
172878|NCT03113890|genomic|genomic
172879|NCT03113890|assay|assay
172880|NCT03113890|PTSD|ptsd
172881|NCT03113890|pharmacodynamic|pharmacodynamic
172882|NCT03113890|pharmacokinetic|pharmacokinetic
172883|NCT03113890|psychiatric disorders|psychiatric disorders
172884|NCT03113864|Vision|vision
172885|NCT03113864|Eye Health|eye health
172886|NCT03113864|Lutein|lutein
172887|NCT03113864|Carotenoids|carotenoids
172888|NCT03113838|Drug-Induced Liver Injury|drug-induced liver injury
172889|NCT03113825|breast carcinoma|breast carcinoma
172890|NCT03113825|DCIS|dcis
172891|NCT03113786|Discectomy|discectomy
172892|NCT03113786|Lumbar discectomy|lumbar discectomy
172893|NCT03113786|Protruding disc|protruding disc
172894|NCT03113747|Allogeneic adipose-derived stem cells|allogeneic adipose-derived stem cells
172895|NCT03113747|burn wounds|burn wounds
172896|NCT03113747|wound healing|wound healing
172897|NCT03113747|regeneration|regeneration
172898|NCT03113747|repair|repair
172899|NCT03113747|skin tissue engineering|skin tissue engineering
172900|NCT03113708|heparin|heparin
172901|NCT03113708|heparin antagonists|heparin antagonists
172902|NCT03113708|cardiac surgery|cardiac surgery
172903|NCT03113708|active clotting time|active clotting time
172904|NCT03113695|Richter's Syndrome|richter's syndrome
172905|NCT03113695|CLL|cll
172906|NCT03113695|Chronic Lumphocytic Leukemia|chronic lumphocytic leukemia
172907|NCT03113695|obinutuzumab|obinutuzumab
172908|NCT03113695|HDMP|hdmp
172909|NCT03113695|lenalidomide|lenalidomide
172910|NCT03113695|cancer|cancer
172911|NCT03113695|methylprednisolone|methylprednisolone
172912|NCT03113643|Acute Myeloid Leukemia|acute myeloid leukemia
172913|NCT03113643|Myelodysplastic Syndrome|myelodysplastic syndrome
172914|NCT03113630|Amyotrophic Lateral Sclerosis|amyotrophic lateral sclerosis
172915|NCT03113630|Virtual Reality Exposure Therapy|virtual reality exposure therapy
172916|NCT03113630|User-Computer Interface|user-computer interface
172917|NCT03113630|Rehabilitation|rehabilitation
172918|NCT03113630|Motor Activity|motor activity
172919|NCT03113591|total hip arthroplasty|total hip arthroplasty
172920|NCT03113591|minimal invasive|minimal invasive
172921|NCT03113578|Balloon enteroscopy|balloon enteroscopy
172922|NCT03113578|colonoscopy|colonoscopy
172923|NCT03113578|polyps|polyps
172924|NCT03113461|cognitive impairment|cognitive impairment
172925|NCT03113461|sleep apnea|sleep apnea
172926|NCT03113461|positive airway pressure therapy|positive airway pressure therapy
172927|NCT03113448|capsaicin|capsaicin
172928|NCT03113448|neuropathic pain|neuropathic pain
172929|NCT03113448|diabetic neuropathy|diabetic neuropathy
172930|NCT03113448|topical lotion|topical lotion
172931|NCT03113435|CO2 gap|co2 gap
172932|NCT03113435|oxygen consumption|oxygen consumption
172933|NCT03113435|Stroke volume optimization|stroke volume optimization
172934|NCT03113422|High Tumor Burden Follicular Lymphoma|high tumor burden follicular lymphoma
172935|NCT03113422|Venetoclax|venetoclax
172936|NCT03113422|Obinutuzumab|obinutuzumab
172937|NCT03113422|Bendamustine|bendamustine
172938|NCT03113422|Bcl-2 Family Protein Inhibitor|bcl-2 family protein inhibitor
172939|NCT03113422|Monoclonal Antibody|monoclonal antibody
172940|NCT03113409|Outpatient detoxification|outpatient detoxification
172941|NCT03113409|Opioid dependence|opioid dependence
172942|NCT03113409|Naltrexone|naltrexone
172943|NCT03113409|Vivitrol|vivitrol
172944|NCT03113409|Buprenorphine|buprenorphine
172945|NCT03113383|Thoracoabdominal Aortic Aneurysm|thoracoabdominal aortic aneurysm
172946|NCT03113383|Endovascular Aneurysm Repair|endovascular aneurysm repair
172947|NCT03113383|Stent-Graft|stent-graft
172948|NCT03113370|n-3 polyunsaturated fatty acids|n-3 polyunsaturated fatty acids
172949|NCT03113370|tobacco use|tobacco use
172950|NCT03113370|postpartum|postpartum
172951|NCT03113357|myofascial release|myofascial release
172952|NCT03113357|cervicogenic headache|cervicogenic headache
172953|NCT03113357|pain intensity|pain intensity
172954|NCT03113357|exercise therapy|exercise therapy
172955|NCT03113357|pressure pain threshold|pressure pain threshold
172956|NCT03113331|Intrauterine growth restriction|intrauterine growth restriction
172957|NCT03113331|Preterm birth|preterm birth
172958|NCT03113331|Birth defect|birth defect
172959|NCT03113331|Infant growth|infant growth
172960|NCT03113331|Neurodevelopmental outcomes|neurodevelopmental outcomes
172961|NCT03113318|Pulmonary neoplasm|pulmonary neoplasm
172962|NCT03113318|Metastasis|metastasis
172963|NCT03113318|colorectal neoplasm|colorectal neoplasm
172964|NCT03113305|Gastric bypass|gastric bypass
172965|NCT03113305|Morbid obesity|morbid obesity
172966|NCT03113305|Food choice|food choice
172967|NCT03113305|Ingestive behaviour|ingestive behaviour
172968|NCT03113292|physical therapy|physical therapy
172969|NCT03113292|therapeutic exercises|therapeutic exercises
172970|NCT03113292|low back pain|low back pain
172971|NCT03113266|anti-PD-1 monoclonal antibody|anti-pd-1 monoclonal antibody
172972|NCT03113266|Metastatic|metastatic
172973|NCT03113266|Advanced|advanced
172974|NCT03113266|Bladder Urothelial Carcinoma|bladder urothelial carcinoma
172975|NCT03113253|Tranexamic Acid|tranexamic acid
172976|NCT03113253|Burn|burn
172977|NCT03113253|Surgery|surgery
172978|NCT03113253|Excision|excision
172979|NCT03113240|Glutamin|glutamin
172980|NCT03113240|Enteral Nutrition|enteral nutrition
172981|NCT03113240|Intensive Care Unit|intensive care unit
172982|NCT03113240|Intestinal Permeability|intestinal permeability
172983|NCT03113227|induction of labor|induction of labor
172984|NCT03113227|Bishop score|bishop score
172985|NCT03113227|posterior cervical angle|posterior cervical angle
172986|NCT03113227|cervical length|cervical length
172987|NCT03113201|Depression|depression
172988|NCT03113201|Collaborative care|collaborative care
172989|NCT03113201|Care manager|care manager
172990|NCT03113201|Anxiety|anxiety
172991|NCT03113201|Psychiatry|psychiatry
172992|NCT03113201|Consultation-liaison|consultation-liaison
172993|NCT03113201|General practitioner|general practitioner
172994|NCT03113175|Anxiety|anxiety
172995|NCT03113175|Collaborative care|collaborative care
172996|NCT03113175|Consultation-liaison|consultation-liaison
172997|NCT03113175|General practitioner|general practitioner
172998|NCT03113175|Psychiatry|psychiatry
172999|NCT03113162|multiple sclerosis|multiple sclerosis
173000|NCT03113162|HSCT|hsct
173001|NCT03113149|Physical Therapy Modalities|physical therapy modalities
173002|NCT03113149|Recovery of Function|recovery of function
173003|NCT03113149|Predictive Value of Tests|predictive value of tests
173004|NCT03113149|Cohort Studies|cohort studies
173005|NCT03113123|Adherence|adherence
173006|NCT03113123|Prevention|prevention
173007|NCT03113123|Tenofovir|tenofovir
173008|NCT03113123|Emtricitabine|emtricitabine
173009|NCT03113123|Antiretroviral|antiretroviral
173010|NCT03113123|Prophylaxis|prophylaxis
173011|NCT03113123|Men who have sex with men|men who have sex with men
173012|NCT03113110|Empagliflozin|empagliflozin
173013|NCT03113110|SGLT-2 Inhibition|sglt-2 inhibition
173014|NCT03113110|Glucose Metabolism|glucose metabolism
173015|NCT03113084|Sodium Heparin|sodium heparin
173016|NCT03113084|Pharmacokinetics|pharmacokinetics
173017|NCT03113084|Coagulation factor|coagulation factor
173018|NCT03113058|HBV infection,γδT cells,Adoptive treatment|hbv infection,γδt cells,adoptive treatment
173019|NCT03113032|total knee replacement|total knee replacement
173020|NCT03113032|sensorimotor training|sensorimotor training
173021|NCT03113032|pre-surgery exercise|pre-surgery exercise
173022|NCT03113032|sensorimotor function|sensorimotor function
173023|NCT03113032|neuromuscular|neuromuscular
173024|NCT03113019|dendritic cell, IL-12, IL-18, сytotoxicity|dendritic cell, il-12, il-18, сytotoxicity
173025|NCT03112993|spine surgery|spine surgery
173026|NCT03112993|neuromuscular blockade|neuromuscular blockade
173027|NCT03112993|sugammadex|sugammadex
173028|NCT03112993|elderly|elderly
173029|NCT03112993|reversal|reversal
173030|NCT03112993|neostigmine|neostigmine
173031|NCT03112993|recovery|recovery
173032|NCT03112980|Aortic Valve Stenosis|aortic valve stenosis
173033|NCT03112980|Transcatheter Aortic Valve Replacement|transcatheter aortic valve replacement
173034|NCT03112980|Surgical aortic valve replacement|surgical aortic valve replacement
173035|NCT03112980|Low to intermediate operative risk|low to intermediate operative risk
173036|NCT03112915|postoperative pain|postoperative pain
173037|NCT03112915|Laparoscopic cholecystectomy|laparoscopic cholecystectomy
173038|NCT03112915|Quadratus lumborum block|quadratus lumborum block
173039|NCT03112915|transversus abdominis plan block|transversus abdominis plan block
173040|NCT03112889|McArdle Disease|mcardle disease
173041|NCT03112889|McArdle's Disease|mcardle's disease
173042|NCT03112889|Glycogen Storage Disease Type V|glycogen storage disease type v
173043|NCT03112889|GSDV|gsdv
173044|NCT03112889|Sodium Valproate|sodium valproate
173045|NCT03112889|Valproic Acid|valproic acid
173046|NCT03112889|Myophosphorylase Deficiency|myophosphorylase deficiency
173047|NCT03112889|Muscle Phosphorylase Deficiency|muscle phosphorylase deficiency
173048|NCT03112889|Glycogenosis|glycogenosis
173049|NCT03112889|Glycogen Storage Disorder|glycogen storage disorder
173050|NCT03112876|younger age|younger age
173051|NCT03112876|older age|older age
173052|NCT03112876|atopic dermatitis|atopic dermatitis
173053|NCT03112876|acne|acne
173054|NCT03112876|smoker|smoker
173055|NCT03112850|Crossover design|crossover design
173056|NCT03112850|Randomized controlled trial|randomized controlled trial
173057|NCT03112850|Aural rehabilitation intervention|aural rehabilitation intervention
173058|NCT03112798|tracheal intubation|tracheal intubation
173059|NCT03112798|Macintosh blade|macintosh blade
173060|NCT03112798|Miller blade|miller blade
173061|NCT03112785|Hip|hip
173062|NCT03112785|Arthroplasty|arthroplasty
173063|NCT03112785|Stem|stem
173064|NCT03112785|Outcome|outcome
173065|NCT03112746|child|child
173066|NCT03112746|goal|goal
173067|NCT03112746|intervention|intervention
173068|NCT03112746|motor skills disorder|motor skills disorder
173069|NCT03112746|occupational therapy|occupational therapy
173070|NCT03112655|diagnosis|diagnosis
173071|NCT03112655|sensitivity|sensitivity
173072|NCT03112655|specificity|specificity
173073|NCT03112655|therapeutic outcome|therapeutic outcome
173074|NCT03112655|cerebrospinal fluid|cerebrospinal fluid
173075|NCT03112629|Quality of Care|quality of care
173076|NCT03112629|aortic stenosis|aortic stenosis
173077|NCT03112629|transcatheter aortic valve implantation|transcatheter aortic valve implantation
173078|NCT03112629|surgical aortic valve replacement|surgical aortic valve replacement
173079|NCT03112629|facilitated data relay|facilitated data relay
173080|NCT03112603|Graft-versus-host disease (GvHD)|graft-versus-host disease (gvhd)
173081|NCT03112603|Chronic GvHD (cGvHD)|chronic gvhd (cgvhd)
173082|NCT03112603|steroid-refractory|steroid-refractory
173083|NCT03112603|ruxolitinib|ruxolitinib
173084|NCT03112603|Janus kinase inhibitor|janus kinase inhibitor
173085|NCT03112590|Histologically confirmed HER2 positive breast cancer|histologically confirmed her2 positive breast cancer
173086|NCT03112590|Unresectable breast cancer|unresectable breast cancer
173087|NCT03112590|Locally advanced breast cancer|locally advanced breast cancer
173088|NCT03112590|Metastatic breast cancer|metastatic breast cancer
173089|NCT03112590|Clinical stage 2-3 early stage breast cancer|clinical stage 2-3 early stage breast cancer
173090|NCT03112564|Endotracheal intubation|endotracheal intubation
173091|NCT03112564|muscle relaxants|muscle relaxants
173092|NCT03112564|inhalational anesthesia|inhalational anesthesia
173093|NCT03112538|insulin pump|insulin pump
173094|NCT03112538|basal bolus insulin|basal bolus insulin
173095|NCT03112525|rivaroxaban|rivaroxaban
173096|NCT03112525|apixaban|apixaban
173097|NCT03112525|cytochrome|cytochrome
173098|NCT03112525|anticoagulant|anticoagulant
173099|NCT03112525|transporter|transporter
173100|NCT03112525|polymorphism|polymorphism
173101|NCT03112525|genotyping|genotyping
173102|NCT03112525|phenotyping|phenotyping
173103|NCT03112512|optimal positive end-expiratory pressure determination|optimal positive end-expiratory pressure determination
173104|NCT03112512|Electrical impedance tomography|electrical impedance tomography
173105|NCT03112499|Acute Kidney Injury|acute kidney injury
173106|NCT03112499|PCNL|pcnl
173107|NCT03112499|mini-PCNL|mini-pcnl
173108|NCT03112499|RIRS|rirs
173109|NCT03112499|urine biomarkers|urine biomarkers
173110|NCT03112486|out-of-hospital cardiac arrest|out-of-hospital cardiac arrest
173111|NCT03112486|neurological outcome|neurological outcome
173112|NCT03112486|prognostication|prognostication
173113|NCT03112486|cerebral performance category|cerebral performance category
173114|NCT03112486|hypoxic-ischemic brain injury|hypoxic-ischemic brain injury
173115|NCT03112486|biomarkers|biomarkers
173116|NCT03112460|Cardiopulmonary Resuscitation|cardiopulmonary resuscitation
173117|NCT03112447|medial epicondyle humerus|medial epicondyle humerus
173118|NCT03112447|absorbable cartilage nail|absorbable cartilage nail
173119|NCT03112421|IVD|ivd
173120|NCT03112408|cerebellar lesion|cerebellar lesion
173121|NCT03112408|saccadic adaptation|saccadic adaptation
173122|NCT03112408|spatial localization|spatial localization
173123|NCT03112408|visuo spatial perception|visuo spatial perception
173124|NCT03112408|eye movements|eye movements
173125|NCT03112369|American Indian / Alaska Native|american indian / alaska native
173126|NCT03112369|HIV Prevention|hiv prevention
173127|NCT03112369|Sexual Risk Behavior|sexual risk behavior
173128|NCT03112369|Trauma|trauma
173129|NCT03112369|Substance Use|substance use
173130|NCT03112356|infectious endocarditis|infectious endocarditis
173131|NCT03112356|prosthetic valve infection|prosthetic valve infection
173132|NCT03112356|implantable cardiac device infection|implantable cardiac device infection
173133|NCT03112356|99mTc-Leukoscan® scintigraphy|99mtc-leukoscan® scintigraphy
173134|NCT03112343|ICT based clinical trial|ict based clinical trial
173135|NCT03112343|Contract research organization (CRO)|contract research organization (cro)
173136|NCT03112343|eCRF|ecrf
173137|NCT03112343|Joint Electronic-institutional review board (eIRB)|joint electronic-institutional review board (eirb)
173138|NCT03112343|Centralized monitoring|centralized monitoring
173139|NCT03112330|atrophic rhinitis|atrophic rhinitis
173140|NCT03112317|Surgery|surgery
173141|NCT03112317|Hypothermia|hypothermia
173142|NCT03112317|Prevention|prevention
173143|NCT03112317|Surgical Site Infection|surgical site infection
173144|NCT03112317|Bleeding|bleeding
173145|NCT03112304|children|children
173146|NCT03112304|youth|youth
173147|NCT03112304|adolescents|adolescents
173148|NCT03112304|anxiety|anxiety
173149|NCT03112304|depression|depression
173150|NCT03112304|trauma|trauma
173151|NCT03112304|behavior problems|behavior problems
173152|NCT03112304|evidence-based treatments|evidence-based treatments
173153|NCT03112304|manualized|manualized
173154|NCT03112304|cognitive-behavioral therapy|cognitive-behavioral therapy
173155|NCT03112304|mental health|mental health
173156|NCT03112291|anti-microbial agents|anti-microbial agents
173157|NCT03112291|apexification|apexification
173158|NCT03112291|dental pulp|dental pulp
173159|NCT03112291|endodontics|endodontics
173160|NCT03112291|root canal therapy|root canal therapy
173161|NCT03112291|dental trauma|dental trauma
173162|NCT03112278|tooth erosion|tooth erosion
173163|NCT03112278|Computer-Aided Design|computer-aided design
173164|NCT03112278|occlusal veneers|occlusal veneers
173165|NCT03112278|dental veneers|dental veneers
173166|NCT03112265|anxiety|anxiety
173167|NCT03112265|depression|depression
173168|NCT03112265|trauma|trauma
173169|NCT03112265|behavior problems|behavior problems
173170|NCT03112265|evidence-based treatments|evidence-based treatments
173171|NCT03112265|manualized treatments|manualized treatments
173172|NCT03112265|cognitive-behavioral therapy|cognitive-behavioral therapy
173173|NCT03112265|youth|youth
173174|NCT03112265|mental health|mental health
173175|NCT03112265|self-regulation|self-regulation
173176|NCT03112265|neuroimaging|neuroimaging
173177|NCT03112252|Immunotherapy|immunotherapy
173178|NCT03112239|Asthma|asthma
173179|NCT03112239|Photobiomodulation|photobiomodulation
173180|NCT03112239|Resistance Training|resistance training
173181|NCT03112226|cognitive impairment|cognitive impairment
173182|NCT03112226|menopause|menopause
173183|NCT03112226|estrogen|estrogen
173184|NCT03112226|functional MRI|functional mri
173185|NCT03112226|executive function|executive function
173186|NCT03112226|endothelial function|endothelial function
173187|NCT03112226|arterial stiffness|arterial stiffness
173188|NCT03112200|Subchondroplasty|subchondroplasty
173189|NCT03112200|Arthroscopy|arthroscopy
173190|NCT03112200|Bone Substitute Material|bone substitute material
173191|NCT03112200|Subchondral Bone Defect|subchondral bone defect
173192|NCT03112200|AccuFill|accufill
173193|NCT03112200|Bone Marrow Lesion|bone marrow lesion
173194|NCT03112200|Knee Replacement|knee replacement
173195|NCT03112200|Knee Replacement Alternative|knee replacement alternative
173196|NCT03112187|IDA|ida
173197|NCT03112187|iron deficiency anemia|iron deficiency anemia
173198|NCT03112187|iron supplements|iron supplements
173199|NCT03112187|Pakistan|pakistan
173200|NCT03112187|Liposomal iron|liposomal iron
173201|NCT03112174|PCYC|pcyc
173202|NCT03112174|MCL|mcl
173203|NCT03112174|Non-Hodgkin's Lymphoma|non-hodgkin's lymphoma
173204|NCT03112174|NHL|nhl
173205|NCT03112174|ibrutinib|ibrutinib
173206|NCT03112174|venetoclax|venetoclax
173207|NCT03112174|Pharmacyclics|pharmacyclics
173208|NCT03112122|Bone Marrow Edema|bone marrow edema
173209|NCT03112122|Mesenchymal Stem Cells|mesenchymal stem cells
173210|NCT03112096|Tau|tau
173211|NCT03112096|neurodegeneration|neurodegeneration
173212|NCT03112096|positron emission tomography|positron emission tomography
173213|NCT03112083|krill powder|krill powder
173214|NCT03112083|krill oil|krill oil
173215|NCT03112083|safety|safety
173216|NCT03112083|tolerability|tolerability
173217|NCT03112083|adverse event|adverse event
173218|NCT03112083|omega-3 fatty acids|omega-3 fatty acids
173219|NCT03112083|eicosapentaenoic acid|eicosapentaenoic acid
173220|NCT03112083|docosahexaenoic acid|docosahexaenoic acid
173221|NCT03112044|Lung|lung
173222|NCT03112044|Transplant|transplant
173223|NCT03112044|Hepatitis C|hepatitis c
173224|NCT03112044|DAAs|daas
173225|NCT03112044|Epclusa|epclusa
173226|NCT03112031|Tamoxifen|tamoxifen
173227|NCT03112031|Cryptococcal meningitis|cryptococcal meningitis
173228|NCT03112031|Cryptococcus neoformans|cryptococcus neoformans
173229|NCT03112031|Human immunodeficiency virus|human immunodeficiency virus
173230|NCT03112018|premature birth|premature birth
173231|NCT03112018|neonatal mortality|neonatal mortality
173232|NCT03112018|premature infant|premature infant
173233|NCT03112005|Diabetic Eye Disease|diabetic eye disease
173234|NCT03111992|Myeloma,|myeloma,
221368|NCT02810795|FFR|ffr
173235|NCT03111992|Multiple Myeloma,|multiple myeloma,
173236|NCT03111992|Hematologic Diseases,|hematologic diseases,
173237|NCT03111992|Myeloma, Multiple,|myeloma, multiple,
173238|NCT03111992|Myeloma-Multiple,|myeloma-multiple,
173239|NCT03111992|Programmed Cell Death 1 Receptor|programmed cell death 1 receptor
173240|NCT03111979|beta-alanine|beta-alanine
173241|NCT03111979|Carnosine|carnosine
173242|NCT03111979|Neuromuscular|neuromuscular
173243|NCT03111979|Stimulation|stimulation
173244|NCT03111979|Skeletal muscle|skeletal muscle
173245|NCT03111966|Hepatitis C|hepatitis c
173246|NCT03111953|Bariatric Surgery|bariatric surgery
173247|NCT03111953|Roux-en-Y gastric bypass|roux-en-y gastric bypass
173248|NCT03111953|Biliopancreatic Diversion|biliopancreatic diversion
173249|NCT03111927|Nutrition, Brain Development, Cognition, Heathy Infants|nutrition, brain development, cognition, heathy infants
173250|NCT03111901|pembrolizumab|pembrolizumab
173251|NCT03111901|IL-2|il-2
173252|NCT03111901|interleukin-2|interleukin-2
173254|NCT03111875|Hypothermia|hypothermia
173255|NCT03111875|Intraoperative warming|intraoperative warming
173256|NCT03111875|non-cardiac surgery|non-cardiac surgery
173257|NCT03111875|myocardial injury|myocardial injury
173258|NCT03111849|COPD|copd
173259|NCT03111849|Sarcopenia|sarcopenia
173260|NCT03111849|Prevalence|prevalence
173261|NCT03111849|Mortality|mortality
173262|NCT03111849|Malnutrition|malnutrition
173263|NCT03111849|Nutritional assessment|nutritional assessment
173264|NCT03111849|Body composition|body composition
173265|NCT03111849|Pulmonary cachexia|pulmonary cachexia
173266|NCT03111810|Corticosteroids|corticosteroids
173267|NCT03111810|Prednisolone|prednisolone
173268|NCT03111810|11 beta-Hydroxysteroid dehydrogenase1 inhibitor|11 beta-hydroxysteroid dehydrogenase1 inhibitor
173269|NCT03111810|Iatrogenic Cushing's disease|iatrogenic cushing's disease
173270|NCT03111810|AZD4017|azd4017
173271|NCT03111784|Fish Consumption, Fatty acid composition, Lipid Profile, Tocopherol, Sociodemographics|fish consumption, fatty acid composition, lipid profile, tocopherol, sociodemographics
173272|NCT03111771|Cancer|cancer
173273|NCT03111771|Cachexia|cachexia
173274|NCT03111771|Myosteatosis|myosteatosis
173275|NCT03111771|Mitochondrial activity|mitochondrial activity
173276|NCT03111771|Upper aerodigestive pathways|upper aerodigestive pathways
173277|NCT03111771|Lipotoxicity|lipotoxicity
173278|NCT03111745|Reactivation or Proliferation of Latent Viral Infections.|reactivation or proliferation of latent viral infections.
173279|NCT03111745|Viral Infection|viral infection
173280|NCT03111745|Lymphoproliferation|lymphoproliferation
173281|NCT03111732|Immune-Based Strategies|immune-based strategies
173282|NCT03111732|Anti-PD1 Therapy|anti-pd1 therapy
173283|NCT03111732|Chronic Inflammation|chronic inflammation
173284|NCT03111732|Combination Chemotherapy|combination chemotherapy
173285|NCT03111693|Epicardial fat|epicardial fat
173286|NCT03111693|Obesity|obesity
173287|NCT03111693|Cardiovascular risks markers|cardiovascular risks markers
173288|NCT03111693|Metabolic syndrome|metabolic syndrome
173289|NCT03111693|Low dose computed tomography|low dose computed tomography
173290|NCT03111667|Marijuana|marijuana
173291|NCT03111667|Motivational Enhancement Therapy|motivational enhancement therapy
173292|NCT03111667|Adolescents|adolescents
173293|NCT03111615|Aromatase inhibitors|aromatase inhibitors
173294|NCT03111615|Luminal Breast Cancer neoadjuvant hormone therapy|luminal breast cancer neoadjuvant hormone therapy
173295|NCT03111602|polyphenols|polyphenols
173296|NCT03111602|pregnant|pregnant
173297|NCT03111602|fetal ductal constriction|fetal ductal constriction
173298|NCT03111602|prostaglandin E2|prostaglandin e2
173299|NCT03111589|Sickle Cell Disease|sickle cell disease
173300|NCT03111589|Heme oxidase-1 (HO-1)|heme oxidase-1 (ho-1)
173301|NCT03111537|cigarette|cigarette
173302|NCT03111537|smoking|smoking
173303|NCT03111537|e-cigarette|e-cigarette
173304|NCT03111537|nicotine replacement therapy|nicotine replacement therapy
173305|NCT03111537|nrt|nrt
173306|NCT03111537|tobacco|tobacco
173307|NCT03111524|stuttering|stuttering
173308|NCT03111524|children who stutter|children who stutter
173309|NCT03111524|peer attitudes|peer attitudes
173310|NCT03111524|classroom-based intervention|classroom-based intervention
173311|NCT03111524|teasing|teasing
173312|NCT03111524|bullying|bullying
173313|NCT03111498|Vacuum assisted delivery|vacuum assisted delivery
173314|NCT03111498|technical skills|technical skills
173315|NCT03111498|training|training
173316|NCT03111459|endograft repair,|endograft repair,
173317|NCT03111433|Type 1 Diabetes mellitus|type 1 diabetes mellitus
173318|NCT03111433|Coenzyme Q10|coenzyme q10
173319|NCT03111433|endothelial dysfunction|endothelial dysfunction
173320|NCT03111433|pediatric patients|pediatric patients
173321|NCT03111407|primary total knee arthroplasty|primary total knee arthroplasty
173323|NCT03111394|23andMe|23andme
173324|NCT03111394|MRI|mri
173325|NCT03111394|Genome-wide association studies|genome-wide association studies
173326|NCT03111368|eus-fna|eus-fna
173327|NCT03111368|pancreatic neoplasm|pancreatic neoplasm
173328|NCT03111368|slow-pull|slow-pull
221509|NCT02810028|ACT|act
173329|NCT03111368|negative pressure|negative pressure
173330|NCT03111355|nuts|nuts
173331|NCT03111355|micronutrients|micronutrients
173332|NCT03111355|nutrigenomics|nutrigenomics
173333|NCT03111355|nutrigenetics|nutrigenetics
173334|NCT03111342|Intrauterine contraception|intrauterine contraception
173335|NCT03111342|Pain|pain
173336|NCT03111342|Anesthesia|anesthesia
173337|NCT03111342|LNG-IUD|lng-iud
173338|NCT03111342|nulligravida|nulligravida
173339|NCT03111329|Gastric residuals assessment|gastric residuals assessment
173340|NCT03111329|Prematurity|prematurity
173341|NCT03111329|Necrotizing Enterocolitis of Newborn|necrotizing enterocolitis of newborn
173342|NCT03111329|Sepsis Newborn|sepsis newborn
173343|NCT03111329|Nutrition of newborn|nutrition of newborn
173344|NCT03111329|feeding tolerance of newborn|feeding tolerance of newborn
173345|NCT03111316|Cervical Ripening|cervical ripening
173346|NCT03111316|Induction of Labor|induction of labor
173347|NCT03111290|Facial recognition|facial recognition
173348|NCT03111277|neuropathic pain|neuropathic pain
173349|NCT03111264|Overweight|overweight
173350|NCT03111264|Obesity|obesity
173351|NCT03111264|Prevention|prevention
173352|NCT03111264|Children|children
173353|NCT03111264|Childcare|childcare
173354|NCT03111264|Physical Activity|physical activity
173355|NCT03111264|Nutrition|nutrition
173356|NCT03111264|Wellness|wellness
173357|NCT03111264|Environment|environment
173358|NCT03111264|Intervention|intervention
173359|NCT03111264|Feeding|feeding
173360|NCT03111238|Autologous|autologous
173361|NCT03111238|Bone Marrow-derived Mononuclear Cells (BM-MNCs)|bone marrow-derived mononuclear cells (bm-mncs)
173362|NCT03111238|Advanced Therapy Medicinal Product (ATMP)|advanced therapy medicinal product (atmp)
173363|NCT03111238|Tissue-engineered Medicinal Product|tissue-engineered medicinal product
173364|NCT03111238|Revascularization|revascularization
173365|NCT03111238|Angiogenesis|angiogenesis
173366|NCT03111238|Vasculogenesis|vasculogenesis
173367|NCT03111238|Arteriogenesis|arteriogenesis
173368|NCT03111212|Acute respiratory distress syndrome|acute respiratory distress syndrome
173369|NCT03111199|Low back pain|low back pain
173370|NCT03111199|Analgesia|analgesia
173371|NCT03111199|Physical therapy|physical therapy
173372|NCT03111186|oxycodone|oxycodone
173373|NCT03111186|ibuprofen|ibuprofen
173374|NCT03111186|acetaminophen|acetaminophen
173375|NCT03111186|soft-tissue hand surgery|soft-tissue hand surgery
173376|NCT03111186|carpal tunnel release|carpal tunnel release
173377|NCT03111186|Dupuytren contracture release|dupuytren contracture release
173378|NCT03111186|Trigger digit release|trigger digit release
173379|NCT03111186|Ganglion cyst removal|ganglion cyst removal
173380|NCT03111186|De Quervain's release|de quervain's release
173381|NCT03111173|ECG|ecg
173382|NCT03111173|Fetus|fetus
173383|NCT03111173|R peak extraction|r peak extraction
173384|NCT03111160|Small-incision lenticule extraction|small-incision lenticule extraction
173385|NCT03111160|femtosecond laser|femtosecond laser
173386|NCT03111160|lower laser energy level|lower laser energy level
173387|NCT03111160|early visual recovery|early visual recovery
173388|NCT03111134|abdominal wound closure techniques|abdominal wound closure techniques
173389|NCT03111134|layered closure|layered closure
173390|NCT03111134|component separation technique|component separation technique
173391|NCT03111121|deeply anesthetized|deeply anesthetized
173392|NCT03111121|ideal surgical exposure|ideal surgical exposure
173393|NCT03111121|muscle relaxation|muscle relaxation
173394|NCT03111121|Adults|adults
173395|NCT03111069|Malignant neoplasms of mesothelial and soft tissue|malignant neoplasms of mesothelial and soft tissue
173396|NCT03111069|Pelvic and Abdominal Rhabdomyosarcoma|pelvic and abdominal rhabdomyosarcoma
173397|NCT03111069|Undifferentiated Sarcomas|undifferentiated sarcomas
173398|NCT03111069|Unresectable or Refractory|unresectable or refractory
173399|NCT03111069|Abdominal tumors|abdominal tumors
173400|NCT03111069|Hyperthermic intra-peritoneal chemotherapy|hyperthermic intra-peritoneal chemotherapy
173401|NCT03111069|HIPEC|hipec
173402|NCT03111069|Abdominal surgery|abdominal surgery
173403|NCT03111069|Doxorubicin|doxorubicin
173404|NCT03111069|Doxorubicin Hydrochloride|doxorubicin hydrochloride
173405|NCT03111069|Adriamycin PFS|adriamycin pfs
173406|NCT03111069|Adriamycin RDF|adriamycin rdf
173407|NCT03111069|Adriamycin|adriamycin
173408|NCT03111069|Rubex|rubex
173409|NCT03111069|Intra-operative radiation|intra-operative radiation
173410|NCT03111069|IORT|iort
173411|NCT03111069|Brachytherapy|brachytherapy
173412|NCT03111043|computed tomography|computed tomography
173413|NCT03111043|Sudden cardiac arrest|sudden cardiac arrest
173414|NCT03111043|Cardiac computed tomography|cardiac computed tomography
173415|NCT03111043|Diagnostic accuracy|diagnostic accuracy
173416|NCT03111043|Clinical outcome|clinical outcome
173417|NCT03111017|muscle sympathetic nerve activity|muscle sympathetic nerve activity
173418|NCT03111017|exercise tolerance|exercise tolerance
173419|NCT03111017|exercise training|exercise training
173420|NCT03111017|peak oxygen uptake|peak oxygen uptake
173421|NCT03111004|information technology|information technology
173422|NCT03111004|telemedicine|telemedicine
173423|NCT03111004|integrated care|integrated care
173424|NCT03111004|MAST framework|mast framework
173425|NCT03111004|organizational change|organizational change
173426|NCT03111004|social care|social care
173427|NCT03111004|elderly patients|elderly patients
173428|NCT03110991|Depression|depression
173429|NCT03110991|Depressive symptoms|depressive symptoms
173430|NCT03110991|Prevention|prevention
173431|NCT03110991|Non-professional caregivers|non-professional caregivers
173432|NCT03110991|App|app
173433|NCT03110913|Healthy|healthy
173434|NCT03110913|Men|men
173435|NCT03110913|Adults|adults
173436|NCT03110913|Methionine|methionine
173437|NCT03110887|Dynamic prediction model|dynamic prediction model
173438|NCT03110822|Ruxolitinib|ruxolitinib
173439|NCT03110822|Steroids|steroids
173440|NCT03110822|Lenalidomide|lenalidomide
173441|NCT03110822|Relapsed/Refractory Multiple Myeloma|relapsed/refractory multiple myeloma
173442|NCT03110809|obesity|obesity
173443|NCT03110809|brown|brown
173444|NCT03110809|fat|fat
173445|NCT03110809|weight|weight
173446|NCT03110809|loss|loss
173447|NCT03110783|Bioseal as an Adjunct to Sutured Dural Repair|bioseal as an adjunct to sutured dural repair
173448|NCT03110783|elective posterior fossa|elective posterior fossa
173449|NCT03110783|supratentorial procedure|supratentorial procedure
173450|NCT03110770|Flavivirus|flavivirus
173452|NCT03110770|Vaccine|vaccine
173453|NCT03110770|Physiological Effects of Drugs|physiological effects of drugs
173454|NCT03110770|Immunologic Factors|immunologic factors
173455|NCT03110770|Virus-like Particles|virus-like particles
173456|NCT03110770|Zika vaccine|zika vaccine
173457|NCT03110757|AP 10-701|ap 10-701
173458|NCT03110757|healthy adults|healthy adults
173459|NCT03110757|Immunogenicity|immunogenicity
173460|NCT03110757|Phase Ib|phase ib
173461|NCT03110757|Reactogenicity|reactogenicity
173462|NCT03110757|Safety|safety
173463|NCT03110757|Schistosomiasis|schistosomiasis
173464|NCT03110757|Sm-TSP-2/Alhydrogel®|sm-tsp-2/alhydrogel®
173465|NCT03110718|robotic rehabilitation|robotic rehabilitation
173466|NCT03110718|muscle vibration|muscle vibration
173467|NCT03110718|combined approach|combined approach
173468|NCT03110679|osteoarthritis|osteoarthritis
173469|NCT03110679|autologous bone marrow concentrate|autologous bone marrow concentrate
173470|NCT03110666|knee osteoarthritis ,|knee osteoarthritis ,
173471|NCT03110666|bone marrow aspirate|bone marrow aspirate
173472|NCT03110666|injections|injections
173473|NCT03110627|Single-chamber ICD (implantable cardioverter-defibrillator)|single-chamber icd (implantable cardioverter-defibrillator)
173474|NCT03110627|Cardiac Arrhythmias|cardiac arrhythmias
173475|NCT03110627|Atrial fibrillation|atrial fibrillation
173476|NCT03110627|Atrial flutter|atrial flutter
173477|NCT03110627|Stroke|stroke
173478|NCT03110614|COPD|copd
173479|NCT03110614|acute|acute
173480|NCT03110614|exacerbation|exacerbation
173481|NCT03110614|lung ultrasound|lung ultrasound
173482|NCT03110588|metastatic prostate cancer|metastatic prostate cancer
173483|NCT03110588|castration-resistant prostate cancer|castration-resistant prostate cancer
173484|NCT03110588|PACE (Prednisone, Abiraterone, Cabazitaxel, and Enzalutamide)|pace (prednisone, abiraterone, cabazitaxel, and enzalutamide)
173485|NCT03110575|TNX-102 SL|tnx-102 sl
173486|NCT03110575|Bedtime|bedtime
173487|NCT03110575|Sublingual|sublingual
173488|NCT03110575|3-month|3-month
173489|NCT03110575|Safety|safety
173490|NCT03110575|Efficacy|efficacy
173491|NCT03110575|PTSD|ptsd
173492|NCT03110562|Relapsed or Refractory Multiple Myeloma|relapsed or refractory multiple myeloma
173493|NCT03110562|RRMM|rrmm
173494|NCT03110562|Bortezomib|bortezomib
173495|NCT03110562|Dexamethasone|dexamethasone
173496|NCT03110536|Burnout syndrome|burnout syndrome
173497|NCT03110536|Triage|triage
173498|NCT03110536|Nurse|nurse
173499|NCT03110536|Emergency Department|emergency department
173500|NCT03110536|Romania|romania
173501|NCT03110497|Cervical cancer|cervical cancer
173502|NCT03110497|Image guided Brachytherapy|image guided brachytherapy
173503|NCT03110497|single application|single application
173504|NCT03110471|Cognitive impairment|cognitive impairment
173505|NCT03110471|antipsychotics|antipsychotics
173506|NCT03110471|antidepressants|antidepressants
173507|NCT03110458|Acute unilateral vestibulopathy, AUV|acute unilateral vestibulopathy, auv
173508|NCT03110419|Elderly|elderly
173509|NCT03110419|Frailty|frailty
173510|NCT03110419|Multicomponent training|multicomponent training
173511|NCT03110419|Physical exercise|physical exercise
173512|NCT03110419|Functional capacity|functional capacity
173513|NCT03110419|Complexity|complexity
173514|NCT03110419|Physical Therapy|physical therapy
173515|NCT03110406|renal transplant recipients|renal transplant recipients
173516|NCT03110406|exercise|exercise
173517|NCT03110406|heart rate variability|heart rate variability
173518|NCT03110406|Cardiovascular mortality|cardiovascular mortality
173519|NCT03110393|Obese|obese
173520|NCT03110393|Laryngeal Mask Airway|laryngeal mask airway
173521|NCT03110393|Anaesthesia|anaesthesia
173522|NCT03110354|AML|aml
173523|NCT03110354|ALL|all
173524|NCT03110354|Enhancer of zeste homolog (EZH) inhibitor|enhancer of zeste homolog (ezh) inhibitor
173525|NCT03110354|DS-3201b|ds-3201b
173526|NCT03110315|Multiple Sclerosis|multiple sclerosis
173527|NCT03110315|Fatigue|fatigue
173528|NCT03110315|Insomnia|insomnia
173529|NCT03110315|Suvorexant|suvorexant
173530|NCT03110315|Belsomra|belsomra
173531|NCT03110315|Sleep disorder|sleep disorder
173532|NCT03110315|Sleep|sleep
173533|NCT03110302|Posttraumatic Stress Disorder|posttraumatic stress disorder
173534|NCT03110302|Telehealth|telehealth
173535|NCT03110302|Video teleconferencing|video teleconferencing
173536|NCT03110302|In home therapy|in home therapy
173537|NCT03110302|Prolonged Exposure|prolonged exposure
173538|NCT03110289|Fecal microbiota transplantation|fecal microbiota transplantation
173539|NCT03110250|Familial Hypercholesterolemia|familial hypercholesterolemia
173540|NCT03110250|registry|registry
173541|NCT03110250|Turkey|turkey
173542|NCT03110250|Lipid lowering therapy|lipid lowering therapy
173543|NCT03110224|Subchondroplasty|subchondroplasty
173544|NCT03110224|Bone Marrow Lesion|bone marrow lesion
173545|NCT03110224|Arthroscopy|arthroscopy
173546|NCT03110224|Bone Substitute Material|bone substitute material
173547|NCT03110224|AccuFill|accufill
173548|NCT03110224|Subchondral Bone Defect|subchondral bone defect
173549|NCT03110198|Mesalazine|mesalazine
173550|NCT03110198|Ulcerative Colitis(UC)|ulcerative colitis(uc)
173551|NCT03110198|Enema|enema
173552|NCT03110172|Osteoarthritis|osteoarthritis
173553|NCT03110172|Depression|depression
173554|NCT03110172|Pain|pain
173555|NCT03110159|Photodynamic therapy|photodynamic therapy
173556|NCT03110159|Prevention|prevention
173557|NCT03110159|Actinic Keratosis|actinic keratosis
173558|NCT03110159|Skin Cancer|skin cancer
173559|NCT03110159|Non-melanoma Skin Cancer|non-melanoma skin cancer
173560|NCT03110159|Sun Damaged Skin|sun damaged skin
173561|NCT03110159|Solid Organ Transplant|solid organ transplant
173562|NCT03110159|PDT|pdt
173563|NCT03110133|Clostridium Difficile Infection|clostridium difficile infection
173564|NCT03110133|CP101|cp101
173565|NCT03110133|Crestovo|crestovo
173566|NCT03110133|FMT|fmt
173567|NCT03110133|CDI|cdi
173568|NCT03110133|C. difficile|c. difficile
173569|NCT03110133|C. diff|c. diff
173570|NCT03110133|Recurrent Clostridium Difficile Infection|recurrent clostridium difficile infection
173571|NCT03110133|Recurrent C. diff|recurrent c. diff
173572|NCT03110133|Recurrent CDI|recurrent cdi
173573|NCT03110133|Finch|finch
173574|NCT03110133|Fecal transplant|fecal transplant
173575|NCT03110133|Open Biome|open biome
173576|NCT03110133|Openbiome|openbiome
173577|NCT03110133|Fecal microbiota transplant|fecal microbiota transplant
173578|NCT03110133|rCDI|rcdi
173579|NCT03110068|microvascular invasion|microvascular invasion
173580|NCT03110068|serum biomarker|serum biomarker
173581|NCT03110068|radiological feature|radiological feature
173582|NCT03110068|pathological differentiation|pathological differentiation
173583|NCT03110003|Neuraxial epidural techniques|neuraxial epidural techniques
173584|NCT03110003|Combined spinal epidural|combined spinal epidural
173585|NCT03110003|Epidural volume extension|epidural volume extension
173586|NCT03110003|Transient Neurologic Symptoms (TNS)|transient neurologic symptoms (tns)
173587|NCT03109977|17-059|17-059
173588|NCT03109977|Zr-DFO-pertuzumab|zr-dfo-pertuzumab
173589|NCT03109951|Type 2 diabetes|type 2 diabetes
173590|NCT03109951|colonoscopy|colonoscopy
173591|NCT03109951|hypoglycemia|hypoglycemia
173592|NCT03109951|hyperglycemia|hyperglycemia
173593|NCT03109951|polyethylene glycol|polyethylene glycol
173594|NCT03109925|PAE|pae
173595|NCT03109925|embolization|embolization
173596|NCT03109925|non-surgical|non-surgical
173597|NCT03109925|prostate artery embolization|prostate artery embolization
173598|NCT03109925|radio-opaque embolic|radio-opaque embolic
173599|NCT03109899|mHealth|mhealth
173600|NCT03109899|HIV Prevention|hiv prevention
173601|NCT03109886|Unresectable Hepatocellular Carcinoma|unresectable hepatocellular carcinoma
173602|NCT03109886|Metastatic Hepatocellular Carcinoma|metastatic hepatocellular carcinoma
173603|NCT03109886|Child-Pugh Class A|child-pugh class a
173604|NCT03109860|Chronic neuropathic pain|chronic neuropathic pain
173605|NCT03109834|Weight Management Programs|weight management programs
173606|NCT03109834|Weight loss stabilization|weight loss stabilization
173607|NCT03109834|Cardiometabolic risk|cardiometabolic risk
173608|NCT03109821|Exercise Therapy|exercise therapy
173609|NCT03109821|Rehabilitation|rehabilitation
173610|NCT03109782|Spinal Cord Injury|spinal cord injury
173611|NCT03109782|Spine Surgery|spine surgery
173612|NCT03109782|Patient Registry|patient registry
173613|NCT03109782|Trauma|trauma
173614|NCT03109743|HIV treatment|hiv treatment
173615|NCT03109743|Adherence Group Treatment|adherence group treatment
173616|NCT03109717|Treatment Resistant Depression|treatment resistant depression
173617|NCT03109704|scapular kinematics|scapular kinematics
173618|NCT03109704|thoracic spine|thoracic spine
173619|NCT03109704|thrust manipulation|thrust manipulation
173620|NCT03109652|total knee replacement arthroplasty|total knee replacement arthroplasty
173621|NCT03109652|total knee arthroplasty|total knee arthroplasty
173622|NCT03109652|tranexamic acid|tranexamic acid
173623|NCT03109652|oral tranexamic acid|oral tranexamic acid
173624|NCT03109652|transfusion|transfusion
173625|NCT03109652|blood loss|blood loss
173626|NCT03109639|EUS|eus
173627|NCT03109639|FNA|fna
173628|NCT03109639|FNB|fnb
173629|NCT03109639|Core Histology|core histology
173630|NCT03109626|DHA, replacement, treatment, brain PET-FDG, ataxia|dha, replacement, treatment, brain pet-fdg, ataxia
173631|NCT03109613|Positive end-expiratory pressure|positive end-expiratory pressure
173632|NCT03109613|PEEP|peep
173633|NCT03109613|Bronchopulmonary Dysplasia|bronchopulmonary dysplasia
173634|NCT03109613|Ventilator Induced Lung Injury|ventilator induced lung injury
173635|NCT03109613|V/Q mismatch|v/q mismatch
173636|NCT03109522|axillary reverse mapping (ARM)|axillary reverse mapping (arm)
173637|NCT03109522|sentinel lymph node biopsy (SLNB)|sentinel lymph node biopsy (slnb)
173638|NCT03109522|axillary lymph node dissection (ALND)|axillary lymph node dissection (alnd)
173639|NCT03109522|lymphedema|lymphedema
173640|NCT03109522|breast cancer|breast cancer
173641|NCT03109522|surgery|surgery
173642|NCT03109496|OME|ome
173643|NCT03109496|Otitis Media with Effusion|otitis media with effusion
173644|NCT03109496|Microbiota|microbiota
173645|NCT03109496|Microbiome|microbiome
173646|NCT03109496|URT|urt
173747|NCT03108872|Stroke|stroke
173647|NCT03109496|Upper Respiratory Tract|upper respiratory tract
173648|NCT03109496|Healthy URT microbiota|healthy urt microbiota
173649|NCT03109483|geriatric patients|geriatric patients
173650|NCT03109483|elderly|elderly
173651|NCT03109483|multicomponent physical therapy|multicomponent physical therapy
173652|NCT03109470|Tocilizumab|tocilizumab
173653|NCT03109470|Early Rheumatoid Arthritis|early rheumatoid arthritis
173654|NCT03109470|Observational|observational
173655|NCT03109470|Canadian|canadian
173656|NCT03109457|Hepatitis C Virus|hepatitis c virus
173657|NCT03109457|Oral squamous cell carcinoma|oral squamous cell carcinoma
173658|NCT03109444|Hip Growth Chart|hip growth chart
173659|NCT03109431|HIV Treatment Continuum|hiv treatment continuum
173660|NCT03109431|HIV Disease Progression|hiv disease progression
173661|NCT03109431|Mental Health|mental health
173662|NCT03109431|Substance Use|substance use
173663|NCT03109431|ARV Adherence|arv adherence
173664|NCT03109431|Retention in Care|retention in care
173665|NCT03109431|STI|sti
173666|NCT03109418|Ketamine|ketamine
173667|NCT03109418|Postoperative morbidity|postoperative morbidity
173668|NCT03109353|Photopheresis|photopheresis
173669|NCT03109353|5-aminolevulinic acid|5-aminolevulinic acid
173670|NCT03109353|Extracorporeal Circulation|extracorporeal circulation
173671|NCT03109340|abdominal obesity|abdominal obesity
173672|NCT03109340|walking|walking
173673|NCT03109340|aerobic exercise|aerobic exercise
173674|NCT03109314|amblyopia|amblyopia
173675|NCT03109314|donepezil|donepezil
173676|NCT03109314|perceptual learning|perceptual learning
173677|NCT03109314|crowding|crowding
173678|NCT03109314|contrast sensitivity|contrast sensitivity
173679|NCT03109314|visual acuity|visual acuity
173680|NCT03109301|Mesenchymal Neoplasm|mesenchymal neoplasm
173681|NCT03109301|Neurofibromatosis 1|neurofibromatosis 1
173682|NCT03109301|Plexiform Neurofibromas|plexiform neurofibromas
173683|NCT03109288|Targeted Therapy|targeted therapy
173684|NCT03109288|Multiple Sclerosis|multiple sclerosis
173685|NCT03109288|Biomarkers|biomarkers
173686|NCT03109288|Combination Therapy|combination therapy
173687|NCT03109288|Progressive Multiple Sclerosis|progressive multiple sclerosis
173688|NCT03109184|Dating violence prevention|dating violence prevention
173689|NCT03109184|Adolescent boys|adolescent boys
173690|NCT03109184|Middle school|middle school
173691|NCT03109184|Web-based prevention|web-based prevention
173692|NCT03109171|Endoscopy|endoscopy
173693|NCT03109171|Lasers|lasers
173694|NCT03109171|Fiber Optic Technology|fiber optic technology
173695|NCT03109171|Bronchoscopy|bronchoscopy
173696|NCT03109171|Esthesiometer|esthesiometer
173697|NCT03109171|Mechanoreceptors|mechanoreceptors
173698|NCT03109171|Diagnosis|diagnosis
173699|NCT03109171|Reflex|reflex
173700|NCT03109171|Reproducibility of Results|reproducibility of results
173701|NCT03109171|Reliability of Results|reliability of results
173702|NCT03109171|Validity of Results|validity of results
173703|NCT03109171|Sensory Thresholds|sensory thresholds
173704|NCT03109158|squamous cell carcinoma|squamous cell carcinoma
173705|NCT03109158|head|head
173706|NCT03109158|neck|neck
173707|NCT03109145|Shared decision making|shared decision making
173708|NCT03109145|Knowledge|knowledge
173709|NCT03109145|Patient portal|patient portal
173710|NCT03109145|Secure messaging|secure messaging
173711|NCT03109119|genomic instability|genomic instability
173712|NCT03109119|Sevoflurane|sevoflurane
173713|NCT03109119|General anaesthesia|general anaesthesia
173714|NCT03109106|MICU|micu
173715|NCT03109106|CICU|cicu
173716|NCT03109106|PCT - Procalcitonin|pct - procalcitonin
400608|NCT01866033|Healthy volunteer|healthy volunteer
173717|NCT03109106|B·R·A·H·M·S PCT sensitive Kryptor®|b·r·a·h·m·s pct sensitive kryptor®
173718|NCT03109106|Antibiotic initiation|antibiotic initiation
173719|NCT03109106|Antibiotic de-escalation|antibiotic de-escalation
173720|NCT03109093|ALL|all
173721|NCT03109093|acute lymphoblastic leukemia|acute lymphoblastic leukemia
173722|NCT03109093|MRD positive|mrd positive
173723|NCT03109093|minimal residual disease|minimal residual disease
173724|NCT03109093|blinatumomab|blinatumomab
173725|NCT03109067|Cholesterol, HDL, Postprandial Period, Polymorphism, Genetic|cholesterol, hdl, postprandial period, polymorphism, genetic
173726|NCT03109054|Melatonin|melatonin
173727|NCT03109054|Anxiety|anxiety
173728|NCT03109041|Whipple|whipple
173729|NCT03109041|brachytherapy|brachytherapy
173730|NCT03109041|CivaSheet|civasheet
173731|NCT03109041|CivaTech Oncology|civatech oncology
173732|NCT03109041|radiation|radiation
173733|NCT03109041|intraoperative radiation|intraoperative radiation
173734|NCT03109041|IORT|iort
173735|NCT03109041|resectable pancreatic cancer|resectable pancreatic cancer
173736|NCT03109041|Pd-103|pd-103
173737|NCT03109015|metastatic renal cell carcinoma|metastatic renal cell carcinoma
173738|NCT03109015|sunitinib|sunitinib
173739|NCT03109015|Sutent|sutent
173740|NCT03109015|cardiopulmonary function|cardiopulmonary function
173741|NCT03108976|Autism|autism
173742|NCT03108976|Sensori-motor learning|sensori-motor learning
173743|NCT03108976|Development|development
173744|NCT03108976|Neuroimaging|neuroimaging
173745|NCT03108872|Anticoagulants|anticoagulants
173746|NCT03108872|Atrial Appendage|atrial appendage
173748|NCT03108846|Alzheimer's Disease|alzheimer's disease
173749|NCT03108846|Agitation|agitation
173750|NCT03108807|Emergency Department|emergency department
173751|NCT03108807|Medical patients|medical patients
173752|NCT03108807|D-dimer|d-dimer
173753|NCT03108807|National Early Warning Score|national early warning score
173754|NCT03108807|NEWS|news
173755|NCT03108807|30-days mortality|30-days mortality
173756|NCT03108807|Mortality|mortality
173757|NCT03108794|hepatitis B，registry,cirrhosis, HCC|hepatitis b，registry,cirrhosis, hcc
173758|NCT03108781|Dementia|dementia
173759|NCT03108781|Behavioral Psychiatric symptoms|behavioral psychiatric symptoms
173760|NCT03108781|Treatment|treatment
173761|NCT03108755|ASP7713|asp7713
173762|NCT03108729|epilepsy|epilepsy
173763|NCT03108729|Partial-onset seizures|partial-onset seizures
173764|NCT03108729|Focal epilepsy|focal epilepsy
173765|NCT03108729|Focal seizures|focal seizures
173766|NCT03108729|Partial onset seizures|partial onset seizures
173767|NCT03108729|Pediatric|pediatric
173768|NCT03108729|Partial seizures|partial seizures
173769|NCT03108703|RCC|rcc
173770|NCT03108703|Stereotactic Body Radiotherapy|stereotactic body radiotherapy
173771|NCT03108703|SBRT|sbrt
173772|NCT03108703|Stereotactic Ablative Radiotherapy|stereotactic ablative radiotherapy
173773|NCT03108703|SABR|sabr
173774|NCT03108690|Therapeutic drug monitoring|therapeutic drug monitoring
173775|NCT03108690|Continuous infusion|continuous infusion
173776|NCT03108690|Beta-lactam|beta-lactam
173777|NCT03108690|Antibiotics|antibiotics
173778|NCT03108690|Bacteraemia|bacteraemia
173779|NCT03108677|RNA profiling|rna profiling
173780|NCT03108677|Exosome|exosome
173781|NCT03108677|Lung Metastases|lung metastases
173782|NCT03108677|Osteosarcoma|osteosarcoma
173783|NCT03108664|SYL1001|syl1001
173784|NCT03108664|siRNA|sirna
173785|NCT03108625|children|children
173786|NCT03108625|adolescent|adolescent
173787|NCT03108612|diagnostic accuracy|diagnostic accuracy
173788|NCT03108612|upper limb|upper limb
173789|NCT03108599|Health Promotion|health promotion
173790|NCT03108599|Injury Prevention|injury prevention
173791|NCT03108599|Safety|safety
173792|NCT03108599|Wellbeing|wellbeing
173793|NCT03108599|Physical Activity|physical activity
173794|NCT03108599|Sleep|sleep
173795|NCT03108599|Whole Body Vibration|whole body vibration
173796|NCT03108599|Self-Monitoring|self-monitoring
173797|NCT03108586|restorations|restorations
173798|NCT03108586|diagnosis|diagnosis
173799|NCT03108586|secondary caries|secondary caries
173800|NCT03108586|treatment decision|treatment decision
173801|NCT03108560|sublobar resection|sublobar resection
173802|NCT03108560|lobectomy|lobectomy
173803|NCT03108547|Sarcoidosis|sarcoidosis
173804|NCT03108547|Scalp hair cortisol and testosterone|scalp hair cortisol and testosterone
173805|NCT03108547|Fatigue|fatigue
173806|NCT03108547|Biomarker|biomarker
173807|NCT03108547|Psychological distress|psychological distress
174060|NCT03106779|ABL001|abl001
173808|NCT03108521|DPP - 4; GLP1R ; gene polymorphism research; diabetes|dpp - 4; glp1r ; gene polymorphism research; diabetes
173809|NCT03108495|LN-145|ln-145
173810|NCT03108495|Cell Therapy|cell therapy
173811|NCT03108495|Autologous Adoptive Cell Transfer|autologous adoptive cell transfer
173812|NCT03108495|Autologous Adoptive Cell Therapy|autologous adoptive cell therapy
173813|NCT03108495|Cellular Immuno-therapy|cellular immuno-therapy
173814|NCT03108495|Tumor Infiltrating Lymphocytes|tumor infiltrating lymphocytes
173815|NCT03108495|TIL|til
173816|NCT03108495|IL-2|il-2
173817|NCT03108495|Pembrolizumab|pembrolizumab
173818|NCT03108482|Acute Pain|acute pain
173819|NCT03108482|Post-surgical Pain|post-surgical pain
173820|NCT03108482|Bunionectomy|bunionectomy
173821|NCT03108482|Co-crystal|co-crystal
173822|NCT03108482|Tramadol|tramadol
173823|NCT03108482|Celecoxib|celecoxib
173824|NCT03108469|migraine|migraine
173825|NCT03108456|atherectomy|atherectomy
173826|NCT03108456|CAD|cad
173827|NCT03108456|severe calcium|severe calcium
173828|NCT03108456|orbital atherectomy|orbital atherectomy
173829|NCT03108456|minimum stent area|minimum stent area
173830|NCT03108404|predictive score|predictive score
173831|NCT03108378|Gadolinium|gadolinium
173832|NCT03108378|Bone|bone
173833|NCT03108378|Skin|skin
173834|NCT03108300|efficacy|efficacy
173835|NCT03108300|propranolol hydrochloride|propranolol hydrochloride
173836|NCT03108300|sts|sts
173837|NCT03108274|Midazolam|midazolam
173838|NCT03108274|Fexofenadine|fexofenadine
173839|NCT03108274|Mycophenolate Mofetil|mycophenolate mofetil
173840|NCT03108248|transarterial chemoembolization|transarterial chemoembolization
173841|NCT03108248|stent|stent
173842|NCT03108248|irradiation|irradiation
173843|NCT03108248|survival|survival
173844|NCT03108248|decompensation|decompensation
173845|NCT03108248|tumor response|tumor response
173846|NCT03108222|chronic kidney disease|chronic kidney disease
173847|NCT03108222|CKD|ckd
173848|NCT03108222|renal failure|renal failure
173849|NCT03108222|phosphorus|phosphorus
173850|NCT03108222|phosphate|phosphate
173851|NCT03108222|intestinal absorption|intestinal absorption
173852|NCT03108196|bladder cancer， neobladder, detaenial sigmoid, ileal|bladder cancer， neobladder, detaenial sigmoid, ileal
173853|NCT03108157|IVF|ivf
173854|NCT03108157|DONOR EGGS|donor eggs
173855|NCT03108157|ENDOMETRIAL SCRATCH|endometrial scratch
173856|NCT03108157|PIPELLE|pipelle
173857|NCT03108157|ONGOING PREGNANCY|ongoing pregnancy
173858|NCT03108144|smoking cessation|smoking cessation
173859|NCT03108144|alcohol|alcohol
173860|NCT03108144|primary care|primary care
173861|NCT03108144|screening|screening
173862|NCT03108144|brief intervention|brief intervention
173863|NCT03108144|referral to treatment|referral to treatment
173864|NCT03108144|cancer risk|cancer risk
173865|NCT03108118|Diaphragm dysfunction|diaphragm dysfunction
173866|NCT03108118|Acute respiratory failure|acute respiratory failure
173867|NCT03108118|Weaning|weaning
173868|NCT03108092|Drug Utilization Review|drug utilization review
173869|NCT03108092|Older people|older people
173870|NCT03108092|Health economics|health economics
173871|NCT03108079|Urologic Injuries|urologic injuries
173872|NCT03108079|Urologic Diseases|urologic diseases
173873|NCT03108079|Bladder Infection|bladder infection
173874|NCT03108079|Urinary Tract Infections|urinary tract infections
173875|NCT03108079|Mucosal Inflammation|mucosal inflammation
173876|NCT03108079|Mucosal Infection|mucosal infection
173877|NCT03108079|Bladder Injury|bladder injury
173878|NCT03108079|Catheter Related Infections|catheter related infections
173879|NCT03108079|Catheter Complications|catheter complications
173880|NCT03108079|Catheter Infection|catheter infection
173881|NCT03108079|Indwelling Catheter|indwelling catheter
173882|NCT03108079|Pelvic Floor Disorders|pelvic floor disorders
173883|NCT03108079|Urinary Incontinence|urinary incontinence
173884|NCT03108053|urinary stones|urinary stones
173885|NCT03108053|semirigid ureteroscopy|semirigid ureteroscopy
173886|NCT03108053|guidewire|guidewire
173887|NCT03108027|QVM149,|qvm149,
173888|NCT03108027|asthma,|asthma,
173889|NCT03108027|allergic asthma,|allergic asthma,
173890|NCT03108027|allergy triggered asthma,|allergy triggered asthma,
173891|NCT03108027|reactive asthma,|reactive asthma,
173892|NCT03108027|asthma attack,|asthma attack,
173893|NCT03108027|difficulty breathing|difficulty breathing
173894|NCT03107962|NK/T cell lymphoma|nk/t cell lymphoma
173895|NCT03107962|immunotherapy|immunotherapy
173896|NCT03107962|clinical trial|clinical trial
173897|NCT03107962|RR|rr
173898|NCT03107962|PFS|pfs
173899|NCT03107962|OS|os
173900|NCT03107949|Diaphragm atrophy|diaphragm atrophy
173901|NCT03107949|VIDD|vidd
173902|NCT03107949|weaning failure|weaning failure
173903|NCT03107949|SBT|sbt
173904|NCT03107923|Myocardial fibrosis|myocardial fibrosis
173905|NCT03107923|Aortic Valve Stenosis|aortic valve stenosis
173906|NCT03107923|TAVI|tavi
173907|NCT03107923|Outcome|outcome
173908|NCT03107897|TAVR|tavr
173909|NCT03107897|elevated frailty score|elevated frailty score
173910|NCT03107897|Transcatheter Valve Replacement|transcatheter valve replacement
173911|NCT03107884|Insulin Resistance|insulin resistance
173912|NCT03107884|Muscle Atrophy|muscle atrophy
173913|NCT03107884|Metformin|metformin
173914|NCT03107884|Muscle Loss|muscle loss
173915|NCT03107884|Inactivity-induced muscle loss|inactivity-induced muscle loss
173916|NCT03107884|older adults|older adults
173917|NCT03107871|valganciclovir|valganciclovir
173918|NCT03107845|CBT|cbt
173919|NCT03107845|Psychometric Feedback|psychometric feedback
173920|NCT03107845|Clinical Support Tools|clinical support tools
173921|NCT03107845|Personalized Mental Health|personalized mental health
173922|NCT03107819|Plasma metabolomics|plasma metabolomics
173923|NCT03107819|Urinary metabolomics|urinary metabolomics
173924|NCT03107819|Metabonomics|metabonomics
173925|NCT03107819|Biomarker discovery|biomarker discovery
173926|NCT03107806|acute coronary syndromes|acute coronary syndromes
173927|NCT03107806|hyperglycemia|hyperglycemia
173928|NCT03107806|hypoglycemia|hypoglycemia
173929|NCT03107806|continuous glucose monitoring|continuous glucose monitoring
173930|NCT03107741|Metabolic Syndrome|metabolic syndrome
173931|NCT03107741|Waist circumference|waist circumference
173932|NCT03107741|Blood pressure|blood pressure
173933|NCT03107741|Triglyceride|triglyceride
173934|NCT03107741|HDL cholesterol|hdl cholesterol
173935|NCT03107728|orthotics|orthotics
173936|NCT03107728|high-energy lower extremity trauma|high-energy lower extremity trauma
173937|NCT03107728|physical therapy|physical therapy
173938|NCT03107728|bracing|bracing
173939|NCT03107728|functional performance|functional performance
173940|NCT03107728|performance assessment|performance assessment
173941|NCT03107715|exclusive breastfeeding|exclusive breastfeeding
173942|NCT03107715|health disparity|health disparity
173943|NCT03107715|prenatal intervention|prenatal intervention
173944|NCT03107689|ILE|ile
173945|NCT03107689|lipid|lipid
173946|NCT03107689|overdose|overdose
173947|NCT03107689|resuscitation|resuscitation
173948|NCT03107676|trunk extensors; endurance, peak torque, power, work|trunk extensors; endurance, peak torque, power, work
173949|NCT03107663|PET/CT|pet/ct
173950|NCT03107663|Imaging|imaging
173951|NCT03107663|⁸⁹Zr-Df-IAB22M2C|⁸⁹zr-df-iab22m2c
173952|NCT03107663|CD8 + T Cells|cd8 + t cells
173953|NCT03107663|Standard of Care|standard of care
173954|NCT03107637|Embolic Stroke of Undetermined Source|embolic stroke of undetermined source
173955|NCT03107637|transesophageal echocardiography|transesophageal echocardiography
173956|NCT03107637|cardiac source of embolism|cardiac source of embolism
173957|NCT03107637|ischemic stroke|ischemic stroke
173958|NCT03107598|spinal anesthesia|spinal anesthesia
173959|NCT03107598|neonatal outcome|neonatal outcome
173960|NCT03107598|Caesarean Section|caesarean section
173961|NCT03107585|cervical plexus block|cervical plexus block
173962|NCT03107585|thyroidectomy|thyroidectomy
173963|NCT03107585|opioid consumption|opioid consumption
173964|NCT03107559|perfüsion index|perfüsion index
173965|NCT03107559|epidural analgesia|epidural analgesia
173967|NCT03107546|Syndactyly|syndactyly
173968|NCT03107546|Syndactyly release surgery|syndactyly release surgery
173969|NCT03107546|Full thickness skin graft|full thickness skin graft
173970|NCT03107546|Hyalomatrix|hyalomatrix
173971|NCT03107546|Scar formation|scar formation
173972|NCT03107520|contrast-enhanced ultrasound|contrast-enhanced ultrasound
173973|NCT03107520|Lumason|lumason
173974|NCT03107520|developmental dysplasia of the hip (DDH)|developmental dysplasia of the hip (ddh)
173975|NCT03107520|avascular necrosis|avascular necrosis
173976|NCT03107507|EEG with Periodic Abnormalities|eeg with periodic abnormalities
173977|NCT03107507|Levetiracetam|levetiracetam
173978|NCT03107507|Phenobarbitone|phenobarbitone
173979|NCT03107507|neonatal seizures|neonatal seizures
173980|NCT03107507|Neurodevelopmental Abnormality|neurodevelopmental abnormality
173981|NCT03107481|Acetaminophen|acetaminophen
173982|NCT03107481|Hydromorphone|hydromorphone
173983|NCT03107481|Emergency Department|emergency department
173984|NCT03107481|Narcotics|narcotics
173985|NCT03107481|Analgesics, Opioid|analgesics, opioid
173986|NCT03107481|Analgesics, Non-Narcotic|analgesics, non-narcotic
173987|NCT03107468|Non-surgical treatment|non-surgical treatment
173988|NCT03107468|Acupuncture|acupuncture
173989|NCT03107468|Chuna|chuna
173990|NCT03107468|Physiotherapy|physiotherapy
173991|NCT03107468|Epidural steroid injection|epidural steroid injection
173992|NCT03107455|MitraClip|mitraclip
173993|NCT03107455|Acute mitral regurgitation|acute mitral regurgitation
173994|NCT03107455|Acute myocardial infarction|acute myocardial infarction
173995|NCT03107442|Arterial stiffness|arterial stiffness
173996|NCT03107442|Markers of Inflammation|markers of inflammation
173997|NCT03107442|Exercise|exercise
173998|NCT03107442|Physical fitness|physical fitness
173999|NCT03107442|Cardiovascular risk|cardiovascular risk
174000|NCT03107442|Autoimmune diseases|autoimmune diseases
174001|NCT03107429|Trendelenburg|trendelenburg
174002|NCT03107429|Laparoscopic colorectal surgery|laparoscopic colorectal surgery
174003|NCT03107429|POVL|povl
174004|NCT03107416|Bumetanide|bumetanide
174005|NCT03107416|Diuretic|diuretic
174006|NCT03107416|Transarterial Embolization (TAE)|transarterial embolization (tae)
174007|NCT03107416|17-141|17-141
174008|NCT03107403|dreams bereavement|dreams bereavement
174009|NCT03107403|emotional|emotional
174010|NCT03107403|regulation|regulation
174011|NCT03107403|bereavement|bereavement
174012|NCT03107338|Pre-emptive analgesia; Dexketoprofen trometamol|pre-emptive analgesia; dexketoprofen trometamol
174013|NCT03107208|DKA|dka
174014|NCT03107208|type 1 diabetes|type 1 diabetes
174015|NCT03107208|children|children
174016|NCT03107208|continuous glucose monitoring|continuous glucose monitoring
174017|NCT03107182|HPV- positive HNSCC|hpv- positive hnscc
174018|NCT03107182|head and neck squamous cell carcinoma|head and neck squamous cell carcinoma
174019|NCT03107156|Treatment care planning|treatment care planning
174020|NCT03107143|Pressure ulcer prevention|pressure ulcer prevention
174021|NCT03107143|Pressure injury|pressure injury
174022|NCT03107091|Terlipressin|terlipressin
174023|NCT03107091|Terlipressin acetate|terlipressin acetate
174024|NCT03107065|Sweating|sweating
174025|NCT03107026|Binge eating Disorder|binge eating disorder
174026|NCT03107026|dasotraline|dasotraline
174027|NCT03107013|Mass Balance|mass balance
174028|NCT03107013|Phase 1|phase 1
174029|NCT03106987|polymerisation inhibitor (PARPi)|polymerisation inhibitor (parpi)
174030|NCT03106987|PARPi re-treatment|parpi re-treatment
174031|NCT03106987|BRCA1/2 (+ve)|brca1/2 (+ve)
174032|NCT03106987|BRCA1/2 (-ve)|brca1/2 (-ve)
174033|NCT03106987|Olaparib|olaparib
174034|NCT03106987|ovarian cancer|ovarian cancer
174035|NCT03106987|progression free survival (PFS)|progression free survival (pfs)
174036|NCT03106935|recurrent pregnancy loss|recurrent pregnancy loss
174037|NCT03106935|Clinical hypothyroidism|clinical hypothyroidism
174038|NCT03106935|Subclinical hypothyroidism|subclinical hypothyroidism
174039|NCT03106935|thyroid stimulating hormone|thyroid stimulating hormone
174040|NCT03106935|thyroid peroxidase antibody|thyroid peroxidase antibody
174041|NCT03106935|Levothyroxine|levothyroxine
174042|NCT03106922|Polyethylene glycol|polyethylene glycol
174043|NCT03106922|Bowel cleansing|bowel cleansing
174044|NCT03106922|Colonoscopy|colonoscopy
174045|NCT03106909|stroke|stroke
174046|NCT03106909|pneumonia|pneumonia
174047|NCT03106909|biomarkers|biomarkers
174048|NCT03106909|pulmonary CT|pulmonary ct
174049|NCT03106883|Attention bias modification|attention bias modification
174050|NCT03106883|Cognitive bias modification|cognitive bias modification
174051|NCT03106883|Eye-tracking|eye-tracking
174052|NCT03106883|Treatment|treatment
174053|NCT03106844|FMT|fmt
174054|NCT03106844|IBD|ibd
174055|NCT03106805|intrauterine device|intrauterine device
174056|NCT03106779|Phase 3|phase 3
174057|NCT03106779|Chronic Myelogenous Leukemia|chronic myelogenous leukemia
174058|NCT03106779|CML|cml
174059|NCT03106779|bosutinib|bosutinib
174061|NCT03106779|tyrosine kinase inhibitor|tyrosine kinase inhibitor
174062|NCT03106779|Chronic myelogenous leukemia (CML)|chronic myelogenous leukemia (cml)
174063|NCT03106779|chronic myeloid leukemia (CML)|chronic myeloid leukemia (cml)
174064|NCT03106779|chronic myelocytic leukemia (CML)|chronic myelocytic leukemia (cml)
174065|NCT03106779|chronic granulocytic leukemia (CGL)|chronic granulocytic leukemia (cgl)
174066|NCT03106779|cancer of the white blood cells|cancer of the white blood cells
174067|NCT03106779|clonal bone marrow stem cell disorder|clonal bone marrow stem cell disorder
174068|NCT03106779|proliferation of mature granulocytes|proliferation of mature granulocytes
174069|NCT03106753|External Cephalic Version|external cephalic version
174070|NCT03106753|neuraxial analgesia|neuraxial analgesia
174071|NCT03106740|Microglia|microglia
174072|NCT03106740|Minocycline|minocycline
174073|NCT03106740|Magnetic Resonance Imaging|magnetic resonance imaging
174074|NCT03106740|Positron Emission Tomography|positron emission tomography
174075|NCT03106740|Pain|pain
174076|NCT03106740|Astrocytes|astrocytes
174077|NCT03106740|Glia|glia
174078|NCT03106740|Human|human
174079|NCT03106740|Back Pain|back pain
174080|NCT03106727|Community Health Workers|community health workers
174081|NCT03106727|Maternal and Child Health|maternal and child health
174082|NCT03106727|Integrated Care|integrated care
174083|NCT03106727|Malawi|malawi
174084|NCT03106727|NCD|ncd
174085|NCT03106714|persistence|persistence
174086|NCT03106714|body fluids|body fluids
174087|NCT03106688|PET imaging|pet imaging
174088|NCT03106688|Cannabinoid receptor|cannabinoid receptor
174089|NCT03106688|Opioid receptor|opioid receptor
174090|NCT03106688|Addiction|addiction
174091|NCT03106688|fMRI imaging|fmri imaging
174092|NCT03106675|HIFU|hifu
174093|NCT03106675|MR-HIFU|mr-hifu
174094|NCT03106675|MRgFUs|mrgfus
174095|NCT03106675|MRI-intervention|mri-intervention
174096|NCT03106675|Palliation|palliation
174097|NCT03106662|Mesenchymal stem cell|mesenchymal stem cell
174098|NCT03106662|haploidentical hematopoietic stem cell transplantation|haploidentical hematopoietic stem cell transplantation
174099|NCT03106662|graft-versus-host disease|graft-versus-host disease
174100|NCT03106662|engraftment|engraftment
174101|NCT03106636|Preschool-aged|preschool-aged
174102|NCT03106636|Foster children|foster children
174103|NCT03106636|child welfare|child welfare
174104|NCT03106636|Fostercare|fostercare
174105|NCT03106636|Parent training|parent training
174106|NCT03106636|early adversity|early adversity
174107|NCT03106636|curriculum based|curriculum based
174108|NCT03106636|early intervention|early intervention
174109|NCT03106636|preschool|preschool
174110|NCT03106636|foster placement disruptions|foster placement disruptions
174111|NCT03106636|manualized intervention|manualized intervention
174112|NCT03106636|group based intervention|group based intervention
174113|NCT03106636|high-risk children|high-risk children
174114|NCT03106610|Bladder cancer|bladder cancer
174115|NCT03106610|Cancer of urothelium|cancer of urothelium
174116|NCT03106610|Transitional cell carcinoma|transitional cell carcinoma
174117|NCT03106610|Carcinoma in situ|carcinoma in situ
174118|NCT03106610|Nivolumab|nivolumab
174119|NCT03106610|BMS-936558|bms-936558
174120|NCT03106610|Opdivo|opdivo
174121|NCT03106610|Questionnaires|questionnaires
174122|NCT03106610|Surveys|surveys
174123|NCT03106597|Peripheral Edema|peripheral edema
174124|NCT03106597|Bioimpedance Analysis|bioimpedance analysis
174125|NCT03106584|Knee pain|knee pain
174126|NCT03106584|Glucosamine|glucosamine
174127|NCT03106584|WOMAC|womac
174128|NCT03106584|Osteoarthritis|osteoarthritis
174129|NCT03106571|Phase 1 clinical trial|phase 1 clinical trial
174130|NCT03106506|Implants|implants
174131|NCT03106506|Conjunctive tissue graft|conjunctive tissue graft
174132|NCT03106506|Prospective study|prospective study
174133|NCT03106480|Pre-diabetes|pre-diabetes
174134|NCT03106480|Diabetes Mellitus|diabetes mellitus
174135|NCT03106480|HIV|hiv
174136|NCT03106480|ART|art
174137|NCT03106480|Body composition|body composition
174138|NCT03106480|Inflammation|inflammation
174139|NCT03106480|Insulin resistance|insulin resistance
174140|NCT03106480|Beta-cell function|beta-cell function
174141|NCT03106480|Pre-Hypertension|pre-hypertension
174142|NCT03106480|Hypertension|hypertension
174143|NCT03106467|appendectomy|appendectomy
174144|NCT03106467|laparoscopic|laparoscopic
174145|NCT03106467|single port|single port
174146|NCT03106467|randomized|randomized
174147|NCT03106428|MEDI7247|medi7247
174148|NCT03106428|Acute Myeloid Leukemia|acute myeloid leukemia
174149|NCT03106428|Multiple Myeloma|multiple myeloma
174150|NCT03106428|Diffuse Large B-cell Lymphoma|diffuse large b-cell lymphoma
174151|NCT03106428|AML|aml
174152|NCT03106428|MM|mm
174153|NCT03106428|DLBCL|dlbcl
174154|NCT03106389|misoprostol|misoprostol
174155|NCT03106389|transcervical balloon catheter|transcervical balloon catheter
174156|NCT03106389|second trimester|second trimester
174157|NCT03106389|induced abortion|induced abortion
174158|NCT03106337|Thyroid|thyroid
174159|NCT03106337|Follicular Neoplasms|follicular neoplasms
174160|NCT03106337|Bethesda System|bethesda system
174161|NCT03106337|Elastography|elastography
174162|NCT03106337|Doppler ultrasound|doppler ultrasound
174163|NCT03106337|Thyroidectomy|thyroidectomy
174164|NCT03106324|Multiple Myeloma|multiple myeloma
174165|NCT03106324|Non transplant eligible|non transplant eligible
174166|NCT03106324|Revlimid|revlimid
174167|NCT03106324|PASS|pass
174168|NCT03106324|Non-interventional|non-interventional
174169|NCT03106324|Lenalidomide|lenalidomide
174170|NCT03106298|Iron Deficiency|iron deficiency
174171|NCT03106298|Fibroblast Growth Factor 23|fibroblast growth factor 23
174172|NCT03106298|Phosphate|phosphate
174173|NCT03106259|FURESTEM-RA|furestem-ra
174174|NCT03106246|Extracellular vesicles|extracellular vesicles
174175|NCT03106246|Autoimmunity|autoimmunity
174176|NCT03106246|Beta-cell injury|beta-cell injury
174177|NCT03106233|Breast reconstruction|breast reconstruction
174178|NCT03106233|Perforator flap|perforator flap
174179|NCT03106233|Microsurgery|microsurgery
174180|NCT03106168|Extraction|extraction
174181|NCT03106168|Local Anesthetic|local anesthetic
174182|NCT03106168|Mepivacaine|mepivacaine
174183|NCT03106168|Mandibular Molar|mandibular molar
174184|NCT03106142|intervention, improvement strategy|intervention, improvement strategy
174185|NCT03106116|Coronary Heart Disease|coronary heart disease
174186|NCT03106116|Ventricular Function|ventricular function
174187|NCT03106116|Vascular Endothelium|vascular endothelium
174188|NCT03106116|Counterpulsation, External|counterpulsation, external
174189|NCT03106103|urodynamics|urodynamics
174190|NCT03106103|cystitis|cystitis
174191|NCT03106103|prophylactic antibiotics|prophylactic antibiotics
174192|NCT03106103|bacteriuria|bacteriuria
174193|NCT03106090|survivorship care plan|survivorship care plan
174194|NCT03106090|head and neck cancer|head and neck cancer
174195|NCT03106090|survivorship|survivorship
174196|NCT03106051|Arthritis|arthritis
174197|NCT03106051|Psoriatic|psoriatic
174198|NCT03106051|Observational|observational
174199|NCT03106051|Apremilast|apremilast
174200|NCT03106038|contrast agent|contrast agent
174201|NCT03106038|ureter imaging|ureter imaging
174202|NCT03106038|intraoperative monitoring|intraoperative monitoring
174203|NCT03106038|intraoperative procedures|intraoperative procedures
174204|NCT03106038|near infrared fluorescence|near infrared fluorescence
174205|NCT03106038|minimally invasive|minimally invasive
174206|NCT03105973|jail|jail
174207|NCT03105973|prison|prison
174208|NCT03105973|technology|technology
174209|NCT03105973|depression|depression
174210|NCT03105973|CBT|cbt
174211|NCT03105947|lipids|lipids
174212|NCT03105947|dietary fats|dietary fats
174213|NCT03105921|Locally advanced pancreatic carcinoma|locally advanced pancreatic carcinoma
174214|NCT03105921|Irreversible electroporation|irreversible electroporation
174215|NCT03105921|Interventional radiology|interventional radiology
174216|NCT03105895|Incisional hernia|incisional hernia
174217|NCT03105895|Mesh prevention|mesh prevention
174218|NCT03105895|Mesh augmentation|mesh augmentation
174219|NCT03105882|Spinal Cord Injury|spinal cord injury
174220|NCT03105882|SCI|sci
174221|NCT03105882|Complete (AIS A) Traumatic Acute Spinal Cord Injury|complete (ais a) traumatic acute spinal cord injury
174222|NCT03105869|repeatability|repeatability
174223|NCT03105869|positron emission tomography (PET)|positron emission tomography (pet)
174224|NCT03105869|fluorocholine|fluorocholine
174225|NCT03105856|Mass screening|mass screening
174226|NCT03105856|Vaccination|vaccination
174227|NCT03105856|Mexico|mexico
174228|NCT03105843|Asthma|asthma
174229|NCT03105843|Cough|cough
174230|NCT03105843|Eucapneic Voluntary Hyperventilation|eucapneic voluntary hyperventilation
174231|NCT03105843|Hypertonic Saline|hypertonic saline
174232|NCT03105817|Asymmetric cellulose triacetate|asymmetric cellulose triacetate
174233|NCT03105817|Biocompatibility|biocompatibility
174234|NCT03105817|Hemodiafiltration on-line|hemodiafiltration on-line
174235|NCT03105817|Convective volume|convective volume
174236|NCT03105817|Adequacy|adequacy
174237|NCT03105778|BNP|bnp
174238|NCT03105778|IVD|ivd
174239|NCT03105765|Neuropathic Pain|neuropathic pain
174240|NCT03105765|Chronic Pain|chronic pain
174241|NCT03105765|Posterolateral thoracotomy|posterolateral thoracotomy
174242|NCT03105752|Outcome Assessments (Health Care)|outcome assessments (health care)
174243|NCT03105752|Volunteers|volunteers
174244|NCT03105752|Informed consent|informed consent
174245|NCT03105752|Comprehension|comprehension
174246|NCT03105752|Language tests|language tests
174247|NCT03105726|End Stage Heart Failure|end stage heart failure
174248|NCT03105726|New York Heart Association functional class III or IV|new york heart association functional class iii or iv
174249|NCT03105726|Heart transplantation|heart transplantation
174351|NCT03105167|RCT|rct
174250|NCT03105726|Ventricular assisted devices|ventricular assisted devices
174251|NCT03105726|Cardiogenic shock|cardiogenic shock
174252|NCT03105713|Checklist|checklist
174253|NCT03105713|Patient Checklist|patient checklist
174254|NCT03105713|Surgery|surgery
174255|NCT03105713|Safety|safety
174256|NCT03105713|Patient Involvement|patient involvement
174257|NCT03105700|epilepsy|epilepsy
174258|NCT03105700|depression|depression
174259|NCT03105700|refractory|refractory
174260|NCT03105700|temporal lobe|temporal lobe
174261|NCT03105700|TMS|tms
174262|NCT03105700|biomarker|biomarker
174263|NCT03105687|mHealth|mhealth
174264|NCT03105687|SMS reminders|sms reminders
174265|NCT03105687|adherence|adherence
174266|NCT03105687|antihypertensive drugs|antihypertensive drugs
174267|NCT03105687|pharmacists|pharmacists
174268|NCT03105687|cost-effectiveness|cost-effectiveness
174269|NCT03105674|analgesia|analgesia
174270|NCT03105674|peri-anal procedure|peri-anal procedure
174271|NCT03105674|peri-anal block|peri-anal block
174272|NCT03105674|anal surgery|anal surgery
174273|NCT03105635|Community Resources|community resources
174274|NCT03105635|Health Navigator|health navigator
174275|NCT03105622|Exercise|exercise
174276|NCT03105622|Screen|screen
174277|NCT03105622|Music|music
174278|NCT03105622|Energy compensation|energy compensation
174279|NCT03105622|Adolescents|adolescents
174280|NCT03105622|Running+screen|running+screen
174281|NCT03105622|Running+music|running+music
174282|NCT03105622|Running without stimulus (control condition)|running without stimulus (control condition)
174283|NCT03105609|hyperspectral imaging, Ranibizumab|hyperspectral imaging, ranibizumab
174284|NCT03105583|Medication beliefs|medication beliefs
174285|NCT03105583|Information desire|information desire
174286|NCT03105583|Vitamin deficiencies|vitamin deficiencies
174287|NCT03105570|breast neoplasms|breast neoplasms
174288|NCT03105570|Mastectomy, Subcutaneous|mastectomy, subcutaneous
174289|NCT03105570|Areola|areola
174290|NCT03105557|Prematurely born newborns|prematurely born newborns
174291|NCT03105557|Urine|urine
174292|NCT03105557|Collecting device|collecting device
174293|NCT03105544|simulation-based training|simulation-based training
174294|NCT03105544|obstetric ultrasound|obstetric ultrasound
174295|NCT03105544|intrauterine growth restriction|intrauterine growth restriction
174296|NCT03105544|ultrasound simulation|ultrasound simulation
174297|NCT03105531|primary aldosteronism|primary aldosteronism
174298|NCT03105531|hypertension|hypertension
174299|NCT03105531|screening|screening
174300|NCT03105531|secondary hypertension|secondary hypertension
174301|NCT03105518|assisted reproduction|assisted reproduction
174302|NCT03105518|postoperative pain|postoperative pain
174303|NCT03105518|opioid|opioid
174304|NCT03105492|Prenatal Testing|prenatal testing
174305|NCT03105479|vancomycin|vancomycin
174306|NCT03105479|children|children
174307|NCT03105479|cadazolid|cadazolid
174308|NCT03105479|clostridium difficile associated diarrhea|clostridium difficile associated diarrhea
174309|NCT03105466|Corneal Transplantation|corneal transplantation
174310|NCT03105466|Xenotransplantation|xenotransplantation
174311|NCT03105466|Bioegineered cornea|bioegineered cornea
174312|NCT03105453|Assisted reproductive technologies|assisted reproductive technologies
174313|NCT03105453|Microbiome|microbiome
174314|NCT03105440|breast cancer|breast cancer
174315|NCT03105440|lymphedema|lymphedema
174316|NCT03105440|pain|pain
174317|NCT03105440|range of motion|range of motion
174318|NCT03105440|technologic innovation|technologic innovation
174319|NCT03105440|rehabilitation|rehabilitation
174320|NCT03105414|Mechanical ventilation|mechanical ventilation
174321|NCT03105414|Pediatrics|pediatrics
174322|NCT03105414|Cross infection|cross infection
174323|NCT03105414|Intensive care|intensive care
174324|NCT03105414|Diagnosis|diagnosis
174325|NCT03105375|Potassium competitive acid blocker|potassium competitive acid blocker
174326|NCT03105375|X842|x842
174327|NCT03105375|Gastroesophageal reflux disease|gastroesophageal reflux disease
174328|NCT03105375|Esophagitis|esophagitis
174329|NCT03105375|Intragastric pH|intragastric ph
174330|NCT03105375|Acid inhibition|acid inhibition
174331|NCT03105362|Oral Rehydration Solutions|oral rehydration solutions
174332|NCT03105310|Hepatitis D|hepatitis d
174333|NCT03105310|Ezetimibe|ezetimibe
174334|NCT03105310|Pegylated interferon|pegylated interferon
174335|NCT03105297|Nasal dilator strip|nasal dilator strip
174336|NCT03105297|Sleep disordered breathing|sleep disordered breathing
174337|NCT03105284|stem cell|stem cell
174338|NCT03105284|liposuction|liposuction
174339|NCT03105284|regenerative medicine|regenerative medicine
174340|NCT03105245|electroconvulsive therapy|electroconvulsive therapy
174341|NCT03105245|anaesthesia|anaesthesia
174342|NCT03105206|lowl pole renal calculus|lowl pole renal calculus
174343|NCT03105206|anatomical parameters|anatomical parameters
174344|NCT03105206|flexible ureteroscopy|flexible ureteroscopy
174345|NCT03105193|Colon surgery|colon surgery
174346|NCT03105193|Lignocaine|lignocaine
174347|NCT03105193|Lidocaine|lidocaine
174348|NCT03105193|Analgesia|analgesia
174349|NCT03105193|Local anaesthetic|local anaesthetic
174350|NCT03105167|CBT|cbt
174352|NCT03105167|TLIF|tlif
174353|NCT03105141|Intracranial atherosclerotic stenosis|intracranial atherosclerotic stenosis
174354|NCT03105141|Remote ischemic conditioning|remote ischemic conditioning
174355|NCT03105141|Stroke|stroke
174356|NCT03105115|fentanyl|fentanyl
174357|NCT03105115|dexmedetomidine|dexmedetomidine
174358|NCT03105102|risankizumab|risankizumab
174359|NCT03105102|ABBV-066|abbv-066
174360|NCT03105102|BI 655066|bi 655066
174361|NCT03105050|access|access
174362|NCT03105050|policy|policy
174363|NCT03105024|specific phobia|specific phobia
174364|NCT03105024|height phobia|height phobia
174365|NCT03105024|exposure|exposure
174366|NCT03105024|virtual reality|virtual reality
174367|NCT03105024|extinction|extinction
174368|NCT03105024|self-efficacy|self-efficacy
174369|NCT03105011|Type 2 diabetes|type 2 diabetes
174370|NCT03104998|Idiopathic|idiopathic
174371|NCT03104998|Infertility|infertility
174372|NCT03104998|coenzyme q10|coenzyme q10
174373|NCT03104998|Pakistan|pakistan
174374|NCT03104985|Trophic ulcer; low level laser therapy; Chronic Venous Insufficiency|trophic ulcer; low level laser therapy; chronic venous insufficiency
174375|NCT03104972|ADHD|adhd
174376|NCT03104972|TRANS CRANIAL ELECTRIC STIMULATION|trans cranial electric stimulation
174377|NCT03104959|hangovers|hangovers
174378|NCT03104959|N-acetyl cysteine|n-acetyl cysteine
174379|NCT03104959|alcohol|alcohol
174380|NCT03104933|Proadrenomedullin|proadrenomedullin
174381|NCT03104933|Copeptin|copeptin
174382|NCT03104933|Vasopressors|vasopressors
174383|NCT03104933|Septic Shock|septic shock
174384|NCT03104920|ERAS|eras
174385|NCT03104920|Time to ready for discharge|time to ready for discharge
174386|NCT03104907|IPSS|ipss
174387|NCT03104907|Quality of Life|quality of life
174388|NCT03104907|DAN-PSS|dan-pss
174389|NCT03104907|Complications|complications
174390|NCT03104907|Prostate cancer|prostate cancer
174391|NCT03104881|stroke|stroke
174392|NCT03104855|cystic fibrosis|cystic fibrosis
174393|NCT03104855|vitamin d catabolism|vitamin d catabolism
174394|NCT03104816|Acetaminophen po|acetaminophen po
174395|NCT03104816|Acetaminophen IV|acetaminophen iv
174396|NCT03104816|Pain management|pain management
174397|NCT03104816|minimally invasive lumbar fusions|minimally invasive lumbar fusions
174398|NCT03104816|Ofirmev|ofirmev
174399|NCT03104816|Analgesics|analgesics
174400|NCT03104816|Opioid|opioid
174401|NCT03104816|Pain|pain
174402|NCT03104816|Postoperative|postoperative
174403|NCT03104816|Spinal|spinal
174404|NCT03104764|labial frenulum|labial frenulum
174405|NCT03104764|surgery|surgery
174406|NCT03104764|scalpel technique|scalpel technique
174407|NCT03104764|Er:YAG laser|er:yag laser
174408|NCT03104751|Complex Congenital Heart Defect|complex congenital heart defect
174409|NCT03104751|Infants|infants
174410|NCT03104725|5-S-Cysteinyldopamine|5-s-cysteinyldopamine
174411|NCT03104725|Cerebrospinal Fluid|cerebrospinal fluid
174412|NCT03104725|PARKINSONS DISEASE|parkinsons disease
174413|NCT03104725|MONOAMINE OXIDASE INHIBITOR|monoamine oxidase inhibitor
174414|NCT03104712|glycemic index|glycemic index
174415|NCT03104699|Antibodies|antibodies
174416|NCT03104699|Immunologic effects|immunologic effects
174417|NCT03104699|Physiological Effects of Drugs|physiological effects of drugs
174418|NCT03104673|Molecular signature|molecular signature
174419|NCT03104673|Thailand-Myanmar border|thailand-myanmar border
174420|NCT03104621|preservative-free, tafluprost|preservative-free, tafluprost
174421|NCT03104595|EC-18, febrile neutropenia, breast cancer, chemotherapy|ec-18, febrile neutropenia, breast cancer, chemotherapy
174422|NCT03104582|ERCP|ercp
174423|NCT03104582|PTBD|ptbd
174425|NCT03104582|Cholangitis|cholangitis
174426|NCT03104582|Complication|complication
174427|NCT03104582|Klatskin tumor|klatskin tumor
174428|NCT03104569|ERCP|ercp
174429|NCT03104569|Contrast agent|contrast agent
174430|NCT03104569|Hilar cholangiocarcinoma|hilar cholangiocarcinoma
174431|NCT03104569|Cholangitis|cholangitis
174432|NCT03104569|Nonionic|nonionic
174433|NCT03104543|survivor|survivor
174434|NCT03104543|undertreatment|undertreatment
174435|NCT03104543|adherence|adherence
174436|NCT03104543|self-efficacy|self-efficacy
174437|NCT03104530|Crab|crab
174438|NCT03104530|Brown meat|brown meat
174439|NCT03104530|Cadmium body burden|cadmium body burden
174440|NCT03104530|Ferritin|ferritin
174441|NCT03104530|Zinc|zinc
174442|NCT03104530|Selenium|selenium
174443|NCT03104530|Creatinine|creatinine
174444|NCT03104530|B2-Microglobulin|b2-microglobulin
174445|NCT03104517|Urinary Incontinence|urinary incontinence
174446|NCT03104517|Urinary Stress Incontinence|urinary stress incontinence
174447|NCT03104517|Lower Urinary Tract Symptoms|lower urinary tract symptoms
174448|NCT03104517|Urinary Bladder|urinary bladder
174449|NCT03104517|Urinary Tract Diseases|urinary tract diseases
174451|NCT03104517|Urinary Leak|urinary leak
174452|NCT03104517|Urine Leak|urine leak
174453|NCT03104517|Bladder Leak|bladder leak
174454|NCT03104517|Urethra|urethra
174455|NCT03104517|Urethral Sphincter|urethral sphincter
174456|NCT03104504|Suicide Screening|suicide screening
174457|NCT03104504|Safety Planning|safety planning
174458|NCT03104491|allogeneic hematopoietic stem cell transplantation|allogeneic hematopoietic stem cell transplantation
174459|NCT03104491|donor chimerism|donor chimerism
174460|NCT03104478|DLBCL|dlbcl
174461|NCT03104478|Real time molecular characterization|real time molecular characterization
174462|NCT03104465|Chronic Pain|chronic pain
174463|NCT03104465|Mindfulness|mindfulness
174464|NCT03104465|Behavioral Health|behavioral health
174465|NCT03104465|Quality of Life|quality of life
174466|NCT03104439|Pancreatic Cancer|pancreatic cancer
174467|NCT03104439|Microsatellite Stable Colorectal Cancer|microsatellite stable colorectal cancer
174468|NCT03104426|Hemolytic disease of the fetus and newborn|hemolytic disease of the fetus and newborn
174469|NCT03104426|HDFN|hdfn
174470|NCT03104426|Red blood cell alloimmunization|red blood cell alloimmunization
174471|NCT03104413|ABBV-066|abbv-066
174472|NCT03104413|BI 655066|bi 655066
174473|NCT03104400|Arthritis|arthritis
174474|NCT03104400|Psoriasis|psoriasis
174475|NCT03104400|Anti-inflammatory|anti-inflammatory
174476|NCT03104400|Joint disease|joint disease
174477|NCT03104400|Musculoskeletal disease|musculoskeletal disease
174478|NCT03104400|Anti-Rheumatic|anti-rheumatic
174479|NCT03104387|Air pollution|air pollution
174480|NCT03104387|Diesel exhaust|diesel exhaust
174481|NCT03104387|Ultrafine particles|ultrafine particles
174482|NCT03104387|Vascular function|vascular function
174483|NCT03104387|Endothelium function|endothelium function
174484|NCT03104387|Heart rate variability|heart rate variability
174485|NCT03104387|DNA damage|dna damage
174486|NCT03104374|Arthritis|arthritis
174487|NCT03104374|Psoriasis|psoriasis
174488|NCT03104374|Anti-Rheumatic|anti-rheumatic
174489|NCT03104374|Anti-inflammatory|anti-inflammatory
174490|NCT03104374|Joint disease|joint disease
174491|NCT03104374|Musculoskeletal disease|musculoskeletal disease
174492|NCT03104361|intersitial cystitis|intersitial cystitis
174493|NCT03104361|Bladder pain syndrome|bladder pain syndrome
174494|NCT03104361|Intravesical treatment|intravesical treatment
174495|NCT03104348|COPD|copd
174496|NCT03104348|Primary care|primary care
174497|NCT03104335|soft tissue sarcoma|soft tissue sarcoma
174498|NCT03104335|advanced|advanced
174499|NCT03104335|apatinib|apatinib
174500|NCT03104335|tyrosine-kinase inhibitors|tyrosine-kinase inhibitors
174501|NCT03104322|digital health|digital health
174502|NCT03104322|home spirometry|home spirometry
174503|NCT03104322|patient reported outcome measure|patient reported outcome measure
174504|NCT03104322|e-health|e-health
174505|NCT03104322|pirfenidone|pirfenidone
174506|NCT03104322|nintedanib|nintedanib
174507|NCT03104322|FVC|fvc
174508|NCT03104322|antifibrotic|antifibrotic
174509|NCT03104296|NIRS|nirs
174510|NCT03104296|Griffiths Mental Development Scales|griffiths mental development scales
174511|NCT03104296|prematurity|prematurity
174512|NCT03104283|apatinib|apatinib
174513|NCT03104283|gastric cancer|gastric cancer
174514|NCT03104283|elderly patients|elderly patients
174515|NCT03104270|Elotuzumab, Multiple Myeloma, Phase 2|elotuzumab, multiple myeloma, phase 2
174516|NCT03104257|Healthy Control, Cannabis, Dependence|healthy control, cannabis, dependence
174517|NCT03104244|concussion|concussion
174518|NCT03104244|subconcussive impacts|subconcussive impacts
174519|NCT03104244|brain function|brain function
174520|NCT03104244|football|football
174521|NCT03104231|atrial fibrillation|atrial fibrillation
174522|NCT03104231|oral anticoagulantion|oral anticoagulantion
174523|NCT03104231|stroke prevention|stroke prevention
174524|NCT03104231|education|education
174525|NCT03104231|e-medicine|e-medicine
174526|NCT03104205|frail elderly|frail elderly
174527|NCT03104205|telemedicine|telemedicine
174528|NCT03104205|obesity|obesity
174529|NCT03104205|rural health|rural health
174530|NCT03104205|health promotion|health promotion
174531|NCT03104205|weight loss|weight loss
174532|NCT03104192|frail elderly|frail elderly
174533|NCT03104192|telemedicine|telemedicine
174534|NCT03104192|obesity|obesity
174535|NCT03104192|rural health|rural health
174536|NCT03104192|health promotion|health promotion
174537|NCT03104192|weight loss|weight loss
174538|NCT03104127|Lower-limb robotic device|lower-limb robotic device
174539|NCT03104127|Gait|gait
174540|NCT03104127|Balance|balance
174541|NCT03104127|Pressure|pressure
174542|NCT03104127|Chronic stroke|chronic stroke
174543|NCT03104127|Blood pressure|blood pressure
174544|NCT03104127|Blood velocity|blood velocity
174545|NCT03104127|Aerobic fitness|aerobic fitness
174546|NCT03104127|Strength|strength
174547|NCT03104101|PTNS|ptns
174548|NCT03104101|Neuromodulation|neuromodulation
174549|NCT03104101|TPTNS|tptns
174550|NCT03104101|Trospium chloride|trospium chloride
174551|NCT03104075|Genomics|genomics
174552|NCT03104075|Epigenomics|epigenomics
174553|NCT03104075|Pneumococcal vaccine|pneumococcal vaccine
174554|NCT03104075|Elderly|elderly
174555|NCT03104049|Parkinson's Disease|parkinson's disease
174556|NCT03104049|Neuromuscular taping|neuromuscular taping
174557|NCT03104049|Trunk|trunk
174558|NCT03104049|Posture|posture
174559|NCT03104049|Kinematic|kinematic
174560|NCT03104049|rehabilitation|rehabilitation
174561|NCT03104036|Feacal bacterial transplantation|feacal bacterial transplantation
174562|NCT03104036|Left-sided ulcerative colitis|left-sided ulcerative colitis
174563|NCT03103997|Liver|liver
174564|NCT03103997|EUS|eus
174565|NCT03103997|Biopsy|biopsy
174566|NCT03103997|Heparin|heparin
174567|NCT03103984|Obesity|obesity
174568|NCT03103984|Liver transplantation|liver transplantation
174569|NCT03103984|weight loss diet|weight loss diet
174570|NCT03103984|immunosuppression|immunosuppression
174571|NCT03103958|probiotic|probiotic
174572|NCT03103958|metagenomic|metagenomic
174573|NCT03103958|constipation|constipation
174574|NCT03103945|Atrial Fibrillation|atrial fibrillation
174575|NCT03103945|Atrial Arrhythmia|atrial arrhythmia
174576|NCT03103945|Arrhythmias, Cardiac|arrhythmias, cardiac
174577|NCT03103945|Cardiac Diseases|cardiac diseases
174578|NCT03103945|Electrophysiologic Techniques, Cardiac|electrophysiologic techniques, cardiac
174579|NCT03103945|Electrophysiology|electrophysiology
174580|NCT03103945|Remote Magnetic Navigation|remote magnetic navigation
174581|NCT03103945|Contact Detection System|contact detection system
174582|NCT03103932|biomarkers|biomarkers
174583|NCT03103932|heart failure|heart failure
174584|NCT03103932|hospital admission|hospital admission
174585|NCT03103919|Parkinson´s Disease|parkinson´s disease
174586|NCT03103919|Kinesia-360™|kinesia-360™
174587|NCT03103919|Kinesia-ONE™|kinesia-one™
174588|NCT03103919|Biosensor|biosensor
174589|NCT03103880|Patient Adherence|patient adherence
174590|NCT03103880|Mobile Applications|mobile applications
174591|NCT03103880|Mobile Health|mobile health
174592|NCT03103854|Exercise|exercise
174593|NCT03103854|Secondary Prevention|secondary prevention
174594|NCT03103854|Diabetes|diabetes
174595|NCT03103854|Rehabilitation|rehabilitation
174596|NCT03103841|Children|children
174597|NCT03103815|Amyotrophic lateral sclerosis, survival, adverse event|amyotrophic lateral sclerosis, survival, adverse event
174598|NCT03103763|Elderly|elderly
174599|NCT03103763|Anticoagulation|anticoagulation
174600|NCT03103763|Risk Assessment|risk assessment
174601|NCT03103750|Vitamin D|vitamin d
174602|NCT03103737|Well-being|well-being
174603|NCT03103737|Information and communication technologies|information and communication technologies
174604|NCT03103737|Hospital|hospital
174605|NCT03103711|Virtual reality|virtual reality
174606|NCT03103711|Well-being|well-being
174607|NCT03103711|Hospital|hospital
174608|NCT03103698|analgesia per-operative|analgesia per-operative
174609|NCT03103685|Dual antiplatelet therapy|dual antiplatelet therapy
174610|NCT03103685|Dental procedure|dental procedure
174611|NCT03103672|quality of anesthesia|quality of anesthesia
174612|NCT03103672|reduce recovery time|reduce recovery time
174613|NCT03103633|oxygen dynamics|oxygen dynamics
174614|NCT03103633|Prognosis|prognosis
174615|NCT03103555|Anti-interferon gamma autoantibody|anti-interferon gamma autoantibody
174616|NCT03103542|ITI|iti
174617|NCT03103542|rFVIIIFc|rfviiifc
174618|NCT03103542|Immune Tolerance Induction|immune tolerance induction
174619|NCT03103490|PET/MR|pet/mr
174620|NCT03103425|New onset seizures|new onset seizures
174621|NCT03103412|Active Mild Ulcerative Colitis, Active Moderate Ulcerative Colitis, Healthy Subjects|active mild ulcerative colitis, active moderate ulcerative colitis, healthy subjects
174622|NCT03103386|fermented rye bran|fermented rye bran
174623|NCT03103386|H. pylori infections|h. pylori infections
174624|NCT03103386|non-communicable diseases|non-communicable diseases
174625|NCT03103373|Echocardiography|echocardiography
174626|NCT03103373|anesthesia|anesthesia
174627|NCT03103373|general surgery|general surgery
174628|NCT03103347|EEG|eeg
174629|NCT03103347|Parkinson Disease|parkinson disease
174630|NCT03103347|Beta Oscillations|beta oscillations
174631|NCT03103308|Cancer|cancer
174632|NCT03103308|Exercise|exercise
174633|NCT03103308|Physical Function|physical function
174634|NCT03103295|tissue engineering,|tissue engineering,
174635|NCT03103295|regeneration,|regeneration,
174636|NCT03103295|repair,|repair,
174637|NCT03103295|traumatic bone defects,|traumatic bone defects,
174638|NCT03103295|regenerative therapy|regenerative therapy
174639|NCT03103269|Overweight|overweight
174640|NCT03103269|Obesity|obesity
174641|NCT03103269|Prevention|prevention
174642|NCT03103269|Diet|diet
174643|NCT03103269|Physical activity|physical activity
174644|NCT03103269|Depression|depression
174645|NCT03103269|Anxiety|anxiety
174646|NCT03103269|Stages of change|stages of change
174647|NCT03103269|Barriers|barriers
174648|NCT03103269|Perceptions|perceptions
174649|NCT03103269|Environment|environment
174650|NCT03103269|Eating Disorder|eating disorder
174651|NCT03103269|Self efficacy|self efficacy
174652|NCT03103243|Lupus|lupus
174653|NCT03103243|SLE|sle
174654|NCT03103243|Erythematosus|erythematosus
174655|NCT03103230|Motor evoked potentials|motor evoked potentials
174656|NCT03103230|aphasia|aphasia
174657|NCT03103230|prognosis|prognosis
174658|NCT03103230|stroke|stroke
174659|NCT03103204|Obesity|obesity
174660|NCT03103204|Periodontitis|periodontitis
174661|NCT03103204|Therapeutics|therapeutics
174662|NCT03103204|Chlorhexidine|chlorhexidine
174663|NCT03103152|Prostate Cancer|prostate cancer
174664|NCT03103152|Active Surveillance|active surveillance
174665|NCT03103152|Chemo-prevention|chemo-prevention
174666|NCT03103126|pedometer-determined walking|pedometer-determined walking
174667|NCT03103126|resistance exercise|resistance exercise
174668|NCT03103100|Local anesthetic|local anesthetic
174669|NCT03103100|Labor epidural|labor epidural
174670|NCT03103074|botulinum toxin|botulinum toxin
174671|NCT03103061|Computed Tomography|computed tomography
174673|NCT03102996|Graft|graft
174674|NCT03102996|Acid base|acid base
174675|NCT03102996|Metabolic acidosis|metabolic acidosis
174676|NCT03102996|Chronic kidney disease|chronic kidney disease
174677|NCT03102983|MRI, Functional|mri, functional
174678|NCT03102970|COPD, Pain, Exacerbation|copd, pain, exacerbation
174679|NCT03102918|Cannabidiol|cannabidiol
174680|NCT03102879|mesenchymal stem cells|mesenchymal stem cells
174681|NCT03102879|regenerative procedures|regenerative procedures
174682|NCT03102879|tissue engineering|tissue engineering
174683|NCT03102879|regenerative endodontic|regenerative endodontic
174684|NCT03102879|scaffold|scaffold
174685|NCT03102879|cell encapsulation|cell encapsulation
174686|NCT03102879|dental pulp|dental pulp
174687|NCT03102879|pulp regeneration|pulp regeneration
174688|NCT03102879|plasma-derived biomaterial|plasma-derived biomaterial
174689|NCT03102879|allogenic stem cells|allogenic stem cells
174690|NCT03102879|mesenchymal stromal cells|mesenchymal stromal cells
174691|NCT03102879|adult stem cells|adult stem cells
174692|NCT03102879|umbilical cord stem cells|umbilical cord stem cells
174693|NCT03102840|Carriage|carriage
174694|NCT03102840|Immunogenicity|immunogenicity
174695|NCT03102840|Pneumococcal conjugate vaccine 13 (PCV 13)|pneumococcal conjugate vaccine 13 (pcv 13)
174696|NCT03102840|Children|children
174697|NCT03102840|Pneumococcus|pneumococcus
174698|NCT03102775|poverty|poverty
174699|NCT03102775|unemployment|unemployment
174700|NCT03102775|cluster-randomized|cluster-randomized
174701|NCT03102775|family-project|family-project
174702|NCT03102762|Erectile dysfunction|erectile dysfunction
174703|NCT03102762|Botulinum toxin A|botulinum toxin a
174704|NCT03102762|Botox|botox
174705|NCT03102749|Airways|airways
174706|NCT03102749|asthma|asthma
174707|NCT03102749|overweight|overweight
174708|NCT03102736|depression|depression
174709|NCT03102736|ketamine|ketamine
174710|NCT03102736|nitroprusside|nitroprusside
174711|NCT03102723|STEMI|stemi
174712|NCT03102723|primary percutaneous coronary intervention (PPCI)|primary percutaneous coronary intervention (ppci)
174713|NCT03102723|cangrelor|cangrelor
174714|NCT03102723|reperfusion|reperfusion
174715|NCT03102697|Intragastric balloon|intragastric balloon
174716|NCT03102697|obesity|obesity
174717|NCT03102697|metabolic syndrome|metabolic syndrome
174718|NCT03102697|bariatric surgery|bariatric surgery
174719|NCT03102684|e-cigarette|e-cigarette
400609|NCT01866033|PCI-32765|pci-32765
174720|NCT03102684|electronic cigarette|electronic cigarette
174721|NCT03102684|passive exposure|passive exposure
174722|NCT03102684|secondhand exposure|secondhand exposure
174723|NCT03102684|smoking|smoking
174724|NCT03102684|respiratory system|respiratory system
174725|NCT03102619|Wireless monitoring|wireless monitoring
174726|NCT03102619|Postoperative complications|postoperative complications
174727|NCT03102619|Vital parameters|vital parameters
174728|NCT03102619|Continuous monitoring|continuous monitoring
174729|NCT03102606|Plinabulin|plinabulin
174730|NCT03102606|Pegfilgrastim|pegfilgrastim
174731|NCT03102606|Duration of Severe Neutropenia|duration of severe neutropenia
174732|NCT03102606|Bone Pain|bone pain
174733|NCT03102580|Shared Decision Making|shared decision making
174734|NCT03102554|Exome Sequencing|exome sequencing
174735|NCT03102502|Coronary Heart Disease|coronary heart disease
174736|NCT03102502|Atherosclerosis|atherosclerosis
174737|NCT03102502|Vascular Endothelium|vascular endothelium
174738|NCT03102502|Counterpulsation, External|counterpulsation, external
174739|NCT03102463|Insulin sensitivity|insulin sensitivity
174740|NCT03102463|Obesity|obesity
174741|NCT03102463|Insulin resistance|insulin resistance
174742|NCT03102463|Milk derived hydrolysate|milk derived hydrolysate
174743|NCT03102463|Hyperinsulinemic-euglycaemic clamp|hyperinsulinemic-euglycaemic clamp
174744|NCT03102437|Cardiac Contractility Modulation|cardiac contractility modulation
174745|NCT03102437|CCM|ccm
174746|NCT03102437|FIX-HF-5CA|fix-hf-5ca
174747|NCT03102437|Continued Access|continued access
174748|NCT03102398|Erectile Dysfunction|erectile dysfunction
174749|NCT03102398|PDE5 inhibitor|pde5 inhibitor
174750|NCT03102398|Sexual Dysfunction|sexual dysfunction
174751|NCT03102385|blood donation|blood donation
174752|NCT03102385|motivation|motivation
174753|NCT03102385|donor retention|donor retention
174754|NCT03102372|FFM|ffm
174755|NCT03102372|VLCD|vlcd
174756|NCT03102372|exercise|exercise
174757|NCT03102372|Protein|protein
174758|NCT03102372|Obesity|obesity
174759|NCT03102346|cardiorespiratory fitness|cardiorespiratory fitness
174760|NCT03102346|coronary artery disease|coronary artery disease
174761|NCT03102346|cardiac rehabilitation|cardiac rehabilitation
174762|NCT03102346|remote control|remote control
174763|NCT03102346|major adverse cardiac and cerebrovascular events|major adverse cardiac and cerebrovascular events
174764|NCT03102320|cholangiocarcinoma|cholangiocarcinoma
174765|NCT03102320|pancreatic cancer|pancreatic cancer
174766|NCT03102320|triple-negative breast cancer|triple-negative breast cancer
174767|NCT03102320|non-small cell lung cancer|non-small cell lung cancer
174768|NCT03102320|thymic carcinoma|thymic carcinoma
174769|NCT03102320|gastric including gastroesophageal junction cancer|gastric including gastroesophageal junction cancer
174770|NCT03102307|Targeted axillary dissection|targeted axillary dissection
174771|NCT03102307|Sentinel node biopsy|sentinel node biopsy
174772|NCT03102307|Neoadjuvant chemotherapy|neoadjuvant chemotherapy
174773|NCT03102255|Nasotracheal intubation|nasotracheal intubation
174774|NCT03102229|Activity Monitoring|activity monitoring
174775|NCT03102229|Chemotherapy|chemotherapy
174776|NCT03102229|Radiotherapy|radiotherapy
174777|NCT03102164|heart failure|heart failure
174778|NCT03102164|decompensation|decompensation
174779|NCT03102125|heart transplant, acute graft rejection, chronic graft rejection|heart transplant, acute graft rejection, chronic graft rejection
174780|NCT03102112|Glioma APT MRI|glioma apt mri
174781|NCT03102073|Reading speed|reading speed
174782|NCT03102047|microsatellite stable|microsatellite stable
174783|NCT03102047|MSS|mss
174784|NCT03102047|durvalumab|durvalumab
174785|NCT03102047|NSABP|nsabp
174786|NCT03102008|Transdiagnostic Treatment|transdiagnostic treatment
174787|NCT03102008|Emotional Disorders|emotional disorders
174788|NCT03102008|Adolescence|adolescence
174789|NCT03102008|Psychotherapy|psychotherapy
174790|NCT03101995|Treatment|treatment
174791|NCT03101995|Locally advanced cervical cancer|locally advanced cervical cancer
174792|NCT03101995|Renal failure|renal failure
174793|NCT03101995|Gemcitabine|gemcitabine
174794|NCT03101969|language|language
174795|NCT03101969|scheduled|scheduled
174796|NCT03101969|appointment|appointment
174797|NCT03101956|Spine Manipulation|spine manipulation
174798|NCT03101943|Sugar|sugar
174799|NCT03101943|Sweetened|sweetened
174800|NCT03101943|Beverages|beverages
174801|NCT03101891|Amnioinfusion|amnioinfusion
174802|NCT03101891|Fetal therapy|fetal therapy
174803|NCT03101891|Bilateral Renal Agenesis|bilateral renal agenesis
174804|NCT03101891|Fetal Renal Failure|fetal renal failure
174805|NCT03101891|Lower Urinary Tract Obstruction (LUTO)|lower urinary tract obstruction (luto)
174806|NCT03101891|Anhydramnios|anhydramnios
174807|NCT03101878|Healthy Volunteers, IONIS AGT-Lrx|healthy volunteers, ionis agt-lrx
174808|NCT03101865|Type 1 diabetes|type 1 diabetes
174809|NCT03101865|Artificial Pancreas|artificial pancreas
174810|NCT03101865|Closed-loop glucose control|closed-loop glucose control
174811|NCT03101865|Very young children|very young children
174812|NCT03101865|Continuous subcutaneous insulin infusion|continuous subcutaneous insulin infusion
174813|NCT03101865|Continuous glucose monitoring|continuous glucose monitoring
174814|NCT03101852|severe acute malnutrition|severe acute malnutrition
174815|NCT03101852|moderate acute malnutrition|moderate acute malnutrition
174816|NCT03101852|HIV-infection|hiv-infection
174817|NCT03101852|adolescents|adolescents
174818|NCT03101852|antiretroviral|antiretroviral
174819|NCT03101852|Africa|africa
174820|NCT03101852|ready-to-use food|ready-to-use food
174821|NCT03101852|outpatient care|outpatient care
174822|NCT03101839|AZD4785|azd4785
174823|NCT03101839|KRAS|kras
174824|NCT03101839|KRAS mutations|kras mutations
174825|NCT03101839|Non-small cell lung cancer|non-small cell lung cancer
174826|NCT03101839|Advanced solid tumours|advanced solid tumours
174827|NCT03101826|Polyvagal Theory|polyvagal theory
174828|NCT03101826|Respiratory Sinus Arrhythmia|respiratory sinus arrhythmia
174829|NCT03101826|Heart rate|heart rate
174830|NCT03101826|Social Behavior|social behavior
174831|NCT03101826|Arginine Vasopressin|arginine vasopressin
174832|NCT03101826|Dichotic Listening Tests|dichotic listening tests
174833|NCT03101826|Oxytocin|oxytocin
174834|NCT03101826|Hyperacusis|hyperacusis
174835|NCT03101826|Affect|affect
174836|NCT03101826|Auditory perception|auditory perception
174837|NCT03101826|Sound spectrography|sound spectrography
174838|NCT03101800|Azathioprine|azathioprine
174839|NCT03101800|Allopurinol|allopurinol
174840|NCT03101800|Antimetabolites|antimetabolites
174841|NCT03101800|Ulcerative Colitis|ulcerative colitis
174842|NCT03101787|ECPR|ecpr
174843|NCT03101787|Extracorporeal CardioPulmonary Resuscitation|extracorporeal cardiopulmonary resuscitation
174844|NCT03101787|OHCA|ohca
174845|NCT03101787|Out-of-Hospital Cardiac Arrest|out-of-hospital cardiac arrest
174846|NCT03101787|CPR|cpr
174847|NCT03101787|CardioPulmonary Resuscitation|cardiopulmonary resuscitation
174848|NCT03101787|ECMO|ecmo
174849|NCT03101787|ExtraCorporeal Membrane Oxygenation|extracorporeal membrane oxygenation
174850|NCT03101787|Refractory Cardiac Arrest|refractory cardiac arrest
174851|NCT03101774|inspiratory muscle training|inspiratory muscle training
174852|NCT03101722|presbycusis|presbycusis
174853|NCT03101722|tinnitus|tinnitus
174854|NCT03101722|cognitive impairment|cognitive impairment
174855|NCT03101722|Huperzine A|huperzine a
174856|NCT03101722|age-related hearing impairment|age-related hearing impairment
174857|NCT03101696|coronary angiography|coronary angiography
174858|NCT03101696|coronary conductance|coronary conductance
174859|NCT03101696|hyperemia|hyperemia
174860|NCT03101696|regadenoson|regadenoson
174861|NCT03101696|fractional flow reserve|fractional flow reserve
174862|NCT03101696|coronary flow reserve|coronary flow reserve
174863|NCT03101696|index of microcirculatory resistance|index of microcirculatory resistance
174864|NCT03101631|Elderly population with cancer|elderly population with cancer
174865|NCT03101631|Toxicity risk|toxicity risk
174866|NCT03101631|Mortality risk|mortality risk
174867|NCT03101631|Frailty conditions in elderly population|frailty conditions in elderly population
174868|NCT03101631|Chemotherapy in elderly population|chemotherapy in elderly population
174869|NCT03101618|allergen|allergen
174870|NCT03101618|allergy|allergy
174871|NCT03101618|pet|pet
174872|NCT03101592|antiretroviral therapy|antiretroviral therapy
174873|NCT03101592|retention|retention
174874|NCT03101592|ART|art
174875|NCT03101592|cost-effectiveness|cost-effectiveness
174876|NCT03101592|virologic suppression|virologic suppression
174877|NCT03101579|Leptomeningeal metastasis|leptomeningeal metastasis
174878|NCT03101579|Recurrence|recurrence
174879|NCT03101579|Intrathecal chemotherapy|intrathecal chemotherapy
174880|NCT03101579|Pemetrexed|pemetrexed
174881|NCT03101540|Major Depressive Disorder,|major depressive disorder,
174882|NCT03101540|omega-3 polyunsaturated fatty acid|omega-3 polyunsaturated fatty acid
174883|NCT03101540|PUFA|pufa
174884|NCT03101540|Pregnancy|pregnancy
174885|NCT03101540|eicosapentaenoic acid (EPA) supplementation|eicosapentaenoic acid (epa) supplementation
174886|NCT03101540|cytokine|cytokine
174887|NCT03101540|docosahexaenoic acid (DHA)|docosahexaenoic acid (dha)
174888|NCT03101527|Major Depressive Disorder|major depressive disorder
174889|NCT03101527|omega-3 polyunsaturated fatty acid|omega-3 polyunsaturated fatty acid
174890|NCT03101527|PUFA|pufa
174891|NCT03101527|Pregnancy|pregnancy
174892|NCT03101527|eicosapentaenoic acid (EPA) supplementation|eicosapentaenoic acid (epa) supplementation
174893|NCT03101514|head and neck|head and neck
174894|NCT03101514|tumor|tumor
174895|NCT03101514|radiotherapy|radiotherapy
174896|NCT03101514|mucositis|mucositis
174897|NCT03101514|toxicity|toxicity
174898|NCT03101514|Kanglaite injection|kanglaite injection
174899|NCT03101488|KN035|kn035
174900|NCT03101488|phase 1|phase 1
174901|NCT03101475|Colorectal Cancer|colorectal cancer
174902|NCT03101475|Liver Metastases|liver metastases
174903|NCT03101475|Durvalumab|durvalumab
174904|NCT03101475|Tremelimumab|tremelimumab
174905|NCT03101436|Insulin Resistance|insulin resistance
174906|NCT03101436|Extra Virgin Olive Oil|extra virgin olive oil
174907|NCT03101436|Red Wine|red wine
174908|NCT03101436|Diet|diet
174909|NCT03101436|Microbiota|microbiota
174910|NCT03101423|thalassemia|thalassemia
174911|NCT03101423|transplantation|transplantation
174912|NCT03101423|chimerism|chimerism
174913|NCT03101423|donor ymphocytes|donor ymphocytes
174914|NCT03101410|Gluten|gluten
174915|NCT03101410|sport performance|sport performance
174916|NCT03101397|serum KL-6|serum kl-6
174917|NCT03101397|pulmonary function test|pulmonary function test
174918|NCT03101397|CT score|ct score
174919|NCT03101397|evaluation|evaluation
174920|NCT03101358|cutaneous metastases|cutaneous metastases
174921|NCT03101358|cutaneous metastasis|cutaneous metastasis
174922|NCT03101358|skin metastases|skin metastases
174923|NCT03101358|skin metastasis|skin metastasis
174924|NCT03101306|cervix, radiotherapy, magnetic resonance imaging|cervix, radiotherapy, magnetic resonance imaging
174925|NCT03101293|Drug therapy|drug therapy
174926|NCT03101267|Cedar pollinosis|cedar pollinosis
174927|NCT03101267|ASP4070|asp4070
174928|NCT03101267|DNA plasmid vaccine|dna plasmid vaccine
174929|NCT03101254|Melanoma|melanoma
174930|NCT03101241|Essential Tremor|essential tremor
174931|NCT03101241|Movement Disorders|movement disorders
174932|NCT03101241|thalamocortical dysrhythmias|thalamocortical dysrhythmias
174933|NCT03101228|Physical Activity|physical activity
174934|NCT03101228|Metabolic Syndrome|metabolic syndrome
174935|NCT03101228|Insulin Sensitivity|insulin sensitivity
174936|NCT03101228|Cardiovascular Risk Factor|cardiovascular risk factor
174937|NCT03101228|Sedentary Lifestyle|sedentary lifestyle
174938|NCT03101228|Accelerometry|accelerometry
174939|NCT03101189|safety|safety
174940|NCT03101189|Japanese|japanese
174941|NCT03101189|pharmacokinetics|pharmacokinetics
174942|NCT03101176|multiparametric ultrasound|multiparametric ultrasound
174943|NCT03101176|prostate cancer|prostate cancer
174944|NCT03101176|contrast ultrasound|contrast ultrasound
174945|NCT03101176|CEUS|ceus
174946|NCT03101176|radical prostatectomy|radical prostatectomy
174947|NCT03101150|Maternal vitamin D|maternal vitamin d
174948|NCT03101150|Deficiency|deficiency
174949|NCT03101150|Insufficiency|insufficiency
174950|NCT03101150|Pregnancy|pregnancy
174951|NCT03101150|Pre-eclampsia|pre-eclampsia
174952|NCT03101150|IUGR|iugr
174953|NCT03101124|Hemostasis, Surgical|hemostasis, surgical
174954|NCT03101124|Tranexamic Acid|tranexamic acid
174955|NCT03101124|Antifibrinolytic Agents|antifibrinolytic agents
175056|NCT03100565|coughing|coughing
174956|NCT03101124|Administration, Cutaneous|administration, cutaneous
174957|NCT03101124|Administration, Intravenous|administration, intravenous
174958|NCT03101124|Administration, Topical|administration, topical
174959|NCT03101072|Gram-negative bacteremia|gram-negative bacteremia
174960|NCT03101072|antibiotic durations|antibiotic durations
174961|NCT03101072|point-of-care randomization|point-of-care randomization
174962|NCT03101059|Tracheal|tracheal
174963|NCT03101059|Bronchial|bronchial
174964|NCT03101059|Tracheobronchiomegaly|tracheobronchiomegaly
174965|NCT03101059|Collapse|collapse
174966|NCT03101059|obstructive sleep apnea syndrome|obstructive sleep apnea syndrome
174967|NCT03101059|Computer Tomography|computer tomography
174968|NCT03101059|Impedance Tomography|impedance tomography
174969|NCT03101046|Docetaxel|docetaxel
174970|NCT03101046|Cabazitaxel|cabazitaxel
174971|NCT03101033|Herniated lumbar disc|herniated lumbar disc
174972|NCT03101033|Epidural neuroplasty|epidural neuroplasty
174973|NCT03101033|Epidural injection|epidural injection
174974|NCT03101020|Visceral Manipulation|visceral manipulation
174975|NCT03101007|Comparative study|comparative study
174976|NCT03101007|Knee Prosthesis|knee prosthesis
174977|NCT03101007|Prosthesis Design|prosthesis design
174978|NCT03101007|Treatment Outcome|treatment outcome
174979|NCT03101007|Follow-up studies|follow-up studies
174980|NCT03101007|Arthroplast, Replacement, Knee/methods|arthroplast, replacement, knee/methods
174981|NCT03100981|Mindfulness-Based Cognitive Therapy|mindfulness-based cognitive therapy
174982|NCT03100981|Internet-delivered|internet-delivered
174983|NCT03100981|Breast cancer|breast cancer
174984|NCT03100981|Prostate cancer|prostate cancer
174985|NCT03100981|Survivors|survivors
174986|NCT03100981|Depression|depression
174987|NCT03100981|Anxiety|anxiety
174988|NCT03100981|Stress|stress
174989|NCT03100838|Proton Pump Inhibitor|proton pump inhibitor
174990|NCT03100838|Bioequivalence|bioequivalence
174991|NCT03100838|Drug-Drug Interaction|drug-drug interaction
174992|NCT03100838|Modified Release|modified release
174993|NCT03100838|Nifedipine|nifedipine
174994|NCT03100825|QVM149,|qvm149,
174995|NCT03100825|Asthma,|asthma,
174996|NCT03100825|Japanese,|japanese,
174997|NCT03100825|Allergic asthma,|allergic asthma,
174998|NCT03100825|Allergy triggered asthma,|allergy triggered asthma,
174999|NCT03100825|Reactive asthma,|reactive asthma,
175000|NCT03100825|Asthma attack,|asthma attack,
175001|NCT03100825|Difficulty breathing|difficulty breathing
175002|NCT03100812|Hypertensive|hypertensive
175003|NCT03100812|Hypertension|hypertension
175004|NCT03100812|Filipino|filipino
175005|NCT03100799|Osteoarthritis|osteoarthritis
175006|NCT03100799|Senescence|senescence
175007|NCT03100799|Magnetic resonance imaging|magnetic resonance imaging
175008|NCT03100799|Arthroscopy|arthroscopy
175009|NCT03100799|Arthrocentesis|arthrocentesis
175010|NCT03100799|Biomarker|biomarker
175011|NCT03100786|Tuberculosis|tuberculosis
175012|NCT03100786|tuberculous meningitis|tuberculous meningitis
175013|NCT03100786|drug induced liver injury|drug induced liver injury
175014|NCT03100786|dexamethasone|dexamethasone
175015|NCT03100786|LTA4H|lta4h
175016|NCT03100786|host genotype|host genotype
175017|NCT03100786|personalized medicine|personalized medicine
175018|NCT03100773|alpha-amylases|alpha-amylases
175019|NCT03100773|child|child
175020|NCT03100773|cortisol|cortisol
175021|NCT03100773|dental anxiety|dental anxiety
175022|NCT03100773|dental atraumatic restorative treatment|dental atraumatic restorative treatment
175023|NCT03100773|health education|health education
175024|NCT03100773|microbiota|microbiota
175025|NCT03100773|oral hygiene|oral hygiene
175026|NCT03100773|quality of life|quality of life
175027|NCT03100773|saliva|saliva
175028|NCT03100734|Observational|observational
175029|NCT03100734|Biosimilar|biosimilar
175030|NCT03100734|Etanercept|etanercept
175031|NCT03100734|Benepali|benepali
175032|NCT03100734|Enbrel|enbrel
175033|NCT03100721|Education|education
175034|NCT03100721|Neuroscience|neuroscience
175035|NCT03100721|Chronic pain|chronic pain
175036|NCT03100721|Musculoskeletal pain|musculoskeletal pain
175037|NCT03100721|Primary care|primary care
175038|NCT03100656|psychopathology|psychopathology
175039|NCT03100656|treatment|treatment
175040|NCT03100656|epoxide hydrolases|epoxide hydrolases
175041|NCT03100656|polyunsaturated fatty acids|polyunsaturated fatty acids
175042|NCT03100656|eicosanoids|eicosanoids
175043|NCT03100643|HIV/AIDS, mHealth, intervention development, African American men|hiv/aids, mhealth, intervention development, african american men
175044|NCT03100617|Family caregiver|family caregiver
175045|NCT03100604|middle ear pressure|middle ear pressure
175046|NCT03100604|sevoflurane|sevoflurane
175047|NCT03100604|desflurane|desflurane
175048|NCT03100578|PANCREAS|pancreas
175049|NCT03100578|ENDOSCOPIC INTERVENTION|endoscopic intervention
175050|NCT03100578|PLASTIC STENT|plastic stent
175051|NCT03100578|SELF EXPANDING METALLIC STENT|self expanding metallic stent
175052|NCT03100578|ENDOSCOPIC TRANSMURAL DRAINAGE|endoscopic transmural drainage
175053|NCT03100578|WALLED OFF PANCREATIC NECROSIS|walled off pancreatic necrosis
175054|NCT03100565|colposcopy|colposcopy
175055|NCT03100565|pain|pain
175057|NCT03100565|anesthetic spray|anesthetic spray
175058|NCT03100552|Colonoscopy|colonoscopy
175059|NCT03100552|Endoscopic resection|endoscopic resection
175060|NCT03100552|Sessile serrated adenoma|sessile serrated adenoma
175062|NCT03100539|Caregiver|caregiver
175063|NCT03100539|Fascia|fascia
175064|NCT03100526|High-Risk Patients|high-risk patients
175065|NCT03100500|QVM149,|qvm149,
175066|NCT03100500|Asthma,|asthma,
175067|NCT03100500|Japanese,|japanese,
175068|NCT03100500|Allergic asthma,|allergic asthma,
175069|NCT03100500|Allergy triggered asthma,|allergy triggered asthma,
175070|NCT03100500|Reactive asthma,|reactive asthma,
175071|NCT03100500|Asthma attack,|asthma attack,
175072|NCT03100500|Difficulty breathing|difficulty breathing
175073|NCT03100474|tremor|tremor
175074|NCT03100474|Parkinson's|parkinson's
175075|NCT03100474|movement|movement
175076|NCT03100474|neuropathic|neuropathic
175077|NCT03100474|pain|pain
175078|NCT03100461|Cancer Screening|cancer screening
175079|NCT03100461|Colon Cancer|colon cancer
175080|NCT03100461|Colon Cancer Screening|colon cancer screening
175081|NCT03100409|Cervical cancer|cervical cancer
175082|NCT03100383|gestational diabetes|gestational diabetes
175083|NCT03100383|Type2 Diabetes|type2 diabetes
175084|NCT03100331|neuropsychological outcomes|neuropsychological outcomes
175085|NCT03100331|HIV/AIDS|hiv/aids
175086|NCT03100331|international adoption|international adoption
175087|NCT03100331|perinatal infection|perinatal infection
175088|NCT03100292|primary bariatric surgery|primary bariatric surgery
175089|NCT03100292|morbid obesity|morbid obesity
175090|NCT03100292|South Korea|south korea
175091|NCT03100292|sleeve gastrectomy|sleeve gastrectomy
175092|NCT03100292|Roux-en Y gastric bypass|roux-en y gastric bypass
175093|NCT03100279|cognitive behavioral therapy|cognitive behavioral therapy
175094|NCT03100279|treatment mediators|treatment mediators
175095|NCT03100279|trajectories of change|trajectories of change
175096|NCT03100253|Rheumatoid Arthritis|rheumatoid arthritis
175097|NCT03100253|Tocilizumab|tocilizumab
175098|NCT03100253|anti-TNF treatment|anti-tnf treatment
175099|NCT03100201|robotic-assisted rehabilitation|robotic-assisted rehabilitation
175100|NCT03100201|humeral fracture|humeral fracture
175101|NCT03100201|randomised controlled study|randomised controlled study
175102|NCT03100188|peritoneal dialysis|peritoneal dialysis
175103|NCT03100188|incremental peritoneal dialysis|incremental peritoneal dialysis
175104|NCT03100188|quality of life|quality of life
175105|NCT03100188|end stage renal disease|end stage renal disease
175106|NCT03100188|adequacy|adequacy
175107|NCT03100162|probiotics|probiotics
175108|NCT03100162|metabolic syndrome|metabolic syndrome
175109|NCT03100162|obesity|obesity
175110|NCT03100162|microbiome|microbiome
175111|NCT03100136|PET|pet
175112|NCT03100136|[11C]PF-06809247|[11c]pf-06809247
175113|NCT03100136|Reliability|reliability
175114|NCT03100136|Scan, Safety|scan, safety
175115|NCT03100110|Brain-Computer Interface|brain-computer interface
175116|NCT03100110|Brain-Machine Interface|brain-machine interface
175117|NCT03100110|Prefrontal Cortex|prefrontal cortex
175118|NCT03100084|Preeclampsia|preeclampsia
175119|NCT03100084|Diabetes in Pregnancy|diabetes in pregnancy
175120|NCT03100084|Fetal Growth Restriction|fetal growth restriction
175121|NCT03100084|Reduced Fetal Movements|reduced fetal movements
175122|NCT03100058|Obesity|obesity
175123|NCT03100058|Overweight|overweight
175124|NCT03100045|HPV|hpv
175125|NCT03100045|suppository|suppository
175126|NCT03100045|Artesunate|artesunate
175127|NCT03100045|artemisinin|artemisinin
175128|NCT03100045|anal dysplasia|anal dysplasia
175129|NCT03100045|treatment|treatment
175130|NCT03100045|alternative treatment|alternative treatment
175131|NCT03100045|anal precancer|anal precancer
175132|NCT03100045|Johns Hopkins|johns hopkins
175133|NCT03100045|Sandy Fang|sandy fang
175134|NCT03100045|Frantz Viral Therapeutics|frantz viral therapeutics
175135|NCT03100045|Wisconsin|wisconsin
175136|NCT03100045|Evie Carchman|evie carchman
175137|NCT03100032|Spinal Fusion|spinal fusion
175138|NCT03100032|Lumbar Interbody Fusion|lumbar interbody fusion
175139|NCT03100032|Autologous Stem Cell Therapy|autologous stem cell therapy
175140|NCT03100032|Bone Graft|bone graft
175141|NCT03100032|Demineralized Bone Matrix|demineralized bone matrix
175142|NCT03100032|Polyetheretherketone (PEEK) cage|polyetheretherketone (peek) cage
175143|NCT03100019|Resveratrol|resveratrol
175144|NCT03100019|Cerebral blood flow|cerebral blood flow
175145|NCT03100019|Cognition|cognition
175146|NCT03099993|Unilateral cerebral palsy|unilateral cerebral palsy
175147|NCT03099993|kinematics|kinematics
175148|NCT03099993|electromyography|electromyography
175149|NCT03099993|constraint-induced therapy|constraint-induced therapy
175150|NCT03099993|muscle activation|muscle activation
175151|NCT03099993|upper limb|upper limb
175152|NCT03099993|child|child
175153|NCT03099941|Low Back Pain, Mechanical, Biofeedback, Pain, Chronic|low back pain, mechanical, biofeedback, pain, chronic
175154|NCT03099902|Asthma|asthma
175155|NCT03099902|Wheezing|wheezing
175156|NCT03099902|GSTP1|gstp1
175157|NCT03099902|TNFa|tnfa
175158|NCT03099902|Secondhand smoking|secondhand smoking
175159|NCT03099902|Passive smoking|passive smoking
175160|NCT03099902|Intrauterine smoking|intrauterine smoking
175161|NCT03099850|Chronic Pancreatitis|chronic pancreatitis
175162|NCT03099850|Data management|data management
175163|NCT03099850|Regulatory compliance|regulatory compliance
175164|NCT03099850|Protocol monitoring|protocol monitoring
175165|NCT03099772|Cognitive-Behavioral Therapy|cognitive-behavioral therapy
175166|NCT03099759|Vitamin D Dosing Regimens|vitamin d dosing regimens
175167|NCT03099759|Blood Serum 25(OH)D3 Levels|blood serum 25(oh)d3 levels
175168|NCT03099746|chronically critically ill|chronically critically ill
175169|NCT03099746|surrogate decision maker|surrogate decision maker
175170|NCT03099707|Treatment|treatment
175172|NCT03099707|South Africa|south africa
175173|NCT03099694|NRDS|nrds
175174|NCT03099694|nHFOV|nhfov
175175|NCT03099694|nCPAP|ncpap
175176|NCT03099694|preterm infants|preterm infants
175177|NCT03099655|Heart Failure|heart failure
175178|NCT03099655|Cardiac Pacing|cardiac pacing
175179|NCT03099655|Cardiac Resynchronization Therapy|cardiac resynchronization therapy
175180|NCT03099655|Left Ventricular Lead|left ventricular lead
175181|NCT03099642|lumbar puncture|lumbar puncture
175182|NCT03099642|Point of care ultrasound|point of care ultrasound
175183|NCT03099642|children|children
175184|NCT03099629|Inspiratory muscle training|inspiratory muscle training
175185|NCT03099629|Diaphragmatic surface electromyography|diaphragmatic surface electromyography
175186|NCT03099629|Respiratory muscle strength|respiratory muscle strength
175187|NCT03099629|Functional capacity|functional capacity
175188|NCT03099616|propofol|propofol
175189|NCT03099616|CLADS|clads
175190|NCT03099616|Desflurane|desflurane
175191|NCT03099616|Obesity|obesity
175192|NCT03099564|Pembrolizumab|pembrolizumab
175193|NCT03099564|Y90 Radioembolization|y90 radioembolization
175194|NCT03099564|KEYTRUDA®|keytruda®
175195|NCT03099564|TheraSphere®|therasphere®
175196|NCT03099564|PD-1|pd-1
175197|NCT03099564|IgG4/kappa isotype|igg4/kappa isotype
175198|NCT03099551|Plaque|plaque
175199|NCT03099551|oral hygiene|oral hygiene
175200|NCT03099551|gingivitis|gingivitis
175201|NCT03099551|sonic toothbrush|sonic toothbrush
175202|NCT03099551|manual toothbrush|manual toothbrush
175203|NCT03099538|Ixekizumab|ixekizumab
175204|NCT03099538|Bullous Pemphigoid|bullous pemphigoid
175205|NCT03099538|Pemphigoid|pemphigoid
175206|NCT03099538|IL17|il17
175207|NCT03099538|IL-17|il-17
175208|NCT03099538|Interleukin 17|interleukin 17
175209|NCT03099512|Patellofemoral pain|patellofemoral pain
175210|NCT03099512|foot deformity|foot deformity
175211|NCT03099512|foot pronation|foot pronation
175212|NCT03099512|short foot exercise|short foot exercise
175213|NCT03099473|electroacupuncture|electroacupuncture
175214|NCT03099473|trochlear nerve palsy|trochlear nerve palsy
175215|NCT03099473|eyeball movement|eyeball movement
175216|NCT03099473|diplopia|diplopia
175217|NCT03099473|ocular motility disorder|ocular motility disorder
175218|NCT03099460|electroacupuncture|electroacupuncture
175219|NCT03099460|abducens nerve palsy|abducens nerve palsy
175220|NCT03099460|eyeball movement|eyeball movement
175221|NCT03099460|diplopia|diplopia
175222|NCT03099460|ocular motility disorder|ocular motility disorder
175223|NCT03099447|electroacupuncture|electroacupuncture
175224|NCT03099447|oculomotor nerve palsy|oculomotor nerve palsy
175225|NCT03099447|rehabilitation|rehabilitation
175226|NCT03099447|diplopia|diplopia
175227|NCT03099447|ocular motility disorder|ocular motility disorder
175228|NCT03099434|Live Donor Transplant, Social Media, Education, Advocacy, Live Donor|live donor transplant, social media, education, advocacy, live donor
175229|NCT03099421|Benign prostatic obstruction|benign prostatic obstruction
175230|NCT03099421|benign prostatic enlargement|benign prostatic enlargement
175231|NCT03099421|benign prostatic hyperplasia|benign prostatic hyperplasia
175232|NCT03099421|prostatic artery embolization|prostatic artery embolization
175233|NCT03099421|Quality of Life|quality of life
175234|NCT03099421|IPSS|ipss
175235|NCT03099421|DAN-PSS|dan-pss
175236|NCT03099421|Complications|complications
175237|NCT03099408|Recurrence|recurrence
175238|NCT03099408|Lactobacillus Vaginal Suppositories|lactobacillus vaginal suppositories
175239|NCT03099395|myocardial infarction|myocardial infarction
175240|NCT03099369|Peripheral Artery Disease|peripheral artery disease
175241|NCT03099369|Peripheral Arterial Disease|peripheral arterial disease
175242|NCT03099369|Exercise|exercise
175243|NCT03099369|Step Count|step count
175244|NCT03099369|Fitness Monitor|fitness monitor
175245|NCT03099369|Mobile Health|mobile health
175246|NCT03099369|Walking Ability|walking ability
175247|NCT03099369|Quality of Life|quality of life
175248|NCT03099343|sodium|sodium
175249|NCT03099343|salt|salt
175250|NCT03099343|diet|diet
175251|NCT03099343|tailored messaging|tailored messaging
175252|NCT03099343|mobile application|mobile application
175253|NCT03099317|Knee Osteoarthritis|knee osteoarthritis
175254|NCT03099317|Sinew Acupuncture|sinew acupuncture
175255|NCT03099317|Pain|pain
175256|NCT03099304|Vitiligo|vitiligo
175257|NCT03099304|depigmenting disorder|depigmenting disorder
175258|NCT03099304|topical JAK inhibitor|topical jak inhibitor
175259|NCT03099278|hepatitis D|hepatitis d
175260|NCT03099278|Ezetimibe|ezetimibe
175261|NCT03099278|HDV RNA|hdv rna
175262|NCT03099161|Advanced Solid Tumor|advanced solid tumor
175263|NCT03099161|Programmed Cell Death Receptor 1 (PD-1)|programmed cell death receptor 1 (pd-1)
175264|NCT03099161|Programmed Cell Death Receptor Ligand 1 (PD-L1)|programmed cell death receptor ligand 1 (pd-l1)
175265|NCT03099161|PD1|pd1
175266|NCT03099161|PD-1|pd-1
175267|NCT03099161|PDL1|pdl1
175268|NCT03099161|PD-L1|pd-l1
175269|NCT03099109|TIM-3|tim-3
175270|NCT03099109|PD-L1|pd-l1
175271|NCT03099096|SB240563|sb240563
175272|NCT03099096|Mepolizumab|mepolizumab
175273|NCT03099096|self-administration|self-administration
175274|NCT03099096|eosinophilic asthma|eosinophilic asthma
175275|NCT03099096|autoinjector|autoinjector
175276|NCT03099083|Psoriasis|psoriasis
175277|NCT03099083|Adalimumab|adalimumab
175278|NCT03099083|Humira|humira
175279|NCT03099083|Korea|korea
175280|NCT03099070|Stress|stress
175281|NCT03099070|Fasting|fasting
175282|NCT03099070|Migraine|migraine
175283|NCT03099031|Ottawa score|ottawa score
175284|NCT03099031|tinzaparin|tinzaparin
175285|NCT03099031|low-molecular weight heparin|low-molecular weight heparin
175286|NCT03099031|anticoagulants|anticoagulants
175287|NCT03099031|venous thrombosis|venous thrombosis
175288|NCT03099031|thromboembolism|thromboembolism
175289|NCT03099031|hemostatic disorders|hemostatic disorders
175290|NCT03099031|vascular disease|vascular disease
175291|NCT03099031|neoplasms|neoplasms
175292|NCT03099031|breast neoplasms|breast neoplasms
175293|NCT03099031|lung neoplasms|lung neoplasms
175294|NCT03099031|prostatic neoplasms|prostatic neoplasms
175295|NCT03099031|colorectal neoplasms|colorectal neoplasms
175296|NCT03099031|genital neoplasms|genital neoplasms
175297|NCT03099031|urogenital neoplasms|urogenital neoplasms
175298|NCT03099031|intestinal neoplasms|intestinal neoplasms
175299|NCT03099031|digestive system neoplasms|digestive system neoplasms
175300|NCT03099031|lymphoma|lymphoma
175301|NCT03099031|leukemia|leukemia
175302|NCT03099031|multiple myeloma|multiple myeloma
175303|NCT03099031|lymphoproliferative disorders|lymphoproliferative disorders
175304|NCT03099031|myeloproliferative disorders|myeloproliferative disorders
175305|NCT03099031|lymphatic disease|lymphatic disease
175306|NCT03099018|GAS|gas
175307|NCT03099018|pharyngitis|pharyngitis
175308|NCT03099018|children|children
175309|NCT03099018|RADT|radt
175310|NCT03099005|neuropathic pain|neuropathic pain
175311|NCT03099005|human immunovirus|human immunovirus
175312|NCT03099005|vaporized cannabis|vaporized cannabis
175313|NCT03098979|Chronic Heart Failure|chronic heart failure
175314|NCT03098979|Heart Failure with Preserved Ejection Fraction|heart failure with preserved ejection fraction
175315|NCT03098953|Ocular Installation|ocular installation
175316|NCT03098927|Motor Imagery|motor imagery
175317|NCT03098927|Spinal Cord Injury|spinal cord injury
175318|NCT03098927|Motor Function Improvement|motor function improvement
175319|NCT03098914|Pathogen|pathogen
175320|NCT03098914|Mortality|mortality
175321|NCT03098914|Community-acquired Pneumonia|community-acquired pneumonia
175322|NCT03098914|Risk factors|risk factors
175323|NCT03098901|TTR Amyloidosis|ttr amyloidosis
175324|NCT03098901|Heart Failure with Preserved Ejection Fraction|heart failure with preserved ejection fraction
175325|NCT03098901|Ventricular arrhythmia|ventricular arrhythmia
175326|NCT03098901|Cardiac Conduction Disturbances|cardiac conduction disturbances
175327|NCT03098888|side effects|side effects
175328|NCT03098888|decision making|decision making
175329|NCT03098888|indications|indications
175330|NCT03098888|risk factors|risk factors
175331|NCT03098862|Ebola Virus|ebola virus
175332|NCT03098862|Genome-Wide Association Study|genome-wide association study
175333|NCT03098862|Liberia|liberia
175334|NCT03098862|Ebola Survivors|ebola survivors
175335|NCT03098862|Ebola Contacts|ebola contacts
175336|NCT03098849|Buteyko-based breathing technique training|buteyko-based breathing technique training
175337|NCT03098836|metastatic|metastatic
175338|NCT03098836|castrate resistant|castrate resistant
175339|NCT03098797|Barth Syndrome|barth syndrome
175340|NCT03098797|elamipretide|elamipretide
175341|NCT03098797|MTP-131|mtp-131
175342|NCT03098797|Stealth|stealth
175343|NCT03098797|Stealth BT|stealth bt
175344|NCT03098797|BTHS|bths
175345|NCT03098784|airport environment|airport environment
175346|NCT03098784|Air France|air france
175347|NCT03098784|flightline employees|flightline employees
175348|NCT03098784|administrative employees|administrative employees
175349|NCT03098758|Polymerase Chain Reaction|polymerase chain reaction
175350|NCT03098758|gastric cancer|gastric cancer
175351|NCT03098758|citology|citology
175352|NCT03098758|peritoneal washing|peritoneal washing
175353|NCT03098758|CK20|ck20
175355|NCT03098758|BER-EP4|ber-ep4
175356|NCT03098732|Stroke|stroke
175357|NCT03098732|Ischemic|ischemic
175358|NCT03098732|Tissue Plasminogen Activator|tissue plasminogen activator
175359|NCT03098732|Thrombolysis|thrombolysis
175360|NCT03098732|Vascular Diseases|vascular diseases
175361|NCT03098732|Cerebrovascular Disorders|cerebrovascular disorders
175362|NCT03098732|Fibrinolytic Agents|fibrinolytic agents
175363|NCT03098732|Plasminogen|plasminogen
175364|NCT03098693|Serodiscordant|serodiscordant
175365|NCT03098693|Pre-exposure Prophylaxis|pre-exposure prophylaxis
175366|NCT03098693|Self-testing|self-testing
175367|NCT03098693|Tanzania|tanzania
175368|NCT03098680|Adverse reactions|adverse reactions
175369|NCT03098680|Cardiovascular|cardiovascular
175370|NCT03098680|Translation|translation
175371|NCT03098680|Modelling|modelling
175372|NCT03098680|Pharmacokinetics|pharmacokinetics
175373|NCT03098680|Pharmacodynamics|pharmacodynamics
175374|NCT03098654|Human Immunodeficiency Virus|human immunodeficiency virus
175375|NCT03098654|Community Health Services|community health services
175376|NCT03098654|Chronic Disease|chronic disease
175377|NCT03098654|Integrated Delivery of Health Care|integrated delivery of health care
175378|NCT03098654|Tanzania|tanzania
175379|NCT03098589|Adult T-cell Leukemia Lymphoma|adult t-cell leukemia lymphoma
175380|NCT03098589|Teratogenicity|teratogenicity
175381|NCT03098589|Myelosuppression|myelosuppression
175382|NCT03098589|Haemorrhage|haemorrhage
175383|NCT03098589|Infection|infection
175384|NCT03098589|Thromboembolism|thromboembolism
175385|NCT03098589|Hypersensitivity|hypersensitivity
175386|NCT03098589|Tumor lysis syndrome|tumor lysis syndrome
175387|NCT03098589|Peripheral neuropathy|peripheral neuropathy
175388|NCT03098589|Ischaemic heart disease|ischaemic heart disease
175389|NCT03098589|Cardiac failure|cardiac failure
175390|NCT03098589|Arrhythmia|arrhythmia
175391|NCT03098589|Renal failure|renal failure
175392|NCT03098589|Interstitial lung disease|interstitial lung disease
175393|NCT03098589|Hepatic disorder|hepatic disorder
175394|NCT03098589|Hypothyroidism|hypothyroidism
175395|NCT03098589|Gastrointestinal perforation|gastrointestinal perforation
175396|NCT03098589|Orthostatic hypotension|orthostatic hypotension
175397|NCT03098589|Convulsion|convulsion
175398|NCT03098589|Somnolence|somnolence
175399|NCT03098589|Confusion|confusion
175400|NCT03098589|Fatigue|fatigue
175401|NCT03098589|Dizziness|dizziness
175402|NCT03098589|Blurred vision|blurred vision
175403|NCT03098589|Second primary cancer|second primary cancer
175404|NCT03098589|Cataract|cataract
175405|NCT03098589|Revlimid capsules|revlimid capsules
175406|NCT03098576|advanced|advanced
175407|NCT03098576|metastatic solid tumors|metastatic solid tumors
175408|NCT03098563|Clinical Trial|clinical trial
175409|NCT03098563|Phase II|phase ii
175410|NCT03098550|Non-small cell lung cancer (NSCLC)|non-small cell lung cancer (nsclc)
175411|NCT03098550|Triple Negative Breast Cancer (TNBC)|triple negative breast cancer (tnbc)
175412|NCT03098550|Pancreatic Cancer (PAC)|pancreatic cancer (pac)
175413|NCT03098524|Cardiac surgery|cardiac surgery
175414|NCT03098524|Mechanical ventilation|mechanical ventilation
175415|NCT03098524|Cardiopulmonary bypass|cardiopulmonary bypass
175416|NCT03098524|Pneumonia|pneumonia
175417|NCT03098524|Atelectasis|atelectasis
175418|NCT03098511|Neurological Determination of Death|neurological determination of death
175419|NCT03098511|Determination of Death|determination of death
175420|NCT03098511|CT-Perfusion scan|ct-perfusion scan
175421|NCT03098511|Ancillary Test|ancillary test
175422|NCT03098511|Organ Donation|organ donation
175423|NCT03098498|periodontitis|periodontitis
175424|NCT03098498|scaling|scaling
175425|NCT03098498|attachment gain|attachment gain
175426|NCT03098498|air polishing|air polishing
175427|NCT03098498|periodontal lesion|periodontal lesion
175428|NCT03098459|Delirium|delirium
175429|NCT03098459|Cognitive Impairment|cognitive impairment
175430|NCT03098459|Alzheimer's Disease|alzheimer's disease
175431|NCT03098459|Encephalopathy|encephalopathy
175432|NCT03098459|Trauma|trauma
175433|NCT03098459|Polytrauma|polytrauma
175435|NCT03098459|Critical Illness|critical illness
175436|NCT03098459|Traumatic Brain Injury|traumatic brain injury
175437|NCT03098459|INSIGHT-ICU|insight-icu
175438|NCT03098459|INSIGHT|insight
175439|NCT03098459|Intracerebral hemorrhage|intracerebral hemorrhage
175440|NCT03098459|Subarachnoid hemorrhage|subarachnoid hemorrhage
175441|NCT03098459|Neurotrauma|neurotrauma
175442|NCT03098459|Neuropsychology|neuropsychology
175443|NCT03098459|Dementia|dementia
175444|NCT03098459|Critical Care|critical care
175445|NCT03098459|Subdural hemorrhage|subdural hemorrhage
175446|NCT03098459|Cognition|cognition
175447|NCT03098459|Neuropsychological Outcomes|neuropsychological outcomes
175448|NCT03098459|Neuropsychology Dysfunction|neuropsychology dysfunction
175449|NCT03098459|Inflammation|inflammation
175450|NCT03098459|Neuroinflammation|neuroinflammation
175451|NCT03098459|Inflammatory Mechanisms|inflammatory mechanisms
175452|NCT03098459|Burn|burn
175453|NCT03098459|Critically Injured|critically injured
175454|NCT03098459|Injury|injury
175455|NCT03098459|Head Injury|head injury
175456|NCT03098459|Long-term Cognitive Impairment|long-term cognitive impairment
175457|NCT03098459|ICU-related Dementia|icu-related dementia
175458|NCT03098459|Employment|employment
175459|NCT03098459|Return to Work|return to work
175460|NCT03098394|Rapid turnaround test|rapid turnaround test
175461|NCT03098394|RTAT|rtat
175462|NCT03098394|Gonorrhea|gonorrhea
175463|NCT03098394|Chlamydia|chlamydia
175464|NCT03098394|STI|sti
175465|NCT03098368|Parkinson's disease|parkinson's disease
175466|NCT03098368|Rotigotine transdermal patch|rotigotine transdermal patch
175467|NCT03098368|Nocturnal hypokinesia|nocturnal hypokinesia
175468|NCT03098355|CART|cart
175469|NCT03098355|CD19|cd19
175470|NCT03098355|CD22|cd22
175471|NCT03098355|Interleukin-2|interleukin-2
175472|NCT03098342|Onychomycosis|onychomycosis
175473|NCT03098342|photodynamic therapy|photodynamic therapy
175474|NCT03098342|methylene blue|methylene blue
175475|NCT03098342|amorolfine, nail lacquer|amorolfine, nail lacquer
175476|NCT03098342|Asians|asians
175477|NCT03098329|Screening|screening
175478|NCT03098329|men|men
175479|NCT03098329|expedited treatment|expedited treatment
175480|NCT03098316|Cross sectional studies|cross sectional studies
175481|NCT03098316|Metabolomics|metabolomics
175482|NCT03098316|Glaucoma|glaucoma
175483|NCT03098316|Low tension glaucoma|low tension glaucoma
175484|NCT03098316|Ophthalmologic surgical procedures|ophthalmologic surgical procedures
175485|NCT03098290|GermanVasc|germanvasc
175486|NCT03098290|Peripheral Arterial Disease|peripheral arterial disease
175487|NCT03098290|IDOMENEO|idomeneo
175488|NCT03098290|Routine Data|routine data
175489|NCT03098290|Registry Data|registry data
175490|NCT03098290|Data Validity|data validity
175491|NCT03098199|Antimullerian Hormone|antimullerian hormone
175492|NCT03098199|In vitro fertilization|in vitro fertilization
175493|NCT03098199|Medications|medications
175494|NCT03098199|Dosing|dosing
175495|NCT03098186|Medication adherence|medication adherence
175496|NCT03098186|mHealth|mhealth
175497|NCT03098173|Early colonoscopy|early colonoscopy
175498|NCT03098173|Stigmata of recent hemorrhage|stigmata of recent hemorrhage
175499|NCT03098173|Rebleeding|rebleeding
175500|NCT03098160|Immunotherapy|immunotherapy
175501|NCT03098160|Hypoxia|hypoxia
175502|NCT03098160|Evofosfamide|evofosfamide
175503|NCT03098160|Ipilimumab|ipilimumab
175504|NCT03098160|TH-302|th-302
175505|NCT03098069|Kangaroo Mother Care|kangaroo mother care
175506|NCT03098069|Low Birth Weight|low birth weight
175507|NCT03098069|Implementation research|implementation research
175508|NCT03098043|Hypothermic machine perfusion|hypothermic machine perfusion
175509|NCT03098043|Donation after circulatory death|donation after circulatory death
175510|NCT03098043|Extended criteria liver grafts|extended criteria liver grafts
175511|NCT03098030|Dinutuximab|dinutuximab
175512|NCT03098030|Irinotecan|irinotecan
175513|NCT03098030|Topotecan|topotecan
175514|NCT03097991|Coparenting Unmarried African-American Prenatal|coparenting unmarried african-american prenatal
175515|NCT03097913|nasotracheal intubation|nasotracheal intubation
175516|NCT03097913|video-stylet|video-stylet
175517|NCT03097913|nasal cavity injury|nasal cavity injury
175518|NCT03097900|Postoperative Ileus|postoperative ileus
175519|NCT03097900|Caffeine Citrate|caffeine citrate
175520|NCT03097887|Omega Loop Gastric Bypass|omega loop gastric bypass
175521|NCT03097887|Reflux|reflux
175522|NCT03097887|Mini Gastric Bypass|mini gastric bypass
175523|NCT03097874|anorexia|anorexia
175524|NCT03097874|anorexia nervosa|anorexia nervosa
175525|NCT03097874|eating disorder|eating disorder
175526|NCT03097874|weight|weight
175527|NCT03097874|eating|eating
175528|NCT03097874|weight loss|weight loss
175529|NCT03097874|family based treatment|family based treatment
175530|NCT03097874|FBT|fbt
175531|NCT03097874|family treatment|family treatment
175532|NCT03097874|therapy|therapy
175533|NCT03097874|Maudsley method|maudsley method
175534|NCT03097783|hyaluronic acid, midface|hyaluronic acid, midface
175535|NCT03097757|Ultrasound|ultrasound
175536|NCT03097757|Forearm Fracture Reduction|forearm fracture reduction
175537|NCT03097757|Pediatric Emergency Department|pediatric emergency department
175538|NCT03097744|Lateral Meniscus Tear|lateral meniscus tear
175539|NCT03097744|Medial Meniscus Tear|medial meniscus tear
175540|NCT03097731|interleukin-10|interleukin-10
175541|NCT03097731|inflammatory bowel disease|inflammatory bowel disease
175542|NCT03097692|cardiac preconditioning|cardiac preconditioning
175543|NCT03097692|open heart surgery|open heart surgery
175544|NCT03097692|createnine|createnine
175545|NCT03097692|inflammation|inflammation
175546|NCT03097653|breast cancer screening|breast cancer screening
175547|NCT03097653|mammography|mammography
175548|NCT03097653|decision-aid|decision-aid
175549|NCT03097653|informed choice|informed choice
175550|NCT03097653|National Cancer Screening Program|national cancer screening program
175551|NCT03097627|Indocyanine Green|indocyanine green
175552|NCT03097627|Near-infrared imaging|near-infrared imaging
175553|NCT03097575|Lung lesions|lung lesions
175554|NCT03097575|Navigational bronchoscopy|navigational bronchoscopy
175555|NCT03097575|Near infrared imaging|near infrared imaging
175556|NCT03097575|Lymphadenectomy|lymphadenectomy
175557|NCT03097562|Cataract|cataract
175558|NCT03097562|Femtosecond laser|femtosecond laser
175559|NCT03097562|Cornea|cornea
175560|NCT03097562|Anatomy|anatomy
175561|NCT03097562|FSL|fsl
175562|NCT03097562|surgery|surgery
175563|NCT03097549|urinary incontinence|urinary incontinence
175564|NCT03097549|urgency urinary incontinence|urgency urinary incontinence
175565|NCT03097549|mixed urinary incontinence|mixed urinary incontinence
175566|NCT03097549|smartphone application|smartphone application
175567|NCT03097549|ehealth|ehealth
175568|NCT03097549|mhealth|mhealth
175569|NCT03097549|randomized controlled trial|randomized controlled trial
175570|NCT03097549|self management|self management
175571|NCT03097549|treatment|treatment
175572|NCT03097536|Blood Sugar|blood sugar
175573|NCT03097523|NSBRI|nsbri
175574|NCT03097510|Perceived stress|perceived stress
175575|NCT03097510|Leadership|leadership
175576|NCT03097510|Transcendental Meditation|transcendental meditation
175577|NCT03097497|Chronic Non-specific Low-Back Pain|chronic non-specific low-back pain
175578|NCT03097497|Chronic Low-Back Pain|chronic low-back pain
175579|NCT03097497|Physiotherapy|physiotherapy
175580|NCT03097497|Therapeutic Exercise|therapeutic exercise
175581|NCT03097497|Primary Care|primary care
175582|NCT03097497|Transverse Abdominal Muscle|transverse abdominal muscle
175583|NCT03097458|Counselling for Families|counselling for families
175584|NCT03097458|Parental cancer|parental cancer
175585|NCT03097458|Psychological distress and adjustment|psychological distress and adjustment
175586|NCT03097445|Smoking|smoking
175587|NCT03097445|Nicotine|nicotine
175588|NCT03097445|Nicotine Replacement Therapy|nicotine replacement therapy
175589|NCT03097445|Nicotine Patch|nicotine patch
175590|NCT03097445|Mass Distribution|mass distribution
175591|NCT03097445|Tobacco Control|tobacco control
175592|NCT03097445|Cancer Prevention|cancer prevention
175593|NCT03097445|Randomized Controlled Trial|randomized controlled trial
175594|NCT03097419|non-ST segment elevation myocardial infarction|non-st segment elevation myocardial infarction
175595|NCT03097419|myocardial infarction|myocardial infarction
175596|NCT03097419|remote ischemic conditioning|remote ischemic conditioning
175597|NCT03097419|ischemic conditioning|ischemic conditioning
175598|NCT03097419|sphygmomanometer|sphygmomanometer
175599|NCT03097419|metabolomics|metabolomics
175600|NCT03097380|Healthy volunteer study|healthy volunteer study
175601|NCT03097367|laparoscopic radical prostatectomy|laparoscopic radical prostatectomy
175602|NCT03097367|urinary incontinence|urinary incontinence
175603|NCT03097367|prostate cancer|prostate cancer
175604|NCT03097367|bladder neck level|bladder neck level
175605|NCT03097367|urodynamics|urodynamics
175606|NCT03097354|alcohol use|alcohol use
175607|NCT03097354|consumption measure|consumption measure
175608|NCT03097354|Composite International Diagnostic Interview (CIDI)|composite international diagnostic interview (cidi)
175609|NCT03097354|internet survey|internet survey
175610|NCT03097354|standardized assessment|standardized assessment
175611|NCT03097328|Renal Cell Carcinoma|renal cell carcinoma
175612|NCT03097315|Uveitis|uveitis
175614|NCT03097315|Posterior Uveitis|posterior uveitis
175615|NCT03097315|Anterior Uveitis|anterior uveitis
175616|NCT03097315|Intermediate Uveitis|intermediate uveitis
175617|NCT03097315|Panuveitis|panuveitis
175618|NCT03097315|Non-infectious Uveitis|non-infectious uveitis
175619|NCT03097315|Triamcinolone|triamcinolone
175620|NCT03097315|Choroid|choroid
175621|NCT03097315|Choroidal Injection|choroidal injection
175622|NCT03097315|Suprachoroidal|suprachoroidal
175623|NCT03097315|Microneedle|microneedle
175624|NCT03097315|Microinjection|microinjection
175625|NCT03097302|laser-assisted keratotomy|laser-assisted keratotomy
175626|NCT03097302|anterior astigmatism|anterior astigmatism
175627|NCT03097302|posterior astigmatism|posterior astigmatism
175628|NCT03097302|total corneal refractive power|total corneal refractive power
175629|NCT03097302|nomogram|nomogram
175630|NCT03097289|Healthy Adults|healthy adults
175631|NCT03097250|PKU|pku
175632|NCT03097250|Neuropsychology|neuropsychology
175633|NCT03097250|MRI|mri
175634|NCT03097198|Juvenile|juvenile
175635|NCT03097198|Traditional Chinese Medicine|traditional chinese medicine
175636|NCT03097198|Plum-blossom needle|plum-blossom needle
175637|NCT03097185|pancreatitis|pancreatitis
175638|NCT03097185|islet cell|islet cell
175639|NCT03097172|Percutaneous Coronary Intervention (PCI)|percutaneous coronary intervention (pci)
175640|NCT03097172|Chronic Total Occlusion (CTO)|chronic total occlusion (cto)
175641|NCT03097172|Cardiac MRI|cardiac mri
175642|NCT03097172|Fractional Flow Reserve (FFR)|fractional flow reserve (ffr)
175643|NCT03097172|Doppler Flow Velocity|doppler flow velocity
175644|NCT03097172|Cardiovascular Disease|cardiovascular disease
175645|NCT03097172|Atherosclerosis|atherosclerosis
175646|NCT03097172|Hydrostatic Pressure|hydrostatic pressure
175647|NCT03097159|costoclavicular block|costoclavicular block
175648|NCT03097146|Stroke|stroke
175649|NCT03097146|Aftercare|aftercare
175650|NCT03097146|Comprehensive Care|comprehensive care
175651|NCT03097107|hypertriglyceridemia|hypertriglyceridemia
175652|NCT03097107|dyslipidemia|dyslipidemia
175653|NCT03097107|saroglitazar magnesium|saroglitazar magnesium
175654|NCT03097107|lipid disorder|lipid disorder
175655|NCT03097094|Dog allergy|dog allergy
175656|NCT03097094|Can f 5|can f 5
175657|NCT03097094|Male dog|male dog
175658|NCT03097094|Female dog|female dog
175659|NCT03097094|Allergen components|allergen components
175660|NCT03097055|Stroke|stroke
175661|NCT03097055|Acupuncture|acupuncture
175662|NCT03097055|antiinflammatory|antiinflammatory
175663|NCT03097055|NIHSS|nihss
175664|NCT03097029|pancreatic enzymes|pancreatic enzymes
175665|NCT03097016|Renal Impairment|renal impairment
175666|NCT03097016|Pharmacokinetics|pharmacokinetics
175667|NCT03097016|CC-122|cc-122
175668|NCT03097016|Mild|mild
175669|NCT03097016|Moderate|moderate
175670|NCT03097016|Severe|severe
175671|NCT03097003|Proriasis|proriasis
175672|NCT03097003|Real-life management|real-life management
175673|NCT03097003|Observational|observational
175674|NCT03097003|Otezla|otezla
175675|NCT03097003|CC-10004|cc-10004
175676|NCT03097003|Apremilast|apremilast
175677|NCT03097003|Belgium|belgium
175678|NCT03097003|OTELO|otelo
175679|NCT03096990|Psoriatic Arthritis|psoriatic arthritis
175680|NCT03096990|Observational|observational
175681|NCT03096990|Otezla|otezla
175682|NCT03096990|Apremilast|apremilast
175683|NCT03096990|Real-Life management|real-life management
175684|NCT03096990|Belgium|belgium
175685|NCT03096990|APOLO|apolo
175686|NCT03096990|CC-10004|cc-10004
175687|NCT03096977|Hand dexterity|hand dexterity
175688|NCT03096977|Multiple sclerosis|multiple sclerosis
175689|NCT03096977|Nine Holes Peg|nine holes peg
175690|NCT03096964|Elderly training|elderly training
175691|NCT03096964|Pole walking|pole walking
175692|NCT03096964|Locomotor Rehabilitation Index|locomotor rehabilitation index
175693|NCT03096964|Self-selected speed of walking|self-selected speed of walking
175694|NCT03096964|Recovery|recovery
175695|NCT03096938|cell-free DNA|cell-free dna
175696|NCT03096938|methylation|methylation
175697|NCT03096938|markers|markers
175698|NCT03096938|cancer|cancer
175699|NCT03096938|screening|screening
175700|NCT03096925|non-cardiac chest pain|non-cardiac chest pain
175701|NCT03096925|anxiety|anxiety
175702|NCT03096912|CDK4 inhibitor|cdk4 inhibitor
175703|NCT03096912|LEE011|lee011
175704|NCT03096912|ribociclib|ribociclib
175705|NCT03096912|liposarcoma dedifferentiated|liposarcoma dedifferentiated
175706|NCT03096912|liposarcoma well differentiated|liposarcoma well differentiated
175707|NCT03096886|Cognitive Behavioral Therapy|cognitive behavioral therapy
175708|NCT03096886|Computer-Assisted Cognitive Behavioral Therapy|computer-assisted cognitive behavioral therapy
175709|NCT03096886|Computer-Augmented Cognitive Behavioral Therapy|computer-augmented cognitive behavioral therapy
175710|NCT03096886|CBT|cbt
175711|NCT03096886|Computer-Assisted CBT|computer-assisted cbt
175712|NCT03096886|Computer-Augmented CBT|computer-augmented cbt
175713|NCT03096847|ribociclib|ribociclib
175714|NCT03096847|LEE011|lee011
175715|NCT03096847|RIBECCA|ribecca
175716|NCT03096847|breast cancer|breast cancer
175717|NCT03096847|breast carcinoma|breast carcinoma
175718|NCT03096847|HR-positive|hr-positive
175719|NCT03096847|HER2-negative|her2-negative
175720|NCT03096847|advanced breast cancer|advanced breast cancer
175721|NCT03096847|Letrozole|letrozole
175722|NCT03096847|CDK4/6|cdk4/6
175723|NCT03096834|Migraine|migraine
175724|NCT03096834|attack|attack
175725|NCT03096834|headache|headache
175726|NCT03096834|episodic|episodic
175727|NCT03096834|aura|aura
175728|NCT03096834|AMG 334|amg 334
175729|NCT03096834|CGRP receptor agonist|cgrp receptor agonist
175730|NCT03096834|erenumab|erenumab
175731|NCT03096808|adaptive radiotherapy|adaptive radiotherapy
175732|NCT03096808|ART|art
175733|NCT03096808|intensity modulated radiation therapy|intensity modulated radiation therapy
175734|NCT03096808|IMRT|imrt
175735|NCT03096795|MEDI3506|medi3506
175736|NCT03096795|Safety|safety
175737|NCT03096795|Tolerability|tolerability
175738|NCT03096795|Pharmacokinetics|pharmacokinetics
175739|NCT03096795|Immunogenicity|immunogenicity
175740|NCT03096756|Oral Formulation|oral formulation
175741|NCT03096756|Food Effect|food effect
175742|NCT03096756|Superoxide Dismutase|superoxide dismutase
175743|NCT03096756|Single Ascending Dose|single ascending dose
175744|NCT03096756|GC4702|gc4702
175745|NCT03096756|Bioavailability|bioavailability
175746|NCT03096756|Pharmacokinetics|pharmacokinetics
175747|NCT03096756|Active Comparator|active comparator
175748|NCT03096730|Remifentanil|remifentanil
175749|NCT03096730|Opioid-induced hyperalgesia|opioid-induced hyperalgesia
175750|NCT03096730|Postoperative pain|postoperative pain
175751|NCT03096730|pain intensity|pain intensity
175752|NCT03096691|cervical pessary|cervical pessary
175753|NCT03096691|preterm labor|preterm labor
175754|NCT03096691|Cervical insufficiency|cervical insufficiency
175755|NCT03096678|Left Bundle Branch Block|left bundle branch block
175756|NCT03096678|Regional/Globle cardiac function|regional/globle cardiac function
175757|NCT03096678|Mechanical asynchrony|mechanical asynchrony
175758|NCT03096678|Cardiovascular Magnetic Resonance|cardiovascular magnetic resonance
175759|NCT03096678|Outcome|outcome
175760|NCT03096678|Cardiovascular events|cardiovascular events
175761|NCT03096665|venous blood|venous blood
175762|NCT03096665|arterial blood|arterial blood
175763|NCT03096665|capillary blood|capillary blood
175764|NCT03096652|gynecologic cancer - panniculectomy|gynecologic cancer - panniculectomy
175765|NCT03096639|Diaphragm atrophy|diaphragm atrophy
175766|NCT03096639|VIDD|vidd
175767|NCT03096639|Weaning failure|weaning failure
175768|NCT03096626|Depression|depression
175769|NCT03096613|heart failure|heart failure
175770|NCT03096613|Subclinical Hypothyroidism|subclinical hypothyroidism
175771|NCT03096613|levothyroxine|levothyroxine
175772|NCT03096613|6-minute walk test|6-minute walk test
175773|NCT03096600|spine|spine
175774|NCT03096587|XP Endo Finisher|xp endo finisher
175775|NCT03096587|ultrasonic activated irrigation|ultrasonic activated irrigation
175776|NCT03096587|postoperative pain|postoperative pain
175777|NCT03096574|Respiratory Syncytial Virus (RSV)|respiratory syncytial virus (rsv)
175778|NCT03096574|Maternal vaccination|maternal vaccination
175779|NCT03096574|Attitudes|attitudes
175780|NCT03096574|Pregnancy|pregnancy
175781|NCT03096548|Skin Cancer|skin cancer
175782|NCT03096548|Tattoo|tattoo
175783|NCT03096496|Quality of life|quality of life
175784|NCT03096496|acute promyelocytic leukemia|acute promyelocytic leukemia
175785|NCT03096496|ATO|ato
175786|NCT03096457|leishmaniasis|leishmaniasis
175787|NCT03096457|L.braziliensis|l.braziliensis
175788|NCT03096457|paromomycin cream|paromomycin cream
175789|NCT03096457|intralesional pentamidine|intralesional pentamidine
175790|NCT03096457|leishmaniasis local therapy|leishmaniasis local therapy
175791|NCT03096431|whole-brain radiation therapy|whole-brain radiation therapy
175792|NCT03096431|sterotactic radiosurgery|sterotactic radiosurgery
175793|NCT03096431|cognitive rehabilitation|cognitive rehabilitation
175794|NCT03096431|physical activity|physical activity
175795|NCT03096379|TB|tb
175796|NCT03096379|CD|cd
175797|NCT03096379|MRE|mre
175798|NCT03096379|ileocecal|ileocecal
175799|NCT03096366|anterior cruciate ligament reconstruction|anterior cruciate ligament reconstruction
175800|NCT03096353|NALOXONE|naloxone
175801|NCT03096353|fMRI|fmri
175802|NCT03096353|Functional Magnetic Resonance Imaging (fMRI)|functional magnetic resonance imaging (fmri)
175803|NCT03096340|SN-38|sn-38
175804|NCT03096340|irinotecan|irinotecan
175805|NCT03096327|Quality of Life|quality of life
175806|NCT03096327|Asthma control test|asthma control test
175807|NCT03096327|Montelukast|montelukast
175808|NCT03096327|Asthma|asthma
175809|NCT03096314|ARDS|ards
175810|NCT03096314|Vitamin D|vitamin d
175811|NCT03096301|temporomandibular disorder|temporomandibular disorder
175812|NCT03096301|photobiomodulation|photobiomodulation
175813|NCT03096301|pain|pain
175814|NCT03096275|Mycophenolate mofetil|mycophenolate mofetil
175815|NCT03096275|Methotrexate|methotrexate
175816|NCT03096275|cyclophosphamide|cyclophosphamide
175817|NCT03096262|cognitive skills|cognitive skills
175818|NCT03096262|technical|technical
175819|NCT03096262|internet platform|internet platform
175820|NCT03096262|Stroke|stroke
175821|NCT03096262|Hemiparesis|hemiparesis
175822|NCT03096249|oxytocin|oxytocin
175823|NCT03096249|emotion recognition|emotion recognition
175824|NCT03096249|emotion processing|emotion processing
175825|NCT03096249|social salience|social salience
175826|NCT03096249|face processing|face processing
175827|NCT03096249|Electroencephalography (EEG)|electroencephalography (eeg)
175828|NCT03096210|Maxillar sinus|maxillar sinus
175829|NCT03096210|Titanium-Prepared Platelet Rich Fibrin|titanium-prepared platelet rich fibrin
175830|NCT03096210|Allograft|allograft
175831|NCT03096210|implant|implant
175832|NCT03096197|Spinal Cord injury (SCI)|spinal cord injury (sci)
175833|NCT03096197|Transcutaneous lumbosacral stimulation (TLS)|transcutaneous lumbosacral stimulation (tls)
175834|NCT03096197|Exoskeleton-Assisted Walking (EAW)|exoskeleton-assisted walking (eaw)
175835|NCT03096184|head and neck cancer|head and neck cancer
175836|NCT03096184|Apatinib|apatinib
175837|NCT03096184|Tegafur Gimeracil Oteracil|tegafur gimeracil oteracil
175838|NCT03096171|Stress|stress
175839|NCT03096171|Well-being|well-being
175840|NCT03096171|Positive Psychology|positive psychology
175841|NCT03096158|Coronary artery bypass grafting|coronary artery bypass grafting
175842|NCT03096158|Cardiorespiratory rehabilitation|cardiorespiratory rehabilitation
175843|NCT03096158|Functional electrical stimulation|functional electrical stimulation
175844|NCT03096158|Inspiratory muscle training|inspiratory muscle training
175845|NCT03096158|Aerobic training|aerobic training
175846|NCT03096158|Isometric handgrip training|isometric handgrip training
175847|NCT03096158|Functional capacity|functional capacity
175848|NCT03096158|Endothelial function|endothelial function
175849|NCT03096158|Cardiac function|cardiac function
175850|NCT03096145|tobacco|tobacco
175851|NCT03096145|quitlines|quitlines
175852|NCT03096145|social support|social support
175853|NCT03096145|mobile support|mobile support
175854|NCT03096132|Obesity|obesity
175855|NCT03096132|Overweight|overweight
175856|NCT03096132|Overeating|overeating
175857|NCT03096132|Body Mass Index|body mass index
175858|NCT03096132|Treatment|treatment
175859|NCT03096132|Intervention|intervention
175860|NCT03096132|Family Based Therapy|family based therapy
175861|NCT03096132|Weight|weight
175862|NCT03096132|Children|children
176149|NCT03094364|motor|motor
175863|NCT03096119|blood pressure monitoring, home|blood pressure monitoring, home
175864|NCT03096119|Asia|asia
175865|NCT03096093|Pancreatic|pancreatic
175866|NCT03096093|Late stage cancer|late stage cancer
175867|NCT03096093|Immunotherapy|immunotherapy
175868|NCT03096093|Phase I|phase i
175869|NCT03096093|Vaccination|vaccination
175870|NCT03096080|ARPKD|arpkd
175871|NCT03096080|Autosomal Recessive Polycystic Kidney Disease|autosomal recessive polycystic kidney disease
175872|NCT03096080|Pediatric Polycystic Kidney|pediatric polycystic kidney
175873|NCT03096080|Tesevatinib|tesevatinib
175874|NCT03096080|Polycystic Kidney Disease|polycystic kidney disease
175875|NCT03096041|auriculotherapy|auriculotherapy
175876|NCT03096041|aromatase inhibitors|aromatase inhibitors
175877|NCT03096041|adjuvant treatment|adjuvant treatment
175878|NCT03096028|maternal nutrition|maternal nutrition
175879|NCT03096028|neurocognitive development|neurocognitive development
175880|NCT03096028|brain volume|brain volume
175881|NCT03096002|PreDiabetes, Lifestyle intervention, Exercise Behavior, Adherence|prediabetes, lifestyle intervention, exercise behavior, adherence
175882|NCT03095989|mindfulness|mindfulness
175883|NCT03095976|Guided Tissue Regeneration,|guided tissue regeneration,
175884|NCT03095976|Amnion-Chorion,|amnion-chorion,
175885|NCT03095976|Intrabony defects,|intrabony defects,
175886|NCT03095976|furcation|furcation
175887|NCT03095950|Spin|spin
175888|NCT03095950|Misleading reporting|misleading reporting
175889|NCT03095950|Misleading interpretation|misleading interpretation
175890|NCT03095950|Misleading extrapolation|misleading extrapolation
175891|NCT03095950|Randomized controlled trials|randomized controlled trials
175892|NCT03095950|Patients|patients
175893|NCT03095924|Spin|spin
175894|NCT03095924|Misleading reporting|misleading reporting
175895|NCT03095924|Misleading interpretation|misleading interpretation
175896|NCT03095924|Misleading extrapolation|misleading extrapolation
175897|NCT03095924|Randomized controlled trials|randomized controlled trials
175898|NCT03095924|Patients|patients
175899|NCT03095911|Spin|spin
175900|NCT03095911|Misleading reporting|misleading reporting
175901|NCT03095911|Misleading interpretation|misleading interpretation
175902|NCT03095911|Misleading extrapolation|misleading extrapolation
175903|NCT03095911|Randomized controlled trials|randomized controlled trials
175904|NCT03095911|Patients|patients
175905|NCT03095898|Colonoscopy|colonoscopy
175906|NCT03095898|Acupuncture|acupuncture
175907|NCT03095885|Urine Oxalate|urine oxalate
175908|NCT03095885|Nephrolithiasis|nephrolithiasis
175909|NCT03095885|Kidney Stones|kidney stones
175910|NCT03095885|Hyperoxaluria|hyperoxaluria
175911|NCT03095885|Enteric Hyperoxaluria|enteric hyperoxaluria
175912|NCT03095885|urological Diseases|urological diseases
175913|NCT03095885|Kidney Diseases|kidney diseases
175914|NCT03095885|Dietary Oxalate|dietary oxalate
175915|NCT03095885|Idiopathic Hyperoxaluria|idiopathic hyperoxaluria
175916|NCT03095885|Oxalate Absorption|oxalate absorption
175917|NCT03095872|photodamaged skin|photodamaged skin
175918|NCT03095872|wound healing|wound healing
175919|NCT03095872|CO2 laser|co2 laser
175920|NCT03095820|Community|community
175921|NCT03095820|Depressive Symptoms|depressive symptoms
175922|NCT03095820|Mental Health Program|mental health program
175923|NCT03095820|Older adults|older adults
175924|NCT03095768|Lifestyle|lifestyle
175925|NCT03095768|Nutrition|nutrition
175926|NCT03095768|Cooking|cooking
175927|NCT03095742|Microdialysis|microdialysis
175928|NCT03095742|Cerebral metabolism|cerebral metabolism
175929|NCT03095742|Cardiac arrest|cardiac arrest
175930|NCT03095742|Intravenous|intravenous
175931|NCT03095742|Neurological prognosis|neurological prognosis
175932|NCT03095716|Carbon dioxide pneumoperitoneum|carbon dioxide pneumoperitoneum
175933|NCT03095716|Intraperitoneal pressure|intraperitoneal pressure
175934|NCT03095716|Post-operative recovery|post-operative recovery
175935|NCT03095716|Laparoscopic Humidification System|laparoscopic humidification system
175936|NCT03095703|Sirolimus|sirolimus
175937|NCT03095703|Intestinal adenomas|intestinal adenomas
175938|NCT03095690|Osteoporosis|osteoporosis
175939|NCT03095690|Parkinson|parkinson
175940|NCT03095690|HR-pQCT|hr-pqct
175941|NCT03095690|bone microstructure|bone microstructure
175942|NCT03095690|fracture risk|fracture risk
175943|NCT03095677|dynamic apnea|dynamic apnea
175944|NCT03095677|muscle oxygenation|muscle oxygenation
175945|NCT03095677|physical performance|physical performance
175946|NCT03095664|lifestyle intervention|lifestyle intervention
175947|NCT03095664|endometrial cancer|endometrial cancer
175948|NCT03095664|survival|survival
175949|NCT03095638|Dispersible tablets|dispersible tablets
175950|NCT03095638|Bioavailability|bioavailability
175951|NCT03095638|Dolutegravir|dolutegravir
175952|NCT03095638|Healthy|healthy
175953|NCT03095638|Conventional tablets|conventional tablets
175954|NCT03095625|Sepsis|sepsis
175955|NCT03095625|Bleeding disorder|bleeding disorder
175956|NCT03095625|Viscoelastic tests|viscoelastic tests
175957|NCT03095599|Influenza|influenza
175958|NCT03095599|Vaccine|vaccine
175959|NCT03095586|Spin|spin
175960|NCT03095586|Misleading reporting|misleading reporting
176247|NCT03093922|Gemcitabine|gemcitabine
175961|NCT03095586|Misleading interpretation|misleading interpretation
175962|NCT03095586|Misleading extrapolation|misleading extrapolation
175963|NCT03095586|Randomized controlled trials|randomized controlled trials
175964|NCT03095586|Patients|patients
175965|NCT03095573|Celiac disease|celiac disease
175966|NCT03095573|Enteropathy associated T cell lymphoma|enteropathy associated t cell lymphoma
175967|NCT03095573|Refractory celiac disease|refractory celiac disease
175968|NCT03095573|Small bowel adenocarcinoma|small bowel adenocarcinoma
175969|NCT03095534|Occupational Therapy|occupational therapy
175970|NCT03095534|Aging in place|aging in place
175971|NCT03095534|Activities of daily living|activities of daily living
175972|NCT03095534|Community program|community program
175973|NCT03095521|Angal|angal
175974|NCT03095521|ANTI-ANGIN® FORMULA|anti-angin® formula
175975|NCT03095521|sore throat|sore throat
175976|NCT03095521|no less therapeutic efficacy|no less therapeutic efficacy
175977|NCT03095508|Angal S|angal s
175978|NCT03095508|ANTI-ANGIN FORMULA|anti-angin formula
175979|NCT03095508|Sore Throat|sore throat
175980|NCT03095508|no less therapeutic efficacy|no less therapeutic efficacy
175981|NCT03095495|Heated Humidified High Flow Nasal Cannula (HHHFNC)|heated humidified high flow nasal cannula (hhhfnc)
175982|NCT03095495|Low Flow Nasal Cannula|low flow nasal cannula
175983|NCT03095495|Bronchiolitis|bronchiolitis
175984|NCT03095495|Respiratory Syncytial Virus (RSV)|respiratory syncytial virus (rsv)
175985|NCT03095495|Respiratory Failure|respiratory failure
175986|NCT03095495|High Flow Nasal Cannula (HFNC)|high flow nasal cannula (hfnc)
175987|NCT03095495|Lung Diseases, Obstructive|lung diseases, obstructive
175988|NCT03095482|Arachnophobia (fear of spiders)|arachnophobia (fear of spiders)
175989|NCT03095482|Ophidophobia (fear of snakes)|ophidophobia (fear of snakes)
175990|NCT03095482|Claustrophobia (fear of tightly enclosed spaces)|claustrophobia (fear of tightly enclosed spaces)
175991|NCT03095482|Germaphobia (fear of germs, dirtiness, and contamination)|germaphobia (fear of germs, dirtiness, and contamination)
175992|NCT03095456|Chronic Obstructive Pulmonary Disease, COPD|chronic obstructive pulmonary disease, copd
400610|NCT01866033|PCI 45227|pci 45227
224901|NCT02790359|Air|air
175993|NCT03095456|Low Peak Inspiratory Flow Rate (PIFR)|low peak inspiratory flow rate (pifr)
175994|NCT03095443|Delirium|delirium
175995|NCT03095443|Critical Illness|critical illness
175996|NCT03095443|Music Therapy|music therapy
175997|NCT03095430|Trauma|trauma
175998|NCT03095430|General Anesthesia|general anesthesia
175999|NCT03095430|Surgical Pleth Index|surgical pleth index
176000|NCT03095430|Entropy|entropy
176001|NCT03095417|Delirium|delirium
176002|NCT03095417|Alzheimer's Disease|alzheimer's disease
176003|NCT03095417|Aging|aging
176004|NCT03095417|Exercise Therapy|exercise therapy
176005|NCT03095417|Cognitive Training|cognitive training
176006|NCT03095378|gingival recession|gingival recession
176007|NCT03095339|Burkina Faso|burkina faso
176008|NCT03095339|Community-based randomized controlled trial|community-based randomized controlled trial
176009|NCT03095339|Cysticercosis|cysticercosis
176010|NCT03095339|Implementation Research|implementation research
176011|NCT03095339|Effectiveness|effectiveness
176012|NCT03095313|Transcatheter Aortic Valve Replacement (TAVR).|transcatheter aortic valve replacement (tavr).
176013|NCT03095313|Surgical bioprosthetic aortic valve replacement|surgical bioprosthetic aortic valve replacement
176014|NCT03095300|Prone Position|prone position
176015|NCT03095300|High-flow oxygen therapy|high-flow oxygen therapy
176016|NCT03095287|Factor VIII|factor viii
176017|NCT03095287|von Willebrand Factor|von willebrand factor
176018|NCT03095287|Plasma-derived|plasma-derived
176019|NCT03095287|Inhibitors|inhibitors
176020|NCT03095287|Immune tolerance induction|immune tolerance induction
176021|NCT03095287|ITI|iti
176022|NCT03095287|Antibodies|antibodies
176023|NCT03095287|Hemophilia A|hemophilia a
176024|NCT03095261|Cardiovascular Disease|cardiovascular disease
176025|NCT03095261|Cardiac Rehabilitation|cardiac rehabilitation
176026|NCT03095261|Financial Incentives|financial incentives
176027|NCT03095261|Outpatient (Phase II) Cardiac Rehabilitation Exercise Adherence|outpatient (phase ii) cardiac rehabilitation exercise adherence
176028|NCT03095235|keratoconus|keratoconus
176029|NCT03095235|cornea ectasia|cornea ectasia
176030|NCT03095183|Posterior oropharynx exam|posterior oropharynx exam
176031|NCT03095183|Pediatric|pediatric
176032|NCT03095183|Tongue Depressor|tongue depressor
176033|NCT03095183|Flavored Tongue Depressor|flavored tongue depressor
176034|NCT03095144|pyloromyotomy|pyloromyotomy
176035|NCT03095144|spinal anaesthesia|spinal anaesthesia
176036|NCT03095144|surgical outcomes|surgical outcomes
176037|NCT03095144|general anaesthesia|general anaesthesia
176038|NCT03095144|infants|infants
176039|NCT03095131|Heart Spectrum Blood Pressure MonitorHeart Spectrum|heart spectrum blood pressure monitorheart spectrum
176040|NCT03095079|endostar|endostar
176041|NCT03095079|dacarbazine|dacarbazine
176042|NCT03095079|cisplatin|cisplatin
176043|NCT03095066|aggression|aggression
176044|NCT03095066|agitation|agitation
176045|NCT03095066|irritability|irritability
176046|NCT03095066|non-penetrating brain injury|non-penetrating brain injury
176047|NCT03095066|traumatic brain injury|traumatic brain injury
176048|NCT03095066|TBI|tbi
176049|NCT03095066|AVP-786|avp-786
176050|NCT03095053|morphological score|morphological score
176448|NCT03092765|Japan|japan
176051|NCT03095053|preimplantation genetic testing|preimplantation genetic testing
176052|NCT03095053|frozen embryo transfer|frozen embryo transfer
176053|NCT03095053|blastocyst|blastocyst
176054|NCT03095027|contact lens, silicone hydrogel, daily disposable, visual acuity|contact lens, silicone hydrogel, daily disposable, visual acuity
176055|NCT03095001|bevacizumab|bevacizumab
176056|NCT03095001|Intraperitoneal administration|intraperitoneal administration
176057|NCT03095001|Ovarian Cancer|ovarian cancer
176058|NCT03095001|Peritoneal Adhesion|peritoneal adhesion
176059|NCT03094962|Kinematics|kinematics
176060|NCT03094962|MRI Scans|mri scans
176061|NCT03094962|CT Scan, Single-Photon Emission|ct scan, single-photon emission
176062|NCT03094962|finger interphalangeal joint|finger interphalangeal joint
176063|NCT03094949|microwave ablation|microwave ablation
176064|NCT03094949|partial nephrectomy|partial nephrectomy
176065|NCT03094910|Raynaud Phenomenon|raynaud phenomenon
176066|NCT03094910|Hand and Arm Vibration Syndrome|hand and arm vibration syndrome
176067|NCT03094910|Autonomic Imbalance|autonomic imbalance
176068|NCT03094910|Thermography|thermography
176069|NCT03094897|Breast Neoplasms,Prostatic Neoplasms|breast neoplasms,prostatic neoplasms
176070|NCT03094858|Smartphone, sedentary behavior, smartphone intervention|smartphone, sedentary behavior, smartphone intervention
176071|NCT03094832|ARQ 092|arq 092
176072|NCT03094832|ArQule|arqule
176073|NCT03094832|AKT|akt
176074|NCT03094832|PIK3CA|pik3ca
176075|NCT03094832|Overgrowth|overgrowth
176076|NCT03094832|Congenital malformations|congenital malformations
176077|NCT03094832|Miransertib|miransertib
176078|NCT03094832|MOSAIC|mosaic
176079|NCT03094793|abnormal EEGs (AIC)|abnormal eegs (aic)
176080|NCT03094767|Type 2 Diabetes Mellitus|type 2 diabetes mellitus
176081|NCT03094767|Heart Rate Variability|heart rate variability
176082|NCT03094767|Rehabilitation|rehabilitation
176083|NCT03094767|Hemoglobin Glycated|hemoglobin glycated
176084|NCT03094715|Mechanical thrombectomy|mechanical thrombectomy
176085|NCT03094715|Endovascular thrombectomy|endovascular thrombectomy
176086|NCT03094689|Physical activity|physical activity
176087|NCT03094689|Muscle pain|muscle pain
176088|NCT03094689|Cryotherapy|cryotherapy
176089|NCT03094676|Massage|massage
176090|NCT03094676|Autonomic nervous system|autonomic nervous system
176091|NCT03094676|Recovery of Physiological Function|recovery of physiological function
176092|NCT03094676|Heart Rate|heart rate
176093|NCT03094663|IPACK|ipack
176094|NCT03094663|PAI|pai
176095|NCT03094650|stroke|stroke
176096|NCT03094650|neurorehabilitation|neurorehabilitation
176097|NCT03094650|virtual reality|virtual reality
176098|NCT03094650|rehabilitation dose|rehabilitation dose
176099|NCT03094650|motor rehabilitation|motor rehabilitation
176100|NCT03094624|Amusia|amusia
176101|NCT03094624|Audition|audition
176102|NCT03094624|Short-term memory|short-term memory
176103|NCT03094624|Emotions|emotions
176104|NCT03094624|EEG|eeg
176105|NCT03094624|MEG|meg
176106|NCT03094624|MRI|mri
176107|NCT03094585|Healthy nurses|healthy nurses
176108|NCT03094572|spinal cord circuitry|spinal cord circuitry
176109|NCT03094572|hemiplegia|hemiplegia
176110|NCT03094572|rhythmic task|rhythmic task
176111|NCT03094559|peripheral arterial disease|peripheral arterial disease
176112|NCT03094546|subjective cognitive decline|subjective cognitive decline
176113|NCT03094546|Alzheimer's disease, dementia|alzheimer's disease, dementia
176114|NCT03094546|dietary supplement|dietary supplement
176115|NCT03094546|polyamine|polyamine
176116|NCT03094546|prevention|prevention
176117|NCT03094546|treatment|treatment
176118|NCT03094546|lifestyle|lifestyle
176119|NCT03094546|memory|memory
176120|NCT03094546|autophagy|autophagy
176121|NCT03094533|Anesthesia, intravenous|anesthesia, intravenous
176122|NCT03094533|Anesthesia, inhalation|anesthesia, inhalation
176123|NCT03094533|propofol|propofol
176124|NCT03094533|sevoflurane|sevoflurane
176125|NCT03094533|glucose|glucose
176126|NCT03094468|terbinafine nail solution|terbinafine nail solution
176127|NCT03094468|nail fungal infection|nail fungal infection
176128|NCT03094468|topical antifungal drug|topical antifungal drug
176129|NCT03094455|Tele-rehabilitation|tele-rehabilitation
176130|NCT03094455|Action Observation|action observation
176131|NCT03094455|Mirror neurons|mirror neurons
176132|NCT03094455|ICT|ict
176133|NCT03094442|Quality of Recovery|quality of recovery
176134|NCT03094442|Minimally Invasive Sacrocolpopexy|minimally invasive sacrocolpopexy
176135|NCT03094442|Dexamethasone|dexamethasone
176136|NCT03094377|Multisensory stimulation; motor recovery|multisensory stimulation; motor recovery
176137|NCT03094364|Constraint-induced movement therapy|constraint-induced movement therapy
176138|NCT03094364|video game|video game
176139|NCT03094364|virtual reality|virtual reality
176140|NCT03094364|upper extremity|upper extremity
176141|NCT03094364|CI therapy|ci therapy
176142|NCT03094364|rehabilitation|rehabilitation
176143|NCT03094364|hemiparesis|hemiparesis
176144|NCT03094364|MS|ms
176145|NCT03094364|multiple sclerosis|multiple sclerosis
176146|NCT03094364|progressive multiple sclerosis|progressive multiple sclerosis
176147|NCT03094364|primary progressive multiple sclerosis|primary progressive multiple sclerosis
176148|NCT03094364|secondary progressive multiple sclerosis|secondary progressive multiple sclerosis
176150|NCT03094364|physical therapy|physical therapy
176151|NCT03094364|physiotherapy|physiotherapy
176152|NCT03094364|occupational therapy|occupational therapy
176153|NCT03094364|arm|arm
176154|NCT03094364|hand|hand
176155|NCT03094351|robot assisted esophagectomy|robot assisted esophagectomy
176156|NCT03094351|minimally invasive esophagectomy|minimally invasive esophagectomy
176157|NCT03094351|esophageal cancer|esophageal cancer
176158|NCT03094338|Psychology, Educational [F02.784.629]|psychology, educational [f02.784.629]
176159|NCT03094325|Septal Myectomy|septal myectomy
176160|NCT03094312|SEEG|seeg
176161|NCT03094312|ISD|isd
176162|NCT03094312|cognitive disorder|cognitive disorder
176163|NCT03094312|epilepsy surgery|epilepsy surgery
176164|NCT03094286|HIV|hiv
176165|NCT03094286|HIV with cancer patient|hiv with cancer patient
176166|NCT03094286|D006678|d006678
176167|NCT03094273|Melanocytic neoplasm|melanocytic neoplasm
176168|NCT03094273|Biopsy|biopsy
176169|NCT03094273|Saucerization biopsy|saucerization biopsy
176170|NCT03094273|Skin lesion|skin lesion
176171|NCT03094247|Malnutrition|malnutrition
176172|NCT03094247|Micronutrients|micronutrients
176173|NCT03094247|Polyunsaturated fatty acids|polyunsaturated fatty acids
176174|NCT03094247|Ready-to-use therapeutic foods|ready-to-use therapeutic foods
176175|NCT03094247|Omega-3 fatty acids|omega-3 fatty acids
176176|NCT03094247|Peanuts|peanuts
176177|NCT03094195|post-herpetic neuralgia|post-herpetic neuralgia
176178|NCT03094195|neuropathic pain|neuropathic pain
176179|NCT03094195|angiotensin II type 2 receptor antagonist|angiotensin ii type 2 receptor antagonist
176180|NCT03094195|dose ranging|dose ranging
176181|NCT03094130|Spin|spin
176182|NCT03094130|Misleading reporting|misleading reporting
176183|NCT03094130|Misleading interpretation|misleading interpretation
176184|NCT03094130|Misleading extrapolation|misleading extrapolation
176185|NCT03094130|phase I/II trials|phase i/ii trials
176186|NCT03094130|non-randomized trials|non-randomized trials
176187|NCT03094130|Patients|patients
176188|NCT03094117|Spin|spin
176189|NCT03094117|Misleading reporting|misleading reporting
176190|NCT03094117|Misleading interpretation|misleading interpretation
176191|NCT03094117|Misleading extrapolation|misleading extrapolation
176192|NCT03094117|phase I/II trials|phase i/ii trials
176193|NCT03094117|non-randomized trials|non-randomized trials
176194|NCT03094117|Patients|patients
176195|NCT03094104|Spin|spin
176196|NCT03094104|Misleading reporting|misleading reporting
176197|NCT03094104|Misleading interpretation|misleading interpretation
176198|NCT03094104|Misleading extrapolation|misleading extrapolation
176199|NCT03094104|phase I/II trials|phase i/ii trials
176200|NCT03094104|non-randomized trials|non-randomized trials
176201|NCT03094104|Patients|patients
176202|NCT03094091|Spin|spin
176203|NCT03094091|Misleading reporting|misleading reporting
176204|NCT03094091|Misleading interpretation|misleading interpretation
176205|NCT03094091|Misleading extrapolation|misleading extrapolation
176206|NCT03094091|phase I/II trials|phase i/ii trials
176207|NCT03094091|non-randomized trials|non-randomized trials
176208|NCT03094091|Patients|patients
176209|NCT03094078|Spin|spin
176210|NCT03094078|Misleading reporting|misleading reporting
176211|NCT03094078|Misleading interpretation|misleading interpretation
176212|NCT03094078|Misleading extrapolation|misleading extrapolation
176213|NCT03094078|Animal studies|animal studies
176214|NCT03094078|Cell culture studies|cell culture studies
176215|NCT03094078|Pre-clinical studies|pre-clinical studies
176216|NCT03094065|Spin|spin
176217|NCT03094065|Misleading reporting|misleading reporting
176218|NCT03094065|Misleading interpretation|misleading interpretation
176219|NCT03094065|Misleading extrapolation|misleading extrapolation
176220|NCT03094065|Animal studies|animal studies
176221|NCT03094065|Cell culture studies|cell culture studies
176222|NCT03094065|Pre-clinical studies|pre-clinical studies
176223|NCT03094052|neratinib|neratinib
176224|NCT03094052|trastuzumab|trastuzumab
176225|NCT03094052|crofelemer|crofelemer
176226|NCT03094026|Hematologic cancers|hematologic cancers
176227|NCT03094026|Hematopoietic cell transplantation|hematopoietic cell transplantation
176228|NCT03094026|cognitive training|cognitive training
176229|NCT03094026|genetic knowledge|genetic knowledge
176230|NCT03094026|genetic attitude|genetic attitude
176231|NCT03094026|adult cancer survivors|adult cancer survivors
176232|NCT03094013|psycho-social factors, psychological symptoms|psycho-social factors, psychological symptoms
176233|NCT03094000|Bulimia Nervosa|bulimia nervosa
176234|NCT03094000|Binge-Eating|binge-eating
176235|NCT03094000|Self monitoring|self monitoring
176236|NCT03094000|Cognitive Behavioral Therapy (CBT)|cognitive behavioral therapy (cbt)
176237|NCT03094000|Mindfulness|mindfulness
176238|NCT03093987|Shock|shock
176239|NCT03093987|Critical Care Ultrasound|critical care ultrasound
176240|NCT03093987|Lactate|lactate
176241|NCT03093987|Mortality|mortality
176242|NCT03093987|Prognosis|prognosis
176243|NCT03093935|Post-Stroke|post-stroke
176244|NCT03093935|Neuromodulation|neuromodulation
176245|NCT03093935|Axillary nerve|axillary nerve
176246|NCT03093935|Peripheral Nerve Stimulation|peripheral nerve stimulation
176248|NCT03093922|Atezolizumab|atezolizumab
176249|NCT03093922|Cisplatin|cisplatin
176250|NCT03093922|16-1621|16-1621
176251|NCT03093909|Solid Tumors and Pulmonary Metastases|solid tumors and pulmonary metastases
176252|NCT03093909|aerosol gemcitabine|aerosol gemcitabine
176253|NCT03093909|aerosol GCB|aerosol gcb
176254|NCT03093909|Lung metastases|lung metastases
176255|NCT03093909|osteosarcoma|osteosarcoma
176256|NCT03093896|almonds|almonds
176257|NCT03093896|cereal snack|cereal snack
176258|NCT03093870|Neoplasms|neoplasms
176259|NCT03093870|Biliary Tract Neoplasms|biliary tract neoplasms
176260|NCT03093870|Bile Duct Neoplasms|bile duct neoplasms
176261|NCT03093870|Gallbladder Neoplasms|gallbladder neoplasms
176262|NCT03093844|Stem Cell Transplant|stem cell transplant
176263|NCT03093844|Umbilical Cord Blood Transplant|umbilical cord blood transplant
176264|NCT03093844|Haploidentical CD34+ Selected Cells|haploidentical cd34+ selected cells
176265|NCT03093805|Hematopoietic Stem Cell Transplant|hematopoietic stem cell transplant
176266|NCT03093805|Graft Versus Host Disease|graft versus host disease
176267|NCT03093779|Hearing Loss|hearing loss
176268|NCT03093779|Deaf|deaf
176269|NCT03093779|Health Literacy|health literacy
176270|NCT03093779|Health Information|health information
176271|NCT03093779|Visual Learning|visual learning
176272|NCT03093766|Aetiology|aetiology
176273|NCT03093740|hemodialysis|hemodialysis
176274|NCT03093740|renal failure|renal failure
176275|NCT03093740|kidney transplant|kidney transplant
176276|NCT03093714|Cystic Fibrosis|cystic fibrosis
176277|NCT03093636|Type 1 Diabetes Mellitus (T1DM)|type 1 diabetes mellitus (t1dm)
176278|NCT03093636|Continuous Glucose Monitor (CGM)|continuous glucose monitor (cgm)
400611|NCT01866033|13C6 PCI-32765|13c6 pci-32765
176279|NCT03093636|Multiple Daily Injections (MDI)|multiple daily injections (mdi)
176280|NCT03093636|Insulin Pen|insulin pen
176281|NCT03093636|inControl Advice|incontrol advice
176282|NCT03093636|Decision Support System (DSS)|decision support system (dss)
176283|NCT03093623|physical activity|physical activity
176284|NCT03093623|abstain from smoking|abstain from smoking
176285|NCT03093623|human papillomavirus (HPV)|human papillomavirus (hpv)
176286|NCT03093623|cervical intraepithelial neoplasia (CIN)|cervical intraepithelial neoplasia (cin)
176287|NCT03093558|adherence|adherence
176288|NCT03093558|quality of life|quality of life
176289|NCT03093558|health literacy|health literacy
176290|NCT03093545|rabies|rabies
176291|NCT03093545|obese|obese
176292|NCT03093545|immunoglobulin|immunoglobulin
176293|NCT03093545|rabies vaccine|rabies vaccine
176294|NCT03093545|post-exposure|post-exposure
176295|NCT03093545|immunogenicity|immunogenicity
176296|NCT03093532|emergency department|emergency department
176297|NCT03093532|stage 2 hypertension|stage 2 hypertension
176298|NCT03093532|minorities|minorities
176299|NCT03093506|Erythropoietin|erythropoietin
176300|NCT03093506|Randomized controlled trial|randomized controlled trial
176301|NCT03093506|Human volunteers|human volunteers
176302|NCT03093506|Mitochondrial function|mitochondrial function
176303|NCT03093506|Cognitive performance|cognitive performance
176304|NCT03093467|Internet|internet
176305|NCT03093467|Mental Health|mental health
176306|NCT03093441|High-intensity interval training|high-intensity interval training
176307|NCT03093441|cardiometabolic|cardiometabolic
176308|NCT03093441|physical performance|physical performance
176309|NCT03093441|psychosocial adaptation|psychosocial adaptation
176310|NCT03093428|Prostate Cancer|prostate cancer
176311|NCT03093415|Hepatitis C|hepatitis c
176313|NCT03093415|People Who Inject Drugs|people who inject drugs
176314|NCT03093415|PWID|pwid
176315|NCT03093415|Medication Assisted Therapy|medication assisted therapy
176316|NCT03093415|MAT|mat
176317|NCT03093415|Needle Exchange Program|needle exchange program
176318|NCT03093402|JBT-101 (also known as lenabasum)|jbt-101 (also known as lenabasum)
176319|NCT03093402|efficacy|efficacy
176320|NCT03093402|musculoskeletal disease|musculoskeletal disease
176321|NCT03093402|randomized trial|randomized trial
176322|NCT03093376|Anxiety|anxiety
176323|NCT03093376|Effortful Control|effortful control
176324|NCT03093376|Preschool|preschool
176325|NCT03093376|ERN|ern
176326|NCT03093350|Breast Cancer|breast cancer
176327|NCT03093350|Tumor Associated Antigen Specific T cells|tumor associated antigen specific t cells
176328|NCT03093337|Neuromotor sequelae|neuromotor sequelae
176329|NCT03093337|Cognitive disorders|cognitive disorders
176330|NCT03093337|Cerebral development|cerebral development
176331|NCT03093337|Psychomotoricity|psychomotoricity
176332|NCT03093337|Postural management|postural management
176333|NCT03093337|Motor coordination|motor coordination
176334|NCT03093337|Parenthood|parenthood
176335|NCT03093324|Relapsing Remitting Multiple Sclerosis|relapsing remitting multiple sclerosis
176336|NCT03093324|RRMS|rrms
176337|NCT03093324|Multiple Sclerosis|multiple sclerosis
176338|NCT03093324|MS|ms
176339|NCT03093324|Alkermes|alkermes
176340|NCT03093324|ALKS 8700|alks 8700
176341|NCT03093324|Dimethyl Fumarate|dimethyl fumarate
176342|NCT03093324|DMF|dmf
176343|NCT03093324|Tecfidera|tecfidera
176344|NCT03093311|Near-Infrared Spectroscopy|near-infrared spectroscopy
176345|NCT03093311|Neurosurgical Procedures|neurosurgical procedures
176346|NCT03093311|Cognitive Dysfunction|cognitive dysfunction
176347|NCT03093272|Prostate Cancer|prostate cancer
176348|NCT03093259|ABX464|abx464
176349|NCT03093259|Ulcerative Colitis|ulcerative colitis
176350|NCT03093259|Refractory|refractory
176351|NCT03093246|Full-mouth ultrasonic debridement|full-mouth ultrasonic debridement
176352|NCT03093246|Aspirin|aspirin
176353|NCT03093246|Omega-3 polyunsaturated fatty acids|omega-3 polyunsaturated fatty acids
176354|NCT03093246|Non-surgical therapy|non-surgical therapy
176355|NCT03093207|Aggressive periodontitis|aggressive periodontitis
176356|NCT03093207|Aspirin|aspirin
176357|NCT03093207|Omega-3 polyunsaturated fatty acids|omega-3 polyunsaturated fatty acids
176358|NCT03093207|Surgical therapy|surgical therapy
176359|NCT03093142|transcranial direct current stimulation (tDCs)|transcranial direct current stimulation (tdcs)
176360|NCT03093142|neurofeedback|neurofeedback
176361|NCT03093116|ALK|alk
176362|NCT03093116|ROS1|ros1
176363|NCT03093116|NTRK|ntrk
176364|NCT03093116|Sarcoma|sarcoma
176365|NCT03093116|Lung Neoplasms|lung neoplasms
176366|NCT03093116|Carcinoma, NSCL|carcinoma, nscl
176367|NCT03093116|NSCLC|nsclc
176368|NCT03093116|Non Small Cell Lung|non small cell lung
176369|NCT03093116|Thyroid Disease|thyroid disease
176370|NCT03093116|Colonic Neoplasms|colonic neoplasms
176371|NCT03093116|Thyroid Neoplasms|thyroid neoplasms
176372|NCT03093116|Carcinoma, Neuroendocrine|carcinoma, neuroendocrine
176373|NCT03093116|Respiratory Tract Neoplasms|respiratory tract neoplasms
176374|NCT03093116|Thoracic Neoplasms|thoracic neoplasms
176375|NCT03093116|Neoplasms by Site|neoplasms by site
176376|NCT03093116|Neoplasms|neoplasms
225409|NCT02787304|NAS|nas
176377|NCT03093116|Lung Disease|lung disease
176378|NCT03093116|Respiratory Tract Disease|respiratory tract disease
176379|NCT03093116|Carcinoma, Bronchogenic|carcinoma, bronchogenic
176380|NCT03093116|Bronchial Neoplasms|bronchial neoplasms
176381|NCT03093116|Endocrine System Disease|endocrine system disease
176382|NCT03093116|Colorectol Neoplasms|colorectol neoplasms
176383|NCT03093116|Intestinal Neoplasms|intestinal neoplasms
176384|NCT03093116|Gastrointestinal Neoplasms|gastrointestinal neoplasms
176385|NCT03093116|Digestive System Neoplasms|digestive system neoplasms
176386|NCT03093116|Gastrointestinal Disease|gastrointestinal disease
176387|NCT03093116|Colonic Disease|colonic disease
176388|NCT03093116|Intestinal Disease|intestinal disease
176389|NCT03093116|Endocrine Gland Neoplasms|endocrine gland neoplasms
176390|NCT03093116|Head and Neck Neoplasms|head and neck neoplasms
176391|NCT03093116|Neuroendocrine Tumors|neuroendocrine tumors
176392|NCT03093116|Neuroectodermal Tumors|neuroectodermal tumors
176393|NCT03093116|Neoplasms, Germ Cell and Embryonal|neoplasms, germ cell and embryonal
176394|NCT03093116|Neoplasms by Histologic Type|neoplasms by histologic type
176395|NCT03093116|Adenocarcinoma|adenocarcinoma
176396|NCT03093116|Non Small Cell Lung Cancer|non small cell lung cancer
176397|NCT03093116|Solid Tumors|solid tumors
176398|NCT03093116|Rearrangements|rearrangements
176399|NCT03093116|TRIDENT-1|trident-1
176400|NCT03093116|TKI|tki
176401|NCT03093116|TKI naive|tki naive
176402|NCT03093116|TKI pretreated|tki pretreated
176403|NCT03093116|Anti-tumor activity|anti-tumor activity
176404|NCT03093116|Repotrectinib|repotrectinib
176405|NCT03093116|Advanced Solid Malignancies|advanced solid malignancies
176406|NCT03093103|empagliflozin|empagliflozin
176407|NCT03093103|kidney|kidney
176408|NCT03093103|BOLD-MRI|bold-mri
176409|NCT03093090|furosemide|furosemide
176410|NCT03093051|Termination|termination
176411|NCT03093051|Unpinning|unpinning
176412|NCT03093051|Therapy|therapy
176413|NCT03093025|Major Depressive Disorder|major depressive disorder
176414|NCT03093025|Adjunctive Treatment|adjunctive treatment
176415|NCT03092999|Pharmacokinetics|pharmacokinetics
176416|NCT03092960|Latino|latino
176417|NCT03092960|Male|male
176418|NCT03092908|calcium oxalate|calcium oxalate
176419|NCT03092908|nephrolithiasis|nephrolithiasis
176420|NCT03092908|Mature vinegar|mature vinegar
176421|NCT03092908|prophylaxis|prophylaxis
176422|NCT03092869|Feet|feet
176423|NCT03092869|Ankle|ankle
176424|NCT03092869|Balance|balance
176425|NCT03092869|Manual Therapy|manual therapy
176426|NCT03092869|Older Adult|older adult
176427|NCT03092830|SCC|scc
176428|NCT03092830|BCC|bcc
176429|NCT03092830|DNA|dna
176430|NCT03092830|RNA|rna
176431|NCT03092830|HEDGE HOG|hedge hog
176432|NCT03092830|epidermal growth factor receptor|epidermal growth factor receptor
176433|NCT03092817|Tuberculosis|tuberculosis
176434|NCT03092817|tuberculous meningitis|tuberculous meningitis
176435|NCT03092817|drug induced liver injury|drug induced liver injury
176436|NCT03092817|HIV|hiv
176437|NCT03092817|IRIS|iris
176438|NCT03092817|randomized controlled trial|randomized controlled trial
176439|NCT03092817|dexamethasone|dexamethasone
176440|NCT03092804|Shunting|shunting
176441|NCT03092804|Brain constructure|brain constructure
176442|NCT03092804|Neural network|neural network
176443|NCT03092791|Drug Therapy|drug therapy
176444|NCT03092778|Cryoablation|cryoablation
176445|NCT03092778|Radiology|radiology
176446|NCT03092765|E6011|e6011
176447|NCT03092765|Ursodeoxycholic acid|ursodeoxycholic acid
176449|NCT03092726|ASP8062|asp8062
176450|NCT03092726|Fibromyalgia|fibromyalgia
176451|NCT03092713|Cognitive Rehabilitation|cognitive rehabilitation
176452|NCT03092713|Supported employment|supported employment
176453|NCT03092713|Mild and moderate TBI|mild and moderate tbi
176454|NCT03092713|Return to work|return to work
176455|NCT03092713|Randomized Controlled Trial|randomized controlled trial
176456|NCT03092687|Mental Illness|mental illness
176457|NCT03092687|Aging|aging
176458|NCT03092687|Normal Development|normal development
176459|NCT03092661|Oxygen saturation|oxygen saturation
176460|NCT03092661|Pulse oximetry|pulse oximetry
176461|NCT03092661|Neonate|neonate
176462|NCT03092661|Infant|infant
176463|NCT03092622|Exercise Therapy|exercise therapy
176464|NCT03092609|Attentional Bias to Threat|attentional bias to threat
176465|NCT03092596|HIV infection|hiv infection
176466|NCT03092596|drug abuse|drug abuse
176467|NCT03092596|substance use|substance use
176468|NCT03092596|alcohol abuse|alcohol abuse
176469|NCT03092596|screening|screening
176470|NCT03092596|treatment|treatment
176471|NCT03092596|primary care|primary care
176472|NCT03092596|motivational interviewing|motivational interviewing
176473|NCT03092570|Motor learning|motor learning
176474|NCT03092570|stroke|stroke
176475|NCT03092570|tDCS|tdcs
176476|NCT03092570|upper limb|upper limb
176477|NCT03092531|HIV|hiv
176478|NCT03092531|ART Adherence|art adherence
176479|NCT03092531|Adolescents|adolescents
176480|NCT03092518|Surgical Resection|surgical resection
176481|NCT03092518|Progression Free Survival|progression free survival
176482|NCT03092518|Gastroesophageal Junction (Siewert III) Adenocarcinoma|gastroesophageal junction (siewert iii) adenocarcinoma
176483|NCT03092505|Herpes|herpes
176484|NCT03092505|Uganda|uganda
176485|NCT03092505|HSV|hsv
176486|NCT03092505|Sample|sample
176487|NCT03092492|Age Related Macular Degeneration|age related macular degeneration
176488|NCT03092492|Age Related Macular Degeneration (AMD)|age related macular degeneration (amd)
176489|NCT03092492|Reticular Pseudodrusen|reticular pseudodrusen
176490|NCT03092466|femoral nerve block|femoral nerve block
176491|NCT03092466|elderly patient|elderly patient
176492|NCT03092466|cognitive impairment|cognitive impairment
176493|NCT03092466|hip fracture|hip fracture
176494|NCT03092466|regional anesthesia|regional anesthesia
176495|NCT03092440|Medical Education|medical education
176496|NCT03092440|simulation|simulation
176497|NCT03092440|serious game|serious game
176498|NCT03092440|validity|validity
176499|NCT03092401|Liver transplantation|liver transplantation
176500|NCT03092401|Hepatopulmonary Syndrome|hepatopulmonary syndrome
176501|NCT03092401|Liver Cirrhosis|liver cirrhosis
176502|NCT03092388|Sleep-Disordered Breathing|sleep-disordered breathing
176503|NCT03092388|Heart Failure|heart failure
176504|NCT03092388|Leg Fluid Shift|leg fluid shift
176505|NCT03092375|HCV|hcv
176506|NCT03092375|Previously treated|previously treated
176507|NCT03092362|persistent atrial fibrillation|persistent atrial fibrillation
176508|NCT03092362|Heart rate variability|heart rate variability
176509|NCT03092362|quality of life|quality of life
176510|NCT03092336|Peripheral Arterial Disease, training|peripheral arterial disease, training
176511|NCT03092310|Artificial Pancreas|artificial pancreas
176512|NCT03092271|suicide|suicide
176513|NCT03092271|suicide attempt|suicide attempt
176514|NCT03092271|self harm|self harm
176515|NCT03092271|depression|depression
176516|NCT03092193|Naproxen|naproxen
176517|NCT03092193|Association of naproxen-esomeprazole|association of naproxen-esomeprazole
176518|NCT03092193|High pressure liquid chromatography|high pressure liquid chromatography
176519|NCT03092193|Cytochrome P450|cytochrome p450
176520|NCT03092180|Dermatomyositis|dermatomyositis
176521|NCT03092180|Immunomodulation|immunomodulation
176522|NCT03092180|Immunosuppressive agents|immunosuppressive agents
176523|NCT03092180|Myositis|myositis
176524|NCT03092180|Polymyositis|polymyositis
176525|NCT03092180|Necrotizing myopathies|necrotizing myopathies
176526|NCT03092180|Antisynthetase syndrome|antisynthetase syndrome
176527|NCT03092128|Gastrointestinal stromal tumor (GIST)|gastrointestinal stromal tumor (gist)
176528|NCT03092128|Imatinib|imatinib
176529|NCT03092128|Pharmacogenetics|pharmacogenetics
176530|NCT03092128|Pharmacokinetics|pharmacokinetics
176531|NCT03092128|Precision medicine|precision medicine
176532|NCT03092128|Somatic and germ-line mutations|somatic and germ-line mutations
176533|NCT03092115|Men who have sex with men (MSM)|men who have sex with men (msm)
176534|NCT03092115|mHealth|mhealth
176535|NCT03092115|antiretroviral therapy (ART)|antiretroviral therapy (art)
176536|NCT03092115|native android app|native android app
176537|NCT03092089|Sonothrombolysis, STEMI, PPCI, Microbubbles|sonothrombolysis, stemi, ppci, microbubbles
176538|NCT03092076|pharmacokinetics|pharmacokinetics
176539|NCT03092076|antiplatelet effects|antiplatelet effects
176540|NCT03092076|single nucleotide polymorphism (SNP)|single nucleotide polymorphism (snp)
176541|NCT03092024|Systemic Sclerosis|systemic sclerosis
176542|NCT03092024|Scleroderma|scleroderma
176543|NCT03092024|Hand|hand
176544|NCT03092024|Intervention|intervention
176545|NCT03092024|Exercise|exercise
176546|NCT03091985|Breastshield|breastshield
176547|NCT03091985|Breastpump|breastpump
176548|NCT03091985|Breastfeeding|breastfeeding
176549|NCT03091972|Persistent Atrial Fibrillation|persistent atrial fibrillation
176550|NCT03091972|Linear ablation|linear ablation
176551|NCT03091972|Catheter ablation|catheter ablation
176552|NCT03091972|Contact force|contact force
176553|NCT03091946|Oatmeal; Post-prandial glycemic response ; Post-prandial insulin response; Post-prandial hunger|oatmeal; post-prandial glycemic response ; post-prandial insulin response; post-prandial hunger
176554|NCT03091933|allogeneic hematopoietic stem cell transplantation|allogeneic hematopoietic stem cell transplantation
176555|NCT03091933|relapsed hematopoietic malignancy|relapsed hematopoietic malignancy
176556|NCT03091933|HLA matched donor|hla matched donor
176557|NCT03091933|minor histocompatibilty antigen (MiHA)|minor histocompatibilty antigen (miha)
176558|NCT03091907|Necrotizing enterocolitis|necrotizing enterocolitis
176559|NCT03091907|Followup|followup
176560|NCT03091907|Neurodevelopmental impairments|neurodevelopmental impairments
176561|NCT03091907|Growth impairments|growth impairments
176562|NCT03091907|Gut function|gut function
176563|NCT03091907|Behavioural impairments|behavioural impairments
176564|NCT03091894|Dexmedetomidine|dexmedetomidine
176566|NCT03091894|Endoscopy|endoscopy
176567|NCT03091894|Propofol|propofol
176568|NCT03091881|Granisetron|granisetron
176569|NCT03091881|Spinal induced hypotension|spinal induced hypotension
176570|NCT03091790|ventral hernia|ventral hernia
176571|NCT03091790|mesh|mesh
176572|NCT03091777|bacterial vaginosis|bacterial vaginosis
176573|NCT03091777|vaginal infection|vaginal infection
176574|NCT03091777|BV|bv
176575|NCT03091764|NMIBC|nmibc
176576|NCT03091764|non-muscle invasive bladder cancer|non-muscle invasive bladder cancer
176577|NCT03091764|Patient reported outcome|patient reported outcome
176578|NCT03091764|Symptom burden|symptom burden
176579|NCT03091764|Questionnaire|questionnaire
176580|NCT03091751|Factor IX (FIX)|factor ix (fix)
176581|NCT03091738|sleep|sleep
176582|NCT03091725|Obesity|obesity
176583|NCT03091725|Roux-en-Y gastric bypass (RYGB)|roux-en-y gastric bypass (rygb)
176584|NCT03091725|Very low calorie diet|very low calorie diet
176585|NCT03091725|Fibroblast growth factor 21 (FGF21)|fibroblast growth factor 21 (fgf21)
176586|NCT03091712|Degludec|degludec
176587|NCT03091712|MIDS|mids
176588|NCT03091712|Mobile Insulin Dosing System|mobile insulin dosing system
176589|NCT03091712|Glooko|glooko
176590|NCT03091712|Tresiba|tresiba
176591|NCT03091712|Tresiba® U-200 FlexTouch®|tresiba® u-200 flextouch®
176592|NCT03091699|Smoking|smoking
176593|NCT03091699|Nicotine|nicotine
176594|NCT03091699|Exercise|exercise
176595|NCT03091699|Cognition|cognition
176596|NCT03091686|Sedentary Behaviour|sedentary behaviour
176597|NCT03091686|Health Behaviour Change|health behaviour change
176598|NCT03091686|Health Action Process Approach|health action process approach
176599|NCT03091686|Intervention|intervention
176600|NCT03091686|Prolonged Sitting|prolonged sitting
176601|NCT03091686|Light Intensity Physical Activity|light intensity physical activity
176602|NCT03091686|Motivational Factors|motivational factors
176603|NCT03091686|Intentions|intentions
176604|NCT03091686|Diabetes|diabetes
176605|NCT03091686|Self-Efficacy|self-efficacy
176606|NCT03091686|Risk Perception|risk perception
176607|NCT03091686|Outcome Expectancies|outcome expectancies
176608|NCT03091647|Chinese women|chinese women
176609|NCT03091647|Cancer-related fatigue|cancer-related fatigue
176610|NCT03091647|Acupressure|acupressure
176611|NCT03091634|Xue-Fu-Zhu-Yu Capsule|xue-fu-zhu-yu capsule
176612|NCT03091634|Qi Stagnation and Blood Stasis syndrome|qi stagnation and blood stasis syndrome
176613|NCT03091634|National Center for Complementary and Integrative Health|national center for complementary and integrative health
176614|NCT03091621|Deep Vein Thrombosis|deep vein thrombosis
176615|NCT03091621|pulmonary embolism|pulmonary embolism
176616|NCT03091608|Drug-Induced Liver Injury|drug-induced liver injury
176617|NCT03091582|Psychological Therapy|psychological therapy
176618|NCT03091556|Drug-Induced Liver Injury|drug-induced liver injury
176619|NCT03091530|Throwing|throwing
176620|NCT03091530|Sleeper Stretch|sleeper stretch
176621|NCT03091530|Balloon Blow|balloon blow
176622|NCT03091530|GIRD (Glenohumeral internal rotation deficit)|gird (glenohumeral internal rotation deficit)
176623|NCT03091517|Online lifestyle modification|online lifestyle modification
176624|NCT03091517|Self-management|self-management
176625|NCT03091517|HbA1c|hba1c
176626|NCT03091439|Osteomyelitis|osteomyelitis
176627|NCT03091439|dalbavancin|dalbavancin
176628|NCT03091439|antibiotic|antibiotic
176629|NCT03091400|Memory Disorders|memory disorders
176630|NCT03091400|Multiple Sclerosis|multiple sclerosis
176631|NCT03091400|Atomoxetine Hydrochloride|atomoxetine hydrochloride
176632|NCT03091387|neonates, extubation|neonates, extubation
176633|NCT03091361|Bacterial imaging|bacterial imaging
176634|NCT03091361|PPV|ppv
176635|NCT03091361|Chronic wounds|chronic wounds
176636|NCT03091309|Inflammatory Bowel Diseases|inflammatory bowel diseases
176637|NCT03091309|Medication Adherence|medication adherence
176638|NCT03091309|Crohn Disease|crohn disease
176639|NCT03091309|Ulcerative Colitis|ulcerative colitis
176640|NCT03091309|Pregnancy|pregnancy
176641|NCT03091309|Counselling|counselling
176642|NCT03091309|Patient Education|patient education
176643|NCT03091283|time management, anaesthesia training program|time management, anaesthesia training program
176644|NCT03091270|gliomas|gliomas
176645|NCT03091270|motor functional cortex|motor functional cortex
176646|NCT03091270|ZOOMit-fMRI|zoomit-fmri
176647|NCT03091270|BOLD-fMRI|bold-fmri
176648|NCT03091257|Multiple Myeloma|multiple myeloma
176649|NCT03091244|Drug-Induced Liver Injury|drug-induced liver injury
176650|NCT03091218|Drug-Induced Liver Injury|drug-induced liver injury
176651|NCT03091192|Papillary Renal Cell Cancer|papillary renal cell cancer
176652|NCT03091192|AZD6094|azd6094
176653|NCT03091192|Savolitinib|savolitinib
176654|NCT03091179|airway management|airway management
176655|NCT03091179|high flow nasal oxygen|high flow nasal oxygen
176656|NCT03091179|high flow nasal cannula|high flow nasal cannula
176657|NCT03091179|THRIVE|thrive
176658|NCT03091140|Parathyroidectomy|parathyroidectomy
176659|NCT03091140|Muscular Functional Characteristics|muscular functional characteristics
176660|NCT03091140|Parathyroid Glands|parathyroid glands
176661|NCT03091114|fractures, risk prediction|fractures, risk prediction
176662|NCT03091101|keratoconus|keratoconus
176663|NCT03091101|corneal innervation|corneal innervation
176664|NCT03091101|scleral contact lenses|scleral contact lenses
176665|NCT03091075|Rotator Cuff Tear|rotator cuff tear
176666|NCT03091075|Rotator Cuff|rotator cuff
176667|NCT03091075|Anabolic Steroid|anabolic steroid
176668|NCT03091075|Testosterone|testosterone
176669|NCT03091075|Oxandrolone|oxandrolone
176670|NCT03091049|coronary|coronary
176671|NCT03091049|catheterization|catheterization
176672|NCT03091049|transradial|transradial
176673|NCT03091049|anesthesia|anesthesia
176674|NCT03091036|Chronic|chronic
176675|NCT03091036|Complex|complex
176676|NCT03091023|Endometrial receptivity|endometrial receptivity
176677|NCT03091023|Transcriptomic|transcriptomic
176678|NCT03091023|Single cell|single cell
176679|NCT03091023|Endometrial fluid|endometrial fluid
176680|NCT03090997|resveratrol, vitamin C, antioxidant therapy, antioxidant capacity|resveratrol, vitamin c, antioxidant therapy, antioxidant capacity
176681|NCT03090984|Hemodialysis|hemodialysis
176682|NCT03090984|Coagulation activation|coagulation activation
176683|NCT03090958|technology|technology
176684|NCT03090958|app|app
176685|NCT03090958|YMSM|ymsm
176686|NCT03090958|HIV|hiv
176687|NCT03090945|Endoscopy|endoscopy
176688|NCT03090945|GI Bleeding|gi bleeding
176689|NCT03090945|Pediatrics|pediatrics
176690|NCT03090945|Upper Gastrointestinal Bleeding|upper gastrointestinal bleeding
176691|NCT03090945|Gastro Intestinal Bleeding|gastro intestinal bleeding
176692|NCT03090906|volume gain|volume gain
176693|NCT03090906|soft tissue augmentation|soft tissue augmentation
176694|NCT03090906|dental implants|dental implants
176695|NCT03090906|histology|histology
176696|NCT03090880|Low-molecular-weight Heparin|low-molecular-weight heparin
176697|NCT03090880|Tinzaparin|tinzaparin
176698|NCT03090867|Clinical Practice Guideline|clinical practice guideline
176699|NCT03090867|Critical care|critical care
176700|NCT03090867|Family-centered care|family-centered care
176701|NCT03090867|Professional-family relations|professional-family relations
176702|NCT03090867|Family nursing|family nursing
176703|NCT03090867|Anxiety|anxiety
176704|NCT03090867|Depression|depression
176705|NCT03090867|Participation in care|participation in care
176706|NCT03090854|Alzheimer's Disease|alzheimer's disease
176707|NCT03090854|Cognition|cognition
176708|NCT03090854|Cholinergic target|cholinergic target
176709|NCT03090841|Cytomegalovirus Congenital|cytomegalovirus congenital
176710|NCT03090841|Non-invasive diagnosis|non-invasive diagnosis
176711|NCT03090841|Omics|omics
176712|NCT03090841|Biomarkers|biomarkers
176713|NCT03090828|economic evaluation|economic evaluation
176714|NCT03090828|e health|e health
176715|NCT03090815|Circulating Tumor DNA|circulating tumor dna
176716|NCT03090815|Prognostic|prognostic
176717|NCT03090815|Molecular tests|molecular tests
176718|NCT03090802|Human Immunodeficiency Virus|human immunodeficiency virus
176719|NCT03090802|resilience|resilience
176720|NCT03090802|adolescent mothers|adolescent mothers
176721|NCT03090802|Sub-Saharan Africa|sub-saharan africa
176722|NCT03090802|intimate partner violence|intimate partner violence
176723|NCT03090802|postpartum period|postpartum period
176724|NCT03090789|Friedreich Ataxia|friedreich ataxia
176725|NCT03090789|Neuro-degenerative disease|neuro-degenerative disease
176726|NCT03090698|osteoarthritis|osteoarthritis
176727|NCT03090698|knee|knee
176728|NCT03090698|treatment|treatment
176729|NCT03090685|Chikungunya Fever|chikungunya fever
176730|NCT03090685|Pain|pain
176731|NCT03090685|Mobility Limitation|mobility limitation
176732|NCT03090685|Auriculotherapy|auriculotherapy
176733|NCT03090685|Complementary Therapies|complementary therapies
176734|NCT03090685|Physical Therapy|physical therapy
176735|NCT03090672|Arthritis|arthritis
176736|NCT03090672|Degenerative|degenerative
176737|NCT03090672|Tendinosis|tendinosis
176738|NCT03090672|Jont disease|jont disease
176739|NCT03090672|Low back pain|low back pain
176740|NCT03090659|multiple myeloma|multiple myeloma
176741|NCT03090659|BCMA|bcma
176742|NCT03090659|CAR-T|car-t
176743|NCT03090646|social behavioral|social behavioral
176744|NCT03090646|living donor kidney transplant|living donor kidney transplant
176745|NCT03090646|follow-up|follow-up
176746|NCT03090646|health utilization|health utilization
176747|NCT03090646|incentives|incentives
176748|NCT03090633|Fetoscopy|fetoscopy
176749|NCT03090633|Fetal surgery|fetal surgery
176750|NCT03090633|Fetal spina bifida|fetal spina bifida
176751|NCT03090594|Cryoprobe|cryoprobe
176752|NCT03090594|Bronchoscopy|bronchoscopy
176753|NCT03090594|Acute cellular rejection|acute cellular rejection
176754|NCT03090581|Graft Rejection/diagnosis|graft rejection/diagnosis
176755|NCT03090581|Lung Transplantation|lung transplantation
176756|NCT03090581|Cryoprobe|cryoprobe
176757|NCT03090555|adhesive capsulitis|adhesive capsulitis
176758|NCT03090555|clinical trial|clinical trial
176759|NCT03090555|manipulation|manipulation
176760|NCT03090529|Exercise training|exercise training
176761|NCT03090529|Ambulatory blood pressure|ambulatory blood pressure
176762|NCT03090529|Resistant Hypertension|resistant hypertension
176763|NCT03090529|Nitric Oxide|nitric oxide
176764|NCT03090516|Ginkgo biloba dispersible tablets|ginkgo biloba dispersible tablets
176765|NCT03090516|Alzheimer's|alzheimer's
176766|NCT03090503|Antipsychotic agents|antipsychotic agents
176767|NCT03090503|Treatment|treatment
176768|NCT03090503|Effectiveness|effectiveness
176769|NCT03090503|Aripiprazole|aripiprazole
176770|NCT03090503|Risperidone|risperidone
176771|NCT03090490|Treatment|treatment
176772|NCT03090490|Maintenance|maintenance
176773|NCT03090464|Type 2 diabetes mellitus|type 2 diabetes mellitus
176774|NCT03090464|Digital disease management|digital disease management
176775|NCT03090464|T2DM|t2dm
176776|NCT03090464|Hyperglycemia|hyperglycemia
176777|NCT03090464|Diabetes mellitus|diabetes mellitus
176778|NCT03090451|Insulin|insulin
176779|NCT03090451|Glucose Clamp|glucose clamp
176780|NCT03090451|Glucose Tracer|glucose tracer
176781|NCT03090451|Artificial Pancreas|artificial pancreas
176782|NCT03090451|Exercise|exercise
176783|NCT03090451|Aerobic|aerobic
176784|NCT03090399|Goal Directed Fluid Therapy|goal directed fluid therapy
176785|NCT03090373|Catheter|catheter
176786|NCT03090373|UTI's|uti's
176787|NCT03090360|Healthy babies|healthy babies
176788|NCT03090360|Infant formula|infant formula
176789|NCT03090360|Growth|growth
176790|NCT03090334|beta-d-glucan|beta-d-glucan
176791|NCT03090334|abdominal candidiasis|abdominal candidiasis
176792|NCT03090321|fitness|fitness
176793|NCT03090321|health|health
176794|NCT03090321|activity|activity
176795|NCT03090321|heart risk|heart risk
176796|NCT03090321|wellness|wellness
176797|NCT03090282|mechanical treatment|mechanical treatment
176798|NCT03090282|implant|implant
176799|NCT03090269|cocaine|cocaine
176800|NCT03090269|methylphenidate|methylphenidate
176801|NCT03090269|psychostimulant|psychostimulant
176802|NCT03090269|ADHD|adhd
176803|NCT03090269|effective dose|effective dose
176804|NCT03090269|pharmacokinetics|pharmacokinetics
176805|NCT03090269|crack|crack
176806|NCT03090256|Trifocal IOL|trifocal iol
176807|NCT03090243|Glaucoma|glaucoma
176808|NCT03090243|Intraocular pressure|intraocular pressure
176809|NCT03090243|Colonoscopy|colonoscopy
176810|NCT03090243|Virtual Colonoscopy|virtual colonoscopy
176811|NCT03090243|Valsalva|valsalva
176812|NCT03090230|Descending Thoracic Aorta|descending thoracic aorta
176813|NCT03090230|DTA|dta
176814|NCT03090230|Transection|transection
176815|NCT03090230|Traumatic Injury of the Descending Thoracic Aorta|traumatic injury of the descending thoracic aorta
176816|NCT03090217|Radiotherapy|radiotherapy
176817|NCT03090217|Brachytherapy|brachytherapy
176818|NCT03090217|Physiotherapy|physiotherapy
176819|NCT03090217|Vaginal dilators|vaginal dilators
176820|NCT03090217|Pelvic floor exercises|pelvic floor exercises
176821|NCT03090217|Vaginal Stenosis|vaginal stenosis
176822|NCT03090204|strain|strain
176823|NCT03090204|myocarditic deformation imaging|myocarditic deformation imaging
176824|NCT03090204|right ventricle (RV)|right ventricle (rv)
176825|NCT03090204|systolic RV function|systolic rv function
176826|NCT03090204|preload dependence|preload dependence
176827|NCT03090204|contractility|contractility
176828|NCT03090204|intermittent hemodialysis (HDI)|intermittent hemodialysis (hdi)
176829|NCT03090165|Triple Negative Breast Neoplasms|triple negative breast neoplasms
176830|NCT03090165|ribociclib|ribociclib
176831|NCT03090165|LEE011|lee011
176832|NCT03090165|CDK 4/6 inhibitor|cdk 4/6 inhibitor
176833|NCT03090165|bicalutamide|bicalutamide
176834|NCT03090152|Total Hip Replacement|total hip replacement
176835|NCT03090152|Total Hip Arthroplasty|total hip arthroplasty
176836|NCT03090139|Drug therapy|drug therapy
176837|NCT03090113|Stroke|stroke
176838|NCT03090113|Embolic Stroke|embolic stroke
176839|NCT03090113|Shuxuetong|shuxuetong
176840|NCT03090113|Recurrence|recurrence
176841|NCT03090113|Symptomatic New Cerebral Infarction|symptomatic new cerebral infarction
176842|NCT03090113|Asymptomatic New Cerebral Infarction|asymptomatic new cerebral infarction
176843|NCT03090087|Diameter of retinal arteries|diameter of retinal arteries
176844|NCT03090087|Adenosine|adenosine
176845|NCT03090087|Hypoxia|hypoxia
176846|NCT03090035|HCV genotype 2, HCV genotype 3, IL-28B, PEG-INF.|hcv genotype 2, hcv genotype 3, il-28b, peg-inf.
176847|NCT03090009|Peri-implant Mucositis|peri-implant mucositis
176848|NCT03090009|NSAID|nsaid
176849|NCT03090009|Microbiome|microbiome
176850|NCT03090009|16s Ribosomal Pyro-sequencing|16s ribosomal pyro-sequencing
176851|NCT03089996|piezocision|piezocision
176852|NCT03089996|corticotomy|corticotomy
176853|NCT03089996|Gingival Crevicular Fluid|gingival crevicular fluid
176854|NCT03089983|prison|prison
176855|NCT03089957|Acute Respiratory Distress Syndrome|acute respiratory distress syndrome
176856|NCT03089957|Critical Illness|critical illness
176857|NCT03089957|Randomized Controlled Trial|randomized controlled trial
176858|NCT03089957|Ulinastatin|ulinastatin
176859|NCT03089944|Hepatitis C Virus (HCV)|hepatitis c virus (hcv)
176860|NCT03089944|Glecaprevir|glecaprevir
176861|NCT03089944|Pibrentasvir|pibrentasvir
176862|NCT03089944|Treatment Naïve|treatment naïve
176863|NCT03089944|Cirrhosis|cirrhosis
176864|NCT03089944|Compensated Cirrhosis|compensated cirrhosis
176865|NCT03089944|Genotype (GT) 1-6|genotype (gt) 1-6
176866|NCT03089944|Pangenotypic|pangenotypic
400612|NCT01866033|Pharmacokinetic|pharmacokinetic
176867|NCT03089944|Chronic Hepatitis C Virus (HCV)|chronic hepatitis c virus (hcv)
176868|NCT03089879|Immunogenicity, Vaccine|immunogenicity, vaccine
176869|NCT03089879|Immunologic Memory|immunologic memory
176870|NCT03089879|GMMA|gmma
176871|NCT03089879|Shigella Vaccines|shigella vaccines
176872|NCT03089879|Shigellosis|shigellosis
176873|NCT03089879|Dysentery, Bacillary|dysentery, bacillary
176874|NCT03089879|Healthy Volunteers|healthy volunteers
176875|NCT03089879|Safety|safety
176876|NCT03089879|Bacteria|bacteria
176877|NCT03089879|Clinical Trials, Phase 1|clinical trials, phase 1
176878|NCT03089879|Shigella sonnei|shigella sonnei
176879|NCT03089866|Central nervous System|central nervous system
176880|NCT03089866|Memory functions|memory functions
176881|NCT03089866|Executive functions|executive functions
176882|NCT03089866|Cognitive impairment|cognitive impairment
176883|NCT03089853|COPD|copd
176884|NCT03089853|pulmonary rehabilitation|pulmonary rehabilitation
176885|NCT03089853|telehealth|telehealth
176886|NCT03089853|smart|smart
176887|NCT03089853|technology|technology
176888|NCT03089853|NEMS|nems
176889|NCT03089853|acute exacerbation|acute exacerbation
176890|NCT03089840|normothermic perfusion|normothermic perfusion
176891|NCT03089840|liver transplantation|liver transplantation
176892|NCT03089827|Memory|memory
176893|NCT03089814|tissue oxygen saturation, ischemic conditioning|tissue oxygen saturation, ischemic conditioning
176894|NCT03089801|health care access|health care access
176895|NCT03089801|eHealth|ehealth
176896|NCT03089801|telehealth|telehealth
176897|NCT03089775|Contact|contact
176898|NCT03089775|Treatment|treatment
176899|NCT03089775|Prevention|prevention
176900|NCT03089775|BBI-2000|bbi-2000
176901|NCT03089775|Dermatitis|dermatitis
176902|NCT03089775|Allergic|allergic
176903|NCT03089736|Pain|pain
176904|NCT03089736|Head and neck cancer|head and neck cancer
176905|NCT03089736|depression|depression
176906|NCT03089736|anxiety|anxiety
176907|NCT03089736|health|health
176908|NCT03089736|catastrophizing|catastrophizing
176909|NCT03089723|carpometacarpal joint ostearthritis|carpometacarpal joint ostearthritis
176910|NCT03089723|hyaluronic acid|hyaluronic acid
176911|NCT03089723|Rhizarthrosis|rhizarthrosis
176912|NCT03089697|N-Rephasin SAL200|n-rephasin sal200
176913|NCT03089697|Methicillin-Sensitive Staphylococcus aureus|methicillin-sensitive staphylococcus aureus
176914|NCT03089697|Methicillin Resistant Staphylococcus Aureus|methicillin resistant staphylococcus aureus
176915|NCT03089684|NHANES|nhanes
176916|NCT03089684|Folate|folate
176917|NCT03089684|Folic Acid|folic acid
176918|NCT03089671|Vitamin B|vitamin b
176919|NCT03089671|5% Dextrose in Water|5% dextrose in water
176920|NCT03089671|Cystoscopy|cystoscopy
176921|NCT03089671|Ureter|ureter
176922|NCT03089658|Metastatic Merkel Cell Carcinoma|metastatic merkel cell carcinoma
176923|NCT03089658|Expanded Access Program|expanded access program
176924|NCT03089658|Temporary Authorisation for Use|temporary authorisation for use
176925|NCT03089658|Avelumab|avelumab
176926|NCT03089632|gluten-free diet|gluten-free diet
176927|NCT03089632|gluten sensitivity|gluten sensitivity
176928|NCT03089632|dyspepsia|dyspepsia
176929|NCT03089632|diabetes mellitus, type 1|diabetes mellitus, type 1
176930|NCT03089632|gastroparesis|gastroparesis
176931|NCT03089632|motility|motility
176932|NCT03089619|Alveolar bone|alveolar bone
176933|NCT03089619|Bone resorption|bone resorption
176934|NCT03089619|dental implants|dental implants
176935|NCT03089593|Thermic Effect of Food|thermic effect of food
176936|NCT03089593|Energy Expenditure|energy expenditure
176937|NCT03089593|Ginger|ginger
176938|NCT03089567|Silver diamine Fluoride|silver diamine fluoride
176939|NCT03089567|Streptococcus mutans|streptococcus mutans
176940|NCT03089567|Caries prevention|caries prevention
176941|NCT03089567|Fluoride|fluoride
176942|NCT03089528|Direct laryngoscopy|direct laryngoscopy
176943|NCT03089528|Videolaryngoscopy|videolaryngoscopy
176944|NCT03089528|Diabetes Mellitus|diabetes mellitus
176945|NCT03089528|Intubation|intubation
176946|NCT03089528|Anesthesia|anesthesia
176947|NCT03089515|World Trade Center|world trade center
176948|NCT03089515|World Trade Center Survivors|world trade center survivors
176949|NCT03089502|Exercise|exercise
176950|NCT03089502|Cardiac Rehabilitation|cardiac rehabilitation
176951|NCT03089502|Breast Caner|breast caner
176952|NCT03089502|Left Ventricular Dysfunction|left ventricular dysfunction
176953|NCT03089502|Trastuzumab|trastuzumab
176954|NCT03089502|Anthracyclines|anthracyclines
176955|NCT03089489|Primary graft dysfunction|primary graft dysfunction
176956|NCT03089489|Lung transplantation|lung transplantation
176957|NCT03089489|Surfactant Protein|surfactant protein
176958|NCT03089489|inflammation|inflammation
176959|NCT03089476|Prevention|prevention
176960|NCT03089476|Predictors|predictors
176961|NCT03089463|Diabetes|diabetes
176962|NCT03089463|Diabetic Foot|diabetic foot
176963|NCT03089463|Biomechanics|biomechanics
176964|NCT03089463|Stratification|stratification
176965|NCT03089463|Diabetes Complications|diabetes complications
176966|NCT03089463|Diabetes; Neuropathic (Manifestation)|diabetes; neuropathic (manifestation)
176967|NCT03089463|Risk Factors|risk factors
176968|NCT03089463|Prospective Studies|prospective studies
176969|NCT03089424|low back pain, photobiomodulation therapy, LLLT|low back pain, photobiomodulation therapy, lllt
176970|NCT03089411|myeloma multiple|myeloma multiple
176971|NCT03089411|newly diagnosed|newly diagnosed
176972|NCT03089398|Hybrid Coronary Revascularization|hybrid coronary revascularization
176973|NCT03089398|Coronary Artery Bypass Grafting|coronary artery bypass grafting
176974|NCT03089398|Percutaneous Coronary Intervention|percutaneous coronary intervention
176975|NCT03089372|Erectile Dysfunction|erectile dysfunction
176976|NCT03089372|Low intensity extracorporeal shock wave treatment|low intensity extracorporeal shock wave treatment
176977|NCT03089359|Unspecific symptoms|unspecific symptoms
176978|NCT03089359|Soluvent urokinase plasminogen activator receptor|soluvent urokinase plasminogen activator receptor
176979|NCT03089359|Lactate|lactate
176980|NCT03089359|Emergency Medical Services|emergency medical services
176981|NCT03089346|Imaging|imaging
176982|NCT03089346|Bronchial Remodeling|bronchial remodeling
176983|NCT03089320|HIV, Heavy drinking, Alcohol Abuse, AIDS|hiv, heavy drinking, alcohol abuse, aids
176984|NCT03089307|Erectile Dysfunction|erectile dysfunction
176985|NCT03089307|Low intensity extracorporeal shock wave treatment|low intensity extracorporeal shock wave treatment
176986|NCT03089294|Erectile Dysfunction|erectile dysfunction
176987|NCT03089294|Low intensity extracorporeal shock wave treatment|low intensity extracorporeal shock wave treatment
176988|NCT03089268|sessile serrated polyp|sessile serrated polyp
176989|NCT03089268|prevalence|prevalence
176990|NCT03089268|colorectal cancer|colorectal cancer
176991|NCT03089268|molecular biology|molecular biology
176992|NCT03089255|Thrombophylaxis|thrombophylaxis
176993|NCT03089255|Deep Venous Thrombosis|deep venous thrombosis
176994|NCT03089255|Pulmonary Embolism|pulmonary embolism
176995|NCT03089255|Lower Leg Trauma|lower leg trauma
176996|NCT03089229|Topical Cream|topical cream
176997|NCT03089229|Novel|novel
176998|NCT03089190|Appetite|appetite
176999|NCT03089190|Satiety|satiety
177000|NCT03089190|Energy intake|energy intake
177001|NCT03089190|Hunger|hunger
177002|NCT03089190|Peptide|peptide
177003|NCT03089190|Encapsulation|encapsulation
177004|NCT03089177|Randomized Controlled Trial|randomized controlled trial
177005|NCT03089177|Community Gardening|community gardening
177006|NCT03089177|Health Behavior Change|health behavior change
177007|NCT03089177|Physical Activity|physical activity
177008|NCT03089177|Diet|diet
177009|NCT03089177|Obesity|obesity
177010|NCT03089177|Cancer Prevention|cancer prevention
177011|NCT03089177|Neighborhood|neighborhood
177012|NCT03089151|Pilot Randomized Controlled Trial|pilot randomized controlled trial
177013|NCT03089151|Community Garden|community garden
177014|NCT03089151|Health Behavior Change|health behavior change
177015|NCT03089151|Physical Activity|physical activity
177016|NCT03089151|Diet|diet
177017|NCT03089151|Obesity|obesity
177018|NCT03089151|Neighborhood|neighborhood
177019|NCT03089151|Microbiome|microbiome
177020|NCT03089151|Inflammatory biomarkers|inflammatory biomarkers
177021|NCT03089125|Lung Cancer|lung cancer
177022|NCT03089099|Metastatic Castration-Resistant Prostate Cancer|metastatic castration-resistant prostate cancer
177023|NCT03089099|circulating tumor cells|circulating tumor cells
177024|NCT03089099|Prognosis|prognosis
177025|NCT03089099|Liquid biopsy|liquid biopsy
177026|NCT03089086|meningococcal B vaccine|meningococcal b vaccine
177027|NCT03089086|herd immunity|herd immunity
177028|NCT03089086|adolescents|adolescents
177029|NCT03089086|young adults|young adults
177030|NCT03089086|south australia|south australia
177031|NCT03089060|Fingertip Amputation|fingertip amputation
177032|NCT03089060|Fingertip Regeneration|fingertip regeneration
177033|NCT03089060|Infection|infection
177034|NCT03089060|Occlusive Dressings|occlusive dressings
177035|NCT03089060|Pediatric Surgery|pediatric surgery
177036|NCT03089060|Silicone Finger Cap|silicone finger cap
177037|NCT03089021|neck pain,|neck pain,
177038|NCT03088982|Family Medicine|family medicine
177039|NCT03088982|multimorbidity|multimorbidity
177040|NCT03088982|prevention|prevention
177041|NCT03088969|Chronic Low Back Pain|chronic low back pain
177042|NCT03088969|Function|function
177043|NCT03088969|Self-efficacy|self-efficacy
177044|NCT03088969|Return to work|return to work
177045|NCT03088969|Questionnaire|questionnaire
177046|NCT03088956|Longitudinal|longitudinal
177047|NCT03088956|Caregiver|caregiver
177048|NCT03088956|Cognitive assessments|cognitive assessments
177049|NCT03088956|Behavioral assessments|behavioral assessments
177050|NCT03088956|Functional assessments|functional assessments
177051|NCT03088904|Inactivated influenza vaccine quadrivalent|inactivated influenza vaccine quadrivalent
177052|NCT03088904|Live, attenuated influenza vaccine quadrivalent|live, attenuated influenza vaccine quadrivalent
177053|NCT03088904|Monozygotic twins|monozygotic twins
177054|NCT03088904|Dizygotic twins|dizygotic twins
177056|NCT03088904|Adolescents|adolescents
177057|NCT03088891|altitude training|altitude training
177058|NCT03088891|antioxidants|antioxidants
177059|NCT03088891|oxidative stress|oxidative stress
177060|NCT03088891|elite athletes|elite athletes
177061|NCT03088891|inflammation|inflammation
177062|NCT03088891|diet|diet
177063|NCT03088878|Chronic lymphocytic leukemia|chronic lymphocytic leukemia
177064|NCT03088878|Small lymphocytic lymphoma|small lymphocytic lymphoma
177065|NCT03088878|Mantle cell lymphoma|mantle cell lymphoma
177066|NCT03088878|Receptor Tyrosine Kinase-like Orphan Receptor 1 (ROR1)|receptor tyrosine kinase-like orphan receptor 1 (ror1)
177067|NCT03088878|Bruton Tyrosine Kinase (BTK)|bruton tyrosine kinase (btk)
177068|NCT03088774|Low back pain|low back pain
177069|NCT03088761|tracheal tube|tracheal tube
177070|NCT03088761|cuff pressure|cuff pressure
177071|NCT03088748|total knee arthroplasty|total knee arthroplasty
177072|NCT03088722|Contraceptive implant|contraceptive implant
177073|NCT03088722|Task sharing|task sharing
177074|NCT03088722|Nigeria|nigeria
177075|NCT03088709|NHL|nhl
177076|NCT03088709|Non-Hodgkin Lymphoma|non-hodgkin lymphoma
177077|NCT03088709|Haploidentical|haploidentical
177078|NCT03088709|Bone Marrow Transplant|bone marrow transplant
177079|NCT03088709|Stem Cell Transplant|stem cell transplant
177080|NCT03088709|Acute Myeloid Leukemia|acute myeloid leukemia
177081|NCT03088709|Acute Lymphocytic Leukemia|acute lymphocytic leukemia
177082|NCT03088709|Myelodysplastic Syndrome|myelodysplastic syndrome
177083|NCT03088709|Chronic Lymphocytic Leukemia|chronic lymphocytic leukemia
177084|NCT03088709|GVHD|gvhd
177085|NCT03088696|laparoscopic|laparoscopic
177086|NCT03088696|acupuncture|acupuncture
177087|NCT03088683|sleeve gastrectomy|sleeve gastrectomy
177088|NCT03088683|liver retractor|liver retractor
177089|NCT03088683|nathanson|nathanson
177090|NCT03088683|reveel|reveel
177091|NCT03088683|liver trauma|liver trauma
177092|NCT03088657|Cohort study|cohort study
177093|NCT03088657|early-onset mood disorders|early-onset mood disorders
177094|NCT03088618|Nasal obstruction|nasal obstruction
177095|NCT03088618|Septal deformity|septal deformity
177096|NCT03088618|Septoplasty|septoplasty
177097|NCT03088618|TnR Mesh|tnr mesh
177098|NCT03088618|polycaprolactone|polycaprolactone
177099|NCT03088592|Deep Brain Stimulation|deep brain stimulation
177100|NCT03088579|radiation shielding|radiation shielding
177101|NCT03088553|Ganciclovir|ganciclovir
177102|NCT03088553|trough concentrations|trough concentrations
177103|NCT03088553|CMV viral load|cmv viral load
177104|NCT03088553|safety|safety
177105|NCT03088553|Solid organ transplantation (heart, kidney or liver)|solid organ transplantation (heart, kidney or liver)
177106|NCT03088540|Previous Smoker|previous smoker
177107|NCT03088540|Current Smoker|current smoker
177108|NCT03088540|Stage IIIB|stage iiib
177109|NCT03088540|Stage IIIC|stage iiic
177110|NCT03088540|Stage IV|stage iv
177111|NCT03088540|PD-L1|pd-l1
177112|NCT03088514|Hypertension|hypertension
177113|NCT03088514|Left Ventricular Hypertrophy|left ventricular hypertrophy
177114|NCT03088514|Endothelial Dysfunction|endothelial dysfunction
177115|NCT03088514|Nitrate|nitrate
177116|NCT03088501|Birth cohort, follow-up, IVRS|birth cohort, follow-up, ivrs
177117|NCT03088488|25-OH vitamin D|25-oh vitamin d
177118|NCT03088488|RANKL|rankl
177119|NCT03088488|Osteoprotogerin|osteoprotogerin
177120|NCT03088488|TNF-α|tnf-α
177121|NCT03088462|Bipolar Disorder|bipolar disorder
177122|NCT03088462|Smartphone|smartphone
177123|NCT03088462|Behavior Therapy|behavior therapy
177124|NCT03088449|Crohns disease|crohns disease
177125|NCT03088449|primary non response|primary non response
177126|NCT03088449|lose of response|lose of response
177127|NCT03088449|personalising anti-TNF therapy|personalising anti-tnf therapy
177128|NCT03088449|Anti-TNF|anti-tnf
177129|NCT03088449|PANTS|pants
177130|NCT03088449|Biosimilars|biosimilars
177131|NCT03088436|MRI|mri
177132|NCT03088436|Breast|breast
177133|NCT03088423|MRI|mri
177134|NCT03088423|Stereotactic body radiation therapy|stereotactic body radiation therapy
177135|NCT03088384|Post Traumatic Stress Disorder|post traumatic stress disorder
177136|NCT03088384|PTSD|ptsd
177137|NCT03088384|Combat Trauma|combat trauma
177138|NCT03088371|Total knee replacement|total knee replacement
177139|NCT03088371|Psoas Sciatic block|psoas sciatic block
177140|NCT03088371|Epidural anaesthesia|epidural anaesthesia
177141|NCT03088345|Fontan Palliation Surgery|fontan palliation surgery
177142|NCT03088345|Post-Operative Care|post-operative care
177143|NCT03088319|postnatal depression stress mindfulness allostatic load|postnatal depression stress mindfulness allostatic load
177144|NCT03088293|idiopathic refractory scleritis|idiopathic refractory scleritis
177145|NCT03088293|infliximab|infliximab
177146|NCT03088293|cyclophosphamide|cyclophosphamide
177147|NCT03088241|randomized clinical trial|randomized clinical trial
177148|NCT03088241|low level viremia|low level viremia
177149|NCT03088241|lesotho|lesotho
177150|NCT03088241|resource-limited setting|resource-limited setting
177151|NCT03088241|ART first-line failure|art first-line failure
177152|NCT03088215|Trigger Point Pain, Myofascial|trigger point pain, myofascial
177153|NCT03088215|shock-waves|shock-waves
177154|NCT03088215|extracorporeal shock-wave treatment (ESWT)|extracorporeal shock-wave treatment (eswt)
177155|NCT03088215|pain|pain
177156|NCT03088215|trigger point|trigger point
177157|NCT03088215|referred pain|referred pain
177158|NCT03088202|cancer|cancer
177159|NCT03088202|palliative care|palliative care
177160|NCT03088202|PROMs|proms
177161|NCT03088202|survival|survival
177162|NCT03088202|QoL|qol
177163|NCT03088202|referral|referral
177164|NCT03088189|maternal nutrition|maternal nutrition
177165|NCT03088189|periconceptional|periconceptional
177166|NCT03088189|neurocognitive development|neurocognitive development
177167|NCT03088176|Melanoma|melanoma
177168|NCT03088176|BRAF inhibitor|braf inhibitor
177169|NCT03088176|Intratumoral injection|intratumoral injection
177170|NCT03088176|Talimogene laherparepvec|talimogene laherparepvec
177171|NCT03088176|MEK inhibitor|mek inhibitor
177172|NCT03088176|dabrafenib|dabrafenib
177173|NCT03088176|trametinib|trametinib
177174|NCT03088150|Hepatic resection|hepatic resection
177175|NCT03088150|Liver surgery|liver surgery
177176|NCT03088150|Thermal ablation|thermal ablation
177177|NCT03088150|Radiofrequency ablation|radiofrequency ablation
177178|NCT03088150|Microwave ablation|microwave ablation
177179|NCT03088150|RFA|rfa
177180|NCT03088150|MWA|mwa
177181|NCT03088137|in vitro fertilization|in vitro fertilization
177182|NCT03088111|Anthim®|anthim®
177183|NCT03088111|Obiltoxaximab|obiltoxaximab
177184|NCT03088111|anthrax|anthrax
177185|NCT03088111|anti-toxin|anti-toxin
177186|NCT03088098|left atrial appendage occlusion|left atrial appendage occlusion
177187|NCT03088098|transcatheter aortic valve implantation|transcatheter aortic valve implantation
177188|NCT03088098|atrial fibrillation|atrial fibrillation
177189|NCT03088072|Edoxaban|edoxaban
177190|NCT03088072|WATCHMAN device|watchman device
177191|NCT03088020|CCHS|cchs
177192|NCT03088020|PHOX2B|phox2b
177193|NCT03088020|Paired-like Homeobox gene PHOX2B|paired-like homeobox gene phox2b
177194|NCT03088020|autonomic nervous system dysregulation|autonomic nervous system dysregulation
177195|NCT03088020|control of breathing|control of breathing
177196|NCT03088020|Hirschsprung disease|hirschsprung disease
177197|NCT03088020|neural crest tumors|neural crest tumors
177198|NCT03088020|neuroblastoma|neuroblastoma
177199|NCT03088020|ganglioneuroma|ganglioneuroma
177200|NCT03088020|ganglioneuroblastoma|ganglioneuroblastoma
177201|NCT03088020|artificial ventilation|artificial ventilation
177202|NCT03088020|diaphragm pacing|diaphragm pacing
177203|NCT03088007|Intellectual Deficiency|intellectual deficiency
177204|NCT03088007|cognitive, adaptive|cognitive, adaptive
177205|NCT03088007|behavioral and academic profile|behavioral and academic profile
177206|NCT03088007|regular and special schools|regular and special schools
177207|NCT03087942|end stage renal disase ESRD|end stage renal disase esrd
177208|NCT03087942|dialysis effect on pharmacokinetics PK|dialysis effect on pharmacokinetics pk
177209|NCT03087942|renal impairment|renal impairment
177210|NCT03087903|Prostate Specific Antigen (PSA)|prostate specific antigen (psa)
177211|NCT03087903|Non-Metastatic Prostate Cancer|non-metastatic prostate cancer
177212|NCT03087890|Microbial drug resistance|microbial drug resistance
177213|NCT03087890|Beta-lactamase|beta-lactamase
177214|NCT03087890|Cotrimoxazole|cotrimoxazole
177215|NCT03087890|Trimethoprim-sulfamethoxazole|trimethoprim-sulfamethoxazole
177216|NCT03087890|Tanzania|tanzania
177217|NCT03087864|esophageal cancer|esophageal cancer
177218|NCT03087864|PD-L1 inhibition|pd-l1 inhibition
177219|NCT03087864|chemoradiation|chemoradiation
177220|NCT03087851|Denosumab|denosumab
177221|NCT03087851|Bone turnover markers|bone turnover markers
177222|NCT03087851|Bone mineral density|bone mineral density
177223|NCT03087812|Microbiological burden|microbiological burden
177224|NCT03087812|kidney|kidney
177225|NCT03087812|stone|stone
177226|NCT03087812|durability of flexible endoscopes|durability of flexible endoscopes
177227|NCT03087734|Prostheses and Implants|prostheses and implants
177228|NCT03087721|Metabolic Syndrome|metabolic syndrome
177229|NCT03087721|Exercise Training|exercise training
177230|NCT03087721|Interval Training|interval training
177231|NCT03087721|Skeletal Muscle|skeletal muscle
177232|NCT03087721|Risk Factors|risk factors
177233|NCT03087721|Insulin Resistance|insulin resistance
177234|NCT03087695|Nasopharyngeal carcinoma|nasopharyngeal carcinoma
177235|NCT03087695|EBV DNA|ebv dna
177236|NCT03087695|Chemoradiotherapy|chemoradiotherapy
177237|NCT03087669|Left Ventricular Assist Device|left ventricular assist device
177238|NCT03087669|Hemodynamic monitoring|hemodynamic monitoring
177239|NCT03087656|levofloxacin|levofloxacin
177240|NCT03087656|Ceftriaxone|ceftriaxone
177241|NCT03087656|Cholangitis|cholangitis
177242|NCT03087656|ERCP|ercp
177243|NCT03087643|Flow-mediated dilation|flow-mediated dilation
177244|NCT03087643|Passive limb movement|passive limb movement
177245|NCT03087604|epidural catheter placement|epidural catheter placement
177246|NCT03087578|overactive bladder, acupuncture|overactive bladder, acupuncture
177247|NCT03087526|Non Invasive Prenatal Diagnosis (NIPD)|non invasive prenatal diagnosis (nipd)
177248|NCT03087526|Circulating Fetal Trophoblastic Cells (CFTC)|circulating fetal trophoblastic cells (cftc)
177249|NCT03087526|Huntington's Disease|huntington's disease
177250|NCT03087526|Myotonic Dystrophy Type 1|myotonic dystrophy type 1
177251|NCT03087526|Fragile X syndrome|fragile x syndrome
177252|NCT03087526|Spinocerebellar Ataxia type 1|spinocerebellar ataxia type 1
177253|NCT03087526|Spinocerebellar Ataxia type 2|spinocerebellar ataxia type 2
177254|NCT03087526|Spinocerebellar Ataxia type 3|spinocerebellar ataxia type 3
177255|NCT03087500|Down Syndrome|down syndrome
177256|NCT03087500|Typically Developing Participants|typically developing participants
177257|NCT03087500|Children|children
177258|NCT03087500|Adolescents|adolescents
177259|NCT03087500|Adults|adults
177260|NCT03087448|ALK rearranged|alk rearranged
177261|NCT03087448|Stage IIIB NSCLC|stage iiib nsclc
177262|NCT03087448|Stage IV NSCLC|stage iv nsclc
177263|NCT03087448|ROS-1 rearranged NSCLC|ros-1 rearranged nsclc
177264|NCT03087396|bone marrow defect|bone marrow defect
177265|NCT03087396|bone marrow lesion|bone marrow lesion
177266|NCT03087396|stress fracture|stress fracture
177267|NCT03087396|calcium phosphate|calcium phosphate
177268|NCT03087396|bone substitute material|bone substitute material
177269|NCT03087370|CXCR4 Mutation|cxcr4 mutation
177270|NCT03087370|Primary immunodeficiency disorder|primary immunodeficiency disorder
177271|NCT03087370|Warts|warts
177272|NCT03087370|Hypogammaglobulinemia|hypogammaglobulinemia
177273|NCT03087370|Infections|infections
177274|NCT03087370|Myelokathexis|myelokathexis
177275|NCT03087370|Human papillomavirus (HPV)|human papillomavirus (hpv)
177276|NCT03087370|Neutropenia|neutropenia
177277|NCT03087370|Herpes|herpes
177278|NCT03087344|Postprandial liver and spleen stiffness measurements|postprandial liver and spleen stiffness measurements
177279|NCT03087344|Transient elastography|transient elastography
177280|NCT03087344|Cirrhosis|cirrhosis
177281|NCT03087344|Acoustic radiation force impulse|acoustic radiation force impulse
177282|NCT03087318|Obstructive sleep apnea (OSA)|obstructive sleep apnea (osa)
177283|NCT03087318|Overweight and moderate obesity|overweight and moderate obesity
177284|NCT03087318|Sport prescription|sport prescription
177285|NCT03087318|Physical activity|physical activity
177286|NCT03087305|Interventional Pulmonary|interventional pulmonary
177287|NCT03087305|EBUS-TBNA|ebus-tbna
177288|NCT03087305|Lung cancer staging|lung cancer staging
177289|NCT03087292|blood flow restriction|blood flow restriction
177290|NCT03087292|resistance training|resistance training
177291|NCT03087292|coronary heart disease|coronary heart disease
177292|NCT03087240|Disease Activity Score 28 (DAS28)|disease activity score 28 (das28)
177293|NCT03087240|Health Assessment Questionnaire (HAQ)|health assessment questionnaire (haq)
177294|NCT03087240|Dental Scaling|dental scaling
177295|NCT03087240|Dental Polishing|dental polishing
177296|NCT03087240|Oral Health|oral health
177297|NCT03087240|Gingival Crevicular Fluid|gingival crevicular fluid
177298|NCT03087240|Inflammatory Cytokine Profile|inflammatory cytokine profile
177299|NCT03087240|Biofilm|biofilm
177300|NCT03087240|Oral Microbiome|oral microbiome
177301|NCT03087240|Intestinal Microbiome|intestinal microbiome
177302|NCT03087227|mHealth|mhealth
177303|NCT03087227|febrile neutropenia|febrile neutropenia
177304|NCT03087227|neutropenia/chemically induced/*complications|neutropenia/chemically induced/*complications
177305|NCT03087227|antineoplastic agents/*adverse events|antineoplastic agents/*adverse events
177306|NCT03087227|Patient readmission|patient readmission
177307|NCT03087227|disease management|disease management
177308|NCT03087201|Chronic tic disorders|chronic tic disorders
177309|NCT03087201|Tourette syndrome|tourette syndrome
177310|NCT03087149|vitamin D|vitamin d
177311|NCT03087149|supplementation|supplementation
177312|NCT03087149|hydroxyvitamin D|hydroxyvitamin d
177313|NCT03087149|pretrem infants|pretrem infants
177314|NCT03087149|osteopenia|osteopenia
177315|NCT03087136|multiple sclerosis|multiple sclerosis
177316|NCT03087136|pediatric|pediatric
177317|NCT03087123|single-case design|single-case design
177318|NCT03087123|children|children
177319|NCT03087123|health equity|health equity
177320|NCT03087123|mobile health|mobile health
177321|NCT03087097|SAM|sam
177322|NCT03087058|Treatment of Hyperkalemia|treatment of hyperkalemia
177323|NCT03087058|Hyperkalemia|hyperkalemia
177324|NCT03087058|Potassium|potassium
177325|NCT03087058|Chronic Kidney Disease|chronic kidney disease
177326|NCT03087032|Liraglutide|liraglutide
177327|NCT03087032|Insulin Glargine|insulin glargine
177721|NCT03084445|newborn|newborn
177328|NCT03087032|Prandial Insulin|prandial insulin
177329|NCT03087019|adenoid cystic carcinoma|adenoid cystic carcinoma
177330|NCT03086980|health related quality of life|health related quality of life
177331|NCT03086980|utility|utility
177332|NCT03086980|regression|regression
177333|NCT03086967|cervical ripening|cervical ripening
177334|NCT03086967|double lumen catheter|double lumen catheter
177335|NCT03086954|CD19 positive lymphoma|cd19 positive lymphoma
177336|NCT03086915|neuromuscular blockade|neuromuscular blockade
177337|NCT03086915|muscle relaxation|muscle relaxation
177338|NCT03086915|muscle relaxant|muscle relaxant
177339|NCT03086902|Ablation; Cryo Energy; Radofrequency Ablation|ablation; cryo energy; radofrequency ablation
177340|NCT03086863|electroacupuncture|electroacupuncture
177341|NCT03086863|randomized controlled trial|randomized controlled trial
177342|NCT03086824|Bone Metastasis|bone metastasis
177343|NCT03086811|feeding interaction, infant eating habits, hunger satiety cues, childhood obesity|feeding interaction, infant eating habits, hunger satiety cues, childhood obesity
177344|NCT03086798|Magill forceps|magill forceps
177345|NCT03086798|cuff inflation|cuff inflation
177346|NCT03086798|Nasotracheal Intubation|nasotracheal intubation
177347|NCT03086746|Remodeling|remodeling
177348|NCT03086733|Lung Cancer|lung cancer
177349|NCT03086733|Non small cell lung cancer|non small cell lung cancer
177350|NCT03086733|Metformin|metformin
177351|NCT03086733|Pre-operative treatment|pre-operative treatment
177352|NCT03086733|Neoadjuvant treatments|neoadjuvant treatments
177353|NCT03086733|Cancer|cancer
177354|NCT03086733|Phase II|phase ii
177355|NCT03086720|Adhesive system|adhesive system
177356|NCT03086720|Controlled clinical trial|controlled clinical trial
177357|NCT03086720|Dental restoration|dental restoration
177358|NCT03086720|Noncarious cervical lesions|noncarious cervical lesions
177359|NCT03086720|Dental restoration failure|dental restoration failure
177360|NCT03086720|Sodium hypochlorite|sodium hypochlorite
177361|NCT03086707|nasal mucociliary clearance|nasal mucociliary clearance
177362|NCT03086707|saccharine transit time|saccharine transit time
177363|NCT03086694|oromaxillofacial surgery|oromaxillofacial surgery
177364|NCT03086694|nasotracheal intubation|nasotracheal intubation
177365|NCT03086694|stroke volume variation|stroke volume variation
177366|NCT03086681|Cervical carcinoma|cervical carcinoma
177367|NCT03086681|endostar|endostar
177368|NCT03086681|concurrent chemoradiotherapy|concurrent chemoradiotherapy
177369|NCT03086668|Nasotracheal Intubation|nasotracheal intubation
177370|NCT03086668|jaw thrust|jaw thrust
177371|NCT03086668|hook-finger|hook-finger
177372|NCT03086655|biological markers|biological markers
177373|NCT03086655|monitoring device|monitoring device
177374|NCT03086655|wireless technology|wireless technology
177375|NCT03086642|locally advanced pancreatic cancer|locally advanced pancreatic cancer
177376|NCT03086642|locally advanced pancreas cancer|locally advanced pancreas cancer
177377|NCT03086642|metastatic pancreatic cancer|metastatic pancreatic cancer
177378|NCT03086642|metastatic pancreas cancer|metastatic pancreas cancer
177379|NCT03086642|refractory|refractory
177380|NCT03086642|refractory pancreatic cancer|refractory pancreatic cancer
177381|NCT03086642|refractory pancreas cancer|refractory pancreas cancer
177382|NCT03086642|T-Vec|t-vec
177383|NCT03086642|T Vec|t vec
177384|NCT03086616|DIPG|dipg
177385|NCT03086616|CED|ced
177386|NCT03086616|glioma|glioma
177387|NCT03086590|Body composition|body composition
177388|NCT03086590|Ultrasound|ultrasound
177389|NCT03086590|Chronic Pulmonary Obstructive Disease|chronic pulmonary obstructive disease
177390|NCT03086590|Respiratory muscles|respiratory muscles
177391|NCT03086564|HCC|hcc
177392|NCT03086564|ADCC|adcc
177393|NCT03086564|TACE|tace
177394|NCT03086564|immuno therapy|immuno therapy
177395|NCT03086551|Transcranial Magnetic Stimulation|transcranial magnetic stimulation
177396|NCT03086551|Motor Impairment|motor impairment
177397|NCT03086551|Rehabilitation|rehabilitation
177398|NCT03086551|Motor Learning|motor learning
177399|NCT03086525|Chronic pain|chronic pain
177400|NCT03086525|Psychological factors|psychological factors
177401|NCT03086525|Musculoskeletal pain|musculoskeletal pain
177402|NCT03086525|Prognosis|prognosis
177403|NCT03086499|pectus excavatum|pectus excavatum
177404|NCT03086486|Tuberculosis|tuberculosis
177405|NCT03086486|Multi Drug-Resistant Tuberculosis|multi drug-resistant tuberculosis
177406|NCT03086486|Extensively Drug-Resistant Tuberculosis|extensively drug-resistant tuberculosis
177407|NCT03086486|Drug-Resistant Tuberculosis|drug-resistant tuberculosis
177408|NCT03086486|Pretomanid|pretomanid
177409|NCT03086486|PA-824|pa-824
177410|NCT03086486|Bedaquiline|bedaquiline
177411|NCT03086486|Linezolid|linezolid
177412|NCT03086486|NC-007|nc-007
177413|NCT03086486|TB Alliance|tb alliance
177414|NCT03086486|pre-XDR-TB|pre-xdr-tb
177415|NCT03086486|Sirturo|sirturo
177416|NCT03086473|caffeine|caffeine
177417|NCT03086473|intubation|intubation
177418|NCT03086473|hemodynamics|hemodynamics
177419|NCT03086473|mechanical ventilation|mechanical ventilation
177420|NCT03086473|cardiac output|cardiac output
177421|NCT03086473|near infrared spectroscopy|near infrared spectroscopy
177422|NCT03086473|functional echocardiography|functional echocardiography
177621|NCT03085329|respiratory support|respiratory support
177423|NCT03086434|Culturally tailored intervention|culturally tailored intervention
177424|NCT03086434|American Indian early adolescents|american indian early adolescents
177425|NCT03086434|Prevention of substance use|prevention of substance use
177426|NCT03086421|Childhood cancer|childhood cancer
177427|NCT03086421|Social functioning|social functioning
177428|NCT03086421|Social development|social development
177429|NCT03086408|airway management|airway management
177430|NCT03086408|high flow nasal oxygen|high flow nasal oxygen
177431|NCT03086408|high flow nasal cannula|high flow nasal cannula
177432|NCT03086408|THRIVE|thrive
177433|NCT03086395|relapsed|relapsed
177434|NCT03086395|refractory|refractory
177435|NCT03086382|Lacosamide|lacosamide
177436|NCT03086382|Syrup|syrup
177437|NCT03086382|Bioequivalence|bioequivalence
177438|NCT03086382|Tablet|tablet
177439|NCT03086343|Musculoskeletal Disease|musculoskeletal disease
177440|NCT03086343|Arthritis|arthritis
177441|NCT03086343|Joint Disease|joint disease
177442|NCT03086343|Anti-inflammatory agents|anti-inflammatory agents
177443|NCT03086343|Antirheumatic agents|antirheumatic agents
177444|NCT03086317|Pulmonary Medicine|pulmonary medicine
177445|NCT03086317|Therapy Evaluation|therapy evaluation
177446|NCT03086304|postoperative intestinal obstruction;TEAS|postoperative intestinal obstruction;teas
177447|NCT03086265|airway management|airway management
177448|NCT03086265|high flow nasal oxygen high flow nasal cannula THRIVE|high flow nasal oxygen high flow nasal cannula thrive
177449|NCT03086265|high flow nasal cannula THRIVE|high flow nasal cannula thrive
177450|NCT03086265|THRIVE|thrive
177451|NCT03086239|Advanced, Recurrent Small Cell Lung Cancer|advanced, recurrent small cell lung cancer
177452|NCT03086239|Small Cell Lung Cancer|small cell lung cancer
177453|NCT03086239|Rovalpituzumab tesirine|rovalpituzumab tesirine
177454|NCT03086239|Cancer|cancer
177455|NCT03086226|Mycetoma Fosravuconazole Itraconazole Surgery Sudan|mycetoma fosravuconazole itraconazole surgery sudan
177456|NCT03086213|nonintubated uniport thoracoscopic surgery|nonintubated uniport thoracoscopic surgery
177457|NCT03086213|paravertebral nerve block|paravertebral nerve block
177458|NCT03086213|intercostal nerve block|intercostal nerve block
177459|NCT03086213|peripheral solitary pulmonary nodule|peripheral solitary pulmonary nodule
177460|NCT03086200|PrEP|prep
177461|NCT03086200|Pre-exposure Prophylaxis|pre-exposure prophylaxis
177462|NCT03086200|Text messaging|text messaging
177463|NCT03086200|Truvada|truvada
177464|NCT03086200|Motivational interviewing|motivational interviewing
177465|NCT03086200|Transgender|transgender
177466|NCT03086200|Gender Non-conforming|gender non-conforming
177467|NCT03086187|weight bearing|weight bearing
177468|NCT03086187|muscle unloading|muscle unloading
177469|NCT03086187|bone loss|bone loss
177470|NCT03086187|arterial adaptation|arterial adaptation
177471|NCT03086187|muscular adaptation|muscular adaptation
177472|NCT03086174|anti-PD-1 monoclonal antibody|anti-pd-1 monoclonal antibody
177473|NCT03086174|advanced|advanced
177474|NCT03086174|melanoma|melanoma
177475|NCT03086174|kidney cancer|kidney cancer
177476|NCT03086122|OSA|osa
177477|NCT03086122|Erectile Dysfunction|erectile dysfunction
177478|NCT03086122|CPAP treatment|cpap treatment
177479|NCT03086122|Endothelial Dysfunction|endothelial dysfunction
177480|NCT03086122|Cardiovascular risk|cardiovascular risk
177481|NCT03086109|prevalence|prevalence
177482|NCT03086109|Bone Degenerative Disease|bone degenerative disease
177483|NCT03086083|Traumatic memories|traumatic memories
177484|NCT03086083|comparative study|comparative study
177485|NCT03086083|single session|single session
177486|NCT03086083|EMDR|emdr
177487|NCT03086083|Beck inventory|beck inventory
177488|NCT03086070|omeprazole|omeprazole
177489|NCT03086070|placebo|placebo
177490|NCT03086070|treatment|treatment
177491|NCT03086070|adults|adults
177492|NCT03086057|PrEP|prep
177493|NCT03086057|Prevention|prevention
177494|NCT03086057|Male Sex Workers (MSW)|male sex workers (msw)
177495|NCT03086031|Traumatic brain injury, Vocational rehabilitation, Caregiver intervention,|traumatic brain injury, vocational rehabilitation, caregiver intervention,
177496|NCT03086005|Metformin|metformin
177497|NCT03085992|rectal cancer|rectal cancer
177498|NCT03085992|FOLFOXIRI|folfoxiri
177499|NCT03085992|bevacizumab|bevacizumab
177500|NCT03085992|trust|trust
177501|NCT03085966|central memory T cell|central memory t cell
177502|NCT03085966|metastatic castration-resistant prostate cancer|metastatic castration-resistant prostate cancer
177503|NCT03085953|Psychological health|psychological health
177504|NCT03085953|Well-being|well-being
177505|NCT03085953|Employee|employee
177506|NCT03085927|music therapy|music therapy
177507|NCT03085927|neoplasms|neoplasms
177508|NCT03085927|play|play
177509|NCT03085927|children|children
177510|NCT03085927|parents|parents
177511|NCT03085914|solid tumors|solid tumors
177512|NCT03085914|colorectal cancer|colorectal cancer
177513|NCT03085914|pancreatic ductal adenocarcinoma|pancreatic ductal adenocarcinoma
177514|NCT03085914|non-small cell lung cancer|non-small cell lung cancer
177515|NCT03085914|PD-1|pd-1
177516|NCT03085914|PD-L1|pd-l1
177517|NCT03085914|epacadostat|epacadostat
177518|NCT03085914|IDO inhibitor|ido inhibitor
177519|NCT03085888|Cancer Screening|cancer screening
177520|NCT03085888|High-Throughput Nucleotide Sequencing|high-throughput nucleotide sequencing
177521|NCT03085888|Deep Sequencing|deep sequencing
177522|NCT03085888|Circulating cell-free tumor DNA|circulating cell-free tumor dna
177523|NCT03085875|Weight Change|weight change
177524|NCT03085875|Healthy Pregnancy|healthy pregnancy
177525|NCT03085875|Physiologic Sensors|physiologic sensors
177526|NCT03085862|Ultrasonography|ultrasonography
177527|NCT03085862|Extravascular lung water|extravascular lung water
177528|NCT03085862|PaO2/FiO2 ratio|pao2/fio2 ratio
177529|NCT03085836|Drug Therapy|drug therapy
177530|NCT03085797|SB240563|sb240563
177531|NCT03085797|Nasal Polyps|nasal polyps
177532|NCT03085797|Mepolizumab|mepolizumab
177533|NCT03085797|Phase 3|phase 3
177534|NCT03085797|Parallel group|parallel group
177535|NCT03085797|Efficacy|efficacy
177536|NCT03085758|Early Septic Shock|early septic shock
177537|NCT03085745|Writer's cramp|writer's cramp
177538|NCT03085745|Sensorimotor plasticity|sensorimotor plasticity
177539|NCT03085745|TMS|tms
177540|NCT03085745|Afferent inhibition|afferent inhibition
177541|NCT03085745|Motor mapping|motor mapping
177542|NCT03085745|Sensory mapping|sensory mapping
177543|NCT03085745|adaptive sensorimotor synergies|adaptive sensorimotor synergies
177544|NCT03085745|fine motor control|fine motor control
177545|NCT03085732|saline irrigation|saline irrigation
177546|NCT03085732|abdominal hysterectomy|abdominal hysterectomy
177547|NCT03085732|postoperative infectious morbidities|postoperative infectious morbidities
177548|NCT03085732|gastrointestinal disturbances|gastrointestinal disturbances
177549|NCT03085719|Head and Neck Cancer|head and neck cancer
177550|NCT03085680|Curcumin, physical function, cognitive function|curcumin, physical function, cognitive function
177551|NCT03085667|Left atrial appendage occluder|left atrial appendage occluder
177552|NCT03085667|Watchman device|watchman device
177553|NCT03085667|Atrial fibrillation|atrial fibrillation
177554|NCT03085667|atrial natriureitc peptide|atrial natriureitc peptide
177555|NCT03085667|brain natriuretic peptide|brain natriuretic peptide
177556|NCT03085654|multiple doses|multiple doses
177557|NCT03085654|oxytocin|oxytocin
177558|NCT03085654|trait anxiety|trait anxiety
177559|NCT03085641|High flow oxygen therapy|high flow oxygen therapy
177560|NCT03085628|social sharing|social sharing
177561|NCT03085628|social reward|social reward
177692|NCT03084692|caregiver|caregiver
177562|NCT03085628|functional magnetic resonance imaging|functional magnetic resonance imaging
177563|NCT03085628|reward circuit|reward circuit
177564|NCT03085589|elderly|elderly
177565|NCT03085589|telemedicine|telemedicine
177566|NCT03085589|obesity|obesity
177567|NCT03085589|rural health|rural health
177568|NCT03085589|health promotion|health promotion
177569|NCT03085576|Atrial Fibrillation|atrial fibrillation
177570|NCT03085576|Anticoagulation|anticoagulation
177571|NCT03085576|Stroke|stroke
177572|NCT03085576|Vitamin K antagonist|vitamin k antagonist
177573|NCT03085576|Cardioversion|cardioversion
177574|NCT03085576|INR (International Normalized Ratio)|inr (international normalized ratio)
177575|NCT03085550|diabetic foot ulcer|diabetic foot ulcer
177576|NCT03085550|diabetes mellitus|diabetes mellitus
177577|NCT03085550|fat grafting|fat grafting
177578|NCT03085550|platelet rich plasma|platelet rich plasma
177579|NCT03085550|wound healing|wound healing
177580|NCT03085537|home monitoring|home monitoring
177581|NCT03085537|Non-invasive mechanical ventilation|non-invasive mechanical ventilation
177582|NCT03085511|Egg breakfast|egg breakfast
177583|NCT03085511|Weight loss|weight loss
177584|NCT03085511|Satiety|satiety
177585|NCT03085511|Insulin|insulin
177586|NCT03085511|Glucagon-Like Peptide 1|glucagon-like peptide 1
177587|NCT03085511|PYY (3-36) peptide|pyy (3-36) peptide
177588|NCT03085511|Ghrelin|ghrelin
177589|NCT03085511|Glucose|glucose
177590|NCT03085511|Protein quality|protein quality
177591|NCT03085498|retinal vessels|retinal vessels
177592|NCT03085498|physical activity|physical activity
177593|NCT03085498|children|children
177594|NCT03085498|psychosocial health|psychosocial health
177595|NCT03085485|COPD|copd
177596|NCT03085485|CFTR|cftr
177597|NCT03085485|ivacaftor|ivacaftor
177598|NCT03085485|topic trial|topic trial
177599|NCT03085472|intracerebral hemrrohage|intracerebral hemrrohage
177600|NCT03085472|stroke|stroke
177601|NCT03085472|China|china
177602|NCT03085472|hematoma|hematoma
177603|NCT03085472|CT|ct
177604|NCT03085472|predictor|predictor
177605|NCT03085472|prognosis|prognosis
177606|NCT03085472|outcome|outcome
177607|NCT03085420|Burns|burns
177608|NCT03085420|Pediatrics|pediatrics
177609|NCT03085420|Cardiac Arrhythmia|cardiac arrhythmia
177610|NCT03085394|Morbid Obesity|morbid obesity
177611|NCT03085394|Sleeve gastrectomy|sleeve gastrectomy
177612|NCT03085368|breast cancer|breast cancer
177613|NCT03085368|her-2 positive|her-2 positive
177614|NCT03085368|lapatinib|lapatinib
177615|NCT03085368|herceptin|herceptin
177616|NCT03085355|neck pain|neck pain
177617|NCT03085342|liver|liver
177618|NCT03085342|fibrosis|fibrosis
177619|NCT03085342|MRI|mri
177620|NCT03085329|bubble nasal continuous positive airway pressure|bubble nasal continuous positive airway pressure
177622|NCT03085290|dry eye syndrome|dry eye syndrome
177623|NCT03085290|serum eye drops|serum eye drops
177624|NCT03085277|Bovine colostrum|bovine colostrum
177625|NCT03085277|Preterm formula|preterm formula
177626|NCT03085277|Very preterm infants|very preterm infants
177627|NCT03085277|Enteral feeding|enteral feeding
177628|NCT03085225|Advanced tumor|advanced tumor
177629|NCT03085225|Pretreated tumor|pretreated tumor
177630|NCT03085225|Soft Tissue Sarcomas|soft tissue sarcomas
177631|NCT03085225|Ovarian Carcinomas|ovarian carcinomas
177632|NCT03085225|Phase Ib|phase ib
227003|NCT02778763|TLR2|tlr2
177633|NCT03085225|Circulating DNA|circulating dna
177634|NCT03085199|gastric cancer|gastric cancer
177635|NCT03085199|laparoscopic gastrectomy|laparoscopic gastrectomy
177636|NCT03085199|laparoscopic reinforcement suture (LARS)|laparoscopic reinforcement suture (lars)
177637|NCT03085173|CAR T Cells Targeting CD19|car t cells targeting cd19
177638|NCT03085173|EGFRt/19-28z/4-1BBL|egfrt/19-28z/4-1bbl
177639|NCT03085173|16-1570|16-1570
177640|NCT03085147|Tongue|tongue
177641|NCT03085147|Mouth|mouth
177642|NCT03085147|Fluorescent PARP1 Binding Imaging Agent|fluorescent parp1 binding imaging agent
177643|NCT03085147|PARPi-FL|parpi-fl
177644|NCT03085147|15-336|15-336
177645|NCT03085121|extramedullary|extramedullary
177646|NCT03085121|intramedullary|intramedullary
177647|NCT03085121|total knee arthroplasty (TKA)|total knee arthroplasty (tka)
177648|NCT03085069|PD-1|pd-1
177649|NCT03085069|PD-L1|pd-l1
177650|NCT03085069|shr-1210|shr-1210
177651|NCT03085056|Trametinib|trametinib
177652|NCT03085056|Paclitaxel|paclitaxel
177653|NCT03085056|15-055|15-055
177654|NCT03085030|infertility|infertility
177655|NCT03085030|IVF|ivf
177656|NCT03085030|ICSI|icsi
177657|NCT03085030|poor responders in IVF/ICSI cycles|poor responders in ivf/icsi cycles
177658|NCT03085030|antioxidant|antioxidant
177659|NCT03085004|Pancreatic cyst|pancreatic cyst
177660|NCT03085004|EUS-FNA|eus-fna
177661|NCT03085004|Chemotherapy|chemotherapy
177662|NCT03085004|Endoscopic ultrasound-guided fine needle infusion|endoscopic ultrasound-guided fine needle infusion
177663|NCT03085004|paclitaxel|paclitaxel
177664|NCT03085004|gemcitabine|gemcitabine
177665|NCT03085004|cyst ablation|cyst ablation
177666|NCT03084952|safety|safety
177667|NCT03084952|pharmacokynetics|pharmacokynetics
177668|NCT03084952|leishmaniasis treatment|leishmaniasis treatment
177669|NCT03084913|dietary treatment|dietary treatment
177670|NCT03084887|Tissue Expansion Devices|tissue expansion devices
177671|NCT03084887|Tissue Expansion|tissue expansion
177672|NCT03084887|common complications|common complications
177673|NCT03084887|intervention study|intervention study
177674|NCT03084874|COPD|copd
177675|NCT03084874|Physical Activity|physical activity
177676|NCT03084874|Sedentary behaviour|sedentary behaviour
177677|NCT03084874|Hospitalization|hospitalization
177678|NCT03084848|brain/cognitive measures|brain/cognitive measures
177679|NCT03084848|condition|condition
177680|NCT03084848|inhibitor control|inhibitor control
177681|NCT03084848|training at adolescence|training at adolescence
177682|NCT03084835|tobacco|tobacco
177683|NCT03084835|smoking|smoking
177684|NCT03084835|low dose computed tomography|low dose computed tomography
177685|NCT03084835|lung screening|lung screening
177686|NCT03084835|text messaging|text messaging
177687|NCT03084783|dexamethasone|dexamethasone
177688|NCT03084783|HSV encephalitis|hsv encephalitis
177689|NCT03084770|NF-PNEN|nf-pnen
177690|NCT03084731|Microbiota|microbiota
177691|NCT03084731|Complementary Food|complementary food
177693|NCT03084692|lung cancer|lung cancer
177694|NCT03084692|yoga|yoga
177695|NCT03084692|resistance exercise|resistance exercise
177696|NCT03084679|Heart Failure|heart failure
177697|NCT03084679|Hypertrophy|hypertrophy
177698|NCT03084679|Fibrosis|fibrosis
177699|NCT03084679|Magnetic Resonance|magnetic resonance
177700|NCT03084653|Trocar entery|trocar entery
177701|NCT03084653|Surgery, Laparoscopic|surgery, laparoscopic
177702|NCT03084627|tailored dietary advice|tailored dietary advice
177703|NCT03084627|nutrient adequacy|nutrient adequacy
177704|NCT03084627|dietary modifications|dietary modifications
177705|NCT03084614|Infectious Diseases|infectious diseases
177706|NCT03084614|Dendritic Cells|dendritic cells
177707|NCT03084614|Pathogens|pathogens
177708|NCT03084614|Passive Cellular Immunity|passive cellular immunity
177709|NCT03084575|neuroaxial rhizolysis -selective rhizolysis-thermal radiofrequency|neuroaxial rhizolysis -selective rhizolysis-thermal radiofrequency
177710|NCT03084510|High risk for surgical valve replacement|high risk for surgical valve replacement
177711|NCT03084510|transcatheter aortic valve replacement|transcatheter aortic valve replacement
177712|NCT03084497|Massage|massage
177713|NCT03084497|Development|development
177714|NCT03084471|Programmed death ligand 1 (PD-L1)|programmed death ligand 1 (pd-l1)
177715|NCT03084471|Cytotoxic T-lymphocyte antigen-4 (CTLA-4)|cytotoxic t-lymphocyte antigen-4 (ctla-4)
177716|NCT03084471|Durvalumab in combination with tremelimumab|durvalumab in combination with tremelimumab
177717|NCT03084458|Increasing daily physical activity|increasing daily physical activity
177718|NCT03084445|Brominated Flame Retardants (BFRs)|brominated flame retardants (bfrs)
177719|NCT03084445|Phthalates|phthalates
177720|NCT03084445|pregnant women|pregnant women
177722|NCT03084445|Heavy Metals|heavy metals
177723|NCT03084445|Volatile Organic Compounds|volatile organic compounds
177724|NCT03084432|caffeine|caffeine
177725|NCT03084432|bone mineral content|bone mineral content
177726|NCT03084419|Rheumatoid Arthritis|rheumatoid arthritis
177727|NCT03084419|Interstitial Lung Disease|interstitial lung disease
177729|NCT03084419|Abatacept|abatacept
177730|NCT03084406|Substance Abuse|substance abuse
177731|NCT03084406|Implementation Science|implementation science
177732|NCT03084406|Evidence-based Practices|evidence-based practices
177733|NCT03084393|non-cardiac surgery|non-cardiac surgery
177734|NCT03084393|Postoperative Cognitive Dysfunction|postoperative cognitive dysfunction
177735|NCT03084354|pelvic floor|pelvic floor
177736|NCT03084354|women's experiences|women's experiences
177737|NCT03084354|bladder care|bladder care
177738|NCT03084354|pregnancy|pregnancy
177739|NCT03084354|labour|labour
177740|NCT03084354|postpartum|postpartum
177741|NCT03084341|Elasticity|elasticity
177742|NCT03084341|Electric Stimulation|electric stimulation
177743|NCT03084341|Muscle Stretching Exercises|muscle stretching exercises
177744|NCT03084315|smoking|smoking
177745|NCT03084315|electronic cigarettes|electronic cigarettes
177746|NCT03084315|nicotine|nicotine
177747|NCT03084302|sedentary behavior|sedentary behavior
177748|NCT03084302|physical activity|physical activity
177749|NCT03084276|meal ingestion|meal ingestion
177750|NCT03084276|meal composition|meal composition
177751|NCT03084276|postprandial responses|postprandial responses
177752|NCT03084276|hedonic sensations|hedonic sensations
177753|NCT03084276|homeostatic sensations|homeostatic sensations
177754|NCT03084276|new composition|new composition
177755|NCT03084211|emergency department|emergency department
177756|NCT03084211|concussion|concussion
177757|NCT03084211|head injury|head injury
177758|NCT03084198|Bioartificial Liver|bioartificial liver
177759|NCT03084198|Acute Liver Failure|acute liver failure
177760|NCT03084185|decompensation|decompensation
177761|NCT03084185|deficit|deficit
177762|NCT03084185|metabolomics|metabolomics
177763|NCT03084185|portal hypertension|portal hypertension
177764|NCT03084133|Therapeutic education strategy|therapeutic education strategy
177765|NCT03084107|Elder care|elder care
177766|NCT03084107|Active aging|active aging
177767|NCT03084107|Intelligent Care Facilities for Elders|intelligent care facilities for elders
177768|NCT03084094|Fibromyalgia|fibromyalgia
177769|NCT03084094|tDCS|tdcs
177770|NCT03084081|Human Papilloma Virus (HPV)|human papilloma virus (hpv)
177771|NCT03084081|Cryotherapy|cryotherapy
177772|NCT03084081|Thermoablation|thermoablation
177773|NCT03084081|Thermocoagulation|thermocoagulation
177774|NCT03084081|Low and Middle Income Countries (LMICs)|low and middle income countries (lmics)
177775|NCT03084042|emotional impairments|emotional impairments
177776|NCT03084042|cognitive impairments|cognitive impairments
177777|NCT03084029|oxytocin|oxytocin
177778|NCT03084029|fMRI|fmri
177779|NCT03084029|empathy|empathy
177780|NCT03083964|Middle aged women|middle aged women
177781|NCT03083964|35-64yrs|35-64yrs
177782|NCT03083964|BMI= >30|bmi= >30
177783|NCT03083951|Complete mesocolon excision|complete mesocolon excision
177784|NCT03083951|Sigmoid cancer|sigmoid cancer
177785|NCT03083951|Colorectal cancer|colorectal cancer
177786|NCT03083938|Pancreatoduodenectomy|pancreatoduodenectomy
177787|NCT03083938|Omentum|omentum
177788|NCT03083938|Wrapping|wrapping
177789|NCT03083938|Roll-up|roll-up
177790|NCT03083938|Whipple|whipple
177791|NCT03083912|Malnutrition|malnutrition
177792|NCT03083912|Disability|disability
177793|NCT03083912|Oral Nutritional Supplementation|oral nutritional supplementation
177794|NCT03083899|Diabetes|diabetes
177795|NCT03083899|Organization|organization
177796|NCT03083899|Out-patient control|out-patient control
177797|NCT03083873|LN-145|ln-145
177798|NCT03083873|Cell Therapy|cell therapy
177799|NCT03083873|Autologous Adoptive Cell Transfer|autologous adoptive cell transfer
177800|NCT03083873|Autologous Adoptive Cell Therapy|autologous adoptive cell therapy
177801|NCT03083873|Cellular Immuno-therapy|cellular immuno-therapy
177802|NCT03083873|Tumor Infiltrating Lymphocytes|tumor infiltrating lymphocytes
177803|NCT03083873|TIL|til
177804|NCT03083873|IL-2|il-2
177805|NCT03083847|Malaria|malaria
177806|NCT03083847|Parasitemia|parasitemia
177807|NCT03083847|Immune|immune
177808|NCT03083847|Responses|responses
177809|NCT03083847|Sporozoites|sporozoites
177810|NCT03083834|cosyntropin|cosyntropin
177811|NCT03083834|salivary free cortisol|salivary free cortisol
177812|NCT03083834|mitotane|mitotane
177813|NCT03083808|PD-1|pd-1
177814|NCT03083808|PD-L1 Inhibitor|pd-l1 inhibitor
177815|NCT03083808|Pembrolizumab|pembrolizumab
177816|NCT03083808|Docetaxel|docetaxel
177817|NCT03083808|Pemetrexed|pemetrexed
177818|NCT03083808|Gemcitabine|gemcitabine
177819|NCT03083795|Social relationships|social relationships
177820|NCT03083795|Vulnerable connections|vulnerable connections
177821|NCT03083795|Diabetes Distress|diabetes distress
177822|NCT03083795|Support group|support group
177823|NCT03083782|Apixaban|apixaban
177824|NCT03083782|Cyclosporine|cyclosporine
177825|NCT03083782|Tacrolimus|tacrolimus
177826|NCT03083782|Cytochrome P450 CYP3A4|cytochrome p450 cyp3a4
177827|NCT03083782|Permeability Glycoprotein P-gp|permeability glycoprotein p-gp
177828|NCT03083782|Breast cancer resistance protein BCRP|breast cancer resistance protein bcrp
177829|NCT03083782|Factor Xa Inhibitors|factor xa inhibitors
177830|NCT03083782|Anticoagulants|anticoagulants
177831|NCT03083782|Enzyme Inhibitors|enzyme inhibitors
177832|NCT03083769|tacrolimus|tacrolimus
177833|NCT03083769|genetic variants|genetic variants
177834|NCT03083769|side effects|side effects
177835|NCT03083743|Carcinoma, Non-Small-Cell Lung|carcinoma, non-small-cell lung
177836|NCT03083743|Carcinoma, Bronchogenic|carcinoma, bronchogenic
177837|NCT03083743|Bronchial Neoplasms|bronchial neoplasms
177838|NCT03083743|Lung Neoplasms|lung neoplasms
177839|NCT03083743|Thoracic Neoplasms|thoracic neoplasms
177840|NCT03083743|Neoplasms|neoplasms
177841|NCT03083743|Lung Diseases|lung diseases
177842|NCT03083743|Antineoplastic Agents, Cytokines|antineoplastic agents, cytokines
177843|NCT03083743|Antineoplastic Agents|antineoplastic agents
177844|NCT03083743|Biological activity factor|biological activity factor
177845|NCT03083743|Genetic Engineering|genetic engineering
177846|NCT03083743|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action
177847|NCT03083743|Physiological Effects of Drugs|physiological effects of drugs
177848|NCT03083730|Atopic Dermatitis|atopic dermatitis
177850|NCT03083730|Systemic Inflammation|systemic inflammation
177851|NCT03083730|UVB Phototherapy|uvb phototherapy
177852|NCT03083691|Nivolumab|nivolumab
177853|NCT03083691|Ipilimumab|ipilimumab
177854|NCT03083678|EGFR|egfr
177855|NCT03083678|Afatinib|afatinib
177856|NCT03083665|Epilepsy|epilepsy
177857|NCT03083665|Partial seizures with or without secondary generalization|partial seizures with or without secondary generalization
177858|NCT03083665|Brivaracetam|brivaracetam
177859|NCT03083665|Briviact|briviact
177860|NCT03083652|physiotherapy|physiotherapy
177861|NCT03083652|neuromuscular electrical stimulation|neuromuscular electrical stimulation
177862|NCT03083652|exercise capacity|exercise capacity
177863|NCT03083639|Drug Therapy|drug therapy
177864|NCT03083626|Chronic pain|chronic pain
177865|NCT03083626|Narcotic abuse|narcotic abuse
177866|NCT03083626|Opioid related disorders|opioid related disorders
177867|NCT03083626|Opiate substitution treatment|opiate substitution treatment
177868|NCT03083626|Buprenorphine|buprenorphine
177869|NCT03083626|Pregabalin|pregabalin
177870|NCT03083626|Methadone|methadone
177871|NCT03083613|Raltitrexed|raltitrexed
177872|NCT03083613|Paclitaxel|paclitaxel
177873|NCT03083613|chemotherapy|chemotherapy
177874|NCT03083613|Gastric cancer|gastric cancer
177875|NCT03083613|Gastroesophageal Junction Adenocarcinoma|gastroesophageal junction adenocarcinoma
177876|NCT03083600|protein hydrolysates|protein hydrolysates
177877|NCT03083600|HbA1c|hba1c
177878|NCT03083600|prediabetes|prediabetes
177879|NCT03083574|Hematology|hematology
177880|NCT03083574|Chronic graft versus host disease (cGVHD)|chronic graft versus host disease (cgvhd)
177881|NCT03083574|Extracorporeal photopheresis|extracorporeal photopheresis
177882|NCT03083574|Hematopoietic stem cell transplantation|hematopoietic stem cell transplantation
177883|NCT03083574|Donor lymphocyte infusion|donor lymphocyte infusion
177884|NCT03083522|Cold Hypersensitivity|cold hypersensitivity
177885|NCT03083522|Korean medicine|korean medicine
177886|NCT03083522|Ojeok-san|ojeok-san
177887|NCT03083522|Cold intolerance|cold intolerance
177888|NCT03083418|AECOPD|aecopd
177889|NCT03083418|EDP|edp
177890|NCT03083418|Neural Respiratory Drive|neural respiratory drive
177891|NCT03083418|Surface EMGdi|surface emgdi
177892|NCT03083392|DIVA|diva
177893|NCT03083392|sinusitis|sinusitis
177894|NCT03083392|maxillary|maxillary
177895|NCT03083379|Incentive spirometry|incentive spirometry
177896|NCT03083379|EzPAP|ezpap
177897|NCT03083379|Electrical impedance tomography|electrical impedance tomography
177898|NCT03083366|spinal cord injury|spinal cord injury
177899|NCT03083366|Neurogenic|neurogenic
177900|NCT03083366|bladder|bladder
177901|NCT03083366|electrical stimulation|electrical stimulation
177902|NCT03083366|neuromodulation|neuromodulation
177903|NCT03083301|Cardiac resynchronisation|cardiac resynchronisation
177904|NCT03083223|patient positioning|patient positioning
177905|NCT03083223|lung diseases|lung diseases
177906|NCT03083223|oxygenation|oxygenation
177907|NCT03083223|hemodynamic parameters|hemodynamic parameters
177908|NCT03083223|vital signs|vital signs
177909|NCT03083197|Scrub Typhus|scrub typhus
177910|NCT03083197|Antibiotic Resistance|antibiotic resistance
177911|NCT03083184|Hemodialysis|hemodialysis
177912|NCT03083184|hemodiafiltration|hemodiafiltration
177913|NCT03083184|tunnelled dialysis catheter|tunnelled dialysis catheter
177914|NCT03083184|interdialytic lock solution|interdialytic lock solution
177915|NCT03083184|preventing tunnelled catheter infection|preventing tunnelled catheter infection
177916|NCT03083171|Adrecizumab|adrecizumab
177917|NCT03083171|Adrenomedullin|adrenomedullin
177918|NCT03083171|Healthy volunteers|healthy volunteers
177919|NCT03083171|LPS|lps
177920|NCT03083171|Monoclonal recombinant antibody|monoclonal recombinant antibody
177921|NCT03083132|freezing of gait|freezing of gait
177922|NCT03083067|AECOPD|aecopd
177923|NCT03083067|air pollution|air pollution
177924|NCT03083067|COPD|copd
177925|NCT03083067|salvational Intervention|salvational intervention
177926|NCT03083041|SHR-1210|shr-1210
177927|NCT03083041|Apatinib|apatinib
177928|NCT03083041|NSCLC|nsclc
177929|NCT03083028|Ankle Fracture|ankle fracture
177930|NCT03083015|regeneration, MTA apexification and TAP|regeneration, mta apexification and tap
177931|NCT03083015|revascularization|revascularization
177932|NCT03082963|atrial fibrillation|atrial fibrillation
177933|NCT03082963|ablation|ablation
177934|NCT03082950|hpv prevalence|hpv prevalence
177935|NCT03082950|recurrence rate|recurrence rate
177936|NCT03082950|survival|survival
177937|NCT03082924|surface EMGdi|surface emgdi
177938|NCT03082924|pulmonary rehabilitation|pulmonary rehabilitation
177939|NCT03082924|inspiratory muscle training|inspiratory muscle training
177940|NCT03082924|exercise training|exercise training
177941|NCT03082911|screening|screening
177942|NCT03082911|early detection|early detection
177943|NCT03082911|participation|participation
177944|NCT03082872|Reduction, Fracture|reduction, fracture
177945|NCT03082859|Exercise|exercise
177946|NCT03082859|Interval Training|interval training
177947|NCT03082859|Glycaemic Control|glycaemic control
177948|NCT03082859|Type 2 Diabetes|type 2 diabetes
177949|NCT03082846|malignant glioma|malignant glioma
177950|NCT03082846|intensity modulated radiation therapy|intensity modulated radiation therapy
177951|NCT03082846|simultaneous integrated boost|simultaneous integrated boost
177952|NCT03082846|hypofractionation|hypofractionation
177953|NCT03082846|temozolomide|temozolomide
177954|NCT03082846|maximum tolerated dose|maximum tolerated dose
177955|NCT03082807|Caloric Restriction|caloric restriction
177956|NCT03082807|Diet|diet
177957|NCT03082807|Exercise|exercise
177958|NCT03082807|Obesity|obesity
177959|NCT03082807|Overweight|overweight
177960|NCT03082807|Sedentary lifestyle|sedentary lifestyle
177961|NCT03082807|weight loss|weight loss
177962|NCT03082807|Men|men
177963|NCT03082794|Dietary Formulations|dietary formulations
177964|NCT03082794|Lifestyle|lifestyle
177965|NCT03082794|Obesity|obesity
177966|NCT03082794|Overweight|overweight
177967|NCT03082794|weight loss|weight loss
177968|NCT03082781|Diet|diet
177969|NCT03082781|Exercise|exercise
177970|NCT03082781|Obesity|obesity
177971|NCT03082781|Overweight|overweight
177972|NCT03082781|Weight loss|weight loss
177973|NCT03082768|HV|hv
177974|NCT03082742|diuretics|diuretics
177975|NCT03082742|furosemide|furosemide
177976|NCT03082742|hydrochlorothiazide|hydrochlorothiazide
177977|NCT03082742|CKD-MBD|ckd-mbd
177978|NCT03082742|HRpQCT|hrpqct
177979|NCT03082742|parathyroid hormone|parathyroid hormone
177980|NCT03082716|cardioplegia|cardioplegia
177981|NCT03082716|myocardial protection|myocardial protection
177982|NCT03082716|custodiol|custodiol
177983|NCT03082716|htk|htk
177984|NCT03082677|Ixazomib|ixazomib
177985|NCT03082677|Graft-versus-Host Disease|graft-versus-host disease
177986|NCT03082677|Allogeneic Hematopoietic Stem Cell Transplantation|allogeneic hematopoietic stem cell transplantation
177987|NCT03082677|16-076|16-076
177988|NCT03082651|Running injuries, footwear, alternating load|running injuries, footwear, alternating load
177989|NCT03082612|Behavioral research|behavioral research
177990|NCT03082612|Social research|social research
177991|NCT03082612|Spirituality|spirituality
177992|NCT03082612|Late stage cancer|late stage cancer
177993|NCT03082547|Headache|headache
177994|NCT03082547|Neuropsychological tests|neuropsychological tests
177995|NCT03082547|Myofascial trigger points|myofascial trigger points
177996|NCT03082547|electrophysiology|electrophysiology
177997|NCT03082534|Head and Neck Cancer|head and neck cancer
177998|NCT03082534|Pembrolizumab|pembrolizumab
177999|NCT03082534|Keytruda®|keytruda®
178000|NCT03082534|Cetuximab|cetuximab
178001|NCT03082534|Erbitux®|erbitux®
178002|NCT03082534|Recurrent|recurrent
178003|NCT03082534|Metastatic|metastatic
178004|NCT03082534|PD-1|pd-1
178005|NCT03082534|PD-L1|pd-l1
178006|NCT03082534|non-EBV related Nasopharynx|non-ebv related nasopharynx
178007|NCT03082521|After hours care; Primary care; Antibiotics; Action Research|after hours care; primary care; antibiotics; action research
178008|NCT03082508|Algisyl|algisyl
178009|NCT03082508|Heart Failure|heart failure
178010|NCT03082508|Dilated Cardiomyopathy|dilated cardiomyopathy
178011|NCT03082508|Alginate Hydrogel|alginate hydrogel
178012|NCT03082508|Heart Failure with Reduced Ejection Fraction|heart failure with reduced ejection fraction
178013|NCT03082508|Congestive Heart Failure|congestive heart failure
178014|NCT03082495|Exercise|exercise
178015|NCT03082495|Cancer|cancer
178016|NCT03082495|Symptom management|symptom management
178017|NCT03082495|Quality of life|quality of life
178018|NCT03082495|presurgical|presurgical
178019|NCT03082495|chemoradiotherapy|chemoradiotherapy
178020|NCT03082495|Physical Fitness|physical fitness
178021|NCT03082482|Smoking Cessation|smoking cessation
178022|NCT03082482|HIV|hiv
178023|NCT03082482|AIDS|aids
178024|NCT03082469|Severe acute pancreatitis|severe acute pancreatitis
178025|NCT03082469|Haemodynamic monitoring|haemodynamic monitoring
178026|NCT03082469|Cytokine removal|cytokine removal
178027|NCT03082469|Vasopressor dependency index|vasopressor dependency index
178028|NCT03082456|molecuiar breast imaging|molecuiar breast imaging
178029|NCT03082456|MBI|mbi
178030|NCT03082456|breast cancer|breast cancer
178031|NCT03082456|mammography|mammography
178032|NCT03082456|sonography|sonography
178033|NCT03082456|recall rate|recall rate
178034|NCT03082456|diagnostic accuracy|diagnostic accuracy
178035|NCT03082456|breast echo|breast echo
178036|NCT03082456|female population|female population
178037|NCT03082443|Cardiac rehabilitation|cardiac rehabilitation
178038|NCT03082443|psychology|psychology
178039|NCT03082443|nutrition|nutrition
178040|NCT03082443|stress|stress
178041|NCT03082443|quality of life|quality of life
178042|NCT03082417|Bone Fracture|bone fracture
178043|NCT03082417|75 years old|75 years old
178044|NCT03082417|Elderly|elderly
178045|NCT03082417|Older adults|older adults
178046|NCT03082417|Pain scale|pain scale
178047|NCT03082417|Pain documentation|pain documentation
178048|NCT03082417|Analgesics|analgesics
178049|NCT03082417|Acetaminophen|acetaminophen
178050|NCT03082417|Opioid|opioid
178051|NCT03082417|Nonsteroidal anti-inflammatory drugs|nonsteroidal anti-inflammatory drugs
178052|NCT03082417|Emergency Department|emergency department
178053|NCT03082404|Chronic kidney disease|chronic kidney disease
178054|NCT03082404|Inspiratory muscle training|inspiratory muscle training
178055|NCT03082391|Ventral Hernia Repair|ventral hernia repair
178056|NCT03082391|Heavyweight Mesh|heavyweight mesh
178057|NCT03082391|Mediumweight Mesh|mediumweight mesh
178058|NCT03082365|oral findings or oral manifestations|oral findings or oral manifestations
178059|NCT03082365|pre-dialysis or end stage renal disease|pre-dialysis or end stage renal disease
178060|NCT03082326|shock|shock
178061|NCT03082326|critical care ultrasound|critical care ultrasound
178062|NCT03082326|hemodynamics|hemodynamics
178063|NCT03082326|lung pathology|lung pathology
178064|NCT03082326|epidemic|epidemic
178065|NCT03082326|prognosis|prognosis
178066|NCT03082313|infant|infant
178067|NCT03082313|leg movement|leg movement
178068|NCT03082313|wearable sensors|wearable sensors
178069|NCT03082313|early intervention|early intervention
178070|NCT03082300|ASP8273|asp8273
178071|NCT03082300|Epidermal growth factor receptor (EGFR) mutations|epidermal growth factor receptor (egfr) mutations
178072|NCT03082300|naquotinib|naquotinib
178073|NCT03082300|Non-small cell lung cancer (NSCLC)|non-small cell lung cancer (nsclc)
178074|NCT03082300|Bioequivalence|bioequivalence
178075|NCT03082261|Failed Back Surgery Syndrome|failed back surgery syndrome
178076|NCT03082261|Radiculopathy|radiculopathy
178077|NCT03082261|Post Laminectomy Syndrome|post laminectomy syndrome
178078|NCT03082248|Low Back Pain|low back pain
178079|NCT03082248|Surgery|surgery
178080|NCT03082248|Lumbar Spine|lumbar spine
178081|NCT03082248|Physical Therapy Modalities|physical therapy modalities
178082|NCT03082248|Rehabilitation|rehabilitation
178083|NCT03082235|Healthy participants|healthy participants
178084|NCT03082235|E6742|e6742
178085|NCT03082235|pharmacokinetics|pharmacokinetics
178086|NCT03082222|partial onset seizures with or without secondary generalization|partial onset seizures with or without secondary generalization
178087|NCT03082209|Solid Tumors|solid tumors
178088|NCT03082209|Hematologic Malignancies|hematologic malignancies
178089|NCT03082209|Cancer|cancer
178090|NCT03082209|non-Hodgkin lymphoma|non-hodgkin lymphoma
178091|NCT03082209|acute myeloid leukemia (AML)|acute myeloid leukemia (aml)
178092|NCT03082209|colorectal cancer (CRC)|colorectal cancer (crc)
178093|NCT03082209|Diffuse Large B-Cell Lymphoma (DLBCL)|diffuse large b-cell lymphoma (dlbcl)
178094|NCT03082196|sodium fluoride|sodium fluoride
178095|NCT03082196|povidone iodine|povidone iodine
178096|NCT03082196|varnish|varnish
178097|NCT03082170|sleep apnea|sleep apnea
178098|NCT03082170|robotic surgery for base of tongue|robotic surgery for base of tongue
178099|NCT03082170|soft palate surgery|soft palate surgery
178100|NCT03082170|post operative swallowing evaluation|post operative swallowing evaluation
178101|NCT03082170|dysphagia|dysphagia
178102|NCT03082131|Gut Microbiota|gut microbiota
178103|NCT03082131|Glycemic Response|glycemic response
178104|NCT03082131|Resistant Starch|resistant starch
178105|NCT03082131|Fiber|fiber
178106|NCT03082092|Knee|knee
178107|NCT03082092|Pain|pain
178108|NCT03082092|Recovery|recovery
178109|NCT03082092|Steroid|steroid
178110|NCT03082092|Replacement|replacement
178111|NCT03082092|Arthroplasty|arthroplasty
178112|NCT03082079|GIST|gist
178113|NCT03082079|ESD|esd
178114|NCT03082066|bone access|bone access
178115|NCT03082066|intraosseus needle|intraosseus needle
178116|NCT03082066|resuscitation|resuscitation
178117|NCT03082066|infusion|infusion
178118|NCT03082066|volume therapy|volume therapy
178119|NCT03082066|emergency|emergency
178120|NCT03082027|ultrasonography|ultrasonography
178121|NCT03082027|carpal tunnel syndrome|carpal tunnel syndrome
178122|NCT03082014|Hypertension|hypertension
178123|NCT03082014|Cerebrovascular Reactivity|cerebrovascular reactivity
178124|NCT03082014|Blood Pressure Variability|blood pressure variability
178125|NCT03082001|Neonate|neonate
178126|NCT03082001|Pain|pain
178127|NCT03082001|ELBW|elbw
178128|NCT03081988|Esophageal Cancer|esophageal cancer
178129|NCT03081988|chemoradiotherapy response|chemoradiotherapy response
178130|NCT03081988|molecular factors|molecular factors
178131|NCT03081975|adenoma detection rate|adenoma detection rate
178132|NCT03081975|narrow band imaging|narrow band imaging
178133|NCT03081949|peripartum cardiomyopathy|peripartum cardiomyopathy
178134|NCT03081949|Ventricular remodelling|ventricular remodelling
178135|NCT03081949|Survival|survival
178136|NCT03081949|Selenium|selenium
178137|NCT03081949|Oxidative stress|oxidative stress
178138|NCT03081949|Nigeria|nigeria
178139|NCT03081923|Immunotherapy|immunotherapy
178140|NCT03081923|Durvalumab|durvalumab
178141|NCT03081923|Tremelimumab|tremelimumab
178142|NCT03081923|Combination therapy|combination therapy
178143|NCT03081923|Testicular cancer|testicular cancer
178144|NCT03081910|Autologous CAR T cells|autologous car t cells
178145|NCT03081910|T-cell acute lymphoblastic lymphoma|t-cell acute lymphoblastic lymphoma
178146|NCT03081910|T-non-Hodgkin Lymphoma|t-non-hodgkin lymphoma
178147|NCT03081910|T-cell Acute Lymphoblastic Leukemia|t-cell acute lymphoblastic leukemia
178148|NCT03081884|Prostate cancer|prostate cancer
178149|NCT03081884|Metastatic cancer|metastatic cancer
178150|NCT03081884|Urogenital disorders|urogenital disorders
178151|NCT03081884|Oncology|oncology
178152|NCT03081884|Radiology|radiology
178153|NCT03081858|NMIBC|nmibc
178154|NCT03081858|Paclitaxel|paclitaxel
178155|NCT03081858|Antineoplastic Agents|antineoplastic agents
178156|NCT03081832|Prader-Willi|prader-willi
178157|NCT03081832|Oxytocin|oxytocin
178158|NCT03081832|Communication skills|communication skills
178159|NCT03081832|Oral skills|oral skills
178160|NCT03081832|Brain activity|brain activity
178161|NCT03081832|Hormonal disease|hormonal disease
178162|NCT03081806|Phase 3|phase 3
178163|NCT03081806|Efficacy|efficacy
178164|NCT03081806|Safety|safety
178165|NCT03081806|Osteoarthritis, Knee|osteoarthritis, knee
178166|NCT03081793|postoperative monitoring|postoperative monitoring
178167|NCT03081793|plethysmography|plethysmography
178168|NCT03081793|monitoring|monitoring
178170|NCT03081767|PET/CT|pet/ct
178171|NCT03081767|digital PET/CT|digital pet/ct
178172|NCT03081715|esophageal cancer|esophageal cancer
178173|NCT03081715|immune checkpoint|immune checkpoint
178174|NCT03081715|PD-1|pd-1
178175|NCT03081715|CRISPER|crisper
178176|NCT03081715|autologous cell infusion|autologous cell infusion
178177|NCT03081676|Maturity-Onset Diabetes of the Young, Type 3|maturity-onset diabetes of the young, type 3
178178|NCT03081676|Glucose-dependent insulinotropic peptide|glucose-dependent insulinotropic peptide
178179|NCT03081676|Glucagon-like-peptide 1|glucagon-like-peptide 1
178180|NCT03081676|Dipeptidyl peptidase 4|dipeptidyl peptidase 4
178181|NCT03081676|Glimepiride|glimepiride
178182|NCT03081676|Sulphonylurea|sulphonylurea
178183|NCT03081676|Glucose clamp|glucose clamp
178184|NCT03081676|Hepatocyte nuclear factor 1 alpha|hepatocyte nuclear factor 1 alpha
178185|NCT03081663|total knee arthroplasty|total knee arthroplasty
178186|NCT03081663|quadriceps sparing mid-vastus|quadriceps sparing mid-vastus
178187|NCT03081663|medial para-patellar|medial para-patellar
178188|NCT03081624|preterm|preterm
178189|NCT03081624|neurological status|neurological status
178190|NCT03081624|School Readiness|school readiness
178191|NCT03081585|fmri|fmri
178192|NCT03081585|neuronal reward processing|neuronal reward processing
178193|NCT03081585|hormonal satiety signalling|hormonal satiety signalling
178194|NCT03081585|fasting|fasting
178195|NCT03081559|transgender|transgender
178196|NCT03081559|women|women
178197|NCT03081533|Healthy Aging|healthy aging
178198|NCT03081533|Family Health|family health
178199|NCT03081533|Exercise|exercise
178200|NCT03081533|Dance Therapy|dance therapy
178201|NCT03081507|Muslim Americans|muslim americans
178202|NCT03081507|Patient Navigation|patient navigation
178203|NCT03081507|Breast Cancer|breast cancer
178204|NCT03081507|Cervical Cancer|cervical cancer
178205|NCT03081494|PDR001|pdr001
178206|NCT03081494|MCC|mcc
178207|NCT03081494|immunotherapy|immunotherapy
178208|NCT03081494|regorafenib|regorafenib
178209|NCT03081494|CRC|crc
178210|NCT03081494|MMS|mms
178211|NCT03081494|CMS4|cms4
178212|NCT03081494|ElevatION:CRC-102|elevation:crc-102
178213|NCT03081481|Intraprostatic|intraprostatic
178214|NCT03081481|MRI lesion|mri lesion
178215|NCT03081481|Prostate biopsies|prostate biopsies
178216|NCT03081468|Optical coherence tomography|optical coherence tomography
178217|NCT03081468|Pupillometry|pupillometry
178218|NCT03081468|Automated|automated
178219|NCT03081468|Binocular|binocular
178220|NCT03081455|Screening|screening
178221|NCT03081455|Hereditary Cancer|hereditary cancer
178222|NCT03081403|Sensitive skin|sensitive skin
178223|NCT03081403|Quantitative Sensory Testing|quantitative sensory testing
178224|NCT03081364|Cardiac Implanted Device|cardiac implanted device
178225|NCT03081351|Extended retroperitoneal lymphadenectomy, Nerve plexus clearance, Survival benefit|extended retroperitoneal lymphadenectomy, nerve plexus clearance, survival benefit
178226|NCT03081338|ALS, MND, Care, Patient journey|als, mnd, care, patient journey
178227|NCT03081325|uRM|urm
178228|NCT03081325|RIF|rif
178229|NCT03081325|Th1|th1
178230|NCT03081325|Th2|th2
178231|NCT03081325|Treg|treg
178232|NCT03081325|lymphocyte immunotherapy|lymphocyte immunotherapy
178233|NCT03081312|Family Cancer Caregivers,|family cancer caregivers,
178234|NCT03081312|Needs|needs
178235|NCT03081312|Burden of Care|burden of care
178236|NCT03081312|Quality of Life|quality of life
178237|NCT03081273|Antimicrobial susceptibility|antimicrobial susceptibility
178238|NCT03081273|Biofilm formation|biofilm formation
178239|NCT03081273|Bone and joint infection|bone and joint infection
178240|NCT03081273|Corynebacterium spp|corynebacterium spp
178241|NCT03081273|Osteoblast|osteoblast
178242|NCT03081273|Outcome|outcome
178243|NCT03081273|Prosthetic joint infection|prosthetic joint infection
178244|NCT03081260|Total Knee Arthroplasty|total knee arthroplasty
178245|NCT03081260|Patella|patella
178246|NCT03081260|Resurfacing|resurfacing
178247|NCT03081260|IKS score|iks score
178248|NCT03081234|Hormone receptor-positive|hormone receptor-positive
178249|NCT03081234|Estrogen and/or progesterone receptor-positive|estrogen and/or progesterone receptor-positive
178250|NCT03081234|HER2-negative|her2-negative
178251|NCT03081234|Intermediate risk early breast cancer|intermediate risk early breast cancer
178252|NCT03081234|Adjuvant|adjuvant
178253|NCT03081234|Ribociclib|ribociclib
178254|NCT03081234|LEE011|lee011
178255|NCT03081234|CDK4/6 inhibitor|cdk4/6 inhibitor
178256|NCT03081234|Endocrine therapy|endocrine therapy
178257|NCT03081234|Phase III|phase iii
178258|NCT03081234|breast carcinoma|breast carcinoma
178259|NCT03081234|breast cancer|breast cancer
178260|NCT03081208|IVF|ivf
178261|NCT03081208|ICSI|icsi
178262|NCT03081195|child behavior|child behavior
178263|NCT03081195|intervention|intervention
178264|NCT03081195|multiple family group|multiple family group
178265|NCT03081195|Sub Saharan Africa|sub saharan africa
178266|NCT03081195|caregivers|caregivers
178267|NCT03081156|chronic obstructive pulmonary disease (COPD)|chronic obstructive pulmonary disease (copd)
178268|NCT03081156|exercise intolerance|exercise intolerance
178269|NCT03081156|dynamic hyperinflation|dynamic hyperinflation
178270|NCT03081117|HIV-Associated Neurocognitive Disorder (HAND)|hiv-associated neurocognitive disorder (hand)
178271|NCT03081117|Intranasal|intranasal
178272|NCT03081052|Heart and Lung transplantation surgery|heart and lung transplantation surgery
178273|NCT03081052|Pulmonary vasodilation therapy|pulmonary vasodilation therapy
178274|NCT03081039|cholangiocarcinoma|cholangiocarcinoma
178275|NCT03081039|gemcitabine|gemcitabine
178276|NCT03081039|carboplatin|carboplatin
178277|NCT03081039|cisplatin|cisplatin
178278|NCT03081026|surgery|surgery
178279|NCT03081026|ages 6-16|ages 6-16
178280|NCT03081013|adolescents|adolescents
178281|NCT03081013|social norms|social norms
178282|NCT03080974|irreversible electroporation|irreversible electroporation
178283|NCT03080974|Nivolumab|nivolumab
178284|NCT03080961|Barrier cream|barrier cream
178285|NCT03080922|Acute Myeloid Leukemia|acute myeloid leukemia
178286|NCT03080922|Relapsed|relapsed
178287|NCT03080922|Refractory|refractory
178288|NCT03080922|hematopoietic stem cell|hematopoietic stem cell
178289|NCT03080909|Satiety|satiety
178290|NCT03080909|Nutrient|nutrient
178291|NCT03080909|Appetite|appetite
178292|NCT03080909|Encapsulation|encapsulation
178293|NCT03080909|Lipid|lipid
178294|NCT03080909|Amino acid|amino acid
178295|NCT03080909|Probiotic bacteria|probiotic bacteria
178296|NCT03080870|Art intervention|art intervention
178297|NCT03080870|Quality of Life|quality of life
178298|NCT03080870|Well-being|well-being
178299|NCT03080870|Physical performance|physical performance
178300|NCT03080870|Family caregivers|family caregivers
178301|NCT03080870|Older adults|older adults
178302|NCT03080831|Maintenance Fluid Therapy|maintenance fluid therapy
178303|NCT03080818|Probiotic, Cognitive Function, Mood|probiotic, cognitive function, mood
178304|NCT03080792|stem cell transplantation|stem cell transplantation
178305|NCT03080792|exercise|exercise
178306|NCT03080792|high intensity interval training|high intensity interval training
178307|NCT03080792|resistance training|resistance training
178308|NCT03080792|physical fitness|physical fitness
178309|NCT03080792|cancer|cancer
178310|NCT03080753|Sphinkeeper|sphinkeeper
178311|NCT03080753|Intersphincteric implants|intersphincteric implants
178312|NCT03080753|Gatekeeper|gatekeeper
178313|NCT03080714|no known ocular pathology|no known ocular pathology
178314|NCT03080714|Glaucoma|glaucoma
178315|NCT03080714|Retinal Disease|retinal disease
178316|NCT03080701|Behavioral: Automated Mailing|behavioral: automated mailing
178317|NCT03080675|Aging population|aging population
178318|NCT03080649|dental caries, Er:YAG laser, rotary bur|dental caries, er:yag laser, rotary bur
178319|NCT03080636|Post-exercise hypotension|post-exercise hypotension
178320|NCT03080636|Aerobic Exercise|aerobic exercise
178621|NCT03079206|allergens|allergens
178321|NCT03080636|Resistance Exercise|resistance exercise
178322|NCT03080636|Autonomic Stress|autonomic stress
178323|NCT03080636|Heart Rate Variability|heart rate variability
178324|NCT03080636|Sex difference|sex difference
178325|NCT03080610|Post-Dural Puncture Headache [C10.228.140.546.699.124]|post-dural puncture headache [c10.228.140.546.699.124]
178326|NCT03080610|Blood Patch, Epidural [E02.319.267.530.580.300.145]|blood patch, epidural [e02.319.267.530.580.300.145]
178327|NCT03080584|acupuncture|acupuncture
178328|NCT03080584|IVF|ivf
178329|NCT03080584|AMH|amh
178330|NCT03080584|ovarian reserve|ovarian reserve
178331|NCT03080558|Indocyanine green fluorescence|indocyanine green fluorescence
178332|NCT03080558|Rectal vascularisation|rectal vascularisation
178333|NCT03080558|Vaginal vascularisation|vaginal vascularisation
178334|NCT03080558|Laparoscopic surgery|laparoscopic surgery
178335|NCT03080558|Rectal shaving|rectal shaving
178336|NCT03080558|Recto vaginal node|recto vaginal node
178337|NCT03080558|Deep Endometriosis|deep endometriosis
178338|NCT03080532|Microbiome|microbiome
178339|NCT03080532|Mediterranean diet|mediterranean diet
178340|NCT03080519|renal artery stenosis|renal artery stenosis
178341|NCT03080519|balloon angioplasty|balloon angioplasty
178342|NCT03080519|stents|stents
178343|NCT03080493|Abortion|abortion
178344|NCT03080493|Osmotic dilators|osmotic dilators
178345|NCT03080493|Gabapentin|gabapentin
178346|NCT03080493|Text message|text message
178347|NCT03080480|Chronic Granulomatous Disease|chronic granulomatous disease
178348|NCT03080480|Severe Infection|severe infection
178349|NCT03080480|PPARγ|pparγ
178350|NCT03080480|Pioglitazone|pioglitazone
178351|NCT03080480|phagocytes|phagocytes
178352|NCT03080467|Trauma|trauma
178353|NCT03080467|Laceration|laceration
178354|NCT03080467|Suture|suture
178355|NCT03080467|Cosmesis|cosmesis
178356|NCT03080467|Ethyl-2-Cyanoacrylate|ethyl-2-cyanoacrylate
178357|NCT03080467|Tissue adhesive|tissue adhesive
178358|NCT03080467|Lip lacerations|lip lacerations
178359|NCT03080467|Skalp lacerations|skalp lacerations
178360|NCT03080467|Facial injuries|facial injuries
178361|NCT03080454|stroke|stroke
178362|NCT03080454|CVA|cva
178363|NCT03080454|Spasticity|spasticity
178364|NCT03080454|hemiparesis|hemiparesis
178365|NCT03080454|rehabilitation|rehabilitation
178366|NCT03080454|trans-spinal direct current stimulation (tsDCS)|trans-spinal direct current stimulation (tsdcs)
178367|NCT03080454|non-invasive stimulation|non-invasive stimulation
178368|NCT03080428|Breast cancer|breast cancer
178369|NCT03080428|ER-positive|er-positive
178370|NCT03080428|Her-2 negative|her-2 negative
178371|NCT03080428|genomic test|genomic test
178372|NCT03080402|Anterior Cruciate Ligament|anterior cruciate ligament
178373|NCT03080402|ACL injury|acl injury
178374|NCT03080402|Injury prevention|injury prevention
178375|NCT03080402|Perturbation training|perturbation training
178376|NCT03080402|Risk factors|risk factors
178377|NCT03080389|overactive bladder|overactive bladder
178378|NCT03080389|overactive detrusor|overactive detrusor
178379|NCT03080389|urgency-frequency|urgency-frequency
178380|NCT03080389|urinary tract infection|urinary tract infection
178381|NCT03080376|Exercise|exercise
178382|NCT03080376|Web-based intervention|web-based intervention
178383|NCT03080363|Extracorporeal Shockwave Lithotripsy|extracorporeal shockwave lithotripsy
178384|NCT03080363|Quadratus Lumborum Block|quadratus lumborum block
178385|NCT03080363|bupivacaine|bupivacaine
178386|NCT03080363|lidocaine|lidocaine
178387|NCT03080350|Fentanyl|fentanyl
178388|NCT03080350|Transmucosal administration|transmucosal administration
178389|NCT03080350|Endovenous administration|endovenous administration
178390|NCT03080350|Pain therapy|pain therapy
178391|NCT03080350|Mountain emergency medicine|mountain emergency medicine
178392|NCT03080324|Fentanyl|fentanyl
178393|NCT03080324|Transmucosal administration|transmucosal administration
178394|NCT03080324|Endovenous administration|endovenous administration
178395|NCT03080324|Pain therapy|pain therapy
178396|NCT03080311|Bcl-2/Bcl-xL dual inhibitor|bcl-2/bcl-xl dual inhibitor
178397|NCT03080272|individual patient|individual patient
178398|NCT03080259|ADHD|adhd
178399|NCT03080259|Stimulant Misuse|stimulant misuse
178400|NCT03080259|Stimulant Diversion|stimulant diversion
178401|NCT03080233|stroke|stroke
178402|NCT03080233|Validation|validation
178403|NCT03080233|Clinical decision support tool|clinical decision support tool
178404|NCT03080207|Lower Extremity Lymphedema|lower extremity lymphedema
178405|NCT03080207|Physiotherapy|physiotherapy
178406|NCT03080207|Complex Decongestive Physiotherapy|complex decongestive physiotherapy
178407|NCT03080207|Low Level Laser|low level laser
178408|NCT03080207|Platelet rich plasma|platelet rich plasma
178409|NCT03080194|schizophrenia|schizophrenia
178410|NCT03080194|violence risk|violence risk
178411|NCT03080194|long-acting antipsychotics|long-acting antipsychotics
178412|NCT03080194|community-based|community-based
178413|NCT03080168|suicidal ideation|suicidal ideation
178414|NCT03080168|suicidal behavior|suicidal behavior
178415|NCT03080168|Veterans|veterans
178416|NCT03080168|inpatients|inpatients
178417|NCT03080168|Actigraphy|actigraphy
178418|NCT03080168|implicit associations|implicit associations
178419|NCT03080168|risk factors|risk factors
178420|NCT03080129|Liver cirrhosis|liver cirrhosis
178421|NCT03080129|Sarcopenia|sarcopenia
178422|NCT03080129|Microbiome|microbiome
178423|NCT03080116|Randomized|randomized
178424|NCT03080116|Placebo-controlled|placebo-controlled
178425|NCT03080116|Neoadjuvant|neoadjuvant
178426|NCT03080116|Androgen deprivation|androgen deprivation
178427|NCT03080116|Antiandrogen|antiandrogen
178428|NCT03080116|Radical Prostatectomy|radical prostatectomy
178429|NCT03080103|Acute Appendicitis|acute appendicitis
178430|NCT03080103|Uncomplicated Acute Appendicitis|uncomplicated acute appendicitis
178431|NCT03080103|Appendectomy|appendectomy
178432|NCT03080103|Conservative Treatment|conservative treatment
178433|NCT03080103|Antibiotic-first Treatment|antibiotic-first treatment
178434|NCT03080103|Recurrent Appendicitis|recurrent appendicitis
178435|NCT03080103|Prospective Study|prospective study
178436|NCT03080051|PSP|psp
178437|NCT03080051|AD|ad
178438|NCT03080051|HV|hv
178439|NCT03080038|Sepsis|sepsis
178440|NCT03080038|Shock|shock
178441|NCT03080038|Septic Shock|septic shock
178442|NCT03080038|Fluid Therapy|fluid therapy
178443|NCT03080038|Resuscitation|resuscitation
178444|NCT03080038|Pediatrics|pediatrics
178445|NCT03080038|Emergency Medicine|emergency medicine
178446|NCT03080038|Critical Care|critical care
178447|NCT03080025|CBCT® (Cognitively Based Compassion-Training)|cbct® (cognitively based compassion-training)
178448|NCT03080025|Psychobiological Evaluation|psychobiological evaluation
178449|NCT03080025|Real Time Social Interaction|real time social interaction
178450|NCT03080025|Eye-Tracking|eye-tracking
178451|NCT03080025|Heart Rate Variability|heart rate variability
178452|NCT03080025|IL-6|il-6
178453|NCT03080025|IL-1b|il-1b
178454|NCT03080025|Cortisol|cortisol
178455|NCT03080025|Alpha-Amylase|alpha-amylase
178456|NCT03080025|Randomised Controlled Trial|randomised controlled trial
178457|NCT03080025|Compassion|compassion
178458|NCT03080025|Empathy|empathy
178459|NCT03080025|Relationship Quality|relationship quality
178460|NCT03080025|Interpersonal Relations|interpersonal relations
178461|NCT03080025|Stress|stress
178462|NCT03079986|Pancreatic surgery|pancreatic surgery
178463|NCT03079986|Chylous ascites|chylous ascites
178464|NCT03079973|Calcipotriene|calcipotriene
178465|NCT03079960|Parkinson|parkinson
178466|NCT03079960|DBS|dbs
178467|NCT03079960|Deep Brain Stimulation|deep brain stimulation
178468|NCT03079960|LFP|lfp
178469|NCT03079960|Local Field Potentials|local field potentials
178470|NCT03079960|EEG|eeg
178471|NCT03079960|Electroencephalogram|electroencephalogram
178472|NCT03079947|Circulating DNA|circulating dna
178473|NCT03079947|Diffuse Large B Cell Lymphoma|diffuse large b cell lymphoma
178474|NCT03079947|Peripheral T-Cell Lymphoma|peripheral t-cell lymphoma
178475|NCT03079947|prognosis|prognosis
178476|NCT03079934|Bioresorbable vascular scaffold|bioresorbable vascular scaffold
178477|NCT03079934|Optical coherence tomography|optical coherence tomography
178478|NCT03079934|strut coverage|strut coverage
178479|NCT03079934|acute coronary syndrome|acute coronary syndrome
178480|NCT03079921|Islet Graft Function|islet graft function
178481|NCT03079921|Islet Cell transplantation|islet cell transplantation
178482|NCT03079921|Auto-islet transplantation|auto-islet transplantation
178483|NCT03079921|Intra-hepatic islets|intra-hepatic islets
178484|NCT03079921|Extra-hepatic islets|extra-hepatic islets
178485|NCT03079908|Laparoscopy|laparoscopy
178486|NCT03079908|Surgery|surgery
178487|NCT03079908|Training|training
178488|NCT03079908|Virtual reality|virtual reality
178489|NCT03079908|Simulation|simulation
178490|NCT03079908|Robotic Surgery|robotic surgery
178491|NCT03079908|Da Vinci|da vinci
178492|NCT03079895|Depression|depression
178493|NCT03079895|internet|internet
178494|NCT03079895|Cognitive Behavioral Therapy|cognitive behavioral therapy
178495|NCT03079895|CBT|cbt
178496|NCT03079895|computer|computer
178497|NCT03079895|Primary Care|primary care
178498|NCT03079895|Psychiatry|psychiatry
178499|NCT03079895|treatment|treatment
178500|NCT03079895|self-help|self-help
178501|NCT03079895|managed care|managed care
178502|NCT03079882|Ultrasound|ultrasound
178503|NCT03079882|Viscoelasticity|viscoelasticity
178504|NCT03079882|Viscoelastic Response (VisR) Ultrasound|viscoelastic response (visr) ultrasound
178505|NCT03079856|Emerging adults|emerging adults
178506|NCT03079856|Drugs|drugs
178507|NCT03079856|HIV|hiv
178508|NCT03079856|Risky Sex Behaviors|risky sex behaviors
178509|NCT03079830|aortic valve surgery|aortic valve surgery
178510|NCT03079830|postoperative pain|postoperative pain
178511|NCT03079791|OCT|oct
178512|NCT03079791|cardiac allograft vasculopathy|cardiac allograft vasculopathy
178513|NCT03079791|CAV|cav
178514|NCT03079791|intravascular imaging|intravascular imaging
178515|NCT03079765|Telehealth|telehealth
178516|NCT03079765|Functional behavior assessment|functional behavior assessment
178517|NCT03079713|pain|pain
178518|NCT03079713|anesthesia|anesthesia
178519|NCT03079713|vibrator|vibrator
178520|NCT03079713|intravitreal|intravitreal
178521|NCT03079713|injection|injection
228140|NCT02771899|Spine|spine
178522|NCT03079687|Ovarian cancer|ovarian cancer
178821|NCT03078010|cefepime|cefepime
178523|NCT03079687|gynaecological cancer|gynaecological cancer
178524|NCT03079687|platinum-sensitive disease|platinum-sensitive disease
178525|NCT03079687|platinum-sensitive relapsed|platinum-sensitive relapsed
178526|NCT03079687|Olaparib|olaparib
178527|NCT03079687|Ovarian Neoplasms|ovarian neoplasms
178528|NCT03079687|Neoplasms|neoplasms
178529|NCT03079687|Ovarian Disease|ovarian disease
178530|NCT03079687|fallopean tube cancer|fallopean tube cancer
178531|NCT03079687|primary peritoneal cancer|primary peritoneal cancer
178532|NCT03079687|epithelial ovarian cancer|epithelial ovarian cancer
178533|NCT03079687|PARP inhibitors|parp inhibitors
178534|NCT03079687|Poly (ADP-ribose) polymerase inhibitors.|poly (adp-ribose) polymerase inhibitors.
178535|NCT03079674|transient Ischemic Attack|transient ischemic attack
178536|NCT03079674|minor Stroke|minor stroke
178537|NCT03079674|non-disabling ischemic cerebrovascular events|non-disabling ischemic cerebrovascular events
178538|NCT03079674|biomarker|biomarker
178539|NCT03079674|epidemiology|epidemiology
178540|NCT03079674|prognosis|prognosis
178541|NCT03079661|pollution|pollution
178542|NCT03079661|ozone|ozone
178543|NCT03079661|Copd|copd
178544|NCT03079661|particles|particles
178545|NCT03079648|Angelica gigas N. extract|angelica gigas n. extract
178546|NCT03079648|Hyperlipidemia|hyperlipidemia
178547|NCT03079648|Clinical Trial|clinical trial
178548|NCT03079596|gastric cancer|gastric cancer
178549|NCT03079596|ERAS (early recovery after surgery)|eras (early recovery after surgery)
178550|NCT03079596|laparoscopic total gastrectomy|laparoscopic total gastrectomy
178551|NCT03079557|Adolescent|adolescent
178552|NCT03079557|Injections, intraperitoneal|injections, intraperitoneal
178553|NCT03079557|Endoscopy|endoscopy
178554|NCT03079557|Botulinum Toxins, Type A|botulinum toxins, type a
178555|NCT03079557|OnabotulinumtoxinA|onabotulinumtoxina
178556|NCT03079518|iron deficiency|iron deficiency
178557|NCT03079518|HFREF|hfref
178558|NCT03079518|FGF23|fgf23
178559|NCT03079518|ferric carboxymaltose|ferric carboxymaltose
178560|NCT03079479|Arthoplasty|arthoplasty
178561|NCT03079479|Gait|gait
178562|NCT03079479|muscle strenght|muscle strenght
178563|NCT03079479|Quality of life|quality of life
178564|NCT03079466|Sleep apnea|sleep apnea
178565|NCT03079466|Elderly|elderly
178566|NCT03079466|CPAP|cpap
178567|NCT03079453|Dexamethasone|dexamethasone
178568|NCT03079453|Tonsillectomy|tonsillectomy
178569|NCT03079453|Uvula|uvula
178570|NCT03079453|Edema|edema
178571|NCT03079453|Uvula edema|uvula edema
178572|NCT03079453|Post-tonsillectomy|post-tonsillectomy
178573|NCT03079440|Neuroendocrine tumors|neuroendocrine tumors
178574|NCT03079440|Neuroendocrine Carcinoma|neuroendocrine carcinoma
178575|NCT03079440|Capecitabine|capecitabine
178576|NCT03079440|Temozolomide|temozolomide
178577|NCT03079427|Cholangiocarcinoma|cholangiocarcinoma
178578|NCT03079427|Adjuvant chemotherapy|adjuvant chemotherapy
178579|NCT03079414|Sudden Cardiac Death|sudden cardiac death
178580|NCT03079414|Cardiac Arrhythmia|cardiac arrhythmia
178581|NCT03079414|Electrophysiology Study|electrophysiology study
178582|NCT03079414|Genetics|genetics
178583|NCT03079401|biventricular conversion|biventricular conversion
178584|NCT03079375|cross sectional|cross sectional
178585|NCT03079375|medication review|medication review
178586|NCT03079375|readmissions|readmissions
178587|NCT03079375|follow-up|follow-up
178588|NCT03079336|Randomized controlled design development|randomized controlled design development
178589|NCT03079336|Translational Research|translational research
178590|NCT03079336|Psychological Interventions|psychological interventions
178591|NCT03079336|Contextual Model of Psychotherapy|contextual model of psychotherapy
178592|NCT03079323|External beam radiotherapy|external beam radiotherapy
178593|NCT03079323|Prostate cancer|prostate cancer
178594|NCT03079323|Elective para-aortic radiation therapy|elective para-aortic radiation therapy
178595|NCT03079323|PART|part
178596|NCT03079310|spinal cord stimulation|spinal cord stimulation
178597|NCT03079310|gait analysis|gait analysis
178598|NCT03079310|whole-body kinematics|whole-body kinematics
178599|NCT03079310|Parkinson's disease|parkinson's disease
178600|NCT03079310|Neuromodulation|neuromodulation
178601|NCT03079310|Feature extraction|feature extraction
178602|NCT03079297|Antidepressant|antidepressant
178603|NCT03079297|Inflammation|inflammation
178604|NCT03079297|Biomarker|biomarker
178605|NCT03079297|Depression|depression
178606|NCT03079297|Treatment Resistant Depression|treatment resistant depression
178607|NCT03079297|Leucine|leucine
178608|NCT03079258|vascular structure|vascular structure
178609|NCT03079258|vascular function|vascular function
178610|NCT03079258|cerebrovascular reactivity|cerebrovascular reactivity
178611|NCT03079258|physical activity|physical activity
178612|NCT03079258|sedentary behaviour|sedentary behaviour
178613|NCT03079258|offspring health|offspring health
178614|NCT03079258|maternal health|maternal health
178615|NCT03079245|Neonatal ICU|neonatal icu
178616|NCT03079245|antimicrobial stewardship|antimicrobial stewardship
178617|NCT03079232|Optical biopsy|optical biopsy
178618|NCT03079232|Skin cancer|skin cancer
178619|NCT03079232|Diagnostic performance|diagnostic performance
178620|NCT03079206|hazelnut|hazelnut
178622|NCT03079206|basophile-activation-test|basophile-activation-test
178623|NCT03079206|food|food
178624|NCT03079206|allergy|allergy
178625|NCT03079193|post thyroidectomy|post thyroidectomy
178626|NCT03079193|laryngeoscopic examination|laryngeoscopic examination
178627|NCT03079180|Tendon|tendon
178628|NCT03079180|Ageing|ageing
178629|NCT03079180|Training|training
178630|NCT03079180|Achilles tendon|achilles tendon
178631|NCT03079180|Patella tendon|patella tendon
178632|NCT03079180|Skeletal muscle|skeletal muscle
178633|NCT03079180|Adaptation|adaptation
178634|NCT03079180|Triceps Surae|triceps surae
178635|NCT03079180|Quadriceps|quadriceps
178636|NCT03079115|Atorvastatin|atorvastatin
178637|NCT03079089|Allogenic cell stem transplant|allogenic cell stem transplant
178638|NCT03079089|Sequential chemotherapy|sequential chemotherapy
178639|NCT03079089|Haploidentical transplant|haploidentical transplant
178640|NCT03079076|Postoperative Analgesia|postoperative analgesia
178641|NCT03079076|Ultrasound guided thoracolumbar interfascial plane block|ultrasound guided thoracolumbar interfascial plane block
178642|NCT03079024|Cognitive Training|cognitive training
178643|NCT03079024|First Episode Psychosis|first episode psychosis
178644|NCT03079024|Recent Onset Psychosis|recent onset psychosis
178645|NCT03079011|ESR1 mutation detection, ctDNA|esr1 mutation detection, ctdna
178646|NCT03078998|Juvenile Idiopathic Arthritis|juvenile idiopathic arthritis
178647|NCT03078998|Cerebral Palsy|cerebral palsy
178648|NCT03078998|Obstetric Brachial Plexus Palsy|obstetric brachial plexus palsy
178649|NCT03078998|Human Computer Interaction|human computer interaction
178650|NCT03078998|Leap Motion|leap motion
178651|NCT03078998|Video Game Based Rehabilitation|video game based rehabilitation
178652|NCT03078985|real-time MRI|real-time mri
178653|NCT03078985|electrophysiology study|electrophysiology study
178654|NCT03078985|atrial flutter ablation|atrial flutter ablation
178655|NCT03078985|active tracking|active tracking
178656|NCT03078946|Cardiac surgery|cardiac surgery
178657|NCT03078946|delirium|delirium
178658|NCT03078946|dexmedetomidine|dexmedetomidine
178659|NCT03078946|morphine|morphine
178660|NCT03078946|midazolam|midazolam
178661|NCT03078933|DFU|dfu
178662|NCT03078907|daily life|daily life
178663|NCT03078907|physical activity|physical activity
178664|NCT03078907|actigraphy|actigraphy
178665|NCT03078907|PAH-SYMPACT|pah-sympact
178666|NCT03078894|Zika|zika
178667|NCT03078894|Dengue|dengue
178668|NCT03078894|Chikagunya|chikagunya
178669|NCT03078894|Peru|peru
178670|NCT03078829|gender identity|gender identity
178671|NCT03078829|trans female|trans female
178672|NCT03078829|GnRH agonists|gnrh agonists
178673|NCT03078829|QTc interval|qtc interval
178674|NCT03078803|fecal transplant|fecal transplant
178675|NCT03078803|inflammatory bowel disease|inflammatory bowel disease
178676|NCT03078777|Pharmacokinetics|pharmacokinetics
178677|NCT03078764|Mobile health (mHealth)|mobile health (mhealth)
178678|NCT03078751|Hormone receptor-positive|hormone receptor-positive
178679|NCT03078751|Estrogen and/or progesterone receptor-positive|estrogen and/or progesterone receptor-positive
178680|NCT03078751|HER2-negative|her2-negative
178681|NCT03078751|High risk early breast cancer|high risk early breast cancer
178682|NCT03078751|Adjuvant|adjuvant
178683|NCT03078751|Ribociclib|ribociclib
178684|NCT03078751|LEE011|lee011
178685|NCT03078751|CDK4/6 inhibitor|cdk4/6 inhibitor
178686|NCT03078751|Endocrine therapy|endocrine therapy
178687|NCT03078751|Phase II|phase ii
178688|NCT03078751|Breast carcinoma|breast carcinoma
178689|NCT03078751|Breast cancer|breast cancer
178690|NCT03078738|OMT-28|omt-28
178691|NCT03078738|Atrial Fibrillation|atrial fibrillation
178692|NCT03078738|SAD|sad
178693|NCT03078738|MAD|mad
178694|NCT03078738|First-in-Man|first-in-man
178695|NCT03078738|Cardiovascular|cardiovascular
178696|NCT03078725|gestational diabetes|gestational diabetes
178697|NCT03078725|glyburide|glyburide
178698|NCT03078725|metformin|metformin
178699|NCT03078725|failure rate|failure rate
178700|NCT03078712|Septic Shock|septic shock
178701|NCT03078712|Lactate|lactate
178702|NCT03078712|Capillary Refill Time|capillary refill time
178703|NCT03078712|Fluid Responsiveness|fluid responsiveness
178704|NCT03078712|Mortality|mortality
178705|NCT03078699|Thymoma|thymoma
178706|NCT03078699|Thymic tumor|thymic tumor
178707|NCT03078699|Stereotactic body radiotherapy|stereotactic body radiotherapy
178708|NCT03078686|Stem Cells,PRP, tSVF,cSVF,Alopecia Areata,Scarring Alopecia|stem cells,prp, tsvf,csvf,alopecia areata,scarring alopecia
178709|NCT03078673|Cross country poling, motor skill, strength training|cross country poling, motor skill, strength training
178710|NCT03078634|Irritable bowel syndrome|irritable bowel syndrome
178711|NCT03078634|Constipation|constipation
178712|NCT03078634|Functional dyspepsia|functional dyspepsia
178713|NCT03078634|Multi-disciplinary treatment|multi-disciplinary treatment
228479|NCT02769923|IPV|ipv
178714|NCT03078621|stem cells|stem cells
178715|NCT03078608|anxiety|anxiety
178716|NCT03078608|quality of life|quality of life
178717|NCT03078608|mindfulness|mindfulness
178718|NCT03078608|meditation|meditation
178719|NCT03078608|depression|depression
178720|NCT03078595|periodontal disease|periodontal disease
178822|NCT03078010|aztreonam|aztreonam
178721|NCT03078595|plaque-induced gingivitis|plaque-induced gingivitis
178722|NCT03078595|bleeding on probing|bleeding on probing
178723|NCT03078595|von willebrand disease|von willebrand disease
178724|NCT03078595|gingival bleeding|gingival bleeding
178725|NCT03078582|PNH|pnh
178726|NCT03078569|Poor responders|poor responders
178727|NCT03078556|FDC|fdc
178728|NCT03078556|Lamivudine|lamivudine
178729|NCT03078556|Bio-equivalence|bio-equivalence
178730|NCT03078556|Dolutegravir|dolutegravir
178731|NCT03078556|HIV|hiv
178732|NCT03078530|GWI|gwi
178733|NCT03078530|IBS|ibs
178734|NCT03078530|Irritable Bowel Syndrome|irritable bowel syndrome
178735|NCT03078530|Gulf War Illness|gulf war illness
178736|NCT03078530|Probiotics|probiotics
178737|NCT03078517|I-gel|i-gel
178738|NCT03078517|Laryngeal mask airway protector|laryngeal mask airway protector
178739|NCT03078491|type 1 diabetes|type 1 diabetes
178740|NCT03078491|geriatrics|geriatrics
178741|NCT03078491|older adults|older adults
178742|NCT03078491|technology|technology
178743|NCT03078491|CGM|cgm
178744|NCT03078491|clinical decision support|clinical decision support
178745|NCT03078491|hypoglycemia|hypoglycemia
178746|NCT03078439|very preterm birth|very preterm birth
178747|NCT03078439|developmental disorders|developmental disorders
178748|NCT03078439|health problems|health problems
178749|NCT03078439|prospective population-based cohort|prospective population-based cohort
178750|NCT03078426|Lung|lung
178751|NCT03078426|MRI|mri
178752|NCT03078426|CT|ct
178753|NCT03078426|Usual interstitial pneumonia|usual interstitial pneumonia
178754|NCT03078426|Ultra-short echo time|ultra-short echo time
178755|NCT03078413|Mustard Procedure|mustard procedure
178756|NCT03078374|Reduced anti-coagulation, mechanical circulatory support.|reduced anti-coagulation, mechanical circulatory support.
178757|NCT03078361|cancer screening|cancer screening
178758|NCT03078361|colon|colon
178759|NCT03078348|cancer screening|cancer screening
178760|NCT03078335|Late onset sepsis|late onset sepsis
178761|NCT03078335|glove based care|glove based care
178762|NCT03078335|NICU|nicu
178763|NCT03078335|Non sterile gloves|non sterile gloves
178764|NCT03078335|infection control|infection control
178765|NCT03078309|retinitis pigmentosa|retinitis pigmentosa
178766|NCT03078309|retinal degeneration|retinal degeneration
178767|NCT03078309|cannabis|cannabis
178768|NCT03078309|THC|thc
178769|NCT03078309|CBD|cbd
178770|NCT03078309|electrophysiology|electrophysiology
178771|NCT03078309|visual functions|visual functions
178772|NCT03078309|eye|eye
178773|NCT03078309|retina|retina
178774|NCT03078270|social anxiety|social anxiety
178775|NCT03078270|botulinum toxin|botulinum toxin
178776|NCT03078270|botox|botox
178777|NCT03078257|Platelet Activities|platelet activities
178778|NCT03078257|light aggregometry|light aggregometry
178779|NCT03078257|VerifyNow P2Y12-assay|verifynow p2y12-assay
178780|NCT03078257|peripheral vein|peripheral vein
178781|NCT03078257|peripheral artery|peripheral artery
178782|NCT03078257|intracoronary artery|intracoronary artery
178783|NCT03078257|tirofiban|tirofiban
178784|NCT03078257|antiplatelet thrombolysin|antiplatelet thrombolysin
178785|NCT03078218|Pulse oximetry|pulse oximetry
178786|NCT03078218|Asymptomatic newborns|asymptomatic newborns
178787|NCT03078205|TCM multi-channel therapy|tcm multi-channel therapy
178788|NCT03078205|ART failure|art failure
178789|NCT03078192|right heart catheterization for evaluation of PAH or other cardiac or pulmonary disease|right heart catheterization for evaluation of pah or other cardiac or pulmonary disease
178790|NCT03078179|Probiotic|probiotic
178791|NCT03078179|Child|child
178792|NCT03078179|Care, dental|care, dental
178793|NCT03078166|Cardiac Failure|cardiac failure
178794|NCT03078166|Congestive Heart Failure|congestive heart failure
178795|NCT03078166|Heart Decompensation|heart decompensation
178796|NCT03078166|Heart Failure, Congestive|heart failure, congestive
178797|NCT03078166|Heart Failure, Left-Sided|heart failure, left-sided
178798|NCT03078166|Heart Failure, Right-Sided|heart failure, right-sided
178799|NCT03078166|Left-Sided Heart Failure|left-sided heart failure
178800|NCT03078166|Myocardial Failure|myocardial failure
178801|NCT03078166|Right-Sided Heart Failure|right-sided heart failure
178802|NCT03078166|Outcomes|outcomes
178803|NCT03078166|Co-morbidities|co-morbidities
178804|NCT03078166|Biomarkers|biomarkers
178805|NCT03078101|Empagliflozin|empagliflozin
178806|NCT03078101|SGLT-2 Inhibiton and RAS in CKD|sglt-2 inhibiton and ras in ckd
178807|NCT03078075|Methamphetamine|methamphetamine
178808|NCT03078075|Methamphetamine Use Disorder|methamphetamine use disorder
178809|NCT03078075|Naltrexone|naltrexone
178810|NCT03078075|Bupropion|bupropion
178811|NCT03078075|Vivitrol®|vivitrol®
178812|NCT03078062|Spinal anesthesia|spinal anesthesia
178813|NCT03078062|Motor block|motor block
178814|NCT03078062|Sensory block|sensory block
178815|NCT03078062|Dexamethasone|dexamethasone
178816|NCT03078036|HER2-ve metastatic breast cancer|her2-ve metastatic breast cancer
178817|NCT03078036|gBRCA, sBRCA and HRR gene mutations|gbrca, sbrca and hrr gene mutations
178818|NCT03078023|EoE|eoe
178819|NCT03078010|Antibiotic|antibiotic
178820|NCT03078010|piperacillin-tazobactam|piperacillin-tazobactam
178823|NCT03078010|17-097|17-097
178824|NCT03077997|Diabetes|diabetes
178825|NCT03077997|Diabetes distress|diabetes distress
178826|NCT03077971|Carers of People with Multiple Sclerosis|carers of people with multiple sclerosis
178827|NCT03077971|Carer Strain|carer strain
178828|NCT03077971|Acceptance and Commitment Therapy|acceptance and commitment therapy
178829|NCT03077945|biofeedback|biofeedback
178830|NCT03077945|heart rate variability|heart rate variability
178831|NCT03077945|HRV|hrv
178832|NCT03077945|psychophysiology|psychophysiology
178833|NCT03077945|reappraisal|reappraisal
178834|NCT03077945|cognitive reappraisal|cognitive reappraisal
178835|NCT03077945|arousal reappraisal|arousal reappraisal
178836|NCT03077945|woman|woman
178837|NCT03077945|women|women
178838|NCT03077945|female|female
178839|NCT03077945|smoker|smoker
178840|NCT03077945|relapse|relapse
178841|NCT03077945|cigarette|cigarette
178842|NCT03077945|craving|craving
178843|NCT03077945|self regulation|self regulation
178844|NCT03077945|emotion regulation|emotion regulation
178845|NCT03077945|stress response|stress response
178846|NCT03077945|cognitive behavioral intervention|cognitive behavioral intervention
178847|NCT03077945|respiratory sinus arrhythmia|respiratory sinus arrhythmia
178848|NCT03077945|smoking cessation intervention|smoking cessation intervention
178849|NCT03077919|Posttraumatic Stress Disorder|posttraumatic stress disorder
178850|NCT03077919|Generalized Anxiety Disorder|generalized anxiety disorder
178851|NCT03077919|Depression|depression
178852|NCT03077919|Distress|distress
178853|NCT03077919|Alcohol Use|alcohol use
178854|NCT03077919|Pain|pain
178855|NCT03077906|Gastroœsophageal Reflux|gastroœsophageal reflux
178856|NCT03077906|Sleeve Gastrectomy|sleeve gastrectomy
178857|NCT03077880|implant insertion|implant insertion
178858|NCT03077880|bone resorption|bone resorption
178859|NCT03077880|soft tissue|soft tissue
178860|NCT03077867|sinus lift|sinus lift
178861|NCT03077867|synthetic hydroxyapatite|synthetic hydroxyapatite
178862|NCT03077867|bone graft|bone graft
178863|NCT03077854|Lung Cancer|lung cancer
178864|NCT03077854|Radiotherapy|radiotherapy
178865|NCT03077854|Biomarkers|biomarkers
178866|NCT03077854|Radiation Lung Injury|radiation lung injury
178867|NCT03077854|Quality of Life|quality of life
178868|NCT03077841|Malignant neoplasm of breast|malignant neoplasm of breast
178869|NCT03077841|Breast cancer|breast cancer
178870|NCT03077841|Radiation therapy|radiation therapy
178871|NCT03077841|XRT|xrt
178872|NCT03077841|External beam radiation therapy|external beam radiation therapy
178873|NCT03077841|Shorter course|shorter course
178874|NCT03077841|Questionnaires|questionnaires
178875|NCT03077841|Surveys|surveys
178876|NCT03077802|Seldinger technique|seldinger technique
178877|NCT03077802|Modified Seldinger technique|modified seldinger technique
178878|NCT03077802|Complication|complication
178879|NCT03077802|Success rate|success rate
178880|NCT03077789|visual acuity|visual acuity
178881|NCT03077789|prognosis epidemiology|prognosis epidemiology
178882|NCT03077763|nitrite|nitrite
178883|NCT03077763|haemoglobin|haemoglobin
178884|NCT03077763|normoxia|normoxia
178885|NCT03077763|hypoxia|hypoxia
178886|NCT03077763|vasodilatation|vasodilatation
178887|NCT03077763|blood|blood
178888|NCT03077750|viral skin disease|viral skin disease
178889|NCT03077737|Treatment access|treatment access
178890|NCT03077737|Treatment utilization|treatment utilization
178891|NCT03077737|Smoking cessation|smoking cessation
178892|NCT03077737|Low income|low income
178893|NCT03077737|Electronic health record system|electronic health record system
178894|NCT03077737|Electronic referral|electronic referral
178895|NCT03077724|n-3 polyunsaturated fatty acids|n-3 polyunsaturated fatty acids
178896|NCT03077724|tobacco use|tobacco use
178897|NCT03077724|pregnancy|pregnancy
178898|NCT03077698|Endometrial cancer|endometrial cancer
178899|NCT03077698|Recurrent or persistent endometrial carcinoma|recurrent or persistent endometrial carcinoma
178900|NCT03077698|Progesterone Receptor Negative|progesterone receptor negative
178901|NCT03077698|Sodium Cridanimod|sodium cridanimod
178902|NCT03077685|pancreatic neoplasms|pancreatic neoplasms
178903|NCT03077685|digestive system neoplasms|digestive system neoplasms
178904|NCT03077685|pancreatic diseases|pancreatic diseases
178905|NCT03077685|digestive system diseases|digestive system diseases
178906|NCT03077685|pancreatic adenocarcinoma|pancreatic adenocarcinoma
178907|NCT03077685|pancreatic cancer|pancreatic cancer
178908|NCT03077672|Mitochondrial DNA|mitochondrial dna
178909|NCT03077672|Lactate|lactate
178910|NCT03077672|Mortality|mortality
178911|NCT03077672|Emergency Department|emergency department
178912|NCT03077672|Intensive Care Unit|intensive care unit
178913|NCT03077672|Triage|triage
178914|NCT03077672|Organ Dysfunction|organ dysfunction
178915|NCT03077672|Biomarker|biomarker
178916|NCT03077672|Prognosis|prognosis
178917|NCT03077659|prostate cancer|prostate cancer
178918|NCT03077659|prostatic neoplasms|prostatic neoplasms
178919|NCT03077659|genital neoplasms, male|genital neoplasms, male
178920|NCT03077659|urogenital neoplasms|urogenital neoplasms
178921|NCT03077659|prostatic diseases|prostatic diseases
178922|NCT03077646|firearm|firearm
178923|NCT03077646|gun|gun
178925|NCT03077646|pediatric|pediatric
178926|NCT03077646|inpatient|inpatient
178927|NCT03077633|Cerclage|cerclage
178928|NCT03077633|Cervical shortening|cervical shortening
178929|NCT03077633|Twins|twins
178930|NCT03077633|Progesterone|progesterone
178931|NCT03077568|internet|internet
178932|NCT03077568|web-based|web-based
178933|NCT03077568|behavior change|behavior change
178934|NCT03077568|stress-management|stress-management
178935|NCT03077555|quick starting contraception|quick starting contraception
178936|NCT03077542|Peripheral Blood Stem Cells|peripheral blood stem cells
178937|NCT03077542|Host-Donor Chimerism|host-donor chimerism
178938|NCT03077542|Graft Versus Host Disease|graft versus host disease
178939|NCT03077542|Haploidentical|haploidentical
178940|NCT03077542|Donor Apheresis|donor apheresis
178941|NCT03077503|Hemodynamic response|hemodynamic response
178942|NCT03077503|Skull pins application|skull pins application
178943|NCT03077503|Dexmedetomidine|dexmedetomidine
178944|NCT03077503|Fentanyl|fentanyl
178945|NCT03077490|Pelvic organ prolapse|pelvic organ prolapse
178946|NCT03077490|transvaginal mesh|transvaginal mesh
178947|NCT03077490|complications|complications
178948|NCT03077464|nutrition education|nutrition education
178949|NCT03077464|Vegetables|vegetables
178950|NCT03077464|Fruit|fruit
178951|NCT03077438|Meningitis|meningitis
178952|NCT03077438|Meningococcal Meningitis|meningococcal meningitis
178953|NCT03077438|MenACYW conjugate vaccine|menacyw conjugate vaccine
178954|NCT03077438|MENVEO®|menveo®
178955|NCT03077399|lateropulsion|lateropulsion
178957|NCT03077399|Pusher syndrome|pusher syndrome
178958|NCT03077386|patient navigator|patient navigator
178959|NCT03077386|community health navigator|community health navigator
178960|NCT03077386|multi-morbidity|multi-morbidity
178961|NCT03077386|primary care|primary care
178962|NCT03077386|social determinants of health|social determinants of health
178963|NCT03077373|systolic blood pressure|systolic blood pressure
178964|NCT03077373|physical activity|physical activity
178965|NCT03077373|sedentary time|sedentary time
178966|NCT03077373|smoking|smoking
178967|NCT03077347|Schizophrenia|schizophrenia
178968|NCT03077347|Transcranial Direct Current Stimulation|transcranial direct current stimulation
178969|NCT03077347|tDCS|tdcs
178970|NCT03077347|Cognitive Control|cognitive control
178971|NCT03077347|fMRI|fmri
178972|NCT03077347|Dorsolateral Prefrontal Cortex|dorsolateral prefrontal cortex
178973|NCT03077308|Auditory ERP, Visual ERP, EEG|auditory erp, visual erp, eeg
178974|NCT03077282|Prasaprohyai extract, Healthy volunteers|prasaprohyai extract, healthy volunteers
178975|NCT03077269|burn|burn
178976|NCT03077269|coagulation|coagulation
178977|NCT03077269|inflammation|inflammation
178978|NCT03077256|Ankle Arthrodesis|ankle arthrodesis
178979|NCT03077256|Cellular Allograft|cellular allograft
178980|NCT03077243|Human Papillomavirus|human papillomavirus
178981|NCT03077243|Oropharynx|oropharynx
178982|NCT03077243|Oropharyngeal Squamous Cell Carcinoma|oropharyngeal squamous cell carcinoma
178983|NCT03077243|Squamous Cell Carcinoma|squamous cell carcinoma
178984|NCT03077243|Radiation Therapy|radiation therapy
178985|NCT03077243|Chemotherapy|chemotherapy
178986|NCT03077243|p16|p16
178987|NCT03077217|covert hepatic encephalopathy|covert hepatic encephalopathy
178988|NCT03077217|low-dose rifaximin|low-dose rifaximin
178989|NCT03077204|Total cervical vertebrectomy|total cervical vertebrectomy
178990|NCT03077204|Partial cervical vertebrectomy|partial cervical vertebrectomy
178991|NCT03077204|Failed previous fusion|failed previous fusion
178992|NCT03077204|Spinal stenosis|spinal stenosis
178993|NCT03077204|Tumor|tumor
178994|NCT03077204|Decompression of the spinal cord|decompression of the spinal cord
178995|NCT03077204|Pseudoarthrosis|pseudoarthrosis
178996|NCT03077204|Curvatures|curvatures
178997|NCT03077204|Deformities|deformities
178998|NCT03077191|hypofractionated whole breast radiotherapy|hypofractionated whole breast radiotherapy
178999|NCT03077191|breast cancer|breast cancer
179000|NCT03077191|conservative treatment|conservative treatment
179001|NCT03077191|quality of life|quality of life
179002|NCT03077178|Soft Tissue Sarcoma|soft tissue sarcoma
179003|NCT03077178|Surgery|surgery
179004|NCT03077178|Functional Impact|functional impact
179005|NCT03077178|Elderly Patient|elderly patient
179006|NCT03077178|Geriatrics|geriatrics
179007|NCT03077152|copd, aecopd, antibiotic use|copd, aecopd, antibiotic use
179008|NCT03077126|elastography|elastography
179009|NCT03077126|ultrasound|ultrasound
179010|NCT03077126|prostate|prostate
179011|NCT03077126|cancer screening|cancer screening
228773|NCT02767908|Tobacco|tobacco
179012|NCT03077113|lung cancer|lung cancer
179013|NCT03077113|radiation therapy|radiation therapy
179014|NCT03077048|CKD|ckd
179015|NCT03077048|Ketosteril|ketosteril
179016|NCT03077048|keto-acids|keto-acids
179017|NCT03077048|ketoanalogues|ketoanalogues
179018|NCT03077048|Chronic kidney disease|chronic kidney disease
179019|NCT03077035|ICDAS|icdas
179020|NCT03077035|DIAGNOdent|diagnodent
179021|NCT03077035|glass ionomer sealant|glass ionomer sealant
179022|NCT03077035|resin-based sealant|resin-based sealant
179023|NCT03077035|pit and fissure sealants|pit and fissure sealants
179024|NCT03077035|effectiveness of preventing caries|effectiveness of preventing caries
179025|NCT03076983|Ventilation Monitoring|ventilation monitoring
179026|NCT03076983|Electrical Impedance Tomography|electrical impedance tomography
179027|NCT03076931|Voice|voice
179028|NCT03076931|Biomarker|biomarker
179029|NCT03076931|Airway Reconstruction|airway reconstruction
179030|NCT03076918|PDT, Methyl Aminolevulinate, Light Emitting Textile|pdt, methyl aminolevulinate, light emitting textile
179031|NCT03076892|PDT|pdt
179032|NCT03076892|Methyl Aminolevulinate|methyl aminolevulinate
179033|NCT03076892|light emitting textile|light emitting textile
179034|NCT03076879|Cervical Cancer|cervical cancer
179035|NCT03076879|Pap smear|pap smear
179036|NCT03076879|Screening|screening
179037|NCT03076879|Beliefs|beliefs
179038|NCT03076879|Attitude|attitude
179039|NCT03076879|Nursing|nursing
179040|NCT03076840|hamstring tightness|hamstring tightness
179041|NCT03076801|Choral Singing|choral singing
179042|NCT03076801|Music|music
179043|NCT03076801|Quality of Life|quality of life
179044|NCT03076801|Psychosocial Stress|psychosocial stress
179045|NCT03076801|Cardiac Rehabilitation|cardiac rehabilitation
179046|NCT03076788|echocardiography|echocardiography
179047|NCT03076788|intraventricular pressure gradients|intraventricular pressure gradients
179048|NCT03076788|cardiac remodeling|cardiac remodeling
179049|NCT03076788|athletes|athletes
179050|NCT03076775|Betamethasone|betamethasone
179051|NCT03076775|Late preterm|late preterm
179052|NCT03076775|Steroids|steroids
179053|NCT03076762|interstitial cystitis|interstitial cystitis
179054|NCT03076762|pain|pain
179055|NCT03076762|intravesical injection|intravesical injection
179056|NCT03076762|therapy|therapy
179057|NCT03076762|bladder|bladder
179058|NCT03076749|Betalactam|betalactam
179059|NCT03076749|Decision tree|decision tree
179060|NCT03076749|Drug hypersensitivity|drug hypersensitivity
179061|NCT03076749|Logistic regression|logistic regression
179062|NCT03076749|Predictive modelling|predictive modelling
179063|NCT03076710|spine surgery|spine surgery
179064|NCT03076710|post-operative pain|post-operative pain
179065|NCT03076710|patient controlled analgesia|patient controlled analgesia
179066|NCT03076710|Exparel®|exparel®
179067|NCT03076710|bupivacaine|bupivacaine
179068|NCT03076697|fundus photography|fundus photography
179069|NCT03076697|smartphone-based photography|smartphone-based photography
179070|NCT03076671|Palliative Care|palliative care
179071|NCT03076671|Supportive Care|supportive care
179072|NCT03076671|Movement Disorders|movement disorders
179073|NCT03076671|Brain Disease|brain disease
179074|NCT03076671|Neurodegeneration|neurodegeneration
179075|NCT03076671|Parkinson's Disease|parkinson's disease
179076|NCT03076671|Alzheimer's Disease|alzheimer's disease
179077|NCT03076632|transcranial magnetic stimulation|transcranial magnetic stimulation
179078|NCT03076632|neurostimulation|neurostimulation
179079|NCT03076632|non-invasive stimulation|non-invasive stimulation
179080|NCT03076632|closed-loop stimulation|closed-loop stimulation
179081|NCT03076619|pregnancy induced hypertension|pregnancy induced hypertension
179082|NCT03076619|ophthalmoscopy|ophthalmoscopy
179083|NCT03076593|geriatric|geriatric
179084|NCT03076567|Epidemiology|epidemiology
179085|NCT03076567|Cancer|cancer
179086|NCT03076567|Methylation|methylation
179087|NCT03076567|Genetics|genetics
179088|NCT03076567|Screening|screening
179089|NCT03076554|Programmed Death 1 (PD-1)|programmed death 1 (pd-1)
179090|NCT03076554|Immune Checkpoint Blockade|immune checkpoint blockade
179091|NCT03076541|Restless legs syndrome|restless legs syndrome
179092|NCT03076541|Periodic leg movements|periodic leg movements
179093|NCT03076541|Heart rate|heart rate
179094|NCT03076541|Heart rate variability|heart rate variability
179095|NCT03076541|Microarousals|microarousals
179096|NCT03076541|Autonomic nervous system activity|autonomic nervous system activity
179097|NCT03076528|exercise|exercise
179098|NCT03076528|exergame|exergame
179099|NCT03076528|hemodialysis|hemodialysis
179100|NCT03076528|balance|balance
179101|NCT03076502|ctDNA|ctdna
179102|NCT03076502|Gastrointestinal Cancer|gastrointestinal cancer
179103|NCT03076502|ROS|ros
179104|NCT03076502|Hepatobiliary Pancreatic Cancer|hepatobiliary pancreatic cancer
179105|NCT03076476|Coronary Stent|coronary stent
179106|NCT03076476|PCI|pci
179107|NCT03076476|BVS|bvs
179108|NCT03076476|Index of microcirculatory resistance|index of microcirculatory resistance
179109|NCT03076463|Polyphenols|polyphenols
179110|NCT03076463|Metabolic syndrome|metabolic syndrome
179111|NCT03076463|Cardiometabolic risk|cardiometabolic risk
179112|NCT03076463|Grape pomace|grape pomace
179113|NCT03076463|Postprandial glucose|postprandial glucose
179114|NCT03076463|Insulin resistance|insulin resistance
179115|NCT03076463|Obesity|obesity
179116|NCT03076450|Acute respiratory distress syndrome, ARDS|acute respiratory distress syndrome, ards
179117|NCT03076450|Point-of-care lung ultrasound,POC-LUS|point-of-care lung ultrasound,poc-lus
179118|NCT03076450|Pressure-volume curve, PVC|pressure-volume curve, pvc
179119|NCT03076450|Positive end-expiratory pressure, PEEP|positive end-expiratory pressure, peep
179120|NCT03076450|Ultrasound re-aeration score, US-RAS|ultrasound re-aeration score, us-ras
179121|NCT03076411|Dyspepsia|dyspepsia
179122|NCT03076411|Observational trial|observational trial
179123|NCT03076411|Enzyme therapy|enzyme therapy
179125|NCT03076385|VAL-506440|val-506440
179126|NCT03076385|H10N8 antigen mRNA|h10n8 antigen mrna
179127|NCT03076385|Influenza vaccine|influenza vaccine
179128|NCT03076372|Cancer|cancer
179129|NCT03076372|Oncology|oncology
179130|NCT03076372|Phase I|phase i
179131|NCT03076372|Gemcitabine|gemcitabine
179132|NCT03076372|Carboplatin|carboplatin
179133|NCT03076372|MM-310|mm-310
179134|NCT03076372|EphA2|epha2
179135|NCT03076372|Ephrin A2|ephrin a2
179136|NCT03076372|Solid tumors|solid tumors
179137|NCT03076372|urothelial carcinoma|urothelial carcinoma
179138|NCT03076372|gastric carcinoma|gastric carcinoma
179139|NCT03076372|squamous cell carcinoma of the head and neck|squamous cell carcinoma of the head and neck
179140|NCT03076372|ovarian cancer|ovarian cancer
179141|NCT03076372|pancreatic ductal adenocarcinoma|pancreatic ductal adenocarcinoma
179142|NCT03076372|prostate adenocarcinoma|prostate adenocarcinoma
179143|NCT03076372|non-small cell lung cancer|non-small cell lung cancer
179144|NCT03076372|small cell lung cancer|small cell lung cancer
179145|NCT03076372|triple negative breast cancer|triple negative breast cancer
179146|NCT03076372|endometrial carcinoma|endometrial carcinoma
179147|NCT03076372|soft tissue sarcoma|soft tissue sarcoma
179148|NCT03076372|Merrimack|merrimack
179149|NCT03076320|Modified diallyl disulfide oxide (M-DDO)|modified diallyl disulfide oxide (m-ddo)
179150|NCT03076320|Pirfenidone (PFD)|pirfenidone (pfd)
179151|NCT03076320|Adapalene + Benzoyl peroxide (A-BPO)|adapalene + benzoyl peroxide (a-bpo)
179152|NCT03076294|knee ostearthritis|knee ostearthritis
179153|NCT03076294|transcranial magnetic stimulation|transcranial magnetic stimulation
179154|NCT03076294|repetitive transcranial magnetic stimulation|repetitive transcranial magnetic stimulation
179155|NCT03076294|chronic pain|chronic pain
179156|NCT03076294|musculoskeletal manipulations|musculoskeletal manipulations
179157|NCT03076216|Pancreatic Cancer|pancreatic cancer
179158|NCT03076216|Pancreas|pancreas
179159|NCT03076216|metastases|metastases
179160|NCT03076216|pancreatic tumour|pancreatic tumour
179161|NCT03076216|unresectable|unresectable
179162|NCT03076216|locally advanced|locally advanced
179163|NCT03076216|implantable|implantable
179164|NCT03076216|radiographic|radiographic
179165|NCT03076216|device|device
179166|NCT03076216|Phosphorous-32 (P32)|phosphorous-32 (p32)
179167|NCT03076216|OncoSil™|oncosil™
179168|NCT03076216|brachytherapy|brachytherapy
179169|NCT03076216|gemcitabine|gemcitabine
179170|NCT03076216|nab-paclitaxel|nab-paclitaxel
179171|NCT03076216|Abraxane|abraxane
179172|NCT03076190|psychology|psychology
179173|NCT03076190|pain|pain
179174|NCT03076190|surgery|surgery
179175|NCT03076190|treatment|treatment
179176|NCT03076190|catastrophizing|catastrophizing
179177|NCT03076190|cancer|cancer
179178|NCT03076177|knee osteoarthritis, kinesio taping, knee function, pain|knee osteoarthritis, kinesio taping, knee function, pain
179179|NCT03076164|erlotinib|erlotinib
179180|NCT03076164|trametinib|trametinib
179181|NCT03076164|15-098|15-098
179182|NCT03076151|Transplantation|transplantation
179183|NCT03076151|Kidney|kidney
179184|NCT03076151|pharmacokinetic|pharmacokinetic
179185|NCT03076151|bayesian estimators|bayesian estimators
179186|NCT03076138|Gene-activated matrix|gene-activated matrix
179187|NCT03076138|Bone substitute|bone substitute
179188|NCT03076138|Bone grafting|bone grafting
179189|NCT03076138|Dental implantation|dental implantation
179190|NCT03076138|gene therapy|gene therapy
179191|NCT03076138|plasmid DNA|plasmid dna
179192|NCT03076138|VEGF gene|vegf gene
179193|NCT03076138|octacalcium phosphate|octacalcium phosphate
179194|NCT03076125|Primary Stroke Prevention, Risk Factors for Stroke|primary stroke prevention, risk factors for stroke
179195|NCT03076112|Ipragliflozin|ipragliflozin
179196|NCT03076112|Sitagliptin|sitagliptin
179197|NCT03076099|Dexmedetomidine|dexmedetomidine
179198|NCT03076099|brain arteriovenous malformation|brain arteriovenous malformation
179199|NCT03076099|embolization|embolization
179200|NCT03076099|post-operative hypertension|post-operative hypertension
179201|NCT03076073|Ultrasound|ultrasound
179202|NCT03076073|Achilles tendon|achilles tendon
179203|NCT03076073|Patellar tendon|patellar tendon
179204|NCT03076073|obesity|obesity
179205|NCT03076060|Ketogenic Diet|ketogenic diet
179206|NCT03076060|Very low calories diet|very low calories diet
179207|NCT03076060|ketone bodies|ketone bodies
179208|NCT03075995|lapatinib|lapatinib
179209|NCT03075995|steady state plasma concentration|steady state plasma concentration
179210|NCT03075995|high-fat breakfast|high-fat breakfast
179211|NCT03075969|Chronic myeloid leukemia; quality of life|chronic myeloid leukemia; quality of life
179212|NCT03075930|Atrial fibrillation|atrial fibrillation
179213|NCT03075930|ECG|ecg
179214|NCT03075930|Body surface potential map|body surface potential map
179215|NCT03075930|Recurrence of AF|recurrence of af
179216|NCT03075917|Allergic rhinitis|allergic rhinitis
179217|NCT03075865|intermaxillary fixation|intermaxillary fixation
179218|NCT03075865|maxillo-mandibular fixation|maxillo-mandibular fixation
179322|NCT03075189|protein intake|protein intake
179219|NCT03075852|Heads-up display, NGENUITY, Vitreoretinal surgery|heads-up display, ngenuity, vitreoretinal surgery
179220|NCT03075800|Assertive Community Treatment (ACT) Only|assertive community treatment (act) only
179221|NCT03075800|Assertive Community Treatment (ACT) + Illness Management and Recovery (IMR)|assertive community treatment (act) + illness management and recovery (imr)
179222|NCT03075787|Obstructive sleep apnea|obstructive sleep apnea
179223|NCT03075787|Heart rate|heart rate
179224|NCT03075787|Heart rate variability|heart rate variability
179225|NCT03075787|Microarousals|microarousals
179226|NCT03075787|Autonomic nervous system activity|autonomic nervous system activity
179227|NCT03075761|Venous thromboembolism|venous thromboembolism
179228|NCT03075761|Deep Vein Thrombosis|deep vein thrombosis
179229|NCT03075761|Lower Extremity|lower extremity
179230|NCT03075761|Blood clot|blood clot
179231|NCT03075761|Anticoagulation|anticoagulation
179232|NCT03075761|Physical Activity|physical activity
179233|NCT03075761|Fitbit|fitbit
179234|NCT03075761|Post-thrombotic syndrome|post-thrombotic syndrome
179235|NCT03075761|Post-phlebitic syndrome|post-phlebitic syndrome
179236|NCT03075761|Thrombosis|thrombosis
179237|NCT03075748|Vascular|vascular
179238|NCT03075748|Stent|stent
179239|NCT03075748|Graft|graft
179240|NCT03075735|Castration-Resistant Prostate Cancer|castration-resistant prostate cancer
179241|NCT03075735|DNA-repair|dna-repair
179242|NCT03075735|BRCA1|brca1
179243|NCT03075735|BRCA2|brca2
179244|NCT03075735|ATM|atm
179245|NCT03075735|PALB2|palb2
179246|NCT03075709|Clinical Pathway|clinical pathway
179247|NCT03075709|CPW|cpw
179248|NCT03075709|Chronic Obstructive Pulmonary Disease|chronic obstructive pulmonary disease
179249|NCT03075709|COPD|copd
179250|NCT03075709|Protocol|protocol
179251|NCT03075709|Adherence|adherence
179252|NCT03075709|Readmission|readmission
179253|NCT03075709|Length of Stay|length of stay
179254|NCT03075709|Cost|cost
179255|NCT03075683|Cognitive behavioural therapy|cognitive behavioural therapy
179256|NCT03075683|Non-pharmacological treatment|non-pharmacological treatment
179257|NCT03075683|Internet mediated|internet mediated
179258|NCT03075579|ADHD, cortisol, α-amylase, actometer|adhd, cortisol, α-amylase, actometer
179259|NCT03075566|coronary artery disease|coronary artery disease
179260|NCT03075566|risk factors|risk factors
179261|NCT03075566|inflammation|inflammation
179262|NCT03075566|biomarkers|biomarkers
179263|NCT03075566|atherosclerosis|atherosclerosis
179264|NCT03075540|Latinas|latinas
179265|NCT03075527|Mesothelioma|mesothelioma
179266|NCT03075514|ketogenic|ketogenic
179267|NCT03075501|drug cues|drug cues
179268|NCT03075475|Child|child
179269|NCT03075475|Adolescent|adolescent
179270|NCT03075475|Mental Health|mental health
179271|NCT03075475|Randomized Controlled Trial|randomized controlled trial
179272|NCT03075462|PARP inhibitor|parp inhibitor
179273|NCT03075462|VEGFR inhibitor|vegfr inhibitor
179274|NCT03075462|Combination therapy|combination therapy
179275|NCT03075462|Ovarian Cancer|ovarian cancer
179276|NCT03075462|Triple Negative Breast Cancer|triple negative breast cancer
179277|NCT03075436|Sanitation|sanitation
179278|NCT03075436|Hygiene|hygiene
179279|NCT03075436|Public Health|public health
179280|NCT03075436|Behavior change|behavior change
179281|NCT03075436|Neglected tropical diseases|neglected tropical diseases
179282|NCT03075436|Demand-side sanitation and hygiene|demand-side sanitation and hygiene
179283|NCT03075436|Mental well-being|mental well-being
179284|NCT03075436|Water insecurity|water insecurity
179285|NCT03075436|Sanitation insecurity|sanitation insecurity
179286|NCT03075436|Collective efficacy|collective efficacy
179287|NCT03075410|ascending dose|ascending dose
179288|NCT03075410|Pharmacokinetics|pharmacokinetics
179289|NCT03075410|GSK3036656|gsk3036656
179290|NCT03075410|FTIH|ftih
179291|NCT03075410|Safety|safety
179292|NCT03075397|HIV-1|hiv-1
179293|NCT03075397|Colo-rectal transmission|colo-rectal transmission
179294|NCT03075397|seminal plasma|seminal plasma
179295|NCT03075384|computer-assisted navigation system|computer-assisted navigation system
179296|NCT03075332|Detraining|detraining
179297|NCT03075332|Physical aptitude|physical aptitude
179298|NCT03075332|HIV|hiv
179299|NCT03075280|ERCP|ercp
179300|NCT03075280|ERAS|eras
179301|NCT03075280|complication|complication
179302|NCT03075280|fatigue|fatigue
179303|NCT03075280|high carbohydrate diet|high carbohydrate diet
229140|NCT02765542|mHealth|mhealth
179304|NCT03075254|Pain|pain
179305|NCT03075254|Fatigue|fatigue
179306|NCT03075241|Sleep Disturbances|sleep disturbances
179307|NCT03075241|Alzheimer Disease|alzheimer disease
179308|NCT03075241|Insomnia|insomnia
179309|NCT03075241|Z-Drugs|z-drugs
179310|NCT03075241|Treatment|treatment
179311|NCT03075228|microbiota|microbiota
179312|NCT03075228|small intestine|small intestine
179313|NCT03075228|metabolic disease|metabolic disease
179314|NCT03075202|Schizophrenia|schizophrenia
179315|NCT03075202|Smoking|smoking
179316|NCT03075202|E-cigarette|e-cigarette
179317|NCT03075189|Frailty|frailty
179318|NCT03075189|geriatric|geriatric
179319|NCT03075189|hospitalized|hospitalized
179320|NCT03075189|enrichment|enrichment
179321|NCT03075189|whey protein|whey protein
179323|NCT03075189|sarcopenia|sarcopenia
179324|NCT03075189|dietary counseling|dietary counseling
179325|NCT03075176|Photorefractive keratectomy|photorefractive keratectomy
179326|NCT03075176|Laser-assisted in situ keratomileusis|laser-assisted in situ keratomileusis
179327|NCT03075163|PONV|ponv
179328|NCT03075163|Nausea|nausea
179329|NCT03075163|Vomiting|vomiting
179330|NCT03075163|Acupressure|acupressure
179331|NCT03075137|ischemic stroke|ischemic stroke
179332|NCT03075137|external counter pulsation|external counter pulsation
179333|NCT03075137|mRS|mrs
179334|NCT03075124|Coronary Artery Disease|coronary artery disease
179335|NCT03075124|external counter pulsation|external counter pulsation
179336|NCT03075124|major adverse cardiovascular events|major adverse cardiovascular events
179337|NCT03075098|Colposcopy|colposcopy
179338|NCT03075098|oral epithelial dysplasia|oral epithelial dysplasia
179339|NCT03075098|diagnostic accuracy|diagnostic accuracy
179340|NCT03075072|Brain metastases|brain metastases
179341|NCT03075072|Brain metastasis|brain metastasis
179342|NCT03075072|Lung cancer|lung cancer
179343|NCT03075072|Melanoma|melanoma
179344|NCT03075072|Breast cancer|breast cancer
179345|NCT03075072|Kidney cancer|kidney cancer
179346|NCT03075072|Renal cell carcinoma|renal cell carcinoma
179347|NCT03075072|Stereotactic radiation|stereotactic radiation
179348|NCT03075072|Stereotactic radiosurgery|stereotactic radiosurgery
179349|NCT03075072|SRS|srs
179350|NCT03075072|Stereotactic|stereotactic
179351|NCT03075072|Whole brain radiation|whole brain radiation
179352|NCT03075072|WBRT|wbrt
179353|NCT03075072|Hippocampal avoidance|hippocampal avoidance
179354|NCT03075072|Hippocampal sparing|hippocampal sparing
179355|NCT03075072|Hippocampal|hippocampal
179356|NCT03075072|Hippocampus|hippocampus
179357|NCT03075072|Radiation|radiation
179358|NCT03075072|Quality of Life|quality of life
179359|NCT03075072|Neurocognitive|neurocognitive
179360|NCT03075072|Neurocognition|neurocognition
179361|NCT03075072|Survival|survival
179362|NCT03075072|Salvage|salvage
179363|NCT03075072|MDASI|mdasi
179364|NCT03075072|Chemotherapy|chemotherapy
179365|NCT03075072|Recurrence|recurrence
179366|NCT03075046|Blue Light Emitting Diode|blue light emitting diode
179367|NCT03075046|Women|women
179368|NCT03075033|Shikani optical stylet, rigid optical stylets, awake, fiber-optic intubation, and cervical spine injury.|shikani optical stylet, rigid optical stylets, awake, fiber-optic intubation, and cervical spine injury.
179369|NCT03075007|Alzheimer Disease|alzheimer disease
179370|NCT03075007|Aging|aging
179371|NCT03075007|Dementia|dementia
179372|NCT03075007|PET|pet
179373|NCT03074994|Tranexamic acid|tranexamic acid
179374|NCT03074994|Peri-articular injection|peri-articular injection
179375|NCT03074994|Intraarticular injection|intraarticular injection
179376|NCT03074994|Total knee arthroplasty|total knee arthroplasty
179377|NCT03074994|Blood loss|blood loss
179378|NCT03074955|Hypotension|hypotension
179379|NCT03074955|Propofol|propofol
179380|NCT03074955|Trendelenburg|trendelenburg
179381|NCT03074955|leg wrapping|leg wrapping
179382|NCT03074929|risk communication|risk communication
179383|NCT03074903|intrauterine device|intrauterine device
179384|NCT03074903|bleeding|bleeding
179385|NCT03074877|Substance Use|substance use
179386|NCT03074864|Activating mutations,lung cancer,radiotherapy|activating mutations,lung cancer,radiotherapy
179387|NCT03074851|low sodium salt|low sodium salt
179388|NCT03074851|blood pressure|blood pressure
179389|NCT03074851|reporter|reporter
179390|NCT03074838|Cardiac surgery|cardiac surgery
179391|NCT03074838|TAVI|tavi
179392|NCT03074825|Non-Hodgkin's lymphoma|non-hodgkin's lymphoma
179393|NCT03074825|Relapsed/Refractory|relapsed/refractory
179394|NCT03074825|Aurora kinase B|aurora kinase b
179395|NCT03074734|secondhand smoke|secondhand smoke
179396|NCT03074734|passive smoking|passive smoking
179397|NCT03074734|respiratory diseases|respiratory diseases
179398|NCT03074734|COPD|copd
179399|NCT03074734|asthma|asthma
179400|NCT03074734|SHS health effect|shs health effect
179401|NCT03074708|Three-Dimensional Image|three-dimensional image
179402|NCT03074708|Three Dimensional Printing|three dimensional printing
179403|NCT03074682|Resuscitation|resuscitation
179404|NCT03074669|Anxiety symptoms/disorders (OCD, PTSD, GAD, SAD, Panic)|anxiety symptoms/disorders (ocd, ptsd, gad, sad, panic)
179405|NCT03074656|infliximab|infliximab
179406|NCT03074656|therapeutic drug monitoring|therapeutic drug monitoring
179407|NCT03074656|anti drug antibodies|anti drug antibodies
179408|NCT03074656|TDM|tdm
179409|NCT03074604|Brain Injuries|brain injuries
179410|NCT03074604|Neurological Injury|neurological injury
179411|NCT03074604|Stroke|stroke
179412|NCT03074604|Postoperative Cognitive Dysfunction|postoperative cognitive dysfunction
179413|NCT03074604|Postoperative Delirium|postoperative delirium
179414|NCT03074604|Coronary Artery Disease|coronary artery disease
179415|NCT03074604|Coronary Artery Bypass Grafting|coronary artery bypass grafting
179416|NCT03074604|Coronary Artery Bypass Surgery|coronary artery bypass surgery
179417|NCT03074604|Bypass surgery|bypass surgery
179418|NCT03074604|Beating Heart Coronary Artery Bypass|beating heart coronary artery bypass
179419|NCT03074604|Off-Pump Coronary Artery Bypass|off-pump coronary artery bypass
179420|NCT03074591|Iron deficiency|iron deficiency
179421|NCT03074591|Heart failure|heart failure
179422|NCT03074578|sleep|sleep
179423|NCT03074578|verbal abuse|verbal abuse
179424|NCT03074578|polysomnography|polysomnography
179425|NCT03074578|perception|perception
179426|NCT03074578|neuropsychological tests|neuropsychological tests
179427|NCT03074565|Sanative Therapy|sanative therapy
179428|NCT03074565|Ultrasonic Therapy|ultrasonic therapy
179429|NCT03074565|Deep Scaling|deep scaling
179430|NCT03074565|Hand Scaling|hand scaling
179431|NCT03074552|probiotics|probiotics
179432|NCT03074552|VAP|vap
179433|NCT03074552|microbiome|microbiome
179434|NCT03074552|trauma|trauma
179435|NCT03074552|infections|infections
179436|NCT03074500|Kinesio taping|kinesio taping
179437|NCT03074500|lateral epicondylitis|lateral epicondylitis
179438|NCT03074500|tennis elbow|tennis elbow
179439|NCT03074500|treatment|treatment
179440|NCT03074487|Spinal cord ischemia|spinal cord ischemia
179441|NCT03074487|Postoperative|postoperative
179442|NCT03074487|Thoracoabdominal Aneurysm|thoracoabdominal aneurysm
179443|NCT03074487|Monitoring|monitoring
179444|NCT03074474|use of mesh|use of mesh
179445|NCT03074461|Rectal Cancer|rectal cancer
179446|NCT03074461|Low Anterior Resection|low anterior resection
179447|NCT03074461|Coloplasty Pouch|coloplasty pouch
179448|NCT03074461|Side-to-end Anastomosis|side-to-end anastomosis
179449|NCT03074461|Continence|continence
179450|NCT03074461|Quality of Life|quality of life
179451|NCT03074448|Colonoscopy|colonoscopy
179452|NCT03074448|Intestinal Cleaning|intestinal cleaning
179453|NCT03074448|Picoprep|picoprep
179454|NCT03074448|Aquanet|aquanet
179455|NCT03074422|Functional neurosurgery|functional neurosurgery
179456|NCT03074422|Pain management|pain management
179457|NCT03074422|Hypnosis|hypnosis
179458|NCT03074422|Stereotaxy|stereotaxy
179459|NCT03074422|Parkinson disease|parkinson disease
179460|NCT03074422|Essential tremor|essential tremor
179461|NCT03074422|Dystonia|dystonia
179462|NCT03074422|Invasive monitoring of epilepsy|invasive monitoring of epilepsy
179463|NCT03074409|Oxytocin|oxytocin
179464|NCT03074344|Dry Eye Syndrome|dry eye syndrome
179465|NCT03074344|artificial tear|artificial tear
179466|NCT03074344|CoQ10|coq10
179467|NCT03074344|Hyaluronic acid|hyaluronic acid
179468|NCT03074305|In-bioresorbable vascular scaffold restenosis|in-bioresorbable vascular scaffold restenosis
179469|NCT03074305|drug-eluting stent|drug-eluting stent
179470|NCT03074305|drug-eluting balloon|drug-eluting balloon
179471|NCT03074305|bioresorbable scaffold|bioresorbable scaffold
179472|NCT03074279|Epilepsy|epilepsy
179473|NCT03074279|SUDEP|sudep
179474|NCT03074279|case-control study|case-control study
179475|NCT03074279|risks factors|risks factors
179476|NCT03074240|Truncal block|truncal block
179477|NCT03074240|Surgical anesthesia|surgical anesthesia
179478|NCT03074240|Postoperative pain control|postoperative pain control
179479|NCT03074214|copeptin|copeptin
179480|NCT03074214|myocardial infarct size|myocardial infarct size
179481|NCT03074214|prognosis|prognosis
179482|NCT03074214|ST-elevation myocardial infarction|st-elevation myocardial infarction
179483|NCT03074214|percutaneous coronary intervention|percutaneous coronary intervention
179484|NCT03074201|ERCP, choledocholithiasis, cholangioscopy|ercp, choledocholithiasis, cholangioscopy
179485|NCT03074188|oral findings or oral manifestation|oral findings or oral manifestation
179486|NCT03074188|pre-dialysis stage or end stage renal disease|pre-dialysis stage or end stage renal disease
179487|NCT03074136|photodynamic therapy|photodynamic therapy
179488|NCT03074136|diode laser|diode laser
179489|NCT03074136|immature permanent teeth|immature permanent teeth
179490|NCT03074136|endodontic therapy|endodontic therapy
179491|NCT03074123|cosyntropin stimulation test|cosyntropin stimulation test
179492|NCT03074123|low-dose|low-dose
179493|NCT03074110|Inhalation Anaesthetics, Sevoflurane|inhalation anaesthetics, sevoflurane
179494|NCT03074110|Carbon Dioxide|carbon dioxide
179495|NCT03074110|Hyperventilation|hyperventilation
179496|NCT03074110|Anaesthesia Recovery Period|anaesthesia recovery period
179497|NCT03074110|Ventilators|ventilators
179498|NCT03074097|Rectus sheath block, Postoperative pain,TNF alpha and IL-6|rectus sheath block, postoperative pain,tnf alpha and il-6
179499|NCT03074084|abdominal pain|abdominal pain
179500|NCT03074084|adult|adult
179501|NCT03074084|emergency department|emergency department
179502|NCT03074084|electronic nose|electronic nose
179503|NCT03074084|celiac disease|celiac disease
179504|NCT03074071|Disambiguation, Depression, Burnout|disambiguation, depression, burnout
179505|NCT03074045|Intrauterine|intrauterine
179506|NCT03074045|Birth control|birth control
179507|NCT03073993|nasogastric|nasogastric
179508|NCT03073993|orogastric|orogastric
179509|NCT03073993|nutrition|nutrition
179510|NCT03073993|preterm|preterm
179511|NCT03073993|feeding tube|feeding tube
179512|NCT03073993|insertion|insertion
179513|NCT03073993|episodes|episodes
179514|NCT03073993|bradycardia|bradycardia
179515|NCT03073993|desaturation|desaturation
179516|NCT03073980|in vitro fertilization|in vitro fertilization
179517|NCT03073980|oocyte retrieval|oocyte retrieval
179518|NCT03073980|acetaminophen|acetaminophen
179519|NCT03073980|postoperative pain control|postoperative pain control
179520|NCT03073954|Health Behavior|health behavior
179521|NCT03073954|Executive function|executive function
179522|NCT03073954|Working-memory training|working-memory training
179523|NCT03073954|Feasibility|feasibility
179524|NCT03073954|Impulsivity|impulsivity
179525|NCT03073941|Knee arthroplasty|knee arthroplasty
179526|NCT03073941|Knee function|knee function
179527|NCT03073941|Total knee replacement|total knee replacement
179528|NCT03073941|Persona total knee system|persona total knee system
179529|NCT03073941|NexGen total knee system|nexgen total knee system
179530|NCT03073928|Nerve block|nerve block
179531|NCT03073928|Diaphragm function|diaphragm function
179532|NCT03073889|Aneurysm Clipping|aneurysm clipping
179533|NCT03073889|Scalp nerve block|scalp nerve block
179534|NCT03073889|Scalp infiltration|scalp infiltration
179535|NCT03073889|Ropivacaine|ropivacaine
179536|NCT03073876|Alzheimer Disease|alzheimer disease
179537|NCT03073876|Attention|attention
179538|NCT03073876|Donepezil hydrochloride|donepezil hydrochloride
179539|NCT03073863|LDL Cholesterol|ldl cholesterol
179540|NCT03073863|Statin intensity|statin intensity
179541|NCT03073863|post hoc analysis|post hoc analysis
179542|NCT03073863|Achieved LDL Cholesterol level|achieved ldl cholesterol level
179543|NCT03073811|protein supplementation|protein supplementation
179544|NCT03073811|older adults|older adults
179545|NCT03073811|nutrition perihabilitation|nutrition perihabilitation
179546|NCT03073811|perioperative optimization|perioperative optimization
179547|NCT03073811|Veterans|veterans
179548|NCT03073798|Lung Disease|lung disease
179549|NCT03073798|Breathing Difficulty|breathing difficulty
179550|NCT03073798|Smoking|smoking
179551|NCT03073798|Mucociliary|mucociliary
179552|NCT03073746|Google|google
179553|NCT03073746|Knowledge Panels|knowledge panels
179554|NCT03073746|Health Search|health search
179555|NCT03073746|Online|online
179556|NCT03073746|Internet|internet
179557|NCT03073746|Smartphone|smartphone
179558|NCT03073746|Tablet|tablet
179559|NCT03073746|Digital|digital
179560|NCT03073746|Mobile|mobile
179561|NCT03073746|Symptoms|symptoms
179562|NCT03073746|Differential diagnosis|differential diagnosis
179563|NCT03073746|Diagnosis|diagnosis
179564|NCT03073746|Anxiety|anxiety
179565|NCT03073707|Non-Typhoid Salmonella|non-typhoid salmonella
179566|NCT03073707|Invasive blood stream infections|invasive blood stream infections
179567|NCT03073707|Reservoir|reservoir
179568|NCT03073707|Household environment|household environment
179569|NCT03073707|Children|children
179570|NCT03073694|Peritoneal Surface Disease|peritoneal surface disease
179571|NCT03073694|mitomycin-c|mitomycin-c
179572|NCT03073694|melphalan|melphalan
179573|NCT03073694|Cytoreductive Surgery and Hyperthermic Intraperitoneal Chemotherapy (CRS-HIPEC)|cytoreductive surgery and hyperthermic intraperitoneal chemotherapy (crs-hipec)
179574|NCT03073694|Peritoneal Carcinomatosis|peritoneal carcinomatosis
179575|NCT03073681|cataract|cataract
179576|NCT03073655|shoulder pain|shoulder pain
179577|NCT03073655|shoulder function|shoulder function
179578|NCT03073642|Hydrotherapy|hydrotherapy
179579|NCT03073642|Pain education|pain education
179580|NCT03073577|Type 1 Diabetes Mellitus|type 1 diabetes mellitus
179581|NCT03073577|Islet Transplantation|islet transplantation
179582|NCT03073577|Diabetes|diabetes
179583|NCT03073577|Diabetes Treatment|diabetes treatment
179584|NCT03073564|Dyspnea|dyspnea
179585|NCT03073564|Cardiopulmonary Exercise Test|cardiopulmonary exercise test
179586|NCT03073564|Positive-Pressure Respiration|positive-pressure respiration
179587|NCT03073525|Stage IIIb|stage iiib
179588|NCT03073525|Stage IV|stage iv
179589|NCT03073525|Ovarian Cancer|ovarian cancer
179590|NCT03073525|Cervical Cancer|cervical cancer
179591|NCT03073525|Uterine Cancer|uterine cancer
179592|NCT03073525|Immunotherapy|immunotherapy
179593|NCT03073447|Myocardial infarction|myocardial infarction
179594|NCT03073447|Women|women
179595|NCT03073447|Young|young
179596|NCT03073447|Primary PCI|primary pci
179597|NCT03073447|Hormone|hormone
179598|NCT03073408|Propofol|propofol
179599|NCT03073408|Bispectral index (BIS)|bispectral index (bis)
179600|NCT03073408|Closed loop|closed loop
179601|NCT03073356|Myocardial metabolism|myocardial metabolism
179602|NCT03073356|Positron emission tomography|positron emission tomography
179603|NCT03073356|Echocardiography|echocardiography
179604|NCT03073356|Right sided heart catheterization|right sided heart catheterization
179605|NCT03073317|Preterm Infants|preterm infants
179606|NCT03073317|Premature Birth|premature birth
179607|NCT03073317|Placenta growth factor|placenta growth factor
179608|NCT03073317|Prenatal Care|prenatal care
179609|NCT03073317|PERINATAL MORTALITY|perinatal mortality
179610|NCT03073317|Pre-Eclampsia|pre-eclampsia
179611|NCT03073304|isolated limb perfusion|isolated limb perfusion
179612|NCT03073291|cannabis|cannabis
179613|NCT03073291|commerce|commerce
179614|NCT03073265|DOAC|doac
179615|NCT03073265|apixaban|apixaban
179616|NCT03073265|IVD|ivd
179617|NCT03073239|Amyotrophic Lateral Sclerosis|amyotrophic lateral sclerosis
179618|NCT03073239|Bulbar disfunction|bulbar disfunction
179619|NCT03073239|Rik factors ALS|rik factors als
179620|NCT03073200|children|children
179621|NCT03073200|psoriasis treatment|psoriasis treatment
179622|NCT03073200|adolescents|adolescents
179623|NCT03073187|Asthma|asthma
179624|NCT03073187|Sleep|sleep
179625|NCT03073187|Adolescents|adolescents
179626|NCT03073187|Urban|urban
179627|NCT03073187|Intervention|intervention
179628|NCT03073187|High school|high school
179629|NCT03073174|dietary intake|dietary intake
179630|NCT03073174|nutritional supplements|nutritional supplements
179631|NCT03073174|sanative therapy|sanative therapy
179632|NCT03073174|healing|healing
179633|NCT03073174|flavonoids|flavonoids
179634|NCT03073174|tea|tea
179635|NCT03073161|flavonoids|flavonoids
179636|NCT03073161|tea|tea
179637|NCT03073161|dietary intake|dietary intake
179638|NCT03073161|nutritional supplements|nutritional supplements
179639|NCT03073161|periodontal disease|periodontal disease
179640|NCT03073161|healing|healing
179641|NCT03073161|sanative therapy|sanative therapy
179642|NCT03073096|axillary nodal dissection|axillary nodal dissection
179643|NCT03073096|groin nodal dissection|groin nodal dissection
179644|NCT03073083|autograft|autograft
179645|NCT03073070|diabetic children|diabetic children
179646|NCT03073070|RBC lifespan|rbc lifespan
179647|NCT03073044|Quality of life|quality of life
179648|NCT03073044|psychosocial and psychological problems|psychosocial and psychological problems
179649|NCT03073005|ventricular assist device (VAD)|ventricular assist device (vad)
179650|NCT03073005|heart failure|heart failure
179651|NCT03073005|simulation|simulation
179652|NCT03072966|Distress|distress
179653|NCT03072966|Exercise|exercise
179654|NCT03072966|Wearable device|wearable device
179655|NCT03072966|Smartphone|smartphone
179656|NCT03072927|Lumbar Spinal Stenosis|lumbar spinal stenosis
179657|NCT03072927|Interspinous process decompression|interspinous process decompression
179658|NCT03072927|MILD|mild
179659|NCT03072927|Medicare|medicare
179660|NCT03072888|acute pain|acute pain
179661|NCT03072888|Transcutaneous Electric Nerve Stimulation|transcutaneous electric nerve stimulation
179662|NCT03072888|Anesthesia Recovery Period|anesthesia recovery period
179663|NCT03072875|Suicidality|suicidality
179664|NCT03072875|Collaborative Assessment and Management of Suicidality|collaborative assessment and management of suicidality
179665|NCT03072875|Technology|technology
179666|NCT03072875|Suicide Prevention|suicide prevention
179667|NCT03072875|Suicide Intervention|suicide intervention
179668|NCT03072862|Cochlear implant treatment, aging adults|cochlear implant treatment, aging adults
179669|NCT03072849|Pediatrics|pediatrics
179670|NCT03072849|Airflow obstruction|airflow obstruction
179671|NCT03072849|Chronic graft-vs-host disease|chronic graft-vs-host disease
179672|NCT03072849|Bronchiolitis obliterans syndrome|bronchiolitis obliterans syndrome
179673|NCT03072823|CVDs|cvds
179674|NCT03072823|cardiovascular diseases|cardiovascular diseases
179675|NCT03072823|n-3 polyunsaturated fatty acids|n-3 polyunsaturated fatty acids
179676|NCT03072823|depression|depression
179677|NCT03072810|Positive psychology|positive psychology
179678|NCT03072810|Wellbeing|wellbeing
179679|NCT03072810|Chronic pain|chronic pain
179680|NCT03072810|Mindfulness|mindfulness
179681|NCT03072797|Atherosclerosis|atherosclerosis
179682|NCT03072797|Longitudinal|longitudinal
179683|NCT03072797|Biomarker|biomarker
179684|NCT03072797|Coronary angiography|coronary angiography
179685|NCT03072797|Follow-up|follow-up
179686|NCT03072797|Metabolomics|metabolomics
179687|NCT03072797|Risk factor|risk factor
179688|NCT03072758|Male partner involvement|male partner involvement
179689|NCT03072745|Cognitive Impairment|cognitive impairment
179690|NCT03072732|Heart Failure|heart failure
179691|NCT03072732|Hemodialysis|hemodialysis
179692|NCT03072706|hip replacement|hip replacement
179693|NCT03072706|acetabulum|acetabulum
179694|NCT03072706|anteversion|anteversion
179695|NCT03072706|position|position
179696|NCT03072706|guide|guide
179697|NCT03072667|prematurity|prematurity
229681|NCT02762227|CT|ct
179698|NCT03072667|bowel atresia|bowel atresia
179699|NCT03072667|necrotizing entercolitis|necrotizing entercolitis
179700|NCT03072667|parenteral nutrition associated liver disease (PNALD)|parenteral nutrition associated liver disease (pnald)
179701|NCT03072667|intestinal failure|intestinal failure
179828|NCT03072030|Ebola Virus Vaccines|ebola virus vaccines
179702|NCT03072667|parenteral nutrition associated cholestasis|parenteral nutrition associated cholestasis
179703|NCT03072667|fish oil|fish oil
179704|NCT03072641|Probiotics|probiotics
179705|NCT03072641|Epigenetics|epigenetics
179706|NCT03072641|Microbiota|microbiota
179707|NCT03072628|nicotine|nicotine
179708|NCT03072628|sympathetic nerve activity|sympathetic nerve activity
179709|NCT03072628|oxidative stress|oxidative stress
179710|NCT03072602|Racial differences|racial differences
179711|NCT03072576|Diagnosis|diagnosis
179712|NCT03072576|Xpert MTB/RIF|xpert mtb/rif
179713|NCT03072576|Ultra Xpert MTB/RIF|ultra xpert mtb/rif
179714|NCT03072550|fungal nail|fungal nail
179715|NCT03072550|toenail fungus|toenail fungus
179716|NCT03072537|growth|growth
179717|NCT03072537|BMI|bmi
179718|NCT03072537|obesity|obesity
179719|NCT03072537|childhood|childhood
179720|NCT03072537|adolescence|adolescence
179721|NCT03072537|development|development
179722|NCT03072524|pre-hospital stroke scale test|pre-hospital stroke scale test
179723|NCT03072524|severe hemiparesis|severe hemiparesis
179724|NCT03072524|large vessel occlusion|large vessel occlusion
179725|NCT03072524|mechanical thrombectomy|mechanical thrombectomy
179726|NCT03072485|aging|aging
179727|NCT03072472|Colorectal Cancer|colorectal cancer
179728|NCT03072472|Endoscopy|endoscopy
179729|NCT03072472|Screening|screening
179730|NCT03072472|Colonic Adenoma|colonic adenoma
179731|NCT03072472|Adenoma Detection Rate|adenoma detection rate
179732|NCT03072472|Endocuff|endocuff
179733|NCT03072472|Endocuff Vision|endocuff vision
179734|NCT03072446|Uterine Fibroid|uterine fibroid
179735|NCT03072446|Embolization|embolization
179736|NCT03072446|symptoms|symptoms
179737|NCT03072446|Gel-Beads|gel-beads
179738|NCT03072433|child malnutrition|child malnutrition
179739|NCT03072433|child development|child development
179740|NCT03072433|counseling|counseling
179741|NCT03072420|MRI, fingers compression|mri, fingers compression
179742|NCT03072381|CLE|cle
179743|NCT03072381|epicondylosis|epicondylosis
179744|NCT03072381|platelet rich plasma|platelet rich plasma
179745|NCT03072381|PRP|prp
179746|NCT03072381|ultrasound|ultrasound
179747|NCT03072381|shear wave ultrasound|shear wave ultrasound
179748|NCT03072381|tendinopathy|tendinopathy
179749|NCT03072381|elbow|elbow
179750|NCT03072381|tenis elbow|tenis elbow
179751|NCT03072381|plasma|plasma
179752|NCT03072381|plasma injection|plasma injection
179753|NCT03072381|tendinosis|tendinosis
179754|NCT03072381|tendinitis|tendinitis
179755|NCT03072355|fatigue|fatigue
179756|NCT03072355|resistance test|resistance test
179757|NCT03072316|breast cancer|breast cancer
179758|NCT03072316|mastectomy|mastectomy
179759|NCT03072316|deep inferior perforator flap reconstruction|deep inferior perforator flap reconstruction
179760|NCT03072316|post mastectomy radiotherapy|post mastectomy radiotherapy
179761|NCT03072303|Brittle Bone|brittle bone
179762|NCT03072303|Osteogenesis Imperfecta|osteogenesis imperfecta
179763|NCT03072303|BBD|bbd
179764|NCT03072303|OI|oi
179765|NCT03072303|Congenital Abnormalities|congenital abnormalities
179766|NCT03072303|Congenital Bone Disorder|congenital bone disorder
179767|NCT03072303|Lobstein Syndrome|lobstein syndrome
179768|NCT03072277|DHA|dha
179769|NCT03072277|Docosa Hexaenoic Acid|docosa hexaenoic acid
179770|NCT03072277|Omega 3 fatty acid|omega 3 fatty acid
179771|NCT03072277|Newborn Outcome|newborn outcome
179772|NCT03072277|Birth Size|birth size
179773|NCT03072277|Gestational Age|gestational age
179774|NCT03072277|DASII|dasii
179775|NCT03072277|Prenatal Supplementation|prenatal supplementation
179776|NCT03072277|Randomized Controlled Trial|randomized controlled trial
179777|NCT03072277|Neurodevelopment|neurodevelopment
179778|NCT03072277|Pregnancy outcome|pregnancy outcome
179779|NCT03072264|Generalized Anxiety Disorder, GAD, mindfulness, anxiety|generalized anxiety disorder, gad, mindfulness, anxiety
179780|NCT03072238|Metastatic Castrate-Resistant Prostate Cancer|metastatic castrate-resistant prostate cancer
179781|NCT03072225|herbal medicine|herbal medicine
179782|NCT03072225|stroke|stroke
179783|NCT03072225|vulnerable plaques of carotid artery|vulnerable plaques of carotid artery
179784|NCT03072212|HIV|hiv
179785|NCT03072212|Stroke|stroke
179786|NCT03072212|Cerebral vascular accident|cerebral vascular accident
179787|NCT03072212|Uganda|uganda
179788|NCT03072199|Rituximab|rituximab
179789|NCT03072199|B cells|b cells
179790|NCT03072160|Anti-PD1/PDL1|anti-pd1/pdl1
179791|NCT03072160|Vaccine Therapy|vaccine therapy
179792|NCT03072160|TKI-Naive|tki-naive
179793|NCT03072134|Glioma|glioma
179794|NCT03072134|Glioblastoma|glioblastoma
179795|NCT03072134|Astrocytoma|astrocytoma
179796|NCT03072134|Brain Cancer|brain cancer
229831|NCT02761369|PAS|pas
179797|NCT03072134|New Diagnosed Glioma|new diagnosed glioma
179798|NCT03072134|Temozolomide|temozolomide
179799|NCT03072134|Radiation|radiation
179800|NCT03072134|Neural Stem Cells|neural stem cells
179801|NCT03072134|Virotherapy|virotherapy
179802|NCT03072134|Adenovirus|adenovirus
179803|NCT03072134|Oncolytic virotherapy|oncolytic virotherapy
179804|NCT03072121|coronary artery disease|coronary artery disease
179805|NCT03072121|revascularization|revascularization
179806|NCT03072121|Shexiang Baoxin Pill|shexiang baoxin pill
179807|NCT03072095|Colorectal Neoplasms|colorectal neoplasms
179808|NCT03072095|Colonic Neoplasms|colonic neoplasms
179809|NCT03072095|Gastrointestinal Neoplasms|gastrointestinal neoplasms
179810|NCT03072095|Digestive System Neoplasms|digestive system neoplasms
179811|NCT03072095|Neoplasms|neoplasms
179812|NCT03072095|Digestive System Diseases|digestive system diseases
179813|NCT03072095|Gastrointestinal Diseases|gastrointestinal diseases
179814|NCT03072095|Colonic Diseases|colonic diseases
179815|NCT03072095|Rectal Diseases|rectal diseases
179816|NCT03072082|coronary artery disease|coronary artery disease
179817|NCT03072082|revascularization|revascularization
179818|NCT03072082|Danlou Tablet|danlou tablet
179819|NCT03072043|myelodysplastic syndrome (MDS)|myelodysplastic syndrome (mds)
179820|NCT03072043|TP53 mutant myelodysplastic syndrome|tp53 mutant myelodysplastic syndrome
179821|NCT03072043|MDS/myeloproliferative neoplasm (MPN)|mds/myeloproliferative neoplasm (mpn)
179822|NCT03072043|chronic myelomonocytic leukemia (CMML)|chronic myelomonocytic leukemia (cmml)
179823|NCT03072043|acute myeloid leukemia (AML)|acute myeloid leukemia (aml)
179824|NCT03072030|Ebola Virus Disease|ebola virus disease
179825|NCT03072030|Hemorrhagic Fever, Ebola|hemorrhagic fever, ebola
179826|NCT03072030|Vaccines|vaccines
179827|NCT03072030|GP protein, Ebola virus|gp protein, ebola virus
179829|NCT03072004|Leprosy|leprosy
179830|NCT03072004|Neuropathy|neuropathy
179831|NCT03072004|LLLT|lllt
179832|NCT03071991|preinsicional bupivacain|preinsicional bupivacain
179833|NCT03071991|laparoscopic bariatric surgery|laparoscopic bariatric surgery
179834|NCT03071991|postoperative pain|postoperative pain
179835|NCT03071978|Heart Failure|heart failure
179836|NCT03071978|LV-fusion pacing|lv-fusion pacing
179837|NCT03071978|Cardiac Resynchronization Therapy|cardiac resynchronization therapy
179838|NCT03071952|Heart Failure|heart failure
179839|NCT03071952|Chronotropic Incompetence|chronotropic incompetence
179840|NCT03071952|Rate Response|rate response
179841|NCT03071952|Exercise Test|exercise test
179842|NCT03071874|Meningioma|meningioma
179843|NCT03071861|darbepoetin|darbepoetin
179844|NCT03071861|Brain Diseases|brain diseases
179845|NCT03071835|Stem Cells|stem cells
179846|NCT03071835|Cardiovascular|cardiovascular
179847|NCT03071835|Quality of Life|quality of life
179848|NCT03071835|Cardiomyopathy|cardiomyopathy
179849|NCT03071822|PTCLs|ptcls
179850|NCT03071809|Solid tumor|solid tumor
179851|NCT03071809|carcinoma|carcinoma
179852|NCT03071809|sarcoma|sarcoma
179853|NCT03071809|stage I|stage i
179854|NCT03071809|stage II|stage ii
179855|NCT03071809|stage III|stage iii
179856|NCT03071770|Healthy Volunteers|healthy volunteers
179857|NCT03071770|Japanese|japanese
179858|NCT03071770|Caucasian|caucasian
179859|NCT03071757|Solid Tumors|solid tumors
179860|NCT03071757|Cancer|cancer
179861|NCT03071757|Metastatic Solid Tumors|metastatic solid tumors
179862|NCT03071757|Advanced Solid Tumors|advanced solid tumors
179863|NCT03071757|Triple negative breast cancer (TNBC)|triple negative breast cancer (tnbc)
179864|NCT03071757|Ovarian cancer|ovarian cancer
179865|NCT03071757|Hepatocellular carcinoma (HCC)|hepatocellular carcinoma (hcc)
179866|NCT03071757|Gastric cancer|gastric cancer
179867|NCT03071757|Mesothelioma|mesothelioma
179868|NCT03071757|Small cell lung cancer (SCLC)|small cell lung cancer (sclc)
179869|NCT03071757|Cholangiocarcinoma|cholangiocarcinoma
179870|NCT03071757|Merkel cell carcinoma|merkel cell carcinoma
179871|NCT03071757|Melanoma|melanoma
179872|NCT03071757|Non-small cell lung cancer (NSCLC)|non-small cell lung cancer (nsclc)
179873|NCT03071757|2'-Deoxy-2'-[18F]Fluoro-9-β-DArabinofuranosylguanine (18F-AraG)|2'-deoxy-2'-[18f]fluoro-9-β-darabinofuranosylguanine (18f-arag)
179874|NCT03071731|Glittre|glittre
179875|NCT03071731|COPD|copd
179876|NCT03071731|sit-to-stand|sit-to-stand
179877|NCT03071731|responsiveness|responsiveness
179878|NCT03071731|bronchodilation|bronchodilation
179879|NCT03071718|cardiovascular diseases|cardiovascular diseases
179880|NCT03071718|gut microbiota|gut microbiota
179881|NCT03071718|Mediterranean diet|mediterranean diet
179882|NCT03071705|NSCLC|nsclc
179883|NCT03071705|metformin|metformin
179884|NCT03071705|metformin plus TKI|metformin plus tki
179885|NCT03071705|EGFR positive status|egfr positive status
179886|NCT03071666|Nepal|nepal
179887|NCT03071666|South Asia|south asia
179888|NCT03071666|Nutrition|nutrition
179889|NCT03071666|Pregnancy|pregnancy
179890|NCT03071666|Neurodevelopment|neurodevelopment
179891|NCT03071666|Growth|growth
179892|NCT03071653|Cardiomyopathy|cardiomyopathy
179893|NCT03071653|Left Cardiac Sympathetic Denervation|left cardiac sympathetic denervation
179894|NCT03071640|old|old
179895|NCT03071640|elderly|elderly
179896|NCT03071640|radiotherapy|radiotherapy
179897|NCT03071640|geriatric assessment|geriatric assessment
179898|NCT03071627|Spin|spin
179899|NCT03071627|Misleading reporting|misleading reporting
179900|NCT03071627|Misleading interpretation|misleading interpretation
179901|NCT03071627|Misleading extrapolation|misleading extrapolation
179902|NCT03071627|Animal studies|animal studies
179903|NCT03071627|Cell culture studies|cell culture studies
179904|NCT03071627|Pre-clinical studies|pre-clinical studies
179905|NCT03071614|Spin, misleading reporting, misleading interpretation, misleading extrapolation, animal studies, cell culture studies, pre-clinical studies|spin, misleading reporting, misleading interpretation, misleading extrapolation, animal studies, cell culture studies, pre-clinical studies
179906|NCT03071614|Misleading reporting|misleading reporting
179907|NCT03071614|Misleading interpretation|misleading interpretation
179908|NCT03071614|Misleading extrapolation|misleading extrapolation
179909|NCT03071614|Animal studies|animal studies
179910|NCT03071614|Cell culture studies|cell culture studies
179911|NCT03071614|Pre-clinical studies|pre-clinical studies
179912|NCT03071601|Laceration|laceration
179913|NCT03071601|Suture|suture
179914|NCT03071601|Topical anesthesia|topical anesthesia
179915|NCT03071601|Lidocaine|lidocaine
179916|NCT03071575|measles|measles
179917|NCT03071575|rubella|rubella
179918|NCT03071575|immunogenicity|immunogenicity
179919|NCT03071575|congenital rubella syndrome|congenital rubella syndrome
179920|NCT03071575|measles-rubella vaccine|measles-rubella vaccine
179922|NCT03071562|Cognitive impairment|cognitive impairment
179923|NCT03071562|Aging|aging
179924|NCT03071562|Physical Activity|physical activity
179925|NCT03071562|Exercise|exercise
179926|NCT03071562|Yoga|yoga
179927|NCT03071562|Neuroplasticity|neuroplasticity
179928|NCT03071549|Acne vulgaris|acne vulgaris
179929|NCT03071549|Chemical peeling|chemical peeling
179930|NCT03071549|Dermoscopy|dermoscopy
179931|NCT03071536|furosemide stress test|furosemide stress test
179932|NCT03071536|kidney transplantation|kidney transplantation
179933|NCT03071536|urine output|urine output
179934|NCT03071536|perioperation|perioperation
179935|NCT03071536|delayed graft function|delayed graft function
179936|NCT03071497|Iron-deficiency|iron-deficiency
179937|NCT03071497|Anemia|anemia
179938|NCT03071497|Iron-deficiency Anemia|iron-deficiency anemia
179939|NCT03071497|Zinc protoporphyrin|zinc protoporphyrin
179940|NCT03071484|Early Stages of Psychosis|early stages of psychosis
179941|NCT03071484|Schizophrenia|schizophrenia
179942|NCT03071484|Transcranial Direct Current Stimulation|transcranial direct current stimulation
179943|NCT03071484|Cognitive Symptomatology|cognitive symptomatology
179944|NCT03071484|Double-blind Randomized Controlled Trial|double-blind randomized controlled trial
179945|NCT03071419|fathers|fathers
179946|NCT03071406|Merkel cell carcinoma (MCC)|merkel cell carcinoma (mcc)
179947|NCT03071406|Metastatic|metastatic
179948|NCT03071406|Metastasis|metastasis
179949|NCT03071406|Stereotactic body radiation therapy (SBRT)|stereotactic body radiation therapy (sbrt)
179950|NCT03071406|Immunology|immunology
179951|NCT03071406|Antibody|antibody
179952|NCT03071406|Nivolumab|nivolumab
179953|NCT03071406|Ipilimumab|ipilimumab
179954|NCT03071406|Metastatic skin cancer|metastatic skin cancer
179955|NCT03071406|Cutaneous|cutaneous
179956|NCT03071393|acute intermittent hypoxia|acute intermittent hypoxia
179957|NCT03071393|walking|walking
179958|NCT03071393|breathing|breathing
179959|NCT03071393|standing|standing
179960|NCT03071393|sitting|sitting
179961|NCT03071393|spinal cord injury|spinal cord injury
179962|NCT03071367|Airway Management|airway management
179963|NCT03071367|Medical students|medical students
179964|NCT03071367|Intratracheal intubation|intratracheal intubation
179965|NCT03071367|Educational Technology|educational technology
179966|NCT03071354|ICU-acquired weakness|icu-acquired weakness
179967|NCT03071341|MPS I; Hurler Syndrome|mps i; hurler syndrome
179968|NCT03071315|Economic evaluation|economic evaluation
179969|NCT03071315|Heroin dependence|heroin dependence
179970|NCT03071315|Compulsory treatment|compulsory treatment
179971|NCT03071315|Methadone treatment|methadone treatment
179972|NCT03071315|Vietnam|vietnam
179973|NCT03071315|East and Southeast Asia|east and southeast asia
179974|NCT03071315|Cost-effectiveness|cost-effectiveness
179975|NCT03071302|Keratoconus,Corneal Dystrophies, corneal Tomography, topography|keratoconus,corneal dystrophies, corneal tomography, topography
179976|NCT03071263|Treatment of Hyperkalemia|treatment of hyperkalemia
179977|NCT03071263|Hyperkalemia|hyperkalemia
179978|NCT03071263|Potassium|potassium
179979|NCT03071263|Chronic Kidney Disease|chronic kidney disease
179980|NCT03071263|Hypertension|hypertension
179981|NCT03071263|Resistant Hypertension|resistant hypertension
179982|NCT03071263|Spironolactone|spironolactone
179983|NCT03071237|infrapyloric artery|infrapyloric artery
179984|NCT03071237|gastric cancer|gastric cancer
179985|NCT03071224|AD|ad
179986|NCT03071224|HV|hv
179987|NCT03071211|pelvic organ prolapse|pelvic organ prolapse
179988|NCT03071211|urinary catheters|urinary catheters
179989|NCT03071198|Neoadjuvant Chemotherapy|neoadjuvant chemotherapy
179990|NCT03071185|free flap|free flap
179991|NCT03071185|nerve block|nerve block
179992|NCT03071185|elective reconstructive surgery|elective reconstructive surgery
179993|NCT03071185|free fibular|free fibular
179994|NCT03071185|anterolateral thigh flaps|anterolateral thigh flaps
179995|NCT03071159|Flash Glucose Monitoring|flash glucose monitoring
179996|NCT03071159|Usability|usability
179997|NCT03071159|Metabolic control|metabolic control
179998|NCT03071055|Macular Degeneration|macular degeneration
179999|NCT03071055|AMD|amd
180000|NCT03071055|Wet AMD|wet amd
180001|NCT03071055|Lucentis|lucentis
180002|NCT03071029|family planning|family planning
180003|NCT03071029|reproductive health|reproductive health
180004|NCT03071029|abortion|abortion
180005|NCT03071029|health providers|health providers
180006|NCT03071016|T2D,|t2d,
180007|NCT03071016|Type 2 Diabetes,|type 2 diabetes,
180008|NCT03071016|T2DM|t2dm
180009|NCT03071003|Pharmacokinetics|pharmacokinetics
180010|NCT03071003|Healthy Volunteer Study|healthy volunteer study
180011|NCT03070990|Enfortumab vedotin|enfortumab vedotin
180012|NCT03070990|ASG-22CE|asg-22ce
180013|NCT03070990|ASG-22ME|asg-22me
180014|NCT03070990|Metastatic Urothelial Cancer|metastatic urothelial cancer
180015|NCT03070977|Interprofessional education|interprofessional education
180016|NCT03070977|Training unit|training unit
180017|NCT03070977|Psychiatry|psychiatry
180018|NCT03070977|Patient reported outcome|patient reported outcome
180019|NCT03070951|Uterine Fibroid|uterine fibroid
180020|NCT03070951|Leiomyomata|leiomyomata
180021|NCT03070951|Heavy Menstrual Bleeding|heavy menstrual bleeding
180022|NCT03070951|HMB|hmb
180023|NCT03070951|Heavy Uterine Bleeding|heavy uterine bleeding
180024|NCT03070951|Menorrhagia|menorrhagia
180025|NCT03070951|OBE2109 + Add-back|obe2109 + add-back
180026|NCT03070938|Chronic wounds|chronic wounds
180027|NCT03070938|Acute Wounds|acute wounds
180028|NCT03070938|PHMB|phmb
180029|NCT03070938|Wound Management|wound management
180030|NCT03070938|Bioburden|bioburden
180031|NCT03070938|Collagen|collagen
180032|NCT03070925|Antimicrobial|antimicrobial
180033|NCT03070925|Collagen|collagen
180034|NCT03070925|Bioburden|bioburden
180035|NCT03070925|Biofilm|biofilm
180036|NCT03070925|PHMB|phmb
180037|NCT03070925|Chronic wounds|chronic wounds
180038|NCT03070925|Acute wounds|acute wounds
180039|NCT03070912|mechanical circulatory support|mechanical circulatory support
180040|NCT03070912|bleeding, acquired von willebrand disease|bleeding, acquired von willebrand disease
180041|NCT03070912|acquired von willebrand disease|acquired von willebrand disease
180042|NCT03070899|Uterine Fibroid|uterine fibroid
180043|NCT03070899|Leiomyomata|leiomyomata
180044|NCT03070899|Heavy Menstrual Bleeding|heavy menstrual bleeding
180045|NCT03070899|HMB|hmb
180046|NCT03070899|Heavy Uterine Bleeding|heavy uterine bleeding
180047|NCT03070899|Menorrhagia|menorrhagia
180048|NCT03070899|OBE2109 + Add-back|obe2109 + add-back
180049|NCT03070873|Quality of life|quality of life
180050|NCT03070873|Vaginal mesh|vaginal mesh
180051|NCT03070873|Mesh complications|mesh complications
180052|NCT03070860|Low Grade Chronic vascular and skin Inflammation|low grade chronic vascular and skin inflammation
180053|NCT03070860|Molecular vascular and skin Calcification|molecular vascular and skin calcification
180054|NCT03070860|Calcium Score|calcium score
180055|NCT03070847|tranexamic acid|tranexamic acid
180056|NCT03070847|rhinoplasty|rhinoplasty
180057|NCT03070847|bleeding reduction|bleeding reduction
180058|NCT03070821|neurofeedback|neurofeedback
180059|NCT03070821|real-time functional MRI|real-time functional mri
180060|NCT03070821|parahippocampus|parahippocampus
180061|NCT03070808|obesity|obesity
180062|NCT03070808|voice|voice
180063|NCT03070795|post-operative ileus|post-operative ileus
180064|NCT03070795|early feeding|early feeding
180065|NCT03070795|delayed feeding|delayed feeding
180066|NCT03070782|IONIS-APO(a)-LRx|ionis-apo(a)-lrx
180067|NCT03070782|AKCEA-APO(a)-LRx|akcea-apo(a)-lrx
180068|NCT03070782|Dyslipidemia|dyslipidemia
180069|NCT03070782|Dyslipoproteinemia|dyslipoproteinemia
180070|NCT03070782|Hyperlipidemia|hyperlipidemia
180071|NCT03070782|Hyperlipoproteinemia|hyperlipoproteinemia
180072|NCT03070782|Hyperlipoproteinemia(a)|hyperlipoproteinemia(a)
180073|NCT03070782|Hyperlipoproteinemia a|hyperlipoproteinemia a
180074|NCT03070782|Lipoprotein|lipoprotein
180075|NCT03070782|Lipoprotein(a)|lipoprotein(a)
180076|NCT03070782|Lipoprotein a|lipoprotein a
180077|NCT03070782|Lp(a)|lp(a)
180078|NCT03070782|Lp a|lp a
180079|NCT03070756|auto-CPAP|auto-cpap
180080|NCT03070756|forced oscillation technique|forced oscillation technique
180081|NCT03070756|obstructive sleep apnea|obstructive sleep apnea
180082|NCT03070743|basilar invagination|basilar invagination
180083|NCT03070743|atlantoaxial dislocation|atlantoaxial dislocation
180084|NCT03070743|surgery|surgery
180085|NCT03070743|restoration technique|restoration technique
180086|NCT03070730|Tachycardia|tachycardia
180087|NCT03070730|orthostatic symptoms|orthostatic symptoms
180088|NCT03070730|autonomic reflex|autonomic reflex
180089|NCT03070717|High myopia, shortsightedness, retinal changes|high myopia, shortsightedness, retinal changes
180090|NCT03070691|Basal cell carcinoma|basal cell carcinoma
180091|NCT03070691|Nevoid Basal Cell Carcinoma Syndrome|nevoid basal cell carcinoma syndrome
180092|NCT03070691|NBCCS, Gorlin syndrome|nbccs, gorlin syndrome
180093|NCT03070691|Gorlin-Goltz Syndrome|gorlin-goltz syndrome
180094|NCT03070691|Basal Cell Nevus Syndrome|basal cell nevus syndrome
180095|NCT03070691|BCNS, Hedgehog pathway inhibitor|bcns, hedgehog pathway inhibitor
180096|NCT03070691|topical|topical
180097|NCT03070691|Smoothened|smoothened
180098|NCT03070665|endoscopic submucosal dissection|endoscopic submucosal dissection
180099|NCT03070665|postoperation bleeding|postoperation bleeding
180100|NCT03070652|attachment|attachment
180101|NCT03070652|bonding psychological|bonding psychological
180102|NCT03070626|General Surgery|general surgery
180103|NCT03070626|Carbohydrates|carbohydrates
180104|NCT03070626|Perioperative|perioperative
180105|NCT03070613|Colonoscopy|colonoscopy
180106|NCT03070613|Fluorescence guided surgery|fluorescence guided surgery
180107|NCT03070600|PrEP|prep
180108|NCT03070574|Lynch Syndrome|lynch syndrome
180109|NCT03070574|Chemoprevention|chemoprevention
180110|NCT03070574|Mesalazine|mesalazine
180111|NCT03070574|5-ASA|5-asa
180112|NCT03070535|APOE E4; cognition; metabolic markers; beta-amyloid|apoe e4; cognition; metabolic markers; beta-amyloid
180113|NCT03070496|Myocardial infarction|myocardial infarction
180114|NCT03070496|bio-collection|bio-collection
180115|NCT03070496|Imaging markers|imaging markers
180116|NCT03070496|biomarkers|biomarkers
180117|NCT03070496|STEMI|stemi
180118|NCT03070496|clinical outcomes|clinical outcomes
180119|NCT03070457|bariatric surgery|bariatric surgery
180120|NCT03070457|sleeve gastrectomy|sleeve gastrectomy
180121|NCT03070457|eras|eras
180122|NCT03070444|Essix retainer|essix retainer
180123|NCT03070444|Cuspid-to-cuspid retainer|cuspid-to-cuspid retainer
180124|NCT03070431|spinal cord compression, radiotherapy|spinal cord compression, radiotherapy
180126|NCT03070418|DCS|dcs
180127|NCT03070418|Boyd and Griffin Classification|boyd and griffin classification
180128|NCT03070405|Tenofovir Disoproxil Fumarate|tenofovir disoproxil fumarate
180129|NCT03070405|4-Aminosalicylic Acid|4-aminosalicylic acid
180130|NCT03070405|Tuberculosis|tuberculosis
180131|NCT03070405|HIV|hiv
180132|NCT03070392|Melanoma|melanoma
180133|NCT03070392|Uveal Cancer|uveal cancer
180134|NCT03070392|IMCgp100|imcgp100
180135|NCT03070392|Immunotherapy|immunotherapy
180136|NCT03070366|Oligometastasis|oligometastasis
180137|NCT03070366|stereotactic irradiation|stereotactic irradiation
180138|NCT03070353|Cirrhosis|cirrhosis
180139|NCT03070353|AKI|aki
180140|NCT03070353|Albumin|albumin
180141|NCT03070353|Dextran|dextran
180142|NCT03070340|mastectomy|mastectomy
180143|NCT03070340|breast MRI|breast mri
180144|NCT03070340|contrast enhanced mammography|contrast enhanced mammography
180145|NCT03070340|CEDM|cedm
180146|NCT03070340|17-045|17-045
180147|NCT03070327|B-cell Maturation Antigen (BCMA)|b-cell maturation antigen (bcma)
180148|NCT03070327|Targeted EGFRt/BCMA-41BBz|targeted egfrt/bcma-41bbz
180149|NCT03070327|Chimeric antigen receptor (CAR)|chimeric antigen receptor (car)
180150|NCT03070327|Lenalidomide|lenalidomide
180151|NCT03070327|17-025|17-025
180152|NCT03070314|Echinacea|echinacea
180153|NCT03070314|bioavailability|bioavailability
180154|NCT03070314|children|children
180155|NCT03070301|LEE011|lee011
180156|NCT03070301|Everolimus|everolimus
180157|NCT03070301|16-1535|16-1535
180158|NCT03070288|RGB|rgb
180159|NCT03070288|red-green-blue|red-green-blue
180160|NCT03070288|rhinitis|rhinitis
180161|NCT03070288|allergic rhinitis|allergic rhinitis
180162|NCT03070288|nasal mucosa|nasal mucosa
180163|NCT03070275|surgical implant placement|surgical implant placement
180164|NCT03070275|crestal bone|crestal bone
180165|NCT03070275|mucosa thickness|mucosa thickness
180166|NCT03070275|stem cells|stem cells
180167|NCT03070275|fibrin glue|fibrin glue
180168|NCT03070275|collagen fleece|collagen fleece
180169|NCT03070262|esophageal cancer|esophageal cancer
180170|NCT03070262|caffeic acid|caffeic acid
180171|NCT03070249|Emergency Department|emergency department
180172|NCT03070236|Breast Cancer|breast cancer
180173|NCT03070184|Racial differences|racial differences
180174|NCT03070158|Premature Infant|premature infant
180175|NCT03070158|Mother-Infant Interaction|mother-infant interaction
180176|NCT03070158|Acoustic stimulation/methods|acoustic stimulation/methods
180177|NCT03070158|Touch|touch
180178|NCT03070158|Visual Stimulation|visual stimulation
180179|NCT03070158|Vestibule, Labyrinth/physiology|vestibule, labyrinth/physiology
180180|NCT03070145|Prostate Cancer|prostate cancer
180181|NCT03070093|Acute myeloid leukemia (AML)|acute myeloid leukemia (aml)
180182|NCT03070093|FMS-like Tyrosine kinase-3 (FLT3) mutations|fms-like tyrosine kinase-3 (flt3) mutations
180183|NCT03070093|gilteritinib|gilteritinib
180184|NCT03070093|Expanded access|expanded access
180185|NCT03070093|ASP2215|asp2215
180186|NCT03070015|Weight Loss|weight loss
180187|NCT03070015|Obesity|obesity
180188|NCT03070015|Overweight|overweight
180189|NCT03069989|Tolerability|tolerability
180190|NCT03069989|IPF|ipf
180191|NCT03069989|PET imaging|pet imaging
180192|NCT03069989|Idiopathic Pulmonary Fibrosis|idiopathic pulmonary fibrosis
180193|NCT03069989|Safety|safety
180194|NCT03069989|Pharmacokinetics|pharmacokinetics
180195|NCT03069989|Double-blind|double-blind
180196|NCT03069950|Hepatic Arterial Infusion|hepatic arterial infusion
180197|NCT03069950|Floxuridine (FUDR)|floxuridine (fudr)
180198|NCT03069950|Irinotecan (CPT-11)|irinotecan (cpt-11)
180199|NCT03069950|FLUOROURACIL|fluorouracil
180200|NCT03069950|PANITUMUMAB|panitumumab
180201|NCT03069950|16-1341|16-1341
180202|NCT03069911|Parkinson Disease|parkinson disease
180203|NCT03069911|Parkinsonism|parkinsonism
180204|NCT03069911|Depression|depression
180205|NCT03069911|OnabotulinumtoxinA|onabotulinumtoxina
180206|NCT03069911|BOTOX|botox
180207|NCT03069898|Marital relationship|marital relationship
180208|NCT03069872|Transvaginal ultrasound|transvaginal ultrasound
180209|NCT03069872|General practice|general practice
180210|NCT03069872|Early diagnosis|early diagnosis
180211|NCT03069872|Symptoms|symptoms
180212|NCT03069859|Post partum hemorrhage|post partum hemorrhage
180213|NCT03069859|Tranexamic acid|tranexamic acid
180214|NCT03069859|Spontaneous vaginal delivery|spontaneous vaginal delivery
180215|NCT03069859|C-section|c-section
180216|NCT03069846|skin cancer|skin cancer
180217|NCT03069846|laser spectroscopy|laser spectroscopy
180218|NCT03069846|non-invasive diagnostics|non-invasive diagnostics
180219|NCT03069781|estrogen|estrogen
180220|NCT03069768|Nicotine addiction|nicotine addiction
180221|NCT03069768|Cigarette smoking|cigarette smoking
180222|NCT03069768|Smoking cessation|smoking cessation
180223|NCT03069768|Quit smoking|quit smoking
180224|NCT03069755|India|india
180225|NCT03069755|Perioperative mortality|perioperative mortality
180226|NCT03069755|Trauma|trauma
180227|NCT03069755|Surgery|surgery
180228|NCT03069742|Breast Cancer Prevention|breast cancer prevention
180229|NCT03069742|Risk Assessment|risk assessment
180230|NCT03069742|Chemoprevention|chemoprevention
180231|NCT03069742|Decision Making|decision making
180232|NCT03069729|screen|screen
180233|NCT03069716|Pulmonary Arterial Hypertension|pulmonary arterial hypertension
180234|NCT03069703|Vaccine|vaccine
180235|NCT03069703|ANCA- associated vasculitides|anca- associated vasculitides
180236|NCT03069703|pneumovax|pneumovax
180237|NCT03069703|prevenar|prevenar
180238|NCT03069703|pneumovas|pneumovas
180239|NCT03069677|midazolam|midazolam
180240|NCT03069664|Pancreatic Cancer|pancreatic cancer
180241|NCT03069664|Pancreatic Duct Stricture|pancreatic duct stricture
180242|NCT03069664|Endoscopic treatment|endoscopic treatment
180243|NCT03069638|sedation|sedation
180244|NCT03069638|pediatrics|pediatrics
180245|NCT03069638|intranasal sedation|intranasal sedation
180246|NCT03069638|dexmedetomidine|dexmedetomidine
180247|NCT03069638|dinitrous oxide|dinitrous oxide
180248|NCT03069638|intra-articular joint injection|intra-articular joint injection
180249|NCT03069625|Cystic Fibrosis|cystic fibrosis
180250|NCT03069625|Exercise Testing|exercise testing
180251|NCT03069625|Muscular strength|muscular strength
180252|NCT03069625|Pediatrics|pediatrics
180253|NCT03069625|Quality of life|quality of life
180254|NCT03069612|repetitive transcranial magnetic stimulation|repetitive transcranial magnetic stimulation
180255|NCT03069612|working memory|working memory
180256|NCT03069612|gamma oscillations|gamma oscillations
180257|NCT03069612|dorsolateral prefrontal cortex|dorsolateral prefrontal cortex
180258|NCT03069573|Eosinophilic Esophagitis|eosinophilic esophagitis
180259|NCT03069573|Gastroesophageal Reflux|gastroesophageal reflux
180260|NCT03069573|Diagnose|diagnose
180261|NCT03069573|Biomarker|biomarker
180262|NCT03069560|suicide attempt|suicide attempt
180263|NCT03069560|SMS monitoring|sms monitoring
180264|NCT03069560|Phone|phone
180265|NCT03069560|Prevention control|prevention control
180266|NCT03069560|tertiary healthcare|tertiary healthcare
180267|NCT03069534|MDR-TB|mdr-tb
180268|NCT03069534|rhIL-2|rhil-2
180269|NCT03069534|immunotherapy|immunotherapy
180270|NCT03069495|Allergy|allergy
180271|NCT03069495|Asthma|asthma
180272|NCT03069495|Urticaria|urticaria
180273|NCT03069482|Smoking|smoking
180274|NCT03069482|mHealth|mhealth
180275|NCT03069482|Serious Mental Illness|serious mental illness
180276|NCT03069482|Acceptance and Commitment Therapy|acceptance and commitment therapy
180277|NCT03069482|US DHHS Clinical Practice Guidelines|us dhhs clinical practice guidelines
180278|NCT03069469|CSF1R|csf1r
180279|NCT03069469|Breast cancer|breast cancer
180280|NCT03069469|Prostate cancer|prostate cancer
180281|NCT03069469|NSCLC|nsclc
180282|NCT03069469|DTGCT|dtgct
180283|NCT03069469|PVNS|pvns
180284|NCT03069456|sevoflurane|sevoflurane
180285|NCT03069456|Bistpectral index|bistpectral index
180286|NCT03069456|Anesthetic Depth Monitoring System|anesthetic depth monitoring system
180287|NCT03069456|population pharmacodynamics|population pharmacodynamics
180288|NCT03069443|Isometric handgrip training|isometric handgrip training
180289|NCT03069443|home training|home training
180290|NCT03069443|older adults|older adults
180291|NCT03069443|Hypertension|hypertension
180292|NCT03069417|HIV|hiv
180293|NCT03069417|Medication adherence|medication adherence
180294|NCT03069417|PMTCT|pmtct
180295|NCT03069417|Depression|depression
180296|NCT03069391|exercise|exercise
180297|NCT03069391|exergame|exergame
180298|NCT03069378|Metastatic|metastatic
180299|NCT03069378|Locally Advanced|locally advanced
180300|NCT03069378|Talimogene Laherparepvec (T-VEC)|talimogene laherparepvec (t-vec)
180301|NCT03069378|Pembrolizumab|pembrolizumab
180302|NCT03069378|16-1534|16-1534
180303|NCT03069365|Chronic Hepatitis C Virus|chronic hepatitis c virus
180304|NCT03069365|Chronic Kidney Disease|chronic kidney disease
180305|NCT03069365|Glecaprevir|glecaprevir
180306|NCT03069365|Pibrentasvir|pibrentasvir
180307|NCT03069365|Hepatitis C Virus Genotype|hepatitis c virus genotype
180308|NCT03069365|Compensated cirrhosis|compensated cirrhosis
180309|NCT03069365|Non-cirrhotic|non-cirrhotic
180310|NCT03069365|Interferon (IFN)|interferon (ifn)
180311|NCT03069365|Treatment naïve|treatment naïve
180312|NCT03069365|Sofosbuvir (SOF)|sofosbuvir (sof)
180313|NCT03069365|Pegylated interferon (pegIFN)|pegylated interferon (pegifn)
180314|NCT03069365|Ribavirin (RBV)|ribavirin (rbv)
180315|NCT03069352|Acute Myeloid Leukemia|acute myeloid leukemia
180316|NCT03069352|Leukemia|leukemia
180317|NCT03069352|Treatment naïve|treatment naïve
180318|NCT03069352|Venetoclax|venetoclax
180319|NCT03069352|Cytarabine|cytarabine
180320|NCT03069326|Ruxolitinib|ruxolitinib
180321|NCT03069326|Thalidomide|thalidomide
180322|NCT03069326|16-1498|16-1498
180323|NCT03069313|Aromatase Inhibitor|aromatase inhibitor
180324|NCT03069313|Breast Cancer|breast cancer
180325|NCT03069313|Arthralgia|arthralgia
180326|NCT03069313|Musculoskeletal symptoms|musculoskeletal symptoms
180327|NCT03069313|Joint pain|joint pain
180328|NCT03069261|Breast reconstruction|breast reconstruction
180329|NCT03069261|Autologous tissue flaps|autologous tissue flaps
180330|NCT03069261|Indocyanine green angiography|indocyanine green angiography
180331|NCT03069261|Breast cancer|breast cancer
180332|NCT03069235|HIV|hiv
180333|NCT03069235|Breast Feeding|breast feeding
180334|NCT03069222|diffusion tensor imaging|diffusion tensor imaging
180335|NCT03069196|Prevalence|prevalence
180336|NCT03069196|Incidence|incidence
180337|NCT03069196|Type 1 diabetes and its Micro-vascular complications|type 1 diabetes and its micro-vascular complications
180338|NCT03069196|Type 1 diabetes and its Macro-vascular complications|type 1 diabetes and its macro-vascular complications
180339|NCT03069196|Type 1 Diabetes and its complications in India|type 1 diabetes and its complications in india
180340|NCT03069183|Fascia Iliaca Block|fascia iliaca block
180341|NCT03069183|Total Hip Arthroplasty|total hip arthroplasty
180342|NCT03069183|Total Hip Replacement|total hip replacement
180343|NCT03069183|Ultrasound|ultrasound
180344|NCT03069144|Psoriasis|psoriasis
180345|NCT03069144|Topical|topical
180346|NCT03069131|primary prophylaxis|primary prophylaxis
180347|NCT03069131|rifaximin|rifaximin
180348|NCT03069118|Telemedicine|telemedicine
180349|NCT03069118|Online Treatment|online treatment
180350|NCT03069118|Digital Intervention|digital intervention
180351|NCT03069079|primary immunodeficiency|primary immunodeficiency
180352|NCT03069079|dental health|dental health
180353|NCT03069079|neutrophil defect|neutrophil defect
180354|NCT03069079|periodontitis|periodontitis
180355|NCT03069066|In-stent restenosis|in-stent restenosis
180356|NCT03069066|Bioresorbable vascular scaffold|bioresorbable vascular scaffold
180357|NCT03069066|Stent|stent
180358|NCT03069066|Drug-eluting stent|drug-eluting stent
180359|NCT03069066|Coronary angiography|coronary angiography
180360|NCT03069066|Scoring balloon|scoring balloon
180361|NCT03069040|cervical cancer|cervical cancer
180362|NCT03069040|NSRH|nsrh
180363|NCT03069040|RH|rh
180364|NCT03069040|urine flow mechanics|urine flow mechanics
180365|NCT03069040|anorectal dynamics|anorectal dynamics
180366|NCT03069027|Nasal surgery|nasal surgery
180367|NCT03069027|external nasal nerve block|external nasal nerve block
180368|NCT03069027|postoperative agitation|postoperative agitation
180369|NCT03069001|HCV treatment|hcv treatment
180370|NCT03068988|bone marrow stem cells|bone marrow stem cells
180371|NCT03068988|rotator cuff lesion|rotator cuff lesion
180372|NCT03068936|Nasopharyngeal Carcinoma|nasopharyngeal carcinoma
180373|NCT03068936|Intensity modulated radiotherapy|intensity modulated radiotherapy
180374|NCT03068936|Cisplatin|cisplatin
180375|NCT03068923|Blood clot|blood clot
180376|NCT03068923|Deep Vein Thrombosis|deep vein thrombosis
180377|NCT03068923|Pulmonary Embolism|pulmonary embolism
180378|NCT03068923|Lower Extremity|lower extremity
180379|NCT03068923|Upper Extremity|upper extremity
180380|NCT03068923|Cerebral sinus|cerebral sinus
180381|NCT03068923|Renal vein|renal vein
180382|NCT03068923|Portal vein|portal vein
180383|NCT03068923|thrombin|thrombin
180384|NCT03068923|fibrinolysis|fibrinolysis
180385|NCT03068923|coagulation|coagulation
180386|NCT03068923|anticoagulation|anticoagulation
180387|NCT03068923|Post trombotic syndrome|post trombotic syndrome
180388|NCT03068923|Post pulmonary embolism syndrome|post pulmonary embolism syndrome
180389|NCT03068923|Chronic thromboembolic pulmonary hypertension|chronic thromboembolic pulmonary hypertension
180390|NCT03068910|Hyperandrogenism|hyperandrogenism
180391|NCT03068910|Polycystic ovary syndrome|polycystic ovary syndrome
180392|NCT03068910|Puberty|puberty
180393|NCT03068845|non-maturing arteriovenous fistula|non-maturing arteriovenous fistula
180394|NCT03068845|stenosis of arteriovenous fistula|stenosis of arteriovenous fistula
180395|NCT03068845|drug-eluting balloon|drug-eluting balloon
180396|NCT03068767|HBV DNA, qHBsAg|hbv dna, qhbsag
180397|NCT03068754|ALS|als
180398|NCT03068728|bilateral chronic rhino sinusitis|bilateral chronic rhino sinusitis
180399|NCT03068715|transcranial magnetic stimulation|transcranial magnetic stimulation
180400|NCT03068715|theta burst|theta burst
180401|NCT03068689|Partial nephrectomy, RIPC, Reperfusion Injury|partial nephrectomy, ripc, reperfusion injury
180402|NCT03068676|Depression|depression
180403|NCT03068676|Anxiety|anxiety
180404|NCT03068676|Internet-delivered|internet-delivered
180405|NCT03068676|CBT|cbt
180406|NCT03068676|Primary Care|primary care
180407|NCT03068663|lung cancer|lung cancer
180408|NCT03068663|intestinal microbiota|intestinal microbiota
180409|NCT03068663|lung microbiota|lung microbiota
180410|NCT03068663|surgery|surgery
180411|NCT03068663|chemotherapy|chemotherapy
180412|NCT03068585|PAD|pad
180413|NCT03068585|CLI|cli
180414|NCT03068585|stage 2a-3 of Pokrovsky-Fonteine|stage 2a-3 of pokrovsky-fonteine
180415|NCT03068572|minimal change esophageal reflux disease diagnosis|minimal change esophageal reflux disease diagnosis
180416|NCT03068572|Linked Color imaging|linked color imaging
180417|NCT03068572|non-erosive reflux disease|non-erosive reflux disease
180418|NCT03068546|Oral Microbiota|oral microbiota
180519|NCT03068013|Cancer|cancer
180419|NCT03068533|DH, dentin hypersensitivity, chronic periodontitis|dh, dentin hypersensitivity, chronic periodontitis
180420|NCT03068520|PET|pet
180421|NCT03068520|MRI|mri
180422|NCT03068520|BRAIN METASTASIS|brain metastasis
180423|NCT03068520|BRAIN PRIMARY TUMOR|brain primary tumor
180424|NCT03068520|RESPONSE TO TREATMENT|response to treatment
180425|NCT03068507|Perioperative|perioperative
180426|NCT03068507|functional capability|functional capability
180427|NCT03068507|Prehabilitation|prehabilitation
180428|NCT03068507|thoracoscopic lobectomy|thoracoscopic lobectomy
180429|NCT03068507|Lung Cancer|lung cancer
180430|NCT03068494|Coronary Bifurcation Lesion|coronary bifurcation lesion
180431|NCT03068494|2nd generation drug-eluting stent|2nd generation drug-eluting stent
180432|NCT03068442|Carotid artery|carotid artery
180433|NCT03068442|MRI|mri
180434|NCT03068442|PET|pet
180435|NCT03068442|Intraplaque hemorrhage|intraplaque hemorrhage
180436|NCT03068429|obsessive-compulsive disorder|obsessive-compulsive disorder
180437|NCT03068429|fear conditioning|fear conditioning
180438|NCT03068429|functional neuroimaging|functional neuroimaging
180439|NCT03068429|sertraline|sertraline
180440|NCT03068403|CEUS Perfusion|ceus perfusion
180441|NCT03068403|Rectal Cancer|rectal cancer
180442|NCT03068403|Tumor Perfusion|tumor perfusion
180443|NCT03068403|Radiochemotherapy|radiochemotherapy
180444|NCT03068377|lycopene|lycopene
180445|NCT03068377|eye|eye
180446|NCT03068377|vessel function|vessel function
180447|NCT03068364|Mortality|mortality
180448|NCT03068364|Hypertension|hypertension
180449|NCT03068364|Left ventricular hypertrophy|left ventricular hypertrophy
180450|NCT03068364|NT-proBNP|nt-probnp
180451|NCT03068364|ECG|ecg
180452|NCT03068364|Transthoracic echocardiography|transthoracic echocardiography
180453|NCT03068299|Prevention|prevention
180454|NCT03068299|Cognition|cognition
180455|NCT03068299|Aged care|aged care
180456|NCT03068299|Caregivers|caregivers
180457|NCT03068299|Frail elderly|frail elderly
180458|NCT03068299|Dancing therapy|dancing therapy
180459|NCT03068299|Rural population|rural population
180460|NCT03068273|Hospitalization|hospitalization
180461|NCT03068260|caesarean section|caesarean section
180462|NCT03068260|postoperative pain|postoperative pain
180463|NCT03068260|transmuscular quadratus lumborum block|transmuscular quadratus lumborum block
180464|NCT03068260|reduction of opioid consumption|reduction of opioid consumption
180465|NCT03068208|Methylene blue|methylene blue
180466|NCT03068208|photodynamic therapy|photodynamic therapy
180467|NCT03068208|primary cutaneous localized amyloidosis|primary cutaneous localized amyloidosis
180468|NCT03068208|lichen amyloidosis|lichen amyloidosis
180469|NCT03068195|laparoscopy|laparoscopy
180470|NCT03068195|microwave|microwave
180471|NCT03068195|ablation technique|ablation technique
180472|NCT03068182|Exercise ,Autonomic cardiac function ,Adult subjects|exercise ,autonomic cardiac function ,adult subjects
180473|NCT03068169|remote ECG|remote ecg
180474|NCT03068169|atrial fibrillation|atrial fibrillation
180475|NCT03068169|cardiac rehabilitation|cardiac rehabilitation
180476|NCT03068169|cardiac resynchronization therapy|cardiac resynchronization therapy
180477|NCT03068169|supraventricular tachycardia|supraventricular tachycardia
180478|NCT03068156|308-nm excimer laser|308-nm excimer laser
180479|NCT03068156|primary localized cutaneous amyloidosis|primary localized cutaneous amyloidosis
180480|NCT03068156|lichen amyloidosis|lichen amyloidosis
180481|NCT03068156|Asians|asians
180482|NCT03068130|Pulmonary Arterial Hypertension|pulmonary arterial hypertension
180483|NCT03068130|Pulmonary Hypertension|pulmonary hypertension
180484|NCT03068130|PH|ph
180485|NCT03068130|PAH|pah
180486|NCT03068130|Bardoxolone methyl|bardoxolone methyl
180487|NCT03068130|6-minute walk distance|6-minute walk distance
180488|NCT03068130|CDDO-ME|cddo-me
180489|NCT03068130|RTA 402|rta 402
180490|NCT03068130|LARIAT|lariat
180491|NCT03068130|CATALYST|catalyst
180492|NCT03068130|RANGER|ranger
180493|NCT03068117|Specialist Palliative Care|specialist palliative care
180494|NCT03068117|Symptom Control|symptom control
180495|NCT03068117|Early Referral|early referral
180496|NCT03068117|Quality of Life|quality of life
180497|NCT03068117|Malignant Pleural Mesothelioma|malignant pleural mesothelioma
180498|NCT03068117|Mesothelioma|mesothelioma
180499|NCT03068104|Trauma|trauma
180500|NCT03068104|Haemorrhage|haemorrhage
180501|NCT03068104|Massive transfusion|massive transfusion
180502|NCT03068104|India|india
180503|NCT03068091|Interstitial Lung Disease|interstitial lung disease
180504|NCT03068091|Idiopathic Pulmonary Fibrosis|idiopathic pulmonary fibrosis
180505|NCT03068065|Liraglutide|liraglutide
180506|NCT03068065|Metformin|metformin
180507|NCT03068065|Gliclazide|gliclazide
180508|NCT03068039|MRI|mri
180509|NCT03068039|blood glucose|blood glucose
180510|NCT03068039|porridge|porridge
180511|NCT03068039|breakfast|breakfast
180512|NCT03068039|satiety|satiety
180513|NCT03068039|plasma peptides|plasma peptides
180514|NCT03068026|Chronic Obstructive Pulmonary Disease|chronic obstructive pulmonary disease
180515|NCT03068026|Non-invasive ventilation|non-invasive ventilation
180516|NCT03068013|CALM|calm
180517|NCT03068013|Depression|depression
180518|NCT03068013|Demoralization|demoralization
180520|NCT03068013|Spirituality|spirituality
180521|NCT03068013|Psychotherapy|psychotherapy
180522|NCT03068013|Quality of Life|quality of life
180523|NCT03068013|Anxiety|anxiety
180524|NCT03068013|Post-Traumatic Growth|post-traumatic growth
180525|NCT03068000|Martial arts|martial arts
180526|NCT03068000|Judo|judo
180527|NCT03068000|Motor skills|motor skills
180528|NCT03068000|Physical fitness|physical fitness
180529|NCT03068000|Cardiovascular parameters|cardiovascular parameters
180530|NCT03068000|Quality of life|quality of life
180531|NCT03068000|Physical Activity|physical activity
180532|NCT03067974|ketamine|ketamine
180533|NCT03067974|pediatric|pediatric
180534|NCT03067974|procedural sedation|procedural sedation
180535|NCT03067961|Enteric fever|enteric fever
180536|NCT03067961|Typhoid|typhoid
180537|NCT03067961|Salmonella Typhi|salmonella typhi
180538|NCT03067961|Challenge study|challenge study
180539|NCT03067961|Human model of infection|human model of infection
180540|NCT03067961|Typhoid toxin|typhoid toxin
180541|NCT03067922|Mastectomy|mastectomy
180542|NCT03067922|Pain|pain
180543|NCT03067922|Severity|severity
180544|NCT03067922|Life quality|life quality
180545|NCT03067896|spinal block|spinal block
180546|NCT03067896|stress response|stress response
180547|NCT03067896|dexmedetomidine|dexmedetomidine
180548|NCT03067896|intrathecally|intrathecally
180549|NCT03067870|Stem cells|stem cells
180550|NCT03067870|Rheumatoid arthritis|rheumatoid arthritis
180551|NCT03067831|stem cells|stem cells
180552|NCT03067818|arm|arm
180553|NCT03067818|rehabilitation|rehabilitation
180554|NCT03067818|non-invasive brain stimulation|non-invasive brain stimulation
180555|NCT03067818|transcranial magnetic stimulation|transcranial magnetic stimulation
180556|NCT03067818|upper extremity|upper extremity
180557|NCT03067805|Oxytocin effect|oxytocin effect
180558|NCT03067805|romantic jealousy|romantic jealousy
180559|NCT03067805|Arousal Rating|arousal rating
180560|NCT03067805|Jealousy Rating|jealousy rating
180561|NCT03067792|inoperable gastric cancer|inoperable gastric cancer
180562|NCT03067792|palliative chemotherapy|palliative chemotherapy
180563|NCT03067740|appendicectomy|appendicectomy
180564|NCT03067740|children|children
180565|NCT03067740|local anesthetics|local anesthetics
180566|NCT03067740|laparoscopy|laparoscopy
180567|NCT03067740|peritoneum|peritoneum
180568|NCT03067675|no known ocular pathology|no known ocular pathology
180569|NCT03067623|Thin endometrium|thin endometrium
180570|NCT03067623|Endometrial thickness|endometrial thickness
180571|NCT03067584|Familial cancer|familial cancer
180572|NCT03067584|Genetic predisposition|genetic predisposition
180573|NCT03067584|Heritable disease|heritable disease
180574|NCT03067584|Cancer risk|cancer risk
180575|NCT03067584|Genome analysis|genome analysis
180576|NCT03067584|Genetic modifiers|genetic modifiers
180577|NCT03067584|Next generation sequencing (NGS)|next generation sequencing (ngs)
180578|NCT03067584|Genetic counseling|genetic counseling
180579|NCT03067584|DNA|dna
180580|NCT03067558|Pneumonia|pneumonia
180581|NCT03067558|Diagnostics|diagnostics
180582|NCT03067558|Childhood|childhood
180583|NCT03067558|Respiratory rate|respiratory rate
180584|NCT03067558|Ethiopia|ethiopia
180585|NCT03067506|Drug Therapy|drug therapy
180586|NCT03067454|early mobilisation|early mobilisation
180587|NCT03067454|metacarpal fracture|metacarpal fracture
180588|NCT03067454|operation|operation
180589|NCT03067441|hyperlipidemia|hyperlipidemia
180590|NCT03067441|cholesterol|cholesterol
180591|NCT03067441|heterozygous familial hypercholesterolemia|heterozygous familial hypercholesterolemia
180592|NCT03067441|atherosclerotic cardiovascular disease|atherosclerotic cardiovascular disease
180593|NCT03067441|ASCVD|ascvd
180594|NCT03067441|HeFH|hefh
180595|NCT03067441|LDL|ldl
180596|NCT03067428|Fructose|fructose
180597|NCT03067428|Diet|diet
180598|NCT03067415|Glaucoma, Primary Open Angle|glaucoma, primary open angle
180599|NCT03067415|Ocular hypertension|ocular hypertension
180600|NCT03067415|CKD-351|ckd-351
180601|NCT03067402|Myocardial Infarction|myocardial infarction
180602|NCT03067402|Physiological Stress Test|physiological stress test
180603|NCT03067402|Nuclear Image Perfusion|nuclear image perfusion
180604|NCT03067402|Angioplasty|angioplasty
180605|NCT03067402|Coronary Artery Bypass Graft|coronary artery bypass graft
180606|NCT03067402|Percutaneous Coronary Intervention|percutaneous coronary intervention
180607|NCT03067402|Angina|angina
180608|NCT03067402|Ischemia|ischemia
180609|NCT03067376|Absorption, distribution, metabolism, and excretion (ADME)|absorption, distribution, metabolism, and excretion (adme)
180610|NCT03067376|Metabolism|metabolism
180611|NCT03067376|Metabolite Profiling|metabolite profiling
180612|NCT03067376|Excretion|excretion
180613|NCT03067350|voriconazole|voriconazole
180614|NCT03067350|pharmacogenetics|pharmacogenetics
180615|NCT03067350|pharmacokinetics|pharmacokinetics
180616|NCT03067350|therapeutic drug monitoring|therapeutic drug monitoring
180617|NCT03067337|Stainless Steel Crowns|stainless steel crowns
180618|NCT03067337|Zirconia Crowns|zirconia crowns
180619|NCT03067337|Aesthetic restorations|aesthetic restorations
180620|NCT03067324|Islet Transplantation|islet transplantation
180621|NCT03067298|pregnancy|pregnancy
180622|NCT03067298|screening|screening
180623|NCT03067298|doppler|doppler
180624|NCT03067298|markers|markers
180625|NCT03067298|PlGF|plgf
180626|NCT03067298|sFlt-1|sflt-1
180627|NCT03067298|placenta|placenta
180628|NCT03067272|Permanent contraception|permanent contraception
180629|NCT03067272|Birth control|birth control
180630|NCT03067259|eldery patients|eldery patients
180631|NCT03067259|cognitive impairment|cognitive impairment
180632|NCT03067246|Supraglottic device|supraglottic device
180633|NCT03067246|Fibre optic scope|fibre optic scope
180634|NCT03067246|Endotracheal intubation|endotracheal intubation
180635|NCT03067220|outpatients|outpatients
180636|NCT03067220|general surgery|general surgery
180637|NCT03067220|virtual clinic|virtual clinic
180638|NCT03067220|patient satisfaction|patient satisfaction
180639|NCT03067207|mindfulness meditation|mindfulness meditation
180640|NCT03067207|Adolescent|adolescent
180641|NCT03067207|eHealth|ehealth
180642|NCT03067207|randomized trial|randomized trial
180643|NCT03067194|Osteoarthritis Hand|osteoarthritis hand
180644|NCT03067155|allogeneic stem cell transplantation|allogeneic stem cell transplantation
180645|NCT03067155|CMV reactivation|cmv reactivation
180646|NCT03067129|Chronic Hepatitis C Virus|chronic hepatitis c virus
180647|NCT03067129|Glecaprevir|glecaprevir
180648|NCT03067129|Pibrentasvir|pibrentasvir
180649|NCT03067129|Pharmacokinetic|pharmacokinetic
180650|NCT03067129|Treatment naïve|treatment naïve
180651|NCT03067129|Treatment experienced|treatment experienced
180652|NCT03067129|Interferon (IFN)|interferon (ifn)
180653|NCT03067129|pegylated interferon (pegIFN)|pegylated interferon (pegifn)
180654|NCT03067129|Ribavirin (RBV)|ribavirin (rbv)
180655|NCT03067129|sofosbuvir|sofosbuvir
180656|NCT03067129|Non-cirrhotic cirrhosis|non-cirrhotic cirrhosis
180657|NCT03067129|Compensated (Child-Pugh A) cirrhosis|compensated (child-pugh a) cirrhosis
180658|NCT03067116|balance, postural|balance, postural
180659|NCT03067116|fall risk|fall risk
180660|NCT03067116|anthropometrics|anthropometrics
180661|NCT03067116|blood pressure|blood pressure
180662|NCT03067116|SpO2|spo2
180663|NCT03067116|heart rate|heart rate
180664|NCT03067116|heart rate variability|heart rate variability
180665|NCT03067116|stance width|stance width
180666|NCT03067103|Adenotonsillectomy|adenotonsillectomy
180667|NCT03067103|pain|pain
180668|NCT03067103|topic analgesia|topic analgesia
180669|NCT03067103|child|child
180670|NCT03067077|SMILE|smile
180671|NCT03067077|LASIK|lasik
180672|NCT03067077|Myopia|myopia
180673|NCT03067077|Wavefront-guided|wavefront-guided
180674|NCT03067012|Oncometabolic surgery|oncometabolic surgery
180675|NCT03067012|Long limb uncut Roux-en-Y gastrojejunostomy|long limb uncut roux-en-y gastrojejunostomy
180676|NCT03067012|Obesity|obesity
180677|NCT03067012|Diabetes|diabetes
180678|NCT03067012|Early gastric cancer|early gastric cancer
180679|NCT03066986|Venom anaphylaxis|venom anaphylaxis
180680|NCT03066986|Myrmecia piluosa|myrmecia piluosa
180681|NCT03066986|Immunological adjuvant|immunological adjuvant
180682|NCT03066986|Immunotherapy|immunotherapy
180683|NCT03066986|Jack jumper ant|jack jumper ant
180684|NCT03066973|breath exercises|breath exercises
180685|NCT03066973|labor pain|labor pain
180686|NCT03066973|labor duration|labor duration
180687|NCT03066973|VAS|vas
180688|NCT03066960|radiofrequency neurotomy|radiofrequency neurotomy
180689|NCT03066960|zygapophyseal joint|zygapophyseal joint
180690|NCT03066934|Noninvasive Positive Pressure Ventilation|noninvasive positive pressure ventilation
180691|NCT03066934|Nasal high flow|nasal high flow
180692|NCT03066934|Respiratory Failure|respiratory failure
180693|NCT03066934|Childhood|childhood
180694|NCT03066921|Lactic acid bacteria|lactic acid bacteria
180695|NCT03066921|dyslipidemia uremic toxins|dyslipidemia uremic toxins
180696|NCT03066921|Hemodialysis|hemodialysis
180697|NCT03066908|Chronic Rhinosinusitis|chronic rhinosinusitis
180698|NCT03066882|Caloric Restriction|caloric restriction
180699|NCT03066882|Diet|diet
180700|NCT03066882|Obesity|obesity
180701|NCT03066882|Overweight|overweight
180702|NCT03066882|Sedentary Lifestyle|sedentary lifestyle
180703|NCT03066882|Weight loss|weight loss
180704|NCT03066882|Women|women
180705|NCT03066856|BRCA genes|brca genes
180706|NCT03066856|Mutation carriers|mutation carriers
180707|NCT03066856|IGF-I|igf-i
180708|NCT03066856|Diet|diet
180709|NCT03066817|Vitamin D|vitamin d
180710|NCT03066817|Deficiency|deficiency
180711|NCT03066817|Insufficiency|insufficiency
180712|NCT03066817|Bone turnover|bone turnover
180713|NCT03066817|Bone healing|bone healing
180714|NCT03066817|Polytrauma|polytrauma
180715|NCT03066804|Cardiovascular Diseases|cardiovascular diseases
180716|NCT03066804|Heart Failure|heart failure
180717|NCT03066804|Heart failure with Preserved Ejection Fraction|heart failure with preserved ejection fraction
180718|NCT03066804|NT-proBNP|nt-probnp
180719|NCT03066804|6 MWT|6 mwt
180720|NCT03066804|KCCQ|kccq
180721|NCT03066804|SF-36|sf-36
180722|NCT03066804|NYHA Class|nyha class
180723|NCT03066804|LCZ696|lcz696
180724|NCT03066804|Enalapril|enalapril
180725|NCT03066804|Valsartan|valsartan
180726|NCT03066804|Angiotensin-Converting Enzyme Inhibitors (ACEi)|angiotensin-converting enzyme inhibitors (acei)
180727|NCT03066804|Angiotensin II Type 1 Receptor Blockers (ARB)|angiotensin ii type 1 receptor blockers (arb)
180728|NCT03066804|Renin Angiotensin System Inhibitors (RASi)|renin angiotensin system inhibitors (rasi)
180729|NCT03066778|Extensive stage small cell lung cancer (ES-SCLC)|extensive stage small cell lung cancer (es-sclc)
180730|NCT03066778|Programmed cell death protein-1 (PD-1)|programmed cell death protein-1 (pd-1)
180731|NCT03066778|Programmed cell death-ligand 1 (PD-L1)|programmed cell death-ligand 1 (pd-l1)
180732|NCT03066778|PD1|pd1
180733|NCT03066778|PDL1|pdl1
180734|NCT03066726|Biophysical profile|biophysical profile
180735|NCT03066726|Cesarean section|cesarean section
180736|NCT03066726|Estimated fetal weight|estimated fetal weight
180737|NCT03066726|Middle cerebral artery|middle cerebral artery
180738|NCT03066726|Umbilical artery|umbilical artery
180739|NCT03066726|Fetal growth restriction|fetal growth restriction
180740|NCT03066726|Pulsatility index|pulsatility index
180741|NCT03066726|Estimated gestational age|estimated gestational age
180742|NCT03066726|Doppler|doppler
180743|NCT03066648|Acute Myeloid Leukemia|acute myeloid leukemia
180744|NCT03066648|Myelodysplastic syndromes|myelodysplastic syndromes
180745|NCT03066635|Nerve block|nerve block
180746|NCT03066635|Ganglia, Parasympathetic|ganglia, parasympathetic
180747|NCT03066635|Botulinum Toxins, Type A|botulinum toxins, type a
180748|NCT03066635|Injection|injection
180749|NCT03066609|Plaque psoriasis|plaque psoriasis
180750|NCT03066609|Secukinumab|secukinumab
180751|NCT03066609|Skin condition|skin condition
180752|NCT03066609|skin disease|skin disease
180753|NCT03066609|itching|itching
180754|NCT03066609|psoriasis vulgaris|psoriasis vulgaris
180755|NCT03066609|immune-mediated systemic disease|immune-mediated systemic disease
180756|NCT03066609|skin lesions|skin lesions
180757|NCT03066609|scaly patches|scaly patches
180758|NCT03066609|papules|papules
180759|NCT03066609|psoriasis|psoriasis
180760|NCT03066583|meniscus repair|meniscus repair
180761|NCT03066583|platelet rich plasma|platelet rich plasma
180762|NCT03066570|Graded Exposure|graded exposure
180763|NCT03066570|Quality of Life|quality of life
180764|NCT03066570|Physical Activity|physical activity
180765|NCT03066570|Anxiety|anxiety
180766|NCT03066557|Hepatocellular Carcinoma|hepatocellular carcinoma
180767|NCT03066557|Apatinib|apatinib
180768|NCT03066544|migraine|migraine
180769|NCT03066544|responder|responder
180770|NCT03066544|non-responder|non-responder
180771|NCT03066544|treatment|treatment
180772|NCT03066531|ACT|act
180773|NCT03066531|CBT obesity|cbt obesity
180774|NCT03066531|Eating disorders|eating disorders
180775|NCT03066531|Health psychology|health psychology
180776|NCT03066518|melatonin|melatonin
180777|NCT03066518|sleep|sleep
180778|NCT03066518|dementia|dementia
180779|NCT03066518|cognition|cognition
180780|NCT03066492|Tertiary Care Center|tertiary care center
180781|NCT03066492|Patient Readmission|patient readmission
180782|NCT03066492|Health Services Research|health services research
180783|NCT03066492|Hospital Readmissions|hospital readmissions
180784|NCT03066466|Acute Myeloid Leukemia|acute myeloid leukemia
180785|NCT03066466|Acute Lymphocytic Leukemia|acute lymphocytic leukemia
180786|NCT03066466|Myelodysplastic Syndrome|myelodysplastic syndrome
180787|NCT03066466|BMT|bmt
180788|NCT03066466|Matched unrelated donor transplant|matched unrelated donor transplant
180789|NCT03066466|Graft versus Host Disease|graft versus host disease
180790|NCT03066466|GVHD|gvhd
180791|NCT03066453|cystic fibrosis, tobramycin, antibiotic courses, FEV1|cystic fibrosis, tobramycin, antibiotic courses, fev1
180792|NCT03066440|diabetic ketoacidosis|diabetic ketoacidosis
180793|NCT03066440|fluid management|fluid management
180794|NCT03066440|hyperchloremia|hyperchloremia
180795|NCT03066427|Clear Cell Renal Carcinoma|clear cell renal carcinoma
180796|NCT03066427|Sunitinib|sunitinib
180797|NCT03066414|hemochromatosis|hemochromatosis
180798|NCT03066414|blood withdrawal|blood withdrawal
180799|NCT03066414|respiratory variations|respiratory variations
180800|NCT03066414|inferior vena cava|inferior vena cava
180801|NCT03066414|internal jugular vein|internal jugular vein
180802|NCT03066414|ultrasound|ultrasound
180803|NCT03066414|ultrasonography|ultrasonography
180804|NCT03066414|echography|echography
180805|NCT03066401|hyperferritinemia|hyperferritinemia
180806|NCT03066401|dysmetabolic hyperferritinemia|dysmetabolic hyperferritinemia
180807|NCT03066401|obese|obese
180808|NCT03066401|blood withdrawal|blood withdrawal
180809|NCT03066401|respiratory variations|respiratory variations
180810|NCT03066401|inferior vena cava|inferior vena cava
180811|NCT03066401|internal jugular vein|internal jugular vein
180812|NCT03066401|ultrasound|ultrasound
180813|NCT03066401|ultrasonography|ultrasonography
180814|NCT03066401|echography|echography
180815|NCT03066388|fluid|fluid
180816|NCT03066388|fluid responsiveness|fluid responsiveness
180817|NCT03066388|pulse pressure|pulse pressure
180818|NCT03066388|noninvasive monitoring|noninvasive monitoring
180819|NCT03066388|pulse pressure variations|pulse pressure variations
180820|NCT03066388|volume expansion|volume expansion
180821|NCT03066388|SIRS|sirs
180822|NCT03066388|systemic inflammatory response syndrome|systemic inflammatory response syndrome
180823|NCT03066375|vena cava|vena cava
180824|NCT03066375|fluid|fluid
180825|NCT03066375|sepsis|sepsis
180826|NCT03066375|echocardiography|echocardiography
180827|NCT03066375|ultrasound|ultrasound
180828|NCT03066375|ultrasonography|ultrasonography
180829|NCT03066375|collapsibility index|collapsibility index
180830|NCT03066375|circulatory failure|circulatory failure
180831|NCT03066375|irregular cardiac rhythm|irregular cardiac rhythm
180832|NCT03066375|fluid responsiveness|fluid responsiveness
180833|NCT03066375|Spontaneous breathing|spontaneous breathing
180834|NCT03066362|Spontaneous ventilation|spontaneous ventilation
180835|NCT03066323|Blood glucose|blood glucose
180836|NCT03066310|Bladder cancer|bladder cancer
180837|NCT03066310|Urine|urine
180838|NCT03066310|DNA biomarker|dna biomarker
180839|NCT03066310|Diagnosis|diagnosis
180840|NCT03066297|Clinical stage IA non-small cell lung cancer|clinical stage ia non-small cell lung cancer
180841|NCT03066297|Lobectomy|lobectomy
180842|NCT03066297|Segmentectomy|segmentectomy
180843|NCT03066297|Wedge resection|wedge resection
180844|NCT03066297|Sublobar resection|sublobar resection
180845|NCT03066297|Limited resection|limited resection
180846|NCT03066284|Children|children
180847|NCT03066284|Adolescents|adolescents
180848|NCT03066284|Parents|parents
180849|NCT03066284|Insulin Pump Therapy|insulin pump therapy
180850|NCT03066271|Aerobic exercise|aerobic exercise
180851|NCT03066271|Lung Cancer|lung cancer
180852|NCT03066258|nAMD|namd
180853|NCT03066258|wet AMD|wet amd
180854|NCT03066258|gene therapy|gene therapy
180855|NCT03066245|Aneurysmal bone cysts|aneurysmal bone cysts
180856|NCT03066245|PLGA|plga
180857|NCT03066245|Platelet Lysate|platelet lysate
180858|NCT03066245|Bone marrow|bone marrow
180859|NCT03066245|Mesenchymal stem cells|mesenchymal stem cells
180860|NCT03066232|Delirium|delirium
180861|NCT03066232|Dementia|dementia
180862|NCT03066232|Physical function|physical function
180863|NCT03066193|Motor tics|motor tics
180864|NCT03066193|Vocal tics|vocal tics
180865|NCT03066193|Cannabinoids|cannabinoids
180866|NCT03066193|Dronabinol|dronabinol
180867|NCT03066193|PEA|pea
180868|NCT03066193|Palmitoylethanolamide|palmitoylethanolamide
180869|NCT03066193|Tourettes|tourettes
180870|NCT03066193|TS|ts
180871|NCT03066167|Cancer of the gastro-esophageal junction|cancer of the gastro-esophageal junction
180872|NCT03066167|Watson score|watson score
180873|NCT03066167|Ogilvie score|ogilvie score
180874|NCT03066167|Goldschmid score|goldschmid score
180875|NCT03066167|Validation|validation
180876|NCT03066167|Quality of Life|quality of life
180877|NCT03066154|High risk prostate cancer|high risk prostate cancer
180878|NCT03066154|>T2cN+M0|>t2cn+m0
180879|NCT03066128|Task shifting|task shifting
180880|NCT03066128|HIV care|hiv care
231197|NCT02753049|HIV|hiv
180881|NCT03066115|Cerebral blood flow|cerebral blood flow
180882|NCT03066115|Cyclooxygenase|cyclooxygenase
180883|NCT03066115|Nitric oxide synthase|nitric oxide synthase
180884|NCT03066115|Reactive Oxygen Species|reactive oxygen species
180885|NCT03066102|sensorimotor system|sensorimotor system
180886|NCT03066102|scapular joint position sense|scapular joint position sense
180887|NCT03066102|fatigue|fatigue
180888|NCT03066089|FBS,HbA1C, PPBS|fbs,hba1c, ppbs
180889|NCT03066050|Ischemic Mitral Regurgitation|ischemic mitral regurgitation
180890|NCT03066050|Mitral Valve Disease|mitral valve disease
180891|NCT03066050|Moderate Mitral Regurgitation|moderate mitral regurgitation
180892|NCT03066050|Severe Mitral Regurgitation|severe mitral regurgitation
180893|NCT03066037|regional-anaesthesiological infiltration|regional-anaesthesiological infiltration
180894|NCT03066037|block series|block series
180895|NCT03066037|invasive pain treatment|invasive pain treatment
180896|NCT03066011|mold-active triazoles|mold-active triazoles
180897|NCT03065972|kidney disease|kidney disease
180898|NCT03065972|vascular access|vascular access
180899|NCT03065972|graft|graft
180900|NCT03065972|fistula|fistula
180901|NCT03065972|hemodialysis|hemodialysis
180902|NCT03065972|dialysis|dialysis
180903|NCT03065959|CK-2127107|ck-2127107
180904|NCT03065959|Mobility Limitation|mobility limitation
180905|NCT03065959|Phase 1b|phase 1b
180906|NCT03065959|skeletal muscle fatigue|skeletal muscle fatigue
180907|NCT03065946|Therapeutic hypothermia|therapeutic hypothermia
180908|NCT03065946|Electroencephalogram|electroencephalogram
180909|NCT03065946|Neuron-Specific Enolase|neuron-specific enolase
180910|NCT03065946|Return of Spontaneous Circulation|return of spontaneous circulation
180911|NCT03065946|S-100B|s-100b
180912|NCT03065933|mania|mania
180913|NCT03065933|clonidine|clonidine
180914|NCT03065933|bipolar disorder|bipolar disorder
180915|NCT03065894|stratified care|stratified care
180916|NCT03065894|psychologically informed practice|psychologically informed practice
180917|NCT03065894|matched care|matched care
180918|NCT03065868|gastric polyp|gastric polyp
180919|NCT03065868|Helicobacter pylori eradication|helicobacter pylori eradication
180920|NCT03065855|laparoscopic mesorectal excision|laparoscopic mesorectal excision
180921|NCT03065855|rectal cancer|rectal cancer
180922|NCT03065855|urinary distention|urinary distention
180923|NCT03065842|Stigma|stigma
180924|NCT03065842|Pregnancy|pregnancy
180925|NCT03065842|Abortion|abortion
180926|NCT03065842|Contraception|contraception
180927|NCT03065842|Adolescence|adolescence
180928|NCT03065829|caregiver|caregiver
180929|NCT03065829|chronically critically ill|chronically critically ill
180930|NCT03065777|single file.|single file.
180931|NCT03065777|ONE ENDO.|one endo.
180932|NCT03065777|F6 SkyTaper.|f6 skytaper.
180933|NCT03065777|ProTaper Universal.|protaper universal.
180934|NCT03065777|irreversible pulpitis.|irreversible pulpitis.
180935|NCT03065777|postoperative pain.|postoperative pain.
180936|NCT03065764|Pembrolizumab|pembrolizumab
180937|NCT03065764|89Zirconium|89zirconium
180938|NCT03065738|reduction osteotomy|reduction osteotomy
180939|NCT03065738|knee arthroplasty|knee arthroplasty
180940|NCT03065712|Breast Cancer|breast cancer
180941|NCT03065712|PET/CT|pet/ct
180942|NCT03065712|FES|fes
180943|NCT03065712|18F Fluoroestradiol|18f fluoroestradiol
180944|NCT03065712|Breast|breast
180945|NCT03065699|Medical device|medical device
180946|NCT03065699|Liver dialysis|liver dialysis
180947|NCT03065699|Haemofilter|haemofilter
180948|NCT03065699|ACLF|aclf
180949|NCT03065686|Cleft Lip and Palate|cleft lip and palate
180950|NCT03065686|CL/P|cl/p
180951|NCT03065686|WES|wes
180952|NCT03065673|Tooth bleaching|tooth bleaching
180953|NCT03065673|Tooth sensitivity|tooth sensitivity
180954|NCT03065660|Missed miscarriage|missed miscarriage
180955|NCT03065660|Mifepristone|mifepristone
180956|NCT03065660|Misoprostol|misoprostol
180957|NCT03065660|Medical management|medical management
180958|NCT03065647|Out-of-hospital cardiac arrest|out-of-hospital cardiac arrest
180959|NCT03065647|Cardiac Arrest|cardiac arrest
180960|NCT03065647|Heart Arrest|heart arrest
180961|NCT03065647|Sudden Cardiac Arrest|sudden cardiac arrest
180962|NCT03065647|Cardiopulmonary Resuscitation|cardiopulmonary resuscitation
180963|NCT03065647|Extracorporeal Cardiopulmonary Resuscitation|extracorporeal cardiopulmonary resuscitation
180964|NCT03065647|Extracorporeal Membrane Oxygenation|extracorporeal membrane oxygenation
180965|NCT03065647|CPR|cpr
180966|NCT03065647|ECPR|ecpr
180967|NCT03065647|ECMO|ecmo
180968|NCT03065647|Emergency Medical Services|emergency medical services
180969|NCT03065647|EMS|ems
180970|NCT03065647|OHCA|ohca
180971|NCT03065621|Breast|breast
180972|NCT03065595|Ophiocephalus striatus|ophiocephalus striatus
180973|NCT03065595|IGF-1|igf-1
180974|NCT03065595|hypoalbuminemia|hypoalbuminemia
180975|NCT03065595|MNA score|mna score
180976|NCT03065595|elderly|elderly
180977|NCT03065543|Hyperlipidemias|hyperlipidemias
180978|NCT03065543|Secondary prevention|secondary prevention
180979|NCT03065543|high risk patients|high risk patients
180980|NCT03065543|very high risk patients|very high risk patients
180981|NCT03065530|Dexmedetomidine|dexmedetomidine
180982|NCT03065530|Butorphanol tartrate|butorphanol tartrate
180983|NCT03065530|Analgesia|analgesia
180984|NCT03065530|Breastfeeding|breastfeeding
180985|NCT03065530|Relative infant dose|relative infant dose
180986|NCT03065517|Criminal Justice|criminal justice
180987|NCT03065517|Juvenile Delinquency|juvenile delinquency
180988|NCT03065491|Red yeast rice|red yeast rice
180989|NCT03065491|Phytosterols|phytosterols
180990|NCT03065491|L-Tyrosol|l-tyrosol
180991|NCT03065491|Lipids|lipids
180992|NCT03065491|LDL-cholesterol|ldl-cholesterol
180993|NCT03065491|Endothelial function|endothelial function
180994|NCT03065478|Peripheral Neuropathy|peripheral neuropathy
180995|NCT03065478|Chemotherapy induced|chemotherapy induced
180996|NCT03065478|CIPN|cipn
180997|NCT03065465|Upper GI hemorrhage|upper gi hemorrhage
180998|NCT03065465|Stigmata of recent hemorrhage|stigmata of recent hemorrhage
180999|NCT03065465|Diverticular Hemorrhage|diverticular hemorrhage
181000|NCT03065465|Ulcers|ulcers
181001|NCT03065400|Myelofibrosis|myelofibrosis
181002|NCT03065400|Acute Leukemia|acute leukemia
181003|NCT03065361|Chronic Kidney Disease|chronic kidney disease
181004|NCT03065361|Handgrip Strength|handgrip strength
181005|NCT03065361|Fine Motor Skills|fine motor skills
181006|NCT03065361|Sensitivity|sensitivity
181007|NCT03065348|prehabilitation|prehabilitation
181008|NCT03065348|nutrition|nutrition
181009|NCT03065348|hydration|hydration
181010|NCT03065348|cystectomy and urinary diversion|cystectomy and urinary diversion
181011|NCT03065348|regional anesthesia|regional anesthesia
181012|NCT03065348|cognition|cognition
181013|NCT03065335|Magnetic Resonance Imaging|magnetic resonance imaging
181014|NCT03065335|Magnetoencephalography|magnetoencephalography
181015|NCT03065335|Major Depressive Disorder|major depressive disorder
181016|NCT03065335|Ketamine|ketamine
181017|NCT03065335|Neuropharmacology|neuropharmacology
181018|NCT03065322|PCOS|pcos
181019|NCT03065322|OSA|osa
181020|NCT03065296|Behavior|behavior
181021|NCT03065296|education|education
181022|NCT03065296|medical residents|medical residents
181023|NCT03065296|knowledge|knowledge
181024|NCT03065296|confidence|confidence
181025|NCT03065296|skills assessment|skills assessment
181026|NCT03065257|EMR|emr
181027|NCT03065257|ESD|esd
181028|NCT03065257|Resection|resection
181029|NCT03065257|STER|ster
181030|NCT03065257|EFTR|eftr
181031|NCT03065257|Submucosal dissection|submucosal dissection
181032|NCT03065257|Endoscopic resection|endoscopic resection
181033|NCT03065244|Kawasaki disease|kawasaki disease
181034|NCT03065218|Thyroid|thyroid
181035|NCT03065218|sestamibi|sestamibi
181036|NCT03065192|Gene Therapy|gene therapy
181037|NCT03065192|PD|pd
181038|NCT03065192|Parkinson's Disease|parkinson's disease
181039|NCT03065192|Aromatic L- Amino Acid Decarboxylase|aromatic l- amino acid decarboxylase
181040|NCT03065192|AADC|aadc
181041|NCT03065192|AAV2-AADC|aav2-aadc
181042|NCT03065192|AAV2|aav2
181043|NCT03065192|Viral Vector|viral vector
181044|NCT03065192|Gene Transfer|gene transfer
181045|NCT03065192|MRI|mri
181046|NCT03065192|PET|pet
181047|NCT03065192|VY-AADC01|vy-aadc01
181048|NCT03065153|Torso|torso
181049|NCT03065153|Trunk|trunk
181050|NCT03065088|Exercise|exercise
181051|NCT03065088|Feasibility Studies|feasibility studies
181052|NCT03065088|Healthy Lifestyle|healthy lifestyle
181053|NCT03065088|Health Promotion|health promotion
181054|NCT03065088|Health Behavior|health behavior
181055|NCT03065088|Aging|aging
181056|NCT03065088|Activities of Daily Living|activities of daily living
181057|NCT03065088|Mobile Applications|mobile applications
181058|NCT03065062|Lung Cancer Squamous Cell|lung cancer squamous cell
181059|NCT03065062|Head & Neck Cancer|head & neck cancer
181060|NCT03065062|Neoplasms|neoplasms
181061|NCT03065062|Endometrial Cancer|endometrial cancer
181062|NCT03065049|Physical Activity|physical activity
181063|NCT03065049|Peer-facilitation|peer-facilitation
181064|NCT03065049|Methadone Maintenance Therapy|methadone maintenance therapy
181065|NCT03065036|Primary Open Angle Glaucoma|primary open angle glaucoma
181066|NCT03065036|POAG|poag
181067|NCT03065023|Advanced tumor|advanced tumor
181068|NCT03065023|Intratumoral injection|intratumoral injection
181069|NCT03065023|Intralesional injection|intralesional injection
181070|NCT03064997|prebiotic|prebiotic
181071|NCT03064997|pediatric patients|pediatric patients
181072|NCT03064997|health status|health status
181073|NCT03064997|intestine permeability|intestine permeability
181074|NCT03064971|Quitline|quitline
181075|NCT03064971|culturally specific|culturally specific
181076|NCT03064958|glucose regulation|glucose regulation
181077|NCT03064958|lipids|lipids
181078|NCT03064958|Immune markers|immune markers
181079|NCT03064958|Endothelium, Vascular|endothelium, vascular
181080|NCT03064945|Livia TENS|livia tens
181081|NCT03064945|safety and efficacy|safety and efficacy
181082|NCT03064945|menstruating women|menstruating women
181083|NCT03064919|hunger and fullness|hunger and fullness
181084|NCT03064919|regulation of energy intake|regulation of energy intake
181085|NCT03064919|energy compensation|energy compensation
181086|NCT03064919|nutrition knowledge|nutrition knowledge
181087|NCT03064906|T1D, Omnipod|t1d, omnipod
181088|NCT03064880|Thoracic surgery|thoracic surgery
181089|NCT03064880|Fluid responsiveness|fluid responsiveness
181090|NCT03064880|Hemodynamics|hemodynamics
181091|NCT03064880|Oxidative stress|oxidative stress
181092|NCT03064880|Goal-directed fluid therapy|goal-directed fluid therapy
181093|NCT03064867|venetoclax|venetoclax
181094|NCT03064867|rituximab|rituximab
181095|NCT03064867|ifosfamide|ifosfamide
181096|NCT03064867|carboplatin|carboplatin
181097|NCT03064867|etoposide|etoposide
181098|NCT03064854|PDR001|pdr001
181099|NCT03064854|immunotherapy|immunotherapy
181100|NCT03064854|Non-small cell lung cancer|non-small cell lung cancer
181101|NCT03064854|lung|lung
181102|NCT03064854|NSCLC|nsclc
181103|NCT03064802|BioBurst|bioburst
181104|NCT03064802|Spinal Fusion|spinal fusion
181105|NCT03064802|Cellular Allograft|cellular allograft
181106|NCT03064789|Candidiases|candidiases
181107|NCT03064789|Vaginal Infections|vaginal infections
181108|NCT03064776|telemedicine|telemedicine
181109|NCT03064763|Unresectable Stage IIIB-IV Malignant Melanoma|unresectable stage iiib-iv malignant melanoma
181110|NCT03064750|Exercise Therapy|exercise therapy
181111|NCT03064750|Pelvic Floor|pelvic floor
181112|NCT03064750|Preoperative Care|preoperative care
181113|NCT03064724|smoking|smoking
181114|NCT03064724|tobacco use|tobacco use
181115|NCT03064724|Asian|asian
181116|NCT03064724|patients|patients
181117|NCT03064724|provider advice|provider advice
181118|NCT03064724|digital health intervention|digital health intervention
181119|NCT03064685|Pyogenic Liver abscess|pyogenic liver abscess
181120|NCT03064685|Liver transplantation|liver transplantation
181121|NCT03064685|Biliary disease|biliary disease
181122|NCT03064659|Postoperative pulmonary complications|postoperative pulmonary complications
181123|NCT03064659|Driving Pressure|driving pressure
181124|NCT03064659|Limitation of Expiratory Flow|limitation of expiratory flow
181125|NCT03064659|Cardiac Surgery|cardiac surgery
181126|NCT03064659|Cardio-pulmonary bypass|cardio-pulmonary bypass
181127|NCT03064646|ORGAN PRESERVATION|organ preservation
181128|NCT03064646|WATCH AND WAIT|watch and wait
181129|NCT03064646|TRANSANAL ENDOSCOPIC MICROSURGERY|transanal endoscopic microsurgery
181130|NCT03064633|Dexamethasone|dexamethasone
181131|NCT03064633|Dexmedetomidine|dexmedetomidine
181132|NCT03064633|Transversus abdominis plane block|transversus abdominis plane block
181133|NCT03064633|Local anesthetic adjuvants|local anesthetic adjuvants
181134|NCT03064633|postoperative pain|postoperative pain
181135|NCT03064620|PCV effects|pcv effects
181136|NCT03064620|S. pneumoniae carriage|s. pneumoniae carriage
181137|NCT03064620|S. aureus carriage|s. aureus carriage
181138|NCT03064620|Indirect vaccination effects|indirect vaccination effects
181139|NCT03064620|Palestinian-Israeli Collaborative Research (PICR)|palestinian-israeli collaborative research (picr)
181140|NCT03064607|Neonates|neonates
181141|NCT03064607|biomarkers|biomarkers
181142|NCT03064607|EXIT procedure|exit procedure
181143|NCT03064607|Cesarean Section|cesarean section
181144|NCT03064581|Cervical Cancer|cervical cancer
181145|NCT03064581|Screening|screening
181146|NCT03064581|Pap Test|pap test
181147|NCT03064581|Pacific Islander Americans|pacific islander americans
181148|NCT03064568|Myomectomy, Misoprostol, Vasopressin, Blood loss|myomectomy, misoprostol, vasopressin, blood loss
181149|NCT03064555|Renal|renal
181150|NCT03064555|Acute|acute
181151|NCT03064555|Exercise|exercise
181152|NCT03064555|Dialysis|dialysis
181153|NCT03064555|Hemodialysis|hemodialysis
181154|NCT03064555|End stage renal disease|end stage renal disease
181155|NCT03064555|Aerobic|aerobic
181156|NCT03064503|myocardial fibrosis|myocardial fibrosis
181157|NCT03064503|cardiac function|cardiac function
181158|NCT03064503|ageing|ageing
181159|NCT03064477|Unified Protocol|unified protocol
181160|NCT03064477|Transdiagnostic approach|transdiagnostic approach
181161|NCT03064477|Public health|public health
181162|NCT03064464|methicillin-resistant Staphylococcus aureus|methicillin-resistant staphylococcus aureus
181163|NCT03064451|persistent atrial fibrillation - ablation procedure|persistent atrial fibrillation - ablation procedure
181164|NCT03064373|S. aureus|s. aureus
181165|NCT03064373|carriage|carriage
181166|NCT03064373|mother-neonatal transmission|mother-neonatal transmission
181167|NCT03064373|microbiome|microbiome
181168|NCT03064347|Diabetes Mellitus, Type 2|diabetes mellitus, type 2
181169|NCT03064347|Obesity|obesity
181170|NCT03064347|Nutrient|nutrient
181171|NCT03064321|cognitive behavioral treatment|cognitive behavioral treatment
181172|NCT03064308|Frailty|frailty
181173|NCT03064308|Surgery|surgery
181174|NCT03064308|Physical function|physical function
181175|NCT03064308|Cognitive function|cognitive function
181176|NCT03064308|Quality of life|quality of life
181177|NCT03064308|Exercise|exercise
181178|NCT03064308|Rehabilitation|rehabilitation
181179|NCT03064308|Delirium|delirium
181180|NCT03064308|Morbidity|morbidity
181181|NCT03064308|Mortality|mortality
181182|NCT03064308|Length of stay|length of stay
181183|NCT03064308|Well-being|well-being
181184|NCT03064308|Elderly|elderly
181185|NCT03064308|Older surgical patient|older surgical patient
181186|NCT03064308|Radical prostatectomy|radical prostatectomy
181187|NCT03064308|Radical cystectomy|radical cystectomy
181188|NCT03064308|Radical cystoprostatectomy|radical cystoprostatectomy
181189|NCT03064308|Aortic Aneurysm Repair|aortic aneurysm repair
181190|NCT03064308|Major Cavity Surgery|major cavity surgery
181191|NCT03064308|Abdominal Surgery|abdominal surgery
181192|NCT03064308|Recovery|recovery
181193|NCT03064308|Nephrectomy|nephrectomy
181194|NCT03064269|CNS B cell acute lymphocytic leukemia|cns b cell acute lymphocytic leukemia
181195|NCT03064256|Exercisy therapy|exercisy therapy
181196|NCT03064256|Hypertension|hypertension
181197|NCT03064256|Physiopathology|physiopathology
181198|NCT03064256|Heart rate|heart rate
181199|NCT03064256|Nonlinear dynamics|nonlinear dynamics
181200|NCT03064217|Clinical crown lengthening|clinical crown lengthening
181201|NCT03064217|intraoral imaging|intraoral imaging
181202|NCT03064217|Emax crown|emax crown
181203|NCT03064191|intra-canal medications|intra-canal medications
181204|NCT03064178|periodontal therapy|periodontal therapy
181205|NCT03064178|anticipated pain|anticipated pain
181206|NCT03064178|experienced pain|experienced pain
181207|NCT03064178|pain medication use|pain medication use
181208|NCT03064139|physical activity|physical activity
181209|NCT03064139|gait|gait
181210|NCT03064139|biomechanics|biomechanics
181211|NCT03064139|mindfulness|mindfulness
181212|NCT03064126|Artery|artery
181213|NCT03064126|Atherosclerosis|atherosclerosis
181214|NCT03064126|Arterial|arterial
181215|NCT03064126|Peripheral|peripheral
181216|NCT03064126|Plaque|plaque
181217|NCT03064126|Angioplasty|angioplasty
181218|NCT03064126|PTA|pta
181219|NCT03064113|Chronic Obstructive Pulmonary Disease, COPD|chronic obstructive pulmonary disease, copd
181220|NCT03064087|Self-Sampling|self-sampling
181221|NCT03064087|HPV Testing|hpv testing
181222|NCT03064087|Diagnostic Test Accuracy|diagnostic test accuracy
181223|NCT03064087|Cervical Intraepithelial Neoplasia|cervical intraepithelial neoplasia
181224|NCT03064087|Urine|urine
181225|NCT03064087|Cervical Cancer Screening|cervical cancer screening
181226|NCT03064048|Argininosuccinate Lyase Deficiency|argininosuccinate lyase deficiency
181227|NCT03064048|Urea Cycle Disorder|urea cycle disorder
181228|NCT03064022|weight gain|weight gain
181229|NCT03064022|head circumference|head circumference
181230|NCT03064022|length|length
181231|NCT03064022|neurodevelopment|neurodevelopment
181232|NCT03063983|osteosarcoma|osteosarcoma
181233|NCT03063983|metastatic|metastatic
181234|NCT03063983|metronomic therapy|metronomic therapy
181235|NCT03063970|Upper extremity|upper extremity
181236|NCT03063970|Rehabilitation|rehabilitation
181237|NCT03063931|Breast cancer|breast cancer
181238|NCT03063931|Mastectomy|mastectomy
181239|NCT03063931|Pain|pain
181240|NCT03063931|Anxiety and Depression|anxiety and depression
181241|NCT03063931|Cognition|cognition
181242|NCT03063931|Quality of life|quality of life
181243|NCT03063905|Opioid related disorders|opioid related disorders
181244|NCT03063905|Narcotic abuse|narcotic abuse
181245|NCT03063879|hepatitis C|hepatitis c
181246|NCT03063879|renal failure|renal failure
181247|NCT03063879|sofosbuvir|sofosbuvir
181248|NCT03063879|daclatasvir|daclatasvir
181249|NCT03063840|hepatocellular carcinoma|hepatocellular carcinoma
181250|NCT03063840|microwave ablation|microwave ablation
181251|NCT03063840|liver cancer|liver cancer
181252|NCT03063801|Congenital Heart Disease|congenital heart disease
181253|NCT03063801|Blood products transfusion|blood products transfusion
181254|NCT03063762|Renal Cell Carcinoma|renal cell carcinoma
181255|NCT03063762|RO6874281|ro6874281
181256|NCT03063762|Atezolizumab|atezolizumab
181257|NCT03063762|Bevacizumab|bevacizumab
181258|NCT03063723|Chronic Hepatitis C|chronic hepatitis c
181259|NCT03063723|Monocytes|monocytes
181260|NCT03063723|Nk cells|nk cells
181261|NCT03063723|direct-acting antiviral agents|direct-acting antiviral agents
181262|NCT03063697|Carvedilol SR Cap|carvedilol sr cap
181263|NCT03063697|Essential hypertension|essential hypertension
181264|NCT03063697|Chronic stable angina|chronic stable angina
181265|NCT03063697|Congestive heart failure|congestive heart failure
181266|NCT03063671|postmastectomy pain|postmastectomy pain
181267|NCT03063658|Ibuprofen|ibuprofen
181268|NCT03063658|Paracetamol|paracetamol
181269|NCT03063658|Laparoscopic cholecystectomy|laparoscopic cholecystectomy
181270|NCT03063658|Morphine|morphine
181271|NCT03063658|Visual analog scale|visual analog scale
181272|NCT03063645|Healthy volunteer|healthy volunteer
181273|NCT03063645|AC-1202|ac-1202
181274|NCT03063645|AC-SD-01|ac-sd-01
181275|NCT03063645|Pharacokinetic|pharacokinetic
181276|NCT03063645|ketone body|ketone body
181277|NCT03063554|Endoscopy|endoscopy
181278|NCT03063554|Pancreatic Cancer|pancreatic cancer
181279|NCT03063554|Bile duct|bile duct
181280|NCT03063554|Periampullary|periampullary
181281|NCT03063554|ERCP|ercp
181282|NCT03063554|Biliary drainage|biliary drainage
181283|NCT03063554|Biliary obstruction|biliary obstruction
181284|NCT03063554|EUSBD|eusbd
181285|NCT03063554|TEUS|teus
181286|NCT03063554|EUS|eus
181287|NCT03063554|Endoscopic Ultrasound|endoscopic ultrasound
181288|NCT03063528|Pregnancy|pregnancy
181289|NCT03063528|Weight|weight
181290|NCT03063528|Gestational weight gain|gestational weight gain
181291|NCT03063528|Stress reduction|stress reduction
181292|NCT03063528|Exercise|exercise
181293|NCT03063515|Insulin secretion|insulin secretion
181294|NCT03063450|anti PD-L1|anti pd-l1
181295|NCT03063450|nivolumab|nivolumab
181296|NCT03063450|immunotherapy|immunotherapy
181297|NCT03063450|RECIST|recist
181298|NCT03063450|quality of life|quality of life
181299|NCT03063450|survival|survival
181300|NCT03063450|immune checkpoint inhibition|immune checkpoint inhibition
181301|NCT03063437|vancomycin resistant enterococcus|vancomycin resistant enterococcus
181302|NCT03063437|VRE|vre
181303|NCT03063437|decolonization|decolonization
181304|NCT03063437|VRE colonization|vre colonization
181305|NCT03063437|fecal microbiota transplantation|fecal microbiota transplantation
181306|NCT03063437|FMT|fmt
181307|NCT03063437|FMT capsule|fmt capsule
181308|NCT03063437|capsule|capsule
181309|NCT03063437|antimicrobial resistance|antimicrobial resistance
181310|NCT03063437|antibiotic resistance|antibiotic resistance
181311|NCT03063437|MDRO|mdro
181312|NCT03063437|multidrug-resistant organism|multidrug-resistant organism
181313|NCT03063437|OpenBiome|openbiome
181314|NCT03063424|isocapnic voluntary hyperventilation|isocapnic voluntary hyperventilation
181315|NCT03063424|eucapnic voluntary hyperventilation|eucapnic voluntary hyperventilation
181316|NCT03063424|exercise induced bronchoconstriction|exercise induced bronchoconstriction
181317|NCT03063424|exercise challenge cycle ergometer|exercise challenge cycle ergometer
181318|NCT03063411|Maths reasoning|maths reasoning
181319|NCT03063411|Working memory|working memory
181320|NCT03063411|Executive Functions|executive functions
181321|NCT03063411|Cognitive Control|cognitive control
181322|NCT03063411|Academic Skills|academic skills
181323|NCT03063411|Randomised Control Trial|randomised control trial
181324|NCT03063385|Adolescents|adolescents
181325|NCT03063385|Parents|parents
181326|NCT03063385|Web-based|web-based
181327|NCT03063385|Puerto Rico|puerto rico
181328|NCT03063385|Latino|latino
181329|NCT03063385|Sexual communication|sexual communication
181330|NCT03063385|Stigma|stigma
181529|NCT03062176|Lipidomics|lipidomics
181331|NCT03063385|Randomized controlled trial|randomized controlled trial
181332|NCT03063385|STD|std
181333|NCT03063385|Intercourse|intercourse
181334|NCT03063385|Sexual behavior|sexual behavior
181335|NCT03063385|HIV/AIDS|hiv/aids
181336|NCT03063372|Pomegranate|pomegranate
181337|NCT03063372|Burnout|burnout
181338|NCT03063372|Psychological Distress|psychological distress
181339|NCT03063372|Antioxidant|antioxidant
181340|NCT03063359|traumatic pain|traumatic pain
181341|NCT03063359|children|children
181342|NCT03063359|fentanyl|fentanyl
181343|NCT03063359|intranasal use|intranasal use
181344|NCT03063333|spinal cord injury|spinal cord injury
181345|NCT03063333|hypnosis|hypnosis
181346|NCT03063333|pain|pain
181347|NCT03063333|pain catastrophizing|pain catastrophizing
181348|NCT03063333|coping|coping
181349|NCT03063307|Tooth, Deciduous|tooth, deciduous
181350|NCT03063307|Dental Caries|dental caries
181351|NCT03063307|Glass Ionomer Cements|glass ionomer cements
181352|NCT03063307|Dental Atraumatic Restorative Treatment|dental atraumatic restorative treatment
181353|NCT03063307|Cariostatic Agents|cariostatic agents
181354|NCT03063307|Fluorides|fluorides
181355|NCT03063294|Coordination, Administrative|coordination, administrative
181356|NCT03063294|Coaching|coaching
181357|NCT03063294|Primary Care|primary care
181358|NCT03063294|Quality Improvement|quality improvement
181359|NCT03063281|ficolin-2|ficolin-2
181360|NCT03063281|anti-ficolin-2 antibodies|anti-ficolin-2 antibodies
181361|NCT03063281|lupus nephritis|lupus nephritis
181362|NCT03063281|Lupus Erythematosus, Systemic|lupus erythematosus, systemic
181363|NCT03063281|biomarker|biomarker
181364|NCT03063281|ficolin-3|ficolin-3
181365|NCT03063281|anti-ficolin-3 antibodies|anti-ficolin-3 antibodies
181366|NCT03063268|Electronic Consent|electronic consent
181367|NCT03063268|Human Behavior|human behavior
181368|NCT03063268|Bioethics|bioethics
181369|NCT03063268|Research Ethics|research ethics
181370|NCT03063268|Electronic Medical Records (EMR)|electronic medical records (emr)
181371|NCT03063268|Electronic Health Records (EHR)|electronic health records (ehr)
181372|NCT03063268|Informed Consent Form|informed consent form
181373|NCT03063268|Interactive Consent|interactive consent
181374|NCT03063268|Health Record Data|health record data
181375|NCT03063242|Sargramostim|sargramostim
181376|NCT03063229|Insulin Pump Therapy|insulin pump therapy
181377|NCT03063229|Islet Cell Transplant|islet cell transplant
181378|NCT03063229|Energy Expenditure|energy expenditure
181379|NCT03063177|chronic thoracic pain|chronic thoracic pain
181380|NCT03063177|spine stiffness|spine stiffness
181381|NCT03063177|spinal manipulation|spinal manipulation
181382|NCT03063177|spinal manipulative therapy|spinal manipulative therapy
181383|NCT03063164|Femtosecond laser|femtosecond laser
181384|NCT03063164|Visumax|visumax
181385|NCT03063164|Intralase IFS150|intralase ifs150
181386|NCT03063164|LASIK|lasik
181387|NCT03063138|Diabetic foot ulcer|diabetic foot ulcer
181388|NCT03063138|Measurement|measurement
181389|NCT03063138|Wound healing|wound healing
181390|NCT03063138|Measurement device|measurement device
181391|NCT03063138|Three-dimensional measurements|three-dimensional measurements
181392|NCT03063125|radical cystectomy|radical cystectomy
181393|NCT03063125|hypogonadism|hypogonadism
181394|NCT03063008|Lumbar spine; Fusion; Titanium; PEEK|lumbar spine; fusion; titanium; peek
181395|NCT03062930|stroke|stroke
181396|NCT03062930|hemiparesis|hemiparesis
181397|NCT03062930|lesion hemisphere|lesion hemisphere
181398|NCT03062930|ipsilesional deficits|ipsilesional deficits
181399|NCT03062930|contralesional deficits|contralesional deficits
181400|NCT03062930|rehabilitation|rehabilitation
181401|NCT03062930|remediation|remediation
181402|NCT03062930|paretic arm|paretic arm
181403|NCT03062904|healthy|healthy
181404|NCT03062904|respiratory system|respiratory system
181405|NCT03062904|ventilation|ventilation
181406|NCT03062904|paradoxical effect|paradoxical effect
181407|NCT03062904|methacholine|methacholine
181408|NCT03062904|bronchodilator|bronchodilator
181409|NCT03062904|NEP|nep
181410|NCT03062904|EFL|efl
181411|NCT03062865|Rheumatoid arthritis (RA)|rheumatoid arthritis (ra)
181412|NCT03062865|TNF-alpha inhibitors|tnf-alpha inhibitors
181413|NCT03062852|Medication Errors/prevention & control|medication errors/prevention & control
181414|NCT03062852|Nursing Staff, Hospital/organization & administration|nursing staff, hospital/organization & administration
181415|NCT03062852|Drug Therapy/nursing|drug therapy/nursing
181416|NCT03062852|Safety Management|safety management
181417|NCT03062852|Medication Systems, Hospital/organization & administration|medication systems, hospital/organization & administration
181418|NCT03062826|OCT|oct
181419|NCT03062826|STEMI|stemi
181420|NCT03062813|Hepatitis B virus, tacrolimus,membranous nephropathy|hepatitis b virus, tacrolimus,membranous nephropathy
181421|NCT03062800|thalidomide|thalidomide
181422|NCT03062800|pemetrexed|pemetrexed
181423|NCT03062800|nsclc|nsclc
181424|NCT03062800|maintenance treatment|maintenance treatment
181425|NCT03062722|microsurgical treatment|microsurgical treatment
181426|NCT03062722|pain|pain
181427|NCT03062722|dexterity|dexterity
181428|NCT03062722|Phalen sign|phalen sign
181429|NCT03062722|functional status|functional status
181430|NCT03062709|tobacco cessation|tobacco cessation
181431|NCT03062709|bronchiolitis|bronchiolitis
181432|NCT03062709|pneumonia|pneumonia
181433|NCT03062709|pediatric|pediatric
181434|NCT03062709|environmental tobacco smoke|environmental tobacco smoke
181435|NCT03062709|secondhand tobacco smoke|secondhand tobacco smoke
181436|NCT03062709|thirdhand tobacco smoke|thirdhand tobacco smoke
181437|NCT03062709|tobacco smoke|tobacco smoke
181438|NCT03062709|asthma|asthma
181439|NCT03062709|reactive airway disease|reactive airway disease
181440|NCT03062709|bronchopulmonary dysplasia|bronchopulmonary dysplasia
181441|NCT03062683|lactate|lactate
181442|NCT03062683|syncope|syncope
181443|NCT03062644|Open Total or Subtotal Abdominal Hysterectomy|open total or subtotal abdominal hysterectomy
181444|NCT03062631|Congenital Myasthenic Syndrome|congenital myasthenic syndrome
181445|NCT03062631|Lambert-Eaton Myasthenic Syndrome|lambert-eaton myasthenic syndrome
181446|NCT03062631|3,4 DAP|3,4 dap
181447|NCT03062631|3,4 Diaminopyridine|3,4 diaminopyridine
181448|NCT03062592|incretin|incretin
181449|NCT03062592|insulin|insulin
181450|NCT03062592|glucose|glucose
181451|NCT03062592|appetite|appetite
181452|NCT03062592|ghrelin|ghrelin
181453|NCT03062566|biomarkers|biomarkers
181454|NCT03062566|point-of-care analysis|point-of-care analysis
181455|NCT03062540|PTSD|ptsd
181456|NCT03062540|Military-related PTSD|military-related ptsd
181457|NCT03062527|Nutrition|nutrition
181458|NCT03062527|Training support|training support
181459|NCT03062527|Low Glycemic Index|low glycemic index
181460|NCT03062527|Moderate Glycemic Index|moderate glycemic index
181461|NCT03062527|Endurance|endurance
181462|NCT03062527|Running|running
181463|NCT03062449|L-Serine, Alzheimer's Disease, AD, Memory,|l-serine, alzheimer's disease, ad, memory,
181464|NCT03062436|CML, treatment free remission|cml, treatment free remission
181465|NCT03062410|Health Related Quality of Life|health related quality of life
181466|NCT03062410|Routine clinical practice|routine clinical practice
181467|NCT03062410|Electronic Patient Reported Outcome|electronic patient reported outcome
181468|NCT03062410|EORTC QLQ-C30|eortc qlq-c30
181469|NCT03062410|Pazopanib|pazopanib
181470|NCT03062410|Sunitinib|sunitinib
181597|NCT03061591|mutyh mutation|mutyh mutation
181471|NCT03062410|Tyrosine Kinase Inhibitor anti-VEGF|tyrosine kinase inhibitor anti-vegf
181472|NCT03062410|Patient Reported Outcome|patient reported outcome
181473|NCT03062410|Supportive Care|supportive care
181474|NCT03062410|Quality of Life|quality of life
181475|NCT03062384|brain|brain
181476|NCT03062384|health|health
181477|NCT03062358|Programmed Cell Death Receptor 1 (PD-1)|programmed cell death receptor 1 (pd-1)
181478|NCT03062358|Programmed Cell Death Receptor Ligand 1 (PD-L1)|programmed cell death receptor ligand 1 (pd-l1)
181479|NCT03062358|Programmed Cell Death Receptor Ligand 2 (PD-L2)|programmed cell death receptor ligand 2 (pd-l2)
181481|NCT03062358|PD-1|pd-1
181482|NCT03062358|PDL1|pdl1
181483|NCT03062358|PD-L1|pd-l1
181484|NCT03062358|PDL2|pdl2
181485|NCT03062345|Stroke|stroke
181486|NCT03062345|Virtual Reality Therapy|virtual reality therapy
181487|NCT03062345|Rehabilitation|rehabilitation
181488|NCT03062345|Upper Extremity|upper extremity
181489|NCT03062345|Arm|arm
181490|NCT03062345|Telerehabilitation|telerehabilitation
181491|NCT03062319|anticoagulant|anticoagulant
181492|NCT03062319|antiplatelet|antiplatelet
181493|NCT03062306|Cerebral Oxygenation|cerebral oxygenation
181494|NCT03062306|Cardiopulmonary Resuscitation|cardiopulmonary resuscitation
181495|NCT03062306|Chest Compression|chest compression
181496|NCT03062293|Lumbo-pelvic muscles|lumbo-pelvic muscles
181497|NCT03062293|Rehabilitation|rehabilitation
181498|NCT03062293|Exercise|exercise
181499|NCT03062293|Low back pain|low back pain
181500|NCT03062293|Functional Re-adaptive Exercise Device|functional re-adaptive exercise device
181501|NCT03062280|Extension study|extension study
181502|NCT03062267|mhealth|mhealth
181503|NCT03062267|texting intervention|texting intervention
181504|NCT03062267|mobile health|mobile health
181505|NCT03062267|mobile mental health|mobile mental health
181506|NCT03062254|PSMA|psma
181507|NCT03062241|cryoablation|cryoablation
181508|NCT03062241|conventional treatment of heart failure|conventional treatment of heart failure
181509|NCT03062228|stillbirth|stillbirth
181510|NCT03062228|sleep|sleep
181511|NCT03062228|low birth weight|low birth weight
181512|NCT03062228|pregnancy|pregnancy
181513|NCT03062228|supine|supine
181514|NCT03062228|small for gestational age|small for gestational age
181515|NCT03062215|Culturally adapted psychotherapy|culturally adapted psychotherapy
181516|NCT03062215|Internet-delivered treatment|internet-delivered treatment
181517|NCT03062215|Depression|depression
181518|NCT03062215|Latin America|latin america
181519|NCT03062202|Depression|depression
181520|NCT03062202|Anxiety|anxiety
181521|NCT03062202|Online interventions|online interventions
181522|NCT03062202|CBT|cbt
181523|NCT03062202|IAPT|iapt
181524|NCT03062176|Heart failure|heart failure
181525|NCT03062176|End-stage renal disease|end-stage renal disease
181526|NCT03062176|Interleukin-1|interleukin-1
181527|NCT03062176|Interleukin-1 receptor antagonist|interleukin-1 receptor antagonist
181528|NCT03062176|Metabolomics|metabolomics
181530|NCT03062176|Chronic kidney disease|chronic kidney disease
181531|NCT03062137|bronchoscopy|bronchoscopy
181532|NCT03062137|saturation|saturation
181533|NCT03062124|SpyGlass|spyglass
181534|NCT03062124|Pancreatoscopy|pancreatoscopy
181535|NCT03062111|Laser Enucleation of Prostate (LEP)|laser enucleation of prostate (lep)
181536|NCT03062111|Transurethral Resection of Prostate (TURP)|transurethral resection of prostate (turp)
181537|NCT03062072|normoglycemia|normoglycemia
181538|NCT03062072|cancer|cancer
181539|NCT03062072|chemotherapy|chemotherapy
181540|NCT03062072|Hyperglycemia Drug Induced|hyperglycemia drug induced
181541|NCT03062046|Atrial Fibrillation|atrial fibrillation
181542|NCT03062020|Preterm Birth|preterm birth
181543|NCT03062020|Asymptomatic high-risk women|asymptomatic high-risk women
181544|NCT03062020|QUIPP|quipp
181545|NCT03062020|Quantitative fetal fibronectin|quantitative fetal fibronectin
181546|NCT03062020|Cervical length|cervical length
181547|NCT03061968|acupressure|acupressure
181548|NCT03061968|very-low- birth-weight premature|very-low- birth-weight premature
181549|NCT03061968|body weight|body weight
181550|NCT03061968|behavioral state|behavioral state
181551|NCT03061968|developmental status|developmental status
181552|NCT03061903|total hip arthroplasty|total hip arthroplasty
181553|NCT03061903|direct anterior approach|direct anterior approach
181554|NCT03061903|wound complication|wound complication
181555|NCT03061890|children's environmental health|children's environmental health
181556|NCT03061890|prematurity|prematurity
181557|NCT03061890|preterm birth|preterm birth
181558|NCT03061890|phthalates|phthalates
181559|NCT03061890|NICU|nicu
181560|NCT03061890|stress|stress
181561|NCT03061890|lung health|lung health
181562|NCT03061890|neurodevelopment|neurodevelopment
181563|NCT03061890|growth|growth
181564|NCT03061877|Rheumatoid arthritis|rheumatoid arthritis
181565|NCT03061877|Anxiety|anxiety
181566|NCT03061877|Depression|depression
181567|NCT03061825|Aneurysm|aneurysm
181568|NCT03061825|Aortic Aneurysm|aortic aneurysm
181569|NCT03061825|Aortic Aneurysm, Abdominal|aortic aneurysm, abdominal
181570|NCT03061825|Iliac Aneurysm|iliac aneurysm
181571|NCT03061825|Vascular Diseases|vascular diseases
181572|NCT03061825|Cardiovascular Diseases|cardiovascular diseases
181573|NCT03061825|Aortic Diseases|aortic diseases
181574|NCT03061812|Small cell lung cancer (SCLC)|small cell lung cancer (sclc)
181575|NCT03061812|Delta-like protein 3 (DLL3)|delta-like protein 3 (dll3)
181576|NCT03061812|rovalpituzumab tesirine|rovalpituzumab tesirine
181577|NCT03061812|topotecan|topotecan
181578|NCT03061812|metastatic|metastatic
181579|NCT03061760|Prostate cancer|prostate cancer
181580|NCT03061760|Incontinence|incontinence
181581|NCT03061760|Radical prostatectomy|radical prostatectomy
181582|NCT03061760|Urge urinary incontinence|urge urinary incontinence
181583|NCT03061734|Migraine Disorders|migraine disorders
181584|NCT03061734|Headache Disorders|headache disorders
181585|NCT03061734|Migraine with Aura|migraine with aura
181586|NCT03061734|Migraine without Aura|migraine without aura
181587|NCT03061721|NASH|nash
181588|NCT03061721|NAFLD|nafld
181589|NCT03061721|Saroglitazar|saroglitazar
181590|NCT03061669|heart failure|heart failure
181591|NCT03061669|pulmonary hypertension|pulmonary hypertension
181592|NCT03061669|right heart catheterization|right heart catheterization
181593|NCT03061591|Turmeric|turmeric
181594|NCT03061591|Curcumin|curcumin
181595|NCT03061591|colorectal polyps|colorectal polyps
181596|NCT03061591|colorectal neoplasia|colorectal neoplasia
181598|NCT03061591|apc mutation|apc mutation
181599|NCT03061578|Tear Film|tear film
181600|NCT03061578|Hyperspectral imaging|hyperspectral imaging
181601|NCT03061578|Low Humidity Environmental Exposure Chamber|low humidity environmental exposure chamber
181602|NCT03061565|erythropoietin|erythropoietin
181603|NCT03061565|traumatic brain injury|traumatic brain injury
181604|NCT03061539|Immunogenic signature|immunogenic signature
181605|NCT03061513|Parkinson Disease|parkinson disease
181606|NCT03061513|ubiquinol|ubiquinol
181607|NCT03061513|CoQ10|coq10
181608|NCT03061513|magnetic resonance spectroscopy|magnetic resonance spectroscopy
181609|NCT03061513|lactate|lactate
181610|NCT03061513|glutathione|glutathione
181611|NCT03061500|Proadrenomedullin|proadrenomedullin
181612|NCT03061500|Sepsis|sepsis
181613|NCT03061500|Intraabdominal Infections|intraabdominal infections
181614|NCT03061500|prognosis|prognosis
181615|NCT03061474|Mild Cognitive Impairment|mild cognitive impairment
181616|NCT03061474|Alzheimer's Disease|alzheimer's disease
181617|NCT03061474|Nicotinamide|nicotinamide
181618|NCT03061474|Niacinamide|niacinamide
181619|NCT03061474|Niacin|niacin
181620|NCT03061474|Nicotinic Acids|nicotinic acids
181621|NCT03061474|Vitamin|vitamin
181622|NCT03061474|Neurodegenerative Diseases|neurodegenerative diseases
181623|NCT03061474|Tauopathies|tauopathies
181624|NCT03061474|Dementia|dementia
181625|NCT03061461|Extracorporeal shock wave therapy|extracorporeal shock wave therapy
181626|NCT03061461|ESWT|eswt
181627|NCT03061461|Radial extracorporeal shock wave therapy|radial extracorporeal shock wave therapy
181628|NCT03061461|rESWT|reswt
181629|NCT03061461|Diabetes|diabetes
181630|NCT03061435|Vulvar Cancer|vulvar cancer
181631|NCT03061435|Cervical Cancer|cervical cancer
181632|NCT03061435|Vulvar Dysplasia|vulvar dysplasia
181633|NCT03061435|Cervical Dysplasia|cervical dysplasia
181634|NCT03061435|Anal Cancer|anal cancer
181635|NCT03061435|Anal Dysplasia|anal dysplasia
181637|NCT03061357|activity tracker|activity tracker
181638|NCT03061357|behavior change|behavior change
181639|NCT03061318|Fine Needle Aspiration, Genetic Classifier|fine needle aspiration, genetic classifier
181640|NCT03061279|Medial Malleolus fractures|medial malleolus fractures
181641|NCT03061279|headless screws|headless screws
181642|NCT03061279|headed screws|headed screws
181643|NCT03061266|type 2 diabetes mellitus, application, e-health education|type 2 diabetes mellitus, application, e-health education
181644|NCT03061253|Electronic Cigarettes|electronic cigarettes
181645|NCT03061253|Laser Doppler Flowmetry|laser doppler flowmetry
181646|NCT03061253|Ultrasound|ultrasound
181647|NCT03061253|Nicotine Replacement Therapy|nicotine replacement therapy
181648|NCT03061240|Internet of Things|internet of things
181649|NCT03061136|Cognition|cognition
181650|NCT03061136|Gamma oscillations|gamma oscillations
181652|NCT03061136|Executive function|executive function
181653|NCT03061136|Benzodiazepine|benzodiazepine
181654|NCT03061136|GABA|gaba
181655|NCT03061097|Autologous Fecal Microbiota Transplantation|autologous fecal microbiota transplantation
181656|NCT03061084|Spina Bifida, Neurogenic bladder, Myelomeningocele|spina bifida, neurogenic bladder, myelomeningocele
181657|NCT03061071|Positional Sleep Apnea|positional sleep apnea
181658|NCT03061071|Positional Obstructive Sleep Apnea|positional obstructive sleep apnea
181659|NCT03061071|POSA|posa
181660|NCT03061071|OSA|osa
181661|NCT03061071|Obstructive Sleep Apnea|obstructive sleep apnea
181662|NCT03061071|Sleep Apnea|sleep apnea
181663|NCT03061019|child|child
181664|NCT03061019|myofunctional therapy|myofunctional therapy
181665|NCT03061019|adenotonsillectomy|adenotonsillectomy
181666|NCT03061019|randomized controlled trial|randomized controlled trial
181667|NCT03060993|Cannabis|cannabis
181668|NCT03060993|Marijuana|marijuana
181669|NCT03060967|motivation, instrumental tasks, food-related stimuli, size/time discrimination, major depression|motivation, instrumental tasks, food-related stimuli, size/time discrimination, major depression
181670|NCT03060928|Rotator Cuff Tear|rotator cuff tear
181671|NCT03060928|Artelon®|artelon®
232166|NCT02746939|fitness|fitness
181672|NCT03060915|Actigraphy|actigraphy
181673|NCT03060915|Polysomnography|polysomnography
181674|NCT03060915|Obstructive Sleep Apnea|obstructive sleep apnea
181675|NCT03060889|Cesarean section|cesarean section
181676|NCT03060889|placenta previa|placenta previa
181677|NCT03060889|Tranexamic acid|tranexamic acid
181678|NCT03060876|shoulder fractures|shoulder fractures
181679|NCT03060876|humeral fractures|humeral fractures
181680|NCT03060876|operative therapy|operative therapy
181681|NCT03060876|conservative therapy|conservative therapy
181682|NCT03060876|range of motion, articular|range of motion, articular
181683|NCT03060876|quality of life|quality of life
181684|NCT03060876|proximal|proximal
181685|NCT03060863|children|children
181686|NCT03060837|RIRS|rirs
181687|NCT03060837|Kidney Stone|kidney stone
181688|NCT03060837|Single lung ventilation|single lung ventilation
181689|NCT03060837|Simultaneous normal ventilation|simultaneous normal ventilation
181690|NCT03060824|Osmolality|osmolality
181691|NCT03060824|Sodium|sodium
181692|NCT03060824|CABG|cabg
181693|NCT03060824|Cardiovascular Diseases|cardiovascular diseases
181694|NCT03060824|Cardiopulmonary bypass|cardiopulmonary bypass
181695|NCT03060772|Pulmonary Medicine|pulmonary medicine
181696|NCT03060772|Oxidative Stress|oxidative stress
181697|NCT03060772|Pioglitazone|pioglitazone
181698|NCT03060772|Immunology|immunology
181699|NCT03060772|Addictive/Compulsive Behavior|addictive/compulsive behavior
181700|NCT03060759|Multiple Sclerosis|multiple sclerosis
181701|NCT03060759|Relapsing-Remitting Multiple Sclerosis|relapsing-remitting multiple sclerosis
181702|NCT03060759|Fatigue|fatigue
181703|NCT03060759|Light Therapy|light therapy
181704|NCT03060720|Pancreatic Cancer|pancreatic cancer
181705|NCT03060694|Non-alcoholic Fatty Liver Disease|non-alcoholic fatty liver disease
181706|NCT03060694|Diabetes Mellitus, Type 2|diabetes mellitus, type 2
181707|NCT03060668|Critical Illness|critical illness
181708|NCT03060668|Indirect Calorimetry|indirect calorimetry
181709|NCT03060668|Dietary Proteins|dietary proteins
181710|NCT03060655|PLGA-Mg|plga-mg
181711|NCT03060655|fracture|fracture
181712|NCT03060655|fixation|fixation
181713|NCT03060655|union|union
181714|NCT03060642|Microenvironment|microenvironment
181715|NCT03060642|Microbiome|microbiome
181716|NCT03060642|Screening|screening
181717|NCT03060642|Barrett Esophagus|barrett esophagus
181718|NCT03060642|Esophageal Adenocarcinoma|esophageal adenocarcinoma
181719|NCT03060603|Erythropoietin|erythropoietin
181720|NCT03060603|Endometrium|endometrium
181721|NCT03060603|Doppler Ultrasonography|doppler ultrasonography
181722|NCT03060590|sarcopenia, uremic toxins|sarcopenia, uremic toxins
181723|NCT03060564|shoulder|shoulder
181724|NCT03060564|orthopaedics|orthopaedics
181725|NCT03060525|Deaf|deaf
181726|NCT03060525|American Sign Language|american sign language
181727|NCT03060525|Overweight|overweight
181728|NCT03060525|Obese|obese
181729|NCT03060512|Opioid Induced constipation,|opioid induced constipation,
181730|NCT03060512|constipation,|constipation,
181731|NCT03060512|laxative,|laxative,
181732|NCT03060512|bowel movement,|bowel movement,
181733|NCT03060512|Movantik,|movantik,
181734|NCT03060512|Naloxegol|naloxegol
181735|NCT03060499|Thyroidectomy|thyroidectomy
181736|NCT03060499|Myocardial Function|myocardial function
181737|NCT03060499|Thyroid gland|thyroid gland
181738|NCT03060499|Heart|heart
181739|NCT03060473|PPROM|pprom
181740|NCT03060473|Azithromycin|azithromycin
181741|NCT03060473|Erythromycin|erythromycin
181742|NCT03060434|pentoxifylline|pentoxifylline
181743|NCT03060434|Disc hernia|disc hernia
181744|NCT03060434|sciatica|sciatica
181745|NCT03060434|lumbar radiculopathy|lumbar radiculopathy
181746|NCT03060408|Fluid Therapy|fluid therapy
181747|NCT03060408|Laparoscopy|laparoscopy
181748|NCT03060369|Tissue Perfusion|tissue perfusion
181749|NCT03060369|Noninvasive Monitoring|noninvasive monitoring
181750|NCT03060369|Near-infrared spectroscopy|near-infrared spectroscopy
181751|NCT03060369|CareGuide|careguide
181752|NCT03060317|Disorders of consciousness|disorders of consciousness
181753|NCT03060317|validation studies|validation studies
181754|NCT03060317|coma|coma
181755|NCT03060317|vegetative state|vegetative state
181756|NCT03060304|tamoxifen|tamoxifen
181757|NCT03060304|thin endometrium|thin endometrium
181758|NCT03060304|frozen embryo transfer|frozen embryo transfer
181759|NCT03060304|pregnancy rate|pregnancy rate
181760|NCT03060291|Family Check-up|family check-up
181761|NCT03060278|smoking cessation, food pantry|smoking cessation, food pantry
181762|NCT03060265|multimodal analgesia|multimodal analgesia
181763|NCT03060265|paracetamol|paracetamol
181764|NCT03060265|cesarean section|cesarean section
181765|NCT03060252|Drug-Induced Liver Injury|drug-induced liver injury
181766|NCT03060239|Parkinson Disease|parkinson disease
181767|NCT03060239|Near infrared Spectroscopy|near infrared spectroscopy
181768|NCT03060239|REM sleep behaviour disorder|rem sleep behaviour disorder
181769|NCT03060239|Supplementary motor area|supplementary motor area
232284|NCT02745899|asthma|asthma
181770|NCT03060213|Well-Being|well-being
181771|NCT03060213|e-Health|e-health
181772|NCT03060213|Randomized Controlled Trial|randomized controlled trial
181773|NCT03060213|Self-Efficacy|self-efficacy
181774|NCT03060213|Interpersonal well-being|interpersonal well-being
181775|NCT03060213|Community well-being|community well-being
181776|NCT03060213|Occupational well-being|occupational well-being
181777|NCT03060213|Physical well-being|physical well-being
181778|NCT03060213|Psychological well-being|psychological well-being
181779|NCT03060213|Economic well-being|economic well-being
181780|NCT03060200|depression|depression
181781|NCT03060200|treatment|treatment
181782|NCT03060200|CBT|cbt
181783|NCT03060200|online|online
181784|NCT03060200|app|app
181785|NCT03060161|Health promotion|health promotion
181786|NCT03060161|Healthy Diet|healthy diet
181787|NCT03060161|Exercise|exercise
181788|NCT03060148|Heart failure|heart failure
181789|NCT03060148|Spinal cord stimulation|spinal cord stimulation
181790|NCT03060109|Traumatic brain injury|traumatic brain injury
181791|NCT03060109|Head injury|head injury
181792|NCT03060031|Oxytocin|oxytocin
181793|NCT03060005|Sjögren's syndrome|sjögren's syndrome
181794|NCT03060005|meibomian gland dysfunction|meibomian gland dysfunction
181795|NCT03060005|dry eye disease|dry eye disease
181796|NCT03059940|Smoking Cessation|smoking cessation
181797|NCT03059940|Low Dose computed tomography|low dose computed tomography
181798|NCT03059940|LDCT|ldct
181799|NCT03059940|Quitline|quitline
181800|NCT03059940|Questionnaires|questionnaires
181801|NCT03059940|Surveys|surveys
181802|NCT03059940|Counseling|counseling
181803|NCT03059940|Smoking cessation drugs|smoking cessation drugs
181804|NCT03059940|Anti-Smoking Drug|anti-smoking drug
181805|NCT03059940|Nicotine replacement therapy|nicotine replacement therapy
181806|NCT03059940|NRT|nrt
181807|NCT03059940|Nicotine Patch|nicotine patch
181808|NCT03059927|Cruciate retaining|cruciate retaining
181809|NCT03059927|Anterior stabilized|anterior stabilized
181810|NCT03059927|Posterior stabilized|posterior stabilized
181811|NCT03059927|Posterior cruciate ligament|posterior cruciate ligament
181812|NCT03059927|Degenerative knee joint disease|degenerative knee joint disease
181813|NCT03059927|Knee injury and Osteoarthritis Outcome Score|knee injury and osteoarthritis outcome score
181814|NCT03059927|Kinematic radiostereometry|kinematic radiostereometry
181815|NCT03059901|Physical Activity|physical activity
181816|NCT03059901|Latina Women|latina women
181817|NCT03059901|Minority Health|minority health
181818|NCT03059901|Mobile Technology|mobile technology
181819|NCT03059901|Social Support|social support
181820|NCT03059875|Breastcancer|breastcancer
181821|NCT03059875|Standardized Geriatric Evaluation|standardized geriatric evaluation
181822|NCT03059875|Onco-Geriatric Filter|onco-geriatric filter
181823|NCT03059862|immunity|immunity
181824|NCT03059862|Aryl-hydrocarbon receptor|aryl-hydrocarbon receptor
181825|NCT03059862|immune homeostasis|immune homeostasis
181826|NCT03059862|microbiota|microbiota
181827|NCT03059862|tryptophan|tryptophan
181828|NCT03059836|n3 PUFA|n3 pufa
181829|NCT03059823|Solid tumors|solid tumors
181830|NCT03059823|Metastatic cancer|metastatic cancer
181831|NCT03059745|Cholecystitis|cholecystitis
181832|NCT03059745|Cholelithiasis|cholelithiasis
181833|NCT03059732|Gastric cancer|gastric cancer
181834|NCT03059732|Thailand|thailand
181835|NCT03059732|Japan|japan
181836|NCT03059719|safety|safety
181837|NCT03059719|pharmacokinetics|pharmacokinetics
181838|NCT03059719|pharmacodynamics|pharmacodynamics
181839|NCT03059693|Eczema|eczema
181840|NCT03059693|Topical|topical
181841|NCT03059680|Potassium|potassium
181842|NCT03059680|Nutrition|nutrition
181843|NCT03059667|Small Cell Lun cancer|small cell lun cancer
181844|NCT03059667|IFCT|ifct
181845|NCT03059667|immune therapy|immune therapy
181846|NCT03059654|Percutaneous tracheostomy|percutaneous tracheostomy
181847|NCT03059654|surgical tracheostomy|surgical tracheostomy
181848|NCT03059654|airway ultrasound|airway ultrasound
181849|NCT03059654|intensive care|intensive care
181850|NCT03059641|Next Generation Sequencing (NGS)|next generation sequencing (ngs)
181851|NCT03059641|Tyrosine Kinase Inhibitor (TKI)|tyrosine kinase inhibitor (tki)
181852|NCT03059641|liquid biopsy|liquid biopsy
181853|NCT03059641|EGFR Gene mutation|egfr gene mutation
181854|NCT03059589|food anaphylaxis|food anaphylaxis
181855|NCT03059589|peanut anaphylaxis|peanut anaphylaxis
181856|NCT03059589|food oral immunotherapy|food oral immunotherapy
181857|NCT03059589|food allergy|food allergy
181858|NCT03059589|food allergy treatment|food allergy treatment
181859|NCT03059576|Chronobiology|chronobiology
181860|NCT03059576|Circadian rhythms|circadian rhythms
181861|NCT03059576|Heritability|heritability
181862|NCT03059576|Twins|twins
181863|NCT03059563|Varenicline|varenicline
181864|NCT03059563|Positron Emission Tomography|positron emission tomography
181865|NCT03059563|Functional Magnetic Resonance Imaging|functional magnetic resonance imaging
181866|NCT03059563|Methamphetamine Abuse|methamphetamine abuse
181867|NCT03059550|cardiac rehabilitation|cardiac rehabilitation
181868|NCT03059550|prediabetes|prediabetes
181869|NCT03059524|microRNA|microrna
181870|NCT03059498|PECS I and II|pecs i and ii
181871|NCT03059498|PECS blocks|pecs blocks
181872|NCT03059485|Leukemia|leukemia
181873|NCT03059472|physical activity|physical activity
181874|NCT03059472|nutrition|nutrition
181875|NCT03059472|social network|social network
181876|NCT03059472|civic engagement|civic engagement
181877|NCT03059459|Lung Diseases, Obstructive|lung diseases, obstructive
181878|NCT03059459|Air Pollution|air pollution
181879|NCT03059459|Particulate Matter|particulate matter
181880|NCT03059433|Substance use|substance use
181881|NCT03059433|adolescent|adolescent
181882|NCT03059433|health|health
181883|NCT03059433|social network|social network
181884|NCT03059420|CFEOM (Congenital Fibrosis of Extraocular Muscles)|cfeom (congenital fibrosis of extraocular muscles)
181885|NCT03059420|CCDD (Congenital Cranial Dysinnervation Disorders)|ccdd (congenital cranial dysinnervation disorders)
181886|NCT03059420|DRS (Duane Retraction Syndrome)|drs (duane retraction syndrome)
181887|NCT03059420|DRRS (Duane Radial Ray Syndrome)|drrs (duane radial ray syndrome)
181888|NCT03059420|Strabismus|strabismus
181889|NCT03059420|MGJWS (Marcus Gunn Jaw Winking Syndrome)|mgjws (marcus gunn jaw winking syndrome)
181890|NCT03059420|HGP (Horizontal Gaze Palsy)|hgp (horizontal gaze palsy)
181891|NCT03059420|HGPPS (Horizontal Gaze Palsy with Progressive Scoliosis)|hgpps (horizontal gaze palsy with progressive scoliosis)
181892|NCT03059420|Moebius|moebius
181893|NCT03059394|reliability|reliability
181894|NCT03059394|validity|validity
181895|NCT03059394|measurement error|measurement error
181896|NCT03059381|adolescent epilepsy participants|adolescent epilepsy participants
181897|NCT03059381|partial seizures|partial seizures
181898|NCT03059381|primary generalized Tonic-clonic seizures|primary generalized tonic-clonic seizures
181899|NCT03059342|spastic diplegic CP|spastic diplegic cp
181900|NCT03059342|self-care|self-care
181901|NCT03059342|functional mobility|functional mobility
181902|NCT03059342|multilevel surgery|multilevel surgery
181903|NCT03059329|adult epilepsy participants|adult epilepsy participants
181904|NCT03059329|partial seizures|partial seizures
181905|NCT03059329|primary generalized Tonic-clonic seizures|primary generalized tonic-clonic seizures
181906|NCT03059316|controlled hypotension, perfusion|controlled hypotension, perfusion
181907|NCT03059290|post operative pain|post operative pain
181908|NCT03059290|Post operative flare ups|post operative flare ups
181909|NCT03059290|Post endodontic pain|post endodontic pain
181910|NCT03059290|Post endodontic flare ups|post endodontic flare ups
181911|NCT03059290|Necrotic teeth|necrotic teeth
181912|NCT03059290|Non vital teeth|non vital teeth
181913|NCT03059290|Neolix file|neolix file
181914|NCT03059290|Single rotating file|single rotating file
181915|NCT03059290|Protaper next file|protaper next file
181916|NCT03059290|Multiple rotating file|multiple rotating file
181917|NCT03059290|Single visit|single visit
181918|NCT03059277|Diabetic Macular Edema|diabetic macular edema
181919|NCT03059277|Diabetes|diabetes
181920|NCT03059277|reduced treatment frequency|reduced treatment frequency
181921|NCT03059251|CLL, obinutuzumab, treatment|cll, obinutuzumab, treatment
181922|NCT03059238|Pain control|pain control
181924|NCT03059238|Opioids|opioids
181925|NCT03059238|NSAIDs|nsaids
181926|NCT03059225|Stroke|stroke
181927|NCT03059225|Aphasia|aphasia
181928|NCT03059225|rTMS|rtms
181929|NCT03059225|Functional MRI|functional mri
181930|NCT03059225|Speech training|speech training
181931|NCT03059212|working memory|working memory
181932|NCT03059212|parkinson's disease|parkinson's disease
181933|NCT03059199|Prospective/Retrospective|prospective/retrospective
181934|NCT03059173|Polycystic ovary syndrome|polycystic ovary syndrome
181935|NCT03059173|Reproductive medicine|reproductive medicine
181936|NCT03059160|Rett syndrome, Triheptanoic acid, Walking, EEG|rett syndrome, triheptanoic acid, walking, eeg
181937|NCT03059134|Overactive bladder|overactive bladder
181938|NCT03059134|Pharmacotherapy|pharmacotherapy
181939|NCT03059134|Adverse event|adverse event
181940|NCT03059121|HIV|hiv
181941|NCT03059121|Lipodystrophy|lipodystrophy
181942|NCT03059043|Phakic Intraocular Lenses|phakic intraocular lenses
181943|NCT03059043|viscoelastic|viscoelastic
181944|NCT03059030|Thrombocytopenia|thrombocytopenia
181945|NCT03059030|cirrhosis|cirrhosis
181946|NCT03059030|Therasphere®|therasphere®
181947|NCT03059030|Y90|y90
181948|NCT03059030|Radioembolization|radioembolization
181949|NCT03059004|physical therapy|physical therapy
181950|NCT03058965|AD|ad
181951|NCT03058965|HV|hv
181952|NCT03058965|PSP|psp
181953|NCT03058952|pain management|pain management
181954|NCT03058952|fatigue|fatigue
181955|NCT03058952|mindfulness|mindfulness
181956|NCT03058952|Gulf War|gulf war
181957|NCT03058939|Breast Cancer|breast cancer
181958|NCT03058939|Breast Cancer Stage II|breast cancer stage ii
181959|NCT03058939|Breast Cancer Stage III|breast cancer stage iii
181960|NCT03058939|Paclitaxel|paclitaxel
181961|NCT03058939|Taxol|taxol
181962|NCT03058926|Chronic Pancreatitis|chronic pancreatitis
181963|NCT03058926|Diabetes|diabetes
181964|NCT03058926|Pancreatic Cancer|pancreatic cancer
181965|NCT03058926|Data Management|data management
181966|NCT03058926|Protocol compliance|protocol compliance
181967|NCT03058926|Regulatory compliance|regulatory compliance
181968|NCT03058926|Consortium studies|consortium studies
181969|NCT03058900|Fecal Microbiota Transplantation|fecal microbiota transplantation
181970|NCT03058900|FMT|fmt
181971|NCT03058900|Randomized Controlled Trial|randomized controlled trial
181972|NCT03058900|Intestinal microbiome|intestinal microbiome
181974|NCT03058900|Faecal microbiota transplantation|faecal microbiota transplantation
181975|NCT03058887|High Intensity Interval Training|high intensity interval training
181976|NCT03058887|Exercise|exercise
181977|NCT03058887|Microcirculation|microcirculation
181978|NCT03058874|Chronic Kidney Disease|chronic kidney disease
181979|NCT03058874|Hemodialysis|hemodialysis
181980|NCT03058874|Hypertension|hypertension
181981|NCT03058874|Arterial Stifness|arterial stifness
181982|NCT03058874|Ambulatory Blood Pressure Monitoring|ambulatory blood pressure monitoring
181983|NCT03058848|Phenylketonuria|phenylketonuria
181984|NCT03058848|PKU|pku
181985|NCT03058848|Metabolism|metabolism
181986|NCT03058848|Metabolic|metabolic
181987|NCT03058848|Control|control
181988|NCT03058848|Acceptability|acceptability
181989|NCT03058835|HIV|hiv
181990|NCT03058835|Truvada|truvada
181991|NCT03058796|stroke|stroke
181992|NCT03058796|rehabilitation|rehabilitation
181993|NCT03058796|Hemipelegia|hemipelegia
181994|NCT03058770|chronic stroke, sensorimotor retraining|chronic stroke, sensorimotor retraining
181995|NCT03058692|Immunogenicity|immunogenicity
181996|NCT03058692|Influenza Vaccine|influenza vaccine
181997|NCT03058692|M-001 vaccine|m-001 vaccine
181998|NCT03058692|Reactogenicity|reactogenicity
181999|NCT03058692|Safety|safety
182000|NCT03058679|diet|diet
182001|NCT03058679|specific carbohydrate diet|specific carbohydrate diet
182002|NCT03058679|Mediterranean style diet|mediterranean style diet
182003|NCT03058679|randomized controlled trial|randomized controlled trial
182004|NCT03058666|Aerosol|aerosol
182005|NCT03058666|surfactant|surfactant
182006|NCT03058666|calfactant|calfactant
182007|NCT03058666|Infasurf|infasurf
182008|NCT03058666|Respiratory Distress Syndrome|respiratory distress syndrome
182009|NCT03058666|RDS|rds
182010|NCT03058666|Premature|premature
182011|NCT03058666|Neonates|neonates
182012|NCT03058614|Contrast-enhanced ultrasound|contrast-enhanced ultrasound
182013|NCT03058614|Percutaneous nephrolithotomy|percutaneous nephrolithotomy
182014|NCT03058575|Microbiome|microbiome
182015|NCT03058575|Gut|gut
182016|NCT03058575|Skin|skin
182017|NCT03058575|Fiber|fiber
182018|NCT03058575|Starch|starch
182019|NCT03058549|Expectant parents|expectant parents
182020|NCT03058549|Relationship education|relationship education
182021|NCT03058536|twin short cervix pessary progesterone preterm birth|twin short cervix pessary progesterone preterm birth
182022|NCT03058523|Flavour|flavour
182023|NCT03058523|Infants|infants
182024|NCT03058523|Taste|taste
182025|NCT03058523|Pregnancy|pregnancy
182026|NCT03058523|Programming|programming
182027|NCT03058523|Fruit|fruit
182028|NCT03058523|Vegetables|vegetables
182029|NCT03058523|Bitter profile|bitter profile
182030|NCT03058523|Food preferences|food preferences
182031|NCT03058510|bifurcation lesion|bifurcation lesion
182032|NCT03058510|atherectomy|atherectomy
182033|NCT03058510|calcification|calcification
182034|NCT03058510|stent|stent
182035|NCT03058445|Central venous catheter|central venous catheter
182036|NCT03058445|MMode echocardiography|mmode echocardiography
182037|NCT03058406|Sarcoma, Soft Tissue|sarcoma, soft tissue
182038|NCT03058406|Halaven Injection|halaven injection
182039|NCT03058406|E7389|e7389
182040|NCT03058341|postoperative pain|postoperative pain
182041|NCT03058341|propofol|propofol
182042|NCT03058341|TIVA|tiva
182043|NCT03058328|Inflammation/physiopathology, Immune System/immunology,|inflammation/physiopathology, immune system/immunology,
182044|NCT03058328|Neuroimmunomodulation/physiology, General Surgery|neuroimmunomodulation/physiology, general surgery
182045|NCT03058328|Heart Rate/physiology*Vagus Nerve/physiology*|heart rate/physiology*vagus nerve/physiology*
182046|NCT03058315|Physical activity|physical activity
182047|NCT03058315|Disease perception|disease perception
182048|NCT03058315|Pain beliefs|pain beliefs
182049|NCT03058315|Disability|disability
182050|NCT03058315|Advice|advice
182051|NCT03058289|Neoplasm|neoplasm
182052|NCT03058289|Malignancy|malignancy
182053|NCT03058289|Intratumoral|intratumoral
182054|NCT03058289|Intralesional|intralesional
182055|NCT03058289|anti-PD-1 antibodies|anti-pd-1 antibodies
182056|NCT03058289|Immuno therapy|immuno therapy
182057|NCT03058289|Dose escalation|dose escalation
182058|NCT03058289|Platinum|platinum
182059|NCT03058289|Intensity Therapeutics|intensity therapeutics
182060|NCT03058289|INT230-6|int230-6
182061|NCT03058289|Cisplatin|cisplatin
182062|NCT03058289|Vinblastine|vinblastine
182063|NCT03058289|PD-1|pd-1
182064|NCT03058289|Vinca|vinca
182065|NCT03058289|Keytruda|keytruda
182066|NCT03058289|Pembrolizumab|pembrolizumab
182067|NCT03058289|CTLA-4|ctla-4
182068|NCT03058289|Carcinoma|carcinoma
182069|NCT03058276|rTMS|rtms
182070|NCT03058276|AAT|aat
182071|NCT03058276|Alcohol-Dependence|alcohol-dependence
182072|NCT03058276|Relapses|relapses
182073|NCT03058224|Pain, Symptom Severity|pain, symptom severity
182074|NCT03058224|Immunoglobulin IgY|immunoglobulin igy
182075|NCT03058224|Fibromyalgia|fibromyalgia
182076|NCT03058224|Widespread Pain Index|widespread pain index
182077|NCT03058224|Eggyolk|eggyolk
182078|NCT03058224|FIQ-R|fiq-r
182079|NCT03058224|SF-36v2TM|sf-36v2tm
182080|NCT03058224|MOS-SS|mos-ss
182081|NCT03058224|FSS|fss
182082|NCT03058224|PGIC|pgic
182083|NCT03058224|Quality of life|quality of life
182084|NCT03058211|Pneumococcal pneumonia|pneumococcal pneumonia
182085|NCT03058211|Acute cardiovascular events|acute cardiovascular events
182086|NCT03058198|Glioma|glioma
182087|NCT03058198|PET|pet
182088|NCT03058198|EGFR vIII|egfr viii
182089|NCT03058198|Multimodal neuronavigation|multimodal neuronavigation
182090|NCT03058198|Molecular pathology|molecular pathology
182091|NCT03058198|PET-CT|pet-ct
182092|NCT03058198|Neuronavigation|neuronavigation
182093|NCT03058185|Lamin A/C|lamin a/c
182094|NCT03058185|Emerin|emerin
182095|NCT03058146|Exercise|exercise
182096|NCT03058146|Fitness|fitness
182097|NCT03058146|Physical Activity|physical activity
182098|NCT03058146|Cognitive Aging|cognitive aging
182099|NCT03058146|Cerebral Blood Flow|cerebral blood flow
182100|NCT03058146|Brain Imaging|brain imaging
182101|NCT03058146|Unsupervised Intervention|unsupervised intervention
182102|NCT03058146|Mobile Health|mobile health
182103|NCT03058146|Free-living exercise intervention|free-living exercise intervention
182104|NCT03058133|fMRI, perception, face-voice processing|fmri, perception, face-voice processing
182105|NCT03058107|Nutrition Therapy|nutrition therapy
182106|NCT03058081|COPD|copd
182107|NCT03058081|Exercise|exercise
182108|NCT03058081|High Flow Nasal|high flow nasal
182109|NCT03058081|Muscle Oxygenation|muscle oxygenation
182110|NCT03058081|Pulmonary Rehabilitation|pulmonary rehabilitation
182111|NCT03058042|Urinary Incontinence, Stress|urinary incontinence, stress
182112|NCT03058042|Pelvic Floor; Exercise|pelvic floor; exercise
182113|NCT03058042|Physical Therapy Modalities|physical therapy modalities
182114|NCT03058003|balance, postural|balance, postural
182115|NCT03058003|postural equilibrium|postural equilibrium
182116|NCT03058003|chronic pain|chronic pain
182117|NCT03058003|Chronic nonspecific low back pain|chronic nonspecific low back pain
182118|NCT03058003|Fibromyalgia|fibromyalgia
182119|NCT03058003|Cervicogenic headache|cervicogenic headache
182120|NCT03058003|Chronic tension type headache|chronic tension type headache
182121|NCT03058003|Irritable bowel syndrome|irritable bowel syndrome
182122|NCT03058003|Whiplash associated disorder|whiplash associated disorder
182123|NCT03058003|Temporomandibular disorder|temporomandibular disorder
182124|NCT03057990|Pyrimethamine|pyrimethamine
182125|NCT03057990|Myelodysplastic Syndromes (MDS)|myelodysplastic syndromes (mds)
182126|NCT03057990|Refractory|refractory
182127|NCT03057990|Relapsed|relapsed
182128|NCT03057938|Alzheimer|alzheimer
182129|NCT03057938|Subjective Cognitive Decline|subjective cognitive decline
182130|NCT03057938|Florbetaben|florbetaben
182131|NCT03057925|thyroid nodule|thyroid nodule
182132|NCT03057925|microwave ablation|microwave ablation
182133|NCT03057912|Cervical intraepithelial neoplasiaⅠ|cervical intraepithelial neoplasiaⅰ
182134|NCT03057912|TALEN|talen
182135|NCT03057912|CRISPR/Cas9|crispr/cas9
182136|NCT03057899|Herbal medicine|herbal medicine
182137|NCT03057899|phytotherapy|phytotherapy
182138|NCT03057899|testosterone|testosterone
182139|NCT03057873|protein|protein
182140|NCT03057873|fiber|fiber
182141|NCT03057873|weight loss|weight loss
182142|NCT03057873|fat loss|fat loss
182143|NCT03057821|hydrogen peroxide|hydrogen peroxide
182144|NCT03057821|Propionibacterium Acnes|propionibacterium acnes
182145|NCT03057821|shoulder arthroplasty|shoulder arthroplasty
182146|NCT03057808|Pregnancy|pregnancy
182147|NCT03057808|Postpartum|postpartum
182148|NCT03057782|Pain|pain
182149|NCT03057782|Sedation|sedation
182150|NCT03057782|Surgery|surgery
182151|NCT03057769|ERCP, post-ERCP pancreatitis, indomethacin, epinephrine|ercp, post-ercp pancreatitis, indomethacin, epinephrine
182152|NCT03057756|Multi-drug Resistant Tuberculosis|multi-drug resistant tuberculosis
182153|NCT03057756|short course regimen protocol|short course regimen protocol
182154|NCT03057730|acellular dermal matrix|acellular dermal matrix
182155|NCT03057704|Propofol|propofol
182156|NCT03057704|lidocaine|lidocaine
182157|NCT03057704|pain|pain
182158|NCT03057691|Acute Coronary Syndrome|acute coronary syndrome
182159|NCT03057691|Depression|depression
182160|NCT03057691|Anxiety|anxiety
182161|NCT03057691|Percutaneous Coronary Intervention|percutaneous coronary intervention
182162|NCT03057691|Major Adverse Cardiovascular Events|major adverse cardiovascular events
182163|NCT03057613|radiation|radiation
182164|NCT03057613|resected|resected
182165|NCT03057600|African ancestry|african ancestry
182166|NCT03057600|African American|african american
182167|NCT03057600|CB-839|cb-839
182168|NCT03057600|Glutaminase Inhibitor|glutaminase inhibitor
182169|NCT03057600|Glutaminase|glutaminase
182170|NCT03057600|TNBC|tnbc
182171|NCT03057600|Tumor Metabolism|tumor metabolism
182172|NCT03057600|Glutamine|glutamine
182173|NCT03057561|CAD|cad
182174|NCT03057548|Atrial Fibrillation|atrial fibrillation
182175|NCT03057548|Long-Standing Atrial Fibrillation|long-standing atrial fibrillation
182176|NCT03057548|Posterior Left Atrial Wall Ablation|posterior left atrial wall ablation
182177|NCT03057535|Exercise|exercise
182178|NCT03057535|Sodium Bicarbonate|sodium bicarbonate
182179|NCT03057535|Ventilatory equivalent for carbon dioxide|ventilatory equivalent for carbon dioxide
182180|NCT03057522|Run|run
182181|NCT03057522|Cadence|cadence
182182|NCT03057522|Home exercise|home exercise
182183|NCT03057509|Carcinoid Tumors|carcinoid tumors
182184|NCT03057470|Diabetes|diabetes
182185|NCT03057470|Exercise|exercise
182186|NCT03057470|Insulin|insulin
182187|NCT03057444|resistant starch type III|resistant starch type iii
182188|NCT03057444|butyrate-producing gut bacteria|butyrate-producing gut bacteria
182189|NCT03057444|diabetes mellitus type 2|diabetes mellitus type 2
182190|NCT03057444|prediabetes|prediabetes
182191|NCT03057431|kidney stones|kidney stones
182192|NCT03057431|hydrochlorothiazide|hydrochlorothiazide
182193|NCT03057405|intra-operative navigation|intra-operative navigation
182194|NCT03057405|3D virtual planning|3d virtual planning
182195|NCT03057405|intra-operative cone beam computed tomography (CBCT)|intra-operative cone beam computed tomography (cbct)
182196|NCT03057392|immersion|immersion
182197|NCT03057392|ultrafiltration|ultrafiltration
182198|NCT03057392|dialysis|dialysis
182199|NCT03057379|HPV vaccine|hpv vaccine
182200|NCT03057379|Immunization registry|immunization registry
182201|NCT03057379|Reminder recall|reminder recall
182202|NCT03057366|Drug therapy|drug therapy
182203|NCT03057340|Advanced non-small cell lung cancer|advanced non-small cell lung cancer
182204|NCT03057340|Dribbles|dribbles
182205|NCT03057275|Threatened Premature Labor|threatened premature labor
182206|NCT03057275|Abdominal Fetal ECG|abdominal fetal ecg
182207|NCT03057262|temporomandibular joint disorders|temporomandibular joint disorders
182208|NCT03057262|disc displacement with reduction|disc displacement with reduction
182209|NCT03057262|anterior repositioning splint|anterior repositioning splint
182210|NCT03057249|Surgery|surgery
182211|NCT03057249|Thermography|thermography
182212|NCT03057249|Perfusion|perfusion
182213|NCT03057249|Imaging|imaging
182214|NCT03057236|psychological, behavioral, psychosocial, antiviral, liver|psychological, behavioral, psychosocial, antiviral, liver
182215|NCT03057223|3D printing|3d printing
182216|NCT03057223|patient-specific titanium plate|patient-specific titanium plate
182217|NCT03057223|mandibular malignancy|mandibular malignancy
182218|NCT03057223|dento-maxillofacial deformity|dento-maxillofacial deformity
182219|NCT03057223|orthognathic surgery|orthognathic surgery
182220|NCT03057223|mandibular reconstruction|mandibular reconstruction
182221|NCT03057210|Exercise|exercise
182222|NCT03057210|Massage|massage
182223|NCT03057210|Post-exercise recovery|post-exercise recovery
182224|NCT03057210|Athletic performance|athletic performance
182225|NCT03057184|Adult Day Care Center|adult day care center
182226|NCT03057184|behavioral problems|behavioral problems
182227|NCT03057184|caregivers|caregivers
182228|NCT03057171|Helicobacter pylori|helicobacter pylori
182229|NCT03057171|long non-coding RNA|long non-coding rna
182230|NCT03057171|THRIL|thril
182231|NCT03057171|PACER|pacer
182232|NCT03057171|cagA|caga
182233|NCT03057158|OAB|oab
182234|NCT03057158|Insulin resistance|insulin resistance
182235|NCT03057158|diabetes|diabetes
182236|NCT03057158|pre-diabetes|pre-diabetes
182237|NCT03057145|Solid Tumor|solid tumor
182238|NCT03057093|NSTEMI, ECG|nstemi, ecg
182239|NCT03057067|Embolization, Therapeutic|embolization, therapeutic
182240|NCT03057067|Pelvis|pelvis
182241|NCT03056976|Overdenture|overdenture
182242|NCT03056976|Dental implant|dental implant
182243|NCT03056976|Complete denture|complete denture
182244|NCT03056976|Cost analysis|cost analysis
182245|NCT03056963|Guided Imagery|guided imagery
182246|NCT03056950|Blood Flow Restriciton|blood flow restriciton
182247|NCT03056950|Occlusion training|occlusion training
182248|NCT03056950|Distal radius fracture|distal radius fracture
182249|NCT03056911|ozone therapy|ozone therapy
182250|NCT03056911|percutaneous treatment|percutaneous treatment
182251|NCT03056911|Oswestry Disability Index (ODI)|oswestry disability index (odi)
182252|NCT03056911|Visual analog Scale (VAS)|visual analog scale (vas)
182253|NCT03056911|Neuropathic Pain Questionnaire (DN-4)|neuropathic pain questionnaire (dn-4)
182254|NCT03056911|cervical|cervical
182255|NCT03056898|eicosapentaenoic acid|eicosapentaenoic acid
182256|NCT03056898|EPA|epa
182257|NCT03056898|docosahexaenoic acid|docosahexaenoic acid
182258|NCT03056898|DHA|dha
182259|NCT03056898|omega-3 index|omega-3 index
182260|NCT03056885|one-lung ventilation|one-lung ventilation
182261|NCT03056885|broncho-alveolar lavage|broncho-alveolar lavage
182262|NCT03056885|protective ventilation|protective ventilation
182263|NCT03056885|cytokines|cytokines
182264|NCT03056885|thoracic surgery|thoracic surgery
182265|NCT03056859|Operator satisfaction with device|operator satisfaction with device
182266|NCT03056846|probiotic|probiotic
182267|NCT03056846|gastrointestinal|gastrointestinal
182268|NCT03056846|stress|stress
182269|NCT03056846|student|student
182270|NCT03056820|tracheal intubation|tracheal intubation
182271|NCT03056807|tolerable apneic time|tolerable apneic time
182272|NCT03056807|bariatric surgery|bariatric surgery
182273|NCT03056807|gastric band surgery|gastric band surgery
182274|NCT03056807|intubation|intubation
182275|NCT03056794|pyruvate|pyruvate
182276|NCT03056794|pyruvate dehydrogenase|pyruvate dehydrogenase
182277|NCT03056794|PDC|pdc
182278|NCT03056794|PDCD|pdcd
182279|NCT03056755|advanced breast cancer|advanced breast cancer
182280|NCT03056755|PIK3CA|pik3ca
182281|NCT03056755|CDK 4/6 inhibitor|cdk 4/6 inhibitor
182282|NCT03056755|fulvestrant|fulvestrant
182283|NCT03056755|letrozole|letrozole
182284|NCT03056755|HR+|hr+
182285|NCT03056755|HER-negative|her-negative
182286|NCT03056755|post menopausal|post menopausal
182287|NCT03056755|pre-menopausal|pre-menopausal
182288|NCT03056755|aromatase inhibitor|aromatase inhibitor
182289|NCT03056755|endocrine treatment|endocrine treatment
182290|NCT03056755|AI|ai
182291|NCT03056755|ET|et
182292|NCT03056716|thoracic surgery|thoracic surgery
182293|NCT03056716|silastic drains|silastic drains
182294|NCT03056716|conventional drains|conventional drains
182295|NCT03056690|ASP0819|asp0819
182296|NCT03056690|Fibromyalgia|fibromyalgia
182297|NCT03056677|Whey protein|whey protein
182298|NCT03056677|Dietary supplementation|dietary supplementation
182299|NCT03056677|Glucose|glucose
182300|NCT03056677|GLP-1|glp-1
182301|NCT03056677|Satiety|satiety
182302|NCT03056651|heart failure|heart failure
182303|NCT03056651|day care|day care
182304|NCT03056651|prognosis|prognosis
182305|NCT03056638|Androgen Deprivation Therapy|androgen deprivation therapy
182306|NCT03056638|Ultra-Hypofractionated SBRT|ultra-hypofractionated sbrt
182307|NCT03056638|16-1686|16-1686
182308|NCT03056625|fortified rice|fortified rice
182309|NCT03056625|lactating women|lactating women
182310|NCT03056625|13C2-retinol isotope dilution|13c2-retinol isotope dilution
182311|NCT03056625|vitamin A liver store|vitamin a liver store
182312|NCT03056599|in vivo drug sensitivity|in vivo drug sensitivity
182313|NCT03056599|personalized medicine|personalized medicine
182314|NCT03056599|precision oncology|precision oncology
182315|NCT03056599|in vivo oncology|in vivo oncology
182316|NCT03056599|soft tissue sarcoma|soft tissue sarcoma
182317|NCT03056599|chemotherapy|chemotherapy
182318|NCT03056599|microinjection|microinjection
182319|NCT03056599|microdosing|microdosing
182320|NCT03056573|TAVI|tavi
182321|NCT03056573|Valvular heart disease|valvular heart disease
182322|NCT03056573|Transcatheter aortic valve implantation|transcatheter aortic valve implantation
182323|NCT03056534|Primary Total Hip Arthroplasty|primary total hip arthroplasty
182324|NCT03056534|Non-Inflammatory Arthritis|non-inflammatory arthritis
182325|NCT03056534|Degenerative Joint Disease|degenerative joint disease
182326|NCT03056534|R3 Delta Ceramic Acetabular Insert|r3 delta ceramic acetabular insert
182327|NCT03056508|diet|diet
182328|NCT03056508|nutrition|nutrition
182329|NCT03056508|aerobic exercise|aerobic exercise
182330|NCT03056508|cognition|cognition
182331|NCT03056508|grey matter|grey matter
182332|NCT03056508|cerebral blood flow|cerebral blood flow
182333|NCT03056508|neural activity|neural activity
182334|NCT03056508|resting state connectivity|resting state connectivity
182335|NCT03056482|cannabis|cannabis
182336|NCT03056482|haloperidol|haloperidol
182337|NCT03056482|ondansetron|ondansetron
182338|NCT03056482|hyperemesis|hyperemesis
182339|NCT03056482|cyclic vomiting syndrome|cyclic vomiting syndrome
182340|NCT03056469|patient-reported outcomes|patient-reported outcomes
182341|NCT03056469|supportive care|supportive care
182342|NCT03056469|clinical practice|clinical practice
182343|NCT03056469|hematological cancer|hematological cancer
182344|NCT03056430|MRI, Neuroplasticity, Balance, Spatial orientation, Hippocampus, Slacklining|mri, neuroplasticity, balance, spatial orientation, hippocampus, slacklining
182345|NCT03056417|chronic pain|chronic pain
182346|NCT03056417|telomere|telomere
182347|NCT03056417|telomerase|telomerase
182348|NCT03056417|life style|life style
182349|NCT03056391|knowlesi malaria|knowlesi malaria
182350|NCT03056391|paracetamol|paracetamol
182351|NCT03056391|renal function|renal function
182352|NCT03056391|haemolysis|haemolysis
182353|NCT03056391|oxidative stress|oxidative stress
182354|NCT03056365|Detoxification|detoxification
182355|NCT03056365|Outpatient|outpatient
182356|NCT03056365|Advanced Nursing|advanced nursing
182357|NCT03056365|Health Services|health services
182358|NCT03056339|B-Lymphoid Malignancies|b-lymphoid malignancies
182359|NCT03056339|Relapsed/Refractory|relapsed/refractory
182360|NCT03056339|Acute lymphocytic leukemia|acute lymphocytic leukemia
182361|NCT03056339|ALL|all
182362|NCT03056339|Chronic lymphocytic leukemia|chronic lymphocytic leukemia
182363|NCT03056339|CLL|cll
182364|NCT03056339|Non-Hodgkin lymphoma|non-hodgkin lymphoma
182365|NCT03056339|NHL|nhl
182366|NCT03056339|(CAR).CD19-CD28-zeta-2A-iCasp9-IL15-transduced cord blood natural killer cells|(car).cd19-cd28-zeta-2a-icasp9-il15-transduced cord blood natural killer cells
182367|NCT03056339|CB-NK cells|cb-nk cells
182368|NCT03056339|Fludarabine|fludarabine
182369|NCT03056339|Fludarabine phosphate|fludarabine phosphate
182370|NCT03056339|Fludara|fludara
182371|NCT03056339|Cyclophosphamide|cyclophosphamide
182372|NCT03056339|Cytoxan|cytoxan
182373|NCT03056339|Neosar|neosar
182374|NCT03056339|AP1903|ap1903
182375|NCT03056339|Mesna|mesna
182376|NCT03056339|Mesnex|mesnex
182377|NCT03056313|Delivery, Obstetric|delivery, obstetric
182378|NCT03056313|Uterine Contraction|uterine contraction
182379|NCT03056313|Cervix Uteri|cervix uteri
182380|NCT03056274|Metformin|metformin
182381|NCT03056274|Ursodeoxycholic acid|ursodeoxycholic acid
182382|NCT03056274|Outcomes|outcomes
182383|NCT03056261|Combined general-epidural anesthesia intestinal recovery|combined general-epidural anesthesia intestinal recovery
182384|NCT03056235|Atrophic acne scar|atrophic acne scar
182385|NCT03056209|Mitochondrial DNA tRNALeu(UUR) m.3243A<G Mutation|mitochondrial dna trnaleu(uur) m.3243a<g mutation
182386|NCT03056157|Moral Injury|moral injury
182387|NCT03056157|Post-traumatic Stress Disorder|post-traumatic stress disorder
182388|NCT03056157|Traumatic Loss|traumatic loss
182389|NCT03056157|Adaptive Disclosure|adaptive disclosure
182390|NCT03056157|Veterans|veterans
182391|NCT03056144|spinal muscular atrophy|spinal muscular atrophy
182392|NCT03056144|total body vibration|total body vibration
182393|NCT03056144|children|children
182394|NCT03056118|OPTIMA-C|optima-c
182395|NCT03056105|Well-being, affiliation, inflammation|well-being, affiliation, inflammation
182396|NCT03056092|ranibizumab|ranibizumab
182397|NCT03056092|aqueous cytokine|aqueous cytokine
182398|NCT03056092|age related macular degeneration|age related macular degeneration
182399|NCT03056092|diabetic macular edema|diabetic macular edema
182400|NCT03056092|retinal vein occlusion|retinal vein occlusion
182401|NCT03056079|neovascular age related macular degeneration|neovascular age related macular degeneration
182402|NCT03056079|diabetic macular edema|diabetic macular edema
182403|NCT03056079|retinal vein occlusion|retinal vein occlusion
182404|NCT03056079|aflibercept|aflibercept
182405|NCT03056079|aqueous humor cytokine|aqueous humor cytokine
182406|NCT03056053|insomnia|insomnia
182407|NCT03055975|Bacteria|bacteria
182408|NCT03055975|Root canal treatment|root canal treatment
182409|NCT03055975|Endodontics|endodontics
182410|NCT03055962|Healthy Participants|healthy participants
182411|NCT03055962|E2609|e2609
182412|NCT03055962|Pharmacokinetics|pharmacokinetics
182413|NCT03055962|Japan|japan
182414|NCT03055949|early rehabilitation|early rehabilitation
182415|NCT03055949|early mobilization|early mobilization
182416|NCT03055949|surgical intensive care unit|surgical intensive care unit
182417|NCT03055884|transcranial Direct Current Stimulation (tDCS)|transcranial direct current stimulation (tdcs)
182418|NCT03055884|accelerated learning|accelerated learning
182419|NCT03055884|memory|memory
182420|NCT03055871|Behavioural: Family physical activity habit|behavioural: family physical activity habit
182421|NCT03055858|PDA, ADO II AS|pda, ado ii as
182422|NCT03055832|iLux|ilux
182423|NCT03055832|LipiFlow|lipiflow
182424|NCT03055832|dry eye|dry eye
182425|NCT03055832|Meibomian Gland Dysfunction|meibomian gland dysfunction
182426|NCT03055832|evaporative dry eye|evaporative dry eye
182427|NCT03055819|Brow Lift|brow lift
182428|NCT03055819|Brow Ptosis|brow ptosis
182429|NCT03055806|Sex|sex
182430|NCT03055806|Sexual Dysfunction|sexual dysfunction
182431|NCT03055806|IX-01|ix-01
182432|NCT03055741|Alzheimer's disease|alzheimer's disease
182433|NCT03055728|streptococcal infections|streptococcal infections
182434|NCT03055728|rapid strep testing|rapid strep testing
182435|NCT03055728|rapid antigen detection test|rapid antigen detection test
182436|NCT03055715|NSCLC|nsclc
182437|NCT03055715|Radiotherapy|radiotherapy
182438|NCT03055715|young DEGRO|young degro
182439|NCT03055715|tumor volume|tumor volume
182440|NCT03055715|lung cancer|lung cancer
182441|NCT03055715|radiochemotherapy|radiochemotherapy
182442|NCT03055715|prognostic factors|prognostic factors
182443|NCT03055702|Short Message Service|short message service
182444|NCT03055702|appointment reminder|appointment reminder
182445|NCT03055702|Attendance rate|attendance rate
182446|NCT03055689|Colonoscopy|colonoscopy
182447|NCT03055689|Educational intervention|educational intervention
182448|NCT03055676|Pancreaticoduodenectomy|pancreaticoduodenectomy
182449|NCT03055676|Time of drain removal|time of drain removal
182450|NCT03055624|prostate artery embolization (PAE)|prostate artery embolization (pae)
182451|NCT03055624|benign prostatic hyperplasia (BPH)|benign prostatic hyperplasia (bph)
182452|NCT03055624|lower urinary tract symptoms (LUTS)|lower urinary tract symptoms (luts)
182453|NCT03055611|Blood Coagulation Disorder|blood coagulation disorder
182454|NCT03055611|Hematologic Diseases|hematologic diseases
233168|NCT02740634|PCA|pca
182455|NCT03055611|Coagulation Protein Disorder|coagulation protein disorder
182456|NCT03055611|Hemorrhagic Disorder|hemorrhagic disorder
182457|NCT03055611|Genetic Diseases, Inborn|genetic diseases, inborn
182458|NCT03055585|Wolbachia; Ae. aegypti; Indonesia; Dengue; Cluster-randomised trial|wolbachia; ae. aegypti; indonesia; dengue; cluster-randomised trial
182459|NCT03055572|Rhinitis|rhinitis
182460|NCT03055572|Chronic Rhinosinusitis|chronic rhinosinusitis
182461|NCT03055572|Olfactory Training|olfactory training
182462|NCT03055559|Iron, Hemoglobin, Feritin, erytrocyty. transferin|iron, hemoglobin, feritin, erytrocyty. transferin
182463|NCT03055546|oxytocin|oxytocin
182464|NCT03055546|emotion regulation|emotion regulation
182465|NCT03055533|Behavioral|behavioral
182466|NCT03055533|Social|social
182467|NCT03055533|Headsprout reading program|headsprout reading program
182468|NCT03055520|schizophrenia|schizophrenia
182469|NCT03055520|cognition|cognition
182470|NCT03055520|arithmetic training|arithmetic training
182471|NCT03055520|Kumon method|kumon method
182472|NCT03055481|neonatal jaundice|neonatal jaundice
182473|NCT03055481|phototherapy|phototherapy
182474|NCT03055481|neonate|neonate
182475|NCT03055429|Prisoners|prisoners
182476|NCT03055429|End-of-life care|end-of-life care
182477|NCT03055429|Geriatric care|geriatric care
182478|NCT03055429|Palliative care|palliative care
182479|NCT03055429|Hospice care|hospice care
182480|NCT03055416|Overweight|overweight
182481|NCT03055416|Obesity|obesity
182482|NCT03055416|Physical Activity|physical activity
182483|NCT03055416|African-American Men|african-american men
182484|NCT03055416|mHealth|mhealth
182485|NCT03055416|Mobile Health|mobile health
182486|NCT03055390|hyoscine butylbromide|hyoscine butylbromide
182487|NCT03055390|progress of labor|progress of labor
182488|NCT03055390|duration of labor|duration of labor
182489|NCT03055377|cannabis|cannabis
182490|NCT03055377|marijuana|marijuana
182491|NCT03055377|youth|youth
182492|NCT03055377|adolescent|adolescent
182493|NCT03055377|pharmacotherapy|pharmacotherapy
182494|NCT03055377|medication|medication
182495|NCT03055377|n-acetylcysteine|n-acetylcysteine
182496|NCT03055377|trial|trial
182497|NCT03055351|Exercise motivation|exercise motivation
182498|NCT03055351|Psychological well-being|psychological well-being
182499|NCT03055351|Healthy living|healthy living
182500|NCT03055351|Physical activity|physical activity
182501|NCT03055351|Autonomy support|autonomy support
182502|NCT03055351|Self-determination theory|self-determination theory
182503|NCT03055338|Schizophrenia, acute episode|schizophrenia, acute episode
182504|NCT03055338|Schizophrenia Spectrum and Other Psychotic Disorders|schizophrenia spectrum and other psychotic disorders
182505|NCT03055338|Mental Disorders|mental disorders
182506|NCT03055247|Chronic granulomatous disease X-linked|chronic granulomatous disease x-linked
182507|NCT03055247|Ibuprofen|ibuprofen
182508|NCT03055247|Mobilization regimen|mobilization regimen
182509|NCT03055247|Gene Therapy|gene therapy
182510|NCT03055234|Oral treprostinil|oral treprostinil
182511|NCT03055234|6-Minute Walk Distance|6-minute walk distance
182512|NCT03055234|PH|ph
182513|NCT03055234|sickle cell|sickle cell
182514|NCT03055221|Remodulin|remodulin
182515|NCT03055221|6-Minute Walk Test|6-minute walk test
182516|NCT03055208|Glioblastoma|glioblastoma
182517|NCT03055208|Radiosurgery|radiosurgery
182518|NCT03055208|Gamma Knife|gamma knife
182519|NCT03055195|subcutaneous|subcutaneous
182520|NCT03055195|safety|safety
182521|NCT03055195|mepolizumab|mepolizumab
182522|NCT03055195|efficacy|efficacy
182523|NCT03055195|atopic dermatitis|atopic dermatitis
182524|NCT03055182|Isokinetic|isokinetic
182525|NCT03055182|oxygenation|oxygenation
182526|NCT03055182|deoxygenation|deoxygenation
182527|NCT03055182|aerobic metabolism|aerobic metabolism
182528|NCT03055169|hyperglycemia|hyperglycemia
182529|NCT03055169|Multiple Organ Failure|multiple organ failure
182530|NCT03055169|biobank|biobank
182531|NCT03055169|diabetes|diabetes
182532|NCT03055156|Sleep Apnea|sleep apnea
182533|NCT03055156|Insomnia|insomnia
182534|NCT03055156|sleep disorders|sleep disorders
182535|NCT03055156|sleep environment|sleep environment
182536|NCT03055156|core body temperature|core body temperature
182537|NCT03055117|Shoulder pain|shoulder pain
182538|NCT03055117|Physiotherapy|physiotherapy
182539|NCT03055117|Rehabilitation|rehabilitation
182540|NCT03055117|Exercise|exercise
182541|NCT03055104|severe malnutrition|severe malnutrition
182542|NCT03055104|Critically Ill|critically ill
182543|NCT03055104|refeeding syndrome|refeeding syndrome
182544|NCT03055104|guideline|guideline
182545|NCT03055065|Adenoviral conjunctivitis diagnosed with AdenoPlus™ Test|adenoviral conjunctivitis diagnosed with adenoplus™ test
182546|NCT03055000|Mosquito-Borne Diseases|mosquito-borne diseases
182547|NCT03055000|Universal Mosquito Vaccine|universal mosquito vaccine
182548|NCT03055000|Mosquito Transmission|mosquito transmission
182549|NCT03055000|Vector Borne Viruses|vector borne viruses
182550|NCT03055000|Vaccine|vaccine
182551|NCT03054974|Stroke|stroke
182552|NCT03054974|Traditional Chinese Medicine|traditional chinese medicine
182553|NCT03054974|Rehabilitation|rehabilitation
182554|NCT03054961|epilepsy|epilepsy
182555|NCT03054961|cytochrome oxidase redox state|cytochrome oxidase redox state
182556|NCT03054961|childhood epilepsy|childhood epilepsy
182557|NCT03054961|partial epilepsy|partial epilepsy
182558|NCT03054961|NIRS|nirs
182559|NCT03054961|near-infrared spectroscopy|near-infrared spectroscopy
182560|NCT03054961|regional cerebral oxygen saturation|regional cerebral oxygen saturation
182561|NCT03054935|Energy Expenditure|energy expenditure
182562|NCT03054935|Body Composition|body composition
182563|NCT03054935|Food Intake|food intake
182564|NCT03054896|Richter Syndrome|richter syndrome
182565|NCT03054883|Mantle Cell Lymphoma|mantle cell lymphoma
182566|NCT03054883|minimal residual disease|minimal residual disease
182567|NCT03054883|cytosine arabinoside|cytosine arabinoside
182568|NCT03054870|pulmonary ventilation|pulmonary ventilation
182569|NCT03054870|ventilation scintigraphy|ventilation scintigraphy
182570|NCT03054844|Intranasal|intranasal
182571|NCT03054844|Pain|pain
182572|NCT03054844|Lidocaine|lidocaine
182573|NCT03054844|Midazolam|midazolam
182574|NCT03054844|Emergency department|emergency department
182575|NCT03054766|Laser Photocoagulation|laser photocoagulation
182576|NCT03054766|Ranibizumab|ranibizumab
182577|NCT03054766|Branch Retinal Vein Occlusion|branch retinal vein occlusion
182578|NCT03054766|Vascular Endothecial Growth Factor|vascular endothecial growth factor
182579|NCT03054753|Abduction brace|abduction brace
182580|NCT03054753|Compliance|compliance
182581|NCT03054753|Rotator cuff tear|rotator cuff tear
182582|NCT03054753|Rotator cuff repair|rotator cuff repair
182583|NCT03054740|Vapocoolant applied prior to IV access|vapocoolant applied prior to iv access
182584|NCT03054727|Post Thrombotic Syndrome|post thrombotic syndrome
182585|NCT03054727|Venous Thromboembolism|venous thromboembolism
182586|NCT03054727|Incidence|incidence
182587|NCT03054727|Risk factors|risk factors
182588|NCT03054727|Venous ulcer|venous ulcer
182589|NCT03054701|Patellofemoral pain|patellofemoral pain
182591|NCT03054701|PFPS|pfps
182592|NCT03054675|lung resection|lung resection
182593|NCT03054675|lung function|lung function
182594|NCT03054675|VATS|vats
182595|NCT03054675|Thoracotomy|thoracotomy
182596|NCT03054662|Haemophilia|haemophilia
182597|NCT03054610|plantar fascitis|plantar fascitis
182598|NCT03054610|Botulinum toxin A|botulinum toxin a
182599|NCT03054610|Betamethason Sodium Phosphate|betamethason sodium phosphate
182600|NCT03054610|infiltration|infiltration
182601|NCT03054610|plantar fascia|plantar fascia
182602|NCT03054558|Junctional zone|junctional zone
182603|NCT03054558|recurrent pregnancy loss|recurrent pregnancy loss
182604|NCT03054558|3D power Doppler|3d power doppler
182605|NCT03054480|Fractional Micro-Needle Radiofrequency|fractional micro-needle radiofrequency
182606|NCT03054480|Intradermal Botulinum Toxin A|intradermal botulinum toxin a
182607|NCT03054441|Upper limb|upper limb
182608|NCT03054441|Inertial sensors|inertial sensors
182609|NCT03054415|neuronal-glial-epithelial unit, anorectal function|neuronal-glial-epithelial unit, anorectal function
182610|NCT03054376|Immobilization|immobilization
182611|NCT03054376|Angiogenesis|angiogenesis
182612|NCT03054376|Skeletal muscle|skeletal muscle
182613|NCT03054376|Exercise training|exercise training
182614|NCT03054376|Vascular function|vascular function
182615|NCT03054363|Metastatic Breast Cancer|metastatic breast cancer
182616|NCT03054363|Tucatinib|tucatinib
182617|NCT03054363|Palbociclib|palbociclib
182618|NCT03054363|Letrozole|letrozole
182619|NCT03054363|HR-positive|hr-positive
182620|NCT03054363|HER2-positive|her2-positive
182621|NCT03054363|ER-positive|er-positive
182622|NCT03054363|PR-positive|pr-positive
182623|NCT03054363|HER2-targeted therapy|her2-targeted therapy
182624|NCT03054363|CDK4/6 inhibitor|cdk4/6 inhibitor
182625|NCT03054363|ONT-380|ont-380
182626|NCT03054363|Ibrance|ibrance
182627|NCT03054350|Anemia|anemia
182628|NCT03054350|kidney|kidney
182629|NCT03054350|dialysis dependent chronic kidney disease|dialysis dependent chronic kidney disease
182630|NCT03054350|CKD|ckd
182631|NCT03054350|DD|dd
182632|NCT03054350|renal|renal
182633|NCT03054350|vadadustat|vadadustat
182634|NCT03054350|AKB-6548|akb-6548
182635|NCT03054350|hypoxia-inducible factor|hypoxia-inducible factor
182636|NCT03054350|Akebia (AKB)|akebia (akb)
182637|NCT03054350|hypoxia-inducible factor (HIF)|hypoxia-inducible factor (hif)
182638|NCT03054350|HIF|hif
182639|NCT03054350|prolyl-hydroxylase inhibitor (PHI)|prolyl-hydroxylase inhibitor (phi)
182640|NCT03054350|PHI|phi
182641|NCT03054350|Japan|japan
182642|NCT03054350|Japanese|japanese
182643|NCT03054337|Anemia|anemia
182644|NCT03054337|kidney|kidney
182645|NCT03054337|non-dialysis dependent chronic kidney disease|non-dialysis dependent chronic kidney disease
182646|NCT03054337|CKD|ckd
182647|NCT03054337|NDD-CKD|ndd-ckd
182648|NCT03054337|renal|renal
182649|NCT03054337|vadadustat|vadadustat
182650|NCT03054337|AKB-6548|akb-6548
182651|NCT03054337|hypoxia-inducible factor|hypoxia-inducible factor
182652|NCT03054337|hypoxia-inducible factor (HIF)|hypoxia-inducible factor (hif)
182653|NCT03054337|HIF|hif
182654|NCT03054337|prolyl-hydroxylase inhibitor (PHI)|prolyl-hydroxylase inhibitor (phi)
182655|NCT03054337|PHI|phi
182656|NCT03054337|Japan|japan
182657|NCT03054337|Japanese|japanese
182658|NCT03054337|Akebia (AKB)|akebia (akb)
182659|NCT03054324|Cardiovascular Diseases|cardiovascular diseases
182660|NCT03054324|Fractional Flow Reserve|fractional flow reserve
182661|NCT03054324|Ischemic Heart Disease|ischemic heart disease
182662|NCT03054324|CT Angiogram|ct angiogram
182663|NCT03054285|Seizures|seizures
182664|NCT03054285|Traumatic Brain Injury|traumatic brain injury
182665|NCT03054285|Prophylaxis|prophylaxis
182666|NCT03054285|Levetiracetam|levetiracetam
182667|NCT03054272|High-fidelity simulation|high-fidelity simulation
182668|NCT03054272|Eye-tracking|eye-tracking
182669|NCT03054272|Difficult intubation|difficult intubation
182670|NCT03054233|spinal anesthesia|spinal anesthesia
182671|NCT03054233|spinal-bone contact|spinal-bone contact
182672|NCT03054233|caesarian section|caesarian section
182673|NCT03054233|crossed leg sitting position|crossed leg sitting position
182674|NCT03054194|Healthy participants|healthy participants
182675|NCT03054194|E2730|e2730
182676|NCT03054194|Pharmacokinetics|pharmacokinetics
182677|NCT03054181|Observational|observational
182678|NCT03054181|Infection|infection
182679|NCT03054181|Utilisation|utilisation
182680|NCT03054181|Safety|safety
182681|NCT03054181|Tolerability|tolerability
182682|NCT03054181|Infusion|infusion
182683|NCT03054181|chronic|chronic
182684|NCT03054168|Protein Synthesis|protein synthesis
182685|NCT03054168|Hypertrophy|hypertrophy
182686|NCT03054168|Testosterone|testosterone
182687|NCT03054155|hidradenitis suppurativa|hidradenitis suppurativa
182688|NCT03054155|hidradenitis|hidradenitis
182689|NCT03054155|laser|laser
182690|NCT03054103|ketamine|ketamine
182691|NCT03054103|midazolam|midazolam
182692|NCT03054103|sedation|sedation
182693|NCT03054090|Cardiovascular Diseases|cardiovascular diseases
182694|NCT03054090|Primary Care|primary care
182695|NCT03054077|pre-procedural anxiety|pre-procedural anxiety
182696|NCT03054077|children|children
182697|NCT03054077|pediatric sedation|pediatric sedation
182698|NCT03054051|HIV prevention|hiv prevention
182699|NCT03054051|Preadolescence|preadolescence
182700|NCT03054051|Mobile phone game|mobile phone game
182701|NCT03054051|Feasibility|feasibility
182702|NCT03054012|CAD-CAM software|cad-cam software
182703|NCT03054012|accuracy|accuracy
182704|NCT03054012|head and neck region|head and neck region
182705|NCT03054012|mandibular reconstruction|mandibular reconstruction
182706|NCT03053999|Multiple Endocrine Neoplasia|multiple endocrine neoplasia
182707|NCT03053999|Pancreatic Neuroendocrine Tumors|pancreatic neuroendocrine tumors
182708|NCT03053999|Hyperparathyroidism|hyperparathyroidism
182709|NCT03053999|HPTH|hpth
182710|NCT03053999|PNET|pnet
182711|NCT03053999|Biomarkers|biomarkers
182712|NCT03053999|Parathyroidectomy|parathyroidectomy
182713|NCT03053999|Genome sequencing|genome sequencing
182714|NCT03053999|Data review|data review
182715|NCT03053973|COPD|copd
182716|NCT03053973|airway inflammation|airway inflammation
182717|NCT03053973|airway remodeling|airway remodeling
182718|NCT03053973|health-related auality of life|health-related auality of life
182719|NCT03053973|forced expiratory volume 1 second|forced expiratory volume 1 second
182720|NCT03053947|Intranasal Ketamine|intranasal ketamine
182721|NCT03053947|Pain Management|pain management
182722|NCT03053934|Online counselling|online counselling
182723|NCT03053921|gingival recession|gingival recession
182724|NCT03053921|Zuchellis technique,|zuchellis technique,
182725|NCT03053921|placental membrane|placental membrane
182726|NCT03053908|Orexin|orexin
182727|NCT03053908|Core Body Temperature|core body temperature
182728|NCT03053882|mouth wash , green tea , peppermint , bad breath|mouth wash , green tea , peppermint , bad breath
182729|NCT03053856|stage IIIA non-small cell lung cancer|stage iiia non-small cell lung cancer
182730|NCT03053856|Adjuvant pembrolizumab|adjuvant pembrolizumab
182731|NCT03053843|Atrial fibrillation|atrial fibrillation
182732|NCT03053843|Mediterranean Diet|mediterranean diet
182733|NCT03053843|Extra Virgin Olive Oil|extra virgin olive oil
182734|NCT03053843|Ablation|ablation
182735|NCT03053830|Ketamine|ketamine
182736|NCT03053830|Major Depressive Disorder|major depressive disorder
182737|NCT03053804|MR/PET|mr/pet
182738|NCT03053804|Non-small cell lung cancer (NSCLC)|non-small cell lung cancer (nsclc)
182739|NCT03053791|Deep brain stimulation|deep brain stimulation
182740|NCT03053791|DBS|dbs
182741|NCT03053791|Spinal cord injury|spinal cord injury
182742|NCT03053791|SCI|sci
182743|NCT03053791|Paraplegia|paraplegia
182744|NCT03053791|Mesencephalic locomotor region|mesencephalic locomotor region
182745|NCT03053791|MLR|mlr
182746|NCT03053791|Pedunculopontine nucleus|pedunculopontine nucleus
182747|NCT03053791|PPN|ppn
182748|NCT03053778|Readmission|readmission
182749|NCT03053778|Early follow-up|early follow-up
182750|NCT03053778|Heart valves|heart valves
182751|NCT03053778|Heart valve surgery|heart valve surgery
182752|NCT03053739|Systemic sclerosis, Associated Pulmonary Arterial Hypertension|systemic sclerosis, associated pulmonary arterial hypertension
182753|NCT03053726|Variable Frequency Stimulation|variable frequency stimulation
182754|NCT03053713|Mediterranean diet pattern|mediterranean diet pattern
182755|NCT03053713|nutrition|nutrition
182756|NCT03053713|diet intervention|diet intervention
182757|NCT03053713|disease activity|disease activity
182758|NCT03053713|intestinal microbiome|intestinal microbiome
182759|NCT03053713|inflammatory bowel disease|inflammatory bowel disease
182760|NCT03053700|Rosacea, Bromonidine, intensed pulse light|rosacea, bromonidine, intensed pulse light
182761|NCT03053661|Head and Neck Squamous Cell Carcinoma|head and neck squamous cell carcinoma
182762|NCT03053661|cancer-specific immunity|cancer-specific immunity
182763|NCT03053661|cancer immunology|cancer immunology
182764|NCT03053661|cancer-testis antigens|cancer-testis antigens
182765|NCT03053661|human papilloma virus|human papilloma virus
182766|NCT03053661|immune modulatory cells|immune modulatory cells
182767|NCT03053648|Insomnia|insomnia
182768|NCT03053648|Randomized controlled trial|randomized controlled trial
182769|NCT03053648|Acupressure|acupressure
182770|NCT03053648|Self-help|self-help
182771|NCT03053635|Photodynamic Therapy|photodynamic therapy
182772|NCT03053635|Non-muscle invasive bladder cancer (NMIBC)|non-muscle invasive bladder cancer (nmibc)
182773|NCT03053635|Urothelial carcinoma|urothelial carcinoma
182774|NCT03053635|Ta bladder cancer|ta bladder cancer
182775|NCT03053635|T1 bladder cancer|t1 bladder cancer
182776|NCT03053635|Refractory to BCG|refractory to bcg
182777|NCT03053609|gastroesophageal reflux|gastroesophageal reflux
182778|NCT03053609|apnea|apnea
182779|NCT03053609|bradycardia|bradycardia
182780|NCT03053609|desaturation|desaturation
182781|NCT03053609|impedance|impedance
182782|NCT03053596|HCC|hcc
182783|NCT03053596|LifePearl|lifepearl
182784|NCT03053583|larynx, laryngoscopy|larynx, laryngoscopy
182785|NCT03053583|vocal cords, laryngoscopy|vocal cords, laryngoscopy
182786|NCT03053583|airway|airway
182787|NCT03053583|pediatric|pediatric
182788|NCT03053570|Cryoballoon|cryoballoon
182789|NCT03053570|Contact Force|contact force
182790|NCT03053570|Persistent Atrial Fibrillation|persistent atrial fibrillation
182791|NCT03053557|mental health consumers|mental health consumers
182792|NCT03053544|rectal cancer|rectal cancer
182793|NCT03053544|adenocarcinoma of the rectum|adenocarcinoma of the rectum
182794|NCT03053544|node positive rectal tumors|node positive rectal tumors
182795|NCT03053544|metformin|metformin
182796|NCT03053544|neoadjuvant chemoradiation|neoadjuvant chemoradiation
182797|NCT03053518|Type 2 Diabetes|type 2 diabetes
182798|NCT03053518|Hyperglycemia|hyperglycemia
182799|NCT03053518|Personal Nutrition Project|personal nutrition project
182800|NCT03053505|fecal microbiota transplantation (FMT)|fecal microbiota transplantation (fmt)
182801|NCT03053505|Clostridium difficile infection|clostridium difficile infection
182802|NCT03053505|gut flora|gut flora
182803|NCT03053505|human microbiome|human microbiome
182804|NCT03053505|colitis|colitis
182805|NCT03053492|Video Games|video games
182806|NCT03053479|surgery|surgery
182807|NCT03053479|native tissue prolapse repair|native tissue prolapse repair
182808|NCT03053479|laparoscopic sacrocolpopexy|laparoscopic sacrocolpopexy
182809|NCT03053479|vaginal mesh|vaginal mesh
182810|NCT03053466|Advanced Solid Tumor|advanced solid tumor
182811|NCT03053466|Relapsed Solid Tumor|relapsed solid tumor
182812|NCT03053466|Recurrent Solid Tumor|recurrent solid tumor
182813|NCT03053453|Total Knee Replacement Arthroplasty|total knee replacement arthroplasty
182814|NCT03053427|Restless Legs Syndrome|restless legs syndrome
182815|NCT03053427|ASP8825|asp8825
182816|NCT03053427|Gabapentin enacarbil|gabapentin enacarbil
182817|NCT03053401|Quadriceps muscle strength|quadriceps muscle strength
182818|NCT03053401|Anterior cruciate ligament reconstruction|anterior cruciate ligament reconstruction
182819|NCT03053401|Femoral nerve block|femoral nerve block
182820|NCT03053401|Adductor Canal block|adductor canal block
182821|NCT03053401|Saphenous nerve block in the Adductor Canal|saphenous nerve block in the adductor canal
182822|NCT03053401|Pediatrics|pediatrics
182823|NCT03053401|Postoperative analgesia|postoperative analgesia
182824|NCT03053401|Ultrasound guided nerve block|ultrasound guided nerve block
182825|NCT03053323|Preconception|preconception
182826|NCT03053323|Pregnancy|pregnancy
182827|NCT03053323|Lifestyle|lifestyle
182828|NCT03053310|surgery|surgery
182829|NCT03053310|curative intent|curative intent
182830|NCT03053310|geriatric assessment|geriatric assessment
182831|NCT03053310|30-day postoperative morbidity|30-day postoperative morbidity
182832|NCT03053297|EGFR|egfr
182833|NCT03053297|EGFR mutation|egfr mutation
182834|NCT03053297|EGFRm|egfrm
182835|NCT03053297|EGFR-TKI|egfr-tki
182836|NCT03053297|Health care resource utilization|health care resource utilization
182837|NCT03053297|Health-Related Quality of Life|health-related quality of life
182838|NCT03053297|Locally advanced or metastatic lung cancer|locally advanced or metastatic lung cancer
182839|NCT03053297|NSCLC|nsclc
182840|NCT03053297|Non-Small Cell Lung Cancer|non-small cell lung cancer
233661|NCT02737358|tobacco|tobacco
182841|NCT03053297|Observational study|observational study
182842|NCT03053297|Osimertinib|osimertinib
182843|NCT03053297|Personalized medicine|personalized medicine
182844|NCT03053297|PRO|pro
182970|NCT03052335|colon capsule|colon capsule
182845|NCT03053297|Patient Reported Outcome|patient reported outcome
182846|NCT03053297|Resistance|resistance
182847|NCT03053297|T790M|t790m
182848|NCT03053297|Carcinoma, Non-Small-Cell Lung|carcinoma, non-small-cell lung
182849|NCT03053297|Carcinoma, Bronchogenic|carcinoma, bronchogenic
182850|NCT03053297|Bronchial Neoplasms|bronchial neoplasms
182851|NCT03053297|Lung Neoplasms|lung neoplasms
182852|NCT03053297|Respiratory Tract Neoplasms|respiratory tract neoplasms
182853|NCT03053297|Thoracic neoplasms, Neoplasms by site|thoracic neoplasms, neoplasms by site
182854|NCT03053297|Lung diseases|lung diseases
182855|NCT03053297|Respiratory Tract diseases|respiratory tract diseases
182856|NCT03053297|Cancer Chemotherapy|cancer chemotherapy
182857|NCT03053297|Combination Chemotherapy|combination chemotherapy
182858|NCT03053297|Immunotherapy|immunotherapy
182859|NCT03053297|Radiation|radiation
182860|NCT03053271|Endogenous Cushing's Syndrome|endogenous cushing's syndrome
182861|NCT03053271|ATR-101|atr-101
182862|NCT03053271|CS|cs
182863|NCT03053245|Collaborative Care Model|collaborative care model
182864|NCT03053245|Intensive Care Unit|intensive care unit
182865|NCT03053193|breast cancer|breast cancer
182866|NCT03053193|stage I|stage i
182867|NCT03053193|stage II|stage ii
182868|NCT03053193|stage III|stage iii
182869|NCT03053180|Paritaprevir|paritaprevir
182870|NCT03053180|Dasabuvir|dasabuvir
182871|NCT03053180|Ombitasvir|ombitasvir
182872|NCT03053180|Ritonavir|ritonavir
182873|NCT03053180|Ribavirin free|ribavirin free
182874|NCT03053180|Chronic Hepatitis C genotype 1b (GT1b)|chronic hepatitis c genotype 1b (gt1b)
182875|NCT03053180|Cirrhosis|cirrhosis
182876|NCT03053180|Compensated liver cirrhosis|compensated liver cirrhosis
182877|NCT03053180|Hepatitis|hepatitis
182878|NCT03053167|Raltitrexed|raltitrexed
182879|NCT03053167|Irinotecan|irinotecan
182880|NCT03053167|Second-line Treatment|second-line treatment
182881|NCT03053167|Advanced Colorectal Cancer(ACC)|advanced colorectal cancer(acc)
182882|NCT03053154|Pelvic Inclination|pelvic inclination
182883|NCT03053154|Sit to Stand|sit to stand
182884|NCT03053154|Stroke|stroke
182885|NCT03053154|Anterior pelvic tilt|anterior pelvic tilt
182886|NCT03053154|Posterior pelvic tilt|posterior pelvic tilt
182887|NCT03053128|cardiac ischemia|cardiac ischemia
182888|NCT03053102|PNH|pnh
182889|NCT03053102|Paroxysmal|paroxysmal
182890|NCT03053102|Hemoglobinuria|hemoglobinuria
182891|NCT03053089|MPS I; Hurler Syndrome|mps i; hurler syndrome
182892|NCT03053076|cord blood mononuclear cells|cord blood mononuclear cells
182893|NCT03053076|safety|safety
182894|NCT03053076|effect|effect
182895|NCT03053076|neonates|neonates
182896|NCT03053037|apical size|apical size
182897|NCT03053037|root canal treatment success|root canal treatment success
182898|NCT03053037|micro biome analysis|micro biome analysis
182899|NCT03053037|pulp necrosis|pulp necrosis
182900|NCT03052985|medical devices (meshes)|medical devices (meshes)
182901|NCT03052985|surgery|surgery
182902|NCT03052946|fecal incontinence, anorectal manometry, bulking agents|fecal incontinence, anorectal manometry, bulking agents
182903|NCT03052933|copanlisib|copanlisib
182904|NCT03052933|gemcitabine|gemcitabine
182905|NCT03052933|peripheral T-cell lymphoma|peripheral t-cell lymphoma
182906|NCT03052933|extranodal NK/T-cell lymphoma|extranodal nk/t-cell lymphoma
182907|NCT03052920|cochlear implant|cochlear implant
182908|NCT03052920|asymmetric hearing loss|asymmetric hearing loss
182909|NCT03052894|anesthesiology|anesthesiology
182910|NCT03052894|neuromuscular blockade|neuromuscular blockade
182911|NCT03052894|monitoring device|monitoring device
182912|NCT03052855|Psychiatry|psychiatry
182913|NCT03052855|Suicidal behaviour|suicidal behaviour
182914|NCT03052855|Cerebral metabolites|cerebral metabolites
182915|NCT03052855|MRI|mri
182916|NCT03052855|Inflammatory markers|inflammatory markers
182917|NCT03052803|coronary stenosis|coronary stenosis
182918|NCT03052803|fractional flow reserve|fractional flow reserve
182919|NCT03052751|UCB7665|ucb7665
182920|NCT03052751|Myasthenia Gravis|myasthenia gravis
182921|NCT03052738|central nervous system (brain or spinal) tumor|central nervous system (brain or spinal) tumor
182922|NCT03052712|Disorders of socio-emotional|disorders of socio-emotional
182923|NCT03052712|Alzheimer|alzheimer
182924|NCT03052712|frontal temporal dementia|frontal temporal dementia
182925|NCT03052712|Parkinson|parkinson
182926|NCT03052712|Huntington|huntington
182927|NCT03052712|traumatic brain injury|traumatic brain injury
182928|NCT03052712|stroke|stroke
182929|NCT03052712|focal lesions|focal lesions
182930|NCT03052699|Complications; Cesarean Section|complications; cesarean section
182931|NCT03052686|Uterine rupture|uterine rupture
182932|NCT03052673|ketamine|ketamine
182933|NCT03052673|fentanyl|fentanyl
182934|NCT03052673|postoperative pain|postoperative pain
182935|NCT03052660|Midazolam|midazolam
182936|NCT03052660|Anxiety|anxiety
182937|NCT03052660|Clinical trial|clinical trial
182938|NCT03052660|Patient Satisfaction|patient satisfaction
182939|NCT03052647|dermaclip|dermaclip
182940|NCT03052647|subcuticular|subcuticular
182941|NCT03052647|cesarean section|cesarean section
182942|NCT03052647|staples|staples
182943|NCT03052647|adhesive latch|adhesive latch
182944|NCT03052647|rousseau|rousseau
182945|NCT03052608|ALK; anaplastic lymphoma kinase; Non-Small-Cell Lung cancer; NSCLC|alk; anaplastic lymphoma kinase; non-small-cell lung cancer; nsclc
182946|NCT03052556|cystic Fibrosis|cystic fibrosis
182947|NCT03052556|cervical cancer|cervical cancer
182948|NCT03052556|screening|screening
182949|NCT03052556|human papilloma virus (HPV)|human papilloma virus (hpv)
182950|NCT03052556|pap smear test|pap smear test
182951|NCT03052517|Asthma, QAW039|asthma, qaw039
182952|NCT03052465|Motility|motility
182953|NCT03052413|thinning hair|thinning hair
182954|NCT03052413|female pattern hair loss|female pattern hair loss
182955|NCT03052400|type 2 diabetes mellitus|type 2 diabetes mellitus
182956|NCT03052400|insulin resistance|insulin resistance
182957|NCT03052400|mifepristone|mifepristone
182958|NCT03052400|glucocorticoids|glucocorticoids
182959|NCT03052374|Video-Feedback Interaction Guidance|video-feedback interaction guidance
182960|NCT03052374|Depressed Mothers and their Infants|depressed mothers and their infants
182961|NCT03052361|Children|children
182962|NCT03052361|emergency department|emergency department
182963|NCT03052361|ondansetron|ondansetron
182964|NCT03052348|Topical Antibiotics|topical antibiotics
182965|NCT03052348|Fusidic Acid|fusidic acid
182966|NCT03052348|Atopic Dermatitis|atopic dermatitis
182967|NCT03052348|Eczema|eczema
182968|NCT03052335|colorectal cancer|colorectal cancer
182969|NCT03052335|screening|screening
182971|NCT03052335|colonoscopy|colonoscopy
182972|NCT03052283|Cystic fibrosis|cystic fibrosis
182973|NCT03052283|Abdomen|abdomen
182974|NCT03052283|Pancreas|pancreas
182975|NCT03052283|Liver|liver
182977|NCT03052283|Symptom Score|symptom score
182978|NCT03052283|Patient reported outcome measure (PROM)|patient reported outcome measure (prom)
182979|NCT03052257|Glaucoma|glaucoma
182980|NCT03052257|Disease management|disease management
182981|NCT03052257|Smart bottle|smart bottle
182982|NCT03052244|tDCS (trans cranial direct current stimulation)|tdcs (trans cranial direct current stimulation)
182983|NCT03052244|Visual illusion|visual illusion
182984|NCT03052244|Neuropathic pain|neuropathic pain
182985|NCT03052244|Spinal cord Injury|spinal cord injury
182986|NCT03052231|adherence|adherence
182987|NCT03052231|cystic fibrosis|cystic fibrosis
182988|NCT03052218|children|children
182989|NCT03052218|pain|pain
182990|NCT03052218|Cytochrome P450 CYP2D6 genotype|cytochrome p450 cyp2d6 genotype
182991|NCT03052218|Cytochrome P450 CYP2D6 phenotype|cytochrome p450 cyp2d6 phenotype
182992|NCT03052218|Pupillometry|pupillometry
182993|NCT03052205|ILLUMINATE-101|illuminate-101
182994|NCT03052205|melanoma|melanoma
182995|NCT03052127|Uveal melanoma|uveal melanoma
182996|NCT03052127|Eye cancer|eye cancer
182997|NCT03052127|Ocular melanoma|ocular melanoma
182998|NCT03052127|Choroidal melanoma|choroidal melanoma
182999|NCT03052114|Electrical Impedance Tomography|electrical impedance tomography
183000|NCT03052114|EIT|eit
183001|NCT03052114|Stroke|stroke
183002|NCT03052114|Craniocerebral Injury|craniocerebral injury
183003|NCT03052114|Head Injury|head injury
183004|NCT03052101|PLCH|plch
183005|NCT03052101|Air travel|air travel
183006|NCT03052101|pneumothorax|pneumothorax
183007|NCT03052101|pleurodesis|pleurodesis
183008|NCT03052075|Primary Hyperparathyroidism|primary hyperparathyroidism
183009|NCT03052075|Parathyroidectomy|parathyroidectomy
183010|NCT03052075|Bone mineral density|bone mineral density
183011|NCT03052075|BMD|bmd
183012|NCT03052075|Data Review|data review
183013|NCT03052049|Prostate Artery Embolization|prostate artery embolization
183014|NCT03052036|Acute Coronary Syndrome|acute coronary syndrome
183015|NCT03052023|dual approach|dual approach
183016|NCT03052023|laparoscopic hernioplasty|laparoscopic hernioplasty
183017|NCT03052010|HIV-1 serodiscordant couples|hiv-1 serodiscordant couples
183018|NCT03052010|PrEP as Bridge to ART|prep as bridge to art
183019|NCT03051919|Laparoscopic sleeve gastrectomy|laparoscopic sleeve gastrectomy
183020|NCT03051919|reinforcement|reinforcement
183021|NCT03051919|leak|leak
183022|NCT03051906|Carcinoma, squamous cell|carcinoma, squamous cell
183023|NCT03051906|Head and Neck Neoplasms|head and neck neoplasms
183024|NCT03051906|Radiotherapy|radiotherapy
183025|NCT03051906|Immunotherapy|immunotherapy
183026|NCT03051880|Epidermal Growth Factor|epidermal growth factor
183027|NCT03051854|Violence|violence
183028|NCT03051854|Children|children
183029|NCT03051854|Prevalence|prevalence
183030|NCT03051854|Abuse|abuse
183031|NCT03051854|Prevention|prevention
183032|NCT03051828|fencing, cancer|fencing, cancer
183033|NCT03051815|obstructive sleep apnea|obstructive sleep apnea
183034|NCT03051802|Endoscopy|endoscopy
183035|NCT03051802|HDR Brachytherapy|hdr brachytherapy
183036|NCT03051802|navigation|navigation
183037|NCT03051789|Menstrual hygiene management|menstrual hygiene management
183038|NCT03051789|Sexual and Reproductive Health|sexual and reproductive health
183039|NCT03051789|Adolescent schoolgirls|adolescent schoolgirls
183040|NCT03051789|School dropoout|school dropoout
183041|NCT03051789|sub-Saharan Africa|sub-saharan africa
183042|NCT03051789|Kenya|kenya
183043|NCT03051776|Compression garments|compression garments
183044|NCT03051776|Kinesio Taping|kinesio taping
183045|NCT03051776|Breast Cancer-Related Lymphedema|breast cancer-related lymphedema
183046|NCT03051763|pulmonary hypertension|pulmonary hypertension
183047|NCT03051763|commercial air travel|commercial air travel
183048|NCT03051750|Breast Cancer-Related Lymphedema|breast cancer-related lymphedema
183049|NCT03051750|Complex Physical Therapy|complex physical therapy
183050|NCT03051750|Pressotherapy|pressotherapy
183051|NCT03051750|Kinesio Taping|kinesio taping
183052|NCT03051750|Physiotherapy|physiotherapy
183053|NCT03051750|Manual Lymph Drainage|manual lymph drainage
183054|NCT03051750|Multilayer Bandage|multilayer bandage
183055|NCT03051750|TTDL questionnaire|ttdl questionnaire
183056|NCT03051737|Multi-scale|multi-scale
183057|NCT03051737|Prediction|prediction
183058|NCT03051737|Patient Flow|patient flow
183059|NCT03051737|Emergency Department|emergency department
183060|NCT03051737|Hospitalization|hospitalization
183061|NCT03051737|Ile-de-France|ile-de-france
183062|NCT03051724|OSA|osa
183063|NCT03051724|CPAP management|cpap management
183064|NCT03051724|Telemedicine|telemedicine
183065|NCT03051698|C1-inhibitor|c1-inhibitor
183066|NCT03051698|house dust mite|house dust mite
183067|NCT03051698|complement system|complement system
183068|NCT03051672|Breast Cancer|breast cancer
183069|NCT03051659|Breast Cancer|breast cancer
183070|NCT03051646|Exercise|exercise
183071|NCT03051646|Time to Exhaustion|time to exhaustion
183072|NCT03051620|Bone turnover markers|bone turnover markers
183073|NCT03051620|Alendronate|alendronate
183074|NCT03051620|Drug Holiday|drug holiday
183075|NCT03051607|Motor Fluctuations|motor fluctuations
183076|NCT03051607|Off time|off time
183077|NCT03051607|On time|on time
183078|NCT03051607|Dyskinesia|dyskinesia
183079|NCT03051581|Lymphoma, T-Cell, Peripheral|lymphoma, t-cell, peripheral
183080|NCT03051581|Positron-Emission Tomography|positron-emission tomography
183081|NCT03051581|Prognosis|prognosis
183082|NCT03051568|Lymphoma, T-Cell, Peripheral|lymphoma, t-cell, peripheral
183083|NCT03051568|Positron-Emission Tomography|positron-emission tomography
183084|NCT03051568|Prognosis|prognosis
183085|NCT03051555|Lymphoma, Extranodal NK-T-Cell|lymphoma, extranodal nk-t-cell
183086|NCT03051555|Positron-Emission Tomography|positron-emission tomography
183087|NCT03051555|Prognosis|prognosis
183088|NCT03051542|Lymphoma, Extranodal NK-T-Cell|lymphoma, extranodal nk-t-cell
183089|NCT03051542|Positron-Emission Tomography|positron-emission tomography
183090|NCT03051542|Prognosis|prognosis
183091|NCT03051451|Hydrochloride of Metformin / Fluoxetine|hydrochloride of metformin / fluoxetine
183092|NCT03051451|Placebo|placebo
183093|NCT03051451|Obesity|obesity
183094|NCT03051425|Probiotics|probiotics
183095|NCT03051425|Immune function|immune function
183096|NCT03051425|Natural killer cell activity|natural killer cell activity
183097|NCT03051425|Interleukin-12|interleukin-12
183098|NCT03051425|Interferon-gamma|interferon-gamma
183099|NCT03051425|Immunoglobulin|immunoglobulin
183100|NCT03051399|Constipation|constipation
183101|NCT03051399|Gastrointestinal symptoms of discomfort|gastrointestinal symptoms of discomfort
183102|NCT03051399|Quality of life|quality of life
183103|NCT03051399|Saccharomyces cerevisiae|saccharomyces cerevisiae
183104|NCT03051399|Gut microbiome|gut microbiome
183105|NCT03051360|aortic valve stenosis|aortic valve stenosis
183106|NCT03051360|PCSK9 inhibitor|pcsk9 inhibitor
183107|NCT03051308|Parathyroid cell viability|parathyroid cell viability
183108|NCT03051308|Ischemia|ischemia
183109|NCT03051308|Parathyroid allotransplantation|parathyroid allotransplantation
183110|NCT03051308|Vitamin D Receptor|vitamin d receptor
183111|NCT03051308|Calcium Sensing Receptor|calcium sensing receptor
183112|NCT03051295|Communication Barriers|communication barriers
183113|NCT03051295|Persuasive Communication|persuasive communication
183114|NCT03051295|Risk|risk
183115|NCT03051269|Electroporation|electroporation
183116|NCT03051269|Calcium|calcium
183117|NCT03051269|Head and Neck cancer|head and neck cancer
183118|NCT03051256|REL-1017|rel-1017
183119|NCT03051256|d-Methadone|d-methadone
183120|NCT03051256|Methadone|methadone
183121|NCT03051256|Depression|depression
183122|NCT03051256|Refractory Depression|refractory depression
183123|NCT03051256|Antidepressant|antidepressant
183124|NCT03051256|Adjunctive Treatment|adjunctive treatment
183125|NCT03051256|NMDA Receptor Antagonist|nmda receptor antagonist
183126|NCT03051256|Excitatory Amino Acid Antagonist|excitatory amino acid antagonist
183127|NCT03051256|Glutamate Antagonist|glutamate antagonist
183128|NCT03051230|Blood Coagulation Disorders|blood coagulation disorders
183129|NCT03051230|Cell-Derived Microparticles|cell-derived microparticles
183130|NCT03051230|Superovulation|superovulation
183131|NCT03051230|Fertilization in Vitro|fertilization in vitro
183132|NCT03051230|Biomarkers|biomarkers
183133|NCT03051217|Psoriasis|psoriasis
183135|NCT03051217|Chronic plaque psoriasis|chronic plaque psoriasis
183136|NCT03051217|Certolizumb Pegol|certolizumb pegol
183137|NCT03051217|Cimzia|cimzia
183138|NCT03051217|Generalized pustular psoriasis and erythrodermic psoriasis|generalized pustular psoriasis and erythrodermic psoriasis
183139|NCT03051191|atherosclerotic cardiovascular diseases|atherosclerotic cardiovascular diseases
183140|NCT03051191|nonischemic heart failure|nonischemic heart failure
183141|NCT03051191|cancer|cancer
183142|NCT03051165|Cardiovascular Disease|cardiovascular disease
183143|NCT03051165|Pulmonary Medicine|pulmonary medicine
183144|NCT03051165|Hypoglossal Nerve Stimulation|hypoglossal nerve stimulation
183145|NCT03051139|Implementation Science|implementation science
183146|NCT03051139|Low Tidal Volume Ventilation (LTVV)|low tidal volume ventilation (ltvv)
183147|NCT03051126|Parathyroid disease|parathyroid disease
183148|NCT03051126|Parathyroid Tissue Bank|parathyroid tissue bank
183149|NCT03051126|Database|database
183150|NCT03051126|Blood samples|blood samples
183151|NCT03051100|hyperlididemia|hyperlididemia
183152|NCT03051100|LDL|ldl
183153|NCT03051100|cholesterol|cholesterol
183154|NCT03051074|Anxiety|anxiety
183155|NCT03051074|Floating|floating
183156|NCT03051061|Atrial Fibrillation|atrial fibrillation
183157|NCT03051061|Coronary Heart Disease|coronary heart disease
183158|NCT03051061|antithrombotic treatment|antithrombotic treatment
183159|NCT03051061|clinical prognosis|clinical prognosis
183160|NCT03051048|Acute Myocardial Infarction|acute myocardial infarction
183161|NCT03051035|non-hematological malignancies|non-hematological malignancies
183162|NCT03051035|non-squamous|non-squamous
183163|NCT03051035|squamous|squamous
183164|NCT03051035|BRAF|braf
183165|NCT03051035|KRAS|kras
183166|NCT03051035|NRAS|nras
183167|NCT03051022|Bupivacaine|bupivacaine
183168|NCT03051022|adjuvant|adjuvant
183169|NCT03051022|regional anesthesia|regional anesthesia
183170|NCT03051022|dexamethasone|dexamethasone
183171|NCT03051022|morphine|morphine
183172|NCT03050983|Respiratory Compromise|respiratory compromise
183173|NCT03050970|minor head trauma|minor head trauma
183174|NCT03050970|child|child
183175|NCT03050970|age less than 2 years|age less than 2 years
183176|NCT03050970|Clinically-important traumatic brain injury (ciTBI)|clinically-important traumatic brain injury (citbi)
183177|NCT03050970|Computed tomography scan|computed tomography scan
183178|NCT03050970|Radiation exposure from CT scans|radiation exposure from ct scans
183179|NCT03050944|Fertility|fertility
183180|NCT03050944|Infertility|infertility
183181|NCT03050944|Dietary Patterns|dietary patterns
183182|NCT03050944|Mediterranean diet|mediterranean diet
183183|NCT03050944|Adiponectin|adiponectin
183184|NCT03050944|Follistatin|follistatin
183185|NCT03050944|Assisted Reproduction|assisted reproduction
183186|NCT03050944|In Vitro Fertilization|in vitro fertilization
183187|NCT03050944|Semen quality|semen quality
183188|NCT03050944|Diet|diet
183189|NCT03050944|IVF|ivf
183190|NCT03050931|Electrical Impedance Tomography|electrical impedance tomography
183191|NCT03050931|EIT|eit
183192|NCT03050931|Epilepsy|epilepsy
183193|NCT03050879|Stomach Neoplasms|stomach neoplasms
183194|NCT03050879|Indocyanine Green Tracer|indocyanine green tracer
183195|NCT03050879|Laparoscopic Gastrectomy|laparoscopic gastrectomy
183196|NCT03050879|Lymph Node Dissection|lymph node dissection
183197|NCT03050866|Androgen Receptor|androgen receptor
183198|NCT03050866|AR-V7|ar-v7
183199|NCT03050866|Predictive Factor|predictive factor
183200|NCT03050814|Anti-PDL1 Antibody|anti-pdl1 antibody
183201|NCT03050814|Therapeutic Cancer Vaccine|therapeutic cancer vaccine
183202|NCT03050814|Mismatch Repair Deficiency|mismatch repair deficiency
183203|NCT03050814|Progression Free Survival|progression free survival
183204|NCT03050814|Adenovirus Based, CEA-Targeting Vaccine|adenovirus based, cea-targeting vaccine
183205|NCT03050801|Explicit Memory|explicit memory
183206|NCT03050801|Implicit Memory|implicit memory
183207|NCT03050801|Memory Disorder|memory disorder
183208|NCT03050788|Smartphone confocal microscopy|smartphone confocal microscopy
183209|NCT03050788|Kaposi Sarcoma|kaposi sarcoma
183210|NCT03050788|Point of care diagnosis|point of care diagnosis
183211|NCT03050762|Endocrine Disease|endocrine disease
183212|NCT03050762|Thyroid disease|thyroid disease
183213|NCT03050762|Parathyroid disease|parathyroid disease
183214|NCT03050762|Adrenal disease|adrenal disease
183215|NCT03050762|Data Review|data review
183216|NCT03050762|Database|database
183217|NCT03050736|Glioma|glioma
183218|NCT03050736|Glioblastoma|glioblastoma
183219|NCT03050736|Glioblastoma multiforme|glioblastoma multiforme
183220|NCT03050736|GBM|gbm
183221|NCT03050736|brain tumor|brain tumor
183222|NCT03050736|brain cancer|brain cancer
183223|NCT03050632|working memory|working memory
183224|NCT03050632|adherence|adherence
183225|NCT03050606|Exercise Therapy|exercise therapy
183226|NCT03050606|Exercise Movement Techniques|exercise movement techniques
183227|NCT03050606|Pilates-Based Exercises|pilates-based exercises
183228|NCT03050606|Cost-effectiveness|cost-effectiveness
183229|NCT03050593|HFpEF|hfpef
183230|NCT03050593|HFrEF|hfref
183231|NCT03050580|Abused women|abused women
183232|NCT03050580|treatment group|treatment group
183233|NCT03050580|family violence|family violence
183234|NCT03050567|Microemboli|microemboli
183235|NCT03050554|cancer|cancer
183236|NCT03050554|Non-Small Cell Lung Cancer|non-small cell lung cancer
183237|NCT03050554|SBRT|sbrt
183238|NCT03050554|Avelumab|avelumab
183239|NCT03050554|Stereotactic Body Radiation Therapy|stereotactic body radiation therapy
183240|NCT03050554|radiation|radiation
183241|NCT03050554|NSCLC|nsclc
183242|NCT03050554|PD-1|pd-1
183243|NCT03050554|PD-L1|pd-l1
183244|NCT03050554|Immunotherapy|immunotherapy
183245|NCT03050554|Lung|lung
183246|NCT03050541|MDMA|mdma
183247|NCT03050541|adult|adult
183248|NCT03050528|Acceptance and Commitment Therapy|acceptance and commitment therapy
183249|NCT03050528|Exercise|exercise
183250|NCT03050528|Psychology|psychology
183251|NCT03050528|Psychological therapy|psychological therapy
183252|NCT03050528|Physiotherapy|physiotherapy
183253|NCT03050528|Physical therapy|physical therapy
183254|NCT03050502|Hemothorax|hemothorax
183255|NCT03050502|Management|management
183256|NCT03050489|CABG|cabg
183257|NCT03050489|Off-Pump CABG|off-pump cabg
183258|NCT03050489|On-Pump CABG|on-pump cabg
183259|NCT03050489|ischemic-reperfusion injury during CABG|ischemic-reperfusion injury during cabg
183260|NCT03050489|comparison of On- and Off- Pump CABG|comparison of on- and off- pump cabg
183261|NCT03050489|Ischemic Heart Disease|ischemic heart disease
183262|NCT03050489|Myocardial ischemia-reperfusion and myeloperoxidase|myocardial ischemia-reperfusion and myeloperoxidase
183263|NCT03050489|Myocardial ischemia-reperfusion biomarkers|myocardial ischemia-reperfusion biomarkers
183264|NCT03050476|side-effects|side-effects
183265|NCT03050476|heart-lung machine|heart-lung machine
183266|NCT03050476|alkaline phosphatase|alkaline phosphatase
183267|NCT03050437|Failed in First Line EGFR-TKI|failed in first line egfr-tki
183268|NCT03050437|EGFR Activating Mutation|egfr activating mutation
183269|NCT03050437|Pemetrexed|pemetrexed
183270|NCT03050424|COPD|copd
183271|NCT03050424|Iron|iron
183272|NCT03050424|Exercise Capacity|exercise capacity
183273|NCT03050424|Non-anaemic iron deficiency|non-anaemic iron deficiency
183274|NCT03050411|Non Small Cell Lung Cancer|non small cell lung cancer
183275|NCT03050411|EGFR-TKI resistance|egfr-tki resistance
183276|NCT03050411|Apatinib|apatinib
183277|NCT03050411|anti-angiogenesis drugs|anti-angiogenesis drugs
183278|NCT03050398|HR-positive|hr-positive
183279|NCT03050398|HER2-negative|her2-negative
183280|NCT03050398|Advanced breast cancer|advanced breast cancer
183281|NCT03050398|LEE011|lee011
183282|NCT03050398|ribociclib|ribociclib
183283|NCT03050398|letrozole|letrozole
183284|NCT03050398|femara|femara
183285|NCT03050398|CDK|cdk
183286|NCT03050398|CDK4|cdk4
183287|NCT03050398|CDK6|cdk6
183288|NCT03050398|CDK4/6|cdk4/6
183289|NCT03050398|CDK4/6 inhibitor|cdk4/6 inhibitor
183290|NCT03050398|Phase III|phase iii
183291|NCT03050398|Phase IIIb|phase iiib
183292|NCT03050398|ER-positive|er-positive
183293|NCT03050398|PR-positive|pr-positive
183294|NCT03050398|Postmenopausal|postmenopausal
183295|NCT03050398|Premenopausal|premenopausal
183296|NCT03050398|Men|men
183297|NCT03050385|cognitive rehabilitation|cognitive rehabilitation
183298|NCT03050359|Drug therapy|drug therapy
183299|NCT03050359|Gastrointestinal Diseases|gastrointestinal diseases
183300|NCT03050359|Digestive System Diseases|digestive system diseases
183301|NCT03050359|Lansoprazole|lansoprazole
183302|NCT03050359|Anti-Ulcer Agents|anti-ulcer agents
183303|NCT03050359|Gastrointestinal Agents|gastrointestinal agents
183304|NCT03050359|Proton Pump Inhibitors|proton pump inhibitors
183305|NCT03050359|Enzyme Inhibitors|enzyme inhibitors
183306|NCT03050359|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action
183307|NCT03050346|Magnetic Resonance Imaging|magnetic resonance imaging
183308|NCT03050346|Coronary Artery Disease|coronary artery disease
183309|NCT03050346|Apnea|apnea
183310|NCT03050346|Hyperventilation|hyperventilation
183311|NCT03050346|BOLD|bold
183312|NCT03050346|Breathing Maneuvers|breathing maneuvers
183313|NCT03050346|Myocardial Oxygenation|myocardial oxygenation
183314|NCT03050320|Resilience|resilience
183315|NCT03050320|Exercise in the workplace|exercise in the workplace
183316|NCT03050307|Drug therapy|drug therapy
183317|NCT03050268|Familial cancer|familial cancer
183318|NCT03050268|Genetic predisposition|genetic predisposition
183319|NCT03050268|Heritable disease|heritable disease
183320|NCT03050268|Cancer risk|cancer risk
183321|NCT03050268|Genome analysis|genome analysis
183322|NCT03050268|Genetic modifiers|genetic modifiers
183323|NCT03050268|Next generation sequencing (NGS)|next generation sequencing (ngs)
183324|NCT03050268|Genetic counseling|genetic counseling
183325|NCT03050268|DNA|dna
183326|NCT03050255|supplemental oxygen|supplemental oxygen
183327|NCT03050255|walking capacity|walking capacity
183328|NCT03050255|exercise capacity|exercise capacity
183329|NCT03050255|endurance shuttle walk test|endurance shuttle walk test
183330|NCT03050190|CART therapy|cart therapy
183331|NCT03050190|4SCAR19|4scar19
183332|NCT03050190|CD19|cd19
183333|NCT03050190|B cell leukemia|b cell leukemia
183334|NCT03050190|B-ALL|b-all
183335|NCT03050177|Bioequivalence Study|bioequivalence study
183336|NCT03050138|Postthrombotic Syndrome|postthrombotic syndrome
183337|NCT03050138|Venous Thrombosis|venous thrombosis
183338|NCT03050138|Quality of Life|quality of life
183339|NCT03050138|Hemorrhage|hemorrhage
183340|NCT03050138|Recurrence|recurrence
183341|NCT03050112|MacNew questionnaire|macnew questionnaire
183342|NCT03050112|Quality of life|quality of life
183343|NCT03050034|Wireless monitoring system|wireless monitoring system
183344|NCT03050034|Acute Medicine|acute medicine
183345|NCT03050034|Poly-pathological patients|poly-pathological patients
183346|NCT03050034|Internal Medicine core competencies|internal medicine core competencies
183347|NCT03050034|Acute Complex Care Model|acute complex care model
183348|NCT03050021|Delirium|delirium
183349|NCT03050021|Intensive care unit|intensive care unit
183350|NCT03050008|Cataract Surgery|cataract surgery
183351|NCT03049995|effectiveness; imaging; prognosis; stress echocardiography|effectiveness; imaging; prognosis; stress echocardiography
183352|NCT03049982|Oral appliance therapy|oral appliance therapy
183353|NCT03049969|Working Memory|working memory
183354|NCT03049969|Cognitive Training|cognitive training
183355|NCT03049969|Transcranial Magnetic Stimulation|transcranial magnetic stimulation
183356|NCT03049956|Ocular Vestibular Evoked Myogenic Potentials|ocular vestibular evoked myogenic potentials
183357|NCT03049943|low level laser therapy|low level laser therapy
183358|NCT03049943|hyposalivation|hyposalivation
183359|NCT03049930|Burns|burns
183360|NCT03049930|Ketamine|ketamine
183361|NCT03049930|Anesthesia|anesthesia
183362|NCT03049917|financial incentive|financial incentive
183363|NCT03049917|pediatric HIV testing|pediatric hiv testing
183364|NCT03049904|Indian, North America|indian, north america
183365|NCT03049904|Male, Two-Spirit|male, two-spirit
183366|NCT03049904|HIV Prevention|hiv prevention
183367|NCT03049904|MSM|msm
183368|NCT03049891|Antiretroviral Therapy|antiretroviral therapy
183369|NCT03049891|Retention|retention
183370|NCT03049891|Loss to Follow Up|loss to follow up
183371|NCT03049878|postoperative pain|postoperative pain
183372|NCT03049878|paracetamol|paracetamol
183373|NCT03049878|codeine|codeine
183374|NCT03049878|tooth extractions|tooth extractions
183375|NCT03049878|analgesia|analgesia
183376|NCT03049878|premedication|premedication
183377|NCT03049826|nutrient|nutrient
183378|NCT03049800|Recent onset psychotic illness|recent onset psychotic illness
183379|NCT03049800|Healthy controls|healthy controls
183380|NCT03049800|Cognitive training|cognitive training
183381|NCT03049800|7T Magnetic Resonance Imaging|7t magnetic resonance imaging
183382|NCT03049800|Prisma 3T Magnetic Resonance Imaging|prisma 3t magnetic resonance imaging
183383|NCT03049787|physical therapy|physical therapy
183384|NCT03049787|home exercise|home exercise
183385|NCT03049787|adhesive capsulitis|adhesive capsulitis
183386|NCT03049748|Heart-Assist Devices, Self-care, Quality of Life|heart-assist devices, self-care, quality of life
183387|NCT03049709|central blood pressure|central blood pressure
183388|NCT03049709|measurement|measurement
183389|NCT03049709|oscillometric radial pulse wave analysis|oscillometric radial pulse wave analysis
183390|NCT03049696|Roux-En-Y Gastric Bypass|roux-en-y gastric bypass
183391|NCT03049696|Bariatric Surgery|bariatric surgery
183392|NCT03049696|Pre-Operative Physical Activity and Education Program|pre-operative physical activity and education program
183393|NCT03049696|Obesity|obesity
183394|NCT03049696|Exercise|exercise
183395|NCT03049696|Behaviour Modification|behaviour modification
183396|NCT03049696|Surgical Outcomes|surgical outcomes
183397|NCT03049696|Quality of Life|quality of life
183398|NCT03049683|Vestibular evoked myogenic potentials|vestibular evoked myogenic potentials
183399|NCT03049670|Safety Issue|safety issue
183400|NCT03049644|chronic lower back pain|chronic lower back pain
183401|NCT03049644|Manual Therapy|manual therapy
183402|NCT03049644|Mechanical Diagnosis and Treatment|mechanical diagnosis and treatment
183403|NCT03049631|Pre-diabetes|pre-diabetes
183404|NCT03049631|red raspberry|red raspberry
183405|NCT03049631|fructooligosaccharide|fructooligosaccharide
183406|NCT03049631|metagenomics|metagenomics
183407|NCT03049631|polyphenol bioavailability|polyphenol bioavailability
183408|NCT03049631|glycemic response|glycemic response
183409|NCT03049631|insulin response|insulin response
183410|NCT03049605|Neuropathies laser and magnetic therapy|neuropathies laser and magnetic therapy
183411|NCT03049592|Diabetes|diabetes
183412|NCT03049592|Contraception|contraception
183413|NCT03049592|Prenatal Counseling|prenatal counseling
183414|NCT03049566|Bleeding|bleeding
183415|NCT03049566|Adverse Cardiac Events|adverse cardiac events
183416|NCT03049566|Adherence, Medication|adherence, medication
183417|NCT03049566|Aspirin|aspirin
183418|NCT03049566|Acetylsalicylic acid|acetylsalicylic acid
183419|NCT03049553|Cervical screening|cervical screening
183420|NCT03049553|Human papillomavirus (HPV)|human papillomavirus (hpv)
183421|NCT03049553|Cytology|cytology
183422|NCT03049553|HPV-test|hpv-test
183423|NCT03049553|Cervical intraepithelial neoplasia (CIN)|cervical intraepithelial neoplasia (cin)
183424|NCT03049527|Chronic Kidney Disease|chronic kidney disease
183425|NCT03049527|Unknown Origin|unknown origin
183426|NCT03049514|Thrombolysis|thrombolysis
183427|NCT03049514|Recanalization|recanalization
183428|NCT03049514|Dynamic retinal angiography|dynamic retinal angiography
183429|NCT03049501|Alzheimer's caregivers|alzheimer's caregivers
183430|NCT03049501|Technology-based intervention|technology-based intervention
183431|NCT03049501|Culturally-tailored intervention|culturally-tailored intervention
183432|NCT03049488|Immune Response|immune response
183433|NCT03049488|Respiratory Syncytial Virus|respiratory syncytial virus
183434|NCT03049488|Vaccine-Mediated Protection|vaccine-mediated protection
183435|NCT03049488|Neutralizing Antibody|neutralizing antibody
183436|NCT03049488|Antibody Response|antibody response
183437|NCT03049475|Pain|pain
183438|NCT03049475|Cell Free DNA|cell free dna
183439|NCT03049475|Inflammatory Markers|inflammatory markers
183440|NCT03049475|Microparticles|microparticles
183441|NCT03049475|NETosis|netosis
183442|NCT03049462|Brown Adipose Tissue|brown adipose tissue
183443|NCT03049462|Energy Expenditure|energy expenditure
183444|NCT03049462|Energy Metabolism|energy metabolism
183445|NCT03049462|Obesity|obesity
183446|NCT03049449|Gene Therapy|gene therapy
183447|NCT03049449|Adoptive T Cell Therapy|adoptive t cell therapy
183448|NCT03049449|T-cell infusion|t-cell infusion
183449|NCT03049449|Allogeneic Stem Cell Transplantation|allogeneic stem cell transplantation
183450|NCT03049436|Physical activity|physical activity
183451|NCT03049436|cancer|cancer
183452|NCT03049436|chemotherapy|chemotherapy
183453|NCT03049436|daily care unit|daily care unit
183454|NCT03049410|Cystectomy|cystectomy
183455|NCT03049332|Quality of Life|quality of life
183456|NCT03049306|Obstructive sleep apnea|obstructive sleep apnea
183457|NCT03049306|CPAP|cpap
183458|NCT03049306|Propranolol|propranolol
183459|NCT03049306|Metabolism|metabolism
183460|NCT03049293|COPD,IVF|copd,ivf
183461|NCT03049267|acne inversa|acne inversa
183462|NCT03049241|Children|children
183463|NCT03049241|Neuromuscular fatigue|neuromuscular fatigue
183464|NCT03049241|Muscle group|muscle group
183465|NCT03049241|Magnetic Nerve stimulation|magnetic nerve stimulation
183466|NCT03049241|Muscle length|muscle length
183467|NCT03049241|Stiffness|stiffness
183468|NCT03049241|prepubertal children|prepubertal children
183469|NCT03049241|adults|adults
183470|NCT03049228|Spectrum Analysis|spectrum analysis
183471|NCT03049228|Mitochondria|mitochondria
183472|NCT03049228|Peroxisome Proliferator-Activated Receptors|peroxisome proliferator-activated receptors
183473|NCT03049228|Respirometry|respirometry
183474|NCT03049228|Human|human
183475|NCT03049228|Heart|heart
183476|NCT03049189|non-functional and functional P-NET|non-functional and functional p-net
183477|NCT03049189|non-functional GE-NET|non-functional ge-net
183478|NCT03049176|HIV-discordant couple|hiv-discordant couple
183480|NCT03049176|PrEP|prep
183481|NCT03049176|semen washing|semen washing
183482|NCT03049176|artificial vaginal insemination|artificial vaginal insemination
183483|NCT03049176|safer conception|safer conception
183484|NCT03049176|pregnancy|pregnancy
183485|NCT03049150|Urine|urine
183486|NCT03049150|Mass Spectometry|mass spectometry
183487|NCT03049150|Observational|observational
183488|NCT03049124|Exercise|exercise
183489|NCT03049124|Feasibility trial|feasibility trial
183490|NCT03049124|Cancer|cancer
183491|NCT03049124|Chemoradiation|chemoradiation
183492|NCT03049111|Der F (House Dust Mite)|der f (house dust mite)
183493|NCT03049098|Eye-tracking|eye-tracking
183494|NCT03049098|High Fidelity Simulation Training|high fidelity simulation training
183495|NCT03049098|Visual Perception|visual perception
183496|NCT03049085|OPCAB|opcab
183497|NCT03049085|ASA|asa
183498|NCT03049085|Aspirin|aspirin
183499|NCT03049020|pelvic organ prolapse|pelvic organ prolapse
183500|NCT03049020|sacrocolpopexy|sacrocolpopexy
183501|NCT03049020|pelvic floor ultrasound|pelvic floor ultrasound
183502|NCT03049007|bereavement|bereavement
183503|NCT03049007|natural grief|natural grief
183504|NCT03049007|prolonged grief|prolonged grief
183505|NCT03049007|complicated grief|complicated grief
183506|NCT03048994|Glutamine|glutamine
183507|NCT03048994|Severe sepsis|severe sepsis
183508|NCT03048981|Thrombocyte aggregation|thrombocyte aggregation
183509|NCT03048981|Fish oil|fish oil
183510|NCT03048981|Alternative medicine|alternative medicine
183511|NCT03048981|Point of care testing|point of care testing
183512|NCT03048981|Coagulation monitoring|coagulation monitoring
183513|NCT03048968|Exoskeleton Device|exoskeleton device
183514|NCT03048968|elderly|elderly
183515|NCT03048968|stroke|stroke
183516|NCT03048942|Breast cancer|breast cancer
183517|NCT03048942|HER2 negative|her2 negative
183518|NCT03048942|Cabazitaxel|cabazitaxel
183519|NCT03048942|Paclitaxel|paclitaxel
183520|NCT03048942|Chemotherapy|chemotherapy
183521|NCT03048916|dysphagia|dysphagia
183522|NCT03048916|stroke|stroke
183523|NCT03048916|magnetic resonance imaging|magnetic resonance imaging
183524|NCT03048916|videofluoroscopy|videofluoroscopy
183525|NCT03048903|Gastrointestinal dysfunction|gastrointestinal dysfunction
183526|NCT03048903|sepsis|sepsis
183527|NCT03048903|trauma|trauma
183528|NCT03048890|PAD|pad
183529|NCT03048877|Radioactive iodine-refractory|radioactive iodine-refractory
183530|NCT03048877|differentiated thyroid cancer|differentiated thyroid cancer
183531|NCT03048877|Apatinib|apatinib
183532|NCT03048877|anti-angiogenesis drugs|anti-angiogenesis drugs
183533|NCT03048864|Metabolic Screening|metabolic screening
183534|NCT03048864|24 hour urine|24 hour urine
183535|NCT03048851|Cerebral palsy|cerebral palsy
183536|NCT03048851|sensory electrical stimulation|sensory electrical stimulation
183537|NCT03048851|virtual reality constraint-induced therapy|virtual reality constraint-induced therapy
183538|NCT03048812|Dental implant|dental implant
183539|NCT03048812|Mandibular overdenture|mandibular overdenture
183540|NCT03048812|Cross-over study|cross-over study
183541|NCT03048786|Peer mentoring|peer mentoring
183542|NCT03048786|social support|social support
183543|NCT03048786|text messaging|text messaging
183544|NCT03048786|smoking cessation|smoking cessation
183545|NCT03048773|shockwave therapy|shockwave therapy
183546|NCT03048773|knee osteoarthritis|knee osteoarthritis
183547|NCT03048760|MRI scan|mri scan
183548|NCT03048760|Organs at Risk|organs at risk
183549|NCT03048708|Bariatric surgery|bariatric surgery
183550|NCT03048708|Leptin|leptin
183551|NCT03048708|Thyroid function tests|thyroid function tests
183552|NCT03048617|Primary Mitochondrial Disease|primary mitochondrial disease
183553|NCT03048617|Stealth|stealth
183554|NCT03048617|Myopathy|myopathy
183555|NCT03048617|exercise intolerance|exercise intolerance
183556|NCT03048617|muscle pain|muscle pain
183557|NCT03048617|Mitochondrial Myopathy|mitochondrial myopathy
183558|NCT03048617|Primary Mitochondrial Myopathy|primary mitochondrial myopathy
183559|NCT03048578|Roux-en-Y gastric bypass (RYGB)|roux-en-y gastric bypass (rygb)
183560|NCT03048565|mindfulness|mindfulness
183561|NCT03048565|caregivers|caregivers
183562|NCT03048552|drug use|drug use
183563|NCT03048552|drug addiction|drug addiction
183564|NCT03048552|drug habituation|drug habituation
183565|NCT03048552|drug use disorders|drug use disorders
183566|NCT03048552|organic mental disorders|organic mental disorders
183567|NCT03048552|substance-induced|substance-induced
183568|NCT03048552|substance abuse|substance abuse
183569|NCT03048552|substance addiction|substance addiction
183570|NCT03048552|substance dependence|substance dependence
183571|NCT03048552|substance use disorders|substance use disorders
183572|NCT03048539|Endoscopic surgery|endoscopic surgery
183573|NCT03048539|Thyroidectomy|thyroidectomy
183574|NCT03048539|Quality of life|quality of life
183575|NCT03048513|Melioidosis|melioidosis
183576|NCT03048513|Head and Neck|head and neck
183577|NCT03048513|Clinical|clinical
183578|NCT03048474|progressive disease after at least 1 course of chemotherapy|progressive disease after at least 1 course of chemotherapy
183579|NCT03048448|Hepatic impairment,|hepatic impairment,
183580|NCT03048448|Fevipiprant,|fevipiprant,
183581|NCT03048448|adults,|adults,
183582|NCT03048448|pharmacokinetics|pharmacokinetics
183583|NCT03048435|Cervical Cancer|cervical cancer
183584|NCT03048435|Patient Reported Outcomes|patient reported outcomes
183585|NCT03048435|Radiation Therapy|radiation therapy
183586|NCT03048435|EORTC QLQ-CX24|eortc qlq-cx24
183587|NCT03048435|Quality of Life|quality of life
183588|NCT03048383|Facial paralysis|facial paralysis
183589|NCT03048383|Facial synkinesis|facial synkinesis
183590|NCT03048383|Botulinum toxin|botulinum toxin
183591|NCT03048344|acute promyelocytic leukemia|acute promyelocytic leukemia
183592|NCT03048344|APL|apl
183593|NCT03048344|arsenic trioxide|arsenic trioxide
183594|NCT03048331|Functional Electrical Stimulation|functional electrical stimulation
183595|NCT03048331|Tetraplegia|tetraplegia
183596|NCT03048331|Reconstructive Hand Surgery|reconstructive hand surgery
183597|NCT03048292|Embolectomy|embolectomy
183598|NCT03048292|Embolus|embolus
183599|NCT03048292|Thrombectomy|thrombectomy
183600|NCT03048292|Thrombolysis|thrombolysis
183601|NCT03048292|Thrombus|thrombus
183602|NCT03048292|Mobile|mobile
183603|NCT03048292|Interventional|interventional
183604|NCT03048292|Neurointervention|neurointervention
183605|NCT03048292|Stroke|stroke
183606|NCT03048292|Ischemic|ischemic
183607|NCT03048292|Acute|acute
183608|NCT03048292|Endovascular|endovascular
183609|NCT03048292|Cerebrovascular|cerebrovascular
183610|NCT03048292|Clot|clot
183611|NCT03048292|Stent Retriever|stent retriever
183612|NCT03048292|Tissue Plasminogen Activator|tissue plasminogen activator
183613|NCT03048292|Drip and Ship|drip and ship
183614|NCT03048292|Mothership|mothership
183615|NCT03048292|Trip and Treat|trip and treat
183616|NCT03048279|Multiple Endocrine Neoplasia Syndromes|multiple endocrine neoplasia syndromes
183617|NCT03048279|MEN1|men1
183618|NCT03048279|MEN2|men2
183619|NCT03048279|Relatives|relatives
183620|NCT03048279|Database|database
234707|NCT02730884|MF|mf
183621|NCT03048279|Questionnaires|questionnaires
183622|NCT03048279|Surveys|surveys
183623|NCT03048266|Multiple endocrine neoplasia|multiple endocrine neoplasia
183624|NCT03048266|MEN1|men1
183625|NCT03048266|Aggressive pancreatic neuroendocrine tumors|aggressive pancreatic neuroendocrine tumors
183626|NCT03048266|PNET|pnet
183627|NCT03048266|Non-aggressive pancreatic neuroendocrine tumors|non-aggressive pancreatic neuroendocrine tumors
183628|NCT03048266|Metabolomics|metabolomics
183629|NCT03048266|Genetics|genetics
183630|NCT03048266|Biomarkers|biomarkers
183631|NCT03048240|Glioblastoma|glioblastoma
183632|NCT03048227|TIDM|tidm
183633|NCT03048227|Type1diabetes|type1diabetes
183634|NCT03048227|Implantable Pump|implantable pump
183635|NCT03048227|CGM|cgm
183636|NCT03048214|Nerve block; Infraclavicular; Acute pain|nerve block; infraclavicular; acute pain
183637|NCT03048201|Physica KR|physica kr
183638|NCT03048201|Physica CR|physica cr
183639|NCT03048201|Physica PS|physica ps
183640|NCT03048201|Kinematic Retaining|kinematic retaining
183641|NCT03048201|Cruciate Retaining|cruciate retaining
183642|NCT03048201|Posterior Stabilized|posterior stabilized
183643|NCT03048201|Physica System|physica system
183644|NCT03048175|C-reactive protein|c-reactive protein
183645|NCT03048175|Systemic inflammation|systemic inflammation
183646|NCT03048175|Third molar|third molar
183647|NCT03048175|Wisdom tooth|wisdom tooth
183648|NCT03048149|hazelnut allergy|hazelnut allergy
183649|NCT03048123|Hepatic arterial infusion chemotherapy|hepatic arterial infusion chemotherapy
183650|NCT03048123|Transarterial Chemoembolization|transarterial chemoembolization
183651|NCT03048123|Large and unresectable HCC|large and unresectable hcc
183652|NCT03048071|Contegra|contegra
183653|NCT03048071|Homograft|homograft
183654|NCT03048045|chronic periodontitis|chronic periodontitis
183655|NCT03048045|aggressive periodontitis|aggressive periodontitis
183656|NCT03048045|supportive periodontal treatment|supportive periodontal treatment
183657|NCT03048032|acute heart failure|acute heart failure
183658|NCT03048032|right ventricular failure|right ventricular failure
183659|NCT03048032|cardiac biomarkers|cardiac biomarkers
183660|NCT03048032|echocardiography|echocardiography
183661|NCT03048032|diagnosis|diagnosis
183662|NCT03048032|prognosis|prognosis
183663|NCT03047980|SWS|sws
183664|NCT03047980|Cognitive impairment|cognitive impairment
183665|NCT03047980|sirolimus|sirolimus
183666|NCT03047915|Anxiety|anxiety
183667|NCT03047915|Music intervention|music intervention
183668|NCT03047915|Emergency department (ED)|emergency department (ed)
183669|NCT03047902|Adolescent Smoking Cessation Asthma Carbon Monoxide.|adolescent smoking cessation asthma carbon monoxide.
183670|NCT03047876|cardiac|cardiac
183671|NCT03047876|aortic arch surgery|aortic arch surgery
183672|NCT03047876|Brain vascular reactivity|brain vascular reactivity
183673|NCT03047876|neonates|neonates
183674|NCT03047876|infants|infants
183675|NCT03047863|Epidermal Growth Factor|epidermal growth factor
183676|NCT03047850|Sternotomy|sternotomy
183677|NCT03047837|Colorectal cancer|colorectal cancer
183678|NCT03047837|aspirin|aspirin
183679|NCT03047837|metformin|metformin
183680|NCT03047837|chemoprevention|chemoprevention
183681|NCT03047798|centella asiatica|centella asiatica
183682|NCT03047798|bamboo salt|bamboo salt
183683|NCT03047798|magnolia bark|magnolia bark
183684|NCT03047798|gingivitis|gingivitis
183685|NCT03047798|dental plaque|dental plaque
183686|NCT03047798|mouthrinse|mouthrinse
183687|NCT03047785|Myocardial Infarction|myocardial infarction
183688|NCT03047785|Highly sensitive troponin|highly sensitive troponin
183689|NCT03047785|Hospital population|hospital population
183690|NCT03047785|99th percentile|99th percentile
183691|NCT03047785|Upper limit of normal|upper limit of normal
183692|NCT03047733|Vitiligo|vitiligo
183693|NCT03047733|308 nm excimer laser|308 nm excimer laser
183694|NCT03047720|bedwetting|bedwetting
183695|NCT03047707|ultrasound elastography|ultrasound elastography
183696|NCT03047707|S-Shearwave|s-shearwave
183697|NCT03047707|liver|liver
183698|NCT03047707|fibrosis|fibrosis
183699|NCT03047694|Lexico-semantic stimulation|lexico-semantic stimulation
183700|NCT03047694|tactile tablet|tactile tablet
183701|NCT03047681|TAVR|tavr
183702|NCT03047681|tryptse|tryptse
183703|NCT03047681|mast|mast
183704|NCT03047642|biomarker|biomarker
183705|NCT03047642|low and middle income countries|low and middle income countries
183706|NCT03047642|fever|fever
183707|NCT03047642|antimicrobial resistance|antimicrobial resistance
183708|NCT03047642|diagnostic|diagnostic
183709|NCT03047629|non-motor symptoms|non-motor symptoms
183710|NCT03047603|Hepatocellular carcinoma|hepatocellular carcinoma
183711|NCT03047603|Protein induced by vitamin K absence or antagonist-II|protein induced by vitamin k absence or antagonist-ii
183712|NCT03047603|Differential diagnosis|differential diagnosis
183713|NCT03047603|Des-γ-carboxy prothrombin|des-γ-carboxy prothrombin
183714|NCT03047603|Alpha-fetoprotein|alpha-fetoprotein
400613|NCT01866033|Bioavailability|bioavailability
400614|NCT01866020|aspergillosis|aspergillosis
183715|NCT03047603|Lens culinaris agglutinin-reactive fraction of alpha-fetoprotein-fetoprotein|lens culinaris agglutinin-reactive fraction of alpha-fetoprotein-fetoprotein
183716|NCT03047590|exercise behavior|exercise behavior
183717|NCT03047590|exercise prescription|exercise prescription
183718|NCT03047590|affect-based exercise|affect-based exercise
183719|NCT03047590|affect-guided exercise|affect-guided exercise
183720|NCT03047590|self-paced exercise|self-paced exercise
183721|NCT03047590|self-selected exercise|self-selected exercise
183722|NCT03047577|Brief intervention|brief intervention
183723|NCT03047577|Alcohol|alcohol
183724|NCT03047577|Alcohol use disorder|alcohol use disorder
183725|NCT03047577|Intensive care unit|intensive care unit
183726|NCT03047577|Critically ill|critically ill
183727|NCT03047577|Audit|audit
183728|NCT03047564|Total Knee Arthroplasty|total knee arthroplasty
183729|NCT03047564|Total Knee Replacement|total knee replacement
183730|NCT03047564|Outcome|outcome
183731|NCT03047564|Metal ion concentration|metal ion concentration
183732|NCT03047564|Results|results
183733|NCT03047551|Abortion, induced|abortion, induced
183734|NCT03047551|Ultrasonography|ultrasonography
183735|NCT03047551|Health Services accessibility|health services accessibility
183736|NCT03047551|Pragmatic Clinical Trial|pragmatic clinical trial
183737|NCT03047551|Randomized controlled trial as topic|randomized controlled trial as topic
183738|NCT03047538|Arterial hypertension|arterial hypertension
183739|NCT03047538|Dyslipidemia|dyslipidemia
183740|NCT03047538|Blood pressure control|blood pressure control
183741|NCT03047538|Fixed combination|fixed combination
183742|NCT03047525|cytokine-induced killer cell|cytokine-induced killer cell
183743|NCT03047525|dendritic and cytokine-induced killer cells|dendritic and cytokine-induced killer cells
183744|NCT03047512|Depression in adolescents|depression in adolescents
183745|NCT03047512|Mental Health|mental health
183746|NCT03047512|E-mental health|e-mental health
183747|NCT03047512|Prevention and Early intervention|prevention and early intervention
183748|NCT03047486|insulin pump|insulin pump
183749|NCT03047486|continuous glucose monitoring sensor|continuous glucose monitoring sensor
183750|NCT03047486|predictive low glucose suspend|predictive low glucose suspend
183751|NCT03047473|newly diagnosed|newly diagnosed
183752|NCT03047460|motor evoked potential|motor evoked potential
183753|NCT03047460|somatosensory evoked potentials|somatosensory evoked potentials
183754|NCT03047460|biomarker|biomarker
183755|NCT03047408|REM Sleep Behavior Disorder|rem sleep behavior disorder
183756|NCT03047408|Parkinson's Disease|parkinson's disease
183757|NCT03047408|REM sleep without Atonia|rem sleep without atonia
183758|NCT03047395|ABBV-066|abbv-066
183759|NCT03047395|BI 655066|bi 655066
183760|NCT03047369|leukodystrophy|leukodystrophy
183761|NCT03047369|white matter disease|white matter disease
183762|NCT03047369|leukoencephalopathy|leukoencephalopathy
183763|NCT03047369|myelin|myelin
183764|NCT03047369|demyelinating|demyelinating
183765|NCT03047369|mdbp|mdbp
183766|NCT03047343|pulmonary artery strapping|pulmonary artery strapping
183767|NCT03047330|menopause|menopause
183768|NCT03047330|sleep fragmentation|sleep fragmentation
183769|NCT03047330|leuprolide|leuprolide
183770|NCT03047330|adipokine|adipokine
183771|NCT03047330|weight gain|weight gain
183772|NCT03047330|leptin|leptin
183773|NCT03047317|pharmacokinetics|pharmacokinetics
183774|NCT03047291|mucositis, periimplantitis, probiotic|mucositis, periimplantitis, probiotic
183775|NCT03047226|Lynch Syndrome|lynch syndrome
183776|NCT03047226|mismatch repair|mismatch repair
183777|NCT03047226|microsatellite instability|microsatellite instability
183778|NCT03047226|next-generation sequencing|next-generation sequencing
183779|NCT03047226|immunohistochemistry|immunohistochemistry
183780|NCT03047200|Diabetes Mellitus|diabetes mellitus
183781|NCT03047200|Hypoglycemia|hypoglycemia
183782|NCT03047200|Hyperglycemia|hyperglycemia
183783|NCT03047200|Type 1 Diabetes|type 1 diabetes
183784|NCT03047200|Islet Cell Transplantation|islet cell transplantation
183785|NCT03047174|Head and Neck Neoplasms, Radio(chemo)therapy|head and neck neoplasms, radio(chemo)therapy
183786|NCT03047161|magnetocardiography|magnetocardiography
183787|NCT03047135|high-risk biochemically-recurrent|high-risk biochemically-recurrent
183788|NCT03047122|Breast|breast
183789|NCT03047122|ultrasonography|ultrasonography
183790|NCT03047109|Ephedrine|ephedrine
183791|NCT03047109|Phenylephrine|phenylephrine
183792|NCT03047109|Spinal Hypotension|spinal hypotension
183793|NCT03047109|Cesarean Section|cesarean section
183794|NCT03047109|Maternal Cardiodynamics|maternal cardiodynamics
183795|NCT03047083|Retrospective|retrospective
183796|NCT03047083|Non-interventional Study|non-interventional study
183797|NCT03047083|FMS-like tyrosine kinase-3 (FLT3) mutations|fms-like tyrosine kinase-3 (flt3) mutations
183798|NCT03047044|lumbar fusion surgery|lumbar fusion surgery
183799|NCT03047044|Patient Controlled Analgesia|patient controlled analgesia
183800|NCT03047044|Optimizing Basal Infusion Mode|optimizing basal infusion mode
183801|NCT03047018|Nutrition|nutrition
183802|NCT03046992|EGFR|egfr
183803|NCT03046992|Non-Small Cell Lung Cancer|non-small cell lung cancer
183804|NCT03046992|T790M|t790m
183805|NCT03046992|Brain Metastasis|brain metastasis
183806|NCT03046979|apatinib|apatinib
183807|NCT03046979|advanced hepatocellular carcinoma|advanced hepatocellular carcinoma
183808|NCT03046953|Lymphoma|lymphoma
183809|NCT03046927|Type 1 diabetes|type 1 diabetes
183810|NCT03046927|vitamin D|vitamin d
183811|NCT03046927|honeymoon phase|honeymoon phase
183812|NCT03046901|Vancomycin|vancomycin
183813|NCT03046901|Primary Sclerosing cholangitis|primary sclerosing cholangitis
183814|NCT03046901|Post-liver transplantation|post-liver transplantation
183815|NCT03046849|Lynch Syndrome|lynch syndrome
183816|NCT03046849|next-generation sequencing|next-generation sequencing
183817|NCT03046849|germline mutation|germline mutation
183818|NCT03046836|Couples|couples
183819|NCT03046836|Oxytocin|oxytocin
183820|NCT03046836|Aggression|aggression
183821|NCT03046836|Alcohol|alcohol
183822|NCT03046771|falls|falls
183823|NCT03046771|readmissions|readmissions
183824|NCT03046771|emergency department visits|emergency department visits
183825|NCT03046771|transitions of care|transitions of care
183826|NCT03046745|Gastric cancer, endoscopy, pepsinogen, TFF3, biomarker|gastric cancer, endoscopy, pepsinogen, tff3, biomarker
183827|NCT03046732|Kidney Transplant Education|kidney transplant education
183828|NCT03046732|Transplant Readiness|transplant readiness
183829|NCT03046732|Living Donor Kidney Transplant|living donor kidney transplant
183830|NCT03046732|Chronic Kidney Disease|chronic kidney disease
183831|NCT03046732|End Stage Kidney Disease|end stage kidney disease
183832|NCT03046732|Renal Replacement Therapy|renal replacement therapy
183833|NCT03046719|bupivacaine|bupivacaine
183834|NCT03046719|intravitreal|intravitreal
183835|NCT03046719|analgesia|analgesia
183836|NCT03046719|silicone oil removal|silicone oil removal
183837|NCT03046719|retinal detachment|retinal detachment
183838|NCT03046719|subconjunctival|subconjunctival
183839|NCT03046706|voice rest|voice rest
183840|NCT03046706|laryngeal surgery|laryngeal surgery
183841|NCT03046706|glottic polyp|glottic polyp
183842|NCT03046706|glottic cyst|glottic cyst
183843|NCT03046693|Non-arteritic anterior ischemic optic neuropathy|non-arteritic anterior ischemic optic neuropathy
183844|NCT03046693|pattern electroretinography|pattern electroretinography
183845|NCT03046693|citicoline|citicoline
183846|NCT03046693|retinal ganglion cell|retinal ganglion cell
183847|NCT03046693|visual field|visual field
183848|NCT03046667|Beta glucans|beta glucans
183849|NCT03046667|Barley|barley
183850|NCT03046667|SCFA|scfa
183851|NCT03046667|Calprotectin|calprotectin
183852|NCT03046667|Microbiota|microbiota
183853|NCT03046667|Hydrogene|hydrogene
183854|NCT03046667|Methane|methane
183855|NCT03046667|Metabolomics|metabolomics
183856|NCT03046667|Stool volume|stool volume
183857|NCT03046667|Stool frequency|stool frequency
183858|NCT03046641|Caloric Restriction|caloric restriction
183859|NCT03046641|Dietary Formulations|dietary formulations
183860|NCT03046641|Exercise|exercise
183861|NCT03046641|Men|men
183862|NCT03046615|EEG electrodes|eeg electrodes
183863|NCT03046563|acupressure|acupressure
183864|NCT03046563|abdominal massage|abdominal massage
183865|NCT03046563|constipation|constipation
183866|NCT03046563|stroke patients|stroke patients
183867|NCT03046563|Traditional Chinese medicine|traditional chinese medicine
183868|NCT03046524|Parathyroid Carcinoma|parathyroid carcinoma
183869|NCT03046524|Parathyroid Neoplasm|parathyroid neoplasm
183870|NCT03046524|Chart Review|chart review
183871|NCT03046485|AMD|amd
183872|NCT03046485|vision loss|vision loss
183873|NCT03046485|self-management strategies|self-management strategies
183874|NCT03046485|low-vision rehabilitation|low-vision rehabilitation
183875|NCT03046485|IVI|ivi
183876|NCT03046472|thorax curve angle|thorax curve angle
183877|NCT03046459|cytokines|cytokines
183878|NCT03046459|interleukin-2|interleukin-2
183879|NCT03046459|Safety Issues|safety issues
183880|NCT03046446|Osteoarthritis|osteoarthritis
183881|NCT03046446|Knee|knee
183882|NCT03046446|Pain|pain
183883|NCT03046446|Steroid|steroid
183884|NCT03046446|Intra-articular|intra-articular
183885|NCT03046446|Injection|injection
183886|NCT03046433|children|children
183887|NCT03046433|asthma|asthma
183888|NCT03046433|China|china
183889|NCT03046394|prosthetic feet|prosthetic feet
183890|NCT03046394|gait pattern|gait pattern
183891|NCT03046394|one leg standing|one leg standing
183892|NCT03046394|walking speed|walking speed
183893|NCT03046342|Gastroenteritis, Polymerase chain reaction|gastroenteritis, polymerase chain reaction
183894|NCT03046329|patient care planning|patient care planning
183895|NCT03046316|Therapeutics|therapeutics
183896|NCT03046303|ERAS,gastric cancer|eras,gastric cancer
183897|NCT03046264|central blood pressure|central blood pressure
183898|NCT03046264|measurement|measurement
183899|NCT03046264|oscillometric radial pulse wave analysis|oscillometric radial pulse wave analysis
183900|NCT03046186|Gastric sleeve|gastric sleeve
183901|NCT03046186|Gastric bypass|gastric bypass
183902|NCT03046160|PPT|ppt
183903|NCT03046160|Scapula|scapula
183904|NCT03046160|Intervention|intervention
183905|NCT03046160|Manual therapy|manual therapy
183906|NCT03046160|mobilization|mobilization
235059|NCT02728752|DM|dm
183907|NCT03046121|dementia|dementia
183908|NCT03046121|acute care|acute care
183909|NCT03046121|post-acute recovery|post-acute recovery
183910|NCT03046121|family caregivers|family caregivers
183911|NCT03046095|Muscle Hypertrophy|muscle hypertrophy
183912|NCT03046095|Muscle Atrophy|muscle atrophy
183913|NCT03046095|Resistance Training|resistance training
183914|NCT03046095|Immobilization|immobilization
183915|NCT03046069|Triple therapy|triple therapy
183916|NCT03046069|COPD|copd
183917|NCT03046069|DCE|dce
183918|NCT03046069|Qualitative|qualitative
183919|NCT03046004|breast cancer|breast cancer
183920|NCT03046004|screening|screening
183921|NCT03046004|decision aid|decision aid
183922|NCT03046004|informed choice|informed choice
183923|NCT03046004|decisional conflict|decisional conflict
183924|NCT03045965|Salpingectomy|salpingectomy
183925|NCT03045965|Hysterectomy|hysterectomy
183926|NCT03045965|Ovarian cancer|ovarian cancer
183927|NCT03045952|Multicenter study|multicenter study
183928|NCT03045952|microwave|microwave
183929|NCT03045939|cervical ripening|cervical ripening
183930|NCT03045939|labor induction|labor induction
183931|NCT03045939|double balloon device|double balloon device
183932|NCT03045939|cervical ripening device|cervical ripening device
183933|NCT03045939|unfavorable cervix|unfavorable cervix
183934|NCT03045913|Observational registry|observational registry
183935|NCT03045913|All-comers open label registry|all-comers open label registry
183936|NCT03045913|Genoss DES|genoss des
183937|NCT03045913|Multicenter|multicenter
183938|NCT03045913|Stenting|stenting
183939|NCT03045913|Coronary Artery Disease|coronary artery disease
183940|NCT03045913|Coronary revascularization|coronary revascularization
183941|NCT03045913|Percutaneous Coronary Intervention|percutaneous coronary intervention
183942|NCT03045887|repeat dose|repeat dose
183943|NCT03045887|GSK2292767|gsk2292767
183944|NCT03045887|smoke|smoke
183945|NCT03045887|tolerability|tolerability
183946|NCT03045887|safety|safety
183947|NCT03045887|dry powder inhalation|dry powder inhalation
183948|NCT03045887|pharmacokinetics|pharmacokinetics
183949|NCT03045887|single dose|single dose
183950|NCT03045848|Observational registry|observational registry
183951|NCT03045848|All-comers open label registry|all-comers open label registry
183952|NCT03045848|Drug coated stent|drug coated stent
183953|NCT03045848|Multicenter|multicenter
183954|NCT03045848|Stenting|stenting
183955|NCT03045848|Coronary Artery Disease|coronary artery disease
183956|NCT03045848|Coronary revascularization|coronary revascularization
183957|NCT03045848|Percutaneous Coronary Intervention|percutaneous coronary intervention
183958|NCT03045835|laparoscopic cholecystectomy BASKA mask Endotracheal tube|laparoscopic cholecystectomy baska mask endotracheal tube
183959|NCT03045822|Bioimpedance analysis|bioimpedance analysis
183960|NCT03045822|implantable cardioverter-defibrillators|implantable cardioverter-defibrillators
183961|NCT03045822|pacemakers|pacemakers
183962|NCT03045809|Syndromic management|syndromic management
183963|NCT03045809|Point of care testing|point of care testing
183964|NCT03045783|gastric varices|gastric varices
183965|NCT03045783|endoscopic injection of tissue adhesive|endoscopic injection of tissue adhesive
183966|NCT03045731|kidney transplantation|kidney transplantation
183967|NCT03045731|ultrasound|ultrasound
183968|NCT03045731|mathematical model|mathematical model
183969|NCT03045718|Horticultural Therapy|horticultural therapy
183970|NCT03045718|Dementia|dementia
183971|NCT03045718|Randomized Controlled Trial|randomized controlled trial
183973|NCT03045718|Prevention|prevention
183974|NCT03045692|drug dosing, eGFR, CCr|drug dosing, egfr, ccr
183975|NCT03045679|Roux-en Y gastric bypass|roux-en y gastric bypass
183976|NCT03045679|One-anastomosis gastric bypass|one-anastomosis gastric bypass
183977|NCT03045679|Mini-gastric bypass|mini-gastric bypass
183978|NCT03045679|metabolic surgery|metabolic surgery
183979|NCT03045653|Breast Cancer|breast cancer
183980|NCT03045653|high dose Tamoxifen|high dose tamoxifen
183981|NCT03045653|endocrine therapy|endocrine therapy
183982|NCT03045653|Hormone Receptor Positive Malignant Neoplasm of Breast|hormone receptor positive malignant neoplasm of breast
183983|NCT03045653|Tamoxifen|tamoxifen
183984|NCT03045653|Breast Cancer Metastatic|breast cancer metastatic
183985|NCT03045640|ECD|ecd
183986|NCT03045640|parenting program|parenting program
183987|NCT03045640|home visiting|home visiting
183988|NCT03045627|Acute Myeloid Leukemia|acute myeloid leukemia
183989|NCT03045627|PEG-G-CSF|peg-g-csf
183990|NCT03045601|Diagnostic Techniques, Cardiovascular|diagnostic techniques, cardiovascular
183991|NCT03045601|Coronary Angiography|coronary angiography
183992|NCT03045601|Fractional Flow Reserve, Myocardial|fractional flow reserve, myocardial
183993|NCT03045601|Echocardiography, Stress|echocardiography, stress
183994|NCT03045510|Decitabine Myelodysplastic syndrome|decitabine myelodysplastic syndrome
183995|NCT03045484|nasopharyngeal carcinoma|nasopharyngeal carcinoma
183996|NCT03045484|Oral Mucositis Pain|oral mucositis pain
183997|NCT03045484|Oxycodone|oxycodone
183998|NCT03045458|one stage dental implant|one stage dental implant
183999|NCT03045458|two stage dental implant|two stage dental implant
184000|NCT03045458|Interleukin-1β|interleukin-1β
184001|NCT03045445|CT|ct
184002|NCT03045445|dual energy|dual energy
184003|NCT03045445|low dose|low dose
184004|NCT03045432|Stroke|stroke
184005|NCT03045432|Hemiplegia|hemiplegia
184006|NCT03045432|Rotator Cuff Injury|rotator cuff injury
184007|NCT03045419|MRI|mri
184008|NCT03045419|gadoxetic acid|gadoxetic acid
184009|NCT03045419|CT|ct
184010|NCT03045393|Neoadjuvant|neoadjuvant
184011|NCT03045393|Breast Cancer|breast cancer
184012|NCT03045393|Folate Receptor Alpha|folate receptor alpha
184013|NCT03045393|FRa|fra
184014|NCT03045393|TNBC|tnbc
184015|NCT03045393|Triple Negative Breast Cancer|triple negative breast cancer
184016|NCT03045393|Preoperative|preoperative
184017|NCT03045393|Presurgery|presurgery
184018|NCT03045393|Mirvetuximab Soravtansine|mirvetuximab soravtansine
184019|NCT03045393|IMGN853|imgn853
184020|NCT03045367|Metamorphopsia|metamorphopsia
184021|NCT03045367|Epiretinal membrane|epiretinal membrane
184022|NCT03045367|Vitrectomy|vitrectomy
184023|NCT03045354|children|children
184024|NCT03045354|dietary carbohydrates|dietary carbohydrates
184025|NCT03045354|satiety|satiety
184026|NCT03045354|appetite|appetite
184027|NCT03045354|blood glucose|blood glucose
184028|NCT03045354|solanum tuberosum|solanum tuberosum
184029|NCT03045354|obesity|obesity
184030|NCT03045354|breakfast|breakfast
184031|NCT03045276|Spina Bifida|spina bifida
184032|NCT03045276|Kidney Transplant|kidney transplant
184033|NCT03045263|ASD|asd
184034|NCT03045237|Pregnancy|pregnancy
184035|NCT03045237|Physical activity|physical activity
184036|NCT03045237|Newborn|newborn
184037|NCT03045237|Depressive Symptoms|depressive symptoms
184038|NCT03045237|Dietary habits|dietary habits
184039|NCT03045237|Healthy lifestyles|healthy lifestyles
184040|NCT03045224|PAD, PTA, mortality, morbidity, amputation rate, quality of life|pad, pta, mortality, morbidity, amputation rate, quality of life
184041|NCT03045224|Percutaneous transluminal angioplasty (PTA), Stenting, balloon angioplasty|percutaneous transluminal angioplasty (pta), stenting, balloon angioplasty
184042|NCT03045198|cystic fibrosis|cystic fibrosis
184043|NCT03045185|Non Vital teeth|non vital teeth
184044|NCT03045185|Traumatised teeth|traumatised teeth
184045|NCT03045185|Immature teeth|immature teeth
184046|NCT03045185|Regenerative Endodontics|regenerative endodontics
184047|NCT03045172|Lichen Sclerosus|lichen sclerosus
184048|NCT03045172|Platelet Rich Plasma|platelet rich plasma
184049|NCT03045172|Vulvar|vulvar
184050|NCT03045172|Vulva|vulva
184051|NCT03045159|deployment cycle|deployment cycle
184052|NCT03045159|military family|military family
184053|NCT03045159|prevention|prevention
184054|NCT03045159|stress|stress
184055|NCT03045159|military child|military child
184056|NCT03045159|parenting|parenting
184057|NCT03045159|coparenting|coparenting
184058|NCT03045146|Acute Ischemic Stroke, Thrombectomy|acute ischemic stroke, thrombectomy
184059|NCT03045133|Postoperative pain|postoperative pain
184060|NCT03045133|Postoperative nausea and vomiting|postoperative nausea and vomiting
184061|NCT03045133|Quality of recovery|quality of recovery
184062|NCT03045133|QoR-40|qor-40
184063|NCT03045133|Total intravenous anesthesia|total intravenous anesthesia
184064|NCT03045107|right colon|right colon
184065|NCT03045107|laparoscopic right colectomy|laparoscopic right colectomy
184066|NCT03045107|intracorporeal anastomosis|intracorporeal anastomosis
184067|NCT03045107|extracorporeal anastomosis|extracorporeal anastomosis
184068|NCT03045107|hospital stay|hospital stay
184069|NCT03045107|quality of life|quality of life
184070|NCT03045107|costs|costs
184071|NCT03045094|pediatric|pediatric
184072|NCT03045094|intubation|intubation
184073|NCT03045094|neck movement|neck movement
184074|NCT03045055|Acute ischemic stroke|acute ischemic stroke
184075|NCT03045055|Endovascular treatment|endovascular treatment
184076|NCT03045055|Remote ischemic conditioning|remote ischemic conditioning
184077|NCT03045042|Pompe|pompe
184078|NCT03045042|microRNA|microrna
184079|NCT03045042|biomarker|biomarker
184080|NCT03045042|muscle MRI|muscle mri
184081|NCT03045042|glycogenosis|glycogenosis
184082|NCT03045029|PAH|pah
184083|NCT03045029|Oral Treprostiinil|oral treprostiinil
184084|NCT03045029|Orenitram|orenitram
184085|NCT03045016|Acute stress Disorder|acute stress disorder
184086|NCT03045016|Post Traumatic Stress Disorder|post traumatic stress disorder
184087|NCT03045016|Prevention|prevention
184088|NCT03045016|trauma|trauma
184089|NCT03045016|prazosin|prazosin
184090|NCT03045003|Resilience, Supportive Care, Psychosocial Care, Nursing|resilience, supportive care, psychosocial care, nursing
184091|NCT03044990|Acute coronary syndrome|acute coronary syndrome
184092|NCT03044990|renal insufficiency|renal insufficiency
184093|NCT03044990|mortality|mortality
184094|NCT03044977|3-Iodobenzylguanidine|3-iodobenzylguanidine
184095|NCT03044977|dose-response relationship, radiation|dose-response relationship, radiation
184096|NCT03044977|theranostic|theranostic
184097|NCT03044977|radionuclide|radionuclide
184098|NCT03044977|MIBG|mibg
184099|NCT03044977|DOTA|dota
184100|NCT03044964|Angina, Chest Pain|angina, chest pain
184101|NCT03044951|atrial fibrillation|atrial fibrillation
184102|NCT03044951|cryoablation|cryoablation
184103|NCT03044951|irrigated radiofrequency ablation|irrigated radiofrequency ablation
184104|NCT03044951|pulmonary vein isolation|pulmonary vein isolation
184105|NCT03044938|Asthma|asthma
184106|NCT03044938|Salbutamol|salbutamol
184107|NCT03044938|Exercise|exercise
184108|NCT03044938|Heart Rate|heart rate
184109|NCT03044938|Blood pressure|blood pressure
184110|NCT03044925|persistent atrial fibrillation|persistent atrial fibrillation
184111|NCT03044925|remote magnetic navigation|remote magnetic navigation
184112|NCT03044925|cryoablation|cryoablation
184113|NCT03044899|Surgery|surgery
184114|NCT03044899|Complications|complications
184115|NCT03044899|Mortality|mortality
184116|NCT03044886|Vitamin D|vitamin d
184117|NCT03044821|Neural Tube Defect|neural tube defect
184118|NCT03044795|homologous recombination deficiency|homologous recombination deficiency
184119|NCT03044795|veliparib|veliparib
184120|NCT03044795|PARP inhibitor|parp inhibitor
184121|NCT03044795|biomarker|biomarker
184122|NCT03044769|Congenital Lung Anomalies|congenital lung anomalies
184123|NCT03044756|GnRH antagonist|gnrh antagonist
184124|NCT03044756|Pituitary downregulation|pituitary downregulation
184125|NCT03044756|IVF|ivf
184126|NCT03044756|ICSI|icsi
184127|NCT03044743|PD-1|pd-1
184128|NCT03044743|CRISPR Cas9|crispr cas9
184129|NCT03044743|EBV|ebv
184130|NCT03044743|advanced stage malignancies|advanced stage malignancies
184131|NCT03044717|Nutrition Education|nutrition education
184132|NCT03044717|Cardiology Fellows|cardiology fellows
184133|NCT03044652|Vulvovaginal Dryness|vulvovaginal dryness
184134|NCT03044626|Nivolumab|nivolumab
184135|NCT03044626|Radiotherapy|radiotherapy
184136|NCT03044600|Parathyroid disease|parathyroid disease
184137|NCT03044600|Hyperparathyroidism|hyperparathyroidism
184138|NCT03044600|Chart review|chart review
184139|NCT03044600|MEN1-negative|men1-negative
184140|NCT03044600|HRPT2 mutations|hrpt2 mutations
184141|NCT03044587|Biliary Tract Cancer|biliary tract cancer
184142|NCT03044587|NaI-IRI|nai-iri
184143|NCT03044574|venous thromboembolism|venous thromboembolism
184144|NCT03044574|deep vein thrombosis|deep vein thrombosis
184145|NCT03044574|pulmonary embolism|pulmonary embolism
184146|NCT03044574|prevention|prevention
184147|NCT03044574|intermittent pneumatic compression|intermittent pneumatic compression
184148|NCT03044574|sequential pneumatic compression|sequential pneumatic compression
184149|NCT03044574|surgery|surgery
184150|NCT03044574|elastic compression|elastic compression
184151|NCT03044574|low-molecular weight heparin|low-molecular weight heparin
184152|NCT03044574|prophylaxis|prophylaxis
184153|NCT03044535|quality of life|quality of life
184154|NCT03044535|mechanical circulatory support|mechanical circulatory support
184155|NCT03044509|Immunodiagnostics tests|immunodiagnostics tests
184156|NCT03044509|TB exposure|tb exposure
184157|NCT03044509|Latent TB|latent tb
184158|NCT03044509|TB disease|tb disease
184159|NCT03044509|Biomarkers|biomarkers
184160|NCT03044496|NIR Spectroscopy|nir spectroscopy
184161|NCT03044496|Nerve Blockade|nerve blockade
184162|NCT03044496|Surgical Arteriovenous Shunt|surgical arteriovenous shunt
184163|NCT03044483|Sepsis|sepsis
184164|NCT03044483|Microcirculatory function|microcirculatory function
184165|NCT03044444|performance|performance
184166|NCT03044444|polyphenols|polyphenols
184167|NCT03044444|nutrition|nutrition
184168|NCT03044444|sports|sports
184169|NCT03044431|Shortness of breath|shortness of breath
184170|NCT03044431|Breathlessness|breathlessness
184171|NCT03044431|Stem cells|stem cells
184172|NCT03044431|Platelet rich plasma|platelet rich plasma
184173|NCT03044431|Quality of life|quality of life
184174|NCT03044431|Pulmonary Function|pulmonary function
184175|NCT03044418|laser|laser
184176|NCT03044418|endotracheal tube|endotracheal tube
184177|NCT03044418|total intravenous anesthesia|total intravenous anesthesia
184178|NCT03044418|side effect|side effect
184179|NCT03044418|endolaryngeal surgery|endolaryngeal surgery
184180|NCT03044405|fluid responsiveness|fluid responsiveness
184181|NCT03044405|focused echocardiography|focused echocardiography
184182|NCT03044405|major surgery|major surgery
184183|NCT03044392|Programmed Intermittent Epidural Bolus|programmed intermittent epidural bolus
184184|NCT03044392|Labour Analgesia|labour analgesia
184185|NCT03044392|Pain|pain
184186|NCT03044353|echocardiography (ECHO)|echocardiography (echo)
184187|NCT03044353|skin biopsy|skin biopsy
184188|NCT03044353|monoclonal anti-serum amyloid p component antibody (anti-SAP mAb)|monoclonal anti-serum amyloid p component antibody (anti-sap mab)
184189|NCT03044353|Amyloidosis|amyloidosis
184190|NCT03044353|cardiac magnetic resonance imaging (CMR)|cardiac magnetic resonance imaging (cmr)
184191|NCT03044353|biomarkers|biomarkers
184192|NCT03044353|cardiac functional measures|cardiac functional measures
184193|NCT03044353|left ventricular mass|left ventricular mass
184194|NCT03044314|pulmonary hypertension|pulmonary hypertension
184195|NCT03044314|vasodilator challenge|vasodilator challenge
184196|NCT03044314|echocardiography|echocardiography
184197|NCT03044314|outcomes|outcomes
184198|NCT03044314|iloprost|iloprost
235484|NCT02725970|DGA|dga
184199|NCT03044314|inhaled nitric oxide|inhaled nitric oxide
184200|NCT03044249|Psychotic Disorders|psychotic disorders
184201|NCT03044223|pseudomonas aeruginosa|pseudomonas aeruginosa
184202|NCT03044223|critically ill patient|critically ill patient
184203|NCT03044223|sepsis|sepsis
184204|NCT03044223|monocyte|monocyte
184205|NCT03044223|macrophage|macrophage
184206|NCT03044223|cytokine|cytokine
184207|NCT03044223|severity of disease|severity of disease
184208|NCT03044210|Rest energetic cost measured by indirect calorimetry|rest energetic cost measured by indirect calorimetry
184209|NCT03044210|Hormonal axis|hormonal axis
184210|NCT03044210|Mitochondrial oxidative phosphorylation|mitochondrial oxidative phosphorylation
184211|NCT03044210|Basal metabolism|basal metabolism
184212|NCT03044197|prostate cancer|prostate cancer
184213|NCT03044197|magnetic resonance imaging|magnetic resonance imaging
184214|NCT03044197|transperineal biopsy|transperineal biopsy
184215|NCT03044197|target lesion|target lesion
184216|NCT03044197|fusion biopsy|fusion biopsy
184217|NCT03044184|Tranexamic Acid|tranexamic acid
184218|NCT03044184|Antifibrinolytic|antifibrinolytic
184219|NCT03044158|tuberculosis|tuberculosis
184220|NCT03044158|implementation science|implementation science
184221|NCT03044158|point-of-care|point-of-care
184222|NCT03044158|diagnostics|diagnostics
184223|NCT03044158|GeneXpert|genexpert
184224|NCT03044158|Uganda|uganda
184225|NCT03044145|Cultural Competence|cultural competence
184226|NCT03044145|Patient-Clinician communication|patient-clinician communication
184227|NCT03044132|Diabetic Foot Ulcer|diabetic foot ulcer
184228|NCT03044132|DFU|dfu
184229|NCT03044132|Lower Extremity Wound|lower extremity wound
184230|NCT03044132|Skin Substitute|skin substitute
184231|NCT03044106|hamstrings|hamstrings
184232|NCT03044106|flexibility|flexibility
184233|NCT03044106|strength|strength
184234|NCT03044106|pain pressure threshold|pain pressure threshold
184235|NCT03044106|lllt|lllt
184236|NCT03044106|photobiomodulation|photobiomodulation
184237|NCT03044106|cranial reflex|cranial reflex
184238|NCT03044106|cranial laser reflex technique|cranial laser reflex technique
184239|NCT03044106|CLRT|clrt
184240|NCT03044080|Walking Disorder|walking disorder
184241|NCT03044080|Stroke|stroke
184242|NCT03044080|Botulinum Toxin|botulinum toxin
184243|NCT03044080|Spasticity|spasticity
184244|NCT03044067|Chronic pain|chronic pain
184245|NCT03044067|Fibromyalgia|fibromyalgia
184246|NCT03044067|Pain neuroscience education|pain neuroscience education
184247|NCT03044067|Exercise|exercise
184248|NCT03044054|HIFU|hifu
184249|NCT03044041|Blood loss|blood loss
184250|NCT03044041|Tranexamic acid|tranexamic acid
184251|NCT03044041|Total knee arthroplasty|total knee arthroplasty
184252|NCT03044041|Topical administration|topical administration
184253|NCT03043989|docetaxel|docetaxel
184254|NCT03043989|cabazitaxel|cabazitaxel
184255|NCT03043989|phase 1b|phase 1b
184256|NCT03043989|castration-resistant|castration-resistant
184257|NCT03043989|bone metastasis|bone metastasis
184258|NCT03043976|Physical activity|physical activity
184259|NCT03043976|Steps count|steps count
184260|NCT03043950|mCRC|mcrc
184261|NCT03043950|First line|first line
184262|NCT03043950|Panitumumab|panitumumab
184263|NCT03043950|mCCS Prognostic Score|mccs prognostic score
184264|NCT03043950|Prognosis|prognosis
184265|NCT03043950|Ras wild type|ras wild type
184266|NCT03043924|hypothalamus|hypothalamus
184267|NCT03043924|Diffusion Magnetic Resonance Imaging|diffusion magnetic resonance imaging
184268|NCT03043924|Magnetic Resonance Spectroscopy|magnetic resonance spectroscopy
184269|NCT03043911|early detection|early detection
184270|NCT03043911|respiratory events|respiratory events
184271|NCT03043911|sepsis|sepsis
184272|NCT03043872|Carcinoma, Small Cell Lung|carcinoma, small cell lung
184273|NCT03043872|Oat Cell Carcinoma of Lung|oat cell carcinoma of lung
184274|NCT03043872|Oat Cell Lung Cancer|oat cell lung cancer
184275|NCT03043872|Small Cell Cancer Of The Lung|small cell cancer of the lung
184276|NCT03043872|Small Cell Lung Cancer|small cell lung cancer
184277|NCT03043846|Treat to Target approach|treat to target approach
184278|NCT03043820|raloxifene|raloxifene
184279|NCT03043820|selective estrogen receptor modulator (SERM)|selective estrogen receptor modulator (serm)
184280|NCT03043820|schizophrenia|schizophrenia
184281|NCT03043820|psychosis|psychosis
184282|NCT03043820|cognition|cognition
184283|NCT03043820|negative symptoms|negative symptoms
184284|NCT03043807|prostatectomy|prostatectomy
184285|NCT03043807|androgen deprivation|androgen deprivation
184286|NCT03043807|chemotherapy|chemotherapy
184287|NCT03043807|radiation|radiation
184288|NCT03043794|early stage|early stage
184289|NCT03043794|low risk|low risk
184290|NCT03043768|Parkinson's disease|parkinson's disease
184291|NCT03043768|Autonomic|autonomic
184292|NCT03043768|Diagnosis|diagnosis
184293|NCT03043768|Pilomotor|pilomotor
184294|NCT03043768|Alpha-synuclein|alpha-synuclein
184295|NCT03043768|Axon-reflex|axon-reflex
184296|NCT03043768|Peripheral nerve fibers|peripheral nerve fibers
184297|NCT03043729|neoadjuvant|neoadjuvant
184298|NCT03043729|MRI-defined T3|mri-defined t3
184299|NCT03043729|mFOLFOX6|mfolfox6
184300|NCT03043729|Aflibercept|aflibercept
184301|NCT03043690|menopause|menopause
184302|NCT03043690|ammonium succinate|ammonium succinate
184303|NCT03043664|GEP-NET|gep-net
184304|NCT03043664|Pembrolizumab|pembrolizumab
184305|NCT03043664|Lanreotide depot|lanreotide depot
184306|NCT03043664|PD-1|pd-1
184307|NCT03043651|Pulmonary Hypertension|pulmonary hypertension
184308|NCT03043651|HFpEF|hfpef
184309|NCT03043651|6-Minute Walk Test|6-minute walk test
184310|NCT03043651|Oral Treprostinil|oral treprostinil
184311|NCT03043638|multiple adjacent gingival recessions|multiple adjacent gingival recessions
184312|NCT03043638|platelet rich plasma|platelet rich plasma
184313|NCT03043638|acellular dermal matrix|acellular dermal matrix
184314|NCT03043638|coronally advanced flap|coronally advanced flap
184315|NCT03043638|gingival recession|gingival recession
184316|NCT03043638|root coverage|root coverage
184317|NCT03043638|clinical attachment level|clinical attachment level
184318|NCT03043625|Neck pain|neck pain
184319|NCT03043625|visceral manipulation|visceral manipulation
184320|NCT03043625|functional dyspepsia|functional dyspepsia
184321|NCT03043625|electromyography|electromyography
184322|NCT03043625|pain|pain
184323|NCT03043612|Ureteroscopy for urolithiasis|ureteroscopy for urolithiasis
184324|NCT03043599|Thoracic|thoracic
184325|NCT03043599|Radiotherapy|radiotherapy
184326|NCT03043599|Platinum Based Chemotherapy|platinum based chemotherapy
184327|NCT03043599|Immunotherapy|immunotherapy
184328|NCT03043599|Ipilimumab|ipilimumab
184329|NCT03043599|Nivolumab|nivolumab
184330|NCT03043599|Extensive-Stage Disease Small Cell Lung Cancer (ED-SCLC)|extensive-stage disease small cell lung cancer (ed-sclc)
184331|NCT03043586|Acromegaly|acromegaly
184332|NCT03043560|depression|depression
184333|NCT03043560|anhedonia|anhedonia
184334|NCT03043560|reward|reward
184335|NCT03043547|nal-IRI|nal-iri
184336|NCT03043547|5-Fluorouracil|5-fluorouracil
184337|NCT03043508|Genetic mutation|genetic mutation
184338|NCT03043508|MEN1|men1
184339|NCT03043508|Pancreatic neuroendocrine tumor|pancreatic neuroendocrine tumor
184340|NCT03043508|PNET|pnet
184341|NCT03043508|Chart review|chart review
184342|NCT03043508|Questionnaire|questionnaire
184343|NCT03043508|Survey|survey
184344|NCT03043495|dexamethasone|dexamethasone
184345|NCT03043495|supraclavicular brachial plexus block|supraclavicular brachial plexus block
184346|NCT03043495|ultrasound|ultrasound
184347|NCT03043482|VS-105|vs-105
184348|NCT03043482|Renal Insufficiency, Chronic|renal insufficiency, chronic
184349|NCT03043482|Secondary hyperparathyroidism|secondary hyperparathyroidism
184350|NCT03043469|dysfunctional breathing|dysfunctional breathing
184351|NCT03043443|sleep|sleep
184352|NCT03043443|Alcohol dependence|alcohol dependence
184353|NCT03043443|Melatonin|melatonin
184354|NCT03043417|Stigma|stigma
184355|NCT03043417|Primary Health Care|primary health care
184356|NCT03043417|Recovery|recovery
184357|NCT03043391|Pediatric Malignant Glioma|pediatric malignant glioma
184358|NCT03043391|PVSRIPO|pvsripo
184359|NCT03043391|Pro00071228|pro00071228
184360|NCT03043391|Eric Thompson|eric thompson
184361|NCT03043391|Darell Bigner|darell bigner
184362|NCT03043391|Oncolytic Poliovirus|oncolytic poliovirus
184363|NCT03043391|Daniel Landi|daniel landi
184364|NCT03043378|Malignant Neoplasms of Independent (Primary) Multiple Sites|malignant neoplasms of independent (primary) multiple sites
184365|NCT03043378|Non-malignant pain|non-malignant pain
184366|NCT03043378|Supportive care|supportive care
184367|NCT03043378|Questionnaires|questionnaires
184368|NCT03043378|Surveys|surveys
184369|NCT03043378|Chronic non-malignant pain|chronic non-malignant pain
184370|NCT03043365|Fish Oils|fish oils
184371|NCT03043365|Long Chain Monounsaturated Fatty Acids|long chain monounsaturated fatty acids
184372|NCT03043365|Lipoproteins|lipoproteins
184373|NCT03043365|Cardiovascular Disease|cardiovascular disease
184375|NCT03043352|Malnutrition|malnutrition
184376|NCT03043352|LHW|lhw
184377|NCT03043352|CMAM|cmam
184378|NCT03043339|Microbiota composition|microbiota composition
184379|NCT03043339|Kidney transplant recipient|kidney transplant recipient
184380|NCT03043339|Kidney transplant donor|kidney transplant donor
184381|NCT03043339|Antibiotics|antibiotics
184382|NCT03043339|Drug resistance|drug resistance
184383|NCT03043339|Transplantation surgery|transplantation surgery
184384|NCT03043326|Pre-exposure Prophylaxis|pre-exposure prophylaxis
184385|NCT03043326|MSM and transgender women|msm and transgender women
184386|NCT03043313|HER2|her2
184387|NCT03043313|ERBB2|erbb2
184388|NCT03043313|Colorectal cancer|colorectal cancer
184389|NCT03043300|Travelers' diarrhea|travelers' diarrhea
184390|NCT03043300|Intestinal microbiota|intestinal microbiota
184391|NCT03043300|Antibiotic resistance|antibiotic resistance
184392|NCT03043300|Antibiotics|antibiotics
184393|NCT03043300|Gastrointestinal disorders|gastrointestinal disorders
184394|NCT03043300|Infectious diseases|infectious diseases
184395|NCT03043300|International Travel|international travel
235676|NCT02724943|BMI|bmi
184396|NCT03043300|Travel Medicine|travel medicine
184397|NCT03043300|Resistome|resistome
184398|NCT03043300|Microbiome|microbiome
184399|NCT03043261|CHF|chf
184400|NCT03043248|TRK-700|trk-700
184401|NCT03043248|PK|pk
184402|NCT03043248|Digoxin|digoxin
184403|NCT03043248|Midazolam|midazolam
184404|NCT03043248|Drug-Drug interaction|drug-drug interaction
184405|NCT03043248|P-glycoprotein|p-glycoprotein
184406|NCT03043248|CYP3A4|cyp3a4
184407|NCT03043248|MDR1|mdr1
184408|NCT03043248|pharmacokinetics|pharmacokinetics
184409|NCT03043248|multidrug resistance 1|multidrug resistance 1
184410|NCT03043222|prostate artery embolization|prostate artery embolization
184411|NCT03043222|Prostatic Urethral Lift, Urolift|prostatic urethral lift, urolift
184412|NCT03043222|Minimally invasive|minimally invasive
184413|NCT03043222|non-surgical|non-surgical
184414|NCT03043222|maintenance of sexual function|maintenance of sexual function
184415|NCT03043222|complications of TURP , surgery|complications of turp , surgery
184416|NCT03043183|gastric cancer|gastric cancer
184417|NCT03043183|Enhanced recovery after surgery|enhanced recovery after surgery
184418|NCT03043170|Adults|adults
184419|NCT03043170|Emergency Department|emergency department
184420|NCT03043170|Haemodynamics|haemodynamics
184421|NCT03043170|Resuscitation|resuscitation
184422|NCT03043170|Shock|shock
184423|NCT03043170|Uscom|uscom
184424|NCT03043131|Cardiopulmonary bypass prime|cardiopulmonary bypass prime
184425|NCT03043131|Plasma Lyte - A|plasma lyte - a
184426|NCT03043131|Ringer;s lactate|ringer;s lactate
184427|NCT03043131|Acidosis|acidosis
184428|NCT03043118|Eating Behaviors|eating behaviors
184429|NCT03043118|Preschool|preschool
184430|NCT03043118|Vegetable Intake|vegetable intake
184431|NCT03043105|Multicentric Castleman's Disease|multicentric castleman's disease
184432|NCT03043105|Thalidomide, cyclophosphamide and prednisone (TCP regimen)|thalidomide, cyclophosphamide and prednisone (tcp regimen)
184433|NCT03043105|Efficacy|efficacy
184434|NCT03043105|Safety|safety
184435|NCT03043092|ultrasound, transcranial Doppler, arterial diseases|ultrasound, transcranial doppler, arterial diseases
184436|NCT03043066|Chronic Periodontitis|chronic periodontitis
184437|NCT03043066|TRAP-5b|trap-5b
184438|NCT03043066|Non-surgical periodontal therapy|non-surgical periodontal therapy
184439|NCT03043066|Systemic antibiotics|systemic antibiotics
184440|NCT03043053|weight loss|weight loss
184441|NCT03043053|body mass index|body mass index
184442|NCT03043053|oxytocin|oxytocin
184443|NCT03043053|magnetic resonance imaging|magnetic resonance imaging
184444|NCT03043040|suicide, attempted|suicide, attempted
184445|NCT03043040|prevention|prevention
184446|NCT03043040|telemedicine|telemedicine
184447|NCT03042988|supine hypertension|supine hypertension
184448|NCT03042988|autonomic failure|autonomic failure
184449|NCT03042988|heat stress|heat stress
184450|NCT03042988|orthostatic hypotension|orthostatic hypotension
184451|NCT03042975|spasmodic dysphonia|spasmodic dysphonia
184452|NCT03042975|dystonia|dystonia
184453|NCT03042975|laryngeal dystonia|laryngeal dystonia
184454|NCT03042975|imaging|imaging
184455|NCT03042975|genetics|genetics
184456|NCT03042962|dystonia|dystonia
184457|NCT03042962|imaging|imaging
184458|NCT03042962|genetics|genetics
184459|NCT03042962|neuropathology|neuropathology
184460|NCT03042936|Children|children
184461|NCT03042936|Teens|teens
184462|NCT03042936|Adolescents|adolescents
184463|NCT03042936|Type 2 diabetes|type 2 diabetes
184464|NCT03042936|Impaired glucose tolerance|impaired glucose tolerance
184465|NCT03042936|Exercise|exercise
184466|NCT03042936|Nutrition|nutrition
184467|NCT03042936|Education|education
184468|NCT03042923|Intestinal permeability|intestinal permeability
184469|NCT03042884|Benign Neoplasms|benign neoplasms
184470|NCT03042884|In Situ Neoplasms|in situ neoplasms
184471|NCT03042884|Malignant Neoplasms of Independent (Primary) Multiple Sites|malignant neoplasms of independent (primary) multiple sites
184472|NCT03042884|Wearable exercise trackers|wearable exercise trackers
184473|NCT03042884|Questionnaires|questionnaires
184474|NCT03042884|Surveys|surveys
184475|NCT03042871|PM-CNV ,Ranibizumab, Dosing Strategy|pm-cnv ,ranibizumab, dosing strategy
184477|NCT03042858|patent processus vaginalis|patent processus vaginalis
184478|NCT03042858|inguinal hernia|inguinal hernia
184479|NCT03042832|Leadership|leadership
184480|NCT03042832|Organizational Climate|organizational climate
184481|NCT03042832|Implementation|implementation
184482|NCT03042832|Implementation Climate|implementation climate
184483|NCT03042832|Motivational Interviewing|motivational interviewing
184484|NCT03042832|Fidelity|fidelity
184485|NCT03042806|Physical Activity|physical activity
184486|NCT03042806|Questionnaire|questionnaire
184487|NCT03042793|myeloma|myeloma
184488|NCT03042793|vaccination|vaccination
184489|NCT03042793|PD-L1|pd-l1
184490|NCT03042793|peptide vaccine|peptide vaccine
184491|NCT03042793|cancer vaccine|cancer vaccine
184492|NCT03042793|immunotherapy|immunotherapy
184493|NCT03042780|Gastroenteropancreatic neuroendocrine carcinomas (GEP-NECs)|gastroenteropancreatic neuroendocrine carcinomas (gep-necs)
184494|NCT03042780|Metastatic|metastatic
184495|NCT03042780|High grade|high grade
184496|NCT03042780|Pancreas|pancreas
184497|NCT03042780|Neuroendocrine carcinoma of gastrointestinal tract|neuroendocrine carcinoma of gastrointestinal tract
184498|NCT03042754|LAM|lam
184499|NCT03042754|XpertMTB/RIF|xpertmtb/rif
184500|NCT03042754|treatment outcome|treatment outcome
184501|NCT03042754|Microbacterial tuberculosis|microbacterial tuberculosis
184996|NCT03039374|MRI|mri
184502|NCT03042715|Supportive Care|supportive care
184503|NCT03042689|AML|aml
184504|NCT03042676|anti-T lymphocytic globulin (ATG)|anti-t lymphocytic globulin (atg)
184505|NCT03042676|allogeneic stem cell transplant|allogeneic stem cell transplant
184506|NCT03042676|prophylaxis of GVHD|prophylaxis of gvhd
184507|NCT03042663|stellate ganglion block|stellate ganglion block
184508|NCT03042663|arterial cannula|arterial cannula
184509|NCT03042663|ischemia|ischemia
184510|NCT03042663|septic shock|septic shock
184511|NCT03042611|Gastric Cancer|gastric cancer
184512|NCT03042611|Gastric Adenocarcinoma|gastric adenocarcinoma
184513|NCT03042611|Gastro-esophageal Cancer|gastro-esophageal cancer
184514|NCT03042611|Gastro-esophageal junction Cancer|gastro-esophageal junction cancer
184515|NCT03042611|Stomach Cancer|stomach cancer
184516|NCT03042611|Tumor|tumor
184517|NCT03042611|Oncology|oncology
184518|NCT03042611|Antiangiogenesis|antiangiogenesis
184519|NCT03042611|Metastatic|metastatic
184520|NCT03042598|Safe Apneic Period|safe apneic period
184521|NCT03042598|Emergency Intubation|emergency intubation
184522|NCT03042598|Biphasic Cuirass Ventilation (BCV)|biphasic cuirass ventilation (bcv)
184523|NCT03042598|Non-invasive ventilation|non-invasive ventilation
184524|NCT03042598|Peri-intubation Hemodynamic instability|peri-intubation hemodynamic instability
184525|NCT03042598|desaturation|desaturation
184526|NCT03042598|waveform capnography|waveform capnography
184527|NCT03042598|Patient safety|patient safety
184528|NCT03042585|BMT|bmt
184529|NCT03042585|NHL|nhl
184530|NCT03042585|Non-Hodgkin Lymphoma|non-hodgkin lymphoma
184531|NCT03042585|Relapsed Non-Hodgkin Lymphoma|relapsed non-hodgkin lymphoma
184532|NCT03042585|Refractory Non-Hodgkin Lymphoma|refractory non-hodgkin lymphoma
184533|NCT03042585|autologous stem cell transplantation|autologous stem cell transplantation
184534|NCT03042572|Critical Limb Ischemia (CLI)|critical limb ischemia (cli)
184535|NCT03042572|Severe Limb Ischemia (SLI)|severe limb ischemia (sli)
184536|NCT03042572|Peripheral Artery Disease (PAD)|peripheral artery disease (pad)
184537|NCT03042572|Peripheral Artery Occlusive Disease (PAOD)|peripheral artery occlusive disease (paod)
184538|NCT03042572|Cardiovascular disease|cardiovascular disease
184539|NCT03042572|Mesenchymal stromal cell (MSC)|mesenchymal stromal cell (msc)
184540|NCT03042572|Mesenchymal stem cell (MSC)|mesenchymal stem cell (msc)
184541|NCT03042494|Prebiotic|prebiotic
184542|NCT03042494|Gut microbiota|gut microbiota
184543|NCT03042494|Dietary fiber|dietary fiber
184544|NCT03042494|Gastrointestinal tolerance|gastrointestinal tolerance
184545|NCT03042481|chronic hepatitis B|chronic hepatitis b
184546|NCT03042481|entecavir|entecavir
184547|NCT03042481|tenofovir|tenofovir
184548|NCT03042481|off-therapy|off-therapy
184549|NCT03042481|relapse|relapse
184550|NCT03042442|pancreatic cancer|pancreatic cancer
184551|NCT03042442|cachexia|cachexia
184552|NCT03042442|perineural invasion|perineural invasion
184553|NCT03042442|pain|pain
184554|NCT03042442|diabetes|diabetes
184555|NCT03042429|neuroblastoma|neuroblastoma
184556|NCT03042429|chemotherapy|chemotherapy
184557|NCT03042429|autologous stem cell transplantation|autologous stem cell transplantation
184558|NCT03042429|radiotherapy|radiotherapy
184559|NCT03042429|mIBG|mibg
184560|NCT03042429|tumor resection|tumor resection
184561|NCT03042416|18F-DOPA PET/CT|18f-dopa pet/ct
184562|NCT03042403|hemodynamics|hemodynamics
184563|NCT03042403|physiotherapy|physiotherapy
184564|NCT03042403|breath stacking|breath stacking
184565|NCT03042377|Endodontics|endodontics
184566|NCT03042377|Retreatment|retreatment
184567|NCT03042377|Postoperative Pain|postoperative pain
184568|NCT03042377|Visual Analogue Pain Scale|visual analogue pain scale
184569|NCT03042364|Endometrium, Cytokines, Endometrial secretion, Implantation, Endometrial scratching|endometrium, cytokines, endometrial secretion, implantation, endometrial scratching
184570|NCT03042351|Urinary Incontinence|urinary incontinence
184571|NCT03042351|Pelvic Floor|pelvic floor
184572|NCT03042325|Drug therapy|drug therapy
184573|NCT03042299|Drug therapy|drug therapy
184574|NCT03042286|statin|statin
184575|NCT03042286|myalgia|myalgia
184576|NCT03042286|myopathy|myopathy
184577|NCT03042286|adverse drug reactions (ADRs)|adverse drug reactions (adrs)
184578|NCT03042286|pharmacokinetics and pharmacogenetics|pharmacokinetics and pharmacogenetics
184579|NCT03042273|recurrent|recurrent
184580|NCT03042260|trimethoprim, sulfamethoxazole drug combination|trimethoprim, sulfamethoxazole drug combination
184581|NCT03042260|Infection|infection
184582|NCT03042260|Prophylaxis|prophylaxis
184583|NCT03042234|Obesity|obesity
184584|NCT03042234|Exercise|exercise
184585|NCT03042234|Fat oxidation|fat oxidation
184586|NCT03042234|Adolescent|adolescent
184587|NCT03042234|Insulin resistance|insulin resistance
184588|NCT03042195|Supplementary Parenteral Nutrition|supplementary parenteral nutrition
184589|NCT03042195|Postoperative Nutrition|postoperative nutrition
184590|NCT03042195|Postoperative complications|postoperative complications
184591|NCT03042169|Stage IV gastric cancer|stage iv gastric cancer
184592|NCT03042169|palliative surgery|palliative surgery
184593|NCT03042169|chemotherapy|chemotherapy
184594|NCT03042169|survival|survival
184595|NCT03042169|quality of life|quality of life
184596|NCT03042143|Acute respiratory distress syndrome|acute respiratory distress syndrome
184597|NCT03042143|Human umbilical cord-derived mesenchymal stem cells|human umbilical cord-derived mesenchymal stem cells
184598|NCT03042104|Stenosis|stenosis
184599|NCT03042104|Heart Disease|heart disease
184600|NCT03042104|Valve|valve
184601|NCT03042104|Tricuspid|tricuspid
184602|NCT03042104|Aortic Valve|aortic valve
184603|NCT03042104|Asymptomatic|asymptomatic
184604|NCT03042078|Fluoroscopy|fluoroscopy
184605|NCT03042078|Ablation|ablation
184606|NCT03042078|Three dimensional|three dimensional
184607|NCT03042078|Paroxysmal supraventricular tachycardia|paroxysmal supraventricular tachycardia
184608|NCT03042078|Radiation|radiation
184609|NCT03042065|pediatrics|pediatrics
184610|NCT03042065|asthma|asthma
184611|NCT03042065|nebulization|nebulization
184612|NCT03042065|vibrating mesh|vibrating mesh
184613|NCT03042065|salbutamol|salbutamol
184614|NCT03042065|Efficiency|efficiency
184615|NCT03042013|ASP8273|asp8273
184616|NCT03042013|Non-Small-Cell Lung Cancer|non-small-cell lung cancer
184617|NCT03042013|EGFR mutations|egfr mutations
184618|NCT03042013|Oncology|oncology
184619|NCT03042000|rectal cancer|rectal cancer
184620|NCT03042000|neoadjuvant chemoradiation|neoadjuvant chemoradiation
184621|NCT03042000|circulating tumor DNA|circulating tumor dna
184622|NCT03042000|local recurrence|local recurrence
184623|NCT03042000|long-term survival|long-term survival
184624|NCT03041987|Cohort studies|cohort studies
184625|NCT03041987|Prognosis|prognosis
184626|NCT03041974|Red Blood Cell Transfusion|red blood cell transfusion
184627|NCT03041974|Cell-Derived Microparticles|cell-derived microparticles
184628|NCT03041961|Vascular function|vascular function
184629|NCT03041961|Endothelial function|endothelial function
184630|NCT03041961|(Poly)phenols|(poly)phenols
184631|NCT03041948|Inguinal hernia|inguinal hernia
184632|NCT03041948|Caudal nerve block|caudal nerve block
184633|NCT03041948|Ilioinguinal nerve block|ilioinguinal nerve block
184634|NCT03041948|Pain|pain
184635|NCT03041935|Testicle|testicle
184636|NCT03041935|Pain|pain
184637|NCT03041935|Orchiopexy|orchiopexy
184638|NCT03041935|Caudal nerve block|caudal nerve block
184639|NCT03041935|Ilioinguinal nerve block|ilioinguinal nerve block
184640|NCT03041922|Elastography|elastography
184641|NCT03041922|Buttocks|buttocks
184642|NCT03041922|Ultrasound|ultrasound
184643|NCT03041922|Soft tissue|soft tissue
184644|NCT03041870|PET-fMRI|pet-fmri
184645|NCT03041870|dominance|dominance
184646|NCT03041870|5HT transporter|5ht transporter
184647|NCT03041857|Videofluoroscopy|videofluoroscopy
184648|NCT03041857|GMK Sphere|gmk sphere
184649|NCT03041857|GMK PS Fixed Bearing|gmk ps fixed bearing
184650|NCT03041857|GMK UC Mobile Bearing|gmk uc mobile bearing
184651|NCT03041844|therapeutic ultrasound|therapeutic ultrasound
184652|NCT03041844|quality of life|quality of life
184653|NCT03041831|frail elderly|frail elderly
184654|NCT03041831|telemedicine|telemedicine
184655|NCT03041831|obesity|obesity
184656|NCT03041831|rural health|rural health
184657|NCT03041831|health promotion|health promotion
184658|NCT03041818|cerebral palsy|cerebral palsy
184659|NCT03041818|horseback riding|horseback riding
184660|NCT03041805|venous thromboembolism|venous thromboembolism
184661|NCT03041805|deep vein thrombosis|deep vein thrombosis
184662|NCT03041805|pulmonary embolism|pulmonary embolism
184663|NCT03041805|varicose veins|varicose veins
184664|NCT03041805|surgery|surgery
184665|NCT03041805|endovenous laser treatment|endovenous laser treatment
184666|NCT03041805|radiofrequency ablation|radiofrequency ablation
184667|NCT03041805|ultrasound-guided foam sclerotherapy|ultrasound-guided foam sclerotherapy
184668|NCT03041805|register|register
184669|NCT03041805|anticoagulation|anticoagulation
184670|NCT03041766|Schistosomiasis|schistosomiasis
184671|NCT03041766|Recombinant vaccine|recombinant vaccine
184672|NCT03041766|rSm14|rsm14
184673|NCT03041766|GLA-SE|gla-se
184674|NCT03041766|Fatty acid-binding protein (FABP)|fatty acid-binding protein (fabp)
184675|NCT03041766|Phase II Clinical Trial|phase ii clinical trial
184676|NCT03041766|Senegal|senegal
184677|NCT03041753|stroke|stroke
184678|NCT03041753|thrombolysis|thrombolysis
184679|NCT03041753|metalloproteinases|metalloproteinases
184680|NCT03041753|blood brain barrier|blood brain barrier
184681|NCT03041740|Bronchopulmonary Dysplasia|bronchopulmonary dysplasia
184682|NCT03041740|Neonates|neonates
184683|NCT03041714|Essential Tremor|essential tremor
184684|NCT03041714|Cervical Dystonia|cervical dystonia
184685|NCT03041714|Hand Dystonia|hand dystonia
236113|NCT02722668|AML|aml
184686|NCT03041714|Neurophysiology|neurophysiology
184687|NCT03041714|Dystonic Tremor|dystonic tremor
184688|NCT03041701|ERMS|erms
184689|NCT03041701|ARMS|arms
184690|NCT03041701|Monoclonal Antibody|monoclonal antibody
184691|NCT03041701|YES|yes
184692|NCT03041701|RMS|rms
184693|NCT03041675|Lacer Acupuncture|lacer acupuncture
184694|NCT03041675|Paralytic ileus|paralytic ileus
184695|NCT03041649|Gastroesophageal Reflux|gastroesophageal reflux
184696|NCT03041649|Feeding Disorder|feeding disorder
184697|NCT03041649|Gastrostomy tube|gastrostomy tube
184698|NCT03041649|Family Satisfaction|family satisfaction
184699|NCT03041649|GT button|gt button
184700|NCT03041649|Enteral nutrition|enteral nutrition
184701|NCT03041649|Gastrostomy button|gastrostomy button
184703|NCT03041558|healthy relationships|healthy relationships
184704|NCT03041558|interpersonal relations|interpersonal relations
184705|NCT03041558|domestic violence|domestic violence
184706|NCT03041532|retroflexion proximal|retroflexion proximal
184707|NCT03041532|colorectal cancer screening programme|colorectal cancer screening programme
184708|NCT03041532|adenoma detection rate|adenoma detection rate
184709|NCT03041532|right colon|right colon
184710|NCT03041519|Fluoroscopy|fluoroscopy
184711|NCT03041519|Ablation|ablation
184712|NCT03041519|Three dimensional|three dimensional
184713|NCT03041519|Ventricular arrhythmias|ventricular arrhythmias
184714|NCT03041519|Radiation|radiation
184715|NCT03041506|Shoulder dislocation reduction|shoulder dislocation reduction
184716|NCT03041506|Ultrasound guided interscalene block (ISCB)|ultrasound guided interscalene block (iscb)
184717|NCT03041506|Sedation|sedation
184718|NCT03041493|Electronic Cigarettes|electronic cigarettes
184719|NCT03041493|17-071|17-071
184720|NCT03041480|chronic periodontitis|chronic periodontitis
184721|NCT03041480|lipids|lipids
184722|NCT03041480|Lp-PLA2|lp-pla2
184723|NCT03041402|non-invasive ventilation|non-invasive ventilation
184724|NCT03041402|Pressure Support Ventilation|pressure support ventilation
184725|NCT03041402|Neurally Adjusted Ventilatory Assist|neurally adjusted ventilatory assist
184726|NCT03041402|patient-ventilator interaction|patient-ventilator interaction
184727|NCT03041402|ventilator performance|ventilator performance
184728|NCT03041402|asynchrony|asynchrony
184729|NCT03041389|Computerized Cognitive Behavioral Therapy|computerized cognitive behavioral therapy
184730|NCT03041350|Emergency Medical Services|emergency medical services
184731|NCT03041350|Smartphone|smartphone
184732|NCT03041350|Survival|survival
184733|NCT03041324|MPS ll|mps ll
184734|NCT03041324|Mucopolysaccharidosis II|mucopolysaccharidosis ii
184735|NCT03041324|Hunter syndrome|hunter syndrome
184736|NCT03041324|Gene Editing|gene editing
184737|NCT03041324|Gene therapy|gene therapy
184738|NCT03041324|Zinc Finger|zinc finger
184739|NCT03041324|ZFN|zfn
184740|NCT03041324|SB-913|sb-913
184741|NCT03041324|Rare|rare
184742|NCT03041324|Genetic|genetic
184743|NCT03041324|DNA|dna
184744|NCT03041324|Sangamo|sangamo
184745|NCT03041324|Genome editing|genome editing
184746|NCT03041324|Champions|champions
184747|NCT03041324|Hunter|hunter
184748|NCT03041324|Gene Specific Targeted Insertion|gene specific targeted insertion
184749|NCT03041311|Small Cell Lung Cancer|small cell lung cancer
184750|NCT03041311|CDK 4/6 Inhibitor|cdk 4/6 inhibitor
184751|NCT03041311|Immune Checkpoint Inhibitor|immune checkpoint inhibitor
184752|NCT03041246|pelvic floor|pelvic floor
184753|NCT03041207|ventilator associated infection|ventilator associated infection
184754|NCT03041207|ventilator associated pneumonia|ventilator associated pneumonia
184755|NCT03041207|ventilator associated tracheitis|ventilator associated tracheitis
184756|NCT03041207|Lower respiratory infection|lower respiratory infection
184757|NCT03041181|Nivolumab|nivolumab
184758|NCT03041181|BMS-936558-01|bms-936558-01
184759|NCT03041181|Anti-PD-1 Antibody|anti-pd-1 antibody
184760|NCT03041181|Docetaxel|docetaxel
184761|NCT03041181|Pemetrexed|pemetrexed
184762|NCT03041181|Gemcitabine|gemcitabine
184763|NCT03041142|Obesity|obesity
184764|NCT03041142|Cardiovascular risk factors|cardiovascular risk factors
184765|NCT03041142|Interdisciplinary intervention|interdisciplinary intervention
184766|NCT03041129|hepatic de novo lipogenesis|hepatic de novo lipogenesis
184767|NCT03041116|PKAN|pkan
184768|NCT03041090|infiltration|infiltration
184769|NCT03041090|extravasation|extravasation
184770|NCT03041090|PET/CT|pet/ct
184771|NCT03041090|PET|pet
184772|NCT03041090|PET-CT|pet-ct
184773|NCT03041025|Systemic Sclerosis|systemic sclerosis
184774|NCT03041025|Repeat-dose|repeat-dose
184775|NCT03041025|Phase IIA|phase iia
184776|NCT03041025|GSK2330811|gsk2330811
184777|NCT03041025|Pharmacodynamics|pharmacodynamics
184778|NCT03041025|Pharmacokinetics|pharmacokinetics
184779|NCT03041025|Proof of mechanism study|proof of mechanism study
184780|NCT03041012|HIV-1|hiv-1
184781|NCT03041012|Latency Reversal Agent|latency reversal agent
184782|NCT03041012|Immunotherapy|immunotherapy
184783|NCT03040999|Head and Neck Squamous Cell Carcinoma|head and neck squamous cell carcinoma
184784|NCT03040999|Programmed Cell Death Receptor 1 (PD-1)|programmed cell death receptor 1 (pd-1)
184785|NCT03040999|Programmed Cell Death Receptor Ligand 1 (PD-L1)|programmed cell death receptor ligand 1 (pd-l1)
184786|NCT03040999|Programmed Cell Death Receptor Ligand 2 (PD-L2)|programmed cell death receptor ligand 2 (pd-l2)
184787|NCT03040999|PD1|pd1
184788|NCT03040999|PD-1|pd-1
184789|NCT03040999|PDL1|pdl1
184790|NCT03040999|PD-L1|pd-l1
184791|NCT03040999|PDL2|pdl2
184792|NCT03040973|capmatinib|capmatinib
184793|NCT03040973|cMET|cmet
184794|NCT03040973|advanced solid tumor|advanced solid tumor
184795|NCT03040973|cancer|cancer
184796|NCT03040960|infection|infection
184797|NCT03040960|wound infection|wound infection
184798|NCT03040960|surgical wound infection|surgical wound infection
184799|NCT03040960|Staphylococcal infections|staphylococcal infections
184800|NCT03040960|wound and injuries|wound and injuries
184801|NCT03040960|postoperative complications|postoperative complications
184802|NCT03040960|Gram-positive bacterial infections|gram-positive bacterial infections
184803|NCT03040960|bacterial infections|bacterial infections
184804|NCT03040895|Parenting practices|parenting practices
184805|NCT03040856|Omega 3|omega 3
184806|NCT03040856|Supplements|supplements
184807|NCT03040856|Alpha Linolenic Acid|alpha linolenic acid
184808|NCT03040843|documentation|documentation
184809|NCT03040843|altered mental status|altered mental status
184810|NCT03040843|definition|definition
184811|NCT03040843|clinically|clinically
184812|NCT03040804|hidradenitis suppurativa|hidradenitis suppurativa
184813|NCT03040804|HS|hs
184814|NCT03040804|radiotherapy|radiotherapy
184815|NCT03040791|prostate cancer|prostate cancer
184816|NCT03040778|MRONJ|mronj
184817|NCT03040778|BRONJ|bronj
184818|NCT03040765|Osteoporosis|osteoporosis
184819|NCT03040765|Beta-Thalassemia Major|beta-thalassemia major
184820|NCT03040765|Denosumab|denosumab
184821|NCT03040765|Zoledronic Acid|zoledronic acid
184822|NCT03040739|O'ARM|o'arm
184823|NCT03040700|coronary artery disease|coronary artery disease
184824|NCT03040700|surgery|surgery
184825|NCT03040700|angina|angina
184826|NCT03040700|myocardial ischemia|myocardial ischemia
184827|NCT03040700|non-invasive testing|non-invasive testing
184828|NCT03040687|ETEC|etec
184829|NCT03040687|Escherichia coli|escherichia coli
184830|NCT03040687|enteritis|enteritis
184831|NCT03040687|challenge|challenge
184832|NCT03040687|CS6|cs6
184833|NCT03040687|B7A|b7a
184834|NCT03040674|Shortness of breath|shortness of breath
184835|NCT03040674|Breathlessness|breathlessness
184836|NCT03040674|Stem cells|stem cells
184837|NCT03040674|Platelet rich plasma|platelet rich plasma
184838|NCT03040674|Quality of life|quality of life
184839|NCT03040674|Pulmonary function|pulmonary function
184840|NCT03040622|WATCHMAN|watchman
184841|NCT03040622|Left Atrial Appendage Closure|left atrial appendage closure
184842|NCT03040622|Thrombosis|thrombosis
184843|NCT03040622|Platelet Function|platelet function
184844|NCT03040609|Profound Multiple Intellectual Disabilities|profound multiple intellectual disabilities
184845|NCT03040609|Visual-Behavioral Scale|visual-behavioral scale
184846|NCT03040596|vocal fold nodules|vocal fold nodules
184847|NCT03040596|inhaled steroid|inhaled steroid
184848|NCT03040596|steroid|steroid
184849|NCT03040596|children|children
184850|NCT03040596|nodules|nodules
184851|NCT03040583|Primary Sjögren's syndrome (PSS)|primary sjögren's syndrome (pss)
184852|NCT03040583|auto-immune diseases|auto-immune diseases
184853|NCT03040557|plantar fasciitis|plantar fasciitis
184854|NCT03040557|shoes|shoes
184855|NCT03040557|insoles|insoles
184856|NCT03040557|pain|pain
184857|NCT03040557|foot|foot
184858|NCT03040544|minimally invasive surgery|minimally invasive surgery
184859|NCT03040544|video-based trainer|video-based trainer
184860|NCT03040544|laparoscopic|laparoscopic
184861|NCT03040544|simulation training|simulation training
184862|NCT03040544|surgical education|surgical education
184863|NCT03040531|glucocorticoid|glucocorticoid
184864|NCT03040531|genistein|genistein
184865|NCT03040531|alendronate|alendronate
184866|NCT03040518|Behaviour change|behaviour change
184867|NCT03040518|Male obesity|male obesity
184868|NCT03040518|SMS|sms
184869|NCT03040518|Financial Incentive|financial incentive
184870|NCT03040518|Endowment incentive|endowment incentive
184871|NCT03040466|ureteroscopy|ureteroscopy
184872|NCT03040466|flexible ureteroscope|flexible ureteroscope
184873|NCT03040466|randomized controlled trial|randomized controlled trial
184874|NCT03040453|Irreversible electroporation|irreversible electroporation
184875|NCT03040453|Microwave ablation|microwave ablation
184876|NCT03040427|F-18 florbetapir|f-18 florbetapir
184877|NCT03040427|Amyvid|amyvid
184878|NCT03040427|PET scan|pet scan
184879|NCT03040427|Early detection|early detection
184880|NCT03040414|Hybrid closed loop|hybrid closed loop
184881|NCT03040414|Closed loop|closed loop
184882|NCT03040414|Artificial pancreas|artificial pancreas
184883|NCT03040401|CMML|cmml
184884|NCT03040401|Ceplene|ceplene
184885|NCT03040401|Interleukin-2|interleukin-2
236362|NCT02720796|PDX|pdx
184886|NCT03040388|Electroconvulsive therapy|electroconvulsive therapy
184887|NCT03040388|Depressive Disorder|depressive disorder
184888|NCT03040388|Magnetic Resonance Imaging|magnetic resonance imaging
184889|NCT03040388|Hippocampus|hippocampus
184890|NCT03040388|Brain-Derived Neurotrophic Factor|brain-derived neurotrophic factor
184891|NCT03040388|Vascular Endothelial Growth Factor|vascular endothelial growth factor
184892|NCT03040388|Blood-Brain Barrier|blood-brain barrier
184893|NCT03040349|primary care|primary care
184894|NCT03040349|greece|greece
184895|NCT03040349|cyprus|cyprus
184896|NCT03040349|tobacco use treatment|tobacco use treatment
184897|NCT03040349|evidence-based guidelines|evidence-based guidelines
184898|NCT03040336|surgery|surgery
184899|NCT03040336|prehabilitation|prehabilitation
184900|NCT03040336|exercise therapy|exercise therapy
184901|NCT03040336|nutrition support|nutrition support
184902|NCT03040297|Weaning from mechanical ventilation|weaning from mechanical ventilation
184903|NCT03040297|tracheostomized patients|tracheostomized patients
184904|NCT03040297|Tracheal gas insufflation|tracheal gas insufflation
184905|NCT03040284|noninvasive monitoring|noninvasive monitoring
184906|NCT03040284|intracranial pressure|intracranial pressure
184907|NCT03040284|cochlear electrophysiology|cochlear electrophysiology
184908|NCT03040284|aneurysmal subarachnoid haemorrhage|aneurysmal subarachnoid haemorrhage
184909|NCT03040284|cerebrovascular disorders|cerebrovascular disorders
184910|NCT03040284|brain diseases|brain diseases
184911|NCT03040271|School-based intervention|school-based intervention
184912|NCT03040258|School-based intervention|school-based intervention
184913|NCT03040245|Emergency physician|emergency physician
184914|NCT03040245|Whiplash Book|whiplash book
184915|NCT03040245|Whiplash trauma|whiplash trauma
184916|NCT03040245|Fears|fears
184917|NCT03040245|Beliefs|beliefs
184918|NCT03040193|Lignocaine|lignocaine
184919|NCT03040180|Neoplasms|neoplasms
184920|NCT03040180|Neoplasms, primary|neoplasms, primary
184921|NCT03040180|Cancer|cancer
184922|NCT03040180|Colorectal cancer|colorectal cancer
184923|NCT03040180|rectal cancer|rectal cancer
184924|NCT03040180|rectal cancer, locally advanced|rectal cancer, locally advanced
184925|NCT03040180|Electrochemotherapy|electrochemotherapy
184926|NCT03040180|Electroporation|electroporation
184927|NCT03040180|Neoadjuvant therapy|neoadjuvant therapy
184928|NCT03040180|Antineoplastic, antibodies|antineoplastic, antibodies
184929|NCT03040180|Bleomycin|bleomycin
184930|NCT03040180|Pathologic processes|pathologic processes
184931|NCT03040180|Neoplastic processes|neoplastic processes
184932|NCT03040154|Filipino|filipino
184933|NCT03040102|Advanced Cancer|advanced cancer
184934|NCT03040063|aneurysm, poplietl artery, acute limb ischemia|aneurysm, poplietl artery, acute limb ischemia
184935|NCT03040024|Anesthesiology|anesthesiology
184936|NCT03040011|Vaginal Surgery|vaginal surgery
184937|NCT03040011|Pelvic Organ Prolapse|pelvic organ prolapse
184938|NCT03040011|Postoperative Pain|postoperative pain
184939|NCT03039959|Renal Doppler ultrasonography|renal doppler ultrasonography
184940|NCT03039959|Venous Congestion|venous congestion
184941|NCT03039946|Fluid therapy|fluid therapy
184942|NCT03039946|Hemodynamic flow monitoring|hemodynamic flow monitoring
184943|NCT03039946|Closed-loop system|closed-loop system
184944|NCT03039946|Goal-directed fluid therapy|goal-directed fluid therapy
184945|NCT03039946|Anesthesiology|anesthesiology
184946|NCT03039907|Knee|knee
184947|NCT03039907|Replacement|replacement
184948|NCT03039894|school-based, evaluation, interrupted time series|school-based, evaluation, interrupted time series
184949|NCT03039881|Minute ventilation, ExSpiron monitor|minute ventilation, exspiron monitor
184950|NCT03039855|Mitral|mitral
184951|NCT03039855|Regurgitation|regurgitation
184952|NCT03039855|Heart valve|heart valve
184953|NCT03039855|Transcatheter|transcatheter
184954|NCT03039855|Transapical|transapical
184955|NCT03039855|Functional|functional
184956|NCT03039855|Degenerative|degenerative
184957|NCT03039855|TMVR|tmvr
184958|NCT03039842|dextromethorphan; memantine; treatment response|dextromethorphan; memantine; treatment response
184959|NCT03039790|Drug Therapy|drug therapy
184960|NCT03039686|muscular dystrophy|muscular dystrophy
184961|NCT03039686|Duchenne's Muscular Dystrophy|duchenne's muscular dystrophy
184962|NCT03039686|DMD|dmd
184963|NCT03039673|interleukin-2|interleukin-2
184964|NCT03039673|low-dose interleukin-2|low-dose interleukin-2
184965|NCT03039608|esophageal stricture|esophageal stricture
184966|NCT03039608|endoscopic submucosal dissection|endoscopic submucosal dissection
184967|NCT03039608|prevention|prevention
184968|NCT03039595|Early rectal cancer|early rectal cancer
184969|NCT03039595|Ploidy|ploidy
184970|NCT03039595|Tumour:stroma ratio|tumour:stroma ratio
184971|NCT03039582|perineal tear|perineal tear
184972|NCT03039582|bidigital palpation|bidigital palpation
184973|NCT03039582|perineal ultrasound|perineal ultrasound
184974|NCT03039582|post partum diagnostics|post partum diagnostics
184975|NCT03039569|Type 2 diabetes patients|type 2 diabetes patients
184976|NCT03039569|Diabetes self-management|diabetes self-management
184977|NCT03039569|Cardiovascular diseases awareness|cardiovascular diseases awareness
236430|NCT02720380|Asthma|asthma
184978|NCT03039569|Home food environment|home food environment
184979|NCT03039569|Text message|text message
184980|NCT03039530|Postpartum Depression|postpartum depression
184981|NCT03039530|Cognitive Behavioral Therapy|cognitive behavioral therapy
184982|NCT03039530|Public Health|public health
184983|NCT03039530|Mother|mother
184984|NCT03039530|Infant|infant
184985|NCT03039530|Emotion|emotion
184986|NCT03039517|Adaptive Compression Therapy Delivery System|adaptive compression therapy delivery system
184987|NCT03039504|Succinates|succinates
184988|NCT03039504|Dietary supplement|dietary supplement
184989|NCT03039491|pneumococcal vaccination|pneumococcal vaccination
184990|NCT03039465|Indwelling Trachea-oesophageal Prosthesis|indwelling trachea-oesophageal prosthesis
184991|NCT03039465|Voice Rehabilitation|voice rehabilitation
184992|NCT03039465|Total Laryngectomy|total laryngectomy
184993|NCT03039374|OASI|oasi
184994|NCT03039374|Faecal incontinence|faecal incontinence
184995|NCT03039374|Obstetric anal sphincter injury|obstetric anal sphincter injury
184997|NCT03039348|Breast Cancer Female|breast cancer female
184998|NCT03039348|Mastectomy|mastectomy
184999|NCT03039348|Breast Reconstruction|breast reconstruction
185000|NCT03039348|questionnaire|questionnaire
185001|NCT03039309|Endoscopic Submucosal Dissection|endoscopic submucosal dissection
185002|NCT03039296|Low back pain|low back pain
185003|NCT03039296|Facet joints|facet joints
185004|NCT03039296|Endoscopic rhizotomy|endoscopic rhizotomy
185005|NCT03039283|Moderate to profound sensorineural hearing loss|moderate to profound sensorineural hearing loss
185006|NCT03039270|Tooth Sensitivity|tooth sensitivity
185007|NCT03039270|Tooth Bleaching|tooth bleaching
185008|NCT03039270|Desensitizing agent|desensitizing agent
185009|NCT03039270|Sonic vibration|sonic vibration
185010|NCT03039257|hematopoietic stem cell transplant|hematopoietic stem cell transplant
185011|NCT03039257|vitamin a|vitamin a
185012|NCT03039244|Photochemotherapy|photochemotherapy
185013|NCT03039244|Photosensitizing agents|photosensitizing agents
185014|NCT03039244|Smokers|smokers
185015|NCT03039231|PTSD|ptsd
185016|NCT03039218|erectile dysfunction|erectile dysfunction
185017|NCT03039218|shockwave|shockwave
185018|NCT03039218|Dornier|dornier
185019|NCT03039205|Platelet aggregation|platelet aggregation
185020|NCT03039205|Adenosine|adenosine
185021|NCT03039205|Coronary artery disease|coronary artery disease
185022|NCT03039205|Kidney dysfunction|kidney dysfunction
185023|NCT03039205|Ticagrelor|ticagrelor
185024|NCT03039205|Clopidogrel|clopidogrel
185025|NCT03039127|Hyperthermia|hyperthermia
185026|NCT03039127|Laser Coagulation|laser coagulation
185027|NCT03039127|Laser Therapy|laser therapy
185028|NCT03039127|Induced|induced
185029|NCT03039114|Follicular lymphoma|follicular lymphoma
185030|NCT03039114|relapsed|relapsed
185031|NCT03039114|refractory|refractory
185032|NCT03039114|non-Hodgkin lymphoma|non-hodgkin lymphoma
185033|NCT03039114|phosphatidylinositol 3-kinase (PI3K)|phosphatidylinositol 3-kinase (pi3k)
185034|NCT03039101|allergen|allergen
185035|NCT03039101|neutrophils|neutrophils
185036|NCT03039101|allergy|allergy
185037|NCT03039062|Serum miR-122|serum mir-122
185038|NCT03039062|drug-induced liver injury by chemotherapy|drug-induced liver injury by chemotherapy
185039|NCT03039062|malignant tumor patients|malignant tumor patients
185040|NCT03039049|GnRH agonist trigger|gnrh agonist trigger
185042|NCT03039049|Luteal phase support|luteal phase support
185043|NCT03039049|Mid-luteal GnRH agonist|mid-luteal gnrh agonist
185044|NCT03039036|Labor Induction|labor induction
185045|NCT03039036|Early Amniotomy|early amniotomy
185046|NCT03039036|Foley catheter|foley catheter
185047|NCT03039023|TMAO|tmao
185048|NCT03039023|choline|choline
185049|NCT03039023|eggs|eggs
185050|NCT03039023|gastrointestinal microbiome|gastrointestinal microbiome
185051|NCT03039023|healthy volunteers|healthy volunteers
185052|NCT03038984|IBD|ibd
185053|NCT03038984|Telemedicine|telemedicine
185054|NCT03038984|At-home monitoring|at-home monitoring
185055|NCT03038984|Disease activity|disease activity
185056|NCT03038984|fecal calprotectin|fecal calprotectin
185057|NCT03038984|Total inflammation burden|total inflammation burden
185058|NCT03038984|11 years follow up|11 years follow up
185059|NCT03038958|Local Anaesthetic|local anaesthetic
185060|NCT03038958|spinal anesthesia|spinal anesthesia
185061|NCT03038958|Knee arthroscopy|knee arthroscopy
185062|NCT03038945|Laparoscopy|laparoscopy
185063|NCT03038945|Hysterectomy|hysterectomy
185064|NCT03038945|Suture Techniques|suture techniques
185065|NCT03038932|whole genome sequencing (WGS)|whole genome sequencing (wgs)
185066|NCT03038919|prolonged mechanical ventilation|prolonged mechanical ventilation
185067|NCT03038919|critically ill patients|critically ill patients
185068|NCT03038919|anabolic steroid|anabolic steroid
185069|NCT03038893|Ultrasonography|ultrasonography
185070|NCT03038893|Point-of-care systems|point-of-care systems
185071|NCT03038893|Deep venous thrombosis|deep venous thrombosis
185072|NCT03038893|Hospitalization|hospitalization
185073|NCT03038776|vaccine|vaccine
185074|NCT03038750|Healthy Volunteers|healthy volunteers
185075|NCT03038750|Genetic Risk Markers for Cardiovascular Disease|genetic risk markers for cardiovascular disease
185076|NCT03038750|Non-Alcoholic Fatty Liver Disease|non-alcoholic fatty liver disease
185077|NCT03038750|Coronary Disease|coronary disease
185078|NCT03038750|Hypertension|hypertension
185079|NCT03038750|Venous Thromboses|venous thromboses
185080|NCT03038750|Venous Thromboembolism|venous thromboembolism
185081|NCT03038750|Coronary Heart Disease|coronary heart disease
185082|NCT03038750|Coronary Artery Disease|coronary artery disease
185083|NCT03038737|nylon|nylon
185084|NCT03038737|polyamide|polyamide
185085|NCT03038737|PEEK|peek
185086|NCT03038737|partial denture|partial denture
185087|NCT03038724|HIV testing|hiv testing
185088|NCT03038698|spirometry|spirometry
185089|NCT03038698|normative values|normative values
185090|NCT03038698|health|health
185091|NCT03038698|south africa|south africa
185092|NCT03038698|children|children
185093|NCT03038685|Secondary prevention|secondary prevention
185094|NCT03038685|Web-based intervention|web-based intervention
185095|NCT03038685|Strokecoach|strokecoach
185096|NCT03038646|Pharmacokinetics|pharmacokinetics
185097|NCT03038646|Food Effect|food effect
185098|NCT03038620|Obesity|obesity
185099|NCT03038620|Visceral|visceral
185100|NCT03038620|Cardiovascular Disease|cardiovascular disease
185101|NCT03038620|Fat|fat
185102|NCT03038594|Burns|burns
185103|NCT03038594|Growth Hormone|growth hormone
185104|NCT03038594|Lean Body Mass|lean body mass
185105|NCT03038594|Strength|strength
185106|NCT03038594|Exercise Endurance|exercise endurance
185107|NCT03038581|Deep wrist injury|deep wrist injury
185108|NCT03038581|Self inflicted|self inflicted
185109|NCT03038581|Traumatic wrist injury|traumatic wrist injury
185110|NCT03038568|colorectal liver metastases|colorectal liver metastases
185111|NCT03038568|CT scan|ct scan
185112|NCT03038568|17-010|17-010
185113|NCT03038555|Medical staff|medical staff
185114|NCT03038555|preeclampsia|preeclampsia
185115|NCT03038555|cohort study|cohort study
185116|NCT03038555|further effect|further effect
185117|NCT03038529|low back pain , Ozone|low back pain , ozone
185118|NCT03038503|refractory septic shock|refractory septic shock
185119|NCT03038503|catecholamine resistance septic shock|catecholamine resistance septic shock
185120|NCT03038503|terlipressin|terlipressin
185121|NCT03038503|methylene blue|methylene blue
185122|NCT03038477|Borderline Resectable Pancreatic Ductal Adenocarcinoma|borderline resectable pancreatic ductal adenocarcinoma
185123|NCT03038477|Durvalumab|durvalumab
185124|NCT03038399|Duchenne muscular dystrophy|duchenne muscular dystrophy
185125|NCT03038399|vamorolone|vamorolone
185126|NCT03038347|cross-cultural competencies|cross-cultural competencies
185127|NCT03038347|internet-based training|internet-based training
185128|NCT03038347|cognitive-behavioural therapy (CBT)|cognitive-behavioural therapy (cbt)
185129|NCT03038347|psychotherapy training|psychotherapy training
185130|NCT03038347|competence training|competence training
185131|NCT03038321|BCG Cystitis|bcg cystitis
185132|NCT03038321|Bladder Cancer|bladder cancer
185133|NCT03038321|Levofloxacin|levofloxacin
185134|NCT03038321|Solifenacin|solifenacin
185135|NCT03038321|Lornoxicam|lornoxicam
185136|NCT03038308|ropinirole|ropinirole
185137|NCT03038308|hyperprolactinemia|hyperprolactinemia
185138|NCT03038308|prolactin|prolactin
185139|NCT03038295|Retinopathy of Prematurity|retinopathy of prematurity
185140|NCT03038295|propranolol|propranolol
185141|NCT03038295|ROP|rop
185142|NCT03038269|Robotics|robotics
185143|NCT03038269|Upper Extremity|upper extremity
185144|NCT03038256|High Risk Rectal Cancer|high risk rectal cancer
185145|NCT03038256|Total neoadjuvant chemoradiotherapy|total neoadjuvant chemoradiotherapy
185146|NCT03038256|Lengthening interval between radiotherapy and surgery|lengthening interval between radiotherapy and surgery
185147|NCT03038243|Shigella|shigella
185148|NCT03038243|vaccine|vaccine
185149|NCT03038243|shigellosis|shigellosis
185150|NCT03038243|dysentery|dysentery
185151|NCT03038243|whole cell|whole cell
185152|NCT03038230|human bispecific full length IgG antibody, CLEC12A, CD3|human bispecific full length igg antibody, clec12a, cd3
185153|NCT03038230|MCLA-117|mcla-117
185154|NCT03038230|First in Human|first in human
185155|NCT03038230|Antibodies, Bispecific|antibodies, bispecific
185156|NCT03038230|Immunologic Factors|immunologic factors
185157|NCT03038230|relapsed, refractory patient|relapsed, refractory patient
185158|NCT03038230|AML, minimal residual disease (MRD)|aml, minimal residual disease (mrd)
185159|NCT03038230|Acute Myelogenous Leukemia|acute myelogenous leukemia
185160|NCT03038230|Acute Myeloid Leukemia|acute myeloid leukemia
185161|NCT03038230|CD34+CD38|cd34+cd38
185162|NCT03038230|T-cell recruiting|t-cell recruiting
185163|NCT03038217|rectal cancer|rectal cancer
185164|NCT03038217|neoajuvant chemoradiation|neoajuvant chemoradiation
185165|NCT03038217|circulating tumor DNA|circulating tumor dna
185166|NCT03038204|Papillary muscles approximation|papillary muscles approximation
185167|NCT03038178|Mycobacterium Infections, Nontuberculous|mycobacterium infections, nontuberculous
185168|NCT03038178|Mycobacteria, Atypical|mycobacteria, atypical
185169|NCT03038178|Amikacin|amikacin
185170|NCT03038178|Inhalation|inhalation
236680|NCT02718833|Relapse|relapse
185171|NCT03038165|Hemodialysis|hemodialysis
185172|NCT03038165|Intradialytic hypertension|intradialytic hypertension
185173|NCT03038165|Hemodynamics changes|hemodynamics changes
185174|NCT03038139|forward head posture|forward head posture
185175|NCT03038139|postural correction|postural correction
185176|NCT03038139|spinal muscles|spinal muscles
185177|NCT03038126|chronic kidney disease|chronic kidney disease
185178|NCT03038126|patient safety|patient safety
185179|NCT03038126|home telehealth|home telehealth
185180|NCT03038061|Diaphragm|diaphragm
185181|NCT03038061|EIT|eit
185182|NCT03038061|Laparoscopy|laparoscopy
185183|NCT03038009|Coronary Artery Bypass Graft|coronary artery bypass graft
185184|NCT03038009|Dual Antiplatelet Therapy|dual antiplatelet therapy
185185|NCT03038009|Gastrointestinal|gastrointestinal
185186|NCT03038009|Mucosal Injury|mucosal injury
185187|NCT03038009|Proton Pump Inhibitor|proton pump inhibitor
185188|NCT03037996|anesthesia|anesthesia
185189|NCT03037996|satisfaction|satisfaction
185190|NCT03037983|Schizophrenia|schizophrenia
185191|NCT03037983|Transcranial magnetic stimulation|transcranial magnetic stimulation
185192|NCT03037983|Electroencephalography|electroencephalography
185193|NCT03037944|Adenomyosis|adenomyosis
185194|NCT03037944|Contraceptive pills|contraceptive pills
185195|NCT03037944|Levonorgestrel-releasing Intrauterine System|levonorgestrel-releasing intrauterine system
185196|NCT03037918|Gut Microbiota|gut microbiota
185197|NCT03037918|High Fat Diets|high fat diets
185198|NCT03037918|Probiotics|probiotics
185199|NCT03037918|Glycaemic Control|glycaemic control
185200|NCT03037853|Atlas|atlas
185201|NCT03037853|Full human Body|full human body
185202|NCT03037853|MRI|mri
185203|NCT03037840|RF EMF|rf emf
185204|NCT03037840|In Vivo|in vivo
185205|NCT03037840|tumor specific frequencies|tumor specific frequencies
185206|NCT03037827|endovenous laser ablation|endovenous laser ablation
185207|NCT03037827|radial fiber|radial fiber
185208|NCT03037827|linear endovenous energy density|linear endovenous energy density
185209|NCT03037827|1470 nm|1470 nm
185210|NCT03037827|occlusion rate|occlusion rate
185211|NCT03037814|restorative materials|restorative materials
185212|NCT03037814|primary teeth|primary teeth
185213|NCT03037814|children|children
185214|NCT03037788|Excessive sweating|excessive sweating
185215|NCT03037775|tobacco|tobacco
185216|NCT03037775|cardiovascular system|cardiovascular system
185217|NCT03037775|sympathetic nervous system|sympathetic nervous system
185218|NCT03037684|neuropathic pain|neuropathic pain
185219|NCT03037684|chronic postoperative pain|chronic postoperative pain
185220|NCT03037671|Malglycemia|malglycemia
185221|NCT03037658|physical activity|physical activity
185222|NCT03037658|walking|walking
185223|NCT03037658|incentive|incentive
185224|NCT03037658|step count|step count
185226|NCT03037645|hematological diseases|hematological diseases
185227|NCT03037645|relapsed|relapsed
185228|NCT03037645|cancer|cancer
185229|NCT03037645|malignancy|malignancy
185230|NCT03037645|SNS-062|sns-062
185231|NCT03037645|B-lymphoid|b-lymphoid
185232|NCT03037645|chronic lymphocytic leukemia|chronic lymphocytic leukemia
185233|NCT03037645|small lymphocytic lymphoma|small lymphocytic lymphoma
185234|NCT03037645|lymphoplasmacytoid lymphoma|lymphoplasmacytoid lymphoma
185235|NCT03037645|Waldenström's macrogloulinemia|waldenström's macrogloulinemia
185236|NCT03037645|mantle cell lymphoma|mantle cell lymphoma
185237|NCT03037645|SLL|sll
185238|NCT03037645|LPL|lpl
185239|NCT03037645|WM|wm
185240|NCT03037645|MCL|mcl
185241|NCT03037645|refractory|refractory
185242|NCT03037645|DLBCL-ABC|dlbcl-abc
185243|NCT03037645|DLBCL|dlbcl
185244|NCT03037645|follicular lymphoma|follicular lymphoma
185245|NCT03037645|diffuse large B-cell lymphoma|diffuse large b-cell lymphoma
185246|NCT03037645|CLL/SLL|cll/sll
185247|NCT03037645|MZL|mzl
185248|NCT03037645|marginal zone lymphoma|marginal zone lymphoma
185249|NCT03037593|Pregnancy|pregnancy
185250|NCT03037593|Gestational Diabetes|gestational diabetes
185251|NCT03037580|Pulmonary Hypertension|pulmonary hypertension
185252|NCT03037580|6-Minute Walk Test|6-minute walk test
185253|NCT03037580|HFpEF|hfpef
185254|NCT03037580|Oral Treprostinil|oral treprostinil
185255|NCT03037554|Skin Temperature|skin temperature
185256|NCT03037554|Hot Flashes|hot flashes
185257|NCT03037554|Sleep Disturbance|sleep disturbance
185258|NCT03037541|Wake Forest|wake forest
185259|NCT03037541|Actinic Keratosis|actinic keratosis
185260|NCT03037541|Cryosurgery|cryosurgery
185261|NCT03037541|Cream|cream
185262|NCT03037502|Men's Health|men's health
185263|NCT03037502|weight loss|weight loss
185264|NCT03037502|African American men|african american men
185265|NCT03037502|Latino men|latino men
185266|NCT03037437|Hepatocellular Cancer|hepatocellular cancer
185267|NCT03037437|Sorafenib|sorafenib
185268|NCT03037437|Hydroxychloroquine|hydroxychloroquine
185269|NCT03037424|Cyroprecipitate|cyroprecipitate
185270|NCT03037424|Fibrinogen|fibrinogen
185271|NCT03037424|Cardiac Surgery|cardiac surgery
185272|NCT03037411|Atherosclerosis|atherosclerosis
185273|NCT03037411|Superficial Femoral Artery (SFA)|superficial femoral artery (sfa)
185274|NCT03037411|Proximal Popliteal Artery (PPA)|proximal popliteal artery (ppa)
185275|NCT03037411|Stenting|stenting
185276|NCT03037411|Paclitaxel|paclitaxel
185277|NCT03037411|Health Economics|health economics
185278|NCT03037385|RET Lung|ret lung
185279|NCT03037385|RET Thyroid|ret thyroid
185280|NCT03037385|RET fusion|ret fusion
185281|NCT03037385|RET alteration|ret alteration
185282|NCT03037385|RET mutation|ret mutation
185283|NCT03037385|RET positive|ret positive
185284|NCT03037385|RET inhibitor|ret inhibitor
185285|NCT03037385|RET altered|ret altered
185286|NCT03037385|RET rearrangement|ret rearrangement
185287|NCT03037385|RET NSCLC|ret nsclc
185288|NCT03037385|RET medullary thyroid cancer|ret medullary thyroid cancer
185289|NCT03037385|RET-rearranged NSCLC|ret-rearranged nsclc
185290|NCT03037385|RET-rearranged thyroid|ret-rearranged thyroid
185291|NCT03037385|M918T|m918t
185292|NCT03037385|TRIM33-RET|trim33-ret
185293|NCT03037385|RET fusion lung cancer|ret fusion lung cancer
185294|NCT03037385|RET fusion thyroid cancer|ret fusion thyroid cancer
185295|NCT03037385|lung cancer mutation|lung cancer mutation
185296|NCT03037385|BLU 667|blu 667
185297|NCT03037385|RET tyrosine kinase|ret tyrosine kinase
185298|NCT03037385|RET gene mutation|ret gene mutation
185299|NCT03037385|RET kinase|ret kinase
185300|NCT03037385|RET MTC|ret mtc
185301|NCT03037385|advanced lung cancer|advanced lung cancer
185302|NCT03037385|advanced non small cell lung cancer|advanced non small cell lung cancer
185303|NCT03037385|metastatic lung cancer|metastatic lung cancer
185304|NCT03037385|KIF5B-RET|kif5b-ret
185305|NCT03037385|CCDC6-RET|ccdc6-ret
185306|NCT03037385|NCOA4-RET|ncoa4-ret
185307|NCT03037385|advance solid tumor|advance solid tumor
185308|NCT03037385|V804L|v804l
185309|NCT03037385|V804M|v804m
185310|NCT03037385|thyroid cancer RET inhibitor|thyroid cancer ret inhibitor
185311|NCT03037385|lung cancer RET inhibitor|lung cancer ret inhibitor
185312|NCT03037385|RET PTC|ret ptc
185313|NCT03037385|rearranged during transfection|rearranged during transfection
185314|NCT03037385|RET-PTC1|ret-ptc1
185315|NCT03037385|RET-PTC|ret-ptc
185316|NCT03037385|RET-PTC3|ret-ptc3
185317|NCT03037385|RET-PTC4|ret-ptc4
185318|NCT03037385|PRKAR1A-RET|prkar1a-ret
185319|NCT03037385|RET-PTC2|ret-ptc2
185320|NCT03037385|GOLGA5-RET|golga5-ret
185321|NCT03037385|RET-PTC5|ret-ptc5
185322|NCT03037385|ERC1-RET|erc1-ret
185323|NCT03037385|KTN1-RET|ktn1-ret
185324|NCT03037385|RET-PTC8|ret-ptc8
185325|NCT03037385|HOOK3-RET|hook3-ret
185326|NCT03037385|PCM1-RET|pcm1-ret
185327|NCT03037385|TRIM24-RET|trim24-ret
185328|NCT03037385|RET-PTC6|ret-ptc6
185329|NCT03037385|TRIM27-RET|trim27-ret
185330|NCT03037385|RET-PTC7|ret-ptc7
185331|NCT03037385|AKAP13-RET|akap13-ret
185332|NCT03037385|FKBP15-RET|fkbp15-ret
185333|NCT03037385|SPECC1L-RET|specc1l-ret
185334|NCT03037385|TBL1XR1-RET|tbl1xr1-ret
185335|NCT03037385|BCR-RET|bcr-ret
185336|NCT03037385|FGRF1OP-RET|fgrf1op-ret
185337|NCT03037385|RFG8-RET|rfg8-ret
185338|NCT03037372|adults|adults
185339|NCT03037372|antiretroviral therapy|antiretroviral therapy
185340|NCT03037359|PID|pid
185341|NCT03037333|echocardiogram|echocardiogram
185342|NCT03037333|Electrocardiogram: Electrical Alternans|electrocardiogram: electrical alternans
185343|NCT03037333|fluoroscopy|fluoroscopy
185344|NCT03037229|Myocardial Infarction|myocardial infarction
185345|NCT03037229|Ischemia|ischemia
185346|NCT03037229|Myocardial Ischemia|myocardial ischemia
185347|NCT03037229|Heart Diseases|heart diseases
185348|NCT03037229|Cardiovascular Diseases|cardiovascular diseases
185349|NCT03037229|Vascular Diseases|vascular diseases
185350|NCT03037216|Exercise|exercise
185351|NCT03037164|INTERCEPT|intercept
185352|NCT03037164|Red Blood Cells|red blood cells
185353|NCT03037164|RBC|rbc
185354|NCT03037164|Pathogen Inactivation|pathogen inactivation
185355|NCT03037164|Zika|zika
185356|NCT03037164|Cerus|cerus
185357|NCT03037164|Pathogen Reduction|pathogen reduction
185358|NCT03037151|Safety|safety
185359|NCT03037151|Efficacy|efficacy
185360|NCT03037151|grazoprevir|grazoprevir
185361|NCT03037151|elbasvir|elbasvir
185362|NCT03037151|compensated cirrhosis|compensated cirrhosis
185363|NCT03037151|genotype 1 (GT1)|genotype 1 (gt1)
185364|NCT03037151|genotype 6 (GT6)|genotype 6 (gt6)
185365|NCT03037151|hepatitis virus C (HCV)|hepatitis virus c (hcv)
185366|NCT03037151|human immunodeficiency virus (HIV)|human immunodeficiency virus (hiv)
185367|NCT03037138|postdialysis washed-out|postdialysis washed-out
185368|NCT03037099|Glycemic index|glycemic index
185369|NCT03037099|dietary intakes|dietary intakes
185370|NCT03037086|NSCLC|nsclc
185371|NCT03037073|Duloxetine|duloxetine
185372|NCT03037073|Succinylcholine|succinylcholine
185373|NCT03037073|Postoperative Myalgia|postoperative myalgia
185374|NCT03037073|Microlaryngoscopy|microlaryngoscopy
185375|NCT03037060|Alcohol use, problem|alcohol use, problem
185376|NCT03037021|Sickle Cell Disease|sickle cell disease
185377|NCT03037021|Needs Assessment|needs assessment
185378|NCT03037021|Barriers to care|barriers to care
185379|NCT03037021|Access to care|access to care
185380|NCT03037021|Primary care|primary care
185381|NCT03037008|perineal sonography|perineal sonography
185382|NCT03037008|male sling|male sling
185383|NCT03037008|post prostatectomy incontinence|post prostatectomy incontinence
185384|NCT03037008|ultrasonography|ultrasonography
185385|NCT03036956|subclinical hypothyroidism in pregnancy|subclinical hypothyroidism in pregnancy
185386|NCT03036904|venetoclax|venetoclax
185387|NCT03036904|dose-adjusted EPOCH-R|dose-adjusted epoch-r
185388|NCT03036904|aggressive B-Cell lymphoma|aggressive b-cell lymphoma
185389|NCT03036904|Lymphoma|lymphoma
185390|NCT03036904|Non-Hodgkin lymphoma|non-hodgkin lymphoma
185391|NCT03036904|Diffuse large B-cell lymphoma|diffuse large b-cell lymphoma
185392|NCT03036904|Double hit lymphoma|double hit lymphoma
185393|NCT03036891|Gastroparesis|gastroparesis
185394|NCT03036891|Opioid-Induced|opioid-induced
185395|NCT03036891|Delayed Gastric Emptying|delayed gastric emptying
185396|NCT03036878|Osteochondral|osteochondral
185397|NCT03036878|Marrow Stimulation|marrow stimulation
185398|NCT03036878|ReNu|renu
185399|NCT03036865|Healthy participants|healthy participants
185400|NCT03036865|BOS161721|bos161721
185401|NCT03036865|Pharmacokinetics|pharmacokinetics
185402|NCT03036865|Pharmacodynamics|pharmacodynamics
185403|NCT03036826|renal replacement therapy|renal replacement therapy
185404|NCT03036787|Premature Baby|premature baby
185405|NCT03036787|motor development|motor development
185406|NCT03036787|cognitive development|cognitive development
185407|NCT03036774|Gastric contents|gastric contents
185408|NCT03036774|Ultrasound|ultrasound
185409|NCT03036774|Diabetes|diabetes
185410|NCT03036761|Auriculotherapy|auriculotherapy
185411|NCT03036696|Retention|retention
185412|NCT03036696|Lactation|lactation
185413|NCT03036696|Human milk|human milk
185414|NCT03036696|Pregnancy|pregnancy
185415|NCT03036696|Clinical Research Studies|clinical research studies
185416|NCT03036696|BEACH|beach
185417|NCT03036657|Acupuncture|acupuncture
185418|NCT03036657|Electroacupuncture|electroacupuncture
185419|NCT03036657|Nerve Conduction Studies|nerve conduction studies
185420|NCT03036657|Quantitative Sensory Testing|quantitative sensory testing
185421|NCT03036644|electronic cigarette|electronic cigarette
185422|NCT03036644|e-cigarette|e-cigarette
185423|NCT03036644|oxidative stress|oxidative stress
185424|NCT03036644|tobacco smoking|tobacco smoking
185425|NCT03036618|BMI|bmi
185426|NCT03036618|Blood Cholesterol|blood cholesterol
185427|NCT03036618|Glucose|glucose
185428|NCT03036618|Insulin|insulin
185429|NCT03036618|Gut health|gut health
185430|NCT03036605|dexamethasone|dexamethasone
185431|NCT03036605|bupivacaine|bupivacaine
185432|NCT03036605|nasal surgery|nasal surgery
185433|NCT03036605|nasal packing|nasal packing
185434|NCT03036592|Glucose tolerance test, MTNR1B, nutrigenomics, food timing|glucose tolerance test, mtnr1b, nutrigenomics, food timing
185435|NCT03036579|CAD/CAM|cad/cam
185436|NCT03036579|Ceramic|ceramic
185437|NCT03036579|Crown|crown
185438|NCT03036553|Chronic pain|chronic pain
185439|NCT03036553|Psychological factors|psychological factors
185440|NCT03036553|Musculoskeletal pain|musculoskeletal pain
185441|NCT03036553|Prognosis|prognosis
185442|NCT03036540|upper limb thrombosis, midline catheter|upper limb thrombosis, midline catheter
185443|NCT03036527|Bladder|bladder
185444|NCT03036527|Sexual Function|sexual function
185445|NCT03036514|numeric rating scale|numeric rating scale
185446|NCT03036514|opioid side effects|opioid side effects
185447|NCT03036488|PD1|pd1
185448|NCT03036488|PD-1|pd-1
185449|NCT03036488|PDL1|pdl1
185450|NCT03036488|PD-L1|pd-l1
185451|NCT03036462|intravenous iron|intravenous iron
185452|NCT03036462|systolic heart failure|systolic heart failure
185453|NCT03036462|iron deficiency|iron deficiency
185454|NCT03036462|morbidity|morbidity
185455|NCT03036462|mortality|mortality
185456|NCT03036449|Medication errors|medication errors
185457|NCT03036449|Patient safety|patient safety
185458|NCT03036436|Cancer|cancer
185459|NCT03036436|EHealth|ehealth
185460|NCT03036436|Cancer Survivor|cancer survivor
185461|NCT03036436|Rehabilitation|rehabilitation
185462|NCT03036410|Hearing Aid Usage (monaural, binaural)|hearing aid usage (monaural, binaural)
185463|NCT03036410|Cochlear Implant Usage (monaural, binaural)|cochlear implant usage (monaural, binaural)
185464|NCT03036410|Hearing Aid and Cochlear Implant Usage (monaural)|hearing aid and cochlear implant usage (monaural)
185465|NCT03036397|Anxiety|anxiety
185466|NCT03036397|Vasopressin|vasopressin
185467|NCT03036397|Fear|fear
185468|NCT03036384|scheduled cesarean delivery|scheduled cesarean delivery
185469|NCT03036384|spinal anesthesia|spinal anesthesia
185470|NCT03036384|local anesthesia|local anesthesia
185471|NCT03036371|Neurogenesis|neurogenesis
185472|NCT03036371|Memory|memory
185473|NCT03036371|Spatial Processing|spatial processing
185474|NCT03036371|Hippocampus|hippocampus
185475|NCT03036371|Cognition|cognition
185476|NCT03036371|Aerobic Exercise|aerobic exercise
185477|NCT03036332|aerobic interval training|aerobic interval training
185478|NCT03036332|biomarkers|biomarkers
185479|NCT03036306|scar|scar
185480|NCT03036306|nefopam|nefopam
185481|NCT03036306|cicatrix|cicatrix
185482|NCT03036280|Elenbecestat|elenbecestat
185483|NCT03036280|E2609|e2609
185484|NCT03036280|Alzheimer's Disease|alzheimer's disease
185485|NCT03036280|Early Alzheimer's Disease|early alzheimer's disease
185486|NCT03036280|Prodromal Alzheimer's Disease|prodromal alzheimer's disease
185487|NCT03036280|Dementia|dementia
185488|NCT03036280|Dementia, Alzheimer's type|dementia, alzheimer's type
185489|NCT03036280|Mild Cognitive Impairment|mild cognitive impairment
185490|NCT03036280|MissionAD2|missionad2
185491|NCT03036267|health disparity|health disparity
185492|NCT03036267|motivational interviewing|motivational interviewing
185493|NCT03036267|African American adults|african american adults
185494|NCT03036267|Federally Qualified Health Centers|federally qualified health centers
185495|NCT03036267|adherence|adherence
185496|NCT03036267|health beliefs|health beliefs
185497|NCT03036267|self-management|self-management
185498|NCT03036267|asthma control|asthma control
185499|NCT03036254|Diabetes Mellitus|diabetes mellitus
185500|NCT03036254|Cognition|cognition
185501|NCT03036241|drug-eluting balloon,|drug-eluting balloon,
185502|NCT03036241|target lesion revascularization (TLR)|target lesion revascularization (tlr)
185503|NCT03036241|restenosis|restenosis
185504|NCT03036228|Solid tumours|solid tumours
185505|NCT03036202|epinephrine|epinephrine
185506|NCT03036163|Tuberculosis|tuberculosis
185507|NCT03036150|Chronic Kidney Disease (CKD)|chronic kidney disease (ckd)
185508|NCT03036150|Cardiovascular Events (CV)|cardiovascular events (cv)
185509|NCT03036150|Phase III outcome trial|phase iii outcome trial
185510|NCT03036137|Tinnitus|tinnitus
185511|NCT03036137|Electroencephalogram|electroencephalogram
185512|NCT03036137|Transcranial Direct Current Stimulation|transcranial direct current stimulation
185513|NCT03036124|HFrEF|hfref
185514|NCT03036124|Heart Failure (HF)|heart failure (hf)
185515|NCT03036124|Cardiovascular Events (CV)|cardiovascular events (cv)
185516|NCT03036124|Phase III outcome trial|phase iii outcome trial
185517|NCT03036085|postoperative pain|postoperative pain
185518|NCT03036085|video-assisted thoracoscopic surgery (VATS)|video-assisted thoracoscopic surgery (vats)
185519|NCT03036085|opioids|opioids
185520|NCT03036085|bupivacaine|bupivacaine
185521|NCT03036085|liposomal bupivacaine|liposomal bupivacaine
185522|NCT03036085|analgesia|analgesia
185523|NCT03036085|local anesthetics|local anesthetics
185524|NCT03036072|Therapeutic Hypothermia|therapeutic hypothermia
185525|NCT03036059|Twice a year treatment|twice a year treatment
185526|NCT03036059|Biannual treatment|biannual treatment
185527|NCT03036059|Wuchereria bancrofti|wuchereria bancrofti
185528|NCT03036007|Spine, Disc, Neck pain, Rehabilitation, Exercise Therapy, Internet|spine, disc, neck pain, rehabilitation, exercise therapy, internet
185529|NCT03035968|Vojta therapy|vojta therapy
185530|NCT03035968|reflex locomotion|reflex locomotion
185531|NCT03035968|stroke rehabilitation|stroke rehabilitation
185532|NCT03035968|stroke|stroke
185533|NCT03035968|physiotherapy|physiotherapy
185534|NCT03035955|Rosacea|rosacea
185535|NCT03035955|Wake Forest|wake forest
185536|NCT03035955|Demodex|demodex
185537|NCT03035955|Finacea Gel|finacea gel
185538|NCT03035942|Intrathecal morphine|intrathecal morphine
185539|NCT03035942|Nausea and vomiting|nausea and vomiting
185540|NCT03035942|Quality of recovery|quality of recovery
185541|NCT03035942|Patient satisfaction|patient satisfaction
185542|NCT03035942|Pruritus|pruritus
185543|NCT03035942|Postoperative pain|postoperative pain
185544|NCT03035916|transversus abdominal plane block|transversus abdominal plane block
185545|NCT03035916|epidural anesthesia|epidural anesthesia
185546|NCT03035916|stress response|stress response
185547|NCT03035916|anesthetic recovery|anesthetic recovery
185548|NCT03035890|NSCLC|nsclc
185549|NCT03035890|Lung Cancer|lung cancer
185550|NCT03035890|Non Small Cell Lung Cancer|non small cell lung cancer
185551|NCT03035877|Antisocial Behavior|antisocial behavior
185552|NCT03035877|Alcohol Abuse|alcohol abuse
185553|NCT03035877|Drug Abuse|drug abuse
185554|NCT03035877|Young Adults|young adults
185555|NCT03035864|Ocular discomfort after cataract and refractive surgery|ocular discomfort after cataract and refractive surgery
185556|NCT03035864|cataract surgery|cataract surgery
185557|NCT03035864|refractive surgery|refractive surgery
185558|NCT03035851|Alzheimer Disease|alzheimer disease
185559|NCT03035851|Dementia|dementia
185560|NCT03035851|Exercise|exercise
185561|NCT03035851|Physical Activity|physical activity
185562|NCT03035851|Brain blood flow|brain blood flow
185563|NCT03035851|Cognition|cognition
185564|NCT03035851|Fitness|fitness
185565|NCT03035812|Bicarbonate|bicarbonate
185566|NCT03035773|Oncology|oncology
185567|NCT03035773|Survivorship|survivorship
185568|NCT03035760|Helminths|helminths
185569|NCT03035760|Oxfendazole|oxfendazole
185570|NCT03035760|Pharmacokinetics|pharmacokinetics
185571|NCT03035760|Safety|safety
185572|NCT03035747|registry|registry
185573|NCT03035747|varicose veins|varicose veins
237182|NCT02715856|IM|im
185574|NCT03035747|conventional surgery|conventional surgery
185575|NCT03035747|thermal ablation|thermal ablation
185576|NCT03035747|radiofrequency|radiofrequency
185577|NCT03035747|laser|laser
185578|NCT03035747|sclerotherapy|sclerotherapy
185579|NCT03035721|Full term healthy infants|full term healthy infants
185580|NCT03035721|Low protein content formula|low protein content formula
185581|NCT03035721|Safety|safety
185582|NCT03035721|Growth|growth
185583|NCT03035721|Body composition|body composition
185584|NCT03035695|Trauma|trauma
185585|NCT03035695|Scalp injuries|scalp injuries
185586|NCT03035695|Profused Bleeding|profused bleeding
185587|NCT03035695|Accident|accident
185588|NCT03035656|Pain|pain
185589|NCT03035656|analgesic|analgesic
185590|NCT03035656|spinal fusion|spinal fusion
185591|NCT03035630|Avelumab|avelumab
185592|NCT03035630|Sunitinib|sunitinib
185593|NCT03035630|MSB0010718C|msb0010718c
185594|NCT03035630|Sutent|sutent
185595|NCT03035630|IgG1 antibody|igg1 antibody
185596|NCT03035630|Anti-PD-L1|anti-pd-l1
185597|NCT03035630|Tyrosine kinase inhibitor|tyrosine kinase inhibitor
185598|NCT03035617|Bupivacaine|bupivacaine
185599|NCT03035578|Pharmacokinetics|pharmacokinetics
185600|NCT03035578|Pharmacodynamics|pharmacodynamics
185601|NCT03035578|Morphine|morphine
185602|NCT03035578|Neonatal|neonatal
185603|NCT03035565|Heart Failure|heart failure
185604|NCT03035565|Cognition in Heart Failure|cognition in heart failure
185605|NCT03035552|Congenital heart disease (CCHD)|congenital heart disease (cchd)
185606|NCT03035552|Non-Nutritive Suck|non-nutritive suck
185607|NCT03035539|Rehabilitation|rehabilitation
185608|NCT03035513|Continuous spikes|continuous spikes
185609|NCT03035513|Epilepsy|epilepsy
185610|NCT03035513|Nervous system disease|nervous system disease
185611|NCT03035513|Neuronal plasticity|neuronal plasticity
185612|NCT03035513|Diffusion MRI|diffusion mri
185613|NCT03035513|Functional MRI|functional mri
185614|NCT03035513|waves during slow sleep (CSWS)|waves during slow sleep (csws)
185615|NCT03035474|Heart Failure|heart failure
185616|NCT03035474|Quality Improvement|quality improvement
185617|NCT03035461|diagnosis annoucement|diagnosis annoucement
185618|NCT03035461|patient's feelings|patient's feelings
185619|NCT03035448|Malignant neoplasms of independent (primary) multiple sites|malignant neoplasms of independent (primary) multiple sites
185620|NCT03035448|Advanced cancer|advanced cancer
185621|NCT03035448|Recurrent cancer|recurrent cancer
185622|NCT03035448|Metastatic disease|metastatic disease
185623|NCT03035448|Palliative care|palliative care
185624|NCT03035448|Videos|videos
185625|NCT03035448|Questionnaires|questionnaires
185626|NCT03035448|Surveys|surveys
185627|NCT03035435|fast-track rehabilitation|fast-track rehabilitation
185628|NCT03035435|fast-track surgery|fast-track surgery
185629|NCT03035422|Allogenic cell stem transplant, Sequential chemotherapy Haploidentical transplant|allogenic cell stem transplant, sequential chemotherapy haploidentical transplant
185630|NCT03035383|Large thyroid|large thyroid
185631|NCT03035383|purse string suture|purse string suture
185632|NCT03035383|thyroidectomy|thyroidectomy
185633|NCT03035370|Pertussis|pertussis
185634|NCT03035370|Epicutaneous ImmunoTherapy (EPIT)|epicutaneous immunotherapy (epit)
185635|NCT03035370|Vaccine|vaccine
185636|NCT03035370|Viaskin PT|viaskin pt
185637|NCT03035357|Malignant neoplasms of male genital organs|malignant neoplasms of male genital organs
185638|NCT03035357|Prostate cancer|prostate cancer
185639|NCT03035357|Adenocarcinoma of the prostate|adenocarcinoma of the prostate
185640|NCT03035357|Daratumumab|daratumumab
185641|NCT03035357|Biomarker response|biomarker response
185642|NCT03035305|Seasonal malaria chemoprevention|seasonal malaria chemoprevention
185643|NCT03035305|Lipid-based nutrient supplement|lipid-based nutrient supplement
185644|NCT03035305|Children|children
185645|NCT03035305|Mali|mali
185646|NCT03035279|Advanced colorectal cancer|advanced colorectal cancer
185647|NCT03035279|Cancer|cancer
185648|NCT03035279|Metastatic colorectal cancer|metastatic colorectal cancer
185649|NCT03035279|Unresectable colorectal cancer|unresectable colorectal cancer
185650|NCT03035279|Maximum tolerated dose|maximum tolerated dose
185651|NCT03035279|Pharmacokinetics|pharmacokinetics
185652|NCT03035266|blood flow restriction|blood flow restriction
185653|NCT03035266|strength|strength
185654|NCT03035266|muscle atrophy|muscle atrophy
185655|NCT03035266|post-operative therapy|post-operative therapy
185656|NCT03035266|knee|knee
185657|NCT03035201|Memory|memory
185658|NCT03035201|Mild Cognitive Impairment|mild cognitive impairment
185659|NCT03035201|Alzheimer's Disease|alzheimer's disease
185660|NCT03035201|Cognition|cognition
185661|NCT03035188|resectable|resectable
185662|NCT03035175|Residences|residences
185663|NCT03035175|Video Laryngoscopy|video laryngoscopy
185664|NCT03035175|Intubations|intubations
185665|NCT03035175|Neonatal|neonatal
185666|NCT03035175|NICU|nicu
185667|NCT03035175|neonates|neonates
185668|NCT03035175|Medical Education|medical education
185669|NCT03035162|dual tDCS|dual tdcs
185670|NCT03035162|physical rehabilitation|physical rehabilitation
185671|NCT03035162|lower limb functions|lower limb functions
185672|NCT03035149|Obesity|obesity
185673|NCT03035149|Metabolic Syndrome|metabolic syndrome
185674|NCT03035149|Dyspnea|dyspnea
185675|NCT03035149|Pulmonary Function|pulmonary function
185676|NCT03035149|Exercise Capacity|exercise capacity
185677|NCT03035136|polyps|polyps
185678|NCT03035123|Heart Failure|heart failure
185679|NCT03035123|Therapeutic education|therapeutic education
185680|NCT03035123|Quality of life|quality of life
185681|NCT03035071|Minimal-invasive esophagectomy|minimal-invasive esophagectomy
185682|NCT03035071|Esophageal resection|esophageal resection
185683|NCT03035071|Hybrid esophagectomy|hybrid esophagectomy
185684|NCT03035058|Drug therapy|drug therapy
185685|NCT03035032|Leuprolide acetate|leuprolide acetate
185686|NCT03035032|Prostate cancer|prostate cancer
185687|NCT03035019|anxiety|anxiety
185688|NCT03035019|behavioral app|behavioral app
185689|NCT03035006|Hepatocellular carcinoma|hepatocellular carcinoma
185690|NCT03035006|Portal vein tumor thrombosis|portal vein tumor thrombosis
185691|NCT03035006|TLC388|tlc388
185692|NCT03035006|Chemoradiotherapy|chemoradiotherapy
185693|NCT03035006|Lipotecan|lipotecan
185694|NCT03034993|Healthcare for homeless|healthcare for homeless
185695|NCT03034993|Text messages|text messages
185696|NCT03034993|Primary care visits|primary care visits
185697|NCT03034993|Medication adherence|medication adherence
185698|NCT03034993|Inpatient admissions|inpatient admissions
185699|NCT03034967|HCRU exacerbations|hcru exacerbations
185700|NCT03034967|SGRQ|sgrq
185701|NCT03034967|CXCR2 antagonist|cxcr2 antagonist
185702|NCT03034967|GSK1325756|gsk1325756
185703|NCT03034967|Danirixin|danirixin
185705|NCT03034941|Obesity|obesity
185706|NCT03034941|PCOS|pcos
185707|NCT03034941|Infertility|infertility
185708|NCT03034941|Liraglutide|liraglutide
185709|NCT03034941|Metformin|metformin
185711|NCT03034915|Vilanterol|vilanterol
185712|NCT03034915|COPD|copd
185713|NCT03034915|HRQoL|hrqol
185714|NCT03034915|Salmeterol|salmeterol
185715|NCT03034915|Umeclidinium|umeclidinium
185716|NCT03034889|Anesthesia|anesthesia
185717|NCT03034889|Children|children
185718|NCT03034889|General Anesthesia|general anesthesia
185719|NCT03034889|Neurocognitive Outcome|neurocognitive outcome
185720|NCT03034876|"Acute Kidney Injury, diagnosis, children, shock"|"acute kidney injury, diagnosis, children, shock"
185721|NCT03034863|Family Caregivers|family caregivers
185722|NCT03034863|Spouse Caregivers|spouse caregivers
185723|NCT03034863|Veterans|veterans
185724|NCT03034863|Suicide|suicide
185725|NCT03034863|Clinical Trial|clinical trial
185726|NCT03034863|Military Families|military families
185727|NCT03034863|Military Psychology|military psychology
185728|NCT03034850|cytoreductive surgery|cytoreductive surgery
185729|NCT03034850|hyperthermic intraperitoneal peroperative chemotherapy|hyperthermic intraperitoneal peroperative chemotherapy
185730|NCT03034850|platelet function|platelet function
185731|NCT03034850|thrombin generation|thrombin generation
185732|NCT03034850|thromboelastometry|thromboelastometry
185733|NCT03034824|diode laser|diode laser
185734|NCT03034824|Er,Cr:YSGG laser|er,cr:ysgg laser
185735|NCT03034824|Aggressive Periodontitis|aggressive periodontitis
185736|NCT03034824|Clinical periodontal parameters|clinical periodontal parameters
185737|NCT03034824|Gingival crevicular fluid cytokines levels|gingival crevicular fluid cytokines levels
185738|NCT03034811|Noninflammatory degenerative joint disease|noninflammatory degenerative joint disease
185739|NCT03034811|Osteoarthritis|osteoarthritis
185740|NCT03034811|Avascular necrosis|avascular necrosis
185741|NCT03034811|Traumatic arthritis|traumatic arthritis
185742|NCT03034811|Partial knee arthroplasty|partial knee arthroplasty
185743|NCT03034811|Unicompartmental knee arthroplasty|unicompartmental knee arthroplasty
185744|NCT03034772|neovascular|neovascular
185745|NCT03034772|wet|wet
185746|NCT03034772|age-related|age-related
185747|NCT03034772|macular degeneration|macular degeneration
185748|NCT03034772|dorzolamide|dorzolamide
185749|NCT03034772|timolol|timolol
185750|NCT03034759|continuous glucose monitoring|continuous glucose monitoring
185751|NCT03034746|alzheimer's disease, physical activity, cognitive training|alzheimer's disease, physical activity, cognitive training
185752|NCT03034733|Arthroplasty|arthroplasty
185753|NCT03034733|Knee Replacement|knee replacement
185754|NCT03034733|Pain, Postoperative|pain, postoperative
185755|NCT03034733|Glucocorticoids|glucocorticoids
185756|NCT03034733|Dexamethasone|dexamethasone
185757|NCT03034720|Concussion|concussion
185758|NCT03034720|persistent post-concussive symptoms|persistent post-concussive symptoms
185759|NCT03034720|CBT|cbt
185760|NCT03034720|collaborative care|collaborative care
185761|NCT03034720|Depression|depression
185762|NCT03034720|Anxiety|anxiety
185763|NCT03034707|biotin pharmacokinetic|biotin pharmacokinetic
185764|NCT03034707|biotinylated assay|biotinylated assay
185765|NCT03034707|hormone measurement|hormone measurement
185766|NCT03034707|thyroid|thyroid
185767|NCT03034707|parathyroid|parathyroid
185768|NCT03034707|prolactin|prolactin
185769|NCT03034668|Botanical Supplement|botanical supplement
185770|NCT03034668|Performance-Enhancing Supplement|performance-enhancing supplement
185771|NCT03034655|Vestibular rehabilitation|vestibular rehabilitation
185772|NCT03034655|Falls in elderly|falls in elderly
185773|NCT03034655|Computerized dynamic posturography|computerized dynamic posturography
185774|NCT03034655|Mobile posturography|mobile posturography
185775|NCT03034642|Apoptosis|apoptosis
185776|NCT03034642|Bronchoscopy|bronchoscopy
185777|NCT03034642|Human|human
185778|NCT03034642|Mice, inbred strains|mice, inbred strains
185779|NCT03034642|Macrophages, Alveolar|macrophages, alveolar
185780|NCT03034642|MicroRNAs|micrornas
185781|NCT03034642|Streptococcus pneumoniae|streptococcus pneumoniae
185782|NCT03034642|Fluticasone|fluticasone
185783|NCT03034616|Primary ovarian insufficiency|primary ovarian insufficiency
185784|NCT03034616|In-vivo activation|in-vivo activation
185785|NCT03034551|Adherence|adherence
185786|NCT03034551|Financial Incentives|financial incentives
185787|NCT03034551|Remote Monitoring|remote monitoring
185788|NCT03034551|Self-Weighing|self-weighing
185789|NCT03034551|Behavioral Economics|behavioral economics
185790|NCT03034551|Telehealth|telehealth
185791|NCT03034551|mobile health (mHealth)|mobile health (mhealth)
185792|NCT03034551|Smartphone App|smartphone app
185793|NCT03034551|Wellth App|wellth app
185794|NCT03034486|Glaucoma|glaucoma
185795|NCT03034473|locally advanced rectal cancer|locally advanced rectal cancer
185796|NCT03034473|translational research|translational research
185797|NCT03034473|Biomarker|biomarker
185798|NCT03034447|Asthma|asthma
185799|NCT03034447|Obstructive Sleep Apnea|obstructive sleep apnea
185800|NCT03034447|Children|children
185801|NCT03034447|Teenagers|teenagers
185802|NCT03034408|Impulsivity|impulsivity
185803|NCT03034408|Nalmefene|nalmefene
185804|NCT03034408|Baclofen|baclofen
185805|NCT03034395|Melanoma|melanoma
185806|NCT03034395|cT2N0M0|ct2n0m0
185807|NCT03034382|morphine|morphine
185808|NCT03034382|nalbuphine|nalbuphine
185809|NCT03034382|arthroscopic rotator cuff repair|arthroscopic rotator cuff repair
185810|NCT03034382|ultrasound guided interscalene block|ultrasound guided interscalene block
185811|NCT03034369|Integration|integration
185812|NCT03034369|Primary Care|primary care
185813|NCT03034369|Behavioral Health|behavioral health
185814|NCT03034369|Health Care Reform|health care reform
185815|NCT03034369|Medical Home|medical home
185816|NCT03034369|Accountable Care Organization|accountable care organization
185817|NCT03034356|Schizophrenia|schizophrenia
185818|NCT03034343|Mindfulness|mindfulness
185819|NCT03034343|Internet program|internet program
185820|NCT03034343|Depression|depression
185821|NCT03034343|Cost-effectiveness|cost-effectiveness
185822|NCT03034330|informal care|informal care
185823|NCT03034330|empowerment|empowerment
185824|NCT03034330|family-focused intervention|family-focused intervention
185825|NCT03034330|stroke rehabilitation|stroke rehabilitation
185826|NCT03034317|Diaphragm Pacing|diaphragm pacing
185827|NCT03034304|MASCT-I，DC，T cell|masct-i，dc，t cell
185828|NCT03034304|Advanced solid tumors|advanced solid tumors
185829|NCT03034304|Bladder Cancer|bladder cancer
185830|NCT03034304|Soft Tissue Sarcoma|soft tissue sarcoma
185831|NCT03034291|Cocoa|cocoa
185832|NCT03034291|obesity|obesity
185833|NCT03034291|HOMA-IR|homa-ir
185834|NCT03034291|BMI|bmi
185835|NCT03034291|Quality of life|quality of life
185836|NCT03034278|opioid use|opioid use
185837|NCT03034265|hypertension; exosome; angiotensin; sodium channel; kidney; aldosterone; renin; urine|hypertension; exosome; angiotensin; sodium channel; kidney; aldosterone; renin; urine
185838|NCT03034226|Hypoglycemia-Associated Autonomic Failure (HAAF)|hypoglycemia-associated autonomic failure (haaf)
185839|NCT03034213|mesh|mesh
185840|NCT03034200|Pheochromocytoma-paraganglioma|pheochromocytoma-paraganglioma
185841|NCT03034200|ONC201|onc201
185842|NCT03034187|Acute toxicity|acute toxicity
185843|NCT03034187|Late toxicity|late toxicity
185844|NCT03034187|Quality of Life since 2011(set-up SFP-prostate)|quality of life since 2011(set-up sfp-prostate)
185845|NCT03034174|tigecycline|tigecycline
185846|NCT03034174|pharmacokinetics|pharmacokinetics
185847|NCT03034148|Coronary artery disease|coronary artery disease
185848|NCT03034148|Atherothrombosis|atherothrombosis
185849|NCT03034148|Thrombin generation|thrombin generation
185850|NCT03034148|Platelet Acetyl Coenzyme A carboxylase phosphorylation|platelet acetyl coenzyme a carboxylase phosphorylation
185851|NCT03034109|Transcranial Direct Current Stimulation|transcranial direct current stimulation
185852|NCT03034109|Stroke|stroke
185853|NCT03034109|Electric Stimulation Therapy|electric stimulation therapy
185854|NCT03034109|Prefrontal Cortex|prefrontal cortex
185855|NCT03034109|Electroencephalography|electroencephalography
185856|NCT03034109|Cognition|cognition
185857|NCT03034109|Neurological Rehabilitation|neurological rehabilitation
185858|NCT03034109|Memory|memory
185859|NCT03034109|Working Memory|working memory
185860|NCT03034109|Attention|attention
185861|NCT03034109|Concentration|concentration
185862|NCT03034109|Short-Term Memory|short-term memory
185863|NCT03034109|Planning|planning
185864|NCT03034109|Executive Function|executive function
185865|NCT03034109|Cerebrovascular disease|cerebrovascular disease
185866|NCT03034083|healthy marriage|healthy marriage
185867|NCT03034083|healthy relationships|healthy relationships
185868|NCT03034083|parenting|parenting
185869|NCT03034083|healthy marriage and relationship education|healthy marriage and relationship education
185870|NCT03034070|MRI|mri
185871|NCT03034070|MRI sequences|mri sequences
185872|NCT03034070|prostate cancer|prostate cancer
185873|NCT03034070|cancer|cancer
185874|NCT03034070|staging|staging
185875|NCT03034070|bone metastasis|bone metastasis
185876|NCT03034070|node metastasis|node metastasis
185877|NCT03034031|Traumatic Brain Injury|traumatic brain injury
185878|NCT03034031|Children|children
185879|NCT03034031|Pediatric|pediatric
185880|NCT03034031|MRI|mri
185881|NCT03034031|fMRI|fmri
185882|NCT03034031|Cognition|cognition
185883|NCT03034031|DTI|dti
185884|NCT03034031|Longitudinal|longitudinal
185885|NCT03034031|Connectivity|connectivity
185886|NCT03034031|DAI|dai
185887|NCT03034031|Neuropsychology|neuropsychology
185888|NCT03034031|Rehabilitation|rehabilitation
185889|NCT03034018|insomnia|insomnia
185890|NCT03034018|hot flashes|hot flashes
185891|NCT03034018|menopause|menopause
185892|NCT03034018|suvorexant|suvorexant
185893|NCT03034018|belsomra|belsomra
185894|NCT03034005|Inhaled corticosteroids|inhaled corticosteroids
185895|NCT03034005|Airway hyper-responsiveness|airway hyper-responsiveness
185896|NCT03034005|Airway smooth muscle|airway smooth muscle
185897|NCT03034005|sodium-potassium pump|sodium-potassium pump
185898|NCT03033966|Cerebral Oximetry|cerebral oximetry
185899|NCT03033966|Cerebral Venous Thrombosis|cerebral venous thrombosis
185900|NCT03033966|Decompressive Craniectomy|decompressive craniectomy
185901|NCT03033927|Stage IV Pancreatic Cancer|stage iv pancreatic cancer
185902|NCT03033927|FOLFIRINOX|folfirinox
185903|NCT03033927|gem/nab-P chemotherapy|gem/nab-p chemotherapy
185904|NCT03033927|17-042|17-042
185905|NCT03033914|Nivolumab|nivolumab
185906|NCT03033914|adriamycin|adriamycin
185907|NCT03033914|bleomycin|bleomycin
185908|NCT03033914|vinblastine|vinblastine
185909|NCT03033914|dacarbazine|dacarbazine
185910|NCT03033914|16-1536|16-1536
185911|NCT03033901|Veterans|veterans
185912|NCT03033901|Comparative Effectiveness Research|comparative effectiveness research
185913|NCT03033901|Diagnosis|diagnosis
185914|NCT03033836|transgender women|transgender women
185915|NCT03033823|Alcoholism|alcoholism
185916|NCT03033823|Delirium|delirium
185917|NCT03033823|Magnesium Deficiency|magnesium deficiency
185918|NCT03033797|assitive technology|assitive technology
185919|NCT03033797|virtual reality games|virtual reality games
185920|NCT03033797|intellectual disability|intellectual disability
185921|NCT03033797|augmentative and alternative communication|augmentative and alternative communication
185922|NCT03033784|Neuroscience|neuroscience
185923|NCT03033758|comorbidities|comorbidities
185924|NCT03033732|opioid agonist treatment|opioid agonist treatment
185925|NCT03033732|pragmatic|pragmatic
185926|NCT03033732|prescription opioid use|prescription opioid use
185927|NCT03033732|patient engagement|patient engagement
185928|NCT03033719|Colorectal Surgery|colorectal surgery
185929|NCT03033719|Geriatrics|geriatrics
185930|NCT03033719|Digestive Oncology|digestive oncology
185931|NCT03033719|Colon cancer|colon cancer
185932|NCT03033719|Elderly patients|elderly patients
185933|NCT03033719|Laparoscopy|laparoscopy
185934|NCT03033719|Laparotomy|laparotomy
185935|NCT03033719|Morbidity|morbidity
185936|NCT03033667|perioperative fasting|perioperative fasting
185937|NCT03033667|free fatty acids|free fatty acids
185938|NCT03033667|coronary bypass grfting|coronary bypass grfting
185939|NCT03033589|Pain control|pain control
185940|NCT03033589|Anterior Cruciate Ligament (ACL_ Reconstruction)|anterior cruciate ligament (acl_ reconstruction)
185941|NCT03033589|Regional Anesthesia|regional anesthesia
185942|NCT03033550|HPV vaccination|hpv vaccination
185943|NCT03033550|Cervical cancer screening|cervical cancer screening
185944|NCT03033550|Primary care setting|primary care setting
185945|NCT03033550|Primary prevention of cervical cancer|primary prevention of cervical cancer
185946|NCT03033550|Secondary prevention of cervical cancer|secondary prevention of cervical cancer
185947|NCT03033550|Mobile health information|mobile health information
185948|NCT03033511|Extensive-Stage Small Cell Lung Cancer (ED SCLC)|extensive-stage small cell lung cancer (ed sclc)
185949|NCT03033511|Cancer|cancer
185950|NCT03033511|Platinum-Based Chemotherapy|platinum-based chemotherapy
185951|NCT03033511|Rovalpituzumab tesirine|rovalpituzumab tesirine
185952|NCT03033511|first-line chemotherapy|first-line chemotherapy
185953|NCT03033511|Small Cell Lung Cancer (SCLC)|small cell lung cancer (sclc)
185954|NCT03033511|Delta-like protein 3 (DLL3)|delta-like protein 3 (dll3)
185955|NCT03033485|Picolinamide|picolinamide
185956|NCT03033485|PET/CT|pet/ct
185957|NCT03033485|Diagnosis|diagnosis
185958|NCT03033485|Melanoma|melanoma
185959|NCT03033459|breast feeding|breast feeding
185960|NCT03033459|motivational interviewing|motivational interviewing
185961|NCT03033420|Unipolar disorder|unipolar disorder
185962|NCT03033420|Bipolar disorder|bipolar disorder
185963|NCT03033420|Randomized controlled trial|randomized controlled trial
185964|NCT03033420|Smartphone|smartphone
185965|NCT03033420|Re-admission|re-admission
185966|NCT03033420|CBT|cbt
185967|NCT03033394|Penicillins|penicillins
185968|NCT03033394|Drug Monitoring|drug monitoring
185969|NCT03033394|Pharmacokinetics|pharmacokinetics
185970|NCT03033381|Children|children
185971|NCT03033381|Inguinal hernia|inguinal hernia
185972|NCT03033381|Testis|testis
185973|NCT03033381|Doppler ultrasonography|doppler ultrasonography
185974|NCT03033368|immunological outcome|immunological outcome
185975|NCT03033368|virologic outcomes|virologic outcomes
185976|NCT03033368|HIV-1 infected adolescents|hiv-1 infected adolescents
185977|NCT03033368|EFV switch to RPV|efv switch to rpv
185978|NCT03033368|Rilpivirine pharmacokinetic|rilpivirine pharmacokinetic
185979|NCT03033368|neuropsychiatric adverse events|neuropsychiatric adverse events
185980|NCT03033355|Neurogenic Bladder, Detrusor Overactivity, Botox, fMRI, neurogenic detrusor overactivity|neurogenic bladder, detrusor overactivity, botox, fmri, neurogenic detrusor overactivity
185981|NCT03033342|Phase 1|phase 1
185982|NCT03033316|Multiple Myeloma|multiple myeloma
185983|NCT03033316|Liposomal Dexamethasone|liposomal dexamethasone
185984|NCT03033316|Targeted Drug Delivery|targeted drug delivery
185985|NCT03033303|Hu3F8|hu3f8
185986|NCT03033303|GM-CSF|gm-csf
185987|NCT03033303|Isotretinoin|isotretinoin
185988|NCT03033303|16-1643|16-1643
185989|NCT03033290|Qi-tonifying regimen|qi-tonifying regimen
185990|NCT03033290|immune-modulation|immune-modulation
185991|NCT03033290|gut microbiota|gut microbiota
185992|NCT03033251|COPD exacerbation|copd exacerbation
185993|NCT03033251|Work of breathing|work of breathing
185994|NCT03033251|Non invasive ventilation|non invasive ventilation
185995|NCT03033251|High Flow Oxygen Cannula|high flow oxygen cannula
185996|NCT03033225|Pancrease|pancrease
185997|NCT03033225|Cancer|cancer
185998|NCT03033225|Photodynamic Therapy|photodynamic therapy
185999|NCT03033225|Pancreatic|pancreatic
186000|NCT03033225|Tumor|tumor
186001|NCT03033225|unresectable|unresectable
186002|NCT03033199|Gut microbiota|gut microbiota
186003|NCT03033199|Immune thrombocytopenia|immune thrombocytopenia
186004|NCT03033186|Everolimus|everolimus
186005|NCT03033186|Long term site effects|long term site effects
186006|NCT03033186|Dried Blood Spot|dried blood spot
186007|NCT03033186|Therapeutic Drug Monitoring|therapeutic drug monitoring
186008|NCT03033160|Estrogen|estrogen
186009|NCT03033160|Hematuria|hematuria
186010|NCT03033121|growth hormone|growth hormone
186011|NCT03033121|children|children
186012|NCT03033121|metabolism|metabolism
186013|NCT03033095|TNF inhibitor|tnf inhibitor
186014|NCT03033095|Etanercept|etanercept
186015|NCT03033095|Spondyloarthritis|spondyloarthritis
186016|NCT03033095|Biomarkers analysis|biomarkers analysis
186017|NCT03033095|Personnalized medicine|personnalized medicine
186018|NCT03033056|fear-conditioning|fear-conditioning
186019|NCT03033056|behavioral avoidance|behavioral avoidance
186020|NCT03033056|anxiety disorders|anxiety disorders
186021|NCT03033056|fMRI|fmri
186022|NCT03033043|aortic|aortic
186023|NCT03033043|dissection|dissection
186024|NCT03033043|type B|type b
186025|NCT03033043|thoracic|thoracic
186026|NCT03033030|Ultrasound|ultrasound
186027|NCT03033030|Digital Breast Tomosynthesis|digital breast tomosynthesis
186028|NCT03033030|Cancer Detection rate|cancer detection rate
186029|NCT03033030|Sensitivity|sensitivity
186030|NCT03033030|Specificity|specificity
186031|NCT03033030|Breast density|breast density
186032|NCT03033017|HIV|hiv
186033|NCT03032991|Gestational diabetes|gestational diabetes
186034|NCT03032991|Neurodevelopment|neurodevelopment
186035|NCT03032991|Placenta|placenta
186036|NCT03032991|Gut microbiota|gut microbiota
186037|NCT03032991|Protectins|protectins
186038|NCT03032991|MFSD2a|mfsd2a
186039|NCT03032991|AdipoRon|adiporon
186040|NCT03032965|atrial fibrillation|atrial fibrillation
186041|NCT03032965|ablation|ablation
186042|NCT03032965|adenosine|adenosine
186043|NCT03032952|RCT|rct
186044|NCT03032952|Computerised interventions|computerised interventions
186045|NCT03032952|Mobile applications|mobile applications
186046|NCT03032952|Stress, Psychological|stress, psychological
186047|NCT03032952|Depressive symptoms|depressive symptoms
186048|NCT03032952|Anxious symptoms|anxious symptoms
186049|NCT03032952|Students|students
186050|NCT03032952|Mental health|mental health
186051|NCT03032926|Anxiety|anxiety
186052|NCT03032913|Pancreas|pancreas
186053|NCT03032913|Pancreatic|pancreatic
186054|NCT03032913|Cancer|cancer
186055|NCT03032913|Circulating tumor cell (CTC)|circulating tumor cell (ctc)
186056|NCT03032913|Adenocarcinoma|adenocarcinoma
186057|NCT03032913|Ductal|ductal
186058|NCT03032913|Exosome|exosome
186059|NCT03032900|Major lung resection|major lung resection
186060|NCT03032900|Right Ventricular Dysfunction|right ventricular dysfunction
186061|NCT03032900|2D Strain|2d strain
186062|NCT03032887|hygiene|hygiene
186063|NCT03032887|prenatal care|prenatal care
186064|NCT03032887|postnatal care|postnatal care
237899|NCT02711917|BIS|bis
186065|NCT03032874|Colorectal cancer|colorectal cancer
186066|NCT03032874|Polyps|polyps
186067|NCT03032874|Colonoscopy|colonoscopy
186068|NCT03032874|Rectal bleeding|rectal bleeding
186069|NCT03032874|Nigeria|nigeria
186070|NCT03032861|Orange juice|orange juice
186071|NCT03032861|Microbiota|microbiota
186072|NCT03032861|Prebiotic|prebiotic
186073|NCT03032861|Flavanones|flavanones
186074|NCT03032861|Bioavailability|bioavailability
186075|NCT03032835|Calciphylaxis|calciphylaxis
186076|NCT03032835|Warfarin|warfarin
186077|NCT03032835|Dialysis|dialysis
186078|NCT03032822|Opioid consumption|opioid consumption
186079|NCT03032822|postdischarge|postdischarge
186080|NCT03032822|cystectomy|cystectomy
186081|NCT03032744|Pediatric|pediatric
186082|NCT03032744|School Based Health Center|school based health center
186083|NCT03032731|Physical activity|physical activity
186084|NCT03032731|Diet|diet
186085|NCT03032731|Health Behavior|health behavior
186086|NCT03032705|Restorations|restorations
186087|NCT03032705|Composite|composite
186088|NCT03032679|pain, acute, chronic, knee arthroplasty|pain, acute, chronic, knee arthroplasty
186089|NCT03032666|Thalassemia|thalassemia
186090|NCT03032666|HCV|hcv
186091|NCT03032666|Sofosbuvir|sofosbuvir
186092|NCT03032666|Ledipasvir|ledipasvir
186093|NCT03032653|ankle, fracture, rehabilitation, weightbearing, early, late|ankle, fracture, rehabilitation, weightbearing, early, late
186094|NCT03032640|Glucose|glucose
186095|NCT03032640|Sweet taste receptors|sweet taste receptors
186096|NCT03032640|Artificial sweeteners|artificial sweeteners
186097|NCT03032601|MS (Multiple Sclerosis)|ms (multiple sclerosis)
186098|NCT03032601|Acute Fulminating|acute fulminating
186099|NCT03032601|Sclerosis|sclerosis
186100|NCT03032601|FDG|fdg
186101|NCT03032601|18F Fluorodeoxyglucose|18f fluorodeoxyglucose
186102|NCT03032601|18F-FDG|18f-fdg
186103|NCT03032601|18FDG|18fdg
186104|NCT03032601|2-Fluoro-2-deoxy-D-glucose|2-fluoro-2-deoxy-d-glucose
186105|NCT03032601|2-Fluoro-2-deoxyglucose|2-fluoro-2-deoxyglucose
186106|NCT03032601|Fludeoxyglucose F 18|fludeoxyglucose f 18
186107|NCT03032601|Fluorine-18-fluorodeoxyglucose|fluorine-18-fluorodeoxyglucose
186108|NCT03032601|Fluorodeoxyglucose F 18|fluorodeoxyglucose f 18
186109|NCT03032601|PET Scan|pet scan
186110|NCT03032601|Tomography, Positron-Emission|tomography, positron-emission
186111|NCT03032601|Magnetic Resonance Imaging, Functional|magnetic resonance imaging, functional
186112|NCT03032601|fMRI|fmri
186113|NCT03032601|PET-MRI|pet-mri
186114|NCT03032601|Acetylcysteine|acetylcysteine
186115|NCT03032601|N-acetyl cysteine|n-acetyl cysteine
186116|NCT03032601|NAC|nac
186117|NCT03032601|Oral supplements|oral supplements
186118|NCT03032575|HIV|hiv
186119|NCT03032562|respiratory muscle strength|respiratory muscle strength
186120|NCT03032562|sleep-disordered breathing|sleep-disordered breathing
186121|NCT03032562|neuromuscular disease|neuromuscular disease
186122|NCT03032562|chronic-obstructive pulmonary disease|chronic-obstructive pulmonary disease
186123|NCT03032497|Brain Computer Interface|brain computer interface
186124|NCT03032497|Electroencephalogram (EEG)|electroencephalogram (eeg)
186125|NCT03032497|Chronic Pain|chronic pain
186126|NCT03032471|Subarachnoid Hemorrhage|subarachnoid hemorrhage
186127|NCT03032471|Delayed cerebral ischemia|delayed cerebral ischemia
186128|NCT03032471|Cognitive Impairment|cognitive impairment
186129|NCT03032471|Montreal Cognitive Assessment|montreal cognitive assessment
186130|NCT03032471|MoCA|moca
186131|NCT03032471|Cognitive Deterioration|cognitive deterioration
186132|NCT03032458|Shock Wave Lithotripsy|shock wave lithotripsy
186133|NCT03032458|Ketorolac|ketorolac
186134|NCT03032458|Xylocaine Gel|xylocaine gel
186135|NCT03032458|Pethidine|pethidine
186136|NCT03032445|Body Water/physiology|body water/physiology
186137|NCT03032445|Hyponatremia/etiology|hyponatremia/etiology
186138|NCT03032445|Physical Exertion/physiology|physical exertion/physiology
186139|NCT03032445|Running/physiology|running/physiology
186140|NCT03032445|Sodium/blood|sodium/blood
186141|NCT03032445|Ethanol|ethanol
186142|NCT03032380|Hospital-acquired pneumonia (HAP)|hospital-acquired pneumonia (hap)
186143|NCT03032380|S-649266|s-649266
186144|NCT03032380|linezolid|linezolid
186145|NCT03032380|meropenem|meropenem
186146|NCT03032380|Healthcare-associated pneumonia (HCAP)|healthcare-associated pneumonia (hcap)
186147|NCT03032380|nosocomial pneumonia|nosocomial pneumonia
186148|NCT03032380|Ventilator-associated pneumonia (VAP)|ventilator-associated pneumonia (vap)
186149|NCT03032380|Gram-negative pathogens|gram-negative pathogens
186150|NCT03032380|pneumonia|pneumonia
186151|NCT03032380|cefiderocol|cefiderocol
186152|NCT03032354|probiotics|probiotics
186153|NCT03032354|children|children
186154|NCT03032354|remission|remission
186155|NCT03032341|mobility assessment tool|mobility assessment tool
186156|NCT03032302|TBI|tbi
186157|NCT03032289|active transport|active transport
186158|NCT03032289|cycling|cycling
186159|NCT03032289|walking|walking
186160|NCT03032276|Safe motherhood|safe motherhood
186161|NCT03032276|Newborn survival|newborn survival
186162|NCT03032276|Community|community
237939|NCT02711605|fat|fat
186163|NCT03032276|Cluster Randomized Trial|cluster randomized trial
186164|NCT03032237|Protein intake|protein intake
186165|NCT03032237|Older adults|older adults
186166|NCT03032237|Protein-rich|protein-rich
186167|NCT03032237|Acceptance|acceptance
186168|NCT03032237|Liking|liking
186169|NCT03032237|Readymade meals|readymade meals
186170|NCT03032224|Body composition|body composition
186171|NCT03032224|sarcopenia|sarcopenia
186172|NCT03032224|Dysphagia|dysphagia
186173|NCT03032224|Surgery|surgery
186174|NCT03032224|Quality of Life|quality of life
186175|NCT03032224|Morbidity|morbidity
186176|NCT03032185|menopause|menopause
186177|NCT03032185|post-menopause|post-menopause
186178|NCT03032185|transcutaneous electrical nerve stimulation|transcutaneous electrical nerve stimulation
186179|NCT03032185|electrical stimulation therapy|electrical stimulation therapy
186180|NCT03032185|women's health|women's health
186181|NCT03032133|Total Knee Arthroplasty|total knee arthroplasty
186182|NCT03032133|Total Knee Replacement|total knee replacement
186183|NCT03032133|Outcome|outcome
186184|NCT03032133|Results|results
186185|NCT03032133|Pain|pain
186186|NCT03032107|Breast Cancer|breast cancer
186187|NCT03032094|Gingival Recession|gingival recession
186188|NCT03032055|sickle cell desease|sickle cell desease
186189|NCT03032055|vaso occlusive crisis|vaso occlusive crisis
186190|NCT03032055|acute chest syndrome|acute chest syndrome
186191|NCT03032055|Validation of predictif score of acute chest syndrome|validation of predictif score of acute chest syndrome
186192|NCT03032042|intestinal microbiome|intestinal microbiome
186193|NCT03032042|soil-transmitted helminths|soil-transmitted helminths
186194|NCT03032042|mass drug administration|mass drug administration
186195|NCT03032016|VOD|vod
186196|NCT03032016|Defibrotide|defibrotide
186197|NCT03032016|Defitelio|defitelio
186198|NCT03032016|Registry|registry
186199|NCT03032016|SOS|sos
186200|NCT03031990|Yoga|yoga
186201|NCT03031990|Oocyte cryopreservation|oocyte cryopreservation
186202|NCT03031990|In-vitro fertilization|in-vitro fertilization
186203|NCT03031951|Former athletes|former athletes
186204|NCT03031951|Body composition|body composition
186205|NCT03031951|Adaptive thermogenesis|adaptive thermogenesis
186206|NCT03031951|Physical activity|physical activity
186207|NCT03031951|Energy expenditure|energy expenditure
186208|NCT03031951|Sedentary behavior|sedentary behavior
186209|NCT03031951|Fat mass|fat mass
186210|NCT03031951|Abdominal fat mass|abdominal fat mass
186211|NCT03031951|Nutrition|nutrition
186212|NCT03031951|Behavior modification|behavior modification
186213|NCT03031938|Exposure in utero in tanezumab program|exposure in utero in tanezumab program
186214|NCT03031925|Annexin A2|annexin a2
186215|NCT03031925|biomarker|biomarker
186216|NCT03031821|Prostate Cancer|prostate cancer
186217|NCT03031821|ADT|adt
186218|NCT03031821|iADT|iadt
186219|NCT03031821|Metabolic Syndrome|metabolic syndrome
186220|NCT03031821|Androgen Deprivation Therapy|androgen deprivation therapy
186221|NCT03031821|Phase III|phase iii
186222|NCT03031821|Phase 3|phase 3
186223|NCT03031821|Randomized|randomized
186224|NCT03031821|Intermittent Androgen Deprivation Therapy|intermittent androgen deprivation therapy
186225|NCT03031795|intrauterine device|intrauterine device
186226|NCT03031782|JIA, JPsA, ERA, Secukinumab, ILAR|jia, jpsa, era, secukinumab, ilar
186227|NCT03031756|Air polishing|air polishing
186228|NCT03031743|rotavirus vaccine|rotavirus vaccine
186229|NCT03031743|human microbiome|human microbiome
186230|NCT03031743|fecal microbiome|fecal microbiome
186231|NCT03031743|vaccine immunogenicity|vaccine immunogenicity
186232|NCT03031743|Rotarix|rotarix
186233|NCT03031743|immune response, mucosal|immune response, mucosal
186234|NCT03031665|GABA|gaba
186235|NCT03031665|Depression|depression
186236|NCT03031665|Stress|stress
186237|NCT03031665|Androgens|androgens
186238|NCT03031652|pain|pain
186239|NCT03031652|axial length|axial length
186240|NCT03031652|anterior chamber depth|anterior chamber depth
186241|NCT03031652|intraocular pressure|intraocular pressure
186242|NCT03031639|endoscopic|endoscopic
186243|NCT03031639|thyroidectomy|thyroidectomy
186244|NCT03031613|intraocular pressure|intraocular pressure
186245|NCT03031613|intracerebral pressure|intracerebral pressure
186246|NCT03031587|Thermometric MRI|thermometric mri
186247|NCT03031587|Myocardium|myocardium
186248|NCT03031574|Serotonin 4 (5-HT4) receptor|serotonin 4 (5-ht4) receptor
186249|NCT03031574|Phase 1|phase 1
186250|NCT03031509|Nonunion Fracture of limb|nonunion fracture of limb
186251|NCT03031496|Cross-over|cross-over
186252|NCT03031496|Hydrochlorothiazide|hydrochlorothiazide
186253|NCT03031496|Amiloride hydrochloride|amiloride hydrochloride
186254|NCT03031496|Phase I|phase i
186255|NCT03031496|GSK3542503|gsk3542503
186256|NCT03031496|Bioequivalence|bioequivalence
186257|NCT03031496|FTIH|ftih
186258|NCT03031470|Liver Transplant|liver transplant
186259|NCT03031470|Ischemia-reperfusion injury|ischemia-reperfusion injury
186260|NCT03031470|Early allograft dysfunction|early allograft dysfunction
186261|NCT03031444|colorectal liver metastasis|colorectal liver metastasis
186262|NCT03031444|preoperative|preoperative
186263|NCT03031444|chemotherapy|chemotherapy
186264|NCT03031444|targeted therapy|targeted therapy
186265|NCT03031431|Hypothermia|hypothermia
186266|NCT03031431|Infant Warmer|infant warmer
186267|NCT03031340|Spinal fusion|spinal fusion
186268|NCT03031340|pregabalin|pregabalin
186269|NCT03031340|Spinal fusion surgeries|spinal fusion surgeries
186270|NCT03031340|two or more vertebrae|two or more vertebrae
186271|NCT03031327|Ocular Discomfort Following Refractive Surgery|ocular discomfort following refractive surgery
186272|NCT03031327|Refractive Surgery|refractive surgery
186273|NCT03031314|Joint Replacement|joint replacement
186274|NCT03031314|Knee Replacement|knee replacement
186275|NCT03031314|Wound Healing|wound healing
186276|NCT03031314|Hip Replacement|hip replacement
186277|NCT03031288|gastroesophageal reflux|gastroesophageal reflux
186278|NCT03031288|swallow|swallow
186279|NCT03031288|feeding bottle|feeding bottle
186280|NCT03031288|cardiorespiratory|cardiorespiratory
186281|NCT03031288|apnoea|apnoea
186282|NCT03031288|preterm|preterm
186283|NCT03031288|impedance-pH-metry|impedance-ph-metry
186284|NCT03031275|extracorporeal circulation|extracorporeal circulation
186285|NCT03031275|critical care outcomes|critical care outcomes
186286|NCT03031236|Early Childhood Development (ECD)|early childhood development (ecd)
186287|NCT03031236|Psychosocial stimulation|psychosocial stimulation
186288|NCT03031236|Cognition|cognition
186289|NCT03031236|Parenting|parenting
186290|NCT03031236|Malnutrition|malnutrition
186291|NCT03031236|Bangladesh|bangladesh
186292|NCT03031236|Childhood Maltreatment|childhood maltreatment
186293|NCT03031223|Spinal cord injuries|spinal cord injuries
186294|NCT03031223|low-level laser therapy|low-level laser therapy
186295|NCT03031210|Non-severe community-acquired pneumonia|non-severe community-acquired pneumonia
186296|NCT03031210|Amoxicillin treatment|amoxicillin treatment
186297|NCT03031210|Twice daily antibiotic regimen|twice daily antibiotic regimen
186298|NCT03031197|adherence|adherence
186299|NCT03031197|adolescent|adolescent
186300|NCT03031197|HIV/AIDS|hiv/aids
186301|NCT03031197|Vietnam|vietnam
186302|NCT03031184|Agitation|agitation
186500|NCT03030001|CAR T|car t
186303|NCT03031184|Agitated behaviours|agitated behaviours
186304|NCT03031184|Alzheimer's Disease|alzheimer's disease
186305|NCT03031171|community engagement, navigation, cancer screening|community engagement, navigation, cancer screening
186306|NCT03031132|Protein-rich breakfast|protein-rich breakfast
186307|NCT03031132|Breakfast Skipping|breakfast skipping
186308|NCT03031132|Young Adults|young adults
186309|NCT03031132|Breakfast|breakfast
186310|NCT03031132|Food form|food form
186311|NCT03031132|fMRI|fmri
186312|NCT03031132|Ghrelin|ghrelin
186313|NCT03031132|PYY|pyy
186314|NCT03031132|Sleep|sleep
186315|NCT03031119|nonalcoholic steatohepatitis|nonalcoholic steatohepatitis
186316|NCT03031106|Patient-reported outcomes, Health-related QoL, Internet-based tool|patient-reported outcomes, health-related qol, internet-based tool
186317|NCT03031093|aerosol therapy|aerosol therapy
186318|NCT03031093|pulmonary scintigraphy|pulmonary scintigraphy
186319|NCT03031093|upper airways anatomy|upper airways anatomy
186320|NCT03031093|High Flow Nasal Cannula|high flow nasal cannula
186321|NCT03031080|Collagenase, Night-splinting, Dupuytrens, Contracture|collagenase, night-splinting, dupuytrens, contracture
186322|NCT03031067|Donors and donation|donors and donation
186323|NCT03031067|Extended criteria donor|extended criteria donor
186324|NCT03031067|Organ perfusion and preservation|organ perfusion and preservation
186325|NCT03031067|Liver transplantation|liver transplantation
186326|NCT03031067|Kidney transplantation|kidney transplantation
186327|NCT03031067|Preservation injury|preservation injury
186328|NCT03031067|Ischemia reperfusion injury|ischemia reperfusion injury
186329|NCT03031054|Hydrodissection|hydrodissection
186330|NCT03031054|hyaluronic acid|hyaluronic acid
186331|NCT03031041|Hydrodissection|hydrodissection
186332|NCT03031041|short-axis|short-axis
186333|NCT03031041|long-axis|long-axis
186334|NCT03031028|refractory epilepsy,|refractory epilepsy,
186335|NCT03031028|ketogenic diet|ketogenic diet
186336|NCT03031028|classic ketogenic diet|classic ketogenic diet
186337|NCT03031028|seizure rate|seizure rate
186338|NCT03031028|efficacy|efficacy
186339|NCT03031028|epilepsy|epilepsy
186340|NCT03031015|Reduction, Fracture|reduction, fracture
186341|NCT03031002|exposure|exposure
186342|NCT03031002|spider phobia|spider phobia
186343|NCT03031002|generalization|generalization
186344|NCT03031002|extinction|extinction
186345|NCT03030976|CD19|cd19
186346|NCT03030976|CAR-T|car-t
186347|NCT03030976|SLE|sle
186348|NCT03030963|Equal ratio ventilation(ERV)|equal ratio ventilation(erv)
186349|NCT03030963|Peak inspiratory pressure(PIP)|peak inspiratory pressure(pip)
186350|NCT03030963|Blood loss|blood loss
186351|NCT03030963|Posterior lumbar interbody fusion(PLIF)|posterior lumbar interbody fusion(plif)
186352|NCT03030963|Prone position|prone position
186353|NCT03030924|suicide|suicide
186354|NCT03030885|Radiopharmaceutical (131I-MIP-1095)|radiopharmaceutical (131i-mip-1095)
186355|NCT03030885|16-1110|16-1110
186356|NCT03030846|pregnancy|pregnancy
186357|NCT03030846|pelvic floor muscles|pelvic floor muscles
186358|NCT03030846|Lumbo-pelvic pain|lumbo-pelvic pain
186359|NCT03030846|Stabilization exercises|stabilization exercises
186360|NCT03030846|abdominal muscles thickness|abdominal muscles thickness
186361|NCT03030846|Multifidus muscles thickness|multifidus muscles thickness
186362|NCT03030846|Multifidus muscles cross section area|multifidus muscles cross section area
186363|NCT03030820|cirrhosis|cirrhosis
186364|NCT03030820|Periodontitis|periodontitis
186365|NCT03030820|oral health|oral health
186366|NCT03030820|gingivitis|gingivitis
186367|NCT03030820|inflammation|inflammation
186368|NCT03030794|Gulf War Illness|gulf war illness
186369|NCT03030794|Headache|headache
186370|NCT03030794|Muscle Pain|muscle pain
186371|NCT03030794|Joint Pain|joint pain
186372|NCT03030794|TMS|tms
186373|NCT03030768|Pre-Exposure Prophylaxis|pre-exposure prophylaxis
186374|NCT03030768|Fertility|fertility
186375|NCT03030768|mHealth|mhealth
186376|NCT03030768|Pregnancy|pregnancy
186377|NCT03030716|antinutrients|antinutrients
186378|NCT03030716|tannins|tannins
186379|NCT03030716|proanthocyanidins|proanthocyanidins
186380|NCT03030716|salivary proline-rich proteins|salivary proline-rich proteins
186381|NCT03030703|Phytic acid|phytic acid
186382|NCT03030703|Cystatin|cystatin
186383|NCT03030703|Salivary proline-rich protein|salivary proline-rich protein
186384|NCT03030703|antinutrient|antinutrient
186385|NCT03030690|Proximal Dental Caries|proximal dental caries
186386|NCT03030690|Glass Carbomer|glass carbomer
186387|NCT03030690|Hydroxyapatite Enhanced Glass Ionomer|hydroxyapatite enhanced glass ionomer
186388|NCT03030690|Primary Teeth|primary teeth
186389|NCT03030677|pecs block|pecs block
186390|NCT03030677|breast surgery|breast surgery
186391|NCT03030677|ultrasound guidence|ultrasound guidence
186392|NCT03030664|constipation|constipation
186393|NCT03030664|Lactobacillus reuteri|lactobacillus reuteri
186394|NCT03030664|probiotics|probiotics
186395|NCT03030651|Breastfeeding|breastfeeding
186396|NCT03030651|Education and support|education and support
186397|NCT03030651|Ethiopia|ethiopia
186398|NCT03030651|Timely initiation of breastfeeding|timely initiation of breastfeeding
186399|NCT03030625|Prostate Cancer|prostate cancer
186400|NCT03030625|VMAT|vmat
186401|NCT03030625|Dominant Intraprostatic Lesion|dominant intraprostatic lesion
186402|NCT03030625|Intensity modulated radiotherapy|intensity modulated radiotherapy
186403|NCT03030586|Blood cell biomarkers, peripheral circulating biomarkers|blood cell biomarkers, peripheral circulating biomarkers
186404|NCT03030573|Bile duct injury|bile duct injury
186405|NCT03030573|Bile duct defect|bile duct defect
186406|NCT03030573|Round ligament|round ligament
186407|NCT03030573|Reconstruction|reconstruction
186408|NCT03030508|biomarks|biomarks
186409|NCT03030508|colorectal cancer|colorectal cancer
186410|NCT03030508|capecitabine|capecitabine
186411|NCT03030508|gene polymorphism|gene polymorphism
186412|NCT03030495|Ischemic Heart Disease|ischemic heart disease
186413|NCT03030495|Stable angina|stable angina
186414|NCT03030495|Fractional flow reserve|fractional flow reserve
186415|NCT03030495|Index of Microcirculatory Resistance|index of microcirculatory resistance
186416|NCT03030495|Coronary Flow Reserve|coronary flow reserve
186417|NCT03030495|Intravascular Imaging|intravascular imaging
186418|NCT03030482|Anxiety|anxiety
186419|NCT03030482|intensive care|intensive care
186420|NCT03030482|mechanical ventilation|mechanical ventilation
186421|NCT03030482|touch massage|touch massage
186422|NCT03030456|whole body vibration|whole body vibration
186423|NCT03030456|Oxidative Stress|oxidative stress
186424|NCT03030456|Aged|aged
186425|NCT03030456|Biochemical profile|biochemical profile
186426|NCT03030456|muscle strength|muscle strength
186427|NCT03030456|flexibility|flexibility
186428|NCT03030443|Pain management|pain management
186429|NCT03030443|Nitrous|nitrous
186430|NCT03030417|Topoisomerase I Inhibitor|topoisomerase i inhibitor
186431|NCT03030417|Epithelial-Mesenchymal Transition|epithelial-mesenchymal transition
186432|NCT03030417|Pharmacodynamics|pharmacodynamics
186433|NCT03030417|DNA Damage|dna damage
186434|NCT03030417|Pharmacokinetics|pharmacokinetics
186435|NCT03030404|Genetics|genetics
186436|NCT03030404|Familial Background|familial background
186437|NCT03030404|Inherited Cancer Syndrome|inherited cancer syndrome
186438|NCT03030404|Germline Mutation in the CDH1 Gene|germline mutation in the cdh1 gene
186439|NCT03030404|Lobular Breast Cancer|lobular breast cancer
186440|NCT03030391|Camp|camp
186441|NCT03030391|Radiation Absorbed Dose|radiation absorbed dose
186442|NCT03030391|Compartmental Analysis|compartmental analysis
186443|NCT03030365|Orientation, Disorientation.|orientation, disorientation.
186444|NCT03030352|Child Mental Health|child mental health
186445|NCT03030352|Parenting|parenting
186446|NCT03030352|Autonomy Support|autonomy support
186447|NCT03030352|How-to Parenting Program|how-to parenting program
186448|NCT03030352|Randomized Controlled Trial|randomized controlled trial
186449|NCT03030352|Primary Prevention|primary prevention
186450|NCT03030352|Parental Mental Health|parental mental health
186451|NCT03030352|Child Well-Being|child well-being
186452|NCT03030339|Vitamin A status|vitamin a status
186453|NCT03030339|infant|infant
186454|NCT03030339|dietary assessment|dietary assessment
186455|NCT03030339|retinol isotope dilution|retinol isotope dilution
186456|NCT03030339|breast milk intake|breast milk intake
186457|NCT03030300|type 2 diabetes|type 2 diabetes
186458|NCT03030300|remission|remission
186459|NCT03030300|short-term intensive insulin therapy|short-term intensive insulin therapy
186460|NCT03030235|heart failure|heart failure
186461|NCT03030235|dapagliflozin|dapagliflozin
186462|NCT03030235|SGLT-2 inhibitors|sglt-2 inhibitors
186463|NCT03030222|heart failure|heart failure
186464|NCT03030222|empagliflozin|empagliflozin
186465|NCT03030222|SGLT-2 inhibitors|sglt-2 inhibitors
186466|NCT03030209|pancreatectomy|pancreatectomy
186467|NCT03030209|diabetes mellitus|diabetes mellitus
186469|NCT03030157|urothelial cancer|urothelial cancer
186470|NCT03030157|bladder cancer|bladder cancer
186471|NCT03030157|nephroureterectomy|nephroureterectomy
186472|NCT03030131|IFCT|ifct
186473|NCT03030131|neodjuvant|neodjuvant
186474|NCT03030131|immune therapy|immune therapy
186475|NCT03030131|Non small cell lung cancer|non small cell lung cancer
186476|NCT03030118|hydroxychloroquine|hydroxychloroquine
186477|NCT03030105|Cognition|cognition
186478|NCT03030105|Dementia|dementia
186479|NCT03030105|Phosphodiesterase Type 4D|phosphodiesterase type 4d
186480|NCT03030105|PDE4D|pde4d
186481|NCT03030105|Scopolamine|scopolamine
186482|NCT03030105|Donepezil|donepezil
186483|NCT03030066|DS-1001b|ds-1001b
186484|NCT03030066|IDH1 mutation|idh1 mutation
186485|NCT03030066|Developmental Phase I|developmental phase i
186486|NCT03030066|Glioma|glioma
186487|NCT03030053|Flavanols|flavanols
186488|NCT03030053|Flavonoids|flavonoids
186489|NCT03030053|Polyphenols|polyphenols
186490|NCT03030053|Cognition|cognition
186491|NCT03030053|Aging|aging
186492|NCT03030040|mindfulness-based cognitive therapy|mindfulness-based cognitive therapy
186493|NCT03030040|self-help|self-help
186494|NCT03030040|healthcare staff|healthcare staff
186495|NCT03030027|Intergeneration|intergeneration
186496|NCT03030027|Reappraisal|reappraisal
186497|NCT03030027|Caregiving|caregiving
186498|NCT03030001|mesothelin|mesothelin
186499|NCT03030001|PD-1|pd-1
186501|NCT03030001|solid tumor|solid tumor
186502|NCT03029988|adenocarcinoma, Colorectal Carcinoma, liver metastases|adenocarcinoma, colorectal carcinoma, liver metastases
186503|NCT03029975|beef|beef
186504|NCT03029975|protein|protein
186505|NCT03029975|resistance training|resistance training
186506|NCT03029975|strength|strength
186507|NCT03029975|performance|performance
186508|NCT03029962|Teenage Pregnancy Prevention|teenage pregnancy prevention
186509|NCT03029962|LGB Girls|lgb girls
186510|NCT03029962|Text-Messaging|text-messaging
186511|NCT03029962|Information-Motivation-Behavioral Skills(IMB)Model|information-motivation-behavioral skills(imb)model
186512|NCT03029949|chronic dizziness|chronic dizziness
186513|NCT03029949|persistent postural-perceptual dizziness|persistent postural-perceptual dizziness
186514|NCT03029949|acceptance and commitment therapy|acceptance and commitment therapy
186515|NCT03029949|behavior therapy|behavior therapy
186516|NCT03029949|vestibular rehabilitation|vestibular rehabilitation
186517|NCT03029936|obesity|obesity
186518|NCT03029936|asthma|asthma
186519|NCT03029936|diaphragm excursion|diaphragm excursion
186520|NCT03029936|pulmonary function test|pulmonary function test
186521|NCT03029923|smoking|smoking
186522|NCT03029923|depression|depression
186523|NCT03029923|Behavioral Activation|behavioral activation
186524|NCT03029910|Eccentric exercise|eccentric exercise
186525|NCT03029910|Whole body vibration|whole body vibration
186526|NCT03029910|Cryotherapy|cryotherapy
186527|NCT03029884|thalamic pain|thalamic pain
186528|NCT03029884|chronic pain|chronic pain
186529|NCT03029884|spinal cord injury|spinal cord injury
186530|NCT03029884|phantom limb|phantom limb
186531|NCT03029871|lung cancer|lung cancer
186532|NCT03029871|adenovirus|adenovirus
186533|NCT03029871|gene therapy|gene therapy
186534|NCT03029871|SBRT|sbrt
186535|NCT03029793|Esophageal Cancer|esophageal cancer
186536|NCT03029793|Prediction|prediction
186537|NCT03029793|Biomarker|biomarker
186538|NCT03029793|MRI-DWI|mri-dwi
186539|NCT03029793|PET-CT|pet-ct
186540|NCT03029767|Hypertension|hypertension
186541|NCT03029767|Anthropometry|anthropometry
186542|NCT03029767|Aerobic exercise|aerobic exercise
186543|NCT03029767|Resistance exercise|resistance exercise
186544|NCT03029728|Angioedema, Hereditary|angioedema, hereditary
186545|NCT03029728|Biomarker|biomarker
186546|NCT03029715|Sleeve gastrectomy|sleeve gastrectomy
186547|NCT03029715|TIVA|tiva
186548|NCT03029702|Gestational diabetes|gestational diabetes
186549|NCT03029702|Diabetes in pregnancy|diabetes in pregnancy
186550|NCT03029702|Insulin resistance|insulin resistance
186551|NCT03029702|Insulin secretion deficiency|insulin secretion deficiency
186552|NCT03029689|HIV infection|hiv infection
186553|NCT03029689|Gut microbiome|gut microbiome
238510|NCT02707861|HIV|hiv
186554|NCT03029689|Raltegravir|raltegravir
186555|NCT03029689|Raltegravir intensification|raltegravir intensification
186556|NCT03029689|Bacterial richness|bacterial richness
186557|NCT03029676|spinal anesthesia, TURBT, POCD, premedication|spinal anesthesia, turbt, pocd, premedication
186558|NCT03029663|bladder cancer|bladder cancer
186559|NCT03029663|postoperative complications|postoperative complications
186560|NCT03029650|Peer Review|peer review
186561|NCT03029650|Research|research
186562|NCT03029637|Resin bonded bridges|resin bonded bridges
186563|NCT03029637|Randomized controlled trial|randomized controlled trial
186564|NCT03029585|ovarian carcinoma|ovarian carcinoma
186565|NCT03029585|ovarian cancer|ovarian cancer
186566|NCT03029585|ovarian neoplasms|ovarian neoplasms
186567|NCT03029585|ovarian diseases|ovarian diseases
186568|NCT03029559|Inspiratory threshold loading|inspiratory threshold loading
186569|NCT03029520|Endodontic Postoperative Pain|endodontic postoperative pain
186570|NCT03029520|iRoot SP Sealer|iroot sp sealer
186571|NCT03029520|Randomized Clinical Trial|randomized clinical trial
186572|NCT03029520|Herofill carrier-based obturation|herofill carrier-based obturation
186573|NCT03029507|Obesity|obesity
186574|NCT03029507|Military|military
186575|NCT03029507|Acceptance and Commitment Therapy|acceptance and commitment therapy
186576|NCT03029507|Overweight|overweight
186577|NCT03029507|Weight-management|weight-management
186578|NCT03029507|Navy Personnel|navy personnel
186579|NCT03029507|Fitness|fitness
186580|NCT03029494|oxidative stress|oxidative stress
186581|NCT03029494|saliva|saliva
186582|NCT03029468|Cognitive behavioral therapy|cognitive behavioral therapy
186583|NCT03029468|Chronic pain|chronic pain
186584|NCT03029468|Sickle cell disease|sickle cell disease
186585|NCT03029468|Mobile phone app|mobile phone app
186586|NCT03029468|Mental health|mental health
186587|NCT03029468|Behavioral intervention|behavioral intervention
186588|NCT03029468|Behavioral health|behavioral health
186589|NCT03029442|Spinal Cord Injury|spinal cord injury
186590|NCT03029442|Denosumab|denosumab
186591|NCT03029442|Osteoporosis|osteoporosis
186592|NCT03029442|Dual Energy X-ray Absorptiometry|dual energy x-ray absorptiometry
186593|NCT03029429|pseudohypoparathyroidism|pseudohypoparathyroidism
186594|NCT03029429|AHO|aho
186595|NCT03029429|Albright Hereditary Osteodystrophy|albright hereditary osteodystrophy
186596|NCT03029390|Prediabetes|prediabetes
186597|NCT03029390|hyperglycemia|hyperglycemia
186697|NCT03028844|EEG|eeg
186598|NCT03029390|Impaired Fasting Glucose|impaired fasting glucose
186599|NCT03029390|Metformin|metformin
186600|NCT03029390|Berberine|berberine
186601|NCT03029390|glucose intolerance|glucose intolerance
186602|NCT03029377|CFS|cfs
186603|NCT03029377|Stress|stress
186856|NCT03027960|cardio-renal|cardio-renal
186604|NCT03029377|Norepinephrine Transporter (NET)|norepinephrine transporter (net)
186605|NCT03029377|Norepinephrine (NE)|norepinephrine (ne)
186606|NCT03029377|Healthy Controls|healthy controls
186607|NCT03029377|Fatigue|fatigue
186608|NCT03029364|Maximal Fat Oxidation|maximal fat oxidation
186609|NCT03029364|Exercise|exercise
186610|NCT03029364|Intra-individual variability|intra-individual variability
186611|NCT03029364|Determinants|determinants
186612|NCT03029364|Whole-body fat oxidation|whole-body fat oxidation
186613|NCT03029364|Body composition|body composition
186614|NCT03029351|albuminuria|albuminuria
186615|NCT03029351|GLP-1 Receptor Agonist|glp-1 receptor agonist
186616|NCT03029351|Type 2 Diabetes|type 2 diabetes
186617|NCT03029338|lymphoma|lymphoma
186618|NCT03029338|non-hodgkin|non-hodgkin
186619|NCT03029338|B-cell|b-cell
186620|NCT03029338|CD19 CAR T cells|cd19 car t cells
186621|NCT03029338|refractory|refractory
186622|NCT03029338|relapse|relapse
186623|NCT03029312|whole body vibration|whole body vibration
186624|NCT03029312|Muscle function|muscle function
186625|NCT03029312|Physical activity|physical activity
186626|NCT03029312|bone density|bone density
186627|NCT03029286|Breast Cancer|breast cancer
186628|NCT03029286|Breast Density|breast density
186629|NCT03029247|Anemia|anemia
186630|NCT03029247|Daprodustat|daprodustat
186631|NCT03029247|Blood pressure|blood pressure
186632|NCT03029247|ESA|esa
186633|NCT03029247|CKD|ckd
186634|NCT03029208|Daprodustat, recombinant human erythropoietin, darbepoetin, anemia, chronic kidney disease, dialysis, ESRD|daprodustat, recombinant human erythropoietin, darbepoetin, anemia, chronic kidney disease, dialysis, esrd
186635|NCT03029195|cleft lip and palate|cleft lip and palate
186636|NCT03029195|nasoalveolar molding|nasoalveolar molding
186637|NCT03029195|Egyptian infants|egyptian infants
186638|NCT03029195|quantitative analysis|quantitative analysis
186639|NCT03029182|Exercise|exercise
186640|NCT03029182|Cancer|cancer
186641|NCT03029182|Obesity|obesity
186642|NCT03029169|Supraventricular Arrhythmia|supraventricular arrhythmia
186643|NCT03029169|Septic shock|septic shock
186644|NCT03029169|Propafenone|propafenone
186645|NCT03029169|Amiodarone|amiodarone
186646|NCT03029169|Intensive Care|intensive care
186647|NCT03029156|Asthma|asthma
186648|NCT03029156|Aeroneb|aeroneb
186649|NCT03029156|Aerogen|aerogen
186650|NCT03029156|Bronchodilator|bronchodilator
186651|NCT03029143|Drug Therapy|drug therapy
186652|NCT03029130|vesicovaginal fistula|vesicovaginal fistula
186653|NCT03029130|urinary catheter|urinary catheter
186654|NCT03029130|catheter extension|catheter extension
186655|NCT03029117|rheumatic pregnancy|rheumatic pregnancy
186656|NCT03029104|Keratoconus|keratoconus
186657|NCT03029104|Forme fruste keratoconus|forme fruste keratoconus
186658|NCT03029104|Post-LASIK ectasia|post-lasik ectasia
186659|NCT03029104|Pellucid marginal degeneration|pellucid marginal degeneration
186660|NCT03029104|Forme fruste pellucid marginal degeneration|forme fruste pellucid marginal degeneration
186661|NCT03029104|Diurnal fluctuation post-radial keratotomy|diurnal fluctuation post-radial keratotomy
186662|NCT03029104|Terrien's marginal degeneration|terrien's marginal degeneration
186663|NCT03029078|XDR|xdr
186664|NCT03029078|fecal microbiota transplant|fecal microbiota transplant
186665|NCT03029078|eradicate|eradicate
186666|NCT03029078|colonization|colonization
186667|NCT03029078|CRE|cre
186668|NCT03029078|GRE|gre
186669|NCT03029078|bacteria|bacteria
186670|NCT03029065|lung Adenocarcinoma with brain (meningeal) metastasis|lung adenocarcinoma with brain (meningeal) metastasis
186671|NCT03029039|Platelet|platelet
186672|NCT03029039|severe sepsis|severe sepsis
186673|NCT03029039|inflammation|inflammation
186674|NCT03029039|S. aureus|s. aureus
186675|NCT03029039|biomarkers|biomarkers
186676|NCT03029026|Cardiac amyloidosis|cardiac amyloidosis
186677|NCT03029026|Aortic stenosis|aortic stenosis
186678|NCT03029026|DPD scintigraphy|dpd scintigraphy
186679|NCT03028987|Quadrivalent, inactivated influenza vaccine|quadrivalent, inactivated influenza vaccine
186680|NCT03028987|Quadrivalent, live, attenuated influenza vaccine|quadrivalent, live, attenuated influenza vaccine
186681|NCT03028987|Identical twin adults|identical twin adults
186682|NCT03028974|Inactivated influenza vaccine|inactivated influenza vaccine
186683|NCT03028974|Live, attenuated influenza vaccine|live, attenuated influenza vaccine
186684|NCT03028974|Young children|young children
186685|NCT03028974|Adults|adults
186686|NCT03028922|creos xenogain|creos xenogain
186687|NCT03028909|Influenza A|influenza a
186688|NCT03028909|MEDI8852|medi8852
186689|NCT03028896|LMA Flexible|lma flexible
186690|NCT03028870|Osteoarthritis|osteoarthritis
186691|NCT03028870|Pain|pain
186692|NCT03028870|Osteoarthritis Knee|osteoarthritis knee
186693|NCT03028844|Neonate|neonate
186694|NCT03028844|preterm|preterm
186695|NCT03028844|pain|pain
186696|NCT03028844|music|music
186698|NCT03028844|venepuncture|venepuncture
186699|NCT03028805|Informatics|informatics
186701|NCT03028805|quality improvement|quality improvement
186702|NCT03028792|attention training, youth, latino|attention training, youth, latino
186703|NCT03028779|Outpatient,fast-track, arthroplasty, Total knee arthroplasty (TKA), Total hip Arthroplasty (THA)|outpatient,fast-track, arthroplasty, total knee arthroplasty (tka), total hip arthroplasty (tha)
186704|NCT03028714|University|university
186705|NCT03028714|College|college
186706|NCT03028714|University students|university students
186707|NCT03028714|Health education|health education
186708|NCT03028714|Educational techonology|educational techonology
186709|NCT03028714|Internet|internet
186710|NCT03028714|Nutrition knowledge|nutrition knowledge
186711|NCT03028714|Eating behaviour|eating behaviour
186712|NCT03028714|Diet|diet
186713|NCT03028714|Physical Activity|physical activity
186714|NCT03028714|Weight gain prevention|weight gain prevention
186715|NCT03028701|Formoterol|formoterol
186716|NCT03028701|Budesonide|budesonide
186717|NCT03028701|Dry powder inhalation|dry powder inhalation
186718|NCT03028701|Discair|discair
186719|NCT03028701|COPD|copd
186720|NCT03028662|Alcohol Dependence|alcohol dependence
186721|NCT03028662|Brain Connectivity|brain connectivity
186722|NCT03028662|Inhibition|inhibition
186723|NCT03028649|β-hydroxy-β-methylbutyric acid|β-hydroxy-β-methylbutyric acid
186724|NCT03028649|Sport supplements|sport supplements
186725|NCT03028649|Training support|training support
186726|NCT03028649|Adaptation|adaptation
186727|NCT03028636|fecal incontinence|fecal incontinence
186728|NCT03028636|bowel control|bowel control
186729|NCT03028636|accidental bowel leakage|accidental bowel leakage
186730|NCT03028636|medical device|medical device
186731|NCT03028636|women's health|women's health
186732|NCT03028636|vaginal insert|vaginal insert
186733|NCT03028636|pessary|pessary
186734|NCT03028636|incontinence|incontinence
186735|NCT03028636|bowel continence|bowel continence
186736|NCT03028636|pump|pump
186737|NCT03028597|Hypertension|hypertension
186738|NCT03028597|Medication Adherence|medication adherence
186739|NCT03028597|Values Affirmation|values affirmation
186740|NCT03028597|African Americans|african americans
186741|NCT03028584|BrCa|brca
186742|NCT03028584|PrCa|prca
186743|NCT03028584|CRCa|crca
186744|NCT03028558|Electronic Cigarettes|electronic cigarettes
186745|NCT03028558|Healthy Volunteers|healthy volunteers
186746|NCT03028558|E-Cigarettes Smokers|e-cigarettes smokers
186747|NCT03028558|E-Cigarettes|e-cigarettes
186748|NCT03028545|schizophrenia|schizophrenia
186749|NCT03028545|anorexia|anorexia
186750|NCT03028545|bipolar disorders|bipolar disorders
186751|NCT03028545|personality disorders|personality disorders
186752|NCT03028532|Healthy Volunteers|healthy volunteers
186753|NCT03028532|Sports Medicine|sports medicine
186754|NCT03028532|Anti-doping|anti-doping
186755|NCT03028532|Athletes|athletes
186756|NCT03028532|Men's Health|men's health
186757|NCT03028480|Exacerbation|exacerbation
186758|NCT03028480|Mepolizumab|mepolizumab
186759|NCT03028480|NUCALA|nucala
186760|NCT03028467|GSK3196165|gsk3196165
186761|NCT03028467|Active Rheumatoid Arthritis|active rheumatoid arthritis
186762|NCT03028467|Methotrexate|methotrexate
186763|NCT03028467|Monoclonal Antibody|monoclonal antibody
186764|NCT03028467|Efficacy|efficacy
186765|NCT03028467|Electrocardiogram|electrocardiogram
186766|NCT03028467|Tolerability|tolerability
186767|NCT03028467|Pharmacokinetics|pharmacokinetics
186768|NCT03028467|Japanese Subjects|japanese subjects
186769|NCT03028441|Chikungunya|chikungunya
186770|NCT03028441|Immunogenicity|immunogenicity
186771|NCT03028441|Measles|measles
186772|NCT03028441|Vaccine|vaccine
186773|NCT03028428|Osteoarthritis|osteoarthritis
186774|NCT03028428|Stem Cell|stem cell
186775|NCT03028428|Knee|knee
186776|NCT03028428|Mesenchymal Stem Cell|mesenchymal stem cell
186777|NCT03028389|elderly patients|elderly patients
186778|NCT03028389|non-cardiac surgery|non-cardiac surgery
186779|NCT03028389|ischemic preconditioning|ischemic preconditioning
186780|NCT03028389|delirium|delirium
186781|NCT03028376|biomarker|biomarker
186782|NCT03028376|point-of-care analysis|point-of-care analysis
186783|NCT03028337|Malignant neoplasms of eye brain and other parts of central nervous system|malignant neoplasms of eye brain and other parts of central nervous system
186784|NCT03028337|Solid tumor malignancy|solid tumor malignancy
186785|NCT03028337|Radiographic evidence of spine metastasis|radiographic evidence of spine metastasis
186786|NCT03028337|Spine radiosurgery|spine radiosurgery
186787|NCT03028337|Radiation therapy|radiation therapy
186788|NCT03028337|Radiotherapy|radiotherapy
186789|NCT03028337|Questionnaires|questionnaires
186790|NCT03028337|Surveys|surveys
186791|NCT03028337|XRT|xrt
186792|NCT03028285|succinate|succinate
186793|NCT03028285|arginine|arginine
186794|NCT03028285|vasodilation|vasodilation
186795|NCT03028285|peripheral vascular disease|peripheral vascular disease
186796|NCT03028272|tympanic membrane perforation|tympanic membrane perforation
186797|NCT03028233|physical activity|physical activity
186798|NCT03028233|healthy eating|healthy eating
186799|NCT03028233|weight|weight
186800|NCT03028233|families|families
186801|NCT03028233|Community Health Worker|community health worker
186802|NCT03028233|childhood obesity|childhood obesity
186803|NCT03028233|built environment|built environment
186804|NCT03028220|Type 1 Diabetes|type 1 diabetes
186805|NCT03028220|Hypoglycemia|hypoglycemia
186806|NCT03028207|EPI-Scan-II Study|epi-scan-ii study
186807|NCT03028207|COPD|copd
186808|NCT03028207|Epidemiology|epidemiology
186809|NCT03028207|Spain|spain
186810|NCT03028207|Chronic Obstructive Pulmonary Disease|chronic obstructive pulmonary disease
186811|NCT03028207|Prevalence|prevalence
186812|NCT03028207|Cross-sectional|cross-sectional
186813|NCT03028194|Pre-eclampsia|pre-eclampsia
186814|NCT03028194|Eclampsia|eclampsia
186815|NCT03028194|Postpartum uterine curettage|postpartum uterine curettage
186816|NCT03028181|smoke|smoke
186817|NCT03028181|acute pancreatitis|acute pancreatitis
186818|NCT03028181|pro/antioxidant status|pro/antioxidant status
186819|NCT03028181|pro-inflammatory factors|pro-inflammatory factors
186820|NCT03028181|lipid profile|lipid profile
186821|NCT03028181|exocrine functions of pancreas|exocrine functions of pancreas
186822|NCT03028168|Yôga|yôga
186823|NCT03028168|Breathing Techniques|breathing techniques
186824|NCT03028168|Heart Failure and Preserved Ejection Fraction|heart failure and preserved ejection fraction
186825|NCT03028129|Tuberculosis|tuberculosis
186826|NCT03028129|Primary prevention|primary prevention
186827|NCT03028129|Prisoners|prisoners
186828|NCT03028129|Controlled Clinical Trial|controlled clinical trial
186829|NCT03028129|Isoniazid|isoniazid
186830|NCT03028116|vaccine|vaccine
186831|NCT03028116|1 phase|1 phase
186832|NCT03028116|safety|safety
186833|NCT03028077|ultrafiltered red ginseng|ultrafiltered red ginseng
186834|NCT03028077|hydrolyzed ginseng|hydrolyzed ginseng
186835|NCT03028077|acute respiratory illness|acute respiratory illness
186836|NCT03028077|clinical trial|clinical trial
186837|NCT03028038|Platelet-rich plasma|platelet-rich plasma
186838|NCT03028038|Rapid maxillary expansion|rapid maxillary expansion
186839|NCT03028038|Buccal bone thickness|buccal bone thickness
186840|NCT03028038|Alveolar bone loss|alveolar bone loss
186841|NCT03028038|Alveolar bone resorption|alveolar bone resorption
186842|NCT03028025|radial artery occlusion|radial artery occlusion
186843|NCT03028025|time to hemostasis|time to hemostasis
186844|NCT03028025|radial artery|radial artery
186845|NCT03028025|transradial catheterization|transradial catheterization
186846|NCT03028025|TR band|tr band
186847|NCT03028025|Statseal|statseal
186848|NCT03028025|hemostasis band|hemostasis band
186849|NCT03028025|potassium ferrate|potassium ferrate
186850|NCT03028025|percutaneous coronary intervention|percutaneous coronary intervention
186851|NCT03028012|Trigger Point Injections|trigger point injections
186852|NCT03028012|steroid|steroid
186853|NCT03028012|nsaid|nsaid
186854|NCT03027999|Rituximab|rituximab
186855|NCT03027999|tight monitoring|tight monitoring
186857|NCT03027947|Phantom Limb Pain|phantom limb pain
186858|NCT03027947|Lower-Limb Amputation|lower-limb amputation
186859|NCT03027947|Electrodes|electrodes
186860|NCT03027947|Stimulation|stimulation
186861|NCT03027947|Pain|pain
186862|NCT03027947|Sensation|sensation
186863|NCT03027882|Reliability|reliability
186864|NCT03027882|Validity|validity
186865|NCT03027882|Functional Testing|functional testing
186866|NCT03027856|Percutaneous intervention (PCI)|percutaneous intervention (pci)
186867|NCT03027856|Optical coherence tomography (OCT)|optical coherence tomography (oct)
186868|NCT03027856|Bifurcation lesion|bifurcation lesion
186869|NCT03027856|Bioresorbable stents (BRS)|bioresorbable stents (brs)
186870|NCT03027843|low ovarian reserve|low ovarian reserve
186871|NCT03027843|growth hormone|growth hormone
186872|NCT03027843|embryo quality|embryo quality
186873|NCT03027843|live birth|live birth
186874|NCT03027843|clinical pregnancy|clinical pregnancy
186875|NCT03027830|Provisional side-branch intervention strategy|provisional side-branch intervention strategy
186876|NCT03027830|iFR|ifr
186877|NCT03027830|Pilot study|pilot study
186878|NCT03027817|Prone positioning|prone positioning
186879|NCT03027817|Non-invasive Cardiac Output Monitoring|non-invasive cardiac output monitoring
186880|NCT03027791|Biosensors|biosensors
186881|NCT03027791|Virtual Reality|virtual reality
186882|NCT03027791|Dietary Sodium|dietary sodium
186883|NCT03027778|arterial stiffness|arterial stiffness
186884|NCT03027778|hemodialysis|hemodialysis
186885|NCT03027778|intradialytic pedalling exercise|intradialytic pedalling exercise
186886|NCT03027778|carotid-femoral pulse wave velocity|carotid-femoral pulse wave velocity
186887|NCT03027778|chronic kidney disease|chronic kidney disease
186888|NCT03027778|hemodynamics|hemodynamics
186889|NCT03027778|augmentation index|augmentation index
186890|NCT03027752|carotid endaretectomy|carotid endaretectomy
186891|NCT03027713|NAVA: neurally adjusted ventilatory assist|nava: neurally adjusted ventilatory assist
186892|NCT03027713|Diaphragm electromyographic activity|diaphragm electromyographic activity
186893|NCT03027713|Weaning|weaning
186894|NCT03027687|Smoking|smoking
186895|NCT03027687|EMA|ema
186896|NCT03027687|ERPs|erps
186897|NCT03027687|tDCS|tdcs
186898|NCT03027687|Cigarette consumption|cigarette consumption
186899|NCT03027687|Inhibitory control|inhibitory control
186900|NCT03027687|Reward processing|reward processing
186901|NCT03027687|Tobacco addiction|tobacco addiction
186902|NCT03027687|Craving|craving
186903|NCT03027687|electrophysiological|electrophysiological
186904|NCT03027674|Raynaud Phenomena|raynaud phenomena
186905|NCT03027674|System; Sclerosis|system; sclerosis
186906|NCT03027674|Lupus Erythematosus, Systemic|lupus erythematosus, systemic
186907|NCT03027674|Ultrasound|ultrasound
186908|NCT03027674|sildenafil|sildenafil
186909|NCT03027674|Nifedipine|nifedipine
186910|NCT03027661|para-cervical block|para-cervical block
186911|NCT03027661|laparoscopic hysterectomy|laparoscopic hysterectomy
186912|NCT03027648|levonorgestrel-releasing intrauterine system|levonorgestrel-releasing intrauterine system
186913|NCT03027648|adenomyosis|adenomyosis
186914|NCT03027635|diuretic resistant ascites|diuretic resistant ascites
186915|NCT03027635|Paracentesis|paracentesis
186916|NCT03027635|PleurX|pleurx
186917|NCT03027635|Peritoneal tunnelated catheter|peritoneal tunnelated catheter
186918|NCT03027622|quality of life|quality of life
186919|NCT03027622|pericoronitis|pericoronitis
186920|NCT03027622|third molar|third molar
186921|NCT03027609|Pseudomonas aeruginosa|pseudomonas aeruginosa
186922|NCT03027609|pneumonia|pneumonia
186923|NCT03027570|Exergame|exergame
186924|NCT03027570|Cellular apps|cellular apps
186925|NCT03027570|Smartphone|smartphone
186926|NCT03027570|Overweight|overweight
186927|NCT03027570|Obesity|obesity
186928|NCT03027570|Children|children
186929|NCT03027570|Physical activity|physical activity
186930|NCT03027570|Fitness|fitness
186931|NCT03027570|Motivation|motivation
186932|NCT03027570|BMI|bmi
186933|NCT03027557|Primary Hyperparathyroidism|primary hyperparathyroidism
186934|NCT03027557|Parathyroid Adenoma|parathyroid adenoma
186935|NCT03027557|Parathyroid Hyperplasia|parathyroid hyperplasia
186936|NCT03027557|Cinacalcet|cinacalcet
186937|NCT03027557|Denosumab|denosumab
186938|NCT03027557|Drug Therapy|drug therapy
186939|NCT03027557|Bone Mineral Density|bone mineral density
186940|NCT03027557|Calcium|calcium
186941|NCT03027544|multiple brain metastases|multiple brain metastases
186942|NCT03027544|large brain metastases|large brain metastases
186943|NCT03027544|meningeal metastases|meningeal metastases
186944|NCT03027544|tomotherapy|tomotherapy
186945|NCT03027531|reproductive health, condoms, sexually transmitted diseases, contraception|reproductive health, condoms, sexually transmitted diseases, contraception
186946|NCT03027505|MUAC|muac
186947|NCT03027505|Acute malnutrition|acute malnutrition
186948|NCT03027505|RUTF|rutf
186949|NCT03027505|Children|children
186950|NCT03027505|Burkina Faso|burkina faso
186951|NCT03027492|Non-celiac Wheat Sensitivity|non-celiac wheat sensitivity
186952|NCT03027492|gynaecological disorders|gynaecological disorders
186953|NCT03027492|gluten-free diet|gluten-free diet
186954|NCT03027479|weight loss|weight loss
186955|NCT03027479|ovarian cancer|ovarian cancer
186956|NCT03027479|endometrial cancer|endometrial cancer
186957|NCT03027479|energy metabolism|energy metabolism
186958|NCT03027479|Body mass index|body mass index
186959|NCT03027479|obesity|obesity
186960|NCT03027479|muscle energy|muscle energy
186961|NCT03027466|Quitting Smoking|quitting smoking
186962|NCT03027466|Phone Application|phone application
186963|NCT03027440|Stress Response|stress response
186964|NCT03027440|Neurodevelopment|neurodevelopment
186965|NCT03027440|Biomarkers|biomarkers
186966|NCT03027440|Cohort Study|cohort study
186967|NCT03027427|Screening|screening
186968|NCT03027427|Heritable Gastric Malignancy|heritable gastric malignancy
186969|NCT03027427|Molecular Profiling|molecular profiling
186970|NCT03027427|Molecular Alterations|molecular alterations
186971|NCT03027414|Anxiety|anxiety
186972|NCT03027414|Startle|startle
186973|NCT03027414|Dorsolateral Prefrontal Cortex|dorsolateral prefrontal cortex
186974|NCT03027414|Transcranial Magnetic Stimulation (TMS)|transcranial magnetic stimulation (tms)
186975|NCT03027414|Working Memory|working memory
186976|NCT03027401|Genetic Testing|genetic testing
186977|NCT03027401|Tumor Profiling|tumor profiling
186978|NCT03027401|Biorepository|biorepository
186979|NCT03027388|Brain Tumor|brain tumor
186980|NCT03027388|Blood Brain Barrier|blood brain barrier
186981|NCT03027388|Pharmacokinetics|pharmacokinetics
186982|NCT03027388|Pharmacodynamics|pharmacodynamics
186983|NCT03027375|chronic heart failure|chronic heart failure
186984|NCT03027375|traditional Chinese medicine|traditional chinese medicine
186985|NCT03027375|Qishen granules|qishen granules
186986|NCT03027336|dyslipidemia|dyslipidemia
186987|NCT03027336|dietary supplement|dietary supplement
186988|NCT03027323|undifferentiated hypotension|undifferentiated hypotension
186989|NCT03027323|central venous cannulation|central venous cannulation
186990|NCT03027310|Dystonic Tremor|dystonic tremor
186991|NCT03027310|Essential Tremor|essential tremor
186992|NCT03027310|Tremor|tremor
186993|NCT03027310|Voice Tremor|voice tremor
186994|NCT03027310|Parkinson's Disease|parkinson's disease
186995|NCT03027284|Neoplasm|neoplasm
186996|NCT03027258|Mobile health technology|mobile health technology
186997|NCT03027245|locally advanced or metastatic breast cancer|locally advanced or metastatic breast cancer
186998|NCT03027245|peripheral neuropathy|peripheral neuropathy
186999|NCT03027245|chemotherapy-induced peripheral neuropathy|chemotherapy-induced peripheral neuropathy
187000|NCT03027245|eribulin|eribulin
187001|NCT03027232|infection|infection
187002|NCT03027193|Vaccine|vaccine
187003|NCT03027193|MAP|map
187004|NCT03027154|diagnostic test|diagnostic test
187005|NCT03027154|children|children
187006|NCT03027154|diagnosis of tuberculosis|diagnosis of tuberculosis
187007|NCT03027141|Face Transplant|face transplant
187008|NCT03027128|Phase 1|phase 1
187009|NCT03027128|Metastatic|metastatic
187010|NCT03027128|Locally Advanced|locally advanced
187011|NCT03027128|Cancer|cancer
187012|NCT03027128|Cell Therapy|cell therapy
187013|NCT03027102|allogenic double negative T cells|allogenic double negative t cells
187014|NCT03027102|DNT cells|dnt cells
187015|NCT03027089|Aspergillus-specific IgG|aspergillus-specific igg
187016|NCT03027076|prostatitis|prostatitis
187017|NCT03027076|chronic prostatitis|chronic prostatitis
187018|NCT03027076|chronic pelvic pain syndrome|chronic pelvic pain syndrome
187019|NCT03027076|interstitial cystitis|interstitial cystitis
187020|NCT03027076|painful bladder syndrome|painful bladder syndrome
187021|NCT03027076|bladder pain syndrome|bladder pain syndrome
187022|NCT03027076|biomarkers|biomarkers
187023|NCT03027076|biological markers|biological markers
187024|NCT03027076|bacteria|bacteria
187025|NCT03027076|microbiome|microbiome
187026|NCT03027076|inflammation|inflammation
187027|NCT03027063|Speckle tracking echocardiography|speckle tracking echocardiography
187028|NCT03027050|periodontitis|periodontitis
187029|NCT03027050|Growth factors|growth factors
187030|NCT03027050|Periodontal healing|periodontal healing
187031|NCT03027024|Intraocular Lens|intraocular lens
187032|NCT03027024|trifocal|trifocal
187033|NCT03027024|cataract|cataract
187034|NCT03027024|PhysIOL|physiol
187035|NCT03026998|hereditary retinoblastoma,|hereditary retinoblastoma,
187036|NCT03026998|External beam radiation therapy (EBRT)|external beam radiation therapy (ebrt)
187037|NCT03026985|Extracorporeal Membrane Oxygenation|extracorporeal membrane oxygenation
187038|NCT03026985|Ultrasonography|ultrasonography
187039|NCT03026985|Intensive Care Units|intensive care units
187040|NCT03026972|Safety|safety
187041|NCT03026972|Tolerance|tolerance
187042|NCT03026946|Alitretinoin|alitretinoin
187043|NCT03026946|Cyclosporine A|cyclosporine a
187044|NCT03026946|Hand eczema|hand eczema
187045|NCT03026920|Fracture|fracture
187046|NCT03026920|outcome|outcome
187047|NCT03026920|pelvic|pelvic
187048|NCT03026920|acetabular|acetabular
187049|NCT03026907|Alitretinoin|alitretinoin
187050|NCT03026907|Azathioprine|azathioprine
187051|NCT03026907|Hand eczema|hand eczema
187052|NCT03026881|PARP inhibitor|parp inhibitor
187053|NCT03026881|VEGFR inhibitor|vegfr inhibitor
187054|NCT03026881|Combination therapy|combination therapy
187055|NCT03026881|Gastric cancer|gastric cancer
187056|NCT03026868|acetabular|acetabular
187057|NCT03026868|quadrilateral surface plate|quadrilateral surface plate
187058|NCT03026855|Autologous PRP|autologous prp
187059|NCT03026855|Non-healing ulcer|non-healing ulcer
187060|NCT03026855|Point-of-care|point-of-care
187061|NCT03026829|Sound therapy|sound therapy
187062|NCT03026829|Tinnitus relief|tinnitus relief
187063|NCT03026816|epidural stimulation|epidural stimulation
187064|NCT03026816|spinal cord stimulation|spinal cord stimulation
187065|NCT03026816|autonomic dysfunction|autonomic dysfunction
187066|NCT03026790|Opioid analgesics|opioid analgesics
187067|NCT03026790|Opioid partial agonists|opioid partial agonists
187068|NCT03026790|Health care delivery|health care delivery
187069|NCT03026790|Back pain|back pain
187070|NCT03026790|Osteoarthritis|osteoarthritis
187071|NCT03026790|Veterans health|veterans health
187072|NCT03026764|cost|cost
187073|NCT03026764|total hip replacement|total hip replacement
187074|NCT03026764|outpatient Surgery|outpatient surgery
187075|NCT03026764|satisfaction|satisfaction
187076|NCT03026764|arthroplasty|arthroplasty
187077|NCT03026725|tooth sensitivity|tooth sensitivity
187078|NCT03026725|tri calcium phosphate|tri calcium phosphate
187079|NCT03026725|at-home whitening|at-home whitening
187080|NCT03026712|Robotic therapy|robotic therapy
187081|NCT03026712|tDCS|tdcs
187082|NCT03026712|non invasive electrical stimulation|non invasive electrical stimulation
187083|NCT03026712|ArmeoPower|armeopower
187084|NCT03026712|interhemispheric balance|interhemispheric balance
187085|NCT03026699|Brain|brain
187086|NCT03026699|Nervous system|nervous system
187087|NCT03026699|Neuro-oncology|neuro-oncology
187088|NCT03026699|Caregivers|caregivers
187089|NCT03026699|Cancer patient|cancer patient
187090|NCT03026699|Family caregivers|family caregivers
187091|NCT03026699|Brain tumors|brain tumors
187092|NCT03026699|Quality of life|quality of life
187093|NCT03026699|Stress|stress
187094|NCT03026699|Social support|social support
187095|NCT03026699|Feasibility|feasibility
187096|NCT03026699|Electronic Social Network Assessment Program (eSNAP)|electronic social network assessment program (esnap)
187598|NCT03023215|HR|hr
187097|NCT03026660|Moringa Oleifera|moringa oleifera
187098|NCT03026634|Sleep-Disordered Breathing|sleep-disordered breathing
187099|NCT03026634|Heart Failure|heart failure
187100|NCT03026634|Heart Transplantation|heart transplantation
187101|NCT03026569|orange juice|orange juice
187102|NCT03026569|chronic hepatitis C|chronic hepatitis c
187103|NCT03026569|biochemical markers|biochemical markers
187104|NCT03026569|oxidative stress|oxidative stress
187105|NCT03026569|nutritional status|nutritional status
187106|NCT03026569|antioxidants|antioxidants
187107|NCT03026517|Phenformin|phenformin
187108|NCT03026517|Dabrafenib|dabrafenib
187109|NCT03026517|Trametinib|trametinib
187110|NCT03026517|BRAF|braf
187111|NCT03026517|15-318|15-318
187112|NCT03026478|oral lichen planus|oral lichen planus
187113|NCT03026478|betamethasone|betamethasone
187114|NCT03026478|clobetasol|clobetasol
187115|NCT03026478|orabase|orabase
187116|NCT03026439|mild COPD|mild copd
187117|NCT03026439|early COPD|early copd
187118|NCT03026439|six-min walk test|six-min walk test
187119|NCT03026439|computed tomography|computed tomography
187120|NCT03026439|emphysema|emphysema
187121|NCT03026439|airway disease|airway disease
187122|NCT03026439|peripheral muscle mass|peripheral muscle mass
187123|NCT03026439|Saint George's Respiratory Questionnaire|saint george's respiratory questionnaire
187124|NCT03026426|Depression|depression
187125|NCT03026426|Chronic diseases|chronic diseases
187126|NCT03026426|Mobile technology|mobile technology
187127|NCT03026426|Clinical trial|clinical trial
187128|NCT03026413|atrial fibrillation|atrial fibrillation
187129|NCT03026413|pulmonary vein isolation|pulmonary vein isolation
187130|NCT03026413|Contact Force|contact force
187131|NCT03026413|antrum|antrum
187132|NCT03026387|Suicidal behavior|suicidal behavior
187133|NCT03026387|Suicide attempt|suicide attempt
187134|NCT03026387|Emergency department|emergency department
187135|NCT03026387|Psychometrics|psychometrics
187136|NCT03026387|Neuropsychological tests|neuropsychological tests
187137|NCT03026387|Suicidal ideation|suicidal ideation
187138|NCT03026374|psychosocial support|psychosocial support
187139|NCT03026374|resilience|resilience
187140|NCT03026374|metastatic breast cancer|metastatic breast cancer
187141|NCT03026374|survival|survival
239242|NCT02703116|HIV|hiv
187142|NCT03026374|Quality of Life|quality of life
187143|NCT03026348|RSV|rsv
187144|NCT03026335|Positive Youth Development|positive youth development
187145|NCT03026296|Physical Fitness|physical fitness
187146|NCT03026296|Health Status|health status
187147|NCT03026296|Exercise|exercise
187148|NCT03026296|Tobacco Use Cessation|tobacco use cessation
187149|NCT03026296|Quality of Life|quality of life
187150|NCT03026296|Healthy Diet|healthy diet
187151|NCT03026296|Health Promotion|health promotion
187152|NCT03026296|Patient Education as Topic|patient education as topic
187153|NCT03026296|Counseling|counseling
187154|NCT03026270|Physiotherapy|physiotherapy
187155|NCT03026270|Paraffin|paraffin
187156|NCT03026270|Burn|burn
187157|NCT03026270|Contracture|contracture
187158|NCT03026244|Immunity|immunity
187159|NCT03026244|Elderly|elderly
187160|NCT03026244|Inflammation|inflammation
187161|NCT03026244|Milk protein|milk protein
187162|NCT03026244|Prebiotics|prebiotics
187163|NCT03026231|Fecal microbiota transplantation|fecal microbiota transplantation
187164|NCT03026166|Cancer|cancer
187165|NCT03026166|Extensive-Stage Small Cell Lung Cancer|extensive-stage small cell lung cancer
187166|NCT03026166|Nivolumab|nivolumab
187167|NCT03026166|Ipilimumab|ipilimumab
187168|NCT03026166|Rovalpituzumab tesirine|rovalpituzumab tesirine
187169|NCT03026140|MSI tumors|msi tumors
187170|NCT03026140|MSS tumors|mss tumors
187171|NCT03026140|short-term immunotherapy|short-term immunotherapy
187172|NCT03026140|surgical resection|surgical resection
187173|NCT03026140|nivolumab|nivolumab
187174|NCT03026140|ipilimumab|ipilimumab
187175|NCT03026127|Suicide|suicide
187176|NCT03026127|Middle-aged and Older Adults|middle-aged and older adults
187177|NCT03026127|Cognitive Reappraisal|cognitive reappraisal
187178|NCT03026127|Emotion Regulation|emotion regulation
187179|NCT03026088|Chronic Heart Failure|chronic heart failure
187180|NCT03026088|Bisoprolol|bisoprolol
187181|NCT03026088|Heart rate control|heart rate control
187182|NCT03026036|Depression|depression
187183|NCT03026036|MRI|mri
187184|NCT03026036|PET|pet
187185|NCT03026036|Reward|reward
187186|NCT03026023|Heart Transplant|heart transplant
187187|NCT03026023|Cardiac Transplant|cardiac transplant
187188|NCT03026023|Hepatitis C|hepatitis c
187189|NCT03026023|Zepatier|zepatier
187190|NCT03025971|Severe Aortic Stenosis and/or severe aortic regurgitation|severe aortic stenosis and/or severe aortic regurgitation
187191|NCT03025919|Advanced glycation end-product|advanced glycation end-product
187192|NCT03025919|Glycosuria|glycosuria
187193|NCT03025893|Sunitinib|sunitinib
187194|NCT03025893|Lomustine|lomustine
187195|NCT03025893|High-dose|high-dose
187196|NCT03025893|Intermittent|intermittent
187197|NCT03025880|Advanced Breast Cancer|advanced breast cancer
187198|NCT03025880|Pembrolizumab|pembrolizumab
187199|NCT03025880|HER2-negative|her2-negative
187200|NCT03025828|Membranous nephropathy|membranous nephropathy
187201|NCT03025828|adrenocorticotropic hormone|adrenocorticotropic hormone
187202|NCT03025828|ACTH|acth
187203|NCT03025828|proteinuria|proteinuria
187204|NCT03025828|glomerulonephritis|glomerulonephritis
187205|NCT03025815|Infant, Premature|infant, premature
187206|NCT03025802|Molecular diagnosis|molecular diagnosis
187207|NCT03025802|Pathogen identification|pathogen identification
187208|NCT03025802|Sepsis|sepsis
187209|NCT03025802|Bacteremia|bacteremia
187210|NCT03025802|Rapid diagnostics|rapid diagnostics
187211|NCT03025789|T.b gambiense|t.b gambiense
187212|NCT03025789|HAT|hat
187213|NCT03025789|outpatients|outpatients
187214|NCT03025763|Craniosynostosis|craniosynostosis
187215|NCT03025763|Bone|bone
187216|NCT03025763|Birth Defect|birth defect
187217|NCT03025763|Congenital Anomaly|congenital anomaly
187218|NCT03025763|Malformation|malformation
187219|NCT03025763|Genetics|genetics
187220|NCT03025763|Genomics|genomics
187221|NCT03025763|Skull|skull
187222|NCT03025763|Human|human
187223|NCT03025763|Mouse|mouse
187224|NCT03025763|Imaging|imaging
187225|NCT03025763|Cell Biology|cell biology
187226|NCT03025763|Induced Pluripotent Stem Cells|induced pluripotent stem cells
187227|NCT03025763|System Biology|system biology
187228|NCT03025737|Hypertrophy, Left Ventricular|hypertrophy, left ventricular
187229|NCT03025737|Ventricular Remodeling|ventricular remodeling
187230|NCT03025711|Advanced HER2+ breast cancer|advanced her2+ breast cancer
187231|NCT03025711|Pertuzumab|pertuzumab
187232|NCT03025711|Trastuzumab emtansine|trastuzumab emtansine
187233|NCT03025711|Compassionate use|compassionate use
187234|NCT03025711|Early access program|early access program
187235|NCT03025711|Effectiveness|effectiveness
187236|NCT03025711|Safety|safety
187237|NCT03025698|Eltrombopag|eltrombopag
187238|NCT03025698|hATG|hatg
187239|NCT03025698|CsA|csa
187240|NCT03025698|previously untreated or relapsed severe aplastic anemia|previously untreated or relapsed severe aplastic anemia
187241|NCT03025698|recurrent aplastic anemia|recurrent aplastic anemia
187242|NCT03025698|Severe aplastic anemia|severe aplastic anemia
239331|NCT02702492|NHL|nhl
187243|NCT03025698|Pharmacokinetics|pharmacokinetics
187244|NCT03025698|Immunosuppressive therapy|immunosuppressive therapy
187245|NCT03025698|ETB115|etb115
187246|NCT03025685|Percutaneous Coronary Intervention|percutaneous coronary intervention
187247|NCT03025685|Coronary Artery Disease|coronary artery disease
187248|NCT03025685|Wire|wire
187249|NCT03025685|Coronary stenting|coronary stenting
187250|NCT03025659|pediatric|pediatric
187251|NCT03025659|congenital heart disease|congenital heart disease
187252|NCT03025646|Maternal depression|maternal depression
187253|NCT03025646|ASD|asd
187254|NCT03025646|Home based training program|home based training program
187255|NCT03025633|PEARL|pearl
187256|NCT03025620|Alphalinolenic acid|alphalinolenic acid
187257|NCT03025620|Lipid cardiovascular risk factors|lipid cardiovascular risk factors
187258|NCT03025620|Inflammation|inflammation
187259|NCT03025607|Prevention|prevention
187260|NCT03025607|Mobile health|mobile health
187261|NCT03025607|Autonomous motivation|autonomous motivation
187262|NCT03025594|Paralytic sellfish toxins|paralytic sellfish toxins
187263|NCT03025594|Gonyautoxin|gonyautoxin
187264|NCT03025594|Post surgery pain management|post surgery pain management
187265|NCT03025594|total knee arthroplasty|total knee arthroplasty
187266|NCT03025568|nylon|nylon
187267|NCT03025568|polyamide|polyamide
187268|NCT03025568|denture base|denture base
187269|NCT03025555|nylon|nylon
187270|NCT03025555|polyamide|polyamide
187271|NCT03025555|PEEK|peek
187272|NCT03025555|partial denture|partial denture
187273|NCT03025542|Psoriasis|psoriasis
187274|NCT03025542|Chronic Plaque Psoriasis|chronic plaque psoriasis
187275|NCT03025542|Bimekizumab|bimekizumab
187276|NCT03025490|Capnography|capnography
187277|NCT03025490|Electrophysiology|electrophysiology
187278|NCT03025477|Intraperitoneal|intraperitoneal
187279|NCT03025477|Intravenous|intravenous
187280|NCT03025477|Completeness of cytoreduction score|completeness of cytoreduction score
187281|NCT03025477|Carboplatin|carboplatin
187282|NCT03025477|Epirubicin|epirubicin
187283|NCT03025477|Paclitaxel|paclitaxel
187284|NCT03025477|Cisplatin|cisplatin
187285|NCT03025451|nutrition|nutrition
187286|NCT03025451|exercise|exercise
187287|NCT03025451|stress|stress
187288|NCT03025451|gender|gender
187289|NCT03025451|age|age
187290|NCT03025451|community support|community support
187291|NCT03025451|cardiovascular disease|cardiovascular disease
187292|NCT03025451|diabetes|diabetes
187293|NCT03025451|hypertension|hypertension
187294|NCT03025451|dyslipidemia|dyslipidemia
187295|NCT03025451|cholesterol|cholesterol
187296|NCT03025451|overweight|overweight
187297|NCT03025451|obesity|obesity
187298|NCT03025451|lifestyle|lifestyle
187299|NCT03025438|angiosarcoma|angiosarcoma
187300|NCT03025438|Cytology|cytology
187301|NCT03025438|liver|liver
187302|NCT03025438|cancer|cancer
187303|NCT03025412|Achilles Tendon|achilles tendon
187304|NCT03025412|Endoscopy|endoscopy
187795|NCT03022019|ReNovaCell|renovacell
187305|NCT03025412|Minimally Invasive Surgical Procedures|minimally invasive surgical procedures
187306|NCT03025412|Exercise therapy|exercise therapy
187307|NCT03025399|tang wang prescription|tang wang prescription
187308|NCT03025360|Neurotrophic tyrosine receptor kinase (NTRK)|neurotrophic tyrosine receptor kinase (ntrk)
187309|NCT03025360|NTRK1|ntrk1
187310|NCT03025360|NTRK2|ntrk2
187311|NCT03025360|NTRK3|ntrk3
187312|NCT03025360|Fusion Positive|fusion positive
187313|NCT03025321|Cocaine|cocaine
187314|NCT03025321|tDCS|tdcs
187315|NCT03025321|EMA|ema
187316|NCT03025321|Inhibitory control|inhibitory control
187317|NCT03025321|Reward processing|reward processing
187318|NCT03025321|Addiction|addiction
187319|NCT03025321|dlPFC|dlpfc
187320|NCT03025321|craving|craving
187321|NCT03025321|cognitive control|cognitive control
187322|NCT03025243|computer aided design , dental implants , accuracy|computer aided design , dental implants , accuracy
187323|NCT03025204|Regeneration Procedures|regeneration procedures
187324|NCT03025204|Intrabony Defects|intrabony defects
187325|NCT03025204|Cronic Periodontitis|cronic periodontitis
187326|NCT03025191|incarceration|incarceration
187327|NCT03025191|HIV|hiv
187328|NCT03025152|Hou Gu Mi Xi|hou gu mi xi
187329|NCT03025152|Shen Ling Bai Zhu San|shen ling bai zhu san
187330|NCT03025152|radical gastrectomy|radical gastrectomy
187331|NCT03025152|gastric cancer|gastric cancer
187332|NCT03025152|traditional Chinese medicine|traditional chinese medicine
187333|NCT03025152|randomized controlled trial|randomized controlled trial
187334|NCT03025139|breast cancer|breast cancer
187335|NCT03025139|younger women|younger women
187336|NCT03025139|education|education
187337|NCT03025139|mindfulness meditation|mindfulness meditation
187338|NCT03025139|depression|depression
187339|NCT03025139|cancer survivor|cancer survivor
187340|NCT03025074|Liver Disease|liver disease
187341|NCT03025074|Obesity|obesity
187342|NCT03025074|Hepatitis|hepatitis
187343|NCT03025074|HIV|hiv
187344|NCT03025074|Hepatology|hepatology
187345|NCT03025061|Breath pattern|breath pattern
187346|NCT03025061|Children|children
187347|NCT03025061|Repeatability|repeatability
187348|NCT03025035|BRCA-mutation|brca-mutation
187349|NCT03025035|Immune checkpoint inhibition|immune checkpoint inhibition
187350|NCT03025035|Immunotherapy|immunotherapy
187351|NCT03025035|Advanced BRCA-mutated breast cancer|advanced brca-mutated breast cancer
187352|NCT03024957|morphine|morphine
187353|NCT03024957|dexmedetomidine|dexmedetomidine
187354|NCT03024957|immune system|immune system
187355|NCT03024944|Diabetes Mellitus|diabetes mellitus
187356|NCT03024944|Alzheimer's Disease|alzheimer's disease
187357|NCT03024944|Dementia|dementia
187358|NCT03024944|THK|thk
187359|NCT03024918|monochorionic|monochorionic
187360|NCT03024918|placental sharing|placental sharing
187361|NCT03024892|Fluorenscent image guided surgery|fluorenscent image guided surgery
187362|NCT03024892|indocyanide green|indocyanide green
187363|NCT03024892|laparoscopic cholecystectomy|laparoscopic cholecystectomy
187364|NCT03024892|common bile duct injury|common bile duct injury
187365|NCT03024879|Motilin|motilin
187366|NCT03024879|Erythromycin|erythromycin
187367|NCT03024879|Food intake|food intake
187368|NCT03024853|Best Possible Self|best possible self
187369|NCT03024853|Positive Intervention|positive intervention
187370|NCT03024853|Optimism|optimism
187371|NCT03024840|Propofol|propofol
187372|NCT03024840|Neurocognitive Disorders|neurocognitive disorders
187373|NCT03024840|Liver transplantation|liver transplantation
187374|NCT03024840|Pediatrics|pediatrics
187375|NCT03024840|Brain Injuries|brain injuries
187376|NCT03024827|Infantile Spasms|infantile spasms
187377|NCT03024827|Lennox Gastaut Syndrome|lennox gastaut syndrome
187378|NCT03024827|Doose Syndrome|doose syndrome
187379|NCT03024827|Continuous Spike Wave in Sleep|continuous spike wave in sleep
187380|NCT03024827|Landau-Kleffner Syndrome|landau-kleffner syndrome
187381|NCT03024827|Dravet Syndrome|dravet syndrome
187382|NCT03024827|Malignant Migrating Partial Seizures of Infancy (MMPSI)|malignant migrating partial seizures of infancy (mmpsi)
187383|NCT03024788|Glycosylated haemoglobin|glycosylated haemoglobin
187384|NCT03024788|advanced glycation end products|advanced glycation end products
187385|NCT03024775|Non-celiac Wheat Sensitivity|non-celiac wheat sensitivity
187386|NCT03024775|ancient wheats|ancient wheats
187387|NCT03024775|modern wheats|modern wheats
187388|NCT03024775|ATIs|atis
187389|NCT03024749|Spinal Arteriovenous Malformation|spinal arteriovenous malformation
187390|NCT03024749|Spinal Arteriovenous Fistula|spinal arteriovenous fistula
187391|NCT03024723|Obese patient|obese patient
187392|NCT03024723|nasal CPAP|nasal cpap
187393|NCT03024710|Stunting|stunting
187394|NCT03024710|complementary feeding Index|complementary feeding index
187395|NCT03024710|Bangladesh|bangladesh
187396|NCT03024697|Breast surgery|breast surgery
187397|NCT03024697|Pectoral plane block|pectoral plane block
187398|NCT03024697|PECs|pecs
187399|NCT03024697|Local anaesthesia infusion|local anaesthesia infusion
187400|NCT03024697|Analgesia|analgesia
187401|NCT03024684|Hepatocellular carcinoma|hepatocellular carcinoma
187402|NCT03024684|statin|statin
187403|NCT03024684|curative ablation|curative ablation
187404|NCT03024658|Pulmonary artery systolic pressure|pulmonary artery systolic pressure
187405|NCT03024658|Positive end expiratory pressure|positive end expiratory pressure
187406|NCT03024658|morbidly obese|morbidly obese
187407|NCT03024658|laparoscopic bariatric surgery|laparoscopic bariatric surgery
187408|NCT03024645|Postpartum Depression|postpartum depression
187409|NCT03024645|Cognitive-Behavioral Therapy|cognitive-behavioral therapy
187410|NCT03024645|Prevention|prevention
187411|NCT03024645|Web-Based Psychological Intervention|web-based psychological intervention
187412|NCT03024593|Cyberchondria|cyberchondria
187413|NCT03024593|health-related internet use|health-related internet use
187414|NCT03024593|pathological health anxiety|pathological health anxiety
187415|NCT03024580|Megestrol Acetate|megestrol acetate
187416|NCT03024580|Steroid, Receptors|steroid, receptors
187417|NCT03024567|Calorimetry|calorimetry
187418|NCT03024567|Blood pressure|blood pressure
187419|NCT03024567|Immunophenotyping|immunophenotyping
187420|NCT03024567|Gut microbial composition|gut microbial composition
187421|NCT03024554|aortic aneurysm involving iliac arteries|aortic aneurysm involving iliac arteries
187422|NCT03024554|abdominal aortic aneurysm|abdominal aortic aneurysm
187423|NCT03024554|MFM|mfm
187424|NCT03024554|Multilayer Flow Modulator|multilayer flow modulator
187425|NCT03024554|Multilayer Stent|multilayer stent
187426|NCT03024528|Pain|pain
187427|NCT03024528|CPOT|cpot
187428|NCT03024528|ICU Delirium|icu delirium
187429|NCT03024528|Critical Care Pain Observation Tool|critical care pain observation tool
187430|NCT03024528|NRS|nrs
187431|NCT03024528|Behaviour|behaviour
187432|NCT03024528|Critical care|critical care
187433|NCT03024528|Intensive Care|intensive care
187434|NCT03024502|vulvovaginal candidiasis|vulvovaginal candidiasis
187435|NCT03024502|EPPAF mucoadhesive gel|eppaf mucoadhesive gel
187436|NCT03024502|clotrimazol|clotrimazol
187437|NCT03024489|Phase I/II|phase i/ii
187438|NCT03024476|behavioral intervention|behavioral intervention
187439|NCT03024476|prespecified medication algorithm|prespecified medication algorithm
187440|NCT03024476|bluetooth-equipped sphygmomanometer|bluetooth-equipped sphygmomanometer
187441|NCT03024463|Breast Neoplasm; Internal Lymph Node; Sentinel Lymph Node Biospy|breast neoplasm; internal lymph node; sentinel lymph node biospy
187442|NCT03024450|Gastric cancer|gastric cancer
187443|NCT03024450|HER2|her2
187444|NCT03024450|trastuzumab|trastuzumab
187445|NCT03024450|prognosis|prognosis
187446|NCT03024437|PD-L1 inhibitor|pd-l1 inhibitor
187447|NCT03024359|Obesity|obesity
187448|NCT03024359|Brown adipose tissue|brown adipose tissue
187449|NCT03024359|Monounsaturated fatty acids|monounsaturated fatty acids
187450|NCT03024359|Hypothalamic inflammation|hypothalamic inflammation
187451|NCT03024333|Dysphagia|dysphagia
187452|NCT03024333|Swallowing Sound|swallowing sound
187453|NCT03024333|Acoustic Analysis|acoustic analysis
187454|NCT03024307|Pharmaceutical Care|pharmaceutical care
187455|NCT03024307|Medication Adherence|medication adherence
187456|NCT03024307|Direct Costs|direct costs
187457|NCT03024281|Aspergillus|aspergillus
187458|NCT03024281|Antifungal susceptibility|antifungal susceptibility
187459|NCT03024281|Azole resistance|azole resistance
187460|NCT03024255|sweat gland disease|sweat gland disease
187461|NCT03024255|sweating|sweating
187462|NCT03024255|underarm|underarm
187463|NCT03024229|Transplantation;perfusion machine|transplantation;perfusion machine
187464|NCT03024190|stroke|stroke
187465|NCT03024190|spasticity|spasticity
187466|NCT03024190|Kinesiotaping|kinesiotaping
187467|NCT03024190|sonography|sonography
187468|NCT03024190|exercise|exercise
187469|NCT03024177|Human rhinovirus|human rhinovirus
187470|NCT03024177|HRV|hrv
187471|NCT03024177|Hematopoietic Stem Cell Transplant|hematopoietic stem cell transplant
187472|NCT03024177|HSCT|hsct
187473|NCT03024177|Antiviral|antiviral
187474|NCT03024177|vapendavir|vapendavir
187475|NCT03024177|Allogeneic|allogeneic
187476|NCT03024177|Autologous|autologous
187477|NCT03024164|youth; etiology; prognosis; recurrence; biomarkers|youth; etiology; prognosis; recurrence; biomarkers
187478|NCT03024125|lean mass|lean mass
187479|NCT03024125|postmenopausal|postmenopausal
187480|NCT03024125|protein|protein
187481|NCT03024099|hippotherapy Gross Motor Function Functional performance.|hippotherapy gross motor function functional performance.
187482|NCT03024060|Actinic Keratosis|actinic keratosis
187483|NCT03024021|therapeutic hypothermia|therapeutic hypothermia
187484|NCT03024021|targeted temperature management|targeted temperature management
187485|NCT03024021|neurological outcome|neurological outcome
187486|NCT03024021|post-cardiac arrest syndrome|post-cardiac arrest syndrome
187487|NCT03024008|Critical Gap|critical gap
187488|NCT03024008|Comminuted Fracture|comminuted fracture
187489|NCT03024008|Extra-Articular|extra-articular
187490|NCT03023930|Opioid Use Disorder|opioid use disorder
187491|NCT03023917|jaundice,complication|jaundice,complication
187492|NCT03023891|glucocorticoids|glucocorticoids
187493|NCT03023891|efficacy|efficacy
187494|NCT03023891|metabolic toxicity|metabolic toxicity
187495|NCT03023865|Long gap esophageal atresia|long gap esophageal atresia
187496|NCT03023839|Delirium|delirium
187497|NCT03023839|Trauma|trauma
187498|NCT03023839|Injury|injury
187499|NCT03023839|restraints|restraints
187500|NCT03023761|Endodontic retreatments|endodontic retreatments
187501|NCT03023761|Low level laser|low level laser
187502|NCT03023761|Pain|pain
187503|NCT03023748|activated vitamin D treatment|activated vitamin d treatment
187504|NCT03023709|Quadrivalent inactivated influenza vaccine|quadrivalent inactivated influenza vaccine
187505|NCT03023709|Quadrivalent live, attenuated influenza vaccine|quadrivalent live, attenuated influenza vaccine
187506|NCT03023709|Adults with obstructive sleep apnea|adults with obstructive sleep apnea
187507|NCT03023696|C5 Palsy|c5 palsy
187508|NCT03023683|Live, attenuated influenza vaccine|live, attenuated influenza vaccine
187509|NCT03023683|Children and young adults|children and young adults
187510|NCT03023670|Lung|lung
187511|NCT03023670|Cardiopulmonary Bypass|cardiopulmonary bypass
187512|NCT03023670|Pediatric|pediatric
187513|NCT03023670|Cardiac surgery|cardiac surgery
187514|NCT03023657|arousal|arousal
187515|NCT03023657|Consciousness Disorders|consciousness disorders
187516|NCT03023657|vegetative state|vegetative state
187517|NCT03023657|minimally conscious state|minimally conscious state
187518|NCT03023644|Congenital Heart Disease|congenital heart disease
187519|NCT03023644|Neurodevelopmental Disorders|neurodevelopmental disorders
187520|NCT03023644|Children|children
187521|NCT03023644|Executive Function|executive function
187522|NCT03023644|Working Memory|working memory
187523|NCT03023644|Cognitive interventions|cognitive interventions
187524|NCT03023644|Infant Open Heart Surgery|infant open heart surgery
187525|NCT03023618|[G09.330.380]|[g09.330.380]
187526|NCT03023605|Pulmonary embolism|pulmonary embolism
187527|NCT03023605|Adherence to practice guidelines|adherence to practice guidelines
187528|NCT03023605|Age-adjusted D-dimer|age-adjusted d-dimer
187529|NCT03023605|Clinical prediction rules|clinical prediction rules
187530|NCT03023605|Elderly patients|elderly patients
239703|NCT02700477|FBS|fbs
187531|NCT03023592|Sjogren's Syndrome|sjogren's syndrome
187532|NCT03023592|Iguratimod|iguratimod
187533|NCT03023566|Dotarem|dotarem
187534|NCT03023566|MRI|mri
187535|NCT03023566|pediatric|pediatric
187536|NCT03023566|safety|safety
187537|NCT03023566|efficacy|efficacy
187538|NCT03023553|Trivalent, inactivated influenza vaccine|trivalent, inactivated influenza vaccine
187539|NCT03023553|Live, attenuated influenza vaccine|live, attenuated influenza vaccine
187540|NCT03023553|Nasopharyngeal swabs|nasopharyngeal swabs
187541|NCT03023553|Young adults|young adults
187542|NCT03023540|Charcot Marie Tooth Type 1A|charcot marie tooth type 1a
187543|NCT03023540|Peripheral neuropathy|peripheral neuropathy
187544|NCT03023540|PXT3003|pxt3003
187545|NCT03023527|Refractory|refractory
187546|NCT03023527|Relapsed|relapsed
187547|NCT03023527|Nivolumab|nivolumab
187548|NCT03023514|Oocyte donation|oocyte donation
187549|NCT03023514|IVF|ivf
187550|NCT03023514|Lipoic acid|lipoic acid
187551|NCT03023514|Implantation rate|implantation rate
187552|NCT03023514|Endometrial receptivity|endometrial receptivity
187553|NCT03023488|flexible ureteroscopy|flexible ureteroscopy
187554|NCT03023488|blood flow|blood flow
187555|NCT03023436|Stomach Neoplasms|stomach neoplasms
187556|NCT03023436|Cytoreduction Surgical Procedures|cytoreduction surgical procedures
187557|NCT03023410|Revision TKA|revision tka
187558|NCT03023410|Instability|instability
187559|NCT03023410|Stiffness|stiffness
187560|NCT03023410|Aseptic Loosening|aseptic loosening
187561|NCT03023410|Polyethylene Wear|polyethylene wear
187562|NCT03023410|Malrotation|malrotation
187563|NCT03023410|Soft Tissue Imbalance|soft tissue imbalance
187564|NCT03023397|E-cig smokers|e-cig smokers
187565|NCT03023384|Acute Myeloid Leukemia|acute myeloid leukemia
187566|NCT03023384|Chemotherapy|chemotherapy
187567|NCT03023384|Autologous Stem Cell Transplantation|autologous stem cell transplantation
187568|NCT03023384|Developing country|developing country
187569|NCT03023384|Clinical network|clinical network
187570|NCT03023371|Registry; cohort study; IgG4-related disease|registry; cohort study; igg4-related disease
187571|NCT03023358|peripheral T cell lymphoma|peripheral t cell lymphoma
187572|NCT03023345|cancer|cancer
187573|NCT03023345|prostate|prostate
187574|NCT03023345|PSA|psa
187575|NCT03023345|biopsies|biopsies
187576|NCT03023345|microwave trans rectal focal treatment|microwave trans rectal focal treatment
187577|NCT03023332|Caregiver|caregiver
187578|NCT03023332|Biofeedback|biofeedback
187579|NCT03023332|Resourcefulness|resourcefulness
187580|NCT03023332|Self-Management|self-management
187581|NCT03023293|n-3 polyunsaturated fatty acids|n-3 polyunsaturated fatty acids
187582|NCT03023293|irisin|irisin
187583|NCT03023241|BPS/IC|bps/ic
187584|NCT03023241|OAB|oab
187585|NCT03023228|Diabetes mellitus|diabetes mellitus
187586|NCT03023228|Hyperglycemia|hyperglycemia
187587|NCT03023228|Inpatient|inpatient
187588|NCT03023228|self-management education|self-management education
187589|NCT03023215|Meditation|meditation
187590|NCT03023215|Breast Biopsy|breast biopsy
187591|NCT03023215|Stereotactic Breast Biopsy|stereotactic breast biopsy
187592|NCT03023215|SBB|sbb
187593|NCT03023215|Guided meditation|guided meditation
187594|NCT03023215|Focused breathing|focused breathing
187595|NCT03023215|Electroencephalogram|electroencephalogram
187596|NCT03023215|EEG|eeg
187597|NCT03023215|Heart rate|heart rate
187599|NCT03023215|Questionnaires|questionnaires
187600|NCT03023215|Surveys|surveys
187601|NCT03023189|Upper digestive bleeding|upper digestive bleeding
187602|NCT03023189|Haemorrhage|haemorrhage
187603|NCT03023189|Cirrhosis|cirrhosis
187604|NCT03023189|Antifibrinolytic|antifibrinolytic
187605|NCT03023189|Tranexamic acid|tranexamic acid
187606|NCT03023189|Emergency|emergency
187607|NCT03023176|Trivalent, inactivated influenza vaccine|trivalent, inactivated influenza vaccine
187608|NCT03023176|Child identical twins|child identical twins
187609|NCT03023176|Child fraternal twins|child fraternal twins
187610|NCT03023163|autonomic dysreflexia|autonomic dysreflexia
187611|NCT03023163|baroreceptor integrity|baroreceptor integrity
187612|NCT03023163|sympathetic integrity|sympathetic integrity
187613|NCT03023163|vagal integrity|vagal integrity
187614|NCT03023163|autonomic integrity|autonomic integrity
187615|NCT03023163|arterial stiffness|arterial stiffness
187616|NCT03023163|cognitive function|cognitive function
187617|NCT03023163|traumatic brain injury|traumatic brain injury
187618|NCT03023163|cerebral blood flow|cerebral blood flow
187619|NCT03023163|white matter hyperintensities|white matter hyperintensities
187620|NCT03023163|cerebral vascular resistance index|cerebral vascular resistance index
187621|NCT03023137|prevention|prevention
187622|NCT03023137|carbohydrate|carbohydrate
187623|NCT03023137|exercise|exercise
187624|NCT03023137|neonatal hypoglycemia|neonatal hypoglycemia
187625|NCT03023111|Cutaneous leishmaniasis|cutaneous leishmaniasis
187626|NCT03023111|miltefosine|miltefosine
187627|NCT03023111|cytokines|cytokines
187628|NCT03023111|treatment|treatment
187629|NCT03023098|Restenosis|restenosis
187630|NCT03023098|Drug-eluting balloon|drug-eluting balloon
187631|NCT03023098|Vein graft|vein graft
187632|NCT03023059|L-DOPA|l-dopa
187633|NCT03023059|GPR143|gpr143
187634|NCT03023059|PEDF|pedf
187635|NCT03023059|VEGF|vegf
187636|NCT03023033|PMTCT|pmtct
187637|NCT03023033|MNCH|mnch
187638|NCT03023020|Dual Antiplatelet Therapy|dual antiplatelet therapy
187639|NCT03022994|Non-celiac wheat sensitivity|non-celiac wheat sensitivity
187640|NCT03022994|eosinophils|eosinophils
187641|NCT03022994|lymphocytes|lymphocytes
187642|NCT03022994|duodenal biopsies|duodenal biopsies
187643|NCT03022994|rectal biopsies|rectal biopsies
187645|NCT03022825|bladder cancer|bladder cancer
187646|NCT03022825|immunotherapy|immunotherapy
187647|NCT03022825|interleukin-15|interleukin-15
187648|NCT03022825|intravesical|intravesical
187649|NCT03022825|non-muscle invasive|non-muscle invasive
187650|NCT03022825|NMIBC|nmibc
187651|NCT03022812|Neck pain|neck pain
187652|NCT03022812|Rehabilitation|rehabilitation
187653|NCT03022812|Exercise Therapy|exercise therapy
187654|NCT03022812|Internet|internet
187655|NCT03022799|FAF1|faf1
187656|NCT03022799|Fas (TNFRSF6)-associated factor 1|fas (tnfrsf6)-associated factor 1
187657|NCT03022799|FAF1 inhibitor|faf1 inhibitor
187658|NCT03022799|KM-819|km-819
187659|NCT03022786|Dermatitis|dermatitis
187660|NCT03022760|Exhaustion Disorder|exhaustion disorder
187661|NCT03022682|ethnicity|ethnicity
187662|NCT03022682|inflammation|inflammation
187663|NCT03022669|mobile health|mobile health
187664|NCT03022669|veterans|veterans
187665|NCT03022669|cardiovascular disease|cardiovascular disease
187666|NCT03022669|medication adherence|medication adherence
187667|NCT03022656|Orthotic treatment, Ultrasound Imaging|orthotic treatment, ultrasound imaging
187668|NCT03022630|palliative care|palliative care
187669|NCT03022630|cirrhosis|cirrhosis
187670|NCT03022630|liver disease|liver disease
187671|NCT03022630|hepatology|hepatology
187672|NCT03022630|end of life care|end of life care
187673|NCT03022630|supportive care|supportive care
187674|NCT03022565|Uveal Melanoma|uveal melanoma
187675|NCT03022552|Myocardial Infarction|myocardial infarction
187676|NCT03022552|Women|women
187677|NCT03022552|Platelets|platelets
187678|NCT03022552|Blood Collection|blood collection
187679|NCT03022552|Genomics|genomics
187680|NCT03022526|Pregnant|pregnant
187681|NCT03022526|Analgesia|analgesia
187682|NCT03022526|Labor analgesia|labor analgesia
187683|NCT03022526|Epidural|epidural
187684|NCT03022526|Combined spinal epidural|combined spinal epidural
187685|NCT03022513|Non-celiac Wheat Sensitivity|non-celiac wheat sensitivity
187686|NCT03022513|fibromyalgia|fibromyalgia
187687|NCT03022513|synovitis|synovitis
187688|NCT03022487|Sudden Cardiac Death (SCD)|sudden cardiac death (scd)
187689|NCT03022487|implantable cardioverter defibrillator|implantable cardioverter defibrillator
187690|NCT03022487|electrophysiological|electrophysiological
187691|NCT03022487|EP|ep
187692|NCT03022487|Ischaemic cardiomyopathy|ischaemic cardiomyopathy
187693|NCT03022487|Ventricular Arrhythmia|ventricular arrhythmia
187694|NCT03022487|ICD|icd
187695|NCT03022474|Childhood obesity|childhood obesity
187696|NCT03022461|Heart Failure|heart failure
187697|NCT03022461|Ventricular Dysfunction|ventricular dysfunction
187698|NCT03022461|Cardiomyopathies|cardiomyopathies
187699|NCT03022461|Heart Disease|heart disease
187700|NCT03022461|Cardiovascular Disease|cardiovascular disease
187701|NCT03022461|Heart-assist Devices|heart-assist devices
187702|NCT03022461|Thoratec Corporation|thoratec corporation
187703|NCT03022448|soft tissue sarcomas (STS)|soft tissue sarcomas (sts)
187704|NCT03022448|trabectedin|trabectedin
187705|NCT03022448|metastatic STS patients|metastatic sts patients
187706|NCT03022448|overall survival|overall survival
187707|NCT03022435|Inactivated influenza vaccine|inactivated influenza vaccine
187708|NCT03022435|Live, attenuated influenza vaccine|live, attenuated influenza vaccine
187709|NCT03022435|Adult and elderly identical twins|adult and elderly identical twins
187710|NCT03022435|Adult fraternal twins|adult fraternal twins
187711|NCT03022422|Trivalent, inactivated influenza vaccine|trivalent, inactivated influenza vaccine
187712|NCT03022422|High-Dose trivalent, inactivated influenza vaccine|high-dose trivalent, inactivated influenza vaccine
187713|NCT03022422|Adult and elderly identical twins|adult and elderly identical twins
187714|NCT03022422|Adult fraternal twins|adult fraternal twins
187715|NCT03022409|Treatment naïve|treatment naïve
187716|NCT03022409|Head and Neck Squamous Cell Carcinoma (HNSCC)|head and neck squamous cell carcinoma (hnscc)
187717|NCT03022409|DNA Damage Repair (DDR)|dna damage repair (ddr)
187718|NCT03022396|Inactivated influenza vaccine|inactivated influenza vaccine
187719|NCT03022396|Identical twins|identical twins
187720|NCT03022396|Fraternal twins|fraternal twins
187721|NCT03022396|High-Dose influenza vaccine|high-dose influenza vaccine
187722|NCT03022396|Elderly twins|elderly twins
187723|NCT03022396|Child twins|child twins
187724|NCT03022396|Inactivated influenza vaccine, high-dose|inactivated influenza vaccine, high-dose
187725|NCT03022383|no known ocular pathology|no known ocular pathology
187726|NCT03022370|informal settlements|informal settlements
187727|NCT03022370|poverty|poverty
187728|NCT03022344|DD2 plaque study|dd2 plaque study
187729|NCT03022344|Coronary plaque|coronary plaque
187730|NCT03022344|Type-2 diabetes mellitus|type-2 diabetes mellitus
187731|NCT03022331|Idiopathic aortitis|idiopathic aortitis
187732|NCT03022331|Isolated aortitis|isolated aortitis
187733|NCT03022331|Vasculitis|vasculitis
187734|NCT03022318|GPR143|gpr143
187735|NCT03022318|PEDF|pedf
187736|NCT03022318|VEGF|vegf
187737|NCT03022318|LDOPA|ldopa
187738|NCT03022305|Hip alignment|hip alignment
187739|NCT03022305|Hip misalignment|hip misalignment
187740|NCT03022305|Shoulder function|shoulder function
187741|NCT03022305|Shoulder rotation|shoulder rotation
187742|NCT03022305|Athletic shoulder injuries|athletic shoulder injuries
187743|NCT03022305|Athletic hip alignment|athletic hip alignment
187744|NCT03022305|Hip and shoulder alignment|hip and shoulder alignment
187745|NCT03022305|Hip joint|hip joint
187746|NCT03022305|Hip joint alignment|hip joint alignment
187747|NCT03022305|Hip joint misalignment|hip joint misalignment
187748|NCT03022279|Pediatric|pediatric
187749|NCT03022279|post-operative pain prevention|post-operative pain prevention
187750|NCT03022279|Anesthesia, Infiltration|anesthesia, infiltration
187751|NCT03022279|Nerve Blockade|nerve blockade
187752|NCT03022266|Adherence|adherence
187753|NCT03022266|CleverCap® Lite BLE C035|clevercap® lite ble c035
187754|NCT03022266|Smartphone App|smartphone app
187755|NCT03022266|Telehealth|telehealth
187756|NCT03022266|Digital Health|digital health
187757|NCT03022266|Mobile Phone App|mobile phone app
187758|NCT03022266|Behavioral Economics|behavioral economics
187759|NCT03022266|Aspirin|aspirin
187760|NCT03022266|Wellth App|wellth app
187762|NCT03022253|Platelets|platelets
187763|NCT03022227|cochlear implant ;|cochlear implant ;
187764|NCT03022214|Dietary supplementation|dietary supplementation
187765|NCT03022214|Exercise|exercise
187766|NCT03022214|Increase Resilience|increase resilience
187767|NCT03022214|Oxidative Stress|oxidative stress
187768|NCT03022214|Efficacy|efficacy
187769|NCT03022201|Motilitone|motilitone
187770|NCT03022188|pancreatic incidentaloma|pancreatic incidentaloma
187771|NCT03022188|pancreatic neuroendocrine tumor|pancreatic neuroendocrine tumor
187772|NCT03022188|EUS-guided fine-needle aspiration|eus-guided fine-needle aspiration
187773|NCT03022188|contrast-enhanced endoscopic ultrasound|contrast-enhanced endoscopic ultrasound
187774|NCT03022175|Safety|safety
187775|NCT03022175|Tolerability|tolerability
187776|NCT03022175|Pharmacokinetics|pharmacokinetics
187777|NCT03022162|Neuropathic Pain, Paclitaxel, CIPN|neuropathic pain, paclitaxel, cipn
187778|NCT03022136|epidural block|epidural block
187779|NCT03022136|dermatome|dermatome
187780|NCT03022136|human|human
187781|NCT03022136|spinal nerve|spinal nerve
187782|NCT03022136|thoracic|thoracic
187783|NCT03022071|Cognitive behavior therapy|cognitive behavior therapy
187784|NCT03022071|Psychodynamic therapy|psychodynamic therapy
187785|NCT03022071|Mediators|mediators
187786|NCT03022071|Moderators|moderators
187787|NCT03022045|Generalized Pustular Psoriasis|generalized pustular psoriasis
187788|NCT03022045|Erythrodermic Psoriasis|erythrodermic psoriasis
187789|NCT03022045|risankizumab|risankizumab
187790|NCT03022045|Japanese|japanese
187791|NCT03022032|Gynecologic cancer|gynecologic cancer
187792|NCT03022019|autologous cell suspension grafting|autologous cell suspension grafting
187793|NCT03022019|vitiligo|vitiligo
187794|NCT03022019|non-segmental|non-segmental
187796|NCT03021967|incurable pathologies|incurable pathologies
187797|NCT03021967|palliative care|palliative care
187798|NCT03021954|platelet rich plasma|platelet rich plasma
187799|NCT03021954|pelvic floor disorders|pelvic floor disorders
187800|NCT03021954|primipara|primipara
187801|NCT03021941|Gaucher Disease|gaucher disease
187802|NCT03021941|Enzyme Replacement Therapy|enzyme replacement therapy
187803|NCT03021928|Stroke|stroke
187804|NCT03021928|Atrial Fibrillation|atrial fibrillation
187805|NCT03021928|Anticoagulation|anticoagulation
187806|NCT03021928|NOAC|noac
187807|NCT03021889|HIV / AIDS|hiv / aids
187808|NCT03021889|Dyslipidemia|dyslipidemia
187809|NCT03021889|Adolescents|adolescents
187810|NCT03021889|Nutritional Therapy|nutritional therapy
187811|NCT03021863|Dissemination|dissemination
187812|NCT03021863|Tone|tone
187813|NCT03021863|Survey reminders|survey reminders
187814|NCT03021863|Questionnaires|questionnaires
187815|NCT03021850|Pliability|pliability
187816|NCT03021850|Cryotherapy|cryotherapy
187817|NCT03021850|Hot temperature|hot temperature
187818|NCT03021850|Hyperthermia, induced|hyperthermia, induced
187819|NCT03021850|Randomized Controlled Trial|randomized controlled trial
187820|NCT03021850|Hamstring muscles|hamstring muscles
187821|NCT03021850|Muscle stretching exercises|muscle stretching exercises
187822|NCT03021824|Acute Respiratory Distress Syndrome|acute respiratory distress syndrome
187823|NCT03021824|ARDS|ards
187824|NCT03021824|Acute Lung Injury|acute lung injury
187825|NCT03021824|ALI|ali
187826|NCT03021824|Mechanical Ventilation|mechanical ventilation
187827|NCT03021824|Extracorporeal Membrane Oxygenation|extracorporeal membrane oxygenation
187828|NCT03021824|Neuromuscular Blockade|neuromuscular blockade
187829|NCT03021824|Vasodilator Agents|vasodilator agents
187830|NCT03021824|Prone Position|prone position
187831|NCT03021824|ECMO|ecmo
187832|NCT03021824|Acute Respiratory Failure|acute respiratory failure
187833|NCT03021798|Sarcopenia|sarcopenia
187834|NCT03021798|Sarcopenic Obesity|sarcopenic obesity
187835|NCT03021798|observational study|observational study
187836|NCT03021798|6-minute walking distance|6-minute walking distance
187837|NCT03021798|400 meters walking test|400 meters walking test
187838|NCT03021798|Patient Reported Outcomes|patient reported outcomes
187839|NCT03021785|Neovascular Age-Related Macular Degeneration|neovascular age-related macular degeneration
187840|NCT03021785|Anti-VEGF|anti-vegf
187841|NCT03021785|CNV|cnv
187842|NCT03021785|TK001|tk001
187843|NCT03021772|Neostigmine|neostigmine
187844|NCT03021772|Dexamethasone|dexamethasone
187845|NCT03021772|Intravenous Local Anesthesia|intravenous local anesthesia
187846|NCT03021746|African-American|african-american
187847|NCT03021720|Uterine fibroid embolization|uterine fibroid embolization
187848|NCT03021720|Uterine artery embolization|uterine artery embolization
187849|NCT03021720|Arterial access|arterial access
187850|NCT03021720|Radial access|radial access
187851|NCT03021720|Interventional radiology|interventional radiology
187852|NCT03021720|Quality of life|quality of life
187853|NCT03021720|Patient Satisfaction|patient satisfaction
187854|NCT03021720|Patient centered care|patient centered care
187855|NCT03021720|Uterine fibroid|uterine fibroid
187856|NCT03021655|Youth|youth
187857|NCT03021655|Randomized controlled trial|randomized controlled trial
187858|NCT03021655|Adventure-based training|adventure-based training
187859|NCT03021655|WhatsApp|whatsapp
187860|NCT03021642|Healthy volunteer|healthy volunteer
187861|NCT03021642|Tepotinib|tepotinib
187862|NCT03021642|Mesenchymal-epithelial transition factor|mesenchymal-epithelial transition factor
187863|NCT03021642|Translocated promoter region|translocated promoter region
187864|NCT03021616|energy drink|energy drink
187865|NCT03021616|qtc interval|qtc interval
187866|NCT03021616|clotting time|clotting time
187867|NCT03021616|thorough qt study|thorough qt study
187868|NCT03021603|Hope|hope
187869|NCT03021603|psychotherapy|psychotherapy
187870|NCT03021603|palliative|palliative
187871|NCT03021603|low-intensity intervention|low-intensity intervention
187872|NCT03021590|Helicobacter pylori|helicobacter pylori
187873|NCT03021590|Helicobacter Infections|helicobacter infections
187874|NCT03021590|Proton Pump Inhibitors|proton pump inhibitors
187875|NCT03021590|sequential therapy|sequential therapy
187876|NCT03021590|Clarithromycin|clarithromycin
187877|NCT03021590|Tinidazole|tinidazole
187878|NCT03021577|orbital atherectomy system|orbital atherectomy system
187879|NCT03021577|rotational atherectomy|rotational atherectomy
187880|NCT03021577|Fractional flow reserve|fractional flow reserve
187881|NCT03021577|coronary flow reserve|coronary flow reserve
187882|NCT03021577|index of microcirculatory resistance (IMR)|index of microcirculatory resistance (imr)
187883|NCT03021538|Cardiopulmonary Bypass|cardiopulmonary bypass
187884|NCT03021538|Extracorporeal Membrane Oxygenation|extracorporeal membrane oxygenation
187885|NCT03021538|Primary Graft Dysfunction|primary graft dysfunction
187886|NCT03021538|Hemorrhage|hemorrhage
187887|NCT03021538|Mechanical Ventilator|mechanical ventilator
187888|NCT03021525|Goal-directed therapy|goal-directed therapy
187889|NCT03021525|postoperative morbidity|postoperative morbidity
187890|NCT03021525|haemodynamic optimisation|haemodynamic optimisation
187891|NCT03021525|individualised medicine|individualised medicine
187892|NCT03021525|Pulse pressure variation|pulse pressure variation
187893|NCT03021525|Cardiac output|cardiac output
187894|NCT03021499|lupus nephritis|lupus nephritis
187895|NCT03021499|calcineurin inhibitors|calcineurin inhibitors
187896|NCT03021499|voclosporin|voclosporin
187897|NCT03021473|oxygen reserve index|oxygen reserve index
187898|NCT03021473|desaturation|desaturation
187899|NCT03021473|safety|safety
187900|NCT03021434|Water Supply/standards|water supply/standards
187901|NCT03021434|Water microbiology|water microbiology
187902|NCT03021434|India|india
187903|NCT03021434|Hand disinfection|hand disinfection
187904|NCT03021434|Escherichia coli Infections/prevention & control|escherichia coli infections/prevention & control
187905|NCT03021434|Hygiene|hygiene
187906|NCT03021434|Health behavior|health behavior
187907|NCT03021434|Drinking water|drinking water
187908|NCT03021434|Informational intervention|informational intervention
187909|NCT03021421|Total knee arthroplasty|total knee arthroplasty
187910|NCT03021421|unilateral spinal anaesthesia|unilateral spinal anaesthesia
187911|NCT03021421|psoas compartment block|psoas compartment block
187912|NCT03021421|sciatic nerve block|sciatic nerve block
187913|NCT03021421|haemodynamic effects|haemodynamic effects
187914|NCT03021343|Atrial fibrillation|atrial fibrillation
187915|NCT03021343|Colchicine|colchicine
187916|NCT03021343|Cardiac surgery|cardiac surgery
187917|NCT03021304|SB240563|sb240563
187918|NCT03021304|self-administration|self-administration
187919|NCT03021304|Mepolizumab|mepolizumab
187920|NCT03021304|safety syringe|safety syringe
187921|NCT03021304|Eosinophilic asthma|eosinophilic asthma
187922|NCT03021278|Tactile acuity|tactile acuity
187923|NCT03021278|Chronic pain|chronic pain
187924|NCT03021278|Two-point discrimination|two-point discrimination
187925|NCT03021278|Point-to-point test|point-to-point test
187926|NCT03021278|Two-point estimation|two-point estimation
187927|NCT03021278|Body image|body image
187928|NCT03021239|Ramp Test|ramp test
187929|NCT03021239|Continuous Flow -Left Ventricular Assist Device (CF-LVAD)|continuous flow -left ventricular assist device (cf-lvad)
187930|NCT03021239|LVAD Hemodynamics|lvad hemodynamics
187931|NCT03021226|Health Behavior|health behavior
187932|NCT03021174|CIPN|cipn
187933|NCT03021174|Chemotherapy-induced peripheral neuropathy|chemotherapy-induced peripheral neuropathy
187934|NCT03021161|probiotic|probiotic
187935|NCT03021148|Non-celiac wheat sensitivity|non-celiac wheat sensitivity
187936|NCT03021148|self-reported|self-reported
187937|NCT03021122|Medication errors|medication errors
187938|NCT03021122|Resuscitation|resuscitation
187939|NCT03021122|Drugs|drugs
187940|NCT03021122|Pediatrics|pediatrics
187941|NCT03021122|Biomedical technology|biomedical technology
187942|NCT03021109|ultrasound|ultrasound
187943|NCT03021109|pediatrics|pediatrics
187944|NCT03021109|gastroenteritis|gastroenteritis
187945|NCT03021083|Lumbar multi-level fusions|lumbar multi-level fusions
187946|NCT03021083|Patient Controlled Analgesia|patient controlled analgesia
187947|NCT03021083|Fentanyl|fentanyl
187948|NCT03021083|Opioid Analgesia|opioid analgesia
187949|NCT03021070|Ante natal visit|ante natal visit
187950|NCT03021070|Facility delivery|facility delivery
187951|NCT03021070|Post natal visit|post natal visit
187952|NCT03021070|Continuum of care|continuum of care
187953|NCT03021070|Conditional cash transfer|conditional cash transfer
187954|NCT03021070|Maternal and child health|maternal and child health
187955|NCT03021070|Cluster randomized trial|cluster randomized trial
187956|NCT03021031|Parkinson's Disease|parkinson's disease
187957|NCT03021018|Epilepsy|epilepsy
187958|NCT03021018|Brivaracetam|brivaracetam
187959|NCT03021018|Epilepsy Monitoring Unit|epilepsy monitoring unit
187960|NCT03021018|Increased seizure activity|increased seizure activity
187961|NCT03020992|Axial Spondyloarthritis|axial spondyloarthritis
187962|NCT03020992|axSpA|axspa
187963|NCT03020992|Anterior Uveitis|anterior uveitis
187964|NCT03020992|Certolizumab Pegol|certolizumab pegol
187965|NCT03020992|Cimzia|cimzia
187966|NCT03020875|Acetaminophen|acetaminophen
187967|NCT03020875|Pain management|pain management
187968|NCT03020862|Dietary nitrate|dietary nitrate
187969|NCT03020862|Physical performance|physical performance
187970|NCT03020862|Blood pressure|blood pressure
187971|NCT03020862|Nitrite|nitrite
187972|NCT03020862|Exercise|exercise
187973|NCT03020849|hypofibrinogenemia|hypofibrinogenemia
187974|NCT03020849|prediction score|prediction score
187975|NCT03020849|severe trauma|severe trauma
187976|NCT03020823|SCB01A|scb01a
187977|NCT03020823|squamous cell carcinoma of head and neck|squamous cell carcinoma of head and neck
187978|NCT03020784|acute neuroinflammatory|acute neuroinflammatory
187979|NCT03020771|Crimean-congo hemorrhagic fever|crimean-congo hemorrhagic fever
187980|NCT03020771|vaccine|vaccine
187981|NCT03020771|human|human
187982|NCT03020771|phase I|phase i
187983|NCT03020745|Pharmacokinetics|pharmacokinetics
187984|NCT03020745|Safety|safety
187985|NCT03020745|Pharmacodynamics|pharmacodynamics
187986|NCT03020745|Efficacy|efficacy
187987|NCT03020745|Chronic Hepatitis B|chronic hepatitis b
187988|NCT03020745|GSK3389404|gsk3389404
187989|NCT03020732|growth factor|growth factor
188191|NCT03019341|Nausea|nausea
187990|NCT03020732|mucogingival surgery|mucogingival surgery
187991|NCT03020732|gingival recession|gingival recession
187992|NCT03020719|Growth Parameters|growth parameters
187993|NCT03020719|Cystic Fibrosis|cystic fibrosis
187994|NCT03020706|magnesium sulphate|magnesium sulphate
187995|NCT03020706|neostigmine|neostigmine
187996|NCT03020693|electrostimulation|electrostimulation
187997|NCT03020693|exercise program|exercise program
187998|NCT03020667|Cigarette|cigarette
187999|NCT03020667|IQOS|iqos
188000|NCT03020667|Nicotine-containing product|nicotine-containing product
188001|NCT03020667|Tobacco|tobacco
188002|NCT03020641|low pressure pneumoperitoneum|low pressure pneumoperitoneum
188003|NCT03020641|standard pressure pneumoperitoneum|standard pressure pneumoperitoneum
188004|NCT03020641|laparoscopy cholecystectomy|laparoscopy cholecystectomy
188005|NCT03020628|Influenza Vaccines|influenza vaccines
188006|NCT03020628|Vaccines, Inactivated|vaccines, inactivated
188007|NCT03020628|Cell Culture-Derived|cell culture-derived
188008|NCT03020615|Sickle cell|sickle cell
188009|NCT03020615|Hydroxyurea|hydroxyurea
188010|NCT03020615|Infants|infants
188011|NCT03020589|Renal Transplant|renal transplant
188012|NCT03020589|Tacrolimus|tacrolimus
188014|NCT03020589|Phase IV|phase iv
188015|NCT03020550|GERD|gerd
188016|NCT03020550|Galvanic Skin Response|galvanic skin response
188017|NCT03020550|Heart Rate Variability|heart rate variability
188018|NCT03020537|Trivalent inactivated influenza vaccine|trivalent inactivated influenza vaccine
188019|NCT03020537|Young children|young children
188020|NCT03020537|Young adults|young adults
188021|NCT03020511|Modern grains|modern grains
188022|NCT03020511|ancient grains|ancient grains
188023|NCT03020511|immunologic response|immunologic response
188024|NCT03020511|microbiota|microbiota
188025|NCT03020498|Inactivated influenza vaccine|inactivated influenza vaccine
188026|NCT03020498|Live, attenuated influenza vaccine|live, attenuated influenza vaccine
188027|NCT03020498|Child identical twins and non-twins|child identical twins and non-twins
188028|NCT03020498|Young and elderly non-twin adults|young and elderly non-twin adults
188029|NCT03020472|Live, attenuated influenza vaccine|live, attenuated influenza vaccine
188030|NCT03020472|Children|children
188031|NCT03020459|macular holes|macular holes
188032|NCT03020433|Stroke|stroke
188033|NCT03020433|rehab|rehab
188034|NCT03020433|rehabilitation|rehabilitation
188035|NCT03020433|paresis|paresis
188036|NCT03020433|paralysis|paralysis
188037|NCT03020433|stroke therapy|stroke therapy
188038|NCT03020433|CVA|cva
188039|NCT03020433|cerebrovascular accident|cerebrovascular accident
188040|NCT03020433|brain diseases|brain diseases
188041|NCT03020433|TMS|tms
188042|NCT03020433|transcranial magnetic stimulation|transcranial magnetic stimulation
188043|NCT03020433|CIMT|cimt
188044|NCT03020433|constraint induced movement therapy|constraint induced movement therapy
188045|NCT03020433|MRI|mri
188046|NCT03020407|Septic Shock|septic shock
188047|NCT03020407|Inferior vene cava diameter|inferior vene cava diameter
188048|NCT03020407|Resuscitation|resuscitation
188049|NCT03020407|Mortality|mortality
188050|NCT03020394|COPD Exacerbation|copd exacerbation
188051|NCT03020394|Noninvasive Positive Ventilation|noninvasive positive ventilation
188052|NCT03020394|Invasive Positive Ventilation|invasive positive ventilation
188053|NCT03020394|severe|severe
188054|NCT03020394|High flow nasal cannula|high flow nasal cannula
188055|NCT03020342|HCC|hcc
188056|NCT03020342|chimera DNA|chimera dna
188057|NCT03020342|circulating DNA|circulating dna
188058|NCT03020342|biomarker|biomarker
188059|NCT03020329|Induction Chemotherapy|induction chemotherapy
188060|NCT03020329|Nasopharyngeal carcinoma|nasopharyngeal carcinoma
188061|NCT03020329|Chemoradiotherapy|chemoradiotherapy
188062|NCT03020290|femoropopliteal artery|femoropopliteal artery
188063|NCT03020290|interwoven nitinol stent|interwoven nitinol stent
188064|NCT03020290|self-expanding-endovascular|self-expanding-endovascular
188065|NCT03020290|TASC C and TASC D|tasc c and tasc d
188066|NCT03020290|Peripheral Arterial Disease|peripheral arterial disease
188067|NCT03020264|Type 2 Diabetes|type 2 diabetes
188068|NCT03020264|Hypoglycemia|hypoglycemia
188069|NCT03020264|Elderly|elderly
188070|NCT03020264|Insulinotherapy|insulinotherapy
188071|NCT03020251|preoperative rehabilitation program|preoperative rehabilitation program
188072|NCT03020251|chest physiotherapy|chest physiotherapy
188073|NCT03020251|lung cancer resection|lung cancer resection
188074|NCT03020212|Chronic obstructive pulmonary disease|chronic obstructive pulmonary disease
188075|NCT03020212|High altitude|high altitude
188076|NCT03020212|Oxygen|oxygen
188077|NCT03020212|long-term oxygen therapy|long-term oxygen therapy
188078|NCT03020212|pulmonary hypertension|pulmonary hypertension
188079|NCT03020212|chronic hypoxemia|chronic hypoxemia
188080|NCT03020199|Psoriasis|psoriasis
188081|NCT03020134|pharmacokinetics|pharmacokinetics
188082|NCT03020134|Danoprevir/r|danoprevir/r
188083|NCT03020134|Ravidasvir|ravidasvir
188084|NCT03020095|Ravidasvir|ravidasvir
188085|NCT03020095|HCV GT1|hcv gt1
188086|NCT03020095|SVR12|svr12
188087|NCT03020095|Danoprevir/r|danoprevir/r
188088|NCT03020082|Danoprevir|danoprevir
188089|NCT03020082|non-cirrhotic|non-cirrhotic
188090|NCT03020082|Chinese HCV G1|chinese hcv g1
188091|NCT03020082|SVR12|svr12
188092|NCT03020069|Type 1 Diabetes|type 1 diabetes
188093|NCT03020069|Adolescents|adolescents
188094|NCT03020069|Glucose Monitoring|glucose monitoring
188095|NCT03020056|cataract surgery|cataract surgery
188096|NCT03020056|socioeconomic status|socioeconomic status
188097|NCT03020056|quality of life|quality of life
188098|NCT03020056|rural area|rural area
188099|NCT03020056|China|china
188100|NCT03020056|randomized controlled trial|randomized controlled trial
188101|NCT03020030|acute lymphoblastic leukemia|acute lymphoblastic leukemia
188102|NCT03020004|Danoprevir|danoprevir
188103|NCT03020004|SVR12|svr12
188104|NCT03020004|Chinese HCV G1|chinese hcv g1
188105|NCT03020004|non-cirrhotic|non-cirrhotic
188106|NCT03019991|pharmacokinetics,Danoprevir|pharmacokinetics,danoprevir
188107|NCT03019926|systemic lupus erythematosus|systemic lupus erythematosus
188108|NCT03019926|observance|observance
188109|NCT03019926|hydroxychloroquine dosage|hydroxychloroquine dosage
188110|NCT03019926|risk factors of non-observance|risk factors of non-observance
188111|NCT03019926|SLICC score|slicc score
188112|NCT03019926|SLEDAI score|sledai score
188113|NCT03019913|Skeletal muscle|skeletal muscle
188114|NCT03019861|Ayurveda|ayurveda
188115|NCT03019861|IBS|ibs
188116|NCT03019861|Complementary medicine|complementary medicine
188117|NCT03019861|nutritional counseling|nutritional counseling
188118|NCT03019848|Redox and pro-inflammatory status|redox and pro-inflammatory status
188119|NCT03019835|mivacurium|mivacurium
188120|NCT03019835|neostigmine|neostigmine
188121|NCT03019835|antagonism|antagonism
188122|NCT03019783|Endothelial function|endothelial function
188123|NCT03019770|Pre-Exposure Prophylaxis|pre-exposure prophylaxis
188124|NCT03019770|HIV|hiv
188125|NCT03019770|Decision Aid|decision aid
188126|NCT03019770|Shared Decision Making|shared decision making
188127|NCT03019744|Functional Electrical Stimulation|functional electrical stimulation
188128|NCT03019744|Cerebrovascular accident|cerebrovascular accident
188129|NCT03019744|Stroke|stroke
188130|NCT03019744|Electromyography|electromyography
188131|NCT03019731|Tics|tics
188132|NCT03019731|Behavioral therapy|behavioral therapy
188133|NCT03019731|Neurologic Examination|neurologic examination
188134|NCT03019718|Inpatient rehabilitation|inpatient rehabilitation
188135|NCT03019718|Internet-based intervention|internet-based intervention
188136|NCT03019718|Aftercare|aftercare
188137|NCT03019718|Return to work|return to work
188138|NCT03019718|Psychodynamic|psychodynamic
188139|NCT03019705|Cyberchondria|cyberchondria
188140|NCT03019705|health-related internet use|health-related internet use
188141|NCT03019705|pathological health anxiety|pathological health anxiety
188142|NCT03019705|ambulatory assessment|ambulatory assessment
188143|NCT03019666|MM|mm
188144|NCT03019666|NHL|nhl
188145|NCT03019666|NK Cell|nk cell
188146|NCT03019666|NK Cells|nk cells
188147|NCT03019601|HIV|hiv
188148|NCT03019601|PMTCT|pmtct
188149|NCT03019588|PD1|pd1
188150|NCT03019588|PD-1|pd-1
188151|NCT03019588|PDL1|pdl1
188152|NCT03019588|PD-L1|pd-l1
188153|NCT03019562|postoperative pain|postoperative pain
188154|NCT03019523|caffeine|caffeine
188155|NCT03019523|mental performance|mental performance
188156|NCT03019523|reaction time|reaction time
188157|NCT03019523|focus|focus
188158|NCT03019497|PTSD|ptsd
188159|NCT03019497|Related Problems|related problems
188160|NCT03019497|Therapy|therapy
188161|NCT03019497|Traumatic Event|traumatic event
188162|NCT03019497|Quality of Life|quality of life
188163|NCT03019497|Cognitive Behavioral Therapy (CBT)|cognitive behavioral therapy (cbt)
188164|NCT03019497|Major depression|major depression
188165|NCT03019497|Sleep disorders|sleep disorders
188166|NCT03019497|Pain|pain
188167|NCT03019497|Stressors|stressors
188168|NCT03019497|Social support|social support
188169|NCT03019497|Substance use disorder|substance use disorder
188170|NCT03019497|Anxiety disorder|anxiety disorder
188171|NCT03019484|Self-efficacy|self-efficacy
188172|NCT03019484|Self Efficacy|self efficacy
188173|NCT03019484|Nurses's Role|nurses's role
188174|NCT03019484|Professional Role|professional role
188175|NCT03019484|Clinical Trial|clinical trial
188176|NCT03019484|Breast Feeding|breast feeding
188177|NCT03019458|prospective randomized trial|prospective randomized trial
188178|NCT03019419|sporadic ALS|sporadic als
188179|NCT03019419|perampanel|perampanel
188180|NCT03019393|non-transferrin bound iron (NTBI)|non-transferrin bound iron (ntbi)
188181|NCT03019393|Red meat|red meat
188182|NCT03019393|Non-transferrin bound iron (NTBI) in serum|non-transferrin bound iron (ntbi) in serum
188183|NCT03019367|Premature infants|premature infants
188184|NCT03019367|Umbilical cord milking|umbilical cord milking
188185|NCT03019367|Delayed cord clamping|delayed cord clamping
188186|NCT03019367|Intraventricular Hemorrhage|intraventricular hemorrhage
188187|NCT03019367|Death|death
188188|NCT03019354|high flow oxygen|high flow oxygen
188189|NCT03019354|pulmonary atelectasis|pulmonary atelectasis
188190|NCT03019354|intravenous general anesthesia|intravenous general anesthesia
188192|NCT03019341|Vomiting|vomiting
188193|NCT03019341|Non-ionic contrast media|non-ionic contrast media
188194|NCT03019341|Side effect|side effect
188195|NCT03019328|peanut allergy|peanut allergy
188196|NCT03019328|food allergens|food allergens
188197|NCT03019328|atopic dermatitis|atopic dermatitis
188198|NCT03019328|eczema|eczema
188199|NCT03019328|infant food allergy testing|infant food allergy testing
188200|NCT03019328|skin prick testing|skin prick testing
188201|NCT03019328|peanut IgE|peanut ige
188202|NCT03019328|early peanut introduction|early peanut introduction
188203|NCT03019328|food allergy prevention|food allergy prevention
188204|NCT03019315|Ovarian Cancer|ovarian cancer
188205|NCT03019315|Chemotherapy|chemotherapy
188206|NCT03019315|Response Rate|response rate
188207|NCT03019315|Survival|survival
188208|NCT03019250|Colostrum|colostrum
188209|NCT03019250|Critical Care Outcomes|critical care outcomes
188210|NCT03019250|Intensive Care Unit|intensive care unit
188211|NCT03019250|Inflammation|inflammation
188212|NCT03019250|Infection|infection
188213|NCT03019250|mortality|mortality
188214|NCT03019224|Tooth whitening|tooth whitening
188215|NCT03019224|Dentifrice|dentifrice
188216|NCT03019224|Sensitivity|sensitivity
188217|NCT03019211|Physical Therapy Modalities|physical therapy modalities
188218|NCT03019211|Accidental Fall|accidental fall
188219|NCT03019211|Elderly|elderly
188220|NCT03019211|Hydrotherapy|hydrotherapy
188221|NCT03019211|Nursing Home|nursing home
188222|NCT03019198|Tranexamic Acid|tranexamic acid
188223|NCT03019198|Blood loss|blood loss
188224|NCT03019198|Tranfusion|tranfusion
188225|NCT03019185|Alport Syndrome|alport syndrome
188226|NCT03019185|Bardoxolone methyl|bardoxolone methyl
188227|NCT03019185|CDDO-ME|cddo-me
188228|NCT03019185|RTA 402|rta 402
188229|NCT03019146|Prehabilitation|prehabilitation
188230|NCT03019133|Heart rate|heart rate
188231|NCT03019133|Blood pressure variability|blood pressure variability
188232|NCT03019094|overactive bladder|overactive bladder
188233|NCT03019094|urge urinary incontinence|urge urinary incontinence
188234|NCT03019094|urgency frequency|urgency frequency
188235|NCT03019068|recruitment potential|recruitment potential
188236|NCT03019068|prediction|prediction
188237|NCT03019068|databases|databases
188238|NCT03019068|Clinical Trial Recruitment Support Systems (CTRSS)|clinical trial recruitment support systems (ctrss)
188239|NCT03019042|Hou Gu Mi Xi|hou gu mi xi
188240|NCT03019042|Shen Ling Bai Zhu San|shen ling bai zhu san
188241|NCT03019042|mild gastrointestinal disorders|mild gastrointestinal disorders
188242|NCT03019042|traditional Chinese medicine|traditional chinese medicine
188243|NCT03019042|randomized controlled trial|randomized controlled trial
188244|NCT03019029|Peripheral Nerve Amyloidosis|peripheral nerve amyloidosis
188245|NCT03019003|Head and Neck Cancer|head and neck cancer
188246|NCT03018964|Single incision|single incision
188247|NCT03018964|Solo surgery|solo surgery
188248|NCT03018951|frailty, assessement|frailty, assessement
188249|NCT03018938|mid mixture insulin analog|mid mixture insulin analog
188250|NCT03018938|basal insulin analog|basal insulin analog
188251|NCT03018912|Subjective Sleep Vital Sign (VS)|subjective sleep vital sign (vs)
188252|NCT03018912|Primary Care|primary care
188253|NCT03018912|Sleep Medicine|sleep medicine
188254|NCT03018912|Cognitive Behavioral Therapy (CBT)|cognitive behavioral therapy (cbt)
188255|NCT03018912|Obstructive Sleep Apnea (OSA)|obstructive sleep apnea (osa)
188256|NCT03018912|Insomnia|insomnia
188257|NCT03018912|Complex Sleep Disorders|complex sleep disorders
188258|NCT03018912|Predictive Analytics|predictive analytics
188259|NCT03018912|Screening|screening
188260|NCT03018912|Therapy Outcomes|therapy outcomes
188261|NCT03018899|paravertebral block|paravertebral block
188262|NCT03018899|ultrasound|ultrasound
188263|NCT03018899|percutaneous nephrolithotomy|percutaneous nephrolithotomy
188264|NCT03018899|postoperative pain|postoperative pain
188265|NCT03018873|remote ischemic preconditioning|remote ischemic preconditioning
188266|NCT03018873|acute myocardial infarction|acute myocardial infarction
188267|NCT03018860|Active second stage|active second stage
188268|NCT03018860|Neonatal morbidity|neonatal morbidity
188269|NCT03018860|Operative delivery|operative delivery
188270|NCT03018860|Labor|labor
188271|NCT03018834|Acute Myocarditis|acute myocarditis
188272|NCT03018834|ANAKINRA|anakinra
188273|NCT03018808|Eosinophilia|eosinophilia
188274|NCT03018808|COPD prevalence|copd prevalence
188275|NCT03018808|Primary care subjects|primary care subjects
188276|NCT03018795|peri-implantitis|peri-implantitis
188277|NCT03018795|Surgical regenerative treatment|surgical regenerative treatment
188278|NCT03018795|ozone therapy|ozone therapy
188279|NCT03018730|Fabry disease|fabry disease
188280|NCT03018730|Enzyme-Replacement Therapy|enzyme-replacement therapy
188281|NCT03018730|pegunigalsidase alfa|pegunigalsidase alfa
188282|NCT03018730|PRX-102|prx-102
188283|NCT03018730|alpha galactosidase-A|alpha galactosidase-a
188284|NCT03018704|alcoholism|alcoholism
188285|NCT03018704|treatment|treatment
188286|NCT03018652|COPD|copd
188287|NCT03018652|Ig|ig
188288|NCT03018652|IPRAC|iprac
188289|NCT03018652|outpatient|outpatient
188290|NCT03018626|Non-germinal b-cell-like|non-germinal b-cell-like
188291|NCT03018626|R-ACVBP|r-acvbp
188292|NCT03018626|DA-EPOCH-R|da-epoch-r
188293|NCT03018613|Chronic Functional Constipation|chronic functional constipation
188294|NCT03018613|Intestinal Bacteria Flora Disturbance|intestinal bacteria flora disturbance
188295|NCT03018613|Fecal Microbiota Transplantation|fecal microbiota transplantation
188296|NCT03018600|prednisone, autoimmune disease|prednisone, autoimmune disease
188297|NCT03018509|JTE-451|jte-451
188298|NCT03018509|psoriasis|psoriasis
188299|NCT03018470|COPD|copd
188300|NCT03018470|Non invasive ventilation|non invasive ventilation
188301|NCT03018470|NIV|niv
188302|NCT03018470|Acute exacerbation COPD|acute exacerbation copd
188303|NCT03018470|AECOPD|aecopd
188304|NCT03018470|Telemonitoring|telemonitoring
188305|NCT03018457|Trabecular microarchitecture|trabecular microarchitecture
188306|NCT03018457|alveolar bone|alveolar bone
188307|NCT03018457|osseointegration|osseointegration
188308|NCT03018457|dental implant|dental implant
188309|NCT03018431|Lung ultrasonography|lung ultrasonography
188310|NCT03018431|Chest CT scan|chest ct scan
188311|NCT03018431|ventilator-associated pneumonia|ventilator-associated pneumonia
188312|NCT03018431|ventilator-associated tracheobronchitis|ventilator-associated tracheobronchitis
188313|NCT03018431|antibiotic stewardship|antibiotic stewardship
188314|NCT03018418|Anal Cancer|anal cancer
188315|NCT03018379|Obesity|obesity
188316|NCT03018379|Body composition|body composition
188317|NCT03018379|energy expenditure|energy expenditure
188318|NCT03018379|sedentarity|sedentarity
188319|NCT03018379|dietary behaviors|dietary behaviors
188320|NCT03018366|estrogen|estrogen
188321|NCT03018366|premenopause|premenopause
188322|NCT03018366|menopause|menopause
188323|NCT03018366|amenorrhea|amenorrhea
188324|NCT03018353|Hepatitis C, Chronic|hepatitis c, chronic
188325|NCT03018353|Jail|jail
188326|NCT03018353|Patient Navigation|patient navigation
188327|NCT03018353|Incarcerated Population|incarcerated population
188328|NCT03018353|HCV|hcv
188329|NCT03018353|Sofosbuvir/Velpatasvir|sofosbuvir/velpatasvir
188330|NCT03018353|Hepatitis C|hepatitis c
188331|NCT03018288|Malignant Gliomas|malignant gliomas
188332|NCT03018288|Immunotherapy|immunotherapy
188333|NCT03018275|Lyophilized Biotherapeutic, Microbiome, Probiotic|lyophilized biotherapeutic, microbiome, probiotic
188334|NCT03018275|Commensal Gram-negative Bacteria|commensal gram-negative bacteria
188335|NCT03018275|Staphylococcus Aureus|staphylococcus aureus
188336|NCT03018275|Transepidermal Water Loss|transepidermal water loss
188337|NCT03018275|Allergic Diseases|allergic diseases
188338|NCT03018262|Surround Inhibition|surround inhibition
188339|NCT03018262|Motor Control|motor control
188340|NCT03018262|Transcranial Magnetic Stimulation (TMS)|transcranial magnetic stimulation (tms)
188341|NCT03018262|TMS-Evoked Potential|tms-evoked potential
188342|NCT03018236|cocaine|cocaine
188343|NCT03018236|alcohol|alcohol
188344|NCT03018236|substance use disorders|substance use disorders
188345|NCT03018236|addiction|addiction
188346|NCT03018236|N-acetylcysteine|n-acetylcysteine
188347|NCT03018236|randomized controlled trial|randomized controlled trial
188348|NCT03018223|Acute leukemia in CR|acute leukemia in cr
188349|NCT03018223|Chronic myeloid leukemia|chronic myeloid leukemia
188350|NCT03018223|Non-Hodgkin lymphoma in high risk|non-hodgkin lymphoma in high risk
188351|NCT03018223|Graft vs. Host Disease|graft vs. host disease
188352|NCT03018223|GVHD|gvhd
188353|NCT03018223|Hematopoietic cell transplant (HCT)|hematopoietic cell transplant (hct)
188354|NCT03018197|Personal Health Record|personal health record
188355|NCT03018197|Medication Knowledge|medication knowledge
188356|NCT03018197|Anticoagulants|anticoagulants
188357|NCT03018197|Patient Engagement|patient engagement
188358|NCT03018184|MRI|mri
188359|NCT03018184|CCSA|ccsa
188360|NCT03018184|Contractile Cross Sectional Area|contractile cross sectional area
188361|NCT03018184|Strength|strength
188362|NCT03018171|clonidine, spinal injections|clonidine, spinal injections
188363|NCT03018132|perinatal mental health|perinatal mental health
188364|NCT03018106|Female sexual disorder|female sexual disorder
188365|NCT03018106|Aging|aging
188366|NCT03018106|Menopause|menopause
188367|NCT03018106|Obstetrics/Gynecology|obstetrics/gynecology
188368|NCT03018106|Female urogenital disorder|female urogenital disorder
188369|NCT03018093|Relapsed or refractory acute lymphoblastic leukemia|relapsed or refractory acute lymphoblastic leukemia
188370|NCT03018093|Anti-CD19 chimeric antigen receptor T-cell|anti-cd19 chimeric antigen receptor t-cell
188371|NCT03018054|moderate active ulcerative colitis|moderate active ulcerative colitis
188372|NCT03018054|Japanese|japanese
188373|NCT03018041|Kidney transplantation|kidney transplantation
188374|NCT03018041|Renal transplantation|renal transplantation
188375|NCT03018041|Omega-3 fatty acids|omega-3 fatty acids
188376|NCT03018041|Marine n-3 fatty acids|marine n-3 fatty acids
188377|NCT03018041|Fatty acids|fatty acids
188378|NCT03018041|Inflammation|inflammation
188379|NCT03018041|Interstitial fibrosis|interstitial fibrosis
188380|NCT03018041|Glomerular filtration rate|glomerular filtration rate
188381|NCT03018041|Renal function|renal function
188382|NCT03018041|Allograft function|allograft function
188383|NCT03018041|Proteinuria|proteinuria
188384|NCT03018041|Blood pressure|blood pressure
188583|NCT03016637|EUS-FNA|eus-fna
188385|NCT03018041|Heart rate variability|heart rate variability
188386|NCT03018041|Lipids|lipids
188387|NCT03018041|Blood glucose|blood glucose
188388|NCT03018041|Body mass index|body mass index
188389|NCT03018041|Fatty acid composition|fatty acid composition
188390|NCT03018041|Gas chromatography|gas chromatography
188391|NCT03018041|Interventional study|interventional study
188392|NCT03018041|Allograft biopsy|allograft biopsy
188393|NCT03018041|Kidney biopsy|kidney biopsy
188394|NCT03018015|Bioequivalence|bioequivalence
188395|NCT03018015|Healthy|healthy
188396|NCT03018015|Bioavailability|bioavailability
188397|NCT03018015|Ibuprofen|ibuprofen
188398|NCT03018002|HIV, PMTCT|hiv, pmtct
188399|NCT03017989|Near Infrared Fluorescence Imaging|near infrared fluorescence imaging
188400|NCT03017989|Indocyanine green (ICG)|indocyanine green (icg)
188401|NCT03017963|acute coronary syndrome|acute coronary syndrome
188402|NCT03017963|sodium thiosulfate|sodium thiosulfate
188403|NCT03017963|maximum tolerable dose|maximum tolerable dose
188404|NCT03017963|dose-limiting toxicity|dose-limiting toxicity
188405|NCT03017911|PICC Line|picc line
240818|NCT02693730|IBS|ibs
188406|NCT03017911|Complications|complications
188407|NCT03017911|Thrombosis|thrombosis
188408|NCT03017911|Infection|infection
188409|NCT03017898|FiLaC|filac
188410|NCT03017898|Fistula Laser Closure|fistula laser closure
188411|NCT03017898|Laser Coagulation|laser coagulation
188412|NCT03017872|HIV, second-line|hiv, second-line
188413|NCT03017794|Radiotherapy|radiotherapy
188414|NCT03017794|Chromogranin A|chromogranin a
188415|NCT03017794|Neuroendocrine differentiation|neuroendocrine differentiation
188416|NCT03017781|Bipolar|bipolar
188417|NCT03017781|High-Risk Off-Spring|high-risk off-spring
188418|NCT03017781|Psychosocial Functioning|psychosocial functioning
188419|NCT03017768|Acute tryptophan depletion, esophageal sensitivity,|acute tryptophan depletion, esophageal sensitivity,
188420|NCT03017716|Inflammatory back pain|inflammatory back pain
188421|NCT03017716|gluten-free diet|gluten-free diet
188422|NCT03017716|celiac disease|celiac disease
188423|NCT03017716|non-celiac wheat sensitivity|non-celiac wheat sensitivity
188424|NCT03017703|Endothelial dysfunction|endothelial dysfunction
188425|NCT03017703|Insulin resistance|insulin resistance
188426|NCT03017703|Type 2 diabetes|type 2 diabetes
188427|NCT03017703|Mineralocorticoid blocker|mineralocorticoid blocker
188428|NCT03017625|COPD|copd
188429|NCT03017625|Cardiovascular Disease|cardiovascular disease
188430|NCT03017625|Platelets|platelets
188431|NCT03017625|Inflammation|inflammation
188432|NCT03017612|Presbyopia|presbyopia
188433|NCT03017573|Immunological biomarkers|immunological biomarkers
188434|NCT03017573|molecular profil|molecular profil
188435|NCT03017573|Circulating tumor DNA (ctDNA)|circulating tumor dna (ctdna)
188436|NCT03017560|Breast Cancer|breast cancer
188437|NCT03017560|Chemotherapy|chemotherapy
188438|NCT03017560|Verbal Memory|verbal memory
188439|NCT03017560|Processing Speed|processing speed
188440|NCT03017534|Patient-Therapist Interaction|patient-therapist interaction
188441|NCT03017534|Non-Specific Effects|non-specific effects
188442|NCT03017534|Manual Therapy|manual therapy
188443|NCT03017534|Neurodynamics|neurodynamics
188444|NCT03017534|Sham|sham
188445|NCT03017521|Refractory solid tumors|refractory solid tumors
188446|NCT03017521|AKT inhibitor|akt inhibitor
188447|NCT03017508|Cross-over study|cross-over study
188448|NCT03017508|Riluzole|riluzole
188449|NCT03017508|Double-blind study|double-blind study
188450|NCT03017508|Speech task|speech task
188451|NCT03017508|Social Anxiety Disorder|social anxiety disorder
188452|NCT03017495|food-drug interaction|food-drug interaction
188453|NCT03017495|drug-drug interaction|drug-drug interaction
188454|NCT03017495|pharmacokinetics|pharmacokinetics
188455|NCT03017469|Resilience|resilience
188456|NCT03017469|Workplace Stress|workplace stress
188457|NCT03017469|Occupational Fatigue|occupational fatigue
188458|NCT03017469|Compassion Fatigue|compassion fatigue
188459|NCT03017469|Peer Support|peer support
188460|NCT03017469|Self-Care|self-care
188461|NCT03017469|Employee Assistance|employee assistance
188462|NCT03017456|Survivorship|survivorship
188463|NCT03017456|Prostate Cancer|prostate cancer
188464|NCT03017456|Survivorship Care Plan|survivorship care plan
188465|NCT03017443|Weight Loss|weight loss
188466|NCT03017443|Obesity|obesity
188467|NCT03017443|Overweight|overweight
188468|NCT03017391|palliative care|palliative care
188469|NCT03017391|palliative medicine|palliative medicine
188470|NCT03017391|palliative|palliative
188471|NCT03017378|influenza vector|influenza vector
188472|NCT03017378|tuberculosis|tuberculosis
188473|NCT03017378|vaccine|vaccine
188474|NCT03017365|Motor Control|motor control
188475|NCT03017365|Balance|balance
188476|NCT03017352|Diabetes Mellitus, Type 1|diabetes mellitus, type 1
188477|NCT03017352|Exenatide|exenatide
188478|NCT03017352|Incretins|incretins
188479|NCT03017352|GLP-1|glp-1
188480|NCT03017352|Insulin|insulin
188481|NCT03017339|Low Lever Laser Therapy|low lever laser therapy
188482|NCT03017339|Exercise Therapy|exercise therapy
188483|NCT03017339|Chronic Pain|chronic pain
188582|NCT03016637|endoscopic ultrasonography|endoscopic ultrasonography
188484|NCT03017287|Glucose blood measurements, glucometer, BGM, Diabetes App|glucose blood measurements, glucometer, bgm, diabetes app
188485|NCT03017274|Non-celiac wheat sensitivity|non-celiac wheat sensitivity
188486|NCT03017274|celiac disease|celiac disease
188487|NCT03017274|abdominal ultrasonography;|abdominal ultrasonography;
188488|NCT03017261|Osteoarthritis|osteoarthritis
188489|NCT03017261|Arthroplasty|arthroplasty
188490|NCT03017261|Robotic Surgery|robotic surgery
188491|NCT03017261|Knee|knee
188492|NCT03017248|pain|pain
188493|NCT03017248|ketamine|ketamine
188494|NCT03017248|morphine|morphine
188495|NCT03017248|analgesia|analgesia
188496|NCT03017248|emergency|emergency
188497|NCT03017144|non-technical skills (NTS)|non-technical skills (nts)
188498|NCT03017144|human factors|human factors
188499|NCT03017144|team work|team work
188500|NCT03017144|Crew Resource Management / Crisis Resource Management (CRM)|crew resource management / crisis resource management (crm)
188501|NCT03017144|technical skills (TS)|technical skills (ts)
188502|NCT03017144|Cardiopulmonary resuscitation|cardiopulmonary resuscitation
188503|NCT03017144|Advanced cardiac life support|advanced cardiac life support
188504|NCT03017079|Semi-solidification|semi-solidification
188505|NCT03017079|caloric debt|caloric debt
188506|NCT03017079|enteral nutrition|enteral nutrition
188507|NCT03017079|critical illness|critical illness
188508|NCT03017066|Ultrasonography|ultrasonography
188509|NCT03017066|Child|child
188510|NCT03017066|Preoperative period|preoperative period
188511|NCT03017053|Neck dissection|neck dissection
188512|NCT03017053|Survival|survival
188513|NCT03017053|Early oral cancer|early oral cancer
188514|NCT03017053|Early oral cavity squamous cancer with node negative neck|early oral cavity squamous cancer with node negative neck
188515|NCT03017027|human-animal interaction|human-animal interaction
188516|NCT03017014|Crohn's Disease|crohn's disease
188517|NCT03017014|Adalimumab|adalimumab
188518|NCT03017014|Humira®|humira®
188519|NCT03016988|Mantle cell lymphoma|mantle cell lymphoma
188520|NCT03016988|Bortezomib|bortezomib
188521|NCT03016988|Fludarabine|fludarabine
188522|NCT03016988|Cytarabine|cytarabine
188523|NCT03016975|Edwards Cardioband|edwards cardioband
188524|NCT03016975|Mitral Valve|mitral valve
188525|NCT03016975|Transcatheter|transcatheter
188526|NCT03016975|Mitral repair|mitral repair
188527|NCT03016975|Functional mitral regurgitation|functional mitral regurgitation
188528|NCT03016975|Secondary mitral regurgitation|secondary mitral regurgitation
188529|NCT03016975|Annuloplasty|annuloplasty
188530|NCT03016936|Metabolic equivalents (METs)|metabolic equivalents (mets)
188531|NCT03016936|European Society of Anaesthesiology (ESA)|european society of anaesthesiology (esa)
188532|NCT03016936|Noncardiac surgery|noncardiac surgery
188533|NCT03016936|Cardiovascular Mortality|cardiovascular mortality
188534|NCT03016923|cerebral palsy|cerebral palsy
188535|NCT03016923|hemiplegia|hemiplegia
188536|NCT03016923|fes|fes
188537|NCT03016923|grasping|grasping
188538|NCT03016897|ALS|als
188539|NCT03016897|neurodegenerative|neurodegenerative
188540|NCT03016884|Herpes Zoster|herpes zoster
188541|NCT03016884|anti TNF alpha|anti tnf alpha
188542|NCT03016884|tofacitinib|tofacitinib
188543|NCT03016884|Rheumatoid Arthritis|rheumatoid arthritis
188544|NCT03016845|ciprofloxacin|ciprofloxacin
188545|NCT03016845|pharmacokinetics|pharmacokinetics
188546|NCT03016845|Intensive Care Unit|intensive care unit
188547|NCT03016845|Cystatin C|cystatin c
188548|NCT03016845|CKD-EPI|ckd-epi
188549|NCT03016845|renal function|renal function
188550|NCT03016780|Ulcerative Colitis|ulcerative colitis
188551|NCT03016780|Intestinal Bacteria Flora Disturbance|intestinal bacteria flora disturbance
188552|NCT03016780|Fecal Microbiota Transplantation|fecal microbiota transplantation
188553|NCT03016780|Intestinal Mucosal Immunity|intestinal mucosal immunity
188554|NCT03016767|oral feeding|oral feeding
188555|NCT03016767|oral stimulation|oral stimulation
188556|NCT03016767|physiotherapy intervention|physiotherapy intervention
188557|NCT03016754|sudden cardiac death|sudden cardiac death
188558|NCT03016754|SCD|scd
188559|NCT03016754|sudden cardiac arrest|sudden cardiac arrest
188560|NCT03016754|SCA|sca
188561|NCT03016754|heart failure|heart failure
188562|NCT03016754|HF|hf
188563|NCT03016741|cognitive function|cognitive function
188564|NCT03016741|hormonal therapy|hormonal therapy
188565|NCT03016741|cancer survivorship|cancer survivorship
188566|NCT03016741|dementia|dementia
188567|NCT03016741|cognitive dysfunction|cognitive dysfunction
188568|NCT03016741|mild cognitive impairment|mild cognitive impairment
188569|NCT03016728|exercise|exercise
188570|NCT03016728|physical activity|physical activity
188571|NCT03016728|pilot study|pilot study
188572|NCT03016728|randomized controlled trial|randomized controlled trial
188573|NCT03016728|cancer|cancer
188574|NCT03016728|adolescent and young adult|adolescent and young adult
188575|NCT03016728|AYA|aya
188576|NCT03016715|Epidermolysis bullosa simplex|epidermolysis bullosa simplex
188577|NCT03016676|Spinal Manipulation|spinal manipulation
188578|NCT03016676|Postural Instability|postural instability
188579|NCT03016676|Quality of Life|quality of life
188580|NCT03016650|Acetaminophen|acetaminophen
188581|NCT03016650|Ibuprofen|ibuprofen
188584|NCT03016598|oxytocin|oxytocin
188585|NCT03016598|substance-related disorders|substance-related disorders
188586|NCT03016598|Opioid Replacement Therapy|opioid replacement therapy
188587|NCT03016598|Psychophysiology|psychophysiology
188588|NCT03016598|Stress Biomarkers|stress biomarkers
188589|NCT03016572|Suicide|suicide
188590|NCT03016572|Adolescent|adolescent
188591|NCT03016572|Intervention|intervention
188592|NCT03016572|Crisis|crisis
188593|NCT03016572|Follow-Up|follow-up
188594|NCT03016559|releasing muscle|releasing muscle
188595|NCT03016559|quadratus lumborum|quadratus lumborum
188596|NCT03016559|hip angle|hip angle
188597|NCT03016546|Pregnancy|pregnancy
188598|NCT03016533|Dolutegravir|dolutegravir
188599|NCT03016533|Continued access study|continued access study
188600|NCT03016533|HIV-1|hiv-1
241127|NCT02692183|ET|et
188601|NCT03016533|GSK1349572|gsk1349572
188602|NCT03016533|Pediatric|pediatric
188603|NCT03016507|intraocular pressure|intraocular pressure
188604|NCT03016507|phacoemulsification|phacoemulsification
188605|NCT03016507|cataract|cataract
188606|NCT03016468|Oral Treprostinil|oral treprostinil
188607|NCT03016468|Remodulin|remodulin
188608|NCT03016468|Selexipag|selexipag
188609|NCT03016468|6 Minute Walk Test|6 minute walk test
188610|NCT03016455|Kidney Transplant|kidney transplant
188611|NCT03016455|Immunology|immunology
188612|NCT03016442|Double balloon catheter|double balloon catheter
188613|NCT03016442|Dinoprostone|dinoprostone
188614|NCT03016442|Labor induction|labor induction
188615|NCT03016429|pacemaker|pacemaker
188616|NCT03016429|defibrillator|defibrillator
188617|NCT03016429|magnetic resonance imaging|magnetic resonance imaging
188618|NCT03016429|cardiac implantable electronic device|cardiac implantable electronic device
188619|NCT03016390|Cardiac Implantable Electronic Device|cardiac implantable electronic device
188620|NCT03016390|Pacemaker|pacemaker
188621|NCT03016390|Automatic Implantable Cardioverter-Defibrillator (AICD)|automatic implantable cardioverter-defibrillator (aicd)
188622|NCT03016390|Electromagnetic interference (EMI)|electromagnetic interference (emi)
188623|NCT03016390|Keyless access system|keyless access system
188624|NCT03016390|Keyless entry system|keyless entry system
188625|NCT03016377|CAR T cells|car t cells
188626|NCT03016377|CD19|cd19
188627|NCT03016377|Leukemia|leukemia
188628|NCT03016377|T Lymphocytes|t lymphocytes
188629|NCT03016377|AP1903|ap1903
188630|NCT03016377|Cytokine Release Syndrome|cytokine release syndrome
188631|NCT03016377|Rimiducid|rimiducid
188632|NCT03016377|ICANS|icans
188633|NCT03016377|Immune effector cell mediated neurotoxicity syndrome|immune effector cell mediated neurotoxicity syndrome
188634|NCT03016351|Hypertension|hypertension
188635|NCT03016351|Exercise|exercise
188636|NCT03016351|African Americans|african americans
188637|NCT03016351|Arterial Function|arterial function
188638|NCT03016351|Arterial Stiffness|arterial stiffness
188639|NCT03016286|Whole body vibration|whole body vibration
188640|NCT03016286|Bone myoregulation reflex|bone myoregulation reflex
188641|NCT03016286|H-reflex|h-reflex
188642|NCT03016260|Rheumatoid Arthritis|rheumatoid arthritis
188643|NCT03016260|Anti TNF|anti tnf
188644|NCT03016260|Infliximab|infliximab
188645|NCT03016260|Adalimumab|adalimumab
188646|NCT03016260|Etanercept|etanercept
188647|NCT03016260|Golimumab|golimumab
188648|NCT03016260|Certolizumab Pegol|certolizumab pegol
188649|NCT03016260|Infliximab biosimilar|infliximab biosimilar
188650|NCT03016260|Etanercept biosimilar|etanercept biosimilar
188651|NCT03016260|Methotrexate|methotrexate
188652|NCT03016247|magnetic resonance imaging, trust, reward|magnetic resonance imaging, trust, reward
188653|NCT03016234|intraocular pressure|intraocular pressure
188654|NCT03016234|trendelenburg position|trendelenburg position
188655|NCT03016234|pneumoperitoneum|pneumoperitoneum
188656|NCT03016221|local skin responses|local skin responses
188657|NCT03016221|hyperemia|hyperemia
188658|NCT03016221|thermal sensation|thermal sensation
188659|NCT03016221|topical warming ointments|topical warming ointments
188660|NCT03016221|topical cooling ointments|topical cooling ointments
188661|NCT03016221|skin perfusion|skin perfusion
188662|NCT03016221|subjective thermal sensation|subjective thermal sensation
188663|NCT03016221|muscle tissue oxygenation|muscle tissue oxygenation
188664|NCT03016221|skin temperature|skin temperature
188665|NCT03016221|skin redness|skin redness
188666|NCT03016221|erythema|erythema
188667|NCT03016143|phase II|phase ii
188668|NCT03016143|split|split
188669|NCT03016143|vaccine|vaccine
188670|NCT03016130|leukemia|leukemia
188671|NCT03016130|myelodysplastic|myelodysplastic
188672|NCT03016130|myeloid|myeloid
188673|NCT03016130|lymphoblastic|lymphoblastic
188674|NCT03016130|diet|diet
188675|NCT03016130|infection|infection
188676|NCT03016130|hematopoietic|hematopoietic
188677|NCT03016130|stem cell|stem cell
188678|NCT03016130|transplant|transplant
188679|NCT03016104|magnetic seizure therapy|magnetic seizure therapy
188680|NCT03016104|electroconvulsive therapy|electroconvulsive therapy
188681|NCT03016104|bipolar mania|bipolar mania
188682|NCT03016104|cognition|cognition
188683|NCT03016104|controlled trial|controlled trial
188684|NCT03016052|ABMT|abmt
188685|NCT03016052|social anxiety|social anxiety
188686|NCT03016052|generalized anxiety|generalized anxiety
188687|NCT03016026|ERAS,Laparoscopy,Distal Gastrectomy,Safety,Effectiveness|eras,laparoscopy,distal gastrectomy,safety,effectiveness
188688|NCT03016000|diffuse large B-cell lymphoma|diffuse large b-cell lymphoma
188689|NCT03016000|Thalidomide|thalidomide
188690|NCT03016000|Maintenance|maintenance
188691|NCT03015987|Diode laser|diode laser
188692|NCT03015987|asymptomatic pulp|asymptomatic pulp
188693|NCT03015987|Laser activated irrigation|laser activated irrigation
188694|NCT03015987|continuous ultrasonic activation|continuous ultrasonic activation
188695|NCT03015987|post obturation pain|post obturation pain
188696|NCT03015935|Obesity, Morbid|obesity, morbid
188697|NCT03015883|Squamous Cell Carcinoma|squamous cell carcinoma
188698|NCT03015883|Alpha emitting radiation|alpha emitting radiation
188699|NCT03015883|Skin Cancer|skin cancer
188700|NCT03015883|Carcinoma, Squamous|carcinoma, squamous
188701|NCT03015883|HNSCC|hnscc
188702|NCT03015870|vocal dysfunction|vocal dysfunction
188703|NCT03015870|voice|voice
188704|NCT03015870|vocal folds|vocal folds
188705|NCT03015870|vocal aging|vocal aging
188706|NCT03015844|MIBG|mibg
188707|NCT03015844|131I-MIBG|131i-mibg
188708|NCT03015844|relapsed|relapsed
188709|NCT03015844|neuroblastoma|neuroblastoma
188710|NCT03015844|pheochromocytoma|pheochromocytoma
188711|NCT03015831|Atrial fibrillation|atrial fibrillation
188712|NCT03015831|Cardiac surgery|cardiac surgery
188713|NCT03015831|Colchicine|colchicine
188714|NCT03015766|insomnia|insomnia
188715|NCT03015766|hemodialysis|hemodialysis
188716|NCT03015766|auricular acupressure|auricular acupressure
188717|NCT03015766|randomized controlled trial|randomized controlled trial
188718|NCT03015753|Migraine|migraine
188719|NCT03015753|Tai Chi|tai chi
188720|NCT03015753|Prophylaxis|prophylaxis
188721|NCT03015753|Randomized controlled trial|randomized controlled trial
188722|NCT03015727|nasopharyngeal carcinoma|nasopharyngeal carcinoma
188723|NCT03015727|Induction chemotherapy|induction chemotherapy
188724|NCT03015727|radiotherapy|radiotherapy
188725|NCT03015727|chemoradiotherapy|chemoradiotherapy
188726|NCT03015701|Unresectable|unresectable
188727|NCT03015688|Biomarkers|biomarkers
188728|NCT03015662|Quality of Life|quality of life
188729|NCT03015662|Fatigue|fatigue
188730|NCT03015662|Anxiety|anxiety
188731|NCT03015662|Physical Therapy Modalities|physical therapy modalities
188732|NCT03015662|Pain|pain
188733|NCT03015649|breast cancer|breast cancer
188734|NCT03015649|neoadjuvant treatment|neoadjuvant treatment
188735|NCT03015649|surgical guidance system|surgical guidance system
188736|NCT03015636|Cognitive Behaviour Therapy|cognitive behaviour therapy
188737|NCT03015636|Psychological Intervention|psychological intervention
188738|NCT03015623|Mesenchymal stromal cells|mesenchymal stromal cells
188739|NCT03015623|MSC|msc
188740|NCT03015623|Stem cells|stem cells
188741|NCT03015623|Mesenchymal stem cells|mesenchymal stem cells
188742|NCT03015610|Personalized Medicine|personalized medicine
188743|NCT03015610|CYP2C19|cyp2c19
188744|NCT03015610|Lansoprazole|lansoprazole
188745|NCT03015610|Pharmacokinetics|pharmacokinetics
188746|NCT03015597|Smoking|smoking
188747|NCT03015597|Tobacco Smoking|tobacco smoking
188748|NCT03015597|Smoking, Tobacco|smoking, tobacco
188749|NCT03015597|Smoking Cessation|smoking cessation
188750|NCT03015597|Opiate Addiction|opiate addiction
188751|NCT03015597|Opiate Dependence|opiate dependence
188752|NCT03015597|Contingency Management|contingency management
188753|NCT03015571|heterotopic gastric mucosa|heterotopic gastric mucosa
188754|NCT03015571|cervical inlet patch|cervical inlet patch
188755|NCT03015571|narrow band imaging|narrow band imaging
188756|NCT03015571|endoscopy|endoscopy
188757|NCT03015558|Drug Resistance|drug resistance
188758|NCT03015558|Neuropathic Pain|neuropathic pain
188759|NCT03015558|opercular-insular cortex|opercular-insular cortex
188760|NCT03015558|Transcranial Direct Current Stimulation|transcranial direct current stimulation
188761|NCT03015545|Muscle Stiffness|muscle stiffness
188762|NCT03015545|Ultrasound elastography|ultrasound elastography
188763|NCT03015545|H-reflex|h-reflex
188764|NCT03015545|Whole body vibration|whole body vibration
188765|NCT03015545|blood perfusion|blood perfusion
188766|NCT03015532|knee|knee
188767|NCT03015532|knee replacement|knee replacement
188768|NCT03015532|arthroplasty|arthroplasty
188769|NCT03015532|joint replacement|joint replacement
188770|NCT03015532|knee pain|knee pain
188771|NCT03015519|GSK716155|gsk716155
188772|NCT03015519|Type 2 diabetes mellitus|type 2 diabetes mellitus
188773|NCT03015519|albiglutide|albiglutide
188774|NCT03015519|safety|safety
188775|NCT03015519|pediatric|pediatric
188776|NCT03015519|efficacy|efficacy
188777|NCT03015493|Neck pain|neck pain
188778|NCT03015493|Neurodynamics|neurodynamics
188779|NCT03015493|Spinal manipulative therapy|spinal manipulative therapy
188780|NCT03015480|Mobile Application|mobile application
188781|NCT03015480|Chronic Kidney Disease|chronic kidney disease
188782|NCT03015480|Diabetes Mellitus|diabetes mellitus
188783|NCT03015480|Albuminuria|albuminuria
188784|NCT03015480|Diet|diet
188785|NCT03015467|acute pancreatitis|acute pancreatitis
188786|NCT03015467|intestinal mucosal barrier|intestinal mucosal barrier
188787|NCT03015467|Fecal Microbiota Transplantation|fecal microbiota transplantation
188788|NCT03015454|InSight|insight
188789|NCT03015454|Dascena|dascena
188790|NCT03015441|Healthy subjects|healthy subjects
188791|NCT03015441|Probiotics|probiotics
188792|NCT03015441|Breath test|breath test
188793|NCT03015441|Dihydrogen|dihydrogen
188794|NCT03015441|Methane|methane
188795|NCT03015441|Intestinal gas production|intestinal gas production
188796|NCT03015441|Gut microbiota|gut microbiota
241319|NCT02690818|Texting|texting
188797|NCT03015428|Family caregivers|family caregivers
188798|NCT03015428|training programme|training programme
188799|NCT03015428|dementia|dementia
188800|NCT03015415|elbow|elbow
188801|NCT03015415|posttraumatic stiffness|posttraumatic stiffness
188802|NCT03015415|elbow contractures|elbow contractures
188803|NCT03015415|stiff elbow|stiff elbow
188804|NCT03015415|dynamic orthoses|dynamic orthoses
188805|NCT03015415|Dynamic splint|dynamic splint
188806|NCT03015415|Rehabilitation|rehabilitation
188807|NCT03015415|Splint|splint
188808|NCT03015415|Effectiveness of bracing|effectiveness of bracing
188809|NCT03015376|epithelial ovarian cancer|epithelial ovarian cancer
188810|NCT03015376|Hereditary Breast and Ovarian Cancer Syndrome|hereditary breast and ovarian cancer syndrome
188811|NCT03015376|next-generation sequencing|next-generation sequencing
188812|NCT03015376|High-Throughput Nucleotide Sequencing|high-throughput nucleotide sequencing
188813|NCT03015363|Hypertension|hypertension
188814|NCT03015363|Telemonitoring|telemonitoring
188815|NCT03015363|Vital signs|vital signs
188816|NCT03015350|blood sevoflurane concentration|blood sevoflurane concentration
188817|NCT03015350|blood desflurane concentration|blood desflurane concentration
188818|NCT03015350|one lung ventilation|one lung ventilation
188819|NCT03015311|Blood pressure control|blood pressure control
188820|NCT03015298|gastric cancer|gastric cancer
188821|NCT03015298|Simultaneous PET/MRI|simultaneous pet/mri
188822|NCT03015298|PET/CT|pet/ct
188823|NCT03015272|minimally-verbal|minimally-verbal
188824|NCT03015272|children|children
188825|NCT03015272|intervention|intervention
188826|NCT03015272|singing|singing
188827|NCT03015272|music|music
188828|NCT03015259|bioequivalence|bioequivalence
188829|NCT03015233|Lactate|lactate
188830|NCT03015233|Acute Abdominal Pain|acute abdominal pain
188831|NCT03015233|Acute Abdomen|acute abdomen
188832|NCT03015233|Strong Ion Gap|strong ion gap
188833|NCT03015233|Renal Colic|renal colic
188834|NCT03015233|Emergency Department|emergency department
188835|NCT03015233|Emergency|emergency
188836|NCT03015233|Surgery|surgery
188837|NCT03015233|Stewart|stewart
188838|NCT03015194|LVOT (left ventricular outflow tract, obstruction)|lvot (left ventricular outflow tract, obstruction)
188839|NCT03015194|Transcatheter Mitral Valve Implantation|transcatheter mitral valve implantation
188840|NCT03015194|Transcatheter Heart Valve|transcatheter heart valve
188841|NCT03015194|Mitral Valve Regurgitation|mitral valve regurgitation
188842|NCT03015194|Mitral Valve Stenosis|mitral valve stenosis
188843|NCT03015181|Broadly Neutralizing|broadly neutralizing
188844|NCT03015181|HIV Prevention|hiv prevention
188845|NCT03015181|Anti-Drug Antibody|anti-drug antibody
188846|NCT03015181|HIV-1|hiv-1
188847|NCT03015181|Immune Response|immune response
188848|NCT03015129|Durvalumab|durvalumab
188849|NCT03015129|MEDI4736|medi4736
188850|NCT03015129|Tremelimumab|tremelimumab
188851|NCT03015129|anti-PD-L1 Antibody|anti-pd-l1 antibody
188852|NCT03015129|anti-CTLA-4 antibody|anti-ctla-4 antibody
188853|NCT03015129|16-1491|16-1491
188854|NCT03015116|photobiomodulation|photobiomodulation
188855|NCT03015116|plantar fasciitis|plantar fasciitis
188856|NCT03015090|COPD|copd
188857|NCT03015090|CYP1A2|cyp1a2
188858|NCT03015090|Theophylline|theophylline
188859|NCT03015077|Glutamine|glutamine
188860|NCT03015051|Bronchiolitis|bronchiolitis
188861|NCT03015051|High flow nasal cannula|high flow nasal cannula
188862|NCT03015051|Oxygen therapy|oxygen therapy
188863|NCT03015025|Acenocoumarol|acenocoumarol
188864|NCT03015025|Cytochrome P450|cytochrome p450
188865|NCT03015025|Pharmacogenetics|pharmacogenetics
188866|NCT03015025|Algorithm|algorithm
188867|NCT03015025|CYP2C9|cyp2c9
188868|NCT03015025|VKORC1|vkorc1
188869|NCT03015025|CYP4F2|cyp4f2
188870|NCT03015025|P450 oxidoreductase (POR)|p450 oxidoreductase (por)
188871|NCT03015012|Nutrigenomics|nutrigenomics
188872|NCT03015012|Genetics|genetics
188873|NCT03015012|Overweight|overweight
188874|NCT03015012|Obesity|obesity
188875|NCT03015012|Transplantation|transplantation
188876|NCT03015012|Nutrition|nutrition
188877|NCT03015012|Dietetics|dietetics
188878|NCT03015012|BMI|bmi
188879|NCT03015012|Body Composition|body composition
188880|NCT03014999|Transcranial Magnetic Stimulation|transcranial magnetic stimulation
188881|NCT03014999|Spinal Cord Injury|spinal cord injury
188882|NCT03014999|Humans|humans
188883|NCT03014986|HCV|hcv
188884|NCT03014947|MSB11022|msb11022
188885|NCT03014947|Humira®|humira®
188886|NCT03014934|Aspergillosis|aspergillosis
188887|NCT03014934|IA|ia
188888|NCT03014908|Type 1 diabetes|type 1 diabetes
188889|NCT03014908|1H-NMR spectroscopy|1h-nmr spectroscopy
188890|NCT03014908|Metabolomics|metabolomics
188891|NCT03014908|Pediatrics|pediatrics
188892|NCT03014895|E3112|e3112
188893|NCT03014895|Pharmacokinetics|pharmacokinetics
188894|NCT03014895|Japanese|japanese
188895|NCT03014869|COPD Exacerbation|copd exacerbation
188896|NCT03014869|High Flow Oxygen|high flow oxygen
188897|NCT03014869|Noninvasive Positive Ventilation|noninvasive positive ventilation
188898|NCT03014869|moderate|moderate
188899|NCT03014856|Metabolic syndrome|metabolic syndrome
188900|NCT03014856|Metabolomics|metabolomics
188901|NCT03014856|NMR spectroscopy|nmr spectroscopy
188902|NCT03014843|Esophagal sensitivity, GERD, endogenous opiods|esophagal sensitivity, gerd, endogenous opiods
188903|NCT03014791|Epidemiology|epidemiology
188904|NCT03014791|Ethnicity|ethnicity
188905|NCT03014791|Age|age
188906|NCT03014791|Weight|weight
188907|NCT03014791|Hypertensive|hypertensive
188908|NCT03014791|Cardiac Output|cardiac output
188909|NCT03014791|Peripheral Vascular Resistance|peripheral vascular resistance
188910|NCT03014791|Arterial Stiffness|arterial stiffness
188911|NCT03014791|Healthy Volunteers|healthy volunteers
188912|NCT03014791|Endothelial function|endothelial function
188913|NCT03014791|Arterial Structure|arterial structure
188914|NCT03014791|Left ventricular mass/function|left ventricular mass/function
188915|NCT03014765|endothelial dysfunction|endothelial dysfunction
188916|NCT03014765|perioperative stress|perioperative stress
188917|NCT03014765|cardiovascular complications|cardiovascular complications
188918|NCT03014765|inflammatory markers|inflammatory markers
188919|NCT03014739|Elastography|elastography
188920|NCT03014739|Musculoskeletal System|musculoskeletal system
188921|NCT03014726|reduced urine flow rate|reduced urine flow rate
188922|NCT03014726|low peak flow rate|low peak flow rate
188923|NCT03014726|urinary tract infections|urinary tract infections
188924|NCT03014713|Dexmedetomidine|dexmedetomidine
188925|NCT03014713|Dezocine|dezocine
188926|NCT03014713|Flubiprofen|flubiprofen
188927|NCT03014713|Analgesia|analgesia
188928|NCT03014713|Colorectal Surgery|colorectal surgery
188929|NCT03014687|transsphenoidal surgery|transsphenoidal surgery
188930|NCT03014674|SB-240563|sb-240563
188931|NCT03014674|subcutaneous|subcutaneous
188932|NCT03014674|lyophilized drug product|lyophilized drug product
188933|NCT03014674|Mepolizumab|mepolizumab
188934|NCT03014674|liquid drug product|liquid drug product
188935|NCT03014674|safety syringe|safety syringe
188936|NCT03014674|auto injector|auto injector
188937|NCT03014661|pollinosis, quality of life, specific immunotherapy|pollinosis, quality of life, specific immunotherapy
188938|NCT03014635|glabellar lines, frown lines|glabellar lines, frown lines
188939|NCT03014622|glabellar lines, frown lines|glabellar lines, frown lines
188940|NCT03014609|chronic obstructive pulmonary disease|chronic obstructive pulmonary disease
188941|NCT03014609|cardiovascular risk|cardiovascular risk
188942|NCT03014609|inflammation|inflammation
188943|NCT03014609|oxidative stress|oxidative stress
188944|NCT03014609|peripheral muscle function|peripheral muscle function
188945|NCT03014570|behavior,|behavior,
188946|NCT03014570|apathy|apathy
188947|NCT03014570|mood|mood
188948|NCT03014570|function|function
188949|NCT03014570|cognition|cognition
188950|NCT03014557|atrial fibrillation|atrial fibrillation
188951|NCT03014557|left atrial appendage closure|left atrial appendage closure
188952|NCT03014557|WATCHMAN|watchman
188953|NCT03014518|Adolescent|adolescent
188954|NCT03014518|Biological Markers|biological markers
188955|NCT03014518|Biomarkers|biomarkers
188956|NCT03014518|Biomarkers for suicidality|biomarkers for suicidality
188957|NCT03014518|Blood brain barrier|blood brain barrier
188958|NCT03014518|Clinical predictors|clinical predictors
188959|NCT03014518|Cytokine|cytokine
188960|NCT03014518|Feeling suicidal|feeling suicidal
188961|NCT03014518|Inflammation|inflammation
188962|NCT03014518|Inflammatory marker|inflammatory marker
188963|NCT03014518|Inpatient discharge|inpatient discharge
188964|NCT03014518|Interleukin-1 beta|interleukin-1 beta
188965|NCT03014518|IL-1ß|il-1ß
188966|NCT03014518|Interleukin-6|interleukin-6
188967|NCT03014518|IL-6|il-6
188968|NCT03014518|Kynurenic acid|kynurenic acid
188969|NCT03014518|Kynurenine pathway|kynurenine pathway
188970|NCT03014518|Neuroinflammation|neuroinflammation
188971|NCT03014518|Novel marker|novel marker
188972|NCT03014518|Peripheral blood biomarkers|peripheral blood biomarkers
188973|NCT03014518|Picolinic acid|picolinic acid
188974|NCT03014518|Plasma biomarker|plasma biomarker
188975|NCT03014518|Psychiatric inpatient|psychiatric inpatient
188976|NCT03014518|S100B|s100b
188977|NCT03014518|Serum biomarker|serum biomarker
188978|NCT03014518|Stress|stress
188979|NCT03014518|Suicide|suicide
188980|NCT03014518|Suicidal behavior|suicidal behavior
188981|NCT03014518|Suicidal risk|suicidal risk
188982|NCT03014518|Tumor necrosis factor alpha|tumor necrosis factor alpha
188983|NCT03014518|TNF-α|tnf-α
188984|NCT03014505|Cirrhosis|cirrhosis
188985|NCT03014505|Fecal Microbiota Transplantation|fecal microbiota transplantation
188986|NCT03014505|Intestinal flora|intestinal flora
188987|NCT03014505|Intestinal mucosal barrier|intestinal mucosal barrier
188988|NCT03014505|Intestinal Bacteria Flora Disturbance|intestinal bacteria flora disturbance
188989|NCT03014401|stem cell|stem cell
188990|NCT03014401|knee pain|knee pain
188991|NCT03014401|osteoarthritis|osteoarthritis
188992|NCT03014401|arthritis|arthritis
188993|NCT03014401|ADSC|adsc
241609|NCT02689284|GEJ|gej
188994|NCT03014401|fat stem cell|fat stem cell
188995|NCT03014349|Glaucoma|glaucoma
188996|NCT03014349|Ocular hypertension|ocular hypertension
188997|NCT03014336|co2 removal, anesthesia|co2 removal, anesthesia
188998|NCT03014323|insulin sensitivity|insulin sensitivity
188999|NCT03014323|African American|african american
189000|NCT03014323|obese|obese
189001|NCT03014310|A/H5N8|a/h5n8
189002|NCT03014310|Adjuvants|adjuvants
189003|NCT03014310|AS03|as03
189004|NCT03014310|Inactivated|inactivated
189005|NCT03014310|Influenza|influenza
189006|NCT03014310|MF59|mf59
189007|NCT03014310|Monovalent|monovalent
189008|NCT03014284|Tissue collection|tissue collection
189009|NCT03014284|colonoscopic surgical procedures|colonoscopic surgical procedures
189010|NCT03014258|Biology|biology
189011|NCT03014258|falciparum|falciparum
189012|NCT03014258|Immunity|immunity
189013|NCT03014258|Infections|infections
189014|NCT03014258|Malaria|malaria
189016|NCT03014258|Plasmodium|plasmodium
189017|NCT03014258|Systems|systems
189018|NCT03014232|sustained low-efficiency diafiltration (SLED-f)|sustained low-efficiency diafiltration (sled-f)
189019|NCT03014232|high cut-off dialyzer|high cut-off dialyzer
189020|NCT03014232|cytokines|cytokines
189021|NCT03014180|Heart failure, CRT|heart failure, crt
189022|NCT03014167|transmission interruption|transmission interruption
189023|NCT03014167|intestinal nematodes|intestinal nematodes
189024|NCT03014167|soil-transmitted helminths|soil-transmitted helminths
189025|NCT03014167|mass drug administration|mass drug administration
189026|NCT03014167|Benin|benin
189027|NCT03014167|India|india
189028|NCT03014167|Malawi|malawi
189029|NCT03014154|video games|video games
189030|NCT03014154|asthma|asthma
189031|NCT03014154|physical exercise|physical exercise
189032|NCT03014128|musculoskeletal disorders|musculoskeletal disorders
189033|NCT03014128|upper extremity|upper extremity
189034|NCT03014128|work|work
189035|NCT03014128|surgical instruments|surgical instruments
189036|NCT03014115|arachidonic|arachidonic
189037|NCT03014115|docosahexaenoic acid|docosahexaenoic acid
189038|NCT03014115|infant formula|infant formula
189039|NCT03014089|mRNA-1325|mrna-1325
189040|NCT03014089|Zika vaccine|zika vaccine
189041|NCT03014063|sepsis|sepsis
189042|NCT03014063|septic shock|septic shock
189043|NCT03014063|vasopressin|vasopressin
189044|NCT03014063|AVP|avp
189045|NCT03014050|physical activity|physical activity
189046|NCT03014050|fitness|fitness
189047|NCT03014050|cognition|cognition
189048|NCT03014050|mood|mood
189049|NCT03014050|depression|depression
189050|NCT03014050|anxiety|anxiety
189051|NCT03014050|sleep quality|sleep quality
189052|NCT03014050|tremor|tremor
189053|NCT03014050|gait|gait
189054|NCT03014037|Orthopedics|orthopedics
189055|NCT03014024|Distal Radius Fracture|distal radius fracture
189056|NCT03014024|Low Level Laser Therapy|low level laser therapy
189057|NCT03013985|Blood glucose|blood glucose
189058|NCT03013972|ColoRectal Cancer|colorectal cancer
189059|NCT03013972|Adjuvant Chemotherapy|adjuvant chemotherapy
189060|NCT03013972|Cancer-related Fatigue|cancer-related fatigue
189061|NCT03013972|Brief fatigue inventory (BFI)|brief fatigue inventory (bfi)
189062|NCT03013972|Functional Assessment of Cancer Therapy-General 7 (FACT-G7)|functional assessment of cancer therapy-general 7 (fact-g7)
189063|NCT03013920|upper urinary tract cancer|upper urinary tract cancer
189064|NCT03013920|confocal laser endomicroscopy|confocal laser endomicroscopy
189065|NCT03013920|urothelial carcinoma|urothelial carcinoma
189066|NCT03013907|Hypertension|hypertension
189067|NCT03013907|Coping|coping
189068|NCT03013907|Relaxing|relaxing
189069|NCT03013894|bladder neoplasm|bladder neoplasm
189070|NCT03013894|urothelium carcinoma|urothelium carcinoma
189071|NCT03013894|confocal laser endomicroscopy|confocal laser endomicroscopy
189072|NCT03013881|UB-921|ub-921
189073|NCT03013881|anti-HER2 monoclonal antibody|anti-her2 monoclonal antibody
189074|NCT03013881|breast neoplasm|breast neoplasm
189075|NCT03013881|breast cancer|breast cancer
189076|NCT03013881|Herceptin|herceptin
189077|NCT03013881|Trastuzumab|trastuzumab
189078|NCT03013881|HER2|her2
189079|NCT03013855|Digital rectal exam|digital rectal exam
189080|NCT03013855|Colon cancer screening|colon cancer screening
189081|NCT03013842|pregnancy|pregnancy
189082|NCT03013842|fetal monitoring|fetal monitoring
189083|NCT03013842|fetal oximetry|fetal oximetry
189084|NCT03013842|fetal heart rate|fetal heart rate
189085|NCT03013842|pulse oximetry|pulse oximetry
189086|NCT03013842|near infrared spectroscopy|near infrared spectroscopy
189087|NCT03013829|Kidney Paired Donation|kidney paired donation
189088|NCT03013777|Familial dysautonomia|familial dysautonomia
189089|NCT03013699|diet|diet
189090|NCT03013699|nutrition|nutrition
189091|NCT03013699|survival|survival
189092|NCT03013699|recurrence|recurrence
189093|NCT03013699|cruciferous|cruciferous
189094|NCT03013699|dark leafy greens|dark leafy greens
400615|NCT01866020|fungal infection|fungal infection
400616|NCT01866020|ICU|icu
189095|NCT03013673|leishmaniasis, visceral, neglected, HIV, co-infection, asymptomatic, Ethiopia|leishmaniasis, visceral, neglected, hiv, co-infection, asymptomatic, ethiopia
189096|NCT03013647|actinic keratosis|actinic keratosis
189097|NCT03013647|field cancerization|field cancerization
189098|NCT03013647|photodynamic therapy|photodynamic therapy
189099|NCT03013647|daylight photodynamic therapy|daylight photodynamic therapy
189100|NCT03013634|dexmedetomidine|dexmedetomidine
189101|NCT03013621|Renal Failure|renal failure
189102|NCT03013621|Renal Insufficiency|renal insufficiency
189103|NCT03013621|Acute Renal Failure|acute renal failure
189104|NCT03013621|Acute Renal Injury|acute renal injury
189105|NCT03013621|Kidney Failure|kidney failure
189106|NCT03013621|Kidney Insufficiency|kidney insufficiency
189107|NCT03013621|Acute Kidney Failure|acute kidney failure
189108|NCT03013621|Acute Kidney Injury|acute kidney injury
189109|NCT03013621|Ventricular dysfunction|ventricular dysfunction
189110|NCT03013621|Venous congestion|venous congestion
189111|NCT03013621|Renal function|renal function
189112|NCT03013621|Kidney function|kidney function
189113|NCT03013621|Venous heart failure|venous heart failure
189114|NCT03013608|Nail bed injury|nail bed injury
189115|NCT03013608|Nail bed injuries|nail bed injuries
189116|NCT03013608|Nail|nail
189117|NCT03013608|Children|children
189118|NCT03013608|Fingertip injury|fingertip injury
189119|NCT03013595|Mental health|mental health
189120|NCT03013595|Youth mental health|youth mental health
189121|NCT03013595|Adolescent|adolescent
189122|NCT03013595|Health services|health services
189123|NCT03013595|Transition|transition
189124|NCT03013595|Longitudinal cohort study|longitudinal cohort study
189125|NCT03013595|Cluster randomised controlled trial|cluster randomised controlled trial
189126|NCT03013595|Young adult|young adult
189127|NCT03013556|HBeAg positive|hbeag positive
189128|NCT03013543|POMC deficiency obesity|pomc deficiency obesity
189129|NCT03013543|LepR deficiency obesity|lepr deficiency obesity
189130|NCT03013543|Bardet-Biedl syndrome|bardet-biedl syndrome
189131|NCT03013543|Alström Syndrome|alström syndrome
189132|NCT03013543|Smith-Magenis Syndrome|smith-magenis syndrome
189133|NCT03013530|Intensive care unit|intensive care unit
189134|NCT03013530|Triage and Therapy.|triage and therapy.
189135|NCT03013530|Advance Directives (AD).|advance directives (ad).
189136|NCT03013530|Simulation model of real situations. (hypothetical scenario)|simulation model of real situations. (hypothetical scenario)
189137|NCT03013530|Intensivist physician.|intensivist physician.
189138|NCT03013517|Allergy|allergy
189139|NCT03013517|food allergy|food allergy
189140|NCT03013517|viaskin|viaskin
189141|NCT03013517|peanut|peanut
189142|NCT03013517|epicutaneous|epicutaneous
189143|NCT03013504|randomized|randomized
189144|NCT03013504|double-blind|double-blind
189145|NCT03013504|parallel group|parallel group
189146|NCT03013504|equivalence|equivalence
189147|NCT03013504|multicentre|multicentre
189148|NCT03013504|phase III|phase iii
189149|NCT03013504|efficacy|efficacy
189150|NCT03013504|safety|safety
189151|NCT03013504|pharmacokinetics|pharmacokinetics
189152|NCT03013504|HD201|hd201
189153|NCT03013504|docetaxel|docetaxel
189154|NCT03013504|Herceptin|herceptin
189155|NCT03013504|HER2 positive|her2 positive
189156|NCT03013504|breast cancer|breast cancer
189157|NCT03013504|early breast cancer|early breast cancer
189158|NCT03013491|cancer|cancer
189159|NCT03013491|checkpoint inhibitor|checkpoint inhibitor
189160|NCT03013491|monotherapy|monotherapy
189161|NCT03013491|combination|combination
189162|NCT03013491|PD-L1|pd-l1
189163|NCT03013491|CTLA-4|ctla-4
189164|NCT03013491|solid tumor|solid tumor
189165|NCT03013491|lymphoma|lymphoma
189166|NCT03013491|BRAF|braf
189167|NCT03013491|PROCLAIM|proclaim
189168|NCT03013491|CX-072|cx-072
189169|NCT03013491|PROCLAIM-CX-072|proclaim-cx-072
189170|NCT03013374|protein accretion|protein accretion
189171|NCT03013374|body composition|body composition
189172|NCT03013361|ropivacaine, bupivacaine|ropivacaine, bupivacaine
189173|NCT03013335|Clear-cell|clear-cell
189174|NCT03013335|Nivolumab|nivolumab
189175|NCT03013335|Renal cell carcinoma|renal cell carcinoma
189176|NCT03013335|Immunotherapy|immunotherapy
189177|NCT03013309|Hybrid|hybrid
189178|NCT03013309|Implementation|implementation
189179|NCT03013309|Effectiveness|effectiveness
189180|NCT03013309|Parent training|parent training
189181|NCT03013309|Fidelity|fidelity
189182|NCT03013309|Cost-Effectiveness|cost-effectiveness
189183|NCT03013309|Primary Care|primary care
189184|NCT03013296|GIP|gip
189185|NCT03013296|GIP receptor antagonist|gip receptor antagonist
189186|NCT03013270|Rehabilitation|rehabilitation
189187|NCT03013270|Exercise|exercise
189188|NCT03013270|Training|training
189189|NCT03013257|Relapsed Graves' disease|relapsed graves' disease
189190|NCT03013257|High Intensity Focused Ultrasound|high intensity focused ultrasound
189191|NCT03013257|RAI|rai
189192|NCT03013244|prevention|prevention
189193|NCT03013244|eating disorder|eating disorder
189194|NCT03013244|men|men
189195|NCT03013244|intervention|intervention
189196|NCT03013244|muscle dysmorphia|muscle dysmorphia
189197|NCT03013244|peer-led|peer-led
189198|NCT03013231|ACL Reconstruction|acl reconstruction
189199|NCT03013231|Return to Sport|return to sport
189200|NCT03013231|Resilience|resilience
189201|NCT03013218|Neoplasms|neoplasms
189202|NCT03013218|CD47|cd47
189203|NCT03013218|SIRPα|sirpα
189204|NCT03013218|ALX148|alx148
189205|NCT03013205|adhesive capsulitis|adhesive capsulitis
189206|NCT03013153|Rectal Cancer|rectal cancer
189207|NCT03013153|Inferior Mesenteric Artery|inferior mesenteric artery
189208|NCT03013153|Ligation|ligation
189209|NCT03013153|Apical Lymph Nodes|apical lymph nodes
189210|NCT03013153|Laparoscopy|laparoscopy
189211|NCT03013153|IMA Types|ima types
189212|NCT03013140|Anesthesia, Obstetric|anesthesia, obstetric
189213|NCT03013140|fluid therapy|fluid therapy
189214|NCT03013140|cesarean section|cesarean section
189215|NCT03013140|spinal anesthesia|spinal anesthesia
189216|NCT03013127|Osteogenic Sarcoma|osteogenic sarcoma
189217|NCT03013127|Osteosarcoma|osteosarcoma
189218|NCT03013127|Sarcoma, Osteogenic|sarcoma, osteogenic
189219|NCT03013127|Pembrolizumab|pembrolizumab
189220|NCT03013127|Immunotherapy|immunotherapy
189221|NCT03013114|Bortezomib Immune thrombocytopenia|bortezomib immune thrombocytopenia
189222|NCT03013101|anti-PD-1 monoclonal antibody|anti-pd-1 monoclonal antibody
189223|NCT03013101|advanced|advanced
189224|NCT03013101|metastatic|metastatic
189225|NCT03013101|melanoma|melanoma
189226|NCT03013088|Chronic|chronic
189227|NCT03013088|Occlusion|occlusion
189228|NCT03013088|CTO|cto
189229|NCT03013023|Behavioral and Transaction Interventions|behavioral and transaction interventions
189230|NCT03013023|Parents' Biopsychosocial Well-being|parents' biopsychosocial well-being
189231|NCT03013023|Preterm Infants|preterm infants
189232|NCT03013023|Sleep|sleep
189233|NCT03013023|Salivary cortisol|salivary cortisol
189234|NCT03013010|Randomized|randomized
189235|NCT03013010|Open Label|open label
189236|NCT03013010|Multicenter|multicenter
189237|NCT03012984|elderly|elderly
189238|NCT03012984|surgery|surgery
189239|NCT03012984|analgesia|analgesia
189240|NCT03012984|dexmedetomidine|dexmedetomidine
189241|NCT03012984|delirium|delirium
189242|NCT03012971|Elderly|elderly
189244|NCT03012971|Analgesia|analgesia
189245|NCT03012971|Dexmedetomidine|dexmedetomidine
189246|NCT03012971|Long-term outcome|long-term outcome
189247|NCT03012945|Elderly|elderly
189248|NCT03012945|Cancer surgery|cancer surgery
189249|NCT03012945|Epidural anesthesia and analgesia|epidural anesthesia and analgesia
189250|NCT03012945|Long-term survival|long-term survival
189251|NCT03012945|Quality of life|quality of life
189252|NCT03012919|active decision support system|active decision support system
189253|NCT03012919|goal directed therapy|goal directed therapy
189254|NCT03012919|Lidco|lidco
189255|NCT03012919|vascular surgery|vascular surgery
189256|NCT03012919|hemodynamic optimization|hemodynamic optimization
189257|NCT03012893|ultrasonography to identify C7 spinous process|ultrasonography to identify c7 spinous process
189258|NCT03012867|criticall illness|criticall illness
189259|NCT03012867|enteral nutrition|enteral nutrition
189260|NCT03012854|Esophageal achalasia|esophageal achalasia
189261|NCT03012854|Peroral endoscopic myotomy|peroral endoscopic myotomy
189262|NCT03012854|POEM|poem
189263|NCT03012815|gabapentin|gabapentin
189264|NCT03012815|Alcohol Withdrawal Syndrome|alcohol withdrawal syndrome
189265|NCT03012815|benzodiazepine|benzodiazepine
189266|NCT03012815|symptom-triggered|symptom-triggered
189267|NCT03012724|TMS|tms
189268|NCT03012724|Deep Transcranial Magnetic Stimulation|deep transcranial magnetic stimulation
189269|NCT03012724|MDD|mdd
189270|NCT03012724|Major Depressive Disorder|major depressive disorder
189271|NCT03012659|contraceptive counseling|contraceptive counseling
189272|NCT03012659|cluster randomized trial|cluster randomized trial
189273|NCT03012659|provider counseling training|provider counseling training
189274|NCT03012646|Treprostinil|treprostinil
189275|NCT03012646|PH|ph
189276|NCT03012646|COPD|copd
189277|NCT03012646|6 Minute Walk Test|6 minute walk test
189278|NCT03012633|hyperfibrinolysis, Lysis Timer|hyperfibrinolysis, lysis timer
189279|NCT03012607|PrEP|prep
189280|NCT03012594|Small bowel motility disorder|small bowel motility disorder
189281|NCT03012594|Slow intestinal motility|slow intestinal motility
189282|NCT03012594|Small bowel bacterial overgrowth|small bowel bacterial overgrowth
189283|NCT03012555|Sickle Cell Disease|sickle cell disease
189284|NCT03012555|Vitamin D|vitamin d
189285|NCT03012529|Rifampin|rifampin
189286|NCT03012529|Double-blind|double-blind
189287|NCT03012529|Clinical Trial|clinical trial
189288|NCT03012529|Veterans|veterans
189289|NCT03012529|Diabetes|diabetes
189290|NCT03012516|Physical Therapy Specialty|physical therapy specialty
189291|NCT03012516|Exercise Test|exercise test
189292|NCT03012516|Prescriptions|prescriptions
189293|NCT03012516|Counseling|counseling
189294|NCT03012516|Primary Health Care|primary health care
189295|NCT03012516|Exercise|exercise
189296|NCT03012490|Remote monitoring|remote monitoring
241955|NCT02686970|ICU|icu
189587|NCT03010579|Lymphoma|lymphoma
189297|NCT03012477|Triple-negative metastatic breast cancer|triple-negative metastatic breast cancer
189298|NCT03012451|Stress|stress
189299|NCT03012451|Insecurity|insecurity
189300|NCT03012451|Mental Health|mental health
189301|NCT03012438|Near infrared fluorescence|near infrared fluorescence
189302|NCT03012438|ICG|icg
189303|NCT03012438|Parathyroid gland|parathyroid gland
189304|NCT03012425|Cognitive Behavioral Therapy|cognitive behavioral therapy
189305|NCT03012425|Acupuncture|acupuncture
189306|NCT03012425|17-001|17-001
189307|NCT03012386|CD36|cd36
189308|NCT03012386|Endothelial dysfunction|endothelial dysfunction
189309|NCT03012386|African Americans|african americans
189310|NCT03012373|methadone|methadone
189311|NCT03012373|heroin|heroin
189312|NCT03012373|acupuncture|acupuncture
189313|NCT03012360|Infectiology|infectiology
189314|NCT03012360|Biology of infectious agents|biology of infectious agents
189315|NCT03012360|Hygiene|hygiene
189316|NCT03012360|Pneumology|pneumology
189317|NCT03012360|Critical Care|critical care
189318|NCT03012308|Myocardial Dysfunction|myocardial dysfunction
189319|NCT03012308|left ventricular|left ventricular
189320|NCT03012308|mitral valve doppler|mitral valve doppler
189321|NCT03012308|mitral ring doppler|mitral ring doppler
189322|NCT03012308|ultrasound signs|ultrasound signs
189323|NCT03012308|lung edema|lung edema
189324|NCT03012295|Genetic Testing|genetic testing
189325|NCT03012295|Chinese Population|chinese population
189326|NCT03012256|Cardio-Respiratory Disease Management|cardio-respiratory disease management
189327|NCT03012256|Chronic Disease Management|chronic disease management
189328|NCT03012256|Cluster-randomized Trial|cluster-randomized trial
189329|NCT03012256|Multi-component Intervention|multi-component intervention
189330|NCT03012256|DIVERT Scale|divert scale
189331|NCT03012256|Frail Elderly|frail elderly
189332|NCT03012256|Interprofessional Care|interprofessional care
189333|NCT03012256|Pragmatic Trial|pragmatic trial
189334|NCT03012256|Targeted Intervention|targeted intervention
189335|NCT03012256|Home Care|home care
189336|NCT03012204|Cerebrovascular Disease|cerebrovascular disease
189337|NCT03012204|Repetitive Transcranial Magnetic Stimulation|repetitive transcranial magnetic stimulation
189338|NCT03012178|Mitral Regurgitation|mitral regurgitation
189339|NCT03012178|Mitral valve Surgery|mitral valve surgery
189340|NCT03012178|MRI|mri
189341|NCT03012165|ADX-102|adx-102
189342|NCT03012165|Allergic Conjunctivitis|allergic conjunctivitis
189343|NCT03012152|Oncoplastic surgery|oncoplastic surgery
189344|NCT03012152|Standard conservative surgery|standard conservative surgery
189345|NCT03012152|Patient satisfaction|patient satisfaction
189346|NCT03012152|Margin Status|margin status
189347|NCT03012113|Adipose tissue|adipose tissue
189348|NCT03012113|Type 2 Diabetes|type 2 diabetes
189349|NCT03012074|diabetes, mHealth, mobile health technology|diabetes, mhealth, mobile health technology
189350|NCT03012061|Respiratory|respiratory
189351|NCT03012061|Efficacy|efficacy
189352|NCT03012061|Umeclidinium bromide|umeclidinium bromide
189353|NCT03012061|Parallel|parallel
189354|NCT03012061|Asthma|asthma
189355|NCT03012061|Dry powder inhaler|dry powder inhaler
189356|NCT03012048|water treatment|water treatment
189357|NCT03012035|psychotherapy|psychotherapy
189358|NCT03012035|exposition|exposition
189359|NCT03012035|spider fear|spider fear
189360|NCT03012035|expectation|expectation
189361|NCT03012022|Healthy Volunteers|healthy volunteers
189362|NCT03012022|Congestive Heart Failure|congestive heart failure
189363|NCT03012022|Cardiomyopathies|cardiomyopathies
189364|NCT03012022|Heart Failure|heart failure
189365|NCT03012022|Risk Factors|risk factors
189366|NCT03012009|Bowen's Disease|bowen's disease
189367|NCT03012009|Superficial Basal Cel Carcinoma|superficial basal cel carcinoma
189368|NCT03012009|Non melanoma skin cancer|non melanoma skin cancer
189369|NCT03012009|Photodynamic therapy|photodynamic therapy
189370|NCT03012009|PDT|pdt
189371|NCT03012009|CO2 laser|co2 laser
189372|NCT03012009|Laser assisted drug delivery|laser assisted drug delivery
189373|NCT03012009|Carbon dioxide laser|carbon dioxide laser
189374|NCT03012009|Laser assisted photodynamic therapy|laser assisted photodynamic therapy
189375|NCT03011983|Magnetoencephalography (MEG)|magnetoencephalography (meg)
189376|NCT03011983|Magnetic resonance imaging (MRI)|magnetic resonance imaging (mri)
189377|NCT03011892|Atopic dermatitis|atopic dermatitis
189378|NCT03011892|eczema|eczema
189379|NCT03011892|pruritus|pruritus
189380|NCT03011892|Janus kinase (JAK) inhibitors|janus kinase (jak) inhibitors
189381|NCT03011840|Patient education handout|patient education handout
189382|NCT03011840|Patient satisfaction|patient satisfaction
189383|NCT03011775|Pioglitazone, Insulin Resistance|pioglitazone, insulin resistance
189384|NCT03011775|Atherosclerosis, Coronary Heart Disease|atherosclerosis, coronary heart disease
189385|NCT03011749|Radium-223 therapy|radium-223 therapy
189386|NCT03011710|e-cigarette|e-cigarette
189387|NCT03011710|blood flow|blood flow
189388|NCT03011710|oral effects|oral effects
189389|NCT03011710|oral pH|oral ph
189390|NCT03011684|Fertility Preservation|fertility preservation
189391|NCT03011684|Breast Cancer|breast cancer
189392|NCT03011671|Malignant Glioma of Brain|malignant glioma of brain
189686|NCT03009864|RCT|rct
189393|NCT03011671|Acetazolamide|acetazolamide
189394|NCT03011671|Temozolomide|temozolomide
189395|NCT03011619|Depression|depression
189396|NCT03011619|Cognitive Behavioral Therapy (CBT)|cognitive behavioral therapy (cbt)
189397|NCT03011606|prostate|prostate
189398|NCT03011606|ablation|ablation
189399|NCT03011606|focal|focal
189400|NCT03011606|cancer|cancer
189401|NCT03011580|Vitamin D|vitamin d
189402|NCT03011567|Postpartum|postpartum
189403|NCT03011541|Stem Cells|stem cells
189404|NCT03011541|Bone Marrow Derived Stem Cells|bone marrow derived stem cells
189405|NCT03011541|BMSC|bmsc
189406|NCT03011541|Mesenchymal Stem Cells|mesenchymal stem cells
189407|NCT03011541|MSC|msc
189408|NCT03011541|Eye Disease|eye disease
189409|NCT03011541|Ophthalmology|ophthalmology
189410|NCT03011541|Ophthalmic Disease|ophthalmic disease
189411|NCT03011541|Retina|retina
189412|NCT03011541|Retinal Disease|retinal disease
189413|NCT03011541|Macular Degeneration|macular degeneration
189414|NCT03011541|Age Related Macular Degeneration|age related macular degeneration
189415|NCT03011541|Myopic Macular Degeneration|myopic macular degeneration
189416|NCT03011541|Geographic Atrophy|geographic atrophy
189417|NCT03011541|Dry Macular Degeneration|dry macular degeneration
189418|NCT03011541|Wet Macular Degeneration|wet macular degeneration
189419|NCT03011541|Retinal Atrophy|retinal atrophy
189420|NCT03011541|Retinal Dystrophy|retinal dystrophy
189421|NCT03011541|Hereditary Retinal Dystrophy|hereditary retinal dystrophy
189422|NCT03011541|Malattia Leventinese|malattia leventinese
189423|NCT03011541|Retinitis Pigmentosa|retinitis pigmentosa
189424|NCT03011541|Stargardt Disease|stargardt disease
189425|NCT03011541|Cone Dystrophy|cone dystrophy
189426|NCT03011541|Rod-Cone Dystrophy|rod-cone dystrophy
189427|NCT03011541|Cone-Rod Dystrophy|cone-rod dystrophy
189428|NCT03011541|Maculopathy|maculopathy
189429|NCT03011541|Optic Nerve Disease|optic nerve disease
189430|NCT03011541|Optic Atrophy|optic atrophy
189431|NCT03011541|Optic Neuropathy|optic neuropathy
189432|NCT03011541|Ischemic Optic Neuropathy|ischemic optic neuropathy
189433|NCT03011541|Optic Nerve Damage|optic nerve damage
189434|NCT03011541|Optic Nerve Compression|optic nerve compression
189435|NCT03011541|Compressive Optic Neuropathy|compressive optic neuropathy
189436|NCT03011541|Devics Syndrome|devics syndrome
189437|NCT03011541|Ushers Syndrome|ushers syndrome
189438|NCT03011541|Neuromyelitis Optica|neuromyelitis optica
189439|NCT03011541|Dominant Optic Atrophy|dominant optic atrophy
189440|NCT03011541|Kjers Optic Atrophy|kjers optic atrophy
189441|NCT03011541|Leber Hereditary Optic Neuropathy|leber hereditary optic neuropathy
189442|NCT03011541|Blindness|blindness
189443|NCT03011541|Vision Loss|vision loss
189444|NCT03011541|Retina Atrophy|retina atrophy
189445|NCT03011437|linked color imaging|linked color imaging
189446|NCT03011437|Helicobacter Pylori|helicobacter pylori
189447|NCT03011424|Liver resection|liver resection
189448|NCT03011424|post hepatectomy liver failure|post hepatectomy liver failure
189449|NCT03011424|liver dialysis|liver dialysis
189450|NCT03011424|encephalopathy|encephalopathy
189451|NCT03011424|mortality|mortality
189452|NCT03011411|methods, qualitative research|methods, qualitative research
189453|NCT03011372|Myeloid neoplasm|myeloid neoplasm
189454|NCT03011372|fibroblast growth factor receptor inhibitor|fibroblast growth factor receptor inhibitor
189455|NCT03011372|FGFR1 rearrangement|fgfr1 rearrangement
189456|NCT03011372|8p11|8p11
189457|NCT03011372|eosinophilia|eosinophilia
189458|NCT03011372|eosinophilic syndrome|eosinophilic syndrome
189459|NCT03011372|Lymphoid neoplasm|lymphoid neoplasm
189460|NCT03011359|Colon resection|colon resection
189461|NCT03011359|Patient Controlled Analgesia|patient controlled analgesia
189462|NCT03011359|Optimizing Basal Infusion Mode|optimizing basal infusion mode
189463|NCT03011346|Aortic valve stenosis|aortic valve stenosis
189464|NCT03011346|Transcatheter aortic valve implantation|transcatheter aortic valve implantation
189465|NCT03011346|Transcatheter aortic valve replacement|transcatheter aortic valve replacement
189466|NCT03011346|Randomized controlled trial|randomized controlled trial
189467|NCT03011320|ovarian cancer|ovarian cancer
189468|NCT03011320|specimen collection|specimen collection
189469|NCT03011268|Tumor Necrosis Factor-alpha/antagonists & inhibitors|tumor necrosis factor-alpha/antagonists & inhibitors
189470|NCT03011268|Infliximab|infliximab
189471|NCT03011268|Adalimumab|adalimumab
189472|NCT03011268|Golimumab|golimumab
189473|NCT03011268|Recurrence|recurrence
189474|NCT03011255|Esophageal cancer|esophageal cancer
189475|NCT03011255|Peptide specific CTL|peptide specific ctl
189476|NCT03011255|Radiation|radiation
189477|NCT03011242|Psoriatic Arthritis|psoriatic arthritis
189478|NCT03011242|US|us
189479|NCT03011242|DC-STAMP|dc-stamp
189480|NCT03011242|Osteoclast Precursor (OCPs)|osteoclast precursor (ocps)
189481|NCT03011203|glycogen storage disease type IIIa|glycogen storage disease type iiia
189482|NCT03011203|exercise|exercise
189483|NCT03011203|ketone esters|ketone esters
189484|NCT03011203|magnetic resonance spectroscopy|magnetic resonance spectroscopy
189485|NCT03011190|Terapia Iconica|terapia iconica
189486|NCT03011190|BPD|bpd
189487|NCT03011190|adolescence|adolescence
189488|NCT03011190|suicide|suicide
189489|NCT03011164|Running|running
189490|NCT03011164|Gait velocity|gait velocity
189491|NCT03011164|Kinematics|kinematics
189492|NCT03011151|pediatric|pediatric
189493|NCT03011151|critical illness|critical illness
189494|NCT03011151|surgery|surgery
189495|NCT03011151|gastrointestinal dysfunction|gastrointestinal dysfunction
189496|NCT03011151|gastric emptying|gastric emptying
189497|NCT03011151|epithelial barrier|epithelial barrier
189498|NCT03011151|nutrition|nutrition
189499|NCT03011138|knee|knee
189500|NCT03011138|gait velocity|gait velocity
189501|NCT03011138|kinematic parameters|kinematic parameters
189502|NCT03011112|Osteoarthritis, Knee|osteoarthritis, knee
189503|NCT03011112|WOMAC|womac
189504|NCT03011112|gait|gait
189505|NCT03011112|kinematics|kinematics
189506|NCT03011086|Autoantibodies, Oral Submucous Fibrosis|autoantibodies, oral submucous fibrosis
189507|NCT03011060|neo-adjuvant chemotherapy|neo-adjuvant chemotherapy
189508|NCT03011060|pathological complete response|pathological complete response
189509|NCT03011060|Neoadjuvant Therapy|neoadjuvant therapy
189510|NCT03011060|Capecitabine|capecitabine
189511|NCT03011060|Chemotherapy, Adjuvant|chemotherapy, adjuvant
189512|NCT03011047|endoscopic, trans-antral, subciliary|endoscopic, trans-antral, subciliary
189513|NCT03011021|Autoimmune Diabetes|autoimmune diabetes
189514|NCT03011021|Umbilical Cord Blood Regulatory T Lymphocyte|umbilical cord blood regulatory t lymphocyte
189515|NCT03011021|Liraglutide|liraglutide
189516|NCT03010995|electronic cigarette|electronic cigarette
189517|NCT03010995|endothelial function|endothelial function
189518|NCT03010969|Endothelial dysfunction|endothelial dysfunction
189519|NCT03010969|Surgery|surgery
189520|NCT03010969|Pulmonary function|pulmonary function
189521|NCT03010969|Blood glucose level|blood glucose level
189522|NCT03010969|Patient-related outcomes|patient-related outcomes
189523|NCT03010956|Arterial stiffness|arterial stiffness
189524|NCT03010956|Endothelial glycocalyx|endothelial glycocalyx
189525|NCT03010956|Coronary flow reserve|coronary flow reserve
189526|NCT03010943|virtual reality|virtual reality
189527|NCT03010943|glioma surgery|glioma surgery
189528|NCT03010943|awake craniotomy|awake craniotomy
189529|NCT03010943|brain tumor|brain tumor
189530|NCT03010943|glioma|glioma
189531|NCT03010943|neurosurgery|neurosurgery
189532|NCT03010917|Alcohol Dependence|alcohol dependence
189533|NCT03010917|Fish Oil|fish oil
189534|NCT03010891|Preterm infant|preterm infant
189535|NCT03010891|Stress|stress
189536|NCT03010891|Salivary DHEA|salivary dhea
189537|NCT03010891|Salivary cortisol|salivary cortisol
189538|NCT03010891|Actigraphy|actigraphy
189539|NCT03010878|yoga|yoga
189540|NCT03010878|chronic pain|chronic pain
189541|NCT03010878|occupational therapy|occupational therapy
189542|NCT03010878|self-management|self-management
189543|NCT03010865|HDAC inhibitors|hdac inhibitors
189544|NCT03010865|Inflammation|inflammation
189545|NCT03010852|Bariatric Surgery|bariatric surgery
189546|NCT03010852|Spirometry Monitoring|spirometry monitoring
189547|NCT03010761|addiction|addiction
189548|NCT03010761|betel-quid|betel-quid
189549|NCT03010761|drug therapy|drug therapy
189550|NCT03010761|clinical trial|clinical trial
189551|NCT03010748|corneal morphology|corneal morphology
189552|NCT03010748|Chinese population|chinese population
189553|NCT03010748|corneal curvature|corneal curvature
189554|NCT03010748|corneal thickness|corneal thickness
189555|NCT03010748|higher order aberrations|higher order aberrations
189556|NCT03010735|Kidney Failure, Chronic|kidney failure, chronic
189557|NCT03010735|Probiotics|probiotics
189558|NCT03010735|Uremic toxins|uremic toxins
189559|NCT03010735|Gastrointestinal Microbiome|gastrointestinal microbiome
189560|NCT03010709|Aneurysmal Subarachnoid Haemorrhage|aneurysmal subarachnoid haemorrhage
189561|NCT03010709|Delayed Ischaemic Neurological Deficit|delayed ischaemic neurological deficit
189562|NCT03010709|Induced Hypertension|induced hypertension
189563|NCT03010709|Partial Brain Tissue Oxygen Tension|partial brain tissue oxygen tension
189564|NCT03010709|Cerebral Microdialysis|cerebral microdialysis
189565|NCT03010696|Kidney Failure, Chronic|kidney failure, chronic
189566|NCT03010696|Uremic toxins|uremic toxins
189567|NCT03010696|Gastrointestinal Microbiome|gastrointestinal microbiome
189568|NCT03010696|Metabolomics|metabolomics
189569|NCT03010683|Arterial stiffness|arterial stiffness
189570|NCT03010683|Endothelial glycocalyx|endothelial glycocalyx
189571|NCT03010683|Coronary flow reserve|coronary flow reserve
189572|NCT03010670|Oxytocin|oxytocin
189573|NCT03010670|Gaze processing|gaze processing
189574|NCT03010670|Interpersonal motor resonance|interpersonal motor resonance
189575|NCT03010618|hall technique|hall technique
189576|NCT03010618|stainless steel crowns|stainless steel crowns
189577|NCT03010618|temporomandibular joint|temporomandibular joint
189578|NCT03010618|dental caries|dental caries
189579|NCT03010618|occlusion|occlusion
400617|NCT01866007|Healthy|healthy
189580|NCT03010605|physical therapy post total knee replacement|physical therapy post total knee replacement
189581|NCT03010605|range of motion|range of motion
189582|NCT03010605|goniometry|goniometry
189583|NCT03010592|Lung volume reduction treatment|lung volume reduction treatment
189584|NCT03010592|Endobronchial cryotherapy|endobronchial cryotherapy
189585|NCT03010592|Microvesicles|microvesicles
189586|NCT03010579|Anemia|anemia
189588|NCT03010579|Hematopoietic stem cell transplantation|hematopoietic stem cell transplantation
189589|NCT03010579|Erythropoietin|erythropoietin
189590|NCT03010566|Lung volume reduction coil|lung volume reduction coil
189591|NCT03010566|Lung Microbiome|lung microbiome
189592|NCT03010527|Chronic plaque psoriasis|chronic plaque psoriasis
189593|NCT03010527|Psoriasis|psoriasis
189594|NCT03010527|Bimekizumab|bimekizumab
189595|NCT03010488|Chronotherapy|chronotherapy
189596|NCT03010488|Light Therapy|light therapy
189597|NCT03010462|Stroke|stroke
189598|NCT03010462|rTMS|rtms
189599|NCT03010462|Motor rehabilitation|motor rehabilitation
189600|NCT03010449|Lung volume reduction treatment|lung volume reduction treatment
189601|NCT03010449|Autologous blood instillation|autologous blood instillation
189602|NCT03010449|Intra-bronchial valve (IBV)|intra-bronchial valve (ibv)
189603|NCT03010449|Endobronchial valve|endobronchial valve
189604|NCT03010423|Non-obstructive coronary artery disease|non-obstructive coronary artery disease
189605|NCT03010423|Nicorandil|nicorandil
189606|NCT03010371|positive psychotherapy, online, breast cancer, survivors|positive psychotherapy, online, breast cancer, survivors
189607|NCT03010332|Cytomegalovirus|cytomegalovirus
189608|NCT03010332|Cytomegalovirus Viremia|cytomegalovirus viremia
189609|NCT03010332|Cytomegalovirus Infection|cytomegalovirus infection
189610|NCT03010332|CMV Infection|cmv infection
189611|NCT03010332|Hematopoietic Cell Transplant|hematopoietic cell transplant
189612|NCT03010332|Solid Organ Transplant|solid organ transplant
189613|NCT03010332|Human Immunodeficiency Virus|human immunodeficiency virus
189614|NCT03010332|Cytomegalovirus Disease|cytomegalovirus disease
189615|NCT03010332|Hematopoietic Stem Cell Transplant|hematopoietic stem cell transplant
189616|NCT03010332|CMV|cmv
189617|NCT03010332|CMV syndrome|cmv syndrome
189618|NCT03010332|Cytomegalovirus syndrome|cytomegalovirus syndrome
189619|NCT03010332|CMV disease|cmv disease
189620|NCT03010332|CMV viremia|cmv viremia
189621|NCT03010332|allogeneic|allogeneic
189622|NCT03010332|third-party|third-party
189623|NCT03010293|Antimicrobial therapy|antimicrobial therapy
189624|NCT03010293|Debridement|debridement
189625|NCT03010293|Osteomyelitis|osteomyelitis
189626|NCT03010293|Muscular flap|muscular flap
189627|NCT03010293|Pressure ulcer|pressure ulcer
189628|NCT03010293|Treatment failure|treatment failure
189629|NCT03010293|Vacuum-assisted closure therapy|vacuum-assisted closure therapy
189630|NCT03010267|DP-R213|dp-r213
189631|NCT03010241|Diabetes Distal Symmetric Polyneuropathy|diabetes distal symmetric polyneuropathy
189632|NCT03010241|Chinese medicine|chinese medicine
189633|NCT03010228|VLA15|vla15
189634|NCT03010228|Lyme Borreliosis|lyme borreliosis
189635|NCT03010228|Multivalent Recombinant OspA Vaccine|multivalent recombinant ospa vaccine
189636|NCT03010215|Minimally Invasive Surgery|minimally invasive surgery
189637|NCT03010215|Percutaneous distal osteotomy|percutaneous distal osteotomy
189638|NCT03010215|Distal Metatarsal Minimally-invasive Osteotomy (DMMO)|distal metatarsal minimally-invasive osteotomy (dmmo)
189639|NCT03010215|Percutaneous Tenotomy|percutaneous tenotomy
189640|NCT03010215|Forefoot|forefoot
189641|NCT03010215|Metatarsal bones|metatarsal bones
189642|NCT03010202|immune thrombocytopenia|immune thrombocytopenia
189643|NCT03010202|rituximab|rituximab
189644|NCT03010202|thrombocytopenia|thrombocytopenia
189645|NCT03010189|Cluster headache|cluster headache
189646|NCT03010189|Actigraphy|actigraphy
189647|NCT03010189|Pupillometry|pupillometry
189648|NCT03010163|pedometer|pedometer
189649|NCT03010163|walking|walking
189650|NCT03010163|taxi driver|taxi driver
189651|NCT03010163|16-1659|16-1659
189652|NCT03010111|Latent Tuberculosis|latent tuberculosis
189653|NCT03010111|Interferons|interferons
189654|NCT03010111|Tuberculosis|tuberculosis
189655|NCT03010111|Healthcare|healthcare
189656|NCT03010098|POCD|pocd
189657|NCT03010098|narcotrend|narcotrend
189658|NCT03010098|closed-loop of target controlled infusion|closed-loop of target controlled infusion
189659|NCT03010033|pulmonary rehabilitation|pulmonary rehabilitation
189660|NCT03010033|lobectomy|lobectomy
189661|NCT03010033|smoker|smoker
189662|NCT03010020|HIV Prevention|hiv prevention
189663|NCT03010020|MSM|msm
189664|NCT03010020|Rectal Gonorrhea|rectal gonorrhea
189665|NCT03010020|Rectal Chlamydia|rectal chlamydia
189666|NCT03010020|Personalized Cognitive Counseling|personalized cognitive counseling
189667|NCT03010007|Influenza|influenza
189668|NCT03010007|High-Throughput Nucleotide Sequencing|high-throughput nucleotide sequencing
189669|NCT03010007|Viral Transmission|viral transmission
189670|NCT03009981|PSA|psa
189671|NCT03009981|Degarelix|degarelix
189672|NCT03009981|Apalutamide|apalutamide
189673|NCT03009981|Abiraterone Acetate|abiraterone acetate
189674|NCT03009981|Radical Prostatectomy|radical prostatectomy
189675|NCT03009981|Bicalutamide|bicalutamide
189676|NCT03009981|Leuprolide|leuprolide
189677|NCT03009981|Lupron|lupron
189678|NCT03009942|nitric oxide|nitric oxide
189679|NCT03009942|arginase|arginase
189680|NCT03009942|loading|loading
189681|NCT03009890|elderly|elderly
189682|NCT03009890|intra articular|intra articular
189683|NCT03009890|RCT|rct
189684|NCT03009864|Diabetic Kidney Disease|diabetic kidney disease
189685|NCT03009864|TCM|tcm
189687|NCT03009825|Trauma exposure|trauma exposure
189688|NCT03009825|Psychological distress|psychological distress
189689|NCT03009825|Emotion regulation|emotion regulation
189690|NCT03009825|Mindfulness|mindfulness
189691|NCT03009825|Eating pathology|eating pathology
189692|NCT03009799|adenoviral conjunctivis|adenoviral conjunctivis
189693|NCT03009799|iota-carrageenan|iota-carrageenan
189694|NCT03009773|subacute stroke|subacute stroke
189695|NCT03009773|multitasking rehabilitation|multitasking rehabilitation
189696|NCT03009773|walking|walking
189697|NCT03009747|rectal cancer|rectal cancer
189698|NCT03009747|anterior resection syndrome|anterior resection syndrome
189699|NCT03009747|sphincter-preserving surgery|sphincter-preserving surgery
189700|NCT03009708|Allograft|allograft
189701|NCT03009708|Cytomegalovirus|cytomegalovirus
189702|NCT03009708|Platelets|platelets
189703|NCT03009708|Hematopoietic stem cells|hematopoietic stem cells
189704|NCT03009708|Graft Versus Host Disease (GVH)|graft versus host disease (gvh)
189705|NCT03009708|Hemostasis|hemostasis
189706|NCT03009708|Adaptive immunity|adaptive immunity
189707|NCT03009708|Innate immunity|innate immunity
189708|NCT03009708|Post graft follow up|post graft follow up
189709|NCT03009695|Transcranial Magnetic Stimulation|transcranial magnetic stimulation
189710|NCT03009695|Obesity|obesity
189711|NCT03009695|Food Craving|food craving
189712|NCT03009695|Appetite/Satiety Hormones|appetite/satiety hormones
189713|NCT03009695|fMRI|fmri
189714|NCT03009695|Intestinal microbiota|intestinal microbiota
189715|NCT03009695|Physical activity|physical activity
189716|NCT03009669|pleth variability index|pleth variability index
189717|NCT03009669|stroke volume variation|stroke volume variation
189718|NCT03009669|perfusion Index|perfusion index
189719|NCT03009669|intraoperative|intraoperative
189720|NCT03009669|intestinal tumor|intestinal tumor
189721|NCT03009656|Stroke|stroke
189722|NCT03009656|Emergency|emergency
189723|NCT03009656|Focal Neurological Deficits|focal neurological deficits
189724|NCT03009656|Diagnostic|diagnostic
189725|NCT03009643|Nitric Oxide|nitric oxide
189726|NCT03009643|hypoxemia|hypoxemia
189727|NCT03009643|aortic surgery|aortic surgery
189728|NCT03009630|Electromagnetic navigation bronchoscopy(ENB)|electromagnetic navigation bronchoscopy(enb)
189729|NCT03009630|Radiofrequency ablation(RFA)|radiofrequency ablation(rfa)
189730|NCT03009630|Peripheral lung cancer|peripheral lung cancer
189731|NCT03009617|adolescents|adolescents
189732|NCT03009617|web-based health education|web-based health education
189733|NCT03009617|eHealth literacy|ehealth literacy
189734|NCT03009591|Hemophilia|hemophilia
189735|NCT03009591|Elbow|elbow
189736|NCT03009591|Arthropathy|arthropathy
189737|NCT03009591|Joint pain|joint pain
189738|NCT03009591|Range of motion|range of motion
189739|NCT03009591|Myofascial techniques|myofascial techniques
189740|NCT03009591|Safety patients|safety patients
189741|NCT03009591|Quality of life|quality of life
189742|NCT03009591|Functionality|functionality
189743|NCT03009565|coronary artery disease|coronary artery disease
189744|NCT03009565|human gut microbiota|human gut microbiota
189745|NCT03009565|microbiome|microbiome
189746|NCT03009552|speckle tracking echocardiography|speckle tracking echocardiography
189747|NCT03009552|strain|strain
189748|NCT03009552|strain rate|strain rate
189749|NCT03009552|torsion|torsion
189750|NCT03009539|Prevention with Hispanic youth|prevention with hispanic youth
189751|NCT03009539|eHealth preventive intervention in primary care|ehealth preventive intervention in primary care
189752|NCT03009539|Hispanic adolescent|hispanic adolescent
189753|NCT03009539|Familias Unidas|familias unidas
189754|NCT03009539|eHealth Familias Unidas|ehealth familias unidas
189755|NCT03009539|effectiveness trial|effectiveness trial
189756|NCT03009539|sexually transmitted disease|sexually transmitted disease
189757|NCT03009539|parent-centered|parent-centered
189758|NCT03009539|Hispanic|hispanic
189759|NCT03009539|sexual risk behavior|sexual risk behavior
189760|NCT03009526|Malaria|malaria
189761|NCT03009526|Pregnancy|pregnancy
189762|NCT03009526|Malawi|malawi
189763|NCT03009526|Intermittent preventive treatment|intermittent preventive treatment
189764|NCT03009526|dihydroartemisinin-piperaquine|dihydroartemisinin-piperaquine
189765|NCT03009526|sulfadoxine-pyrimethamine|sulfadoxine-pyrimethamine
189766|NCT03009461|Hepatocellular carcinoma|hepatocellular carcinoma
189767|NCT03009461|Portal vein tumor thrombosis|portal vein tumor thrombosis
189768|NCT03009461|Hepatic arterial infusion chemotherapy|hepatic arterial infusion chemotherapy
189769|NCT03009461|Sorafenib|sorafenib
189770|NCT03009396|Crohn's Disease,|crohn's disease,
189771|NCT03009396|moderate to severe|moderate to severe
189772|NCT03009396|remission|remission
400618|NCT01866007|Guselkumab|guselkumab
189773|NCT03009396|Mycobacterium avium paratuberculosis|mycobacterium avium paratuberculosis
189774|NCT03009396|antibiotic|antibiotic
189775|NCT03009370|Ovarian reserve, pregnancy loss|ovarian reserve, pregnancy loss
189776|NCT03009357|wearable activity tracker|wearable activity tracker
189777|NCT03009357|thyrotoxicosis|thyrotoxicosis
189778|NCT03009344|relapsed or refractory B-cell non-Hodgkin's lymphoma|relapsed or refractory b-cell non-hodgkin's lymphoma
189779|NCT03009344|tazemetostat|tazemetostat
189780|NCT03009344|Japan|japan
189781|NCT03009331|Postoperative pulmonary dysfunction|postoperative pulmonary dysfunction
189782|NCT03009331|Postoperative pulmonary complication|postoperative pulmonary complication
189783|NCT03009331|Recruitment manouver|recruitment manouver
189784|NCT03009331|Prone position|prone position
189785|NCT03009318|Glioma|glioma
189786|NCT03009318|Magnetic resonance spectroscopy|magnetic resonance spectroscopy
189787|NCT03009318|Methionine|methionine
189788|NCT03009318|PET/CT|pet/ct
189789|NCT03009292|solid tumor|solid tumor
189790|NCT03009292|Lenvatinib|lenvatinib
189791|NCT03009292|pharmacokinetics|pharmacokinetics
189792|NCT03009279|blood pressure|blood pressure
189793|NCT03009279|fasting plasma glucose|fasting plasma glucose
189794|NCT03009279|thyroid stimulating hormone|thyroid stimulating hormone
189795|NCT03009253|Neoadjuvant therapy|neoadjuvant therapy
189796|NCT03009253|Pancreatic Cancer|pancreatic cancer
189797|NCT03009227|colon cancer|colon cancer
189798|NCT03009227|lymph node dissection|lymph node dissection
189799|NCT03009227|D3 lymph node dissection|d3 lymph node dissection
189800|NCT03009214|solid epithelial cancer|solid epithelial cancer
189801|NCT03009214|CD44v6|cd44v6
189802|NCT03009214|c-Met|c-met
189803|NCT03009214|VEGFR-2|vegfr-2
189804|NCT03009214|RON|ron
189805|NCT03009214|receptor tyrosine kinase|receptor tyrosine kinase
189806|NCT03009188|Axenfeld-Rieger syndrom, genetic findings|axenfeld-rieger syndrom, genetic findings
189807|NCT03009136|Perennial Allergic Rhinitis|perennial allergic rhinitis
189808|NCT03009136|Herbal Medicine|herbal medicine
189809|NCT03009136|Korean Medicine|korean medicine
189810|NCT03009136|So-Cheong-Ryong-Tang|so-cheong-ryong-tang
189811|NCT03009123|cohort study|cohort study
189812|NCT03009123|prostate cancer|prostate cancer
189813|NCT03009123|population-based study|population-based study
189814|NCT03009123|benign prostatic hypertrophy|benign prostatic hypertrophy
189815|NCT03009097|Chronic periodontitis|chronic periodontitis
189816|NCT03009097|atorvastatin|atorvastatin
189817|NCT03009097|intrabony defect|intrabony defect
189818|NCT03009071|Neck Pain|neck pain
189819|NCT03009071|Disability Evaluation|disability evaluation
189820|NCT03009071|Costs and Cost Analysis|costs and cost analysis
189821|NCT03009071|Doin Exercise Therapy|doin exercise therapy
189822|NCT03009071|Acupuncture|acupuncture
189823|NCT03009058|Unresectable cancer|unresectable cancer
189824|NCT03009058|pancreatic|pancreatic
189825|NCT03009058|melanoma|melanoma
189826|NCT03009058|breast|breast
189827|NCT03009058|lung|lung
189828|NCT03009058|colorectal|colorectal
189829|NCT03009058|cholangio|cholangio
189830|NCT03009058|sarcoma|sarcoma
189831|NCT03009045|bone and joint infection|bone and joint infection
189832|NCT03009045|osteomyelitis|osteomyelitis
189833|NCT03009045|tedizolid|tedizolid
189834|NCT03009032|HIV|hiv
189835|NCT03009032|immunologic recovery|immunologic recovery
189836|NCT03009032|microbiota|microbiota
189837|NCT03009032|prebiotics|prebiotics
189838|NCT03009032|probiotics|probiotics
189839|NCT03009032|synbiotics|synbiotics
189840|NCT03009006|Calcium hydroxide intracanal medication|calcium hydroxide intracanal medication
189841|NCT03009006|Ca(OH)2 intracanal medication|ca(oh)2 intracanal medication
189842|NCT03009006|Chlorhexidene gel|chlorhexidene gel
189843|NCT03009006|CHX gel|chx gel
189844|NCT03009006|Root canal treatment|root canal treatment
189845|NCT03008967|Total Knee Arthroplasty|total knee arthroplasty
189846|NCT03008967|Total Hip Arthroplasty|total hip arthroplasty
189847|NCT03008967|Rehabilitation|rehabilitation
189848|NCT03008954|weight loss|weight loss
189849|NCT03008954|body composition|body composition
189850|NCT03008954|glycemic control|glycemic control
189851|NCT03008954|satiety|satiety
189852|NCT03008941|HIV|hiv
189853|NCT03008941|microbiota|microbiota
189854|NCT03008941|inflammation|inflammation
189855|NCT03008941|fecal microbiota restoration|fecal microbiota restoration
189856|NCT03008915|alpha-1 antitrypsin deficiency|alpha-1 antitrypsin deficiency
189857|NCT03008915|Emphysema|emphysema
189858|NCT03008915|chronic obstructive pulmonary disease|chronic obstructive pulmonary disease
189859|NCT03008889|Repetitive Self-Injurious Behavior|repetitive self-injurious behavior
189860|NCT03008889|N-acetylcysteine (NAC)|n-acetylcysteine (nac)
189861|NCT03008876|neonate|neonate
189862|NCT03008876|acetaminophen|acetaminophen
189863|NCT03008850|Shivering|shivering
189864|NCT03008850|Intrathecal|intrathecal
189865|NCT03008850|Magnesium Sulfate|magnesium sulfate
189866|NCT03008811|Atrial Fibrillation|atrial fibrillation
189867|NCT03008811|Catheter Ablation|catheter ablation
189868|NCT03008798|Intracranial Artery|intracranial artery
189869|NCT03008798|in-stent restenosis|in-stent restenosis
189870|NCT03008798|Herbal Medicine|herbal medicine
189871|NCT03008785|isoflavone|isoflavone
189872|NCT03008785|blood pressure|blood pressure
189873|NCT03008785|climateric symptoms|climateric symptoms
189874|NCT03008785|exercise|exercise
189875|NCT03008759|Fluoride|fluoride
189876|NCT03008759|Dental caries|dental caries
189877|NCT03008759|Dentifrice|dentifrice
189878|NCT03008720|functional electrical simulation|functional electrical simulation
189879|NCT03008707|Laparoscopic peritoneal lavage|laparoscopic peritoneal lavage
189880|NCT03008707|laparoscopic sigmoidectomy|laparoscopic sigmoidectomy
189979|NCT03007940|Sustainability|sustainability
189881|NCT03008707|complicated acute diverticulitis|complicated acute diverticulitis
189882|NCT03008707|D004238|d004238
189883|NCT03008694|PET/CT|pet/ct
189884|NCT03008642|Polycythemia|polycythemia
189885|NCT03008642|CO-Rebreathing|co-rebreathing
189886|NCT03008642|red cell mass determination|red cell mass determination
189887|NCT03008642|myeloproliferative neoplasms|myeloproliferative neoplasms
189888|NCT03008603|CT-guided minimally invasive procedures|ct-guided minimally invasive procedures
189889|NCT03008603|Robot|robot
189890|NCT03008590|Pain management|pain management
189891|NCT03008590|Naltrexone|naltrexone
189892|NCT03008590|Controlled clinical trials, randomized|controlled clinical trials, randomized
189893|NCT03008512|Liver Neoplasms|liver neoplasms
189894|NCT03008512|Antineoplastic Agents|antineoplastic agents
189895|NCT03008512|Carcinoma, Hepatocellular|carcinoma, hepatocellular
189896|NCT03008512|Genexol-PM|genexol-pm
189897|NCT03008512|Neoplasms by Site|neoplasms by site
189898|NCT03008512|Sorafenib|sorafenib
189899|NCT03008512|Liver Diseases|liver diseases
189900|NCT03008512|Digestive System Neoplasms|digestive system neoplasms
189901|NCT03008499|Metastatic colorectal cancer|metastatic colorectal cancer
189902|NCT03008499|High-activity natural killer|high-activity natural killer
189903|NCT03008447|E2006|e2006
189904|NCT03008447|postural stability|postural stability
189905|NCT03008447|auditory awakening threshold|auditory awakening threshold
189906|NCT03008447|cognitive performance|cognitive performance
189907|NCT03008447|healthy participants|healthy participants
189908|NCT03008434|yoga|yoga
189909|NCT03008434|Traumatic Brain Injury|traumatic brain injury
189910|NCT03008408|Malignant neoplasms of female genital organs|malignant neoplasms of female genital organs
189911|NCT03008408|Endometrial carcinoma|endometrial carcinoma
189912|NCT03008408|Advanced or Recurrent|advanced or recurrent
189913|NCT03008408|Endometrioid and mixed endometrioid tumors|endometrioid and mixed endometrioid tumors
189914|NCT03008408|Ribociclib|ribociclib
189915|NCT03008408|LEE011|lee011
189916|NCT03008408|Everolimus|everolimus
189917|NCT03008408|Afinitor|afinitor
189918|NCT03008408|Zortress|zortress
189919|NCT03008408|RAD001|rad001
189920|NCT03008408|Letrozole|letrozole
189921|NCT03008408|Femara|femara
189922|NCT03008382|Interstitial Cystitis|interstitial cystitis
189923|NCT03008382|Pelvic Pain|pelvic pain
189924|NCT03008343|Irreversible Electroporation|irreversible electroporation
189925|NCT03008343|NK Immunotherapy|nk immunotherapy
189926|NCT03008343|Recurrent Liver Carcinoma|recurrent liver carcinoma
189927|NCT03008330|Metastatic tongue cancer|metastatic tongue cancer
189928|NCT03008330|High-activity natural killer|high-activity natural killer
189929|NCT03008304|Metastatic pancreatic cancer|metastatic pancreatic cancer
189930|NCT03008304|High-activity natural killer Immunotherapy|high-activity natural killer immunotherapy
189931|NCT03008265|Fascial dehiscence|fascial dehiscence
189932|NCT03008265|Mortality|mortality
189933|NCT03008252|Non-celiac wheat sensitivity|non-celiac wheat sensitivity
189934|NCT03008252|lactose intolerance|lactose intolerance
189935|NCT03008252|cow's milk protein allergy|cow's milk protein allergy
189937|NCT03008187|Relapsed/Refractory Acute Myeloid Leukemia|relapsed/refractory acute myeloid leukemia
189938|NCT03008174|tracheostomy|tracheostomy
189939|NCT03008174|quality of life|quality of life
189940|NCT03008174|speaking valve|speaking valve
189941|NCT03008174|speech|speech
189942|NCT03008174|mechanically ventilated patients|mechanically ventilated patients
189943|NCT03008161|GAIM|gaim
189944|NCT03008161|amyloid|amyloid
189945|NCT03008161|anti-aBeta|anti-abeta
189946|NCT03008161|anti-tau|anti-tau
189947|NCT03008122|Flavivirus|flavivirus
189948|NCT03008122|Inactivated|inactivated
189949|NCT03008122|Phase I|phase i
189950|NCT03008122|Vaccine|vaccine
189951|NCT03008122|ZIKA|zika
189952|NCT03008122|ZPIV|zpiv
189953|NCT03008109|EGFR-TKI|egfr-tki
189954|NCT03008109|Recombinant human endostatin|recombinant human endostatin
189955|NCT03008070|Non-Alcoholic Steatohepatitis|non-alcoholic steatohepatitis
189956|NCT03008070|NASH|nash
189957|NCT03008070|peroxisome proliferator-activated receptor (PPAR)|peroxisome proliferator-activated receptor (ppar)
189958|NCT03008070|Liver Diseases|liver diseases
189959|NCT03008070|Fibrosis|fibrosis
189960|NCT03008070|Fatty Liver|fatty liver
189961|NCT03008070|Non-alcoholic Fatty Liver Disease|non-alcoholic fatty liver disease
189962|NCT03008070|Digestive System Diseases|digestive system diseases
189963|NCT03008070|IVA337|iva337
189964|NCT03008057|vitamin D|vitamin d
189965|NCT03008057|YKL40|ykl40
189966|NCT03008057|PAI-1|pai-1
189967|NCT03008057|RAGE|rage
189968|NCT03008057|AGEs|ages
189969|NCT03008057|glyoxalase enzyme|glyoxalase enzyme
189970|NCT03008057|TNF-alpha|tnf-alpha
189971|NCT03008057|IL-6|il-6
189972|NCT03008057|Diabetes|diabetes
189973|NCT03007992|Breast cancer|breast cancer
189974|NCT03007992|Vinorelbine|vinorelbine
189975|NCT03007992|Metronomic chemotherapy|metronomic chemotherapy
189976|NCT03007953|Palliative Care|palliative care
189977|NCT03007953|Supportive Care|supportive care
189978|NCT03007940|Implementation Strategies|implementation strategies
189980|NCT03007940|Integrated Services|integrated services
189982|NCT03007927|hernia repair|hernia repair
189983|NCT03007927|Dexamethasone|dexamethasone
189984|NCT03007914|Pulmonary Disease, Chronic Obstructive|pulmonary disease, chronic obstructive
189985|NCT03007914|Medicine, Chinese Traditional|medicine, chinese traditional
189986|NCT03007914|Humans|humans
189987|NCT03007914|Treatment Outcome|treatment outcome
189988|NCT03007888|IPX203 (carbidopa-levodopa) Extended-Release capsules|ipx203 (carbidopa-levodopa) extended-release capsules
189989|NCT03007875|Metastatic lung cancer|metastatic lung cancer
189990|NCT03007875|High-activity natural killer|high-activity natural killer
189991|NCT03007836|Metastatic Nasopharyngeal Cancer|metastatic nasopharyngeal cancer
189992|NCT03007836|High-activity natural killer|high-activity natural killer
189993|NCT03007823|Metastatic Melanoma|metastatic melanoma
189994|NCT03007823|High-activity natural killer|high-activity natural killer
189995|NCT03007784|Consciousness|consciousness
189996|NCT03007784|Disorder of consciousness|disorder of consciousness
189997|NCT03007784|Minimally conscious state|minimally conscious state
189998|NCT03007784|Vegetative state|vegetative state
189999|NCT03007784|Exit-MCS|exit-mcs
190000|NCT03007784|Transcranial direct current stimulation (tDCS)|transcranial direct current stimulation (tdcs)
190001|NCT03007784|CRS-R|crs-r
190002|NCT03007784|EEG|eeg
190003|NCT03007784|Cognitive ERPs|cognitive erps
190004|NCT03007758|Hernia repair|hernia repair
190005|NCT03007758|Robotic hernia repair|robotic hernia repair
190006|NCT03007758|Open hernia repair|open hernia repair
190007|NCT03007758|Incisional hernia|incisional hernia
190008|NCT03007745|Continuous positive airway pressure|continuous positive airway pressure
190009|NCT03007628|magnetic seizure therapy|magnetic seizure therapy
190010|NCT03007628|electroconvulsive therapy|electroconvulsive therapy
190011|NCT03007628|controlled trial|controlled trial
190012|NCT03007602|Hematopoietic stem cell transplantation|hematopoietic stem cell transplantation
190013|NCT03007602|Aerobic exercise|aerobic exercise
190014|NCT03007602|Quality of Life|quality of life
190015|NCT03007602|Muscle Strength|muscle strength
190016|NCT03007602|Depression|depression
190017|NCT03007602|exercise capacity|exercise capacity
190018|NCT03007602|dyspnea|dyspnea
190019|NCT03007602|anxiety|anxiety
190020|NCT03007602|fatigue|fatigue
190021|NCT03007602|pulmonary functions|pulmonary functions
190022|NCT03007589|erythema|erythema
190023|NCT03007589|persistent pigment darkening|persistent pigment darkening
190024|NCT03007589|sunburn|sunburn
190025|NCT03007589|suntan|suntan
190026|NCT03007563|Diagnosis|diagnosis
190027|NCT03007563|Cell Phones|cell phones
190028|NCT03007563|Infant, Newborn|infant, newborn
190029|NCT03007550|Gastric cancer|gastric cancer
190030|NCT03007550|Laparoscopic total gastrectomy|laparoscopic total gastrectomy
190031|NCT03007550|Open total gastrectomy|open total gastrectomy
190032|NCT03007537|Erythropoietin|erythropoietin
190033|NCT03007537|Cardiac Surgery Associated-acute Kidney Injury|cardiac surgery associated-acute kidney injury
190034|NCT03007524|rosuvastatin|rosuvastatin
190035|NCT03007524|optical coherence tomography|optical coherence tomography
190036|NCT03007524|acute coronary syndrome|acute coronary syndrome
190037|NCT03007511|Percutaneous Endoscopic Gastrostomy|percutaneous endoscopic gastrostomy
190038|NCT03007511|Feeding tube|feeding tube
190039|NCT03007511|Enteral nutrition|enteral nutrition
190040|NCT03007511|Endoscopy|endoscopy
190041|NCT03007511|Gastrointestinal|gastrointestinal
190042|NCT03007472|cochlear implant, sound processor|cochlear implant, sound processor
190043|NCT03007459|Body composition|body composition
190044|NCT03007459|Bone mineral density|bone mineral density
190045|NCT03007459|Binge Eating|binge eating
190046|NCT03007459|Eating Disorder|eating disorder
190047|NCT03007459|Exercise Dependency|exercise dependency
190048|NCT03007459|Depression|depression
190049|NCT03007459|Perfectionism|perfectionism
190050|NCT03007459|Body building|body building
190051|NCT03007459|Drive for Muscularity|drive for muscularity
190052|NCT03007459|Drive for leanness|drive for leanness
190053|NCT03007446|Apatinib|apatinib
190054|NCT03007446|SOX|sox
190055|NCT03007446|Conversion Surgery|conversion surgery
190056|NCT03007446|unresectable gastric cancer|unresectable gastric cancer
190057|NCT03007433|gastric emptying|gastric emptying
190058|NCT03007433|functional dyspepsia|functional dyspepsia
190059|NCT03007433|non invasive imaging|non invasive imaging
190060|NCT03007433|MRI|mri
190061|NCT03007433|gamma scintigraphy|gamma scintigraphy
190062|NCT03007433|gastroparesis|gastroparesis
190063|NCT03007407|microsatellite stable|microsatellite stable
190064|NCT03007407|MSS|mss
190065|NCT03007407|durvalumab|durvalumab
190066|NCT03007407|tremelimumab|tremelimumab
190067|NCT03007407|mCRC|mcrc
190068|NCT03007407|NSABP|nsabp
190069|NCT03007394|Cocaine Use Disorder|cocaine use disorder
190070|NCT03007342|Amoxicillin|amoxicillin
190071|NCT03007342|clavulanic acid|clavulanic acid
190072|NCT03007342|Periapical periodontitis|periapical periodontitis
190073|NCT03007342|Post-operative pain|post-operative pain
190074|NCT03007329|SGLT2 inhibitor|sglt2 inhibitor
190075|NCT03007329|GLP1 agonist|glp1 agonist
190076|NCT03007329|type 2 Diabetes|type 2 diabetes
190077|NCT03007329|steatosis of the liver|steatosis of the liver
190078|NCT03007329|ectopic lipids|ectopic lipids
190079|NCT03007329|combined therapy|combined therapy
190080|NCT03007264|cold atmospheric plasma|cold atmospheric plasma
190081|NCT03007264|pain|pain
190082|NCT03007264|bacteria|bacteria
190083|NCT03007264|skin parameters|skin parameters
190084|NCT03007186|Blood glucose monitoring|blood glucose monitoring
190085|NCT03007186|Glucose tolerance|glucose tolerance
190086|NCT03007186|HbA1C|hba1c
190087|NCT03007186|Insulin|insulin
190088|NCT03007186|Betamethasone|betamethasone
190089|NCT03007173|umbilical pilonidal sinus|umbilical pilonidal sinus
190090|NCT03007082|endovascular treatment|endovascular treatment
190091|NCT03007082|mechanical thrombectomy|mechanical thrombectomy
190092|NCT03007082|stent retriever|stent retriever
190093|NCT03007082|human|human
190094|NCT03007056|high flow nasal cannula|high flow nasal cannula
190095|NCT03007056|nasal continuous positive airway pressure|nasal continuous positive airway pressure
190096|NCT03007056|noninvasive ventilatory support|noninvasive ventilatory support
190097|NCT03007056|newborn developmental care|newborn developmental care
190098|NCT03007056|bronchopulmonary dysplasia|bronchopulmonary dysplasia
190099|NCT03007056|weaning|weaning
190100|NCT03007056|pain|pain
190101|NCT03007056|length of stay|length of stay
190102|NCT03007004|Systemic aclerosis|systemic aclerosis
190103|NCT03007004|digital ulcer|digital ulcer
190104|NCT03007004|botulinum toxin|botulinum toxin
190105|NCT03006991|methotrexate, Juvenile Idiopathic Arthritis|methotrexate, juvenile idiopathic arthritis
190106|NCT03006965|Hemophilia|hemophilia
190107|NCT03006965|Hemophilia A|hemophilia a
190108|NCT03006965|Factor VIII|factor viii
190109|NCT03006965|Advate|advate
190110|NCT03006965|Antithrombotic factor|antithrombotic factor
190111|NCT03006965|Pharmacokinetic dosing|pharmacokinetic dosing
190112|NCT03006965|Hemarthrosis|hemarthrosis
190113|NCT03006965|myPKFiT|mypkfit
190114|NCT03006926|hepatocellular carcinoma|hepatocellular carcinoma
190115|NCT03006926|E7080|e7080
190116|NCT03006926|lenvatinib|lenvatinib
190117|NCT03006926|pembrolizumab|pembrolizumab
190118|NCT03006926|Japan|japan
190119|NCT03006913|Genetic counseling modes|genetic counseling modes
190120|NCT03006887|solid tumors|solid tumors
190121|NCT03006887|non-small cell lung cancer|non-small cell lung cancer
190122|NCT03006887|predominantly clear cell renal cell carcinoma|predominantly clear cell renal cell carcinoma
190123|NCT03006887|endometrial carcinoma|endometrial carcinoma
190124|NCT03006887|urothelial carcinoma|urothelial carcinoma
190125|NCT03006887|squamous cell carcinoma of the head and neck|squamous cell carcinoma of the head and neck
190126|NCT03006887|non-uveal melanoma|non-uveal melanoma
190127|NCT03006887|E7080|e7080
190128|NCT03006887|lenvatinib|lenvatinib
190129|NCT03006887|pembrolizumab|pembrolizumab
190130|NCT03006887|Japan|japan
190131|NCT03006848|Osteosarcoma|osteosarcoma
190132|NCT03006848|PD-L1|pd-l1
190133|NCT03006848|Immunotherapy|immunotherapy
190134|NCT03006835|Clopidogrel; Platelet Inhibition Ratio|clopidogrel; platelet inhibition ratio
190135|NCT03006822|Myofascial Trigger Points|myofascial trigger points
190136|NCT03006822|Liberation for Pression|liberation for pression
190137|NCT03006822|Therapy Soft Tissue|therapy soft tissue
190138|NCT03006809|Ulcerative colitis|ulcerative colitis
190139|NCT03006809|FMT|fmt
190140|NCT03006809|fecal transplant|fecal transplant
190141|NCT03006796|Obesity|obesity
190142|NCT03006705|ONO-4538,BMS-936558,Nivolumab,gastric,adjuvant,S-1,CapeOX|ono-4538,bms-936558,nivolumab,gastric,adjuvant,s-1,capeox
190143|NCT03006614|Breast Cancer Model|breast cancer model
190144|NCT03006614|Effects of Chemotherapy|effects of chemotherapy
190145|NCT03006614|breast cancer|breast cancer
190146|NCT03006588|FNA,EUS,retropharyngeal lymph node (RPLN),NPC|fna,eus,retropharyngeal lymph node (rpln),npc
190147|NCT03006575|Non-small cell lung cancer|non-small cell lung cancer
190148|NCT03006575|Split-course Chemoradiotherapy|split-course chemoradiotherapy
190149|NCT03006575|Locoregional recurrence|locoregional recurrence
190150|NCT03006575|Postoperative recurrence|postoperative recurrence
190151|NCT03006549|Emergency Manual|emergency manual
190152|NCT03006549|Crisis Checklist|crisis checklist
190153|NCT03006523|donor intrauterine insemination|donor intrauterine insemination
190154|NCT03006523|insemination volume|insemination volume
190155|NCT03006523|Live Birth Rates|live birth rates
190156|NCT03006523|donor sperm|donor sperm
190157|NCT03006510|inpatient diabetes|inpatient diabetes
190158|NCT03006510|hypoglycemia|hypoglycemia
190159|NCT03006497|neck|neck
190160|NCT03006497|motor control|motor control
190161|NCT03006497|motor learning|motor learning
190162|NCT03006484|Cardiac arrest|cardiac arrest
190163|NCT03006484|Inhospital Cardiac Arrest|inhospital cardiac arrest
190164|NCT03006484|Cardiopulmonary Resuscitation|cardiopulmonary resuscitation
190165|NCT03006471|Prediabetes|prediabetes
190166|NCT03006471|Prehypertension|prehypertension
190167|NCT03006471|Variability of blood pressure|variability of blood pressure
190168|NCT03006471|ABPM|abpm
190169|NCT03006471|Dapagliflozin|dapagliflozin
190170|NCT03006471|SGLT2|sglt2
190171|NCT03006432|OESOPHAGO-GASTRIC CARCINOMA|oesophago-gastric carcinoma
190172|NCT03006419|kidney transplantation|kidney transplantation
190173|NCT03006419|induction|induction
190174|NCT03006419|thymoglobulin|thymoglobulin
190175|NCT03006419|basiliximab|basiliximab
190176|NCT03006419|acute rejection|acute rejection
190177|NCT03006419|graft loss|graft loss
190178|NCT03006406|endometriosis|endometriosis
190179|NCT03006406|long term GnRH-a|long term gnrh-a
190180|NCT03006393|Neuroscience|neuroscience
190181|NCT03006393|Behavioral|behavioral
190182|NCT03006393|Social|social
190183|NCT03006354|high frequency oscillatory ventilation|high frequency oscillatory ventilation
190184|NCT03006354|newborn|newborn
190185|NCT03006354|noninvasive ventilation|noninvasive ventilation
190186|NCT03006354|transient tachypnea of the newborn|transient tachypnea of the newborn
190187|NCT03006328|weight gain|weight gain
190188|NCT03006328|weight loss|weight loss
190189|NCT03006315|multiple myeloma|multiple myeloma
190190|NCT03006315|garmin vivofit|garmin vivofit
190191|NCT03006302|pancreatic cancer|pancreatic cancer
190192|NCT03006302|vaccine|vaccine
190193|NCT03006302|immunotherapy|immunotherapy
190194|NCT03006302|MK-3475|mk-3475
190195|NCT03006302|PD-1|pd-1
190196|NCT03006302|IDO|ido
190197|NCT03006289|Metabolic Syndrome|metabolic syndrome
190198|NCT03006289|fasting plasma glucose|fasting plasma glucose
190199|NCT03006263|Stomach Neoplasms|stomach neoplasms
190200|NCT03006263|Totally Laparoscopic Total Gastrectomy|totally laparoscopic total gastrectomy
190201|NCT03006263|Laparoscopy Assisted Total Gastrectomy|laparoscopy assisted total gastrectomy
190202|NCT03006250|Desflurane|desflurane
190203|NCT03006250|Sevoflurane|sevoflurane
190204|NCT03006250|Respiratory Complications|respiratory complications
190205|NCT03006224|secondary smoking|secondary smoking
190206|NCT03006224|one lung ventilation|one lung ventilation
190207|NCT03006224|arterial oxygen tension|arterial oxygen tension
190208|NCT03006224|lobectomy|lobectomy
190209|NCT03006211|nitrogen protoxide|nitrogen protoxide
190210|NCT03006211|oxygen|oxygen
190211|NCT03006211|corneal endothelial|corneal endothelial
190212|NCT03006211|pediatric|pediatric
190213|NCT03006107|Irreversible pulpitis|irreversible pulpitis
190214|NCT03006107|Post endodontic pain|post endodontic pain
190215|NCT03006107|Symptomatic pulpitis pain|symptomatic pulpitis pain
190216|NCT03006107|Single visit RCT pain|single visit rct pain
190217|NCT03006107|Root canal treatment flare up|root canal treatment flare up
190218|NCT03006107|Single dose piroxicam|single dose piroxicam
190219|NCT03006107|Intraligamentary piroxicam|intraligamentary piroxicam
190220|NCT03006107|Intraligamentary mepecaine|intraligamentary mepecaine
190221|NCT03006094|questionnaire|questionnaire
190222|NCT03006094|hip|hip
190223|NCT03006094|pain|pain
190224|NCT03006081|Retinal nonperfusion|retinal nonperfusion
190225|NCT03006081|Aflibercept|aflibercept
190226|NCT03006068|Ulcerative Colitis (UC)|ulcerative colitis (uc)
190227|NCT03006068|Upadacitinib (ABT-494)|upadacitinib (abt-494)
190228|NCT03006068|Long Term Extension (LTE)|long term extension (lte)
190229|NCT03006068|Safety|safety
190230|NCT03006068|Efficacy|efficacy
190231|NCT03006042|bupivacaine|bupivacaine
190232|NCT03006042|local anaesthetics|local anaesthetics
190233|NCT03006042|cesarean section|cesarean section
190234|NCT03006042|transversus abdominis plane block|transversus abdominis plane block
190235|NCT03006042|toxicity|toxicity
190236|NCT03006042|ultrasound guidance|ultrasound guidance
190237|NCT03006042|QTc interval|qtc interval
190238|NCT03006003|Osteoporosis|osteoporosis
190239|NCT03006003|Raloxifene|raloxifene
190240|NCT03006003|Central nervous disorders|central nervous disorders
190241|NCT03005990|Sleep disturbance|sleep disturbance
190242|NCT03005990|Body composition|body composition
190243|NCT03005990|Energy metabolism|energy metabolism
190244|NCT03005990|Exercise training|exercise training
190245|NCT03005990|Community-dwelling elderly|community-dwelling elderly
190246|NCT03005977|Urodynamics|urodynamics
190247|NCT03005977|Pyridium pad test|pyridium pad test
190248|NCT03005977|Cough stress test|cough stress test
190249|NCT03005977|Pelvic organ prolapse|pelvic organ prolapse
190250|NCT03005938|Cerebral Palsy|cerebral palsy
190251|NCT03005938|Spinal Manipulation|spinal manipulation
190252|NCT03005938|Muscle Spasticity|muscle spasticity
190253|NCT03005938|Manual Dexterity|manual dexterity
190254|NCT03005912|Speech Comprehension|speech comprehension
190255|NCT03005912|Telephony|telephony
190256|NCT03005912|VoIP|voip
190257|NCT03005886|Periodontitis|periodontitis
190258|NCT03005886|Periodontal-systemic disease|periodontal-systemic disease
190259|NCT03005886|Cardiovascular diseases|cardiovascular diseases
190260|NCT03005886|Gingival crevicular fluid|gingival crevicular fluid
190261|NCT03005886|Acute myocardial infarction|acute myocardial infarction
190262|NCT03005886|Neopterin|neopterin
190263|NCT03005886|Vascular cell adhesion molecule-1|vascular cell adhesion molecule-1
190264|NCT03005873|osteoarthritis of the knee|osteoarthritis of the knee
190265|NCT03005873|TLC599|tlc599
190266|NCT03005873|Dexamethasone|dexamethasone
190268|NCT03005834|Atherosclerotic cardiovascular diseases, cancers|atherosclerotic cardiovascular diseases, cancers
190269|NCT03005821|pediatric massage|pediatric massage
190270|NCT03005821|Tuina therapy|tuina therapy
190271|NCT03005821|acute diarrhea|acute diarrhea
190272|NCT03005808|appendectomy, pediatrics, nerve block, abdominal wall|appendectomy, pediatrics, nerve block, abdominal wall
190273|NCT03005795|cervical dysplasia|cervical dysplasia
190274|NCT03005795|colposcopy|colposcopy
190275|NCT03005795|anxiety|anxiety
190276|NCT03005795|music|music
190277|NCT03005795|mozart|mozart
190278|NCT03005795|randomized controlled trial|randomized controlled trial
190279|NCT03005769|persistence|persistence
190280|NCT03005769|long-acting injectable antipsychotic|long-acting injectable antipsychotic
190281|NCT03005769|adherence|adherence
190282|NCT03005743|Cervical cancer|cervical cancer
190283|NCT03005743|Brachytherapy|brachytherapy
190284|NCT03005743|Conventional planning|conventional planning
190285|NCT03005743|MR based Brachytherapy|mr based brachytherapy
190286|NCT03005717|submental|submental
190287|NCT03005717|Salmeterol Xinafoate|salmeterol xinafoate
190288|NCT03005717|LIPO-202|lipo-202
190289|NCT03005717|bulge|bulge
190290|NCT03005704|Ticagrelor|ticagrelor
190291|NCT03005704|Acetylsalicylic acid|acetylsalicylic acid
190292|NCT03005704|Platelet transfusion|platelet transfusion
190293|NCT03005704|Reversal|reversal
190294|NCT03005691|metabolite|metabolite
190295|NCT03005691|central sensitization|central sensitization
190296|NCT03005691|whiplash|whiplash
190297|NCT03005678|glucocorticoids, steroids, osteoporosis|glucocorticoids, steroids, osteoporosis
190298|NCT03005665|optic nerve sheath diameter|optic nerve sheath diameter
190299|NCT03005665|acetazolamide|acetazolamide
190300|NCT03005652|Subjective Cognitive Decline|subjective cognitive decline
190301|NCT03005652|Mental Health|mental health
190302|NCT03005652|Meditation|meditation
190303|NCT03005652|Health Education|health education
190304|NCT03005613|Pelvic organ prolapse|pelvic organ prolapse
190305|NCT03005613|Sacrospinous ligament fixation|sacrospinous ligament fixation
190306|NCT03005613|Ischial spine fascia fixation|ischial spine fascia fixation
190307|NCT03005613|Clinical outcome|clinical outcome
190308|NCT03005600|Screening, diagnosis, risk stratification, ethnic|screening, diagnosis, risk stratification, ethnic
190309|NCT03005574|Severe Mental Illness|severe mental illness
190310|NCT03005574|Cognitive Remediation|cognitive remediation
190311|NCT03005574|Employment|employment
190312|NCT03005548|Transcranial Direct Current Stimulation|transcranial direct current stimulation
190313|NCT03005548|Pain Postoperative|pain postoperative
190314|NCT03005548|Thoracotomy|thoracotomy
190315|NCT03005509|Quality improvement|quality improvement
190316|NCT03005509|Injury|injury
190317|NCT03005509|Injuries|injuries
190318|NCT03005483|GABAPENTIN POSTOPERATIVE PAIN CHILD|gabapentin postoperative pain child
190319|NCT03005470|Prehypertension|prehypertension
190320|NCT03005470|Hypertension|hypertension
190321|NCT03005470|Blood pressure|blood pressure
190322|NCT03005470|Intervention|intervention
190323|NCT03005470|Lifestyle|lifestyle
190324|NCT03005470|Blood pressure monitoring|blood pressure monitoring
190325|NCT03005470|Ambulatory Blood Pressure Monitoring|ambulatory blood pressure monitoring
190326|NCT03005470|Text Messages|text messages
190327|NCT03005470|High blood pressure|high blood pressure
190328|NCT03005444|liver cirrhosis|liver cirrhosis
190329|NCT03005444|Transjugular Intrahepatic Portosystemic Stent Shunt|transjugular intrahepatic portosystemic stent shunt
190330|NCT03005444|Anticoagulation|anticoagulation
190331|NCT03005444|Survival|survival
190332|NCT03005444|Additional decompensation|additional decompensation
190333|NCT03005431|Parenting|parenting
190334|NCT03005431|Training|training
190335|NCT03005431|Support|support
190336|NCT03005431|On-line|on-line
190337|NCT03005431|Stress|stress
190338|NCT03005405|Dental Caries|dental caries
190339|NCT03005405|Primary tooth|primary tooth
190340|NCT03005405|Ionomer Sealants|ionomer sealants
190341|NCT03005405|Glass Ionomer Restoration|glass ionomer restoration
190342|NCT03005392|Cancer|cancer
190343|NCT03005392|Physical therapy|physical therapy
190344|NCT03005392|Cardiorespiratory fitness|cardiorespiratory fitness
190346|NCT03005379|recurrent c. difficile|recurrent c. difficile
190347|NCT03005379|infectious disease|infectious disease
190348|NCT03005379|intestine|intestine
190349|NCT03005379|clinical trial|clinical trial
190350|NCT03005379|gastrointestinal|gastrointestinal
190351|NCT03005379|prevention|prevention
190352|NCT03005379|randomized|randomized
190353|NCT03005379|diarrhea|diarrhea
190354|NCT03005379|fecal microbiota therapy|fecal microbiota therapy
190355|NCT03005366|Atrial fibrillation|atrial fibrillation
190356|NCT03005366|vernakalant|vernakalant
190357|NCT03005366|flecainide|flecainide
190358|NCT03005366|cardioversion|cardioversion
190359|NCT03005301|electroacupuncture instrument|electroacupuncture instrument
190360|NCT03005288|type 2 diabetes|type 2 diabetes
190361|NCT03005288|obesity|obesity
190362|NCT03005288|DXA|dxa
190363|NCT03005288|MRI|mri
190364|NCT03005236|Kidney transplant|kidney transplant
190365|NCT03005236|Tacrolimus|tacrolimus
190366|NCT03005236|Envarsus|envarsus
190367|NCT03005236|Older adult|older adult
190368|NCT03005236|Elderly|elderly
190369|NCT03005158|High-sensitivity cardiac troponin I|high-sensitivity cardiac troponin i
190370|NCT03005158|Myocardial infarction|myocardial infarction
190371|NCT03005158|Acute coronary syndrome|acute coronary syndrome
190372|NCT03005158|Cluster-randomized trial|cluster-randomized trial
190373|NCT03005132|GBM; Integrative Analysis; WES|gbm; integrative analysis; wes
190374|NCT03004989|Qualitative study|qualitative study
190375|NCT03004989|Musculoskeletal Disorders|musculoskeletal disorders
190376|NCT03004989|Return to Work Programme|return to work programme
190377|NCT03004976|hematopoietic stem cells|hematopoietic stem cells
190378|NCT03004976|umbilical cord blood|umbilical cord blood
190379|NCT03004976|stroke|stroke
190380|NCT03004976|ischemic stroke|ischemic stroke
190381|NCT03004963|Peritoneal Dialysis|peritoneal dialysis
190382|NCT03004963|Volume Status|volume status
190383|NCT03004963|Body Composition Monitor|body composition monitor
190384|NCT03004911|fibromyalgia|fibromyalgia
190385|NCT03004911|mobile application|mobile application
190386|NCT03004911|self-care|self-care
190387|NCT03004911|quality of life|quality of life
190388|NCT03004872|birth experience|birth experience
190389|NCT03004872|postpartum depression|postpartum depression
190390|NCT03004872|PTSD|ptsd
190391|NCT03004872|pain during labor|pain during labor
190392|NCT03004872|pain during cesarean delivery|pain during cesarean delivery
190393|NCT03004872|non-elective induction of labor|non-elective induction of labor
190394|NCT03004872|unplanned surgery for urgent/emergent cesarean delivery|unplanned surgery for urgent/emergent cesarean delivery
190395|NCT03004872|postpartum hemorrhage|postpartum hemorrhage
190396|NCT03004859|atrial fibrillation|atrial fibrillation
190397|NCT03004859|screening|screening
190398|NCT03004859|electrocardiogram|electrocardiogram
190399|NCT03004859|community pharmacy|community pharmacy
190400|NCT03004859|Germany|germany
190401|NCT03004846|Vehicle- controlled|vehicle- controlled
190402|NCT03004846|GSK2981278|gsk2981278
190403|NCT03004846|Plaque psoriasis|plaque psoriasis
190404|NCT03004820|Minor Ischemic Stroke|minor ischemic stroke
190405|NCT03004820|Transient Ischemic Attack|transient ischemic attack
190406|NCT03004820|Remote Ischemic Conditioning|remote ischemic conditioning
190407|NCT03004807|Nutrition|nutrition
190408|NCT03004807|Aging|aging
190409|NCT03004807|Multivitamin|multivitamin
190410|NCT03004781|parenting intervention|parenting intervention
190411|NCT03004781|externalizing behavior|externalizing behavior
190412|NCT03004781|emotion coaching practices|emotion coaching practices
190413|NCT03004781|self-efficacy beliefs|self-efficacy beliefs
190414|NCT03004742|polyphenols|polyphenols
190415|NCT03004742|metabolomics|metabolomics
190416|NCT03004742|oxidative stress|oxidative stress
190417|NCT03004729|Allergy|allergy
190418|NCT03004729|Atopic Dermatitis|atopic dermatitis
190419|NCT03004729|Immunoglobulin E (IgE)|immunoglobulin e (ige)
190420|NCT03004729|CMPA|cmpa
190421|NCT03004703|Interleukin 6|interleukin 6
190422|NCT03004703|Tocilizumab|tocilizumab
190423|NCT03004703|Acute coronary syndrome|acute coronary syndrome
190424|NCT03004703|STEMI|stemi
190425|NCT03004703|Inflammation|inflammation
190426|NCT03004690|biosafety|biosafety
190427|NCT03004690|outbreaks|outbreaks
190428|NCT03004690|clinic|clinic
190429|NCT03004690|personal protective equipment|personal protective equipment
190430|NCT03004690|ergonomics|ergonomics
190431|NCT03004690|error rates|error rates
190432|NCT03004664|Latinos|latinos
190433|NCT03004664|Low Income|low income
190434|NCT03004664|Self Management|self management
190435|NCT03004664|Education|education
190436|NCT03004664|Cultural Competence|cultural competence
190437|NCT03004638|Atherosclerosis|atherosclerosis
190438|NCT03004638|Cardiovascular Disease|cardiovascular disease
190439|NCT03004638|CAD|cad
190440|NCT03004638|Atherosclerotic Cardiovascular Disease|atherosclerotic cardiovascular disease
190441|NCT03004612|prediabetes|prediabetes
190442|NCT03004599|Valvular Heart Disease|valvular heart disease
190443|NCT03004599|Critical Aortic Stenosis|critical aortic stenosis
190444|NCT03004599|Severe Aortic Stenosis|severe aortic stenosis
190445|NCT03004599|High Risk|high risk
190446|NCT03004599|Aortic Valve Replacement|aortic valve replacement
190447|NCT03004599|Cardiovascular Disease|cardiovascular disease
190448|NCT03004599|Aortic Stenosis|aortic stenosis
400619|NCT01866007|CNTO1959|cnto1959
190449|NCT03004599|Heart Valve Therapy|heart valve therapy
190450|NCT03004599|Transcatheter|transcatheter
190451|NCT03004599|Transfemoral|transfemoral
190452|NCT03004599|TAVI|tavi
190453|NCT03004599|TAVR|tavr
190454|NCT03004599|ACURATE neo™ Aortic Bioprosthesis|acurate neo™ aortic bioprosthesis
190455|NCT03004599|ACURATE TF™ Transfemoral Delivery System|acurate tf™ transfemoral delivery system
190456|NCT03004586|Malignant Neoplasm of Respiratory and Intrathoracic Organ Carcinoma|malignant neoplasm of respiratory and intrathoracic organ carcinoma
190457|NCT03004586|Lung cancer|lung cancer
190458|NCT03004586|Ultrasound-guided transbronchial needle aspiration|ultrasound-guided transbronchial needle aspiration
190459|NCT03004586|EBUS-TBNA|ebus-tbna
190460|NCT03004586|25-gauge needle|25-gauge needle
190461|NCT03004586|22-gauge needle|22-gauge needle
190462|NCT03004573|Parkinson Disease|parkinson disease
190463|NCT03004573|emotional recognition|emotional recognition
190464|NCT03004573|Deep Brain Stimulation|deep brain stimulation
190465|NCT03004560|Bariatric|bariatric
190466|NCT03004560|standard laparoscopic surgery|standard laparoscopic surgery
190467|NCT03004560|minimally invasive|minimally invasive
190468|NCT03004560|scars|scars
190469|NCT03004560|psychology|psychology
190470|NCT03004534|Breast Cancer|breast cancer
190471|NCT03004534|Breast Carcinoma|breast carcinoma
190472|NCT03004534|Breast Tumours|breast tumours
190473|NCT03004534|Early Breast Cancer|early breast cancer
190474|NCT03004521|Lithium|lithium
190475|NCT03004521|Quetiapine|quetiapine
190476|NCT03004521|Augmentation|augmentation
190477|NCT03004508|Ginkgo Biloba Extract|ginkgo biloba extract
190478|NCT03004508|Safety|safety
190479|NCT03004508|Genomic Stability|genomic stability
190480|NCT03004508|DNA cell maintenance|dna cell maintenance
190481|NCT03004482|NICU|nicu
190482|NCT03004482|Recorded video images|recorded video images
190483|NCT03004482|physiological disorders|physiological disorders
190484|NCT03004456|Phlebotomy|phlebotomy
190485|NCT03004456|Pain|pain
190486|NCT03004456|Distress|distress
190487|NCT03004443|Psychiatry|psychiatry
190488|NCT03004430|Mantra|mantra
190489|NCT03004430|Meditation|meditation
190490|NCT03004391|Shared decision making|shared decision making
190491|NCT03004391|Follow-up|follow-up
190492|NCT03004378|obesity|obesity
190493|NCT03004378|adolescent|adolescent
190494|NCT03004378|tracking device|tracking device
190495|NCT03004378|fitbit|fitbit
190496|NCT03004326|DIV|div
190497|NCT03004326|CSS|css
190498|NCT03004326|EGPA|egpa
190499|NCT03004326|HSP|hsp
190500|NCT03004326|GPA|gpa
190501|NCT03004326|MPA|mpa
190502|NCT03004326|PAN|pan
190503|NCT03004326|Wegeners|wegeners
190504|NCT03004313|migraine|migraine
190505|NCT03004300|maxillary expansion|maxillary expansion
190506|NCT03004300|adenotonsillar hypertrophy|adenotonsillar hypertrophy
190507|NCT03004300|airway volume|airway volume
190508|NCT03004261|cytomegalovirus infection|cytomegalovirus infection
190509|NCT03004261|cytotoxic T lymphocyte|cytotoxic t lymphocyte
190510|NCT03004261|hematopoietic stem cell transplantation|hematopoietic stem cell transplantation
190511|NCT03004248|glabellar lines, frown lines|glabellar lines, frown lines
190512|NCT03004209|Erythropoietin|erythropoietin
190513|NCT03004209|Autoimmune encephalitis|autoimmune encephalitis
190514|NCT03004196|White Spot Lesion|white spot lesion
190515|NCT03004196|Probiotics|probiotics
190516|NCT03004196|Chlorhexidine|chlorhexidine
190517|NCT03004196|Streptococcus Mutans|streptococcus mutans
190518|NCT03004196|Fixed Orthodontic Treatment|fixed orthodontic treatment
190519|NCT03004170|HIV|hiv
190520|NCT03004170|Motivational Interviewing|motivational interviewing
190521|NCT03004170|Telephone|telephone
190522|NCT03004170|Telehealth|telehealth
190523|NCT03004170|Risky Sex|risky sex
190524|NCT03004170|Unprotected Sex|unprotected sex
190525|NCT03004170|Condoms|condoms
190526|NCT03004170|Older Adults|older adults
190527|NCT03004157|infant|infant
190528|NCT03004157|cardiopulmonary resuscitation|cardiopulmonary resuscitation
190529|NCT03004157|hemodynamics|hemodynamics
190530|NCT03004157|chest compressions|chest compressions
190531|NCT03004105|Malignant Neoplasm of Respiratory and Intrathoracic Organ Carcinoma|malignant neoplasm of respiratory and intrathoracic organ carcinoma
190532|NCT03004105|Advanced Lung Cancer|advanced lung cancer
190533|NCT03004105|Recurrent Nonsmall Cell Lung Cancer|recurrent nonsmall cell lung cancer
190534|NCT03004105|Selumetinib|selumetinib
190535|NCT03004105|AZD6244|azd6244
190536|NCT03004105|Durvalumab|durvalumab
190537|NCT03004105|MEDI4736|medi4736
190538|NCT03004092|bis(methylthio)gliotoxin|bis(methylthio)gliotoxin
190539|NCT03004092|lateral flow device|lateral flow device
190540|NCT03004092|JF5|jf5
190541|NCT03004092|Galactomannan|galactomannan
190542|NCT03004092|Invasive aspergillosis|invasive aspergillosis
190543|NCT03004053|Reflectance Confocal Microscopy|reflectance confocal microscopy
190544|NCT03004053|Normal Oral Tissue|normal oral tissue
190545|NCT03004053|16-1652|16-1652
190546|NCT03004027|health behaviour change|health behaviour change
190547|NCT03004027|implementation intention|implementation intention
190548|NCT03004027|if then plan|if then plan
190549|NCT03004027|skin condition|skin condition
190550|NCT03004027|visible difference|visible difference
190551|NCT03004027|self help|self help
190552|NCT03004014|sleep endoscopy|sleep endoscopy
190553|NCT03004014|sedation|sedation
190554|NCT03004001|Severe proteinuria|severe proteinuria
190555|NCT03004001|Dyslipidemia|dyslipidemia
190556|NCT03003975|Ablation|ablation
190557|NCT03003975|Cryoballoon|cryoballoon
190558|NCT03003975|Achieve|achieve
190559|NCT03003962|NSCLC|nsclc
190560|NCT03003962|PD-L1|pd-l1
190561|NCT03003962|Durvalumab (MEDI4736)|durvalumab (medi4736)
190562|NCT03003962|OS|os
190563|NCT03003949|perimenopause|perimenopause
190564|NCT03003949|menopause transition|menopause transition
190565|NCT03003949|estrogen|estrogen
190566|NCT03003949|stress|stress
190567|NCT03003949|mood|mood
190568|NCT03003936|Glucose tolerance|glucose tolerance
190569|NCT03003936|MTNR1B|mtnr1b
190570|NCT03003936|nutrigenomics|nutrigenomics
190571|NCT03003936|Food timing|food timing
190572|NCT03003923|Vegetable intake|vegetable intake
190573|NCT03003923|Taste exposures|taste exposures
190574|NCT03003923|Educational intervention|educational intervention
190575|NCT03003923|Preschool children|preschool children
190576|NCT03003923|Healthy eating intervention|healthy eating intervention
190577|NCT03003910|Best Possible Self|best possible self
190578|NCT03003897|Dietary Fiber|dietary fiber
190579|NCT03003897|Soluble Fiber|soluble fiber
190580|NCT03003897|Body Mass Index|body mass index
190581|NCT03003897|Body Weight|body weight
190582|NCT03003897|Blood Glucose|blood glucose
190583|NCT03003897|Insulin|insulin
190584|NCT03003871|stroke|stroke
190585|NCT03003871|randomized controled clinical trial|randomized controled clinical trial
190586|NCT03003871|oral health promotion|oral health promotion
190587|NCT03003858|gingivitis|gingivitis
190588|NCT03003858|hyaluronic acid|hyaluronic acid
190589|NCT03003858|pediatrics|pediatrics
190590|NCT03003858|medical devices|medical devices
190591|NCT03003806|Insulin pump treatment|insulin pump treatment
190592|NCT03003806|Type 1 diabetes|type 1 diabetes
190593|NCT03003806|Pump setting advisor|pump setting advisor
190594|NCT03003689|Scaling and Root Planing|scaling and root planing
190595|NCT03003689|Er:YAG|er:yag
190596|NCT03003663|Fall Prevention|fall prevention
190597|NCT03003663|Interrupted Time-Series Study|interrupted time-series study
190598|NCT03003663|Patient Safety|patient safety
190599|NCT03003663|Patient-Centered Care|patient-centered care
190600|NCT03003663|Patient Monitoring|patient monitoring
190601|NCT03003663|Health Care Technology|health care technology
190602|NCT03003663|Mobile Applications|mobile applications
190603|NCT03003663|Bedside Monitor|bedside monitor
190604|NCT03003663|Mechanical Fall|mechanical fall
190605|NCT03003650|Severe Symptomatic Aortic Valve Stenosis|severe symptomatic aortic valve stenosis
190606|NCT03003624|Incisions|incisions
190607|NCT03003624|microdissection needle|microdissection needle
190608|NCT03003598|Intraocular pressure|intraocular pressure
190609|NCT03003598|videolaryngoscope|videolaryngoscope
190610|NCT03003598|direct laryngoscope|direct laryngoscope
190611|NCT03003585|intraocular pressure|intraocular pressure
190612|NCT03003585|direct laryngoscopy|direct laryngoscopy
190613|NCT03003585|fiberoptic bronchoscopy|fiberoptic bronchoscopy
190614|NCT03003572|Sjögren's syndrome|sjögren's syndrome
190615|NCT03003572|Immunoglobulin E|immunoglobulin e
190616|NCT03003572|Anti-Ro/SSA|anti-ro/ssa
190617|NCT03003572|Autoimmune disease|autoimmune disease
190618|NCT03003572|Biomarker|biomarker
190619|NCT03003559|COPD Exacerbation|copd exacerbation
190620|NCT03003559|High Flow Oxygen|high flow oxygen
190621|NCT03003559|Nasal Cannula|nasal cannula
190622|NCT03003559|mild|mild
190623|NCT03003533|Adeno-Associated Virus (AAV)|adeno-associated virus (aav)
190624|NCT03003533|Blood Coagulation Disorders|blood coagulation disorders
190625|NCT03003533|Blood Coagulation Disorders, Inherited|blood coagulation disorders, inherited
190626|NCT03003533|Coagulation Protein Disorders|coagulation protein disorders
190627|NCT03003533|Factor VIII (FVIII)|factor viii (fviii)
190628|NCT03003533|Factor VIII (FVIII) Deficiency|factor viii (fviii) deficiency
190629|NCT03003533|Factor VIII (FVIII) Gene|factor viii (fviii) gene
190630|NCT03003533|Factor VIII (FVIII) Protein|factor viii (fviii) protein
190631|NCT03003533|Genetic Diseases, Inborn|genetic diseases, inborn
190632|NCT03003533|Genetic Diseases, X-Linked|genetic diseases, x-linked
190633|NCT03003533|Gene Therapy|gene therapy
190634|NCT03003533|Gene Transfer|gene transfer
190635|NCT03003533|Hematologic Diseases|hematologic diseases
190636|NCT03003533|Hemorrhagic Disorders|hemorrhagic disorders
190637|NCT03003533|Recombinant|recombinant
190638|NCT03003533|Vector|vector
190639|NCT03003520|Lymphoma|lymphoma
190640|NCT03003520|Diffuse-large B-Cell Lymphoma|diffuse-large b-cell lymphoma
190641|NCT03003520|Durvalumab|durvalumab
190642|NCT03003520|Anti-PD-L1 Antibody|anti-pd-l1 antibody
190643|NCT03003520|MEDI4736|medi4736
190644|NCT03003520|Immune Checkpoint|immune checkpoint
190645|NCT03003520|Rituximab|rituximab
190646|NCT03003520|Cyclophosphamide|cyclophosphamide
190647|NCT03003520|Doxorubicin|doxorubicin
243718|NCT02675400|ADD|add
190648|NCT03003520|Vincristine|vincristine
190649|NCT03003520|Prednisone/Prednisolone|prednisone/prednisolone
190650|NCT03003520|Lenalidomide|lenalidomide
190651|NCT03003507|Hyperglycemia|hyperglycemia
190652|NCT03003507|Fructose|fructose
190653|NCT03003507|Diabetes mellitus|diabetes mellitus
190654|NCT03003507|Enteral Nutrition|enteral nutrition
190655|NCT03003507|Glycemic Variability|glycemic variability
190656|NCT03003468|Anti-PD-1|anti-pd-1
190657|NCT03003468|Pembrolizumab|pembrolizumab
190658|NCT03003468|Imprime PGG|imprime pgg
190659|NCT03003468|MK-3475|mk-3475
190660|NCT03003455|Nasotracheal Intubation|nasotracheal intubation
190661|NCT03003442|Multivitamin/mineral|multivitamin/mineral
190662|NCT03003442|Exercise|exercise
190663|NCT03003442|Fatigue|fatigue
190664|NCT03003442|Stress|stress
190665|NCT03003442|Arousal|arousal
190666|NCT03003442|Energy expenditure|energy expenditure
190667|NCT03003442|Recovery biomarkers|recovery biomarkers
190668|NCT03003442|Cognition|cognition
190669|NCT03003429|Heart rate variability|heart rate variability
190670|NCT03003429|anxiety|anxiety
190671|NCT03003429|Autonomic dysfunction|autonomic dysfunction
190672|NCT03003403|mHealth|mhealth
190673|NCT03003403|Digital Health|digital health
190674|NCT03003403|Primary Care|primary care
190675|NCT03003403|Pragmatic Clinical Trial|pragmatic clinical trial
190676|NCT03003403|Behavior Change|behavior change
190677|NCT03003403|Weight Management|weight management
190678|NCT03003390|child|child
190679|NCT03003390|critical illness|critical illness
190680|NCT03003390|venous thromboembolism|venous thromboembolism
190681|NCT03003390|enoxaparin|enoxaparin
190682|NCT03003390|thrombin generation|thrombin generation
190683|NCT03003377|Sevoflurane|sevoflurane
190684|NCT03003377|Remifentanil|remifentanil
190685|NCT03003377|Laryngeal mask supreme|laryngeal mask supreme
190686|NCT03003377|laryngeal mask proseal|laryngeal mask proseal
190687|NCT03003351|Fistula|fistula
190688|NCT03003351|Cohort Study|cohort study
190689|NCT03003338|chronic HCV Genotype 1b infection|chronic hcv genotype 1b infection
190690|NCT03003338|HCV RNA|hcv rna
190691|NCT03003338|OBV/PTV/r in combination with DSV|obv/ptv/r in combination with dsv
190692|NCT03003338|neuropsychiatric manifestations|neuropsychiatric manifestations
190693|NCT03003325|low risk of thrombosis|low risk of thrombosis
190694|NCT03003325|Interferon|interferon
190695|NCT03003312|Urolithiasis|urolithiasis
190696|NCT03003312|Uyghur|uyghur
190697|NCT03003312|Prevalence|prevalence
190698|NCT03003312|Associated factors|associated factors
190699|NCT03003312|Children|children
190700|NCT03003299|Sapien 3|sapien 3
190701|NCT03003299|Partner 3|partner 3
190702|NCT03003299|cardiovascular disease|cardiovascular disease
190703|NCT03003299|heart disease|heart disease
190704|NCT03003299|aortic stenosis|aortic stenosis
190705|NCT03003299|SAVR|savr
190706|NCT03003299|TAVR|tavr
190707|NCT03003299|failing surgical valve|failing surgical valve
190708|NCT03003299|failing bioprosthetic valve|failing bioprosthetic valve
190709|NCT03003299|failing valve|failing valve
190710|NCT03003286|Contingency Behavior Management|contingency behavior management
190711|NCT03003286|Flexible|flexible
190712|NCT03003286|Unstuck|unstuck
190713|NCT03003286|Low Income|low income
190714|NCT03003286|Behavior|behavior
190715|NCT03003286|Coping|coping
190716|NCT03003286|Disparity|disparity
190717|NCT03003286|Problem Solving|problem solving
190718|NCT03003286|Self-Control|self-control
190719|NCT03003286|impulsive|impulsive
190720|NCT03003286|intervention|intervention
190721|NCT03003221|Parent training|parent training
190722|NCT03003221|Dental care|dental care
190723|NCT03003169|surgery|surgery
190724|NCT03003169|breast cancer|breast cancer
190725|NCT03003169|quality of life|quality of life
190726|NCT03003156|magnetic seizure therapy|magnetic seizure therapy
190727|NCT03003156|schizophrenia|schizophrenia
190728|NCT03003156|controlled trial|controlled trial
190729|NCT03003156|cognition|cognition
190730|NCT03003130|Hyaluronic acid|hyaluronic acid
190731|NCT03003130|Comparative study|comparative study
190733|NCT03003117|Infant|infant
190734|NCT03003117|Diet|diet
190735|NCT03003117|Growth|growth
190736|NCT03003117|Breastfeeding|breastfeeding
190737|NCT03003117|Complementary feeding|complementary feeding
190738|NCT03003117|Pregnancy|pregnancy
190739|NCT03003117|Body mass index|body mass index
190740|NCT03003117|Social disadvantage|social disadvantage
190741|NCT03003117|Randomized controlled trial|randomized controlled trial
190742|NCT03003117|Education|education
190743|NCT03003117|Food vouchers|food vouchers
190744|NCT03003104|Skin diseases|skin diseases
190745|NCT03003104|rosacea|rosacea
190746|NCT03003078|Pancreatic cancer|pancreatic cancer
190747|NCT03003078|Pancreas|pancreas
190748|NCT03003078|metastases|metastases
190749|NCT03003078|pancreatic tumour|pancreatic tumour
190750|NCT03003078|unresectable|unresectable
190751|NCT03003078|locally advanced|locally advanced
190752|NCT03003078|implantable|implantable
190753|NCT03003078|radiographic|radiographic
190754|NCT03003078|device|device
190755|NCT03003078|Phosphorous-32|phosphorous-32
190756|NCT03003078|OncoSil™|oncosil™
190757|NCT03003078|brachytherapy|brachytherapy
190758|NCT03003078|FOLFIRINOX|folfirinox
190759|NCT03003078|gemcitabine|gemcitabine
190760|NCT03003078|nab-paclitaxel|nab-paclitaxel
190761|NCT03003078|Abraxane|abraxane
190762|NCT03003065|Inoperable cholangiocarcinoma|inoperable cholangiocarcinoma
190763|NCT03003065|Photodynamic therapy|photodynamic therapy
190764|NCT03003065|Endoscopic retrograde cholangiopancreatography|endoscopic retrograde cholangiopancreatography
190765|NCT03003052|dental implants|dental implants
190766|NCT03003052|edentulous|edentulous
190767|NCT03003052|dental hygiene|dental hygiene
190768|NCT03003052|evidence-based dentistry|evidence-based dentistry
190769|NCT03003039|GB241|gb241
190770|NCT03003039|Rituximab|rituximab
190771|NCT03003039|B-cell Lymphoma|b-cell lymphoma
190772|NCT03003026|motor learning|motor learning
190773|NCT03003026|participation|participation
190774|NCT03003013|Odontogenic cysts|odontogenic cysts
190775|NCT03003013|Bone substitutes materials|bone substitutes materials
190776|NCT03003013|SYMBIOS®|symbios®
190777|NCT03003013|Platelets rich fibrin (PRF)|platelets rich fibrin (prf)
190778|NCT03003013|Bone regeneration|bone regeneration
190779|NCT03002974|Gout|gout
190780|NCT03002974|Interleukin 1 receptor antagonist|interleukin 1 receptor antagonist
190781|NCT03002974|IL-1 receptor antagonist|il-1 receptor antagonist
190782|NCT03002896|Cancer|cancer
190783|NCT03002896|Caregivers|caregivers
190784|NCT03002896|Pep-pal|pep-pal
190785|NCT03002896|Pep-Pal + Treatment as Usual|pep-pal + treatment as usual
190786|NCT03002896|Treatment as Usual|treatment as usual
190787|NCT03002857|Laryngeal Mask Airway|laryngeal mask airway
190788|NCT03002857|Urologic Surgical Procedure|urologic surgical procedure
190789|NCT03002831|CIK|cik
190790|NCT03002831|Chemotherapy|chemotherapy
190791|NCT03002831|Pancreatic Cancer|pancreatic cancer
190792|NCT03002818|Chronic Hepatitis C (HCV)|chronic hepatitis c (hcv)
190793|NCT03002818|Genotype 1|genotype 1
190794|NCT03002818|Paritaprevir|paritaprevir
190795|NCT03002818|Ritonavir|ritonavir
190796|NCT03002818|ombitasvir|ombitasvir
190797|NCT03002818|Dasabuvir|dasabuvir
190798|NCT03002818|Sustained Virological Response|sustained virological response
190799|NCT03002805|Phase I|phase i
190800|NCT03002805|CBT-1®|cbt-1®
190801|NCT03002805|Doxorubicin|doxorubicin
190802|NCT03002805|Sarcoma|sarcoma
190803|NCT03002792|anesthesia|anesthesia
190804|NCT03002792|neurodevelopment|neurodevelopment
190805|NCT03002792|dental caries|dental caries
190806|NCT03002753|OCD|ocd
190807|NCT03002753|obsessive-compulsive disorder|obsessive-compulsive disorder
190808|NCT03002753|cognitive therapy|cognitive therapy
190809|NCT03002753|metacognitive therapy|metacognitive therapy
190810|NCT03002753|cognitive restructuring|cognitive restructuring
190811|NCT03002753|detached mindfulness|detached mindfulness
190812|NCT03002753|comparison|comparison
190813|NCT03002753|Germany|germany
190814|NCT03002753|Muenster|muenster
190815|NCT03002753|Christoph-Dornier-Stiftung|christoph-dornier-stiftung
190816|NCT03002753|metacognition|metacognition
190817|NCT03002727|Colorectal cancer|colorectal cancer
190818|NCT03002727|Microsatellite|microsatellite
190819|NCT03002727|Colorectal cancer stem cells|colorectal cancer stem cells
190820|NCT03002714|Resistance Training|resistance training
190821|NCT03002714|Psychological Stress|psychological stress
190822|NCT03002714|Aging|aging
190823|NCT03002714|Hypertension|hypertension
190824|NCT03002714|Autonomic Nervous System|autonomic nervous system
190825|NCT03002701|Prevention|prevention
190826|NCT03002701|Critical care|critical care
190827|NCT03002701|Delirium|delirium
190828|NCT03002701|Nurse|nurse
190829|NCT03002701|RCT|rct
190830|NCT03002675|Adipose tissue|adipose tissue
190831|NCT03002675|Type 2 diabetes|type 2 diabetes
190832|NCT03002649|Dermatomyositis|dermatomyositis
190833|NCT03002649|Tofacitinib|tofacitinib
190834|NCT03002649|Refractory dermatomyositis|refractory dermatomyositis
190835|NCT03002636|Obesity|obesity
190836|NCT03002636|Anesthesia Complications|anesthesia complications
190837|NCT03002636|Body Mass Index (BMI)|body mass index (bmi)
190838|NCT03002623|Dual Inhibitor of HDAC and P13K Signaling|dual inhibitor of hdac and p13k signaling
190839|NCT03002623|HDAC2|hdac2
190840|NCT03002623|EGFR/RAS/RAF/MEK/ERK Signaling Pathway Inhibition|egfr/ras/raf/mek/erk signaling pathway inhibition
190841|NCT03002584|IBS, population|ibs, population
190842|NCT03002558|Hypertension|hypertension
190843|NCT03002558|Continuous Positive Airway Pressure|continuous positive airway pressure
190844|NCT03002558|Obstructive Sleep Apnea|obstructive sleep apnea
190845|NCT03002558|Cardiovascular Diseases|cardiovascular diseases
190846|NCT03002545|Magnesium|magnesium
190847|NCT03002545|Type II diabetes|type ii diabetes
190848|NCT03002545|magnesium-sensitive genes|magnesium-sensitive genes
190849|NCT03002532|Breast cancer|breast cancer
190850|NCT03002532|Brain metastasis|brain metastasis
190851|NCT03002532|Whole brain radiotherapy|whole brain radiotherapy
190852|NCT03002532|Hippocampal avoidance|hippocampal avoidance
190853|NCT03002532|Neurocognitive function|neurocognitive function
190854|NCT03002532|intracranial failure|intracranial failure
190855|NCT03002506|ceftolozane|ceftolozane
190856|NCT03002506|tazobactam|tazobactam
190857|NCT03002493|Rifampicin|rifampicin
190858|NCT03002493|Pharmacokinetics|pharmacokinetics
190859|NCT03002493|Eribulin Mesylate|eribulin mesylate
190860|NCT03002493|E7389|e7389
190861|NCT03002493|Advanced Solid Tumors|advanced solid tumors
190862|NCT03002493|Tumors|tumors
190863|NCT03002454|99mTc Pertechnetate|99mtc pertechnetate
190864|NCT03002454|Sodium Pertechnetate|sodium pertechnetate
190865|NCT03002454|Technetium|technetium
190866|NCT03002454|Molybdenum|molybdenum
190867|NCT03002454|MDP|mdp
190868|NCT03002454|neutron activation|neutron activation
190869|NCT03002402|asthma|asthma
190870|NCT03002402|insomnia|insomnia
190871|NCT03002402|cognitive-behavioral treatment|cognitive-behavioral treatment
190872|NCT03002389|chronic obstructive pulmonary disease|chronic obstructive pulmonary disease
190873|NCT03002389|COPD|copd
190874|NCT03002389|emphysema|emphysema
190875|NCT03002389|MRI|mri
190876|NCT03002389|hyper polarized gas MRI|hyper polarized gas mri
190877|NCT03002363|autism|autism
190878|NCT03002363|audiology|audiology
190879|NCT03002363|video modeling|video modeling
190880|NCT03002363|testing compliance|testing compliance
190881|NCT03002350|Circulating tumor cells (CTCs)|circulating tumor cells (ctcs)
190882|NCT03002350|Optically induced dielectrophoresis (ODEP)|optically induced dielectrophoresis (odep)
190883|NCT03002350|Cell sorting|cell sorting
190884|NCT03002350|Next-generation sequencing (NGS)|next-generation sequencing (ngs)
190885|NCT03002350|disruptive mutation|disruptive mutation
190886|NCT03002337|aromatherapy massage, yoga|aromatherapy massage, yoga
190887|NCT03002324|Vaccines|vaccines
190888|NCT03002324|Childhood Vaccination|childhood vaccination
190889|NCT03002324|Decision Making|decision making
190890|NCT03002324|Health Belief Model|health belief model
190891|NCT03002311|Bioinformatics|bioinformatics
190892|NCT03002311|Electronic pharmacology|electronic pharmacology
190893|NCT03002311|Mobile health|mobile health
190894|NCT03002311|Electronic health|electronic health
190895|NCT03002311|Adherence|adherence
190896|NCT03002311|Digital health|digital health
190897|NCT03002311|Health information technology|health information technology
190898|NCT03002311|mHealth|mhealth
190899|NCT03002311|eHealth|ehealth
190900|NCT03002259|cardiac surgery|cardiac surgery
190901|NCT03002233|TRK-820|trk-820
190902|NCT03002233|Hemodialysis|hemodialysis
190903|NCT03002233|Uremic Pruritus|uremic pruritus
190904|NCT03002194|rhytides|rhytides
190905|NCT03002194|wrinkle|wrinkle
190906|NCT03002142|Alzheimer|alzheimer
190907|NCT03002142|Hearing loss|hearing loss
190908|NCT03002142|Cognition|cognition
190909|NCT03002142|Quality of life|quality of life
190910|NCT03002142|Hearing aids|hearing aids
190911|NCT03002090|iron deficiency|iron deficiency
190912|NCT03002090|anemia|anemia
190913|NCT03002090|exercise training|exercise training
190914|NCT03002090|aerobic|aerobic
190915|NCT03002090|performance|performance
190916|NCT03002090|Chinese medicine|chinese medicine
190917|NCT03002090|BaZhen KeLi|bazhen keli
190918|NCT03002064|Esophagus squamous carcinoma|esophagus squamous carcinoma
190919|NCT03002064|First-line chemotherapy|first-line chemotherapy
190920|NCT03002064|Docetaxel|docetaxel
190921|NCT03002064|Cisplatin|cisplatin
190922|NCT03002064|5-fluorouracil|5-fluorouracil
190923|NCT03002038|neuromyelitis optica spectrum disorder|neuromyelitis optica spectrum disorder
190924|NCT03002038|azathioprine|azathioprine
190925|NCT03002038|rituximab|rituximab
190926|NCT03002038|clinical trial|clinical trial
190927|NCT03002038|annual relapse rate|annual relapse rate
190928|NCT03002038|expanded disability status scale|expanded disability status scale
190929|NCT03002012|cryptococcal antigen|cryptococcal antigen
190930|NCT03002012|preemptive treatment|preemptive treatment
190931|NCT03002012|CRAG+|crag+
190932|NCT03002012|sertraline|sertraline
190933|NCT03002012|fluconazole|fluconazole
190934|NCT03002012|randomized clinical trial|randomized clinical trial
190935|NCT03002012|HIV|hiv
190936|NCT03001999|Diabetes|diabetes
190937|NCT03001999|Positive Psychology|positive psychology
190938|NCT03001999|Physical Activity|physical activity
190939|NCT03001986|effectiveness|effectiveness
190940|NCT03001986|safety|safety
190941|NCT03001986|hand, foot and mouth disease (HFMD)|hand, foot and mouth disease (hfmd)
190942|NCT03001986|Enterovirus A, Human|enterovirus a, human
190943|NCT03001986|vaccine|vaccine
190944|NCT03001973|Lupus nephritis|lupus nephritis
190945|NCT03001973|Patient survival|patient survival
190946|NCT03001973|Renal survival|renal survival
190947|NCT03001947|IgA nephropathy|iga nephropathy
190948|NCT03001947|All-cause mortality|all-cause mortality
190949|NCT03001947|Cardiovascular mortality|cardiovascular mortality
190950|NCT03001947|A composite renal outcome|a composite renal outcome
190951|NCT03001934|Nephrotic syndrome|nephrotic syndrome
190952|NCT03001934|Treatment response|treatment response
244120|NCT02672878|Stent|stent
190953|NCT03001934|Renal function|renal function
190954|NCT03001921|Hemodialysis|hemodialysis
190955|NCT03001921|Patient survival|patient survival
190956|NCT03001921|Quality of life|quality of life
190957|NCT03001921|Hemodialysis access|hemodialysis access
190958|NCT03001908|shoulder|shoulder
190959|NCT03001908|mobilization|mobilization
190960|NCT03001908|electromyography|electromyography
190961|NCT03001908|imaging ultrasound|imaging ultrasound
190962|NCT03001804|Multiple Myeloma|multiple myeloma
190963|NCT03001804|Revlimid|revlimid
190964|NCT03001804|Lenalidomide|lenalidomide
190965|NCT03001804|Non-transplantable|non-transplantable
190966|NCT03001791|CO2 laser|co2 laser
190967|NCT03001791|thermal damage zone|thermal damage zone
190968|NCT03001791|Er:YAG laser|er:yag laser
190969|NCT03001778|Physical Activity|physical activity
190970|NCT03001778|Older Adults|older adults
190971|NCT03001778|Independent Living Facilities|independent living facilities
190972|NCT03001778|Multimedia technology|multimedia technology
190973|NCT03001752|post-extraction dental implant|post-extraction dental implant
190974|NCT03001752|immediate dental implant|immediate dental implant
190975|NCT03001752|open flap|open flap
190976|NCT03001752|flapless|flapless
190977|NCT03001752|bone grafting|bone grafting
190978|NCT03001752|CT Cone Beam|ct cone beam
190979|NCT03001687|hepcidin|hepcidin
190980|NCT03001687|sepsis|sepsis
190981|NCT03001687|surgery|surgery
190982|NCT03001687|vitamin D|vitamin d
190983|NCT03001661|Propess|propess
190984|NCT03001661|Dilapan-S|dilapan-s
190985|NCT03001661|Dinoprostone|dinoprostone
190986|NCT03001661|Labour|labour
190987|NCT03001661|Induction|induction
190988|NCT03001661|Child birth|child birth
190989|NCT03001596|Neoadjuvant Chemoradiotherapy|neoadjuvant chemoradiotherapy
190990|NCT03001596|Neoadjuvant Chemotherapy|neoadjuvant chemotherapy
190991|NCT03001596|Minimally Invasive Esophagectomy|minimally invasive esophagectomy
190992|NCT03001596|Esophageal Squamous Cell Carcinoma（cT3-4aN0-1M0）|esophageal squamous cell carcinoma（ct3-4an0-1m0）
190993|NCT03001583|Mediterranean diet|mediterranean diet
190994|NCT03001583|weight loss|weight loss
190995|NCT03001583|type 2 diabetes|type 2 diabetes
190996|NCT03001583|education program|education program
190997|NCT03001583|cooking|cooking
190998|NCT03001557|Mild to Moderate Alzheimer's Disease Dementia|mild to moderate alzheimer's disease dementia
190999|NCT03001557|sleep|sleep
191000|NCT03001557|circadian rhythms|circadian rhythms
191001|NCT03001531|Complete paraplegia|complete paraplegia
191002|NCT03001466|Cataract|cataract
191003|NCT03001466|Urea-loaded NPs|urea-loaded nps
191004|NCT03001466|TEM examination|tem examination
191005|NCT03001453|Exparel|exparel
191006|NCT03001453|total hip replacement|total hip replacement
191007|NCT03001453|bupivacaine|bupivacaine
191008|NCT03001440|REMS|rems
191009|NCT03001440|Smoking cessation|smoking cessation
191010|NCT03001440|WELLBUTRIN|wellbutrin
191011|NCT03001440|ZYBAN|zyban
191012|NCT03001440|Neuropsychiatric adverse events|neuropsychiatric adverse events
191013|NCT03001388|Cystic Fibrosis Liver Disease|cystic fibrosis liver disease
191014|NCT03001388|Pancreatic insufficiency|pancreatic insufficiency
191015|NCT03001388|Cystic Fibrosis|cystic fibrosis
191016|NCT03001388|Transient Elastography|transient elastography
191017|NCT03001375|Laparoscopic colectomy.|laparoscopic colectomy.
191018|NCT03001375|Splenic flexure mobilization.|splenic flexure mobilization.
191019|NCT03001375|Anastomotic leakage.|anastomotic leakage.
191020|NCT03001336|Thyroid|thyroid
191021|NCT03001336|Diabetes Mellitus|diabetes mellitus
191022|NCT03001297|atherosclerosis; acute coronary syndrome; MEDI5884|atherosclerosis; acute coronary syndrome; medi5884
191023|NCT03001271|Angiotensin-(1-7)|angiotensin-(1-7)
191024|NCT03001271|Renin-angiotensin System|renin-angiotensin system
191025|NCT03001271|Autonomic Nervous System|autonomic nervous system
191026|NCT03001245|adolescents|adolescents
191027|NCT03001245|depression|depression
191028|NCT03001245|psychotherapy|psychotherapy
191029|NCT03001245|interpersonal therapy|interpersonal therapy
191030|NCT03001232|Movement-oriented Dementia Care|movement-oriented dementia care
191032|NCT03001232|ADL|adl
191033|NCT03001232|Nursing Home|nursing home
191034|NCT03001193|Primary slow progress|primary slow progress
191035|NCT03001193|Prolonged latent phase|prolonged latent phase
191036|NCT03001193|Labor arrest|labor arrest
191037|NCT03001180|Generalized Lymphatic Anomaly|generalized lymphatic anomaly
191038|NCT03001180|Vascular Anomaly|vascular anomaly
191039|NCT03001180|Kaposiform Hemangioendothelioma|kaposiform hemangioendothelioma
191040|NCT03001180|Kaposiform Lymphangiomatosis|kaposiform lymphangiomatosis
191041|NCT03001180|Vascular Endothelial Growth Factor|vascular endothelial growth factor
191042|NCT03001180|Biomarkers|biomarkers
191043|NCT03001180|GLA|gla
191044|NCT03001180|KLA|kla
191045|NCT03001180|KHE|khe
191046|NCT03001180|GSD|gsd
191047|NCT03001167|Microbiome|microbiome
191048|NCT03001167|Antibiotics|antibiotics
191049|NCT03001167|Growth|growth
191050|NCT03001141|MultiPoint Pacing|multipoint pacing
191051|NCT03001141|Heart Failure|heart failure
191052|NCT03001141|Cardiac Resynchronization Therapy|cardiac resynchronization therapy
191053|NCT03001141|Quadripolar pacing|quadripolar pacing
191054|NCT03001115|Adalimumab|adalimumab
191055|NCT03001115|Safety|safety
191056|NCT03001115|Hidradenitis Suppurativa|hidradenitis suppurativa
191057|NCT03001115|Korean participants|korean participants
191058|NCT03001102|Preoperative Care|preoperative care
191059|NCT03001102|Baths|baths
191060|NCT03001102|Chlorhexidine|chlorhexidine
191061|NCT03001102|Soaps|soaps
191062|NCT03001102|Povidone-Iodine|povidone-iodine
191063|NCT03001102|Arthroplasty, Replacement, Hip|arthroplasty, replacement, hip
191064|NCT03001102|Surgical Wound Infection|surgical wound infection
191065|NCT03001089|Neonatology|neonatology
191066|NCT03001089|Endocrinology|endocrinology
191067|NCT03001076|hyperlididemia|hyperlididemia
191068|NCT03001076|LDL|ldl
191069|NCT03001076|cholesterol|cholesterol
191070|NCT03001076|statin intolerance|statin intolerance
191071|NCT03001037|Functional Outcome Measures|functional outcome measures
191072|NCT03001037|Wearable Sensors|wearable sensors
191073|NCT03001037|ViMove|vimove
191074|NCT03001037|Low Back Pain|low back pain
191075|NCT03001037|Range of Movement|range of movement
191076|NCT03001037|Muscle Activity|muscle activity
191077|NCT03000998|HPV|hpv
191078|NCT03000998|Cancer|cancer
191079|NCT03000985|schizophrenia|schizophrenia
191080|NCT03000985|psychoeducation program|psychoeducation program
191081|NCT03000985|family caregiver|family caregiver
191082|NCT03000985|relapse|relapse
191083|NCT03000985|medication adherence|medication adherence
191084|NCT03000985|burden|burden
191085|NCT03000972|Augmentation|augmentation
191086|NCT03000972|PET-CT|pet-ct
191087|NCT03000972|Positron Emission Tomography|positron emission tomography
191088|NCT03000972|Fluorine-18|fluorine-18
191089|NCT03000946|Pancreatectomy|pancreatectomy
191090|NCT03000946|Somatostatin analogue|somatostatin analogue
191091|NCT03000946|Octreotide|octreotide
191092|NCT03000946|Pancreatic fistula|pancreatic fistula
191093|NCT03000920|short message service (SMS)|short message service (sms)
191094|NCT03000920|screening|screening
191095|NCT03000920|cost-effectiveness|cost-effectiveness
191096|NCT03000907|prevention|prevention
191097|NCT03000907|frailty|frailty
191098|NCT03000907|obese|obese
191099|NCT03000907|elderly|elderly
191100|NCT03000907|physical exercise|physical exercise
191101|NCT03000894|cognitive-behavioral therapy for insomnia|cognitive-behavioral therapy for insomnia
191102|NCT03000894|insomnia|insomnia
191103|NCT03000894|mood disorder|mood disorder
191104|NCT03000868|Colonic Polyps|colonic polyps
191105|NCT03000868|Endoscopic Mucosal Resection|endoscopic mucosal resection
191106|NCT03000868|Colonoscopy|colonoscopy
191107|NCT03000855|Malignant biliary obstruction|malignant biliary obstruction
191108|NCT03000855|EUS - guided choledocho-duodenostomy|eus - guided choledocho-duodenostomy
191109|NCT03000855|ERCP with covered metallic stents|ercp with covered metallic stents
191110|NCT03000842|autonomic control|autonomic control
191111|NCT03000842|transcutaneous vagal nerve stimulation|transcutaneous vagal nerve stimulation
191112|NCT03000842|transauricular vagal nerve stimulation|transauricular vagal nerve stimulation
191113|NCT03000829|Code blue|code blue
191114|NCT03000829|Code team|code team
191115|NCT03000829|Crisis team leadership|crisis team leadership
191116|NCT03000829|Cardiopulmonary resuscitation|cardiopulmonary resuscitation
191117|NCT03000829|Telemedicine|telemedicine
191118|NCT03000829|Simulation|simulation
191119|NCT03000829|Mock code|mock code
191120|NCT03000829|In-hospital cardiac arrest|in-hospital cardiac arrest
191121|NCT03000790|Anterior disc displacement|anterior disc displacement
191122|NCT03000790|TMD therapy|tmd therapy
191123|NCT03000790|internal derangement|internal derangement
191124|NCT03000790|Lingual Ring|lingual ring
191125|NCT03000777|melatonin|melatonin
191126|NCT03000777|zinc|zinc
191127|NCT03000777|Myalgic Encephalomyelitis|myalgic encephalomyelitis
191128|NCT03000777|Chronic Fatigue Syndrome|chronic fatigue syndrome
191129|NCT03000777|sleep|sleep
191130|NCT03000777|pain|pain
191131|NCT03000764|Skin biopsy|skin biopsy
191132|NCT03000764|Radiotherapy|radiotherapy
191133|NCT03000764|RNA biomarker|rna biomarker
191134|NCT03000764|HSP biomarker|hsp biomarker
191135|NCT03000764|Exon junction array|exon junction array
191136|NCT03000764|Gene expression|gene expression
191137|NCT03000764|Radiosensitivity prediction|radiosensitivity prediction
191138|NCT03000751|CT scan|ct scan
191139|NCT03000751|CT exam|ct exam
191140|NCT03000751|ionizing radiation|ionizing radiation
191141|NCT03000751|medical imaging|medical imaging
191142|NCT03000751|cat scan|cat scan
191143|NCT03000751|radiation|radiation
191144|NCT03000738|CD16- monocyte/CD16+ monocyte ratio|cd16- monocyte/cd16+ monocyte ratio
191145|NCT03000738|CytoDiff flow cytometric system|cytodiff flow cytometric system
191146|NCT03000738|Diffuse Large B Cell Lymphoma|diffuse large b cell lymphoma
191147|NCT03000738|Peripheral T-Cell Lymphoma|peripheral t-cell lymphoma
191148|NCT03000738|prognosis|prognosis
400620|NCT01866007|Pharmacokinetics|pharmacokinetics
244399|NCT02670720|HAE|hae
191149|NCT03000712|adipose tissue derived mesenchymal stem cell|adipose tissue derived mesenchymal stem cell
191150|NCT03000712|osteoarthritis|osteoarthritis
191151|NCT03000712|degenerative arthritis|degenerative arthritis
191152|NCT03000712|kyung hee university hospital|kyung hee university hospital
191153|NCT03000712|biostar|biostar
191154|NCT03000712|Rbio|rbio
191155|NCT03000712|Osteoarthritis, Knee|osteoarthritis, knee
191156|NCT03000712|High tibial osteotomy|high tibial osteotomy
191157|NCT03000712|Joint Diseases|joint diseases
191158|NCT03000699|cognitive bias modification|cognitive bias modification
191159|NCT03000699|interpretation bias|interpretation bias
191160|NCT03000699|suicidal ideation|suicidal ideation
191161|NCT03000699|depression|depression
191162|NCT03000686|GSK2586881, Acute hypoxia, Exercise|gsk2586881, acute hypoxia, exercise
191163|NCT03000660|Amyloidosis|amyloidosis
191164|NCT03000660|AL Amyloidosis|al amyloidosis
191165|NCT03000660|Amyloid Light Chain Amylodosis|amyloid light chain amylodosis
191166|NCT03000660|ABT-199|abt-199
191167|NCT03000660|Venetoclax|venetoclax
191168|NCT03000647|Pelvic floor muscle exercise|pelvic floor muscle exercise
191169|NCT03000647|Supervision|supervision
191170|NCT03000647|Physiotherapy|physiotherapy
191171|NCT03000621|MicroRNA|microrna
191172|NCT03000621|miR-122|mir-122
191173|NCT03000621|Diagnosis|diagnosis
191174|NCT03000621|Prognosis|prognosis
191175|NCT03000595|eczema|eczema
191176|NCT03000569|Parkinson|parkinson
191177|NCT03000543|vitamin A|vitamin a
191178|NCT03000543|vitamin A isotope|vitamin a isotope
191179|NCT03000543|Inflammation|inflammation
191180|NCT03000530|Depression|depression
191181|NCT03000517|levofloxacin|levofloxacin
191182|NCT03000517|multi-drug resistant TB|multi-drug resistant tb
191183|NCT03000517|pharmacokinetics|pharmacokinetics
191184|NCT03000465|pneumoperitoneum pressure|pneumoperitoneum pressure
191185|NCT03000465|laparoscopic pressure|laparoscopic pressure
191186|NCT03000465|intra-abdominal insufflation|intra-abdominal insufflation
191187|NCT03000465|intra-abdominal pressures|intra-abdominal pressures
191188|NCT03000465|abdominal compliance|abdominal compliance
191189|NCT03000452|Multiple Myeloma|multiple myeloma
191190|NCT03000452|Daratumumab|daratumumab
191191|NCT03000452|Durvalumab|durvalumab
191192|NCT03000452|Relapsed and Refractory Multiple Myeloma|relapsed and refractory multiple myeloma
191193|NCT03000439|systemic Juvenile Idiopathic Arthritis|systemic juvenile idiopathic arthritis
191194|NCT03000439|Xeljanz|xeljanz
191195|NCT03000439|Tofacitinib|tofacitinib
191196|NCT03000439|sJIA|sjia
191197|NCT03000439|CP-690 550|cp-690 550
191198|NCT03000426|Low level laser therapy|low level laser therapy
191199|NCT03000387|Nicotine Replacement Therapy|nicotine replacement therapy
191200|NCT03000387|Smoking Cessation|smoking cessation
191201|NCT03000387|Randomized Clinical Trial|randomized clinical trial
191202|NCT03000387|Nicotine Patch|nicotine patch
191203|NCT03000387|Abstinence|abstinence
191204|NCT03000387|Placebo|placebo
191205|NCT03000387|Double blind|double blind
191206|NCT03000361|Colonoscopy|colonoscopy
191207|NCT03000361|motorized spiral endoscopy|motorized spiral endoscopy
191208|NCT03000361|adenoma detection rate|adenoma detection rate
191209|NCT03000348|Exacerbation|exacerbation
191210|NCT03000348|CF|cf
191211|NCT03000348|Lung disease|lung disease
191212|NCT03000348|Lung infection|lung infection
191213|NCT03000348|Gram negative|gram negative
191214|NCT03000348|Bacterial Infection|bacterial infection
191215|NCT03000348|pneumonia|pneumonia
191216|NCT03000348|bronchitis|bronchitis
191217|NCT03000335|microRNA|microrna
191218|NCT03000335|relapse|relapse
191219|NCT03000335|blood|blood
191220|NCT03000335|in vitro diagnostics|in vitro diagnostics
191221|NCT03000335|prediction|prediction
191222|NCT03000335|lab test|lab test
191223|NCT03000296|autologous|autologous
191224|NCT03000296|lymphoablation|lymphoablation
191225|NCT03000296|hematopoetic stem cell transplant|hematopoetic stem cell transplant
191226|NCT03000296|immune system|immune system
191227|NCT03000296|Bone marrow transplant|bone marrow transplant
191228|NCT03000283|Conivaptan|conivaptan
191229|NCT03000270|Infarct Size|infarct size
191230|NCT03000270|Impella|impella
191231|NCT03000270|Unloading|unloading
191232|NCT03000270|Left Ventricle|left ventricle
191233|NCT03000270|PPCI|ppci
191234|NCT03000270|STEMI|stemi
191235|NCT03000257|Cancer|cancer
191236|NCT03000257|Advanced Solid Tumors|advanced solid tumors
191237|NCT03000257|Non-small cell lung cancer (NSCLC)|non-small cell lung cancer (nsclc)
191238|NCT03000257|Triple negative breast cancer|triple negative breast cancer
191239|NCT03000257|Ovarian cancer|ovarian cancer
191240|NCT03000257|Hepatocellular carcinoma|hepatocellular carcinoma
191241|NCT03000257|Gastric cancer|gastric cancer
191242|NCT03000257|Small cell lung cancer|small cell lung cancer
191243|NCT03000257|Mesothelioma|mesothelioma
191244|NCT03000257|Cholangiocarcinoma|cholangiocarcinoma
191245|NCT03000257|Merkel cell carcinoma|merkel cell carcinoma
191246|NCT03000257|Head and neck cancer|head and neck cancer
244457|NCT02670356|EPA|epa
191247|NCT03000244|Natural History|natural history
191248|NCT03000244|HCT|hct
191249|NCT03000205|Dextrose prolotherapy|dextrose prolotherapy
191250|NCT03000205|patients|patients
191251|NCT03000192|Survivorship|survivorship
191252|NCT03000192|Cancer|cancer
191253|NCT03000192|Recovery|recovery
191254|NCT03000192|Self-management|self-management
191255|NCT03000192|Cohort|cohort
191256|NCT03000179|small bowel cancer, small bowel carcinoma|small bowel cancer, small bowel carcinoma
191257|NCT03000127|testosterone|testosterone
191258|NCT03000127|multiple sclerosis|multiple sclerosis
191259|NCT03000127|fatigue|fatigue
191260|NCT03000114|Collagenase injection|collagenase injection
191261|NCT03000114|percutaneous needle aponeurotomy|percutaneous needle aponeurotomy
191262|NCT03000101|Biomarkers|biomarkers
191263|NCT03000101|Colitis|colitis
191264|NCT03000101|Colitis, Ulcerative|colitis, ulcerative
191265|NCT03000101|Colonic Diseases|colonic diseases
191266|NCT03000101|Crohn Disease|crohn disease
191267|NCT03000101|Digestive System Diseases|digestive system diseases
191268|NCT03000101|Fruit|fruit
191269|NCT03000101|Fruit and Vegetable Juices|fruit and vegetable juices
191270|NCT03000101|Gastroenteritis|gastroenteritis
191271|NCT03000101|Gastrointestinal Diseases|gastrointestinal diseases
191272|NCT03000101|Humans|humans
191273|NCT03000101|Hydrolysable Tannins|hydrolysable tannins
191274|NCT03000101|Inflammation|inflammation
191275|NCT03000101|Inflammatory Bowel Disease|inflammatory bowel disease
191276|NCT03000101|Intestinal Diseases|intestinal diseases
191277|NCT03000101|Punicaceae|punicaceae
191278|NCT03000075|BI 655066|bi 655066
191279|NCT03000075|ABBV-066|abbv-066
191280|NCT03000075|risankizumab|risankizumab
191281|NCT03000062|overweight, general practice|overweight, general practice
191282|NCT03000049|sepsis|sepsis
191283|NCT03000049|septic shock|septic shock
191284|NCT03000049|blood cultures|blood cultures
191285|NCT03000049|anti-infective therapy|anti-infective therapy
191286|NCT03000036|Breast cancer|breast cancer
191287|NCT03000036|Doxorubicin|doxorubicin
191288|NCT03000036|Cardiovascular Magnetic Resonance|cardiovascular magnetic resonance
191289|NCT03000036|T1 mapping|t1 mapping
191290|NCT03000023|Hepatitis C|hepatitis c
191291|NCT03000023|Patient-Reported Outcomes|patient-reported outcomes
191292|NCT03000023|DAA Treatment|daa treatment
191293|NCT03000023|Qualitative|qualitative
191294|NCT03000023|Mixed methods|mixed methods
191295|NCT03000010|Wound Vac|wound vac
191296|NCT03000010|Neuromuscular Scoliosis|neuromuscular scoliosis
191297|NCT03000010|Posterior Spinal Fusion|posterior spinal fusion
191298|NCT02999997|Physical therapy modalities|physical therapy modalities
191299|NCT02999997|Dual-task performance|dual-task performance
191300|NCT02999997|Parkinson's disease|parkinson's disease
191301|NCT02999997|Active music therapy|active music therapy
191302|NCT02999997|Physical activity|physical activity
191303|NCT02999971|circuit class therapy|circuit class therapy
191304|NCT02999971|ICF model|icf model
191305|NCT02999971|aquatic therapy|aquatic therapy
191306|NCT02999971|neuro-rehabilitation|neuro-rehabilitation
191307|NCT02999945|preterm infants|preterm infants
191308|NCT02999945|SGA infants|sga infants
191309|NCT02999945|IUGR infants|iugr infants
191310|NCT02999945|growth|growth
191311|NCT02999945|body composition|body composition
191312|NCT02999945|metabolomics|metabolomics
191313|NCT02999945|microbiome|microbiome
191314|NCT02999945|adiposity markers|adiposity markers
191315|NCT02999945|metabolic programming|metabolic programming
191316|NCT02999945|neurodevelopmental outcome|neurodevelopmental outcome
191317|NCT02999906|PAH|pah
191318|NCT02999906|Oral Treprostinil|oral treprostinil
191319|NCT02999906|dual therapy|dual therapy
191320|NCT02999906|6 Minute Walk Test|6 minute walk test
191321|NCT02999854|Haploidentical stem cell transplantation|haploidentical stem cell transplantation
191322|NCT02999854|Graft-versus-host disease|graft-versus-host disease
191323|NCT02999854|Immune reconstitution|immune reconstitution
191324|NCT02999854|Alloreactive T-cells|alloreactive t-cells
191325|NCT02999854|Photodynamic treatment|photodynamic treatment
191326|NCT02999854|Hematologic malignancy|hematologic malignancy
191327|NCT02999854|Transplant-related mortality|transplant-related mortality
191328|NCT02999854|Overall survival|overall survival
191329|NCT02999854|GRFS|grfs
191330|NCT02999854|GVHD|gvhd
191331|NCT02999841|Visceral fat|visceral fat
191332|NCT02999828|safety|safety
191333|NCT02999828|immune persistence|immune persistence
191334|NCT02999815|Tetanus|tetanus
191335|NCT02999802|Nutrient Sensing|nutrient sensing
191336|NCT02999802|Exercise|exercise
191337|NCT02999802|Elderly|elderly
191338|NCT02999789|Asthma/drug therapy|asthma/drug therapy
191339|NCT02999789|Medication Adherence/statistics & numerical data|medication adherence/statistics & numerical data
191340|NCT02999789|Reminder Systems|reminder systems
191341|NCT02999789|Communication Barriers|communication barriers
191342|NCT02999776|Plaques Psoriasis|plaques psoriasis
191343|NCT02999776|Topical|topical
191344|NCT02999776|Laser microporation|laser microporation
191345|NCT02999763|lipolysis|lipolysis
191346|NCT02999763|fat reduction|fat reduction
191347|NCT02999763|circumference reduction|circumference reduction
191348|NCT02999737|Platelet Rich Plasma|platelet rich plasma
191349|NCT02999737|PRP|prp
191350|NCT02999737|Hair loss|hair loss
191351|NCT02999737|Alopecia|alopecia
191352|NCT02999737|Hypotrichosis|hypotrichosis
191353|NCT02999737|Hair diseases|hair diseases
191354|NCT02999698|Psoriasis|psoriasis
191355|NCT02999698|Hidradenitis|hidradenitis
191356|NCT02999698|Psychological impact|psychological impact
191357|NCT02999698|Quality of life|quality of life
191358|NCT02999659|pupillometry|pupillometry
191359|NCT02999659|autonomous nerve system|autonomous nerve system
191360|NCT02999646|head and neck squamous cell carcinoma|head and neck squamous cell carcinoma
191361|NCT02999646|cancer|cancer
191362|NCT02999646|HNSCC|hnscc
191363|NCT02999646|immunotherapy|immunotherapy
191364|NCT02999646|MVX-ONCO-1|mvx-onco-1
191365|NCT02999607|Transcranial direct current stimulation|transcranial direct current stimulation
191366|NCT02999607|Positron emission tomography|positron emission tomography
191367|NCT02999529|Chemotherapy|chemotherapy
191368|NCT02999529|Oncology|oncology
191369|NCT02999503|adhd treatment|adhd treatment
191370|NCT02999503|nutrition|nutrition
191371|NCT02999477|Breast Cancer|breast cancer
191372|NCT02999464|stroke|stroke
191373|NCT02999464|qigong|qigong
191374|NCT02999464|randomized controlled trial|randomized controlled trial
191375|NCT02999464|body-mind exercise|body-mind exercise
191376|NCT02999464|balance|balance
191377|NCT02999464|quality of life|quality of life
191378|NCT02999464|wellbeing|wellbeing
191477|NCT02998957|Physiotherapy|physiotherapy
191379|NCT02999412|Integrated Healthcare System|integrated healthcare system
191380|NCT02999412|Inappropriate Prescribing|inappropriate prescribing
191381|NCT02999412|Pragmatic Clinical Trial|pragmatic clinical trial
191382|NCT02999412|Crossover Design|crossover design
191383|NCT02999412|Randomised Controlled Trial|randomised controlled trial
191384|NCT02999399|Smoker|smoker
191385|NCT02999399|Former smoker|former smoker
191386|NCT02999386|stress, hyperglycemia, inflammatory markers, trauma, HbA1c|stress, hyperglycemia, inflammatory markers, trauma, hba1c
191387|NCT02999386|interleukin-6|interleukin-6
191388|NCT02999373|prevention, infection, preterm, cord blood mononuclear cells|prevention, infection, preterm, cord blood mononuclear cells
191389|NCT02999360|Aphasia|aphasia
191390|NCT02999360|Speech Therapy|speech therapy
191391|NCT02999360|Aerobic Exercise (AE)|aerobic exercise (ae)
191392|NCT02999347|Treatment Outcome|treatment outcome
191393|NCT02999347|Mid-urethral slings|mid-urethral slings
191394|NCT02999347|Gynecologic Surgery Procedures|gynecologic surgery procedures
191395|NCT02999334|Group healthcare models|group healthcare models
191396|NCT02999334|Antenatal care|antenatal care
191397|NCT02999334|Prenatal care|prenatal care
191398|NCT02999334|Perinatal health|perinatal health
191399|NCT02999334|CenteringPregnancy|centeringpregnancy
191400|NCT02999334|sub-Saharan Africa|sub-saharan africa
191401|NCT02999334|Malawi|malawi
191402|NCT02999334|Tanzania|tanzania
191403|NCT02999334|Pregnancy|pregnancy
191404|NCT02999308|haemophilia|haemophilia
191405|NCT02999308|prophylaxis|prophylaxis
191406|NCT02999308|children|children
191407|NCT02999282|TMS|tms
191408|NCT02999282|tDCS|tdcs
191409|NCT02999282|Rehabilitation|rehabilitation
191410|NCT02999269|electroconvulsive therapy|electroconvulsive therapy
191411|NCT02999269|MRI|mri
191412|NCT02999269|major depressive disorder|major depressive disorder
191413|NCT02999256|Tart Cherry Juice|tart cherry juice
191414|NCT02999256|Fat Oxidation|fat oxidation
191415|NCT02999256|Lipid Profile|lipid profile
191416|NCT02999256|Anthocyanins|anthocyanins
191417|NCT02999256|Exercise|exercise
191418|NCT02999256|Calorie Restrictive Mimetic|calorie restrictive mimetic
191419|NCT02999230|Cavities|cavities
191420|NCT02999217|iron isomaltoside|iron isomaltoside
191421|NCT02999217|plasma ferritin|plasma ferritin
191422|NCT02999217|haemoglobin|haemoglobin
191423|NCT02999217|colorectal cancer|colorectal cancer
191424|NCT02999165|Breastfeeding|breastfeeding
191425|NCT02999165|CPAP|cpap
191426|NCT02999165|Humidified High Flow Nasal Cannula Oxygen|humidified high flow nasal cannula oxygen
191427|NCT02999165|preterm neonate|preterm neonate
191428|NCT02999152|Bio-markers|bio-markers
191429|NCT02999152|Radiation|radiation
191430|NCT02999152|Appropriate therapeutic strategy|appropriate therapeutic strategy
191431|NCT02999152|Total Body Irradiation|total body irradiation
191432|NCT02999152|Partial Body Irradiation|partial body irradiation
191433|NCT02999139|Injury|injury
191434|NCT02999139|Prevention|prevention
191435|NCT02999126|Total Intravenous Anesthesia|total intravenous anesthesia
191436|NCT02999126|Titration|titration
191437|NCT02999126|Target Controlled Infusion|target controlled infusion
191438|NCT02999126|Propofol|propofol
191439|NCT02999126|Bispectral index|bispectral index
191440|NCT02999113|non-technical skills|non-technical skills
191441|NCT02999113|patient safety|patient safety
191442|NCT02999113|medical education|medical education
191443|NCT02999100|oxytocin|oxytocin
191444|NCT02999100|non-pregnant|non-pregnant
191445|NCT02999100|pregnant|pregnant
191446|NCT02999100|Postpartum Hemorrhage|postpartum hemorrhage
191447|NCT02999087|Head and Neck cancer|head and neck cancer
191448|NCT02999087|Immunotherapy|immunotherapy
191449|NCT02999074|exercise|exercise
191450|NCT02999074|resistance training|resistance training
191451|NCT02999074|aerobic training|aerobic training
191452|NCT02999074|breast cancer|breast cancer
191453|NCT02999074|neoadjuvant chemotherapy|neoadjuvant chemotherapy
191454|NCT02999074|fatigue|fatigue
191455|NCT02999074|quality of life|quality of life
191456|NCT02999074|tumor response|tumor response
191457|NCT02999061|pre-term children|pre-term children
191458|NCT02999048|panax notoginseng saponins|panax notoginseng saponins
191459|NCT02999048|hypertensive intracerebral hemorrhage|hypertensive intracerebral hemorrhage
191460|NCT02999048|hematoma|hematoma
191461|NCT02999048|neurological function|neurological function
191462|NCT02999035|ocular surface sensitivity|ocular surface sensitivity
191463|NCT02999022|bone fractures|bone fractures
191464|NCT02999022|bony callus|bony callus
191465|NCT02999022|fractures, bone|fractures, bone
191466|NCT02999022|lithium|lithium
191467|NCT02999022|lithium carbonate|lithium carbonate
191468|NCT02999022|osteogenesis|osteogenesis
191469|NCT02999022|bone development|bone development
191470|NCT02999022|fracture healing|fracture healing
191471|NCT02999022|fracture repair|fracture repair
191472|NCT02998970|Cardiovascular Disease|cardiovascular disease
191473|NCT02998970|Type 2 Diabetes|type 2 diabetes
191474|NCT02998970|Cardiac Magnetic Resonance Imaging|cardiac magnetic resonance imaging
191475|NCT02998957|Acupuncture|acupuncture
191476|NCT02998957|TENS|tens
191478|NCT02998931|Glutamin|glutamin
191479|NCT02998931|Enteral Nutrition|enteral nutrition
191480|NCT02998931|Intensive Care Unit|intensive care unit
191481|NCT02998931|Critical Care Outcomes|critical care outcomes
191482|NCT02998931|inflammatory|inflammatory
191483|NCT02998931|Immune System|immune system
191484|NCT02998918|Inflammation|inflammation
191485|NCT02998918|HDL|hdl
191486|NCT02998918|Anti-inflammatory|anti-inflammatory
191487|NCT02998918|Supplementation|supplementation
191488|NCT02998918|Curcumin|curcumin
191489|NCT02998918|polyphenol|polyphenol
191490|NCT02998918|V-cam|v-cam
191491|NCT02998918|I-cam|i-cam
191492|NCT02998918|atherosclerosis|atherosclerosis
191493|NCT02998918|cardiovascular disease|cardiovascular disease
191494|NCT02998918|atherogenesis|atherogenesis
191495|NCT02998918|antioxidant|antioxidant
191496|NCT02998918|resveratrol|resveratrol
191497|NCT02998918|quercetin|quercetin
191498|NCT02998892|Sedentary Behavior|sedentary behavior
191499|NCT02998866|Cryoballoon Pulmonary Vein Isolation|cryoballoon pulmonary vein isolation
191500|NCT02998866|Esophageal Effects|esophageal effects
191501|NCT02998853|Non culprit|non culprit
191502|NCT02998853|STEMI PCI|stemi pci
191503|NCT02998853|angio QFR|angio qfr
191505|NCT02998853|Staged procedure|staged procedure
191506|NCT02998840|elevated blood pressure|elevated blood pressure
191507|NCT02998814|fissure sealant|fissure sealant
191508|NCT02998814|etch and rinse|etch and rinse
191509|NCT02998814|self etch|self etch
191510|NCT02998788|heart failure|heart failure
191511|NCT02998788|risk factor|risk factor
191512|NCT02998788|cardiovascular disease|cardiovascular disease
191513|NCT02998788|lifestyle behavior|lifestyle behavior
191514|NCT02998775|in vitro protein binding|in vitro protein binding
191515|NCT02998775|hepatic impairment|hepatic impairment
191516|NCT02998775|renal impairment|renal impairment
191517|NCT02998762|major depression|major depression
191518|NCT02998762|major depressive disorder|major depressive disorder
191519|NCT02998762|biomarkers|biomarkers
191520|NCT02998762|MDD|mdd
191521|NCT02998762|long term follow up|long term follow up
191522|NCT02998736|Colon|colon
191523|NCT02998723|Basic Life Support|basic life support
191524|NCT02998723|Education, Medical|education, medical
191525|NCT02998723|Cardiopulmonary Resuscitation|cardiopulmonary resuscitation
191526|NCT02998723|Learning|learning
191527|NCT02998697|Systolic Heart Failure|systolic heart failure
191528|NCT02998697|Anemia|anemia
191529|NCT02998697|Iron Deficiency|iron deficiency
191530|NCT02998684|Autism|autism
191531|NCT02998684|Adolescent|adolescent
191532|NCT02998684|Social skills|social skills
191533|NCT02998671|Acne, inflammatory acne, efficacy, safety, PK|acne, inflammatory acne, efficacy, safety, pk
191534|NCT02998658|Laparoscopy|laparoscopy
191535|NCT02998658|Barbed sutures|barbed sutures
191536|NCT02998658|Hysterectomy|hysterectomy
191537|NCT02998645|severe acquired aplastic anemia|severe acquired aplastic anemia
191538|NCT02998645|SAA|saa
191539|NCT02998645|first line|first line
191540|NCT02998645|eltrombopag|eltrombopag
191541|NCT02998645|cyclosporine|cyclosporine
191542|NCT02998645|h-ATG|h-atg
191543|NCT02998645|severe aplastic anemia|severe aplastic anemia
191544|NCT02998645|aplastic anemia|aplastic anemia
244872|NCT02667652|RCT|rct
191545|NCT02998593|Semen parameters Male infertility oligospermia Traditional Medicine|semen parameters male infertility oligospermia traditional medicine
191546|NCT02998580|late-life depression|late-life depression
191547|NCT02998580|treatment resistance|treatment resistance
191548|NCT02998515|supplemental oxygen|supplemental oxygen
191549|NCT02998515|concentrator|concentrator
191550|NCT02998515|endurance shuttle walk test|endurance shuttle walk test
191551|NCT02998502|Obsessive Compulsive Disorder (OCD)|obsessive compulsive disorder (ocd)
191552|NCT02998502|Anxiety|anxiety
191553|NCT02998502|Pediatrics|pediatrics
191554|NCT02998489|enteral nutrition|enteral nutrition
191555|NCT02998489|infant,premature|infant,premature
191556|NCT02998489|feeding method|feeding method
191557|NCT02998476|Diffuse large B-cell lymphoma|diffuse large b-cell lymphoma
191558|NCT02998476|relapsed|relapsed
191559|NCT02998476|refractory|refractory
191560|NCT02998476|non-Hodgkin lymphoma|non-hodgkin lymphoma
191561|NCT02998476|phosphatidylinositol 3-kinase δ (PI3Kδ) inhibitor|phosphatidylinositol 3-kinase δ (pi3kδ) inhibitor
191562|NCT02998476|Bruton's tyrosine kinase (BTK)|bruton's tyrosine kinase (btk)
191563|NCT02998463|Skin-to-skin|skin-to-skin
191564|NCT02998463|Kangaroo Care|kangaroo care
191565|NCT02998463|Kangaroo Mother Care|kangaroo mother care
191566|NCT02998450|Sickle Cell Disease|sickle cell disease
191567|NCT02998450|Sickle Beta 0 Thalassemia|sickle beta 0 thalassemia
191568|NCT02998424|propofol|propofol
191569|NCT02998424|pupillary diameter|pupillary diameter
191570|NCT02998411|anti-infectives|anti-infectives
191571|NCT02998411|adults|adults
191572|NCT02998411|pharmacokinetic|pharmacokinetic
191573|NCT02998411|pharmacodynamic end-points|pharmacodynamic end-points
191574|NCT02998411|clinical cure|clinical cure
191575|NCT02998398|Biosimilar|biosimilar
191576|NCT02998385|salivary glands|salivary glands
191577|NCT02998385|sinus carcinoma|sinus carcinoma
191578|NCT02998385|radiochemotherapy concomitant|radiochemotherapy concomitant
191579|NCT02998385|cisplatin|cisplatin
191580|NCT02998385|protontherapy|protontherapy
191581|NCT02998346|Nutrition|nutrition
191582|NCT02998346|CRRT|crrt
191583|NCT02998346|CVVH|cvvh
191584|NCT02998346|citrate|citrate
191585|NCT02998346|anticoagulation|anticoagulation
191586|NCT02998346|caloric uptake|caloric uptake
191587|NCT02998333|Instability|instability
191588|NCT02998333|Ankle|ankle
191589|NCT02998333|Surgical stabilization|surgical stabilization
191590|NCT02998281|cerebral palsy|cerebral palsy
191591|NCT02998281|inspiratory muscle training|inspiratory muscle training
191592|NCT02998255|PEG|peg
191593|NCT02998255|Bowel preparation|bowel preparation
191594|NCT02998255|Colonoscopy|colonoscopy
191595|NCT02998203|organic diet|organic diet
191596|NCT02998203|health|health
191597|NCT02998203|pesticides|pesticides
191598|NCT02998203|inflammation biomarkers|inflammation biomarkers
191599|NCT02998203|oxidative stress biomarkers|oxidative stress biomarkers
191600|NCT02998177|Postoperative pain|postoperative pain
191601|NCT02998177|Rebound pain|rebound pain
191602|NCT02998177|Gut microbiome|gut microbiome
191603|NCT02998177|Gut microbiota|gut microbiota
191604|NCT02998177|Peripheral nerve block|peripheral nerve block
191605|NCT02998177|Axillary brachial plexus block|axillary brachial plexus block
191606|NCT02998138|Chronic Pain|chronic pain
191607|NCT02998138|Pain, Postoperative|pain, postoperative
191608|NCT02998112|fecal microbiota transplantation|fecal microbiota transplantation
191609|NCT02998112|Ulcerative colitis|ulcerative colitis
191610|NCT02998099|Healthy Volunteers|healthy volunteers
191611|NCT02998099|Rivipansel|rivipansel
191612|NCT02998060|Robot|robot
191613|NCT02998060|Spinal Fusion|spinal fusion
191614|NCT02998060|Spine|spine
191615|NCT02998060|Navigation|navigation
191616|NCT02998060|Freehand|freehand
191617|NCT02998008|Exercise Therapy|exercise therapy
191618|NCT02998008|Heart Function Tests|heart function tests
191619|NCT02998008|Heart/physiology|heart/physiology
191620|NCT02998008|Echocardiography|echocardiography
191621|NCT02997995|T2-T4 Breast cancer|t2-t4 breast cancer
191622|NCT02997995|Estrogen Receptor Positive Tumor|estrogen receptor positive tumor
191623|NCT02997995|PD-1|pd-1
191624|NCT02997995|Neoadjuvant|neoadjuvant
191625|NCT02997995|Immune-attractants|immune-attractants
191626|NCT02997995|lymphocytes activation|lymphocytes activation
191627|NCT02997982|Alzheimer's Disease|alzheimer's disease
191628|NCT02997982|Herpes Simplex Virus|herpes simplex virus
191629|NCT02997982|HSV|hsv
191630|NCT02997982|Antiviral Drugs|antiviral drugs
191631|NCT02997969|HIV|hiv
191632|NCT02997943|Obesity|obesity
191633|NCT02997943|Weight Loss|weight loss
191634|NCT02997943|Diet|diet
191635|NCT02997943|Physical Activity|physical activity
191636|NCT02997943|Mobile Health|mobile health
191637|NCT02997904|lice comb|lice comb
191638|NCT02997904|human head lice infestations|human head lice infestations
191639|NCT02997904|combing solution|combing solution
191640|NCT02997891|cognition|cognition
191641|NCT02997891|hip replacement|hip replacement
191642|NCT02997891|physical activity|physical activity
191643|NCT02997891|quality of life|quality of life
191644|NCT02997891|psychological distress|psychological distress
191645|NCT02997878|autoimmune|autoimmune
191646|NCT02997878|AiH|aih
191647|NCT02997878|PSC|psc
191648|NCT02997878|liver disease|liver disease
191649|NCT02997878|cholangitis|cholangitis
191650|NCT02997865|heart failure|heart failure
191651|NCT02997865|depressive disorder, major|depressive disorder, major
191652|NCT02997865|cognitive therapy|cognitive therapy
191653|NCT02997865|self-care|self-care
191654|NCT02997852|human-animal interaction|human-animal interaction
191655|NCT02997787|adenomyosis|adenomyosis
191656|NCT02997787|leiomyoma|leiomyoma
191657|NCT02997787|neutrophil to lymphocyte ratio|neutrophil to lymphocyte ratio
191658|NCT02997787|platelet to lymphocyte ratio|platelet to lymphocyte ratio
191659|NCT02997748|acute kidney injury|acute kidney injury
191660|NCT02997748|cardiac surgery|cardiac surgery
191661|NCT02997748|Remote ischemic preconditioning|remote ischemic preconditioning
191662|NCT02997748|[TIMP-2]*[IGFBP7]|[timp-2]*[igfbp7]
191663|NCT02997735|Secondhand Smoke|secondhand smoke
191664|NCT02997735|Nicotine Replacement Therapy|nicotine replacement therapy
191665|NCT02997735|Clinical Decision Support|clinical decision support
191666|NCT02997735|Tobacco quitline|tobacco quitline
191667|NCT02997722|ketamine|ketamine
191668|NCT02997722|suicide|suicide
191669|NCT02997709|Prostate Cancer|prostate cancer
191670|NCT02997709|Circulating Tumor Cells|circulating tumor cells
191671|NCT02997709|CTCs|ctcs
191672|NCT02997709|Androgen Deprivation Therapy|androgen deprivation therapy
191673|NCT02997709|ADT|adt
191674|NCT02997670|Cardiac resynchronization pacing therapy|cardiac resynchronization pacing therapy
191675|NCT02997644|patient education|patient education
191676|NCT02997644|orthopaedic surgery|orthopaedic surgery
191677|NCT02997644|post-surgical pain|post-surgical pain
191678|NCT02997644|chronic opioid use|chronic opioid use
191679|NCT02997631|Pain Management|pain management
191680|NCT02997631|Distraction Therapy|distraction therapy
191681|NCT02997631|Robot Based Distraction|robot based distraction
191682|NCT02997631|MEDi|medi
191683|NCT02997605|low disease activity|low disease activity
191684|NCT02997605|remission|remission
191685|NCT02997566|Autonomic Nervous System|autonomic nervous system
191686|NCT02997566|Sympathetic Nervous System|sympathetic nervous system
191687|NCT02997566|Heart Rate|heart rate
191688|NCT02997553|Indocyanine green (ICG)|indocyanine green (icg)
191689|NCT02997553|Sentinel lymph node biopsy|sentinel lymph node biopsy
191690|NCT02997553|Technetium99|technetium99
191691|NCT02997553|Tumors|tumors
191692|NCT02997553|Optonuclear probe|optonuclear probe
191693|NCT02997553|Surgery|surgery
191694|NCT02997540|female breast lesion|female breast lesion
191695|NCT02997540|ultrasound examination|ultrasound examination
191696|NCT02997514|Solution focused coaching|solution focused coaching
191697|NCT02997514|Self determination|self determination
191698|NCT02997488|videolaryngoscope|videolaryngoscope
191699|NCT02997475|Bulimia Nervosa|bulimia nervosa
191700|NCT02997475|Bulimia|bulimia
191701|NCT02997475|fMRI|fmri
191702|NCT02997475|Emotion Regulation|emotion regulation
191703|NCT02997475|Response Inhibition|response inhibition
191704|NCT02997462|Monocyte|monocyte
191705|NCT02997462|Oxidative Stress|oxidative stress
191706|NCT02997462|Endothelial Function|endothelial function
191707|NCT02997462|Congestive Heart Failure|congestive heart failure
191708|NCT02997449|Non-Small Cell Lung Cancer (NSCLC)|non-small cell lung cancer (nsclc)
191709|NCT02997449|Stereotactic ablative radiotherapy (SABR)|stereotactic ablative radiotherapy (sabr)
191710|NCT02997449|Intrathoracic nodal staging|intrathoracic nodal staging
191711|NCT02997423|Glioblastoma Multiforme|glioblastoma multiforme
191712|NCT02997423|Biomarker|biomarker
191713|NCT02997423|Cytochrome C Oxidase|cytochrome c oxidase
191714|NCT02997423|Newly diagnosed|newly diagnosed
191715|NCT02997410|Ozone|ozone
191716|NCT02997371|Traumatic brain injury|traumatic brain injury
191717|NCT02997371|Microdialysis|microdialysis
191718|NCT02997371|Interleukin-1 receptor antagonist|interleukin-1 receptor antagonist
191719|NCT02997371|Magnetic Resonance Imaging|magnetic resonance imaging
191720|NCT02997371|Positron Emission Tomography|positron emission tomography
191721|NCT02997345|PPROM|pprom
191722|NCT02997319|Diabetes Mellitus, Type 2|diabetes mellitus, type 2
191723|NCT02997319|Insulin Resistance|insulin resistance
191724|NCT02997319|Shift Work|shift work
191725|NCT02997319|Circadian Rhythms|circadian rhythms
191726|NCT02997319|MTNR1B|mtnr1b
191727|NCT02997306|Moh's Surgery|moh's surgery
191728|NCT02997306|Erythema|erythema
191729|NCT02997306|Face|face
191730|NCT02997306|Simple Interrupted Sutures|simple interrupted sutures
191731|NCT02997306|Running Sutures|running sutures
191732|NCT02997306|Image Processing|image processing
191733|NCT02997280|acute graft-versus-host disease|acute graft-versus-host disease
191734|NCT02997280|chronic graft-versus-host disease|chronic graft-versus-host disease
191735|NCT02997280|Steroid-refractory GVHD|steroid-refractory gvhd
191736|NCT02997280|ruxolitinib|ruxolitinib
191737|NCT02997280|JAK inhibitors|jak inhibitors
191738|NCT02997254|atrial fibrillation|atrial fibrillation
191739|NCT02997254|ablation|ablation
191740|NCT02997254|abnormal heart rhythm|abnormal heart rhythm
191741|NCT02997241|Colonic Neoplasms|colonic neoplasms
191742|NCT02997241|recurrence|recurrence
191743|NCT02997215|intravenous lidocaine|intravenous lidocaine
191744|NCT02997215|postoperative pain management|postoperative pain management
191745|NCT02997202|Gilteritinib|gilteritinib
191746|NCT02997202|ASP2215|asp2215
191747|NCT02997202|Safety and Efficacy|safety and efficacy
191748|NCT02997202|Acute Myeloid Leukemia|acute myeloid leukemia
191749|NCT02997150|Idiopathic nephrotic syndrome-child-steroid dependant-IL2|idiopathic nephrotic syndrome-child-steroid dependant-il2
191750|NCT02997150|Safety|safety
191751|NCT02997150|Efficacy|efficacy
191752|NCT02997137|Chronic psychological distress|chronic psychological distress
191753|NCT02997137|Chronic exhaustion conditions|chronic exhaustion conditions
191754|NCT02997137|Perceived Stress Questionnaire 30 (PSQ30)|perceived stress questionnaire 30 (psq30)
191755|NCT02997137|Stress management|stress management
191756|NCT02997137|Dietary supplement|dietary supplement
191757|NCT02997124|Alveolar bone grafting|alveolar bone grafting
191758|NCT02997124|delirium|delirium
191759|NCT02997124|early ambulation|early ambulation
191760|NCT02997098|Hepatectomy|hepatectomy
191761|NCT02997085|Pain|pain
191762|NCT02997085|Virtual Reality|virtual reality
191763|NCT02997085|Opioid|opioid
191764|NCT02997085|Prescription pain reliever|prescription pain reliever
191765|NCT02997085|Treatment|treatment
191766|NCT02997072|electrical impedance tomography|electrical impedance tomography
191767|NCT02997072|high frequency jet ventilation|high frequency jet ventilation
191768|NCT02997072|drive pressure|drive pressure
191769|NCT02997059|Crohn disease|crohn disease
191770|NCT02997059|Candida|candida
191771|NCT02997059|ASCA|asca
191772|NCT02997046|Ferumoxytol|ferumoxytol
191773|NCT02997046|MRI|mri
191774|NCT02997046|fistula|fistula
191775|NCT02997046|graft|graft
191776|NCT02997046|kidney transplant|kidney transplant
191777|NCT02997046|angiography|angiography
191778|NCT02997046|arteriovenous|arteriovenous
191779|NCT02997033|Bone|bone
191780|NCT02997033|Sex steroids|sex steroids
191781|NCT02997033|Body composition|body composition
191782|NCT02997033|Men|men
191783|NCT02997007|tDCS|tdcs
191784|NCT02997007|Mild Cognitive Impairment|mild cognitive impairment
191785|NCT02997007|fMRI|fmri
191786|NCT02997007|Healthy ageing|healthy ageing
191787|NCT02996955|Low Back Pain|low back pain
191788|NCT02996955|Social Support|social support
191789|NCT02996955|Illness Perceptions|illness perceptions
191790|NCT02996955|Activity Advice|activity advice
191791|NCT02996942|haemophilia, joint disease, quality of life|haemophilia, joint disease, quality of life
191792|NCT02996903|Cardiac Computed Tomography (CT) Angiography (CCTA)|cardiac computed tomography (ct) angiography (ccta)
191793|NCT02996903|coronary artery disease|coronary artery disease
191794|NCT02996903|malignancy induction|malignancy induction
191795|NCT02996903|radiation dose|radiation dose
191796|NCT02996903|dose saving techniques|dose saving techniques
191797|NCT02996903|effective dose|effective dose
191798|NCT02996864|college students|college students
191799|NCT02996864|physical activity|physical activity
191800|NCT02996864|sleep behaviors|sleep behaviors
191801|NCT02996864|diet|diet
191802|NCT02996851|Fibrinolytic Agents|fibrinolytic agents
191803|NCT02996851|Adverse effects|adverse effects
191804|NCT02996851|Norway|norway
191805|NCT02996851|Registries|registries
191806|NCT02996812|Post-bariatric hypoglycemia|post-bariatric hypoglycemia
191807|NCT02996812|Non-insulinoma pancreatogenous hypoglycemia syndrome|non-insulinoma pancreatogenous hypoglycemia syndrome
191808|NCT02996812|Late dumping syndrome|late dumping syndrome
191809|NCT02996773|high-risk malignancies|high-risk malignancies
191810|NCT02996773|Lymphoma|lymphoma
191811|NCT02996773|Haploidentical|haploidentical
191812|NCT02996773|Bone Marrow Transplant (BMT)|bone marrow transplant (bmt)
191813|NCT02996773|Post-transplant|post-transplant
191814|NCT02996773|myeloablative (MAC)|myeloablative (mac)
191815|NCT02996773|reduced intensity conditioning (RIC)|reduced intensity conditioning (ric)
191816|NCT02996773|haploidentical hematopoietic cell transplantation (HHCT)|haploidentical hematopoietic cell transplantation (hhct)
191817|NCT02996773|Leukemia|leukemia
191818|NCT02996747|bone tumors|bone tumors
191819|NCT02996747|chondroma|chondroma
191820|NCT02996747|chondrosarcoma|chondrosarcoma
191821|NCT02996734|bone tumors|bone tumors
191822|NCT02996734|giant cell tumor|giant cell tumor
191823|NCT02996734|treatment|treatment
191824|NCT02996708|Telemedicine|telemedicine
191825|NCT02996708|Health economics|health economics
191826|NCT02996695|Chemoprophylaxis|chemoprophylaxis
191827|NCT02996695|Chloroquine|chloroquine
191828|NCT02996695|Cryopreserved|cryopreserved
191829|NCT02996695|Malaria|malaria
191830|NCT02996695|Plasmodium|plasmodium
191831|NCT02996695|Sporozoites|sporozoites
191832|NCT02996682|Communicable Diseases|communicable diseases
191833|NCT02996682|Hepatitis|hepatitis
191834|NCT02996682|Hepatitis C|hepatitis c
191835|NCT02996682|Virus Diseases|virus diseases
191836|NCT02996682|Liver Diseases|liver diseases
191837|NCT02996682|Digestive System Diseases|digestive system diseases
191838|NCT02996682|Hepatitis, Viral, Human|hepatitis, viral, human
191839|NCT02996682|Velpatasvir|velpatasvir
191840|NCT02996682|RNA Virus Infections|rna virus infections
191841|NCT02996682|Ribavirin|ribavirin
191842|NCT02996682|Sofosbuvir|sofosbuvir
191843|NCT02996682|Antiviral Agents|antiviral agents
191844|NCT02996682|Antimetabolites|antimetabolites
191845|NCT02996682|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action
191846|NCT02996682|Anti-Infective Agents|anti-infective agents
191847|NCT02996682|Decompensated Cirrhosis|decompensated cirrhosis
191848|NCT02996643|Adolescent Idiopathic Scoliosis|adolescent idiopathic scoliosis
191849|NCT02996643|Brace Treatment|brace treatment
191850|NCT02996643|Ultrasound Imaging|ultrasound imaging
191851|NCT02996630|LVOTO|lvoto
191852|NCT02996630|Fallot|fallot
191853|NCT02996630|Great Arteries Transposition|great arteries transposition
191854|NCT02996617|Lymphomas Non-Hodgkin's B-Cell|lymphomas non-hodgkin's b-cell
191855|NCT02996617|Lymphomas Non-Hodgkin's T-Cell|lymphomas non-hodgkin's t-cell
191856|NCT02996617|PEG-rhG-CSF|peg-rhg-csf
191857|NCT02996617|Neutropenia|neutropenia
191858|NCT02996604|acupuncture|acupuncture
191859|NCT02996604|functional dyspepsia|functional dyspepsia
191860|NCT02996604|functional magnetic resonance imaging (fMRI)|functional magnetic resonance imaging (fmri)
191861|NCT02996591|Nerve Block|nerve block
191862|NCT02996591|General Anesthesia|general anesthesia
191863|NCT02996591|Spinal Anesthesia|spinal anesthesia
191864|NCT02996591|Pain|pain
191865|NCT02996591|Postoperative Nausea and Vomiting|postoperative nausea and vomiting
191866|NCT02996578|Cognition|cognition
191867|NCT02996578|Cacao|cacao
191868|NCT02996578|Flavan-3-ols|flavan-3-ols
191869|NCT02996578|Blood Pressure|blood pressure
191870|NCT02996578|hemoglobin A1c protein, human|hemoglobin a1c protein, human
191871|NCT02996578|Memory|memory
191872|NCT02996565|Clinic care|clinic care
191873|NCT02996565|Team-based care|team-based care
191874|NCT02996565|Medication Therapy Management (MTM)|medication therapy management (mtm)
191875|NCT02996565|Telehealth|telehealth
191876|NCT02996565|Cluster-randomized|cluster-randomized
191877|NCT02996565|Home blood pressure monitoring|home blood pressure monitoring
191878|NCT02996565|Pharmacist|pharmacist
191879|NCT02996552|Tricuspid annulus dilation|tricuspid annulus dilation
191880|NCT02996552|mitral valve regurgitation|mitral valve regurgitation
191881|NCT02996526|vocal cord palsy dysfunction thoracic surgery complication|vocal cord palsy dysfunction thoracic surgery complication
191882|NCT02996513|Vitamin A status|vitamin a status
191883|NCT02996513|Retinol Isotope Dilution|retinol isotope dilution
191884|NCT02996513|Nigeria|nigeria
191885|NCT02996513|Preschool children|preschool children
191886|NCT02996513|Malaria|malaria
191887|NCT02996513|Inflammation|inflammation
191888|NCT02996474|Pembrolizumab|pembrolizumab
191889|NCT02996474|Decitabine|decitabine
191890|NCT02996474|AML (Acute Myelogenous Leukemia)|aml (acute myelogenous leukemia)
191891|NCT02996461|Zika Infection|zika infection
191892|NCT02996461|Immune Response|immune response
191893|NCT02996461|Flavivirus|flavivirus
191894|NCT02996461|Arthropod-Borne Virus|arthropod-borne virus
191895|NCT02996448|AD-HIES|ad-hies
191896|NCT02996448|Anti-rAls3 Antibody|anti-rals3 antibody
191897|NCT02996448|Staphylococcus Aureus|staphylococcus aureus
191898|NCT02996448|Candida Albicans|candida albicans
191899|NCT02996448|RNA Transcriptome|rna transcriptome
191900|NCT02996396|AAA, Aortoiliac Aneurysm|aaa, aortoiliac aneurysm
191901|NCT02996383|arthroplasty|arthroplasty
191902|NCT02996370|esthetic|esthetic
191903|NCT02996370|inter-implant papilla|inter-implant papilla
191904|NCT02996370|soft tissue tickness|soft tissue tickness
191905|NCT02996370|crestal bone loss|crestal bone loss
191906|NCT02996370|second stage surgery|second stage surgery
191907|NCT02996357|Incontinence-associated dermatitis|incontinence-associated dermatitis
191908|NCT02996357|Risk factor|risk factor
191909|NCT02996357|Intensive care unit|intensive care unit
191910|NCT02996357|Prevention|prevention
191911|NCT02996331|Ulcer|ulcer
191912|NCT02996331|Pressure Ulcer|pressure ulcer
191913|NCT02996331|Pathologic Processes|pathologic processes
191914|NCT02996331|Skin Ulcer|skin ulcer
191915|NCT02996331|Skin Diseases|skin diseases
191916|NCT02996292|Crowding|crowding
191917|NCT02996292|Self ligating|self ligating
191918|NCT02996292|CBCT|cbct
191919|NCT02996292|RCT|rct
191920|NCT02996279|Neonate|neonate
191921|NCT02996279|Chorioamnionitis|chorioamnionitis
191922|NCT02996279|S100A12|s100a12
191923|NCT02996266|Targeted Temperature Management|targeted temperature management
191924|NCT02996175|Behavior|behavior
191925|NCT02996175|Sleep|sleep
191926|NCT02996175|Problems|problems
191927|NCT02996175|Intervention|intervention
191928|NCT02996162|Bronchopulmonary Dysplasia|bronchopulmonary dysplasia
191929|NCT02996162|Chronic Lung Disease|chronic lung disease
191930|NCT02996162|Prematurity|prematurity
191931|NCT02996084|Imaging research|imaging research
191932|NCT02995980|breast cancer screening|breast cancer screening
191933|NCT02995980|dense breasts|dense breasts
191934|NCT02995980|dual-energy contrast-enhanced digital mammography|dual-energy contrast-enhanced digital mammography
191935|NCT02995954|Combination therapy|combination therapy
191936|NCT02995954|ACE inhibitor Calcium Antagonist|ace inhibitor calcium antagonist
191937|NCT02995941|reliability|reliability
191938|NCT02995941|validity|validity
191939|NCT02995941|classification|classification
191940|NCT02995941|irritability|irritability
191941|NCT02995941|symptom|symptom
191942|NCT02995941|intensity|intensity
191943|NCT02995941|intervention|intervention
191944|NCT02995928|Subarachnoid Hemorrhage|subarachnoid hemorrhage
191945|NCT02995928|Decompressive Craniectomy|decompressive craniectomy
191946|NCT02995928|Cerebral Aneurysm|cerebral aneurysm
191947|NCT02995837|Obstructive Sleep Apnea Syndrome|obstructive sleep apnea syndrome
191948|NCT02995837|Cerebral Blood Flow|cerebral blood flow
191949|NCT02995837|Neurocognition|neurocognition
191950|NCT02995824|Liver transplantation|liver transplantation
191951|NCT02995824|HIV infection|hiv infection
191952|NCT02995824|Antiretroviral therapy|antiretroviral therapy
191953|NCT02995824|Raltegravir|raltegravir
191954|NCT02995785|Simulation|simulation
191955|NCT02995733|asthma|asthma
191956|NCT02995733|African Americans|african americans
191957|NCT02995733|Hispanics|hispanics
191958|NCT02995707|Thalidomide NTDT|thalidomide ntdt
191959|NCT02995681|COPD|copd
191960|NCT02995681|Falls|falls
191961|NCT02995681|Balance training|balance training
191962|NCT02995642|Aortic Aneurysm, Abdominal|aortic aneurysm, abdominal
191963|NCT02995642|Carotid Stenosis|carotid stenosis
191964|NCT02995642|Atherosclerosis|atherosclerosis
191965|NCT02995642|Angiogenesis|angiogenesis
191966|NCT02995642|Inflammation|inflammation
191967|NCT02995642|Macrophages|macrophages
191968|NCT02995642|Positron-Emission Tomography|positron-emission tomography
191969|NCT02995642|Computerized tomography|computerized tomography
191970|NCT02995642|Magnetic Resonance Imaging|magnetic resonance imaging
191971|NCT02995642|(18F)FPP(RGD)2|(18f)fpp(rgd)2
191972|NCT02995616|Robot-Assisted Gait Training|robot-assisted gait training
191973|NCT02995616|Guidance force|guidance force
191974|NCT02995616|Stroke|stroke
191975|NCT02995616|Energy Consumption|energy consumption
191976|NCT02995616|Cardiorespiratory Load|cardiorespiratory load
192081|NCT02994758|NGS|ngs
191977|NCT02995603|Radiotherapy|radiotherapy
191978|NCT02995603|Rotation|rotation
191979|NCT02995564|Social Skills|social skills
191980|NCT02995564|Asperger's|asperger's
191981|NCT02995564|High-functioning autism|high-functioning autism
191982|NCT02995564|Young adults|young adults
191983|NCT02995551|Menisci, Tibial|menisci, tibial
191984|NCT02995551|Knee Injuries|knee injuries
191985|NCT02995551|Arthroscopy|arthroscopy
191986|NCT02995551|Exercise|exercise
191987|NCT02995551|Young adults|young adults
191988|NCT02995551|Treatment Outcome|treatment outcome
191989|NCT02995551|Humans|humans
191990|NCT02995512|myocardial infarction|myocardial infarction
191991|NCT02995512|colchicine|colchicine
191992|NCT02995512|anti-inflammatory|anti-inflammatory
191993|NCT02995499|ASA-PS classification|asa-ps classification
191994|NCT02995499|inter-rater reliability|inter-rater reliability
191995|NCT02995499|general surgery|general surgery
191996|NCT02995473|Psoriasis|psoriasis
191997|NCT02995460|Exercise Therapy|exercise therapy
191998|NCT02995447|propofol|propofol
191999|NCT02995447|electroencephalogram|electroencephalogram
192000|NCT02995434|Virtual Reality|virtual reality
192001|NCT02995434|Cancer Survivorship|cancer survivorship
192002|NCT02995434|Pain Management|pain management
192003|NCT02995434|Cancer Pain Management|cancer pain management
192004|NCT02995434|Chronic Pain Management|chronic pain management
192005|NCT02995434|Adjunctive Pain Management|adjunctive pain management
192006|NCT02995408|resiliency training|resiliency training
192007|NCT02995408|parenting|parenting
192008|NCT02995408|Autism Spectrum Disorders|autism spectrum disorders
192009|NCT02995369|Sealants|sealants
192010|NCT02995369|Dryshield|dryshield
192011|NCT02995369|Cotton roll|cotton roll
192012|NCT02995369|Isolation|isolation
192013|NCT02995369|Efficiency|efficiency
192014|NCT02995369|Preference|preference
192015|NCT02995356|Ectopic pregnancy|ectopic pregnancy
192016|NCT02995356|Axonemal Dynein Heavy Chain 5|axonemal dynein heavy chain 5
192017|NCT02995356|Creatine Kinase|creatine kinase
192018|NCT02995356|Cervical fluid|cervical fluid
192019|NCT02995330|Metastatic Castration-Resistant Prostate Cancer|metastatic castration-resistant prostate cancer
192020|NCT02995330|Bone Marrow Transplantation|bone marrow transplantation
192021|NCT02995317|Aged|aged
192022|NCT02995317|Gait|gait
192023|NCT02995317|Postural Balance|postural balance
192024|NCT02995317|Accelerometry|accelerometry
192025|NCT02995317|Physical Activity|physical activity
192026|NCT02995265|Exoskeleton|exoskeleton
192027|NCT02995265|Stroke|stroke
192028|NCT02995265|Walking|walking
192029|NCT02995265|Rehabilitation|rehabilitation
192030|NCT02995187|Apatinib|apatinib
192031|NCT02995187|Third-line and Later Therapy|third-line and later therapy
192032|NCT02995187|Small Cell Lung Cancer|small cell lung cancer
192033|NCT02995174|amblyopia|amblyopia
192034|NCT02995174|fixation stability|fixation stability
192035|NCT02995174|perceptual learning|perceptual learning
192036|NCT02995083|osteoarthritis|osteoarthritis
192037|NCT02995057|Microneedles|microneedles
192038|NCT02995057|Biocompatibility|biocompatibility
192039|NCT02995057|Allergy|allergy
192040|NCT02995057|Metal|metal
192041|NCT02995057|Nickel|nickel
192042|NCT02995057|Contact dermatitis|contact dermatitis
192043|NCT02995005|mother to child transmission|mother to child transmission
192044|NCT02995005|hepatitis B|hepatitis b
192045|NCT02995005|tenofovir|tenofovir
192046|NCT02994953|Avelumab|avelumab
192047|NCT02994953|M9241|m9241
192048|NCT02994953|NHS-IL12|nhs-il12
192049|NCT02994953|Advanced Solid Tumors|advanced solid tumors
192050|NCT02994927|ANCA-associated vasculitis|anca-associated vasculitis
192051|NCT02994927|complement|complement
192052|NCT02994927|vasculitis|vasculitis
192053|NCT02994927|C5aR|c5ar
192054|NCT02994927|avacopan|avacopan
192055|NCT02994927|CCX168|ccx168
192056|NCT02994927|MPA|mpa
192057|NCT02994927|GPA|gpa
192058|NCT02994914|Breast Cancer|breast cancer
192059|NCT02994914|Onco Geriatric Evaluation|onco geriatric evaluation
192060|NCT02994914|Radiotherapy|radiotherapy
192061|NCT02994914|Hypo fractionated radiotherapy|hypo fractionated radiotherapy
192062|NCT02994914|Normo fractionated radiotherapy|normo fractionated radiotherapy
192063|NCT02994914|Large hypo fractionated radiotherapy|large hypo fractionated radiotherapy
192064|NCT02994901|Sarcopenia|sarcopenia
192065|NCT02994901|Geriatrics|geriatrics
192066|NCT02994901|Biomarker|biomarker
192067|NCT02994836|Crohn's Disease|crohn's disease
192068|NCT02994836|Inflammatory bowel disease|inflammatory bowel disease
192069|NCT02994836|Anti-TNF discontinuation|anti-tnf discontinuation
192070|NCT02994836|Ulcerative colitis|ulcerative colitis
192071|NCT02994810|Breastfeeding|breastfeeding
192072|NCT02994810|Orientation|orientation
192073|NCT02994797|salivary glands|salivary glands
192074|NCT02994797|ultrasonography|ultrasonography
192075|NCT02994797|elastometry|elastometry
192076|NCT02994797|elastography|elastography
192077|NCT02994771|Lymphedema, Breast cancer|lymphedema, breast cancer
192078|NCT02994758|Prostate|prostate
192079|NCT02994758|bladder|bladder
192080|NCT02994758|renal|renal
192082|NCT02994758|DSRT|dsrt
192083|NCT02994758|drug screening|drug screening
192084|NCT02994758|sequencing|sequencing
192085|NCT02994758|personalised medicine|personalised medicine
192086|NCT02994693|Barrett's Esophagus|barrett's esophagus
192087|NCT02994693|Natural History|natural history
192088|NCT02994693|Device|device
192089|NCT02994693|OCT|oct
192090|NCT02994693|Capsule|capsule
192091|NCT02994693|Tethered Capsule Endomicroscopy|tethered capsule endomicroscopy
192092|NCT02994680|Air Pollution|air pollution
192093|NCT02994680|Liquefied Petroleum Gas|liquefied petroleum gas
192094|NCT02994680|Cookstove|cookstove
192095|NCT02994680|Behavioral Intervention|behavioral intervention
192096|NCT02994680|Propane Stove|propane stove
192097|NCT02994667|Electrophysiology|electrophysiology
192098|NCT02994641|critical care|critical care
192099|NCT02994641|patient discharge|patient discharge
192100|NCT02994641|costs and cost analysis|costs and cost analysis
192101|NCT02994641|length of stay|length of stay
192102|NCT02994641|hospital mortality|hospital mortality
192103|NCT02994628|oxidative stress|oxidative stress
192104|NCT02994628|immune function|immune function
192105|NCT02994628|muscle damage|muscle damage
192106|NCT02994628|carbohydrate|carbohydrate
192107|NCT02994628|polyphenols|polyphenols
192108|NCT02994628|cycling|cycling
192109|NCT02994615|Index of Microvascular Resistance|index of microvascular resistance
192110|NCT02994615|Microvascular dysfunction|microvascular dysfunction
192111|NCT02994602|Healthy Men|healthy men
192112|NCT02994602|Male Contraception|male contraception
192113|NCT02994602|Healthy Women|healthy women
192114|NCT02994602|Transfer|transfer
192115|NCT02994602|Transference|transference
192116|NCT02994602|Gel|gel
192117|NCT02994602|Nestorone|nestorone
192118|NCT02994602|Testosterone|testosterone
192119|NCT02994550|FSH|fsh
192120|NCT02994550|LH|lh
192121|NCT02994550|IVF|ivf
192122|NCT02994511|Circulating tumour DNA|circulating tumour dna
192123|NCT02994511|ctDNA|ctdna
192124|NCT02994420|Obesity|obesity
192125|NCT02994420|Menstrual Cycle|menstrual cycle
192126|NCT02994420|Gonadal Steroid Hormones|gonadal steroid hormones
192127|NCT02994420|Satiety Response|satiety response
192128|NCT02994420|Glucagon-Like Peptide 1|glucagon-like peptide 1
192129|NCT02994420|Cholecystokinin|cholecystokinin
192130|NCT02994420|Magnetic Resonance Imaging|magnetic resonance imaging
192131|NCT02994381|Healthy Male Adults|healthy male adults
192133|NCT02994381|RPC1063|rpc1063
192134|NCT02994368|retinal degeneration|retinal degeneration
192135|NCT02994368|eye|eye
192136|NCT02994368|REP-1 gene|rep-1 gene
192137|NCT02994355|Family planning clinics|family planning clinics
192138|NCT02994355|Implementation Science|implementation science
192139|NCT02994355|Systems Analysis and Improvement Approach (SAIA)|systems analysis and improvement approach (saia)
192140|NCT02994342|vaginal dryness|vaginal dryness
192141|NCT02994342|vaginal gel|vaginal gel
192142|NCT02994342|colostrum|colostrum
192143|NCT02994342|vaginal atrophy|vaginal atrophy
192144|NCT02994329|HIV testing|hiv testing
192145|NCT02994329|Linkage to care|linkage to care
192146|NCT02994303|Fabry disease|fabry disease
192147|NCT02994303|Fabry nephropathy|fabry nephropathy
192148|NCT02994303|end-stage renal disease|end-stage renal disease
192149|NCT02994303|Anderson-Fabry disease|anderson-fabry disease
192150|NCT02994303|Fabry's disease|fabry's disease
192151|NCT02994277|"Artificial Pancreas"|"artificial pancreas"
192152|NCT02994277|"control System"|"control system"
192153|NCT02994277|"Closed loop"|"closed loop"
192154|NCT02994277|diabetes|diabetes
192155|NCT02994277|"T1DM"|"t1dm"
192156|NCT02994277|"pump"|"pump"
192157|NCT02994277|algorithm|algorithm
192158|NCT02994277|CGM|cgm
192159|NCT02994199|Active video gaming|active video gaming
192160|NCT02994199|Energy expenditure|energy expenditure
192161|NCT02994186|cognitive function|cognitive function
192162|NCT02994186|obesity|obesity
192163|NCT02994186|bariatric surgery|bariatric surgery
192164|NCT02994186|metabolic surgery|metabolic surgery
192165|NCT02994160|peripheral nerve|peripheral nerve
192166|NCT02994160|intraneural electrode|intraneural electrode
192167|NCT02994160|hand amputation|hand amputation
192168|NCT02994160|forearm amputation|forearm amputation
192169|NCT02994108|Human Papillomavirus|human papillomavirus
192170|NCT02994108|Men Who Have Sex with Men|men who have sex with men
192171|NCT02994082|Rural health|rural health
192172|NCT02994082|Veterans|veterans
192173|NCT02994082|Smokeless tobacco cessation|smokeless tobacco cessation
192174|NCT02994069|Cisplatin|cisplatin
192175|NCT02994069|Squamous Cell|squamous cell
192176|NCT02994069|Carcinoma|carcinoma
192177|NCT02994030|Duchenne Disease|duchenne disease
192178|NCT02994030|Biomarker|biomarker
192179|NCT02994017|cystic fibrosis|cystic fibrosis
192180|NCT02994017|Cardiopulmonary exercise testing|cardiopulmonary exercise testing
192181|NCT02994017|prognostic|prognostic
192182|NCT02994004|Hospital, medical decision-making, role conflict, f-MRI|hospital, medical decision-making, role conflict, f-mri
192183|NCT02993978|Pediatric radiotherapy|pediatric radiotherapy
192184|NCT02993926|Drug Therapy|drug therapy
192185|NCT02993887|Caregiver|caregiver
192186|NCT02993887|Technology Dependent Children|technology dependent children
192187|NCT02993887|Resourcefulness|resourcefulness
192188|NCT02993887|Mindfulness|mindfulness
192189|NCT02993874|Ergonemic resources|ergonemic resources
192190|NCT02993874|Walking capacity|walking capacity
192191|NCT02993874|Peripheral artery disease|peripheral artery disease
192192|NCT02993861|Epilepsy|epilepsy
192193|NCT02993861|Obese|obese
192194|NCT02993848|Scapula|scapula
192195|NCT02993848|Fracture|fracture
192196|NCT02993796|Krabbe disease|krabbe disease
192197|NCT02993796|globoid cell leukodystrophy|globoid cell leukodystrophy
192198|NCT02993796|galactosylceramide lipidosis|galactosylceramide lipidosis
192199|NCT02993796|sphingolipidosis|sphingolipidosis
192200|NCT02993783|Drug Therapy|drug therapy
192201|NCT02993757|Dengue Fever|dengue fever
192202|NCT02993757|Dengue Hemorrhagic Fever|dengue hemorrhagic fever
192203|NCT02993757|Human Papillomavirus Disease|human papillomavirus disease
192204|NCT02993757|CYD Dengue Vaccine|cyd dengue vaccine
192205|NCT02993757|Dengvaxia®|dengvaxia®
192206|NCT02993757|Gardasil®|gardasil®
192207|NCT02993744|preterm birth|preterm birth
192208|NCT02993744|corticosteroids|corticosteroids
192209|NCT02993744|inflammatory parameters|inflammatory parameters
192210|NCT02993744|betamethasone|betamethasone
192211|NCT02993744|leukocytes|leukocytes
192212|NCT02993731|Neoplasms|neoplasms
192213|NCT02993731|Neoplasms by Site|neoplasms by site
192214|NCT02993731|Digestive System Neoplasms|digestive system neoplasms
192215|NCT02993731|Endocrine Gland Neoplasms|endocrine gland neoplasms
192216|NCT02993731|Pancreatic Neoplasms|pancreatic neoplasms
192217|NCT02993731|Adenocarcinoma|adenocarcinoma
192218|NCT02993731|Neoplasms, Glandular and Epithelial|neoplasms, glandular and epithelial
192219|NCT02993731|Neoplasms by Histologic Type|neoplasms by histologic type
192220|NCT02993731|Digestive System Diseases|digestive system diseases
192221|NCT02993731|Pancreatic Diseases|pancreatic diseases
192222|NCT02993731|Endocrine System Diseases|endocrine system diseases
192223|NCT02993731|Albumin-Bound Paclitaxel|albumin-bound paclitaxel
192224|NCT02993731|Gemcitabine|gemcitabine
192225|NCT02993692|direct laryngoscopy|direct laryngoscopy
192226|NCT02993692|fiberopitc bronchoscopy|fiberopitc bronchoscopy
192227|NCT02993692|nasotracheal intubation|nasotracheal intubation
192228|NCT02993640|vasopressin|vasopressin
192229|NCT02993640|nitroglycerine|nitroglycerine
192230|NCT02993640|portal pressure|portal pressure
192231|NCT02993640|portal flow|portal flow
192232|NCT02993627|obesity|obesity
192233|NCT02993627|BMI|bmi
192234|NCT02993627|body weight|body weight
192235|NCT02993601|Heart Failure|heart failure
192236|NCT02993601|Edema|edema
192237|NCT02993601|Oedema|oedema
245711|NCT02662803|GAD|gad
192238|NCT02993601|Decompensated Heartfailure|decompensated heartfailure
192239|NCT02993588|Melatonin|melatonin
192240|NCT02993588|IVF/ICSI|ivf/icsi
192241|NCT02993588|Poor ovarian response|poor ovarian response
192242|NCT02993575|Pharmacokinetics|pharmacokinetics
192243|NCT02993575|Flucloxacillin|flucloxacillin
192244|NCT02993575|Continuous infusion|continuous infusion
192245|NCT02993575|Intensive Care Unit|intensive care unit
192246|NCT02993562|Food intake|food intake
192247|NCT02993562|Resting Energy Expenditure|resting energy expenditure
192248|NCT02993562|Gall Bladder emptying|gall bladder emptying
192249|NCT02993562|Insulin response|insulin response
192250|NCT02993562|Body Composition|body composition
192251|NCT02993523|Acute Myeloid Leukemia|acute myeloid leukemia
192252|NCT02993523|Venetoclax|venetoclax
192253|NCT02993523|Treatment Naïve|treatment naïve
192254|NCT02993523|Azacitidine|azacitidine
192255|NCT02993510|microfracture|microfracture
192256|NCT02993510|enhanced marrow stimulation|enhanced marrow stimulation
192257|NCT02993510|articular cartilage|articular cartilage
192258|NCT02993510|Autologous Matrix-Induced Chondrogenesis|autologous matrix-induced chondrogenesis
192259|NCT02993510|Chondro-Gide®|chondro-gide®
192260|NCT02993510|knee surgery|knee surgery
192261|NCT02993510|AMIC|amic
192262|NCT02993458|dietary patterns|dietary patterns
192263|NCT02993458|blood pressure|blood pressure
192264|NCT02993458|adolescents|adolescents
192265|NCT02993458|dietary sodium|dietary sodium
192266|NCT02993393|Simulation Training [I02.903.847]|simulation training [i02.903.847]
192267|NCT02993393|Problem-Based Learning [F02.463.425.720]|problem-based learning [f02.463.425.720]
192268|NCT02993380|Olive oil|olive oil
192269|NCT02993380|Erythrocyte membrane fatty acid contents|erythrocyte membrane fatty acid contents
192270|NCT02993380|Oleic acid|oleic acid
192271|NCT02993367|Butylphthalide Soft Capsules|butylphthalide soft capsules
192272|NCT02993367|VCIND|vcind
192273|NCT02993367|fMRI|fmri
192274|NCT02993302|vitamin D|vitamin d
192275|NCT02993302|graves' disease|graves' disease
192276|NCT02993302|dendritic cells|dendritic cells
192277|NCT02993224|thalassemia|thalassemia
192278|NCT02993224|TDT|tdt
192279|NCT02993224|transfusion-dependent|transfusion-dependent
192280|NCT02993224|non-transfusion-dependent|non-transfusion-dependent
192281|NCT02993224|NTDT|ntdt
192282|NCT02993211|Bladder cancer|bladder cancer
192283|NCT02993211|Transurethral resection|transurethral resection
192284|NCT02993211|En bloc resection|en bloc resection
192286|NCT02993185|pregnancy|pregnancy
192287|NCT02993185|adolescents|adolescents
192288|NCT02993185|sexually transmitted diseases|sexually transmitted diseases
192289|NCT02993185|decision making|decision making
192290|NCT02993185|prevention education|prevention education
192291|NCT02993107|AR101|ar101
192292|NCT02993107|Characterized Peanut Allergen|characterized peanut allergen
192293|NCT02993107|CPNA (Characterized Peanut Allergen)|cpna (characterized peanut allergen)
192294|NCT02993107|OIT (oral immunotherapy)|oit (oral immunotherapy)
192295|NCT02993107|Peanut Allergy|peanut allergy
192296|NCT02993107|Allergy|allergy
192297|NCT02993107|Peanut-Allergic Children|peanut-allergic children
192298|NCT02993107|Peanut-Allergic Adults|peanut-allergic adults
192299|NCT02993107|Desensitization|desensitization
192300|NCT02993107|PALISADE|palisade
192301|NCT02993094|breast cancer|breast cancer
192302|NCT02993094|advanced triple negative|advanced triple negative
192303|NCT02993094|ixazomib|ixazomib
192304|NCT02993094|carboplatin|carboplatin
192305|NCT02993094|CARIXA|carixa
192306|NCT02993094|Study Group of Medical Tumor Therapy (AGMT)|study group of medical tumor therapy (agmt)
192307|NCT02993081|YAG laser|yag laser
192308|NCT02993042|Rehabilitation|rehabilitation
192309|NCT02993042|Robot-assisted gait training|robot-assisted gait training
192310|NCT02993029|99Tc-MDP|99tc-mdp
192311|NCT02993029|osteoarthritis|osteoarthritis
192312|NCT02993029|celecoxib|celecoxib
192313|NCT02992977|Vaccine, neoantigen|vaccine, neoantigen
192314|NCT02992951|Infection|infection
192315|NCT02992951|Surgical Site Infection|surgical site infection
192316|NCT02992951|Dialkylcarbamoylchloride|dialkylcarbamoylchloride
192317|NCT02992938|Opioid hyperalgesia|opioid hyperalgesia
192318|NCT02992938|Acetazolamide|acetazolamide
192319|NCT02992938|Remifentanil|remifentanil
192320|NCT02992925|Haemophilus influenza type b|haemophilus influenza type b
192321|NCT02992925|Adsorbed Diphteria-purified Pertussis-Tetanus-Inactivate poliovirus combined vaccine|adsorbed diphteria-purified pertussis-tetanus-inactivate poliovirus combined vaccine
192322|NCT02992925|Hib|hib
192323|NCT02992925|DPT-IPV|dpt-ipv
192324|NCT02992899|stress disorders, post-traumatic|stress disorders, post-traumatic
192325|NCT02992899|posttraumatic stress disorder|posttraumatic stress disorder
192326|NCT02992899|PTSD|ptsd
192327|NCT02992899|vagal nerve|vagal nerve
192328|NCT02992886|elderly patients|elderly patients
192329|NCT02992886|rectal cancer|rectal cancer
192330|NCT02992886|preoperative chemoradiotherapy|preoperative chemoradiotherapy
192331|NCT02992886|comprehensive geriatric assessment|comprehensive geriatric assessment
192332|NCT02992860|Myelodysplastic Syndrome (MDS)|myelodysplastic syndrome (mds)
192333|NCT02992860|Acute Myeloid Leukemia (AML)|acute myeloid leukemia (aml)
192334|NCT02992860|hypomethylating agent (HMA) treatment|hypomethylating agent (hma) treatment
192335|NCT02992860|leukemic stem cell|leukemic stem cell
192336|NCT02992860|CD123|cd123
192337|NCT02992860|immunotherapy|immunotherapy
192338|NCT02992847|Multiple sclerosis|multiple sclerosis
192339|NCT02992847|Gadolinium based contrast agent|gadolinium based contrast agent
192340|NCT02992847|MRI|mri
192341|NCT02992847|Dentate nucleus|dentate nucleus
192342|NCT02992821|Hand-held|hand-held
192343|NCT02992821|Ultrasound|ultrasound
192344|NCT02992821|Diagnosis|diagnosis
192345|NCT02992821|Carotid artery stenosis|carotid artery stenosis
192346|NCT02992808|IVF|ivf
192347|NCT02992808|Ovarian stimulation|ovarian stimulation
192348|NCT02992808|Androgenic profile|androgenic profile
192349|NCT02992808|Follicular fluid|follicular fluid
192350|NCT02992808|Recombinant gonadotropins|recombinant gonadotropins
192351|NCT02992808|human menopausal gonadotropin|human menopausal gonadotropin
192352|NCT02992769|Breast Cancer|breast cancer
192353|NCT02992769|Nomogram|nomogram
192354|NCT02992769|Ultrasound|ultrasound
192355|NCT02992769|Axillary Metastases|axillary metastases
192356|NCT02992743|Previously treated|previously treated
192357|NCT02992743|Metastatic|metastatic
192358|NCT02992743|Cell Therapy|cell therapy
192359|NCT02992743|T Cell Therapy|t cell therapy
192360|NCT02992743|Sarcoma|sarcoma
192361|NCT02992743|NY-ESO-1|ny-eso-1
192362|NCT02992743|Immuno-oncology|immuno-oncology
192363|NCT02992743|T Cell Receptor|t cell receptor
192364|NCT02992730|Medication Adherence|medication adherence
192365|NCT02992665|Calcium ionophore|calcium ionophore
192366|NCT02992665|Fertilization|fertilization
192367|NCT02992665|Sperm|sperm
192368|NCT02992665|Oocyte|oocyte
192369|NCT02992665|ICSI|icsi
192370|NCT02992639|High visceral fat|high visceral fat
192371|NCT02992639|Liver enzymes|liver enzymes
192372|NCT02992639|Aminotransferase|aminotransferase
192373|NCT02992639|Mild calorie restriction|mild calorie restriction
192374|NCT02992600|non-cardiac surgery|non-cardiac surgery
192375|NCT02992600|Postoperative Cognitive Dysfunction|postoperative cognitive dysfunction
192376|NCT02992574|Post-Mastectomy Radiation|post-mastectomy radiation
192377|NCT02992574|Node Negative|node negative
192378|NCT02992574|Early breast Cancer|early breast cancer
192379|NCT02992561|Aggression|aggression
192380|NCT02992561|Violence|violence
192381|NCT02992561|Post-conflict reconstruction|post-conflict reconstruction
192382|NCT02992561|Demobilization|demobilization
192383|NCT02992561|Traumatized offenders|traumatized offenders
192384|NCT02992548|chronic kidney disease|chronic kidney disease
192385|NCT02992548|pravastatin|pravastatin
192386|NCT02992548|erythrocyte membrane fatty acid|erythrocyte membrane fatty acid
192387|NCT02992483|multiple myeloma|multiple myeloma
192388|NCT02992483|lymphoma|lymphoma
192389|NCT02992483|dlbcl|dlbcl
192390|NCT02992431|patient care planning|patient care planning
192391|NCT02992431|primary health care|primary health care
192392|NCT02992431|comorbidity|comorbidity
192393|NCT02992418|Dengue Fever|dengue fever
192394|NCT02992418|Dengue Hemorrhagic Fever|dengue hemorrhagic fever
192395|NCT02992418|CYD Dengue Vaccine|cyd dengue vaccine
192396|NCT02992418|Degavaxia®|degavaxia®
192397|NCT02992392|Tear film|tear film
192398|NCT02992392|Lipid layer|lipid layer
192399|NCT02992392|Liposic|liposic
192400|NCT02992392|Tears Naturale Forte|tears naturale forte
192401|NCT02992379|Anterior disc displacement|anterior disc displacement
192402|NCT02992379|Stabilizing splint|stabilizing splint
192403|NCT02992366|socket shield|socket shield
192404|NCT02992366|volumetric tissue alteration|volumetric tissue alteration
192405|NCT02992366|immediate implant|immediate implant
192406|NCT02992353|VATS|vats
192407|NCT02992353|NSCLC|nsclc
192408|NCT02992353|recurrence rate|recurrence rate
192409|NCT02992288|Chronic Heart Failure|chronic heart failure
192410|NCT02992288|Heart Failure with Reduced Ejection Fraction|heart failure with reduced ejection fraction
192411|NCT02992275|Hip|hip
192412|NCT02992275|Muscle|muscle
192413|NCT02992275|Skeletal/physiopathology|skeletal/physiopathology
192414|NCT02992223|Aggressive B-cell non-Hodgkin Lymphoma|aggressive b-cell non-hodgkin lymphoma
192415|NCT02992223|Relapsed|relapsed
192416|NCT02992223|Refractory|refractory
192417|NCT02992223|Zevalin|zevalin
192418|NCT02992223|Y90 Ibritumomab Tiuxetan|y90 ibritumomab tiuxetan
192419|NCT02992223|Autologous stem cell transplant|autologous stem cell transplant
192420|NCT02992223|BEAM|beam
192421|NCT02992223|Recurrent|recurrent
192422|NCT02992210|CAR|car
192423|NCT02992210|chimeric antigen receptor|chimeric antigen receptor
192424|NCT02992210|adoptive T cell transfer|adoptive t cell transfer
192425|NCT02992197|Rotavirus|rotavirus
192426|NCT02992197|Oral vaccines|oral vaccines
192427|NCT02992197|Vaccine underperformance|vaccine underperformance
192428|NCT02992197|Vaccine shedding|vaccine shedding
192429|NCT02992184|HCV|hcv
192430|NCT02992184|Genedrive|genedrive
192431|NCT02992184|Point of Care|point of care
192432|NCT02992119|safety|safety
192433|NCT02992119|immunogenicity|immunogenicity
192434|NCT02992106|Maternal Obesity|maternal obesity
192435|NCT02992106|Endothelial Dysfunction|endothelial dysfunction
192436|NCT02992106|Childhood Obesity|childhood obesity
192437|NCT02992093|Polycystic ovary syndrome|polycystic ovary syndrome
192438|NCT02992093|Metabonomics|metabonomics
192439|NCT02992093|Traditional Chinese medicine syndromes|traditional chinese medicine syndromes
192440|NCT02992080|Patient with Cystic Fibrosis|patient with cystic fibrosis
192441|NCT02992080|Patient without Cystic fibrosis|patient without cystic fibrosis
192442|NCT02992067|lymph node metastasis|lymph node metastasis
192443|NCT02992067|breast cancer|breast cancer
192444|NCT02992067|CK19|ck19
192445|NCT02992067|contrast-enhanced ultrasonography|contrast-enhanced ultrasonography
192446|NCT02992028|Rotator cuff repair|rotator cuff repair
192447|NCT02992028|Vitamin C|vitamin c
192448|NCT02992028|postoperative pain|postoperative pain
192449|NCT02991989|Home-based exercise|home-based exercise
192450|NCT02991989|Exercise snacking|exercise snacking
192451|NCT02991989|Protein|protein
192452|NCT02991989|Yogurt|yogurt
192453|NCT02991976|Normobaric hyperoxia|normobaric hyperoxia
192454|NCT02991976|Cerebral oxygenation|cerebral oxygenation
192455|NCT02991976|Near-infrared spectroscopy|near-infrared spectroscopy
192456|NCT02991976|Carotid endarterectomy|carotid endarterectomy
192457|NCT02991976|TIVA|tiva
192458|NCT02991924|endobronchial ultrasound|endobronchial ultrasound
192459|NCT02991924|EBUS-TBNA|ebus-tbna
192460|NCT02991924|lung cancer|lung cancer
192461|NCT02991924|staging|staging
192462|NCT02991911|metastatic, prostate cancer|metastatic, prostate cancer
192463|NCT02991898|CML|cml
192464|NCT02991898|MDS|mds
192465|NCT02991898|CLL|cll
192466|NCT02991898|ALL|all
192467|NCT02991898|AML|aml
192468|NCT02991872|Persistence|persistence
192469|NCT02991872|Purified chicken-embryo cell rabies vaccine|purified chicken-embryo cell rabies vaccine
192470|NCT02991872|Rabies Virus Neutralizing Antibody (RVNA)|rabies virus neutralizing antibody (rvna)
192471|NCT02991872|Immunogenicity|immunogenicity
192472|NCT02991872|Post-Exposure Prophylaxis (PEP)|post-exposure prophylaxis (pep)
192473|NCT02991872|Rabipur|rabipur
192474|NCT02991859|Dose-response|dose-response
192475|NCT02991859|AMP challenge|amp challenge
192476|NCT02991859|cortisol suppression|cortisol suppression
192477|NCT02991859|dose escalation|dose escalation
192478|NCT02991859|therapeutic index|therapeutic index
192479|NCT02991846|chronic graft-versus-host disease cGVHD|chronic graft-versus-host disease cgvhd
192480|NCT02991846|Hematopoietic stem cell transplantation HSCT|hematopoietic stem cell transplantation hsct
192481|NCT02991846|NIH consensus criteria|nih consensus criteria
192482|NCT02991846|GITMO|gitmo
192483|NCT02991833|fecal incontinence|fecal incontinence
192484|NCT02991833|care product|care product
192485|NCT02991833|bowel incontinence|bowel incontinence
192486|NCT02991807|PTEN|pten
192487|NCT02991807|PTEN Gene Mutation|pten gene mutation
192488|NCT02991807|PTEN Hamartoma Tumor Syndrome|pten hamartoma tumor syndrome
192489|NCT02991807|Autism|autism
192490|NCT02991807|Intellectual Disability|intellectual disability
192491|NCT02991807|Neurocognition|neurocognition
192492|NCT02991807|Afinitor|afinitor
192493|NCT02991807|Everolimus|everolimus
192494|NCT02991807|RAD001|rad001
192495|NCT02991794|prostatectomy|prostatectomy
192496|NCT02991794|laparoscopy|laparoscopy
192497|NCT02991794|3D visualization|3d visualization
192498|NCT02991794|learning curve|learning curve
192499|NCT02991794|anastomosis|anastomosis
192500|NCT02991742|nephropathy|nephropathy
192501|NCT02991742|catheterization|catheterization
192502|NCT02991742|contrast media|contrast media
192503|NCT02991742|ioxaglate|ioxaglate
192504|NCT02991742|iodixanol|iodixanol
192505|NCT02991742|high risk|high risk
192506|NCT02991742|prevention|prevention
192507|NCT02991729|Decision aid|decision aid
192508|NCT02991703|Arterial stiffness|arterial stiffness
192509|NCT02991703|pulse wave velocity|pulse wave velocity
192510|NCT02991703|Sphygmocor|sphygmocor
192511|NCT02991703|applanation tonometry|applanation tonometry
192512|NCT02991703|pOpmètre|popmètre
192513|NCT02991703|children|children
192514|NCT02991703|EPIPAGE cohort|epipage cohort
192515|NCT02991690|Hypothermia|hypothermia
192516|NCT02991690|Cervical Spinal Cord Injury|cervical spinal cord injury
192517|NCT02991690|Trauma|trauma
192518|NCT02991677|exercise|exercise
192519|NCT02991677|neuropathy|neuropathy
192520|NCT02991664|glass ionomer cement|glass ionomer cement
192521|NCT02991664|composite resin|composite resin
192522|NCT02991651|RXR agonist IRX4204 erlotinib|rxr agonist irx4204 erlotinib
192523|NCT02991599|Hepatitis B, Vaccine|hepatitis b, vaccine
192524|NCT02991599|Immunogenicity|immunogenicity
192525|NCT02991599|methadone maintenance treatment|methadone maintenance treatment
192526|NCT02991599|Randomized Controlled Trial|randomized controlled trial
192527|NCT02991586|Emotional Instability|emotional instability
192528|NCT02991586|Family Therapy|family therapy
192530|NCT02991586|DBT|dbt
192531|NCT02991560|physiotherapy|physiotherapy
192532|NCT02991560|taping|taping
192533|NCT02991560|conservative treatment|conservative treatment
192534|NCT02991534|Patient Participation [N05.300.150.600.620]|patient participation [n05.300.150.600.620]
192535|NCT02991534|Health Behavior [F01.145.488]|health behavior [f01.145.488]
192536|NCT02991534|Women [M01.975]|women [m01.975]
192537|NCT02991534|Patient Satisfaction [N05.715.360.600]|patient satisfaction [n05.715.360.600]
192538|NCT02991534|Physicians, Primary Care [M01.526.485.810.800]|physicians, primary care [m01.526.485.810.800]
192539|NCT02991534|Physicians, Women [M01.526.485.810.820]|physicians, women [m01.526.485.810.820]
192540|NCT02991534|Health Educators [M01.526.485.410]|health educators [m01.526.485.410]
192541|NCT02991534|Cardiovascular Diseases [C14]|cardiovascular diseases [c14]
192542|NCT02991534|Hypertension [C14.907.489]|hypertension [c14.907.489]
192543|NCT02991534|Hyperlipidemias [C18.452.584.500.500]|hyperlipidemias [c18.452.584.500.500]
192544|NCT02991534|Dyslipidemias [C18.452.584.500]|dyslipidemias [c18.452.584.500]
192545|NCT02991534|Obesity [C18.654.726.500]|obesity [c18.654.726.500]
192546|NCT02991534|Diabetes Mellitus [C18.452.394.750]|diabetes mellitus [c18.452.394.750]
192547|NCT02991534|Tobacco Use Disorder [C25.775.912]|tobacco use disorder [c25.775.912]
192548|NCT02991534|Overweight [C23.888.144.699]|overweight [c23.888.144.699]
192549|NCT02991508|Adrecizumab|adrecizumab
192550|NCT02991508|Phase 1 clinical trial|phase 1 clinical trial
192551|NCT02991508|Adrenomedullin|adrenomedullin
192552|NCT02991508|Healthy volunteers|healthy volunteers
192553|NCT02991508|Monoclonal recombinant antibody|monoclonal recombinant antibody
192554|NCT02991495|Epidemic response|epidemic response
192555|NCT02991482|MPM|mpm
192556|NCT02991456|malignant glioma|malignant glioma
192557|NCT02991456|temozolomide|temozolomide
192558|NCT02991456|temodar|temodar
192559|NCT02991456|radiation|radiation
192560|NCT02991456|emesis|emesis
192561|NCT02991456|nausea|nausea
192562|NCT02991456|vomiting|vomiting
192563|NCT02991456|chemotherapy|chemotherapy
192564|NCT02991456|Affronti|affronti
192565|NCT02991456|Peters|peters
192566|NCT02991456|00076418|00076418
192567|NCT02991430|migraine headache, episodic|migraine headache, episodic
192568|NCT02991378|preschool children|preschool children
192569|NCT02991378|emotional disorders/problems|emotional disorders/problems
192570|NCT02991378|stress related disorders/problems|stress related disorders/problems
192571|NCT02991378|early intervention|early intervention
192572|NCT02991352|Vascular Malformations|vascular malformations
192573|NCT02991352|Image Guidance|image guidance
192574|NCT02991339|Dexamethasone|dexamethasone
192575|NCT02991339|Liver Dysfunction|liver dysfunction
192576|NCT02991339|Hepatectomy|hepatectomy
192577|NCT02991339|Bilirubinaemia|bilirubinaemia
192578|NCT02991339|Jaundice|jaundice
192579|NCT02991326|Osteopathic Manipulative Treatment|osteopathic manipulative treatment
192580|NCT02991326|Temporomandibular Disorder|temporomandibular disorder
192581|NCT02991300|focal defect|focal defect
192582|NCT02991300|focal lesion|focal lesion
192583|NCT02991300|chondral lesion|chondral lesion
192584|NCT02991300|osteochondral lesion|osteochondral lesion
192585|NCT02991274|T790M|t790m
192586|NCT02991274|EGFR (Epidermal Growth Factor Receptor) mutation|egfr (epidermal growth factor receptor) mutation
192587|NCT02991274|NSCLC|nsclc
192588|NCT02991196|Advanced colorectal cancer|advanced colorectal cancer
192589|NCT02991196|DNA mismatch repair (MMR)|dna mismatch repair (mmr)
192590|NCT02991196|MMR-proficient Subjects|mmr-proficient subjects
192591|NCT02991196|TRAIL-R2 (DR5) Antibody|trail-r2 (dr5) antibody
192592|NCT02991183|Caregivers|caregivers
192593|NCT02991183|Acceptance and Commitment Therapy|acceptance and commitment therapy
192594|NCT02991170|myocardial infarction|myocardial infarction
192595|NCT02991170|ventricular arrhythmia|ventricular arrhythmia
192596|NCT02991170|radiofrequency ablation|radiofrequency ablation
192597|NCT02991170|Coronary Artery Bypass Grafts|coronary artery bypass grafts
192598|NCT02991157|cerebral vasospasm|cerebral vasospasm
192599|NCT02991157|nimodipine|nimodipine
192600|NCT02991144|Gene Transfer|gene transfer
192601|NCT02991144|OTC Deficiency|otc deficiency
192602|NCT02991144|Urea Cycle Disorder|urea cycle disorder
192603|NCT02991131|Acute bacterial skin infection|acute bacterial skin infection
192604|NCT02991131|Acute Bacterial Skin and Skin Structure Infection (ABSSSI)|acute bacterial skin and skin structure infection (absssi)
192605|NCT02991131|Abscess|abscess
192606|NCT02991131|Cellulitis|cellulitis
192607|NCT02991131|Erysipelas|erysipelas
192608|NCT02991131|Wound infection|wound infection
192609|NCT02991131|Methicillin resistant Staphylococcus aureus (MRSA)|methicillin resistant staphylococcus aureus (mrsa)
192610|NCT02991118|hyperlipidemia|hyperlipidemia
192611|NCT02991118|cholesterol|cholesterol
192612|NCT02991118|familial hypercholesterolemia|familial hypercholesterolemia
192613|NCT02991118|atherosclerotic cardiovascular disease|atherosclerotic cardiovascular disease
192614|NCT02991118|ASCVD|ascvd
192615|NCT02991118|HeFH|hefh
192617|NCT02991105|Malignancy|malignancy
192618|NCT02991105|Cancer|cancer
192619|NCT02991105|Organ Transplantation|organ transplantation
192620|NCT02991092|colon carcinoma|colon carcinoma
192621|NCT02991092|liquid treatment|liquid treatment
192622|NCT02991092|fast-track surgery|fast-track surgery
192623|NCT02991079|Food Habits|food habits
192624|NCT02991079|Health education|health education
192625|NCT02991079|Physical activity|physical activity
192626|NCT02991079|Information and Communication Technologies|information and communication technologies
192627|NCT02991066|Acute promyelocytic leukemia|acute promyelocytic leukemia
192628|NCT02991066|Coagulopathy|coagulopathy
192629|NCT02991066|Microparticles|microparticles
192630|NCT02991066|Mechanism|mechanism
192631|NCT02991053|Intra-operative anesthesia|intra-operative anesthesia
192632|NCT02991053|Pediatric patient|pediatric patient
192633|NCT02991053|Transversus Abdominis Plane Block|transversus abdominis plane block
192634|NCT02991053|ilioinguinal / iliohypogastric nerve block|ilioinguinal / iliohypogastric nerve block
192635|NCT02991027|no known ocular pathology|no known ocular pathology
192636|NCT02991014|music intervention|music intervention
192637|NCT02991014|heart rate variability|heart rate variability
192638|NCT02991014|frequency modulation|frequency modulation
192639|NCT02991014|pain perception|pain perception
192640|NCT02991014|cold pressor test (CPT)|cold pressor test (cpt)
192641|NCT02991001|Hydrodissection|hydrodissection
192642|NCT02990988|Blood donation|blood donation
192643|NCT02990988|Iron repletion|iron repletion
192644|NCT02990988|Transfusion|transfusion
192645|NCT02990975|Intra-operative anesthesia|intra-operative anesthesia
192646|NCT02990975|Pediatric patient|pediatric patient
192647|NCT02990975|Transversus Abdominis Plane Block|transversus abdominis plane block
192648|NCT02990962|perineural injection|perineural injection
192649|NCT02990962|ultrasound-guided|ultrasound-guided
192650|NCT02990962|dextrose|dextrose
192651|NCT02990962|steroid|steroid
192652|NCT02990936|hea and neck squamous cell carcinoma|hea and neck squamous cell carcinoma
192653|NCT02990936|tumor growth|tumor growth
192654|NCT02990936|predictive markers|predictive markers
192655|NCT02990936|tumoral kinetics|tumoral kinetics
192656|NCT02990910|respiratory adverse events|respiratory adverse events
192657|NCT02990910|adenotonsillectomy|adenotonsillectomy
192658|NCT02990910|opioid analgesia|opioid analgesia
192659|NCT02990910|children|children
192660|NCT02990897|Medical informatics|medical informatics
192661|NCT02990897|Quality of care|quality of care
192662|NCT02990897|Referral|referral
192663|NCT02990884|Intra-operative anesthesia and analgesia|intra-operative anesthesia and analgesia
192664|NCT02990884|ilioinguinal / iliohyogogastric nerve block|ilioinguinal / iliohyogogastric nerve block
192665|NCT02990884|Pediatric patient|pediatric patient
192666|NCT02990819|Immunodeficiencies|immunodeficiencies
192667|NCT02990819|Immune dysregulation syndromes|immune dysregulation syndromes
192668|NCT02990793|PTSD|ptsd
192669|NCT02990793|Concussion|concussion
192670|NCT02990793|TBI|tbi
192671|NCT02990793|TMS|tms
192672|NCT02990741|atrial fibrillation|atrial fibrillation
192673|NCT02990741|automated ECG system|automated ecg system
192674|NCT02990728|Endometrial Cancer.Mirena®|endometrial cancer.mirena®
192675|NCT02990715|average risk CRC screening|average risk crc screening
192676|NCT02990715|Non compliant patients for CRC screening|non compliant patients for crc screening
192677|NCT02990715|Counterindicated patients for colonoscopy|counterindicated patients for colonoscopy
192678|NCT02990702|Infraclavicular block|infraclavicular block
192679|NCT02990702|Retroclavicular block|retroclavicular block
192680|NCT02990702|Ultrasound|ultrasound
192681|NCT02990676|Cognition|cognition
192682|NCT02990676|Computerised cognitive training|computerised cognitive training
192683|NCT02990676|Feasibility study|feasibility study
192684|NCT02990676|Huntington's disease|huntington's disease
192685|NCT02990676|Translational|translational
192686|NCT02990663|Pragmatic|pragmatic
192687|NCT02990663|Primary Care|primary care
192688|NCT02990663|Chronotherapy|chronotherapy
192689|NCT02990663|Administrative Data|administrative data
192690|NCT02990663|Stroke|stroke
192691|NCT02990663|Myocardial Infarction|myocardial infarction
192692|NCT02990663|Congestive Heart Failure|congestive heart failure
192693|NCT02990663|Glaucoma|glaucoma
192694|NCT02990663|Dementia|dementia
192695|NCT02990663|Hip Fracture|hip fracture
192696|NCT02990637|Olive leaf extract|olive leaf extract
192697|NCT02990637|Cardiovascular health|cardiovascular health
192698|NCT02990637|Cholesterol|cholesterol
192699|NCT02990624|psoriasis|psoriasis
192700|NCT02990624|photochemotherapy|photochemotherapy
192701|NCT02990624|atherosclerosis|atherosclerosis
192702|NCT02990624|metabolic syndrome|metabolic syndrome
192703|NCT02990624|cardiovascular risk|cardiovascular risk
192704|NCT02990598|Hydroxyurea|hydroxyurea
192705|NCT02990572|Amish|amish
192706|NCT02990572|Mennonite|mennonite
192707|NCT02990559|Iron repletion|iron repletion
192708|NCT02990559|Blood donation|blood donation
192709|NCT02990559|Transfusion|transfusion
192710|NCT02990507|mobility impairment|mobility impairment
192711|NCT02990507|virtual environment|virtual environment
192712|NCT02990507|exercise|exercise
192713|NCT02990507|physical activity|physical activity
192714|NCT02990468|Mucositis|mucositis
192715|NCT02990468|Xerostomia|xerostomia
192716|NCT02990455|alcohol|alcohol
192717|NCT02990455|drinking|drinking
192718|NCT02990455|smoking|smoking
192719|NCT02990455|cigarette|cigarette
192720|NCT02990455|nicotine|nicotine
192721|NCT02990442|rTMS|rtms
192722|NCT02990442|Repetitive Transcranial Magnetic Stimulation|repetitive transcranial magnetic stimulation
192723|NCT02990442|Brain Stimulation|brain stimulation
192724|NCT02990429|hypothermia|hypothermia
192725|NCT02990429|Shivering|shivering
192726|NCT02990429|Gynecologic laparoscopic surgery|gynecologic laparoscopic surgery
192727|NCT02990429|Warming|warming
192728|NCT02990429|General anesthesia|general anesthesia
192729|NCT02990377|Opioid Analgesics|opioid analgesics
192730|NCT02990377|Opioid Safety|opioid safety
192731|NCT02990377|Emergency Department|emergency department
192732|NCT02990377|Motivational Enhancement|motivational enhancement
192733|NCT02990377|Interactive Voice Response|interactive voice response
192734|NCT02990377|Reinforcement Learning|reinforcement learning
192735|NCT02990377|mHealth|mhealth
192736|NCT02990364|Circumcision|circumcision
192737|NCT02990364|Analgesia|analgesia
192738|NCT02990364|Controlled Clinical Trial|controlled clinical trial
192739|NCT02990325|ABX464, HIV infection|abx464, hiv infection
192740|NCT02990299|Diabetes Mellitus, Type 2|diabetes mellitus, type 2
192741|NCT02990299|Medication Adherence|medication adherence
192742|NCT02990299|Telemedicine|telemedicine
192743|NCT02990299|Community Health Workers|community health workers
192744|NCT02990299|Pharmacists|pharmacists
192745|NCT02990299|Mobile Health|mobile health
192746|NCT02990286|Non specific intertitial pneumonia|non specific intertitial pneumonia
192747|NCT02990286|interstitial pneumonia with autoimmune feature|interstitial pneumonia with autoimmune feature
192748|NCT02990286|connective tissue disease|connective tissue disease
192749|NCT02990286|rituximab|rituximab
192750|NCT02990286|Mycophenolate Mofetil|mycophenolate mofetil
192751|NCT02990286|pulmonary fibrosis|pulmonary fibrosis
192752|NCT02990247|Asthma|asthma
192753|NCT02990247|Exacerbations|exacerbations
192754|NCT02990247|Telemonitoring|telemonitoring
192755|NCT02990247|Biomarkers|biomarkers
192756|NCT02990234|Capsular Repair|capsular repair
192757|NCT02990234|FAI|fai
192758|NCT02990234|Hip|hip
192759|NCT02990221|Field Cancerization|field cancerization
192760|NCT02990208|Diaphragmatic Breathing|diaphragmatic breathing
192761|NCT02990208|Virtual Reality Exposure Therapy|virtual reality exposure therapy
192762|NCT02990182|Yellow Fever Vaccine|yellow fever vaccine
192763|NCT02990182|Immunity, Humoral|immunity, humoral
192764|NCT02990182|Immunity, Cellular|immunity, cellular
192765|NCT02990182|children|children
192766|NCT02990156|Coils|coils
192767|NCT02990091|TBI|tbi
192768|NCT02990091|DHA|dha
192769|NCT02990091|omega-3 highly unsaturated fatty acids|omega-3 highly unsaturated fatty acids
192770|NCT02990091|synaptamide|synaptamide
192771|NCT02990078|TBI|tbi
192772|NCT02990078|CVR|cvr
192773|NCT02990078|Hypercapnia|hypercapnia
192774|NCT02990078|fNIRS|fnirs
192775|NCT02990065|PROTEIN SUPPLEMENTATION|protein supplementation
192776|NCT02990065|NUTRITIONAL STATUS|nutritional status
192777|NCT02990039|physical activity|physical activity
192778|NCT02990039|sedentary time|sedentary time
192779|NCT02990039|feasibility study|feasibility study
192780|NCT02990039|accelerometer|accelerometer
192781|NCT02989987|PTSD|ptsd
192782|NCT02989987|Shame|shame
192783|NCT02989987|Narrative Exposure Therapy|narrative exposure therapy
192784|NCT02989987|Sexual and gender based violence (SGBV)|sexual and gender based violence (sgbv)
192785|NCT02989987|DR Congo|dr congo
192786|NCT02989974|Survivorship Care|survivorship care
192787|NCT02989974|Caregiving|caregiving
192788|NCT02989948|Endovascular|endovascular
192789|NCT02989935|respiratory muscle|respiratory muscle
192790|NCT02989935|bronchodilator|bronchodilator
192791|NCT02989896|Perfusion index|perfusion index
192792|NCT02989896|Peripheral nerve block success|peripheral nerve block success
192793|NCT02989896|older age|older age
192794|NCT02989883|achalasia|achalasia
192795|NCT02989883|POEM|poem
192796|NCT02989883|outcome|outcome
192797|NCT02989870|Liver Disease|liver disease
192798|NCT02989870|Child-Pugh Class A|child-pugh class a
192799|NCT02989870|Child-Pugh Class B7|child-pugh class b7
192800|NCT02989857|IDH1|idh1
192801|NCT02989831|diabetic neuropathy|diabetic neuropathy
192802|NCT02989831|foot ulcers|foot ulcers
192803|NCT02989831|random vibration|random vibration
192804|NCT02989831|vibration perception threshold|vibration perception threshold
192805|NCT02989831|mechanical noise|mechanical noise
192806|NCT02989805|Emergency Medicine|emergency medicine
192807|NCT02989805|Psychiatry|psychiatry
192808|NCT02989805|Health Promotion|health promotion
192809|NCT02989805|Public Health|public health
192810|NCT02989792|pain|pain
192811|NCT02989753|Prevention|prevention
192812|NCT02989740|Diabetes Mellitus|diabetes mellitus
192813|NCT02989740|Thincap fibroatheroma|thincap fibroatheroma
192814|NCT02989740|Optical Coherence Tomography|optical coherence tomography
192815|NCT02989740|Fractional Flow Reserve|fractional flow reserve
192816|NCT02989701|Plerixafor|plerixafor
192817|NCT02989675|pediatric|pediatric
192818|NCT02989675|critical illness|critical illness
192819|NCT02989675|Malawi|malawi
192820|NCT02989649|Drug Therapy|drug therapy
192821|NCT02989584|bladder cancer|bladder cancer
192822|NCT02989584|metastatic bladder cancer|metastatic bladder cancer
192823|NCT02989584|atezolizumab|atezolizumab
192824|NCT02989584|urothelial carcinoma|urothelial carcinoma
192825|NCT02989519|preterm labor|preterm labor
192826|NCT02989519|progesterone efficacy|progesterone efficacy
192827|NCT02989519|threatened preterm labor|threatened preterm labor
192828|NCT02989493|Alcoholism|alcoholism
192829|NCT02989493|Stress|stress
192830|NCT02989493|Norepinephrine|norepinephrine
192831|NCT02989493|Doxazosin|doxazosin
192832|NCT02989493|Anxiety|anxiety
192833|NCT02989493|Startle Potentiation|startle potentiation
192834|NCT02989493|Relapse|relapse
192835|NCT02989493|Adrenergic Antagonists|adrenergic antagonists
192836|NCT02989493|Surrogate Endpoint|surrogate endpoint
192837|NCT02989480|Cardiomyopathy|cardiomyopathy
192838|NCT02989441|Perfusion Index|perfusion index
192839|NCT02989441|Hemodynamics|hemodynamics
192840|NCT02989441|Anesthesia|anesthesia
192841|NCT02989441|Stroke Volume|stroke volume
192842|NCT02989415|Anesthesia|anesthesia
192843|NCT02989415|Mechanical Ventilation|mechanical ventilation
192844|NCT02989415|Robotic Surgery|robotic surgery
192845|NCT02989415|Postoperative Pulmonary Complications|postoperative pulmonary complications
192846|NCT02989402|Alzheimer, Rivastigmine|alzheimer, rivastigmine
192847|NCT02989363|deep brain surgery and complex back surgery|deep brain surgery and complex back surgery
192848|NCT02989337|Hyperemesis Gravidarum|hyperemesis gravidarum
192849|NCT02989337|Inflammatory adhesion molecules|inflammatory adhesion molecules
192850|NCT02989337|Dehydration|dehydration
192851|NCT02989311|Iron absorption|iron absorption
192852|NCT02989311|Iron deficiency|iron deficiency
192853|NCT02989311|Hepcidin|hepcidin
192854|NCT02989311|Stable isotopes|stable isotopes
192855|NCT02989311|Anemia|anemia
192856|NCT02989311|Infants|infants
192857|NCT02989298|Peritoneal Dialysis (PD)|peritoneal dialysis (pd)
192858|NCT02989298|Residual renal function|residual renal function
192859|NCT02989298|Peritoneum function|peritoneum function
192860|NCT02989298|Peritonitis rate|peritonitis rate
192861|NCT02989298|Technical survival|technical survival
192862|NCT02989298|Patient survival|patient survival
192863|NCT02989285|HIV|hiv
192864|NCT02989285|HIV-associated neurocognitive disorder (HAND)|hiv-associated neurocognitive disorder (hand)
192865|NCT02989285|Neurology|neurology
192866|NCT02989285|Latent HIV|latent hiv
192867|NCT02989285|HIV Reservoirs|hiv reservoirs
192868|NCT02989259|apatinib|apatinib
192869|NCT02989259|advanced head and neck cancer|advanced head and neck cancer
192870|NCT02989259|non-squamous|non-squamous
192871|NCT02989246|pediatrics|pediatrics
192872|NCT02989246|ventilator weaning|ventilator weaning
192873|NCT02989220|Miscarriage|miscarriage
192874|NCT02989207|Glaucoma|glaucoma
192875|NCT02989207|Trabeculectomy|trabeculectomy
192876|NCT02989207|Glaucoma drainage implant|glaucoma drainage implant
192877|NCT02989207|Africa and Africa-Caribbean|africa and africa-caribbean
192878|NCT02989168|Idiopathic pulmonary fibrosis|idiopathic pulmonary fibrosis
192879|NCT02989168|hypoxemia|hypoxemia
192880|NCT02989168|oxygen|oxygen
192881|NCT02989142|interpregnancy|interpregnancy
192882|NCT02989142|pregnancy-induced hypertension|pregnancy-induced hypertension
192883|NCT02989142|gestational diabetes mellitus|gestational diabetes mellitus
192884|NCT02989142|caesarean section|caesarean section
192885|NCT02989142|large-for-gestational-age|large-for-gestational-age
192886|NCT02989129|Polyneuropathies and Other Disorders of the Peripheral Nervous System|polyneuropathies and other disorders of the peripheral nervous system
192887|NCT02989129|Chemotherapy Induced Neuropathic Pain|chemotherapy induced neuropathic pain
192888|NCT02989129|CINP|cinp
192889|NCT02989129|Quercetin|quercetin
192890|NCT02989129|Questionnaires|questionnaires
192891|NCT02989129|Surveys|surveys
192892|NCT02989116|Learning|learning
192893|NCT02989116|Executive functions|executive functions
192894|NCT02989116|Cognitive control|cognitive control
192895|NCT02989116|Prefrontal Cortex|prefrontal cortex
192896|NCT02989116|Typically developing children|typically developing children
192897|NCT02989116|Genotype|genotype
192898|NCT02989116|Functional Magnetic Resonance Imaging|functional magnetic resonance imaging
192899|NCT02989116|Structural Magnetic Resonance Imaging|structural magnetic resonance imaging
192900|NCT02989116|Inhibition|inhibition
192901|NCT02989116|Working Memory|working memory
192902|NCT02989116|Metacognition|metacognition
192903|NCT02989116|Mindfulness|mindfulness
192904|NCT02989116|Preterm children|preterm children
192905|NCT02989116|Developmental Psychology|developmental psychology
192906|NCT02989116|Developmental cognitive neuroscience|developmental cognitive neuroscience
192907|NCT02989116|Touch screen tablet|touch screen tablet
192908|NCT02989116|Adaptive training|adaptive training
192909|NCT02989103|Hyperthyroidism|hyperthyroidism
192910|NCT02989103|Radiation|radiation
192911|NCT02989103|Mortality|mortality
192912|NCT02989090|Patient Engagement|patient engagement
192913|NCT02989090|Defibrillators|defibrillators
192914|NCT02989090|Health Records, Personal|health records, personal
192915|NCT02989090|Patient Portal|patient portal
192916|NCT02989077|combined coronary and cerebral ischemia|combined coronary and cerebral ischemia
192917|NCT02989064|Cell Therapy|cell therapy
192918|NCT02989064|T Cell Therapy|t cell therapy
192919|NCT02989064|SPEAR T Cell|spear t cell
192920|NCT02989064|MAGE-A10|mage-a10
192921|NCT02989064|Immuno-oncology|immuno-oncology
192922|NCT02989064|Metastatic|metastatic
192923|NCT02989064|Urothelial Cancer|urothelial cancer
192924|NCT02989064|Previously Treated|previously treated
192925|NCT02989064|T Cell Receptor|t cell receptor
192926|NCT02989064|Inoperable|inoperable
192927|NCT02989064|Advanced|advanced
192928|NCT02989064|Cancer|cancer
192929|NCT02989064|Bladder|bladder
192930|NCT02989064|Head and neck|head and neck
192931|NCT02989064|Melanoma|melanoma
192932|NCT02989038|smoker|smoker
192933|NCT02989038|young adult|young adult
192934|NCT02988999|D-allulose or erythritol|d-allulose or erythritol
192935|NCT02988986|mTOR|mtor
192936|NCT02988986|Tamoxifen|tamoxifen
192937|NCT02988986|Breast Cancer|breast cancer
192938|NCT02988973|Roxadustat|roxadustat
192939|NCT02988973|Anemia|anemia
192940|NCT02988973|Non-dialysis chronic kidney disease|non-dialysis chronic kidney disease
192941|NCT02988973|ASP1517|asp1517
192942|NCT02988960|Non-small cell lung cancer (NSCLC)|non-small cell lung cancer (nsclc)
192943|NCT02988960|Squamous cell carcinoma of the head and neck (SCCHN)|squamous cell carcinoma of the head and neck (scchn)
192944|NCT02988960|Advanced solid tumor|advanced solid tumor
192945|NCT02988960|Cancer|cancer
192946|NCT02988960|Pancreatic adenocarcinoma|pancreatic adenocarcinoma
192947|NCT02988960|Cutaneous melanoma|cutaneous melanoma
192948|NCT02988947|Knee Arthroplasty|knee arthroplasty
192949|NCT02988947|Hypnosis|hypnosis
192950|NCT02988947|Pain Neuroscience Education|pain neuroscience education
192951|NCT02988947|Pain|pain
192952|NCT02988947|Catastrophizing|catastrophizing
192953|NCT02988947|Optimism|optimism
192954|NCT02988947|Distress|distress
192955|NCT02988947|Hope|hope
192956|NCT02988947|Self-Efficacy|self-efficacy
192957|NCT02988895|Brachytherapy|brachytherapy
192958|NCT02988895|Wet AMD|wet amd
192959|NCT02988869|COPD|copd
192960|NCT02988869|Tiotropium|tiotropium
192961|NCT02988869|Formoterol|formoterol
192962|NCT02988843|GCT|gct
192963|NCT02988830|Subcutaneous stimulation|subcutaneous stimulation
192964|NCT02988804|endoscopic endonasal transsphenoidal surgery|endoscopic endonasal transsphenoidal surgery
192965|NCT02988804|laryngeal mask|laryngeal mask
192966|NCT02988765|vulvar cancer|vulvar cancer
192967|NCT02988765|inguinal lymph node|inguinal lymph node
192968|NCT02988765|lymph node status|lymph node status
192969|NCT02988765|cytology|cytology
192970|NCT02988765|core biopsy|core biopsy
192971|NCT02988726|Neurofibroma|neurofibroma
192972|NCT02988726|Schwannoma|schwannoma
192973|NCT02988713|stimulation|stimulation
192974|NCT02988713|chronic pain|chronic pain
192975|NCT02988713|back pain|back pain
192976|NCT02988713|leg pain|leg pain
192977|NCT02988687|fatigue|fatigue
192978|NCT02988687|quality of life|quality of life
192979|NCT02988687|depression|depression
192980|NCT02988687|cognitive function|cognitive function
192981|NCT02988687|growth hormone|growth hormone
192982|NCT02988687|traumatic brain injury|traumatic brain injury
192983|NCT02988674|Adalimumab|adalimumab
192984|NCT02988674|Ankylosing spondylitis|ankylosing spondylitis
192985|NCT02988674|Psoriatic arthritis|psoriatic arthritis
192986|NCT02988674|Spondylarthritis|spondylarthritis
192987|NCT02988674|Humira®|humira®
192988|NCT02988661|Autoimmunity|autoimmunity
192989|NCT02988661|Immune System Disorders|immune system disorders
192990|NCT02988648|Metastatic Breast Cancer|metastatic breast cancer
192991|NCT02988635|Early Palliative Care|early palliative care
192992|NCT02988635|Simultaneous Care|simultaneous care
192993|NCT02988635|Chemotherapy|chemotherapy
192994|NCT02988635|Quality of Life|quality of life
192995|NCT02988596|Concussion|concussion
192996|NCT02988596|Rehabilitation|rehabilitation
192997|NCT02988583|silicone oil|silicone oil
192998|NCT02988583|emulsification|emulsification
192999|NCT02988583|retinal detachment surgery|retinal detachment surgery
193000|NCT02988557|cerebral palsy|cerebral palsy
193001|NCT02988557|gait|gait
193002|NCT02988557|slope|slope
193003|NCT02988557|electromyography|electromyography
193004|NCT02988531|PET|pet
193005|NCT02988531|MRI|mri
193006|NCT02988531|Attenuation|attenuation
193007|NCT02988531|Correction|correction
193008|NCT02988531|Cardiovascular|cardiovascular
193009|NCT02988531|coronary|coronary
193010|NCT02988531|disease|disease
193011|NCT02988518|Psychiatry|psychiatry
193012|NCT02988518|Bipolar disorder|bipolar disorder
193013|NCT02988518|Memory complaints|memory complaints
193014|NCT02988518|Global functioning|global functioning
193015|NCT02988518|Cognitive remediation|cognitive remediation
193016|NCT02988518|Working memory|working memory
246721|NCT02657447|ARC|arc
193017|NCT02988466|Acute Leukemias|acute leukemias
193018|NCT02988466|Acute myeloid leukemia (AML)|acute myeloid leukemia (aml)
193019|NCT02988466|Acute lymphoblastic leukemia (ALL)/lymphoma|acute lymphoblastic leukemia (all)/lymphoma
193020|NCT02988466|Biphenotypic/Undifferentiated/Prolymphocytic Leukemias|biphenotypic/undifferentiated/prolymphocytic leukemias
193021|NCT02988466|Myelodysplastic syndrome|myelodysplastic syndrome
193022|NCT02988466|Chronic myelogenous leukemia|chronic myelogenous leukemia
193023|NCT02988466|Minimal Residual Disease (MRD) positive leukemia|minimal residual disease (mrd) positive leukemia
193024|NCT02988466|Leukemia or Myelodysplastic Syndromes (MDS) in aplasia|leukemia or myelodysplastic syndromes (mds) in aplasia
193025|NCT02988466|Myeloproliferative neoplasms/myelofibrosis|myeloproliferative neoplasms/myelofibrosis
193026|NCT02988466|Relapsed large-cell lymphoma, mantle-cell lymphoma and Hodgkin lymphoma|relapsed large-cell lymphoma, mantle-cell lymphoma and hodgkin lymphoma
193027|NCT02988466|Burkitt's lymphoma|burkitt's lymphoma
193028|NCT02988466|Relapsed T-cell lymphoma|relapsed t-cell lymphoma
193029|NCT02988466|Natural Killer cell malignancies|natural killer cell malignancies
193030|NCT02988466|Relapsed chronic lymphocytic leukemia/small lymphocytic lymphoma (CLL/SLL), marginal zone B-cell lymphoma, follicular lymphoma|relapsed chronic lymphocytic leukemia/small lymphocytic lymphoma (cll/sll), marginal zone b-cell lymphoma, follicular lymphoma
193031|NCT02988466|Lymphoplasmacytic lymphoma|lymphoplasmacytic lymphoma
193032|NCT02988466|Relapsed multiple myeloma|relapsed multiple myeloma
193033|NCT02988466|Bone marrow failure syndromes|bone marrow failure syndromes
193034|NCT02988453|mentalization-based treatment|mentalization-based treatment
193035|NCT02988453|conduct disorder|conduct disorder
193036|NCT02988453|adolescents|adolescents
193037|NCT02988440|HCC|hcc
193038|NCT02988440|Hepatocellular carcinoma|hepatocellular carcinoma
193039|NCT02988440|Hepatocellular carcinoma (HCC)|hepatocellular carcinoma (hcc)
193040|NCT02988440|PDR001|pdr001
193041|NCT02988440|liver cancer|liver cancer
193042|NCT02988440|immunotherapy liver|immunotherapy liver
193043|NCT02988440|malignant hepatoma|malignant hepatoma
193044|NCT02988440|Hepatocellular cancer|hepatocellular cancer
193045|NCT02988440|advanced hepatocellular carcinoma (HCC)|advanced hepatocellular carcinoma (hcc)
193046|NCT02988440|advanced liver cancer|advanced liver cancer
193047|NCT02988440|liver cancer progression|liver cancer progression
193048|NCT02988440|sorafenib|sorafenib
193049|NCT02988440|anti-PD1|anti-pd1
193050|NCT02988440|first line|first line
193051|NCT02988414|Sepsis|sepsis
193052|NCT02988414|Infection|infection
193053|NCT02988414|Culture|culture
193054|NCT02988414|Sequencing|sequencing
193055|NCT02988414|Non-invasive|non-invasive
193056|NCT02988414|NGS|ngs
193057|NCT02988375|insomnia|insomnia
193058|NCT02988375|depression|depression
193059|NCT02988375|digital CBTI|digital cbti
193060|NCT02988375|online CBTI|online cbti
193061|NCT02988336|difficult intubation|difficult intubation
193062|NCT02988336|thyromental height|thyromental height
193063|NCT02988323|sport concussion|sport concussion
193064|NCT02988323|cervical spine|cervical spine
193065|NCT02988323|vestibular rehabilitation|vestibular rehabilitation
193066|NCT02988323|exercise|exercise
193067|NCT02988323|rehabilitation|rehabilitation
193068|NCT02988323|children|children
193069|NCT02988323|youth|youth
193070|NCT02988310|Limb Loss|limb loss
193071|NCT02988310|Gait Characteristics|gait characteristics
193072|NCT02988284|Gait variability|gait variability
193073|NCT02988258|Ex vivo gene therapy|ex vivo gene therapy
193074|NCT02988258|T cell receptor transduction|t cell receptor transduction
193075|NCT02988258|Immunotherapy|immunotherapy
193076|NCT02988258|Allogeneic Haematopoietic Stem Cell Transplantation|allogeneic haematopoietic stem cell transplantation
193077|NCT02988258|CMV|cmv
193078|NCT02988232|Work Related Chronic Low Back Pain|work related chronic low back pain
193079|NCT02988232|Korean Medicine|korean medicine
193080|NCT02988232|Sogyeonghwalhyeol-tang|sogyeonghwalhyeol-tang
193081|NCT02988219|cardiac arrhythmia|cardiac arrhythmia
193082|NCT02988219|epidural anesthesia|epidural anesthesia
193083|NCT02988219|combined anesthesia|combined anesthesia
193084|NCT02988219|general anesthesia|general anesthesia
193085|NCT02988219|NSS|nss
193086|NCT02988219|radical nephrectomy|radical nephrectomy
193087|NCT02988219|extraperitoneal|extraperitoneal
193088|NCT02988193|clinical reasoning artificial intelligence|clinical reasoning artificial intelligence
193089|NCT02988193|poorly controlled hypertension|poorly controlled hypertension
193090|NCT02988167|Spontaneous Breathing Trial (SBT)|spontaneous breathing trial (sbt)
193091|NCT02988167|Extubation Decision Support Tool|extubation decision support tool
193092|NCT02988167|Extubation|extubation
193093|NCT02988167|Extubation Readiness|extubation readiness
193094|NCT02988154|Medical education|medical education
193095|NCT02988154|simulation|simulation
193096|NCT02988154|neurosurgical education|neurosurgical education
193097|NCT02988154|Simulation laboratory|simulation laboratory
193098|NCT02988154|Ventricular drain|ventricular drain
193099|NCT02988128|Embolization Device|embolization device
193100|NCT02988128|Flow Diverter|flow diverter
193101|NCT02988128|Intra saccular device|intra saccular device
193102|NCT02988128|Vascular Reconstruction Device|vascular reconstruction device
193103|NCT02988128|Ruptured Intracranial Aneurysm|ruptured intracranial aneurysm
193104|NCT02988128|Unruptured Intracranial Aneurysm|unruptured intracranial aneurysm
193105|NCT02988115|hyperlipidemia|hyperlipidemia
193106|NCT02988115|cholesterol|cholesterol
193107|NCT02988115|familial hypercholesterolemia|familial hypercholesterolemia
193108|NCT02988115|atherosclerotic cardiovascular disease|atherosclerotic cardiovascular disease
193109|NCT02988115|ASCVD|ascvd
193110|NCT02988115|HeFH|hefh
193111|NCT02988115|LDL|ldl
193112|NCT02988115|statin intolerence|statin intolerence
193113|NCT02988102|S100B, NSE|s100b, nse
193114|NCT02988102|moderate brain trauma|moderate brain trauma
193115|NCT02988102|mild brain trauma|mild brain trauma
193116|NCT02988089|Helicobacter Pylori Infection|helicobacter pylori infection
193117|NCT02988089|Antimicrobial susceptibility testing (AST)|antimicrobial susceptibility testing (ast)
193118|NCT02988076|database|database
193119|NCT02988076|probability|probability
193120|NCT02988076|response|response
193121|NCT02988076|depression|depression
193122|NCT02988076|medication|medication
193123|NCT02988076|quantitative|quantitative
193124|NCT02988076|electroencephalogram|electroencephalogram
193125|NCT02988063|Varithena|varithena
193126|NCT02988063|Polidocanol Endovenous Microfoam|polidocanol endovenous microfoam
193127|NCT02988050|Epilepsy Surgery|epilepsy surgery
193128|NCT02988050|Conscious sedation|conscious sedation
193129|NCT02988011|type 2 diabetes|type 2 diabetes
193130|NCT02988011|gastric by-pass surgery|gastric by-pass surgery
193131|NCT02988011|low calorie diet|low calorie diet
193132|NCT02988011|glucose metabolism|glucose metabolism
193133|NCT02987998|Pembrolizumab|pembrolizumab
193134|NCT02987998|Chemoradiation|chemoradiation
193135|NCT02987985|Opioid-sparing|opioid-sparing
193136|NCT02987985|Opioid-free|opioid-free
193137|NCT02987959|TAK-228|tak-228
193138|NCT02987959|MLN0128|mln0128
193139|NCT02987959|mTOR|mtor
193140|NCT02987933|Chronic Pain|chronic pain
193141|NCT02987933|fMRI|fmri
193142|NCT02987933|DTI|dti
193143|NCT02987894|TAVI|tavi
193144|NCT02987894|Transcatheter Aortic Valve Replacement|transcatheter aortic valve replacement
193145|NCT02987894|Transcatheter Aortic Valve Implant|transcatheter aortic valve implant
193146|NCT02987894|Transfemoral access|transfemoral access
193147|NCT02987894|Aortic valve regurgitation|aortic valve regurgitation
193148|NCT02987868|Somatostatin|somatostatin
193149|NCT02987868|Thyroid Hormone|thyroid hormone
193150|NCT02987868|Growth Hormone|growth hormone
193151|NCT02987842|Mild cognitive impairment|mild cognitive impairment
193152|NCT02987842|Alzhiemer's disease|alzhiemer's disease
193153|NCT02987842|Neurofeedback|neurofeedback
193154|NCT02987842|EEG|eeg
193155|NCT02987803|Patient Engagement|patient engagement
193156|NCT02987803|Public Reporting|public reporting
193157|NCT02987803|Quality Measurement|quality measurement
193158|NCT02987790|Intensive care|intensive care
193159|NCT02987790|Sepsis|sepsis
193160|NCT02987790|Biomarkers|biomarkers
193161|NCT02987790|C-reactive Protein|c-reactive protein
193162|NCT02987790|Antimicrobial|antimicrobial
193163|NCT02987790|Systemic infection|systemic infection
193164|NCT02987764|Premature|premature
193165|NCT02987764|Birth weight|birth weight
193166|NCT02987725|Adolescence|adolescence
193167|NCT02987725|Autonomic Nervous System|autonomic nervous system
193168|NCT02987725|Hypnosis|hypnosis
193169|NCT02987725|Pain|pain
193170|NCT02987725|Sickle Cell Disease|sickle cell disease
193171|NCT02987712|Thromboelastography|thromboelastography
193172|NCT02987699|Hepatocellular Carcinoma|hepatocellular carcinoma
193173|NCT02987699|Hepatic arterial infusion chemotherapy|hepatic arterial infusion chemotherapy
193174|NCT02987699|optimal dose|optimal dose
193175|NCT02987686|Topical Infliximab|topical infliximab
193176|NCT02987686|Cornea|cornea
193177|NCT02987686|Keratolysis|keratolysis
193178|NCT02987673|Mini/One anastomosis gastric bypass|mini/one anastomosis gastric bypass
193179|NCT02987673|Sleeve Gastrectomy|sleeve gastrectomy
193180|NCT02987673|Gastro-esophageal sphincter function|gastro-esophageal sphincter function
193181|NCT02987634|gingivitis|gingivitis
193182|NCT02987634|dental implant|dental implant
193183|NCT02987634|mouthwash|mouthwash
193184|NCT02987595|intervention|intervention
193185|NCT02987595|lignans|lignans
193186|NCT02987595|whole-grain|whole-grain
193187|NCT02987582|mental health|mental health
193188|NCT02987582|mindfulness|mindfulness
193189|NCT02987582|shame|shame
193190|NCT02987569|Home Parenteral Nutrition|home parenteral nutrition
193191|NCT02987569|HPN|hpn
193192|NCT02987569|Total Parenteral Nutrition|total parenteral nutrition
193193|NCT02987569|TPN|tpn
193194|NCT02987569|mConnect|mconnect
193195|NCT02987569|SBS|sbs
193196|NCT02987569|short bowel disorder|short bowel disorder
193197|NCT02987569|telehealth|telehealth
193198|NCT02987569|telemedicine|telemedicine
193199|NCT02987543|metastatic castration-resistant prostate cancer (mCRPC)|metastatic castration-resistant prostate cancer (mcrpc)
193200|NCT02987543|homologous recombination repair (HRR)|homologous recombination repair (hrr)
193201|NCT02987530|primary infection|primary infection
193202|NCT02987517|running|running
193203|NCT02987517|vertical load rates|vertical load rates
193204|NCT02987517|cadence|cadence
193205|NCT02987517|footstrike|footstrike
193206|NCT02987504|Cancer|cancer
193207|NCT02987504|Solid tumor|solid tumor
193208|NCT02987504|Phase 1|phase 1
193209|NCT02987491|exercise|exercise
193210|NCT02987478|Vitamin D following intra cytoplasmic sperm injection|vitamin d following intra cytoplasmic sperm injection
193211|NCT02987452|exercise|exercise
193212|NCT02987452|resistant hypertension|resistant hypertension
193213|NCT02987452|blood pressure|blood pressure
193214|NCT02987439|COPD|copd
193215|NCT02987439|Exacerbation|exacerbation
193216|NCT02987439|Rehabilitation|rehabilitation
193217|NCT02987413|Amyotrophic Lateral Sclerosis|amyotrophic lateral sclerosis
193218|NCT02987400|DLBCL|dlbcl
193219|NCT02987400|GA-101|ga-101
193220|NCT02987400|ABT-199|abt-199
193221|NCT02987400|relapsed DLBCL|relapsed dlbcl
193222|NCT02987400|refractory DLBCL|refractory dlbcl
193223|NCT02987400|AGMT|agmt
193224|NCT02987400|Diffuse large B-cell lymphoma|diffuse large b-cell lymphoma
193225|NCT02987400|window of opportunity|window of opportunity
193226|NCT02987387|Tetralogy of Fallot|tetralogy of fallot
193227|NCT02987387|Aortic Valve Defect/Disease Resulting in Ross Procedure|aortic valve defect/disease resulting in ross procedure
193228|NCT02987387|Transcatheter pulmonary valve implantation|transcatheter pulmonary valve implantation
193229|NCT02987387|Transcatheter pulmonary valve replacement|transcatheter pulmonary valve replacement
193230|NCT02987387|Pulmonary Atresia|pulmonary atresia
193231|NCT02987387|Pulmonary Stenosis|pulmonary stenosis
193232|NCT02987374|Influenza Vaccine|influenza vaccine
193233|NCT02987348|type 2 diabetes|type 2 diabetes
193234|NCT02987309|indirect calorimetry|indirect calorimetry
193235|NCT02987309|method comparison|method comparison
193236|NCT02987296|Colorectal Cancer|colorectal cancer
193237|NCT02987296|Surgery|surgery
193238|NCT02987296|Arginine depletion|arginine depletion
193239|NCT02987296|Immune system dysfunction|immune system dysfunction
193240|NCT02987296|Arginine Supplementation|arginine supplementation
193241|NCT02987270|mass screen and treat|mass screen and treat
193242|NCT02987270|malaria|malaria
193243|NCT02987270|asymptomatic infections|asymptomatic infections
193244|NCT02987270|transmission reduction|transmission reduction
193245|NCT02987270|infectious reservoir|infectious reservoir
193246|NCT02987270|kenya|kenya
193247|NCT02987257|Therapeutics|therapeutics
193248|NCT02987257|Management|management
193249|NCT02987257|Cyclosporine|cyclosporine
193250|NCT02987257|Etanercept|etanercept
193251|NCT02987257|Supportive Care|supportive care
193252|NCT02987257|Immunopathogenesis|immunopathogenesis
193253|NCT02987257|Genetics|genetics
193254|NCT02987257|Adverse Drug Reaction|adverse drug reaction
193255|NCT02987244|Chidamide, T Cell Non-Hodgkin's Lymphoma|chidamide, t cell non-hodgkin's lymphoma
193256|NCT02987218|POCD|pocd
193257|NCT02987218|subarachnoid hemorrhage|subarachnoid hemorrhage
193258|NCT02987218|Propofol|propofol
193259|NCT02987218|Desflurane|desflurane
193260|NCT02987192|spinal anesthesia|spinal anesthesia
193261|NCT02987192|anticoagulation|anticoagulation
193262|NCT02987192|minimally invasive|minimally invasive
193263|NCT02987192|Cesarean Section|cesarean section
193264|NCT02987192|Maternal|maternal
193265|NCT02987166|immunotherapy|immunotherapy
193266|NCT02987166|pembrolizumab|pembrolizumab
193267|NCT02987166|MK-3475|mk-3475
193268|NCT02987166|High-dose conformal radiation therapy|high-dose conformal radiation therapy
193269|NCT02987166|HDCRT|hdcrt
193270|NCT02987166|advanced solid tumor|advanced solid tumor
193271|NCT02987153|Kyphoplasty|kyphoplasty
193272|NCT02987153|Spinal metastases|spinal metastases
193273|NCT02987153|IORT|iort
193274|NCT02987153|Intraoperative radiation therapy|intraoperative radiation therapy
193275|NCT02987153|Pain management|pain management
193276|NCT02987140|Parkinson's disease|parkinson's disease
193277|NCT02987140|freezing of gait|freezing of gait
193278|NCT02987140|context-dependency|context-dependency
193279|NCT02987140|transcranial magnetic stimulation|transcranial magnetic stimulation
193280|NCT02987140|visual cues|visual cues
193281|NCT02987062|Atrial Fibrillation|atrial fibrillation
193282|NCT02987062|Non-vitamin K Oral Anticoagulants|non-vitamin k oral anticoagulants
193283|NCT02987062|Vitamin K Antagonists|vitamin k antagonists
193284|NCT02987062|ROCKET-AF|rocket-af
193285|NCT02987062|RE-LY|re-ly
193286|NCT02987062|ARISTOTLE|aristotle
193287|NCT02987049|heart disease, cardiac rehabilitation|heart disease, cardiac rehabilitation
193288|NCT02987036|nebulizer technologies, lung mechanics, beta-agonistic drug|nebulizer technologies, lung mechanics, beta-agonistic drug
193289|NCT02987023|infertility, uterus, transplantation|infertility, uterus, transplantation
193290|NCT02986997|epidural anesthesia|epidural anesthesia
193291|NCT02986997|prone position|prone position
193292|NCT02986997|percutaneous nephrolithotomy|percutaneous nephrolithotomy
193293|NCT02986984|Diabetes|diabetes
193294|NCT02986984|Chronic kidney disease|chronic kidney disease
193295|NCT02986984|Progression|progression
193296|NCT02986984|Genomics|genomics
193297|NCT02986984|Transcriptomics|transcriptomics
193298|NCT02986971|Contraceptive implant|contraceptive implant
193299|NCT02986945|Depressive symptoms|depressive symptoms
193300|NCT02986945|resiliency|resiliency
193301|NCT02986945|Health Promotion|health promotion
193302|NCT02986945|minority health|minority health
193303|NCT02986945|text-messaging app|text-messaging app
193304|NCT02986945|participatory technology development|participatory technology development
193305|NCT02986932|Blood-Brain Barrier|blood-brain barrier
193306|NCT02986919|Malignant peripheral Nerve Sheath Tumors (MPNST); Neurofibromatosis sarcoma|malignant peripheral nerve sheath tumors (mpnst); neurofibromatosis sarcoma
193307|NCT02986906|ulnar neuropathy at elbow|ulnar neuropathy at elbow
193308|NCT02986906|Dextrose|dextrose
193309|NCT02986906|perineural injection|perineural injection
193310|NCT02986893|Multiple Sclerosis|multiple sclerosis
193311|NCT02986893|Diet|diet
193312|NCT02986893|Clinical Trial|clinical trial
193313|NCT02986854|Meningococcal disease|meningococcal disease
193314|NCT02986854|Booster vaccination|booster vaccination
193315|NCT02986854|Meningitis|meningitis
193316|NCT02986854|Antibody persistence|antibody persistence
193317|NCT02986828|platelet rich plasma|platelet rich plasma
193318|NCT02986828|Hydrodissection|hydrodissection
193319|NCT02986737|TAVI|tavi
193320|NCT02986737|Aortic Stenosis|aortic stenosis
193321|NCT02986737|Transcatether Aortic Valve Implantation|transcatether aortic valve implantation
193322|NCT02986724|Drug therapy|drug therapy
193323|NCT02986698|intrauterine transfusion|intrauterine transfusion
193324|NCT02986698|in utero human stem cell transplantation|in utero human stem cell transplantation
193325|NCT02986685|Refractory reflux esophagitis|refractory reflux esophagitis
193326|NCT02986685|Rabeprazole|rabeprazole
193327|NCT02986685|trimebutine maleate|trimebutine maleate
193328|NCT02986672|ADHD|adhd
193329|NCT02986672|omega 3|omega 3
193330|NCT02986672|children|children
193331|NCT02986672|nutrition|nutrition
193332|NCT02986672|MUFA|mufa
193334|NCT02986672|PUFA|pufa
193335|NCT02986672|Calanus|calanus
193336|NCT02986672|learning difficulties|learning difficulties
193337|NCT02986633|Cardiac Resynchronization Therapy|cardiac resynchronization therapy
193338|NCT02986633|Echocardiography|echocardiography
193339|NCT02986633|Biventricular Pacing|biventricular pacing
193340|NCT02986568|Ontogenetic surgery|ontogenetic surgery
193341|NCT02986568|TMMR|tmmr
193342|NCT02986568|PMMR|pmmr
193343|NCT02986568|LEER|leer
193344|NCT02986555|Stress|stress
193345|NCT02986555|Virtual Reality|virtual reality
193346|NCT02986555|Motion sickness|motion sickness
193347|NCT02986555|Visual Fatigue|visual fatigue
193348|NCT02986555|Biofeedback|biofeedback
193349|NCT02986542|newborns,femoral artery, catheterization|newborns,femoral artery, catheterization
193350|NCT02986490|Mental disorders|mental disorders
193351|NCT02986490|Antipsychotic agents|antipsychotic agents
193352|NCT02986490|Magnesium|magnesium
193353|NCT02986490|Cardiovascular risk factor|cardiovascular risk factor
193354|NCT02986490|Metabolic syndrome|metabolic syndrome
193355|NCT02986464|Virtual reality|virtual reality
193356|NCT02986464|Immersive distraction|immersive distraction
193357|NCT02986464|Virtual world|virtual world
193358|NCT02986464|Virtual environment|virtual environment
193359|NCT02986464|Procedural pain|procedural pain
193360|NCT02986464|Acute pain|acute pain
193361|NCT02986464|Pain Management|pain management
193362|NCT02986464|Children, Child|children, child
193363|NCT02986464|Kid, Kids|kid, kids
193364|NCT02986464|Pediatric, Pediatrics|pediatric, pediatrics
193365|NCT02986464|Young children|young children
193366|NCT02986464|Burns|burns
193367|NCT02986464|Burn injuries|burn injuries
193368|NCT02986464|Burn unit|burn unit
193369|NCT02986464|Hydrotherapy|hydrotherapy
193370|NCT02986464|Burn dressing|burn dressing
193371|NCT02986464|Non-pharmacological|non-pharmacological
193372|NCT02986464|Clinical Research|clinical research
193373|NCT02986464|Nursing Practice|nursing practice
193374|NCT02986438|Cocaine|cocaine
193375|NCT02986438|Addiction|addiction
193376|NCT02986438|rTMS|rtms
193377|NCT02986438|fMRI|fmri
193378|NCT02986425|Drug Utilization Review|drug utilization review
193379|NCT02986425|Older people|older people
193380|NCT02986399|fast track|fast track
193381|NCT02986386|Dental Occlusion|dental occlusion
193382|NCT02986386|Oral Health|oral health
193383|NCT02986386|Mastication|mastication
193384|NCT02986386|Dementia|dementia
193385|NCT02986386|Psychological health|psychological health
193386|NCT02986373|risankizumab|risankizumab
193387|NCT02986373|ABBV-066|abbv-066
193388|NCT02986373|BI655066|bi655066
193389|NCT02986334|chronic|chronic
193390|NCT02986334|low back|low back
193391|NCT02986334|back|back
193392|NCT02986334|pain|pain
193393|NCT02986334|brain|brain
193394|NCT02986334|MRI|mri
193395|NCT02986321|anti-inflammatory respiratory drug|anti-inflammatory respiratory drug
193396|NCT02986321|PDE4 inhibitor|pde4 inhibitor
193397|NCT02986308|Metabolomics|metabolomics
193398|NCT02986308|Intestinal Polyps|intestinal polyps
193399|NCT02986308|TCM Syndromes|tcm syndromes
193400|NCT02986308|TCM Constitution Types|tcm constitution types
193401|NCT02986295|BioMime, Ultimaster, Ischemic heart disease, DES|biomime, ultimaster, ischemic heart disease, des
193402|NCT02986282|ankle - brachial index|ankle - brachial index
193403|NCT02986269|Respiratory Function|respiratory function
193404|NCT02986269|Patient Positioning|patient positioning
193405|NCT02986269|anesthesia|anesthesia
193406|NCT02986256|telemedicine|telemedicine
193407|NCT02986230|Cancer prevention|cancer prevention
193408|NCT02986230|Clinical Decision Support|clinical decision support
193409|NCT02986230|Rural Health|rural health
193410|NCT02986230|Shared Decision Making|shared decision making
193411|NCT02986204|implant removal|implant removal
193412|NCT02986204|Nexplanon|nexplanon
193413|NCT02986204|Implanon|implanon
193414|NCT02986204|contraception|contraception
193415|NCT02986204|ENG|eng
193416|NCT02986191|gingival graft|gingival graft
193417|NCT02986191|free gingival graft|free gingival graft
193418|NCT02986191|coronally advanced flap|coronally advanced flap
193419|NCT02986191|reduced keratinized gingiva|reduced keratinized gingiva
193420|NCT02986178|Glioblastoma|glioblastoma
193421|NCT02986178|Glioma|glioma
193422|NCT02986178|PVSRIPO|pvsripo
193423|NCT02986178|Duke|duke
193424|NCT02986178|Pro00077024|pro00077024
193425|NCT02986178|Randazzo|randazzo
193426|NCT02986178|Brain tumor|brain tumor
193427|NCT02986178|Bigner|bigner
193428|NCT02986178|Istari|istari
193429|NCT02986165|Platelet Aggregation|platelet aggregation
193430|NCT02986152|PTSD|ptsd
193431|NCT02986152|anxiety|anxiety
193432|NCT02986152|depression|depression
193433|NCT02986152|distress|distress
193434|NCT02986152|fear|fear
193435|NCT02986152|coping|coping
193436|NCT02986152|support|support
193437|NCT02986152|caregiver|caregiver
193438|NCT02986152|oncology|oncology
193439|NCT02986152|app|app
193440|NCT02986152|mobile app|mobile app
193441|NCT02986126|Depression|depression
193442|NCT02986126|Resilience|resilience
193443|NCT02986126|Minority health|minority health
193444|NCT02986126|Community-based participatory research|community-based participatory research
193445|NCT02986126|Lesbian, gay, bisexual, transgender, and intersex (LGBTI) health|lesbian, gay, bisexual, transgender, and intersex (lgbti) health
193446|NCT02986126|Racial / ethnic health disparities|racial / ethnic health disparities
193447|NCT02986126|Patient-centered outcomes research|patient-centered outcomes research
193448|NCT02986126|Comparative-effectiveness research|comparative-effectiveness research
193449|NCT02986100|rucaparib|rucaparib
193450|NCT02986100|CO-338|co-338
193451|NCT02986100|Clovis|clovis
193452|NCT02986100|Clovis Oncology|clovis oncology
193453|NCT02986100|PARP inhibitor|parp inhibitor
193454|NCT02986100|Absorption|absorption
193455|NCT02986100|Metabolism|metabolism
193456|NCT02986100|Excretion|excretion
193457|NCT02986048|proton beam|proton beam
193458|NCT02986048|registry|registry
193459|NCT02986048|radiation|radiation
193460|NCT02986048|cancer|cancer
193461|NCT02986022|Self-efficacy|self-efficacy
193462|NCT02986022|optimism|optimism
193463|NCT02986022|altruism|altruism
193464|NCT02986022|goal setting|goal setting
193465|NCT02986009|emotion management|emotion management
193466|NCT02986009|positive and negative affect|positive and negative affect
194254|NCT02981147|Ivy Leaves|ivy leaves
193467|NCT02986009|satisfaction with parent-child relationship|satisfaction with parent-child relationship
193468|NCT02986009|subjective happiness|subjective happiness
193469|NCT02986009|family harmony|family harmony
193470|NCT02985996|Preventative Medicine|preventative medicine
193471|NCT02985996|Infectious Diseases|infectious diseases
193472|NCT02985996|Sexually Transmitted Diseases|sexually transmitted diseases
193473|NCT02985983|Brodalumab|brodalumab
193474|NCT02985983|KHK4827|khk4827
193475|NCT02985983|Axial Spondyloarthritis|axial spondyloarthritis
193476|NCT02985970|crush induction, RSI|crush induction, rsi
193477|NCT02985944|colorectal cancer|colorectal cancer
193478|NCT02985944|Colon polyp|colon polyp
193479|NCT02985944|Colonoscopy|colonoscopy
193480|NCT02985944|Adenoma detection rate|adenoma detection rate
193481|NCT02985905|Zinc supplementation|zinc supplementation
193482|NCT02985905|Thiol|thiol
193483|NCT02985905|Glutathione peroxidase|glutathione peroxidase
193484|NCT02985905|Sulfhydryl oxidase|sulfhydryl oxidase
193485|NCT02985892|Physical therapy|physical therapy
193486|NCT02985892|Muscle Stretching Exercises|muscle stretching exercises
193487|NCT02985892|Low Back pain|low back pain
193489|NCT02985879|Steele-Richardson-Olszewski syndrome|steele-richardson-olszewski syndrome
193490|NCT02985879|tauopathy|tauopathy
193491|NCT02985866|Artificial Pancreas|artificial pancreas
193492|NCT02985866|Closed Loop Control|closed loop control
193493|NCT02985866|Continuous Glucose Monitor (CGM)|continuous glucose monitor (cgm)
193494|NCT02985866|inControl Diabetes Management Platform|incontrol diabetes management platform
193495|NCT02985840|ondansetron|ondansetron
193496|NCT02985840|dexamethasone|dexamethasone
193497|NCT02985814|COPD Asthma Overlap|copd asthma overlap
193498|NCT02985775|CMV-specific T cell|cmv-specific t cell
193499|NCT02985775|haploidentical stem cell transplantation|haploidentical stem cell transplantation
193500|NCT02985775|immunologic response|immunologic response
193501|NCT02985775|acute GVHD|acute gvhd
193502|NCT02985762|bupivacaine|bupivacaine
193503|NCT02985762|exparel|exparel
193504|NCT02985762|analgesic|analgesic
193505|NCT02985762|lumbar spine|lumbar spine
193506|NCT02985749|Autism Spectrum Disorders|autism spectrum disorders
193507|NCT02985749|Pervasive Developmental Disorder|pervasive developmental disorder
193508|NCT02985749|ASD|asd
193509|NCT02985749|PDD|pdd
193510|NCT02985749|Oxytocin|oxytocin
193511|NCT02985749|Syntocinon|syntocinon
193512|NCT02985749|Social Impairment|social impairment
193513|NCT02985749|Treatment|treatment
193514|NCT02985671|Postural Low Back Pain|postural low back pain
193515|NCT02985671|Mechanical Low Back Pain|mechanical low back pain
193516|NCT02985671|Low Back Pain|low back pain
193517|NCT02985671|acetaminophen|acetaminophen
193518|NCT02985671|caffeine|caffeine
193519|NCT02985671|orphenadrine|orphenadrine
193520|NCT02985671|diclofenac sodium|diclofenac sodium
193521|NCT02985645|CGF|cgf
193522|NCT02985645|sinus augmentation|sinus augmentation
193523|NCT02985645|DIVA|diva
193524|NCT02985645|Platelet-Rich Plasma|platelet-rich plasma
193525|NCT02985554|hematologic malignancies|hematologic malignancies
193526|NCT02985554|allogeneic stem cell transplantation (allo-SCT)|allogeneic stem cell transplantation (allo-sct)
193527|NCT02985541|Birth Control|birth control
193528|NCT02985541|Heavy menstrual bleeding|heavy menstrual bleeding
193529|NCT02985515|Anosmia|anosmia
193530|NCT02985515|Hyposmia|hyposmia
193531|NCT02985515|Intranasal Steroid Irrigation|intranasal steroid irrigation
193532|NCT02985515|Olfactory Neuroplasticity|olfactory neuroplasticity
193533|NCT02985515|Olfactory training|olfactory training
193534|NCT02985502|Quality of Life|quality of life
193535|NCT02985502|Diabetes Mellitus|diabetes mellitus
193536|NCT02985502|Pancreatectomy|pancreatectomy
193537|NCT02985476|Electronic health records|electronic health records
193538|NCT02985476|Health records personal|health records personal
193539|NCT02985437|wound healing|wound healing
193540|NCT02985437|Bovine Lung Surfactant|bovine lung surfactant
193541|NCT02985437|SATOSU|satosu
193542|NCT02985385|Congenital Lethal Malformations|congenital lethal malformations
193543|NCT02985359|Program impact evaluation|program impact evaluation
193544|NCT02985359|Malawi|malawi
193545|NCT02985359|Lipid-based nutrient supplements|lipid-based nutrient supplements
193546|NCT02985359|Social behavior change communication|social behavior change communication
193547|NCT02985359|Childhood stunting|childhood stunting
193548|NCT02985346|Idiopathic pulmonary hemosiderosis|idiopathic pulmonary hemosiderosis
193549|NCT02985346|Bone marrow mesenchymal stem cells|bone marrow mesenchymal stem cells
193550|NCT02985333|paclitaxe,cyclophosphamide,dexamethasone, Multiple Myeloma|paclitaxe,cyclophosphamide,dexamethasone, multiple myeloma
193551|NCT02985320|Sabin strain|sabin strain
193552|NCT02985320|Inactivated poliovirus vaccine|inactivated poliovirus vaccine
193553|NCT02985320|poliomyelitis|poliomyelitis
193554|NCT02985320|safety|safety
193555|NCT02985320|immunogenicity|immunogenicity
193556|NCT02985320|infant|infant
193557|NCT02985294|Neuropathic pain|neuropathic pain
193558|NCT02985294|Quantitative Sensory Testing|quantitative sensory testing
193559|NCT02985294|Multiple Excitability Measures|multiple excitability measures
193560|NCT02985294|Threshold Tracking|threshold tracking
193561|NCT02985281|direct acting antiviral drugs, chronic hepatitis C virus infection|direct acting antiviral drugs, chronic hepatitis c virus infection
193562|NCT02985268|MitraClip|mitraclip
193563|NCT02985268|Cardiovascular resynchronization therapy|cardiovascular resynchronization therapy
193564|NCT02985268|Six minute walk test|six minute walk test
193565|NCT02985268|Mitral regurgitation|mitral regurgitation
193566|NCT02985268|CRT-D|crt-d
193567|NCT02985255|Neoadjuvant Chemotherapy|neoadjuvant chemotherapy
193568|NCT02985255|Tongue Malignancy|tongue malignancy
193569|NCT02985255|Squamous Cell Carcinoma|squamous cell carcinoma
193570|NCT02985203|lung cancer|lung cancer
193571|NCT02985203|vinorelbine|vinorelbine
193572|NCT02985203|metronomic chemotherapy|metronomic chemotherapy
193573|NCT02985190|Azacitidine|azacitidine
193574|NCT02985190|MDS|mds
193575|NCT02985190|Systemic auto-immune and inflammatory disorders|systemic auto-immune and inflammatory disorders
193576|NCT02985177|Children|children
193577|NCT02985177|Musculoskeletal injury|musculoskeletal injury
193578|NCT02985177|Emergency department|emergency department
193579|NCT02985177|Analgesia|analgesia
193580|NCT02985177|Opioids|opioids
193581|NCT02985164|Anesthesiology( H02.403.066 )|anesthesiology( h02.403.066 )
193582|NCT02985164|Radiation Protection( N06.850.810.425)|radiation protection( n06.850.810.425)
193583|NCT02985164|Cholangiopancreatography, Endoscopic Retrograde(D002760 )|cholangiopancreatography, endoscopic retrograde(d002760 )
193584|NCT02985151|Scar|scar
193585|NCT02985151|Carbon Dioxide Laser|carbon dioxide laser
193586|NCT02985151|Laser Ablation|laser ablation
193587|NCT02985125|Pancreas|pancreas
247496|NCT02652871|AML|aml
193588|NCT02985125|5-FU|5-fu
193589|NCT02985125|Gemcitabine|gemcitabine
193590|NCT02985125|LEE011|lee011
193591|NCT02985125|Everolimus|everolimus
193592|NCT02985125|Refractory|refractory
193593|NCT02985125|Chemotherapy|chemotherapy
193594|NCT02985086|term premature rupture of membranes, antibiotic prophylaxis, chorioamnionitis, endometritis, neonatal infection|term premature rupture of membranes, antibiotic prophylaxis, chorioamnionitis, endometritis, neonatal infection
193595|NCT02985060|Therapeutic hypothermia|therapeutic hypothermia
193596|NCT02985047|Brief admission|brief admission
193597|NCT02985047|admission|admission
193598|NCT02985047|deliberate self-harm|deliberate self-harm
193599|NCT02985047|self-harm|self-harm
193600|NCT02985034|HCC|hcc
193601|NCT02985034|RFA|rfa
193602|NCT02985034|Liver tumor|liver tumor
193603|NCT02985008|Shock, IVBP, ECMO, In hospital death|shock, ivbp, ecmo, in hospital death
193604|NCT02984995|FLT3-ITD|flt3-itd
193605|NCT02984995|Positive refractory or relapsed acute myeloid leukemia|positive refractory or relapsed acute myeloid leukemia
193606|NCT02984995|Hematology malignancy|hematology malignancy
193607|NCT02984995|Developmental Phase II|developmental phase ii
193608|NCT02984956|Hypotension|hypotension
193609|NCT02984956|Pleth variability index|pleth variability index
193610|NCT02984956|Hip Fracture|hip fracture
193611|NCT02984956|Spinal anesthesia|spinal anesthesia
193612|NCT02984943|Rheumatoid Arthritis|rheumatoid arthritis
193613|NCT02984943|Hyperbaric Oxygen|hyperbaric oxygen
193614|NCT02984917|anterior transversalis fascia repair; preperitoneal repair|anterior transversalis fascia repair; preperitoneal repair
193615|NCT02984904|Fusarium Infection|fusarium infection
193616|NCT02984904|Corneal ulcer|corneal ulcer
193617|NCT02984904|Spain|spain
193618|NCT02984904|Epidemiology|epidemiology
193619|NCT02984891|Intravascular ultrasound|intravascular ultrasound
193620|NCT02984891|Optical coherence tomography|optical coherence tomography
193621|NCT02984865|transversus plane block|transversus plane block
193622|NCT02984865|opioid|opioid
193623|NCT02984865|nalbuphine|nalbuphine
193624|NCT02984865|gastrointestinal surgery|gastrointestinal surgery
193625|NCT02984865|elderly patient|elderly patient
193626|NCT02984865|rectus sheath block|rectus sheath block
193627|NCT02984865|Peritoneal dialysis|peritoneal dialysis
193628|NCT02984839|intra-abdominal surgery|intra-abdominal surgery
193629|NCT02984839|neuromuscular blocking agent|neuromuscular blocking agent
193630|NCT02984839|post-anesthesia care unit|post-anesthesia care unit
193631|NCT02984787|Gastric Cancer|gastric cancer
193632|NCT02984787|3D|3d
193633|NCT02984787|2D|2d
193634|NCT02984774|Endometriosis|endometriosis
193635|NCT02984774|Infertility|infertility
193636|NCT02984774|Telomerase activity|telomerase activity
193637|NCT02984761|Carcinoma, Non-Small Cell Lung|carcinoma, non-small cell lung
193638|NCT02984761|Respiratory Tract Neoplasms|respiratory tract neoplasms
193639|NCT02984761|Thoracic Neoplasms|thoracic neoplasms
193640|NCT02984761|Neoplasms by Site|neoplasms by site
193641|NCT02984761|Neoplasms|neoplasms
193642|NCT02984761|Lung Diseases|lung diseases
193643|NCT02984761|Respiratory Tract Diseases|respiratory tract diseases
193644|NCT02984761|Carcinoma, Bronchogenic|carcinoma, bronchogenic
193645|NCT02984761|Bronchial Neoplasms|bronchial neoplasms
193646|NCT02984761|Radiosurgery|radiosurgery
193647|NCT02984761|Radiotherapy|radiotherapy
193648|NCT02984761|Radiotherapy, Image-Guided|radiotherapy, image-guided
193649|NCT02984761|Lung Neoplasms|lung neoplasms
193650|NCT02984748|cochlear implants|cochlear implants
193651|NCT02984748|hearing loss|hearing loss
193652|NCT02984735|chewing|chewing
193653|NCT02984735|cerebral palsy|cerebral palsy
193654|NCT02984735|chewing disorders|chewing disorders
193655|NCT02984735|gross motor function|gross motor function
193656|NCT02984722|PCOS|pcos
193657|NCT02984722|metformin|metformin
193658|NCT02984670|Cognitive therapy|cognitive therapy
193659|NCT02984670|Behavior therapy|behavior therapy
193660|NCT02984670|Moderation|moderation
193661|NCT02984670|Mediation|mediation
193662|NCT02984657|Hypoxemia|hypoxemia
193663|NCT02984657|Reverse Trendelenburg|reverse trendelenburg
193664|NCT02984592|premature ejaculation|premature ejaculation
193665|NCT02984592|intravaginal ejaculatory latency time|intravaginal ejaculatory latency time
193666|NCT02984592|premature ejaculation diagnostic tools|premature ejaculation diagnostic tools
193667|NCT02984566|Primary liver cancer|primary liver cancer
193668|NCT02984566|Secondary liver cancer|secondary liver cancer
193669|NCT02984566|Kilovoltage Intrafraction Monitoring|kilovoltage intrafraction monitoring
193670|NCT02984566|Stereotactic Ablative Body Radiation|stereotactic ablative body radiation
193671|NCT02984553|accelerometry|accelerometry
193672|NCT02984553|aerobic fitness|aerobic fitness
193673|NCT02984553|metabolic thresholds|metabolic thresholds
193674|NCT02984553|moderate to vigorous physical activity|moderate to vigorous physical activity
193675|NCT02984501|radiochemotherapy|radiochemotherapy
193676|NCT02984501|neoadjuvant therapy|neoadjuvant therapy
193677|NCT02984488|necrotic teeth|necrotic teeth
193678|NCT02984488|single visit|single visit
193679|NCT02984488|multiple visits|multiple visits
193680|NCT02984488|protaper next|protaper next
193681|NCT02984475|Beta Thalassemia|beta thalassemia
193682|NCT02984475|Metformin|metformin
193683|NCT02984475|Oxidative stress|oxidative stress
193684|NCT02984475|Iron overload|iron overload
193685|NCT02984475|Liver function|liver function
193686|NCT02984462|percutaneous|percutaneous
193687|NCT02984462|non-fixed|non-fixed
193688|NCT02984462|Akin ;|akin ;
193689|NCT02984462|osteotomy|osteotomy
193690|NCT02984449|cardiac rehabilitation|cardiac rehabilitation
193691|NCT02984449|surgical complications|surgical complications
193692|NCT02984449|quality of life|quality of life
193693|NCT02984449|preoperative|preoperative
193694|NCT02984449|cardiac surgery|cardiac surgery
193695|NCT02984423|Ovarian Cancer|ovarian cancer
193696|NCT02984423|BRCA mutations|brca mutations
193697|NCT02984410|T1-T2, N0 oropharyngeal carcinoma|t1-t2, n0 oropharyngeal carcinoma
193698|NCT02984397|pain|pain
193699|NCT02984397|ketotifen|ketotifen
193700|NCT02984397|pediatric|pediatric
193701|NCT02984397|mast cell|mast cell
193702|NCT02984384|Trauma|trauma
193703|NCT02984384|Blood clot|blood clot
193704|NCT02984384|Venous Thromboembolism|venous thromboembolism
193705|NCT02984384|Pulmonary Embolism|pulmonary embolism
193706|NCT02984384|Deep Vein Thrombosis|deep vein thrombosis
193707|NCT02984384|Thromboprophylaxis|thromboprophylaxis
193708|NCT02984384|Blood clot prevention|blood clot prevention
193709|NCT02984384|trauma patients|trauma patients
193710|NCT02984371|atrial fibrillation|atrial fibrillation
193711|NCT02984371|ganglionated plexi|ganglionated plexi
193712|NCT02984371|ischemic heart disease|ischemic heart disease
193713|NCT02984293|Atorvastatin|atorvastatin
193714|NCT02984293|LILRB5|lilrb5
193715|NCT02984293|Statin intolerance|statin intolerance
193716|NCT02984254|knee|knee
193717|NCT02984254|knee osteoarthritis|knee osteoarthritis
193718|NCT02984254|Bracing|bracing
193719|NCT02984254|patellofemoral osteoarthritis|patellofemoral osteoarthritis
193720|NCT02984189|Physical Exercise|physical exercise
193721|NCT02984189|Physical Therapy|physical therapy
193722|NCT02984189|Physical Performance|physical performance
193723|NCT02984189|Critical Power|critical power
193724|NCT02984189|Respiratory Muscle|respiratory muscle
193725|NCT02984176|Simethicone|simethicone
193726|NCT02984176|Laparoscopies|laparoscopies
193727|NCT02984176|Pain|pain
193728|NCT02984163|cancer|cancer
193729|NCT02984163|exercise|exercise
193730|NCT02984137|Lewy body disease|lewy body disease
193731|NCT02984137|REM Sleep Behavior Disorder|rem sleep behavior disorder
193732|NCT02984137|Parkinson disease|parkinson disease
193733|NCT02984137|Imaging|imaging
193734|NCT02984137|Bio-markers|bio-markers
193735|NCT02984137|Prospective cohort|prospective cohort
193736|NCT02984111|Coronary artery bypass|coronary artery bypass
193737|NCT02984111|Erythropoietin|erythropoietin
193738|NCT02984111|Inflammation|inflammation
193739|NCT02984111|IL-6|il-6
193740|NCT02984111|Reperfusion injury|reperfusion injury
193741|NCT02984111|YKL- 40|ykl- 40
193742|NCT02984098|procedural pain, 40% Dextrose, heel lance|procedural pain, 40% dextrose, heel lance
193743|NCT02984085|RDEB|rdeb
193744|NCT02984085|Stem cells|stem cells
193745|NCT02984085|Gene therapy|gene therapy
193746|NCT02984046|Acute bronchiolitis|acute bronchiolitis
193747|NCT02984046|RSV|rsv
193748|NCT02984046|CC16|cc16
193749|NCT02984046|SP-D|sp-d
193750|NCT02984046|sRAGE|srage
193751|NCT02984046|Severity|severity
193752|NCT02984046|Biomarkers|biomarkers
193753|NCT02983994|asthma, devices|asthma, devices
193754|NCT02983968|Oncology|oncology
193755|NCT02983968|Hepatology|hepatology
193756|NCT02983968|Public Health|public health
193757|NCT02983968|Liver|liver
193758|NCT02983942|ketogenic diet|ketogenic diet
193759|NCT02983942|Primary Central Nervous System Lymphoma|primary central nervous system lymphoma
193760|NCT02983942|chemotherapy|chemotherapy
193761|NCT02983916|Adhesions|adhesions
193762|NCT02983916|Adhesiolysis|adhesiolysis
193763|NCT02983916|chronic pain|chronic pain
193764|NCT02983916|post-operative complications|post-operative complications
193765|NCT02983916|anti-adhesion barrier|anti-adhesion barrier
193766|NCT02983916|cine-MRI|cine-mri
193767|NCT02983916|shared decision making|shared decision making
193768|NCT02983851|Noninvasive mechanical ventilation|noninvasive mechanical ventilation
193769|NCT02983851|Invasive mechanical ventilation|invasive mechanical ventilation
193770|NCT02983838|Amyloid|amyloid
193771|NCT02983838|BDNF|bdnf
193772|NCT02983838|major depressive disorder|major depressive disorder
193773|NCT02983838|cognitive decline|cognitive decline
193774|NCT02983825|CPAP|cpap
193775|NCT02983825|Bronchopulmonary Dysplasia|bronchopulmonary dysplasia
193776|NCT02983825|Ventilator Induced Lung Injury|ventilator induced lung injury
193777|NCT02983825|V/Q mismatch|v/q mismatch
193778|NCT02983799|BRCA, ovarian, platinum, chemotherapy|brca, ovarian, platinum, chemotherapy
193779|NCT02983760|Pulmonary embolism|pulmonary embolism
193780|NCT02983747|Platelet Rich Plasma|platelet rich plasma
712671|NCT00579215|Advance Lung Cancer|advance lung cancer
247747|NCT02651285|IVF|ivf
193781|NCT02983747|Intervertebral Disk Injection Therapy|intervertebral disk injection therapy
193782|NCT02983747|Low Back Pain|low back pain
193783|NCT02983747|Ultrasound Guided|ultrasound guided
193784|NCT02983747|Degenerative Spinal Disease|degenerative spinal disease
193785|NCT02983734|Gulf War|gulf war
193786|NCT02983734|D-cycloserine|d-cycloserine
193787|NCT02983734|Neuroinflammation|neuroinflammation
193788|NCT02983734|Cognition|cognition
193789|NCT02983734|Memory|memory
193790|NCT02983708|Neuroregeneration|neuroregeneration
193791|NCT02983708|G-CSF|g-csf
193792|NCT02983708|Peripheral blood mononuclear cells|peripheral blood mononuclear cells
193793|NCT02983708|Cerebral palsy|cerebral palsy
193794|NCT02983682|Anesthetics, Local|anesthetics, local
193795|NCT02983682|Lidocaine|lidocaine
193796|NCT02983682|Pediatrics|pediatrics
193797|NCT02983682|Children|children
193798|NCT02983682|Adolescents|adolescents
193799|NCT02983669|Thymus Plant|thymus plant
193800|NCT02983669|Multiflotriol [Supplementary Concept]|multiflotriol [supplementary concept]
193801|NCT02983669|Zataria multiflora|zataria multiflora
193802|NCT02983669|Complementary Therapies|complementary therapies
193803|NCT02983669|Herbal Medicine|herbal medicine
193804|NCT02983669|Medicine, traditional|medicine, traditional
193805|NCT02983656|Vaccine Safety|vaccine safety
193806|NCT02983643|Skeletal Muscle Index|skeletal muscle index
193807|NCT02983643|Visceral Adipose Tissue|visceral adipose tissue
193808|NCT02983643|Metabolic Syndrome|metabolic syndrome
193809|NCT02983604|Exemestane|exemestane
193810|NCT02983604|Aromasin|aromasin
193811|NCT02983604|Fulvestrant|fulvestrant
193812|NCT02983604|Faslodex|faslodex
193813|NCT02983604|Breast Cancer|breast cancer
193814|NCT02983604|HER 2-|her 2-
193815|NCT02983604|Estrogen receptor positive|estrogen receptor positive
193816|NCT02983578|Pancreatic cancer|pancreatic cancer
193817|NCT02983578|Mismatch deficient colorectal cancer|mismatch deficient colorectal cancer
193818|NCT02983578|Non-small cell lung cancer|non-small cell lung cancer
193819|NCT02983578|NSCLC|nsclc
193820|NCT02983578|AZD9150|azd9150
193821|NCT02983578|MEDI4736|medi4736
193822|NCT02983578|Durvalumab|durvalumab
193823|NCT02983565|Long-term oxygen therapy|long-term oxygen therapy
193824|NCT02983565|Intelligent oxygen therapy system|intelligent oxygen therapy system
193825|NCT02983565|Auto-titrating oxygen system|auto-titrating oxygen system
193826|NCT02983552|Amblyopia|amblyopia
193827|NCT02983539|sarcomas|sarcomas
193828|NCT02983539|immunocytochemistry|immunocytochemistry
193829|NCT02983539|circulating tumor cells|circulating tumor cells
193830|NCT02983526|short stem|short stem
193831|NCT02983513|Early intervention|early intervention
193832|NCT02983513|Brain Development|brain development
193833|NCT02983513|Neurodevelopment|neurodevelopment
193834|NCT02983500|Patient Reported Outcome (PRO)|patient reported outcome (pro)
193835|NCT02983487|Bordetella Pertussis|bordetella pertussis
193836|NCT02983487|Whooping Cough|whooping cough
193837|NCT02983487|vaccine|vaccine
193838|NCT02983461|urinary incontinence|urinary incontinence
193839|NCT02983461|pelvic floor dysfunction|pelvic floor dysfunction
193840|NCT02983435|Osteopathic Treatment|osteopathic treatment
193841|NCT02983435|Postural control|postural control
193842|NCT02983435|Neuromuscular activation|neuromuscular activation
193843|NCT02983435|Physiotherapy|physiotherapy
193844|NCT02983409|computerized tomography|computerized tomography
193845|NCT02983409|Urinary Calculi|urinary calculi
193846|NCT02983409|Patient admission|patient admission
193847|NCT02983409|Pain|pain
193848|NCT02983396|RELF method|relf method
193849|NCT02983396|Medical device|medical device
193850|NCT02983396|Admission delay|admission delay
193851|NCT02983383|Varicocele|varicocele
193852|NCT02983383|TAP block|tap block
193853|NCT02983383|spinal anesthesia|spinal anesthesia
193854|NCT02983357|Shoulder Arthroplasty|shoulder arthroplasty
194351|NCT02980536|Mutation|mutation
193855|NCT02983357|glenohumeral arthritis|glenohumeral arthritis
193856|NCT02983344|fascia iliaca compartment block|fascia iliaca compartment block
193857|NCT02983344|fentanyl|fentanyl
193858|NCT02983266|Hyperadrenergia|hyperadrenergia
193859|NCT02983266|Inflammatory stress|inflammatory stress
193860|NCT02983214|Cilostazol|cilostazol
193861|NCT02983214|Clopidogrel|clopidogrel
193862|NCT02983214|Peripheral Artery Disease|peripheral artery disease
193863|NCT02983201|Orthopedic Pain Syndromes|orthopedic pain syndromes
193864|NCT02983201|Thumbtack Intra-dermal Needle|thumbtack intra-dermal needle
193865|NCT02983201|Filiform needle|filiform needle
193866|NCT02983201|Acupuncture|acupuncture
193867|NCT02983188|Schizophrenia|schizophrenia
193868|NCT02983188|Berberine|berberine
193869|NCT02983188|Metabolic Syndrome|metabolic syndrome
193870|NCT02983188|Chinese medicine|chinese medicine
193871|NCT02983188|Herbal medicine|herbal medicine
193872|NCT02983175|ultrasonogaphy|ultrasonogaphy
193873|NCT02983175|full stomach|full stomach
193874|NCT02983175|pulmonary aspiration|pulmonary aspiration
193875|NCT02983175|anaesthesia|anaesthesia
193876|NCT02983136|Hand Hygiene|hand hygiene
193877|NCT02983136|Implementation|implementation
193878|NCT02983136|Partnership|partnership
193880|NCT02983123|Acute MI|acute mi
193881|NCT02983123|Acute myocardial infarction cardiac troponin|acute myocardial infarction cardiac troponin
193882|NCT02983123|High-sensitivity cardiac troponin T|high-sensitivity cardiac troponin t
193883|NCT02983123|0/1-hour algorithm|0/1-hour algorithm
193884|NCT02983123|Outpatient clinic|outpatient clinic
193885|NCT02983123|Cardiac troponin|cardiac troponin
193886|NCT02983123|Chest pain|chest pain
193887|NCT02983110|Hormones, Transgender|hormones, transgender
193888|NCT02983097|lymphoma|lymphoma
193889|NCT02983097|relapse|relapse
193890|NCT02983097|recurrence|recurrence
193891|NCT02983097|progress|progress
193892|NCT02983097|progressive|progressive
193893|NCT02983097|b-cell lymphoma|b-cell lymphoma
193894|NCT02983097|chemotherapy|chemotherapy
193895|NCT02983097|immunotherapy|immunotherapy
193896|NCT02983097|IMiD|imid
193897|NCT02983097|Salvage chemotherapy|salvage chemotherapy
193898|NCT02983097|peripheral stem cell mobilization|peripheral stem cell mobilization
193899|NCT02983097|lenalidomide|lenalidomide
193900|NCT02983097|Rituximab|rituximab
193901|NCT02983097|CD20|cd20
193902|NCT02983097|Cytarabine|cytarabine
193903|NCT02983097|Ara-C|ara-c
193904|NCT02983097|platinum-based chemotherapy|platinum-based chemotherapy
193905|NCT02983097|Cisplatin|cisplatin
193906|NCT02983097|Carboplatin|carboplatin
193907|NCT02983097|Cisplatinum|cisplatinum
193908|NCT02983097|Carboplatinum|carboplatinum
193909|NCT02983097|Dexamethasone|dexamethasone
193910|NCT02983084|Orthodontic wires|orthodontic wires
193911|NCT02983084|Root resorption|root resorption
193912|NCT02983071|Breast Cancer|breast cancer
193913|NCT02983071|CDK 4/6 Inhibitor|cdk 4/6 inhibitor
193914|NCT02983071|HER2-Negative|her2-negative
193915|NCT02983071|HR-Positive|hr-positive
193916|NCT02983071|HR+|hr+
193917|NCT02983071|HER2-|her2-
193918|NCT02983071|HER2 -ve|her2 -ve
193919|NCT02983071|HER2 +ve|her2 +ve
193920|NCT02983045|NKTR-214|nktr-214
193921|NCT02983045|Bempegaldesleukin|bempegaldesleukin
193922|NCT02983045|Nivolumab|nivolumab
193923|NCT02983045|Ipilimumab|ipilimumab
193924|NCT02983045|Paclitaxel|paclitaxel
193925|NCT02983045|Carboplatin|carboplatin
193926|NCT02983045|Cisplatin|cisplatin
193927|NCT02983045|Pemetrexed|pemetrexed
193928|NCT02983045|Melanoma|melanoma
193929|NCT02983045|Renal Cell Carcinoma|renal cell carcinoma
193930|NCT02983045|Non Small Cell Lung Cancer|non small cell lung cancer
193931|NCT02983045|Urothelial Carcinoma|urothelial carcinoma
193932|NCT02983045|Triple Negative Breast Cancer|triple negative breast cancer
193933|NCT02983045|Colorectal Cancer|colorectal cancer
193934|NCT02983045|Metastatic|metastatic
193935|NCT02983045|Advanced|advanced
193936|NCT02983045|Immunotherapy|immunotherapy
193937|NCT02983045|Anti-PD-1|anti-pd-1
193938|NCT02983045|anti-CTLA-4|anti-ctla-4
193939|NCT02983032|Caregivers|caregivers
193940|NCT02983032|Insomnia|insomnia
193941|NCT02983019|influenza|influenza
193942|NCT02983019|flu|flu
193943|NCT02983019|acute respiratory viral infection|acute respiratory viral infection
193944|NCT02983019|ARVI|arvi
193945|NCT02983019|acute upper respiratory infection|acute upper respiratory infection
193946|NCT02983019|AURI|auri
193947|NCT02983006|TRAIL-DR5|trail-dr5
193948|NCT02983006|DS-8273a|ds-8273a
193949|NCT02983006|Immunoglobulin gamma-1 (IgG1)|immunoglobulin gamma-1 (igg1)
193950|NCT02983006|Cell mediated cytotoxicity (ADCC)|cell mediated cytotoxicity (adcc)
193951|NCT02983006|Complement dependent cytotoxicity (CDC)|complement dependent cytotoxicity (cdc)
193952|NCT02983006|DR5|dr5
193953|NCT02983006|Immunoglobulin G4 (IgG4)|immunoglobulin g4 (igg4)
193954|NCT02983006|Monoclonal antibody|monoclonal antibody
193955|NCT02983006|Programmed Cell Death 1 (PD-1)|programmed cell death 1 (pd-1)
193956|NCT02982993|hepatitis C virus|hepatitis c virus
193957|NCT02982993|linkage-to-care|linkage-to-care
193958|NCT02982993|World Trade Center Health Program cohort|world trade center health program cohort
193959|NCT02982993|Baby Boomer|baby boomer
193960|NCT02982993|risk factors for hepatitis C virus infection|risk factors for hepatitis c virus infection
193961|NCT02982967|child|child
193962|NCT02982967|physical activity|physical activity
193963|NCT02982967|irisin|irisin
193964|NCT02982967|EPCs|epcs
193965|NCT02982941|Neuroblastoma|neuroblastoma
193966|NCT02982941|Rhabdomyosarcoma|rhabdomyosarcoma
193967|NCT02982941|Osteosarcoma|osteosarcoma
193968|NCT02982941|Ewing Sarcoma|ewing sarcoma
193969|NCT02982941|Wilms Tumor|wilms tumor
193970|NCT02982941|Desmoplastic Small Round Cell Tumor|desmoplastic small round cell tumor
193971|NCT02982941|pediatric|pediatric
193972|NCT02982928|Obesity|obesity
193973|NCT02982928|Bariatrics|bariatrics
193974|NCT02982928|Acetaminophen|acetaminophen
193975|NCT02982928|robot-assisted or laparoscopic bariatric surgery|robot-assisted or laparoscopic bariatric surgery
193976|NCT02982928|Pharmacokinetics|pharmacokinetics
193977|NCT02982902|Immunotherapy|immunotherapy
193978|NCT02982902|T-Cell Therapy|t-cell therapy
193979|NCT02982902|Lymphoproliferative Disorder|lymphoproliferative disorder
193980|NCT02982889|Analytical, Diagnostic,Therapeutic Technique and Equipment|analytical, diagnostic,therapeutic technique and equipment
193981|NCT02982889|Anesthesia and Analgesia|anesthesia and analgesia
193982|NCT02982876|Silicone Airway stent|silicone airway stent
193983|NCT02982876|Metallic Airway stent|metallic airway stent
193984|NCT02982850|Atrial Fibrillation|atrial fibrillation
193985|NCT02982850|Valvular Insufficiency|valvular insufficiency
193986|NCT02982850|Valvular Stenosis|valvular stenosis
193987|NCT02982824|Children|children
193988|NCT02982824|IQ|iq
193989|NCT02982824|Idiopathic epilepsy|idiopathic epilepsy
193990|NCT02982824|Magnesium supplementation|magnesium supplementation
193991|NCT02982824|Seizure control|seizure control
193992|NCT02982824|Chalfont score|chalfont score
193993|NCT02982811|Activity-based|activity-based
193994|NCT02982811|Client-centred|client-centred
193995|NCT02982811|Rehabilitation|rehabilitation
193996|NCT02982811|Quality of life|quality of life
193997|NCT02982772|Nicotine Replacement|nicotine replacement
193998|NCT02982772|Smoking|smoking
193999|NCT02982772|HIV|hiv
194000|NCT02982746|Head and neck cancer|head and neck cancer
194001|NCT02982746|Person Centred Care|person centred care
194002|NCT02982746|Health related quality of life|health related quality of life
194003|NCT02982746|EORTC QLQ-C30|eortc qlq-c30
194004|NCT02982746|EORTC QLQ-C35|eortc qlq-c35
194005|NCT02982720|cholangiocarcinoma|cholangiocarcinoma
194006|NCT02982720|Pembrolizumab|pembrolizumab
194007|NCT02982720|MK-3475|mk-3475
194008|NCT02982720|Sylatron|sylatron
194009|NCT02982720|peginterferon alfa-2b|peginterferon alfa-2b
194010|NCT02982694|MSI|msi
194011|NCT02982694|colorectal|colorectal
194012|NCT02982694|chemotherapy|chemotherapy
194013|NCT02982694|Bevacizumab|bevacizumab
194014|NCT02982694|Atezolizumab|atezolizumab
194015|NCT02982681|Periodontal disease|periodontal disease
194016|NCT02982681|Platelet rich fibrin|platelet rich fibrin
194017|NCT02982668|severe stroke|severe stroke
194018|NCT02982668|Acute Stroke|acute stroke
194019|NCT02982668|Enteral Feeding|enteral feeding
194020|NCT02982668|Mortality|mortality
194021|NCT02982668|Disability|disability
194022|NCT02982668|Clinical trial|clinical trial
194023|NCT02982655|Severe Stroke|severe stroke
194024|NCT02982655|Acute Stroke|acute stroke
194025|NCT02982655|Antihypertension|antihypertension
194026|NCT02982655|mortality|mortality
194027|NCT02982655|disability|disability
194028|NCT02982655|clinical trial|clinical trial
194029|NCT02982629|Glaucoma|glaucoma
194030|NCT02982629|Eye Care|eye care
194031|NCT02982629|Community Outreach|community outreach
194032|NCT02982577|Xerostomia|xerostomia
194033|NCT02982577|Pilocarpine|pilocarpine
194034|NCT02982577|Quality of life|quality of life
194035|NCT02982564|Exercise|exercise
194036|NCT02982564|Physical Functioning|physical functioning
194037|NCT02982564|Hispanic|hispanic
194038|NCT02982538|posttraumatic stress symptoms|posttraumatic stress symptoms
194039|NCT02982538|implementation|implementation
194040|NCT02982538|dissemination|dissemination
194041|NCT02982538|PTSD|ptsd
194042|NCT02982525|Mussels|mussels
194043|NCT02982525|Dietary Intervention|dietary intervention
194044|NCT02982525|Long-term intervention|long-term intervention
194045|NCT02982525|Vitamin D status|vitamin d status
194046|NCT02982525|Selenium|selenium
194047|NCT02982525|Iodine|iodine
194048|NCT02982525|Vitamin B12|vitamin b12
194049|NCT02982525|Omega-3 index|omega-3 index
194050|NCT02982512|Potential local fields|potential local fields
194051|NCT02982512|Subthalamic neuronal activity|subthalamic neuronal activity
194052|NCT02982499|glaucoma|glaucoma
194053|NCT02982499|Leber optic neuropathy|leber optic neuropathy
194054|NCT02982499|anterior ischemic optic neuropathy|anterior ischemic optic neuropathy
194055|NCT02982486|nivolumab|nivolumab
194056|NCT02982486|ipilimumab|ipilimumab
194057|NCT02982486|immunotherapy|immunotherapy
194058|NCT02982486|PD-1 inhibitor|pd-1 inhibitor
194059|NCT02982486|sarcoma|sarcoma
194060|NCT02982460|Rotator cuff tendinopathy|rotator cuff tendinopathy
194061|NCT02982460|Eccentric exercise|eccentric exercise
194062|NCT02982460|Isoinertial training|isoinertial training
194063|NCT02982447|blue laser imaging,detection,randomized trial|blue laser imaging,detection,randomized trial
194064|NCT02982434|atrial fibrillation|atrial fibrillation
194065|NCT02982434|botulinum toxin|botulinum toxin
194066|NCT02982434|ischemic heart disease|ischemic heart disease
194067|NCT02982395|Nanoxel M|nanoxel m
194068|NCT02982395|Docetaxel PM|docetaxel pm
194069|NCT02982395|Docetaxel|docetaxel
194070|NCT02982395|Mitomycin C|mitomycin c
194072|NCT02982395|BCG refractory|bcg refractory
194073|NCT02982395|Non muscle invasive bladder cancer|non muscle invasive bladder cancer
194074|NCT02982395|intravesical|intravesical
194075|NCT02982395|superficial bladder cancer|superficial bladder cancer
194076|NCT02982395|Urothelial carcinoma|urothelial carcinoma
194077|NCT02982395|Transitional cell carcinoma|transitional cell carcinoma
194078|NCT02982382|Low Back Pain|low back pain
194079|NCT02982382|Musculoskeletal Manipulations|musculoskeletal manipulations
194080|NCT02982382|Neurophysiology|neurophysiology
194081|NCT02982382|Education|education
194082|NCT02982317|Neuraxial anesthesia|neuraxial anesthesia
194083|NCT02982317|Obstetrics|obstetrics
194084|NCT02982317|Ultrasound|ultrasound
194085|NCT02982252|Power mobility|power mobility
194086|NCT02982252|Wheelchair skills training|wheelchair skills training
194087|NCT02982252|Older adults|older adults
194088|NCT02982226|Plantar Fasciitis|plantar fasciitis
194089|NCT02982226|Jogger's Heel|jogger's heel
194090|NCT02982226|ReNu|renu
194091|NCT02982213|Newest Vital Sign|newest vital sign
194092|NCT02982213|Anxiety|anxiety
194093|NCT02982213|Health literacy|health literacy
194094|NCT02982213|Neuraxial Analgesia|neuraxial analgesia
194095|NCT02982213|Epidural catheter placement|epidural catheter placement
194096|NCT02982213|Pregnancy|pregnancy
194097|NCT02982213|Parturients|parturients
194098|NCT02982213|Pain Catastrophizing Scale|pain catastrophizing scale
194099|NCT02982213|STAI questionnaire|stai questionnaire
194100|NCT02982213|Companion|companion
194101|NCT02982200|Embolization Device|embolization device
194102|NCT02982200|Medina|medina
194103|NCT02982200|Rupture Intracranial Aneurysm|rupture intracranial aneurysm
194104|NCT02982200|Unrupture Intracranial Aneurysm|unrupture intracranial aneurysm
194105|NCT02982187|HANDIHALER|handihaler
194106|NCT02982187|ELLIPTA|ellipta
194107|NCT02982187|TURBUHALER|turbuhaler
194108|NCT02982187|DISKUS|diskus
194109|NCT02982187|COPD|copd
194110|NCT02982187|critical error|critical error
194111|NCT02982187|inhaler preference|inhaler preference
194112|NCT02982174|no known ocular pathology|no known ocular pathology
194113|NCT02982161|Third Molar Tooth Extraction|third molar tooth extraction
194114|NCT02982148|sentinel lymph node biopsy|sentinel lymph node biopsy
194115|NCT02982148|methylene blue|methylene blue
194116|NCT02982148|intradermal injection|intradermal injection
194117|NCT02982148|subcutaneous injection|subcutaneous injection
194118|NCT02982135|hemorrhagic moyamoya disease|hemorrhagic moyamoya disease
194119|NCT02982135|bypass|bypass
194120|NCT02982135|indirect bypass|indirect bypass
194121|NCT02982083|Rheumatoid arthritis|rheumatoid arthritis
194122|NCT02982083|Raloxifene|raloxifene
194123|NCT02982083|Disease activity|disease activity
194124|NCT02982070|psychological well-being, academic success|psychological well-being, academic success
194125|NCT02982044|blood flow|blood flow
194126|NCT02982044|endothelial function|endothelial function
194127|NCT02982044|shear stress|shear stress
194128|NCT02982031|Ultrasound-guided lumbar plexus blockade|ultrasound-guided lumbar plexus blockade
194129|NCT02982031|Shamrock technique|shamrock technique
194130|NCT02982031|Paramedian transverse scan|paramedian transverse scan
194131|NCT02982031|USG LPB|usg lpb
194132|NCT02982031|USGRA|usgra
194133|NCT02982005|KHK4827 (brodalumab)|khk4827 (brodalumab)
194134|NCT02981979|Takayasu Arteritis|takayasu arteritis
194135|NCT02981979|Leflunomide|leflunomide
194136|NCT02981953|Valtech Cardio|valtech cardio
194137|NCT02981953|Cardioband|cardioband
194138|NCT02981953|Tricuspid|tricuspid
194139|NCT02981940|Brain Tumor|brain tumor
194140|NCT02981914|Classical Hodgkin Lymphoma|classical hodgkin lymphoma
194141|NCT02981914|B-cell Non-Hodgkin Lymphoma|b-cell non-hodgkin lymphoma
194142|NCT02981914|Acute Myeloid Leukemia|acute myeloid leukemia
194143|NCT02981914|Myelodysplastic Syndromes|myelodysplastic syndromes
194144|NCT02981914|pembrolizumab|pembrolizumab
194145|NCT02981875|reading eye movement|reading eye movement
194146|NCT02981862|HPV infection|hpv infection
194147|NCT02981862|Blood sample|blood sample
194148|NCT02981862|Biopsy|biopsy
194149|NCT02981836|live attenuated varicella vaccine|live attenuated varicella vaccine
194150|NCT02981836|protective effect|protective effect
194151|NCT02981836|safety|safety
194152|NCT02981836|immunogenicity|immunogenicity
194153|NCT02981836|child|child
194154|NCT02981810|TONSILLAR COBLATION|tonsillar coblation
194155|NCT02981797|symptomatic bone metastasis|symptomatic bone metastasis
194156|NCT02981797|metastatic|metastatic
194157|NCT02981797|castration resistant|castration resistant
194158|NCT02981784|chronic myeloid leukemia (CML)|chronic myeloid leukemia (cml)
194159|NCT02981784|Philadelphia-positive (Ph+)|philadelphia-positive (ph+)
194160|NCT02981784|Acute Lymphoblastic Leukemia (ALL)|acute lymphoblastic leukemia (all)
194161|NCT02981732|Osteoporosis|osteoporosis
194162|NCT02981732|kidney yin deficiency syndrome|kidney yin deficiency syndrome
194163|NCT02981732|liuwei dihuang pill|liuwei dihuang pill
194164|NCT02981706|Arteriovenous Fistula (AVF)|arteriovenous fistula (avf)
194165|NCT02981706|Arteriovenous Graft (AVG)|arteriovenous graft (avg)
194166|NCT02981680|remote ischemic preconditioning; transient limb ischemia; acute kidney injury; coronary artery bypass graft surgery|remote ischemic preconditioning; transient limb ischemia; acute kidney injury; coronary artery bypass graft surgery
194167|NCT02981641|Pancreatic cancer|pancreatic cancer
194168|NCT02981641|Intraoperative radiotherapy (IORT)|intraoperative radiotherapy (iort)
194169|NCT02981641|Concurrent Chemoradiotherapy (CCRT)|concurrent chemoradiotherapy (ccrt)
194170|NCT02981602|Hepatitis|hepatitis
194171|NCT02981602|Chronic|chronic
194172|NCT02981602|HBV|hbv
194173|NCT02981576|Spinal Cord Injury|spinal cord injury
194174|NCT02981576|Mesenchymal Stem Cells|mesenchymal stem cells
194175|NCT02981563|engagement|engagement
194176|NCT02981563|psychiatric in-patient care|psychiatric in-patient care
194177|NCT02981563|mental health nursing|mental health nursing
194178|NCT02981563|quality interactions|quality interactions
194179|NCT02981550|Infection|infection
194180|NCT02981524|Colorectal Neoplasms|colorectal neoplasms
194181|NCT02981524|Gastrointestinal Neoplasms|gastrointestinal neoplasms
194182|NCT02981524|Digestive System Neoplasms|digestive system neoplasms
194183|NCT02981524|Neoplasms by Site|neoplasms by site
194184|NCT02981524|Neoplasms|neoplasms
194185|NCT02981524|Digestive System Diseases|digestive system diseases
194186|NCT02981524|Gastrointestinal Diseases|gastrointestinal diseases
194187|NCT02981524|Intestinal Diseases|intestinal diseases
194188|NCT02981524|Rectal Diseases|rectal diseases
194189|NCT02981524|Colonic Diseases|colonic diseases
194190|NCT02981498|Hepatic arterial infusion chemotherapy|hepatic arterial infusion chemotherapy
194191|NCT02981498|Sorafenib|sorafenib
194192|NCT02981485|Fat Grafting, Breast Cancer Lymphedema|fat grafting, breast cancer lymphedema
194193|NCT02981459|bladder pain|bladder pain
194194|NCT02981459|urinary frequency|urinary frequency
194195|NCT02981459|urinary urgency|urinary urgency
194196|NCT02981459|mirabegron|mirabegron
194197|NCT02981407|Red Blood Cell Transfusion|red blood cell transfusion
194198|NCT02981407|Anemia|anemia
194199|NCT02981407|Heart Disease|heart disease
194200|NCT02981407|Cardiovascular Disease|cardiovascular disease
194201|NCT02981381|sTMS|stms
194202|NCT02981381|NeoSync|neosync
194203|NCT02981381|NEST|nest
194204|NCT02981381|synchronous|synchronous
194205|NCT02981381|non-invasive neuromodulation|non-invasive neuromodulation
194206|NCT02981381|TMS|tms
194207|NCT02981381|Transcranial Magnetic Stimulation|transcranial magnetic stimulation
194208|NCT02981381|PTSD|ptsd
194209|NCT02981381|EEG|eeg
194210|NCT02981381|Depression|depression
194211|NCT02981368|Diagnostic|diagnostic
194212|NCT02981368|Imaging|imaging
194213|NCT02981368|2301|2301
194214|NCT02981368|PET/CT|pet/ct
194215|NCT02981368|PyL|pyl
194216|NCT02981368|PSMA|psma
194217|NCT02981368|radical prostatectomy|radical prostatectomy
194218|NCT02981368|metastatic prostate cancer|metastatic prostate cancer
194219|NCT02981368|recurrent prostate cancer|recurrent prostate cancer
194220|NCT02981355|BST-CarGel|bst-cargel
194221|NCT02981355|Microfracture|microfracture
194222|NCT02981355|Cartilage Lesion, Chondral Lesion|cartilage lesion, chondral lesion
194223|NCT02981355|Femoral condyle|femoral condyle
194224|NCT02981355|Bone Marrow Stimulation|bone marrow stimulation
194225|NCT02981355|Cartilage Repair|cartilage repair
194226|NCT02981355|Tear of Articular Cartilage of Knee, Current|tear of articular cartilage of knee, current
194227|NCT02981342|pancreatic cancer|pancreatic cancer
194228|NCT02981329|Metformin|metformin
194229|NCT02981329|Sickle Cell Anemia|sickle cell anemia
194230|NCT02981329|Sickle Cell Disease|sickle cell disease
194231|NCT02981329|Hemoglobinopathies|hemoglobinopathies
194232|NCT02981329|Hemoglobin Disorder|hemoglobin disorder
194233|NCT02981329|Blood Disease|blood disease
194234|NCT02981329|Hemoglobin Disease; Sickle-Cell, Thalassemia|hemoglobin disease; sickle-cell, thalassemia
194235|NCT02981329|Hemoglobin Disease|hemoglobin disease
194236|NCT02981277|Bronchoscopy|bronchoscopy
194237|NCT02981277|Lignocaine|lignocaine
194238|NCT02981264|Bronchoscopy|bronchoscopy
194239|NCT02981264|Lignocaine|lignocaine
194240|NCT02981264|Endobronchial Ultrasound|endobronchial ultrasound
194241|NCT02981251|Hypertension|hypertension
194242|NCT02981251|Uncontrolled blood pressure|uncontrolled blood pressure
194243|NCT02981251|Health education|health education
194244|NCT02981251|Community based|community based
194245|NCT02981199|microtransplantation|microtransplantation
194246|NCT02981199|multiple myeloma|multiple myeloma
194247|NCT02981186|Intraocular Lens|intraocular lens
194248|NCT02981186|trifocal|trifocal
194249|NCT02981186|cataract|cataract
194250|NCT02981186|PhysIOL|physiol
194251|NCT02981147|cough|cough
194252|NCT02981147|thyme|thyme
194253|NCT02981147|Cisti|cisti
194255|NCT02981134|bioabsorbable scaffold|bioabsorbable scaffold
194256|NCT02981134|computed tomography|computed tomography
194257|NCT02981121|Diabetes Prevention|diabetes prevention
194258|NCT02981082|Systemic Sclerosis, Scleroderma, PAH, Pulmonary Hypertension|systemic sclerosis, scleroderma, pah, pulmonary hypertension
194259|NCT02981056|Skincare regimens|skincare regimens
194260|NCT02981056|Skin moisturization|skin moisturization
194261|NCT02981056|Skin barrier|skin barrier
194262|NCT02981056|Skin development|skin development
194263|NCT02981017|Chronic sinusitis|chronic sinusitis
194264|NCT02981017|Frontal sinusitis|frontal sinusitis
194265|NCT02981017|Skull base neoplasm|skull base neoplasm
194266|NCT02981004|Aortic valve disease, patient prosthesis mismatch|aortic valve disease, patient prosthesis mismatch
194267|NCT02980965|breast cancer|breast cancer
194268|NCT02980965|neoadjuvant chemotherapy|neoadjuvant chemotherapy
194269|NCT02980965|endocrine therapy|endocrine therapy
194270|NCT02980965|concurrent|concurrent
194271|NCT02980887|Pulmonary arterial hypertension|pulmonary arterial hypertension
194272|NCT02980874|RVO|rvo
194273|NCT02980874|ME|me
194274|NCT02980874|Central Subfield Thickness|central subfield thickness
194275|NCT02980874|OCT|oct
194276|NCT02980874|Optical Coherence Tomography|optical coherence tomography
194277|NCT02980874|Cystoid Macular Edema|cystoid macular edema
194278|NCT02980874|Subretinal Fluid|subretinal fluid
194279|NCT02980874|Eylea|eylea
194280|NCT02980874|Aflibercept|aflibercept
194281|NCT02980874|Anti-VEGF|anti-vegf
194282|NCT02980874|Suprachoroidal|suprachoroidal
194283|NCT02980861|Gastric Cancer|gastric cancer
194284|NCT02980861|Splenic Hilum Lymph Nodes Dissection|splenic hilum lymph nodes dissection
194285|NCT02980861|Gastrectomy|gastrectomy
194286|NCT02980848|digital mammography|digital mammography
194287|NCT02980848|digital breast tomosynthesis|digital breast tomosynthesis
194288|NCT02980848|breast magnetic resonance imaging|breast magnetic resonance imaging
194289|NCT02980848|screening|screening
194290|NCT02980848|breast density|breast density
194291|NCT02980848|breast imaging|breast imaging
194292|NCT02980848|pre-operative magnetic resonance imaging|pre-operative magnetic resonance imaging
194293|NCT02980796|Brain|brain
194294|NCT02980796|MRI|mri
194295|NCT02980796|Exercise|exercise
194296|NCT02980796|Rehabilitation|rehabilitation
194297|NCT02980796|TMS|tms
194298|NCT02980770|Obstructive Sleep Apnea|obstructive sleep apnea
194299|NCT02980770|Obesity Hypoventilation Syndrome|obesity hypoventilation syndrome
194300|NCT02980770|Hypercapnia|hypercapnia
194301|NCT02980770|Post-Op Complication|post-op complication
194302|NCT02980770|Acid-Base Imbalance|acid-base imbalance
194303|NCT02980744|Stroke|stroke
194304|NCT02980744|Sedentary behaviour|sedentary behaviour
194305|NCT02980744|Intervention|intervention
194306|NCT02980731|Relapsed CLL|relapsed cll
194307|NCT02980731|Refractory CLL|refractory cll
194308|NCT02980731|17p deletion|17p deletion
194309|NCT02980731|TP53 gene|tp53 gene
194310|NCT02980731|B-Cell receptor inhibitor (BCRi)|b-cell receptor inhibitor (bcri)
194311|NCT02980731|European Organization of Research and Treatment of Cancer Quality of Life Core Questionnaire (EORTC QLQ-C30)|european organization of research and treatment of cancer quality of life core questionnaire (eortc qlq-c30)
194312|NCT02980731|Overall response rate (ORR)|overall response rate (orr)
194313|NCT02980731|Duration of overall response (Dor)|duration of overall response (dor)
194314|NCT02980731|Complete remission rate (CR + CRi)|complete remission rate (cr + cri)
194315|NCT02980731|Progression-free survival (PFS)|progression-free survival (pfs)
194316|NCT02980731|Overall survival (OS)|overall survival (os)
194317|NCT02980718|Olfaction training|olfaction training
194318|NCT02980718|Smell|smell
194319|NCT02980653|Phase II study|phase ii study
194320|NCT02980653|Critical body weight loss|critical body weight loss
194321|NCT02980653|Concurrent chemoradiotherapy|concurrent chemoradiotherapy
194322|NCT02980653|Megestrol acetate|megestrol acetate
194323|NCT02980653|Head and neck cancer|head and neck cancer
194324|NCT02980640|Multiple Sclerosis|multiple sclerosis
194325|NCT02980640|Treatment|treatment
194326|NCT02980640|Quality of Life|quality of life
194327|NCT02980640|Symptoms|symptoms
194328|NCT02980627|Eating Disorders|eating disorders
194329|NCT02980627|Diabulimia|diabulimia
194330|NCT02980627|ED-T1DM|ed-t1dm
194331|NCT02980627|Type 1 Diabetes|type 1 diabetes
194332|NCT02980627|Mobile Technology|mobile technology
194333|NCT02980627|Acceptance and Commitment Therapy|acceptance and commitment therapy
194334|NCT02980614|phase-contrast MRI|phase-contrast mri
194335|NCT02980614|blood flow|blood flow
194336|NCT02980614|velocity mapping|velocity mapping
194337|NCT02980614|Quantitative MRI|quantitative mri
194338|NCT02980614|Cardiac imaging|cardiac imaging
194339|NCT02980614|Tetralogy of Fallot|tetralogy of fallot
194340|NCT02980601|Traumatic Defect|traumatic defect
194341|NCT02980601|Chronic Wounds|chronic wounds
194342|NCT02980575|COPD|copd
194343|NCT02980575|Music|music
194344|NCT02980575|Exercise|exercise
194345|NCT02980562|Bowel preparation|bowel preparation
194346|NCT02980562|Ascorbic acid|ascorbic acid
194347|NCT02980562|Bisacodyl|bisacodyl
194348|NCT02980562|Polyethylene glycol|polyethylene glycol
194349|NCT02980536|NSCLC|nsclc
194350|NCT02980536|TKI|tki
194352|NCT02980536|Liquid Biopsy|liquid biopsy
194353|NCT02980497|mouthrinse|mouthrinse
194355|NCT02980497|gingivitis|gingivitis
194356|NCT02980497|gum bleeding|gum bleeding
194357|NCT02980484|rTMS|rtms
194358|NCT02980458|Healthy|healthy
194359|NCT02980458|Bioequivalence|bioequivalence
194360|NCT02980458|Deferiprone|deferiprone
194361|NCT02980445|Myopia|myopia
194362|NCT02980445|Outdoor time|outdoor time
194363|NCT02980445|Children|children
194364|NCT02980445|Intervention|intervention
194365|NCT02980445|Prevention|prevention
194366|NCT02980432|vestibular|vestibular
194367|NCT02980432|spatial orientation|spatial orientation
194368|NCT02980432|vision|vision
194369|NCT02980432|optokinetic|optokinetic
194370|NCT02980406|FODMAP|fodmap
194371|NCT02980406|Irritable bowel syndrome|irritable bowel syndrome
194372|NCT02980406|Gastric accommodation|gastric accommodation
194373|NCT02980406|Gastric motility|gastric motility
194374|NCT02980406|brain-gut axis|brain-gut axis
194375|NCT02980393|congenital heart disease|congenital heart disease
194376|NCT02980393|smart mobile technology|smart mobile technology
194377|NCT02980393|children|children
194378|NCT02980393|adolescents|adolescents
194379|NCT02980393|lifestyle counselling|lifestyle counselling
194380|NCT02980393|nutrition|nutrition
194381|NCT02980393|physical activity|physical activity
194382|NCT02980380|non-invasive brain computer interface|non-invasive brain computer interface
194383|NCT02980380|communication|communication
194384|NCT02980380|amyotrophic lateral sclerosis|amyotrophic lateral sclerosis
194385|NCT02980380|complete locked-in state|complete locked-in state
194386|NCT02980367|Anterior Cruciate Ligament|anterior cruciate ligament
194387|NCT02980367|ACL|acl
194388|NCT02980367|Anterior Cruciate Ligament deficiency|anterior cruciate ligament deficiency
194389|NCT02980367|ACL deficiency|acl deficiency
194390|NCT02980367|ACLD|acld
194391|NCT02980367|Anterior Cruciate Ligament reconstruction|anterior cruciate ligament reconstruction
194392|NCT02980367|ACL reconstruction|acl reconstruction
194393|NCT02980367|Anterior Cruciate Ligament physiotherapy|anterior cruciate ligament physiotherapy
194394|NCT02980367|Anterior Cruciate Ligament rehabilitation|anterior cruciate ligament rehabilitation
194395|NCT02980367|ACL physiotherapy|acl physiotherapy
194396|NCT02980367|ACL rehabilitation|acl rehabilitation
194397|NCT02980367|Anterior Cruciate Ligament management|anterior cruciate ligament management
194398|NCT02980367|ACL management|acl management
194399|NCT02980354|endothelial progenitor cells, ischaemic stroke, aging|endothelial progenitor cells, ischaemic stroke, aging
194400|NCT02980341|Oncology|oncology
194401|NCT02980341|HER3|her3
194402|NCT02980341|Antibody drug conjugate|antibody drug conjugate
194403|NCT02980341|Developmental Phase I/II|developmental phase i/ii
194404|NCT02980328|Overactive bladder|overactive bladder
194405|NCT02980328|Urinary incontinence|urinary incontinence
194406|NCT02980328|Low-level light therapy|low-level light therapy
194407|NCT02980315|nasopharyngeal carcinoma|nasopharyngeal carcinoma
194408|NCT02980315|EBV related cancers|ebv related cancers
194409|NCT02980302|Mental retardation MR|mental retardation mr
194410|NCT02980302|IQ|iq
194411|NCT02980302|Mutation|mutation
194412|NCT02980302|Gene MYT1L|gene myt1l
194413|NCT02980276|Gestational Diabetes|gestational diabetes
194414|NCT02980276|Diabetes|diabetes
194415|NCT02980276|Pregnancy|pregnancy
194416|NCT02980263|Kawasaki disease|kawasaki disease
194417|NCT02980263|Coronary artery aneurysm|coronary artery aneurysm
194418|NCT02980263|mucocutaneous lymph node syndrome|mucocutaneous lymph node syndrome
194419|NCT02980263|lymph node syndrome|lymph node syndrome
194420|NCT02980263|canakinumab|canakinumab
194421|NCT02980263|intravenous immunoglobulin naïve (IVIG-naïve)|intravenous immunoglobulin naïve (ivig-naïve)
194422|NCT02980263|intravenous immunoglobulin refractory (IVIG-refractory)|intravenous immunoglobulin refractory (ivig-refractory)
194423|NCT02980263|pediatric|pediatric
194424|NCT02980250|feeding intolerance|feeding intolerance
194425|NCT02980250|premature infant|premature infant
194426|NCT02980250|domperidone|domperidone
194427|NCT02980237|Office workers|office workers
194428|NCT02980237|Quality of life|quality of life
194429|NCT02980237|e-Learning|e-learning
194430|NCT02980237|Occupational health|occupational health
194431|NCT02980211|Alveolar Bone|alveolar bone
194432|NCT02980211|Alveolar Ridge|alveolar ridge
194433|NCT02980211|Bone Resorption|bone resorption
194434|NCT02980211|Bone Grafting|bone grafting
194435|NCT02980211|Barrier Membrane|barrier membrane
194436|NCT02980172|triage|triage
194437|NCT02980120|Eating Disorders|eating disorders
194438|NCT02980120|Anorexia Nervosa|anorexia nervosa
194439|NCT02980120|Bulimia Nervosa|bulimia nervosa
194440|NCT02980094|aging|aging
194441|NCT02980094|nutrients|nutrients
194442|NCT02980094|milk|milk
194443|NCT02980094|dietary supplementation|dietary supplementation
194444|NCT02980055|connective tissue graft|connective tissue graft
194445|NCT02980055|transplantation|transplantation
194446|NCT02980055|collagen|collagen
194447|NCT02980055|autologous|autologous
194448|NCT02980055|gingiva|gingiva
194449|NCT02980029|Resectable Tumors|resectable tumors
194450|NCT02980003|contrast media|contrast media
194451|NCT02980003|contrast-induced acute kidney injury (AKI)|contrast-induced acute kidney injury (aki)
194452|NCT02980003|contrast-induced nephropathy (CIN)|contrast-induced nephropathy (cin)
194453|NCT02979990|infertility|infertility
194454|NCT02979990|education|education
194455|NCT02979951|Observational Study|observational study
194456|NCT02979951|Non-Interventional Study|non-interventional study
194457|NCT02979951|Registries|registries
194458|NCT02979951|Prospective|prospective
194459|NCT02979951|Monitored|monitored
194460|NCT02979951|Multicentric|multicentric
194461|NCT02979951|International|international
194462|NCT02979951|Fosfomycin|fosfomycin
194463|NCT02979951|Infectofos|infectofos
194464|NCT02979951|Fomicyt|fomicyt
194465|NCT02979951|Bacterial Infections|bacterial infections
194466|NCT02979951|Gram-Negative Bacterial Infections|gram-negative bacterial infections
194467|NCT02979951|Gram-Positive Bacterial Infections|gram-positive bacterial infections
194468|NCT02979951|Bone Diseases, Infectious|bone diseases, infectious
194469|NCT02979951|Osteomyelitis|osteomyelitis
194470|NCT02979951|Central Nervous System Bacterial Infections|central nervous system bacterial infections
194471|NCT02979951|Meningitis, Bacterial|meningitis, bacterial
194472|NCT02979951|Encephalitis|encephalitis
194473|NCT02979951|Brain Abscess|brain abscess
194474|NCT02979951|Urinary Tract Infections|urinary tract infections
194475|NCT02979951|Respiratory Tract Infections|respiratory tract infections
194476|NCT02979951|Pneumonia, Bacterial|pneumonia, bacterial
194477|NCT02979951|Skin Diseases, Bacterial|skin diseases, bacterial
194478|NCT02979951|Soft Tissue Infections|soft tissue infections
194479|NCT02979951|Intraabdominal Infections|intraabdominal infections
194480|NCT02979951|Sepsis|sepsis
194481|NCT02979951|Bacteremia|bacteremia
194482|NCT02979951|Endocarditis, Bacterial|endocarditis, bacterial
194483|NCT02979951|Treatment Outcome|treatment outcome
194484|NCT02979951|Clinical Efficacy|clinical efficacy
194485|NCT02979951|Microbiological Efficacy|microbiological efficacy
194486|NCT02979951|Safety|safety
194487|NCT02979925|neuropathic pain|neuropathic pain
194488|NCT02979925|TMS|tms
194489|NCT02979925|nerve injury|nerve injury
194490|NCT02979925|transcutaneous magnetic stimulation|transcutaneous magnetic stimulation
194491|NCT02979912|Persistent corneal epithelial defect|persistent corneal epithelial defect
194492|NCT02979912|Platelet Lysate|platelet lysate
194493|NCT02979899|angiosarcoma|angiosarcoma
194615|NCT02978924|3D motion capture|3d motion capture
194494|NCT02979886|single nucleotide polymorphism,GnRH receptor, IVF|single nucleotide polymorphism,gnrh receptor, ivf
194495|NCT02979873|Rapamycin|rapamycin
194496|NCT02979873|Relapse Prevention|relapse prevention
194497|NCT02979873|Immune Tolerance|immune tolerance
194498|NCT02979847|persistent atrial fibrillation|persistent atrial fibrillation
194499|NCT02979847|catheter ablation|catheter ablation
194501|NCT02979834|fetal movement|fetal movement
194502|NCT02979834|placenta site|placenta site
194503|NCT02979834|body mass index|body mass index
194504|NCT02979834|maternal education|maternal education
194505|NCT02979821|pan-HER inhibitor|pan-her inhibitor
194506|NCT02979782|cardiac surgery|cardiac surgery
194507|NCT02979782|neurological outcome|neurological outcome
194508|NCT02979782|minimal invasive coronary artery bypass graft (Endo-CABG)|minimal invasive coronary artery bypass graft (endo-cabg)
194509|NCT02979769|Open-label extension study|open-label extension study
194510|NCT02979769|Clinical trial Phase 2|clinical trial phase 2
194511|NCT02979769|Efficacy and safety|efficacy and safety
194512|NCT02979769|Heterotopic ossification|heterotopic ossification
194513|NCT02979769|Flare-up|flare-up
194514|NCT02979769|Palovarotene|palovarotene
194515|NCT02979769|Retinoic acide receptor agonist|retinoic acide receptor agonist
194516|NCT02979769|Retinoic acide receptor gamma agonist|retinoic acide receptor gamma agonist
194517|NCT02979769|Clementia|clementia
194518|NCT02979769|Myositis Ossificans|myositis ossificans
194519|NCT02979769|Munchmeyer's Disease|munchmeyer's disease
194520|NCT02979769|FOP|fop
194521|NCT02979717|satiety|satiety
194522|NCT02979717|protein|protein
194523|NCT02979717|fiber|fiber
194524|NCT02979678|Breast cancer, quality of life|breast cancer, quality of life
194525|NCT02979639|Herpes Zoster|herpes zoster
194526|NCT02979639|Reactogenicity|reactogenicity
194527|NCT02979639|Quality of life|quality of life
194528|NCT02979639|Shingles|shingles
194529|NCT02979626|hospitalization|hospitalization
194530|NCT02979626|intensive care unit|intensive care unit
194531|NCT02979626|school absenteeism|school absenteeism
194532|NCT02979626|work absenteeism|work absenteeism
194533|NCT02979600|Oral immunotherapy|oral immunotherapy
194534|NCT02979600|Oral tolerance induction|oral tolerance induction
194535|NCT02979574|acupuncture|acupuncture
194536|NCT02979574|pain|pain
194537|NCT02979574|chronic pain|chronic pain
194538|NCT02979574|pain management|pain management
194539|NCT02979574|16-1579|16-1579
194540|NCT02979561|Dabigatran etexilate|dabigatran etexilate
194541|NCT02979561|Recurrence of DVT|recurrence of dvt
194542|NCT02979561|Pulmonary Embolism|pulmonary embolism
194543|NCT02979561|Warfarin|warfarin
194544|NCT02979548|Aprepitant|aprepitant
194545|NCT02979535|Dengue Fever|dengue fever
194546|NCT02979535|Dengue Hemorrhagic Fever|dengue hemorrhagic fever
194547|NCT02979535|Human Papillomavirus Disease|human papillomavirus disease
194548|NCT02979535|CYD Dengue Vaccine|cyd dengue vaccine
194549|NCT02979535|Dengvaxia®|dengvaxia®
194550|NCT02979535|Cervarix®|cervarix®
194551|NCT02979522|Drug therapy, pediatric Hodgkin disease, frontline Hodgkin disease, advanced stage Hodgkin disease, pediatric lymphoma|drug therapy, pediatric hodgkin disease, frontline hodgkin disease, advanced stage hodgkin disease, pediatric lymphoma
194553|NCT02979496|citrus|citrus
194554|NCT02979470|advanced colon cancer|advanced colon cancer
194555|NCT02979470|advanced rectum cancer|advanced rectum cancer
194556|NCT02979470|circulating tumor cells|circulating tumor cells
194557|NCT02979470|immune response|immune response
194558|NCT02979470|mutations|mutations
194559|NCT02979457|telephone consultation, patient involvement|telephone consultation, patient involvement
194560|NCT02979431|RSV, Lower Respiratory Tract Infection, pediattric patients|rsv, lower respiratory tract infection, pediattric patients
194561|NCT02979418|Water insecurity|water insecurity
194562|NCT02979340|Cystic Fibrosis Liver Disease|cystic fibrosis liver disease
194563|NCT02979340|Pancreatic Insufficiency|pancreatic insufficiency
194564|NCT02979275|acute kidney injury|acute kidney injury
194565|NCT02979275|cardiopulmonary bypass|cardiopulmonary bypass
194566|NCT02979275|neutrophil gelatinase-associated lipocalin|neutrophil gelatinase-associated lipocalin
194567|NCT02979275|tissue hypoxia|tissue hypoxia
194568|NCT02979249|Interventional|interventional
194569|NCT02979249|open-label|open-label
194570|NCT02979249|EPP|epp
194571|NCT02979249|XLP|xlp
194572|NCT02979249|porphyria|porphyria
194573|NCT02979197|High blood pressure|high blood pressure
194574|NCT02979197|Systolic blood pressure|systolic blood pressure
194575|NCT02979197|Diastolic blood pressure|diastolic blood pressure
194576|NCT02979197|Antihypertensive|antihypertensive
194577|NCT02979184|Lymphedema, Obstructive Sleep Apnea , Intensive Decongestive Physiotherapy|lymphedema, obstructive sleep apnea , intensive decongestive physiotherapy
194578|NCT02979119|Hemophilia|hemophilia
194579|NCT02979119|Children, ,|children, ,
194580|NCT02979119|Inhibitors,|inhibitors,
194581|NCT02979119|Prophylaxis|prophylaxis
194582|NCT02979119|Long-term outcome|long-term outcome
194583|NCT02979119|Congenital|congenital
194584|NCT02979093|maternal drug addiction|maternal drug addiction
194585|NCT02979093|mother-infant attachment|mother-infant attachment
194586|NCT02979093|intranasal oxytocin|intranasal oxytocin
194587|NCT02979093|unresolved trauma|unresolved trauma
194588|NCT02979093|maternal brain responses|maternal brain responses
194589|NCT02979093|mother-infant synchrony|mother-infant synchrony
194590|NCT02979067|Apnoea time, preoxygenation, difficult airway, emergency|apnoea time, preoxygenation, difficult airway, emergency
194591|NCT02979041|neck pain|neck pain
194592|NCT02979041|Virtual reality|virtual reality
194593|NCT02979041|Range of motion|range of motion
194594|NCT02979041|physiotherapy|physiotherapy
194595|NCT02979041|Air force|air force
194596|NCT02979041|kinematics|kinematics
194597|NCT02979028|TEAS|teas
194598|NCT02979028|complication|complication
194599|NCT02978989|Laparoscopic cholecystectomy|laparoscopic cholecystectomy
194600|NCT02978989|Solo surgery|solo surgery
194601|NCT02978989|Camera holder|camera holder
194602|NCT02978989|Cholecystitis|cholecystitis
194603|NCT02978976|RDS|rds
194604|NCT02978976|Doppler on fetal pulmonary artery|doppler on fetal pulmonary artery
194605|NCT02978963|Excessive worry|excessive worry
194606|NCT02978963|Worry|worry
194607|NCT02978963|Adolescents|adolescents
194608|NCT02978963|Intolerance of uncertainty|intolerance of uncertainty
194609|NCT02978950|duplex ultrasound|duplex ultrasound
194610|NCT02978950|trauma|trauma
194611|NCT02978950|venous thromboembolism|venous thromboembolism
194612|NCT02978950|prevention|prevention
194613|NCT02978924|spinal cord|spinal cord
194614|NCT02978924|tsDCS|tsdcs
194616|NCT02978924|EMG|emg
194617|NCT02978911|RMI|rmi
194618|NCT02978898|Follicular Lymphoma|follicular lymphoma
194619|NCT02978898|flow cytometry|flow cytometry
194620|NCT02978898|CD180|cd180
194621|NCT02978898|Toll-like receptor|toll-like receptor
194622|NCT02978898|lymphoproliferative disease|lymphoproliferative disease
194623|NCT02978885|Acute lung injury|acute lung injury
194624|NCT02978885|Chronic obstructive pulmonary disease (COPD)|chronic obstructive pulmonary disease (copd)
194625|NCT02978885|Whipple procedures|whipple procedures
194626|NCT02978885|pancreatico-duodenectomies|pancreatico-duodenectomies
194627|NCT02978872|Cardiac surgery|cardiac surgery
194628|NCT02978872|Quantra|quantra
194629|NCT02978872|Viscoelastic testing|viscoelastic testing
194630|NCT02978872|Coagulation|coagulation
194631|NCT02978859|MGCD516|mgcd516
194632|NCT02978859|Sarcoma|sarcoma
194633|NCT02978859|Liposarcoma|liposarcoma
194634|NCT02978859|Unresectable Liposarcoma|unresectable liposarcoma
194635|NCT02978859|Metastatic Liposarcoma|metastatic liposarcoma
194636|NCT02978859|Sitravatinib|sitravatinib
194637|NCT02978833|Gluteus Medius Tendinosis|gluteus medius tendinosis
194638|NCT02978820|scientific exercise approach to scoliosis|scientific exercise approach to scoliosis
194639|NCT02978820|core stabilization training|core stabilization training
194640|NCT02978820|bracing|bracing
194641|NCT02978820|adolescent idiopathic scoliosis|adolescent idiopathic scoliosis
194642|NCT02978794|stroke, clinical pathway, medical care|stroke, clinical pathway, medical care
194643|NCT02978781|Tremor|tremor
194644|NCT02978768|dementia|dementia
194645|NCT02978768|Tai Chi|tai chi
194646|NCT02978768|mental training|mental training
194647|NCT02978768|cognitive rehabilitation|cognitive rehabilitation
194648|NCT02978742|Eating Disorders|eating disorders
194649|NCT02978742|Bulimia Nervosa|bulimia nervosa
194650|NCT02978742|Binge Eating Disorder|binge eating disorder
194651|NCT02978742|App|app
194652|NCT02978742|Smartphone|smartphone
194653|NCT02978742|Self-Help|self-help
194654|NCT02978742|Coaching|coaching
194655|NCT02978742|Recovery Record|recovery record
194656|NCT02978742|Mobile Phone|mobile phone
194657|NCT02978742|Cognitive Behavioral Therapy|cognitive behavioral therapy
194658|NCT02978729|Telemedicine|telemedicine
194659|NCT02978729|Counseling, Genetic|counseling, genetic
194660|NCT02978716|Breast Cancer|breast cancer
194661|NCT02978716|CDK 4/6 Inhibitor|cdk 4/6 inhibitor
194662|NCT02978716|Triple Negative Breast Cancer|triple negative breast cancer
194663|NCT02978716|Metastatic|metastatic
194664|NCT02978677|brain tumors|brain tumors
194665|NCT02978677|proton radiotherapy|proton radiotherapy
194666|NCT02978677|photon radiotherapy|photon radiotherapy
194667|NCT02978664|colonoscopy|colonoscopy
194668|NCT02978664|water exchange|water exchange
194669|NCT02978664|adenoma detection rate|adenoma detection rate
194670|NCT02978664|distraction|distraction
194671|NCT02978651|EDS|eds
194672|NCT02978651|OSA|osa
194673|NCT02978638|Spinal cord injury|spinal cord injury
194674|NCT02978638|Bladder capacity|bladder capacity
194675|NCT02978638|Electrical stimulation|electrical stimulation
194676|NCT02978638|Continence|continence
194677|NCT02978638|Urodynamics|urodynamics
194678|NCT02978612|Colorectal Neoplasms|colorectal neoplasms
194679|NCT02978586|PSMA|psma
194680|NCT02978586|PET/MRI|pet/mri
194681|NCT02978573|First MTP Joint|first mtp joint
194682|NCT02978573|Hallux Rigidus|hallux rigidus
194683|NCT02978573|Hallux Limitus|hallux limitus
194684|NCT02978573|Cartilage Replacement|cartilage replacement
194685|NCT02978573|Osteoarthritis|osteoarthritis
194686|NCT02978573|First MTP Joint Osteoarthritis|first mtp joint osteoarthritis
194687|NCT02978573|Big Toe Pain|big toe pain
194688|NCT02978547|Resectable pancreatic ductal adenocarcinoma|resectable pancreatic ductal adenocarcinoma
194689|NCT02978547|PDAC|pdac
194690|NCT02978547|Metformin|metformin
194691|NCT02978534|pregnant|pregnant
194692|NCT02978534|quetiapine|quetiapine
194693|NCT02978534|bipolar|bipolar
194694|NCT02978534|women|women
194695|NCT02978534|female|female
194696|NCT02978534|postpartum|postpartum
194697|NCT02978534|seroquel|seroquel
194698|NCT02978534|perinatal|perinatal
194699|NCT02978534|manic-depressive|manic-depressive
194700|NCT02978469|Habitual Physical Activity (HPA); Sedentary Behavior;|habitual physical activity (hpa); sedentary behavior;
194701|NCT02978456|IVUS guided PCI|ivus guided pci
194702|NCT02978456|QCA guided PCI|qca guided pci
194703|NCT02978443|Melanoma|melanoma
194704|NCT02978443|Mucosal|mucosal
194705|NCT02978443|Acral Lentiginous|acral lentiginous
194706|NCT02978443|Ipilimumab|ipilimumab
194707|NCT02978443|Nivolumab|nivolumab
194708|NCT02978443|Anti-tumor|anti-tumor
194709|NCT02978443|Potential Predictors|potential predictors
194710|NCT02978443|Opdivo|opdivo
194711|NCT02978443|Yervoy|yervoy
194712|NCT02978430|Fluid therapy|fluid therapy
194713|NCT02978430|Anesthesiology|anesthesiology
194714|NCT02978430|Major surgery|major surgery
194715|NCT02978430|Goal-directed fluid therapy|goal-directed fluid therapy
194716|NCT02978430|Fluid responsiveness|fluid responsiveness
194717|NCT02978430|Closed-loop system|closed-loop system
194718|NCT02978417|Medication-assisted treatment|medication-assisted treatment
194719|NCT02978417|Drug Court|drug court
194720|NCT02978417|Pilot study|pilot study
194721|NCT02978417|Opioid dependence|opioid dependence
194722|NCT02978417|Criminal justice|criminal justice
194723|NCT02978404|radiosurgery|radiosurgery
194724|NCT02978404|PD-1|pd-1
194725|NCT02978404|Nivolumab|nivolumab
194726|NCT02978326|Postpartum Care|postpartum care
194727|NCT02978287|Calcium sensing receptor|calcium sensing receptor
194728|NCT02978287|Parathyroid cell viability|parathyroid cell viability
194729|NCT02978287|Parathyroid allotransplantation|parathyroid allotransplantation
194730|NCT02978287|Transporting solution|transporting solution
194731|NCT02978235|Multiple Myeloma|multiple myeloma
194732|NCT02978235|Relapsed/Refractory|relapsed/refractory
194733|NCT02978235|Lymphoma|lymphoma
194734|NCT02978235|Non-Hodgkin Lymphoma|non-hodgkin lymphoma
194735|NCT02978235|Diffuse Large B-Cell Lymphoma|diffuse large b-cell lymphoma
194736|NCT02978235|DLBCL|dlbcl
194737|NCT02978235|Mantle Cell Lymphoma|mantle cell lymphoma
194738|NCT02978235|MCL|mcl
194739|NCT02978235|Peripheral T-Cell Lymphoma|peripheral t-cell lymphoma
194740|NCT02978235|PTCL|ptcl
194741|NCT02978235|TAS4464|tas4464
194742|NCT02978235|NEDD8|nedd8
194743|NCT02978235|NAE inhibitor|nae inhibitor
194744|NCT02978235|Neoplasms|neoplasms
194745|NCT02978235|Hematologic Diseases|hematologic diseases
194746|NCT02978235|Myeloma|myeloma
194747|NCT02978157|Helicobacter pylori|helicobacter pylori
194748|NCT02978157|Eradication rate|eradication rate
194749|NCT02978157|Rescue treatment|rescue treatment
194750|NCT02978144|Chronic Obstructive Pulmonary Disease (COPD)|chronic obstructive pulmonary disease (copd)
194751|NCT02978131|TUBERCULOSIS|tuberculosis
194752|NCT02978131|Sensitivity and Specificity|sensitivity and specificity
194753|NCT02978131|Polymerase Chain Reaction|polymerase chain reaction
194754|NCT02978131|Immunohistochemistry|immunohistochemistry
194755|NCT02978131|Histochemistry|histochemistry
194756|NCT02978131|Paraformaldehyde and paraffin embedded tissues|paraformaldehyde and paraffin embedded tissues
194757|NCT02978053|Bright light|bright light
194758|NCT02978053|Sleepiness|sleepiness
194759|NCT02978053|Sleep|sleep
194760|NCT02978053|Psychomotor vigilance|psychomotor vigilance
194761|NCT02978040|Antiplatelet therapy|antiplatelet therapy
194762|NCT02978040|Cangrelor|cangrelor
194763|NCT02978040|Tirofiban|tirofiban
194764|NCT02978040|Prasugrel|prasugrel
194765|NCT02978040|Acute Myocardial Infarction|acute myocardial infarction
194766|NCT02978040|Primary Percutaneous Coronary Intervention|primary percutaneous coronary intervention
194767|NCT02978040|Pharmacokinetic/Pharmacodynamic|pharmacokinetic/pharmacodynamic
194768|NCT02978027|motivational interviewing|motivational interviewing
194769|NCT02978027|brief alcohol intervention in primary care|brief alcohol intervention in primary care
194770|NCT02978014|Prostate|prostate
194771|NCT02978014|Radiotherapy|radiotherapy
194772|NCT02978014|Obturator|obturator
194773|NCT02978014|Toxicity|toxicity
194774|NCT02978014|Bowel|bowel
194775|NCT02978014|Urinary|urinary
194776|NCT02978014|Sexual|sexual
194777|NCT02978014|PROM|prom
194778|NCT02978014|EPIC|epic
194779|NCT02977988|Mindfulness|mindfulness
194780|NCT02977988|Women|women
194781|NCT02977988|Relapse prevention|relapse prevention
194782|NCT02977988|Clinical trial|clinical trial
194783|NCT02977988|Substance use disorder|substance use disorder
194784|NCT02977988|Ethnically diverse|ethnically diverse
194785|NCT02977988|Underserved|underserved
194786|NCT02977988|Health disparities|health disparities
194787|NCT02977988|Stress|stress
194788|NCT02977988|Addiction|addiction
194789|NCT02977988|Latina/Hispanic|latina/hispanic
194790|NCT02977988|African American|african american
194791|NCT02977988|Treatment retention|treatment retention
194792|NCT02977988|Residential treatment|residential treatment
194793|NCT02977988|Brain Imaging|brain imaging
194794|NCT02977975|Irritable bowel syndrome|irritable bowel syndrome
194795|NCT02977975|The human microbiome|the human microbiome
194796|NCT02977975|Microbiota|microbiota
194797|NCT02977975|Gut microbiota|gut microbiota
194798|NCT02977975|Probiotics|probiotics
194799|NCT02977975|Sauerkraut|sauerkraut
194800|NCT02977949|SERM|serm
194801|NCT02977949|Season|season
194802|NCT02977949|Variation|variation
194803|NCT02977949|Vitamin D|vitamin d
194804|NCT02977923|Virtual reality|virtual reality
194805|NCT02977923|Immersive distraction|immersive distraction
194806|NCT02977923|Oculus rift|oculus rift
194807|NCT02977923|Virtual world|virtual world
194808|NCT02977923|Virtual environment|virtual environment
194809|NCT02977923|Procedural pain|procedural pain
194810|NCT02977923|Procedural anxiety|procedural anxiety
194811|NCT02977923|Acute pain|acute pain
194812|NCT02977923|Pain management|pain management
194813|NCT02977923|Anxiety|anxiety
194814|NCT02977923|Children, Child|children, child
194815|NCT02977923|Kid, Kids|kid, kids
194816|NCT02977923|Pediatric, Pediatrics|pediatric, pediatrics
194817|NCT02977923|Young children|young children
194818|NCT02977923|Burns|burns
194819|NCT02977923|Burn injuries|burn injuries
194820|NCT02977923|Burn unit|burn unit
194821|NCT02977923|Physiotherapy|physiotherapy
194822|NCT02977923|Physical therapy|physical therapy
194823|NCT02977923|Burn dressing|burn dressing
194824|NCT02977923|Dressing change|dressing change
194825|NCT02977923|Non-pharmacological, nonpharmacological|non-pharmacological, nonpharmacological
194826|NCT02977923|Clinical Research|clinical research
194827|NCT02977923|Nursing Practice|nursing practice
194828|NCT02977923|Trauma|trauma
194829|NCT02977897|Diarrhea|diarrhea
194830|NCT02977897|Immunosuppression|immunosuppression
194831|NCT02977897|Post-transplantation|post-transplantation
194832|NCT02977897|Octreotide|octreotide
194833|NCT02977897|Mycophenolate Mofetil|mycophenolate mofetil
194834|NCT02977897|Fecal Calprotectin|fecal calprotectin
194835|NCT02977884|nutrition|nutrition
194836|NCT02977884|exercise|exercise
194837|NCT02977884|stress|stress
194838|NCT02977884|cardiovascular disease|cardiovascular disease
194839|NCT02977884|diabetes|diabetes
194840|NCT02977884|hypertension|hypertension
194841|NCT02977884|dyslipidemia|dyslipidemia
194842|NCT02977884|cholesterol|cholesterol
194843|NCT02977884|overweight|overweight
194844|NCT02977884|obesity|obesity
194845|NCT02977884|lifestyle|lifestyle
194846|NCT02977871|Cesarean section|cesarean section
194847|NCT02977871|operating time|operating time
194848|NCT02977871|bladder|bladder
194849|NCT02977871|urinary retention|urinary retention
194850|NCT02977845|dypsnea|dypsnea
194851|NCT02977845|fatigue|fatigue
194852|NCT02977845|anxiety|anxiety
194853|NCT02977845|Qigong|qigong
194854|NCT02977845|Lung cancer|lung cancer
194855|NCT02977832|LUTS|luts
194856|NCT02977832|Iresine celosia|iresine celosia
194857|NCT02977832|Odyliresin|odyliresin
194858|NCT02977832|medical therapy|medical therapy
194859|NCT02977780|Glioblastoma|glioblastoma
194860|NCT02977728|MTBI|mtbi
194861|NCT02977728|olfaction|olfaction
194862|NCT02977728|acute|acute
194863|NCT02977715|Democratic Republic of the Congo|democratic republic of the congo
194864|NCT02977715|IMVAMUNE|imvamune
194865|NCT02977715|Modified Vaccinia Ankara (MVA)|modified vaccinia ankara (mva)
194866|NCT02977715|Monkeypox|monkeypox
194867|NCT02977715|Orthopoxvirus|orthopoxvirus
194868|NCT02977715|Vaccine|vaccine
194869|NCT02977715|Vaccinia virus|vaccinia virus
194870|NCT02977689|Isocitrate dehydrogenase (IDH)|isocitrate dehydrogenase (idh)
194871|NCT02977689|R-2-Hydroxyglutarate (2-HG)|r-2-hydroxyglutarate (2-hg)
194872|NCT02977689|Gene encoding UDP-glucuronosyltransferase (UGT1A1)|gene encoding udp-glucuronosyltransferase (ugt1a1)
194873|NCT02977689|Glioblastoma (GBM)|glioblastoma (gbm)
194874|NCT02977689|IDH305|idh305
194875|NCT02977689|IDHR132 mutations|idhr132 mutations
194876|NCT02977689|Astrocytoma|astrocytoma
194877|NCT02977689|Oligodendroglioma|oligodendroglioma
194878|NCT02977689|Oligoastrocytoma|oligoastrocytoma
194879|NCT02977689|IDH1 R132H|idh1 r132h
194880|NCT02977689|IDH1|idh1
194881|NCT02977637|hht|hht
194882|NCT02977637|hereditary|hereditary
194883|NCT02977637|hemorrhagic|hemorrhagic
194884|NCT02977637|telangiectasia|telangiectasia
194885|NCT02977637|feraheme|feraheme
194886|NCT02977585|continous positive airway pressure|continous positive airway pressure
194887|NCT02977585|helmet|helmet
194888|NCT02977585|non invasive|non invasive
194889|NCT02977585|positive end expiratory pressure|positive end expiratory pressure
194890|NCT02977585|severe bronchiolitis|severe bronchiolitis
194891|NCT02977585|pediatric intensive care unit|pediatric intensive care unit
194892|NCT02977572|Non-invasive ventilation,|non-invasive ventilation,
194893|NCT02977572|continuous positive airway pressure|continuous positive airway pressure
194894|NCT02977572|cardiogenic pulmonary oedema,|cardiogenic pulmonary oedema,
194895|NCT02977572|acute respiratory failure|acute respiratory failure
194896|NCT02977559|Laryngeal Tube Suction Ambu AuraGain Leak Pressure|laryngeal tube suction ambu auragain leak pressure
194897|NCT02977546|Hemodynamics|hemodynamics
194898|NCT02977546|Noninvasive|noninvasive
194899|NCT02977546|Pulse contour analysis|pulse contour analysis
194900|NCT02977546|Heart failure|heart failure
194901|NCT02977546|Swan Ganz Catheterization|swan ganz catheterization
194902|NCT02977546|Pulmonary artery Catheter|pulmonary artery catheter
194903|NCT02977468|triple negative breast cancer|triple negative breast cancer
194904|NCT02977468|Pembrolizumab|pembrolizumab
194905|NCT02977468|IORT|iort
194906|NCT02977468|tumor microenvironment|tumor microenvironment
194907|NCT02977442|Mitochondrial Dynamics|mitochondrial dynamics
194908|NCT02977442|Insulin Resistance|insulin resistance
194909|NCT02977442|Exercise and Diabetes|exercise and diabetes
194910|NCT02977429|Tumor|tumor
194911|NCT02977429|Abdominal infection|abdominal infection
194912|NCT02977429|Hemodynamics|hemodynamics
194913|NCT02977429|Pcv-aCO2|pcv-aco2
194914|NCT02977429|Early Goal-directed Therapy (EGDT)|early goal-directed therapy (egdt)
194915|NCT02977416|Juvenile idiopathic arthritis|juvenile idiopathic arthritis
194916|NCT02977416|fat oxidation|fat oxidation
194917|NCT02977416|exercise|exercise
194918|NCT02977403|Binge Eating|binge eating
194919|NCT02977403|Eating Behavior|eating behavior
194920|NCT02977403|Children|children
194921|NCT02977403|Magnetoencephalography|magnetoencephalography
194922|NCT02977403|Loss of Control|loss of control
194923|NCT02977351|Periodontopathogenic microorganisms|periodontopathogenic microorganisms
194924|NCT02977351|Non-surgical periodontal treatment|non-surgical periodontal treatment
194925|NCT02977325|Physical activity level|physical activity level
194926|NCT02977325|Personal efficacy|personal efficacy
194927|NCT02977325|Knee osteoarthritis|knee osteoarthritis
194928|NCT02977325|Self-management|self-management
194929|NCT02977325|Self-care|self-care
194930|NCT02977325|Education and exercise in knee osteoarthritis|education and exercise in knee osteoarthritis
194931|NCT02977273|Meal size|meal size
194932|NCT02977260|Meal size|meal size
194933|NCT02977247|SoftVue|softvue
194934|NCT02977247|Dense Breast Tissue|dense breast tissue
194935|NCT02977247|Breast Screening|breast screening
194936|NCT02977247|Abnormal Breast|abnormal breast
194937|NCT02977247|Normal Breast|normal breast
194938|NCT02977247|Breast Imaging|breast imaging
194939|NCT02977247|Breast Biopsy|breast biopsy
194940|NCT02977247|Mammography|mammography
194941|NCT02977247|Tomosynthesis|tomosynthesis
194942|NCT02977247|Automated Breast Ultrasound|automated breast ultrasound
194943|NCT02977247|Breast Cancer|breast cancer
194944|NCT02977247|Breast Carcinoma|breast carcinoma
194945|NCT02977247|Breast Tumors|breast tumors
194946|NCT02977247|Mammary Carcinoma|mammary carcinoma
194947|NCT02977247|Malignant Breast Tumor|malignant breast tumor
194948|NCT02977247|Mammary Neoplasm|mammary neoplasm
194949|NCT02977247|Mammary Cancer|mammary cancer
194950|NCT02977247|ABUS|abus
194951|NCT02977247|AWBUS|awbus
194952|NCT02977247|Breast Tomography|breast tomography
194953|NCT02977247|ATUS|atus
194954|NCT02977247|ABTUS|abtus
249320|NCT02641522|T1D|t1d
194955|NCT02977247|Mammogram|mammogram
194956|NCT02977247|3D Mammogram|3d mammogram
194957|NCT02977247|3D ABUS|3d abus
194958|NCT02977247|3D Breast Ultrasound|3d breast ultrasound
194959|NCT02977247|DBT|dbt
194960|NCT02977247|FFDM|ffdm
194961|NCT02977247|Digital Mammography|digital mammography
194962|NCT02977247|Breast Ultrasound|breast ultrasound
194963|NCT02977247|Dense Breasts|dense breasts
194964|NCT02977247|Breast Density|breast density
194965|NCT02977247|Dense Parenchyma|dense parenchyma
194966|NCT02977247|Asymptomatic|asymptomatic
194967|NCT02977247|Delphinus|delphinus
194968|NCT02977247|Delphinus Medical Technologies|delphinus medical technologies
194969|NCT02977247|Diagnostic Breast Imaging|diagnostic breast imaging
194970|NCT02977221|corticotomy|corticotomy
194971|NCT02977221|piezocision|piezocision
194972|NCT02977221|piezosurgery|piezosurgery
194973|NCT02977221|acceleration of tooth movement|acceleration of tooth movement
194974|NCT02977221|crowded anterior teeth|crowded anterior teeth
194975|NCT02977208|Gabapentin|gabapentin
194976|NCT02977208|OCT2|oct2
194977|NCT02977208|OCTN1|octn1
194978|NCT02977208|Pharmacogenetics|pharmacogenetics
194979|NCT02977208|Pharmacokinetics|pharmacokinetics
194980|NCT02977208|Polymorphisms|polymorphisms
194981|NCT02977195|First in Human|first in human
194982|NCT02977195|monoclonal antibody|monoclonal antibody
194983|NCT02977195|Netrin-1|netrin-1
194984|NCT02977156|Injectable lesion|injectable lesion
194985|NCT02977156|Intra-tumoral injection|intra-tumoral injection
194986|NCT02977143|fluid responsiveness|fluid responsiveness
194987|NCT02977143|central venous pressure|central venous pressure
194988|NCT02977143|positive end-expiratory pressure|positive end-expiratory pressure
194989|NCT02977143|robot surgery|robot surgery
194990|NCT02977117|magnesium|magnesium
194991|NCT02977117|ectopic calcification|ectopic calcification
194992|NCT02977117|chronic kidney disease - mineral and bone disorder|chronic kidney disease - mineral and bone disorder
194993|NCT02977117|serum calcification propensity|serum calcification propensity
194994|NCT02977091|short stature|short stature
194995|NCT02977091|fitness|fitness
194996|NCT02977091|children|children
194997|NCT02977078|Inhaler|inhaler
194998|NCT02977065|Dyslipidemia|dyslipidemia
194999|NCT02977065|CETP Inhibitors|cetp inhibitors
195000|NCT02977065|Hyperlipidemia|hyperlipidemia
195001|NCT02977052|Melanoma|melanoma
195002|NCT02977052|Ipilimumab|ipilimumab
195003|NCT02977052|Nivolumab|nivolumab
195004|NCT02977052|Neo-adjuvant|neo-adjuvant
195005|NCT02976987|Colvir|colvir
195006|NCT02976987|high grade squamous intraepithelial lesions|high grade squamous intraepithelial lesions
195007|NCT02976987|cervix|cervix
195008|NCT02976974|chronic pain|chronic pain
195009|NCT02976974|central sensitization|central sensitization
195010|NCT02976974|function|function
195011|NCT02976974|force|force
195012|NCT02976974|ultrasonography|ultrasonography
195013|NCT02976961|Information|information
195014|NCT02976961|Empowerment|empowerment
195015|NCT02976922|RAS|ras
195016|NCT02976922|microbiome|microbiome
195017|NCT02976922|probiotics|probiotics
195018|NCT02976883|Hypoxia|hypoxia
195019|NCT02976883|HX4|hx4
195020|NCT02976883|PET CT|pet ct
195021|NCT02976883|Radiotherapy|radiotherapy
195022|NCT02976870|Hydronephrosis|hydronephrosis
195023|NCT02976870|Anterior Lumbar Interbody Fusion|anterior lumbar interbody fusion
195024|NCT02976857|refractory diffuse large B-cell lymphoma|refractory diffuse large b-cell lymphoma
195025|NCT02976857|anti-CD19 chimeric antigen receptor T-cell|anti-cd19 chimeric antigen receptor t-cell
195026|NCT02976844|optimal balloon volume|optimal balloon volume
195027|NCT02976844|positive end-expiratory pressure|positive end-expiratory pressure
195028|NCT02976831|Plaque psoriasis vulgaris|plaque psoriasis vulgaris
195029|NCT02976792|Transcatheter aortic valve implantation|transcatheter aortic valve implantation
195030|NCT02976792|Acute Kidney Injury|acute kidney injury
195031|NCT02976792|early acute kidney injury detection|early acute kidney injury detection
195032|NCT02976792|Nephrocheck™|nephrocheck™
195033|NCT02976792|Renal Resistive Index|renal resistive index
195034|NCT02976766|Neuroprotection|neuroprotection
195035|NCT02976766|Clinical trial|clinical trial
195036|NCT02976766|Traditional Chinese medicine|traditional chinese medicine
195037|NCT02976766|Axonal loss|axonal loss
195038|NCT02976766|Jiaogulan|jiaogulan
195039|NCT02976766|Gynostemma pentaphyllum|gynostemma pentaphyllum
195040|NCT02976766|Optical coherence tomography|optical coherence tomography
195041|NCT02976753|Blood Coagulation Disorders|blood coagulation disorders
195042|NCT02976753|Hematologic Diseases|hematologic diseases
195043|NCT02976753|Coagulation Protein Disorders|coagulation protein disorders
195044|NCT02976753|Hemorrhagic Disorders|hemorrhagic disorders
195045|NCT02976753|Genetic Diseases, Inborn|genetic diseases, inborn
195046|NCT02976740|lung cancer|lung cancer
195047|NCT02976740|SBRT|sbrt
195048|NCT02976740|rhGM-CSF|rhgm-csf
195049|NCT02976740|Thymosin Alpha 1|thymosin alpha 1
195050|NCT02976727|Vitamin D|vitamin d
195051|NCT02976727|Calcipotriol|calcipotriol
195052|NCT02976727|Ablative fractional laser|ablative fractional laser
195053|NCT02976727|Actinic keratosis|actinic keratosis
195054|NCT02976727|Photodynamic therapy|photodynamic therapy
195055|NCT02976714|Cystic Fibrosis|cystic fibrosis
195056|NCT02976714|Lung disease|lung disease
195057|NCT02976714|DNA methylation|dna methylation
195058|NCT02976714|Predictive biomarkers|predictive biomarkers
195059|NCT02976701|STEMI|stemi
195060|NCT02976701|acute coronary syndrome|acute coronary syndrome
195061|NCT02976701|DLBS1033|dlbs1033
195062|NCT02976701|microvascular resistance index|microvascular resistance index
195063|NCT02976701|Left ventricular function|left ventricular function
195064|NCT02976688|Endstage renal Disease|endstage renal disease
195065|NCT02976688|Hemodialysis|hemodialysis
195066|NCT02976649|Morbid obesity|morbid obesity
195067|NCT02976649|Bariatric surgery|bariatric surgery
195068|NCT02976649|Multi-dimensional score|multi-dimensional score
195069|NCT02976636|Obesity treatment|obesity treatment
195070|NCT02976636|Parenting training|parenting training
195071|NCT02976636|Parenting style|parenting style
195072|NCT02976636|Family-based behavioral therapy|family-based behavioral therapy
195073|NCT02976623|metrics|metrics
195074|NCT02976623|feedback|feedback
195075|NCT02976623|ultrasound-guided|ultrasound-guided
195076|NCT02976623|procedural skills|procedural skills
195077|NCT02976610|hemolysis|hemolysis
195078|NCT02976597|Abdominal surgery, pain, local, transversus abdominus block.|abdominal surgery, pain, local, transversus abdominus block.
195079|NCT02976584|EEG|eeg
195080|NCT02976584|Cardiac Surgery|cardiac surgery
195081|NCT02976584|Seizure|seizure
195082|NCT02976584|Tranexamic acid|tranexamic acid
195083|NCT02976558|CAM|cam
195084|NCT02976558|allogenic Stem Cell Transplantation|allogenic stem cell transplantation
195085|NCT02976558|Graft-Versus-Host Disease|graft-versus-host disease
195086|NCT02976558|Depression|depression
195087|NCT02976558|Quality of Life|quality of life
195088|NCT02976558|Acupuncture|acupuncture
195089|NCT02976558|Traditional chinese Medicine|traditional chinese medicine
195090|NCT02976558|Integrative medicine|integrative medicine
195091|NCT02976558|Complementary and Alternative Medicine|complementary and alternative medicine
195092|NCT02976558|Music therapy TaKeTiNa|music therapy taketina
195093|NCT02976558|Clown theatrical performance|clown theatrical performance
195094|NCT02976558|Humour|humour
195095|NCT02976558|Chemotherapy side effects|chemotherapy side effects
195096|NCT02976558|Psycho neuro immune system|psycho neuro immune system
195097|NCT02976558|GvHD|gvhd
195098|NCT02976558|PNEIS|pneis
195099|NCT02976558|CMV|cmv
195100|NCT02976558|EBV|ebv
195101|NCT02976558|holistic medicine|holistic medicine
195102|NCT02976532|Electromagnetic tracking|electromagnetic tracking
195103|NCT02976532|Internal rotation gait|internal rotation gait
195104|NCT02976532|Femoral derotation osteotomy|femoral derotation osteotomy
195105|NCT02976480|Irrigation|irrigation
195106|NCT02976454|Obesity treatment|obesity treatment
195107|NCT02976454|Primary care|primary care
195108|NCT02976454|Guided Self-Help|guided self-help
195109|NCT02976428|knee soft tissue balancing|knee soft tissue balancing
195110|NCT02976428|sensor-guided|sensor-guided
195111|NCT02976428|range of motion|range of motion
195112|NCT02976415|Cardiac Surgery|cardiac surgery
195113|NCT02976415|Physiotherapy|physiotherapy
195114|NCT02976415|In-Bed Cycling|in-bed cycling
195115|NCT02976415|Mechanical Ventilation|mechanical ventilation
195116|NCT02976415|Cycle Ergometry|cycle ergometry
195117|NCT02976415|Early Mobilization|early mobilization
195118|NCT02976415|Rehabilitation|rehabilitation
195119|NCT02976415|Critical Care|critical care
195120|NCT02976415|Intensive Care Unit|intensive care unit
195121|NCT02976389|Supplemental Nutrition Assistance Program|supplemental nutrition assistance program
195122|NCT02976389|Food insecurity|food insecurity
195123|NCT02976389|fruit and vegetable|fruit and vegetable
195124|NCT02976389|healthy diet|healthy diet
195125|NCT02976376|Myocardial infarction|myocardial infarction
195126|NCT02976376|e-Health|e-health
195127|NCT02976376|mHealth|mhealth
195128|NCT02976376|mobile phones|mobile phones
195129|NCT02976376|smartphone|smartphone
195130|NCT02976376|follow-up|follow-up
195131|NCT02976363|Radiotherapy|radiotherapy
195132|NCT02976363|Respiratory muscles|respiratory muscles
195133|NCT02976363|Neoplasms|neoplasms
195134|NCT02976363|Breast|breast
195135|NCT02976350|Heart failure|heart failure
195136|NCT02976350|Heart failure with preserved ejection fraction|heart failure with preserved ejection fraction
195137|NCT02976350|GH deficiency|gh deficiency
195138|NCT02976350|Testosterone deficiency|testosterone deficiency
195139|NCT02976350|Low- T3 syndrome|low- t3 syndrome
195140|NCT02976350|Multiple Hormone Deficiencies|multiple hormone deficiencies
195141|NCT02976337|Central sensitization|central sensitization
195142|NCT02976337|Endogenous opioids|endogenous opioids
195143|NCT02976337|Humans|humans
195144|NCT02976337|Latent sensitization|latent sensitization
195347|NCT02975167|outpatient|outpatient
195145|NCT02976337|Mandibular third molar extraction|mandibular third molar extraction
195146|NCT02976337|Naloxone|naloxone
195147|NCT02976337|Pain|pain
195148|NCT02976337|Pressure algometry|pressure algometry
195149|NCT02976337|Randomized controlled trial|randomized controlled trial
195150|NCT02976337|Secondary hyperalgesia|secondary hyperalgesia
195151|NCT02976337|Target controlled infusion|target controlled infusion
195152|NCT02976311|inflammatory reaction|inflammatory reaction
195153|NCT02976311|IL-6|il-6
195155|NCT02976311|Misgav Ladach technique|misgav ladach technique
195156|NCT02976311|Pfannenstiel-Kerr technique|pfannenstiel-kerr technique
195157|NCT02976311|cesarean delivery|cesarean delivery
195158|NCT02976311|cesarean technique|cesarean technique
195159|NCT02976298|cerebellum|cerebellum
195160|NCT02976298|supplementary motor area|supplementary motor area
195161|NCT02976285|arthroscopic rotator cuff repair|arthroscopic rotator cuff repair
195162|NCT02976285|patch augmentation|patch augmentation
195163|NCT02976272|Bortezomib regimen|bortezomib regimen
195164|NCT02976272|patients with multiple myeloma|patients with multiple myeloma
195165|NCT02976233|Acute Respiratory Failure|acute respiratory failure
195166|NCT02976233|Non Invasive Ventilation|non invasive ventilation
195167|NCT02976233|Ultrasound|ultrasound
195168|NCT02976233|Diaphragm Thickening|diaphragm thickening
195169|NCT02976168|Cognitive functioning|cognitive functioning
195170|NCT02976168|Brain tissue oxygenation|brain tissue oxygenation
195171|NCT02976168|cerebral perfusion|cerebral perfusion
195172|NCT02976168|head down tilt|head down tilt
195173|NCT02976155|critically ill, intensive care, enteral nutrition|critically ill, intensive care, enteral nutrition
195174|NCT02976142|gastric cancer, metastatic|gastric cancer, metastatic
195175|NCT02976142|positive wash cytology|positive wash cytology
195176|NCT02976142|neoadjuvant intraperitoneal immunotherapy|neoadjuvant intraperitoneal immunotherapy
195177|NCT02976116|Fruquintinib|fruquintinib
195178|NCT02976116|NSCLC|nsclc
195179|NCT02976116|1st line|1st line
195180|NCT02976103|recovery|recovery
195181|NCT02976103|pain|pain
195182|NCT02976103|surgical drains|surgical drains
195183|NCT02976077|social cognition|social cognition
195184|NCT02976077|cognitive remediation|cognitive remediation
195185|NCT02976077|emotions|emotions
195186|NCT02976077|theory of mind|theory of mind
195187|NCT02976077|attributions|attributions
195188|NCT02976077|social perception|social perception
195189|NCT02976064|physical activity|physical activity
195190|NCT02976064|lifestyle|lifestyle
195191|NCT02976064|adaptive case management|adaptive case management
195192|NCT02976064|telemedicine|telemedicine
195193|NCT02976064|integrated care|integrated care
195194|NCT02976064|collaborative self-management|collaborative self-management
195195|NCT02976038|Primary Mitochondrial Disease|primary mitochondrial disease
195196|NCT02976038|Stealth|stealth
195197|NCT02976038|elamipretide|elamipretide
195198|NCT02976012|Proliferative Diabetic Retinopathy|proliferative diabetic retinopathy
195199|NCT02976012|Aflibercept|aflibercept
195200|NCT02976012|Vitreous Hemorrhage|vitreous hemorrhage
195201|NCT02975986|Nephrolithiasis, Uric Acid|nephrolithiasis, uric acid
195202|NCT02975986|Fatty Acid|fatty acid
195203|NCT02975973|tDCS|tdcs
195204|NCT02975973|cognitive control|cognitive control
195205|NCT02975973|EEG|eeg
195206|NCT02975973|gamma oscillations|gamma oscillations
195207|NCT02975960|systemic sclerosis|systemic sclerosis
195208|NCT02975960|adipose derived stem cell|adipose derived stem cell
195209|NCT02975960|stromal vascular fraction|stromal vascular fraction
195210|NCT02975960|digital ulcer|digital ulcer
195211|NCT02975960|gangrene|gangrene
195212|NCT02975934|CRPC|crpc
195213|NCT02975934|PARP inhibitor|parp inhibitor
195214|NCT02975934|PARPi|parpi
195215|NCT02975934|BRCA|brca
195216|NCT02975934|ATM|atm
195217|NCT02975934|HRD|hrd
195218|NCT02975934|TRITON|triton
195219|NCT02975934|homologous recombination|homologous recombination
195220|NCT02975934|DNA repair|dna repair
195221|NCT02975934|DNA defect|dna defect
195222|NCT02975934|DNA anomaly|dna anomaly
195223|NCT02975934|germline|germline
195224|NCT02975934|somatic|somatic
195225|NCT02975934|mCRPC|mcrpc
195226|NCT02975921|Pleural Effusion|pleural effusion
195227|NCT02975921|Thoracentesis|thoracentesis
195228|NCT02975921|Pleural Cavity|pleural cavity
195229|NCT02975921|Pleurodesis|pleurodesis
195230|NCT02975921|Tunneled Pleural Catheter|tunneled pleural catheter
195231|NCT02975908|Acute Respiratory Distress Syndrome|acute respiratory distress syndrome
195232|NCT02975908|epidemiology|epidemiology
195233|NCT02975908|clinical features|clinical features
195234|NCT02975908|management|management
195235|NCT02975908|prognosis|prognosis
195236|NCT02975869|Leukemia|leukemia
195237|NCT02975869|Acute Myeloid Leukemia|acute myeloid leukemia
195238|NCT02975856|Anthocyanins|anthocyanins
195239|NCT02975856|Bioavailability|bioavailability
195240|NCT02975856|Flavonoids|flavonoids
195241|NCT02975856|Port wine|port wine
195242|NCT02975856|Red wine|red wine
195243|NCT02975817|pediatric, intraoperative, neurosurgery, inadvertent|pediatric, intraoperative, neurosurgery, inadvertent
195244|NCT02975804|cerebral palsy|cerebral palsy
195245|NCT02975804|video games|video games
195246|NCT02975804|postural control|postural control
195247|NCT02975804|balance|balance
195248|NCT02975804|children|children
195249|NCT02975791|Airway Obstruction|airway obstruction
195250|NCT02975778|80 years old|80 years old
195251|NCT02975765|corticotomy|corticotomy
195252|NCT02975765|minimally invasive|minimally invasive
195253|NCT02975765|piezosurgery|piezosurgery
195254|NCT02975765|piezocision|piezocision
195255|NCT02975765|pain|pain
195256|NCT02975765|discomfort|discomfort
195257|NCT02975739|Intratumoral|intratumoral
195258|NCT02975739|Tongue|tongue
195259|NCT02975739|Microspheres|microspheres
195260|NCT02975726|Liver Cirrhosis|liver cirrhosis
195261|NCT02975726|Refractory ascites|refractory ascites
195262|NCT02975726|PD catheter|pd catheter
195263|NCT02975713|P4,ART,IVF,FSH,LH,AMH|p4,art,ivf,fsh,lh,amh
195264|NCT02975700|PLX3397|plx3397
195265|NCT02975700|Kit-mutant Melanoma|kit-mutant melanoma
195266|NCT02975700|Unresectable or Metastatic KIT-mutated Melanoma|unresectable or metastatic kit-mutated melanoma
195267|NCT02975700|Developmental Phase I/II|developmental phase i/ii
195268|NCT02975687|Acute|acute
195269|NCT02975687|Leukemia|leukemia
195270|NCT02975687|Lymphoid|lymphoid
195271|NCT02975687|CD19|cd19
195272|NCT02975687|Refractory|refractory
195273|NCT02975635|Patients' Preferences|patients' preferences
195274|NCT02975596|educational intervention|educational intervention
195275|NCT02975583|Atherosclerosis|atherosclerosis
195276|NCT02975557|Brimonidine|brimonidine
195277|NCT02975557|Dry Eye|dry eye
195278|NCT02975557|oGVHD|ogvhd
195279|NCT02975557|MGD|mgd
195280|NCT02975544|social and emotional competence|social and emotional competence
195281|NCT02975544|healthy lifestyles|healthy lifestyles
195282|NCT02975544|children|children
195283|NCT02975544|educational programme|educational programme
195284|NCT02975531|Pompage|pompage
195285|NCT02975479|Hay fever|hay fever
195286|NCT02975479|Pollen allergy|pollen allergy
195287|NCT02975479|Allergic rhinitis|allergic rhinitis
195288|NCT02975440|Vilaprisan|vilaprisan
195289|NCT02975440|PK|pk
195290|NCT02975440|rifampicin|rifampicin
195291|NCT02975440|midazolam,|midazolam,
195292|NCT02975440|CYP3A4 induction|cyp3a4 induction
195293|NCT02975440|drug-drug interaction|drug-drug interaction
195294|NCT02975427|Diet|diet
195295|NCT02975427|Abdominal bioelectrical impedance analysis|abdominal bioelectrical impedance analysis
195296|NCT02975427|Anthropometry|anthropometry
195297|NCT02975427|Insulin resistance|insulin resistance
195298|NCT02975362|Acupuncture Treatment; Motor Dysfunction; Stroke Patients|acupuncture treatment; motor dysfunction; stroke patients
195299|NCT02975349|M2951|m2951
195300|NCT02975349|Relapsing Multiple Sclerosis|relapsing multiple sclerosis
195301|NCT02975349|Bruton's Tyrosine Kinase inhibitor|bruton's tyrosine kinase inhibitor
195302|NCT02975336|Systemic Lupus Erythematosus|systemic lupus erythematosus
195303|NCT02975336|M2951|m2951
195304|NCT02975336|Placebo|placebo
195305|NCT02975336|Dose response|dose response
195306|NCT02975336|Oral Corticosteroids|oral corticosteroids
195307|NCT02975336|Safety|safety
195308|NCT02975336|Efficacy|efficacy
195309|NCT02975336|Autoimmune And Inflammatory Disorders|autoimmune and inflammatory disorders
195310|NCT02975323|hepatic venous pressure gradient|hepatic venous pressure gradient
195311|NCT02975323|liver disease|liver disease
195312|NCT02975323|US Doppler waveform|us doppler waveform
195313|NCT02975323|Cirrhosis|cirrhosis
195314|NCT02975297|smoking|smoking
195315|NCT02975297|pre-diabetes|pre-diabetes
195316|NCT02975297|overweight|overweight
195317|NCT02975297|exenatide|exenatide
195318|NCT02975297|GLP-1 agonists|glp-1 agonists
195319|NCT02975284|bronchial thermoplasty|bronchial thermoplasty
195320|NCT02975284|long term|long term
195321|NCT02975284|interventional bronchoscopy|interventional bronchoscopy
195322|NCT02975258|HIV|hiv
195323|NCT02975258|Asthma|asthma
195324|NCT02975258|Adiposity|adiposity
195325|NCT02975258|Lung disease|lung disease
195326|NCT02975258|Weight|weight
195327|NCT02975258|Fat|fat
195328|NCT02975258|Obese|obese
195329|NCT02975245|Male infertility|male infertility
195330|NCT02975245|Germ cells|germ cells
195331|NCT02975245|Chemotherapy|chemotherapy
195332|NCT02975245|Sperm|sperm
195333|NCT02975232|nutrition disparities|nutrition disparities
195334|NCT02975232|SNAP population|snap population
195335|NCT02975232|behavioral economics|behavioral economics
195336|NCT02975232|retail setting|retail setting
195337|NCT02975232|point of purchase education|point of purchase education
195338|NCT02975232|pediatric obesity|pediatric obesity
195339|NCT02975232|rural population|rural population
195340|NCT02975232|fruit and vegetable purchases|fruit and vegetable purchases
195341|NCT02975232|fruit and vegetable consumption|fruit and vegetable consumption
195342|NCT02975193|Parkinsons Disease|parkinsons disease
195343|NCT02975193|Cognition|cognition
195344|NCT02975167|Induction of labor|induction of labor
195345|NCT02975167|mechanical cervical ripening|mechanical cervical ripening
195346|NCT02975167|patient satisfaction|patient satisfaction
195348|NCT02975167|cost savings|cost savings
195349|NCT02975154|osteoarthritis|osteoarthritis
195350|NCT02975154|microcurrent|microcurrent
195351|NCT02975154|knee|knee
195352|NCT02975154|electrotherapy|electrotherapy
195353|NCT02975141|Palliative Chemotherapy|palliative chemotherapy
195354|NCT02975141|Afatinib|afatinib
195355|NCT02975141|Gemcitabine|gemcitabine
195356|NCT02975141|nab-paclitaxel|nab-paclitaxel
195357|NCT02975141|pancreatic cancer|pancreatic cancer
195358|NCT02975128|Minimal invasive|minimal invasive
195359|NCT02975128|Biopsy|biopsy
195360|NCT02975089|Frailty|frailty
195361|NCT02975089|nutrition education|nutrition education
195362|NCT02975089|designed dishware|designed dishware
195363|NCT02975089|balanced diet|balanced diet
195364|NCT02975089|multiple dietary components|multiple dietary components
195365|NCT02975076|Sanchitongshu|sanchitongshu
195366|NCT02975076|Acute Minor Stroke|acute minor stroke
195367|NCT02975076|Transient Ischemic Attack|transient ischemic attack
195368|NCT02975063|Exclusive breastfeeding|exclusive breastfeeding
195369|NCT02975024|mandibular vestibuloplasty|mandibular vestibuloplasty
195370|NCT02975024|wound healing|wound healing
195371|NCT02975024|microcirculation|microcirculation
195372|NCT02975024|Laser Speckle Contrast Imager|laser speckle contrast imager
195373|NCT02975024|Mucograft|mucograft
195374|NCT02975024|strip gingival graft|strip gingival graft
195375|NCT02975011|Magnetic Resonance Imaging|magnetic resonance imaging
195376|NCT02975011|Patient Satisfaction|patient satisfaction
195377|NCT02975011|Numeric Rating Scale|numeric rating scale
195378|NCT02974998|Human Immunodeficiency Virus (HIV)|human immunodeficiency virus (hiv)
195379|NCT02974998|HIV Testing and Counseling (HTC)|hiv testing and counseling (htc)
195380|NCT02974998|Sexually Transmitted Infections (STIs)|sexually transmitted infections (stis)
195381|NCT02974998|Substance Abuse|substance abuse
195382|NCT02974998|Gender Based Violence|gender based violence
195383|NCT02974998|Gang Violence|gang violence
195384|NCT02974998|Victimization|victimization
195385|NCT02974998|Linkage to Care|linkage to care
195386|NCT02974998|Sexual Risk|sexual risk
195387|NCT02974998|Out-of-school Adolescents|out-of-school adolescents
195388|NCT02974998|Young Women|young women
195389|NCT02974985|Facelift|facelift
195390|NCT02974985|HA Filler|ha filler
195391|NCT02974985|Hyaluronic acid|hyaluronic acid
195392|NCT02974985|Facial Rejuvenation|facial rejuvenation
195393|NCT02974985|Aging Face|aging face
195394|NCT02974985|WIZDOM|wizdom
195395|NCT02974985|Midface lift|midface lift
195396|NCT02974985|Midface augmentation|midface augmentation
195397|NCT02974933|apatinib|apatinib
195398|NCT02974933|pemetrexed|pemetrexed
195399|NCT02974933|NSCLC|nsclc
195400|NCT02974907|Dry Eye Syndrome|dry eye syndrome
195401|NCT02974907|Dry Eye|dry eye
195402|NCT02974907|DES|des
195403|NCT02974868|Phase 2|phase 2
195404|NCT02974868|randomized|randomized
195405|NCT02974868|double-blind|double-blind
195406|NCT02974868|placebo|placebo
195407|NCT02974868|alopecia areata|alopecia areata
195408|NCT02974868|safety|safety
195409|NCT02974868|efficacy|efficacy
195410|NCT02974868|JAK|jak
195411|NCT02974868|janus kinase|janus kinase
195412|NCT02974868|moderate|moderate
195413|NCT02974868|severe|severe
195414|NCT02974855|hemophilia|hemophilia
195415|NCT02974829|Chronic Hepatitis B|chronic hepatitis b
195416|NCT02974816|Glooko|glooko
195417|NCT02974816|Mobile health application|mobile health application
195418|NCT02974816|Insulin treated|insulin treated
195419|NCT02974816|Type 2 Diabetes|type 2 diabetes
195420|NCT02974816|Remote patient monitoring|remote patient monitoring
195421|NCT02974816|Certified diabetes educator|certified diabetes educator
195422|NCT02974816|mHealth Advantage|mhealth advantage
195423|NCT02974816|Population health|population health
195424|NCT02974790|echocardiography|echocardiography
195425|NCT02974790|training|training
195426|NCT02974790|emergency department|emergency department
195427|NCT02974790|circulatory failure|circulatory failure
195428|NCT02974751|Aquablation|aquablation
195429|NCT02974751|AQUABEAM|aquabeam
195430|NCT02974751|BPH|bph
195431|NCT02974751|LUTS|luts
195432|NCT02974725|NSCLC|nsclc
195433|NCT02974725|Melanoma|melanoma
195434|NCT02974725|NRAS|nras
195435|NCT02974725|KRAS|kras
195436|NCT02974725|BRAF|braf
195437|NCT02974725|LXH254|lxh254
195438|NCT02974725|LTT462|ltt462
195439|NCT02974725|Trametinib|trametinib
195440|NCT02974725|Ribocliclib|ribocliclib
195441|NCT02974725|Non-small cell lung carcinoma (NSCLC)|non-small cell lung carcinoma (nsclc)
195442|NCT02974725|treatment of lung cancer after first metastasis|treatment of lung cancer after first metastasis
195443|NCT02974725|lung cancer|lung cancer
195444|NCT02974725|lung adenocarcinoma|lung adenocarcinoma
195445|NCT02974725|Large-cell lung carcinoma|large-cell lung carcinoma
195446|NCT02974725|Non small cell lung carcinoma|non small cell lung carcinoma
195447|NCT02974725|Non small cell lung cancer|non small cell lung cancer
195448|NCT02974725|Large cell lung carcinoma|large cell lung carcinoma
195449|NCT02974725|Large cell lung cancer|large cell lung cancer
195450|NCT02974725|squamous cell lung carcinoma|squamous cell lung carcinoma
195451|NCT02974712|Arterial blood gases|arterial blood gases
195452|NCT02974712|MAP|map
195453|NCT02974712|HR|hr
195454|NCT02974673|Spinal Cord Injury|spinal cord injury
195455|NCT02974673|Genito sexuals disorders|genito sexuals disorders
195456|NCT02974673|Ejaculatory test|ejaculatory test
195457|NCT02974647|Ruxolitinib|ruxolitinib
195458|NCT02974647|T or NK Cell|t or nk cell
195459|NCT02974647|Relapsed|relapsed
195460|NCT02974647|Refractory|refractory
195461|NCT02974634|Ileostomy|ileostomy
195462|NCT02974608|Placental|placental
195463|NCT02974608|Fetal Loss|fetal loss
195464|NCT02974608|Observational|observational
195465|NCT02974608|Antenatal|antenatal
195466|NCT02974608|Infection|infection
195467|NCT02974595|Study of pathogenesis of patients affected with autoinflammatory diseases|study of pathogenesis of patients affected with autoinflammatory diseases
195468|NCT02974595|This Includes the Clinical, Immunological , Genetic, and Metabolic Characteristi|this includes the clinical, immunological , genetic, and metabolic characteristi
195469|NCT02974595|Collection of Clinical and Laboratory Outcome Data|collection of clinical and laboratory outcome data
195470|NCT02974595|Evaluation of Characteristics/Disease Manifestations|evaluation of characteristics/disease manifestations
195471|NCT02974582|Cigarette|cigarette
195472|NCT02974582|Behaviors|behaviors
195473|NCT02974582|Attitudes|attitudes
195474|NCT02974582|Beliefs|beliefs
195475|NCT02974569|adolescents|adolescents
195476|NCT02974569|young adults|young adults
195477|NCT02974543|tinnitus|tinnitus
195478|NCT02974517|time-lapes|time-lapes
195479|NCT02974517|IVF/ICSI|ivf/icsi
195480|NCT02974517|pregnancy outcome|pregnancy outcome
195481|NCT02974491|hemodialysis|hemodialysis
195482|NCT02974491|diabetes mellitus|diabetes mellitus
195483|NCT02974491|apple juice|apple juice
195484|NCT02974491|potassium|potassium
195485|NCT02974478|orange juice consumption|orange juice consumption
195486|NCT02974478|glucose homeostasis|glucose homeostasis
195487|NCT02974478|antioxidative status|antioxidative status
195488|NCT02974465|Brain injuries|brain injuries
195489|NCT02974465|upper extremity|upper extremity
195490|NCT02974465|biofeedback|biofeedback
195491|NCT02974465|electromyography|electromyography
195492|NCT02974465|recovery of function|recovery of function
195493|NCT02974400|internet-based intervention|internet-based intervention
195494|NCT02974400|e-mental health|e-mental health
195495|NCT02974400|cognitive behavioural intervention|cognitive behavioural intervention
195496|NCT02974322|Crohn's Disease|crohn's disease
195497|NCT02974322|GED-0301|ged-0301
195498|NCT02974322|Mongersen|mongersen
195499|NCT02974322|Adolescent|adolescent
195500|NCT02974322|Pediatric|pediatric
195501|NCT02974322|Children|children
195502|NCT02974309|Youth|youth
195503|NCT02974309|Diabetes Management|diabetes management
195504|NCT02974309|Sleep|sleep
195505|NCT02974283|Normobaric hyperoxia|normobaric hyperoxia
195506|NCT02974283|r-tPA thrombolytic therapy|r-tpa thrombolytic therapy
195507|NCT02974257|cardiac arrest|cardiac arrest
195508|NCT02974257|thiamine|thiamine
195509|NCT02974257|oxygen consumption|oxygen consumption
195510|NCT02974257|lactate|lactate
195511|NCT02974257|shock|shock
195512|NCT02974244|Type 2 diabetes|type 2 diabetes
195513|NCT02974192|Ischemic stroke|ischemic stroke
195514|NCT02974192|Soluble CD40 Ligand|soluble cd40 ligand
195515|NCT02974192|Neopetrin|neopetrin
195516|NCT02974192|stroke risk factors|stroke risk factors
195517|NCT02974192|functional outcome|functional outcome
195518|NCT02974166|Temporomandibular Disorder|temporomandibular disorder
195519|NCT02974166|Osteopathic Manipulative Treatment|osteopathic manipulative treatment
195520|NCT02974166|Rigid Splint|rigid splint
195521|NCT02974166|Speech Therapy|speech therapy
195522|NCT02974127|intracranial benign meningioma|intracranial benign meningioma
195523|NCT02974127|radiosurgery|radiosurgery
195524|NCT02974127|large meningioma|large meningioma
195525|NCT02974127|critical site|critical site
195526|NCT02974127|multisession radiosurgery|multisession radiosurgery
195527|NCT02974101|Spinal cord stimulation|spinal cord stimulation
195528|NCT02974101|AdaptiveStim|adaptivestim
195529|NCT02974062|Position sense|position sense
195530|NCT02974062|Lumbar stabilization exercise|lumbar stabilization exercise
195531|NCT02974049|Ivermectin|ivermectin
195532|NCT02974049|Albendazole|albendazole
195533|NCT02974049|Diethylcarbamazine|diethylcarbamazine
195534|NCT02974036|Patient education|patient education
195535|NCT02974036|Osteoarthritis|osteoarthritis
195536|NCT02974036|Primary health care|primary health care
195537|NCT02974010|d-cycloserine|d-cycloserine
195538|NCT02974010|lurasidone|lurasidone
195539|NCT02974010|ketamine|ketamine
195540|NCT02974010|randomized controlled trial|randomized controlled trial
195541|NCT02973984|Anticoagulant Treatments|anticoagulant treatments
195542|NCT02973984|Multidimensional Prognostic Index (MPI)|multidimensional prognostic index (mpi)
195543|NCT02973984|Comprehensive Geriatric Assessment (CGA)|comprehensive geriatric assessment (cga)
195544|NCT02973984|Frailty|frailty
195545|NCT02973984|Elderly|elderly
195546|NCT02973984|Atrial Fibrillation|atrial fibrillation
195547|NCT02973971|Blood cell biomarkers, peripheral circulating biomarkers|blood cell biomarkers, peripheral circulating biomarkers
195548|NCT02973958|Penis|penis
195549|NCT02973958|Pain|pain
195550|NCT02973958|Ketorolac|ketorolac
195551|NCT02973958|Circumcision|circumcision
195552|NCT02973945|Pulmonary Rehabilitation|pulmonary rehabilitation
195553|NCT02973945|High Flow Nasal Cannula|high flow nasal cannula
195554|NCT02973945|The Venturi Mask|the venturi mask
195555|NCT02973945|Exercise capacity|exercise capacity
195556|NCT02973945|Aerobic capacity|aerobic capacity
195557|NCT02973945|HFNC|hfnc
195558|NCT02973932|cognitive-behavioral psychotherapy|cognitive-behavioral psychotherapy
195559|NCT02973932|obsessive-compulsive disorder|obsessive-compulsive disorder
195560|NCT02973932|internet-based|internet-based
195561|NCT02973893|Chronic Venous Leg Ulcer|chronic venous leg ulcer
195562|NCT02973880|Steroid/antibiotic associated treatment|steroid/antibiotic associated treatment
195563|NCT02973880|Phaco-emulsification|phaco-emulsification
195564|NCT02973880|Cataract extraction|cataract extraction
195565|NCT02973867|Bone mineral density|bone mineral density
195566|NCT02973867|Myokines|myokines
195567|NCT02973867|Adipokines|adipokines
195568|NCT02973815|family meals|family meals
195569|NCT02973815|home food availability|home food availability
195570|NCT02973802|Graves Disease|graves disease
195571|NCT02973802|Phase 1|phase 1
195572|NCT02973789|Non-Small Cell Lung Cancer|non-small cell lung cancer
195573|NCT02973789|NSCLC|nsclc
195574|NCT02973789|Treatment|treatment
195575|NCT02973789|Minimal Toxicity|minimal toxicity
195576|NCT02973789|TTFields|ttfields
195577|NCT02973789|TTF|ttf
195578|NCT02973789|Tumor Treating Fields|tumor treating fields
195579|NCT02973789|Novocure|novocure
195580|NCT02973789|Docetaxel|docetaxel
195581|NCT02973789|PD-1 inhibitor|pd-1 inhibitor
195582|NCT02973789|PD-L1 inhibitor|pd-l1 inhibitor
195583|NCT02973789|Immune checkpoint inhibitor|immune checkpoint inhibitor
195584|NCT02973750|high-grade serous cancer|high-grade serous cancer
195585|NCT02973750|stage III cancer|stage iii cancer
195586|NCT02973750|stage IV cancer|stage iv cancer
195587|NCT02973724|Extubation|extubation
195588|NCT02973724|Remifentanil|remifentanil
195589|NCT02973724|Laryngomicrosurgery|laryngomicrosurgery
195590|NCT02973685|Hepatic arterial infusion chemotherapy|hepatic arterial infusion chemotherapy
195591|NCT02973685|Transarterial Chemoembolization|transarterial chemoembolization
195592|NCT02973685|BCLC A/B|bclc a/b
195593|NCT02973672|Fluorescence|fluorescence
195594|NCT02973672|Surgery|surgery
195595|NCT02973672|Cancer|cancer
195596|NCT02973672|SGM-101|sgm-101
195597|NCT02973672|Near Infrared|near infrared
195598|NCT02973672|Immunophotodetection|immunophotodetection
195599|NCT02973646|chronic hepatitis b|chronic hepatitis b
195600|NCT02973646|peginterferon alfa-2b|peginterferon alfa-2b
195601|NCT02973646|interferon gene mutation|interferon gene mutation
195602|NCT02973646|interferon receptor|interferon receptor
195603|NCT02973633|Heart Failure|heart failure
195604|NCT02973633|Remodeling|remodeling
195605|NCT02973633|Myocardial Infarction|myocardial infarction
195606|NCT02973633|Left Ventricular Hypertrophy|left ventricular hypertrophy
195607|NCT02973633|Diffusion Tensor MRI|diffusion tensor mri
195608|NCT02973594|left ventricular reverse remodeling|left ventricular reverse remodeling
195609|NCT02973594|beta-1 adrenergic receptor signaling|beta-1 adrenergic receptor signaling
195610|NCT02973594|idiopathic dilated cardiomyopathy|idiopathic dilated cardiomyopathy
195611|NCT02973594|HCN4 inhibition|hcn4 inhibition
195612|NCT02973594|beta-1 adrenergic receptor blocker|beta-1 adrenergic receptor blocker
195613|NCT02973594|gene expression|gene expression
195614|NCT02973581|Surgical Pleth Index (SPI)|surgical pleth index (spi)
195615|NCT02973581|General Anaesthesia (GA),|general anaesthesia (ga),
195616|NCT02973581|Numerical Rating Scale (NRS)|numerical rating scale (nrs)
195617|NCT02973581|Adequacy of Anaesthesia (AoA)|adequacy of anaesthesia (aoa)
195618|NCT02973581|Peribulbar Block (PBB)|peribulbar block (pbb)
195619|NCT02973581|Topical Analgesia (TA)|topical analgesia (ta)
195620|NCT02973581|Oculocardiac reflex (OCR)|oculocardiac reflex (ocr)
195621|NCT02973581|Postoperative nausea nad vomiting (PONV)|postoperative nausea nad vomiting (ponv)
195622|NCT02973581|paracetamol|paracetamol
195623|NCT02973581|metamizol|metamizol
195625|NCT02973542|Ethosuximide|ethosuximide
195626|NCT02973542|Pain|pain
195627|NCT02973529|Percutaneous intervention (PCI)|percutaneous intervention (pci)
195628|NCT02973529|Optical coherence tomography (OCT)|optical coherence tomography (oct)
195629|NCT02973529|Bifurcation lesion|bifurcation lesion
195630|NCT02973529|Bioresorbable stents (BRS)|bioresorbable stents (brs)
195631|NCT02973503|Hepatitis C|hepatitis c
195632|NCT02973503|Genotype 1B|genotype 1b
195633|NCT02973503|Non Severe Fibrosis|non severe fibrosis
195634|NCT02973503|Treatment Naïve|treatment naïve
195635|NCT02973503|8 Weeks of Treatment|8 weeks of treatment
195636|NCT02973503|Elbasvir/Grazoprevir Combination|elbasvir/grazoprevir combination
195637|NCT02973490|ESD;Transanal Tube Drainage;Colorectal Tumor|esd;transanal tube drainage;colorectal tumor
195638|NCT02973438|Spinal Cord Injuries|spinal cord injuries
195639|NCT02973438|Obesity|obesity
195640|NCT02973438|Insulin Resistance|insulin resistance
195641|NCT02973438|Intermittent hypoxia|intermittent hypoxia
195642|NCT02973425|mHealth, Smoking cessation,|mhealth, smoking cessation,
195643|NCT02973399|CLL|cll
195644|NCT02973399|Leukemia, Chronic Lymphocytic|leukemia, chronic lymphocytic
195645|NCT02973399|Hsp90|hsp90
195646|NCT02973399|Ibrutinib|ibrutinib
195647|NCT02973386|Local advanced|local advanced
195648|NCT02973386|High Risk|high risk
195649|NCT02973386|Nasopharyngeal Carcinoma|nasopharyngeal carcinoma
195650|NCT02973373|MRI|mri
195651|NCT02973373|Chest|chest
195652|NCT02973373|Apnea|apnea
195653|NCT02973347|Enteral Feeding|enteral feeding
195654|NCT02973347|Ventilator-Associated Pneumonia|ventilator-associated pneumonia
195655|NCT02973347|Mechanical Ventilation|mechanical ventilation
195656|NCT02973347|Pediatric Intensive Care Unit|pediatric intensive care unit
195657|NCT02973347|Critical Illness|critical illness
195658|NCT02973334|sweeteners|sweeteners
195659|NCT02973334|sugar|sugar
195660|NCT02973334|stress response|stress response
195661|NCT02973295|NAFLD;|nafld;
195662|NCT02973295|Fibroscan|fibroscan
195663|NCT02973295|Silymarin|silymarin
195664|NCT02973256|Meningioma grade II|meningioma grade ii
195665|NCT02973256|Meningioma grade III|meningioma grade iii
195666|NCT02973243|early warning scoring|early warning scoring
195667|NCT02973243|respiration rate|respiration rate
195668|NCT02973243|acute care teams|acute care teams
195669|NCT02973243|NEWS|news
195670|NCT02973243|CREWS|crews
195671|NCT02973230|Pregnancy, Ectopic|pregnancy, ectopic
195672|NCT02973230|Vascular Endothelial Growth Factor A|vascular endothelial growth factor a
195673|NCT02973230|Pregnancy, Tubal|pregnancy, tubal
195674|NCT02973217|Hyperthermia, Induced|hyperthermia, induced
195675|NCT02973217|Laser Coagulation|laser coagulation
195676|NCT02973217|Laser Therapy|laser therapy
195677|NCT02973204|tumor DNA|tumor dna
195678|NCT02973204|circulating tumor cells|circulating tumor cells
195679|NCT02973204|biopsy|biopsy
195680|NCT02973191|Leukemia|leukemia
195681|NCT02973191|B-Cell Acute Lymphoblastic Leukemia|b-cell acute lymphoblastic leukemia
195682|NCT02973191|JCAR015|jcar015
195683|NCT02973152|Type I Thyroplasty|type i thyroplasty
195684|NCT02973152|Reinnervation|reinnervation
195685|NCT02973113|Nivolumab|nivolumab
195686|NCT02973113|Hodgkin Lymphoma|hodgkin lymphoma
195687|NCT02973113|Non-Hodgkin Lymphoma|non-hodgkin lymphoma
195688|NCT02973113|Lymphoproliferative Disorders|lymphoproliferative disorders
195689|NCT02973113|EBV-specific T Cells|ebv-specific t cells
195690|NCT02973074|iron deficiency|iron deficiency
195691|NCT02973074|patient blood management|patient blood management
195692|NCT02973074|anemia|anemia
195693|NCT02973048|Cesarean delivery|cesarean delivery
195694|NCT02973048|Spinal anesthesia|spinal anesthesia
195695|NCT02973048|Local anesthetics|local anesthetics
195696|NCT02973009|The Sleeve Gastrectomy (SG)|the sleeve gastrectomy (sg)
195697|NCT02973009|bariatric surgery|bariatric surgery
195698|NCT02973009|laparoscopy|laparoscopy
195699|NCT02973009|systematic closure of the epigastric|systematic closure of the epigastric
195700|NCT02972983|Staphylococcus aureus|staphylococcus aureus
195701|NCT02972983|Bacteremia|bacteremia
195702|NCT02972983|Daptomycin|daptomycin
195703|NCT02972957|intranasal|intranasal
195704|NCT02972957|flu vaccine|flu vaccine
195705|NCT02972957|Gambian children|gambian children
195706|NCT02972931|HIV infection|hiv infection
195707|NCT02972931|low HIV reservoir|low hiv reservoir
195708|NCT02972931|functional cure|functional cure
195709|NCT02972905|pharmacokinetics|pharmacokinetics
195710|NCT02972905|GSK2269557|gsk2269557
195711|NCT02972905|Dry powder Inhaler (DPI)|dry powder inhaler (dpi)
195712|NCT02972905|tolerability|tolerability
195713|NCT02972905|safety|safety
195714|NCT02972905|ELLIPTA|ellipta
195715|NCT02972879|trigger finger|trigger finger
195716|NCT02972879|Therapeutic Modalities|therapeutic modalities
195717|NCT02972879|Corticosteroid Injection|corticosteroid injection
195718|NCT02972879|non-surgical treatment|non-surgical treatment
195719|NCT02972879|physical therapy|physical therapy
195720|NCT02972840|Bruton tyrosine kinase inhibitor|bruton tyrosine kinase inhibitor
195721|NCT02972840|Acalabrutinib|acalabrutinib
195722|NCT02972840|Mantle Cell Lymphoma|mantle cell lymphoma
195723|NCT02972840|ACE-LY-308|ace-ly-308
195724|NCT02972840|Treatment naive|treatment naive
195725|NCT02972840|non-Hodgkins Lymphoma|non-hodgkins lymphoma
195726|NCT02972840|Bendomustine|bendomustine
195727|NCT02972840|Rituximab|rituximab
195728|NCT02972814|Troponin|troponin
195729|NCT02972814|Point of care test|point of care test
195730|NCT02972814|myocardial infarction|myocardial infarction
195731|NCT02972801|Spermatogonial stem cells|spermatogonial stem cells
195732|NCT02972801|Testis|testis
195733|NCT02972801|Fertility|fertility
195734|NCT02972801|Infertility|infertility
195735|NCT02972801|Oncofertility|oncofertility
195736|NCT02972762|depth of anesthesia\postoperation delirium|depth of anesthesia\postoperation delirium
195737|NCT02972736|Radiation dose|radiation dose
195738|NCT02972736|percutaneous coronary intervention|percutaneous coronary intervention
195739|NCT02972736|Coronary|coronary
195740|NCT02972736|Interventional radiology|interventional radiology
195741|NCT02972736|Electrophysiology|electrophysiology
195742|NCT02972723|Metformin Therapy in HCV|metformin therapy in hcv
195743|NCT02972684|Cardiopulmonary Bypass|cardiopulmonary bypass
195744|NCT02972684|Hemorrhage|hemorrhage
195745|NCT02972684|blood transfusion|blood transfusion
195746|NCT02972684|Point-of-care test|point-of-care test
195747|NCT02972684|health economics|health economics
195748|NCT02972671|MiStent|mistent
195749|NCT02972658|Alzheimer's Disease|alzheimer's disease
195750|NCT02972658|Dementia|dementia
195751|NCT02972658|Brain Diseases|brain diseases
195752|NCT02972658|Neurodegenerative Diseases|neurodegenerative diseases
195753|NCT02972658|Central Nervous System Diseases|central nervous system diseases
195754|NCT02972658|Nervous System Diseases|nervous system diseases
195755|NCT02972658|Mental Disorders|mental disorders
195756|NCT02972658|Delirium, Dementia, Amnestic, Cognitive Disorders|delirium, dementia, amnestic, cognitive disorders
195757|NCT02972658|Tauopathies|tauopathies
195758|NCT02972658|Memory|memory
195759|NCT02972658|Amyloid|amyloid
195760|NCT02972632|Drug Therapy|drug therapy
195761|NCT02972619|Blood Pressure|blood pressure
195762|NCT02972619|Lipids|lipids
195763|NCT02972619|Cardiovascular|cardiovascular
195764|NCT02972619|Health Services|health services
195765|NCT02972619|Hypertension|hypertension
195767|NCT02972606|Peripheral Neuropathy|peripheral neuropathy
195768|NCT02972606|Chronic Pain|chronic pain
195769|NCT02972606|Qualitative Research|qualitative research
195770|NCT02972567|probiotics|probiotics
195771|NCT02972567|metabolic syndrome|metabolic syndrome
195772|NCT02972567|non-alcoholic fatty liver disease|non-alcoholic fatty liver disease
195773|NCT02972528|DFU|dfu
195774|NCT02972528|Diabetic Foot Ulcer|diabetic foot ulcer
195775|NCT02972528|Diabetes|diabetes
195776|NCT02972528|Platelet Rich Plasma|platelet rich plasma
195777|NCT02972515|Smoking|smoking
195778|NCT02972515|Smoking cessation|smoking cessation
195779|NCT02972515|Multiple behaviors|multiple behaviors
195780|NCT02972515|mHealth|mhealth
195781|NCT02972515|Mobile Application|mobile application
195782|NCT02972502|Metoclopramide (Reglan)|metoclopramide (reglan)
195783|NCT02972502|Haloperidol (Haldol)|haloperidol (haldol)
195784|NCT02972476|Chronic Obstructive Pulmonary Disease|chronic obstructive pulmonary disease
195785|NCT02972463|Gastrointestinal|gastrointestinal
195786|NCT02972463|Microbiome|microbiome
195787|NCT02972463|Inflammation|inflammation
195788|NCT02972437|GAS in oral cavity|gas in oral cavity
195789|NCT02972424|pelvic fracture|pelvic fracture
195790|NCT02972424|healing|healing
195791|NCT02972424|teriparatide|teriparatide
195792|NCT02972398|treatment resistant depression|treatment resistant depression
195793|NCT02972398|N-Acetyl Cysteine|n-acetyl cysteine
195794|NCT02972398|inflammation mediators|inflammation mediators
195795|NCT02972398|oxidative stress|oxidative stress
195796|NCT02972398|brain imaging|brain imaging
195797|NCT02972385|warfarin|warfarin
195798|NCT02972385|blood clotting|blood clotting
195799|NCT02972372|esophageal cancer|esophageal cancer
195800|NCT02972372|chemoradiation|chemoradiation
195801|NCT02972372|esophagectomy|esophagectomy
195802|NCT02972359|Neridronic Acid|neridronic acid
195803|NCT02972359|Neridronate|neridronate
195804|NCT02972359|CRPS|crps
195805|NCT02972359|RSD (reflex sympathetic dystrophy)|rsd (reflex sympathetic dystrophy)
195806|NCT02972294|iron isomaltoside|iron isomaltoside
195807|NCT02972294|tranexamic acid|tranexamic acid
195808|NCT02972203|Mindfulness|mindfulness
195809|NCT02972203|primary care|primary care
195810|NCT02972203|self-control|self-control
195811|NCT02972203|self-regulation|self-regulation
195812|NCT02972203|adherence|adherence
195813|NCT02972177|Lung cancer|lung cancer
195814|NCT02972177|Transbronchial ablation|transbronchial ablation
195815|NCT02972177|Radiofrequency ablation|radiofrequency ablation
195816|NCT02972177|Microwave ablation|microwave ablation
195817|NCT02972164|Childhood obesity|childhood obesity
195818|NCT02972164|Lifestyle|lifestyle
195819|NCT02972164|Prevention|prevention
195820|NCT02972164|Intervention|intervention
195821|NCT02972164|Behavioural psychology|behavioural psychology
195822|NCT02972138|Sickle-cells Disease|sickle-cells disease
195823|NCT02972138|bisphosphonates|bisphosphonates
195824|NCT02972138|Vitamine D|vitamine d
195825|NCT02972125|Lacosamide|lacosamide
195826|NCT02972125|Bioequivalence|bioequivalence
195827|NCT02972125|Dry Syrup|dry syrup
195828|NCT02972073|Low back pain|low back pain
195829|NCT02972073|Neuromuscular control|neuromuscular control
195830|NCT02972060|Hormone Naive Prostate Cancer|hormone naive prostate cancer
195831|NCT02972047|Reflux|reflux
195832|NCT02972021|respiratory insufficiency|respiratory insufficiency
195833|NCT02972021|High-flow nasal cannula|high-flow nasal cannula
195834|NCT02972008|Aortic stenosis|aortic stenosis
195835|NCT02972008|Transaortic valve replacement|transaortic valve replacement
195836|NCT02972008|stroke|stroke
195837|NCT02972008|Epigenetic|epigenetic
195838|NCT02971969|gene therapy|gene therapy
195839|NCT02971969|Hemophilia B|hemophilia b
195840|NCT02971956|Esophageal Cancer|esophageal cancer
195841|NCT02971917|Chest radiography|chest radiography
195842|NCT02971917|Image improvements|image improvements
195843|NCT02971917|Image Reconstruction|image reconstruction
195844|NCT02971917|Preprocessing|preprocessing
195845|NCT02971917|MTF|mtf
195846|NCT02971904|newborn|newborn
195847|NCT02971904|prematurity|prematurity
195848|NCT02971904|preterm|preterm
195849|NCT02971904|human milk|human milk
195850|NCT02971904|human milk analyzer|human milk analyzer
195851|NCT02971904|neonatology|neonatology
195852|NCT02971904|neonatal intensive care unit|neonatal intensive care unit
195853|NCT02971904|low birth weight|low birth weight
195854|NCT02971865|Cognitive Behavior Therapy|cognitive behavior therapy
195855|NCT02971865|Chiropractic|chiropractic
195856|NCT02971865|Diabetes Mellitus, Type 2|diabetes mellitus, type 2
195857|NCT02971865|Primary care shared visit|primary care shared visit
195858|NCT02971852|Hypnosis|hypnosis
195859|NCT02971852|Anesthesia|anesthesia
195860|NCT02971852|Suggestion|suggestion
195861|NCT02971852|Thermography|thermography
195862|NCT02971826|Stroke|stroke
195863|NCT02971826|thrombectomy|thrombectomy
195864|NCT02971826|REVIVETM SE|revivetm se
195865|NCT02971826|MRI|mri
195866|NCT02971826|Computed Tomography|computed tomography
195867|NCT02971813|cardiac rehabilitation|cardiac rehabilitation
195868|NCT02971813|social media|social media
195869|NCT02971813|adherence|adherence
195870|NCT02971813|motivation|motivation
195871|NCT02971800|sodium fluorescein|sodium fluorescein
195872|NCT02971800|ureteral efflux|ureteral efflux
195873|NCT02971800|laparoscopic hysterectomy|laparoscopic hysterectomy
195874|NCT02971774|stroke|stroke
195875|NCT02971774|botulinum toxin injection|botulinum toxin injection
195876|NCT02971774|daily life|daily life
195877|NCT02971735|cognitive style|cognitive style
195878|NCT02971735|e-learning|e-learning
195879|NCT02971735|mobile technology|mobile technology
195880|NCT02971735|randomized controlled trial|randomized controlled trial
195881|NCT02971735|otolaryngology-head and neck surgery|otolaryngology-head and neck surgery
195882|NCT02971722|GLP-1 receptor agonist|glp-1 receptor agonist
195883|NCT02971657|Staphylococcus aureus phenotypic characterization|staphylococcus aureus phenotypic characterization
195884|NCT02971657|Antibiotic resistance|antibiotic resistance
195885|NCT02971657|Orthopedic device related infections|orthopedic device related infections
195886|NCT02971657|Phenotypic characterization|phenotypic characterization
195887|NCT02971631|Dumping syndrome|dumping syndrome
195888|NCT02971631|Gastrectomy|gastrectomy
195889|NCT02971631|GLP-1|glp-1
195890|NCT02971631|Insulin|insulin
195891|NCT02971618|dapagliflozin,|dapagliflozin,
195892|NCT02971618|Russia,|russia,
195893|NCT02971618|retrospective study,|retrospective study,
195894|NCT02971618|diabetes mellitus type 2|diabetes mellitus type 2
195895|NCT02971579|ERCP|ercp
195896|NCT02971579|biliary diseases|biliary diseases
195897|NCT02971579|Pancreatic diseases|pancreatic diseases
195898|NCT02971579|outcome|outcome
195899|NCT02971579|Quality|quality
195900|NCT02971579|Training|training
195901|NCT02971566|feeding intolerance|feeding intolerance
195902|NCT02971566|preterm infants|preterm infants
195903|NCT02971566|near infrared spectroscopy|near infrared spectroscopy
195904|NCT02971566|abnormal antenatal Doppler|abnormal antenatal doppler
195905|NCT02971540|Surgical Pleth Index (SPI)|surgical pleth index (spi)
195906|NCT02971540|General Anaesthesia (GA),|general anaesthesia (ga),
195907|NCT02971540|Numerical Rating Scale (NRS)|numerical rating scale (nrs)
195908|NCT02971540|Adequacy of Anaesthesia (AoA|adequacy of anaesthesia (aoa
195909|NCT02971540|Spectral Entropy (SE)|spectral entropy (se)
195910|NCT02971540|Local Anesthetic (LA)|local anesthetic (la)
195911|NCT02971488|Hepatitis C|hepatitis c
195912|NCT02971488|PWID|pwid
195913|NCT02971488|Linkage-to-care|linkage-to-care
195914|NCT02971475|Extracorporeal Shock Wave lithotripsy(ESWL)|extracorporeal shock wave lithotripsy(eswl)
195915|NCT02971475|Endoscopic Retrograde Cholangiopancreatography(ERCP)|endoscopic retrograde cholangiopancreatography(ercp)
195916|NCT02971475|chronic pancreatitis|chronic pancreatitis
195917|NCT02971475|pain relief|pain relief
195918|NCT02971462|stroke|stroke
195919|NCT02971462|Vertebrobasilar atherosclerosis|vertebrobasilar atherosclerosis
195920|NCT02971462|remote ischemic conditioning|remote ischemic conditioning
195921|NCT02971449|Village Healthcare Team|village healthcare team
195922|NCT02971449|mHealth|mhealth
195923|NCT02971449|Telemedicine|telemedicine
195924|NCT02971423|infection|infection
195925|NCT02971423|gram-negative bacterium|gram-negative bacterium
195926|NCT02971345|Hepatocellular carcinoma|hepatocellular carcinoma
195927|NCT02971345|main portal vein tumor thrombus|main portal vein tumor thrombus
195928|NCT02971345|endovascular brachytherapy|endovascular brachytherapy
195929|NCT02971345|stent|stent
195930|NCT02971345|chemoembolization|chemoembolization
195931|NCT02971306|alcoholic hepatitis|alcoholic hepatitis
195932|NCT02971306|alcoholic liver disease|alcoholic liver disease
195933|NCT02971306|jaundice|jaundice
195934|NCT02971306|ascites|ascites
195935|NCT02971306|regeneration|regeneration
195936|NCT02971293|AZD8871|azd8871
195937|NCT02971293|long-acting muscarinic antagonist (LAMA)|long-acting muscarinic antagonist (lama)
195938|NCT02971293|long-acting β2-agonist (LABA)|long-acting β2-agonist (laba)
195939|NCT02971293|inhaled long-acting bronchodilator|inhaled long-acting bronchodilator
195940|NCT02971293|pharmacokinetics|pharmacokinetics
195941|NCT02971293|safety|safety
195942|NCT02971293|tolerability|tolerability
195943|NCT02971293|efficacy|efficacy
195944|NCT02971293|Phase IIa|phase iia
195945|NCT02971293|Muscarinic receptor antagonist β2 adrenoceptor agonist (MABA)|muscarinic receptor antagonist β2 adrenoceptor agonist (maba)
195946|NCT02971267|heart failure|heart failure
195947|NCT02971267|cardiomyopathy|cardiomyopathy
195948|NCT02971267|myocarditis|myocarditis
195949|NCT02971254|cognitive functions|cognitive functions
195950|NCT02971254|anaesthesia recovery|anaesthesia recovery
195951|NCT02971254|sevoflurane|sevoflurane
195952|NCT02971254|desflurane|desflurane
195953|NCT02971241|Integeneration|integeneration
195954|NCT02971241|Mobile technology|mobile technology
195955|NCT02971241|Chronic disease management|chronic disease management
195956|NCT02971241|Diabetes self-management|diabetes self-management
195957|NCT02971228|glucagon|glucagon
195958|NCT02971228|T1DM|t1dm
195959|NCT02971228|Bionic Pancreas|bionic pancreas
195960|NCT02971228|diabetes|diabetes
195961|NCT02971228|iLet|ilet
195962|NCT02971228|iPhone|iphone
195963|NCT02971228|Beta Bionics|beta bionics
195964|NCT02971228|Anti-hypoglycemia|anti-hypoglycemia
195965|NCT02971228|Glucagon Analog|glucagon analog
195966|NCT02971202|o-glcnacylation|o-glcnacylation
195967|NCT02971202|hexosamine|hexosamine
195968|NCT02971163|Syncope|syncope
195969|NCT02971163|Shared Decision-Making|shared decision-making
195970|NCT02971163|Emergency Medicine|emergency medicine
195971|NCT02971163|Decision Aid|decision aid
195972|NCT02971137|Smoking|smoking
195973|NCT02971137|Cigarette Smoking|cigarette smoking
195974|NCT02971137|Veterans|veterans
195975|NCT02971137|Tobacco Use|tobacco use
195976|NCT02971137|Pain|pain
195977|NCT02971124|Cognitive Performance|cognitive performance
195978|NCT02971124|Meaningful Play|meaningful play
195979|NCT02971124|Screening test|screening test
195980|NCT02971124|Dementia|dementia
195981|NCT02971085|low-risk prostate cancer|low-risk prostate cancer
195982|NCT02971085|active surveillance|active surveillance
195983|NCT02971085|pathologic reclassification|pathologic reclassification
195984|NCT02971072|address|address
195985|NCT02971072|atrophic|atrophic
195986|NCT02971072|base|base
195987|NCT02971072|clinical|clinical
195988|NCT02971072|cost|cost
195989|NCT02971072|data|data
195990|NCT02971072|disability|disability
195991|NCT02971072|effectiveness|effectiveness
195992|NCT02971072|attention|attention
195993|NCT02971072|biofeedback|biofeedback
195994|NCT02971072|electrical stimulation|electrical stimulation
195995|NCT02971072|electromyography|electromyography
195996|NCT02971072|exercise|exercise
195997|NCT02971072|exertion|exertion
195998|NCT02971072|health care service utilization|health care service utilization
195999|NCT02971072|improved|improved
196000|NCT02971072|injection of therapeutic agent|injection of therapeutic agent
196001|NCT02971072|innovation|innovation
196002|NCT02971072|intervention|intervention
196003|NCT02971072|knowledge|knowledge
196004|NCT02971072|local anesthetics|local anesthetics
196005|NCT02971072|measures|measures
196006|NCT02971072|modeling|modeling
196007|NCT02971072|motor|motor
196008|NCT02971072|motor control|motor control
196009|NCT02971072|muscle|muscle
196010|NCT02971072|neuroadaptation|neuroadaptation
196011|NCT02971072|neurophysiology|neurophysiology
196012|NCT02971072|novel|novel
196013|NCT02971072|outcome|outcome
196014|NCT02971072|outcome measure|outcome measure
196015|NCT02971072|pain inhibition|pain inhibition
196016|NCT02971072|patients|patients
196017|NCT02971072|pattern|pattern
196018|NCT02971072|programs|programs
196019|NCT02971072|public health relevance|public health relevance
196020|NCT02971072|rehabilitation strategy|rehabilitation strategy
196021|NCT02971072|relating to nervous system|relating to nervous system
196022|NCT02971072|reporting|reporting
196023|NCT02971072|research|research
196024|NCT02971072|rotator cuff|rotator cuff
196025|NCT02971072|shoulder|shoulder
196026|NCT02971072|staging|staging
196027|NCT02971072|strength training|strength training
196028|NCT02971072|success|success
196029|NCT02971072|systematic review|systematic review
196030|NCT02971072|techniques|techniques
196031|NCT02971072|testing|testing
196032|NCT02971072|time|time
196033|NCT02971072|training|training
196034|NCT02971072|treatment strategy|treatment strategy
196035|NCT02971072|United States|united states
196036|NCT02971072|work|work
196037|NCT02971059|Elderly|elderly
196038|NCT02971059|Phenylalanine|phenylalanine
196039|NCT02971059|Healthy|healthy
196040|NCT02971046|healthy children|healthy children
196041|NCT02971046|protein|protein
196042|NCT02971046|glutathione|glutathione
196043|NCT02971046|protein requirement|protein requirement
196044|NCT02971033|hepatitis C virus|hepatitis c virus
196045|NCT02971033|antiviral treatment|antiviral treatment
196046|NCT02971033|viral entry inhibitor|viral entry inhibitor
196047|NCT02971033|mathematical modeling|mathematical modeling
196048|NCT02970994|Linear growth and neurodevelopment outcome|linear growth and neurodevelopment outcome
196049|NCT02970994|< 34 weeks|< 34 weeks
196050|NCT02970981|Monoclonal antibody|monoclonal antibody
196051|NCT02970981|Programmed Death-1 (PD-1)|programmed death-1 (pd-1)
196052|NCT02970981|Programmed Death-Ligand 1 (PD-L1)|programmed death-ligand 1 (pd-l1)
196053|NCT02970981|Cytotoxic T lymphocyte-associated antigen 4 (CTLA-4)|cytotoxic t lymphocyte-associated antigen 4 (ctla-4)
196054|NCT02970981|Antigen|antigen
196055|NCT02970929|Schizophrenia|schizophrenia
196056|NCT02970916|metastatic colorectal cancer|metastatic colorectal cancer
196057|NCT02970916|FOLFIRI|folfiri
196058|NCT02970916|aflibercept|aflibercept
196059|NCT02970916|oxaliplatin|oxaliplatin
196060|NCT02970916|ACE polymorphisms|ace polymorphisms
196061|NCT02970890|Total Hip Arthroplasty (THA)|total hip arthroplasty (tha)
196062|NCT02970890|Phototherapy|phototherapy
196063|NCT02970890|Low-level laser therapy|low-level laser therapy
196064|NCT02970890|Light-emitting diodes|light-emitting diodes
196065|NCT02970877|Fecal microbiota transplant|fecal microbiota transplant
196066|NCT02970877|Intestinal microbiome|intestinal microbiome
196067|NCT02970877|Oral microbiome|oral microbiome
196068|NCT02970877|Mucosa associated microbiome|mucosa associated microbiome
196069|NCT02970877|Appetite|appetite
196070|NCT02970877|Metabolome|metabolome
196071|NCT02970877|Depression|depression
196072|NCT02970877|Anxiety|anxiety
196073|NCT02970864|Nerve regeneration|nerve regeneration
196074|NCT02970864|Peripheral nerve injury|peripheral nerve injury
196075|NCT02970864|Nerve conduits|nerve conduits
196076|NCT02970864|Sensory nerve transection|sensory nerve transection
196077|NCT02970851|Endothelin receptor antagonist (ERA)|endothelin receptor antagonist (era)
196078|NCT02970851|pulmonary artery hypertension (PAH),|pulmonary artery hypertension (pah),
196079|NCT02970851|18F-2-fluoro-2-deoxy-D-glucose (18F-FDG) Positron Emission Tomography/Computed Tomography (PET/CT)|18f-2-fluoro-2-deoxy-d-glucose (18f-fdg) positron emission tomography/computed tomography (pet/ct)
196080|NCT02970851|Rubidium-82 (82Rb) PET/CT|rubidium-82 (82rb) pet/ct
196081|NCT02970838|Formula diet|formula diet
196082|NCT02970825|exercise medicine|exercise medicine
196083|NCT02970825|youth|youth
196084|NCT02970825|adolescents|adolescents
196085|NCT02970825|students|students
196086|NCT02970721|bipolar disorder|bipolar disorder
196087|NCT02970721|adverse outcomes|adverse outcomes
196088|NCT02970721|readmission|readmission
196089|NCT02970721|polytherapy|polytherapy
196090|NCT02970695|insomnia|insomnia
196091|NCT02970695|older people|older people
196092|NCT02970695|auriculotherapy|auriculotherapy
196093|NCT02970669|Heart failure with reduced left ventricular ejection fraction (LVEF)|heart failure with reduced left ventricular ejection fraction (lvef)
196094|NCT02970669|Cardiac dysfunction|cardiac dysfunction
196095|NCT02970669|Heart muscle dysfunction|heart muscle dysfunction
196096|NCT02970669|Left ventricular (LV) dilation|left ventricular (lv) dilation
196097|NCT02970669|Left ventricular hypertrophy|left ventricular hypertrophy
196098|NCT02970669|HF|hf
196099|NCT02970669|AHF|ahf
196100|NCT02970669|CHF|chf
196101|NCT02970669|acute heart failure|acute heart failure
196102|NCT02970669|chronic heart failure|chronic heart failure
196103|NCT02970669|congestive heart failure|congestive heart failure
196104|NCT02970669|congestive cardiac failure|congestive cardiac failure
196105|NCT02970669|Heart failure|heart failure
196106|NCT02970669|HReEF|hreef
196107|NCT02970669|Physical Activity|physical activity
196108|NCT02970669|Actigraphy|actigraphy
196109|NCT02970669|Home sleep test|home sleep test
196110|NCT02970669|wake|wake
196111|NCT02970643|Olanzapine|olanzapine
196112|NCT02970643|Chemotherapy-Induced Nausea and Vomiting|chemotherapy-induced nausea and vomiting
196113|NCT02970643|Moderate risk|moderate risk
196114|NCT02970630|prophylaxis|prophylaxis
196115|NCT02970591|FODMAPS|fodmaps
196116|NCT02970591|carbohydrates|carbohydrates
196117|NCT02970591|metabolomics|metabolomics
196118|NCT02970591|microbiota|microbiota
196119|NCT02970565|Family Nurture Intervention|family nurture intervention
196120|NCT02970565|Martha G. Welch MD|martha g. welch md
196121|NCT02970565|Randomized Control Trial|randomized control trial
196122|NCT02970565|Pre-school Intervention|pre-school intervention
196123|NCT02970565|Preschool Intervention|preschool intervention
196124|NCT02970565|Multiple Family Group Intervention|multiple family group intervention
196125|NCT02970565|Emotional Connection|emotional connection
196126|NCT02970565|Co-regulation|co-regulation
196127|NCT02970552|PreTerm Birth|preterm birth
196128|NCT02970552|HIV|hiv
196129|NCT02970552|Vaginal Progesterone|vaginal progesterone
196130|NCT02970552|ART|art
196131|NCT02970552|Adherence|adherence
196132|NCT02970552|Feasibility|feasibility
196133|NCT02970526|Colorectal cancer survivors|colorectal cancer survivors
196134|NCT02970513|Escherichia coli|escherichia coli
196135|NCT02970513|Microbiota|microbiota
196136|NCT02970513|Colorectal cancer|colorectal cancer
196137|NCT02970513|Psychiatric disorders|psychiatric disorders
196138|NCT02970513|Personality traits|personality traits
196139|NCT02970500|Cognitive impairment|cognitive impairment
196140|NCT02970500|Methylphenidate|methylphenidate
196141|NCT02970500|Cancer-related cognitive impairment|cancer-related cognitive impairment
196142|NCT02970500|Mixed method|mixed method
196143|NCT02970500|Phase II study|phase ii study
196144|NCT02970500|Breast cancer|breast cancer
196145|NCT02970487|cataract|cataract
196146|NCT02970461|personal health record|personal health record
196147|NCT02970461|gamification|gamification
196148|NCT02970461|chronic patient care|chronic patient care
196149|NCT02970448|LITT|litt
196150|NCT02970448|Brain Tumor|brain tumor
196151|NCT02970448|Temozolomide|temozolomide
196152|NCT02970435|surgery|surgery
196153|NCT02970435|video discharge instructions|video discharge instructions
196154|NCT02970422|Survey|survey
196155|NCT02970422|Priorities|priorities
196156|NCT02970422|Activities|activities
196157|NCT02970422|Participation|participation
196158|NCT02970357|Evaluation|evaluation
196159|NCT02970357|Therapeutic education|therapeutic education
196160|NCT02970357|Type 1 Diabetes|type 1 diabetes
196161|NCT02970357|Children|children
196162|NCT02970344|Coping Skills Training|coping skills training
196163|NCT02970344|Diabetes Education|diabetes education
196164|NCT02970318|CLL|cll
196165|NCT02970318|BTK|btk
196166|NCT02970318|Bruton Tyrosine Kinase|bruton tyrosine kinase
196167|NCT02970318|acalabrutinib|acalabrutinib
196168|NCT02970318|ACP-196|acp-196
196169|NCT02970279|Behavioural activation|behavioural activation
196170|NCT02970279|Psychotherapy, group|psychotherapy, group
196171|NCT02970279|Depression|depression
196172|NCT02970279|Depressive disorder|depressive disorder
196173|NCT02970266|Leber Congenital Amaurosis|leber congenital amaurosis
196174|NCT02970266|Genetic Decryption|genetic decryption
196175|NCT02970266|The genotype-phenotype correlations|the genotype-phenotype correlations
196176|NCT02970266|Ethnicity families|ethnicity families
196177|NCT02970240|cardiopulmonary exercise testing|cardiopulmonary exercise testing
196178|NCT02970240|inflammation|inflammation
196179|NCT02970240|oxidative status|oxidative status
196180|NCT02970227|heart failure|heart failure
196181|NCT02970227|cardiomyopathies|cardiomyopathies
196182|NCT02970227|myocarditis|myocarditis
196183|NCT02970214|heart failure|heart failure
196184|NCT02970214|heart disease|heart disease
196185|NCT02970214|cardiovascular disease|cardiovascular disease
196186|NCT02970214|metabolic risk|metabolic risk
196187|NCT02970214|comorbidities|comorbidities
196188|NCT02970201|eHealth|ehealth
196189|NCT02970201|mHealth|mhealth
196190|NCT02970201|Hemodialysis|hemodialysis
196191|NCT02970201|Adherence|adherence
196192|NCT02970201|Electronic intervention|electronic intervention
196193|NCT02970201|ESRD|esrd
196194|NCT02970201|Nephrology|nephrology
196195|NCT02970188|time restricted feeding|time restricted feeding
196196|NCT02970188|endothelial function|endothelial function
196197|NCT02970188|arterial stiffness|arterial stiffness
196198|NCT02970188|intermittent fasting|intermittent fasting
196199|NCT02970175|Terlipressin|terlipressin
196200|NCT02970162|LEMS|lems
196201|NCT02970136|Increased Screening Uptake|increased screening uptake
196202|NCT02970136|Community Health Worker|community health worker
196203|NCT02970136|Medically Underserved|medically underserved
196204|NCT02970097|infraclavicular brachial plexus block|infraclavicular brachial plexus block
196205|NCT02970097|wrist arthroscopy|wrist arthroscopy
196206|NCT02970097|quality of recovery score|quality of recovery score
196207|NCT02970097|pain score|pain score
196208|NCT02970097|modified sleep quality assessment|modified sleep quality assessment
196209|NCT02970071|Spatio-Temporal Image Correlation|spatio-temporal image correlation
196210|NCT02970071|Complicated congenital heart disease|complicated congenital heart disease
196211|NCT02970071|Echocardiography|echocardiography
196212|NCT02970006|spinal cord stimulation|spinal cord stimulation
196213|NCT02970006|virtual reality|virtual reality
196214|NCT02970006|full body illusion|full body illusion
196215|NCT02969980|MDS|mds
196216|NCT02969980|AML progressed from MDS|aml progressed from mds
196217|NCT02969980|CMML|cmml
196218|NCT02969967|rehabilitation|rehabilitation
196219|NCT02969967|upper extremity|upper extremity
196220|NCT02969967|orthosis|orthosis
196221|NCT02969967|SaeboFlex|saeboflex
196222|NCT02969941|Parkinson Disease|parkinson disease
196223|NCT02969941|Functional Magnetic Resonance Imaging|functional magnetic resonance imaging
196224|NCT02969941|Transcranial Magnetic Stimulation|transcranial magnetic stimulation
196225|NCT02969928|Full-mouth ultrasonic debridement|full-mouth ultrasonic debridement
196226|NCT02969928|Clarithromycin|clarithromycin
196227|NCT02969928|Amoxicillin|amoxicillin
196228|NCT02969928|Metronidazole|metronidazole
196229|NCT02969915|people who inject drugs|people who inject drugs
196230|NCT02969915|men who have sex with men|men who have sex with men
196231|NCT02969915|HIV|hiv
196232|NCT02969915|India|india
196233|NCT02969902|Procedural pain|procedural pain
196234|NCT02969902|Phlebotomy|phlebotomy
196235|NCT02969902|Distraction|distraction
196236|NCT02969902|Hand-held computer|hand-held computer
196237|NCT02969902|Children|children
196238|NCT02969889|Airtraq|airtraq
196239|NCT02969889|Intubating laryngeal mask airway|intubating laryngeal mask airway
196240|NCT02969889|BMI>35|bmi>35
196241|NCT02969863|bionic pancreas|bionic pancreas
196242|NCT02969850|vitamin D supplementation|vitamin d supplementation
196243|NCT02969850|calcium supplementation|calcium supplementation
196244|NCT02969837|Multiple Myeloma|multiple myeloma
196245|NCT02969837|Elotuzumab|elotuzumab
196246|NCT02969837|Carfilzomib (Kyprolis)|carfilzomib (kyprolis)
196247|NCT02969837|Lenalidomide (Revlimid)|lenalidomide (revlimid)
196248|NCT02969837|Dexamethasone (E-KRd)|dexamethasone (e-krd)
196249|NCT02969824|Sport Injury|sport injury
196250|NCT02969824|Concussion|concussion
196251|NCT02969824|Active Recovery|active recovery
196252|NCT02969785|Postural control|postural control
196253|NCT02969785|Physiotherapy|physiotherapy
196254|NCT02969785|Sports injuries|sports injuries
196255|NCT02969785|Low back pain|low back pain
196256|NCT02969785|training|training
196257|NCT02969759|Bioenergetics|bioenergetics
196258|NCT02969759|Protein Metabolism|protein metabolism
196259|NCT02969759|Sporadic Amyotrophic Lateral Sclerosis|sporadic amyotrophic lateral sclerosis
196260|NCT02969746|activated charcoal, direct oral anticoagulant|activated charcoal, direct oral anticoagulant
196261|NCT02969733|postoperative analgesia|postoperative analgesia
196262|NCT02969733|PainMatcher|painmatcher
196263|NCT02969707|repetitive Transcranial Magnetic Stimulation|repetitive transcranial magnetic stimulation
196264|NCT02969707|functional MRI|functional mri
196265|NCT02969707|Fibromyalgia|fibromyalgia
196266|NCT02969707|Hypnosis|hypnosis
196267|NCT02969707|Pain Assessment|pain assessment
196268|NCT02969694|addiction|addiction
196269|NCT02969694|hypersexuality|hypersexuality
196270|NCT02969694|psychostimulants|psychostimulants
196271|NCT02969668|opioid substitution treatment|opioid substitution treatment
196272|NCT02969668|interferon-free direct acting antivirals|interferon-free direct acting antivirals
196273|NCT02969668|hepatitis c therapy|hepatitis c therapy
196274|NCT02969655|Safety|safety
196275|NCT02969655|Efficacy|efficacy
196276|NCT02969655|Daprodustat|daprodustat
196277|NCT02969655|Chronic kidney disease|chronic kidney disease
196278|NCT02969616|lumbar, fusion, DDD, Trinity Elite|lumbar, fusion, ddd, trinity elite
196279|NCT02969603|PET/MRI|pet/mri
196280|NCT02969603|muscular activity|muscular activity
196281|NCT02969603|11C-acetate|11c-acetate
196282|NCT02969590|Contraception|contraception
196283|NCT02969590|Mucus|mucus
196284|NCT02969590|Cervix|cervix
196285|NCT02969590|progestin|progestin
196286|NCT02969590|hormones|hormones
196287|NCT02969577|Androgen deprivation therapy|androgen deprivation therapy
196289|NCT02969564|prostate cancer|prostate cancer
196290|NCT02969564|bone metastases|bone metastases
196291|NCT02969564|PET/MRI|pet/mri
196292|NCT02969525|Psoriatic Arthritis|psoriatic arthritis
196293|NCT02969525|PsA|psa
196294|NCT02969525|Bimekizumab|bimekizumab
196295|NCT02969512|Patient education|patient education
196296|NCT02969512|Advanced hip osteoarthritis|advanced hip osteoarthritis
196297|NCT02969512|Online education|online education
196298|NCT02969512|Computer-assisted instruction|computer-assisted instruction
196299|NCT02969512|e-learning|e-learning
196300|NCT02969512|Older adult|older adult
196301|NCT02969499|Electroconvulsive Therapy|electroconvulsive therapy
196302|NCT02969499|Dementia|dementia
196303|NCT02969473|esophageal squamous cell carcinoma|esophageal squamous cell carcinoma
196304|NCT02969473|concurrent chemoradiotherapy|concurrent chemoradiotherapy
196305|NCT02969473|docetaxel|docetaxel
196306|NCT02969473|cisplatin|cisplatin
196307|NCT02969473|5-fluorouracil|5-fluorouracil
196308|NCT02969447|Retained Placenta|retained placenta
196309|NCT02969447|Second trimester medical termination|second trimester medical termination
196310|NCT02969447|Third stage labor|third stage labor
196311|NCT02969447|Oxytocin|oxytocin
196312|NCT02969395|3T|3t
196313|NCT02969395|Magnetic Resonance Imaging (MRI)|magnetic resonance imaging (mri)
196314|NCT02969395|Implantable Cardioverter Defibrillator (ICD)|implantable cardioverter defibrillator (icd)
196315|NCT02969395|Implantable Pulse Generator (IPG)|implantable pulse generator (ipg)
196316|NCT02969395|Cardiac Resynchronization Therapy (CRT)|cardiac resynchronization therapy (crt)
196317|NCT02969395|Cardiac Implantable Electronic Device (CIED)|cardiac implantable electronic device (cied)
196318|NCT02969382|Schizophrenia|schizophrenia
196319|NCT02969369|Parkinson's Disease Psychosis|parkinson's disease psychosis
196320|NCT02969304|Tecfidera|tecfidera
196321|NCT02969304|Off-label|off-label
196322|NCT02969304|Utilization|utilization
196323|NCT02969278|vulvar cancer|vulvar cancer
196324|NCT02969278|sentinel node biopsy|sentinel node biopsy
196325|NCT02969278|inguino-femoral lymphadenectomy|inguino-femoral lymphadenectomy
251097|NCT02631993|UVA|uva
196326|NCT02969278|18F FDG- PET/TC|18f fdg- pet/tc
196327|NCT02969278|guidelines|guidelines
196328|NCT02969278|preoperative imaging|preoperative imaging
196329|NCT02969265|Drug therapy|drug therapy
196330|NCT02969226|mechanical ventilation|mechanical ventilation
196331|NCT02969226|weaning|weaning
196332|NCT02969226|critically ill|critically ill
196333|NCT02969226|spontaneous breathing trial|spontaneous breathing trial
196334|NCT02969226|screening|screening
196335|NCT02969226|invasive ventilation|invasive ventilation
196336|NCT02969226|SBT technique|sbt technique
196337|NCT02969213|Electronic management of epilepsy|electronic management of epilepsy
196338|NCT02969213|biological etiology|biological etiology
196339|NCT02969213|Chinese children|chinese children
196340|NCT02969200|Fabry Disease|fabry disease
196341|NCT02969200|Nephropathy|nephropathy
196342|NCT02969200|Measured GFR|measured gfr
196343|NCT02969200|Enzyme replacement therapy|enzyme replacement therapy
196344|NCT02969161|PMTCT (Prevention of Mother-to-Child Transmission)|pmtct (prevention of mother-to-child transmission)
196345|NCT02969161|HIV (Human Immunodeficiency Virus)|hiv (human immunodeficiency virus)
196346|NCT02969161|Loss to follow-up (LTF)|loss to follow-up (ltf)
196347|NCT02969161|Option B+ (B+)|option b+ (b+)
196348|NCT02969161|ART (antiretroviral therapy)|art (antiretroviral therapy)
196349|NCT02969148|Laparoscopic|laparoscopic
196350|NCT02969148|Bursectomy|bursectomy
196351|NCT02969148|D2 lymphadenectomy|d2 lymphadenectomy
196352|NCT02969148|Gastric Cancer|gastric cancer
196353|NCT02969122|gastric cancer|gastric cancer
196354|NCT02969122|peritoneal cytology|peritoneal cytology
196355|NCT02969083|UTUC|utuc
196356|NCT02969083|Upper Tract Urothelial Carcinoma|upper tract urothelial carcinoma
196357|NCT02969083|Neoadjuvant chemotherapy|neoadjuvant chemotherapy
196358|NCT02969083|Adjuvant chemotherapy|adjuvant chemotherapy
196359|NCT02969083|Radical nephroureterectomy|radical nephroureterectomy
196360|NCT02969057|Lipidemic Response|lipidemic response
196361|NCT02969031|communication|communication
196362|NCT02969018|plaque psoriasis|plaque psoriasis
196363|NCT02969005|radiopaque localizer grid|radiopaque localizer grid
196364|NCT02969005|methylene blue|methylene blue
196365|NCT02969005|reduce radiation exposure|reduce radiation exposure
196366|NCT02968979|Cachexia|cachexia
196367|NCT02968979|Non-Small Cell Lung cancer|non-small cell lung cancer
196368|NCT02968979|Anorexia|anorexia
196369|NCT02968979|Malnutrition|malnutrition
196370|NCT02968940|Programmed cell death protein 1 (PD-1)|programmed cell death protein 1 (pd-1)
196371|NCT02968940|Programmed death-ligand 1 (PD-L1)|programmed death-ligand 1 (pd-l1)
196372|NCT02968940|Immunotherapy|immunotherapy
196373|NCT02968940|Hypofractionated Radiotherapy (HFRT)|hypofractionated radiotherapy (hfrt)
196374|NCT02968940|Isocitrate dehydrogenase (IDH)|isocitrate dehydrogenase (idh)
196375|NCT02968940|Glioma|glioma
196376|NCT02968914|Asthma|asthma
196377|NCT02968914|Chronic Obstructive pulmonary Disease|chronic obstructive pulmonary disease
196378|NCT02968914|Pharmacokinetics|pharmacokinetics
196379|NCT02968914|Healthy volunteers|healthy volunteers
196380|NCT02968875|endurance training|endurance training
196381|NCT02968875|BDNF analysis|bdnf analysis
196382|NCT02968875|cognitive function|cognitive function
196383|NCT02968875|physiological abilities|physiological abilities
196384|NCT02968849|HIV|hiv
196385|NCT02968823|Postoperative Pain|postoperative pain
196386|NCT02968823|Anesthesia|anesthesia
196387|NCT02968823|Oral Surgery|oral surgery
196388|NCT02968784|Prostate Cancer|prostate cancer
196389|NCT02968784|MRgFUS|mrgfus
196390|NCT02968784|ExAblate|exablate
196391|NCT02968784|Focused Ultrasound|focused ultrasound
196392|NCT02968771|Coronary artery disease|coronary artery disease
196393|NCT02968771|Cardiac perfusion SPECT|cardiac perfusion spect
196394|NCT02968771|Metabolomics|metabolomics
196395|NCT02968745|Rheumatoid arthritis|rheumatoid arthritis
196396|NCT02968745|human activity|human activity
196397|NCT02968745|Canadian Occupational Performance Measure|canadian occupational performance measure
196398|NCT02968706|High Flow Nasal Cannula|high flow nasal cannula
196399|NCT02968706|Colonoscopy|colonoscopy
196400|NCT02968706|Obesity|obesity
196401|NCT02968654|Blood Transfusion|blood transfusion
196402|NCT02968654|Brain Injury|brain injury
196403|NCT02968654|Outcome|outcome
196404|NCT02968654|Hemoglobin|hemoglobin
196405|NCT02968615|fiber|fiber
196406|NCT02968615|lean protein|lean protein
196407|NCT02968615|loss weight|loss weight
196408|NCT02968589|Tele-rehabilitation|tele-rehabilitation
196409|NCT02968589|Function|function
196410|NCT02968589|Quality of life|quality of life
196411|NCT02968589|Exercise|exercise
196412|NCT02968589|Occupational Therapy|occupational therapy
196413|NCT02968589|Physiotherapy|physiotherapy
196414|NCT02968589|Caregiver burden|caregiver burden
196415|NCT02968576|healthy volunteers|healthy volunteers
196416|NCT02968576|pharmacokinetics|pharmacokinetics
196417|NCT02968537|Alcohol use disorders|alcohol use disorders
196418|NCT02968537|inhibition|inhibition
196419|NCT02968537|EEG|eeg
196420|NCT02968537|cortisol|cortisol
196421|NCT02968537|Training|training
196422|NCT02968537|clinical outcome measures|clinical outcome measures
196423|NCT02968498|Blood glucose level|blood glucose level
196424|NCT02968498|Oral intake|oral intake
196425|NCT02968498|Lactulose|lactulose
196426|NCT02968498|Healthy volunteers|healthy volunteers
196427|NCT02968485|advanced solid tumor|advanced solid tumor
196428|NCT02968485|Protein Kinase MEK inhibitor (MEKi)|protein kinase mek inhibitor (meki)
196429|NCT02968485|Safety|safety
196430|NCT02968485|Pharmacokinetics|pharmacokinetics
196431|NCT02968472|4s CAR-T19|4s car-t19
196432|NCT02968472|B cell leukemia|b cell leukemia
196433|NCT02968472|B-ALL|b-all
196434|NCT02968459|Mesenchymal Stem Cells|mesenchymal stem cells
196435|NCT02968459|Cesarean Section|cesarean section
196436|NCT02968459|Uterine Scar|uterine scar
196437|NCT02968446|Valchlor|valchlor
196438|NCT02968446|Vitamin D|vitamin d
196837|NCT02965690|Dynamic RSA|dynamic rsa
196439|NCT02968446|Healthy Volunteer|healthy volunteer
196440|NCT02968433|Young Male Plasma|young male plasma
196441|NCT02968381|tobacco|tobacco
196442|NCT02968381|smoking|smoking
196443|NCT02968381|imagery|imagery
196444|NCT02968342|Hypoactive sexual desire disorder|hypoactive sexual desire disorder
196445|NCT02968212|Mycobacterium avium Complex|mycobacterium avium complex
196446|NCT02968212|Clofazimine|clofazimine
196447|NCT02968186|Mass Screening|mass screening
196448|NCT02968186|Counseling|counseling
196449|NCT02968186|Primary Health Care|primary health care
196450|NCT02968173|Bronchopulmonary dysplasia (BPD)|bronchopulmonary dysplasia (bpd)
196451|NCT02968173|RSV hospitalization|rsv hospitalization
196452|NCT02968173|Palivizumab|palivizumab
196453|NCT02968173|Immunoprophylaxis|immunoprophylaxis
196454|NCT02968173|Chronic lung disease (CLD) of prematurity|chronic lung disease (cld) of prematurity
196455|NCT02968147|atrial fibrillation|atrial fibrillation
196456|NCT02968147|catheter ablation|catheter ablation
196457|NCT02968147|general anaesthesia|general anaesthesia
196458|NCT02968082|MVD|mvd
196459|NCT02968082|Scopolamine|scopolamine
196460|NCT02968082|Microvascular Decompression|microvascular decompression
196461|NCT02968056|atrial fibrillation|atrial fibrillation
196462|NCT02968056|radiofrequency ablation|radiofrequency ablation
196463|NCT02968043|physiotherapeutic scoliosis specific exercise|physiotherapeutic scoliosis specific exercise
196464|NCT02968030|Aged|aged
196465|NCT02968030|Postural balance|postural balance
196466|NCT02968030|Muscle strength|muscle strength
196467|NCT02967991|EUS|eus
196468|NCT02967991|Biopsy|biopsy
196469|NCT02967991|Liver|liver
196470|NCT02967991|FNA|fna
196471|NCT02967991|FNB|fnb
196472|NCT02967978|risk factors|risk factors
196473|NCT02967978|Calcium isotopes|calcium isotopes
196474|NCT02967978|calcium turnover|calcium turnover
196475|NCT02967978|DXA|dxa
196476|NCT02967965|clinical confounders|clinical confounders
196477|NCT02967965|myocardial infarction size|myocardial infarction size
196478|NCT02967965|determinants of myocardial infarct injury|determinants of myocardial infarct injury
196479|NCT02967952|out-of-hospital cardiac arrest (OHCA)|out-of-hospital cardiac arrest (ohca)
196480|NCT02967952|supraglottic airway (SGA)|supraglottic airway (sga)
196481|NCT02967952|endotracheal intubation (ETI)|endotracheal intubation (eti)
196482|NCT02967952|emergency medical system (EMS)|emergency medical system (ems)
196483|NCT02967952|Supraglottic Airway Versus Endotracheal tube (SAVE)|supraglottic airway versus endotracheal tube (save)
196484|NCT02967926|common bile duct stone|common bile duct stone
196485|NCT02967926|cholangioscopy|cholangioscopy
196486|NCT02967926|SpyGlass|spyglass
196487|NCT02967926|non-fluoroscopic|non-fluoroscopic
196488|NCT02967913|Cesarean delivery|cesarean delivery
196489|NCT02967913|Obstetrical delivery|obstetrical delivery
196490|NCT02967913|PFDI-20|pfdi-20
196491|NCT02967913|UDI-6|udi-6
196492|NCT02967913|Bladder flap|bladder flap
196493|NCT02967874|Adipose -Derived Stromal Vascular Fraction Cells|adipose -derived stromal vascular fraction cells
196494|NCT02967874|Knee Osteoarthritis|knee osteoarthritis
196495|NCT02967874|Intra-articular Administration|intra-articular administration
196496|NCT02967874|Liposuction|liposuction
196497|NCT02967861|chronic periodontitis|chronic periodontitis
196498|NCT02967861|Nuclear factor-kappa B|nuclear factor-kappa b
196499|NCT02967861|Pranayama|pranayama
196500|NCT02967861|Peroxisome proliferator - activated receptor gamma|peroxisome proliferator - activated receptor gamma
196501|NCT02967861|Red complex microorganisms|red complex microorganisms
196502|NCT02967848|Radiotherapy|radiotherapy
196503|NCT02967848|Mebrofenin|mebrofenin
196504|NCT02967848|Liver|liver
196505|NCT02967848|Cancer|cancer
196506|NCT02967848|SPECT|spect
196507|NCT02967770|Metastatic|metastatic
196508|NCT02967770|Pancreas|pancreas
196509|NCT02967770|Cancer|cancer
196510|NCT02967705|Pain Management|pain management
196511|NCT02967705|Chronic Pain|chronic pain
196512|NCT02967705|Health Services|health services
196513|NCT02967705|Occupational Health|occupational health
196514|NCT02967692|Spartalizumab (PDR001)|spartalizumab (pdr001)
196515|NCT02967692|dabrafenib|dabrafenib
196516|NCT02967692|trametinib|trametinib
196517|NCT02967692|melanoma|melanoma
196518|NCT02967692|immunotherapy|immunotherapy
196519|NCT02967692|PD 1 inhibitor|pd 1 inhibitor
196520|NCT02967692|anti PD1|anti pd1
196521|NCT02967692|PD-1|pd-1
196522|NCT02967692|anti-PD-1|anti-pd-1
196523|NCT02967692|combination treatment|combination treatment
196524|NCT02967692|malignant skin cancer|malignant skin cancer
196525|NCT02967692|skin cancer|skin cancer
196526|NCT02967692|BRAF V600|braf v600
196527|NCT02967692|unresectable BRAF V600 mutated melanoma|unresectable braf v600 mutated melanoma
196528|NCT02967692|metastatic BRAF V600 mutated melanoma|metastatic braf v600 mutated melanoma
196529|NCT02967679|Neuropathy|neuropathy
196530|NCT02967679|Demyelinating polyradiculoneuropathy|demyelinating polyradiculoneuropathy
196531|NCT02967640|Ketamine|ketamine
196532|NCT02967640|Analgesics|analgesics
196533|NCT02967640|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists
196534|NCT02967640|Receptors, Glutamate|receptors, glutamate
196535|NCT02967640|Shoulder|shoulder
196838|NCT02965690|Fluoroscopy|fluoroscopy
196536|NCT02967601|shivering, cesarean section, anxiety, STAI|shivering, cesarean section, anxiety, stai
196537|NCT02967588|Medication adherence|medication adherence
196538|NCT02967588|Behavioural intervention|behavioural intervention
196539|NCT02967588|Acute coronary syndrome|acute coronary syndrome
196540|NCT02967588|Medication beliefs|medication beliefs
196541|NCT02967588|Implementation intentions|implementation intentions
196542|NCT02967575|cervical total disc replacement (cTDR)|cervical total disc replacement (ctdr)
196543|NCT02967536|cognitive function|cognitive function
196544|NCT02967536|microglia|microglia
196545|NCT02967536|neuroinflammation|neuroinflammation
196546|NCT02967523|Hepatocellular carcinoma|hepatocellular carcinoma
196547|NCT02967523|DEB-TACE|deb-tace
196548|NCT02967497|Chemotherapy|chemotherapy
196549|NCT02967497|Herbal medicine|herbal medicine
196550|NCT02967497|Lung cancer|lung cancer
196551|NCT02967484|Acupuncture|acupuncture
196552|NCT02967484|Hypertension|hypertension
196553|NCT02967484|Second prevention of Stroke|second prevention of stroke
196554|NCT02967484|Efficacy|efficacy
196555|NCT02967484|RCT|rct
196556|NCT02967484|Study protocol|study protocol
196557|NCT02967471|ARDS|ards
196558|NCT02967458|prostate cancer|prostate cancer
196559|NCT02967458|prostate ultrasound|prostate ultrasound
196560|NCT02967458|subharmonic imaging|subharmonic imaging
196561|NCT02967458|prostate biopsy|prostate biopsy
196562|NCT02967432|Staphylococcus aureus|staphylococcus aureus
196563|NCT02967432|Staphylococcal colonization|staphylococcal colonization
196564|NCT02967432|Staphylococcal infection|staphylococcal infection
196565|NCT02967432|Mupirocin|mupirocin
196566|NCT02967432|Mupirocin-resistance|mupirocin-resistance
196567|NCT02967419|Repeated Implantation Failure; TWEAK;Fn14;JAK/STAT3;Indoleamine 2,3-dioxygenase|repeated implantation failure; tweak;fn14;jak/stat3;indoleamine 2,3-dioxygenase
196568|NCT02967406|Lifestyle modification|lifestyle modification
196569|NCT02967406|Primary prevention|primary prevention
196570|NCT02967406|Community-based intervention|community-based intervention
196571|NCT02967406|Randomized control trial|randomized control trial
196572|NCT02967328|Reticulated Platelets|reticulated platelets
196573|NCT02967328|Immune Thrombocytopenia|immune thrombocytopenia
196574|NCT02967302|knee arthritis, morphine, local injection, pain|knee arthritis, morphine, local injection, pain
196575|NCT02967289|colon|colon
196576|NCT02967289|cancer|cancer
196577|NCT02967289|stage 3|stage 3
196578|NCT02967289|high-risk|high-risk
196579|NCT02967289|mFolfirinox|mfolfirinox
196580|NCT02967289|mFolfox6|mfolfox6
196581|NCT02967289|adjuvant|adjuvant
196582|NCT02967276|Metformin|metformin
196583|NCT02967276|Dexamethasone|dexamethasone
196584|NCT02967276|Multiple Myeloma|multiple myeloma
196585|NCT02967263|Acute Kidney Injury|acute kidney injury
196586|NCT02967263|Proteinosis|proteinosis
196587|NCT02967263|Epidemiology|epidemiology
196588|NCT02967263|Risk factors|risk factors
196589|NCT02967198|Fusion|fusion
196590|NCT02967198|Ablation|ablation
196591|NCT02967198|Percutaneous biopsy|percutaneous biopsy
196592|NCT02967198|Shear wave elastography|shear wave elastography
196593|NCT02967159|chronic obstructive pulmonary disease (COPD)|chronic obstructive pulmonary disease (copd)
196594|NCT02967159|asthma|asthma
196595|NCT02967107|adenoma|adenoma
196596|NCT02967107|colorectal cancer|colorectal cancer
196597|NCT02967107|polypectomy|polypectomy
196598|NCT02967107|colonoscopy|colonoscopy
196599|NCT02967081|Pulpitis|pulpitis
196600|NCT02967081|Biomarker|biomarker
196601|NCT02967081|Diagnostic|diagnostic
196602|NCT02967081|Dentinal fluid|dentinal fluid
196603|NCT02967068|CSS|css
196604|NCT02967068|EGPA|egpa
196605|NCT02967068|GCA|gca
196606|NCT02967068|GPA|gpa
196607|NCT02967068|MPA|mpa
196608|NCT02967068|PAN|pan
196609|NCT02967068|TAK|tak
196610|NCT02967068|HSP|hsp
196611|NCT02966951|osteoarthrosis|osteoarthrosis
196612|NCT02966951|knee|knee
196613|NCT02966951|adipose tissue|adipose tissue
196614|NCT02966951|stem cells|stem cells
196615|NCT02966951|cell therapy|cell therapy
196616|NCT02966925|Vulvovaginal dryness|vulvovaginal dryness
196617|NCT02966886|Surgical Management|surgical management
196618|NCT02966873|Post Traumatic Stress Disorder (PTSD)|post traumatic stress disorder (ptsd)
196619|NCT02966873|Addiction|addiction
196620|NCT02966873|Alcohol Use Disorder|alcohol use disorder
196621|NCT02966873|Cognitive Behavioral Therapy|cognitive behavioral therapy
196622|NCT02966873|N-acetylcysteine (NAC)|n-acetylcysteine (nac)
196623|NCT02966847|Video assisted thoracoscopy|video assisted thoracoscopy
196624|NCT02966847|Cone beam computed tomography|cone beam computed tomography
196625|NCT02966834|PBC|pbc
196626|NCT02966834|itch|itch
196627|NCT02966834|GSK2330672|gsk2330672
196628|NCT02966834|GLIMMER|glimmer
196629|NCT02966834|primary biliary cholangitis|primary biliary cholangitis
196630|NCT02966834|pruritus|pruritus
196631|NCT02966821|Surufatinib|surufatinib
196632|NCT02966821|Biliary Tract Cancer|biliary tract cancer
196633|NCT02966821|Second-line|second-line
196634|NCT02966795|glecaprevir|glecaprevir
196635|NCT02966795|pibrentasvir|pibrentasvir
196636|NCT02966795|compensated cirrhosis|compensated cirrhosis
197233|NCT02963051|Disulfiram|disulfiram
196637|NCT02966795|non-cirrhotic|non-cirrhotic
196638|NCT02966795|interferon (IFN)|interferon (ifn)
196639|NCT02966795|pegylated interferon (pegIFN)|pegylated interferon (pegifn)
196640|NCT02966795|ribavirin (RBV)|ribavirin (rbv)
196641|NCT02966795|sofosbuvir (SOF)|sofosbuvir (sof)
196642|NCT02966795|Sustained Virologic Response 12 weeks post dosing (SVR12)|sustained virologic response 12 weeks post dosing (svr12)
196643|NCT02966795|Chronic|chronic
196644|NCT02966795|Genotype 5 or 6 Infection|genotype 5 or 6 infection
196645|NCT02966782|Relapsed/refractory|relapsed/refractory
196646|NCT02966782|Venetoclax|venetoclax
196647|NCT02966782|Azacitidine|azacitidine
196648|NCT02966756|Relapsed chronic lymphocytic leukemia (CLL)|relapsed chronic lymphocytic leukemia (cll)
196649|NCT02966756|Refractory chronic lymphocytic leukemia (CLL)|refractory chronic lymphocytic leukemia (cll)
196650|NCT02966756|17p deletion|17p deletion
196651|NCT02966756|venetoclax|venetoclax
196652|NCT02966756|Leukemia|leukemia
196653|NCT02966756|Lymphoproliferative Disorders|lymphoproliferative disorders
196654|NCT02966730|follicular lymphoma|follicular lymphoma
196655|NCT02966730|Ibrutinib|ibrutinib
196656|NCT02966730|FLIPP|flipp
196657|NCT02966730|16-396|16-396
196658|NCT02966717|Rituximab|rituximab
196659|NCT02966717|Mesenchymal stem cells|mesenchymal stem cells
196660|NCT02966717|primary nephrotic syndrome|primary nephrotic syndrome
196661|NCT02966717|chronic kidney disease|chronic kidney disease
196662|NCT02966678|Glaucoma, Dychromatopsia|glaucoma, dychromatopsia
196663|NCT02966652|Male|male
196664|NCT02966652|Hypogonadism|hypogonadism
196665|NCT02966652|Primary|primary
196666|NCT02966652|Secondary|secondary
196667|NCT02966652|Androgen deficiency|androgen deficiency
196668|NCT02966626|Pragmatic, Sodium-Glucose Transporter 2 inhibitor, Malaysia|pragmatic, sodium-glucose transporter 2 inhibitor, malaysia
196669|NCT02966574|Whole body MRI|whole body mri
196670|NCT02966574|Breastcancer|breastcancer
196671|NCT02966561|Pulmonary Rehabilitation|pulmonary rehabilitation
196672|NCT02966561|Physical Activity|physical activity
196673|NCT02966561|Behaviour Change|behaviour change
196674|NCT02966561|Pedometer|pedometer
196675|NCT02966522|Thalidoide|thalidoide
196676|NCT02966483|Rectal cancer|rectal cancer
196677|NCT02966483|Laparoscopic surgery|laparoscopic surgery
196678|NCT02966483|Total mesorectal excision|total mesorectal excision
196679|NCT02966483|Transanal|transanal
196680|NCT02966483|Multicentre randomised clinical trial|multicentre randomised clinical trial
196681|NCT02966470|surgical outcomes|surgical outcomes
196682|NCT02966457|hematological infection, decolonization|hematological infection, decolonization
196683|NCT02966418|Hypoxic preconditioning|hypoxic preconditioning
196684|NCT02966418|Carotid artery stenosis|carotid artery stenosis
196685|NCT02966418|Ischemic cerebrovascular disease|ischemic cerebrovascular disease
196686|NCT02966392|Cuff pressure|cuff pressure
196687|NCT02966392|Ventilator associated pneumonia|ventilator associated pneumonia
196688|NCT02966392|Respiratory tract infections|respiratory tract infections
196689|NCT02966379|Electroacoustic stimulation|electroacoustic stimulation
196690|NCT02966353|Ruxolitinib|ruxolitinib
196691|NCT02966353|anemia|anemia
196692|NCT02966353|Primary Myelofibrosis|primary myelofibrosis
196693|NCT02966353|PMF|pmf
196694|NCT02966353|Post-Polycythemia Vera-Myelofibrosis|post-polycythemia vera-myelofibrosis
196695|NCT02966353|PPV-MF|ppv-mf
196696|NCT02966353|Post-Essential Thrombocythemia Myelofibrosis|post-essential thrombocythemia myelofibrosis
196697|NCT02966353|PET-MF|pet-mf
196698|NCT02966340|Alcoholism|alcoholism
196699|NCT02966340|Prazosin|prazosin
196700|NCT02966340|Startle Potentiation|startle potentiation
196701|NCT02966340|Norepinephrine|norepinephrine
196702|NCT02966340|Anxiety|anxiety
196703|NCT02966340|Fear|fear
196704|NCT02966340|Stress|stress
196705|NCT02966314|Angioedema|angioedema
196706|NCT02966314|Idiopathic Angioedema|idiopathic angioedema
196707|NCT02966314|IAE|iae
196708|NCT02966301|c GvHD|c gvhd
196709|NCT02966301|Arsenic Trioxyde|arsenic trioxyde
196710|NCT02966301|Hematology|hematology
196711|NCT02966275|glucagon|glucagon
196712|NCT02966275|continuous glucose monitorering (CGM)|continuous glucose monitorering (cgm)
196713|NCT02966275|artificial pancreas|artificial pancreas
196714|NCT02966275|hypoglycemia|hypoglycemia
196715|NCT02966275|post-bariatric hypoglycemia|post-bariatric hypoglycemia
196716|NCT02966275|bionic pancreas|bionic pancreas
196717|NCT02966275|bariatric surgery|bariatric surgery
196718|NCT02966249|dexmetomidine, intrathecally, intavenously,anesthesia|dexmetomidine, intrathecally, intavenously,anesthesia
196719|NCT02966236|percutaneous nephrolithotomy|percutaneous nephrolithotomy
196720|NCT02966171|Advanced Solid Malignancies|advanced solid malignancies
196721|NCT02966158|Aerobic Interval Training|aerobic interval training
196722|NCT02966158|Fitness|fitness
196723|NCT02966158|Endothelial Function|endothelial function
196724|NCT02966158|Cognition|cognition
196725|NCT02966145|CBD|cbd
196726|NCT02966145|CBS|cbs
196727|NCT02966145|CBGD|cbgd
196728|NCT02966145|PSP|psp
196729|NCT02966145|nfvPPA|nfvppa
196730|NCT02966145|oPSP|opsp
196731|NCT02966145|vPSP|vpsp
196732|NCT02966145|o/vPSP|o/vpsp
196733|NCT02966145|Corticobasal Degeneration|corticobasal degeneration
196734|NCT02966145|Corticobasal Syndrome|corticobasal syndrome
196735|NCT02966145|Cortocal-basal Ganglionic Degeneration|cortocal-basal ganglionic degeneration
196736|NCT02966145|Progressive Supranuclear Palsy|progressive supranuclear palsy
196737|NCT02966145|Nonfluent Variant Primary Progressive Aphasia|nonfluent variant primary progressive aphasia
196738|NCT02966145|Oligosymptomatic Progressive Supranuclear Palsy|oligosymptomatic progressive supranuclear palsy
196739|NCT02966145|Variant Progressive Supranuclear Palsy|variant progressive supranuclear palsy
196740|NCT02966145|Biomarker|biomarker
196741|NCT02966145|Neuroimaging|neuroimaging
196742|NCT02966145|MRI|mri
196743|NCT02966145|PET|pet
196744|NCT02966145|Tau|tau
196745|NCT02966145|Oculomotor|oculomotor
196746|NCT02966145|Retinal Imaging|retinal imaging
196747|NCT02966132|Asian American|asian american
196748|NCT02966132|Immigrant Health|immigrant health
196749|NCT02966132|Digital Health Intervention|digital health intervention
196750|NCT02966132|Federally Qualified Health Centers|federally qualified health centers
196751|NCT02966119|stroke|stroke
196752|NCT02966119|intracranial hemorrhage|intracranial hemorrhage
196753|NCT02966119|intracerebral hemorrhage|intracerebral hemorrhage
196754|NCT02966119|antithrombotic drugs|antithrombotic drugs
196755|NCT02966119|brain microbleeds|brain microbleeds
196756|NCT02966093|Differentiated thyroid cancer|differentiated thyroid cancer
196757|NCT02966093|Chinese participants|chinese participants
196758|NCT02966093|Phase 3|phase 3
196759|NCT02966093|Lenvatinib|lenvatinib
196760|NCT02966093|E7080|e7080
196761|NCT02966080|extracorporeal membrane oxygenation|extracorporeal membrane oxygenation
196762|NCT02966080|intravenous heparin|intravenous heparin
196763|NCT02966067|Microneedles|microneedles
196764|NCT02966067|Dental Anaesthesia|dental anaesthesia
196765|NCT02966041|Postoperative Nausea and Vomiting|postoperative nausea and vomiting
196766|NCT02966041|PONV|ponv
196767|NCT02966041|CSICU|csicu
196768|NCT02966041|post-cardiac surgery|post-cardiac surgery
196769|NCT02966041|cardiac intensive care unit|cardiac intensive care unit
196770|NCT02966028|CAC|cac
196771|NCT02966028|calcium|calcium
196772|NCT02966028|ESRD|esrd
196773|NCT02966028|calcification|calcification
196774|NCT02966028|cardiovascular|cardiovascular
196775|NCT02966028|heart|heart
196776|NCT02966028|kidney|kidney
196777|NCT02966028|hemodialysis|hemodialysis
196778|NCT02966028|Agatston|agatston
196779|NCT02965989|nursery care|nursery care
196780|NCT02965989|nursery infection|nursery infection
196781|NCT02965989|online learning|online learning
196782|NCT02965950|breast cancer|breast cancer
196783|NCT02965950|TP53|tp53
196784|NCT02965950|cyclophosphamide|cyclophosphamide
196785|NCT02965937|Attentively embracing story|attentively embracing story
196786|NCT02965937|story-centred care|story-centred care
196787|NCT02965937|heart rate variability|heart rate variability
196788|NCT02965937|cognitive function|cognitive function
196789|NCT02965911|UDCA, Fenofibrate|udca, fenofibrate
196790|NCT02965898|chronic pancreatitis|chronic pancreatitis
196791|NCT02965898|vitamin d|vitamin d
196792|NCT02965898|pancreatitis|pancreatitis
196793|NCT02965898|Pancreatic stellate cell|pancreatic stellate cell
196794|NCT02965898|rct|rct
196795|NCT02965885|Phase I|phase i
196796|NCT02965885|Solid Tumors|solid tumors
196797|NCT02965885|Pharmacokinetics|pharmacokinetics
196798|NCT02965885|Pharmacodynamics|pharmacodynamics
196799|NCT02965885|MTD|mtd
196800|NCT02965885|TAS116|tas116
196801|NCT02965885|HSP90 Inhibitor|hsp90 inhibitor
196802|NCT02965885|Neoplasms|neoplasms
196803|NCT02965885|HER2 positive MBC|her2 positive mbc
196804|NCT02965885|NSCLC EGFR|nsclc egfr
196805|NCT02965885|NSCLC ALK positive|nsclc alk positive
196806|NCT02965872|Postural Balance|postural balance
196807|NCT02965859|Chronic Hepatitis B|chronic hepatitis b
196808|NCT02965846|EDE|ede
196809|NCT02965846|evaporative dry eye|evaporative dry eye
251611|NCT02629107|Sleep|sleep
196810|NCT02965833|Contact lens induced dryness|contact lens induced dryness
196811|NCT02965820|Contact lens induced dryness|contact lens induced dryness
196812|NCT02965807|Bronchial Thermoplasty|bronchial thermoplasty
196813|NCT02965807|moderate asthma|moderate asthma
196814|NCT02965807|China|china
196815|NCT02965794|surgery|surgery
196816|NCT02965794|bowel|bowel
196817|NCT02965794|rectum|rectum
196818|NCT02965794|cancer|cancer
196819|NCT02965794|nutrition|nutrition
196820|NCT02965755|Metastatic Breast Cancer|metastatic breast cancer
196821|NCT02965755|Breast Cancer|breast cancer
196822|NCT02965755|Molecular profiling|molecular profiling
196823|NCT02965755|Personalized medicine|personalized medicine
196824|NCT02965742|DXA|dxa
196825|NCT02965742|DMS|dms
196826|NCT02965742|DMS Imaging|dms imaging
196827|NCT02965742|STRATOS|stratos
196828|NCT02965742|Horizon A|horizon a
196829|NCT02965742|QDR4500A|qdr4500a
196830|NCT02965729|behavior goals|behavior goals
196831|NCT02965729|self-monitoring|self-monitoring
196832|NCT02965729|pedometer|pedometer
196833|NCT02965729|physical activity|physical activity
196834|NCT02965690|Total Knee Arthroplasty (TKA)|total knee arthroplasty (tka)
196835|NCT02965690|TKR|tkr
196836|NCT02965690|Knee kinematics|knee kinematics
196839|NCT02965690|Roentgen Fluoroscopic Stereophotogrammetric Analysis|roentgen fluoroscopic stereophotogrammetric analysis
196840|NCT02965677|drug eluting balloon|drug eluting balloon
196841|NCT02965677|Femoral Popliteal Artery|femoral popliteal artery
196842|NCT02965651|embodied conversational agent|embodied conversational agent
196843|NCT02965651|virtual patient agent|virtual patient agent
196844|NCT02965651|meditation|meditation
196845|NCT02965651|mindfulness based stress reduction|mindfulness based stress reduction
196846|NCT02965651|nutrition|nutrition
196848|NCT02965612|Grass Allergy|grass allergy
196849|NCT02965612|Allergic Rhinitis|allergic rhinitis
196850|NCT02965612|Allergic Asthma|allergic asthma
196851|NCT02965612|Paediatric|paediatric
196852|NCT02965599|pharmacodynamics|pharmacodynamics
196853|NCT02965599|tolerability|tolerability
196854|NCT02965599|GSK3117391|gsk3117391
196855|NCT02965599|safety|safety
196856|NCT02965599|efficacy|efficacy
196857|NCT02965599|rheumatoid arthritis|rheumatoid arthritis
196858|NCT02965599|pharmacokinetics|pharmacokinetics
196859|NCT02965547|Ischemic Preconditioning|ischemic preconditioning
196860|NCT02965547|dynamic cerebral autoregulation|dynamic cerebral autoregulation
196861|NCT02965534|night vision|night vision
196862|NCT02965534|mesopic visual acuity|mesopic visual acuity
196863|NCT02965534|aberrometry|aberrometry
196864|NCT02965534|mesopic spectacle correction|mesopic spectacle correction
196865|NCT02965534|night myopia|night myopia
196866|NCT02965508|Home-bound|home-bound
196867|NCT02965508|home-based primary care|home-based primary care
196868|NCT02965495|Osteoarthritis|osteoarthritis
196869|NCT02965482|methacholine, airway hyperresponsiveness|methacholine, airway hyperresponsiveness
196870|NCT02965417|Resistance to anti-EGFR monoclonal antibodies|resistance to anti-egfr monoclonal antibodies
196871|NCT02965417|Mutation of ECD-EGFR|mutation of ecd-egfr
196872|NCT02965404|live attenuated varicella vaccine|live attenuated varicella vaccine
196873|NCT02965404|safety|safety
196874|NCT02965404|adult|adult
196875|NCT02965404|adolescent|adolescent
196876|NCT02965404|child|child
196877|NCT02965391|Circulating Tumor DNA|circulating tumor dna
196878|NCT02965391|Half time|half time
196879|NCT02965391|Lung cancer|lung cancer
196880|NCT02965391|Surgery|surgery
196881|NCT02965391|Surveillance|surveillance
196882|NCT02965339|Vasoplegia|vasoplegia
196883|NCT02965339|endothelial dysfunction|endothelial dysfunction
196884|NCT02965339|extracorporeal circulation|extracorporeal circulation
196885|NCT02965339|cardiac surgery|cardiac surgery
196886|NCT02965300|Pulmonary lesion|pulmonary lesion
196887|NCT02965300|Volatile Organic Compositions(VOCs)|volatile organic compositions(vocs)
196888|NCT02965248|Locally advanced colorectal cancer|locally advanced colorectal cancer
196889|NCT02965248|Hyperthermic intraperitoneal chemotherapy|hyperthermic intraperitoneal chemotherapy
196890|NCT02965222|blastocyst|blastocyst
196891|NCT02965222|pregnancy rate|pregnancy rate
196892|NCT02965209|endoscopy|endoscopy
196893|NCT02965209|small bowel endoscopy|small bowel endoscopy
196894|NCT02965209|motorized spiral endoscopy|motorized spiral endoscopy
196895|NCT02965209|spiral endoscopy|spiral endoscopy
196896|NCT02965144|long-term survivors, high-grade glioma|long-term survivors, high-grade glioma
196897|NCT02965079|extracorporeal CO2 removal|extracorporeal co2 removal
196898|NCT02965079|registry|registry
196899|NCT02965079|COPD and ARDS|copd and ards
196900|NCT02965079|CEDIT on behalf of APHP|cedit on behalf of aphp
196901|NCT02965040|ASP1517|asp1517
196902|NCT02965040|Normal renal function|normal renal function
196903|NCT02965040|Dialysis|dialysis
196904|NCT02965040|Roxadustat|roxadustat
196905|NCT02965040|Metabolites|metabolites
196906|NCT02965040|Pharmacokinetics|pharmacokinetics
196907|NCT02965040|Impaired renal function|impaired renal function
196908|NCT02965027|Chronic Headache|chronic headache
196909|NCT02965027|Post-Traumatic Stress Disorder|post-traumatic stress disorder
196910|NCT02965027|Iraq/Afghanistan Veteran|iraq/afghanistan veteran
196911|NCT02965014|Human Immunodeficiency Virus (HIV)|human immunodeficiency virus (hiv)
196912|NCT02965014|Sexually transmitted infections (STI)|sexually transmitted infections (sti)
196913|NCT02965014|mHealth|mhealth
196914|NCT02965014|Substance abuse|substance abuse
196915|NCT02965014|Violence|violence
196916|NCT02965014|Victimization|victimization
196917|NCT02965014|Sexual Risk|sexual risk
196918|NCT02965001|Molecular Imaging|molecular imaging
196919|NCT02965001|uPAR-PET/CT|upar-pet/ct
196920|NCT02965001|Head and neck cancer|head and neck cancer
196921|NCT02965001|curative intended radiotherapy|curative intended radiotherapy
196922|NCT02964949|Nonvalvular Atrial Fibrillation|nonvalvular atrial fibrillation
196923|NCT02964949|High Creatinine Clearance|high creatinine clearance
196924|NCT02964949|Developmental Phase III|developmental phase iii
196925|NCT02964949|Anticoagulant Naïve|anticoagulant naïve
196926|NCT02964936|Anemia|anemia
196927|NCT02964936|Non-dialysis chronic kidney disease|non-dialysis chronic kidney disease
196928|NCT02964936|Roxadustat|roxadustat
196929|NCT02964936|ASP1517|asp1517
196930|NCT02964923|Genetic polymorphism|genetic polymorphism
196931|NCT02964923|Metabolic side effects of drugs|metabolic side effects of drugs
196932|NCT02964923|schizophrenia|schizophrenia
196933|NCT02964923|Second-Generation Antipsychotic|second-generation antipsychotic
196934|NCT02964923|Cannabinoid Receptor Type 1|cannabinoid receptor type 1
196935|NCT02964910|Hepatitis E|hepatitis e
196936|NCT02964897|justice involvement|justice involvement
196937|NCT02964897|Homeless|homeless
196938|NCT02964897|Vulnerable Populations|vulnerable populations
196939|NCT02964897|Linkage to care|linkage to care
196940|NCT02964897|Veterans|veterans
196941|NCT02964884|Neurofibromatosis Type 1|neurofibromatosis type 1
196942|NCT02964884|Learning Disability|learning disability
196943|NCT02964884|Reading Disability|reading disability
196945|NCT02964871|Long-term care facility|long-term care facility
196946|NCT02964871|Elderly|elderly
196947|NCT02964858|Radiation Dose|radiation dose
196948|NCT02964858|Optimization|optimization
196949|NCT02964858|NHL|nhl
196950|NCT02964858|DLBCL|dlbcl
196951|NCT02964858|R-CHOP|r-chop
196952|NCT02964832|Basic Cardiac Life Support, Education, Feedback|basic cardiac life support, education, feedback
196953|NCT02964793|Fetal Growth Restriction|fetal growth restriction
196954|NCT02964793|Customised Fetal Weight Reference|customised fetal weight reference
196955|NCT02964793|Estimated fetal Weight|estimated fetal weight
196956|NCT02964793|Symphysis Fundal Height|symphysis fundal height
196957|NCT02964767|HIV|hiv
196958|NCT02964767|HIV-Tb co infection|hiv-tb co infection
196959|NCT02964767|CD4 Cell|cd4 cell
196960|NCT02964741|Episodic Migraine|episodic migraine
196961|NCT02964741|Headache|headache
196962|NCT02964741|Opioid|opioid
196963|NCT02964689|Advanced non-small cell lung cancer|advanced non-small cell lung cancer
196964|NCT02964689|KRAS mutations|kras mutations
196965|NCT02964689|Binimetinib|binimetinib
196966|NCT02964689|Pemetrexed|pemetrexed
196967|NCT02964689|Cisplatin|cisplatin
196968|NCT02964689|Phase IB trial|phase ib trial
196969|NCT02964624|Osteoarthritis|osteoarthritis
196970|NCT02964624|biomarkers|biomarkers
196971|NCT02964624|HMGB1|hmgb1
196972|NCT02964624|knee|knee
196973|NCT02964598|Adolescent|adolescent
196974|NCT02964598|Population-based|population-based
196975|NCT02964598|Social jetlag|social jetlag
196976|NCT02964598|Intervention|intervention
196977|NCT02964598|Bright light|bright light
196978|NCT02964598|Motivation|motivation
196979|NCT02964598|Circadian regulation|circadian regulation
196980|NCT02964598|Behavioral change|behavioral change
196981|NCT02964585|Type 2 Diabetes Mellitus|type 2 diabetes mellitus
196982|NCT02964585|Endothelial Cells|endothelial cells
196983|NCT02964585|Cellular Biomarker|cellular biomarker
196984|NCT02964585|Endothelial Dysfunction|endothelial dysfunction
196985|NCT02964585|CD34+|cd34+
196986|NCT02964585|Impaired renal function|impaired renal function
196987|NCT02964546|direct oral anticoagulants|direct oral anticoagulants
196988|NCT02964546|atrial fibrillation|atrial fibrillation
196989|NCT02964546|renal function|renal function
196990|NCT02964546|ckd-epi|ckd-epi
196991|NCT02964546|plasmatic concentration|plasmatic concentration
196992|NCT02964520|trait anxiety|trait anxiety
196993|NCT02964520|A/T neurofeedback|a/t neurofeedback
196994|NCT02964520|EEG biofeedback|eeg biofeedback
196995|NCT02964520|randomized|randomized
196996|NCT02964507|GSK525762|gsk525762
196997|NCT02964507|HR+/HER2- advanced or metastatic breast cancer|hr+/her2- advanced or metastatic breast cancer
196998|NCT02964507|mTPI|mtpi
196999|NCT02964481|malignant|malignant
197000|NCT02964481|genetics|genetics
197001|NCT02964481|RYR1|ryr1
197002|NCT02964481|CAC-NA1S|cac-na1s
197003|NCT02964481|hyperthermia|hyperthermia
197004|NCT02964468|Rectal Cancer|rectal cancer
197005|NCT02964468|IMRT|imrt
197006|NCT02964468|Radiation Dose Escalation|radiation dose escalation
197007|NCT02964455|Esophageal squamous cell carcinoma|esophageal squamous cell carcinoma
197008|NCT02964455|Chemoradiotherapy|chemoradiotherapy
197009|NCT02964455|Docetaxel|docetaxel
197010|NCT02964455|Nedaplatin|nedaplatin
197011|NCT02964455|Twice weekly|twice weekly
197012|NCT02964416|supratentorial craniotomy|supratentorial craniotomy
197013|NCT02964416|extubation response|extubation response
197014|NCT02964416|emergence|emergence
197015|NCT02964416|tramadol|tramadol
197016|NCT02964403|COX-2|cox-2
197017|NCT02964403|ERCP|ercp
197018|NCT02964403|Pancreatitis|pancreatitis
197019|NCT02964390|CTEPH|cteph
197020|NCT02964390|balloon pulmonary angioplasty|balloon pulmonary angioplasty
197021|NCT02964377|Pediatric|pediatric
197022|NCT02964377|muscle disease|muscle disease
197023|NCT02964377|Duchenne muscular dystrophy|duchenne muscular dystrophy
197024|NCT02964377|cardiomyopathy|cardiomyopathy
197025|NCT02964364|TAKAYASU ARTERITIS|takayasu arteritis
197026|NCT02964351|MicroRNA|microrna
197027|NCT02964351|Prostate Carcinoma|prostate carcinoma
197028|NCT02964351|PET-MR|pet-mr
197029|NCT02964325|hypoproliferative thrombocytopenia|hypoproliferative thrombocytopenia
197030|NCT02964325|hematologic malignancies|hematologic malignancies
197031|NCT02964325|thrombocytopenia|thrombocytopenia
197032|NCT02964325|platelet therapy|platelet therapy
197033|NCT02964325|apheresis|apheresis
197034|NCT02964325|pathogen reduction therapy|pathogen reduction therapy
197035|NCT02964312|nasal valve collapse|nasal valve collapse
197036|NCT02964312|absorbable nasal implant|absorbable nasal implant
197037|NCT02964299|Gastrointestinal endoscopy|gastrointestinal endoscopy
197038|NCT02964299|Moderate sedation|moderate sedation
197039|NCT02964299|Airway management|airway management
197040|NCT02964286|Cancer|cancer
197041|NCT02964286|Acupressure|acupressure
197042|NCT02964286|Hematopoietic Cell Growth Factors|hematopoietic cell growth factors
197043|NCT02964273|Autosomal Dominant Polycystic Kidney Disease|autosomal dominant polycystic kidney disease
197044|NCT02964273|ADPKD|adpkd
197045|NCT02964273|Tolvaptan|tolvaptan
197046|NCT02964273|Renal cysts|renal cysts
197047|NCT02964273|Chronic Kidney Disease|chronic kidney disease
197048|NCT02964273|Genetic Kidney Disease|genetic kidney disease
197049|NCT02964260|HCC; Embolization; Ablation; simultaneously; sequentially|hcc; embolization; ablation; simultaneously; sequentially
197050|NCT02964234|Mammography Screening|mammography screening
197051|NCT02964234|Latinas|latinas
197052|NCT02964234|Breast cancer disparities|breast cancer disparities
197053|NCT02964208|Atrial Fibrillation|atrial fibrillation
197054|NCT02964208|Thromboembolism|thromboembolism
197055|NCT02964208|Stroke|stroke
197056|NCT02964208|ACP|acp
197057|NCT02964208|Left Atrial Appendage|left atrial appendage
197058|NCT02964208|Cardiac Plug|cardiac plug
197059|NCT02964208|Amulet|amulet
197060|NCT02964208|Amplatzer|amplatzer
197061|NCT02964156|RA|ra
197062|NCT02964156|Insole|insole
197063|NCT02964156|Forefoot|forefoot
197064|NCT02964156|Walking Ability|walking ability
197065|NCT02964156|Pain|pain
197066|NCT02964117|Chronic Obstructive Pulmonary Disease|chronic obstructive pulmonary disease
197067|NCT02964091|Hepatitis C Virus|hepatitis c virus
197068|NCT02964091|sofosbuvir/ledipasvir|sofosbuvir/ledipasvir
197069|NCT02964091|Efficacy|efficacy
197070|NCT02964078|Kidney Disease|kidney disease
197071|NCT02964078|Metastatic|metastatic
197072|NCT02964078|Antibody|antibody
197073|NCT02964065|Influenza Vaccines|influenza vaccines
197074|NCT02964065|LAIV|laiv
197075|NCT02964039|stroke|stroke
197076|NCT02964039|rehabilitation|rehabilitation
197077|NCT02964039|gait|gait
197078|NCT02964026|pulmonary artery catheter|pulmonary artery catheter
197079|NCT02964026|Swan-Ganz catheter|swan-ganz catheter
197080|NCT02964013|Programmed Cell Death Receptor 1 (PD-1)|programmed cell death receptor 1 (pd-1)
197081|NCT02964013|Programmed Cell Death Receptor Ligand 1 (PD-L1)|programmed cell death receptor ligand 1 (pd-l1)
197082|NCT02964013|Programmed Cell Death Receptor Ligand 2 (PD-L2)|programmed cell death receptor ligand 2 (pd-l2)
197083|NCT02964013|PD-1|pd-1
197084|NCT02964013|PDL1|pdl1
197085|NCT02964013|PD-L1|pd-l1
197086|NCT02964013|PD-L2|pd-l2
197087|NCT02964000|Pain|pain
197088|NCT02964000|Low level laser therapy|low level laser therapy
197089|NCT02964000|Sham|sham
197090|NCT02964000|Chronic Pain|chronic pain
197091|NCT02964000|Opioid|opioid
197092|NCT02964000|Physical activity|physical activity
197093|NCT02964000|Quality of sleep|quality of sleep
197094|NCT02963974|cochlear implant|cochlear implant
197095|NCT02963961|Delirium|delirium
197096|NCT02963961|Cognition|cognition
197097|NCT02963961|Prehabilitation|prehabilitation
197098|NCT02963961|Neuroplasticity|neuroplasticity
197099|NCT02963909|Adjuvant|adjuvant
197100|NCT02963909|Alum|alum
197101|NCT02963909|Inactivated|inactivated
197102|NCT02963909|Purified|purified
197103|NCT02963909|Vaccine|vaccine
197104|NCT02963909|Virus|virus
197105|NCT02963909|Zika|zika
197106|NCT02963896|vestibular rehabilitation|vestibular rehabilitation
197107|NCT02963883|ScVO2|scvo2
197108|NCT02963883|Post operative red cell transfusion|post operative red cell transfusion
197109|NCT02963870|Cognitive behavioral|cognitive behavioral
197110|NCT02963870|security plan|security plan
197111|NCT02963870|suicidal Recidivism in adolescents|suicidal recidivism in adolescents
197112|NCT02963857|breast surgery|breast surgery
197113|NCT02963857|acute pain|acute pain
197114|NCT02963857|regional anesthesia|regional anesthesia
197115|NCT02963831|Oncos-102|oncos-102
197116|NCT02963831|Durvalumab|durvalumab
197117|NCT02963831|Peritoneal|peritoneal
197118|NCT02963831|Cyclophosphamide|cyclophosphamide
197119|NCT02963818|Brief intervention|brief intervention
197120|NCT02963818|Harm reduction|harm reduction
197121|NCT02963818|Young adult|young adult
197122|NCT02963818|College Student|college student
197123|NCT02963805|Children|children
197124|NCT02963805|Physical activity|physical activity
197125|NCT02963805|Physical competence|physical competence
197126|NCT02963805|Obesity|obesity
197127|NCT02963805|School|school
197128|NCT02963805|Health|health
197129|NCT02963805|Fundamental movement skills|fundamental movement skills
197130|NCT02963792|Professionalism|professionalism
197131|NCT02963792|Burnout prevention|burnout prevention
197132|NCT02963792|Resiliency|resiliency
197133|NCT02963792|Student education|student education
197134|NCT02963766|Pediatrics|pediatrics
197135|NCT02963753|Hyperemesis gravidarum|hyperemesis gravidarum
197136|NCT02963753|gestational diabetes mellitus|gestational diabetes mellitus
197234|NCT02962999|Ketamine|ketamine
197137|NCT02963753|oral glucose tolerance test|oral glucose tolerance test
197138|NCT02963740|breast cancer survivor|breast cancer survivor
197139|NCT02963740|weight loss program|weight loss program
197140|NCT02963727|osteoarthrosis|osteoarthrosis
197141|NCT02963727|Knee|knee
197142|NCT02963727|Wharton Jelly|wharton jelly
197143|NCT02963714|Hepatitis B, Vaccine|hepatitis b, vaccine
197144|NCT02963714|Randomized Controlled Trial|randomized controlled trial
197145|NCT02963714|Hemodialysis|hemodialysis
197146|NCT02963714|Immunogenicity|immunogenicity
197147|NCT02963662|obesity|obesity
197148|NCT02963662|bariatric surgery|bariatric surgery
197149|NCT02963662|gut hormones|gut hormones
197150|NCT02963662|inflammatory adipokine|inflammatory adipokine
197151|NCT02963649|Drug-eluting angioplasty balloon, Drug coated angioplasty balloon, Experimental, percutaneous transluminal angioplasty (PTA)|drug-eluting angioplasty balloon, drug coated angioplasty balloon, experimental, percutaneous transluminal angioplasty (pta)
197152|NCT02963636|family medicine group|family medicine group
197153|NCT02963636|pharmacists|pharmacists
197154|NCT02963636|primary health care|primary health care
197155|NCT02963636|pharmaceutical services|pharmaceutical services
197156|NCT02963636|interprofessional relations|interprofessional relations
197157|NCT02963623|fibtem|fibtem
197158|NCT02963623|total knee replacement|total knee replacement
197159|NCT02963584|chronic total occlusion|chronic total occlusion
197160|NCT02963584|decision aid|decision aid
197161|NCT02963506|AS|as
197162|NCT02963506|Ankylosing Spondylitis|ankylosing spondylitis
197163|NCT02963506|Bimekizumab|bimekizumab
197164|NCT02963493|relapsed refractory multiple myeloma|relapsed refractory multiple myeloma
197165|NCT02963467|multiple inert gas elimination technique|multiple inert gas elimination technique
197166|NCT02963467|smoking|smoking
197167|NCT02963467|pulmonary disorder|pulmonary disorder
197168|NCT02963441|Diabetic Retinopathy|diabetic retinopathy
197169|NCT02963441|Macular Edema|macular edema
197170|NCT02963415|Subjective memory complaint|subjective memory complaint
197171|NCT02963363|Breast cancer|breast cancer
197172|NCT02963363|HER2+|her2+
197173|NCT02963363|Adapted physical activity|adapted physical activity
197174|NCT02963363|Neoadjuvant chemotherapy|neoadjuvant chemotherapy
197175|NCT02963337|remifentanil|remifentanil
197176|NCT02963337|combined spinal-epidural analgesia|combined spinal-epidural analgesia
197177|NCT02963337|multiparous|multiparous
197178|NCT02963272|Heart failure|heart failure
197179|NCT02963272|ST2|st2
197180|NCT02963272|fibrosis|fibrosis
197181|NCT02963246|mindfulness|mindfulness
197182|NCT02963246|quality of life|quality of life
197183|NCT02963246|Bowel Disease|bowel disease
197184|NCT02963207|colorectal polyp|colorectal polyp
197185|NCT02963207|colorectal lesion|colorectal lesion
197186|NCT02963207|Modified Sano's Classification|modified sano's classification
197187|NCT02963207|NICE classification|nice classification
197188|NCT02963207|NBI|nbi
197189|NCT02963207|PIVI guidelines|pivi guidelines
197190|NCT02963207|SSA/P|ssa/p
197191|NCT02963207|sessile serrated adenoma|sessile serrated adenoma
197192|NCT02963207|sessile serrated polyp|sessile serrated polyp
197193|NCT02963194|self-processing|self-processing
197194|NCT02963194|endowment effect|endowment effect
197195|NCT02963194|neuroimage|neuroimage
197196|NCT02963181|Melatonin|melatonin
197197|NCT02963181|Yohimbine|yohimbine
197198|NCT02963181|Anti-hypertensive agents|anti-hypertensive agents
197199|NCT02963155|prostate, metastatic|prostate, metastatic
197200|NCT02963142|Intensive care|intensive care
197201|NCT02963142|Extra-corporeal membrane oxygenation (ECMO)|extra-corporeal membrane oxygenation (ecmo)
197202|NCT02963142|Severe Respiratory Infections|severe respiratory infections
197203|NCT02963142|Sequencing|sequencing
197204|NCT02963142|Metagenome|metagenome
197205|NCT02963142|Diagnosis|diagnosis
197206|NCT02963129|Hereditary Hemorrhagic Telangiectasia|hereditary hemorrhagic telangiectasia
197207|NCT02963129|Epistaxis|epistaxis
197208|NCT02963116|Pharmacokinetics (PK)|pharmacokinetics (pk)
197209|NCT02963116|Bioavailability (BA)|bioavailability (ba)
197210|NCT02963116|Safety|safety
197211|NCT02963116|Tolerability|tolerability
197212|NCT02963116|Healthy Volunteers|healthy volunteers
197213|NCT02963103|Tacrolimus|tacrolimus
197214|NCT02963103|Kidney transplantation|kidney transplantation
197215|NCT02963090|SCLC|sclc
197216|NCT02963090|small cell lung cancer|small cell lung cancer
197217|NCT02963090|lung cancer|lung cancer
197218|NCT02963090|topotecan|topotecan
197219|NCT02963090|pembrolizumab|pembrolizumab
197220|NCT02963064|Immunodeficiency|immunodeficiency
197221|NCT02963064|Pediatric|pediatric
197222|NCT02963064|SCID|scid
197223|NCT02963064|Bone Marrow Transplantation|bone marrow transplantation
197224|NCT02963064|GVHD|gvhd
197225|NCT02963064|Stem Cells|stem cells
197226|NCT02963064|Chimerism|chimerism
197227|NCT02963064|Transplant|transplant
197228|NCT02963064|BMT|bmt
197229|NCT02963051|metastatic castrate-resistant prostate cancer (mCRPC)|metastatic castrate-resistant prostate cancer (mcrpc)
197230|NCT02963051|neuroendocrine prostate cancer (NEPC)|neuroendocrine prostate cancer (nepc)
197231|NCT02963051|adenocarcinoma castrate-resistant prostate cancer (CRPC)|adenocarcinoma castrate-resistant prostate cancer (crpc)
197232|NCT02963051|Copper|copper
197235|NCT02962999|One lung ventilation|one lung ventilation
197236|NCT02962999|Chronic obstructive pulmonary disease|chronic obstructive pulmonary disease
197237|NCT02962986|vasopressor|vasopressor
197238|NCT02962986|blood pressure|blood pressure
197239|NCT02962986|cesarean section|cesarean section
197240|NCT02962986|spinal anesthesia|spinal anesthesia
197241|NCT02962973|Advanced heart failure|advanced heart failure
197242|NCT02962973|Total artificial heart|total artificial heart
197243|NCT02962947|Melanoma|melanoma
197244|NCT02962947|Propanolol|propanolol
197245|NCT02962947|Betablockers|betablockers
197246|NCT02962908|broad|broad
197247|NCT02962908|universal|universal
197248|NCT02962908|vaccine|vaccine
197249|NCT02962908|influenza|influenza
197250|NCT02962908|peptide|peptide
197251|NCT02962908|Tcell|tcell
197252|NCT02962908|UNISEC|unisec
197253|NCT02962895|Sjogren, VAY736, ianalumab|sjogren, vay736, ianalumab
197254|NCT02962843|Behavior Problem|behavior problem
197255|NCT02962843|Social Competence|social competence
197256|NCT02962843|Student|student
197257|NCT02962843|Children|children
197258|NCT02962830|fetal pain|fetal pain
197259|NCT02962830|fetal analgesia|fetal analgesia
197260|NCT02962804|kidney|kidney
197261|NCT02962804|renal cell|renal cell
197262|NCT02962804|cancer|cancer
197263|NCT02962804|metastatic|metastatic
197264|NCT02962804|recurrent|recurrent
197265|NCT02962791|symptomatic heart failure|symptomatic heart failure
197266|NCT02962778|treatment-resistant|treatment-resistant
197267|NCT02962739|healthy volunteers|healthy volunteers
197268|NCT02962726|Anorexia|anorexia
197269|NCT02962726|Depression|depression
197270|NCT02962726|Microbiome|microbiome
197271|NCT02962713|Atraumatic Restorative Treatment|atraumatic restorative treatment
197272|NCT02962713|glass ionomer cement|glass ionomer cement
197273|NCT02962713|primary teeth|primary teeth
197274|NCT02962713|dental caries.|dental caries.
197275|NCT02962700|continuous haemofiltration|continuous haemofiltration
197276|NCT02962700|intermittent haemodialysis|intermittent haemodialysis
197277|NCT02962687|Veterans|veterans
197278|NCT02962687|Cognitive impairments|cognitive impairments
197279|NCT02962687|Nursing care management|nursing care management
197280|NCT02962687|Videoconferencing|videoconferencing
197281|NCT02962674|BPH|bph
197282|NCT02962661|Other forms of heart disease|other forms of heart disease
197283|NCT02962661|Left ventricular dysfunction|left ventricular dysfunction
197284|NCT02962661|LV|lv
197285|NCT02962661|Heart failure secondary to chemotherapy with anthracyclines|heart failure secondary to chemotherapy with anthracyclines
197286|NCT02962661|Human mesenchymal stem cells|human mesenchymal stem cells
197287|NCT02962661|hMSCs|hmscs
197288|NCT02962661|Mesenchymal Stromal Cells|mesenchymal stromal cells
197289|NCT02962661|MSCs|mscs
197290|NCT02962661|Intravenous infusion|intravenous infusion
197291|NCT02962661|Transendocardial injection|transendocardial injection
197292|NCT02962661|Standard of care drugs for heart failure|standard of care drugs for heart failure
197293|NCT02962648|IDA|ida
197294|NCT02962622|Neurocognition|neurocognition
197295|NCT02962622|Exercise|exercise
197296|NCT02962622|Metabolism|metabolism
197297|NCT02962622|Hispanic women|hispanic women
197298|NCT02962609|Feeding|feeding
197299|NCT02962609|preterm infant|preterm infant
197300|NCT02962609|physiological characteristics|physiological characteristics
197301|NCT02962609|position|position
197302|NCT02962609|ESL|esl
197303|NCT02962609|ESU|esu
197304|NCT02962557|ventilatory depression|ventilatory depression
197305|NCT02962544|Femtosecond|femtosecond
197306|NCT02962544|Small incision lenticule extraction|small incision lenticule extraction
197307|NCT02962544|Lenticule extraction|lenticule extraction
197308|NCT02962544|LASIK|lasik
197309|NCT02962544|Myopia|myopia
197310|NCT02962518|Pressure Device|pressure device
197311|NCT02962518|Clip|clip
197312|NCT02962518|Triamcinolone|triamcinolone
197313|NCT02962518|Fillet Technique|fillet technique
197314|NCT02962492|Dapagliflozin|dapagliflozin
197315|NCT02962492|Ketogenesis|ketogenesis
197316|NCT02962492|Type 1 Diabetes|type 1 diabetes
197317|NCT02962492|DKA|dka
197318|NCT02962492|ketones|ketones
197319|NCT02962492|exenatide/Bydureon|exenatide/bydureon
197320|NCT02962414|Everolimus|everolimus
197321|NCT02962414|Tuberous sclerosis complex|tuberous sclerosis complex
197322|NCT02962414|TSC|tsc
197323|NCT02962414|Refractory seizure|refractory seizure
197324|NCT02962414|Roll over study|roll over study
197325|NCT02962414|Long term safety|long term safety
197326|NCT02962414|PASS|pass
197327|NCT02962388|efficacy|efficacy
197328|NCT02962388|safety|safety
197329|NCT02962375|orange pomace fiber|orange pomace fiber
197330|NCT02962375|glycemic response|glycemic response
197331|NCT02962297|Vitamin E, Non Diabetic|vitamin e, non diabetic
197332|NCT02962271|Musculoskeletal Ultrasound|musculoskeletal ultrasound
197333|NCT02962271|Psoriatic Arthritis|psoriatic arthritis
197334|NCT02962271|Enthesopathy|enthesopathy
197335|NCT02962245|Ulcerative Colitis|ulcerative colitis
197336|NCT02962245|Berberine|berberine
197337|NCT02962232|drug eluting balloon|drug eluting balloon
197828|NCT02959294|Headaches|headaches
197338|NCT02962232|arterial vasculature below the knee|arterial vasculature below the knee
197339|NCT02962219|oesophagectomy|oesophagectomy
197340|NCT02962193|ADL|adl
197341|NCT02962193|Bariatric surgery|bariatric surgery
197342|NCT02962193|Daily participation|daily participation
197343|NCT02962180|derma-rolling system, vitiligo|derma-rolling system, vitiligo
197344|NCT02962167|measles virus|measles virus
197345|NCT02962167|recurrent medulloblastoma|recurrent medulloblastoma
197346|NCT02962167|recurrent ATRT|recurrent atrt
197347|NCT02962154|Invasive Coronary Angiography|invasive coronary angiography
197348|NCT02962154|Myocardial Infarction|myocardial infarction
197349|NCT02962154|Major Depressive Disorder|major depressive disorder
197350|NCT02962154|Bipolar I Disorder|bipolar i disorder
197351|NCT02962154|Bipolar II Disorder|bipolar ii disorder
197352|NCT02962154|Mental Stress|mental stress
197353|NCT02962141|drug eluting balloon, Arteriovenous Fistulae|drug eluting balloon, arteriovenous fistulae
197354|NCT02962089|Protein-energy wasting|protein-energy wasting
197355|NCT02962089|Hemodialysis patients|hemodialysis patients
197356|NCT02962089|Microbiota|microbiota
197357|NCT02962089|Branched chain amino acids|branched chain amino acids
197358|NCT02962089|Undernutrition|undernutrition
197359|NCT02962089|Malnutrition|malnutrition
197360|NCT02962089|Renal failure|renal failure
197361|NCT02962089|Dialysis|dialysis
197362|NCT02962089|Protein|protein
197363|NCT02962089|Appetite|appetite
197364|NCT02962089|Body composition|body composition
197365|NCT02962089|Energy expenditure|energy expenditure
197366|NCT02962063|Durvalumab|durvalumab
197367|NCT02962063|Anti-PD-L1 Antibody|anti-pd-l1 antibody
197368|NCT02962063|16-1405|16-1405
197369|NCT02962011|Cesarean, incision, suture,|cesarean, incision, suture,
197370|NCT02961998|hepatocellular carcinoma|hepatocellular carcinoma
197371|NCT02961998|sorafenib|sorafenib
197372|NCT02961998|celecoxib|celecoxib
197373|NCT02961972|vegetarianism|vegetarianism
197374|NCT02961972|Hyperhomocysteinemia|hyperhomocysteinemia
197375|NCT02961972|vegan vegetarian|vegan vegetarian
197376|NCT02961933|hypoxemia|hypoxemia
197377|NCT02961933|intubation|intubation
197378|NCT02961933|apneic oxygenation|apneic oxygenation
197379|NCT02961907|periconceptional habits|periconceptional habits
197380|NCT02961907|Pregnancy|pregnancy
197381|NCT02961907|Infertility|infertility
197382|NCT02961894|Atherectomy|atherectomy
197383|NCT02961894|Atherosclerosis|atherosclerosis
197384|NCT02961868|Renal Artery Obstruction|renal artery obstruction
197385|NCT02961868|Carotid Artery Diseases|carotid artery diseases
197386|NCT02961868|Genetic Association Studies|genetic association studies
197387|NCT02961829|Dendritic Cell vaccination using|dendritic cell vaccination using
197388|NCT02961829|antiretroviral intensification|antiretroviral intensification
197389|NCT02961829|Auranofin|auranofin
197390|NCT02961829|Histone Deacetylase Inhibitor|histone deacetylase inhibitor
197391|NCT02961829|residual viral replication|residual viral replication
197392|NCT02961829|HIV sanctuaries|hiv sanctuaries
197393|NCT02961829|HIV latency|hiv latency
197394|NCT02961816|Lymphoma|lymphoma
197395|NCT02961816|Refractory/Relapsed Lymphoma|refractory/relapsed lymphoma
197396|NCT02961816|Diffuse large B-cell lymphoma|diffuse large b-cell lymphoma
197397|NCT02961816|Hodgkin's lymphoma|hodgkin's lymphoma
197398|NCT02961816|T-cell Lymphoma|t-cell lymphoma
197399|NCT02961816|Palifermin|palifermin
197400|NCT02961816|Kepivance|kepivance
197401|NCT02961816|Panobinostat|panobinostat
252415|NCT02624947|RSV|rsv
197402|NCT02961816|LBH589B|lbh589b
197403|NCT02961816|Gemcitabine|gemcitabine
197404|NCT02961816|Gemcitabine Hydrochloride|gemcitabine hydrochloride
197405|NCT02961816|Gemzar|gemzar
197406|NCT02961816|Busulfan|busulfan
197407|NCT02961816|Busulfex|busulfex
197408|NCT02961816|Myleran|myleran
197409|NCT02961816|Melphalan|melphalan
197410|NCT02961816|Alkeran|alkeran
197411|NCT02961816|Rituximab|rituximab
197412|NCT02961816|Rituxan|rituxan
197413|NCT02961816|Dexamethasone|dexamethasone
197414|NCT02961816|Decadron|decadron
197415|NCT02961816|Caphosol|caphosol
197416|NCT02961816|Glutamine|glutamine
197417|NCT02961816|Enterex|enterex
197418|NCT02961816|Glutapak-10|glutapak-10
197419|NCT02961816|NutreStore|nutrestore
197420|NCT02961816|Resource|resource
197421|NCT02961816|GlutaSolve|glutasolve
197422|NCT02961816|Sympt-X G.I.|sympt-x g.i.
197423|NCT02961816|Sympt-X|sympt-x
197424|NCT02961816|Pyridoxine|pyridoxine
197425|NCT02961816|G-CSF|g-csf
197426|NCT02961816|Filgrastim|filgrastim
197427|NCT02961816|Neupogen|neupogen
197428|NCT02961816|Stem cell transplant|stem cell transplant
197429|NCT02961803|AMN|amn
197430|NCT02961803|MD1003|md1003
197431|NCT02961803|Adrenomyeloneuropathy|adrenomyeloneuropathy
197432|NCT02961803|ALD|ald
197433|NCT02961803|Adrenoleukodystrophy|adrenoleukodystrophy
197434|NCT02961803|Biotin|biotin
197435|NCT02961803|2MWT|2mwt
197436|NCT02961803|Two-minute walk test|two-minute walk test
197437|NCT02961803|TW25|tw25
197438|NCT02961803|Timed 25-Foot Walk|timed 25-foot walk
197439|NCT02961764|Critical Pathways|critical pathways
197440|NCT02961764|Health Facilities|health facilities
197931|NCT02958527|Depression|depression
197441|NCT02961764|Clinical Protocols|clinical protocols
197442|NCT02961764|Patient Satisfaction|patient satisfaction
197443|NCT02961764|Absenteeism|absenteeism
197444|NCT02961764|Anti-Bacterial Agents|anti-bacterial agents
197445|NCT02961764|Quality of Life|quality of life
197446|NCT02961764|Economics, Medical|economics, medical
197447|NCT02961764|Health Resources|health resources
197448|NCT02961764|Health resource utilization|health resource utilization
197449|NCT02961764|Acute bacterial skin and skin structure infection (ABSSSI)|acute bacterial skin and skin structure infection (absssi)
197450|NCT02961751|Ciprofloxacin-susceptibility|ciprofloxacin-susceptibility
197451|NCT02961751|Efficacy|efficacy
197452|NCT02961751|Gyrase A Assay|gyrase a assay
197453|NCT02961751|Neisseria gonorrhoeae|neisseria gonorrhoeae
197454|NCT02961647|Hemodynamic stress test|hemodynamic stress test
197455|NCT02961647|Surgical intervention|surgical intervention
197456|NCT02961634|onychomycosis|onychomycosis
197457|NCT02961634|nail|nail
197458|NCT02961595|Oral polio vaccine|oral polio vaccine
197459|NCT02961595|Inactivated polio vaccine|inactivated polio vaccine
197460|NCT02961595|Enterovirus|enterovirus
197461|NCT02961595|Type 1 diabetes|type 1 diabetes
197462|NCT02961595|Autoantibody|autoantibody
197463|NCT02961582|Sacral neuromodulation|sacral neuromodulation
197464|NCT02961582|Constipation|constipation
197465|NCT02961582|Slow-transit constipation|slow-transit constipation
197466|NCT02961582|Surgery|surgery
197467|NCT02961582|Colorectal surgery|colorectal surgery
197468|NCT02961582|Cost-effectiveness|cost-effectiveness
197469|NCT02961582|Quality of life|quality of life
197470|NCT02961556|AJG555|ajg555
197471|NCT02961556|Constipation|constipation
197472|NCT02961556|Phase 3|phase 3
197473|NCT02961556|Pediatric participants|pediatric participants
197474|NCT02961491|MIBG|mibg
197475|NCT02961491|Azedra|azedra
197476|NCT02961491|Rare neuroendocrine tumors|rare neuroendocrine tumors
197477|NCT02961491|Iobenguane I 131|iobenguane i 131
197478|NCT02961491|Progenics|progenics
197479|NCT02961465|Sacral neuromodulation|sacral neuromodulation
197480|NCT02961465|Constipation|constipation
197481|NCT02961465|Slow-transit constipation|slow-transit constipation
197482|NCT02961465|Surgery|surgery
197483|NCT02961465|Colorectal surgery|colorectal surgery
197484|NCT02961465|Cost-effectiveness|cost-effectiveness
197485|NCT02961465|Quality of life|quality of life
197486|NCT02961387|Tracheal stenosis, Hydrogen generator, Hydrogen-oxygen, Dyspnea.|tracheal stenosis, hydrogen generator, hydrogen-oxygen, dyspnea.
197487|NCT02961361|dexmedetomidine|dexmedetomidine
197488|NCT02961361|coracoid|coracoid
197489|NCT02961361|brachial plexus block|brachial plexus block
197490|NCT02961348|Oral anticoagulants (NOAC)|oral anticoagulants (noac)
197491|NCT02961309|THC|thc
197492|NCT02961309|marijuana|marijuana
197493|NCT02961309|tobacco cigarette|tobacco cigarette
197494|NCT02961309|smoking|smoking
197495|NCT02961296|Helicobacter Pylori|helicobacter pylori
197496|NCT02961283|BRAF Kinases|braf kinases
197497|NCT02961283|PIK3CA protein, human|pik3ca protein, human
197498|NCT02961244|Surgical Site Infection|surgical site infection
197499|NCT02961244|normothermia|normothermia
197500|NCT02961244|hypothermia|hypothermia
197501|NCT02961244|prewarming|prewarming
197502|NCT02961231|Pneumococcal conjugate vaccine|pneumococcal conjugate vaccine
197503|NCT02961231|Herd immunity|herd immunity
197504|NCT02961231|Reduced dosing schedule|reduced dosing schedule
197505|NCT02961218|Sickle cell disease|sickle cell disease
197506|NCT02961218|hemoglobinopathy|hemoglobinopathy
197507|NCT02961218|pediatric|pediatric
197508|NCT02961166|IVIG|ivig
197509|NCT02961166|ARDS|ards
197510|NCT02961166|ECMO|ecmo
197511|NCT02961140|Outcome|outcome
197512|NCT02961127|tissue factor pathway inhibitor|tissue factor pathway inhibitor
197513|NCT02961114|Prostatitis, Chronic|prostatitis, chronic
197514|NCT02961114|Nocturia|nocturia
197515|NCT02961114|BPH With Urinary Obstruction|bph with urinary obstruction
197516|NCT02961101|relapsed or refractory|relapsed or refractory
197517|NCT02961101|malignancies|malignancies
197518|NCT02961101|decitabine|decitabine
197519|NCT02961101|anti-PD-1 antibody|anti-pd-1 antibody
197520|NCT02961101|chemotherapy|chemotherapy
197521|NCT02961088|Systematic review and meta-analysis|systematic review and meta-analysis
197522|NCT02961088|Evidence-based medicine (EBM)|evidence-based medicine (ebm)
197523|NCT02961088|Evidence-based nutrition (EBN)|evidence-based nutrition (ebn)
197524|NCT02961088|Clinical practice guidelines|clinical practice guidelines
197525|NCT02961088|Glycemic index|glycemic index
197526|NCT02961088|Pasta|pasta
197527|NCT02961088|Glycemic load|glycemic load
197528|NCT02961088|Body weight|body weight
197529|NCT02961088|Cardiovascular risk factors|cardiovascular risk factors
197530|NCT02961088|Cardiovascular disease|cardiovascular disease
197531|NCT02961062|ocular pain|ocular pain
197532|NCT02961062|photorefractive keratectomy (PRK)|photorefractive keratectomy (prk)
197533|NCT02961062|SAF312|saf312
197534|NCT02961062|corneal epithelial defect|corneal epithelial defect
197535|NCT02961036|Surveys and Questionnaires|surveys and questionnaires
197536|NCT02961010|school based prevention, child sexual and domestic abuse|school based prevention, child sexual and domestic abuse
198135|NCT02957344|legislation|legislation
197537|NCT02960997|epidermolysis bullosa simplex|epidermolysis bullosa simplex
197538|NCT02960958|Rheumatoid arthritis|rheumatoid arthritis
197539|NCT02960958|Metabolomics|metabolomics
197540|NCT02960958|urine|urine
197541|NCT02960932|Hemiplegic|hemiplegic
197542|NCT02960932|Child|child
197543|NCT02960932|Elastography|elastography
197544|NCT02960932|paralysis|paralysis
197545|NCT02960893|Ataxia|ataxia
197546|NCT02960893|SCA|sca
197547|NCT02960893|Spinocerebellar Ataxia|spinocerebellar ataxia
197548|NCT02960880|Rivaroxaban, Phenprocoumon, retrospective cohort study, Non-Valvular Atrial fibrillation, NVAF|rivaroxaban, phenprocoumon, retrospective cohort study, non-valvular atrial fibrillation, nvaf
197549|NCT02960867|paediatric|paediatric
197550|NCT02960867|kidney|kidney
197551|NCT02960815|influenza vaccine|influenza vaccine
197552|NCT02960815|Transplantation|transplantation
197553|NCT02960815|imiquimod|imiquimod
197554|NCT02960815|HIV infection|hiv infection
197555|NCT02960815|immunogenicity|immunogenicity
197556|NCT02960802|kidney transplant|kidney transplant
197557|NCT02960802|renal blood flow|renal blood flow
197558|NCT02960789|Dehydration|dehydration
197559|NCT02960789|Children|children
197560|NCT02960789|Measurement|measurement
197561|NCT02960776|Body Weight|body weight
197562|NCT02960776|Habitual sleep|habitual sleep
197563|NCT02960763|Comparative Effectiveness Research|comparative effectiveness research
197564|NCT02960763|Pragmatic Clinical Trials|pragmatic clinical trials
197565|NCT02960763|Patient-Centered Outcomes Research|patient-centered outcomes research
197566|NCT02960750|workplace|workplace
197567|NCT02960750|sedentary behavior|sedentary behavior
197568|NCT02960750|physical activity|physical activity
197569|NCT02960750|physical risk factors|physical risk factors
197570|NCT02960750|mental well-being|mental well-being
197571|NCT02960750|presenteeism|presenteeism
197572|NCT02960750|work productivity|work productivity
197573|NCT02960750|activity-related energy expenditures|activity-related energy expenditures
197574|NCT02960737|Dysphagia|dysphagia
197575|NCT02960737|Stroke|stroke
197576|NCT02960737|Intervention|intervention
197577|NCT02960737|Oral screen|oral screen
197578|NCT02960737|Incidence|incidence
197579|NCT02960724|Uroplasminogen Plasminogen Activator Receptor|uroplasminogen plasminogen activator receptor
197580|NCT02960724|Oropharyngeal cancer|oropharyngeal cancer
197581|NCT02960724|oral cancer|oral cancer
197582|NCT02960724|Positron Emission Tomography|positron emission tomography
197583|NCT02960698|cognitive impulsivity|cognitive impulsivity
197584|NCT02960698|IRM|irm
197585|NCT02960698|Tourette Syndrome|tourette syndrome
197586|NCT02960672|KL-6|kl-6
197587|NCT02960672|disease progression|disease progression
197588|NCT02960672|predict|predict
197589|NCT02960672|biomarkers|biomarkers
197590|NCT02960672|MMP-7|mmp-7
197591|NCT02960659|Diabetes|diabetes
197592|NCT02960659|Metformin|metformin
197593|NCT02960659|Glucose|glucose
197594|NCT02960620|Humanitarian Device Exemption|humanitarian device exemption
197595|NCT02960620|Liver Disease|liver disease
197596|NCT02960620|HDE #980006|hde #980006
197597|NCT02960594|Immunotherapy|immunotherapy
197598|NCT02960594|Human Telomerase Reverse Transcriptase (hTERT)|human telomerase reverse transcriptase (htert)
197599|NCT02960594|Breast Neoplasms|breast neoplasms
197600|NCT02960594|Lung Neoplasms|lung neoplasms
197601|NCT02960594|Pancreatic Neoplasms|pancreatic neoplasms
197602|NCT02960594|High Risk of Relapse|high risk of relapse
197603|NCT02960594|Post Definitive Surgery|post definitive surgery
197604|NCT02960594|Post Adjuvant Therapy|post adjuvant therapy
197605|NCT02960594|No Evidence of Disease|no evidence of disease
197606|NCT02960568|primaquine|primaquine
197607|NCT02960568|metabolism|metabolism
197608|NCT02960568|malaria|malaria
197609|NCT02960568|hypnozoite|hypnozoite
197610|NCT02960568|vivax|vivax
197611|NCT02960568|CYP2D6|cyp2d6
197612|NCT02960568|active duty personnel|active duty personnel
197613|NCT02960542|lifestyle intervention|lifestyle intervention
197614|NCT02960542|weight-loss|weight-loss
197615|NCT02960503|sickle cell disease|sickle cell disease
197616|NCT02960503|pulmonary complications|pulmonary complications
197617|NCT02960503|reduced FEV1|reduced fev1
197618|NCT02960503|azithromycin|azithromycin
197619|NCT02960503|lung function|lung function
197620|NCT02960490|E6011|e6011
197621|NCT02960490|rheumatoid arthritis|rheumatoid arthritis
197622|NCT02960477|Shoulder pain|shoulder pain
197623|NCT02960477|Shoulder surgery|shoulder surgery
197624|NCT02960477|Pain neuroscience education|pain neuroscience education
197625|NCT02960477|Chronic pain|chronic pain
197626|NCT02960464|Parkinson Disease|parkinson disease
197627|NCT02960464|Depression|depression
197628|NCT02960464|Transcranial Direct Current Stimulation|transcranial direct current stimulation
197629|NCT02960464|Neuromodulation|neuromodulation
197630|NCT02960451|prodrome|prodrome
197631|NCT02960451|cognitive behavioral therapy|cognitive behavioral therapy
197632|NCT02960451|family focused therapy|family focused therapy
197633|NCT02960438|E6011|e6011
197634|NCT02960438|rheumatoid arthritis|rheumatoid arthritis
197635|NCT02960373|Dried fruit|dried fruit
197636|NCT02960373|Glycemic Index|glycemic index
197637|NCT02960373|Catalytic dose|catalytic dose
197638|NCT02960373|Glycemic response|glycemic response
197639|NCT02960373|Fructose|fructose
197640|NCT02960373|Postprandial|postprandial
197641|NCT02960373|Randomized clinical trial|randomized clinical trial
197642|NCT02960373|Carbohydrate metabolism|carbohydrate metabolism
197643|NCT02960334|Screening|screening
197644|NCT02960334|Silent Atrial Fibrillation|silent atrial fibrillation
197645|NCT02960334|Undertreated Atrial Fibrillation|undertreated atrial fibrillation
197646|NCT02960334|Actionable Atrial Fibrillation|actionable atrial fibrillation
197647|NCT02960334|MyDiagnostick|mydiagnostick
197648|NCT02960334|Opportunistic Screening|opportunistic screening
197649|NCT02960334|Preoperative Consultation|preoperative consultation
197650|NCT02960334|OAC|oac
197651|NCT02960334|VKA|vka
197652|NCT02960334|NOAC|noac
197653|NCT02960321|myocardial injury|myocardial injury
197654|NCT02960321|high-sensitivity troponin I|high-sensitivity troponin i
197655|NCT02960321|periprocedural myocardial infarction|periprocedural myocardial infarction
197656|NCT02960269|rural health|rural health
197657|NCT02960269|telehealth|telehealth
197658|NCT02960269|physiotherapy|physiotherapy
197659|NCT02960269|interprofessional|interprofessional
197660|NCT02960243|Deep Brain Stimulation|deep brain stimulation
197661|NCT02960243|Laryngeal Motor Cortex|laryngeal motor cortex
197662|NCT02960243|Essential Voice Tremor|essential voice tremor
197663|NCT02960243|Essential Tremor|essential tremor
197664|NCT02960230|peptide vaccine|peptide vaccine
197665|NCT02960230|immunotherapy|immunotherapy
197666|NCT02960230|DIPG|dipg
197667|NCT02960230|vaccine|vaccine
197668|NCT02960204|cirrhosis|cirrhosis
197669|NCT02960204|Portal Hypertension|portal hypertension
197670|NCT02960204|Non-alcoholic Steatohepatitis|non-alcoholic steatohepatitis
197671|NCT02960204|Liver cirrhosis|liver cirrhosis
197672|NCT02960152|periodontitis|periodontitis
197673|NCT02960113|cesarean section|cesarean section
197674|NCT02960113|acupressure point p6|acupressure point p6
197675|NCT02960113|scopolamine patch|scopolamine patch
197676|NCT02960100|Cancer prevention|cancer prevention
197677|NCT02960100|HPV|hpv
197678|NCT02960100|Human papillomavirus vaccine|human papillomavirus vaccine
197679|NCT02960074|Allergy, Peanut|allergy, peanut
197680|NCT02960074|Hypersensitivity Peanut|hypersensitivity peanut
197681|NCT02960074|Peanut Allergy|peanut allergy
197682|NCT02960074|Donor Feces Infusion|donor feces infusion
197683|NCT02960074|Fecal Transplant|fecal transplant
197684|NCT02960074|Fecal Transplantation|fecal transplantation
197685|NCT02960074|Intestinal Microbiota Transfer|intestinal microbiota transfer
197686|NCT02960074|Fecal Microbiota Transplantation|fecal microbiota transplantation
197687|NCT02960074|Food allergy|food allergy
197688|NCT02960061|Intraperitoneal chemotherapy|intraperitoneal chemotherapy
197689|NCT02960061|gastric cancer|gastric cancer
197690|NCT02960061|Neo-adjuvant chemotherapy|neo-adjuvant chemotherapy
197691|NCT02960048|Anterior disc displacement|anterior disc displacement
197692|NCT02960048|TMD therapy|tmd therapy
197693|NCT02960048|internal derangement|internal derangement
252803|NCT02622607|ZOL|zol
197694|NCT02960048|occlusal splint|occlusal splint
197695|NCT02960048|anterior repositioning splint|anterior repositioning splint
197696|NCT02960035|Mardird sonographic enthesis index|mardird sonographic enthesis index
197697|NCT02960035|Spondyloarthropathy|spondyloarthropathy
197698|NCT02960035|Ultrasonics|ultrasonics
197699|NCT02960035|Etanercept|etanercept
197700|NCT02960022|prostate cancer|prostate cancer
197701|NCT02960022|prednisone|prednisone
197702|NCT02960022|MDV3100|mdv3100
197703|NCT02960022|enzalutamide|enzalutamide
197704|NCT02960022|Xtandi|xtandi
197705|NCT02960022|abiraterone acetate|abiraterone acetate
197706|NCT02959944|chronic graft versus host disease|chronic graft versus host disease
197707|NCT02959944|PCYC1140|pcyc1140
197708|NCT02959944|PCYC1140IM|pcyc1140im
197709|NCT02959944|1140|1140
197710|NCT02959944|Ibrutinib|ibrutinib
197711|NCT02959944|GVHD|gvhd
197712|NCT02959944|Steroid dependent|steroid dependent
197713|NCT02959944|refractory|refractory
197714|NCT02959944|chronic|chronic
197715|NCT02959944|PCI32765|pci32765
197716|NCT02959944|IMBRUVICA|imbruvica
197717|NCT02959944|Pharmacyclics|pharmacyclics
197718|NCT02959944|PCYC|pcyc
197719|NCT02959944|graft versus host disease|graft versus host disease
197720|NCT02959944|immunology|immunology
197721|NCT02959944|new onset graft versus host disease|new onset graft versus host disease
197722|NCT02959944|INTEGRATE|integrate
197723|NCT02959944|Corticosteroids|corticosteroids
197724|NCT02959944|prednisone|prednisone
197725|NCT02959931|Dietary Potassium|dietary potassium
197726|NCT02959905|Metastatic Melanoma|metastatic melanoma
197727|NCT02959905|Colorectal Cancer|colorectal cancer
197728|NCT02959905|neoantigen|neoantigen
197729|NCT02959892|Drug therapy|drug therapy
197730|NCT02959879|FOLFOX|folfox
197731|NCT02959879|FOLFIRINOX|folfirinox
197732|NCT02959853|Hypogonadism|hypogonadism
197733|NCT02959853|Severe obesity|severe obesity
197734|NCT02959827|Hypothyroidism,|hypothyroidism,
197735|NCT02959827|children,|children,
197736|NCT02959827|iodinated contrast agents,|iodinated contrast agents,
197737|NCT02959827|retrospective cohort,|retrospective cohort,
197738|NCT02959827|database|database
197739|NCT02959814|Fractional Flow Reserve|fractional flow reserve
197740|NCT02959814|Quantitative Coronary Analysis|quantitative coronary analysis
197741|NCT02959814|Stable coronary artery disease|stable coronary artery disease
197742|NCT02959814|Angina pectoris|angina pectoris
197743|NCT02959801|Deep Venous Thrombosis|deep venous thrombosis
197744|NCT02959801|Percutaneous Mechanical Thrombectomy|percutaneous mechanical thrombectomy
197745|NCT02959788|Heart rate variability|heart rate variability
197746|NCT02959775|Hepatitis B vaccination|hepatitis b vaccination
197747|NCT02959775|Immunogenicity|immunogenicity
197748|NCT02959775|Randomized controlled trial|randomized controlled trial
197749|NCT02959775|Drug abuse|drug abuse
197750|NCT02959762|G01 [Biological Sciences]|g01 [biological sciences]
197751|NCT02959762|G02.513 [Nutrition]|g02.513 [nutrition]
197752|NCT02959762|G06.696.259 [Child Nutrition]|g06.696.259 [child nutrition]
197753|NCT02959762|G07.553.481.398.571 [Obesity]|g07.553.481.398.571 [obesity]
197876|NCT02958904|Spinal cord injuries|spinal cord injuries
197754|NCT02959762|G06 [Biochemical Phenomena, Metabolism, and Nutrition]|g06 [biochemical phenomena, metabolism, and nutrition]
197755|NCT02959762|G12.392.617 [Insulin Resistance]|g12.392.617 [insulin resistance]
197756|NCT02959762|G06.696.259.500 [Adolescent Nutrition]|g06.696.259.500 [adolescent nutrition]
197757|NCT02959762|A06 [Endocrine System]|a06 [endocrine system]
197758|NCT02959762|A07 [Cardiovascular System]|a07 [cardiovascular system]
197759|NCT02959762|C18.452.297.681 [Obesity in Diabetes]|c18.452.297.681 [obesity in diabetes]
197760|NCT02959762|C18.452.555 [Insulin Resistance]|c18.452.555 [insulin resistance]
197761|NCT02959762|C18 [Nutritional and Metabolic Diseases]|c18 [nutritional and metabolic diseases]
197762|NCT02959762|C18.452.494 [Hyperlipidemia]|c18.452.494 [hyperlipidemia]
197763|NCT02959762|C18.452.460 [Hyperglycemia]|c18.452.460 [hyperglycemia]
197764|NCT02959762|C14 [Cardiovascular Diseases]|c14 [cardiovascular diseases]
197765|NCT02959762|D11.786.875.844 [Vitamin K 2]|d11.786.875.844 [vitamin k 2]
197766|NCT02959762|D02.806.550.750 [Vitamin K 2]|d02.806.550.750 [vitamin k 2]
197767|NCT02959762|E02.293 [Diet Therapy]|e02.293 [diet therapy]
197768|NCT02959762|E02 [Therapeutics]|e02 [therapeutics]
197769|NCT02959762|F04.096.544.215.508.428 [Primary Prevention]|f04.096.544.215.508.428 [primary prevention]
197770|NCT02959762|N01.224.425.525 [Nutritional Status]|n01.224.425.525 [nutritional status]
197771|NCT02959749|Osimertinib|osimertinib
197772|NCT02959749|EGFR T790M Resistant Mutation|egfr t790m resistant mutation
197773|NCT02959749|Docetaxel|docetaxel
197774|NCT02959749|Bevacizumab|bevacizumab
197775|NCT02959749|Non Small Cell Lung|non small cell lung
197776|NCT02959736|Vegetative State (VS)|vegetative state (vs)
197777|NCT02959736|Minimally Conscious State (MCS)|minimally conscious state (mcs)
197778|NCT02959736|Brain Injuries|brain injuries
197779|NCT02959723|Pulmonary Arterial Hypertension|pulmonary arterial hypertension
197781|NCT02959723|Inflammation|inflammation
197782|NCT02959710|Healthy volunteers|healthy volunteers
197783|NCT02959710|AC-1202|ac-1202
252895|NCT02622074|PD1|pd1
197784|NCT02959710|AC-1204|ac-1204
197785|NCT02959710|Pharmacokinetic|pharmacokinetic
197786|NCT02959710|ketone body|ketone body
197787|NCT02959697|Blepharoptosis|blepharoptosis
197788|NCT02959697|Ptosis|ptosis
197789|NCT02959697|Surgery|surgery
197790|NCT02959697|Pain Reduction|pain reduction
197791|NCT02959697|Anesthetic|anesthetic
197792|NCT02959697|Local Anesthetic|local anesthetic
197793|NCT02959697|Subconjunctival|subconjunctival
197794|NCT02959593|Primary open-angle glaucoma|primary open-angle glaucoma
197795|NCT02959593|retinal capillary blood flow|retinal capillary blood flow
197796|NCT02959593|visual stimulation|visual stimulation
197797|NCT02959580|Granulomatous|granulomatous
197798|NCT02959580|Mastitis|mastitis
197799|NCT02959580|topical steroids|topical steroids
197800|NCT02959567|cervix|cervix
197801|NCT02959567|cervical dilation|cervical dilation
197802|NCT02959567|balloon catheter|balloon catheter
197803|NCT02959554|Advanced|advanced
197804|NCT02959554|Metastatic|metastatic
197805|NCT02959554|RCC|rcc
197806|NCT02959541|Leukovorin|leukovorin
197807|NCT02959476|Postoperative pain|postoperative pain
197808|NCT02959476|Postsurgical pain|postsurgical pain
197809|NCT02959450|Nutritional Intervention in Oropharyngeal Dysphagia|nutritional intervention in oropharyngeal dysphagia
197810|NCT02959437|Solid tumors|solid tumors
197811|NCT02959437|NSCLC|nsclc
197812|NCT02959437|CRC|crc
197813|NCT02959359|Chronic hepatitis C|chronic hepatitis c
197814|NCT02959359|Hepatocellular Carcinoma|hepatocellular carcinoma
197815|NCT02959359|Direct-acting antiviral (DAA)|direct-acting antiviral (daa)
197816|NCT02959359|Recurrence|recurrence
197817|NCT02959346|Minimal invasive thoracoscopic surgery|minimal invasive thoracoscopic surgery
197818|NCT02959346|Pain control|pain control
197819|NCT02959346|Acupuncture|acupuncture
197820|NCT02959346|Randomized controlled trial|randomized controlled trial
197821|NCT02959307|Depression|depression
197822|NCT02959307|Major Depressive Disorder|major depressive disorder
197823|NCT02959307|Major Depressive Episode|major depressive episode
197824|NCT02959294|TBI|tbi
197825|NCT02959294|mTBI|mtbi
197826|NCT02959294|Concussion, Brain|concussion, brain
197827|NCT02959294|Loss Consciousness, Traumatic|loss consciousness, traumatic
197829|NCT02959242|glaucoma, follow-up intervals, treatment efficiency|glaucoma, follow-up intervals, treatment efficiency
197830|NCT02959229|Late onset sepsis|late onset sepsis
197831|NCT02959229|Bovine Lactoferrin|bovine lactoferrin
197832|NCT02959216|Aerobic Exercise|aerobic exercise
197833|NCT02959203|Central Venous Catheter|central venous catheter
197834|NCT02959203|Ultrasound|ultrasound
197835|NCT02959203|Chest X-ray|chest x-ray
197836|NCT02959203|Pneumothorax|pneumothorax
197837|NCT02959190|prevention|prevention
197838|NCT02959190|prophylaxis|prophylaxis
197839|NCT02959190|headache|headache
197840|NCT02959177|prevention|prevention
197841|NCT02959177|prophylaxis|prophylaxis
197842|NCT02959177|headache|headache
197843|NCT02959112|pancreatitis after ERCP|pancreatitis after ercp
197844|NCT02959112|epinephrine|epinephrine
197845|NCT02959112|papilla|papilla
197846|NCT02959112|rectal indomethacin|rectal indomethacin
197847|NCT02959099|Acute coronary syndrome (ACS)|acute coronary syndrome (acs)
197848|NCT02959099|Atherosclerotic plaque morphology|atherosclerotic plaque morphology
197849|NCT02959099|Coronary Computed Tomographic Angiography (CCTA)|coronary computed tomographic angiography (ccta)
197850|NCT02959099|Gender disparities|gender disparities
197851|NCT02959086|Epidemiology|epidemiology
197852|NCT02959086|Shanghai|shanghai
197853|NCT02959086|Cancer|cancer
197854|NCT02959086|Adolescents|adolescents
197855|NCT02959086|Children|children
197856|NCT02959073|Symptom recording|symptom recording
197857|NCT02959047|MRI|mri
197858|NCT02959047|PCSK9 inhibition|pcsk9 inhibition
197859|NCT02959047|LDL cholesterol|ldl cholesterol
197860|NCT02959021|weight loss|weight loss
197861|NCT02959021|behavioral|behavioral
197862|NCT02959021|primary care|primary care
197863|NCT02959021|lifestyle|lifestyle
197864|NCT02958995|Drug Therapy|drug therapy
197865|NCT02958982|RP3128|rp3128
197866|NCT02958982|Phase 1|phase 1
197867|NCT02958982|Healthy volunteers|healthy volunteers
197868|NCT02958969|venous thromboembolism|venous thromboembolism
197869|NCT02958969|multiple myeloma|multiple myeloma
197870|NCT02958969|anticoagulation|anticoagulation
197871|NCT02958956|Drug Therapy|drug therapy
197872|NCT02958943|atrial fibrillation|atrial fibrillation
197873|NCT02958943|stroke|stroke
197874|NCT02958943|computerized decision support|computerized decision support
197875|NCT02958904|Sexuality|sexuality
197877|NCT02958904|Erectile dysfunction|erectile dysfunction
197878|NCT02958904|depression|depression
197879|NCT02958865|Mayo score|mayo score
197880|NCT02958852|Breast Cancer|breast cancer
197881|NCT02958852|Endocrine Treatment|endocrine treatment
197882|NCT02958852|Atorvastatin|atorvastatin
197883|NCT02958852|Mechanisms of Resistance|mechanisms of resistance
197885|NCT02958852|Fulvestrant|fulvestrant
197886|NCT02958852|Circulating Tumor Cells|circulating tumor cells
197887|NCT02958852|Statins and Endocrine Treatment|statins and endocrine treatment
197888|NCT02958852|Tumor Marker Expression|tumor marker expression
197889|NCT02958852|ER+ Metastatic Breast Cancer|er+ metastatic breast cancer
197890|NCT02958852|Circulating Tumor DNA|circulating tumor dna
197891|NCT02958852|Cholesterol|cholesterol
197892|NCT02958839|Atrial fibrillation|atrial fibrillation
197893|NCT02958839|Fibroblast Growth factor 23|fibroblast growth factor 23
197894|NCT02958800|Deprescribing|deprescribing
197895|NCT02958800|Single patient open label trial|single patient open label trial
197896|NCT02958800|Long-term care|long-term care
197897|NCT02958761|knee arthrosis|knee arthrosis
197898|NCT02958761|platelet-derived growth factors|platelet-derived growth factors
197899|NCT02958735|exercise|exercise
197900|NCT02958735|cognition|cognition
197901|NCT02958735|brain-derived neurotrophic factor|brain-derived neurotrophic factor
197902|NCT02958735|insulin-like growth factor 1|insulin-like growth factor 1
197903|NCT02958735|cortisol|cortisol
197904|NCT02958683|Optoelectronic plethysmography|optoelectronic plethysmography
197905|NCT02958683|Structure light plethysmography|structure light plethysmography
197906|NCT02958683|Respiratory Function Tests|respiratory function tests
197907|NCT02958657|Platelet function|platelet function
197908|NCT02958657|Autonomic Nervous System|autonomic nervous system
197909|NCT02958657|Multiplate® (Multiple Electrode Aggregometry - MEA)|multiplate® (multiple electrode aggregometry - mea)
197910|NCT02958657|VerifyNow®|verifynow®
197911|NCT02958644|synbiotic|synbiotic
197912|NCT02958644|obesity|obesity
197913|NCT02958644|body mass index|body mass index
197914|NCT02958644|microbiota|microbiota
197915|NCT02958605|Children|children
197916|NCT02958605|resuscitation|resuscitation
197917|NCT02958605|smartphone|smartphone
197918|NCT02958592|shear-wave elastography|shear-wave elastography
197919|NCT02958592|hepatic fibrosis|hepatic fibrosis
197920|NCT02958592|liver tumor|liver tumor
197921|NCT02958566|Pain control|pain control
197922|NCT02958566|Post-operative pain|post-operative pain
197923|NCT02958566|Narcotic|narcotic
197924|NCT02958566|Non-narcotic|non-narcotic
197925|NCT02958566|Side effect|side effect
197926|NCT02958566|Toxicity|toxicity
197927|NCT02958553|Lower Extremity Limb Loss|lower extremity limb loss
197928|NCT02958553|Prosthesis Use|prosthesis use
197929|NCT02958540|Prophylaxis|prophylaxis
197930|NCT02958527|Effexor|effexor
197932|NCT02958527|Depressed state|depressed state
197933|NCT02958514|IPL|ipl
197934|NCT02958514|MGD|mgd
197935|NCT02958501|Vitamin D|vitamin d
197936|NCT02958501|Inflammatory Bowel Diseases|inflammatory bowel diseases
197937|NCT02958488|34 to 36 Weeks Preterm Neonates|34 to 36 weeks preterm neonates
197938|NCT02958488|Respiratory Distress Syndrom|respiratory distress syndrom
197939|NCT02958488|High Flow Nasal Cannula|high flow nasal cannula
197940|NCT02958436|Safety|safety
197941|NCT02958436|Tolerability|tolerability
197942|NCT02958436|Pharmacokinetics|pharmacokinetics
197943|NCT02958436|REGN3500|regn3500
197944|NCT02958410|CD30|cd30
197945|NCT02958410|CAR-T|car-t
197946|NCT02958397|Myeloid Malignancies|myeloid malignancies
197947|NCT02958397|CAR-T|car-t
197948|NCT02958397|CD33|cd33
197949|NCT02958384|Myeloid Malignancies|myeloid malignancies
197950|NCT02958384|CAR-T|car-t
197951|NCT02958384|LeY|ley
197952|NCT02958371|Functional magnetic resonance imaging|functional magnetic resonance imaging
197953|NCT02958371|Taste|taste
197954|NCT02958371|Feeding behavior|feeding behavior
197955|NCT02958371|Choice behavior|choice behavior
197956|NCT02958358|pulmonary hypertension|pulmonary hypertension
197957|NCT02958358|ambrisentan|ambrisentan
197958|NCT02958358|PET imaging|pet imaging
197959|NCT02958358|CT/PET|ct/pet
197960|NCT02958332|video games|video games
197961|NCT02958306|cleft lip repair|cleft lip repair
197962|NCT02958306|cheiloplasty|cheiloplasty
197963|NCT02958306|PRP|prp
197964|NCT02958306|platelet rich plasma|platelet rich plasma
197965|NCT02958280|Exercise|exercise
197966|NCT02958280|Smartphone|smartphone
197967|NCT02958267|knee osteoarthritis|knee osteoarthritis
197968|NCT02958267|regenerative medicine|regenerative medicine
197969|NCT02958267|orthobiologics|orthobiologics
197970|NCT02958267|cellular therapy|cellular therapy
197971|NCT02958254|hamstring|hamstring
197972|NCT02958254|ultrasonography|ultrasonography
197973|NCT02958254|validation|validation
197974|NCT02958254|magnetic resonance imaging|magnetic resonance imaging
197975|NCT02958254|muscle thickness|muscle thickness
197976|NCT02958241|spondylolisthesis|spondylolisthesis
197977|NCT02958241|Lumbar spine|lumbar spine
197978|NCT02958241|MRI|mri
197979|NCT02958228|Positive Affect|positive affect
197980|NCT02958228|Mental Imagery|mental imagery
197981|NCT02958228|Cognitive Bias Modification|cognitive bias modification
197982|NCT02958228|Cognitive Control Training|cognitive control training
197983|NCT02958215|Orthostatic|orthostatic
197984|NCT02958215|Cesarean section|cesarean section
197985|NCT02958215|Pregnant|pregnant
197986|NCT02958215|Phenyephrine|phenyephrine
197987|NCT02958215|Hypotension|hypotension
197988|NCT02958202|Duchenne Muscular Dystrophy|duchenne muscular dystrophy
197989|NCT02958202|DMD|dmd
197990|NCT02958202|Dystrophin|dystrophin
197991|NCT02958202|BMN 044|bmn 044
197992|NCT02958202|PRO044|pro044
197993|NCT02958202|BioMarin|biomarin
197994|NCT02958189|Twitter|twitter
197995|NCT02958189|social support|social support
197996|NCT02958189|internet intervention|internet intervention
197997|NCT02958189|sedentary lifestyle|sedentary lifestyle
197998|NCT02958189|walking|walking
197999|NCT02958189|behavior change|behavior change
198000|NCT02958163|Hepatocellular cancer|hepatocellular cancer
198001|NCT02958163|Stereotactic Body Radiotherapy|stereotactic body radiotherapy
198002|NCT02958163|Chemoembolization, Therapeutic|chemoembolization, therapeutic
198003|NCT02958111|Nasopharyngeal Carcinoma|nasopharyngeal carcinoma
198004|NCT02958111|Adjuvant chemotherapy|adjuvant chemotherapy
198005|NCT02958111|Capecitabine|capecitabine
198006|NCT02958098|myocardial infarction|myocardial infarction
198008|NCT02958098|dilated cardiomyopathy|dilated cardiomyopathy
198009|NCT02958098|systolic heart failure|systolic heart failure
198010|NCT02958098|atrial fibrillation|atrial fibrillation
198011|NCT02958098|aortic dissection|aortic dissection
198012|NCT02958098|wearable devices|wearable devices
198013|NCT02958098|genomic sequencing|genomic sequencing
198014|NCT02958072|Malleoli ulcers|malleoli ulcers
198015|NCT02958072|Diabetes|diabetes
198016|NCT02958072|Healing|healing
198017|NCT02958072|Dressing|dressing
198018|NCT02958072|LeucoPatch|leucopatch
198019|NCT02958059|ERCP|ercp
198020|NCT02958059|prophylaxis|prophylaxis
198021|NCT02958059|antibiotics|antibiotics
198022|NCT02958059|infection|infection
198023|NCT02958059|cholangitis|cholangitis
198024|NCT02958020|cohort, osteoporosis, bone mineral density, Chinese|cohort, osteoporosis, bone mineral density, chinese
198025|NCT02957981|BRCA1|brca1
198026|NCT02957981|BRCA2|brca2
198027|NCT02957981|Men|men
198028|NCT02957981|Hereditary Cancer|hereditary cancer
198029|NCT02957981|Prostate Cancer|prostate cancer
198030|NCT02957981|Male Breast Cancer|male breast cancer
198031|NCT02957968|Breast Cancer|breast cancer
198032|NCT02957955|Heart failure|heart failure
198033|NCT02957942|Repetitive transcranial magnetic stimulation (rTMS)|repetitive transcranial magnetic stimulation (rtms)
198034|NCT02957942|Spasmodic dysphonia|spasmodic dysphonia
198035|NCT02957942|Dystonia|dystonia
198036|NCT02957877|Anticoagulation|anticoagulation
198136|NCT02957344|vaccination|vaccination
198037|NCT02957877|Anti-Xa activity|anti-xa activity
198038|NCT02957877|Low-molecular weight heparin|low-molecular weight heparin
198039|NCT02957877|Unfractionated heparin|unfractionated heparin
198040|NCT02957838|Transferrin Receptor|transferrin receptor
198041|NCT02957838|Type 2 Diabetes|type 2 diabetes
198042|NCT02957838|Stearic Acid (C18:0)|stearic acid (c18:0)
198043|NCT02957838|Mitochondrial Morphology|mitochondrial morphology
198044|NCT02957838|Crossover Study|crossover study
198046|NCT02957812|Balance Control|balance control
198047|NCT02957812|Orthotics|orthotics
198048|NCT02957799|Pregnancy|pregnancy
198049|NCT02957799|Home Healthcare Visits|home healthcare visits
198050|NCT02957799|Community Health Workers|community health workers
198051|NCT02957799|Infants|infants
198052|NCT02957786|cytisine|cytisine
198053|NCT02957786|varenicline|varenicline
198054|NCT02957786|smoking cessation|smoking cessation
198055|NCT02957786|indigenous|indigenous
198056|NCT02957747|Women Veterans|women veterans
198057|NCT02957747|Sexual Trauma|sexual trauma
198058|NCT02957734|Vertical dimension of occlusion|vertical dimension of occlusion
198059|NCT02957734|Direct composite restorations|direct composite restorations
198060|NCT02957734|Indirect composite restorations|indirect composite restorations
198061|NCT02957734|Tooth wear|tooth wear
198062|NCT02957734|Failure|failure
198063|NCT02957734|Quality of Life|quality of life
198064|NCT02957695|frontal brain lesions|frontal brain lesions
198065|NCT02957695|neurofeedback|neurofeedback
198066|NCT02957695|cognitive functions|cognitive functions
198067|NCT02957682|Hyperlipidemias|hyperlipidemias
198068|NCT02957682|Dyslipidemias|dyslipidemias
198069|NCT02957682|Lipid Metabolism Disorders|lipid metabolism disorders
198070|NCT02957630|Estetrol (E4)|estetrol (e4)
198071|NCT02957630|Drospirenone (DRSP)|drospirenone (drsp)
198072|NCT02957630|Ethinylestradiol (EE)|ethinylestradiol (ee)
198073|NCT02957630|Levonorgestrel (LNG)|levonorgestrel (lng)
198074|NCT02957630|Oral contraceptive|oral contraceptive
198075|NCT02957630|Prevention of pregnancy|prevention of pregnancy
198076|NCT02957630|Hemostasis|hemostasis
198077|NCT02957630|Metabolism|metabolism
198078|NCT02957617|Neuropathic Pain From Lumbosacral Radiculopathy|neuropathic pain from lumbosacral radiculopathy
198079|NCT02957604|Pregnancy; Cardiovascular Diseases; High serum cholesterol; FH; ASCVD|pregnancy; cardiovascular diseases; high serum cholesterol; fh; ascvd
198080|NCT02957591|Depression|depression
198081|NCT02957591|probiotic supplementation|probiotic supplementation
198082|NCT02957591|Adjuvant Therapy|adjuvant therapy
198083|NCT02957591|Gut microbiome|gut microbiome
198084|NCT02957591|Psychological functioning|psychological functioning
198085|NCT02957591|Brain imaging|brain imaging
198086|NCT02957591|Brain-Gut interactions|brain-gut interactions
198087|NCT02957591|Sleep|sleep
198088|NCT02957578|Tympanostomy Tube|tympanostomy tube
198089|NCT02957578|Ventilation Tube|ventilation tube
198090|NCT02957578|Grommet|grommet
198091|NCT02957578|Otitis Media|otitis media
198092|NCT02957578|Middle Ear Effusion|middle ear effusion
198093|NCT02957565|Malignant neoplasms of independent (primary) multiple sites|malignant neoplasms of independent (primary) multiple sites
198094|NCT02957565|Questionnaires|questionnaires
198095|NCT02957565|Surveys|surveys
198096|NCT02957565|Videos|videos
198097|NCT02957565|Advanced Cancer|advanced cancer
198098|NCT02957539|motivation|motivation
198099|NCT02957539|patient incentives|patient incentives
198100|NCT02957513|Diabetes|diabetes
198101|NCT02957513|Uncontrolled|uncontrolled
198102|NCT02957513|Chronic Disease|chronic disease
198103|NCT02957513|Chronic Conditions|chronic conditions
198104|NCT02957513|Medically Underserved Areas|medically underserved areas
198105|NCT02957513|African Americans|african americans
198106|NCT02957513|Health Coaching|health coaching
198107|NCT02957513|Health Education|health education
198108|NCT02957513|Text Messaging|text messaging
198109|NCT02957513|Text Messages|text messages
198110|NCT02957513|Mobile Health|mobile health
198111|NCT02957474|Healthy Volunteers|healthy volunteers
198112|NCT02957474|Pharmacokinetics|pharmacokinetics
198113|NCT02957474|Food Effect|food effect
198114|NCT02957474|Proton Pump|proton pump
198115|NCT02957474|GED-0301|ged-0301
198116|NCT02957474|Mongersen|mongersen
198117|NCT02957461|Concussion|concussion
198118|NCT02957461|Mild Traumatic Brain Injury|mild traumatic brain injury
198119|NCT02957461|Sport Related Concussion|sport related concussion
198120|NCT02957422|milk|milk
198121|NCT02957422|brain aging|brain aging
198122|NCT02957422|antioxidant|antioxidant
198123|NCT02957422|glutathione|glutathione
198124|NCT02957422|dietary intervention|dietary intervention
198125|NCT02957422|brain imaging|brain imaging
198126|NCT02957409|Heart failure|heart failure
198127|NCT02957409|Heart Failure with Reduced Ejection Fraction|heart failure with reduced ejection fraction
198128|NCT02957409|HFrEF|hfref
198129|NCT02957383|Sleep, Melatonin|sleep, melatonin
198130|NCT02957383|Circadian Rhythm|circadian rhythm
198131|NCT02957383|Temperature|temperature
198132|NCT02957383|screen illumination|screen illumination
198133|NCT02957344|health communication|health communication
198134|NCT02957344|Zika virus|zika virus
198137|NCT02957344|Child Care|child care
198138|NCT02957305|misoprostol|misoprostol
198139|NCT02957305|miscarriage|miscarriage
198140|NCT02957279|sepsis|sepsis
198141|NCT02957279|exosomes|exosomes
198142|NCT02957279|dendritic cell|dendritic cell
198143|NCT02957266|cervical cancer|cervical cancer
198144|NCT02957266|interstitial brachytherapy|interstitial brachytherapy
198145|NCT02957266|gemcitabine|gemcitabine
198146|NCT02957266|volumetric arc therapy|volumetric arc therapy
198147|NCT02957253|Quality of care|quality of care
198148|NCT02957253|Health related quality of life|health related quality of life
198149|NCT02957253|Nurse-led clinic|nurse-led clinic
198150|NCT02957253|Health economics|health economics
198151|NCT02957240|Forearm [A01.378.800.585]|forearm [a01.378.800.585]
198152|NCT02957240|Radius [A02.835.232.087.090.700]|radius [a02.835.232.087.090.700]
198153|NCT02957240|Motor Skills [F02.808.260]|motor skills [f02.808.260]
198154|NCT02957240|Task Performance and Analysis [F02.808.600]|task performance and analysis [f02.808.600]
198155|NCT02957240|Casts, Surgical [E07.858.442.660.430.500]|casts, surgical [e07.858.442.660.430.500]
198156|NCT02957240|Splints [E07.858.690.725.430.750]|splints [e07.858.690.725.430.750]
198157|NCT02957240|motor representation techniques|motor representation techniques
198158|NCT02957240|mirror therapy|mirror therapy
198159|NCT02957240|Women [M01.975]|women [m01.975]
198160|NCT02957227|Alzheimer's disease|alzheimer's disease
198161|NCT02957227|Frontotemporal Dementia|frontotemporal dementia
198162|NCT02957227|Lewy Body Dementia|lewy body dementia
198163|NCT02957227|Diagnosis|diagnosis
198164|NCT02957188|Eicosapentaenoic acid|eicosapentaenoic acid
198165|NCT02957188|Arachidonic acid|arachidonic acid
198166|NCT02957188|Metabolism|metabolism
198167|NCT02957188|Healthy aging|healthy aging
198168|NCT02957175|Immunophenotyping|immunophenotyping
198169|NCT02957175|Perioperative Care|perioperative care
198170|NCT02957175|Innate Immunity|innate immunity
198171|NCT02957175|Cardiac Surgical Procedures|cardiac surgical procedures
198172|NCT02957136|Respiratory Tract Infections|respiratory tract infections
198173|NCT02957136|Influenza, Human|influenza, human
198174|NCT02957136|Common Cold|common cold
198175|NCT02957136|Viral Infection|viral infection
198176|NCT02957136|Pathology, Molecular|pathology, molecular
198177|NCT02957136|Molecular Diagnostics|molecular diagnostics
198178|NCT02957136|Diagnostic Testing|diagnostic testing
198179|NCT02957136|Clinical Microbiology|clinical microbiology
198180|NCT02957136|Polymerase Chain Reaction|polymerase chain reaction
198181|NCT02957136|Antibiotic Stewardship|antibiotic stewardship
198182|NCT02957136|Antimicrobial Use|antimicrobial use
198183|NCT02957136|Emergency Department|emergency department
198184|NCT02957136|Emergency Room|emergency room
198185|NCT02957123|macrophages M2 type|macrophages m2 type
198186|NCT02957123|cytokines|cytokines
198187|NCT02957123|intranasal administration|intranasal administration
198188|NCT02957123|neuroprotection|neuroprotection
198189|NCT02957123|neuroregeneration|neuroregeneration
198190|NCT02957123|organic brain syndrome|organic brain syndrome
198191|NCT02957123|neurocognitive disorders|neurocognitive disorders
198192|NCT02957097|Gabapentin|gabapentin
198193|NCT02957097|acute pain|acute pain
198194|NCT02957084|difficult laryngoscopy|difficult laryngoscopy
198195|NCT02957084|neck circumference|neck circumference
198196|NCT02957084|sternomental distance|sternomental distance
198197|NCT02957084|thyromental distance|thyromental distance
198198|NCT02957084|hyomental distance|hyomental distance
198199|NCT02957084|thyrosternal distance|thyrosternal distance
198200|NCT02957058|Colonoscopy|colonoscopy
198201|NCT02957058|Endoscopic Mucosal Resection|endoscopic mucosal resection
198202|NCT02957058|Adenoma Recurrence|adenoma recurrence
198203|NCT02957058|EMR defect thermal ablation|emr defect thermal ablation
198204|NCT02956993|peripheral artery disease|peripheral artery disease
198205|NCT02956993|PAD|pad
198206|NCT02956993|vonapanitase|vonapanitase
198207|NCT02956993|critical limb ischemia|critical limb ischemia
198208|NCT02956993|CLI|cli
198209|NCT02956993|tibial artery|tibial artery
198210|NCT02956993|stenosis|stenosis
198211|NCT02956993|distal popliteal artery|distal popliteal artery
198212|NCT02956993|peroneal artery|peroneal artery
198213|NCT02956993|below the knee|below the knee
198214|NCT02956993|BTK|btk
198215|NCT02956993|elastase|elastase
198216|NCT02956993|chymotrypsin-like elastase 1|chymotrypsin-like elastase 1
198217|NCT02956993|CELA1|cela1
198218|NCT02956993|PRT-201|prt-201
198219|NCT02956980|type 1 interferons|type 1 interferons
198220|NCT02956980|children|children
198221|NCT02956980|gender|gender
198222|NCT02956980|pubertal status|pubertal status
198223|NCT02956980|sex difference|sex difference
198224|NCT02956967|Non-Interventional Study|non-interventional study
198225|NCT02956954|Enzyme replacement therapy|enzyme replacement therapy
198226|NCT02956941|Academic performance|academic performance
198227|NCT02956941|Behaviour change communication|behaviour change communication
198228|NCT02956941|Nutritional status|nutritional status
198229|NCT02956941|School children|school children
198230|NCT02956941|Ethiopia|ethiopia
198231|NCT02956915|Transcatheter aortic valve implantation|transcatheter aortic valve implantation
198232|NCT02956915|SAPIEN-3 prostheses|sapien-3 prostheses
198233|NCT02956915|Length of stay|length of stay
198234|NCT02956915|Aortic stenosis|aortic stenosis
198235|NCT02956889|Carcinoma, Basal Cell|carcinoma, basal cell
198236|NCT02956889|Vismodegib|vismodegib
198237|NCT02956889|Radiotherapy|radiotherapy
198238|NCT02956837|Vaccines|vaccines
198239|NCT02956837|Respiratory Syncytial Viruses|respiratory syncytial viruses
198240|NCT02956837|Safety|safety
198241|NCT02956837|Reactogenicity|reactogenicity
198242|NCT02956837|Ranking of Formulations|ranking of formulations
198243|NCT02956837|Immunogenicity|immunogenicity
198244|NCT02956824|Magnetic Resonance Imaging (MRI)|magnetic resonance imaging (mri)
198245|NCT02956824|Sacro-iliac joints|sacro-iliac joints
198246|NCT02956824|Pelvis|pelvis
198247|NCT02956824|Erosion|erosion
198248|NCT02956824|Fat deposit|fat deposit
198249|NCT02956824|Subchondral sclerosis|subchondral sclerosis
198250|NCT02956824|Bone marrow edema|bone marrow edema
198251|NCT02956824|Axial spondyloarthritis|axial spondyloarthritis
198252|NCT02956811|Type 2 Diabetes|type 2 diabetes
198253|NCT02956811|Left Ventricular Hypertrophy|left ventricular hypertrophy
198254|NCT02956811|Dapagliflozin|dapagliflozin
198255|NCT02956798|Renal Cell, Stereotactic ablative body radiotherapy (SAbR), Pazopanib, Oligo-mets|renal cell, stereotactic ablative body radiotherapy (sabr), pazopanib, oligo-mets
198256|NCT02956785|Propess|propess
198257|NCT02956759|diabetic retinopathy|diabetic retinopathy
198258|NCT02956759|Pan-retinal photocoagulation|pan-retinal photocoagulation
198259|NCT02956759|proliferative|proliferative
198260|NCT02956759|non-proliferative|non-proliferative
198261|NCT02956733|inexpensive, fasciotomy|inexpensive, fasciotomy
198262|NCT02956707|neonates|neonates
198263|NCT02956707|cardiopulmonary bypass|cardiopulmonary bypass
198264|NCT02956707|adrenal insufficiency|adrenal insufficiency
198265|NCT02956707|congenital heart disease|congenital heart disease
198266|NCT02956694|Aged|aged
198267|NCT02956694|Cognitive impairment|cognitive impairment
198268|NCT02956694|Neurocognitive Disorders|neurocognitive disorders
198269|NCT02956694|Shared decision making|shared decision making
198270|NCT02956694|Distance learning|distance learning
198271|NCT02956694|Primary care|primary care
198272|NCT02956694|Decision support tool|decision support tool
198273|NCT02956694|Patient decision aid|patient decision aid
198274|NCT02956668|tDCS|tdcs
198275|NCT02956668|Visual field|visual field
198276|NCT02956668|Stroke|stroke
198277|NCT02956616|Enhanced Recovery|enhanced recovery
198278|NCT02956590|dyslipidemia|dyslipidemia
198279|NCT02956590|obesity|obesity
198280|NCT02956590|pitavastatin|pitavastatin
198281|NCT02956590|lipids|lipids
198282|NCT02956577|Global Longitudinal Strain (GLS)|global longitudinal strain (gls)
198283|NCT02956577|Coronary Flow Velocity Reserve (CFVR)|coronary flow velocity reserve (cfvr)
198284|NCT02956577|Cardiac dysfunction|cardiac dysfunction
198285|NCT02956577|Microcirculation|microcirculation
198286|NCT02956577|Coronary Computed Tomography Angiography (CCTA)|coronary computed tomography angiography (ccta)
198287|NCT02956577|Type 1 Diabetes|type 1 diabetes
198288|NCT02956577|Type 2 Diabetes|type 2 diabetes
198289|NCT02956551|advanced non-small cell lung cancer|advanced non-small cell lung cancer
198290|NCT02956551|cell based therapy|cell based therapy
198291|NCT02956551|safety|safety
198292|NCT02956551|clinical efficacy|clinical efficacy
198293|NCT02956486|Elenbecestat|elenbecestat
198294|NCT02956486|E2609|e2609
198295|NCT02956486|Alzheimer's Disease|alzheimer's disease
198296|NCT02956486|Early Alzheimer's Disease|early alzheimer's disease
198297|NCT02956486|Prodromal Alzheimer's Disease|prodromal alzheimer's disease
198298|NCT02956486|Dementia|dementia
198299|NCT02956486|Dementia, Alzheimer's type|dementia, alzheimer's type
198300|NCT02956486|Mild Cognitive Impairment|mild cognitive impairment
198301|NCT02956486|MissionAD1|missionad1
198302|NCT02956473|Breast Cancer|breast cancer
198303|NCT02956447|Kisspeptin|kisspeptin
198304|NCT02956447|Hyperprolactinemia|hyperprolactinemia
198305|NCT02956408|Obesity|obesity
198306|NCT02956408|Pediatrics|pediatrics
198307|NCT02956408|Vitamin D deficiency|vitamin d deficiency
198308|NCT02956395|adaptive case management approach|adaptive case management approach
198309|NCT02956395|Transitional Care|transitional care
198310|NCT02956395|multimorbidity|multimorbidity
198311|NCT02956382|Ibrutinib|ibrutinib
198312|NCT02956382|Venetoclax|venetoclax
198313|NCT02956382|Follicular|follicular
198314|NCT02956382|Refractory|refractory
198315|NCT02956382|Relapsed|relapsed
198316|NCT02956382|Lymphoma|lymphoma
198317|NCT02956343|Atrial fibrillation|atrial fibrillation
198318|NCT02956343|cardiovascular App|cardiovascular app
198319|NCT02956343|Rhythm monitoring|rhythm monitoring
198320|NCT02956343|Stroke prevention|stroke prevention
198322|NCT02956330|ME|me
198323|NCT02956330|Central Subfield Thickness|central subfield thickness
198324|NCT02956330|OCT|oct
198325|NCT02956330|Optical Coherence Tomography|optical coherence tomography
198326|NCT02956330|Cystoid Macular Edema|cystoid macular edema
198327|NCT02956330|Subretinal Fluid|subretinal fluid
198328|NCT02956330|Eylea|eylea
198329|NCT02956330|Aflibercept|aflibercept
198330|NCT02956330|Anti-VEGF|anti-vegf
198331|NCT02956291|glioma|glioma
198332|NCT02956291|brain tumor|brain tumor
198333|NCT02956291|brain metastasis|brain metastasis
198334|NCT02956278|allopurinol|allopurinol
198335|NCT02956252|cholecystectomy, laparoscopic|cholecystectomy, laparoscopic
198336|NCT02956252|spinal anesthesia|spinal anesthesia
198337|NCT02956252|general anesthesia|general anesthesia
198338|NCT02956252|cholecystectomy|cholecystectomy
198339|NCT02956239|cervical precancer|cervical precancer
198340|NCT02956239|screening|screening
198341|NCT02956239|treatment|treatment
198342|NCT02956239|thermo-coagulation|thermo-coagulation
198343|NCT02956239|thermal ablation|thermal ablation
198344|NCT02956239|Reducing overtreatment|reducing overtreatment
198345|NCT02956213|COPD|copd
198346|NCT02956213|air filter|air filter
198347|NCT02956213|indoor air quality|indoor air quality
198348|NCT02956213|respiratory symptoms|respiratory symptoms
198349|NCT02956213|emphysema|emphysema
198350|NCT02956213|chronic obstructive pulmonary disease|chronic obstructive pulmonary disease
198351|NCT02956213|tobacco use|tobacco use
198352|NCT02956200|Fingolimod Hydrochloride|fingolimod hydrochloride
198353|NCT02956200|Intravenous thrombolysis|intravenous thrombolysis
198354|NCT02956200|Mechanical thrombectomy|mechanical thrombectomy
198355|NCT02956200|Acute ischemic stroke|acute ischemic stroke
198356|NCT02956161|Sleep|sleep
198357|NCT02956161|Auditory stimulations|auditory stimulations
198358|NCT02956161|Slow oscillations|slow oscillations
198359|NCT02956096|tDCS|tdcs
198360|NCT02956096|Stroke|stroke
198361|NCT02956096|Autonomic Modulation|autonomic modulation
198362|NCT02956070|dental bleaching|dental bleaching
198363|NCT02956070|antiinflammatory|antiinflammatory
198364|NCT02956070|tooth sensitivity|tooth sensitivity
198365|NCT02956031|cancer prevention|cancer prevention
198366|NCT02956031|cervical screening|cervical screening
198367|NCT02956031|cervical cancer|cervical cancer
198368|NCT02956031|cervical disease|cervical disease
198369|NCT02956031|cervical neoplasm|cervical neoplasm
198370|NCT02956031|HPV testing|hpv testing
198371|NCT02956031|immunocytochemistry|immunocytochemistry
198372|NCT02956031|triage techniques|triage techniques
198373|NCT02956018|children|children
198374|NCT02955979|acute renal insufficiency|acute renal insufficiency
198375|NCT02955979|Iodinated Contrast Agents|iodinated contrast agents
198376|NCT02955979|pediatric|pediatric
198377|NCT02955966|Aspergillosis|aspergillosis
198378|NCT02955966|Haematological malignancy|haematological malignancy
198379|NCT02955966|18F-FDG PET/CT|18f-fdg pet/ct
198380|NCT02955966|Biomarkers|biomarkers
198381|NCT02955940|Solid tumors|solid tumors
198382|NCT02955940|ruxolitinib|ruxolitinib
198383|NCT02955940|regorafenib|regorafenib
198384|NCT02955940|capecitabine|capecitabine
198385|NCT02955927|Myopia control,ortho-k, atropine eye drops, children|myopia control,ortho-k, atropine eye drops, children
198386|NCT02955914|Optimism|optimism
198387|NCT02955914|Pessimism|pessimism
198388|NCT02955914|Recovery|recovery
198389|NCT02955914|Elective Cardiac surgery|elective cardiac surgery
198390|NCT02955901|Randomized controlled trial|randomized controlled trial
198391|NCT02955901|Colonoscopy|colonoscopy
198392|NCT02955901|Colon Disease|colon disease
198393|NCT02955901|Low residue diet|low residue diet
198394|NCT02955901|Colon preparation|colon preparation
198395|NCT02955875|Diabetes Mellitus, Type 2|diabetes mellitus, type 2
198396|NCT02955875|Pharmaceutical Services|pharmaceutical services
198397|NCT02955862|Cryptococcal antigenemia|cryptococcal antigenemia
198398|NCT02955862|Cryptococcal meningitis|cryptococcal meningitis
198399|NCT02955862|HIV/AIDS|hiv/aids
198400|NCT02955849|glaucoma|glaucoma
198401|NCT02955849|rural|rural
198402|NCT02955849|China|china
198404|NCT02955836|Patient Safety|patient safety
198405|NCT02955836|Quality indicator|quality indicator
198406|NCT02955836|Information system|information system
198407|NCT02955836|Nursing|nursing
198408|NCT02955836|Healthcare Quality|healthcare quality
198409|NCT02955836|Quality measurement|quality measurement
198410|NCT02955823|B cell Lymphoma|b cell lymphoma
198411|NCT02955823|non-Hodgkin Lymphoma|non-hodgkin lymphoma
198412|NCT02955823|Elderly patients|elderly patients
198413|NCT02955810|Newly Diagnosed|newly diagnosed
198414|NCT02955810|Treatment Naiive|treatment naiive
198415|NCT02955797|Meningitis|meningitis
198416|NCT02955797|Meningococcal Meningitis|meningococcal meningitis
198417|NCT02955797|MenACYW conjugate vaccine|menacyw conjugate vaccine
198418|NCT02955797|Nimenrix®|nimenrix®
198419|NCT02955797|Menjugate®|menjugate®
198420|NCT02955771|photodynamic therapy(PDT)|photodynamic therapy(pdt)
198421|NCT02955771|stenting|stenting
198422|NCT02955771|Hilar Cholangiocarcinoma|hilar cholangiocarcinoma
198423|NCT02955771|Deuteporfin|deuteporfin
198424|NCT02955719|Collaborative Care|collaborative care
198425|NCT02955719|Depression|depression
198426|NCT02955719|Anxiety|anxiety
198427|NCT02955719|Mild Cognitive Impairment|mild cognitive impairment
198428|NCT02955719|Integrated Care Pathway|integrated care pathway
198429|NCT02955693|Pharmacokinetics|pharmacokinetics
198430|NCT02955693|Healthy volunteers|healthy volunteers
198431|NCT02955693|Monomethylfumarate|monomethylfumarate
198432|NCT02955693|Dimethyl fumarate|dimethyl fumarate
198433|NCT02955693|Fumaderm®|fumaderm®
198434|NCT02955693|Ethyl fumarate|ethyl fumarate
198435|NCT02955680|emergence delirium|emergence delirium
198436|NCT02955680|emergence time|emergence time
198437|NCT02955680|bispectral index|bispectral index
198438|NCT02955667|invivo microscopy|invivo microscopy
198439|NCT02955667|colposcopy|colposcopy
198440|NCT02955667|cervical precancer and cancer|cervical precancer and cancer
198441|NCT02955641|Laser peripheral iridotomy|laser peripheral iridotomy
198442|NCT02955641|topical anti-inflammatory drops|topical anti-inflammatory drops
198443|NCT02955602|PBC|pbc
198444|NCT02955602|Primary Biliary Cholangitis (PBC)|primary biliary cholangitis (pbc)
198445|NCT02955576|Psoriasis|psoriasis
198446|NCT02955563|decision making for incapacitated patients|decision making for incapacitated patients
198447|NCT02955563|intensive care|intensive care
198448|NCT02955563|surrogate decision making|surrogate decision making
198449|NCT02955563|patient centered care|patient centered care
198450|NCT02955563|Palliative Care|palliative care
198451|NCT02955563|End of Life|end of life
198452|NCT02955563|Quality of Communication|quality of communication
198453|NCT02955563|Anxiety|anxiety
198454|NCT02955563|Depression|depression
198455|NCT02955550|Multiple Myeloma|multiple myeloma
198456|NCT02955550|Plasma Cell Myeloma|plasma cell myeloma
198457|NCT02955550|Plasma Cell Neoplasm|plasma cell neoplasm
198458|NCT02955550|Relapsed/refractory Myeloma|relapsed/refractory myeloma
198459|NCT02955550|PNK-007|pnk-007
198460|NCT02955550|Recombinant Human IL-2 (RHIL-2)|recombinant human il-2 (rhil-2)
198461|NCT02955550|Human IL-2|human il-2
198462|NCT02955550|Bone Marrow Transplant|bone marrow transplant
198463|NCT02955537|Hypertension|hypertension
198464|NCT02955537|mHealth|mhealth
198465|NCT02955485|Ankle|ankle
198466|NCT02955485|Instability|instability
198467|NCT02955485|Prediction|prediction
198468|NCT02955472|Neuralgia, Postherpetic|neuralgia, postherpetic
198469|NCT02955472|Postherpetic Neuralgia|postherpetic neuralgia
198470|NCT02955472|Diabetic Neuropathies|diabetic neuropathies
198471|NCT02955472|Diabetic Neuralgia|diabetic neuralgia
198472|NCT02955472|Diabetic Polyneuropathy|diabetic polyneuropathy
198473|NCT02955472|Diabetic Neuropathy, Painful|diabetic neuropathy, painful
198474|NCT02955472|Neuralgia|neuralgia
198475|NCT02955472|Neuropathic Pain|neuropathic pain
253758|NCT02616640|PD-L1|pd-l1
198476|NCT02955472|Pregabalin|pregabalin
198477|NCT02955472|Pharmacokinetics|pharmacokinetics
198478|NCT02955472|Bioequivalent|bioequivalent
198479|NCT02955459|Healthy volunteers|healthy volunteers
198480|NCT02955459|Pharmacokinetics|pharmacokinetics
198481|NCT02955446|Refractory Tumors|refractory tumors
198482|NCT02955446|Advanced Solid Tumors|advanced solid tumors
198483|NCT02955433|Rideshare|rideshare
198484|NCT02955433|Digital transportation network|digital transportation network
198485|NCT02955433|Missed appointment|missed appointment
198486|NCT02955420|Autoantibodies|autoantibodies
198487|NCT02955420|Heart Failure|heart failure
198488|NCT02955420|Fatigue Syndrome, Chronic|fatigue syndrome, chronic
198489|NCT02955420|Idiopathic Pulmonary Hypertension|idiopathic pulmonary hypertension
198490|NCT02955420|Cardiomyopathies|cardiomyopathies
198491|NCT02955394|ER+/Her2 - breast cancer|er+/her2 - breast cancer
198492|NCT02955394|Preoperative Fulvestrant|preoperative fulvestrant
198493|NCT02955394|Enzalutamide|enzalutamide
198494|NCT02955368|DP-R212|dp-r212
198495|NCT02955329|THC|thc
198496|NCT02955329|Tobacco|tobacco
198497|NCT02955329|Vaping|vaping
198498|NCT02955303|Cognitive training|cognitive training
198499|NCT02955303|Tablet computers|tablet computers
198500|NCT02955277|Cognitive training|cognitive training
198501|NCT02955277|Tablet computers|tablet computers
198502|NCT02955264|Glycosylation|glycosylation
198503|NCT02955264|Glucose Metabolic Disorder|glucose metabolic disorder
198504|NCT02955264|Galactose|galactose
198505|NCT02955251|Cancer|cancer
198506|NCT02955251|Neoplasm|neoplasm
198507|NCT02955251|Advanced solid tumor|advanced solid tumor
198508|NCT02955251|Nivolumab|nivolumab
198509|NCT02955251|Non-small cell lung cancer (NSCLC)|non-small cell lung cancer (nsclc)
198510|NCT02955251|Non-squamous NSCLC|non-squamous nsclc
198511|NCT02955251|Ovarian cancer|ovarian cancer
198512|NCT02955238|Intervention|intervention
198513|NCT02955238|Cardiovascular Disease|cardiovascular disease
198514|NCT02955238|CVD|cvd
198515|NCT02955238|Diabetes|diabetes
198516|NCT02955238|Latinos|latinos
198517|NCT02955238|CIMT|cimt
198518|NCT02955238|Medication Adherence|medication adherence
198519|NCT02955238|Risk Factors|risk factors
198520|NCT02955238|T2D|t2d
198521|NCT02955225|Knee loads|knee loads
198522|NCT02955225|Knee adduction moment|knee adduction moment
198523|NCT02955225|Biomechanical intervention|biomechanical intervention
198524|NCT02955225|Insole|insole
198525|NCT02955225|Shoe|shoe
198526|NCT02955212|Rheumatoid Arthritis|rheumatoid arthritis
198527|NCT02955212|Conventional Synthetic Disease-Modifying Anti-Rheumatic Drugs (csDMARDs)|conventional synthetic disease-modifying anti-rheumatic drugs (csdmards)
198528|NCT02955212|ABT-494|abt-494
198630|NCT02954536|esophagogastric cancer|esophagogastric cancer
198529|NCT02955134|central blinded histological assessment|central blinded histological assessment
198530|NCT02955134|traditional Chinese medicine intervention|traditional chinese medicine intervention
198531|NCT02955134|biological specimen banks|biological specimen banks
198532|NCT02955121|Cytochrome P-450 CYP2C19|cytochrome p-450 cyp2c19
198533|NCT02955121|Pharmacogenetics|pharmacogenetics
198534|NCT02955121|Platelet Aggregation Inhibitors|platelet aggregation inhibitors
198535|NCT02955121|Percutaneous Coronary Intervention|percutaneous coronary intervention
198536|NCT02955069|Advanced or metastatic|advanced or metastatic
198537|NCT02955069|NET|net
198538|NCT02955069|pNET|pnet
198539|NCT02955069|GI NET|gi net
198540|NCT02955069|thoracic NET|thoracic net
198541|NCT02955069|GEP-NEC|gep-nec
198542|NCT02955056|Weber B|weber b
198543|NCT02955043|Hematopoietic Stem Cell Transplantation (HSCT)|hematopoietic stem cell transplantation (hsct)
198544|NCT02955043|Fatigue|fatigue
198545|NCT02955043|Insomnia|insomnia
198546|NCT02955043|Depression|depression
198547|NCT02955043|Behavioral Intervention|behavioral intervention
198548|NCT02955017|obesity|obesity
198549|NCT02955017|children|children
198550|NCT02955017|adolescents|adolescents
198551|NCT02955017|new technology|new technology
198552|NCT02955017|mobile health|mobile health
198553|NCT02955017|chronic disease|chronic disease
198554|NCT02955004|silent brain embolism|silent brain embolism
198555|NCT02955004|atrial fibrillation|atrial fibrillation
198556|NCT02955004|cardioversion|cardioversion
198557|NCT02954965|graduate student|graduate student
198558|NCT02954965|burnout|burnout
198559|NCT02954965|stress|stress
198560|NCT02954965|mood|mood
198561|NCT02954939|lupus nephritis|lupus nephritis
198562|NCT02954939|lymphocyte subsets|lymphocyte subsets
198563|NCT02954939|cytokines|cytokines
198564|NCT02954939|mycophenolate mofetil|mycophenolate mofetil
198565|NCT02954939|cyclophosphamide|cyclophosphamide
198566|NCT02954900|Breast Cancer Prevention|breast cancer prevention
198567|NCT02954900|Risk Assessment|risk assessment
198568|NCT02954900|Chemoprevention|chemoprevention
198569|NCT02954900|Decision Making|decision making
198570|NCT02954887|GWP42003-P|gwp42003-p
198571|NCT02954887|Cannabidiol|cannabidiol
198572|NCT02954848|Drug therapy|drug therapy
198573|NCT02954809|fatigue|fatigue
198574|NCT02954809|sleep disturbances|sleep disturbances
198575|NCT02954809|circadian activity rhythms|circadian activity rhythms
198576|NCT02954783|Prostate cancer|prostate cancer
198577|NCT02954783|Localized|localized
198578|NCT02954783|Exercise|exercise
198579|NCT02954783|Physical activity|physical activity
198580|NCT02954783|Natural killer cells|natural killer cells
198581|NCT02954783|Immune cells|immune cells
198582|NCT02954757|uterine adenomyosis|uterine adenomyosis
198583|NCT02954744|uterine fibroid|uterine fibroid
198584|NCT02954731|Cognitive Behavior Therapy|cognitive behavior therapy
198585|NCT02954731|Negative Affect|negative affect
198586|NCT02954731|Unified Protocol|unified protocol
198587|NCT02954731|Session Tracking|session tracking
198588|NCT02954731|Mechanisms of Change in Psychotherapy|mechanisms of change in psychotherapy
198589|NCT02954718|activity performance|activity performance
198590|NCT02954718|juvenile idiopathic arthritis|juvenile idiopathic arthritis
198591|NCT02954718|virtual reality|virtual reality
198592|NCT02954679|Psychoactive Substances Consumption|psychoactive substances consumption
198593|NCT02954679|Substance-related Disorder|substance-related disorder
198594|NCT02954679|Off label-use|off label-use
198595|NCT02954679|Cognitive Enhancement|cognitive enhancement
198596|NCT02954679|Students|students
198597|NCT02954679|Doping|doping
198598|NCT02954679|Stimulants|stimulants
198599|NCT02954679|Drug abuse|drug abuse
198600|NCT02954679|Methylphenidate|methylphenidate
198601|NCT02954679|Addictovigilance|addictovigilance
198602|NCT02954679|CEIP|ceip
198603|NCT02954666|cardio-neuromodulation|cardio-neuromodulation
198604|NCT02954666|cardio-neuroablation|cardio-neuroablation
198605|NCT02954666|ablation|ablation
198606|NCT02954666|ganglionated plexi|ganglionated plexi
198607|NCT02954666|anterior right ganglionated plexus|anterior right ganglionated plexus
198608|NCT02954666|syncope|syncope
198609|NCT02954653|relapsed|relapsed
198610|NCT02954653|refractory|refractory
198611|NCT02954653|acute myeloid leukemia|acute myeloid leukemia
198612|NCT02954653|AML|aml
198613|NCT02954627|Osteoarthritis|osteoarthritis
198614|NCT02954627|Obesity|obesity
198615|NCT02954627|Liraglutide 3 mg|liraglutide 3 mg
198616|NCT02954627|Liraglutide|liraglutide
198617|NCT02954627|Ultrasound|ultrasound
198618|NCT02954601|Oral Insulin|oral insulin
198619|NCT02954601|DM T2 (Diabetes Mellitus Type 2)|dm t2 (diabetes mellitus type 2)
198620|NCT02954562|anxiety|anxiety
198621|NCT02954562|fMRI|fmri
198622|NCT02954562|emotion regulation|emotion regulation
198623|NCT02954549|vitamin D deficiency, genomics, vitamin D supplementation|vitamin d deficiency, genomics, vitamin d supplementation
198624|NCT02954536|pembrolizumab|pembrolizumab
198625|NCT02954536|trastuzumab|trastuzumab
198626|NCT02954536|capecitabine|capecitabine
198627|NCT02954536|cisplatin|cisplatin
198628|NCT02954536|Stage IV|stage iv
198629|NCT02954536|HER2-positive|her2-positive
198632|NCT02954536|Oxaliplatin|oxaliplatin
198633|NCT02954536|5-Fluorouracil (5-FU)|5-fluorouracil (5-fu)
198634|NCT02954523|NSCLC|nsclc
198635|NCT02954523|Non-small cell|non-small cell
198636|NCT02954523|Lung Cancer|lung cancer
198637|NCT02954523|Dasatinib|dasatinib
198638|NCT02954523|Osimertinib|osimertinib
198639|NCT02954523|AZD9291|azd9291
198640|NCT02954523|EGFR Mutations|egfr mutations
198641|NCT02954523|Epidermal growth factor receptor (EGFR)|epidermal growth factor receptor (egfr)
198642|NCT02954445|BCMA|bcma
198643|NCT02954445|CAR-T|car-t
198644|NCT02954432|transcranial Direct Current Stimulation|transcranial direct current stimulation
198645|NCT02954432|Transcranial Ultrasound|transcranial ultrasound
198646|NCT02954432|non-invasive brain stimulation|non-invasive brain stimulation
198647|NCT02954419|IgA Nephropathy|iga nephropathy
198648|NCT02954419|Biomarker|biomarker
198649|NCT02954406|Drug Therapy|drug therapy
198650|NCT02954393|Periodontal disease|periodontal disease
198651|NCT02954393|Metronidazole|metronidazole
198652|NCT02954393|Amoxicillin|amoxicillin
198653|NCT02954393|Scaling and root planing|scaling and root planing
198654|NCT02954393|Healing phase|healing phase
198656|NCT02954354|Baloxavir Marboxil|baloxavir marboxil
198657|NCT02954354|Oseltamivir|oseltamivir
198658|NCT02954354|Tamiflu®|tamiflu®
198659|NCT02954302|Delayed gastric emptying|delayed gastric emptying
198660|NCT02954302|pancreaticoduodenectomy|pancreaticoduodenectomy
198661|NCT02954289|modifiable risk factors|modifiable risk factors
198662|NCT02954289|lifestyle|lifestyle
198663|NCT02954289|nutrition|nutrition
198664|NCT02954289|weight control|weight control
198665|NCT02954289|dietary intervention|dietary intervention
198666|NCT02954289|health promotion|health promotion
198667|NCT02954289|patient-partner outcomes|patient-partner outcomes
198668|NCT02954289|survivorship|survivorship
198669|NCT02954289|prostate cancer outcomes|prostate cancer outcomes
198670|NCT02954276|safety|safety
198671|NCT02954263|Multiple ascending dose (MAD)|multiple ascending dose (mad)
198672|NCT02954237|Non-valvular atrial fibrillation (NVAF)|non-valvular atrial fibrillation (nvaf)
198673|NCT02954237|Anticoagulant|anticoagulant
198674|NCT02954237|Warfarin|warfarin
198675|NCT02954237|Stroke|stroke
198676|NCT02954224|sleep apnea, delirium|sleep apnea, delirium
198677|NCT02954211|rTMS|rtms
198678|NCT02954211|noninvasive brain stimulation|noninvasive brain stimulation
198679|NCT02954211|physical therapy|physical therapy
198680|NCT02954185|Shoulder Pain|shoulder pain
198681|NCT02954146|Veterans|veterans
198682|NCT02954146|Posttraumatic Stress Disorder|posttraumatic stress disorder
198683|NCT02954146|Anger|anger
198684|NCT02954146|Behavioral Health|behavioral health
198685|NCT02954146|Mobile Health Technology|mobile health technology
198686|NCT02954133|Alignment phase|alignment phase
198687|NCT02954133|Photobiomodulation|photobiomodulation
198688|NCT02954133|Orthodontic treatment|orthodontic treatment
198689|NCT02954133|Malocclusion|malocclusion
198690|NCT02954133|OrthoPulse™|orthopulse™
198691|NCT02954133|Invisalign|invisalign
198692|NCT02954120|8- hydroxy -2´- deoxyguanosine|8- hydroxy -2´- deoxyguanosine
198693|NCT02954120|Malondialdehyde|malondialdehyde
198694|NCT02954120|Total antioxidant status|total antioxidant status
198695|NCT02954120|Oxidative stres|oxidative stres
198696|NCT02954068|Oxytocin|oxytocin
198697|NCT02954055|locally advanced|locally advanced
198698|NCT02954055|metastatic|metastatic
198699|NCT02954055|breast cancer|breast cancer
198700|NCT02954055|ER-positive|er-positive
198701|NCT02954055|HER2-negative|her2-negative
198702|NCT02954055|Stage IV|stage iv
198703|NCT02954042|Incontinence|incontinence
198704|NCT02954016|Obesity|obesity
198705|NCT02954016|Weight Loss|weight loss
198706|NCT02954016|Hypertension|hypertension
198707|NCT02954016|Type 2 Diabetes Mellitus|type 2 diabetes mellitus
198708|NCT02954016|Hyperlipidemia|hyperlipidemia
198709|NCT02954003|Obesity|obesity
198710|NCT02954003|Weight Loss|weight loss
198711|NCT02953990|Pregnancy|pregnancy
198712|NCT02953990|Self-Management|self-management
198713|NCT02953990|Yoga|yoga
198714|NCT02953951|blood transfusion|blood transfusion
198715|NCT02953951|free hemoglobin|free hemoglobin
198716|NCT02953951|nitric oxide|nitric oxide
198717|NCT02953951|endothelium-dependent vasodilatation|endothelium-dependent vasodilatation
198718|NCT02953951|peripheral artery tonometry|peripheral artery tonometry
198719|NCT02953951|cardiac surgery.|cardiac surgery.
198720|NCT02953938|Ranibizumab|ranibizumab
198721|NCT02953938|Grid&Direct short pulse laser photocoagulation|grid&direct short pulse laser photocoagulation
198722|NCT02953938|Macular edema|macular edema
198723|NCT02953938|Branch retinal vein occlusion|branch retinal vein occlusion
198724|NCT02953938|BRVO|brvo
198725|NCT02953938|BCVA|bcva
198726|NCT02953938|CSFT|csft
198727|NCT02953938|pro re nata|pro re nata
198728|NCT02953925|primary health care|primary health care
198729|NCT02953925|village doctor|village doctor
198730|NCT02953925|township hospital|township hospital
198731|NCT02953925|community health center|community health center
198732|NCT02953912|Rotation|rotation
198733|NCT02953912|Reciprocation|reciprocation
198734|NCT02953912|single file|single file
198735|NCT02953912|postoperative pain|postoperative pain
198736|NCT02953912|Reciproc|reciproc
198737|NCT02953912|One Shape|one shape
198738|NCT02953912|Symptomatic irreversible pulpitis|symptomatic irreversible pulpitis
198739|NCT02953899|Internet|internet
198740|NCT02953899|Contingency Management|contingency management
198741|NCT02953899|Gambling Disorder|gambling disorder
198742|NCT02953899|Rural|rural
198743|NCT02953886|Caries|caries
198744|NCT02953886|Cavity|cavity
198745|NCT02953886|Silver Diamine Fluoride (SDF)|silver diamine fluoride (sdf)
198746|NCT02953886|HOMINGS|homings
198747|NCT02953860|Advanced Breast Cancer|advanced breast cancer
198748|NCT02953860|ER+/Her2 Advanced Breast Cancer|er+/her2 advanced breast cancer
198749|NCT02953834|insulin regulation in pregnancy|insulin regulation in pregnancy
198750|NCT02953834|kisspeptin|kisspeptin
198751|NCT02953808|GSK2315698|gsk2315698
198752|NCT02953808|Dose-ascending|dose-ascending
198753|NCT02953808|Systemic amyloidosis|systemic amyloidosis
198754|NCT02953782|Colorectal Neoplasms, Hu5F9-G4, CD47, cetuximab|colorectal neoplasms, hu5f9-g4, cd47, cetuximab
198755|NCT02953756|Brain metastases|brain metastases
198756|NCT02953756|Cognition|cognition
198757|NCT02953756|Radiosurgery|radiosurgery
198758|NCT02953756|Stereotactic radiosurgery|stereotactic radiosurgery
198759|NCT02953756|Gamma Knife Radiosurgery|gamma knife radiosurgery
198760|NCT02953756|Quality of Life|quality of life
198761|NCT02953756|Fatigue|fatigue
198762|NCT02953756|Anxiety|anxiety
198763|NCT02953756|Depression|depression
198764|NCT02953743|E7080|e7080
198765|NCT02953743|Lenvatinib|lenvatinib
198766|NCT02953743|Pharmacokinetic study|pharmacokinetic study
198767|NCT02953743|Chinese participants|chinese participants
198768|NCT02953743|Unresectable Hepatocellular Carcinoma|unresectable hepatocellular carcinoma
198769|NCT02953717|Brain metastases|brain metastases
198770|NCT02953717|Cognition|cognition
198771|NCT02953717|Radiosurgery|radiosurgery
198772|NCT02953717|Gamma Knife Radiosurgery|gamma knife radiosurgery
198773|NCT02953717|Stereotactic radiosurgery|stereotactic radiosurgery
198774|NCT02953717|Whole Brain Radiation Therapy|whole brain radiation therapy
198775|NCT02953717|Quality of Life|quality of life
198776|NCT02953717|Fatigue|fatigue
198777|NCT02953717|Anxiety|anxiety
198778|NCT02953717|Depression|depression
198779|NCT02953704|Myelofibrosis|myelofibrosis
198780|NCT02953704|essential thrombocythemia|essential thrombocythemia
198781|NCT02953704|clinical characteristics|clinical characteristics
198782|NCT02953704|disease burden|disease burden
198783|NCT02953704|patient-reported outcomes|patient-reported outcomes
198784|NCT02953691|perioperative|perioperative
198785|NCT02953691|surgery|surgery
198786|NCT02953691|pain|pain
198787|NCT02953691|anxiety|anxiety
198788|NCT02953691|post operative cognitive dysfunction|post operative cognitive dysfunction
198789|NCT02953691|cognition|cognition
198790|NCT02953678|Graft-versus-host disease (GVHD)|graft-versus-host disease (gvhd)
198791|NCT02953678|acute GVHD|acute gvhd
198792|NCT02953678|steroid-refractory|steroid-refractory
198793|NCT02953678|ruxolitinib|ruxolitinib
198794|NCT02953678|Janus kinase inhibitor|janus kinase inhibitor
198795|NCT02953665|Parkinson's Disease, Liraglutide|parkinson's disease, liraglutide
198796|NCT02953665|Antidiabetic agents|antidiabetic agents
198797|NCT02953665|GLP-1 agonists|glp-1 agonists
198798|NCT02953665|Insulin resistance|insulin resistance
198799|NCT02953626|pilot RCT|pilot rct
198800|NCT02953626|waitlist-controlled RCT|waitlist-controlled rct
198801|NCT02953626|postpartum depression|postpartum depression
198802|NCT02953613|Cardiac Catheterization|cardiac catheterization
198803|NCT02953613|Cardiac intervention|cardiac intervention
198804|NCT02953613|coronary angiogram|coronary angiogram
198805|NCT02953613|coronary artery disease|coronary artery disease
198806|NCT02953613|atherosclerosis|atherosclerosis
198807|NCT02953587|Obesity|obesity
198808|NCT02953587|Bariatric Surgery|bariatric surgery
198809|NCT02953574|geriatric nursing|geriatric nursing
198810|NCT02953548|GWP42003-P|gwp42003-p
198811|NCT02953548|Cannabidiol|cannabidiol
198812|NCT02953522|Polymorphism|polymorphism
198813|NCT02953522|Folate|folate
198814|NCT02953522|Oxidative stress|oxidative stress
198815|NCT02953522|Overweight and Obesity|overweight and obesity
198816|NCT02953509|non-Hodgkin's lymphoma|non-hodgkin's lymphoma
198817|NCT02953509|diffuse large B-cell lymphoma|diffuse large b-cell lymphoma
198818|NCT02953509|indolent lymphoma|indolent lymphoma
198819|NCT02953509|Hu5F9-G4|hu5f9-g4
198820|NCT02953509|CD47|cd47
198821|NCT02953496|peripheral artery disease|peripheral artery disease
198822|NCT02953496|PAD|pad
198823|NCT02953496|vonapanitase|vonapanitase
198824|NCT02953496|claudication|claudication
198825|NCT02953496|superficial femoral artery|superficial femoral artery
198826|NCT02953496|SFA|sfa
198827|NCT02953496|popliteal artery|popliteal artery
198828|NCT02953496|stenosis|stenosis
198829|NCT02953496|elastase|elastase
198830|NCT02953496|chymotrypsin-like elastase 1|chymotrypsin-like elastase 1
198831|NCT02953496|CELA1|cela1
198832|NCT02953496|PRT-201|prt-201
198833|NCT02953483|Ex Vivo lung perfusion|ex vivo lung perfusion
198834|NCT02953470|chronic pain|chronic pain
198835|NCT02953470|community-dwelling|community-dwelling
198836|NCT02953470|older adults|older adults
198837|NCT02953470|physical activity|physical activity
198838|NCT02953470|physiotherapy|physiotherapy
198839|NCT02953470|behavioural medicine|behavioural medicine
198840|NCT02953470|biopsychosocial|biopsychosocial
198841|NCT02953470|exercise|exercise
198842|NCT02953470|independency|independency
198843|NCT02953470|everyday activities|everyday activities
198844|NCT02953470|self-efficacy|self-efficacy
198845|NCT02953470|quality of life|quality of life
198846|NCT02953470|pain-related beliefs|pain-related beliefs
198847|NCT02953470|pain-related disability|pain-related disability
198848|NCT02953431|Asthma|asthma
198849|NCT02953431|Obesity|obesity
198850|NCT02953353|Obesity|obesity
198851|NCT02953353|Feeding behavior|feeding behavior
198852|NCT02953353|Transcranial direct current stimulation|transcranial direct current stimulation
198853|NCT02953353|Weight loss|weight loss
198854|NCT02953340|Neutropenia|neutropenia
198855|NCT02953340|Breast Cancer|breast cancer
198856|NCT02953340|Long-acting Myeloid Growth Factor|long-acting myeloid growth factor
198857|NCT02953340|Early Stage Breast Cancer|early stage breast cancer
198858|NCT02953340|Docetaxel + Cyclophosphamide (TC) chemotherapy|docetaxel + cyclophosphamide (tc) chemotherapy
198859|NCT02953327|Non-Specific Effect of Vaccine|non-specific effect of vaccine
198860|NCT02953327|Middle aged|middle aged
198861|NCT02953327|Immunity, heterologous|immunity, heterologous
198862|NCT02953301|Cutaneous T-Cell Lymphoma (CTLC)|cutaneous t-cell lymphoma (ctlc)
198863|NCT02953301|Maintenance|maintenance
198864|NCT02953301|resminostat|resminostat
198865|NCT02953301|4SC|4sc
198866|NCT02953301|HDAC|hdac
198867|NCT02953301|Mycosis Fungoides|mycosis fungoides
198868|NCT02953301|Sézary Syndrome|sézary syndrome
198869|NCT02953262|Diabetes Mellitus|diabetes mellitus
198870|NCT02953262|Personal Health Records|personal health records
198871|NCT02953262|Patient Outcome Assessment|patient outcome assessment
254301|NCT02612987|CBT|cbt
198872|NCT02953262|Mental Health|mental health
198873|NCT02953184|neoadjuvant chemotherapy|neoadjuvant chemotherapy
198874|NCT02953184|Pegylated liposomal doxorubicin|pegylated liposomal doxorubicin
198875|NCT02953184|breast cancer|breast cancer
198876|NCT02953171|Irritable Bowel Syndrome|irritable bowel syndrome
198877|NCT02953171|The human microbiome|the human microbiome
198878|NCT02953171|Microbiota|microbiota
198879|NCT02953171|Gut microbiota|gut microbiota
198880|NCT02953171|Probiotics|probiotics
198881|NCT02953171|Sauerkraut|sauerkraut
198883|NCT02953106|Rhinitis|rhinitis
198884|NCT02953106|Dymista|dymista
198885|NCT02953106|allergy|allergy
198886|NCT02953093|acarbose|acarbose
198887|NCT02953093|aging|aging
198888|NCT02953054|Pain|pain
198889|NCT02953054|Bunionectomy|bunionectomy
198890|NCT02953054|Dexmedetomidine|dexmedetomidine
198891|NCT02953054|Transdermal|transdermal
198892|NCT02953054|Patch|patch
198893|NCT02953054|Postoperative|postoperative
198894|NCT02953054|DMTS|dmts
198895|NCT02953028|Continuous Positive Airway Pressure|continuous positive airway pressure
198896|NCT02953028|Mandibular Advancing Splint|mandibular advancing splint
198897|NCT02953028|Efficacy|efficacy
198898|NCT02953028|Compliance|compliance
198899|NCT02953028|Health related quality of life|health related quality of life
198900|NCT02953028|Randomized Controlled Trial|randomized controlled trial
198901|NCT02953028|Snoring|snoring
198902|NCT02953028|Mandibular Advancing Appliance|mandibular advancing appliance
198903|NCT02953028|Mandibular Advancing Device|mandibular advancing device
198904|NCT02953028|Humans|humans
198905|NCT02953028|Quality of Life|quality of life
198906|NCT02953028|Sleep Apnea, Obstructive|sleep apnea, obstructive
198907|NCT02953015|Chronic Migraine|chronic migraine
198908|NCT02953015|Manipulative treatments|manipulative treatments
198909|NCT02953015|Transcutaneous Electrical Nerve Stimulation|transcutaneous electrical nerve stimulation
198910|NCT02952989|MSI-high|msi-high
198911|NCT02952989|dMMR|dmmr
198912|NCT02952989|PD-L1|pd-l1
198913|NCT02952976|open abdomen|open abdomen
198914|NCT02952976|Damage control|damage control
198915|NCT02952976|Abdominal Compartment Syndrome|abdominal compartment syndrome
198916|NCT02952950|Intra Oral Vacuum|intra oral vacuum
198917|NCT02952950|protein content breastmilk|protein content breastmilk
198918|NCT02952937|Neuralgia, Postherpetic|neuralgia, postherpetic
198919|NCT02952937|Postherpetic Neuralgia|postherpetic neuralgia
198920|NCT02952937|Diabetic Neuropathies|diabetic neuropathies
198921|NCT02952937|Diabetic Neuralgia|diabetic neuralgia
198922|NCT02952937|Diabetic Polyneuropathy|diabetic polyneuropathy
198923|NCT02952937|Diabetic Neuropathy, Painful|diabetic neuropathy, painful
198924|NCT02952937|Neuralgia|neuralgia
198925|NCT02952937|Neuropathic Pain|neuropathic pain
198926|NCT02952937|Pregabalin|pregabalin
198927|NCT02952937|Pharmacokinetics|pharmacokinetics
198928|NCT02952937|Bioequivalent|bioequivalent
198929|NCT02952898|solar keratoses|solar keratoses
198930|NCT02952872|Computerized Brief Intervention|computerized brief intervention
198931|NCT02952833|Inactivated|inactivated
198932|NCT02952833|Phase I|phase i
198933|NCT02952833|placebo-controlled|placebo-controlled
198934|NCT02952833|Vaccine|vaccine
198935|NCT02952833|ZIKA|zika
198936|NCT02952820|insomnia|insomnia
198937|NCT02952794|endoscopic submucosal dissection (ESD)|endoscopic submucosal dissection (esd)
198938|NCT02952794|endoscopic mucosal band ligation (EMBL)|endoscopic mucosal band ligation (embl)
198939|NCT02952781|ECG Monitoring|ecg monitoring
198940|NCT02952781|Palpitations|palpitations
198941|NCT02952716|carbon monoxide poisoning|carbon monoxide poisoning
198942|NCT02952716|delayed encephalopathy|delayed encephalopathy
198943|NCT02952638|Lipids|lipids
198944|NCT02952638|lysophosphatidic acid|lysophosphatidic acid
198945|NCT02952638|Lysophospholipids|lysophospholipids
198946|NCT02952638|phosphatidylcholine|phosphatidylcholine
198947|NCT02952638|lysophosphatidylcholine|lysophosphatidylcholine
198948|NCT02952638|autotaxin|autotaxin
198949|NCT02952638|dietary|dietary
198950|NCT02952625|PET/MRI|pet/mri
198951|NCT02952599|Non-interventional Study|non-interventional study
198952|NCT02952599|Real World Evidence|real world evidence
198953|NCT02952599|Patients with Acute VTE treated with Edoxaban|patients with acute vte treated with edoxaban
198954|NCT02952599|Efficacy/Safety|efficacy/safety
198955|NCT02952560|Ultrasound|ultrasound
198956|NCT02952560|Computed Tomography|computed tomography
198957|NCT02952560|Oral cavity size|oral cavity size
198958|NCT02952560|The Mallampati classification|the mallampati classification
198959|NCT02952534|CRPC|crpc
198960|NCT02952534|PARP inhibitor|parp inhibitor
198961|NCT02952534|PARPi|parpi
198962|NCT02952534|BRCA|brca
198964|NCT02952534|HRD|hrd
198965|NCT02952534|TRITON|triton
198966|NCT02952534|homologous recombination|homologous recombination
198967|NCT02952534|DNA repair|dna repair
198968|NCT02952534|DNA defect|dna defect
198969|NCT02952534|DNA anomaly|dna anomaly
198970|NCT02952534|BARD1|bard1
198971|NCT02952534|BRIP1|brip1
198972|NCT02952534|CDK12|cdk12
198973|NCT02952534|CHEK2|chek2
198974|NCT02952534|FANCA|fanca
198975|NCT02952534|NBN|nbn
198976|NCT02952534|PALB2|palb2
198977|NCT02952534|RAD51|rad51
198978|NCT02952534|RAD51B|rad51b
198979|NCT02952534|RAD51C|rad51c
198980|NCT02952534|RAD51D|rad51d
198981|NCT02952534|RAD54L|rad54l
198982|NCT02952534|germline|germline
198983|NCT02952534|somatic|somatic
198984|NCT02952534|mCRPC|mcrpc
198985|NCT02952495|Alcohol Consumption|alcohol consumption
198986|NCT02952495|Older Adults|older adults
198987|NCT02952482|adrenoleukodystrophy|adrenoleukodystrophy
198988|NCT02952482|C26:0-lyso-PC|c26:0-lyso-pc
198989|NCT02952469|Positron-Emission Tomography|positron-emission tomography
198990|NCT02952469|(68Ga)Glu-urea-Lys(Ahx)-HBED-CC|(68ga)glu-urea-lys(ahx)-hbed-cc
198991|NCT02952469|(68Ga)PSMA-HBED-CC|(68ga)psma-hbed-cc
198992|NCT02952469|Glu-NH-CO-NH-Lys-(Ahx)-((68)Ga(HBED-CC))|glu-nh-co-nh-lys-(ahx)-((68)ga(hbed-cc))
198993|NCT02952469|(68)Ga-PSMA|(68)ga-psma
198994|NCT02952469|68Ga-PSMA-11|68ga-psma-11
198995|NCT02952456|SUDEP|sudep
198996|NCT02952456|Epilepsy|epilepsy
198997|NCT02952456|Qualitative research|qualitative research
198998|NCT02952456|Risks associated with epilepsy|risks associated with epilepsy
198999|NCT02952456|Epilepsy-related deaths|epilepsy-related deaths
199000|NCT02952391|cognition|cognition
199001|NCT02952391|cholinergic system|cholinergic system
199002|NCT02952365|LASIK, Ingrowth, Tissue sealant|lasik, ingrowth, tissue sealant
199003|NCT02952300|irreversible pulpitis|irreversible pulpitis
199004|NCT02952300|reciprocation|reciprocation
199005|NCT02952300|rotation|rotation
199006|NCT02952300|single file|single file
199007|NCT02952300|wave one|wave one
199008|NCT02952300|neolix|neolix
199009|NCT02952261|Printing, Three-dimensional|printing, three-dimensional
199010|NCT02952209|Alveolar Ridge Preservation|alveolar ridge preservation
199011|NCT02952209|Xenograft bone graft|xenograft bone graft
199012|NCT02952209|Collagen membrane|collagen membrane
199013|NCT02952196|Amphetamine|amphetamine
199014|NCT02952196|Cannabinoids|cannabinoids
199015|NCT02952183|Autonomic nerve monitoring|autonomic nerve monitoring
199016|NCT02952183|Nerve-sparing surgery|nerve-sparing surgery
199017|NCT02952131|IBD,Crohn's,Ulcerative Bowel; Diverticulitis;IBS;UC|ibd,crohn's,ulcerative bowel; diverticulitis;ibs;uc
199018|NCT02952105|cardiac arrest|cardiac arrest
199019|NCT02952105|identify of electrocardiac rhythm|identify of electrocardiac rhythm
199020|NCT02952105|ventricuar fibrillation|ventricuar fibrillation
199021|NCT02952105|defibrillation|defibrillation
199022|NCT02952092|ASP1517|asp1517
199023|NCT02952092|Renal anemia|renal anemia
199024|NCT02952092|Hemodialysis|hemodialysis
199025|NCT02952092|Roxadustat|roxadustat
199026|NCT02952053|Myofascial Trigger Points|myofascial trigger points
199027|NCT02952053|Dry needling|dry needling
199028|NCT02952053|Myotonometry|myotonometry
199029|NCT02952040|ASP1517|asp1517
199030|NCT02952040|Pharmacokinetics|pharmacokinetics
199031|NCT02952040|Drug-drug interaction|drug-drug interaction
199032|NCT02952001|Uveitis|uveitis
199033|NCT02952001|UME|ume
199034|NCT02952001|Posterior Uveitis|posterior uveitis
199035|NCT02952001|Anterior Uveitis|anterior uveitis
199036|NCT02952001|Intermediate Uveitis|intermediate uveitis
199037|NCT02952001|Panuveitis|panuveitis
199038|NCT02952001|Non-infectious Uveitis|non-infectious uveitis
199039|NCT02952001|Triamcinolone|triamcinolone
199040|NCT02952001|Choroid|choroid
199041|NCT02952001|Choroidal Injection|choroidal injection
199042|NCT02952001|Suprachoroidal|suprachoroidal
199043|NCT02952001|Microneedle|microneedle
199044|NCT02952001|Microinjection|microinjection
199045|NCT02951949|atherosclerosis, endogenous estrogens, age|atherosclerosis, endogenous estrogens, age
199046|NCT02951897|circulating tumor cells|circulating tumor cells
199047|NCT02951897|lung adenocarcinoma|lung adenocarcinoma
199048|NCT02951897|treatment|treatment
199049|NCT02951897|early diagnosis|early diagnosis
199050|NCT02951884|Aspiration|aspiration
199051|NCT02951884|Bupivacaine|bupivacaine
199052|NCT02951884|Epinephrine|epinephrine
199053|NCT02951884|Marcaine|marcaine
199054|NCT02951884|Pain|pain
199055|NCT02951884|Shin Bone|shin bone
199056|NCT02951871|Follicular lymphoma; death, rituximab, treatment related toxicity|follicular lymphoma; death, rituximab, treatment related toxicity
199057|NCT02951858|Alcohol,Smoking,and Substance Use Involvement Screening Test|alcohol,smoking,and substance use involvement screening test
199058|NCT02951858|Brief Intervention|brief intervention
199059|NCT02951858|Substance Use|substance use
199060|NCT02951858|Primary Medical and Health Care Institution|primary medical and health care institution
199061|NCT02951793|intensive care unit|intensive care unit
199062|NCT02951793|delirium|delirium
199063|NCT02951793|substance withdrawal|substance withdrawal
199064|NCT02951767|anti-PD-L1|anti-pd-l1
199065|NCT02951767|PD-L1|pd-l1
199066|NCT02951767|MPDL3280A|mpdl3280a
199067|NCT02951767|PD-1|pd-1
199068|NCT02951767|bladder cancer|bladder cancer
199069|NCT02951767|atezolizumab|atezolizumab
199070|NCT02951767|Tecentriq|tecentriq
199071|NCT02951754|ADHD|adhd
199072|NCT02951754|Adults|adults
199073|NCT02951754|treatment|treatment
199074|NCT02951754|Methylphenidate|methylphenidate
199075|NCT02951650|vagus nerve stimulation|vagus nerve stimulation
199076|NCT02951637|Adenocarcinoma, EGFR, Gefitinib, Pemetrexed, Carboplatin|adenocarcinoma, egfr, gefitinib, pemetrexed, carboplatin
199077|NCT02951624|Exercise|exercise
199078|NCT02951624|Breaking prolonged sitting|breaking prolonged sitting
199079|NCT02951624|physical activity|physical activity
199080|NCT02951572|Noninvasive Ventilation|noninvasive ventilation
199081|NCT02951572|Physical activity|physical activity
199082|NCT02951520|Patients|patients
199083|NCT02951481|Clostridium difficile.|clostridium difficile.
199084|NCT02951481|Antimicrobial Stewardship.|antimicrobial stewardship.
199085|NCT02951481|Enterocolitis, Pseudomembranous|enterocolitis, pseudomembranous
199086|NCT02951442|Arterial stiffness|arterial stiffness
199087|NCT02951442|Klotho-FGF23|klotho-fgf23
199088|NCT02951403|elbow arthroscopy|elbow arthroscopy
199089|NCT02951403|DASH|dash
199090|NCT02951403|elbow locking|elbow locking
199091|NCT02951403|elbow osteoarthritis|elbow osteoarthritis
199092|NCT02951390|Surveillance|surveillance
199093|NCT02951390|Colorectal cancer|colorectal cancer
199094|NCT02951390|Colonoscopy|colonoscopy
199095|NCT02951390|Adenoma|adenoma
199096|NCT02951390|Chromoendoscopy|chromoendoscopy
199097|NCT02951377|mechanical diagnosis therapy (MDT)|mechanical diagnosis therapy (mdt)
199098|NCT02951377|physical therapy|physical therapy
199099|NCT02951377|steroid injection|steroid injection
199100|NCT02951377|exercise|exercise
199101|NCT02951364|observational|observational
199102|NCT02951338|Physical activity|physical activity
199103|NCT02951338|Exercise|exercise
199104|NCT02951338|Behaviour change|behaviour change
199105|NCT02951338|Rehabilitation|rehabilitation
199106|NCT02951338|Self-management|self-management
199107|NCT02951338|Education|education
199108|NCT02951325|adjuvant RT|adjuvant rt
199109|NCT02951312|Emphysema|emphysema
199110|NCT02951312|Chronic bronchitis|chronic bronchitis
199111|NCT02951312|COPD|copd
199112|NCT02951312|Chronic Obstructive Pulmonary Disease|chronic obstructive pulmonary disease
199113|NCT02951286|Skeletal openbite|skeletal openbite
199114|NCT02951286|Molar intrusion|molar intrusion
199115|NCT02951286|high pull headgear|high pull headgear
199116|NCT02951273|abdominal surgery|abdominal surgery
199117|NCT02951273|blood pressure|blood pressure
199118|NCT02951273|cardiac output|cardiac output
199119|NCT02951273|cerebral blood flow|cerebral blood flow
199120|NCT02951273|cerebral oxygenation|cerebral oxygenation
199121|NCT02951273|CO2 reactivity|co2 reactivity
199122|NCT02951273|duplex ultrasound|duplex ultrasound
199123|NCT02951273|general anaesthesia|general anaesthesia
199124|NCT02951273|mesenteric traction syndrome|mesenteric traction syndrome
199125|NCT02951273|near-infrared spectroscopy|near-infrared spectroscopy
199126|NCT02951273|upper gastrointestinal cancer surgery|upper gastrointestinal cancer surgery
199127|NCT02951234|coronary artery lesions|coronary artery lesions
199128|NCT02951234|intravenous immunoglobulin|intravenous immunoglobulin
199129|NCT02951234|Kawasaki disease|kawasaki disease
199130|NCT02951234|randomized clinical trial|randomized clinical trial
199131|NCT02951234|aspirin|aspirin
199132|NCT02951130|CDH|cdh
199133|NCT02951130|PPHN|pphn
199135|NCT02951117|lymphoid malignancies|lymphoid malignancies
199136|NCT02951117|Next generation sequencing|next generation sequencing
199137|NCT02951117|Refractory Multiple Myeloma|refractory multiple myeloma
199138|NCT02951117|Relapsed Multiple Myeloma|relapsed multiple myeloma
199139|NCT02951052|Long-acting cabotegravir|long-acting cabotegravir
199140|NCT02951052|Virologic failure|virologic failure
199141|NCT02951052|long-acting rilpivirine|long-acting rilpivirine
199142|NCT02951052|Antiretroviral|antiretroviral
199143|NCT02951039|Non valvular Atrial Fibrillation|non valvular atrial fibrillation
199144|NCT02951039|Non-interventional Study|non-interventional study
199145|NCT02951039|Efficacy/Safety|efficacy/safety
199146|NCT02951039|Real World Evidence|real world evidence
199147|NCT02951026|knee|knee
199148|NCT02951026|osteoarthritis|osteoarthritis
199149|NCT02951026|intra-articular injection|intra-articular injection
199150|NCT02951026|SM04690|sm04690
199151|NCT02951000|thyroidectomy|thyroidectomy
199152|NCT02951000|postoperative pain|postoperative pain
199153|NCT02951000|wound healing|wound healing
199154|NCT02950987|Li-Fraumeni Syndrome (LFS)|li-fraumeni syndrome (lfs)
199155|NCT02950987|Cancer Predisposition Syndromes|cancer predisposition syndromes
199156|NCT02950987|LFS|lfs
199157|NCT02950974|sterofundin|sterofundin
199158|NCT02950974|resuscitation|resuscitation
199159|NCT02950974|normal saline|normal saline
199160|NCT02950974|chloride|chloride
199161|NCT02950974|fluid|fluid
199162|NCT02950974|SID|sid
199163|NCT02950974|pH|ph
199164|NCT02950974|osmolality|osmolality
199165|NCT02950974|urine|urine
199166|NCT02950961|Anxiety [F01.470.132]|anxiety [f01.470.132]
199167|NCT02950961|Depression [F01.145.126.350]|depression [f01.145.126.350]
199168|NCT02950961|Stress Disorders, Post-Traumatic [F03.950.750.500]|stress disorders, post-traumatic [f03.950.750.500]
712672|NCT00579215|Questionaires|questionaires
199169|NCT02950961|Primary Health Care [N04.590.233.727]|primary health care [n04.590.233.727]
199170|NCT02950961|Mental Health [F02.418]|mental health [f02.418]
199171|NCT02950961|Patient Participation [N05.300.150.600.620]|patient participation [n05.300.150.600.620]
199172|NCT02950961|Patient Satisfaction [N05.300.150.600.630]|patient satisfaction [n05.300.150.600.630]
199173|NCT02950961|Patient Preference [N05.300.150.600.630.500]|patient preference [n05.300.150.600.630.500]
199174|NCT02950961|Physicians, Primary Care [M01.526.485.810.800]|physicians, primary care [m01.526.485.810.800]
199175|NCT02950961|Physicians, Women [M01.526.485.810.820]|physicians, women [m01.526.485.810.820]
199176|NCT02950961|Health Behavior [F01.145.488]|health behavior [f01.145.488]
199177|NCT02950909|Therapeutic exercise|therapeutic exercise
199178|NCT02950909|Chronic pain|chronic pain
199179|NCT02950909|Neck extensors|neck extensors
199180|NCT02950883|Cystic Fibrosis|cystic fibrosis
199181|NCT02950883|Hypertonic Saline|hypertonic saline
199182|NCT02950883|Inhaled Saline|inhaled saline
199183|NCT02950883|Digestive System Diseases|digestive system diseases
199184|NCT02950883|Genetic Diseases, Inborn|genetic diseases, inborn
199185|NCT02950883|Lung Diseases|lung diseases
199186|NCT02950883|Pancreatic Diseases|pancreatic diseases
199187|NCT02950883|Pathologic Processes|pathologic processes
199188|NCT02950883|Respiratory Tract Diseases|respiratory tract diseases
199189|NCT02950883|Computed Tomography (CT)|computed tomography (ct)
199190|NCT02950844|Atrial fibrillation|atrial fibrillation
199191|NCT02950844|Electrogram|electrogram
199192|NCT02950844|Ablation|ablation
199193|NCT02950844|Drivers|drivers
199194|NCT02950831|Chronic Pain|chronic pain
199195|NCT02950831|BurstDR|burstdr
199196|NCT02950831|spinal cord stimulation|spinal cord stimulation
199197|NCT02950831|Accelerometry|accelerometry
199198|NCT02950818|self-care|self-care
199199|NCT02950818|health education|health education
199200|NCT02950818|chronic disease|chronic disease
199201|NCT02950818|heart diseases|heart diseases
199202|NCT02950818|risk factors for heart disease|risk factors for heart disease
199203|NCT02950805|AZD5634|azd5634
199204|NCT02950805|Mucociliary Clearance|mucociliary clearance
199205|NCT02950805|Safety|safety
199206|NCT02950805|Tolerability|tolerability
199207|NCT02950805|Pharmacokinetic|pharmacokinetic
199208|NCT02950805|Cystic Fibrosis|cystic fibrosis
199209|NCT02950805|Cross-Over Study|cross-over study
199210|NCT02950792|Non-Small Cell Lung Cancer|non-small cell lung cancer
199211|NCT02950792|NSCLC|nsclc
199212|NCT02950766|Kidney Cancer|kidney cancer
199213|NCT02950753|Elevated Serum Lactate|elevated serum lactate
199214|NCT02950753|Serum lactate|serum lactate
199215|NCT02950753|Ringer's Lactate|ringer's lactate
199216|NCT02950753|Lactated Ringer's|lactated ringer's
199217|NCT02950753|Hyperlactatemia|hyperlactatemia
199218|NCT02950740|malnutrition|malnutrition
199219|NCT02950727|orthognathic surgery|orthognathic surgery
199220|NCT02950727|bicortical screws|bicortical screws
199221|NCT02950727|monocortical plates|monocortical plates
199222|NCT02950675|Burn patient|burn patient
199223|NCT02950675|Developmental Disabilities|developmental disabilities
199224|NCT02950675|Body function|body function
199225|NCT02950675|Participation|participation
199226|NCT02950675|Quality of Life|quality of life
199227|NCT02950675|longitudinal study|longitudinal study
199228|NCT02950636|Epilepsy|epilepsy
199229|NCT02950610|Electronic nose|electronic nose
199533|NCT02948881|bone|bone
199230|NCT02950610|Non invasive diagnosis of NAFLD|non invasive diagnosis of nafld
199231|NCT02950610|NAFLD|nafld
199232|NCT02950610|exhaled breath analysis|exhaled breath analysis
199233|NCT02950610|Volatile organic compounds|volatile organic compounds
199234|NCT02950545|astigmatism, contact lens, driving|astigmatism, contact lens, driving
199235|NCT02950532|Posterior ligamentous complex|posterior ligamentous complex
199236|NCT02950532|Thoracolumbar fractures|thoracolumbar fractures
199237|NCT02950532|Interspinous distance|interspinous distance
199238|NCT02950532|Local kyphosis|local kyphosis
199239|NCT02950506|Interictal|interictal
199240|NCT02950506|Cognitive|cognitive
199241|NCT02950506|Dysfunction|dysfunction
199242|NCT02950506|tDCS|tdcs
199243|NCT02950506|transcranial direct current stimulation|transcranial direct current stimulation
199244|NCT02950480|Mastectomy|mastectomy
199245|NCT02950467|HIV/AIDS|hiv/aids
199246|NCT02950467|Demoralization|demoralization
199247|NCT02950467|Psilocybin|psilocybin
199248|NCT02950467|Group therapy|group therapy
199249|NCT02950454|Progressive Multiple Sclerosis|progressive multiple sclerosis
199250|NCT02950454|Rehabilitation|rehabilitation
199251|NCT02950454|Exercise|exercise
199252|NCT02950441|Nicotinamide Riboside|nicotinamide riboside
199253|NCT02950441|Nicotinamide Adenine Dinucleotide|nicotinamide adenine dinucleotide
199254|NCT02950441|Skeletal muscle|skeletal muscle
199255|NCT02950441|Metabolism|metabolism
199256|NCT02950428|TAVI|tavi
199257|NCT02950428|Aortic Stenosis|aortic stenosis
199258|NCT02950428|transcatether Aortic Valve Implantation|transcatether aortic valve implantation
199259|NCT02950389|PMMA|pmma
199260|NCT02950389|on-line HFR|on-line hfr
199261|NCT02950389|free light chains|free light chains
199262|NCT02950389|toxins|toxins
199263|NCT02950389|removal|removal
199264|NCT02950389|hemodialysis|hemodialysis
199265|NCT02950376|synthetic drugs|synthetic drugs
199266|NCT02950376|virtual reality|virtual reality
199267|NCT02950376|addiction evaluation|addiction evaluation
199268|NCT02950376|physiological data|physiological data
199269|NCT02950376|eye movement index|eye movement index
199270|NCT02950363|Depression|depression
199271|NCT02950363|Suicide|suicide
199272|NCT02950363|Anxiety disorder|anxiety disorder
199273|NCT02950363|Burn out|burn out
199274|NCT02950363|Sleep quality|sleep quality
199275|NCT02950363|Stress|stress
199276|NCT02950350|Cervical cancer|cervical cancer
199277|NCT02950350|Precision medicine|precision medicine
199278|NCT02950350|Individualized treatment|individualized treatment
199279|NCT02950350|Surgical staging|surgical staging
199280|NCT02950337|Unbiopsied Early Stage Non Small Cell Lung Cancer|unbiopsied early stage non small cell lung cancer
199281|NCT02950324|Prehabilitation|prehabilitation
199282|NCT02950324|Oesophago-gastric|oesophago-gastric
199283|NCT02950324|Cancer|cancer
199284|NCT02950324|Neo-adjuvant|neo-adjuvant
199285|NCT02950324|Exercise|exercise
199286|NCT02950324|Cardiopulmonary exercise test|cardiopulmonary exercise test
199287|NCT02950324|Insulin resistance|insulin resistance
199288|NCT02950298|Pompe|pompe
199289|NCT02950298|Glycogen Storage Disease II|glycogen storage disease ii
199290|NCT02950298|Telemedicine|telemedicine
199291|NCT02950298|Duke University Medical Center|duke university medical center
199292|NCT02950259|Breast Cancer|breast cancer
199293|NCT02950259|Early Stage Breast Cancer|early stage breast cancer
199294|NCT02950259|Male breast cancer|male breast cancer
199295|NCT02950259|IRX-2|irx-2
199296|NCT02950259|Immunotherapy|immunotherapy
199297|NCT02950259|Triple Negative Breast Cancer|triple negative breast cancer
199298|NCT02950233|postoperative pain|postoperative pain
199299|NCT02950233|VATS|vats
199300|NCT02950233|activities of daily living|activities of daily living
199301|NCT02950233|quality of life|quality of life
199302|NCT02950194|mesh|mesh
199303|NCT02950194|rectus diastasis|rectus diastasis
199304|NCT02950194|panniculectomy|panniculectomy
199305|NCT02950194|abdominoplasty|abdominoplasty
199306|NCT02950168|Diagnostic procedures|diagnostic procedures
199307|NCT02950168|Interventional procedures|interventional procedures
199308|NCT02950168|Planned or unplanned|planned or unplanned
199309|NCT02950168|Edoxaban-treated population|edoxaban-treated population
199310|NCT02950142|order sets|order sets
199311|NCT02950142|decision support|decision support
199312|NCT02950142|laboratory test|laboratory test
199313|NCT02950142|primary care|primary care
199314|NCT02950129|pelvic girdle dysfunction|pelvic girdle dysfunction
199315|NCT02950103|solid tumor|solid tumor
199316|NCT02950103|phase II|phase ii
199317|NCT02950103|phosphoethanolamine|phosphoethanolamine
199318|NCT02950090|Knee symptoms|knee symptoms
199319|NCT02950090|physical activity|physical activity
199320|NCT02950090|Fitbit|fitbit
199321|NCT02950090|Accelerometer|accelerometer
199322|NCT02950090|remote coaching|remote coaching
199323|NCT02950064|BRCA|brca
199324|NCT02950064|BRCA1|brca1
199325|NCT02950064|BRCA2|brca2
199326|NCT02950064|Pancreatic cancer|pancreatic cancer
199327|NCT02950064|Ovarian cancer|ovarian cancer
199328|NCT02950064|Castrate resistant prostate cancer|castrate resistant prostate cancer
199329|NCT02950064|Triple negative breast cancer|triple negative breast cancer
199330|NCT02950064|Breast cancer|breast cancer
199331|NCT02950064|DNA repair mutation-positive solid tumors|dna repair mutation-positive solid tumors
199333|NCT02950038|Lung Cancer, Nonsmall Cell|lung cancer, nonsmall cell
199334|NCT02950038|Advanced non-small cell lung cancer|advanced non-small cell lung cancer
199335|NCT02950038|NSCLC|nsclc
199336|NCT02950038|Stage IV non-small cell lung cancer|stage iv non-small cell lung cancer
199337|NCT02950038|Recurrent non-small cell lung cancer|recurrent non-small cell lung cancer
199338|NCT02950038|Ibrutinib|ibrutinib
199339|NCT02950038|PCI-32765|pci-32765
199340|NCT02950038|Imbruvica|imbruvica
199341|NCT02950038|Nivolumab|nivolumab
199342|NCT02950038|BMS-936558|bms-936558
199343|NCT02950038|Opdivo|opdivo
199344|NCT02950012|Healthy|healthy
199345|NCT02950012|Bloating|bloating
199346|NCT02950012|Abdominal Discomfort|abdominal discomfort
199347|NCT02950012|Gas|gas
199348|NCT02950012|Probiotic|probiotic
199349|NCT02950012|Bacillus Subtillis|bacillus subtillis
199350|NCT02949999|Calcineurin inhibitor|calcineurin inhibitor
199351|NCT02949999|Voclosporin|voclosporin
199352|NCT02949973|lupus nephritis|lupus nephritis
199353|NCT02949973|calcineurin inhibitors|calcineurin inhibitors
199354|NCT02949973|voclosporin|voclosporin
199355|NCT02949960|Eczema|eczema
199356|NCT02949960|Dermatitis|dermatitis
199357|NCT02949960|Skin Diseases|skin diseases
199358|NCT02949960|Skin Diseases, Genetic|skin diseases, genetic
199359|NCT02949960|Dermatitis, Atopic|dermatitis, atopic
199360|NCT02949960|Skin Diseases, Eczematous|skin diseases, eczematous
199361|NCT02949960|Hypersensitivity|hypersensitivity
199362|NCT02949960|Immune System Diseases|immune system diseases
199363|NCT02949947|Malignant Neoplasms of Mesothelial and Soft Tissue|malignant neoplasms of mesothelial and soft tissue
199364|NCT02949947|Gastrointestinal Stromal Tumor|gastrointestinal stromal tumor
199365|NCT02949947|GIST|gist
199366|NCT02949947|Iron-deficiency anemia|iron-deficiency anemia
199367|NCT02949947|Ferric Carboxymaltose|ferric carboxymaltose
199368|NCT02949947|Injectafer|injectafer
199369|NCT02949947|Iron supplement|iron supplement
199370|NCT02949947|Health Questionnaire|health questionnaire
199371|NCT02949947|Survey|survey
199372|NCT02949908|Relapsing Remitting Multiple Sclerosis|relapsing remitting multiple sclerosis
199373|NCT02949908|Rebif|rebif
199374|NCT02949908|Treatment Satisfaction Questionnaire for Medication Version II|treatment satisfaction questionnaire for medication version ii
199375|NCT02949908|Multiple Sclerosis International Quality of Life Questionnaire|multiple sclerosis international quality of life questionnaire
199376|NCT02949882|Diarrhea|diarrhea
199377|NCT02949882|Constipation|constipation
199378|NCT02949882|Elderly|elderly
199379|NCT02949882|Nursing Homes|nursing homes
199380|NCT02949882|Probiotics|probiotics
199381|NCT02949882|Bowel Habits|bowel habits
199382|NCT02949830|RNAi therapeutic|rnai therapeutic
199383|NCT02949830|Porphyria|porphyria
199384|NCT02949830|AIP|aip
199385|NCT02949830|Heme/Haem Arginate|heme/haem arginate
199386|NCT02949817|upper limb function|upper limb function
199387|NCT02949817|multi-IMU (inertial measurement unit) sensors|multi-imu (inertial measurement unit) sensors
199388|NCT02949817|Melbourne Assessment of Unilateral Upper Limb Function (MUUL-2)|melbourne assessment of unilateral upper limb function (muul-2)
199389|NCT02949791|cisplatin|cisplatin
199390|NCT02949791|HIPEC|hipec
199391|NCT02949791|Intra abdominal pressure|intra abdominal pressure
199392|NCT02949791|tissue drug concentration|tissue drug concentration
199393|NCT02949713|HIV|hiv
199394|NCT02949713|infant feeding|infant feeding
199395|NCT02949713|mHealth|mhealth
199396|NCT02949713|behavioural intervention|behavioural intervention
199397|NCT02949700|metformin|metformin
199398|NCT02949700|head and neck cancer|head and neck cancer
199399|NCT02949687|ileal interposition|ileal interposition
199400|NCT02949687|metabolic surgery|metabolic surgery
199401|NCT02949687|diabetes|diabetes
199402|NCT02949687|intra abdominal selective denervation|intra abdominal selective denervation
199403|NCT02949648|Electronic cigarette|electronic cigarette
199404|NCT02949635|Aged|aged
199405|NCT02949635|Patient readmission|patient readmission
199406|NCT02949635|Geriatric Assessment|geriatric assessment
199407|NCT02949635|Mortality|mortality
199408|NCT02949622|Metabolic syndrome|metabolic syndrome
199409|NCT02949622|Mediterranean diet|mediterranean diet
199410|NCT02949622|Stress|stress
199411|NCT02949622|quality of life|quality of life
199412|NCT02949622|psychological factors|psychological factors
199413|NCT02949609|stroke|stroke
199414|NCT02949609|mirror therapy|mirror therapy
199415|NCT02949609|neurorehabilitation|neurorehabilitation
199416|NCT02949596|quality of sexual life|quality of sexual life
199417|NCT02949596|intensity-modulated radiotherapy|intensity-modulated radiotherapy
199418|NCT02949596|concurrent chemoradiotherapy|concurrent chemoradiotherapy
199419|NCT02949583|DENTAL PLAQUE|dental plaque
199420|NCT02949583|MEDICINAL PLANTS|medicinal plants
199421|NCT02949583|GINGIVITIS|gingivitis
199422|NCT02949505|Prehabilitation|prehabilitation
199423|NCT02949505|liver transplant|liver transplant
199424|NCT02949505|functional capacity|functional capacity
199425|NCT02949505|exercise|exercise
199426|NCT02949492|Liver|liver
199427|NCT02949492|Transplant|transplant
199428|NCT02949492|Immunosuppression|immunosuppression
199429|NCT02949479|sex offenses|sex offenses
199430|NCT02949466|knee osteoarthritis|knee osteoarthritis
199431|NCT02949466|triamcinolone|triamcinolone
199432|NCT02949466|therapeutic effects|therapeutic effects
199433|NCT02949453|suicide|suicide
199434|NCT02949453|prevention|prevention
199435|NCT02949440|Laparoscopic right Hemicolectomy|laparoscopic right hemicolectomy
199436|NCT02949440|Caudal-to-cranial Approach|caudal-to-cranial approach
199437|NCT02949427|Microbiome|microbiome
199438|NCT02949427|Mycobiome|mycobiome
199439|NCT02949427|Virome|virome
199440|NCT02949427|Pediatric leukemia|pediatric leukemia
199441|NCT02949427|Pediatric bone marrow transplantation|pediatric bone marrow transplantation
199442|NCT02949414|Malacia|malacia
199443|NCT02949414|Stenosis|stenosis
199444|NCT02949414|Trachea|trachea
199445|NCT02949414|Transplant|transplant
199446|NCT02949401|Virtual Reality|virtual reality
199447|NCT02949401|Stress Inoculation|stress inoculation
199448|NCT02949401|Procedure|procedure
199449|NCT02949349|Systemic Lupus Erythematosus|systemic lupus erythematosus
199450|NCT02949349|Lupus Nephritis|lupus nephritis
199451|NCT02949349|Mycophenolate Mofetil|mycophenolate mofetil
199452|NCT02949349|Azathioprine|azathioprine
199453|NCT02949349|Maintenance Therapy|maintenance therapy
199454|NCT02949349|Prednisolone|prednisolone
199455|NCT02949349|Serum albumin|serum albumin
199456|NCT02949349|Serum creatinine|serum creatinine
712770|NCT00578773|ear drops|ear drops
199457|NCT02949349|Spot urine protein/creatinine ratio|spot urine protein/creatinine ratio
199458|NCT02949323|children|children
199459|NCT02949323|renal stone|renal stone
199460|NCT02949323|metabolic evaluation|metabolic evaluation
199461|NCT02949323|Mutational analysis|mutational analysis
199462|NCT02949297|abdominal|abdominal
199463|NCT02949297|aortic|aortic
199464|NCT02949297|aneurysm|aneurysm
199465|NCT02949271|epidural analgesia|epidural analgesia
199466|NCT02949258|gastric cancer|gastric cancer
199467|NCT02949258|Borrmann type 4|borrmann type 4
199468|NCT02949258|Neoadjuvant chemotherapy|neoadjuvant chemotherapy
199469|NCT02949258|Intra-arterial administration|intra-arterial administration
199470|NCT02949245|Spine|spine
199471|NCT02949245|Surgery|surgery
199472|NCT02949245|Prospective Studies|prospective studies
199473|NCT02949245|Deformity|deformity
199474|NCT02949245|Neurologic deficit|neurologic deficit
199475|NCT02949180|Atrial fibrillation|atrial fibrillation
199476|NCT02949180|Rhythm monitoring|rhythm monitoring
199477|NCT02949180|Cardiovascular App|cardiovascular app
199478|NCT02949180|m-health|m-health
199479|NCT02949167|Nurse-led follow-up after breast cancer|nurse-led follow-up after breast cancer
199480|NCT02949115|Red beetroot|red beetroot
199481|NCT02949115|Dietary Nitrate|dietary nitrate
199482|NCT02949115|Polyphenols|polyphenols
199483|NCT02949115|Endothelial Function|endothelial function
199484|NCT02949115|High-Fat Meal|high-fat meal
199485|NCT02949115|Overweight|overweight
199486|NCT02949115|Obesity|obesity
199487|NCT02949115|Aging|aging
199488|NCT02949115|Cardiometabolic|cardiometabolic
199489|NCT02949089|safety|safety
199490|NCT02949089|tolerability|tolerability
199491|NCT02949089|rising multiple doses|rising multiple doses
199492|NCT02949089|ACH04|ach04
199493|NCT02949089|adult|adult
199494|NCT02949089|male|male
199495|NCT02949063|school lunch|school lunch
199496|NCT02949063|occupational therapy|occupational therapy
199497|NCT02949024|Diabetes mellitus|diabetes mellitus
199498|NCT02949024|Diabetic retinopathy|diabetic retinopathy
199499|NCT02949024|Microneedle|microneedle
199500|NCT02949024|Microinjection|microinjection
199501|NCT02949024|Triamcinolone|triamcinolone
199502|NCT02949024|Choroid|choroid
199503|NCT02949024|Choroid Injection|choroid injection
199504|NCT02949024|Aflibercept|aflibercept
199505|NCT02949024|Suprachoroidal|suprachoroidal
199506|NCT02949011|Tamiflu®|tamiflu®
199507|NCT02949011|Influenza|influenza
199508|NCT02949011|Oseltamivir|oseltamivir
199509|NCT02949011|Flu|flu
199510|NCT02949011|S-033188|s-033188
199511|NCT02948985|Metastatic colorectal cancer|metastatic colorectal cancer
199512|NCT02948985|Cetuximab|cetuximab
199513|NCT02948985|CTCs|ctcs
199514|NCT02948985|ct DNA|ct dna
199515|NCT02948972|deep infiltrating endometriosis|deep infiltrating endometriosis
199516|NCT02948972|endometriosis surgery|endometriosis surgery
199517|NCT02948972|In vitro fertilization|in vitro fertilization
199518|NCT02948946|lung cancer|lung cancer
199519|NCT02948946|pancreatic cancer|pancreatic cancer
199520|NCT02948933|Dengue Fever|dengue fever
199521|NCT02948933|Dengue Hemorrhagic Fever|dengue hemorrhagic fever
199522|NCT02948933|Dengvaxia®|dengvaxia®
199523|NCT02948920|ephedrine|ephedrine
199524|NCT02948920|core temperature|core temperature
199525|NCT02948920|tympanic temperature|tympanic temperature
199526|NCT02948920|heat loss|heat loss
199527|NCT02948920|spinal anesthesia|spinal anesthesia
199528|NCT02948920|neuraxial|neuraxial
199529|NCT02948920|hypothermia|hypothermia
199530|NCT02948920|shivering|shivering
199531|NCT02948881|Osteoporosis|osteoporosis
199532|NCT02948881|bisphosphonates|bisphosphonates
199534|NCT02948855|Long non-coding RNA（LncRNA）|long non-coding rna（lncrna）
199535|NCT02948855|Thymoma|thymoma
199536|NCT02948855|Autoimmune disease|autoimmune disease
199537|NCT02948855|Notch2 Signaling pathway|notch2 signaling pathway
199538|NCT02948855|Regulatory B cell（Breg）|regulatory b cell（breg）
199539|NCT02948829|Drug therapy|drug therapy
199540|NCT02948803|intervention|intervention
199541|NCT02948803|mHealth|mhealth
199542|NCT02948803|physical activity|physical activity
199543|NCT02948803|active transport|active transport
199544|NCT02948803|smartphone|smartphone
199545|NCT02948803|application|application
199546|NCT02948764|breast cancer|breast cancer
199547|NCT02948764|vacuum-assisted biopsy|vacuum-assisted biopsy
199548|NCT02948764|pathological complete response|pathological complete response
199549|NCT02948712|distress|distress
199550|NCT02948712|survivorship|survivorship
199551|NCT02948712|transition period|transition period
199552|NCT02948699|nasopharyngeal carcinoma|nasopharyngeal carcinoma
199553|NCT02948699|intensity-modulated radiotherapy|intensity-modulated radiotherapy
199554|NCT02948699|nutrition support|nutrition support
199555|NCT02948699|nutrition assessment|nutrition assessment
199556|NCT02948686|dentin bonding agents|dentin bonding agents
199557|NCT02948686|tooth sensitivity|tooth sensitivity
199558|NCT02948686|composite resin restoration|composite resin restoration
712971|NCT00577993|Vincristine|vincristine
199559|NCT02948673|type 2 diabetes|type 2 diabetes
199560|NCT02948673|mitochondrial reactive oxygen species production|mitochondrial reactive oxygen species production
199561|NCT02948673|oxidative stress|oxidative stress
199562|NCT02948673|antioxidant treatment|antioxidant treatment
199563|NCT02948673|glutathione supplementation|glutathione supplementation
199564|NCT02948647|obesity|obesity
199565|NCT02948647|fatty liver|fatty liver
199566|NCT02948647|sugar|sugar
199567|NCT02948647|PNPLA3|pnpla3
199568|NCT02948621|Endoscopic sleeve gastroplasty|endoscopic sleeve gastroplasty
199569|NCT02948621|Excess weight loss|excess weight loss
199570|NCT02948621|Quality of life|quality of life
199571|NCT02948608|spondyloarthropathy|spondyloarthropathy
199572|NCT02948608|ankylosing spondylitis|ankylosing spondylitis
199573|NCT02948608|spinal diseases|spinal diseases
199574|NCT02948608|spondylitis|spondylitis
199575|NCT02948608|spondylarthritis|spondylarthritis
199576|NCT02948608|psoriasis|psoriasis
199577|NCT02948608|uveitis|uveitis
199578|NCT02948608|joint diseases|joint diseases
199579|NCT02948582|Chronic Obstructive Pulmonary Disease|chronic obstructive pulmonary disease
199580|NCT02948582|COPD|copd
199581|NCT02948582|Emphysema|emphysema
199582|NCT02948582|Chronic bronchitis|chronic bronchitis
199583|NCT02948569|Obesity|obesity
199584|NCT02948569|Hyperlipidemia|hyperlipidemia
199585|NCT02948569|Impaired fasting glucose|impaired fasting glucose
199586|NCT02948569|Insulin resistance|insulin resistance
199587|NCT02948569|Hypertension|hypertension
199588|NCT02948504|Unruptured Intracranial Aneurysm|unruptured intracranial aneurysm
199589|NCT02948504|Small aneurysms|small aneurysms
199590|NCT02948504|Risk of rupture|risk of rupture
199591|NCT02948504|Natural history|natural history
199592|NCT02948504|Endovascular Coiling|endovascular coiling
199593|NCT02948504|Surgical clipping|surgical clipping
199594|NCT02948491|Complementary Therapies|complementary therapies
199595|NCT02948491|Neonate Intensive Care Units (NICU)|neonate intensive care units (nicu)
199596|NCT02948491|Child Development|child development
199597|NCT02948491|Infants Premature|infants premature
199598|NCT02948478|precariousness|precariousness
199599|NCT02948478|care pathways|care pathways
199600|NCT02948465|Neutrophil Extracellular Traps|neutrophil extracellular traps
199601|NCT02948452|anorexia nervosa|anorexia nervosa
199602|NCT02948452|anxiety|anxiety
199603|NCT02948452|reward|reward
199604|NCT02948452|recurrence|recurrence
199605|NCT02948452|magnetic resonance imaging|magnetic resonance imaging
199606|NCT02948439|pregnancy|pregnancy
199607|NCT02948439|cardiovascular|cardiovascular
199608|NCT02948439|nervous system|nervous system
199609|NCT02948439|exercise|exercise
199610|NCT02948426|Immunotherapy|immunotherapy
199611|NCT02948426|Adoptive Cell Therapy|adoptive cell therapy
199612|NCT02948426|Carcinomatosis|carcinomatosis
199613|NCT02948426|CA125|ca125
199614|NCT02948413|Traumatic Stress|traumatic stress
199615|NCT02948413|Oncology|oncology
199616|NCT02948413|Lymphoma|lymphoma
199617|NCT02948413|Leukemia|leukemia
199618|NCT02948335|Microbial communities|microbial communities
199619|NCT02948335|Hospital environment|hospital environment
199620|NCT02948335|Disinfection|disinfection
199621|NCT02948335|Adenosine triphosphate measures|adenosine triphosphate measures
199622|NCT02948335|Bioburden|bioburden
199623|NCT02948322|Acromegaly,|acromegaly,
199624|NCT02948322|water retention|water retention
199625|NCT02948322|myocardial fibrosis|myocardial fibrosis
199626|NCT02948322|left ventricular hypertrophy|left ventricular hypertrophy
199627|NCT02948322|left ventricular dysfunction|left ventricular dysfunction
199628|NCT02948309|Primary diagnosis|primary diagnosis
199629|NCT02948309|Relapse|relapse
199630|NCT02948257|Vessel closure|vessel closure
199631|NCT02948257|Antegrade access|antegrade access
200541|NCT02942264|Temodar|temodar
199632|NCT02948257|Femoral arteriotomy|femoral arteriotomy
199633|NCT02948257|Peripheral endovascular interventions|peripheral endovascular interventions
199634|NCT02948244|fshd|fshd
199635|NCT02948244|creatine monohydrate|creatine monohydrate
199636|NCT02948244|children|children
199637|NCT02948244|pediatrics|pediatrics
199638|NCT02948244|Facio-Scapulo-Humeral Dystrophy|facio-scapulo-humeral dystrophy
199639|NCT02948205|Infertility, TU-LESS, 3D laparoscopy|infertility, tu-less, 3d laparoscopy
199640|NCT02948192|Preterm Delivery|preterm delivery
199641|NCT02948192|Preterm Birth|preterm birth
199642|NCT02948192|Vaginal Microbiome|vaginal microbiome
199643|NCT02948192|Microbiome|microbiome
199644|NCT02948192|Gut Microbiome|gut microbiome
199645|NCT02948192|African American|african american
199646|NCT02948192|Metabolomics|metabolomics
199647|NCT02948192|Pregnancy|pregnancy
199648|NCT02948166|remote endarterectomy|remote endarterectomy
199649|NCT02948166|Angioplasty with stenting of the superficial femoral artery|angioplasty with stenting of the superficial femoral artery
199650|NCT02948140|Subdiaphragmatic infarction|subdiaphragmatic infarction
199651|NCT02948088|Tenosynovial Giant Cell Tumors|tenosynovial giant cell tumors
199652|NCT02948088|Disease registry|disease registry
199653|NCT02948088|Routine clinical practice|routine clinical practice
255269|NCT02606916|S-1|s-1
199654|NCT02948088|Real World Evidence|real world evidence
199656|NCT02948062|Newborn Screening|newborn screening
199657|NCT02948049|Accelerometer|accelerometer
199658|NCT02948049|Spinal Cord Stimulator|spinal cord stimulator
199659|NCT02948049|Peripheral Nerve Stimulator|peripheral nerve stimulator
199660|NCT02948049|Physical Function|physical function
199661|NCT02947997|Healthy Volunteers|healthy volunteers
199662|NCT02947984|sphenoid region|sphenoid region
199663|NCT02947984|parasellar area|parasellar area
199664|NCT02947984|photon radiation therapy|photon radiation therapy
199665|NCT02947984|proton radiation therapy|proton radiation therapy
199666|NCT02947971|Device|device
199667|NCT02947971|OFDI|ofdi
199668|NCT02947971|Tethered Capsule Endomicroscopy|tethered capsule endomicroscopy
199669|NCT02947958|teleconsultation|teleconsultation
199670|NCT02947958|urology|urology
199671|NCT02947958|primary care|primary care
199672|NCT02947958|tertiary care|tertiary care
199673|NCT02947932|acute pancreatitis|acute pancreatitis
199674|NCT02947932|post-ERCP|post-ercp
199675|NCT02947932|endoscopy|endoscopy
199676|NCT02947919|Perioperative Period|perioperative period
199677|NCT02947919|Music|music
199678|NCT02947906|Gait|gait
199679|NCT02947906|Loading|loading
199680|NCT02947906|Multiple Sclerosis|multiple sclerosis
199681|NCT02947906|Plantar Pressure|plantar pressure
199682|NCT02947893|Nilotinib in Alzheimer's disease|nilotinib in alzheimer's disease
199683|NCT02947880|autism, Bumetanide|autism, bumetanide
199684|NCT02947854|Vaccine|vaccine
199685|NCT02947854|Photochemical Internalisation|photochemical internalisation
199686|NCT02947854|Immune Response|immune response
199687|NCT02947854|Peptide vaccine|peptide vaccine
199688|NCT02947854|Anti cancer vaccine|anti cancer vaccine
199689|NCT02947828|Diabetes Mellitus, Type 2|diabetes mellitus, type 2
199690|NCT02947828|Polyneuropathies, Diabetic|polyneuropathies, diabetic
199691|NCT02947750|Hypertension|hypertension
199692|NCT02947750|Kidney Disorder|kidney disorder
199693|NCT02947750|Nephrology|nephrology
199694|NCT02947750|Physiology|physiology
199695|NCT02947737|Skin graft|skin graft
199696|NCT02947724|chocolate cyst|chocolate cyst
199697|NCT02947724|laparoscopy|laparoscopy
199698|NCT02947724|surgicel|surgicel
199699|NCT02947711|E2027|e2027
199700|NCT02947711|Healthy participants|healthy participants
199701|NCT02947711|Pharmacokinetics|pharmacokinetics
199702|NCT02947698|acute kidney injury|acute kidney injury
199703|NCT02947698|weekend admission|weekend admission
199704|NCT02947698|mortality|mortality
199705|NCT02947685|breast cancer|breast cancer
199706|NCT02947685|malignant tumor of the breast|malignant tumor of the breast
199707|NCT02947685|HER2+|her2+
199708|NCT02947685|HR+|hr+
199709|NCT02947685|metastatic breast cancer|metastatic breast cancer
199710|NCT02947659|Body mass index|body mass index
199711|NCT02947659|Academic stress|academic stress
199712|NCT02947659|Musculoskeletal disorders|musculoskeletal disorders
199713|NCT02947607|Human gut microbiome|human gut microbiome
199714|NCT02947607|Colorectal cancer|colorectal cancer
199715|NCT02947607|Colorectal adenoma|colorectal adenoma
199716|NCT02947607|Gut bacteria|gut bacteria
199717|NCT02947607|Metagenomics|metagenomics
199718|NCT02947607|Metatranscriptomics|metatranscriptomics
199719|NCT02947581|subarachnoid neurocysticercosis|subarachnoid neurocysticercosis
199720|NCT02947581|albendazole|albendazole
199721|NCT02947581|praziquantel|praziquantel
199722|NCT02947568|Non-alcoholic Fatty Liver Disease|non-alcoholic fatty liver disease
199723|NCT02947568|Chronic Kidney Disease|chronic kidney disease
199724|NCT02947568|Diabetes Mellitus|diabetes mellitus
199725|NCT02947568|Cross-sectional|cross-sectional
199726|NCT02947555|diabetes mellitus|diabetes mellitus
199727|NCT02947555|atherosclerosis|atherosclerosis
199728|NCT02947555|AGE|age
199729|NCT02947555|lens autofluorescence|lens autofluorescence
199730|NCT02947529|Hemiarthroplasty|hemiarthroplasty
199731|NCT02947529|Intramedullary nail|intramedullary nail
199732|NCT02947529|Tranexamic acid|tranexamic acid
199733|NCT02947529|Transfusion|transfusion
199734|NCT02947516|Endoscopic Ultrasound-Guided Fine Needle Aspiration|endoscopic ultrasound-guided fine needle aspiration
199735|NCT02947516|liver|liver
199736|NCT02947516|biopsy|biopsy
199737|NCT02947516|pain|pain
199738|NCT02947503|Gestational Diabetes|gestational diabetes
199739|NCT02947503|Insulin Resistance|insulin resistance
199740|NCT02947503|Metformin|metformin
199741|NCT02947503|Hyperinsulinaemia|hyperinsulinaemia
199742|NCT02947503|Prevention of Complications|prevention of complications
199743|NCT02947503|Long Term Study|long term study
199744|NCT02947503|Mother and Child|mother and child
199745|NCT02947503|Health Benefits|health benefits
199746|NCT02947490|Blood pressure monitoring|blood pressure monitoring
199747|NCT02947490|self BP monitoring|self bp monitoring
199748|NCT02947490|self BP management|self bp management
199749|NCT02947438|Renal anemia|renal anemia
199750|NCT02947438|Haemodialysis|haemodialysis
199751|NCT02947438|Maintenance phase|maintenance phase
199752|NCT02947412|sleeve gastrectomy|sleeve gastrectomy
199753|NCT02947412|long-term follow-up|long-term follow-up
199754|NCT02947412|gastroesophageal reflux disease after sleeve|gastroesophageal reflux disease after sleeve
199755|NCT02947412|revisional surgery|revisional surgery
199756|NCT02947399|Thyroid|thyroid
199757|NCT02947399|I-124|i-124
199758|NCT02947399|Thyroid hormone Withdrawal|thyroid hormone withdrawal
199759|NCT02947373|brain tumor|brain tumor
199760|NCT02947373|children|children
199761|NCT02947321|Radiofrequency ablation|radiofrequency ablation
199762|NCT02947308|Anxiety|anxiety
199763|NCT02947308|Depression|depression
199764|NCT02947243|Virtual reality|virtual reality
199765|NCT02947243|Immersive distraction|immersive distraction
199766|NCT02947243|Oculus rift|oculus rift
199767|NCT02947243|Virtual world|virtual world
199768|NCT02947243|Virtual environment|virtual environment
199769|NCT02947243|Procedural pain|procedural pain
199770|NCT02947243|Procedural anxiety|procedural anxiety
199771|NCT02947243|Acute pain|acute pain
199772|NCT02947243|Pain management|pain management
199773|NCT02947243|Anxiety|anxiety
199774|NCT02947243|Children, Child|children, child
199775|NCT02947243|Kid, Kids|kid, kids
199776|NCT02947243|Pediatric, Pediatrics|pediatric, pediatrics
199777|NCT02947243|Young children|young children
199778|NCT02947243|Burns|burns
199779|NCT02947243|Burn injuries|burn injuries
199780|NCT02947243|Burn unit|burn unit
199781|NCT02947243|Physiotherapy|physiotherapy
199782|NCT02947243|Physical therapy|physical therapy
199783|NCT02947243|Burn dressing|burn dressing
199784|NCT02947243|Dressing change|dressing change
199785|NCT02947243|Non-pharmacological, nonpharmacological|non-pharmacological, nonpharmacological
199786|NCT02947243|Clinical Research|clinical research
199787|NCT02947243|Nursing Practice|nursing practice
199788|NCT02947230|Mobility|mobility
199789|NCT02947230|Aging|aging
199790|NCT02947230|Knowledge Translation|knowledge translation
199791|NCT02947230|Physical Activity|physical activity
199792|NCT02947217|Immunology|immunology
199793|NCT02947217|Pregnancy|pregnancy
199794|NCT02947217|Implantation Rate|implantation rate
199795|NCT02947217|Fertilization in Vitro|fertilization in vitro
199796|NCT02947204|Bronchiolitis|bronchiolitis
199797|NCT02947204|Length of Hospital Stay|length of hospital stay
199798|NCT02947204|Clinical Trial|clinical trial
199799|NCT02947204|Oxygen Saturation Monitoring|oxygen saturation monitoring
199800|NCT02947152|HKT288|hkt288
199801|NCT02947152|CDH6|cdh6
199803|NCT02947152|maytansine|maytansine
199804|NCT02947152|epithelial ovarian cancer|epithelial ovarian cancer
199805|NCT02947152|renal cell carcinoma|renal cell carcinoma
199806|NCT02947152|RCC|rcc
199807|NCT02947126|cystic fibrosis|cystic fibrosis
199808|NCT02947126|mucociliary clearance|mucociliary clearance
199809|NCT02947126|CFTR|cftr
199810|NCT02947113|cancer|cancer
199811|NCT02947100|Sickle Cell Disease|sickle cell disease
199812|NCT02947100|omega-3 fatty acids|omega-3 fatty acids
199813|NCT02947100|Docosahexaenoic Acid (DHA)|docosahexaenoic acid (dha)
199814|NCT02947100|Eicosapentaenoic Acid (EPA)|eicosapentaenoic acid (epa)
199815|NCT02947087|Islet autotransplantation|islet autotransplantation
199816|NCT02947087|Alpha1 anti trypsin|alpha1 anti trypsin
199817|NCT02947074|Yoga|yoga
199818|NCT02947074|Meditation|meditation
199819|NCT02947074|Glutathione|glutathione
199820|NCT02947074|Catecholamine|catecholamine
199821|NCT02947074|polysomnography|polysomnography
199822|NCT02947061|Advanced Breast Cancer,first treatment, S1, Capecitabine|advanced breast cancer,first treatment, s1, capecitabine
199823|NCT02947035|thyroid cancer|thyroid cancer
199824|NCT02947035|thyroid nodule|thyroid nodule
199825|NCT02947035|thyroidectomy|thyroidectomy
199826|NCT02947035|personalized medicine|personalized medicine
199827|NCT02947022|gadolinium|gadolinium
199828|NCT02947022|deposition|deposition
199829|NCT02947022|GBCA|gbca
199830|NCT02947022|Extremity Pain|extremity pain
199831|NCT02947022|Skin Pain|skin pain
199832|NCT02947022|Chest Wall Pain|chest wall pain
199833|NCT02946944|Pulmonary Embolism|pulmonary embolism
199834|NCT02946944|sildenafil|sildenafil
199835|NCT02946944|oral anticoagulation therapy|oral anticoagulation therapy
199836|NCT02946918|levothyroxine|levothyroxine
199837|NCT02946853|Atrial Fibrillation|atrial fibrillation
199838|NCT02946853|CRT|crt
199839|NCT02946853|AV Junction Ablation|av junction ablation
199840|NCT02946853|LVESV|lvesv
199841|NCT02946827|FODMAPs diet|fodmaps diet
199842|NCT02946827|micro-macro nutrients intake|micro-macro nutrients intake
199843|NCT02946827|IBS (Irritable Bowel Syndrome)|ibs (irritable bowel syndrome)
199844|NCT02946814|essential oils|essential oils
199845|NCT02946814|microscope, colfocal|microscope, colfocal
199846|NCT02946814|dental plaque|dental plaque
199847|NCT02946801|Biofilms|biofilms
199848|NCT02946801|essential oils|essential oils
199849|NCT02946801|alcohol|alcohol
199850|NCT02946801|microscopy, confocal|microscopy, confocal
199851|NCT02946801|mouthwashes|mouthwashes
199852|NCT02946775|septicemia|septicemia
199853|NCT02946775|bacteremia|bacteremia
199854|NCT02946775|pneumonia|pneumonia
199855|NCT02946775|meningitis|meningitis
199856|NCT02946762|HIV|hiv
199857|NCT02946762|TB|tb
199858|NCT02946762|Antiretroviral Treatment|antiretroviral treatment
199859|NCT02946762|Anti-tuberculosis Treatment|anti-tuberculosis treatment
199860|NCT02946762|HIV Counselling and Testing|hiv counselling and testing
199861|NCT02946762|Treatment as Prevention|treatment as prevention
199862|NCT02946749|Scar pregnancy|scar pregnancy
199863|NCT02946749|Placenta planting abnormal disease|placenta planting abnormal disease
199864|NCT02946749|Early diagnosis|early diagnosis
199865|NCT02946749|Individualized treatment|individualized treatment
199866|NCT02946736|Sleep|sleep
199867|NCT02946736|Physical Health|physical health
199868|NCT02946736|Psychological Health|psychological health
199869|NCT02946736|Well-Being|well-being
199870|NCT02946736|Employee|employee
199871|NCT02946736|Actigraphy|actigraphy
199872|NCT02946710|Alzheimer disease|alzheimer disease
199873|NCT02946710|Alzheimer's disease, biomarkers|alzheimer's disease, biomarkers
199874|NCT02946710|p75NTR-ECD|p75ntr-ecd
199875|NCT02946697|Chinese|chinese
199876|NCT02946697|cancer survivors|cancer survivors
199877|NCT02946697|Quality of Life|quality of life
199878|NCT02946697|Social Support|social support
199879|NCT02946658|COPD, Emphysema|copd, emphysema
199880|NCT02946619|Chinese breast cancer survivors|chinese breast cancer survivors
199881|NCT02946619|expressive writing|expressive writing
199882|NCT02946554|Acute-On-Chronic Liver Failure|acute-on-chronic liver failure
199883|NCT02946554|ACLF|aclf
199884|NCT02946541|DA-1229|da-1229
199885|NCT02946541|evogliptin|evogliptin
199886|NCT02946541|DPP-IV inhibitor|dpp-iv inhibitor
199887|NCT02946541|Suganon|suganon
199888|NCT02946541|DPP-4 inhibitor|dpp-4 inhibitor
199889|NCT02946515|Pediatrics|pediatrics
199890|NCT02946489|cannabis|cannabis
199891|NCT02946489|mindfulness based relapse prevention|mindfulness based relapse prevention
199892|NCT02946489|motivational enhancement therapy|motivational enhancement therapy
199893|NCT02946437|severe SAH|severe sah
199894|NCT02946437|prevention of vasospasm and/ or brain oedema|prevention of vasospasm and/ or brain oedema
199895|NCT02946437|Sevoflurane|sevoflurane
199896|NCT02946437|Postconditioning|postconditioning
199897|NCT02946411|Hyperglycemia|hyperglycemia
199898|NCT02946385|meningococcal disease|meningococcal disease
199899|NCT02946385|meningitis|meningitis
199900|NCT02946385|booster|booster
199901|NCT02946385|antibody persistence|antibody persistence
199902|NCT02946372|retina surgery|retina surgery
199903|NCT02946372|macula|macula
199904|NCT02946372|macular hole|macular hole
199905|NCT02946372|internal limiting membrane (ILM)|internal limiting membrane (ilm)
199906|NCT02946372|vitrectomy|vitrectomy
199907|NCT02946372|autologous transplantation|autologous transplantation
199908|NCT02946346|Human papillomaviruses|human papillomaviruses
199909|NCT02946346|Clearance|clearance
199910|NCT02946346|Kinetics|kinetics
199911|NCT02946346|Ecology|ecology
199912|NCT02946346|Bacterial vaginosis|bacterial vaginosis
199913|NCT02946346|Immune response|immune response
199914|NCT02946346|Microbiota|microbiota
199915|NCT02946333|Multiple Myeloma|multiple myeloma
199916|NCT02946333|autologous stem cell transplant (ASCT)|autologous stem cell transplant (asct)
199917|NCT02946333|QoLMMBuS|qolmmbus
199918|NCT02946333|healthcare costs|healthcare costs
199919|NCT02946320|PCI, bioabsorbable scaffold|pci, bioabsorbable scaffold
199920|NCT02946281|self-management|self-management
199921|NCT02946281|health behavior|health behavior
199922|NCT02946281|cardiac disease|cardiac disease
199923|NCT02946281|habits|habits
199924|NCT02946281|lifestyle|lifestyle
199925|NCT02946255|Psychosis|psychosis
199926|NCT02946255|Psychosis NOS|psychosis nos
199927|NCT02946255|Schizophrenia|schizophrenia
199928|NCT02946255|Hospital discharge|hospital discharge
199929|NCT02946255|Inpatient psychiatry|inpatient psychiatry
199930|NCT02946190|Acellular pertussis vaccines Genetically-detoxified pertussis toxin Adolescents|acellular pertussis vaccines genetically-detoxified pertussis toxin adolescents
199931|NCT02946177|Immunology|immunology
199932|NCT02946177|Pregnancy|pregnancy
199933|NCT02946177|Implantation Rate|implantation rate
199934|NCT02946177|Fertilization in Vitro|fertilization in vitro
199935|NCT02946177|Oocyte donor egg recipient|oocyte donor egg recipient
199936|NCT02946151|Epilepsy|epilepsy
199937|NCT02946151|Seizure monitoring|seizure monitoring
199938|NCT02946151|Electroencephalography|electroencephalography
199939|NCT02946138|Hepatocellular Carcinoma|hepatocellular carcinoma
199940|NCT02946138|carbon-ion radiotherapy|carbon-ion radiotherapy
199942|NCT02946138|immunotherapy|immunotherapy
199943|NCT02946086|motor skill learning, visuo-spatial attention|motor skill learning, visuo-spatial attention
199944|NCT02946047|HIV|hiv
199945|NCT02946047|ART|art
199946|NCT02946047|Antiretroviral|antiretroviral
199947|NCT02946047|Therapy|therapy
199948|NCT02946047|Reservoir|reservoir
199949|NCT02946047|Cure|cure
199950|NCT02946034|CKD|ckd
199951|NCT02946034|HCV|hcv
199952|NCT02946021|Lymphedema|lymphedema
199953|NCT02946021|Cancer|cancer
199954|NCT02946021|Head Cancer|head cancer
199955|NCT02946021|Neck Cancer|neck cancer
199956|NCT02945982|Portal Hypertension|portal hypertension
199957|NCT02945982|Fuzheng Huayu|fuzheng huayu
199958|NCT02945982|Hepatitis B|hepatitis b
199959|NCT02945969|dietary sodium|dietary sodium
199960|NCT02945969|albuminuria|albuminuria
199961|NCT02945969|chronic kidney disease|chronic kidney disease
199962|NCT02945956|Portal Hypertension|portal hypertension
199963|NCT02945956|Fuzheng Huayu|fuzheng huayu
199964|NCT02945956|Hepatitis B|hepatitis b
199965|NCT02945930|Enbucrilate|enbucrilate
199966|NCT02945930|Esophageal and Gastric Varices|esophageal and gastric varices
199967|NCT02945930|Endoscopy|endoscopy
199968|NCT02945930|Safety|safety
199969|NCT02945930|Efficacy|efficacy
199970|NCT02945891|mass screening|mass screening
199971|NCT02945891|coverage|coverage
199972|NCT02945891|self-sampling|self-sampling
199973|NCT02945891|clinical validity|clinical validity
199974|NCT02945878|radiotherapy, oral mucositis,oral mucosa protection|radiotherapy, oral mucositis,oral mucosa protection
199975|NCT02945839|Migraine|migraine
199976|NCT02945839|emergency department|emergency department
199977|NCT02945826|urokinase plasminogen activator receptor|urokinase plasminogen activator receptor
199978|NCT02945826|positron emission tomography|positron emission tomography
199979|NCT02945826|glioblastoma multiforme|glioblastoma multiforme
199980|NCT02945813|Prostate Cancer|prostate cancer
199981|NCT02945813|Prostate Cancer after Prostatectomy|prostate cancer after prostatectomy
199982|NCT02945813|Phase II Trial|phase ii trial
199983|NCT02945813|Salvage Radiotherapy|salvage radiotherapy
199984|NCT02945813|Metformin|metformin
199985|NCT02945800|relapsed|relapsed
199986|NCT02945800|refractory|refractory
199987|NCT02945800|soft tissue|soft tissue
199988|NCT02945800|bones and joints|bones and joints
199989|NCT02945800|non-rhabdomyosarcoma soft tissue sarcoma|non-rhabdomyosarcoma soft tissue sarcoma
199990|NCT02945800|pediatric|pediatric
199991|NCT02945787|Spanish speaking|spanish speaking
199992|NCT02945787|self-help|self-help
199993|NCT02945787|tobacco abstinence|tobacco abstinence
199994|NCT02945787|public health|public health
199995|NCT02945787|Forever Free|forever free
199996|NCT02945787|Stop Smoking for Good|stop smoking for good
199997|NCT02945774|PET|pet
199998|NCT02945774|MRI|mri
199999|NCT02945774|Inflammation|inflammation
200000|NCT02945774|Microglia|microglia
200001|NCT02945774|FEPPA|feppa
200002|NCT02945748|pediatric|pediatric
200003|NCT02945748|cardiac output|cardiac output
200004|NCT02945748|fluid responsiveness|fluid responsiveness
200005|NCT02945748|critically ill|critically ill
200006|NCT02945748|hemodynamic monitoring|hemodynamic monitoring
200007|NCT02945735|depression|depression
200008|NCT02945735|cognitive bias modification|cognitive bias modification
200009|NCT02945735|MDD|mdd
200010|NCT02945735|major depressive disorder|major depressive disorder
200011|NCT02945735|attention bias modification treatment|attention bias modification treatment
200012|NCT02945722|Hemodialysis|hemodialysis
200013|NCT02945722|S. Aureus|s. aureus
200014|NCT02945722|Decolonization|decolonization
200015|NCT02945722|Persistent carriage|persistent carriage
200016|NCT02945709|PTSD|ptsd
200017|NCT02945709|attention training|attention training
200018|NCT02945709|cognitive bias modification|cognitive bias modification
200019|NCT02945696|nerve block|nerve block
200020|NCT02945696|laparoscopy|laparoscopy
200021|NCT02945696|anesthesia|anesthesia
200022|NCT02945683|atopic dermatitis, probiotics, vitamin D3, L. reuteri|atopic dermatitis, probiotics, vitamin d3, l. reuteri
200023|NCT02945644|obstructive sleep apnea|obstructive sleep apnea
200024|NCT02945644|trazodone|trazodone
200025|NCT02945644|positive airway pressure|positive airway pressure
200026|NCT02945644|adherence|adherence
200028|NCT02945631|Induction Chemotherapy|induction chemotherapy
200029|NCT02945631|De-Intensified Chemoradiotherapy|de-intensified chemoradiotherapy
200030|NCT02945631|Oropharynx Cancer|oropharynx cancer
200031|NCT02945618|cryotherapy|cryotherapy
200032|NCT02945618|physical therapy|physical therapy
200033|NCT02945592|Hemispatial Neglect|hemispatial neglect
200034|NCT02945592|cueing|cueing
200035|NCT02945592|egocentric-allocentric|egocentric-allocentric
200036|NCT02945592|early rehabilitation|early rehabilitation
200037|NCT02945592|parietal tDCS|parietal tdcs
200038|NCT02945540|Gestational diabetes|gestational diabetes
200039|NCT02945540|Patient education|patient education
200040|NCT02945540|Patient Satisfaction|patient satisfaction
200041|NCT02945514|Healthy|healthy
200042|NCT02945514|Diet|diet
200043|NCT02945514|Microbiome|microbiome
200044|NCT02945514|Personalized|personalized
200045|NCT02945514|Custom|custom
200046|NCT02945475|functional magnetic resonance imaging|functional magnetic resonance imaging
200047|NCT02945475|eating behavior|eating behavior
200048|NCT02945475|sugar|sugar
200049|NCT02945475|fructose|fructose
200050|NCT02945449|Wharton jelly mesenchymal stem cells|wharton jelly mesenchymal stem cells
200051|NCT02945449|Erectile Dysfunction|erectile dysfunction
200052|NCT02945449|Diabetes|diabetes
200053|NCT02945449|safety|safety
200054|NCT02945397|Return to work|return to work
200055|NCT02945397|Work rehabilitation|work rehabilitation
200056|NCT02945397|Sick-leave|sick-leave
200057|NCT02945384|family well-being|family well-being
200058|NCT02945332|exercise|exercise
200059|NCT02945332|activity|activity
200060|NCT02945332|behavior|behavior
200061|NCT02945306|Sleep Disordered Breathing|sleep disordered breathing
200062|NCT02945306|Adenotonsillectomy|adenotonsillectomy
200063|NCT02945306|Child|child
200064|NCT02945293|Pain|pain
200065|NCT02945293|Elderly|elderly
200066|NCT02945293|Aged|aged
200067|NCT02945293|Opioid|opioid
200068|NCT02945293|Cognition|cognition
200069|NCT02945293|Side-effects|side-effects
200070|NCT02945293|Alcohol|alcohol
200071|NCT02945293|Alcohol Use Disorder (AUD)|alcohol use disorder (aud)
200072|NCT02945293|Older|older
200073|NCT02945280|apixaban|apixaban
200074|NCT02945280|factor Xa inhibitors|factor xa inhibitors
200075|NCT02945280|antithrombotic agent|antithrombotic agent
200076|NCT02945280|deep vein thrombosis|deep vein thrombosis
200077|NCT02945280|upper extremity|upper extremity
200078|NCT02945267|Pancreatic Cancer|pancreatic cancer
200079|NCT02945267|Unresectable|unresectable
200080|NCT02945267|Maintenance Treatment|maintenance treatment
200081|NCT02945254|sleep onset latency|sleep onset latency
200082|NCT02945254|sleep quality|sleep quality
200083|NCT02945254|insomnia|insomnia
200084|NCT02945228|Genotype 2|genotype 2
200085|NCT02945228|Paritaprevir|paritaprevir
200086|NCT02945228|Hepatitis C Virus (HCV)|hepatitis c virus (hcv)
200087|NCT02945228|Ritonavir|ritonavir
200088|NCT02945228|Ombitasvir|ombitasvir
200089|NCT02945189|Pregnancy|pregnancy
200090|NCT02945176|Boston Keratoprosthesis|boston keratoprosthesis
200091|NCT02945150|hemodialysis|hemodialysis
200092|NCT02945150|peritoneal dialysis|peritoneal dialysis
200093|NCT02945150|renal failure|renal failure
200094|NCT02945150|kidney transplant|kidney transplant
200095|NCT02945085|older adults|older adults
200096|NCT02945085|family caregivers|family caregivers
200097|NCT02945085|Medicare Advantage beneficiaries|medicare advantage beneficiaries
200098|NCT02945072|Child Behavior|child behavior
200099|NCT02945072|Problem Behavior|problem behavior
200100|NCT02945072|postoperative behaviour problems|postoperative behaviour problems
200101|NCT02945059|Liver regeneration|liver regeneration
200102|NCT02945059|portal vein embolization|portal vein embolization
200103|NCT02945059|gelatin powder|gelatin powder
200104|NCT02945059|liver surgery|liver surgery
200105|NCT02945059|hepatectomy|hepatectomy
200106|NCT02945033|Pi3k mutation|pi3k mutation
200107|NCT02945033|Aspirin|aspirin
200108|NCT02944968|Interventional|interventional
200109|NCT02944968|Radiofrequency Ablation|radiofrequency ablation
200110|NCT02944968|Paroxysmal Atrial Fibrillation|paroxysmal atrial fibrillation
200111|NCT02944929|Spastic hemiparesis|spastic hemiparesis
200112|NCT02944929|Stroke|stroke
200113|NCT02944929|Self-rehabilitation|self-rehabilitation
200114|NCT02944929|Botulinum Toxin Injections|botulinum toxin injections
200115|NCT02944903|audit|audit
200116|NCT02944903|Lung cancer|lung cancer
200117|NCT02944903|screening practice|screening practice
200118|NCT02944903|Egypt|egypt
200119|NCT02944851|Blood donors|blood donors
200120|NCT02944851|blood donation|blood donation
200121|NCT02944851|traumatic blood loss|traumatic blood loss
200122|NCT02944851|Trauma|trauma
200123|NCT02944838|older adults|older adults
200124|NCT02944838|physical activity|physical activity
200125|NCT02944838|built environment|built environment
200126|NCT02944825|Urolithiasis|urolithiasis
200128|NCT02944786|Chronic pain|chronic pain
200129|NCT02944786|Adolescents|adolescents
200130|NCT02944786|School nurse|school nurse
200131|NCT02944773|newborn|newborn
200132|NCT02944773|facilitated tucking|facilitated tucking
200133|NCT02944773|position|position
200134|NCT02944773|weight|weight
200135|NCT02944773|stress|stress
200136|NCT02944747|Gestational age, Preterm birth, LMP, Bangladesh|gestational age, preterm birth, lmp, bangladesh
200137|NCT02944734|Candesartan|candesartan
200138|NCT02944734|Amlodipine|amlodipine
200139|NCT02944734|Hypertension|hypertension
200140|NCT02944734|Vascular Diseases|vascular diseases
200141|NCT02944734|Cardiovascular Diseases|cardiovascular diseases
200142|NCT02944734|Antihypertensive Agents|antihypertensive agents
200143|NCT02944734|Vasodilator Agents|vasodilator agents
200144|NCT02944734|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers
200145|NCT02944734|Angiotensin Receptor Antagonists|angiotensin receptor antagonists
200146|NCT02944734|Calcium Channel Blockers|calcium channel blockers
200147|NCT02944721|Neuropathic Pain|neuropathic pain
200148|NCT02944708|maintenance chemotherapy|maintenance chemotherapy
200149|NCT02944695|audit|audit
200150|NCT02944695|infection control|infection control
200151|NCT02944695|bronchoscopy unit|bronchoscopy unit
200152|NCT02944695|Egypt|egypt
200153|NCT02944682|Obstetrics|obstetrics
200154|NCT02944682|Pregnancy Outcomes|pregnancy outcomes
200155|NCT02944682|Pediatrics|pediatrics
200156|NCT02944682|Atherosclerosis|atherosclerosis
200157|NCT02944682|Cancer|cancer
200158|NCT02944682|Cardiovascular Disease|cardiovascular disease
200159|NCT02944682|Public Health|public health
200160|NCT02944682|Environmental Air Pollutants|environmental air pollutants
200161|NCT02944656|Perioperative pain|perioperative pain
200162|NCT02944656|Outpatient surgery|outpatient surgery
200163|NCT02944656|Obstetrics/gynecology|obstetrics/gynecology
200164|NCT02944656|Pain management|pain management
200165|NCT02944630|quality of life|quality of life
200166|NCT02944630|psychotherapy|psychotherapy
200167|NCT02944630|psoriasis|psoriasis
200168|NCT02944630|treatments|treatments
200169|NCT02944578|Cancer|cancer
200171|NCT02944578|Oncology|oncology
200172|NCT02944578|Infectious Diseases|infectious diseases
200173|NCT02944578|HPV|hpv
200174|NCT02944578|Preventive Medicine|preventive medicine
200175|NCT02944539|Mitochondrial DNA copy number|mitochondrial dna copy number
200176|NCT02944539|Gastric cancer|gastric cancer
200177|NCT02944526|suprascapular nerve|suprascapular nerve
200178|NCT02944500|Brain|brain
200179|NCT02944500|Liraglutide|liraglutide
200180|NCT02944500|MRI|mri
200181|NCT02944487|safety|safety
200182|NCT02944487|pharmacokinetics|pharmacokinetics
200183|NCT02944474|Pharmacokinetics|pharmacokinetics
200184|NCT02944474|Safety|safety
200185|NCT02944448|Osteoarthritis|osteoarthritis
200186|NCT02944448|Hip|hip
200187|NCT02944448|Knee|knee
200188|NCT02944448|CR845|cr845
200189|NCT02944448|Analgesic|analgesic
200190|NCT02944448|Kappa opioid|kappa opioid
200191|NCT02944448|difelikefalin|difelikefalin
200192|NCT02944435|Glutaminase Inhibitor|glutaminase inhibitor
200193|NCT02944435|Glutaminase|glutaminase
200194|NCT02944435|CB-839|cb-839
200195|NCT02944396|metastatic|metastatic
200196|NCT02944396|non-small cell lung cancer|non-small cell lung cancer
200197|NCT02944396|Eastern Cooperative Oncology Group (ECOG)|eastern cooperative oncology group (ecog)
200198|NCT02944396|veliparib|veliparib
200199|NCT02944396|nivolumab|nivolumab
200200|NCT02944396|Platinum Doublet Chemotherapy|platinum doublet chemotherapy
200201|NCT02944396|carboplatin|carboplatin
200202|NCT02944396|paclitaxel|paclitaxel
200203|NCT02944396|pemetrexed|pemetrexed
200204|NCT02944396|Response Evaluation Criteria In Solid Tumors (RECIST)|response evaluation criteria in solid tumors (recist)
200205|NCT02944396|Common Terminology Criteria for Adverse Events (CTCAE)|common terminology criteria for adverse events (ctcae)
200206|NCT02944396|Poly (ADP) ribose polymerase (PARP)|poly (adp) ribose polymerase (parp)
200207|NCT02944396|Immuno Oncology|immuno oncology
200208|NCT02944396|Metastatic or Advanced Non-Small Cell Lung Cancer (NSCLC)|metastatic or advanced non-small cell lung cancer (nsclc)
200209|NCT02944383|Hypertriglycerides|hypertriglycerides
200210|NCT02944344|breast cancer|breast cancer
200211|NCT02944344|stage 4|stage 4
200212|NCT02944344|metastatic|metastatic
200213|NCT02944344|hospice|hospice
200214|NCT02944344|palliative care|palliative care
200215|NCT02944344|end of life|end of life
200216|NCT02944344|advance directive|advance directive
200217|NCT02944344|oncology|oncology
200218|NCT02944344|caregiver|caregiver
200219|NCT02944344|provider|provider
200220|NCT02944344|coping|coping
200221|NCT02944344|support|support
200222|NCT02944344|online|online
200223|NCT02944331|Steam ablation|steam ablation
200224|NCT02944331|Endothermal ablation|endothermal ablation
200225|NCT02944331|Varicose vein treatment|varicose vein treatment
200226|NCT02944331|Venous insufficiency|venous insufficiency
200227|NCT02944331|Saphenous vein reflux|saphenous vein reflux
200228|NCT02944331|Recurrent varicosity|recurrent varicosity
200229|NCT02944318|Physical Activity|physical activity
200230|NCT02944318|Healthy Lifestyle|healthy lifestyle
200231|NCT02944318|Academic performance|academic performance
200232|NCT02944292|Intra-abdominal pressure|intra-abdominal pressure
200233|NCT02944292|Intra-abdominal hypertension|intra-abdominal hypertension
200234|NCT02944266|post general anaesthesia induced|post general anaesthesia induced
200235|NCT02944253|Diet, Reducing|diet, reducing
200236|NCT02944253|Hunger|hunger
200237|NCT02944253|Appetite Regulation|appetite regulation
200238|NCT02944253|Ketogenic Diet|ketogenic diet
200239|NCT02944253|Caloric Restriction|caloric restriction
200240|NCT02944253|Weight Loss|weight loss
200241|NCT02944253|Ketosis|ketosis
200242|NCT02944214|Hyperuricemia|hyperuricemia
200243|NCT02944214|Renal Function|renal function
200244|NCT02944214|Chronic kidney disease|chronic kidney disease
200245|NCT02944214|Febuxostat|febuxostat
200246|NCT02944214|Benzbromarone|benzbromarone
200247|NCT02944201|carvedilol|carvedilol
200248|NCT02944201|biomarkers|biomarkers
200249|NCT02944201|autonomic nerves|autonomic nerves
200250|NCT02944188|enhanced recovery after surgery|enhanced recovery after surgery
200251|NCT02944188|right hemicolectomy|right hemicolectomy
200252|NCT02944162|AML|aml
200253|NCT02944162|CD33|cd33
200254|NCT02944162|CAR-NK|car-nk
200255|NCT02944136|cancer|cancer
200256|NCT02944136|stepped collaborative care intervention|stepped collaborative care intervention
200257|NCT02944136|depression|depression
200258|NCT02944136|quality of life|quality of life
200259|NCT02944136|stress|stress
200260|NCT02944136|dyadic function|dyadic function
200261|NCT02944136|spousal or intimate caregiver|spousal or intimate caregiver
200262|NCT02944123|Half dose|half dose
200263|NCT02944123|Newer oral P2Y12 receptor inhibitors|newer oral p2y12 receptor inhibitors
200264|NCT02944123|Acute coronary syndrome|acute coronary syndrome
200265|NCT02944097|Bioavailability|bioavailability
200266|NCT02944097|Pharmacokinetics|pharmacokinetics
200267|NCT02944097|trans-resveratrol|trans-resveratrol
200268|NCT02944097|trans-epsilon-viniferin|trans-epsilon-viniferin
200269|NCT02944097|Vineatrol 30|vineatrol 30
200270|NCT02944084|Bioavailability|bioavailability
200271|NCT02944084|Pharmacokinetics|pharmacokinetics
200272|NCT02944084|Rice bran extract|rice bran extract
200273|NCT02944084|Vitamin E|vitamin e
200274|NCT02944084|Gamma-oryzanol|gamma-oryzanol
200275|NCT02944084|Ferulic acid|ferulic acid
200276|NCT02944071|femoropopliteal artery lesions|femoropopliteal artery lesions
200277|NCT02944071|Percutaneous Transluminal Angioplasty|percutaneous transluminal angioplasty
200278|NCT02944071|Peripheral Artery Disease|peripheral artery disease
200279|NCT02944071|Drug-coated Balloon|drug-coated balloon
200280|NCT02944058|Multiloc|multiloc
200281|NCT02944058|Philos|philos
200282|NCT02944058|Locking plate|locking plate
200283|NCT02944058|Straight nail|straight nail
200284|NCT02944058|Randomized controlled trial|randomized controlled trial
200285|NCT02944058|3 and 4 part fractures|3 and 4 part fractures
200286|NCT02944019|Nonvalvular Atrial Fibrillation|nonvalvular atrial fibrillation
200287|NCT02944019|Post Authorisation Safety Study|post authorisation safety study
200288|NCT02944019|Safety|safety
200289|NCT02944019|Real World Evidence|real world evidence
200290|NCT02944006|MRI|mri
200291|NCT02943993|Post-Authorisation Safety Study|post-authorisation safety study
200292|NCT02943993|Real World Evidence|real world evidence
200293|NCT02943993|Edoxaban|edoxaban
200294|NCT02943993|Efficacy/Safety|efficacy/safety
200295|NCT02943980|Intraoperative nerve monitoring, airway management|intraoperative nerve monitoring, airway management
200296|NCT02943967|Refractive Surgical Procedures|refractive surgical procedures
200297|NCT02943967|Photorefractive Keratectomy|photorefractive keratectomy
200298|NCT02943967|Aberrometry|aberrometry
200299|NCT02943954|Fractional Flow Reserve|fractional flow reserve
200300|NCT02943915|Spinal Cord|spinal cord
200301|NCT02943915|Injury|injury
200302|NCT02943915|Exoskeleton|exoskeleton
200303|NCT02943915|Ekso|ekso
200304|NCT02943915|Rehabilitation|rehabilitation
200305|NCT02943902|immunogenicity|immunogenicity
200306|NCT02943889|Mesenchymal stem cells|mesenchymal stem cells
200307|NCT02943889|Liver cirrhosis|liver cirrhosis
200308|NCT02943889|Stem cell therapy|stem cell therapy
200309|NCT02943876|risk prediction|risk prediction
200310|NCT02943876|risk score|risk score
200311|NCT02943876|accuracy of risk perception|accuracy of risk perception
200312|NCT02943876|self-help|self-help
200313|NCT02943876|psychological distress|psychological distress
200314|NCT02943850|stem cells|stem cells
200315|NCT02943850|growth factor|growth factor
200316|NCT02943850|ALS|als
200317|NCT02943824|brachytherapy|brachytherapy
200318|NCT02943824|machine learning|machine learning
200319|NCT02943824|treatment planning|treatment planning
200320|NCT02943824|Low-Dose-Rate brachytherapy|low-dose-rate brachytherapy
200321|NCT02943811|endometrial cancer|endometrial cancer
200322|NCT02943811|survival|survival
200323|NCT02943811|uterine manipulator|uterine manipulator
200324|NCT02943798|Pulmonary Large Cell Neuroendocrine Carcinoma,chemotherapy|pulmonary large cell neuroendocrine carcinoma,chemotherapy
200325|NCT02943785|Transcatheter Aortic Valve Implantation -- TAVI|transcatheter aortic valve implantation -- tavi
200326|NCT02943785|Anticoagulation|anticoagulation
200327|NCT02943785|Atrial Fibrillation|atrial fibrillation
200328|NCT02943785|ENVISAGE-TAVI-AF|envisage-tavi-af
200329|NCT02943746|Standard Protein Diet|standard protein diet
200330|NCT02943746|High Protein Diet|high protein diet
200331|NCT02943746|Growth|growth
200332|NCT02943746|Body Composition|body composition
200333|NCT02943746|Extremely Low Birth Weight|extremely low birth weight
200334|NCT02943746|Human Milk Derived Fortifier|human milk derived fortifier
200335|NCT02943746|Protein|protein
200336|NCT02943746|Targeted Fortification|targeted fortification
200337|NCT02943746|Human Milk Diet|human milk diet
200338|NCT02943746|Prematurity|prematurity
200339|NCT02943733|Pancreatic neuroendocrine tumors (pNETs)|pancreatic neuroendocrine tumors (pnets)
200340|NCT02943733|Pancreatic neuroendocrine tumors|pancreatic neuroendocrine tumors
200341|NCT02943733|pNETs|pnets
200342|NCT02943733|NETs|nets
200343|NCT02943707|liver diseases|liver diseases
200344|NCT02943707|Bone Marrow Cell Transplantation|bone marrow cell transplantation
200345|NCT02943694|TaTME|tatme
200346|NCT02943694|Complications|complications
200347|NCT02943694|Instrument|instrument
200348|NCT02943642|MF|mf
200349|NCT02943642|CTCL|ctcl
200350|NCT02943642|Cutaneous T Cell Lymphoma|cutaneous t cell lymphoma
200351|NCT02943616|Absorb GT1 BVS|absorb gt1 bvs
200352|NCT02943616|BVS|bvs
200353|NCT02943616|Bioabsorbable|bioabsorbable
200354|NCT02943616|Myocardial ischemia|myocardial ischemia
200355|NCT02943616|Stent thrombosis|stent thrombosis
200356|NCT02943616|Stents|stents
200357|NCT02943603|mFOLFOX6|mfolfox6
200358|NCT02943603|pembrolizumab|pembrolizumab
200359|NCT02943590|Cancer Treatment Related to Heart Failure|cancer treatment related to heart failure
200360|NCT02943551|Pediatrics|pediatrics
200361|NCT02943551|Respiratory disease|respiratory disease
200362|NCT02943551|antibiotic use|antibiotic use
200363|NCT02943538|Crohn's Disease|crohn's disease
200364|NCT02943538|Colitis, Ulcerative|colitis, ulcerative
200365|NCT02943538|Telemedicine|telemedicine
200366|NCT02943525|vaginal packing|vaginal packing
200367|NCT02943525|pelvic organ prolapse|pelvic organ prolapse
200368|NCT02943525|pain and satisfaction|pain and satisfaction
200369|NCT02943486|Mesenchymal stromal cells|mesenchymal stromal cells
200370|NCT02943486|Fitostimoline|fitostimoline
200371|NCT02943486|MSC derivatives|msc derivatives
200372|NCT02943486|Diabetes|diabetes
200373|NCT02943473|Smoldering multiple myeloma|smoldering multiple myeloma
200374|NCT02943473|myeloma|myeloma
200375|NCT02943473|smoldering|smoldering
200376|NCT02943473|ibrutinib|ibrutinib
200377|NCT02943408|Veterans|veterans
200378|NCT02943408|mental health|mental health
200379|NCT02943408|Patient-Centered Care|patient-centered care
200380|NCT02943382|MGD|mgd
200381|NCT02943382|Autologous Serum|autologous serum
200382|NCT02943382|Meibomian gland dysfunction|meibomian gland dysfunction
200383|NCT02943382|Dry eye disease|dry eye disease
200384|NCT02943382|FAB|fab
200385|NCT02943382|Fingerprick autologous blood|fingerprick autologous blood
200386|NCT02943369|cangrelor|cangrelor
200387|NCT02943369|ticagrelor|ticagrelor
200388|NCT02943369|P2Y12 receptor antagonist|p2y12 receptor antagonist
200389|NCT02943369|acute myocardial infarction|acute myocardial infarction
200390|NCT02943330|Depression|depression
200391|NCT02943330|Cytokines|cytokines
200392|NCT02943330|Hemodialysis|hemodialysis
200393|NCT02943330|Interferon treatment|interferon treatment
200394|NCT02943330|Hepatitis C|hepatitis c
200395|NCT02943304|Pregnancy|pregnancy
200396|NCT02943304|Fetal Development|fetal development
200397|NCT02943304|Child Development|child development
200398|NCT02943304|Developmental Disabilities|developmental disabilities
200399|NCT02943304|Zika Virus Infection|zika virus infection
200400|NCT02943291|Exercise therapy|exercise therapy
200401|NCT02943291|Adipose tissue|adipose tissue
200402|NCT02943291|Mitochondria|mitochondria
200403|NCT02943291|Oxidative Phosphorylation|oxidative phosphorylation
200404|NCT02943265|Care Coordination|care coordination
200405|NCT02943252|apatinib|apatinib
200407|NCT02943252|advanced head and neck cancer|advanced head and neck cancer
200408|NCT02943252|non-squamous|non-squamous
200409|NCT02943213|Chlorpromazine|chlorpromazine
200410|NCT02943213|Hydrochloride|hydrochloride
200411|NCT02943213|Chlorpromazine Hydrochloride|chlorpromazine hydrochloride
200412|NCT02943213|Bioavailability|bioavailability
200413|NCT02943213|Variability|variability
200414|NCT02943213|Variable|variable
200415|NCT02943213|Absorption|absorption
200416|NCT02943213|USL Pharma|usl pharma
200417|NCT02943213|USL|usl
200418|NCT02943213|Healthy|healthy
200419|NCT02943213|South Africa|south africa
200420|NCT02943213|Cycle|cycle
200421|NCT02943213|Anti-Psychotic|anti-psychotic
200422|NCT02943161|Obesity|obesity
200423|NCT02943161|L-citrulline|l-citrulline
200424|NCT02943109|patient portal|patient portal
200425|NCT02943109|Health Information Technology|health information technology
200426|NCT02943109|Electronic Health Records|electronic health records
200427|NCT02943109|Inpatient Care|inpatient care
200428|NCT02943109|Outpatient Care|outpatient care
200429|NCT02943109|Patient Engagement|patient engagement
200430|NCT02943070|Rezum|rezum
200431|NCT02943070|Water Vapor Ablation|water vapor ablation
200432|NCT02943031|bile duct tumor|bile duct tumor
200433|NCT02943031|individualized precise treatment programs|individualized precise treatment programs
200434|NCT02943018|ultrasound anovaginal distance, observer variation|ultrasound anovaginal distance, observer variation
200435|NCT02942979|Facilitation|facilitation
200436|NCT02942979|Implementation|implementation
200437|NCT02942979|Homelessness|homelessness
200438|NCT02942979|Substance Use Disorder|substance use disorder
200542|NCT02942251|MDD|mdd
200439|NCT02942979|Mental Illness|mental illness
200440|NCT02942979|Co-Occurring Disorders|co-occurring disorders
200441|NCT02942979|Veterans|veterans
200442|NCT02942979|Primary Care|primary care
200443|NCT02942966|Angioplasty|angioplasty
200444|NCT02942966|Below the Knee|below the knee
200445|NCT02942966|PAD|pad
200446|NCT02942966|Critical Limb Ischemia|critical limb ischemia
200447|NCT02942966|Lesion|lesion
200448|NCT02942966|Claudication|claudication
200449|NCT02942953|Pacemaker, Artificial|pacemaker, artificial
200450|NCT02942953|Diaphragmatic pacing|diaphragmatic pacing
200451|NCT02942927|Polypharmacy|polypharmacy
200452|NCT02942927|Multimorbidity|multimorbidity
200453|NCT02942927|Randomized Control Trial|randomized control trial
200454|NCT02942927|Drug Discontinuation|drug discontinuation
200455|NCT02942927|Patient Preference|patient preference
256345|NCT02600442|FDG|fdg
200456|NCT02942927|eHealth|ehealth
200457|NCT02942901|PET-CT|pet-ct
200458|NCT02942901|pulmonary metstasectomy|pulmonary metstasectomy
200459|NCT02942888|Mild Cognitive Impairment|mild cognitive impairment
200460|NCT02942888|MCI|mci
200461|NCT02942888|NAD|nad
200462|NCT02942888|nicotinamide riboside|nicotinamide riboside
200463|NCT02942888|aging|aging
200464|NCT02942875|upper limb|upper limb
200465|NCT02942875|mirror therapy|mirror therapy
200466|NCT02942875|rehabilitation|rehabilitation
200467|NCT02942875|subacute|subacute
200468|NCT02942849|Bemfola|bemfola
200469|NCT02942849|r-hFSH|r-hfsh
200470|NCT02942849|Oocytes|oocytes
200471|NCT02942849|Pregnancy|pregnancy
200472|NCT02942849|OHSS|ohss
200473|NCT02942836|Respiration Rate Detection|respiration rate detection
200474|NCT02942823|obesity|obesity
200475|NCT02942823|child|child
200476|NCT02942823|primary prevention|primary prevention
200477|NCT02942823|serious game|serious game
200478|NCT02942823|nutrition|nutrition
200479|NCT02942823|physical activity|physical activity
200480|NCT02942823|psychosocial|psychosocial
200481|NCT02942823|stress|stress
200482|NCT02942823|knowledge|knowledge
200483|NCT02942823|diet|diet
200484|NCT02942823|energy density|energy density
200485|NCT02942823|beverages|beverages
200486|NCT02942823|food pyramide|food pyramide
200487|NCT02942732|Vitamin D|vitamin d
200488|NCT02942732|Glucose|glucose
200489|NCT02942732|HbA1C|hba1c
200490|NCT02942732|Insulin resistance|insulin resistance
200491|NCT02942732|Blood lipids|blood lipids
200492|NCT02942693|Apatinib|apatinib
200493|NCT02942693|Particle therapy|particle therapy
200494|NCT02942680|coronary artery bypass grafting|coronary artery bypass grafting
200495|NCT02942641|Urethral catheter|urethral catheter
200496|NCT02942641|clean intermittent catheterization|clean intermittent catheterization
200497|NCT02942641|UTI|uti
200498|NCT02942641|pain|pain
200499|NCT02942641|quality of life|quality of life
200500|NCT02942641|hematuria|hematuria
200501|NCT02942641|cloudy urine|cloudy urine
200502|NCT02942589|Portion Size|portion size
200503|NCT02942563|Local Advanced Rectal Cancer|local advanced rectal cancer
200504|NCT02942563|Total Neoadjuvant Therapy|total neoadjuvant therapy
200505|NCT02942563|FOLFOXIRI|folfoxiri
200506|NCT02942498|behavior, cognitive|behavior, cognitive
200507|NCT02942472|clinical pregnancy rate after embryo transfer|clinical pregnancy rate after embryo transfer
200508|NCT02942459|music therapy|music therapy
200509|NCT02942459|double-blinded|double-blinded
200510|NCT02942459|Randomized Controlled study (RCT)|randomized controlled study (rct)
200511|NCT02942459|Schizophrenia, negative symptoms|schizophrenia, negative symptoms
200512|NCT02942407|Renal dialysis|renal dialysis
200513|NCT02942329|humanized anti-PD-1 monoclonal antibody|humanized anti-pd-1 monoclonal antibody
200514|NCT02942329|apatinib|apatinib
200515|NCT02942329|Gastric Neoplasms|gastric neoplasms
200516|NCT02942329|Gastric Cancer|gastric cancer
200517|NCT02942329|Cancer of Stomach|cancer of stomach
200518|NCT02942329|Hepatocellular Carcinoma|hepatocellular carcinoma
200519|NCT02942329|Liver Cancer, Adult|liver cancer, adult
200520|NCT02942329|Liver Cell Carcinoma|liver cell carcinoma
200521|NCT02942316|Heart Rate|heart rate
200522|NCT02942316|Reflex, Pupillary|reflex, pupillary
200523|NCT02942316|Monitoring, Intraoperative|monitoring, intraoperative
200524|NCT02942303|Botulinum Toxin, Rejuvenation, Brow lift, Eyebrow.|botulinum toxin, rejuvenation, brow lift, eyebrow.
200525|NCT02942290|Higher-Risk (HR) Myelodysplastic Syndromes (MDS)|higher-risk (hr) myelodysplastic syndromes (mds)
200526|NCT02942290|Pharmacokinetic|pharmacokinetic
200527|NCT02942290|Venetoclax|venetoclax
200528|NCT02942290|Azacitidine|azacitidine
200529|NCT02942290|Acute Myelogenous Leukemia|acute myelogenous leukemia
200530|NCT02942290|Myelodysplastic Syndromes (MDS)|myelodysplastic syndromes (mds)
200531|NCT02942290|Treatment-Naïve Higher-Risk|treatment-naïve higher-risk
200532|NCT02942277|Malaria|malaria
200533|NCT02942277|Reactogenicity|reactogenicity
200534|NCT02942277|Antibody|antibody
200535|NCT02942277|Direct Skin Feed|direct skin feed
200536|NCT02942277|Mosquito|mosquito
200537|NCT02942264|Brain Tumor|brain tumor
200538|NCT02942264|Glioblastoma|glioblastoma
200539|NCT02942264|Relapse|relapse
200540|NCT02942264|Randomized|randomized
200543|NCT02942251|big data analytics|big data analytics
200544|NCT02942238|CME|cme
200545|NCT02942238|Right hemi Colon cancer|right hemi colon cancer
200546|NCT02942238|D3|d3
200547|NCT02942238|laparoscopy|laparoscopy
200548|NCT02942225|Attention-deficit/hyperactivity disorder|attention-deficit/hyperactivity disorder
200549|NCT02942225|metabolomics|metabolomics
200550|NCT02942225|neuropsychological deficits|neuropsychological deficits
200551|NCT02942225|pathway analysis|pathway analysis
200552|NCT02942212|Smoking Cessation|smoking cessation
200553|NCT02942212|Nicotine patch|nicotine patch
200554|NCT02942212|Nicoderm Committed Quitters|nicoderm committed quitters
200555|NCT02942212|CQ|cq
200556|NCT02942212|Nicoderm CQ|nicoderm cq
712972|NCT00577993|Bleomycin|bleomycin
200557|NCT02942212|Questionnaires|questionnaires
200558|NCT02942212|Surveys|surveys
200559|NCT02942212|Interviews|interviews
200560|NCT02942212|Breath tests|breath tests
200561|NCT02942173|CD45RA-depletion|cd45ra-depletion
200562|NCT02942173|TCR-alpha/beta depletion|tcr-alpha/beta depletion
200563|NCT02942173|Hematopoietic Stem Cell Transplantation|hematopoietic stem cell transplantation
200564|NCT02942121|surgery education|surgery education
200565|NCT02942121|radical cystectomy|radical cystectomy
200566|NCT02942121|cystectomy|cystectomy
200567|NCT02942121|muscle-invasive bladder cancer|muscle-invasive bladder cancer
200568|NCT02942108|piezolectric surgery|piezolectric surgery
200569|NCT02942108|conventional surgery|conventional surgery
200570|NCT02942108|lower third molars|lower third molars
200571|NCT02942095|Advanced Solid Tumors|advanced solid tumors
200572|NCT02942095|Metastatic cancer|metastatic cancer
200573|NCT02942095|Ixazomib|ixazomib
200574|NCT02942095|MLN9708|mln9708
200575|NCT02942095|Erlotinib|erlotinib
200576|NCT02942095|Erlotinib hydrochloride|erlotinib hydrochloride
200577|NCT02942095|OSI-774|osi-774
200578|NCT02942095|CP358774|cp358774
200579|NCT02942095|Tarceva|tarceva
200580|NCT02942043|Malignant pleural effusion|malignant pleural effusion
200581|NCT02942043|Bevacizumab|bevacizumab
200582|NCT02942017|Moderate Postpartum Depression|moderate postpartum depression
200583|NCT02942017|SAGE-547|sage-547
200584|NCT02942004|Severe Postpartum Depression|severe postpartum depression
200585|NCT02942004|SAGE-547|sage-547
200586|NCT02941991|Stargardt's Macular Dystrophy|stargardt's macular dystrophy
200587|NCT02941991|Retinal Diseases|retinal diseases
200588|NCT02941991|Macular Degeneration|macular degeneration
200589|NCT02941991|fundus flavimaculatus|fundus flavimaculatus
200590|NCT02941991|hESC-RPE|hesc-rpe
200591|NCT02941991|ASP7316|asp7316
200592|NCT02941991|juvenile macular dystrophy|juvenile macular dystrophy
200593|NCT02941991|SMD|smd
200594|NCT02941978|atrial fibrillation|atrial fibrillation
200595|NCT02941978|oral anticoagulation|oral anticoagulation
200596|NCT02941978|motivational intervention|motivational intervention
200597|NCT02941978|adherence|adherence
200598|NCT02941978|treatment gaps|treatment gaps
200599|NCT02941939|high intensity interval training|high intensity interval training
200600|NCT02941939|hyperbaric oxygen|hyperbaric oxygen
200601|NCT02941926|HR-positive HER2-negative|hr-positive her2-negative
200602|NCT02941926|advanced breast cancer|advanced breast cancer
200603|NCT02941926|LEE011|lee011
200604|NCT02941926|ribociclib|ribociclib
200605|NCT02941926|letrozole|letrozole
200606|NCT02941926|goserelin|goserelin
200607|NCT02941926|CDK|cdk
200608|NCT02941926|CDK4|cdk4
200609|NCT02941926|CDK6|cdk6
200610|NCT02941926|CDK4/6|cdk4/6
200611|NCT02941926|Phase IIIb|phase iiib
200612|NCT02941926|ER-positive|er-positive
200613|NCT02941926|PR-positive|pr-positive
200614|NCT02941926|premenopausal|premenopausal
200615|NCT02941926|postmenopausal|postmenopausal
200616|NCT02941926|men with advanced breast cancer|men with advanced breast cancer
200617|NCT02941900|Genetic Testing|genetic testing
200618|NCT02941900|16-1243|16-1243
200619|NCT02941887|Social behavior|social behavior
200620|NCT02941887|Gingivitis|gingivitis
200621|NCT02941887|Periodontitis|periodontitis
200622|NCT02941887|Down's Syndrome|down's syndrome
200623|NCT02941874|IRAP|irap
200624|NCT02941874|Insulin Regulated Amino Peptidase|insulin regulated amino peptidase
200625|NCT02941874|Diagnostic biomarker|diagnostic biomarker
200626|NCT02941874|Type 2 diabetes|type 2 diabetes
200627|NCT02941861|Hepatocellular carcinoma|hepatocellular carcinoma
200628|NCT02941861|Cholangiocarcinoma|cholangiocarcinoma
200629|NCT02941861|Recurrence|recurrence
200630|NCT02941835|pre-operative radiotherapy|pre-operative radiotherapy
200631|NCT02941783|Kovaltry|kovaltry
200632|NCT02941783|hemophilia A|hemophilia a
200633|NCT02941783|Japan|japan
200634|NCT02941783|Post-marketing surveillance|post-marketing surveillance
200635|NCT02941770|Adolescents|adolescents
200636|NCT02941770|Overweight|overweight
200637|NCT02941770|Obesity|obesity
200638|NCT02941770|Weight Loss|weight loss
200639|NCT02941770|Physical activity consultation|physical activity consultation
200640|NCT02941770|Cardiorespiratory fitness|cardiorespiratory fitness
200641|NCT02941770|Endothelial structure|endothelial structure
200642|NCT02941770|Endothelial function|endothelial function
200643|NCT02941757|Mediterranean Diet|mediterranean diet
200644|NCT02941757|Firefighters|firefighters
200645|NCT02941757|workplace|workplace
200646|NCT02941757|Intervention|intervention
200647|NCT02941757|obesity|obesity
200648|NCT02941757|Randomized Control Trial|randomized control trial
200649|NCT02941744|nivolumab|nivolumab
200650|NCT02941744|ipilimumab|ipilimumab
200651|NCT02941744|low fixed dose|low fixed dose
200652|NCT02941744|adjuvant therapy|adjuvant therapy
200653|NCT02941744|Melanoma|melanoma
200654|NCT02941718|Smoking|smoking
200655|NCT02941718|Smoking cessation|smoking cessation
200656|NCT02941718|Nicotine|nicotine
200657|NCT02941705|stem cell research|stem cell research
200658|NCT02941640|Laparoscopic appendectomy|laparoscopic appendectomy
200659|NCT02941640|Endoloop|endoloop
200660|NCT02941640|Stapler|stapler
200661|NCT02941640|Hem-o-lok clip|hem-o-lok clip
200662|NCT02941640|DS clip|ds clip
200663|NCT02941601|Thoracic Neoplasms|thoracic neoplasms
200664|NCT02941601|Lung Diseases|lung diseases
200665|NCT02941601|Lung Cancer|lung cancer
200666|NCT02941601|Respiratory Tract Diseases|respiratory tract diseases
200667|NCT02941601|Respiratory Tract Neoplasms|respiratory tract neoplasms
200668|NCT02941601|Antineoplastic Agents|antineoplastic agents
200669|NCT02941601|Monoclonal Antibodies|monoclonal antibodies
200670|NCT02941562|rectal cancer, radiotherapy|rectal cancer, radiotherapy
200671|NCT02941536|Circulating Tumor Cells|circulating tumor cells
200672|NCT02941536|Stereotactic Radiosurgery|stereotactic radiosurgery
200673|NCT02941497|Stress, Psychological|stress, psychological
200674|NCT02941497|Obesity|obesity
200675|NCT02941497|Physical Activity|physical activity
200676|NCT02941497|Fruit|fruit
200677|NCT02941497|Vegetables|vegetables
200678|NCT02941497|Social Marketing|social marketing
200679|NCT02941497|Peer Influence|peer influence
200680|NCT02941497|Community-Based Participatory Research|community-based participatory research
200681|NCT02941471|Constipation|constipation
200682|NCT02941471|Neuromodulation|neuromodulation
200683|NCT02941471|Interferential|interferential
200684|NCT02941471|Transabdominal|transabdominal
200685|NCT02941445|DPP4-inhibitors|dpp4-inhibitors
200686|NCT02941419|Platelet lysate|platelet lysate
200687|NCT02941419|Critical limb ischemia|critical limb ischemia
200688|NCT02941419|Peripheral arterial disease|peripheral arterial disease
200689|NCT02941406|Retina|retina
200690|NCT02941406|Perimetry|perimetry
200691|NCT02941393|internal tocodynamometry, external tocodynamometry, cesarean section, labor, newborn, vacuum extraction, dystocia|internal tocodynamometry, external tocodynamometry, cesarean section, labor, newborn, vacuum extraction, dystocia
200692|NCT02941380|coronary artery bypass grafting|coronary artery bypass grafting
200693|NCT02941380|cardiopulmonary bypass|cardiopulmonary bypass
200694|NCT02941380|Cerebral oxidative stress|cerebral oxidative stress
200695|NCT02941380|Cerebral inflammatory stress|cerebral inflammatory stress
200696|NCT02941380|Cerebral hemodynamics|cerebral hemodynamics
200697|NCT02941380|Postoperative cognitive dysfunction|postoperative cognitive dysfunction
200698|NCT02941341|Bemfola|bemfola
200699|NCT02941341|r-hFSH|r-hfsh
200700|NCT02941341|ART|art
200701|NCT02941341|Oocytes|oocytes
200702|NCT02941341|OHSS|ohss
200703|NCT02941341|Pregnancy|pregnancy
200704|NCT02941328|SMA, SMN1, Kugelberg-Welander|sma, smn1, kugelberg-welander
200705|NCT02941315|Cardiomyopathy|cardiomyopathy
200706|NCT02941315|Heart Failure|heart failure
200707|NCT02941315|Cardiac Magnetic Resonance|cardiac magnetic resonance
200708|NCT02941302|gliomas|gliomas
200709|NCT02941302|biological boundary|biological boundary
200710|NCT02941302|imaging border|imaging border
200711|NCT02941302|operation|operation
200712|NCT02941263|AMD|amd
200713|NCT02941263|Georgraphic Atrophy|georgraphic atrophy
200714|NCT02941263|Macular Degeneration|macular degeneration
200715|NCT02941237|Pulse oximetry|pulse oximetry
200716|NCT02941237|Children|children
200717|NCT02941211|cervix|cervix
200718|NCT02941211|cervical dilation|cervical dilation
200719|NCT02941211|balloon catheter|balloon catheter
200720|NCT02941172|Brown adipose tissue|brown adipose tissue
200721|NCT02941172|Cannabinoid receptor|cannabinoid receptor
200722|NCT02941172|PET imaging|pet imaging
200723|NCT02941172|Metabolism|metabolism
200724|NCT02941120|Cartilage defect|cartilage defect
200725|NCT02941120|Knee|knee
200726|NCT02941120|ACT (Autologous chondrocyte implantation)|act (autologous chondrocyte implantation)
200727|NCT02941120|NOVOCART® Inject|novocart® inject
200728|NCT02941107|Aboriginal|aboriginal
200729|NCT02941107|Rotavirus|rotavirus
200730|NCT02941107|Vaccine|vaccine
200731|NCT02941107|Diarrhoea|diarrhoea
200732|NCT02941081|iron supplement|iron supplement
200733|NCT02941068|severe sepsis|severe sepsis
200734|NCT02941068|intra-abdominal perforation|intra-abdominal perforation
200735|NCT02941068|surgical intensive care unit|surgical intensive care unit
200736|NCT02941068|fungal infection|fungal infection
200737|NCT02941068|prophylactic anti-fungal treatment|prophylactic anti-fungal treatment
200738|NCT02941055|Diet|diet
200739|NCT02941055|Inflammation|inflammation
200740|NCT02941055|Metabolomics|metabolomics
200741|NCT02941029|Radiation|radiation
200742|NCT02941029|Chemotherapy|chemotherapy
200743|NCT02941003|Early stage lung adenocarcinoma|early stage lung adenocarcinoma
200744|NCT02941003|Intraoperative frozen section|intraoperative frozen section
200745|NCT02941003|Diagnostic criteria|diagnostic criteria
200746|NCT02940977|Circulating tumor cell|circulating tumor cell
200747|NCT02940977|Epithelial to mesenchymal transition|epithelial to mesenchymal transition
200748|NCT02940977|Prostate specific antigen (PSA)|prostate specific antigen (psa)
200749|NCT02940977|Partin table|partin table
200750|NCT02940925|Nasopharyngeal carcinoma|nasopharyngeal carcinoma
200751|NCT02940925|induction chemotherapy|induction chemotherapy
200752|NCT02940912|Parkinson disease|parkinson disease
200753|NCT02940912|Insomnia|insomnia
200754|NCT02940912|Sleep disorders|sleep disorders
200755|NCT02940912|Polysomnography|polysomnography
200756|NCT02940912|Apomorphine|apomorphine
200757|NCT02940912|Multiple sleep latency test|multiple sleep latency test
200758|NCT02940912|Parkinson Disease Sleep Scale 2 (PDSS-2)|parkinson disease sleep scale 2 (pdss-2)
200759|NCT02940873|severe hypoglycemia|severe hypoglycemia
200760|NCT02940873|impaired awareness of hypoglycemia|impaired awareness of hypoglycemia
200761|NCT02940873|type 1 diabetes mellitus|type 1 diabetes mellitus
200762|NCT02940873|cognitive behavioral therapy|cognitive behavioral therapy
200763|NCT02940873|structured education|structured education
200764|NCT02940847|ultrasound-guided technique|ultrasound-guided technique
200765|NCT02940847|blind technique|blind technique
200766|NCT02940847|medial brachial cutaneous nerve block|medial brachial cutaneous nerve block
200767|NCT02940847|intercostobrachial nerve block|intercostobrachial nerve block
200768|NCT02940821|Tooth Whitening|tooth whitening
200769|NCT02940808|Caffeine|caffeine
200770|NCT02940808|EEG|eeg
200771|NCT02940808|Theta/beta ratio|theta/beta ratio
200772|NCT02940808|Eye-blink rates|eye-blink rates
200773|NCT02940808|Cognitive control|cognitive control
200774|NCT02940808|Emotional Stroop|emotional stroop
200775|NCT02940808|Global/local congruency|global/local congruency
200776|NCT02940808|N-Back|n-back
200777|NCT02940808|Prefrontal Cortex|prefrontal cortex
200778|NCT02940795|breast feeding|breast feeding
200779|NCT02940795|fructose|fructose
200780|NCT02940769|depression|depression
200781|NCT02940769|insomnia|insomnia
200782|NCT02940769|light|light
200783|NCT02940769|cortisol|cortisol
200784|NCT02940769|melatonin|melatonin
200785|NCT02940756|Malaria, efficacy, safety, ACT, DR Congo|malaria, efficacy, safety, act, dr congo
200786|NCT02940743|Hemodialysis|hemodialysis
200787|NCT02940704|Reciproc|reciproc
200788|NCT02940704|One Shape|one shape
200789|NCT02940704|reciprocation|reciprocation
200790|NCT02940704|continuous rotation|continuous rotation
200791|NCT02940704|irreversible pulpitis|irreversible pulpitis
200792|NCT02940704|postoperative pain|postoperative pain
200793|NCT02940678|Trauma|trauma
200794|NCT02940678|Clinical prediction models|clinical prediction models
200795|NCT02940678|Transferability studies|transferability studies
200796|NCT02940678|Sweden|sweden
200797|NCT02940652|Laryngeal mask,MRI|laryngeal mask,mri
200798|NCT02940626|Pneumonia|pneumonia
200799|NCT02940626|S. aureus|s. aureus
200800|NCT02940626|Mechanically ventilated|mechanically ventilated
200801|NCT02940613|Rapid response|rapid response
200802|NCT02940613|Eating Disorders|eating disorders
200803|NCT02940613|Cognitive Behavior Therapy|cognitive behavior therapy
200804|NCT02940613|Bulimia Nervosa|bulimia nervosa
200805|NCT02940613|Binge Eating Disorder|binge eating disorder
200806|NCT02940613|Purging Disorder|purging disorder
200807|NCT02940600|normothermic perfusion|normothermic perfusion
200808|NCT02940600|old donors|old donors
200809|NCT02940600|extended criteria grafts|extended criteria grafts
200810|NCT02940600|reconditioning|reconditioning
200811|NCT02940587|Non Healing Wound|non healing wound
200812|NCT02940574|Oxytocin|oxytocin
200813|NCT02940574|Autism Spectrum Disorders|autism spectrum disorders
200814|NCT02940548|non-dipper hypertension|non-dipper hypertension
200815|NCT02940548|young|young
200816|NCT02940548|middle-aged|middle-aged
200817|NCT02940548|ambulatory blood pressure monitoring|ambulatory blood pressure monitoring
200818|NCT02940548|arterial stiffness|arterial stiffness
200819|NCT02940548|nifedipine gastrointestinal therapeutic system (GITS)|nifedipine gastrointestinal therapeutic system (gits)
200820|NCT02940483|Ependymoma|ependymoma
200821|NCT02940457|tDCS|tdcs
200822|NCT02940457|MCI|mci
200823|NCT02940457|Working Memory|working memory
200824|NCT02940457|fNIRS|fnirs
200825|NCT02940418|Diabetes Mellitus|diabetes mellitus
200826|NCT02940418|Type 1|type 1
200827|NCT02940418|Adipose derived mesenchymal stem cells|adipose derived mesenchymal stem cells
200828|NCT02940405|Ketorolac Premedication|ketorolac premedication
200829|NCT02940405|Anesthetic Efficiency|anesthetic efficiency
200830|NCT02940405|Post-Endodontic Pain|post-endodontic pain
200831|NCT02940405|Post-operative pain|post-operative pain
200832|NCT02940405|Irreversible Pulpitis|irreversible pulpitis
200833|NCT02940405|Oral premedication|oral premedication
200834|NCT02940392|Rezum|rezum
200835|NCT02940340|infective endocarditis|infective endocarditis
200836|NCT02940340|systemic microcirculation|systemic microcirculation
200837|NCT02940327|ECMO|ecmo
200838|NCT02940327|PPHN|pphn
200839|NCT02940327|Pulmonary Hypertension of the Newborn|pulmonary hypertension of the newborn
200840|NCT02940327|Markers of inflammation|markers of inflammation
200841|NCT02940327|Mi-Ecmo|mi-ecmo
200842|NCT02940249|Polyphenol|polyphenol
200843|NCT02940249|Apple|apple
200844|NCT02940249|Fruit|fruit
200845|NCT02940249|Hyperglycaemia|hyperglycaemia
200846|NCT02940249|Metabolic|metabolic
200847|NCT02940197|overweight|overweight
200848|NCT02940197|Caloric Restriction|caloric restriction
200849|NCT02940184|Physiology|physiology
200850|NCT02940171|burns|burns
200851|NCT02940171|critically ill|critically ill
200852|NCT02940171|surgery outcome|surgery outcome
200853|NCT02940171|mortality|mortality
200854|NCT02940158|lentils|lentils
200855|NCT02940158|diabetes|diabetes
200856|NCT02940158|glycemia|glycemia
200857|NCT02940158|insulin|insulin
200858|NCT02940158|glucose|glucose
200859|NCT02940145|inflammatory biomarkers|inflammatory biomarkers
200860|NCT02940145|Interleukines|interleukines
200861|NCT02940145|resistance training|resistance training
200862|NCT02940145|phase angle|phase angle
200863|NCT02940145|oxidative stress|oxidative stress
200864|NCT02940106|oocyte cryopreservation|oocyte cryopreservation
200865|NCT02940106|closed vitrification|closed vitrification
200866|NCT02940106|open vitrification|open vitrification
200867|NCT02940067|prehabilitation|prehabilitation
200868|NCT02940067|pancreatectomy|pancreatectomy
200869|NCT02940067|nutrition|nutrition
200870|NCT02940067|exercise|exercise
200871|NCT02940054|Early diagnosis|early diagnosis
200872|NCT02940041|Diagnosis|diagnosis
200873|NCT02940041|Sonography|sonography
200874|NCT02940041|Magnetic Ressonance|magnetic ressonance
200875|NCT02940015|Quality Control|quality control
200876|NCT02940015|Urine|urine
200877|NCT02940015|Tissue|tissue
200878|NCT02940015|Normal|normal
200879|NCT02940002|Plaque form psoriasis vulgaris|plaque form psoriasis vulgaris
200880|NCT02939989|Chronic Hepatitis C (HCV)|chronic hepatitis c (hcv)
200881|NCT02939989|HCV Genotype 1 (HCV GT1)|hcv genotype 1 (hcv gt1)
200882|NCT02939989|HCV Genotype 2 (HCV GT2)|hcv genotype 2 (hcv gt2)
200883|NCT02939989|HCV Genotype 3 (HCV GT3)|hcv genotype 3 (hcv gt3)
200884|NCT02939989|HCV Genotype 4 (HCV GT4)|hcv genotype 4 (hcv gt4)
200885|NCT02939989|HCV Genotype 5 (HCV GT5)|hcv genotype 5 (hcv gt5)
200886|NCT02939989|HCV Genotype 6 (HCV GT6)|hcv genotype 6 (hcv gt6)
200887|NCT02939989|Compensated Cirrhosis|compensated cirrhosis
200888|NCT02939989|Non-cirrhotics|non-cirrhotics
200889|NCT02939989|Virologic failure|virologic failure
200890|NCT02939989|Hepatitis C Virus Infection|hepatitis c virus infection
200891|NCT02939976|ST-Elevation Myocardial Infarction|st-elevation myocardial infarction
200892|NCT02939963|weaning|weaning
200893|NCT02939963|mechanical ventilation|mechanical ventilation
200894|NCT02939963|work of breathing|work of breathing
200895|NCT02939963|automatic tube compensation|automatic tube compensation
200896|NCT02939963|pressure support ventilation|pressure support ventilation
200897|NCT02939911|Residual neuromuscular blockade|residual neuromuscular blockade
200898|NCT02939872|DAPT|dapt
200900|NCT02939872|Bioresorbable Vascular Scaffold|bioresorbable vascular scaffold
200901|NCT02939872|Dual Antiplatelet Therapy|dual antiplatelet therapy
200902|NCT02939859|Multiple Sclerosis|multiple sclerosis
200903|NCT02939859|Demyelinating Diseases|demyelinating diseases
200904|NCT02939859|Nervous System Diseases|nervous system diseases
200905|NCT02939859|Autoimmune Disorders|autoimmune disorders
200906|NCT02939846|Safety|safety
200907|NCT02939846|Solid tumor|solid tumor
200908|NCT02939846|Trametinib|trametinib
200909|NCT02939846|Pharmacokinetics|pharmacokinetics
200910|NCT02939820|RNAi therapeutic|rnai therapeutic
200911|NCT02939820|FAP|fap
200912|NCT02939820|Familial Amyloid Polyneuropathies|familial amyloid polyneuropathies
200913|NCT02939820|TTR|ttr
200914|NCT02939820|Transthyretin|transthyretin
200915|NCT02939820|Amyloidosis|amyloidosis
200916|NCT02939807|Yeliva™|yeliva™
200917|NCT02939807|hepatocellular carcinoma|hepatocellular carcinoma
200918|NCT02939807|ABC294640|abc294640
200919|NCT02939807|hepatic neoplasms|hepatic neoplasms
200920|NCT02939807|liver neoplasms|liver neoplasms
200921|NCT02939807|hepatic cancer|hepatic cancer
200922|NCT02939794|cardiac surgery|cardiac surgery
200923|NCT02939794|hemoglobin|hemoglobin
200924|NCT02939794|iron|iron
200925|NCT02939755|Collaborative care intervention|collaborative care intervention
200926|NCT02939755|Cancer|cancer
200927|NCT02939755|Depression|depression
200928|NCT02939755|Palliative care|palliative care
200929|NCT02939755|Quality of life|quality of life
200930|NCT02939755|Fatigue|fatigue
200931|NCT02939755|Pain|pain
200932|NCT02939742|preterm premature rupture of membranes|preterm premature rupture of membranes
200933|NCT02939742|complications of prematurity|complications of prematurity
200934|NCT02939742|neonatal morbidity|neonatal morbidity
200935|NCT02939742|respiratory distress syndrome|respiratory distress syndrome
200936|NCT02939742|antenatal corticosteroids|antenatal corticosteroids
200937|NCT02939742|betamethasone|betamethasone
200938|NCT02939729|prehabilitation|prehabilitation
200939|NCT02939729|physiotherapy|physiotherapy
200940|NCT02939729|cardiac|cardiac
200941|NCT02939729|thoracic|thoracic
200942|NCT02939729|preoperative|preoperative
200943|NCT02939716|small bowel|small bowel
200944|NCT02939716|bloating|bloating
200945|NCT02939716|flow|flow
200946|NCT02939703|Adipose tissue|adipose tissue
200947|NCT02939703|calorimetry|calorimetry
200948|NCT02939703|energy expenditure|energy expenditure
200949|NCT02939703|microbiome|microbiome
200950|NCT02939690|Catheter|catheter
200951|NCT02939690|Umbilical vein|umbilical vein
200952|NCT02939690|Neonate|neonate
200953|NCT02939664|banded gastric bypass|banded gastric bypass
200954|NCT02939664|weight loss|weight loss
200955|NCT02939651|Metastatic|metastatic
200956|NCT02939651|High grade|high grade
200957|NCT02939638|Plant-based diet|plant-based diet
200958|NCT02939638|Obesity|obesity
200959|NCT02939638|Insulin sensitivity|insulin sensitivity
200960|NCT02939638|Intracellular lipid|intracellular lipid
200961|NCT02939638|Postprandial metabolism|postprandial metabolism
200962|NCT02939638|Vegan diet|vegan diet
200963|NCT02939638|Beta-cell function|beta-cell function
200964|NCT02939612|Stress management|stress management
200966|NCT02939599|Pulmonary hypertension (PH),|pulmonary hypertension (ph),
200967|NCT02939599|Increase blood pressure in the pulmonary artery|increase blood pressure in the pulmonary artery
200968|NCT02939599|Increased blood pressure in the pulmonary vein|increased blood pressure in the pulmonary vein
200969|NCT02939599|Increased blood pressure in the lung vasculature|increased blood pressure in the lung vasculature
200970|NCT02939599|Shortness of breath|shortness of breath
200971|NCT02939599|Dizziness|dizziness
200972|NCT02939599|Fainting|fainting
200973|NCT02939599|Leg swelling|leg swelling
200974|NCT02939599|Cough|cough
200975|NCT02939599|Angina pector|angina pector
200976|NCT02939586|Sleep, Sleep apnoea, Haemodialysis, Haemodiafiltration, end stage kidney disease|sleep, sleep apnoea, haemodialysis, haemodiafiltration, end stage kidney disease
200977|NCT02939560|Autism Spectrum Disorder|autism spectrum disorder
200978|NCT02939560|Autism|autism
200979|NCT02939560|Depressive|depressive
200980|NCT02939560|Depression|depression
200981|NCT02939547|intravenous|intravenous
200982|NCT02939547|cyclodextrin|cyclodextrin
200983|NCT02939547|compassionate|compassionate
200984|NCT02939547|Trappsol|trappsol
200985|NCT02939534|Parkinson's disease|parkinson's disease
200986|NCT02939534|autoimmunity|autoimmunity
200987|NCT02939521|Pincer Nail|pincer nail
200988|NCT02939521|Surgery|surgery
200989|NCT02939508|Acute lower gastrointestinal dysfunction|acute lower gastrointestinal dysfunction
200990|NCT02939508|Colon-originated lesions|colon-originated lesions
200991|NCT02939508|Critical patient|critical patient
200992|NCT02939508|Colonoscopic decompression|colonoscopic decompression
200993|NCT02939508|Anticholinergic drugs|anticholinergic drugs
200994|NCT02939495|Premature Ejaculation|premature ejaculation
200995|NCT02939495|Erectile Dysfunction|erectile dysfunction
200996|NCT02939495|DAP-SPEED|dap-speed
200997|NCT02939495|Dapoxetine|dapoxetine
200998|NCT02939495|Sildenafil|sildenafil
200999|NCT02939469|Sympathetic Nerve Activity|sympathetic nerve activity
201000|NCT02939469|Skin Sympathetic Nerve Activity|skin sympathetic nerve activity
201001|NCT02939456|prostate|prostate
201002|NCT02939456|cancer|cancer
201003|NCT02939456|MRI|mri
201004|NCT02939417|Laminate veneers|laminate veneers
201005|NCT02939417|Grape seed extract|grape seed extract
201006|NCT02939417|Emax|emax
201007|NCT02939417|collagen cross-linking agent|collagen cross-linking agent
201008|NCT02939404|Energy Intake|energy intake
201009|NCT02939404|Energy Expenditure|energy expenditure
201010|NCT02939404|Eating Behavior|eating behavior
201011|NCT02939404|Cold Exposure|cold exposure
201012|NCT02939378|ketogenic diet|ketogenic diet
201013|NCT02939378|recurrent glioblastoma|recurrent glioblastoma
201014|NCT02939378|chemotherapy|chemotherapy
201015|NCT02939352|Transcranial Magnetic Stimulation|transcranial magnetic stimulation
201016|NCT02939352|Magnetic Resonance Imaging|magnetic resonance imaging
201017|NCT02939352|MRI, Functional|mri, functional
201018|NCT02939339|Transcranial Magnetic Stimulation|transcranial magnetic stimulation
201019|NCT02939313|alcohol|alcohol
201020|NCT02939313|addiction|addiction
201021|NCT02939313|cTBS|ctbs
201022|NCT02939300|Leptomeningeal Metastases|leptomeningeal metastases
201023|NCT02939287|autologous|autologous
201024|NCT02939287|myeloma|myeloma
201025|NCT02939287|transplant|transplant
201026|NCT02939209|Rotator cuff repair|rotator cuff repair
201027|NCT02939209|Interscalene block|interscalene block
201028|NCT02939209|Hydromorphone|hydromorphone
201029|NCT02939209|Pain|pain
201030|NCT02939209|Rebound pain|rebound pain
201031|NCT02939209|Acromioplasty|acromioplasty
201032|NCT02939183|Multiple Myeloma|multiple myeloma
201033|NCT02939157|Diagnostic Ultrasound|diagnostic ultrasound
201034|NCT02939157|Primary Care|primary care
201035|NCT02939131|Cognitive Behavioral Therapy|cognitive behavioral therapy
201036|NCT02939131|Medication Management|medication management
201037|NCT02939092|Gingival Bleeding on probing|gingival bleeding on probing
201038|NCT02939079|Multiple Sclerosis|multiple sclerosis
201039|NCT02939079|Fingolimod|fingolimod
201040|NCT02939079|Fish Oil|fish oil
201041|NCT02939053|Bioimpedance spectroscopy|bioimpedance spectroscopy
201042|NCT02939040|positive activities intervention|positive activities intervention
201043|NCT02939040|peri-operative|peri-operative
201044|NCT02939014|Drug therapy|drug therapy
201045|NCT02938988|Periodontal Diseases|periodontal diseases
201046|NCT02938988|Down Syndrome|down syndrome
201047|NCT02938975|malaria|malaria
201048|NCT02938975|personal protection|personal protection
713948|NCT00573638|glaucoma|glaucoma
201049|NCT02938975|permethrin treated clothing|permethrin treated clothing
201050|NCT02938975|insect repellents|insect repellents
201051|NCT02938975|army personnel|army personnel
201052|NCT02938975|cluster randomised trial|cluster randomised trial
201053|NCT02938949|Myocardial Infarction|myocardial infarction
201054|NCT02938949|Low Density Lipoprotein Cholesterol|low density lipoprotein cholesterol
201055|NCT02938949|proprotein convertase subtilisin kexin 9, human|proprotein convertase subtilisin kexin 9, human
201056|NCT02938949|alirocumab|alirocumab
201057|NCT02938910|Primary hyperaldosteronism|primary hyperaldosteronism
201058|NCT02938910|Secondary hyperaldosteronism|secondary hyperaldosteronism
201059|NCT02938910|Cardiac fibrosis|cardiac fibrosis
201060|NCT02938910|magnetic resonance imaging|magnetic resonance imaging
201061|NCT02938897|Telehealth|telehealth
201062|NCT02938897|Weight loss|weight loss
201063|NCT02938897|Diet quality|diet quality
201064|NCT02938897|Behavioral counseling|behavioral counseling
201065|NCT02938871|synbiotic|synbiotic
201066|NCT02938871|infections|infections
201067|NCT02938871|probiotics|probiotics
201068|NCT02938871|liver transplantation|liver transplantation
201069|NCT02938832|cardiovascular disease, diet, diabetes|cardiovascular disease, diet, diabetes
201070|NCT02938819|upper limbs|upper limbs
201071|NCT02938819|physiotherapy|physiotherapy
201072|NCT02938793|cancer, malignancy|cancer, malignancy
201073|NCT02938780|Behavioral economics|behavioral economics
201074|NCT02938780|Breast cancer survivors|breast cancer survivors
201075|NCT02938780|nutrition|nutrition
201076|NCT02938780|physical activity|physical activity
201077|NCT02938767|peritoneal dialysis|peritoneal dialysis
201078|NCT02938767|carotid intima-media thickness|carotid intima-media thickness
201079|NCT02938767|coronary flow reserve|coronary flow reserve
201080|NCT02938767|cardiovascular mortality|cardiovascular mortality
201081|NCT02938754|Hemiparesis|hemiparesis
201082|NCT02938754|Functional independence|functional independence
201083|NCT02938754|Virtual Rehabilitation|virtual rehabilitation
201084|NCT02938741|Acute Lymphoblastic Leukemia|acute lymphoblastic leukemia
201085|NCT02938741|lymphoblastic lymphoma|lymphoblastic lymphoma
201086|NCT02938741|stem-cell transplant|stem-cell transplant
201087|NCT02938741|T-cell lymphoma|t-cell lymphoma
201088|NCT02938741|ATG|atg
201089|NCT02938728|AntiPD1|antipd1
201090|NCT02938702|Active surveillance|active surveillance
201091|NCT02938650|nitrolipid|nitrolipid
201092|NCT02938650|microbiome|microbiome
201093|NCT02938650|inflammation|inflammation
201094|NCT02938650|cytokine|cytokine
201095|NCT02938598|maternal depression|maternal depression
201096|NCT02938598|pediatric-based maternal depression screening|pediatric-based maternal depression screening
201097|NCT02938598|maternal health services|maternal health services
201098|NCT02938546|Non-small-cell lung cancer|non-small-cell lung cancer
201099|NCT02938546|18F-FDG PET/CT|18f-fdg pet/ct
201100|NCT02938546|treatment response assessment|treatment response assessment
201101|NCT02938520|Antiretroviral agent|antiretroviral agent
201102|NCT02938520|Maintenance|maintenance
201103|NCT02938520|rilpivirine|rilpivirine
201104|NCT02938520|dolutegravir|dolutegravir
201105|NCT02938520|TMC278|tmc278
201106|NCT02938520|Triumeq|triumeq
201107|NCT02938520|non-nucleoside reverse transcriptase inhibitor|non-nucleoside reverse transcriptase inhibitor
201108|NCT02938520|once monthly, every 4 weeks, once daily|once monthly, every 4 weeks, once daily
201109|NCT02938520|GSK1265744|gsk1265744
201110|NCT02938520|CAB|cab
201111|NCT02938520|Tivicay|tivicay
201112|NCT02938520|Long-Acting Intramuscular rilpivirine|long-acting intramuscular rilpivirine
201113|NCT02938520|lamivudine|lamivudine
201114|NCT02938520|integrase inhibitor|integrase inhibitor
201115|NCT02938520|Long-Acting Intramuscular Cabotegravir|long-acting intramuscular cabotegravir
201116|NCT02938520|ART naïve|art naïve
201117|NCT02938520|cabotegravir|cabotegravir
201118|NCT02938520|abacavir|abacavir
201119|NCT02938507|Overactive bladder, Incontinence|overactive bladder, incontinence
201120|NCT02938481|colon cancer, lymph node, extent of bowel resection|colon cancer, lymph node, extent of bowel resection
201121|NCT02938455|Hyperalgesia|hyperalgesia
201122|NCT02938455|Opioids|opioids
201123|NCT02938455|Postoperative pain|postoperative pain
201124|NCT02938455|DNA methylation|dna methylation
201125|NCT02938429|congenital|congenital
201126|NCT02938390|Nipple Sparing Mastectomy|nipple sparing mastectomy
201127|NCT02938390|Ultrasound|ultrasound
201128|NCT02938351|Collaborative care intervention|collaborative care intervention
201129|NCT02938351|kidney transplant|kidney transplant
201130|NCT02938325|Electroencephalogram|electroencephalogram
201131|NCT02938325|awareness|awareness
201132|NCT02938286|Fractional laser|fractional laser
201133|NCT02938286|Topical anesthesia|topical anesthesia
201134|NCT02938286|Drug delivery|drug delivery
201135|NCT02938286|CO2 laser|co2 laser
201136|NCT02938286|Er:YAG laser|er:yag laser
201137|NCT02938247|Malnutrition|malnutrition
201138|NCT02938247|Geriatric subjects|geriatric subjects
201139|NCT02938247|Nursing home|nursing home
201140|NCT02938234|Malnutrition|malnutrition
201141|NCT02938234|Geriatric subjects|geriatric subjects
201142|NCT02938234|Nursing home|nursing home
201143|NCT02938221|TeleStroke|telestroke
201144|NCT02938221|HINTS|hints
201145|NCT02938221|Diagnosis|diagnosis
201146|NCT02938221|Telemedicine|telemedicine
201147|NCT02938221|Acute Vestibular Syndrome|acute vestibular syndrome
201148|NCT02938169|low back pain|low back pain
201149|NCT02938169|surface EMG|surface emg
201150|NCT02938169|exercise|exercise
201151|NCT02938156|Hemophilia|hemophilia
201152|NCT02938143|Jumpers knee|jumpers knee
201153|NCT02938143|Patellar Tendinopathy|patellar tendinopathy
201154|NCT02938143|Jumping Athletes|jumping athletes
201155|NCT02938143|UTE MRI|ute mri
201156|NCT02938143|Exercise Therapy|exercise therapy
201157|NCT02938143|NBA|nba
201158|NCT02938117|obesity|obesity
201159|NCT02938117|eccentric exercise|eccentric exercise
201160|NCT02938117|body composition|body composition
201161|NCT02938117|training program|training program
201162|NCT02938091|Hispanics|hispanics
201163|NCT02938091|Single nucleotide polymorphism|single nucleotide polymorphism
201164|NCT02938091|Hepatic lipase|hepatic lipase
201165|NCT02938052|Heart Failure|heart failure
201166|NCT02938052|Positive Psychology|positive psychology
201167|NCT02938052|Adherence to Health Behaviors|adherence to health behaviors
201168|NCT02938039|laryngeal airways|laryngeal airways
201169|NCT02938039|infants|infants
201170|NCT02938039|neonates|neonates
201171|NCT02938039|children|children
201172|NCT02938039|anesthetized|anesthetized
201173|NCT02938000|aerobic training|aerobic training
201174|NCT02938000|stroke|stroke
201175|NCT02938000|exercise|exercise
201176|NCT02938000|stroke recovery|stroke recovery
201177|NCT02937974|Pulmonary Disease, Chronic Obstructive|pulmonary disease, chronic obstructive
201178|NCT02937974|Xuebijing|xuebijing
201179|NCT02937948|Locally advanced|locally advanced
201180|NCT02937922|Exercise|exercise
201181|NCT02937922|Endothelium|endothelium
201182|NCT02937922|Hypertension|hypertension
201183|NCT02937922|Endothelial progenitor cell|endothelial progenitor cell
201184|NCT02937922|Endothelial microparticle|endothelial microparticle
201185|NCT02937909|woundcare community nursing competence|woundcare community nursing competence
201186|NCT02937883|Daily Activities|daily activities
201187|NCT02937818|Platinum Refractory Extensive-Stage Carcinoma, Small Cell Lung|platinum refractory extensive-stage carcinoma, small cell lung
201188|NCT02937818|Platinum Refractory Extensive-Stage Oat Cell Carcinoma of Lung|platinum refractory extensive-stage oat cell carcinoma of lung
201189|NCT02937818|Platinum Refractory Extensive-Stage Oat Cell Lung Cancer|platinum refractory extensive-stage oat cell lung cancer
201190|NCT02937818|Platinum Refractory Extensive-Stage Small Cell Cancer Of The Lung|platinum refractory extensive-stage small cell cancer of the lung
201191|NCT02937818|Platinum Refractory Extensive-Stage Small Cell Lung Cancer|platinum refractory extensive-stage small cell lung cancer
201192|NCT02937740|Hypogonadism|hypogonadism
201193|NCT02937714|Teachers|teachers
201194|NCT02937714|mental health literacy|mental health literacy
201195|NCT02937714|school mental health promotion|school mental health promotion
201196|NCT02937688|Parkinson's disease|parkinson's disease
201197|NCT02937688|Deep Brain Stimulation|deep brain stimulation
201198|NCT02937675|small molecule inhibitor of protein translation|small molecule inhibitor of protein translation
201199|NCT02937675|immunomodulator|immunomodulator
201200|NCT02937675|phase 1 dose escalation|phase 1 dose escalation
201201|NCT02937649|Obesity|obesity
201202|NCT02937649|Bariatric surgery|bariatric surgery
201203|NCT02937649|Sleeve gastrectomy|sleeve gastrectomy
201204|NCT02937649|Staple-line Leak|staple-line leak
201205|NCT02937649|Bougie|bougie
201206|NCT02937649|Calibration|calibration
201207|NCT02937597|proficiency based progression|proficiency based progression
201208|NCT02937597|feedback|feedback
201209|NCT02937597|computer based assessment|computer based assessment
201210|NCT02937597|non technical skills|non technical skills
201211|NCT02937597|deteriorating patient|deteriorating patient
201212|NCT02937597|ISBAR|isbar
201213|NCT02937571|Carfilzomib|carfilzomib
201214|NCT02937571|Lenalidomide|lenalidomide
201215|NCT02937571|Dexamethasone|dexamethasone
201216|NCT02937571|15-326|15-326
201217|NCT02937558|hypoglycemia|hypoglycemia
201218|NCT02937532|Fear of falling|fear of falling
201219|NCT02937532|Fear avoidance behavior|fear avoidance behavior
201220|NCT02937532|cognitive behavioral therapy|cognitive behavioral therapy
201221|NCT02937532|Rehabilitation|rehabilitation
201222|NCT02937519|Chronomodulated Chemotherapy|chronomodulated chemotherapy
201223|NCT02937519|Intensity Modulated Radiation Therapy|intensity modulated radiation therapy
201224|NCT02937519|Advanced Nasopharyngeal Cancer|advanced nasopharyngeal cancer
201225|NCT02937506|propofol|propofol
201226|NCT02937506|colonoscopy|colonoscopy
201227|NCT02937506|patient satisfaction|patient satisfaction
201228|NCT02937480|stroke|stroke
201229|NCT02937480|physical activity|physical activity
201230|NCT02937480|task performance|task performance
201231|NCT02937480|clinical protocol|clinical protocol
201232|NCT02937467|SWE|swe
201233|NCT02937467|diagnosis|diagnosis
201234|NCT02937454|Acute Heart Failure|acute heart failure
201235|NCT02937454|Iron Deficiency|iron deficiency
713949|NCT00573638|compliance|compliance
201236|NCT02937441|C10.228.140.187|c10.228.140.187
201237|NCT02937428|vaccination|vaccination
201238|NCT02937428|pain|pain
201239|NCT02937428|fear|fear
201240|NCT02937428|psychological intervention|psychological intervention
201241|NCT02937415|carbon monoxide|carbon monoxide
201242|NCT02937415|oxidative stress|oxidative stress
201243|NCT02937415|waterpipe smoking|waterpipe smoking
201244|NCT02937415|cigarette smoking|cigarette smoking
201245|NCT02937415|pulmonary function test|pulmonary function test
201246|NCT02937350|chronic kidney disease|chronic kidney disease
201247|NCT02937350|vitamin d catabolism|vitamin d catabolism
201248|NCT02937311|Taping, stroke|taping, stroke
201249|NCT02937311|rehabilitation|rehabilitation
201250|NCT02937311|shoulder pain|shoulder pain
201251|NCT02937311|electrical stimulation|electrical stimulation
201252|NCT02937298|Diet Induced Thermogenesis|diet induced thermogenesis
201253|NCT02937298|Obesity|obesity
201254|NCT02937298|Energy balance|energy balance
201255|NCT02937298|Energy expenditure|energy expenditure
201256|NCT02937298|berries|berries
201257|NCT02937298|Sea Buckthorn|sea buckthorn
201258|NCT02937298|Wild garlic|wild garlic
201259|NCT02937272|TGF Beta|tgf beta
201260|NCT02937233|Zika|zika
201261|NCT02937233|Vaccine|vaccine
201262|NCT02937233|ZPIV|zpiv
201263|NCT02937207|Bronchial Asthma|bronchial asthma
201264|NCT02937207|Traditional Chinese Medicine|traditional chinese medicine
201265|NCT02937194|Early childhood caries (ECC)|early childhood caries (ecc)
201266|NCT02937194|Oral health promotion|oral health promotion
201267|NCT02937194|Randomized controlled trial|randomized controlled trial
201268|NCT02937142|Behavior Therapy|behavior therapy
201269|NCT02937142|Cognitive Therapy|cognitive therapy
201270|NCT02937142|Adolescents|adolescents
201271|NCT02937142|Psychotherapy, Group|psychotherapy, group
201272|NCT02937129|Infrared tympanic thermometer|infrared tympanic thermometer
201273|NCT02937129|Axillary thermometer|axillary thermometer
201274|NCT02937129|Mercury glass thermometer|mercury glass thermometer
201275|NCT02937129|Adult emergency department|adult emergency department
201276|NCT02937103|Leukemia|leukemia
201277|NCT02937103|Myeloid|myeloid
201278|NCT02937103|CD123|cd123
201279|NCT02937103|CAR-T|car-t
201280|NCT02937090|Polycystic Ovary Syndrome|polycystic ovary syndrome
201281|NCT02937090|Intestinal Microbiota|intestinal microbiota
201282|NCT02937077|etiology|etiology
201283|NCT02937038|Urine Biomarkers|urine biomarkers
201284|NCT02937038|Child Nutrition|child nutrition
201285|NCT02937038|Hydration|hydration
201286|NCT02937038|Parent Nutrition Habits|parent nutrition habits
201287|NCT02937025|Nonvalvular atrial fibrillation|nonvalvular atrial fibrillation
201288|NCT02937025|Stroke|stroke
201289|NCT02937025|Left Atrial Appendage Closure|left atrial appendage closure
201290|NCT02937025|Intervention|intervention
201291|NCT02937012|Primary Biliary Cirrhosis|primary biliary cirrhosis
201292|NCT02937012|Primary Biliary Cholangitis|primary biliary cholangitis
201293|NCT02937012|Bezafibrate|bezafibrate
201294|NCT02937012|Ursodeoxycholic acid|ursodeoxycholic acid
201295|NCT02936973|simple obesity|simple obesity
201296|NCT02936973|catgut implantation|catgut implantation
201297|NCT02936934|Adverse Drug Reaction|adverse drug reaction
201298|NCT02936934|Morphine|morphine
201299|NCT02936934|Oxycodone|oxycodone
201300|NCT02936934|Abdominal hysterectomy|abdominal hysterectomy
201301|NCT02936921|Toxoplasma gondii|toxoplasma gondii
201302|NCT02936921|Toxoplasmosis|toxoplasmosis
201303|NCT02936921|congenital|congenital
201304|NCT02936921|prenatal|prenatal
201305|NCT02936921|screening|screening
201306|NCT02936921|treatment|treatment
201307|NCT02936921|diagnosis|diagnosis
201308|NCT02936908|Neuromuscular Diseases|neuromuscular diseases
201309|NCT02936908|Muscular dystrophy|muscular dystrophy
201310|NCT02936908|Amyotrophic Lateral Sclerosis|amyotrophic lateral sclerosis
201311|NCT02936908|Acute respiratory failure|acute respiratory failure
201312|NCT02936908|respiratory care|respiratory care
201313|NCT02936908|mechanical ventilation|mechanical ventilation
201314|NCT02936908|weaning|weaning
201315|NCT02936908|Intensive Care Unit|intensive care unit
201316|NCT02936908|Critical Care|critical care
201317|NCT02936908|Survival|survival
201318|NCT02936882|ultrasonography|ultrasonography
201319|NCT02936882|aspiration|aspiration
201320|NCT02936882|emergency|emergency
201321|NCT02936882|children|children
201322|NCT02936882|antrum|antrum
201323|NCT02936843|Pain|pain
201324|NCT02936843|Inflammation|inflammation
201325|NCT02936843|Diabetes Mellitus|diabetes mellitus
201326|NCT02936843|Adult|adult
201327|NCT02936843|Neuropathy|neuropathy
201328|NCT02936817|HRCT|hrct
201329|NCT02936817|High Resolution Computed Tomography scans|high resolution computed tomography scans
201330|NCT02936817|Functional Respiratory Imaging|functional respiratory imaging
201331|NCT02936817|CT scan|ct scan
201332|NCT02936817|Computed Tomography|computed tomography
201333|NCT02936817|COPD|copd
201334|NCT02936817|sputum producing COPD patients|sputum producing copd patients
201335|NCT02936817|Aerobika® device|aerobika® device
201336|NCT02936804|early stage lung cancer|early stage lung cancer
201337|NCT02936804|LDCT screening|ldct screening
201338|NCT02936804|lung resection|lung resection
201339|NCT02936804|electromagnetic navigation bronchoscopy|electromagnetic navigation bronchoscopy
201340|NCT02936804|peripheral biomarker|peripheral biomarker
201341|NCT02936791|autosomal dominant polycystic kidney disease|autosomal dominant polycystic kidney disease
201342|NCT02936791|ADPKD|adpkd
201343|NCT02936791|PKD biomarkers|pkd biomarkers
201344|NCT02936791|Kidney Institute|kidney institute
201345|NCT02936791|University of Kansas Medical Center|university of kansas medical center
201346|NCT02936778|Short-term medical and psychosocial functioning|short-term medical and psychosocial functioning
201347|NCT02936713|flatulence|flatulence
201349|NCT02936713|probiotics|probiotics
201350|NCT02936713|fermented milk|fermented milk
201351|NCT02936713|diet|diet
201352|NCT02936713|functional gastrointestinal disorders|functional gastrointestinal disorders
201353|NCT02936700|Psychiatry|psychiatry
201354|NCT02936700|Suicide|suicide
201355|NCT02936700|Randomized controlled trial|randomized controlled trial
201356|NCT02936700|ACT|act
201357|NCT02936700|fMRI|fmri
201358|NCT02936687|blood flow|blood flow
201359|NCT02936687|magnetic resonance imaging|magnetic resonance imaging
201360|NCT02936687|insulin|insulin
201361|NCT02936687|vasodilation|vasodilation
201362|NCT02936661|postpartum hemorrhage， cesarean section， tranexamic acid|postpartum hemorrhage， cesarean section， tranexamic acid
201363|NCT02936648|Hepatitis C|hepatitis c
201364|NCT02936635|Amyotrophic Lateral Sclerosis|amyotrophic lateral sclerosis
201365|NCT02936635|ALS|als
201366|NCT02936635|tirasemtiv|tirasemtiv
201367|NCT02936609|healthcare access|healthcare access
201368|NCT02936609|healthcare utilization|healthcare utilization
201369|NCT02936609|preventive services|preventive services
201370|NCT02936609|cancer survivors|cancer survivors
201371|NCT02936531|evoked response potential|evoked response potential
201372|NCT02936531|ERP|erp
201373|NCT02936531|Brain Network Activation|brain network activation
201374|NCT02936531|BNA|bna
201375|NCT02936531|Biomarker|biomarker
201376|NCT02936518|ankyloglossia|ankyloglossia
201377|NCT02936518|breastfeeding|breastfeeding
201378|NCT02936518|lip tie|lip tie
201379|NCT02936505|chronic lung allograft dysfunction|chronic lung allograft dysfunction
201380|NCT02936505|cyclosporin|cyclosporin
201381|NCT02936505|tacrolimus|tacrolimus
201382|NCT02936505|Bronchiolitis Obliterans Syndrome|bronchiolitis obliterans syndrome
201383|NCT02936505|Restrictive Allograft Syndrome|restrictive allograft syndrome
201384|NCT02936505|CLAD|clad
201385|NCT02936492|Phase I|phase i
201386|NCT02936492|Healthy volunteers|healthy volunteers
201387|NCT02936466|Psychiatry|psychiatry
201388|NCT02936466|Randomized controlled trial|randomized controlled trial
201389|NCT02936466|Bipolar disorder|bipolar disorder
201390|NCT02936466|Serious game|serious game
201391|NCT02936466|Compliance|compliance
201392|NCT02936466|Psychoeducation|psychoeducation
201393|NCT02936453|Spinal Cord Injury|spinal cord injury
201394|NCT02936453|Epidural Electrical Stimulation|epidural electrical stimulation
201395|NCT02936453|Robot-assisted|robot-assisted
201396|NCT02936440|acute kidney injury|acute kidney injury
201397|NCT02936440|intensive care unit|intensive care unit
201398|NCT02936440|bioelectrical impedance analysis|bioelectrical impedance analysis
201399|NCT02936414|Berberine|berberine
201400|NCT02936414|Cytokine|cytokine
201401|NCT02936414|CRP|crp
201402|NCT02936414|Metabolism|metabolism
201403|NCT02936414|Schizophrenia|schizophrenia
201404|NCT02936388|uveal melanoma|uveal melanoma
201405|NCT02936388|liver metastasis|liver metastasis
201406|NCT02936388|chemoembolisation|chemoembolisation
201407|NCT02936388|radioembolisation|radioembolisation
201408|NCT02936375|lupus|lupus
201409|NCT02936375|nephritis|nephritis
201410|NCT02936375|iguratimod|iguratimod
201411|NCT02936362|Bread|bread
201412|NCT02936362|Microbiome|microbiome
201413|NCT02936362|Blood tests|blood tests
201414|NCT02936362|Sourdough bread|sourdough bread
201415|NCT02936362|Dietary intervention|dietary intervention
201416|NCT02936349|Hereditary Hemorrhagic Telangiectasia (HHT)|hereditary hemorrhagic telangiectasia (hht)
201417|NCT02936349|Pulmonary Arteriovenous Malformation (PAVM)|pulmonary arteriovenous malformation (pavm)
201418|NCT02936349|Transthoracic Contrast Echocardiogram (TTCE)|transthoracic contrast echocardiogram (ttce)
201419|NCT02936323|SCLC small cell lung cancer|sclc small cell lung cancer
201420|NCT02936323|pancreatic neuroendocrine NET|pancreatic neuroendocrine net
201421|NCT02936323|GI neuroendocrine NET|gi neuroendocrine net
201422|NCT02936310|stress|stress
201423|NCT02936310|mindfulness|mindfulness
201424|NCT02936310|Mindful Living With Stress Intervention|mindful living with stress intervention
201425|NCT02936310|nurse|nurse
201426|NCT02936310|HIV/AIDS|hiv/aids
201427|NCT02936271|Radiofrequency Ablation|radiofrequency ablation
201428|NCT02936271|Sclerotherapy|sclerotherapy
201429|NCT02936271|Vasculera|vasculera
201430|NCT02936219|complementary feeding|complementary feeding
201431|NCT02936219|breast milk|breast milk
201432|NCT02936219|formula feeding|formula feeding
257524|NCT02593409|HIV-1|hiv-1
201433|NCT02936219|combined feeding|combined feeding
201434|NCT02936219|preterm infants|preterm infants
201435|NCT02936219|body composition|body composition
201436|NCT02936206|proliferation Index|proliferation index
201437|NCT02936206|Tamoxifen|tamoxifen
201438|NCT02936206|Fulvestrant|fulvestrant
201439|NCT02936206|cyclinD1|cyclind1
201440|NCT02936206|Breast cancer|breast cancer
201441|NCT02936180|Rheumatoid arthritis|rheumatoid arthritis
201442|NCT02936180|Flu vaccine|flu vaccine
201443|NCT02936180|Influenza|influenza
201444|NCT02936167|Ringer Lactate|ringer lactate
201445|NCT02936167|Plasmalyte|plasmalyte
201446|NCT02936167|Perioperative Period|perioperative period
201447|NCT02936141|homeless, mental disorders, attendance|homeless, mental disorders, attendance
201448|NCT02936102|Phase I|phase i
201449|NCT02936102|FAZ053|faz053
201450|NCT02936102|PDR001|pdr001
201451|NCT02936102|Checkpoint inhibitor|checkpoint inhibitor
201452|NCT02936102|PD-L1|pd-l1
201453|NCT02936102|PD-1|pd-1
201454|NCT02936063|Head and neck surgery|head and neck surgery
201455|NCT02936063|Scar cosmesis|scar cosmesis
201456|NCT02936063|Surgical staples|surgical staples
201457|NCT02936063|Sutures|sutures
201458|NCT02936063|Patient satisfaction|patient satisfaction
201459|NCT02936050|Echocardiography|echocardiography
201460|NCT02936050|Telemedicine|telemedicine
201461|NCT02936050|Nurses|nurses
201462|NCT02936050|Decision support|decision support
201463|NCT02936050|eHealth|ehealth
201464|NCT02936037|progressive multiple sclerosis|progressive multiple sclerosis
201465|NCT02936037|MS|ms
201466|NCT02936037|EDSS|edss
201467|NCT02936037|TW25|tw25
201468|NCT02936037|multiple sclerosis|multiple sclerosis
201469|NCT02935998|schizophrenia|schizophrenia
201470|NCT02935998|agitation|agitation
201471|NCT02935998|ziprasidone|ziprasidone
201472|NCT02935985|spontaneous intracerebral hemorrhage|spontaneous intracerebral hemorrhage
201473|NCT02935985|point-of-care bio-markers|point-of-care bio-markers
201474|NCT02935985|multicenter|multicenter
201475|NCT02935985|Emergency Department|emergency department
201476|NCT02935985|Romania|romania
201477|NCT02935972|prostate biopsy, analgesia, anesthesia, pain, prostate cancer|prostate biopsy, analgesia, anesthesia, pain, prostate cancer
201478|NCT02935946|pharyngeal swallow, NICU, intervention, thickening|pharyngeal swallow, nicu, intervention, thickening
201479|NCT02935920|PRO, follow up|pro, follow up
201480|NCT02935894|oxygenated lipids|oxygenated lipids
201481|NCT02935894|metabolic profiling|metabolic profiling
201482|NCT02935894|sphingoid bases|sphingoid bases
201483|NCT02935894|ceramides|ceramides
201484|NCT02935894|endocannabinoids|endocannabinoids
201485|NCT02935894|non-invasive sampling|non-invasive sampling
201486|NCT02935868|Saliva|saliva
201487|NCT02935855|Diabetic patients|diabetic patients
201488|NCT02935855|nondiabetic patients|nondiabetic patients
201489|NCT02935842|Parkinson's Disease|parkinson's disease
201490|NCT02935842|Word Retrieval|word retrieval
201491|NCT02935842|Apraxia Symptoms|apraxia symptoms
201492|NCT02935842|Dysarthria|dysarthria
201493|NCT02935829|energy intake|energy intake
201494|NCT02935829|blood glucose|blood glucose
201495|NCT02935829|carob flour|carob flour
201496|NCT02935790|unresectable|unresectable
201497|NCT02935790|melanoma|melanoma
201498|NCT02935777|Pomegranate extract|pomegranate extract
201499|NCT02935777|cognitive function|cognitive function
201500|NCT02935777|cognition|cognition
201501|NCT02935777|polyphenols|polyphenols
201502|NCT02935777|memory|memory
201503|NCT02935738|prednisolone|prednisolone
201504|NCT02935738|anti-sperm antibodies|anti-sperm antibodies
201505|NCT02935738|sperm penetration assay|sperm penetration assay
201506|NCT02935712|Safety|safety
201507|NCT02935712|Tolerability|tolerability
201508|NCT02935712|AZD8601|azd8601
201509|NCT02935712|Type II Diabetes|type ii diabetes
201510|NCT02935582|Topical|topical
201511|NCT02935582|Real-world|real-world
201512|NCT02935582|Local standard of care|local standard of care
201513|NCT02935582|Non-interventional|non-interventional
201514|NCT02935582|Calcipotriol|calcipotriol
201515|NCT02935569|Alopecia|alopecia
201516|NCT02935569|Radiotherapy|radiotherapy
201517|NCT02935556|Post Partum Pre-eclampsia|post partum pre-eclampsia
201518|NCT02935517|Color vision deficiency|color vision deficiency
201519|NCT02935517|Color vision defects|color vision defects
201520|NCT02935517|Vision disorders|vision disorders
201521|NCT02935517|Sensation disorders|sensation disorders
201522|NCT02935517|Neurologic manifestations|neurologic manifestations
201523|NCT02935517|Nervous system diseases|nervous system diseases
201524|NCT02935517|Eye diseases|eye diseases
201525|NCT02935517|Signs and symptoms|signs and symptoms
201526|NCT02935504|Depression|depression
201527|NCT02935504|Pregnancy|pregnancy
201528|NCT02935504|Postpartum|postpartum
201529|NCT02935491|TAVI|tavi
201530|NCT02935491|Aortic stenosis|aortic stenosis
201531|NCT02935491|aortic stiffness|aortic stiffness
201532|NCT02935491|calcifications|calcifications
201533|NCT02935491|CT-scan|ct-scan
201534|NCT02935491|Vascular impedance|vascular impedance
201535|NCT02935478|bariatric surgery|bariatric surgery
201536|NCT02935478|minimally invasive|minimally invasive
201537|NCT02935478|Embolization|embolization
201538|NCT02935478|ghrelin|ghrelin
201539|NCT02935478|gastric artery embolization|gastric artery embolization
201540|NCT02935452|Self-management|self-management
201541|NCT02935452|Supportive self-management|supportive self-management
201542|NCT02935452|Normalisation process theory|normalisation process theory
201543|NCT02935452|Social networks|social networks
201544|NCT02935439|Mobile Phone|mobile phone
201545|NCT02935439|Self-efficacy|self-efficacy
201546|NCT02935439|Quality of Life|quality of life
201547|NCT02935439|Knowledge|knowledge
201548|NCT02935439|Feasibility|feasibility
201549|NCT02935426|cyanoacrylate|cyanoacrylate
201550|NCT02935426|sutures|sutures
201551|NCT02935400|porphyria|porphyria
201552|NCT02935400|biomarkers|biomarkers
201553|NCT02935387|Very early rheumatoid arthritis|very early rheumatoid arthritis
201554|NCT02935374|children|children
201555|NCT02935374|intestinal microbiome|intestinal microbiome
201556|NCT02935374|microbiota|microbiota
201557|NCT02935374|antimicrobial course|antimicrobial course
201558|NCT02935374|amoxicillin|amoxicillin
201559|NCT02935374|amoxicillin-clavulanate|amoxicillin-clavulanate
201560|NCT02935374|macrolide|macrolide
201561|NCT02935322|Prevention|prevention
201562|NCT02935309|rectum|rectum
201563|NCT02935309|transrectal|transrectal
201564|NCT02935309|carcinoma|carcinoma
201565|NCT02935270|Stroke|stroke
201566|NCT02935270|Neglect|neglect
201567|NCT02935270|Rehabilitation|rehabilitation
201568|NCT02935244|Epidemiology|epidemiology
201569|NCT02935244|Staphylococcus aureus|staphylococcus aureus
201570|NCT02935244|Prospective observational|prospective observational
201571|NCT02935244|Surgical site or wound infection|surgical site or wound infection
201572|NCT02935231|minimal cessation advice|minimal cessation advice
201573|NCT02935231|proactive|proactive
201574|NCT02935231|nicotine replacement therapy|nicotine replacement therapy
201575|NCT02935231|smoking hotspots|smoking hotspots
201576|NCT02935192|seasonal influenza|seasonal influenza
201577|NCT02935192|vaccine|vaccine
201578|NCT02935153|CD22|cd22
201579|NCT02935153|CAR-T|car-t
201580|NCT02935153|Leukemia|leukemia
201581|NCT02935153|Lymphoma|lymphoma
201582|NCT02935127|absorbable sutures|absorbable sutures
201583|NCT02935114|Tooth Bleaching|tooth bleaching
201584|NCT02935114|Tooth Bleaching Agents|tooth bleaching agents
201585|NCT02935114|Tooth Whitening|tooth whitening
201586|NCT02935114|Hydrogen Peroxide|hydrogen peroxide
201587|NCT02935114|Carbamide Peroxide|carbamide peroxide
201588|NCT02935101|glucocorticoids|glucocorticoids
201589|NCT02935101|craving|craving
201590|NCT02935101|Heroin|heroin
201591|NCT02935101|Cocaine|cocaine
201592|NCT02935101|dependency|dependency
201594|NCT02935088|Percutaneous coronary intervention|percutaneous coronary intervention
201595|NCT02935062|Speech|speech
201596|NCT02935062|Speech Therapy|speech therapy
201597|NCT02935062|Speech Sound Disorders|speech sound disorders
201598|NCT02935062|Phonological Disorders|phonological disorders
201599|NCT02935062|Auditory Perception|auditory perception
201600|NCT02935010|Helicobacter pylori|helicobacter pylori
201601|NCT02935010|Bismuth quadruple therapy|bismuth quadruple therapy
201602|NCT02935010|Tailored therapy|tailored therapy
201603|NCT02935010|Empiric therapy|empiric therapy
201604|NCT02935010|clarithromycin susceptibility|clarithromycin susceptibility
201605|NCT02934997|sepsis|sepsis
201606|NCT02934997|septic shock|septic shock
201607|NCT02934997|cholesterol|cholesterol
201608|NCT02934997|high density lipoprotein|high density lipoprotein
201609|NCT02934984|Pancreatic Cancer|pancreatic cancer
201610|NCT02934984|recurrence|recurrence
201611|NCT02934984|DNA|dna
201612|NCT02934958|Colon Cancer Screening|colon cancer screening
201613|NCT02934945|Budesonide/formoterol|budesonide/formoterol
201614|NCT02934945|Typical asthma|typical asthma
201615|NCT02934945|Cough variant asthma|cough variant asthma
201616|NCT02934919|Nalmefene|nalmefene
201617|NCT02934919|Impulse control disorders|impulse control disorders
201618|NCT02934919|Parkinson's disease|parkinson's disease
201619|NCT02934919|Tolerance|tolerance
201620|NCT02934919|Efficacy|efficacy
201621|NCT02934906|Neonatal Alloimmune Thrombocytopenia|neonatal alloimmune thrombocytopenia
201622|NCT02934906|pregnancy|pregnancy
201623|NCT02934906|human platelet allogantigen|human platelet allogantigen
201624|NCT02934906|asian|asian
201625|NCT02934906|Chinese|chinese
201626|NCT02934880|adapted physical activity, cognitive functions|adapted physical activity, cognitive functions
201627|NCT02934854|Creatine Transporter Deficiency (CTD)|creatine transporter deficiency (ctd)
201628|NCT02934854|Guanidinoacetate Methyltransferase Deficiency (GAMT)|guanidinoacetate methyltransferase deficiency (gamt)
201629|NCT02934854|Arginine: Glycine Amidinotransferase Deficiency (AGAT)|arginine: glycine amidinotransferase deficiency (agat)
201630|NCT02934854|Biomarker|biomarker
201631|NCT02934815|psychological intervention|psychological intervention
201632|NCT02934815|breast cancer|breast cancer
201633|NCT02934815|supportive-expressive group therapy|supportive-expressive group therapy
201634|NCT02934815|emotion regulation|emotion regulation
201635|NCT02934815|social support|social support
201636|NCT02934815|attachment|attachment
201637|NCT02934815|quality of life|quality of life
201638|NCT02934789|submucosal fibroids|submucosal fibroids
201639|NCT02934789|heavy menstrual bleeding|heavy menstrual bleeding
201640|NCT02934789|quality of life|quality of life
201641|NCT02934776|DTI|dti
201642|NCT02934776|prostate cancer|prostate cancer
201643|NCT02934776|MRI|mri
201644|NCT02934750|pursed lip breathing|pursed lip breathing
201645|NCT02934750|interstitial lund disease|interstitial lund disease
201646|NCT02934750|exercise physiology|exercise physiology
201647|NCT02934737|Obesity|obesity
201648|NCT02934737|Diabetes Mellitus|diabetes mellitus
201649|NCT02934724|HPV vaccines|hpv vaccines
201650|NCT02934724|HPV-6|hpv-6
201651|NCT02934724|HPV-11|hpv-11
201652|NCT02934724|HPV-16|hpv-16
201653|NCT02934724|HPV-18|hpv-18
201654|NCT02934724|Gardasil|gardasil
201655|NCT02934711|Multimorbidity|multimorbidity
201656|NCT02934711|Exercise coordinated groups (GECO)|exercise coordinated groups (geco)
201657|NCT02934711|Caregivers|caregivers
201658|NCT02934685|Prostatic Neoplasms|prostatic neoplasms
201659|NCT02934685|radiotherapy|radiotherapy
201660|NCT02934646|Robotics|robotics
201661|NCT02934646|Upper Extremity|upper extremity
201662|NCT02934633|injury|injury
201663|NCT02934633|child|child
201664|NCT02934633|cars|cars
201665|NCT02934633|pedestrians|pedestrians
201666|NCT02934633|child safety|child safety
201667|NCT02934633|interactive|interactive
201668|NCT02934633|computer|computer
201669|NCT02934633|prevention|prevention
201670|NCT02934633|internet|internet
201671|NCT02934633|CD-ROM|cd-rom
201672|NCT02934620|pregnancy|pregnancy
201673|NCT02934620|condom|condom
201675|NCT02934620|sexually transmitted infections|sexually transmitted infections
201676|NCT02934607|Asthma|asthma
201677|NCT02934607|Chronic obstructive pulmonary disease|chronic obstructive pulmonary disease
201678|NCT02934607|Spacer device|spacer device
201679|NCT02934607|Symbicort|symbicort
201680|NCT02934607|Pressurized metered-dose inhaler|pressurized metered-dose inhaler
201681|NCT02934607|Relative bioavailability|relative bioavailability
201682|NCT02934607|Crossover|crossover
201683|NCT02934607|AstraZeneca|astrazeneca
201684|NCT02934607|Safety|safety
201685|NCT02934607|Activated charcoal|activated charcoal
201686|NCT02934607|AeroChamber Plus Flow-Vu spacer device|aerochamber plus flow-vu spacer device
201687|NCT02934568|Ribociclib|ribociclib
201688|NCT02934568|LEE011|lee011
201689|NCT02934542|Laparoscope holder|laparoscope holder
201690|NCT02934542|Colon resection|colon resection
201691|NCT02934542|Right hemicolectomy|right hemicolectomy
201692|NCT02934542|Left hemicolectomy|left hemicolectomy
201693|NCT02934542|Sigmoid resection|sigmoid resection
201694|NCT02934542|Anti-reflux|anti-reflux
201695|NCT02934542|Hiatal hernia|hiatal hernia
201696|NCT02934516|Obstructed labor|obstructed labor
201697|NCT02934516|C section. push method|c section. push method
201698|NCT02934516|reverse breech|reverse breech
201699|NCT02934503|Chemotherapy|chemotherapy
201700|NCT02934503|PD-L1|pd-l1
201701|NCT02934503|Thoracic radiotherapy|thoracic radiotherapy
201702|NCT02934503|PD-1|pd-1
201703|NCT02934503|MK-3475|mk-3475
201704|NCT02934477|Myelofibrosis|myelofibrosis
201705|NCT02934477|Hematopoietic Stem Cell Transplant|hematopoietic stem cell transplant
201706|NCT02934477|Medicare|medicare
201707|NCT02934438|nitric oxide|nitric oxide
201708|NCT02934438|Neo40 supplement,|neo40 supplement,
201709|NCT02934438|exercise tolerance|exercise tolerance
201710|NCT02934425|Pork|pork
201711|NCT02934425|Refined carbohydrates|refined carbohydrates
201712|NCT02934425|Satiety|satiety
201713|NCT02934425|Glucose|glucose
201714|NCT02934425|Insulin|insulin
201715|NCT02934425|Breakfast|breakfast
201716|NCT02934425|Lipoprotein lipids|lipoprotein lipids
201717|NCT02934399|dynamic hormone diagnostics|dynamic hormone diagnostics
201718|NCT02934399|adrenal insufficiency|adrenal insufficiency
201719|NCT02934399|congenital adrenal hyperplasia|congenital adrenal hyperplasia
201720|NCT02934399|primary hyperaldosteronism|primary hyperaldosteronism
201721|NCT02934399|cushing syndrome|cushing syndrome
201722|NCT02934399|growth hormone deficiency|growth hormone deficiency
201723|NCT02934399|acromegaly|acromegaly
201724|NCT02934360|Lung Cancer|lung cancer
201725|NCT02934360|Breast Cancer|breast cancer
201726|NCT02934360|cell free DNA|cell free dna
201727|NCT02934360|biomarker|biomarker
201728|NCT02934347|Intubation, Back-up position; Glottis, View|intubation, back-up position; glottis, view
201729|NCT02934334|major depression|major depression
201730|NCT02934334|major depressive episode|major depressive episode
201731|NCT02934334|biomarkers|biomarkers
201732|NCT02934334|relapse|relapse
201733|NCT02934334|near term relapse|near term relapse
201734|NCT02934334|m-health|m-health
201735|NCT02934321|Erythritol|erythritol
713950|NCT00573638|eye drops|eye drops
201736|NCT02934321|Satiety Response|satiety response
201737|NCT02934321|Ghrelin|ghrelin
201738|NCT02934295|Rubeola|rubeola
201739|NCT02934269|Healthy subjects|healthy subjects
201740|NCT02934269|Safety|safety
201741|NCT02934269|CC-90006|cc-90006
201742|NCT02934269|Phase 1|phase 1
201743|NCT02934269|Tolerability|tolerability
201744|NCT02934256|Neurofibromatosis Type 2|neurofibromatosis type 2
201745|NCT02934256|Vestibular Schwannoma|vestibular schwannoma
201746|NCT02934256|Other NF2-related tumors|other nf2-related tumors
201747|NCT02934243|Laryngeal Masks|laryngeal masks
201748|NCT02934243|Ventilation|ventilation
201749|NCT02934243|Risk factors|risk factors
201750|NCT02934204|PCNSL|pcnsl
201751|NCT02934204|DLBCL|dlbcl
201752|NCT02934204|methotrexate|methotrexate
201753|NCT02934204|temozolomide|temozolomide
201754|NCT02934191|Tonsillectomy|tonsillectomy
201755|NCT02934191|Post-operative complications|post-operative complications
201756|NCT02934191|Post-operative pain|post-operative pain
201757|NCT02934178|shigellosis|shigellosis
201758|NCT02934178|Enterobacteriaceae Infections|enterobacteriaceae infections
201759|NCT02934178|Gram-Negative Bacterial Infections|gram-negative bacterial infections
201760|NCT02934178|Bacterial Infections|bacterial infections
201761|NCT02934178|Gastroenteritis|gastroenteritis
201762|NCT02934178|Gastrointestinal Diseases|gastrointestinal diseases
201763|NCT02934178|Digestive System Diseases|digestive system diseases
201764|NCT02934178|Intestinal Diseases|intestinal diseases
201765|NCT02934165|child safety|child safety
201766|NCT02934165|injury|injury
201767|NCT02934165|computer|computer
201768|NCT02934165|prevention|prevention
201769|NCT02934165|internet|internet
201770|NCT02934152|Gastroesophageal reflux disease|gastroesophageal reflux disease
201771|NCT02934152|Helicobacter pylori|helicobacter pylori
201772|NCT02934139|N91115|n91115
201773|NCT02934139|Cavosonstat|cavosonstat
201774|NCT02934139|Healthy Volunteer|healthy volunteer
201775|NCT02934113|weight loss|weight loss
201776|NCT02934113|text messaging|text messaging
201777|NCT02934113|workplace|workplace
201778|NCT02934113|participatory approach|participatory approach
201779|NCT02934113|health care workers|health care workers
201780|NCT02934100|Calcaneal spur|calcaneal spur
201781|NCT02934100|Heel spur|heel spur
201782|NCT02934100|ESWT|eswt
201783|NCT02934100|Extracorporeal shock wave therapy|extracorporeal shock wave therapy
201784|NCT02934100|ultrasound therapy|ultrasound therapy
201785|NCT02934100|electric field diathermy|electric field diathermy
201786|NCT02934100|skanlab 25 bodywave|skanlab 25 bodywave
201787|NCT02934100|sham laser therapy|sham laser therapy
201788|NCT02934087|snare technique|snare technique
201789|NCT02934087|cannulation of contralateral gate|cannulation of contralateral gate
201790|NCT02934087|endovascular|endovascular
201791|NCT02934087|aneurysm|aneurysm
201792|NCT02934087|AAA|aaa
201793|NCT02934087|Abdominal Aortic Aneurysm|abdominal aortic aneurysm
201794|NCT02934074|Limb Loss|limb loss
201795|NCT02934074|Gait Variability|gait variability
201796|NCT02934074|Phantom Sensation|phantom sensation
201797|NCT02934074|Phantom Pain|phantom pain
201798|NCT02934074|Peripheral Sensation|peripheral sensation
201799|NCT02934061|Acute low back pain|acute low back pain
201800|NCT02934022|Maraviroc|maraviroc
201801|NCT02934022|HAART regimen|haart regimen
201802|NCT02934022|Immunologic response|immunologic response
201803|NCT02933996|immunosuppression|immunosuppression
201804|NCT02933996|cardiac surgery|cardiac surgery
201805|NCT02933996|TEAS(Transcutaneous electrical acupoint stimulation)|teas(transcutaneous electrical acupoint stimulation)
201806|NCT02933996|postoperative|postoperative
201807|NCT02933957|Vascular Evaluation|vascular evaluation
201808|NCT02933957|influencing factor|influencing factor
201809|NCT02933957|She Minority population|she minority population
201810|NCT02933944|locally recurrent|locally recurrent
201811|NCT02933918|Probiotics|probiotics
201812|NCT02933918|Nasal Irrigation|nasal irrigation
201813|NCT02933918|Healthy Volunteers|healthy volunteers
201814|NCT02933801|metastatic castration resistant prostate cancer (mCRPC)|metastatic castration resistant prostate cancer (mcrpc)
201815|NCT02933801|Prostate Cancer|prostate cancer
201816|NCT02933801|phase II trial|phase ii trial
201817|NCT02933801|ODM-201|odm-201
201818|NCT02933801|maintenance therapy|maintenance therapy
201819|NCT02933788|cardiovascular disease|cardiovascular disease
201820|NCT02933788|atherosclerosis|atherosclerosis
201821|NCT02933723|influenza vaccine|influenza vaccine
201822|NCT02933723|nursing home|nursing home
201823|NCT02933723|influenza|influenza
201824|NCT02933723|vaccination|vaccination
201825|NCT02933723|immunity|immunity
201826|NCT02933723|cell-mediated immunity|cell-mediated immunity
201827|NCT02933723|humoral immunity|humoral immunity
201828|NCT02933710|Japanese encephalitis|japanese encephalitis
201829|NCT02933710|IMOJEV®|imojev®
201830|NCT02933710|Japanese encephalitis chimeric virus vaccine|japanese encephalitis chimeric virus vaccine
201831|NCT02933697|Atrial Fibrillation|atrial fibrillation
201832|NCT02933697|Kidney disease|kidney disease
201833|NCT02933697|Anticoagulation|anticoagulation
201834|NCT02933671|suprainguinal fascia iliaca (SIFI)|suprainguinal fascia iliaca (sifi)
201835|NCT02933671|nerve block|nerve block
201836|NCT02933645|Insulin|insulin
201837|NCT02933645|Intranasal|intranasal
201838|NCT02933645|Glucose/metabolism|glucose/metabolism
201839|NCT02933645|Glucose homeostasis|glucose homeostasis
201942|NCT02932865|piRNA|pirna
201840|NCT02933632|Osteoarthritis|osteoarthritis
201841|NCT02933632|Physiotherapy|physiotherapy
201842|NCT02933632|Rehabilitation|rehabilitation
201843|NCT02933632|Clinical Trials|clinical trials
201844|NCT02933632|Accelerated rehabilitation|accelerated rehabilitation
201845|NCT02933632|Hip Replacement Arthroplasty|hip replacement arthroplasty
201846|NCT02933554|bariatric surgery|bariatric surgery
201847|NCT02933554|minimally invasive|minimally invasive
201848|NCT02933554|Embolization|embolization
201849|NCT02933554|NASH|nash
201850|NCT02933554|ghrelin|ghrelin
201851|NCT02933554|gastric artery embolization|gastric artery embolization
201852|NCT02933515|yoga|yoga
201853|NCT02933515|occupational therapy|occupational therapy
201854|NCT02933515|stroke|stroke
201855|NCT02933463|children with high caries risk|children with high caries risk
201856|NCT02933437|Brugada syndrome|brugada syndrome
201857|NCT02933437|SCN5A|scn5a
201858|NCT02933437|SCN10A|scn10a
201859|NCT02933437|Ajmaline|ajmaline
201860|NCT02933411|Bleeding Disorders|bleeding disorders
201861|NCT02933411|Heavy Menstrual Bleeding|heavy menstrual bleeding
201862|NCT02933359|cranial vault|cranial vault
201863|NCT02933359|calvarial trauma|calvarial trauma
201864|NCT02933359|calvarial reconstruction|calvarial reconstruction
201865|NCT02933320|Indolent B-cell Lymphoma|indolent b-cell lymphoma
201866|NCT02933320|Chronic Lymphocytic Leukaemia|chronic lymphocytic leukaemia
201867|NCT02933320|Waldenström Macroglobulinaemia|waldenström macroglobulinaemia
201868|NCT02933320|BI-1206|bi-1206
201869|NCT02933320|CD32b|cd32b
201870|NCT02933294|uniportal|uniportal
201871|NCT02933294|lung cancer|lung cancer
201872|NCT02933294|VATS|vats
201873|NCT02933268|Autosomal Dominant Polycystic Kidney Disease|autosomal dominant polycystic kidney disease
201874|NCT02933268|Polycystic Kidney Disease|polycystic kidney disease
201875|NCT02933268|ADPKD|adpkd
201876|NCT02933268|Water|water
201877|NCT02933268|Vasopressin|vasopressin
201878|NCT02933268|Dietary|dietary
201879|NCT02933255|Safety|safety
201880|NCT02933255|Neoadjuvant|neoadjuvant
201881|NCT02933255|Prostatectomy|prostatectomy
201882|NCT02933255|Immunotherapy|immunotherapy
201883|NCT02933255|Vaccine|vaccine
201884|NCT02933242|Cancer|cancer
201885|NCT02933216|Cesarean Scar Diverticula|cesarean scar diverticula
201886|NCT02933177|Dementia|dementia
201887|NCT02933177|Alzheimer disease|alzheimer disease
201888|NCT02933177|Behavioral and Psychological Symptoms of Dementia|behavioral and psychological symptoms of dementia
201889|NCT02933177|non-drug intervention|non-drug intervention
201890|NCT02933138|Lipoprotein Lipase|lipoprotein lipase
201891|NCT02933138|Hypertriglyceridemia|hypertriglyceridemia
201892|NCT02933138|Triglycerides|triglycerides
201893|NCT02933138|Lipolysis|lipolysis
201894|NCT02933138|Multifactorial Chylomicronemia|multifactorial chylomicronemia
201895|NCT02933125|substance abuse|substance abuse
201896|NCT02933125|group psychotherapy|group psychotherapy
201897|NCT02933125|family therapy|family therapy
201898|NCT02933125|longitudinal study|longitudinal study
201899|NCT02933125|child and adolescent|child and adolescent
201900|NCT02933112|Oral appliance therapy|oral appliance therapy
201901|NCT02933086|Pregnant|pregnant
201902|NCT02933086|Low Back Pain|low back pain
201903|NCT02933086|Postural Control|postural control
201904|NCT02933060|intravenous fluid|intravenous fluid
201905|NCT02933060|headache|headache
201906|NCT02933047|Hysterectomy|hysterectomy
201907|NCT02933047|Patient satisfaction|patient satisfaction
201908|NCT02933047|Rehabilitation|rehabilitation
201909|NCT02933047|Laparoscopy|laparoscopy
201910|NCT02933047|Return to work|return to work
201911|NCT02933047|Exercise|exercise
201912|NCT02933034|ISCHEMIC OR CORONARY HEART DISEASE|ischemic or coronary heart disease
201913|NCT02933034|MYOCARDIAL INFARCTION|myocardial infarction
201914|NCT02933034|MAGNETIC RESONANCE IMAGING|magnetic resonance imaging
201915|NCT02933034|DELAYED GADOLINIUM ENHANCEMENT MRI|delayed gadolinium enhancement mri
201916|NCT02933034|MANGANESE-ENHANCED MRI|manganese-enhanced mri
201917|NCT02933034|INFARCT VOLUME/SIZE|infarct volume/size
201918|NCT02933034|ALL CAUSE MORTALITY|all cause mortality
201919|NCT02933034|VENTRICULAR ARRHYTHMIAS|ventricular arrhythmias
201920|NCT02933021|MGUS|mgus
201921|NCT02933008|ACL|acl
201922|NCT02933008|biofeedback|biofeedback
201923|NCT02933008|injury prevention|injury prevention
201924|NCT02933008|virtual reality|virtual reality
201925|NCT02932995|Optical Coherence Tomography|optical coherence tomography
201926|NCT02932995|Drug-Eluting Stent|drug-eluting stent
201927|NCT02932982|primary care|primary care
201928|NCT02932982|chest pain|chest pain
201929|NCT02932982|dyspnea|dyspnea
201930|NCT02932956|GPC3-CAR T cells|gpc3-car t cells
201931|NCT02932956|GPC3|gpc3
201932|NCT02932956|Glypican|glypican
201933|NCT02932956|Liver cancer|liver cancer
201934|NCT02932930|QLB|qlb
201935|NCT02932930|Abdominoplasty|abdominoplasty
201936|NCT02932930|Quadratus lumborum block|quadratus lumborum block
201937|NCT02932904|Drug therapy|drug therapy
201938|NCT02932865|azoospermia|azoospermia
201939|NCT02932865|male fertility|male fertility
201940|NCT02932865|MD-TESE|md-tese
201941|NCT02932865|miRNA|mirna
201943|NCT02932865|male infertility|male infertility
201944|NCT02932852|stem cell|stem cell
201945|NCT02932852|mesenchymal|mesenchymal
201946|NCT02932852|ADASc|adasc
201947|NCT02932852|transplantation|transplantation
201948|NCT02932852|cornea|cornea
201949|NCT02932852|corneal defects|corneal defects
201950|NCT02932852|keratoconus|keratoconus
201951|NCT02932852|scaffold|scaffold
201952|NCT02932852|lamina|lamina
201953|NCT02932839|Epilepsy surgery|epilepsy surgery
201954|NCT02932839|Micro-electrode arrays|micro-electrode arrays
201955|NCT02932839|Single-neuron recordings|single-neuron recordings
201956|NCT02932839|Electrocorticography|electrocorticography
201957|NCT02932826|Autoimmune Diabetes|autoimmune diabetes
201958|NCT02932826|Umbilical Cord Blood Cell|umbilical cord blood cell
201959|NCT02932826|Regulatory T Lymphocyte|regulatory t lymphocyte
201960|NCT02932826|Cell Therapy|cell therapy
201961|NCT02932800|Catheters|catheters
201962|NCT02932800|Vascular Access Devices|vascular access devices
201963|NCT02932800|Suture Techniques|suture techniques
201964|NCT02932800|microbiota|microbiota
201965|NCT02932800|Blood Circulation|blood circulation
201966|NCT02932774|SAR|sar
201967|NCT02932774|seasonal allergic rhinitis|seasonal allergic rhinitis
201968|NCT02932774|hay fever|hay fever
201969|NCT02932774|seasonal allergic rhinoconjunctivitis|seasonal allergic rhinoconjunctivitis
201970|NCT02932761|cesarean scar diverticula|cesarean scar diverticula
201971|NCT02932761|vaginal repair|vaginal repair
201972|NCT02932761|GnRHa|gnrha
201973|NCT02932722|Propofol|propofol
201974|NCT02932722|Sevoflurane|sevoflurane
201975|NCT02932722|Preconditioning|preconditioning
201976|NCT02932709|Emergency|emergency
201977|NCT02932709|follow-up|follow-up
201978|NCT02932709|nurse|nurse
201979|NCT02932709|phone|phone
201980|NCT02932709|suicide attempts|suicide attempts
201981|NCT02932683|Resuscitation|resuscitation
201982|NCT02932683|Neonatal|neonatal
201983|NCT02932683|Education|education
201984|NCT02932644|Rheumatoid Arthritis|rheumatoid arthritis
201985|NCT02932644|Cardiovascular event|cardiovascular event
201986|NCT02932644|Cardiovascular mortality|cardiovascular mortality
201987|NCT02932644|Vitamin D|vitamin d
201988|NCT02932631|hemiparesis|hemiparesis
201989|NCT02932631|STROKE|stroke
201990|NCT02932631|neural plasticity|neural plasticity
201991|NCT02932631|PHYSICAL THERAPY|physical therapy
201992|NCT02932605|Schizophrenia|schizophrenia
201993|NCT02932605|Cannabidiol|cannabidiol
201994|NCT02932605|Magnetic Resonance Spectroscopy (1H-MRS)|magnetic resonance spectroscopy (1h-mrs)
201995|NCT02932605|Microglia|microglia
201996|NCT02932566|Heart failure|heart failure
201997|NCT02932566|Heart failure with preserved ejection fraction (HFpEF)|heart failure with preserved ejection fraction (hfpef)
201998|NCT02932566|Myocardial fibrosis|myocardial fibrosis
201999|NCT02932566|Extracellular volume fraction (ECV)|extracellular volume fraction (ecv)
202000|NCT02932566|Interstitial fibrosis|interstitial fibrosis
202001|NCT02932553|bioresorbable vascular scaffold|bioresorbable vascular scaffold
202002|NCT02932553|variant angina|variant angina
202003|NCT02932553|moderate coronary artery disease|moderate coronary artery disease
202004|NCT02932553|vasospastic angina|vasospastic angina
202005|NCT02932527|cannabis|cannabis
202006|NCT02932501|Bisphosphonate|bisphosphonate
202007|NCT02932501|Jaw|jaw
202008|NCT02932501|Osteonecrosis|osteonecrosis
202009|NCT02932501|Antiresorptive drugs|antiresorptive drugs
202010|NCT02932501|Denosumab|denosumab
202011|NCT02932488|PET-MR|pet-mr
202012|NCT02932488|5-HT1B receptor|5-ht1b receptor
202013|NCT02932488|Sumatriptan|sumatriptan
202014|NCT02932488|phMRI|phmri
202015|NCT02932488|[11C]AZ10419369|[11c]az10419369
202016|NCT02932436|empagliflozin|empagliflozin
202017|NCT02932436|diastolic function|diastolic function
202018|NCT02932436|poorly controlled type 2 diabetes mellitus|poorly controlled type 2 diabetes mellitus
202019|NCT02932423|Sugar-sweetened beverage|sugar-sweetened beverage
202020|NCT02932423|Overweight|overweight
202021|NCT02932423|Obese|obese
202022|NCT02932423|Sugar|sugar
202023|NCT02932423|Water|water
202024|NCT02932397|Ambulatory surgery|ambulatory surgery
202025|NCT02932397|Perioperative outcomes|perioperative outcomes
202026|NCT02932397|General anesthesia under desflurane|general anesthesia under desflurane
202027|NCT02932397|Prevention of coughing|prevention of coughing
202028|NCT02932397|Propofol|propofol
202029|NCT02932384|HIV|hiv
202030|NCT02932384|Black/African American|black/african american
202031|NCT02932384|Men|men
202032|NCT02932384|Gay/bisexual|gay/bisexual
202033|NCT02932384|Los Angeles|los angeles
202034|NCT02932371|Cardiac output|cardiac output
202035|NCT02932358|Intensive care units|intensive care units
202036|NCT02932358|Delirium|delirium
202037|NCT02932358|Cross infection|cross infection
202038|NCT02932358|Mortality|mortality
202039|NCT02932358|Length of stay|length of stay
202040|NCT02932358|Burnout, Professional|burnout, professional
202041|NCT02932358|Depression|depression
202042|NCT02932358|Anxiety|anxiety
202043|NCT02932345|EGFR mutation; non-small-cell lung cancer;|egfr mutation; non-small-cell lung cancer;
202044|NCT02932332|shortness of breath|shortness of breath
202045|NCT02932332|oxygen|oxygen
202046|NCT02932332|breathing therapies|breathing therapies
202047|NCT02932319|induction of labour|induction of labour
202048|NCT02932319|nulliparous|nulliparous
202049|NCT02932319|prolonged pregnancy|prolonged pregnancy
202050|NCT02932319|foley catheter|foley catheter
202051|NCT02932319|vaginal birth|vaginal birth
202052|NCT02932280|Recurrent|recurrent
202053|NCT02932280|Refractory Disease|refractory disease
202054|NCT02932280|Neratinib|neratinib
202055|NCT02932280|16-878|16-878
202056|NCT02932267|Acne|acne
202057|NCT02932267|Dark skin|dark skin
202058|NCT02932254|Physiological Effects of Drugs|physiological effects of drugs
202059|NCT02932254|Rocuronium|rocuronium
202060|NCT02932254|Sugammadex sodium|sugammadex sodium
202061|NCT02932254|Magnesium|magnesium
202062|NCT02932254|Neuromuscular block, antagonism|neuromuscular block, antagonism
202063|NCT02932215|mobile health device|mobile health device
202064|NCT02932215|substance abuse treatment|substance abuse treatment
202065|NCT02932215|quality of life|quality of life
202066|NCT02932215|lorcaserin|lorcaserin
202067|NCT02932202|Obesity|obesity
202068|NCT02932202|Pregnancy|pregnancy
202069|NCT02932202|Weight Gain|weight gain
202070|NCT02932189|Mechanical Ventilator Weaning|mechanical ventilator weaning
202071|NCT02932189|Respiratory Muscle Training|respiratory muscle training
202072|NCT02932189|Mortality Rate|mortality rate
202073|NCT02932176|Arteries|arteries
202074|NCT02932163|Chronic low back pain|chronic low back pain
202075|NCT02932163|disability|disability
202076|NCT02932163|endurance|endurance
202077|NCT02932150|CHB|chb
202078|NCT02932150|HBV|hbv
202079|NCT02932137|SLE,IL-2|sle,il-2
202080|NCT02932124|German Resuscitation Registry|german resuscitation registry
202081|NCT02932124|out-of-hospital cardiac arrest|out-of-hospital cardiac arrest
202082|NCT02932124|cardiopulmonary resuscitation|cardiopulmonary resuscitation
202083|NCT02932124|mechanical chest compression devices|mechanical chest compression devices
202084|NCT02932111|IBS|ibs
202085|NCT02932111|Osteopathic manipulative treatment|osteopathic manipulative treatment
202086|NCT02932111|pain|pain
202087|NCT02932085|Transcranial magnetic stimulation|transcranial magnetic stimulation
202088|NCT02932085|Magnetic resonance imaging|magnetic resonance imaging
202089|NCT02932085|Magnetic resonance spectroscopy|magnetic resonance spectroscopy
202090|NCT02932059|Metamemory|metamemory
202091|NCT02932059|Schizophrenia|schizophrenia
202092|NCT02932059|Aging|aging
202093|NCT02932059|Learning|learning
202094|NCT02932059|Judgement of learning|judgement of learning
202095|NCT02932059|Sentence construction strategy|sentence construction strategy
202096|NCT02932046|eating disorders|eating disorders
202097|NCT02932046|anorexia nervosa|anorexia nervosa
202098|NCT02932046|appetite|appetite
202099|NCT02932020|disc herniation|disc herniation
202100|NCT02932020|spinal stenosis|spinal stenosis
202101|NCT02932007|persistent|persistent
202102|NCT02931994|dental floss|dental floss
202103|NCT02931994|gingival embrasure|gingival embrasure
202104|NCT02931994|oral hygiene|oral hygiene
202105|NCT02931981|DKK4|dkk4
202106|NCT02931981|Gastrointestinal Stromal Tumor|gastrointestinal stromal tumor
202107|NCT02931981|Biomarker|biomarker
202108|NCT02931968|Monolithic Zirconia|monolithic zirconia
202109|NCT02931968|Implant supported prosthesis|implant supported prosthesis
202110|NCT02931968|Fixed partial denture|fixed partial denture
202111|NCT02931955|allergy|allergy
202112|NCT02931955|insect venom|insect venom
202113|NCT02931955|pollen|pollen
202114|NCT02931955|systems biology|systems biology
202115|NCT02931942|AA|aa
202116|NCT02931916|smart-phone|smart-phone
202117|NCT02931916|assessment|assessment
202118|NCT02931916|chronic ankle instability|chronic ankle instability
202119|NCT02931903|implant supported restorations|implant supported restorations
202120|NCT02931903|IPS Emax (lithium disilicate glass-ceramic)|ips emax (lithium disilicate glass-ceramic)
202121|NCT02931903|Vita Enamic (hybrid dental ceramic)|vita enamic (hybrid dental ceramic)
202122|NCT02931903|implant survival|implant survival
202123|NCT02931903|peri-implant tissue response|peri-implant tissue response
202124|NCT02931890|gastric cancer|gastric cancer
202125|NCT02931890|radiotherapy|radiotherapy
202126|NCT02931890|chemoradiotherapy|chemoradiotherapy
202127|NCT02931877|Sevoflurane|sevoflurane
202128|NCT02931877|Propofol|propofol
202129|NCT02931877|Cardiac valvular surgery|cardiac valvular surgery
202130|NCT02931877|Cardiopulmonary bypass|cardiopulmonary bypass
202131|NCT02931877|Postoperative cognitive dysfunction|postoperative cognitive dysfunction
202132|NCT02931825|high risk|high risk
202133|NCT02931825|surveillance|surveillance
202134|NCT02931825|screening|screening
202135|NCT02931825|colonoscopy|colonoscopy
202136|NCT02931812|cirrhosis|cirrhosis
202137|NCT02931812|reward system|reward system
202138|NCT02931812|taste sensitivity|taste sensitivity
202139|NCT02931812|chronic renal failure|chronic renal failure
202140|NCT02931799|Colitis, Ulcerative|colitis, ulcerative
202141|NCT02931799|Crohn Disease|crohn disease
202142|NCT02931799|Inflammatory Bowel Diseases|inflammatory bowel diseases
202143|NCT02931799|Gastroenterology|gastroenterology
202144|NCT02931799|Quality Improvement|quality improvement
202145|NCT02931799|Post-Discharge|post-discharge
202146|NCT02931786|core body temperature|core body temperature
202147|NCT02931786|magnetic resonance imaging|magnetic resonance imaging
202148|NCT02931786|propofol|propofol
202149|NCT02931786|ketofol|ketofol
202150|NCT02931773|Diabetes Autonomic Cardiovascular|diabetes autonomic cardiovascular
202151|NCT02931747|Bacopa Monnieri|bacopa monnieri
202152|NCT02931747|Working memory|working memory
202153|NCT02931747|Cognitive processing|cognitive processing
202154|NCT02931747|Student|student
202155|NCT02931721|Azospermia|azospermia
202156|NCT02931721|Micro Dissection Testicular Sperm Extraction|micro dissection testicular sperm extraction
202157|NCT02931721|Male infertility|male infertility
202158|NCT02931721|Testis|testis
202159|NCT02931721|MRI|mri
202160|NCT02931708|Heart Failure|heart failure
202161|NCT02931708|Diaphragm|diaphragm
202162|NCT02931708|Electrical Stimulation|electrical stimulation
202163|NCT02931695|post partum|post partum
202164|NCT02931682|Creatine transporter|creatine transporter
202165|NCT02931682|developmental delay|developmental delay
202166|NCT02931682|intellectual disability|intellectual disability
202167|NCT02931682|X-linked|x-linked
202168|NCT02931682|language|language
202169|NCT02931682|seizure|seizure
202170|NCT02931682|observational|observational
202171|NCT02931682|brain spectroscopy|brain spectroscopy
202172|NCT02931656|Gestational Diabetes|gestational diabetes
202173|NCT02931643|Spices|spices
202174|NCT02931643|Functional food|functional food
202175|NCT02931643|Cardiometabolic risk|cardiometabolic risk
202176|NCT02931643|Metabolic syndrome|metabolic syndrome
202177|NCT02931643|Inflammation|inflammation
202178|NCT02931643|Peripheral blood mononuclear cell|peripheral blood mononuclear cell
202179|NCT02931643|Acute|acute
202180|NCT02931643|miRNA|mirna
202181|NCT02931630|Whey protein|whey protein
202182|NCT02931630|Dietary fibers|dietary fibers
202183|NCT02931630|Wheat bran|wheat bran
202184|NCT02931630|Arabinoxylan|arabinoxylan
202185|NCT02931630|Postprandial lipaemia|postprandial lipaemia
202186|NCT02931630|Body composition|body composition
202187|NCT02931630|Blood pressure|blood pressure
202188|NCT02931630|Metabolic rate|metabolic rate
202189|NCT02931630|Insulin sensitivity|insulin sensitivity
202190|NCT02931630|Metabolic syndrome|metabolic syndrome
202191|NCT02931604|sinus wash|sinus wash
202192|NCT02931604|sinus lavage|sinus lavage
202193|NCT02931604|Sinusitis|sinusitis
202194|NCT02931591|Small for gestational age|small for gestational age
202195|NCT02931591|insulin sensitivity|insulin sensitivity
202196|NCT02931591|IGF-1 response|igf-1 response
202197|NCT02931591|growth hormone treatment|growth hormone treatment
202198|NCT02931578|glycemic index|glycemic index
202199|NCT02931552|Breast cancer|breast cancer
202200|NCT02931552|Latinas|latinas
202201|NCT02931552|Peer support counselor|peer support counselor
202202|NCT02931552|Spanish speaking|spanish speaking
202203|NCT02931552|Community based|community based
202204|NCT02931552|Rural|rural
202205|NCT02931526|Tigecycline|tigecycline
202206|NCT02931526|Continuous Renal Replacement Therapy|continuous renal replacement therapy
202207|NCT02931526|Pharmacokinetics|pharmacokinetics
202208|NCT02931500|machine learning|machine learning
202209|NCT02931500|cohort study|cohort study
202210|NCT02931474|Growth Hormone|growth hormone
202211|NCT02931474|Traumatic Brain Injury|traumatic brain injury
202212|NCT02931474|Insomnia|insomnia
202213|NCT02931474|Polysomnography|polysomnography
202214|NCT02931474|NREM Sleep|nrem sleep
202215|NCT02931461|endobronchial transbronchial needle aspiration lung cancer procore|endobronchial transbronchial needle aspiration lung cancer procore
202216|NCT02931448|Device assessment|device assessment
202217|NCT02931435|Genicular Radiofrequency Ablation|genicular radiofrequency ablation
202218|NCT02931435|Knee Arthroplasty, Total|knee arthroplasty, total
202219|NCT02931422|HIV|hiv
202220|NCT02931422|financial incentive|financial incentive
202221|NCT02931422|pediatric HIV testing|pediatric hiv testing
202222|NCT02931409|Positive end-expiratory pressure|positive end-expiratory pressure
202223|NCT02931409|Static pulmonary compliance|static pulmonary compliance
202224|NCT02931409|Lung Protective Ventilation|lung protective ventilation
202225|NCT02931409|Radical cystectomy and urinary diversion|radical cystectomy and urinary diversion
202226|NCT02931409|Postoperative pulmonary complications|postoperative pulmonary complications
202227|NCT02931409|Procalcitonin|procalcitonin
202228|NCT02931383|Liraglutide|liraglutide
202229|NCT02931383|Liraglutide 3 mg|liraglutide 3 mg
202230|NCT02931383|Osteoarthritis|osteoarthritis
202231|NCT02931383|Obesity|obesity
202232|NCT02931383|Ultrasound|ultrasound
202233|NCT02931370|Osteoarthritis|osteoarthritis
202234|NCT02931370|Obesity|obesity
202235|NCT02931370|Ultrasound|ultrasound
202236|NCT02931370|Liraglutide|liraglutide
202237|NCT02931370|Liraglutide 3mg|liraglutide 3mg
202238|NCT02931357|Treatment of teething in infants|treatment of teething in infants
202239|NCT02931344|Osteoarthrtis|osteoarthrtis
202240|NCT02931344|Obesity|obesity
202241|NCT02931344|Liraglutide 3 mg|liraglutide 3 mg
202242|NCT02931344|Liraglutide|liraglutide
202243|NCT02931344|Biomarkers|biomarkers
202835|NCT02927613|Mortality|mortality
202244|NCT02931318|Organ donation|organ donation
202245|NCT02931318|brain death|brain death
202246|NCT02931318|public opinion|public opinion
202247|NCT02931305|Epimedium prenylflavonoids|epimedium prenylflavonoids
202248|NCT02931305|Osteoporosis|osteoporosis
202249|NCT02931305|Cardiovascular diseases|cardiovascular diseases
202250|NCT02931305|Phase 1|phase 1
202251|NCT02931305|safety|safety
202252|NCT02931305|tolerability|tolerability
202253|NCT02931292|sleeve gastrectomy|sleeve gastrectomy
202254|NCT02931292|laparoscopy|laparoscopy
202255|NCT02931292|bariatric surgery|bariatric surgery
202256|NCT02931292|obesity surgery|obesity surgery
202257|NCT02931292|metabolic surgery|metabolic surgery
202258|NCT02931214|Healthy Subjects|healthy subjects
202259|NCT02931214|Pharmacokinetics|pharmacokinetics
202260|NCT02931214|Pharmacodynamics|pharmacodynamics
202261|NCT02931201|Positron-Emission Tomography|positron-emission tomography
202262|NCT02931201|Prognosis|prognosis
202263|NCT02931188|Vascular Diseases|vascular diseases
202264|NCT02931188|Lipids|lipids
202265|NCT02931188|Cholesteryl Ester Transfer Protein (CETP) Inhibition|cholesteryl ester transfer protein (cetp) inhibition
202266|NCT02931188|Anacetrapib|anacetrapib
202267|NCT02931188|Cardiovascular Disease|cardiovascular disease
202268|NCT02931188|Cholesterol|cholesterol
202269|NCT02931175|ACTH gel|acth gel
202270|NCT02931175|Non-Infectious Uveitis|non-infectious uveitis
202271|NCT02931175|ACTHAR|acthar
202272|NCT02931175|Posterior Uveitis|posterior uveitis
202273|NCT02931175|Intermediate Uveitis|intermediate uveitis
202274|NCT02931175|Pan Uveitis|pan uveitis
202275|NCT02931175|Uveitis|uveitis
202276|NCT02931149|platelet-rich plasma|platelet-rich plasma
202277|NCT02931149|endoscopic mucosal resection|endoscopic mucosal resection
202278|NCT02931149|endoscopic submucosal dissection|endoscopic submucosal dissection
202279|NCT02931110|Diffuse large B-cell lymphoma (DLBCL)|diffuse large b-cell lymphoma (dlbcl)
202280|NCT02931110|follicular lymphoma (FL)|follicular lymphoma (fl)
202281|NCT02931110|mantle cell lymphoma (MCL)|mantle cell lymphoma (mcl)
202282|NCT02931110|Hodgkin lymphoma (HL)|hodgkin lymphoma (hl)
202283|NCT02931110|Chronic lymphocytic leukemia/small lymphocytic lymphoma (CLL/SLL)|chronic lymphocytic leukemia/small lymphocytic lymphoma (cll/sll)
202284|NCT02931110|Multiple myeloma (MM)|multiple myeloma (mm)
202285|NCT02931097|Parkinson's disease|parkinson's disease
202286|NCT02931097|Deep brain stimulation|deep brain stimulation
202287|NCT02931097|Mesencephalic locomotor region|mesencephalic locomotor region
202288|NCT02931058|Knee-extension exercise|knee-extension exercise
202289|NCT02931058|Quadriceps exercise|quadriceps exercise
202290|NCT02931058|Knee osteoarthritis|knee osteoarthritis
202291|NCT02931058|Exercise adherence|exercise adherence
202292|NCT02931058|Dose-response relationship|dose-response relationship
202293|NCT02931058|Prehabilitation|prehabilitation
202294|NCT02931045|extracellular vesicles|extracellular vesicles
202295|NCT02931045|inflammation|inflammation
202296|NCT02931045|thrombosis|thrombosis
202297|NCT02931045|antiplatelet drugs|antiplatelet drugs
202298|NCT02931032|nano receptor|nano receptor
202299|NCT02931032|oral microbiology|oral microbiology
202300|NCT02931032|dental caries|dental caries
202301|NCT02931032|periodontal disease|periodontal disease
202302|NCT02931019|fiberoptic|fiberoptic
202303|NCT02931019|intubation|intubation
202304|NCT02931019|posture|posture
202305|NCT02930954|NSCLC, EGFR, Bim, mutation abundance|nsclc, egfr, bim, mutation abundance
202306|NCT02930941|tranexamic acid|tranexamic acid
202307|NCT02930941|epistaxis|epistaxis
202308|NCT02930941|emergency medicine|emergency medicine
202309|NCT02930941|intranasal|intranasal
202310|NCT02930941|TXA|txa
202311|NCT02930928|Anaesthesia|anaesthesia
202312|NCT02930928|Anthropometry|anthropometry
202313|NCT02930928|Body weight and measures|body weight and measures
202314|NCT02930928|Development|development
202315|NCT02930928|Emergency treatment|emergency treatment
202316|NCT02930928|Patient safety|patient safety
202317|NCT02930915|Head and Neck Cancer|head and neck cancer
202318|NCT02930915|Radiotherapy|radiotherapy
202319|NCT02930889|Therapeutic Embolization|therapeutic embolization
202320|NCT02930889|Prostatic Artery Embolization|prostatic artery embolization
202321|NCT02930876|sarcopenia|sarcopenia
202322|NCT02930876|cancer|cancer
202323|NCT02930876|chemotherapy|chemotherapy
202324|NCT02930876|palliative care|palliative care
202325|NCT02930876|resistance training|resistance training
202326|NCT02930733|Postoperative Analgesia|postoperative analgesia
258655|NCT02587039|heart|heart
202327|NCT02930733|Ultrasound guided serratus plane block|ultrasound guided serratus plane block
202328|NCT02930720|TAUS|taus
202329|NCT02930720|breathing protocols and cough|breathing protocols and cough
202330|NCT02930720|pelvic floor displacement|pelvic floor displacement
202331|NCT02930720|women|women
202332|NCT02930720|SUI|sui
202333|NCT02930707|magnesium sulfate|magnesium sulfate
202334|NCT02930707|postoperative pain|postoperative pain
202335|NCT02930707|TAP block|tap block
202336|NCT02930707|total abdominal hysterectomy|total abdominal hysterectomy
202337|NCT02930655|Fabry disease|fabry disease
202338|NCT02930655|lucerastat|lucerastat
202339|NCT02930642|Mindfulness|mindfulness
202340|NCT02930642|Obesity|obesity
202934|NCT02926846|Lavage|lavage
202341|NCT02930642|Food insecurity|food insecurity
202342|NCT02930642|Delay discounting|delay discounting
202343|NCT02930629|Recovery Period, Anesthesia|recovery period, anesthesia
202344|NCT02930629|Neuromuscular Monitoring|neuromuscular monitoring
202345|NCT02930603|Developmental Disabilities|developmental disabilities
202346|NCT02930603|Body function and body structure|body function and body structure
202347|NCT02930603|Participation|participation
202348|NCT02930603|Life activities|life activities
202349|NCT02930603|Quality of Life|quality of life
202350|NCT02930577|treatment adherence|treatment adherence
202351|NCT02930577|outpatient treatment|outpatient treatment
202352|NCT02930577|drug dependence|drug dependence
202353|NCT02930525|apnea|apnea
202354|NCT02930525|children|children
202355|NCT02930525|hypercarbia|hypercarbia
202356|NCT02930525|procedural sedation|procedural sedation
202357|NCT02930525|HFNC|hfnc
202358|NCT02930512|Bone mineral density|bone mineral density
202359|NCT02930512|Osteoporosis|osteoporosis
202360|NCT02930512|Parkinson's disease|parkinson's disease
202361|NCT02930512|Bone turnover markers|bone turnover markers
202362|NCT02930486|Syndesmosis|syndesmosis
202363|NCT02930486|Injury|injury
202364|NCT02930486|Ankle|ankle
202365|NCT02930486|Fracture|fracture
202366|NCT02930486|Weber C|weber c
202367|NCT02930473|Psychotherapy|psychotherapy
202368|NCT02930473|Nursing|nursing
202369|NCT02930473|Nursing Care|nursing care
202370|NCT02930473|Nursing Model|nursing model
202371|NCT02930473|Randomised Controlled Trial|randomised controlled trial
202372|NCT02930434|Vitamin D|vitamin d
202373|NCT02930434|cholecalciferol|cholecalciferol
202374|NCT02930434|Antarctica|antarctica
202375|NCT02930434|Chile|chile
202376|NCT02930434|cathelicidin|cathelicidin
202377|NCT02930434|bone metabolism|bone metabolism
202378|NCT02930434|cardiovascular risk|cardiovascular risk
202379|NCT02930421|mild COPD|mild copd
202380|NCT02930421|Exercise training|exercise training
202381|NCT02930421|Six minute walking distance|six minute walking distance
202382|NCT02930421|Quality of life|quality of life
202383|NCT02930421|Saint George Respiratory Questionnaire (SGRQ)|saint george respiratory questionnaire (sgrq)
202384|NCT02930395|Concussion|concussion
202385|NCT02930395|Professional rugby players|professional rugby players
202386|NCT02930395|S100B|s100b
202387|NCT02930330|Exercise|exercise
202388|NCT02930330|Interval training|interval training
202389|NCT02930330|Blood platelets|blood platelets
202390|NCT02930330|Platelet function tests|platelet function tests
202391|NCT02930330|Physical fitness|physical fitness
202392|NCT02930330|Rehabilitation|rehabilitation
202393|NCT02930304|tennis elbow|tennis elbow
202394|NCT02930304|pain|pain
202395|NCT02930304|shock wave|shock wave
202396|NCT02930304|kinesio taping|kinesio taping
202397|NCT02930252|Self-expandable metal stent|self-expandable metal stent
202398|NCT02930252|strictures|strictures
202399|NCT02930252|biliary|biliary
202400|NCT02930239|ACL-reconstruction|acl-reconstruction
202401|NCT02930239|Gait rehabilitation|gait rehabilitation
202402|NCT02930239|Anti Gravity treadmill|anti gravity treadmill
202403|NCT02930239|ACL-rehabilitation|acl-rehabilitation
202404|NCT02930213|unresponsive wakefulness syndrome|unresponsive wakefulness syndrome
202405|NCT02930213|minimally conscious state|minimally conscious state
202406|NCT02930213|circadian rhythms|circadian rhythms
202407|NCT02930213|free-running period|free-running period
202408|NCT02930200|Smoking Cessation|smoking cessation
202409|NCT02930200|Smartphone Based Smoking Cessation|smartphone based smoking cessation
202410|NCT02930187|Rheumatoid arthritis, remission, ultrasound|rheumatoid arthritis, remission, ultrasound
202411|NCT02930161|Nonalcoholic Fatty Liver Disease|nonalcoholic fatty liver disease
202412|NCT02930161|Nonalcoholic Steatohepatitis|nonalcoholic steatohepatitis
202413|NCT02930161|Methionine|methionine
202414|NCT02930161|Succinic acid|succinic acid
202415|NCT02930148|mHealth|mhealth
202416|NCT02930148|adolescents|adolescents
202417|NCT02930148|quasi-experimental study|quasi-experimental study
202418|NCT02930148|apps|apps
202419|NCT02930148|lifestyles|lifestyles
202420|NCT02930148|lifestyles knowledge|lifestyles knowledge
202421|NCT02930148|dietary behaviour|dietary behaviour
202422|NCT02930148|physical activity|physical activity
713951|NCT00573638|deliver aid|deliver aid
202423|NCT02930148|sleeping behaviour|sleeping behaviour
202424|NCT02930135|Indirect Pulp Capping, Young Permanent Molars|indirect pulp capping, young permanent molars
202425|NCT02930070|sepsis|sepsis
202426|NCT02930070|qSOFA|qsofa
202427|NCT02930070|SOFA|sofa
202428|NCT02930070|diagnostic accuracy|diagnostic accuracy
202429|NCT02930057|lumbar dorsal root ganglion|lumbar dorsal root ganglion
202430|NCT02930057|transforaminal epidural steroid injection|transforaminal epidural steroid injection
202431|NCT02930057|chronic lumbosacral radicular pain|chronic lumbosacral radicular pain
202432|NCT02930057|pulsed radiofrequency treatment|pulsed radiofrequency treatment
202433|NCT02930057|betamethasone|betamethasone
202434|NCT02930057|dorsal root ganglion|dorsal root ganglion
202435|NCT02930044|Emergency department|emergency department
202436|NCT02930044|Insulin|insulin
202437|NCT02930044|Adult|adult
202438|NCT02930031|muscle injury|muscle injury
202439|NCT02930031|exercise|exercise
202440|NCT02930031|redox status|redox status
202441|NCT02930031|immune cells|immune cells
202442|NCT02930018|Acute Ischemic Stroke|acute ischemic stroke
202443|NCT02930018|Endovascular Thrombectomy|endovascular thrombectomy
202444|NCT02930018|Neuroprotection|neuroprotection
202445|NCT02930018|Tat-NR2B9c|tat-nr2b9c
202446|NCT02930018|NA-1|na-1
202447|NCT02930005|Psychotic|psychotic
202448|NCT02930005|Schizophrenia|schizophrenia
202449|NCT02930005|Schizoaffective|schizoaffective
202450|NCT02930005|Bipolar|bipolar
202451|NCT02929979|PTSD|ptsd
202452|NCT02929979|Alcohol Use Disorder|alcohol use disorder
202453|NCT02929979|Cognitive Training|cognitive training
202454|NCT02929979|Veterans|veterans
202455|NCT02929953|premature birth|premature birth
202456|NCT02929953|risk factor|risk factor
202457|NCT02929953|type 1 diabetes mellitus|type 1 diabetes mellitus
202458|NCT02929953|seasonality|seasonality
202459|NCT02929953|prevalence|prevalence
202460|NCT02929953|enteral feeding|enteral feeding
202461|NCT02929953|immunomodulating medications|immunomodulating medications
202462|NCT02929953|early onset|early onset
202464|NCT02929914|Carious dentin|carious dentin
202465|NCT02929914|Photodynamic Therapy|photodynamic therapy
202466|NCT02929888|ST-segment elevacion myocardial infarction, platelets|st-segment elevacion myocardial infarction, platelets
202467|NCT02929836|Ablation Linear Lesions|ablation linear lesions
202468|NCT02929797|pancreatic cancer|pancreatic cancer
202469|NCT02929784|Hemiplegic Shoulder Pain|hemiplegic shoulder pain
202470|NCT02929784|transcranial Direct Current Stimulation|transcranial direct current stimulation
202471|NCT02929784|Stroke|stroke
202472|NCT02929771|Virtual Reality|virtual reality
202473|NCT02929771|Subcutaneous Port Sampling|subcutaneous port sampling
202474|NCT02929771|Pain|pain
202475|NCT02929771|Children|children
202476|NCT02929745|immunology, genetics|immunology, genetics
202477|NCT02929667|Fluoxetine|fluoxetine
202478|NCT02929641|Optical Enhancement technology|optical enhancement technology
202479|NCT02929641|coloractal polyp prediction|coloractal polyp prediction
202480|NCT02929602|prescribing|prescribing
202481|NCT02929602|effectiveness|effectiveness
202482|NCT02929602|dental|dental
202483|NCT02929602|opioid|opioid
202484|NCT02929602|analgesic|analgesic
202485|NCT02929576|metastatic|metastatic
202486|NCT02929576|triple negative|triple negative
202487|NCT02929550|Cardiovascular disease|cardiovascular disease
202488|NCT02929550|Costs|costs
202489|NCT02929550|Guidelines|guidelines
202490|NCT02929550|Lipids|lipids
202491|NCT02929550|Myocardial infarction|myocardial infarction
202492|NCT02929537|Pulmonary Disease, Chronic Obstructive|pulmonary disease, chronic obstructive
202493|NCT02929537|registration research|registration research
202494|NCT02929537|Medicine, Chinese Traditional|medicine, chinese traditional
202495|NCT02929524|Ketamine|ketamine
202496|NCT02929524|Intranasal administration|intranasal administration
202497|NCT02929524|Pediatric nursing|pediatric nursing
202498|NCT02929498|GSK2879552|gsk2879552
202499|NCT02929498|Revised International Prognostic Scoring System (IPSS-R)|revised international prognostic scoring system (ipss-r)
202500|NCT02929498|azacitidine|azacitidine
202501|NCT02929498|hypomethylating agents|hypomethylating agents
202502|NCT02929498|myelodysplastic syndrome|myelodysplastic syndrome
202503|NCT02929472|Physical Activity|physical activity
202504|NCT02929472|Physical Fitness|physical fitness
202505|NCT02929472|Intervention|intervention
202506|NCT02929472|Children and Adolescents|children and adolescents
202507|NCT02929459|Gut Microbiota|gut microbiota
202508|NCT02929459|Riboflavin|riboflavin
202509|NCT02929459|Vitamin B2|vitamin b2
202510|NCT02929459|oGTT|ogtt
202511|NCT02929459|Faecalibacterium prausnitzii|faecalibacterium prausnitzii
202512|NCT02929446|mobilisation|mobilisation
202513|NCT02929446|physiotherapy|physiotherapy
202514|NCT02929433|disability|disability
202515|NCT02929433|pain|pain
202516|NCT02929433|Rotator Cuff Tear|rotator cuff tear
202517|NCT02929433|rehabilitation|rehabilitation
202518|NCT02929433|range of motion (ROM)|range of motion (rom)
202519|NCT02929420|Multicenter|multicenter
202520|NCT02929420|randomized|randomized
202521|NCT02929420|open|open
202522|NCT02929420|parallel controlled|parallel controlled
202523|NCT02929394|Histologically proven locally advanced or metastatic high grade STS (excluding histologies insensitive to chemotherapy such as ASPS, PECOMA subtypes)|histologically proven locally advanced or metastatic high grade sts (excluding histologies insensitive to chemotherapy such as asps, pecoma subtypes)
202524|NCT02929381|Narrow Band Imaging|narrow band imaging
202525|NCT02929381|Colorectal Cancer Screening|colorectal cancer screening
202526|NCT02929381|Colonoscopy|colonoscopy
202527|NCT02929381|Responsive Insertion Technology|responsive insertion technology
202528|NCT02929381|Near Focus|near focus
202529|NCT02929368|PICC-Line|picc-line
202530|NCT02929355|Carotid atherosclerosis|carotid atherosclerosis
202531|NCT02929355|duplex ultrasonography|duplex ultrasonography
202532|NCT02929355|diabetes|diabetes
202533|NCT02929355|vascular events|vascular events
202534|NCT02929277|farm children|farm children
202535|NCT02929277|non-farm children|non-farm children
202536|NCT02929264|Healthy volunteer|healthy volunteer
203524|NCT02923362|Nissen|nissen
202537|NCT02929264|Experimental hyperalgesia|experimental hyperalgesia
202538|NCT02929264|fMRI|fmri
202539|NCT02929225|bacterial translocation;micro-inflammation;hemodialysis|bacterial translocation;micro-inflammation;hemodialysis
202540|NCT02929212|Gastric Bypass|gastric bypass
202541|NCT02929212|Meal Texture|meal texture
202542|NCT02929212|Meal Number|meal number
202543|NCT02929212|GLP-1|glp-1
202544|NCT02929212|Glucose|glucose
202545|NCT02929134|Lymphedema|lymphedema
202546|NCT02929134|Lymphatic Filariasis|lymphatic filariasis
202547|NCT02929134|Filariasis|filariasis
202548|NCT02929134|Doxycycline|doxycycline
202549|NCT02929121|Lymphedema|lymphedema
202550|NCT02929121|Lymphatic Filariasis|lymphatic filariasis
202551|NCT02929121|Filariasis|filariasis
202552|NCT02929121|Doxycycline|doxycycline
202553|NCT02929108|hospice|hospice
202554|NCT02929108|caregiver|caregiver
202555|NCT02929082|magnetic resonance force|magnetic resonance force
202556|NCT02929069|Minority Stress|minority stress
202557|NCT02929017|Idiopathic Pulmonary Fibrosis|idiopathic pulmonary fibrosis
202558|NCT02929017|Fibrosis|fibrosis
202560|NCT02929017|Caregivers|caregivers
202561|NCT02929017|Pulmonary|pulmonary
202562|NCT02929017|Palliative|palliative
202563|NCT02929017|end of life|end of life
202564|NCT02929017|Idiopathic|idiopathic
202565|NCT02929004|Anterior Cruciate Ligament Reconstruction|anterior cruciate ligament reconstruction
202566|NCT02929004|Local vibration training|local vibration training
202567|NCT02929004|Ligamentoplasty|ligamentoplasty
202568|NCT02929004|Anterior cruciate ligament|anterior cruciate ligament
202569|NCT02929004|Corticospinal excitability|corticospinal excitability
202570|NCT02929004|Elastography|elastography
202571|NCT02929004|Knee extensor muscles|knee extensor muscles
202572|NCT02929004|Readaptation|readaptation
202573|NCT02928991|Acquired aplastic anemia|acquired aplastic anemia
202574|NCT02928991|Inherited bone marrow failure|inherited bone marrow failure
202575|NCT02928978|Premalignant Breast Disease|premalignant breast disease
202576|NCT02928978|ALH|alh
202577|NCT02928978|ADH|adh
202578|NCT02928978|DCIS|dcis
202579|NCT02928978|LCIS|lcis
202580|NCT02928978|Breast Cancer Prevention|breast cancer prevention
202581|NCT02928978|Ruxolitinib|ruxolitinib
202582|NCT02928965|psychosis|psychosis
202583|NCT02928965|schizophrenia|schizophrenia
202584|NCT02928965|negative symptoms|negative symptoms
202585|NCT02928965|minocycline|minocycline
202586|NCT02928952|Mindfulness|mindfulness
202587|NCT02928939|multimorbidity|multimorbidity
202588|NCT02928939|multiple chronic conditions|multiple chronic conditions
202589|NCT02928939|drug-drug interactions|drug-drug interactions
202590|NCT02928939|drug-disease interactions|drug-disease interactions
202591|NCT02928939|polypharmacy|polypharmacy
202592|NCT02928939|Oral anticoagulants|oral anticoagulants
202593|NCT02928939|Steroids|steroids
202594|NCT02928913|sedentary|sedentary
202595|NCT02928913|non-sedentary|non-sedentary
202596|NCT02928913|populations|populations
202597|NCT02928900|Adolescents|adolescents
202598|NCT02928900|Clinical training|clinical training
202599|NCT02928900|HIV care and treatment|hiv care and treatment
202600|NCT02928900|Africa|africa
202601|NCT02928861|Positron-Emission Tomography|positron-emission tomography
202602|NCT02928861|Prognosis|prognosis
202603|NCT02928835|Total knee arthroplasty|total knee arthroplasty
202604|NCT02928835|Knee flexion|knee flexion
202605|NCT02928835|Dynamic orthosis|dynamic orthosis
202606|NCT02928822|stroke|stroke
202607|NCT02928822|broca's aphasia|broca's aphasia
202608|NCT02928822|priming|priming
202609|NCT02928822|Intensive language-action therapy|intensive language-action therapy
202610|NCT02928822|Rehabilitation gaming system|rehabilitation gaming system
202611|NCT02928809|temporomandibular joint|temporomandibular joint
202612|NCT02928809|temporomandibular disorder|temporomandibular disorder
202613|NCT02928809|muscle fatigue|muscle fatigue
202614|NCT02928809|low-level laser therapy|low-level laser therapy
202615|NCT02928796|Attentional capacity|attentional capacity
202616|NCT02928796|Working memory|working memory
259106|NCT02583880|ICU|icu
202617|NCT02928796|Simulation-based training|simulation-based training
202618|NCT02928796|Eye-tracking|eye-tracking
202619|NCT02928796|Visual attention|visual attention
202620|NCT02928796|Psychophysiological measurement|psychophysiological measurement
202621|NCT02928796|Surgical simulation|surgical simulation
202622|NCT02928796|Computer-based simulation|computer-based simulation
202623|NCT02928783|Home-based cardiac rehabilitation|home-based cardiac rehabilitation
202624|NCT02928783|Quality of Medical Care|quality of medical care
202625|NCT02928783|Heart Failure|heart failure
202626|NCT02928757|Care coordination|care coordination
202627|NCT02928757|Complex care kids Ontario|complex care kids ontario
202628|NCT02928757|Technology-dependent|technology-dependent
202629|NCT02928757|Quality of life|quality of life
202630|NCT02928744|Resistance|resistance
202631|NCT02928744|Forced oscillations|forced oscillations
202632|NCT02928744|Dyspnea|dyspnea
202633|NCT02928731|Cancer|cancer
202634|NCT02928731|Quality of life|quality of life
202635|NCT02928731|Child|child
202636|NCT02928718|Post-ERCP pancreatitis|post-ercp pancreatitis
202637|NCT02928718|Genetic variation|genetic variation
202638|NCT02928705|analgesia|analgesia
202639|NCT02928705|prehospital|prehospital
202640|NCT02928705|telemedicine|telemedicine
202641|NCT02928705|ambulance|ambulance
202642|NCT02928705|opioids|opioids
202643|NCT02928705|teleconsultation|teleconsultation
202644|NCT02928705|tele-emergency medical services|tele-emergency medical services
202645|NCT02928705|adverse events|adverse events
202646|NCT02928705|prehospital emergency medical service physician|prehospital emergency medical service physician
202647|NCT02928692|Minocycline|minocycline
202648|NCT02928692|Postoperative cognitive dysfunction|postoperative cognitive dysfunction
202649|NCT02928692|Postoperative delirium|postoperative delirium
202650|NCT02928679|Magnetic resonance imaging|magnetic resonance imaging
202651|NCT02928679|Dynamic contrast enhanced MRI|dynamic contrast enhanced mri
202652|NCT02928679|Liraglutide 3 mg|liraglutide 3 mg
202653|NCT02928679|Liraglutide|liraglutide
202654|NCT02928679|Obesity|obesity
202655|NCT02928679|Osteoarthritis|osteoarthritis
202656|NCT02928666|decision-support|decision-support
202657|NCT02928666|ontology|ontology
202658|NCT02928666|computer-interpretable guidelines|computer-interpretable guidelines
202659|NCT02928666|comorbidities|comorbidities
202660|NCT02928653|energy intake|energy intake
202661|NCT02928653|energy expenditure|energy expenditure
202662|NCT02928653|appetite|appetite
202663|NCT02928614|Osteoarthritis|osteoarthritis
202664|NCT02928614|Obesity|obesity
202665|NCT02928614|Liraglutide 3 mg|liraglutide 3 mg
202666|NCT02928614|Liraglutide|liraglutide
202667|NCT02928614|Biomarkers|biomarkers
202668|NCT02928575|Glioblastoma|glioblastoma
202669|NCT02928575|Sunitinib|sunitinib
202670|NCT02928575|Temozolomide|temozolomide
202671|NCT02928575|Radiation Therapy,|radiation therapy,
202672|NCT02928575|MGMT|mgmt
202673|NCT02928575|Biomarkers|biomarkers
202674|NCT02928549|interviews|interviews
202675|NCT02928549|16-1378|16-1378
202676|NCT02928523|Autologous Fecal Microbiota Transplantation|autologous fecal microbiota transplantation
202677|NCT02928497|Non-valvular atrial fibrillation|non-valvular atrial fibrillation
202678|NCT02928497|Left atrial appendage|left atrial appendage
202679|NCT02928484|Functional dyspepsia|functional dyspepsia
202680|NCT02928484|Abdominal pain|abdominal pain
202681|NCT02928484|Flatulence|flatulence
202682|NCT02928484|Probiotics|probiotics
202683|NCT02928484|Bifidobacterium|bifidobacterium
202684|NCT02928484|Lactobacillus|lactobacillus
202685|NCT02928471|Liraglutide|liraglutide
202686|NCT02928471|Liraglutide 3 mg|liraglutide 3 mg
202687|NCT02928471|Osteoarthritis|osteoarthritis
202688|NCT02928471|Obesity|obesity
202689|NCT02928471|Magnetic resonance imaging|magnetic resonance imaging
202690|NCT02928471|Computed tomography|computed tomography
202691|NCT02928471|Dynamic contrast enhanced MRI|dynamic contrast enhanced mri
202692|NCT02928445|Dementia with Lewy bodies|dementia with lewy bodies
202693|NCT02928445|dementia|dementia
202694|NCT02928445|RVT-101|rvt-101
202695|NCT02928445|intepirdine|intepirdine
202696|NCT02928445|Lewy bodies|lewy bodies
202697|NCT02928432|Castration-Resistant Prostate Cancer|castration-resistant prostate cancer
202698|NCT02928432|Abiraterone acetate|abiraterone acetate
202699|NCT02928432|Steroids Switch|steroids switch
202700|NCT02928393|Stroke|stroke
202701|NCT02928393|Motor impairment|motor impairment
202702|NCT02928393|Stroke recovery|stroke recovery
202703|NCT02928393|Middle cerebral artery stroke|middle cerebral artery stroke
202704|NCT02928393|Fugl Meyer|fugl meyer
202705|NCT02928393|Fugl-Meyer Motor Scale (FMMS)|fugl-meyer motor scale (fmms)
202706|NCT02928354|Asthma|asthma
202707|NCT02928354|Chronic obstructive pulmonary disease (COPD)|chronic obstructive pulmonary disease (copd)
202708|NCT02928354|Healthy volunteers|healthy volunteers
202709|NCT02928354|Pharmacokinetics (PK)|pharmacokinetics (pk)
202710|NCT02928354|Bioavailability|bioavailability
202711|NCT02928354|AZD7594|azd7594
202712|NCT02928354|Safety|safety
714043|NCT00573261|Lyrica|lyrica
202713|NCT02928354|Tolerability|tolerability
202714|NCT02928328|craniofacial pain|craniofacial pain
202715|NCT02928328|masticatory muscle|masticatory muscle
202716|NCT02928328|burning mouth syndrome|burning mouth syndrome
202717|NCT02928328|temporomandibular disorders|temporomandibular disorders
202718|NCT02928276|Rheumakit|rheumakit
202719|NCT02928276|Rheumatoid Arthritis|rheumatoid arthritis
202720|NCT02928276|anti-TNF|anti-tnf
202721|NCT02928237|tDCS|tdcs
202722|NCT02928237|cancer liver|cancer liver
202723|NCT02928237|chronic abdominal pain|chronic abdominal pain
202724|NCT02928237|VAS|vas
202725|NCT02928237|VDS|vds
202726|NCT02928237|HAM-D|ham-d
202727|NCT02928237|BPI|bpi
202728|NCT02928237|analgesia|analgesia
202729|NCT02928224|Colorectal cancer|colorectal cancer
202730|NCT02928224|BRAF|braf
202731|NCT02928224|BRAFV600E|brafv600e
202732|NCT02928198|Tomography, Optical Coherence|tomography, optical coherence
202733|NCT02928198|Percutaneous Coronary Intervention|percutaneous coronary intervention
202734|NCT02928198|Cardiac Catheterization|cardiac catheterization
202735|NCT02928198|Coronary Biovascular Scaffold|coronary biovascular scaffold
202736|NCT02928185|training manuals|training manuals
203525|NCT02923349|Solid tumor|solid tumor
202737|NCT02928185|patients and caregivers|patients and caregivers
202739|NCT02928172|q-CON|q-con
202740|NCT02928172|q-NOX|q-nox
202741|NCT02928172|BIS|bis
202742|NCT02928172|Electroencephalograms (EEG)|electroencephalograms (eeg)
202743|NCT02928172|Laryngeal Mask Airway (LMA)|laryngeal mask airway (lma)
202744|NCT02928172|Sedation|sedation
202745|NCT02928172|General Anesthesia|general anesthesia
202746|NCT02928159|Low Pulse Amplitude Seizure Therapy|low pulse amplitude seizure therapy
202747|NCT02928159|Electroconvulsive Therapy|electroconvulsive therapy
202748|NCT02928159|Low Pulse Amplitude Electroconvulsive Therapy|low pulse amplitude electroconvulsive therapy
202749|NCT02928159|Low Pulse Amplitude ECT|low pulse amplitude ect
202750|NCT02928159|LAP|lap
202751|NCT02928159|LAP-ST|lap-st
202752|NCT02928159|ECT|ect
202753|NCT02928159|Mood disorders|mood disorders
202754|NCT02928159|Psychotic disorders|psychotic disorders
202755|NCT02928146|TAPP|tapp
202756|NCT02928146|TEP|tep
202757|NCT02928146|Lichtenstein|lichtenstein
202758|NCT02928146|syntethic mesh|syntethic mesh
202759|NCT02928146|hernioplasty|hernioplasty
202760|NCT02928133|Non-vitamin K antagonist oral anticoagulant (NOAC)|non-vitamin k antagonist oral anticoagulant (noac)
202761|NCT02928133|Congenital heart disease|congenital heart disease
202762|NCT02928133|Atrial fibrillation|atrial fibrillation
202763|NCT02928133|Atrial tachyarrhythmia|atrial tachyarrhythmia
202764|NCT02928133|Thromboembolism|thromboembolism
202765|NCT02928094|refractory angina|refractory angina
202766|NCT02928094|myocardial ischemia|myocardial ischemia
202767|NCT02928094|angiogenesis|angiogenesis
202768|NCT02928068|telehealth|telehealth
202769|NCT02928055|Stroke|stroke
202770|NCT02928055|Shoulder Pain|shoulder pain
202771|NCT02928055|Electrical stimulation|electrical stimulation
202772|NCT02928055|Neuromuscular stimulation|neuromuscular stimulation
202773|NCT02928055|Intramuscular stimulation|intramuscular stimulation
202774|NCT02928029|Radium-223 dichloride|radium-223 dichloride
202775|NCT02928029|Bortezomib|bortezomib
202776|NCT02928029|Dexamethasone|dexamethasone
202777|NCT02928029|Relapsed multiple myeloma|relapsed multiple myeloma
202778|NCT02928029|Combination therapy multiple myeloma|combination therapy multiple myeloma
202779|NCT02928016|carbohydrate counting method|carbohydrate counting method
202780|NCT02928016|protein|protein
202781|NCT02928016|fat|fat
202782|NCT02928016|glucose|glucose
202783|NCT02928016|type 1 diabetes|type 1 diabetes
202784|NCT02928003|Lung surgery|lung surgery
202785|NCT02927977|dry needling|dry needling
202786|NCT02927977|exercise|exercise
202787|NCT02927977|manual therapy|manual therapy
202788|NCT02927951|Diabetes Mellitus|diabetes mellitus
202789|NCT02927951|Peripheral Neuropathy|peripheral neuropathy
202790|NCT02927951|Diabetic Pain|diabetic pain
202791|NCT02927899|Tomato-Soy-Arugula|tomato-soy-arugula
202792|NCT02927873|Safety|safety
202793|NCT02927873|Respiratory syncytial virus (RSV)|respiratory syncytial virus (rsv)
202794|NCT02927873|Immunogenicity|immunogenicity
202795|NCT02927873|Reactogenicity|reactogenicity
202796|NCT02927873|Infants|infants
202797|NCT02927873|Vaccine|vaccine
202798|NCT02927860|sleep|sleep
202799|NCT02927860|exercise|exercise
202800|NCT02927860|activity|activity
202801|NCT02927821|Adult Day Care Centers|adult day care centers
202802|NCT02927821|Caregivers|caregivers
202803|NCT02927808|Motivational Interviewing|motivational interviewing
202804|NCT02927808|LDL-C|ldl-c
202805|NCT02927808|LDL target|ldl target
202806|NCT02927808|Medication adherence|medication adherence
202807|NCT02927782|Cerebrospinal Fluid Leak|cerebrospinal fluid leak
202808|NCT02927782|Lumbar|lumbar
202809|NCT02927756|Non-Hodgkin Lymphoma Transformed Recurrent|non-hodgkin lymphoma transformed recurrent
202810|NCT02927756|Discordant Lymphomas|discordant lymphomas
202811|NCT02927756|Composite Lymphomas|composite lymphomas
202812|NCT02927756|Follicular Lymphoma|follicular lymphoma
202813|NCT02927756|Aggressive Lymphoma|aggressive lymphoma
202814|NCT02927730|Retained placenta, surgical hysteroscopy, residua|retained placenta, surgical hysteroscopy, residua
202815|NCT02927717|Grade 3b Follicular Lymphoma|grade 3b follicular lymphoma
202816|NCT02927717|2016 WHO Criteria|2016 who criteria
202817|NCT02927717|Front-line treatment|front-line treatment
202818|NCT02927717|Rituximab|rituximab
202819|NCT02927704|Aggressive Periodontitis|aggressive periodontitis
202820|NCT02927704|monocyte chemoattractant protein-1|monocyte chemoattractant protein-1
202821|NCT02927704|gingival crevicular fluid|gingival crevicular fluid
202822|NCT02927704|enzyme-linked immunosorbent assay|enzyme-linked immunosorbent assay
202823|NCT02927691|Rehabilitation|rehabilitation
202824|NCT02927691|Parkinson's disease|parkinson's disease
202825|NCT02927691|Swallowing|swallowing
202826|NCT02927691|Cough|cough
202827|NCT02927691|Dysphagia|dysphagia
202828|NCT02927691|Dystussia|dystussia
202829|NCT02927678|Diabetic foot|diabetic foot
202830|NCT02927678|Osteomyelitis|osteomyelitis
202831|NCT02927678|Antibiotic treatment|antibiotic treatment
202832|NCT02927678|White Blood Cell SPECT/CT|white blood cell spect/ct
202833|NCT02927665|Weight Loss|weight loss
202834|NCT02927613|Home mechanical ventilation|home mechanical ventilation
202836|NCT02927613|Complications|complications
202837|NCT02927613|Developing country|developing country
202838|NCT02927600|Glycemic response|glycemic response
202839|NCT02927600|Glycemic index|glycemic index
202840|NCT02927600|Meal intervention|meal intervention
202841|NCT02927600|Chinese population|chinese population
202842|NCT02927587|TCI|tci
202843|NCT02927587|fiberoptic bronchoscopy|fiberoptic bronchoscopy
202844|NCT02927587|sedation|sedation
202845|NCT02927574|drug-coated balloon angioplasty|drug-coated balloon angioplasty
202846|NCT02927574|angioplasty|angioplasty
202847|NCT02927574|plain old balloon angioplasty|plain old balloon angioplasty
202848|NCT02927574|peripheral arterial disease|peripheral arterial disease
202849|NCT02927574|intermittent claudication|intermittent claudication
202850|NCT02927574|systematic review|systematic review
202851|NCT02927574|meta-analysis|meta-analysis
202852|NCT02927574|Paclitaxel|paclitaxel
202853|NCT02927522|Postoperative Cognitive Dysfunction|postoperative cognitive dysfunction
202854|NCT02927522|Donepezil|donepezil
202855|NCT02927522|Hip replacement|hip replacement
202856|NCT02927522|Knee replacement|knee replacement
202857|NCT02927496|Lymphedema|lymphedema
202858|NCT02927496|Lymphatic Filariasis|lymphatic filariasis
202859|NCT02927496|Filariasis|filariasis
202860|NCT02927496|Doxycycline|doxycycline
202861|NCT02927483|Venous Insufficiency|venous insufficiency
202862|NCT02927470|Transcranial Magnetic Stimulation|transcranial magnetic stimulation
202863|NCT02927457|Cutaneous Lupus Erythematosus-CLE|cutaneous lupus erythematosus-cle
202864|NCT02927457|Spleen Tyrosine Kinase-SYK|spleen tyrosine kinase-syk
202865|NCT02927457|Photoprovocation-PV|photoprovocation-pv
202866|NCT02927457|GSK2646264|gsk2646264
202867|NCT02927431|Anti-inflammatory|anti-inflammatory
202868|NCT02927431|Danirixin|danirixin
202869|NCT02927431|Influenza|influenza
202870|NCT02927431|Hospitalized patients|hospitalized patients
202871|NCT02927405|gabapentin|gabapentin
202872|NCT02927405|TAP block|tap block
202873|NCT02927366|Pulmonary hypertension (PH),|pulmonary hypertension (ph),
202874|NCT02927366|Increase blood pressure in the pulmonary artery|increase blood pressure in the pulmonary artery
202875|NCT02927366|Increased blood pressure in the pulmonary vein|increased blood pressure in the pulmonary vein
202876|NCT02927366|Increased blood pressure in the lung vasculature|increased blood pressure in the lung vasculature
202877|NCT02927366|Shortness of breath|shortness of breath
202878|NCT02927366|Dizziness|dizziness
202879|NCT02927366|Fainting|fainting
202880|NCT02927366|Leg swelling|leg swelling
202881|NCT02927366|Cough|cough
202882|NCT02927366|QCC374|qcc374
202883|NCT02927353|Bioequivalence, Biosimilarity, Pharmacokinetics, adalimumab|bioequivalence, biosimilarity, pharmacokinetics, adalimumab
202884|NCT02927340|Lung Cancer|lung cancer
202885|NCT02927288|PTSD, mTBI|ptsd, mtbi
202886|NCT02927262|Acute myeloid leukemia|acute myeloid leukemia
202887|NCT02927262|First Complete Remission|first complete remission
202888|NCT02927262|gilteritinib|gilteritinib
202889|NCT02927262|FLT3/ITD|flt3/itd
202890|NCT02927262|AML|aml
202891|NCT02927262|ASP2215|asp2215
202892|NCT02927236|Non-Invasive Brain Stimulation|non-invasive brain stimulation
202893|NCT02927236|Functional Magnetic Resonance Imaging (fMRI)|functional magnetic resonance imaging (fmri)
202894|NCT02927210|Healthy Men|healthy men
202895|NCT02927210|Male Contraception|male contraception
202896|NCT02927210|Androgen|androgen
202897|NCT02927210|Dimethandrolone|dimethandrolone
202898|NCT02927171|Skilled Nursing Facility|skilled nursing facility
202899|NCT02927171|Post-Acute Care|post-acute care
202900|NCT02927171|Older Adults|older adults
202901|NCT02927171|Physical Function|physical function
202902|NCT02927171|Rehabilitation|rehabilitation
202903|NCT02927132|Drinking, Alcohol|drinking, alcohol
202904|NCT02927119|thyroglobulin|thyroglobulin
202905|NCT02927119|iodine|iodine
202906|NCT02927119|pregnancy|pregnancy
202907|NCT02927106|leukemia|leukemia
202908|NCT02927106|myeloid|myeloid
202909|NCT02927106|genomics|genomics
202910|NCT02927080|FSHD|fshd
202911|NCT02927041|hemodynamic transesophageal echocardiography|hemodynamic transesophageal echocardiography
202912|NCT02927028|energy availability|energy availability
202913|NCT02927028|walnuts|walnuts
202914|NCT02926989|Isotonic|isotonic
202915|NCT02926989|Hypotonic|hypotonic
202916|NCT02926989|Intravenous fluids|intravenous fluids
202917|NCT02926976|Schizophrenia|schizophrenia
202918|NCT02926963|Chronic Granulomatous Disease, Nox2, p22phox, iPS cells|chronic granulomatous disease, nox2, p22phox, ips cells
202919|NCT02926911|Ductal Carcinoma|ductal carcinoma
202920|NCT02926898|seizure|seizure
202921|NCT02926898|tonic clonic|tonic clonic
202922|NCT02926898|epilepsy|epilepsy
202923|NCT02926898|myoclonic|myoclonic
202924|NCT02926898|encephalopathy|encephalopathy
202925|NCT02926885|liver|liver
202926|NCT02926885|laparoscopy|laparoscopy
202927|NCT02926885|Bariatric Surgery|bariatric surgery
202928|NCT02926885|Esophagogastric Junction|esophagogastric junction
202929|NCT02926885|obesity|obesity
202930|NCT02926872|Screening|screening
202931|NCT02926872|Hepatic Injury|hepatic injury
202932|NCT02926872|Pediatric Patients|pediatric patients
202933|NCT02926846|Peritoneal dialysis|peritoneal dialysis
202935|NCT02926820|Huntington disease|huntington disease
202936|NCT02926820|cognitive rehabilitation|cognitive rehabilitation
202937|NCT02926820|cognitive dysfunction|cognitive dysfunction
202938|NCT02926807|Atopic Dermatitis|atopic dermatitis
202939|NCT02926807|Vascular Inflammation|vascular inflammation
202940|NCT02926807|Coronary Atherosclerosis|coronary atherosclerosis
202941|NCT02926807|Ascending aorta|ascending aorta
202942|NCT02926807|Pet scan|pet scan
202943|NCT02926768|Cancer|cancer
202944|NCT02926768|Non Small Cell Lung Cancer|non small cell lung cancer
202945|NCT02926768|EGFR sensitivity mutation|egfr sensitivity mutation
202946|NCT02926768|T790M|t790m
202947|NCT02926768|NSCLC|nsclc
202948|NCT02926768|epidermal growth factor receptor|epidermal growth factor receptor
202949|NCT02926768|EGFR|egfr
202950|NCT02926768|EGFR inhibitor|egfr inhibitor
202951|NCT02926755|Intra Venous Ultrasound (IVUS)|intra venous ultrasound (ivus)
202952|NCT02926755|Fractional Flow Reserve (FFR)|fractional flow reserve (ffr)
202953|NCT02926755|Optical Coherence Tomography (OCT)|optical coherence tomography (oct)
202954|NCT02926755|Acute Myocardial Infarction|acute myocardial infarction
202955|NCT02926755|Coronary Artery Disease (CAD)|coronary artery disease (cad)
202956|NCT02926755|Angiography|angiography
202957|NCT02926742|Thrombolysis|thrombolysis
202958|NCT02926742|Ultrasound Thrombolysis|ultrasound thrombolysis
202959|NCT02926742|Pulmonary Embolism|pulmonary embolism
202960|NCT02926742|Saddle PE|saddle pe
202961|NCT02926742|Submassive PE|submassive pe
202962|NCT02926742|Massive PE|massive pe
202963|NCT02926742|Bilateral PE|bilateral pe
202964|NCT02926729|Breast Cancer|breast cancer
202965|NCT02926716|Stomach neoplasm|stomach neoplasm
202966|NCT02926716|Endoscopy|endoscopy
202967|NCT02926716|Narrow band imaging|narrow band imaging
202968|NCT02926703|seizure|seizure
202969|NCT02926703|lactate|lactate
202970|NCT02926703|creatine kinase|creatine kinase
202971|NCT02926677|PTSD|ptsd
202972|NCT02926677|Child Trauma|child trauma
202973|NCT02926677|Cue-Centered Treatment|cue-centered treatment
202974|NCT02926677|Trauma-Focused Cognitive-Behavioral Therapy|trauma-focused cognitive-behavioral therapy
202975|NCT02926677|fNIRs|fnirs
202976|NCT02926677|CCT|cct
202977|NCT02926677|TF-CBT|tf-cbt
202978|NCT02926677|Posttraumatic stress|posttraumatic stress
202979|NCT02926677|NIRX|nirx
202980|NCT02926625|Unspecific fever|unspecific fever
202981|NCT02926625|Ethiopia|ethiopia
202982|NCT02926625|iCCM|iccm
202983|NCT02926625|CHW|chw
202984|NCT02926625|HEW|hew
202985|NCT02926599|High Fidelity Simulation|high fidelity simulation
202986|NCT02926586|RUNX1-RUNX1T1|runx1-runx1t1
202987|NCT02926586|CBFβ-MYH11|cbfβ-myh11
202988|NCT02926586|fludarabine|fludarabine
202989|NCT02926586|cytarabine|cytarabine
202990|NCT02926573|oral cavity|oral cavity
202991|NCT02926573|oropharynx|oropharynx
202992|NCT02926573|hypopharynx and larynx|hypopharynx and larynx
202993|NCT02926560|Chronic inflammatory rheumatism|chronic inflammatory rheumatism
202994|NCT02926547|proteomics|proteomics
202995|NCT02926534|chronic obstructive pulmonary disease|chronic obstructive pulmonary disease
202996|NCT02926534|smoking|smoking
202997|NCT02926534|prevalence|prevalence
202998|NCT02926534|cross-sectional study|cross-sectional study
202999|NCT02926534|Kazakhstan|kazakhstan
203000|NCT02926521|nerve block catheter|nerve block catheter
203001|NCT02926521|catheter fixation|catheter fixation
203002|NCT02926521|catheter dressing|catheter dressing
203003|NCT02926508|Reading|reading
203004|NCT02926508|Learning|learning
203005|NCT02926508|Cognition|cognition
203006|NCT02926482|Evidence-based practice implementation|evidence-based practice implementation
203007|NCT02926482|Buprenorphine|buprenorphine
203008|NCT02926482|Addiction treatment|addiction treatment
203009|NCT02926482|Extended-release naltrexone|extended-release naltrexone
203010|NCT02926482|Addiction|addiction
203011|NCT02926469|Virtual Reality|virtual reality
203012|NCT02926469|Analgesia|analgesia
203013|NCT02926469|Immersive Virtual Reality|immersive virtual reality
203014|NCT02926469|VR|vr
203015|NCT02926469|Labor|labor
203016|NCT02926469|Pain|pain
203017|NCT02926443|Shoulder|shoulder
203018|NCT02926443|Motor control|motor control
203019|NCT02926443|Usual physiotherapy care|usual physiotherapy care
203020|NCT02926443|Supervised exercise program|supervised exercise program
203021|NCT02926404|Sagittal alignment|sagittal alignment
203022|NCT02926404|Surgical planning|surgical planning
203023|NCT02926404|Patient-specific|patient-specific
203024|NCT02926404|Adult Spinal Deformity|adult spinal deformity
203025|NCT02926352|LLLT|lllt
203026|NCT02926352|LLLS|llls
203027|NCT02926352|Low-Level Laser Stimulation|low-level laser stimulation
203028|NCT02926352|Low-Level Laser Therapy|low-level laser therapy
203029|NCT02926352|Low-Level Light Therapy|low-level light therapy
203030|NCT02926352|Transcranial infrared light stimulation|transcranial infrared light stimulation
203031|NCT02926352|Near-infrared light|near-infrared light
203032|NCT02926352|Photobiomodulation|photobiomodulation
203033|NCT02926352|Fear Extinction|fear extinction
203034|NCT02926352|Exposure Therapy|exposure therapy
203035|NCT02926352|Claustrophobia|claustrophobia
203036|NCT02926352|Fear of enclosed spaces|fear of enclosed spaces
203037|NCT02926352|Fear of contamination|fear of contamination
203038|NCT02926352|Fear of public speaking|fear of public speaking
203039|NCT02926352|Anxiety sensitivity|anxiety sensitivity
203040|NCT02926352|Cytochrome oxidase|cytochrome oxidase
203041|NCT02926352|Memory consolidation|memory consolidation
203042|NCT02926352|Cognitive enhancer|cognitive enhancer
203043|NCT02926326|Healthy Male volunteers|healthy male volunteers
203044|NCT02926313|RCT|rct
203045|NCT02926313|Specialized seating|specialized seating
203046|NCT02926313|Pressure ulcers|pressure ulcers
203047|NCT02926300|crohn's disease|crohn's disease
203048|NCT02926300|stem cell therapy|stem cell therapy
203049|NCT02926300|inflammatory bowel disease|inflammatory bowel disease
203050|NCT02926300|hUCB-MSC|hucb-msc
203051|NCT02926300|UCB-MSC|ucb-msc
203052|NCT02926300|Umbilical cord Blood|umbilical cord blood
203053|NCT02926300|Rheumatoid Arthritis|rheumatoid arthritis
203054|NCT02926300|RA|ra
203055|NCT02926300|Stem cell|stem cell
203056|NCT02926300|Cell therapy|cell therapy
203057|NCT02926300|Furestem|furestem
203058|NCT02926300|Mesenchymal stem cell|mesenchymal stem cell
203059|NCT02926300|MSC|msc
203060|NCT02926287|prolapse surgery|prolapse surgery
203061|NCT02926287|ambulatory surgery|ambulatory surgery
203062|NCT02926274|whole blood|whole blood
203063|NCT02926274|trauma|trauma
203064|NCT02926274|transfusion|transfusion
203065|NCT02926274|coagulopathy|coagulopathy
203066|NCT02926248|Arthrofibrosis|arthrofibrosis
203067|NCT02926235|Total Knee Arthroplasty|total knee arthroplasty
203068|NCT02926209|colonoscopy|colonoscopy
203069|NCT02926209|adenoma|adenoma
203070|NCT02926209|polyp|polyp
203071|NCT02926209|crc screening|crc screening
203072|NCT02926196|ER-Negative|er-negative
203073|NCT02926196|PR-Negative|pr-negative
203074|NCT02926196|HER2-Negative|her2-negative
203075|NCT02926144|Intratracheal intubation|intratracheal intubation
203076|NCT02926144|videolaryngoscope|videolaryngoscope
203077|NCT02926144|McGrath MAC|mcgrath mac
203078|NCT02926131|stick test|stick test
203079|NCT02926118|Glucose|glucose
203080|NCT02926118|Continuous glucose monitor|continuous glucose monitor
203081|NCT02926118|Glycemic load|glycemic load
203082|NCT02926118|Dietary intervention|dietary intervention
203083|NCT02926066|Aromatic L-amino acid decarboxylase (AADC)|aromatic l-amino acid decarboxylase (aadc)
203084|NCT02926014|Dysphagia|dysphagia
203085|NCT02926014|Lingual Tonsil Hypertrophy|lingual tonsil hypertrophy
203086|NCT02926014|Lingual Tonsil Enlargement|lingual tonsil enlargement
203087|NCT02926001|Taxes|taxes
203088|NCT02926001|Beverages/economics|beverages/economics
203089|NCT02926001|Carbonated Beverages/economics|carbonated beverages/economics
203090|NCT02926001|Diet, Food and Nutrition/economics|diet, food and nutrition/economics
203091|NCT02926001|Economics|economics
203092|NCT02926001|Energy Intake|energy intake
203093|NCT02926001|Risk Factors|risk factors
203094|NCT02925988|Critically ill|critically ill
203095|NCT02925988|High risk neonates|high risk neonates
203096|NCT02925949|Treatment|treatment
203097|NCT02925949|Adherence|adherence
203098|NCT02925949|Intervention|intervention
203099|NCT02925949|Sexual and Gender Minority Couples|sexual and gender minority couples
203100|NCT02925936|Radiography|radiography
203101|NCT02925936|Radiation|radiation
203102|NCT02925936|Diagnostic imaging|diagnostic imaging
203103|NCT02925871|stroke|stroke
203104|NCT02925871|rehabilitation|rehabilitation
203105|NCT02925871|interdisciplinary health team|interdisciplinary health team
203106|NCT02925871|patient-centered care|patient-centered care
203107|NCT02925871|care transition|care transition
203108|NCT02925858|Ketamine|ketamine
203109|NCT02925858|Cardiac surgery|cardiac surgery
203110|NCT02925858|Pain|pain
259668|NCT02580552|CLL|cll
203111|NCT02925832|Deep topical fornix nerve block Anesthesia|deep topical fornix nerve block anesthesia
203112|NCT02925832|Ropivacaine|ropivacaine
203113|NCT02925832|Bupivacaine|bupivacaine
203114|NCT02925832|Anaesthesia|anaesthesia
203115|NCT02925832|Eye surgery blocks|eye surgery blocks
203116|NCT02925832|Phacoemulsification|phacoemulsification
203117|NCT02925819|Mitral regurgitation|mitral regurgitation
203118|NCT02925819|Mitral stenosis|mitral stenosis
203119|NCT02925819|Mitral valve repair deterioration|mitral valve repair deterioration
203120|NCT02925819|Bioprosthesis degeneration|bioprosthesis degeneration
203121|NCT02925780|Enamel defects|enamel defects
203122|NCT02925780|Fluorosis|fluorosis
203123|NCT02925780|Icon|icon
203124|NCT02925780|Resin infiltration|resin infiltration
203125|NCT02925741|bed linens|bed linens
203126|NCT02925728|Finger-Food|finger-food
203127|NCT02925702|metastatic Castration Resistant Prostate Cancer|metastatic castration resistant prostate cancer
203128|NCT02925702|Radium-223|radium-223
203129|NCT02925702|Biomarkers|biomarkers
203130|NCT02925663|executive functioning|executive functioning
203131|NCT02925650|Alzheimer's Disease|alzheimer's disease
203132|NCT02925650|SILK™|silk™
203133|NCT02925650|Pharmacodynamics|pharmacodynamics
203134|NCT02925650|Safety|safety
203135|NCT02925650|Pharmacokinetics|pharmacokinetics
203136|NCT02925624|ablation index|ablation index
203628|NCT02922868|Bacteriuria|bacteriuria
203137|NCT02925624|pulmonary vein isolation|pulmonary vein isolation
203138|NCT02925624|implantable loop recorder|implantable loop recorder
203139|NCT02925611|Postoperative delirium|postoperative delirium
203140|NCT02925611|spine surgery|spine surgery
203141|NCT02925611|isoflurane|isoflurane
203142|NCT02925611|desflurane|desflurane
203143|NCT02925598|Laringeal masks|laringeal masks
203144|NCT02925598|Cholecystectomy, Laparascopic|cholecystectomy, laparascopic
203145|NCT02925598|Intubation, intratracheal|intubation, intratracheal
203146|NCT02925572|pediatric obesity|pediatric obesity
203147|NCT02925572|eccentric exercise|eccentric exercise
203148|NCT02925572|body composition|body composition
203149|NCT02925572|training program|training program
203150|NCT02925559|Diabetes Mellitus, Type 2|diabetes mellitus, type 2
203151|NCT02925559|Glycemic Variability|glycemic variability
203152|NCT02925559|Dapagliflozin|dapagliflozin
203153|NCT02925559|Gliclazide MR|gliclazide mr
203154|NCT02925559|Continuous Glucose Monitoring|continuous glucose monitoring
203155|NCT02925559|Mean Amplitude of Glycemic Excursions|mean amplitude of glycemic excursions
203156|NCT02925559|MAGE|mage
203157|NCT02925546|Healthy|healthy
203158|NCT02925546|Pharmacokinetics|pharmacokinetics
203159|NCT02925546|Phase I|phase i
203160|NCT02925546|GSK2798745|gsk2798745
203161|NCT02925546|Tablet|tablet
203162|NCT02925533|Bladder Cancer|bladder cancer
203163|NCT02925533|Urothelial Cancer|urothelial cancer
203164|NCT02925520|Cholestasis|cholestasis
203165|NCT02925494|Uterine Fibroids|uterine fibroids
203166|NCT02925494|Elagolix|elagolix
203167|NCT02925494|Heavy Menstrual Bleeding|heavy menstrual bleeding
203168|NCT02925494|Elagolix Sodium|elagolix sodium
203169|NCT02925494|Elagolix plus Norethindrone Acetate|elagolix plus norethindrone acetate
203170|NCT02925481|Yoga|yoga
203171|NCT02925481|PTSD|ptsd
203172|NCT02925481|mental health|mental health
203173|NCT02925481|stillbirth|stillbirth
203174|NCT02925468|orthodontics|orthodontics
203175|NCT02925455|Hemiplegia|hemiplegia
203176|NCT02925455|Functional Electrical Stimulation|functional electrical stimulation
203177|NCT02925455|Video Games|video games
203178|NCT02925455|Occupational Therapy|occupational therapy
203179|NCT02925442|Unilateral Knee Arthroplasty|unilateral knee arthroplasty
203180|NCT02925442|Radiofrequency Ablation|radiofrequency ablation
203181|NCT02925442|Genicular|genicular
203182|NCT02925442|RFA|rfa
203183|NCT02925442|C-RFA|c-rfa
203184|NCT02925442|t-RFA|t-rfa
203185|NCT02925442|total knee replacement|total knee replacement
203186|NCT02925364|magnetic resonance imaging|magnetic resonance imaging
203187|NCT02925364|central pain processing|central pain processing
203188|NCT02925364|anatomical MRI|anatomical mri
203189|NCT02925364|fMRI|fmri
203190|NCT02925325|Major depressive disorder|major depressive disorder
203191|NCT02925325|Music therapy|music therapy
203192|NCT02925325|Residual symptoms|residual symptoms
203193|NCT02925286|gambling prevention|gambling prevention
203194|NCT02925286|workplace policy|workplace policy
203195|NCT02925273|dementia|dementia
203196|NCT02925234|Molecular tumor profile|molecular tumor profile
203197|NCT02925234|Multidisciplinary tumor board|multidisciplinary tumor board
203198|NCT02925234|Antitumor drugs|antitumor drugs
203199|NCT02925234|Molecular Targeted Therapy|molecular targeted therapy
203200|NCT02925234|Drug Repositioning|drug repositioning
203201|NCT02925234|Off-Label Use|off-label use
203202|NCT02925234|Sequence Analysis, DNA|sequence analysis, dna
203203|NCT02925221|Kidney Disease|kidney disease
203204|NCT02925221|ADPKD-Related Outcome|adpkd-related outcome
203205|NCT02925221|Quality of Life|quality of life
203206|NCT02925195|Vitamin D|vitamin d
203207|NCT02925195|cardiovascular disease|cardiovascular disease
203208|NCT02925195|MESA|mesa
203209|NCT02925195|genetics|genetics
203210|NCT02925195|pharmacogenetics|pharmacogenetics
203211|NCT02925195|blood pressure|blood pressure
203212|NCT02925195|biomarkers|biomarkers
203213|NCT02925169|Subglottis, cricoid, airway shape, CT imaging|subglottis, cricoid, airway shape, ct imaging
203214|NCT02925156|Activity Energy Expenditure|activity energy expenditure
203215|NCT02925156|Doubly Labeled Water|doubly labeled water
203216|NCT02925156|Physical Activity|physical activity
203217|NCT02925156|Obesity|obesity
203218|NCT02925156|Diabetes|diabetes
203219|NCT02925156|Cardiovascular Disease|cardiovascular disease
203220|NCT02925156|Adiponectin|adiponectin
203221|NCT02925156|Leptin|leptin
203222|NCT02925156|Ghrelin|ghrelin
203223|NCT02925143|Residual nerve blockade|residual nerve blockade
203224|NCT02925143|Neuromuscular monitoring|neuromuscular monitoring
203225|NCT02925143|Residual curarization|residual curarization
203226|NCT02925143|Neuromuscular blocking agents|neuromuscular blocking agents
203227|NCT02925143|E-learning|e-learning
203228|NCT02925143|Web based learning|web based learning
203229|NCT02925117|ABT-494|abt-494
203230|NCT02925117|Atopic Dermatitis|atopic dermatitis
203231|NCT02925104|cMET, INC280, food,|cmet, inc280, food,
203232|NCT02925065|Parkinson's|parkinson's
203233|NCT02925065|Non-traditional guitar instruction|non-traditional guitar instruction
203234|NCT02925065|Guitar therapy|guitar therapy
203235|NCT02925065|Upper extremity motor function|upper extremity motor function
203236|NCT02925065|Hand dexterity|hand dexterity
203237|NCT02925039|Rehabilitation|rehabilitation
203238|NCT02925039|Geriatric|geriatric
203239|NCT02925013|Omega 3|omega 3
203240|NCT02925013|Lipids|lipids
203241|NCT02925013|Pregnancy|pregnancy
203242|NCT02925000|Advanced Malignancy|advanced malignancy
203243|NCT02925000|lymphoma|lymphoma
203244|NCT02925000|TLC178|tlc178
203245|NCT02924948|Endoscopic ultrasonography|endoscopic ultrasonography
203246|NCT02924922|renal cell carcinoma|renal cell carcinoma
203247|NCT02924922|laparoscopic partial nephrectomy|laparoscopic partial nephrectomy
203248|NCT02924922|robot-assisted partial nephrectomy|robot-assisted partial nephrectomy
203249|NCT02924922|nephron sparing surgery|nephron sparing surgery
203250|NCT02924922|warm ischemia time|warm ischemia time
203251|NCT02924922|renal function loss|renal function loss
203252|NCT02924870|health education|health education
203253|NCT02924792|Intraosseous access|intraosseous access
203254|NCT02924740|stress urinary incontinence|stress urinary incontinence
203255|NCT02924740|quality of life|quality of life
203256|NCT02924740|pelvic floor muscle training|pelvic floor muscle training
203257|NCT02924740|pelvic floor muscle exercises|pelvic floor muscle exercises
203258|NCT02924740|vaginal tampon training|vaginal tampon training
203259|NCT02924727|Spontaneous AMI|spontaneous ami
203260|NCT02924727|HF hospitalization|hf hospitalization
203261|NCT02924727|outpatient HF|outpatient hf
203262|NCT02924727|LV systolic dysfunction|lv systolic dysfunction
203263|NCT02924727|pulmonary congestion|pulmonary congestion
203264|NCT02924727|STEMI|stemi
203265|NCT02924727|NSTEMI|nstemi
203266|NCT02924727|randomized clinical trial|randomized clinical trial
203267|NCT02924727|LCZ696|lcz696
203268|NCT02924727|ramipril|ramipril
203269|NCT02924714|GIST|gist
203270|NCT02924701|prognosis|prognosis
203271|NCT02924688|umeclidinium bromide|umeclidinium bromide
203272|NCT02924688|fluticasone furoate|fluticasone furoate
203273|NCT02924688|vilanterol|vilanterol
203274|NCT02924688|fixed dose combination|fixed dose combination
203275|NCT02924688|lung function|lung function
203276|NCT02924688|albuterol/salbutamol|albuterol/salbutamol
203277|NCT02924688|asthma|asthma
203278|NCT02924688|closed triple therapy|closed triple therapy
203279|NCT02924675|neuropathic pain, ent cancer, pregabalin|neuropathic pain, ent cancer, pregabalin
203280|NCT02924649|Brain injury|brain injury
203281|NCT02924649|Early mobilisation|early mobilisation
203282|NCT02924649|Consciousness|consciousness
203283|NCT02924649|Cerebral blood flow|cerebral blood flow
203284|NCT02924649|Blood pressure|blood pressure
203285|NCT02924636|C-section|c-section
203286|NCT02924636|Instrumental delivery|instrumental delivery
203287|NCT02924636|Pregnancy complications|pregnancy complications
203288|NCT02924636|Macrosomia|macrosomia
203289|NCT02924636|Neonatal complications|neonatal complications
203290|NCT02924584|hormonal receptor positive, human epidermal growth factor receptor 2 negative, breast cancer, aromatse inhibitor, overall survival, prevalence|hormonal receptor positive, human epidermal growth factor receptor 2 negative, breast cancer, aromatse inhibitor, overall survival, prevalence
203291|NCT02924558|Egg|egg
203292|NCT02924558|Protein|protein
203293|NCT02924558|Unsaturated fatty acids|unsaturated fatty acids
203294|NCT02924558|Triglycerides|triglycerides
203295|NCT02924558|Insulin sensitivity|insulin sensitivity
203296|NCT02924558|Lipid triad|lipid triad
203297|NCT02924506|cervical arthroplasty|cervical arthroplasty
203298|NCT02924493|Endometriosis|endometriosis
203299|NCT02924493|IBS|ibs
203300|NCT02924493|Irritable bowel syndrome|irritable bowel syndrome
203301|NCT02924493|low FODMAP diet|low fodmap diet
203302|NCT02924493|FODMAPs|fodmaps
203303|NCT02924493|visceral syndrome|visceral syndrome
203304|NCT02924493|fermentable carbohydrates|fermentable carbohydrates
203305|NCT02924493|visceral hypersensitivity|visceral hypersensitivity
203306|NCT02924493|cross organ effect|cross organ effect
203307|NCT02924480|invasive bladder cancer|invasive bladder cancer
203308|NCT02924480|cystectomy|cystectomy
203309|NCT02924480|high grade bladder cancer|high grade bladder cancer
203310|NCT02924467|reminder systems|reminder systems
203311|NCT02924467|Influenza vaccines|influenza vaccines
203312|NCT02924454|metoprolol|metoprolol
203313|NCT02924454|lipid emulsion|lipid emulsion
203314|NCT02924454|pharmacodynamics|pharmacodynamics
203315|NCT02924454|pharmacokinetics|pharmacokinetics
203316|NCT02924441|Mammogram|mammogram
203317|NCT02924441|Pain Management|pain management
203318|NCT02924441|Lidocaine|lidocaine
203319|NCT02924428|Acne|acne
203320|NCT02924402|NHL|nhl
203321|NCT02924402|B-cell Prolymphocytic Leukemia|b-cell prolymphocytic leukemia
203322|NCT02924402|Transformed Lymphoma|transformed lymphoma
203323|NCT02924402|Burkitt's Lymphoma|burkitt's lymphoma
203324|NCT02924402|Mantle Cell Lymphoma|mantle cell lymphoma
203325|NCT02924402|Hairy Cell Leukemia|hairy cell leukemia
203326|NCT02924402|Splenic Marginal Zone Lymphoma|splenic marginal zone lymphoma
203327|NCT02924402|Waldenstrom's Macroglobulinemia|waldenstrom's macroglobulinemia
203328|NCT02924402|Variant Hairy Cell Leukemia|variant hairy cell leukemia
203329|NCT02924402|Splenic B-cell Lymphoma/Leukemia|splenic b-cell lymphoma/leukemia
203330|NCT02924402|Lymphoplasmacytic Lymphoma|lymphoplasmacytic lymphoma
203727|NCT02922387|varenicline|varenicline
203331|NCT02924402|Extranodal Marginal Zone Lymphoma (MALT)|extranodal marginal zone lymphoma (malt)
203332|NCT02924402|MALT Lymphoma|malt lymphoma
203333|NCT02924402|Nodal Marginal Zone Lymphoma|nodal marginal zone lymphoma
203334|NCT02924402|Follicular Lymphoma|follicular lymphoma
203335|NCT02924402|In Situ Follicular Neoplasia|in situ follicular neoplasia
203336|NCT02924402|Duodenal-type Follicular Lymphoma|duodenal-type follicular lymphoma
203337|NCT02924402|Large B-cell Lymphoma with IRF4 rearrangement|large b-cell lymphoma with irf4 rearrangement
203338|NCT02924402|Primary Cutaneous Follicle Center Lymphoma|primary cutaneous follicle center lymphoma
203339|NCT02924402|Diffuse Large B-cell Lymphoma|diffuse large b-cell lymphoma
203340|NCT02924402|DLBCL|dlbcl
203341|NCT02924402|T-cell/Histiocyte-Rich Large B-cell Lymphoma|t-cell/histiocyte-rich large b-cell lymphoma
203342|NCT02924402|Primary Cutaneous DLBCL, leg type|primary cutaneous dlbcl, leg type
203343|NCT02924402|EBV-positive DLBCL, NOS|ebv-positive dlbcl, nos
203344|NCT02924402|EBV-positive Mucocutaneous Ulcer|ebv-positive mucocutaneous ulcer
203345|NCT02924402|DLBCL Associated with Chronic Inflammation|dlbcl associated with chronic inflammation
203346|NCT02924402|Lymphomatoid Granulomatosis|lymphomatoid granulomatosis
203347|NCT02924402|Primary Mediastinal (Thymic) Large B-cell Lymphoma|primary mediastinal (thymic) large b-cell lymphoma
203348|NCT02924402|Intravascular Large B-cell Lymphoma|intravascular large b-cell lymphoma
203349|NCT02924402|ALK+ Large B-cell Lymphoma|alk+ large b-cell lymphoma
203350|NCT02924402|Plasmablastic Lymphoma|plasmablastic lymphoma
203351|NCT02924402|Primary Effusion Lymphoma|primary effusion lymphoma
203352|NCT02924402|HHV8+ DLBCL|hhv8+ dlbcl
203353|NCT02924402|Burkitt-like Lymphoma with 11q Aberration|burkitt-like lymphoma with 11q aberration
203354|NCT02924402|High-grade B-cell Lymphoma|high-grade b-cell lymphoma
203355|NCT02924402|B-cell Lymphoma, unclassifiable|b-cell lymphoma, unclassifiable
203356|NCT02924402|Post-transplant Lymphoproliferative Disorder|post-transplant lymphoproliferative disorder
203357|NCT02924402|PTLD|ptld
203358|NCT02924402|CLL|cll
203359|NCT02924402|SLL|sll
203360|NCT02924402|High-grade Lymphoma|high-grade lymphoma
203361|NCT02924402|Richter's Transformation|richter's transformation
203362|NCT02924376|Cholangiocarcinoma|cholangiocarcinoma
203363|NCT02924376|fibroblast growth factor (FGF)|fibroblast growth factor (fgf)
203364|NCT02924376|fibroblast growth factor receptor (FGFR)|fibroblast growth factor receptor (fgfr)
203365|NCT02924376|FGF/FGFR alterations|fgf/fgfr alterations
203366|NCT02924363|Cardiac Magnetic Resonance|cardiac magnetic resonance
203367|NCT02924363|Mitra Clip|mitra clip
203368|NCT02924363|Mitral Valve|mitral valve
203369|NCT02924337|QT/QTC interval|qt/qtc interval
203370|NCT02924337|Hypoglycemic Agents|hypoglycemic agents
203371|NCT02924337|Imeglimin|imeglimin
203372|NCT02924337|Healthy Volunteers|healthy volunteers
203373|NCT02924324|local Injection|local injection
203374|NCT02924324|pain Medication|pain medication
203375|NCT02924324|propofol|propofol
203376|NCT02924324|ropivacaine|ropivacaine
203377|NCT02924324|16-1417|16-1417
203378|NCT02924311|Diabetic Macular Edema|diabetic macular edema
203379|NCT02924272|Drug Therapy|drug therapy
203380|NCT02924259|muscle soreness|muscle soreness
203381|NCT02924259|pain|pain
203382|NCT02924259|myofascial release|myofascial release
203383|NCT02924246|immunity|immunity
203384|NCT02924246|vaccination|vaccination
203385|NCT02924246|milk|milk
203386|NCT02924233|Squamous|squamous
203387|NCT02924233|Non-Small Cell Lung Cancer|non-small cell lung cancer
203388|NCT02924233|NSCLC|nsclc
203389|NCT02924207|diabetes mellitus|diabetes mellitus
203390|NCT02924181|pulmonary vein isolation|pulmonary vein isolation
203391|NCT02924181|contact force sensing catheter|contact force sensing catheter
203392|NCT02924142|Kennedy classification for edentulous ridge|kennedy classification for edentulous ridge
203393|NCT02924129|Chronic Pain|chronic pain
203394|NCT02924129|Back Pain|back pain
203395|NCT02924129|Leg Pain|leg pain
203396|NCT02924129|Pain|pain
203397|NCT02924129|Neurologic Manifestations|neurologic manifestations
203398|NCT02924129|Nervous System Diseases|nervous system diseases
203399|NCT02924129|Signs and Symptoms|signs and symptoms
203400|NCT02924129|SCS|scs
203401|NCT02924129|Closed Loop|closed loop
203402|NCT02924116|insomnia|insomnia
203403|NCT02924116|sleep|sleep
203404|NCT02924116|Bioboosti|bioboosti
203405|NCT02924116|Biomobie|biomobie
203406|NCT02924116|device|device
203407|NCT02924103|acute rhinosinusitis|acute rhinosinusitis
203408|NCT02924103|staphylococcus aureus|staphylococcus aureus
203409|NCT02924103|nasal vestibule|nasal vestibule
203410|NCT02924103|contamination|contamination
203411|NCT02924090|Major depressive disorder|major depressive disorder
203412|NCT02924090|Etomidate|etomidate
203413|NCT02924090|Ketamine|ketamine
203414|NCT02924090|Hyperventilation|hyperventilation
203415|NCT02924090|Electroconvulsive therapy|electroconvulsive therapy
203416|NCT02924090|Depression|depression
203417|NCT02924090|Anesthesia|anesthesia
203418|NCT02924090|Nervous System Diseases|nervous system diseases
203419|NCT02924090|Mental Disorders|mental disorders
203420|NCT02924090|Electroencephalography|electroencephalography
203421|NCT02924090|Cerebral Metabolism|cerebral metabolism
203422|NCT02924038|low-grade glioma|low-grade glioma
203423|NCT02924038|glioma|glioma
203424|NCT02924038|immunotherapy|immunotherapy
203425|NCT02924038|vaccine|vaccine
203426|NCT02924038|WHO grade II|who grade ii
203427|NCT02924012|post exercise hypotension|post exercise hypotension
203428|NCT02924012|exercise|exercise
203429|NCT02924012|video games|video games
203430|NCT02923999|HIV|hiv
203431|NCT02923999|MAB|mab
203432|NCT02923999|PLANT|plant
203433|NCT02923986|Liposomal Grb-2 treatment of Ph+ CML|liposomal grb-2 treatment of ph+ cml
203434|NCT02923986|Liposomal Grb-2 with Das for Ph+ CML|liposomal grb-2 with das for ph+ cml
203435|NCT02923986|Liposomal Grb-2 treatment of Ph+ AML|liposomal grb-2 treatment of ph+ aml
203436|NCT02923986|Liposomal Grb-2 with Das for Ph+ AML|liposomal grb-2 with das for ph+ aml
203437|NCT02923986|Liposomal Grb-2 treatment of Ph+ MDS|liposomal grb-2 treatment of ph+ mds
203438|NCT02923986|Liposomal Grb-2 with Das for Ph+ MDS|liposomal grb-2 with das for ph+ mds
203439|NCT02923947|Pharmacokinetics,|pharmacokinetics,
203440|NCT02923947|Renal impairment,|renal impairment,
203441|NCT02923947|Safety assessments,|safety assessments,
203442|NCT02923947|Solid tumours,|solid tumours,
203443|NCT02923947|EGFRm+|egfrm+
203444|NCT02923947|EGFRm+/T790M+ inhibitor|egfrm+/t790m+ inhibitor
203445|NCT02923908|Palatability|palatability
203446|NCT02923908|Pediatrics|pediatrics
203447|NCT02923908|Facial Recognition|facial recognition
203448|NCT02923908|Taste|taste
203449|NCT02923908|Facial Expressions|facial expressions
203450|NCT02923882|Low-birth-weight|low-birth-weight
203451|NCT02923882|Model kitchen|model kitchen
203452|NCT02923882|Improved cookstove|improved cookstove
203453|NCT02923869|Levobupivacaine|levobupivacaine
203454|NCT02923869|Bupivacaine|bupivacaine
203455|NCT02923869|Nerve Block|nerve block
203456|NCT02923869|Cleft Palate|cleft palate
203457|NCT02923856|Helicobacter pylori|helicobacter pylori
203458|NCT02923856|Antibiotic resistance|antibiotic resistance
203459|NCT02923856|Sequencing|sequencing
203460|NCT02923843|frailty|frailty
203461|NCT02923843|comprehensive geriatric assessment|comprehensive geriatric assessment
203462|NCT02923817|spinal cord injury|spinal cord injury
203463|NCT02923817|autologous transplants|autologous transplants
203464|NCT02923817|bone marrow derived mononuclear cells|bone marrow derived mononuclear cells
203465|NCT02923804|steatosis|steatosis
203466|NCT02923804|NAFL|nafl
203467|NCT02923804|NAFLD|nafld
203468|NCT02923804|Polyunsaturated fatty acids|polyunsaturated fatty acids
203469|NCT02923804|omega-3|omega-3
203470|NCT02923804|EPA|epa
203471|NCT02923804|DHA|dha
203472|NCT02923804|fish oil|fish oil
203473|NCT02923726|Antitachycardia Pacing Therapy|antitachycardia pacing therapy
203474|NCT02923726|Shock Therapy|shock therapy
203475|NCT02923726|Primary Prevention|primary prevention
203476|NCT02923700|platelet rich plasma|platelet rich plasma
203477|NCT02923700|intra-articular injection|intra-articular injection
203478|NCT02923700|leukocytes|leukocytes
203479|NCT02923687|Ketorolac|ketorolac
203480|NCT02923687|Root canal treatment|root canal treatment
203481|NCT02923687|Pain|pain
203482|NCT02923687|Premedication|premedication
203483|NCT02923661|single implant|single implant
203484|NCT02923635|Oncoplastic breast surgery|oncoplastic breast surgery
203485|NCT02923635|Standard Wide Local Excision|standard wide local excision
203486|NCT02923596|Keloid|keloid
203487|NCT02923570|proton-beam radiation therapy (PBRT)|proton-beam radiation therapy (pbrt)
203488|NCT02923570|intensity-modulated radiation therapy (IMRT)|intensity-modulated radiation therapy (imrt)
203489|NCT02923570|16-1416|16-1416
203490|NCT02923544|Uterine Manipulator|uterine manipulator
203491|NCT02923544|Yukio's Uterine Manipulating Instrument (YUMI)|yukio's uterine manipulating instrument (yumi)
203492|NCT02923544|16-1397|16-1397
203493|NCT02923518|Heart Screening|heart screening
203494|NCT02923518|Master Athletes|master athletes
203495|NCT02923518|Cardiovascular Disease|cardiovascular disease
203496|NCT02923479|Rehabilitation|rehabilitation
203497|NCT02923479|Robotics|robotics
203498|NCT02923466|refractory solid tumor|refractory solid tumor
203499|NCT02923427|laryngeal mask Supreme|laryngeal mask supreme
203500|NCT02923427|i-gel|i-gel
203501|NCT02923427|laparoscopic gynecological surgery|laparoscopic gynecological surgery
203502|NCT02923414|Cardioversion|cardioversion
203503|NCT02923401|Exercise|exercise
203504|NCT02923401|Biomarkers|biomarkers
203505|NCT02923401|Breast cancer high risk|breast cancer high risk
203506|NCT02923401|Treadmill|treadmill
203507|NCT02923401|Stationary bicycle|stationary bicycle
203508|NCT02923401|Questionnaires|questionnaires
203509|NCT02923401|Surveys|surveys
203510|NCT02923401|Motivational sessions|motivational sessions
203511|NCT02923401|Phone calls|phone calls
203512|NCT02923401|Printed materials|printed materials
203513|NCT02923362|GERD|gerd
203514|NCT02923362|Reflux|reflux
203515|NCT02923362|Acid Reflux|acid reflux
203516|NCT02923362|Heartburn|heartburn
203517|NCT02923362|Regurgitation|regurgitation
203518|NCT02923362|Laryngopharyngeal Reflux|laryngopharyngeal reflux
203519|NCT02923362|Hiatal Hernia|hiatal hernia
203520|NCT02923362|LPR|lpr
203521|NCT02923362|LINX|linx
203522|NCT02923362|Magnetic Sphincter Augmentation|magnetic sphincter augmentation
203523|NCT02923362|Antireflux Surgery|antireflux surgery
203526|NCT02923349|adenocarcinoma of the endometrium|adenocarcinoma of the endometrium
203527|NCT02923349|ovarian cancer|ovarian cancer
203528|NCT02923349|renal cell carcinoma|renal cell carcinoma
203529|NCT02923349|melanoma|melanoma
203530|NCT02923349|non-small cell lung cancer|non-small cell lung cancer
203531|NCT02923349|OX40|ox40
203532|NCT02923349|immunoglobulin G monoclonal antibody|immunoglobulin g monoclonal antibody
203533|NCT02923336|liver cirrhosis|liver cirrhosis
203534|NCT02923336|variceal bleeding|variceal bleeding
203535|NCT02923336|non selective beta blockers|non selective beta blockers
203536|NCT02923323|Neurocognitive Function|neurocognitive function
203537|NCT02923323|MRI|mri
203538|NCT02923323|Diffusion Tensor Imaging (DTI)|diffusion tensor imaging (dti)
203539|NCT02923323|Sleep|sleep
203540|NCT02923297|parkinson|parkinson
203541|NCT02923297|alpha-synuclein|alpha-synuclein
203542|NCT02923297|GALIG|galig
203543|NCT02923297|quantitative PCR (polymerase chain reaction)|quantitative pcr (polymerase chain reaction)
203544|NCT02923271|Driving|driving
203545|NCT02923271|Teens|teens
203546|NCT02923271|Texting|texting
203547|NCT02923271|Cellphone|cellphone
203548|NCT02923271|DriveID|driveid
203549|NCT02923271|Motor vehicle accident|motor vehicle accident
203550|NCT02923258|head and neck squamous cell carcinoma|head and neck squamous cell carcinoma
203551|NCT02923258|concurrent chemotherapy|concurrent chemotherapy
203552|NCT02923258|High-Risk|high-risk
203553|NCT02923232|Contact lens; Accommodation; Visual performance|contact lens; accommodation; visual performance
203554|NCT02923219|Facial Rejuvenation|facial rejuvenation
203555|NCT02923219|Adipose-Derived Stem Cells|adipose-derived stem cells
203556|NCT02923206|apheresis|apheresis
203557|NCT02923206|pregnancy|pregnancy
203558|NCT02923206|pre-eclampsia|pre-eclampsia
203559|NCT02923206|PE|pe
203560|NCT02923206|sFlt-1|sflt-1
203561|NCT02923206|Pre-term|pre-term
203562|NCT02923167|CP|cp
203563|NCT02923167|Cerebral Palsy|cerebral palsy
203564|NCT02923167|Robotic|robotic
203565|NCT02923167|Hand|hand
203566|NCT02923167|Rehabilitation|rehabilitation
203567|NCT02923154|NASH|nash
203568|NCT02923141|substance use|substance use
203569|NCT02923141|trauma|trauma
203570|NCT02923141|HIV|hiv
203571|NCT02923141|viral load|viral load
203572|NCT02923141|women|women
203573|NCT02923115|Venous thromboembolism|venous thromboembolism
203574|NCT02923115|VTE|vte
203575|NCT02923115|Pulmonary embolism|pulmonary embolism
203576|NCT02923115|PE|pe
203577|NCT02923115|Acute Submassive Pulmonary Embolism|acute submassive pulmonary embolism
203578|NCT02923102|Recovery|recovery
203579|NCT02923102|Muscle soreness|muscle soreness
203580|NCT02923102|Lemon Verbena|lemon verbena
203581|NCT02923089|Diabetes|diabetes
203582|NCT02923089|Lentils|lentils
203583|NCT02923089|Pulses|pulses
203584|NCT02923089|Postprandial glycemia|postprandial glycemia
203585|NCT02923076|Allogeneic Hematopoietic Cell Transplantation|allogeneic hematopoietic cell transplantation
203586|NCT02923063|Chronic Kidney Disease|chronic kidney disease
203587|NCT02923063|Mitochondrial Metabolism|mitochondrial metabolism
203588|NCT02923063|Physical Performance|physical performance
203589|NCT02923063|Exercise Intolerance|exercise intolerance
203590|NCT02923063|Muscle Fatigue|muscle fatigue
203591|NCT02922998|CD64 antigens|cd64 antigens
203592|NCT02922998|Biomarkers|biomarkers
203593|NCT02922998|Granulocyte Colony-Stimulating Factor|granulocyte colony-stimulating factor
203594|NCT02922998|Interleukin-4|interleukin-4
203595|NCT02922998|Interferon-gamma|interferon-gamma
203596|NCT02922998|C-reactive protein|c-reactive protein
203597|NCT02922998|lipopolysaccharide-binding protein|lipopolysaccharide-binding protein
203598|NCT02922998|procalcitonin|procalcitonin
203599|NCT02922998|Cytokines|cytokines
203600|NCT02922998|Patients|patients
203601|NCT02922998|Human|human
203602|NCT02922998|Systemic Inflammatory Response Syndrome|systemic inflammatory response syndrome
203603|NCT02922998|Sepsis|sepsis
203604|NCT02922998|Infection|infection
203605|NCT02922998|Antibiotics|antibiotics
203606|NCT02922998|Intensive Care Units|intensive care units
203607|NCT02922998|Point-of-Care Systems|point-of-care systems
203608|NCT02922998|Bedside Testing|bedside testing
203609|NCT02922985|Cesarean delivery|cesarean delivery
203610|NCT02922985|Multimodal pain management|multimodal pain management
203611|NCT02922972|Keloid scar|keloid scar
203612|NCT02922972|Wound healing|wound healing
203613|NCT02922972|Platelet-Rich Plasma|platelet-rich plasma
203614|NCT02922972|RegenLab|regenlab
203615|NCT02922959|Opioid Substitution Treatment|opioid substitution treatment
203616|NCT02922959|Telephone intervention|telephone intervention
203617|NCT02922959|secondary prevention|secondary prevention
203618|NCT02922959|naloxone|naloxone
203619|NCT02922946|entinostat|entinostat
203620|NCT02922946|Histone Deacetylase Inhibitor|histone deacetylase inhibitor
203621|NCT02922946|HDAC|hdac
203622|NCT02922933|entinostat|entinostat
203623|NCT02922933|Histone Deacetylase Inhibitor|histone deacetylase inhibitor
203624|NCT02922933|HDAC|hdac
203625|NCT02922868|Cystoscopy|cystoscopy
203626|NCT02922868|EndoSheath|endosheath
203627|NCT02922868|Infection Control|infection control
203629|NCT02922842|transcutaneous electrical nerve stimulation|transcutaneous electrical nerve stimulation
203630|NCT02922829|Food Insecurity|food insecurity
203631|NCT02922829|Nutrition|nutrition
203632|NCT02922816|Carbapenem-resistant Enterobacteriaceae (CRE)|carbapenem-resistant enterobacteriaceae (cre)
203633|NCT02922816|Vancomycin-resistant Enterococcus (VRE)|vancomycin-resistant enterococcus (vre)
203634|NCT02922816|Multidrug Resistant Organism (MDRO)|multidrug resistant organism (mdro)
203635|NCT02922816|Fecal Microbiota Transplant (FMT)|fecal microbiota transplant (fmt)
203636|NCT02922816|Renal Transplant|renal transplant
203637|NCT02922816|Colonization|colonization
203638|NCT02922816|Infection|infection
203639|NCT02922816|Antibiotic Resistance|antibiotic resistance
203640|NCT02922816|Resistome|resistome
203641|NCT02922816|Multidrug Resistant (MDR) Pseudomonas|multidrug resistant (mdr) pseudomonas
203642|NCT02922790|smoker|smoker
203643|NCT02922790|smoking|smoking
203644|NCT02922790|cigarette|cigarette
203645|NCT02922790|cessation|cessation
203646|NCT02922790|DNA|dna
203647|NCT02922790|DNA damage|dna damage
203648|NCT02922790|blood draw|blood draw
203649|NCT02922790|feedback|feedback
203650|NCT02922790|cellular|cellular
203651|NCT02922790|tobacco|tobacco
203652|NCT02922790|tobacco smoke|tobacco smoke
203653|NCT02922764|Solid malignancy|solid malignancy
203654|NCT02922764|Lymphoma|lymphoma
203655|NCT02922764|Solid tumor|solid tumor
203656|NCT02922764|Melanoma|melanoma
203657|NCT02922764|Non-small cell lung cancer|non-small cell lung cancer
203658|NCT02922764|Epithelial ovarian carcinoma|epithelial ovarian carcinoma
203659|NCT02922764|NSCLC|nsclc
203660|NCT02922764|EOC|eoc
203661|NCT02922764|LXR|lxr
203662|NCT02922764|ApoE|apoe
203663|NCT02922764|Small cell lung cancer|small cell lung cancer
203664|NCT02922764|SCLC|sclc
203665|NCT02922764|High-grade neuroendocrine tumors|high-grade neuroendocrine tumors
203666|NCT02922764|HG-NET|hg-net
203667|NCT02922751|transient elastography|transient elastography
203668|NCT02922751|pediatric liver disease|pediatric liver disease
203669|NCT02922751|biliary atresia|biliary atresia
203670|NCT02922751|Alagille Syndrome|alagille syndrome
203671|NCT02922751|Alpha1 Anti-Trypsin Deficiency|alpha1 anti-trypsin deficiency
203672|NCT02922751|liver fibrosis|liver fibrosis
203673|NCT02922751|cholestasis|cholestasis
203674|NCT02922738|Clinical Knowledge Systems, Decision support, Dermatology|clinical knowledge systems, decision support, dermatology
203675|NCT02922738|Technology Assessment|technology assessment
203676|NCT02922673|human endotoxemia|human endotoxemia
203677|NCT02922673|LPS|lps
203678|NCT02922673|acetylsalicylic acid|acetylsalicylic acid
203679|NCT02922673|placebo|placebo
203680|NCT02922673|endotoxin tolerance|endotoxin tolerance
203681|NCT02922660|Ambulatory surgery|ambulatory surgery
203682|NCT02922660|Ophthalmic|ophthalmic
203683|NCT02922660|Inhalation anesthesia|inhalation anesthesia
203684|NCT02922660|Desflurane|desflurane
203685|NCT02922660|Total intravenous anesthesia|total intravenous anesthesia
203686|NCT02922634|postoperative health outcomes|postoperative health outcomes
203687|NCT02922634|older surgical patients|older surgical patients
203688|NCT02922634|delirium|delirium
714044|NCT00573248|Nicotine|nicotine
203689|NCT02922608|Education, Medical|education, medical
203690|NCT02922543|Multiple Myeloma|multiple myeloma
203691|NCT02922543|Teratogenicity|teratogenicity
203692|NCT02922543|Thrombocytopenia and haemorrhage|thrombocytopenia and haemorrhage
203693|NCT02922543|Neutropenia and infection|neutropenia and infection
203694|NCT02922543|Venous thromboembolism|venous thromboembolism
203695|NCT02922543|Allergic reactions|allergic reactions
203696|NCT02922543|Diarrhoea or constipation|diarrhoea or constipation
203697|NCT02922543|Peripheral neuropathy|peripheral neuropathy
203698|NCT02922543|Cardiac failure|cardiac failure
203699|NCT02922543|Arrhythmia|arrhythmia
203700|NCT02922543|Renal failure|renal failure
203701|NCT02922543|Myocardial infarction|myocardial infarction
203702|NCT02922543|Interstitial lung disease|interstitial lung disease
203703|NCT02922543|Tumour lysis syndrome|tumour lysis syndrome
203704|NCT02922517|biomarkers|biomarkers
203705|NCT02922517|echocardiography|echocardiography
203706|NCT02922517|MRI imaging|mri imaging
203707|NCT02922517|nuclear medicine|nuclear medicine
203708|NCT02922504|First trimester abortion|first trimester abortion
203709|NCT02922504|Surgical abortion|surgical abortion
203710|NCT02922504|Music intervention|music intervention
203711|NCT02922504|Local anesthesia|local anesthesia
203712|NCT02922504|Pain|pain
203713|NCT02922439|chronic disease|chronic disease
203714|NCT02922439|multimorbidity|multimorbidity
203715|NCT02922439|chronic disease self-management|chronic disease self-management
203716|NCT02922439|tailored information|tailored information
203717|NCT02922439|mobile applications|mobile applications
203718|NCT02922426|ALKS 3831|alks 3831
203719|NCT02922426|Samidorphan|samidorphan
203720|NCT02922426|Olanzapine|olanzapine
203721|NCT02922413|Porphyria|porphyria
203722|NCT02922413|Heme|heme
203723|NCT02922400|Autism|autism
203724|NCT02922400|Traumatic Brain Injury|traumatic brain injury
203725|NCT02922400|Schizophrenia|schizophrenia
203726|NCT02922400|Virtual-Reality Social Cognition Training|virtual-reality social cognition training
203728|NCT02922387|COPD|copd
203729|NCT02922387|asthma|asthma
203730|NCT02922387|pneumonia|pneumonia
203731|NCT02922387|smoking cessation|smoking cessation
203732|NCT02922374|acute severe colitis|acute severe colitis
203733|NCT02922374|corticosteroids|corticosteroids
203734|NCT02922374|UCEIS|uceis
203735|NCT02922374|fecal calprotectin|fecal calprotectin
203736|NCT02922348|premature ovarian failure|premature ovarian failure
203737|NCT02922348|hormone replacement|hormone replacement
203738|NCT02922335|Antisocial Behavior|antisocial behavior
203739|NCT02922335|Mental Illness|mental illness
203740|NCT02922335|Emerging Adulthood|emerging adulthood
203741|NCT02922335|Criminal Behavior|criminal behavior
203742|NCT02922335|Serious Mental Illness|serious mental illness
203743|NCT02922322|Mat Pilates|mat pilates
203744|NCT02922322|Chronic Nonspecific low back pain|chronic nonspecific low back pain
203745|NCT02922322|Quality of life|quality of life
203746|NCT02922322|Disability|disability
203747|NCT02922322|transverse abdominal muscle|transverse abdominal muscle
203748|NCT02922283|T cell response|t cell response
203749|NCT02922283|Interleukin 2|interleukin 2
203750|NCT02922283|PET scan|pet scan
203751|NCT02922283|Ipilimumab|ipilimumab
203752|NCT02922283|Pembrolizumab|pembrolizumab
203753|NCT02922283|Nivolumab|nivolumab
203754|NCT02922270|peritoneal dialysis: outcome|peritoneal dialysis: outcome
203755|NCT02922270|peritoneal dialysis: complications|peritoneal dialysis: complications
203756|NCT02922270|peritoneal dialysis: technique|peritoneal dialysis: technique
203757|NCT02922270|peritoneal dialysis: peritonitis|peritoneal dialysis: peritonitis
203758|NCT02922244|herbal products|herbal products
203759|NCT02922244|reduction of radiation-induced dermatitis|reduction of radiation-induced dermatitis
203760|NCT02922244|breast cancer|breast cancer
203761|NCT02922244|radiotherapy|radiotherapy
203762|NCT02922218|metastatic Castration Resistant Prostate Cancer|metastatic castration resistant prostate cancer
203763|NCT02922218|Enzalutamide|enzalutamide
203764|NCT02922218|Biomarkers|biomarkers
203765|NCT02922192|Anti-inflammatory|anti-inflammatory
203766|NCT02922192|Biologics|biologics
203767|NCT02922192|Biologic and Biosimilars Collective Intelligence Consortium|biologic and biosimilars collective intelligence consortium
203768|NCT02922192|BBCIC|bbcic
203769|NCT02922179|Insulin|insulin
203770|NCT02922179|Diabetes|diabetes
203771|NCT02922179|Biologic and Biosimilars Collective Intelligence Consortium|biologic and biosimilars collective intelligence consortium
203772|NCT02922179|BBCIC|bbcic
203773|NCT02922179|Descriptive analysis|descriptive analysis
203774|NCT02922153|CryoAnalgesia|cryoanalgesia
203775|NCT02922153|Thoracotomy|thoracotomy
203776|NCT02922153|FEV1|fev1
203777|NCT02922153|VAS|vas
203902|NCT02921633|Children|children
203778|NCT02922140|pharmaceutical care service, clinical pharmacist|pharmaceutical care service, clinical pharmacist
203779|NCT02922140|Cardiac rehabilitation unit|cardiac rehabilitation unit
203780|NCT02922140|Acute coronary syndrome|acute coronary syndrome
203781|NCT02922140|patient education and counselling|patient education and counselling
203782|NCT02922127|Ulipristal Acetate (UPA)|ulipristal acetate (upa)
203783|NCT02922127|Breast Cancer|breast cancer
203784|NCT02922127|Combined Oral Contraceptive (COC)|combined oral contraceptive (coc)
203785|NCT02922114|Ultrasonography|ultrasonography
203786|NCT02922114|Clinical assesment|clinical assesment
203787|NCT02922114|joint abnormalities|joint abnormalities
203788|NCT02922088|Vein Graft Failure|vein graft failure
203789|NCT02922088|Coronary Artery Bypass Graft Surgery|coronary artery bypass graft surgery
203790|NCT02922088|Vascular Grafts|vascular grafts
203791|NCT02922088|Saphenous Vein Grafts|saphenous vein grafts
203792|NCT02922088|Vein Graft Disease|vein graft disease
203793|NCT02922088|Vein Graft Treatment|vein graft treatment
203794|NCT02922088|Vein Graft Handling|vein graft handling
203795|NCT02922075|gingival recession|gingival recession
203796|NCT02922075|immediate implant and provisional placement|immediate implant and provisional placement
203797|NCT02922075|bone graft|bone graft
203798|NCT02922075|connective tissue graft|connective tissue graft
203799|NCT02922075|collagen matrix|collagen matrix
203800|NCT02922062|lipids|lipids
203801|NCT02922062|saturated fat|saturated fat
203802|NCT02922062|palm oil|palm oil
203803|NCT02922049|Probe Based Confocal Laser Endomicroscopy (pCLE)|probe based confocal laser endomicroscopy (pcle)
203804|NCT02922049|Barrett's esophagus|barrett's esophagus
203805|NCT02922049|BORN|born
203806|NCT02922049|Intestinal metaplasia|intestinal metaplasia
203807|NCT02921997|A/H5N1|a/h5n1
203808|NCT02921997|A/H7N9|a/h7n9
203809|NCT02921997|ASO3 Adjuvant|aso3 adjuvant
203810|NCT02921997|influenza|influenza
203811|NCT02921997|monovalent|monovalent
203812|NCT02921997|pH1N1|ph1n1
203813|NCT02921997|vaccines|vaccines
203814|NCT02921984|Salivary Gland Tumors|salivary gland tumors
203815|NCT02921984|Head and Neck Cancer|head and neck cancer
203816|NCT02921984|concurrent chemotherapy|concurrent chemotherapy
203817|NCT02921984|genetic testing|genetic testing
203818|NCT02921958|Parents of children with disabilities|parents of children with disabilities
203819|NCT02921932|Physiotherapy|physiotherapy
203820|NCT02921932|Inspiratory Muscle Training|inspiratory muscle training
203821|NCT02921932|Perioperative Medicine|perioperative medicine
203822|NCT02921932|Postoperative outcomes|postoperative outcomes
203823|NCT02921932|Preoperative nutrition|preoperative nutrition
203824|NCT02921932|Elderly, frail|elderly, frail
203825|NCT02921906|Insulin|insulin
203826|NCT02921906|Glucose|glucose
203827|NCT02921906|Incretin|incretin
203828|NCT02921906|GLP-1|glp-1
203829|NCT02921906|Food|food
203830|NCT02921867|ultrasound|ultrasound
203831|NCT02921867|radiology|radiology
203832|NCT02921867|simulation|simulation
203833|NCT02921867|abdominal ultrasound|abdominal ultrasound
203834|NCT02921867|medical education|medical education
203835|NCT02921841|Adolescents|adolescents
203836|NCT02921841|HIV prevention|hiv prevention
203837|NCT02921841|computerized intervention|computerized intervention
203838|NCT02921841|mental health treatment|mental health treatment
203839|NCT02921828|Pomalyst|pomalyst
203840|NCT02921828|Teratogenicity|teratogenicity
203841|NCT02921828|bone marrow suppression|bone marrow suppression
203842|NCT02921828|thromboembolism|thromboembolism
203843|NCT02921828|peripheral neuropathy|peripheral neuropathy
203844|NCT02921828|infection|infection
203845|NCT02921828|tumour lysis syndrome|tumour lysis syndrome
203846|NCT02921828|somnolence|somnolence
203847|NCT02921828|depressed level of consciousness|depressed level of consciousness
203848|NCT02921828|confusion|confusion
203849|NCT02921828|fatigue|fatigue
203850|NCT02921828|dizziness|dizziness
203851|NCT02921828|acute renal failure|acute renal failure
203852|NCT02921828|heart failure|heart failure
203853|NCT02921828|arrhythmia|arrhythmia
203854|NCT02921828|interstitial pneumonia|interstitial pneumonia
203855|NCT02921828|hypersensitivity|hypersensitivity
203856|NCT02921828|hepatic function disorder|hepatic function disorder
203857|NCT02921828|jaundice|jaundice
203858|NCT02921815|Leukemia|leukemia
203859|NCT02921815|Acute Myeloid Leukemia|acute myeloid leukemia
203860|NCT02921815|Revlimid|revlimid
203861|NCT02921802|Teratogenicity|teratogenicity
203862|NCT02921802|Thrombocytopenia and haemorrhage|thrombocytopenia and haemorrhage
203863|NCT02921802|Neutropenia and infection|neutropenia and infection
203864|NCT02921802|Venous thromboembolism|venous thromboembolism
203865|NCT02921802|Allergic reactions|allergic reactions
203866|NCT02921802|Diarrhoea or constipation|diarrhoea or constipation
203867|NCT02921802|Peripheral neuropathy|peripheral neuropathy
203868|NCT02921802|Cardiac failure|cardiac failure
203869|NCT02921802|Arrhythmia|arrhythmia
203870|NCT02921802|Renal failure|renal failure
203871|NCT02921802|Myocardial infarction|myocardial infarction
203872|NCT02921802|Interstitial lung disease|interstitial lung disease
203873|NCT02921802|Tumour lysis syndrome|tumour lysis syndrome
203874|NCT02921802|Transformation from myelodysplastic syndrome to acute myeloid leukemia|transformation from myelodysplastic syndrome to acute myeloid leukemia
203875|NCT02921789|Bleselumab|bleselumab
203876|NCT02921789|ASKP1240|askp1240
203877|NCT02921789|Efficacy and Safety|efficacy and safety
203878|NCT02921776|Vidatalk|vidatalk
203880|NCT02921776|Augmentative and Alternative Communication|augmentative and alternative communication
203881|NCT02921776|iPad|ipad
203882|NCT02921776|Android|android
203883|NCT02921776|Mechanical ventilation|mechanical ventilation
203884|NCT02921776|Patient Communication|patient communication
203885|NCT02921776|Critical Illness|critical illness
203886|NCT02921750|wound reduction wound healing, venous ulcers|wound reduction wound healing, venous ulcers
203887|NCT02921737|metastatic|metastatic
203888|NCT02921737|pancreatic|pancreatic
203889|NCT02921737|adenocarcinoma|adenocarcinoma
203890|NCT02921724|cancer|cancer
203891|NCT02921724|oral drug|oral drug
203892|NCT02921724|sunitinib|sunitinib
203893|NCT02921724|capecitabine|capecitabine
203894|NCT02921724|mobile app|mobile app
203895|NCT02921659|nicotinamide riboside|nicotinamide riboside
203896|NCT02921659|aging|aging
203897|NCT02921659|arterial stiffness|arterial stiffness
203898|NCT02921659|endothelial dysfunction|endothelial dysfunction
203899|NCT02921646|energetic expenditure|energetic expenditure
203900|NCT02921633|Immunization|immunization
203901|NCT02921633|Behavioural insights|behavioural insights
203903|NCT02921620|Gastrointestinal symptoms|gastrointestinal symptoms
203904|NCT02921620|Diarrhea|diarrhea
203905|NCT02921620|Abdominal pain|abdominal pain
203906|NCT02921581|Dose painting|dose painting
203907|NCT02921581|18F-FDG|18f-fdg
203908|NCT02921581|Positron emission tomography|positron emission tomography
203909|NCT02921581|Radiotherapy|radiotherapy
203910|NCT02921555|RCT (randomized controlled trial)|rct (randomized controlled trial)
203911|NCT02921529|Postoperative recovery|postoperative recovery
203912|NCT02921529|colon surgery|colon surgery
203913|NCT02921516|Adolescence|adolescence
203914|NCT02921516|Adherence|adherence
203915|NCT02921477|tyrosine kinase inhibitor|tyrosine kinase inhibitor
203916|NCT02921477|bosutinib|bosutinib
203917|NCT02921477|bosulif|bosulif
203918|NCT02921438|Cardiovascular Diseases|cardiovascular diseases
203919|NCT02921438|Heart Diseases|heart diseases
203920|NCT02921438|Myocardial Ischemia|myocardial ischemia
203921|NCT02921438|NSTE ACS|nste acs
203922|NCT02921438|NSTEMI|nstemi
203923|NCT02921438|Unstable Angina Pectoris|unstable angina pectoris
203924|NCT02921438|Coronary Artery Disease|coronary artery disease
203925|NCT02921425|lifestyle|lifestyle
203926|NCT02921425|patient health record|patient health record
203927|NCT02921425|Veterans|veterans
203928|NCT02921425|prediabetes|prediabetes
203929|NCT02921373|perfluorocarbon imaging|perfluorocarbon imaging
203930|NCT02921373|peripheral blood mononuclear cells|peripheral blood mononuclear cells
203931|NCT02921373|cancer immunotherapy|cancer immunotherapy
203932|NCT02921373|prostate cancer|prostate cancer
203933|NCT02921373|MRI|mri
203934|NCT02921360|thrombolytic therapy|thrombolytic therapy
203935|NCT02921360|tissue plasminogen activator|tissue plasminogen activator
203936|NCT02921360|aspirin|aspirin
203937|NCT02921321|MRI|mri
203938|NCT02921321|Muscular Dystrophy|muscular dystrophy
203939|NCT02921321|Cardiac|cardiac
203940|NCT02921321|Late gadolinium enhancement|late gadolinium enhancement
203941|NCT02921308|Prematurity|prematurity
203942|NCT02921308|Bronchopulmonary dysplasia|bronchopulmonary dysplasia
203943|NCT02921308|MRI|mri
203944|NCT02921308|PFT|pft
203945|NCT02921308|Emphysema|emphysema
203946|NCT02921282|genes|genes
203947|NCT02921282|cues|cues
203948|NCT02921282|reward|reward
203949|NCT02921282|smoking|smoking
203950|NCT02921230|atherosclerosis|atherosclerosis
203951|NCT02921230|Superficial Femoral Artery (SFA)|superficial femoral artery (sfa)
203952|NCT02921230|Proximal Popliteal Artery (PPA)|proximal popliteal artery (ppa)
203953|NCT02921230|stenting|stenting
203954|NCT02921230|paclitaxel|paclitaxel
203955|NCT02921217|Cardiovascular diseases|cardiovascular diseases
203956|NCT02921217|abdominal visceral fat|abdominal visceral fat
203957|NCT02921217|subcutaneous body fat|subcutaneous body fat
203958|NCT02921217|body weight|body weight
203959|NCT02921217|waist circumference|waist circumference
203960|NCT02921217|lipid profile|lipid profile
203961|NCT02921217|insulin resistance|insulin resistance
203962|NCT02921217|glucose metabolism|glucose metabolism
203963|NCT02921217|blood pressure|blood pressure
203964|NCT02921217|inflammation|inflammation
203965|NCT02921217|adiponectin|adiponectin
203966|NCT02921217|leptin|leptin
203967|NCT02921217|metabolomics|metabolomics
203968|NCT02921217|cardiovascular risk factor|cardiovascular risk factor
203969|NCT02921204|Vitamin D|vitamin d
203970|NCT02921204|Calcium|calcium
203971|NCT02921204|Phytic Acid|phytic acid
203972|NCT02921204|body weight|body weight
203973|NCT02921191|recombinant human granulocyte colony-stimulating factors|recombinant human granulocyte colony-stimulating factors
203974|NCT02921191|G-CSFs|g-csfs
203975|NCT02921191|biosimilar|biosimilar
203976|NCT02921191|biologics|biologics
203977|NCT02921191|High Neutropenia Risk Chemotherapy|high neutropenia risk chemotherapy
203978|NCT02921191|Biologic and Biosimilars Collective Intelligence Consortium|biologic and biosimilars collective intelligence consortium
203979|NCT02921191|bbcic|bbcic
203980|NCT02921165|tooth extraction|tooth extraction
203981|NCT02921165|tooth socket healing|tooth socket healing
203982|NCT02921165|hypertension|hypertension
203983|NCT02921165|rinses|rinses
203984|NCT02921139|Hepatocellular Carcinoma|hepatocellular carcinoma
203985|NCT02921139|Transcatheter Arterial Chemoembolization (TACE)|transcatheter arterial chemoembolization (tace)
203986|NCT02921139|Stereotactic ablative radiotherapy (SABR)|stereotactic ablative radiotherapy (sabr)
203987|NCT02921113|suPAR|supar
203988|NCT02921113|Acute Kidney Injury|acute kidney injury
203989|NCT02921113|On-Pump Cardiac Surgery|on-pump cardiac surgery
203990|NCT02921113|Biomarker|biomarker
203991|NCT02921048|Eicosapentaenoic Acid|eicosapentaenoic acid
203992|NCT02921048|Docosahexaenoic Acid|docosahexaenoic acid
203993|NCT02921048|Ambient Air Pollution|ambient air pollution
203994|NCT02921035|Relapsing Multiple Sclerosis|relapsing multiple sclerosis
203995|NCT02921035|Interferon beta-1a|interferon beta-1a
203996|NCT02921035|Rebif®|rebif®
203997|NCT02921035|Morisky Medication Adherence Scale|morisky medication adherence scale
203998|NCT02921022|Gemcitabine|gemcitabine
203999|NCT02921022|Nab-paclitaxel|nab-paclitaxel
204000|NCT02921022|PEGPH20|pegph20
204001|NCT02921022|Rivaroxaban|rivaroxaban
204002|NCT02921022|thromboembolic event (TE)|thromboembolic event (te)
204003|NCT02921022|16-1066|16-1066
204004|NCT02920996|NSCLC|nsclc
204005|NCT02920996|MET|met
204006|NCT02920996|Non-small cell lung cancer|non-small cell lung cancer
204007|NCT02920996|MET mutation|met mutation
204008|NCT02920996|NTRK rearrangement|ntrk rearrangement
204009|NCT02920996|NTRK|ntrk
204010|NCT02920996|targeted therapy|targeted therapy
204011|NCT02920996|MET exon 14|met exon 14
204012|NCT02920996|NTRK1|ntrk1
204013|NCT02920996|NTRK2|ntrk2
204014|NCT02920996|NTRK3|ntrk3
204015|NCT02920996|merestinib|merestinib
204016|NCT02920996|LY2801653|ly2801653
204017|NCT02920918|Systolic Heart Failure|systolic heart failure
204018|NCT02920918|Canagliflozin|canagliflozin
204019|NCT02920918|Sitagliptin Phosphate|sitagliptin phosphate
204020|NCT02920918|Type 2 Diabetes|type 2 diabetes
204021|NCT02920918|SGLT2 inhibitor|sglt2 inhibitor
204022|NCT02920918|DPPIV inhibitor|dppiv inhibitor
204023|NCT02920866|Functional strength integration|functional strength integration
204024|NCT02920866|Rehabilitation|rehabilitation
204025|NCT02920866|Hip arthroplasty|hip arthroplasty
204026|NCT02920866|Physical function|physical function
204027|NCT02920866|Muscle performance|muscle performance
204028|NCT02920866|Movement compensations|movement compensations
204029|NCT02920853|chronic pain|chronic pain
204030|NCT02920827|HIV Infections|hiv infections
204031|NCT02920827|HIV seronegativity|hiv seronegativity
204032|NCT02920801|saxagliptin|saxagliptin
204033|NCT02920801|endothelial progenitor cell|endothelial progenitor cell
204034|NCT02920801|flow-mediated dilation|flow-mediated dilation
204035|NCT02920788|Rehabilitation|rehabilitation
204036|NCT02920788|Functional Magnetic Resonance Imaging|functional magnetic resonance imaging
204037|NCT02920749|anaesthesia|anaesthesia
204038|NCT02920749|costs|costs
204039|NCT02920749|recovery profiles|recovery profiles
204040|NCT02920723|Sleep Apnea Syndromes|sleep apnea syndromes
204041|NCT02920723|Sleep Apnea, Obstructives|sleep apnea, obstructives
204042|NCT02920723|Training|training
204043|NCT02920684|Early rehabilitation|early rehabilitation
204044|NCT02920684|Mechanical ventilation|mechanical ventilation
204045|NCT02920684|Physiotherapy|physiotherapy
204046|NCT02920658|NAVS Naphthalan|navs naphthalan
204047|NCT02920658|Betamethasone dipropionate|betamethasone dipropionate
204048|NCT02920658|Topical treatment|topical treatment
204049|NCT02920645|ICH|ich
204050|NCT02920645|AVM|avm
204051|NCT02920645|intracerebral hemorrhage|intracerebral hemorrhage
204052|NCT02920645|arterio-venous malformation|arterio-venous malformation
204053|NCT02920645|AVICH|avich
204054|NCT02920632|Parkinson|parkinson
204055|NCT02920632|Cognitive training|cognitive training
204056|NCT02920632|Cognitive rehabilitation|cognitive rehabilitation
204057|NCT02920632|Brain networks|brain networks
204058|NCT02920619|ultrasound|ultrasound
204059|NCT02920619|muscle|muscle
204060|NCT02920606|pulpotomy|pulpotomy
204061|NCT02920606|pulpitis|pulpitis
204062|NCT02920606|mature tooth|mature tooth
204063|NCT02920606|tricalcium silicate|tricalcium silicate
204064|NCT02920593|Vitamin D; hypertensive disorders of pregnancy|vitamin d; hypertensive disorders of pregnancy
204065|NCT02920580|Subarachnoid hemorrhage|subarachnoid hemorrhage
204066|NCT02920580|Spontaneous intracerebral hemorrhage|spontaneous intracerebral hemorrhage
204067|NCT02920580|Global cerebral anoxia/cardiac arrest|global cerebral anoxia/cardiac arrest
204068|NCT02920580|Meningitis/Encephalitis/Cerebral abscess|meningitis/encephalitis/cerebral abscess
204069|NCT02920580|Seizure|seizure
204070|NCT02920580|Traumatic Brain Injury (TBI)|traumatic brain injury (tbi)
204071|NCT02920580|Ischemic Stroke|ischemic stroke
204072|NCT02920580|Brain tumor|brain tumor
204073|NCT02920554|gallbladder cancer|gallbladder cancer
204074|NCT02920554|bisegmentectomy|bisegmentectomy
204075|NCT02920515|epidemiology|epidemiology
204076|NCT02920515|treatment|treatment
204077|NCT02920515|molecular pathological mechanism|molecular pathological mechanism
204078|NCT02920515|environmental disrupting chemicals|environmental disrupting chemicals
204079|NCT02920489|severity of labor pain|severity of labor pain
204080|NCT02920489|individualized administration|individualized administration
204081|NCT02920489|neuraxial labor analgesia|neuraxial labor analgesia
204082|NCT02920476|lung|lung
204083|NCT02920476|metastatic|metastatic
204084|NCT02920476|carcinoma|carcinoma
204085|NCT02920463|Anti-Infective agents|anti-infective agents
204086|NCT02920463|Antimicrobial stewardship|antimicrobial stewardship
204087|NCT02920463|Empirical antibiotic therapy|empirical antibiotic therapy
204088|NCT02920463|De-escalation|de-escalation
204089|NCT02920463|Critical care|critical care
204090|NCT02920450|lung|lung
204091|NCT02920450|carcinoma|carcinoma
204092|NCT02920437|dietary salt|dietary salt
204093|NCT02920437|24 hour urinary sodium excretion|24 hour urinary sodium excretion
204094|NCT02920437|blood pressure|blood pressure
204095|NCT02920437|hypertension|hypertension
204096|NCT02920346|Neonatal Systemic lupus erythematosus|neonatal systemic lupus erythematosus
204097|NCT02920346|Sjogren's syndrome|sjogren's syndrome
204098|NCT02920346|Fetal Atrioventricular Block|fetal atrioventricular block
204099|NCT02920346|Fetal Heart Block|fetal heart block
204100|NCT02920333|stroke|stroke
204101|NCT02920333|transcraniel direct current stimulation|transcraniel direct current stimulation
204102|NCT02920333|repetitive transcraniel magnetic stimulation|repetitive transcraniel magnetic stimulation
204103|NCT02920333|rehabilitation|rehabilitation
204104|NCT02920333|lower extremities|lower extremities
204105|NCT02920307|laparoscopic inguinal hernia repair|laparoscopic inguinal hernia repair
204106|NCT02920307|total extraperitoneoscopic hernia repair|total extraperitoneoscopic hernia repair
204107|NCT02920307|transabdominal preperitoneal hernia repair|transabdominal preperitoneal hernia repair
204108|NCT02920307|inguinal hernia|inguinal hernia
204109|NCT02920307|laparoscopy|laparoscopy
204110|NCT02920307|hernia repair|hernia repair
204111|NCT02920307|herniorraphy|herniorraphy
204112|NCT02920307|laparoscopic surgery|laparoscopic surgery
204113|NCT02920294|probiotics, microbiota, ileostoma|probiotics, microbiota, ileostoma
204114|NCT02920268|dance-intervention|dance-intervention
204115|NCT02920268|yoga|yoga
204116|NCT02920268|adolescents|adolescents
204502|NCT02917993|metastatic|metastatic
204117|NCT02920268|recurrent abdominal pain|recurrent abdominal pain
204118|NCT02920242|Travelers|travelers
204119|NCT02920242|diarrhea|diarrhea
204120|NCT02920242|rifaximin|rifaximin
204121|NCT02920242|equivalence|equivalence
204122|NCT02920229|68Ga-PSMA|68ga-psma
204123|NCT02920229|HBED-PET/CT|hbed-pet/ct
204124|NCT02920229|biochemical relapse|biochemical relapse
204125|NCT02920229|prostate cancer|prostate cancer
204126|NCT02920229|radically treated|radically treated
204127|NCT02920216|Head and Neck Neoplasms|head and neck neoplasms
204128|NCT02920216|Recurrence|recurrence
204129|NCT02920216|Indocyanine Green|indocyanine green
204130|NCT02920216|Salvage surgery|salvage surgery
204131|NCT02920203|Sudden unexpected death|sudden unexpected death
204132|NCT02920203|young subjects|young subjects
204133|NCT02920203|molecular genetic autopsy|molecular genetic autopsy
204134|NCT02920203|sequencing|sequencing
204136|NCT02920138|intraabdominal pressure|intraabdominal pressure
204137|NCT02920138|cerebral oxymeter|cerebral oxymeter
204138|NCT02920138|sleeve gastrectomy|sleeve gastrectomy
204139|NCT02920138|laparoscopy|laparoscopy
204140|NCT02920125|Vascular disease|vascular disease
204141|NCT02920112|Obesity|obesity
204142|NCT02920112|Bariatric Surgery|bariatric surgery
204143|NCT02920112|Bariatrics|bariatrics
204144|NCT02920112|Cognitive Therapy|cognitive therapy
204145|NCT02920112|Binge eating|binge eating
204146|NCT02920099|Nutrition literacy|nutrition literacy
204147|NCT02920073|Microbiota|microbiota
204148|NCT02920073|anorexia nervosa|anorexia nervosa
204149|NCT02920073|under nutrition|under nutrition
204150|NCT02920073|inpatients|inpatients
204151|NCT02920073|enteral nutrition|enteral nutrition
204152|NCT02920060|RSE|rse
204153|NCT02920047|Fimasartan|fimasartan
204154|NCT02920008|AML, acute myeloid leukemia, guadecitabine, SGI-110, Phase 3|aml, acute myeloid leukemia, guadecitabine, sgi-110, phase 3
204155|NCT02919982|Anticoagulant|anticoagulant
204156|NCT02919982|Nonvalvular atrial fibrillation|nonvalvular atrial fibrillation
204157|NCT02919982|Registries|registries
204158|NCT02919969|Anal Cancer|anal cancer
204159|NCT02919956|Single Ventricle|single ventricle
204160|NCT02919956|Fontan|fontan
204161|NCT02919904|prostate cancer|prostate cancer
204162|NCT02919904|sleep|sleep
204163|NCT02919904|androgen deprivation therapy|androgen deprivation therapy
204164|NCT02919891|intra-epidermal nerve fibre density|intra-epidermal nerve fibre density
204165|NCT02919891|IENFD|ienfd
204166|NCT02919891|Chronic Pain|chronic pain
204167|NCT02919891|Post-mastectomy|post-mastectomy
204168|NCT02919891|Post-mastectomy pain syndrome|post-mastectomy pain syndrome
204169|NCT02919891|PMPS|pmps
204170|NCT02919891|Chronic Post-Surgical Pain|chronic post-surgical pain
204171|NCT02919891|CPSP|cpsp
204172|NCT02919891|Mastectomy|mastectomy
714045|NCT00573248|ADHD|adhd
261040|NCT02573467|BYM338,|bym338,
204173|NCT02919813|mindfulness group therapy|mindfulness group therapy
204174|NCT02919813|vulvodynia|vulvodynia
204175|NCT02919813|vulvar pain|vulvar pain
204176|NCT02919787|Neoadjuvant treatment|neoadjuvant treatment
204177|NCT02919761|persistant disease activity|persistant disease activity
204178|NCT02919748|dementia|dementia
204179|NCT02919748|cognitive decline|cognitive decline
204180|NCT02919748|choral singing|choral singing
204181|NCT02919748|health education program|health education program
204182|NCT02919748|randomized controlled trial|randomized controlled trial
204183|NCT02919735|Alopecia|alopecia
204184|NCT02919735|Hair|hair
204185|NCT02919735|Chemotherapy|chemotherapy
204186|NCT02919735|Cancer|cancer
204187|NCT02919722|Music therapy|music therapy
204188|NCT02919722|sensorimotor cortex|sensorimotor cortex
204189|NCT02919722|brain injury|brain injury
204190|NCT02919696|CDK4/6 Inhibitor|cdk4/6 inhibitor
204191|NCT02919683|Head and Neck Cancer|head and neck cancer
204192|NCT02919670|Stem Cell Transplant|stem cell transplant
204193|NCT02919644|vaccination|vaccination
204194|NCT02919644|autologous dendritic cells|autologous dendritic cells
204195|NCT02919644|autologous tumour homogenate|autologous tumour homogenate
204196|NCT02919644|curative resection|curative resection
204197|NCT02919644|stage IV colorectal cancer|stage iv colorectal cancer
204198|NCT02919618|Ventricular Tachycardia|ventricular tachycardia
204199|NCT02919618|Ablation|ablation
204200|NCT02919618|Noninvasive|noninvasive
204201|NCT02919605|Cutaneous Leishmaniasis|cutaneous leishmaniasis
204202|NCT02919605|pentamidine isothionate|pentamidine isothionate
204203|NCT02919605|treatment|treatment
204204|NCT02919553|endoscopic ultrasound|endoscopic ultrasound
204205|NCT02919553|wet-suction technique|wet-suction technique
204206|NCT02919553|capillary technique|capillary technique
204207|NCT02919553|fine needle aspiration|fine needle aspiration
204208|NCT02919553|fine needle biopsy|fine needle biopsy
204209|NCT02919514|fall prevention|fall prevention
204210|NCT02919514|Aging|aging
204211|NCT02919514|surfaces|surfaces
204212|NCT02919475|JTE-051|jte-051
204213|NCT02919475|Active Rheumatoid Arthritis|active rheumatoid arthritis
204214|NCT02919475|Efficacy|efficacy
204215|NCT02919475|Safety|safety
204216|NCT02919475|Tolerability|tolerability
204217|NCT02919475|Rheumatoid Arthritis|rheumatoid arthritis
204218|NCT02919462|Carcinoma, Non-Small-Cell Lung|carcinoma, non-small-cell lung
204219|NCT02919462|advanced stage IIIB|advanced stage iiib
204220|NCT02919462|high Thymidylate Synthase expression|high thymidylate synthase expression
204221|NCT02919462|Treatment|treatment
204222|NCT02919462|Chemotherapy Naïve Patients|chemotherapy naïve patients
204223|NCT02919462|stage IIIB-IV Non-Squamous Non-Small Cell Lung Cancer|stage iiib-iv non-squamous non-small cell lung cancer
204224|NCT02919462|Cisplatin and Pemetrexed|cisplatin and pemetrexed
204225|NCT02919462|Cisplatin and Oral Vinorelbine|cisplatin and oral vinorelbine
204226|NCT02919449|Lung Cancer Measles Nivolumab Opdivo|lung cancer measles nivolumab opdivo
204227|NCT02919384|Embryonic development|embryonic development
204228|NCT02919384|blastocyst stage|blastocyst stage
204229|NCT02919345|Dapagliflozin|dapagliflozin
204230|NCT02919345|Glibenclamide|glibenclamide
204231|NCT02919345|Endothelial Function|endothelial function
204232|NCT02919345|Vascular Endothelial Cells|vascular endothelial cells
204233|NCT02919345|Flow Mediated Dilation|flow mediated dilation
204234|NCT02919267|One lung ventilation|one lung ventilation
204235|NCT02919267|Lung collapse|lung collapse
204236|NCT02919267|Bronchial blocker|bronchial blocker
204237|NCT02919267|Double lumen tube|double lumen tube
204238|NCT02919267|video assisted thoracoscopic surgery|video assisted thoracoscopic surgery
204239|NCT02919267|VATS|vats
204240|NCT02919267|DLT|dlt
204241|NCT02919267|Thoracic surgery|thoracic surgery
204242|NCT02919267|Video-assisted|video-assisted
204243|NCT02919241|dental anxiety|dental anxiety
204244|NCT02919241|cognitive therapy|cognitive therapy
204245|NCT02919228|cerebral oxygen metabolism|cerebral oxygen metabolism
204246|NCT02919228|functional near-infrared spectroscopy|functional near-infrared spectroscopy
204247|NCT02919228|partial pressure of carbon dioxide|partial pressure of carbon dioxide
204248|NCT02919228|heart rate variability|heart rate variability
204249|NCT02919228|blood pressure|blood pressure
204250|NCT02919228|affect|affect
204251|NCT02919228|mood|mood
204252|NCT02919228|respiration|respiration
204253|NCT02919228|systematic randomized cross-over study|systematic randomized cross-over study
204254|NCT02919228|systemic physiology|systemic physiology
204255|NCT02919228|electro-dermal activity|electro-dermal activity
204256|NCT02919228|pulse-respiratory quotient|pulse-respiratory quotient
204257|NCT02919189|cerebral oxygen metabolism|cerebral oxygen metabolism
204258|NCT02919189|functional near-infrared spectroscopy|functional near-infrared spectroscopy
204259|NCT02919189|partial pressure of carbon dioxide|partial pressure of carbon dioxide
204260|NCT02919189|heart rate variability|heart rate variability
204261|NCT02919189|blood pressure|blood pressure
204262|NCT02919189|affect|affect
204263|NCT02919189|mood|mood
261160|NCT02572869|15-244|15-244
204264|NCT02919189|respiration|respiration
204265|NCT02919189|systematic randomized cross-over study|systematic randomized cross-over study
204266|NCT02919189|systemic physiology|systemic physiology
204267|NCT02919189|electro-dermal activity|electro-dermal activity
204268|NCT02919189|pulse-respiratory quotient|pulse-respiratory quotient
204269|NCT02919163|cerebral oxygen metabolism|cerebral oxygen metabolism
204270|NCT02919163|functional near-infrared spectroscopy|functional near-infrared spectroscopy
204271|NCT02919163|partial pressure of carbon dioxide|partial pressure of carbon dioxide
204272|NCT02919163|heart rate variability|heart rate variability
204273|NCT02919163|blood pressure|blood pressure
204275|NCT02919163|mood|mood
204276|NCT02919163|respiration|respiration
204277|NCT02919163|systematic randomized cross-over study|systematic randomized cross-over study
204278|NCT02919163|systemic physiology|systemic physiology
204279|NCT02919163|electro-dermal activity|electro-dermal activity
204280|NCT02919163|pulse-respiratory quotient|pulse-respiratory quotient
204281|NCT02919150|Myofascial Trigger Points|myofascial trigger points
204282|NCT02919150|Myotonometry|myotonometry
204283|NCT02919150|Isokinetic Dynamometry|isokinetic dynamometry
204284|NCT02919150|Assessment|assessment
204285|NCT02919150|Reliability|reliability
204286|NCT02919137|cerebral oxygen metabolism|cerebral oxygen metabolism
204287|NCT02919137|functional near-infrared spectroscopy|functional near-infrared spectroscopy
204288|NCT02919137|partial pressure of carbon dioxide|partial pressure of carbon dioxide
204289|NCT02919137|heart rate variability|heart rate variability
204290|NCT02919137|blood pressure|blood pressure
204291|NCT02919137|affect|affect
204292|NCT02919137|mood|mood
204293|NCT02919137|respiration|respiration
204294|NCT02919137|systematic randomized cross-over study|systematic randomized cross-over study
204295|NCT02919137|systemic physiology|systemic physiology
204296|NCT02919137|electro-dermal activity|electro-dermal activity
204297|NCT02919137|pulse-respiratory quotient|pulse-respiratory quotient
204298|NCT02919124|Coronary artery bypass grafting|coronary artery bypass grafting
204299|NCT02919124|Anastomosis|anastomosis
204300|NCT02919124|Ultrasonography|ultrasonography
204301|NCT02919059|Diabetes Mellitus, Type 2|diabetes mellitus, type 2
204302|NCT02919059|DM|dm
204303|NCT02919046|neuroblastoma|neuroblastoma
204304|NCT02919046|CAR-T|car-t
204305|NCT02919033|randomized controlled trial|randomized controlled trial
204306|NCT02919033|telemedicine|telemedicine
204307|NCT02919033|hypertension|hypertension
204308|NCT02919033|primary care|primary care
204602|NCT02917460|Pediatric|pediatric
204309|NCT02919033|medication adherence|medication adherence
204310|NCT02919020|Proprioceptive Neuromuscular Facilitation (PNF )|proprioceptive neuromuscular facilitation (pnf )
204311|NCT02919020|resistance exercise|resistance exercise
204312|NCT02918968|enzalutamide|enzalutamide
204313|NCT02918968|Xtandi|xtandi
204314|NCT02918968|Prostate Cancer|prostate cancer
204315|NCT02918955|head and neck cancer|head and neck cancer
204316|NCT02918955|radiotherapy|radiotherapy
204317|NCT02918955|chemotherapy|chemotherapy
204318|NCT02918955|neck dissection|neck dissection
204319|NCT02918955|surgery|surgery
204320|NCT02918955|quality of life|quality of life
204321|NCT02918955|toxicity|toxicity
204322|NCT02918955|oropharyngeal cancer|oropharyngeal cancer
204323|NCT02918955|laryngeal cancer|laryngeal cancer
204324|NCT02918955|hypopharyngeal cancer|hypopharyngeal cancer
204325|NCT02918929|First-in-human|first-in-human
204326|NCT02918929|Single Ascending Dose|single ascending dose
204327|NCT02918929|Multiple Ascending Dose|multiple ascending dose
204328|NCT02918890|Pediatric|pediatric
204329|NCT02918890|HABIT|habit
204330|NCT02918890|CIMT|cimt
204331|NCT02918890|Cerebral Palsy|cerebral palsy
204332|NCT02918890|Hemiplegia|hemiplegia
204333|NCT02918890|Children|children
204334|NCT02918890|Therapy|therapy
204335|NCT02918877|Volatile Anesthetics|volatile anesthetics
204336|NCT02918877|Intravenous Anesthetics|intravenous anesthetics
204337|NCT02918877|Inflammatory Lung Injury|inflammatory lung injury
204338|NCT02918877|Postoperative Pulmonary Complications|postoperative pulmonary complications
204339|NCT02918877|Cardiac Surgery|cardiac surgery
204340|NCT02918877|Cardiopulmonary Bypass|cardiopulmonary bypass
204341|NCT02918864|Autism Spectrum Disorder|autism spectrum disorder
204342|NCT02918864|Oxytocin|oxytocin
204343|NCT02918864|Social Skills|social skills
204344|NCT02918864|Social cognitive skills|social cognitive skills
204345|NCT02918864|Cognitive Behavioral Intervention|cognitive behavioral intervention
204346|NCT02918864|Combination treatment|combination treatment
204347|NCT02918864|Syntocinon|syntocinon
204348|NCT02918864|NETT (Nonverbal communication, Emotion recognition, Theory of mind Training)|nett (nonverbal communication, emotion recognition, theory of mind training)
204349|NCT02918864|emotion recognition|emotion recognition
204350|NCT02918864|theory of mind|theory of mind
204352|NCT02918838|Antiretroviral (ARV)|antiretroviral (arv)
204353|NCT02918838|co-trimoxazole|co-trimoxazole
204354|NCT02918838|SMS|sms
204355|NCT02918838|Lottery incentive|lottery incentive
204356|NCT02918838|mobile health|mobile health
261283|NCT02572102|ECG|ecg
204357|NCT02918838|Uganda|uganda
204358|NCT02918838|Youth|youth
204359|NCT02918825|schizophrenia|schizophrenia
204360|NCT02918825|clinical trial|clinical trial
204361|NCT02918825|olanzapine|olanzapine
204362|NCT02918825|paliperidone|paliperidone
204363|NCT02918812|Hysterosalpingography|hysterosalpingography
204364|NCT02918812|Pain relief|pain relief
204365|NCT02918812|Infertility|infertility
204366|NCT02918812|Intracervical block|intracervical block
204367|NCT02918812|Diclofenac|diclofenac
204368|NCT02918786|oxygen therapy|oxygen therapy
204369|NCT02918786|continuous positive airway pressure|continuous positive airway pressure
204370|NCT02918786|extubation|extubation
204371|NCT02918773|Pediatrics|pediatrics
204372|NCT02918773|Emergency Medicine|emergency medicine
204373|NCT02918773|Ear infection|ear infection
204374|NCT02918760|Gabapentin, chronic pelvic pain.|gabapentin, chronic pelvic pain.
204375|NCT02918734|Anterior Cruciate Ligament|anterior cruciate ligament
204376|NCT02918734|Bone-Patellar Tendon-Bone Grafting|bone-patellar tendon-bone grafting
204377|NCT02918721|Hyaluronic Acid, Nasolabial Fold, Lidocaine|hyaluronic acid, nasolabial fold, lidocaine
204378|NCT02918708|vaccination|vaccination
204379|NCT02918708|immunisation|immunisation
204380|NCT02918708|pneumococcal|pneumococcal
204381|NCT02918708|conjugate|conjugate
204382|NCT02918695|Geriatric assessment|geriatric assessment
204383|NCT02918695|Fit and frail elderly|fit and frail elderly
204384|NCT02918695|Geriatric oncology|geriatric oncology
204385|NCT02918656|Cochrane|cochrane
204386|NCT02918656|Abstract|abstract
204387|NCT02918656|Infographics|infographics
204388|NCT02918656|Understanding|understanding
204389|NCT02918643|Elderly|elderly
204390|NCT02918643|Potentially Inappropriate Medications|potentially inappropriate medications
204391|NCT02918630|E-cigarettes|e-cigarettes
204392|NCT02918630|Schizophrenia|schizophrenia
204393|NCT02918617|dentin hypersensitivity|dentin hypersensitivity
204394|NCT02918617|nanohydroxyapatite|nanohydroxyapatite
204395|NCT02918617|calcium sodium phosphosilicate|calcium sodium phosphosilicate
204396|NCT02918617|toothpaste|toothpaste
204397|NCT02918617|tooth cream|tooth cream
204398|NCT02918604|peripheral vein access|peripheral vein access
204399|NCT02918604|infrared|infrared
204400|NCT02918604|pediatric|pediatric
204401|NCT02918578|Physical Inactivity|physical inactivity
204402|NCT02918578|Behavior Change|behavior change
204403|NCT02918526|Laryngeal masks|laryngeal masks
204404|NCT02918513|Wellness|wellness
204405|NCT02918513|Mental Wellness|mental wellness
204406|NCT02918513|Well-Being|well-being
204603|NCT02917460|Genomic|genomic
204407|NCT02918500|Coronary Artery Bypass Surgery (CABG)|coronary artery bypass surgery (cabg)
204408|NCT02918500|Nicotine Replacement Therapy (NRT)|nicotine replacement therapy (nrt)
204410|NCT02918435|Pediatric practices|pediatric practices
204411|NCT02918422|Diet Intervention|diet intervention
204412|NCT02918422|Metabolic Syndrome|metabolic syndrome
204413|NCT02918422|Feeding Study|feeding study
204414|NCT02918422|Prediabetes|prediabetes
204415|NCT02918396|Atrial Fibrillation|atrial fibrillation
204416|NCT02918396|Atrial Fibrosis|atrial fibrosis
204417|NCT02918396|Late Gadolinium Enhancement Magnetic Resonance Imaging|late gadolinium enhancement magnetic resonance imaging
204418|NCT02918396|Computational Modeling|computational modeling
204419|NCT02918396|Rotor Anchor Sites|rotor anchor sites
204420|NCT02918370|Alcohol Use Disorder|alcohol use disorder
204421|NCT02918370|Bipolar Disorder|bipolar disorder
204422|NCT02918370|Mood|mood
204423|NCT02918370|Alcohol Craving|alcohol craving
204424|NCT02918370|Aripiprazole|aripiprazole
204425|NCT02918344|calcium phosphate paste|calcium phosphate paste
204426|NCT02918305|denervation|denervation
204427|NCT02918305|resistant hypertension|resistant hypertension
204428|NCT02918292|Haploidentical Bone Marrow|haploidentical bone marrow
204429|NCT02918292|Hematopoietic Stem Cell Transplant (HSCT)|hematopoietic stem cell transplant (hsct)
204430|NCT02918292|Severe Aplastic Anemia (SAA)|severe aplastic anemia (saa)
204431|NCT02918292|Antithymocyte Globulin (ATG)|antithymocyte globulin (atg)
204432|NCT02918266|Drug Therapy|drug therapy
204433|NCT02918253|High dose-rate brachytherapy|high dose-rate brachytherapy
204434|NCT02918227|Ejaculation|ejaculation
204435|NCT02918227|Benign Prostatic Hyperplasia|benign prostatic hyperplasia
204436|NCT02918227|Prostate|prostate
204437|NCT02918214|Septic Shock|septic shock
204438|NCT02918214|echocardiography|echocardiography
204439|NCT02918214|diastolic dysfunction|diastolic dysfunction
204440|NCT02918214|Transthoracic|transthoracic
204441|NCT02918214|Transesophageal|transesophageal
204442|NCT02918214|hyperkinesia|hyperkinesia
204443|NCT02918214|prognosis|prognosis
204444|NCT02918201|Administration, topical|administration, topical
204445|NCT02918201|Tranexamic Acid|tranexamic acid
204446|NCT02918201|Postoperative Care|postoperative care
204447|NCT02918201|Bandages|bandages
204448|NCT02918201|Occlusive Dressings|occlusive dressings
204449|NCT02918175|mHealth|mhealth
204450|NCT02918162|pembrolizumab|pembrolizumab
204451|NCT02918162|adenocarcinoma|adenocarcinoma
204452|NCT02918162|gastric cancer|gastric cancer
204453|NCT02918162|Locoregional gastric adenocarcinoma|locoregional gastric adenocarcinoma
204454|NCT02918162|Locoregional GE junction adenocarcinoma|locoregional ge junction adenocarcinoma
204455|NCT02918149|Ultrasonography|ultrasonography
204456|NCT02918149|Infant|infant
204457|NCT02918149|Newborn|newborn
204458|NCT02918149|Lumbar puncture|lumbar puncture
204459|NCT02918149|Spinal puncture|spinal puncture
204460|NCT02918149|Cerebrospinal fluid|cerebrospinal fluid
204461|NCT02918123|Psoriasis|psoriasis
204462|NCT02918123|Plaque psoriasis|plaque psoriasis
204463|NCT02918123|Stem cell|stem cell
204464|NCT02918123|Cell therapy|cell therapy
204465|NCT02918123|Furestem|furestem
204466|NCT02918123|Mesenchymal stem cell|mesenchymal stem cell
204467|NCT02918123|MSC|msc
204468|NCT02918123|Umbilical cord blood|umbilical cord blood
204469|NCT02918123|hUCB-MSC|hucb-msc
204470|NCT02918123|UCB-MSC|ucb-msc
204471|NCT02918097|Cost effectiveness|cost effectiveness
204472|NCT02918097|Bipolar disorder|bipolar disorder
204473|NCT02918097|Depressive episodes|depressive episodes
204474|NCT02918097|Quality of Life|quality of life
204475|NCT02918084|sequential administration chemiotherapy|sequential administration chemiotherapy
204476|NCT02918084|early breast cancer|early breast cancer
204477|NCT02918084|breast cancer|breast cancer
204478|NCT02918084|aromatase inhibitor|aromatase inhibitor
204479|NCT02918084|adjuvant|adjuvant
204480|NCT02918084|post menopausal|post menopausal
204481|NCT02918071|Asthma,|asthma,
204482|NCT02918071|Bronchial Diseases,|bronchial diseases,
204483|NCT02918071|Respiratory Tract Diseases,|respiratory tract diseases,
204484|NCT02918071|Lung Diseases,|lung diseases,
204485|NCT02918071|Obstructive Lung Diseases,|obstructive lung diseases,
204486|NCT02918071|Benralizumab|benralizumab
204487|NCT02918058|Frailty|frailty
204488|NCT02918058|Deprescription|deprescription
204489|NCT02918045|Tooth Extraction|tooth extraction
204490|NCT02918045|Surgical Hemostasis|surgical hemostasis
204491|NCT02918045|Platelet Aggregation Inhibitors|platelet aggregation inhibitors
204492|NCT02918045|Chitosan|chitosan
204493|NCT02918032|Jordans anomaly|jordans anomaly
204494|NCT02918032|neutral lipid storage disease|neutral lipid storage disease
204495|NCT02918032|triglyceride deposit cardiovasculopathy|triglyceride deposit cardiovasculopathy
204496|NCT02918032|ATGL gene|atgl gene
204497|NCT02918032|CGI-58 gene|cgi-58 gene
204498|NCT02918032|primary triglyceride deposit cardiomyovasculopathy (TGCV)|primary triglyceride deposit cardiomyovasculopathy (tgcv)
204499|NCT02918032|neutral lipid storage disease with myopathy (NLSD-M)|neutral lipid storage disease with myopathy (nlsd-m)
204500|NCT02917993|non-small cell lung cancer|non-small cell lung cancer
204501|NCT02917993|locally advanced|locally advanced
204503|NCT02917993|epidermal growth factor receptor (EGFR) inhibition|epidermal growth factor receptor (egfr) inhibition
204504|NCT02917993|Janus kinase inhibition|janus kinase inhibition
204505|NCT02917980|structural Heart Diseases|structural heart diseases
204506|NCT02917980|surgical treatment|surgical treatment
204507|NCT02917980|interventional treatment|interventional treatment
204508|NCT02917980|hybrid treatment|hybrid treatment
204509|NCT02917954|eHealth/mHealth solutions|ehealth/mhealth solutions
204510|NCT02917954|complex care needs|complex care needs
204512|NCT02917954|patient-centred care|patient-centred care
204513|NCT02917954|goal-oriented care|goal-oriented care
204514|NCT02917954|primary health care|primary health care
204515|NCT02917954|implementation|implementation
204516|NCT02917954|pragmatic trial|pragmatic trial
204517|NCT02917954|health outcomes|health outcomes
204518|NCT02917954|cost-effectiveness analysis|cost-effectiveness analysis
204519|NCT02917928|carnosine, type 2 diabetes, cardiovascular factors|carnosine, type 2 diabetes, cardiovascular factors
204520|NCT02917915|COPD|copd
204521|NCT02917915|Emphysema|emphysema
204522|NCT02917915|Chronic Bronchitis|chronic bronchitis
204523|NCT02917915|Pulmonary rehabilitation|pulmonary rehabilitation
204524|NCT02917915|Lung Diseases, Obstructive|lung diseases, obstructive
204525|NCT02917902|student-run free clinic|student-run free clinic
204526|NCT02917902|food supply|food supply
204527|NCT02917902|food insecure|food insecure
204528|NCT02917902|medically uninsured|medically uninsured
204529|NCT02917902|medically underserved|medically underserved
204530|NCT02917889|Caffeine|caffeine
204531|NCT02917889|Autonomic Nervous System|autonomic nervous system
204532|NCT02917889|Recovery|recovery
204533|NCT02917889|Aerobic exercise|aerobic exercise
204534|NCT02917876|Obstructive Sleep Apnea|obstructive sleep apnea
204535|NCT02917876|Pregnancy|pregnancy
204536|NCT02917876|Obesity|obesity
204537|NCT02917876|Fluid shifts|fluid shifts
204538|NCT02917876|Body composition|body composition
204539|NCT02917876|Sleep|sleep
204540|NCT02917863|Hypothyroidism|hypothyroidism
204541|NCT02917863|Microbiota|microbiota
204542|NCT02917863|Thyroid hormone|thyroid hormone
204543|NCT02917863|L-Thyroxine|l-thyroxine
204544|NCT02917863|Celiac disease|celiac disease
204545|NCT02917850|stroke|stroke
204546|NCT02917850|gait|gait
204547|NCT02917850|hip flexors|hip flexors
204548|NCT02917850|paresis|paresis
204549|NCT02917850|hemiplegia|hemiplegia
261532|NCT02570919|MRI|mri
204550|NCT02917798|Genetic Testing|genetic testing
204551|NCT02917798|16-919|16-919
204552|NCT02917772|tailored immuno therapy|tailored immuno therapy
204553|NCT02917772|Nivolumab|nivolumab
204554|NCT02917772|Ipilimumab|ipilimumab
204555|NCT02917772|boost|boost
204556|NCT02917759|liver cancer|liver cancer
204557|NCT02917759|biliary tract cancer|biliary tract cancer
204558|NCT02917759|cholangiocarcinoma|cholangiocarcinoma
204559|NCT02917759|hepatocellular carcinoma|hepatocellular carcinoma
204560|NCT02917759|liver tumor|liver tumor
204561|NCT02917759|biliary tumor|biliary tumor
204562|NCT02917759|hepatoma|hepatoma
204563|NCT02917759|liver mass|liver mass
204564|NCT02917746|Cervical intraepithelial neoplasia|cervical intraepithelial neoplasia
204565|NCT02917746|Imiquimod|imiquimod
204566|NCT02917746|Treatment|treatment
204567|NCT02917746|Predictive biomarkers|predictive biomarkers
204568|NCT02917720|TKI discontinuation|tki discontinuation
204569|NCT02917707|CRC|crc
204570|NCT02917707|liver metastasis|liver metastasis
204571|NCT02917681|ALS|als
204572|NCT02917681|mesenchymal stem cells|mesenchymal stem cells
204573|NCT02917681|intrathecal|intrathecal
204574|NCT02917668|Obesity|obesity
204575|NCT02917668|Hyperoxia|hyperoxia
204576|NCT02917668|Hypercapnia|hypercapnia
204577|NCT02917668|Postoperative complications|postoperative complications
204578|NCT02917668|Cardiac surgical procedures|cardiac surgical procedures
204579|NCT02917655|Education|education
204580|NCT02917655|Quality of Life|quality of life
204581|NCT02917655|Osteoarthritis|osteoarthritis
204582|NCT02917655|Metabolic Syndrome|metabolic syndrome
204583|NCT02917642|bacterial infection|bacterial infection
204584|NCT02917642|endotoxin|endotoxin
204585|NCT02917642|passive ultrasonic irrigation|passive ultrasonic irrigation
204586|NCT02917642|root canal treatment|root canal treatment
204587|NCT02917590|Spinal cord injury|spinal cord injury
204588|NCT02917590|dual-task obstacle crossing|dual-task obstacle crossing
204589|NCT02917564|Choroidal effusions|choroidal effusions
204590|NCT02917564|Trabeculectomy|trabeculectomy
204591|NCT02917551|Bacteremia, duration, non-critically ill, non-ICU|bacteremia, duration, non-critically ill, non-icu
204592|NCT02917525|Calcium metabolism|calcium metabolism
204593|NCT02917525|Matrix Gla Protein|matrix gla protein
204594|NCT02917525|Vitamin K2|vitamin k2
204595|NCT02917486|ExtraCorporeal Membrane Oxygenation|extracorporeal membrane oxygenation
204596|NCT02917486|patient in intensive care|patient in intensive care
204597|NCT02917486|pharmacokinetic modeling|pharmacokinetic modeling
204598|NCT02917473|Medical skin examination|medical skin examination
204599|NCT02917473|Skin Self Examination|skin self examination
204600|NCT02917473|Sun protection|sun protection
204601|NCT02917460|Rady|rady
204604|NCT02917460|Precision medicine|precision medicine
204605|NCT02917460|Biorepository|biorepository
204607|NCT02917447|Women Veterans|women veterans
204608|NCT02917447|Online intervention|online intervention
204609|NCT02917434|Obesity|obesity
204610|NCT02917434|Psoriatic arthritis|psoriatic arthritis
204611|NCT02917434|Psoriasis|psoriasis
204612|NCT02917434|Metabolic syndrome|metabolic syndrome
204613|NCT02917434|Cardiovascular disease|cardiovascular disease
204614|NCT02917395|hypertrophic cardiomyopathy, disopyramide,|hypertrophic cardiomyopathy, disopyramide,
204615|NCT02917369|LCLC; Integrative Analysis; Metastasis|lclc; integrative analysis; metastasis
204616|NCT02917356|Healing touch|healing touch
204617|NCT02917356|Faith Healing|faith healing
204618|NCT02917356|Pain|pain
204619|NCT02917356|Joint stiffness|joint stiffness
204620|NCT02917356|Functional status|functional status
204621|NCT02917356|Mental health|mental health
204622|NCT02917356|Osteoarthritis|osteoarthritis
204623|NCT02917304|Quadrivalent Influenza Vaccines|quadrivalent influenza vaccines
204624|NCT02917291|Trauma Spinal Cord|trauma spinal cord
204625|NCT02917291|Thoracic Acute Spinal Cord Injury|thoracic acute spinal cord injury
204626|NCT02917291|Neurosurgery|neurosurgery
204627|NCT02917291|Cell Therapy|cell therapy
204628|NCT02917291|ATMP|atmp
204629|NCT02917291|HC016 adipose mesenchymal stem cell|hc016 adipose mesenchymal stem cell
204630|NCT02917291|SPINE|spine
204631|NCT02917265|vagus nerve stimulation|vagus nerve stimulation
204632|NCT02917265|systemic lupus erythematosus|systemic lupus erythematosus
204633|NCT02917213|acute myocardial infarction|acute myocardial infarction
204634|NCT02917213|cardiac embolism|cardiac embolism
204635|NCT02917213|intracardiac fluid dynamics|intracardiac fluid dynamics
204636|NCT02917213|silent brain infarct|silent brain infarct
204637|NCT02917213|intracardiac blood stasis|intracardiac blood stasis
204638|NCT02917174|asthma|asthma
204639|NCT02917174|m-health|m-health
204640|NCT02917174|asthma control|asthma control
204641|NCT02917174|self-management|self-management
204642|NCT02917161|Prostate|prostate
204643|NCT02917161|Prostatic Neoplams|prostatic neoplams
204644|NCT02917161|Therapeutic Embolization|therapeutic embolization
204645|NCT02917161|Prostatectomy|prostatectomy
204646|NCT02917122|Parkinson disease|parkinson disease
204647|NCT02917122|transcranial direct current stimulation|transcranial direct current stimulation
204648|NCT02917122|depression|depression
204649|NCT02917122|dopamine transporter|dopamine transporter
204650|NCT02917122|single photon emission computerized tomography|single photon emission computerized tomography
204651|NCT02917083|chimeric antigen receptors|chimeric antigen receptors
204652|NCT02917083|immunotherapy|immunotherapy
204653|NCT02917083|CAR T-cells|car t-cells
204654|NCT02917083|lymphoma|lymphoma
204655|NCT02917083|Cyclophosphamide|cyclophosphamide
204656|NCT02917083|fludarabine|fludarabine
204657|NCT02917070|Consanguinity-associated kidney diseases|consanguinity-associated kidney diseases
204658|NCT02917070|Turkey population|turkey population
204659|NCT02917044|Atrial Fibrillation|atrial fibrillation
204660|NCT02917031|Type 2 Diabetes Mellitus|type 2 diabetes mellitus
204661|NCT02917031|Heart Failure|heart failure
204662|NCT02917031|Saxagliptin|saxagliptin
204663|NCT02917031|Sitagliptin|sitagliptin
204664|NCT02917018|Dexmedetomidine|dexmedetomidine
204665|NCT02917018|Stress response|stress response
204666|NCT02917018|Emergence agitation|emergence agitation
204667|NCT02917005|breast cancer|breast cancer
204668|NCT02917005|hormone receptor positive, HER2 negative|hormone receptor positive, her2 negative
204669|NCT02917005|palbociclib|palbociclib
204670|NCT02917005|premenopausal|premenopausal
204671|NCT02916992|spontaneous pneumothorax|spontaneous pneumothorax
204672|NCT02916992|familial pneumothorax|familial pneumothorax
204673|NCT02916992|Birt-Hogg-Dube syndrome|birt-hogg-dube syndrome
204674|NCT02916992|prevalence|prevalence
204675|NCT02916992|FLCN mutation|flcn mutation
204676|NCT02916992|Lung cysts|lung cysts
204677|NCT02916992|BHD|bhd
204678|NCT02916992|inherited disease|inherited disease
204679|NCT02916992|genetic disease|genetic disease
204680|NCT02916992|primary pneumothorax|primary pneumothorax
204681|NCT02916992|CAT scan|cat scan
204682|NCT02916992|CT scan|ct scan
204683|NCT02916940|sprains of the proximal interphalangeal joints of the long fingers|sprains of the proximal interphalangeal joints of the long fingers
204684|NCT02916940|Diprophos|diprophos
204685|NCT02916927|ketamine|ketamine
204686|NCT02916927|emergency department|emergency department
204687|NCT02916914|preterm|preterm
204688|NCT02916914|feeding|feeding
204689|NCT02916914|oral transition|oral transition
204690|NCT02916901|Dyslipidemia|dyslipidemia
204691|NCT02916901|CKD-519|ckd-519
204692|NCT02916901|CETP inhibitor|cetp inhibitor
204693|NCT02916901|ABPM|abpm
204694|NCT02916888|Atopic dermatitis|atopic dermatitis
204695|NCT02916888|Topical corticosteroid|topical corticosteroid
204696|NCT02916888|Pediatric|pediatric
204697|NCT02916888|Eczema|eczema
204698|NCT02916888|Quality of life|quality of life
204699|NCT02916875|Shared decision Making|shared decision making
204700|NCT02916875|Follow-up|follow-up
204701|NCT02916862|fiber|fiber
204702|NCT02916862|calcium absorption|calcium absorption
204703|NCT02916862|bone mass|bone mass
204704|NCT02916862|adolescents|adolescents
204705|NCT02916849|Accidental Falls|accidental falls
204706|NCT02916849|Prevention & Control|prevention & control
204707|NCT02916849|Exercise|exercise
204708|NCT02916849|Exercise therapy/methods*|exercise therapy/methods*
204709|NCT02916849|Aged|aged
204710|NCT02916849|Aged 80 and over|aged 80 and over
204711|NCT02916849|Smartphone|smartphone
204712|NCT02916849|Computers|computers
204713|NCT02916849|Computers handheld|computers handheld
204714|NCT02916849|Motivation|motivation
204715|NCT02916849|Postural balance|postural balance
204716|NCT02916849|Health behaviour|health behaviour
204717|NCT02916849|mHealth|mhealth
204718|NCT02916849|eHealth|ehealth
204719|NCT02916810|transcranial magnetic stimulation|transcranial magnetic stimulation
204720|NCT02916810|schizophrenia|schizophrenia
204721|NCT02916810|MRI|mri
204722|NCT02916797|Feedback|feedback
204723|NCT02916797|Physical Therapy|physical therapy
204724|NCT02916784|Sit-to-stand|sit-to-stand
204725|NCT02916784|Walking devices|walking devices
204726|NCT02916771|Smoldering Multiple Myeloma|smoldering multiple myeloma
204727|NCT02916758|older adults|older adults
204728|NCT02916758|community mobility|community mobility
204729|NCT02916758|wellness|wellness
204730|NCT02916758|isolation|isolation
204731|NCT02916745|Non-small cell lung cancer|non-small cell lung cancer
204732|NCT02916745|NSCLC|nsclc
204733|NCT02916745|lung cancer|lung cancer
204734|NCT02916745|lung carcinoma|lung carcinoma
204735|NCT02916745|lung metastasis|lung metastasis
204736|NCT02916732|asymptomatics|asymptomatics
204737|NCT02916732|microcephaly|microcephaly
204738|NCT02916732|abnormalities|abnormalities
204739|NCT02916719|neo-adjuvant radiotherapy|neo-adjuvant radiotherapy
204740|NCT02916719|breast cancer|breast cancer
204741|NCT02916719|MRI|mri
204742|NCT02916693|Mirabegron|mirabegron
204743|NCT02916693|Overactive Bladder|overactive bladder
204744|NCT02916693|Erectile Dysfunction|erectile dysfunction
204745|NCT02916693|Beta 3 agonist|beta 3 agonist
204746|NCT02916680|Pancreatic islet transplantation|pancreatic islet transplantation
204747|NCT02916641|Fuzhenghuayu|fuzhenghuayu
204748|NCT02916628|smoking cessation|smoking cessation
204749|NCT02916628|group counseling|group counseling
204750|NCT02916628|acupressure|acupressure
204751|NCT02916628|serotonin|serotonin
204752|NCT02916628|depressive symptoms|depressive symptoms
204753|NCT02916628|resilience|resilience
204754|NCT02916537|prostate cancer|prostate cancer
204755|NCT02916537|prostate specific membrane antigen|prostate specific membrane antigen
204756|NCT02916537|prostate neoplasms|prostate neoplasms
204757|NCT02916537|metastatic prostate cancer|metastatic prostate cancer
204758|NCT02916537|prostatic hyperplasia|prostatic hyperplasia
204759|NCT02916524|Aphasia|aphasia
204760|NCT02916524|Bilingualism|bilingualism
204761|NCT02916524|Language therapy|language therapy
204762|NCT02916524|Rehabilitation of speech and language disorders|rehabilitation of speech and language disorders
204763|NCT02916524|Speech-language pathology|speech-language pathology
204764|NCT02916498|chronic neuropathic pain in the low back and legs|chronic neuropathic pain in the low back and legs
204765|NCT02916498|subperception spinal cord stimulation|subperception spinal cord stimulation
204766|NCT02916485|bioresorbable scaffold|bioresorbable scaffold
204767|NCT02916485|vascular restoration therapy|vascular restoration therapy
204768|NCT02916472|AYA|aya
204769|NCT02916472|exercise|exercise
204770|NCT02916472|cancer|cancer
204771|NCT02916472|cybercycling|cybercycling
204772|NCT02916407|Anesthesia|anesthesia
204773|NCT02916407|Agitation|agitation
204774|NCT02916407|Extubation|extubation
204775|NCT02916316|Lymphoma|lymphoma
204776|NCT02916316|Large B-Cell|large b-cell
204777|NCT02916316|Cardiotoxicity|cardiotoxicity
204778|NCT02916303|Schizophrenia|schizophrenia
204779|NCT02916303|Psychosis|psychosis
204780|NCT02916303|Effectiveness|effectiveness
204781|NCT02916290|Fuzhenghuayu|fuzhenghuayu
204782|NCT02916264|scalp block, surgical peth index|scalp block, surgical peth index
204783|NCT02916160|Chronic Heart failure|chronic heart failure
204784|NCT02916160|Sleep Apnea Syndrome|sleep apnea syndrome
204785|NCT02916160|Continuous Positive Airways Pressure|continuous positive airways pressure
204786|NCT02916160|SACUBITRIL - VALSARTAN|sacubitril - valsartan
204787|NCT02916108|Concussion|concussion
204788|NCT02916108|Mild traumatic brain injury|mild traumatic brain injury
204789|NCT02916108|EEG|eeg
204790|NCT02916082|Cervical length|cervical length
204791|NCT02916082|Prolonged pregnancy|prolonged pregnancy
204792|NCT02916082|Vaginal birth|vaginal birth
204793|NCT02916069|Spectroscopy|spectroscopy
204794|NCT02916069|Transcranial Doppler|transcranial doppler
204795|NCT02916069|Bispectral index|bispectral index
204796|NCT02916069|Cardiac surgery|cardiac surgery
204797|NCT02916056|Alzheimer's disease|alzheimer's disease
204798|NCT02916056|RAGE|rage
204799|NCT02916056|ADAS-cog|adas-cog
204800|NCT02916056|CDR-sb|cdr-sb
204801|NCT02916043|acute kidney injury|acute kidney injury
204802|NCT02916043|cardiovascular surgery|cardiovascular surgery
204803|NCT02916043|mortality|mortality
204804|NCT02916030|Vitamin D|vitamin d
204805|NCT02916030|Stroke|stroke
204806|NCT02916030|Parathormone|parathormone
204807|NCT02916017|Humira|humira
204808|NCT02916017|Adalimumab|adalimumab
204809|NCT02916017|Non-infectious Intermediate-, Posterior-, or Pan-uveitis|non-infectious intermediate-, posterior-, or pan-uveitis
204810|NCT02916004|Analgesia|analgesia
204811|NCT02916004|Pain measurement|pain measurement
204812|NCT02916004|Nociception|nociception
204813|NCT02916004|Electromyography|electromyography
204814|NCT02916004|Electrical stimulation|electrical stimulation
204815|NCT02916004|Pupillometry|pupillometry
204816|NCT02916004|Critical care|critical care
204817|NCT02916004|Sedation|sedation
204818|NCT02915991|Coronary catheterization|coronary catheterization
204819|NCT02915991|Instantaneous wave free ratio (iFR)|instantaneous wave free ratio (ifr)
204820|NCT02915991|Fractional Flow Reserve (FFR)|fractional flow reserve (ffr)
204821|NCT02915991|automated co-registration|automated co-registration
204822|NCT02915939|Family caregiving|family caregiving
204823|NCT02915939|Institutionalization|institutionalization
204824|NCT02915939|Residential long-term care|residential long-term care
204825|NCT02915939|Placement|placement
204826|NCT02915939|Psychosocial support|psychosocial support
204827|NCT02915939|Dementia|dementia
204828|NCT02915939|Caregivers|caregivers
204829|NCT02915939|Nursing homes|nursing homes
204830|NCT02915939|Assisted Living Facilities|assisted living facilities
204831|NCT02915939|Long-Term Care|long-term care
204832|NCT02915939|Intervention Study|intervention study
204833|NCT02915939|Psychosocial Support Systems|psychosocial support systems
204834|NCT02915939|Social Support|social support
204835|NCT02915939|Coping|coping
204836|NCT02915900|In vitro fertilization|in vitro fertilization
204837|NCT02915887|neck pain|neck pain
204838|NCT02915887|chronic|chronic
204839|NCT02915887|taping|taping
204840|NCT02915887|kinematics|kinematics
204841|NCT02915887|motion analysis|motion analysis
204842|NCT02915887|physiotherapy|physiotherapy
204843|NCT02915861|immune responses|immune responses
204844|NCT02915861|vaccines|vaccines
204845|NCT02915848|deep brain stimulation|deep brain stimulation
714046|NCT00573248|Gender|gender
204846|NCT02915848|local field potential|local field potential
204847|NCT02915848|kinematic analysis|kinematic analysis
204848|NCT02915835|Scleroderma|scleroderma
204849|NCT02915835|Digital Ulcer|digital ulcer
204850|NCT02915809|Influenza Vaccines|influenza vaccines
204851|NCT02915796|Endothelial progenitor cell|endothelial progenitor cell
204852|NCT02915796|Percutaneous transluminal angioplasty|percutaneous transluminal angioplasty
204853|NCT02915783|unresectable advanced|unresectable advanced
204854|NCT02915783|metastatic|metastatic
204855|NCT02915770|Moderate dilatation of common bile duct|moderate dilatation of common bile duct
204856|NCT02915757|Depression|depression
204857|NCT02915757|EDOR test|edor test
204858|NCT02915757|Electrodermal hyporeactivity|electrodermal hyporeactivity
204859|NCT02915744|Breast Cancer Brain Metastases (BCBM)|breast cancer brain metastases (bcbm)
204860|NCT02915744|Carcinoma|carcinoma
204861|NCT02915731|Vitamin A stores|vitamin a stores
204862|NCT02915731|Stable isotope dilution|stable isotope dilution
204863|NCT02915731|Multiple vitamin A interventions|multiple vitamin a interventions
204864|NCT02915718|dilated cardiomyopathy|dilated cardiomyopathy
204865|NCT02915718|immunoadsorption|immunoadsorption
204866|NCT02915692|Foley|foley
204867|NCT02915692|CAUTI|cauti
204868|NCT02915692|ERASE CAUTI|erase cauti
204869|NCT02915679|Suicidal behavior|suicidal behavior
204870|NCT02915679|psychological and social pain|psychological and social pain
204871|NCT02915679|physical pain|physical pain
204872|NCT02915679|pain perception|pain perception
204873|NCT02915666|Melanoma, skin|melanoma, skin
204874|NCT02915627|Antishock Garment|antishock garment
204875|NCT02915614|alpha-1 antitrypsin deficiency|alpha-1 antitrypsin deficiency
204876|NCT02915614|pulmonary rehabilitation|pulmonary rehabilitation
204877|NCT02915614|exercise training|exercise training
204878|NCT02915614|skeletal muscle biopsy|skeletal muscle biopsy
204879|NCT02915562|rehabilitation|rehabilitation
204880|NCT02915562|exercise|exercise
204881|NCT02915562|outcome measurement|outcome measurement
204882|NCT02915549|premature infant|premature infant
204883|NCT02915549|early progressive feeding|early progressive feeding
204884|NCT02915536|iodine excess|iodine excess
204885|NCT02915536|thyroid disease|thyroid disease
204886|NCT02915536|children|children
204887|NCT02915536|tolerable upper intake level|tolerable upper intake level
204888|NCT02915523|Ovarian Cancer|ovarian cancer
204889|NCT02915523|Histone Deacetylase Inhibitors|histone deacetylase inhibitors
204890|NCT02915523|Entinostat|entinostat
204891|NCT02915523|Solid tumor|solid tumor
204892|NCT02915523|Avelumab|avelumab
204893|NCT02915523|SNDX-275|sndx-275
204894|NCT02915523|Ovarian Neoplasms|ovarian neoplasms
204895|NCT02915523|Ovarian Diseases|ovarian diseases
204896|NCT02915523|Fallopian Tube Cancer|fallopian tube cancer
204897|NCT02915523|Peritoneal Cancer|peritoneal cancer
204898|NCT02915497|Prolonged Exposure Therapy|prolonged exposure therapy
204899|NCT02915484|Transcranial Direct Current Stimulation|transcranial direct current stimulation
204901|NCT02915484|Stroke|stroke
204902|NCT02915484|Empathy|empathy
204903|NCT02915484|Electric Stimulation Therapy|electric stimulation therapy
204904|NCT02915484|Depression|depression
204905|NCT02915484|Anhedonia|anhedonia
204906|NCT02915484|Prefrontal Cortex|prefrontal cortex
204907|NCT02915484|Electroencephalography|electroencephalography
204908|NCT02915484|Cognition|cognition
204909|NCT02915484|Emotions|emotions
204910|NCT02915484|Neurological Rehabilitation|neurological rehabilitation
204911|NCT02915484|Brain Diseases|brain diseases
204912|NCT02915484|Cerebrovascular Disorders|cerebrovascular disorders
204913|NCT02915471|Adolescent|adolescent
204914|NCT02915471|Online Peer Support|online peer support
204915|NCT02915471|Managing Cancer|managing cancer
204916|NCT02915471|Mentor|mentor
204917|NCT02915458|Weaning|weaning
204918|NCT02915458|Mechanical ventilation|mechanical ventilation
204919|NCT02915458|synchrosqueezing transform|synchrosqueezing transform
204920|NCT02915445|EpCAM CAR-T, solid tumors, cancer immunotherapy|epcam car-t, solid tumors, cancer immunotherapy
204921|NCT02915432|Anti PD-1|anti pd-1
204922|NCT02915432|JS001|js001
204923|NCT02915432|Gastric Adenocarcinoma|gastric adenocarcinoma
204924|NCT02915432|Esophageal Squamous Cell Carcinoma|esophageal squamous cell carcinoma
204925|NCT02915432|Nasopharyngeal Carcinoma|nasopharyngeal carcinoma
204926|NCT02915432|Head and Neck Squamous Cell Carcinoma|head and neck squamous cell carcinoma
204927|NCT02915432|Simon's Two Stage|simon's two stage
204928|NCT02915432|ORR|orr
204929|NCT02915393|Chronic Gastritis|chronic gastritis
204930|NCT02915393|Qi Deficiency Constitution|qi deficiency constitution
204931|NCT02915393|Next Generation Sequencing|next generation sequencing
204932|NCT02915393|Proteomics|proteomics
204933|NCT02915393|Metabonomics|metabonomics
204934|NCT02915367|HIV/AIDS|hiv/aids
204935|NCT02915367|adherence|adherence
204936|NCT02915367|women|women
204937|NCT02915367|real time monitoring|real time monitoring
204938|NCT02915367|risk|risk
204939|NCT02915367|SMS|sms
204940|NCT02915367|mHealth|mhealth
204941|NCT02915315|blood pressure|blood pressure
204942|NCT02915315|Hypertrophy|hypertrophy
204943|NCT02915315|Left Ventricular|left ventricular
204944|NCT02915315|arterial Stiffness|arterial stiffness
204945|NCT02915315|Proteinuria|proteinuria
204946|NCT02915315|baPWV|bapwv
204947|NCT02915315|ambulatory Blood Pressure|ambulatory blood pressure
204948|NCT02915302|Influenza|influenza
204949|NCT02915302|Influenza virus vaccine|influenza virus vaccine
204950|NCT02915302|Fluzone® Quadrivalent Influenza Vaccine (No Preservative)|fluzone® quadrivalent influenza vaccine (no preservative)
204951|NCT02915289|Caesarean section|caesarean section
204952|NCT02915289|Chlorhexidine gluconate|chlorhexidine gluconate
204953|NCT02915276|Blastocyst|blastocyst
204954|NCT02915276|Human|human
204955|NCT02915276|DNA|dna
204956|NCT02915276|Blastocentesis|blastocentesis
204957|NCT02915263|Diabetes Complications|diabetes complications
204958|NCT02915263|Diabetes Mellitus|diabetes mellitus
204959|NCT02915263|Diabetic Neuropathies|diabetic neuropathies
204960|NCT02915263|IGIV-C|igiv-c
204961|NCT02915263|Immune Globulin Injection (Human), 10% Caprylate/Chromatography|immune globulin injection (human), 10% caprylate/chromatography
204962|NCT02915263|Gamunex-C|gamunex-c
204963|NCT02915237|Veterans|veterans
204964|NCT02915237|Gulf War Illness|gulf war illness
204965|NCT02915237|Gulf War Veterans's Illness|gulf war veterans's illness
204966|NCT02915237|Gulf War Veterans' Medically Unexplained Illnesses|gulf war veterans' medically unexplained illnesses
204967|NCT02915211|Epilepsy|epilepsy
204968|NCT02915211|Glut|glut
204969|NCT02915211|Ketogenic|ketogenic
204970|NCT02915211|Glucose|glucose
204971|NCT02915198|Metformin|metformin
204972|NCT02915198|Atherosclerosis|atherosclerosis
204973|NCT02915198|Prediabetic State|prediabetic state
204974|NCT02915198|Hemoglobin A, Glycosylated|hemoglobin a, glycosylated
204975|NCT02915198|Coronary Artery Disease|coronary artery disease
204976|NCT02915198|Peripheral Arterial Disease|peripheral arterial disease
204977|NCT02915198|Cerebrovascular Disorders|cerebrovascular disorders
204978|NCT02915185|exercise|exercise
204979|NCT02915185|rehabilitation|rehabilitation
204980|NCT02915185|recovery of function|recovery of function
204981|NCT02915185|transcranial magnetic stimulation|transcranial magnetic stimulation
204982|NCT02915185|transcranial direct-current stimulation|transcranial direct-current stimulation
204983|NCT02915172|Advanced Cancer|advanced cancer
204984|NCT02915172|Malignant neoplasm of breast|malignant neoplasm of breast
204985|NCT02915172|Malignant neoplasms of bone and articular cartilage|malignant neoplasms of bone and articular cartilage
204986|NCT02915172|Malignant neoplasms of digestive organs|malignant neoplasms of digestive organs
204987|NCT02915172|Malignant neoplasms of eye brain and other parts of central nervous system|malignant neoplasms of eye brain and other parts of central nervous system
204988|NCT02915172|Malignant neoplasms of female genital organs|malignant neoplasms of female genital organs
204989|NCT02915172|Malignant neoplasms of ill-defined secondary and unspecified sites|malignant neoplasms of ill-defined secondary and unspecified sites
204990|NCT02915172|Malignant neoplasms of independent (primary) multiple sites|malignant neoplasms of independent (primary) multiple sites
205093|NCT02914665|Heart failure|heart failure
204991|NCT02915172|Malignant neoplasms of lip oral cavity and pharynx|malignant neoplasms of lip oral cavity and pharynx
204992|NCT02915172|Malignant neoplasms of male genital organs|malignant neoplasms of male genital organs
204993|NCT02915172|Malignant neoplasms of mesothelial and soft tissue|malignant neoplasms of mesothelial and soft tissue
204994|NCT02915172|Malignant neoplasms of respiratory and intrathoracic organs|malignant neoplasms of respiratory and intrathoracic organs
204995|NCT02915172|Malignant neoplasms of thyroid and other endocrine glands|malignant neoplasms of thyroid and other endocrine glands
204996|NCT02915172|Malignant neoplasms of urinary tract|malignant neoplasms of urinary tract
204997|NCT02915172|Lenvatinib|lenvatinib
204998|NCT02915172|E7080|e7080
204999|NCT02915172|Lenvima|lenvima
205000|NCT02915172|Capecitabine|capecitabine
205001|NCT02915172|Xeloda|xeloda
205002|NCT02915146|eczema|eczema
205003|NCT02915146|phototherapy|phototherapy
205004|NCT02915146|uva1|uva1
205005|NCT02915146|uvb|uvb
205006|NCT02915146|adults|adults
205007|NCT02915146|children|children
205008|NCT02915133|high myopia|high myopia
205009|NCT02915133|myopia foveoschisis|myopia foveoschisis
205010|NCT02915133|macular buckling|macular buckling
205011|NCT02915120|Knee pain|knee pain
205012|NCT02915120|osteoarthritis|osteoarthritis
205013|NCT02915120|genicular nerve|genicular nerve
205014|NCT02915120|ultrasonography|ultrasonography
205015|NCT02915120|pulsed radiofrequency|pulsed radiofrequency
205016|NCT02915107|drug eluting stents|drug eluting stents
205017|NCT02915107|coronary vascular healing|coronary vascular healing
205018|NCT02915068|patient-provider communication|patient-provider communication
205019|NCT02915068|Electronic Health Records|electronic health records
205020|NCT02915068|Provider education|provider education
205021|NCT02915055|Analgesic efficacy|analgesic efficacy
205022|NCT02915055|knee arthroplasty|knee arthroplasty
205023|NCT02915055|Opioid consumption|opioid consumption
205024|NCT02915055|Pain Medicine|pain medicine
205025|NCT02915055|Narcotics|narcotics
205026|NCT02915055|Multimodal Analgesia|multimodal analgesia
205027|NCT02915042|Pain|pain
205028|NCT02915042|dexmedetomidine|dexmedetomidine
205029|NCT02915042|postoperative|postoperative
205030|NCT02915029|Native American|native american
205031|NCT02915029|Community Health Representative|community health representative
205032|NCT02915029|Home base|home base
205033|NCT02915029|Diabetes|diabetes
205034|NCT02915029|Point of care testing|point of care testing
205035|NCT02915029|Patient Activation Measure|patient activation measure
205036|NCT02915029|Patient preferences|patient preferences
205037|NCT02915003|health care navigation|health care navigation
205038|NCT02915003|health literacy|health literacy
205039|NCT02915003|Affordable Care Act|affordable care act
205040|NCT02914977|Relapsed|relapsed
205041|NCT02914977|Refractory|refractory
205042|NCT02914964|Fatigue|fatigue
205043|NCT02914964|Quality of Life|quality of life
205044|NCT02914964|Diet|diet
205045|NCT02914951|Autism|autism
205046|NCT02914951|Irritability|irritability
205047|NCT02914951|Disruptive Behavior|disruptive behavior
205048|NCT02914951|Aggression|aggression
205049|NCT02914951|Behavior Therapy|behavior therapy
205050|NCT02914951|Cognitive Behavioral Therapy|cognitive behavioral therapy
205051|NCT02914951|Intellectual Disability|intellectual disability
205052|NCT02914951|Cognitive Impairment|cognitive impairment
205053|NCT02914925|CIT|cit
205054|NCT02914925|ArmeoSpring|armeospring
205055|NCT02914925|TMS|tms
205056|NCT02914899|Chinese Taxi Drivers|chinese taxi drivers
205057|NCT02914899|16-949|16-949
205058|NCT02914886|Diabetes|diabetes
205059|NCT02914886|Lipoatrophy|lipoatrophy
205060|NCT02914886|children|children
205061|NCT02914886|adolescents|adolescents
205062|NCT02914886|adults|adults
205063|NCT02914886|insulin therapy|insulin therapy
205064|NCT02914873|prostate cancer|prostate cancer
205065|NCT02914873|active surveillance|active surveillance
205066|NCT02914873|standardised treatment triggers|standardised treatment triggers
205067|NCT02914873|MRI|mri
205068|NCT02914873|randomized|randomized
205069|NCT02914821|consumption|consumption
205070|NCT02914821|decision making|decision making
205071|NCT02914821|policy|policy
205072|NCT02914821|sweetened beverages|sweetened beverages
205073|NCT02914821|taxes|taxes
205074|NCT02914821|Diet, Food, and Nutrition|diet, food, and nutrition
205075|NCT02914769|Depression|depression
205076|NCT02914769|Ayahuasca|ayahuasca
205077|NCT02914769|Psychedelics|psychedelics
205078|NCT02914743|Oral health|oral health
205079|NCT02914743|Diabetes|diabetes
205080|NCT02914743|Interprofessionalism|interprofessionalism
205081|NCT02914743|Periodontal disease|periodontal disease
205082|NCT02914730|diabetes|diabetes
205083|NCT02914730|insulin|insulin
205084|NCT02914730|medication adherence|medication adherence
205085|NCT02914717|golimumab|golimumab
205086|NCT02914691|Type 2 diabetes|type 2 diabetes
205087|NCT02914691|Diabetic Nephropathy|diabetic nephropathy
205088|NCT02914691|Proteomics|proteomics
205089|NCT02914691|Albuminuria|albuminuria
205090|NCT02914691|SGLT2 inhibitor|sglt2 inhibitor
205091|NCT02914678|Emergency Medical Services|emergency medical services
205092|NCT02914678|Analgesics|analgesics
205094|NCT02914665|diuresis|diuresis
205096|NCT02914665|congestion|congestion
205097|NCT02914665|elamipretide|elamipretide
205098|NCT02914665|MTP-131|mtp-131
205099|NCT02914665|Bendavia™|bendavia™
205100|NCT02914652|Congenital Heart Disease|congenital heart disease
205101|NCT02914652|Ventricular Septal Defect|ventricular septal defect
205102|NCT02914652|Beta-2-agonists|beta-2-agonists
205103|NCT02914652|Surgery|surgery
205104|NCT02914652|Follow-up|follow-up
205105|NCT02914626|Glaucoma, Neovascular|glaucoma, neovascular
205106|NCT02914626|Ranibizumab|ranibizumab
205107|NCT02914626|Intraocular pressure|intraocular pressure
205108|NCT02914626|anti-VEGF|anti-vegf
205109|NCT02914626|intravitreal injection|intravitreal injection
205110|NCT02914483|Myocardial Infarction|myocardial infarction
205111|NCT02914483|Women|women
205112|NCT02914483|Stress Management|stress management
205113|NCT02914470|advanced|advanced
205114|NCT02914431|Personalized Titanium Plate|personalized titanium plate
205115|NCT02914431|Orthognathic Surgery|orthognathic surgery
205116|NCT02914431|Maxilla Repositioning|maxilla repositioning
205117|NCT02914431|Accuracy|accuracy
205118|NCT02914431|Computer-aided Design and Manufacturing|computer-aided design and manufacturing
205119|NCT02914431|Patient Specified Implants (PSI)|patient specified implants (psi)
205120|NCT02914418|transcranial magnetic stimulation|transcranial magnetic stimulation
205121|NCT02914418|Spinal Cord Injuries|spinal cord injuries
205122|NCT02914418|Muscle Spasticity|muscle spasticity
205123|NCT02914418|Pain|pain
205124|NCT02914418|Spinal Cord|spinal cord
205125|NCT02914418|Spinal Cord Diseases|spinal cord diseases
205126|NCT02914405|131-I-mIBG therapy|131-i-mibg therapy
205127|NCT02914405|ch14.18/CHO|ch14.18/cho
205128|NCT02914405|Nivolumab|nivolumab
205129|NCT02914392|case control study|case control study
205130|NCT02914392|Environmental Factors|environmental factors
205131|NCT02914392|Fetal Congenital Heart Disease|fetal congenital heart disease
205132|NCT02914366|Ambroxol|ambroxol
205133|NCT02914366|Dementia|dementia
205134|NCT02914366|Parkinson's disease|parkinson's disease
205135|NCT02914366|Disease modifying treatment|disease modifying treatment
205136|NCT02914366|Pharmacological Chaperone|pharmacological chaperone
205137|NCT02914366|GBA1|gba1
205138|NCT02914353|Factor X!a|factor x!a
205139|NCT02914353|anticoagulant|anticoagulant
205140|NCT02914353|thromboembolism|thromboembolism
205141|NCT02914353|venous thromboembolism|venous thromboembolism
205142|NCT02914353|embolism and thrombosis|embolism and thrombosis
205143|NCT02914353|enzyme inhibitors|enzyme inhibitors
205144|NCT02914353|hematologic agent|hematologic agent
205145|NCT02914327|CLL|cll
205146|NCT02914327|Leukemia, Chronic Lymphocytic|leukemia, chronic lymphocytic
205147|NCT02914327|Hsp90|hsp90
205148|NCT02914327|BTK|btk
205149|NCT02914327|Ibrutinib|ibrutinib
205150|NCT02914314|epilepsy|epilepsy
205151|NCT02914314|refractory partial seizures|refractory partial seizures
205152|NCT02914249|Orange juice|orange juice
205153|NCT02914249|Low-calorie diet|low-calorie diet
205154|NCT02914249|Body composition|body composition
205155|NCT02914249|Weight-loss|weight-loss
205156|NCT02914249|Metabolic biomarkers|metabolic biomarkers
205157|NCT02914249|Obese|obese
205158|NCT02914236|Nasal valve|nasal valve
205159|NCT02914236|Nasal airway obstruction|nasal airway obstruction
205160|NCT02914210|TKR|tkr
205161|NCT02914210|TKA|tka
205162|NCT02914210|Knee|knee
205163|NCT02914210|Surgery|surgery
205164|NCT02914210|Replacement|replacement
205165|NCT02914210|Rehabilitation|rehabilitation
205166|NCT02914210|Virtual|virtual
205167|NCT02914210|Physical Therapy|physical therapy
205168|NCT02914210|Telerehabilitation|telerehabilitation
205169|NCT02914197|Decision|decision
205170|NCT02914197|Mammography|mammography
205171|NCT02914197|Informed Choice|informed choice
205172|NCT02914197|Full Information|full information
205173|NCT02914197|Decision Aid|decision aid
205174|NCT02914197|Self-efficacy|self-efficacy
205175|NCT02914197|Shared decision making|shared decision making
205176|NCT02914197|Over-detection|over-detection
205177|NCT02914197|Over-diagnosis|over-diagnosis
205178|NCT02914184|Safety|safety
205179|NCT02914184|Healthy infants|healthy infants
205180|NCT02914184|Immunogenicity|immunogenicity
205181|NCT02914184|Human Rotavirus (HRV)|human rotavirus (hrv)
205182|NCT02914171|Myopathic right ventricle|myopathic right ventricle
205183|NCT02914158|breast cancer|breast cancer
205184|NCT02914158|ovarian function suppression (OFS)|ovarian function suppression (ofs)
205185|NCT02914158|aromatase inhibitors（AIs）|aromatase inhibitors（ais）
205186|NCT02914158|tamoxifen（TAM）|tamoxifen（tam）
205187|NCT02914119|Residual nerve blockade|residual nerve blockade
205188|NCT02914119|Neuromuscular monitoring|neuromuscular monitoring
205189|NCT02914119|Residual curarization|residual curarization
205190|NCT02914119|Neuromuscular blocking agents|neuromuscular blocking agents
205191|NCT02914106|Neuroactive steroids|neuroactive steroids
205192|NCT02914106|Acute Ischemic Stroke|acute ischemic stroke
205193|NCT02914106|Patients|patients
205194|NCT02914093|Hypercapnia|hypercapnia
205195|NCT02914093|Physiotherapy|physiotherapy
205196|NCT02914093|Inspiratory Muscle Training|inspiratory muscle training
205197|NCT02914067|Pediatric brain tumors|pediatric brain tumors
205198|NCT02914067|Cognitive deficits|cognitive deficits
205199|NCT02914067|Resting state functional connectivity|resting state functional connectivity
205200|NCT02914067|NIH toolbox|nih toolbox
205202|NCT02914041|Kyphosis|kyphosis
205203|NCT02914041|Kyphosis wall distance|kyphosis wall distance
205204|NCT02914041|elderly|elderly
205205|NCT02914028|TAP block|tap block
205206|NCT02914028|subacute pain|subacute pain
205207|NCT02914028|inguinal herniography|inguinal herniography
205208|NCT02913937|ultrasonic irrigation|ultrasonic irrigation
205209|NCT02913937|pain|pain
205210|NCT02913937|healing|healing
205211|NCT02913937|apical periodontitis|apical periodontitis
205212|NCT02913924|Marijuana|marijuana
205213|NCT02913924|Treatment|treatment
205214|NCT02913911|feedback|feedback
205215|NCT02913898|learning|learning
205216|NCT02913872|Spirometry|spirometry
205217|NCT02913872|Exhaled Nitric Oxide|exhaled nitric oxide
205218|NCT02913872|Primary Care|primary care
205219|NCT02913859|prostate cancer|prostate cancer
205220|NCT02913859|hormone-sensitive|hormone-sensitive
205221|NCT02913859|metastasis|metastasis
205222|NCT02913846|denutrition|denutrition
205223|NCT02913846|hospital length of stay|hospital length of stay
205224|NCT02913846|patient's autonomy|patient's autonomy
205225|NCT02913833|Pain|pain
205226|NCT02913833|Hospital length of stay|hospital length of stay
205227|NCT02913833|Revalidation unit|revalidation unit
205228|NCT02913781|Polar body removal|polar body removal
205229|NCT02913781|ICSI|icsi
205230|NCT02913781|Fertilization failure|fertilization failure
205231|NCT02913742|Intraoperative Neurophysiological Monitoring|intraoperative neurophysiological monitoring
205232|NCT02913729|breast cancer|breast cancer
205233|NCT02913703|Ghrelin|ghrelin
205234|NCT02913690|Hemodialysis|hemodialysis
205235|NCT02913690|Tocotrienol|tocotrienol
205236|NCT02913690|Vitamin E|vitamin e
205237|NCT02913677|feeding intolerance|feeding intolerance
205238|NCT02913677|minimal enteral nutrition|minimal enteral nutrition
205239|NCT02913677|very low birth weight|very low birth weight
205240|NCT02913677|preterm infant|preterm infant
205241|NCT02913664|Dementia|dementia
205242|NCT02913664|Alzheimer's Disease|alzheimer's disease
205243|NCT02913664|Cognitive Function|cognitive function
205244|NCT02913664|Blood Pressure|blood pressure
205245|NCT02913664|Cholesterol|cholesterol
205246|NCT02913664|Physical Activity|physical activity
205247|NCT02913664|Exercise|exercise
205248|NCT02913664|Magnetic Resonance Imaging|magnetic resonance imaging
205249|NCT02913651|Idiopathic hypersomnia|idiopathic hypersomnia
205250|NCT02913651|heart rate variability|heart rate variability
205251|NCT02913651|parasympathetic activity|parasympathetic activity
205252|NCT02913651|autonomic arousal response|autonomic arousal response
205253|NCT02913625|Brachial plexus|brachial plexus
205254|NCT02913625|Regional anesthesia|regional anesthesia
205255|NCT02913625|Infraclavicular|infraclavicular
205256|NCT02913625|Retroclavicular|retroclavicular
205257|NCT02913625|Parasagittal|parasagittal
205258|NCT02913625|Upper limb surgery|upper limb surgery
205259|NCT02913625|Ultrasound guided block|ultrasound guided block
205260|NCT02913625|Coracoid|coracoid
205261|NCT02913612|Hemangioma|hemangioma
205262|NCT02913612|Infantile Hemangioma|infantile hemangioma
205263|NCT02913612|Pharmacokinetics|pharmacokinetics
205264|NCT02913508|Drug therapy|drug therapy
205265|NCT02913495|Progesterone|progesterone
205266|NCT02913495|Prevention of preterm birth|prevention of preterm birth
205267|NCT02913469|Morphine，Ticagrelor，STEMI，PCI|morphine，ticagrelor，stemi，pci
205268|NCT02913417|uveal melanoma|uveal melanoma
205269|NCT02913417|liver metastases|liver metastases
205270|NCT02913391|noninvasive ventilation|noninvasive ventilation
205271|NCT02913391|myocardial revascularization|myocardial revascularization
205272|NCT02913391|pulmonary atelectasis|pulmonary atelectasis
205273|NCT02913391|hypoxia|hypoxia
205274|NCT02913391|positive end-expiratory pressure|positive end-expiratory pressure
205275|NCT02913391|coronary artery bypass grafting|coronary artery bypass grafting
205276|NCT02913391|extracorporeal circulation|extracorporeal circulation
205277|NCT02913365|Haemoptysis|haemoptysis
205278|NCT02913365|Hemoptysis|hemoptysis
205279|NCT02913365|Airway bleeding|airway bleeding
205280|NCT02913365|Pulmonary hemorrhage|pulmonary hemorrhage
205281|NCT02913339|screening|screening
205282|NCT02913339|telemedicine|telemedicine
205283|NCT02913339|risk assessment|risk assessment
205284|NCT02913339|prevention|prevention
205285|NCT02913300|Lignocaine|lignocaine
205286|NCT02913261|GvHD (Graft versus Host Disease)|gvhd (graft versus host disease)
205287|NCT02913261|INC424|inc424
205288|NCT02913261|ruxolitinib|ruxolitinib
205289|NCT02913261|best available therapy (BAT)|best available therapy (bat)
205290|NCT02913261|corticosteroid-refractory acute graft vs. host disease|corticosteroid-refractory acute graft vs. host disease
205291|NCT02913261|allogeneic stem cell transplantation|allogeneic stem cell transplantation
205491|NCT02911493|mobility|mobility
205292|NCT02913261|steroid refractory acute graft vs. host disease|steroid refractory acute graft vs. host disease
205293|NCT02913261|Janus Kinase (JAK) inhibitor|janus kinase (jak) inhibitor
205294|NCT02913248|periodontitis|periodontitis
205295|NCT02913248|saliva|saliva
205296|NCT02913248|bacteria|bacteria
205297|NCT02913235|biofilm|biofilm
205298|NCT02913235|saliva|saliva
205299|NCT02913235|bacteria|bacteria
205300|NCT02913235|oral hygiene|oral hygiene
205301|NCT02913222|femoroacetabular impingement|femoroacetabular impingement
205302|NCT02913222|labral tear|labral tear
205303|NCT02913222|rehabilitation|rehabilitation
205304|NCT02913183|acute stroke|acute stroke
205305|NCT02913183|young health plasma|young health plasma
205306|NCT02913183|efficacy|efficacy
205307|NCT02913183|safety|safety
205308|NCT02913105|Non-alcoholic Steatohepatitis|non-alcoholic steatohepatitis
205309|NCT02913105|NASH|nash
205310|NCT02913105|Fatty liver disease|fatty liver disease
205311|NCT02913014|Antiarrhythmic Agents|antiarrhythmic agents
205312|NCT02913014|Catheter Ablation, electric|catheter ablation, electric
205313|NCT02913014|Cardiac Arrhythmias|cardiac arrhythmias
205314|NCT02913014|Anti-Arrhythmia Drugs|anti-arrhythmia drugs
205315|NCT02913001|Diet|diet
205316|NCT02913001|glycemic index|glycemic index
205317|NCT02913001|glycemic load|glycemic load
205318|NCT02913001|Acne Vulgaris|acne vulgaris
205319|NCT02912988|Subfertility|subfertility
205320|NCT02912988|In-vitro fertilization|in-vitro fertilization
205321|NCT02912988|Letrozole|letrozole
205322|NCT02912949|Bispecific Antibody IgG1, HER2, HER3|bispecific antibody igg1, her2, her3
205323|NCT02912949|MCLA-128|mcla-128
205324|NCT02912949|Antibodies, Bispecific|antibodies, bispecific
205325|NCT02912949|Immunologic Factors|immunologic factors
205326|NCT02912949|NRG1 fusion|nrg1 fusion
205327|NCT02912949|NRG1|nrg1
205328|NCT02912949|Solid tumor|solid tumor
205329|NCT02912949|Pancreatic cancer|pancreatic cancer
205330|NCT02912949|PDAC|pdac
714047|NCT00573235|isolates|isolates
205331|NCT02912949|Non-small cell lung cancer|non-small cell lung cancer
205332|NCT02912949|NSCLC|nsclc
205333|NCT02912949|zenocutuzumab|zenocutuzumab
205334|NCT02912936|medium chain triglyceride|medium chain triglyceride
205335|NCT02912936|MCT|mct
205336|NCT02912936|coconut oil|coconut oil
205337|NCT02912936|MRI|mri
205338|NCT02912936|PET|pet
205339|NCT02912936|ketones|ketones
205340|NCT02912923|Stroke|stroke
205341|NCT02912923|Rehabilitation Robotics|rehabilitation robotics
205342|NCT02912923|Bimanual|bimanual
205343|NCT02912923|Compensatory Movements|compensatory movements
205344|NCT02912923|Hemiplegia|hemiplegia
205345|NCT02912923|Kinematics|kinematics
205346|NCT02912923|Reaching|reaching
205347|NCT02912923|Trunk|trunk
205348|NCT02912897|EBV-CTL|ebv-ctl
205349|NCT02912897|Multiple sclerosis|multiple sclerosis
205350|NCT02912897|cellular therapy|cellular therapy
205351|NCT02912871|subthalamotomy|subthalamotomy
205352|NCT02912871|motor features|motor features
205353|NCT02912871|deep brain stimulation|deep brain stimulation
205354|NCT02912832|Diagnosis|diagnosis
205355|NCT02912806|Knee Arthroplasty|knee arthroplasty
205356|NCT02912806|Total knee replacement|total knee replacement
205357|NCT02912806|Knee osteoarthritis|knee osteoarthritis
205358|NCT02912806|Patient-Outcomes Measurement Program|patient-outcomes measurement program
205359|NCT02912806|Surgical Registries|surgical registries
205360|NCT02912806|Shared Decision Making|shared decision making
205361|NCT02912806|Patient Reported Outcomes|patient reported outcomes
205362|NCT02912806|Patient Experience|patient experience
205363|NCT02912806|Cohort Studies|cohort studies
205364|NCT02912767|lower-extremity lymphedema|lower-extremity lymphedema
205365|NCT02912767|16-1001|16-1001
205366|NCT02912702|Pegaspargase|pegaspargase
205367|NCT02912702|hemophagocytic lymphohistiocytosis|hemophagocytic lymphohistiocytosis
205368|NCT02912702|Epstein Barr virus|epstein barr virus
205369|NCT02912702|initial treatment|initial treatment
205370|NCT02912689|COPD|copd
205371|NCT02912689|Non-invasive ventilation|non-invasive ventilation
205372|NCT02912689|NAVA|nava
205373|NCT02912676|Cancer|cancer
205374|NCT02912676|Thioguanine|thioguanine
205375|NCT02912676|Acute Lymphoblastic Leukemia|acute lymphoblastic leukemia
205376|NCT02912676|6 Mercaptopurine|6 mercaptopurine
205377|NCT02912676|Maintenance Therapy of Leukemia|maintenance therapy of leukemia
205378|NCT02912676|Denmark|denmark
205379|NCT02912676|Lymphoblastic Lymphoma|lymphoblastic lymphoma
205380|NCT02912650|ibuprofen|ibuprofen
205381|NCT02912650|acetaminophen|acetaminophen
205382|NCT02912650|pain|pain
205383|NCT02912650|molar extraction|molar extraction
205384|NCT02912624|Physical Examination|physical examination
205385|NCT02912624|Diagnostic Imaging|diagnostic imaging
205386|NCT02912624|Ultrasonography|ultrasonography
205387|NCT02912624|Hemodynamics|hemodynamics
205388|NCT02912624|Patient Outcome Assessment|patient outcome assessment
205389|NCT02912624|Mortality|mortality
205390|NCT02912585|colostrum|colostrum
205391|NCT02912572|Endometrial Cancer|endometrial cancer
205392|NCT02912546|Stroke, Acute|stroke, acute
205492|NCT02911493|disability|disability
205493|NCT02911428|Ebola|ebola
205393|NCT02912468|Nasal polyposis, Chronic rhinosinusitis, Intranasal corticosteroids, Dupilumab, Human monoclonal antibody|nasal polyposis, chronic rhinosinusitis, intranasal corticosteroids, dupilumab, human monoclonal antibody
205394|NCT02912455|Post-Bariatric Surgery|post-bariatric surgery
205395|NCT02912455|hemoglobin A1c protein, human|hemoglobin a1c protein, human
205396|NCT02912442|thyroid|thyroid
205397|NCT02912442|infertility|infertility
205398|NCT02912442|autoimmunity|autoimmunity
205399|NCT02912442|pregnancy loss|pregnancy loss
205400|NCT02912442|autoantibodies|autoantibodies
205401|NCT02912364|Eslicarbazepine|eslicarbazepine
205402|NCT02912364|Carbamazepine|carbamazepine
205403|NCT02912364|cognition|cognition
205404|NCT02912351|Total Knee Arthroplasty|total knee arthroplasty
205405|NCT02912351|Total Knee Replacement|total knee replacement
205406|NCT02912351|Revision Knee Arthroplasty|revision knee arthroplasty
205407|NCT02912338|Sarcopenic obesity|sarcopenic obesity
205408|NCT02912338|Body composition|body composition
205409|NCT02912338|Physical function|physical function
205410|NCT02912338|quality of life|quality of life
205411|NCT02912338|long term care|long term care
205412|NCT02912312|Breast cancer|breast cancer
205413|NCT02912312|hypofractionation|hypofractionation
205414|NCT02912312|radiation therapy|radiation therapy
205415|NCT02912312|regional nodal irradiation|regional nodal irradiation
205416|NCT02912273|Geriatric assessment|geriatric assessment
205417|NCT02912247|tumor necrosis factor-a blocker|tumor necrosis factor-a blocker
205418|NCT02912247|pharmacokinetics|pharmacokinetics
205419|NCT02912247|safety|safety
205420|NCT02912169|Alzheimer's Disease|alzheimer's disease
205421|NCT02912169|Alzheimer's|alzheimer's
205422|NCT02912169|Stem cell|stem cell
205423|NCT02912169|Adipose-derived stem cells|adipose-derived stem cells
205424|NCT02912169|ASC|asc
205425|NCT02912169|ADSC|adsc
205426|NCT02912156|Pharmacokinetic|pharmacokinetic
205427|NCT02912130|Exercise|exercise
262650|NCT02564302|PVI|pvi
205428|NCT02912130|Nutrition|nutrition
205429|NCT02912130|Sarcopenia|sarcopenia
205430|NCT02912130|Healthy Ageing|healthy ageing
205431|NCT02912130|Elderly|elderly
205432|NCT02912130|Muscular Hypertrophy|muscular hypertrophy
205433|NCT02912104|primary ovarian insufficiency|primary ovarian insufficiency
205434|NCT02912104|premature ovarian failure|premature ovarian failure
205435|NCT02912104|Infertility|infertility
205436|NCT02912104|human amniotic epithelial cells transplantation|human amniotic epithelial cells transplantation
205437|NCT02912052|Perioperative Chemotherapy|perioperative chemotherapy
205438|NCT02912052|Postoperative Chemotherapy|postoperative chemotherapy
205439|NCT02912052|Colon Cancer|colon cancer
205440|NCT02912052|Resectable Liver Metastasis|resectable liver metastasis
205441|NCT02912000|Dental Health Services|dental health services
205442|NCT02912000|Sugar-Sweetened Beverages|sugar-sweetened beverages
205443|NCT02912000|Tobacco control|tobacco control
205444|NCT02912000|Pediatrics|pediatrics
205445|NCT02912000|Parents|parents
205446|NCT02911974|fine needle biopsy|fine needle biopsy
205447|NCT02911974|EUS|eus
205448|NCT02911974|solid pancreatic mass|solid pancreatic mass
205449|NCT02911896|physical function|physical function
205450|NCT02911896|critical care|critical care
205451|NCT02911857|Canakinumab,|canakinumab,
205452|NCT02911857|interleukin-1|interleukin-1
205453|NCT02911857|Periodic Fevers Syndrome|periodic fevers syndrome
205454|NCT02911857|TRAPS|traps
205455|NCT02911857|HIDS|hids
205456|NCT02911857|crFMF|crfmf
205457|NCT02911857|auto-inflammatory diseases|auto-inflammatory diseases
205458|NCT02911857|extension study|extension study
205459|NCT02911805|Exercise|exercise
205460|NCT02911805|Retinal Degeneration|retinal degeneration
205461|NCT02911805|Neuropharmacology|neuropharmacology
205462|NCT02911805|Brain-Derived Neurotrophic Factor|brain-derived neurotrophic factor
205463|NCT02911805|Biometry|biometry
205464|NCT02911805|Immunochemistry|immunochemistry
205465|NCT02911805|Molecular Biology|molecular biology
205466|NCT02911805|Neurosciences|neurosciences
205467|NCT02911805|Ophthalmology|ophthalmology
205468|NCT02911792|hyperfiltering|hyperfiltering
205469|NCT02911792|Type 2 Diabetes Mellitus|type 2 diabetes mellitus
205470|NCT02911766|Periodontal Index|periodontal index
205471|NCT02911727|Cesarean section|cesarean section
205472|NCT02911727|Postnatal Care|postnatal care
205473|NCT02911714|Kidney Transplantation|kidney transplantation
205474|NCT02911714|Delayed Graft Function|delayed graft function
205475|NCT02911714|Acute Allograft Rejection|acute allograft rejection
205476|NCT02911714|Acute Kidney Injury|acute kidney injury
205477|NCT02911597|Ketamine|ketamine
205478|NCT02911597|Naltrexone|naltrexone
205479|NCT02911597|Treatment-Resistant|treatment-resistant
205480|NCT02911597|TRD|trd
205481|NCT02911545|Atrial fibrillation|atrial fibrillation
205482|NCT02911545|Anticoagulation|anticoagulation
205483|NCT02911545|Cardioversion|cardioversion
205484|NCT02911532|pterygium|pterygium
205485|NCT02911532|tissue engineering|tissue engineering
205486|NCT02911532|atretoblepharia|atretoblepharia
205487|NCT02911519|Schizophrenia|schizophrenia
205488|NCT02911519|Patient Education|patient education
205489|NCT02911493|sedentary time|sedentary time
205490|NCT02911493|number of steps/day|number of steps/day
205494|NCT02911428|Ebola Virus Vaccines|ebola virus vaccines
205495|NCT02911428|Haemorrhagic Fever|haemorrhagic fever
205496|NCT02911428|Ebola Infection|ebola infection
205497|NCT02911428|GP protein, Ebola virus|gp protein, ebola virus
205498|NCT02911415|Ebola|ebola
205499|NCT02911415|Ebola Virus Vaccines|ebola virus vaccines
205500|NCT02911415|Haemorrhagic Fever|haemorrhagic fever
205501|NCT02911415|Ebola Infection|ebola infection
205502|NCT02911415|GP protein, Ebola virus|gp protein, ebola virus
205503|NCT02911311|conbercept|conbercept
205504|NCT02911311|anti-VEGF agent|anti-vegf agent
205505|NCT02911311|panretinal photocoagulation|panretinal photocoagulation
205506|NCT02911285|Alcohol|alcohol
205507|NCT02911285|PTSD|ptsd
205508|NCT02911285|Trauma|trauma
205509|NCT02911285|Veteran|veteran
205510|NCT02911285|Substance|substance
205511|NCT02911285|Drug|drug
205512|NCT02911285|Post Traumatic Stress Disorder|post traumatic stress disorder
205513|NCT02911285|Military|military
205514|NCT02911272|Partograph|partograph
205515|NCT02911272|Best action line|best action line
205516|NCT02911272|Prolonged labour prevention|prolonged labour prevention
205517|NCT02911207|chronic ill patients|chronic ill patients
205518|NCT02911207|Emotion management skill|emotion management skill
205519|NCT02911207|Quality of Life|quality of life
205520|NCT02911181|BIVA measurement|biva measurement
205521|NCT02911181|SNAQ score|snaq score
205522|NCT02911168|NERVE BLOCK|nerve block
205523|NCT02911168|ANESTHESIA RECOVERY PERIOD|anesthesia recovery period
205524|NCT02911168|PAIN MANAGEMENT|pain management
205525|NCT02911155|Cohort Study|cohort study
205526|NCT02911155|Radiation|radiation
205527|NCT02911155|Occupation|occupation
205528|NCT02911142|Treatment Naive|treatment naive
205529|NCT02911142|Immune Modulatory|immune modulatory
205530|NCT02911142|Chemotherapy|chemotherapy
205531|NCT02911142|AIDS-Related Lymphoma|aids-related lymphoma
205532|NCT02911142|PEL|pel
205533|NCT02911129|Chronic Stroke|chronic stroke
205534|NCT02911129|Neglect|neglect
205535|NCT02911129|Transcranial Magnetic Stimulation|transcranial magnetic stimulation
205536|NCT02911129|Visual and Motor Integration|visual and motor integration
205537|NCT02911129|Visual Fields|visual fields
205538|NCT02911116|Panuveitis|panuveitis
205539|NCT02911116|Intermediate Uveitis|intermediate uveitis
205540|NCT02911116|Uveitis|uveitis
205541|NCT02911103|Electrophysiology|electrophysiology
205542|NCT02911103|Neurosurgery|neurosurgery
205543|NCT02911103|Dystonia|dystonia
205544|NCT02911103|Deep Brain Stimulation|deep brain stimulation
205545|NCT02911090|Endometriosis|endometriosis
205546|NCT02911090|Chronic pelvic pain|chronic pelvic pain
205547|NCT02911090|Dyspareunia|dyspareunia
205548|NCT02911077|Bacteria|bacteria
205549|NCT02911064|Questionnaires|questionnaires
205550|NCT02911064|Surveys|surveys
205551|NCT02911064|Benign neoplasms|benign neoplasms
205552|NCT02911064|Malignant neoplasms of independent (primary) multiple sites|malignant neoplasms of independent (primary) multiple sites
205553|NCT02911064|Inpatient rehabilitation therapy|inpatient rehabilitation therapy
205554|NCT02911038|Complete denture|complete denture
205555|NCT02911038|PMMA|pmma
205556|NCT02911038|Stereolithography|stereolithography
205557|NCT02911025|epilepsy|epilepsy
205558|NCT02911025|sleep|sleep
205559|NCT02911025|antiepileptic drugs|antiepileptic drugs
205560|NCT02910986|Mammography|mammography
205561|NCT02910986|Breast Density|breast density
205562|NCT02910986|Hispanic|hispanic
205563|NCT02910973|Inflammation, Vagus Nerve Stimulation|inflammation, vagus nerve stimulation
205564|NCT02910960|fine needle biopsy|fine needle biopsy
205565|NCT02910960|EUS|eus
205566|NCT02910960|solid pancreatic mass|solid pancreatic mass
205567|NCT02910934|Indoor Residual Spray|indoor residual spray
205568|NCT02910934|IRS|irs
205569|NCT02910934|Insecticide Treated Net|insecticide treated net
205570|NCT02910934|LLIN|llin
205571|NCT02910934|ITN|itn
205572|NCT02910934|Long lasting insecticidal net|long lasting insecticidal net
205573|NCT02910921|Migraine|migraine
205574|NCT02910921|Prediction|prediction
205575|NCT02910921|Forecast|forecast
205576|NCT02910921|App|app
205577|NCT02910921|Fitbit|fitbit
205578|NCT02910921|Individual|individual
205579|NCT02910921|Algorithm|algorithm
205580|NCT02910921|Machine Learning|machine learning
205581|NCT02910921|Mayo Clinic|mayo clinic
205582|NCT02910921|Allergan|allergan
205583|NCT02910921|Second Opinion|second opinion
205584|NCT02910908|Elderly|elderly
205585|NCT02910908|ESRD prognosis|esrd prognosis
205586|NCT02910908|help decision making dialysis therapeutic project|help decision making dialysis therapeutic project
205587|NCT02910882|Pancreas Cancer|pancreas cancer
205588|NCT02910882|Unresectable|unresectable
205589|NCT02910882|Chemoradiation|chemoradiation
205590|NCT02910882|PEGPH20|pegph20
205591|NCT02910843|rectal cancer|rectal cancer
205592|NCT02910843|Neoadjuvant treatment|neoadjuvant treatment
205593|NCT02910843|Regorafenib|regorafenib
205594|NCT02910843|Capecitabine|capecitabine
205595|NCT02910843|locally advanced rectal cancer|locally advanced rectal cancer
205596|NCT02910843|Phase Ib trial|phase ib trial
205597|NCT02910804|GBM|gbm
205598|NCT02910804|GRPR|grpr
205599|NCT02910804|IRDye800|irdye800
205600|NCT02910804|NIRF|nirf
205601|NCT02910804|surgery|surgery
205602|NCT02910726|indocyanine green fluorescent dye|indocyanine green fluorescent dye
205603|NCT02910726|Technetium lymphoscintigraphy|technetium lymphoscintigraphy
205604|NCT02910726|sentinel lymph node biopsy|sentinel lymph node biopsy
205605|NCT02910726|16-1003|16-1003
205606|NCT02910687|Non ST Elevation Myocardial Infarction (NSTEMI)|non st elevation myocardial infarction (nstemi)
205607|NCT02910687|Elderly|elderly
205608|NCT02910687|Frailty|frailty
205609|NCT02910687|Prognostic value|prognostic value
205610|NCT02910661|Kidney Transplantation|kidney transplantation
205611|NCT02910648|healthy|healthy
205612|NCT02910648|BMI|bmi
205613|NCT02910648|weight loss|weight loss
205614|NCT02910648|sleep|sleep
205615|NCT02910648|healthy sleeper|healthy sleeper
205616|NCT02910648|overweight|overweight
205617|NCT02910648|obese|obese
205618|NCT02910635|Thorough QTc, Therapeutic dose, supra therapeutic dose|thorough qtc, therapeutic dose, supra therapeutic dose
205619|NCT02910622|breast|breast
205620|NCT02910622|ovarian|ovarian
205621|NCT02910622|cancer|cancer
205622|NCT02910609|preterm|preterm
205623|NCT02910609|patent ductus arterioles|patent ductus arterioles
205624|NCT02910609|treatment|treatment
205625|NCT02910557|CTCAE - Common Terminology Criteria for Adverse Events|ctcae - common terminology criteria for adverse events
205626|NCT02910557|eCRF - electronic case report form|ecrf - electronic case report form
205627|NCT02910557|ECOG - Eastern Cooperative Oncology Group|ecog - eastern cooperative oncology group
205628|NCT02910557|EDC - electronic data capture|edc - electronic data capture
400621|NCT01866007|UltraSafe Passive Delivery System (PFS-U)|ultrasafe passive delivery system (pfs-u)
262894|NCT02562872|Human|human
205629|NCT02910557|GM-CSF - human granulocyte macrophage colony-stimulating factor|gm-csf - human granulocyte macrophage colony-stimulating factor
205630|NCT02910557|HCP - health care provider|hcp - health care provider
205631|NCT02910557|HSV-1 - herpes simplex virus type 1|hsv-1 - herpes simplex virus type 1
205632|NCT02910557|ICF - informed consent form|icf - informed consent form
205633|NCT02910557|ICP - infected cell protein|icp - infected cell protein
205634|NCT02910557|IEC - Independent Ethics Committee|iec - independent ethics committee
205635|NCT02910557|IRB - Institutional Review Board|irb - institutional review board
205636|NCT02910557|MedDRA - Medical Dictionary for Regulatory Activities|meddra - medical dictionary for regulatory activities
205637|NCT02910557|PFU - plaque-forming unit|pfu - plaque-forming unit
205638|NCT02910557|qPCR - quantitative polymerase chain reaction|qpcr - quantitative polymerase chain reaction
205639|NCT02910557|SmPC - Summary of Product Characteristics|smpc - summary of product characteristics
205640|NCT02910557|USPI - United States Prescribing Information|uspi - united states prescribing information
205641|NCT02910531|Cystinuria|cystinuria
205642|NCT02910531|Kidney stone|kidney stone
205643|NCT02910531|Alpha lipoic acid|alpha lipoic acid
205644|NCT02910479|Body Temperature|body temperature
205645|NCT02910479|Thermometers|thermometers
205646|NCT02910453|Pulmonary lobectomy|pulmonary lobectomy
205647|NCT02910453|Video-Assisted Thoracic Surgery|video-assisted thoracic surgery
205648|NCT02910453|Opto-electronic plethysmography|opto-electronic plethysmography
205649|NCT02910453|Posterolateral thoracotomy|posterolateral thoracotomy
205650|NCT02910427|stroke|stroke
205651|NCT02910427|potassium and magnesium-enriched salt|potassium and magnesium-enriched salt
205652|NCT02910427|neurological performance|neurological performance
205653|NCT02910414|Renal Denervation|renal denervation
205654|NCT02910414|Alcohol|alcohol
205655|NCT02910388|conization|conization
205656|NCT02910388|LLETZ|lletz
205657|NCT02910388|loop excision|loop excision
205658|NCT02910388|randomized controlled trial|randomized controlled trial
205659|NCT02910388|colposcopy|colposcopy
205660|NCT02910388|direct colposcopic vision|direct colposcopic vision
205661|NCT02910388|intraoperative colposcopy|intraoperative colposcopy
205662|NCT02910375|golimumab|golimumab
205663|NCT02910375|drug monitoring|drug monitoring
205664|NCT02910375|home based care|home based care
205665|NCT02910349|valvular hear disease|valvular hear disease
205666|NCT02910349|echocardiography|echocardiography
205667|NCT02910349|magnetic resonance|magnetic resonance
205668|NCT02910349|global longitudinal strain|global longitudinal strain
205669|NCT02910349|T1 relaxation time|t1 relaxation time
205670|NCT02910310|Uterine Balloon Tamponade|uterine balloon tamponade
205671|NCT02910297|cannabidiol|cannabidiol
205672|NCT02910297|Dravet Syndrome|dravet syndrome
205673|NCT02910297|Lennox Gastaut Syndrome|lennox gastaut syndrome
205674|NCT02910284|HSV|hsv
205675|NCT02910284|Herpes|herpes
205676|NCT02910284|Genital Herpes|genital herpes
205677|NCT02910258|myelofibrosis|myelofibrosis
205678|NCT02910258|pegylated interferon|pegylated interferon
205679|NCT02910245|Therapeutic Drug Monitoring|therapeutic drug monitoring
205680|NCT02910245|Mercaptopurine (6-MP)|mercaptopurine (6-mp)
205681|NCT02910245|Thiopurine|thiopurine
205682|NCT02910245|Efficacy|efficacy
205683|NCT02910232|Rice starch|rice starch
205684|NCT02910232|Porous composite|porous composite
205685|NCT02910232|Biomaterial|biomaterial
205686|NCT02910232|Bone regeneration|bone regeneration
205687|NCT02910232|Clinical trial|clinical trial
205688|NCT02910232|Hydroxyapatite|hydroxyapatite
205689|NCT02910219|HER2|her2
205690|NCT02910219|pertuzumab|pertuzumab
205691|NCT02910219|trastuzumab|trastuzumab
205692|NCT02910219|docetaxel|docetaxel
205693|NCT02910219|paclitaxel|paclitaxel
205694|NCT02910219|carboplatin|carboplatin
205695|NCT02910219|crofelemer|crofelemer
205696|NCT02910219|chemotherapy induced diarrhea|chemotherapy induced diarrhea
205697|NCT02910206|etomidate|etomidate
205698|NCT02910206|propofol|propofol
205699|NCT02910193|alcoholism|alcoholism
205700|NCT02910193|genetics|genetics
205701|NCT02910193|functional MRI|functional mri
205702|NCT02910193|structural MRI|structural mri
205703|NCT02910193|first-degree relatives|first-degree relatives
205704|NCT02910180|Tissue Repository|tissue repository
205705|NCT02910180|Cerebrovascular Diseases|cerebrovascular diseases
205706|NCT02910180|Stroke|stroke
205707|NCT02910180|Aneurysm|aneurysm
205708|NCT02910180|Arteriovenous malformation|arteriovenous malformation
205709|NCT02910180|Fistula|fistula
205710|NCT02910180|Intracranial Stenosis|intracranial stenosis
205711|NCT02910180|Treatment|treatment
205712|NCT02910180|Registry|registry
205713|NCT02910180|Outcomes|outcomes
205714|NCT02910141|Type 2 diabetes|type 2 diabetes
205715|NCT02910141|Continuous subcutaneous insulin infusion|continuous subcutaneous insulin infusion
205716|NCT02910141|Meta-analysis|meta-analysis
205717|NCT02910141|Insulin pump therapy|insulin pump therapy
205718|NCT02910141|Multiple daily insulin injections|multiple daily insulin injections
205719|NCT02910102|RVT-101|rvt-101
205720|NCT02910102|intepirdine|intepirdine
205721|NCT02910102|Alzheimer's disease|alzheimer's disease
205722|NCT02910102|Dementia with Lewy bodies|dementia with lewy bodies
205723|NCT02910102|Lewy body dementia|lewy body dementia
205724|NCT02910102|Parkinson's Disease Dementia|parkinson's disease dementia
205725|NCT02910089|Diabetes Mellitus Type 2|diabetes mellitus type 2
205726|NCT02910063|Relapsed/Refractory Aggressive B-Cell Non Hodgkin Lymphoma|relapsed/refractory aggressive b-cell non hodgkin lymphoma
205727|NCT02910063|Blinatumomab|blinatumomab
205728|NCT02910063|Leukemia|leukemia
205729|NCT02910063|Standard of Care|standard of care
205730|NCT02910063|SOC|soc
205731|NCT02910063|Cancer|cancer
205732|NCT02910063|Chemotherapy|chemotherapy
205733|NCT02910050|androgen receptor|androgen receptor
205734|NCT02910050|bicalutamide|bicalutamide
205735|NCT02910050|aromatase inhibitors|aromatase inhibitors
205736|NCT02910050|advanced breast cancer|advanced breast cancer
205737|NCT02910050|letrozole|letrozole
205738|NCT02910050|anastrozole|anastrozole
205739|NCT02910050|exemestane|exemestane
205740|NCT02910037|metagenomic next-generation sequencing|metagenomic next-generation sequencing
205741|NCT02910037|microbiological diagnosis|microbiological diagnosis
205742|NCT02910037|bacterial infections|bacterial infections
205743|NCT02910037|viral infections|viral infections
205744|NCT02910037|fungal infections|fungal infections
205745|NCT02910037|parasitic infections|parasitic infections
205746|NCT02909998|Biomarkers|biomarkers
205747|NCT02909998|Genetic|genetic
205748|NCT02909998|Chronic arthritis|chronic arthritis
205749|NCT02909998|Treatment|treatment
205750|NCT02909985|Infrared|infrared
205751|NCT02909985|Dark Adaptation|dark adaptation
205752|NCT02909985|Vision|vision
205753|NCT02909985|Scotopic Threshold Response|scotopic threshold response
205754|NCT02909985|Transient Receptor Potential (TRP) Channels|transient receptor potential (trp) channels
205755|NCT02909985|Human|human
205756|NCT02909959|sulforaphane|sulforaphane
205757|NCT02909959|glucoraphanin|glucoraphanin
205758|NCT02909959|physiologic effects of drugs|physiologic effects of drugs
205759|NCT02909946|multidrug-resistant organisms|multidrug-resistant organisms
205760|NCT02909946|nursing home|nursing home
205761|NCT02909946|post-acute care|post-acute care
205762|NCT02909946|long-term care|long-term care
205763|NCT02909946|infection control|infection control
205764|NCT02909920|Telerehabilitation|telerehabilitation
205765|NCT02909920|Physiotherapy|physiotherapy
205766|NCT02909920|Surgery|surgery
205767|NCT02909920|Telemedicine|telemedicine
205768|NCT02909894|Sedentary behaviour|sedentary behaviour
205769|NCT02909894|Postprandial glycaemic response|postprandial glycaemic response
205770|NCT02909881|polysaccharide|polysaccharide
205771|NCT02909881|oxidation|oxidation
205772|NCT02909881|endurance exercise|endurance exercise
205773|NCT02909855|children|children
205774|NCT02909855|psychological predictors|psychological predictors
205775|NCT02909855|side-effects|side-effects
205776|NCT02909855|vaccination|vaccination
205777|NCT02909842|influenza|influenza
205778|NCT02909842|vaccine|vaccine
205779|NCT02909842|probiotic|probiotic
205780|NCT02909842|immune response|immune response
205781|NCT02909829|Diabetes Mellitus, Type 1|diabetes mellitus, type 1
205782|NCT02909829|Artificial Pancreas|artificial pancreas
205783|NCT02909829|Closed-Loop Delivery|closed-loop delivery
205784|NCT02909829|Insulin|insulin
205785|NCT02909829|Adolescent|adolescent
205786|NCT02909829|Missed Bolus|missed bolus
205787|NCT02909803|glucose|glucose
205788|NCT02909803|glycemic index|glycemic index
205789|NCT02909803|lentil|lentil
205790|NCT02909803|polyphenols|polyphenols
205791|NCT02909803|metabolites|metabolites
206093|NCT02907788|Neutrophils|neutrophils
205792|NCT02909803|bioavailability|bioavailability
205793|NCT02909777|Lymphoma|lymphoma
205794|NCT02909777|Neuroblastoma|neuroblastoma
205795|NCT02909777|Brain Tumor|brain tumor
205796|NCT02909777|Solid Tumor|solid tumor
205797|NCT02909764|Salty taste|salty taste
205798|NCT02909764|Psychophysics|psychophysics
205799|NCT02909764|Genetics|genetics
205802|NCT02909725|Physical activity|physical activity
205803|NCT02909725|Sedentary time|sedentary time
205804|NCT02909725|Pregnancy|pregnancy
205805|NCT02909725|Pregnant women|pregnant women
205806|NCT02909725|Weight gain|weight gain
205807|NCT02909712|sub-Saharan|sub-saharan
205808|NCT02909712|dihydroartemisinin|dihydroartemisinin
205809|NCT02909712|piperaquine|piperaquine
205810|NCT02909712|sulphadoxine-pyrimethamine|sulphadoxine-pyrimethamine
205811|NCT02909712|antimalarials|antimalarials
205812|NCT02909686|Gulf War Syndrome|gulf war syndrome
205813|NCT02909686|Chronic Multisymptom Illnesses|chronic multisymptom illnesses
205814|NCT02909686|Medically Unexplained Illnesses|medically unexplained illnesses
205815|NCT02909673|adolescent behavior|adolescent behavior
205816|NCT02909673|intimate partner violence|intimate partner violence
205817|NCT02909673|youth risk behavior|youth risk behavior
205818|NCT02909673|violence prevention|violence prevention
205819|NCT02909673|teen dating violence|teen dating violence
205820|NCT02909621|OsteoArthritis; FLEXOFYTOL®; Curcuma; biomarkers|osteoarthritis; flexofytol®; curcuma; biomarkers
205821|NCT02909556|Transcatheter Aortic Valve Replacement|transcatheter aortic valve replacement
205822|NCT02909556|TAVI|tavi
205823|NCT02909556|Transcatheter Aortic Valve Implant|transcatheter aortic valve implant
205824|NCT02909556|Transfemoral access|transfemoral access
205825|NCT02909530|Endoscopic ultrasound-guided fine needle biopsy|endoscopic ultrasound-guided fine needle biopsy
205826|NCT02909530|Olympus EZ Shot 3Plus|olympus ez shot 3plus
205827|NCT02909530|Olympus EZ Shot 2|olympus ez shot 2
205828|NCT02909452|entinostat|entinostat
205829|NCT02909452|pembrolizumab|pembrolizumab
205830|NCT02909452|solid tumor|solid tumor
205831|NCT02909452|Histone Deacetylase Inhibitor|histone deacetylase inhibitor
205832|NCT02909426|Screening|screening
205833|NCT02909426|Digital mammography|digital mammography
205834|NCT02909426|Ultrasonography|ultrasonography
205835|NCT02909426|Sensitivity|sensitivity
205836|NCT02909426|Specificity|specificity
205837|NCT02909413|desflurane|desflurane
205838|NCT02909413|sevoflurane|sevoflurane
205839|NCT02909400|mitochondrial|mitochondrial
205840|NCT02909400|oxidative phosphorylation (oxphos)|oxidative phosphorylation (oxphos)
205841|NCT02909400|MELAS|melas
205842|NCT02909400|MIDD|midd
205843|NCT02909400|KH176|kh176
205844|NCT02909400|Proof of Concept|proof of concept
205845|NCT02909387|Epilepsy|epilepsy
205846|NCT02909387|Seizure Disorder|seizure disorder
205847|NCT02909374|Implementation|implementation
205848|NCT02909374|fall prevention|fall prevention
205849|NCT02909374|balance training|balance training
205850|NCT02909348|Neoplasms|neoplasms
205851|NCT02909348|Melanoma|melanoma
205852|NCT02909348|Immunotherapy|immunotherapy
205853|NCT02909348|Biomarkers|biomarkers
205854|NCT02909309|Propofol|propofol
205855|NCT02909309|Deep Sedation|deep sedation
205856|NCT02909309|Anoxia|anoxia
205857|NCT02909309|Hypercapnia|hypercapnia
205858|NCT02909231|Patient Outcome Assessment|patient outcome assessment
205859|NCT02909218|HIV/AIDS, Swaziland|hiv/aids, swaziland
205860|NCT02909205|child|child
205861|NCT02909205|gastrostomy|gastrostomy
205862|NCT02909205|supportive care|supportive care
205863|NCT02909205|educational program|educational program
205864|NCT02909192|Parkinson's Disease|parkinson's disease
205865|NCT02909192|Excessive Daytime Sleepiness|excessive daytime sleepiness
205866|NCT02909192|Circadian Rhythms|circadian rhythms
205867|NCT02909192|Light Therapy|light therapy
205868|NCT02909179|Community Health Workers, mHealth, mobile phones, ANC, PNC, essential newborn care|community health workers, mhealth, mobile phones, anc, pnc, essential newborn care
205869|NCT02909153|Triferic|triferic
205870|NCT02909153|ferric pyrophosphate citrate (FPC)|ferric pyrophosphate citrate (fpc)
205871|NCT02909153|peritoneal dialysis|peritoneal dialysis
205872|NCT02909153|anemia|anemia
205873|NCT02909153|chronic kidney disease|chronic kidney disease
205874|NCT02909127|deglutition|deglutition
205875|NCT02909127|deglutition disorders|deglutition disorders
205876|NCT02909127|pediatric dysphagia|pediatric dysphagia
205877|NCT02909127|swallowing|swallowing
205878|NCT02909114|stereotactic boday radiotherapy, oligometastases|stereotactic boday radiotherapy, oligometastases
205879|NCT02909101|Working memory|working memory
205880|NCT02909101|cognitive training|cognitive training
205881|NCT02909101|HIV|hiv
205882|NCT02909101|substance abuse|substance abuse
205883|NCT02909088|stuttering|stuttering
205884|NCT02909088|childhood onset fluency disorder|childhood onset fluency disorder
205885|NCT02909088|ecopipam|ecopipam
205886|NCT02909075|PET/CT|pet/ct
205887|NCT02909075|MRI|mri
205888|NCT02909075|Assess Thymic Function|assess thymic function
205889|NCT02909075|16-1244|16-1244
205890|NCT02909062|Electronic Activity Monitoring (EAM)|electronic activity monitoring (eam)
205891|NCT02909062|16-493|16-493
205892|NCT02909049|Prostate Biopsy|prostate biopsy
205893|NCT02909049|Local Anesthesia|local anesthesia
205895|NCT02909049|Biopsy of prostate|biopsy of prostate
205896|NCT02909036|Melphalan|melphalan
205897|NCT02909036|Autologous Hematopoietic Progenitor Cell Transplant|autologous hematopoietic progenitor cell transplant
205898|NCT02909036|High Dose Therapy|high dose therapy
205899|NCT02909036|16-875|16-875
205900|NCT02909023|Hepatitis B Virus|hepatitis b virus
205901|NCT02909023|Elispot test|elispot test
205902|NCT02909023|T cellular immune response|t cellular immune response
205903|NCT02908984|unilateral headache|unilateral headache
205904|NCT02908984|cervical pain|cervical pain
205905|NCT02908984|neck pain|neck pain
205906|NCT02908984|rehabilitation|rehabilitation
205907|NCT02908984|structural brain changes|structural brain changes
205908|NCT02908984|surface based volumetry|surface based volumetry
205909|NCT02908984|diffusion tensor imaging|diffusion tensor imaging
205910|NCT02908984|functional brain changes|functional brain changes
205911|NCT02908971|soy based formula|soy based formula
205912|NCT02908971|overweight|overweight
205913|NCT02908971|adrenarche,|adrenarche,
205914|NCT02908971|gonadarache|gonadarache
205915|NCT02908945|Ketamine|ketamine
205916|NCT02908945|Anesthesia|anesthesia
205917|NCT02908945|EEG|eeg
205918|NCT02908945|NeuroSENSE|neurosense
205919|NCT02908945|Pain|pain
205920|NCT02908919|Colonoscopy|colonoscopy
205921|NCT02908919|Picosulfate sodium|picosulfate sodium
205922|NCT02908919|Polyethylene glycol|polyethylene glycol
205923|NCT02908919|Magnesium citrate|magnesium citrate
205924|NCT02908919|Ascorbic acid|ascorbic acid
205925|NCT02908919|SPMC (solution picosulfate + magnesium citrate)|spmc (solution picosulfate + magnesium citrate)
205926|NCT02908919|PEGA (Polyethylene glycol + ascorbic acid)|pega (polyethylene glycol + ascorbic acid)
205927|NCT02908880|MANTA|manta
205928|NCT02908880|Arterial Closure Device|arterial closure device
205929|NCT02908880|Large Bore Closure Device|large bore closure device
205930|NCT02908867|Sexuality|sexuality
205931|NCT02908867|Spinal cord injuries|spinal cord injuries
205932|NCT02908867|Complementary Therapies|complementary therapies
205933|NCT02908867|Medicinal plants|medicinal plants
205934|NCT02908854|Spices|spices
205935|NCT02908854|Herbs|herbs
205936|NCT02908854|Vegetables|vegetables
205937|NCT02908854|National School Lunch Program|national school lunch program
205938|NCT02908854|High school|high school
205939|NCT02908828|Biological Products/therapeutic use|biological products/therapeutic use
205940|NCT02908828|Copepoda|copepoda
205941|NCT02908828|Dietary Supplements|dietary supplements
205942|NCT02908828|Fish Oils|fish oils
205943|NCT02908828|Fatty Acids, Omega-3|fatty acids, omega-3
205944|NCT02908828|Oxygen Consumption|oxygen consumption
205945|NCT02908828|Calanus|calanus
205946|NCT02908828|Maximal oxygen uptake|maximal oxygen uptake
205947|NCT02908828|Zooplankton|zooplankton
205948|NCT02908789|Photochemotherapy|photochemotherapy
205949|NCT02908763|Chronic Hepatitis B|chronic hepatitis b
205950|NCT02908763|Peginterferon Alpha|peginterferon alpha
205951|NCT02908750|oncology|oncology
205952|NCT02908750|cancer|cancer
205953|NCT02908750|non small cell lung cancer|non small cell lung cancer
205954|NCT02908750|anticancer drug|anticancer drug
205955|NCT02908750|lung neoplasms|lung neoplasms
205956|NCT02908750|pharmacokinetics|pharmacokinetics
205957|NCT02908750|AZD9291|azd9291
205958|NCT02908750|osimertinib|osimertinib
205959|NCT02908750|fexofenadine|fexofenadine
205960|NCT02908750|TAGRISSO™|tagrisso™
205961|NCT02908750|EGFR genes|egfr genes
205962|NCT02908724|Familial cardiomyopathies|familial cardiomyopathies
205963|NCT02908724|Hypertrophic cardiomyopathy|hypertrophic cardiomyopathy
205964|NCT02908724|Left ventricular hypertrophy|left ventricular hypertrophy
205965|NCT02908659|intensive care unit|intensive care unit
205966|NCT02908659|patient's monitoring|patient's monitoring
205967|NCT02908659|respiratory rate|respiratory rate
205968|NCT02908633|open angle glaucoma|open angle glaucoma
205969|NCT02908633|canaloplasty|canaloplasty
205970|NCT02908633|migs|migs
205971|NCT02908633|abic|abic
205972|NCT02908594|Nursing|nursing
205973|NCT02908594|ESRD|esrd
205974|NCT02908594|hemodialysis|hemodialysis
205975|NCT02908594|intradialytic exercise|intradialytic exercise
205976|NCT02908594|depression|depression
205977|NCT02908594|fatigue|fatigue
205978|NCT02908594|Quality Of Life|quality of life
205979|NCT02908594|self-efficacy|self-efficacy
205980|NCT02908594|resilience|resilience
205981|NCT02908568|mandibular stretching, trigeminocardiac reflex|mandibular stretching, trigeminocardiac reflex
205982|NCT02908555|type 1 diabetes|type 1 diabetes
205983|NCT02908555|adolescents|adolescents
205984|NCT02908555|sleep|sleep
205985|NCT02908490|Arthritis, Rheumatoid|arthritis, rheumatoid
205986|NCT02908490|Atherosclerosis|atherosclerosis
205987|NCT02908464|Cardiac Surgery|cardiac surgery
205988|NCT02908464|Delirium|delirium
205989|NCT02908464|Postoperative Cognitive Dysfunction|postoperative cognitive dysfunction
205990|NCT02908451|Cancer|cancer
205991|NCT02908451|Antibody Drug Conjugate|antibody drug conjugate
205992|NCT02908451|AbGn-107|abgn-107
205993|NCT02908451|Adenocarcinoma|adenocarcinoma
205994|NCT02908451|Gastric|gastric
205995|NCT02908451|Colorectal|colorectal
205996|NCT02908451|Pancreatic|pancreatic
205997|NCT02908451|biliary|biliary
205998|NCT02908451|cholangiocarcinoma|cholangiocarcinoma
205999|NCT02908451|gallbladder|gallbladder
206000|NCT02908451|ampullary carcinomas|ampullary carcinomas
206001|NCT02908412|Nerve Block|nerve block
206002|NCT02908412|Spectrophotometry|spectrophotometry
206003|NCT02908412|Bupivacaine|bupivacaine
206004|NCT02908412|Spinal Surgery|spinal surgery
206005|NCT02908412|Blood Loss, Surgical|blood loss, surgical
206006|NCT02908386|Head and neck tumors|head and neck tumors
206007|NCT02908386|Proton|proton
206008|NCT02908386|Photon|photon
206009|NCT02908386|replanning timing|replanning timing
206010|NCT02908373|risk management|risk management
206011|NCT02908373|nursing home|nursing home
206012|NCT02908373|elderly|elderly
206013|NCT02908373|care|care
206014|NCT02908360|Double positive lymphocyte T F prausnitzii|double positive lymphocyte t f prausnitzii
206015|NCT02908347|Plaque psoriasis|plaque psoriasis
206016|NCT02908347|chronic|chronic
206017|NCT02908347|moderate|moderate
206018|NCT02908347|severe|severe
206019|NCT02908347|Plaque|plaque
206020|NCT02908308|Induced hypothermia|induced hypothermia
206021|NCT02908308|Mild induced hypothermia|mild induced hypothermia
714048|NCT00573235|infection|infection
206022|NCT02908308|Therapeutic hypothermia|therapeutic hypothermia
206023|NCT02908308|Cardiac arrest|cardiac arrest
206270|NCT02906657|Elderly|elderly
206024|NCT02908308|Out-of-hospital cardiac arrest|out-of-hospital cardiac arrest
206025|NCT02908308|Mortality|mortality
206026|NCT02908308|Neurological function|neurological function
206027|NCT02908308|Randomised clinical trial|randomised clinical trial
206028|NCT02908282|tear film|tear film
206029|NCT02908282|omega-3 fatty acids|omega-3 fatty acids
206030|NCT02908282|eye drops|eye drops
206031|NCT02908269|Influenza|influenza
206032|NCT02908269|Fluzone® Quadrivalent, Influenza Vaccine (2016-2017 formulation)|fluzone® quadrivalent, influenza vaccine (2016-2017 formulation)
206033|NCT02908269|Fluzone® High-Dose, Influenza Vaccine (2016-2017 formulation)|fluzone® high-dose, influenza vaccine (2016-2017 formulation)
206034|NCT02908256|PVI|pvi
206035|NCT02908256|delta PP|delta pp
206036|NCT02908256|vascular filling|vascular filling
206037|NCT02908243|Hemophilia|hemophilia
206038|NCT02908243|Primary prophylaxis|primary prophylaxis
206039|NCT02908243|Pettersson Score|pettersson score
206040|NCT02908243|Joint function study|joint function study
206041|NCT02908243|Comorbidity|comorbidity
206042|NCT02908217|Polymyalgia Rheumatica|polymyalgia rheumatica
206043|NCT02908217|Tocilizumab|tocilizumab
206044|NCT02908217|Glucocorticoid|glucocorticoid
206045|NCT02908204|superficial esophageal squamous cell carcinoma|superficial esophageal squamous cell carcinoma
206046|NCT02908204|efficacy|efficacy
206047|NCT02908204|survival|survival
206048|NCT02908178|ductal carcinoma in situ (DCIS)|ductal carcinoma in situ (dcis)
206049|NCT02908178|sentinel lymph node biopsy (SLNB)|sentinel lymph node biopsy (slnb)
206050|NCT02908087|Diabetes Type 1|diabetes type 1
206051|NCT02908087|Diabetes, Insulin-Dependent|diabetes, insulin-dependent
206052|NCT02908087|Liraglutide|liraglutide
206053|NCT02908087|GLP-1 Analogue|glp-1 analogue
206054|NCT02908087|Early diagnosis|early diagnosis
206055|NCT02908074|Hypogonadotropic|hypogonadotropic
206056|NCT02908074|hypogonadism|hypogonadism
206057|NCT02908074|testosterone|testosterone
206058|NCT02908061|Mesh Placement|mesh placement
206059|NCT02908061|Radical Cystectomy|radical cystectomy
206060|NCT02908061|16-1285|16-1285
206061|NCT02908048|liver cancer|liver cancer
206062|NCT02908048|cholangiocarcinoma (CCA)|cholangiocarcinoma (cca)
206063|NCT02908048|cirrhosis|cirrhosis
206064|NCT02908048|hepatitis|hepatitis
206065|NCT02908048|bile duct cancer|bile duct cancer
206066|NCT02908048|hepatocellular carcinoma (HCC)|hepatocellular carcinoma (hcc)
206067|NCT02908048|hepatobiliary carcinoma|hepatobiliary carcinoma
206068|NCT02908048|hepatoma|hepatoma
206069|NCT02908048|liver mass|liver mass
206070|NCT02907983|Menopause|menopause
206071|NCT02907983|Post-menopausal|post-menopausal
206072|NCT02907970|Cervical cancer|cervical cancer
206073|NCT02907970|Screening|screening
206074|NCT02907970|Barriers|barriers
206075|NCT02907931|hemodynamics|hemodynamics
206076|NCT02907931|ultrasonography|ultrasonography
206077|NCT02907879|Subarachnoid Hemorrhage|subarachnoid hemorrhage
206078|NCT02907879|Ultrasound perfusion imaging|ultrasound perfusion imaging
206079|NCT02907879|cerebral hypoperfusion|cerebral hypoperfusion
206080|NCT02907879|vasospasm|vasospasm
206081|NCT02907879|DIND|dind
206082|NCT02907879|infarction|infarction
206083|NCT02907827|complete remission|complete remission
206084|NCT02907827|cfDNA|cfdna
206085|NCT02907827|DW-MRI|dw-mri
206086|NCT02907827|surveillance|surveillance
206087|NCT02907814|Uveitis|uveitis
206088|NCT02907814|Optical Coherence Tomography|optical coherence tomography
206089|NCT02907801|congenital muscular torticollis|congenital muscular torticollis
206090|NCT02907801|infants|infants
206091|NCT02907801|perception-action approach|perception-action approach
206092|NCT02907788|Cystic fibrosis|cystic fibrosis
206094|NCT02907788|PMN|pmn
206095|NCT02907788|Inflammation|inflammation
206096|NCT02907788|Lung disease|lung disease
206097|NCT02907788|PRAGMA|pragma
206098|NCT02907762|Endovascular|endovascular
206099|NCT02907762|EVAR|evar
206100|NCT02907762|Neck Angulation|neck angulation
206101|NCT02907710|Nasopharyngeal carcinoma|nasopharyngeal carcinoma
206102|NCT02907710|endostar|endostar
206103|NCT02907710|chemoradiotherapy|chemoradiotherapy
206104|NCT02907697|HIV/AIDS|hiv/aids
206105|NCT02907697|adherence|adherence
206106|NCT02907697|substance use|substance use
206107|NCT02907697|HIV care continuum|hiv care continuum
206108|NCT02907684|Cardiovascular disease|cardiovascular disease
206109|NCT02907684|Non alcoholic fatty liver|non alcoholic fatty liver
206110|NCT02907684|Diabetes|diabetes
206111|NCT02907684|Almonds|almonds
206112|NCT02907684|Endothelium-dependent vasodilation|endothelium-dependent vasodilation
206113|NCT02907684|Fecal short chain fatty acids (SCFAs)|fecal short chain fatty acids (scfas)
206114|NCT02907684|Snacking|snacking
206115|NCT02907671|carpal tunnel injection|carpal tunnel injection
206116|NCT02907671|corticosteroid|corticosteroid
206117|NCT02907671|ultrasound-guided|ultrasound-guided
206118|NCT02907671|musculoskeletal ultrasound|musculoskeletal ultrasound
206119|NCT02907658|Internet Use Disorder|internet use disorder
206120|NCT02907658|Internet Gaming Disorder|internet gaming disorder
206121|NCT02907658|Cognitive-Behavioral Intervention|cognitive-behavioral intervention
206122|NCT02907658|Indicated Prevention|indicated prevention
206123|NCT02907658|Adolescents|adolescents
206124|NCT02907658|Internet Addiction|internet addiction
206125|NCT02907632|Metoclopramide|metoclopramide
206126|NCT02907632|Pro kinetic|pro kinetic
206127|NCT02907632|Gastroesophageal Reflux|gastroesophageal reflux
206128|NCT02907632|Premature Infant|premature infant
206129|NCT02907632|Low Birth Weight|low birth weight
206130|NCT02907632|Kangaroo Mother Care Method|kangaroo mother care method
206131|NCT02907619|Duchenne muscular dystrophy, myostatin, open-label|duchenne muscular dystrophy, myostatin, open-label
206132|NCT02907606|Non-small-cell Lung Cancer|non-small-cell lung cancer
206133|NCT02907606|circulating tumor DNA|circulating tumor dna
206134|NCT02907606|urine|urine
206135|NCT02907593|Bronchopulmonary dysplasia|bronchopulmonary dysplasia
206136|NCT02907593|Pulmonary|pulmonary
206137|NCT02907593|Surfactant|surfactant
206138|NCT02907593|Steroids|steroids
206139|NCT02907593|Extremely low gestational age|extremely low gestational age
206140|NCT02907580|influenza|influenza
206141|NCT02907580|vaccination|vaccination
206142|NCT02907554|Preconditioning|preconditioning
206143|NCT02907554|Tissue and organ procurement|tissue and organ procurement
206144|NCT02907554|Cyclosporine A|cyclosporine a
206145|NCT02907554|Kidney transplantation|kidney transplantation
206146|NCT02907554|Delayed graft function|delayed graft function
206147|NCT02907541|eLearning|elearning
206148|NCT02907541|Quality Improvement Methods|quality improvement methods
206149|NCT02907541|Knowledge Transfer|knowledge transfer
206150|NCT02907541|Impact of learning|impact of learning
206151|NCT02907515|single implant retained mandibular overdenture|single implant retained mandibular overdenture
206152|NCT02907489|post operative pain|post operative pain
206153|NCT02907489|triple antibiotic paste|triple antibiotic paste
206154|NCT02907489|intracanal medication|intracanal medication
206155|NCT02907476|Vagal-gamma amino-butyric acid (GABA)|vagal-gamma amino-butyric acid (gaba)
206156|NCT02907476|Yoga|yoga
206157|NCT02907476|Walking|walking
206158|NCT02907463|Aortic Valve Replacement|aortic valve replacement
206159|NCT02907463|Aortic Stenosis|aortic stenosis
206160|NCT02907463|EDWARDS INTUITY Elite|edwards intuity elite
206161|NCT02907463|Rapid deployment valves|rapid deployment valves
206162|NCT02907437|Minocycline|minocycline
206163|NCT02907437|Negative symptoms|negative symptoms
206164|NCT02907437|Cognitive symptoms|cognitive symptoms
206165|NCT02907437|Inflammation|inflammation
206166|NCT02907411|Quadrivas|quadrivas
206167|NCT02907411|Veins|veins
206168|NCT02907411|Lipedema|lipedema
206169|NCT02907411|Lymphedema|lymphedema
206170|NCT02907398|Neurostimulation|neurostimulation
206171|NCT02907398|Hypoglossal nerve|hypoglossal nerve
206172|NCT02907398|Tongue|tongue
206173|NCT02907398|Upper airway stimulation|upper airway stimulation
206174|NCT02907398|Surgery|surgery
206175|NCT02907385|Rectal Cancer|rectal cancer
206176|NCT02907385|Low Anterior Resection|low anterior resection
206177|NCT02907385|LifeSeal|lifeseal
206178|NCT02907385|Surgical Sealant|surgical sealant
206179|NCT02907372|cognitive dysfunctions|cognitive dysfunctions
206180|NCT02907372|cognitive complaints|cognitive complaints
206181|NCT02907372|metastatic prostate cancer|metastatic prostate cancer
206182|NCT02907372|new generations of hormone-therapy|new generations of hormone-therapy
206183|NCT02907333|Condom use|condom use
206184|NCT02907333|Human Papillomavirus|human papillomavirus
206185|NCT02907333|Conization|conization
206186|NCT02907307|LactiSal|lactisal
206187|NCT02907307|Vaginal therapy|vaginal therapy
206188|NCT02907294|PDE10 inhibitor|pde10 inhibitor
206189|NCT02907294|phosphodiesterase 10 inhibitor|phosphodiesterase 10 inhibitor
206190|NCT02907294|Huntington's disease|huntington's disease
206191|NCT02907294|psychiatric disorders|psychiatric disorders
206192|NCT02907281|Multiple sclerosis,|multiple sclerosis,
206193|NCT02907281|MS,|ms,
206194|NCT02907281|Optical coherence tomography|optical coherence tomography
206195|NCT02907281|OCT,|oct,
206196|NCT02907281|RRMS|rrms
206197|NCT02907268|botulinum toxin type A, intradermal|botulinum toxin type a, intradermal
206198|NCT02907255|Pulse oximetry|pulse oximetry
206199|NCT02907255|vital signs monitoring|vital signs monitoring
206200|NCT02907255|wireless notification of clinicians|wireless notification of clinicians
206201|NCT02907255|respiratory monitoring system|respiratory monitoring system
206202|NCT02907242|stillbirth|stillbirth
206203|NCT02907242|cerebroplacental ratio|cerebroplacental ratio
206204|NCT02907242|fetal growth restriction|fetal growth restriction
206205|NCT02907216|Healthy Japanese infants|healthy japanese infants
206206|NCT02907216|Safety|safety
206207|NCT02907216|Diphtheria, Tetanus, Pertussis and Inactivated Poliovirus (DPT-IPV) vaccine|diphtheria, tetanus, pertussis and inactivated poliovirus (dpt-ipv) vaccine
206208|NCT02907216|Vaccination|vaccination
206209|NCT02907216|Oral HRV liquid vaccine|oral hrv liquid vaccine
206210|NCT02907216|Immunogenicity|immunogenicity
206211|NCT02907190|pulses|pulses
206212|NCT02907190|beans|beans
206213|NCT02907190|blood glucose|blood glucose
206214|NCT02907190|insulin|insulin
206215|NCT02907112|meat intake|meat intake
206216|NCT02907112|meat analogues|meat analogues
206217|NCT02907112|LDL Cholesterol|ldl cholesterol
206218|NCT02907112|HDL Cholesterol|hdl cholesterol
206219|NCT02907060|prolonged pregnancy|prolonged pregnancy
206220|NCT02907060|mechanical cervical ripening|mechanical cervical ripening
206221|NCT02906995|pharmacokinetics|pharmacokinetics
206222|NCT02906995|nicotine absorption|nicotine absorption
206223|NCT02906982|Periodontal diseases|periodontal diseases
206224|NCT02906982|Periodontitis|periodontitis
206225|NCT02906982|Gingivitis|gingivitis
206226|NCT02906982|Teeth Whitening|teeth whitening
206227|NCT02906982|Dental Plaque Index|dental plaque index
206228|NCT02906982|Periodontal Index|periodontal index
206229|NCT02906982|Teeth Whitening Agents|teeth whitening agents
206230|NCT02906982|Tooth Discoloration|tooth discoloration
206231|NCT02906982|Mean Probing Depth|mean probing depth
206232|NCT02906982|Pocket Depth|pocket depth
206233|NCT02906943|Molecular Profiling|molecular profiling
206234|NCT02906943|Advanced Cancer|advanced cancer
206235|NCT02906943|Advanced Solid Tumors|advanced solid tumors
206236|NCT02906943|Phase I Clinical Trial Candidates|phase i clinical trial candidates
206237|NCT02906943|Next Generation Sequencing|next generation sequencing
206238|NCT02906878|Intensive Care|intensive care
206239|NCT02906878|Haematology|haematology
206240|NCT02906878|Platelets prophylactic transfusion|platelets prophylactic transfusion
206241|NCT02906839|cardiovascular risk|cardiovascular risk
206242|NCT02906839|risk of atrial fibrillation recurrence|risk of atrial fibrillation recurrence
206243|NCT02906839|sleep apnea syndrome|sleep apnea syndrome
206244|NCT02906839|atrial fibrillation|atrial fibrillation
206245|NCT02906826|Airway clearance technique|airway clearance technique
206246|NCT02906826|Positive expiratory pressure technique|positive expiratory pressure technique
206247|NCT02906826|Adherence|adherence
206248|NCT02906813|Drug Therapy|drug therapy
206249|NCT02906800|cisplatin|cisplatin
206250|NCT02906800|head and neck cancer|head and neck cancer
206251|NCT02906800|digoxin|digoxin
206252|NCT02906787|Smoking Cessation|smoking cessation
206253|NCT02906787|Weight Loss|weight loss
206254|NCT02906761|asthma, aspirin|asthma, aspirin
206255|NCT02906748|parathyroid autografting|parathyroid autografting
206256|NCT02906748|thyroidectomy|thyroidectomy
206257|NCT02906748|survival rate|survival rate
206258|NCT02906748|hypoparathyroidism|hypoparathyroidism
206259|NCT02906722|Nebulized colistin|nebulized colistin
206260|NCT02906722|Intravenous colistin|intravenous colistin
206261|NCT02906722|ventilator-associated pneumonia|ventilator-associated pneumonia
206262|NCT02906722|multidrug resistance|multidrug resistance
206263|NCT02906722|Gram-negative bacteria|gram-negative bacteria
206264|NCT02906683|Urinary Incontinence|urinary incontinence
206265|NCT02906683|Urinary Incontinence, Stress|urinary incontinence, stress
206266|NCT02906683|Lower Urinary Tract Symptoms|lower urinary tract symptoms
206267|NCT02906670|Epithelial malignancies|epithelial malignancies
206268|NCT02906657|Medication Reconciliation|medication reconciliation
206269|NCT02906657|Adverse Drug Event|adverse drug event
206271|NCT02906657|patient pharmaceutical record|patient pharmaceutical record
206272|NCT02906644|Nicotine addiction|nicotine addiction
206273|NCT02906644|Cigarette smoking|cigarette smoking
206274|NCT02906644|Smoking cessation|smoking cessation
206275|NCT02906644|lorcaserin|lorcaserin
206276|NCT02906644|Belviq|belviq
206277|NCT02906644|Nicotine patches|nicotine patches
206278|NCT02906631|encephalitis,|encephalitis,
206279|NCT02906631|neurologic outcomes of all-cause encephalitis in intensive care unit|neurologic outcomes of all-cause encephalitis in intensive care unit
206280|NCT02906631|outcome, intensive care unit|outcome, intensive care unit
206281|NCT02906553|Nitric Oxide|nitric oxide
206282|NCT02906553|Cognition|cognition
206283|NCT02906527|Cardiology|cardiology
206284|NCT02906527|Oral anticoagulants|oral anticoagulants
206386|NCT02905864|Liraglutide|liraglutide
206285|NCT02906527|Risk and Benefit analysis|risk and benefit analysis
206286|NCT02906527|Health insurance databases|health insurance databases
206287|NCT02906527|Safety|safety
206288|NCT02906527|Elderly|elderly
206289|NCT02906514|Hydroxyethyl Starch|hydroxyethyl starch
206290|NCT02906514|Cardiac surgery|cardiac surgery
206291|NCT02906514|Priming of cardiopulmonary bypass|priming of cardiopulmonary bypass
206292|NCT02906501|Risperidone|risperidone
206293|NCT02906501|ADHD|adhd
206294|NCT02906501|DBD|dbd
206295|NCT02906501|IGT|igt
206296|NCT02906501|CNP|cnp
206297|NCT02906501|Executive functions|executive functions
206298|NCT02906488|Quality of life|quality of life
206299|NCT02906475|Dermatitis, atopic|dermatitis, atopic
206300|NCT02906475|prevention and control|prevention and control
206301|NCT02906475|Infant|infant
206302|NCT02906475|Skin care|skin care
206303|NCT02906475|randomized controlled trial|randomized controlled trial
206304|NCT02906462|Leonetti French law|leonetti french law
206305|NCT02906462|Palliative care|palliative care
206306|NCT02906449|concussion, mild head injury, mindfulness|concussion, mild head injury, mindfulness
206307|NCT02906436|Lung transplantation|lung transplantation
714247|NCT00572377|Female|female
206308|NCT02906436|ExVivo reconditionning|exvivo reconditionning
206309|NCT02906423|Quality of Life|quality of life
206310|NCT02906423|Patient-Centered Care|patient-centered care
206311|NCT02906423|Patient Outcome Assessment|patient outcome assessment
206312|NCT02906384|hippocampus avoidance|hippocampus avoidance
206313|NCT02906384|volumetric modulated arc therapy|volumetric modulated arc therapy
206314|NCT02906384|functional MRI|functional mri
206315|NCT02906384|hopkins Verbal Learning Test|hopkins verbal learning test
206316|NCT02906384|prophylactic cranial irradiation|prophylactic cranial irradiation
206317|NCT02906345|Septic shock|septic shock
206318|NCT02906345|Fresh frozen plasma|fresh frozen plasma
206319|NCT02906306|Older adults|older adults
206320|NCT02906306|Occupational Therapy|occupational therapy
206321|NCT02906306|Self-Efficacy|self-efficacy
206322|NCT02906306|Psychological Well-being|psychological well-being
206323|NCT02906280|EBUS-TBNA|ebus-tbna
206324|NCT02906241|African Americans|african americans
206325|NCT02906241|prostate cancer|prostate cancer
206326|NCT02906241|Minority|minority
206327|NCT02906241|Racial /Ethnic disparity|racial /ethnic disparity
206328|NCT02906241|Cancer care|cancer care
206329|NCT02906241|patient-physician communication|patient-physician communication
206330|NCT02906241|cancer clinical trial accrual|cancer clinical trial accrual
206331|NCT02906228|non-ionizing radiation|non-ionizing radiation
206332|NCT02906215|mHealth|mhealth
206333|NCT02906215|implementation|implementation
206334|NCT02906215|PrEP|prep
206335|NCT02906215|digital health|digital health
206336|NCT02906163|EGFR mutation positive|egfr mutation positive
206337|NCT02906163|Thymosin Alpha 1|thymosin alpha 1
206338|NCT02906163|Tyrosine Kinase inhibitor|tyrosine kinase inhibitor
206339|NCT02906163|Thymalfasin|thymalfasin
206340|NCT02906163|Non Small Cell Lung Cancer|non small cell lung cancer
206341|NCT02906150|EGFR Wild Type|egfr wild type
206342|NCT02906150|Thymosin Alpha 1|thymosin alpha 1
206343|NCT02906150|Non-Small Cell Lung Cancer|non-small cell lung cancer
206344|NCT02906150|Thymalfasin|thymalfasin
206345|NCT02906124|hypercholesterolaemia|hypercholesterolaemia
206346|NCT02906124|Lipid lowering therapies|lipid lowering therapies
206347|NCT02906124|Pregnancy|pregnancy
206348|NCT02906111|Estriol|estriol
206349|NCT02906111|Prolapse|prolapse
206350|NCT02906111|Quality of life|quality of life
206351|NCT02906111|Vaginal health|vaginal health
206352|NCT02906111|Vaginal surgery|vaginal surgery
206353|NCT02906098|Gingivitis|gingivitis
206354|NCT02906098|Adolescents|adolescents
206355|NCT02906098|Oral hygiene|oral hygiene
206356|NCT02906098|Oral health behavior|oral health behavior
206357|NCT02906098|Periodontal infection control|periodontal infection control
206358|NCT02906085|[C10.228.140.546.399.750.250]|[c10.228.140.546.399.750.250]
206359|NCT02906072|Obesity|obesity
206360|NCT02906072|Body fat|body fat
206361|NCT02906072|Plant-based diet|plant-based diet
206362|NCT02906072|Plant-based meal replacement|plant-based meal replacement
206363|NCT02906059|RAS|ras
206364|NCT02906059|KRAS|kras
206365|NCT02906059|NRAS|nras
206366|NCT02906059|BRAF|braf
206367|NCT02906059|Mutated|mutated
206368|NCT02906059|Wee1 inhibitor|wee1 inhibitor
206369|NCT02906046|SCA 3|sca 3
206370|NCT02906046|Ataxic Gait|ataxic gait
206371|NCT02906033|Surgical Procedures, Operative|surgical procedures, operative
206372|NCT02906033|Operating Rooms|operating rooms
206373|NCT02906033|Quality of Life|quality of life
206374|NCT02906033|Surgery-related anxiety|surgery-related anxiety
206375|NCT02905994|Leukemia|leukemia
206376|NCT02905981|IRIDA|irida
206377|NCT02905981|Triferic|triferic
206378|NCT02905981|soluble ferric pyrophosphate|soluble ferric pyrophosphate
206379|NCT02905981|Shohl's solution|shohl's solution
206380|NCT02905968|Anastomotic leak|anastomotic leak
206381|NCT02905968|Low rectal cancer|low rectal cancer
206382|NCT02905929|sedentary behavior|sedentary behavior
206383|NCT02905929|standing|standing
206384|NCT02905929|sitting|sitting
206385|NCT02905929|inclinometer|inclinometer
206387|NCT02905864|Liraglutide 3 mg|liraglutide 3 mg
206388|NCT02905864|Osteoarthritis|osteoarthritis
206389|NCT02905864|Obesity|obesity
206390|NCT02905799|Osteoarthritis|osteoarthritis
206391|NCT02905799|Knee|knee
206392|NCT02905799|Resveratrol|resveratrol
206393|NCT02905799|Oral Treatment|oral treatment
206394|NCT02905799|Pain|pain
206395|NCT02905799|Trial|trial
206396|NCT02905786|General Practice|general practice
206397|NCT02905786|Nurse practitioner|nurse practitioner
206398|NCT02905786|Natriuretic peptides|natriuretic peptides
206399|NCT02905786|Clinical audit|clinical audit
206400|NCT02905773|Intensity|intensity
206401|NCT02905760|Acute Myocardial Infarction|acute myocardial infarction
206402|NCT02905760|Right ventricular infarction|right ventricular infarction
206403|NCT02905760|Diuretic|diuretic
206404|NCT02905760|Fluid Expansion|fluid expansion
206405|NCT02905747|Exercise Therapy|exercise therapy
206406|NCT02905747|Musculoskeletal Pain|musculoskeletal pain
206407|NCT02905747|Knee osteoarthritis|knee osteoarthritis
206408|NCT02905747|Physical Therapy Modalities|physical therapy modalities
206409|NCT02905734|Nicotine replacement therapy|nicotine replacement therapy
206410|NCT02905734|Tobacco|tobacco
206411|NCT02905708|normothermia|normothermia
206412|NCT02905708|hypothermia|hypothermia
206413|NCT02905695|Post-partum Perineal pain|post-partum perineal pain
206414|NCT02905695|Episiotomy|episiotomy
206415|NCT02905695|First-degree tear|first-degree tear
206416|NCT02905669|distensibility|distensibility
206417|NCT02905669|impedance planimetry|impedance planimetry
206418|NCT02905669|esophagus|esophagus
206419|NCT02905669|esophago-gastric junction|esophago-gastric junction
206420|NCT02905669|pylorus|pylorus
206421|NCT02905656|quitline|quitline
206422|NCT02905656|nicotine replacement therapy|nicotine replacement therapy
206423|NCT02905656|tobacco intervention|tobacco intervention
206424|NCT02905656|smokers not ready to quit|smokers not ready to quit
206425|NCT02905643|Pseudoprogression|pseudoprogression
206426|NCT02905643|Brain Cancer|brain cancer
206427|NCT02905630|coronary flow reserve|coronary flow reserve
206428|NCT02905630|angina|angina
206429|NCT02905630|exercise training|exercise training
206430|NCT02905617|Breast Augmentation|breast augmentation
206431|NCT02905617|Breast Revision-Augmentation|breast revision-augmentation
206432|NCT02905604|rTMS|rtms
206433|NCT02905604|negative symptoms|negative symptoms
206434|NCT02905604|intermittent theta burst|intermittent theta burst
206435|NCT02905604|iTBS|itbs
206436|NCT02905604|repetitive transcranial magnetic stimulation|repetitive transcranial magnetic stimulation
206437|NCT02905604|dorsomedial prefrontal cortex|dorsomedial prefrontal cortex
206438|NCT02905604|dmPFC|dmpfc
206439|NCT02905604|NIRS|nirs
206440|NCT02905591|pharmacological ascorbate|pharmacological ascorbate
206441|NCT02905591|ascorbic acid|ascorbic acid
206442|NCT02905591|radiation|radiation
206443|NCT02905591|chemotherapy|chemotherapy
206444|NCT02905591|carboplatin|carboplatin
206445|NCT02905591|paclitaxel|paclitaxel
206446|NCT02905578|Ascorbate|ascorbate
206447|NCT02905578|Vitamin C|vitamin c
206448|NCT02905578|Pharmacological ascorbate|pharmacological ascorbate
206449|NCT02905578|Pharmacologic ascorbate|pharmacologic ascorbate
206450|NCT02905578|Ascorbic Acid|ascorbic acid
206451|NCT02905578|gemcitabine|gemcitabine
206452|NCT02905578|nab-paclitaxel|nab-paclitaxel
206453|NCT02905578|Gemzar|gemzar
206454|NCT02905578|Abraxane|abraxane
206455|NCT02905565|Multicenter|multicenter
206456|NCT02905565|Randomized|randomized
206457|NCT02905565|Double-Blind|double-blind
206458|NCT02905565|Placebo-Controlled|placebo-controlled
206459|NCT02905565|Add-On to Standard-of-Care|add-on to standard-of-care
206460|NCT02905565|Safety|safety
206461|NCT02905565|Efficacy|efficacy
206462|NCT02905552|Myelodysplastic syndrome (myelodysplasia)|myelodysplastic syndrome (myelodysplasia)
206463|NCT02905552|Infection|infection
206464|NCT02905552|Risk Factors|risk factors
206465|NCT02905539|Iron|iron
206466|NCT02905539|anemia|anemia
206467|NCT02905539|phosphorus|phosphorus
206468|NCT02905539|FGF-23|fgf-23
206469|NCT02905526|Reproductive health|reproductive health
206470|NCT02905513|Reproductive health|reproductive health
206471|NCT02905500|Disability-Adjusted Life Years|disability-adjusted life years
206472|NCT02905500|Epidemiology|epidemiology
206473|NCT02905500|Public Health|public health
206474|NCT02905487|Gestational Diabetes Mellitus|gestational diabetes mellitus
206475|NCT02905487|Obesity|obesity
206476|NCT02905487|Adipocytokin|adipocytokin
206477|NCT02905474|chronic kidney disease, mobile applications, mHealth, medication reconciliation, self-management|chronic kidney disease, mobile applications, mhealth, medication reconciliation, self-management
206478|NCT02905461|Reproductive health|reproductive health
206479|NCT02905448|Obesity|obesity
206480|NCT02905448|Body composition|body composition
206481|NCT02905448|Atherosclerosis|atherosclerosis
206482|NCT02905448|Insulin resistance|insulin resistance
206483|NCT02905448|Hyperuricemia|hyperuricemia
206484|NCT02905435|burns|burns
206485|NCT02905435|autografts|autografts
206486|NCT02905435|humans|humans
206692|NCT02904070|Threat of|threat of
206487|NCT02905435|biodegradable polyurethane|biodegradable polyurethane
206488|NCT02905435|dermal matrix|dermal matrix
206489|NCT02905435|synthetic|synthetic
206490|NCT02905422|physical activity|physical activity
206491|NCT02905422|sleep|sleep
206492|NCT02905422|nutrition|nutrition
206493|NCT02905422|Soldier|soldier
206494|NCT02905422|prevention|prevention
206495|NCT02905422|remote monitoring|remote monitoring
206496|NCT02905422|mobile technology|mobile technology
206497|NCT02905396|small fiber neuropathy|small fiber neuropathy
206498|NCT02905396|spinal cord stimulation|spinal cord stimulation
206499|NCT02905396|treatment|treatment
206500|NCT02905396|pain|pain
206501|NCT02905370|Home Health|home health
206502|NCT02905370|Rehabilitation|rehabilitation
206503|NCT02905370|High Intensity|high intensity
206504|NCT02905370|Hospital Associated Deconditioning|hospital associated deconditioning
206505|NCT02905370|Functional Mobility|functional mobility
206506|NCT02905370|Physical Function|physical function
714248|NCT00572364|Cancer|cancer
206507|NCT02905357|Myocardial Infarction|myocardial infarction
206508|NCT02905357|Women|women
206509|NCT02905357|Imaging|imaging
206510|NCT02905305|cochlear implants|cochlear implants
206511|NCT02905305|Dexamethasone|dexamethasone
206512|NCT02905305|combined device|combined device
206513|NCT02905279|spider phobia|spider phobia
206514|NCT02905279|animal phobia|animal phobia
206515|NCT02905279|exposure therapy|exposure therapy
206516|NCT02905279|biofeedback|biofeedback
206517|NCT02905279|relaxation training|relaxation training
206518|NCT02905240|Autologous Protein Solution|autologous protein solution
206519|NCT02905240|APS|aps
206520|NCT02905240|intra-articular injection|intra-articular injection
206521|NCT02905240|osteoarthritis|osteoarthritis
206522|NCT02905227|Adult smokers|adult smokers
206523|NCT02905227|Asthma|asthma
206524|NCT02905227|Healthy volunteers|healthy volunteers
206525|NCT02905188|hepatocellular carcinoma|hepatocellular carcinoma
206526|NCT02905188|GPC3-CAR T cells|gpc3-car t cells
206527|NCT02905188|GPC3-positive hepatocellular carcinoma|gpc3-positive hepatocellular carcinoma
206528|NCT02905175|rheumatoid arthritis|rheumatoid arthritis
206529|NCT02905175|Porphyromonas gingivalis|porphyromonas gingivalis
206530|NCT02905149|Oncological|oncological
206531|NCT02905149|Surgery|surgery
206532|NCT02905149|Breast|breast
206533|NCT02905149|Reconstruction|reconstruction
206534|NCT02905136|autoantibodies|autoantibodies
206535|NCT02905136|neuronal synaptic receptors|neuronal synaptic receptors
206536|NCT02905136|autoimmune encephalitis|autoimmune encephalitis
206537|NCT02905110|Malignant Neoplasms, Brain|malignant neoplasms, brain
206538|NCT02905110|medulloblastoma|medulloblastoma
206539|NCT02905110|ependymoma|ependymoma
206540|NCT02905110|Atypical Teratoid Rhabdoid Tumor (ATRT)|atypical teratoid rhabdoid tumor (atrt)
206541|NCT02905097|Knee arthroplasty, Total|knee arthroplasty, total
206542|NCT02905097|Knee replacement, Total|knee replacement, total
206543|NCT02905097|Survival rate|survival rate
206544|NCT02905097|Osseointegration|osseointegration
206545|NCT02905097|Gait|gait
206546|NCT02905071|mental health|mental health
206547|NCT02905071|well-being at work|well-being at work
206548|NCT02905071|screening|screening
206549|NCT02905071|psychosocial risk|psychosocial risk
206550|NCT02905071|psychometrics|psychometrics
206551|NCT02905071|questionnaire|questionnaire
206552|NCT02905071|job stress|job stress
206553|NCT02905032|Afib|afib
206554|NCT02905032|Atrial fib|atrial fib
206555|NCT02905032|Shared|shared
206556|NCT02905032|Decision|decision
206557|NCT02905032|Making|making
206558|NCT02905032|Aid|aid
206559|NCT02905032|AF|af
206560|NCT02905006|Psoriasis|psoriasis
206561|NCT02905006|Chronic Plaque Psoriasis|chronic plaque psoriasis
206562|NCT02905006|Bimekizumab|bimekizumab
206563|NCT02904980|Quiet eye training|quiet eye training
206564|NCT02904980|Visual Attention|visual attention
206565|NCT02904954|Lung neoplasms|lung neoplasms
206566|NCT02904954|Bronchial Neoplasms|bronchial neoplasms
206567|NCT02904954|Carcinoma, bronchogenic|carcinoma, bronchogenic
206568|NCT02904954|Neoplasms|neoplasms
206569|NCT02904954|Neoplasms by site|neoplasms by site
206570|NCT02904954|Respiratory Tract Diseases|respiratory tract diseases
206571|NCT02904954|Respiratory Tract Neoplasms|respiratory tract neoplasms
206572|NCT02904954|Thoracic Neoplasms|thoracic neoplasms
206573|NCT02904941|Children|children
206574|NCT02904941|Skin Transplantation|skin transplantation
206575|NCT02904941|Amniotic Membrane|amniotic membrane
206576|NCT02904902|efficacy|efficacy
206577|NCT02904902|safety|safety
206578|NCT02904902|adalimumab|adalimumab
206579|NCT02904902|japanese participants|japanese participants
206580|NCT02904850|Non-small cell lung cancer|non-small cell lung cancer
206581|NCT02904850|locally advanced or metastatic|locally advanced or metastatic
206582|NCT02904850|erlotinib monotherapy|erlotinib monotherapy
206583|NCT02904837|Randomized clinical trial|randomized clinical trial
206584|NCT02904837|Parkinson's disease|parkinson's disease
206585|NCT02904837|Mental practice|mental practice
206586|NCT02904837|Gait|gait
206587|NCT02904824|adipose tissue|adipose tissue
206588|NCT02904824|adult stem cells|adult stem cells
206589|NCT02904824|vocal cord paralysis|vocal cord paralysis
206590|NCT02904811|Chlamydia trachomatis|chlamydia trachomatis
206591|NCT02904811|Pelvic inflammatory disease|pelvic inflammatory disease
206592|NCT02904798|sunscreen|sunscreen
206593|NCT02904798|photoprotection|photoprotection
206594|NCT02904798|visible light|visible light
206595|NCT02904746|follow-up|follow-up
206596|NCT02904746|mental health appointment|mental health appointment
206597|NCT02904720|Vitamin D; Pregnancy|vitamin d; pregnancy
206598|NCT02904707|Skin Graft|skin graft
206599|NCT02904668|chronic pain|chronic pain
206600|NCT02904642|SMS reminder|sms reminder
206601|NCT02904642|incentive|incentive
206602|NCT02904642|mobile phone|mobile phone
206603|NCT02904642|Immunization|immunization
206604|NCT02904590|IBD|ibd
206605|NCT02904590|Infection|infection
206606|NCT02904577|Indolent B-Cell Lymphomas|indolent b-cell lymphomas
714526|NCT00571181|Algorithms|algorithms
206607|NCT02904577|prospective collection|prospective collection
206608|NCT02904564|drug delivery|drug delivery
206609|NCT02904564|Idiopathic Guttate Hypomelanosis|idiopathic guttate hypomelanosis
206610|NCT02904551|prospective study|prospective study
206611|NCT02904551|free gingival graft|free gingival graft
206612|NCT02904551|keratinized gingiva|keratinized gingiva
206613|NCT02904551|dental implant|dental implant
206614|NCT02904538|Dexamethasone|dexamethasone
206615|NCT02904538|Regional anesthesia|regional anesthesia
206616|NCT02904538|Front foot surgery|front foot surgery
206617|NCT02904538|Metacarpal osteotomy|metacarpal osteotomy
206618|NCT02904525|newly diagnosed|newly diagnosed
206619|NCT02904525|MRI|mri
206620|NCT02904499|Atrial Fibrillation|atrial fibrillation
206621|NCT02904499|Anticoagulants|anticoagulants
206622|NCT02904499|Pharmacoepidemiology|pharmacoepidemiology
206623|NCT02904447|hemicap|hemicap
206624|NCT02904447|hallux rigidus|hallux rigidus
206625|NCT02904434|voriconazole|voriconazole
206626|NCT02904434|absorption|absorption
206627|NCT02904434|pharmacokinetic|pharmacokinetic
206628|NCT02904434|grapefruit juice|grapefruit juice
206629|NCT02904434|bioavailability|bioavailability
206630|NCT02904434|intestinal first-pass metabolism|intestinal first-pass metabolism
206631|NCT02904434|pharmacokinetics|pharmacokinetics
206632|NCT02904434|intestinal|intestinal
206633|NCT02904421|scoliosis|scoliosis
206634|NCT02904421|spinal deformity|spinal deformity
206635|NCT02904421|vitamin D|vitamin d
206636|NCT02904421|bone health|bone health
206637|NCT02904408|quality of life|quality of life
206638|NCT02904408|psychotherapy|psychotherapy
206639|NCT02904408|hidradenitis|hidradenitis
206640|NCT02904408|treatments|treatments
206641|NCT02904356|OCD|ocd
206642|NCT02904356|TMS|tms
206643|NCT02904356|Neuromodulation|neuromodulation
206644|NCT02904356|Obsessive-Compulsive Disorder|obsessive-compulsive disorder
206645|NCT02904356|Transcranial Magnetic Stimulation|transcranial magnetic stimulation
206646|NCT02904356|Imaging|imaging
206647|NCT02904343|hemodialysis machine|hemodialysis machine
206648|NCT02904343|quality|quality
206649|NCT02904343|safety|safety
206650|NCT02904343|domestic|domestic
206651|NCT02904304|Flu|flu
206652|NCT02904304|Treatment|treatment
206653|NCT02904291|Bariatric surgery|bariatric surgery
206654|NCT02904291|Gastrointestinal tract|gastrointestinal tract
206655|NCT02904291|Biological availability|biological availability
206656|NCT02904291|Pharmacokinetics|pharmacokinetics
206657|NCT02904291|Amlodipine|amlodipine
206658|NCT02904278|Mobile Application Intervention|mobile application intervention
206659|NCT02904278|Teen Pocket PATH® [TPP]|teen pocket path® [tpp]
206660|NCT02904278|Adherence|adherence
206661|NCT02904278|Medical Management|medical management
206662|NCT02904265|continuous spike wave in sleep|continuous spike wave in sleep
206663|NCT02904265|Landau-Kleffner syndrome|landau-kleffner syndrome
206664|NCT02904265|acetazolamide|acetazolamide
206665|NCT02904265|diazepam|diazepam
206666|NCT02904252|Transient elastography|transient elastography
206667|NCT02904252|Fibrotest|fibrotest
206668|NCT02904239|Multidetector Computed Tomography|multidetector computed tomography
206669|NCT02904239|Incidental cardiac findings|incidental cardiac findings
206670|NCT02904239|Thoracic high-pitch Computed Tomography|thoracic high-pitch computed tomography
206671|NCT02904239|Management guidelines|management guidelines
206672|NCT02904226|ICOS|icos
206673|NCT02904226|ICOS agonist monoclonal antibody|icos agonist monoclonal antibody
206674|NCT02904226|JTX-2011|jtx-2011
206675|NCT02904226|Anti-PD-1|anti-pd-1
206676|NCT02904226|Nivolumab|nivolumab
206677|NCT02904226|ICONIC|iconic
206678|NCT02904226|Immunotherapy|immunotherapy
206679|NCT02904226|Immuno-oncology|immuno-oncology
206680|NCT02904226|Cancer|cancer
206681|NCT02904226|Solid Tumor|solid tumor
206682|NCT02904226|Dose Escalation|dose escalation
206683|NCT02904226|Dose Expansion|dose expansion
206684|NCT02904226|Anti-CTLA-4|anti-ctla-4
206685|NCT02904226|Ipilimumab|ipilimumab
206686|NCT02904226|Pembrolizumab|pembrolizumab
206687|NCT02904213|vaccine|vaccine
206688|NCT02904213|ComBe Five|combe five
206689|NCT02904213|Vietnam|vietnam
206690|NCT02904213|pentavalent|pentavalent
206691|NCT02904135|Circulating Tumor Cells|circulating tumor cells
206693|NCT02904044|School|school
206694|NCT02904044|Sport|sport
206695|NCT02904044|Injuries|injuries
206696|NCT02904005|Suicide|suicide
206697|NCT02904005|Prediction|prediction
206698|NCT02904005|Prospective study|prospective study
206699|NCT02904005|Suicide attempt|suicide attempt
206700|NCT02904005|Risk management|risk management
206701|NCT02903992|Frail Elderly|frail elderly
206702|NCT02903992|sarcopenia|sarcopenia
206703|NCT02903966|Tolerability|tolerability
206704|NCT02903966|GSK2982772|gsk2982772
206705|NCT02903966|Safety|safety
206706|NCT02903966|Pharmacokinetics|pharmacokinetics
206707|NCT02903966|RIP1 kinase inhibitor|rip1 kinase inhibitor
206708|NCT02903966|Ulcerative colitis|ulcerative colitis
206709|NCT02903966|Pharmacodynamics|pharmacodynamics
206710|NCT02903914|Immuno-Oncology|immuno-oncology
206711|NCT02903914|Checkpoint Inhibitors|checkpoint inhibitors
206712|NCT02903914|Tumor Metabolism|tumor metabolism
206713|NCT02903914|Programmed cell death protein-1 (PD-1) inhibitor|programmed cell death protein-1 (pd-1) inhibitor
206714|NCT02903914|Programmed death ligand 1 (PD-L1) inhibitor|programmed death ligand 1 (pd-l1) inhibitor
206715|NCT02903914|Solid Tumors|solid tumors
206716|NCT02903914|RCC|rcc
206717|NCT02903914|MEL|mel
206718|NCT02903914|NSCLC|nsclc
206719|NCT02903914|Arginase|arginase
206720|NCT02903914|Arginase Inhibitor|arginase inhibitor
206721|NCT02903914|INCB001158 (CB-1158)|incb001158 (cb-1158)
206722|NCT02903914|SCCHN|scchn
206723|NCT02903914|GEJ|gej
206724|NCT02903914|Immune Therapy|immune therapy
206725|NCT02903901|Delirium|delirium
206726|NCT02903862|Caregivers|caregivers
206727|NCT02903862|Case Management|case management
206728|NCT02903862|Alzheimer's Disease|alzheimer's disease
206729|NCT02903862|Cognition|cognition
206730|NCT02903862|Caregiver Burden|caregiver burden
206731|NCT02903862|Depression|depression
206732|NCT02903823|spinal cord injury|spinal cord injury
206733|NCT02903823|cerebral palsy|cerebral palsy
206734|NCT02903823|stroke|stroke
206735|NCT02903797|Endometrial hyperplasia|endometrial hyperplasia
206736|NCT02903797|Irisin|irisin
206737|NCT02903797|fibronectin type III domain containing 5|fibronectin type iii domain containing 5
206738|NCT02903797|FNDC5 (fibronectin type III domain containing )|fndc5 (fibronectin type iii domain containing )
206739|NCT02903771|Cantrixil|cantrixil
206740|NCT02903771|Intraperitoneal|intraperitoneal
206741|NCT02903719|Phrenic|phrenic
206742|NCT02903719|Nerve block|nerve block
206743|NCT02903719|Postoperative shoulder pain|postoperative shoulder pain
206744|NCT02903719|Liver resection|liver resection
206745|NCT02903706|gold miners|gold miners
206746|NCT02903706|plasmodium carriers|plasmodium carriers
206747|NCT02903706|artemisinine resistance|artemisinine resistance
206748|NCT02903680|Relapse Prevention|relapse prevention
206749|NCT02903680|Children|children
206750|NCT02903667|bone grafting|bone grafting
206751|NCT02903667|implantology|implantology
206752|NCT02903667|oral surgery|oral surgery
206753|NCT02903628|myopia|myopia
206754|NCT02903615|glucose|glucose
206755|NCT02903615|inflammation|inflammation
206756|NCT02903602|sharing histories|sharing histories
206757|NCT02903602|autobiographical memory|autobiographical memory
206758|NCT02903602|health behavior|health behavior
206759|NCT02903602|narrative communication|narrative communication
206760|NCT02903602|community health workers|community health workers
206761|NCT02903602|global health|global health
206762|NCT02903602|maternal and child health|maternal and child health
206763|NCT02903602|stunting|stunting
206764|NCT02903537|Multiple Sclerosis|multiple sclerosis
206765|NCT02903537|Dendritic Cells|dendritic cells
206766|NCT02903537|Immune Tolerance|immune tolerance
206767|NCT02903537|Myelin Proteins|myelin proteins
206768|NCT02903537|Tolerogenic dendritic cells|tolerogenic dendritic cells
206769|NCT02903511|Metformin|metformin
206770|NCT02903511|total kidney volume|total kidney volume
206771|NCT02903511|glomerular filtration rate|glomerular filtration rate
206772|NCT02903498|disease control survival|disease control survival
206773|NCT02903472|SCI|sci
206774|NCT02903472|microbiome|microbiome
206775|NCT02903472|metabolome|metabolome
206776|NCT02903472|GI|gi
206777|NCT02903472|UTI|uti
206778|NCT02903472|DNA|dna
206779|NCT02903472|genomics|genomics
206780|NCT02903472|infections|infections
206781|NCT02903472|tetraplegic|tetraplegic
206782|NCT02903472|paraplegic|paraplegic
206783|NCT02903459|Central Fat|central fat
206784|NCT02903459|Subcutaneous Fat|subcutaneous fat
206785|NCT02903459|Lumbar Lordosis Degree|lumbar lordosis degree
206786|NCT02903459|Cellulite|cellulite
206787|NCT02903433|Avocado|avocado
206788|NCT02903433|Cardiovascular disease|cardiovascular disease
206789|NCT02903407|Ventilators, Mechanical|ventilators, mechanical
206790|NCT02903407|Intensive Care Units|intensive care units
206791|NCT02903407|Deep Sedation|deep sedation
206792|NCT02903381|Smoldering Multiple Myeloma|smoldering multiple myeloma
206793|NCT02903368|Prostate Cancer|prostate cancer
206794|NCT02903342|Fever|fever
206795|NCT02903342|Febrile illness|febrile illness
206796|NCT02903342|Children|children
206797|NCT02903316|Fluid responsiveness|fluid responsiveness
206798|NCT02903316|Perioperative|perioperative
206799|NCT02903316|Extra systoles|extra systoles
206800|NCT02903316|Coronary artery bypass|coronary artery bypass
206801|NCT02903316|Systolic arterial pressure|systolic arterial pressure
206802|NCT02903264|Gestational Diabetes Mellitus|gestational diabetes mellitus
206803|NCT02903264|Obesity|obesity
206804|NCT02903264|Periodontal Disease|periodontal disease
206805|NCT02903251|Oxytocin|oxytocin
206806|NCT02903251|Administration, Intranasal|administration, intranasal
206807|NCT02903251|Ethanol|ethanol
206808|NCT02903238|placebo|placebo
206809|NCT02903238|pain|pain
206810|NCT02903238|osteoarthritis|osteoarthritis
206811|NCT02903225|Heart rate variability|heart rate variability
206812|NCT02903225|Systolic heart failure|systolic heart failure
206813|NCT02903225|Physical exercise|physical exercise
206814|NCT02903225|Parasympathetic indexes|parasympathetic indexes
206815|NCT02903212|Apoptotic cells|apoptotic cells
206816|NCT02903199|Whey Protein|whey protein
206817|NCT02903199|Postprandial Glycaemia|postprandial glycaemia
206818|NCT02903199|Appetite Response|appetite response
206819|NCT02903186|infants|infants
206820|NCT02903186|minorities|minorities
206821|NCT02903186|overfeeding|overfeeding
206822|NCT02903186|WIC program|wic program
206823|NCT02903186|feeding practices|feeding practices
206824|NCT02903186|breastfeeding|breastfeeding
206825|NCT02903173|respiratory depression|respiratory depression
206826|NCT02903173|postpartum|postpartum
206827|NCT02903173|neuraxial morphine|neuraxial morphine
206828|NCT02903173|cesarean delivery|cesarean delivery
206829|NCT02903160|Castration resistant|castration resistant
206830|NCT02903160|Prostate cancer|prostate cancer
206831|NCT02903160|Metastatic|metastatic
206832|NCT02903160|First-line|first-line
206833|NCT02903160|Treatment naive|treatment naive
206834|NCT02903160|Rapidly cycling|rapidly cycling
206835|NCT02903160|Non-cross resistant|non-cross resistant
206836|NCT02903147|IVDR; driving behavior patterns; Meta-Cognitive Intervention|ivdr; driving behavior patterns; meta-cognitive intervention
206837|NCT02903121|Unscheduled bleeding|unscheduled bleeding
206838|NCT02903121|Long acting contraception|long acting contraception
206839|NCT02903095|Single ascending dose|single ascending dose
206840|NCT02903082|Myeloid-Derivated suppressive cell|myeloid-derivated suppressive cell
206841|NCT02903082|Sepsis|sepsis
206842|NCT02903082|Inflammatory Response Syndrome, Systemic|inflammatory response syndrome, systemic
206843|NCT02903069|newly diagnosed|newly diagnosed
206844|NCT02903069|malignant glioma|malignant glioma
206845|NCT02903069|WHO Grade 4|who grade 4
206846|NCT02903069|WHO Grade IV|who grade iv
206847|NCT02903069|marizomib|marizomib
206848|NCT02903069|MRZ|mrz
206849|NCT02903069|TMZ|tmz
206850|NCT02903069|RT|rt
206851|NCT02903069|brain cancer|brain cancer
206852|NCT02903069|proteasome inhibitor|proteasome inhibitor
206853|NCT02903069|radiation|radiation
206854|NCT02903069|temozolomide|temozolomide
206855|NCT02903069|temodar|temodar
206856|NCT02903069|chemotherapy|chemotherapy
206857|NCT02903069|concurrent|concurrent
206858|NCT02903069|adjuvant|adjuvant
206859|NCT02903069|Optune|optune
206860|NCT02903069|Novocure|novocure
206861|NCT02903069|NovoTTF|novottf
206862|NCT02903056|functional Magnetic Resonance Imaging|functional magnetic resonance imaging
206863|NCT02903056|Diffusion Spectrum Imaging|diffusion spectrum imaging
206864|NCT02903056|Susceptibility weighted imaging|susceptibility weighted imaging
206865|NCT02903056|Magnetic Resonance Imaging|magnetic resonance imaging
206866|NCT02903043|MicroRNAs|micrornas
206867|NCT02903043|Angiogenesis|angiogenesis
206868|NCT02903043|Skeletal muscle|skeletal muscle
206869|NCT02903043|COPD|copd
206870|NCT02903030|Gastrointestinal Microbiome|gastrointestinal microbiome
206871|NCT02902991|liquid biopsy, breast cancer,circulating tumor biomarker|liquid biopsy, breast cancer,circulating tumor biomarker
206872|NCT02902978|E6130|e6130
206873|NCT02902978|Japanese healthy adult male participants|japanese healthy adult male participants
206874|NCT02902978|Phase 1|phase 1
206875|NCT02902978|Pharmacokinetics|pharmacokinetics
206876|NCT02902965|Bruton's Tyrosine Kinase|bruton's tyrosine kinase
206877|NCT02902965|Bortezomib|bortezomib
206878|NCT02902965|Dexamethasone|dexamethasone
206879|NCT02902965|Ibrutinib|ibrutinib
206880|NCT02902939|Immune Suppression, Inflammatory Response, Cardiac Surgery|immune suppression, inflammatory response, cardiac surgery
206881|NCT02902913|platelet reactivity|platelet reactivity
206882|NCT02902913|phenolic|phenolic
206883|NCT02902913|extra virgin olive oil|extra virgin olive oil
206884|NCT02902913|cyclooxygenase|cyclooxygenase
206885|NCT02902913|oleocanthal|oleocanthal
206886|NCT02902913|oxylipin|oxylipin
206887|NCT02902900|Multiple Myeloma|multiple myeloma
206888|NCT02902900|Pomalidomide|pomalidomide
206889|NCT02902900|Efficacy|efficacy
206890|NCT02902835|Buprenorphine treatment|buprenorphine treatment
206891|NCT02902835|Incarceration|incarceration
206892|NCT02902835|Linkage Intervention|linkage intervention
206893|NCT02902835|Opioid use disorder|opioid use disorder
206894|NCT02902822|melanoma|melanoma
206895|NCT02902822|non-melanoma skin cancer|non-melanoma skin cancer
206896|NCT02902822|mole|mole
206897|NCT02902822|app|app
206898|NCT02902822|cliccailneo|cliccailneo
206899|NCT02902809|open-label study|open-label study
206900|NCT02902809|tralokinumab|tralokinumab
206901|NCT02902809|subcutaneous|subcutaneous
206902|NCT02902809|inadequately controlled asthma|inadequately controlled asthma
206904|NCT02902809|medium to high-dose of inhaled corticosteroid|medium to high-dose of inhaled corticosteroid
206905|NCT02902809|long-acting β2-agonist|long-acting β2-agonist
206906|NCT02902770|Pain|pain
206907|NCT02902770|Lidocaine|lidocaine
206908|NCT02902770|Ketorolac|ketorolac
206909|NCT02902757|FDG|fdg
206910|NCT02902757|PET/CT very early response (48 hrs)|pet/ct very early response (48 hrs)
714910|NCT00569465|diabetes|diabetes
206911|NCT02902705|White adipose tissue|white adipose tissue
206912|NCT02902705|chronic kidney disease|chronic kidney disease
206913|NCT02902705|uremia|uremia
206914|NCT02902705|adipocytes|adipocytes
206915|NCT02902692|brief|brief
206916|NCT02902692|mindfulness|mindfulness
206917|NCT02902666|Bioequivalence|bioequivalence
206918|NCT02902666|Paracetamol 1000 mg/codeine 30 mg|paracetamol 1000 mg/codeine 30 mg
206919|NCT02902666|Co-efferalgan 500 mg/30 mg|co-efferalgan 500 mg/30 mg
206920|NCT02902653|misoprostol|misoprostol
206921|NCT02902653|dinoprostonal|dinoprostonal
206922|NCT02902653|induction|induction
206923|NCT02902614|embryo biopsy|embryo biopsy
206924|NCT02902614|preimplantation genetic testing|preimplantation genetic testing
206925|NCT02902614|animal pole|animal pole
206926|NCT02902614|vegetal pole|vegetal pole
206927|NCT02902614|day 3 embryo biopsy|day 3 embryo biopsy
206928|NCT02902614|embryo implantation|embryo implantation
206929|NCT02902614|Blastomeres|blastomeres
206930|NCT02902588|Blood-Brain Barrier|blood-brain barrier
206931|NCT02902588|Magnetic Resonance Imaging|magnetic resonance imaging
206932|NCT02902588|Spectroscopy, Near-Infrared|spectroscopy, near-infrared
206933|NCT02902588|Indocyanine green|indocyanine green
206934|NCT02902575|Stomach Neoplasms|stomach neoplasms
206935|NCT02902575|Laparoscopy|laparoscopy
206936|NCT02902575|Advanced Gastric Cancer|advanced gastric cancer
206937|NCT02902575|Neoadjuvant Chemotherapy|neoadjuvant chemotherapy
206938|NCT02902549|Optical Coherence Tomography|optical coherence tomography
206939|NCT02902549|Fluorescence Imaging|fluorescence imaging
206940|NCT02902549|Sidestream Darkfield Microscopy|sidestream darkfield microscopy
206941|NCT02902549|Laser Speckle Contrast Imaging|laser speckle contrast imaging
206942|NCT02902536|Myasthenia Gravis|myasthenia gravis
206943|NCT02902510|yoga|yoga
206944|NCT02902510|function|function
206945|NCT02902510|Parkinson's disease|parkinson's disease
206946|NCT02902510|gait|gait
206947|NCT02902510|balance|balance
206948|NCT02902458|implantable cardioverter defibrillator|implantable cardioverter defibrillator
206949|NCT02902458|primary prevention|primary prevention
206950|NCT02902458|psychological follow-up|psychological follow-up
206951|NCT02902458|anxiety|anxiety
206952|NCT02902458|depression|depression
206953|NCT02902458|quality of life|quality of life
206954|NCT02902445|Vaccine|vaccine
206955|NCT02902445|Polymorphism|polymorphism
206956|NCT02902432|endostar|endostar
206957|NCT02902432|cisplatin|cisplatin
206958|NCT02902393|Fibrinolysis|fibrinolysis
206959|NCT02902393|tPA|tpa
206960|NCT02902367|mobility|mobility
206961|NCT02902367|exercise|exercise
206962|NCT02902367|walking capacity|walking capacity
206963|NCT02902367|fat mass|fat mass
206964|NCT02902367|muscles|muscles
206965|NCT02902341|Nutrition Therapy|nutrition therapy
206966|NCT02902315|Muscle soreness|muscle soreness
206967|NCT02902315|Free radicals|free radicals
206968|NCT02902315|Ascorbic acid|ascorbic acid
206969|NCT02902315|Alpha-Tocopherol|alpha-tocopherol
206970|NCT02902315|Cryotherapy|cryotherapy
206971|NCT02902315|Exercise tolerance|exercise tolerance
206972|NCT02902315|Resistance training|resistance training
206973|NCT02902302|Bioequivalence|bioequivalence
206974|NCT02902302|Ibuprofen 400 mg/5 ml|ibuprofen 400 mg/5 ml
206975|NCT02902302|Moment 400 mg coated tablet|moment 400 mg coated tablet
206976|NCT02902302|Oral Suspension|oral suspension
206977|NCT02902289|Bioequivalence|bioequivalence
206978|NCT02902289|Ibuprofen 200 mg/5 ml|ibuprofen 200 mg/5 ml
206979|NCT02902289|Moment 200 mg coated tablet|moment 200 mg coated tablet
206980|NCT02902289|Oral Suspension|oral suspension
206981|NCT02902276|plasma citrulline|plasma citrulline
206982|NCT02902276|lipopolysaccharide|lipopolysaccharide
206983|NCT02902276|critically ill|critically ill
206984|NCT02902276|Hospitalization in an Intensive Care Unit|hospitalization in an intensive care unit
206985|NCT02902263|Telemedecine|telemedecine
206986|NCT02902263|Thrombolysis|thrombolysis
206987|NCT02902250|Vertebroplasty|vertebroplasty
206988|NCT02902250|Core decompression|core decompression
206989|NCT02902250|Osteoporosis|osteoporosis
206990|NCT02902211|ankle foot orthosis|ankle foot orthosis
206991|NCT02902211|biomechanics|biomechanics
206992|NCT02902211|mobility|mobility
206993|NCT02902185|Chidamide|chidamide
206994|NCT02902185|Histone Deacetylase Inhibitor|histone deacetylase inhibitor
206995|NCT02902185|HIV-1 Reservoir|hiv-1 reservoir
206996|NCT02902185|Chronic HIV infections|chronic hiv infections
206997|NCT02902185|HIV Eradication|hiv eradication
206998|NCT02902185|Antiretroviral Therapy|antiretroviral therapy
206999|NCT02902159|Stress|stress
207000|NCT02902159|Low Mood|low mood
207001|NCT02902159|Mental Health|mental health
207002|NCT02902159|Peer Support|peer support
207003|NCT02902159|Online|online
207004|NCT02902133|cerebrospinal fluid leak|cerebrospinal fluid leak
207005|NCT02902107|Low Dose Rate Brachytherapy|low dose rate brachytherapy
207006|NCT02902107|CivaSheet|civasheet
207007|NCT02902107|16-605|16-605
207008|NCT02902042|Unresectable or metastatic BRAF V600 mutant melanoma|unresectable or metastatic braf v600 mutant melanoma
715614|NCT00566618|Zometa|zometa
207009|NCT02902042|Encorafenib, binimetinib, pembrolizumab|encorafenib, binimetinib, pembrolizumab
207010|NCT02902029|unresectable stage IIIB, IIIC, IV melanoma|unresectable stage iiib, iiic, iv melanoma
207011|NCT02902016|PPARgamma|ppargamma
207012|NCT02902016|Lactose intolerance|lactose intolerance
207013|NCT02902016|Lactase|lactase
207014|NCT02901990|mumps|mumps
207015|NCT02901990|immunity|immunity
207016|NCT02901990|cohort study|cohort study
207017|NCT02901990|children|children
207018|NCT02901990|vaccine|vaccine
207019|NCT02901977|Hypertension|hypertension
207020|NCT02901977|Blood pressure|blood pressure
207021|NCT02901977|Hemostasis|hemostasis
207022|NCT02901977|Endothelial function|endothelial function
207023|NCT02901951|Hepatitis B surface antigen antibody|hepatitis b surface antigen antibody
207024|NCT02901951|adult subjects|adult subjects
207025|NCT02901951|Hepatitis B|hepatitis b
207026|NCT02901951|HBV|hbv
207027|NCT02901925|ABY-029|aby-029
207028|NCT02901925|Affibody|affibody
207029|NCT02901925|Molecular Fluorescence-Guided Surgery|molecular fluorescence-guided surgery
207030|NCT02901925|Epidermal Growth Factor Receptor (EGFR)|epidermal growth factor receptor (egfr)
207031|NCT02901912|physical activity|physical activity
207032|NCT02901912|sedentarism|sedentarism
207033|NCT02901912|fecal enzymatic activity|fecal enzymatic activity
207034|NCT02901886|Rheumatoid Arthritis|rheumatoid arthritis
207035|NCT02901886|Smoking Cessation|smoking cessation
207036|NCT02901886|Disease Activity|disease activity
207037|NCT02901886|Clinical Prevention|clinical prevention
207038|NCT02901808|NOMI|nomi
207039|NCT02901808|Angiography|angiography
207040|NCT02901808|Digital Subtraction Angiography (DSA)|digital subtraction angiography (dsa)
207041|NCT02901782|Knee|knee
207042|NCT02901782|Titanium Plate|titanium plate
207043|NCT02901730|laser peripheral iridoplasty|laser peripheral iridoplasty
207044|NCT02901730|treatment|treatment
207045|NCT02901678|skelatal open bite, posterior intrusion|skelatal open bite, posterior intrusion
207046|NCT02901626|Short cervix|short cervix
207047|NCT02901626|Preterm delivery|preterm delivery
207048|NCT02901626|Singletons|singletons
207049|NCT02901626|Pregnancy|pregnancy
207050|NCT02901626|Pessary|pessary
207051|NCT02901600|DMBT1 expression|dmbt1 expression
207052|NCT02901600|Colorectal cancer|colorectal cancer
207053|NCT02901548|BCG refractory CIS|bcg refractory cis
207054|NCT02901548|Urothelial CIS of bladder|urothelial cis of bladder
207055|NCT02901548|Carcinoma in situ (CIS)|carcinoma in situ (cis)
207056|NCT02901548|Bacillus Calmette-Guérin (BCG)|bacillus calmette-guérin (bcg)
207057|NCT02901548|Medi4736|medi4736
207058|NCT02901548|Durvalumab|durvalumab
207059|NCT02901548|CIS of the bladder|cis of the bladder
207060|NCT02901548|Bladder cancer|bladder cancer
207061|NCT02901548|BCG Vaccine|bcg vaccine
207062|NCT02901548|Bladder diseases|bladder diseases
207063|NCT02901548|Urothelial diseases|urothelial diseases
207064|NCT02901535|telemedicine|telemedicine
207065|NCT02901535|chronic obstructive pulmonary disease|chronic obstructive pulmonary disease
207066|NCT02901535|Primary Health care|primary health care
207067|NCT02901535|spirometry|spirometry
207068|NCT02901522|telemedicine|telemedicine
207069|NCT02901522|asthma control test|asthma control test
207070|NCT02901522|Primary Health care|primary health care
207071|NCT02901522|spirometry|spirometry
207072|NCT02901509|Chikungunya|chikungunya
207073|NCT02901509|Quality of Life|quality of life
207074|NCT02901483|Head and Neck|head and neck
207075|NCT02901457|Body Image|body image
207076|NCT02901418|chronic hepatitis B|chronic hepatitis b
207077|NCT02901418|mother to child transmission|mother to child transmission
207078|NCT02901418|interruption|interruption
207079|NCT02901418|hepatitis B immunoglobulin|hepatitis b immunoglobulin
207080|NCT02901418|pregnancy|pregnancy
207081|NCT02901418|HBsAg|hbsag
207082|NCT02901418|newborns|newborns
207083|NCT02901405|sarcoma|sarcoma
207084|NCT02901405|infection|infection
207085|NCT02901405|negative pressure|negative pressure
207086|NCT02901392|Male Urethral Slings|male urethral slings
207087|NCT02901392|Artificial Urinary Sphincter|artificial urinary sphincter
207088|NCT02901392|Prostatectomy|prostatectomy
207089|NCT02901392|Radiotherapy|radiotherapy
207090|NCT02901379|atorvastatin|atorvastatin
207091|NCT02901379|myocardial edema|myocardial edema
207092|NCT02901379|Follistatin-like 1|follistatin-like 1
207093|NCT02901379|FSTL1|fstl1
207094|NCT02901379|atorvastatin 80mg|atorvastatin 80mg
207095|NCT02901379|coronary artery bypass surgery|coronary artery bypass surgery
207096|NCT02901366|Mass balance|mass balance
207196|NCT02900664|TNBC|tnbc
207097|NCT02901340|Borderline idiopathic isolated oligohydramnios|borderline idiopathic isolated oligohydramnios
207098|NCT02901340|Fetal renal artery doppler indices|fetal renal artery doppler indices
207099|NCT02901340|neonatal outcomes|neonatal outcomes
207100|NCT02901340|Maternal hydration|maternal hydration
207101|NCT02901327|Lumbar Stabilisation Exercise|lumbar stabilisation exercise
207102|NCT02901327|Treadmill Walk|treadmill walk
207103|NCT02901327|Multifidus Muscle Activation|multifidus muscle activation
207104|NCT02901327|Pain Intensity|pain intensity
207105|NCT02901327|Functional Disability|functional disability
207106|NCT02901288|pulmonary tuberculosis|pulmonary tuberculosis
207107|NCT02901288|shortened regimen|shortened regimen
207108|NCT02901288|clinical trial|clinical trial
207109|NCT02901275|Clinical Trial, Phase II|clinical trial, phase ii
207110|NCT02901275|Analgesia|analgesia
207111|NCT02901262|continuous EEG|continuous eeg
207112|NCT02901249|Cost effectiveness|cost effectiveness
207113|NCT02901249|Unipolar Depression|unipolar depression
207114|NCT02901249|Major Depression Disorder|major depression disorder
207115|NCT02901249|Quality of life disorder|quality of life disorder
207116|NCT02901236|trabeculectomy|trabeculectomy
207117|NCT02901236|glaucoma|glaucoma
207118|NCT02901236|filtration surgery|filtration surgery
207119|NCT02901236|wound healing|wound healing
207120|NCT02901236|angiogenesis|angiogenesis
207121|NCT02901236|mitomycin|mitomycin
207122|NCT02901236|vascular endothelial growth factor inhibition|vascular endothelial growth factor inhibition
207123|NCT02901223|Oncoplastic breast surgery|oncoplastic breast surgery
207124|NCT02901223|oncological safety|oncological safety
207125|NCT02901223|patient satisfaction|patient satisfaction
207126|NCT02901210|Recta prolapse|recta prolapse
207127|NCT02901210|Intraoperative bleeding|intraoperative bleeding
207128|NCT02901210|mucosal cauterization|mucosal cauterization
207129|NCT02901197|capnography|capnography
207130|NCT02901171|Smoking cessation|smoking cessation
207131|NCT02901171|Acceptance and Commitment Therapy|acceptance and commitment therapy
207132|NCT02901171|Smartphone|smartphone
207133|NCT02901158|esophageal pressure|esophageal pressure
207134|NCT02901158|chest wall elastance|chest wall elastance
207135|NCT02901158|lung elastance|lung elastance
207136|NCT02901158|transpulmonary pressure|transpulmonary pressure
207137|NCT02901145|immunotherapy,solid tumor,pediatric|immunotherapy,solid tumor,pediatric
207138|NCT02901106|Multiple Sclerosis, Relapsing-Remitting|multiple sclerosis, relapsing-remitting
207139|NCT02901106|Dimethyl fumarate|dimethyl fumarate
207140|NCT02901093|Stapes surgery|stapes surgery
207141|NCT02901093|Sensorineural complications|sensorineural complications
207142|NCT02901093|Inner ear|inner ear
207143|NCT02901093|Imaging|imaging
207144|NCT02901093|Cone Beam CT|cone beam ct
207145|NCT02901067|Fibrinolysis|fibrinolysis
207146|NCT02901015|schizophrenia|schizophrenia
207147|NCT02901002|Complex Regional Pain Syndromes|complex regional pain syndromes
207148|NCT02901002|Pain|pain
207149|NCT02901002|Spontaneous sensations|spontaneous sensations
207150|NCT02901002|interoception|interoception
207151|NCT02900989|Psychiatry|psychiatry
207152|NCT02900989|Pediatrics|pediatrics
207153|NCT02900989|Suicide|suicide
207154|NCT02900963|Nutrition|nutrition
207155|NCT02900963|Head and Neck Cancer|head and neck cancer
207156|NCT02900950|cancer|cancer
207157|NCT02900950|resection margin|resection margin
207158|NCT02900950|pathology|pathology
207159|NCT02900950|pancreas|pancreas
207160|NCT02900937|Stents|stents
207161|NCT02900937|Angioplasty|angioplasty
207162|NCT02900937|Coronary Vessels|coronary vessels
207163|NCT02900937|Coronary Artery Disease|coronary artery disease
207164|NCT02900937|Angina Pectoris|angina pectoris
207165|NCT02900937|Myocardial Ischemia|myocardial ischemia
207166|NCT02900937|Myocardial Infarction|myocardial infarction
207167|NCT02900937|Myocardial Revascularization|myocardial revascularization
207169|NCT02900924|PVD|pvd
207170|NCT02900924|SFA stent|sfa stent
207171|NCT02900911|head and neck cancer|head and neck cancer
207172|NCT02900911|dysphagia|dysphagia
207173|NCT02900911|rehabilitation|rehabilitation
207174|NCT02900911|radiation therapy|radiation therapy
207175|NCT02900820|Anti-Bacterial Agents|anti-bacterial agents
207176|NCT02900820|Primary Health Care|primary health care
207177|NCT02900820|Drug Resistance, Microbial|drug resistance, microbial
207178|NCT02900820|Respiratory Tract Infections|respiratory tract infections
207179|NCT02900781|Arthroplasty|arthroplasty
207180|NCT02900781|Physical Therapy|physical therapy
207181|NCT02900768|Bone Marrow Transplantation|bone marrow transplantation
207182|NCT02900768|Exercise|exercise
207183|NCT02900768|Rehabilitation|rehabilitation
207184|NCT02900768|Cancer|cancer
207185|NCT02900755|Electroencephalography|electroencephalography
207186|NCT02900755|Perampanel|perampanel
207187|NCT02900742|lung cancer|lung cancer
207188|NCT02900742|traditional Chinese medicine|traditional chinese medicine
207189|NCT02900742|maintenance therapy|maintenance therapy
207190|NCT02900742|chemotherapy|chemotherapy
207191|NCT02900677|Pancreatic Cancer|pancreatic cancer
207192|NCT02900677|Fatigue|fatigue
207193|NCT02900677|Nutrition|nutrition
207194|NCT02900677|Quality of Life|quality of life
207195|NCT02900664|CRC|crc
207197|NCT02900664|NSCLC (adenocarcinoma)|nsclc (adenocarcinoma)
207198|NCT02900664|Immunomodulation|immunomodulation
207199|NCT02900664|Biomarkers|biomarkers
207200|NCT02900664|Bayesian logistic regression model|bayesian logistic regression model
207201|NCT02900664|PDR001|pdr001
207202|NCT02900664|Immunotherapy|immunotherapy
400622|NCT01866007|Prefilled syringe facilitated injection device (PFS FID)|prefilled syringe facilitated injection device (pfs fid)
207203|NCT02900651|MAK683, DLBCL, EED - Embryonic ectoderm development, EZH2 - Enhancer of zeste homolog 2|mak683, dlbcl, eed - embryonic ectoderm development, ezh2 - enhancer of zeste homolog 2
207204|NCT02900638|mentoring|mentoring
207205|NCT02900638|children|children
207206|NCT02900638|cardiovascular health|cardiovascular health
207207|NCT02900612|dyslipidemias,|dyslipidemias,
207208|NCT02900612|aging|aging
207209|NCT02900612|water aerobics training|water aerobics training
207210|NCT02900612|resistance aquatic training|resistance aquatic training
207211|NCT02900612|lipid profile|lipid profile
207212|NCT02900599|HIV|hiv
207213|NCT02900599|Behavior|behavior
207214|NCT02900547|Systolic Heart Failure|systolic heart failure
207215|NCT02900547|medical algorithm decision support system|medical algorithm decision support system
207216|NCT02900534|grief|grief
207217|NCT02900534|depression|depression
207218|NCT02900534|bereavement|bereavement
207219|NCT02900534|divorce|divorce
207220|NCT02900534|online self-help|online self-help
207221|NCT02900495|Nocturnal Enuresis|nocturnal enuresis
207222|NCT02900495|Bedwetting|bedwetting
207223|NCT02900495|TENS|tens
207224|NCT02900469|RANK|rank
207225|NCT02900469|RANKL|rankl
207226|NCT02900456|Intra-aortic Balloon Pumps|intra-aortic balloon pumps
207227|NCT02900456|Registry|registry
207228|NCT02900417|type 2 diabetes|type 2 diabetes
207229|NCT02900417|gut microbiota|gut microbiota
207230|NCT02900417|sitagliptin|sitagliptin
207231|NCT02900378|sacubitril/valsartan|sacubitril/valsartan
207232|NCT02900378|enalapril|enalapril
207233|NCT02900378|physical activity|physical activity
207234|NCT02900378|actigraphy|actigraphy
207235|NCT02900378|sleep|sleep
207236|NCT02900378|heart failure|heart failure
207237|NCT02900378|reduced ejection fraction|reduced ejection fraction
207238|NCT02900378|randomized controlled trial|randomized controlled trial
207239|NCT02900378|accelerometry|accelerometry
207240|NCT02900365|trauma|trauma
207241|NCT02900365|cataract|cataract
207242|NCT02900365|lensectomy|lensectomy
207243|NCT02900365|time|time
207244|NCT02900365|early|early
207245|NCT02900365|late|late
207246|NCT02900352|Alcohol Use Disorder|alcohol use disorder
207247|NCT02900352|Alcoholism|alcoholism
207248|NCT02900352|Alcohol Dependence|alcohol dependence
207249|NCT02900352|Zonisamide|zonisamide
207250|NCT02900352|Alcohol Intoxication|alcohol intoxication
207251|NCT02900352|Drinking Behaviors|drinking behaviors
207252|NCT02900352|Anticonvulsants|anticonvulsants
207253|NCT02900339|MRI|mri
207254|NCT02900339|Sequence optimization|sequence optimization
207255|NCT02900339|Healthy volunteers|healthy volunteers
207256|NCT02900326|Exercise capacity|exercise capacity
207257|NCT02900326|Mindfulness|mindfulness
207258|NCT02900326|Quality of life|quality of life
207259|NCT02900313|acute kidney injury|acute kidney injury
207260|NCT02900313|cardiac surgery|cardiac surgery
207261|NCT02900313|cardiac surgery associated acute kidney injury|cardiac surgery associated acute kidney injury
207262|NCT02900313|renal replacement therapy|renal replacement therapy
207263|NCT02900313|renal recovery|renal recovery
207264|NCT02900313|serum hyperphosphatemia|serum hyperphosphatemia
207265|NCT02900287|Survival|survival
207266|NCT02900287|Cancer|cancer
207267|NCT02900248|Biomarkers|biomarkers
207268|NCT02900248|High-Throughput Nucleotide Sequencing|high-throughput nucleotide sequencing
207269|NCT02900248|Neoplasms|neoplasms
207270|NCT02900248|Myelodysplastic Syndromes|myelodysplastic syndromes
207271|NCT02900235|Healthy|healthy
207272|NCT02900209|Influenza|influenza
207273|NCT02900209|Exacerbations|exacerbations
207274|NCT02900196|Probiotics|probiotics
207275|NCT02900196|Antibiotic Associated Diarrhea|antibiotic associated diarrhea
207276|NCT02900196|Gastro-Intestinal disorders|gastro-intestinal disorders
207277|NCT02900196|Helicobacter pylori|helicobacter pylori
207278|NCT02900170|Rivaroxaban, Acute Kidney Injury|rivaroxaban, acute kidney injury
207279|NCT02900157|Advanced Solid Tumor|advanced solid tumor
207280|NCT02900157|Immunotherapy|immunotherapy
207281|NCT02900157|MEDI9090|medi9090
207282|NCT02900157|MEDI4736|medi4736
207283|NCT02900157|Durvalumab|durvalumab
207284|NCT02900118|Bone metastasis|bone metastasis
207285|NCT02900118|PET-CT|pet-ct
207286|NCT02900118|whole-body MRI|whole-body mri
207287|NCT02900092|postmenopausal|postmenopausal
207288|NCT02900092|women|women
207289|NCT02900092|depression|depression
207290|NCT02900079|malaria|malaria
207291|NCT02900079|rapid diagnostic test|rapid diagnostic test
207292|NCT02900079|travel|travel
207293|NCT02900079|fever|fever
207294|NCT02900079|self care|self care
207295|NCT02900066|fever|fever
207296|NCT02900066|traveler|traveler
207297|NCT02900066|arbovirus|arbovirus
207298|NCT02900066|rickettsia|rickettsia
207299|NCT02900066|malaria|malaria
207300|NCT02900066|filter paper|filter paper
207301|NCT02900066|diagnosis|diagnosis
207302|NCT02900001|myocardial infarction|myocardial infarction
207303|NCT02900001|invasive strategy|invasive strategy
207304|NCT02900001|elderly|elderly
207305|NCT02900001|deferred|deferred
207306|NCT02899988|IL-23|il-23
207307|NCT02899988|dermatology|dermatology
207308|NCT02899975|Validation|validation
207309|NCT02899975|Information and Fitness Software|information and fitness software
207310|NCT02899975|Elderly|elderly
207311|NCT02899975|WeTakeCare|wetakecare
207312|NCT02899949|dapagliflozin|dapagliflozin
207313|NCT02899949|type 2 diabetes|type 2 diabetes
207314|NCT02899949|real-world data|real-world data
207315|NCT02899936|Mass drug administration|mass drug administration
207316|NCT02899936|Safety Data|safety data
207317|NCT02899897|echocardiography|echocardiography
207318|NCT02899884|Drug Therapy|drug therapy
207319|NCT02899871|joint pain|joint pain
207320|NCT02899858|Thoracic spinal cord injury|thoracic spinal cord injury
207321|NCT02899858|Paralysis|paralysis
207322|NCT02899858|ASIA A|asia a
207323|NCT02899858|Device|device
207324|NCT02899832|children|children
207325|NCT02899832|spasms|spasms
207326|NCT02899819|pesticides|pesticides
207327|NCT02899819|exposure|exposure
207328|NCT02899819|in utero|in utero
207329|NCT02899806|Video Information|video information
207330|NCT02899806|Satisfaction|satisfaction
207331|NCT02899806|Anxiety|anxiety
207332|NCT02899806|Epidural Analgesia|epidural analgesia
207333|NCT02899806|Comprehension|comprehension
207334|NCT02899806|delivery|delivery
207335|NCT02899767|transfusion dependency|transfusion dependency
207336|NCT02899767|transfusion intensity|transfusion intensity
207337|NCT02899767|prognosis|prognosis
207338|NCT02899767|chemotherapy|chemotherapy
207339|NCT02899754|lung cancer|lung cancer
207340|NCT02899754|decision support|decision support
207341|NCT02899754|implementation|implementation
207342|NCT02899741|Medically intractable epilepsy, Omega-3|medically intractable epilepsy, omega-3
207343|NCT02899689|Labor|labor
207344|NCT02899689|Foley|foley
207345|NCT02899689|Dilapan|dilapan
207346|NCT02899689|Cervical Dilators|cervical dilators
207347|NCT02899689|Induction|induction
207348|NCT02899650|Delayed Onset Muscle Soreness|delayed onset muscle soreness
207349|NCT02899650|Eccentric exercise|eccentric exercise
207350|NCT02899650|Masters athlete|masters athlete
207351|NCT02899637|Incomplete Spinal Cord Injury|incomplete spinal cord injury
207352|NCT02899637|Rehabilitation|rehabilitation
207353|NCT02899637|Non-invasive brain stimulation|non-invasive brain stimulation
207354|NCT02899637|Transcranial Magnetic Stimulation|transcranial magnetic stimulation
207355|NCT02899611|Epilepsy|epilepsy
207356|NCT02899585|Palliative care|palliative care
207357|NCT02899546|Peripherally Inserted Central Catheter|peripherally inserted central catheter
207358|NCT02899546|Infections|infections
207359|NCT02899546|Radiology|radiology
207361|NCT02899533|Pulmonary hypertension|pulmonary hypertension
207362|NCT02899507|Out-of-hospital cardiac arrest|out-of-hospital cardiac arrest
207363|NCT02899507|Prophylactic antibiotics|prophylactic antibiotics
207364|NCT02899468|TBI|tbi
207365|NCT02899468|Virtual Reality|virtual reality
207366|NCT02899455|Hypertension|hypertension
207367|NCT02899455|Hyperlipidemia|hyperlipidemia
207368|NCT02899442|cardiovascular risk|cardiovascular risk
207369|NCT02899442|Occupational Health|occupational health
207370|NCT02899442|night work|night work
207371|NCT02899442|Public Health|public health
207372|NCT02899442|Preventive Health Services|preventive health services
207373|NCT02899416|cardiovascular risk|cardiovascular risk
207374|NCT02899416|young adulthood|young adulthood
207375|NCT02899403|Cognitive Tasks|cognitive tasks
207376|NCT02899403|Mild Cognitive Impairment|mild cognitive impairment
207377|NCT02899403|Neurophysiological Correlates|neurophysiological correlates
207378|NCT02899403|Healthy Volunteers|healthy volunteers
207379|NCT02899377|PET/CT|pet/ct
207380|NCT02899377|Primary Sjögren's Syndrome|primary sjögren's syndrome
207381|NCT02899377|Magnetic resonance imaging|magnetic resonance imaging
207382|NCT02899377|11^C-MET|11^c-met
207383|NCT02899377|18^F-FDG|18^f-fdg
207384|NCT02899364|Sodium thiosulfate|sodium thiosulfate
207385|NCT02899364|STEMI|stemi
207386|NCT02899364|Infarct size|infarct size
207387|NCT02899364|Cardiac magnetic resonance imaging|cardiac magnetic resonance imaging
207388|NCT02899364|Hydrogen sulfide|hydrogen sulfide
207389|NCT02899286|Acute myeloid leukemia|acute myeloid leukemia
207390|NCT02899286|AML|aml
207391|NCT02899286|pegylated recombinant human arginase|pegylated recombinant human arginase
207392|NCT02899286|PEG-BCT-100|peg-bct-100
207393|NCT02899273|Early Childhood Caries|early childhood caries
207394|NCT02899273|eye-tracking|eye-tracking
207395|NCT02899273|children|children
207396|NCT02899273|dentistry|dentistry
207397|NCT02899273|face perception|face perception
207398|NCT02899247|composite resin|composite resin
207399|NCT02899247|surface sealant|surface sealant
207400|NCT02899234|Nicotine|nicotine
207401|NCT02899234|Electronic Cigarette|electronic cigarette
207402|NCT02899195|Unresectable Mesothelioma|unresectable mesothelioma
207403|NCT02899195|Durvalumab|durvalumab
207404|NCT02899195|Anti-Programmed Death-Ligand 1 Antibody|anti-programmed death-ligand 1 antibody
207405|NCT02899169|Acute promyelocytic leukemia|acute promyelocytic leukemia
207406|NCT02899169|Realgar-Indigo Naturalis Formula|realgar-indigo naturalis formula
207407|NCT02899169|All-trans Retinoic Acid|all-trans retinoic acid
207408|NCT02899091|Alzheimer's disease|alzheimer's disease
207409|NCT02899091|Mesenchymal Stem cells|mesenchymal stem cells
207410|NCT02899052|Multiple Myeloma|multiple myeloma
207411|NCT02899052|Refractory myeloma|refractory myeloma
207412|NCT02899052|Relapsed myeloma|relapsed myeloma
207413|NCT02899052|Relapsed or Refractory|relapsed or refractory
207414|NCT02899026|Glucocorticosteroids|glucocorticosteroids
207415|NCT02899026|Sirukumab|sirukumab
207416|NCT02899026|Prednisone|prednisone
207417|NCT02899026|Polymyalgia Rheumatica|polymyalgia rheumatica
207418|NCT02899013|Perianal Lesions|perianal lesions
207419|NCT02898987|HIV|hiv
207420|NCT02898987|Hepatitis C|hepatitis c
207421|NCT02898987|Comorbidities|comorbidities
207422|NCT02898987|AIDS|aids
207423|NCT02898948|procalcitonin|procalcitonin
207424|NCT02898948|bacterial infection|bacterial infection
207425|NCT02898909|femtosecond laser-assisted cataract surgery|femtosecond laser-assisted cataract surgery
207426|NCT02898909|nuclear lens fragmentation|nuclear lens fragmentation
207427|NCT02898844|dieting|dieting
207428|NCT02898844|dyads|dyads
207429|NCT02898844|psychological well-being|psychological well-being
207430|NCT02898844|weight loss|weight loss
207431|NCT02898844|cortisol|cortisol
207432|NCT02898792|sensitivity, opioid|sensitivity, opioid
207433|NCT02898753|GSD-II|gsd-ii
207434|NCT02898753|Pompe Disease|pompe disease
207435|NCT02898753|Glycogen Storage Diseases|glycogen storage diseases
207436|NCT02898753|GAA|gaa
207437|NCT02898740|Parkinson's disease|parkinson's disease
207438|NCT02898740|exercise therapy|exercise therapy
207439|NCT02898740|quality of life|quality of life
207440|NCT02898701|Motor Learning|motor learning
207441|NCT02898701|Dose of Motor Practice|dose of motor practice
207442|NCT02898701|Postural Control|postural control
207443|NCT02898701|Serial Reaction Time Task|serial reaction time task
207444|NCT02898701|Retention|retention
207445|NCT02898701|Transfer|transfer
207446|NCT02898701|Overpractice|overpractice
207447|NCT02898701|Overtraining|overtraining
207448|NCT02898701|Overlearning|overlearning
207449|NCT02898688|Influenza vaccine|influenza vaccine
207450|NCT02898688|Pertussis vaccine|pertussis vaccine
207451|NCT02898688|Perinatal vaccination|perinatal vaccination
207452|NCT02898688|Infant vaccination|infant vaccination
207453|NCT02898662|inhaled|inhaled
207454|NCT02898662|TLR9 agonist|tlr9 agonist
207455|NCT02898662|withdrawal design|withdrawal design
207456|NCT02898662|loss of control|loss of control
207457|NCT02898532|Children, ADHD, target shooting sport|children, adhd, target shooting sport
207458|NCT02898506|Diabetes Type 1|diabetes type 1
207459|NCT02898506|Diabetes, Insulin-Dependent|diabetes, insulin-dependent
207460|NCT02898506|Liraglutide|liraglutide
207461|NCT02898506|Preclinical Type 1 Diabetes|preclinical type 1 diabetes
207462|NCT02898506|GLP-1 Analogue|glp-1 analogue
207463|NCT02898506|Dysglycemia|dysglycemia
207464|NCT02898506|Prevention|prevention
207465|NCT02898493|Validation of questionnaire|validation of questionnaire
207466|NCT02898493|Quality of life|quality of life
207467|NCT02898441|lung cancer screening|lung cancer screening
207468|NCT02898441|low-dose CT|low-dose ct
207469|NCT02898441|high-risk population|high-risk population
207470|NCT02898415|HCC|hcc
207471|NCT02898415|Liver Transplantation|liver transplantation
207472|NCT02898415|AFP|afp
207473|NCT02898415|Mortality|mortality
207474|NCT02898415|Competing risk|competing risk
207475|NCT02898415|Selection criteria|selection criteria
207476|NCT02898415|Recurrence|recurrence
207477|NCT02898376|spa care|spa care
207478|NCT02898376|randomised controlled trial|randomised controlled trial
207479|NCT02898376|pentoxifylline/tocopherol combination|pentoxifylline/tocopherol combination
207480|NCT02898376|late sequelae|late sequelae
207481|NCT02898376|radiotherapy|radiotherapy
207482|NCT02898363|Care of disabled population|care of disabled population
207483|NCT02898363|Mental retardation|mental retardation
207484|NCT02898363|Cancer screening|cancer screening
207485|NCT02898363|Cancer prevention|cancer prevention
207486|NCT02898324|Bullying|bullying
207487|NCT02898324|KiVa program|kiva program
207488|NCT02898324|Primary school students|primary school students
207489|NCT02898311|CAD-CAM|cad-cam
207490|NCT02898311|composite dental resin|composite dental resin
207491|NCT02898311|Immediate dental implant loading|immediate dental implant loading
207492|NCT02898259|Lenalidomide|lenalidomide
207493|NCT02898259|Ixazomib|ixazomib
207494|NCT02898259|Rituximab|rituximab
207495|NCT02898246|heart failure|heart failure
207496|NCT02898246|fear of physical activity|fear of physical activity
207497|NCT02898246|motor activity|motor activity
207498|NCT02898233|depression|depression
207499|NCT02898233|internet-based|internet-based
207500|NCT02898233|treatment|treatment
207501|NCT02898233|low-level light therapy|low-level light therapy
207502|NCT02898233|LLLT|lllt
207503|NCT02898233|deprexis|deprexis
207504|NCT02898194|Surrogate Decision-making|surrogate decision-making
207505|NCT02898194|Health Care|health care
207506|NCT02898194|Medical Decisions|medical decisions
207507|NCT02898194|End of Life Care|end of life care
207508|NCT02898168|stroke|stroke
207509|NCT02898168|Rehabilitation|rehabilitation
207510|NCT02898168|WalkAide (WA)|walkaide (wa)
207511|NCT02898168|Functional Electrical Stimulation (FES)|functional electrical stimulation (fes)
207512|NCT02898155|Avoidable hospitalizations|avoidable hospitalizations
207513|NCT02898155|primary care|primary care
207514|NCT02898155|geographicvariation|geographicvariation
207515|NCT02898142|Postprandial test|postprandial test
207516|NCT02898142|Metabolic syndrime|metabolic syndrime
207517|NCT02898142|HTG|htg
207518|NCT02898129|chronic respiratory diseases|chronic respiratory diseases
207519|NCT02898129|housing|housing
207520|NCT02898129|lung function test|lung function test
207521|NCT02898116|ALK-rearranged|alk-rearranged
207522|NCT02898116|ALK-positive|alk-positive
207523|NCT02898116|ALK Inhibitor|alk inhibitor
207524|NCT02898116|Ensartinib|ensartinib
207525|NCT02898116|X-396|x-396
207526|NCT02898116|anti-PD-L1|anti-pd-l1
207527|NCT02898116|Durvalumab|durvalumab
207528|NCT02898116|MEDI4736|medi4736
207529|NCT02898116|ALK|alk
207530|NCT02898090|Quality indicators|quality indicators
207531|NCT02898090|Appropriateness|appropriateness
207532|NCT02898090|Oral anticoagulant prescriptions|oral anticoagulant prescriptions
207533|NCT02898090|Development and validation|development and validation
207534|NCT02898090|Hospital information system|hospital information system
207535|NCT02898090|Information Storage and Retrieval|information storage and retrieval
207536|NCT02898090|Natural Language Processing|natural language processing
207537|NCT02898077|Second line|second line
207538|NCT02898077|Angiogenesis|angiogenesis
207539|NCT02898077|Vascular endothelial growth factor receptor 2|vascular endothelial growth factor receptor 2
207540|NCT02898051|heparin low-molecular-weight;pharmacokinetics|heparin low-molecular-weight;pharmacokinetics
207541|NCT02898012|Glioblastoma Multiforme|glioblastoma multiforme
207542|NCT02898012|temozolomide|temozolomide
207543|NCT02898012|bevacizumab|bevacizumab
207544|NCT02897973|Spinal loads|spinal loads
207545|NCT02897973|Trunk muscle force|trunk muscle force
207546|NCT02897973|Computational modeling|computational modeling
207547|NCT02897973|Unilateral lower limb amputation|unilateral lower limb amputation
207548|NCT02897960|wheezing|wheezing
207549|NCT02897960|bronchiolitis|bronchiolitis
207550|NCT02897960|respiratory sound algorithm|respiratory sound algorithm
207551|NCT02897947|Lumbosacral Region|lumbosacral region
207552|NCT02897947|Surgery|surgery
207553|NCT02897947|Registries|registries
207554|NCT02897895|Lung transplantation in end-stage lung diseases|lung transplantation in end-stage lung diseases
207555|NCT02897843|Electroconvulsive Therapy|electroconvulsive therapy
207556|NCT02897843|Transcranial Direct Current Stimulation|transcranial direct current stimulation
207557|NCT02897843|cognition|cognition
207558|NCT02897817|Methotrexate|methotrexate
207559|NCT02897817|Treatment adherence|treatment adherence
207560|NCT02897804|multiphase optimization strategy|multiphase optimization strategy
207561|NCT02897804|college students|college students
207562|NCT02897778|entinostat|entinostat
207563|NCT02897778|solid tumor|solid tumor
207564|NCT02897778|Histone Deacetylase Inhibitors|histone deacetylase inhibitors
207565|NCT02897765|Checkpoint Inhibitor|checkpoint inhibitor
207566|NCT02897765|Immunotherapy|immunotherapy
207567|NCT02897765|Personal Vaccine|personal vaccine
207568|NCT02897765|Neoantigen|neoantigen
207569|NCT02897765|Poly-ICLC|poly-iclc
207570|NCT02897765|Peptide|peptide
207571|NCT02897752|stroke|stroke
207572|NCT02897752|Rehabilitation|rehabilitation
207573|NCT02897752|WalkAide (WA)|walkaide (wa)
207574|NCT02897752|Functional Electrical Stimulation (FES)|functional electrical stimulation (fes)
207575|NCT02897713|mechanical ventilation|mechanical ventilation
207576|NCT02897713|enteral nutrition|enteral nutrition
207577|NCT02897713|feeding intolerance|feeding intolerance
207578|NCT02897700|Chemotherapy|chemotherapy
207579|NCT02897700|Safety|safety
207580|NCT02897700|Tolerability|tolerability
207581|NCT02897700|Efficacy|efficacy
207582|NCT02897687|Autism Spectrum Disorder|autism spectrum disorder
207583|NCT02897687|Social Skills|social skills
207584|NCT02897687|Social Media|social media
207585|NCT02897674|palm oil|palm oil
207586|NCT02897674|lipid profile|lipid profile
207587|NCT02897661|fecal microbiota transplantation|fecal microbiota transplantation
207588|NCT02897661|enteral nutrition|enteral nutrition
207589|NCT02897622|Eating disorders|eating disorders
207590|NCT02897622|severe and enduring|severe and enduring
207591|NCT02897622|quality of life|quality of life
207592|NCT02897622|case management|case management
207593|NCT02897609|Beta-lactamine|beta-lactamine
207594|NCT02897609|β-lactamine|β-lactamine
207595|NCT02897570|ghrelin|ghrelin
207596|NCT02897570|breakfast meal|breakfast meal
207597|NCT02897570|P-300|p-300
207598|NCT02897531|Ileocolic, stapled, laparoscopy, right hemicolectomy|ileocolic, stapled, laparoscopy, right hemicolectomy
207599|NCT02897518|Videolaryngoscopes|videolaryngoscopes
207600|NCT02897518|Intubation|intubation
207601|NCT02897505|post traumatic stress disorder (PTSD)|post traumatic stress disorder (ptsd)
265405|NCT02547818|MCI|mci
207602|NCT02897466|ventilator-associated pneumonia|ventilator-associated pneumonia
207603|NCT02897466|Multidrug-resistant bacteria|multidrug-resistant bacteria
207604|NCT02897440|Femoral Neck Fracture|femoral neck fracture
207605|NCT02897440|Hip Arthroplasty|hip arthroplasty
207606|NCT02897440|Repairing of soft tissue|repairing of soft tissue
207607|NCT02897401|urinary N'Nitrosonornicotine|urinary n'nitrosonornicotine
207608|NCT02897401|nicotine|nicotine
207609|NCT02897401|electronic cigarette|electronic cigarette
207610|NCT02897401|nicotine remplacement treatment|nicotine remplacement treatment
207611|NCT02897362|ADHD|adhd
207612|NCT02897362|Sleep|sleep
207613|NCT02897362|Adolescents|adolescents
207614|NCT02897362|Neurocognition|neurocognition
207615|NCT02897362|Polysomnography|polysomnography
207616|NCT02897310|critically ill patients|critically ill patients
207617|NCT02897310|acute kidney injury|acute kidney injury
207618|NCT02897310|renal replacement therapy|renal replacement therapy
207619|NCT02897310|long term outcome|long term outcome
207620|NCT02897284|Mindfulness-based|mindfulness-based
207621|NCT02897284|Self-care|self-care
207622|NCT02897284|Health workers|health workers
207623|NCT02897284|Epigenetics|epigenetics
207624|NCT02897271|Eosinophilic Gastrointestinal Disorders|eosinophilic gastrointestinal disorders
207625|NCT02897258|Dialysis|dialysis
207626|NCT02897258|Thrombosis|thrombosis
207627|NCT02897258|Haemorrhage|haemorrhage
207628|NCT02897245|Myelogenous|myelogenous
207629|NCT02897245|Chronic|chronic
207630|NCT02897245|BCR-ABL Positive|bcr-abl positive
207631|NCT02897232|Human Papillomavirus Vaccine|human papillomavirus vaccine
207633|NCT02897232|Patient Acceptance|patient acceptance
207634|NCT02897232|Physician Comfort|physician comfort
207635|NCT02897232|Male Vaccination|male vaccination
207636|NCT02897232|HPV Associated Cancers|hpv associated cancers
207637|NCT02897219|SGLT2 inhibitor|sglt2 inhibitor
207638|NCT02897219|ASP1941|asp1941
207639|NCT02897219|type 1 diabetes mellitus|type 1 diabetes mellitus
207640|NCT02897206|Acute pancreatitis|acute pancreatitis
207641|NCT02897206|Antibiotic prophylaxis|antibiotic prophylaxis
207642|NCT02897206|Imipenem-cilastatin|imipenem-cilastatin
207643|NCT02897206|Infected pancreatic necrosis|infected pancreatic necrosis
207644|NCT02897206|Infection|infection
207645|NCT02897206|Organ failure|organ failure
207646|NCT02897180|tuberculosis|tuberculosis
207647|NCT02897180|latent tuberculosis infection|latent tuberculosis infection
207648|NCT02897180|Food supplement|food supplement
207649|NCT02897180|Mycobacterium manresensis|mycobacterium manresensis
207650|NCT02897180|Nyaditum resae|nyaditum resae
207651|NCT02897180|Efficacy trial|efficacy trial
207652|NCT02897167|Psychosis|psychosis
207653|NCT02897167|Antipsychotic Agents|antipsychotic agents
207654|NCT02897167|Immunology|immunology
207655|NCT02897167|Schizophrenia Spectrum and Other Psychotic Disorders|schizophrenia spectrum and other psychotic disorders
207656|NCT02897141|HIV|hiv
207657|NCT02897141|Health Management App|health management app
207658|NCT02897141|HIV symptoms|hiv symptoms
207659|NCT02897128|Sarcoma|sarcoma
207660|NCT02897128|Radiation|radiation
207661|NCT02897128|Wound healing|wound healing
207662|NCT02897115|Axial Spondyloarthritis|axial spondyloarthritis
207663|NCT02897115|Humira|humira
207664|NCT02897089|universal adhesive|universal adhesive
207665|NCT02897089|fissure sealants|fissure sealants
207666|NCT02897089|retention|retention
207667|NCT02897063|midodrine|midodrine
207668|NCT02897063|droxidopa|droxidopa
207669|NCT02897063|splanchnic circulation|splanchnic circulation
207670|NCT02897037|Bivalirudin|bivalirudin
207671|NCT02897037|Acute myocardial infarction|acute myocardial infarction
207672|NCT02897037|percutaneous transluminal coronary angioplasty|percutaneous transluminal coronary angioplasty
207673|NCT02897024|Cerebral Palsy|cerebral palsy
207674|NCT02897024|Motor Impairments|motor impairments
207675|NCT02896985|Patient Reported Outcome 2 (PRO 2)|patient reported outcome 2 (pro 2)
207676|NCT02896985|C-Reactive Protein (CRP)|c-reactive protein (crp)
207677|NCT02896985|Adalimumab|adalimumab
207678|NCT02896985|Harvey Bradshaw Index (HBI)|harvey bradshaw index (hbi)
207679|NCT02896985|Therapeutic Drug Monitoring (TDM)|therapeutic drug monitoring (tdm)
207680|NCT02896985|Anti-Adalimumab Antibody (AAA)|anti-adalimumab antibody (aaa)
207681|NCT02896972|vitrectomy|vitrectomy
207682|NCT02896972|macular hole retinal detachment|macular hole retinal detachment
207683|NCT02896972|high myopia|high myopia
207684|NCT02896920|Hidradenitis Suppurativa (HS)|hidradenitis suppurativa (hs)
207685|NCT02896920|Humira®|humira®
207686|NCT02896920|Canada|canada
207687|NCT02896816|Parkinson's|parkinson's
207688|NCT02896803|Pancreatic Cancer|pancreatic cancer
207689|NCT02896803|Chemotherapy|chemotherapy
207690|NCT02896790|Cancer|cancer
207691|NCT02896790|Oral Therapy|oral therapy
207692|NCT02896790|Compliance|compliance
207693|NCT02896790|Anthropology|anthropology
207694|NCT02896790|Psychology|psychology
207696|NCT02896777|IVF|ivf
207697|NCT02896777|live birth rate|live birth rate
207698|NCT02896751|CPAP|cpap
715809|NCT00565942|Shiatsu|shiatsu
207699|NCT02896751|Noninvasive Ventilation Mask|noninvasive ventilation mask
207700|NCT02896725|Venous leg ulcer|venous leg ulcer
207701|NCT02896725|Acellular skin substitutes|acellular skin substitutes
207702|NCT02896725|Keratin dressings|keratin dressings
207703|NCT02896699|Pre-exposure prophylaxis (PrEP)|pre-exposure prophylaxis (prep)
207704|NCT02896699|diffusion of innovation|diffusion of innovation
207705|NCT02896699|men who have sex with men|men who have sex with men
207706|NCT02896699|LGBT|lgbt
207707|NCT02896699|African American|african american
207708|NCT02896699|Black|black
207710|NCT02896699|network analysis|network analysis
207711|NCT02896699|network intervention|network intervention
207712|NCT02896686|Ileostomy closure|ileostomy closure
207713|NCT02896686|Polypropylene Mesh|polypropylene mesh
207714|NCT02896686|Incisional hernia|incisional hernia
207715|NCT02896673|positive expiratory pressure (PEP)|positive expiratory pressure (pep)
207716|NCT02896673|Acute Respiratory Distress Syndrome (ARDS)|acute respiratory distress syndrome (ards)
207717|NCT02896673|electrical impedance tomography (EIT)|electrical impedance tomography (eit)
207718|NCT02896673|tidal volume (TV)|tidal volume (tv)
207719|NCT02896673|transpulmonary pressure (TPP)|transpulmonary pressure (tpp)
207720|NCT02896621|Sleep Apnea|sleep apnea
207721|NCT02896621|Hypertension|hypertension
207722|NCT02896621|Chlortalidone|chlortalidone
207723|NCT02896621|Diastolic function|diastolic function
207724|NCT02896569|resurfacing|resurfacing
207725|NCT02896569|ablation|ablation
207726|NCT02896556|image analysis|image analysis
207727|NCT02896543|dendritic cells|dendritic cells
207728|NCT02896543|P-selectin|p-selectin
207729|NCT02896504|Chemobrain|chemobrain
207730|NCT02896504|Chemotherapy|chemotherapy
207731|NCT02896504|Hormonal Therapy|hormonal therapy
207732|NCT02896504|Neuroimaging|neuroimaging
207733|NCT02896465|Children|children
207734|NCT02896465|Diarrhea|diarrhea
207735|NCT02896465|Human milk oligosaccharides|human milk oligosaccharides
207736|NCT02896439|Traumatic|traumatic
207737|NCT02896439|Acetabular|acetabular
207738|NCT02896426|Parent training|parent training
207739|NCT02896426|Preschoolers|preschoolers
207740|NCT02896426|Behavior problems|behavior problems
207741|NCT02896426|Oppositional Defiant Disorder|oppositional defiant disorder
207742|NCT02896426|ODD|odd
207743|NCT02896426|Conduct Disorder|conduct disorder
207744|NCT02896426|CD|cd
207745|NCT02896426|Children|children
207746|NCT02896426|Parenting|parenting
207747|NCT02896426|Collaborative Problem Solving|collaborative problem solving
207748|NCT02896426|CPS|cps
207749|NCT02896426|Disruptive behavior|disruptive behavior
207750|NCT02896348|Hemiparesis|hemiparesis
207751|NCT02896348|Stroke|stroke
207752|NCT02896348|Rehabilitation|rehabilitation
207753|NCT02896348|Home-based|home-based
207754|NCT02896335|Recurrent Brain metastases|recurrent brain metastases
207755|NCT02896283|wound healing|wound healing
207756|NCT02896283|low-level laser therapy|low-level laser therapy
207757|NCT02896283|gingival recession|gingival recession
207758|NCT02896270|idiopathic podocytopathies|idiopathic podocytopathies
207759|NCT02896270|Neprology|neprology
207760|NCT02896257|Quality Improvement|quality improvement
207761|NCT02896257|Quality Enhancement Research Initiatives|quality enhancement research initiatives
207762|NCT02896257|QuERI|queri
207763|NCT02896257|Interventional|interventional
207764|NCT02896257|Multicenter|multicenter
207765|NCT02896257|Inhaled corticosteroids|inhaled corticosteroids
207766|NCT02896257|Pneumonia|pneumonia
207767|NCT02896257|Safety|safety
207768|NCT02896257|De-implementation|de-implementation
207769|NCT02896257|Respiratory Tract Diseases|respiratory tract diseases
207770|NCT02896257|Lung Diseases|lung diseases
207771|NCT02896257|Lung Diseases, Obstructive|lung diseases, obstructive
207772|NCT02896257|Pulmonary Diseases, Chronic Obstructive COPD|pulmonary diseases, chronic obstructive copd
207773|NCT02896244|Clostridium difficile|clostridium difficile
207774|NCT02896244|Clostridium difficile infection|clostridium difficile infection
207775|NCT02896244|antibiotics|antibiotics
207776|NCT02896244|antibiotics associated diarrhea|antibiotics associated diarrhea
207777|NCT02896244|microbiome|microbiome
207778|NCT02896244|microbiota|microbiota
207779|NCT02896218|Vancomycin|vancomycin
207780|NCT02896218|Critically Ill|critically ill
207781|NCT02896218|Pharmacist|pharmacist
207782|NCT02896218|Population Pharmacokinetic|population pharmacokinetic
207783|NCT02896218|Bayesian Methods|bayesian methods
207784|NCT02896192|POMC deficiency obesity|pomc deficiency obesity
207785|NCT02896192|PCSK1 deficiency obesity|pcsk1 deficiency obesity
207786|NCT02896179|Multiple sclerosis|multiple sclerosis
207787|NCT02896179|Gait rehabilitation|gait rehabilitation
207788|NCT02896179|Quality of life|quality of life
207789|NCT02896179|Virtual reality|virtual reality
207790|NCT02896179|Cognitive deficit|cognitive deficit
207791|NCT02896179|Robot assisted gait training|robot assisted gait training
207792|NCT02896166|nsclc and stage I and microwave ablation|nsclc and stage i and microwave ablation
207793|NCT02896140|Type 2 diabetes|type 2 diabetes
207794|NCT02896140|Obesity|obesity
207795|NCT02896140|Nutrition|nutrition
207796|NCT02896140|Dairy|dairy
207797|NCT02896127|Ankylosing Spondyloarthritis|ankylosing spondyloarthritis
207798|NCT02896127|Axial spondyloarthritis|axial spondyloarthritis
207799|NCT02896101|Mild to moderate|mild to moderate
207800|NCT02896075|delayed onset muscle soreness|delayed onset muscle soreness
207801|NCT02896075|laughter|laughter
207802|NCT02896049|neoplasms|neoplasms
207803|NCT02896049|hyperthermia|hyperthermia
207804|NCT02896036|Laparoscopic Entry|laparoscopic entry
207805|NCT02896036|Veress Needle|veress needle
207806|NCT02896036|Intraperitoneal insufflation|intraperitoneal insufflation
207807|NCT02896036|Time|time
207808|NCT02896036|Complications|complications
207809|NCT02896023|predictors|predictors
207810|NCT02896023|ovarian reserve|ovarian reserve
207811|NCT02896023|infertile women|infertile women
207812|NCT02896010|Mobile Health|mobile health
207813|NCT02895997|mental fatigue|mental fatigue
207814|NCT02895997|critical care|critical care
207815|NCT02895984|Social network analysis|social network analysis
207816|NCT02895984|Brief Motivational Interviewing|brief motivational interviewing
207817|NCT02895984|College Students|college students
207818|NCT02895971|Venous Thromboembolism|venous thromboembolism
207819|NCT02895971|professional Practices|professional practices
207820|NCT02895906|22q11.2 DS|22q11.2 ds
207821|NCT02895880|Communication Tool|communication tool
207822|NCT02895880|Cancer Survivors|cancer survivors
207823|NCT02895880|Increase Statin|increase statin
207824|NCT02895880|16-1128|16-1128
207825|NCT02895854|Low risk prostate cancer|low risk prostate cancer
207826|NCT02895854|Intermediate risk prostate cancer|intermediate risk prostate cancer
207827|NCT02895854|Low dose-rate brachytherapy|low dose-rate brachytherapy
207828|NCT02895854|Hypofractionated|hypofractionated
207829|NCT02895854|Robotic external beam radiation|robotic external beam radiation
207830|NCT02895854|Quality of life|quality of life
207831|NCT02895841|oncology|oncology
207832|NCT02895841|bone marrow transplant|bone marrow transplant
207833|NCT02895841|sickle cell disease|sickle cell disease
207834|NCT02895802|down syndrome|down syndrome
207835|NCT02895789|spinal muscular atrophy|spinal muscular atrophy
207836|NCT02895789|oxidative capacity|oxidative capacity
207837|NCT02895789|exercise tolerance|exercise tolerance
207838|NCT02895789|mitochondrial myopathy|mitochondrial myopathy
207839|NCT02895789|SMA|sma
207840|NCT02895789|six minute walk test|six minute walk test
207841|NCT02895789|neuromuscular disease|neuromuscular disease
207842|NCT02895789|ambulation|ambulation
207843|NCT02895789|exercise|exercise
207844|NCT02895789|mitochondria|mitochondria
207845|NCT02895789|cycle ergometry|cycle ergometry
207846|NCT02895789|near infrared spectroscopy|near infrared spectroscopy
207847|NCT02895763|QUALITY OF LIFE|quality of life
207848|NCT02895763|NEUROMUSCULAR DISEASES|neuromuscular diseases
207849|NCT02895750|diabetes type 2|diabetes type 2
207850|NCT02895750|Metformin|metformin
207851|NCT02895750|chronic kidney disease|chronic kidney disease
207852|NCT02895750|CKD|ckd
207853|NCT02895737|aortic stenosis, transcatheter aortic valve replacement, stroke, ischemic infarction, cerebral embolic protection device|aortic stenosis, transcatheter aortic valve replacement, stroke, ischemic infarction, cerebral embolic protection device
207854|NCT02895724|Hyperbaric oxygen therapy|hyperbaric oxygen therapy
207855|NCT02895724|secondary lymphedema|secondary lymphedema
207856|NCT02895698|Cupping|cupping
207857|NCT02895698|Dry cupping|dry cupping
207858|NCT02895698|Myofascial trigger points|myofascial trigger points
207859|NCT02895685|Simulation|simulation
207860|NCT02895685|Self-regulated training|self-regulated training
207861|NCT02895685|Education|education
207862|NCT02895685|Open surgery|open surgery
207863|NCT02895685|Dyad training|dyad training
207864|NCT02895659|fluid management|fluid management
207865|NCT02895659|critical illness|critical illness
207866|NCT02895659|hemodynamics|hemodynamics
207867|NCT02895659|buffered infusates|buffered infusates
207868|NCT02895633|MR imaging|mr imaging
207869|NCT02895633|Diffusion weighted imaging|diffusion weighted imaging
207870|NCT02895633|MR proton spectroscopy|mr proton spectroscopy
207871|NCT02895633|CT perfusion|ct perfusion
207872|NCT02895633|Contrast enhanced ultrasound|contrast enhanced ultrasound
207873|NCT02895568|Antimalarial drug|antimalarial drug
207874|NCT02895568|Resistance|resistance
207875|NCT02895568|Republic of Chard|republic of chard
207876|NCT02895555|ODI|odi
207877|NCT02895503|Stage IA Non-Small Cell Lung Carcinoma|stage ia non-small cell lung carcinoma
207878|NCT02895503|Stage IB Non-Small Cell Lung Carcinoma|stage ib non-small cell lung carcinoma
207879|NCT02895503|Stage IIA Non-Small Cell Lung Carcinoma|stage iia non-small cell lung carcinoma
207880|NCT02895503|Stage IIB Non-Small Cell Lung Carcinoma|stage iib non-small cell lung carcinoma
207881|NCT02895503|Stage IIIA Non-Small Cell Lung Cancer|stage iiia non-small cell lung cancer
207882|NCT02895503|Stage IIIB Non-Small Cell Lung Cancer|stage iiib non-small cell lung cancer
207883|NCT02895503|Stage IV Non-Small Cell Lung Cancer|stage iv non-small cell lung cancer
207884|NCT02895451|Exercise-based cardiac rehabilitation|exercise-based cardiac rehabilitation
207885|NCT02895451|Physical capacity|physical capacity
207886|NCT02895451|Adherence|adherence
207887|NCT02895451|Behavioral medicine|behavioral medicine
207888|NCT02895438|Gluten-Sensitive|gluten-sensitive
207889|NCT02895438|Diet, Gluten-Free|diet, gluten-free
207890|NCT02895438|Irritable Bowel Syndrome|irritable bowel syndrome
207891|NCT02895438|non Coeliac Gluten sensitivity|non coeliac gluten sensitivity
207892|NCT02895438|children|children
207893|NCT02895425|Renal Transplant|renal transplant
207894|NCT02895386|Hypertension|hypertension
207895|NCT02895386|High Blood Pressure|high blood pressure
207896|NCT02895386|Systolic Blood Pressure|systolic blood pressure
207897|NCT02895386|Uncontrolled Hypertension|uncontrolled hypertension
207898|NCT02895386|Essential Hypertension|essential hypertension
207899|NCT02895386|Resistant Hypertension|resistant hypertension
207900|NCT02895386|Vascular Disease|vascular disease
207901|NCT02895373|platelet inhibition|platelet inhibition
207902|NCT02895373|alprostadil|alprostadil
207903|NCT02895373|extracorporeal membrane oxygenation|extracorporeal membrane oxygenation
207904|NCT02895373|bleeding|bleeding
207905|NCT02895373|thromboembolic|thromboembolic
207907|NCT02895334|Congenital Heart Disease|congenital heart disease
207908|NCT02895321|nano-hydroxyapatite|nano-hydroxyapatite
207909|NCT02895321|potassium nitrate|potassium nitrate
207910|NCT02895308|compliance|compliance
207911|NCT02895295|Medicare Part D|medicare part d
207912|NCT02895295|decision support|decision support
207913|NCT02895295|prescription drugs|prescription drugs
207914|NCT02895295|expert recommendation|expert recommendation
207915|NCT02895295|health insurance choice|health insurance choice
207916|NCT02895282|Obesity|obesity
207917|NCT02895282|Chronobiology|chronobiology
207918|NCT02895282|Circadian|circadian
207919|NCT02895269|Complementary Alternative Providers|complementary alternative providers
207920|NCT02895269|Collaborative Shared Care|collaborative shared care
207921|NCT02895269|Primary Health Care Providers|primary health care providers
207922|NCT02895269|Psychosis|psychosis
207923|NCT02895230|Androgen-deprivation therapy|androgen-deprivation therapy
207924|NCT02895230|Prostate cancer|prostate cancer
207925|NCT02895230|Nationwide population-based cohort|nationwide population-based cohort
207926|NCT02895230|Myocardial infarction|myocardial infarction
207927|NCT02895230|Ischemic stroke|ischemic stroke
207928|NCT02895217|Energy expenditure|energy expenditure
207929|NCT02895217|Food intake|food intake
207930|NCT02895217|Women|women
207931|NCT02895217|aquacycling|aquacycling
207932|NCT02895204|Fermented Maillard reacted whey protein|fermented maillard reacted whey protein
207933|NCT02895204|Natural killer cell activity|natural killer cell activity
207934|NCT02895204|Immune function|immune function
207935|NCT02895204|Pre-albumin|pre-albumin
207936|NCT02895204|Interleukin-12|interleukin-12
207937|NCT02895178|Breast cancer|breast cancer
207938|NCT02895178|Survivors|survivors
207939|NCT02895178|Exercise|exercise
207940|NCT02895165|breast neoplasms|breast neoplasms
207941|NCT02895165|fertility preservation|fertility preservation
207942|NCT02895165|pregnancy|pregnancy
207943|NCT02895152|COPD|copd
207944|NCT02895152|Chronic Obstructive Pulmonary Disease|chronic obstructive pulmonary disease
207945|NCT02895152|Pulmonary Rehabilitation|pulmonary rehabilitation
207946|NCT02895152|Activity Monitors|activity monitors
207947|NCT02895152|Fitbit|fitbit
207948|NCT02895152|Fitness Tracker|fitness tracker
207949|NCT02895139|Additive Manufacture|additive manufacture
207950|NCT02895139|Orthotic Insole|orthotic insole
207951|NCT02895126|vulnerable family|vulnerable family
207952|NCT02895113|Aspirin|aspirin
207953|NCT02895113|Diabetes|diabetes
207954|NCT02895113|Renal function|renal function
207955|NCT02895113|Thromboxane|thromboxane
207956|NCT02895100|ulcerative colitis|ulcerative colitis
207957|NCT02895100|inflammatory bowel disease|inflammatory bowel disease
207958|NCT02895100|PROPEL|propel
207959|NCT02895100|Propel Study|propel study
207960|NCT02895087|diurnal variation|diurnal variation
207961|NCT02895087|stress|stress
207962|NCT02895074|femtosecond laser-assisted cataract surgery (FLACS)|femtosecond laser-assisted cataract surgery (flacs)
207963|NCT02895074|subfoveal choroidal thickness (SFCT)|subfoveal choroidal thickness (sfct)
207964|NCT02895074|conventional phacoemulsification surgery (CPS)|conventional phacoemulsification surgery (cps)
207965|NCT02895009|Coronary Disease|coronary disease
207966|NCT02895009|Radial artery occlusion|radial artery occlusion
207967|NCT02895009|transradial coronary intervention|transradial coronary intervention
207968|NCT02894996|pediatric|pediatric
207969|NCT02894996|anesthesia|anesthesia
207970|NCT02894996|fluid responsiveness|fluid responsiveness
207971|NCT02894996|hemodynamic|hemodynamic
207972|NCT02894983|wrist fracture|wrist fracture
207973|NCT02894983|colles fracture|colles fracture
207974|NCT02894983|non-operative|non-operative
207975|NCT02894983|rehabilitation|rehabilitation
207976|NCT02894944|Pancreatic cancer|pancreatic cancer
207977|NCT02894944|Adenovirus|adenovirus
207978|NCT02894944|Gene therapy|gene therapy
207979|NCT02894931|macrophage atherogenicity|macrophage atherogenicity
207980|NCT02894931|dietary interventions|dietary interventions
207981|NCT02894931|sugars|sugars
207982|NCT02894931|amino acids|amino acids
207983|NCT02894931|artificial sweeteners|artificial sweeteners
207984|NCT02894931|atherosclerosis|atherosclerosis
207985|NCT02894892|Electron Microscopy|electron microscopy
207986|NCT02894892|Helicobacter pylori|helicobacter pylori
207987|NCT02894892|Bismuth|bismuth
208087|NCT02894307|Mechanical prosthesis|mechanical prosthesis
207988|NCT02894879|Postoperative pulmonary complications|postoperative pulmonary complications
207989|NCT02894866|hypoxic-ischemic encephalopathy|hypoxic-ischemic encephalopathy
207990|NCT02894866|hyperbaric oxygen therapy|hyperbaric oxygen therapy
207991|NCT02894840|GPO Tri Fluvac Vaccine|gpo tri fluvac vaccine
207992|NCT02894840|Tri Fluvac Vaccine|tri fluvac vaccine
207993|NCT02894814|Self administration|self administration
207994|NCT02894814|Medication|medication
207995|NCT02894814|Inpatient|inpatient
207996|NCT02894814|Self-care|self-care
207997|NCT02894814|Self-management|self-management
207998|NCT02894814|Medical patients|medical patients
207999|NCT02894749|hybrid rooms|hybrid rooms
208000|NCT02894749|cone-beam computed tomography|cone-beam computed tomography
208001|NCT02894723|Hypertension,|hypertension,
208002|NCT02894723|Nitric Oxide|nitric oxide
208003|NCT02894723|L-Arginine|l-arginine
208004|NCT02894723|Arterial Stiffness|arterial stiffness
208005|NCT02894723|Ambulatory blood pressure measurement|ambulatory blood pressure measurement
208006|NCT02894710|postoperative pain|postoperative pain
208007|NCT02894710|intravenous lidocaine|intravenous lidocaine
208008|NCT02894710|chronic post-surgical pain|chronic post-surgical pain
208009|NCT02894710|remifentanil|remifentanil
208010|NCT02894710|patient controlled analgesia|patient controlled analgesia
208011|NCT02894710|morphine consumption|morphine consumption
208012|NCT02894710|ENT surgery|ent surgery
208013|NCT02894632|MRI|mri
208014|NCT02894632|Motion|motion
208015|NCT02894632|Respiratory movement|respiratory movement
208016|NCT02894632|Artifacts correction|artifacts correction
208017|NCT02894619|urinary incontinence|urinary incontinence
208018|NCT02894619|anal incontinence|anal incontinence
208019|NCT02894619|sexuality|sexuality
208020|NCT02894619|quality of life|quality of life
208021|NCT02894606|Kidney Transplant|kidney transplant
208022|NCT02894606|Immunology|immunology
208023|NCT02894593|Antiplaque agents|antiplaque agents
208024|NCT02894593|chemical plaque control|chemical plaque control
208025|NCT02894593|oral hygiene|oral hygiene
208026|NCT02894593|essential oils|essential oils
208027|NCT02894593|alcohol|alcohol
208028|NCT02894593|mouthwash|mouthwash
208029|NCT02894541|Dyslipidemia|dyslipidemia
208030|NCT02894541|CKD-519|ckd-519
208031|NCT02894541|CETP inhibitor|cetp inhibitor
208032|NCT02894541|Food Drug Interaction|food drug interaction
208033|NCT02894528|Alveolar ridge|alveolar ridge
208034|NCT02894528|guided bone regeneration|guided bone regeneration
208035|NCT02894528|bone grafts|bone grafts
208036|NCT02894502|Self-care|self-care
208037|NCT02894502|Motivational interviewing|motivational interviewing
208038|NCT02894502|Heart failure|heart failure
208039|NCT02894502|Caregivers|caregivers
208040|NCT02894476|satisfaction with care|satisfaction with care
208041|NCT02894476|outpatient care|outpatient care
208042|NCT02894476|self-reported health status|self-reported health status
208043|NCT02894476|alcohol dependence|alcohol dependence
208044|NCT02894476|opioid dependence|opioid dependence
208045|NCT02894463|dental care|dental care
208046|NCT02894463|emeno|emeno
208047|NCT02894463|abuse|abuse
208048|NCT02894450|Atrial fibrillation|atrial fibrillation
208049|NCT02894450|oral anticoagulant|oral anticoagulant
208050|NCT02894450|bioassay|bioassay
208051|NCT02894450|elderly subject|elderly subject
208052|NCT02894437|prevention|prevention
208053|NCT02894437|organization|organization
208054|NCT02894437|pressure ulcers|pressure ulcers
208055|NCT02894424|Inner limiting membrane|inner limiting membrane
208056|NCT02894424|Microperimetry|microperimetry
208057|NCT02894424|surgical's dye|surgical's dye
208058|NCT02894411|MRI|mri
208059|NCT02894411|Excyclotorsion|excyclotorsion
208060|NCT02894398|HR+|hr+
208061|NCT02894398|HER2-|her2-
208062|NCT02894398|Locally advanced (inoperable or metastatic) Breast Cancer|locally advanced (inoperable or metastatic) breast cancer
208063|NCT02894398|Palbociclib|palbociclib
208064|NCT02894398|Aromatase inhibitor or fulvestrant|aromatase inhibitor or fulvestrant
208065|NCT02894398|Pre-/perimenopausal receiving LHRH agonist / ovarian ablation|pre-/perimenopausal receiving lhrh agonist / ovarian ablation
208066|NCT02894398|Postmenopausal|postmenopausal
208067|NCT02894372|Oral spray|oral spray
208068|NCT02894372|Topical sprays|topical sprays
208069|NCT02894372|Faringomoss|faringomoss
208070|NCT02894372|Local phytotherapy|local phytotherapy
208071|NCT02894359|Cervical spine|cervical spine
208072|NCT02894359|Musculoskeletal imagery|musculoskeletal imagery
208073|NCT02894359|computer modelling of cervical spine|computer modelling of cervical spine
208074|NCT02894359|ConeBeam.|conebeam.
208075|NCT02894346|Motivation|motivation
208076|NCT02894346|Teachers|teachers
208077|NCT02894346|Physical activity|physical activity
208078|NCT02894346|School|school
208079|NCT02894333|Parkinson's disease|parkinson's disease
208080|NCT02894333|Action-effect prediction|action-effect prediction
208081|NCT02894333|Sensory attenuation|sensory attenuation
208082|NCT02894333|Voluntary action|voluntary action
208083|NCT02894320|Parkinson's disease|parkinson's disease
208084|NCT02894320|Voluntary action|voluntary action
208085|NCT02894320|Action-effect preactivation|action-effect preactivation
208086|NCT02894320|Action-effect prediction|action-effect prediction
208088|NCT02894307|Rivaroxaban|rivaroxaban
208090|NCT02894294|chemoprevention|chemoprevention
208091|NCT02894294|season|season
208092|NCT02894294|anemia|anemia
208093|NCT02894294|impact|impact
208094|NCT02894294|coverage|coverage
208095|NCT02894294|children|children
208096|NCT02894281|Pupillary light reflex|pupillary light reflex
208097|NCT02894281|Multiple sclerosis|multiple sclerosis
208098|NCT02894190|Non Invasive Ventilation (NIV)|non invasive ventilation (niv)
208099|NCT02894190|Adherence|adherence
208100|NCT02894190|Beliefs|beliefs
208101|NCT02894190|Development|development
208102|NCT02894190|Validation|validation
208103|NCT02894177|E02.880.820.950|e02.880.820.950
208104|NCT02894164|Cystatin C|cystatin c
208105|NCT02894164|Creatinine|creatinine
208106|NCT02894164|Glomerular Filtration Rate|glomerular filtration rate
208107|NCT02894125|Chronic Low Back Pain|chronic low back pain
208108|NCT02894125|Old subject|old subject
208109|NCT02894125|SPA Therapy|spa therapy
208110|NCT02894125|Pain|pain
208111|NCT02894125|Function|function
208112|NCT02894125|Expectations|expectations
208113|NCT02894125|Fears|fears
208114|NCT02894112|endothelial dependent vasodilation|endothelial dependent vasodilation
208115|NCT02894112|blood flow|blood flow
208116|NCT02894112|blood glucose|blood glucose
208117|NCT02894112|triglycerides|triglycerides
208118|NCT02894112|non-fat milk|non-fat milk
208119|NCT02894112|dairy|dairy
208120|NCT02894099|Aged|aged
208121|NCT02894099|Sedentary Behaviour|sedentary behaviour
208122|NCT02894099|Blood Glucose|blood glucose
208123|NCT02894099|Insulin|insulin
208124|NCT02894099|Inflammatory markers|inflammatory markers
208125|NCT02894086|acute appendicitis|acute appendicitis
208126|NCT02894086|ambulatory appendicectomy|ambulatory appendicectomy
208127|NCT02894073|obese patients|obese patients
208128|NCT02894073|peripheral venous catheter|peripheral venous catheter
208129|NCT02894060|Cardiovascular events|cardiovascular events
208130|NCT02894047|calcium-sensitive receptor|calcium-sensitive receptor
208131|NCT02894034|optic nerve sheath|optic nerve sheath
208132|NCT02894034|meningeal hemorrhage|meningeal hemorrhage
208133|NCT02894034|early phase|early phase
208134|NCT02894034|prognostic|prognostic
208135|NCT02894021|padding|padding
208136|NCT02894021|lymphoceles|lymphoceles
208137|NCT02894021|prevention|prevention
208138|NCT02893995|PAH|pah
208139|NCT02893995|Subcutaneous Treprostinil|subcutaneous treprostinil
208140|NCT02893995|Remodulin|remodulin
208141|NCT02893995|6 Minute Walk Test|6 minute walk test
208142|NCT02893969|Physical Activity|physical activity
208143|NCT02893969|Rest|rest
208144|NCT02893956|Echocardiography|echocardiography
208145|NCT02893956|postural support|postural support
208146|NCT02893956|preterm neonate|preterm neonate
208147|NCT02893904|Propofol|propofol
208148|NCT02893904|Sevoflurane|sevoflurane
208149|NCT02893904|Bispectral Index|bispectral index
208150|NCT02893904|Children|children
208151|NCT02893904|Electroencephalographic signs|electroencephalographic signs
208152|NCT02893891|Obesity|obesity
208153|NCT02893891|Bariatric medicine|bariatric medicine
208154|NCT02893891|Sleeve gastric resection|sleeve gastric resection
208155|NCT02893891|Gastric plication|gastric plication
208156|NCT02893891|Intragastric ballon|intragastric ballon
208157|NCT02893891|Body composition|body composition
208158|NCT02893891|Adipokines|adipokines
208159|NCT02893891|Ghrelin|ghrelin
208160|NCT02893891|Bone mineral density|bone mineral density
208161|NCT02893891|Quality of life|quality of life
208162|NCT02893878|Seasonal influenza vaccines|seasonal influenza vaccines
208163|NCT02893878|Passive Enhanced Safety surveillance|passive enhanced safety surveillance
208164|NCT02893878|England|england
208165|NCT02893878|Pilot study|pilot study
208166|NCT02893865|Apnea syndrome|apnea syndrome
208167|NCT02893865|Coronary artery disease|coronary artery disease
208168|NCT02893865|Oxidative stress|oxidative stress
208169|NCT02893865|Continuous positive airway pressure|continuous positive airway pressure
208170|NCT02893865|Endothelial dysfunction|endothelial dysfunction
208171|NCT02893839|Allergy|allergy
208172|NCT02893839|cross-reactivity|cross-reactivity
208173|NCT02893839|oral allergy syndrome|oral allergy syndrome
208174|NCT02893839|potato|potato
208175|NCT02893839|sensitization|sensitization
208176|NCT02893826|Aneurysm|aneurysm
208177|NCT02893826|Ruptured|ruptured
208178|NCT02893826|nimodipine|nimodipine
208179|NCT02893826|subarachnoid hemorrhage|subarachnoid hemorrhage
208180|NCT02893800|assistive technology|assistive technology
208181|NCT02893800|dementia care|dementia care
208182|NCT02893800|tracking technology|tracking technology
208183|NCT02893800|locating systems|locating systems
208184|NCT02893800|user experience|user experience
208185|NCT02893787|Speckle Tracking|speckle tracking
208186|NCT02893787|Anthracyclines|anthracyclines
208187|NCT02893787|Chilhood cancers|chilhood cancers
208188|NCT02893787|Myocardial function|myocardial function
208189|NCT02893787|Echocardiography|echocardiography
208190|NCT02893761|breast cancer|breast cancer
208191|NCT02893761|survival|survival
208192|NCT02893761|prognosis factors|prognosis factors
208193|NCT02893748|colon|colon
208194|NCT02893748|polyps|polyps
208195|NCT02893748|cancer|cancer
208196|NCT02893748|screening|screening
208197|NCT02893735|Clinical Trial|clinical trial
208198|NCT02893735|Composite resin|composite resin
208199|NCT02893722|ivf ,atosiban,repeated implantation failure,RCT|ivf ,atosiban,repeated implantation failure,rct
208200|NCT02893683|Paris Visual Learning Test|paris visual learning test
208201|NCT02893683|visual memory|visual memory
208202|NCT02893683|criterion validity|criterion validity
208203|NCT02893657|MELD score|meld score
208204|NCT02893657|hemodynamics|hemodynamics
208205|NCT02893657|liver abnormalities|liver abnormalities
208206|NCT02893566|overweight|overweight
208207|NCT02893566|body mass index|body mass index
208208|NCT02893566|university students|university students
208209|NCT02893566|physical activity|physical activity
208210|NCT02893566|sedentary behavior|sedentary behavior
208211|NCT02893566|body composition|body composition
208212|NCT02893566|Mi Band|mi band
208213|NCT02893514|Drug Use|drug use
208214|NCT02893488|dolutegravir|dolutegravir
208215|NCT02893488|abacavir|abacavir
208216|NCT02893488|relative bioavailability|relative bioavailability
208217|NCT02893488|palatability|palatability
208218|NCT02893488|GSK2619619|gsk2619619
208219|NCT02893488|palatability questionnaire|palatability questionnaire
208220|NCT02893488|lamivudine|lamivudine
208221|NCT02893488|pediatric|pediatric
208222|NCT02893488|calcium|calcium
208223|NCT02893488|dispersible tablet|dispersible tablet
208224|NCT02893462|data warehousing|data warehousing
208225|NCT02893462|data aggregation|data aggregation
208226|NCT02893462|data mining|data mining
208227|NCT02893449|Parkinson|parkinson
208228|NCT02893449|SAS-SR|sas-sr
208229|NCT02893449|Social adaptation|social adaptation
208230|NCT02893449|Patients suffering from Parkinson's disease|patients suffering from parkinson's disease
208231|NCT02893423|Ropivacaine|ropivacaine
208232|NCT02893423|C-Section Analgesia|c-section analgesia
208233|NCT02893423|Tap Block|tap block
208234|NCT02893358|Allisartan Isoproxil|allisartan isoproxil
208235|NCT02893358|left ventricular hypertrophy|left ventricular hypertrophy
208236|NCT02893358|large arterial stiffness|large arterial stiffness
208237|NCT02893358|microalbuminuria|microalbuminuria
208238|NCT02893345|Self Care (Rehabilitation)|self care (rehabilitation)
208239|NCT02893345|Community Participation|community participation
208240|NCT02893345|Patient-Centered Outcomes Research|patient-centered outcomes research
208241|NCT02893345|Informatics, Clinical|informatics, clinical
208242|NCT02893319|Infant Feeding|infant feeding
208243|NCT02893319|Infant Growth|infant growth
208244|NCT02893306|Type1 Diabetes Mellitus|type1 diabetes mellitus
208245|NCT02893306|Multipotent stromal cell|multipotent stromal cell
208246|NCT02893306|Mesenchymal stem cell|mesenchymal stem cell
208247|NCT02893306|Insulin|insulin
208248|NCT02893306|Pancreatic reserve|pancreatic reserve
208249|NCT02893306|Disease progression|disease progression
208250|NCT02893267|Stroke|stroke
208251|NCT02893267|Shoulder Pain|shoulder pain
208252|NCT02893267|Electrical stimulation|electrical stimulation
208253|NCT02893267|Neuromuscular stimulation|neuromuscular stimulation
208254|NCT02893267|Intramuscular stimulation|intramuscular stimulation
208255|NCT02893267|Physical Therapy|physical therapy
208256|NCT02893254|ankylosing spondylitis, tumor necrosis factor-α inhibitors|ankylosing spondylitis, tumor necrosis factor-α inhibitors
208257|NCT02893228|forced expiratory volume in 1 second|forced expiratory volume in 1 second
208258|NCT02893228|forced vital capacity|forced vital capacity
208259|NCT02893228|peak expiratory flow rate|peak expiratory flow rate
208260|NCT02893228|interscalene block|interscalene block
208261|NCT02893228|diaphragmatic paresis|diaphragmatic paresis
208262|NCT02893202|PTSD|ptsd
208263|NCT02893202|Equine assisted activities|equine assisted activities
208264|NCT02893202|quality of life|quality of life
208265|NCT02893189|CD19+|cd19+
208266|NCT02893189|allogeneic transplant|allogeneic transplant
208267|NCT02893189|relapse|relapse
208268|NCT02893176|Lung Transplant|lung transplant
208269|NCT02893176|Macitentan|macitentan
208270|NCT02893176|CLAD|clad
208271|NCT02893176|BOS|bos
208272|NCT02893176|bronchiolitis obliterans|bronchiolitis obliterans
208273|NCT02893176|chronic lung allograft dysfunction|chronic lung allograft dysfunction
208274|NCT02893176|Organ Rejection|organ rejection
208275|NCT02893163|Metabolic Syndrome|metabolic syndrome
208276|NCT02893163|Cancer Risk|cancer risk
208277|NCT02893163|Lifestyle Interventions|lifestyle interventions
208278|NCT02893163|Primary Care|primary care
208279|NCT02893163|Behavioural Change|behavioural change
208280|NCT02893150|Mindful Eating|mindful eating
266265|NCT02542371|HIV|hiv
208281|NCT02893150|Overweight|overweight
208282|NCT02893150|Primary Care|primary care
208283|NCT02893150|Randomized Clinical Trial|randomized clinical trial
208284|NCT02893137|Tumour treating fields|tumour treating fields
208285|NCT02893137|Optune|optune
208286|NCT02893137|Craniectomy|craniectomy
208287|NCT02893137|TTFields|ttfields
208288|NCT02893124|chronic hepatitis B|chronic hepatitis b
208289|NCT02893111|neuromyelitis optica spectrum disorders|neuromyelitis optica spectrum disorders
208290|NCT02893111|Bortezomib|bortezomib
208291|NCT02893111|Velcade|velcade
208292|NCT02893111|Proteasome inhibitor|proteasome inhibitor
208293|NCT02893072|Diabetes, Gestational|diabetes, gestational
208294|NCT02893072|Nutrition Therapy|nutrition therapy
208295|NCT02893046|care pathway|care pathway
208296|NCT02893046|hospital- private network|hospital- private network
208297|NCT02893046|early consultation|early consultation
208298|NCT02893033|Dysphagia|dysphagia
208299|NCT02893033|Repetitive Transcranial Magnetic Stimulation|repetitive transcranial magnetic stimulation
208300|NCT02893033|Stroke|stroke
208301|NCT02893020|Emotional experience and burnout in physicians|emotional experience and burnout in physicians
208302|NCT02892994|therapeutic ultrasound|therapeutic ultrasound
208303|NCT02892968|Regional Anesthesia Ultrasound guided|regional anesthesia ultrasound guided
208304|NCT02892968|Emergency Department|emergency department
208305|NCT02892968|Knowledge to Practice Intervention|knowledge to practice intervention
208306|NCT02892955|Heart Failure|heart failure
208307|NCT02892955|LVAS|lvas
208308|NCT02892955|Ventricular Dysfunction|ventricular dysfunction
208309|NCT02892955|Cardiomyopathy|cardiomyopathy
208310|NCT02892955|Heart Disease|heart disease
208311|NCT02892955|Cardiovascular Disease|cardiovascular disease
208312|NCT02892955|Heart-assist devices|heart-assist devices
208313|NCT02892955|Thoratec Corporation|thoratec corporation
208314|NCT02892942|Controlled ovarian hyperstimulation|controlled ovarian hyperstimulation
208315|NCT02892942|Estradiol|estradiol
208316|NCT02892942|Embryo implantation|embryo implantation
208317|NCT02892942|Endometrial receptivity|endometrial receptivity
208318|NCT02892942|Fertility preservation|fertility preservation
208319|NCT02892929|Motivational Interviewing|motivational interviewing
208320|NCT02892929|Hypertension|hypertension
208321|NCT02892929|Nursing|nursing
208322|NCT02892929|Randomized Controlled Trial|randomized controlled trial
208323|NCT02892929|Life Style|life style
208324|NCT02892916|Post-operative cognitive dysfunction (POCD)|post-operative cognitive dysfunction (pocd)
208325|NCT02892916|Delirium|delirium
208326|NCT02892916|Ketamine|ketamine
208327|NCT02892916|Elective orthopaedic surgery|elective orthopaedic surgery
208328|NCT02892903|Fractional flow reserve (FFR)|fractional flow reserve (ffr)
208329|NCT02892903|Pressure wire (PW)|pressure wire (pw)
208330|NCT02892903|Coronary angiography|coronary angiography
208331|NCT02892877|Complete Hydatidiform mole|complete hydatidiform mole
208332|NCT02892877|Partial Hydatidiform mole|partial hydatidiform mole
208333|NCT02892877|Invasive mole|invasive mole
208334|NCT02892877|Choriocarcinoma|choriocarcinoma
208335|NCT02892877|Post-molar neoplasia|post-molar neoplasia
208336|NCT02892877|Placental Site Trophoblastic Tumor (PSTT)|placental site trophoblastic tumor (pstt)
208337|NCT02892877|Epithelioid Trophoblastic Tumor (ETT)|epithelioid trophoblastic tumor (ett)
208338|NCT02892877|hCG follow-up|hcg follow-up
208339|NCT02892864|Bell's Palsy|bell's palsy
208340|NCT02892864|Peripheral facial palsy|peripheral facial palsy
208341|NCT02892851|STN-DBS|stn-dbs
208342|NCT02892851|Craving|craving
208343|NCT02892851|Cocaine addiction|cocaine addiction
208344|NCT02892838|mobile bearing knee prosthesis|mobile bearing knee prosthesis
208345|NCT02892825|Music|music
208346|NCT02892825|cataract surgery|cataract surgery
208347|NCT02892825|topical anaesthesia|topical anaesthesia
208348|NCT02892825|anxiety|anxiety
208349|NCT02892825|hypertension|hypertension
208350|NCT02892799|NICOM device|nicom device
208351|NCT02892786|circulating tumor cell|circulating tumor cell
208352|NCT02892786|CellSearch™ method|cellsearch™ method
208353|NCT02892786|RT-PCR|rt-pcr
208354|NCT02892773|electrical impedance tomography|electrical impedance tomography
208355|NCT02892773|incentive spirometry|incentive spirometry
208356|NCT02892773|EzPAP|ezpap
208357|NCT02892773|lung volume|lung volume
208358|NCT02892773|atelectasis|atelectasis
208359|NCT02892773|positive airway pressure|positive airway pressure
208360|NCT02892773|pulmonary complication|pulmonary complication
208361|NCT02892773|abdominal surgery|abdominal surgery
208362|NCT02892773|end-expiratory lung volume|end-expiratory lung volume
208363|NCT02892747|Chronic Heart Failure (CHF)|chronic heart failure (chf)
208364|NCT02892747|Dietetics education|dietetics education
208365|NCT02892747|Malnutrition|malnutrition
208366|NCT02892721|CT Colonography|ct colonography
208367|NCT02892721|Virtual colonoscopy|virtual colonoscopy
208368|NCT02892721|Colorectal cancer|colorectal cancer
208369|NCT02892721|Colon cancer|colon cancer
208370|NCT02892721|Training|training
208371|NCT02892708|supratentorial gliomas|supratentorial gliomas
208372|NCT02892708|surgery|surgery
208373|NCT02892708|magnetic resonance spectroscopy|magnetic resonance spectroscopy
208374|NCT02892708|elderly|elderly
208375|NCT02892630|Immune Thrombocytopenia|immune thrombocytopenia
208376|NCT02892630|Pregnancy|pregnancy
208377|NCT02892617|Modic 1|modic 1
208378|NCT02892617|low back pain|low back pain
208379|NCT02892604|Type 1 diabetes|type 1 diabetes
208380|NCT02892604|artificial pancreas|artificial pancreas
208381|NCT02892604|closed-loop insulin infusion|closed-loop insulin infusion
208382|NCT02892565|systemic lupus erythematosus|systemic lupus erythematosus
208383|NCT02892565|antiphospholipid syndrome|antiphospholipid syndrome
208384|NCT02892565|antiphospholipid antibodies|antiphospholipid antibodies
208385|NCT02892513|Colorectal Surgery|colorectal surgery
208386|NCT02892513|transcutaneous electric nerve stimulation|transcutaneous electric nerve stimulation
208387|NCT02892487|Quality of life|quality of life
208388|NCT02892487|Radiotherapy|radiotherapy
208389|NCT02892487|Dysphagia|dysphagia
208390|NCT02892487|Oral cavity|oral cavity
208391|NCT02892487|Oropharynx|oropharynx
208392|NCT02892487|Hypopharynx|hypopharynx
208393|NCT02892487|Larynx|larynx
208394|NCT02892487|Swallowing rehabilitation|swallowing rehabilitation
208395|NCT02892487|Toxicity|toxicity
208396|NCT02892474|Coronary Arteriosclerosis|coronary arteriosclerosis
208397|NCT02892474|Hybrid Coronary Revascularization|hybrid coronary revascularization
208398|NCT02892474|Coronary Artery Bypass Grafting|coronary artery bypass grafting
208399|NCT02892461|Anemia, Iron-Deficiency|anemia, iron-deficiency
208400|NCT02892461|Cesarean Section|cesarean section
208401|NCT02892461|Umbilical Cord Milking|umbilical cord milking
208402|NCT02892461|Randomized Controlled Trial|randomized controlled trial
208403|NCT02892409|Drug Therapy|drug therapy
208404|NCT02892344|Phase III, blinded, QMF149, Mometasone furoate (MF), mild asthma, Adolescent, adult|phase iii, blinded, qmf149, mometasone furoate (mf), mild asthma, adolescent, adult
208405|NCT02892331|exercise|exercise
208406|NCT02892331|insulin resistance|insulin resistance
208407|NCT02892331|mitochondrial function|mitochondrial function
208408|NCT02892331|arterial stiffness|arterial stiffness
208409|NCT02892331|exercise intensity|exercise intensity
208410|NCT02892331|fitness|fitness
208411|NCT02892305|Pancreaticoduodenectomy|pancreaticoduodenectomy
208412|NCT02892305|Hepatectomy|hepatectomy
208413|NCT02892305|Liver ablation|liver ablation
208414|NCT02892305|Whipple|whipple
208415|NCT02892279|Microneurography|microneurography
208416|NCT02892279|Air pollution|air pollution
208417|NCT02892266|Transplant recipients|transplant recipients
208418|NCT02892266|Adolescents|adolescents
208419|NCT02892266|Post-Traumatic Stress Symptoms (PTSS)|post-traumatic stress symptoms (ptss)
208420|NCT02892266|Transplant Recipient and Family Impact(s)|transplant recipient and family impact(s)
208421|NCT02892253|postoperative hypocalcemia|postoperative hypocalcemia
208422|NCT02892253|near infrared imaging|near infrared imaging
208423|NCT02892253|parathyroid autofluorescence|parathyroid autofluorescence
208424|NCT02892227|bedside echography|bedside echography
208425|NCT02892162|atrial fibrillation|atrial fibrillation
208426|NCT02892162|catheter ablation|catheter ablation
208427|NCT02892149|AKB-6548|akb-6548
208428|NCT02892149|Chronic kidney disease|chronic kidney disease
208429|NCT02892149|anemia|anemia
208430|NCT02892149|CKD|ckd
208431|NCT02892149|chronic renal insufficiency|chronic renal insufficiency
208432|NCT02892149|renal impairment|renal impairment
208433|NCT02892149|erythropoietin|erythropoietin
208434|NCT02892149|kidney|kidney
208435|NCT02892149|renal|renal
208436|NCT02892149|oral anemia treatment|oral anemia treatment
208437|NCT02892149|hemoglobin|hemoglobin
208438|NCT02892149|hypoxia-inducible factor|hypoxia-inducible factor
208439|NCT02892149|HIF|hif
208440|NCT02892149|hypoxia-inducible factor prolyl-hydroxylase inhibitor|hypoxia-inducible factor prolyl-hydroxylase inhibitor
208441|NCT02892149|HIF-PHI|hif-phi
208442|NCT02892149|efficacy|efficacy
208443|NCT02892149|safety|safety
208444|NCT02892149|Phase 3|phase 3
208445|NCT02892149|cardiovascular|cardiovascular
208446|NCT02892149|DD-CKD|dd-ckd
208447|NCT02892123|HER2|her2
208448|NCT02892123|Bispecific antibody|bispecific antibody
208449|NCT02892123|Biparatopic antibody|biparatopic antibody
208450|NCT02892123|Immunotherapy|immunotherapy
208451|NCT02892123|Breast cancer|breast cancer
208452|NCT02892123|Gastroesophageal adenocarcinoma (GEA)|gastroesophageal adenocarcinoma (gea)
208453|NCT02892123|Gastric cancer|gastric cancer
208454|NCT02892123|Gastroesophageal junction (GEJ) cancer|gastroesophageal junction (gej) cancer
208455|NCT02892123|Ovarian cancer|ovarian cancer
208456|NCT02892123|Non-small cell lung cancer (NSCLC)|non-small cell lung cancer (nsclc)
208457|NCT02892123|Chemotherapy|chemotherapy
208458|NCT02892123|Paclitaxel|paclitaxel
208459|NCT02892123|Capecitabine|capecitabine
208460|NCT02892123|Vinorelbine|vinorelbine
208461|NCT02892110|Marijuana use|marijuana use
208462|NCT02892110|Varenicline/Chantix|varenicline/chantix
208463|NCT02892110|Motivational enhancement therapy|motivational enhancement therapy
208464|NCT02892097|tDCS|tdcs
208465|NCT02892097|neglect|neglect
208466|NCT02892097|paresis|paresis
400623|NCT01865994|Cardiac Output|cardiac output
208467|NCT02892097|transcranial direct current stimulation|transcranial direct current stimulation
208468|NCT02892097|rehabilitation|rehabilitation
208469|NCT02892084|Chronic Stroke ( > 6 months)|chronic stroke ( > 6 months)
208470|NCT02892084|non-invasive brain stimulation|non-invasive brain stimulation
208471|NCT02892084|rehabilitation|rehabilitation
208472|NCT02892084|walking|walking
208473|NCT02892084|kinetics|kinetics
208474|NCT02892045|neuromuscular block|neuromuscular block
208475|NCT02892045|monitoring|monitoring
208476|NCT02892019|indacaterol acetate, asthma, GINA 2015, pediatrics|indacaterol acetate, asthma, gina 2015, pediatrics
208477|NCT02891993|Cancer Care|cancer care
208478|NCT02891980|Ebola|ebola
208479|NCT02891980|Immunogenicity|immunogenicity
208480|NCT02891980|Marburg|marburg
208481|NCT02891980|Omics|omics
208482|NCT02891980|Zaire|zaire
208483|NCT02891954|Glucosuria|glucosuria
208484|NCT02891954|SGLT2 inhibitors|sglt2 inhibitors
208485|NCT02891954|Canagliflozin|canagliflozin
208486|NCT02891954|FGF23|fgf23
208487|NCT02891954|Parathyroid hormone|parathyroid hormone
208488|NCT02891954|1,25-Dihydroxyvitamin D|1,25-dihydroxyvitamin d
208489|NCT02891954|Glucagon|glucagon
208490|NCT02891954|Ketone bodies|ketone bodies
208491|NCT02891954|Uric acid|uric acid
208492|NCT02891954|Pharmacogenomics|pharmacogenomics
208493|NCT02891928|Type 2 diabetes|type 2 diabetes
208494|NCT02891928|Diabetic neuropathy|diabetic neuropathy
208495|NCT02891928|Disorders of equilibrium|disorders of equilibrium
208496|NCT02891928|"Rocker sole shoes"|"rocker sole shoes"
208497|NCT02891928|Walking|walking
208498|NCT02891915|Antimicrobial|antimicrobial
208499|NCT02891915|Beta-Lactam|beta-lactam
208500|NCT02891915|Pneumonia|pneumonia
208501|NCT02891915|Short Course|short course
208502|NCT02891915|Standard Course|standard course
208503|NCT02891915|Therapy|therapy
208504|NCT02891876|direct pulp capping, biodentine|direct pulp capping, biodentine
208505|NCT02891863|Implantable Cardioverter-Defibrillator|implantable cardioverter-defibrillator
208506|NCT02891837|L-citrulline|l-citrulline
208507|NCT02891837|pediatric|pediatric
208508|NCT02891837|Lung Injury|lung injury
208509|NCT02891837|Bypass|bypass
208510|NCT02891837|Heart Defects|heart defects
208511|NCT02891837|Clinical Sequelae|clinical sequelae
208512|NCT02891824|PD-L1|pd-l1
208513|NCT02891824|Atezolizumab|atezolizumab
208514|NCT02891824|Randomized, double blinded|randomized, double blinded
208515|NCT02891824|first or second late relapse|first or second late relapse
208516|NCT02891824|progressive non-mucinous epithelial ovarian cancer, primary peritoneal adenocarcinoma and / or fallopian-tube adenocarcinoma|progressive non-mucinous epithelial ovarian cancer, primary peritoneal adenocarcinoma and / or fallopian-tube adenocarcinoma
208517|NCT02891824|progression-free survival|progression-free survival
208518|NCT02891811|newly diagnosed multiple myeloma|newly diagnosed multiple myeloma
208519|NCT02891811|carfilzomib|carfilzomib
208520|NCT02891811|thalidomide|thalidomide
208521|NCT02891811|lenalidomide|lenalidomide
208522|NCT02891811|dexamethasone|dexamethasone
208523|NCT02891811|transplant ineligible|transplant ineligible
208524|NCT02891811|induction therapy|induction therapy
208525|NCT02891811|maintenance|maintenance
208526|NCT02891811|Study Group of Medical Tumour Therapy (AGMT)|study group of medical tumour therapy (agmt)
208527|NCT02891798|analgesia,|analgesia,
208528|NCT02891798|buprenorphine|buprenorphine
208529|NCT02891798|clonidine|clonidine
208530|NCT02891798|dexamethasone|dexamethasone
208531|NCT02891798|bupivacaine|bupivacaine
208532|NCT02891798|nerve block|nerve block
208533|NCT02891733|Expression of the Neurotensin|expression of the neurotensin
208534|NCT02891733|Neurotensin|neurotensin
208535|NCT02891668|Basal Metabolic rate|basal metabolic rate
208536|NCT02891668|Quality of life|quality of life
208537|NCT02891668|Resting energy expenditure|resting energy expenditure
208538|NCT02891668|Insulin resistance|insulin resistance
208539|NCT02891668|Cognitive Function|cognitive function
208540|NCT02891668|Body Composition|body composition
208541|NCT02891642|malignancy|malignancy
208542|NCT02891642|Pleural Effusion|pleural effusion
208543|NCT02891642|Pleural Neoplasms|pleural neoplasms
208544|NCT02891642|Ascites|ascites
208545|NCT02891616|Melanoma|melanoma
208546|NCT02891616|18F-FLT|18f-flt
208547|NCT02891616|18F-FDG|18f-fdg
208548|NCT02891616|PET/CT|pet/ct
208549|NCT02891616|PET/MR|pet/mr
208550|NCT02891577|intra abdominal hypertension|intra abdominal hypertension
208551|NCT02891577|shock|shock
208552|NCT02891577|critically ill|critically ill
208553|NCT02891564|therapeutic video games, mobile interventions|therapeutic video games, mobile interventions
208554|NCT02891551|Leukemia|leukemia
208555|NCT02891551|Chronic|chronic
208556|NCT02891551|Acute|acute
208557|NCT02891551|Observational|observational
208558|NCT02891551|Non-interventional|non-interventional
208559|NCT02891551|OCEAN|ocean
208560|NCT02891551|Netherlands|netherlands
208561|NCT02891551|azacitidine|azacitidine
208562|NCT02891538|EGCG|egcg
208563|NCT02891538|Green Tea|green tea
208564|NCT02891538|Colon Cancer|colon cancer
208565|NCT02891512|Magnetic Fields|magnetic fields
208566|NCT02891512|Pain|pain
208567|NCT02891512|Paresthesia|paresthesia
208568|NCT02891512|Visual Analogue Scale|visual analogue scale
208569|NCT02891499|Miniscrews|miniscrews
208570|NCT02891499|Mini-implants|mini-implants
208571|NCT02891499|Temporal anchorage devices|temporal anchorage devices
208572|NCT02891499|Bone screws|bone screws
208573|NCT02891499|Stability|stability
208574|NCT02891499|Displacement|displacement
208575|NCT02891499|Low-level laser therapy|low-level laser therapy
208576|NCT02891499|Cone-beam computed tomography|cone-beam computed tomography
208577|NCT02891499|Resonance frequency analysis|resonance frequency analysis
208578|NCT02891499|Orthodontic|orthodontic
208579|NCT02891499|Orthodontic miniscrew implant|orthodontic miniscrew implant
208676|NCT02890836|White coat hypertension|white coat hypertension
208580|NCT02891486|spinal surgery, surgical site infection|spinal surgery, surgical site infection
208581|NCT02891473|Posture|posture
208582|NCT02891473|Pain|pain
208583|NCT02891473|Muscle stretching|muscle stretching
208584|NCT02891473|Mézières method|mézières method
208585|NCT02891473|Camptocormia|camptocormia
208586|NCT02891473|Trunk control|trunk control
208587|NCT02891460|Mitomycin C|mitomycin c
208588|NCT02891460|MMC|mmc
208589|NCT02891460|NMIBC|nmibc
208590|NCT02891460|Non Muscle Invasive Bladder Cancer|non muscle invasive bladder cancer
208591|NCT02891460|Hydrogel Reverse thermal gelation|hydrogel reverse thermal gelation
208592|NCT02891460|Drug retention|drug retention
208593|NCT02891460|Urinary Bladder Neoplasms|urinary bladder neoplasms
208594|NCT02891460|Urologic Neoplasms|urologic neoplasms
208595|NCT02891460|Urinary Bladder Diseases|urinary bladder diseases
208596|NCT02891460|Urologic Diseases|urologic diseases
208597|NCT02891434|Duchenne muscular dystrophy|duchenne muscular dystrophy
208598|NCT02891434|motor learning|motor learning
208599|NCT02891434|motor abilities|motor abilities
208600|NCT02891395|allogeneic stem cell transplantation|allogeneic stem cell transplantation
208601|NCT02891395|imatinib Mesylate|imatinib mesylate
208602|NCT02891395|Nilotinib|nilotinib
208603|NCT02891382|Diabetes Mellitus, Type 2|diabetes mellitus, type 2
208604|NCT02891382|Weight Loss|weight loss
208605|NCT02891382|Financial Incentives|financial incentives
208606|NCT02891382|Hemoglobin A, Glycosylated|hemoglobin a, glycosylated
208607|NCT02891356|Adiponectin|adiponectin
208608|NCT02891356|Bone remodelling markers|bone remodelling markers
208609|NCT02891343|Cognitive Function|cognitive function
208610|NCT02891343|Hypoxia|hypoxia
208611|NCT02891343|Neurophysiological Function|neurophysiological function
208612|NCT02891343|Effect of Alzheimer Disease symptomatic drugs|effect of alzheimer disease symptomatic drugs
208613|NCT02891343|Healthy Subjects|healthy subjects
208614|NCT02891330|Roux-en-Y Gastric ByPass|roux-en-y gastric bypass
208615|NCT02891304|esophagogastroduodenoscopy|esophagogastroduodenoscopy
208616|NCT02891291|optical coherence tomography|optical coherence tomography
208617|NCT02891278|Leukemia|leukemia
208618|NCT02891278|Sertraline|sertraline
208619|NCT02891278|Cytosine Arabinoside|cytosine arabinoside
208620|NCT02891278|Relapsed AML|relapsed aml
208621|NCT02891278|Refractory AML|refractory aml
208622|NCT02891239|laser treatment|laser treatment
208623|NCT02891226|inflammatory bowel disease|inflammatory bowel disease
208624|NCT02891226|IL-23|il-23
208625|NCT02891226|biologic|biologic
208626|NCT02891187|Postoperative Care|postoperative care
208627|NCT02891187|Telephone follow-up|telephone follow-up
208628|NCT02891187|Healthcare Value|healthcare value
208629|NCT02891174|ibuprofen|ibuprofen
208630|NCT02891174|acetaminophen|acetaminophen
208631|NCT02891174|blood pressure|blood pressure
208632|NCT02891174|post-partum|post-partum
208633|NCT02891174|pain control|pain control
208634|NCT02891174|pre-eclampsia|pre-eclampsia
208635|NCT02891174|gestational hypertension|gestational hypertension
208636|NCT02891161|durvalumab|durvalumab
208637|NCT02891161|MEDI4736|medi4736
208638|NCT02891161|anti-PD-L1|anti-pd-l1
208639|NCT02891135|"WHO 'Treat all Antiretroviral Guidelines"|"who 'treat all antiretroviral guidelines"
208640|NCT02891135|Simplified Algorithm for Treatment Eligibility (SLATE)|simplified algorithm for treatment eligibility (slate)
208641|NCT02891096|respiratory complications|respiratory complications
208642|NCT02891096|respiratory muscle strength|respiratory muscle strength
208643|NCT02891096|discriminator|discriminator
208644|NCT02891083|adjuvant chemotherapy|adjuvant chemotherapy
208645|NCT02891083|adjuvant radiotherapy|adjuvant radiotherapy
208646|NCT02891083|lymph node metastasis|lymph node metastasis
208647|NCT02891083|surgery|surgery
208648|NCT02891083|squamous cell carcinoma|squamous cell carcinoma
208649|NCT02891070|Cranial Surgery|cranial surgery
208650|NCT02891070|Cerebrospinal Fluid Leak|cerebrospinal fluid leak
208651|NCT02891070|Tisseel|tisseel
208652|NCT02891031|Rhus|rhus
208653|NCT02891031|Medicine, Traditional|medicine, traditional
208654|NCT02891031|Herbal medicine|herbal medicine
208655|NCT02891031|Uric acid|uric acid
208656|NCT02890966|SHR4640 pharmacokinetics pharmacodynamics|shr4640 pharmacokinetics pharmacodynamics
208657|NCT02890927|Geriatric Nursing|geriatric nursing
208658|NCT02890927|Geriatric co-management|geriatric co-management
266823|NCT02538978|CLI|cli
208659|NCT02890927|Geriatric team|geriatric team
208660|NCT02890901|Escherichia coli|escherichia coli
208661|NCT02890901|Bloodstream infections|bloodstream infections
208662|NCT02890901|Severity|severity
208663|NCT02890901|Score|score
208664|NCT02890901|Host factors|host factors
208665|NCT02890901|Microbiology|microbiology
208666|NCT02890888|small vessel disease of the brain|small vessel disease of the brain
208667|NCT02890888|hyperbaric oxygen|hyperbaric oxygen
208668|NCT02890888|functional connectivity MRI|functional connectivity mri
208669|NCT02890875|ethanol lock|ethanol lock
208670|NCT02890875|parenteral nutrition|parenteral nutrition
208671|NCT02890862|Kinematics|kinematics
208672|NCT02890862|Activity of Daily living|activity of daily living
208673|NCT02890862|3D motion analysis|3d motion analysis
208674|NCT02890836|Blood pressure|blood pressure
208675|NCT02890836|Hypertension|hypertension
208677|NCT02890836|Preeclampsia|preeclampsia
208678|NCT02890836|Anti-hypertensiva|anti-hypertensiva
208679|NCT02890823|Antiepileptic Drugs|antiepileptic drugs
208680|NCT02890823|Vitamin D Deficiency|vitamin d deficiency
208681|NCT02890823|Asian|asian
208682|NCT02890810|Acupuncture|acupuncture
208683|NCT02890810|Back Pain|back pain
208684|NCT02890810|Chronic Pain|chronic pain
208685|NCT02890797|bronchiolitis|bronchiolitis
208686|NCT02890797|parenchymal condensation|parenchymal condensation
208687|NCT02890797|chest X-ray|chest x-ray
208688|NCT02890797|chest ultrasound|chest ultrasound
208689|NCT02890771|Turmeric|turmeric
208690|NCT02890771|Chronic periodontitis|chronic periodontitis
208691|NCT02890758|Natural Killer Cell|natural killer cell
208692|NCT02890758|ALT-803|alt-803
208693|NCT02890745|Empagliflozin|empagliflozin
208694|NCT02890745|Oxidative stress|oxidative stress
208695|NCT02890745|Oxidative nucleic acid modifications|oxidative nucleic acid modifications
208696|NCT02890745|8-oxo-7,8-dihydro-2'-deoxyguanosine|8-oxo-7,8-dihydro-2'-deoxyguanosine
208697|NCT02890745|8-oxo-7,8-dihydroguanosine|8-oxo-7,8-dihydroguanosine
208698|NCT02890706|Pulmonary embolism (PE)|pulmonary embolism (pe)
208699|NCT02890706|Dual-Energy CT (DECT)|dual-energy ct (dect)
208700|NCT02890706|Subtraction imaging|subtraction imaging
208701|NCT02890693|gestational diabetes mellitus|gestational diabetes mellitus
208702|NCT02890693|randomized controlled trial|randomized controlled trial
208703|NCT02890693|lifestyle intervention|lifestyle intervention
208704|NCT02890693|cardiovascular|cardiovascular
208705|NCT02890693|metabolic|metabolic
208706|NCT02890693|mental health|mental health
208707|NCT02890693|depression|depression
208708|NCT02890693|physical activity|physical activity
208709|NCT02890693|dietary intervention|dietary intervention
208710|NCT02890680|platelet-rich fibrin|platelet-rich fibrin
208711|NCT02890680|third molar|third molar
208712|NCT02890680|bone regeneration|bone regeneration
208713|NCT02890667|Cancer|cancer
208714|NCT02890667|incidence|incidence
208715|NCT02890667|health insurance data|health insurance data
208716|NCT02890667|algorithms|algorithms
208717|NCT02890654|Teenagers|teenagers
208718|NCT02890654|Multidisciplinary approach|multidisciplinary approach
208719|NCT02890654|Pain|pain
208720|NCT02890654|Surgery|surgery
208721|NCT02890641|focal cortical dysplasia|focal cortical dysplasia
208722|NCT02890641|malformation of cortical development|malformation of cortical development
208723|NCT02890641|hemimegalencephaly|hemimegalencephaly
208724|NCT02890628|Thai-Myanmar border|thai-myanmar border
208725|NCT02890615|Survivors|survivors
208726|NCT02890615|Self Care|self care
208727|NCT02890589|Acute coronary syndrome|acute coronary syndrome
208728|NCT02890589|ST (Software Test) -elevation|st (software test) -elevation
208729|NCT02890576|cochlear implant|cochlear implant
208730|NCT02890576|telemedicine|telemedicine
208731|NCT02890576|new organization of patient monitoring|new organization of patient monitoring
208732|NCT02890563|Varicose veins|varicose veins
208733|NCT02890563|Compression stockings|compression stockings
208734|NCT02890563|Sclerotherapy|sclerotherapy
208735|NCT02890563|Radiofrequency ablation|radiofrequency ablation
208736|NCT02890550|Ciliopathy|ciliopathy
208737|NCT02890550|Retinitis pigmentosa|retinitis pigmentosa
208738|NCT02890550|ALMS1 gene|alms1 gene
208739|NCT02890537|Osteonecrosis|osteonecrosis
208740|NCT02890537|Femoral Head|femoral head
208741|NCT02890537|Hip|hip
208742|NCT02890537|Orthopedics|orthopedics
208743|NCT02890537|Bone|bone
208744|NCT02890537|Musculoskeletal Disorders|musculoskeletal disorders
208745|NCT02890524|aphthous stomatitis|aphthous stomatitis
208746|NCT02890524|night guard|night guard
208747|NCT02890524|inflammatory cytokine|inflammatory cytokine
208748|NCT02890459|HIV|hiv
208749|NCT02890459|incentives|incentives
208750|NCT02890459|behavioral economics|behavioral economics
208751|NCT02890446|attentional focus|attentional focus
208752|NCT02890446|upper extremity|upper extremity
208753|NCT02890446|hemiparesis|hemiparesis
208754|NCT02890446|stroke|stroke
208755|NCT02890394|Neck Pain|neck pain
208756|NCT02890394|Suboccipital inhibition|suboccipital inhibition
208757|NCT02890394|Physical Therapy|physical therapy
208758|NCT02890368|CD47|cd47
208759|NCT02890368|SIRPa|sirpa
208760|NCT02890368|Immunotherapy|immunotherapy
208761|NCT02890368|Checkpoint inhibitor|checkpoint inhibitor
208762|NCT02890342|Organic Acidemia|organic acidemia
208763|NCT02890342|Inborn Errors of Metabolism|inborn errors of metabolism
208764|NCT02890290|Frail Elderly|frail elderly
208765|NCT02890290|Diet, Food, and Nutrition|diet, food, and nutrition
208766|NCT02890290|physical function|physical function
208767|NCT02890290|marine protein hydrolysates|marine protein hydrolysates
208768|NCT02890290|protein intake|protein intake
208769|NCT02890290|seafood intake|seafood intake
208770|NCT02890290|ageing|ageing
208771|NCT02890290|old|old
208772|NCT02890290|nutrition|nutrition
208773|NCT02890290|frail|frail
208774|NCT02890264|End stage renal disease|end stage renal disease
208775|NCT02890264|Dialysis|dialysis
208776|NCT02890251|Infant|infant
208777|NCT02890251|Premature|premature
208778|NCT02890251|Diseases|diseases
208779|NCT02890238|Sildenafil Citrate|sildenafil citrate
208780|NCT02890238|Induction of Ovulation|induction of ovulation
208781|NCT02890238|Pregnancy Rate|pregnancy rate
208782|NCT02890225|stones|stones
208783|NCT02890225|external physical vibration lithecbole|external physical vibration lithecbole
208784|NCT02890212|Major depression, selenium, placebo, sertraline|major depression, selenium, placebo, sertraline
208785|NCT02890186|narcotrend|narcotrend
208786|NCT02890186|propofol|propofol
208787|NCT02890186|remifentanil|remifentanil
208788|NCT02890186|closed-loop of target controlled infusion|closed-loop of target controlled infusion
208789|NCT02890173|Essential hypertension|essential hypertension
208790|NCT02890173|Mineralocorticoid receptor antagonist|mineralocorticoid receptor antagonist
208791|NCT02890173|Esaxerenone|esaxerenone
208792|NCT02890173|Ambulatory blood pressure monitoring|ambulatory blood pressure monitoring
208793|NCT02890160|Bioresorbable Vascular Scaffold|bioresorbable vascular scaffold
208794|NCT02890147|SADs|sads
208795|NCT02890147|Healthy Volunteers|healthy volunteers
208796|NCT02890147|Molecular profiles|molecular profiles
208797|NCT02890147|Omics Techniques|omics techniques
208798|NCT02890134|SADs|sads
208799|NCT02890134|Molecular Reclassification|molecular reclassification
208800|NCT02890121|SADs|sads
208801|NCT02890121|Molecular Reclassification|molecular reclassification
208802|NCT02890108|High-Intensity Sweeteners|high-intensity sweeteners
208803|NCT02890108|Non-Nutritive Sweeteners|non-nutritive sweeteners
208804|NCT02890108|Artificial sweeteners|artificial sweeteners
208805|NCT02890108|Glucose intolerance|glucose intolerance
208806|NCT02890082|Breast cancer|breast cancer
208807|NCT02890082|fertility|fertility
208808|NCT02890082|chemotherapy|chemotherapy
208809|NCT02890069|PDR001|pdr001
208810|NCT02890069|CRC|crc
208811|NCT02890069|TNBC|tnbc
208812|NCT02890069|NSCLC|nsclc
208813|NCT02890069|RCC|rcc
208814|NCT02890069|Immunomodulation|immunomodulation
208815|NCT02890069|Biomarkers|biomarkers
208816|NCT02890069|Bayesian logistic regression model|bayesian logistic regression model
208817|NCT02890056|sugar-sweetened beverage consumption|sugar-sweetened beverage consumption
208818|NCT02890056|water consumption|water consumption
208819|NCT02890056|dietary behaviors|dietary behaviors
208820|NCT02890056|youth|youth
208821|NCT02890043|spine|spine
208822|NCT02890043|robot-assisted surgery|robot-assisted surgery
208823|NCT02890043|pedicle screw|pedicle screw
208824|NCT02890030|Cisplatin-based therapy|cisplatin-based therapy
208825|NCT02890030|Ototoxicity|ototoxicity
208826|NCT02890030|Neurotoxicity|neurotoxicity
208827|NCT02890017|outpatient surgery|outpatient surgery
208828|NCT02890017|urology medico-economic|urology medico-economic
208829|NCT02890017|hotel|hotel
208830|NCT02890004|Subarachnoid Hemorrhage|subarachnoid hemorrhage
208831|NCT02890004|Neurointensive care|neurointensive care
208832|NCT02890004|Observational registry|observational registry
208833|NCT02889991|Myofascial pain.|myofascial pain.
208834|NCT02889991|Myofascial trigger point.|myofascial trigger point.
208835|NCT02889991|Infraspinatus muscle.|infraspinatus muscle.
208836|NCT02889991|Deep dry needling.|deep dry needling.
208837|NCT02889991|Local twitch response.|local twitch response.
208838|NCT02889991|Fascial mechanotransduction.|fascial mechanotransduction.
208839|NCT02889991|Needle grasp.|needle grasp.
208840|NCT02889991|Myofascial fibrosis.|myofascial fibrosis.
208841|NCT02889991|Elastography.|elastography.
208842|NCT02889978|Cancer Screening|cancer screening
208843|NCT02889978|High-Throughput Nucleotide Sequencing|high-throughput nucleotide sequencing
208844|NCT02889978|Deep Sequencing|deep sequencing
208845|NCT02889978|Circulating cell-free tumor DNA|circulating cell-free tumor dna
208846|NCT02889965|Multiple sclerosis|multiple sclerosis
208847|NCT02889965|Pharmacoepidemiology|pharmacoepidemiology
208848|NCT02889965|Disease modifying drugs|disease modifying drugs
208849|NCT02889965|Neuro-myelitis optica|neuro-myelitis optica
208850|NCT02889952|postoperative hypocalcemia|postoperative hypocalcemia
208851|NCT02889952|near infrared imaging|near infrared imaging
208852|NCT02889952|parathyroid autofluorescence|parathyroid autofluorescence
208853|NCT02889939|rehabilitation|rehabilitation
208854|NCT02889939|recovery of function|recovery of function
208855|NCT02889939|environment|environment
208856|NCT02889900|ovarian cancer|ovarian cancer
208857|NCT02889887|Preterm|preterm
208858|NCT02889887|Sensory Processing|sensory processing
208859|NCT02889887|Motor Development|motor development
208860|NCT02889874|Radiation therapy|radiation therapy
208861|NCT02889874|omission|omission
208862|NCT02889874|non-inferiority|non-inferiority
208863|NCT02889874|breast cancer|breast cancer
208864|NCT02889861|Uveal melanoma|uveal melanoma
208865|NCT02889861|Cutaneous melanoma|cutaneous melanoma
208866|NCT02889835|Class II|class ii
208867|NCT02889835|molar and premolar|molar and premolar
208868|NCT02889835|resin composite|resin composite
208869|NCT02889835|adult|adult
208870|NCT02889835|restoration|restoration
208871|NCT02889809|Growth Velocity|growth velocity
208872|NCT02889809|Prepubertal|prepubertal
208873|NCT02889809|Asthma|asthma
208874|NCT02889809|Paediatric|paediatric
208875|NCT02889783|urodynamics|urodynamics
208982|NCT02889159|photoaging|photoaging
208876|NCT02889783|urethral sensation|urethral sensation
208877|NCT02889783|urethral pain|urethral pain
208878|NCT02889757|tuberculosis|tuberculosis
208879|NCT02889757|acetylcysteine|acetylcysteine
208880|NCT02889757|hepatotoxicity|hepatotoxicity
208881|NCT02889744|Temperature|temperature
208882|NCT02889744|Hypothermia|hypothermia
208883|NCT02889744|Brain|brain
208884|NCT02889744|Oxygen|oxygen
208885|NCT02889744|Prognosis|prognosis
208886|NCT02889731|Suicide|suicide
208887|NCT02889731|Heights|heights
208888|NCT02889731|Suicide hot spots|suicide hot spots
208889|NCT02889731|Bridges|bridges
208890|NCT02889705|Ultrasonography|ultrasonography
208891|NCT02889705|echotexture|echotexture
208892|NCT02889705|K value|k value
208893|NCT02889705|SCM muscles|scm muscles
208894|NCT02889705|CMT infants|cmt infants
208895|NCT02889692|lung cancer|lung cancer
208896|NCT02889692|traditional Chinese medicine|traditional chinese medicine
208897|NCT02889692|maintenance therapy|maintenance therapy
208898|NCT02889692|targeted therapy|targeted therapy
208899|NCT02889679|Colonoscopy|colonoscopy
208900|NCT02889679|Polypectomy|polypectomy
208901|NCT02889666|relapsed|relapsed
208902|NCT02889666|non-small cell lung cancer|non-small cell lung cancer
208903|NCT02889666|cisplatin|cisplatin
208904|NCT02889666|carboplatin|carboplatin
208905|NCT02889666|oxaliplatin|oxaliplatin
208906|NCT02889666|docetaxel|docetaxel
208907|NCT02889666|gemcitabine|gemcitabine
208908|NCT02889640|Educational Achievement|educational achievement
208909|NCT02889640|Individualized Tutoring|individualized tutoring
208910|NCT02889640|Mathematics|mathematics
208911|NCT02889640|Academic Mismatch|academic mismatch
208912|NCT02889640|Achievement Gap|achievement gap
208913|NCT02889627|Fecal Microbiota Transplantation|fecal microbiota transplantation
208914|NCT02889627|Gut microbiota|gut microbiota
208915|NCT02889627|Brain-gut axis|brain-gut axis
208916|NCT02889627|Epilepsy|epilepsy
208917|NCT02889588|Refractive Surgery|refractive surgery
208918|NCT02889588|higher order aberrations|higher order aberrations
208919|NCT02889562|apixaban|apixaban
208920|NCT02889562|anticoagulant|anticoagulant
208921|NCT02889562|CABG|cabg
208922|NCT02889562|thrombosis|thrombosis
208923|NCT02889562|fibrillation|fibrillation
208924|NCT02889536|parastomal hernia|parastomal hernia
208925|NCT02889536|ostomy|ostomy
208926|NCT02889536|qualitative|qualitative
208927|NCT02889536|phenomenological-hermeneutic research|phenomenological-hermeneutic research
208928|NCT02889536|symptoms|symptoms
208929|NCT02889536|parastomal bulging|parastomal bulging
208930|NCT02889523|Front line therapy|front line therapy
208931|NCT02889523|Age-adjusted International Prognostic Index (aa-IPI) >1|age-adjusted international prognostic index (aa-ipi) >1
208932|NCT02889523|60 to 80 years|60 to 80 years
208933|NCT02889510|diabetes|diabetes
208934|NCT02889510|liraglutide|liraglutide
208935|NCT02889510|lung function|lung function
208936|NCT02889497|vaccine|vaccine
208937|NCT02889497|safety|safety
208938|NCT02889497|immunogenicity|immunogenicity
208939|NCT02889458|Chinese|chinese
208940|NCT02889458|Breast Cancer|breast cancer
208941|NCT02889458|Women|women
208942|NCT02889419|Multiple Sclerosis|multiple sclerosis
208943|NCT02889419|Disability|disability
208944|NCT02889419|Underwear|underwear
208945|NCT02889419|Urinary catheter|urinary catheter
208946|NCT02889419|Self-catheterisation|self-catheterisation
208947|NCT02889380|Infertility|infertility
208948|NCT02889380|Cetrotide|cetrotide
208949|NCT02889380|Assisted reproductive technology (ART)|assisted reproductive technology (art)
208950|NCT02889341|Docosahexanoic Acid,|docosahexanoic acid,
208951|NCT02889341|DNA fragmentation|dna fragmentation
208952|NCT02889341|male fertility|male fertility
208953|NCT02889341|Sperm parameters improvements|sperm parameters improvements
208954|NCT02889315|PAH|pah
208955|NCT02889315|treprostinil|treprostinil
208956|NCT02889315|LenusPro|lenuspro
208957|NCT02889315|implantable device|implantable device
208958|NCT02889315|quality of life|quality of life
208959|NCT02889289|traumatic brain injury|traumatic brain injury
208960|NCT02889289|virtual reality|virtual reality
208961|NCT02889289|Xbox kinect|xbox kinect
208962|NCT02889289|balance|balance
208963|NCT02889250|geriatric|geriatric
208964|NCT02889250|depression|depression
208965|NCT02889250|deep brain stimulation|deep brain stimulation
208966|NCT02889250|subcallosal cingulate|subcallosal cingulate
208967|NCT02889237|Fracture healing|fracture healing
208968|NCT02889237|Calcium supplementation|calcium supplementation
208969|NCT02889237|Vitamin D supplementation|vitamin d supplementation
208970|NCT02889237|HR-pQCT|hr-pqct
208971|NCT02889224|Obesity|obesity
208972|NCT02889224|Cortisol|cortisol
208973|NCT02889224|Hydrocortisone|hydrocortisone
208974|NCT02889224|Endocannabinoïds|endocannabinoïds
208975|NCT02889198|web-based tool|web-based tool
208976|NCT02889198|child, preschool|child, preschool
208977|NCT02889198|nutrition|nutrition
208978|NCT02889198|implementation|implementation
208979|NCT02889198|child care|child care
208980|NCT02889185|Optical Coherence Tomography|optical coherence tomography
208981|NCT02889185|Retinal camera|retinal camera
208983|NCT02889146|Intensive Care Units|intensive care units
208984|NCT02889146|Physical Therapy Specialty|physical therapy specialty
208985|NCT02889146|Critical illness|critical illness
208986|NCT02889146|Muscle weakness|muscle weakness
208987|NCT02889146|Bed rest|bed rest
208988|NCT02889133|Iron deficiency|iron deficiency
208989|NCT02889133|Transfusion|transfusion
208990|NCT02889133|Blood donation|blood donation
208991|NCT02889120|Drug advice by phone|drug advice by phone
208992|NCT02889120|Teleprescription|teleprescription
208993|NCT02889120|Medical call centre|medical call centre
208994|NCT02889120|Out of hours call|out of hours call
208995|NCT02889081|birth cohort|birth cohort
208996|NCT02889081|prenatal|prenatal
208997|NCT02889081|skin barrier|skin barrier
208998|NCT02889081|atopic dermatitis|atopic dermatitis
208999|NCT02889081|key nutritional factors|key nutritional factors
209000|NCT02889016|PANS|pans
209001|NCT02889016|PANDAS|pandas
209002|NCT02888951|Diabetes|diabetes
209003|NCT02888951|Diabetes Mellitus|diabetes mellitus
209004|NCT02888951|Gastric Ultrasound|gastric ultrasound
209005|NCT02888951|Preoperative fasting|preoperative fasting
209006|NCT02888951|Empty Stomach|empty stomach
209007|NCT02888951|Gastric Diabetes|gastric diabetes
209008|NCT02888912|glass ionomer cement|glass ionomer cement
209009|NCT02888912|composite resin|composite resin
209010|NCT02888886|systemic inflammation|systemic inflammation
209011|NCT02888873|composite resin|composite resin
209012|NCT02888873|Clinical trial|clinical trial
209013|NCT02888873|FDI (World Dental Federation) criteria|fdi (world dental federation) criteria
209014|NCT02888860|genetic susceptibility|genetic susceptibility
209015|NCT02888860|candida infection|candida infection
209016|NCT02888860|colonization|colonization
209017|NCT02888847|post bleaching teeth sensitivity|post bleaching teeth sensitivity
209018|NCT02888834|elderly|elderly
209019|NCT02888834|adverse drug reactions|adverse drug reactions
209020|NCT02888834|hospitalized subjects|hospitalized subjects
209021|NCT02888834|community-dwelling|community-dwelling
209022|NCT02888808|gastroesophageal reflux disease|gastroesophageal reflux disease
209023|NCT02888808|women|women
209024|NCT02888808|Nigeria|nigeria
209025|NCT02888808|obesity|obesity
209026|NCT02888795|hypertonic dextrose prolotherapy|hypertonic dextrose prolotherapy
209027|NCT02888795|osteoarthritis|osteoarthritis
209028|NCT02888769|Coronary artery disease|coronary artery disease
209029|NCT02888769|Text messages|text messages
209030|NCT02888769|Blood pressure|blood pressure
209031|NCT02888769|Lifestyle|lifestyle
209032|NCT02888769|Risk factors|risk factors
209033|NCT02888756|Immunotherapy|immunotherapy
209034|NCT02888756|mRNA|mrna
209035|NCT02888756|Lentivirus infection|lentivirus infection
209036|NCT02888756|Virus disease|virus disease
209037|NCT02888756|Sexually transmitted disease|sexually transmitted disease
209038|NCT02888756|Immunodeficiency syndrome|immunodeficiency syndrome
209039|NCT02888730|cystic fibrosis|cystic fibrosis
209040|NCT02888730|chronic rhinosinusitis|chronic rhinosinusitis
209041|NCT02888730|Lung Diseases|lung diseases
209042|NCT02888730|tobramycin|tobramycin
209043|NCT02888730|nebulized sonic aerosol therapy|nebulized sonic aerosol therapy
209044|NCT02888704|Atopic dermatitis|atopic dermatitis
209045|NCT02888704|Mesenchymal stem cells|mesenchymal stem cells
209046|NCT02888678|ASPIRES|aspires
209047|NCT02888652|Coronary Heart Disease|coronary heart disease
209049|NCT02888652|Anti-Platelet Agents|anti-platelet agents
209050|NCT02888613|mini-lumbotomy|mini-lumbotomy
209051|NCT02888613|mini-laparotomy|mini-laparotomy
209052|NCT02888613|retroperitoneal approach|retroperitoneal approach
209053|NCT02888613|transperitoneal approach|transperitoneal approach
209054|NCT02888613|abdominal aortic surgery|abdominal aortic surgery
209055|NCT02888535|primary immunodeficiency|primary immunodeficiency
209056|NCT02888535|secondary immunodeficiency|secondary immunodeficiency
209057|NCT02888535|intensive care unit|intensive care unit
209058|NCT02888535|infection|infection
209059|NCT02888535|adult|adult
209060|NCT02888509|depression|depression
209061|NCT02888509|anxiety disorder|anxiety disorder
209062|NCT02888509|bipolar disorder|bipolar disorder
209063|NCT02888509|Magnetic Resonance Imaging|magnetic resonance imaging
209064|NCT02888483|physical activity|physical activity
209065|NCT02888483|energy expenditure|energy expenditure
209066|NCT02888457|nasopharyngeal carriage|nasopharyngeal carriage
209067|NCT02888457|Streptococcus pneumoniae|streptococcus pneumoniae
209068|NCT02888457|acute otitis media|acute otitis media
209069|NCT02888457|day-care centers|day-care centers
209071|NCT02888431|base deficit|base deficit
209072|NCT02888431|lactate values|lactate values
209073|NCT02888431|venous blood samples|venous blood samples
209074|NCT02888431|arterial blood samples|arterial blood samples
209075|NCT02888418|vaccine|vaccine
209076|NCT02888418|safety|safety
209077|NCT02888418|immunogenicity|immunogenicity
209078|NCT02888405|Body Composition|body composition
209079|NCT02888366|breast cancer|breast cancer
209080|NCT02888366|breath test|breath test
209081|NCT02888366|Menssana|menssana
209082|NCT02888366|Ancillary|ancillary
209083|NCT02888366|Mammography|mammography
209084|NCT02888366|Rapid Point-of-care|rapid point-of-care
209085|NCT02888366|Inflatable Bag|inflatable bag
209086|NCT02888353|Magnetic Resonance Imaging and Pacemakers ICD|magnetic resonance imaging and pacemakers icd
209087|NCT02888340|Acupuncture|acupuncture
209088|NCT02888340|Emergency Department|emergency department
209089|NCT02888340|Pain|pain
209090|NCT02888314|mHealth|mhealth
209091|NCT02888314|Pokemon Go|pokemon go
209092|NCT02888288|adolescent|adolescent
209093|NCT02888288|adolescence|adolescence
209094|NCT02888288|HIV/AIDS|hiv/aids
209095|NCT02888288|mental health|mental health
209096|NCT02888288|cognitive behavioral therapy|cognitive behavioral therapy
209097|NCT02888262|Bipolar disorder|bipolar disorder
209098|NCT02888262|Blood|blood
209099|NCT02888262|Smartphone|smartphone
209100|NCT02888262|Brain imaging|brain imaging
209101|NCT02888262|Cognition|cognition
209102|NCT02888262|Neuropsychology|neuropsychology
209103|NCT02888249|Tobacco withdrawal|tobacco withdrawal
209104|NCT02888249|Autonomic Agents|autonomic agents
209105|NCT02888236|Psoriasis|psoriasis
209106|NCT02888080|pulmonary sarcoidosis|pulmonary sarcoidosis
209107|NCT02888080|sarcoidosis|sarcoidosis
209108|NCT02888080|canakinumab|canakinumab
209109|NCT02888080|autoimmune diseases|autoimmune diseases
209110|NCT02888080|granulomas|granulomas
209111|NCT02888080|inflammation|inflammation
209112|NCT02888080|lung function testing|lung function testing
209113|NCT02888080|immunosuppressive agents|immunosuppressive agents
209114|NCT02888080|interleukin|interleukin
209115|NCT02888080|interleukin-1Beta|interleukin-1beta
209116|NCT02888080|[F-18]FDG-PET/CT|[f-18]fdg-pet/ct
209117|NCT02888080|respiratory|respiratory
209118|NCT02888080|pulmonary|pulmonary
209119|NCT02888080|steroids|steroids
209120|NCT02888080|corticosteroids|corticosteroids
209121|NCT02888080|lung diseases|lung diseases
209122|NCT02888067|Neuromuscular Blockade|neuromuscular blockade
209123|NCT02888041|Cervical ripening|cervical ripening
209124|NCT02888041|Pregnancy|pregnancy
209125|NCT02888041|Vaginal Administration|vaginal administration
209126|NCT02888028|Remote ICD follow-up|remote icd follow-up
209127|NCT02888028|HRQoL|hrqol
209128|NCT02888028|Health related Quality of Life|health related quality of life
209129|NCT02888028|Depression|depression
209130|NCT02888028|anxiety|anxiety
209131|NCT02888028|device acceptance|device acceptance
209132|NCT02888028|telemedicine|telemedicine
209133|NCT02888028|telemonitoring|telemonitoring
209134|NCT02887989|Virtual Reality|virtual reality
209135|NCT02887989|Non-Opioid Pain Management|non-opioid pain management
209136|NCT02887976|Prostate Cancer|prostate cancer
209137|NCT02887976|Castrate Resistant Prostate Cancer (CRPC)|castrate resistant prostate cancer (crpc)
209138|NCT02887976|metastatic|metastatic
209139|NCT02887976|castrate resistant|castrate resistant
209140|NCT02887963|Iron Deficiency|iron deficiency
209141|NCT02887963|Iron Deficiency Anemia|iron deficiency anemia
209142|NCT02887963|Pregnant Women|pregnant women
209143|NCT02887963|Gestation|gestation
209144|NCT02887963|China|china
209145|NCT02887963|Epidemiology|epidemiology
209146|NCT02887872|stroke|stroke
209147|NCT02887872|upper extremity function|upper extremity function
209148|NCT02887872|rehabilitation|rehabilitation
209149|NCT02887820|ECMO|ecmo
209150|NCT02887820|TEG|teg
209151|NCT02887807|Cardiac arrest|cardiac arrest
209152|NCT02887807|Shockable|shockable
209153|NCT02887807|Cyclosporine|cyclosporine
209154|NCT02887794|pitch discrimination|pitch discrimination
209155|NCT02887794|auditory processing disorders|auditory processing disorders
209156|NCT02887794|auditory perception|auditory perception
209157|NCT02887794|auditory-verbal hallucinations|auditory-verbal hallucinations
209158|NCT02887794|theory of mind|theory of mind
209159|NCT02887729|Polycystic disease|polycystic disease
209160|NCT02887703|ataxia|ataxia
209161|NCT02887703|balance training|balance training
209162|NCT02887703|vibrotactile biofeedback|vibrotactile biofeedback
209163|NCT02887703|sensory augmentation|sensory augmentation
209164|NCT02887703|cerebellar ataxia|cerebellar ataxia
209166|NCT02887690|prosthetic limb|prosthetic limb
209167|NCT02887690|upper extremity|upper extremity
209168|NCT02887690|prosthesis|prosthesis
209169|NCT02887677|Dapagliflozin|dapagliflozin
209170|NCT02887677|Arterial Stiffness|arterial stiffness
209171|NCT02887677|Aortic Pressure|aortic pressure
209172|NCT02887651|cerebrale metastases|cerebrale metastases
209173|NCT02887651|radiotherapy|radiotherapy
209174|NCT02887651|surgery|surgery
209175|NCT02887651|complete surgical resection|complete surgical resection
209176|NCT02887651|resection|resection
209177|NCT02887651|cavity boost radiation therapy|cavity boost radiation therapy
209178|NCT02887651|observation|observation
209179|NCT02887638|posture, sit|posture, sit
209180|NCT02887586|Auricular Needling|auricular needling
209181|NCT02887586|Mechanism Study|mechanism study
209182|NCT02887586|Anorexia|anorexia
209183|NCT02887586|Cancer|cancer
209184|NCT02887573|Bowel preparation|bowel preparation
209185|NCT02887573|Colorectal polyps|colorectal polyps
209186|NCT02887573|Colon capsule endoscopy|colon capsule endoscopy
209187|NCT02887560|Right ventricle|right ventricle
209188|NCT02887560|Pulmonary transplantation|pulmonary transplantation
209189|NCT02887560|Strain|strain
209190|NCT02887560|isovolumic acceleration (IVA)|isovolumic acceleration (iva)
209191|NCT02887495|scleroderma|scleroderma
209192|NCT02887495|biorepository|biorepository
209193|NCT02887482|DNA|dna
209194|NCT02887482|Vaccine|vaccine
209195|NCT02887469|Hyponatremia|hyponatremia
209196|NCT02887469|Hypertonic saline|hypertonic saline
209197|NCT02887469|Treatment|treatment
209198|NCT02887469|Osmotic demyelination syndrome|osmotic demyelination syndrome
209199|NCT02887430|foot reflexology|foot reflexology
209200|NCT02887430|pain intensity|pain intensity
209201|NCT02887430|health-related quality of life|health-related quality of life
209202|NCT02887417|platelet activation|platelet activation
209203|NCT02887391|hemodialysis|hemodialysis
209204|NCT02887391|nutritional status|nutritional status
209205|NCT02887378|bronchial biopsy|bronchial biopsy
209206|NCT02887365|colon cancer|colon cancer
209207|NCT02887365|MSI-L|msi-l
209208|NCT02887365|MSS|mss
209209|NCT02887365|Tegafur-Uracil|tegafur-uracil
209210|NCT02887365|Low-Level Microsatellite-Instability|low-level microsatellite-instability
209211|NCT02887339|Informed Consent|informed consent
209212|NCT02887339|Research donation request|research donation request
209213|NCT02887339|Effective Communication|effective communication
209214|NCT02887313|Rectal cancer|rectal cancer
209215|NCT02887313|Neoadjuvant chemoradiation therapy|neoadjuvant chemoradiation therapy
209216|NCT02887300|Quality of Health Care|quality of health care
209217|NCT02887300|Psychological Stress|psychological stress
209218|NCT02887300|Burnout|burnout
209219|NCT02887300|Health Care Professional|health care professional
209220|NCT02887300|Mantra Meditation|mantra meditation
209221|NCT02887300|Health Care Economics|health care economics
209222|NCT02887274|Systemic Inflammatory Response Syndrome (SIRS)|systemic inflammatory response syndrome (sirs)
209223|NCT02887274|Sepsis|sepsis
209224|NCT02887274|Severe Sepsis|severe sepsis
209225|NCT02887274|Septic shock|septic shock
209226|NCT02887274|Multiple organ failure|multiple organ failure
209227|NCT02887261|Power Port|power port
209228|NCT02887248|nab-paclitaxel|nab-paclitaxel
209229|NCT02887248|gemcitabine|gemcitabine
209230|NCT02887222|Epidural|epidural
209231|NCT02887222|Labor analgesia|labor analgesia
209232|NCT02887222|Programmed intermittent epidural bolus|programmed intermittent epidural bolus
209233|NCT02887196|Breast Cancer|breast cancer
209234|NCT02887183|Heart failure|heart failure
209235|NCT02887183|Reduced left ventricular ejection fraction|reduced left ventricular ejection fraction
209236|NCT02887183|HFrEF|hfref
209237|NCT02887183|NT-proBNP|nt-probnp
209238|NCT02887183|Cardiac remodeling|cardiac remodeling
209239|NCT02887170|Adolescent|adolescent
209240|NCT02887170|Lost to contact|lost to contact
209241|NCT02887170|Recurrence|recurrence
209242|NCT02887170|Long-term outcome|long-term outcome
209243|NCT02887131|Subtalar arthritis|subtalar arthritis
209244|NCT02887131|Subtalar instability|subtalar instability
209245|NCT02887118|Erythrocytes|erythrocytes
209246|NCT02887118|Sickle Cell Disease|sickle cell disease
209247|NCT02887092|health determinants|health determinants
209248|NCT02887092|epidemiology|epidemiology
209249|NCT02887092|maintaining autonomy|maintaining autonomy
209250|NCT02887092|psychology|psychology
209251|NCT02887092|osteoarthritis|osteoarthritis
209252|NCT02887092|perceived health|perceived health
209253|NCT02887053|MRI|mri
209254|NCT02887053|Healthy subjects|healthy subjects
209255|NCT02887040|Diffuse, intrinsic brain stem glioma|diffuse, intrinsic brain stem glioma
209256|NCT02887040|Antineoplaston therapy|antineoplaston therapy
209257|NCT02887040|Radiation|radiation
209258|NCT02887014|bowel preparation|bowel preparation
209259|NCT02887014|colonoscopy|colonoscopy
209260|NCT02887014|inpatients|inpatients
209261|NCT02887014|cathartics|cathartics
209262|NCT02887001|cost study|cost study
209263|NCT02887001|clinical pharmacist|clinical pharmacist
209264|NCT02886988|Botulinum toxin type A, scar|botulinum toxin type a, scar
209265|NCT02886975|Renal Insufficiency, Chronic|renal insufficiency, chronic
209266|NCT02886975|Diet, Protein-Restricted|diet, protein-restricted
209267|NCT02886936|transtibial amputees|transtibial amputees
209268|NCT02886910|Chorioamnionitis|chorioamnionitis
209269|NCT02886910|Early onset neonatal sepsis|early onset neonatal sepsis
209270|NCT02886910|Antibiotics|antibiotics
209271|NCT02886910|Clinical observation|clinical observation
209272|NCT02886897|Refractory solid tumors|refractory solid tumors
209273|NCT02886897|Dendritic and Cytokine-induced killer cell|dendritic and cytokine-induced killer cell
209274|NCT02886897|Anti-PD-1 antibody|anti-pd-1 antibody
209275|NCT02886897|Combination immunotherapy|combination immunotherapy
209276|NCT02886884|Diabetes|diabetes
209277|NCT02886884|Endothelial dysfunction|endothelial dysfunction
209278|NCT02886884|Stem cells|stem cells
209279|NCT02886858|Depression|depression
209280|NCT02886858|Moods disorders|moods disorders
209281|NCT02886858|electroconvulsive therapy|electroconvulsive therapy
209282|NCT02886845|SNP,Breast Neoplasms|snp,breast neoplasms
209283|NCT02886832|Prostate Health|prostate health
209387|NCT02886091|Cryosurgery|cryosurgery
209284|NCT02886819|Whole body vibration|whole body vibration
209285|NCT02886819|Tonic vibration reflex|tonic vibration reflex
209286|NCT02886819|Bone myoregulation reflex|bone myoregulation reflex
209287|NCT02886806|closed loop|closed loop
209288|NCT02886806|remifentanil|remifentanil
209289|NCT02886806|propofol|propofol
209290|NCT02886767|skin to skin contact|skin to skin contact
209291|NCT02886754|Clinical Communication|clinical communication
209292|NCT02886754|ISBAR|isbar
209293|NCT02886754|Simulation|simulation
209294|NCT02886754|Performance|performance
209295|NCT02886754|Non technical skills|non technical skills
209296|NCT02886754|Proficiency|proficiency
209297|NCT02886741|campaign|campaign
209298|NCT02886741|surgical site infection|surgical site infection
209299|NCT02886741|orthopedic surgery|orthopedic surgery
209300|NCT02886741|quality improvement|quality improvement
209301|NCT02886741|infection control|infection control
209302|NCT02886650|Paediatrics|paediatrics
209303|NCT02886650|epilepsy surgery|epilepsy surgery
209304|NCT02886650|genetic mutation|genetic mutation
209305|NCT02886650|focal seizures|focal seizures
209306|NCT02886637|A baumannii infection|a baumannii infection
209307|NCT02886637|Immunosuppression|immunosuppression
209308|NCT02886637|prognosis|prognosis
209309|NCT02886637|immune function|immune function
209310|NCT02886585|Brain Metastases|brain metastases
209311|NCT02886559|demethylating agent|demethylating agent
209312|NCT02886559|chidamide|chidamide
209313|NCT02886533|Major haemorrhage|major haemorrhage
209314|NCT02886533|Oral anticoagulation|oral anticoagulation
209315|NCT02886533|Antiplatelet drugs|antiplatelet drugs
209316|NCT02886533|Gastrointestinal bleeding|gastrointestinal bleeding
209317|NCT02886533|Intracranial haemorrhage|intracranial haemorrhage
209318|NCT02886520|Urinary incontinence|urinary incontinence
209319|NCT02886520|Materials|materials
209320|NCT02886520|Surgery|surgery
209321|NCT02886520|Transobturator tape|transobturator tape
209322|NCT02886520|Polyvinylidene fluoride|polyvinylidene fluoride
209323|NCT02886520|Polypropylene|polypropylene
209324|NCT02886481|thyroidectomy|thyroidectomy
209325|NCT02886481|Electrophysiologic|electrophysiologic
209326|NCT02886481|vocal cord movement|vocal cord movement
209327|NCT02886429|dexmedetomidine|dexmedetomidine
209328|NCT02886429|bupivacaine|bupivacaine
209329|NCT02886429|Ultrasound guided paravertebral block|ultrasound guided paravertebral block
209330|NCT02886429|pain|pain
209331|NCT02886429|post-thoracotomy|post-thoracotomy
209332|NCT02886416|HIV infection|hiv infection
209333|NCT02886390|remote ischemic conditioning|remote ischemic conditioning
209334|NCT02886390|r-tPA thrombolytic therapy|r-tpa thrombolytic therapy
209335|NCT02886351|Moderate Sedation|moderate sedation
209336|NCT02886351|Pediatric Dentistry|pediatric dentistry
209337|NCT02886351|Anxiety|anxiety
209338|NCT02886299|Fibrates|fibrates
209339|NCT02886299|Statins|statins
209340|NCT02886299|Hemodialysis|hemodialysis
209341|NCT02886299|Dyslipidemia|dyslipidemia
209342|NCT02886299|Improved Oxidative Stress|improved oxidative stress
209343|NCT02886299|Egypt|egypt
209344|NCT02886273|Sudden Cardiac Arrest|sudden cardiac arrest
209345|NCT02886273|Out-of-hospital|out-of-hospital
209346|NCT02886273|Ventricular fibrillation|ventricular fibrillation
209347|NCT02886273|Classification|classification
209348|NCT02886273|Mechanisms|mechanisms
209349|NCT02886273|Biomarkers|biomarkers
209350|NCT02886234|HIV|hiv
209351|NCT02886234|Mindfulness|mindfulness
209352|NCT02886234|Adherence behaviors|adherence behaviors
209353|NCT02886234|Stress|stress
209354|NCT02886234|Depression|depression
209355|NCT02886221|Hallux Valgus|hallux valgus
209356|NCT02886221|Reverdin-Isham Osteotomy|reverdin-isham osteotomy
209357|NCT02886221|Minimally Invasive Surgery|minimally invasive surgery
209358|NCT02886221|Percutaneous Distal Osteotomy|percutaneous distal osteotomy
209359|NCT02886221|First Ray|first ray
209360|NCT02886221|Forefoot|forefoot
209361|NCT02886182|chronic hepatitis B|chronic hepatitis b
209362|NCT02886182|pregnancy|pregnancy
209363|NCT02886182|Cellular immune response|cellular immune response
209364|NCT02886182|Clinical implications|clinical implications
209365|NCT02886169|Sacha Inchi|sacha inchi
209366|NCT02886169|High-fat meal|high-fat meal
209367|NCT02886169|Postprandial inflammatory responses|postprandial inflammatory responses
209368|NCT02886156|OSA|osa
209369|NCT02886156|CPAP|cpap
209370|NCT02886156|cognitive function|cognitive function
209371|NCT02886156|gut microbiota|gut microbiota
209372|NCT02886156|metabolomics|metabolomics
209373|NCT02886130|Alpha-GPC|alpha-gpc
209374|NCT02886130|Volleyball|volleyball
209375|NCT02886130|Athletes|athletes
209376|NCT02886130|Executive functions|executive functions
209377|NCT02886130|Vertical jump|vertical jump
209378|NCT02886130|Peak power|peak power
209379|NCT02886104|synchronous|synchronous
209380|NCT02886104|metachronous|metachronous
209381|NCT02886104|colorectal liver metastasis|colorectal liver metastasis
209382|NCT02886104|resection|resection
209383|NCT02886104|ablation|ablation
209384|NCT02886091|Keloids|keloids
209385|NCT02886091|Shaving|shaving
209386|NCT02886091|Ears|ears
209388|NCT02886091|Hypertrophic scars|hypertrophic scars
209389|NCT02886065|Myeloma|myeloma
209390|NCT02886052|Cognitive behavior therapy|cognitive behavior therapy
209391|NCT02886052|Internet treatment|internet treatment
209392|NCT02886052|Self-help treatment|self-help treatment
209393|NCT02886052|Insomnia|insomnia
209394|NCT02886052|ICBT|icbt
209395|NCT02886052|CBT-i|cbt-i
209396|NCT02886052|Bereavement|bereavement
209397|NCT02886039|Cardiorespiratory arrest|cardiorespiratory arrest
209398|NCT02886039|Neurologic outcome|neurologic outcome
209399|NCT02886039|Electroencephalogram|electroencephalogram
209400|NCT02886039|Somatosensory evoked potential|somatosensory evoked potential
209401|NCT02886039|Synek classification|synek classification
209402|NCT02886039|Cerebral performance category|cerebral performance category
209403|NCT02886039|Hypothermia|hypothermia
209404|NCT02886026|Laser|laser
209405|NCT02886026|Bladder cancer|bladder cancer
209406|NCT02886026|Treatment|treatment
209407|NCT02886026|Outpatient|outpatient
209408|NCT02886026|TUR-BT|tur-bt
209409|NCT02886013|prevalence|prevalence
209410|NCT02885974|Celecoxib|celecoxib
209411|NCT02885974|Bladder Cancer|bladder cancer
209412|NCT02885909|type 2 diabetes|type 2 diabetes
209413|NCT02885909|inpatient|inpatient
209414|NCT02885909|glucose control|glucose control
209415|NCT02885909|continue glucose monitor|continue glucose monitor
209416|NCT02885896|Call center|call center
209417|NCT02885896|nurses|nurses
209418|NCT02885896|pediatrics|pediatrics
209419|NCT02885896|standardized messages|standardized messages
209420|NCT02885896|family counseling|family counseling
209421|NCT02885870|biomarker|biomarker
209422|NCT02885870|spinal cord disease|spinal cord disease
209423|NCT02885870|resonance imaging|resonance imaging
209424|NCT02885870|electrophysiology|electrophysiology
209425|NCT02885831|Abduction splint|abduction splint
209426|NCT02885831|Pubo-femoral distance|pubo-femoral distance
209427|NCT02885792|Schizophrenia|schizophrenia
209428|NCT02885792|Cardiovascular disease|cardiovascular disease
209429|NCT02885792|Premature mortality|premature mortality
209430|NCT02885792|Arteriosclerosis|arteriosclerosis
209431|NCT02885792|Risk factor|risk factor
209432|NCT02885792|Intervention|intervention
209433|NCT02885792|Treatment|treatment
209434|NCT02885792|Somatic morbidity|somatic morbidity
209435|NCT02885766|CML|cml
209436|NCT02885766|Myeloid leukaemia chronic|myeloid leukaemia chronic
209437|NCT02885766|CML progression|cml progression
209438|NCT02885766|Chronic phase chronic myeloid leukemia|chronic phase chronic myeloid leukemia
209439|NCT02885766|PF-114|pf-114
209440|NCT02885766|Cytogenetic response CCyR|cytogenetic response ccyr
209441|NCT02885766|Major molecular response MMR|major molecular response mmr
209442|NCT02885766|Complete molecular response CMR|complete molecular response cmr
209443|NCT02885766|Leukemia, Myelogenous, Chronic, BCR-ABL Positive|leukemia, myelogenous, chronic, bcr-abl positive
209444|NCT02885766|2-nd generation Bcr-Abl inhibitors resistant|2-nd generation bcr-abl inhibitors resistant
209445|NCT02885753|colorectal|colorectal
209446|NCT02885753|cancer|cancer
209447|NCT02885753|metastasis|metastasis
209448|NCT02885753|hepatic|hepatic
209449|NCT02885701|postoperative dressing|postoperative dressing
209450|NCT02885701|postoperative splint|postoperative splint
209451|NCT02885701|mini-open carpal tunnel release|mini-open carpal tunnel release
209452|NCT02885688|Septic Shock|septic shock
209453|NCT02885688|Sepsis|sepsis
209454|NCT02885688|Standard of care|standard of care
209455|NCT02885688|Liquid nutrition|liquid nutrition
209456|NCT02885688|Metabolic support|metabolic support
209457|NCT02885688|Enteral nutrition|enteral nutrition
209458|NCT02885688|Insulin Drip|insulin drip
209459|NCT02885688|Glucose Drip|glucose drip
209460|NCT02885662|Primary aldosteronism|primary aldosteronism
209461|NCT02885662|Hypertension|hypertension
209462|NCT02885662|mineralocorticoid receptor antagonist|mineralocorticoid receptor antagonist
209463|NCT02885662|Developmental Phase III|developmental phase iii
209464|NCT02885636|Heart Failure with Preserved Ejection Fraction|heart failure with preserved ejection fraction
209465|NCT02885636|Pulmonary Hypertension|pulmonary hypertension
209466|NCT02885597|Juanbi Pill|juanbi pill
209467|NCT02885597|Methotrexate|methotrexate
209468|NCT02885597|Active|active
209469|NCT02885597|Rheumatoid Arthritis|rheumatoid arthritis
209470|NCT02885584|Mechanical ventilation|mechanical ventilation
209471|NCT02885558|Receptors, Calcium Channel Blocker|receptors, calcium channel blocker
209472|NCT02885532|alcohol|alcohol
209473|NCT02885519|Vocational Rehabilitation|vocational rehabilitation
209474|NCT02885519|Common Mental Disorders|common mental disorders
209475|NCT02885519|Return to Work|return to work
209476|NCT02885519|Mental Health Services|mental health services
209477|NCT02885519|Psychological Stress|psychological stress
209478|NCT02885519|Adjustment Disorder|adjustment disorder
209479|NCT02885519|Burnout|burnout
209480|NCT02885519|Integration|integration
209481|NCT02885519|Cognitive Behavior Therapy|cognitive behavior therapy
209482|NCT02885493|Parkinson march|parkinson march
209483|NCT02885467|Total Knee Arthroplasty|total knee arthroplasty
209484|NCT02885441|Inflammation|inflammation
209485|NCT02885389|Infantile spasms|infantile spasms
209486|NCT02885389|West syndrome|west syndrome
209487|NCT02885389|variant|variant
209488|NCT02885389|mutation|mutation
209489|NCT02885389|CNV|cnv
209490|NCT02885389|sequencing|sequencing
209491|NCT02885376|Mucositis|mucositis
209492|NCT02885337|Frail Elderly|frail elderly
209493|NCT02885337|Arthroplasty|arthroplasty
209494|NCT02885337|Frailty|frailty
209495|NCT02885324|High Grade Glioma|high grade glioma
209496|NCT02885324|Cabozantinib|cabozantinib
209497|NCT02885324|GBM|gbm
209498|NCT02885324|Children|children
209499|NCT02885324|AA|aa
209500|NCT02885311|Drinking|drinking
209501|NCT02885311|Excessive drinking|excessive drinking
209502|NCT02885311|Alcohol use disorders|alcohol use disorders
209503|NCT02885311|Primary Care|primary care
209504|NCT02885285|Parkinson's disease|parkinson's disease
209505|NCT02885285|fatigue|fatigue
209506|NCT02885285|anxiety|anxiety
209507|NCT02885285|depression|depression
209508|NCT02885285|exercise|exercise
209509|NCT02885246|Panama|panama
209510|NCT02885246|Influenza B|influenza b
209511|NCT02885246|Influenza A|influenza a
209512|NCT02885246|Strain circulation|strain circulation
209513|NCT02885246|Database|database
209514|NCT02885233|Fall Prevention|fall prevention
209515|NCT02885233|Multiple Sclerosis|multiple sclerosis
209516|NCT02885233|Web-based education|web-based education
209517|NCT02885233|Self-efficacy|self-efficacy
209518|NCT02885207|Limbic encephalitis|limbic encephalitis
209519|NCT02885207|anti-neuronal antibodies|anti-neuronal antibodies
209520|NCT02885194|Parkinson Disease|parkinson disease
209521|NCT02885194|Pain|pain
209522|NCT02885194|Deep Brain Stimulation|deep brain stimulation
209523|NCT02885194|Laser-Evoked Potentials|laser-evoked potentials
209524|NCT02885168|vasoreactivity|vasoreactivity
209525|NCT02885168|recombinant activated protein C|recombinant activated protein c
209526|NCT02885116|NHF|nhf
209527|NCT02885116|pulmonary hypertension|pulmonary hypertension
209528|NCT02885103|NHF|nhf
209529|NCT02885103|nasal highflow|nasal highflow
209530|NCT02885038|Platelet Transfusion|platelet transfusion
209531|NCT02885025|hypersensitivity|hypersensitivity
209532|NCT02885025|antioxidants|antioxidants
209533|NCT02884999|trauma|trauma
209534|NCT02884999|bleeding|bleeding
209535|NCT02884999|coagulopathy|coagulopathy
209536|NCT02884999|guidelines compliance|guidelines compliance
209537|NCT02884999|recommendation|recommendation
209538|NCT02884999|transfusion|transfusion
209539|NCT02884986|Etoricoxib|etoricoxib
209540|NCT02884986|Spinal anaesthesia|spinal anaesthesia
209541|NCT02884986|Postoperative pain|postoperative pain
209542|NCT02884973|congenital heart|congenital heart
209543|NCT02884973|NIRS|nirs
209544|NCT02884960|Uterine Fibroids|uterine fibroids
209545|NCT02884960|Embolization|embolization
209546|NCT02884947|Brain Neoplasms|brain neoplasms
209547|NCT02884947|Magnetic Resonance Imaging|magnetic resonance imaging
209548|NCT02884947|Neurosurgery|neurosurgery
209549|NCT02884934|venous thromboembolism|venous thromboembolism
209550|NCT02884934|recurrent venous thromboembolism|recurrent venous thromboembolism
209551|NCT02884934|anticoagulant-related bleeding|anticoagulant-related bleeding
209552|NCT02884921|Postoperative pain|postoperative pain
209553|NCT02884921|Dental treatment|dental treatment
209554|NCT02884921|Paracetamol|paracetamol
209555|NCT02884895|Intubating Laryngeal Tube Suction|intubating laryngeal tube suction
209556|NCT02884895|Blind intubation|blind intubation
209557|NCT02884882|Stroke Basal Ganglia|stroke basal ganglia
209558|NCT02884882|Emotional change|emotional change
400624|NCT01865994|esCCO|escco
209559|NCT02884869|Blind intubation,|blind intubation,
209560|NCT02884869|Laryngeal Mask Airway|laryngeal mask airway
209561|NCT02884856|color|color
209562|NCT02884856|dentistry|dentistry
209563|NCT02884856|gender|gender
209564|NCT02884843|Laryngeal Tube|laryngeal tube
209565|NCT02884843|blind intubation|blind intubation
209566|NCT02884843|fiberoptic|fiberoptic
209567|NCT02884804|Postpartum Hemorrhage|postpartum hemorrhage
209568|NCT02884804|Immature platelet|immature platelet
209569|NCT02884791|FGF21|fgf21
209570|NCT02884791|Fibroblast growth factor|fibroblast growth factor
209571|NCT02884791|fructose|fructose
209572|NCT02884778|pain|pain
209573|NCT02884778|monitoring|monitoring
209574|NCT02884778|anesthesia|anesthesia
209575|NCT02884765|mandibular condyle|mandibular condyle
209576|NCT02884765|subcondylar|subcondylar
209577|NCT02884765|mandible|mandible
209578|NCT02884765|fracture|fracture
209579|NCT02884700|Legionella|legionella
209580|NCT02884700|Legionnaires' disease|legionnaires' disease
209581|NCT02884700|Diagnosis|diagnosis
209582|NCT02884700|Prognosis|prognosis
209583|NCT02884674|Obsessive-Compulsive Disorder|obsessive-compulsive disorder
209584|NCT02884674|Transcranial Magnetic Stimulation|transcranial magnetic stimulation
209585|NCT02884648|Malignant neoplasms of female genital organs|malignant neoplasms of female genital organs
209586|NCT02884648|Ovarian Cancer|ovarian cancer
209587|NCT02884648|Fallopian tube cancer|fallopian tube cancer
209588|NCT02884648|Primary peritoneal cancer|primary peritoneal cancer
209589|NCT02884648|Bevacizumab|bevacizumab
209590|NCT02884648|Avastin|avastin
209591|NCT02884648|Anti-VEGF monoclonal antibody|anti-vegf monoclonal antibody
209592|NCT02884648|rhuMab-VEGF|rhumab-vegf
209593|NCT02884635|Methotrexate|methotrexate
209594|NCT02884635|ASP1707|asp1707
209595|NCT02884635|Rheumatoid arthritis|rheumatoid arthritis
209596|NCT02884622|Lung disease|lung disease
209597|NCT02884622|Epigenetics|epigenetics
209598|NCT02884622|DNA methylation|dna methylation
209599|NCT02884622|Modifier genes|modifier genes
209600|NCT02884596|Inferior alveolar nerve block|inferior alveolar nerve block
209601|NCT02884596|irreversible pulpitis|irreversible pulpitis
209602|NCT02884596|selective serotonin reuptake inhibitor antidepressants|selective serotonin reuptake inhibitor antidepressants
209603|NCT02884583|Food allergy|food allergy
209604|NCT02884583|asthma|asthma
209605|NCT02884583|Predictive factor|predictive factor
209606|NCT02884583|Exacerbation|exacerbation
209607|NCT02884583|Prevalence|prevalence
209608|NCT02884570|Tracheotomy|tracheotomy
209609|NCT02884570|Anxiety|anxiety
209610|NCT02884570|Depression|depression
209611|NCT02884570|Back Home|back home
209612|NCT02884518|dopamine receptor occupancy|dopamine receptor occupancy
209613|NCT02884518|antipsychotics|antipsychotics
209614|NCT02884518|positron emission tomography|positron emission tomography
209615|NCT02884492|inflammation|inflammation
209616|NCT02884492|aging|aging
209617|NCT02884492|mild cognitive impairment|mild cognitive impairment
209618|NCT02884453|gastrooesophageal carcinoma|gastrooesophageal carcinoma
209619|NCT02884427|Direct current|direct current
209620|NCT02884427|Dynamometry|dynamometry
209621|NCT02884427|Hand strength|hand strength
209622|NCT02884427|Electrotherapy|electrotherapy
209623|NCT02884427|Transcutaneous Electric Nerve Stimulation|transcutaneous electric nerve stimulation
209624|NCT02884414|Knee Pathology|knee pathology
209625|NCT02884375|Elderly|elderly
209626|NCT02884375|Cancer|cancer
209627|NCT02884375|Geriatric assessment|geriatric assessment
209628|NCT02884375|Treatment|treatment
209629|NCT02884375|Epidemiology|epidemiology
209630|NCT02884362|melanoma clinical biological database|melanoma clinical biological database
209631|NCT02884349|Computer aided orthopaedic surgery|computer aided orthopaedic surgery
209632|NCT02884349|Implant orientation|implant orientation
209633|NCT02884349|Range of motion|range of motion
209634|NCT02884310|Remifentanil|remifentanil
209635|NCT02884310|Heart Rate Variability|heart rate variability
209636|NCT02884310|Pupil dilation|pupil dilation
209637|NCT02884310|SPI|spi
209638|NCT02884284|breast cancer|breast cancer
209639|NCT02884284|database|database
209640|NCT02884271|CPR|cpr
209641|NCT02884271|cardiac arrest|cardiac arrest
209642|NCT02884271|operating room|operating room
209643|NCT02884258|Assisted Reproductive Technology|assisted reproductive technology
209644|NCT02884258|Obesity|obesity
209645|NCT02884258|Bariatric Surgery|bariatric surgery
209646|NCT02884258|Infertility|infertility
209647|NCT02884258|Fertility Preservation|fertility preservation
209648|NCT02884245|Fertility|fertility
209649|NCT02884245|Reproductive processes|reproductive processes
209650|NCT02884245|In vitro fertilization|in vitro fertilization
209651|NCT02884245|Intracytoplasmic sperm injection|intracytoplasmic sperm injection
209652|NCT02884245|Estrogens|estrogens
209653|NCT02884245|Follicule Stimulating Hormon|follicule stimulating hormon
209654|NCT02884219|Early treatment|early treatment
209655|NCT02884219|Expectative treatment|expectative treatment
209656|NCT02884219|Patent ductus arteriosus|patent ductus arteriosus
209657|NCT02884219|Preterm|preterm
209658|NCT02884206|heart failure|heart failure
209659|NCT02884206|cognition|cognition
209660|NCT02884206|positron emission tomography|positron emission tomography
209661|NCT02884206|magnetic resonance imaging|magnetic resonance imaging
209662|NCT02884206|LCZ696|lcz696
209663|NCT02884206|valsartan|valsartan
209664|NCT02884206|Chronic heart failure|chronic heart failure
209665|NCT02884206|CHF|chf
209666|NCT02884193|Cooling|cooling
209667|NCT02884193|Cryotherapy|cryotherapy
209668|NCT02884193|isometric Force|isometric force
209669|NCT02884193|Palmar Grip|palmar grip
209670|NCT02884193|Dynamometry|dynamometry
209671|NCT02884180|Dexamethasone|dexamethasone
209672|NCT02884180|Arthroplasty, Replacement, Knee|arthroplasty, replacement, knee
209673|NCT02884180|Revision|revision
209674|NCT02884154|Endoscopic ultrasonography|endoscopic ultrasonography
209675|NCT02884154|Biopsy|biopsy
209676|NCT02884154|Gastrointestinal tract|gastrointestinal tract
209677|NCT02884154|Subepithelial tumor|subepithelial tumor
209678|NCT02884141|Renal Artery Obstruction|renal artery obstruction
209679|NCT02884141|Carotid Artery Diseases|carotid artery diseases
209680|NCT02884141|Genetic Association Studies|genetic association studies
209681|NCT02884102|genetic sequencing|genetic sequencing
209682|NCT02884102|relapsed|relapsed
209683|NCT02884076|Hemorrhoids|hemorrhoids
209684|NCT02884076|Sodergren score|sodergren score
209685|NCT02884076|Validation|validation
209686|NCT02884063|PGS|pgs
209687|NCT02884063|PGD|pgd
209688|NCT02884063|free embryo DNA|free embryo dna
209689|NCT02884063|NGS|ngs
209690|NCT02884037|NAFLD|nafld
209691|NCT02884037|Rifaximin|rifaximin
209692|NCT02884037|Endotoxin and Homeostatic Model Assessment|endotoxin and homeostatic model assessment
209693|NCT02884024|obesity|obesity
209694|NCT02884024|inflammation|inflammation
209695|NCT02884024|cancer risk|cancer risk
209696|NCT02884011|Chronic antihypertensives|chronic antihypertensives
209697|NCT02884011|Septic shock|septic shock
209698|NCT02884011|Vasopressor|vasopressor
209699|NCT02884011|Vasopressor dosing|vasopressor dosing
209700|NCT02883998|home-based physical therapy|home-based physical therapy
209701|NCT02883998|outpatient physical therapy|outpatient physical therapy
209702|NCT02883998|unicompartmental knee arthroplasty|unicompartmental knee arthroplasty
209703|NCT02883998|PT (Physical Therapy)|pt (physical therapy)
209704|NCT02883998|osteoarthritis|osteoarthritis
209705|NCT02883972|Immunization|immunization
209706|NCT02883972|Behavioural insights|behavioural insights
209707|NCT02883972|Children|children
209708|NCT02883959|critically ill|critically ill
209709|NCT02883959|mechanical ventilation|mechanical ventilation
209710|NCT02883959|pain|pain
209711|NCT02883959|nursing|nursing
209712|NCT02883959|music|music
209713|NCT02883842|Coronary artery disease|coronary artery disease
209714|NCT02883842|Diabetes|diabetes
209715|NCT02883842|Text messages|text messages
209716|NCT02883777|Kidney Transplantation|kidney transplantation
209717|NCT02883777|Low Glycemic Index|low glycemic index
209718|NCT02883777|High Protein|high protein
209719|NCT02883764|eicosapentaenoic acid|eicosapentaenoic acid
209721|NCT02883764|docosahexaenoic acid|docosahexaenoic acid
209722|NCT02883764|DHA|dha
209723|NCT02883764|omega-3 index|omega-3 index
209724|NCT02883751|diabetes mellitus|diabetes mellitus
209725|NCT02883751|amputation stumps|amputation stumps
209726|NCT02883751|diabetic foot|diabetic foot
209727|NCT02883751|phototherapy|phototherapy
209728|NCT02883751|clinical trial|clinical trial
209729|NCT02883725|Esophageal atresia|esophageal atresia
209730|NCT02883712|epilepsy|epilepsy
209731|NCT02883712|pharmacoresistant|pharmacoresistant
209732|NCT02883712|antiepileptic drug|antiepileptic drug
209733|NCT02883712|pharmacokinetic|pharmacokinetic
209734|NCT02883712|pharmacodynamic|pharmacodynamic
209735|NCT02883712|pharmacogenetic|pharmacogenetic
209736|NCT02883699|Breast cancer|breast cancer
209737|NCT02883699|Prostate cancer|prostate cancer
209738|NCT02883699|Exercise prescription|exercise prescription
209739|NCT02883699|High intensity interval training|high intensity interval training
209740|NCT02883699|Daily undulating periodization training|daily undulating periodization training
209741|NCT02883699|Aerobic training|aerobic training
209742|NCT02883699|Resistance training|resistance training
209743|NCT02883699|Physical fitness|physical fitness
209744|NCT02883699|Exercise|exercise
209745|NCT02883686|Perinatal Depression|perinatal depression
209746|NCT02883686|Postpartum Depression|postpartum depression
209747|NCT02883686|Pregnancy|pregnancy
209748|NCT02883686|Peer-delivered|peer-delivered
209749|NCT02883686|Task-sharing|task-sharing
209750|NCT02883673|Postpartum Hemorrhage|postpartum hemorrhage
209751|NCT02883660|genetics|genetics
209752|NCT02883660|Antidepressants|antidepressants
209753|NCT02883647|chronic hepatitis b, nucleos(t)ide analog|chronic hepatitis b, nucleos(t)ide analog
209754|NCT02883634|Back pain|back pain
209755|NCT02883634|spinal manipulation|spinal manipulation
209756|NCT02883621|upper endoscopy|upper endoscopy
209757|NCT02883621|cap assisted endoscopy|cap assisted endoscopy
209758|NCT02883621|esophagus|esophagus
209759|NCT02883608|Papilla|papilla
209760|NCT02883608|major duodenal papilla|major duodenal papilla
209761|NCT02883608|ampulla of vater|ampulla of vater
209762|NCT02883595|thymosin alpha 1; sepsis; monocyte; pharmacokinetics|thymosin alpha 1; sepsis; monocyte; pharmacokinetics
209763|NCT02883582|asthma ,hydrogen|asthma ,hydrogen
209764|NCT02883569|Low back pain|low back pain
209765|NCT02883569|Intervertebral Disc Degeneration|intervertebral disc degeneration
209766|NCT02883569|Spinal stenosis|spinal stenosis
209767|NCT02883569|Comparative Effectiveness Research|comparative effectiveness research
209768|NCT02883569|Cost-Benefit Analysis|cost-benefit analysis
209769|NCT02883556|Carcinoma|carcinoma
209770|NCT02883556|Squamous Cell|squamous cell
209771|NCT02883556|Skin|skin
209772|NCT02883556|pembrolizumab|pembrolizumab
209773|NCT02883556|Programmed Cell Death 1 Ligand 1|programmed cell death 1 ligand 1
209774|NCT02883517|cell-free circulating DNA;|cell-free circulating dna;
209775|NCT02883517|digital PCR|digital pcr
209776|NCT02883517|liquid biopsy|liquid biopsy
209777|NCT02883504|E/e' ratio|e/e' ratio
209778|NCT02883504|Doppler echocardiography, filling pressure|doppler echocardiography, filling pressure
209779|NCT02883504|Left Ventricular end-Diastolic Pressure|left ventricular end-diastolic pressure
209780|NCT02883465|diaphragmatic dysfunction|diaphragmatic dysfunction
209781|NCT02883465|mechanical ventilation weaning|mechanical ventilation weaning
209782|NCT02883465|failure extubation rate|failure extubation rate
209783|NCT02883439|MP29-02|mp29-02
209784|NCT02883426|H3N2v Influenza Viruses|h3n2v influenza viruses
209785|NCT02883413|Adolescents|adolescents
209786|NCT02883413|Cognitive Flexibility|cognitive flexibility
209787|NCT02883413|Behavioral Flexibility|behavioral flexibility
209788|NCT02883387|DIEP flap|diep flap
209789|NCT02883387|Deep inferior epigastric artery perforator flap|deep inferior epigastric artery perforator flap
210040|NCT02881957|intracranial aneurysm|intracranial aneurysm
209790|NCT02883374|cephalic and cervical adenocystic Carcinoma|cephalic and cervical adenocystic carcinoma
209791|NCT02883374|Chidamide|chidamide
209792|NCT02883309|Hemodialysis|hemodialysis
209793|NCT02883309|Skeletal muscle|skeletal muscle
209794|NCT02883309|Exercise|exercise
209795|NCT02883309|Rehabilitation|rehabilitation
209796|NCT02883309|Disability Evaluation|disability evaluation
209797|NCT02883257|Major Depression|major depression
209798|NCT02883257|Major Depressive Disorder|major depressive disorder
209799|NCT02883257|Persistent Depressive Disorder|persistent depressive disorder
209800|NCT02883257|Cognitive Behavioral Therapy|cognitive behavioral therapy
209801|NCT02883257|Biomarkers|biomarkers
209802|NCT02883218|immunosuppression|immunosuppression
209803|NCT02883218|community-acquired sepsis|community-acquired sepsis
209804|NCT02883218|mortality|mortality
209805|NCT02883192|Cesarean section|cesarean section
209806|NCT02883192|spinal anesthesia|spinal anesthesia
209807|NCT02883192|hypotension|hypotension
209808|NCT02883192|ondansetron|ondansetron
209809|NCT02883153|Zirconium-89|zirconium-89
209810|NCT02883153|PET/CT|pet/ct
209811|NCT02883153|imaging|imaging
209812|NCT02883153|girentuximab|girentuximab
209813|NCT02883140|Sialography|sialography
209814|NCT02883140|Cone-beam CT|cone-beam ct
209815|NCT02883140|MRI sialography|mri sialography
209816|NCT02883140|non tumor salivary symptoms|non tumor salivary symptoms
209817|NCT02883127|Motivational Interviewing|motivational interviewing
209818|NCT02883127|Diet|diet
209819|NCT02883127|Carbohydrates|carbohydrates
209820|NCT02883127|Psychosocial factors|psychosocial factors
209821|NCT02883114|PF-06648671|pf-06648671
209822|NCT02883114|GSM|gsm
209823|NCT02883114|CYP3A|cyp3a
209824|NCT02883114|drug interaction|drug interaction
209825|NCT02883088|Optical coherence tomograhpy|optical coherence tomograhpy
209826|NCT02883088|registry|registry
209827|NCT02883088|Coronary artery disease|coronary artery disease
209828|NCT02883036|tigecycline|tigecycline
209829|NCT02883036|treatment|treatment
209830|NCT02883036|mitochondrial biogenesis|mitochondrial biogenesis
209831|NCT02883036|metabolic characteristics|metabolic characteristics
209832|NCT02883023|Bleomycin|bleomycin
209833|NCT02883023|Electroporation|electroporation
209834|NCT02883010|Surgical incision|surgical incision
209835|NCT02883010|surgical complication|surgical complication
209836|NCT02883010|NPWT|npwt
209837|NCT02883010|negative pressure|negative pressure
209838|NCT02883010|colorectal surgery|colorectal surgery
209839|NCT02883010|dehisced|dehisced
209840|NCT02882971|chronic pain|chronic pain
209841|NCT02882971|rating scale|rating scale
209842|NCT02882958|Radiology|radiology
209843|NCT02882932|peritonitis|peritonitis
209844|NCT02882932|solutions|solutions
209845|NCT02882932|normal saline|normal saline
209846|NCT02882932|infection|infection
209847|NCT02882932|peritoneal lavage|peritoneal lavage
209848|NCT02882906|Stroke|stroke
209849|NCT02882906|Pain|pain
209850|NCT02882906|Shoulder|shoulder
209851|NCT02882867|Prospective|prospective
209852|NCT02882867|Epidemiology|epidemiology
209853|NCT02882867|Track and Field|track and field
400625|NCT01865994|TEE|tee
209854|NCT02882841|AIEC (Adherent and Invasive Escherichia Coli)|aiec (adherent and invasive escherichia coli)
209855|NCT02882841|Mucosal Healing|mucosal healing
209856|NCT02882841|Non-invasive biomarkers|non-invasive biomarkers
209857|NCT02882815|IrisFIT PFO|irisfit pfo
209858|NCT02882802|anger|anger
209859|NCT02882802|aggression|aggression
209860|NCT02882763|Early intervention|early intervention
209861|NCT02882763|ECCE|ecce
209862|NCT02882763|Intervention study|intervention study
209863|NCT02882763|Child development|child development
209864|NCT02882763|At-risk families|at-risk families
209865|NCT02882763|Psychosocial stress|psychosocial stress
209866|NCT02882763|Prevention|prevention
209867|NCT02882763|Educational opportunities|educational opportunities
209868|NCT02882763|Randomized controlled trial|randomized controlled trial
209869|NCT02882763|Evaluation|evaluation
209870|NCT02882763|Parenting|parenting
209871|NCT02882763|Parent-child interaction|parent-child interaction
209872|NCT02882750|Lung Cancer|lung cancer
209873|NCT02882750|Quality of Life|quality of life
209874|NCT02882750|VATS|vats
209875|NCT02882750|SABR|sabr
209876|NCT02882698|Down syndrome|down syndrome
209877|NCT02882698|motor skills|motor skills
209878|NCT02882698|physiotherapy|physiotherapy
209879|NCT02882698|mobile telephone|mobile telephone
209880|NCT02882698|exposure to virtual reality therapy|exposure to virtual reality therapy
209881|NCT02882685|Roux-en-Y gastric bypass|roux-en-y gastric bypass
209882|NCT02882685|Mini-gastric bypass|mini-gastric bypass
209883|NCT02882685|Single anastomosis gastric bypass|single anastomosis gastric bypass
209884|NCT02882659|Clinical Trial, Phase I|clinical trial, phase i
209885|NCT02882646|stroke|stroke
209886|NCT02882646|cerebral palsy|cerebral palsy
209887|NCT02882646|rehabilitation|rehabilitation
209888|NCT02882646|robotics|robotics
209889|NCT02882646|therapy|therapy
209890|NCT02882646|bilateral|bilateral
209891|NCT02882633|lumbar plexus block|lumbar plexus block
209892|NCT02882633|fascia iliac block|fascia iliac block
209893|NCT02882633|quality of recovery score|quality of recovery score
209894|NCT02882633|pain score|pain score
209895|NCT02882620|Colorectal neoplasm|colorectal neoplasm
209896|NCT02882620|Screening|screening
209897|NCT02882620|Patient navigation|patient navigation
209898|NCT02882620|Randomized controlled trial|randomized controlled trial
209899|NCT02882620|Cost-benefit analysis|cost-benefit analysis
209900|NCT02882620|Health behavior|health behavior
209901|NCT02882620|Health equity|health equity
209902|NCT02882620|American Indians|american indians
209903|NCT02882620|Community-based participatory research|community-based participatory research
209904|NCT02882620|Fecal occult blood test|fecal occult blood test
209905|NCT02882607|HIV|hiv
209906|NCT02882607|Prevention|prevention
209907|NCT02882607|unintended pregnancy|unintended pregnancy
209908|NCT02882607|Malawi|malawi
209909|NCT02882607|adolescent women|adolescent women
209910|NCT02882607|community|community
209911|NCT02882607|rural|rural
209912|NCT02882581|Metformin|metformin
209913|NCT02882581|Pharmacokinetics|pharmacokinetics
209914|NCT02882581|Organic cation transporter|organic cation transporter
209915|NCT02882581|Multidrug and toxin extrusion|multidrug and toxin extrusion
209916|NCT02882581|Pharmacogenetics|pharmacogenetics
209917|NCT02882581|positron emission tomography|positron emission tomography
209918|NCT02882542|cerebral oxygen metabolism|cerebral oxygen metabolism
209919|NCT02882542|functional near-infrared spectroscopy|functional near-infrared spectroscopy
209920|NCT02882542|partial pressure of carbon dioxide|partial pressure of carbon dioxide
209921|NCT02882542|heart rate variability|heart rate variability
209922|NCT02882542|blood pressure|blood pressure
209923|NCT02882542|affect|affect
209924|NCT02882542|mood|mood
209925|NCT02882542|respiration|respiration
209926|NCT02882542|systematic randomized cross-over study|systematic randomized cross-over study
209927|NCT02882542|systemic physiology|systemic physiology
209928|NCT02882542|electro-dermal activity|electro-dermal activity
209929|NCT02882542|pulse-respiratory quotient|pulse-respiratory quotient
209930|NCT02882529|cerebral oxygen metabolism|cerebral oxygen metabolism
209931|NCT02882529|functional near-infrared spectroscopy|functional near-infrared spectroscopy
209932|NCT02882529|partial pressure of carbon dioxide|partial pressure of carbon dioxide
209933|NCT02882529|heart rate variability|heart rate variability
209934|NCT02882529|blood pressure|blood pressure
209935|NCT02882529|affect|affect
209936|NCT02882529|mood|mood
209937|NCT02882529|respiration|respiration
209938|NCT02882529|systematic randomized cross-over study|systematic randomized cross-over study
209939|NCT02882529|systemic physiology|systemic physiology
209940|NCT02882529|electro-dermal activity|electro-dermal activity
209941|NCT02882529|pulse-respiratory quotient|pulse-respiratory quotient
209942|NCT02882516|cerebral oxygen metabolism|cerebral oxygen metabolism
209943|NCT02882516|functional near-infrared spectroscopy|functional near-infrared spectroscopy
209944|NCT02882516|partial pressure of carbon dioxide|partial pressure of carbon dioxide
209945|NCT02882516|heart rate variability|heart rate variability
209946|NCT02882516|blood pressure|blood pressure
209947|NCT02882516|affect|affect
209948|NCT02882516|mood|mood
209949|NCT02882516|respiration|respiration
209950|NCT02882516|systematic randomized cross-over study|systematic randomized cross-over study
209951|NCT02882516|systemic physiology|systemic physiology
209952|NCT02882516|electro-dermal activity|electro-dermal activity
209953|NCT02882516|pulse-respiratory quotient|pulse-respiratory quotient
209954|NCT02882503|Endoscopic ultrasound|endoscopic ultrasound
209955|NCT02882503|Radiofrequency ablation|radiofrequency ablation
209956|NCT02882503|Pancreas|pancreas
209957|NCT02882490|Tourette syndrome|tourette syndrome
209958|NCT02882464|gingival recession|gingival recession
209959|NCT02882464|mucogingival surgery|mucogingival surgery
209960|NCT02882451|bile duct|bile duct
209961|NCT02882451|endoscopic retrograde cholangiopancreatography|endoscopic retrograde cholangiopancreatography
209962|NCT02882451|pinaverium bromide|pinaverium bromide
209963|NCT02882425|selexipag|selexipag
209964|NCT02882425|bioavailability|bioavailability
209965|NCT02882412|effectiveness|effectiveness
209966|NCT02882412|buprenorphine/naloxone|buprenorphine/naloxone
209967|NCT02882412|iatrogenic opioid dependence|iatrogenic opioid dependence
209968|NCT02882399|athletes|athletes
209969|NCT02882334|Focal Dystonia|focal dystonia
209970|NCT02882334|Writer's cramp|writer's cramp
209971|NCT02882282|Diseases of oral cavity salivary glands and jaws|diseases of oral cavity salivary glands and jaws
209972|NCT02882282|High risk oral intra-epithelial neoplasias|high risk oral intra-epithelial neoplasias
209973|NCT02882282|IEN|ien
209974|NCT02882282|Oral pre-malignant lesion(s)|oral pre-malignant lesion(s)
209975|NCT02882282|History of invasive oral cancer|history of invasive oral cancer
209976|NCT02882282|Pembrolizumab|pembrolizumab
209977|NCT02882282|Keytruda|keytruda
209978|NCT02882282|MK-3475|mk-3475
209979|NCT02882282|SCH-900475|sch-900475
209980|NCT02882282|Observation only|observation only
209981|NCT02882269|locally advanced colon cancer|locally advanced colon cancer
209982|NCT02882269|neoadjuvant chemotherapy|neoadjuvant chemotherapy
209983|NCT02882256|laceration|laceration
209984|NCT02882256|urinary tract infection|urinary tract infection
209985|NCT02882256|minor head injury|minor head injury
209986|NCT02882256|concussion|concussion
209987|NCT02882217|Double-blind|double-blind
209988|NCT02882217|Randomized|randomized
209989|NCT02882217|Dose-escalating|dose-escalating
209990|NCT02882217|Placebo-controlled|placebo-controlled
209991|NCT02882217|Phase I|phase i
209992|NCT02882217|Healthy volunteers|healthy volunteers
209993|NCT02882217|Bronchial asthma|bronchial asthma
209994|NCT02882217|Histamine glutarimide|histamine glutarimide
209995|NCT02882217|EURRUS|eurrus
209996|NCT02882191|contraception|contraception
209997|NCT02882178|Prostate cancer|prostate cancer
209998|NCT02882178|cabazitaxel|cabazitaxel
209999|NCT02882178|consensus|consensus
210000|NCT02882178|conformity|conformity
210001|NCT02882178|prescription|prescription
210002|NCT02882178|conditions of use|conditions of use
210003|NCT02882165|COPD|copd
210004|NCT02882165|Early Intervention|early intervention
210005|NCT02882165|Risk|risk
210006|NCT02882165|Stratification|stratification
210007|NCT02882152|Analgesia|analgesia
210008|NCT02882152|Nerve Block|nerve block
210009|NCT02882152|Pain, Postoperative|pain, postoperative
210010|NCT02882139|Electrical storm|electrical storm
210012|NCT02882126|Subcutaneous Treprostinil|subcutaneous treprostinil
210013|NCT02882126|Remodulin|remodulin
210014|NCT02882126|6 Minute Walk Test|6 minute walk test
210015|NCT02882100|influenza|influenza
210016|NCT02882100|vaccine|vaccine
210017|NCT02882100|vaccination|vaccination
210018|NCT02882100|nursing home|nursing home
210019|NCT02882100|cluster randomized trial|cluster randomized trial
210020|NCT02882100|respiratory-related hospitalization|respiratory-related hospitalization
210021|NCT02882061|neck pain|neck pain
210022|NCT02882061|physical examination|physical examination
210023|NCT02882061|thoracic manipulation|thoracic manipulation
210024|NCT02882048|Opioid addiction|opioid addiction
210025|NCT02882048|Opioid weaning|opioid weaning
210026|NCT02882035|pain|pain
210027|NCT02882035|patient comfort|patient comfort
210028|NCT02882022|Eustachian tube dysfunction|eustachian tube dysfunction
210029|NCT02882022|Audiometry|audiometry
210030|NCT02881996|appendicitis|appendicitis
210031|NCT02881996|pain|pain
210032|NCT02881996|perforation|perforation
210033|NCT02881983|alcohol use disorder|alcohol use disorder
210034|NCT02881983|emotion processing|emotion processing
210035|NCT02881983|abstinence|abstinence
210036|NCT02881983|sympathetic system|sympathetic system
210037|NCT02881983|parasympathetic system|parasympathetic system
210038|NCT02881957|critical illness|critical illness
210039|NCT02881957|craniocerebral trauma|craniocerebral trauma
210041|NCT02881957|spinal cord injuries|spinal cord injuries
210042|NCT02881957|seizures|seizures
210043|NCT02881957|meningitis|meningitis
210044|NCT02881957|stroke|stroke
210045|NCT02881957|vitamin d deficiency|vitamin d deficiency
210046|NCT02881957|cholecalciferol|cholecalciferol
210047|NCT02881957|intracranial hemorrhages|intracranial hemorrhages
715908|NCT00565422|Lexapro|lexapro
268532|NCT02528071|ALS|als
210048|NCT02881944|Gulf War Illness|gulf war illness
210049|NCT02881944|Diet|diet
210050|NCT02881944|IBS|ibs
210051|NCT02881944|FODMAP|fodmap
210052|NCT02881931|Huntington's disease|huntington's disease
210053|NCT02881931|functional rating scale|functional rating scale
210054|NCT02881931|cognitive pre-testing|cognitive pre-testing
210055|NCT02881931|patient reported outcome (PRO)|patient reported outcome (pro)
210056|NCT02881931|HDGEC participant at Pre-Manifest stage|hdgec participant at pre-manifest stage
210057|NCT02881931|HDGEC participant at Early-Manifest stage|hdgec participant at early-manifest stage
210058|NCT02881931|Corresponding HDGEC participant companion|corresponding hdgec participant companion
210059|NCT02881892|CAPD|capd
210060|NCT02881892|Peritoneal solute transport rate|peritoneal solute transport rate
210061|NCT02881892|Dialysis adequacy|dialysis adequacy
210062|NCT02881866|Air hunger|air hunger
210063|NCT02881866|Work/effort|work/effort
210064|NCT02881866|Aerosolized|aerosolized
210065|NCT02881866|Hypercapnia|hypercapnia
210066|NCT02881866|Resistive load|resistive load
210067|NCT02881866|Nebulised|nebulised
210068|NCT02881853|healthy|healthy
210069|NCT02881853|atopic|atopic
210070|NCT02881827|Saliva|saliva
210071|NCT02881827|Low-level laser therapy|low-level laser therapy
210072|NCT02881827|Masseter muscle|masseter muscle
210073|NCT02881827|Salivary glands|salivary glands
210074|NCT02881814|Lung ultrasound|lung ultrasound
210075|NCT02881814|Chest physiotherapy|chest physiotherapy
210076|NCT02881814|Decision-making process|decision-making process
210077|NCT02881814|Diagnostic|diagnostic
210078|NCT02881801|accelerometry|accelerometry
210079|NCT02881775|TMS|tms
210080|NCT02881775|rTMS|rtms
210081|NCT02881775|corticospinal|corticospinal
210082|NCT02881775|quadriceps|quadriceps
210083|NCT02881762|hepatitis C virus (HCV)|hepatitis c virus (hcv)
210084|NCT02881762|Maraviroc|maraviroc
210085|NCT02881762|Human immunodeficiency virus (HCV)|human immunodeficiency virus (hcv)
210086|NCT02881671|genetic|genetic
210087|NCT02881671|congenital atrioventricular block|congenital atrioventricular block
210088|NCT02881671|progressive Cardiac Conduction Disease|progressive cardiac conduction disease
210089|NCT02881658|Plant sterols|plant sterols
210090|NCT02881658|Low-Density Lipoprotein Cholesterol|low-density lipoprotein cholesterol
210091|NCT02881658|Phytosterols|phytosterols
210092|NCT02881658|Soya Beverage|soya beverage
210093|NCT02881645|Intensive care units|intensive care units
210094|NCT02881645|Nursing Care|nursing care
210095|NCT02881645|Critical incidents|critical incidents
210096|NCT02881645|Best practices|best practices
210097|NCT02881619|Tooth bleaching|tooth bleaching
210098|NCT02881593|Operating in Minimally Invasive|operating in minimally invasive
210099|NCT02881567|Multiple Sclerosis|multiple sclerosis
210100|NCT02881567|Daclizumab|daclizumab
210101|NCT02881567|Tysabri-Switch|tysabri-switch
210102|NCT02881528|Type 1 Diabetes|type 1 diabetes
210103|NCT02881528|Juvenile Diabetes|juvenile diabetes
210104|NCT02881502|granulocyte activation|granulocyte activation
210105|NCT02881502|HDAC2|hdac2
210106|NCT02881502|severe asthma|severe asthma
210107|NCT02881437|Primary Immunodeficiency|primary immunodeficiency
210108|NCT02881437|SubCutaneous Immunoglobulins|subcutaneous immunoglobulins
210109|NCT02881424|Familiarity|familiarity
210110|NCT02881424|Recollection|recollection
210111|NCT02881424|Face Recognition|face recognition
210112|NCT02881424|Alcohol dependence|alcohol dependence
210113|NCT02881424|Social cognition|social cognition
210114|NCT02881411|self-soft tissue therapy|self-soft tissue therapy
210115|NCT02881411|trigger points|trigger points
210116|NCT02881411|feasibility study|feasibility study
210117|NCT02881398|Mobile Health|mobile health
210118|NCT02881398|Telemedicine|telemedicine
210119|NCT02881398|Pocket-Echocardiography|pocket-echocardiography
210120|NCT02881385|Synchrony|synchrony
210121|NCT02881385|Pressure Support Ventilation|pressure support ventilation
210122|NCT02881372|oral food desensitization|oral food desensitization
210123|NCT02881372|food elimination|food elimination
210124|NCT02881372|food reintroduction|food reintroduction
210125|NCT02881346|Psoriasis vulgaris|psoriasis vulgaris
210126|NCT02881346|Plaque|plaque
210127|NCT02881346|Topical|topical
210128|NCT02881346|Calcipotriol|calcipotriol
210129|NCT02881346|Foam|foam
210130|NCT02881346|Spray|spray
210131|NCT02881307|Rheumatoid Arthritis (RA)|rheumatoid arthritis (ra)
210132|NCT02881307|Musculoskeletal Ultrasound (MSUS)|musculoskeletal ultrasound (msus)
210133|NCT02881255|implantable cardioverter defibrillator|implantable cardioverter defibrillator
210134|NCT02881255|subcutaneous ICD|subcutaneous icd
210135|NCT02881255|transvenous ICD|transvenous icd
210136|NCT02881255|inherited arrhythmia syndrome|inherited arrhythmia syndrome
210137|NCT02881203|breast cancer|breast cancer
210138|NCT02881203|radiation|radiation
210139|NCT02881203|DIBH|dibh
210140|NCT02881203|cardiac toxicity|cardiac toxicity
210141|NCT02881177|oxytocin|oxytocin
210142|NCT02881177|tolerability|tolerability
210143|NCT02881177|HIV|hiv
716201|NCT00563875|Platelets|platelets
210144|NCT02881177|men who have sex with men (MSM)|men who have sex with men (msm)
210145|NCT02881177|addiction|addiction
210146|NCT02881164|Glycemia|glycemia
210147|NCT02881164|Satiety|satiety
210148|NCT02881164|Insulin|insulin
210149|NCT02881164|Breakfast|breakfast
210150|NCT02881164|Low glycemic index|low glycemic index
210151|NCT02881164|High glycemic index|high glycemic index
210152|NCT02881151|Deep brain stimulation|deep brain stimulation
210153|NCT02881151|DBS|dbs
210154|NCT02881151|Central thalamus|central thalamus
210155|NCT02881151|TBI|tbi
210156|NCT02881151|Traumatic brain injury|traumatic brain injury
210157|NCT02881086|Acute lymphoblastic leukemia|acute lymphoblastic leukemia
210158|NCT02881086|Lymphoblastic lymphoma|lymphoblastic lymphoma
210159|NCT02881086|Nelarabine|nelarabine
210160|NCT02881086|BCR-ABL|bcr-abl
210161|NCT02881086|MRD|mrd
210162|NCT02881086|PEG-Asparaginase|peg-asparaginase
210163|NCT02881086|Rituximab|rituximab
210164|NCT02881073|Placental Growth Factor|placental growth factor
210165|NCT02881073|Maternal Morbidity|maternal morbidity
210166|NCT02881073|Neonatal Morbidity|neonatal morbidity
210167|NCT02881073|Pre-eclampsia|pre-eclampsia
210168|NCT02881073|Heath Economics|heath economics
210169|NCT02881060|Glucagon|glucagon
210170|NCT02881060|Ethanol|ethanol
210171|NCT02881034|Anemia|anemia
210172|NCT02881034|Antiviral Agents|antiviral agents
210173|NCT02881034|Glomerular Filtration Rate|glomerular filtration rate
210174|NCT02881034|Hepatitis C|hepatitis c
210175|NCT02881034|Ribavirin|ribavirin
210176|NCT02881034|Telaprevir|telaprevir
210177|NCT02881021|elastic tape|elastic tape
210178|NCT02881021|kinesiology taping|kinesiology taping
210179|NCT02881021|physiotherapy|physiotherapy
210180|NCT02881021|rotator cuff|rotator cuff
210181|NCT02881021|shoulder pain|shoulder pain
210182|NCT02881021|tendon injuries|tendon injuries
210183|NCT02880995|dopamine receptor occupancy|dopamine receptor occupancy
210184|NCT02880995|antipsychotics|antipsychotics
210185|NCT02880995|positron emission tomography|positron emission tomography
210186|NCT02880956|Early Alzheimer's Disease (AD)|early alzheimer's disease (ad)
210187|NCT02880956|Mild Cognitive Impairment (MCI)|mild cognitive impairment (mci)
210188|NCT02880956|Mild Alzheimer's Disease (AD)|mild alzheimer's disease (ad)
210189|NCT02880956|Tau|tau
210190|NCT02880956|Early dementia|early dementia
210191|NCT02880956|Tauopathies|tauopathies
210192|NCT02880956|AD|ad
210193|NCT02880956|Neurodegenerative diseases|neurodegenerative diseases
210194|NCT02880956|Memory loss|memory loss
210195|NCT02880956|Nervous system diseases|nervous system diseases
210196|NCT02880930|vitamin D|vitamin d
210197|NCT02880917|Attention|attention
210198|NCT02880917|Memory (short and long-term)|memory (short and long-term)
210199|NCT02880917|Conflict monitoring tasks|conflict monitoring tasks
210200|NCT02880917|Verbal fluency|verbal fluency
210201|NCT02880878|Subcortical Intracerebral Hemorrhage|subcortical intracerebral hemorrhage
210202|NCT02880878|Intracerebral Hemorrhage|intracerebral hemorrhage
210203|NCT02880878|Intracranial Hemorrhages|intracranial hemorrhages
210204|NCT02880878|ICH|ich
210205|NCT02880878|Hemorrhage|hemorrhage
210206|NCT02880878|Cerebrovascular Disorders|cerebrovascular disorders
210207|NCT02880878|Brain Diseases|brain diseases
210208|NCT02880878|Central Nervous System Diseases|central nervous system diseases
210209|NCT02880878|Nervous System Diseases|nervous system diseases
210210|NCT02880878|Vascular Diseases|vascular diseases
210211|NCT02880878|Cardiovascular Diseases|cardiovascular diseases
210212|NCT02880878|Pathologic Processes|pathologic processes
210213|NCT02880878|MIPS|mips
210214|NCT02880878|Minimally Invasive Parafascicular Surgery|minimally invasive parafascicular surgery
210215|NCT02880878|Neurosurgery|neurosurgery
210216|NCT02880878|Medical Economic|medical economic
210217|NCT02880878|Hospital Economics|hospital economics
210218|NCT02880865|vaccine|vaccine
210219|NCT02880852|Systemic Lupus Erythematosus|systemic lupus erythematosus
210220|NCT02880852|Belimumab|belimumab
210221|NCT02880852|Pharmacodynamics|pharmacodynamics
210222|NCT02880852|safety tolerability|safety tolerability
210223|NCT02880852|Pharmacokinetics|pharmacokinetics
210224|NCT02880852|Chinese subjects|chinese subjects
210225|NCT02880800|Analgesia, Patient-Controlled|analgesia, patient-controlled
210226|NCT02880800|Analgesics, Opioid|analgesics, opioid
210227|NCT02880800|Drug-Related Side Effects and Adverse Reactions|drug-related side effects and adverse reactions
210228|NCT02880774|Temporomandibular Joint Disorders|temporomandibular joint disorders
210229|NCT02880774|Mandibular Movement|mandibular movement
210230|NCT02880774|Músculoesqueléticas Manipulations|músculoesqueléticas manipulations
210231|NCT02880774|Modalities of Physiotherapy.|modalities of physiotherapy.
210232|NCT02880761|hemodialysis|hemodialysis
210233|NCT02880761|chronic renal failure|chronic renal failure
210234|NCT02880761|arteriovenous fistulae|arteriovenous fistulae
210235|NCT02880748|Water exchange colonoscopy|water exchange colonoscopy
210236|NCT02880748|Adenoma miss rate|adenoma miss rate
210237|NCT02880748|Polyps|polyps
210238|NCT02880735|Myotonic Dystrophy|myotonic dystrophy
210239|NCT02880735|Noninvasive Ventilation|noninvasive ventilation
268769|NCT02526433|music|music
210240|NCT02880735|Respiratory Failure|respiratory failure
210241|NCT02880722|Irritable Bowel Syndrome (IBS)|irritable bowel syndrome (ibs)
210242|NCT02880722|Experience Sampling Method (ESM)|experience sampling method (esm)
210243|NCT02880722|Ecological Momentary Assessment (EMA)|ecological momentary assessment (ema)
210244|NCT02880722|Abdominal pain|abdominal pain
210245|NCT02880696|Time Perception|time perception
210246|NCT02880696|Tactile Perception|tactile perception
210247|NCT02880696|Spectroscopy, Near-Infrared|spectroscopy, near-infrared
210248|NCT02880683|Electrical Stimulation Therapy|electrical stimulation therapy
210249|NCT02880683|Parasympathetic Nervous System|parasympathetic nervous system
210250|NCT02880683|Sympathetic Fibers|sympathetic fibers
210251|NCT02880683|Post Ganglionic|post ganglionic
210252|NCT02880683|Congestive Heart Failure|congestive heart failure
210253|NCT02880683|Heart Failure|heart failure
210254|NCT02880670|Rheumatoid|rheumatoid
210255|NCT02880657|superoxide dismutase|superoxide dismutase
210256|NCT02880657|melon concentrate|melon concentrate
210257|NCT02880657|oxidative stress|oxidative stress
210258|NCT02880657|physical training|physical training
210259|NCT02880644|Central retinal vein occlusion|central retinal vein occlusion
210260|NCT02880644|OCT-A|oct-a
210261|NCT02880644|CRVO|crvo
210262|NCT02880540|Adolescent|adolescent
210263|NCT02880540|Bariatric|bariatric
210264|NCT02880540|Obesity|obesity
210265|NCT02880540|Pain|pain
210266|NCT02880540|Opiate-sparing|opiate-sparing
210267|NCT02880514|Frontal Sinus|frontal sinus
210268|NCT02880514|Balloon Dilation|balloon dilation
210269|NCT02880475|Moderate to severe chronic non-malignant pain|moderate to severe chronic non-malignant pain
210270|NCT02880462|schizophrenia|schizophrenia
210271|NCT02880462|sulforaphane|sulforaphane
210272|NCT02880423|salpingectomy|salpingectomy
210273|NCT02880423|cesarean section|cesarean section
210274|NCT02880423|tubal ligation|tubal ligation
210275|NCT02880423|morbidity|morbidity
210276|NCT02880410|Glioblastoma|glioblastoma
210277|NCT02880410|NeuroBlate|neuroblate
210278|NCT02880410|LITT|litt
210279|NCT02880410|Quality of Life|quality of life
210280|NCT02880397|Anti-inflammatory agents, antimicrobials, Periodontitis|anti-inflammatory agents, antimicrobials, periodontitis
210281|NCT02880371|Advanced Solid Tumors|advanced solid tumors
210282|NCT02880371|Pembrolizumab|pembrolizumab
210283|NCT02880371|ARRY-382|arry-382
210284|NCT02880371|CSF-1R|csf-1r
210285|NCT02880371|CSF1R|csf1r
210286|NCT02880371|cfms|cfms
210287|NCT02880332|Chronic pain|chronic pain
210288|NCT02880332|Endogenous Pain Processing|endogenous pain processing
210289|NCT02880332|Central sensitization|central sensitization
210290|NCT02880332|Pain neuroscience education|pain neuroscience education
210291|NCT02880319|Bone Cancer|bone cancer
210292|NCT02880293|transplant conditioning|transplant conditioning
210293|NCT02880293|KIR/HLA based haploidentical donor selection|kir/hla based haploidentical donor selection
210294|NCT02880293|allogeneic hematopoietic cell transplantation|allogeneic hematopoietic cell transplantation
210295|NCT02880254|body mass index change|body mass index change
210296|NCT02880254|weight loss|weight loss
210297|NCT02880254|patient compliance|patient compliance
210298|NCT02880202|Massage Therapy|massage therapy
210299|NCT02880202|Hospice|hospice
210300|NCT02880202|Integrative Medicine|integrative medicine
210301|NCT02880202|Palliative Care|palliative care
210302|NCT02880202|Caregivers|caregivers
210303|NCT02880189|Non-Alcoholic Steatohepatitis (NASH)|non-alcoholic steatohepatitis (nash)
210304|NCT02880189|NASH with Fibrosis|nash with fibrosis
210305|NCT02880189|Intragastric Balloon|intragastric balloon
210306|NCT02880189|Orbera|orbera
210307|NCT02880189|Orbera Intragastric Balloon|orbera intragastric balloon
210308|NCT02880176|Behavioral Economics|behavioral economics
210309|NCT02880176|Financial Incentives|financial incentives
210310|NCT02880176|Bladder Cancer|bladder cancer
210311|NCT02880176|Ambulation|ambulation
210312|NCT02880176|Surgical Co-Morbidity|surgical co-morbidity
210313|NCT02880176|Fitbit|fitbit
210314|NCT02880176|Mobile Health|mobile health
210315|NCT02880176|Radical Cystectomy|radical cystectomy
210316|NCT02880150|elite climbers|elite climbers
210317|NCT02880150|near infrared spectroscopy|near infrared spectroscopy
210318|NCT02880124|Isotope Labeling, Stable|isotope labeling, stable
210319|NCT02880124|Exercise, Physical|exercise, physical
210320|NCT02880124|Calorimetry, Indirect|calorimetry, indirect
210321|NCT02880124|Athletic Performance|athletic performance
210322|NCT02880124|Sugar Maple|sugar maple
210323|NCT02880111|Malignant Brain Tumor|malignant brain tumor
210324|NCT02880111|patient sputum|patient sputum
210325|NCT02880098|Neonatology|neonatology
210326|NCT02880098|Troponin T|troponin t
210327|NCT02880098|Standards|standards
210328|NCT02880059|Sleep Apnea, Aneurysm, Subarachnoid Hemorrhage, Blood Pressure.|sleep apnea, aneurysm, subarachnoid hemorrhage, blood pressure.
210329|NCT02880046|immune response|immune response
210330|NCT02880046|T lymphocyte|t lymphocyte
210331|NCT02880046|PD-1/PDL-1 pathway|pd-1/pdl-1 pathway
210332|NCT02880033|Parkinson's disease|parkinson's disease
210333|NCT02880033|Amyotrophic lateral sclerosis|amyotrophic lateral sclerosis
210334|NCT02880033|Peripheral blood mononuclear cells|peripheral blood mononuclear cells
210335|NCT02880033|ex vivo model for oxidative stress|ex vivo model for oxidative stress
210336|NCT02880033|iron metabolism and chelation|iron metabolism and chelation
210337|NCT02880007|Pulsed dose-rate brachytherapy|pulsed dose-rate brachytherapy
210338|NCT02880007|3D dosimetry|3d dosimetry
210339|NCT02880007|Prospective Studies|prospective studies
210340|NCT02880007|Radiotherapy Dosage|radiotherapy dosage
210341|NCT02880007|Uterine Cervical Neoplasms/radiotherapy|uterine cervical neoplasms/radiotherapy
210342|NCT02880007|Brachytherapy/methods|brachytherapy/methods
210343|NCT02879968|serum squamous cell carcinoma antigen|serum squamous cell carcinoma antigen
210344|NCT02879968|tumor volume|tumor volume
210345|NCT02879968|Head and Neck Cancer|head and neck cancer
210346|NCT02879955|Glucagon-Like Peptide 1|glucagon-like peptide 1
210347|NCT02879955|Carbohydrates|carbohydrates
210348|NCT02879955|Gastric bypass|gastric bypass
210349|NCT02879955|Bariatric Surgery|bariatric surgery
210350|NCT02879955|Overweight|overweight
210351|NCT02879942|Placental volume|placental volume
210352|NCT02879942|First-trimester screening|first-trimester screening
210353|NCT02879942|Ultrasound|ultrasound
210354|NCT02879942|Preeclampsia|preeclampsia
210355|NCT02879942|Intrauterine growth restriction|intrauterine growth restriction
210356|NCT02879942|Biochemical markers|biochemical markers
210357|NCT02879942|Uterine artery doppler|uterine artery doppler
210358|NCT02879929|chronic nasal dysfunction|chronic nasal dysfunction
210359|NCT02879929|Quality of life|quality of life
210360|NCT02879929|measurement|measurement
210361|NCT02879929|self-reporting questionnaire|self-reporting questionnaire
210362|NCT02879929|development|development
210363|NCT02879929|validation|validation
210364|NCT02879903|Porphyromonas gingivalis|porphyromonas gingivalis
210365|NCT02879903|Periodontal treatment|periodontal treatment
210366|NCT02879903|Smokers|smokers
210367|NCT02879877|First in human|first in human
210368|NCT02879877|subjects|subjects
210369|NCT02879864|fatigue|fatigue
210370|NCT02879864|tiredness|tiredness
210371|NCT02879864|luxo therapy|luxo therapy
210372|NCT02879864|therapy by light|therapy by light
210373|NCT02879851|ultrasound|ultrasound
210374|NCT02879851|Koelis system|koelis system
210375|NCT02879851|MRI|mri
210376|NCT02879851|gold grain|gold grain
210377|NCT02879825|Ventricular Premature Complexes|ventricular premature complexes
210378|NCT02879812|Transplantation Surgery|transplantation surgery
210379|NCT02879812|Nephrology|nephrology
210380|NCT02879812|Organ and Tissue Transplantation|organ and tissue transplantation
210381|NCT02879799|Family-centered care|family-centered care
210382|NCT02879799|Family-integrated care|family-integrated care
210383|NCT02879799|Neonatal intensive care unit|neonatal intensive care unit
210384|NCT02879799|Premature|premature
210385|NCT02879799|Infant|infant
210386|NCT02879773|Respiratory Function Tests|respiratory function tests
210387|NCT02879773|Computed tomography|computed tomography
210388|NCT02879773|Thoracic surgical procedures|thoracic surgical procedures
210389|NCT02879773|Diagnosis|diagnosis
210390|NCT02879760|Lung|lung
210391|NCT02879760|Cancer|cancer
210392|NCT02879760|Chemotherapy|chemotherapy
210393|NCT02879760|Oncolytic virus|oncolytic virus
210394|NCT02879760|Immunotherapy|immunotherapy
210395|NCT02879760|Pembrolizumab|pembrolizumab
210396|NCT02879760|Keytruda|keytruda
210397|NCT02879747|treatment|treatment
210398|NCT02879747|growth hormone|growth hormone
210399|NCT02879747|childhood|childhood
210400|NCT02879747|short stature|short stature
210401|NCT02879734|peritoneal dialysis|peritoneal dialysis
210402|NCT02879734|laparoscopy|laparoscopy
210403|NCT02879734|omentum|omentum
210404|NCT02879721|Gastrointestinal|gastrointestinal
210405|NCT02879708|Social Accountability|social accountability
210406|NCT02879708|Healthcare Quality|healthcare quality
210407|NCT02879708|Health System Strengthening|health system strengthening
210408|NCT02879708|Child Health|child health
210409|NCT02879708|Childhood pneumonia|childhood pneumonia
210410|NCT02879708|Childhood diarrhea|childhood diarrhea
210411|NCT02879682|glioma|glioma
210412|NCT02879682|brain metastases|brain metastases
210413|NCT02879682|nTMS|ntms
210414|NCT02879630|pharmacokinetics|pharmacokinetics
210415|NCT02879630|acyclovir|acyclovir
210416|NCT02879604|cognitive remediation, cost-effectiveness analysis|cognitive remediation, cost-effectiveness analysis
210417|NCT02879552|Upper blepharoplasty|upper blepharoplasty
210418|NCT02879552|brassiere sutures|brassiere sutures
210419|NCT02879552|tarsal platform show|tarsal platform show
210420|NCT02879552|eyeshadow space|eyeshadow space
210421|NCT02879552|brow fat span|brow fat span
210422|NCT02879539|cochlear implants, power consumption,|cochlear implants, power consumption,
210423|NCT02879526|Relapse/Refratory Peripheral T Cell Lymphoma|relapse/refratory peripheral t cell lymphoma
210424|NCT02879526|Chidamide|chidamide
210425|NCT02879526|Cyclophosphamide、Prednisone、Thalidomide(CPT)|cyclophosphamide、prednisone、thalidomide(cpt)
210426|NCT02879500|Systematic review and meta-analysis|systematic review and meta-analysis
210427|NCT02879500|Evidence-based medicine (EBM)|evidence-based medicine (ebm)
210428|NCT02879500|Evidence-based nutrition (EBN)|evidence-based nutrition (ebn)
210429|NCT02879500|Clinical practice guidelines|clinical practice guidelines
210430|NCT02879500|Randomized controlled trials|randomized controlled trials
210431|NCT02879500|Prospective cohort studies|prospective cohort studies
210432|NCT02879500|Body weight|body weight
210433|NCT02879500|Body mass index|body mass index
210434|NCT02879500|Adiposity|adiposity
210435|NCT02879500|Overweight|overweight
210436|NCT02879500|Obesity|obesity
210437|NCT02879461|SURGERY|surgery
210438|NCT02879461|REHABILITATION|rehabilitation
210439|NCT02879448|Non-valvular atrial fibrillation|non-valvular atrial fibrillation
210440|NCT02879448|Left Atrial Appendage|left atrial appendage
210441|NCT02879409|HbA1c variability|hba1c variability
210442|NCT02879409|Diabetes Mellitus Type 2|diabetes mellitus type 2
210443|NCT02879409|Diabetes microvascular complications|diabetes microvascular complications
210444|NCT02879409|Diabetes macrovascular complications|diabetes macrovascular complications
210445|NCT02879396|Older adults|older adults
210446|NCT02879396|Avoidable admissions|avoidable admissions
210447|NCT02879396|Assisted living home|assisted living home
210448|NCT02879396|Emergency service calls|emergency service calls
210449|NCT02879396|Heading Assisted Living Facilities|heading assisted living facilities
210450|NCT02879383|Type 2 Diabetes, Revita System, DMR|type 2 diabetes, revita system, dmr
210451|NCT02879370|Anastomotic Leak|anastomotic leak
210452|NCT02879370|Rectal cancer|rectal cancer
210453|NCT02879370|Double stapling technique|double stapling technique
210454|NCT02879357|Care management|care management
210455|NCT02879357|end of life|end of life
210456|NCT02879357|advanced care planning|advanced care planning
210457|NCT02879357|palliative care|palliative care
210458|NCT02879331|pulmonary emphysema|pulmonary emphysema
210459|NCT02879331|coils|coils
210460|NCT02879331|cycloergometry|cycloergometry
210461|NCT02879331|lung volume reduction|lung volume reduction
210462|NCT02879305|erythropoiesis stimulating agents|erythropoiesis stimulating agents
210463|NCT02879305|GSK1278863|gsk1278863
210464|NCT02879305|daprodustat|daprodustat
210465|NCT02879305|anemia|anemia
210466|NCT02879305|chronic kidney disease|chronic kidney disease
210467|NCT02879305|hemoglobin|hemoglobin
210468|NCT02879305|recombinant human erythropoietin|recombinant human erythropoietin
210469|NCT02879292|Pyloric stenosis spinal anesthesia postoperative pain|pyloric stenosis spinal anesthesia postoperative pain
210470|NCT02879279|Stroke|stroke
210471|NCT02879279|Upper limb|upper limb
210472|NCT02879279|Robotic rehabilitation|robotic rehabilitation
210473|NCT02879266|Dengue Vaccine|dengue vaccine
210474|NCT02879188|degenerative joint disease|degenerative joint disease
210475|NCT02879188|total knee arthroplasty|total knee arthroplasty
210476|NCT02879188|physical therapy|physical therapy
210477|NCT02879188|arthroplasty, replacement, knee|arthroplasty, replacement, knee
210478|NCT02879149|Ankle Fusions|ankle fusions
210479|NCT02879149|AUGMENT® Bone Graft|augment® bone graft
210480|NCT02879149|Autologous Bone Graft|autologous bone graft
210481|NCT02879149|arthritis|arthritis
210482|NCT02879149|ankle pain|ankle pain
210483|NCT02879149|foot pain|foot pain
210484|NCT02879149|hindfoot fracture|hindfoot fracture
210485|NCT02879149|ankle fracture|ankle fracture
210486|NCT02879136|Gait|gait
210487|NCT02879136|Balance|balance
210488|NCT02879136|PD|pd
210489|NCT02879110|Sulforaphane|sulforaphane
210490|NCT02879110|clinic trial|clinic trial
210491|NCT02879110|Autism Spectrum Disorder|autism spectrum disorder
210492|NCT02879110|Efficacy|efficacy
210493|NCT02879110|Safety|safety
210494|NCT02879110|Mechanism|mechanism
210495|NCT02879032|Treadmill Scores|treadmill scores
210496|NCT02879032|Coronary Angiogram|coronary angiogram
210497|NCT02879032|Coronary Artery Disease|coronary artery disease
210498|NCT02879006|Chinese herbal therapy|chinese herbal therapy
210499|NCT02879006|Oral immunotherapy|oral immunotherapy
210500|NCT02879006|Food allergy|food allergy
210501|NCT02879006|Omalizumab|omalizumab
210502|NCT02878928|Pharmacogenetic testing|pharmacogenetic testing
210503|NCT02878928|PGx|pgx
210504|NCT02878928|Depression|depression
210505|NCT02878928|Neuropsychiatric diseases|neuropsychiatric diseases
210506|NCT02878928|IDgenetix|idgenetix
210507|NCT02878928|AltheaDx|altheadx
210508|NCT02878902|emergency|emergency
210509|NCT02878902|coordination|coordination
210510|NCT02878902|dialysis|dialysis
210511|NCT02878824|Neurophysiology|neurophysiology
210512|NCT02878824|Autonomic|autonomic
210513|NCT02878824|Sensory|sensory
210514|NCT02878824|Child|child
210515|NCT02878824|Ethnicity|ethnicity
210516|NCT02878824|Environment|environment
210517|NCT02878811|heart failure|heart failure
210518|NCT02878811|prospective|prospective
210519|NCT02878811|cohort|cohort
210520|NCT02878785|AML|aml
210521|NCT02878746|Mirror therapy|mirror therapy
210522|NCT02878746|Proprioception|proprioception
210523|NCT02878746|Rehabilitation|rehabilitation
210524|NCT02878746|Stroke|stroke
210525|NCT02878746|Hemiplegia|hemiplegia
210526|NCT02878720|ischemic stroke|ischemic stroke
210527|NCT02878720|hemorrhagic chronic|hemorrhagic chronic
210528|NCT02878720|non-invasive vagus nerve stimulation|non-invasive vagus nerve stimulation
210529|NCT02878720|robot-assisted rehabilitation|robot-assisted rehabilitation
210530|NCT02878681|Diabetic Macular Edema.|diabetic macular edema.
210531|NCT02878668|procalcitonin|procalcitonin
210532|NCT02878668|post-operative|post-operative
210533|NCT02878668|complication|complication
210534|NCT02878668|CRP|crp
210535|NCT02878655|N0 clinical and radiological|n0 clinical and radiological
210536|NCT02878655|dissection IIb sector|dissection iib sector
210537|NCT02878564|Schistosomiasis mansoni|schistosomiasis mansoni
210538|NCT02878564|HIV susceptibility|hiv susceptibility
210539|NCT02878564|Genital immunology|genital immunology
210540|NCT02878564|Mucosal immunology|mucosal immunology
210541|NCT02878564|HIV entry assay|hiv entry assay
210542|NCT02878564|Adult women|adult women
210543|NCT02878512|Segmental Epidural|segmental epidural
210544|NCT02878512|Regional Anesthesia for PCNL|regional anesthesia for pcnl
210545|NCT02878499|autism|autism
210546|NCT02878499|autism spectrum disorder|autism spectrum disorder
210547|NCT02878499|ASD|asd
210548|NCT02878499|sleep|sleep
210549|NCT02878499|Circadian|circadian
210550|NCT02878499|Biological rhythms|biological rhythms
210551|NCT02878499|melatonin|melatonin
210552|NCT02878499|Cognition|cognition
210553|NCT02878499|Behavior|behavior
210554|NCT02878499|Longitudinal|longitudinal
210555|NCT02878499|Longitudinal accelerated design|longitudinal accelerated design
210556|NCT02878486|Physical activity|physical activity
210557|NCT02878486|Alzheimer's disease|alzheimer's disease
210558|NCT02878486|cognitive impairment|cognitive impairment
210559|NCT02878486|sedentary behavior|sedentary behavior
210560|NCT02878486|insulin sensitivity|insulin sensitivity
210561|NCT02878460|HYPEROXIA|hyperoxia
210562|NCT02878460|MECHANICAL VENTILATION|mechanical ventilation
210563|NCT02878460|OXYGEN RESERVE INDEX|oxygen reserve index
210564|NCT02878447|Haemoptysis|haemoptysis
210565|NCT02878447|Radiotherapy|radiotherapy
210566|NCT02878447|Tuberculosis|tuberculosis
210567|NCT02878447|Aspergilloma|aspergilloma
210568|NCT02878447|Bronchiectasis|bronchiectasis
210569|NCT02878434|Cancer|cancer
210570|NCT02878434|Fertility|fertility
210571|NCT02878434|Pregnancy|pregnancy
210572|NCT02878434|Chemotherapy|chemotherapy
210573|NCT02878434|Radiotherapy|radiotherapy
210574|NCT02878434|Long term|long term
210575|NCT02878434|Follow up|follow up
210576|NCT02878395|genomics|genomics
210577|NCT02878395|epigenomics|epigenomics
210578|NCT02878395|recurrence|recurrence
210579|NCT02878382|PDT|pdt
210580|NCT02878382|skin cancer|skin cancer
210581|NCT02878382|calcipotriol|calcipotriol
210582|NCT02878369|fluid replacement|fluid replacement
210583|NCT02878356|Motivational Interviewing, Clinical supervision, Education|motivational interviewing, clinical supervision, education
210584|NCT02878330|Respiratory Syncytial Virus, RSV|respiratory syncytial virus, rsv
210585|NCT02878330|Preterm Infants|preterm infants
210586|NCT02878330|Lower Respiratory Tract Infection|lower respiratory tract infection
210587|NCT02878317|Glycosylation End Products, Advanced|glycosylation end products, advanced
210588|NCT02878317|Skin autofluorescence|skin autofluorescence
210589|NCT02878317|Renal Dialysis|renal dialysis
210590|NCT02878304|Prognosis|prognosis
210591|NCT02878304|Hand function|hand function
210592|NCT02878304|Rehabilitation|rehabilitation
210593|NCT02878304|Spasticity|spasticity
210594|NCT02878304|MRI|mri
210595|NCT02878278|Chidamide|chidamide
210596|NCT02878278|Administration method|administration method
210597|NCT02878265|malaria|malaria
210598|NCT02878265|vitamin A|vitamin a
210599|NCT02878265|Zinc|zinc
210600|NCT02878265|Multivitamin|multivitamin
210601|NCT02878252|COPD, Asthma, ACOS|copd, asthma, acos
210602|NCT02878239|knee osteoarthritis|knee osteoarthritis
210603|NCT02878239|gait|gait
210604|NCT02878239|Kellgren-Lawrence Scores|kellgren-lawrence scores
210605|NCT02878161|rheumatoid arthritis|rheumatoid arthritis
210606|NCT02878161|tumor necrosis factor α inhibitor|tumor necrosis factor α inhibitor
210607|NCT02878161|predictive|predictive
210608|NCT02878161|iTRAQ|itraq
210609|NCT02878161|signal pathway|signal pathway
210610|NCT02878148|Nephrolithiasis|nephrolithiasis
210611|NCT02878148|Ureteral stone|ureteral stone
210612|NCT02878148|Acute renal colic|acute renal colic
210613|NCT02878148|Ultrasonography|ultrasonography
210614|NCT02878148|Computed tomography|computed tomography
210615|NCT02878148|Diagnosis|diagnosis
210616|NCT02878122|ovarian cancer|ovarian cancer
210617|NCT02878122|chemo resistance|chemo resistance
210618|NCT02878122|predictive factors|predictive factors
210619|NCT02878122|cohort study|cohort study
210620|NCT02878122|bio bank|bio bank
210621|NCT02878109|Magnetic resonance imaging (MRI)|magnetic resonance imaging (mri)
210622|NCT02878109|Transarterial chemoembolization (TACE)|transarterial chemoembolization (tace)
210623|NCT02878096|nocturnal polyuria|nocturnal polyuria
210624|NCT02878083|vedolizumab,|vedolizumab,
716299|NCT00563459|topiramate|topiramate
210625|NCT02878083|confocal endomicroscopy|confocal endomicroscopy
210626|NCT02878083|biomarker|biomarker
210627|NCT02878083|ULCERATIVE COLITIS|ulcerative colitis
210628|NCT02878070|Spinal Cord Injuries|spinal cord injuries
210629|NCT02878070|Telemedicine|telemedicine
210630|NCT02878070|Health Behaviors|health behaviors
210631|NCT02878057|Apatinib|apatinib
210632|NCT02878057|HER-2 Negative|her-2 negative
210633|NCT02878057|Chest wall Metastasis|chest wall metastasis
210634|NCT02878057|Multicenter Phase II Study|multicenter phase ii study
210635|NCT02878057|Breast cancer|breast cancer
210636|NCT02878044|Shared Decision Making, Decision Aid|shared decision making, decision aid
210637|NCT02878031|Integrated Community Case Management|integrated community case management
210638|NCT02878031|Community Health Worker|community health worker
210639|NCT02878031|Nigeria|nigeria
210640|NCT02878018|Cohort Study|cohort study
210641|NCT02878018|Children|children
210642|NCT02878018|Henoch-Schonlein Purpura Nephritis|henoch-schonlein purpura nephritis
210643|NCT02878018|Traditional Chinese Medicine|traditional chinese medicine
210644|NCT02878005|Intubating Laryngeal Tube|intubating laryngeal tube
210645|NCT02878005|blind intubation|blind intubation
210646|NCT02878005|fiberoptic|fiberoptic
210647|NCT02877992|Infertility|infertility
210648|NCT02877992|Tachykinin|tachykinin
210649|NCT02877992|Kisspeptin|kisspeptin
210650|NCT02877940|ProSeal LMA|proseal lma
210651|NCT02877940|LTS-D|lts-d
210652|NCT02877940|i-gel|i-gel
210653|NCT02877914|heart failure, retrospective|heart failure, retrospective
210654|NCT02877888|cost effectiveness|cost effectiveness
210655|NCT02877888|fluoride varnish|fluoride varnish
210656|NCT02877888|dental caries|dental caries
210657|NCT02877875|anxiety|anxiety
210658|NCT02877875|depression|depression
210659|NCT02877875|trauma|trauma
210660|NCT02877875|behavior problems|behavior problems
210661|NCT02877875|evidence-based treatments|evidence-based treatments
210662|NCT02877875|manualized treatments|manualized treatments
210663|NCT02877875|cognitive-behavioral therapy|cognitive-behavioral therapy
210664|NCT02877875|youth|youth
210665|NCT02877875|mental health|mental health
210666|NCT02877849|fMRI|fmri
210667|NCT02877849|brain networks|brain networks
210668|NCT02877849|biomarker|biomarker
210669|NCT02877849|relapse|relapse
210670|NCT02877849|alcohol|alcohol
210671|NCT02877836|Dystonia|dystonia
210672|NCT02877836|fMRI|fmri
210673|NCT02877836|DTI|dti
210674|NCT02877836|DBS|dbs
210675|NCT02877823|Pediatric Antipsychotic Treatment|pediatric antipsychotic treatment
210872|NCT02876341|Chronic antihypertensives|chronic antihypertensives
210676|NCT02877823|Pediatric healthy lifestyle intervention|pediatric healthy lifestyle intervention
210677|NCT02877823|Parent peer support|parent peer support
210678|NCT02877784|screening|screening
210679|NCT02877784|OPMD|opmd
210680|NCT02877784|dysphagia|dysphagia
210681|NCT02877784|dysarthria|dysarthria
210682|NCT02877758|cutaneous aging|cutaneous aging
210683|NCT02877758|skin rejuvenation|skin rejuvenation
210684|NCT02877758|wrinkles|wrinkles
210685|NCT02877732|Concussion|concussion
210686|NCT02877732|Athletes|athletes
210687|NCT02877732|Eye-tracking|eye-tracking
210688|NCT02877732|Vision|vision
210689|NCT02877706|Registry|registry
210690|NCT02877693|ICD|icd
210691|NCT02877693|Thoracic MRI Scan|thoracic mri scan
210692|NCT02877693|tachycardia|tachycardia
210693|NCT02877680|Strengths-based|strengths-based
210694|NCT02877680|Mobile Health (mHealth)|mobile health (mhealth)
210695|NCT02877680|Adolescence|adolescence
210696|NCT02877680|Resilience|resilience
210697|NCT02877680|Family|family
210698|NCT02877667|tattoo|tattoo
210699|NCT02877667|laser|laser
210700|NCT02877654|Plasmatic zonulin|plasmatic zonulin
210701|NCT02877654|Irritable Bowel Syndrome|irritable bowel syndrome
210702|NCT02877654|Intestinal permeability|intestinal permeability
210703|NCT02877641|Current Smoker|current smoker
210704|NCT02877641|Former Smoker|former smoker
210705|NCT02877628|pharmacokinetic|pharmacokinetic
210706|NCT02877628|pharmacodynamic|pharmacodynamic
210707|NCT02877628|tacrolimus|tacrolimus
210708|NCT02877628|CYP3A5|cyp3a5
210709|NCT02877628|liver transplantation|liver transplantation
210710|NCT02877563|peripheral artery disease|peripheral artery disease
210711|NCT02877563|contrast enhanced ultrasound|contrast enhanced ultrasound
210712|NCT02877550|untreated Follicular lymphoma|untreated follicular lymphoma
210713|NCT02877550|non-Hodgkin lymphoma|non-hodgkin lymphoma
210714|NCT02877550|Obinutuzumab|obinutuzumab
210715|NCT02877550|Gazyva|gazyva
210716|NCT02877550|Gazyvaro|gazyvaro
210717|NCT02877550|Venetoclax|venetoclax
210718|NCT02877550|Venclexta|venclexta
210719|NCT02877446|Left ventricular assist device (LVAD)|left ventricular assist device (lvad)
210720|NCT02877446|Terminal heart failure|terminal heart failure
210721|NCT02877446|Ventricular assist device (VAD)|ventricular assist device (vad)
210722|NCT02877433|Small diameter implant|small diameter implant
210723|NCT02877433|Cross-arch prostheses|cross-arch prostheses
210724|NCT02877420|Endoscopy|endoscopy
210725|NCT02877420|Simulation Training|simulation training
210726|NCT02877420|Non-technical Skills|non-technical skills
210727|NCT02877381|Tranexamic Acid|tranexamic acid
210728|NCT02877381|Blood Transfusion|blood transfusion
210729|NCT02877342|Injury|injury
210730|NCT02877342|Injuries|injuries
210731|NCT02877342|Triage|triage
210732|NCT02877329|psychological effects|psychological effects
210733|NCT02877290|COPD|copd
210734|NCT02877290|NIRS|nirs
210735|NCT02877290|NIV|niv
210736|NCT02877290|Exercise|exercise
210737|NCT02877264|Vapendavir|vapendavir
210738|NCT02877264|Bioavailability|bioavailability
210739|NCT02877264|Biological Availability|biological availability
210740|NCT02877264|Volunteers|volunteers
210741|NCT02877251|Venous Thromboembolism|venous thromboembolism
210742|NCT02877251|Venous Thrombosis|venous thrombosis
210743|NCT02877251|Pulmonary Thromboembolism|pulmonary thromboembolism
210744|NCT02877251|National Registry|national registry
210745|NCT02877251|Mexico|mexico
210746|NCT02877251|Major Adverse Cardiovascular Events|major adverse cardiovascular events
210747|NCT02877238|remote ischemic preconditioning|remote ischemic preconditioning
210748|NCT02877238|sevoflurane|sevoflurane
210749|NCT02877238|total intravenous anesthetic|total intravenous anesthetic
210750|NCT02877212|ITP|itp
210751|NCT02877212|Eltrombopag|eltrombopag
210752|NCT02877212|Steroid refractory|steroid refractory
210753|NCT02877212|Fc Receptor|fc receptor
210754|NCT02877199|Hepatitis C|hepatitis c
210755|NCT02877199|anti-E1E2 antibodies|anti-e1e2 antibodies
210756|NCT02877199|cirrhosis|cirrhosis
210757|NCT02877199|triple therapy|triple therapy
210758|NCT02877173|Arteriosclerosis Obliterans|arteriosclerosis obliterans
210759|NCT02877173|Atherosclerotic Occlusive Disease of the Lower Extremities|atherosclerotic occlusive disease of the lower extremities
210760|NCT02877173|Intermittent Claudication|intermittent claudication
210761|NCT02877121|interstitial lung disease|interstitial lung disease
210762|NCT02877121|Respiratory Muscle Function|respiratory muscle function
210763|NCT02877121|Neural Respiratory Drive|neural respiratory drive
210764|NCT02877056|Colorectal adenocarcinoma|colorectal adenocarcinoma
210765|NCT02877056|Neoadjuvant therapy|neoadjuvant therapy
210766|NCT02877056|Endoscopy|endoscopy
210767|NCT02877056|Endoscopic biopsy|endoscopic biopsy
210768|NCT02877056|Biomarkers|biomarkers
210769|NCT02877056|Genes|genes
210770|NCT02876991|choline positron emission tomography|choline positron emission tomography
210771|NCT02876991|occult recurrence|occult recurrence
210772|NCT02876991|prostatic adenocarcinoma|prostatic adenocarcinoma
210773|NCT02876991|sodium fluoride positron emission tomography|sodium fluoride positron emission tomography
210774|NCT02876952|Cardio-respiratory fitness|cardio-respiratory fitness
211364|NCT02872818|c-Myc|c-myc
210775|NCT02876952|high intensity exercise training|high intensity exercise training
210776|NCT02876939|Hereditary Sensory Neuropathy|hereditary sensory neuropathy
210777|NCT02876939|Autonomic Neuropathy|autonomic neuropathy
210778|NCT02876939|Familial Dysautonomia|familial dysautonomia
210779|NCT02876939|proprioception|proprioception
210780|NCT02876939|motor control|motor control
210781|NCT02876939|sensory nervous system.|sensory nervous system.
210782|NCT02876939|HSAN III|hsan iii
210783|NCT02876939|IKBKAP gene mutation|ikbkap gene mutation
210784|NCT02876926|HIV testing|hiv testing
210785|NCT02876926|Self-testing|self-testing
210786|NCT02876926|Counseling|counseling
210787|NCT02876926|Referral|referral
210788|NCT02876874|Rheumatoid Arthritis|rheumatoid arthritis
210789|NCT02876874|lymph nodes morphology|lymph nodes morphology
210790|NCT02876874|drainage of lymphatic vessels|drainage of lymphatic vessels
210791|NCT02876861|Neoadjuvant chemotherapy|neoadjuvant chemotherapy
210792|NCT02876861|upper tract urothelial carcinoma|upper tract urothelial carcinoma
210793|NCT02876848|Administrative Claims, Healthcare|administrative claims, healthcare
210794|NCT02876848|Aromatase Inhibitors|aromatase inhibitors
210795|NCT02876848|Breast Neoplasms|breast neoplasms
210796|NCT02876848|Health Services for the Aged|health services for the aged
210797|NCT02876848|Medical Informatics Applications|medical informatics applications
210798|NCT02876848|Medication Adherence|medication adherence
210799|NCT02876848|Outcome and Process Assessment (Health Care)|outcome and process assessment (health care)
210800|NCT02876848|Selective Estrogen Receptor Modulators|selective estrogen receptor modulators
210801|NCT02876848|Telemedicine|telemedicine
210802|NCT02876835|GSK1278863|gsk1278863
210803|NCT02876835|hemoglobin|hemoglobin
210804|NCT02876835|anemia|anemia
210805|NCT02876835|non-dialysis|non-dialysis
210806|NCT02876835|erythropoiesis stimulating agents|erythropoiesis stimulating agents
210807|NCT02876835|daprodustat|daprodustat
210808|NCT02876835|chronic kidney disease|chronic kidney disease
210809|NCT02876809|centenarians|centenarians
210810|NCT02876809|geriatric|geriatric
210811|NCT02876809|telomere length|telomere length
210812|NCT02876809|progerin|progerin
210813|NCT02876809|metagenome|metagenome
210814|NCT02876809|metabolome|metabolome
210815|NCT02876796|fractional de novo lipogenesis|fractional de novo lipogenesis
210816|NCT02876796|DNL|dnl
718013|NCT00556088|Paclitaxel|paclitaxel
210817|NCT02876796|pharmacodynamic|pharmacodynamic
210818|NCT02876796|pharmacokinetic|pharmacokinetic
210819|NCT02876705|Patterns|patterns
210820|NCT02876705|Pain|pain
210821|NCT02876705|Cycling|cycling
210822|NCT02876705|Running|running
210823|NCT02876705|Exhaustion|exhaustion
210824|NCT02876679|Hematopoietic Stem Cell|hematopoietic stem cell
210825|NCT02876679|Transplantation|transplantation
210826|NCT02876679|Graft vs Host Disease|graft vs host disease
210827|NCT02876679|Cyclophosphamide|cyclophosphamide
210828|NCT02876679|Anti-Thymocyte Globulin|anti-thymocyte globulin
210829|NCT02876679|GVHD prophylaxis|gvhd prophylaxis
210830|NCT02876666|Spinal Cord Injuries|spinal cord injuries
210831|NCT02876666|Health Behavior|health behavior
210832|NCT02876653|Obstructive sleep apnea|obstructive sleep apnea
210833|NCT02876653|Aging|aging
210834|NCT02876653|Telomere length|telomere length
210835|NCT02876614|radionuclide cisternography|radionuclide cisternography
210836|NCT02876614|CSF leak|csf leak
210837|NCT02876614|imaging|imaging
210838|NCT02876601|Coagulation|coagulation
210839|NCT02876601|Inflammation|inflammation
210840|NCT02876601|Defibrotide|defibrotide
210841|NCT02876601|Fibrinolysis|fibrinolysis
210842|NCT02876588|Wrong-Patient Errors|wrong-patient errors
210843|NCT02876588|Retract-and-Reorder Tool|retract-and-reorder tool
210844|NCT02876562|Gingival Recession Coverage|gingival recession coverage
210845|NCT02876549|G6PD|g6pd
210846|NCT02876549|Primaquine|primaquine
210847|NCT02876510|Ovarian Cancer|ovarian cancer
210848|NCT02876510|Esophageal Cancer|esophageal cancer
210849|NCT02876510|Head and neck squamous cell carcinoma|head and neck squamous cell carcinoma
210850|NCT02876510|non-small cell lung cancer|non-small cell lung cancer
210851|NCT02876510|Gastric Cancer|gastric cancer
210852|NCT02876510|T-cell Therapy|t-cell therapy
210853|NCT02876510|immunotherapy|immunotherapy
210854|NCT02876510|adoptive cellular therapy|adoptive cellular therapy
210855|NCT02876510|T-cell receptor|t-cell receptor
210856|NCT02876510|cell therapy|cell therapy
210857|NCT02876510|cytotherapy|cytotherapy
210858|NCT02876510|IMA101|ima101
210859|NCT02876510|atezolizumab|atezolizumab
210860|NCT02876510|Tecentriq|tecentriq
210861|NCT02876458|Coronary angiogram|coronary angiogram
210862|NCT02876458|Survival rate|survival rate
210863|NCT02876458|Neurological sequel|neurological sequel
210864|NCT02876445|Huntington's disease|huntington's disease
210865|NCT02876445|Caregiver|caregiver
210866|NCT02876445|ZARIT burden scale|zarit burden scale
210867|NCT02876419|nucleic acid polymer REP 2139 HBsAg hepatitis B hepatitis D|nucleic acid polymer rep 2139 hbsag hepatitis b hepatitis d
210868|NCT02876367|Epidemiology|epidemiology
210869|NCT02876354|Hemodialysis|hemodialysis
210870|NCT02876354|Vitamin k2|vitamin k2
210871|NCT02876354|Vascular calcifications|vascular calcifications
211365|NCT02872818|Caspase-9|caspase-9
210873|NCT02876341|New onset atrial fibrillation|new onset atrial fibrillation
210874|NCT02876341|Septic shock|septic shock
210875|NCT02876328|Ebola Vaccine|ebola vaccine
210876|NCT02876315|innate immunity|innate immunity
210877|NCT02876315|elderly adults|elderly adults
210878|NCT02876315|multivitamin supplement|multivitamin supplement
210879|NCT02876315|vitamin D|vitamin d
210880|NCT02876315|vitamin C|vitamin c
210881|NCT02876315|zinc|zinc
210882|NCT02876302|Inflammatory Breast Cancer|inflammatory breast cancer
210883|NCT02876302|Breast Cancer|breast cancer
210884|NCT02876302|Triple Negative Breast Cancer|triple negative breast cancer
210885|NCT02876263|aortic diseases|aortic diseases
210886|NCT02876263|aortic aneurysm|aortic aneurysm
210887|NCT02876263|electroencephalography|electroencephalography
210888|NCT02876263|Near-Infrared spectroscopy|near-infrared spectroscopy
210889|NCT02876263|Transcranial Doppler ultrasonography|transcranial doppler ultrasonography
210890|NCT02876263|Cardiopulmonary arrest|cardiopulmonary arrest
210891|NCT02876263|Hypothermia, Induced|hypothermia, induced
210892|NCT02876250|Lung transplantation|lung transplantation
210893|NCT02876250|Cyclosporine|cyclosporine
210894|NCT02876250|Postconditioning|postconditioning
210895|NCT02876211|Renal disease|renal disease
210896|NCT02876211|Erythropoiesis|erythropoiesis
210897|NCT02876211|Erythropoietin stimulating agent|erythropoietin stimulating agent
210898|NCT02876211|Iron|iron
210899|NCT02876211|Klotho|klotho
210900|NCT02876211|Selective vitamin D receptor activation|selective vitamin d receptor activation
210901|NCT02876198|Retinal neovascularization|retinal neovascularization
210902|NCT02876198|Anti-VEGF|anti-vegf
210903|NCT02876198|Retinal Nerve Fiber Layer (RNFL)|retinal nerve fiber layer (rnfl)
210904|NCT02876185|Glaucoma surveillance|glaucoma surveillance
210905|NCT02876185|Orthoptist|orthoptist
210906|NCT02876172|PTSD|ptsd
210907|NCT02876172|psychotherapy|psychotherapy
210908|NCT02876172|MDMA|mdma
210909|NCT02876172|dyad|dyad
210910|NCT02876172|cognitive behavioral therapy|cognitive behavioral therapy
210911|NCT02876159|Vaccination|vaccination
210912|NCT02876146|Albendazole|albendazole
210913|NCT02876146|Benzimidazole|benzimidazole
210914|NCT02876146|Echinococcus multilocularis|echinococcus multilocularis
269677|NCT02520440|GIF|gif
210915|NCT02876146|Alveolar echinococcosis|alveolar echinococcosis
210916|NCT02876146|Liver Diseases|liver diseases
210917|NCT02876055|Nerve Block/methods|nerve block/methods
210918|NCT02876055|Pain, Postoperative/prevention & control|pain, postoperative/prevention & control
210919|NCT02876055|Anesthetics, Local/administration & dosage|anesthetics, local/administration & dosage
210920|NCT02876055|Brachial Plexus/ultrasonography|brachial plexus/ultrasonography
210921|NCT02876055|Shoulder Pain/prevention & control|shoulder pain/prevention & control
210922|NCT02875938|left middle cerebral artery|left middle cerebral artery
210923|NCT02875938|cerebrovascular accident (CVA)|cerebrovascular accident (cva)
210924|NCT02875938|stroke|stroke
210925|NCT02875925|blood coagulation|blood coagulation
210926|NCT02875912|Family|family
210927|NCT02875912|Care Rituals|care rituals
210928|NCT02875912|End of Life|end of life
210929|NCT02875912|Discordance of care|discordance of care
210930|NCT02875860|CDH|cdh
210931|NCT02875860|Congenital Diaphragmatic Hernia|congenital diaphragmatic hernia
210932|NCT02875860|Fetal Tracheal Occlusion|fetal tracheal occlusion
210933|NCT02875860|FETO|feto
210934|NCT02875860|plug-unplug|plug-unplug
210935|NCT02875860|GoldBal2|goldbal2
210936|NCT02875860|Balloon|balloon
210937|NCT02875860|Goldvalve Balloon|goldvalve balloon
210938|NCT02875860|TOTAL|total
210939|NCT02875795|linguistic|linguistic
210940|NCT02875795|quality of life|quality of life
210941|NCT02875782|Smoking Cessation|smoking cessation
210942|NCT02875769|cetylpyridinium chloride|cetylpyridinium chloride
210943|NCT02875769|chlorhexidine|chlorhexidine
210944|NCT02875769|oral aerosol|oral aerosol
210945|NCT02875769|oral splatter|oral splatter
210946|NCT02875769|mouthwash|mouthwash
210947|NCT02875769|microbiology|microbiology
210948|NCT02875704|DR|dr
210949|NCT02875704|AMD|amd
210950|NCT02875691|disease activity|disease activity
210951|NCT02875652|circulation tumor DNA|circulation tumor dna
210952|NCT02875652|choroidal melanoma|choroidal melanoma
210953|NCT02875639|Ischemic Heart Failure|ischemic heart failure
210954|NCT02875639|coronary artery disease|coronary artery disease
210955|NCT02875639|qi deficiency and blood stasis|qi deficiency and blood stasis
210956|NCT02875613|Nasopharyngeal|nasopharyngeal
210957|NCT02875613|PD-L1|pd-l1
210958|NCT02875613|monoclonal antibody|monoclonal antibody
210959|NCT02875613|Epstein-barr virus|epstein-barr virus
210960|NCT02875600|chronic gastro-intestinal ischemia|chronic gastro-intestinal ischemia
210961|NCT02875600|oxygen deficiency of the gastro-intestinal tract|oxygen deficiency of the gastro-intestinal tract
210962|NCT02875587|OHSS|ohss
210963|NCT02875587|Infertility|infertility
210964|NCT02875587|Cabergoline|cabergoline
210965|NCT02875587|Calcium gluconate|calcium gluconate
210966|NCT02875587|IVF-ET|ivf-et
210967|NCT02875574|Isoniazid|isoniazid
210968|NCT02875574|Drug Resistance|drug resistance
210969|NCT02875535|Evidence-based|evidence-based
211069|NCT02874859|DIABETIC RETINOPATHY|diabetic retinopathy
210970|NCT02875535|lesbian, gay, bisexual, transgender, intersex, and queer|lesbian, gay, bisexual, transgender, intersex, and queer
210971|NCT02875535|adolescent|adolescent
210972|NCT02875535|Suicide prevention|suicide prevention
210973|NCT02875535|Implementation study|implementation study
210974|NCT02875522|COPD|copd
210975|NCT02875522|Exercise Training|exercise training
210976|NCT02875522|Flow-Mediated Dilation|flow-mediated dilation
210977|NCT02875522|Arterial Stiffness|arterial stiffness
210978|NCT02875522|Echocardiography|echocardiography
210979|NCT02875522|Cerebrovascular Physiology|cerebrovascular physiology
210980|NCT02875470|non-surgical periodontal debridement|non-surgical periodontal debridement
210981|NCT02875470|root planing/instrumentation|root planing/instrumentation
210982|NCT02875470|cytokine(s)|cytokine(s)
210983|NCT02875470|dental plaque|dental plaque
210984|NCT02875470|microscopy, electron, scanning|microscopy, electron, scanning
210985|NCT02875457|small cell lung cancer; apatinib; etoposide; cisplatin|small cell lung cancer; apatinib; etoposide; cisplatin
210986|NCT02875405|postoperative|postoperative
210987|NCT02875405|pericardiotomy|pericardiotomy
210988|NCT02875405|prevention|prevention
210989|NCT02875405|cardiac surgery|cardiac surgery
210990|NCT02875405|left|left
210991|NCT02875405|posterior|posterior
210992|NCT02875379|Noninvasive Ventilation|noninvasive ventilation
210993|NCT02875379|Mechanical Ventilation|mechanical ventilation
210994|NCT02875353|Post-Polypectomy|post-polypectomy
210995|NCT02875353|Colon bleeding|colon bleeding
210996|NCT02875353|Stigmata of recent hemorrhage|stigmata of recent hemorrhage
210997|NCT02875327|SEER|seer
210998|NCT02875327|Medicaid|medicaid
210999|NCT02875327|Cancer|cancer
211000|NCT02875327|Health Services Research|health services research
211001|NCT02875327|Epidemiology|epidemiology
211002|NCT02875301|Exercise|exercise
211003|NCT02875301|Brain Health|brain health
211004|NCT02875301|Dose Response|dose response
211005|NCT02875301|Cognition|cognition
211006|NCT02875262|intracranial aneurysm|intracranial aneurysm
211007|NCT02875262|subarachnoid hemorrhage|subarachnoid hemorrhage
211008|NCT02875262|stroke|stroke
269777|NCT02519829|Suture|suture
211009|NCT02875262|chelator|chelator
211010|NCT02875249|post-antibiotic diarrhea|post-antibiotic diarrhea
211011|NCT02875249|intestinal microbiome|intestinal microbiome
211012|NCT02875223|Safety|safety
211013|NCT02875223|CC-90011|cc-90011
211014|NCT02875223|Relapsed and/or Refractory Solid Tumors|relapsed and/or refractory solid tumors
211015|NCT02875223|Non-Hodgkin's Lymphomas|non-hodgkin's lymphomas
211016|NCT02875210|Anterior Cruciate Ligament|anterior cruciate ligament
211017|NCT02875210|A02.835.583.512.100|a02.835.583.512.100
211018|NCT02875197|Kinetics|kinetics
211019|NCT02875197|Biomechanics|biomechanics
211020|NCT02875197|Amputation|amputation
211021|NCT02875197|Prosthesis|prosthesis
211022|NCT02875197|Transtibial|transtibial
211023|NCT02875184|Psoriatic Arthritis|psoriatic arthritis
211024|NCT02875184|Apremilast|apremilast
211025|NCT02875184|CC-10004|cc-10004
211026|NCT02875171|Anthracyclines; Cardiotoxicity; 2-D Echocardiography|anthracyclines; cardiotoxicity; 2-d echocardiography
211027|NCT02875145|Corneal Transplantation|corneal transplantation
211028|NCT02875145|Graft Survival|graft survival
211029|NCT02875106|Sinus rhythm|sinus rhythm
211030|NCT02875041|rehabilitation|rehabilitation
211031|NCT02875041|balance|balance
211032|NCT02875028|Coagulations|coagulations
211033|NCT02875028|Platelets|platelets
211034|NCT02875028|Inflammation|inflammation
211035|NCT02875028|endotoxemia|endotoxemia
211036|NCT02875028|vorapaxar|vorapaxar
211037|NCT02875015|Anesthetics|anesthetics
211038|NCT02875015|Anesthetic Effects|anesthetic effects
211039|NCT02875015|Mid-urethral sling|mid-urethral sling
211040|NCT02874976|sedentary lifestyle|sedentary lifestyle
211041|NCT02874963|Diabetes|diabetes
211042|NCT02874963|Oral Hygiene|oral hygiene
211043|NCT02874963|Periodontal Surgery|periodontal surgery
211044|NCT02874963|Periodontal Medicine|periodontal medicine
211045|NCT02874950|Exercise|exercise
211046|NCT02874937|Syncope|syncope
211047|NCT02874937|Vasovagal|vasovagal
211048|NCT02874937|Atomoxetine|atomoxetine
211049|NCT02874924|Geriatrics|geriatrics
211050|NCT02874911|Exergaming|exergaming
211051|NCT02874911|Neurodegenerative diseases|neurodegenerative diseases
211052|NCT02874911|Rare disease|rare disease
211053|NCT02874911|Motor exercises|motor exercises
211054|NCT02874911|Training|training
211055|NCT02874911|Spinocerebellar ataxia|spinocerebellar ataxia
211056|NCT02874885|Locally-advanced rectal cancer|locally-advanced rectal cancer
211057|NCT02874885|LARC|larc
211058|NCT02874885|Colorectal cancer|colorectal cancer
211059|NCT02874885|CRC|crc
211060|NCT02874885|Rectosigmoid cancer|rectosigmoid cancer
211061|NCT02874885|No known diagnosis of colorectal cancer|no known diagnosis of colorectal cancer
211062|NCT02874885|Blood draws|blood draws
211063|NCT02874885|Blood samples|blood samples
211064|NCT02874885|Circulating tumor cells (CTC)|circulating tumor cells (ctc)
211065|NCT02874885|CTC|ctc
211066|NCT02874872|Nursing homes|nursing homes
211067|NCT02874872|Antibiotic Stewardship|antibiotic stewardship
211068|NCT02874872|Antibiotic Resistance|antibiotic resistance
211362|NCT02872818|Bcl-2|bcl-2
211070|NCT02874859|Intravitreal aflibercept|intravitreal aflibercept
211071|NCT02874833|Depression|depression
211072|NCT02874833|Unipolar depression|unipolar depression
211073|NCT02874833|Bipolar affective disorder|bipolar affective disorder
211074|NCT02874833|Exercise|exercise
211075|NCT02874833|Internet-based intervention|internet-based intervention
211076|NCT02874820|Imidazoline Receptor 2|imidazoline receptor 2
211077|NCT02874820|(4,5-dihydro-1H-imidazol-2-yl)-1-methyl-1H-indole|(4,5-dihydro-1h-imidazol-2-yl)-1-methyl-1h-indole
211078|NCT02874820|BU99008|bu99008
211079|NCT02874820|[11C]-BU99008|[11c]-bu99008
211080|NCT02874820|Radionuclide Imaging|radionuclide imaging
211081|NCT02874820|Molecular Imaging|molecular imaging
211082|NCT02874807|Hyponatremia|hyponatremia
211083|NCT02874807|SGLT2 inhibitor|sglt2 inhibitor
211084|NCT02874794|Heart Failure|heart failure
211085|NCT02874794|Reduced Ejection Fraction|reduced ejection fraction
211086|NCT02874794|Central Aortic Stiffness|central aortic stiffness
211087|NCT02874794|Vascular|vascular
211088|NCT02874794|Echocardiogram|echocardiogram
211089|NCT02874794|Aortic Stiffness|aortic stiffness
211090|NCT02874755|Quality of Care|quality of care
211091|NCT02874755|Standardized Patients|standardized patients
211092|NCT02874729|Biomarkers, Tumor|biomarkers, tumor
211093|NCT02874729|Biological Assay|biological assay
211094|NCT02874716|Quality of Care|quality of care
211095|NCT02874716|Standardized Patients|standardized patients
211096|NCT02874677|Multiple sclerosis|multiple sclerosis
211097|NCT02874677|Ventilatory threshold|ventilatory threshold
211098|NCT02874677|Effort Reeducation|effort reeducation
211099|NCT02874651|Nasopharyngeal Carcinoma|nasopharyngeal carcinoma
211100|NCT02874651|EB Virus|eb virus
211101|NCT02874651|DNA|dna
211102|NCT02874651|vascular endothecial growth factor receptor inhibitor|vascular endothecial growth factor receptor inhibitor
211103|NCT02874651|Apatinib|apatinib
211104|NCT02874612|Young Adults|young adults
718014|NCT00556088|Carboplatin|carboplatin
269896|NCT02519231|IUD|iud
211105|NCT02874612|Psychosocial Functioning|psychosocial functioning
211106|NCT02874573|Inflammation|inflammation
211107|NCT02874573|Schizophrenia|schizophrenia
211108|NCT02874560|CNS|cns
211109|NCT02874560|Antipsychotic|antipsychotic
211110|NCT02874560|Functional remission|functional remission
211111|NCT02874560|Observational study|observational study
211112|NCT02874560|FROGS|frogs
211113|NCT02874560|PSP|psp
211114|NCT02874560|Functioning|functioning
211115|NCT02874560|Schizophrenia|schizophrenia
211116|NCT02874508|leukocyte subpopulations|leukocyte subpopulations
211117|NCT02874508|perioperative myocardial infarction|perioperative myocardial infarction
211118|NCT02874508|non-cardiac surgery|non-cardiac surgery
211119|NCT02874508|perioperative cardiovascular risk|perioperative cardiovascular risk
211120|NCT02874495|Crohn's disease|crohn's disease
211121|NCT02874495|Rectal Distension|rectal distension
211122|NCT02874495|Remission|remission
211123|NCT02874495|Anticipation|anticipation
211124|NCT02874495|Painful|painful
211125|NCT02874482|Schizophrenia|schizophrenia
211126|NCT02874482|Change blindness|change blindness
211127|NCT02874482|Eye tracking|eye tracking
211128|NCT02874482|Implicit response|implicit response
211129|NCT02874469|sudden death|sudden death
211130|NCT02874469|post-traumatic stress disorder|post-traumatic stress disorder
211131|NCT02874469|psychological distress|psychological distress
211132|NCT02874469|diary|diary
211133|NCT02874469|resuscitation|resuscitation
211134|NCT02874456|Zyca virus|zyca virus
211135|NCT02874352|intensive care|intensive care
211136|NCT02874352|tracheostomy|tracheostomy
211137|NCT02874339|Acute cardiogenic pulmonary|acute cardiogenic pulmonary
211138|NCT02874339|Respiratory failure|respiratory failure
211139|NCT02874339|Hypercapnia|hypercapnia
211140|NCT02874339|High flow nasal oxygen|high flow nasal oxygen
211141|NCT02874339|Non invasive ventilation|non invasive ventilation
211142|NCT02874339|Emergency department|emergency department
211143|NCT02874326|Sandostatin LAR|sandostatin lar
211144|NCT02874326|Somatostatin|somatostatin
211145|NCT02874326|Octreotide|octreotide
211146|NCT02874313|CPAP|cpap
211147|NCT02874313|Sleep apnea|sleep apnea
211148|NCT02874313|Diabetes|diabetes
211149|NCT02874313|Diabetic retinopathy|diabetic retinopathy
211150|NCT02874287|Coronary Artery Disease|coronary artery disease
211151|NCT02874287|Hydroxychloroquine|hydroxychloroquine
211152|NCT02874274|Corticobasal syndrome|corticobasal syndrome
211153|NCT02874274|Dementia with Lewy Bodies|dementia with lewy bodies
211154|NCT02874274|Home Visit Program (HVP)|home visit program (hvp)
211155|NCT02874274|Multidimensional Caregiver Strain Index|multidimensional caregiver strain index
211156|NCT02874274|Parkinson's Disease Dementia|parkinson's disease dementia
211157|NCT02874274|Progressive Supranuclear Palsy|progressive supranuclear palsy
211158|NCT02874222|aromatase inhibitors|aromatase inhibitors
211159|NCT02874183|Heart Failure|heart failure
211160|NCT02874183|HF|hf
211161|NCT02874183|CHF|chf
211162|NCT02874183|RCT|rct
211163|NCT02874183|Self-efficacy|self-efficacy
211164|NCT02874183|Pharmacy|pharmacy
211165|NCT02874183|Pharmacist|pharmacist
211166|NCT02874183|Transition of Care|transition of care
211167|NCT02874183|Readmission|readmission
211363|NCT02872818|Bax|bax
211168|NCT02874131|Posttraumatic Stress Disorder|posttraumatic stress disorder
211169|NCT02874131|Major Depressive Disorder|major depressive disorder
211170|NCT02874131|Behavioral Activation|behavioral activation
211171|NCT02874131|Cognitive Processing Therapy|cognitive processing therapy
211172|NCT02874131|Comorbidity|comorbidity
211173|NCT02874131|Military|military
211174|NCT02874105|Medical treatment|medical treatment
211175|NCT02874105|physiotherapy|physiotherapy
211176|NCT02874092|Methotrexate (MTX)|methotrexate (mtx)
211177|NCT02874092|Ticagrelor|ticagrelor
211178|NCT02874066|Hepatitis C virus|hepatitis c virus
211179|NCT02874066|Hemodialysis|hemodialysis
211180|NCT02874066|Direct acting antiviral agents|direct acting antiviral agents
211181|NCT02874053|Risk Perceptions|risk perceptions
211182|NCT02874053|Medical Tradeoffs|medical tradeoffs
211183|NCT02874053|Regulatory Focus|regulatory focus
211184|NCT02874053|Integral Affect|integral affect
211185|NCT02874027|gut microbiota|gut microbiota
211186|NCT02874027|depression|depression
211187|NCT02874027|gut-brain axis|gut-brain axis
211188|NCT02874027|circadian rhythm|circadian rhythm
211189|NCT02874027|Traumatic Brain Injury|traumatic brain injury
211190|NCT02874001|psychology|psychology
211191|NCT02874001|caregiver support time|caregiver support time
211192|NCT02873975|Advanced Cancers|advanced cancers
211193|NCT02873975|Solid tumors|solid tumors
211194|NCT02873975|MYC amplification|myc amplification
211195|NCT02873975|CCNE1 amplification|ccne1 amplification
211196|NCT02873975|Rb loss|rb loss
211197|NCT02873975|FBXW7 mutation|fbxw7 mutation
211198|NCT02873975|BRCA1 mutation|brca1 mutation
211199|NCT02873975|BRCA2 mutation|brca2 mutation
211200|NCT02873975|PALB2 mutation|palb2 mutation
211201|NCT02873975|RAD51C mutation|rad51c mutation
211202|NCT02873975|RAD51D mutation|rad51d mutation
211203|NCT02873975|ATR mutation|atr mutation
211204|NCT02873975|ATM mutation|atm mutation
211205|NCT02873975|CHK2 mutation|chk2 mutation
211206|NCT02873975|Fanconi anemia|fanconi anemia
211207|NCT02873962|Relapsed Ovarian Cancer|relapsed ovarian cancer
211208|NCT02873949|immunology factors|immunology factors
211209|NCT02873949|TREM|trem
211210|NCT02873949|stress|stress
211211|NCT02873923|clinical trial|clinical trial
211212|NCT02873923|surrogate endpoints|surrogate endpoints
211213|NCT02873923|meta analysis|meta analysis
211214|NCT02873897|elderly|elderly
211215|NCT02873858|elderly|elderly
211216|NCT02873780|Pulmonary rehabilitation|pulmonary rehabilitation
211217|NCT02873780|COPD|copd
211218|NCT02873780|Evaluation|evaluation
211219|NCT02873780|oxygen desaturation|oxygen desaturation
211220|NCT02873780|exercise capacity|exercise capacity
211221|NCT02873767|First in human|first in human
211222|NCT02873767|Healthy volunteers|healthy volunteers
211223|NCT02873741|Sexually Transmitted Diseases (STDs)|sexually transmitted diseases (stds)
211224|NCT02873741|Cancer|cancer
211225|NCT02873741|AIDS|aids
211226|NCT02873728|chronic ulcer|chronic ulcer
211227|NCT02873728|diabetic ulcer|diabetic ulcer
211228|NCT02873728|venous ulcer|venous ulcer
211229|NCT02873728|remote ischemic conditioning|remote ischemic conditioning
211230|NCT02873715|Childhood weight control|childhood weight control
211231|NCT02873702|Drug therapy|drug therapy
211232|NCT02873689|Drug therapy|drug therapy
211233|NCT02873676|prevalence; lifestyle modification; clinical outcomes|prevalence; lifestyle modification; clinical outcomes
211234|NCT02873650|Hepatic impairment|hepatic impairment
211235|NCT02873650|Healthy volunteers|healthy volunteers
211236|NCT02873650|Clinical pharmacology study|clinical pharmacology study
211237|NCT02873650|DRB436|drb436
211238|NCT02873650|dabrafenib|dabrafenib
211239|NCT02873650|normal hepatic function|normal hepatic function
211240|NCT02873650|impaired hepatic function|impaired hepatic function
211241|NCT02873637|total knee replacement|total knee replacement
211242|NCT02873637|anesthesia|anesthesia
211243|NCT02873637|catheter|catheter
211244|NCT02873624|Acute Kidney Injury , Laparoscopic Cholecystectomy|acute kidney injury , laparoscopic cholecystectomy
211245|NCT02873598|Induction Chemotherapy|induction chemotherapy
211246|NCT02873598|Stereotactic Body Radiotherapy (SBRT)|stereotactic body radiotherapy (sbrt)
211247|NCT02873598|Dose Escalation|dose escalation
211248|NCT02873598|Locally Advanced Pancreatic Cancer (LAPC)|locally advanced pancreatic cancer (lapc)
211249|NCT02873598|Maximum Tolerated Dose (MTD)|maximum tolerated dose (mtd)
211250|NCT02873572|Online poker|online poker
211251|NCT02873572|Casino|casino
211252|NCT02873572|Massively Multiplayer Online Role-Playing Game (MMORPG)|massively multiplayer online role-playing game (mmorpg)
211253|NCT02873572|Iowa Gambling Task (IGT)|iowa gambling task (igt)
211254|NCT02873572|High Resolution Electroencephalography (HR-EEG)|high resolution electroencephalography (hr-eeg)
211255|NCT02873559|older|older
211256|NCT02873559|frail|frail
211257|NCT02873559|men|men
211258|NCT02873559|progressive muscle training|progressive muscle training
211259|NCT02873559|muscle training|muscle training
211260|NCT02873559|exercise|exercise
211261|NCT02873559|testosterone|testosterone
211262|NCT02873520|Precision Cell Immunotherapy|precision cell immunotherapy
211263|NCT02873520|Chemotherapy|chemotherapy
211264|NCT02873520|Advanced Gastric Cancer|advanced gastric cancer
211265|NCT02873507|transplantation, liver|transplantation, liver
211266|NCT02873494|Hemodynamic monitoring|hemodynamic monitoring
211267|NCT02873494|cardiac output|cardiac output
211268|NCT02873494|Transthoracic echocardiography|transthoracic echocardiography
211269|NCT02873494|Impedance cardiography|impedance cardiography
211270|NCT02873494|Child|child
211271|NCT02873494|Physioflow|physioflow
211272|NCT02873494|pediatric intensive care unit|pediatric intensive care unit
211273|NCT02873442|Precision Cell Immunotherapy|precision cell immunotherapy
211274|NCT02873442|Transcatheter Arterial Chemoembolization|transcatheter arterial chemoembolization
211275|NCT02873442|Advanced Liver Cancer|advanced liver cancer
211276|NCT02873416|Precision Cell Immunotherapy|precision cell immunotherapy
211277|NCT02873416|Chemotherapy|chemotherapy
211278|NCT02873416|Advanced Lung Cancer|advanced lung cancer
211279|NCT02873390|PD-1 Antibody|pd-1 antibody
211280|NCT02873390|CAR-T Cells|car-t cells
211281|NCT02873390|EGFR family|egfr family
211282|NCT02873390|Advanced Malignancies|advanced malignancies
211283|NCT02873377|Hispanics|hispanics
211284|NCT02873377|Construction workers|construction workers
211285|NCT02873377|Tobacco Quitline|tobacco quitline
211286|NCT02873377|Nicotine replacement therapy|nicotine replacement therapy
211287|NCT02873351|L-DOPA|l-dopa
211288|NCT02873351|GPR143|gpr143
211289|NCT02873351|PEDF|pedf
211290|NCT02873351|VEGF|vegf
211292|NCT02873325|CMV|cmv
211293|NCT02873325|HSCT|hsct
211294|NCT02873299|PTSD, Post Traumatic Stress Disorder|ptsd, post traumatic stress disorder
211295|NCT02873286|RSV Vaccines|rsv vaccines
211296|NCT02873286|Respiratory Syncytial Virus Vaccines|respiratory syncytial virus vaccines
211297|NCT02873260|Dengue Vaccine|dengue vaccine
211298|NCT02873234|Telemedicine|telemedicine
211299|NCT02873234|Chinese Medicine syndrome differentiation|chinese medicine syndrome differentiation
211300|NCT02873234|Long-term study|long-term study
211301|NCT02873234|Relapse rate|relapse rate
211302|NCT02873234|Suicide rate|suicide rate
211303|NCT02873234|Antidepressants|antidepressants
211304|NCT02873208|Alkermes|alkermes
211305|NCT02873208|ALKS 3831|alks 3831
211306|NCT02873208|Samidorphan|samidorphan
211307|NCT02873208|Schizophrenia|schizophrenia
211308|NCT02873208|Safety|safety
211309|NCT02873182|Intraoperative monitoring|intraoperative monitoring
211310|NCT02873182|Intraoperative neuromonitoring|intraoperative neuromonitoring
211311|NCT02873182|Autonomic nervous system|autonomic nervous system
211312|NCT02873182|Spine surgery|spine surgery
211313|NCT02873182|Pelvic surgery|pelvic surgery
211314|NCT02873182|Sexual function|sexual function
211315|NCT02873182|Bowel function|bowel function
211316|NCT02873182|Bladder function|bladder function
211317|NCT02873169|Left ventricular assist device|left ventricular assist device
211318|NCT02873169|Ventricular Arrhythmias|ventricular arrhythmias
211319|NCT02873169|Implantable Cardioverter-defibrillator|implantable cardioverter-defibrillator
211320|NCT02873156|E2027|e2027
211321|NCT02873156|Healthy participants|healthy participants
211322|NCT02873156|Pharmacokinetics|pharmacokinetics
211323|NCT02873156|Pharmacodynamics|pharmacodynamics
211324|NCT02873117|Benign prostate hyperplasia|benign prostate hyperplasia
211325|NCT02873117|5 alpha reductase inhibitor|5 alpha reductase inhibitor
211326|NCT02873117|prostate cancer|prostate cancer
211327|NCT02873117|Symptomatic|symptomatic
211328|NCT02873117|treated|treated
211329|NCT02873013|prostate cancer|prostate cancer
211330|NCT02873013|observational study|observational study
211331|NCT02873000|incentive spirometry|incentive spirometry
211332|NCT02873000|outcome|outcome
211333|NCT02873000|length of stay,|length of stay,
211334|NCT02873000|hospital complication|hospital complication
211335|NCT02873000|general internal medicine|general internal medicine
211336|NCT02873000|hospital medicine|hospital medicine
211337|NCT02873000|non-critically-ill|non-critically-ill
211338|NCT02872974|Cardiovascular diseases|cardiovascular diseases
211339|NCT02872974|Gestational diabetes mellitus|gestational diabetes mellitus
211340|NCT02872974|Pediatrics|pediatrics
211341|NCT02872974|Fetal programming|fetal programming
211342|NCT02872974|Cohort study|cohort study
211343|NCT02872948|Non invasive prenatal testing|non invasive prenatal testing
211344|NCT02872948|Down Syndrome|down syndrome
211345|NCT02872948|Digital PCR|digital pcr
211346|NCT02872922|Endothelial function|endothelial function
211347|NCT02872922|Ultrasonic Therapy|ultrasonic therapy
211348|NCT02872922|Vascular endothelium|vascular endothelium
211349|NCT02872922|Nitric oxide|nitric oxide
211350|NCT02872922|Ultrasound|ultrasound
211351|NCT02872883|Prelabour rupture of membranes|prelabour rupture of membranes
211352|NCT02872883|term pregnancy|term pregnancy
211353|NCT02872883|management|management
211354|NCT02872883|vaginal examination|vaginal examination
211355|NCT02872883|induction of labour|induction of labour
211356|NCT02872883|expectant management|expectant management
211357|NCT02872870|language disorders|language disorders
211358|NCT02872870|developmental disorders of oral and written language|developmental disorders of oral and written language
211359|NCT02872831|Fine needle aspiration|fine needle aspiration
211360|NCT02872818|Apoptotic signal pathway|apoptotic signal pathway
211361|NCT02872818|Survivin|survivin
211366|NCT02872818|endometrial hyperplasia|endometrial hyperplasia
211367|NCT02872818|endometrium cancer|endometrium cancer
211368|NCT02872792|cycloergometer|cycloergometer
211369|NCT02872753|Autologous Conditioned Plasma|autologous conditioned plasma
211370|NCT02872753|meniscectomy|meniscectomy
211371|NCT02872753|randomized controlled trial|randomized controlled trial
211372|NCT02872753|intra-op injection|intra-op injection
211373|NCT02872714|Urothelial carcinoma|urothelial carcinoma
211374|NCT02872714|fibroblast growth factor (FGF)|fibroblast growth factor (fgf)
211375|NCT02872714|fibroblast growth factor receptor (FGFR)|fibroblast growth factor receptor (fgfr)
211376|NCT02872714|FGF/FGFR alterations|fgf/fgfr alterations
211377|NCT02872675|Asthma|asthma
211378|NCT02872675|Exercise-Induced Asthma|exercise-induced asthma
211379|NCT02872675|Gut Bacteria|gut bacteria
211380|NCT02872675|Bimuno® Galactooligosaccharide|bimuno® galactooligosaccharide
211381|NCT02872675|Pulmonary Function|pulmonary function
211382|NCT02872675|Prebiotics|prebiotics
211383|NCT02872675|Exercise-Induced Bronchoconstriction|exercise-induced bronchoconstriction
211384|NCT02872675|Gut Microbiota|gut microbiota
211385|NCT02872675|Nutritional Intervention|nutritional intervention
211386|NCT02872675|Eucapnic Voluntary Hyperpnoea|eucapnic voluntary hyperpnoea
211387|NCT02872675|Systemic Inflammation|systemic inflammation
211388|NCT02872675|Systemic Immune Function|systemic immune function
211389|NCT02872675|Regulatory T Cells|regulatory t cells
211390|NCT02872675|TH1 Cells|th1 cells
211391|NCT02872675|TH2 Cells|th2 cells
211392|NCT02872675|Short-Chain Fatty Acids|short-chain fatty acids
211393|NCT02872675|Acetate|acetate
211394|NCT02872675|Propionate|propionate
211395|NCT02872675|Butyrate|butyrate
211396|NCT02872675|Metabolomics|metabolomics
211397|NCT02872675|Airway Inflammation|airway inflammation
211398|NCT02872675|Intestinal Permeability|intestinal permeability
211399|NCT02872610|suicidal thoughts|suicidal thoughts
211400|NCT02872610|suicidal ideation|suicidal ideation
211401|NCT02872610|Internet intervention|internet intervention
211402|NCT02872610|self-help|self-help
211403|NCT02872571|islet of Langerhans|islet of langerhans
211404|NCT02872571|transplantation|transplantation
211405|NCT02872571|muscle|muscle
211406|NCT02872506|Quality of life|quality of life
211407|NCT02872506|Crohn's disease|crohn's disease
211408|NCT02872506|Ileocecal resection|ileocecal resection
211409|NCT02872506|Anti TNF|anti tnf
211410|NCT02872493|obesity|obesity
211411|NCT02872493|bariatric surgery|bariatric surgery
211412|NCT02872493|bowel length|bowel length
211413|NCT02872480|Concussion|concussion
211414|NCT02872480|Exercise|exercise
211415|NCT02872467|Cocaine|cocaine
211416|NCT02872467|Mothers|mothers
211417|NCT02872467|Pregnant women|pregnant women
211418|NCT02872467|Postpartum women|postpartum women
211419|NCT02872467|Oxytocin|oxytocin
211420|NCT02872467|Substance use disorders|substance use disorders
211421|NCT02872467|Substance abuse|substance abuse
211422|NCT02872467|Prenatal substance use|prenatal substance use
211423|NCT02872467|stress|stress
211424|NCT02872454|Major Depression|major depression
211425|NCT02872454|Text Messaging|text messaging
211426|NCT02872454|Guided Self-Help|guided self-help
211427|NCT02872402|gestational diabetes|gestational diabetes
211428|NCT02872402|dietary modification|dietary modification
211429|NCT02872402|weight loss|weight loss
211430|NCT02872402|physical activity|physical activity
211431|NCT02872402|breastfeeding|breastfeeding
211432|NCT02872376|Anemia|anemia
211433|NCT02872376|Crohn's disease|crohn's disease
211434|NCT02872376|Ulcerative colitis|ulcerative colitis
211435|NCT02872363|breast screening|breast screening
211436|NCT02872363|breast cancer|breast cancer
211437|NCT02872363|mammogram|mammogram
211438|NCT02872363|uptake|uptake
211439|NCT02872363|reminder|reminder
211440|NCT02872363|text message|text message
211442|NCT02872311|Vaccine|vaccine
211443|NCT02872311|Influenza|influenza
211444|NCT02872311|High Dose|high dose
211445|NCT02872311|Adjuvanted|adjuvanted
211446|NCT02872311|Recombinant|recombinant
211447|NCT02872298|Severe|severe
211448|NCT02872298|Refractory|refractory
211449|NCT02872259|metastatic melanoma|metastatic melanoma
211450|NCT02872259|advanced Non-resectable melanoma|advanced non-resectable melanoma
211451|NCT02872181|Maternal Position|maternal position
211452|NCT02872181|Tilt|tilt
211453|NCT02872181|Left Uterine Displacement|left uterine displacement
211454|NCT02872181|Cesarean Delivery|cesarean delivery
211455|NCT02872181|Cesarean Section|cesarean section
211456|NCT02872155|contrast-induced nephropathy|contrast-induced nephropathy
211457|NCT02872155|renal insufficiency|renal insufficiency
211458|NCT02872155|computed tomography|computed tomography
211459|NCT02872129|Fibromyalgia|fibromyalgia
211460|NCT02872129|chronic widespread pain|chronic widespread pain
211461|NCT02872129|follow-up|follow-up
211462|NCT02872129|pain|pain
211463|NCT02872129|fatigue|fatigue
211464|NCT02872129|symptoms|symptoms
211465|NCT02872129|workability|workability
211466|NCT02872129|physical function|physical function
211467|NCT02872090|COPD|copd
211468|NCT02872090|bronchodilatators|bronchodilatators
211469|NCT02872090|autonomic nervous system|autonomic nervous system
211470|NCT02872090|cardiovascular system|cardiovascular system
211471|NCT02872077|AA for NAS|aa for nas
211472|NCT02872064|Early breast cancer|early breast cancer
211473|NCT02872064|Photodynamic therapy|photodynamic therapy
211474|NCT02872064|PDT|pdt
211475|NCT02872064|Visudyne|visudyne
211476|NCT02872064|Verteporfin|verteporfin
211477|NCT02872051|Vocational Rehabilitation|vocational rehabilitation
211478|NCT02872051|Anxiety|anxiety
211479|NCT02872051|Depression|depression
211480|NCT02872051|Common Mental Disorders|common mental disorders
211481|NCT02872051|Cognitive Behavior Therapy|cognitive behavior therapy
211482|NCT02872051|Return to Work|return to work
211483|NCT02872051|Mental Health Services|mental health services
211484|NCT02872051|Integration|integration
211485|NCT02871999|Acupuncture Therapy|acupuncture therapy
211486|NCT02871999|Pain degree after surgery|pain degree after surgery
211487|NCT02871973|parenting|parenting
211488|NCT02871973|child development|child development
211489|NCT02871973|language|language
211490|NCT02871947|severe asthma|severe asthma
211491|NCT02871934|Pharmacogenetics|pharmacogenetics
211492|NCT02871934|SLCO1B1 protein, human|slco1b1 protein, human
211493|NCT02871934|OATP1B1 protein, human|oatp1b1 protein, human
211494|NCT02871934|Simvastatin|simvastatin
211495|NCT02871934|Cardiovascular disease|cardiovascular disease
211496|NCT02871934|Cholesterol|cholesterol
211497|NCT02871934|Statin-related myotoxicity|statin-related myotoxicity
211498|NCT02871934|Veterans|veterans
211499|NCT02871934|Point-of-care|point-of-care
211500|NCT02871921|Behavioral intervention|behavioral intervention
211501|NCT02871921|social interaction|social interaction
211502|NCT02871921|social isolation|social isolation
211503|NCT02871921|MRI/fMRI|mri/fmri
211504|NCT02871921|dementia|dementia
211505|NCT02871921|electronic pill box|electronic pill box
211506|NCT02871921|objective IADL assessment|objective iadl assessment
211507|NCT02871921|speech characteristics|speech characteristics
211508|NCT02871895|sepsis|sepsis
211509|NCT02871895|severe sepsis|severe sepsis
211510|NCT02871895|septic shock|septic shock
211511|NCT02871895|multiple organ failure|multiple organ failure
211512|NCT02871869|Cinobufacini Tablets|cinobufacini tablets
211513|NCT02871869|CHOP protocol|chop protocol
211514|NCT02871856|Screening|screening
211515|NCT02871856|Computed tomography|computed tomography
211516|NCT02871856|Lung cancer|lung cancer
211517|NCT02871830|Physical activity|physical activity
211518|NCT02871830|Walking|walking
211519|NCT02871830|Intervention|intervention
211520|NCT02871830|Adolescent girls|adolescent girls
211521|NCT02871830|Randomised trial|randomised trial
211522|NCT02871817|Near Corrected Visual Acuity|near corrected visual acuity
211523|NCT02871817|Early Treatment Diabetes Retinopathy Study|early treatment diabetes retinopathy study
211524|NCT02871817|Amsler Grid|amsler grid
211525|NCT02871817|Home Monitoring|home monitoring
211526|NCT02871791|Her2-negative metastatic breast cancer|her2-negative metastatic breast cancer
211527|NCT02871791|Hormone receptor (HR)-positive breast cancer|hormone receptor (hr)-positive breast cancer
211528|NCT02871765|Patient education|patient education
211529|NCT02871765|Knowledge|knowledge
211530|NCT02871765|Life distress|life distress
211531|NCT02871765|Quality of life|quality of life
211532|NCT02871752|prostate cancer|prostate cancer
211533|NCT02871752|active surveillance|active surveillance
211534|NCT02871752|MBSR|mbsr
211535|NCT02871752|couples|couples
211536|NCT02871752|health promotion|health promotion
211537|NCT02871752|quality of life|quality of life
211538|NCT02871752|mindfulness|mindfulness
211539|NCT02871739|Communication skills training|communication skills training
211540|NCT02871739|Shared Decision Making|shared decision making
211541|NCT02871739|Decision making|decision making
211542|NCT02871739|Decision Aids|decision aids
211543|NCT02871739|lung cancer screening|lung cancer screening
211544|NCT02871726|Prostate Cancer Detection|prostate cancer detection
211545|NCT02871726|Prostate Biopsy|prostate biopsy
211546|NCT02871726|Prostate Cancer|prostate cancer
211547|NCT02871726|Transrectal Ultrasound|transrectal ultrasound
211548|NCT02871713|quadratus lumborum block|quadratus lumborum block
211549|NCT02871700|stroke|stroke
211550|NCT02871700|translational rehabilitation|translational rehabilitation
211551|NCT02871700|mirror neuron system|mirror neuron system
211552|NCT02871700|action observation|action observation
211553|NCT02871700|mirror therapy|mirror therapy
211554|NCT02871700|MEG|meg
211555|NCT02871674|Behavioural interventions|behavioural interventions
211556|NCT02871674|Sleep difficulties|sleep difficulties
211557|NCT02871674|Children|children
211558|NCT02871674|Attention Deficit Hyperactivity Disorder|attention deficit hyperactivity disorder
211559|NCT02871674|Randomised controlled trial|randomised controlled trial
211560|NCT02871674|Saudi Arabia|saudi arabia
211561|NCT02871674|Behavioural Insomnia|behavioural insomnia
211562|NCT02871661|vulvodynia|vulvodynia
211563|NCT02871661|pelvic floor muscles|pelvic floor muscles
211564|NCT02871661|kinesiotherapy|kinesiotherapy
211565|NCT02871661|electrical therapy|electrical therapy
211566|NCT02871661|physical therapy|physical therapy
211567|NCT02871661|amitriptyline|amitriptyline
211568|NCT02871661|female sexual dysfunction.|female sexual dysfunction.
211570|NCT02871609|Biofilm|biofilm
211571|NCT02871609|Morbidity|morbidity
211572|NCT02871609|Ureteral Catheterization|ureteral catheterization
211573|NCT02871570|Hepatic Impairment|hepatic impairment
211574|NCT02871570|Rivipansel|rivipansel
211575|NCT02871544|BNP|bnp
211576|NCT02871544|NGAL|ngal
211577|NCT02871544|Sepsis|sepsis
211578|NCT02871544|Mortality|mortality
211579|NCT02871531|retinal detachment|retinal detachment
211580|NCT02871531|pneumatic retinopexy|pneumatic retinopexy
211581|NCT02871531|vitrectomy|vitrectomy
211582|NCT02871479|Atopic Dermatitis|atopic dermatitis
211583|NCT02871479|Eczema|eczema
211584|NCT02871453|Ischemic Stroke|ischemic stroke
211585|NCT02871453|Motor Dysfunction|motor dysfunction
211586|NCT02871453|Scalp Acupuncture|scalp acupuncture
211587|NCT02871427|Lewy body dementia|lewy body dementia
211588|NCT02871427|Dementia with Lewy bodies|dementia with lewy bodies
211589|NCT02871427|Parkinson's disease dementia|parkinson's disease dementia
211590|NCT02871427|Visual hallucinations|visual hallucinations
211591|NCT02871427|REM sleep behavior disorder|rem sleep behavior disorder
211592|NCT02871401|IPF|ipf
211593|NCT02871401|Herpesvirus|herpesvirus
211594|NCT02871401|Valganciclovir|valganciclovir
211595|NCT02871388|Physical activity|physical activity
211596|NCT02871388|Diet|diet
211597|NCT02871388|Nutrition|nutrition
211598|NCT02871388|Breast cancer prevention|breast cancer prevention
211599|NCT02871388|Mammography screening|mammography screening
211600|NCT02871375|myopia|myopia
211601|NCT02871375|presbyopia|presbyopia
211602|NCT02871349|Autism|autism
211603|NCT02871349|ASD|asd
211604|NCT02871336|Cata collection|cata collection
211605|NCT02871336|Pancreatic cancer surgery|pancreatic cancer surgery
211606|NCT02871323|Myelofibrosis Transformation in Essential Thrombocythemia|myelofibrosis transformation in essential thrombocythemia
211607|NCT02871297|adolescent|adolescent
211608|NCT02871297|children|children
211609|NCT02871284|cancer|cancer
211610|NCT02871284|anticancer treatment|anticancer treatment
211611|NCT02871284|exercise|exercise
211612|NCT02871284|physical activity|physical activity
211613|NCT02871284|sensorimotor training|sensorimotor training
211614|NCT02871284|chemotherapy-induced polyneuropathy|chemotherapy-induced polyneuropathy
211615|NCT02871245|Acupuncture Therapy|acupuncture therapy
211616|NCT02871245|Laparoscopic Surgery|laparoscopic surgery
211617|NCT02871245|Gastrointestinal Tract Recovery of Function|gastrointestinal tract recovery of function
211618|NCT02871193|paravertebral block|paravertebral block
211619|NCT02871193|patient controlled analgesia|patient controlled analgesia
211620|NCT02871193|ropivacaine|ropivacaine
211621|NCT02871193|dexamethasone|dexamethasone
211622|NCT02871180|Hypoglycemia|hypoglycemia
211623|NCT02871180|Type 1 diabetes|type 1 diabetes
211624|NCT02871167|oocyte/embryo cryopreservation|oocyte/embryo cryopreservation
211625|NCT02871128|Hemoglobin|hemoglobin
211626|NCT02871128|serum iron|serum iron
211627|NCT02871128|serum ferritin|serum ferritin
211628|NCT02871128|Hematocrit|hematocrit
211629|NCT02871128|antioxidant|antioxidant
211630|NCT02871115|Cancer Care|cancer care
211631|NCT02871102|mechanical ventilation|mechanical ventilation
211632|NCT02871102|respiratory mechanics|respiratory mechanics
211633|NCT02871102|acute respiratory distress syndrome|acute respiratory distress syndrome
211634|NCT02871102|positive end-expiratory pressure|positive end-expiratory pressure
211635|NCT02871102|tidal volume|tidal volume
211636|NCT02871089|Type 1 Diabetes|type 1 diabetes
211637|NCT02871089|Closed-loop glucose control|closed-loop glucose control
211638|NCT02871089|Artificial Pancreas|artificial pancreas
211639|NCT02871089|Continuous subcutaneous insulin infusion|continuous subcutaneous insulin infusion
211640|NCT02871089|Multiple daily injection therapy|multiple daily injection therapy
211641|NCT02871089|New onset type 1 diabetes|new onset type 1 diabetes
211642|NCT02871089|Residual C-Peptide secretion|residual c-peptide secretion
211643|NCT02871089|Beta-cell function preservation|beta-cell function preservation
211644|NCT02871089|Continuous glucose monitoring|continuous glucose monitoring
211645|NCT02871050|Biobank|biobank
211646|NCT02871050|biorepository|biorepository
211647|NCT02871050|Castlebank|castlebank
211648|NCT02871050|Castleman Disease|castleman disease
211649|NCT02871050|CD|cd
211650|NCT02871050|MCD|mcd
211651|NCT02871050|iMCD|imcd
211652|NCT02871050|Castleman|castleman
211653|NCT02871050|Castleman's Disease|castleman's disease
211654|NCT02871050|multicentric Castleman's disease|multicentric castleman's disease
211655|NCT02871050|multicentric Castleman disease|multicentric castleman disease
211656|NCT02871050|Angiofollicular Lymph Hyperplasia|angiofollicular lymph hyperplasia
211657|NCT02871024|Polymyxin B|polymyxin b
211658|NCT02871024|Pneumonia|pneumonia
211659|NCT02871024|Sepsis|sepsis
211660|NCT02871024|Urinary tract infection|urinary tract infection
211661|NCT02871011|Tinea Bronchodilator Agents|tinea bronchodilator agents
211662|NCT02871011|Tinea Pedis|tinea pedis
211663|NCT02871011|Nitric Oxide|nitric oxide
211664|NCT02871011|Dermatomycoses|dermatomycoses
211791|NCT02870101|Genital Diseases, Male|genital diseases, male
211665|NCT02871011|Endothelium-Dependent Relaxing Factors|endothelium-dependent relaxing factors
211666|NCT02871011|Infectious|infectious
211667|NCT02871011|Infection|infection
211668|NCT02871011|Mycoses|mycoses
211669|NCT02871011|Skin Diseases|skin diseases
211670|NCT02871011|Foot Dermatoses|foot dermatoses
211671|NCT02871011|Foot Diseases|foot diseases
211672|NCT02871011|Pruritus|pruritus
211673|NCT02871011|Skin Manifestations Signs and Symptoms|skin manifestations signs and symptoms
211674|NCT02870946|Extracorporeal Membrane Oxygenation|extracorporeal membrane oxygenation
211675|NCT02870946|Cardiogenic Shock|cardiogenic shock
211676|NCT02870946|Renal Replacement Therapy|renal replacement therapy
211677|NCT02870933|CD 133+|cd 133+
211678|NCT02870933|Transepicardial with Transseptal Implantation|transepicardial with transseptal implantation
211679|NCT02870933|CABG|cabg
211680|NCT02870907|primary enucleation|primary enucleation
211681|NCT02870907|retinoblastoma|retinoblastoma
211682|NCT02870868|slow breathing|slow breathing
211683|NCT02870868|yoga|yoga
211684|NCT02870868|mind-body practicers|mind-body practicers
211685|NCT02870842|ultrasonography|ultrasonography
211686|NCT02870842|child|child
211687|NCT02870842|perioperative period|perioperative period
211688|NCT02870842|general anesthesia|general anesthesia
211689|NCT02870842|lung|lung
211691|NCT02870777|Acute myeloid leukemia|acute myeloid leukemia
718015|NCT00556088|Bevacizumab|bevacizumab
211692|NCT02870764|Danshenduofensuanyan|danshenduofensuanyan
211693|NCT02870764|Lp-PLA2|lp-pla2
211694|NCT02870764|coronary artery disease|coronary artery disease
211695|NCT02870764|Salvia miltiorrhiza|salvia miltiorrhiza
211696|NCT02870751|ETEC|etec
211697|NCT02870751|human challenge study|human challenge study
211698|NCT02870751|heat stable toxin|heat stable toxin
211699|NCT02870751|tourist diarrhea|tourist diarrhea
211700|NCT02870751|diarrhea|diarrhea
211701|NCT02870751|enterotoxigenic|enterotoxigenic
211702|NCT02870725|chronic headaches, migraines, depression|chronic headaches, migraines, depression
211703|NCT02870712|perineal tear of first degree|perineal tear of first degree
211704|NCT02870712|suture|suture
211705|NCT02870699|chemotherapy neoadjuvant|chemotherapy neoadjuvant
211706|NCT02870686|ERCP|ercp
211707|NCT02870686|EUS guided ERCP without fluoroscopy|eus guided ercp without fluoroscopy
211708|NCT02870673|acupuncture|acupuncture
211709|NCT02870673|electrical stimulation|electrical stimulation
211710|NCT02870673|carpal tunnel syndrome|carpal tunnel syndrome
211711|NCT02870608|Elastography|elastography
211712|NCT02870556|cervical epidural, laryngectomy, pharyngocutaneous fistula|cervical epidural, laryngectomy, pharyngocutaneous fistula
211713|NCT02870543|Bruxism|bruxism
211714|NCT02870543|Sleep bruxism|sleep bruxism
211715|NCT02870543|Sleep related bruxism|sleep related bruxism
211716|NCT02870543|Homeopathy|homeopathy
211717|NCT02870504|laser peripheral iridoplasty|laser peripheral iridoplasty
211718|NCT02870504|treatment|treatment
211719|NCT02870491|Child Diarrhea|child diarrhea
211720|NCT02870491|Cluster Randomized Controlled Trial|cluster randomized controlled trial
211721|NCT02870491|Oral Rehydration|oral rehydration
211722|NCT02870491|ORS|ors
211723|NCT02870491|Zinc|zinc
211724|NCT02870491|Brac|brac
211725|NCT02870491|Community Health Workers|community health workers
211726|NCT02870491|Uganda|uganda
211727|NCT02870465|outpatient versus operating room|outpatient versus operating room
211728|NCT02870465|k wire infection|k wire infection
211729|NCT02870465|closed reduction internal fixation|closed reduction internal fixation
211730|NCT02870452|Haemophilia|haemophilia
211731|NCT02870452|RCT|rct
211732|NCT02870452|Pain|pain
211733|NCT02870452|Hemarthrosis|hemarthrosis
211734|NCT02870452|Hypnosis|hypnosis
211735|NCT02870452|Cognitive-Behavioral Therapy|cognitive-behavioral therapy
211736|NCT02870452|Quality of Life|quality of life
211737|NCT02870452|Distress|distress
211738|NCT02870452|Cytokines|cytokines
211739|NCT02870426|Olfactory ensheathing cells|olfactory ensheathing cells
211740|NCT02870413|telehealth|telehealth
211741|NCT02870387|chronic illness|chronic illness
211742|NCT02870387|children|children
211743|NCT02870387|children with medical complexity|children with medical complexity
211744|NCT02870387|medical home|medical home
211745|NCT02870387|inpatient consultation|inpatient consultation
211746|NCT02870335|low back|low back
211747|NCT02870335|manual therapy|manual therapy
211748|NCT02870335|stretching|stretching
211749|NCT02870322|overweight|overweight
211750|NCT02870322|obesity|obesity
211751|NCT02870322|lifestyle prescription|lifestyle prescription
211752|NCT02870322|prevention|prevention
211753|NCT02870322|physical activity|physical activity
211754|NCT02870322|healthy eating|healthy eating
211755|NCT02870283|Cost effectiveness|cost effectiveness
211756|NCT02870283|Bipolar disorder|bipolar disorder
211757|NCT02870283|Mixed episodes|mixed episodes
211758|NCT02870283|Quality of life|quality of life
211759|NCT02870270|saliva|saliva
211760|NCT02870270|microflora|microflora
211761|NCT02870270|diet|diet
211762|NCT02870270|quality of life|quality of life
211763|NCT02870270|oral cancer|oral cancer
211764|NCT02870244|Melanoma|melanoma
211765|NCT02870244|Gene Therapy|gene therapy
211766|NCT02870244|Adoptive T-Cell Transfer|adoptive t-cell transfer
211767|NCT02870244|IL-2|il-2
211768|NCT02870192|Rectal Prolapse|rectal prolapse
211769|NCT02870179|Pulse Oximetry|pulse oximetry
211770|NCT02870179|Temperature|temperature
211771|NCT02870179|Respiratory Rate|respiratory rate
211772|NCT02870179|Respiratory Gases|respiratory gases
211773|NCT02870179|This study determines the measurement accuracy of the physiological parameters|this study determines the measurement accuracy of the physiological parameters
211774|NCT02870140|CAD|cad
211775|NCT02870140|ACS|acs
211776|NCT02870140|All comers|all comers
211777|NCT02870140|PCI|pci
211778|NCT02870114|Haemophilia|haemophilia
211779|NCT02870114|Quality of Life|quality of life
211780|NCT02870114|Distress|distress
211781|NCT02870114|Hemarthrosis|hemarthrosis
211782|NCT02870114|Pain|pain
211783|NCT02870101|Nucleic acid amplification tests|nucleic acid amplification tests
211784|NCT02870101|Neisseria gonorrhoeae infection|neisseria gonorrhoeae infection
211785|NCT02870101|Chlamydia trachomatis infection|chlamydia trachomatis infection
211786|NCT02870101|Sexually transmitted infection|sexually transmitted infection
211787|NCT02870101|Pharynx|pharynx
211788|NCT02870101|Rectum|rectum
211789|NCT02870101|Gram-Negative Bacterial Infections|gram-negative bacterial infections
211790|NCT02870101|Bacterial Infections|bacterial infections
211792|NCT02870101|Genital Diseases, Female|genital diseases, female
211793|NCT02870062|Chlorhexidine baths|chlorhexidine baths
211794|NCT02870062|Critical patient|critical patient
211795|NCT02870062|Healthcare associated infections|healthcare associated infections
211796|NCT02870062|Critical care environment|critical care environment
211797|NCT02870062|Patient colonization|patient colonization
211798|NCT02870049|early detection|early detection
211799|NCT02869971|Prostatic artery embolization|prostatic artery embolization
211800|NCT02869971|Combined Therapy|combined therapy
211801|NCT02869971|IPSS|ipss
211802|NCT02869958|Asthma|asthma
211803|NCT02869958|Exacerbation|exacerbation
211804|NCT02869958|Treatment|treatment
211805|NCT02869958|Internet|internet
211806|NCT02869958|Emergency care|emergency care
211807|NCT02869945|de novo untreated Parkinson Disease|de novo untreated parkinson disease
211808|NCT02869945|genetic|genetic
211809|NCT02869945|COMT Polymorphism|comt polymorphism
211810|NCT02869945|gene|gene
211811|NCT02869945|brain MRI|brain mri
211812|NCT02869945|brain MPET|brain mpet
211813|NCT02869841|laparotomy|laparotomy
211814|NCT02869841|pain|pain
211815|NCT02869841|rectus sheath block|rectus sheath block
211816|NCT02869815|Methylene blue|methylene blue
211817|NCT02869815|Indocyanine green|indocyanine green
211818|NCT02869815|Neoadjuvant Therapy|neoadjuvant therapy
211819|NCT02869815|Sentinel Lymph Node Biopsy|sentinel lymph node biopsy
211820|NCT02869815|Breast Neoplasms|breast neoplasms
211821|NCT02869802|Cancer|cancer
211822|NCT02869802|Pancreatic Cancer|pancreatic cancer
211823|NCT02869802|Advanced Pancreatic Ductal Adenocarcinoma|advanced pancreatic ductal adenocarcinoma
211824|NCT02869802|PDAC|pdac
211825|NCT02869802|Genomic Analysis|genomic analysis
211826|NCT02869802|Molecular subtyping|molecular subtyping
211827|NCT02869763|Ethanol|ethanol
211828|NCT02869763|Steroid profile|steroid profile
211829|NCT02869763|Pharmacokinetics|pharmacokinetics
211830|NCT02869737|Point of Care Device; post traumatic coagulopathy|point of care device; post traumatic coagulopathy
211831|NCT02869724|IMV : voluntary drug intoxications|imv : voluntary drug intoxications
211832|NCT02869724|Drug|drug
211833|NCT02869724|Divided prescription|divided prescription
211834|NCT02869672|safety|safety
211835|NCT02869672|immunogenicity|immunogenicity
211836|NCT02869672|vaccine|vaccine
211837|NCT02869659|obesity|obesity
211838|NCT02869659|pre-diabetes|pre-diabetes
211839|NCT02869659|overweight|overweight
211840|NCT02869659|lifestyle change|lifestyle change
211841|NCT02869659|glucose|glucose
211842|NCT02869646|PTSD|ptsd
211843|NCT02869646|acupuncture|acupuncture
211844|NCT02869646|integrative medicine|integrative medicine
211845|NCT02869464|Aneurysm|aneurysm
211846|NCT02869464|Intracranial Aneurysm|intracranial aneurysm
211847|NCT02869464|Abdominal Aortic Aneurysm|abdominal aortic aneurysm
211848|NCT02869438|Asthma, Bronchial Diseases, Respiratory Tract Diseases, Lung Diseases, Obstructive Lung Diseases|asthma, bronchial diseases, respiratory tract diseases, lung diseases, obstructive lung diseases
211849|NCT02869399|head and neck cancer, nutritional intervention|head and neck cancer, nutritional intervention
211850|NCT02869386|stroke|stroke
211851|NCT02869386|prehospital|prehospital
211852|NCT02869386|telemedicine|telemedicine
211853|NCT02869386|thrombolysis|thrombolysis
211854|NCT02869386|thrombectomy|thrombectomy
211855|NCT02869386|endovascular treatment|endovascular treatment
211856|NCT02869386|functional outcome|functional outcome
211857|NCT02869347|recombinant C1 esterase inhibitor|recombinant c1 esterase inhibitor
211858|NCT02869347|acute kidney injury|acute kidney injury
211859|NCT02869347|coronary angiography|coronary angiography
211860|NCT02869347|contrast media|contrast media
212154|NCT02867644|care|care
211861|NCT02869347|Conestat alfa|conestat alfa
211862|NCT02869347|inflammation|inflammation
211863|NCT02869308|Cardiomyopathy|cardiomyopathy
211864|NCT02869308|Chemotherapy|chemotherapy
211865|NCT02869308|Left ventricular ejection fraction|left ventricular ejection fraction
211866|NCT02869295|Metastatic Solid Tumors|metastatic solid tumors
211867|NCT02869295|Locally Advanced Solid Tumors|locally advanced solid tumors
211868|NCT02869256|chronic myeloid leukemia|chronic myeloid leukemia
211869|NCT02869256|practices evaluation|practices evaluation
211870|NCT02869243|A malignant growing astrocytoma of central nervous system|a malignant growing astrocytoma of central nervous system
211871|NCT02869230|Breast cancer|breast cancer
211872|NCT02869230|Non palpable breast lesions|non palpable breast lesions
211873|NCT02869230|radioguided occult lesion localization|radioguided occult lesion localization
211874|NCT02869217|NY-ESO-1 expressing solid tumors in HLA-A2 positive patients|ny-eso-1 expressing solid tumors in hla-a2 positive patients
211875|NCT02869165|Postmenopausal|postmenopausal
211876|NCT02869152|sentinel lymph node|sentinel lymph node
211877|NCT02869152|lymphatic mapping|lymphatic mapping
211878|NCT02869152|rectal tumor|rectal tumor
211879|NCT02869152|rectal cancer|rectal cancer
211880|NCT02869152|early stage|early stage
211881|NCT02869139|Thirst|thirst
211882|NCT02869139|Ice|ice
211883|NCT02869139|Menthol|menthol
211884|NCT02869139|Perioperative Nursing.|perioperative nursing.
211885|NCT02869139|Recovery Room|recovery room
211886|NCT02869126|99mTc-Sestamibi|99mtc-sestamibi
211887|NCT02869126|thallium-201|thallium-201
211888|NCT02869126|semiconductor camera|semiconductor camera
211889|NCT02869100|magnetic resonance imaging|magnetic resonance imaging
211890|NCT02869100|sodium fluoride positron emission tomography|sodium fluoride positron emission tomography
211891|NCT02869074|von Willebrand disease (VWD)|von willebrand disease (vwd)
211892|NCT02869074|von Willebrand factor (VWF)|von willebrand factor (vwf)
211893|NCT02869074|von Willebrand factor gene|von willebrand factor gene
211894|NCT02869074|next generation sequencing|next generation sequencing
211895|NCT02869074|diagnosis|diagnosis
211896|NCT02869074|VWD Spanish Cohort|vwd spanish cohort
211897|NCT02869061|Bladder neck obstruction|bladder neck obstruction
211898|NCT02869061|Bladder outlet obstruction|bladder outlet obstruction
211899|NCT02869061|Benign prostatic hyperplasia|benign prostatic hyperplasia
211900|NCT02869061|Urinary bladder neck obstruction|urinary bladder neck obstruction
211901|NCT02869061|Bladder neck contracture|bladder neck contracture
211902|NCT02869061|Bladder neck stricture|bladder neck stricture
211903|NCT02869061|Bladder neck stenosis|bladder neck stenosis
211904|NCT02869061|Transurethral resection of the prostate|transurethral resection of the prostate
211905|NCT02869061|Prostatectomy|prostatectomy
211906|NCT02869061|Stromal vascular fraction (SVF)|stromal vascular fraction (svf)
211907|NCT02869061|Adipose-derived regenerative cells (ADRC)|adipose-derived regenerative cells (adrc)
211908|NCT02869061|Adipose tissue|adipose tissue
211909|NCT02869061|Stem cells|stem cells
211910|NCT02869048|Biological Specimen Banks|biological specimen banks
211911|NCT02869048|Innate Immunity|innate immunity
211912|NCT02869048|Clinical Study|clinical study
211913|NCT02869048|Complement system proteins|complement system proteins
211914|NCT02869048|Amyotrophic lateral sclerosis|amyotrophic lateral sclerosis
211915|NCT02869048|Neurodegenerative disease|neurodegenerative disease
211916|NCT02869048|Motor neuron disease|motor neuron disease
211917|NCT02869035|PET|pet
211918|NCT02869035|Serotonin|serotonin
211919|NCT02869035|5-HT4R|5-ht4r
211920|NCT02869035|MRI|mri
211921|NCT02869035|fMRI|fmri
211922|NCT02869035|EEG|eeg
211923|NCT02869035|Cortisol awakening response|cortisol awakening response
211924|NCT02869035|Oxidative stress|oxidative stress
211925|NCT02869035|Mental health|mental health
211926|NCT02869035|Prediction of treatment response|prediction of treatment response
211927|NCT02869035|Inflammation|inflammation
211928|NCT02869035|5-HTTLPR|5-httlpr
211929|NCT02869035|Brain imaging|brain imaging
211930|NCT02869035|Early life stress|early life stress
211931|NCT02869035|Selective Serotonin Reuptake Inhibitor|selective serotonin reuptake inhibitor
211932|NCT02869035|Escitalopram|escitalopram
211933|NCT02869035|Psychometrics|psychometrics
211934|NCT02869035|Moderate depression|moderate depression
211935|NCT02869035|Severe depression|severe depression
211936|NCT02869035|ERP|erp
211937|NCT02869035|rsfMRI|rsfmri
211938|NCT02869035|11C-SB207145|11c-sb207145
211939|NCT02869035|Sexual function|sexual function
211940|NCT02869035|MDD|mdd
211941|NCT02869035|Affective cognition|affective cognition
211942|NCT02869035|Cold cognition|cold cognition
211943|NCT02869035|Social cognition|social cognition
211944|NCT02869035|Anxiety|anxiety
211945|NCT02869009|stroke|stroke
211946|NCT02869009|clopidogrel|clopidogrel
211947|NCT02869009|antiplatelets|antiplatelets
211948|NCT02868957|CAD|cad
211949|NCT02868957|Digital imaging|digital imaging
211950|NCT02868957|Prosthetic Dentistry|prosthetic dentistry
211951|NCT02868931|self-management|self-management
211952|NCT02868931|empowerment|empowerment
211953|NCT02868931|treatment and education program|treatment and education program
211954|NCT02868931|insulin pump|insulin pump
211955|NCT02868931|diabetes education|diabetes education
211956|NCT02868866|physical activity|physical activity
211957|NCT02868866|nutrition|nutrition
211958|NCT02868866|fruits and vegetables|fruits and vegetables
211959|NCT02868866|faith-based|faith-based
211960|NCT02868866|churches|churches
211962|NCT02868853|weight loss|weight loss
211963|NCT02868853|tracking|tracking
211964|NCT02868853|mobile|mobile
211965|NCT02868853|calories|calories
211966|NCT02868840|stroke|stroke
211967|NCT02868840|Tai ji|tai ji
211968|NCT02868840|postural balance|postural balance
211969|NCT02868840|cognition|cognition
211970|NCT02868827|cholecalciferol and critical illness|cholecalciferol and critical illness
211971|NCT02868827|Mortality and cholecalciferol supplementation|mortality and cholecalciferol supplementation
211972|NCT02868801|Pregabalin|pregabalin
211973|NCT02868788|inflammation|inflammation
211974|NCT02868788|insulin resistance|insulin resistance
211975|NCT02868788|type 2 diabetes|type 2 diabetes
211976|NCT02868788|obesity|obesity
211977|NCT02868762|neck pain, voice disorder|neck pain, voice disorder
211978|NCT02868749|Hyaluronic Acid|hyaluronic acid
211979|NCT02868749|histology|histology
211980|NCT02868749|ultrasound|ultrasound
211981|NCT02868749|subcutaneous|subcutaneous
211982|NCT02868749|adipose tissue|adipose tissue
271037|NCT02512237|ADC|adc
211983|NCT02868723|cerebrovascular disease|cerebrovascular disease
211984|NCT02868723|patient management|patient management
211985|NCT02868723|stroke management|stroke management
211986|NCT02868723|prognosis|prognosis
211987|NCT02868723|3D Carotid Doppler Imaging|3d carotid doppler imaging
211988|NCT02868723|Randomization|randomization
211989|NCT02868710|primary prevention|primary prevention
211990|NCT02868671|mild TBI|mild tbi
211991|NCT02868671|Post-traumatic Stress Disorders|post-traumatic stress disorders
211992|NCT02868671|Acupuncture|acupuncture
211993|NCT02868658|Influenza|influenza
211994|NCT02868658|health care workers|health care workers
211995|NCT02868658|nosocomial|nosocomial
211996|NCT02868658|asymptomatic|asymptomatic
211997|NCT02868658|France|france
211998|NCT02868632|Unresectable|unresectable
211999|NCT02868632|Locally Advanced|locally advanced
212000|NCT02868632|Non-Metastatic|non-metastatic
212001|NCT02868619|fMRI|fmri
212002|NCT02868619|Deep brain stimulation|deep brain stimulation
212003|NCT02868619|Food|food
212004|NCT02868619|Eating|eating
212005|NCT02868619|Reward|reward
212006|NCT02868580|ALS|als
212007|NCT02868580|Antiretroviral Therapy, Triumeq|antiretroviral therapy, triumeq
212008|NCT02868541|microorganisms|microorganisms
212009|NCT02868541|pilgrim|pilgrim
212010|NCT02868541|hajj|hajj
212011|NCT02868528|advanced age women|advanced age women
212012|NCT02868528|blastocyst culture|blastocyst culture
212013|NCT02868528|PGS|pgs
212014|NCT02868528|live birth rate|live birth rate
212015|NCT02868502|Glaucoma|glaucoma
212016|NCT02868502|Open Angle Glaucoma|open angle glaucoma
212017|NCT02868502|Intra Ocular Pressure|intra ocular pressure
212018|NCT02868502|Ocular Hypotensive Drops|ocular hypotensive drops
212019|NCT02868502|Trabeculectomy|trabeculectomy
212020|NCT02868502|Cyclophotocoagulation|cyclophotocoagulation
212021|NCT02868502|Glaucoma Drainage Device|glaucoma drainage device
212022|NCT02868489|Microbiota|microbiota
212023|NCT02868463|oxygen tension|oxygen tension
212024|NCT02868463|Female Urinary Microbiome|female urinary microbiome
212025|NCT02868463|Urinary Tract Symptoms|urinary tract symptoms
212026|NCT02868463|Urine Oxygen Level|urine oxygen level
212027|NCT02868398|Ulcerative Colitis|ulcerative colitis
212028|NCT02868398|Golimumab|golimumab
212029|NCT02868398|Deep and prolonged remission|deep and prolonged remission
212030|NCT02868385|Schistosomiasis|schistosomiasis
212031|NCT02868385|Schistosoma mansoni|schistosoma mansoni
212032|NCT02868385|Bilharzia|bilharzia
212033|NCT02868372|Cesarean section|cesarean section
212034|NCT02868372|Betadine|betadine
212035|NCT02868372|Wound infection|wound infection
212036|NCT02868320|SMS|sms
212037|NCT02868320|text messaging|text messaging
212038|NCT02868320|diabetes self management|diabetes self management
212039|NCT02868320|glycemic control|glycemic control
212040|NCT02868320|mHealth|mhealth
212041|NCT02868320|mobile health|mobile health
212042|NCT02868320|diabetes education|diabetes education
212043|NCT02868281|Cluster Randomization|cluster randomization
212044|NCT02868281|Peak Expiratory Flow|peak expiratory flow
212045|NCT02868281|Forced Expiratory Volume|forced expiratory volume
212046|NCT02868281|Standardized Asthma Quality of Life Questionnaire|standardized asthma quality of life questionnaire
212047|NCT02868281|Asthma Control Test|asthma control test
212048|NCT02868268|Neuroblastoma|neuroblastoma
212049|NCT02868255|Biobank analyses|biobank analyses
212050|NCT02868255|Effect evaluation of the drug|effect evaluation of the drug
212051|NCT02868255|patient-derived cells|patient-derived cells
212052|NCT02868255|SIRPα/CD47 expression|sirpα/cd47 expression
212053|NCT02868242|HCV genotype 1 or 4 (GT-1 or GT-4)|hcv genotype 1 or 4 (gt-1 or gt-4)
212054|NCT02868242|Direct Acting Antiviral|direct acting antiviral
212055|NCT02868242|Combination Therapy|combination therapy
212056|NCT02868242|Hepatitis C, Chronic|hepatitis c, chronic
212057|NCT02868242|Liver Diseases|liver diseases
212058|NCT02868242|Virus Diseases|virus diseases
212059|NCT02868177|Prevention|prevention
212060|NCT02868151|Oral mucositis, chemo radiotherapy, vitamin c,|oral mucositis, chemo radiotherapy, vitamin c,
212061|NCT02868138|Sickle cell disease|sickle cell disease
212062|NCT02868138|Hydroxyurea|hydroxyurea
212063|NCT02868138|Compliance|compliance
212064|NCT02868125|pertrochanteric|pertrochanteric
212065|NCT02868125|radiography|radiography
212066|NCT02868112|Cancer Care|cancer care
212067|NCT02868112|Palliative Care|palliative care
212068|NCT02868112|Geriatrics|geriatrics
212069|NCT02868112|Quality of Life|quality of life
212070|NCT02868086|Age-related macular degeneration|age-related macular degeneration
212071|NCT02868086|Optical coherence tomography angiography|optical coherence tomography angiography
212072|NCT02868047|chronic pancreatitis|chronic pancreatitis
212073|NCT02868047|endoscopic ultrasound|endoscopic ultrasound
212074|NCT02868034|Low Back Pain|low back pain
212075|NCT02868034|Spinal Manipulation|spinal manipulation
212076|NCT02868034|Exercise|exercise
212077|NCT02868021|Elderly|elderly
212078|NCT02868021|Exercise|exercise
212079|NCT02868008|multimodal imaging|multimodal imaging
212080|NCT02868008|surgical risk|surgical risk
212081|NCT02868008|arteriovenous malformations|arteriovenous malformations
212082|NCT02867995|glaucoma drop aid|glaucoma drop aid
212083|NCT02867982|platform switching|platform switching
212084|NCT02867982|crestal bone remodeling|crestal bone remodeling
212085|NCT02867982|soft tissue thickness|soft tissue thickness
212086|NCT02867982|dental implant|dental implant
212087|NCT02867969|Spinocerebellar ataxia|spinocerebellar ataxia
212088|NCT02867969|Exergaming|exergaming
212089|NCT02867969|Neurodegenerative diseases|neurodegenerative diseases
212090|NCT02867969|Rare disease|rare disease
212091|NCT02867969|Motor exercises|motor exercises
212092|NCT02867969|Premanifest stage|premanifest stage
212093|NCT02867969|Training|training
212094|NCT02867956|Ovarian cancer|ovarian cancer
212095|NCT02867956|Apatinib|apatinib
212096|NCT02867956|Etoposide|etoposide
212097|NCT02867956|Chemotherapy|chemotherapy
212098|NCT02867943|sepsis, shock,Lactate,volume controlled ventilation|sepsis, shock,lactate,volume controlled ventilation
212099|NCT02867930|Echocardiography|echocardiography
212100|NCT02867930|Transesophageal|transesophageal
212101|NCT02867930|Dexmedetomidine|dexmedetomidine
212102|NCT02867930|Ketamine|ketamine
212103|NCT02867930|Propofol|propofol
212104|NCT02867917|Fibers|fibers
212105|NCT02867917|Constipation|constipation
212106|NCT02867891|FLT3-ITD|flt3-itd
212107|NCT02867891|AML|aml
212108|NCT02867891|allo-HSCT|allo-hsct
212109|NCT02867839|Gastric cancer|gastric cancer
212110|NCT02867839|Adjuvant chemotherapy|adjuvant chemotherapy
212111|NCT02867839|S1|s1
212112|NCT02867839|Oxaliplatin|oxaliplatin
212113|NCT02867839|Survival|survival
212114|NCT02867826|Endoscopy|endoscopy
212115|NCT02867826|Ampulla of Vater|ampulla of vater
212116|NCT02867826|Duodenoscopy|duodenoscopy
212117|NCT02867813|High Cholesterol|high cholesterol
212118|NCT02867813|Treatment for high cholesterol|treatment for high cholesterol
212119|NCT02867813|Lowering cholesterol|lowering cholesterol
212120|NCT02867813|Lowering high cholesterol|lowering high cholesterol
212121|NCT02867813|Hypercholesterolemia|hypercholesterolemia
212122|NCT02867800|Sickle Cell Disease|sickle cell disease
212123|NCT02867800|Graft Versus Host Disease|graft versus host disease
212124|NCT02867800|Abatacept|abatacept
212125|NCT02867800|Hematopoietic Stem Cell Transplantation|hematopoietic stem cell transplantation
212126|NCT02867787|Shoulder Joint|shoulder joint
212127|NCT02867787|A02.835.583.748|a02.835.583.748
212128|NCT02867774|chronic pelvic pain|chronic pelvic pain
212129|NCT02867774|central pain amplification|central pain amplification
212130|NCT02867774|exercise|exercise
212131|NCT02867774|physical activity|physical activity
212132|NCT02867761|COPD|copd
212133|NCT02867761|Chronic Obstructive Pulmonary Disease|chronic obstructive pulmonary disease
212134|NCT02867761|Pulmonary Function Tests|pulmonary function tests
212135|NCT02867761|Current Smoker|current smoker
212136|NCT02867761|Former Smoker|former smoker
212137|NCT02867761|Chronic Obstructive Airway Disease|chronic obstructive airway disease
212138|NCT02867761|Respiratory Symptoms|respiratory symptoms
212139|NCT02867748|tvt abbrevo , Serasis|tvt abbrevo , serasis
212140|NCT02867735|Macular Edema|macular edema
212141|NCT02867735|Diabetic Macular Edema (DME)|diabetic macular edema (dme)
212142|NCT02867735|Neovascular age-related Macular Degeneration(AMD)|neovascular age-related macular degeneration(amd)
212143|NCT02867735|Retinal Vein Occlusions(RVO)|retinal vein occlusions(rvo)
212144|NCT02867696|Bariatric Surgery|bariatric surgery
212145|NCT02867696|Physical Activity|physical activity
212146|NCT02867696|Weight Management|weight management
212147|NCT02867696|Weight Loss|weight loss
212148|NCT02867683|vibrotactile feedback|vibrotactile feedback
212149|NCT02867683|vestibular rehabilitation|vestibular rehabilitation
212150|NCT02867683|balance|balance
212151|NCT02867670|Transcranial Magnetic Stimulation (TMS)|transcranial magnetic stimulation (tms)
212152|NCT02867644|conversational hypnosis|conversational hypnosis
212153|NCT02867644|imaging|imaging
212155|NCT02867644|breast neoplasia|breast neoplasia
212156|NCT02867644|anxiety|anxiety
212157|NCT02867644|pain|pain
212158|NCT02867631|Intervention study|intervention study
212159|NCT02867631|Maternal obesity|maternal obesity
212160|NCT02867631|Nutrition|nutrition
212161|NCT02867631|Maternal child health|maternal child health
212162|NCT02867514|tobacco|tobacco
212163|NCT02867514|craving|craving
212164|NCT02867514|tDCS|tdcs
212165|NCT02867514|attentional tasks|attentional tasks
212166|NCT02867501|venous distension|venous distension
212167|NCT02867501|venous reflux|venous reflux
212168|NCT02867488|carotenoids|carotenoids
212169|NCT02867488|phylloquinone|phylloquinone
212170|NCT02867488|tocopherols|tocopherols
212171|NCT02867488|vitamin A|vitamin a
212172|NCT02867384|Graft vs. Host Disease|graft vs. host disease
212173|NCT02867358|acute uncomplicated influenza|acute uncomplicated influenza
212174|NCT02867319|safety|safety
212175|NCT02867319|vaccine|vaccine
212176|NCT02867306|methotrexate (MTX)|methotrexate (mtx)
212177|NCT02867306|Pharmacokinetics|pharmacokinetics
212178|NCT02867306|ASP1707|asp1707
212179|NCT02867306|Rheumatoid Arthritis (RA)|rheumatoid arthritis (ra)
212180|NCT02867280|Sorafenib|sorafenib
212181|NCT02867280|Microvascular invasion|microvascular invasion
212182|NCT02867280|adjuvant therapy|adjuvant therapy
212183|NCT02867280|hepatocellular carcinoma|hepatocellular carcinoma
212184|NCT02867267|thymosin alpha 1; thymalfasin; sepsis; immunodepression|thymosin alpha 1; thymalfasin; sepsis; immunodepression
212185|NCT02867254|candida|candida
212186|NCT02867254|endodontic lesion|endodontic lesion
212187|NCT02867254|diabetes|diabetes
212188|NCT02867202|intrauterine balloon|intrauterine balloon
212189|NCT02867202|intrauterine contraceptive device|intrauterine contraceptive device
212190|NCT02867202|Asherman Syndrome|asherman syndrome
212191|NCT02867189|anterior chamber flare|anterior chamber flare
212192|NCT02867189|cataract|cataract
212193|NCT02867189|intraocular pressure|intraocular pressure
212194|NCT02867189|micro-instrument|micro-instrument
212195|NCT02867189|photograph-based atlas|photograph-based atlas
212196|NCT02867189|visual|visual
212197|NCT02867189|training nurse|training nurse
212198|NCT02867111|sperm selection|sperm selection
212199|NCT02867111|ICSI|icsi
212200|NCT02867111|Assisted Reproductive Techniques|assisted reproductive techniques
212201|NCT02867098|healthy|healthy
212202|NCT02867098|volunteer|volunteer
212204|NCT02867085|Myelodysplastic Syndromes|myelodysplastic syndromes
212205|NCT02867033|desmoid tumour|desmoid tumour
212206|NCT02867020|apalutamide|apalutamide
212207|NCT02867020|abiraterone|abiraterone
212208|NCT02867020|prostate cancer|prostate cancer
212209|NCT02867007|KW-0761|kw-0761
212210|NCT02867007|KHK2455|khk2455
212211|NCT02867007|Metastatic Solid Tumors|metastatic solid tumors
212212|NCT02867007|Locally Advanced Solid Tumors|locally advanced solid tumors
212213|NCT02867007|Mogamulizumab|mogamulizumab
212214|NCT02867007|Oncology|oncology
212215|NCT02867007|Anti-Tumor|anti-tumor
212216|NCT02866994|Women|women
212217|NCT02866981|Brain Metastases|brain metastases
212218|NCT02866955|aromatase inhibitors|aromatase inhibitors
212219|NCT02866955|Metastases|metastases
212220|NCT02866929|orthodontics|orthodontics
212221|NCT02866929|periodontics|periodontics
212222|NCT02866929|piezosurgery|piezosurgery
212223|NCT02866929|accelerated orthodontics|accelerated orthodontics
212224|NCT02866929|Surgically Accelerated Orthodontic Treatment|surgically accelerated orthodontic treatment
212225|NCT02866903|Peritoneal carcinosis|peritoneal carcinosis
212226|NCT02866903|intraperitoneal (IP) OXAliplatin|intraperitoneal (ip) oxaliplatin
212227|NCT02866903|Phase I/II dose escalation trial|phase i/ii dose escalation trial
212228|NCT02866903|FOLFIRI Bevacizumab chemotherapy|folfiri bevacizumab chemotherapy
212229|NCT02866890|Laryngeal Tube Suction|laryngeal tube suction
212230|NCT02866890|seal pressure|seal pressure
212231|NCT02866890|mechanical ventilation|mechanical ventilation
212232|NCT02866877|augmented renal clearance|augmented renal clearance
212233|NCT02866864|Allergen|allergen
212234|NCT02866864|Veterinary|veterinary
212235|NCT02866864|Allergy|allergy
212236|NCT02866864|Animals|animals
212237|NCT02866838|Tranexamic acid|tranexamic acid
212238|NCT02866838|NOAC|noac
212239|NCT02866838|Direct Oral Anticoagulant (DOAC)|direct oral anticoagulant (doac)
212240|NCT02866838|Direct oral anticoagulants|direct oral anticoagulants
212241|NCT02866838|Non-Vitamin K antagonist oral anticoagulants|non-vitamin k antagonist oral anticoagulants
212242|NCT02866825|Inflammation|inflammation
212243|NCT02866825|Systemic Inflammatory Response Syndrome|systemic inflammatory response syndrome
212244|NCT02866825|Pathologic Processes|pathologic processes
212245|NCT02866825|Organ Dysfunction|organ dysfunction
212246|NCT02866799|Multimorbidity|multimorbidity
212247|NCT02866799|Primary Health Care|primary health care
212248|NCT02866799|Polypharmacy|polypharmacy
212249|NCT02866799|Comorbidity|comorbidity
212250|NCT02866799|Medication Adherence|medication adherence
212251|NCT02866799|Medication Appropriateness Index|medication appropriateness index
212252|NCT02866799|Patient-Centered Care|patient-centered care
212253|NCT02866773|Family|family
212254|NCT02866773|well-being|well-being
212255|NCT02866773|Physical activity|physical activity
212256|NCT02866773|Diet|diet
212257|NCT02866760|Smoking Cessation|smoking cessation
212258|NCT02866734|Diabetic Retinopathy|diabetic retinopathy
212259|NCT02866734|Screening|screening
212260|NCT02866734|Fee for screening|fee for screening
212261|NCT02866734|Private practice|private practice
212262|NCT02866721|Human Mesenchymal Stem Cells|human mesenchymal stem cells
212263|NCT02866695|Actinic Keratosis|actinic keratosis
212264|NCT02866695|lung transplant|lung transplant
212265|NCT02866695|kidney transplant|kidney transplant
212266|NCT02866643|contraceptive implant|contraceptive implant
212267|NCT02866643|postpartum contraception|postpartum contraception
212268|NCT02866643|breastfeeding and contraception|breastfeeding and contraception
212269|NCT02866630|Sevoflurane|sevoflurane
212270|NCT02866630|Desflurane|desflurane
212271|NCT02866630|Coronary Sinus|coronary sinus
212272|NCT02866630|Oxygenator Exhaust|oxygenator exhaust
212273|NCT02866630|Lactate|lactate
718122|NCT00555698|Depression|depression
212274|NCT02866630|Cardiopulmonary bypass|cardiopulmonary bypass
212275|NCT02866617|Quality of Life|quality of life
212276|NCT02866617|Vacuum formed thermoplastic retainer|vacuum formed thermoplastic retainer
212277|NCT02866617|Orthodontic study model|orthodontic study model
212278|NCT02866617|3D reconstructed study model|3d reconstructed study model
212279|NCT02866604|Traumatic brain injury|traumatic brain injury
212280|NCT02866604|isotonic balanced fluid|isotonic balanced fluid
212281|NCT02866591|mammography|mammography
212282|NCT02866591|pain|pain
212283|NCT02866591|quality of life|quality of life
212284|NCT02866591|screening|screening
212285|NCT02866591|image quality|image quality
212286|NCT02866591|radiology|radiology
212287|NCT02866526|adolescents|adolescents
212288|NCT02866526|young adults|young adults
212289|NCT02866448|Cardiovascular disease|cardiovascular disease
212290|NCT02866448|Flavonoid|flavonoid
212291|NCT02866448|Isoquercetin|isoquercetin
212292|NCT02866448|Aspirin|aspirin
212293|NCT02866448|Platelet function|platelet function
212294|NCT02866448|Vascular function|vascular function
212295|NCT02866448|Blood pressure|blood pressure
212296|NCT02866435|MRI|mri
212297|NCT02866422|OCD|ocd
212298|NCT02866409|dexmedetomidine|dexmedetomidine
212299|NCT02866409|nerve block|nerve block
212300|NCT02866409|anesthesia infiltration|anesthesia infiltration
212301|NCT02866396|chronic pain|chronic pain
212302|NCT02866396|oxycodone|oxycodone
212303|NCT02866396|pregabalin|pregabalin
212304|NCT02866396|lumbar spine surgery|lumbar spine surgery
212305|NCT02866396|multimodal analgesia|multimodal analgesia
212306|NCT02866344|Microwave ablation|microwave ablation
212307|NCT02866344|Ablation techniques|ablation techniques
212308|NCT02866344|Operative surgical procedures|operative surgical procedures
212309|NCT02866344|Hepatic resection|hepatic resection
212310|NCT02866344|Surgery|surgery
212311|NCT02866344|Outcomes assessment|outcomes assessment
212312|NCT02866305|primary spontaneous pneumothorax|primary spontaneous pneumothorax
212313|NCT02866305|epidemiology|epidemiology
212314|NCT02866305|genetics|genetics
212315|NCT02866305|risk factors|risk factors
212316|NCT02866292|Pelvic Floor|pelvic floor
212317|NCT02866292|Pregnancy|pregnancy
212318|NCT02866292|Physical Therapy Specialty|physical therapy specialty
212319|NCT02866253|Dehydroepiandrosterone（DHEA）|dehydroepiandrosterone（dhea）
212320|NCT02866253|DOR（Diminished Ovarian Reserve)|dor（diminished ovarian reserve)
212321|NCT02866253|IVF(In vitro fertilization)|ivf(in vitro fertilization)
212322|NCT02866253|BMP-15(Bone Morphogenetic Protein 15)|bmp-15(bone morphogenetic protein 15)
212323|NCT02866227|Bacterial|bacterial
212324|NCT02866227|Candidiasis|candidiasis
212325|NCT02866227|Gel|gel
212326|NCT02866227|Insert|insert
212327|NCT02866227|TOL-463|tol-463
212328|NCT02866227|Vaginal|vaginal
212329|NCT02866227|Vaginitis|vaginitis
212330|NCT02866227|Vaginoses|vaginoses
212331|NCT02866227|Vulvovaginal|vulvovaginal
212332|NCT02866201|Turista|turista
212333|NCT02866175|percutaneous intervention|percutaneous intervention
212334|NCT02866175|vitamin K antagonist|vitamin k antagonist
212335|NCT02866149|Cancer|cancer
212336|NCT02866149|circulating tumor biomarkers|circulating tumor biomarkers
212337|NCT02866149|circulating tumor DNA|circulating tumor dna
212338|NCT02866149|Circulating tumor Cell (CTC)|circulating tumor cell (ctc)
212339|NCT02866097|integrated community case management|integrated community case management
212340|NCT02866097|Mobile Health (mHealth)|mobile health (mhealth)
212341|NCT02866097|rapid diagnostic test|rapid diagnostic test
212342|NCT02866097|artemether-lumefantrine|artemether-lumefantrine
212343|NCT02866097|amoxicillin|amoxicillin
212344|NCT02866097|zinc|zinc
212345|NCT02866097|oral rehydration solution (ORS)|oral rehydration solution (ors)
212346|NCT02866097|District Health Information System 2 (DHIS2)|district health information system 2 (dhis2)
212347|NCT02866097|iCCM-DHIS2|iccm-dhis2
212348|NCT02866097|ZCAHRD|zcahrd
212349|NCT02866084|vestibular migraines|vestibular migraines
212350|NCT02866084|dizziness|dizziness
212351|NCT02866084|migraine headache|migraine headache
212352|NCT02866045|Subepithelial lesions|subepithelial lesions
212353|NCT02866045|Endoscopic Ultrasound-Guided Fine Needle Aspiration|endoscopic ultrasound-guided fine needle aspiration
212354|NCT02866006|HPV|hpv
212355|NCT02866006|Type 16, 18|type 16, 18
212356|NCT02866006|E6E7|e6e7
212357|NCT02866006|Immune therapeutic vaccine|immune therapeutic vaccine
212358|NCT02865993|cesarean section|cesarean section
212359|NCT02865993|cesarean section complications|cesarean section complications
212360|NCT02865993|betadine irrigation|betadine irrigation
212361|NCT02865980|inflammation, infection|inflammation, infection
212362|NCT02865967|Decision Support Techniques|decision support techniques
212363|NCT02865967|Delayed Diagnosis|delayed diagnosis
212364|NCT02865967|Natural Language Processing|natural language processing
212365|NCT02865967|Geographic Information Systems|geographic information systems
212366|NCT02865941|Target Fortification|target fortification
212367|NCT02865941|Breast milk analysis|breast milk analysis
212368|NCT02865941|Nutrition|nutrition
212369|NCT02865941|Macronutrient intake|macronutrient intake
271559|NCT02509156|AIC|aic
212370|NCT02865941|Protein accretion|protein accretion
212371|NCT02865915|Acne|acne
212372|NCT02865915|Hirsutism|hirsutism
212373|NCT02865915|Menstrual Irregularity|menstrual irregularity
212374|NCT02865915|Alopecia|alopecia
212375|NCT02865902|Low level laser therapy|low level laser therapy
212376|NCT02865902|wound healing|wound healing
212377|NCT02865902|periodontology|periodontology
212378|NCT02865889|laparoscopic surgery|laparoscopic surgery
212379|NCT02865889|Uterine Neoplasms|uterine neoplasms
212380|NCT02865876|Infectious keratitis|infectious keratitis
212381|NCT02865876|Cross-linking|cross-linking
212382|NCT02865863|Multivitamin|multivitamin
212383|NCT02865863|Eurycomalongifoliawater extract|eurycomalongifoliawater extract
212384|NCT02865863|Quality of Life|quality of life
212385|NCT02865863|Mood|mood
212386|NCT02865850|vadadustat|vadadustat
212387|NCT02865850|AKB-6548|akb-6548
212388|NCT02865850|anemia|anemia
212389|NCT02865850|chronic kidney disease|chronic kidney disease
212390|NCT02865850|CKD|ckd
212391|NCT02865850|chronic renal insufficiency|chronic renal insufficiency
212392|NCT02865850|renal impairment|renal impairment
212393|NCT02865850|erythropoietin|erythropoietin
212394|NCT02865850|kidney|kidney
212395|NCT02865850|renal|renal
212396|NCT02865850|oral anemia treatment|oral anemia treatment
212397|NCT02865850|hemoglobin|hemoglobin
212398|NCT02865850|hypoxia-inducible factor|hypoxia-inducible factor
212399|NCT02865850|HIF|hif
212400|NCT02865850|efficacy|efficacy
212401|NCT02865850|safety|safety
212402|NCT02865850|phase 3|phase 3
212403|NCT02865850|cardiovascular|cardiovascular
212404|NCT02865837|Brachytherapy|brachytherapy
212405|NCT02865837|Organs at Risk|organs at risk
212406|NCT02865837|Bladder volume|bladder volume
212407|NCT02865837|Cervical cancer|cervical cancer
212408|NCT02865824|Colonoscopy|colonoscopy
212409|NCT02865811|Ovarian Cancer|ovarian cancer
212410|NCT02865798|Heart Valve Diseases|heart valve diseases
212411|NCT02865798|Cardiovascular Diseases|cardiovascular diseases
212412|NCT02865798|Heart Disease|heart disease
212413|NCT02865798|Valvular Heart Diseases|valvular heart diseases
212414|NCT02865785|recurrent implantation failure|recurrent implantation failure
212415|NCT02865785|intralipid|intralipid
212416|NCT02865785|uterine natural killer cells|uterine natural killer cells
212417|NCT02865746|Steroids|steroids
212418|NCT02865746|Pain measurement|pain measurement
212419|NCT02865733|Remodulin®|remodulin®
212420|NCT02865733|pulmonary vascular resistance|pulmonary vascular resistance
212421|NCT02865733|univentricular physiology|univentricular physiology
212422|NCT02865707|ulcerative colitis|ulcerative colitis
212423|NCT02865707|prebiotics|prebiotics
212424|NCT02865707|b-fructans|b-fructans
212425|NCT02865707|inulin|inulin
212426|NCT02865707|oligofructose|oligofructose
212427|NCT02865707|intestinal microbiota|intestinal microbiota
212428|NCT02865681|Infertility|infertility
212429|NCT02865681|Gonadotropins|gonadotropins
212430|NCT02865681|Menopur|menopur
212431|NCT02865681|Ovarian stimulation|ovarian stimulation
212432|NCT02865642|Stroke|stroke
212433|NCT02865642|Serotonin|serotonin
212434|NCT02865642|Hand Paresis|hand paresis
212435|NCT02865616|CDI|cdi
212436|NCT02865616|recurrent infection|recurrent infection
212437|NCT02865616|MET-2|met-2
212438|NCT02865616|C. difficile|c. difficile
212439|NCT02865590|Maxillary Sinus/surgery|maxillary sinus/surgery
212440|NCT02865590|Bone Substitutes|bone substitutes
212441|NCT02865590|Radiography, Panoramic|radiography, panoramic
212442|NCT02865564|Probiotics|probiotics
212443|NCT02865564|Anti-Bacterial Agents|anti-bacterial agents
212444|NCT02865564|Infant, Newborn|infant, newborn
212445|NCT02865564|Gastrointestinal Microbiome|gastrointestinal microbiome
212446|NCT02865564|Colic|colic
212447|NCT02865564|Gastrointestinal Diseases|gastrointestinal diseases
212448|NCT02865564|Body Composition|body composition
212449|NCT02865564|Bone Density|bone density
212450|NCT02865564|Randomized Controlled Trial|randomized controlled trial
212451|NCT02865564|Lactobacillus reuteri|lactobacillus reuteri
212452|NCT02865564|Pediatrics|pediatrics
212453|NCT02865564|Feces|feces
212454|NCT02865564|ultrasonography|ultrasonography
212455|NCT02865564|High-Throughput Nucleotide Sequencing|high-throughput nucleotide sequencing
212456|NCT02865564|Electric Impedance|electric impedance
212457|NCT02865564|Surveys and Questionnaires|surveys and questionnaires
212458|NCT02865538|Hot flashes|hot flashes
212459|NCT02865538|Post-menopausal|post-menopausal
212460|NCT02865525|Surveys and Questionnaires|surveys and questionnaires
212461|NCT02865525|Patient Education as Topic|patient education as topic
212462|NCT02865525|Medication Adherence|medication adherence
212463|NCT02865525|Pulmonary Disease, Chronic Obstructive|pulmonary disease, chronic obstructive
212464|NCT02865525|Diabetes Mellitus, Type 2|diabetes mellitus, type 2
212465|NCT02865525|Heart failure|heart failure
212466|NCT02865512|thoracic epidural injection|thoracic epidural injection
212467|NCT02865512|patient position|patient position
212468|NCT02865486|Gastric emptying|gastric emptying
212469|NCT02865486|MRI|mri
212470|NCT02865486|lipid emulsions|lipid emulsions
212471|NCT02865486|breath test|breath test
212472|NCT02865486|GI peptide hormones|gi peptide hormones
212473|NCT02865473|Schlemm's canal lumen area|schlemm's canal lumen area
212474|NCT02865473|PEX|pex
212475|NCT02865460|Chronic Pain|chronic pain
212476|NCT02865460|Cognitive Disorders|cognitive disorders
212477|NCT02865460|Inflammation|inflammation
212478|NCT02865460|Neurologic manifestations|neurologic manifestations
212479|NCT02865460|Dementia|dementia
212480|NCT02865460|Mental Disorders|mental disorders
212481|NCT02865460|Ubiquinol/ubiquinone|ubiquinol/ubiquinone
212482|NCT02865460|Pathologic Processes|pathologic processes
212483|NCT02865460|Nervous System Diseases|nervous system diseases
212484|NCT02865460|Hormones, Hormone Substitutes, and Hormone Antagon|hormones, hormone substitutes, and hormone antagon
212485|NCT02865460|Anti-Inflammatory Agents|anti-inflammatory agents
212486|NCT02865460|Pharmacologic Actions|pharmacologic actions
212487|NCT02865460|Therapeutic Uses|therapeutic uses
212488|NCT02865460|Physiological Effects of Drugs|physiological effects of drugs
212489|NCT02865460|Gulf war illness|gulf war illness
212490|NCT02865460|Chronic fatigue|chronic fatigue
212491|NCT02865447|dual energy x-ray absorptiometry|dual energy x-ray absorptiometry
212492|NCT02865447|DEXA|dexa
212493|NCT02865447|DXA|dxa
212494|NCT02865447|total hip arthroplasty|total hip arthroplasty
212495|NCT02865447|PROFEMUR|profemur
212496|NCT02865447|PRESERVE|preserve
212497|NCT02865447|bone mineral density|bone mineral density
212498|NCT02865447|BMD|bmd
212499|NCT02865447|osteoarthritis|osteoarthritis
212500|NCT02865447|THA|tha
212501|NCT02865447|musculoskeletal disease|musculoskeletal disease
212502|NCT02865408|Amino acids|amino acids
212503|NCT02865408|critically-ill|critically-ill
212504|NCT02865408|catabolic|catabolic
212505|NCT02865408|nutrition|nutrition
212506|NCT02865408|anabolic|anabolic
212507|NCT02865395|Belladonna and Opium Suppositories|belladonna and opium suppositories
212508|NCT02865382|Adenoma detection rate|adenoma detection rate
212509|NCT02865382|Optical Enhancement Technonogy|optical enhancement technonogy
212510|NCT02865382|Colonoscopy|colonoscopy
212511|NCT02865369|chronic hepatitis C|chronic hepatitis c
212512|NCT02865369|Daclatasvir|daclatasvir
212513|NCT02865369|Asunaprevir|asunaprevir
212514|NCT02865369|fibrosis|fibrosis
212515|NCT02865369|transient elastography|transient elastography
212516|NCT02865356|atopic dermatitis|atopic dermatitis
212517|NCT02865356|eczema|eczema
212518|NCT02865356|children|children
212519|NCT02865356|skin|skin
212520|NCT02865356|topical|topical
212521|NCT02865356|cyclosporine|cyclosporine
212522|NCT02865343|Functional Electrical Stimulation (FES)-Rowing|functional electrical stimulation (fes)-rowing
212523|NCT02865330|Intermediate Risk Prostate Cancer|intermediate risk prostate cancer
212524|NCT02865330|Low Risk Prostate Cancer|low risk prostate cancer
212525|NCT02865330|Active Surveillance|active surveillance
212526|NCT02865304|metastatic breast cancer|metastatic breast cancer
212527|NCT02865304|HER-2-negative|her-2-negative
212528|NCT02865304|endostar|endostar
212529|NCT02865252|manual therapy|manual therapy
212530|NCT02865252|mobilization with movement|mobilization with movement
212531|NCT02865239|Imaging, Three-Dimensional|imaging, three-dimensional
212532|NCT02865239|Magnetic Resonance Imaging/methods*|magnetic resonance imaging/methods*
212533|NCT02865239|Breast Neoplasms/diagnosis*|breast neoplasms/diagnosis*
212534|NCT02865239|Prone Position|prone position
212535|NCT02865239|Prospective Studies|prospective studies
212536|NCT02865226|thoracic surgery|thoracic surgery
212537|NCT02865226|thoracotomy|thoracotomy
212538|NCT02865213|Open bite|open bite
212539|NCT02865213|Molar intrusion|molar intrusion
212540|NCT02865213|Temporary anchorage devices|temporary anchorage devices
212541|NCT02865200|Nutrition|nutrition
212542|NCT02865200|Public Health|public health
212543|NCT02865187|Vitamin D|vitamin d
212544|NCT02865187|polycystic ovary syndrome|polycystic ovary syndrome
212545|NCT02865187|polycystic ovarian syndrome|polycystic ovarian syndrome
212546|NCT02865187|PCOS|pcos
212547|NCT02865187|sexual dysfunction|sexual dysfunction
212548|NCT02865187|female sexual dysfunction|female sexual dysfunction
212549|NCT02865187|low libido|low libido
212550|NCT02865174|Thrombin-gelatin matrix|thrombin-gelatin matrix
212551|NCT02865174|Floseal|floseal
212552|NCT02865174|Tranexamic Acid|tranexamic acid
212553|NCT02865174|Total Knee Arthroplasty|total knee arthroplasty
212554|NCT02865135|HPV Related Head and Neck|hpv related head and neck
212555|NCT02865135|Cervical|cervical
212556|NCT02865135|Anal Cancer|anal cancer
212557|NCT02865109|Spinal Muscular Atrophy|spinal muscular atrophy
212558|NCT02865109|SMA|sma
212559|NCT02865109|SMN|smn
212560|NCT02865109|SMNRx|smnrx
212561|NCT02865109|ISIS-SMNRx|isis-smnrx
212562|NCT02865109|ISIS-SMN Rx|isis-smn rx
212563|NCT02865109|ISIS 396443|isis 396443
212564|NCT02865109|ISIS-396443|isis-396443
212565|NCT02865109|ENDEAR|endear
212566|NCT02865109|IONIS-SMNRx|ionis-smnrx
212567|NCT02865109|IONIS-SMN Rx|ionis-smn rx
212568|NCT02865109|EMBRACE|embrace
212569|NCT02865109|NURTURE|nurture
212570|NCT02865109|IONIS|ionis
212571|NCT02865109|BIOGEN|biogen
212572|NCT02865109|SHINE|shine
212573|NCT02865109|Nusinersen|nusinersen
212574|NCT02865070|premature|premature
212575|NCT02865070|wireless vitals|wireless vitals
212576|NCT02865070|vitals monitor|vitals monitor
212577|NCT02865044|Fatty Acids|fatty acids
212578|NCT02865044|Fish Oil|fish oil
212579|NCT02865044|Marine Copepod|marine copepod
212580|NCT02865044|Fatty Acid Absorption|fatty acid absorption
212581|NCT02865018|Neuromyelitis Optica|neuromyelitis optica
212582|NCT02865018|Cetirizine|cetirizine
212583|NCT02864992|lung|lung
212584|NCT02864992|neoplasm|neoplasm
212585|NCT02864992|cancer|cancer
212586|NCT02864992|tumor|tumor
212587|NCT02864992|adenocarcinoma|adenocarcinoma
212588|NCT02864992|MET exon 14|met exon 14
212589|NCT02864992|METex14|metex14
212590|NCT02864992|pulmonary|pulmonary
212591|NCT02864992|stage III|stage iii
212592|NCT02864992|stage IV|stage iv
212593|NCT02864992|c-Met|c-met
212594|NCT02864992|cMET|cmet
212595|NCT02864992|NSCLC|nsclc
212596|NCT02864992|advanced non-small cell lung cancer|advanced non-small cell lung cancer
212597|NCT02864992|MET amplification|met amplification
212598|NCT02864966|Safety study|safety study
212599|NCT02864966|new product|new product
212600|NCT02864966|normal healthy skin.|normal healthy skin.
212601|NCT02864953|Stroke|stroke
212602|NCT02864953|Infarction|infarction
212603|NCT02864953|Cerebrovascular Disorders|cerebrovascular disorders
212604|NCT02864953|Brain Diseases|brain diseases
212605|NCT02864953|Brain Edema Ischemia|brain edema ischemia
212606|NCT02864953|Pathological Processes Necrosis|pathological processes necrosis
212607|NCT02864953|Central Nervous System Diseases|central nervous system diseases
212608|NCT02864953|Vascular Diseases|vascular diseases
212609|NCT02864953|Cardiovascular Diseases|cardiovascular diseases
212610|NCT02864953|Glyburide|glyburide
212611|NCT02864953|Hypoglycemic Agents|hypoglycemic agents
212612|NCT02864953|Physiological Effects of Drugs|physiological effects of drugs
212613|NCT02864940|Memory|memory
212614|NCT02864940|aneurysm|aneurysm
212615|NCT02864940|deficits|deficits
212616|NCT02864940|trouble|trouble
212617|NCT02864940|forgetful|forgetful
212618|NCT02864940|ruptured|ruptured
212619|NCT02864940|subarachnoid|subarachnoid
212620|NCT02864940|hemorrhage|hemorrhage
212621|NCT02864927|Meningitis|meningitis
212622|NCT02864927|Meningococcal Meningitis|meningococcal meningitis
212623|NCT02864927|Meningococcal Infections|meningococcal infections
212624|NCT02864927|Menactra®|menactra®
212625|NCT02864927|Meningococcal Vaccine|meningococcal vaccine
212626|NCT02864888|Diffuse, intrinsic brain stem glioma|diffuse, intrinsic brain stem glioma
212627|NCT02864888|QT/QTc interval|qt/qtc interval
212628|NCT02864888|Radiation|radiation
212629|NCT02864888|Antineoplaston therapy|antineoplaston therapy
212630|NCT02864875|Trauma|trauma
212631|NCT02864875|Coagulopathy|coagulopathy
212632|NCT02864875|Fibrinogen|fibrinogen
212633|NCT02864875|Fibrinogen Concentrate|fibrinogen concentrate
212634|NCT02864875|Thromboelastometry|thromboelastometry
212635|NCT02864875|Hypofibrinogenemia|hypofibrinogenemia
212636|NCT02864875|Early Fibrinogen Replacement|early fibrinogen replacement
212637|NCT02864849|Rectal cancer|rectal cancer
212638|NCT02864849|neoadjuvant|neoadjuvant
212639|NCT02864849|radiotherapy|radiotherapy
212640|NCT02864849|chemotherapy|chemotherapy
212641|NCT02864849|toxicity|toxicity
212642|NCT02864836|Copper|copper
212643|NCT02864836|isotopic distribution|isotopic distribution
212644|NCT02864836|cancer|cancer
212645|NCT02864823|Scleromalacia perforans|scleromalacia perforans
212646|NCT02864823|Necrotizing Scleritis|necrotizing scleritis
212647|NCT02864823|Perichondrium|perichondrium
212648|NCT02864797|Health related quality of life|health related quality of life
212649|NCT02864797|patient reported outcomes|patient reported outcomes
212650|NCT02864797|cohort|cohort
212651|NCT02864797|e-health|e-health
212652|NCT02864771|Ventricular Arrhythmias|ventricular arrhythmias
212653|NCT02864771|ICD|icd
212654|NCT02864771|Biological markers|biological markers
212655|NCT02864745|early rehabilitation|early rehabilitation
212656|NCT02864745|critically ill|critically ill
212657|NCT02864745|muscle weakness|muscle weakness
212658|NCT02864745|neuromuscular stimulation|neuromuscular stimulation
212659|NCT02864745|functional electrical stimulation-assisted cycle ergometry|functional electrical stimulation-assisted cycle ergometry
212660|NCT02864745|ICUAW|icuaw
212661|NCT02864732|Low back pain|low back pain
212662|NCT02864732|stabilization exercises|stabilization exercises
212663|NCT02864732|neuromuscular electrical stimulation|neuromuscular electrical stimulation
212664|NCT02864719|Heart arrest|heart arrest
212665|NCT02864719|Cardiac arrest|cardiac arrest
212666|NCT02864719|Fatigue|fatigue
212667|NCT02864706|allograft rejection|allograft rejection
212668|NCT02864706|xenograft rejection|xenograft rejection
212669|NCT02864706|host vs graft disease|host vs graft disease
212670|NCT02864706|transplant|transplant
718225|NCT00555347|Fatigue|fatigue
212671|NCT02864693|Microprocessor Controlled Ankle|microprocessor controlled ankle
212672|NCT02864693|Transtibial Amputee|transtibial amputee
212673|NCT02864693|Pacifica LP|pacifica lp
212674|NCT02864693|Kinnex|kinnex
212675|NCT02864680|cannabis|cannabis
212676|NCT02864680|magnocellular pathway|magnocellular pathway
212677|NCT02864654|Critical lower limb ischemia|critical lower limb ischemia
212678|NCT02864654|Atherosclerosis obliterans|atherosclerosis obliterans
212679|NCT02864654|Diabetic angiopathies|diabetic angiopathies
212680|NCT02864654|Thromboangiitis obliterans|thromboangiitis obliterans
212681|NCT02864654|Ischemic ulcers|ischemic ulcers
212682|NCT02864654|Peripheral arterial disease|peripheral arterial disease
212683|NCT02864654|Indirect revascularisation|indirect revascularisation
212684|NCT02864654|Intramuscular injection|intramuscular injection
212685|NCT02864654|Ankle-brachial index|ankle-brachial index
212686|NCT02864654|Transcutaneous oxygen tension|transcutaneous oxygen tension
212687|NCT02864654|Stromal vascular fraction (SVF)|stromal vascular fraction (svf)
212688|NCT02864654|Adipose-derived regenerative cells (ADRC)|adipose-derived regenerative cells (adrc)
212689|NCT02864654|Adipose tissue|adipose tissue
212690|NCT02864654|Stem cells|stem cells
212691|NCT02864641|chronic kidney disease|chronic kidney disease
212692|NCT02864641|adolescents|adolescents
212693|NCT02864641|renal disease|renal disease
212694|NCT02864641|CKD|ckd
212695|NCT02864628|RSV Vaccines|rsv vaccines
212696|NCT02864628|Respiratory Syncytial Virus Vaccines|respiratory syncytial virus vaccines
212697|NCT02864615|renal cell carcinoma|renal cell carcinoma
212698|NCT02864615|metastasis|metastasis
212699|NCT02864615|stereotactic body radiation therapy|stereotactic body radiation therapy
212700|NCT02864615|targted therapy|targted therapy
212701|NCT02864615|immune checkpoint inhibitors|immune checkpoint inhibitors
212702|NCT02864602|Regional anesthesia|regional anesthesia
212703|NCT02864602|Adjuvant|adjuvant
212704|NCT02864602|Dexamethasone|dexamethasone
212705|NCT02864589|Tourette, Tic, Tics|tourette, tic, tics
212706|NCT02864550|Men who have sex with men|men who have sex with men
212707|NCT02864550|Human immunodeficiency virus|human immunodeficiency virus
212708|NCT02864550|Doxycycline|doxycycline
212709|NCT02864550|Tetracycline|tetracycline
212710|NCT02864537|warfarin|warfarin
212711|NCT02864537|self-management|self-management
212712|NCT02864537|Conventional management|conventional management
212713|NCT02864537|Training|training
212714|NCT02864537|TTR|ttr
212715|NCT02864537|Complications|complications
212716|NCT02864537|Quality of life|quality of life
212717|NCT02864524|Physical Therapy Modalities|physical therapy modalities
212718|NCT02864524|Exercises|exercises
212719|NCT02864524|Musculoskeletal Manipulations|musculoskeletal manipulations
212720|NCT02864485|Live donor liver transplantation|live donor liver transplantation
212721|NCT02864459|Ultrasonography|ultrasonography
212722|NCT02864459|Weaning|weaning
212723|NCT02864433|cholera|cholera
212724|NCT02864433|oral cholera vaccine|oral cholera vaccine
212725|NCT02864433|diarrhea|diarrhea
212726|NCT02864420|home hospital|home hospital
212727|NCT02864420|acute care home|acute care home
212728|NCT02864420|care redesign|care redesign
212729|NCT02864420|delivery innovation|delivery innovation
212730|NCT02864420|heart failure|heart failure
212731|NCT02864420|pneumonia|pneumonia
212732|NCT02864420|cellulitis|cellulitis
212733|NCT02864420|urinary tract infections|urinary tract infections
212734|NCT02864368|PERFORMANCE|performance
212735|NCT02864368|Pro00034208|pro00034208
212736|NCT02864368|Cytomegalovirus|cytomegalovirus
212737|NCT02864368|Ashley|ashley
212738|NCT02864342|chronic obstructive pulmonary disease|chronic obstructive pulmonary disease
212739|NCT02864342|COPD|copd
212740|NCT02864342|Respiratory|respiratory
212741|NCT02864342|adherence|adherence
212742|NCT02864342|medication reminders|medication reminders
212743|NCT02864329|Male Infertility|male infertility
212744|NCT02864329|micro RNAs|micro rnas
212745|NCT02864329|small interfering RNAs|small interfering rnas
212746|NCT02864329|miRNA|mirna
212747|NCT02864329|siRNA|sirna
212748|NCT02864316|radiation-induced solid tumors|radiation-induced solid tumors
212749|NCT02864316|Nivolumab|nivolumab
212750|NCT02864316|Phase 2 study|phase 2 study
212751|NCT02864303|Alzheimer's disease|alzheimer's disease
212752|NCT02864303|Mild Cognitive Impairment|mild cognitive impairment
212753|NCT02864303|Saliva|saliva
212754|NCT02864303|Amyloid peptides|amyloid peptides
212755|NCT02864303|Diagnosis|diagnosis
212756|NCT02864290|AML|aml
212757|NCT02864290|Pharmacokinetics of ASP1235 (AGS62P1)|pharmacokinetics of asp1235 (ags62p1)
212758|NCT02864290|ASP1235|asp1235
212759|NCT02864290|Acute Myeloid Leukemia|acute myeloid leukemia
212760|NCT02864290|ASP1235 (AGS62P1)|asp1235 (ags62p1)
212761|NCT02864277|Gynecology|gynecology
212762|NCT02864277|Cancer|cancer
212763|NCT02864277|General Surgery|general surgery
212764|NCT02864277|Recovery Quality|recovery quality
212765|NCT02864277|Length of hospital stay|length of hospital stay
212766|NCT02864238|electronic milestone pathway|electronic milestone pathway
212767|NCT02864238|cardiac valve surgery|cardiac valve surgery
212768|NCT02864186|Pain|pain
212769|NCT02864186|Quality of life|quality of life
212770|NCT02864186|wound healing|wound healing
212771|NCT02864173|Postoperative cognitive dysfunction|postoperative cognitive dysfunction
212772|NCT02864173|Postoperative cognitive decline|postoperative cognitive decline
212773|NCT02864173|Postoperative delirium|postoperative delirium
212774|NCT02864173|Cognitive outcome|cognitive outcome
212775|NCT02864173|Neuropsychology|neuropsychology
212776|NCT02864173|Genetics|genetics
212777|NCT02864160|Language Concordance|language concordance
212778|NCT02864160|Diabetes Self-Management|diabetes self-management
212779|NCT02864160|Health Coaching|health coaching
212780|NCT02864160|Latinos|latinos
212781|NCT02864134|Optic neuritis|optic neuritis
212782|NCT02864134|ganglion cell layer|ganglion cell layer
212783|NCT02864121|High-risk human papillomavirus|high-risk human papillomavirus
212784|NCT02864121|Integration of HR-HPV DNA|integration of hr-hpv dna
212785|NCT02864121|biomarker of severity|biomarker of severity
212786|NCT02864121|biomarker of evolution|biomarker of evolution
212787|NCT02864095|Arthroplasty, Replacement, Hip|arthroplasty, replacement, hip
212788|NCT02864095|Epinephrine|epinephrine
212789|NCT02864095|Tranexamic acid|tranexamic acid
212790|NCT02864082|X-linked, lamellar|x-linked, lamellar
212791|NCT02864043|Barrett's Esophagus|barrett's esophagus
212792|NCT02864043|Barrett's|barrett's
212793|NCT02864043|OCT|oct
212794|NCT02864043|VLE|vle
212795|NCT02864030|Eribulin mesylate|eribulin mesylate
212796|NCT02864030|Halaven|halaven
212797|NCT02864030|Polymorphisms|polymorphisms
212798|NCT02864030|Tolerability|tolerability
212799|NCT02864004|Parkinson disease|parkinson disease
212800|NCT02864004|Quality of Life|quality of life
212801|NCT02864004|Apomorphine infusion|apomorphine infusion
212802|NCT02863978|Sepsis|sepsis
212803|NCT02863978|Neonates|neonates
212804|NCT02863978|Cardio-respiratory maturation|cardio-respiratory maturation
212805|NCT02863978|Neurobehavioral maturation|neurobehavioral maturation
212806|NCT02863926|BKA|bka
212807|NCT02863926|amputation|amputation
212808|NCT02863926|MarrowStim|marrowstim
212809|NCT02863926|below knee amputation|below knee amputation
212810|NCT02863926|wound complication|wound complication
212811|NCT02863926|vascular disease|vascular disease
212812|NCT02863926|critical limb ischemia|critical limb ischemia
212813|NCT02863926|peripheral artery disease|peripheral artery disease
212814|NCT02863926|AKA|aka
212815|NCT02863926|stem cells|stem cells
212816|NCT02863926|bone marrow|bone marrow
212817|NCT02863887|Weight Loss|weight loss
212818|NCT02863887|African American|african american
212819|NCT02863887|Community Based|community based
212820|NCT02863887|Mobile technology|mobile technology
212821|NCT02863887|Translational science|translational science
212822|NCT02863874|Perineal tear|perineal tear
212823|NCT02863874|Labor|labor
212824|NCT02863874|Triclosan|triclosan
212825|NCT02863861|Sedation|sedation
212826|NCT02863861|Pediatric Patients|pediatric patients
212827|NCT02863822|Functional Dyspepsia|functional dyspepsia
212828|NCT02863822|Low FODMAP|low fodmap
212829|NCT02863822|Dietary Modification|dietary modification
212830|NCT02863809|Keratolysis|keratolysis
212831|NCT02863809|Corneal Melting|corneal melting
212832|NCT02863809|Boston KPro|boston kpro
212833|NCT02863809|Keratoprosthesis|keratoprosthesis
212834|NCT02863770|endosonography|endosonography
212835|NCT02863744|mmp-8|mmp-8
212836|NCT02863744|early stages of wound healing|early stages of wound healing
212837|NCT02863744|wound healing marker|wound healing marker
212838|NCT02863731|postural changes|postural changes
212839|NCT02863731|alternating postures|alternating postures
212840|NCT02863731|Cognitive performance|cognitive performance
212841|NCT02863731|Height-adjustable desk|height-adjustable desk
212842|NCT02863731|Worksite|worksite
212843|NCT02863718|CLL|cll
212844|NCT02863692|CLL|cll
212845|NCT02863692|B-PLL|b-pll
212846|NCT02863692|T-PLL|t-pll
212847|NCT02863692|SLL|sll
212848|NCT02863692|T-NK-LGL|t-nk-lgl
212849|NCT02863692|HCL|hcl
212850|NCT02863692|Richter´s Transformation|richter´s transformation
212851|NCT02863679|tetracaine hydrochloride gel|tetracaine hydrochloride gel
212852|NCT02863679|analgesia|analgesia
212853|NCT02863679|intrauterine balloon|intrauterine balloon
212854|NCT02863679|hysteroscope operation|hysteroscope operation
212855|NCT02863666|Cariopulmonary, cardiac arrest|cariopulmonary, cardiac arrest
212856|NCT02863653|social participation|social participation
212857|NCT02863653|International Classification of Functioning|international classification of functioning
212858|NCT02863640|Senile macular degeneration|senile macular degeneration
212859|NCT02863640|Parkinson's disease|parkinson's disease
212860|NCT02863627|Emergencies|emergencies
212861|NCT02863627|newborn|newborn
212862|NCT02863627|care|care
212863|NCT02863601|Buprenorphine|buprenorphine
212864|NCT02863601|Opiate Substitution Treatment|opiate substitution treatment
212865|NCT02863575|third molar extraction|third molar extraction
212866|NCT02863575|ibuprofen|ibuprofen
212867|NCT02863575|ibuprofen/caffeine|ibuprofen/caffeine
719424|NCT00550342|Proteinuria|proteinuria
212868|NCT02863575|post-surgical dental pain|post-surgical dental pain
212869|NCT02863536|Recurrence of Bacterial Vaginosis|recurrence of bacterial vaginosis
212870|NCT02863510|Carbon dioxide angiography|carbon dioxide angiography
212871|NCT02863510|Renal sympathetic denervation|renal sympathetic denervation
212872|NCT02863510|Uncontrolled hypertension|uncontrolled hypertension
212873|NCT02863510|Chronic kidney disease|chronic kidney disease
212874|NCT02863471|Pancreas|pancreas
212875|NCT02863471|Adenocarcinoma|adenocarcinoma
212876|NCT02863471|Hyperthermic intraperitoneal chemotherapy|hyperthermic intraperitoneal chemotherapy
212877|NCT02863471|HIPEC|hipec
212878|NCT02863471|Pancreatic surgery|pancreatic surgery
212879|NCT02863471|Gemcitabine|gemcitabine
212880|NCT02863458|MDS|mds
212881|NCT02863458|AML|aml
212882|NCT02863458|hypomethylating agents (HMA)|hypomethylating agents (hma)
212883|NCT02863458|Surveillance Epidemiology and End Results (SEER)|surveillance epidemiology and end results (seer)
212884|NCT02863445|Obesity|obesity
212885|NCT02863445|Body weight|body weight
212886|NCT02863445|Emergency contraception|emergency contraception
212887|NCT02863445|Levonogestrel|levonogestrel
212888|NCT02863445|Ulipristal acetate|ulipristal acetate
212889|NCT02863406|Dust rate|dust rate
212890|NCT02863406|Microscopic analysis|microscopic analysis
212891|NCT02863380|Individualized Medicine|individualized medicine
212892|NCT02863380|Transcranial Magnetic Stimulation, Repetitive|transcranial magnetic stimulation, repetitive
212893|NCT02863380|Transcranial Direct Current Stimulation Monocentric|transcranial direct current stimulation monocentric
212894|NCT02863380|Compariative Cross-Over 3 Arms Study Randomized, Single-Blind Method|compariative cross-over 3 arms study randomized, single-blind method
212895|NCT02863380|Functional Neuroimaging|functional neuroimaging
212896|NCT02863302|Acute Myeloid Leukemia, Reflexology|acute myeloid leukemia, reflexology
212897|NCT02863263|foam dressing|foam dressing
212898|NCT02863263|MedifoamⓇ|medifoamⓡ
212899|NCT02863263|BetafoamⓇ|betafoamⓡ
212900|NCT02863263|povidone iodine|povidone iodine
212901|NCT02863237|brain injury|brain injury
212902|NCT02863237|mechanical ventilation|mechanical ventilation
212903|NCT02863237|weaning|weaning
212904|NCT02863198|unexplained infertility|unexplained infertility
212905|NCT02863198|endometrial injury|endometrial injury
212906|NCT02863198|pregnancy|pregnancy
212907|NCT02863185|chronic kidney disease|chronic kidney disease
212908|NCT02863185|pitavastatin|pitavastatin
212909|NCT02863185|erythrocyte membrane fatty acid|erythrocyte membrane fatty acid
212910|NCT02863172|Hereditary colorectal cancer syndrome|hereditary colorectal cancer syndrome
212911|NCT02863172|Questionnaires|questionnaires
212912|NCT02863172|Surveys|surveys
212913|NCT02863172|Blood sample|blood sample
212914|NCT02863172|Saliva sample|saliva sample
212915|NCT02863146|locally advanced breast cancer|locally advanced breast cancer
212916|NCT02863146|alopecia|alopecia
212917|NCT02863146|eribulin|eribulin
212918|NCT02863120|Bupivacaine|bupivacaine
212919|NCT02863120|Osteoarthritis|osteoarthritis
212920|NCT02863120|Arthritis|arthritis
212921|NCT02863120|Joint Diseases|joint diseases
212922|NCT02863120|Ropivacaine|ropivacaine
212923|NCT02863120|Anesthetics, Local|anesthetics, local
212924|NCT02863120|Anesthetics|anesthetics
212925|NCT02863107|Colon Cancer|colon cancer
212926|NCT02863107|Rectal Cancer|rectal cancer
212927|NCT02863107|Questionnaires|questionnaires
212928|NCT02863107|Surveys|surveys
212929|NCT02863107|Blood draw|blood draw
212930|NCT02863094|schizophrenia|schizophrenia
212931|NCT02863094|auditory hallucinations|auditory hallucinations
212932|NCT02863094|functional magnetic resonance imaging|functional magnetic resonance imaging
212933|NCT02863094|transcranial magnetic stimulation|transcranial magnetic stimulation
212934|NCT02863068|Sickle cell disease|sickle cell disease
212935|NCT02863068|sodium nitrite|sodium nitrite
212936|NCT02863068|wound healing|wound healing
212937|NCT02863068|Ulcer|ulcer
212938|NCT02863055|MPM|mpm
212939|NCT02863055|Unresectable|unresectable
212940|NCT02863055|Phase II|phase ii
212941|NCT02863055|Randomized|randomized
212942|NCT02863055|Maintenance|maintenance
212943|NCT02863029|Intestinal stem cells|intestinal stem cells
212944|NCT02863016|dialysis|dialysis
212945|NCT02863016|hemodiafiltration|hemodiafiltration
212946|NCT02862990|Breast cancer|breast cancer
212947|NCT02862990|Fertility|fertility
212948|NCT02862964|back pain|back pain
212949|NCT02862951|pregnancy|pregnancy
212950|NCT02862925|fetal monitoring|fetal monitoring
212951|NCT02862925|cesarean delivery|cesarean delivery
212952|NCT02862925|obstetrics|obstetrics
212953|NCT02862925|midwifery|midwifery
212954|NCT02862925|developing countries|developing countries
212955|NCT02862912|Chloroprocaine|chloroprocaine
212956|NCT02862912|cervical cerclage|cervical cerclage
212957|NCT02862912|spinal anesthesia|spinal anesthesia
212958|NCT02862912|Bupivacaine|bupivacaine
212959|NCT02862873|Spinal anaesthesia|spinal anaesthesia
212960|NCT02862821|biomarkers of psychiatric disorder|biomarkers of psychiatric disorder
212961|NCT02862821|gambling addiction|gambling addiction
212962|NCT02862821|high resolution-ElectroEncephaloGraphy (HR-EEG)|high resolution-electroencephalography (hr-eeg)
212963|NCT02862808|Whole exome sequencing|whole exome sequencing
212964|NCT02862808|Molecular diagnostic|molecular diagnostic
212965|NCT02862808|Genetic counselling|genetic counselling
212966|NCT02862795|colonoscopy|colonoscopy
212967|NCT02862730|diabetes|diabetes
212968|NCT02862730|closed-loop|closed-loop
212969|NCT02862730|dual hormone|dual hormone
212970|NCT02862730|exercise|exercise
212971|NCT02862717|Cost effectiveness|cost effectiveness
212972|NCT02862717|cost utility|cost utility
212973|NCT02862717|ESRD|esrd
212974|NCT02862717|hemodialysis|hemodialysis
212975|NCT02862717|ICER|icer
212976|NCT02862717|Markov model|markov model
212977|NCT02862717|peritoneal dialysis|peritoneal dialysis
212978|NCT02862691|toothache|toothache
212979|NCT02862626|Diabetic children|diabetic children
212980|NCT02862626|Mothers|mothers
212981|NCT02862613|Precision Cells|precision cells
212982|NCT02862613|Transcatheter Arterial Chemoembolization|transcatheter arterial chemoembolization
212983|NCT02862613|Advanced Liver Cancer|advanced liver cancer
212984|NCT02862600|hypertrophic cardiomyopathy|hypertrophic cardiomyopathy
212985|NCT02862600|heart failure|heart failure
212986|NCT02862600|cardiopulmonary exercise testing|cardiopulmonary exercise testing
212987|NCT02862600|6 minute walk test|6 minute walk test
212988|NCT02862600|perhexiline|perhexiline
212989|NCT02862600|carnitine palmitoyltransferase|carnitine palmitoyltransferase
212990|NCT02862600|mixed ion channel effects|mixed ion channel effects
212991|NCT02862600|late sodium current inhibitor|late sodium current inhibitor
212992|NCT02862600|calcium channel inhibition|calcium channel inhibition
212993|NCT02862587|Precision Cells|precision cells
212994|NCT02862587|Chemotherapy|chemotherapy
212995|NCT02862587|Advanced Lung Cancer|advanced lung cancer
212996|NCT02862574|Rheumatoid Arthritis|rheumatoid arthritis
212997|NCT02862574|Tumor Necrosis Factor Inhibitor|tumor necrosis factor inhibitor
212998|NCT02862574|TNF-IR|tnf-ir
212999|NCT02862574|Methotrexate|methotrexate
213000|NCT02862561|Precision Cell Immunotherapy|precision cell immunotherapy
213001|NCT02862561|Chemotherapy|chemotherapy
213002|NCT02862561|Advanced Malignancies|advanced malignancies
213003|NCT02862522|uric acid|uric acid
213004|NCT02862522|microvascular dysfunction|microvascular dysfunction
213005|NCT02862522|inflammation|inflammation
213006|NCT02862509|Post-frontal sinus operation chronic rhinosinusitis patients|post-frontal sinus operation chronic rhinosinusitis patients
213007|NCT02862509|Budesonide nasal instillation|budesonide nasal instillation
213008|NCT02862509|Vertex to floor position|vertex to floor position
213009|NCT02862496|Hyperemesis Gravidarum|hyperemesis gravidarum
213010|NCT02862496|Bone Health|bone health
213011|NCT02862496|Urine N-telopeptide|urine n-telopeptide
213012|NCT02862496|Serum calcium|serum calcium
213013|NCT02862496|Serum parathormone|serum parathormone
213014|NCT02862496|Serum vit D|serum vit d
213015|NCT02862470|Lovastatin|lovastatin
213016|NCT02862470|Vildagliptin|vildagliptin
213017|NCT02862470|Exosome|exosome
213018|NCT02862470|Anaplastic thyroid cancer|anaplastic thyroid cancer
213019|NCT02862470|Proteomics|proteomics
213020|NCT02862470|Urine|urine
213021|NCT02862470|Biological marker|biological marker
213022|NCT02862457|Advanced Solid Tumors|advanced solid tumors
213023|NCT02862457|PD-1|pd-1
213024|NCT02862457|PD1|pd1
213025|NCT02862457|Programmed Cell Death-1|programmed cell death-1
213026|NCT02862457|Programmed Cell Death 1|programmed cell death 1
213027|NCT02862457|Programmed Cell Death-Ligand 1 (PD-L1)|programmed cell death-ligand 1 (pd-l1)
213028|NCT02862457|Programmed Cell Death-Ligand 2 (PD-L2)|programmed cell death-ligand 2 (pd-l2)
213029|NCT02862457|PDL1|pdl1
213030|NCT02862457|PDL2|pdl2
213031|NCT02862418|MRI|mri
213032|NCT02862418|UTE MRI|ute mri
213033|NCT02862418|Pulmonary|pulmonary
213034|NCT02862405|Vision loss|vision loss
213035|NCT02862405|Object recognition|object recognition
213036|NCT02862405|Space recognition|space recognition
213037|NCT02862392|Scoliosis|scoliosis
213038|NCT02862392|Adolescent|adolescent
213039|NCT02862392|Idiopathic scoliosis|idiopathic scoliosis
213040|NCT02862392|Predictive factors|predictive factors
213041|NCT02862366|myeloproliferative neoplasms|myeloproliferative neoplasms
213042|NCT02862366|Circulating Procoagulants Microparticles|circulating procoagulants microparticles
213043|NCT02862353|Validation new test|validation new test
213044|NCT02862327|anaesthetic techniques|anaesthetic techniques
213045|NCT02862327|regional anesthesia|regional anesthesia
213046|NCT02862327|brachial plexus block|brachial plexus block
213047|NCT02862327|Local Anesthetic|local anesthetic
213048|NCT02862327|ropivacaine|ropivacaine
213049|NCT02862327|analgesia|analgesia
213050|NCT02862327|steroid|steroid
213051|NCT02862327|dexamethasone|dexamethasone
213052|NCT02862327|placebo|placebo
213053|NCT02862327|adjuvant|adjuvant
213054|NCT02862327|ultrasound guided|ultrasound guided
213055|NCT02862314|Procalcitonin|procalcitonin
213056|NCT02862301|Histone Deacetylases|histone deacetylases
213057|NCT02862301|Histone Acetyltransferases|histone acetyltransferases
213058|NCT02862223|Coagulation|coagulation
213059|NCT02862223|Circulatory Function|circulatory function
213060|NCT02862223|Blood Pressure|blood pressure
213061|NCT02862223|Inflammatory response|inflammatory response
213062|NCT02862223|Blood Glucose|blood glucose
213063|NCT02862223|Healthy vascular function|healthy vascular function
213064|NCT02862210|Lithium|lithium
213065|NCT02862210|Lithium Carbonate|lithium carbonate
213066|NCT02862145|Biosy accessible melanoma|biosy accessible melanoma
213067|NCT02862132|VDZ: Vedolizumab|vdz: vedolizumab
213068|NCT02862132|UC: Ulcerative colitis|uc: ulcerative colitis
213069|NCT02862132|CD: Crohn's disease|cd: crohn's disease
213070|NCT02862132|TDM: Therapeutic drug monitoring|tdm: therapeutic drug monitoring
213071|NCT02862119|percutaneous coronary intervention|percutaneous coronary intervention
213072|NCT02862119|fractional flow reserve|fractional flow reserve
213073|NCT02862119|all cause mortality|all cause mortality
213074|NCT02862119|myocardial infarction|myocardial infarction
213075|NCT02862119|registry-based randomized clinical trial|registry-based randomized clinical trial
213076|NCT02862106|Chronic Hepatitis B|chronic hepatitis b
213077|NCT02862106|HBeAg positive|hbeag positive
213078|NCT02862106|Therapeutic HBV Vaccine|therapeutic hbv vaccine
213079|NCT02862106|HBV-specific Cytotoxic T Lymphocyte|hbv-specific cytotoxic t lymphocyte
213080|NCT02862067|SGLT2|sglt2
213081|NCT02862067|type 2 diabetes mellitus|type 2 diabetes mellitus
213082|NCT02862067|systolic heart failure|systolic heart failure
213083|NCT02862067|heart failure with reduced ejection fraction|heart failure with reduced ejection fraction
213084|NCT02862054|haemophagocytic lymphohistiocytosis|haemophagocytic lymphohistiocytosis
213085|NCT02862054|splenectomy|splenectomy
213086|NCT02862054|unknown etiology|unknown etiology
213087|NCT02862028|PD-1 antibody|pd-1 antibody
213088|NCT02862028|CAR-T cells|car-t cells
213089|NCT02862028|EGFR family|egfr family
213090|NCT02862028|advanced solid tumor|advanced solid tumor
213091|NCT02862002|opioid therapy|opioid therapy
213092|NCT02862002|medical oncology.|medical oncology.
213093|NCT02861989|osteoporosis|osteoporosis
213094|NCT02861989|prevention|prevention
213095|NCT02861989|care management|care management
213096|NCT02861989|focus groups|focus groups
213097|NCT02861963|Femoral Allogenic Vein Valve Conduit|femoral allogenic vein valve conduit
213098|NCT02861963|Rehabilitation of native pulmonary arteries|rehabilitation of native pulmonary arteries
213099|NCT02861950|hypospadias|hypospadias
213100|NCT02861950|caudal|caudal
213101|NCT02861950|urethrocutaneous fistula|urethrocutaneous fistula
213102|NCT02861950|penile nerve block|penile nerve block
213103|NCT02861911|Muscle function|muscle function
213104|NCT02861911|Oxidative stress|oxidative stress
213105|NCT02861911|Quality of life|quality of life
213106|NCT02861911|Physical activities|physical activities
213107|NCT02861898|EGFR|egfr
213108|NCT02861898|Epidermal Growth Factor Receptor|epidermal growth factor receptor
213109|NCT02861898|EGFRvIII|egfrviii
213110|NCT02861885|Colonoscopy|colonoscopy
213111|NCT02861885|sessile serrated lesions|sessile serrated lesions
213112|NCT02861885|chromoendoscopy|chromoendoscopy
213113|NCT02861885|narrow band imaging|narrow band imaging
213114|NCT02861885|Indigo Carmin®|indigo carmin®
213115|NCT02861885|Pit pattern|pit pattern
213116|NCT02861885|Kudo classification|kudo classification
213117|NCT02861885|NICE classification|nice classification
213118|NCT02861885|neoplasms by histologic type|neoplasms by histologic type
213119|NCT02861872|Ovarian|ovarian
213120|NCT02861872|Ovarian cancer|ovarian cancer
213121|NCT02861872|Chemotherapy|chemotherapy
213122|NCT02861872|Intraperitoneal chemotherapy|intraperitoneal chemotherapy
213123|NCT02861872|pharmacokinetics|pharmacokinetics
213124|NCT02861859|Breast cancer|breast cancer
213125|NCT02861859|Breast Carcinoma|breast carcinoma
213126|NCT02861859|Breast Tumors|breast tumors
213127|NCT02861859|Chemotherapy|chemotherapy
213128|NCT02861859|Antiemetic effects|antiemetic effects
213129|NCT02861859|Antiemetic drugs|antiemetic drugs
213130|NCT02861859|Drug Therapy|drug therapy
213131|NCT02861846|epilepsy|epilepsy
213132|NCT02861846|Alzheimer|alzheimer
213133|NCT02861846|biomarkers|biomarkers
213134|NCT02861846|predictive value|predictive value
213135|NCT02861820|fMRI|fmri
213136|NCT02861820|brain networks|brain networks
213137|NCT02861820|biomarker|biomarker
213138|NCT02861820|relapse|relapse
213139|NCT02861820|stimulants|stimulants
213140|NCT02861794|Total Knee Arthroplasty (TKA)|total knee arthroplasty (tka)
213141|NCT02861794|Total Knee Replacement (TKR)|total knee replacement (tkr)
213142|NCT02861794|Kinematics|kinematics
213143|NCT02861794|RSA|rsa
213144|NCT02861794|Knee arthroplasty|knee arthroplasty
213145|NCT02861794|Implant stability|implant stability
213146|NCT02861781|Bariatric surgery|bariatric surgery
213147|NCT02861755|Depression|depression
213148|NCT02861755|Depressive Disorder|depressive disorder
213149|NCT02861755|Psychological Stress|psychological stress
213150|NCT02861755|Behavioral Symptoms|behavioral symptoms
213151|NCT02861755|Mental Disorders|mental disorders
213152|NCT02861755|Mood Disorders|mood disorders
213153|NCT02861729|Partial coverage restoration|partial coverage restoration
213154|NCT02861729|Crown|crown
213155|NCT02861729|Posterior teeth|posterior teeth
213156|NCT02861729|All ceramic|all ceramic
213157|NCT02861729|Zirconia reinforced lithium silicate|zirconia reinforced lithium silicate
213158|NCT02861729|Lithium disilicate|lithium disilicate
213159|NCT02861729|CAD/CAM|cad/cam
213160|NCT02861690|Esophageal Cancer|esophageal cancer
213161|NCT02861690|nedaplatin|nedaplatin
213162|NCT02861690|Liposomal Paclitaxel|liposomal paclitaxel
213163|NCT02861638|Total hip replacement|total hip replacement
213164|NCT02861638|Action observation treatment|action observation treatment
213165|NCT02861638|Rehabilitation|rehabilitation
213166|NCT02861638|Arthroplasty|arthroplasty
213167|NCT02861612|peripheral nerves|peripheral nerves
213168|NCT02861612|quadriplegia|quadriplegia
213169|NCT02861612|nerve transfer|nerve transfer
213170|NCT02861612|surgical procedures, operative|surgical procedures, operative
213171|NCT02861612|hand|hand
213172|NCT02861612|upper extremity|upper extremity
213173|NCT02861612|quality of life|quality of life
213174|NCT02861586|Chikungunya, infectious disease|chikungunya, infectious disease
213175|NCT02861573|Metastatic Castration-Resistant Prostate Cancer|metastatic castration-resistant prostate cancer
213176|NCT02861573|mCRPC|mcrpc
213177|NCT02861573|PD1|pd1
213178|NCT02861573|PD-1|pd-1
213179|NCT02861573|PDL1|pdl1
213180|NCT02861573|PD-L1|pd-l1
213181|NCT02861508|Ultrasonography|ultrasonography
213182|NCT02861495|upper extremity fracture|upper extremity fracture
213183|NCT02861482|PPH, Bakri Ballon|pph, bakri ballon
213184|NCT02861469|qualitative study, end of life, ethics, palliative care|qualitative study, end of life, ethics, palliative care
213185|NCT02861456|Adolescent|adolescent
213186|NCT02861456|Low Back Pain|low back pain
213187|NCT02861456|Athlete|athlete
213188|NCT02861430|colon cancer|colon cancer
213189|NCT02861430|sentinel node|sentinel node
213190|NCT02861404|HPV|hpv
213191|NCT02861378|anaesthesia, dental|anaesthesia, dental
213192|NCT02861378|lidocaine|lidocaine
213193|NCT02861352|Zinc|zinc
213194|NCT02861352|DNA Integrity|dna integrity
213195|NCT02861352|Gene Expression|gene expression
213196|NCT02861352|diet zinc|diet zinc
213197|NCT02861352|nutrition requirements|nutrition requirements
213198|NCT02861326|chronic periodontitis, dental scaling, periodontal pockets|chronic periodontitis, dental scaling, periodontal pockets
213199|NCT02861300|CB-839|cb-839
213200|NCT02861300|PIK3CA|pik3ca
213201|NCT02861300|capecitabine|capecitabine
213202|NCT02861248|Burn Scar|burn scar
213203|NCT02861248|Micro-plasma Radiofrequency Therapy|micro-plasma radiofrequency therapy
213204|NCT02861183|sodium hyaluronate|sodium hyaluronate
213205|NCT02861183|OVT|ovt
213206|NCT02861183|hyaluronic acid|hyaluronic acid
213207|NCT02861170|Mindfulness|mindfulness
213208|NCT02861170|Chronic Pain|chronic pain
213209|NCT02861170|Chronic Hip Pain|chronic hip pain
213210|NCT02861170|Total Hip Arthroplasty|total hip arthroplasty
213211|NCT02861170|Disability|disability
213212|NCT02861170|Quality of Life|quality of life
213213|NCT02861157|Type 1 Diabetes|type 1 diabetes
213214|NCT02861157|Adolescents|adolescents
213215|NCT02861157|T1D|t1d
213216|NCT02861131|Sugammadex|sugammadex
213217|NCT02861131|Neuromuscular Blockade|neuromuscular blockade
213218|NCT02861118|Drug Therapy|drug therapy
213219|NCT02861092|Serious adverse event|serious adverse event
213220|NCT02861092|bone and joint infection|bone and joint infection
213221|NCT02861092|obesity|obesity
213222|NCT02861092|dose adjustment|dose adjustment
213223|NCT02861066|Mindfulness-based Intervention|mindfulness-based intervention
213224|NCT02861066|Wellbeing|wellbeing
213225|NCT02861066|Treatment|treatment
213226|NCT02861027|Osteoarthritis|osteoarthritis
213227|NCT02861027|Total hip arthroplasty|total hip arthroplasty
213228|NCT02861027|Physiotherapy|physiotherapy
213229|NCT02861027|Functional Electrical Stimulation|functional electrical stimulation
213230|NCT02861001|tracheotomy|tracheotomy
213231|NCT02861001|bronchoscopy|bronchoscopy
213232|NCT02861001|critical care|critical care
213233|NCT02860975|Prolonged Hypoxia|prolonged hypoxia
213234|NCT02860975|Safety|safety
213235|NCT02860975|Mitochondrial function|mitochondrial function
213236|NCT02860949|Local anesthetic infiltration|local anesthetic infiltration
213237|NCT02860949|Posterior capsular infiltration|posterior capsular infiltration
213238|NCT02860949|Multimodal anesthesia|multimodal anesthesia
213239|NCT02860949|Knee arthroplasty|knee arthroplasty
213240|NCT02860949|Pain control|pain control
213241|NCT02860949|Osteoarthritis, Knee|osteoarthritis, knee
213242|NCT02860923|glucagon-like peptide-1|glucagon-like peptide-1
213243|NCT02860923|exenatide|exenatide
213244|NCT02860923|placebo|placebo
213245|NCT02860923|multicenter trial|multicenter trial
213246|NCT02860910|hot flashes|hot flashes
213247|NCT02860910|postmenopause|postmenopause
213248|NCT02860910|perimenopause|perimenopause
213249|NCT02860832|Cyberbullying|cyberbullying
213250|NCT02860832|Traditional bullying|traditional bullying
213251|NCT02860832|Depression|depression
213252|NCT02860819|Multiple relapsed/refractory testicular germ cell tumors|multiple relapsed/refractory testicular germ cell tumors
213253|NCT02860819|PARP inhibition|parp inhibition
213254|NCT02860819|Chemotherapy|chemotherapy
213255|NCT02860819|Gemcitabine|gemcitabine
213256|NCT02860819|Carboplatin|carboplatin
213257|NCT02860793|PTK7|ptk7
213258|NCT02860793|Acute Myeloid Leukemia|acute myeloid leukemia
213259|NCT02860767|Prosthesis-Related Infections|prosthesis-related infections
213260|NCT02860767|Antibiotic dosing|antibiotic dosing
213261|NCT02860767|Reimplantation|reimplantation
213262|NCT02860767|Knee-prothesis|knee-prothesis
213263|NCT02860767|Hip-prothesis|hip-prothesis
213264|NCT02860741|Sub-Clinical Depression|sub-clinical depression
213265|NCT02860728|COPD|copd
213266|NCT02860728|Resistance Training|resistance training
213267|NCT02860728|Exercise Training|exercise training
213268|NCT02860728|Dyspnea|dyspnea
213269|NCT02860715|Safety|safety
213270|NCT02860715|Pharmacodynamics|pharmacodynamics
213271|NCT02860715|Dose-Limiting Toxicity (DLT)|dose-limiting toxicity (dlt)
213272|NCT02860715|Immunogenicity|immunogenicity
213273|NCT02860715|Pharmacokinetics|pharmacokinetics
213274|NCT02860702|Single Ventricle|single ventricle
213275|NCT02860702|Congenital Heart Defect|congenital heart defect
213276|NCT02860689|Sexuality|sexuality
213277|NCT02860689|Spinal cord injuries|spinal cord injuries
213278|NCT02860689|Penile erection|penile erection
213279|NCT02860689|erectile dysfunction|erectile dysfunction
213280|NCT02860689|Psychological Sexual Dysfunctions|psychological sexual dysfunctions
213282|NCT02860676|cancer|cancer
213283|NCT02860676|UC-961|uc-961
213284|NCT02860676|cirmtuzumab|cirmtuzumab
213285|NCT02860637|Sexuality|sexuality
213286|NCT02860637|Spinal cord injuries|spinal cord injuries
213287|NCT02860637|Penile erection|penile erection
213288|NCT02860637|erectile dysfunction|erectile dysfunction
213289|NCT02860624|GERD|gerd
213290|NCT02860611|Type 1 diabetes|type 1 diabetes
213291|NCT02860611|Type 2 diabetes|type 2 diabetes
213292|NCT02860611|T helper 1 cytokines|t helper 1 cytokines
213293|NCT02860598|ESAs|esas
213294|NCT02860598|erythropoietin|erythropoietin
213295|NCT02860598|AML|aml
213296|NCT02860598|HSCT|hsct
213297|NCT02860585|Metastatic breast cancer|metastatic breast cancer
213298|NCT02860585|high-dose chemotherapy|high-dose chemotherapy
213299|NCT02860585|autologous haematopoietic progenitor cell transplantation|autologous haematopoietic progenitor cell transplantation
213300|NCT02860572|fluid therapy|fluid therapy
213301|NCT02860572|oliguria|oliguria
213302|NCT02860572|endothelial injury|endothelial injury
213303|NCT02860559|Hematopoietic Stem Cell Transplantation|hematopoietic stem cell transplantation
213304|NCT02860559|Severe Combined Immunodeficiency|severe combined immunodeficiency
213305|NCT02860546|Refractory|refractory
213306|NCT02860546|Metastatic|metastatic
213307|NCT02860546|Colorectal cancer|colorectal cancer
213308|NCT02860546|TAS-102|tas-102
213309|NCT02860546|Nivolumab|nivolumab
213310|NCT02860546|Microsatellite Stable|microsatellite stable
213311|NCT02860546|Programmed cell death protein1 (PD 1)|programmed cell death protein1 (pd 1)
213312|NCT02860533|Blood pressure|blood pressure
213313|NCT02860533|smartphone App|smartphone app
213314|NCT02860533|Hypertension|hypertension
213315|NCT02860533|Stress testing|stress testing
213316|NCT02860533|Prevention|prevention
213317|NCT02860533|Cardiovascular risk factors|cardiovascular risk factors
213318|NCT02860520|Retinitis pigmentosa:|retinitis pigmentosa:
213319|NCT02860494|Tuberous sclerosis complex (TSC)|tuberous sclerosis complex (tsc)
213320|NCT02860494|topical everolimus|topical everolimus
213321|NCT02860494|seamless design|seamless design
213322|NCT02860494|dose-escalation study|dose-escalation study
213323|NCT02860494|m-TOR inhibitor|m-tor inhibitor
213324|NCT02860455|CO poisoning|co poisoning
213325|NCT02860455|CO-oximetry|co-oximetry
213326|NCT02860455|Pulse oximetry|pulse oximetry
213327|NCT02860455|Carbon monoxide saturation (SpCO)|carbon monoxide saturation (spco)
213328|NCT02860455|Emergency Department|emergency department
213329|NCT02860455|Sensitivity|sensitivity
213330|NCT02860455|Specificity|specificity
213331|NCT02860442|Alcohol misuse|alcohol misuse
213332|NCT02860442|Smartphone app|smartphone app
213333|NCT02860442|Screening, Brief Intervention, Referral to Treatment (SBIRT)|screening, brief intervention, referral to treatment (sbirt)
213334|NCT02860416|Neurology|neurology
213335|NCT02860403|Cervical spinal cord injury|cervical spinal cord injury
213336|NCT02860403|Motor imagery|motor imagery
213337|NCT02860403|Magnetoencephalography|magnetoencephalography
213338|NCT02860377|emergence agitation|emergence agitation
213339|NCT02860377|emergence time|emergence time
213340|NCT02860377|pediatric|pediatric
213341|NCT02860351|subclavian vein|subclavian vein
213342|NCT02860338|Psuedobulbar affect, PBA|psuedobulbar affect, pba
213343|NCT02860299|patients|patients
213344|NCT02860273|Pulmonary Rehabilitation|pulmonary rehabilitation
213345|NCT02860273|COPD|copd
213346|NCT02860273|High Flow Nasal Cannula|high flow nasal cannula
213347|NCT02860273|HFNC|hfnc
213348|NCT02860273|Aerobic capacity|aerobic capacity
213349|NCT02860260|BDNF|bdnf
213350|NCT02860247|antibiotic|antibiotic
213351|NCT02860247|MALDI-TOF MS|maldi-tof ms
213352|NCT02860247|susceptibility testing|susceptibility testing
213353|NCT02860234|Rectal cancer|rectal cancer
213354|NCT02860234|neoadjuvant|neoadjuvant
213355|NCT02860234|radiotherapy|radiotherapy
213356|NCT02860234|chemotherapy|chemotherapy
213357|NCT02860234|organ preservation|organ preservation
213358|NCT02860221|Arthroplasty, Replacement, Knee|arthroplasty, replacement, knee
213359|NCT02860221|Epinephrine|epinephrine
213360|NCT02860221|Tranexamic acid|tranexamic acid
213361|NCT02860208|Peri-Implantitis|peri-implantitis
213362|NCT02860208|Surgical therapy|surgical therapy
213363|NCT02860208|Follow-up|follow-up
213364|NCT02860208|Supportive peri-implant therapy|supportive peri-implant therapy
213365|NCT02860130|Regional Citrate Anticoagulation (RCA)|regional citrate anticoagulation (rca)
213366|NCT02860130|Continuous Renal Replacement Therapy (CRRT)|continuous renal replacement therapy (crrt)
213367|NCT02860130|Acute Kidney Injury|acute kidney injury
213368|NCT02860117|ketamine|ketamine
213369|NCT02860117|continuous infusion|continuous infusion
213370|NCT02860117|severe burned patients|severe burned patients
213371|NCT02860104|microwave ablation|microwave ablation
213372|NCT02860104|breast|breast
213373|NCT02860104|multicenter|multicenter
213374|NCT02860091|ropivacaine infusion|ropivacaine infusion
213375|NCT02860091|regional anesthesia|regional anesthesia
213376|NCT02860091|paravertebral block|paravertebral block
213377|NCT02860078|pain|pain
213378|NCT02860078|epidural|epidural
213379|NCT02860078|ultrasound|ultrasound
213380|NCT02860013|Telemedicine|telemedicine
213381|NCT02860013|Effectiveness|effectiveness
213382|NCT02860013|Cost-effectiveness|cost-effectiveness
213383|NCT02859987|US|us
213384|NCT02859987|Nursing Services|nursing services
213385|NCT02859974|Paradoxical vocal fold motion disorder (PVFMD)|paradoxical vocal fold motion disorder (pvfmd)
213386|NCT02859974|vocal cord dysfunction (VCD)|vocal cord dysfunction (vcd)
213387|NCT02859974|Respiratory retraining|respiratory retraining
213388|NCT02859974|Respiratory disorders|respiratory disorders
213389|NCT02859948|AML|aml
213390|NCT02859935|HIV|hiv
213391|NCT02859935|drug abuse|drug abuse
213392|NCT02859935|MSM|msm
213393|NCT02859935|Risk behavior|risk behavior
213394|NCT02859935|Sexually transmitted diseases|sexually transmitted diseases
213395|NCT02859935|Sexually transmitted infections|sexually transmitted infections
213396|NCT02859922|Laryngeal Tube Supreme Spontaneous Ventilation|laryngeal tube supreme spontaneous ventilation
213397|NCT02859857|Glioblastoma Multiforme|glioblastoma multiforme
213398|NCT02859857|Solid Tumors|solid tumors
213399|NCT02859857|Ependymoma|ependymoma
213400|NCT02859727|APDS; PASLI; PI3Kdelta; p110delta-activating mutation causing senescent T cells, lymphadenopathy and immunodeficiency; Activated PI3Kdelta Syndrome;|apds; pasli; pi3kdelta; p110delta-activating mutation causing senescent t cells, lymphadenopathy and immunodeficiency; activated pi3kdelta syndrome;
213401|NCT02859662|abdominal compartment syndrome|abdominal compartment syndrome
213402|NCT02859662|abdominal aortic aneurysm|abdominal aortic aneurysm
213403|NCT02859662|ruptured aneurysm|ruptured aneurysm
213404|NCT02859649|working memory|working memory
213405|NCT02859649|short term memory|short term memory
213406|NCT02859649|gesture|gesture
213407|NCT02859584|Acute hepatitis|acute hepatitis
213408|NCT02859584|acute liver failure|acute liver failure
213409|NCT02859584|adrenal dysfunction|adrenal dysfunction
213410|NCT02859584|salivary cortisol|salivary cortisol
213411|NCT02859584|serum free cortisol|serum free cortisol
213412|NCT02859545|chronic pain|chronic pain
213413|NCT02859545|pain|pain
213414|NCT02859545|validation|validation
213415|NCT02859545|couples|couples
213416|NCT02859545|romantic relationships|romantic relationships
213417|NCT02859545|emotional validation|emotional validation
213418|NCT02859532|blood coagulation|blood coagulation
213419|NCT02859532|Endogenous Thrombin Potential|endogenous thrombin potential
213420|NCT02859532|rotational thromboelastometry|rotational thromboelastometry
213421|NCT02859480|Rosuvastatin Calcium|rosuvastatin calcium
213422|NCT02859480|Percutaneous Coronary Intervention|percutaneous coronary intervention
213423|NCT02859480|Drug-Eluting Stents|drug-eluting stents
213424|NCT02859480|Patient Outcome Assessment|patient outcome assessment
213425|NCT02859480|Biomarkers|biomarkers
213426|NCT02859480|Hyperlipidemias|hyperlipidemias
213427|NCT02859480|Dyslipidemias|dyslipidemias
213428|NCT02859480|Atherosclerosis|atherosclerosis
213429|NCT02859480|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors
213430|NCT02859480|Anticholesteremic Agents|anticholesteremic agents
213431|NCT02859480|Hypolipidemic Agents|hypolipidemic agents
213432|NCT02859480|Lipid Regulating Agents|lipid regulating agents
213433|NCT02859467|Physical Therapy Modalities|physical therapy modalities
213434|NCT02859467|Exercise|exercise
213435|NCT02859467|Electrical Stimulation Therapy|electrical stimulation therapy
213436|NCT02859467|Bandages|bandages
213437|NCT02859454|PD-L1 Expression|pd-l1 expression
213438|NCT02859454|Human Papilloma Virus (HPV)|human papilloma virus (hpv)
213439|NCT02859454|Juvenile-onset Disease|juvenile-onset disease
213440|NCT02859454|Papillomatous Lesions|papillomatous lesions
213441|NCT02859454|Monoclonal Antibody|monoclonal antibody
213442|NCT02859441|Intravitreal Injection|intravitreal injection
213443|NCT02859441|Retinal Capillary Hemangioma|retinal capillary hemangioma
213444|NCT02859428|Hereditary Spastic Paraplegia|hereditary spastic paraplegia
213445|NCT02859415|Metastatic Colorectal Cancer|metastatic colorectal cancer
213446|NCT02859415|Metastatic Renal Cell Cancer|metastatic renal cell cancer
213448|NCT02859415|ABCB4 Liver Toxicity|abcb4 liver toxicity
213449|NCT02859415|ABCB11 Heptatoxicity|abcb11 heptatoxicity
213450|NCT02859402|T-cell Non-Hodgkin Lymphoma|t-cell non-hodgkin lymphoma
213451|NCT02859402|NK/T-cell Non-Hodgkin Lymphoma|nk/t-cell non-hodgkin lymphoma
213452|NCT02859402|Relapsed, refractory|relapsed, refractory
213453|NCT02859402|Conditioning|conditioning
213454|NCT02859402|Allogeneic stem cell transplantation|allogeneic stem cell transplantation
213455|NCT02859389|Leukemia|leukemia
213456|NCT02859389|Down Syndrome|down syndrome
213457|NCT02859389|Neurocognitive|neurocognitive
213458|NCT02859389|Survivorship|survivorship
213459|NCT02859389|Attention|attention
213460|NCT02859389|Executive function|executive function
213461|NCT02859389|Late effects|late effects
213462|NCT02859376|Preterm infants|preterm infants
213463|NCT02859376|Pain|pain
213464|NCT02859376|Sucrose|sucrose
213465|NCT02859350|Plasmodium falciparum|plasmodium falciparum
213466|NCT02859350|PfSPZ Vaccine|pfspz vaccine
213467|NCT02859350|PfSPZ Challenge (NF54)|pfspz challenge (nf54)
213468|NCT02859350|CHMI|chmi
213469|NCT02859350|Chloroquine|chloroquine
213470|NCT02859350|Chemoprophylaxis|chemoprophylaxis
213471|NCT02859350|PfSPZ-CVac|pfspz-cvac
213472|NCT02859337|obesity|obesity
213473|NCT02859337|body weight|body weight
213474|NCT02859337|BMI|bmi
213475|NCT02859337|emergency contraception|emergency contraception
213476|NCT02859337|levonorgestrel|levonorgestrel
213477|NCT02859337|ulipristal acetate|ulipristal acetate
213478|NCT02859324|CC-122|cc-122
213479|NCT02859324|Nivolumab|nivolumab
213480|NCT02859324|Hepatocellular Carcinoma|hepatocellular carcinoma
213481|NCT02859324|Phase 1/2|phase 1/2
213482|NCT02859324|Safety|safety
213483|NCT02859311|Recovery|recovery
213484|NCT02859298|Premature Delivery|premature delivery
213485|NCT02859298|Polarimetric Imaging|polarimetric imaging
213486|NCT02859298|Polarimetric colposcope|polarimetric colposcope
213487|NCT02859298|Diagnostic tool|diagnostic tool
213488|NCT02859285|Arousal|arousal
213489|NCT02859285|Orgasm|orgasm
213490|NCT02859285|Clitoral|clitoral
213491|NCT02859285|Estradiol|estradiol
213492|NCT02859285|Post Menopausal|post menopausal
213493|NCT02859272|Suspension, benign hysterectomy, post operative prolapse|suspension, benign hysterectomy, post operative prolapse
213494|NCT02859233|Spinal Puncture|spinal puncture
213495|NCT02859233|Dural puncture|dural puncture
213496|NCT02859233|Nursing|nursing
213497|NCT02859220|hemodialysis|hemodialysis
213498|NCT02859220|PTH|pth
213499|NCT02859207|Early Alzheimer's disease|early alzheimer's disease
213500|NCT02859207|E2609|e2609
213501|NCT02859207|Mild and Moderate Hepatic Impairment|mild and moderate hepatic impairment
213502|NCT02859181|Increased Metabolic Requirement|increased metabolic requirement
213503|NCT02859168|Neck|neck
213504|NCT02859168|Shoulder|shoulder
213505|NCT02859168|Manual Therapies|manual therapies
213506|NCT02859142|Varenicline|varenicline
213507|NCT02859129|Epanova|epanova
213508|NCT02859129|omega-3 carboxylic acids|omega-3 carboxylic acids
213509|NCT02859129|Vascepa|vascepa
213510|NCT02859129|Eicosapentaenoic acid ethyl ester|eicosapentaenoic acid ethyl ester
213511|NCT02859129|Crestor|crestor
213512|NCT02859129|rosuvastatin|rosuvastatin
213513|NCT02859116|Metabolic diseases|metabolic diseases
213514|NCT02859077|NSCLC|nsclc
213515|NCT02859077|BIM|bim
213516|NCT02859077|EGFR mutation|egfr mutation
213517|NCT02859064|radioembolization|radioembolization
213518|NCT02859064|somatostatin analogs|somatostatin analogs
213519|NCT02859064|carcinoid|carcinoid
213520|NCT02859064|neuroendocrine|neuroendocrine
213521|NCT02859064|liver-directed therapy|liver-directed therapy
213522|NCT02859051|Cognitive Behavioral Support provided by Robot|cognitive behavioral support provided by robot
213523|NCT02859025|Alveolar cleft|alveolar cleft
213524|NCT02859025|Osteoplasty|osteoplasty
213525|NCT02859025|Tissue engineering|tissue engineering
213526|NCT02859025|Stem cells|stem cells
213527|NCT02859025|Regenerative medicine|regenerative medicine
213528|NCT02859025|Bone|bone
213529|NCT02859025|Lateral ramus|lateral ramus
213530|NCT02858999|primary plasma cell leukaemia|primary plasma cell leukaemia
213531|NCT02858999|treatment|treatment
213532|NCT02858960|High Flow Nasal Cannula|high flow nasal cannula
213533|NCT02858960|COPD|copd
213534|NCT02858960|Pulmonary rehabilitation|pulmonary rehabilitation
213535|NCT02858960|HFNC|hfnc
213536|NCT02858960|Oxygen|oxygen
213537|NCT02858947|composite resin|composite resin
213538|NCT02858947|bulk-fill|bulk-fill
213539|NCT02858947|teeth endodontically-treated|teeth endodontically-treated
213540|NCT02858934|Short preoperative tomotherapy|short preoperative tomotherapy
213541|NCT02858934|Radiotherapy|radiotherapy
213542|NCT02858921|Neoadjuvant Therapy|neoadjuvant therapy
213543|NCT02858921|Pembrolizumab|pembrolizumab
213544|NCT02858921|Dabrafenib|dabrafenib
213545|NCT02858921|Trametinib|trametinib
213546|NCT02858921|Pathological response|pathological response
213547|NCT02858921|RECIST|recist
213548|NCT02858921|Immune response|immune response
213549|NCT02858921|BRAF|braf
213550|NCT02858921|Randomised|randomised
213551|NCT02858921|Stage IIIB/C|stage iiib/c
213552|NCT02858921|Biomarkers, Tumour|biomarkers, tumour
213553|NCT02858921|Biomarkers, Drug response|biomarkers, drug response
213554|NCT02858921|Metabolic Response|metabolic response
213555|NCT02858895|High grade glioma|high grade glioma
213556|NCT02858895|malignant glioma|malignant glioma
213557|NCT02858895|recurrent glioblastoma|recurrent glioblastoma
213558|NCT02858895|recurrent GBM|recurrent gbm
213559|NCT02858895|recurrent GB|recurrent gb
213560|NCT02858895|glioblastoma (GB)|glioblastoma (gb)
213561|NCT02858895|glioblastoma multiforme (GBM)|glioblastoma multiforme (gbm)
213562|NCT02858895|progressive glioblastoma|progressive glioblastoma
213563|NCT02858895|Brain tumor|brain tumor
213564|NCT02858895|Brain cancer|brain cancer
213565|NCT02858895|immunotherapy|immunotherapy
213566|NCT02858895|targeted|targeted
213567|NCT02858895|IL4R|il4r
213568|NCT02858843|genetics|genetics
213569|NCT02858830|FPL|fpl
213570|NCT02858830|adipose tissue|adipose tissue
213571|NCT02858830|diabetes|diabetes
213572|NCT02858830|dyslipidemia|dyslipidemia
213573|NCT02858830|metabolic|metabolic
213574|NCT02858830|hyperinsulinemia|hyperinsulinemia
213575|NCT02858804|mantle cell lymphoma|mantle cell lymphoma
213576|NCT02858804|EDOCH|edoch
213577|NCT02858804|DHAP|dhap
213578|NCT02858804|maintenance therapy|maintenance therapy
213579|NCT02858778|Palliative Care|palliative care
213580|NCT02858778|Emergency Department|emergency department
213581|NCT02858752|Attention|attention
213582|NCT02858752|Short-term memory|short-term memory
213583|NCT02858752|Aural Memory|aural memory
213584|NCT02858752|Visual Memory|visual memory
213585|NCT02858752|Child|child
213586|NCT02858752|EEG|eeg
213587|NCT02858726|Hemodialysis|hemodialysis
213588|NCT02858726|CR845|cr845
213589|NCT02858726|Kappa opioid|kappa opioid
213590|NCT02858726|Anti-itch|anti-itch
213591|NCT02858726|difelikefalin|difelikefalin
213592|NCT02858713|psoriasis|psoriasis
213593|NCT02858700|neonatal bacterial infection|neonatal bacterial infection
213594|NCT02858700|procalcitonin|procalcitonin
213595|NCT02858635|Suicidal behaviour|suicidal behaviour
213596|NCT02858635|Impulsivity|impulsivity
213597|NCT02858635|Genetics|genetics
213598|NCT02858635|Serotonin|serotonin
213599|NCT02858622|pediatric|pediatric
213600|NCT02858622|renal transplant|renal transplant
213601|NCT02858622|pain|pain
213602|NCT02858622|dual TAB|dual tab
213603|NCT02858583|Chest Compression|chest compression
213604|NCT02858583|Newborn|newborn
213605|NCT02858583|Infant|infant
213606|NCT02858583|Sustained Inflation|sustained inflation
213607|NCT02858570|Meningococcal Vaccines|meningococcal vaccines
213608|NCT02858570|Immunogenicity, Reactogenicity and Safety of Vaccine|immunogenicity, reactogenicity and safety of vaccine
213609|NCT02858544|Mild traumatic brain injury|mild traumatic brain injury
213610|NCT02858518|anticoagulant|anticoagulant
213611|NCT02858492|efficacy|efficacy
213612|NCT02858492|safety|safety
213613|NCT02858492|pharmacokinetics|pharmacokinetics
213614|NCT02858492|pharmacodynamics|pharmacodynamics
213615|NCT02858492|Rheumatoid Arthritis|rheumatoid arthritis
213616|NCT02858492|autoimmune|autoimmune
213617|NCT02858453|Interstitial cystitis|interstitial cystitis
213618|NCT02858453|Bladder pain syndrome|bladder pain syndrome
213619|NCT02858453|Painful bladder syndrome|painful bladder syndrome
213620|NCT02858453|Interstitial Cystitis/Bladder Pain Syndrome (IC/BPS)|interstitial cystitis/bladder pain syndrome (ic/bps)
213621|NCT02858453|AQX-1125|aqx-1125
213622|NCT02858453|SHIP1|ship1
213623|NCT02858453|Chronic interstitial cystitis|chronic interstitial cystitis
213624|NCT02858440|Primary dose|primary dose
213625|NCT02858440|Reactogenicity|reactogenicity
213626|NCT02858440|Immunogenicity|immunogenicity
213627|NCT02858440|Booster dose|booster dose
213628|NCT02858440|Combined vaccine|combined vaccine
213629|NCT02858440|Russian Infants|russian infants
213630|NCT02858440|Infanrix®-IPV/Hib|infanrix®-ipv/hib
213631|NCT02858427|cognitive inhibition|cognitive inhibition
213632|NCT02858427|elderly|elderly
213633|NCT02858427|suicide attempt|suicide attempt
213634|NCT02858427|depression|depression
213635|NCT02858388|Otitis Media with Effusion|otitis media with effusion
213636|NCT02858388|Exudative otitis media|exudative otitis media
213637|NCT02858375|quality of life|quality of life
213638|NCT02858375|botulinum toxin|botulinum toxin
213639|NCT02858375|provoked vulvodynia|provoked vulvodynia
213640|NCT02858362|DMD|dmd
213641|NCT02858362|Muscular Dystrophy|muscular dystrophy
213642|NCT02858362|Utrophin|utrophin
213643|NCT02858362|Duchenne|duchenne
213644|NCT02858362|PhaseOut DMD|phaseout dmd
213645|NCT02858336|Luteinizing Hormone (LH)|luteinizing hormone (lh)
213646|NCT02858336|Weight Loss|weight loss
719425|NCT00550342|rituximab|rituximab
213847|NCT02856789|Thromboelastography|thromboelastography
213647|NCT02858336|Functional Hypothalamic Amenorrhea (HA)|functional hypothalamic amenorrhea (ha)
213648|NCT02858336|Energy Deficiency|energy deficiency
213649|NCT02858336|Gonadotropin-Releasing Hormone (GnRH)|gonadotropin-releasing hormone (gnrh)
213650|NCT02858336|Leptin|leptin
213651|NCT02858336|Exercise|exercise
213652|NCT02858336|Ghrelin|ghrelin
213653|NCT02858336|Cortisol|cortisol
213654|NCT02858323|Alloimmunization|alloimmunization
213655|NCT02858323|Refractoriness|refractoriness
213656|NCT02858323|Corrected Count Increment|corrected count increment
213657|NCT02858323|HLA-Compatible|hla-compatible
213658|NCT02858310|Vulvar High Grade Squamous Intraepithelial Lesion|vulvar high grade squamous intraepithelial lesion
213659|NCT02858310|Vulvar Intraepithelial Neoplasia|vulvar intraepithelial neoplasia
213660|NCT02858310|Vaccine|vaccine
213661|NCT02858310|Immunotherapy|immunotherapy
213662|NCT02858310|Human Papillomavirus|human papillomavirus
213663|NCT02858297|Oral lichen planus|oral lichen planus
213664|NCT02858297|Glucosamine|glucosamine
213665|NCT02858297|IL-8|il-8
213666|NCT02858258|MCL|mcl
213667|NCT02858245|MitraClip|mitraclip
213668|NCT02858245|Structural Heart Failure|structural heart failure
213669|NCT02858245|Degenerative Mitral Regurgitation (DMR)|degenerative mitral regurgitation (dmr)
213670|NCT02858245|Actigraphy|actigraphy
213671|NCT02858232|MASCT-I|masct-i
213672|NCT02858232|Solid Tumors|solid tumors
213673|NCT02858219|Botulinum toxin|botulinum toxin
213674|NCT02858219|Pain improvement|pain improvement
213675|NCT02858206|Locally advanced esophageal cancer|locally advanced esophageal cancer
213676|NCT02858206|Radiotherapy and nimotuzumab|radiotherapy and nimotuzumab
213677|NCT02858206|Concurrent chemoradiotherapy|concurrent chemoradiotherapy
213678|NCT02858154|OSA|osa
213679|NCT02858154|obstructive sleep apnea|obstructive sleep apnea
213680|NCT02858154|infants|infants
213681|NCT02858154|high flow nasal cannula|high flow nasal cannula
213682|NCT02858154|HFNC|hfnc
213683|NCT02858141|oncogeriatric evaluation|oncogeriatric evaluation
213684|NCT02858141|pancreatic cancer|pancreatic cancer
213685|NCT02858141|Database|database
213686|NCT02858102|Schizophrenia|schizophrenia
213687|NCT02858102|Psychosis|psychosis
213688|NCT02858102|Obesity|obesity
213689|NCT02858102|Neurocognition|neurocognition
213690|NCT02858102|Depression|depression
213691|NCT02858102|Bipolar disorder|bipolar disorder
213692|NCT02858102|Metabolomics|metabolomics
213693|NCT02858102|Biomarkers|biomarkers
213694|NCT02858102|Hypertension|hypertension
213695|NCT02858102|Dyslipidemia|dyslipidemia
213696|NCT02858102|Hyperglycemia|hyperglycemia
213697|NCT02858102|Hypertriglyceridemia|hypertriglyceridemia
213698|NCT02858076|Anti-VEGF|anti-vegf
213699|NCT02858076|Vitrectomy|vitrectomy
213700|NCT02858063|Breast cancer|breast cancer
213701|NCT02858063|Quality Of Life|quality of life
213702|NCT02858063|Women|women
213703|NCT02858063|Partner|partner
213704|NCT02858011|behavior change communication|behavior change communication
213705|NCT02858011|cash transfer|cash transfer
213706|NCT02858011|household welfare|household welfare
213707|NCT02858011|child nutrition status|child nutrition status
213708|NCT02857985|Myocardial Infarction|myocardial infarction
213709|NCT02857985|MRI|mri
213710|NCT02857985|rotational angiography|rotational angiography
213711|NCT02857972|Menstruation, Female Barrier, Sanitary pads|menstruation, female barrier, sanitary pads
213712|NCT02857933|Motor Impairments|motor impairments
213713|NCT02857933|Gross Motor Delay|gross motor delay
213714|NCT02857920|Vascular Endothelial Growth Factor (VEGF) antibody|vascular endothelial growth factor (vegf) antibody
213715|NCT02857920|solid tumor|solid tumor
213716|NCT02857920|NK Immunotherapy|nk immunotherapy
213717|NCT02857907|Kidney transplantation|kidney transplantation
213718|NCT02857907|Immunosuppressive treatment|immunosuppressive treatment
213719|NCT02857894|Polypoidal choroidal vasculopathy|polypoidal choroidal vasculopathy
213720|NCT02857881|keratoconus|keratoconus
213721|NCT02857881|photokeratectomy|photokeratectomy
213722|NCT02857881|de-epithelization|de-epithelization
213723|NCT02857868|Hepatic Impairment|hepatic impairment
213724|NCT02857868|ABL001|abl001
213725|NCT02857868|Child-Pugh|child-pugh
213726|NCT02857868|healthy subjects with normal hepatic function|healthy subjects with normal hepatic function
213727|NCT02857855|liver transplantation|liver transplantation
213728|NCT02857855|postoperative infection|postoperative infection
213729|NCT02857855|biliary complications|biliary complications
213730|NCT02857855|patient survival|patient survival
213731|NCT02857855|graft survival|graft survival
213732|NCT02857855|supplemental oxygen|supplemental oxygen
213733|NCT02857829|Cognition|cognition
213734|NCT02857829|working memory|working memory
213735|NCT02857829|nootropic|nootropic
213736|NCT02857829|reaction time|reaction time
213737|NCT02857829|healthy individuals|healthy individuals
213738|NCT02857829|cognitive enhancement|cognitive enhancement
213739|NCT02857803|Virtual Reality|virtual reality
213740|NCT02857803|Cognitive Rehabilitation|cognitive rehabilitation
213741|NCT02857803|Motor Rehabilitation|motor rehabilitation
213742|NCT02857803|Ecological validity|ecological validity
213743|NCT02857803|Personalisation|personalisation
213744|NCT02857790|Rotablation|rotablation
213745|NCT02857790|High speed rotational atherectomy|high speed rotational atherectomy
213746|NCT02857790|Type IV myocardial infarction|type iv myocardial infarction
213747|NCT02857790|Cardiac magnetic resonance imaging|cardiac magnetic resonance imaging
213748|NCT02857790|CMR|cmr
213749|NCT02857790|Percutaneous Coronary Intervention|percutaneous coronary intervention
213750|NCT02857751|depression|depression
213751|NCT02857751|PTSD|ptsd
213752|NCT02857751|anxiety|anxiety
213753|NCT02857751|surf therapy|surf therapy
213754|NCT02857699|Quality of life|quality of life
213755|NCT02857699|Phase I trials|phase i trials
213756|NCT02857673|Children with Special Health Care Needs|children with special health care needs
213757|NCT02857673|Violence Prevention|violence prevention
213758|NCT02857660|Sarcopenia|sarcopenia
213759|NCT02857660|Obesity|obesity
213760|NCT02857660|Whole-Body Electromyostimulation|whole-body electromyostimulation
213761|NCT02857660|Protein Supplementation|protein supplementation
213762|NCT02857660|community dwelling men|community dwelling men
213763|NCT02857647|Bariatric surgery|bariatric surgery
213764|NCT02857647|Anxiety|anxiety
213765|NCT02857647|Nutrition knowledge|nutrition knowledge
213766|NCT02857647|Weight loss expectations|weight loss expectations
213767|NCT02857634|Urinary Bladder cancer|urinary bladder cancer
213768|NCT02857634|diagnosis|diagnosis
213769|NCT02857634|Cellvizio Dual Band|cellvizio dual band
213770|NCT02857582|Antibiotic-induced diarrhea|antibiotic-induced diarrhea
213771|NCT02857582|Clostridium-difficile toxin|clostridium-difficile toxin
213772|NCT02857582|Pseudomembranous colitis|pseudomembranous colitis
213773|NCT02857504|double lumen tube|double lumen tube
213774|NCT02857504|hook|hook
213775|NCT02857439|Trauma of the shoulder|trauma of the shoulder
213776|NCT02857413|Xerostomia|xerostomia
213777|NCT02857413|Radiotherapy|radiotherapy
213778|NCT02857348|decision making|decision making
213779|NCT02857348|heuristics|heuristics
213780|NCT02857283|Air pollution|air pollution
213781|NCT02857283|Air pollutant exposure|air pollutant exposure
213782|NCT02857283|Ozone|ozone
213783|NCT02857270|MAPK|mapk
213784|NCT02857270|RAS|ras
213785|NCT02857270|BRAF|braf
213786|NCT02857257|IBS|ibs
213787|NCT02857257|Microbiota|microbiota
213788|NCT02857244|Freezing of Gait|freezing of gait
213789|NCT02857231|Bioimpedance spectroscopy|bioimpedance spectroscopy
213790|NCT02857205|Hirschsprung Associated EnteroColitis (HAEC)|hirschsprung associated enterocolitis (haec)
213791|NCT02857179|bariatric surgery|bariatric surgery
213792|NCT02857179|follow-up|follow-up
213793|NCT02857179|weight loss|weight loss
213794|NCT02857179|complications|complications
213795|NCT02857179|comorbidities evolution|comorbidities evolution
213796|NCT02857166|JS001|js001
213797|NCT02857166|solid tumors|solid tumors
213798|NCT02857153|MAP|map
213799|NCT02857153|Blood loss|blood loss
213800|NCT02857153|Postoperative delirium|postoperative delirium
213801|NCT02857153|Elderly patients|elderly patients
213802|NCT02857153|Noncardiothoracic surgery|noncardiothoracic surgery
213803|NCT02857127|Low income population|low income population
213804|NCT02857127|Motor Activity|motor activity
213805|NCT02857127|Primary Health Care|primary health care
213806|NCT02857088|depression|depression
213807|NCT02857088|emotional reactivity|emotional reactivity
213808|NCT02857036|rhythm|rhythm
213809|NCT02857036|depression|depression
213810|NCT02857036|antidepressant treatment|antidepressant treatment
213811|NCT02857023|Neurocognitive|neurocognitive
213812|NCT02857023|Working memory|working memory
213813|NCT02857023|Cogmed|cogmed
213814|NCT02857023|Cognitive training|cognitive training
213815|NCT02856984|Pregnancy|pregnancy
213816|NCT02856984|Infant|infant
213817|NCT02856971|Hinge Knee Prosthesis|hinge knee prosthesis
213818|NCT02856971|TKA infection|tka infection
213819|NCT02856971|rotating hinge prosthesis|rotating hinge prosthesis
213820|NCT02856971|hinge knee arthroplasty|hinge knee arthroplasty
213821|NCT02856945|fracture|fracture
213822|NCT02856945|children|children
213823|NCT02856945|knee|knee
213824|NCT02856945|clinical criteria|clinical criteria
213825|NCT02856945|decision making|decision making
213826|NCT02856906|Orofacial Pain|orofacial pain
213827|NCT02856906|Electromyography|electromyography
213828|NCT02856906|dental occlusion|dental occlusion
213829|NCT02856893|AZD9291|azd9291
213830|NCT02856893|Osimertinib|osimertinib
213831|NCT02856893|Gefitinib|gefitinib
213832|NCT02856893|NSCLC|nsclc
213833|NCT02856893|liquid biopsy|liquid biopsy
213834|NCT02856893|ctDNA|ctdna
213835|NCT02856841|epithelial ovarian cancer|epithelial ovarian cancer
213836|NCT02856841|optimum cytoreduction|optimum cytoreduction
213837|NCT02856815|Immuncell-LC|immuncell-lc
213838|NCT02856815|Transarterial Chemoembolization|transarterial chemoembolization
213839|NCT02856789|Fibrin structure|fibrin structure
213840|NCT02856789|Coag-Lysis assay|coag-lysis assay
213841|NCT02856789|Fibrin formation|fibrin formation
213842|NCT02856789|Fibrinolysis|fibrinolysis
213843|NCT02856789|TEG 5000|teg 5000
213844|NCT02856789|TEG 6S|teg 6s
213845|NCT02856789|Coagulo-lytic balance|coagulo-lytic balance
213846|NCT02856789|Normal range|normal range
213848|NCT02856776|Vitamin D|vitamin d
213849|NCT02856776|Metabolomics|metabolomics
213850|NCT02856776|Microbiota|microbiota
213851|NCT02856776|Gene Expression|gene expression
213852|NCT02856711|Group Prenatal Visits,CenteringPregnancy|group prenatal visits,centeringpregnancy
213853|NCT02856698|Acute heart failure|acute heart failure
213854|NCT02856698|morphine|morphine
213855|NCT02856698|midazolam|midazolam
213856|NCT02856698|in-hospital mortality|in-hospital mortality
213857|NCT02856672|Laryngeal Tube Supreme Laryngeal Mask Airway Leak Pressure|laryngeal tube supreme laryngeal mask airway leak pressure
213858|NCT02856620|cardiac mechanics|cardiac mechanics
213859|NCT02856620|circulating biomarkers|circulating biomarkers
213860|NCT02856620|frailty|frailty
213861|NCT02856542|Psoriasis vulgaris, scalp, topical, applicator, device|psoriasis vulgaris, scalp, topical, applicator, device
213862|NCT02856503|DCIS|dcis
213863|NCT02856503|IBC|ibc
213864|NCT02856503|Breast Cancer|breast cancer
213865|NCT02856503|Invasive Breast Carcinoma|invasive breast carcinoma
213866|NCT02856503|High Grade Ductal Carcinoma in-situ|high grade ductal carcinoma in-situ
213867|NCT02856412|Stress Disorders, Post-Traumatic|stress disorders, post-traumatic
213868|NCT02856412|Exercise|exercise
213869|NCT02856412|Mindfulness|mindfulness
213870|NCT02856399|methadone|methadone
213871|NCT02856399|cancer pain|cancer pain
213872|NCT02856399|long term effect|long term effect
213873|NCT02856373|Denervation|denervation
213874|NCT02856373|Renal Artery|renal artery
213875|NCT02856360|Football|football
213876|NCT02856360|Cleats|cleats
213877|NCT02856360|Stiffness|stiffness
213878|NCT02856347|Medullary Thyroid Cancer|medullary thyroid cancer
213879|NCT02856347|PET F-DOPA|pet f-dopa
213880|NCT02856347|18-FDOPA|18-fdopa
213881|NCT02856334|chronic pelvic pain|chronic pelvic pain
213882|NCT02856334|vulvodynia|vulvodynia
213883|NCT02856334|pelvic pain|pelvic pain
213884|NCT02856334|psychosocial factors|psychosocial factors
213885|NCT02856334|central sensitization|central sensitization
213886|NCT02856295|postpartum venous thromboembolism|postpartum venous thromboembolism
213887|NCT02856295|prophylactic dose of low molecular weight heparin|prophylactic dose of low molecular weight heparin
213888|NCT02856295|anti 10a|anti 10a
213889|NCT02856269|Zinc|zinc
213890|NCT02856256|Energy drink|energy drink
213891|NCT02856256|Choroid|choroid
213892|NCT02856230|Critical limb ischemia|critical limb ischemia
213893|NCT02856230|bellow-the-knee angioplasty|bellow-the-knee angioplasty
213894|NCT02856230|drug-eluting balloon|drug-eluting balloon
213895|NCT02856165|infant|infant
213896|NCT02856165|oxygen therapy|oxygen therapy
213897|NCT02856165|High flow nasal canula oxygen therapy|high flow nasal canula oxygen therapy
213898|NCT02856165|Bronchiolitis|bronchiolitis
213899|NCT02856152|Healthy Volunteer|healthy volunteer
213900|NCT02856139|ultra-widefield fluorescein angiography|ultra-widefield fluorescein angiography
213901|NCT02856139|peripheral retina|peripheral retina
213902|NCT02856139|normal eyes|normal eyes
213903|NCT02856126|Hepatic arterial infusion chemotherapy|hepatic arterial infusion chemotherapy
213904|NCT02856126|Transarterial Chemoembolization|transarterial chemoembolization
213905|NCT02856113|Drug Therapy|drug therapy
213906|NCT02856087|acute pain|acute pain
213907|NCT02856087|postoperative|postoperative
213908|NCT02856087|surgery|surgery
213909|NCT02856048|GnRH agonist|gnrh agonist
213910|NCT02856048|Ovarian reserve|ovarian reserve
213911|NCT02856048|Fertility Preservation|fertility preservation
213912|NCT02856048|Alkylating Agents|alkylating agents
213913|NCT02856035|chronic stroke|chronic stroke
213914|NCT02856035|functional MRI|functional mri
213915|NCT02856035|functional NIRS|functional nirs
213916|NCT02856035|motor learning|motor learning
213917|NCT02856035|FES|fes
213918|NCT02856035|upper extremity|upper extremity
213919|NCT02856035|neural feedback|neural feedback
213920|NCT02856035|arm/hand functional training|arm/hand functional training
213921|NCT02856022|electrical ilioinguinal nerve stimulation|electrical ilioinguinal nerve stimulation
213922|NCT02856022|bladder pain syndrome|bladder pain syndrome
213923|NCT02856022|intravesical irrigation|intravesical irrigation
213924|NCT02855996|fatherhood|fatherhood
213925|NCT02855996|father involvement|father involvement
213926|NCT02855996|economic stability|economic stability
213927|NCT02855996|co-parenting|co-parenting
213928|NCT02855996|healthy relationships|healthy relationships
213929|NCT02855996|father-child engagement|father-child engagement
213930|NCT02855957|Alpha-Hemoglobin Stabilizing Protein|alpha-hemoglobin stabilizing protein
213931|NCT02855957|alpha-Hb pool|alpha-hb pool
213932|NCT02855957|thalassemias|thalassemias
213933|NCT02855957|diagnostic method|diagnostic method
213934|NCT02855957|biomarker|biomarker
213935|NCT02855944|ovarian cancer|ovarian cancer
213936|NCT02855944|fallopian tube cancer|fallopian tube cancer
213937|NCT02855944|primary peritoneal cancer|primary peritoneal cancer
213938|NCT02855944|peritoneal cancer|peritoneal cancer
213939|NCT02855944|platinum sensitive|platinum sensitive
213940|NCT02855944|relapsed disease|relapsed disease
213941|NCT02855944|PARP Inhibitor|parp inhibitor
213942|NCT02855944|PARP|parp
213943|NCT02855944|rucaparib|rucaparib
213944|NCT02855944|ruca|ruca
213945|NCT02855944|homologous recombination|homologous recombination
213946|NCT02855944|homologous recombination deficiency|homologous recombination deficiency
213947|NCT02855944|genomic scarring|genomic scarring
213948|NCT02855944|loss of heterozygosity|loss of heterozygosity
213949|NCT02855944|CO-338|co-338
213950|NCT02855944|PF-01367338|pf-01367338
213951|NCT02855944|PF 01367338|pf 01367338
213952|NCT02855944|CO-338-043|co-338-043
213953|NCT02855944|platinum sensitive ovarian cancer|platinum sensitive ovarian cancer
213954|NCT02855944|platinum sensitive fallopian tube cancer|platinum sensitive fallopian tube cancer
213955|NCT02855944|platinum sensitive primary peritoneal cancer|platinum sensitive primary peritoneal cancer
213956|NCT02855944|platinum sensitive peritoneal cancer|platinum sensitive peritoneal cancer
213957|NCT02855944|gynecological cancer|gynecological cancer
213958|NCT02855944|Clovis|clovis
213959|NCT02855944|Clovis oncology|clovis oncology
213960|NCT02855944|ARIEL2|ariel2
213961|NCT02855944|ARIEL 2|ariel 2
213962|NCT02855944|ARIEL-2|ariel-2
213963|NCT02855944|ARIEL-3|ariel-3
213964|NCT02855944|ARIEL 3|ariel 3
213965|NCT02855944|ARIEL3|ariel3
213966|NCT02855944|ARIEL4|ariel4
213967|NCT02855944|ARIEL-4|ariel-4
213968|NCT02855944|ARIEL 4|ariel 4
213970|NCT02855944|advanced OC|advanced oc
213971|NCT02855944|platinum resistant ovarian cancer|platinum resistant ovarian cancer
213972|NCT02855944|platinum resistant primary ovarian cancer|platinum resistant primary ovarian cancer
213973|NCT02855944|Rubraca|rubraca
213974|NCT02855944|High grade serous|high grade serous
213975|NCT02855944|Partially platinum sensitive|partially platinum sensitive
213976|NCT02855918|Psychiatry|psychiatry
213977|NCT02855918|Depressive disorder|depressive disorder
213978|NCT02855918|Suicidal behavior|suicidal behavior
213979|NCT02855918|Genetics|genetics
213980|NCT02855905|Exercise|exercise
213981|NCT02855905|Cold Temperature|cold temperature
213982|NCT02855892|GV1001|gv1001
213983|NCT02855892|BPH|bph
213984|NCT02855892|Benign prostatic hyperplasia|benign prostatic hyperplasia
213985|NCT02855788|gastric cancer|gastric cancer
213986|NCT02855788|gastroesophageal cancer|gastroesophageal cancer
213987|NCT02855788|metastatic|metastatic
213988|NCT02855788|advanced|advanced
213989|NCT02855736|Suicidal inpatients|suicidal inpatients
213990|NCT02855736|Positive Psychology|positive psychology
213991|NCT02855736|Gratitude|gratitude
213992|NCT02855736|Psychological pain|psychological pain
213993|NCT02855723|Squamous carcinoma of oral cavity and oropharynx|squamous carcinoma of oral cavity and oropharynx
213994|NCT02855723|Sentinel lymph node|sentinel lymph node
213995|NCT02855723|Lymph node dissection|lymph node dissection
213996|NCT02855723|Equivalence|equivalence
213997|NCT02855671|microcirculation|microcirculation
213998|NCT02855671|thermal|thermal
213999|NCT02855671|temperature|temperature
214000|NCT02855658|Sjögren's syndrome|sjögren's syndrome
214001|NCT02855658|Gan-Lu-Yin|gan-lu-yin
214002|NCT02855658|Sang-Ju-Yin|sang-ju-yin
214003|NCT02855658|Xuefu-Zhuyu-Decoction|xuefu-zhuyu-decoction
214004|NCT02855658|Oxidative stress|oxidative stress
214005|NCT02855658|Immune regulation|immune regulation
214006|NCT02855658|Gene modulation|gene modulation
214007|NCT02855658|SS-1|ss-1
214008|NCT02855645|Trichosanthes root|trichosanthes root
214009|NCT02855645|Traditional Chinese Medicine|traditional chinese medicine
214010|NCT02855645|Clinical trial|clinical trial
214011|NCT02855632|G-CSF|g-csf
214012|NCT02855632|adhesion reformation|adhesion reformation
214013|NCT02855632|Asherman syndrome|asherman syndrome
214014|NCT02855619|inspiratory muscles training programs|inspiratory muscles training programs
214015|NCT02855619|Ventilator-induced diaphragmatic dysfunction|ventilator-induced diaphragmatic dysfunction
214016|NCT02855619|Weaning|weaning
214017|NCT02855619|Intensive care unit|intensive care unit
214018|NCT02855606|Oral PrEP|oral prep
214019|NCT02855606|TGW|tgw
214020|NCT02855606|Thai MSM|thai msm
214021|NCT02855593|acupuncture|acupuncture
214022|NCT02855580|Pharmacogenomic|pharmacogenomic
214023|NCT02855580|child|child
214024|NCT02855580|psychiatry|psychiatry
214025|NCT02855580|Obsessive Compulsive Disorder|obsessive compulsive disorder
214026|NCT02855580|Depression|depression
214027|NCT02855580|Anxiety|anxiety
214028|NCT02855580|CYP2D6|cyp2d6
214029|NCT02855580|CYP2C19|cyp2c19
214030|NCT02855580|Selective serotonin reuptake inhibitor|selective serotonin reuptake inhibitor
214031|NCT02855580|SSRI|ssri
214032|NCT02855567|surgery|surgery
214033|NCT02855567|acupuncture|acupuncture
214034|NCT02855567|gynecology|gynecology
214035|NCT02855567|pain|pain
214036|NCT02855567|narcotics|narcotics
214037|NCT02855554|myocardial tissue characterization|myocardial tissue characterization
214038|NCT02855541|Blood Glucose|blood glucose
214039|NCT02855541|Physical Fitness|physical fitness
214040|NCT02855541|Body Composition|body composition
214041|NCT02855541|Lipids|lipids
214042|NCT02855528|Tin Filter|tin filter
214043|NCT02855528|Coronary Artery Calcium Scoring|coronary artery calcium scoring
214044|NCT02855528|Radiation dose reduction|radiation dose reduction
214045|NCT02855515|drug-induced sleep endoscopy|drug-induced sleep endoscopy
214046|NCT02855515|obstructive sleep apnoea|obstructive sleep apnoea
214047|NCT02855515|VOTE classification|vote classification
214050|NCT02855489|Condom Use|condom use
214051|NCT02855489|HIV/STD|hiv/std
214052|NCT02855489|Intervention|intervention
214053|NCT02855489|Theory of Planned Behavior|theory of planned behavior
214054|NCT02855489|Dismantling Study Design|dismantling study design
214055|NCT02855463|Giant virus|giant virus
214056|NCT02855463|Amoeba|amoeba
214057|NCT02855424|stroke|stroke
214058|NCT02855424|exercise capacity|exercise capacity
214059|NCT02855385|Rectal bleeding, , ,|rectal bleeding, , ,
214060|NCT02855385|Attitude|attitude
214061|NCT02855385|Health seeking behaviour|health seeking behaviour
214062|NCT02855385|Nigeria|nigeria
214063|NCT02855385|Screening|screening
214064|NCT02855385|high risk patients|high risk patients
214065|NCT02855359|Antibodies, Monoclonal|antibodies, monoclonal
214066|NCT02855359|SGN-19A|sgn-19a
214067|NCT02855359|Denintuzumab Mafodotin|denintuzumab mafodotin
214068|NCT02855359|DLBCL|dlbcl
214069|NCT02855359|Antibody-Drug Conjugate|antibody-drug conjugate
214070|NCT02855359|Antigens, CD19|antigens, cd19
214071|NCT02855359|Hematologic Diseases|hematologic diseases
214072|NCT02855359|Immune System Diseases|immune system diseases
214073|NCT02855359|Immunoproliferative Disorders|immunoproliferative disorders
214074|NCT02855359|Immunotherapy|immunotherapy
214075|NCT02855359|Lymphatic Diseases|lymphatic diseases
214076|NCT02855359|Lymphoma|lymphoma
214077|NCT02855359|Lymphoma, B-Cell|lymphoma, b-cell
214078|NCT02855359|Lymphoma, Large B-Cell, Diffuse|lymphoma, large b-cell, diffuse
214079|NCT02855359|Lymphoma, Non-Hodgkin|lymphoma, non-hodgkin
214080|NCT02855359|Monomethyl auristatin F|monomethyl auristatin f
214081|NCT02855359|Neoplasms|neoplasms
214082|NCT02855359|Neoplasms by Histologic Type|neoplasms by histologic type
214083|NCT02855359|Transformed Lymphoma / DLBCL|transformed lymphoma / dlbcl
214084|NCT02855359|Cyclophosphamide|cyclophosphamide
214085|NCT02855359|Doxorubicin|doxorubicin
214086|NCT02855359|Liposomal doxorubicin|liposomal doxorubicin
214087|NCT02855359|Prednisone|prednisone
214088|NCT02855359|Rituximab|rituximab
214089|NCT02855359|Vincristine|vincristine
214090|NCT02855359|Alkylating Agents|alkylating agents
214091|NCT02855359|Anti-Inflammatory Agents|anti-inflammatory agents
214092|NCT02855359|Antibiotic, Antineoplastic|antibiotic, antineoplastic
214093|NCT02855359|Antimitotic Agents|antimitotic agents
214094|NCT02855359|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating
214095|NCT02855359|Antineoplastic Agents|antineoplastic agents
214096|NCT02855359|Phytogenic Antirheumatic Agents|phytogenic antirheumatic agents
214097|NCT02855359|Glucocorticoids|glucocorticoids
214098|NCT02855359|Drug Therapy|drug therapy
214099|NCT02855359|Follicular Lymphoma Grade 3b|follicular lymphoma grade 3b
214100|NCT02855359|immunosuppressive agents|immunosuppressive agents
214101|NCT02855333|Merendino procedure|merendino procedure
214102|NCT02855333|Feasibility, Safety and QoL of the Merendino procedure|feasibility, safety and qol of the merendino procedure
214103|NCT02855320|Biologics safety|biologics safety
214104|NCT02855320|Rheumatoid arthritis|rheumatoid arthritis
214105|NCT02855320|Spondyloarthritis|spondyloarthritis
214106|NCT02855320|patient education|patient education
214107|NCT02855320|self-management|self-management
214108|NCT02855307|Closed-loop system|closed-loop system
214109|NCT02855307|Artificial pancreas|artificial pancreas
214110|NCT02855307|Exercise|exercise
214111|NCT02855307|Hypoglycemia|hypoglycemia
214112|NCT02855307|Insulin|insulin
214113|NCT02855307|Type 1 diabetes|type 1 diabetes
214114|NCT02855294|oral contraceptive pills|oral contraceptive pills
214115|NCT02855294|Joint stability|joint stability
214116|NCT02855268|Kidney disease|kidney disease
214117|NCT02855268|Nephritis|nephritis
214118|NCT02855268|Hereditary nephritis|hereditary nephritis
214119|NCT02855268|Hereditary kidney disease|hereditary kidney disease
214120|NCT02855229|Translational|translational
214121|NCT02855229|Electrophysiology|electrophysiology
214122|NCT02855216|Physiotherapy|physiotherapy
214123|NCT02855216|Range of motion|range of motion
214124|NCT02855216|Inhibition sub-occipital techniques|inhibition sub-occipital techniques
214125|NCT02855190|Ga68-citrate|ga68-citrate
214126|NCT02855190|FDG|fdg
214127|NCT02855190|PET/MR and PET/CT|pet/mr and pet/ct
214128|NCT02855190|Periprosthetic joint infection|periprosthetic joint infection
214129|NCT02855177|Hyperlipidemia|hyperlipidemia
214130|NCT02855164|LJN452|ljn452
214131|NCT02855164|non-alcoholic steatohepatitis|non-alcoholic steatohepatitis
214132|NCT02855164|NASH|nash
214133|NCT02855164|phase 2|phase 2
214134|NCT02855164|adaptive design|adaptive design
214135|NCT02855164|randomized|randomized
214136|NCT02855151|EUS|eus
214137|NCT02855138|isotretinoin|isotretinoin
214138|NCT02855138|PCOS|pcos
214139|NCT02855138|acne vulgaris|acne vulgaris
214140|NCT02855125|NSCLC|nsclc
214141|NCT02855125|phase 2 study|phase 2 study
214142|NCT02855125|TAS-114|tas-114
214143|NCT02855125|S-1|s-1
214144|NCT02855073|adipose-derived mesenchymal progenitor cells|adipose-derived mesenchymal progenitor cells
214145|NCT02855073|Artz|artz
214146|NCT02855034|child and infant|child and infant
214147|NCT02855034|Blood samples|blood samples
214148|NCT02855021|Dementia|dementia
214149|NCT02855021|Cerebral metabolism|cerebral metabolism
214150|NCT02855021|PET scan|pet scan
214151|NCT02855008|Social Problem-Solving|social problem-solving
214152|NCT02855008|Intellectual Disability|intellectual disability
214153|NCT02855008|Problem Behaviors|problem behaviors
214154|NCT02855008|Community based intervention|community based intervention
214155|NCT02855008|Prevention|prevention
214156|NCT02854956|phenotype|phenotype
214157|NCT02854956|X-linked mental retardation|x-linked mental retardation
214158|NCT02854956|neuronal networks|neuronal networks
214159|NCT02854956|cognitive processes|cognitive processes
214160|NCT02854930|Clinical death|clinical death
214161|NCT02854930|state of consciousness|state of consciousness
214162|NCT02854904|Immunomodulatory|immunomodulatory
214163|NCT02854904|dexmedetomidine|dexmedetomidine
214164|NCT02854904|anesthesia|anesthesia
214165|NCT02854904|alpha-2 agonist|alpha-2 agonist
214166|NCT02854904|arthrodesis|arthrodesis
214167|NCT02854904|spinal fusion|spinal fusion
214168|NCT02854904|Immune effect|immune effect
214169|NCT02854904|double randomized clinical trials|double randomized clinical trials
214171|NCT02854891|Heat|heat
214172|NCT02854891|Light|light
214173|NCT02854826|Frail Older Adults, Interprofessional Team|frail older adults, interprofessional team
214174|NCT02854813|overactive bladder|overactive bladder
214175|NCT02854813|coronary artery disease|coronary artery disease
214176|NCT02854813|gensini score|gensini score
214177|NCT02854800|varenicline|varenicline
214178|NCT02854800|buprenorphine|buprenorphine
214179|NCT02854787|Spinal anesthesia|spinal anesthesia
214180|NCT02854787|cesarean|cesarean
214181|NCT02854787|blood pressure|blood pressure
214182|NCT02854787|Norepinephrine|norepinephrine
214183|NCT02854787|Phenylephrine|phenylephrine
214184|NCT02854735|Head and Neck Neoplasms|head and neck neoplasms
214185|NCT02854735|Total body composition|total body composition
214186|NCT02854735|Dual-Energy X-Ray Absorptiometry|dual-energy x-ray absorptiometry
214187|NCT02854735|Malnutrition|malnutrition
214188|NCT02854735|Muscle quantification|muscle quantification
214189|NCT02854722|deferasirox|deferasirox
214190|NCT02854722|iron accumulation|iron accumulation
214191|NCT02854696|Islet cell Transplantation|islet cell transplantation
214192|NCT02854696|cost-effectiveness analysis|cost-effectiveness analysis
214193|NCT02854696|Cost-utility analysis|cost-utility analysis
214194|NCT02854696|Type 1 Diabetes|type 1 diabetes
214195|NCT02854683|Chronic Fatigue Syndrome (CFS)|chronic fatigue syndrome (cfs)
214196|NCT02854683|Myalgic Encephalomyelitis (ME)|myalgic encephalomyelitis (me)
214197|NCT02854683|Postural Tachycardia Syndrome (POTS)|postural tachycardia syndrome (pots)
214198|NCT02854683|Neurally Mediated Syncope (NMS)|neurally mediated syncope (nms)
214199|NCT02854683|Systemic Exertion Intolerance Disease (SEID)|systemic exertion intolerance disease (seid)
214200|NCT02854683|Orthostatic Intolerance (OI)|orthostatic intolerance (oi)
214201|NCT02854683|Oral Rehydration Solution (ORS)|oral rehydration solution (ors)
214202|NCT02854683|Lower Body Negative Pressure (LBNP)|lower body negative pressure (lbnp)
214203|NCT02854670|capsaicin|capsaicin
214204|NCT02854670|pain improvement|pain improvement
214205|NCT02854670|provoked vulvodynia|provoked vulvodynia
214206|NCT02854657|melanoma|melanoma
214207|NCT02854657|skin self-examination|skin self-examination
214208|NCT02854631|Cirrhosis|cirrhosis
214209|NCT02854631|Prednisone|prednisone
214210|NCT02854631|Jaundice|jaundice
214211|NCT02854605|Non-alcoholic fatty liver disease (NAFLD)|non-alcoholic fatty liver disease (nafld)
214212|NCT02854605|Fibrosis|fibrosis
214213|NCT02854605|GS-9674|gs-9674
214214|NCT02854592|rtPA|rtpa
214215|NCT02854592|urokinase|urokinase
214216|NCT02854579|Hypoxic-Ischemic Encephalopathy|hypoxic-ischemic encephalopathy
214217|NCT02854579|progenitor cell|progenitor cell
214218|NCT02854579|paracrine factor|paracrine factor
214219|NCT02854579|adipose mesenchymal stem cell|adipose mesenchymal stem cell
214220|NCT02854579|neonate|neonate
214221|NCT02854566|periprosthetic fracture of the femur|periprosthetic fracture of the femur
214222|NCT02854566|hip prosthesis|hip prosthesis
214223|NCT02854540|hyperhidrosis|hyperhidrosis
214224|NCT02854540|palmar|palmar
214225|NCT02854540|sweating|sweating
214226|NCT02854540|iontophoresis|iontophoresis
214227|NCT02854540|sweat gland diseases|sweat gland diseases
214228|NCT02854540|skin diseases|skin diseases
214229|NCT02854514|endometrial -cytokines|endometrial -cytokines
214230|NCT02854501|Homocysteine|homocysteine
214231|NCT02854501|Preeclampsia|preeclampsia
214232|NCT02854501|poor placentation|poor placentation
214233|NCT02854475|skin parameters|skin parameters
214234|NCT02854475|cholesterol|cholesterol
214235|NCT02854475|Raman spectroscopy|raman spectroscopy
214236|NCT02854462|Language Development|language development
214237|NCT02854462|Shared Picture Book reading|shared picture book reading
214238|NCT02854462|Preschoolers|preschoolers
214239|NCT02854462|Inference making|inference making
214240|NCT02854449|Immune Marker|immune marker
214241|NCT02854449|Immunologic Marker|immunologic marker
214242|NCT02854449|Radiotherapy|radiotherapy
214243|NCT02854449|Dose Hypofractionation|dose hypofractionation
214244|NCT02854436|Prostate cancer|prostate cancer
214245|NCT02854436|CRPC|crpc
214246|NCT02854436|Metastatic castrate-resistant prostate cancer|metastatic castrate-resistant prostate cancer
214247|NCT02854436|Prostate neoplasm|prostate neoplasm
214248|NCT02854436|Galahad|galahad
214249|NCT02854436|Niraparib|niraparib
214250|NCT02854436|DNA anomalies|dna anomalies
214251|NCT02854436|DNA defect|dna defect
214252|NCT02854436|PARP inhibitor|parp inhibitor
214253|NCT02854436|PARPi|parpi
214254|NCT02854410|dietary sodium nitrate|dietary sodium nitrate
214255|NCT02854410|radiotherapy|radiotherapy
214256|NCT02854410|nasopharyngeal carcinoma|nasopharyngeal carcinoma
214257|NCT02854384|Epilepsy|epilepsy
214258|NCT02854384|Mobile phone|mobile phone
214259|NCT02854371|gadoxetic acid|gadoxetic acid
214260|NCT02854371|T1 map|t1 map
214261|NCT02854371|MRI|mri
214262|NCT02854345|CZT camera|czt camera
214263|NCT02854345|pinhole|pinhole
214264|NCT02854332|Pain|pain
214265|NCT02854332|Analgesic|analgesic
214266|NCT02854332|Stimulation|stimulation
214267|NCT02854332|Motor Cortex|motor cortex
214268|NCT02854306|Bariatric surgery|bariatric surgery
214269|NCT02854306|Mindfulness|mindfulness
214270|NCT02854306|Obese|obese
214271|NCT02854293|palliative care|palliative care
214272|NCT02854293|cancer|cancer
214273|NCT02854293|quality of life|quality of life
214274|NCT02854280|Hypoxia|hypoxia
214275|NCT02854280|Brain|brain
214276|NCT02854280|Effort|effort
214277|NCT02854267|organ procurement|organ procurement
214278|NCT02854267|brain death|brain death
214279|NCT02854267|organ donation|organ donation
214280|NCT02854267|next of kins|next of kins
214281|NCT02854254|phlebitis|phlebitis
214282|NCT02854254|catheter|catheter
214283|NCT02854254|congestive heart failure|congestive heart failure
214284|NCT02854254|dobutamine|dobutamine
214285|NCT02854241|MRI|mri
214286|NCT02854241|HCC|hcc
214287|NCT02854241|surveillance|surveillance
214288|NCT02854228|Pituitary tumor|pituitary tumor
214289|NCT02854228|pituitary carcinoma|pituitary carcinoma
214290|NCT02854228|acromegaly|acromegaly
214291|NCT02854228|cushing|cushing
214292|NCT02854228|prolactinoma|prolactinoma
214293|NCT02854163|Secukinumab|secukinumab
214294|NCT02854163|Neutrophils|neutrophils
214295|NCT02854163|Vitamin D|vitamin d
214296|NCT02854124|Melanoma|melanoma
214297|NCT02854124|Dissemination|dissemination
214298|NCT02854124|Initiating stem cells|initiating stem cells
214299|NCT02854098|BHJS, constipation|bhjs, constipation
214430|NCT02853396|self stigma|self stigma
214300|NCT02854085|Prevention of Cognitive Decline|prevention of cognitive decline
214301|NCT02854085|Art Therapy|art therapy
214302|NCT02854085|Music Reminiscence Activity|music reminiscence activity
214303|NCT02854085|Elderly|elderly
214304|NCT02854072|GV1001|gv1001
214305|NCT02854059|Asymptomatic antibody-mediated TTP|asymptomatic antibody-mediated ttp
214306|NCT02854046|calcific uremic arteriolopathy|calcific uremic arteriolopathy
214307|NCT02854046|case-control study|case-control study
214308|NCT02854046|cohort study|cohort study
214309|NCT02854033|amyloid|amyloid
214310|NCT02854033|plaques|plaques
214311|NCT02854033|neuroimaging|neuroimaging
214312|NCT02854033|biomarkers|biomarkers
214313|NCT02854033|cognition disorder|cognition disorder
214314|NCT02854033|early detection|early detection
214315|NCT02854033|pre-dementia|pre-dementia
214316|NCT02854033|dementia|dementia
214317|NCT02854033|Alzheimer's disease|alzheimer's disease
214318|NCT02854033|tau|tau
214319|NCT02854020|Aircraft|aircraft
214320|NCT02854020|Emergency|emergency
214321|NCT02854020|First aid|first aid
214322|NCT02854020|Cabin crew|cabin crew
214323|NCT02854020|Burn|burn
214324|NCT02854020|Cardiac arrest|cardiac arrest
214325|NCT02854007|Coronary artery disease|coronary artery disease
214326|NCT02854007|Angioplasty|angioplasty
214327|NCT02854007|Bioresorbable coronary device|bioresorbable coronary device
214328|NCT02854007|QALY (Quality-Adjusted Life Years)|qaly (quality-adjusted life years)
214329|NCT02853994|DCB|dcb
214330|NCT02853994|DEB|deb
214331|NCT02853994|Sirolimus|sirolimus
214332|NCT02853994|PCI|pci
214333|NCT02853994|ISR|isr
214334|NCT02853994|SVD|svd
214335|NCT02853994|Restenosis|restenosis
214336|NCT02853994|Bifurcation|bifurcation
214337|NCT02853994|CAD|cad
214338|NCT02853994|Coronary artery|coronary artery
214339|NCT02853968|Unlock the Cell|unlock the cell
214340|NCT02853968|Castleman's Disease|castleman's disease
214341|NCT02853968|CD|cd
214342|NCT02853968|Castleman Disease|castleman disease
214343|NCT02853968|MCD|mcd
214344|NCT02853968|iMCD|imcd
214345|NCT02853968|Angiofollicular Lymph Hyperplasia|angiofollicular lymph hyperplasia
214346|NCT02853968|multicentric Castleman's disease|multicentric castleman's disease
214347|NCT02853968|multicentric Castleman disease|multicentric castleman disease
214348|NCT02853968|idiopathic multicentric Castleman disease|idiopathic multicentric castleman disease
214349|NCT02853929|Pertussis|pertussis
214458|NCT02853240|children|children
214350|NCT02853929|Immunogenicity|immunogenicity
214351|NCT02853929|Poliomyelitis|poliomyelitis
214352|NCT02853929|Tetanus|tetanus
214353|NCT02853929|Hepatitis B|hepatitis b
214354|NCT02853929|Diptheria|diptheria
214355|NCT02853903|solid tumor|solid tumor
214356|NCT02853903|NK immunotherapy|nk immunotherapy
214357|NCT02853890|Birth|birth
214358|NCT02853890|obstetric analgesia|obstetric analgesia
214359|NCT02853890|obstetric anesthesia|obstetric anesthesia
214360|NCT02853864|Gender|gender
214361|NCT02853864|Propofol|propofol
214362|NCT02853864|Dexmedetomidine|dexmedetomidine
214363|NCT02853864|Interaction|interaction
214364|NCT02853851|Stress factors,|stress factors,
214365|NCT02853851|intensive care units,|intensive care units,
214366|NCT02853851|scale,|scale,
214367|NCT02853851|quality of care|quality of care
214368|NCT02853838|acute viral bronchiolitis|acute viral bronchiolitis
214369|NCT02853838|respiratory syncytial virus|respiratory syncytial virus
214370|NCT02853838|chest physiotherapy|chest physiotherapy
214371|NCT02853812|tinnitus|tinnitus
214372|NCT02853812|residual inhibition|residual inhibition
214373|NCT02853786|cochlear implant|cochlear implant
214374|NCT02853786|language environment|language environment
214375|NCT02853786|speech therapy assessment|speech therapy assessment
214376|NCT02853786|LENA technology|lena technology
214377|NCT02853773|sweeteners|sweeteners
214378|NCT02853773|sugar|sugar
214379|NCT02853773|EEG|eeg
214380|NCT02853773|food viewing|food viewing
214381|NCT02853773|food intake|food intake
214382|NCT02853747|arterial stiffness|arterial stiffness
214383|NCT02853747|retinal vessels|retinal vessels
214384|NCT02853747|physical activity|physical activity
214385|NCT02853747|children|children
214386|NCT02853708|E. coli|e. coli
214387|NCT02853708|extended-spectrum beta-lactamase|extended-spectrum beta-lactamase
214388|NCT02853708|molecular epidemiology|molecular epidemiology
214389|NCT02853708|risk factors|risk factors
214390|NCT02853695|Hysteroscopy|hysteroscopy
214391|NCT02853695|Diffusion|diffusion
214392|NCT02853695|Implementation|implementation
214393|NCT02853695|Diagnostic hysteroscopy|diagnostic hysteroscopy
214394|NCT02853695|Operative hysteroscopy|operative hysteroscopy
214395|NCT02853682|glycocalyx|glycocalyx
214396|NCT02853682|capillary leak syndrome|capillary leak syndrome
214397|NCT02853656|preterm birth|preterm birth
214398|NCT02853656|gestation|gestation
214399|NCT02853617|S. pneumoniae|s. pneumoniae
214400|NCT02853617|N. meningitidis|n. meningitidis
214401|NCT02853617|H. influenza|h. influenza
214402|NCT02853617|B. pertussis|b. pertussis
214403|NCT02853617|C. tetani|c. tetani
214404|NCT02853617|MRSA|mrsa
214405|NCT02853591|laparoscopy|laparoscopy
214406|NCT02853591|hysterectomy|hysterectomy
214407|NCT02853500|Liver Cancer|liver cancer
214408|NCT02853487|Cluster headache|cluster headache
214409|NCT02853487|actigraphy|actigraphy
214410|NCT02853487|circadian rhythm|circadian rhythm
214411|NCT02853461|biofilm|biofilm
214412|NCT02853461|periprosthetic joint infection|periprosthetic joint infection
214413|NCT02853461|hip|hip
214414|NCT02853461|endoprothesis|endoprothesis
214415|NCT02853461|ceramic|ceramic
214416|NCT02853461|bearing components|bearing components
214417|NCT02853461|sonication|sonication
214418|NCT02853461|low grade infection|low grade infection
214419|NCT02853461|joint aspiration|joint aspiration
214420|NCT02853448|Plasma|plasma
214421|NCT02853448|Serum|serum
214422|NCT02853448|Effective Blood Draws|effective blood draws
214423|NCT02853435|Cross-over|cross-over
214424|NCT02853435|Gepotidacin|gepotidacin
214425|NCT02853435|Pharmacokinetics|pharmacokinetics
214426|NCT02853435|Relative Bioavailability|relative bioavailability
214427|NCT02853435|non-compartmental PK analysis|non-compartmental pk analysis
214428|NCT02853435|High shear wet granulation|high shear wet granulation
214429|NCT02853396|internalised stigma|internalised stigma
214431|NCT02853396|inpatients|inpatients
214432|NCT02853396|CBT|cbt
214433|NCT02853396|Cognitive therapy|cognitive therapy
214434|NCT02853383|Chronic Obstructive Pulmonary Diseases, COPD|chronic obstructive pulmonary diseases, copd
214435|NCT02853357|Thoracic manipulation|thoracic manipulation
214436|NCT02853357|Low back pain|low back pain
214437|NCT02853357|Core strengthening|core strengthening
214438|NCT02853357|Thoracic spine thrust manipulation|thoracic spine thrust manipulation
214439|NCT02853344|PD1|pd1
214440|NCT02853344|PD-1|pd-1
214441|NCT02853344|PDL1|pdl1
214442|NCT02853344|PD-L1|pd-l1
214443|NCT02853331|PD1|pd1
214444|NCT02853331|PD-1|pd-1
214445|NCT02853331|PDL1|pdl1
214446|NCT02853331|PD-L1|pd-l1
214447|NCT02853331|PDL2|pdl2
214448|NCT02853331|PD-L2|pd-l2
214449|NCT02853331|VEGFR TKI|vegfr tki
214450|NCT02853305|PD1|pd1
214451|NCT02853305|PD-1|pd-1
214452|NCT02853305|PDL1|pdl1
214453|NCT02853305|PD-L1|pd-l1
214454|NCT02853266|Kawasaki disease|kawasaki disease
214455|NCT02853266|non-cruzi-related antibody (NCRA)|non-cruzi-related antibody (ncra)
214456|NCT02853253|Preterm neonates|preterm neonates
214457|NCT02853240|Cerebral palsy|cerebral palsy
214459|NCT02853240|muscle spasticity|muscle spasticity
214460|NCT02853240|botulinum toxin injection|botulinum toxin injection
214461|NCT02853227|Telemark score, reliability|telemark score, reliability
214462|NCT02853214|Dysglobulinemia|dysglobulinemia
214463|NCT02853214|Multiple Myeloma|multiple myeloma
214464|NCT02853214|MGUS|mgus
214465|NCT02853214|Waldenström|waldenström
214466|NCT02853214|genetic factors|genetic factors
214467|NCT02853214|Sequencing|sequencing
214468|NCT02853201|Extubation|extubation
214469|NCT02853201|Intercostal Muscles|intercostal muscles
214470|NCT02853201|Diaphragm|diaphragm
214471|NCT02853201|Sternocleidomastoid Muscle|sternocleidomastoid muscle
214472|NCT02853162|Stereotactic body radiotherapy|stereotactic body radiotherapy
214473|NCT02853162|MRI|mri
214474|NCT02853162|Renal cell carcinoma|renal cell carcinoma
214475|NCT02853149|Spinal Cord Injury|spinal cord injury
214476|NCT02853149|disability|disability
214477|NCT02853149|obesity|obesity
214478|NCT02853149|cardiometabolic|cardiometabolic
214479|NCT02853149|Caregiver|caregiver
214480|NCT02853110|MRI, stereotactic body radiotherapy, hypofractionation|mri, stereotactic body radiotherapy, hypofractionation
214481|NCT02853084|Auto-inflammatory diseases|auto-inflammatory diseases
214482|NCT02853084|IL-1 inhibitors|il-1 inhibitors
214483|NCT02853084|HL2351|hl2351
214484|NCT02853084|Cryopyrin‑Associated Periodic Syndromes (CAPS)|cryopyrin‑associated periodic syndromes (caps)
214485|NCT02853084|Neonatal Onset Multisystem Inflammatory Disease (NOMID)|neonatal onset multisystem inflammatory disease (nomid)
214486|NCT02853084|Muckle-Wells Syndrome (MWS)|muckle-wells syndrome (mws)
214487|NCT02853084|Familial Cold Autoinflammatory Syndrome (FCAS)|familial cold autoinflammatory syndrome (fcas)
214488|NCT02853058|stillbirth|stillbirth
214489|NCT02853058|hemorrhage|hemorrhage
214490|NCT02853019|Emotion|emotion
214491|NCT02853019|motivation|motivation
214492|NCT02853019|cognition|cognition
214493|NCT02853019|schizophrenia|schizophrenia
214494|NCT02853006|Cancer lung|cancer lung
214495|NCT02853006|Fluids|fluids
214496|NCT02853006|LungCancerTest|lungcancertest
214497|NCT02853006|radiological anomalies|radiological anomalies
214498|NCT02853006|non-cancerous|non-cancerous
214499|NCT02853006|carriers|carriers
214500|NCT02853006|Patient reference|patient reference
214501|NCT02852993|Erythrocyte Transfusion|erythrocyte transfusion
214502|NCT02852993|Survival|survival
214503|NCT02852967|Skin Diseases|skin diseases
214504|NCT02852967|Auto-Immune Diseases|auto-immune diseases
214505|NCT02852967|Plaque|plaque
214506|NCT02852967|Dermatology|dermatology
214507|NCT02852954|Progesterone Induced Blocking Factor|progesterone induced blocking factor
214508|NCT02852954|Endometrial Cancer|endometrial cancer
214509|NCT02852941|Impedance|impedance
214510|NCT02852941|Kidney Transplantation|kidney transplantation
214511|NCT02852928|ILD; chILD|ild; child
214512|NCT02852915|Colonic Neoplasms|colonic neoplasms
214513|NCT02852915|Laparoscopic Surgery|laparoscopic surgery
214514|NCT02852915|T4|t4
214515|NCT02852902|Bloodstream infections caused by MDR Enterobacteriaceae|bloodstream infections caused by mdr enterobacteriaceae
214516|NCT02852902|Extended-spectrum β-lactamase-producers|extended-spectrum β-lactamase-producers
214517|NCT02852902|Carbapenemase-producing organisms|carbapenemase-producing organisms
214518|NCT02852902|Solid Organ Transplantation|solid organ transplantation
214519|NCT02852902|Multidrug-resistant Enterobacteriaceae|multidrug-resistant enterobacteriaceae
214520|NCT02852902|Anti-Infective Agents|anti-infective agents
214521|NCT02852889|internal jugular vein distensibility,haemodynamics|internal jugular vein distensibility,haemodynamics
214522|NCT02852876|Safety of ASP2151|safety of asp2151
214523|NCT02852876|Phase 1|phase 1
214524|NCT02852876|Pharmacokinetics|pharmacokinetics
214525|NCT02852876|Healthy male subjects|healthy male subjects
214526|NCT02852876|Tolerability|tolerability
214527|NCT02852876|Food effect of ASP2151|food effect of asp2151
214528|NCT02852811|Climacteric|climacteric
214529|NCT02852811|Education|education
214530|NCT02852811|Mental health|mental health
214531|NCT02852811|Menopause|menopause
214532|NCT02852772|Cognitive impairment|cognitive impairment
214533|NCT02852772|HIV|hiv
214534|NCT02852772|Microalbuminuria|microalbuminuria
214535|NCT02852772|Chronic kidney disease|chronic kidney disease
214536|NCT02852720|Pharmacokinetics|pharmacokinetics
214537|NCT02852720|levobupivacaine|levobupivacaine
214538|NCT02852720|Pregnancy|pregnancy
214539|NCT02852720|Cesarean section|cesarean section
214540|NCT02852720|Electrocardiography|electrocardiography
214541|NCT02852668|elderly|elderly
214542|NCT02852668|strength training|strength training
214543|NCT02852668|power training|power training
274317|NCT02493868|Placebo|placebo
214544|NCT02852668|functional capacity|functional capacity
214545|NCT02852668|gait biomechanics|gait biomechanics
214546|NCT02852655|Brain Tumor|brain tumor
214547|NCT02852642|power training|power training
214548|NCT02852642|plyometric training|plyometric training
214549|NCT02852642|functional capacity|functional capacity
214550|NCT02852629|decision-support sheet|decision-support sheet
214551|NCT02852616|Course|course
214552|NCT02852616|Posttraumatic Stress Disorder|posttraumatic stress disorder
214553|NCT02852616|Narrative Exposure Therapy|narrative exposure therapy
214554|NCT02852603|dissection|dissection
214555|NCT02852603|aneurysm|aneurysm
214556|NCT02852603|thoracic aorta|thoracic aorta
214557|NCT02852590|Observational|observational
214558|NCT02852590|Pediatric|pediatric
214559|NCT02852590|Off-Label Use|off-label use
214560|NCT02852590|Unlicensed drug use|unlicensed drug use
214561|NCT02852590|Adverse Drug Reaction|adverse drug reaction
214562|NCT02852590|Hospitalized Children|hospitalized children
214563|NCT02852590|Pediatric inpatients|pediatric inpatients
214564|NCT02852577|panic disorder|panic disorder
214565|NCT02852577|agoraphobia|agoraphobia
214566|NCT02852577|clonazepam|clonazepam
214567|NCT02852577|paroxetine|paroxetine
214568|NCT02852564|Non-Muscle|non-muscle
214569|NCT02852564|Invasive|invasive
214570|NCT02852564|Bladder|bladder
214571|NCT02852564|Cancer|cancer
214572|NCT02852564|Muscle|muscle
214573|NCT02852564|Surgery|surgery
214574|NCT02852564|Transurethral|transurethral
214575|NCT02852564|Resection|resection
214576|NCT02852564|Tumor|tumor
214577|NCT02852564|Ethacrynic|ethacrynic
214578|NCT02852564|Acid|acid
214579|NCT02852564|Mitomycin|mitomycin
214580|NCT02852564|Urine|urine
214581|NCT02852564|NMIBC|nmibc
214582|NCT02852512|Laparoscopic Sacrocolpopexy|laparoscopic sacrocolpopexy
214583|NCT02852512|Robotic Assisted Sacrocolpopexy|robotic assisted sacrocolpopexy
214584|NCT02852512|Pelvic Organ Prolapse|pelvic organ prolapse
214585|NCT02852499|environmental epidemiology|environmental epidemiology
214586|NCT02852499|cohort|cohort
214587|NCT02852499|atmospheric pollutant|atmospheric pollutant
214588|NCT02852499|chemical pollutant|chemical pollutant
214589|NCT02852499|growth, neuro-development, respiratory health|growth, neuro-development, respiratory health
214590|NCT02852499|big data|big data
214591|NCT02852499|biological samples (RNA, DNA, urines ...)|biological samples (rna, dna, urines ...)
214592|NCT02852499|e-dohad and exposome|e-dohad and exposome
214593|NCT02852486|BCR-ABL Positive|bcr-abl positive
214594|NCT02852486|Leukemia, Chronic Myeloid|leukemia, chronic myeloid
214595|NCT02852486|Imatinib|imatinib
214596|NCT02852486|Pioglitazone|pioglitazone
214597|NCT02852473|Continuous Positive Airway Pressure|continuous positive airway pressure
214598|NCT02852473|Radiotherapy|radiotherapy
214599|NCT02852473|Proton Therapy|proton therapy
214600|NCT02852382|scalp block|scalp block
214601|NCT02852382|local infiltration|local infiltration
214602|NCT02852330|Voltage tomography|voltage tomography
214603|NCT02852304|liver|liver
214604|NCT02852304|transplant|transplant
214605|NCT02852304|Lysosomal Acid Lipase|lysosomal acid lipase
214606|NCT02852278|Amyotrophic Lateral Sclerosis|amyotrophic lateral sclerosis
214607|NCT02852278|ALS|als
214608|NCT02852278|motor neuron diseases|motor neuron diseases
214609|NCT02852278|Progressive Muscular Atrophy|progressive muscular atrophy
214610|NCT02852278|Primary Lateral Sclerosis|primary lateral sclerosis
214611|NCT02852278|Hereditary Spastic Paraplegia|hereditary spastic paraplegia
214612|NCT02852265|oral contraceptive|oral contraceptive
214613|NCT02852265|contraceptive implant|contraceptive implant
214614|NCT02852265|contraception|contraception
214615|NCT02852265|adherence|adherence
214616|NCT02852265|adverse event|adverse event
214617|NCT02852239|Renal impairment|renal impairment
214618|NCT02852239|Healthy volunteers|healthy volunteers
214619|NCT02852239|Clinical pharmacology study|clinical pharmacology study
214620|NCT02852239|DRB436|drb436
214621|NCT02852239|dabrafenib|dabrafenib
214622|NCT02852239|normal renal function|normal renal function
214623|NCT02852239|impaired renal function|impaired renal function
214624|NCT02852213|AADC|aadc
214625|NCT02852213|gene therapy|gene therapy
214626|NCT02852187|Intervertebral Disc Degeneration|intervertebral disc degeneration
214627|NCT02852187|Lumbar Spinal Disease|lumbar spinal disease
214628|NCT02852148|Wound|wound
214629|NCT02852148|Pressure Ulcer|pressure ulcer
214630|NCT02852148|Diabetic Foot Ulcer|diabetic foot ulcer
214631|NCT02852148|Venous Leg Ulcer|venous leg ulcer
214632|NCT02852148|Burn|burn
214633|NCT02852148|Quality of Life|quality of life
214634|NCT02852135|Laryngeal Mask Airway|laryngeal mask airway
214635|NCT02852135|lateral position|lateral position
214636|NCT02852135|laparoscopic surgery|laparoscopic surgery
214637|NCT02852122|prostate cancer|prostate cancer
214638|NCT02852122|C11 Choline PET/MR|c11 choline pet/mr
214639|NCT02852122|staging|staging
214640|NCT02852122|biochemical failure|biochemical failure
214641|NCT02852096|gastric cancer|gastric cancer
214642|NCT02852096|Her2/neu|her2/neu
214643|NCT02852096|dual paraffin blocks|dual paraffin blocks
214644|NCT02852096|trastuzumab|trastuzumab
214645|NCT02852070|bronchoalveolar lavage|bronchoalveolar lavage
214646|NCT02852070|lower respiratory tract infections|lower respiratory tract infections
214647|NCT02851979|premature newborns|premature newborns
214648|NCT02851979|apneas prevention|apneas prevention
214649|NCT02851979|olfactory stimulation|olfactory stimulation
214650|NCT02851979|latin square design|latin square design
214651|NCT02851966|Non-obstructive Azoospermia|non-obstructive azoospermia
214652|NCT02851966|Sperm Retrieval|sperm retrieval
214653|NCT02851966|Infertility, Male|infertility, male
214654|NCT02851966|Semen|semen
214655|NCT02851966|Biomarkers|biomarkers
214656|NCT02851966|Proteomics|proteomics
214657|NCT02851966|Enzyme-Linked Immunosorbent Assay|enzyme-linked immunosorbent assay
214658|NCT02851953|cervix, cervical dilation, balloon catheter|cervix, cervical dilation, balloon catheter
214659|NCT02851940|Pain|pain
214660|NCT02851940|Bleeding|bleeding
214661|NCT02851940|Hemorrhoids|hemorrhoids
214662|NCT02851940|Band Ligation|band ligation
214663|NCT02851940|hypertonic saline sclerotherapy|hypertonic saline sclerotherapy
214664|NCT02851836|attachment|attachment
214665|NCT02851836|adolescent|adolescent
214666|NCT02851836|picture|picture
214667|NCT02851823|Er-YAG lasers|er-yag lasers
214668|NCT02851823|Nd-YAG lasers|nd-yag lasers
214669|NCT02851823|chronic periodontitis|chronic periodontitis
214670|NCT02851823|nonsurgical periodontal debridement|nonsurgical periodontal debridement
214671|NCT02851810|attachment|attachment
214672|NCT02851810|oculomotor marker|oculomotor marker
214673|NCT02851810|emotion regulation|emotion regulation
214674|NCT02851784|hepatocellular carcinoma|hepatocellular carcinoma
214675|NCT02851784|ablation|ablation
214676|NCT02851784|immunotherapy|immunotherapy
214677|NCT02851784|cytokine induced kill cell|cytokine induced kill cell
214678|NCT02851732|Quality Improvement|quality improvement
214679|NCT02851732|Cluster Analysis|cluster analysis
214680|NCT02851719|Urinary Incontinence, Stress|urinary incontinence, stress
214681|NCT02851719|Pelvic Floor|pelvic floor
214682|NCT02851719|Exercise|exercise
214683|NCT02851719|Patient Compliance|patient compliance
214684|NCT02851706|Brain Tumor|brain tumor
214685|NCT02851706|Glioma|glioma
214686|NCT02851706|Astrocytoma|astrocytoma
214687|NCT02851706|Brain Cancer|brain cancer
214688|NCT02851706|Spine Cancer|spine cancer
214689|NCT02851615|Anemia, Sickle Cell|anemia, sickle cell
214690|NCT02851615|Self Care|self care
214691|NCT02851615|Adolescent|adolescent
214692|NCT02851615|Young Adult|young adult
214693|NCT02851615|Disease Management|disease management
214694|NCT02851615|Behavioral Activation|behavioral activation
214695|NCT02851615|Peer Communication|peer communication
214696|NCT02851576|Adenovirus|adenovirus
214697|NCT02851550|liver|liver
214698|NCT02851550|transplant|transplant
214699|NCT02851550|Lysosomal Acid Lipase|lysosomal acid lipase
214700|NCT02851472|TRAGI (transfusion related acute gut injury)|tragi (transfusion related acute gut injury)
214701|NCT02851472|inhaled nitric oxide (iNO)|inhaled nitric oxide (ino)
214702|NCT02851472|prematurity|prematurity
214703|NCT02851472|PRBC transfusion|prbc transfusion
214704|NCT02851472|NEC (necrotizing enterocolitis)|nec (necrotizing enterocolitis)
214705|NCT02851472|NIRS (near infrared spectroscopy)|nirs (near infrared spectroscopy)
214706|NCT02851472|ELGAN (extremely low gestational age neonate)|elgan (extremely low gestational age neonate)
214707|NCT02851459|Vaccines|vaccines
214708|NCT02851407|stem cell transplant|stem cell transplant
214709|NCT02851407|hematopoietic stem cell transplant (HSCT)|hematopoietic stem cell transplant (hsct)
214710|NCT02851407|veno-occlusive disease (VOD)|veno-occlusive disease (vod)
214711|NCT02851407|sinosoidial obstruction syndrome (SOS)|sinosoidial obstruction syndrome (sos)
214712|NCT02851368|Indocyanine Green|indocyanine green
214713|NCT02851368|Fluorescence Imaging|fluorescence imaging
214714|NCT02851342|Cognition|cognition
214715|NCT02851342|MEG|meg
214716|NCT02851329|stage IV EGFR-mutant|stage iv egfr-mutant
214717|NCT02851329|EGFR TKIs|egfr tkis
214718|NCT02851329|progression-free survival|progression-free survival
214719|NCT02851329|prognosis|prognosis
214720|NCT02851329|computed tomography|computed tomography
214721|NCT02851290|Hypospadias|hypospadias
214722|NCT02851290|Caudal block|caudal block
214723|NCT02851290|Dorsal penile nerve block|dorsal penile nerve block
214724|NCT02851290|Anesthesia|anesthesia
214725|NCT02851290|Urethrocutaneous fistula|urethrocutaneous fistula
214726|NCT02851290|Urethral stricture|urethral stricture
214727|NCT02851290|Meatal stenosis|meatal stenosis
214728|NCT02851290|Glanular dehiscence|glanular dehiscence
214729|NCT02851277|Peanut Allergy|peanut allergy
214730|NCT02851277|ASP0892|asp0892
214731|NCT02851264|Early Esophageal Squamous Neoplasia|early esophageal squamous neoplasia
214732|NCT02851264|optical enhancement technology|optical enhancement technology
214733|NCT02851264|virtual chromoendoscopy|virtual chromoendoscopy
214734|NCT02851251|eye disease|eye disease
214735|NCT02851251|neonatal eye disease|neonatal eye disease
214736|NCT02851251|newborn|newborn
214737|NCT02851251|screening|screening
214738|NCT02851251|multicenter|multicenter
214739|NCT02851134|genetic|genetic
214740|NCT02851121|Neurophysiological|neurophysiological
214741|NCT02851121|Perception-action|perception-action
214742|NCT02851121|Link|link
214743|NCT02851108|falciparum malaria|falciparum malaria
214744|NCT02851108|sub saharan|sub saharan
214745|NCT02851108|africa|africa
214746|NCT02851108|elimination disorder|elimination disorder
214747|NCT02851082|Training Program|training program
214748|NCT02851082|Endurance|endurance
214749|NCT02851082|Von Willebrand factor|von willebrand factor
214750|NCT02851069|Chronic Hepatitis C|chronic hepatitis c
214751|NCT02851069|Paritaprevir/r - Ombitasvir, ± Dasabuvir|paritaprevir/r - ombitasvir, ± dasabuvir
214752|NCT02851069|Sustained Virological Response|sustained virological response
214753|NCT02851069|Observational Study|observational study
214754|NCT02851069|Chronic Hepatitis C genotype 1|chronic hepatitis c genotype 1
214755|NCT02851056|Myeloma|myeloma
214756|NCT02851056|Vaccine|vaccine
214757|NCT02851056|Dendritic cell|dendritic cell
214758|NCT02851056|autologous hematopoietic cell transplant|autologous hematopoietic cell transplant
214760|NCT02851030|Child, Preschool|child, preschool
214761|NCT02851030|Child Care|child care
214762|NCT02850991|Esophageal cancer, radiation, chemotherapy|esophageal cancer, radiation, chemotherapy
214763|NCT02850939|Breast cancer|breast cancer
214764|NCT02850939|Endocrine hormonal therapy|endocrine hormonal therapy
214765|NCT02850939|mHealth|mhealth
214766|NCT02850926|Concussion|concussion
214767|NCT02850926|Soccer|soccer
214768|NCT02850926|Adolescent|adolescent
214769|NCT02850874|hyperthermic intraperitoneal chemotherapy|hyperthermic intraperitoneal chemotherapy
214770|NCT02850874|perioperative systemic chemotherapy|perioperative systemic chemotherapy
214771|NCT02850874|peritoneal disease|peritoneal disease
214772|NCT02850848|Pharmacokinetic|pharmacokinetic
214773|NCT02850835|Decision Aid|decision aid
214774|NCT02850835|Pelvic Organ Prolapse (POP)|pelvic organ prolapse (pop)
214775|NCT02850822|chemotherapy|chemotherapy
214776|NCT02850809|radiofrequency ablation|radiofrequency ablation
214777|NCT02850809|complications|complications
214778|NCT02850796|Mindfulness|mindfulness
214779|NCT02850796|self-compassion|self-compassion
214780|NCT02850796|Acceptance and Commitment Therapy|acceptance and commitment therapy
214781|NCT02850796|weight self-stigma|weight self-stigma
214782|NCT02850796|quality-of-life|quality-of-life
214783|NCT02850783|colon cancer|colon cancer
214784|NCT02850757|Modified William's airway|modified william's airway
214785|NCT02850757|fiberoptic bronchoscope|fiberoptic bronchoscope
214786|NCT02850757|U shape Guedls airway|u shape guedls airway
214787|NCT02850757|oral airways|oral airways
214788|NCT02850757|efficacy and safety|efficacy and safety
214789|NCT02850705|Neuromyelitis Optica|neuromyelitis optica
214790|NCT02850705|Myelitis|myelitis
214791|NCT02850705|Optic Neuritis|optic neuritis
214792|NCT02850705|autoantibody|autoantibody
214793|NCT02850705|demyelination|demyelination
214794|NCT02850679|Atrial Fibrillation|atrial fibrillation
214795|NCT02850679|Cardioversion|cardioversion
214796|NCT02850666|social skills|social skills
214797|NCT02850666|child|child
214798|NCT02850666|theory of mind|theory of mind
214799|NCT02850666|drama|drama
214800|NCT02850666|occupational therapy|occupational therapy
214801|NCT02850666|Speech-language pathology|speech-language pathology
214802|NCT02850653|Acute Endophthalmitis.|acute endophthalmitis.
214803|NCT02850653|PCR|pcr
214804|NCT02850653|Ocular sampling|ocular sampling
214805|NCT02850627|acute coronary syndrome|acute coronary syndrome
214806|NCT02850627|Tongguan capsule|tongguan capsule
214807|NCT02850627|miRNAs|mirnas
214808|NCT02850601|Oral lichen planus|oral lichen planus
214809|NCT02850601|Dexamethasone solution|dexamethasone solution
214810|NCT02850562|body composition,|body composition,
214811|NCT02850562|Dual-Energy X-Ray Absorptiometry|dual-energy x-ray absorptiometry
214812|NCT02850562|sarcopenia|sarcopenia
214813|NCT02850562|peripheral quantitative computed tomography|peripheral quantitative computed tomography
214814|NCT02850562|muscle density|muscle density
214815|NCT02850562|elderly|elderly
214816|NCT02850549|neck pain|neck pain
214817|NCT02850549|cervical|cervical
214818|NCT02850549|classification|classification
214819|NCT02850549|outcomes|outcomes
214820|NCT02850549|physical therapy|physical therapy
214821|NCT02850536|Colorectal Cancer|colorectal cancer
214822|NCT02850536|Liver Metastases|liver metastases
214823|NCT02850536|Breast Cancer|breast cancer
214824|NCT02850536|Gastric Cancer|gastric cancer
214825|NCT02850536|Pancreas Cancer|pancreas cancer
214826|NCT02850536|Carcinoembryonic antigen|carcinoembryonic antigen
214827|NCT02850536|CAR-T|car-t
214828|NCT02850536|Immunotherapy|immunotherapy
214829|NCT02850523|Cognitive-behavioural therapy (CBT)|cognitive-behavioural therapy (cbt)
214830|NCT02850510|Harsh discipline|harsh discipline
214831|NCT02850510|parental competence|parental competence
214832|NCT02850510|positive parenting|positive parenting
214833|NCT02850497|optical coherence tomography|optical coherence tomography
214834|NCT02850497|malapposition|malapposition
214835|NCT02850497|endothelization|endothelization
214836|NCT02850471|Postoperative pulmonary complications|postoperative pulmonary complications
214837|NCT02850471|Transcutaneous electric acupoint stimulation|transcutaneous electric acupoint stimulation
214838|NCT02850471|pulmonary protection|pulmonary protection
214839|NCT02850432|Magnetic resonance imaging|magnetic resonance imaging
214840|NCT02850432|Extracellular volume matrix fraction|extracellular volume matrix fraction
214841|NCT02850432|Peripheral artery disease|peripheral artery disease
214842|NCT02850432|Blood-oxygen level dependent|blood-oxygen level dependent
214843|NCT02850432|Cardiac function|cardiac function
214844|NCT02850393|suppression mnemonic|suppression mnemonic
214845|NCT02850393|emotional response|emotional response
214846|NCT02850393|inhibitory control of failures|inhibitory control of failures
214847|NCT02850393|neurological alterations|neurological alterations
214848|NCT02850341|Physical Activity|physical activity
214849|NCT02850341|Mental Health|mental health
214850|NCT02850341|Health Behavior|health behavior
214851|NCT02850341|Walking|walking
214852|NCT02850341|Physical Exercise|physical exercise
214853|NCT02850341|Mental disorder|mental disorder
214854|NCT02850315|optimal coherence tomography|optimal coherence tomography
214855|NCT02850315|myocardial reperfusion|myocardial reperfusion
214856|NCT02850276|HIV disease|hiv disease
214857|NCT02850276|gastrointestinal problems|gastrointestinal problems
214858|NCT02850263|Diabetic Retinopathy|diabetic retinopathy
214859|NCT02850263|Diabetic Macular Oedema|diabetic macular oedema
214860|NCT02850263|Diabetic Macular Edema|diabetic macular edema
214861|NCT02850263|Aflibercept|aflibercept
214862|NCT02850250|Observational|observational
214863|NCT02850250|pharmacokinetic|pharmacokinetic
214864|NCT02850250|cardiac|cardiac
214865|NCT02850250|Cefuroxime|cefuroxime
214866|NCT02850250|Paediatric|paediatric
214867|NCT02850237|cerebral saturation|cerebral saturation
214868|NCT02850237|capnography|capnography
214869|NCT02850237|pre-hospital|pre-hospital
214870|NCT02850198|ischemic stroke|ischemic stroke
214871|NCT02850185|COPD|copd
214872|NCT02850185|hydrogen|hydrogen
214873|NCT02850172|nutrition|nutrition
214874|NCT02850172|exercise|exercise
214875|NCT02850172|inspiratory muscle training|inspiratory muscle training
214876|NCT02850146|tau|tau
214877|NCT02850146|cognition|cognition
214878|NCT02850146|longitudinal|longitudinal
214879|NCT02850146|cognitive decline|cognitive decline
214880|NCT02850146|observational|observational
214881|NCT02850146|imaging|imaging
214882|NCT02850120|surgical mesh|surgical mesh
214883|NCT02850120|observational study|observational study
214884|NCT02850120|intraoperative complications|intraoperative complications
214885|NCT02850120|postoperative complications|postoperative complications
214886|NCT02850107|Atherectomy, Drug-Coated Balloon|atherectomy, drug-coated balloon
214887|NCT02850094|Physical activity|physical activity
214888|NCT02850094|Exercise|exercise
214889|NCT02850094|Financial Incentives|financial incentives
214890|NCT02850081|Carotid endarterectomy|carotid endarterectomy
214891|NCT02850081|CEA|cea
214892|NCT02850081|stroke|stroke
214893|NCT02850081|asymptomatic stenosis|asymptomatic stenosis
214894|NCT02850055|physiotherapy, Temporomandibular Joint Disorder, tinnitus.|physiotherapy, temporomandibular joint disorder, tinnitus.
214895|NCT02850042|motor recovery|motor recovery
214896|NCT02850042|human|human
214897|NCT02850042|occupation-based practice|occupation-based practice
214898|NCT02850042|motor training|motor training
214899|NCT02850042|transcranial magnetic stimulation|transcranial magnetic stimulation
214900|NCT02850029|antimicrobial|antimicrobial
214901|NCT02850029|intensive care units|intensive care units
214902|NCT02850016|Romidepsin|romidepsin
214903|NCT02850016|3BNC117|3bnc117
214904|NCT02850016|Broadly neutralizing antibody|broadly neutralizing antibody
214905|NCT02849977|POMC|pomc
214906|NCT02849977|PCSK1|pcsk1
214907|NCT02849977|Pro-opiomelanocortin|pro-opiomelanocortin
214908|NCT02849964|Incidence|incidence
214909|NCT02849964|Renal Replacement Therapy|renal replacement therapy
214910|NCT02849964|Socioeconomic Factors|socioeconomic factors
214911|NCT02849964|Clinical Practice Pattern|clinical practice pattern
214912|NCT02849951|Colitis|colitis
214913|NCT02849951|Colitis, Ulcerative|colitis, ulcerative
214914|NCT02849951|Ulcer|ulcer
214915|NCT02849951|Colonic Diseases|colonic diseases
214916|NCT02849951|Digestive System Diseases|digestive system diseases
214917|NCT02849951|Gastroenteritis|gastroenteritis
214918|NCT02849951|Gastrointestinal Diseases|gastrointestinal diseases
214919|NCT02849951|Inflammatory Bowel Diseases|inflammatory bowel diseases
214920|NCT02849951|Intestinal Diseases|intestinal diseases
214921|NCT02849951|Pathologic Processes|pathologic processes
214922|NCT02849951|Mesalamine|mesalamine
214923|NCT02849938|children with medical complexity|children with medical complexity
214924|NCT02849938|Telemedicine|telemedicine
214925|NCT02849938|Tracheostomy|tracheostomy
214926|NCT02849925|Pit and Fissure Sealants|pit and fissure sealants
214927|NCT02849925|Caries|caries
214928|NCT02849925|Glass ionomer|glass ionomer
214929|NCT02849925|Resin|resin
719426|NCT00550342|B cell|b cell
214931|NCT02849886|Suicide gene|suicide gene
214932|NCT02849886|Dimerizer drug AP1903|dimerizer drug ap1903
214933|NCT02849886|Hematological stem cell transplantation|hematological stem cell transplantation
214934|NCT02849834|Neuropathic Pain|neuropathic pain
214935|NCT02849834|Stimulation of the Motor Cortex (SCM)|stimulation of the motor cortex (scm)
214936|NCT02849834|Pharmacoresistant|pharmacoresistant
214937|NCT02849834|rTMS|rtms
214938|NCT02849808|Corneal Transplantation|corneal transplantation
214939|NCT02849795|Obesity, Abdominal|obesity, abdominal
214940|NCT02849795|Adipokines|adipokines
214941|NCT02849795|Risk of cardiovascular diseases|risk of cardiovascular diseases
214942|NCT02849782|Gait analysis|gait analysis
214943|NCT02849782|Fampridine|fampridine
214944|NCT02849782|Fatigue|fatigue
214945|NCT02849782|Daily activity|daily activity
214946|NCT02849782|Cognition|cognition
214947|NCT02849756|Intensive care|intensive care
214948|NCT02849756|elderly|elderly
214949|NCT02849756|autonomy|autonomy
214950|NCT02849756|Future|future
214951|NCT02849756|older patients|older patients
214952|NCT02849756|intensive care unit|intensive care unit
214953|NCT02849743|oxytocin|oxytocin
214954|NCT02849743|hypothalamic obesity|hypothalamic obesity
214955|NCT02849743|craniopharyngioma|craniopharyngioma
214956|NCT02849743|metabolism|metabolism
214957|NCT02849730|Epi-PCA|epi-pca
214958|NCT02849730|Patient controlled analgesia|patient controlled analgesia
214959|NCT02849730|Epidural patient controlled analgesia|epidural patient controlled analgesia
214960|NCT02849730|Elderly patient|elderly patient
214961|NCT02849730|Side effect|side effect
214962|NCT02849730|Postoperative pain|postoperative pain
214963|NCT02849704|Chronic Pancreatitis|chronic pancreatitis
214964|NCT02849704|Pancreatic Function|pancreatic function
214965|NCT02849704|Reduced Exocrine Pancreatic Function|reduced exocrine pancreatic function
214966|NCT02849704|Pancreatic Insufficiency|pancreatic insufficiency
214967|NCT02849678|Postoperative Pain|postoperative pain
214968|NCT02849678|Bowel Surgery|bowel surgery
214969|NCT02849678|Regional Anesthesia|regional anesthesia
214970|NCT02849665|Kangaroo-Mother Care Method; child development|kangaroo-mother care method; child development
214971|NCT02849652|Smoking cessation|smoking cessation
214972|NCT02849652|Nicotine dependence|nicotine dependence
214973|NCT02849652|Organizational change|organizational change
214974|NCT02849652|Mental Healthcare|mental healthcare
214975|NCT02849639|deprescribing|deprescribing
214976|NCT02849639|medication therapy management|medication therapy management
214977|NCT02849626|Partial-Onset Seizures|partial-onset seizures
214978|NCT02849626|Primary Generalized Tonic-Clonic Seizures|primary generalized tonic-clonic seizures
214979|NCT02849626|Adjunctive Therapy|adjunctive therapy
214980|NCT02849626|Epilepsy|epilepsy
214981|NCT02849613|cell therapy|cell therapy
214982|NCT02849613|stem cell|stem cell
214983|NCT02849613|transplantation|transplantation
214984|NCT02849613|graft|graft
214985|NCT02849613|recovery|recovery
214986|NCT02849613|repair|repair
214987|NCT02849613|stroke|stroke
214988|NCT02849613|mesenchymal stem cell|mesenchymal stem cell
214989|NCT02849613|regenerative|regenerative
214990|NCT02849600|Vital pulp therapy,Young permanent tooth,Treatment outcome|vital pulp therapy,young permanent tooth,treatment outcome
214991|NCT02849587|Driving Under the Influence|driving under the influence
214992|NCT02849587|Memory Impairment|memory impairment
214993|NCT02849587|Reaction Time|reaction time
214994|NCT02849587|Time Perception|time perception
214995|NCT02849561|Pupillary light reflex|pupillary light reflex
214996|NCT02849561|Cardio respiratory arrest|cardio respiratory arrest
214997|NCT02849535|Oral chemotherapy|oral chemotherapy
214998|NCT02849535|Relative dose intensity|relative dose intensity
214999|NCT02849535|Health related program|health related program
215000|NCT02849535|Secured drug intake|secured drug intake
215001|NCT02849522|Lower Urinary Tract Symptoms caused by Benign Prostatic Enlargement (LUTS BPE)|lower urinary tract symptoms caused by benign prostatic enlargement (luts bpe)
215002|NCT02849522|Prostate Artery Embolisation (PAE)|prostate artery embolisation (pae)
215003|NCT02849522|Transurethral Resection of the Prostate (TURP)|transurethral resection of the prostate (turp)
215004|NCT02849522|Open prostatectomy|open prostatectomy
215005|NCT02849522|Laser enucleation or ablation of the prostate (Green Light, KTP, HoLEP)|laser enucleation or ablation of the prostate (green light, ktp, holep)
215006|NCT02849522|IPSS Score|ipss score
215007|NCT02849522|IIEF Score|iief score
215008|NCT02849522|Complications|complications
215009|NCT02849522|Quality of Life|quality of life
215010|NCT02849483|PONV|ponv
215011|NCT02849483|digestive signs and symptoms|digestive signs and symptoms
215012|NCT02849483|vomiting|vomiting
215013|NCT02849483|antiemetics|antiemetics
215014|NCT02849483|nausea|nausea
215015|NCT02849483|ramosetron|ramosetron
215016|NCT02849470|Adipose Stem/Stromal Cells|adipose stem/stromal cells
215017|NCT02849470|PRP|prp
215018|NCT02849470|SVF|svf
215019|NCT02849470|Cell Therapy|cell therapy
215020|NCT02849470|Alopecia|alopecia
215021|NCT02849470|GF|gf
215022|NCT02849444|renal function|renal function
215023|NCT02849444|Relapsed Multiple myeloma|relapsed multiple myeloma
215024|NCT02849444|anti-MM therapy|anti-mm therapy
215025|NCT02849431|mindfulness|mindfulness
215026|NCT02849418|Botulinum toxin type A|botulinum toxin type a
215027|NCT02849418|Urinary Incontinence|urinary incontinence
215028|NCT02849418|Neurogenic Detrusor Overactivity|neurogenic detrusor overactivity
215029|NCT02849392|Pistachio|pistachio
215030|NCT02849392|Body composition|body composition
215031|NCT02849392|Erythrocyte membrane incorporation of fatty acids|erythrocyte membrane incorporation of fatty acids
215032|NCT02849392|Dietary quality/micronutrient quality|dietary quality/micronutrient quality
215033|NCT02849392|Blood lipids|blood lipids
215034|NCT02849392|Inflammatory markers|inflammatory markers
215035|NCT02849392|Bone density|bone density
215036|NCT02849392|Bone turnover markers|bone turnover markers
215037|NCT02849392|Satiety|satiety
215038|NCT02849379|tongue cancer|tongue cancer
215039|NCT02849379|cryosurgery|cryosurgery
215040|NCT02849379|NK immunotherapy|nk immunotherapy
215041|NCT02849366|Sarcoma|sarcoma
215042|NCT02849366|Cryosurgery|cryosurgery
215043|NCT02849366|NK Immunotherapy|nk immunotherapy
215044|NCT02849353|Ovarian Cancer|ovarian cancer
215045|NCT02849353|cryosurgery|cryosurgery
215046|NCT02849353|NK immunotherapy|nk immunotherapy
215047|NCT02849340|Cervical Cancer|cervical cancer
215048|NCT02849340|cryosurgery|cryosurgery
215049|NCT02849340|NK immunotherapy|nk immunotherapy
215050|NCT02849327|Pharyngeal cancer|pharyngeal cancer
215051|NCT02849327|Cryosurgery|cryosurgery
215052|NCT02849327|NK immunotherapy|nk immunotherapy
215053|NCT02849314|laryngeal cancer|laryngeal cancer
215054|NCT02849314|cryosurgery|cryosurgery
215055|NCT02849314|NK immunotherapy|nk immunotherapy
215057|NCT02849249|Immunotherapy|immunotherapy
215058|NCT02849249|SCIT|scit
215059|NCT02849236|PECS block,|pecs block,
215060|NCT02849236|pectoral block,|pectoral block,
215061|NCT02849236|breast augmentation|breast augmentation
215062|NCT02849223|Mild Traumatic Brain Injury|mild traumatic brain injury
215063|NCT02849223|Transcranial Direct Current Stimulation|transcranial direct current stimulation
215064|NCT02849223|Working Memory|working memory
215065|NCT02849197|pilonidal sinus|pilonidal sinus
215066|NCT02849197|complication|complication
215067|NCT02849197|recurrence|recurrence
215068|NCT02849171|11C-Choline (11C-CH) PET|11c-choline (11c-ch) pet
215069|NCT02849171|16-676|16-676
215070|NCT02849171|High-grade Gliomas|high-grade gliomas
215071|NCT02849158|Rectoscopy|rectoscopy
215072|NCT02849158|Proctectomy|proctectomy
215073|NCT02849158|Fibroblasts|fibroblasts
215074|NCT02849145|Circulating tumor DNA|circulating tumor dna
215075|NCT02849119|Robot; Laparoscopic|robot; laparoscopic
215076|NCT02849119|Partial nephrectomy|partial nephrectomy
215077|NCT02849119|Transperitoneal|transperitoneal
215078|NCT02849119|Retroperitoneal|retroperitoneal
215079|NCT02849119|Laparoscopic Surgery|laparoscopic surgery
215080|NCT02849119|Surgical Procedures, Robotic|surgical procedures, robotic
215081|NCT02849119|Nephrectomy|nephrectomy
215082|NCT02849106|3D culture|3d culture
215083|NCT02849106|chemogram|chemogram
215084|NCT02849106|FOLFOX|folfox
215085|NCT02849106|FOLFIRI|folfiri
215086|NCT02849093|Optical coherence tomography|optical coherence tomography
215087|NCT02849093|imaging of ocular structures|imaging of ocular structures
215088|NCT02849067|ischaemic heart disease|ischaemic heart disease
215089|NCT02849067|comedy session|comedy session
215090|NCT02849067|laughter therapy|laughter therapy
215091|NCT02849041|Circulating Tumor Cells|circulating tumor cells
215092|NCT02849041|Lung|lung
215093|NCT02849028|gut microbiota|gut microbiota
215094|NCT02849028|sleep disorder|sleep disorder
215095|NCT02849028|gut-brain axis|gut-brain axis
215096|NCT02849028|circadian rhythm|circadian rhythm
215097|NCT02849028|Traumatic Brain Injury|traumatic brain injury
215098|NCT02849015|liver tumor|liver tumor
215099|NCT02849015|cryosurgery|cryosurgery
215100|NCT02849015|NK immunotherapy|nk immunotherapy
215101|NCT02849002|Concussion|concussion
215102|NCT02848989|Breast Cancer Surgery Pain|breast cancer surgery pain
215103|NCT02848989|Breast Cancer|breast cancer
215104|NCT02848950|Metformin|metformin
215105|NCT02848950|fecundability|fecundability
215106|NCT02848950|uterine doppler|uterine doppler
215107|NCT02848937|calcium balance|calcium balance
215108|NCT02848937|dialysis|dialysis
215109|NCT02848937|concentrate with citrate|concentrate with citrate
215110|NCT02848924|prevalence|prevalence
215111|NCT02848924|surgery|surgery
215112|NCT02848924|Treatments|treatments
215113|NCT02848911|acute lymphoblastic leukemia|acute lymphoblastic leukemia
215114|NCT02848898|Focal Vibrations|focal vibrations
215115|NCT02848898|Neurorehabilitation|neurorehabilitation
215116|NCT02848898|Spasticity|spasticity
215117|NCT02848898|Multiple Sclerosis|multiple sclerosis
215118|NCT02848885|Magnetic resonance imaging|magnetic resonance imaging
215119|NCT02848885|Anosognosia|anosognosia
215120|NCT02848885|Electrical stimulation of the brain|electrical stimulation of the brain
215121|NCT02848872|Tumor-infiltrating lymphocytes (TILs)|tumor-infiltrating lymphocytes (tils)
215122|NCT02848859|cognitive behavioral therapy for insomnia|cognitive behavioral therapy for insomnia
215123|NCT02848859|randomized controlled trial|randomized controlled trial
215124|NCT02848846|Amputees|amputees
215125|NCT02848820|Appendicitis|appendicitis
215126|NCT02848820|Appendectomy|appendectomy
215127|NCT02848820|Antibiotics|antibiotics
215128|NCT02848781|Sudden Cardiac Death|sudden cardiac death
215129|NCT02848781|ICD Therapy|icd therapy
215130|NCT02848781|VT Ablation|vt ablation
215131|NCT02848690|Sodium restriction|sodium restriction
215132|NCT02848690|Dietary sodium restriction questionnaire (DSRQ)|dietary sodium restriction questionnaire (dsrq)
215133|NCT02848690|Low-sodium diet|low-sodium diet
215134|NCT02848690|Adherence|adherence
215135|NCT02848690|Educational intervention|educational intervention
215136|NCT02848677|advanced glycation end-products|advanced glycation end-products
215137|NCT02848677|Cardiovascular disease|cardiovascular disease
215138|NCT02848677|Low Sodium Diet|low sodium diet
215139|NCT02848677|vascular inflammation|vascular inflammation
215140|NCT02848638|PET, Yttrium-90|pet, yttrium-90
215141|NCT02848625|Idiopathic Pulmonary Fibrosis|idiopathic pulmonary fibrosis
215142|NCT02848625|Yoga|yoga
215143|NCT02848625|Quality of life|quality of life
215144|NCT02848612|anticoagulation|anticoagulation
215145|NCT02848612|aneurysmal subarachnoid haemorrhage|aneurysmal subarachnoid haemorrhage
215146|NCT02848612|interventional neuroradiology|interventional neuroradiology
215147|NCT02848612|coil embolization|coil embolization
215148|NCT02848599|postoperative analgesia|postoperative analgesia
215149|NCT02848599|postoperative cognitive disfunction|postoperative cognitive disfunction
215151|NCT02848586|ECIGS|ecigs
215152|NCT02848586|e-cigarettes|e-cigarettes
215153|NCT02848586|lung inflammation|lung inflammation
215154|NCT02848560|Cystic Fibrosis|cystic fibrosis
215155|NCT02848560|orkambi|orkambi
215156|NCT02848560|129Xe MRI|129xe mri
215157|NCT02848560|hyperpolarized xenon|hyperpolarized xenon
215158|NCT02848560|LCI|lci
215159|NCT02848560|CFTR modulator therapy|cftr modulator therapy
215160|NCT02848534|fever|fever
215161|NCT02848534|hyperthermia|hyperthermia
215162|NCT02848534|inflammatory syndrome|inflammatory syndrome
215163|NCT02848521|ADPKD|adpkd
215164|NCT02848521|CKD|ckd
215165|NCT02848521|Rapid progressor|rapid progressor
215166|NCT02848521|quality of life|quality of life
215167|NCT02848521|DCE|dce
215168|NCT02848508|Metformin|metformin
215169|NCT02848508|moderate renal failure|moderate renal failure
215170|NCT02848508|severe renal failure|severe renal failure
215171|NCT02848508|chronic kidney disease|chronic kidney disease
215172|NCT02848508|hyperlactatemia|hyperlactatemia
215173|NCT02848508|lactic acidosis|lactic acidosis
215174|NCT02848495|Aneurysm|aneurysm
215175|NCT02848495|Biocollection|biocollection
215176|NCT02848495|Familial Form|familial form
215177|NCT02848482|Photodynamic therapy|photodynamic therapy
215178|NCT02848456|Manipulation, Spinal|manipulation, spinal
215179|NCT02848456|H-Reflex|h-reflex
215180|NCT02848456|Muscle Contraction|muscle contraction
215181|NCT02848456|Muscle Strength Dynamometer|muscle strength dynamometer
215182|NCT02848443|metastatic|metastatic
215183|NCT02848443|colorectal|colorectal
215184|NCT02848443|cancer|cancer
215185|NCT02848443|oxaliplatin|oxaliplatin
215186|NCT02848443|dose-escalation|dose-escalation
215187|NCT02848443|Lonsurf|lonsurf
215188|NCT02848443|nivolumab|nivolumab
215189|NCT02848443|bevacizumab|bevacizumab
215190|NCT02848430|Humulus lupulus|humulus lupulus
215191|NCT02848404|Mild cognitive impairment|mild cognitive impairment
215192|NCT02848404|Cognitive rehabilitation|cognitive rehabilitation
215193|NCT02848404|Cognitive therapy|cognitive therapy
215194|NCT02848404|Alzheimer's disease|alzheimer's disease
215195|NCT02848404|Memory enhancement|memory enhancement
215196|NCT02848404|Categorical language fluency|categorical language fluency
215197|NCT02848378|Advanced Oxidation Protein Products|advanced oxidation protein products
215198|NCT02848378|Gingival crevicular fluid|gingival crevicular fluid
215199|NCT02848378|Monocyte chemoattractant protein-1|monocyte chemoattractant protein-1
215200|NCT02848378|Periodontal Disease|periodontal disease
215201|NCT02848365|Measurement|measurement
215202|NCT02848248|Acute Myeloid Leukemia|acute myeloid leukemia
215203|NCT02848248|Antibody-Drug Conjugate|antibody-drug conjugate
215204|NCT02848248|CD123 Antigen|cd123 antigen
215205|NCT02848248|Drug Therapy|drug therapy
215206|NCT02848248|AML|aml
215207|NCT02848248|Leukemia, Myeloid, Acute|leukemia, myeloid, acute
215208|NCT02848235|Prevention of Mother to Child Transmission|prevention of mother to child transmission
215209|NCT02848235|Antenatal Care for HIV positive women|antenatal care for hiv positive women
215210|NCT02848235|Kenya|kenya
215211|NCT02848222|contact lens discomfort|contact lens discomfort
215212|NCT02848222|dry eye disease|dry eye disease
215213|NCT02848222|meibomian gland dysfunction|meibomian gland dysfunction
215214|NCT02848222|Bruder mask|bruder mask
215215|NCT02848209|Peeling|peeling
215216|NCT02848209|Histological skin changes|histological skin changes
215217|NCT02848209|Trichloroacetic acid peel|trichloroacetic acid peel
215218|NCT02848209|phenol/croton oil peel|phenol/croton oil peel
215219|NCT02848170|essential hypertension|essential hypertension
719427|NCT00550342|autoimmune|autoimmune
215220|NCT02848170|mineralocorticoid receptor antagonist|mineralocorticoid receptor antagonist
215221|NCT02848170|Developmental Phase III|developmental phase iii
215222|NCT02848157|dexmedetomidine|dexmedetomidine
215223|NCT02848157|pudendal block|pudendal block
215224|NCT02848157|hypospadias|hypospadias
215225|NCT02848144|Immunoparalysis|immunoparalysis
215226|NCT02848144|immune response|immune response
215227|NCT02848144|sepsis|sepsis
215228|NCT02848144|toxic shock syndrome|toxic shock syndrome
215229|NCT02848118|Hypoventilation|hypoventilation
215230|NCT02848118|capnography|capnography
215231|NCT02848118|bronchoscopy|bronchoscopy
215232|NCT02848105|aGVHD|agvhd
215233|NCT02848105|valproic acid|valproic acid
215234|NCT02848092|Visual Attention|visual attention
215235|NCT02848092|Automobile Driving|automobile driving
215236|NCT02848001|CC-90009|cc-90009
215237|NCT02848001|Hematologic Cancers|hematologic cancers
215238|NCT02848001|Leukemia|leukemia
215239|NCT02848001|Acute Myeloid Leukemia|acute myeloid leukemia
215240|NCT02848001|Myelodysplastic Syndrome|myelodysplastic syndrome
215241|NCT02848001|AML|aml
215242|NCT02848001|MDS|mds
215243|NCT02847988|muscle strength|muscle strength
215244|NCT02847988|muscle function|muscle function
215245|NCT02847988|functional status|functional status
215246|NCT02847975|Becker|becker
215247|NCT02847975|dystrophy|dystrophy
215248|NCT02847975|sympatholysis|sympatholysis
215249|NCT02847962|Fortified-blended foods|fortified-blended foods
215250|NCT02847962|Extrusion|extrusion
215251|NCT02847962|Sorghum|sorghum
215252|NCT02847962|Cowpea|cowpea
215253|NCT02847962|Vitamin A|vitamin a
215254|NCT02847962|Iron|iron
215255|NCT02847962|Protein|protein
215256|NCT02847962|Food Aid|food aid
215257|NCT02847962|Anemia, Iron-Deficiency|anemia, iron-deficiency
215258|NCT02847962|Deficiency, Vitamin A|deficiency, vitamin a
215259|NCT02847962|Growth Velocity|growth velocity
215260|NCT02847962|Stunting|stunting
215261|NCT02847962|Wasting|wasting
215262|NCT02847962|Protein-Energy Malnutrition|protein-energy malnutrition
215263|NCT02847962|Complementary Feeding|complementary feeding
215264|NCT02847962|Corn|corn
215266|NCT02847962|Fortified Foods|fortified foods
215267|NCT02847962|Food assistance|food assistance
215268|NCT02847936|triclosan|triclosan
215269|NCT02847936|sutures|sutures
215270|NCT02847936|infection|infection
215271|NCT02847923|Mobile Devices|mobile devices
215272|NCT02847923|Augmentative and Alternative Communication|augmentative and alternative communication
215273|NCT02847923|Cerebral Palsy|cerebral palsy
215274|NCT02847910|tissue suction tube|tissue suction tube
215275|NCT02847910|disposable instrument|disposable instrument
215276|NCT02847910|induced abortion|induced abortion
215277|NCT02847884|IBD|ibd
215278|NCT02847884|Crohn's disease|crohn's disease
215279|NCT02847884|Remicade|remicade
215280|NCT02847884|Infliximab|infliximab
215281|NCT02847884|Level|level
215282|NCT02847884|Drug Level|drug level
215283|NCT02847884|Children|children
215284|NCT02847871|mobility|mobility
215285|NCT02847871|exercise|exercise
215286|NCT02847871|nutrition|nutrition
215287|NCT02847871|primary care|primary care
215288|NCT02847871|prevention|prevention
215289|NCT02847871|care pathway|care pathway
215290|NCT02847871|elderly patient|elderly patient
215291|NCT02847858|unsafe sex|unsafe sex
215292|NCT02847858|unprotected sex|unprotected sex
215293|NCT02847858|adolescents|adolescents
215294|NCT02847858|Latinas|latinas
215295|NCT02847858|Hispanic|hispanic
215296|NCT02847858|mobile health applications|mobile health applications
215297|NCT02847858|unintended pregnancy|unintended pregnancy
215298|NCT02847858|teen pregnancy prevention|teen pregnancy prevention
215299|NCT02847858|school-based health centers|school-based health centers
215300|NCT02847845|chronic fatigue syndrome|chronic fatigue syndrome
215301|NCT02847845|idiopathic chronic fatigue|idiopathic chronic fatigue
215302|NCT02847845|red ginseng|red ginseng
215303|NCT02847845|cortisol|cortisol
215304|NCT02847845|anti-oxidant|anti-oxidant
215305|NCT02847832|Adnexal Diseases|adnexal diseases
215306|NCT02847832|Ovary|ovary
215307|NCT02847832|Ovarian Neoplasms|ovarian neoplasms
215308|NCT02847832|Ovarian Cysts|ovarian cysts
215309|NCT02847832|Ovarian Diseases|ovarian diseases
215310|NCT02847832|Ultrasonography|ultrasonography
215311|NCT02847832|Ultrasonography, Doppler|ultrasonography, doppler
215312|NCT02847832|Diagnosis|diagnosis
215313|NCT02847832|Early Diagnosis|early diagnosis
215314|NCT02847832|Early Detection of Cancer|early detection of cancer
215315|NCT02847832|Genital Neoplasms, Female|genital neoplasms, female
215316|NCT02847832|Genital Diseases, Female|genital diseases, female
215317|NCT02847832|Urogenital Neoplasms|urogenital neoplasms
215318|NCT02847832|Cysts|cysts
215319|NCT02847832|Endocrine System Diseases|endocrine system diseases
215320|NCT02847832|Gonadal Disorders|gonadal disorders
215321|NCT02847832|Neoplasms|neoplasms
215322|NCT02847832|Endocrine Gland Neoplasms|endocrine gland neoplasms
215323|NCT02847832|International Ovarian Tumor Analysis|international ovarian tumor analysis
215324|NCT02847832|Simple Rules|simple rules
215325|NCT02847832|Preoperative evaluation|preoperative evaluation
215326|NCT02847832|Prediction Models|prediction models
215327|NCT02847832|Logistic Regression Models|logistic regression models
215328|NCT02847832|Mathematical Models|mathematical models
215329|NCT02847832|Adnexal Masses|adnexal masses
215330|NCT02847832|Ovarian Tumors|ovarian tumors
215331|NCT02847832|Risk of Malignancy|risk of malignancy
215332|NCT02847793|Attentional Bias Modification (ABM)|attentional bias modification (abm)
215333|NCT02847793|Cognitive Bias Modification (CBM)|cognitive bias modification (cbm)
215334|NCT02847793|Depression|depression
215335|NCT02847793|Dysphoria|dysphoria
215336|NCT02847793|Gaze patterns|gaze patterns
215337|NCT02847793|Eye-tracking|eye-tracking
215338|NCT02847767|Liver Perfusion|liver perfusion
215339|NCT02847767|Hepatocellular Carcinoma|hepatocellular carcinoma
215340|NCT02847767|Dynamic Contrast-Enhanced Computed Tomography|dynamic contrast-enhanced computed tomography
215341|NCT02847754|bony metastases|bony metastases
215342|NCT02847754|physical exercise|physical exercise
215343|NCT02847741|Depression|depression
215344|NCT02847741|Cholesterol|cholesterol
215345|NCT02847741|Suicidal behavior|suicidal behavior
215346|NCT02847741|Predictive factor|predictive factor
215347|NCT02847715|PRO|pro
215348|NCT02847715|PROM|prom
215349|NCT02847715|Adverse event|adverse event
215350|NCT02847715|QTool|qtool
215351|NCT02847715|Aftercare|aftercare
215352|NCT02847702|Osteoarthritis|osteoarthritis
215353|NCT02847702|Pain|pain
215354|NCT02847702|Osteoarthritis, knee|osteoarthritis, knee
215355|NCT02847689|Premature Birth|premature birth
215356|NCT02847689|Obstetric Labor, Premature|obstetric labor, premature
215357|NCT02847689|Obstetric Labor Complications|obstetric labor complications
215358|NCT02847689|Pregnancy Complications|pregnancy complications
215359|NCT02847676|Peritoneal adhesions|peritoneal adhesions
215360|NCT02847676|Stem cells|stem cells
215361|NCT02847676|MSC|msc
215362|NCT02847663|Cold|cold
215363|NCT02847663|recovery|recovery
215364|NCT02847650|Early Parkinson Disease|early parkinson disease
215365|NCT02847650|Phase 2|phase 2
215366|NCT02847637|Hemophilia A|hemophilia a
215367|NCT02847637|Emicizumab|emicizumab
215368|NCT02847611|Dynamometer mechanic|dynamometer mechanic
215369|NCT02847611|Strength of prehension|strength of prehension
215370|NCT02847611|Comparison|comparison
215371|NCT02847611|Device|device
215372|NCT02847611|Diagnosis|diagnosis
215373|NCT02847611|Healthy Volunteers|healthy volunteers
215374|NCT02847598|CLE, SLE, Cutaneous Lupus Erythematosus, Systemic Lupus Erythematosus, Lupus|cle, sle, cutaneous lupus erythematosus, systemic lupus erythematosus, lupus
215375|NCT02847585|water-soluble ubiquinol supplementation|water-soluble ubiquinol supplementation
215376|NCT02847585|pediatric cardiomyopathy|pediatric cardiomyopathy
215377|NCT02847585|antioxidant|antioxidant
215378|NCT02847585|inflammation|inflammation
215379|NCT02847585|complementary therapy|complementary therapy
215380|NCT02847533|resistant depression|resistant depression
215381|NCT02847533|inflammation|inflammation
215382|NCT02847520|Disorders related to gaming and gambling; poker|disorders related to gaming and gambling; poker
215383|NCT02847507|HIV|hiv
215384|NCT02847507|Hepatitis E|hepatitis e
215385|NCT02847481|Fecal Microbiota Transplantation|fecal microbiota transplantation
215386|NCT02847468|FDG PET, FCH PET|fdg pet, fch pet
215387|NCT02847455|Ilaprazole|ilaprazole
215388|NCT02847455|Proton pump inhibitor|proton pump inhibitor
215389|NCT02847455|Duodenal ulcer|duodenal ulcer
215390|NCT02847455|Acid suppression|acid suppression
215391|NCT02847455|Randomized trial|randomized trial
215392|NCT02847442|Ongentys|ongentys
215393|NCT02847403|dysglycemia|dysglycemia
215394|NCT02847403|MCI|mci
215395|NCT02847403|exenatide LAR|exenatide lar
215396|NCT02847403|GLP-1|glp-1
215397|NCT02847390|diabetes mellitus|diabetes mellitus
215398|NCT02847390|physician education|physician education
215399|NCT02847390|nursing education|nursing education
215400|NCT02847390|hyperglycemia|hyperglycemia
215401|NCT02847390|hypoglycemia|hypoglycemia
215402|NCT02847390|inpatient|inpatient
215403|NCT02847390|hospital|hospital
215404|NCT02847390|glycemic control|glycemic control
215405|NCT02847364|chewing gum|chewing gum
215406|NCT02847364|prevention|prevention
215407|NCT02847351|arabinoxylan, HOMA index, glycemic control, obesity.|arabinoxylan, homa index, glycemic control, obesity.
215408|NCT02847338|Hypertension|hypertension
215409|NCT02847312|Oat|oat
215410|NCT02847312|Phenolic acid|phenolic acid
215411|NCT02847312|Avenanthramide|avenanthramide
215412|NCT02847312|FMD|fmd
215413|NCT02847312|LDI|ldi
215414|NCT02847312|Gut microbiota|gut microbiota
215415|NCT02847312|Blood Pressure|blood pressure
215416|NCT02847312|Renin Angiotensin|renin angiotensin
215417|NCT02847312|Nitric Oxide|nitric oxide
215418|NCT02847299|cough help|cough help
215419|NCT02847299|mechanical insufflation|mechanical insufflation
215420|NCT02847299|mechanical ventilation|mechanical ventilation
215421|NCT02847299|neuromuscular diseases|neuromuscular diseases
215422|NCT02847299|peak cough flow|peak cough flow
215423|NCT02847273|NIRS|nirs
215424|NCT02847273|Regional oxygen saturation|regional oxygen saturation
215425|NCT02847273|cardiac surgery with bypass|cardiac surgery with bypass
215426|NCT02847247|healthy|healthy
215427|NCT02847234|Cervical necrotizing fasciitis|cervical necrotizing fasciitis
215428|NCT02847234|mediastinitis|mediastinitis
215429|NCT02847221|cough peak flow|cough peak flow
215430|NCT02847221|scheduled weaning trial|scheduled weaning trial
215431|NCT02847221|scheduled extubation|scheduled extubation
215432|NCT02847221|prognosis|prognosis
215433|NCT02847208|cystic fibrosis|cystic fibrosis
215434|NCT02847208|contraception|contraception
215435|NCT02847208|gynaecological follow-up|gynaecological follow-up
215436|NCT02847208|screening|screening
215437|NCT02847208|Pap smear|pap smear
215438|NCT02847208|counselling|counselling
215439|NCT02847195|pediatric intensive care|pediatric intensive care
215440|NCT02847195|pain assessment|pain assessment
215441|NCT02847195|tracheal aspiration|tracheal aspiration
215442|NCT02847195|sedation|sedation
215443|NCT02847195|pupillometer|pupillometer
215444|NCT02847156|cystic fibrosis|cystic fibrosis
215445|NCT02847156|viruses|viruses
215446|NCT02847156|respiratory viral infection|respiratory viral infection
215447|NCT02847156|children|children
215448|NCT02847143|Attachement|attachement
215449|NCT02847143|Oxytocin|oxytocin
215450|NCT02847143|fMRI|fmri
215451|NCT02847117|Natural Mastiha, Bioavailability|natural mastiha, bioavailability
215452|NCT02847091|Ipragliflozin|ipragliflozin
215453|NCT02847091|SGLT2 inhibitor|sglt2 inhibitor
215454|NCT02847091|Type 2 diabetes mellitus|type 2 diabetes mellitus
215455|NCT02847091|ASP1941|asp1941
215456|NCT02847078|Coronary Disease|coronary disease
215457|NCT02847078|percutaneous coronary intervention|percutaneous coronary intervention
215458|NCT02847078|secondary prevention|secondary prevention
215459|NCT02847078|smart phone app|smart phone app
215460|NCT02847026|inactivated poliovirus vaccine|inactivated poliovirus vaccine
215461|NCT02847026|fractional inactivated poliovirus vaccine|fractional inactivated poliovirus vaccine
215462|NCT02847026|Rotavirus|rotavirus
215463|NCT02847026|Rotarix|rotarix
215464|NCT02847026|RotaTeq|rotateq
215465|NCT02847026|fIPV|fipv
215466|NCT02847026|IPV|ipv
215467|NCT02847013|Postcesarean Section|postcesarean section
215468|NCT02847013|Postoperative|postoperative
215469|NCT02847000|Decitabine|decitabine
215470|NCT02847000|Tetrahydrouridine|tetrahydrouridine
215471|NCT02847000|Epigenetic Therapy|epigenetic therapy
215472|NCT02846987|Abemaciclib i|abemaciclib i
215473|NCT02846987|LY2835219|ly2835219
215474|NCT02846987|16-376|16-376
215475|NCT02846974|Pulse Oximetry|pulse oximetry
215476|NCT02846974|Free and Open Source|free and open source
215477|NCT02846961|inflammatory bowel disease|inflammatory bowel disease
215478|NCT02846961|biosimilar|biosimilar
215479|NCT02846961|anti-drug antibody|anti-drug antibody
215480|NCT02846961|trough drug concentration|trough drug concentration
215481|NCT02846948|sepsis|sepsis
215482|NCT02846948|echocardiography|echocardiography
215483|NCT02846948|urgent|urgent
215484|NCT02846948|abdominal surgery|abdominal surgery
215485|NCT02846935|p16/CDKN2A|p16/cdkn2a
215486|NCT02846935|TP53|tp53
215487|NCT02846935|THU|thu
215488|NCT02846935|Decitabine|decitabine
215489|NCT02846935|Tetrahydrouridine|tetrahydrouridine
215490|NCT02846935|DEC|dec
215491|NCT02846883|aneurysms|aneurysms
215492|NCT02846857|Closed-loop system|closed-loop system
215493|NCT02846857|Artificial pancreas|artificial pancreas
215494|NCT02846857|Type 1 diabetes|type 1 diabetes
215495|NCT02846857|Hypoglycemia|hypoglycemia
215496|NCT02846857|Insulin|insulin
215497|NCT02846857|Glucagon|glucagon
215498|NCT02846831|Type 1 diabetes|type 1 diabetes
215499|NCT02846831|Artificial pancreas|artificial pancreas
215500|NCT02846831|Closed-loop system|closed-loop system
215501|NCT02846831|Hypoglycemia|hypoglycemia
215502|NCT02846831|Insulin|insulin
215503|NCT02846818|Microdialysis|microdialysis
215504|NCT02846818|Cardiac surgery|cardiac surgery
215505|NCT02846818|Lactate to pyruvate ratio|lactate to pyruvate ratio
215506|NCT02846818|Cardiopulmonary bypass|cardiopulmonary bypass
215507|NCT02846818|Neurological complications|neurological complications
215508|NCT02846779|Insulin persistence|insulin persistence
215509|NCT02846779|Telepharmacy|telepharmacy
215510|NCT02846766|advanced cancer|advanced cancer
215511|NCT02846766|FGF|fgf
215512|NCT02846766|FGFR|fgfr
215513|NCT02846766|Fibroblast Growth Factor Receptor|fibroblast growth factor receptor
215514|NCT02846740|cranial electric stimulation|cranial electric stimulation
215515|NCT02846740|suicide|suicide
215516|NCT02846740|psychiatric inpatients|psychiatric inpatients
215517|NCT02846727|Hypoperfusion|hypoperfusion
215518|NCT02846727|Sepsis|sepsis
215519|NCT02846714|Education|education
215520|NCT02846714|Prevention and Control|prevention and control
215521|NCT02846714|Behavioral Research|behavioral research
215522|NCT02846701|Neuropathic pain|neuropathic pain
215523|NCT02846701|Antidepressant|antidepressant
215524|NCT02846701|Duloxetine|duloxetine
215525|NCT02846701|Liquid Chromatography|liquid chromatography
215526|NCT02846701|Mass Spectrometry|mass spectrometry
215527|NCT02846675|SVF|svf
215528|NCT02846675|Stromal Vascular Fraction|stromal vascular fraction
215529|NCT02846675|osteoarthritis(OA)|osteoarthritis(oa)
215530|NCT02846675|knee|knee
215531|NCT02846675|adipose|adipose
215532|NCT02846662|depression|depression
215533|NCT02846662|mobile technology|mobile technology
215534|NCT02846662|community trial|community trial
215535|NCT02846610|anesthesia|anesthesia
215536|NCT02846610|continuous regional anesthesia|continuous regional anesthesia
215537|NCT02846610|complications|complications
215538|NCT02846610|epidural analgesia|epidural analgesia
215539|NCT02846610|antibiotics|antibiotics
215540|NCT02846597|Respiratory distress syndrome|respiratory distress syndrome
215541|NCT02846597|Sustained lung inflation|sustained lung inflation
215542|NCT02846597|Delivery room|delivery room
215543|NCT02846584|CAR T|car t
215544|NCT02846584|HSCT|hsct
215545|NCT02846571|Islet Transplantation|islet transplantation
215546|NCT02846571|Type 1 Diabetes|type 1 diabetes
215547|NCT02846571|Immune Tolerance Induction|immune tolerance induction
215548|NCT02846571|Diabetes Complications|diabetes complications
215549|NCT02846571|Intraocular Transplantation|intraocular transplantation
215550|NCT02846571|Eye Anterior Chamber|eye anterior chamber
215551|NCT02846571|Kidney Transplantation|kidney transplantation
215552|NCT02846571|Immunosuppression|immunosuppression
215553|NCT02846571|Type 2 Diabetes|type 2 diabetes
215554|NCT02846558|calorie restriction|calorie restriction
215555|NCT02846558|weight loss|weight loss
215556|NCT02846532|Thromboembolism|thromboembolism
215557|NCT02846532|Fontan Procedure|fontan procedure
215558|NCT02846532|Children|children
215559|NCT02846493|Ovarian hyperstimulation syndrome|ovarian hyperstimulation syndrome
215560|NCT02846493|Dexamethasone|dexamethasone
215561|NCT02846467|Informed consent|informed consent
215562|NCT02846467|Patient Education|patient education
215563|NCT02846467|Mobile applications|mobile applications
215564|NCT02846441|posthepatectomy liver failure|posthepatectomy liver failure
215565|NCT02846441|ALPPS|alpps
215566|NCT02846441|hepatobiliary scintigraphy|hepatobiliary scintigraphy
215567|NCT02846441|SPECT|spect
215568|NCT02846441|mebrofenin|mebrofenin
215569|NCT02846415|Dementia|dementia
215570|NCT02846415|Play and Playthings|play and playthings
215571|NCT02846415|Cognition|cognition
215572|NCT02846415|Memory|memory
215573|NCT02846402|HIV testing|hiv testing
215574|NCT02846402|Female sex workers|female sex workers
215575|NCT02846402|HIV self-testing|hiv self-testing
215576|NCT02846389|Radiation therapy for Breast Cancer|radiation therapy for breast cancer
215577|NCT02846363|stroke|stroke
215578|NCT02846363|public awareness campaign|public awareness campaign
215579|NCT02846363|call to EMS|call to ems
215580|NCT02846337|cardio-renal syndrome|cardio-renal syndrome
215581|NCT02846337|hemodialysis|hemodialysis
215582|NCT02846337|peritoneal dialysis|peritoneal dialysis
215583|NCT02846337|hemofiltration|hemofiltration
215584|NCT02846337|composite endpoint|composite endpoint
215585|NCT02846311|test|test
215586|NCT02846311|winter|winter
215587|NCT02846311|season|season
215588|NCT02846298|Drug Monitoring|drug monitoring
215589|NCT02846298|ICU|icu
215590|NCT02846298|Pharmacokinetic|pharmacokinetic
215591|NCT02846298|Pharmacodynamic|pharmacodynamic
215592|NCT02846298|antibiotic|antibiotic
215593|NCT02846298|Glycopeptides|glycopeptides
215594|NCT02846298|β-lactam-aminoglycoside|β-lactam-aminoglycoside
215595|NCT02846285|Bleeding|bleeding
215596|NCT02846259|intracranial aneurysm|intracranial aneurysm
215597|NCT02846259|cerebral ischemia|cerebral ischemia
215598|NCT02846259|aspirin|aspirin
215599|NCT02846246|aged care|aged care
215600|NCT02846246|health|health
215601|NCT02846246|home care services|home care services
215602|NCT02846246|person-centred care|person-centred care
215603|NCT02846220|Medication Adherence|medication adherence
215604|NCT02846220|Middle Aged 45-64|middle aged 45-64
215605|NCT02846220|Aged 65-79|aged 65-79
215606|NCT02846220|Aged, 80 and over|aged, 80 and over
215607|NCT02846207|cerebral infarction|cerebral infarction
215608|NCT02846207|syndrome of qi deficiency and blood stasis|syndrome of qi deficiency and blood stasis
215609|NCT02846207|Buyanghuanwu decoction|buyanghuanwu decoction
215610|NCT02846207|clinical effects and mechanisms|clinical effects and mechanisms
215611|NCT02846194|Fibromyalgia|fibromyalgia
215612|NCT02846194|Guided Imagery|guided imagery
215613|NCT02846194|chronic pain|chronic pain
215614|NCT02846155|preparation|preparation
215615|NCT02846155|capsule endoscopy|capsule endoscopy
215616|NCT02846129|multiple gestation|multiple gestation
215617|NCT02846129|complications|complications
215618|NCT02846129|cesarean delivery|cesarean delivery
215619|NCT02846116|all ceramic crown|all ceramic crown
215620|NCT02846116|Lithium disilicate|lithium disilicate
215621|NCT02846116|e-max|e-max
215622|NCT02846116|vita suprinity|vita suprinity
215623|NCT02846077|sleep|sleep
215624|NCT02846077|social networks|social networks
215625|NCT02846077|undergraduates|undergraduates
215626|NCT02846077|mood|mood
215627|NCT02846077|circadian rhythms|circadian rhythms
215628|NCT02846051|varicose vein|varicose vein
215629|NCT02846051|physical activity|physical activity
215630|NCT02846038|Pediatric cancer|pediatric cancer
215631|NCT02846038|Childhood cancer|childhood cancer
215632|NCT02846038|High-risk disease|high-risk disease
215633|NCT02846038|Prognosis|prognosis
215634|NCT02846038|Communication|communication
215635|NCT02846038|Bad news|bad news
215636|NCT02846038|Pediatric oncologist|pediatric oncologist
215637|NCT02846038|Parent|parent
215638|NCT02846038|Relapse|relapse
215639|NCT02846038|Progression|progression
215640|NCT02845999|natural killer cells|natural killer cells
215641|NCT02845999|adoptive transfer|adoptive transfer
215642|NCT02845999|allogenic immunotherapy|allogenic immunotherapy
215643|NCT02845999|gastrointestinal cancer EGFR+|gastrointestinal cancer egfr+
215644|NCT02845986|Stomach Neoplasms|stomach neoplasms
215645|NCT02845986|Laparoscopy|laparoscopy
215646|NCT02845986|Spleen-Preserving|spleen-preserving
215647|NCT02845986|No.10 Lymph Node Dissection|no.10 lymph node dissection
215648|NCT02845973|gut microbiota|gut microbiota
215649|NCT02845921|Propofol|propofol
215650|NCT02845921|Hypotension|hypotension
215651|NCT02845921|Induction of anaesthesia|induction of anaesthesia
215652|NCT02845921|Leg elevation|leg elevation
215653|NCT02845921|Leg wrapping|leg wrapping
215654|NCT02845895|Screening for nutritional disorder|screening for nutritional disorder
215655|NCT02845895|Comparison of two organizations|comparison of two organizations
215656|NCT02845895|Indicator IPAQSS|indicator ipaqss
215657|NCT02845856|recurrent lung cancer|recurrent lung cancer
215658|NCT02845856|EGFR mutation|egfr mutation
215659|NCT02845856|Cetuximab|cetuximab
215660|NCT02845856|NK immunotherapy|nk immunotherapy
215661|NCT02845843|Middle East Respiratory Syndrome Coronavirus|middle east respiratory syndrome coronavirus
215662|NCT02845843|MERS-CoV|mers-cov
215663|NCT02845843|Clinical trial|clinical trial
215664|NCT02845843|Lopinavir|lopinavir
215665|NCT02845843|Ritonavir|ritonavir
215666|NCT02845843|Interferon beta|interferon beta
215667|NCT02845830|dementia|dementia
215669|NCT02845830|quality of life|quality of life
215670|NCT02845830|assessment|assessment
215671|NCT02845830|factor|factor
215672|NCT02845830|trajectory|trajectory
215673|NCT02845830|change|change
215674|NCT02845830|early stage|early stage
215675|NCT02845804|coronary artery disease|coronary artery disease
215676|NCT02845804|percutaneous coronary intervention|percutaneous coronary intervention
215677|NCT02845804|everolimus-eluting stents|everolimus-eluting stents
215678|NCT02845778|melatonin|melatonin
215679|NCT02845778|pharmacokinetics|pharmacokinetics
215680|NCT02845765|Erectile Dysfunction|erectile dysfunction
215681|NCT02845765|ED|ed
215682|NCT02845765|Fundus Oculi|fundus oculi
215683|NCT02845765|Retinal Vascularization|retinal vascularization
215684|NCT02845765|International Index of Erectile Function Questionnaire|international index of erectile function questionnaire
215685|NCT02845765|IIEF|iief
215686|NCT02845765|Dynamic Vessel Analyzer|dynamic vessel analyzer
215687|NCT02845765|DVA|dva
215688|NCT02845765|Phosphodiesterase type 5 Inhibitor|phosphodiesterase type 5 inhibitor
215689|NCT02845765|PDE5Is|pde5is
215690|NCT02845739|kidney transplantation|kidney transplantation
215691|NCT02845739|human papillomavirus|human papillomavirus
215692|NCT02845687|nicotine addiction|nicotine addiction
215693|NCT02845687|cigarette smoking|cigarette smoking
215694|NCT02845661|Narcotrend index|narcotrend index
215695|NCT02845661|OAA/S scale|oaa/s scale
215696|NCT02845661|Dexmedetomidine|dexmedetomidine
215697|NCT02845661|Sedation|sedation
215698|NCT02845648|anticholinergics|anticholinergics
215699|NCT02845648|awakener|awakener
215700|NCT02845622|Hazelnut|hazelnut
215701|NCT02845622|Cocoa|cocoa
215702|NCT02845622|Flavonoid|flavonoid
215703|NCT02845622|Lipids|lipids
215704|NCT02845622|Vascular Reactivity|vascular reactivity
215705|NCT02845609|Congenital macrothrombocytopenia|congenital macrothrombocytopenia
215706|NCT02845609|Sialic acid|sialic acid
215707|NCT02845609|Bleeding|bleeding
215708|NCT02845583|Nursing|nursing
215709|NCT02845583|Diagnosis Related Group|diagnosis related group
215710|NCT02845583|Activity based costing|activity based costing
215711|NCT02845557|Youth|youth
215712|NCT02845557|Type 2 Diabetes|type 2 diabetes
215713|NCT02845557|glucose homeostasis|glucose homeostasis
215714|NCT02845557|incretin effect|incretin effect
215715|NCT02845544|Postural Balance|postural balance
215716|NCT02845531|Variant angina|variant angina
215717|NCT02845531|Aborted sudden cardiac death|aborted sudden cardiac death
215718|NCT02845531|Implantable Cardioverter Defibrillator|implantable cardioverter defibrillator
215719|NCT02845531|Optimal Medical Therapy|optimal medical therapy
215720|NCT02845531|ICD|icd
215721|NCT02845505|intravascular ultrasonography|intravascular ultrasonography
215722|NCT02845505|Computed Tomography|computed tomography
215723|NCT02845492|Exercise|exercise
215724|NCT02845492|Qigong|qigong
215725|NCT02845492|Mind-Body|mind-body
215726|NCT02845492|Fatigue|fatigue
215727|NCT02845492|Cancer|cancer
215728|NCT02845492|EEG|eeg
215729|NCT02845492|HRV|hrv
215730|NCT02845466|Venous Leg Ulcer|venous leg ulcer
215731|NCT02845466|Diabetic Foot Ulcer|diabetic foot ulcer
215732|NCT02845466|Wound Healing|wound healing
215733|NCT02845466|Growth Factor|growth factor
215734|NCT02845466|Protease Inhibitor|protease inhibitor
215735|NCT02845453|youth|youth
215736|NCT02845453|adolescent|adolescent
215737|NCT02845453|young adult|young adult
215738|NCT02845453|substance use disorder|substance use disorder
215739|NCT02845453|bipolar disorder|bipolar disorder
215740|NCT02845453|quetiapine|quetiapine
215741|NCT02845453|mood dysregulation|mood dysregulation
215742|NCT02845440|Pragmatic Trial|pragmatic trial
215743|NCT02845440|Community Health Workers|community health workers
215744|NCT02845440|Academic Detailing|academic detailing
215745|NCT02845427|Closed Suction Drain|closed suction drain
215746|NCT02845427|Wound Hematoma|wound hematoma
215747|NCT02845401|Viral|viral
215748|NCT02845401|Hepatitis|hepatitis
215749|NCT02845388|IVF|ivf
215750|NCT02845362|Neuromuscular|neuromuscular
215751|NCT02845362|dysphagia|dysphagia
215752|NCT02845362|Swallowing disorders|swallowing disorders
215753|NCT02845362|Questionnaire|questionnaire
215754|NCT02845362|Assessment|assessment
215755|NCT02845284|adolescent|adolescent
215756|NCT02845284|reproductive health|reproductive health
215757|NCT02845245|Comminuted intra-articular distal tibia fractures|comminuted intra-articular distal tibia fractures
215758|NCT02845245|3D printing|3d printing
215759|NCT02845245|pre-operative planning|pre-operative planning
215760|NCT02845232|Acute myeloid leukemia|acute myeloid leukemia
215761|NCT02845232|Therapy|therapy
215762|NCT02845232|Blood transfusion|blood transfusion
215763|NCT02845232|Cost-effectiveness|cost-effectiveness
215764|NCT02845232|Prognosis|prognosis
215765|NCT02845206|Total Knee Replacement|total knee replacement
215766|NCT02845206|Patient Specific Instrumentation|patient specific instrumentation
215767|NCT02845180|lipectomy|lipectomy
215768|NCT02845180|panniculectomy|panniculectomy
215769|NCT02845154|Ischemia reperfusion|ischemia reperfusion
215770|NCT02845154|post-reperfusion syndrome|post-reperfusion syndrome
215771|NCT02845154|living donor liver transplantation|living donor liver transplantation
215772|NCT02845154|patient outcome|patient outcome
215773|NCT02845141|ACL|acl
215774|NCT02845141|Revision surgery|revision surgery
215775|NCT02845141|tunnel enlargement|tunnel enlargement
215776|NCT02845141|bone substitute material|bone substitute material
215777|NCT02845141|bone graft|bone graft
215778|NCT02845128|high-flow nasal cannula, HFNC, acute respiratory failure, intubation|high-flow nasal cannula, hfnc, acute respiratory failure, intubation
215779|NCT02845115|Middle Ear Implant|middle ear implant
215780|NCT02845115|laser velocimetry|laser velocimetry
215781|NCT02845102|Chronic Illness|chronic illness
215782|NCT02845102|Chronic Pain|chronic pain
215783|NCT02845102|Depression|depression
215784|NCT02845102|Comorbid Depression|comorbid depression
215785|NCT02845102|Cognitive Behavioral Therapy|cognitive behavioral therapy
215786|NCT02845102|Relational Agent Technology|relational agent technology
215787|NCT02845102|CBT|cbt
215788|NCT02845102|Virtual Counselor|virtual counselor
215789|NCT02845076|Noninvasive ventilation|noninvasive ventilation
215790|NCT02845076|Respiratory insufficiency|respiratory insufficiency
215791|NCT02845076|Hypercapnia|hypercapnia
215792|NCT02845076|ventilator weaning|ventilator weaning
215793|NCT02845063|muscle plasticity|muscle plasticity
215794|NCT02845063|exercise|exercise
215795|NCT02845063|rehabilitation|rehabilitation
215796|NCT02845063|perfusion|perfusion
215797|NCT02845063|ACE|ace
215798|NCT02845063|genotype|genotype
215799|NCT02845063|hypertension|hypertension
215800|NCT02845063|molecular biology|molecular biology
215801|NCT02845050|neo-adjuvant|neo-adjuvant
215802|NCT02845050|vinflunine|vinflunine
215803|NCT02845050|cisplatin|cisplatin
215804|NCT02845050|radical cystectomy|radical cystectomy
215805|NCT02845050|muscle-invasive bladder cancer|muscle-invasive bladder cancer
215806|NCT02845050|JaNEO|janeo
215807|NCT02845011|Cardio first angle|cardio first angle
215808|NCT02845011|CPR|cpr
215809|NCT02845011|Cardiopulmonary Arrest|cardiopulmonary arrest
215810|NCT02845011|Clinical trial|clinical trial
215811|NCT02844998|intravaginal ejaculatory latency time|intravaginal ejaculatory latency time
215812|NCT02844998|international physical activity questionnaire|international physical activity questionnaire
215813|NCT02844998|premature ejaculation diagnostic tool|premature ejaculation diagnostic tool
215814|NCT02844985|Sexual Addiction|sexual addiction
215815|NCT02844985|Genomics|genomics
215816|NCT02844985|Personality|personality
215817|NCT02844985|Polymorphism|polymorphism
215818|NCT02844972|arrest or limitation of active treatment|arrest or limitation of active treatment
215819|NCT02844972|emergency treatment|emergency treatment
215820|NCT02844959|Atrial Fibrillation|atrial fibrillation
215821|NCT02844959|Biomarkers|biomarkers
215822|NCT02844959|Inflammatory Response|inflammatory response
215823|NCT02844959|C-reactive protein|c-reactive protein
215824|NCT02844959|FGF2|fgf2
215825|NCT02844959|MMP8|mmp8
215826|NCT02844959|troponin I|troponin i
215827|NCT02844959|body temperature|body temperature
215828|NCT02844946|Acceptance and Commitment Therapy|acceptance and commitment therapy
215829|NCT02844946|mild Traumatic Brain Injury|mild traumatic brain injury
215830|NCT02844946|Veterans|veterans
215831|NCT02844946|Post Traumatic Stress Disorder|post traumatic stress disorder
215832|NCT02844907|Incretins|incretins
215833|NCT02844907|GLP-1|glp-1
215834|NCT02844907|Exendin-9|exendin-9
215835|NCT02844907|Insulin Resistance|insulin resistance
215836|NCT02844894|intubation, ischemia modified albumine, dexmedetomidine, esmolol|intubation, ischemia modified albumine, dexmedetomidine, esmolol
215837|NCT02844868|stroke|stroke
215838|NCT02844868|hemiplegia|hemiplegia
215839|NCT02844868|transcranial direct current stimulation (tDCS)|transcranial direct current stimulation (tdcs)
215840|NCT02844868|rehabilitation|rehabilitation
215841|NCT02844868|lower extremity|lower extremity
215842|NCT02844868|gait training|gait training
215843|NCT02844855|Alzheimer|alzheimer
215844|NCT02844855|Parkinson|parkinson
215845|NCT02844855|Action memory|action memory
215846|NCT02844842|mild or moderate|mild or moderate
215847|NCT02844829|Prostate Cancer|prostate cancer
215848|NCT02844829|Magnetic Resonance Imaging|magnetic resonance imaging
215849|NCT02844777|topical ointment|topical ointment
215850|NCT02844777|skin|skin
215851|NCT02844777|hexokinase|hexokinase
215852|NCT02844777|precancerous conditions|precancerous conditions
215853|NCT02844777|carcinoma, squamous cell|carcinoma, squamous cell
215854|NCT02844712|Drug hypersensitivity|drug hypersensitivity
215855|NCT02844712|Betalactam|betalactam
215856|NCT02844712|Drug provocation test|drug provocation test
215857|NCT02844699|prostate cancer|prostate cancer
215858|NCT02844699|adenovirus|adenovirus
215859|NCT02844699|TLR5|tlr5
215860|NCT02844699|immunotherapy|immunotherapy
215861|NCT02844699|Ad5|ad5
215862|NCT02844686|Myocardial perfusion imaging|myocardial perfusion imaging
215863|NCT02844686|Single-Photon Emission Computer-Assisted Tomography|single-photon emission computer-assisted tomography
215864|NCT02844673|Sickle cell disease|sickle cell disease
215865|NCT02844673|Hydroxyurea|hydroxyurea
215866|NCT02844673|Adherence|adherence
215867|NCT02844673|randomized trial|randomized trial
215868|NCT02844673|medication possession ratio|medication possession ratio
215869|NCT02844660|Diabetes Mellitus|diabetes mellitus
215870|NCT02844660|Foot Diseases|foot diseases
215871|NCT02844660|Foot Ulcer|foot ulcer
215872|NCT02844634|pre-exposure prophylaxis|pre-exposure prophylaxis
215873|NCT02844634|men who have sex with men|men who have sex with men
215874|NCT02844634|HIV prevention|hiv prevention
215875|NCT02844634|sexually transmitted infection|sexually transmitted infection
215876|NCT02844634|syphilis|syphilis
215877|NCT02844608|Health-related quality of life|health-related quality of life
215878|NCT02844608|Oncology clinical practice|oncology clinical practice
215879|NCT02844608|Electronic collection|electronic collection
215880|NCT02844595|Smoking, psychological treatment, depression|smoking, psychological treatment, depression
215881|NCT02844569|Dental Implants|dental implants
215882|NCT02844569|Bone Grafting|bone grafting
215883|NCT02844556|SMILE surgery|smile surgery
215884|NCT02844556|FS-LASIK surgery|fs-lasik surgery
215885|NCT02844556|multicenter|multicenter
215886|NCT02844543|concussion, eye-tracking, athletes, vision|concussion, eye-tracking, athletes, vision
215887|NCT02844530|adults|adults
215888|NCT02844517|Artificial Pancreas|artificial pancreas
215889|NCT02844517|Closed Loop Control|closed loop control
215890|NCT02844517|Continuous Glucose Monitor (CGM)|continuous glucose monitor (cgm)
215891|NCT02844504|Fatigue|fatigue
215892|NCT02844504|Breast cancer|breast cancer
215893|NCT02844504|Force|force
215894|NCT02844504|Motor imagery|motor imagery
215895|NCT02844504|Cancer Treatment|cancer treatment
215896|NCT02844478|Caregiving|caregiving
215897|NCT02844478|Family caregiving|family caregiving
215898|NCT02844478|Stress|stress
215899|NCT02844478|dementia caregiving|dementia caregiving
215900|NCT02844478|Hispanics|hispanics
215901|NCT02844478|Spanish|spanish
215902|NCT02844478|Telomere|telomere
215903|NCT02844465|epilepsy|epilepsy
215904|NCT02844465|laser ablation|laser ablation
215905|NCT02844465|Visualase|visualase
215906|NCT02844465|laser interstitial thermal therapy|laser interstitial thermal therapy
215907|NCT02844452|Atopic Dermatitis|atopic dermatitis
215908|NCT02844452|acupuncture|acupuncture
215909|NCT02844452|visit frequency|visit frequency
215910|NCT02844452|adult patient with AD|adult patient with ad
215911|NCT02844426|synbiotic|synbiotic
215912|NCT02844426|soluble dietary fiber|soluble dietary fiber
215913|NCT02844426|slow transit constipation|slow transit constipation
215914|NCT02844426|microbiota|microbiota
215915|NCT02844387|cancer|cancer
215916|NCT02844387|brain|brain
215917|NCT02844387|arginine|arginine
215918|NCT02844387|radiation|radiation
215919|NCT02844374|Epilepsy|epilepsy
215920|NCT02844374|Surgery candidate|surgery candidate
215921|NCT02844374|EEG's Signal|eeg's signal
215922|NCT02844361|high-risk|high-risk
215923|NCT02844361|ASCT|asct
215924|NCT02844348|Pain|pain
215925|NCT02844348|Hypnosis|hypnosis
215926|NCT02844348|Chronic Dialysis|chronic dialysis
215927|NCT02844348|Arterial Disease|arterial disease
215928|NCT02844335|Breast Cancer|breast cancer
215929|NCT02844335|Cryosurgery|cryosurgery
215930|NCT02844335|NK Immunotherapy|nk immunotherapy
215931|NCT02844296|short-bout exercise|short-bout exercise
215932|NCT02844296|craving|craving
215933|NCT02844296|handgrip|handgrip
215934|NCT02844296|smoking cessation|smoking cessation
215935|NCT02844296|RCT|rct
215936|NCT02844283|HGF,myocardial infarction|hgf,myocardial infarction
215937|NCT02844257|Acute myeloid leukaemia|acute myeloid leukaemia
215938|NCT02844257|Transfusion dependency|transfusion dependency
215939|NCT02844257|Transfusion intensity|transfusion intensity
215940|NCT02844257|Prognosis|prognosis
215941|NCT02844257|Chemotherapy|chemotherapy
215942|NCT02844244|family well-being|family well-being
215943|NCT02844244|positive psychology|positive psychology
215944|NCT02844218|Acute myeloid leukemia|acute myeloid leukemia
215945|NCT02844218|Chemotherapy|chemotherapy
215946|NCT02844218|Low-intensity therapy|low-intensity therapy
215947|NCT02844218|Older patients|older patients
215948|NCT02844218|Prognosis|prognosis
215949|NCT02844218|Supportive care|supportive care
215950|NCT02844205|nursing care|nursing care
215951|NCT02844205|observational scale|observational scale
215953|NCT02844205|premature infant|premature infant
215954|NCT02844205|developmental care|developmental care
215955|NCT02844192|Vancomycin|vancomycin
215956|NCT02844192|under dosage|under dosage
215957|NCT02844192|intensive care unit|intensive care unit
215958|NCT02844192|pharmacokinetics|pharmacokinetics
215959|NCT02844153|Metformin|metformin
215960|NCT02844153|type 2 diabetes|type 2 diabetes
215961|NCT02844153|chronic kidney disease|chronic kidney disease
215962|NCT02844153|antidiabetic medications|antidiabetic medications
215963|NCT02844153|lactic acidosis|lactic acidosis
215964|NCT02844114|Ganoderma Lucidum Spore|ganoderma lucidum spore
215965|NCT02844114|Carcinoma, Non-Small-Cell Lung|carcinoma, non-small-cell lung
215966|NCT02844114|Chemotherapy|chemotherapy
215967|NCT02844114|Gemcitabine|gemcitabine
215968|NCT02844114|Cisplatin|cisplatin
215969|NCT02844088|meningococcus C|meningococcus c
215970|NCT02844075|Esophageal Squamous Cell Carcinoma|esophageal squamous cell carcinoma
215971|NCT02844075|pembrolizumab|pembrolizumab
215972|NCT02844075|PD-1|pd-1
215973|NCT02844075|neoadjuvant|neoadjuvant
215974|NCT02844075|chemoradiation|chemoradiation
215975|NCT02844049|Deep Brain Stimulation|deep brain stimulation
215976|NCT02844049|Quality of Life|quality of life
215977|NCT02844036|Distal Lesions|distal lesions
215978|NCT02844036|Post-embolic HTP|post-embolic htp
215979|NCT02844036|Angioplasty|angioplasty
215980|NCT02844023|Arteritis|arteritis
215981|NCT02844023|Biomarker|biomarker
215982|NCT02844023|Horton disease|horton disease
215983|NCT02843997|Bipolar disorder|bipolar disorder
215984|NCT02843997|Endophenotype|endophenotype
215985|NCT02843997|Family|family
215986|NCT02843997|Autosomal dominant expression|autosomal dominant expression
215987|NCT02843997|Sequencing|sequencing
215988|NCT02843997|Heritability|heritability
215989|NCT02843984|Amniocentesis|amniocentesis
215990|NCT02843971|Water Drinking Test|water drinking test
215991|NCT02843971|Intraocular Pressure|intraocular pressure
215992|NCT02843971|Sensimed Triggerfish|sensimed triggerfish
215993|NCT02843958|Medical device|medical device
215994|NCT02843958|Hemoptic|hemoptic
215995|NCT02843958|Vitamin K antagonist|vitamin k antagonist
215996|NCT02843958|Diagnostic in vitro|diagnostic in vitro
215997|NCT02843945|brachytherapy|brachytherapy
215998|NCT02843945|CivaSheet|civasheet
215999|NCT02843945|CivaTech|civatech
216000|NCT02843945|whipple|whipple
216001|NCT02843945|radiation|radiation
216002|NCT02843945|borderline resectable|borderline resectable
216003|NCT02843945|locally advanced|locally advanced
216004|NCT02843945|Pd-103|pd-103
216005|NCT02843945|intraoperative radiation|intraoperative radiation
216006|NCT02843932|Somatoform|somatoform
216007|NCT02843932|Psychogenic|psychogenic
216008|NCT02843919|Electrocardiography|electrocardiography
216009|NCT02843919|Electroencephalography|electroencephalography
216010|NCT02843919|Neural Correlates|neural correlates
216011|NCT02843919|Mental Workload|mental workload
216012|NCT02843906|alzheimer disease|alzheimer disease
216013|NCT02843906|bipolar disorders|bipolar disorders
216014|NCT02843906|mild cognitive impairement|mild cognitive impairement
216015|NCT02843893|Pupillary|pupillary
216016|NCT02843893|Reflexes|reflexes
216017|NCT02843893|Analgesia|analgesia
216018|NCT02843893|Sedation|sedation
216019|NCT02843880|CMV reactivation|cmv reactivation
216020|NCT02843880|CMV disease|cmv disease
216021|NCT02843880|Predictive factors|predictive factors
216022|NCT02843880|Critically ill patients|critically ill patients
216023|NCT02843880|Septic shock|septic shock
216024|NCT02843867|Transplantation|transplantation
216025|NCT02843867|Immunology|immunology
216026|NCT02843867|Atherosclerosis|atherosclerosis
216027|NCT02843828|Exoskeleton Device|exoskeleton device
216028|NCT02843828|elderly|elderly
216029|NCT02843828|stroke|stroke
216030|NCT02843828|gait rehabilitation|gait rehabilitation
216031|NCT02843815|Non-small cell lung cancer|non-small cell lung cancer
216032|NCT02843815|Cryosurgery|cryosurgery
216033|NCT02843815|NK Immunotherapy|nk immunotherapy
216034|NCT02843802|Metastatic liver cancer|metastatic liver cancer
216035|NCT02843802|Cryosurgery|cryosurgery
216036|NCT02843802|NK Immunotherapy|nk immunotherapy
216037|NCT02843789|Adipokines|adipokines
216038|NCT02843789|Tocilizumab|tocilizumab
216039|NCT02843776|Palliative Care|palliative care
216040|NCT02843776|Euthanasia|euthanasia
216041|NCT02843776|Epidemiologic Studies|epidemiologic studies
216042|NCT02843750|Rehabilitation|rehabilitation
216043|NCT02843750|Inspiratory Muscle Training|inspiratory muscle training
216044|NCT02843724|Uncontrolled Type 2 Diabetes|uncontrolled type 2 diabetes
216045|NCT02843724|HbA1c >7.0%|hba1c >7.0%
216046|NCT02843711|Lungcarta Panel|lungcarta panel
216047|NCT02843711|lung adenocarcinoma|lung adenocarcinoma
216048|NCT02843672|metatarsalgia|metatarsalgia
216049|NCT02843672|surgery|surgery
216050|NCT02843672|weil|weil
216051|NCT02843672|MIS|mis
216052|NCT02843672|percutaneous|percutaneous
216053|NCT02843672|DMMO|dmmo
216054|NCT02843646|gait training|gait training
216055|NCT02843646|stepping|stepping
216056|NCT02843633|Acute Coronary Syndrome|acute coronary syndrome
216057|NCT02843633|Percutaneous Coronary Intervention|percutaneous coronary intervention
216058|NCT02843633|Drug Coated Stent|drug coated stent
216059|NCT02843633|Drug Eluting Stent|drug eluting stent
216060|NCT02843620|Native Collagen|native collagen
216061|NCT02843620|Joint|joint
216062|NCT02843620|Joint Discomfort|joint discomfort
216063|NCT02843607|Kidney Cancer|kidney cancer
216064|NCT02843607|Cryosurgery|cryosurgery
216065|NCT02843607|NK Immunotherapy|nk immunotherapy
216066|NCT02843581|Esophageal Cancer|esophageal cancer
216067|NCT02843581|NK immunotherapy|nk immunotherapy
216068|NCT02843581|Safety|safety
216069|NCT02843581|Efficacy|efficacy
216070|NCT02843555|Leukodystrophy|leukodystrophy
216071|NCT02843555|Myelin Gene|myelin gene
216072|NCT02843555|Myelin Protein|myelin protein
216073|NCT02843555|Sural Nerve Biopsy|sural nerve biopsy
216074|NCT02843555|Undiagnosed Disease|undiagnosed disease
216075|NCT02843555|Schwann Cell|schwann cell
216076|NCT02843555|White Matter Pathology|white matter pathology
216077|NCT02843555|Motor Delay|motor delay
216078|NCT02843555|Cognitive Regression|cognitive regression
216079|NCT02843555|Motor Deterioration|motor deterioration
216080|NCT02843555|Unknown Disease|unknown disease
216081|NCT02843542|Positron emission tomography-magnetic resonance imaging (PET-MR)|positron emission tomography-magnetic resonance imaging (pet-mr)
216082|NCT02843542|Hyperthyroidism|hyperthyroidism
216083|NCT02843542|Positron emission tomography-computed tomography (PET-CT)|positron emission tomography-computed tomography (pet-ct)
216084|NCT02843529|biomarkers|biomarkers
216085|NCT02843529|CSF|csf
216086|NCT02843529|EEG|eeg
216087|NCT02843529|MRI|mri
216088|NCT02843529|Digital biomarkers|digital biomarkers
216089|NCT02843490|neovascular age-related macular edema|neovascular age-related macular edema
216090|NCT02843490|biomarker|biomarker
216091|NCT02843490|ranibizumab|ranibizumab
216092|NCT02843490|lucentis|lucentis
216093|NCT02843438|Toxoplasmosis|toxoplasmosis
216094|NCT02843438|Uveitis|uveitis
216095|NCT02843438|Chorioretinitis|chorioretinitis
216096|NCT02843438|Infection|infection
216097|NCT02843425|Cancer Prevention|cancer prevention
216098|NCT02843425|Precancerous colorectal polyps|precancerous colorectal polyps
216099|NCT02843425|Canned beans|canned beans
216100|NCT02843425|Questionnaires|questionnaires
216101|NCT02843425|Surveys|surveys
216102|NCT02843425|Stool samples|stool samples
216103|NCT02843412|Gastric cancer|gastric cancer
216104|NCT02843412|Her2/neu|her2/neu
216105|NCT02843412|Dual paraffin blocks|dual paraffin blocks
216106|NCT02843412|Trastuzumab|trastuzumab
216107|NCT02843412|Clinical Prospective Multicenter Cohort Study|clinical prospective multicenter cohort study
216108|NCT02843399|Diabetes Mellitus Type 2|diabetes mellitus type 2
216109|NCT02843386|Uveal melanoma|uveal melanoma
216110|NCT02843386|High risk of metastasis|high risk of metastasis
216111|NCT02843386|Genomic high risk signature|genomic high risk signature
216112|NCT02843386|Adjuvant chemotherapy|adjuvant chemotherapy
216113|NCT02843360|public health|public health
216114|NCT02843347|Biorepository|biorepository
216115|NCT02843347|Genetics|genetics
216116|NCT02843334|Fabry disease|fabry disease
216117|NCT02843334|End Stage Renal Disease|end stage renal disease
216118|NCT02843334|chronic dialysis|chronic dialysis
216119|NCT02843334|alpha galactosidase A|alpha galactosidase a
216120|NCT02843334|Lyso-GB3|lyso-gb3
216121|NCT02843334|GLA mutation|gla mutation
216122|NCT02843334|Prevalence|prevalence
216123|NCT02843321|infection|infection
216124|NCT02843308|hoarding disorder|hoarding disorder
216125|NCT02843308|hoarding|hoarding
216126|NCT02843308|clutter|clutter
216127|NCT02843295|renal transplantation|renal transplantation
216128|NCT02843295|immunology|immunology
216129|NCT02843295|rejection|rejection
216130|NCT02843269|RCT|rct
216131|NCT02843269|Multi-component intervention|multi-component intervention
216132|NCT02843269|Health personnel|health personnel
216133|NCT02843269|Physical exercise training|physical exercise training
216134|NCT02843230|Brain Tumor|brain tumor
216135|NCT02843204|solid tumor|solid tumor
216136|NCT02843204|anti-PD-L1|anti-pd-l1
216137|NCT02843204|NK immunotherapy|nk immunotherapy
216138|NCT02843191|Rectal Cancer|rectal cancer
216139|NCT02843191|Consolidation Chemotherapy|consolidation chemotherapy
216140|NCT02843178|nutrition|nutrition
216141|NCT02843178|food security|food security
216142|NCT02843178|behavioral economics|behavioral economics
216143|NCT02843165|stereotactic body radiation therapy|stereotactic body radiation therapy
216144|NCT02843165|checkpoint blockade immunotherapy|checkpoint blockade immunotherapy
216145|NCT02843139|Circulating microRNA|circulating microrna
216146|NCT02843139|Childhood obesity|childhood obesity
216147|NCT02843139|Adulthood diabetes|adulthood diabetes
216148|NCT02843126|recurrent breast cancer|recurrent breast cancer
216149|NCT02843126|Her-2 positive|her-2 positive
216150|NCT02843126|Trastuzumab|trastuzumab
216151|NCT02843126|NK immunotherapy|nk immunotherapy
216152|NCT02843113|single father|single father
216153|NCT02843113|parenting behavior|parenting behavior
216154|NCT02843100|Crohn's Disease|crohn's disease
216155|NCT02843100|Pediatric|pediatric
216156|NCT02843100|Exclusive Enteral Nutrition|exclusive enteral nutrition
216157|NCT02843100|Diet|diet
216158|NCT02843100|Microbiome|microbiome
216257|NCT02842372|GvHD|gvhd
216159|NCT02843087|Breastfeeding|breastfeeding
216160|NCT02843087|Microbiome|microbiome
216161|NCT02843087|BEACH|beach
216162|NCT02843087|Human milk|human milk
216163|NCT02843087|Pediatric Obesity|pediatric obesity
216164|NCT02843074|B-cell tumors|b-cell tumors
216165|NCT02843074|autologous stem cell transplantation|autologous stem cell transplantation
216166|NCT02843074|blood cancers|blood cancers
216167|NCT02843061|B lymphoma|b lymphoma
216168|NCT02843061|Rituximab|rituximab
216169|NCT02843061|NK immunotherapy|nk immunotherapy
216170|NCT02843048|Osteoporosis|osteoporosis
216171|NCT02843048|Bariatric Surgery|bariatric surgery
216172|NCT02843048|Physical exercise|physical exercise
216173|NCT02843048|Obesity|obesity
216174|NCT02843022|postpartum|postpartum
216175|NCT02843022|nursing|nursing
216176|NCT02843022|follow-up|follow-up
216177|NCT02842983|Esmolol|esmolol
216178|NCT02842983|Hypotension|hypotension
216179|NCT02842983|Shock, Septic|shock, septic
216180|NCT02842983|Sepsis|sepsis
216181|NCT02842983|Systemic Inflammatory Response Syndrome|systemic inflammatory response syndrome
216182|NCT02842983|Adrenergic beta-1 Receptor Antagonists|adrenergic beta-1 receptor antagonists
216183|NCT02842983|Adrenergic Antagonists|adrenergic antagonists
216184|NCT02842983|Pharmacologic Actions|pharmacologic actions
216185|NCT02842983|Physiological Effects of Drugs|physiological effects of drugs
216186|NCT02842931|DLBCL, R-DA-EPOCH-21, R-mNHL-BFM-90, auto-SCT|dlbcl, r-da-epoch-21, r-mnhl-bfm-90, auto-sct
216187|NCT02842918|Thoracic Spine Manipulation|thoracic spine manipulation
216188|NCT02842918|Neurodynamics|neurodynamics
216189|NCT02842918|Sham|sham
216190|NCT02842866|Meningitis|meningitis
216191|NCT02842866|Meningococcal Meningitis|meningococcal meningitis
216192|NCT02842866|Meningococcal Infections|meningococcal infections
216193|NCT02842866|MenACYW conjugate vaccine|menacyw conjugate vaccine
216194|NCT02842866|Menomune® - A/C/Y/W-135|menomune® - a/c/y/w-135
216195|NCT02842853|Meningitis|meningitis
216196|NCT02842853|Meningococcal Meningitis|meningococcal meningitis
216197|NCT02842853|Meningococcal Infections|meningococcal infections
216198|NCT02842853|MenACYW conjugate vaccine|menacyw conjugate vaccine
216199|NCT02842853|Licensed MCV4 vaccine|licensed mcv4 vaccine
216200|NCT02842827|LSD1|lsd1
216201|NCT02842814|Systemic Lupus Erythematosus|systemic lupus erythematosus
216202|NCT02842814|Stable|stable
216203|NCT02842814|Relapse Risk|relapse risk
216204|NCT02842814|Glucocorticoid Withdrawal|glucocorticoid withdrawal
216205|NCT02842788|prone position|prone position
216206|NCT02842788|acute respiratory distress syndrome (ARDS)|acute respiratory distress syndrome (ards)
216207|NCT02842788|mechanical ventilation|mechanical ventilation
216208|NCT02842788|ICU|icu
216209|NCT02842788|prevalence|prevalence
216210|NCT02842775|rehabilitation|rehabilitation
216211|NCT02842762|Echocardiography, Three-dimensional|echocardiography, three-dimensional
216212|NCT02842762|Cardiac Surgical Procedures|cardiac surgical procedures
216213|NCT02842762|Cardiac Pacing, Artificial|cardiac pacing, artificial
216214|NCT02842762|Anesthesia|anesthesia
216215|NCT02842736|heavy menstrual bleeding|heavy menstrual bleeding
216216|NCT02842736|endometrial ablation|endometrial ablation
216217|NCT02842723|craniopharyngioma|craniopharyngioma
216218|NCT02842723|protontherapy|protontherapy
216219|NCT02842697|clinically significant portal hypertension|clinically significant portal hypertension
216220|NCT02842697|hepatic venous pressure gradient|hepatic venous pressure gradient
216221|NCT02842697|computed tomographic angiography|computed tomographic angiography
216222|NCT02842671|autism|autism
216223|NCT02842671|ambassador|ambassador
216224|NCT02842658|Chemotherapy|chemotherapy
216225|NCT02842658|Exercise|exercise
216226|NCT02842645|Foetal Exposure During Pregnancy|foetal exposure during pregnancy
216227|NCT02842645|Health|health
216228|NCT02842645|Growth|growth
216229|NCT02842580|colorectal|colorectal
216230|NCT02842580|cancer|cancer
216231|NCT02842580|metastasis|metastasis
216232|NCT02842554|PDN|pdn
216233|NCT02842554|Painful Diabetic Neuropathy|painful diabetic neuropathy
216234|NCT02842554|Diabetes|diabetes
216235|NCT02842502|Skin Substitutes|skin substitutes
216236|NCT02842489|colonoscopy insertion|colonoscopy insertion
216237|NCT02842489|tilt-down position|tilt-down position
216238|NCT02842476|pulse oximetry|pulse oximetry
216239|NCT02842437|dexmedetomidine|dexmedetomidine
216240|NCT02842437|sepsis|sepsis
216241|NCT02842437|respiration|respiration
216242|NCT02842424|Ramipril|ramipril
216243|NCT02842424|Angiotensin-converting enzyme|angiotensin-converting enzyme
216244|NCT02842424|Claudication|claudication
216245|NCT02842424|Myopathy|myopathy
216246|NCT02842424|Peripheral Arterial Disease|peripheral arterial disease
216247|NCT02842411|bowel preparation|bowel preparation
216248|NCT02842411|chronic constipation|chronic constipation
216249|NCT02842411|risk factor|risk factor
216250|NCT02842398|gait|gait
216251|NCT02842398|balance|balance
216252|NCT02842398|street-crossing|street-crossing
216253|NCT02842385|soft tissue thickness|soft tissue thickness
216254|NCT02842385|dental implant|dental implant
216255|NCT02842385|crestal bone loss|crestal bone loss
216256|NCT02842372|Acute Graft Versus Host Disease in Skin|acute graft versus host disease in skin
216258|NCT02842372|Ectoin|ectoin
216259|NCT02842372|Dermatitis|dermatitis
216260|NCT02842372|Inflammation of the skin|inflammation of the skin
216261|NCT02842372|Topical therapy skin GvHD|topical therapy skin gvhd
216262|NCT02842346|Ultrasound; umbilical Doppler; resistance index; fetal growth|ultrasound; umbilical doppler; resistance index; fetal growth
216263|NCT02842307|Acupuncture|acupuncture
216264|NCT02842307|Expertise-based randomized controlled trial|expertise-based randomized controlled trial
216265|NCT02842307|Nausea|nausea
216266|NCT02842307|Vomiting|vomiting
216267|NCT02842307|Cancer|cancer
216268|NCT02842294|bevacizumab|bevacizumab
216269|NCT02842294|health related quality of life|health related quality of life
216270|NCT02842255|Sleep apnea|sleep apnea
216271|NCT02842255|Oximeter|oximeter
216272|NCT02842255|Calibration|calibration
216273|NCT02842255|Oxygen partial pressure|oxygen partial pressure
216274|NCT02842229|Myelodysplastic Syndromes|myelodysplastic syndromes
216275|NCT02842229|Leukemia Myeloid Acute|leukemia myeloid acute
216276|NCT02842229|Multiple Myeloma|multiple myeloma
216277|NCT02842229|Leukemia, Lymphocytic, Chronic|leukemia, lymphocytic, chronic
216278|NCT02842229|Elderly Patients|elderly patients
216279|NCT02842229|Haematological malignancy|haematological malignancy
216280|NCT02842229|Elderly|elderly
216281|NCT02842229|Health Status|health status
216282|NCT02842229|Scale validation|scale validation
216283|NCT02842229|Retrospective|retrospective
216284|NCT02842216|Pharmaceutical preparations|pharmaceutical preparations
216285|NCT02842216|Dietary supplements|dietary supplements
216286|NCT02842203|colorectal cancer|colorectal cancer
216287|NCT02842190|Neonatal|neonatal
216288|NCT02842190|NIPPV|nippv
216289|NCT02842190|BIPAP|bipap
216290|NCT02842190|Extubation failure|extubation failure
216291|NCT02842151|Intraocular Lens (IOL)|intraocular lens (iol)
216292|NCT02842125|Head and Neck Squamous Cell Cancer|head and neck squamous cell cancer
216293|NCT02842125|solid tumors|solid tumors
216294|NCT02842125|nivolumab|nivolumab
216295|NCT02842125|Ad-P53|ad-p53
216296|NCT02842125|metastatic|metastatic
216297|NCT02842125|capecitabine|capecitabine
216298|NCT02842125|pembrolizumab|pembrolizumab
216299|NCT02842112|Acute myeloid leukemia|acute myeloid leukemia
216300|NCT02842112|prognosis|prognosis
216301|NCT02842112|stem cell harvest|stem cell harvest
216302|NCT02842112|autologous transplant|autologous transplant
216303|NCT02842112|leukemia stem cell|leukemia stem cell
216304|NCT02842060|Prevention & Control|prevention & control
216305|NCT02842060|Young Adult|young adult
216306|NCT02842060|Internet|internet
216307|NCT02842047|caregiver|caregiver
216308|NCT02842047|end of life|end of life
216309|NCT02842034|schizophrenia|schizophrenia
216310|NCT02842034|rTMS|rtms
216311|NCT02842008|Exercise Therapy|exercise therapy
216312|NCT02842008|Shoulder pain|shoulder pain
216313|NCT02842008|Shoulder injuries|shoulder injuries
216314|NCT02842008|Shoulder function|shoulder function
216315|NCT02842008|Prevention|prevention
216316|NCT02842008|Wheelchair users|wheelchair users
216317|NCT02841995|cGVHD|cgvhd
216318|NCT02841995|Allogeneic hematopoietic stem cell transplantation|allogeneic hematopoietic stem cell transplantation
216319|NCT02841995|Immune System Diseases|immune system diseases
400626|NCT01865994|Pediatric cardiac surgery|pediatric cardiac surgery
216320|NCT02841995|Steroid refractory chronic graft vs host disease (cGVHD)|steroid refractory chronic graft vs host disease (cgvhd)
216321|NCT02841995|Bone Marrow Transplantation|bone marrow transplantation
216322|NCT02841995|Anti-Inflammatory Agents|anti-inflammatory agents
216323|NCT02841995|Glucocorticoids|glucocorticoids
216324|NCT02841995|Corticosteroids|corticosteroids
216325|NCT02841969|Ulcer|ulcer
216326|NCT02841969|Electrolysed|electrolysed
216327|NCT02841969|Water|water
216328|NCT02841943|Fluid responsiveness|fluid responsiveness
216329|NCT02841943|Near-infrared spectroscopy|near-infrared spectroscopy
216330|NCT02841943|Thoracic surgery|thoracic surgery
216331|NCT02841943|Hypovolemia|hypovolemia
216332|NCT02841943|veno-arterial carbon dioxide gradient|veno-arterial carbon dioxide gradient
216333|NCT02841943|arterio-venous oxygen gradient|arterio-venous oxygen gradient
216334|NCT02841943|hypercarbia|hypercarbia
216335|NCT02841943|Carotid artery|carotid artery
216336|NCT02841943|ultrasonography|ultrasonography
216337|NCT02841943|Doppler|doppler
216338|NCT02841930|Healthcare Access|healthcare access
216339|NCT02841930|Undocumented Immigrants|undocumented immigrants
216340|NCT02841930|Primary Prevention|primary prevention
216341|NCT02841800|radiofrequency ablation|radiofrequency ablation
216342|NCT02841800|malignant biliary stenosis|malignant biliary stenosis
216343|NCT02841787|Depression|depression
216344|NCT02841787|Web-based intervention|web-based intervention
216345|NCT02841787|Aging|aging
216346|NCT02841787|Geriatrics|geriatrics
216347|NCT02841787|Social network|social network
216348|NCT02841787|Older adults|older adults
216349|NCT02841748|Pembrolizumab|pembrolizumab
216350|NCT02841748|HNSCC|hnscc
216351|NCT02841735|brief intervention|brief intervention
216352|NCT02841735|web-based interventions|web-based interventions
216353|NCT02841735|harm reduction|harm reduction
216354|NCT02841735|young adult|young adult
216355|NCT02841735|college student|college student
216356|NCT02841709|insomnia|insomnia
216357|NCT02841709|elderly|elderly
216358|NCT02841709|Polysomnography|polysomnography
216359|NCT02841696|Heart failure|heart failure
216360|NCT02841696|Systolic dysfunction|systolic dysfunction
216362|NCT02841696|Arterial stiffness|arterial stiffness
216363|NCT02841696|Left ventricular hypertrophy|left ventricular hypertrophy
216364|NCT02841657|3 Dimensional Laparoscopy|3 dimensional laparoscopy
216365|NCT02841657|Visual work load|visual work load
216366|NCT02841657|Nasa Task Load Index|nasa task load index
216367|NCT02841657|Simulator Sickness Questionnaire|simulator sickness questionnaire
216368|NCT02841553|Endoplasmic Reticulum Stress|endoplasmic reticulum stress
216369|NCT02841540|Myelodysplastic Syndromes|myelodysplastic syndromes
216370|NCT02841540|Acute Myeloid Leukemia|acute myeloid leukemia
216371|NCT02841540|Chronic Myelomonocytic Leukemia|chronic myelomonocytic leukemia
216372|NCT02841540|H3B-8800|h3b-8800
216373|NCT02841540|Splicing Modulator|splicing modulator
216374|NCT02841540|CMML|cmml
216375|NCT02841540|AML|aml
216376|NCT02841540|MDS|mds
216377|NCT02841501|Gene Expression Profiling|gene expression profiling
216378|NCT02841501|Genome-Wide Association Study|genome-wide association study
216379|NCT02841501|Polymorphism, Single Nucleotide|polymorphism, single nucleotide
216380|NCT02841501|Drug Resistance, Fungal|drug resistance, fungal
216381|NCT02841475|Atrial Fibrillation , Comorbidities|atrial fibrillation , comorbidities
216382|NCT02841462|thermal ablation|thermal ablation
216383|NCT02841462|recurrent Bursitis|recurrent bursitis
216384|NCT02841462|chronic Bursitis|chronic bursitis
216385|NCT02841462|olecranon|olecranon
216386|NCT02841462|intra-bursal perfusion|intra-bursal perfusion
216387|NCT02841449|Hydration|hydration
216388|NCT02841449|Glycemic control|glycemic control
216389|NCT02841449|Appetite|appetite
216390|NCT02841449|Endocrinology|endocrinology
216391|NCT02841436|irreversible electroporation|irreversible electroporation
216392|NCT02841436|pancreatic cancer|pancreatic cancer
216393|NCT02841423|physical status I-III;|physical status i-iii;
216394|NCT02841423|age > 55 yr)|age > 55 yr)
216395|NCT02841423|undergoing surgery (duration, > 1 h)|undergoing surgery (duration, > 1 h)
216396|NCT02841410|Food|food
216397|NCT02841410|Emotion|emotion
216398|NCT02841410|Health|health
216399|NCT02841410|Nutrition|nutrition
216400|NCT02841410|Heuristic|heuristic
216401|NCT02841410|Reasoning|reasoning
216402|NCT02841410|Magnetic Resonance Imaging|magnetic resonance imaging
216403|NCT02841384|patellofemoral pain syndrome|patellofemoral pain syndrome
216404|NCT02841384|postural balance|postural balance
216405|NCT02841384|knee|knee
216406|NCT02841384|physiotherapy|physiotherapy
216407|NCT02841371|estimated glomerular filtration rate|estimated glomerular filtration rate
216408|NCT02841371|serum creatinine|serum creatinine
216409|NCT02841371|serum cystatin C|serum cystatin c
216410|NCT02841371|chronic kidney disease|chronic kidney disease
216411|NCT02841358|Niemann-Pick Disease, Type C|niemann-pick disease, type c
216412|NCT02841358|Psychiatric|psychiatric
216413|NCT02841358|Psychotic disorders|psychotic disorders
216414|NCT02841345|emotional processing|emotional processing
216415|NCT02841345|action|action
216416|NCT02841332|Recurrent Glioblastoma|recurrent glioblastoma
216417|NCT02841332|Positron emission tomography|positron emission tomography
216418|NCT02841332|Fluoro misonidazole|fluoro misonidazole
216419|NCT02841332|MRI multimodal|mri multimodal
216420|NCT02841319|Virtual reality|virtual reality
216421|NCT02841319|Hemiplegic|hemiplegic
216422|NCT02841319|Cerebral Palsy|cerebral palsy
216423|NCT02841319|upper extremity|upper extremity
216424|NCT02841319|hand function|hand function
216425|NCT02841293|Anorectal cancer|anorectal cancer
216426|NCT02841293|perineal morbidity|perineal morbidity
216427|NCT02841293|cost-utility analysis|cost-utility analysis
216428|NCT02841293|biological meshes|biological meshes
216429|NCT02841241|esmolol|esmolol
216430|NCT02841241|adrenergic storm|adrenergic storm
216431|NCT02841241|septic shock|septic shock
216432|NCT02841228|SIB-IMRT|sib-imrt
216433|NCT02841228|NSCLC|nsclc
216434|NCT02841228|Radiochemothearpy|radiochemothearpy
216435|NCT02841215|Gale|gale
216436|NCT02841215|Severe forms of scabies|severe forms of scabies
216437|NCT02841215|Oral parasitic drug|oral parasitic drug
216438|NCT02841215|Ivermectin|ivermectin
216439|NCT02841202|optical coherence tomography|optical coherence tomography
216440|NCT02841202|oral contraceptive pills|oral contraceptive pills
216441|NCT02841163|Magnetic Resonance Imaging|magnetic resonance imaging
216442|NCT02841163|Patient Satisfaction|patient satisfaction
216443|NCT02841163|Numeric Rating Scale|numeric rating scale
216444|NCT02841124|Decision making|decision making
216445|NCT02841098|Carotid stenosis,stroke,endarterectomy,medical therapy|carotid stenosis,stroke,endarterectomy,medical therapy
216447|NCT02841085|Thrombophilia|thrombophilia
216448|NCT02841059|quality of life|quality of life
216449|NCT02841059|urinary incontinence|urinary incontinence
216450|NCT02841059|POP|pop
216451|NCT02841046|stroke volume variation|stroke volume variation
216452|NCT02841046|cardiac index|cardiac index
216453|NCT02841046|non-severe patients|non-severe patients
216454|NCT02841046|gastrointestinal surgery|gastrointestinal surgery
216455|NCT02841033|Daratumumab|daratumumab
216456|NCT02840994|CV301, NSCLC, Pembrolizumab, Nivolumab|cv301, nsclc, pembrolizumab, nivolumab
216457|NCT02840955|Atopic dermatitis|atopic dermatitis
216458|NCT02840955|Staphylococcus aureus|staphylococcus aureus
216459|NCT02840955|Microbiome|microbiome
216460|NCT02840955|Staphefekt|staphefekt
216461|NCT02840942|intravenous line|intravenous line
216462|NCT02840942|robot|robot
216463|NCT02840916|Laser acupuncture|laser acupuncture
216464|NCT02840916|Postpartum weight retention|postpartum weight retention
216465|NCT02840916|Obesity|obesity
216466|NCT02840903|CTA|cta
216467|NCT02840903|Computed Tomographic Angiography|computed tomographic angiography
216468|NCT02840877|tuberculosis culture|tuberculosis culture
216469|NCT02840877|alcohol use|alcohol use
216470|NCT02840851|Magnetic Resonance Imaging|magnetic resonance imaging
216471|NCT02840851|Transcranial Doppler Ultrasound|transcranial doppler ultrasound
216472|NCT02840851|Hypercapnia|hypercapnia
216473|NCT02840799|Heart Failure|heart failure
216474|NCT02840799|Exercise Intolerance|exercise intolerance
216475|NCT02840799|Ejection Fraction|ejection fraction
216476|NCT02840786|stents|stents
216477|NCT02840786|atherectomy|atherectomy
216478|NCT02840786|femoral artery|femoral artery
216479|NCT02840786|popliteal artery|popliteal artery
216480|NCT02840773|RANKL|rankl
216481|NCT02840773|OPG|opg
216482|NCT02840773|Peri-implant crevicular fluid|peri-implant crevicular fluid
216483|NCT02840760|tardive dyskinesia.|tardive dyskinesia.
216484|NCT02840760|rTMS|rtms
216485|NCT02840747|Lymphomatoid Papulosis|lymphomatoid papulosis
216486|NCT02840747|Sézary Syndrome|sézary syndrome
216487|NCT02840747|T-Cell Lymphoma|t-cell lymphoma
216488|NCT02840734|Kinesio taping|kinesio taping
216489|NCT02840734|Obese adults|obese adults
216490|NCT02840734|Muscular function|muscular function
216491|NCT02840734|Fatigue|fatigue
216492|NCT02840682|resource limited setting|resource limited setting
216493|NCT02840682|Thailand-Myanmar border|thailand-myanmar border
216494|NCT02840669|Cardiomyopathy|cardiomyopathy
216495|NCT02840643|hemispherectomy|hemispherectomy
216496|NCT02840643|brain|brain
216497|NCT02840643|hand function|hand function
216498|NCT02840630|n3 LC-PUFA|n3 lc-pufa
216499|NCT02840630|Type 2 Diabetes Mellitus|type 2 diabetes mellitus
216500|NCT02840630|South Asian|south asian
216501|NCT02840630|HbA1c|hba1c
216502|NCT02840630|Omega 3 status|omega 3 status
216503|NCT02840617|ICG|icg
216504|NCT02840617|prostate cancer|prostate cancer
216505|NCT02840591|Citicoline, Ramelteon, Rozerem|citicoline, ramelteon, rozerem
216506|NCT02840539|Mantle cell lymphoma|mantle cell lymphoma
216507|NCT02840539|Bortezomib|bortezomib
216508|NCT02840539|Cytarabine|cytarabine
216509|NCT02840526|PVB|pvb
216510|NCT02840526|PCA|pca
216511|NCT02840526|nephrectomy|nephrectomy
216512|NCT02840526|postoperative pain|postoperative pain
216513|NCT02840513|Smartphone app|smartphone app
216514|NCT02840513|CO self-monitoring|co self-monitoring
216515|NCT02840500|Breakthrough Cancer Pain|breakthrough cancer pain
216516|NCT02840500|Quality of life|quality of life
216517|NCT02840500|Palliative Care Units|palliative care units
216518|NCT02840487|Zika Infection|zika infection
216519|NCT02840487|Flavivirus|flavivirus
216520|NCT02840487|Vaccine-Mediated Protection|vaccine-mediated protection
216521|NCT02840487|Immune Response|immune response
216522|NCT02840487|Arthropod-Borne Virus|arthropod-borne virus
216523|NCT02840474|HIV Viral Load|hiv viral load
216524|NCT02840474|Antiviral|antiviral
216525|NCT02840474|CD4 Count|cd4 count
216526|NCT02840474|HIV-1 Infection|hiv-1 infection
216527|NCT02840474|Broadly Neutralizing Antibody|broadly neutralizing antibody
216528|NCT02840448|ClinicalTrials.gov Identifier:|clinicaltrials.gov identifier:
216529|NCT02840448|Williams Syndrome|williams syndrome
216530|NCT02840448|Blood Flow|blood flow
216531|NCT02840448|Brain|brain
216532|NCT02840448|Arterial Stiffness|arterial stiffness
216533|NCT02840435|Nicotine addiction|nicotine addiction
216534|NCT02840435|Cigarette smoking|cigarette smoking
216535|NCT02840422|Hyaluronic acid|hyaluronic acid
216536|NCT02840422|Knee osteoarthritis|knee osteoarthritis
216537|NCT02840422|Quality of life|quality of life
216538|NCT02840396|language|language
216539|NCT02840396|DLPFC|dlpfc
216540|NCT02840396|rTMS|rtms
216541|NCT02840396|Executive Functions|executive functions
216542|NCT02840370|transcranial direct current stimulation|transcranial direct current stimulation
216543|NCT02840370|aphasia|aphasia
216544|NCT02840370|language production|language production
216545|NCT02840370|prefrontal cortex|prefrontal cortex
216546|NCT02840357|Chronic inflammation|chronic inflammation
216547|NCT02840357|Adults|adults
216548|NCT02840357|overweight|overweight
216549|NCT02840357|obese|obese
216550|NCT02840344|Couple Functioning|couple functioning
216551|NCT02840344|Stress Reduction|stress reduction
216552|NCT02840331|Gastric carcinoma|gastric carcinoma
216553|NCT02840331|Peritoneal carcinomatosis|peritoneal carcinomatosis
216554|NCT02840331|Photodynamic diagnosis|photodynamic diagnosis
216555|NCT02840331|Photodynamic therapy|photodynamic therapy
216556|NCT02840331|St. John's Wort|st. john's wort
216661|NCT02839694|Surgery|surgery
216557|NCT02840331|Peritoneal metastasis|peritoneal metastasis
216558|NCT02840318|Terminal care|terminal care
216559|NCT02840318|Residential facilities|residential facilities
216560|NCT02840318|Integrated health care systems|integrated health care systems
216561|NCT02840318|Interdisciplinary health team|interdisciplinary health team
216562|NCT02840318|Palliative care|palliative care
216563|NCT02840305|Natural scenes|natural scenes
216564|NCT02840305|Brain bases|brain bases
216565|NCT02840305|Visual perception|visual perception
216566|NCT02840305|MRI|mri
216567|NCT02840292|Late Preterms|late preterms
216568|NCT02840292|Neurobehavioral Assessment of Preterm Infants (NAPI)|neurobehavioral assessment of preterm infants (napi)
216569|NCT02840279|cognition|cognition
216570|NCT02840279|dementia|dementia
216571|NCT02840279|phosphodiesterase type 4D|phosphodiesterase type 4d
216572|NCT02840279|PDE4D|pde4d
216573|NCT02840227|Cancer|cancer
216574|NCT02840227|General anesthesia|general anesthesia
216575|NCT02840227|Epidural anesthesia|epidural anesthesia
216576|NCT02840201|biomarkers|biomarkers
216577|NCT02840188|goalkeeper's fracture|goalkeeper's fracture
216578|NCT02840175|Treatment tapering|treatment tapering
216579|NCT02840175|Oligoarticular|oligoarticular
216580|NCT02840175|Juvenile Idiopathic Arthritis|juvenile idiopathic arthritis
216581|NCT02840175|Inactive disease|inactive disease
216582|NCT02840175|Biologic therapy|biologic therapy
216583|NCT02840162|prostate cancer|prostate cancer
216584|NCT02840162|NSAIDs|nsaids
216585|NCT02840162|chemoprevention|chemoprevention
216586|NCT02840162|celecoxib|celecoxib
216587|NCT02840162|COX-2 inhibitors|cox-2 inhibitors
216588|NCT02840149|68Ga-DOTA-TATE, PET/CT|68ga-dota-tate, pet/ct
216589|NCT02840136|Respiratory infection|respiratory infection
216590|NCT02840136|Antibiotic therapy|antibiotic therapy
216591|NCT02840136|LC-MS/MS|lc-ms/ms
216592|NCT02840136|Sputum antibiotic concentrations|sputum antibiotic concentrations
216593|NCT02840097|Brain injuries|brain injuries
216594|NCT02840097|Wounds and injuries|wounds and injuries
216595|NCT02840097|Hemorrhage|hemorrhage
216596|NCT02840097|Tranexamic acid|tranexamic acid
216597|NCT02840097|Child|child
216598|NCT02840084|breast implant capsular contracture|breast implant capsular contracture
216599|NCT02840045|electroencephalography (EEG)|electroencephalography (eeg)
216600|NCT02840019|Fetal MRI|fetal mri
216601|NCT02840019|Pregnancy|pregnancy
216602|NCT02840019|Pregnant Women|pregnant women
216603|NCT02840019|MRI Coil|mri coil
216604|NCT02840019|MRI Sequence Development/Testing|mri sequence development/testing
216605|NCT02840019|Abnormal Fetuses|abnormal fetuses
216606|NCT02840019|Typically Developing Fetuses|typically developing fetuses
216607|NCT02840019|Fetal MRI Technology Development|fetal mri technology development
216608|NCT02840006|Vasoconstrictor Agents|vasoconstrictor agents
216609|NCT02840006|Vasodilator Agents|vasodilator agents
216610|NCT02839993|tDCS effects|tdcs effects
216611|NCT02839993|associative learning|associative learning
216612|NCT02839980|oropharyngeal colonization|oropharyngeal colonization
216613|NCT02839915|Language Impairment|language impairment
216614|NCT02839850|Arthroplasty|arthroplasty
216615|NCT02839850|replacement|replacement
216616|NCT02839850|Knee|knee
216617|NCT02839850|function|function
216618|NCT02839850|radiographic|radiographic
216619|NCT02839850|survivorship|survivorship
216620|NCT02839837|Depression|depression
216621|NCT02839837|Depressive Disorder|depressive disorder
216622|NCT02839837|Exercise|exercise
216623|NCT02839837|Neuroplasticity|neuroplasticity
216624|NCT02839837|Non-invasive brain stimulation|non-invasive brain stimulation
216625|NCT02839837|Healthy Control|healthy control
216626|NCT02839824|bowel cleansing|bowel cleansing
216627|NCT02839824|bowel preparation|bowel preparation
216628|NCT02839811|Betalactams|betalactams
216629|NCT02839811|In vitro diagnosis|in vitro diagnosis
216630|NCT02839798|sTMS|stms
216631|NCT02839798|NEST|nest
216632|NCT02839798|NeoSync|neosync
216633|NCT02839798|synchronous|synchronous
216634|NCT02839798|non-invasive neuromodulation|non-invasive neuromodulation
216635|NCT02839798|TMS|tms
216636|NCT02839798|transcranial magnetic stimulation|transcranial magnetic stimulation
216637|NCT02839798|EEG|eeg
216638|NCT02839798|bipolar|bipolar
216639|NCT02839798|depression|depression
216640|NCT02839785|Cerebral palsy|cerebral palsy
216641|NCT02839785|Physiotherapy|physiotherapy
216642|NCT02839785|Children|children
216643|NCT02839785|Ibuprofen|ibuprofen
216644|NCT02839785|Pain|pain
216645|NCT02839785|Anxiety|anxiety
216646|NCT02839772|podoconiosis|podoconiosis
216647|NCT02839772|glycerine|glycerine
216648|NCT02839772|RCT|rct
216649|NCT02839772|SBF|sbf
216650|NCT02839772|TEWL|tewl
216651|NCT02839772|SC hydration|sc hydration
216652|NCT02839759|Hearing loss|hearing loss
216653|NCT02839759|Presbycusis|presbycusis
216654|NCT02839759|Aging|aging
216655|NCT02839759|Teleaudiology|teleaudiology
216656|NCT02839733|Brain Imaging|brain imaging
216657|NCT02839733|Adult|adult
216658|NCT02839733|DNA Testing|dna testing
216659|NCT02839733|Children|children
216660|NCT02839694|Lung Resection|lung resection
216662|NCT02839694|Bilateral Lung Metastases|bilateral lung metastases
216663|NCT02839681|Lung Adenocarcinoma|lung adenocarcinoma
216664|NCT02839681|Immunotoxin|immunotoxin
216665|NCT02839681|Immunotherapy|immunotherapy
216666|NCT02839668|breast cancer|breast cancer
216667|NCT02839668|angiogenesis|angiogenesis
216668|NCT02839668|VEGF|vegf
216669|NCT02839603|Visceral leishmaniasis|visceral leishmaniasis
216670|NCT02839603|HIV co-infection|hiv co-infection
216671|NCT02839603|Asymptomatic|asymptomatic
216672|NCT02839590|Glaucoma|glaucoma
216673|NCT02839590|Ocular hypertension|ocular hypertension
216674|NCT02839590|Aqueous dynamics|aqueous dynamics
216675|NCT02839564|chronic abdominal pain|chronic abdominal pain
216676|NCT02839564|laparoscopic adhesiolysis|laparoscopic adhesiolysis
216677|NCT02839564|placebo|placebo
216678|NCT02839551|Betalactams|betalactams
216679|NCT02839551|Drug hypersensitivity|drug hypersensitivity
216680|NCT02839551|Drug provocation test|drug provocation test
216681|NCT02839551|Reactive dose|reactive dose
216682|NCT02839538|infiltration|infiltration
216683|NCT02839538|hemorrhoidectomy|hemorrhoidectomy
216684|NCT02839538|postoperative pain|postoperative pain
216685|NCT02839525|Eccentric exercise|eccentric exercise
216686|NCT02839525|Dietary supplement|dietary supplement
216687|NCT02839525|Muscle damage|muscle damage
216688|NCT02839499|seniors|seniors
216689|NCT02839499|mixed food|mixed food
216690|NCT02839499|normal texture food|normal texture food
216691|NCT02839486|antibiotic prophylaxis|antibiotic prophylaxis
216692|NCT02839486|pharmacokinetics|pharmacokinetics
216693|NCT02839486|cardiopulmonary bypass|cardiopulmonary bypass
216694|NCT02839447|semen|semen
216695|NCT02839447|sperm|sperm
216696|NCT02839447|oxidative stress|oxidative stress
216697|NCT02839447|reactive oxygen species|reactive oxygen species
216698|NCT02839447|idiopathic male infertility|idiopathic male infertility
216699|NCT02839408|periodontitis|periodontitis
216700|NCT02839408|azithromycin|azithromycin
216701|NCT02839408|probiotic|probiotic
216702|NCT02839395|screen illumination|screen illumination
216703|NCT02839395|melatonin|melatonin
216704|NCT02839395|body temperature|body temperature
216705|NCT02839395|cognitive functioning|cognitive functioning
216706|NCT02839395|light pollution|light pollution
216707|NCT02839369|walking performance|walking performance
216708|NCT02839369|Cerebral Palsy, Typically Developed|cerebral palsy, typically developed
216709|NCT02839330|Influenza|influenza
216710|NCT02839330|Vaccine|vaccine
216712|NCT02839330|Avian|avian
216713|NCT02839330|Pandemic|pandemic
216714|NCT02839330|H5N1|h5n1
216715|NCT02839330|MF59|mf59
216716|NCT02839317|Dysbiosis|dysbiosis
216717|NCT02839317|Crohn's disease|crohn's disease
216718|NCT02839317|Age|age
216719|NCT02839278|Immunomodulation|immunomodulation
216720|NCT02839226|ulcers|ulcers
216721|NCT02839226|wounds|wounds
216722|NCT02839226|diabetes|diabetes
277078|NCT02477137|Nursing|nursing
216723|NCT02839226|venous ulcers|venous ulcers
216724|NCT02839226|arterial ulcers|arterial ulcers
216725|NCT02839226|granulation tissue|granulation tissue
216726|NCT02839226|protein kinase c|protein kinase c
216727|NCT02839200|Insomnia|insomnia
216728|NCT02839200|Polysomnography|polysomnography
216729|NCT02839174|low carbohydrate diet|low carbohydrate diet
216730|NCT02839161|Hookworm|hookworm
216731|NCT02839161|Vaccine|vaccine
216732|NCT02839161|Na-GST-1|na-gst-1
216733|NCT02839161|Na-APR-1|na-apr-1
216734|NCT02839161|Necator americanus|necator americanus
216735|NCT02839148|Appetite, Stunting, Satiety, Children|appetite, stunting, satiety, children
216736|NCT02839122|Dutasteride|dutasteride
216737|NCT02839122|Tadalafil|tadalafil
216738|NCT02839070|Sleep|sleep
216739|NCT02839070|Learning|learning
216740|NCT02839070|Circadian Rhythms|circadian rhythms
216741|NCT02839057|Axis fractures|axis fractures
216742|NCT02839057|Elderly|elderly
216743|NCT02839057|Mortality|mortality
216744|NCT02839057|Surgical treatment|surgical treatment
216745|NCT02839031|diabetes mellitus|diabetes mellitus
216746|NCT02839031|glycaemia|glycaemia
216747|NCT02839031|cognitive-behavioral treatment|cognitive-behavioral treatment
216748|NCT02839031|coping|coping
216749|NCT02839031|parents|parents
216750|NCT02839031|children|children
216751|NCT02839005|Wound Closure Thechnical|wound closure thechnical
216752|NCT02839005|Wound Healing|wound healing
216753|NCT02838992|Cyclophosphamide|cyclophosphamide
216754|NCT02838992|Umbilical Cord Blood|umbilical cord blood
216755|NCT02838992|ATG|atg
216756|NCT02838979|Glutamine|glutamine
216757|NCT02838979|Chronic Kidney Disease|chronic kidney disease
216758|NCT02838966|immunomodulation|immunomodulation
216759|NCT02838966|immunonutrition|immunonutrition
216760|NCT02838953|Ultrasonography|ultrasonography
216761|NCT02838953|Respiratory Function Tests|respiratory function tests
216762|NCT02838953|Pulmonary Disease, Chronic Obstructive|pulmonary disease, chronic obstructive
216763|NCT02838953|Rehabilitation|rehabilitation
216764|NCT02838927|Hypoparathyroidism|hypoparathyroidism
216765|NCT02838927|Epidemiology|epidemiology
216766|NCT02838927|Medication Therapy Management|medication therapy management
216767|NCT02838914|Right atrium|right atrium
216768|NCT02838914|Echocardiography|echocardiography
216769|NCT02838914|Remodeling|remodeling
216770|NCT02838888|Adenoma|adenoma
216771|NCT02838888|computer|computer
216772|NCT02838888|automatic|automatic
216773|NCT02838888|polyp|polyp
216774|NCT02838888|detection|detection
216775|NCT02838862|Neuroendocrine Tumors|neuroendocrine tumors
216776|NCT02838862|MALDI-MS|maldi-ms
216777|NCT02838862|Proteomics|proteomics
216778|NCT02838862|Biomarkers, Tumor|biomarkers, tumor
216779|NCT02838862|Precision Medicine|precision medicine
216780|NCT02838836|Cancer|cancer
216781|NCT02838836|Circulating tumor cells (CTCs)|circulating tumor cells (ctcs)
216782|NCT02838836|Disseminated tumor cells (DTCs)|disseminated tumor cells (dtcs)
216783|NCT02838836|Circulating tumor DNA (ctDNA)|circulating tumor dna (ctdna)
216784|NCT02838823|anti-PD-1 monoclonal antibody|anti-pd-1 monoclonal antibody
216785|NCT02838823|triple negative breast cancer|triple negative breast cancer
216786|NCT02838823|safety|safety
216787|NCT02838810|peginterferon alfa|peginterferon alfa
216788|NCT02838810|Chronic Hepatitis B|chronic hepatitis b
216789|NCT02838797|Parkinson's disease|parkinson's disease
216790|NCT02838797|Gastroparesis|gastroparesis
216791|NCT02838797|Constipation|constipation
216792|NCT02838797|Prokinetic|prokinetic
216793|NCT02838797|5-HT4-receptor partial agonist|5-ht4-receptor partial agonist
216794|NCT02838771|Swallowing Disorder|swallowing disorder
216795|NCT02838771|Dysphagia|dysphagia
216796|NCT02838758|Morton's neuroma|morton's neuroma
216797|NCT02838758|Intermetatarsal neuroma|intermetatarsal neuroma
216798|NCT02838758|forefoot pain|forefoot pain
216799|NCT02838758|ultrasound guided cryoablation|ultrasound guided cryoablation
216800|NCT02838758|ultrasound guided perineural lidocaine injection|ultrasound guided perineural lidocaine injection
216801|NCT02838706|postoperative anemia|postoperative anemia
216802|NCT02838706|perfusion index|perfusion index
216803|NCT02838680|aortic stenosis|aortic stenosis
216804|NCT02838680|transcatheter aortic valve replacement (TAVR)|transcatheter aortic valve replacement (tavr)
216805|NCT02838654|cervical epidural space|cervical epidural space
216806|NCT02838654|wave form analysis|wave form analysis
216807|NCT02838615|spinal stenosis|spinal stenosis
216808|NCT02838615|epidural steroid injection|epidural steroid injection
216809|NCT02838602|carbon ions therapy|carbon ions therapy
216810|NCT02838602|radiotherapy|radiotherapy
216811|NCT02838602|radioresistant tumors|radioresistant tumors
216812|NCT02838602|cancer|cancer
216813|NCT02838602|randomized trial|randomized trial
216814|NCT02838589|Cerebrovascular Stroke|cerebrovascular stroke
216815|NCT02838589|Ischemic Stroke|ischemic stroke
216816|NCT02838589|Glucagon like peptide - 1|glucagon like peptide - 1
216817|NCT02838563|Dementia|dementia
216818|NCT02838563|Alzheimer|alzheimer
216819|NCT02838563|Well-Being|well-being
216820|NCT02838550|Physical Activity|physical activity
216821|NCT02838550|Motivational Online Intervention|motivational online intervention
216822|NCT02838550|Pedometers|pedometers
216823|NCT02838537|Triptan|triptan
216824|NCT02838537|Drug utilization|drug utilization
216825|NCT02838537|Elderly|elderly
216826|NCT02838537|Drug abuse|drug abuse
216827|NCT02838537|Cardiovascular disease|cardiovascular disease
216828|NCT02838524|Spontaneous Breathing Trial|spontaneous breathing trial
216829|NCT02838524|Inspiratory Effort|inspiratory effort
216830|NCT02838524|Mechanical Ventilation|mechanical ventilation
216831|NCT02838524|Respiratory muscle load-capacity balance|respiratory muscle load-capacity balance
216832|NCT02838498|ERCP|ercp
216834|NCT02838498|Cannulation|cannulation
216835|NCT02838498|Successful rate|successful rate
216836|NCT02838498|Trainee|trainee
216837|NCT02838407|Chronic lower respiratory tract infection|chronic lower respiratory tract infection
216838|NCT02838407|Bonchoalveolar lavage|bonchoalveolar lavage
216839|NCT02838407|Nasopharyngeal swabs|nasopharyngeal swabs
216840|NCT02838290|Burnout|burnout
216841|NCT02838290|Psychiatric morbidity|psychiatric morbidity
216842|NCT02838290|Anxiety|anxiety
216843|NCT02838290|Grief|grief
216844|NCT02838290|Alcohol and drug use|alcohol and drug use
216845|NCT02838277|lymphatic vessels|lymphatic vessels
216846|NCT02838277|leaky vessels|leaky vessels
216847|NCT02838277|hypertrophic adipocyte|hypertrophic adipocyte
216848|NCT02838212|adverse drug reaction|adverse drug reaction
216849|NCT02838212|hospital mortality|hospital mortality
216850|NCT02838212|incidence|incidence
216851|NCT02838199|Transcatheter aortic valve replacement|transcatheter aortic valve replacement
216852|NCT02838199|TAVR|tavr
216853|NCT02838199|TAVI|tavi
216854|NCT02838199|SAVR|savr
216855|NCT02838186|colonoscopy|colonoscopy
216856|NCT02838186|right colon retroflexion|right colon retroflexion
216857|NCT02838186|adenoma detection rate|adenoma detection rate
216858|NCT02838186|feasibility|feasibility
216859|NCT02838186|surveillance interval|surveillance interval
216860|NCT02838160|educational strategies|educational strategies
216861|NCT02838160|KAP|kap
216862|NCT02838160|psychological and clinical outcomes|psychological and clinical outcomes
216863|NCT02838160|intensive care unit|intensive care unit
216864|NCT02838160|follow-up study|follow-up study
216865|NCT02838160|RCT|rct
216866|NCT02838134|Laparoscopic donor nephrectomy|laparoscopic donor nephrectomy
216867|NCT02838134|Early quality of recovery|early quality of recovery
216868|NCT02838121|bisphosphonate|bisphosphonate
216869|NCT02838121|Total hip replacement|total hip replacement
216870|NCT02838121|functional outcomes|functional outcomes
216871|NCT02838121|bone mineral density|bone mineral density
216873|NCT02838095|sleep restriction|sleep restriction
216874|NCT02838095|recovery sleep|recovery sleep
216875|NCT02838095|cognitive performance|cognitive performance
216876|NCT02838095|subjective sleepiness|subjective sleepiness
216877|NCT02838095|mood|mood
216878|NCT02838095|neurobehavioural functions|neurobehavioural functions
216879|NCT02838082|traumatic brain injury|traumatic brain injury
216880|NCT02838082|sleep-wake cycle disturbance|sleep-wake cycle disturbance
216881|NCT02838082|circadian disruption|circadian disruption
216882|NCT02838056|anesthesia, epidural|anesthesia, epidural
216883|NCT02838056|skin temperature|skin temperature
216884|NCT02838030|Preeclampsia|preeclampsia
216885|NCT02838030|L-arginine|l-arginine
216886|NCT02838004|Refractive lens exchange (RLE) or cataract surgery|refractive lens exchange (rle) or cataract surgery
216887|NCT02837991|Kidney Cancer|kidney cancer
216888|NCT02837991|Celldex|celldex
216889|NCT02837991|Dose Escalation|dose escalation
216890|NCT02837991|Ovarian Cancer|ovarian cancer
216891|NCT02837991|Ovarian Carcinoma|ovarian carcinoma
216892|NCT02837991|Kidney Diseases|kidney diseases
216893|NCT02837978|Arthritis, Rheumatoid|arthritis, rheumatoid
216894|NCT02837978|Tacrolimus|tacrolimus
216895|NCT02837978|Treatment outcome|treatment outcome
216896|NCT02837978|Safety|safety
216897|NCT02837952|Ibuprofen, acetaminophen, pain, molar extraction|ibuprofen, acetaminophen, pain, molar extraction
216898|NCT02837913|Perioperative Warming|perioperative warming
216899|NCT02837887|Cancer|cancer
216900|NCT02837887|Depression|depression
216901|NCT02837874|Gastric cancer|gastric cancer
216902|NCT02837874|gastrojejunostomy|gastrojejunostomy
216903|NCT02837874|isoperistaltic|isoperistaltic
216904|NCT02837874|antiperistaltic|antiperistaltic
216905|NCT02837861|Metabolic Support|metabolic support
216906|NCT02837861|Nutritional Support|nutritional support
216907|NCT02837861|Neuro-endocrine Event|neuro-endocrine event
216908|NCT02837861|Enteral feedings|enteral feedings
216909|NCT02837861|Parenteral feeding|parenteral feeding
216910|NCT02837848|Rotator Cuff Tendinopathy|rotator cuff tendinopathy
216911|NCT02837848|Exercises|exercises
216912|NCT02837848|Coactivation|coactivation
216913|NCT02837848|Strengthening|strengthening
216914|NCT02837822|Spinal Cord Stimulation|spinal cord stimulation
216915|NCT02837822|Quantitative Sensory Testing|quantitative sensory testing
216916|NCT02837809|low-dose computed tomography|low-dose computed tomography
216917|NCT02837809|lung|lung
216918|NCT02837809|randomized controlled trial|randomized controlled trial
216919|NCT02837809|neoplasms|neoplasms
216920|NCT02837809|screening|screening
216921|NCT02837809|smoking|smoking
216922|NCT02837770|pain|pain
216923|NCT02837770|intravitreal injection|intravitreal injection
216924|NCT02837770|anti-VEGF|anti-vegf
216925|NCT02837770|diclofenac eye drops|diclofenac eye drops
216926|NCT02837770|oral diclofenac|oral diclofenac
216927|NCT02837770|Short Form of McGill Pain Questionnaire|short form of mcgill pain questionnaire
216928|NCT02837653|cardiovascular Risk|cardiovascular risk
216929|NCT02837640|Retinitis Pigmentosa|retinitis pigmentosa
216930|NCT02837640|Levodopa|levodopa
216931|NCT02837627|gastroesophageal reflux|gastroesophageal reflux
216932|NCT02837627|tube enteral feeding|tube enteral feeding
216933|NCT02837627|preterm infants|preterm infants
216934|NCT02837601|Laparoscopic surgical procedures|laparoscopic surgical procedures
216935|NCT02837601|Shoulder Pain|shoulder pain
216936|NCT02837601|Abdominal Pain|abdominal pain
216937|NCT02837601|Pediatrics|pediatrics
216938|NCT02837588|chronic pelvic pain|chronic pelvic pain
216939|NCT02837588|trigger points|trigger points
216940|NCT02837588|hiperthermy|hiperthermy
216941|NCT02837575|HSV-2|hsv-2
216942|NCT02837575|Genital Herpes|genital herpes
216943|NCT02837575|Herpes|herpes
216944|NCT02837575|Herpes Simplex Virus, Type 2|herpes simplex virus, type 2
216945|NCT02837562|Radiation exposure|radiation exposure
216946|NCT02837562|Cardiac catheterization|cardiac catheterization
216947|NCT02837523|Cystinosis Disease|cystinosis disease
216948|NCT02837523|Biomarker|biomarker
216949|NCT02837497|pediatric|pediatric
216950|NCT02837497|heart arrest|heart arrest
216951|NCT02837471|Pedometer usability|pedometer usability
216952|NCT02837471|Usability and feasibility|usability and feasibility
216953|NCT02837471|web application|web application
216954|NCT02837458|Electric current|electric current
216955|NCT02837458|Nerve block|nerve block
216956|NCT02837458|somatosensory evaluation|somatosensory evaluation
216957|NCT02837432|Depression|depression
216958|NCT02837432|Cortisol|cortisol
216959|NCT02837432|Sadness|sadness
216960|NCT02837432|Genetics|genetics
216961|NCT02837432|Stress|stress
216962|NCT02837419|extracorporeal life support|extracorporeal life support
216963|NCT02837419|health related quality of life|health related quality of life
216964|NCT02837380|Long-acting muscarinic antagonist|long-acting muscarinic antagonist
216965|NCT02837380|Long-acting beta2 agonist|long-acting beta2 agonist
216966|NCT02837380|Dry powder inhaler|dry powder inhaler
216967|NCT02837380|Inhaled corticosteroid|inhaled corticosteroid
216968|NCT02837367|nutrigenetics|nutrigenetics
216969|NCT02837367|medical foods|medical foods
216970|NCT02837367|obesity|obesity
216971|NCT02837367|children|children
216972|NCT02837367|adults|adults
216973|NCT02837354|Cerebral Autosomal Dominant Arteriopathy with Subcortical Infarcts and Leukoencephalopathy|cerebral autosomal dominant arteriopathy with subcortical infarcts and leukoencephalopathy
216974|NCT02837341|medical device|medical device
216975|NCT02837328|Magnesium Supplementation|magnesium supplementation
216976|NCT02837328|Magnesium|magnesium
216977|NCT02837328|Dietary Supplement|dietary supplement
216978|NCT02837328|Arrhythmia|arrhythmia
216979|NCT02837302|Liver cirrhosis|liver cirrhosis
216980|NCT02837302|Branched chain amino acid|branched chain amino acid
216981|NCT02837302|End-Stage Liver Disease score|end-stage liver disease score
216982|NCT02837289|patellofemoral pain syndrome|patellofemoral pain syndrome
216983|NCT02837289|therapy taping|therapy taping
216984|NCT02837289|knee|knee
216985|NCT02837289|physical therapy|physical therapy
216986|NCT02837289|runners|runners
216987|NCT02837276|Intermittent Hypoxemia|intermittent hypoxemia
216988|NCT02837276|Acute Kidney Injury|acute kidney injury
216989|NCT02837276|Preterm infant|preterm infant
216990|NCT02837250|HIV|hiv
216991|NCT02837250|Substance Use|substance use
216992|NCT02837224|retained surgical sponge|retained surgical sponge
216993|NCT02837224|adverse event|adverse event
216994|NCT02837185|Cervical dystonia|cervical dystonia
216995|NCT02837185|Transcranial magnetic stimulation|transcranial magnetic stimulation
216996|NCT02837185|Electromyography|electromyography
216997|NCT02837185|TMS|tms
216998|NCT02837185|EMG|emg
216999|NCT02837159|colorectal cancer|colorectal cancer
217000|NCT02837159|Health Life Style Habits|health life style habits
217001|NCT02837159|Health|health
217002|NCT02837146|RA|ra
217003|NCT02837120|retrospective study|retrospective study
217004|NCT02837120|acute myocardial infarction|acute myocardial infarction
217005|NCT02837120|acute aortic dissection|acute aortic dissection
217006|NCT02837120|pulmonary embolism|pulmonary embolism
217007|NCT02837120|unstable angina|unstable angina
217008|NCT02837068|Hemiplegia|hemiplegia
217009|NCT02837068|shoulder pain|shoulder pain
217010|NCT02837068|wheelchair|wheelchair
217011|NCT02837068|stroke|stroke
217012|NCT02837068|rehabilitation|rehabilitation
217013|NCT02837055|intubation, intratracheal|intubation, intratracheal
217014|NCT02837055|critical care|critical care
217015|NCT02837042|penile cancer|penile cancer
277465|NCT02474992|HIV|hiv
217016|NCT02837042|Pembrolizumab|pembrolizumab
217017|NCT02837042|penile squamous cell carcinoma|penile squamous cell carcinoma
217018|NCT02837042|squamous cell cancer|squamous cell cancer
217019|NCT02837016|Self-Control|self-control
217020|NCT02837016|Biofeedback|biofeedback
217021|NCT02837016|Respiration|respiration
217022|NCT02837003|Drug-Eluting Stent|drug-eluting stent
217023|NCT02836977|tegafur-uracil|tegafur-uracil
217024|NCT02836925|hepatitis C|hepatitis c
217025|NCT02836925|NHL|nhl
217026|NCT02836925|Indolent B-cell lymphoma|indolent b-cell lymphoma
217027|NCT02836912|Rehabilitation|rehabilitation
217028|NCT02836899|acute kidney injury; nitric oxide; cardiopulmonary bypass; endothelial dysfunction; cardiac surgery|acute kidney injury; nitric oxide; cardiopulmonary bypass; endothelial dysfunction; cardiac surgery
217029|NCT02836834|immunotherapy|immunotherapy
217030|NCT02836834|check point inhibitor|check point inhibitor
217031|NCT02836834|PD-1 antibody|pd-1 antibody
217032|NCT02836834|solid tumor|solid tumor
217033|NCT02836834|lymphoma|lymphoma
217034|NCT02836834|phase 1 trial|phase 1 trial
217035|NCT02836808|Multidisciplinary interventions|multidisciplinary interventions
217036|NCT02836808|Long term control|long term control
217037|NCT02836808|Empowerment|empowerment
217038|NCT02836795|anti-PD-1 monoclonal antibody|anti-pd-1 monoclonal antibody
217039|NCT02836795|advanced solid tumors|advanced solid tumors
217040|NCT02836795|safety|safety
217041|NCT02836782|HIV/HCV|hiv/hcv
217042|NCT02836782|Antiretroviral therapy|antiretroviral therapy
217043|NCT02836782|HIV-DNA|hiv-dna
217044|NCT02836782|Direct acting antiviral|direct acting antiviral
217045|NCT02836769|Rehabilitation|rehabilitation
217046|NCT02836769|Head and neck cancer|head and neck cancer
217047|NCT02836769|Quality of life|quality of life
217048|NCT02836769|self-efficacy|self-efficacy
217049|NCT02836743|REM sleep behavior disorder|rem sleep behavior disorder
217050|NCT02836743|Melatonin|melatonin
217051|NCT02836717|sacral nerve modulation|sacral nerve modulation
217052|NCT02836717|quality of life|quality of life
217053|NCT02836717|stimulator maintenance|stimulator maintenance
217054|NCT02836717|SNM|snm
217055|NCT02836691|Autonomic nervous system|autonomic nervous system
217056|NCT02836691|Uncontrolled severe asthma|uncontrolled severe asthma
217057|NCT02836691|Paucigranulocitic asthma phenotype|paucigranulocitic asthma phenotype
217058|NCT02836691|Stress|stress
217059|NCT02836665|Emergency Room|emergency room
217060|NCT02836665|Manchester Triage System|manchester triage system
217061|NCT02836665|Telemedicine|telemedicine
217062|NCT02836665|Patients|patients
217063|NCT02836652|HeartMate II (HMII)|heartmate ii (hmii)
217064|NCT02836652|Left Ventricular Assist Device (LVAD)|left ventricular assist device (lvad)
217065|NCT02836600|notch inhibitor|notch inhibitor
217066|NCT02836548|advanced melanoma|advanced melanoma
217067|NCT02836548|BRAF V600 mutation|braf v600 mutation
217068|NCT02836548|vorinostat|vorinostat
217069|NCT02836548|HDAC inhibitor|hdac inhibitor
217070|NCT02836535|complications|complications
217071|NCT02836535|surgery|surgery
217072|NCT02836522|Health-Related Symptom Index|health-related symptom index
217073|NCT02836522|ANCHOR( ANal Cancer HSIL (high grade squamous intraepithelial lesions) Outcomes Research study)|anchor( anal cancer hsil (high grade squamous intraepithelial lesions) outcomes research study)
217074|NCT02836509|Low Back Pain|low back pain
217075|NCT02836509|Ibuprofen|ibuprofen
217076|NCT02836509|Paracetamol|paracetamol
217077|NCT02836509|Emergency Medicine|emergency medicine
217078|NCT02836496|Safety|safety
217079|NCT02836496|Mepolizumab|mepolizumab
217080|NCT02836496|Hypereosinophilic syndrome|hypereosinophilic syndrome
217081|NCT02836496|HES flare|hes flare
217082|NCT02836496|Efficacy|efficacy
217083|NCT02836470|Post-operative Ileus|post-operative ileus
217084|NCT02836470|Post-Operative Abdominal Adhesions|post-operative abdominal adhesions
217085|NCT02836470|Return of Gastrointestinal Function|return of gastrointestinal function
217086|NCT02836470|Anastomosis|anastomosis
217087|NCT02836470|Enterotomy|enterotomy
217088|NCT02836470|Enterostomy|enterostomy
217089|NCT02836470|Colorectal Surgery|colorectal surgery
217090|NCT02836470|Intestines Surgery|intestines surgery
217091|NCT02836431|Pediatric|pediatric
217092|NCT02836431|Sedation|sedation
217093|NCT02836431|Dexmedetomidine|dexmedetomidine
217094|NCT02836418|FSHD|fshd
217095|NCT02836418|LGMD|lgmd
217096|NCT02836405|Autism|autism
217097|NCT02836405|ASD|asd
217098|NCT02836405|Autistic Disorder|autistic disorder
217099|NCT02836405|Pervasive Development Disorders|pervasive development disorders
217100|NCT02836405|Pervasive Child Development Disorders|pervasive child development disorders
217101|NCT02836405|Asperger's Syndrome|asperger's syndrome
217102|NCT02836405|Transcranial Magnetic Stimulation|transcranial magnetic stimulation
217103|NCT02836405|TMS|tms
217104|NCT02836405|Autism Spectrum Disorder|autism spectrum disorder
217105|NCT02836379|Breakthrough Cancer Pain|breakthrough cancer pain
217106|NCT02836379|Quality of life|quality of life
217107|NCT02836379|Radiotherapy|radiotherapy
217108|NCT02836366|Proximal humerus|proximal humerus
217109|NCT02836366|Fracture|fracture
217110|NCT02836366|Nailing|nailing
217111|NCT02836340|neuroprotection|neuroprotection
217112|NCT02836327|MRI|mri
217113|NCT02836327|Multiple Sclerosis|multiple sclerosis
217114|NCT02836327|Neuromyelitis Optica Spectrum Disorders|neuromyelitis optica spectrum disorders
217115|NCT02836327|Multimodel|multimodel
217116|NCT02836314|Anorganic bovine bone mineral;|anorganic bovine bone mineral;
217117|NCT02836314|Graft|graft
217118|NCT02836314|Intrabony periodontal defect|intrabony periodontal defect
217119|NCT02836314|platelet rich fibrin|platelet rich fibrin
217120|NCT02836288|Ketamine|ketamine
217121|NCT02836288|Treatment of Depression|treatment of depression
217122|NCT02836275|Adnexal Diseases|adnexal diseases
217123|NCT02836275|Ovary|ovary
217124|NCT02836275|Ovarian Neoplasms|ovarian neoplasms
217125|NCT02836275|Ovarian Cysts|ovarian cysts
217126|NCT02836275|Ovarian Diseases|ovarian diseases
217127|NCT02836275|Ultrasonography|ultrasonography
217128|NCT02836275|Ultrasonography, Doppler|ultrasonography, doppler
217129|NCT02836275|Magnetic Resonance Imaging|magnetic resonance imaging
217130|NCT02836275|Diffusion Magnetic Resonance Imaging|diffusion magnetic resonance imaging
217131|NCT02836275|Diagnosis|diagnosis
217132|NCT02836275|Early Diagnosis|early diagnosis
217133|NCT02836275|Early Detection of Cancer|early detection of cancer
217134|NCT02836275|Genital Neoplasms, Female|genital neoplasms, female
217135|NCT02836275|Genital Diseases, Female|genital diseases, female
217136|NCT02836275|Urogenital Neoplasms|urogenital neoplasms
217137|NCT02836275|Cysts|cysts
217138|NCT02836275|Endocrine System Diseases|endocrine system diseases
217139|NCT02836275|Gonadal Disorders|gonadal disorders
217140|NCT02836275|Neoplasms|neoplasms
217141|NCT02836275|Endocrine Gland Neoplasms|endocrine gland neoplasms
217142|NCT02836275|International Ovarian Tumor Analysis|international ovarian tumor analysis
217143|NCT02836275|Simple Rules|simple rules
217144|NCT02836275|Preoperative Evaluation|preoperative evaluation
217145|NCT02836275|Perfusion -and Diffusion-weighted Imaging|perfusion -and diffusion-weighted imaging
217146|NCT02836275|Adnexal Masses|adnexal masses
217147|NCT02836275|Ovarian Tumors|ovarian tumors
217148|NCT02836249|Hepatitis|hepatitis
217149|NCT02836249|Tenofovir|tenofovir
217150|NCT02836249|Viread|viread
217151|NCT02836236|Hepatitis|hepatitis
217152|NCT02836236|Tenofovir|tenofovir
217153|NCT02836236|Viread|viread
217154|NCT02836210|27-gauge Pars plana vitrectomy|27-gauge pars plana vitrectomy
217155|NCT02836197|Uncertainty;hope;cancer;communication skills training;physicians|uncertainty;hope;cancer;communication skills training;physicians
217255|NCT02835625|Sensitivity|sensitivity
217156|NCT02836184|Hemodialysis,Hyperphosphatemia,Nicotinic Acids|hemodialysis,hyperphosphatemia,nicotinic acids
217157|NCT02836119|Gut Microbiota|gut microbiota
217158|NCT02836119|Gut Microbiome|gut microbiome
217159|NCT02836119|Sleep|sleep
217160|NCT02836119|Infancy|infancy
217161|NCT02836119|Development|development
217162|NCT02836106|Healthy Volunteers|healthy volunteers
217163|NCT02836106|Obese Volunteers|obese volunteers
217164|NCT02836093|Exercise|exercise
217165|NCT02836093|Radiation Treatment|radiation treatment
217166|NCT02836093|16-941|16-941
217167|NCT02836080|Mental Health|mental health
217168|NCT02836080|Randomized|randomized
217169|NCT02836080|Pragmatic|pragmatic
217170|NCT02836080|Integrated Collaborative Care|integrated collaborative care
217171|NCT02836080|Addiction|addiction
217172|NCT02836080|Youth|youth
217173|NCT02836054|biomarkers|biomarkers
217174|NCT02836054|CSF|csf
217175|NCT02836054|MRI|mri
217176|NCT02836054|Alzheimer's disease|alzheimer's disease
217177|NCT02836054|bipolar disorder|bipolar disorder
217178|NCT02836054|cognitive functions|cognitive functions
217179|NCT02836041|assess sleep|assess sleep
217180|NCT02836041|Sleep Deprivation|sleep deprivation
217181|NCT02836041|16-866|16-866
217182|NCT02836015|Shared Medical Visits|shared medical visits
217183|NCT02836015|Spanish-speaking|spanish-speaking
217184|NCT02835989|Community Paramedicine|community paramedicine
217185|NCT02835989|Paramedic|paramedic
217186|NCT02835989|Emergency Medical Services|emergency medical services
217187|NCT02835989|High Frequency Callers|high frequency callers
217188|NCT02835989|Lift Assists|lift assists
217189|NCT02835963|acute heart failure|acute heart failure
217190|NCT02835963|dyspnea|dyspnea
217191|NCT02835963|predictive value|predictive value
217192|NCT02835924|regorafenib|regorafenib
217193|NCT02835924|metastatic colorectal cancer|metastatic colorectal cancer
217194|NCT02835872|fiber|fiber
217195|NCT02835872|cholesterol|cholesterol
217196|NCT02835859|Obesity, sweet taste receptors|obesity, sweet taste receptors
217197|NCT02835846|Overactive Bladder Syndrome|overactive bladder syndrome
217198|NCT02835846|Female Urinary Microbiome|female urinary microbiome
217199|NCT02835846|Urinary Urgency|urinary urgency
217200|NCT02835846|Estrogen|estrogen
217201|NCT02835846|Nocturia|nocturia
217202|NCT02835846|Incontinence|incontinence
217203|NCT02835833|advanced solid tumors|advanced solid tumors
217204|NCT02835833|Nintedanib|nintedanib
217205|NCT02835833|Bevacizumab|bevacizumab
217206|NCT02835833|dose escalation|dose escalation
217207|NCT02835820|HIV|hiv
217208|NCT02835820|Neurocognitive|neurocognitive
217209|NCT02835820|Ketogenic Diet|ketogenic diet
217210|NCT02835807|skin cancer|skin cancer
217211|NCT02835794|Myelodysplastic Syndromes|myelodysplastic syndromes
217212|NCT02835781|Breast Implants|breast implants
217213|NCT02835781|Acellular Dermal Matrix|acellular dermal matrix
217214|NCT02835729|AML|aml
217215|NCT02835716|Phosphodiesterase type 4 inhibitor|phosphodiesterase type 4 inhibitor
217216|NCT02835716|ustekinumab|ustekinumab
217217|NCT02835716|secukinumab|secukinumab
217218|NCT02835716|P40 subunit|p40 subunit
217219|NCT02835716|Interleukin IL-12|interleukin il-12
217220|NCT02835716|Interleukin IL-23|interleukin il-23
217221|NCT02835716|Apoprotein e4|apoprotein e4
217222|NCT02835716|Interleukin IL-17A|interleukin il-17a
217223|NCT02835703|Congenital heart disease|congenital heart disease
217224|NCT02835703|Coarctation of aorta|coarctation of aorta
217225|NCT02835703|Aortic arch hypoplasia|aortic arch hypoplasia
217226|NCT02835703|Cerebral selective antegrade perfusion|cerebral selective antegrade perfusion
217227|NCT02835703|Double arterial cannulation|double arterial cannulation
217228|NCT02835690|programmed cell death 1 (PD-1, PD1)|programmed cell death 1 (pd-1, pd1)
217229|NCT02835690|programmed cell death ligand 1 (PD-L1, PDL1)|programmed cell death ligand 1 (pd-l1, pdl1)
217230|NCT02835690|programmed cell death ligand 2 (PD-L2, PDL2)|programmed cell death ligand 2 (pd-l2, pdl2)
217231|NCT02835677|Caregivers|caregivers
217232|NCT02835677|Activities of Daily Living|activities of daily living
217233|NCT02835664|Nicotinamide Riboside|nicotinamide riboside
217234|NCT02835664|Obesity|obesity
217235|NCT02835664|Metabolic health|metabolic health
217236|NCT02835664|Insulin resistance|insulin resistance
217237|NCT02835664|Mitochondrial function|mitochondrial function
217238|NCT02835664|Brown adipose tissue|brown adipose tissue
217239|NCT02835664|Energy expenditure|energy expenditure
217240|NCT02835664|Ectopic lipid accumulation|ectopic lipid accumulation
217241|NCT02835664|Cardiovascular risk|cardiovascular risk
217242|NCT02835664|Acetylcarnitine|acetylcarnitine
217243|NCT02835651|Palmitic acid|palmitic acid
217244|NCT02835651|Stearic acid|stearic acid
217245|NCT02835651|HDL-metabolism|hdl-metabolism
217246|NCT02835651|Human intervention study|human intervention study
217247|NCT02835625|Diagnostic Imaging|diagnostic imaging
217248|NCT02835625|Mammography|mammography
217249|NCT02835625|Randomized Controlled Trial|randomized controlled trial
217250|NCT02835625|Tomosynthesis|tomosynthesis
217251|NCT02835625|Early performance measures|early performance measures
217252|NCT02835625|Recall|recall
217253|NCT02835625|Radiation dose|radiation dose
217254|NCT02835625|Cancer detection|cancer detection
217256|NCT02835625|Specificity|specificity
217258|NCT02835625|Economy|economy
217259|NCT02835586|paclitaxel|paclitaxel
217260|NCT02835586|critical ischemia|critical ischemia
217261|NCT02835586|restenosis|restenosis
217262|NCT02835586|femoropopliteal artery lesions TASC C and D|femoropopliteal artery lesions tasc c and d
217263|NCT02835547|cardiovascular event|cardiovascular event
217264|NCT02835547|risk factors|risk factors
217265|NCT02835547|inflammatory diseases and acquired dysimmune|inflammatory diseases and acquired dysimmune
217266|NCT02835534|acute ST elevation myocardial infarction|acute st elevation myocardial infarction
217267|NCT02835456|CAUTI|cauti
217268|NCT02835456|Biofilm|biofilm
217269|NCT02835456|Urinary tract infections|urinary tract infections
217270|NCT02835456|micropattern|micropattern
217271|NCT02835456|Catheter|catheter
217272|NCT02835443|Ischemic Stroke|ischemic stroke
217273|NCT02835443|Deep Brain Stimulation|deep brain stimulation
217274|NCT02835443|DBS|dbs
217275|NCT02835443|Physical Therapy|physical therapy
217276|NCT02835443|Rehab|rehab
217277|NCT02835443|Brain Stimulation|brain stimulation
217278|NCT02835430|Coronally advanced flap|coronally advanced flap
217279|NCT02835430|Gingival recession|gingival recession
217280|NCT02835430|Bone, demineralized|bone, demineralized
217281|NCT02835430|Bone, freeze-dried|bone, freeze-dried
217282|NCT02835430|platelet-rich fibrin|platelet-rich fibrin
217283|NCT02835430|root coverage procedures|root coverage procedures
217284|NCT02835417|fetal heart rate variability|fetal heart rate variability
217285|NCT02835417|entropy|entropy
217286|NCT02835417|multifractal analysis|multifractal analysis
217287|NCT02835417|scattering transform|scattering transform
217288|NCT02835417|sparse vector machine|sparse vector machine
217289|NCT02835417|acidosis|acidosis
217290|NCT02835378|bilateral upper limb amputation|bilateral upper limb amputation
217291|NCT02835378|prosthetic fitting|prosthetic fitting
217292|NCT02835378|epidemiology|epidemiology
217293|NCT02835378|clinical practices|clinical practices
217294|NCT02835378|totally non-functional hand|totally non-functional hand
217295|NCT02835365|baclofen|baclofen
217296|NCT02835365|alcohol|alcohol
217297|NCT02835365|withdrawal|withdrawal
217298|NCT02835352|anxiety|anxiety
217299|NCT02835326|Older Adults|older adults
217300|NCT02835326|Weight Loss|weight loss
217301|NCT02835326|Exercise|exercise
217302|NCT02835326|Knee pain|knee pain
217303|NCT02835300|Asthma|asthma
217304|NCT02835300|Adolescents|adolescents
217305|NCT02835300|e-Health|e-health
217306|NCT02835300|Intervention|intervention
217307|NCT02835274|parkinson disease|parkinson disease
217308|NCT02835274|deep brain stimulation|deep brain stimulation
217309|NCT02835274|directional stimulation|directional stimulation
217310|NCT02835261|Obesity|obesity
217311|NCT02835261|Metabolic Disorders|metabolic disorders
217312|NCT02835209|spontaneous breathing test|spontaneous breathing test
217313|NCT02835209|premature infant|premature infant
217314|NCT02835209|work of breathing|work of breathing
217315|NCT02835170|Immunoglobulin G|immunoglobulin g
217316|NCT02835170|Treatment|treatment
217317|NCT02835157|Normal saline|normal saline
217318|NCT02835157|Balanced saline|balanced saline
217319|NCT02835157|Septic shock|septic shock
217320|NCT02835157|Children|children
217321|NCT02835157|Hyperchloremia|hyperchloremia
217322|NCT02835157|Acute kidney injury|acute kidney injury
217323|NCT02835131|hyperinsulinemia|hyperinsulinemia
217324|NCT02835131|hypoglycemia|hypoglycemia
217325|NCT02835131|somatostatin|somatostatin
217326|NCT02835131|pasireotide|pasireotide
217327|NCT02835131|congenital|congenital
217328|NCT02835079|Duchenne Tamoxifen|duchenne tamoxifen
217330|NCT02835066|Stage II|stage ii
217331|NCT02835066|Stage IIIA|stage iiia
217332|NCT02835066|Stage IIIB|stage iiib
217333|NCT02835066|Stage IV|stage iv
217334|NCT02835066|Non-Small Cell|non-small cell
217335|NCT02835040|Corticosteroid|corticosteroid
217336|NCT02835040|Antibiotic|antibiotic
217337|NCT02835040|Early mobilization|early mobilization
217338|NCT02835040|Malnutrition|malnutrition
217339|NCT02835027|Acute limb ischaemia(ALI)|acute limb ischaemia(ali)
217340|NCT02835027|Acute ischaemia of the lower extremity|acute ischaemia of the lower extremity
217341|NCT02835027|Thrombosis|thrombosis
217342|NCT02835027|Emboli|emboli
217343|NCT02835027|Endovascular surgery|endovascular surgery
217344|NCT02835027|Surgery|surgery
217345|NCT02835027|Amputation free survival|amputation free survival
217346|NCT02835027|Long time survival|long time survival
217347|NCT02835027|Demographics|demographics
217348|NCT02835014|Diabetes Mellitus Type I|diabetes mellitus type i
217349|NCT02835014|Adolescents|adolescents
217350|NCT02835014|Mental Health|mental health
217351|NCT02835014|Self efficacy|self efficacy
217352|NCT02835014|parenting styles|parenting styles
217353|NCT02834988|Endometrial Cancer|endometrial cancer
217354|NCT02834988|Sentinel Lymph Node Dissection|sentinel lymph node dissection
217355|NCT02834988|SLND|slnd
217356|NCT02834975|Fallopian Tube Carcinoma|fallopian tube carcinoma
217357|NCT02834975|Peritoneal Carcinoma|peritoneal carcinoma
217358|NCT02834975|Epithelial Ovarian Cancer|epithelial ovarian cancer
217359|NCT02834962|Anterior Cruciate Ligament Reconstruction|anterior cruciate ligament reconstruction
217360|NCT02834897|EOS imagery|eos imagery
217361|NCT02834884|rare cancer|rare cancer
217362|NCT02834884|biomarker|biomarker
217363|NCT02834884|molecular screening|molecular screening
217364|NCT02834884|cancer|cancer
217365|NCT02834884|biobanking|biobanking
217366|NCT02834858|Umbilical Cord Mesenchymal Stem Cells|umbilical cord mesenchymal stem cells
217367|NCT02834819|bronchiolitis|bronchiolitis
217368|NCT02834819|hypoxia|hypoxia
217369|NCT02834819|hypertonic saline|hypertonic saline
217370|NCT02834793|Lennox-Gastaut Syndrome (LGS)|lennox-gastaut syndrome (lgs)
217371|NCT02834793|Inadequately controlled seizures|inadequately controlled seizures
217372|NCT02834780|Advanced Hepatocellular Carcinoma|advanced hepatocellular carcinoma
217373|NCT02834780|H3B-6527|h3b-6527
217374|NCT02834780|Intrahepatic Cholangiocarcinoma|intrahepatic cholangiocarcinoma
217375|NCT02834780|FGFR4|fgfr4
217376|NCT02834780|FGF19|fgf19
217377|NCT02834754|post-operative|post-operative
217378|NCT02834715|Diabetes|diabetes
217379|NCT02834715|Stevia|stevia
217380|NCT02834715|insulin secretion|insulin secretion
217381|NCT02834715|insulin sensitivity|insulin sensitivity
217382|NCT02834715|Sweetener|sweetener
217383|NCT02834702|sinew acupuncture|sinew acupuncture
217384|NCT02834702|neck pain|neck pain
217385|NCT02834702|chronic pain|chronic pain
217386|NCT02834676|DiscoGel(R)|discogel(r)
217387|NCT02834676|gelified ethanol|gelified ethanol
217388|NCT02834676|percutaneous treatment|percutaneous treatment
217389|NCT02834676|Oswestry Disability Index (ODI)|oswestry disability index (odi)
217390|NCT02834676|Visual analog Scale (VAS)|visual analog scale (vas)
217391|NCT02834676|Neuropathic Pain Questionnaire (DN-4)|neuropathic pain questionnaire (dn-4)
217392|NCT02834676|cervical|cervical
217393|NCT02834637|HPV|hpv
217394|NCT02834637|cervical cancer|cervical cancer
217395|NCT02834637|vaccines|vaccines
217396|NCT02834637|HPV vaccine|hpv vaccine
217397|NCT02834637|dose reduction|dose reduction
217398|NCT02834637|Human papilloma virus vaccine schedules|human papilloma virus vaccine schedules
217399|NCT02834624|surfactant|surfactant
217400|NCT02834624|respiratory distress syndrome|respiratory distress syndrome
217401|NCT02834624|inflammation|inflammation
217402|NCT02834624|c-reactive protein|c-reactive protein
217403|NCT02834624|lipid peroxidation|lipid peroxidation
400627|NCT01865981|iPS cells|ips cells
217404|NCT02834546|Hepatocellular Carcinoma|hepatocellular carcinoma
217405|NCT02834546|Sorafenib|sorafenib
217406|NCT02834546|Toxicity|toxicity
217407|NCT02834546|Plasmatic concentration|plasmatic concentration
217408|NCT02834533|Lokomat;|lokomat;
217409|NCT02834533|robotic rehabilitation.|robotic rehabilitation.
217410|NCT02834533|Multiple Sclerosis;|multiple sclerosis;
217411|NCT02834533|Virtual reality|virtual reality
217412|NCT02834494|locally advanced breast cancer|locally advanced breast cancer
217413|NCT02834494|neoadjuvant chemotherapy|neoadjuvant chemotherapy
217414|NCT02834481|Pain Care|pain care
217415|NCT02834481|Pediatric and Neonatal Intensive Care Units|pediatric and neonatal intensive care units
217416|NCT02834468|Dexamethasone|dexamethasone
217417|NCT02834468|Rituximab|rituximab
217418|NCT02834468|Cyclosporin|cyclosporin
217419|NCT02834468|Intravenous Immunoglobulin|intravenous immunoglobulin
217420|NCT02834455|Thoracoscopy|thoracoscopy
217421|NCT02834403|breast cancer|breast cancer
217422|NCT02834403|nitric oxide synthase|nitric oxide synthase
217423|NCT02834403|docetaxel|docetaxel
217424|NCT02834403|L-NMMA|l-nmma
217425|NCT02834390|AML|aml
217426|NCT02834390|phase 1|phase 1
217427|NCT02834390|hematology|hematology
217428|NCT02834390|malignancy|malignancy
217429|NCT02834390|newly diagnosed|newly diagnosed
217430|NCT02834377|Cardiac Output|cardiac output
217431|NCT02834377|Hemodynamics|hemodynamics
217432|NCT02834377|Perioperative Care|perioperative care
217433|NCT02834338|activity tracking|activity tracking
217434|NCT02834338|postoperative recovery|postoperative recovery
217435|NCT02834338|ERAS|eras
217436|NCT02834338|fast-track surgery|fast-track surgery
217437|NCT02834325|high flow nasal cannula|high flow nasal cannula
217438|NCT02834325|success|success
217439|NCT02834325|failure|failure
217440|NCT02834325|ROX index|rox index
217441|NCT02834312|Estetrol|estetrol
217442|NCT02834312|Vasomotor symptoms|vasomotor symptoms
217443|NCT02834312|Menopause|menopause
217444|NCT02834260|absorbable implant|absorbable implant
217445|NCT02834260|subconjunctival|subconjunctival
217446|NCT02834260|immune rejection|immune rejection
217447|NCT02834260|safety profile|safety profile
217448|NCT02834260|dexamethasone|dexamethasone
217449|NCT02834234|mesothelioma|mesothelioma
217450|NCT02834234|peritoneum|peritoneum
217451|NCT02834234|genomic|genomic
217452|NCT02834234|CGH arrays|cgh arrays
217453|NCT02834221|Femoral vein puncture|femoral vein puncture
217454|NCT02834195|Cerebral palsy|cerebral palsy
217455|NCT02834195|reliability|reliability
217456|NCT02834195|upper limb and hand patterns|upper limb and hand patterns
217457|NCT02834195|classification|classification
217458|NCT02834169|Rare peritoneal surface malignancies|rare peritoneal surface malignancies
217459|NCT02834169|pseudomyxoma peritonei|pseudomyxoma peritonei
217460|NCT02834169|peritoneal mesothelioma|peritoneal mesothelioma
217461|NCT02834169|desmoplastic small round cell tumor|desmoplastic small round cell tumor
217462|NCT02834169|psammocarcinoma|psammocarcinoma
217463|NCT02834169|primary peritoneal serous carcinoma|primary peritoneal serous carcinoma
217464|NCT02834169|diffuse peritoneal leiomyomatosis|diffuse peritoneal leiomyomatosis
217465|NCT02834169|appendiceal mucinous neoplasms|appendiceal mucinous neoplasms
217466|NCT02834169|registry|registry
217467|NCT02834169|population-based database|population-based database
217468|NCT02834143|vascular|vascular
217469|NCT02834143|Limb Ischemia|limb ischemia
217470|NCT02834117|Ovulation Induction|ovulation induction
217471|NCT02834117|quality of life|quality of life
217472|NCT02834117|Reproductive Physiological Processes|reproductive physiological processes
217473|NCT02834117|fertility|fertility
217474|NCT02834078|HbA1c|hba1c
217475|NCT02834078|Pre Diabetes|pre diabetes
217476|NCT02834078|Berberine|berberine
217477|NCT02834065|Postoperative Cognitive Decline|postoperative cognitive decline
217478|NCT02834065|Deep Hypothermic Circulatory Arrest|deep hypothermic circulatory arrest
217479|NCT02834065|Cardiovascular Surgical Procedures|cardiovascular surgical procedures
217480|NCT02834065|Functional Magnetic Resonance Imaging|functional magnetic resonance imaging
217481|NCT02834065|Small Ubiquitin-Related Modifier Proteins|small ubiquitin-related modifier proteins
217482|NCT02834052|Immunotherapy|immunotherapy
217483|NCT02834052|Anti-programmed death 1 (PD-1) inhibitor|anti-programmed death 1 (pd-1) inhibitor
217484|NCT02834052|Immunostimulant|immunostimulant
217485|NCT02834052|monoclonal antibody|monoclonal antibody
217486|NCT02834052|TLR3 agonist|tlr3 agonist
217487|NCT02834052|Immunologic factors|immunologic factors
217488|NCT02834039|Tidal volume|tidal volume
217489|NCT02834039|renal transplant|renal transplant
217490|NCT02834039|donor|donor
217491|NCT02834039|nephrectomy|nephrectomy
217492|NCT02834039|ventilation|ventilation
217493|NCT02834039|Living renal transplant donor patient|living renal transplant donor patient
217494|NCT02834026|Muscle Strength|muscle strength
217495|NCT02834026|Muscle Strength Dynamometer|muscle strength dynamometer
217496|NCT02834026|Chronic Renal Disease|chronic renal disease
217497|NCT02834026|Exercise|exercise
217498|NCT02834026|Physical therapy modalities|physical therapy modalities
719428|NCT00550342|CD20|cd20
217499|NCT02833987|Direct oral anticoagulants|direct oral anticoagulants
217500|NCT02833987|Safety|safety
217501|NCT02833987|Major bleed|major bleed
217502|NCT02833987|Adverse events|adverse events
217503|NCT02833974|GSK2245035|gsk2245035
217504|NCT02833974|TLR7 agonist|tlr7 agonist
217505|NCT02833974|allergic asthma|allergic asthma
217506|NCT02833974|FEV1|fev1
217507|NCT02833948|Heart Valve Disease|heart valve disease
217508|NCT02833948|Randomized Controlled Trial|randomized controlled trial
217509|NCT02833948|Transcatheter Aortic Valve Replacement|transcatheter aortic valve replacement
217510|NCT02833948|TAVR|tavr
217511|NCT02833948|Valve Thrombosis|valve thrombosis
217512|NCT02833935|spinal cord injury|spinal cord injury
217513|NCT02833935|physical activity|physical activity
217514|NCT02833935|self-determination theory|self-determination theory
217515|NCT02833935|life satisfaction|life satisfaction
217516|NCT02833883|Enzalutamide|enzalutamide
217517|NCT02833883|CC-115|cc-115
217518|NCT02833883|16-074|16-074
217519|NCT02833857|Secondary Hyperparathyroidism, chronic kidney disease, hemodialysis|secondary hyperparathyroidism, chronic kidney disease, hemodialysis
217520|NCT02833844|Hyperlipidemia|hyperlipidemia
217521|NCT02833844|Dyslipidemia|dyslipidemia
217522|NCT02833844|Proprotein convertase subtilisin/kexin type 9 (PCSK9)|proprotein convertase subtilisin/kexin type 9 (pcsk9)
217523|NCT02833844|Inhibition|inhibition
217524|NCT02833844|HIV infection|hiv infection
217525|NCT02833844|Cluster of differentiation|cluster of differentiation
217526|NCT02833844|Viral load|viral load
217527|NCT02833805|immunosuppression|immunosuppression
217528|NCT02833805|nonmyeloablative|nonmyeloablative
217529|NCT02833805|non-myeloablative|non-myeloablative
217530|NCT02833805|allogeneic|allogeneic
217531|NCT02833805|tacrolimus|tacrolimus
217532|NCT02833805|bone marrow|bone marrow
217533|NCT02833805|bone marrow transplant|bone marrow transplant
217534|NCT02833805|cyclophosphamide|cyclophosphamide
217535|NCT02833805|thymoglobulin|thymoglobulin
217536|NCT02833805|ATG|atg
217537|NCT02833805|fludarabine|fludarabine
217538|NCT02833766|Breast Cancer|breast cancer
217539|NCT02833766|advanced triple Negative, EGFR positive breast cancer|advanced triple negative, egfr positive breast cancer
217540|NCT02833766|doxorubicin|doxorubicin
217541|NCT02833766|triple negative breast cancer (TNBC)|triple negative breast cancer (tnbc)
217542|NCT02833740|Mid-Upper Arm Circumference (MUAC)|mid-upper arm circumference (muac)
217543|NCT02833740|Mother MUAC|mother muac
217544|NCT02833740|Community screening for acute malnutrition|community screening for acute malnutrition
217545|NCT02833727|asthma; smoking; Eosinophils; health care costs|asthma; smoking; eosinophils; health care costs
217546|NCT02833675|angioedema|angioedema
217547|NCT02833675|C1Inhibitor|c1inhibitor
217548|NCT02833675|bradykinin|bradykinin
217549|NCT02833675|Histamin|histamin
217550|NCT02833662|Hypoxia|hypoxia
217551|NCT02833662|Perioperative outcomes|perioperative outcomes
217552|NCT02833649|Keratoconus|keratoconus
217553|NCT02833649|Crosslinking|crosslinking
217554|NCT02833649|Toric ICL|toric icl
217555|NCT02833623|Helicobacter Pylori eradication rate|helicobacter pylori eradication rate
217556|NCT02833623|Efficacy of Short-message-based Re-education (SMRE)|efficacy of short-message-based re-education (smre)
217557|NCT02833610|Multiple Myeloma|multiple myeloma
217558|NCT02833597|peripheral artery disease|peripheral artery disease
217559|NCT02833597|transcutaneous oxygen pressure|transcutaneous oxygen pressure
217560|NCT02833597|claudication|claudication
217561|NCT02833597|rowing ergometer|rowing ergometer
217562|NCT02833584|Paracetamol|paracetamol
217563|NCT02833558|Endoscopy, Gastrointestinal|endoscopy, gastrointestinal
217564|NCT02833558|Endoscopic Submucosal Dissection|endoscopic submucosal dissection
217565|NCT02833558|Bleeding|bleeding
217566|NCT02833519|pregnant women|pregnant women
217567|NCT02833519|exercise|exercise
217568|NCT02833519|depression|depression
217569|NCT02833519|anxiety|anxiety
217570|NCT02833493|Magnetic Resonance Imaging|magnetic resonance imaging
217571|NCT02833493|Iron overload|iron overload
217572|NCT02833493|Iron chelation therapy|iron chelation therapy
217573|NCT02833493|Follow-up|follow-up
217574|NCT02833467|Circulating Tumor DNA|circulating tumor dna
217575|NCT02833467|Heterogeneous|heterogeneous
217576|NCT02833467|Multiple primary lung cancer|multiple primary lung cancer
217577|NCT02833454|Anterior Cruciate Ligament Reconstruction|anterior cruciate ligament reconstruction
217578|NCT02833454|Direct Insertion of Anterior Cruciate Ligament|direct insertion of anterior cruciate ligament
217579|NCT02833415|Visceral|visceral
217580|NCT02833415|Obesity|obesity
217581|NCT02833415|Adipose|adipose
217582|NCT02833415|Diabetes|diabetes
217583|NCT02833402|Sacral Neuromodulation|sacral neuromodulation
217584|NCT02833402|Urinary leakage|urinary leakage
217585|NCT02833402|Urinary incontinence|urinary incontinence
217586|NCT02833402|Urinary microbiome|urinary microbiome
217587|NCT02833376|microbiota|microbiota
217588|NCT02833376|ethanol|ethanol
217589|NCT02833376|chlorhexidine|chlorhexidine
217590|NCT02833363|gastric microbiota|gastric microbiota
217591|NCT02833363|Helicobacter pylori|helicobacter pylori
217592|NCT02833363|Non-atrophic Gasrititis|non-atrophic gasrititis
217593|NCT02833363|Atrophic gastritis|atrophic gastritis
217594|NCT02833363|Intestinal metaplasia|intestinal metaplasia
217595|NCT02833363|intraepithelial neoplasia|intraepithelial neoplasia
217596|NCT02833363|Gastric cancer|gastric cancer
217597|NCT02833337|Bone|bone
217598|NCT02833337|Maxilla|maxilla
217599|NCT02833337|Cone-Beam Computed Tomography|cone-beam computed tomography
217600|NCT02833337|Regeneration|regeneration
217601|NCT02833324|Postoperative Period|postoperative period
217602|NCT02833324|Colorectal Surgery|colorectal surgery
217603|NCT02833324|Surgery|surgery
217604|NCT02833311|Neuromusculoskeletal condition|neuromusculoskeletal condition
217605|NCT02833298|Sustained Virological Response|sustained virological response
217607|NCT02833298|patient navigation|patient navigation
217608|NCT02833298|screening|screening
217609|NCT02833298|HCC|hcc
217610|NCT02833298|HCV|hcv
217611|NCT02833272|benzodiazepines|benzodiazepines
217612|NCT02833272|Z-drugs|z-drugs
217613|NCT02833259|Pneumonia|pneumonia
217614|NCT02833259|Patient readmission|patient readmission
217615|NCT02833259|Community-acquired infections|community-acquired infections
217616|NCT02833259|Observational study|observational study
217617|NCT02833259|Quality of health care|quality of health care
217618|NCT02833259|Models, Statistical|models, statistical
217619|NCT02833246|texting|texting
217620|NCT02833246|Adherence to Oral Anticancer Medications|adherence to oral anticancer medications
217621|NCT02833246|16-810|16-810
217622|NCT02833233|Early stage|early stage
217623|NCT02833233|Resectable|resectable
217624|NCT02833233|Ipilimumab|ipilimumab
217625|NCT02833233|Nivolumab|nivolumab
217626|NCT02833233|Cryoablation|cryoablation
217627|NCT02833233|16-495|16-495
217628|NCT02833220|blood pressure|blood pressure
217629|NCT02833220|heart rate variability|heart rate variability
217630|NCT02833220|single-pulse transcranial magnetic stimulation|single-pulse transcranial magnetic stimulation
217631|NCT02833220|non-invasive brain stimulation|non-invasive brain stimulation
217632|NCT02833207|blood flow|blood flow
217633|NCT02833207|vasodilation|vasodilation
217634|NCT02833207|Doppler Ultrasound|doppler ultrasound
217635|NCT02833207|endothelium dependent dilation|endothelium dependent dilation
217636|NCT02833168|Neuromuscular disorders|neuromuscular disorders
217637|NCT02833168|Sleep disordered breathing|sleep disordered breathing
217638|NCT02833168|Dyspnea|dyspnea
217639|NCT02833155|entinostat|entinostat
217640|NCT02833155|breast cancer|breast cancer
217641|NCT02833142|Healthy Volunteer|healthy volunteer
217642|NCT02833142|opicinumab|opicinumab
217643|NCT02833116|radiculalgia|radiculalgia
217644|NCT02833116|chronic pain|chronic pain
217645|NCT02833116|quality of life|quality of life
217646|NCT02833103|Pinaverium Bromide|pinaverium bromide
217647|NCT02833103|cholecystectomy|cholecystectomy
217648|NCT02833103|Sphincter of Oddi Dysfunction|sphincter of oddi dysfunction
217649|NCT02833012|Healthy volunteers|healthy volunteers
217650|NCT02833012|Caprylic triglyceride oil|caprylic triglyceride oil
217652|NCT02833012|AC-1204|ac-1204
217653|NCT02833012|Pharmacokinetic|pharmacokinetic
217654|NCT02833012|ketone body|ketone body
217655|NCT02833012|Axona|axona
217656|NCT02832999|Diabetes|diabetes
217657|NCT02832999|GLP-1|glp-1
217658|NCT02832999|Insulin secretion|insulin secretion
217659|NCT02832999|insulin sensitivity|insulin sensitivity
217660|NCT02832999|Africa|africa
217661|NCT02832999|Liraglutide|liraglutide
217662|NCT02832999|Vildaglipin|vildaglipin
217663|NCT02832986|Frailty consultation|frailty consultation
217664|NCT02832973|Hypertension Resistant to Conventional Therapy|hypertension resistant to conventional therapy
217665|NCT02832973|Natriuretic Agents|natriuretic agents
217666|NCT02832973|Renin-Angiotensin System|renin-angiotensin system
217667|NCT02832973|Bisoprolol|bisoprolol
217668|NCT02832960|Thyroid Dysfunction|thyroid dysfunction
217669|NCT02832960|Atherosclerosis|atherosclerosis
217670|NCT02832960|Heart Failure|heart failure
217671|NCT02832960|Cardiovascular imaging|cardiovascular imaging
217672|NCT02832960|Randomized Controlled Trial|randomized controlled trial
217673|NCT02832934|Thyroid Dysfunction|thyroid dysfunction
217674|NCT02832934|Atherosclerosis|atherosclerosis
217675|NCT02832934|Heart Failure|heart failure
217676|NCT02832934|Cardiovascular Imaging|cardiovascular imaging
217677|NCT02832934|Randomized Controlled Trial|randomized controlled trial
217678|NCT02832921|Alzheimer's disease|alzheimer's disease
217679|NCT02832921|virtual reality|virtual reality
217680|NCT02832921|cognitive training|cognitive training
217681|NCT02832895|Adults|adults
217682|NCT02832895|Frontal bone window|frontal bone window
217683|NCT02832895|Transcranial doppler|transcranial doppler
217684|NCT02832882|HCC|hcc
217685|NCT02832882|RFA|rfa
217686|NCT02832869|Polyp detection rate|polyp detection rate
217687|NCT02832869|Adenoma detection rate|adenoma detection rate
217688|NCT02832869|Boston Bowel Preparation Scale|boston bowel preparation scale
217689|NCT02832830|bony metastases|bony metastases
217690|NCT02832830|palliative radiotherapy|palliative radiotherapy
217691|NCT02832817|Oxygen therapy|oxygen therapy
217692|NCT02832817|Pulse oximeter|pulse oximeter
217693|NCT02832817|Hypoxia|hypoxia
217694|NCT02832817|Hypoxemia|hypoxemia
217695|NCT02832817|Arterial blood gas|arterial blood gas
217696|NCT02832791|ANTERIOR CRUCIATE LIGAMENT RECONSTRUCTION|anterior cruciate ligament reconstruction
217697|NCT02832791|QUADRICEPS TENDON|quadriceps tendon
217698|NCT02832791|HAMSTRING TENDON|hamstring tendon
217699|NCT02832765|Palliative radiotherapy|palliative radiotherapy
217700|NCT02832765|Bone metastases|bone metastases
217701|NCT02832739|Technology acceptance|technology acceptance
217702|NCT02832739|Usability|usability
217703|NCT02832739|eHealth|ehealth
217704|NCT02832739|self-management support in chronic illness|self-management support in chronic illness
217705|NCT02832739|prevention|prevention
217706|NCT02832739|Special Orthopaedic Co-Morbidity after hip/knee replacement|special orthopaedic co-morbidity after hip/knee replacement
217707|NCT02832726|absorption of Vitamin B12|absorption of vitamin b12
217708|NCT02832713|Knee osteoarthritis|knee osteoarthritis
217709|NCT02832713|Intra-articular botulinum toxin|intra-articular botulinum toxin
217710|NCT02832713|Hyaluronic acid|hyaluronic acid
217711|NCT02832713|Pain|pain
217712|NCT02832713|Function|function
217713|NCT02832700|glycopeptides|glycopeptides
217714|NCT02832700|dietary proteins|dietary proteins
217715|NCT02832700|whey protein|whey protein
217716|NCT02832700|caseinomacropeptide|caseinomacropeptide
217717|NCT02832700|antiinflammatories|antiinflammatories
217718|NCT02832700|human microbiome|human microbiome
217719|NCT02832661|renal allograft|renal allograft
217720|NCT02832661|graft injuries|graft injuries
217721|NCT02832661|biopsy|biopsy
217722|NCT02832661|biomarkers|biomarkers
217723|NCT02832661|omics approach|omics approach
217724|NCT02832635|brain metastasis|brain metastasis
217725|NCT02832635|whole-brain radiotherapy|whole-brain radiotherapy
217726|NCT02832635|TMZ|tmz
217727|NCT02832635|avoidance of hippocampus|avoidance of hippocampus
217728|NCT02832622|MultiPoint Pacing|multipoint pacing
217729|NCT02832622|Heart Failure|heart failure
217730|NCT02832622|Cardiac Resynchronization Therapy|cardiac resynchronization therapy
217731|NCT02832622|SJM Quadripolar Biventricular Pacing|sjm quadripolar biventricular pacing
217732|NCT02832609|closing volume|closing volume
217733|NCT02832609|expiratory flow limitation|expiratory flow limitation
217734|NCT02832609|obesity|obesity
217735|NCT02832609|orthopnea|orthopnea
217736|NCT02832596|Anesthesia|anesthesia
217737|NCT02832596|Blood pressure|blood pressure
217738|NCT02832596|Plasma Volume|plasma volume
217739|NCT02832596|Vasopressor agents|vasopressor agents
217740|NCT02832596|Coronary artery bypass|coronary artery bypass
217741|NCT02832596|Glycocalyx|glycocalyx
217742|NCT02832596|ANP|anp
217743|NCT02832596|Coagulation|coagulation
217744|NCT02832583|PRP, hyaluronic acid, mesotherapy, skin wrinkle, skin rejuvenation|prp, hyaluronic acid, mesotherapy, skin wrinkle, skin rejuvenation
217745|NCT02832557|Autism|autism
217746|NCT02832557|Asperger's Syndrome|asperger's syndrome
217747|NCT02832557|microRNA|microrna
217748|NCT02832557|epigenetic|epigenetic
217749|NCT02832557|biomarker|biomarker
217750|NCT02832544|atrial fibrillation|atrial fibrillation
217751|NCT02832544|stroke|stroke
217752|NCT02832531|atrial fibrillation|atrial fibrillation
217753|NCT02832531|stroke|stroke
217754|NCT02832492|disorders of consciousness|disorders of consciousness
217755|NCT02832492|unresponsive wakefulness syndrome|unresponsive wakefulness syndrome
217756|NCT02832492|pupil near response|pupil near response
217757|NCT02832492|prognosis of consciousness recovery|prognosis of consciousness recovery
217758|NCT02832453|High intensity physical exercise|high intensity physical exercise
217759|NCT02832453|Primary health care|primary health care
217760|NCT02832453|Behaviour change interventions|behaviour change interventions
217761|NCT02832427|Coronary artery bypass grafting|coronary artery bypass grafting
217762|NCT02832427|Heart valve surgery|heart valve surgery
217763|NCT02832427|Postoperative morbidity|postoperative morbidity
217764|NCT02832427|Operative mortality|operative mortality
217765|NCT02832401|event-related potentials|event-related potentials
217766|NCT02832401|EEG|eeg
217767|NCT02832401|caffeine|caffeine
217768|NCT02832401|psychosis|psychosis
217769|NCT02832401|schizophrenia|schizophrenia
217770|NCT02832336|Caffeine|caffeine
217771|NCT02832336|Caffeine citrate|caffeine citrate
217772|NCT02832336|Neurological disorder|neurological disorder
217773|NCT02832336|Excessive daytime sleepiness|excessive daytime sleepiness
217774|NCT02832336|Orexin|orexin
217775|NCT02832336|adenosine antagonist|adenosine antagonist
217776|NCT02832323|hemodialysis|hemodialysis
217777|NCT02832323|EPO|epo
217778|NCT02832323|MIRCERA|mircera
217779|NCT02832310|valsalva|valsalva
217780|NCT02832258|Enterobacteria|enterobacteria
217781|NCT02832258|Children|children
217782|NCT02832258|Febrile urinary tract infection|febrile urinary tract infection
217783|NCT02832258|Cystitis|cystitis
217784|NCT02832258|Extended-spectrum beta-lactamase-producing Enterobacteriaceae|extended-spectrum beta-lactamase-producing enterobacteriaceae
217785|NCT02832232|Physiotherapy|physiotherapy
217786|NCT02832232|Manual Therapy|manual therapy
217787|NCT02832232|Neck Pain|neck pain
217788|NCT02832219|Overweight|overweight
217789|NCT02832219|Molecular hydrogen|molecular hydrogen
217790|NCT02832219|Insulin|insulin
217791|NCT02832206|Atrial fibrillation|atrial fibrillation
217792|NCT02832206|Hybrid ablation|hybrid ablation
217793|NCT02832180|Rheumatoid|rheumatoid
217794|NCT02832141|Skin blood flow|skin blood flow
217795|NCT02832141|Skin redness|skin redness
217796|NCT02832141|Sympathetic nervous system|sympathetic nervous system
217797|NCT02832141|Regional Blood Flow|regional blood flow
217798|NCT02832128|Cochlear Implant|cochlear implant
217799|NCT02832115|Radial Artery Spasm|radial artery spasm
217800|NCT02832115|Cardiac Catheterization|cardiac catheterization
217801|NCT02832115|Vascular Access Site Complications|vascular access site complications
217802|NCT02832115|Vasodilator|vasodilator
217803|NCT02832115|Nitroglycerine|nitroglycerine
217804|NCT02832115|Lidocaine|lidocaine
217805|NCT02832102|prognostic modelling|prognostic modelling
217806|NCT02832102|radiomics|radiomics
217807|NCT02832102|clinical decision support system|clinical decision support system
217808|NCT02832102|big data analysis|big data analysis
217809|NCT02832102|multiscale prognostic signatures|multiscale prognostic signatures
217810|NCT02832102|patient-clinician co-decision tools|patient-clinician co-decision tools
217811|NCT02832089|atrial fibrillation|atrial fibrillation
217812|NCT02832089|rate reduction|rate reduction
217813|NCT02832050|play|play
217814|NCT02832050|therapy|therapy
217815|NCT02832024|stents|stents
217816|NCT02832024|atherectomy|atherectomy
217817|NCT02832024|femoral artery|femoral artery
217818|NCT02832024|popliteal artery|popliteal artery
217819|NCT02832024|In-stent Restenosis|in-stent restenosis
217820|NCT02831985|Child|child
217821|NCT02831985|Middle ear ventilation|middle ear ventilation
217822|NCT02831985|Follow-up studies|follow-up studies
217823|NCT02831985|General practitioners|general practitioners
217824|NCT02831972|Healthy Volunteers|healthy volunteers
217825|NCT02831959|Non-Small Cell Lung Cancer|non-small cell lung cancer
217826|NCT02831959|NSCLC|nsclc
217827|NCT02831959|Brain metastases|brain metastases
217828|NCT02831959|Treatment|treatment
217829|NCT02831959|Minimal toxicity|minimal toxicity
217830|NCT02831959|TTFields|ttfields
217831|NCT02831959|TTF|ttf
217832|NCT02831959|Tumor Treating Fields|tumor treating fields
217833|NCT02831959|Novocure|novocure
217834|NCT02831959|SRS|srs
217835|NCT02831959|Stereotactic radiosurgery|stereotactic radiosurgery
217836|NCT02831946|skin closure|skin closure
217837|NCT02831946|intracuticular suture|intracuticular suture
217838|NCT02831946|glue (dermabond)|glue (dermabond)
217839|NCT02831933|lung cancer|lung cancer
217840|NCT02831933|metastatic|metastatic
217841|NCT02831933|gene therapy|gene therapy
217842|NCT02831933|immunotherapy|immunotherapy
217843|NCT02831933|melanoma|melanoma
217844|NCT02831933|uveal|uveal
217845|NCT02831920|Prostate Cancer|prostate cancer
217846|NCT02831920|MRI|mri
217847|NCT02831920|CEUS|ceus
217848|NCT02831920|Contrast Ultrasound|contrast ultrasound
217849|NCT02831920|Fusion|fusion
217850|NCT02831920|targeted biopsy|targeted biopsy
217851|NCT02831907|Ultrasonography|ultrasonography
217852|NCT02831907|Portal vein Doppler|portal vein doppler
217853|NCT02831907|Renal Doppler|renal doppler
217854|NCT02831907|Cardio-Intestinal syndrome|cardio-intestinal syndrome
217855|NCT02831907|Delirium|delirium
217856|NCT02831907|Renal congestion|renal congestion
217857|NCT02831907|Intra-renal hemodynamics|intra-renal hemodynamics
217858|NCT02831894|insomnia|insomnia
217859|NCT02831894|sedative hypnotics|sedative hypnotics
217860|NCT02831894|hypnotic tapering|hypnotic tapering
217861|NCT02831855|Rheumatoid Arthritis|rheumatoid arthritis
217862|NCT02831855|Tofacitinib|tofacitinib
217863|NCT02831855|CP-690,550|cp-690,550
217864|NCT02831855|Xeljanz|xeljanz
217865|NCT02831855|methotrexate withdrawal|methotrexate withdrawal
217866|NCT02831855|withdrawal study|withdrawal study
217867|NCT02831829|cardiac rehabilitation|cardiac rehabilitation
217868|NCT02831829|coronary artery disease|coronary artery disease
217869|NCT02831777|non-invasive blood pressure|non-invasive blood pressure
217870|NCT02831764|tolerability|tolerability
217871|NCT02831764|HIV 1|hiv 1
217872|NCT02831764|efficacy|efficacy
217873|NCT02831764|treatment naïve|treatment naïve
217874|NCT02831764|two-drug regimen|two-drug regimen
217875|NCT02831764|safety|safety
217876|NCT02831764|non inferiority|non inferiority
217877|NCT02831751|Influenza|influenza
217878|NCT02831751|Human|human
217879|NCT02831751|RNA Virus Infections|rna virus infections
217880|NCT02831751|Immulogic|immulogic
217881|NCT02831751|Immunogenic Factors|immunogenic factors
217882|NCT02831751|Physiological Effects of Drug|physiological effects of drug
217883|NCT02831751|Virus Diseases|virus diseases
217884|NCT02831751|Orthomyxoviridae Infections|orthomyxoviridae infections
217885|NCT02831751|Infection|infection
217886|NCT02831738|Fiber|fiber
217887|NCT02831738|Polydextrose|polydextrose
217888|NCT02831738|Glycemic Index|glycemic index
217889|NCT02831712|NTBI|ntbi
217890|NCT02831712|Iron status|iron status
217891|NCT02831712|Iron supplement|iron supplement
217892|NCT02831699|Zika|zika
217893|NCT02831699|Guillain Barré|guillain barré
217894|NCT02831686|Selinexor (KPT-330)|selinexor (kpt-330)
217895|NCT02831686|Ixazomib|ixazomib
217896|NCT02831686|dexamethasone|dexamethasone
217897|NCT02831686|15-310|15-310
217898|NCT02831673|safety|safety
217899|NCT02831673|treatment naïve|treatment naïve
217900|NCT02831673|HIV 1|hiv 1
217901|NCT02831673|dolutegravir plus lamivudine|dolutegravir plus lamivudine
217902|NCT02831673|non inferiority|non inferiority
217903|NCT02831673|tolerability|tolerability
217904|NCT02831673|dolutegravir plus tenofovir/emtricitabine|dolutegravir plus tenofovir/emtricitabine
217905|NCT02831673|efficacy|efficacy
217906|NCT02831634|Breast cancer|breast cancer
217907|NCT02831634|cutaneous melanoma|cutaneous melanoma
217908|NCT02831621|overweight|overweight
217909|NCT02831621|ectopic fat|ectopic fat
217910|NCT02831621|exercise|exercise
217911|NCT02831621|diet|diet
217912|NCT02831582|Breast Cancer|breast cancer
217913|NCT02831582|Postmenopausal|postmenopausal
217914|NCT02831582|Stage IA|stage ia
217915|NCT02831582|Stage IB|stage ib
217916|NCT02831582|Stage IIA|stage iia
217917|NCT02831582|Stage IIB|stage iib
217918|NCT02831582|Stage IIIA|stage iiia
217919|NCT02831582|Stage IIIB|stage iiib
217920|NCT02831582|Stage IIIC|stage iiic
217921|NCT02831556|Ultrasound|ultrasound
217922|NCT02831556|Abdomen|abdomen
217923|NCT02831556|Pelvis|pelvis
217924|NCT02831556|3D|3d
217925|NCT02831504|Myotonic Dystrophy type 1|myotonic dystrophy type 1
217926|NCT02831504|DM1|dm1
217927|NCT02831504|Muscular Dystrophy|muscular dystrophy
217928|NCT02831504|Neuromuscular Diseases|neuromuscular diseases
217929|NCT02831491|metastatic|metastatic
217930|NCT02831465|Dynamic hyperinflation|dynamic hyperinflation
217931|NCT02831465|Maximal Voluntary Ventilation|maximal voluntary ventilation
217932|NCT02831465|Inspiratory capacity|inspiratory capacity
217933|NCT02831465|healthy subjects|healthy subjects
217934|NCT02831452|pelvic floor muscles|pelvic floor muscles
217935|NCT02831452|evaluation|evaluation
217936|NCT02831452|dynamometer|dynamometer
217937|NCT02831452|perineometer|perineometer
217938|NCT02831439|Choosing Wisely|choosing wisely
217939|NCT02831439|Breast cancer|breast cancer
217940|NCT02831439|Controlled trial|controlled trial
217941|NCT02831439|High-value health care|high-value health care
217942|NCT02831439|Health services research|health services research
217943|NCT02831348|Asthma|asthma
217944|NCT02831348|Allergic rhinitis|allergic rhinitis
217945|NCT02831348|Rhinitis|rhinitis
217946|NCT02831348|Pneumonia|pneumonia
217947|NCT02831348|Cystic fibrosis|cystic fibrosis
217948|NCT02831322|Transradial|transradial
217949|NCT02831322|ﬂow-mediated vasodilation|ﬂow-mediated vasodilation
217950|NCT02831309|physical activity|physical activity
217951|NCT02831296|SMA|sma
217952|NCT02831296|Werdnig-Hoffmann disease|werdnig-hoffmann disease
217953|NCT02831296|Kugelberg-Welander disease|kugelberg-welander disease
217954|NCT02831283|inflammation|inflammation
217955|NCT02831283|aging|aging
218152|NCT02830061|Cancer|cancer
217956|NCT02831283|mild cognitive impairment|mild cognitive impairment
217957|NCT02831270|cardiac surgery|cardiac surgery
217958|NCT02831270|acute normovolemic hemodilution|acute normovolemic hemodilution
217959|NCT02831257|Neurofibromatosis 2|neurofibromatosis 2
217960|NCT02831218|bioresorbable vascular scaffold|bioresorbable vascular scaffold
217961|NCT02831218|coronary artery disease|coronary artery disease
217962|NCT02831205|bioresorbable vascular scaffold|bioresorbable vascular scaffold
217963|NCT02831205|coronary artery disease|coronary artery disease
217964|NCT02831166|Vascular closure devices|vascular closure devices
217965|NCT02831166|Transradial approach|transradial approach
217966|NCT02831166|Transfemoral approach|transfemoral approach
217967|NCT02831140|Fast track|fast track
217968|NCT02831140|rehabilitation|rehabilitation
217969|NCT02831140|post operative complications|post operative complications
217970|NCT02831127|short message service; adherence; stent exchange; ERCP|short message service; adherence; stent exchange; ercp
217971|NCT02831101|BIS|bis
217972|NCT02831101|Elderly|elderly
217973|NCT02831101|Propofol|propofol
217974|NCT02831101|Sufentanil|sufentanil
217975|NCT02831101|Loss of consciousness|loss of consciousness
217976|NCT02831088|Neu2000KWL|neu2000kwl
217977|NCT02831088|Neuroprotection|neuroprotection
217978|NCT02831088|endovascular therapy|endovascular therapy
217979|NCT02831088|glutamate|glutamate
217980|NCT02831088|free radical|free radical
217981|NCT02831075|Adipose-derived Stem Cells|adipose-derived stem cells
217982|NCT02831062|nutrition|nutrition
217983|NCT02831062|progression|progression
217984|NCT02831049|Reconsolidation|reconsolidation
217985|NCT02831010|prematurity|prematurity
217986|NCT02830971|standardized learning curve|standardized learning curve
217987|NCT02830971|Nurse|nurse
217988|NCT02830971|intensive care unit|intensive care unit
217989|NCT02830971|Mastery|mastery
217990|NCT02830971|Training|training
217991|NCT02830971|Developing|developing
217992|NCT02830971|Skills|skills
217993|NCT02830919|Osteoarthritis of knee|osteoarthritis of knee
217994|NCT02830919|Glucosamine sulfate|glucosamine sulfate
217995|NCT02830919|Chondroitin sulfate|chondroitin sulfate
217996|NCT02830906|Total Knee Arthroplasty|total knee arthroplasty
217997|NCT02830906|Intrathecal Morphine|intrathecal morphine
217998|NCT02830906|Ramosetron|ramosetron
217999|NCT02830906|Ondansetron|ondansetron
218000|NCT02830906|postoperative nausea and vomiting|postoperative nausea and vomiting
218001|NCT02830880|Imaging|imaging
218002|NCT02830880|Nuclear medicine|nuclear medicine
218003|NCT02830880|Oncology|oncology
218004|NCT02830880|Radiology|radiology
218005|NCT02830880|Urogenital disorders|urogenital disorders
218006|NCT02830867|glutathione|glutathione
218007|NCT02830867|glutathione synthetase deficiency|glutathione synthetase deficiency
218008|NCT02830867|autosomal inheritance|autosomal inheritance
218009|NCT02830867|recessive|recessive
218010|NCT02830841|RIPC|ripc
218011|NCT02830841|hepatic ischemic and reperfusion injury|hepatic ischemic and reperfusion injury
218012|NCT02830841|pediatric living donor liver transplantation|pediatric living donor liver transplantation
218013|NCT02830815|Broadband click stimulus testing|broadband click stimulus testing
218014|NCT02830815|General Anesthesia|general anesthesia
218015|NCT02830815|Sevoflurane|sevoflurane
218016|NCT02830815|Propofol|propofol
218017|NCT02830815|Amplitude latency|amplitude latency
218018|NCT02830815|Wave V|wave v
218019|NCT02830776|dermatochalasis|dermatochalasis
218020|NCT02830776|bimatoprost|bimatoprost
218021|NCT02830776|blepharoplasty|blepharoplasty
218022|NCT02830763|neutral lipid storage disease|neutral lipid storage disease
218023|NCT02830763|CNT-02|cnt-02
218024|NCT02830763|primary triglyceride deposit cardiomyovasculopathy (TGCV)|primary triglyceride deposit cardiomyovasculopathy (tgcv)
218025|NCT02830763|neutral lipid storage disease with myopathy (NLSD-M)|neutral lipid storage disease with myopathy (nlsd-m)
218026|NCT02830737|Small Hepatocellular Carcinoma|small hepatocellular carcinoma
218027|NCT02830737|No-touch RFA|no-touch rfa
218028|NCT02830737|Traditional RFA|traditional rfa
218029|NCT02830737|Recurrence rate|recurrence rate
218030|NCT02830724|Metastatic Solid Cancers|metastatic solid cancers
218031|NCT02830724|Renal Cell Cancer|renal cell cancer
218032|NCT02830724|Cell Therapy|cell therapy
218033|NCT02830724|CAR T Cells|car t cells
218034|NCT02830711|happiness|happiness
218035|NCT02830711|anger|anger
218036|NCT02830711|sadness|sadness
218037|NCT02830711|anticipation|anticipation
218038|NCT02830698|Nervous System|nervous system
218039|NCT02830698|Hypnosis|hypnosis
218040|NCT02830698|Electrocardiography, Ambulatory|electrocardiography, ambulatory
218041|NCT02830698|Abdominal pain disorders functional|abdominal pain disorders functional
218042|NCT02830685|pre-pectoral breast reconstruction|pre-pectoral breast reconstruction
218043|NCT02830685|subcutaneous breast reconstruction|subcutaneous breast reconstruction
218044|NCT02830633|laparoscopy|laparoscopy
218045|NCT02830633|rectal cancer|rectal cancer
218046|NCT02830633|pelvic autonomic nerve|pelvic autonomic nerve
218047|NCT02830568|Kidney transplantation|kidney transplantation
218048|NCT02830568|Surgical procedures|surgical procedures
218049|NCT02830568|Kidney living donors|kidney living donors
218050|NCT02830568|Quality of life|quality of life
218153|NCT02830061|Teenage|teenage
218051|NCT02830542|Clostridium difficile|clostridium difficile
218052|NCT02830542|C Diff|c diff
218053|NCT02830542|CDI|cdi
218054|NCT02830529|Mindfulness|mindfulness
218055|NCT02830529|African American|african american
218056|NCT02830529|fMRI|fmri
218057|NCT02830477|Previously treated patients|previously treated patients
218058|NCT02830451|Registry|registry
218059|NCT02830451|Spine|spine
218060|NCT02830451|Surgery|surgery
218061|NCT02830451|Medical Oncology|medical oncology
218062|NCT02830451|Radiation Oncology|radiation oncology
218063|NCT02830451|Neoplasms|neoplasms
218064|NCT02830451|Metastasis|metastasis
218065|NCT02830451|Chemotherapy|chemotherapy
218066|NCT02830451|Radiation Therapy|radiation therapy
218067|NCT02830451|Tumor Markers|tumor markers
218068|NCT02830438|kidney disease|kidney disease
218069|NCT02830438|fibrosis|fibrosis
218070|NCT02830438|ultrasound|ultrasound
218071|NCT02830438|elastography|elastography
218072|NCT02830425|Multimorbidity|multimorbidity
218073|NCT02830425|Polypharmacy|polypharmacy
218074|NCT02830425|Appropriateness|appropriateness
218075|NCT02830425|STOPP|stopp
218076|NCT02830425|START|start
218077|NCT02830399|treatment-resistant-depression|treatment-resistant-depression
218078|NCT02830399|rTMS|rtms
218079|NCT02830399|ECT|ect
218080|NCT02830399|Augmentation strategy|augmentation strategy
218081|NCT02830373|LVIS stents|lvis stents
218082|NCT02830373|Intracranial aneurysm|intracranial aneurysm
218083|NCT02830373|Unruptured aneurysm|unruptured aneurysm
218084|NCT02830373|Wide-necked aneurysm|wide-necked aneurysm
218085|NCT02830360|Antiarrhythmic drug therapy|antiarrhythmic drug therapy
218086|NCT02830360|VT Catheter ablation|vt catheter ablation
218087|NCT02830360|ICD Therapy|icd therapy
218088|NCT02830360|Ischemic Heart Disease|ischemic heart disease
719429|NCT00550342|treatment|treatment
218089|NCT02830347|antibiotic resistance|antibiotic resistance
218090|NCT02830347|oral microbiome|oral microbiome
218091|NCT02830334|Suicide|suicide
218092|NCT02830334|Youth Suicide|youth suicide
218093|NCT02830308|Hormones|hormones
218094|NCT02830308|Endocrine|endocrine
218095|NCT02830308|Hypercortisolism|hypercortisolism
218096|NCT02830308|Bone|bone
218097|NCT02830308|Hypothalamic-Pituitary Dysfunction|hypothalamic-pituitary dysfunction
218098|NCT02830295|body awareness therapy|body awareness therapy
218099|NCT02830295|physical therapy|physical therapy
218100|NCT02830295|movement therapy|movement therapy
218101|NCT02830269|Neuro-ICU|neuro-icu
218102|NCT02830269|Third ventricle|third ventricle
218103|NCT02830269|Computer Tomography|computer tomography
218104|NCT02830269|Transcranial Doppler ultrasonography|transcranial doppler ultrasonography
218105|NCT02830256|Intensive care unit|intensive care unit
218106|NCT02830256|Neuro-ICU|neuro-icu
218107|NCT02830256|Pain|pain
218108|NCT02830256|Intubation|intubation
218109|NCT02830256|critical care|critical care
218110|NCT02830256|patients|patients
218111|NCT02830217|STEMI|stemi
218112|NCT02830217|primary PCI|primary pci
218113|NCT02830217|sST2|sst2
218114|NCT02830217|prognosis|prognosis
218115|NCT02830204|mitral valve regurgitation|mitral valve regurgitation
218116|NCT02830204|mitral valve stenosis|mitral valve stenosis
218117|NCT02830191|Cyclosporine, Dried blood spot|cyclosporine, dried blood spot
218118|NCT02830152|Stroke|stroke
218119|NCT02830152|intracerebral hemorrhage|intracerebral hemorrhage
218120|NCT02830152|left atrial appendage occlusion|left atrial appendage occlusion
218121|NCT02830152|atrial fibrillation|atrial fibrillation
218122|NCT02830152|oral anticoagulation|oral anticoagulation
218123|NCT02830152|preventive therapy|preventive therapy
218124|NCT02830126|Outcomes|outcomes
218125|NCT02830126|Information technology|information technology
218126|NCT02830113|periodontitis|periodontitis
218127|NCT02830113|diabetes|diabetes
218128|NCT02830113|prevention|prevention
218129|NCT02830113|impaired glucose tolerance|impaired glucose tolerance
218130|NCT02830113|insulin resistance|insulin resistance
218131|NCT02830100|Intern speech|intern speech
218132|NCT02830100|Speech and visual imaging|speech and visual imaging
218133|NCT02830100|Mind and oral drift|mind and oral drift
218134|NCT02830100|Cognitive performance|cognitive performance
218135|NCT02830100|Magnetic Resonance Imaging|magnetic resonance imaging
218136|NCT02830087|randomized controlled trial|randomized controlled trial
218137|NCT02830087|tourniquet|tourniquet
218138|NCT02830087|tourniquet cuff pressure|tourniquet cuff pressure
218139|NCT02830087|total knee arthroplasty|total knee arthroplasty
218140|NCT02830087|total knee replacement|total knee replacement
218141|NCT02830087|pain, postoperative|pain, postoperative
218142|NCT02830087|range of motion, articular|range of motion, articular
218143|NCT02830087|blood loss, surgical|blood loss, surgical
218144|NCT02830087|muscle strength, quadriceps|muscle strength, quadriceps
218145|NCT02830087|walking|walking
218146|NCT02830087|manipulation, orthopedic/therapeutic use|manipulation, orthopedic/therapeutic use
218147|NCT02830087|wound healing/surgery|wound healing/surgery
218148|NCT02830074|Sleep Apnea Syndromes|sleep apnea syndromes
218149|NCT02830074|Spinal Cord Injuries|spinal cord injuries
218150|NCT02830074|Sleep|sleep
218151|NCT02830074|Quality of life|quality of life
218154|NCT02830061|Young Adult|young adult
218155|NCT02830061|Fertility|fertility
218156|NCT02830061|Cryopreservation|cryopreservation
218157|NCT02830061|Experience|experience
218158|NCT02830048|diabetes|diabetes
218159|NCT02830048|glibenclamide|glibenclamide
218160|NCT02830048|glucagon|glucagon
218161|NCT02830035|ultrasound guided|ultrasound guided
218162|NCT02830035|spinal anesthesia|spinal anesthesia
218163|NCT02830035|neuraxial block|neuraxial block
218164|NCT02830035|paramedian|paramedian
218165|NCT02830022|autism spectrum disorder|autism spectrum disorder
218166|NCT02829996|glaucoma|glaucoma
218167|NCT02829996|primary open-angle glaucoma|primary open-angle glaucoma
218168|NCT02829996|ocular hypertension|ocular hypertension
218169|NCT02829996|adenosine agonist|adenosine agonist
218170|NCT02829996|eye drop|eye drop
218171|NCT02829996|trabodenoson|trabodenoson
218172|NCT02829996|trabecular meshwork|trabecular meshwork
218173|NCT02829983|clarithromycin|clarithromycin
218174|NCT02829983|periodontal debridement|periodontal debridement
218175|NCT02829983|aggressive periodontitis|aggressive periodontitis
218176|NCT02829970|Attention Deficit Hyperactivity Disorder|attention deficit hyperactivity disorder
218177|NCT02829970|Alcohol-Related Disorders|alcohol-related disorders
218178|NCT02829970|Substance-Related Disorders|substance-related disorders
218179|NCT02829970|Motivational Interviewing|motivational interviewing
218180|NCT02829970|Behavior Therapy|behavior therapy
218181|NCT02829944|Cesarean section|cesarean section
218182|NCT02829931|recurrent glioma|recurrent glioma
218183|NCT02829931|high grade glioma|high grade glioma
218184|NCT02829931|head and neck disease|head and neck disease
218185|NCT02829931|grade III glioma|grade iii glioma
218186|NCT02829931|grade IV glioma|grade iv glioma
218187|NCT02829931|radiation therapy|radiation therapy
218188|NCT02829918|advanced biliary tract cancer|advanced biliary tract cancer
218189|NCT02829918|refractory biliary tract cancer|refractory biliary tract cancer
218190|NCT02829918|digestive diseases|digestive diseases
218191|NCT02829918|immunotherapy|immunotherapy
218192|NCT02829905|mass screening|mass screening
218193|NCT02829905|patient satisfaction|patient satisfaction
218194|NCT02829905|radiography|radiography
218195|NCT02829905|mammography|mammography
218196|NCT02829879|Dentin Sensitivity|dentin sensitivity
218197|NCT02829879|Arginin|arginin
218198|NCT02829879|Potassium Nitrate|potassium nitrate
218199|NCT02829879|Dentifrice|dentifrice
218201|NCT02829853|SARCOIDOSIS|sarcoidosis
218202|NCT02829853|GRANULOMA DISEASES|granuloma diseases
218203|NCT02829853|GENETICS|genetics
218204|NCT02829853|PREDISPOSITION|predisposition
218205|NCT02829853|EXOME (WES-NGS)|exome (wes-ngs)
218206|NCT02829840|Leukemia|leukemia
218207|NCT02829840|FLT3-Mutated Acute Myeloid Leukemia|flt3-mutated acute myeloid leukemia
218208|NCT02829840|FLT3-Mutated High-Risk Myelodysplastic Syndrome|flt3-mutated high-risk myelodysplastic syndrome
218209|NCT02829840|Acute Myeloid Leukemia|acute myeloid leukemia
218211|NCT02829840|Myelodysplastic Syndrome|myelodysplastic syndrome
218212|NCT02829840|MDS|mds
218213|NCT02829840|Ponatinib|ponatinib
218214|NCT02829840|Iclusig|iclusig
218215|NCT02829840|AP24534|ap24534
218216|NCT02829840|5-azacytidine|5-azacytidine
218217|NCT02829840|Azacitidine|azacitidine
218218|NCT02829840|5-aza|5-aza
218219|NCT02829840|Vidaza|vidaza
218220|NCT02829840|5-AZC|5-azc
218221|NCT02829840|AZA-CR|aza-cr
218222|NCT02829840|Ladakamycin|ladakamycin
218223|NCT02829840|NSC-102816|nsc-102816
218224|NCT02829840|Azacytidine|azacytidine
218225|NCT02829827|Radiprodil|radiprodil
218226|NCT02829827|Infantile spasms|infantile spasms
218227|NCT02829827|IS|is
218228|NCT02829827|Infantile|infantile
218229|NCT02829827|Spasms|spasms
218230|NCT02829827|Epilepsy|epilepsy
218231|NCT02829827|Paediatrics|paediatrics
218232|NCT02829827|Drug-resistant|drug-resistant
218233|NCT02829827|West Syndrome|west syndrome
218234|NCT02829827|Hypsarrhythmia|hypsarrhythmia
218235|NCT02829814|Pain|pain
218236|NCT02829814|Sleep|sleep
218237|NCT02829814|Fibromyalgia|fibromyalgia
218238|NCT02829814|FM|fm
218239|NCT02829801|animal assisted therapy|animal assisted therapy
218240|NCT02829801|well-being|well-being
218241|NCT02829801|Alzheimer's Disease|alzheimer's disease
218242|NCT02829788|Digestive peritoneal carcinomatosis|digestive peritoneal carcinomatosis
218243|NCT02829788|laparoscopy|laparoscopy
218244|NCT02829788|laparotomy|laparotomy
218245|NCT02829788|peritoneal cancer index (PCI)|peritoneal cancer index (pci)
218246|NCT02829788|staging|staging
218247|NCT02829762|isolated|isolated
218248|NCT02829762|at risk of isolation|at risk of isolation
218249|NCT02829762|patients|patients
218250|NCT02829749|Heart Valve Diseases|heart valve diseases
218251|NCT02829749|Heart failure|heart failure
218252|NCT02829749|Heart diseases|heart diseases
218253|NCT02829749|Mitral valve insufficiency|mitral valve insufficiency
218254|NCT02829736|lung neoplasm|lung neoplasm
218255|NCT02829736|lung metastasis|lung metastasis
218256|NCT02829736|enhanced recovery after surgery|enhanced recovery after surgery
218257|NCT02829736|fast-track surgery|fast-track surgery
218258|NCT02829736|intraoperative chest tube removal|intraoperative chest tube removal
218259|NCT02829736|pain|pain
218260|NCT02829736|lung function|lung function
218261|NCT02829736|reasons for admission|reasons for admission
218262|NCT02829723|Phase I/II|phase i/ii
218263|NCT02829723|BLZ945|blz945
218264|NCT02829723|PDR001|pdr001
218265|NCT02829723|CSF-1R|csf-1r
218266|NCT02829723|PD-1|pd-1
218267|NCT02829710|Analgesia|analgesia
218268|NCT02829710|intensive care units|intensive care units
218269|NCT02829710|clinical protocol|clinical protocol
218270|NCT02829710|deep sedation|deep sedation
218271|NCT02829710|nursing assessment|nursing assessment
218272|NCT02829697|Regional anaesthesia|regional anaesthesia
218273|NCT02829671|Loneliness|loneliness
218274|NCT02829671|Suicidal behavior|suicidal behavior
218275|NCT02829671|Depression|depression
218276|NCT02829645|eating disoders|eating disoders
218277|NCT02829645|neuropsychology|neuropsychology
218278|NCT02829645|pronostic|pronostic
218279|NCT02829632|mobile technology|mobile technology
218280|NCT02829632|feedback message|feedback message
218281|NCT02829632|self-monitoring|self-monitoring
218282|NCT02829619|Obesity|obesity
218283|NCT02829619|Nutrigenetics|nutrigenetics
218284|NCT02829619|Food Timing|food timing
218285|NCT02829619|Weight loss|weight loss
218286|NCT02829606|Age-related Macular Degeneration|age-related macular degeneration
218287|NCT02829606|Central Scotoma|central scotoma
218288|NCT02829606|Head Mounted Display|head mounted display
218289|NCT02829580|endothelial function|endothelial function
218290|NCT02829580|flow-mediated dilation|flow-mediated dilation
218291|NCT02829580|vascular elastic properties|vascular elastic properties
218292|NCT02829554|Emotion|emotion
218293|NCT02829554|Judgment|judgment
218294|NCT02829554|Decision Making|decision making
218295|NCT02829541|Single Ascending Dose (SAD), Healthy Volunteers|single ascending dose (sad), healthy volunteers
218296|NCT02829502|Cerebrovascular disease|cerebrovascular disease
218297|NCT02829502|Glucagon like peptide 1|glucagon like peptide 1
218298|NCT02829489|nutrition|nutrition
218299|NCT02829489|foregut tumors|foregut tumors
218300|NCT02829489|patient related outcomes|patient related outcomes
218301|NCT02829489|audit|audit
218302|NCT02829476|Adolescent idiopathic Scoliosis|adolescent idiopathic scoliosis
218303|NCT02829476|Ghrelin|ghrelin
218304|NCT02829450|peritoneal ultrafiltration|peritoneal ultrafiltration
218305|NCT02829450|congestive heart failure|congestive heart failure
218306|NCT02829450|chronic kidney disease|chronic kidney disease
218307|NCT02829398|cerebral ischemia|cerebral ischemia
218308|NCT02829385|Apatinib|apatinib
218309|NCT02829385|XELOX Regimen|xelox regimen
218310|NCT02829385|metastatic colorectal cancer|metastatic colorectal cancer
218311|NCT02829346|Tranexamic acid|tranexamic acid
218312|NCT02829346|Peri-articular injection|peri-articular injection
218313|NCT02829346|Total knee arthroplasty|total knee arthroplasty
218314|NCT02829346|Blood loss|blood loss
218315|NCT02829346|Osteoarthritis, Knee|osteoarthritis, knee
218316|NCT02829333|analgesia|analgesia
218317|NCT02829333|anesthesia|anesthesia
218318|NCT02829333|leiomyomas|leiomyomas
218319|NCT02829333|tumor|tumor
218320|NCT02829333|vascular endothelial growth factor|vascular endothelial growth factor
218321|NCT02829333|anesthesia technique on tumor|anesthesia technique on tumor
218322|NCT02829320|efficacy|efficacy
218323|NCT02829320|hemodialysis (HD)|hemodialysis (hd)
218324|NCT02829320|hemoglobin (Hgb)|hemoglobin (hgb)
218325|NCT02829320|erythropoiesis-stimulating agents (ESAs)|erythropoiesis-stimulating agents (esas)
218326|NCT02829320|GSK1278863|gsk1278863
218327|NCT02829307|89Zirconium|89zirconium
218328|NCT02829307|Open label|open label
218329|NCT02829307|Pharmacokinetics|pharmacokinetics
218330|NCT02829307|Radioactive|radioactive
218331|NCT02829307|Clearance|clearance
218332|NCT02829307|Biodistribution|biodistribution
218333|NCT02829281|knee osteoarthritis|knee osteoarthritis
218334|NCT02829281|Intra-articular injection|intra-articular injection
218335|NCT02829281|Botulinum Toxin Type A|botulinum toxin type a
218336|NCT02829281|Corticosteroid|corticosteroid
218337|NCT02829268|Wolfram syndrome|wolfram syndrome
218338|NCT02829268|Diabetes Mellitus|diabetes mellitus
218339|NCT02829268|Optic Nerve Atrophy|optic nerve atrophy
218341|NCT02829268|Endoplasmic Reticulum Stress|endoplasmic reticulum stress
218342|NCT02829255|High altitude|high altitude
218343|NCT02829255|Cerebral autoregulation|cerebral autoregulation
218344|NCT02829255|Transfer function analysis|transfer function analysis
218345|NCT02829242|Near Infrared Spectroscopy|near infrared spectroscopy
218346|NCT02829242|Somatic Saturation|somatic saturation
218347|NCT02829242|Well Leg Compartment Syndrome|well leg compartment syndrome
218348|NCT02829242|Robotic Assisted Laparoscopic Surgery|robotic assisted laparoscopic surgery
218349|NCT02829242|Trendelenburg Position|trendelenburg position
218350|NCT02829216|myelosuppression|myelosuppression
218351|NCT02829216|mesenchymal stromal cells|mesenchymal stromal cells
218352|NCT02829203|Frailty|frailty
218353|NCT02829203|Surgery|surgery
218354|NCT02829190|External carotid artery|external carotid artery
218355|NCT02829190|Facial artery|facial artery
218356|NCT02829190|Lingual artery|lingual artery
218357|NCT02829190|Superior thyroid artery|superior thyroid artery
218358|NCT02829190|Internal maxillary artery|internal maxillary artery
218359|NCT02829190|Phase-contrast MRI|phase-contrast mri
218360|NCT02829190|Rate of flow|rate of flow
218361|NCT02829190|Superficial temporal artery|superficial temporal artery
218362|NCT02829177|Type 1 diabetes|type 1 diabetes
218363|NCT02829177|Diabetic nephropathy|diabetic nephropathy
218364|NCT02829177|Albuminuria|albuminuria
218365|NCT02829177|Allopurinol|allopurinol
218366|NCT02829164|Tonsillectomy|tonsillectomy
218367|NCT02829164|primary IgA nephropathy|primary iga nephropathy
218368|NCT02829164|primary nephropathy|primary nephropathy
218369|NCT02829164|IgA|iga
218370|NCT02829164|Berger's disease|berger's disease
218371|NCT02829164|Purpura rheumatoid|purpura rheumatoid
218372|NCT02829164|kidney failure|kidney failure
218373|NCT02829151|Peripheral artery disease|peripheral artery disease
218374|NCT02829151|Critical limb ischemia|critical limb ischemia
218375|NCT02829151|Angioplasty|angioplasty
218376|NCT02829151|Antiplatelet therapy|antiplatelet therapy
218377|NCT02829125|Early rehabilitation|early rehabilitation
218378|NCT02829125|abdominal surgery|abdominal surgery
218379|NCT02829125|ERAS|eras
218380|NCT02829112|Shulman|shulman
218381|NCT02829112|fasciitis|fasciitis
218382|NCT02829112|Shulman fasciitis|shulman fasciitis
218383|NCT02829112|eosinophilic fasciitis|eosinophilic fasciitis
218384|NCT02829112|inflammatory disease|inflammatory disease
218385|NCT02829112|prevalence|prevalence
218386|NCT02829073|Tinnitus|tinnitus
218387|NCT02829073|Double-blind|double-blind
218388|NCT02829073|Neuromonic Tinnitus Treatment Program|neuromonic tinnitus treatment program
218389|NCT02829073|Oasis™|oasis™
218390|NCT02829060|nephrolithiasis|nephrolithiasis
218391|NCT02829060|percutaneous nephrolithiasis|percutaneous nephrolithiasis
218392|NCT02829060|urinary tract infection (UTI)|urinary tract infection (uti)
218393|NCT02829060|Sepsis|sepsis
218394|NCT02829034|pulmonary hypertension|pulmonary hypertension
218395|NCT02829034|right ventricular function|right ventricular function
218396|NCT02829034|ranolazine|ranolazine
218397|NCT02829021|Sensitivity|sensitivity
218398|NCT02829021|Specificity|specificity
218399|NCT02829021|Breast cancer|breast cancer
218400|NCT02829021|Mammography|mammography
218401|NCT02829021|Thermography|thermography
218402|NCT02829021|Infrared|infrared
218403|NCT02829021|Dynamic|dynamic
218404|NCT02829021|Diagnostic accuracy|diagnostic accuracy
218405|NCT02829021|Diagnostic odds ratio|diagnostic odds ratio
218406|NCT02829008|HER2 negative breast cancer|her2 negative breast cancer
218407|NCT02829008|low-dose bevacizumab|low-dose bevacizumab
218408|NCT02829008|pemetrexed|pemetrexed
218409|NCT02828995|Diabetes Mellitus|diabetes mellitus
218410|NCT02828995|Stigma|stigma
218411|NCT02828995|Social Determinants of Health|social determinants of health
218412|NCT02828982|powered ankle prosthesis|powered ankle prosthesis
218413|NCT02828982|activity monitoring|activity monitoring
218414|NCT02828982|muscle fatigue|muscle fatigue
218415|NCT02828982|below knee amputation|below knee amputation
218416|NCT02828969|Trajectory|trajectory
218417|NCT02828969|Emergency room|emergency room
218418|NCT02828969|Conduct disorder|conduct disorder
218419|NCT02828969|Care management|care management
218420|NCT02828956|eating disorders|eating disorders
218421|NCT02828956|ANSOCQ|ansocq
218422|NCT02828956|anorexia nervosa|anorexia nervosa
218423|NCT02828878|Apoptosis|apoptosis
218424|NCT02828878|FAS Ligand|fas ligand
218425|NCT02828878|Bone marrow transplantation|bone marrow transplantation
218426|NCT02828878|GvHD|gvhd
218427|NCT02828878|Stem cells|stem cells
218428|NCT02828865|Hepatocellular Carcinoma|hepatocellular carcinoma
218429|NCT02828865|irreversible electroporation|irreversible electroporation
218430|NCT02828865|liver cancer|liver cancer
218431|NCT02828852|pregnancy|pregnancy
218432|NCT02828852|platelets|platelets
218433|NCT02828839|Transperineal|transperineal
218434|NCT02828839|Transrectal|transrectal
218435|NCT02828839|Needle Guide|needle guide
218436|NCT02828839|Biopsy|biopsy
218437|NCT02828761|chest pain|chest pain
218438|NCT02828761|calcium score|calcium score
218439|NCT02828761|coronary calcium score|coronary calcium score
218440|NCT02828761|coronary calcium scoring|coronary calcium scoring
218441|NCT02828761|calcium scoring|calcium scoring
218442|NCT02828761|cacs|cacs
218443|NCT02828761|ccs|ccs
218444|NCT02828748|cannabinoids|cannabinoids
218445|NCT02828748|inflammatory bowel disease|inflammatory bowel disease
218446|NCT02828722|Circadian rhythm|circadian rhythm
218447|NCT02828722|Critical Illness|critical illness
218448|NCT02828722|Mechanical ventilation|mechanical ventilation
218449|NCT02828722|Environmental modulation|environmental modulation
218450|NCT02828696|CAD-CAM composites|cad-cam composites
218451|NCT02828696|Worn dentition|worn dentition
218452|NCT02828696|minimally invasive treatment|minimally invasive treatment
218453|NCT02828683|DES|des
218454|NCT02828683|PCI|pci
218455|NCT02828683|STEMI|stemi
218456|NCT02828683|Interventional Cardiology|interventional cardiology
218457|NCT02828657|ORBERA|orbera
218458|NCT02828644|ADHD|adhd
218460|NCT02828579|obesity|obesity
218461|NCT02828579|bariatric surgery|bariatric surgery
218462|NCT02828579|non-alcoholic fatty liver disease|non-alcoholic fatty liver disease
218463|NCT02828553|Wearable device|wearable device
218464|NCT02828553|Fitbit|fitbit
218465|NCT02828553|Inpatient|inpatient
218466|NCT02828540|HT047|ht047
218467|NCT02828540|Pueraria lobata|pueraria lobata
218468|NCT02828540|Scutellaria baicalensis|scutellaria baicalensis
218469|NCT02828501|Pain Threshold|pain threshold
218470|NCT02828436|Hypertension|hypertension
218471|NCT02828436|High Blood Pressure|high blood pressure
218472|NCT02828423|periodontal regeneration|periodontal regeneration
218473|NCT02828410|serum bovine immunoglobulin protein isolate|serum bovine immunoglobulin protein isolate
218474|NCT02828410|IPAA|ipaa
218475|NCT02828410|quality of life|quality of life
218476|NCT02828384|fodmap diet|fodmap diet
218477|NCT02828332|Autism Spectrum Disorders|autism spectrum disorders
218478|NCT02828332|Cohort|cohort
218479|NCT02828306|stroke|stroke
218480|NCT02828306|head trauma|head trauma
218481|NCT02828306|Patient Specific Implant|patient specific implant
218482|NCT02828306|skull defect|skull defect
218483|NCT02828267|Tanzania|tanzania
218484|NCT02828267|Alcohol Use|alcohol use
218485|NCT02828267|Brief Intervention|brief intervention
218486|NCT02828228|obesity|obesity
218487|NCT02828228|weight loss|weight loss
218488|NCT02828228|vitamin D deficiency|vitamin d deficiency
218489|NCT02828228|body composition|body composition
218490|NCT02828202|Melanoma|melanoma
218491|NCT02828202|Skin|skin
218492|NCT02828202|Biobank|biobank
218493|NCT02828189|Physical Therapy Modalities|physical therapy modalities
218494|NCT02828189|Breast Cancer Treatment|breast cancer treatment
218495|NCT02828189|Exercise Therapy|exercise therapy
218496|NCT02828189|Dyspnea|dyspnea
218497|NCT02828176|cardiometry|cardiometry
218498|NCT02828176|uterine displacement|uterine displacement
218499|NCT02828111|Gorlin Syndrome|gorlin syndrome
218500|NCT02828111|Basal Cell Nevus Syndrome BCNS|basal cell nevus syndrome bcns
218501|NCT02828111|nevoid basal cell carcinoma syndrome|nevoid basal cell carcinoma syndrome
218502|NCT02828111|Basal cell carcinoma|basal cell carcinoma
218503|NCT02828111|Hedgehog inhibitor|hedgehog inhibitor
218504|NCT02828111|Surgically Eligible Basal Cell Carcinomas|surgically eligible basal cell carcinomas
218505|NCT02828111|High Frequency Basal Cell Carcinomas|high frequency basal cell carcinomas
218506|NCT02828098|aggressive solid tumors|aggressive solid tumors
218507|NCT02828059|Caesarean section|caesarean section
218508|NCT02828007|EIT|eit
218509|NCT02828007|NIV|niv
218510|NCT02827968|PDL-1|pdl-1
218511|NCT02827942|pylori|pylori
218512|NCT02827903|Metformin|metformin
218513|NCT02827903|Rosuvastatin|rosuvastatin
218514|NCT02827903|type 2 diabetes|type 2 diabetes
218515|NCT02827903|dyslipidemia|dyslipidemia
218516|NCT02827864|Mirror therapy|mirror therapy
218517|NCT02827864|transcranial direct current stimulation|transcranial direct current stimulation
218518|NCT02827864|stroke|stroke
218519|NCT02827864|neurorehabilitation|neurorehabilitation
218520|NCT02827851|Damage of articular cartilage|damage of articular cartilage
218521|NCT02827851|Cartilage degeneration|cartilage degeneration
218522|NCT02827851|Intraarticular injection|intraarticular injection
218523|NCT02827851|SVF|svf
218524|NCT02827851|Stromal vascular fraction|stromal vascular fraction
218525|NCT02827851|Adipose-derived regenerative cells (ADRC)|adipose-derived regenerative cells (adrc)
218526|NCT02827851|Adipose tissue|adipose tissue
218527|NCT02827851|Stem cells|stem cells
218528|NCT02827825|Neurosurgical|neurosurgical
218529|NCT02827825|Intensive Care|intensive care
218530|NCT02827799|heart failure|heart failure
218531|NCT02827799|insomnia|insomnia
218532|NCT02827799|sleep disorders|sleep disorders
218533|NCT02827799|actigraphy|actigraphy
218534|NCT02827799|cardiomyopathy|cardiomyopathy
218535|NCT02827799|depression|depression
218536|NCT02827799|sleepiness|sleepiness
218537|NCT02827799|anxiety|anxiety
218538|NCT02827799|fatigue|fatigue
218539|NCT02827786|hepatic tumours|hepatic tumours
218540|NCT02827773|Literacy|literacy
218541|NCT02827747|Keratoconus progression|keratoconus progression
218542|NCT02827747|Vitamins and keratoconus|vitamins and keratoconus
218543|NCT02827747|Vitamin supplementation|vitamin supplementation
218544|NCT02827682|IoC|ioc
218545|NCT02827682|monitor|monitor
218546|NCT02827682|elderly|elderly
218547|NCT02827682|postoperative effectiveness|postoperative effectiveness
218548|NCT02827656|Fertilization in vitro|fertilization in vitro
218549|NCT02827656|Luteal Phase|luteal phase
218550|NCT02827656|ovarian hyperstimulation syndrome|ovarian hyperstimulation syndrome
218551|NCT02827617|Ibrutinib|ibrutinib
218552|NCT02827617|TP53|tp53
218553|NCT02827617|Chronic lymphocytic leukemia|chronic lymphocytic leukemia
218554|NCT02827604|Caesarean section|caesarean section
218555|NCT02827604|lower uterine segment|lower uterine segment
218556|NCT02827604|sonography|sonography
218557|NCT02827591|repeat cesarean section|repeat cesarean section
218558|NCT02827591|lower uterine segment|lower uterine segment
218559|NCT02827591|quantitative sonography|quantitative sonography
218560|NCT02827565|colorectal cancer|colorectal cancer
218561|NCT02827565|Kras mutation|kras mutation
218562|NCT02827565|Nras mutation|nras mutation
218563|NCT02827565|Braf mutation|braf mutation
218564|NCT02827552|pediatric oncology|pediatric oncology
218565|NCT02827552|radiotherapy|radiotherapy
218566|NCT02827552|radiosensitivity|radiosensitivity
218567|NCT02827513|Centanafadine|centanafadine
218568|NCT02827513|Adult attention-deficit hyperactivity disorder|adult attention-deficit hyperactivity disorder
218569|NCT02827513|Healthy participants|healthy participants
218570|NCT02827448|Left Ventricular Assist Device|left ventricular assist device
218571|NCT02827448|Heart Transplantation|heart transplantation
218572|NCT02827448|Perioperative|perioperative
218573|NCT02827448|Acute Kidney Injury|acute kidney injury
218574|NCT02827448|Renal|renal
218575|NCT02827448|Kidney|kidney
218576|NCT02827448|Total Artificial Heart|total artificial heart
218577|NCT02827422|therapeutic hypothermia|therapeutic hypothermia
218578|NCT02827409|Delayed cord clamping|delayed cord clamping
218579|NCT02827396|Disability|disability
218580|NCT02827396|children|children
218581|NCT02827396|parents|parents
218582|NCT02827396|depression|depression
218583|NCT02827396|knowledge|knowledge
218584|NCT02827396|psychosocial intervention|psychosocial intervention
218585|NCT02827344|PD-1/PD-L1|pd-1/pd-l1
218586|NCT02827344|Immune checkpoints|immune checkpoints
218587|NCT02827344|Immunotherapy|immunotherapy
218588|NCT02827344|lung cancer|lung cancer
218589|NCT02827344|circulating tumor cells|circulating tumor cells
218590|NCT02827344|immunocytochemistry|immunocytochemistry
218591|NCT02827344|ISET|iset
218592|NCT02827344|MDSC|mdsc
218593|NCT02827344|Stage IV non-small cell lung cancer|stage iv non-small cell lung cancer
218594|NCT02827331|Benzodiazepines|benzodiazepines
218595|NCT02827331|Fracture|fracture
218596|NCT02827318|Blood glucose|blood glucose
218597|NCT02827305|antiplaque|antiplaque
218598|NCT02827305|antigingivitis|antigingivitis
218599|NCT02827292|music|music
218600|NCT02827292|inflammation|inflammation
218601|NCT02827279|Autism Spectrum Disorder|autism spectrum disorder
218602|NCT02827279|Emotion|emotion
218603|NCT02827253|brain|brain
218604|NCT02827253|haemodialysis|haemodialysis
218605|NCT02827253|intradialytic hypotension|intradialytic hypotension
218606|NCT02827240|Female sex workers|female sex workers
218607|NCT02827240|HIV testing|hiv testing
218608|NCT02827240|HIV self-test|hiv self-test
218609|NCT02827227|HIV-infected patients|hiv-infected patients
218610|NCT02827227|cART|cart
218611|NCT02827227|immune restoration|immune restoration
218612|NCT02827227|markers|markers
218613|NCT02827214|Thoracolumbar spine|thoracolumbar spine
218614|NCT02827214|Burst fractures|burst fractures
218615|NCT02827214|Conservative treatment|conservative treatment
218616|NCT02827214|Surgical treatment|surgical treatment
218617|NCT02827214|Thoracic or lumbar vertebrae|thoracic or lumbar vertebrae
218618|NCT02827201|pancreatic cancer|pancreatic cancer
218619|NCT02827162|Dengue Fever|dengue fever
218620|NCT02827162|Dengue Haemorrhagic Fever|dengue haemorrhagic fever
218621|NCT02827162|Tetravalent Dengue Vaccine|tetravalent dengue vaccine
218622|NCT02827149|HSCT|hsct
218623|NCT02827149|high resolution HLA typing|high resolution hla typing
218624|NCT02827149|unrelated donor|unrelated donor
218625|NCT02827084|electromyography|electromyography
218626|NCT02827084|torque|torque
218627|NCT02827084|quadriceps muscle|quadriceps muscle
218628|NCT02827058|Delivery, obstetric|delivery, obstetric
218629|NCT02827058|Analgesia, Epidural|analgesia, epidural
218630|NCT02827058|Injections, Epidural|injections, epidural
218631|NCT02827058|Needles|needles
218632|NCT02827058|Cesarean Section|cesarean section
218633|NCT02827032|Hypertension|hypertension
218634|NCT02827006|Bone graft|bone graft
218635|NCT02827006|Calcium phosphate bone cement|calcium phosphate bone cement
218637|NCT02827006|Xray|xray
218638|NCT02827006|CT|ct
218639|NCT02826993|PillCAM2|pillcam2
218640|NCT02826967|Hydro-San Plus colonic irrigation system|hydro-san plus colonic irrigation system
218641|NCT02826967|Screening colonoscopy|screening colonoscopy
218642|NCT02826954|Paranasal Sinus Diseases|paranasal sinus diseases
218643|NCT02826954|Nasal Obstruction|nasal obstruction
218644|NCT02826941|hypothermia treatment|hypothermia treatment
218645|NCT02826915|newborn|newborn
218646|NCT02826915|infant|infant
218647|NCT02826915|child|child
218648|NCT02826915|EEG|eeg
218649|NCT02826915|NIRS|nirs
218650|NCT02826902|Total intravenous anesthesia|total intravenous anesthesia
218651|NCT02826902|desflurane|desflurane
218652|NCT02826902|QoR-40|qor-40
218653|NCT02826902|correctional tibial osteotomy|correctional tibial osteotomy
218654|NCT02826889|Fluid responsiveness|fluid responsiveness
218655|NCT02826889|corrected flow time|corrected flow time
218656|NCT02826889|pleth variability index|pleth variability index
218657|NCT02826889|prone position|prone position
218658|NCT02826876|Laparoscopic surgery|laparoscopic surgery
218659|NCT02826863|seizure|seizure
218660|NCT02826863|tonic-atonic|tonic-atonic
218661|NCT02826863|epilepsy|epilepsy
218662|NCT02826863|myoclonic|myoclonic
218663|NCT02826863|encephalopathy|encephalopathy
218664|NCT02826850|Osteoarthritis, Knee|osteoarthritis, knee
218665|NCT02826850|Pulsed Radiofrequency Treatment|pulsed radiofrequency treatment
218666|NCT02826850|Ultrasonography, Interventional|ultrasonography, interventional
218667|NCT02826837|Advanced Colorectal Cancer|advanced colorectal cancer
218668|NCT02826824|corpus callosum agenesis|corpus callosum agenesis
218669|NCT02826824|agenesis|agenesis
218670|NCT02826824|corpus callosum|corpus callosum
218671|NCT02826811|Graft dysfunction|graft dysfunction
218672|NCT02826811|Graft loss|graft loss
218674|NCT02826811|Transplantation|transplantation
218675|NCT02826811|BKV|bkv
218676|NCT02826811|Anti-BKV|anti-bkv
218677|NCT02826811|Nephropathy|nephropathy
218678|NCT02826811|Immunosuppression|immunosuppression
218679|NCT02826811|Prognostic markers|prognostic markers
218680|NCT02826798|VBI-1501A|vbi-1501a
218681|NCT02826798|VBI-1501|vbi-1501
218682|NCT02826798|prophylactic vaccine|prophylactic vaccine
218683|NCT02826798|virus diseases|virus diseases
218684|NCT02826798|cytomegalovirus|cytomegalovirus
218685|NCT02826798|CMV|cmv
218686|NCT02826798|cytomegalovirus infections|cytomegalovirus infections
218687|NCT02826798|cytomegalovirus vaccines|cytomegalovirus vaccines
218688|NCT02826798|Herpesviridae Infections|herpesviridae infections
218689|NCT02826798|Phase 1|phase 1
218690|NCT02826798|Human Herpesvirus 5|human herpesvirus 5
218691|NCT02826798|HHV5|hhv5
218692|NCT02826798|Vaccines, virus-like particle|vaccines, virus-like particle
218693|NCT02826798|VLP|vlp
218694|NCT02826798|enveloped virus-like particle|enveloped virus-like particle
218695|NCT02826798|eVLP|evlp
218696|NCT02826759|sphingolipid|sphingolipid
218697|NCT02826759|diabetes mellitus|diabetes mellitus
218698|NCT02826759|biomarker|biomarker
218699|NCT02826759|obesity|obesity
218700|NCT02826759|insulin resistance|insulin resistance
218701|NCT02826733|preterm infants|preterm infants
218702|NCT02826733|term infants|term infants
218703|NCT02826733|hemispheric dominance|hemispheric dominance
218704|NCT02826720|HDL cholesterol|hdl cholesterol
218705|NCT02826720|Hyperlipidemia|hyperlipidemia
218706|NCT02826720|LDL cholesterol|ldl cholesterol
218707|NCT02826720|Periodontal disease|periodontal disease
218708|NCT02826720|Triglyceride|triglyceride
218710|NCT02826655|OCT|oct
218711|NCT02826655|diabetic retinopathy|diabetic retinopathy
218712|NCT02826655|diabetic macular edema|diabetic macular edema
218713|NCT02826642|newly diagnosed acute myeloid leukemia|newly diagnosed acute myeloid leukemia
218714|NCT02826642|AML|aml
218715|NCT02826642|myeloid dysplastic syndrome|myeloid dysplastic syndrome
218716|NCT02826642|MDS|mds
218717|NCT02826642|IDH305|idh305
218718|NCT02826642|standard of care in IDH1 mutant acute myeloid leukemia|standard of care in idh1 mutant acute myeloid leukemia
218719|NCT02826629|Sensorimotor Integration|sensorimotor integration
218720|NCT02826629|Schizophrenia|schizophrenia
218721|NCT02826629|TMS|tms
218722|NCT02826629|Oculomotor|oculomotor
218723|NCT02826629|Motor Control|motor control
218724|NCT02826616|Trimetazidine|trimetazidine
218725|NCT02826616|ST-segment elevation myocardial|st-segment elevation myocardial
218726|NCT02826616|Reperfusion injury|reperfusion injury
218727|NCT02826616|Percutaneous coronary intervention|percutaneous coronary intervention
218728|NCT02826603|Plaque psoriasis|plaque psoriasis
218729|NCT02826603|secukinumab|secukinumab
218730|NCT02826603|ustekinumab|ustekinumab
218731|NCT02826603|ain457|ain457
218732|NCT02826603|ain457a|ain457a
218733|NCT02826564|radiotherapy|radiotherapy
218734|NCT02826564|immunotherapy|immunotherapy
218735|NCT02826512|BRCA1-like|brca1-like
218736|NCT02826512|HER2 negative|her2 negative
218737|NCT02826499|Pediguard|pediguard
218738|NCT02826499|Pedicular screws|pedicular screws
218739|NCT02826499|Fluoroscopy|fluoroscopy
218740|NCT02826473|Dementia|dementia
218741|NCT02826473|Dementia screening|dementia screening
218742|NCT02826473|General Hospital|general hospital
218743|NCT02826473|Inpatients|inpatients
218744|NCT02826460|Transplant|transplant
218745|NCT02826460|Adherence|adherence
218746|NCT02826434|Breast Cancer|breast cancer
218747|NCT02826434|vaccine|vaccine
218748|NCT02826434|immunotherapy|immunotherapy
218749|NCT02826434|PD-L1 Inhibitor|pd-l1 inhibitor
218750|NCT02826434|triple negative breast cancer|triple negative breast cancer
218751|NCT02826421|Intraocular lens|intraocular lens
218752|NCT02826395|Prostate cancer|prostate cancer
218753|NCT02826395|diagnostic|diagnostic
218754|NCT02826395|imaging|imaging
218755|NCT02826395|PET/CT|pet/ct
218756|NCT02826395|Acetate carbon-11|acetate carbon-11
218757|NCT02826369|Algorithms|algorithms
218758|NCT02826369|Image Processing, Computer-Assisted/methods*|image processing, computer-assisted/methods*
218759|NCT02826369|Magnetic Resonance Imaging/methods*|magnetic resonance imaging/methods*
218760|NCT02826369|Data Compression|data compression
218761|NCT02826369|Breast Neoplasms|breast neoplasms
218762|NCT02826356|Angioedema|angioedema
218763|NCT02826356|Emergency treatment|emergency treatment
218764|NCT02826356|Treatment availability|treatment availability
218765|NCT02826356|Health Equity|health equity
218767|NCT02826330|Crohn's Disease|crohn's disease
218768|NCT02826330|Healthy relatives|healthy relatives
218769|NCT02826330|Dysbiosis|dysbiosis
218770|NCT02826330|Biomarkers|biomarkers
218771|NCT02826304|Vaginal Hysterectomy|vaginal hysterectomy
218772|NCT02826304|Laparoscopic assisted vaginal hysterectomy|laparoscopic assisted vaginal hysterectomy
218773|NCT02826304|Large uteri|large uteri
218774|NCT02826291|OSNA|osna
218775|NCT02826291|sentinel|sentinel
218776|NCT02826291|lymph|lymph
218777|NCT02826291|node|node
218778|NCT02826291|endometrial|endometrial
218779|NCT02826291|cancer|cancer
218780|NCT02826278|Newborn genitalia|newborn genitalia
218781|NCT02826278|reference charts|reference charts
218782|NCT02826252|Pulmonary Arterial Hypertension (PAH)|pulmonary arterial hypertension (pah)
218783|NCT02826213|Renal infusion|renal infusion
218784|NCT02826213|Renal infusion device|renal infusion device
218785|NCT02826200|Transcatheter aortic valve implantation|transcatheter aortic valve implantation
218786|NCT02826200|Transcatheter aortic valve replacement|transcatheter aortic valve replacement
218787|NCT02826200|Prosthetic Cardiac Valve Thrombosis|prosthetic cardiac valve thrombosis
218788|NCT02826200|Cerebrovascular Accident|cerebrovascular accident
218789|NCT02826200|Prosthetic Valve Malfunction|prosthetic valve malfunction
218790|NCT02826200|Four-dimensional volume rendered cardiac CT|four-dimensional volume rendered cardiac ct
218791|NCT02826200|Transesophageal echocardiography|transesophageal echocardiography
218792|NCT02826200|Transthoracic echocardiography|transthoracic echocardiography
218793|NCT02826200|Brain MRI|brain mri
218794|NCT02826187|Acetabular implant|acetabular implant
218795|NCT02826161|Neoplasms|neoplasms
218796|NCT02826161|Neoplasms by Site|neoplasms by site
218797|NCT02826161|Lung Neoplasms|lung neoplasms
218798|NCT02826161|Thoracic Neoplasms|thoracic neoplasms
218799|NCT02826161|Respiratory Tract Neoplasms|respiratory tract neoplasms
218800|NCT02826161|Bronchial Neoplasms|bronchial neoplasms
218801|NCT02826096|Psychiatry|psychiatry
218802|NCT02826096|psychological|psychological
218803|NCT02826096|psychotherapy|psychotherapy
218804|NCT02826096|randomize|randomize
218805|NCT02826096|Biofeedback|biofeedback
218806|NCT02826070|Chronic Hepatitis B|chronic hepatitis b
218807|NCT02826031|Sodium Hyaluronate|sodium hyaluronate
218808|NCT02826031|mild to moderate knee osteoarthritis|mild to moderate knee osteoarthritis
218809|NCT02826018|RNAi therapeutic|rnai therapeutic
218810|NCT02826018|Hepatitis B|hepatitis b
218811|NCT02826018|Chronic Hepatitis B|chronic hepatitis b
218812|NCT02826018|Hepatitis B, Chronic|hepatitis b, chronic
218813|NCT02826018|Hepatitis B Infection|hepatitis b infection
218814|NCT02826018|HBV|hbv
218815|NCT02825927|Dysphagia|dysphagia
218816|NCT02825927|Oral screen|oral screen
218817|NCT02825927|Intervention|intervention
218818|NCT02825927|Oral Health|oral health
218819|NCT02825927|Food Intake|food intake
218820|NCT02825927|Quality of life|quality of life
218821|NCT02825927|Elderly|elderly
218822|NCT02825927|Short-term care facilities|short-term care facilities
218823|NCT02825914|glycopeptides|glycopeptides
218824|NCT02825914|human microbiome|human microbiome
218825|NCT02825914|caseinomacropeptide|caseinomacropeptide
218826|NCT02825914|whey protein|whey protein
218827|NCT02825914|dietary proteins|dietary proteins
218828|NCT02825849|endometrium|endometrium
218829|NCT02825849|thin uterine lining|thin uterine lining
218830|NCT02825849|uterine scarring|uterine scarring
218831|NCT02825836|M7583|m7583
218832|NCT02825836|Bruton's Tyrosine Kinase Inhibitor|bruton's tyrosine kinase inhibitor
218833|NCT02825836|Lymphoma|lymphoma
218834|NCT02825836|Open|open
218835|NCT02825836|Phase I|phase i
218836|NCT02825810|breast cancer|breast cancer
218837|NCT02825810|long-term survival|long-term survival
218838|NCT02825810|motor control|motor control
218839|NCT02825810|cervical pain|cervical pain
218840|NCT02825797|Broadly neutralizing antibody|broadly neutralizing antibody
218841|NCT02825797|3BNC117|3bnc117
218842|NCT02825797|10-1074|10-1074
218843|NCT02825784|potassium chronic kidney disease CKD children|potassium chronic kidney disease ckd children
218844|NCT02825758|Micronutrients|micronutrients
218845|NCT02825758|restricted|restricted
218846|NCT02825758|ketogenic|ketogenic
218847|NCT02825758|diet|diet
218848|NCT02825758|acceptability|acceptability
218849|NCT02825732|Alzheimer's disease or related disorder|alzheimer's disease or related disorder
218850|NCT02825732|Comorbidity|comorbidity
218851|NCT02825732|Charlson comorbidity index|charlson comorbidity index
218852|NCT02825732|Caregiver burden|caregiver burden
218853|NCT02825732|Cohort|cohort
218854|NCT02825732|Dementia|dementia
218855|NCT02825732|Behavioral disorders|behavioral disorders
218856|NCT02825732|Functional dependency|functional dependency
218857|NCT02825719|Fibroid|fibroid
218858|NCT02825719|Ulipristal|ulipristal
218859|NCT02825719|Selective progesterone receptor modulator|selective progesterone receptor modulator
218860|NCT02825719|Chinese|chinese
218861|NCT02825706|Hemophilia|hemophilia
218862|NCT02825706|Educational Physiotherapy|educational physiotherapy
218863|NCT02825706|Pain|pain
218864|NCT02825706|Quality of life|quality of life
218865|NCT02825706|Illness Behaviour|illness behaviour
218866|NCT02825706|Elbow|elbow
218867|NCT02825680|Weight Loss|weight loss
218868|NCT02825680|Body Weight Maintenance|body weight maintenance
218869|NCT02825680|Quality Improvement|quality improvement
218870|NCT02825667|Haemophilia|haemophilia
218871|NCT02825667|Ankle|ankle
218872|NCT02825667|Arthropathy|arthropathy
218873|NCT02825667|Pain|pain
218874|NCT02825667|Range of motion|range of motion
218875|NCT02825667|Myofascial techniques|myofascial techniques
218876|NCT02825654|Pulmonary|pulmonary
218877|NCT02825654|Lung|lung
218878|NCT02825654|Military and environmental exposures|military and environmental exposures
218879|NCT02825654|Epidemiologic|epidemiologic
218880|NCT02825654|Observational|observational
218881|NCT02825654|Interview or questionnaire|interview or questionnaire
218882|NCT02825654|Deployment related|deployment related
218883|NCT02825654|Enduring Freedom|enduring freedom
218884|NCT02825654|Iraqi Freedom|iraqi freedom
218885|NCT02825615|radial artery cannulation|radial artery cannulation
218886|NCT02825615|ultrasound guided|ultrasound guided
218887|NCT02825615|first success rate|first success rate
218888|NCT02825615|systolic blood pressure|systolic blood pressure
218889|NCT02825615|shock|shock
218890|NCT02825602|Vietnam veteran|vietnam veteran
218891|NCT02825602|aging|aging
218892|NCT02825602|health|health
218893|NCT02825602|War Injury|war injury
218894|NCT02825602|Conventional Warfare|conventional warfare
218895|NCT02825602|Toxic Effect|toxic effect
218896|NCT02825602|Chemical|chemical
218897|NCT02825589|BIA|bia
218898|NCT02825589|chronic hemodialysis|chronic hemodialysis
218899|NCT02825589|sleep quality|sleep quality
218900|NCT02825550|Hepatoma|hepatoma
218901|NCT02825550|Transcatheter Arterial chemo-embolization|transcatheter arterial chemo-embolization
218902|NCT02825550|Microsphere|microsphere
218903|NCT02825511|basal cell carcinoma, histological diagnosis, prognostic impact|basal cell carcinoma, histological diagnosis, prognostic impact
218904|NCT02825472|Congenital Heart Disease|congenital heart disease
218905|NCT02825472|Sport|sport
218906|NCT02825472|Exercise training|exercise training
218907|NCT02825459|abstinence|abstinence
218908|NCT02825459|abuse liability|abuse liability
218909|NCT02825459|electronic cigarette|electronic cigarette
218910|NCT02825459|e-cigarette|e-cigarette
218911|NCT02825459|electronic nicotine delivery device|electronic nicotine delivery device
218912|NCT02825459|harm reduction|harm reduction
218913|NCT02825459|nicotine|nicotine
218914|NCT02825459|nicotine dependence|nicotine dependence
218915|NCT02825459|smoking|smoking
218916|NCT02825459|smoking cessation|smoking cessation
218917|NCT02825459|tobacco|tobacco
218918|NCT02825459|vape|vape
218919|NCT02825459|vaping|vaping
218920|NCT02825459|withdrawal|withdrawal
218921|NCT02825446|radio frequency denervation|radio frequency denervation
218922|NCT02825446|tibial arteries|tibial arteries
218923|NCT02825446|atherosclerosis of the peripheral arteries|atherosclerosis of the peripheral arteries
218924|NCT02825381|Arthroplasty|arthroplasty
218925|NCT02825381|Hip|hip
218926|NCT02825355|robotic surgery procedure|robotic surgery procedure
218927|NCT02825355|indocyanine green|indocyanine green
218928|NCT02825355|sentinel lymph node mapping|sentinel lymph node mapping
218929|NCT02825342|Gastroesophageal Reflux Disease (GERD)|gastroesophageal reflux disease (gerd)
218930|NCT02825342|Proton Pump Inhibitor (PPI)|proton pump inhibitor (ppi)
218931|NCT02825316|Crohn's disease|crohn's disease
218932|NCT02825316|inflammatory bowel diseases|inflammatory bowel diseases
218933|NCT02825316|Mediterranean diet|mediterranean diet
218934|NCT02825316|microbiome|microbiome
218935|NCT02825303|postural changes|postural changes
218936|NCT02825303|Height adjustable desk|height adjustable desk
218937|NCT02825303|Prolonged sitting|prolonged sitting
218938|NCT02825303|Cognitive performance|cognitive performance
218939|NCT02825290|Frozen-thawed embryo transfer (FET)|frozen-thawed embryo transfer (fet)
218940|NCT02825290|Luteal support|luteal support
218941|NCT02825290|Progesterone|progesterone
218942|NCT02825290|Natural cycle|natural cycle
218943|NCT02825290|Cryopreservation|cryopreservation
218944|NCT02825290|IVF|ivf
218945|NCT02825290|hCG|hcg
218946|NCT02825290|GnRH-Agonist|gnrh-agonist
218947|NCT02825290|Pregnancy rate|pregnancy rate
218948|NCT02825277|3D Power Doppler|3d power doppler
218949|NCT02825277|uteroplacental vascularization|uteroplacental vascularization
218950|NCT02825277|preeclampsia|preeclampsia
218951|NCT02825277|intra-uterine growth restriction|intra-uterine growth restriction
218952|NCT02825277|placental morphology|placental morphology
218953|NCT02825264|Glaucoma Drainage Device|glaucoma drainage device
218954|NCT02825264|STARflo|starflo
218955|NCT02825238|exercise|exercise
218956|NCT02825238|osteoarthritis|osteoarthritis
218957|NCT02825238|knee|knee
218958|NCT02825238|patellofemoral pain|patellofemoral pain
218959|NCT02825225|Prostatic Neoplasms|prostatic neoplasms
218960|NCT02825225|Biopsy|biopsy
218961|NCT02825225|Anesthesia|anesthesia
218962|NCT02825225|Detection|detection
218963|NCT02825212|Hepatitis C|hepatitis c
218964|NCT02825212|Cryoglobulinemia|cryoglobulinemia
218965|NCT02825160|Iloprost|iloprost
218966|NCT02825160|Ventavis|ventavis
218967|NCT02825160|Prostacycline analogue|prostacycline analogue
218968|NCT02825160|Pulmonary arterial hypertension|pulmonary arterial hypertension
218969|NCT02825160|Japan|japan
218970|NCT02825160|Post-marketing surveillance|post-marketing surveillance
218971|NCT02825147|pegaspargase,methotrexate|pegaspargase,methotrexate
218972|NCT02825134|heart valve disease|heart valve disease
218973|NCT02825134|valvular bioprosthesis|valvular bioprosthesis
218974|NCT02825134|aortic valve replacement|aortic valve replacement
218975|NCT02825134|Randomized clinical trial|randomized clinical trial
218976|NCT02825108|human chorionic gonadotropin (hCG), implantation rate intrauterine hCG clinical pregnancy rate frozen embryo transfer cycles|human chorionic gonadotropin (hcg), implantation rate intrauterine hcg clinical pregnancy rate frozen embryo transfer cycles
218977|NCT02825095|malignant pleural effusion,talc pleurodesis,quality of life|malignant pleural effusion,talc pleurodesis,quality of life
218978|NCT02825082|Emergency general surgery|emergency general surgery
218979|NCT02825082|Geriatric|geriatric
218980|NCT02825082|Outcomes|outcomes
218981|NCT02825082|Frailty|frailty
218982|NCT02825043|COPD|copd
218983|NCT02825004|Burnout|burnout
218984|NCT02825004|Health Care Workers|health care workers
218985|NCT02825004|Coping Skills|coping skills
218986|NCT02825004|Clinical Trial|clinical trial
218987|NCT02824952|Tagrisso|tagrisso
218988|NCT02824952|AZD9291|azd9291
218989|NCT02824952|EGFRm|egfrm
218990|NCT02824952|NSCLC|nsclc
218991|NCT02824900|Vibration Stimuli|vibration stimuli
218992|NCT02824900|Contraversive Pusher Syndrome|contraversive pusher syndrome
218993|NCT02824887|Electroacupuncture|electroacupuncture
218994|NCT02824887|Deep needling|deep needling
218995|NCT02824887|Lumbar disc herniation five points|lumbar disc herniation five points
218996|NCT02824887|Long term effect|long term effect
218997|NCT02824887|Prospective cohort study|prospective cohort study
218998|NCT02824848|congenital muscular torticollis|congenital muscular torticollis
218999|NCT02824848|infants|infants
219000|NCT02824848|passive stretching|passive stretching
219001|NCT02824848|perception-action approach|perception-action approach
219002|NCT02824822|Sudden Unexpected Death in Epilepsy|sudden unexpected death in epilepsy
219003|NCT02824822|SUDEP|sudep
219004|NCT02824822|Sudden Cardiac Arrest|sudden cardiac arrest
219005|NCT02824822|Sudden Cardiac Death|sudden cardiac death
219006|NCT02824822|Sleep|sleep
219007|NCT02824822|Ion channel disease|ion channel disease
219008|NCT02824822|Long QT syndrome|long qt syndrome
219009|NCT02824822|Brugada|brugada
219010|NCT02824822|Catecholaminergic Polymorphic Ventricular Tachycardia|catecholaminergic polymorphic ventricular tachycardia
219011|NCT02824809|hypogonadism|hypogonadism
219012|NCT02824809|Chronic Obstructive Pulmonary Disease|chronic obstructive pulmonary disease
219013|NCT02824809|Severity of Illness Index|severity of illness index
219014|NCT02824809|Testosterone|testosterone
219015|NCT02824796|ADHD|adhd
219016|NCT02824783|colorectal surgery|colorectal surgery
219017|NCT02824783|enhanced recovery|enhanced recovery
219018|NCT02824757|interstitial lung disease|interstitial lung disease
219019|NCT02824757|glucocorticcoid|glucocorticcoid
219020|NCT02824757|glucose|glucose
219021|NCT02824757|continuous glucose monitor|continuous glucose monitor
219022|NCT02824744|Bronchiolitis|bronchiolitis
219023|NCT02824744|High flow nasal canula|high flow nasal canula
219024|NCT02824731|brain tumors|brain tumors
219025|NCT02824731|proton radiotherapy|proton radiotherapy
219026|NCT02824731|photon radiotherapy|photon radiotherapy
219027|NCT02824718|Hypoparathyroidism|hypoparathyroidism
219028|NCT02824718|PTH(1-34)|pth(1-34)
219029|NCT02824718|Thiazides|thiazides
219030|NCT02824718|Hypercalciuria|hypercalciuria
219031|NCT02824718|Calcium sensing receptor|calcium sensing receptor
219032|NCT02824705|Heart|heart
219033|NCT02824705|multiple organ dysfunction syndrome|multiple organ dysfunction syndrome
219034|NCT02824705|pediatric critical care|pediatric critical care
219035|NCT02824705|congenital heart disease|congenital heart disease
219036|NCT02824679|Normal labour|normal labour
219037|NCT02824679|Augmentation of labour|augmentation of labour
219038|NCT02824679|Hyoscine butylbromide|hyoscine butylbromide
219039|NCT02824653|acute GVHD|acute gvhd
219040|NCT02824653|chronic GVHD|chronic gvhd
219041|NCT02824653|steroid-refractory|steroid-refractory
219042|NCT02824653|Mesenchymal Stem Cells|mesenchymal stem cells
219043|NCT02824640|Addiction|addiction
219044|NCT02824640|Adherence|adherence
219045|NCT02824640|Adverse Effects|adverse effects
219046|NCT02824640|Direct Acting Antiviral Agent|direct acting antiviral agent
219047|NCT02824640|Chronic Hepatitis C|chronic hepatitis c
219048|NCT02824640|Resistance Development|resistance development
219049|NCT02824640|Methadone Clinic|methadone clinic
219050|NCT02824640|Primary Care|primary care
219051|NCT02824640|Directly Observed Therapy|directly observed therapy
219052|NCT02824640|Randomized Controlled Trial|randomized controlled trial
219053|NCT02824640|Resistance|resistance
219054|NCT02824640|Reinfection|reinfection
219055|NCT02824640|Treatment Outcome|treatment outcome
219056|NCT02824640|Patient Navigation|patient navigation
219057|NCT02824640|Multi-Site|multi-site
219058|NCT02824640|Liver Disease|liver disease
219059|NCT02824640|Intervention|intervention
219060|NCT02824640|Sustained Viral Response|sustained viral response
219061|NCT02824588|Pain|pain
219062|NCT02824588|Working memory|working memory
219063|NCT02824575|breast cancer|breast cancer
219064|NCT02824575|chemotherapy|chemotherapy
219065|NCT02824575|metastasis|metastasis
219066|NCT02824575|tumor micro-environment|tumor micro-environment
219067|NCT02824549|Flash glucose monitoring|flash glucose monitoring
219068|NCT02824549|skin reactions|skin reactions
219069|NCT02824549|usability|usability
219070|NCT02824549|accuracy|accuracy
219071|NCT02824536|3BNC117|3bnc117
219072|NCT02824536|10-1074|10-1074
219073|NCT02824536|Broadly neutralizing antibody|broadly neutralizing antibody
219074|NCT02824536|HIV Prevention|hiv prevention
219075|NCT02824523|asthma|asthma
219076|NCT02824523|nasal polyps|nasal polyps
219077|NCT02824523|aspirin sensitivity|aspirin sensitivity
219078|NCT02824523|AERD|aerd
219079|NCT02824484|Guided written disclosure protocol|guided written disclosure protocol
219080|NCT02824484|Emotional disclosure|emotional disclosure
219081|NCT02824484|Meaning|meaning
219082|NCT02824484|Post-Traumatic Growth|post-traumatic growth
219083|NCT02824484|Cancer|cancer
219084|NCT02824471|Sickle Cell Disease|sickle cell disease
219085|NCT02824471|Biofluidic Chip Technology|biofluidic chip technology
219086|NCT02824458|EGFR tyrosine kinase inhibitors|egfr tyrosine kinase inhibitors
219087|NCT02824458|VEGFR inhibitor|vegfr inhibitor
219088|NCT02824458|NSCLC|nsclc
219089|NCT02824406|Sickle Cell Anemia|sickle cell anemia
219090|NCT02824406|Cerebrovascular Reserve|cerebrovascular reserve
219091|NCT02824406|Perfusion|perfusion
219092|NCT02824406|Vasculopathy|vasculopathy
219093|NCT02824406|Magnetic Resonance Imaging|magnetic resonance imaging
219094|NCT02824393|Mesenchymal stem cell|mesenchymal stem cell
219095|NCT02824393|Chronic autoimmune urticaria|chronic autoimmune urticaria
219096|NCT02824367|Parkinson|parkinson
219097|NCT02824367|Perfectionism|perfectionism
219098|NCT02824341|Parkinson 's disease|parkinson 's disease
219099|NCT02824341|REM sleep behavior disorder|rem sleep behavior disorder
219100|NCT02824341|Reward system|reward system
219101|NCT02824341|Functional MRI|functional mri
219102|NCT02824289|skin cancer|skin cancer
219103|NCT02824289|prevention|prevention
219104|NCT02824289|worksite|worksite
219105|NCT02824289|policy|policy
219106|NCT02824263|obstructive sleep apnea|obstructive sleep apnea
219107|NCT02824263|CPAP|cpap
219108|NCT02824263|metabolism|metabolism
219109|NCT02824250|Migraine|migraine
219110|NCT02824250|Mindfulness|mindfulness
219111|NCT02824250|MBSR|mbsr
219112|NCT02824224|levonorgestrel|levonorgestrel
219113|NCT02824224|breakthrough bleeding|breakthrough bleeding
219114|NCT02824198|Dengue Hemorrhagic Fever|dengue hemorrhagic fever
219115|NCT02824198|Dengue Virus|dengue virus
219116|NCT02824198|CYD Dengue Vaccine|cyd dengue vaccine
219117|NCT02824185|FCH-PET/MRI|fch-pet/mri
219118|NCT02824185|primary HCC|primary hcc
219119|NCT02824185|curative treatment|curative treatment
219120|NCT02824185|resection|resection
219121|NCT02824185|thermo-ablation|thermo-ablation
219122|NCT02824185|transplantation|transplantation
219123|NCT02824172|Cast immobilization|cast immobilization
219124|NCT02824172|Complete rest|complete rest
219125|NCT02824172|Osgood Schlatter|osgood schlatter
219126|NCT02824159|ibrutinib|ibrutinib
219127|NCT02824159|idelalisib|idelalisib
219128|NCT02824159|side effect|side effect
219129|NCT02824159|pharmacokinetic|pharmacokinetic
219130|NCT02824159|plasma balance mean concentration|plasma balance mean concentration
219131|NCT02824146|atelectasis|atelectasis
219132|NCT02824146|children|children
219133|NCT02824146|lung ultrasound|lung ultrasound
219134|NCT02824146|lung recruitment|lung recruitment
219135|NCT02824133|Glioma grade III|glioma grade iii
219136|NCT02824133|Glioma grade IV|glioma grade iv
219137|NCT02824133|Glioma recurrent|glioma recurrent
219138|NCT02824133|IDHwt|idhwt
219139|NCT02824133|FGFR-TACC fusion|fgfr-tacc fusion
219140|NCT02824120|ischemic heart disease|ischemic heart disease
219141|NCT02824120|laugh therapy|laugh therapy
219142|NCT02824094|Expanded Access Protocol|expanded access protocol
219143|NCT02824094|crizotinib|crizotinib
219144|NCT02824094|Xalkori|xalkori
219145|NCT02824094|ROS1|ros1
219146|NCT02824094|Japanese|japanese
219147|NCT02824094|A8081064|a8081064
219148|NCT02824081|Psychiatry|psychiatry
219149|NCT02824081|Depressive disorder|depressive disorder
219150|NCT02824081|Suicide|suicide
219151|NCT02824081|Inflammation|inflammation
219152|NCT02824042|Phase 1|phase 1
219153|NCT02824042|Solid tumors|solid tumors
219154|NCT02824042|Mesothelin|mesothelin
219155|NCT02824042|Itraconazole|itraconazole
219156|NCT02824042|PK DDI|pk ddi
219157|NCT02824042|ECG thorough QTC|ecg thorough qtc
219158|NCT02823977|ketamine|ketamine
219159|NCT02823977|dexmedetomidine|dexmedetomidine
219160|NCT02823977|alcohol|alcohol
219161|NCT02823964|exocrine pancreatic insufficiency|exocrine pancreatic insufficiency
219162|NCT02823964|cystic fibrosis|cystic fibrosis
219259|NCT02823392|pediatric anesthesia|pediatric anesthesia
219163|NCT02823964|pancreatic enzyme replacement therapy|pancreatic enzyme replacement therapy
219164|NCT02823912|Capsaicin|capsaicin
219165|NCT02823912|Dyslipidemia|dyslipidemia
219166|NCT02823912|Inflammatory cytokines|inflammatory cytokines
219167|NCT02823899|cholera vaccine|cholera vaccine
219168|NCT02823899|hikojima serotype|hikojima serotype
219169|NCT02823899|randomized trial|randomized trial
219170|NCT02823899|immunogenicity|immunogenicity
219171|NCT02823886|myocardial infarction|myocardial infarction
219173|NCT02823886|inflammatory biomarkers|inflammatory biomarkers
219174|NCT02823873|Hypertension|hypertension
219175|NCT02823873|Pregnant|pregnant
219176|NCT02823873|Preeclampsia|preeclampsia
219177|NCT02823873|Gestational Hypertension|gestational hypertension
219178|NCT02823873|Blood Pressure|blood pressure
219179|NCT02823873|Pregnant Women|pregnant women
219180|NCT02823873|Postpartum Women|postpartum women
219181|NCT02823860|Peritoneal carcinomatosis|peritoneal carcinomatosis
219182|NCT02823860|Biobanking|biobanking
219183|NCT02823860|Biospecimen research|biospecimen research
219184|NCT02823860|Prospective clinical database|prospective clinical database
219185|NCT02823860|Tissue banking|tissue banking
219186|NCT02823860|Quality of Life|quality of life
219187|NCT02823860|various histological subtypes|various histological subtypes
219188|NCT02823847|Malignant neoplasms of mesothelial and soft tissue|malignant neoplasms of mesothelial and soft tissue
219189|NCT02823847|Human immunodeficiency virus|human immunodeficiency virus
219190|NCT02823847|HIV|hiv
219191|NCT02823847|Carbon monoxide test|carbon monoxide test
219192|NCT02823847|Self-help materials|self-help materials
219193|NCT02823847|Visual Oral Screening Examination|visual oral screening examination
219194|NCT02823847|Direct Fluorescent Oral Visualization Examination|direct fluorescent oral visualization examination
219195|NCT02823847|Oral Biopsy|oral biopsy
219196|NCT02823834|osteoarthritis|osteoarthritis
219197|NCT02823834|avascular necrosis|avascular necrosis
219198|NCT02823834|ankylosis|ankylosis
219199|NCT02823834|protrusio acetabuli|protrusio acetabuli
219200|NCT02823834|painful hip dysplasia|painful hip dysplasia
219201|NCT02823834|rheumatoid arthritis|rheumatoid arthritis
219328|NCT02823028|Social Media|social media
219202|NCT02823834|correction of functional deformity|correction of functional deformity
219203|NCT02823821|End-Stage Kidney Disease|end-stage kidney disease
219204|NCT02823821|Hemodialysis|hemodialysis
219205|NCT02823821|Dialysate|dialysate
219206|NCT02823821|Sodium|sodium
219207|NCT02823821|Cluster-randomisation|cluster-randomisation
219208|NCT02823821|Dialysis|dialysis
219209|NCT02823821|RESOLVE|resolve
219210|NCT02823795|Patient participation|patient participation
219211|NCT02823795|Empowerment|empowerment
219212|NCT02823795|Medication management|medication management
219213|NCT02823795|Symptom management|symptom management
219214|NCT02823795|Self determination theory|self determination theory
219215|NCT02823795|Motivational Interviewing|motivational interviewing
219216|NCT02823782|Laminar HP|laminar hp
219217|NCT02823782|Complex HP|complex hp
219218|NCT02823769|clinical study|clinical study
219219|NCT02823769|dental fillings|dental fillings
219220|NCT02823743|recurrent pregnancy loss, Habitual abortion|recurrent pregnancy loss, habitual abortion
219221|NCT02823704|Sepsis|sepsis
219222|NCT02823704|Chest pain|chest pain
219223|NCT02823704|Abdominal pain|abdominal pain
219224|NCT02823704|Electrolyte disturbances|electrolyte disturbances
219225|NCT02823704|Stroke|stroke
219226|NCT02823704|Triage|triage
219227|NCT02823704|Risk for death|risk for death
219228|NCT02823691|NETs|nets
219229|NCT02823665|gastric bypass surgery|gastric bypass surgery
219230|NCT02823665|Hypoglycemia|hypoglycemia
219231|NCT02823665|sleeve gastrectomy|sleeve gastrectomy
219232|NCT02823665|glucose tolerance|glucose tolerance
219233|NCT02823613|ENaC|enac
219234|NCT02823613|Exosomes|exosomes
219235|NCT02823613|Urinary biomarker|urinary biomarker
219236|NCT02823613|Salt regulation|salt regulation
219237|NCT02823600|retinal screening|retinal screening
219238|NCT02823600|outpatient dialysis|outpatient dialysis
219239|NCT02823587|Bronchiectasis|bronchiectasis
219240|NCT02823587|Mucociliary clearance|mucociliary clearance
219241|NCT02823587|Exercise|exercise
219242|NCT02823587|Inflammation|inflammation
219243|NCT02823535|military|military
219244|NCT02823535|veteran|veteran
219245|NCT02823535|military spouse|military spouse
219246|NCT02823444|Magnetic Resonance Imaging|magnetic resonance imaging
219247|NCT02823444|Magnetic Resonance Angiography|magnetic resonance angiography
219248|NCT02823431|voiding efficiency|voiding efficiency
219249|NCT02823431|detrusor underactivity|detrusor underactivity
219250|NCT02823431|urodynamics|urodynamics
219251|NCT02823418|primipara|primipara
219252|NCT02823418|childbirth|childbirth
219253|NCT02823418|neuraxial labor analgesia|neuraxial labor analgesia
219254|NCT02823418|postpartum depression|postpartum depression
219255|NCT02823405|Advance malignancy|advance malignancy
219256|NCT02823392|unexpected difficult bag mask ventilation|unexpected difficult bag mask ventilation
219257|NCT02823392|difficult intubation|difficult intubation
219258|NCT02823392|predictors|predictors
219260|NCT02823379|physical activity|physical activity
219261|NCT02823379|overweight|overweight
219262|NCT02823379|obese|obese
219263|NCT02823379|exercise|exercise
219264|NCT02823379|women|women
219265|NCT02823379|African American|african american
219266|NCT02823379|Smartphone|smartphone
219267|NCT02823379|cardiovascular disease risk|cardiovascular disease risk
219268|NCT02823366|PBC|pbc
219269|NCT02823366|UDCA|udca
219270|NCT02823366|Fenofibrate|fenofibrate
219271|NCT02823353|PBC|pbc
219272|NCT02823353|UDCA|udca
219273|NCT02823353|Fenofibrate|fenofibrate
219274|NCT02823288|intimate partner violence|intimate partner violence
219275|NCT02823288|masculinity|masculinity
219276|NCT02823288|community mobilization|community mobilization
219277|NCT02823288|social intervention|social intervention
219278|NCT02823288|rape|rape
219279|NCT02823262|Breast Cancer|breast cancer
219280|NCT02823262|Estrogen Receptor Positive Breast Cancer|estrogen receptor positive breast cancer
219281|NCT02823262|Node-negative Breast Cancer|node-negative breast cancer
219282|NCT02823262|Human Epidermal Growth Factor 2 Negative Carcinoma of Breast|human epidermal growth factor 2 negative carcinoma of breast
219283|NCT02823236|Keloid|keloid
219284|NCT02823236|Scar|scar
719430|NCT00550342|children|children
219285|NCT02823223|Endobronchial Valve|endobronchial valve
219286|NCT02823197|determinants|determinants
219287|NCT02823197|active transport|active transport
219288|NCT02823197|intervention|intervention
219289|NCT02823197|adolescents|adolescents
219290|NCT02823184|Myeloproliferative neoplasms|myeloproliferative neoplasms
219291|NCT02823184|Endoplasmic reticulum stress|endoplasmic reticulum stress
219292|NCT02823171|Bioequivalence Study|bioequivalence study
219293|NCT02823171|Healthy subjects|healthy subjects
219294|NCT02823158|Parkinson Disease|parkinson disease
219295|NCT02823158|Morbus Parkinson|morbus parkinson
219296|NCT02823158|Basal Ganglia|basal ganglia
219297|NCT02823158|Pallidal Stimulation|pallidal stimulation
219298|NCT02823145|seizure|seizure
219299|NCT02823145|tonic clonic|tonic clonic
219300|NCT02823145|epilepsy|epilepsy
219301|NCT02823145|myoclonic|myoclonic
219302|NCT02823145|encephalopathy|encephalopathy
219303|NCT02823119|Mini-hysteroscopy|mini-hysteroscopy
219304|NCT02823119|Office hysteroscopy|office hysteroscopy
219305|NCT02823119|Pain|pain
219306|NCT02823093|vascular calcification|vascular calcification
219307|NCT02823093|aortic calcification|aortic calcification
219308|NCT02823093|vitamin K antagonist|vitamin k antagonist
219309|NCT02823093|fluindione|fluindione
219310|NCT02823093|warfarin|warfarin
219311|NCT02823093|matrix gla protein|matrix gla protein
219312|NCT02823067|Pemphigoid|pemphigoid
219313|NCT02823067|Bullous pemphigoid|bullous pemphigoid
219314|NCT02823067|Pruritus|pruritus
219315|NCT02823067|Senile pruritus|senile pruritus
219316|NCT02823067|Neuropsychiatric symptoms|neuropsychiatric symptoms
219317|NCT02823054|elective surgery|elective surgery
219318|NCT02823054|CABG|cabg
219319|NCT02823054|One-lung ventilation|one-lung ventilation
219320|NCT02823054|EZ Blockers|ez blockers
219321|NCT02823054|pleural effusion|pleural effusion
219322|NCT02823041|cognitive training|cognitive training
219323|NCT02823041|aerobic exercise|aerobic exercise
219324|NCT02823041|neurotrophic factors|neurotrophic factors
219325|NCT02823041|randomized controlled trial|randomized controlled trial
219326|NCT02823041|functional outcome|functional outcome
219327|NCT02823028|Smoking|smoking
219329|NCT02823028|Twitter|twitter
219330|NCT02823028|Behavior Change|behavior change
219331|NCT02823028|Social Support|social support
219332|NCT02822989|Lupus Erythematosus, Systemic|lupus erythematosus, systemic
219333|NCT02822989|Musculoskeletal Pain|musculoskeletal pain
219334|NCT02822989|Inflammation|inflammation
219335|NCT02822963|Transurethral resection of the prostate|transurethral resection of the prostate
219336|NCT02822963|Anticoagulants|anticoagulants
219337|NCT02822963|Platelet aggregation inhibitors|platelet aggregation inhibitors
219338|NCT02822911|elderly|elderly
219339|NCT02822911|chronic alcoholism|chronic alcoholism
219340|NCT02822911|Carbohydrate Deficient Transferrin|carbohydrate deficient transferrin
219341|NCT02822911|Biological Detection / Diagnosis|biological detection / diagnosis
219342|NCT02822898|Maintenance|maintenance
219343|NCT02822898|Intravenous solutions|intravenous solutions
219344|NCT02822898|Intravenous fluids|intravenous fluids
219345|NCT02822898|Tonicity|tonicity
219346|NCT02822898|Potassium|potassium
219347|NCT02822898|Sodium|sodium
219348|NCT02822898|Fluid retention|fluid retention
219349|NCT02822872|infertility|infertility
219350|NCT02822872|stress|stress
219351|NCT02822872|scalp hair|scalp hair
219352|NCT02822872|cortisol|cortisol
219353|NCT02822846|Lung ultrasound|lung ultrasound
219354|NCT02822846|Sliding lung|sliding lung
219355|NCT02822846|Probe position|probe position
219356|NCT02822755|Exercise|exercise
219357|NCT02822755|Adherence|adherence
219358|NCT02822755|Physical Therapy|physical therapy
219359|NCT02822703|smoking cessation|smoking cessation
219360|NCT02822703|tobacco use disorder|tobacco use disorder
219361|NCT02822703|delay discounting|delay discounting
219451|NCT02821975|Depression|depression
219362|NCT02822703|repetitive transcranial magnetic stimulation|repetitive transcranial magnetic stimulation
219363|NCT02822703|relapse prevention|relapse prevention
219364|NCT02822690|palliative care|palliative care
219365|NCT02822690|Quality of dying|quality of dying
219366|NCT02822664|Brain, pedophilia, neuroimaging|brain, pedophilia, neuroimaging
219367|NCT02822638|Myocardial infarction|myocardial infarction
219368|NCT02822638|biomarkers|biomarkers
219369|NCT02822638|STEMI|stemi
219370|NCT02822625|Capsaicin|capsaicin
219371|NCT02822625|QUTENZA®|qutenza®
219372|NCT02822625|Hypnosis|hypnosis
219373|NCT02822625|Peripheral Neuropathic|peripheral neuropathic
219374|NCT02822612|optical coherence tomography|optical coherence tomography
219375|NCT02822612|optical imaging|optical imaging
219376|NCT02822612|retinal imaging|retinal imaging
219377|NCT02822599|CBP, congenital heart defects, cardiopulmonary bypass|cbp, congenital heart defects, cardiopulmonary bypass
219378|NCT02822586|CD30-positive|cd30-positive
219379|NCT02822586|Stage IB to Stage IVA|stage ib to stage iva
219380|NCT02822573|Donepezil|donepezil
219381|NCT02822573|Cognition|cognition
219382|NCT02822573|Breast Cancer|breast cancer
219383|NCT02822560|Endovascular Aortic Repair (EVAR)|endovascular aortic repair (evar)
219384|NCT02822560|percutaneous EVAR (pEVAR)|percutaneous evar (pevar)
219385|NCT02822560|cost analysis|cost analysis
219386|NCT02822560|procedure time|procedure time
219387|NCT02822521|Rheumatoid Arthritis|rheumatoid arthritis
219388|NCT02822521|Mobile Health|mobile health
219389|NCT02822521|Pain|pain
219390|NCT02822521|Arthritis|arthritis
219391|NCT02822495|Epstein-Barr Virus (EBV)|epstein-barr virus (ebv)
219392|NCT02822495|Solid Organ Transplant (HCT)|solid organ transplant (hct)
219393|NCT02822495|Hematopoietic Cell Transplant (SOT)|hematopoietic cell transplant (sot)
219394|NCT02822495|Primary Immunodeficiency (PID)|primary immunodeficiency (pid)
219395|NCT02822495|Acquired Immunodeficiency (AID)|acquired immunodeficiency (aid)
219396|NCT02822495|Epstein-Barr Virus-associated Lymphoma|epstein-barr virus-associated lymphoma
219397|NCT02822495|HIV/AIDS Lymphoma|hiv/aids lymphoma
219398|NCT02822495|Rheumatoid Arthritis and Lymphoma|rheumatoid arthritis and lymphoma
219399|NCT02822495|Allogeneic, Off-The-Shelf T-cell Immunotherapy|allogeneic, off-the-shelf t-cell immunotherapy
219400|NCT02822495|Tumor Necrosis Factor (TNF)-alpha Inhibitors and Lymphoma|tumor necrosis factor (tnf)-alpha inhibitors and lymphoma
219401|NCT02822495|Inflammatory Bowel Disease and Lymphoma|inflammatory bowel disease and lymphoma
219402|NCT02822495|Epstein-Barr Virus-specific Cytotoxic T lymphocyte (EBV-CTL)|epstein-barr virus-specific cytotoxic t lymphocyte (ebv-ctl)
219403|NCT02822495|Epstein-Barr Virus+ associated Nasopharyngeal Carcinoma (EBV+ NPC)|epstein-barr virus+ associated nasopharyngeal carcinoma (ebv+ npc)
219404|NCT02822495|Epstein-Barr Virus+ associated Leiomyosarcoma (EBV+ LMS)|epstein-barr virus+ associated leiomyosarcoma (ebv+ lms)
219405|NCT02822469|TMD Infrared Thermography Physical Therapy Modalities|tmd infrared thermography physical therapy modalities
219406|NCT02822456|dysphagia|dysphagia
219407|NCT02822456|intermittent tube|intermittent tube
219408|NCT02822456|individual 3D printed guiding tube|individual 3d printed guiding tube
219409|NCT02822430|Pain|pain
219410|NCT02822430|Psychiatric disorders|psychiatric disorders
219411|NCT02822417|Recover time|recover time
219412|NCT02822404|kidney toxicity|kidney toxicity
219413|NCT02822378|Postmenopausal Osteoporosis|postmenopausal osteoporosis
219414|NCT02822378|Human|human
219415|NCT02822378|Female|female
219416|NCT02822378|Non-pharmacologic therapy|non-pharmacologic therapy
219417|NCT02822326|Leukemia|leukemia
219418|NCT02822326|CART CD19|cart cd19
219419|NCT02822326|Chemotherapy Resistant|chemotherapy resistant
219420|NCT02822326|Chemotherapy Refractory|chemotherapy refractory
219421|NCT02822326|CD19 +|cd19 +
219422|NCT02822326|Lymphoma|lymphoma
219423|NCT02822235|Drug Therapy|drug therapy
219424|NCT02822222|essential hypertension|essential hypertension
219425|NCT02822222|hypertension|hypertension
219426|NCT02822222|high blood pressure|high blood pressure
219427|NCT02822222|cardiovascular diseases|cardiovascular diseases
219428|NCT02822222|RMJH-111b|rmjh-111b
219429|NCT02822222|magnesium|magnesium
219430|NCT02822222|magnesium citrate|magnesium citrate
219431|NCT02822222|calcium channel blockers|calcium channel blockers
219432|NCT02822222|vasodilators|vasodilators
219433|NCT02822222|antihypertensive agents|antihypertensive agents
219434|NCT02822209|coordinating nurse of thoracic oncology|coordinating nurse of thoracic oncology
219435|NCT02822209|quality of care in thoracic oncology|quality of care in thoracic oncology
219436|NCT02822209|lung cancer quality of life|lung cancer quality of life
219437|NCT02822144|ischemic stroke|ischemic stroke
219438|NCT02822144|thrombectomy|thrombectomy
219439|NCT02822144|anesthesia|anesthesia
219440|NCT02822144|sedation|sedation
219441|NCT02822118|IBS-D; Chang'an I Recipe; Placebo|ibs-d; chang'an i recipe; placebo
219442|NCT02822066|Effectivity|effectivity
219443|NCT02822066|safety|safety
219444|NCT02822066|irreversible electroporation|irreversible electroporation
219445|NCT02822066|liver|liver
219446|NCT02822066|pancreas|pancreas
219447|NCT02822053|Ultrasonography-guided Laser Ablation|ultrasonography-guided laser ablation
219448|NCT02822040|Root Resorption|root resorption
219449|NCT02822040|Panoramic Radiograph|panoramic radiograph
219450|NCT02822001|Sugammadex|sugammadex
219452|NCT02821975|Cognitive function|cognitive function
219453|NCT02821975|Work|work
219454|NCT02821962|Sedentary behaviour|sedentary behaviour
219455|NCT02821949|Non Small Cells Lung Cancer|non small cells lung cancer
219456|NCT02821949|Procalcitonin|procalcitonin
219457|NCT02821936|positron emission tomography|positron emission tomography
219458|NCT02821936|parametric imaging|parametric imaging
219459|NCT02821936|lung cancer|lung cancer
219460|NCT02821884|Stroke|stroke
219461|NCT02821884|Transcranial direct current stimulation|transcranial direct current stimulation
219462|NCT02821884|Neuromuscular electrical stimulation|neuromuscular electrical stimulation
219463|NCT02821884|upper extremity motor recovery|upper extremity motor recovery
219464|NCT02821832|Tuberculosis|tuberculosis
219465|NCT02821832|PET/CT Scanning|pet/ct scanning
219466|NCT02821832|Immunological Markers|immunological markers
219467|NCT02821832|4-Month Treatment Completion|4-month treatment completion
219468|NCT02821819|ovarian stimulation|ovarian stimulation
219469|NCT02821819|random|random
219470|NCT02821819|egg donation|egg donation
219471|NCT02821819|antagonist|antagonist
219472|NCT02821819|gnrh agonist trigger|gnrh agonist trigger
219473|NCT02821806|Normal Volunteer|normal volunteer
219474|NCT02821806|Donation|donation
219475|NCT02821806|Adoptive T Cell Therapy|adoptive t cell therapy
219476|NCT02821806|Peripheral Blood Mononuclear Cells|peripheral blood mononuclear cells
219477|NCT02821780|Stroke|stroke
219478|NCT02821780|progressive white matter degeneration, and debilitating dementia.|progressive white matter degeneration, and debilitating dementia.
219479|NCT02821780|progressive chronic hypoperfusion|progressive chronic hypoperfusion
219480|NCT02821780|Biospecimen Procurement|biospecimen procurement
219481|NCT02821780|Laboratory Research Specimens|laboratory research specimens
219482|NCT02821767|Pathogenesis|pathogenesis
219483|NCT02821767|Ocular Disorders|ocular disorders
219484|NCT02821767|Eye|eye
219485|NCT02821767|Eye Diseases|eye diseases
219486|NCT02821754|PDL1-Mediated Adaptive Resistance|pdl1-mediated adaptive resistance
219487|NCT02821754|Monoclonal Antibody|monoclonal antibody
219488|NCT02821754|CTLA-4|ctla-4
219489|NCT02821754|Ablative Therapy|ablative therapy
219490|NCT02821754|Combination of Tremelimumab and Durvalumab|combination of tremelimumab and durvalumab
219491|NCT02821741|Sensory Stimulation|sensory stimulation
219492|NCT02821728|Prostate|prostate
219493|NCT02821728|Sulphate|sulphate
219494|NCT02821728|ATP|atp
219495|NCT02821728|PTEN|pten
219496|NCT02821702|placenta accreta|placenta accreta
219497|NCT02821702|cesarean section|cesarean section
219498|NCT02821702|artery embolization|artery embolization
219499|NCT02821689|Dermatopolymyositis|dermatopolymyositis
219500|NCT02821689|Interstitial lung disease|interstitial lung disease
219501|NCT02821689|Pirfenidone|pirfenidone
219502|NCT02821637|teens|teens
219503|NCT02821637|effort rehabilitation|effort rehabilitation
219504|NCT02821637|quality of life|quality of life
219505|NCT02821637|wellbeing|wellbeing
219506|NCT02821637|physical skills assessment|physical skills assessment
219507|NCT02821611|Student Stress|student stress
219508|NCT02821611|Meditation|meditation
219509|NCT02821611|Sleep Quality|sleep quality
219510|NCT02821611|Blood Pressure|blood pressure
219511|NCT02821559|Colorectal cancer|colorectal cancer
219512|NCT02821559|raltitrexed|raltitrexed
219513|NCT02821559|oxaliplatin|oxaliplatin
219514|NCT02821559|bevacizumab|bevacizumab
219515|NCT02821559|biweekly|biweekly
219516|NCT02821559|triweekly|triweekly
219517|NCT02821520|Polypoidal Choroidal Vasculopathy|polypoidal choroidal vasculopathy
219518|NCT02821520|Photodynamic Therapy|photodynamic therapy
219519|NCT02821520|Conbercept|conbercept
219520|NCT02821520|Efficacy|efficacy
219521|NCT02821520|Safety|safety
219522|NCT02821520|vascular endothelial growth factor|vascular endothelial growth factor
219523|NCT02821494|HPV|hpv
219524|NCT02821494|Vaccination|vaccination
219525|NCT02821494|Immunotherapy|immunotherapy
219526|NCT02821481|Neuromuscular|neuromuscular
219527|NCT02821481|Supplementation|supplementation
219528|NCT02821481|Elderly|elderly
219529|NCT02821455|Isoflurane|isoflurane
219530|NCT02821455|Sevoflurane|sevoflurane
219531|NCT02821455|Bispectral Index|bispectral index
219532|NCT02821455|Pulmonary Surgical Procedures|pulmonary surgical procedures
219533|NCT02821442|Electroacupuncture|electroacupuncture
219534|NCT02821442|Neuropathic Pain|neuropathic pain
219535|NCT02821442|Chemotherapy Induced Peripheral Neuropathy|chemotherapy induced peripheral neuropathy
219536|NCT02821429|Respiratory weaning|respiratory weaning
219537|NCT02821429|Pulmonary ventilation|pulmonary ventilation
219538|NCT02821416|asthma|asthma
219539|NCT02821390|intravitreal injection|intravitreal injection
219540|NCT02821390|pain|pain
219541|NCT02821390|non-steroidal anti-inflammatory drugs|non-steroidal anti-inflammatory drugs
219542|NCT02821390|anti-VEGF|anti-vegf
219543|NCT02821390|nepafenac|nepafenac
219544|NCT02821377|cirrhosis|cirrhosis
219545|NCT02821377|ascites|ascites
219546|NCT02821377|immunology|immunology
219547|NCT02821377|inflammation|inflammation
219548|NCT02821377|nutrition|nutrition
219549|NCT02821351|Afib|afib
219550|NCT02821338|Bioequivalence|bioequivalence
219551|NCT02821338|Lamotrigine Extended Release|lamotrigine extended release
219552|NCT02821338|Generic|generic
219553|NCT02821338|Pharmacokinetic|pharmacokinetic
219554|NCT02821299|Laryngeal transplantation|laryngeal transplantation
219555|NCT02821299|Laryngeal function|laryngeal function
219556|NCT02821299|Swallowing|swallowing
219557|NCT02821299|Voice production|voice production
219558|NCT02821299|Respiration|respiration
219559|NCT02821299|Quality of life|quality of life
219560|NCT02821247|Treatment Naïve Patients|treatment naïve patients
219561|NCT02821234|Insomnia|insomnia
219562|NCT02821234|Hyperarousal|hyperarousal
219563|NCT02821208|Psychogenic nonepileptic seizure, quality of life|psychogenic nonepileptic seizure, quality of life
219564|NCT02821169|sinus surgery|sinus surgery
219565|NCT02821169|sphenopalatin ganglion|sphenopalatin ganglion
219566|NCT02821169|ropivacaine|ropivacaine
219567|NCT02821169|local anesthesia|local anesthesia
219568|NCT02821143|Telemedicine|telemedicine
719431|NCT00550290|vulvectomy|vulvectomy
219569|NCT02821143|Nursing Home|nursing home
219570|NCT02821143|Hospitalization|hospitalization
219571|NCT02821130|Dyspnea|dyspnea
219572|NCT02821130|Exercise|exercise
219573|NCT02821130|Cystic Fibrosis|cystic fibrosis
219574|NCT02821117|Diabetes Mellitus, Paediatric|diabetes mellitus, paediatric
219575|NCT02821117|Sensing Technology|sensing technology
219576|NCT02821104|Complement|complement
219577|NCT02821104|endothelial function|endothelial function
219578|NCT02821104|insulin sensitivity|insulin sensitivity
219579|NCT02821104|adolescents|adolescents
219580|NCT02821104|inflammation|inflammation
219581|NCT02821078|phase-contrast MRI|phase-contrast mri
219582|NCT02821078|blood flow|blood flow
219583|NCT02821078|velocity mapping|velocity mapping
219584|NCT02821078|abdominal imaging|abdominal imaging
219585|NCT02821078|Quantitative MRI|quantitative mri
219586|NCT02821039|Idiopathic Pulmonary Fibrosis, Usual Interstitial Pneumonia|idiopathic pulmonary fibrosis, usual interstitial pneumonia
219587|NCT02821000|PD1|pd1
219588|NCT02821000|PD-1|pd-1
219589|NCT02821000|PDL1|pdl1
219590|NCT02821000|PD-L1|pd-l1
219591|NCT02820987|Septic shock, Beta Lactams, Extended infusion, PK/PD|septic shock, beta lactams, extended infusion, pk/pd
219592|NCT02820961|Breast Neoplasms|breast neoplasms
219593|NCT02820961|Breast Diseases|breast diseases
219594|NCT02820961|Exemestane|exemestane
219595|NCT02820961|Protein Kinase Inhibitors|protein kinase inhibitors
219596|NCT02820961|Aromatase Inhibitors|aromatase inhibitors
219597|NCT02820961|entinostat|entinostat
219598|NCT02820961|Cancer of the Breast|cancer of the breast
219599|NCT02820961|Metastatic Breast Cancer|metastatic breast cancer
219600|NCT02820961|Hormone Receptor Positive Breast Cancer|hormone receptor positive breast cancer
219601|NCT02820961|Estrogen Receptor|estrogen receptor
219602|NCT02820961|ER+ Breast Cancer|er+ breast cancer
219603|NCT02820961|Breast Tumor|breast tumor
219604|NCT02820935|Cytochrome P450|cytochrome p450
219605|NCT02820935|Pharmacokinetics|pharmacokinetics
219606|NCT02820935|CC-220|cc-220
219607|NCT02820935|Healthy Subjects|healthy subjects
219608|NCT02820922|Emergency orthopedic surgery|emergency orthopedic surgery
219609|NCT02820922|anesthesia|anesthesia
219610|NCT02820922|general anesthesia|general anesthesia
219611|NCT02820922|regional anesthesia|regional anesthesia
219612|NCT02820909|ultrasound guidance|ultrasound guidance
219613|NCT02820909|emergency wards|emergency wards
219614|NCT02820909|arterial and venous catheters|arterial and venous catheters
219615|NCT02820909|femoral|femoral
219616|NCT02820909|complications|complications
219617|NCT02820870|Cardiovascular Disease|cardiovascular disease
219618|NCT02820870|Quality Improvement|quality improvement
219619|NCT02820870|Decision Support Tool|decision support tool
219620|NCT02820870|Performance Measurement|performance measurement
219621|NCT02820870|Primary Prevention|primary prevention
219622|NCT02820857|Gastroentero-pancreatic neuroendocrine carcinomas|gastroentero-pancreatic neuroendocrine carcinomas
219623|NCT02820857|Second-line treatment|second-line treatment
219624|NCT02820857|Bevacizumab|bevacizumab
219625|NCT02820857|Folfiri|folfiri
219626|NCT02820844|Overactive bladder|overactive bladder
219627|NCT02820844|Botulinum toxin type A|botulinum toxin type a
219628|NCT02820844|Urinary incontinence|urinary incontinence
219629|NCT02820831|Frail Elderly|frail elderly
219630|NCT02820831|Peripheral Vascular Surgery|peripheral vascular surgery
219631|NCT02820831|Risk Assessment|risk assessment
219632|NCT02820831|Functional status|functional status
219633|NCT02820818|thoracic magnetic resonance imaging|thoracic magnetic resonance imaging
219634|NCT02820818|pulmonary function test|pulmonary function test
219635|NCT02820805|children|children
219636|NCT02820805|dietary carbohydrates|dietary carbohydrates
219637|NCT02820805|solanum tuberosum|solanum tuberosum
219638|NCT02820805|cognition|cognition
219639|NCT02820805|memory|memory
219640|NCT02820805|emotions|emotions
219641|NCT02820805|blood glucose|blood glucose
219642|NCT02820779|Willis|willis
219643|NCT02820779|Intracranial aneurysms|intracranial aneurysms
219644|NCT02820766|Posterior Stabilized Knee|posterior stabilized knee
219645|NCT02820766|Total Knee Arthroscopy|total knee arthroscopy
219646|NCT02820766|Journey II BCS|journey ii bcs
219849|NCT02819674|target organ damage|target organ damage
219647|NCT02820753|Universal Medication Schedule|universal medication schedule
219648|NCT02820753|Health Literacy|health literacy
219649|NCT02820753|Medication adherence|medication adherence
219650|NCT02820740|Epilepsy|epilepsy
219651|NCT02820740|Medial Temporal Lobe Epilepsy|medial temporal lobe epilepsy
219652|NCT02820740|Seizure|seizure
219653|NCT02820740|NeuroBlate|neuroblate
219654|NCT02820740|LITT|litt
219655|NCT02820740|Quality of Life|quality of life
219656|NCT02820701|Osteopathic Manipulation|osteopathic manipulation
219657|NCT02820701|Somatic Dysfunction|somatic dysfunction
219658|NCT02820701|Musculoskeletal Ultrasound|musculoskeletal ultrasound
219659|NCT02820688|Local Anesthtetics|local anesthtetics
219660|NCT02820688|Nerve Block|nerve block
219661|NCT02820688|Bupivacaine|bupivacaine
219662|NCT02820688|Prilocaine|prilocaine
219663|NCT02820675|quality improvement|quality improvement
219664|NCT02820675|routine data|routine data
219665|NCT02820675|risk adjustment|risk adjustment
219666|NCT02820675|sepsis, severe sepsis, septic shock|sepsis, severe sepsis, septic shock
219667|NCT02820675|quality of coding|quality of coding
219668|NCT02820649|Exercise training|exercise training
219669|NCT02820649|Endothelial function|endothelial function
219670|NCT02820623|implementation|implementation
219671|NCT02820623|fidelity|fidelity
219672|NCT02820623|cognitive behavioral therapy|cognitive behavioral therapy
219673|NCT02820558|Neuropeptide|neuropeptide
219674|NCT02820558|Therapy|therapy
219675|NCT02820558|Onset|onset
219676|NCT02820545|patient safety culture|patient safety culture
219677|NCT02820545|hospital|hospital
219678|NCT02820545|patient perception|patient perception
219679|NCT02820545|healthcare professional perception|healthcare professional perception
219680|NCT02820545|sociological|sociological
219681|NCT02820545|qualitative|qualitative
219682|NCT02820545|questionnaire construct|questionnaire construct
219683|NCT02820545|psychometrics|psychometrics
219684|NCT02820519|Neuropathic pain|neuropathic pain
219685|NCT02820519|Loxapine|loxapine
219686|NCT02820519|Antipsychotics|antipsychotics
219687|NCT02820519|Co-Analgesics|co-analgesics
219688|NCT02820519|Tolerability|tolerability
219689|NCT02820519|Analgesic efficacy|analgesic efficacy
219690|NCT02820506|robotic surgery procedures|robotic surgery procedures
219691|NCT02820506|indocyanine green|indocyanine green
219692|NCT02820506|sentinel lymph node mapping|sentinel lymph node mapping
219693|NCT02820480|stroke|stroke
219694|NCT02820480|rehabilitation|rehabilitation
219695|NCT02820480|robotics|robotics
219696|NCT02820480|cerebral palsy|cerebral palsy
219697|NCT02820480|therapy|therapy
219698|NCT02820467|Indocyanine|indocyanine
219699|NCT02820467|Angiography|angiography
219700|NCT02820467|Ischemia|ischemia
219701|NCT02820454|AGuIX|aguix
219702|NCT02820454|polysiloxane gadolinium-chelates based nanoparticles|polysiloxane gadolinium-chelates based nanoparticles
219703|NCT02820415|aneuploidy|aneuploidy
219704|NCT02820415|next generation sequencing|next generation sequencing
219705|NCT02820415|oocyte vitrification|oocyte vitrification
219706|NCT02820415|preimplantation genetic diagnosis|preimplantation genetic diagnosis
219707|NCT02820415|preimplantation genetic screening|preimplantation genetic screening
219708|NCT02820402|Pregnancy|pregnancy
219709|NCT02820402|Obesity|obesity
219710|NCT02820402|Diet|diet
219711|NCT02820402|Maternal/child health|maternal/child health
219712|NCT02820402|Asthma/allergy|asthma/allergy
219713|NCT02820402|Air pollution|air pollution
219714|NCT02820402|Epigenetics|epigenetics
219715|NCT02820402|Cognition/behavior|cognition/behavior
219716|NCT02820376|4D computed tomography|4d computed tomography
219717|NCT02820376|Kidney function tests|kidney function tests
219718|NCT02820376|Living Donors|living donors
219719|NCT02820363|wound|wound
219720|NCT02820363|open fracture|open fracture
219721|NCT02820363|fracture|fracture
219722|NCT02820363|tibial|tibial
219723|NCT02820350|Acute Renal Failure|acute renal failure
219724|NCT02820350|Acute kidney injury|acute kidney injury
219725|NCT02820350|Continuous Renal Replacement Therapy|continuous renal replacement therapy
219726|NCT02820350|Selective cytopheretic device|selective cytopheretic device
219727|NCT02820350|Pediatric|pediatric
219728|NCT02820311|Thorough QT (TQT)|thorough qt (tqt)
219729|NCT02820311|cardiac safety|cardiac safety
219730|NCT02820272|Cold water|cold water
219731|NCT02820272|Negative pressure wound therapy|negative pressure wound therapy
219732|NCT02820272|pain|pain
219733|NCT02820246|nutrition assessment|nutrition assessment
219734|NCT02820246|nutrition therapy|nutrition therapy
219735|NCT02820246|nutrition surveys|nutrition surveys
219736|NCT02820246|patient outcome assessment|patient outcome assessment
219737|NCT02820246|outcome and process assessment|outcome and process assessment
219738|NCT02820246|benchmarking|benchmarking
219739|NCT02820246|risk assessment|risk assessment
219740|NCT02820246|scoring system|scoring system
219741|NCT02820220|Knowledge|knowledge
219742|NCT02820220|Programs|programs
219743|NCT02820220|Patients|patients
219744|NCT02820220|Students|students
219745|NCT02820220|Nurses|nurses
219746|NCT02820207|Carotid Artery Plaque|carotid artery plaque
219747|NCT02820207|Contrast Enhanced Ultrasound|contrast enhanced ultrasound
219748|NCT02820207|Plague Histopathology|plague histopathology
219749|NCT02820181|tracheostomy ties|tracheostomy ties
219750|NCT02820168|Designing|designing
219751|NCT02820168|Patient-Oriented|patient-oriented
219752|NCT02820168|Prescriptions|prescriptions
219753|NCT02820155|Alzheimer's disease,cognitive function|alzheimer's disease,cognitive function
219754|NCT02820142|biomarker|biomarker
219755|NCT02820142|Renal Function|renal function
219756|NCT02820129|polypharmacy|polypharmacy
219757|NCT02820129|wallet card|wallet card
219758|NCT02820129|medication|medication
219759|NCT02820129|self-efficacy|self-efficacy
219760|NCT02820129|patient enablement|patient enablement
219761|NCT02820103|Patient delay|patient delay
720275|NCT00545974|dementia|dementia
219762|NCT02820103|Behaviour change|behaviour change
219763|NCT02820103|Intervention Modelling Experiment|intervention modelling experiment
219764|NCT02820090|Inflammatory Factor|inflammatory factor
219765|NCT02820090|Mechanical Ventilation|mechanical ventilation
219766|NCT02820077|Endoscopy, Gastrointestinal|endoscopy, gastrointestinal
219767|NCT02820051|bronchoscopy|bronchoscopy
219768|NCT02820051|conscious sedation|conscious sedation
219769|NCT02820051|midazolam|midazolam
219770|NCT02820051|patient comfort|patient comfort
219771|NCT02820051|propofol|propofol
219772|NCT02820012|Scoliosis|scoliosis
219773|NCT02820012|ST2R|st2r
219774|NCT02819986|occupational functioning|occupational functioning
219775|NCT02819986|Worries|worries
219776|NCT02819986|Pain|pain
219777|NCT02819986|Disability|disability
219778|NCT02819973|Patient Education|patient education
219779|NCT02819973|ICD|icd
219780|NCT02819973|Implantable Cardioverter Defibrillator|implantable cardioverter defibrillator
219781|NCT02819973|Video|video
219782|NCT02819973|Decision|decision
219783|NCT02819973|Decision making|decision making
219784|NCT02819960|probiotics|probiotics
219785|NCT02819960|irinotecan|irinotecan
219786|NCT02819960|diarrhea|diarrhea
219787|NCT02819960|Lactobacillus rhamnosus|lactobacillus rhamnosus
219788|NCT02819960|Bifidobacterium animalis|bifidobacterium animalis
219789|NCT02819960|prevention|prevention
219790|NCT02819960|chemotherapy|chemotherapy
219791|NCT02819947|systemic sclerosis|systemic sclerosis
219792|NCT02819947|cohort|cohort
219793|NCT02819947|Korean|korean
219794|NCT02819921|Hot Flashes|hot flashes
219795|NCT02819921|Breast Neoplasms|breast neoplasms
219796|NCT02819921|Tamoxifen|tamoxifen
219797|NCT02819921|Desvenlafaxine Succinate|desvenlafaxine succinate
219798|NCT02819895|Phone Appointment Reminder|phone appointment reminder
219799|NCT02819895|Immunization Rates|immunization rates
219800|NCT02819895|mHealth|mhealth
219801|NCT02819882|Unresectable|unresectable
219802|NCT02819882|locally|locally
219803|NCT02819882|advanced|advanced
219804|NCT02819882|metastatic disease|metastatic disease
219805|NCT02819856|Ebselen|ebselen
219806|NCT02819856|Tinnitus|tinnitus
219807|NCT02819856|Hearing Loss|hearing loss
219808|NCT02819856|Vertigo|vertigo
219809|NCT02819856|Cystic Fibrosis|cystic fibrosis
219810|NCT02819856|Pulmonary Exacerbation|pulmonary exacerbation
219811|NCT02819856|Tobramycin|tobramycin
219812|NCT02819856|Safety|safety
219813|NCT02819856|Pharmacokinetics|pharmacokinetics
219814|NCT02819856|Pharmacodynamics|pharmacodynamics
219815|NCT02819856|Aminoglycoside|aminoglycoside
219816|NCT02819856|SPI-1005|spi-1005
219817|NCT02819856|Efficacy|efficacy
219818|NCT02819856|Pharmacogenomics|pharmacogenomics
219819|NCT02819856|Ototoxicity|ototoxicity
219820|NCT02819843|T-VEC (Talimogene Laherparepvec)|t-vec (talimogene laherparepvec)
219821|NCT02819843|Radiotherapy|radiotherapy
219822|NCT02819843|16-224|16-224
219823|NCT02819830|Aerobic exercise|aerobic exercise
219824|NCT02819830|Strength training|strength training
219825|NCT02819830|Inflammation|inflammation
219826|NCT02819830|cardiovascular disease|cardiovascular disease
219827|NCT02819817|Aloe Vera, wound, healing|aloe vera, wound, healing
219828|NCT02819791|Cardiovascular|cardiovascular
219829|NCT02819791|therapeutic education|therapeutic education
219830|NCT02819778|Diagnosis|diagnosis
219831|NCT02819778|Craniocerebral Trauma|craniocerebral trauma
219832|NCT02819778|Pediatrics|pediatrics
219833|NCT02819778|S100B|s100b
219834|NCT02819778|mild traumatic brain injury|mild traumatic brain injury
219835|NCT02819752|squamous cell carcinoma|squamous cell carcinoma
219836|NCT02819752|squamous cell carcinoma of the head and neck|squamous cell carcinoma of the head and neck
219837|NCT02819726|an inadquate response to anti -TNF therapy|an inadquate response to anti -tnf therapy
219838|NCT02819713|Prostate Biopsy|prostate biopsy
219839|NCT02819713|NRS-score|nrs-score
219840|NCT02819713|instillagel|instillagel
219841|NCT02819713|ultrasound conductive gel|ultrasound conductive gel
219842|NCT02819700|behavioural disorders|behavioural disorders
219843|NCT02819687|Phase I|phase i
219844|NCT02819687|Healthy|healthy
219845|NCT02819687|Pharmacokinetics|pharmacokinetics
219846|NCT02819687|Pharmacodynamics|pharmacodynamics
219847|NCT02819674|hypertension|hypertension
219848|NCT02819674|early onset|early onset
220202|NCT02817607|Sensation|sensation
219850|NCT02819661|Elective Caesarean Section|elective caesarean section
219851|NCT02819661|obese women|obese women
219852|NCT02819661|BMI≥30|bmi≥30
219853|NCT02819661|spinal anesthesia combined with intrathecal morphine|spinal anesthesia combined with intrathecal morphine
219854|NCT02819648|symptomatic|symptomatic
219855|NCT02819648|irreversible|irreversible
219856|NCT02819635|Upadacitinib (ABT-494)|upadacitinib (abt-494)
219857|NCT02819635|Moderately to Severely Active UC|moderately to severely active uc
219858|NCT02819570|early-onset neonatal sepsis|early-onset neonatal sepsis
219859|NCT02819570|Prophylactic antibiotics|prophylactic antibiotics
219860|NCT02819570|Pregnancy|pregnancy
219861|NCT02819570|PPROM|pprom
219862|NCT02819570|EOS|eos
219863|NCT02819544|Digestive System|digestive system
219864|NCT02819531|Coronary Atherectomy|coronary atherectomy
219865|NCT02819531|percutaneous coronary intervention|percutaneous coronary intervention
219866|NCT02819518|Programmed Cell Death-1 (PD1, PD-1)|programmed cell death-1 (pd1, pd-1)
219867|NCT02819518|Programmed Death-Ligand 1 (PDL1, PD-L1)|programmed death-ligand 1 (pdl1, pd-l1)
219868|NCT02819505|beta-alanine|beta-alanine
219869|NCT02819505|carnosine|carnosine
219870|NCT02819505|neuromuscular|neuromuscular
219871|NCT02819505|stimulation|stimulation
219872|NCT02819505|skeletal muscle|skeletal muscle
219873|NCT02819492|Adenoma|adenoma
219874|NCT02819492|Colonoscopy|colonoscopy
219875|NCT02819492|Withdrawal|withdrawal
219876|NCT02819492|Proximal|proximal
219877|NCT02819492|Observation Time|observation time
219878|NCT02819479|Radiation necrosis|radiation necrosis
219879|NCT02819479|Radiation adverse event|radiation adverse event
219880|NCT02819479|Intra-arterial chemotherapy|intra-arterial chemotherapy
219881|NCT02819479|Bevacizumab|bevacizumab
219882|NCT02819479|Blood brain barrier disruption|blood brain barrier disruption
219883|NCT02819479|Blood brain barrier breakdown|blood brain barrier breakdown
219884|NCT02819466|intragastric volume|intragastric volume
219885|NCT02819466|stomach|stomach
219886|NCT02819466|fasting|fasting
219887|NCT02819453|Corticosteroid|corticosteroid
219888|NCT02819427|Spectroscopy, Near-Infrared|spectroscopy, near-infrared
219889|NCT02819427|Electroencephalography|electroencephalography
219890|NCT02819427|children|children
219891|NCT02819388|randomized control trial; contraception; inequalities|randomized control trial; contraception; inequalities
219892|NCT02819375|propofol|propofol
219893|NCT02819375|ketamine|ketamine
219894|NCT02819375|remifentanil|remifentanil
219895|NCT02819349|Relapse Prevention|relapse prevention
219896|NCT02819349|People with Schizophrenia|people with schizophrenia
219897|NCT02819349|Text-Messaging|text-messaging
219898|NCT02819349|Assertive Community Treatment (ACT)|assertive community treatment (act)
219899|NCT02819336|urinary incontinence|urinary incontinence
219900|NCT02819336|electroacupuncture|electroacupuncture
219901|NCT02819336|stroke|stroke
219902|NCT02819336|complications|complications
219903|NCT02819336|randomized controlled trial|randomized controlled trial
219904|NCT02819336|pilot projects|pilot projects
219905|NCT02819284|Ocular Discomfort|ocular discomfort
219906|NCT02819284|Pain|pain
219907|NCT02819284|Corticosteroid|corticosteroid
219908|NCT02819284|Hyperemia|hyperemia
219909|NCT02819284|Dry Eye|dry eye
219910|NCT02819219|Dietary Supplements|dietary supplements
219911|NCT02819219|Exercise|exercise
219912|NCT02819193|Breastfeeding|breastfeeding
219913|NCT02819193|mother's milk|mother's milk
219914|NCT02819193|breast milk|breast milk
219915|NCT02819193|raw milk|raw milk
219916|NCT02819193|neonate|neonate
219917|NCT02819193|Neonatal intensive care unit (NICU)|neonatal intensive care unit (nicu)
219918|NCT02819180|Influenza|influenza
219919|NCT02819167|ischemic stroke|ischemic stroke
219920|NCT02819167|brain reserve|brain reserve
219921|NCT02819167|cognitive reserve|cognitive reserve
219922|NCT02819167|cognitive prognosis|cognitive prognosis
219923|NCT02819115|Influenza|influenza
219924|NCT02819089|anterior cervical spine surgery|anterior cervical spine surgery
219925|NCT02819089|ACDF|acdf
219926|NCT02819089|Dexmedetomidine|dexmedetomidine
219927|NCT02819089|Anesthesia|anesthesia
219928|NCT02819089|Agitation|agitation
219929|NCT02819089|Riker sedation agitation scores|riker sedation agitation scores
219930|NCT02819050|CPAP|cpap
219931|NCT02819050|Extremely Low Birth Weight Infant (ELBW)|extremely low birth weight infant (elbw)
219932|NCT02819050|Non-invasive respiratory support|non-invasive respiratory support
219933|NCT02819050|Premature infants|premature infants
219934|NCT02819050|Non invasive ventilation weaning|non invasive ventilation weaning
219935|NCT02819037|Gastric bypass|gastric bypass
219936|NCT02819037|Intestinal Bacterial Overgrowth Syndrome|intestinal bacterial overgrowth syndrome
219937|NCT02819037|Gas chromatography|gas chromatography
219938|NCT02819011|Ankle Foot Orthoses|ankle foot orthoses
219939|NCT02819011|falls|falls
219940|NCT02819011|Fall Prevention|fall prevention
219941|NCT02819011|Frailty|frailty
219942|NCT02819011|Concern for falls|concern for falls
219943|NCT02819011|Footwear|footwear
219944|NCT02819011|Mobility|mobility
219945|NCT02818998|Diabetic macular edema|diabetic macular edema
219946|NCT02818998|DME|dme
219947|NCT02818959|Aortic Valve Disease|aortic valve disease
219948|NCT02818959|Aortic Valve Replacement|aortic valve replacement
219949|NCT02818959|Transcatheter|transcatheter
219950|NCT02818959|Transfemoral|transfemoral
219951|NCT02818959|Aortic Stenosis|aortic stenosis
219952|NCT02818946|MRI|mri
219953|NCT02818946|Spontaneous Nipple Discharge|spontaneous nipple discharge
219954|NCT02818946|Breast Cancer|breast cancer
219955|NCT02818933|24-hour diet recall|24-hour diet recall
219956|NCT02818933|Adolescents|adolescents
219957|NCT02818933|Web-based diet recall|web-based diet recall
219958|NCT02818920|Pembrolizumab|pembrolizumab
219959|NCT02818920|Neoadjuvant|neoadjuvant
720976|NCT00543647|creatinine|creatinine
219960|NCT02818920|Tumor Infiltrating Lymphocytes (TILs)|tumor infiltrating lymphocytes (tils)
219961|NCT02818894|THA, Hip Replacement, Spinal Anesthesia|tha, hip replacement, spinal anesthesia
219962|NCT02818894|Total hip arthroplasty|total hip arthroplasty
219963|NCT02818894|anterior total hip replacement|anterior total hip replacement
219964|NCT02818881|aerobic|aerobic
219965|NCT02818881|muscle activity|muscle activity
219966|NCT02818881|energy expenditure|energy expenditure
219967|NCT02818855|Root coverage|root coverage
219968|NCT02818855|Gingival recession|gingival recession
219969|NCT02818855|Plastic surgery|plastic surgery
219970|NCT02818855|Connective tissue graft|connective tissue graft
219971|NCT02818855|Mucograft|mucograft
219972|NCT02818842|Database|database
219973|NCT02818842|Birth defects|birth defects
219974|NCT02818842|Neonatal pathologies|neonatal pathologies
219975|NCT02818829|Adenocarcinoma|adenocarcinoma
219976|NCT02818829|Endoscopic ultrasonography|endoscopic ultrasonography
219977|NCT02818829|Fine-needle aspiration|fine-needle aspiration
219978|NCT02818829|Biomarkers|biomarkers
219979|NCT02818829|Epidemiology|epidemiology
219980|NCT02818829|DNA tumors|dna tumors
219981|NCT02818816|Brimonidine tartrate|brimonidine tartrate
219982|NCT02818816|Intraocular pressure|intraocular pressure
219983|NCT02818816|Prostate Cancer|prostate cancer
219984|NCT02818816|Prostatectomy|prostatectomy
219985|NCT02818803|propolis|propolis
219986|NCT02818803|therapeutic|therapeutic
219987|NCT02818803|miconazole|miconazole
219988|NCT02818803|denture stomatitis|denture stomatitis
219989|NCT02818790|mHealth|mhealth
219990|NCT02818790|Motivational Interviewing|motivational interviewing
219991|NCT02818790|Obesity|obesity
219992|NCT02818790|Prevention|prevention
219993|NCT02818790|Diet|diet
219994|NCT02818790|Physical Activity|physical activity
219995|NCT02818790|Health Preventive System|health preventive system
219996|NCT02818777|Parkinson's Disease|parkinson's disease
219997|NCT02818777|Tremor|tremor
219998|NCT02818777|tolerability|tolerability
219999|NCT02818777|safety|safety
220000|NCT02818777|cognition|cognition
220001|NCT02818777|anxiety|anxiety
220002|NCT02818777|psychosis|psychosis
220003|NCT02818777|mood|mood
220004|NCT02818777|dyskinesia|dyskinesia
220005|NCT02818777|cannabidiol|cannabidiol
220006|NCT02818777|cannabis|cannabis
220007|NCT02818777|efficacy|efficacy
220008|NCT02818777|sleep|sleep
220009|NCT02818777|motor symptoms|motor symptoms
220010|NCT02818777|non-motor symptoms|non-motor symptoms
220011|NCT02818777|quality of life|quality of life
220012|NCT02818777|marijuana|marijuana
220013|NCT02818764|serum biomarkers|serum biomarkers
220014|NCT02818764|cerebral blood flow|cerebral blood flow
220015|NCT02818764|modified Blessed Dementia Rating scale|modified blessed dementia rating scale
220016|NCT02818764|Confusion Assessment Method|confusion assessment method
220017|NCT02818764|Delirium Rating Scale-98|delirium rating scale-98
220018|NCT02818751|Anxiety|anxiety
220019|NCT02818751|Adolescents with Anxiety|adolescents with anxiety
220020|NCT02818738|Idiopathic nephrotic syndrome|idiopathic nephrotic syndrome
220021|NCT02818738|Steroid sensitive nephrotic syndrome|steroid sensitive nephrotic syndrome
220022|NCT02818738|Levamisole|levamisole
220023|NCT02818738|Prednisone|prednisone
220024|NCT02818738|Children|children
220025|NCT02818686|Ulcerative Colitis, Active Moderate and Severe|ulcerative colitis, active moderate and severe
220026|NCT02818673|diagnostic performances|diagnostic performances
220027|NCT02818673|ascites|ascites
220028|NCT02818647|tonsillectomy|tonsillectomy
220029|NCT02818647|electrocautery|electrocautery
220030|NCT02818647|postoperative pain|postoperative pain
220031|NCT02818647|visual analogue scale|visual analogue scale
220032|NCT02818608|Cerebrovascular Accident|cerebrovascular accident
220033|NCT02818608|Cerebrovascular Stroke|cerebrovascular stroke
220034|NCT02818608|Cerebral Stroke|cerebral stroke
220035|NCT02818595|voice recognition|voice recognition
220036|NCT02818582|Liberia|liberia
220037|NCT02818582|Guinea|guinea
220038|NCT02818504|obesity|obesity
220039|NCT02818504|dysglycemia|dysglycemia
220040|NCT02818504|hypercholesterolemia|hypercholesterolemia
220041|NCT02818504|lifestyle|lifestyle
220042|NCT02818504|smoking|smoking
220043|NCT02818504|physical activity|physical activity
220044|NCT02818439|Old person|old person
220045|NCT02818426|cancer immunotherapy|cancer immunotherapy
220046|NCT02818426|CD4 T lymphocyte helper|cd4 t lymphocyte helper
220047|NCT02818426|telomerase|telomerase
220048|NCT02818413|Stool microbiome|stool microbiome
220049|NCT02818413|Stool metabolome|stool metabolome
220050|NCT02818413|Single nucleotide polymorphisms|single nucleotide polymorphisms
220051|NCT02818400|maxillofacial surgery|maxillofacial surgery
220052|NCT02818400|face graft|face graft
220053|NCT02818400|composite tissue|composite tissue
220054|NCT02818400|stem cell infusion|stem cell infusion
220055|NCT02818400|allotransplantation|allotransplantation
220056|NCT02818400|microsurgery|microsurgery
220057|NCT02818387|propofol|propofol
220058|NCT02818387|midazolam|midazolam
220059|NCT02818387|remifentanil|remifentanil
220060|NCT02818387|combination|combination
220061|NCT02818387|synergic|synergic
220062|NCT02818387|pharmacodynamics|pharmacodynamics
220063|NCT02818387|Loss of consciousness|loss of consciousness
220064|NCT02818361|Rheumatoid Arthritis|rheumatoid arthritis
220065|NCT02818361|Tripterygium wilfordii Hook F|tripterygium wilfordii hook f
220066|NCT02818361|double-blinded|double-blinded
220067|NCT02818361|randomized controlled trial|randomized controlled trial
220068|NCT02818361|Tripterygium|tripterygium
220069|NCT02818361|Administration|administration
220070|NCT02818361|Topical|topical
220071|NCT02818348|HIV infection|hiv infection
220072|NCT02818348|Darunavir/cobicistat|darunavir/cobicistat
220073|NCT02818348|Etravirine, drug-drug interactions|etravirine, drug-drug interactions
220074|NCT02818348|Population PK analysis|population pk analysis
220075|NCT02818296|Intolerance of uncertainty|intolerance of uncertainty
220076|NCT02818296|Anxiety|anxiety
220077|NCT02818283|Human Immunodeficiency Virus|human immunodeficiency virus
220078|NCT02818283|hypercholesterolemia|hypercholesterolemia
220079|NCT02818283|pretzels|pretzels
220080|NCT02818283|nutritional study|nutritional study
220081|NCT02818283|dietary soy|dietary soy
220082|NCT02818283|antiretroviral therapy|antiretroviral therapy
220083|NCT02818244|commercial heart monitors|commercial heart monitors
220084|NCT02818244|accuracy|accuracy
220085|NCT02818244|EKG|ekg
220086|NCT02818244|varying degrees of exertion|varying degrees of exertion
220087|NCT02818166|magnetic resonance|magnetic resonance
220088|NCT02818166|right mini-thoracotomy|right mini-thoracotomy
220089|NCT02818153|Allergic rhinitis|allergic rhinitis
220090|NCT02818140|Postoperative pain|postoperative pain
220091|NCT02818140|Transmuscular quadratus lumborum block|transmuscular quadratus lumborum block
220092|NCT02818140|Block|block
220093|NCT02818140|Ropivacaine|ropivacaine
220094|NCT02818140|TQL|tql
220095|NCT02818140|percutaneous nephrolithotomy|percutaneous nephrolithotomy
220096|NCT02818140|PNL|pnl
220097|NCT02818140|Ultrasound-guided|ultrasound-guided
220098|NCT02818114|PTSD|ptsd
220099|NCT02818114|Prolonged Exposure|prolonged exposure
220100|NCT02818114|Peer Support|peer support
220101|NCT02818075|Peer support|peer support
220102|NCT02818075|Postpartum Depression|postpartum depression
220103|NCT02818075|Adolescent Pregnancy|adolescent pregnancy
220104|NCT02818062|Endophthalmitis|endophthalmitis
220105|NCT02818062|Cytokines|cytokines
220106|NCT02818062|Chemokines|chemokines
220107|NCT02818062|Inflammation|inflammation
220108|NCT02818062|Regulation|regulation
220109|NCT02818049|Bronchioalveolar Lavage|bronchioalveolar lavage
220110|NCT02818010|physical activity|physical activity
220111|NCT02818010|chronic kidney disease|chronic kidney disease
220112|NCT02818010|nephrology|nephrology
220113|NCT02818010|stage 3|stage 3
220114|NCT02818010|stage 4|stage 4
220115|NCT02818010|stage 5|stage 5
220116|NCT02817997|patient registry|patient registry
220117|NCT02817997|ACCELERATE study|accelerate study
220118|NCT02817997|CD|cd
220119|NCT02817997|MCD|mcd
220120|NCT02817997|iMCD|imcd
220121|NCT02817997|Castleman|castleman
220122|NCT02817997|Castleman's Disease|castleman's disease
220123|NCT02817997|Angiofollicular Lymph Hyperplasia|angiofollicular lymph hyperplasia
220124|NCT02817997|multicentric Castleman's disease|multicentric castleman's disease
220125|NCT02817997|multicentric Castleman disease|multicentric castleman disease
220126|NCT02817984|Abdominoplasty|abdominoplasty
220127|NCT02817971|feedback|feedback
220128|NCT02817971|pneumonia|pneumonia
220129|NCT02817971|quality of care|quality of care
220130|NCT02817958|inguinal lymph nodes|inguinal lymph nodes
220131|NCT02817958|penile cancer|penile cancer
220132|NCT02817958|squamous|squamous
220133|NCT02817958|TIP chemotherapy|tip chemotherapy
220134|NCT02817945|TATE-RGD|tate-rgd
220135|NCT02817945|SSTR2|sstr2
220136|NCT02817945|integrin αvβ3|integrin αvβ3
220137|NCT02817919|Pharmacovigilance|pharmacovigilance
220138|NCT02817919|Africa|africa
220139|NCT02817893|∆POP: variation of the plethysmographic waveform of pulse oximetry|∆pop: variation of the plethysmographic waveform of pulse oximetry
220140|NCT02817893|∆PP: pulse pressure variation|∆pp: pulse pressure variation
220141|NCT02817893|pulse oximetry plethysmographic|pulse oximetry plethysmographic
220142|NCT02817893|abdominal surgery|abdominal surgery
220143|NCT02817880|rTMS, tDCS, tsDCS, pain, algoneurodystrophy , neurostimulation|rtms, tdcs, tsdcs, pain, algoneurodystrophy , neurostimulation
220144|NCT02817841|Estetrol|estetrol
220145|NCT02817841|Drospirenone|drospirenone
220146|NCT02817841|Prevention of pregnancy|prevention of pregnancy
220147|NCT02817841|Oral contraception|oral contraception
220148|NCT02817828|Estetrol|estetrol
220149|NCT02817815|Atrial fibrillation, blood platelet|atrial fibrillation, blood platelet
220150|NCT02817802|Registry|registry
220151|NCT02817802|Magmaris|magmaris
220152|NCT02817802|Coronary Artery Disease|coronary artery disease
220153|NCT02817802|PCI|pci
220154|NCT02817789|TAVI|tavi
220155|NCT02817789|Antiplatelet agent|antiplatelet agent
220156|NCT02817789|Ticagrelor|ticagrelor
220157|NCT02817789|Cerebrovascular events|cerebrovascular events
220158|NCT02817776|Interventional|interventional
220159|NCT02817776|Radiofrequency Ablation|radiofrequency ablation
220160|NCT02817776|Persistent Atrial Fibrillation|persistent atrial fibrillation
220161|NCT02817750|volunteers|volunteers
220162|NCT02817750|Pharmacokinetics|pharmacokinetics
220163|NCT02817724|Breast Neoplasms|breast neoplasms
220164|NCT02817724|survivor|survivor
220165|NCT02817724|occupational therapy|occupational therapy
220166|NCT02817724|mobile applications|mobile applications
220167|NCT02817724|Quality of Life|quality of life
220168|NCT02817711|infection|infection
220169|NCT02817711|bone and joint infection|bone and joint infection
220170|NCT02817711|relapse|relapse
220171|NCT02817711|adverse event|adverse event
220172|NCT02817698|smoking|smoking
220173|NCT02817698|cannabis|cannabis
220174|NCT02817698|cocaine|cocaine
220175|NCT02817685|surveillance|surveillance
220176|NCT02817685|hepatocellular carcinoma|hepatocellular carcinoma
220177|NCT02817685|ultrasound|ultrasound
220178|NCT02817685|cirrhosis|cirrhosis
220179|NCT02817685|chronic hepatitis B|chronic hepatitis b
220180|NCT02817672|Human|human
220181|NCT02817672|Mental Disorders|mental disorders
220182|NCT02817672|intervention|intervention
220183|NCT02817672|digital health|digital health
220184|NCT02817659|Glucagon|glucagon
220185|NCT02817646|Intensive Care Unit|intensive care unit
220186|NCT02817646|Critical Illness|critical illness
220187|NCT02817646|Body composition|body composition
220188|NCT02817646|Protein nutrition|protein nutrition
220189|NCT02817633|Antibodies|antibodies
220190|NCT02817633|TSR-022|tsr-022
220191|NCT02817633|Advanced solid tumors|advanced solid tumors
220192|NCT02817633|Metastatic solid tumors|metastatic solid tumors
220193|NCT02817633|Immunotherapy|immunotherapy
220194|NCT02817633|PD-1|pd-1
220195|NCT02817633|Anti-PD-1|anti-pd-1
220196|NCT02817633|colorectal cancer|colorectal cancer
220197|NCT02817633|non-small cell lung cancer|non-small cell lung cancer
220198|NCT02817633|Melanoma|melanoma
220199|NCT02817633|Anti-LAG-3|anti-lag-3
220200|NCT02817633|TSR-033|tsr-033
220201|NCT02817633|TSR-042|tsr-042
220203|NCT02817594|Chronic Hepatitis C|chronic hepatitis c
220204|NCT02817594|Paritaprevir/r - Ombitasvir, ± Dasabuvir|paritaprevir/r - ombitasvir, ± dasabuvir
220205|NCT02817594|Sustained Virological Response|sustained virological response
220206|NCT02817594|Observational Study|observational study
220207|NCT02817594|Chronic Hepatitis C genotype 1|chronic hepatitis c genotype 1
220208|NCT02817594|Chronic Hepatitis C genotype 4|chronic hepatitis c genotype 4
220209|NCT02817581|National Early Warning Score (NEWS)|national early warning score (news)
220210|NCT02817581|Lactate|lactate
220211|NCT02817581|Emergency Department|emergency department
220212|NCT02817568|Aggressive Periodontitis|aggressive periodontitis
220213|NCT02817568|C-C chemokine receptor 2|c-c chemokine receptor 2
220214|NCT02817568|Gene expression|gene expression
220215|NCT02817568|monocyte chemoattractant protein-1,|monocyte chemoattractant protein-1,
220216|NCT02817568|restriction fragment length polymorphism|restriction fragment length polymorphism
220217|NCT02817555|Anemia|anemia
220218|NCT02817555|Hemodialysis|hemodialysis
220219|NCT02817555|Erythropoiesis Stimulating Agent|erythropoiesis stimulating agent
220220|NCT02817555|Cost|cost
220221|NCT02817516|Drug Therapy|drug therapy
220222|NCT02817503|hypertension|hypertension
220223|NCT02817503|BP titration|bp titration
220224|NCT02817503|intensive blood pressure control|intensive blood pressure control
220225|NCT02817503|primary prevention|primary prevention
220226|NCT02817503|China|china
220227|NCT02817503|H-type Hypertension|h-type hypertension
220228|NCT02817490|hypermobility|hypermobility
220229|NCT02817490|Ehlers-Danlos Syndrome|ehlers-danlos syndrome
220230|NCT02817490|patient education program|patient education program
220231|NCT02817477|Intranasal Ketamine, Analgesia, Trauma, Morphine, Mass Casualty|intranasal ketamine, analgesia, trauma, morphine, mass casualty
220232|NCT02817451|Diphtheria|diphtheria
220233|NCT02817451|Tetanus|tetanus
220234|NCT02817451|Pertussis|pertussis
220235|NCT02817451|Hepatitis B|hepatitis b
220236|NCT02817451|DTaP IPV HB PRP-T Combined Vaccine|dtap ipv hb prp-t combined vaccine
220237|NCT02817451|Human Immunodeficiency Virus|human immunodeficiency virus
220238|NCT02817425|S-1|s-1
220239|NCT02817425|Adjuvant Chemotherapy|adjuvant chemotherapy
220240|NCT02817425|TEGAFOX|tegafox
220241|NCT02817412|binge eating|binge eating
220242|NCT02817412|obesity|obesity
220243|NCT02817412|overeating|overeating
220244|NCT02817399|anterior cruciate ligament reconstruction|anterior cruciate ligament reconstruction
220245|NCT02817399|Functional Electrical stimulation|functional electrical stimulation
220246|NCT02817399|Gait analysis|gait analysis
220247|NCT02817399|Physical therapy|physical therapy
220248|NCT02817386|postoperative delirium|postoperative delirium
220249|NCT02817386|microRNA|microrna
220250|NCT02817373|IVF|ivf
220251|NCT02817373|embryo transfer|embryo transfer
220252|NCT02817373|ultrasound|ultrasound
220253|NCT02817373|implantation|implantation
220254|NCT02817334|Near-infrared fluorescence|near-infrared fluorescence
220255|NCT02817334|Indocyanine green, ICG|indocyanine green, icg
281623|NCT02451085|hip|hip
220256|NCT02817334|breast cancer|breast cancer
220257|NCT02817308|Antigen, CA-19-9|antigen, ca-19-9
220258|NCT02817308|Salivas|salivas
220259|NCT02817308|body fluids|body fluids
220260|NCT02817269|Shoulder pain|shoulder pain
220261|NCT02817269|Trigger points|trigger points
220262|NCT02817269|Referred pain|referred pain
220263|NCT02817269|Visual analogue scale|visual analogue scale
220264|NCT02817191|age-related cataract|age-related cataract
220265|NCT02817191|Holy-Comod|holy-comod
220266|NCT02817191|Tears Naturale Forte|tears naturale forte
220267|NCT02817191|phacoemulsification|phacoemulsification
220268|NCT02817191|inflammatory mediators|inflammatory mediators
220269|NCT02817165|Probiotics, diarrhea, antibiotic, children, hospital|probiotics, diarrhea, antibiotic, children, hospital
220270|NCT02817152|periodontal treatment|periodontal treatment
220271|NCT02817152|low-level light therapy|low-level light therapy
220272|NCT02817126|Minimally Invasive Surgical Procedures|minimally invasive surgical procedures
220273|NCT02817126|Robotic Surgical Procedures|robotic surgical procedures
220274|NCT02817126|Laparoscopic Surgical Procedures|laparoscopic surgical procedures
220275|NCT02817126|Rectal Cancer|rectal cancer
220276|NCT02817126|Intraoperative Complications|intraoperative complications
220277|NCT02817126|Postoperative Complications|postoperative complications
220278|NCT02817126|Recovery of Function|recovery of function
220279|NCT02817126|Recurrence|recurrence
220280|NCT02817126|Disease Progression|disease progression
220281|NCT02817126|Survival|survival
220282|NCT02817087|Stroke|stroke
220283|NCT02817087|chronic ischemic stroke|chronic ischemic stroke
220284|NCT02817087|cerebrovascular accident (CVA)|cerebrovascular accident (cva)
220285|NCT02817087|ischaemic stroke|ischaemic stroke
220286|NCT02817061|no keywords for disease type and/or category|no keywords for disease type and/or category
220287|NCT02817035|interstitial lung disease|interstitial lung disease
220288|NCT02817035|chronic obstructive pulmonary disease|chronic obstructive pulmonary disease
220289|NCT02817035|mechanical ventilation|mechanical ventilation
220290|NCT02817035|expiratory delay|expiratory delay
220291|NCT02817035|neural inspiratory time|neural inspiratory time
220292|NCT02817022|Developmentally Supportive Care|developmentally supportive care
220293|NCT02817009|Behavioral Health Intervention|behavioral health intervention
220294|NCT02817009|Randomized Control Trial|randomized control trial
220295|NCT02817009|Family Intervention|family intervention
220296|NCT02817009|Nutrition|nutrition
220297|NCT02817009|Weight Management|weight management
220298|NCT02817009|Multidisciplinary Program|multidisciplinary program
220299|NCT02816944|Endoscopic ultrasonography|endoscopic ultrasonography
220300|NCT02816944|Laser ablation|laser ablation
220301|NCT02816931|Treatment|treatment
220302|NCT02816931|Drug Monitoring|drug monitoring
220303|NCT02816931|Minimum Inhibitory Concentration|minimum inhibitory concentration
220304|NCT02816931|Dried Blood Spot Method|dried blood spot method
220305|NCT02816931|Pharmacokinetics|pharmacokinetics
220306|NCT02816931|Pharmacodynamics|pharmacodynamics
220307|NCT02816905|intraocular pressure|intraocular pressure
220308|NCT02816905|topical steroids|topical steroids
220309|NCT02816905|strabismus|strabismus
220310|NCT02816892|aortic dissection|aortic dissection
220311|NCT02816892|biomarkers|biomarkers
220312|NCT02816892|diagnosis|diagnosis
220313|NCT02816866|childhood cancer|childhood cancer
220314|NCT02816866|survivorship care|survivorship care
220315|NCT02816866|health services|health services
220316|NCT02816866|barriers|barriers
220317|NCT02816840|prostate cancer|prostate cancer
220318|NCT02816840|radiotherapy|radiotherapy
220319|NCT02816840|PET-CT/MRI|pet-ct/mri
220320|NCT02816814|Menopause|menopause
220321|NCT02816814|Diet|diet
220322|NCT02816814|Lipidomic profile|lipidomic profile
220323|NCT02816814|Vasomotor symptoms|vasomotor symptoms
220324|NCT02816814|Omega-3 fatty acids|omega-3 fatty acids
220325|NCT02816788|PTSD|ptsd
220326|NCT02816788|Equine Assisted Therapy|equine assisted therapy
220327|NCT02816775|hemodynamics|hemodynamics
220328|NCT02816775|QT interval|qt interval
220329|NCT02816762|CPAP|cpap
220330|NCT02816762|Sleep apnea|sleep apnea
220331|NCT02816762|Diabetes|diabetes
220332|NCT02816762|Nephropathy|nephropathy
220333|NCT02816762|Albuminuria|albuminuria
220334|NCT02816749|Diabetic Foot|diabetic foot
220335|NCT02816749|Wound Healing|wound healing
220336|NCT02816749|Larva|larva
220337|NCT02816749|Occlusive Dressings|occlusive dressings
220338|NCT02816736|Heart Failure|heart failure
220339|NCT02816736|Heart Diseases|heart diseases
220340|NCT02816736|Cardiovascular Diseases|cardiovascular diseases
220341|NCT02816736|Valsartan|valsartan
220342|NCT02816736|Entresto|entresto
220343|NCT02816723|mindfulness|mindfulness
220344|NCT02816723|aging|aging
220345|NCT02816723|Veterans|veterans
220346|NCT02816710|Conbercept|conbercept
220347|NCT02816710|Proliferative diabetic retinopathy|proliferative diabetic retinopathy
220348|NCT02816710|Silicone oil tamponade|silicone oil tamponade
220349|NCT02816697|Smoking Habits|smoking habits
220350|NCT02816684|phobic disorders|phobic disorders
220351|NCT02816684|anxiety disorders|anxiety disorders
220352|NCT02816645|Parkinson's Disease|parkinson's disease
220353|NCT02816645|Biomarker|biomarker
220354|NCT02816645|Iron|iron
220355|NCT02816645|R2*|r2*
220356|NCT02816645|MRI|mri
220357|NCT02816645|Patients|patients
220358|NCT02816645|UK Parkinson's Disease Society Brain Bank|uk parkinson's disease society brain bank
220359|NCT02816632|functional Magnetic Resonance Imaging|functional magnetic resonance imaging
220360|NCT02816632|Galvanic Vestibular Stimulation|galvanic vestibular stimulation
220361|NCT02816632|Feedback Processing|feedback processing
220362|NCT02816632|Reward, Social, Vestibular System|reward, social, vestibular system
220363|NCT02816632|Cingulate Cortex|cingulate cortex
220364|NCT02816632|Decision-making|decision-making
220365|NCT02816619|Parkinson's disease|parkinson's disease
220366|NCT02816619|Physical activity|physical activity
220367|NCT02816619|Physical exercise|physical exercise
220368|NCT02816606|ACL reconstruction|acl reconstruction
220369|NCT02816593|carbamide peroxide|carbamide peroxide
220370|NCT02816593|Hydrogen peroxide|hydrogen peroxide
220371|NCT02816593|Quality of life|quality of life
220372|NCT02816554|Japanese Encephalitis|japanese encephalitis
220373|NCT02816554|JECEVAX|jecevax
220374|NCT02816554|Vietnam|vietnam
220375|NCT02816528|Antibiotics|antibiotics
220376|NCT02816528|Primary care|primary care
220377|NCT02816528|Stewardship|stewardship
220378|NCT02816528|General practitioners|general practitioners
220379|NCT02816515|Non interventional study|non interventional study
220380|NCT02816515|Ectoin|ectoin
220381|NCT02816515|Mouth wash|mouth wash
220382|NCT02816515|Mucositis|mucositis
220383|NCT02816515|Chemotherapy|chemotherapy
220384|NCT02816515|Radiotherapy|radiotherapy
220385|NCT02816502|childhood|childhood
220386|NCT02816502|adversity|adversity
220387|NCT02816450|Water|water
220388|NCT02816450|Children|children
220389|NCT02816450|Cognition|cognition
220390|NCT02816450|Hydration|hydration
220391|NCT02816424|Screening and Brief Intervention|screening and brief intervention
220392|NCT02816424|Motivational Interviewing|motivational interviewing
220393|NCT02816424|Teen Pregnancy Prevention|teen pregnancy prevention
220394|NCT02816385|PV-loops (pressure-volume loops)|pv-loops (pressure-volume loops)
220395|NCT02816385|Myocardial contractility|myocardial contractility
220396|NCT02816385|Cardioplegia|cardioplegia
220397|NCT02816385|Induced|induced
220398|NCT02816359|Position patient|position patient
220399|NCT02816359|Esophageal pressure|esophageal pressure
220400|NCT02816346|shigella|shigella
220401|NCT02816320|hospital mortality|hospital mortality
220402|NCT02816320|standardized mortality ratios|standardized mortality ratios
220403|NCT02816320|patient safety|patient safety
220404|NCT02816320|healthcare quality|healthcare quality
220405|NCT02816320|hospital performance|hospital performance
220406|NCT02816320|administrative data|administrative data
220407|NCT02816281|Surgical case cancellation|surgical case cancellation
220408|NCT02816281|Pre-operative assessment clinic|pre-operative assessment clinic
220409|NCT02816242|Concept Map|concept map
220410|NCT02816242|critical thinking|critical thinking
220411|NCT02816242|medical student teaching|medical student teaching
220412|NCT02816229|Haemoptysis|haemoptysis
220413|NCT02816229|Aspergillus|aspergillus
220414|NCT02816229|Endobronchial valve|endobronchial valve
220415|NCT02816229|Interventional pulmonology|interventional pulmonology
220416|NCT02816229|Tuberculosis|tuberculosis
220417|NCT02816138|Geriatrics|geriatrics
220418|NCT02816138|Depression|depression
220419|NCT02816138|Elderly|elderly
220420|NCT02816138|Cognition|cognition
220421|NCT02816138|Memory|memory
220422|NCT02816125|breast cancer|breast cancer
220423|NCT02816125|fatty acids|fatty acids
220424|NCT02816125|omega-3|omega-3
220425|NCT02816060|pain measurement|pain measurement
220426|NCT02816047|wearable cardioverter defibrillator|wearable cardioverter defibrillator
220427|NCT02816047|LifeVest|lifevest
220428|NCT02816047|sudden death|sudden death
220429|NCT02816047|defibrillator|defibrillator
220430|NCT02816034|Learning|learning
220431|NCT02816034|Cerebellum|cerebellum
220432|NCT02816021|Melanoma and other malignant neoplasms of skin|melanoma and other malignant neoplasms of skin
220433|NCT02816021|Metastatic melanoma|metastatic melanoma
220434|NCT02816021|Advanced melanoma|advanced melanoma
220435|NCT02816021|Azacitidine|azacitidine
220436|NCT02816021|5-azacytidine|5-azacytidine
220437|NCT02816021|5-aza|5-aza
220438|NCT02816021|Vidaza|vidaza
220439|NCT02816021|5-AZC|5-azc
220440|NCT02816021|Ladakamycin|ladakamycin
220441|NCT02816021|NSC-102816|nsc-102816
220442|NCT02816021|Azacytidine|azacytidine
220443|NCT02816021|Pembrolizumab|pembrolizumab
220444|NCT02816021|Keytruda|keytruda
220445|NCT02816021|MK-3475|mk-3475
220446|NCT02816021|SCH-900475|sch-900475
220447|NCT02816008|cognitive rehabilitation|cognitive rehabilitation
220448|NCT02816008|memory|memory
220449|NCT02816008|attention|attention
220450|NCT02816008|spatial neglect|spatial neglect
721083|NCT00543036|Craving|craving
281878|NCT02449629|HIV|hiv
220451|NCT02816008|executive dysfunctioning|executive dysfunctioning
220452|NCT02815995|Malignant neoplasms of bone and articular cartilage|malignant neoplasms of bone and articular cartilage
220453|NCT02815995|Multiple sarcoma subtypes|multiple sarcoma subtypes
220454|NCT02815995|Advanced and/or metastatic sarcoma|advanced and/or metastatic sarcoma
220455|NCT02815995|Adipocytic tumors|adipocytic tumors
220456|NCT02815995|Vascular tumors|vascular tumors
220457|NCT02815995|Leiomyosarcoma|leiomyosarcoma
220458|NCT02815995|Angiosarcoma|angiosarcoma
220459|NCT02815995|Epithelioid hemangioendothelioma|epithelioid hemangioendothelioma
220460|NCT02815995|Undifferentiated pleomorphic sarcoma|undifferentiated pleomorphic sarcoma
220461|NCT02815995|Synovial sarcoma|synovial sarcoma
220462|NCT02815995|Osteosarcoma|osteosarcoma
220463|NCT02815995|Other sarcoma histologies|other sarcoma histologies
220464|NCT02815995|Durvalumab|durvalumab
220465|NCT02815995|Tremelimumab|tremelimumab
220466|NCT02815969|neuroendocrine tumors|neuroendocrine tumors
220467|NCT02815969|indol profile|indol profile
220468|NCT02815969|catecholamines|catecholamines
220469|NCT02815969|LC-MS/MS|lc-ms/ms
220470|NCT02815956|percutaneous tibial nerve stimulation|percutaneous tibial nerve stimulation
220471|NCT02815956|randomized|randomized
220472|NCT02815956|controlled study|controlled study
220473|NCT02815930|High cost user (HCU)|high cost user (hcu)
220474|NCT02815930|Healthcare utilization|healthcare utilization
220475|NCT02815930|Healthcare expenditures|healthcare expenditures
220476|NCT02815930|Medication use|medication use
220477|NCT02815930|Medication expenditures|medication expenditures
220478|NCT02815930|Multimorbidity|multimorbidity
220479|NCT02815930|Observational study|observational study
220480|NCT02815904|Neonates|neonates
220481|NCT02815904|physical therapy|physical therapy
220482|NCT02815904|neonatal intensive care units|neonatal intensive care units
220483|NCT02815904|yakson touch|yakson touch
220484|NCT02815904|kinesthetic stimulation|kinesthetic stimulation
220485|NCT02815865|Primiparous|primiparous
220486|NCT02815865|Foley catheter|foley catheter
220487|NCT02815865|Dinoprostone|dinoprostone
220488|NCT02815865|Induction|induction
220489|NCT02815852|breast cancer in women under 40 years old|breast cancer in women under 40 years old
220490|NCT02815852|biopsy|biopsy
220491|NCT02815852|ultrasonography|ultrasonography
220492|NCT02815852|Magnetic Resonance Imaging|magnetic resonance imaging
220493|NCT02815839|urate transporter 1|urate transporter 1
220494|NCT02815839|SHR4640|shr4640
220495|NCT02815839|single ascending dose|single ascending dose
220496|NCT02815839|pharmacokinetics|pharmacokinetics
220497|NCT02815839|pharmacodynamics|pharmacodynamics
220498|NCT02815813|Serious Mental Illness|serious mental illness
220499|NCT02815813|Young Adults|young adults
220500|NCT02815813|Obesity|obesity
220501|NCT02815813|Cardiometabolic Risk|cardiometabolic risk
220502|NCT02815813|Physical Activity|physical activity
220503|NCT02815813|Weight Loss|weight loss
220504|NCT02815813|Fitness|fitness
220505|NCT02815813|Peer Support|peer support
220506|NCT02815813|Smartphone|smartphone
220507|NCT02815813|Mobile Technology|mobile technology
220508|NCT02815813|mHealth|mhealth
220509|NCT02815813|Social Media|social media
220510|NCT02815813|Facebook|facebook
220511|NCT02815813|Lifestyle Intervention|lifestyle intervention
220512|NCT02815800|Treatment|treatment
220513|NCT02815800|Motor signs|motor signs
220514|NCT02815800|Non motor signs|non motor signs
220515|NCT02815800|Fluctuations|fluctuations
220516|NCT02815800|Open labelled|open labelled
220517|NCT02815787|SP2086|sp2086
220518|NCT02815787|Glyburide|glyburide
220519|NCT02815787|drug-drug interaction|drug-drug interaction
220520|NCT02815774|SP2086|sp2086
220521|NCT02815774|Renal Insufficiency|renal insufficiency
220522|NCT02815774|Pharmacokinetic|pharmacokinetic
220523|NCT02815748|SP2086|sp2086
220524|NCT02815748|Metabolite identification|metabolite identification
220525|NCT02815748|Material balance|material balance
220526|NCT02815722|SP2086|sp2086
220527|NCT02815722|Simvastatin|simvastatin
220528|NCT02815722|drug-drug interaction|drug-drug interaction
220529|NCT02815696|MRI T2 weighted|mri t2 weighted
220530|NCT02815696|intervertebral disc|intervertebral disc
220531|NCT02815696|glycosaminoglycans|glycosaminoglycans
220532|NCT02815683|Bronchoscopy|bronchoscopy
220533|NCT02815683|Emphysema|emphysema
220534|NCT02815657|SP2086|sp2086
220535|NCT02815657|Valsartan|valsartan
220536|NCT02815657|Drug-drug Interaction|drug-drug interaction
220537|NCT02815631|fractional flow reserve|fractional flow reserve
220538|NCT02815631|cardiogoniometry|cardiogoniometry
220539|NCT02815618|Time-resolved spectroscopy|time-resolved spectroscopy
220540|NCT02815618|Diffuse correlation spectroscopy|diffuse correlation spectroscopy
220541|NCT02815618|Neonatology|neonatology
220542|NCT02815579|HIV|hiv
220543|NCT02815579|Food insecurity|food insecurity
220544|NCT02815579|Microcredit loan|microcredit loan
220545|NCT02815579|Agriculture|agriculture
220546|NCT02815579|Livelihoods|livelihoods
220646|NCT02814903|mitochondria|mitochondria
220547|NCT02815566|kidney, antiretroviral agent, tenofovir, osteoporosis, women|kidney, antiretroviral agent, tenofovir, osteoporosis, women
220548|NCT02815527|enteral nutrition|enteral nutrition
220549|NCT02815527|intensive care unit|intensive care unit
220550|NCT02815527|whey|whey
220551|NCT02815527|protein|protein
220552|NCT02815527|muscle mass|muscle mass
220553|NCT02815527|leucin|leucin
220554|NCT02815527|energy expenditure|energy expenditure
220555|NCT02815514|aortic valve stenosis|aortic valve stenosis
220556|NCT02815514|aortic valve insufficiency|aortic valve insufficiency
220557|NCT02815514|transapical aortic valve implantation|transapical aortic valve implantation
220558|NCT02815514|aortic valve replacement|aortic valve replacement
220559|NCT02815514|percutaneous aortic valve replacement|percutaneous aortic valve replacement
220560|NCT02815514|aortic valve valvuloplasty|aortic valve valvuloplasty
220561|NCT02815501|Thyroid dysfunction|thyroid dysfunction
220562|NCT02815501|obstetric complications|obstetric complications
220563|NCT02815462|Frequent hospital admissions|frequent hospital admissions
220564|NCT02815462|Risk stratification|risk stratification
220565|NCT02815462|Readmissions|readmissions
220566|NCT02815449|Iron fortification|iron fortification
220567|NCT02815449|Bioavailability|bioavailability
220568|NCT02815449|Nigeria|nigeria
220569|NCT02815449|Women|women
220570|NCT02815449|Bouillon cubes|bouillon cubes
220571|NCT02815410|Glioblastoma Multiforme|glioblastoma multiforme
220572|NCT02815410|Levetiracetam|levetiracetam
220573|NCT02815410|Temozolomide|temozolomide
220574|NCT02815410|Survival outcome|survival outcome
220575|NCT02815397|Double Hit DLBCL|double hit dlbcl
220576|NCT02815319|Dexamethasone|dexamethasone
220577|NCT02815319|Chemotherapy|chemotherapy
220578|NCT02815306|Congenital idiopathic clubfoot|congenital idiopathic clubfoot
220579|NCT02815306|Pirani score|pirani score
220580|NCT02815306|infant|infant
220581|NCT02815306|polyaxial brace|polyaxial brace
220583|NCT02815293|evaporative dry eye|evaporative dry eye
220584|NCT02815280|acne|acne
220585|NCT02815267|acne|acne
220586|NCT02815254|Physiotherapy|physiotherapy
220587|NCT02815254|hip fracture|hip fracture
220588|NCT02815254|rehabilitation|rehabilitation
220589|NCT02815254|high dose exercise|high dose exercise
220590|NCT02815254|low dose exercise|low dose exercise
220591|NCT02815215|congenital clubfoot|congenital clubfoot
220592|NCT02815189|pain|pain
220593|NCT02815176|Plasminogen activator inhibitor-1|plasminogen activator inhibitor-1
220594|NCT02815176|Wide angle fluorescein angiography|wide angle fluorescein angiography
220595|NCT02815176|Choroid|choroid
220596|NCT02815137|Digital PCR|digital pcr
220597|NCT02815137|classical|classical
220598|NCT02815137|Hodgkin Lymphoma|hodgkin lymphoma
220599|NCT02815137|mutation|mutation
220600|NCT02815085|heart failure|heart failure
220601|NCT02815085|mHealth|mhealth
220602|NCT02815072|Fontan palliation|fontan palliation
220603|NCT02815072|Marfan's syndrome|marfan's syndrome
220604|NCT02815046|urgency urinary incontinence|urgency urinary incontinence
220605|NCT02815046|stress urinary incontinence|stress urinary incontinence
220606|NCT02815046|Botulinum toxin A|botulinum toxin a
220607|NCT02815046|Bulkamid|bulkamid
220608|NCT02815033|Hormono-Sensitive prostate cancer|hormono-sensitive prostate cancer
220609|NCT02815033|Enzalutamide|enzalutamide
220610|NCT02815033|Imaging|imaging
220611|NCT02815033|PET/CT|pet/ct
220612|NCT02815033|Whole body MRI|whole body mri
220613|NCT02815033|Circulating tumour cells|circulating tumour cells
220614|NCT02815033|Cell-free tumour DNA|cell-free tumour dna
220615|NCT02815020|Primary care|primary care
220616|NCT02815020|Self-management support|self-management support
220617|NCT02815020|Care coordination|care coordination
220618|NCT02815020|Practice-based research network|practice-based research network
220619|NCT02814994|Mechanical Ventilation|mechanical ventilation
220620|NCT02814994|ARDS|ards
220621|NCT02814994|Ventilator Strategy|ventilator strategy
220622|NCT02814994|Outcome|outcome
220623|NCT02814981|hydroxyzine|hydroxyzine
220624|NCT02814981|Long QT|long qt
220625|NCT02814968|Castration-resistant prostate cancer|castration-resistant prostate cancer
220626|NCT02814968|Enzalutamide|enzalutamide
220627|NCT02814968|Imaging|imaging
220628|NCT02814968|PET/CT|pet/ct
220629|NCT02814968|Whole body MRI|whole body mri
220630|NCT02814968|Circulating tumour cells|circulating tumour cells
220631|NCT02814968|Cell-free tumour DNA|cell-free tumour dna
220632|NCT02814955|atrial fibrillation|atrial fibrillation
220633|NCT02814955|pulmonary veins|pulmonary veins
220634|NCT02814955|oral anticoagulant|oral anticoagulant
220635|NCT02814955|electrophysiology|electrophysiology
220636|NCT02814955|anticoagulant drugs|anticoagulant drugs
220637|NCT02814929|ROP|rop
220638|NCT02814929|Risk factors|risk factors
220639|NCT02814929|Incidence|incidence
220640|NCT02814929|Turkey|turkey
220641|NCT02814916|Acute Bacterial Skin and Skin Structure Infection (ABSSSI)|acute bacterial skin and skin structure infection (absssi)
220642|NCT02814903|aldosterone|aldosterone
220643|NCT02814903|cardiac surgery|cardiac surgery
220644|NCT02814903|atrial fibrillation|atrial fibrillation
220645|NCT02814903|galectin-3|galectin-3
220647|NCT02814903|ngal|ngal
220648|NCT02814903|acute kidney failure|acute kidney failure
220649|NCT02814903|epicardial fat|epicardial fat
220650|NCT02814903|right atrial sample|right atrial sample
220651|NCT02814890|Thoracic paravertebral block|thoracic paravertebral block
220652|NCT02814890|Dexmedetomidine|dexmedetomidine
220653|NCT02814890|Video-assisted Pneumonectomy|video-assisted pneumonectomy
220654|NCT02814890|Ropivacaine|ropivacaine
220655|NCT02814890|Pain, Postoperative|pain, postoperative
220656|NCT02814877|Antibiotic stewardship|antibiotic stewardship
220657|NCT02814877|cost-effectiveness evaluation|cost-effectiveness evaluation
220658|NCT02814877|Antibiotic use|antibiotic use
220659|NCT02814864|Hematology|hematology
220660|NCT02814864|Mesenchymal Stromal Cell|mesenchymal stromal cell
220661|NCT02814864|radiotherapy|radiotherapy
220662|NCT02814864|gastro-intestinal complications|gastro-intestinal complications
220663|NCT02814864|lower digestive tract cancers|lower digestive tract cancers
220664|NCT02814864|colitis|colitis
220665|NCT02814864|bleeding|bleeding
220666|NCT02814864|diarrhea|diarrhea
220667|NCT02814864|pelvic radiation disease|pelvic radiation disease
220668|NCT02814851|Left atrium appendage (LAA) occlusion|left atrium appendage (laa) occlusion
220669|NCT02814851|Transesophageal echocardiography|transesophageal echocardiography
220670|NCT02814851|Cardiac output hemodynamic measurement|cardiac output hemodynamic measurement
220671|NCT02814851|Leycom Pressure/Volume Combination Catheter|leycom pressure/volume combination catheter
220672|NCT02814838|Diabetes mellitus Type 1|diabetes mellitus type 1
220673|NCT02814838|Beta cells function|beta cells function
220674|NCT02814825|ViviGen|vivigen
220675|NCT02814825|ACDF|acdf
220676|NCT02814825|Cervical|cervical
220677|NCT02814760|acute ischemic stroke|acute ischemic stroke
220678|NCT02814760|stepped-wedge|stepped-wedge
220679|NCT02814760|interactive training|interactive training
220680|NCT02814760|implementation|implementation
220681|NCT02814760|emergency department|emergency department
220682|NCT02814734|Intra-Abdominal Hypertension|intra-abdominal hypertension
220683|NCT02814734|Abdominal Compartment Syndrome|abdominal compartment syndrome
220684|NCT02814734|Round Belly Sign|round belly sign
220685|NCT02814734|Radiology|radiology
220686|NCT02814734|CT findings|ct findings
220687|NCT02814734|Intensive Care|intensive care
220688|NCT02814708|Sepsis|sepsis
220689|NCT02814708|Vaccination|vaccination
220690|NCT02814695|Male infertility|male infertility
220691|NCT02814695|oxidative stress|oxidative stress
220692|NCT02814695|antioxidants|antioxidants
220693|NCT02814695|probiotics|probiotics
220694|NCT02814695|Vitamin E|vitamin e
220695|NCT02814695|Baker's Yeast|baker's yeast
220696|NCT02814682|palliative care|palliative care
220697|NCT02814682|quality|quality
220698|NCT02814682|indicator|indicator
220699|NCT02814682|multi-dimensional|multi-dimensional
220700|NCT02814656|muscarinic receptor antagonist and β2 adrenoceptor agonist [MABA]|muscarinic receptor antagonist and β2 adrenoceptor agonist [maba]
220701|NCT02814656|chronic obstructive pulmonary disease|chronic obstructive pulmonary disease
220702|NCT02814656|Asthma (in combination with an inhaled corticosteroid [ICS]|asthma (in combination with an inhaled corticosteroid [ics]
220703|NCT02814656|alpha-lactose monohydrate|alpha-lactose monohydrate
220704|NCT02814656|dry powder inhaler|dry powder inhaler
220705|NCT02814656|long-acting β2-agonist (LABA)|long-acting β2-agonist (laba)
220706|NCT02814656|long-acting muscarinic antagonist (LAMA)|long-acting muscarinic antagonist (lama)
220707|NCT02814656|fixed-dose combination (FDC)|fixed-dose combination (fdc)
220708|NCT02814643|Male and female adolescent patients|male and female adolescent patients
220709|NCT02814643|severe asthma|severe asthma
220710|NCT02814604|Front-of-Pack Labelling|front-of-pack labelling
220711|NCT02814604|Star rating system|star rating system
220712|NCT02814604|Traffic light rating system|traffic light rating system
220713|NCT02814604|Consumer Behavior|consumer behavior
220714|NCT02814604|Health Literacy|health literacy
220715|NCT02814604|Mobile Apps|mobile apps
220716|NCT02814604|Nutrition Labeling|nutrition labeling
220717|NCT02814604|Healthy food choices|healthy food choices
220719|NCT02814578|IVUS|ivus
220720|NCT02814578|BVS|bvs
220721|NCT02814565|Drug therapy|drug therapy
220722|NCT02814526|exercise|exercise
220723|NCT02814513|Children|children
220724|NCT02814513|Adolescents|adolescents
220725|NCT02814487|DAM|dam
220726|NCT02814487|multiple sclerosis|multiple sclerosis
220727|NCT02814487|MSFC|msfc
220728|NCT02814487|application|application
220729|NCT02814487|smartphone|smartphone
220730|NCT02814474|PET/CT|pet/ct
220731|NCT02814474|Heart failure|heart failure
220732|NCT02814474|hydroxybutyrate|hydroxybutyrate
220733|NCT02814435|Retina|retina
220734|NCT02814435|Retinal Degeneration|retinal degeneration
220735|NCT02814435|Quality of Life Measures|quality of life measures
220736|NCT02814422|Triglyceride-rich lipoprotein|triglyceride-rich lipoprotein
220737|NCT02814422|dementia|dementia
220738|NCT02814422|Alzheimer's disease|alzheimer's disease
220739|NCT02814422|mild cognition impairment|mild cognition impairment
220740|NCT02814422|amyloid-beta|amyloid-beta
220741|NCT02814396|Ventricular|ventricular
220742|NCT02814396|CVD|cvd
220843|NCT02813746|Obesity|obesity
220743|NCT02814396|Ventricular arrhythmias|ventricular arrhythmias
220744|NCT02814383|Prematurity|prematurity
220745|NCT02814383|Extremely Low Birth Weight (ELBW)|extremely low birth weight (elbw)
220746|NCT02814383|Cerebral Perfusion|cerebral perfusion
220747|NCT02814383|Cerebral Autoregulation|cerebral autoregulation
220748|NCT02814357|Blood glucose, serum insulin|blood glucose, serum insulin
220749|NCT02814344|labour|labour
220750|NCT02814331|Video-EEG|video-eeg
220751|NCT02814331|near-infrared spectroscopy (NIRS)|near-infrared spectroscopy (nirs)
220752|NCT02814318|Vancomycin|vancomycin
220753|NCT02814318|Penicillin|penicillin
220754|NCT02814318|Clindamycin|clindamycin
220755|NCT02814318|Group B streptococcal infection|group b streptococcal infection
220756|NCT02814318|Rectovaginal GBS colonization|rectovaginal gbs colonization
220757|NCT02814318|Vaginal GBS colonization|vaginal gbs colonization
220758|NCT02814318|Intrapartum|intrapartum
220759|NCT02814318|Prophylaxis|prophylaxis
220760|NCT02814227|obstructive sleep apnea screening device|obstructive sleep apnea screening device
220761|NCT02814201|Motor slowing|motor slowing
220762|NCT02814201|Computerized mental chronometry paradigm|computerized mental chronometry paradigm
220763|NCT02814188|Exercise|exercise
220764|NCT02814175|Psoriatic Arthritis|psoriatic arthritis
220765|NCT02814162|Subarachnoid Hemorrhage, Aneurysmal|subarachnoid hemorrhage, aneurysmal
220766|NCT02814162|Predictive|predictive
220767|NCT02814162|Adiponectin|adiponectin
220768|NCT02814149|delayed implant|delayed implant
220769|NCT02814149|esthetics|esthetics
220770|NCT02814149|immediate implant|immediate implant
220771|NCT02814149|bone augmentation|bone augmentation
220772|NCT02814123|Diabetes Mellitus, Type 1|diabetes mellitus, type 1
220773|NCT02814123|Pramlintide|pramlintide
220774|NCT02814123|Artificial Pancreas|artificial pancreas
220775|NCT02814123|Closed-Loop System|closed-loop system
220776|NCT02814123|Insulin|insulin
220777|NCT02814110|Granulocyte colony-stimulating factor|granulocyte colony-stimulating factor
220778|NCT02814110|muscular dystrophy|muscular dystrophy
220779|NCT02814110|muscle strength|muscle strength
220780|NCT02814110|children|children
220781|NCT02814110|adolescents|adolescents
220782|NCT02814097|Heart Failure|heart failure
220783|NCT02814097|HFpEF|hfpef
220784|NCT02814097|elamipretide|elamipretide
220785|NCT02814097|MTP-131|mtp-131
220786|NCT02814097|Bendavia™|bendavia™
220787|NCT02814071|Early Feeding|early feeding
220788|NCT02814071|Acute Pancreatitis|acute pancreatitis
220789|NCT02814071|Pediatric|pediatric
220790|NCT02814058|pharmacokinetics|pharmacokinetics
220791|NCT02814058|Healthy Volunteers|healthy volunteers
220792|NCT02814045|biomarkers, sleep fragmentation, intermittent hypoxia|biomarkers, sleep fragmentation, intermittent hypoxia
220793|NCT02814032|proteomic|proteomic
220794|NCT02814032|cervical lymph node metastasis|cervical lymph node metastasis
220795|NCT02814019|respiratory function in DMD|respiratory function in dmd
220796|NCT02814006|marital relationship|marital relationship
220797|NCT02813993|infertility|infertility
220798|NCT02813993|fertility awareness|fertility awareness
220799|NCT02813993|preconceptional care|preconceptional care
220800|NCT02813993|health interventions|health interventions
220801|NCT02813993|couples|couples
220802|NCT02813980|SUDEP|sudep
220803|NCT02813980|Sudden cardiac death|sudden cardiac death
220804|NCT02813980|Sudden unexpected death in epilepsy|sudden unexpected death in epilepsy
220805|NCT02813980|Sleep|sleep
220806|NCT02813980|Polysomnography|polysomnography
220807|NCT02813980|Autonomic|autonomic
220808|NCT02813980|Cardiovascular|cardiovascular
220809|NCT02813941|Randomized controlled trial|randomized controlled trial
220810|NCT02813941|Systematic review|systematic review
220811|NCT02813941|Summary of finding tables|summary of finding tables
220812|NCT02813941|GRADE|grade
220813|NCT02813941|AHRQ|ahrq
220814|NCT02813928|ColoRectal Cancer|colorectal cancer
220815|NCT02813928|Cancerology|cancerology
220816|NCT02813928|Translational Research|translational research
220817|NCT02813928|ccfDNA|ccfdna
220818|NCT02813915|cardiac monitoring, Cheetah Medical, passive leg raises|cardiac monitoring, cheetah medical, passive leg raises
220819|NCT02813889|infant|infant
220820|NCT02813889|baby|baby
220821|NCT02813889|developmental delay|developmental delay
220822|NCT02813889|robotics|robotics
220823|NCT02813889|cerebral palsy|cerebral palsy
220824|NCT02813850|sickle cell disease|sickle cell disease
220825|NCT02813850|oxygen therapy|oxygen therapy
220826|NCT02813850|pregnancy|pregnancy
220827|NCT02813850|pregnancy in sickle cell disease|pregnancy in sickle cell disease
220828|NCT02813837|relapsed|relapsed
220829|NCT02813837|refractory|refractory
220830|NCT02813837|CD19+|cd19+
220831|NCT02813837|leukemia|leukemia
220832|NCT02813837|lymphoma|lymphoma
220833|NCT02813811|Temperature-controlled Laminar Airflow|temperature-controlled laminar airflow
220834|NCT02813811|Exacerbation frequency|exacerbation frequency
220835|NCT02813798|Renal Insufficiency|renal insufficiency
220836|NCT02813772|infants|infants
220837|NCT02813772|colic|colic
220838|NCT02813759|GLYCEMIA|glycemia
220839|NCT02813759|SATIETY|satiety
220840|NCT02813759|C PEPTIDE|c peptide
220841|NCT02813759|PRELOAD|preload
220842|NCT02813759|INSULIN|insulin
220845|NCT02813746|Epigenetic|epigenetic
220846|NCT02813746|Transcriptomic|transcriptomic
220847|NCT02813746|microRNAs|micrornas
220848|NCT02813746|miRNAs|mirnas
220849|NCT02813733|thyroid surgery|thyroid surgery
220850|NCT02813733|surgical outcomes|surgical outcomes
220851|NCT02813733|patient safety|patient safety
220852|NCT02813733|healthcare quality|healthcare quality
220853|NCT02813733|surgeons performance|surgeons performance
220854|NCT02813720|Erosions|erosions
220855|NCT02813720|Onycholysis|onycholysis
220856|NCT02813720|HR-pQCT|hr-pqct
220857|NCT02813720|Psoriatic arthritis|psoriatic arthritis
220858|NCT02813707|Vitamins|vitamins
220859|NCT02813707|Mineral|mineral
220860|NCT02813707|Surgery|surgery
220861|NCT02813694|Pneumonia|pneumonia
220862|NCT02813694|CABP|cabp
220863|NCT02813694|CAP|cap
220864|NCT02813694|Community acquired bacterial pneumonia|community acquired bacterial pneumonia
220865|NCT02813681|Acute Pain|acute pain
220866|NCT02813681|ultrasonography|ultrasonography
220867|NCT02813668|Nutrition|nutrition
220868|NCT02813668|Occupational Health|occupational health
220869|NCT02813655|tetracosactide|tetracosactide
220870|NCT02813655|Synacthène®|synacthène®
220871|NCT02813655|cosyntropin|cosyntropin
220872|NCT02813655|post-dural syndrom|post-dural syndrom
220873|NCT02813655|post-dural puncture headache|post-dural puncture headache
220874|NCT02813642|chronic kidney disease starting dialysis|chronic kidney disease starting dialysis
220875|NCT02813642|cardiovascular risk|cardiovascular risk
220876|NCT02813642|bone mineral metabolism markers|bone mineral metabolism markers
220877|NCT02813629|transcranial Direct Current Stimulation|transcranial direct current stimulation
220878|NCT02813629|Peripheral Electrical Stimulation|peripheral electrical stimulation
220879|NCT02813629|Sickle Cell Disease|sickle cell disease
220880|NCT02813629|Transcutaneous Electrical Nerve Stimulation|transcutaneous electrical nerve stimulation
220881|NCT02813629|quantitative Electroencephalography|quantitative electroencephalography
220882|NCT02813603|EBUS-TBNA|ebus-tbna
220883|NCT02813603|staging|staging
220884|NCT02813603|lymph node metastases|lymph node metastases
220885|NCT02813577|Legs|legs
220886|NCT02813577|Drug Coated Angioplasty Balloon|drug coated angioplasty balloon
220887|NCT02813577|Experimental|experimental
220888|NCT02813577|Standard Angioplasty Balloon|standard angioplasty balloon
220889|NCT02813564|Autism|autism
220890|NCT02813564|Cognitive Training|cognitive training
220891|NCT02813564|Brain|brain
220892|NCT02813564|fMRI|fmri
220893|NCT02813551|Preeclampsia, puerperium|preeclampsia, puerperium
220894|NCT02813538|Thrombelastography|thrombelastography
220895|NCT02813538|Antithrombin proteins|antithrombin proteins
220896|NCT02813538|Liver surgery|liver surgery
220897|NCT02813538|Liver function tests|liver function tests
220898|NCT02813525|Aortic Isthmus|aortic isthmus
220899|NCT02813525|Isthmic Systolic Index|isthmic systolic index
220900|NCT02813525|feasibility|feasibility
220901|NCT02813525|reproducibility|reproducibility
220902|NCT02813525|mortality|mortality
220903|NCT02813525|delivery|delivery
220904|NCT02813499|Acute Coronary Syndrome|acute coronary syndrome
220905|NCT02813473|SYNTAX Score II|syntax score ii
220906|NCT02813473|Multi Slice Computed Tomography|multi slice computed tomography
220907|NCT02813473|MSCT|msct
220908|NCT02813473|Heart Team|heart team
220909|NCT02813473|Fractional Flow Reserve Computed Tomography|fractional flow reserve computed tomography
220910|NCT02813473|FFR|ffr
220911|NCT02813473|FFR MSCT|ffr msct
220912|NCT02813473|PCI|pci
220913|NCT02813473|CABG|cabg
220914|NCT02813473|Percutaneous Coronary Intervention|percutaneous coronary intervention
220915|NCT02813473|Coronary Artery Bypass Graft|coronary artery bypass graft
220916|NCT02813434|Cerebral amyloid imaging|cerebral amyloid imaging
220917|NCT02813434|Florbetapir|florbetapir
220918|NCT02813434|18F-AV-45|18f-av-45
220919|NCT02813434|poststroke|poststroke
220920|NCT02813421|CGM|cgm
220921|NCT02813382|bupivacaine|bupivacaine
220922|NCT02813382|prilocaine|prilocaine
220923|NCT02813382|2-chloroprocaine|2-chloroprocaine
220924|NCT02813330|Women|women
220925|NCT02813330|severe|severe
220926|NCT02813330|low back ache|low back ache
220927|NCT02813330|labor|labor
220928|NCT02813317|Surgery|surgery
220929|NCT02813317|Breast cancer|breast cancer
220930|NCT02813317|Quality of life|quality of life
220931|NCT02813317|Care pathway|care pathway
220932|NCT02813317|Economic evaluation|economic evaluation
220933|NCT02813304|Acute|acute
220934|NCT02813304|rotator cuff tendinopathy|rotator cuff tendinopathy
220935|NCT02813304|exercise|exercise
220936|NCT02813304|loading|loading
220937|NCT02813304|ice|ice
220938|NCT02813304|cryotherapy|cryotherapy
220939|NCT02813304|randomised control trial|randomised control trial
220940|NCT02813291|Motor imagery|motor imagery
220941|NCT02813291|transcranial direct current stimulation|transcranial direct current stimulation
721084|NCT00543036|TMS|tms
220942|NCT02813291|motor learning|motor learning
220943|NCT02813291|aging|aging
220944|NCT02813265|Ocular Discomfort|ocular discomfort
220945|NCT02813265|Pain|pain
220946|NCT02813265|Corticosteroid|corticosteroid
220947|NCT02813265|Hyperemia|hyperemia
220948|NCT02813265|Dry Eye|dry eye
220949|NCT02813252|long-term follow-up|long-term follow-up
220950|NCT02813252|chimeric antigen receptor (CAR) T cells|chimeric antigen receptor (car) t cells
220951|NCT02813252|JCAR015|jcar015
220952|NCT02813239|IVF|ivf
220953|NCT02813239|Dual trigger|dual trigger
220954|NCT02813239|GnRH agonist|gnrh agonist
220955|NCT02813239|hCG|hcg
220956|NCT02813239|mature oocytes|mature oocytes
220957|NCT02813226|castration-resistant|castration-resistant
220958|NCT02813226|molecular imaging|molecular imaging
220959|NCT02813226|abiraterone acetate|abiraterone acetate
220960|NCT02813226|enzalutamide|enzalutamide
220961|NCT02813226|metabolic response|metabolic response
220962|NCT02813213|skin transplantation|skin transplantation
220963|NCT02813213|grafting skin|grafting skin
220964|NCT02813200|COPD, inhaler device, handling|copd, inhaler device, handling
220965|NCT02813187|venous leg ulcer|venous leg ulcer
220966|NCT02813187|venous|venous
220967|NCT02813187|QCDR|qcdr
220968|NCT02813187|quality measure|quality measure
220969|NCT02813187|wound|wound
220970|NCT02813187|Outcome|outcome
220971|NCT02813187|Lymphedema|lymphedema
220972|NCT02813161|diabetic foot ulcer|diabetic foot ulcer
220973|NCT02813161|diabetes|diabetes
220974|NCT02813161|arterial disease|arterial disease
220975|NCT02813161|neuropathy|neuropathy
220976|NCT02813161|amputation|amputation
220977|NCT02813161|QCDR|qcdr
220978|NCT02813161|quality measure|quality measure
220979|NCT02813161|wound|wound
220980|NCT02813096|HCC|hcc
220981|NCT02813096|PVTT|pvtt
220982|NCT02813096|Folofox4|folofox4
220983|NCT02813096|Early Recurrence|early recurrence
220984|NCT02813044|anesthesia|anesthesia
220985|NCT02813044|intravenous|intravenous
220986|NCT02813044|neurosurgery|neurosurgery
220987|NCT02813044|pituitary neoplasm|pituitary neoplasm
220988|NCT02813044|postoperative period|postoperative period
220989|NCT02813031|functional meat products|functional meat products
220990|NCT02813031|hypocaloric fats|hypocaloric fats
220991|NCT02813031|diglyceride|diglyceride
220992|NCT02813031|obesity|obesity
220993|NCT02813018|child|child
220994|NCT02813018|analgesia|analgesia
220995|NCT02813018|epidural|epidural
220996|NCT02813018|pain|pain
220997|NCT02813018|postoperative|postoperative
220998|NCT02813018|orthopedics|orthopedics
220999|NCT02813005|High frequency jet ventilation|high frequency jet ventilation
221000|NCT02812966|peripheral arterial disease|peripheral arterial disease
221001|NCT02812966|drug coated balloon|drug coated balloon
221002|NCT02812927|Glycemic lability index|glycemic lability index
221003|NCT02812927|Continuous glucose monitoring system|continuous glucose monitoring system
221004|NCT02812927|intensive care|intensive care
221005|NCT02812927|Insulin|insulin
221006|NCT02812888|Hyperthyroidism|hyperthyroidism
221007|NCT02812888|Betatrophin|betatrophin
221008|NCT02812875|Mesothelioma|mesothelioma
221009|NCT02812875|PD-L1|pd-l1
221010|NCT02812875|VISTA|vista
221011|NCT02812875|PD-1|pd-1
221012|NCT02812836|anorectal manometry|anorectal manometry
221013|NCT02812836|children|children
221014|NCT02812836|constipation|constipation
221015|NCT02812823|manometry|manometry
221016|NCT02812823|children|children
221017|NCT02812823|constipation|constipation
221018|NCT02812823|functional disorders|functional disorders
221019|NCT02812797|Adipokines|adipokines
221020|NCT02812797|Chronic Heart Failure|chronic heart failure
221021|NCT02812797|Prognosis|prognosis
221022|NCT02812784|Nephrocheck™|nephrocheck™
221023|NCT02812784|acute kidney injury|acute kidney injury
221024|NCT02812758|sedation depth|sedation depth
221025|NCT02812758|indices of preload dependence|indices of preload dependence
221026|NCT02812745|anaesthesia|anaesthesia
221027|NCT02812732|HPV vaccination|hpv vaccination
221028|NCT02812732|provider education|provider education
221029|NCT02812667|Metastatic|metastatic
221030|NCT02812667|NSCLC|nsclc
221031|NCT02812667|nivolumab|nivolumab
221032|NCT02812667|plinabulin|plinabulin
221033|NCT02812667|BPI-2358|bpi-2358
221034|NCT02812667|opdivo|opdivo
221035|NCT02812667|Non-Small Cell Lung Cancer|non-small cell lung cancer
221036|NCT02812667|cancer|cancer
221037|NCT02812654|Sarcoma|sarcoma
221038|NCT02812654|soft tissue sarcoma|soft tissue sarcoma
221039|NCT02812654|neoadjuvant chemotherapy|neoadjuvant chemotherapy
221040|NCT02812654|neoadjuvant radiotherapy|neoadjuvant radiotherapy
221041|NCT02812654|hypofractionated radiotherapy|hypofractionated radiotherapy
221042|NCT02812641|Concurrent chemoradiation|concurrent chemoradiation
221043|NCT02812641|Esophageal squamous cell carcinoma|esophageal squamous cell carcinoma
221044|NCT02812641|Vascular endothelial growth factor|vascular endothelial growth factor
221045|NCT02812628|laparoscopic surgery|laparoscopic surgery
722786|NCT00537342|Polymerized|polymerized
282623|NCT02444910|KDT501|kdt501
221046|NCT02812628|abdominoperineal resection|abdominoperineal resection
221047|NCT02812628|rectal cancer|rectal cancer
221048|NCT02812628|individualized surgery|individualized surgery
221049|NCT02812628|levator muscle|levator muscle
221050|NCT02812615|Environmental Enteric Dysfunction|environmental enteric dysfunction
221151|NCT02812056|Alisertib|alisertib
221051|NCT02812602|Total Knee Replacement|total knee replacement
221052|NCT02812602|Stitch|stitch
221053|NCT02812602|Removal|removal
221054|NCT02812602|Pain|pain
221055|NCT02812589|MRI|mri
221056|NCT02812576|Group B streptococcus|group b streptococcus
221057|NCT02812576|Infants|infants
221058|NCT02812576|China|china
221059|NCT02812550|full-spectrum endoscopy|full-spectrum endoscopy
221060|NCT02812550|polyp detection rate|polyp detection rate
221061|NCT02812550|colorectal cancer|colorectal cancer
221062|NCT02812550|colorectal screening|colorectal screening
221063|NCT02812550|adenoma detection rate|adenoma detection rate
221064|NCT02812550|endoscopic innovations|endoscopic innovations
221065|NCT02812537|Trajectories|trajectories
221066|NCT02812537|emergency room|emergency room
221067|NCT02812537|conduct disorder|conduct disorder
221068|NCT02812537|care management|care management
221069|NCT02812524|Immunotherapy|immunotherapy
221070|NCT02812524|Yervoy|yervoy
221071|NCT02812524|Head and neck cancer|head and neck cancer
221072|NCT02812524|Pre-operative|pre-operative
221073|NCT02812498|teleconsultation|teleconsultation
221074|NCT02812498|insulin therapy|insulin therapy
221075|NCT02812498|HbA1c|hba1c
221076|NCT02812459|Electrical Stimulation Therapy|electrical stimulation therapy
221077|NCT02812459|Kinesio taping|kinesio taping
221078|NCT02812459|Exercise|exercise
221079|NCT02812446|biofilm|biofilm
221080|NCT02812446|staphylokinase|staphylokinase
221081|NCT02812446|Staphylococcus aureus|staphylococcus aureus
221082|NCT02812446|microarrays|microarrays
221083|NCT02812446|bone binding sialoprotein|bone binding sialoprotein
221084|NCT02812446|bone and joint infection|bone and joint infection
221085|NCT02812446|blood group|blood group
221086|NCT02812433|birth asphyxia|birth asphyxia
221087|NCT02812433|brain|brain
221088|NCT02812433|hypoxic-ischemic encephalopathy|hypoxic-ischemic encephalopathy
221089|NCT02812433|neonate|neonate
221090|NCT02812433|neuroprotection|neuroprotection
221091|NCT02812433|neurorestoration|neurorestoration
221092|NCT02812433|newborn|newborn
221093|NCT02812433|sildenafil|sildenafil
221094|NCT02812394|Parkinson's disease|parkinson's disease
221095|NCT02812394|Episodic motor fluctuations (OFF periods)|episodic motor fluctuations (off periods)
221096|NCT02812381|Trigger Points, movement|trigger points, movement
221097|NCT02812355|off-pump|off-pump
221098|NCT02812355|coronary artery bypass|coronary artery bypass
221099|NCT02812355|heparinization|heparinization
221100|NCT02812342|Alopecia|alopecia
221101|NCT02812316|Myopia|myopia
221102|NCT02812316|Scleral lens|scleral lens
221103|NCT02812316|Astigmatism|astigmatism
221104|NCT02812316|Presbyopia|presbyopia
221105|NCT02812290|antibody mediated rejection|antibody mediated rejection
221106|NCT02812290|T cell mediated rejection|t cell mediated rejection
221107|NCT02812277|anastrozole|anastrozole
221108|NCT02812277|letrozole|letrozole
221109|NCT02812277|postmenopausal patients|postmenopausal patients
221110|NCT02812238|Inflammasome|inflammasome
221111|NCT02812238|Sirt3|sirt3
221112|NCT02812238|Nicotinamide Riboside|nicotinamide riboside
221113|NCT02812238|Fasting|fasting
221114|NCT02812212|ureteropelvic junction obstruction|ureteropelvic junction obstruction
221115|NCT02812212|cortical transit time|cortical transit time
221116|NCT02812186|Neuromuscular blockade|neuromuscular blockade
221117|NCT02812173|urinary drainage|urinary drainage
221118|NCT02812173|urethral catheter|urethral catheter
221119|NCT02812173|suprapubic tube|suprapubic tube
221120|NCT02812173|pain|pain
221121|NCT02812173|discomfort|discomfort
221122|NCT02812173|radical prostatectomy|radical prostatectomy
221123|NCT02812173|robotic surgery|robotic surgery
221124|NCT02812173|urinary infection|urinary infection
221125|NCT02812160|weight loss|weight loss
221126|NCT02812147|L-dihydoxyphenylserine|l-dihydoxyphenylserine
221127|NCT02812147|L-DOPS|l-dops
221128|NCT02812147|Northera|northera
221129|NCT02812134|phosphorus supplementation|phosphorus supplementation
221130|NCT02812134|FGF23|fgf23
221131|NCT02812134|anorexic|anorexic
221132|NCT02812134|adolescents|adolescents
221133|NCT02812134|undernutrition|undernutrition
221134|NCT02812108|intracranial aneurysm|intracranial aneurysm
221135|NCT02812108|endovascular treatment|endovascular treatment
221136|NCT02812108|recanalization|recanalization
221137|NCT02812108|outcome|outcome
221138|NCT02812108|hemodynamics|hemodynamics
221139|NCT02812108|computational fluid dynamic|computational fluid dynamic
221140|NCT02812108|stent|stent
221141|NCT02812108|flow diversion|flow diversion
221142|NCT02812082|Web-based|web-based
221143|NCT02812082|patient education application|patient education application
221144|NCT02812082|16-769|16-769
221145|NCT02812056|Malignant neoplasms of digestive organs|malignant neoplasms of digestive organs
221146|NCT02812056|Malignant neoplasms of female genital organs|malignant neoplasms of female genital organs
221147|NCT02812056|Malignant neoplasms of lip oral cavity and pharynx|malignant neoplasms of lip oral cavity and pharynx
221148|NCT02812056|Malignant neoplasms of male genital organs|malignant neoplasms of male genital organs
221149|NCT02812056|Human papilloma virus associated malignancies|human papilloma virus associated malignancies
221150|NCT02812056|HPV|hpv
221152|NCT02812056|MLN8237|mln8237
221153|NCT02812056|TAK-228|tak-228
221154|NCT02812056|MLN0128|mln0128
221155|NCT02812043|onychomycosis|onychomycosis
221156|NCT02812043|amorolfine|amorolfine
221157|NCT02812043|long-pulsed Nd:YAG|long-pulsed nd:yag
221158|NCT02812043|fungal infection|fungal infection
221159|NCT02812030|Observational Study|observational study
221160|NCT02812030|aflibercept|aflibercept
221161|NCT02812030|Diabetic Retinopathy|diabetic retinopathy
221162|NCT02812030|Visual Acuity|visual acuity
221163|NCT02812017|educational intervention|educational intervention
221164|NCT02812017|language development|language development
221165|NCT02812017|postpartum|postpartum
221166|NCT02812017|parental attachment|parental attachment
221167|NCT02812017|achievement gap|achievement gap
221168|NCT02812017|language gap|language gap
221169|NCT02812017|school readiness|school readiness
221170|NCT02812004|Vitreous Floaters|vitreous floaters
221171|NCT02812004|Mouches Voulantes|mouches voulantes
221172|NCT02811991|paracetamol|paracetamol
221173|NCT02811991|post-operative analgesia|post-operative analgesia
221174|NCT02811965|heel|heel
221175|NCT02811965|pressure ulcer|pressure ulcer
221176|NCT02811965|pressure mapping|pressure mapping
221177|NCT02811952|bladder cancer|bladder cancer
221178|NCT02811939|Cannabis|cannabis
221179|NCT02811939|Marijuana|marijuana
221180|NCT02811939|THC|thc
221181|NCT02811939|Dronabinol|dronabinol
221182|NCT02811939|Pregnenolone|pregnenolone
221183|NCT02811939|PREG|preg
221184|NCT02811939|Psychotic Disorders|psychotic disorders
221185|NCT02811926|parastomal bulging|parastomal bulging
221186|NCT02811926|peristomal bulging|peristomal bulging
221187|NCT02811926|ileostomy|ileostomy
221188|NCT02811926|colostomy|colostomy
221189|NCT02811926|enterostomy|enterostomy
221190|NCT02811926|incidence|incidence
221191|NCT02811926|risk factor|risk factor
221192|NCT02811913|sensory impairment|sensory impairment
221193|NCT02811913|sensory deficit|sensory deficit
221194|NCT02811913|upper limb|upper limb
221195|NCT02811913|transcranial magnetic stimulation|transcranial magnetic stimulation
221196|NCT02811913|brain stimulation|brain stimulation
221197|NCT02811913|rehabilitation|rehabilitation
221198|NCT02811900|obesity surgery|obesity surgery
221199|NCT02811900|Roux en Y gastric bypass|roux en y gastric bypass
221200|NCT02811900|sleeve gastrectomy|sleeve gastrectomy
221201|NCT02811900|excess weight loss|excess weight loss
221202|NCT02811900|quality of life|quality of life
221203|NCT02811874|diabetes education|diabetes education
221204|NCT02811874|community health workers|community health workers
221205|NCT02811874|diabetes control|diabetes control
221206|NCT02811861|Renal Cell Carcinoma (RCC)|renal cell carcinoma (rcc)
221207|NCT02811861|Lenvatinib|lenvatinib
221208|NCT02811861|First-line RCC|first-line rcc
221209|NCT02811861|Treatment-naive RCC|treatment-naive rcc
221210|NCT02811861|Everolimus|everolimus
221211|NCT02811861|Pembrolizumab|pembrolizumab
221212|NCT02811861|Sunitinib|sunitinib
221213|NCT02811861|Phase 3 RCC|phase 3 rcc
221214|NCT02811861|Phase 3 first-line RCC|phase 3 first-line rcc
221215|NCT02811861|Phase 3 treatment-naive RCC|phase 3 treatment-naive rcc
221216|NCT02811822|GMI-1271|gmi-1271
221217|NCT02811822|bortezomib|bortezomib
221218|NCT02811822|carfilzomib|carfilzomib
221219|NCT02811822|multiple myeloma|multiple myeloma
221220|NCT02811809|Prostate cancer|prostate cancer
221221|NCT02811809|Apalutamide|apalutamide
221222|NCT02811809|IHT|iht
221223|NCT02811809|BCR|bcr
221224|NCT02811809|Biochemical recurrence|biochemical recurrence
221225|NCT02811809|intermittent hormone therapy|intermittent hormone therapy
221226|NCT02811796|drug eluting stents|drug eluting stents
221227|NCT02811796|flow fractional reserve|flow fractional reserve
221228|NCT02811796|prognosis|prognosis
221229|NCT02811796|angio-based FFR|angio-based ffr
221230|NCT02811783|Pruritus|pruritus
221231|NCT02811783|Mycosis Fungoides|mycosis fungoides
221232|NCT02811783|CTCL|ctcl
221233|NCT02811783|naloxone|naloxone
221234|NCT02811783|opiate antagonist|opiate antagonist
221235|NCT02811783|Sézary Syndrome|sézary syndrome
221236|NCT02811718|Stress Management|stress management
221237|NCT02811718|Resiliency|resiliency
221238|NCT02811718|Skype|skype
221239|NCT02811692|Database|database
221240|NCT02811692|Diabetic Macular Edema (DME)|diabetic macular edema (dme)
221241|NCT02811692|Wet Age-related Macular Degeneration (wAMD)|wet age-related macular degeneration (wamd)
221242|NCT02811692|Retinal Diseases|retinal diseases
221243|NCT02811692|Optic Nerve Diseases|optic nerve diseases
221244|NCT02811692|Corneal Diseases|corneal diseases
221245|NCT02811692|Vision Disorders|vision disorders
221246|NCT02811679|Lymphoma|lymphoma
221247|NCT02811653|Motor slowing|motor slowing
221248|NCT02811640|Intra-Abdominal Pressure|intra-abdominal pressure
221249|NCT02811640|Stryker Pressure Monitor|stryker pressure monitor
221250|NCT02811627|Magnetic Resonance Spectroscopy|magnetic resonance spectroscopy
221251|NCT02811627|Memantine|memantine
221252|NCT02811627|Treatment prediction biomarker|treatment prediction biomarker
221253|NCT02811614|intracerebral hemorrhage,hypertensive|intracerebral hemorrhage,hypertensive
221254|NCT02811614|minimally invasive surgery|minimally invasive surgery
221255|NCT02811614|neuroendoscopic surgery|neuroendoscopic surgery
221256|NCT02811614|stereotactic aspiration|stereotactic aspiration
221257|NCT02811601|Minimally Invasive Surgical Procedures|minimally invasive surgical procedures
221258|NCT02811575|Coloscopy|coloscopy
221259|NCT02811549|Cochlear Implant|cochlear implant
221260|NCT02811549|HiRes™ 90K Advantage Implant|hires™ 90k advantage implant
221261|NCT02811549|HiFocus™ Mid-Scala electrode|hifocus™ mid-scala electrode
221262|NCT02811549|HiFocus™ 1J electrode|hifocus™ 1j electrode
221263|NCT02811549|HiFocus Helix™ electrode|hifocus helix™ electrode
221264|NCT02811549|Cochlear Implantation|cochlear implantation
221265|NCT02811549|Listening Benefits|listening benefits
221266|NCT02811549|Adults|adults
221267|NCT02811549|Cochlear Implant Benefit|cochlear implant benefit
221268|NCT02811549|Electrical Stimulation|electrical stimulation
221269|NCT02811549|HiRes™ Ultra Implant with HiFocus™ Mid‐Scala electrode|hires™ ultra implant with hifocus™ mid‐scala electrode
221270|NCT02811484|Obesity|obesity
221271|NCT02811458|Panic Disorder|panic disorder
221272|NCT02811458|Agoraphobia|agoraphobia
221273|NCT02811458|Social Anxiety Disorder|social anxiety disorder
221274|NCT02811458|Generalized Anxiety Disorder|generalized anxiety disorder
221275|NCT02811458|Cognitive-Behavioral Therapy|cognitive-behavioral therapy
221276|NCT02811445|microbiome, metabolome, aging, lean mass, physical function|microbiome, metabolome, aging, lean mass, physical function
221277|NCT02811432|Kangaroo mother care|kangaroo mother care
221278|NCT02811432|Preterm infant|preterm infant
221279|NCT02811432|Low birth weight|low birth weight
221280|NCT02811432|Unstable|unstable
221281|NCT02811393|Bariatric surgery, sarcopenia|bariatric surgery, sarcopenia
221282|NCT02811380|CVC|cvc
221283|NCT02811380|Healthcare associated infections (HAI)|healthcare associated infections (hai)
221284|NCT02811380|CLABSI|clabsi
221285|NCT02811380|Noble metal alloy coating|noble metal alloy coating
221286|NCT02811380|CVC related thrombosis|cvc related thrombosis
221287|NCT02811341|Scopolamine butylbromide PCLE|scopolamine butylbromide pcle
221288|NCT02811276|High-protein diet|high-protein diet
221289|NCT02811276|Energy metabolism|energy metabolism
221290|NCT02811276|Substrate oxidation|substrate oxidation
221291|NCT02811250|Renal cancer|renal cancer
221292|NCT02811250|Stereotactic radiotherapy|stereotactic radiotherapy
221293|NCT02811185|PET|pet
221294|NCT02811185|CT|ct
221295|NCT02811185|PET/CT|pet/ct
221296|NCT02811172|Biological multi-paradigm model|biological multi-paradigm model
221297|NCT02811172|Biomarkers|biomarkers
221298|NCT02811172|Triglycerides|triglycerides
221299|NCT02811172|Cholesterol|cholesterol
221300|NCT02811172|Prolactin|prolactin
221301|NCT02811172|Glucose|glucose
221302|NCT02811146|Heart Failure|heart failure
221303|NCT02811146|Noninvasive Ventilation|noninvasive ventilation
221304|NCT02811146|Positive- Pressure Respiration|positive- pressure respiration
221305|NCT02811133|inositol|inositol
221306|NCT02811120|meningococcal|meningococcal
221307|NCT02811120|conjugate|conjugate
221308|NCT02811120|vaccine|vaccine
221309|NCT02811120|quadrivalent|quadrivalent
221310|NCT02811120|meningococcal quadrivalent conjugate vaccine|meningococcal quadrivalent conjugate vaccine
221311|NCT02811107|anxiety|anxiety
221312|NCT02811107|pain|pain
221313|NCT02811107|preoperative area|preoperative area
221314|NCT02811107|premedication|premedication
221315|NCT02811068|HPV|hpv
221316|NCT02811068|vaccine|vaccine
221317|NCT02811068|Human Papillomavirus Virus Vaccine|human papillomavirus virus vaccine
221318|NCT02811029|neurological|neurological
221319|NCT02811029|difficulties|difficulties
221320|NCT02811016|High Altitude|high altitude
221321|NCT02811016|budesonide|budesonide
221322|NCT02811016|hypoxia|hypoxia
221323|NCT02811003|Insertional Achilles|insertional achilles
221324|NCT02810990|bosutinib|bosutinib
221325|NCT02810990|chronic myeloid leukemia|chronic myeloid leukemia
221326|NCT02810977|gastric volume|gastric volume
221327|NCT02810977|gastric content|gastric content
221328|NCT02810977|ultrasound|ultrasound
221329|NCT02810977|perioperative fasting|perioperative fasting
221330|NCT02810964|Schizophrenia|schizophrenia
221331|NCT02810964|Schizoaffective Disorder|schizoaffective disorder
221332|NCT02810964|Sulforaphane|sulforaphane
221333|NCT02810964|Sulforaphane supplement|sulforaphane supplement
221334|NCT02810951|RDEB|rdeb
221335|NCT02810938|Ablation|ablation
221336|NCT02810938|Mifi technology|mifi technology
221337|NCT02810938|maximum voltage-guided ablation|maximum voltage-guided ablation
221338|NCT02810899|child|child
283010|NCT02442492|FGR|fgr
221339|NCT02810899|craniotomy|craniotomy
221340|NCT02810899|intelligence tests|intelligence tests
221341|NCT02810899|dexmedetomidine|dexmedetomidine
221342|NCT02810899|Disruption|disruption
221343|NCT02810899|Dehiscence|dehiscence
221344|NCT02810899|Mild Cognitive Disorder|mild cognitive disorder
221345|NCT02810886|Prostate Cancer|prostate cancer
221346|NCT02810860|laparoscopic cholecystectomy|laparoscopic cholecystectomy
221347|NCT02810847|Amblyopia|amblyopia
221348|NCT02810847|strabismus|strabismus
221349|NCT02810847|virtual reality|virtual reality
221350|NCT02810847|computer games|computer games
221458|NCT02810262|EGFR|egfr
221351|NCT02810834|Executive Function|executive function
221352|NCT02810834|Academic Performance|academic performance
221353|NCT02810821|Gonadal hormones|gonadal hormones
221354|NCT02810821|Gonadotropins|gonadotropins
221355|NCT02810821|Cardiovascular diseases|cardiovascular diseases
221356|NCT02810821|Lipids|lipids
221357|NCT02810821|Obesity|obesity
221358|NCT02810821|Atherosclerosis|atherosclerosis
221359|NCT02810821|Glucose metabolism disorders|glucose metabolism disorders
221360|NCT02810821|Metabolic syndrome|metabolic syndrome
221361|NCT02810821|Non-alcoholic fatty liver disease|non-alcoholic fatty liver disease
221362|NCT02810808|Neovascular Age-related Macular Degeneration|neovascular age-related macular degeneration
221363|NCT02810808|Ranibizumab|ranibizumab
221364|NCT02810808|Pro Re Nata|pro re nata
221365|NCT02810795|Coronary|coronary
221366|NCT02810795|Artery|artery
221367|NCT02810795|Computed tomography|computed tomography
221369|NCT02810795|CT myocardial perfusion|ct myocardial perfusion
221370|NCT02810795|Dynamic|dynamic
221371|NCT02810782|opiate dependence|opiate dependence
221372|NCT02810782|withdrawal|withdrawal
221373|NCT02810782|newborn|newborn
221374|NCT02810730|pancreas|pancreas
221375|NCT02810730|adenocarcinoma|adenocarcinoma
221376|NCT02810704|Anticoagulant|anticoagulant
221377|NCT02810704|Venous Thromboembolism|venous thromboembolism
221378|NCT02810704|Pulmonary Embolism|pulmonary embolism
221379|NCT02810704|Total Knee Arthroplasty|total knee arthroplasty
221380|NCT02810704|Total Hip Arthroplasty|total hip arthroplasty
221381|NCT02810691|Diabetes|diabetes
221382|NCT02810691|Fiber|fiber
221383|NCT02810691|Supplementation|supplementation
221384|NCT02810691|Soluble fiber|soluble fiber
221385|NCT02810691|Post-prandial blood glucose|post-prandial blood glucose
221386|NCT02810691|Nutrition|nutrition
221387|NCT02810678|Tuberculosis|tuberculosis
221388|NCT02810665|Repeatability|repeatability
221389|NCT02810665|Concordance|concordance
221390|NCT02810665|Agreement|agreement
221391|NCT02810665|ETDRS visual acuity chart|etdrs visual acuity chart
221392|NCT02810665|numeric|numeric
221393|NCT02810665|Landolt C|landolt c
221394|NCT02810665|Roman alphabet|roman alphabet
221395|NCT02810652|Cancer Surgery Care|cancer surgery care
221396|NCT02810639|pain|pain
221397|NCT02810587|Endophthalmitis|endophthalmitis
221398|NCT02810587|Intravitreous injection|intravitreous injection
221399|NCT02810587|anti-vascular endothelial growth factor|anti-vascular endothelial growth factor
221400|NCT02810587|topical antibiotics|topical antibiotics
221401|NCT02810561|Troponin|troponin
221402|NCT02810535|Local IgE|local ige
221403|NCT02810535|Non-allergic rhinitis|non-allergic rhinitis
221404|NCT02810535|Allergic rhinitis to house dust mite|allergic rhinitis to house dust mite
221405|NCT02810509|Wafarin|wafarin
221406|NCT02810509|Cardioembolic (CE) stroke|cardioembolic (ce) stroke
221407|NCT02810509|ischemic stroke|ischemic stroke
221408|NCT02810483|Prader-Willi|prader-willi
221409|NCT02810483|SPW|spw
221410|NCT02810483|impulsivity|impulsivity
221411|NCT02810483|eating disorders|eating disorders
221412|NCT02810483|topiramate|topiramate
221413|NCT02810457|Cancer|cancer
221414|NCT02810457|Bevacizumab|bevacizumab
221415|NCT02810457|Carboplatin|carboplatin
221416|NCT02810457|Paclitaxel|paclitaxel
221417|NCT02810418|Immunotoxin|immunotoxin
221418|NCT02810418|Mesothelin|mesothelin
221419|NCT02810418|Antibody-based Therapeutics|antibody-based therapeutics
221420|NCT02810418|Advanced Cancer|advanced cancer
221421|NCT02810405|Sample|sample
221422|NCT02810405|Storage|storage
221423|NCT02810405|Molecular Profiling|molecular profiling
221424|NCT02810405|Biopsy|biopsy
221425|NCT02810405|Repository|repository
221426|NCT02810379|informed consent|informed consent
221427|NCT02810379|ERCP|ercp
221428|NCT02810379|video|video
221429|NCT02810366|Verbal Autopsy|verbal autopsy
221430|NCT02810366|Physician-coded verbal autopsy|physician-coded verbal autopsy
221431|NCT02810366|Computer-coded verbal autopsy|computer-coded verbal autopsy
221432|NCT02810366|InterVA|interva
221433|NCT02810366|Naive Bayes Classifier (NBC)|naive bayes classifier (nbc)
221434|NCT02810366|Tariff|tariff
221435|NCT02810366|InSilicoVA|insilicova
221436|NCT02810366|Randomised Control Trial|randomised control trial
221437|NCT02810366|SmartVA|smartva
221438|NCT02810366|King-Lu|king-lu
221439|NCT02810327|Alpha-1 antitrypsin deficiency|alpha-1 antitrypsin deficiency
221440|NCT02810327|AATD|aatd
221441|NCT02810327|Alpha-1|alpha-1
221442|NCT02810327|SERPINA1|serpina1
221443|NCT02810327|MZ|mz
221444|NCT02810327|Carrier|carrier
221445|NCT02810327|Heterozygote|heterozygote
221446|NCT02810327|Smoking|smoking
221447|NCT02810327|COPD|copd
221448|NCT02810327|Emphysema|emphysema
221449|NCT02810327|Sequencing|sequencing
221450|NCT02810301|gluten|gluten
221451|NCT02810301|non-celiac|non-celiac
221452|NCT02810301|gluten sensitivity|gluten sensitivity
221453|NCT02810288|Airway anatomy|airway anatomy
221454|NCT02810288|difficult intubation|difficult intubation
221455|NCT02810288|congenital syndromes|congenital syndromes
221456|NCT02810262|Lung cancer|lung cancer
221457|NCT02810262|Bone metastases|bone metastases
221459|NCT02810262|KRAS|kras
221460|NCT02810262|Bone biomarkers|bone biomarkers
221461|NCT02810262|Metabolic parameters|metabolic parameters
221462|NCT02810249|African American YMSM|african american ymsm
221463|NCT02810249|PrEP|prep
221464|NCT02810249|HIV Pre-Exposure Prophylaxis|hiv pre-exposure prophylaxis
221465|NCT02810249|Common Sense Model|common sense model
221466|NCT02810249|Healthcare|healthcare
221467|NCT02810249|HIV Prevention|hiv prevention
221468|NCT02810236|Focal breast pain|focal breast pain
221469|NCT02810236|Directed Ultrasound|directed ultrasound
221470|NCT02810236|Reassurance|reassurance
221471|NCT02810236|Anxiety|anxiety
221472|NCT02810210|Zika|zika
221473|NCT02810210|microcephaly|microcephaly
221474|NCT02810210|congenital abnormalities|congenital abnormalities
221475|NCT02810210|new-born|new-born
221476|NCT02810210|infant|infant
221477|NCT02810184|bone augmentation|bone augmentation
221478|NCT02810184|long-term bone volume changes|long-term bone volume changes
221479|NCT02810184|immediate provisional implant|immediate provisional implant
221480|NCT02810171|anxiety|anxiety
221481|NCT02810171|social anxiety disorder|social anxiety disorder
221482|NCT02810171|generalized anxiety disorder|generalized anxiety disorder
221483|NCT02810171|phobias|phobias
221484|NCT02810171|fears|fears
221485|NCT02810171|worry|worry
221486|NCT02810145|traumatic brain injury|traumatic brain injury
221487|NCT02810145|cerebral desaturation|cerebral desaturation
221488|NCT02810145|intensive care|intensive care
221489|NCT02810145|hemodynamics|hemodynamics
221490|NCT02810145|Loss|loss
221491|NCT02810145|Consciousness|consciousness
221492|NCT02810106|Spect|spect
221493|NCT02810106|Stress Test|stress test
221494|NCT02810106|Myocardial Perfusion CT|myocardial perfusion ct
221495|NCT02810106|CT angiography|ct angiography
221496|NCT02810093|Breast cancer|breast cancer
221497|NCT02810093|Text mining|text mining
221498|NCT02810093|Big Data|big data
221499|NCT02810093|Machine Learning|machine learning
221500|NCT02810054|regeneration|regeneration
221501|NCT02810054|intrabony defects|intrabony defects
221502|NCT02810054|enamel matrix derivative|enamel matrix derivative
221503|NCT02810054|MIST|mist
221504|NCT02810028|Limb girdle muscular dystrophy|limb girdle muscular dystrophy
221505|NCT02810028|Becker's muscular dystrophy|becker's muscular dystrophy
221506|NCT02810028|Facioscapulohumeral muscular dystrophy|facioscapulohumeral muscular dystrophy
221507|NCT02810028|Inclusion-body myositis|inclusion-body myositis
221508|NCT02810028|Acceptance and Commitment Therapy|acceptance and commitment therapy
221510|NCT02809950|postoperative nausea and vomiting, oral carbohydrate beverage|postoperative nausea and vomiting, oral carbohydrate beverage
221511|NCT02809937|aged|aged
221512|NCT02809937|surgical procedures, operative|surgical procedures, operative
221513|NCT02809937|delirium|delirium
221514|NCT02809937|dexmedetomidine|dexmedetomidine
221515|NCT02809937|long-term outcome|long-term outcome
221516|NCT02809924|endotracheal intubation|endotracheal intubation
221517|NCT02809924|teaching|teaching
221518|NCT02809924|just-in-time|just-in-time
221519|NCT02809898|Biomarkers, Neoplasms|biomarkers, neoplasms
221520|NCT02809885|Hepatitis E|hepatitis e
221521|NCT02809885|Pediatric|pediatric
221522|NCT02809885|Transplantation|transplantation
221523|NCT02809885|Prevalence|prevalence
221525|NCT02809820|Beta Blockers|beta blockers
221526|NCT02809820|platelet aggregation|platelet aggregation
221527|NCT02809820|light transmission aggregometry|light transmission aggregometry
221528|NCT02809820|Beta-Adrenergic Blockers|beta-adrenergic blockers
221529|NCT02809807|Work of Breathing; Hypoxemia; Respiratory Acidosis; Respiratory effort; COPD|work of breathing; hypoxemia; respiratory acidosis; respiratory effort; copd
221530|NCT02809781|ankylosing spondylitis|ankylosing spondylitis
221531|NCT02809781|mesenchymal stem cell|mesenchymal stem cell
221532|NCT02809781|etanercept|etanercept
221533|NCT02809768|Healthy participants|healthy participants
221534|NCT02809768|Pharmacokinetic Drug-Drug Interaction|pharmacokinetic drug-drug interaction
221535|NCT02809768|Avatrombopag|avatrombopag
221536|NCT02809755|Obesity|obesity
221537|NCT02809755|laparoscopic gastric banding|laparoscopic gastric banding
221538|NCT02809755|band revision|band revision
221539|NCT02809755|laparoscopic gastric banding sleeve gastrectomy|laparoscopic gastric banding sleeve gastrectomy
221540|NCT02809742|Pregnant|pregnant
221541|NCT02809742|Labor|labor
221542|NCT02809742|Epidural|epidural
221543|NCT02809742|Analgesia|analgesia
221544|NCT02809742|Intermittent|intermittent
221545|NCT02809651|Infrascanner|infrascanner
221546|NCT02809651|Intracranial hemorrhage|intracranial hemorrhage
221547|NCT02809625|Dynamic contrast -enhanced MRI|dynamic contrast -enhanced mri
221548|NCT02809625|brucella spondylitis|brucella spondylitis
221549|NCT02809599|vertigo|vertigo
221550|NCT02809599|dizziness|dizziness
221551|NCT02809586|Alcohol|alcohol
221552|NCT02809586|Teens|teens
221553|NCT02809586|Young Adults|young adults
221554|NCT02809586|Social Media|social media
221555|NCT02809573|peripheral T-cell lymphoma|peripheral t-cell lymphoma
221556|NCT02809573|PTCL|ptcl
221557|NCT02809573|chidamide|chidamide
221558|NCT02809573|CHOP|chop
221559|NCT02809573|phase Ib|phase ib
221560|NCT02809560|Lymphocytes Th2|lymphocytes th2
221561|NCT02809560|Cav1 channels|cav1 channels
221562|NCT02809534|Anlotinib|anlotinib
221563|NCT02809534|AL3818|al3818
221564|NCT02809508|Omega-3|omega-3
221565|NCT02809508|Child nutrition|child nutrition
221566|NCT02809508|Dietary recommendations|dietary recommendations
221567|NCT02809508|Cardiovascular risk markers|cardiovascular risk markers
221568|NCT02809508|Cognitive function|cognitive function
221569|NCT02809508|Mental health|mental health
221570|NCT02809482|Volunteers|volunteers
221571|NCT02809443|Zika|zika
221572|NCT02809443|Vaccine|vaccine
221574|NCT02809391|Postural Balance|postural balance
221575|NCT02809391|Gait|gait
221576|NCT02809391|Foot Orthotic|foot orthotic
221577|NCT02809391|Proprioception|proprioception
221578|NCT02809391|Somatosensory|somatosensory
221579|NCT02809365|insulin treated|insulin treated
221580|NCT02809339|Chemotherapy|chemotherapy
221581|NCT02809339|ovarian cancer|ovarian cancer
221582|NCT02809339|Patient reported outcome|patient reported outcome
221583|NCT02809339|Quality of Care|quality of care
221584|NCT02809326|efficiency|efficiency
221585|NCT02809326|exposure therapy|exposure therapy
221586|NCT02809326|PTSD|ptsd
221587|NCT02809326|combat|combat
221588|NCT02809326|veterans|veterans
221589|NCT02809313|gingivitis|gingivitis
221590|NCT02809313|probiotic|probiotic
221591|NCT02809313|non- surgical treatment|non- surgical treatment
221592|NCT02809274|iron deficiency|iron deficiency
221593|NCT02809274|polycythemia vera|polycythemia vera
221594|NCT02809261|Carpal Tunnel Syndrome|carpal tunnel syndrome
221595|NCT02809261|Perineural injection|perineural injection
221596|NCT02809261|Dextrose|dextrose
221597|NCT02809248|LTX Study|ltx study
221598|NCT02809235|asthma|asthma
221599|NCT02809235|smooth muscle|smooth muscle
221600|NCT02809235|lauric acid|lauric acid
221601|NCT02809235|dietary supplement|dietary supplement
221602|NCT02809222|Myelodysplastic syndrome|myelodysplastic syndrome
221603|NCT02809222|Ascorbic acid|ascorbic acid
221604|NCT02809222|Oxidative stress|oxidative stress
221605|NCT02809222|Preleukemia|preleukemia
221606|NCT02809196|Food Habits|food habits
221607|NCT02809196|Adolescents|adolescents
221608|NCT02809196|Digital Communication|digital communication
221609|NCT02809183|metabolic acidosis|metabolic acidosis
221610|NCT02809183|serum bicarbonate|serum bicarbonate
221611|NCT02809183|kidney disease|kidney disease
221612|NCT02809131|CIED infection|cied infection
221613|NCT02809118|Deafness|deafness
221614|NCT02809118|Hearing Loss|hearing loss
221615|NCT02809118|Hearing Loss, Sensorineural|hearing loss, sensorineural
221616|NCT02809118|Ear Diseases|ear diseases
221617|NCT02809118|Hearing Disorders|hearing disorders
221618|NCT02809118|Nervous System Diseases|nervous system diseases
221619|NCT02809118|Neurologic Manifestations|neurologic manifestations
221620|NCT02809118|Otorhinolaryngologic Diseases|otorhinolaryngologic diseases
221621|NCT02809118|Sensation Disorders|sensation disorders
221622|NCT02809118|Signs and Symptoms|signs and symptoms
221623|NCT02809118|Hearing and Speech Impairment|hearing and speech impairment
221624|NCT02809118|Hearing Loss, Unilateral|hearing loss, unilateral
221625|NCT02809105|Chronic constipation|chronic constipation
221626|NCT02809105|Linaclotide|linaclotide
221627|NCT02809105|ASP0456|asp0456
221628|NCT02809092|Acute Myeloid Leukemia, Natural Killer Cells|acute myeloid leukemia, natural killer cells
221629|NCT02809066|premenstrual syndrome|premenstrual syndrome
221630|NCT02809066|calcium|calcium
221631|NCT02809066|quality of life|quality of life
221632|NCT02809053|low tumor burden follicular lymphoma (LTBFL)|low tumor burden follicular lymphoma (ltbfl)
221633|NCT02809014|Fluoride|fluoride
221634|NCT02809014|Dental caries|dental caries
221635|NCT02809014|Dentifrice|dentifrice
221636|NCT02809001|Fat grafting|fat grafting
221637|NCT02809001|Expansion-related complications|expansion-related complications
221638|NCT02808988|Bisphosphonate|bisphosphonate
221639|NCT02808988|osteoporosis|osteoporosis
221640|NCT02808988|RANKL|rankl
221641|NCT02808988|OPG|opg
221642|NCT02808988|periodontitis|periodontitis
221643|NCT02808975|Hidradenitis Suppurativa|hidradenitis suppurativa
221644|NCT02808975|axilla|axilla
221645|NCT02808975|inguinal region|inguinal region
221646|NCT02808975|Hurley Stage I, II, or III|hurley stage i, ii, or iii
221647|NCT02808975|adalimumab|adalimumab
221648|NCT02808975|secondary intention|secondary intention
221649|NCT02808975|abcess and inflammatory nodule (AN) count|abcess and inflammatory nodule (an) count
221650|NCT02808949|Prevention|prevention
221651|NCT02808949|Lactating Women|lactating women
221652|NCT02808949|Healthy|healthy
221653|NCT02808936|remote ischemic conditioning|remote ischemic conditioning
221654|NCT02808936|orthopedic surgery|orthopedic surgery
221655|NCT02808936|ischemic heart disease|ischemic heart disease
221656|NCT02808910|behavior|behavior
221657|NCT02808910|food intake|food intake
221658|NCT02808910|salt|salt
221659|NCT02808910|vegetables|vegetables
221660|NCT02808910|portion size|portion size
221661|NCT02808910|weight loss|weight loss
221662|NCT02808910|habits|habits
221663|NCT02808897|Chest tubes|chest tubes
221664|NCT02808897|Atrial fibrillation|atrial fibrillation
221665|NCT02808897|Thoracic surgery|thoracic surgery
221666|NCT02808897|Critical care|critical care
221667|NCT02808871|TRAIL1|trail1
221668|NCT02808871|TRAIL|trail
221669|NCT02808871|Pirfenidone|pirfenidone
221670|NCT02808858|MDS|mds
221671|NCT02808858|Myelodisplastic Syndrome|myelodisplastic syndrome
221672|NCT02808845|coronary angiography|coronary angiography
221673|NCT02808845|contrast-induced acute kidney injury|contrast-induced acute kidney injury
221674|NCT02808845|microalbuminuria|microalbuminuria
221675|NCT02808832|Human papillomavirus (HPV) vaccine|human papillomavirus (hpv) vaccine
221676|NCT02808832|Cervical cancer screening|cervical cancer screening
221677|NCT02808832|Provider intervention|provider intervention
221678|NCT02808819|Asthma|asthma
221679|NCT02808819|Bronchial Diseases|bronchial diseases
221680|NCT02808819|Respiratory Tract Diseases|respiratory tract diseases
221681|NCT02808819|Lung Diseases|lung diseases
221682|NCT02808819|Obstructive Lung Diseases|obstructive lung diseases
221683|NCT02808806|stroke|stroke
221684|NCT02808806|cerebral infarction|cerebral infarction
221685|NCT02808806|brain infarction|brain infarction
221686|NCT02808806|ischemic stroke|ischemic stroke
221687|NCT02808806|treatment|treatment
221688|NCT02808806|intravenous thrombolysis|intravenous thrombolysis
221689|NCT02808806|intraarterial thrombectomy|intraarterial thrombectomy
221690|NCT02808806|delay|delay
221691|NCT02808806|total system delay|total system delay
221692|NCT02808806|pre-hospital delay|pre-hospital delay
221693|NCT02808806|in-hospital delay|in-hospital delay
221694|NCT02808806|feedback|feedback
221695|NCT02808806|real-time feedback|real-time feedback
221696|NCT02808806|visual feedback|visual feedback
221697|NCT02808793|ISM|ism
221698|NCT02808793|Mastocytosis|mastocytosis
221699|NCT02808793|Indolent Mastocytosis|indolent mastocytosis
221700|NCT02808780|Ulcerative Colitis|ulcerative colitis
221701|NCT02808780|Simponi (Golimumab)|simponi (golimumab)
221702|NCT02808780|Thiopurines|thiopurines
221703|NCT02808780|Lymphoma|lymphoma
221704|NCT02808780|Malignancies|malignancies
221705|NCT02808767|Acute myocardial infarction|acute myocardial infarction
221706|NCT02808767|Primary coronary intervention|primary coronary intervention
221707|NCT02808767|Antiplatelet therapy|antiplatelet therapy
221708|NCT02808728|Total Knee Arthroplasty|total knee arthroplasty
221709|NCT02808728|Total Knee Replacement|total knee replacement
221710|NCT02808728|Exparel|exparel
221711|NCT02808728|Liposomal Bupivacaine|liposomal bupivacaine
221712|NCT02808728|Ropivacaine|ropivacaine
221713|NCT02808728|Postoperative Pain Management|postoperative pain management
221714|NCT02808702|Attention|attention
221715|NCT02808702|Cognitive behavioral therapy|cognitive behavioral therapy
221716|NCT02808702|Neuroimaging|neuroimaging
221717|NCT02808689|Moderate|moderate
221718|NCT02808689|Severe|severe
221719|NCT02808676|Cognitive training|cognitive training
221720|NCT02808676|Vitamin D|vitamin d
221721|NCT02808676|Exercise|exercise
221722|NCT02808637|Pain management|pain management
221723|NCT02808637|vaccination|vaccination
221724|NCT02808637|manual pressure|manual pressure
221725|NCT02808637|needle aspiration|needle aspiration
221726|NCT02808624|Oxaliplatin, peripheral neuropathy, L-CARNOSINE|oxaliplatin, peripheral neuropathy, l-carnosine
221727|NCT02808598|Clinical Trials|clinical trials
221728|NCT02808598|Education|education
221729|NCT02808598|Hispanic Americans|hispanic americans
221730|NCT02808598|African Americans|african americans
221731|NCT02808598|Health Disparities|health disparities
221732|NCT02808598|Patient Participation|patient participation
221733|NCT02808598|Refusal to Participate|refusal to participate
221734|NCT02808572|chronic kidney disease|chronic kidney disease
221735|NCT02808572|vascular calcifications|vascular calcifications
221736|NCT02808572|cardiovascular risk|cardiovascular risk
221737|NCT02808546|Gallbladder stone|gallbladder stone
221738|NCT02808546|Risk factor|risk factor
221739|NCT02808546|Case-control study|case-control study
221740|NCT02808546|Obesity|obesity
221741|NCT02808546|Hypertension|hypertension
221742|NCT02808546|Alcohol consumption|alcohol consumption
221743|NCT02808520|Social participation|social participation
722960|NCT00536705|child|child
221744|NCT02808520|Children and adolescents with cancer|children and adolescents with cancer
221745|NCT02808520|Quality of life with hodgkin-lymphoma|quality of life with hodgkin-lymphoma
221746|NCT02808520|Social inequalities and cancer|social inequalities and cancer
221747|NCT02808494|Preeclampsia|preeclampsia
221748|NCT02808494|Fetal Growth Restriction|fetal growth restriction
221749|NCT02808481|systemic sclerosis|systemic sclerosis
221750|NCT02808481|cardiac disease|cardiac disease
221751|NCT02808481|Heart transplantation|heart transplantation
221752|NCT02808481|primitive cardiac damage|primitive cardiac damage
221753|NCT02808468|Sexual assault|sexual assault
221754|NCT02808468|Posttraumatic Stress Disorder|posttraumatic stress disorder
221755|NCT02808468|Alcohol use|alcohol use
221756|NCT02808468|Cognitive therapy|cognitive therapy
221757|NCT02808429|Atacicept|atacicept
221758|NCT02808429|IgA Nephropathy|iga nephropathy
221759|NCT02808429|Berger´s disease|berger´s disease
221760|NCT02808429|Glomerulonephritis|glomerulonephritis
221761|NCT02808429|Proteinuria|proteinuria
221762|NCT02808416|Solid tumors|solid tumors
221763|NCT02808416|Brain metastases|brain metastases
221764|NCT02808416|DC vaccine|dc vaccine
221765|NCT02808416|Personalized vaccine|personalized vaccine
221766|NCT02808416|Tumor antigens|tumor antigens
221767|NCT02808364|Recurrent glioblastoma|recurrent glioblastoma
221768|NCT02808364|DC vaccine|dc vaccine
221769|NCT02808364|tumor antigen|tumor antigen
221770|NCT02808364|personalized vaccine|personalized vaccine
221771|NCT02808299|statin|statin
221772|NCT02808299|hepatitis B virus|hepatitis b virus
221773|NCT02808273|Bemiparine|bemiparine
221774|NCT02808273|Antithrombotic microsurgery protocol|antithrombotic microsurgery protocol
221775|NCT02808273|Comparative study|comparative study
221776|NCT02808273|Anticoagulant microsurgery protocol|anticoagulant microsurgery protocol
221777|NCT02808260|sub-clinical atrial fibrillation|sub-clinical atrial fibrillation
221778|NCT02808260|biomarkers|biomarkers
221779|NCT02808260|implanted pacemaker or defibrillator|implanted pacemaker or defibrillator
221780|NCT02808247|advanced metastatic soft tissue sarcoma|advanced metastatic soft tissue sarcoma
221781|NCT02808221|Heart failure|heart failure
221782|NCT02808221|heart disease|heart disease
221783|NCT02808221|left ventricular|left ventricular
221784|NCT02808195|Cerebral Palsy|cerebral palsy
221785|NCT02808195|Neurological Rehabilitation|neurological rehabilitation
221786|NCT02808195|Upper Extremity|upper extremity
221787|NCT02808156|Cerebral Palsy,|cerebral palsy,
221788|NCT02808156|Upper limb neurorehabilitation|upper limb neurorehabilitation
221789|NCT02808156|Upper Extremity|upper extremity
221790|NCT02808156|Neurological Rehabilitation|neurological rehabilitation
221791|NCT02808130|hyperlipidemia, periodontal disease, oxidative stress,|hyperlipidemia, periodontal disease, oxidative stress,
221792|NCT02808117|microfinance institution|microfinance institution
221793|NCT02808117|MFI|mfi
221794|NCT02808078|Instrumented treadmill|instrumented treadmill
221795|NCT02808078|Augmented reality|augmented reality
221796|NCT02808078|Neurorehabilitation|neurorehabilitation
221797|NCT02808078|Gait disorders|gait disorders
221798|NCT02808065|Kidney transplant|kidney transplant
221799|NCT02808065|Kidney transplantation|kidney transplantation
221800|NCT02808065|Renal transplant|renal transplant
221801|NCT02808065|Renal transplantation|renal transplantation
221802|NCT02808052|Bacterial infections|bacterial infections
221803|NCT02808026|severe hypertension|severe hypertension
221804|NCT02808026|grade III hypertension|grade iii hypertension
221805|NCT02808026|mineralocorticoid receptor antagonist|mineralocorticoid receptor antagonist
221806|NCT02807987|Mineralocorticoid receptor antagonist|mineralocorticoid receptor antagonist
221807|NCT02807987|Moderate renal impairment|moderate renal impairment
221808|NCT02807987|Hypertension|hypertension
221809|NCT02807974|Hypertension with Type 2 Diabetes and Albuminuria|hypertension with type 2 diabetes and albuminuria
221810|NCT02807974|Diabetic nephropathy|diabetic nephropathy
221811|NCT02807974|Diabetic renal disease|diabetic renal disease
221812|NCT02807974|Albuminuria|albuminuria
221813|NCT02807974|Mineralocorticoid receptor antagonist|mineralocorticoid receptor antagonist
221814|NCT02807961|Translational read through|translational read through
221815|NCT02807948|MRI Scan, pacemakers, ICD, CRT|mri scan, pacemakers, icd, crt
221816|NCT02807922|Palliative Care|palliative care
221817|NCT02807922|zopiclone|zopiclone
221818|NCT02807896|biomarker|biomarker
221819|NCT02807896|pancreatic cancer|pancreatic cancer
221820|NCT02807896|bile duct cancer|bile duct cancer
221821|NCT02807896|miRNA|mirna
221822|NCT02807883|Acute Lymphoblastic Leukemia|acute lymphoblastic leukemia
221823|NCT02807883|ALL|all
221824|NCT02807883|B-lineage Acute Lymphoblastic Leukemia|b-lineage acute lymphoblastic leukemia
221825|NCT02807883|Malignant neoplasms stated as primary lymphoid haematopoietic|malignant neoplasms stated as primary lymphoid haematopoietic
221826|NCT02807883|Blinatumomab|blinatumomab
221827|NCT02807883|Blincyto|blincyto
221828|NCT02807883|Post allogeneic stem cell transplant|post allogeneic stem cell transplant
221829|NCT02807870|Parental training|parental training
221830|NCT02807870|Preschool age|preschool age
400628|NCT01865981|cardiomyocytes|cardiomyocytes
221831|NCT02807870|Attention Deficit/Hyperactivity Disorder (ADHD)|attention deficit/hyperactivity disorder (adhd)
221832|NCT02807857|low-interventional observational study,|low-interventional observational study,
221833|NCT02807857|CHF,|chf,
221834|NCT02807857|heart failure,|heart failure,
221835|NCT02807857|primary care,|primary care,
221836|NCT02807857|ESC guidelines,|esc guidelines,
221837|NCT02807857|Europe,|europe,
221838|NCT02807857|NT-proBNP,|nt-probnp,
221839|NCT02807857|reduced ventricular ejection fraction (EF),|reduced ventricular ejection fraction (ef),
221840|NCT02807844|Triple negative breast cancer|triple negative breast cancer
221841|NCT02807844|Pancreatic carcinoma|pancreatic carcinoma
221842|NCT02807844|Melanoma|melanoma
221843|NCT02807844|Endometrial Carcinoma|endometrial carcinoma
221844|NCT02807844|Immuno oncology|immuno oncology
221845|NCT02807844|Monoclonal antibody|monoclonal antibody
221846|NCT02807844|PDR001|pdr001
221847|NCT02807844|MCS110|mcs110
221848|NCT02807831|Executive Function|executive function
221849|NCT02807831|Language|language
221850|NCT02807831|Preschool child|preschool child
221851|NCT02807831|Development|development
221852|NCT02807818|Child development|child development
221853|NCT02807818|Infant|infant
221854|NCT02807818|Mother-Child Relations|mother-child relations
221855|NCT02807805|castration resistant prostate cancer|castration resistant prostate cancer
221856|NCT02807792|Perianal surgery|perianal surgery
221857|NCT02807779|angioplasty|angioplasty
221858|NCT02807779|peripheral artery disease|peripheral artery disease
221859|NCT02807779|peripheral vascular disease|peripheral vascular disease
221860|NCT02807779|atherosclerosis|atherosclerosis
221861|NCT02807779|balloon angioplasty|balloon angioplasty
221862|NCT02807779|dexamethasone|dexamethasone
221863|NCT02807779|drug coated balloon|drug coated balloon
221864|NCT02807779|paclitaxel|paclitaxel
221865|NCT02807779|walking|walking
221866|NCT02807779|claudication|claudication
221867|NCT02807766|autism|autism
221868|NCT02807766|Brain Plasticity|brain plasticity
221869|NCT02807766|Behavioral Intervention|behavioral intervention
221870|NCT02807766|Magnetic Resonance Imaging|magnetic resonance imaging
221871|NCT02807753|Hemophilia|hemophilia
221872|NCT02807753|Arthropathy|arthropathy
221873|NCT02807753|Pediatric|pediatric
221874|NCT02807740|Virtual Reality|virtual reality
221875|NCT02807740|Rehabilitation|rehabilitation
221876|NCT02807740|Cardiocirculatory system|cardiocirculatory system
221877|NCT02807740|Parkinson Disease|parkinson disease
221878|NCT02807688|health promotion|health promotion
221879|NCT02807688|lifestyles|lifestyles
221880|NCT02807688|physical comorbidity|physical comorbidity
221881|NCT02807688|risk factors|risk factors
221882|NCT02807688|behavioural change|behavioural change
221883|NCT02807662|posttraumatic stress disorder|posttraumatic stress disorder
221884|NCT02807662|prenatal care|prenatal care
221885|NCT02807636|Urothelial carcinoma|urothelial carcinoma
221886|NCT02807636|Bladder cancer|bladder cancer
221887|NCT02807636|Anti-PD-L1|anti-pd-l1
221888|NCT02807636|Transitional carcinoma|transitional carcinoma
221889|NCT02807636|Tecentriq|tecentriq
221890|NCT02807636|Atezolizumab|atezolizumab
221891|NCT02807636|IMvigor130|imvigor130
221892|NCT02807610|Etomidate lipuro|etomidate lipuro
221893|NCT02807610|Induction characteristics|induction characteristics
221894|NCT02807584|Wound|wound
221895|NCT02807584|burns|burns
221896|NCT02807584|acute|acute
221897|NCT02807584|chronic|chronic
221898|NCT02807584|foam|foam
221899|NCT02807584|adhesive|adhesive
221900|NCT02807584|dressing|dressing
221901|NCT02807571|Hand|hand
221902|NCT02807558|AML|aml
221903|NCT02807558|MDS|mds
221904|NCT02807545|Scoliosis-Specific Exercises|scoliosis-specific exercises
221905|NCT02807545|Schroth|schroth
221906|NCT02807519|Oral health|oral health
221907|NCT02807519|Saliva|saliva
221908|NCT02807519|Biomarker|biomarker
221909|NCT02807519|Cytokines|cytokines
221910|NCT02807519|Cancer|cancer
221911|NCT02807519|children|children
221912|NCT02807506|elders|elders
221913|NCT02807506|robotics|robotics
221914|NCT02807506|low income population|low income population
221915|NCT02807506|activities of daily living|activities of daily living
221916|NCT02807506|instrumental activities of daily living|instrumental activities of daily living
221917|NCT02807506|social robotics|social robotics
221918|NCT02807506|stroke|stroke
221919|NCT02807506|aged|aged
221920|NCT02807506|Retirement|retirement
221921|NCT02807506|Housing for elderly|housing for elderly
221922|NCT02807506|Homes for the aged|homes for the aged
221923|NCT02807493|Pregnancy|pregnancy
221924|NCT02807493|Labor and Delivery|labor and delivery
221925|NCT02807493|Occlusal Support Device|occlusal support device
221926|NCT02807467|reduction|reduction
221927|NCT02807467|delirium|delirium
221928|NCT02807467|duration|duration
221929|NCT02807467|severity|severity
221930|NCT02807454|Phase 2|phase 2
221931|NCT02807454|Open-Label|open-label
221932|NCT02807454|Durvalumab|durvalumab
221933|NCT02807454|Daratumumab|daratumumab
221934|NCT02807454|Multiple Myeloma|multiple myeloma
221935|NCT02807454|Relapsed and Refractory (RRMM)|relapsed and refractory (rrmm)
221936|NCT02807454|FUSION MM-003|fusion mm-003
221937|NCT02807454|PD-L1|pd-l1
221938|NCT02807441|Bleeding|bleeding
221939|NCT02807441|Aspirin|aspirin
221940|NCT02807441|Spine|spine
221941|NCT02807441|Surgery|surgery
221942|NCT02807428|post-surgical pain|post-surgical pain
221943|NCT02807428|total knee arthroplasty|total knee arthroplasty
221944|NCT02807428|total knee replacement|total knee replacement
221945|NCT02807415|cystic fibrosis|cystic fibrosis
221946|NCT02807415|CFTR|cftr
221947|NCT02807415|CFTR modulation|cftr modulation
221948|NCT02807415|sweat test|sweat test
221949|NCT02807415|intestinal current measurement, ICM|intestinal current measurement, icm
221950|NCT02807415|nasal transepithelial potential difference measurement, NPD|nasal transepithelial potential difference measurement, npd
221951|NCT02807402|Chronic Hepatitis C|chronic hepatitis c
221952|NCT02807402|Paritaprevir|paritaprevir
221953|NCT02807402|Ombitasvir|ombitasvir
221954|NCT02807402|Dasabuvir|dasabuvir
221955|NCT02807402|HCV|hcv
221956|NCT02807363|endometriosis|endometriosis
221957|NCT02807363|gonadotropin-releasing hormone agonist|gonadotropin-releasing hormone agonist
221958|NCT02807363|healthy volunteers|healthy volunteers
221959|NCT02807363|leuprolide oral tablet|leuprolide oral tablet
221960|NCT02807350|Intermittent Exotropia|intermittent exotropia
221961|NCT02807350|IXT|ixt
221962|NCT02807350|overminus|overminus
221963|NCT02807337|Oral mucositis|oral mucositis
221964|NCT02807311|Malnutrition|malnutrition
221965|NCT02807311|Undernutrition|undernutrition
221966|NCT02807311|lung transplantation|lung transplantation
221967|NCT02807311|artificial nutrition|artificial nutrition
221968|NCT02807311|nutritional supplements|nutritional supplements
221969|NCT02807311|enteral nutrition|enteral nutrition
221970|NCT02807298|Intarligamentary|intarligamentary
221971|NCT02807298|Articaine|articaine
221972|NCT02807298|Lidocaine|lidocaine
221973|NCT02807246|Probiotic|probiotic
221974|NCT02807246|Neonatal Hyperbilirubinemia|neonatal hyperbilirubinemia
221975|NCT02807220|Imuneks|imuneks
221976|NCT02807207|To Study pharmacokinetics and Cardiac safety pacritinib study|to study pharmacokinetics and cardiac safety pacritinib study
221977|NCT02807155|Transitional Care|transitional care
221978|NCT02807155|Young Adult|young adult
221979|NCT02807155|Guided Imagery|guided imagery
221980|NCT02807116|Drug-Interaction Study|drug-interaction study
221981|NCT02807103|Rituximab|rituximab
221982|NCT02807103|remission induction|remission induction
221983|NCT02807103|eosinophilic granulomatosis with polyangiitis|eosinophilic granulomatosis with polyangiitis
221984|NCT02807090|Low Back Pain|low back pain
221985|NCT02807090|Exercise|exercise
221986|NCT02807090|Dance Therapy|dance therapy
221987|NCT02807090|Physical Therapy|physical therapy
221988|NCT02807077|Healthy subjects|healthy subjects
221989|NCT02807038|Respiratory Function Tests|respiratory function tests
221990|NCT02807038|Air pollution|air pollution
221991|NCT02807038|Pregnancy|pregnancy
221992|NCT02807038|Spirometry|spirometry
221993|NCT02807012|Home care services|home care services
221994|NCT02807012|Nursing|nursing
221995|NCT02807012|Clinical trial|clinical trial
221996|NCT02807012|Geriatric nursing|geriatric nursing
221997|NCT02807012|Family caregiver|family caregiver
221998|NCT02807012|Aged|aged
221999|NCT02806999|Heart disease|heart disease
222000|NCT02806999|Postoperative period|postoperative period
222001|NCT02806999|Hyperglycemia|hyperglycemia
222002|NCT02806999|Berberine|berberine
222003|NCT02806999|Insulin|insulin
222004|NCT02806999|Clinical trials as topic|clinical trials as topic
222005|NCT02806947|Acute GVHD|acute gvhd
222006|NCT02806947|Standard-Risk|standard-risk
222007|NCT02806947|Sirolimus|sirolimus
222008|NCT02806947|Refined Minnesota Risk Criteria|refined minnesota risk criteria
222009|NCT02806947|Ann Arbor|ann arbor
222010|NCT02806947|Biomarker|biomarker
222011|NCT02806947|Steroid-Free|steroid-free
222012|NCT02806921|Scleral Contact Lens|scleral contact lens
222013|NCT02806921|Tear Proteases|tear proteases
222014|NCT02806921|Tear Cytokines|tear cytokines
222015|NCT02806908|Driving|driving
222016|NCT02806895|Driving|driving
222017|NCT02806856|Middle Cerebral Artery Stroke|middle cerebral artery stroke
222018|NCT02806856|tDCS|tdcs
222019|NCT02806856|Acute|acute
222020|NCT02806843|stroke|stroke
222021|NCT02806843|hemiplegia|hemiplegia
222022|NCT02806843|healthy|healthy
222023|NCT02806843|robotics|robotics
222024|NCT02806843|rehabilitation|rehabilitation
222025|NCT02806843|therapy|therapy
222026|NCT02806830|Intravitreal injection|intravitreal injection
222027|NCT02806830|AMD|amd
222028|NCT02806830|Diabetic Retinopathy|diabetic retinopathy
222029|NCT02806830|Retinal Artery Occlusion|retinal artery occlusion
222030|NCT02806830|Myopia, Degenerative|myopia, degenerative
222031|NCT02806830|eye drops|eye drops
222032|NCT02806804|vaccine|vaccine
222033|NCT02806804|safety|safety
222034|NCT02806804|immunogenicity|immunogenicity
222035|NCT02806791|Patients|patients
222036|NCT02806778|cardiac arrest|cardiac arrest
222037|NCT02806778|jugular venous oximetry|jugular venous oximetry
222038|NCT02806778|hypoxic brain injury|hypoxic brain injury
222039|NCT02806765|Dynamic Stability|dynamic stability
222040|NCT02806765|Postural Stability|postural stability
222041|NCT02806765|Gait Speed|gait speed
222042|NCT02806765|Hand Grip Strength|hand grip strength
222043|NCT02806765|Timed Get-up and Go|timed get-up and go
222044|NCT02806765|Older Adults|older adults
222045|NCT02806752|Polypoidal Choroidal Vasculopathy|polypoidal choroidal vasculopathy
222046|NCT02806739|Soy protein|soy protein
222047|NCT02806739|isoflavones|isoflavones
222048|NCT02806739|gestational diabetes|gestational diabetes
222049|NCT02806700|Diabetes|diabetes
222050|NCT02806700|Social Media|social media
222051|NCT02806687|Locally advanced pancreatic adenocarcinoma|locally advanced pancreatic adenocarcinoma
222052|NCT02806687|gene therapy|gene therapy
222053|NCT02806687|gemcitabine|gemcitabine
222054|NCT02806687|chemosensitization|chemosensitization
222055|NCT02806674|Helicobacter pylori|helicobacter pylori
222056|NCT02806674|Antibiotic resistance|antibiotic resistance
222057|NCT02806674|Sequencing|sequencing
222058|NCT02806661|Robotic surgery|robotic surgery
222059|NCT02806661|Vagus nerve preserving|vagus nerve preserving
222060|NCT02806635|Relationship Distress|relationship distress
222061|NCT02806635|Relationship Satisfaction|relationship satisfaction
222062|NCT02806635|Marriage|marriage
222063|NCT02806635|Web-based|web-based
222064|NCT02806635|Internet|internet
222065|NCT02806622|Sports|sports
222066|NCT02806622|University|university
222067|NCT02806622|Lower Extremity|lower extremity
222068|NCT02806622|Hip Joint|hip joint
222069|NCT02806609|football|football
222070|NCT02806609|cryotherapy|cryotherapy
222071|NCT02806609|balance|balance
222072|NCT02806609|electromyography|electromyography
222073|NCT02806557|Neoplasms|neoplasms
222074|NCT02806557|Neutropenia|neutropenia
222075|NCT02806557|drug therapy|drug therapy
222076|NCT02806557|Hematologic tests|hematologic tests
222077|NCT02806557|Point-of-care Systems|point-of-care systems
222078|NCT02806557|Febrile neutropenia|febrile neutropenia
222079|NCT02806544|Breast neoplasms|breast neoplasms
222080|NCT02806544|Breast cancer|breast cancer
222081|NCT02806544|Locally advanced breast cancer|locally advanced breast cancer
222082|NCT02806544|Neoadjuvant endocrine therapy|neoadjuvant endocrine therapy
222083|NCT02806544|Tamoxifen|tamoxifen
222084|NCT02806544|Low and middle income country|low and middle income country
222085|NCT02806531|vaccine|vaccine
222086|NCT02806531|safety|safety
222087|NCT02806518|DIEP|diep
222088|NCT02806518|Computed Tomography|computed tomography
222089|NCT02806518|Doppler|doppler
222090|NCT02806518|Thermography|thermography
222091|NCT02806440|Low dose naltrexone|low dose naltrexone
222092|NCT02806440|Pain|pain
222093|NCT02806375|Myelofibrosis|myelofibrosis
222094|NCT02806375|Ruxolitinib|ruxolitinib
222095|NCT02806375|Cyclophosphamide|cyclophosphamide
222593|NCT02803151|cell-free DNA|cell-free dna
222096|NCT02806375|Immunosuppressive Agents|immunosuppressive agents
222097|NCT02806375|Immune System Diseases|immune system diseases
222098|NCT02806375|Busulfan|busulfan
222099|NCT02806375|Fludarabine|fludarabine
222100|NCT02806375|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating
222101|NCT02806375|Myeloablative Agonists|myeloablative agonists
222102|NCT02806375|Hematopoietic Stem Cell Transplantation|hematopoietic stem cell transplantation
222103|NCT02806375|Allogeneic|allogeneic
222104|NCT02806362|Non-cirrhotic|non-cirrhotic
222105|NCT02806362|End Stage Renal Disease (ESRD)|end stage renal disease (esrd)
222106|NCT02806362|moderate fibrosis|moderate fibrosis
222107|NCT02806362|Chronic Hepatitis C Virus ( HCV)|chronic hepatitis c virus ( hcv)
222108|NCT02806362|Chronic Hepatitis C Genotype 1b|chronic hepatitis c genotype 1b
222109|NCT02806349|American ginseng|american ginseng
222110|NCT02806349|Konjac glucomannan fiber|konjac glucomannan fiber
222111|NCT02806336|exercise training|exercise training
222112|NCT02806336|assistive device|assistive device
222113|NCT02806336|weight loss|weight loss
222114|NCT02806336|function|function
222115|NCT02806336|mobility|mobility
222116|NCT02806310|Aortic Valve|aortic valve
222117|NCT02806310|Bicuspid|bicuspid
222118|NCT02806297|cholecystectomy|cholecystectomy
222119|NCT02806284|vaccination|vaccination
222120|NCT02806284|Streptococcus pneumoniae|streptococcus pneumoniae
222121|NCT02806271|Worry Postponement|worry postponement
222122|NCT02806271|Stimulus Control|stimulus control
222123|NCT02806245|Congenital Heart Disease (CHD)|congenital heart disease (chd)
222124|NCT02806245|Cardiopulmonary Bypass (CPB)|cardiopulmonary bypass (cpb)
222125|NCT02806245|Cardiac Index|cardiac index
222126|NCT02806245|Hemodynamics|hemodynamics
222127|NCT02806245|Pediatrics|pediatrics
222128|NCT02806232|Praziquantel ODT formulation|praziquantel odt formulation
222129|NCT02806232|Biltricide|biltricide
222130|NCT02806219|Bioequivalence|bioequivalence
222131|NCT02806219|Certolizumab pegol|certolizumab pegol
222132|NCT02806219|Human Volunteers|human volunteers
222133|NCT02806193|cardiovascular|cardiovascular
284100|NCT02436616|EEG|eeg
222134|NCT02806193|cardiac|cardiac
222135|NCT02806193|MRI|mri
222136|NCT02806193|CMR|cmr
222137|NCT02806193|CT|ct
222138|NCT02806193|ECG|ecg
222139|NCT02806193|magnetic resonance|magnetic resonance
222140|NCT02806193|imaging|imaging
222141|NCT02806154|Cancer|cancer
222142|NCT02806154|Chemotherapy toxicity|chemotherapy toxicity
222143|NCT02806154|Elderly patients|elderly patients
222144|NCT02806154|DEXA|dexa
222145|NCT02806154|muscle mass|muscle mass
222146|NCT02806141|Aerosolized colistin|aerosolized colistin
222147|NCT02806141|Intravenous colistin|intravenous colistin
222148|NCT02806128|cerebral infarction|cerebral infarction
222149|NCT02806128|kallikrein|kallikrein
222150|NCT02806128|KLK|klk
222151|NCT02806089|chronic kidney disease|chronic kidney disease
222152|NCT02806089|malnutrition inflammation atherogenesis syndrome|malnutrition inflammation atherogenesis syndrome
222153|NCT02806089|muscle strength|muscle strength
222154|NCT02806089|muscle mass|muscle mass
222155|NCT02806089|lean body mass|lean body mass
222156|NCT02806089|physical activity|physical activity
222157|NCT02806076|HCC|hcc
222158|NCT02806076|RFA|rfa
222159|NCT02806063|Prosthesis|prosthesis
222160|NCT02806063|joint infection|joint infection
222161|NCT02806063|perioperative samples|perioperative samples
222162|NCT02806050|FES PET|fes pet
222163|NCT02806050|Palbociclib|palbociclib
222164|NCT02805985|Degenerative Disc Disease|degenerative disc disease
222165|NCT02805985|Spondylolisthesis|spondylolisthesis
222166|NCT02805985|Retrolisthesis|retrolisthesis
222167|NCT02805972|Obesity|obesity
222168|NCT02805972|Binge eating|binge eating
222169|NCT02805868|Severe|severe
222170|NCT02805868|Anemia|anemia
222171|NCT02805868|Aplastic|aplastic
222172|NCT02805868|Post-Polycythemic|post-polycythemic
222173|NCT02805868|Transformation|transformation
222174|NCT02805868|Thrombocythemia|thrombocythemia
222175|NCT02805868|Essential|essential
222176|NCT02805842|non adherence|non adherence
222177|NCT02805842|Tacrolimus|tacrolimus
222178|NCT02805842|Advagraf|advagraf
222179|NCT02805829|NK cells|nk cells
222180|NCT02805829|Trastuzumab|trastuzumab
222181|NCT02805816|Celiac disease|celiac disease
222182|NCT02805816|Tissue transglutaminase|tissue transglutaminase
222183|NCT02805816|Histology|histology
222184|NCT02805790|Primary Mitochondrial Disease|primary mitochondrial disease
222185|NCT02805790|Mitochondrial Myopathy|mitochondrial myopathy
222186|NCT02805790|Elamipretide|elamipretide
222187|NCT02805790|MTP-131|mtp-131
222188|NCT02805790|Bendavia™|bendavia™
222189|NCT02805764|obstructive sleep apnea|obstructive sleep apnea
222190|NCT02805764|malocclusion|malocclusion
222191|NCT02805764|polysomnography|polysomnography
222192|NCT02805764|quality of life|quality of life
222193|NCT02805751|Achilles|achilles
222194|NCT02805751|Tendon|tendon
222195|NCT02805751|Loading|loading
222196|NCT02805751|Rehabilitation|rehabilitation
222197|NCT02805738|Chronic Hepatitis B|chronic hepatitis b
222198|NCT02805738|tenofovir|tenofovir
222199|NCT02805738|CKD-390|ckd-390
222200|NCT02805725|Advanced solid tumor|advanced solid tumor
222201|NCT02805725|Advanced pretreated soft tissue sarcomas|advanced pretreated soft tissue sarcomas
222202|NCT02805725|Phase I/II trial|phase i/ii trial
222203|NCT02805725|Dose escalation|dose escalation
222204|NCT02805725|PK study|pk study
222205|NCT02805712|Heart Failure|heart failure
222206|NCT02805712|Palliative Care|palliative care
222207|NCT02805699|Clinical Efficacy|clinical efficacy
222208|NCT02805699|Baofeikang Granules|baofeikang granules
222209|NCT02805699|Combined Pulmonary Fibrosis and Emphysema|combined pulmonary fibrosis and emphysema
222210|NCT02805686|Toxicity, Drug|toxicity, drug
222211|NCT02805673|Osteopathy|osteopathy
222212|NCT02805673|Support|support
222213|NCT02805673|Treatment|treatment
222214|NCT02805673|Pain|pain
222215|NCT02805673|Quality of Life|quality of life
222216|NCT02805660|MGCD0103|mgcd0103
222217|NCT02805660|MEDI4736|medi4736
222218|NCT02805660|Mocetinostat|mocetinostat
222219|NCT02805660|Durvalumab|durvalumab
222220|NCT02805660|HDAC Inhibitor|hdac inhibitor
222221|NCT02805660|PD-L1 Inhibitor|pd-l1 inhibitor
222222|NCT02805660|Phase 1|phase 1
222223|NCT02805660|Phase 2|phase 2
222224|NCT02805660|Metastatic Solid Tumor|metastatic solid tumor
222225|NCT02805660|Non-small cell lung cancer|non-small cell lung cancer
222226|NCT02805660|immunotherapy|immunotherapy
222227|NCT02805660|checkpoint inhibitor|checkpoint inhibitor
222228|NCT02805647|25-Hydroxy-vitamin D, children, bone fractures, vitamin D receptor polymorphism|25-hydroxy-vitamin d, children, bone fractures, vitamin d receptor polymorphism
222229|NCT02805634|nine holes peg|nine holes peg
222230|NCT02805634|triple stimulation|triple stimulation
222231|NCT02805634|multiple sclerosis|multiple sclerosis
222232|NCT02805582|Peripheral Nerve Block|peripheral nerve block
222233|NCT02805569|videolaryngoscope|videolaryngoscope
222234|NCT02805569|intubation stylet|intubation stylet
222235|NCT02805569|articulating stylet|articulating stylet
222236|NCT02805569|difficult airway|difficult airway
222237|NCT02805530|oligometastatic disease, radical treatment|oligometastatic disease, radical treatment
222238|NCT02805517|Minimally Invasive Surgical Procedures|minimally invasive surgical procedures
222239|NCT02805517|Transplant Donors|transplant donors
222240|NCT02805504|Bupivacaine|bupivacaine
222241|NCT02805504|Minimally Invasive Surgical Procedures|minimally invasive surgical procedures
222242|NCT02805491|Hypospadias|hypospadias
222243|NCT02805491|newborns|newborns
222244|NCT02805491|pesticide|pesticide
222245|NCT02805491|Picardie|picardie
222246|NCT02805465|Heart Failure|heart failure
222247|NCT02805465|Atrial Fibrillation|atrial fibrillation
222248|NCT02805465|CRT|crt
222249|NCT02805465|BiVP|bivp
222250|NCT02805465|HBP|hbp
222251|NCT02805387|labor dystocia|labor dystocia
222252|NCT02805374|Pharmacokinetics|pharmacokinetics
222253|NCT02805374|ASP1517|asp1517
222254|NCT02805374|Food effect|food effect
222255|NCT02805348|Kiklin|kiklin
222256|NCT02805348|Bixalomer|bixalomer
222257|NCT02805348|Chronic Kidney Disease|chronic kidney disease
222258|NCT02805335|Central Venous Catheter|central venous catheter
222259|NCT02805335|Catheter Bloodstream Related Infection|catheter bloodstream related infection
222260|NCT02805335|Economic evaluation|economic evaluation
222261|NCT02805309|Transcatheter Aortic Valve Replacement|transcatheter aortic valve replacement
222262|NCT02805309|Exercise|exercise
222263|NCT02805309|Frailty|frailty
222264|NCT02805309|Functional Outcomes|functional outcomes
222265|NCT02805309|Cognitive Behavioral Intervention|cognitive behavioral intervention
222266|NCT02805283|Diabetes Mellitus, Type 2|diabetes mellitus, type 2
222267|NCT02805270|adverse drug events, preventable, potential, counselling, medication reconciliation|adverse drug events, preventable, potential, counselling, medication reconciliation
222268|NCT02805244|JTZ-951|jtz-951
222269|NCT02805244|Pharmacokinetics|pharmacokinetics
222270|NCT02805244|14C-JTZ-951|14c-jtz-951
222271|NCT02805244|Mass balance|mass balance
222272|NCT02805244|Time course|time course
222273|NCT02805205|PEG-rhG-CSF neutropenia|peg-rhg-csf neutropenia
222274|NCT02805192|Emergency Department|emergency department
222275|NCT02805192|Estimation of age and weight|estimation of age and weight
222276|NCT02805192|Size measurement|size measurement
222277|NCT02805166|PEG-rhG-CSF|peg-rhg-csf
222278|NCT02805153|PEG-rhG-CSF|peg-rhg-csf
222279|NCT02805140|mother|mother
222280|NCT02805140|social support|social support
222281|NCT02805140|mobile app|mobile app
222282|NCT02805140|videoconference|videoconference
222283|NCT02805140|sedentary|sedentary
222284|NCT02805140|physical activity|physical activity
222285|NCT02805127|Asthma|asthma
222286|NCT02805127|COPD|copd
222287|NCT02805127|Capnography|capnography
222288|NCT02805114|Asthma|asthma
222289|NCT02805114|Chronic Obstructive Pulmonary Disease (COPD)|chronic obstructive pulmonary disease (copd)
222290|NCT02805114|Capnography|capnography
222291|NCT02805062|Trapped Lung|trapped lung
222292|NCT02805036|alveolar recruitment|alveolar recruitment
222293|NCT02805036|stroke volume/physiology|stroke volume/physiology
222294|NCT02805036|cardiac output/physiology|cardiac output/physiology
222295|NCT02804997|non-invasive ventilation|non-invasive ventilation
222296|NCT02804997|cardiac surgery|cardiac surgery
222297|NCT02804984|idiopathic cytopenia of undetermined significance (ICUS)|idiopathic cytopenia of undetermined significance (icus)
222298|NCT02804984|molecular defects|molecular defects
222299|NCT02804958|ST-segment elevation myocardial infarction|st-segment elevation myocardial infarction
222300|NCT02804958|Primary percutaneous coronary intervention|primary percutaneous coronary intervention
222301|NCT02804958|Clinical outcomes|clinical outcomes
222302|NCT02804945|Blood And Marrow Transplantation|blood and marrow transplantation
222303|NCT02804945|Adult Respiratory Distress Syndrome|adult respiratory distress syndrome
222304|NCT02804945|ARDS|ards
222305|NCT02804945|Allogeneic human mesenchymal stem cells|allogeneic human mesenchymal stem cells
222306|NCT02804945|hMSCs|hmscs
222307|NCT02804945|Placebo|placebo
222308|NCT02804945|Plasma-Lyte A solution|plasma-lyte a solution
222309|NCT02804945|Standard of Care|standard of care
222310|NCT02804945|Recent onset pulmonary toxicity|recent onset pulmonary toxicity
222311|NCT02804893|Lung cancer, video-assisted thoracoscopic surgery, robotic-assisted thoracoscopic surgery|lung cancer, video-assisted thoracoscopic surgery, robotic-assisted thoracoscopic surgery
222312|NCT02804880|Smoking cessation|smoking cessation
222313|NCT02804880|Quit to Win|quit to win
222314|NCT02804880|Brief intervention|brief intervention
222315|NCT02804880|Personalized active referral|personalized active referral
222316|NCT02804880|Instant messaging|instant messaging
222317|NCT02804880|SMS|sms
222318|NCT02804880|Smoking Cessation Intervention|smoking cessation intervention
222319|NCT02804841|Vitamin D supplementation|vitamin d supplementation
222320|NCT02804841|Cognitive function|cognitive function
222321|NCT02804841|Physical function|physical function
222322|NCT02804841|Successful ageing|successful ageing
222323|NCT02804841|Prevention|prevention
222324|NCT02804841|Cholecalciferol|cholecalciferol
222325|NCT02804841|Dementia|dementia
222326|NCT02804841|Muscle mass|muscle mass
222327|NCT02804815|Aspirin|aspirin
222328|NCT02804815|prostate|prostate
222329|NCT02804815|colorectal|colorectal
222330|NCT02804815|breast|breast
222331|NCT02804815|gastro-oesophageal|gastro-oesophageal
222332|NCT02804815|recurrence|recurrence
222333|NCT02804789|Prevention|prevention
222334|NCT02804763|Systemic Lupus Erythematosus (SLE)|systemic lupus erythematosus (sle)
222335|NCT02804763|Dapirolizumab Pegol (DZP)|dapirolizumab pegol (dzp)
222336|NCT02804750|Cushing's Syndrome|cushing's syndrome
222337|NCT02804750|Cushing's Disease|cushing's disease
222338|NCT02804750|Cushing's|cushing's
222339|NCT02804750|Hypercortisolemia|hypercortisolemia
222340|NCT02804750|Cushingoid|cushingoid
222341|NCT02804750|Type 2 Diabetes|type 2 diabetes
222342|NCT02804750|Impaired Glucose Intolerance|impaired glucose intolerance
222343|NCT02804750|Hypertension|hypertension
222344|NCT02804750|Adrenal Corticotrophic Hormone (ACTH)|adrenal corticotrophic hormone (acth)
222345|NCT02804750|Adrenocortical Carcinoma|adrenocortical carcinoma
222346|NCT02804750|Primary Pigmented Nodular Adrenal Disease (PPNAD)|primary pigmented nodular adrenal disease (ppnad)
222347|NCT02804750|Moon Facies|moon facies
222348|NCT02804750|Dorsocervical Fat Pad|dorsocervical fat pad
222349|NCT02804750|Adrenal Adenoma|adrenal adenoma
222350|NCT02804750|Adrenal Carcinoma|adrenal carcinoma
222351|NCT02804750|Adrenal Autonomy|adrenal autonomy
222352|NCT02804750|Cortisol|cortisol
222353|NCT02804724|HIV|hiv
222354|NCT02804724|Human immunodeficiency virus|human immunodeficiency virus
222355|NCT02804724|Late diagnosis|late diagnosis
222356|NCT02804672|Cardiovascular health|cardiovascular health
222357|NCT02804672|Diet|diet
222358|NCT02804672|Functional limitations|functional limitations
222359|NCT02804672|Frailty|frailty
222360|NCT02804672|Older adults|older adults
222361|NCT02804659|micro-RNA|micro-rna
222362|NCT02804646|Recombinant human endostatin(Endostar)|recombinant human endostatin(endostar)
222363|NCT02804646|Durative transfusion|durative transfusion
222364|NCT02804646|adenocarcinoma of lung|adenocarcinoma of lung
222365|NCT02804633|IV acetaminophen|iv acetaminophen
222366|NCT02804633|Colorectal Surgery|colorectal surgery
222367|NCT02804633|Enhance Recovery|enhance recovery
222368|NCT02804633|Opioid Consumption|opioid consumption
222369|NCT02804633|Pain Management|pain management
222370|NCT02804607|burn|burn
222371|NCT02804607|child|child
222372|NCT02804607|graft|graft
222373|NCT02804607|development|development
222374|NCT02804607|complications|complications
222375|NCT02804607|autonomy|autonomy
222376|NCT02804568|Schizophrenia|schizophrenia
222377|NCT02804568|Alkermes|alkermes
222378|NCT02804568|ALK 3831|alk 3831
222379|NCT02804568|Samidorphan|samidorphan
222380|NCT02804555|reactive oxygen species|reactive oxygen species
222381|NCT02804555|elective cesarean section|elective cesarean section
222382|NCT02804555|oxygen therapy|oxygen therapy
222383|NCT02804555|newborn|newborn
222384|NCT02804542|fascia iliaca blocks|fascia iliaca blocks
222385|NCT02804529|Laparoscopic entry|laparoscopic entry
222386|NCT02804529|Meng's point|meng's point
222387|NCT02804529|Veress needle|veress needle
222388|NCT02804477|adherence|adherence
222389|NCT02804477|opioid|opioid
222390|NCT02804477|MMAS 8, morisky medication adherence scale|mmas 8, morisky medication adherence scale
222391|NCT02804477|validation|validation
222392|NCT02804425|Medical Education|medical education
222393|NCT02804425|Simulation|simulation
222394|NCT02804425|Anesthesia crisis management|anesthesia crisis management
222395|NCT02804425|Learning outcomes|learning outcomes
222396|NCT02804412|communication disorders|communication disorders
222397|NCT02804412|language and speech disorder rehabilitation|language and speech disorder rehabilitation
222398|NCT02804412|stroke|stroke
222399|NCT02804399|rifampin|rifampin
222400|NCT02804399|pharmacokinetics|pharmacokinetics
222401|NCT02804399|PF-06463922|pf-06463922
222402|NCT02804399|drug interaction|drug interaction
222403|NCT02804386|HCV|hcv
222404|NCT02804386|safety|safety
222405|NCT02804386|efficacy|efficacy
222406|NCT02804386|EVR|evr
222407|NCT02804386|SVR|svr
222408|NCT02804373|oxytocin|oxytocin
222409|NCT02804373|adults|adults
222410|NCT02804347|Olfactory Dysfunction|olfactory dysfunction
222411|NCT02804347|Electroconvulsive Therapy|electroconvulsive therapy
222412|NCT02804347|Theta Burst Stimulation|theta burst stimulation
222413|NCT02804321|catheter ablation|catheter ablation
222414|NCT02804321|galectin 3|galectin 3
222415|NCT02804321|ngal|ngal
222416|NCT02804321|aldosterone|aldosterone
222417|NCT02804321|atrial fibrillation|atrial fibrillation
222418|NCT02804308|Combined Training|combined training
222419|NCT02804308|Breast Cancer|breast cancer
222420|NCT02804308|Body Composition|body composition
222421|NCT02804308|Postmenopausal Women|postmenopausal women
222422|NCT02804308|Aromatase Inhibitors|aromatase inhibitors
222423|NCT02804308|Quality of life|quality of life
222424|NCT02804295|Prescription Drug|prescription drug
222425|NCT02804295|Misuse|misuse
222426|NCT02804269|Healthy Volunteer|healthy volunteer
222427|NCT02804269|Dilated cardiomyopathy|dilated cardiomyopathy
222428|NCT02804269|Hypertrophic cardiomyopathy|hypertrophic cardiomyopathy
222429|NCT02804269|ischemic heart disease|ischemic heart disease
222430|NCT02804269|Cardiovascular Magnetic Resonance Imaging|cardiovascular magnetic resonance imaging
222431|NCT02804243|nasal high flow therapy|nasal high flow therapy
222432|NCT02804243|rehabilitation|rehabilitation
222433|NCT02804243|exercise endurance|exercise endurance
222434|NCT02804178|ATR-101|atr-101
222435|NCT02804178|classic congenital adrenal hyperplasia|classic congenital adrenal hyperplasia
222436|NCT02804178|21-hydroxylase deficiency|21-hydroxylase deficiency
222437|NCT02804178|CAH|cah
222438|NCT02804165|Type 1 diabetes|type 1 diabetes
222439|NCT02804165|Enterovirus|enterovirus
222440|NCT02804165|Genetics|genetics
222441|NCT02804165|Gene-Virus interaction|gene-virus interaction
222442|NCT02804152|pregnancy|pregnancy
222443|NCT02804152|pain|pain
222444|NCT02804152|prescription opioid|prescription opioid
222445|NCT02804139|Cesarean Section|cesarean section
222446|NCT02804139|Postpartum issues|postpartum issues
222447|NCT02804126|acute pain|acute pain
222448|NCT02804126|transversus abdominis plane block|transversus abdominis plane block
222449|NCT02804126|quadratus lumborum block|quadratus lumborum block
222450|NCT02804126|neuropathic pain|neuropathic pain
222451|NCT02804100|Circulating Tumor DNA|circulating tumor dna
222452|NCT02804100|Lung cancer|lung cancer
222453|NCT02804100|Plasma DNA|plasma dna
222454|NCT02804061|nutrition|nutrition
222455|NCT02804061|exercise|exercise
222456|NCT02804061|behavior change|behavior change
222457|NCT02804061|adherence|adherence
222458|NCT02804048|Dyspareunia|dyspareunia
222459|NCT02804048|Pelvic floor muscles|pelvic floor muscles
222460|NCT02804048|Women|women
222461|NCT02804022|Respiratory Depression|respiratory depression
222462|NCT02804009|anxiety|anxiety
222463|NCT02804009|coronary angiography|coronary angiography
222464|NCT02803957|Degenerative|degenerative
222465|NCT02803957|Mitral Regurgitation|mitral regurgitation
222466|NCT02803944|azithromycin|azithromycin
222467|NCT02803944|cystic fibrosis|cystic fibrosis
222468|NCT02803944|pulmonary function|pulmonary function
222469|NCT02803931|Cardiogoniometry|cardiogoniometry
222470|NCT02803931|Electrocardiography|electrocardiography
222594|NCT02803138|Chronic Hepatitis C|chronic hepatitis c
222471|NCT02803879|cardiac resynchronisation therapy|cardiac resynchronisation therapy
222472|NCT02803879|cardiogoniometry|cardiogoniometry
222473|NCT02803866|Parenting Self-efficacy|parenting self-efficacy
222474|NCT02803866|Parent training program|parent training program
222475|NCT02803866|Perceived self-efficacy tool|perceived self-efficacy tool
222476|NCT02803853|Native American|native american
222477|NCT02803853|Obesity|obesity
222478|NCT02803853|Multi level|multi level
222479|NCT02803853|Policy|policy
222480|NCT02803853|Schools|schools
222481|NCT02803853|Worksite|worksite
222482|NCT02803853|Social Media|social media
222483|NCT02803853|Food Store|food store
222484|NCT02803840|Large B-Cell|large b-cell
222485|NCT02803840|Diffuse|diffuse
222486|NCT02803827|diarrhoea|diarrhoea
222487|NCT02803827|gastroenteritis|gastroenteritis
222488|NCT02803827|rapid diagnostics|rapid diagnostics
222489|NCT02803827|probiotics|probiotics
222490|NCT02803814|Pancreatoduodenectomy|pancreatoduodenectomy
222491|NCT02803814|Pancreatic tumors|pancreatic tumors
222492|NCT02803814|Periampullary tumors|periampullary tumors
222493|NCT02803801|Parents' ability to guide their child|parents' ability to guide their child
222494|NCT02803801|Parent perception of competence|parent perception of competence
222495|NCT02803801|Parent understanding of their child's unique learning style|parent understanding of their child's unique learning style
222496|NCT02803788|ramosetron, ondansetron, dexamethasone,|ramosetron, ondansetron, dexamethasone,
222497|NCT02803762|ADME|adme
222498|NCT02803762|Pacritinib|pacritinib
222499|NCT02803671|preterm neonates|preterm neonates
222500|NCT02803671|EEG-NIRS|eeg-nirs
222501|NCT02803658|smoking|smoking
222502|NCT02803645|healthy subjects|healthy subjects
222503|NCT02803645|cardiovascular risk factors|cardiovascular risk factors
222504|NCT02803645|markers of arterial inflammation|markers of arterial inflammation
222505|NCT02803645|markers of oxidative stress|markers of oxidative stress
222506|NCT02803632|young|young
222507|NCT02803632|disruptive mood dysregulation disorder|disruptive mood dysregulation disorder
222508|NCT02803632|actigraphic profile|actigraphic profile
222509|NCT02803619|Non-small cell lung cancer|non-small cell lung cancer
222510|NCT02803619|leptomeningeal metastasis|leptomeningeal metastasis
222511|NCT02803619|EGFR sensitive mutations|egfr sensitive mutations
222512|NCT02803606|hypothermia|hypothermia
222513|NCT02803606|routine care|routine care
222514|NCT02803606|preterm neonates|preterm neonates
222515|NCT02803593|a technology-based intervention|a technology-based intervention
222516|NCT02803593|Asian American|asian american
222517|NCT02803593|survivorship|survivorship
222518|NCT02803541|chronic kidney disease|chronic kidney disease
222519|NCT02803541|exercise|exercise
222520|NCT02803541|pediatrics|pediatrics
222521|NCT02803541|summer camp|summer camp
222522|NCT02803515|intra peritonal chemo hyperthermia|intra peritonal chemo hyperthermia
222523|NCT02803515|peritoneal carcinomatosis|peritoneal carcinomatosis
222524|NCT02803515|ovarian cancer|ovarian cancer
222525|NCT02803502|thrombin generation test|thrombin generation test
222526|NCT02803502|factor VIII|factor viii
222527|NCT02803502|hemophilia|hemophilia
222528|NCT02803489|chronic heart failure|chronic heart failure
222529|NCT02803489|chronic obstructive pulmonary disease|chronic obstructive pulmonary disease
222530|NCT02803489|diabetes|diabetes
222531|NCT02803476|PCO|pco
222532|NCT02803476|Vitamin D|vitamin d
222533|NCT02803476|Insulin resistance|insulin resistance
222534|NCT02803463|peritoneal closure|peritoneal closure
222535|NCT02803463|appendectomy|appendectomy
222536|NCT02803463|postoperative pain|postoperative pain
222537|NCT02803463|life quality|life quality
222538|NCT02803450|Effects of; Anesthesia|effects of; anesthesia
222539|NCT02803450|spinal and epidural|spinal and epidural
222540|NCT02803437|Castration-resistant prostate cancer|castration-resistant prostate cancer
222541|NCT02803424|robot-assisted laparoscopic radical prostatectomy|robot-assisted laparoscopic radical prostatectomy
222542|NCT02803424|Autoflow|autoflow
222543|NCT02803424|trendelenburg position|trendelenburg position
222544|NCT02803424|pneumoperitoneum|pneumoperitoneum
222545|NCT02803411|Coronary Heart Disease|coronary heart disease
222546|NCT02803411|Coronary Computed Tomography Angiography (CCTA)|coronary computed tomography angiography (ccta)
222547|NCT02803411|Coronary Atherosclerotic Plaque|coronary atherosclerotic plaque
222548|NCT02803411|coronary atherosclerosis|coronary atherosclerosis
222549|NCT02803398|Compression bandages|compression bandages
222961|NCT02801084|Reduced|reduced
222550|NCT02803385|Patient Controlled Epidural Analgesia|patient controlled epidural analgesia
222551|NCT02803385|Continous Epidural Infusion Analgesia|continous epidural infusion analgesia
222552|NCT02803372|partial nephrectomy|partial nephrectomy
222553|NCT02803372|acute kidney injury|acute kidney injury
222554|NCT02803372|LiDCOrapid|lidcorapid
222555|NCT02803372|circulatory management|circulatory management
222556|NCT02803359|Laryngeal evoked brainstem response (LEBR)|laryngeal evoked brainstem response (lebr)
222557|NCT02803359|laryngopharyngeal sensory discrimination testing (LPSDT)|laryngopharyngeal sensory discrimination testing (lpsdt)
222558|NCT02803359|brainstem activity|brainstem activity
222559|NCT02803346|sepsis|sepsis
222560|NCT02803346|septic shock|septic shock
222561|NCT02803346|immunosuppression|immunosuppression
222562|NCT02803346|HLA-DR|hla-dr
222563|NCT02803346|lymphopenia|lymphopenia
222564|NCT02803333|NSCLC|nsclc
222565|NCT02803333|Carcinoma, Non-Small-Cell Lung|carcinoma, non-small-cell lung
222566|NCT02803333|Lung Diseases|lung diseases
222567|NCT02803333|Thoracic Neoplasms|thoracic neoplasms
222568|NCT02803320|Sunscreen active|sunscreen active
222569|NCT02803307|osteoarthritis of the knee|osteoarthritis of the knee
222570|NCT02803307|TLC599|tlc599
222571|NCT02803307|Dexamethasone|dexamethasone
222572|NCT02803307|DSP|dsp
222573|NCT02803255|Injuries|injuries
222574|NCT02803255|Spinal Cord|spinal cord
222575|NCT02803242|copd|copd
222576|NCT02803242|emphysema|emphysema
222577|NCT02803242|bronchitis|bronchitis
222578|NCT02803242|bronchiectasis|bronchiectasis
222579|NCT02803203|Osimertinib|osimertinib
222580|NCT02803203|bevacizumab|bevacizumab
222581|NCT02803203|metastatic|metastatic
222582|NCT02803203|16-033|16-033
222583|NCT02803190|Spine curve|spine curve
222584|NCT02803190|Posture|posture
222585|NCT02803190|Fracture|fracture
222586|NCT02803190|sarcopenia|sarcopenia
222587|NCT02803190|Exercise|exercise
222588|NCT02803177|large bone defect|large bone defect
222589|NCT02803177|bone marrow-derived mononuclear cells|bone marrow-derived mononuclear cells
222590|NCT02803151|Stereotactic ablative radiotherapy|stereotactic ablative radiotherapy
222591|NCT02803151|Lymph node metastasis|lymph node metastasis
222592|NCT02803151|T cell immunity|t cell immunity
222595|NCT02803138|Ombitasvir/paritaprevir/ritonavir ± dasabuvir|ombitasvir/paritaprevir/ritonavir ± dasabuvir
222596|NCT02803138|Sustained Virological Response|sustained virological response
222597|NCT02803138|Observational Study|observational study
222598|NCT02803138|Chronic Hepatitis C genotype 1|chronic hepatitis c genotype 1
222599|NCT02803138|Chronic Hepatitis C genotype 4|chronic hepatitis c genotype 4
222600|NCT02803125|PTSD|ptsd
222601|NCT02803125|Aging|aging
222602|NCT02803125|Veteran|veteran
222603|NCT02803125|Intervention|intervention
222604|NCT02803086|Prostate cancer|prostate cancer
222605|NCT02803086|Radiotherapy|radiotherapy
222606|NCT02803086|Hematopoietic stem cells|hematopoietic stem cells
222607|NCT02803086|Radiotoxicity|radiotoxicity
222608|NCT02802982|Thrombocytopenia|thrombocytopenia
222609|NCT02802982|Neonates|neonates
222610|NCT02802956|Life participation|life participation
222611|NCT02802943|CLL, Peptid Vaccination|cll, peptid vaccination
222612|NCT02802917|Eye stinging potential|eye stinging potential
222613|NCT02802904|Healthy subjects|healthy subjects
222614|NCT02802891|Asthma|asthma
222615|NCT02802891|Allergy|allergy
222616|NCT02802891|Diagnosis|diagnosis
222617|NCT02802891|Endocrine disruptors|endocrine disruptors
222618|NCT02802891|Children|children
222619|NCT02802839|Virtual Reality|virtual reality
222620|NCT02802839|venipuncture|venipuncture
222621|NCT02802826|Exercise|exercise
222622|NCT02802826|Chemotherapy|chemotherapy
222623|NCT02802826|Physical Activity|physical activity
222624|NCT02802826|Breast Cancer|breast cancer
222625|NCT02802813|Single-blinded controlled trial|single-blinded controlled trial
222626|NCT02802813|Primaquine|primaquine
222627|NCT02802787|Quality of life|quality of life
222628|NCT02802787|Occupation|occupation
222629|NCT02802787|Pain|pain
222630|NCT02802787|Fatigue|fatigue
222631|NCT02802774|Post-operative treatment|post-operative treatment
222632|NCT02802748|Early Breast Cancer|early breast cancer
222633|NCT02802748|Hormone Receptor-positive|hormone receptor-positive
222634|NCT02802748|Window-of-opportunity|window-of-opportunity
222635|NCT02802748|PAM50|pam50
222636|NCT02802748|Luminal A|luminal a
222637|NCT02802748|Luminal B|luminal b
222638|NCT02802748|proliferation signature|proliferation signature
222639|NCT02802748|metronomic vinorelbine|metronomic vinorelbine
222640|NCT02802748|letrozole|letrozole
222641|NCT02802735|Pharmacokinetics|pharmacokinetics
222642|NCT02802735|Apremilast|apremilast
222643|NCT02802735|Healthy Adult Male|healthy adult male
222644|NCT02802735|Korean Subjects|korean subjects
222645|NCT02802722|convalescence|convalescence
222646|NCT02802722|inflammation|inflammation
222647|NCT02802722|resolution|resolution
222648|NCT02802722|vitamin D|vitamin d
222649|NCT02802709|knee|knee
222650|NCT02802696|Transfusion|transfusion
222651|NCT02802696|Transfusion Medicine|transfusion medicine
222652|NCT02802696|Diuretic|diuretic
222653|NCT02802683|Hypotension|hypotension
222654|NCT02802683|cesarean section|cesarean section
222655|NCT02802657|Age-related Macular Degeneration|age-related macular degeneration
222656|NCT02802657|Conbercept|conbercept
222657|NCT02802657|Treat-and-Extend Regimen|treat-and-extend regimen
222658|NCT02802657|Pro Re Nata|pro re nata
222659|NCT02802631|Bacterial infections|bacterial infections
222660|NCT02802618|Validity|validity
222661|NCT02802618|Reliability|reliability
222662|NCT02802618|Rehabilitation|rehabilitation
222663|NCT02802618|Translation|translation
222664|NCT02802618|Education|education
222665|NCT02802579|obesity|obesity
222666|NCT02802579|dual source CT|dual source ct
222667|NCT02802579|coronary CT angiography|coronary ct angiography
222668|NCT02802579|prognosis|prognosis
222669|NCT02802579|bariatric surgery|bariatric surgery
222670|NCT02802579|gastric bypass surgery|gastric bypass surgery
222671|NCT02802579|coronary arterial disease|coronary arterial disease
222672|NCT02802579|major adverse coronary event|major adverse coronary event
222673|NCT02802566|Maternal Obesity|maternal obesity
222674|NCT02802566|Inflammation|inflammation
222675|NCT02802553|SmartGoggles|smartgoggles
222676|NCT02802553|sentinel lymph nodes|sentinel lymph nodes
222677|NCT02802553|indocyanine green|indocyanine green
222678|NCT02802553|Cardio-Green|cardio-green
222679|NCT02802553|Spy Elite|spy elite
222680|NCT02802540|nabilone|nabilone
222681|NCT02802540|anorexia|anorexia
222682|NCT02802540|Non-Small Cell Lung Cancer|non-small cell lung cancer
222683|NCT02802514|Gastrointestinal|gastrointestinal
222684|NCT02802514|Glucagon like peptide|glucagon like peptide
222685|NCT02802514|Nausea|nausea
222686|NCT02802514|Magnetic resonance imaging|magnetic resonance imaging
222687|NCT02802501|Safety|safety
222688|NCT02802501|Artemisinin Combination Therapy|artemisinin combination therapy
222689|NCT02802501|Efficacy|efficacy
222690|NCT02802501|Tafenoquine|tafenoquine
222691|NCT02802501|Superiority|superiority
222692|NCT02802501|Primaquine|primaquine
222693|NCT02802501|Radical cure|radical cure
222694|NCT02802501|Vivax|vivax
222695|NCT02802501|ACT|act
222696|NCT02802501|Plasmodium vivax malaria|plasmodium vivax malaria
222697|NCT02802501|Dihydroartemisinin-piperaquine|dihydroartemisinin-piperaquine
222698|NCT02802488|D-dimers|d-dimers
222699|NCT02802488|Atrial fibrillation|atrial fibrillation
222700|NCT02802475|antibodies|antibodies
222701|NCT02802475|auto-immune encephalitis|auto-immune encephalitis
222702|NCT02802475|epilepsy|epilepsy
222703|NCT02802475|limbic encephalitis|limbic encephalitis
222704|NCT02802462|endothelial progenitor cell|endothelial progenitor cell
222705|NCT02802462|hemodynamic|hemodynamic
222706|NCT02802462|Exercise|exercise
222707|NCT02802462|HIIT|hiit
222708|NCT02802449|Vitamin D|vitamin d
222709|NCT02802449|Hypovitaminosis D|hypovitaminosis d
222710|NCT02802449|HTN|htn
222711|NCT02802423|TNBC|tnbc
222712|NCT02802423|Breast cancer|breast cancer
222713|NCT02802423|Triple negative|triple negative
222714|NCT02802397|Early ovarian reserve decreased|early ovarian reserve decreased
222715|NCT02802384|Paget's Disease of Bone|paget's disease of bone
222716|NCT02802384|Healthy controls|healthy controls
222717|NCT02802371|caregiver burden|caregiver burden
222718|NCT02802371|Alzheimer disease and related disorders|alzheimer disease and related disorders
222719|NCT02802371|elderly|elderly
222720|NCT02802371|pharmaceutical care|pharmaceutical care
222721|NCT02802371|optimization of drug prescribing|optimization of drug prescribing
400629|NCT01865981|Brugada|brugada
222722|NCT02802371|psychosocial intervention|psychosocial intervention
222723|NCT02802358|Falls|falls
222724|NCT02802358|Functionality|functionality
222725|NCT02802332|neonatal|neonatal
222726|NCT02802332|preterm|preterm
222727|NCT02802332|Nepal|nepal
222728|NCT02802332|family-initiated identification|family-initiated identification
222729|NCT02802332|basic newborn care|basic newborn care
222730|NCT02802306|Angioplasty|angioplasty
222731|NCT02802306|Peripheral Artery Disease|peripheral artery disease
222732|NCT02802306|PAD|pad
222733|NCT02802306|Lesion|lesion
222734|NCT02802306|Claudication|claudication
222735|NCT02802293|Repetitive Transcranial Magnetic Stimulation|repetitive transcranial magnetic stimulation
222736|NCT02802293|Major Depressive Disorder|major depressive disorder
222737|NCT02802280|endothelial dysfunction|endothelial dysfunction
222738|NCT02802254|physical activity|physical activity
222739|NCT02802254|patient feedback|patient feedback
222740|NCT02802254|risk perception|risk perception
222741|NCT02802254|pedometer|pedometer
222742|NCT02802215|Diabetes Mellitus|diabetes mellitus
222743|NCT02802215|Pregnancy|pregnancy
222744|NCT02802202|Palpation|palpation
222745|NCT02802202|Chronic Pain|chronic pain
222746|NCT02802202|Muscle|muscle
222747|NCT02802189|Chronic Mechanical Neck Pain|chronic mechanical neck pain
222748|NCT02802189|exercise|exercise
222749|NCT02802189|Integrated Neuromuscular Inhibition Technique|integrated neuromuscular inhibition technique
222750|NCT02802163|untreated multiple myeloma|untreated multiple myeloma
222751|NCT02802163|newly diagnosed myeloma|newly diagnosed myeloma
222752|NCT02802163|transplant eligible|transplant eligible
222753|NCT02802150|Zanthoxylum schinifolium seed Oil|zanthoxylum schinifolium seed oil
222754|NCT02802150|soy bean oil|soy bean oil
222755|NCT02802150|omega-3 fatty acid|omega-3 fatty acid
222756|NCT02802150|dry eye disease|dry eye disease
222757|NCT02802137|tafluprost|tafluprost
222758|NCT02802137|dorzolamide|dorzolamide
222760|NCT02802137|FC|fc
222761|NCT02802124|hepatocellular carcinoma|hepatocellular carcinoma
222762|NCT02802124|carbon-ion radiotherapy|carbon-ion radiotherapy
222763|NCT02802124|toxicity|toxicity
222764|NCT02802124|efficacy|efficacy
222765|NCT02802111|Beta Agonists|beta agonists
222766|NCT02802111|Asthma|asthma
222767|NCT02802111|Albuterol|albuterol
222768|NCT02802111|Levalbuterol|levalbuterol
222769|NCT02802098|Metastatic breast cancer|metastatic breast cancer
222770|NCT02802098|bevacizumab maintenance|bevacizumab maintenance
222771|NCT02802098|Durvalumab|durvalumab
222772|NCT02802085|Total Knee Arthroplasty|total knee arthroplasty
222773|NCT02802085|Total Knee Replacement|total knee replacement
222774|NCT02802085|TKA|tka
222775|NCT02802085|TKR|tkr
222776|NCT02802085|Stiffness of Knee|stiffness of knee
222777|NCT02802085|Deformity|deformity
222778|NCT02802085|Knee Joint|knee joint
222779|NCT02802085|Instability|instability
222780|NCT02802085|Post-traumatic|post-traumatic
222781|NCT02802085|Arthrosis|arthrosis
222782|NCT02802046|FFRCT|ffrct
222783|NCT02802046|Angina pectoris grade|angina pectoris grade
222784|NCT02802046|Fractional flow reserve|fractional flow reserve
222785|NCT02802046|CCTA|ccta
222786|NCT02802033|Registry|registry
222787|NCT02802033|Spine|spine
222788|NCT02802033|Osteobiologics|osteobiologics
222789|NCT02802033|Spinal Fusion|spinal fusion
222790|NCT02801994|Patient-ventilator interaction|patient-ventilator interaction
222791|NCT02801994|Inspiratory muscles|inspiratory muscles
222792|NCT02801994|Electromyogram|electromyogram
222793|NCT02801994|Mechanical ventilation|mechanical ventilation
222794|NCT02801994|Proportional Assist Ventilation|proportional assist ventilation
222795|NCT02801981|tolerability|tolerability
222796|NCT02801981|healthy volunteers|healthy volunteers
222797|NCT02801981|Cholestasis|cholestasis
222798|NCT02801981|safety|safety
222799|NCT02801955|gastric adenocarcinoma|gastric adenocarcinoma
222800|NCT02801955|tumor markers|tumor markers
222801|NCT02801955|peritoneal cytology|peritoneal cytology
222802|NCT02801942|Biomarker|biomarker
222803|NCT02801942|Immune Profile|immune profile
222804|NCT02801942|Biopsy|biopsy
222805|NCT02801942|Leukocyte subsets|leukocyte subsets
222806|NCT02801942|Inguinal lymph nodes|inguinal lymph nodes
222807|NCT02801942|Type 1 Diabetes Mellitus|type 1 diabetes mellitus
222808|NCT02801916|Humans|humans
222809|NCT02801916|Glycemic response|glycemic response
222810|NCT02801916|Oat beta-glucan|oat beta-glucan
222811|NCT02801877|Depression|depression
222812|NCT02801877|Anxiety|anxiety
222813|NCT02801877|Behavior Therapy|behavior therapy
222814|NCT02801877|Technology Assisted|technology assisted
222815|NCT02801877|Mobile Phone|mobile phone
222816|NCT02801877|Cellular Phone|cellular phone
222817|NCT02801877|Smartphone|smartphone
222818|NCT02801877|App|app
222819|NCT02801877|Coach|coach
222820|NCT02801864|tDCS|tdcs
222821|NCT02801864|transcranial direct current stimulation|transcranial direct current stimulation
222822|NCT02801864|intensive speech therapy|intensive speech therapy
222823|NCT02801864|chronic|chronic
222824|NCT02801864|post stroke|post stroke
284904|NCT02431975|HIV|hiv
222825|NCT02801864|aphasia|aphasia
222826|NCT02801864|production|production
222827|NCT02801864|language|language
222828|NCT02801851|Delirium|delirium
222829|NCT02801838|Inspiratory muscles|inspiratory muscles
222830|NCT02801838|Patient-ventilator interaction|patient-ventilator interaction
222831|NCT02801838|Electromyogram|electromyogram
222832|NCT02801838|Mechanical ventilation|mechanical ventilation
222833|NCT02801825|axillay artery|axillay artery
222834|NCT02801825|cannulation|cannulation
222835|NCT02801825|femoral artery|femoral artery
222836|NCT02801812|Nailfold Capillaroscopy|nailfold capillaroscopy
222837|NCT02801799|Anaesthesia|anaesthesia
222838|NCT02801799|Analgesia|analgesia
222839|NCT02801799|Nerve blocks|nerve blocks
222840|NCT02801799|Peripheral nerve blocks|peripheral nerve blocks
222841|NCT02801799|Regional anaesthesia|regional anaesthesia
222842|NCT02801799|therapeutic techniques|therapeutic techniques
222843|NCT02801799|ropivacaine|ropivacaine
222844|NCT02801799|nerve block duration|nerve block duration
222845|NCT02801799|lower limb|lower limb
222846|NCT02801799|Postoperative pain|postoperative pain
222847|NCT02801786|Mammography|mammography
222848|NCT02801786|Premedication|premedication
222849|NCT02801786|Pain|pain
222850|NCT02801786|Discomfort|discomfort
222851|NCT02801786|Breast|breast
222852|NCT02801773|gingivitis|gingivitis
222853|NCT02801773|probiotic|probiotic
222854|NCT02801773|non- surgical treatment|non- surgical treatment
222855|NCT02801760|HIV|hiv
222856|NCT02801760|Self-Consent|self-consent
222857|NCT02801760|PrEP|prep
222858|NCT02801760|Autonomous Research Consent|autonomous research consent
222859|NCT02801760|Participation-associated Outcomes|participation-associated outcomes
222860|NCT02801747|HIV care continuum|hiv care continuum
222861|NCT02801747|antiretroviral therapy|antiretroviral therapy
222862|NCT02801747|engagement in HIV care|engagement in hiv care
222863|NCT02801747|Multiphase Optimization Strategy (MOST)|multiphase optimization strategy (most)
222864|NCT02801708|Embolic stroke of undetermined source|embolic stroke of undetermined source
222865|NCT02801708|Atrial fibrillation|atrial fibrillation
222866|NCT02801695|pre-eclampsia|pre-eclampsia
222867|NCT02801695|citrulline|citrulline
222868|NCT02801695|pregnancy|pregnancy
222869|NCT02801669|anticoagulants|anticoagulants
222870|NCT02801669|DU-176b|du-176b
222871|NCT02801669|edoxaban|edoxaban
222872|NCT02801669|factor Xa|factor xa
222873|NCT02801669|oral|oral
222874|NCT02801669|prevention|prevention
222875|NCT02801669|atrial fibrillation|atrial fibrillation
222876|NCT02801643|PET|pet
222877|NCT02801643|dopamine|dopamine
222878|NCT02801643|fMRI|fmri
222879|NCT02801643|reward|reward
222880|NCT02801617|Latanoprost|latanoprost
222881|NCT02801617|Glaucoma|glaucoma
222882|NCT02801617|Ocular hypertension|ocular hypertension
222883|NCT02801617|Crossover study|crossover study
222884|NCT02801578|Chronic Lymphocytic Leukemia|chronic lymphocytic leukemia
222885|NCT02801578|CLL|cll
222886|NCT02801578|Malignant neoplasms stated as primary lymphoid haematopoietic|malignant neoplasms stated as primary lymphoid haematopoietic
222887|NCT02801578|Ibrutinib|ibrutinib
222888|NCT02801578|PCI-32765|pci-32765
222889|NCT02801578|Imbruvica|imbruvica
222890|NCT02801578|Pharmacodynamics|pharmacodynamics
222891|NCT02801552|regenerative endodontic treatment|regenerative endodontic treatment
222892|NCT02801552|platelet-rich fibrin|platelet-rich fibrin
222893|NCT02801552|Immature permanent tooth|immature permanent tooth
222894|NCT02801552|apical periodontitis|apical periodontitis
222895|NCT02801513|mindfulness|mindfulness
222896|NCT02801513|EEG|eeg
222897|NCT02801513|error-related negativity|error-related negativity
222898|NCT02801513|late positive potential|late positive potential
222899|NCT02801513|long-range temporal correlations|long-range temporal correlations
222900|NCT02801500|bilioenteric anastomosis|bilioenteric anastomosis
222901|NCT02801487|Carbon Ion Therapy|carbon ion therapy
222902|NCT02801487|Concurrent Chemoradiotherapy|concurrent chemoradiotherapy
222903|NCT02801435|EGFR inhibitor|egfr inhibitor
222904|NCT02801435|topical agent|topical agent
222905|NCT02801435|psoriasis|psoriasis
222906|NCT02801435|phase 1|phase 1
222907|NCT02801422|cannabis|cannabis
222908|NCT02801422|fMRI|fmri
222909|NCT02801422|addiction|addiction
222910|NCT02801422|relapse|relapse
222911|NCT02801409|Lung Cancer|lung cancer
222912|NCT02801409|Surgical Resection|surgical resection
222913|NCT02801409|Epidural Anesthesia and Analgesia|epidural anesthesia and analgesia
222914|NCT02801409|Long-Term Outcome|long-term outcome
222915|NCT02801357|substance withdrawal syndrome|substance withdrawal syndrome
222916|NCT02801357|opiate addiction|opiate addiction
222917|NCT02801357|opiate dependence|opiate dependence
222918|NCT02801357|opioid withdrawal syndrome|opioid withdrawal syndrome
222919|NCT02801357|buprenorphine|buprenorphine
222920|NCT02801344|exercise|exercise
222921|NCT02801344|performance|performance
222922|NCT02801344|recovery|recovery
222923|NCT02801344|muscle|muscle
222924|NCT02801344|protein|protein
222925|NCT02801331|Stochastic Resonance|stochastic resonance
222926|NCT02801331|Fetus/Newborn Infant|fetus/newborn infant
222927|NCT02801331|Drug Withdrawal|drug withdrawal
222928|NCT02801331|Substance Abuse|substance abuse
222929|NCT02801318|Patient|patient
222930|NCT02801305|Scleroderma|scleroderma
222931|NCT02801305|Diltiazem|diltiazem
222932|NCT02801305|Nitroglycerin|nitroglycerin
222933|NCT02801305|Topical|topical
222934|NCT02801279|Cerebral Palsy|cerebral palsy
222935|NCT02801279|Occupational Therapy|occupational therapy
222936|NCT02801279|Upper Limb Motor Training|upper limb motor training
222937|NCT02801266|Contraception|contraception
222938|NCT02801266|Reproductive and Sexual Health|reproductive and sexual health
222939|NCT02801266|Counseling|counseling
222940|NCT02801266|Contraceptive Counseling|contraceptive counseling
222941|NCT02801240|Inflammatory Bowel Disease|inflammatory bowel disease
222942|NCT02801227|premature rupture of membrane|premature rupture of membrane
222943|NCT02801227|primipara|primipara
222944|NCT02801227|term|term
222945|NCT02801227|bishop|bishop
222946|NCT02801214|cannabis|cannabis
222947|NCT02801214|fMRI|fmri
222948|NCT02801214|emotion|emotion
222949|NCT02801201|sedation|sedation
222950|NCT02801201|spinal anesthesia|spinal anesthesia
222951|NCT02801162|arterial blood gas|arterial blood gas
222952|NCT02801123|Complimentary Cancer Therapies|complimentary cancer therapies
222953|NCT02801123|Psychosocial Oncology|psychosocial oncology
222954|NCT02801123|Behavioural Medicine|behavioural medicine
222955|NCT02801123|Mindfulness Based Cancer Recovery|mindfulness based cancer recovery
222956|NCT02801123|Tai Chi|tai chi
222957|NCT02801123|Qigong|qigong
222958|NCT02801123|Mindfulness-Based Stress Reduction|mindfulness-based stress reduction
222959|NCT02801123|Yoga|yoga
222960|NCT02801123|Preference-based trial|preference-based trial
222962|NCT02801084|Environmental|environmental
222963|NCT02801084|Stimulation|stimulation
222964|NCT02801071|Post-Polio Syndrome|post-polio syndrome
222965|NCT02801071|PPS|pps
222966|NCT02801058|Osteopathic manipulative treatment|osteopathic manipulative treatment
222967|NCT02801058|Abdominal Diaphragm mobility|abdominal diaphragm mobility
222968|NCT02801058|Thoracic Ultrasounds|thoracic ultrasounds
222969|NCT02800980|lymphocele|lymphocele
222970|NCT02800980|sclerotherapy|sclerotherapy
222971|NCT02800980|drainage|drainage
222972|NCT02800980|percutaneous|percutaneous
222973|NCT02800967|platelet activation|platelet activation
222974|NCT02800967|platelet aggregation|platelet aggregation
222975|NCT02800967|Aronia|aronia
222976|NCT02800967|flow cytometry|flow cytometry
222977|NCT02800967|polyphenols|polyphenols
222978|NCT02800967|cardiovascular disease risk|cardiovascular disease risk
222979|NCT02800954|Multiple Myeloma|multiple myeloma
222980|NCT02800954|bone lesions|bone lesions
222981|NCT02800954|Macrophage-Colony Stimulating Factor|macrophage-colony stimulating factor
222982|NCT02800941|Pulmonary Arterial hypertension|pulmonary arterial hypertension
222983|NCT02800941|Oral anticoagulants|oral anticoagulants
222984|NCT02800941|Major bleedings|major bleedings
222985|NCT02800915|Spinal Cord Injury|spinal cord injury
222986|NCT02800915|Pressure Ulcer|pressure ulcer
222987|NCT02800915|Health Related Quality of Life|health related quality of life
222988|NCT02800915|Telemedicine|telemedicine
222989|NCT02800915|Service Innovation|service innovation
222990|NCT02800915|Rehabilitation|rehabilitation
222991|NCT02800915|Interdisciplinary collaboration|interdisciplinary collaboration
222992|NCT02800915|User- participation|user- participation
222993|NCT02800915|Activity and participation|activity and participation
222994|NCT02800915|Health economics|health economics
222995|NCT02800889|relapsed|relapsed
222996|NCT02800889|refractory|refractory
222997|NCT02800889|solid tumors|solid tumors
222998|NCT02800850|Dementia|dementia
222999|NCT02800850|Depression|depression
223000|NCT02800850|Agitation|agitation
223001|NCT02800850|Bright Light|bright light
223002|NCT02800837|left main|left main
223003|NCT02800837|stent|stent
223004|NCT02800837|self-expandable|self-expandable
223005|NCT02800837|DES|des
223006|NCT02800837|Stentys|stentys
223007|NCT02800811|FR104|fr104
223008|NCT02800811|CD28|cd28
223009|NCT02800811|immunomodulation|immunomodulation
223010|NCT02800811|T regulatory cell|t regulatory cell
223011|NCT02800811|Pegylated monovalent anti-CD28 Fab antibody|pegylated monovalent anti-cd28 fab antibody
223012|NCT02800798|Obstructive sleep apnea|obstructive sleep apnea
223013|NCT02800798|Preeclampsia|preeclampsia
223014|NCT02800798|Pregnancy|pregnancy
223015|NCT02800798|Stopbang|stopbang
223016|NCT02800772|pancreatic duct|pancreatic duct
223017|NCT02800772|ERCP|ercp
223018|NCT02800772|acetic acid|acetic acid
223019|NCT02800746|Prognathic surgery|prognathic surgery
223020|NCT02800746|intravenous iron|intravenous iron
223021|NCT02800720|Fibromyalgia Syndromey|fibromyalgia syndromey
223022|NCT02800681|Asperger Syndrome|asperger syndrome
223023|NCT02800681|Autism Spectrum Disorder|autism spectrum disorder
223024|NCT02800681|Schizotypal disorder|schizotypal disorder
401433|NCT01862536|COPD|copd
223025|NCT02800681|Schizophrenia Spectrum Disorder|schizophrenia spectrum disorder
223026|NCT02800681|Psychopathology|psychopathology
223027|NCT02800681|Examination of Anomalous Self Disorder|examination of anomalous self disorder
223028|NCT02800681|Autism Diagnostic Observation Schedule|autism diagnostic observation schedule
223029|NCT02800681|Phenomenology|phenomenology
223030|NCT02800681|Differential diagnosis|differential diagnosis
223031|NCT02800681|Young Adult|young adult
223032|NCT02800668|Duodenal Jejunal Bypass Liner|duodenal jejunal bypass liner
223033|NCT02800668|obesity|obesity
223034|NCT02800668|weight loss therapy|weight loss therapy
223035|NCT02800655|ARV treatment|arv treatment
223036|NCT02800655|Medication Adherence|medication adherence
223037|NCT02800655|Digital Health Feedback System|digital health feedback system
223038|NCT02800655|Proteus Digital Health|proteus digital health
223039|NCT02800642|Bayer|bayer
223040|NCT02800642|Aflibercept|aflibercept
223041|NCT02800642|Eylea|eylea
223042|NCT02800642|Intravitreal|intravitreal
223043|NCT02800616|Academic Achievement|academic achievement
223044|NCT02800616|Accelerometry|accelerometry
223045|NCT02800616|Children|children
223046|NCT02800616|Primary school Intervention|primary school intervention
223047|NCT02800616|Nutrition|nutrition
223048|NCT02800616|Obesity|obesity
223049|NCT02800616|Physical Activity|physical activity
223050|NCT02800616|Prevention|prevention
223051|NCT02800616|School Health|school health
223052|NCT02800603|preschool mental health|preschool mental health
223053|NCT02800603|emotional and behaviour problems|emotional and behaviour problems
223054|NCT02800590|Adult participants|adult participants
223055|NCT02800590|Sedation|sedation
223056|NCT02800590|elective|elective
223057|NCT02800525|Benign pigmented lesions|benign pigmented lesions
223058|NCT02800525|Picosecond laser|picosecond laser
223059|NCT02800525|Q-switched laser|q-switched laser
223060|NCT02800512|pelvic organ prolapse|pelvic organ prolapse
223061|NCT02800512|cystocele|cystocele
223062|NCT02800512|rectocele|rectocele
223063|NCT02800512|enterocele|enterocele
223064|NCT02800473|Bladder cancer|bladder cancer
223065|NCT02800473|Hexvix|hexvix
223066|NCT02800473|Bimodal Endoscopic Imager|bimodal endoscopic imager
223067|NCT02800473|Cystoscopy|cystoscopy
223068|NCT02800460|Subthalamic nucleus|subthalamic nucleus
223069|NCT02800460|Basal ganglia|basal ganglia
223070|NCT02800460|Parkinson disease|parkinson disease
223071|NCT02800460|Magnetic Resonance Imaging|magnetic resonance imaging
223072|NCT02800460|Susceptibility-Weighted Imaging|susceptibility-weighted imaging
223073|NCT02800434|allograft|allograft
223074|NCT02800434|hands|hands
223075|NCT02800434|immunosuppression|immunosuppression
223076|NCT02800434|fMRI|fmri
223077|NCT02800395|Alzheimer|alzheimer
223078|NCT02800395|oxydative stress|oxydative stress
223079|NCT02800395|nutrition|nutrition
223080|NCT02800395|biomarkers|biomarkers
223081|NCT02800382|paraoxonase|paraoxonase
223082|NCT02800382|lung diseases|lung diseases
223083|NCT02800369|Human papillomavirus|human papillomavirus
223084|NCT02800369|cervical intraepithelial neoplasia|cervical intraepithelial neoplasia
223085|NCT02800369|zinc finger nuclease|zinc finger nuclease
223086|NCT02800356|Age-Related Macular Degeneration|age-related macular degeneration
223087|NCT02800356|Geographic Atrophy|geographic atrophy
223088|NCT02800356|Reticular pseudodrusen|reticular pseudodrusen
223089|NCT02800356|Lasers|lasers
223090|NCT02800356|PASCAL 577|pascal 577
223091|NCT02800304|malnutrition|malnutrition
223092|NCT02800304|food intake|food intake
223093|NCT02800304|frailty|frailty
223094|NCT02800291|food intake|food intake
223095|NCT02800265|healthy volunteer|healthy volunteer
223096|NCT02800265|healthy|healthy
223097|NCT02800265|cancer prevention|cancer prevention
223098|NCT02800265|prevention|prevention
223099|NCT02800252|fatty acids|fatty acids
223100|NCT02800252|aspirin|aspirin
223101|NCT02800252|diabetes mellitus|diabetes mellitus
223102|NCT02800252|chronic periodontitis|chronic periodontitis
223103|NCT02800252|periodontal debridement|periodontal debridement
223104|NCT02800200|platelet rich plasma|platelet rich plasma
223105|NCT02800200|extracorporeal shock wave|extracorporeal shock wave
223106|NCT02800122|acute dyspnea|acute dyspnea
223107|NCT02800122|emergency|emergency
223108|NCT02800122|acute heart failure|acute heart failure
223109|NCT02800109|Fetal growth|fetal growth
223110|NCT02800109|Newborn growth|newborn growth
223111|NCT02800070|autologous stem cell transplant|autologous stem cell transplant
223112|NCT02800070|gene therapy|gene therapy
223113|NCT02800070|Fabry disease|fabry disease
223114|NCT02800070|lentivirus|lentivirus
223115|NCT02800070|haematopoietic stem cell transplant|haematopoietic stem cell transplant
223116|NCT02800018|hypothermia therapy|hypothermia therapy
223117|NCT02800018|perinatal asphyxia|perinatal asphyxia
223118|NCT02800005|gastric cancer|gastric cancer
223119|NCT02800005|gastrectomy|gastrectomy
223120|NCT02800005|laparotomy|laparotomy
223121|NCT02800005|surgical outcome|surgical outcome
223122|NCT02800005|survival|survival
223123|NCT02800005|abdominal fat area|abdominal fat area
285256|NCT02430142|hypoxia|hypoxia
223124|NCT02800005|Body Mass Index|body mass index
223125|NCT02799953|diabetes mellitus and hypertension|diabetes mellitus and hypertension
223126|NCT02799953|consumer health information technology|consumer health information technology
223127|NCT02799953|self-monitoring|self-monitoring
223128|NCT02799953|randomized controlled trial|randomized controlled trial
223129|NCT02799927|Indirect Pulp Treatment|indirect pulp treatment
223130|NCT02799927|Primary Teeth|primary teeth
223131|NCT02799927|Biodentine|biodentine
223132|NCT02799927|Calcium Hydroxide|calcium hydroxide
223133|NCT02799927|Split-Mouth design|split-mouth design
223134|NCT02799901|advanced melanoma|advanced melanoma
223135|NCT02799901|high dose radiotherapy|high dose radiotherapy
223136|NCT02799901|Nivolumab|nivolumab
223137|NCT02799888|Graft-versus-host Disease|graft-versus-host disease
223138|NCT02799888|Hematopoietic Stem Cell Transplantation|hematopoietic stem cell transplantation
223139|NCT02799888|Acute Leukemia|acute leukemia
223140|NCT02799888|Myelodysplastic syndrome|myelodysplastic syndrome
223141|NCT02799888|Lymphoma|lymphoma
223142|NCT02799875|respiratory distress syndrome|respiratory distress syndrome
223143|NCT02799875|permissive hypercapnia|permissive hypercapnia
223144|NCT02799875|ventilator strategy|ventilator strategy
223145|NCT02799862|metastatic|metastatic
223146|NCT02799862|locally advanced|locally advanced
223147|NCT02799862|unresectable|unresectable
223148|NCT02799862|NSCLC|nsclc
223149|NCT02799849|narcolepsy|narcolepsy
223150|NCT02799849|metabolism|metabolism
223151|NCT02799823|aortic stenosis|aortic stenosis
223152|NCT02799823|transcatheter aortic valve replacement|transcatheter aortic valve replacement
223153|NCT02799810|lung transplantation|lung transplantation
223154|NCT02799810|psychosocial functioning|psychosocial functioning
223155|NCT02799810|longitudinal|longitudinal
223156|NCT02799810|TERS|ters
223157|NCT02799810|adherence|adherence
223158|NCT02799810|Quality of life|quality of life
223159|NCT02799797|adductor canal block|adductor canal block
223160|NCT02799784|tiotropium|tiotropium
223161|NCT02799784|COPD|copd
223162|NCT02799784|olodaterol|olodaterol
223163|NCT02799784|Umeclidinium bromide|umeclidinium bromide
223164|NCT02799784|efficacy|efficacy
223165|NCT02799784|vilanterol|vilanterol
223166|NCT02799771|Pulmonary arterial hypertension|pulmonary arterial hypertension
223167|NCT02799771|Interstitial lung disease at HRCT|interstitial lung disease at hrct
223168|NCT02799745|Therapeutic Cancer Progression|therapeutic cancer progression
223169|NCT02799745|Pathological Cancer Progression|pathological cancer progression
223170|NCT02799745|Enzalutamide|enzalutamide
223171|NCT02799745|Prostate Cancer|prostate cancer
223172|NCT02799745|Active surveillance|active surveillance
223173|NCT02799732|Feasibility Study|feasibility study
223174|NCT02799732|HPV vaccine|hpv vaccine
223175|NCT02799732|1Dose Trial|1dose trial
223176|NCT02799719|Fat mass|fat mass
223177|NCT02799719|hemodialysis patients|hemodialysis patients
223178|NCT02799719|inflammation|inflammation
223179|NCT02799719|adipocytokines|adipocytokines
223180|NCT02799719|bioimpedance spectroscopy|bioimpedance spectroscopy
223181|NCT02799706|Prostate cancer|prostate cancer
223182|NCT02799706|GnRH antagonist|gnrh antagonist
223183|NCT02799706|GnRH agonist|gnrh agonist
223184|NCT02799706|radiation therapy|radiation therapy
223185|NCT02799706|very high risk localized prostate cancer|very high risk localized prostate cancer
223186|NCT02799706|locally advanced prostate cancer|locally advanced prostate cancer
223187|NCT02799693|Catheter Ablation|catheter ablation
223188|NCT02799693|Ventricular Tachycardia|ventricular tachycardia
223189|NCT02799693|Intramural Needle Catheter|intramural needle catheter
223190|NCT02799680|CART|cart
223191|NCT02799680|AML|aml
223192|NCT02799667|negative pressure wound therapy|negative pressure wound therapy
223193|NCT02799667|cesarean delivery|cesarean delivery
223194|NCT02799654|Total Hip Arthroplasty|total hip arthroplasty
223195|NCT02799641|Contraception|contraception
223196|NCT02799641|IUD|iud
223197|NCT02799641|levonorgestrel releasing intrauterine device|levonorgestrel releasing intrauterine device
223198|NCT02799641|lidocaine|lidocaine
223199|NCT02799641|valium|valium
223200|NCT02799641|diazepam|diazepam
223201|NCT02799641|pain|pain
223202|NCT02799641|VAS|vas
223203|NCT02799641|visual analog scale|visual analog scale
223204|NCT02799628|Trust|trust
223205|NCT02799628|Low Back Pain|low back pain
223206|NCT02799628|Treatment Outcome|treatment outcome
223207|NCT02799602|Metastatic hormone sensitive prostate cancer|metastatic hormone sensitive prostate cancer
223208|NCT02799576|Ultrasound|ultrasound
223209|NCT02799576|Regional blockade|regional blockade
223210|NCT02799576|Infraclavicular brachial plexus|infraclavicular brachial plexus
223211|NCT02799550|CART|cart
223212|NCT02799550|ALL|all
223213|NCT02799550|Relapsed|relapsed
223214|NCT02799550|Refractory|refractory
223215|NCT02799550|CD19+|cd19+
223216|NCT02799511|biological markers|biological markers
223217|NCT02799498|etanercept|etanercept
223218|NCT02799498|healthy subject|healthy subject
223219|NCT02799498|open-label|open-label
223220|NCT02799498|randomized|randomized
223221|NCT02799498|PK|pk
223222|NCT02799498|auto-injection|auto-injection
223223|NCT02799498|pharmacokinetic|pharmacokinetic
223224|NCT02799472|GSK3196165|gsk3196165
223225|NCT02799472|magnetic resonance imaging (MRI)|magnetic resonance imaging (mri)
223226|NCT02799472|disease-modifying antirheumatic drugs (DMARDs)|disease-modifying antirheumatic drugs (dmards)
223227|NCT02799472|granulocyte-macrophage colony stimulating factor (GM-CSF)|granulocyte-macrophage colony stimulating factor (gm-csf)
223228|NCT02799472|Rheumatoid Arthritis|rheumatoid arthritis
223229|NCT02799472|Methotrexate|methotrexate
223230|NCT02799459|Hypnoanesthesia|hypnoanesthesia
223231|NCT02799459|Hypnosis|hypnosis
223232|NCT02799459|conization|conization
223233|NCT02799446|sinusitis, rhinitis, rhinosinusitis, chronic|sinusitis, rhinitis, rhinosinusitis, chronic
223234|NCT02799433|Water|water
223235|NCT02799433|Physical activity|physical activity
223236|NCT02799433|Child care|child care
223237|NCT02799433|Weight change|weight change
223238|NCT02799420|confocal laser endomicroscopy|confocal laser endomicroscopy
223239|NCT02799420|undifferentiated gastric cancer|undifferentiated gastric cancer
223240|NCT02799420|target biopsy|target biopsy
223241|NCT02799381|carbidopa|carbidopa
223242|NCT02799381|levodopa|levodopa
223243|NCT02799381|efficacy|efficacy
223244|NCT02799381|levodopa-carbidopa intestinal gel|levodopa-carbidopa intestinal gel
223245|NCT02799381|Advanced Parkinson's Disease|advanced parkinson's disease
223246|NCT02799303|screening|screening
223247|NCT02799303|biopsy|biopsy
223248|NCT02799303|magnetic resonance imaging|magnetic resonance imaging
223249|NCT02799303|prostate specific antigen|prostate specific antigen
223250|NCT02799264|fasted|fasted
223251|NCT02799264|healthy volunteers|healthy volunteers
223252|NCT02799264|cabotegravir|cabotegravir
223253|NCT02799264|high fat|high fat
223254|NCT02799264|pharmacokinetics|pharmacokinetics
223255|NCT02799264|randomized|randomized
223256|NCT02799264|Phase I|phase i
223257|NCT02799264|two way crossover|two way crossover
223258|NCT02799251|lymphopenia|lymphopenia
223259|NCT02799251|postoperative infection|postoperative infection
223450|NCT02798406|SCH 900475|sch 900475
223260|NCT02799251|thoracic cancer surgery|thoracic cancer surgery
223261|NCT02799251|digestive cancer surgery|digestive cancer surgery
223262|NCT02799238|glioblastoma, GBM, immunotherapy, autologous lymphoid effector cells specific against tumour cells, ALECSAT, Stupp regimen, TMZ, radiotherapy/TMZ|glioblastoma, gbm, immunotherapy, autologous lymphoid effector cells specific against tumour cells, alecsat, stupp regimen, tmz, radiotherapy/tmz
223263|NCT02799225|carbapenems|carbapenems
223264|NCT02799212|Hepatocellular carcinoma|hepatocellular carcinoma
223265|NCT02799212|Hepatectomy|hepatectomy
223266|NCT02799212|Ascites|ascites
223267|NCT02799212|Somatostatin|somatostatin
223268|NCT02799186|Spontaneous Coronary Artery Dissection|spontaneous coronary artery dissection
223269|NCT02799186|haematoma|haematoma
223270|NCT02799186|Fibromuscular Dysplasia|fibromuscular dysplasia
223271|NCT02799186|genetic analysis|genetic analysis
223272|NCT02799186|Acute Coronary Syndrome|acute coronary syndrome
223273|NCT02799173|cardiovascular calcification|cardiovascular calcification
223274|NCT02799173|RANK: Receptor Activator of Nuclear Factor kappa B|rank: receptor activator of nuclear factor kappa b
223275|NCT02799173|RANKL: Receptor Activator of Nuclear Factor kappa B Ligand|rankl: receptor activator of nuclear factor kappa b ligand
223276|NCT02799173|OPG: Osteoprotegerin|opg: osteoprotegerin
223277|NCT02799173|SLE: Systemic lupus erythematosus|sle: systemic lupus erythematosus
223278|NCT02799147|Allogeneic Transplantation|allogeneic transplantation
223279|NCT02799147|Hematopoietic Stem Cell Transplantation|hematopoietic stem cell transplantation
223280|NCT02799147|Leukemia, Acute Lymphoblastic|leukemia, acute lymphoblastic
223281|NCT02799147|Acute Myeloid Leukemia|acute myeloid leukemia
223282|NCT02799147|Mixed-Lineage Acute Leukemias|mixed-lineage acute leukemias
223283|NCT02799147|Immune System Diseases|immune system diseases
223284|NCT02799147|Immunosuppressive Agents|immunosuppressive agents
223285|NCT02799147|Myeloablative Agonists|myeloablative agonists
223286|NCT02799147|Busulfan|busulfan
223287|NCT02799147|Fludarabine|fludarabine
223288|NCT02799147|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating
223289|NCT02799147|Bendamustine Hydrochloride|bendamustine hydrochloride
223290|NCT02799134|Cortisol Awakening Response suppression|cortisol awakening response suppression
223291|NCT02799134|Dexamethasone Suppression Test|dexamethasone suppression test
223292|NCT02799134|high-order cognition|high-order cognition
223293|NCT02799134|social cognition|social cognition
223294|NCT02799108|children|children
223295|NCT02799108|language|language
223296|NCT02799108|NIRS|nirs
223297|NCT02799095|Immunotherapy|immunotherapy
223298|NCT02799095|IL-2|il-2
223299|NCT02799095|Interleukin-2|interleukin-2
223300|NCT02799095|Solid tumors|solid tumors
223301|NCT02799095|Melanoma|melanoma
223302|NCT02799095|Renal cell carcinoma|renal cell carcinoma
223303|NCT02799095|Non-small-cell lung cancer|non-small-cell lung cancer
223304|NCT02799095|Squamous cell carcinoma of the head and neck|squamous cell carcinoma of the head and neck
223305|NCT02799056|Airway Extubation|airway extubation
223306|NCT02799056|Ultrasonography|ultrasonography
223307|NCT02799056|Ventilator Weaning|ventilator weaning
223308|NCT02799043|FIRMap, Rotor, FIRM-guided procedure|firmap, rotor, firm-guided procedure
223309|NCT02799017|Aphasia|aphasia
223310|NCT02799017|Reading|reading
223311|NCT02799017|Writing|writing
223312|NCT02799017|Naming|naming
223313|NCT02799017|Language|language
223314|NCT02799017|Chronic post stroke|chronic post stroke
223315|NCT02799017|Phonology|phonology
223316|NCT02799017|Semantic Feature Analysis|semantic feature analysis
223317|NCT02799017|Recovery|recovery
223318|NCT02798991|REarranged during Transfection Growth Factor Receptor Tyrosine Kinase Inhibitor|rearranged during transfection growth factor receptor tyrosine kinase inhibitor
223319|NCT02798978|pharmacokinetics|pharmacokinetics
223320|NCT02798978|TLR4 agonist|tlr4 agonist
223321|NCT02798978|cancer|cancer
223322|NCT02798978|tolerability|tolerability
223323|NCT02798978|GSK1795091|gsk1795091
223324|NCT02798978|pharmacodynamics|pharmacodynamics
223325|NCT02798978|safety|safety
223326|NCT02798965|parvovirus genome|parvovirus genome
223327|NCT02798952|Hepatitis B antibodies|hepatitis b antibodies
223328|NCT02798952|Safety|safety
223329|NCT02798952|Challenge dose|challenge dose
223330|NCT02798952|Persistence|persistence
223331|NCT02798952|Engerix B Kinder|engerix b kinder
223332|NCT02798952|Infanrix hexa|infanrix hexa
223333|NCT02798952|Immunogenicity|immunogenicity
223334|NCT02798952|Adolescents|adolescents
223335|NCT02798939|spontaneous bacterial peritonitis|spontaneous bacterial peritonitis
223336|NCT02798939|lactoferrin|lactoferrin
223337|NCT02798939|procalcitonin|procalcitonin
223338|NCT02798939|Aution® urine dipsticks|aution® urine dipsticks
223339|NCT02798926|hypothermia|hypothermia
223340|NCT02798926|central venous catheter placement|central venous catheter placement
223341|NCT02798926|Polyethylene bag|polyethylene bag
223342|NCT02798913|dual antiplatelet therapy|dual antiplatelet therapy
223343|NCT02798913|peripheral transluminal angioplasty|peripheral transluminal angioplasty
223344|NCT02798900|Task-specific exercise|task-specific exercise
223345|NCT02798900|Ultrasonic Waves|ultrasonic waves
223346|NCT02798900|Biomechanics|biomechanics
223347|NCT02798900|Gait|gait
223348|NCT02798900|Rehabilitation|rehabilitation
223349|NCT02798900|Exercise therapy|exercise therapy
223350|NCT02798887|Regeneration|regeneration
223351|NCT02798887|Bone regeneration|bone regeneration
223352|NCT02798887|Grafting, Bone|grafting, bone
223353|NCT02798887|Allograft|allograft
223354|NCT02798887|Xenograft|xenograft
223355|NCT02798874|Ticagrelor|ticagrelor
223356|NCT02798874|No-reflow|no-reflow
223357|NCT02798874|Acute ST-segment elevation myocardial|acute st-segment elevation myocardial
223358|NCT02798874|Reperfusion injury|reperfusion injury
223359|NCT02798874|Percutaneous coronary intervention|percutaneous coronary intervention
223360|NCT02798796|breast cancer|breast cancer
223361|NCT02798796|conservative surgery|conservative surgery
223363|NCT02798783|Vestibular Aqueduct|vestibular aqueduct
223364|NCT02798783|SLC26A4|slc26a4
223365|NCT02798783|FOXI1|foxi1
223366|NCT02798783|Temporal Bone|temporal bone
223367|NCT02798731|Heart transplant|heart transplant
223368|NCT02798731|Microvascular dysfunction|microvascular dysfunction
223369|NCT02798731|Cardiac allograft vasculopathy|cardiac allograft vasculopathy
223370|NCT02798731|Fractional flow reserve|fractional flow reserve
223371|NCT02798731|Coronary flow reserve|coronary flow reserve
223372|NCT02798731|Index of microvascular resistance|index of microvascular resistance
223373|NCT02798705|Cardiac amyloidosis|cardiac amyloidosis
223374|NCT02798705|Fractional flow reserve|fractional flow reserve
223375|NCT02798705|Microvascular dysfunction|microvascular dysfunction
223376|NCT02798705|Coronary flow reserve|coronary flow reserve
223377|NCT02798705|Index of microcirculatory resistance|index of microcirculatory resistance
223378|NCT02798692|Prevention|prevention
223379|NCT02798666|Physical fitness|physical fitness
223380|NCT02798666|Respiratory exchange ratio|respiratory exchange ratio
223381|NCT02798666|Insulin sensitivity|insulin sensitivity
223382|NCT02798666|High intensity interval training|high intensity interval training
223383|NCT02798666|Continuous exercise training|continuous exercise training
223384|NCT02798601|Cerebral edema|cerebral edema
223385|NCT02798601|Hypernatremia|hypernatremia
223386|NCT02798601|Extended Glasgow Outcome Scale|extended glasgow outcome scale
223387|NCT02798601|Intracranial pressure|intracranial pressure
223388|NCT02798601|Mannitol|mannitol
223389|NCT02798601|Hypertonic saline|hypertonic saline
223390|NCT02798601|Mortality|mortality
223391|NCT02798588|coma|coma
223392|NCT02798588|prognosis|prognosis
223393|NCT02798588|comparative study|comparative study
223394|NCT02798588|functional imaging|functional imaging
223395|NCT02798588|PET-MRI|pet-mri
223396|NCT02798588|electrophysiology|electrophysiology
223397|NCT02798575|COPD|copd
223398|NCT02798575|invasive ventilation|invasive ventilation
223399|NCT02798575|exacerbation|exacerbation
223400|NCT02798575|home care|home care
223401|NCT02798575|mechanical ventilation|mechanical ventilation
223402|NCT02798575|unsuccessful weaning|unsuccessful weaning
223403|NCT02798575|ventilatory parameters|ventilatory parameters
223404|NCT02798562|low dose CT|low dose ct
223405|NCT02798562|contrast-enhanced|contrast-enhanced
223406|NCT02798562|breast cancer screening|breast cancer screening
223407|NCT02798562|computer tomography|computer tomography
223408|NCT02798549|HBV|hbv
223409|NCT02798549|liver|liver
223410|NCT02798536|Immunotoxin|immunotoxin
223411|NCT02798536|Mesothelin|mesothelin
223412|NCT02798536|Targeted Therapy|targeted therapy
223413|NCT02798523|Methylprednisolone|methylprednisolone
223414|NCT02798523|Immunologic|immunologic
223415|NCT02798523|Infusion|infusion
223416|NCT02798523|Topical|topical
223417|NCT02798523|Intravenous|intravenous
223418|NCT02798510|Gallbladder Carcinoma|gallbladder carcinoma
223419|NCT02798510|Extrahepatic Cholangiocarcinoma|extrahepatic cholangiocarcinoma
223420|NCT02798510|Chemoradiotherapy|chemoradiotherapy
223421|NCT02798497|PVL|pvl
223422|NCT02798497|Pneumonias|pneumonias
223423|NCT02798497|Staphylococcus aureus|staphylococcus aureus
223424|NCT02798484|Diffusion Weighted Magnetic Resonance Imaging|diffusion weighted magnetic resonance imaging
223425|NCT02798484|Breast cancer|breast cancer
223426|NCT02798484|Neo-adjuvant therapy|neo-adjuvant therapy
223427|NCT02798471|Pediatric|pediatric
223428|NCT02798471|Venous thrombolism|venous thrombolism
223429|NCT02798471|Pulmonary embolism|pulmonary embolism
223430|NCT02798458|Fabry's Disease|fabry's disease
223431|NCT02798458|Fabry|fabry
223432|NCT02798445|venous ulcer|venous ulcer
223433|NCT02798445|vein|vein
223434|NCT02798445|juxta cures|juxta cures
223435|NCT02798445|foam|foam
223436|NCT02798445|laser|laser
223437|NCT02798432|Total Knee Arthroplasty|total knee arthroplasty
223438|NCT02798432|Hybrid|hybrid
223439|NCT02798432|Cemented|cemented
223440|NCT02798432|Fixation|fixation
223441|NCT02798406|brain|brain
223442|NCT02798406|Central Nervous System (CNS) diseases|central nervous system (cns) diseases
223443|NCT02798406|Central Nervous System (CNS) neoplasms|central nervous system (cns) neoplasms
223444|NCT02798406|CNS|cns
223445|NCT02798406|conditionally replicative adenovirus|conditionally replicative adenovirus
223446|NCT02798406|DNX-2401|dnx-2401
223447|NCT02798406|pembrolizumab|pembrolizumab
223448|NCT02798406|KEYTRUDA|keytruda
223449|NCT02798406|MK-3475|mk-3475
223451|NCT02798406|lambrolizumab|lambrolizumab
223452|NCT02798406|neoplasm, germ cell and embryonal|neoplasm, germ cell and embryonal
223453|NCT02798406|neoplasm, granular and epithelial|neoplasm, granular and epithelial
223454|NCT02798406|Alcyone|alcyone
223455|NCT02798406|Alcyone Lifesciences|alcyone lifesciences
223456|NCT02798406|AMC|amc
223457|NCT02798406|cannula|cannula
223458|NCT02798406|MEMS cannula|mems cannula
223459|NCT02798406|DNX-2401 + pembrolizumab|dnx-2401 + pembrolizumab
223460|NCT02798406|Delta-24|delta-24
223461|NCT02798406|Delta-24-RGD|delta-24-rgd
223462|NCT02798406|Checkpoint inhibitor|checkpoint inhibitor
223463|NCT02798406|anti-PD1/PD-L1|anti-pd1/pd-l1
223464|NCT02798406|immunotherapy|immunotherapy
223465|NCT02798406|monoclonal antibody|monoclonal antibody
223466|NCT02798406|KEYNOTE-192|keynote-192
223467|NCT02798367|insomnia|insomnia
223468|NCT02798367|cognitive behavioral therapy for insomnia|cognitive behavioral therapy for insomnia
223469|NCT02798367|melatonin|melatonin
223470|NCT02798354|Depression|depression
223471|NCT02798354|Blood Pressure|blood pressure
223472|NCT02798354|Anemias, Iron-Deficiency|anemias, iron-deficiency
223473|NCT02798354|Streptococcal Infections|streptococcal infections
223474|NCT02798354|Sexually Transmitted Diseases|sexually transmitted diseases
223475|NCT02798354|Lead Poisoning, Nervous System, Childhood|lead poisoning, nervous system, childhood
223476|NCT02798354|Thyrotropin|thyrotropin
223477|NCT02798315|Paritaprevir/r - Ombitasvir, ± Dasabuvir|paritaprevir/r - ombitasvir, ± dasabuvir
223478|NCT02798315|Sustained Virological Response|sustained virological response
223479|NCT02798315|Chronic Hepatitis C genotype 4|chronic hepatitis c genotype 4
223480|NCT02798315|Observational Study|observational study
223481|NCT02798315|Chronic Hepatitis C genotype 1|chronic hepatitis c genotype 1
223482|NCT02798315|Chronic Hepatitis C|chronic hepatitis c
223483|NCT02798276|Myocardial infarction|myocardial infarction
223484|NCT02798276|Cardiac regeneration|cardiac regeneration
223485|NCT02798276|Cardiac surgery|cardiac surgery
223486|NCT02798250|Type 1 diabetes|type 1 diabetes
223487|NCT02798250|Artificial pancreas|artificial pancreas
223488|NCT02798250|Closed-loop system|closed-loop system
223489|NCT02798250|Postprandial glucose control|postprandial glucose control
223490|NCT02798250|Hypoglycemia|hypoglycemia
223491|NCT02798250|Insulin|insulin
223492|NCT02798250|Glucagon|glucagon
223493|NCT02798237|exercise|exercise
223494|NCT02798237|walking|walking
223495|NCT02798237|health|health
223496|NCT02798224|Colorectal Cancer Screening|colorectal cancer screening
223497|NCT02798224|CRC Screening|crc screening
223498|NCT02798224|Rectum|rectum
223499|NCT02798224|Colon|colon
223500|NCT02798224|Screening|screening
223501|NCT02798224|Populations at Risk|populations at risk
223502|NCT02798224|CRC|crc
723462|NCT00534534|treatment|treatment
223503|NCT02798224|colorectal cancer (CRC)|colorectal cancer (crc)
223504|NCT02798211|PsA, ACR, CASPAR|psa, acr, caspar
223505|NCT02798159|Sexual Dysfunction|sexual dysfunction
223506|NCT02798159|Physiological Sexual Dysfunctions|physiological sexual dysfunctions
223507|NCT02798159|Psychological Sexual and Gender Disorders|psychological sexual and gender disorders
223508|NCT02798159|Sildenafil|sildenafil
223509|NCT02798146|in-vitro fertilization|in-vitro fertilization
223510|NCT02798146|luteal phase|luteal phase
223511|NCT02798081|augmentative and alternative communication|augmentative and alternative communication
223512|NCT02798081|social inclusion|social inclusion
223513|NCT02798081|serious games|serious games
223514|NCT02798081|Information and communication technologies|information and communication technologies
223515|NCT02798068|Steroids|steroids
223516|NCT02798068|Cardiac surgery|cardiac surgery
223517|NCT02798068|Endothelial dysfunction|endothelial dysfunction
223518|NCT02798068|Glycocalyx|glycocalyx
223519|NCT02798068|Flow mediated vasodilation|flow mediated vasodilation
223520|NCT02798003|Cachexia|cachexia
223521|NCT02798003|Food reward|food reward
223522|NCT02797990|[G08.686.785.760.769.500]|[g08.686.785.760.769.500]
223523|NCT02797990|[G08.686.785.760.769]|[g08.686.785.760.769]
223524|NCT02797990|[N02.360]|[n02.360]
223525|NCT02797990|[C25.775.650]|[c25.775.650]
223526|NCT02797990|[C25.775.793]|[c25.775.793]
223527|NCT02797990|[C25.775.635]|[c25.775.635]
223528|NCT02797990|[C25.775.675]|[c25.775.675]
223529|NCT02797990|[C25.775.300]|[c25.775.300]
223530|NCT02797990|[C25.775.467]|[c25.775.467]
223531|NCT02797990|[C25.775.225]|[c25.775.225]
223532|NCT02797990|[C25.775.100]|[c25.775.100]
223533|NCT02797990|[C25.775]|[c25.775]
223534|NCT02797977|Replication Stress|replication stress
223535|NCT02797977|Advanced solid tumors|advanced solid tumors
223536|NCT02797977|CCNE1|ccne1
223537|NCT02797977|TP53|tp53
223538|NCT02797977|BRCA1|brca1
223539|NCT02797977|BRCA2|brca2
223540|NCT02797977|MYC|myc
223541|NCT02797977|RAD50|rad50
223542|NCT02797977|Fanconi anemia|fanconi anemia
223543|NCT02797977|Cell Cycle|cell cycle
223544|NCT02797977|High grade serious ovarian cancer|high grade serious ovarian cancer
223545|NCT02797977|Small cell lung cancer|small cell lung cancer
223546|NCT02797977|Soft tissue sarcoma|soft tissue sarcoma
223547|NCT02797977|Cervical/anogenital cancer|cervical/anogenital cancer
223548|NCT02797977|Phase 1|phase 1
223549|NCT02797977|Phase 2|phase 2
223550|NCT02797977|Dose escalation|dose escalation
223551|NCT02797977|Chk1 inhibitor|chk1 inhibitor
223552|NCT02797977|Checkpoint Kinase 1|checkpoint kinase 1
223553|NCT02797977|Synthetic lethality|synthetic lethality
223554|NCT02797977|Next-Generation Sequencing|next-generation sequencing
223555|NCT02797977|Genetic biomarkers|genetic biomarkers
223556|NCT02797964|Replication stress|replication stress
223557|NCT02797964|Advanced solid tumors|advanced solid tumors
223558|NCT02797964|CCNE1|ccne1
223559|NCT02797964|TP53|tp53
223560|NCT02797964|BRCA1|brca1
223561|NCT02797964|BRCA2|brca2
223562|NCT02797964|MYC|myc
223563|NCT02797964|RAD50|rad50
223564|NCT02797964|Fanconi anemia|fanconi anemia
223565|NCT02797964|Cell cycle|cell cycle
223566|NCT02797964|Metastatic Colorectal Cancer|metastatic colorectal cancer
223567|NCT02797964|Platinum-Resistant or Intolerant High Grade Serious Ovarian Cancer|platinum-resistant or intolerant high grade serious ovarian cancer
223568|NCT02797964|Advanced Non-Small Cell Lung Cancer|advanced non-small cell lung cancer
223569|NCT02797964|Metastatic Castration-Resistant Prostate Cancer|metastatic castration-resistant prostate cancer
223570|NCT02797964|Head and Neck Squamous Cell Carcinoma|head and neck squamous cell carcinoma
223571|NCT02797964|Squamous Cell Carcinoma of the Anus|squamous cell carcinoma of the anus
223572|NCT02797964|Phase 1|phase 1
223573|NCT02797964|Phase 2|phase 2
223574|NCT02797964|Dose escalation|dose escalation
223575|NCT02797964|Chk1 inhibitor|chk1 inhibitor
223576|NCT02797964|Checkpoint kinase 1|checkpoint kinase 1
223577|NCT02797964|Synthetic lethality|synthetic lethality
223578|NCT02797964|Next-Generation Sequencing|next-generation sequencing
223579|NCT02797964|Genetic biomarkers|genetic biomarkers
223580|NCT02797951|cluster headache|cluster headache
223581|NCT02797951|headache|headache
223582|NCT02797951|brain diseases|brain diseases
223583|NCT02797951|central nervous system diseases|central nervous system diseases
223584|NCT02797951|headache disorders|headache disorders
223585|NCT02797951|headache disorders, primary|headache disorders, primary
223586|NCT02797951|nervous system diseases|nervous system diseases
223587|NCT02797951|neurologic manifestations|neurologic manifestations
223588|NCT02797951|pain|pain
223589|NCT02797951|trigeminal autonomic cephalalgias|trigeminal autonomic cephalalgias
223590|NCT02797925|Achilles tendon|achilles tendon
223591|NCT02797925|Patella tendon|patella tendon
223592|NCT02797925|Inflammation|inflammation
223593|NCT02797925|Edema|edema
223594|NCT02797925|Clinical|clinical
223595|NCT02797925|Structural|structural
223596|NCT02797912|pulmonary function|pulmonary function
223597|NCT02797912|respiratory muscle function|respiratory muscle function
223598|NCT02797912|body composition|body composition
223599|NCT02797912|exercise tolerance|exercise tolerance
223600|NCT02797886|Hemiplegia|hemiplegia
223601|NCT02797886|Drop foot|drop foot
223602|NCT02797886|Foot drop|foot drop
223603|NCT02797860|Transabdominal cervicoisthmic cerclage|transabdominal cervicoisthmic cerclage
223604|NCT02797860|Rocuronium|rocuronium
223605|NCT02797860|Pregnant Women|pregnant women
223606|NCT02797847|TTR-mediated Amyloidosis|ttr-mediated amyloidosis
223607|NCT02797847|Amyloidosis, Hereditary|amyloidosis, hereditary
223608|NCT02797847|Amyloid Neuropathies, Familial|amyloid neuropathies, familial
223609|NCT02797847|Familial Amyloid Polyneuropathies|familial amyloid polyneuropathies
223610|NCT02797847|Amyloid Neuropathies|amyloid neuropathies
223611|NCT02797847|Amyloidosis, Hereditary, Transthyretin-Related|amyloidosis, hereditary, transthyretin-related
223612|NCT02797847|Familial Amyloidosis|familial amyloidosis
223613|NCT02797847|RNAi therapeutic|rnai therapeutic
223614|NCT02797834|Extracellular vesicles|extracellular vesicles
223615|NCT02797834|Endometrial fluid|endometrial fluid
223616|NCT02797834|Menstrual cycle|menstrual cycle
223617|NCT02797834|Exosomes|exosomes
223618|NCT02797834|Microvesicles|microvesicles
223619|NCT02797834|Apoptotic bodies|apoptotic bodies
223620|NCT02797821|HPP|hpp
223621|NCT02797821|asfotase alfa|asfotase alfa
223622|NCT02797808|OCD|ocd
223623|NCT02797743|Healthy Volunteers|healthy volunteers
223624|NCT02797730|Art Therapy|art therapy
223625|NCT02797730|Caregiver's|caregiver's
223626|NCT02797691|Cognitive Behavior Therapy|cognitive behavior therapy
223627|NCT02797691|Depression|depression
223628|NCT02797691|Anxiety|anxiety
223629|NCT02797691|Pashto|pashto
223630|NCT02797691|Pakistani|pakistani
223631|NCT02797691|Afghan|afghan
223632|NCT02797652|Breast cancer|breast cancer
223633|NCT02797652|ctDNA|ctdna
223634|NCT02797652|Neoadjuvant chemotherapy|neoadjuvant chemotherapy
223635|NCT02797652|Adjuvant chemotherapy|adjuvant chemotherapy
223636|NCT02797639|Intellectual Disability|intellectual disability
223637|NCT02797639|Collaborative Consultation|collaborative consultation
223638|NCT02797639|Participation|participation
223639|NCT02797600|Appalachia|appalachia
223640|NCT02797587|Alcohol Use|alcohol use
223641|NCT02797587|Tobacco Use|tobacco use
223642|NCT02797587|Smoking|smoking
223643|NCT02797587|Inflammation|inflammation
223644|NCT02797587|Coronary Heart Disease|coronary heart disease
223645|NCT02797587|Russia|russia
223646|NCT02797587|Varenicline|varenicline
223647|NCT02797587|Cytisine|cytisine
223744|NCT02797028|anthocyanidins|anthocyanidins
223648|NCT02797587|Nicotine Replacement Therapy|nicotine replacement therapy
223649|NCT02797587|Partial Agonist Therapy|partial agonist therapy
223650|NCT02797587|HIV|hiv
223651|NCT02797587|Reynolds risk score|reynolds risk score
223652|NCT02797587|VACS index|vacs index
223653|NCT02797561|Fractional flow reserve|fractional flow reserve
223654|NCT02797561|Tandem|tandem
223655|NCT02797561|Percutaneous Coronary Intervention|percutaneous coronary intervention
223656|NCT02797548|drug-eluting stent|drug-eluting stent
223657|NCT02797548|antiplatelet therapy|antiplatelet therapy
223658|NCT02797548|noncardiac surgery|noncardiac surgery
223659|NCT02797509|Intensive Care Unit|intensive care unit
223660|NCT02797496|Parkinson's disease|parkinson's disease
223661|NCT02797496|Mild to moderate stage|mild to moderate stage
223662|NCT02797496|Asymmetric Motor Strengthening|asymmetric motor strengthening
223663|NCT02797496|Rehabilitation|rehabilitation
223664|NCT02797457|Bilateral amputation of the forearms|bilateral amputation of the forearms
223665|NCT02797457|Bilateral allograft|bilateral allograft
223666|NCT02797457|Prosthetic forehands|prosthetic forehands
223667|NCT02797457|Medical economic evaluation|medical economic evaluation
223668|NCT02797418|Attentional disorders, intellectual deficiency|attentional disorders, intellectual deficiency
223669|NCT02797405|radiation therapy|radiation therapy
223670|NCT02797405|radiosensitivity|radiosensitivity
223671|NCT02797405|in vitro diagnostic medical devices|in vitro diagnostic medical devices
223672|NCT02797405|Adverse Event post radiotherapy|adverse event post radiotherapy
223673|NCT02797392|Tailored lifestyle intervention|tailored lifestyle intervention
223674|NCT02797392|Selective prevention|selective prevention
223675|NCT02797392|Primary care|primary care
223676|NCT02797392|Web based health risk assessment|web based health risk assessment
223677|NCT02797392|Patient-centered health information system|patient-centered health information system
223678|NCT02797392|Lifestyle intervention|lifestyle intervention
223679|NCT02797392|preventive treatment|preventive treatment
223680|NCT02797379|Psychoeducation|psychoeducation
223681|NCT02797379|Self-help|self-help
223682|NCT02797327|Molecular signature|molecular signature
223683|NCT02797327|Thailand-Myanmar border|thailand-myanmar border
223684|NCT02797314|Type 2 diabetes|type 2 diabetes
223685|NCT02797314|Bone quality|bone quality
223686|NCT02797314|Bone biopsies|bone biopsies
223687|NCT02797314|Vertebral fractures|vertebral fractures
223688|NCT02797314|Osteodensitometry|osteodensitometry
223689|NCT02797314|Trabecular Bone Score|trabecular bone score
223690|NCT02797301|early reading skills|early reading skills
223691|NCT02797249|preeclampsia|preeclampsia
723539|NCT00534352|PREZISTA|prezista
223692|NCT02797249|low dose aspirin|low dose aspirin
223693|NCT02797249|prevention|prevention
223694|NCT02797236|Phase I|phase i
223695|NCT02797236|conjugate vaccine|conjugate vaccine
223696|NCT02797236|Shigella flexneri 2a|shigella flexneri 2a
223697|NCT02797236|safety|safety
223698|NCT02797236|Immunogenicity|immunogenicity
223699|NCT02797236|Healthy adults|healthy adults
223700|NCT02797223|alopecia|alopecia
223701|NCT02797223|chemotherapy|chemotherapy
223702|NCT02797223|breast cancer|breast cancer
223703|NCT02797158|TAVI|tavi
223704|NCT02797158|Aortic stenosis|aortic stenosis
223705|NCT02797158|Coronary artery disease|coronary artery disease
223706|NCT02797158|Coronary angiography|coronary angiography
223707|NCT02797158|Percutaneous Coronary Intervention|percutaneous coronary intervention
223708|NCT02797158|Myocardial ischemia|myocardial ischemia
223709|NCT02797158|SPECT|spect
223710|NCT02797158|Coronary revascularization|coronary revascularization
223711|NCT02797145|Digoxin|digoxin
223712|NCT02797132|CF|cf
223713|NCT02797119|Tranexamic acid|tranexamic acid
223714|NCT02797119|Fibrinolysis|fibrinolysis
223715|NCT02797119|Cesarean section|cesarean section
223716|NCT02797119|Pharmacokinetics|pharmacokinetics
223717|NCT02797119|D dimers|d dimers
223718|NCT02797119|Fibrinogen|fibrinogen
223719|NCT02797119|Plasmin|plasmin
223720|NCT02797119|Transfusion|transfusion
223721|NCT02797106|Drooling|drooling
223722|NCT02797106|Cerebral palsy|cerebral palsy
223723|NCT02797106|Botulinium toxin|botulinium toxin
223724|NCT02797106|Practice survey of health professionals|practice survey of health professionals
223725|NCT02797106|Children|children
223726|NCT02797093|anti-retroviral therapy|anti-retroviral therapy
223727|NCT02797080|ACTIMMUNE|actimmune
223728|NCT02797080|interferon y-1b|interferon y-1b
223729|NCT02797067|Extracorporeal Shock Wave lithotripsy(ESWL)|extracorporeal shock wave lithotripsy(eswl)
223730|NCT02797067|Prophylaxis|prophylaxis
223731|NCT02797067|Indomethacin|indomethacin
223732|NCT02797067|Chronic pancreatitis|chronic pancreatitis
223733|NCT02797054|HPV vaccination|hpv vaccination
223734|NCT02797054|Vaccination decision-making|vaccination decision-making
223735|NCT02797054|Tailored health messaging|tailored health messaging
223736|NCT02797054|Barriers to vaccination|barriers to vaccination
223737|NCT02797054|Attitudes|attitudes
223738|NCT02797041|Multiple myeloma|multiple myeloma
223739|NCT02797041|Bortezomib|bortezomib
223740|NCT02797041|Relapsed multiple myeloma|relapsed multiple myeloma
223741|NCT02797041|Rechallenge|rechallenge
223742|NCT02797028|Hyperuricemia|hyperuricemia
223743|NCT02797028|endothelial function|endothelial function
223745|NCT02797015|MS|ms
223746|NCT02797015|RMS|rms
223747|NCT02797015|Multiple Sclerosis|multiple sclerosis
223748|NCT02797015|Relapsing Multiple Sclerosis|relapsing multiple sclerosis
223749|NCT02796976|arterial stiffness|arterial stiffness
223750|NCT02796976|retinal vessels|retinal vessels
223751|NCT02796976|physical activity|physical activity
223752|NCT02796976|ageing|ageing
223753|NCT02796963|HIV|hiv
223754|NCT02796963|MSM|msm
223755|NCT02796963|test uptake|test uptake
223756|NCT02796963|crowdsourcing|crowdsourcing
223757|NCT02796950|Acipimox|acipimox
223758|NCT02796950|GLP-1|glp-1
223759|NCT02796950|Insulin secretion|insulin secretion
223760|NCT02796937|Pulmonary Emphysema|pulmonary emphysema
223761|NCT02796937|Alpha-1 Antitrypsin Deficiency|alpha-1 antitrypsin deficiency
223762|NCT02796937|AATD|aatd
223763|NCT02796937|Alpha-1 PI Deficiency|alpha-1 pi deficiency
223764|NCT02796937|Alpha-1 Proteinase Inhibitor|alpha-1 proteinase inhibitor
223765|NCT02796924|Psychogenic Non-Epileptic Seizure|psychogenic non-epileptic seizure
223766|NCT02796924|Transcranial Magnetic Stimulation|transcranial magnetic stimulation
223767|NCT02796924|Brain Stimulation|brain stimulation
223768|NCT02796898|Prostate Cancer|prostate cancer
223769|NCT02796898|PSA|psa
223770|NCT02796898|Androgen Deprivation Therapy (ADT)|androgen deprivation therapy (adt)
223771|NCT02796859|Inflammation|inflammation
223772|NCT02796859|Psychosis|psychosis
223773|NCT02796859|Schizophrenia|schizophrenia
223774|NCT02796846|CPAP (continuous positive airway pressure)|cpap (continuous positive airway pressure)
223775|NCT02796846|OSA (Obstructive sleep apnea)|osa (obstructive sleep apnea)
223776|NCT02796833|Home parenteral nutrition|home parenteral nutrition
223777|NCT02796833|Liver injury|liver injury
223778|NCT02796833|Intravenous Lipid Emulsions|intravenous lipid emulsions
223779|NCT02796833|Catheter-related infections|catheter-related infections
223780|NCT02796833|Safety|safety
223781|NCT02796820|Huaier Granule|huaier granule
223782|NCT02796820|After radical surgery|after radical surgery
223783|NCT02796820|Prevention of Recurrence and Metastasis|prevention of recurrence and metastasis
223784|NCT02796820|Efficacy and safety|efficacy and safety
223785|NCT02796794|Enteral nutrition|enteral nutrition
223786|NCT02796794|Genistein|genistein
223787|NCT02796794|Cytokine|cytokine
223788|NCT02796755|Central Nervous System (CNS) Glutamate|central nervous system (cns) glutamate
223789|NCT02796755|Breast Cancer Treatment|breast cancer treatment
223790|NCT02796755|Fatigue|fatigue
723540|NCT00534352|darunavir|darunavir
223791|NCT02796755|Cognitive Dysfunction|cognitive dysfunction
223792|NCT02796755|Behavioral|behavioral
223793|NCT02796755|Psychometrics|psychometrics
223794|NCT02796755|Imaging Technology|imaging technology
223795|NCT02796755|Magnetic Resonance Spectroscopy|magnetic resonance spectroscopy
223796|NCT02796742|SSTIs|sstis
223797|NCT02796742|Methicillin-resistant Staphylococcus aureus (MRSA)|methicillin-resistant staphylococcus aureus (mrsa)
223798|NCT02796742|Methicillin susceptible Staphylococcus aureus (MSSA)|methicillin susceptible staphylococcus aureus (mssa)
223799|NCT02796742|the toxin Panton-Valentine Leukocidin (PVL)|the toxin panton-valentine leukocidin (pvl)
223800|NCT02796742|Emergency Departments|emergency departments
223801|NCT02796716|Wounded warriors|wounded warriors
223802|NCT02796716|Battlefield infection|battlefield infection
223803|NCT02796716|ESBL|esbl
223804|NCT02796716|MRSA|mrsa
223805|NCT02796716|KPC|kpc
223806|NCT02796690|nasal carriage|nasal carriage
223807|NCT02796690|Staphylococcus aureus|staphylococcus aureus
223808|NCT02796690|good hygiene practices|good hygiene practices
223809|NCT02796677|Safety|safety
223810|NCT02796677|Efficacy|efficacy
223811|NCT02796677|Aclidinium bromide|aclidinium bromide
223812|NCT02796677|Formoterol fumarate|formoterol fumarate
223813|NCT02796677|Tiotropium|tiotropium
223814|NCT02796677|Bronchodilation|bronchodilation
223815|NCT02796677|COPD|copd
223816|NCT02796664|Ginseng|ginseng
223817|NCT02796664|Stroke|stroke
223818|NCT02796664|Quantitative MR flow analysis|quantitative mr flow analysis
223819|NCT02796651|Perforomist|perforomist
223820|NCT02796651|Pressair|pressair
223821|NCT02796651|COPD|copd
223822|NCT02796651|Cigarette smoking|cigarette smoking
223823|NCT02796651|Formoterol fumarate|formoterol fumarate
223824|NCT02796651|long-acting β2-adrenergic agonists (LABA)|long-acting β2-adrenergic agonists (laba)
223825|NCT02796651|long-acting muscarinic antagonists (LAMA)|long-acting muscarinic antagonists (lama)
223826|NCT02796638|Acute Heart Failure|acute heart failure
223827|NCT02796638|Positive-Pressure Ventilation|positive-pressure ventilation
223828|NCT02796638|Adaptive Servo-Ventilation|adaptive servo-ventilation
223829|NCT02796625|EEG|eeg
223830|NCT02796625|healthy subjects|healthy subjects
223831|NCT02796612|anxiety|anxiety
223832|NCT02796612|breast cancer, suspected|breast cancer, suspected
223833|NCT02796612|breast biopsy|breast biopsy
223834|NCT02796612|empathy|empathy
223835|NCT02796612|standardized and structured information|standardized and structured information
223836|NCT02796612|anxiety reduction|anxiety reduction
223837|NCT02796586|Refugee Health|refugee health
223838|NCT02796586|Resettled Refugee|resettled refugee
223839|NCT02796586|Family Planning|family planning
223840|NCT02796586|Contraception|contraception
223841|NCT02796586|Group Counseling|group counseling
223842|NCT02796586|Group contraceptive counseling|group contraceptive counseling
223843|NCT02796573|blended care|blended care
223844|NCT02796573|CBT|cbt
223845|NCT02796573|B-CBT|b-cbt
223846|NCT02796573|depression|depression
223847|NCT02796560|Drugs, Generic|drugs, generic
223848|NCT02796560|Generic Equivalency|generic equivalency
223849|NCT02796547|Episiotomy|episiotomy
223850|NCT02796547|Levobupivacaine|levobupivacaine
223851|NCT02796534|Obstructive Sleep Apnea Syndrome|obstructive sleep apnea syndrome
223852|NCT02796521|malnutrition|malnutrition
223853|NCT02796521|aging|aging
223854|NCT02796521|diet therapy|diet therapy
223855|NCT02796508|Healthy aging|healthy aging
223856|NCT02796508|Cognitive training|cognitive training
223857|NCT02796508|Video-games|video-games
223858|NCT02796508|Attention|attention
223859|NCT02796508|Working memory|working memory
223860|NCT02796508|Wellbeing|wellbeing
223861|NCT02796495|Neuroplasticity|neuroplasticity
223862|NCT02796495|Sensory Feedback|sensory feedback
223863|NCT02796495|Nerve stimulation|nerve stimulation
223864|NCT02796495|Robotic Hand|robotic hand
223865|NCT02796456|apelin|apelin
223866|NCT02796456|colostrum|colostrum
223867|NCT02796456|plasma|plasma
223868|NCT02796456|glycemic markers|glycemic markers
223869|NCT02796456|lipidic markers|lipidic markers
223870|NCT02796456|pregnancy|pregnancy
223871|NCT02796456|postpartum|postpartum
223872|NCT02796443|acute cholecystitis|acute cholecystitis
223873|NCT02796443|early versus delayed surgery|early versus delayed surgery
223874|NCT02796430|Indirect calorimetry|indirect calorimetry
223875|NCT02796430|critical care|critical care
223876|NCT02796430|mechanical ventilation|mechanical ventilation
223877|NCT02796430|energy expenditure|energy expenditure
223878|NCT02796430|ICALIC study|icalic study
223879|NCT02796404|home monitoring|home monitoring
223880|NCT02796404|cardiac monitoring|cardiac monitoring
223881|NCT02796391|nicotine|nicotine
223882|NCT02796391|cigarettes|cigarettes
223883|NCT02796391|very low nicotine content (VLNC)|very low nicotine content (vlnc)
223884|NCT02796391|smoking cessation|smoking cessation
223885|NCT02796378|physical activity|physical activity
223886|NCT02796378|statin therapy|statin therapy
223887|NCT02796378|diabetes mellitus|diabetes mellitus
223888|NCT02796378|cardiovascular disease|cardiovascular disease
223889|NCT02796378|Q10-supplementation|q10-supplementation
223890|NCT02796365|Exercise|exercise
223891|NCT02796365|Cancer|cancer
223892|NCT02796365|Cardiotoxicity|cardiotoxicity
223893|NCT02796365|Cardiomyopathy|cardiomyopathy
223894|NCT02796365|Cardiac Rehabilitation|cardiac rehabilitation
223895|NCT02796339|Inflammatory Bowel Diseases|inflammatory bowel diseases
223896|NCT02796339|natural Mastiha|natural mastiha
223897|NCT02796339|supplement|supplement
223898|NCT02796326|tracheal stenosis|tracheal stenosis
223899|NCT02796326|tracheal dilatation|tracheal dilatation
223900|NCT02796326|ventilation|ventilation
223901|NCT02796300|bioflo|bioflo
223902|NCT02796300|Duramax catheter|duramax catheter
223903|NCT02796300|dialysis|dialysis
223904|NCT02796287|Amnesia|amnesia
223905|NCT02796287|transient global amnesia|transient global amnesia
223906|NCT02796261|Anaplastic Astrocytoma|anaplastic astrocytoma
223907|NCT02796261|Grade 3 Glioma|grade 3 glioma
223908|NCT02796261|Glioma|glioma
223909|NCT02796261|Eflornithine|eflornithine
223910|NCT02796261|Brain Cancer|brain cancer
223911|NCT02796261|Brain Tumor|brain tumor
223912|NCT02796261|Neuro-oncology|neuro-oncology
223913|NCT02796261|Progressive Anaplastic Astrocytoma|progressive anaplastic astrocytoma
223914|NCT02796261|Recurrent Anaplastic Astrocytoma|recurrent anaplastic astrocytoma
223915|NCT02796261|Progressive Glioma|progressive glioma
223916|NCT02796261|Recurrent Glioma|recurrent glioma
223917|NCT02796261|Malignant Glioma|malignant glioma
223918|NCT02796261|Progressive Brain Tumor|progressive brain tumor
223919|NCT02796261|Recurrent Brain Tumor|recurrent brain tumor
223920|NCT02796248|type 1 diabetes|type 1 diabetes
223921|NCT02796248|glucose control|glucose control
223922|NCT02796248|stigma|stigma
223923|NCT02796248|youth|youth
223924|NCT02796222|Hemophilia|hemophilia
223925|NCT02796222|Recombinant factor VIII|recombinant factor viii
223926|NCT02796222|Recombinant factor VIII Fc|recombinant factor viii fc
223927|NCT02796222|Recombinant factor IX|recombinant factor ix
223928|NCT02796222|Patient-reported outcomes|patient-reported outcomes
223929|NCT02796222|Recombinant factor IX Fc|recombinant factor ix fc
223930|NCT02796209|atomoxetine|atomoxetine
223931|NCT02796209|autonomic failure|autonomic failure
223932|NCT02796196|Hematopoietic|hematopoietic
223933|NCT02796196|Recipient|recipient
223934|NCT02796170|SGLT-2 inhibitor|sglt-2 inhibitor
223935|NCT02796170|urinary angiotensinogen|urinary angiotensinogen
223936|NCT02796157|bioresorbable vascular scaffold, drug eluting stent, coronary artery disease|bioresorbable vascular scaffold, drug eluting stent, coronary artery disease
223937|NCT02796144|schizophrenia|schizophrenia
223938|NCT02796144|schizoaffective disorder|schizoaffective disorder
223939|NCT02796144|overweight|overweight
223940|NCT02796144|obesity|obesity
223941|NCT02796144|weight loss|weight loss
223942|NCT02796144|metformin|metformin
223943|NCT02796144|lorcaserin|lorcaserin
223944|NCT02796131|Phase I|phase i
223945|NCT02796131|Healthy|healthy
223946|NCT02796131|Pharmacodynamics|pharmacodynamics
223947|NCT02796118|Pharmacokinetics|pharmacokinetics
223948|NCT02796118|Healthy non-elderly and elderly subjects|healthy non-elderly and elderly subjects
223949|NCT02796118|ASP2151|asp2151
223950|NCT02796118|Safety|safety
223951|NCT02796092|Pelvic Congestion Syndrome|pelvic congestion syndrome
223952|NCT02796092|Pelvic Venous Insufficiency|pelvic venous insufficiency
223953|NCT02796092|Chronic pelvic pain|chronic pelvic pain
223954|NCT02796066|Acne, topical, SCD-1 inhibitor, moderate, severe|acne, topical, scd-1 inhibitor, moderate, severe
223955|NCT02796040|Parkinson's disease|parkinson's disease
223956|NCT02796040|Impulse control disorders|impulse control disorders
223957|NCT02796040|Diffusion tensor imaging|diffusion tensor imaging
223959|NCT02796040|Mesocorticolimbic pathway|mesocorticolimbic pathway
223960|NCT02796027|Health Services Research|health services research
223961|NCT02795988|Secondary|secondary
223962|NCT02795962|Endovascular Procedures|endovascular procedures
223963|NCT02795962|Emergency Medical Services|emergency medical services
223964|NCT02795949|Enterobacteriaceae|enterobacteriaceae
223965|NCT02795949|Bacteremia|bacteremia
223966|NCT02795949|Escalation|escalation
223967|NCT02795949|Bacterial resistance|bacterial resistance
223968|NCT02795949|Bloodstream infection|bloodstream infection
223969|NCT02795949|Recurrence|recurrence
223970|NCT02795936|rehabilitation|rehabilitation
223971|NCT02795936|exercise|exercise
223972|NCT02795897|genetics|genetics
223973|NCT02795897|genomics|genomics
223974|NCT02795897|amyotrophic lateral sclerosis (ALS)|amyotrophic lateral sclerosis (als)
223975|NCT02795897|primary lateral sclerosis (PLS)|primary lateral sclerosis (pls)
223976|NCT02795897|progressive muscular atrophy (PMA)|progressive muscular atrophy (pma)
223977|NCT02795897|motor neuron disease|motor neuron disease
223978|NCT02795884|Lung cancer|lung cancer
223979|NCT02795884|NSCLC|nsclc
223980|NCT02795884|adjuvant treatment|adjuvant treatment
223981|NCT02795871|Congenital Adrenal Hyperplasia|congenital adrenal hyperplasia
223982|NCT02795871|Prenatal treatment|prenatal treatment
223983|NCT02795871|Dexamethasone|dexamethasone
223984|NCT02795871|Neuropsychological assessment|neuropsychological assessment
286388|NCT02423915|MMF|mmf
223985|NCT02795871|Cognitive development|cognitive development
223986|NCT02795858|Carcinoid Tumors|carcinoid tumors
223987|NCT02795806|Address|address
223988|NCT02795793|appendicitis|appendicitis
223989|NCT02795793|non-operative management|non-operative management
223990|NCT02795793|children|children
223991|NCT02795793|pediatric|pediatric
223992|NCT02795754|GSK2838232|gsk2838232
223993|NCT02795754|HIV|hiv
223994|NCT02795754|repeated dose escalation|repeated dose escalation
223995|NCT02795754|immediate release tablet|immediate release tablet
223996|NCT02795754|single dose escalation|single dose escalation
223997|NCT02795715|tDCS|tdcs
223998|NCT02795702|tDCS|tdcs
223999|NCT02795676|Glomerular filtration rate|glomerular filtration rate
224000|NCT02795676|Proteinuria|proteinuria
224001|NCT02795676|PRX-102|prx-102
224002|NCT02795676|pegunigalsidase alfa|pegunigalsidase alfa
224003|NCT02795676|Fabry Disease|fabry disease
224004|NCT02795663|Near-InfraRed Spectroscopy (NIRS)|near-infrared spectroscopy (nirs)
224005|NCT02795663|Deep brain stimulation of SubThalamic Nucleus (DBS)|deep brain stimulation of subthalamic nucleus (dbs)
224006|NCT02795650|Metastatic|metastatic
224007|NCT02795650|Pancreas|pancreas
224008|NCT02795637|Attention deficit hyperactivity disorder (ADHD),|attention deficit hyperactivity disorder (adhd),
224009|NCT02795637|Binge-Eating Disorder (BED)|binge-eating disorder (bed)
224010|NCT02795611|Family-centered|family-centered
224011|NCT02795611|Autism spectrum disorder|autism spectrum disorder
224012|NCT02795611|Occupational therapy|occupational therapy
224013|NCT02795611|Participation|participation
224014|NCT02795611|Play|play
224015|NCT02795585|Fractional Flow Reserve|fractional flow reserve
224016|NCT02795585|Coronary Artery Disease|coronary artery disease
224017|NCT02795572|Breast Neoplasms|breast neoplasms
224018|NCT02795572|Peripheral Neuropathies|peripheral neuropathies
224019|NCT02795559|Nutrition|nutrition
224020|NCT02795559|Humans|humans
224021|NCT02795559|Obesity|obesity
224022|NCT02795559|Blood glucose|blood glucose
224023|NCT02795559|Dietary fiber|dietary fiber
224024|NCT02795559|Appetite|appetite
224025|NCT02795559|Short chain fatty acids|short chain fatty acids
224026|NCT02795546|periodontal regeneration|periodontal regeneration
224027|NCT02795533|Cognitive function|cognitive function
224028|NCT02795533|Quality of Life|quality of life
224029|NCT02795507|cross education|cross education
224030|NCT02795507|visual feedback|visual feedback
224031|NCT02795468|Peripheral|peripheral
224032|NCT02795468|Arterial|arterial
224033|NCT02795468|Catheterization|catheterization
224034|NCT02795455|Eating Disorders|eating disorders
224035|NCT02795455|Food Avoidance|food avoidance
224036|NCT02795455|Reward Learning|reward learning
224037|NCT02795455|Reward System|reward system
224038|NCT02795455|Family-based treatment|family-based treatment
224039|NCT02795455|interoceptive exposure|interoceptive exposure
224040|NCT02795455|insula-amygdala-ventral striatum subcircuits|insula-amygdala-ventral striatum subcircuits
224041|NCT02795429|Phase Ib/II|phase ib/ii
224042|NCT02795429|INC280|inc280
224043|NCT02795429|PDR001|pdr001
224044|NCT02795429|checkpoint inhibitor|checkpoint inhibitor
224045|NCT02795429|PD-1|pd-1
224046|NCT02795416|Moderate to severe plaque psoriasis, PASI, secukinumab, monoclonal antibody, Turkish population|moderate to severe plaque psoriasis, pasi, secukinumab, monoclonal antibody, turkish population
224047|NCT02795403|HCV, liver|hcv, liver
224048|NCT02795390|Chinese herbal medicine formula|chinese herbal medicine formula
224049|NCT02795390|MaZiRenWan|mazirenwan
224050|NCT02795390|Randomized controlled trial|randomized controlled trial
224051|NCT02795390|Constipation|constipation
224052|NCT02795390|Palliative care in cancer|palliative care in cancer
224053|NCT02795377|arterial hypertension|arterial hypertension
224054|NCT02795377|microparticle|microparticle
224055|NCT02795377|endothelial function|endothelial function
224056|NCT02795364|High Grade Glioma|high grade glioma
224057|NCT02795364|Magnetic Resonance Spectroscopy|magnetic resonance spectroscopy
224058|NCT02795364|Surgical resection|surgical resection
224059|NCT02795364|Prognosis|prognosis
224060|NCT02795325|Primary Hyperoxaluria Type 1|primary hyperoxaluria type 1
224061|NCT02795325|PH1|ph1
224062|NCT02795325|Calcium Oxalate Stones|calcium oxalate stones
224063|NCT02795325|Kidney Stones|kidney stones
224064|NCT02795325|Liver Enzyme Deficiency|liver enzyme deficiency
224065|NCT02795325|Genetic Diseases|genetic diseases
224066|NCT02795325|Inborn Kidney Diseases|inborn kidney diseases
224067|NCT02795325|Metabolic Diseases|metabolic diseases
224068|NCT02795325|Inborn Errors|inborn errors
224069|NCT02795325|Urological Diseases|urological diseases
224070|NCT02795325|Carbohydrate Metabolism|carbohydrate metabolism
224071|NCT02795325|Hyperoxaluria|hyperoxaluria
224072|NCT02795325|AGT|agt
224073|NCT02795325|RNAi|rnai
224074|NCT02795325|siRNA|sirna
224075|NCT02795325|DCR-PH1|dcr-ph1
224076|NCT02795312|Cigarette Smoking|cigarette smoking
224077|NCT02795286|Chronic Kidney Disease (CKD)|chronic kidney disease (ckd)
224078|NCT02795286|End Stage Renal Disease (ESRD)|end stage renal disease (esrd)
224079|NCT02795286|Chronic Hemodialysis|chronic hemodialysis
224080|NCT02795286|In-center HD|in-center hd
224081|NCT02795286|Sodium|sodium
224082|NCT02795286|Isotonic Dialysis|isotonic dialysis
224083|NCT02795273|Rhinitis|rhinitis
224084|NCT02795273|Conjunctivitis|conjunctivitis
224085|NCT02795273|Grass|grass
224086|NCT02795273|Allergy|allergy
224087|NCT02795260|ESAT6|esat6
224088|NCT02795260|CFP10|cfp10
224089|NCT02795260|skin test|skin test
224090|NCT02795260|diagnostic test|diagnostic test
224091|NCT02795195|re-irradiation|re-irradiation
224092|NCT02795195|carbon ion therapy|carbon ion therapy
224093|NCT02795182|Relapsed|relapsed
224094|NCT02795182|Refractory|refractory
224095|NCT02795156|regorafenib|regorafenib
224096|NCT02795156|afatinib|afatinib
224097|NCT02795156|targeted therapy|targeted therapy
224098|NCT02795156|cabozantinib|cabozantinib
224099|NCT02795143|TEN|ten
224100|NCT02795104|RISE|rise
224101|NCT02795091|clean supplies|clean supplies
224102|NCT02795091|ICU floor|icu floor
224103|NCT02795091|bacteria colony|bacteria colony
224104|NCT02795091|catheter associated with infection|catheter associated with infection
224105|NCT02795078|Atherosclerotic Intracranial Arterial Stenosis|atherosclerotic intracranial arterial stenosis
224106|NCT02795078|Intracranial Aneurysms|intracranial aneurysms
224107|NCT02795052|Neurologic Disease|neurologic disease
224108|NCT02795052|Cerebral Vascular Accident|cerebral vascular accident
224109|NCT02795052|Stroke|stroke
224110|NCT02795052|Traumatic Brain Injury|traumatic brain injury
224111|NCT02795052|Multiple Sclerosis|multiple sclerosis
224112|NCT02795052|Parkinsons Disease|parkinsons disease
224113|NCT02795052|Neuropathy|neuropathy
224114|NCT02795052|Neurodegeneration|neurodegeneration
224115|NCT02795052|Diabetic Neuropathy|diabetic neuropathy
224116|NCT02795052|Cerebral Ischemia|cerebral ischemia
224117|NCT02795026|dry needling|dry needling
224118|NCT02795026|vulvodynia|vulvodynia
224119|NCT02795026|pelvic pain chronic|pelvic pain chronic
224120|NCT02795013|Genetic studies|genetic studies
224121|NCT02795013|Pediatric|pediatric
224122|NCT02795000|Primary Ovarian Insufficiency|primary ovarian insufficiency
224123|NCT02795000|nomogram|nomogram
224124|NCT02794987|Bile duct|bile duct
224125|NCT02794987|indeterminate stricture|indeterminate stricture
224126|NCT02794987|cholangioscopy|cholangioscopy
224127|NCT02794987|Spyglass|spyglass
224128|NCT02794948|primary ovarian insufficiency|primary ovarian insufficiency
224129|NCT02794948|TCM intervention|tcm intervention
224130|NCT02794935|inspiratory muscle training|inspiratory muscle training
224131|NCT02794935|heart failure|heart failure
224132|NCT02794935|obstructive sleep apnea|obstructive sleep apnea
224133|NCT02794922|Vitamin B|vitamin b
224134|NCT02794922|Temporomandibular joint disorder|temporomandibular joint disorder
224135|NCT02794922|trpv1|trpv1
224136|NCT02794909|Point-of-care ultrasound|point-of-care ultrasound
224137|NCT02794909|ED|ed
224138|NCT02794909|Low and middle-income country|low and middle-income country
224139|NCT02794909|Echocardiography|echocardiography
224140|NCT02794909|Lung ultrasound|lung ultrasound
224141|NCT02794909|Resuscitation|resuscitation
224142|NCT02794857|ALS|als
224143|NCT02794857|Amyotrophic Lateral Sclerosis|amyotrophic lateral sclerosis
224144|NCT02794857|Motor Neuron Disease|motor neuron disease
224145|NCT02794857|Central Nervous System Diseases|central nervous system diseases
224146|NCT02794857|Nervous System Diseases|nervous system diseases
224147|NCT02794857|Neurodegenerative Diseases|neurodegenerative diseases
224148|NCT02794857|Neuromuscular Diseases|neuromuscular diseases
224149|NCT02794857|Inflammation|inflammation
224150|NCT02794857|C-Reactive Protein|c-reactive protein
224151|NCT02794831|NSAIDs|nsaids
224152|NCT02794831|Bacterial Infections|bacterial infections
224153|NCT02794831|Severity|severity
224154|NCT02794831|Self Medication|self medication
224155|NCT02794818|Prevention|prevention
224156|NCT02794818|Nutrition|nutrition
224157|NCT02794792|Type 2 Diabetes Mellitus|type 2 diabetes mellitus
224158|NCT02794792|ASP1941|asp1941
224159|NCT02794792|Ipragliflozin|ipragliflozin
224160|NCT02794779|cesarean section|cesarean section
224161|NCT02794779|labor|labor
224162|NCT02794779|oxytocin|oxytocin
224163|NCT02794753|Trichotillomania|trichotillomania
224164|NCT02794753|Hair-pulling Disorder|hair-pulling disorder
224165|NCT02794753|Cognitive Training|cognitive training
224166|NCT02794753|Neuroplasticity|neuroplasticity
224167|NCT02794753|Working Memory|working memory
224168|NCT02794740|Osteoarthritis|osteoarthritis
224169|NCT02794714|Laparoscopic Gynecologic Surgeries|laparoscopic gynecologic surgeries
224170|NCT02794688|Non-lactating|non-lactating
224171|NCT02794688|idiopathic granulomatous mastitis|idiopathic granulomatous mastitis
224172|NCT02794688|periductal mastitis|periductal mastitis
224173|NCT02794688|ductal lavage|ductal lavage
224174|NCT02794675|resectable|resectable
224175|NCT02794675|Cesium 131|cesium 131
224176|NCT02794675|brachytherapy|brachytherapy
224177|NCT02794662|Oxygen Delivery System, Nasal Cannula|oxygen delivery system, nasal cannula
400630|NCT01865981|Ventricular Fibrillation|ventricular fibrillation
224178|NCT02794662|Oxygen Delivery System, Incubator|oxygen delivery system, incubator
224179|NCT02794623|cochlear implants|cochlear implants
224180|NCT02794623|hearing loss|hearing loss
224181|NCT02794610|Tacrolimus|tacrolimus
224182|NCT02794610|Ocular penetration|ocular penetration
224183|NCT02794610|Topical|topical
224184|NCT02794597|Unplanned Pregnancy, LARC|unplanned pregnancy, larc
224185|NCT02794558|Breast Cancer, MRgFus, Focused Ultrasound|breast cancer, mrgfus, focused ultrasound
224186|NCT02794519|Asthma Control Questionnaire|asthma control questionnaire
224187|NCT02794519|interleukin-6|interleukin-6
224188|NCT02794519|Sirukumab|sirukumab
224189|NCT02794519|severe, poorly controlled asthma|severe, poorly controlled asthma
224190|NCT02794519|asthma|asthma
224191|NCT02794519|ACQ|acq
224192|NCT02794506|Diabetes mellitus|diabetes mellitus
224193|NCT02794506|Chronic periodontitis|chronic periodontitis
224194|NCT02794506|Propolis|propolis
224195|NCT02794480|ELLIPTA|ellipta
224196|NCT02794480|metered dose inhaler|metered dose inhaler
224197|NCT02794480|Dry powder inhaler|dry powder inhaler
224198|NCT02794467|Heavy menstrual bleeding|heavy menstrual bleeding
224199|NCT02794467|Adenomyosis|adenomyosis
224200|NCT02794467|Safety|safety
224201|NCT02794467|Epelsiban|epelsiban
224202|NCT02794467|Tolerability|tolerability
224203|NCT02794467|Proof of concept|proof of concept
224204|NCT02794428|Gastric adenocarcinoma|gastric adenocarcinoma
224205|NCT02794428|Gastric intestinal metaplasia|gastric intestinal metaplasia
224206|NCT02794428|Atrophic gastritis|atrophic gastritis
224207|NCT02794428|Gastric premalignant lesion|gastric premalignant lesion
224208|NCT02794415|HIV|hiv
224209|NCT02794415|disability|disability
224210|NCT02794415|rehabilitation|rehabilitation
224211|NCT02794415|exercise|exercise
224212|NCT02794389|Acetylcysteine|acetylcysteine
224213|NCT02794376|IBS|ibs
224214|NCT02794350|RBANS-H|rbans-h
224215|NCT02794350|Cochlear implantation|cochlear implantation
224216|NCT02794350|Cognition|cognition
224217|NCT02794350|Older adults|older adults
224218|NCT02794350|RBANS|rbans
224345|NCT02793713|Diagnostic Techniques, Respiratory System|diagnostic techniques, respiratory system
224219|NCT02794285|Lupus Erythematosus, Systemic Autoimmune Diseases, Connective Tissue Diseases,Immune System Diseases|lupus erythematosus, systemic autoimmune diseases, connective tissue diseases,immune system diseases
224220|NCT02794272|GABA concentration|gaba concentration
224221|NCT02794272|tDCS|tdcs
224222|NCT02794259|GABA concentration|gaba concentration
224223|NCT02794259|tDCS|tdcs
224224|NCT02794233|Deep Brain Stimulation|deep brain stimulation
224225|NCT02794233|Electric Impedance|electric impedance
224226|NCT02794233|Parkinson disease|parkinson disease
224227|NCT02794220|E-cigarette|e-cigarette
224228|NCT02794220|healthy volunteer study|healthy volunteer study
224229|NCT02794220|Pharmacokinetics|pharmacokinetics
224230|NCT02794220|Nicorette|nicorette
224231|NCT02794207|Pediatric|pediatric
224232|NCT02794207|Cancer|cancer
224233|NCT02794207|AML|aml
224234|NCT02794207|Qualitative Interview|qualitative interview
224235|NCT02794194|Chronic Ankle Instability|chronic ankle instability
224335|NCT02793752|Fertility|fertility
224236|NCT02794194|Whole Body Vibration|whole body vibration
224237|NCT02794194|Proprioception|proprioception
224238|NCT02794181|Transfusion-Transmitted Infections|transfusion-transmitted infections
224239|NCT02794181|Dengue Virus|dengue virus
224240|NCT02794181|Chikungunya Virus|chikungunya virus
224241|NCT02794181|Natural History|natural history
224242|NCT02794181|Blood Transfusion|blood transfusion
224243|NCT02794142|hemodialysis|hemodialysis
224244|NCT02794142|muscle dysfunction|muscle dysfunction
224245|NCT02794142|mitochondria|mitochondria
224246|NCT02794142|oxidative stress|oxidative stress
224247|NCT02794142|inflammation|inflammation
224248|NCT02794142|renal transplantation|renal transplantation
224249|NCT02794103|Virtual reality|virtual reality
224250|NCT02794103|Immersive distraction|immersive distraction
224251|NCT02794103|Virtual world|virtual world
224252|NCT02794103|Virtual environment|virtual environment
224253|NCT02794103|Procedural pain|procedural pain
224254|NCT02794103|Procedural anxiety|procedural anxiety
224255|NCT02794103|Acute pain|acute pain
224256|NCT02794103|Pain management|pain management
224257|NCT02794103|Anxiety|anxiety
224258|NCT02794103|Children, Child|children, child
224259|NCT02794103|Kid, Kids|kid, kids
224260|NCT02794103|Pediatric, Pediatrics|pediatric, pediatrics
224261|NCT02794103|Young children|young children
224262|NCT02794103|Burns|burns
224263|NCT02794103|Burn injuries|burn injuries
224264|NCT02794103|Burn unit|burn unit
224265|NCT02794103|Hydrotherapy|hydrotherapy
224266|NCT02794103|Burn dressing|burn dressing
224267|NCT02794103|Non-pharmacological|non-pharmacological
224268|NCT02794103|Clinical Research|clinical research
224269|NCT02794103|Nursing Practice|nursing practice
224270|NCT02794090|Behavioral treatment|behavioral treatment
224271|NCT02794090|Telephone coaching|telephone coaching
224272|NCT02794090|Outpatient clinic|outpatient clinic
400631|NCT01865981|electrophysiology|electrophysiology
224273|NCT02794077|Nasopharyngeal undifferentiated carcinoma|nasopharyngeal undifferentiated carcinoma
224274|NCT02793947|Peri-incisional injection|peri-incisional injection
224275|NCT02793947|Multimodal analgesia|multimodal analgesia
224276|NCT02793947|Femur fracture|femur fracture
224277|NCT02793934|Rehabilitation|rehabilitation
224279|NCT02793934|Pilot project|pilot project
224280|NCT02793934|Stroke|stroke
224281|NCT02793934|Acute myocardial infarction|acute myocardial infarction
224282|NCT02793934|Total hip replacement|total hip replacement
224283|NCT02793921|Alteration|alteration
224284|NCT02793921|Cognitive Function|cognitive function
224285|NCT02793921|Exercise|exercise
224286|NCT02793908|Endometriosis|endometriosis
224287|NCT02793908|Subcutaneous progesterone|subcutaneous progesterone
224288|NCT02793908|luteal phase|luteal phase
224289|NCT02793895|Atrial fibrillation/flutter|atrial fibrillation/flutter
224290|NCT02793895|Postoperative atrial arrhythmia|postoperative atrial arrhythmia
224291|NCT02793895|Cardiac surgery|cardiac surgery
224292|NCT02793895|Stroke prevention|stroke prevention
224293|NCT02793895|Oral anticoagulation|oral anticoagulation
224294|NCT02793895|Cardiac rhythm monitoring|cardiac rhythm monitoring
224295|NCT02793869|congenital cataract;anterior segment characteristics|congenital cataract;anterior segment characteristics
224296|NCT02793856|lung cancer|lung cancer
224297|NCT02793856|immune checkpoint|immune checkpoint
224298|NCT02793856|PD-1|pd-1
224299|NCT02793856|CRISPER|crisper
224300|NCT02793856|autologous cell infusion|autologous cell infusion
224301|NCT02793830|medication adherence|medication adherence
224302|NCT02793830|mHealth|mhealth
224303|NCT02793830|China|china
224304|NCT02793830|heart disease|heart disease
224305|NCT02793817|postsurgical|postsurgical
224306|NCT02793817|postoperative|postoperative
224307|NCT02793817|ocular|ocular
224308|NCT02793817|cataract|cataract
224309|NCT02793817|inflammation|inflammation
224310|NCT02793817|pain|pain
224311|NCT02793817|corticosteroid|corticosteroid
224312|NCT02793804|HIV self-testing|hiv self-testing
224313|NCT02793804|HIV|hiv
224314|NCT02793804|Zambia|zambia
224315|NCT02793791|high grade dysplastic nodule (HGDN)|high grade dysplastic nodule (hgdn)
224316|NCT02793791|low grade dysplastic nodule (LGDN)|low grade dysplastic nodule (lgdn)
224317|NCT02793778|Crohn's Disease|crohn's disease
224318|NCT02793778|Digestive System Diseases|digestive system diseases
224319|NCT02793778|Gastrointestinal Diseases|gastrointestinal diseases
224320|NCT02793778|Intestinal Diseases|intestinal diseases
224321|NCT02793778|mucosal healing|mucosal healing
224322|NCT02793778|inflammatory bowel disease|inflammatory bowel disease
224323|NCT02793778|Medical Food|medical food
224324|NCT02793778|Nutritional intervention|nutritional intervention
224325|NCT02793765|Advanced Prostate Cancer|advanced prostate cancer
224326|NCT02793765|Castration-Resistant Prostate Cancer|castration-resistant prostate cancer
224327|NCT02793765|Adenocarcinoma of the prostate|adenocarcinoma of the prostate
224328|NCT02793765|Metastatic disease|metastatic disease
224329|NCT02793765|CRPC|crpc
224330|NCT02793752|IVF|ivf
224331|NCT02793752|In vitro fertilization|in vitro fertilization
224332|NCT02793752|Cumulus Cells|cumulus cells
224333|NCT02793752|Oocyte|oocyte
224334|NCT02793752|Embryo|embryo
224336|NCT02793739|Safety|safety
224337|NCT02793739|Efficacy|efficacy
224338|NCT02793739|Longevity|longevity
224339|NCT02793726|Hip Prosthesis|hip prosthesis
224340|NCT02793713|EBUS|ebus
224341|NCT02793713|Prediction|prediction
224342|NCT02793713|malignancy|malignancy
224343|NCT02793713|lymph nodes|lymph nodes
224344|NCT02793713|lung cancer|lung cancer
224346|NCT02793700|Betamethasone|betamethasone
224347|NCT02793674|effort of breathing|effort of breathing
224348|NCT02793674|high flow nasal cannula|high flow nasal cannula
224349|NCT02793674|respiratory distress|respiratory distress
224350|NCT02793648|Depression|depression
224351|NCT02793648|Elderly|elderly
224352|NCT02793635|Paraplegia|paraplegia
224353|NCT02793635|Gait|gait
224354|NCT02793635|Exoskeleton|exoskeleton
224355|NCT02793622|Chemoprevention|chemoprevention
224356|NCT02793622|Malaria|malaria
224357|NCT02793622|Sulfadoxine-Pyrimethamine|sulfadoxine-pyrimethamine
224358|NCT02793622|Dihydroartemisinin-Piperaquine|dihydroartemisinin-piperaquine
224359|NCT02793609|induction of labor|induction of labor
224360|NCT02793609|double balloon catheter|double balloon catheter
224361|NCT02793609|mechanical ripening|mechanical ripening
224362|NCT02793505|metformin|metformin
224363|NCT02793505|pregnancy outcomes|pregnancy outcomes
224364|NCT02793505|birth defects|birth defects
224365|NCT02793505|spontaneous abortion|spontaneous abortion
224366|NCT02793505|pharmacoepidemiology|pharmacoepidemiology
224367|NCT02793466|Durvalumab|durvalumab
224368|NCT02793466|solid tumors|solid tumors
224369|NCT02793466|Immunotherapy|immunotherapy
224370|NCT02793466|Check Point Inhibitor|check point inhibitor
224371|NCT02793466|pediatrics|pediatrics
224372|NCT02793466|children|children
224373|NCT02793401|High Intensity Laser|high intensity laser
224374|NCT02793401|Ultrasound|ultrasound
224375|NCT02793401|Chronic Shoulder Pain|chronic shoulder pain
224376|NCT02793375|Montelukast|montelukast
224377|NCT02793375|Tonsillectomy|tonsillectomy
224378|NCT02793349|angioplasty|angioplasty
224379|NCT02793349|stents|stents
224380|NCT02793349|polymers|polymers
224381|NCT02793349|absorbable implants|absorbable implants
224382|NCT02793271|Depression|depression
224383|NCT02793271|Primary Health Care|primary health care
224384|NCT02793271|Social Stigma|social stigma
224385|NCT02793271|Stereotyping|stereotyping
224386|NCT02793271|Health Care Quality|health care quality
224387|NCT02793271|Access|access
224388|NCT02793271|Evaluation|evaluation
224389|NCT02793258|tDCS|tdcs
224390|NCT02793258|neuromodulation|neuromodulation
224391|NCT02793258|depression|depression
224392|NCT02793258|cognition|cognition
224393|NCT02793232|Safety|safety
224394|NCT02793232|Tolerability|tolerability
224395|NCT02793232|Pharmacokinetics|pharmacokinetics
224396|NCT02793232|Alzheimer's disease|alzheimer's disease
224397|NCT02793219|Advanced Prostate Cancer|advanced prostate cancer
224398|NCT02793219|Castration-Resistant Prostate Cancer|castration-resistant prostate cancer
224399|NCT02793219|CRPC|crpc
224400|NCT02793219|Adenocarcinoma of the prostate|adenocarcinoma of the prostate
224401|NCT02793219|Metastatic disease|metastatic disease
224402|NCT02793206|Drusen|drusen
224403|NCT02793206|SD-OCT|sd-oct
224404|NCT02793167|acute kidney injury|acute kidney injury
224405|NCT02793167|medication alert systems|medication alert systems
224406|NCT02793154|gastric emptying|gastric emptying
224407|NCT02793154|albiglutide|albiglutide
224408|NCT02793154|GMA|gma
224409|NCT02793154|exenatide|exenatide
224410|NCT02793154|type 2 diabetes mellitus|type 2 diabetes mellitus
224411|NCT02793141|Pneumonia|pneumonia
224412|NCT02793141|Intensive Care Unit|intensive care unit
224413|NCT02793141|Nosocomial pneumonia|nosocomial pneumonia
224414|NCT02793141|Hospital-acquired pneumonia|hospital-acquired pneumonia
224415|NCT02793141|Ventilator-associated pneumonia|ventilator-associated pneumonia
224416|NCT02793141|ICU|icu
224417|NCT02793141|HAP|hap
224418|NCT02793141|VAP|vap
224419|NCT02793141|Critical Care|critical care
224420|NCT02793128|TC-3|tc-3
224421|NCT02793128|Mitogel|mitogel
224422|NCT02793128|UTUC|utuc
224423|NCT02793128|Ureteral|ureteral
224424|NCT02793128|Upper Tract|upper tract
224425|NCT02793128|Carcinoma|carcinoma
224426|NCT02793128|Kidney|kidney
224427|NCT02793128|Renal|renal
224428|NCT02793128|Gel|gel
224429|NCT02793128|Local|local
224430|NCT02793128|Mitomycin C|mitomycin c
224431|NCT02793128|Prolonged Release|prolonged release
224432|NCT02793128|Slow Release|slow release
224433|NCT02793128|Kidney Sparing|kidney sparing
224434|NCT02793128|T1|t1
224435|NCT02793128|T0|t0
224436|NCT02793128|Low Grade|low grade
224437|NCT02793128|Transitional Cell Carcinoma of Renal Pelvis|transitional cell carcinoma of renal pelvis
224438|NCT02793128|TCC|tcc
224439|NCT02793102|mental anorexia|mental anorexia
224440|NCT02793102|sensory workshops|sensory workshops
224441|NCT02793102|BMI|bmi
224442|NCT02793076|Posture|posture
224443|NCT02793076|Body image|body image
224444|NCT02793076|Dancing|dancing
224445|NCT02793076|Group|group
224446|NCT02793076|Survivors|survivors
224447|NCT02793063|Brittle Bone|brittle bone
224448|NCT02793063|Osteogenesis Imperfecta|osteogenesis imperfecta
224449|NCT02793063|BBD|bbd
224450|NCT02793063|OI|oi
224451|NCT02793063|Congenital Abnormalities|congenital abnormalities
224452|NCT02793063|Congenital Bone Disorder|congenital bone disorder
224453|NCT02793063|Lobstein Syndrome|lobstein syndrome
224454|NCT02793050|Trabectedin|trabectedin
224455|NCT02793050|Soft Tissue Sarcoma|soft tissue sarcoma
224456|NCT02793050|Observational|observational
224457|NCT02793037|zirconia|zirconia
224458|NCT02793037|resin bonded bridge|resin bonded bridge
224459|NCT02793024|food shopping intervention|food shopping intervention
224460|NCT02792972|Analgesic|analgesic
224461|NCT02792972|Medicinal plants|medicinal plants
224462|NCT02792972|Skin|skin
224463|NCT02792972|Antimicrobial agents|antimicrobial agents
224464|NCT02792972|Pain Measurement|pain measurement
224465|NCT02792907|Foot Surgery|foot surgery
224466|NCT02792907|Compliance|compliance
224467|NCT02792907|Compressive Stockings|compressive stockings
224468|NCT02792894|cluster randomized trial|cluster randomized trial
224469|NCT02792894|developmental delays|developmental delays
224470|NCT02792894|neurodevelopmental disorders|neurodevelopmental disorders
224471|NCT02792894|autism|autism
224472|NCT02792894|intellectual disability|intellectual disability
224473|NCT02792894|low resource settings|low resource settings
224474|NCT02792894|family volunteers|family volunteers
224475|NCT02792881|Stomach Neoplasms|stomach neoplasms
224476|NCT02792881|Laparoscopy|laparoscopy
224477|NCT02792881|Remnant gastric cancer|remnant gastric cancer
224478|NCT02792855|Snifﬁng Position|snifﬁng position
224479|NCT02792855|Simple Head Extension|simple head extension
712519|NCT00579891|tissue collection|tissue collection
287020|NCT02420873|AML|aml
224480|NCT02792829|Bioavailability of Lenvatinib suspension|bioavailability of lenvatinib suspension
224481|NCT02792829|Palatability of Lenvatinib suspension|palatability of lenvatinib suspension
224482|NCT02792829|Lenvatinib|lenvatinib
224483|NCT02792829|Lenvima|lenvima
224484|NCT02792829|E7080|e7080
224485|NCT02792829|Capsule formulation|capsule formulation
224486|NCT02792829|Healthy volunteers|healthy volunteers
224487|NCT02792803|POAG|poag
224488|NCT02792803|Primary open angle glaucoma|primary open angle glaucoma
224489|NCT02792803|Ocular Hypertension|ocular hypertension
224490|NCT02792803|Xalatan|xalatan
224491|NCT02792803|Latanoprost|latanoprost
224492|NCT02792803|Ocular Hyperemia|ocular hyperemia
224493|NCT02792803|IOP|iop
224494|NCT02792803|Intraocular Pressure|intraocular pressure
224495|NCT02792803|Allergan|allergan
224496|NCT02792803|prostaglandin|prostaglandin
224497|NCT02792790|Amyloidosis|amyloidosis
224498|NCT02792790|Carpal tunnel syndrome|carpal tunnel syndrome
224499|NCT02792777|Concept Mapping|concept mapping
224500|NCT02792777|VOICe|voice
224501|NCT02792777|Interviews|interviews
224502|NCT02792777|Patient-Centered Research|patient-centered research
224503|NCT02792764|port|port
224504|NCT02792764|peripheral intravenous lines|peripheral intravenous lines
224505|NCT02792764|oncology|oncology
224506|NCT02792751|Depth of anesthesia|depth of anesthesia
224507|NCT02792751|BIS|bis
224508|NCT02792751|ERCP|ercp
224509|NCT02792751|Positive Regulation|positive regulation
224510|NCT02792712|Acute myocardial infarction|acute myocardial infarction
224511|NCT02792712|Antiplatelet agents|antiplatelet agents
224512|NCT02792712|Magnetic resonance imaging (MRI)|magnetic resonance imaging (mri)
224513|NCT02792686|Healthy Volunteers|healthy volunteers
224514|NCT02792673|Embryo transfer media|embryo transfer media
224515|NCT02792673|improvement of embryo transfer technique|improvement of embryo transfer technique
224516|NCT02792673|improvement of implantation|improvement of implantation
224517|NCT02792673|"Hyaluronan-enriched media Embryo Glue®"|"hyaluronan-enriched media embryo glue®"
224518|NCT02792673|"30% Protein-supplemented Culture Medium Global Total®"|"30% protein-supplemented culture medium global total®"
224519|NCT02792673|Autologous Follicular Fluid as embryo transfer medium|autologous follicular fluid as embryo transfer medium
224520|NCT02792634|Bariatric surgery|bariatric surgery
224521|NCT02792634|Nonalcoholic Steatohepatitis|nonalcoholic steatohepatitis
224522|NCT02792634|Obesity|obesity
224523|NCT02792608|Mindfulness-based Therapy|mindfulness-based therapy
224524|NCT02792608|Brain Tumour Survivors|brain tumour survivors
224525|NCT02792608|Depressive Symptoms|depressive symptoms
224526|NCT02792608|Quality of Life|quality of life
224527|NCT02792608|Perceived Stress|perceived stress
224528|NCT02792608|Wellbeing|wellbeing
224529|NCT02792608|Treatment|treatment
224530|NCT02792582|Brain tumor|brain tumor
224531|NCT02792582|Pediatrics|pediatrics
224532|NCT02792582|Radiation therapy|radiation therapy
224533|NCT02792582|Proton therapy|proton therapy
224534|NCT02792582|Surgery|surgery
224535|NCT02792569|IVA|iva
224536|NCT02792569|Hippo Pathway|hippo pathway
224537|NCT02792569|Follicle activation|follicle activation
224538|NCT02792569|Low Responder|low responder
224539|NCT02792569|POI|poi
224540|NCT02792569|Poor Ovarian Reserve|poor ovarian reserve
224541|NCT02792569|Poor Ovarian Response|poor ovarian response
224542|NCT02792569|Salvador/Warts/Hippo pathway|salvador/warts/hippo pathway
224543|NCT02792556|drug abortion|drug abortion
224647|NCT02791932|Pregnancy|pregnancy
224544|NCT02792556|urine pregnancy test|urine pregnancy test
224545|NCT02792556|negative predictive value|negative predictive value
224546|NCT02792556|check Top test|check top test
224547|NCT02792556|transvaginal ultrasound|transvaginal ultrasound
224548|NCT02792543|nutrition|nutrition
224549|NCT02792543|double enterostomy|double enterostomy
224550|NCT02792543|chyme reinfusion|chyme reinfusion
224551|NCT02792543|randomized controlled trial|randomized controlled trial
224552|NCT02792439|Fitness|fitness
224553|NCT02792439|Health kit|health kit
224554|NCT02792439|Researchkit|researchkit
224555|NCT02792439|Walking|walking
224556|NCT02792426|Smoking Cessation|smoking cessation
224557|NCT02792426|Nicotine Dependence|nicotine dependence
224558|NCT02792426|Tobacco Dependence|tobacco dependence
224559|NCT02792413|osteoporosis|osteoporosis
224560|NCT02792413|chronic kidney disease|chronic kidney disease
224561|NCT02792413|anti-RANK ligand antibody|anti-rank ligand antibody
224562|NCT02792413|bone mineral density|bone mineral density
224563|NCT02792413|vascular calcifications|vascular calcifications
224564|NCT02792387|cardio-renal syndrome|cardio-renal syndrome
224565|NCT02792387|right heart dysfunction|right heart dysfunction
224566|NCT02792387|central venous pressure|central venous pressure
224567|NCT02792387|eGFR|egfr
224568|NCT02792387|low-flow theory|low-flow theory
224569|NCT02792374|Dental patients|dental patients
224570|NCT02792374|Psychological Profile|psychological profile
224571|NCT02792361|Post-Operative Pterional Craniotomy|post-operative pterional craniotomy
224572|NCT02792361|Suction Drain|suction drain
224573|NCT02792361|Benefits|benefits
224574|NCT02792348|congenital urine flow impairment|congenital urine flow impairment
224575|NCT02792348|urinary metabolomics profile|urinary metabolomics profile
224576|NCT02792348|Nuclear Magnetic Resonance|nuclear magnetic resonance
224577|NCT02792322|Cancer|cancer
224578|NCT02792322|Oropharynx|oropharynx
224579|NCT02792270|Surgery|surgery
224580|NCT02792231|Relapsing multiple sclerosis|relapsing multiple sclerosis
224581|NCT02792231|Ofatumumab|ofatumumab
224582|NCT02792218|Relapsing multiple sclerosis|relapsing multiple sclerosis
224583|NCT02792218|Ofatumumab|ofatumumab
224584|NCT02792205|Willebrand factor deficiency|willebrand factor deficiency
224585|NCT02792205|hematology|hematology
224586|NCT02792205|Willebrand:Collagen-binding|willebrand:collagen-binding
224587|NCT02792166|Morbid obesity|morbid obesity
224588|NCT02792166|Metabolic syndrome|metabolic syndrome
224589|NCT02792166|Metabolic surgery|metabolic surgery
224590|NCT02792166|Bariatric surgery|bariatric surgery
224591|NCT02792166|SADI|sadi
224592|NCT02792166|BPD-DS|bpd-ds
224593|NCT02792153|estrogen|estrogen
224594|NCT02792153|anxiety|anxiety
224595|NCT02792153|amenorrhea|amenorrhea
224596|NCT02792153|eating disorders|eating disorders
224597|NCT02792140|Psychology|psychology
224598|NCT02792140|Dreams|dreams
224599|NCT02792127|Social Anxiety|social anxiety
224600|NCT02792127|Cognitive Behaviour Therapy|cognitive behaviour therapy
224601|NCT02792127|Online Program|online program
224602|NCT02792114|T-Cell|t-cell
224603|NCT02792114|Chimeric antigen receptor (CAR)|chimeric antigen receptor (car)
224604|NCT02792114|CAR T cells|car t cells
224605|NCT02792114|Triple-negative breast cancer|triple-negative breast cancer
224606|NCT02792114|Immunotherapy T-cell therapy|immunotherapy t-cell therapy
224607|NCT02792114|16-040|16-040
224608|NCT02792114|immunotherapy|immunotherapy
224609|NCT02792114|CAR|car
224610|NCT02792088|HBV|hbv
224611|NCT02792075|Coronary Stenosis|coronary stenosis
224612|NCT02792075|Intracoronary Imaging|intracoronary imaging
224613|NCT02792075|VH-IVUS|vh-ivus
224614|NCT02792075|OCT|oct
224615|NCT02792075|NIRS|nirs
224616|NCT02792075|gray scale IVUS|gray scale ivus
224617|NCT02792062|Drug therapy|drug therapy
224618|NCT02792023|Colorectal cancer|colorectal cancer
224619|NCT02792023|Immunochemical occult blood test|immunochemical occult blood test
224620|NCT02792010|T1rho MRI|t1rho mri
224621|NCT02792010|hip|hip
224622|NCT02792010|cartilage|cartilage
224623|NCT02792010|Healthy participants|healthy participants
224624|NCT02791997|Audition|audition
224625|NCT02791997|Stroke|stroke
224626|NCT02791997|Migraine|migraine
224627|NCT02791997|Attention|attention
224628|NCT02791997|Short-term memory,|short-term memory,
224629|NCT02791997|Emotions|emotions
224630|NCT02791997|EEG|eeg
224631|NCT02791997|MEG|meg
224632|NCT02791984|Suprasternal|suprasternal
224633|NCT02791984|echography|echography
224634|NCT02791984|fluid responsiveness|fluid responsiveness
224635|NCT02791971|Contraception|contraception
224636|NCT02791971|Birth control|birth control
224637|NCT02791971|Social communication|social communication
224638|NCT02791971|Adolescent|adolescent
224639|NCT02791971|Social network|social network
224640|NCT02791971|Health education|health education
224641|NCT02791971|Reproductive health|reproductive health
224642|NCT02791945|TBI|tbi
224643|NCT02791945|hazardous and harmful alcohol use|hazardous and harmful alcohol use
224644|NCT02791945|Veterans|veterans
224645|NCT02791945|co-occurring disorders|co-occurring disorders
224646|NCT02791945|pharmacotherapy|pharmacotherapy
224648|NCT02791932|Postpartum period|postpartum period
224649|NCT02791932|Depression|depression
224650|NCT02791906|Chronic Kidney Diseases|chronic kidney diseases
224651|NCT02791906|Chronic Kidney Insufficiency|chronic kidney insufficiency
224652|NCT02791906|Chronic Renal Diseases|chronic renal diseases
224653|NCT02791906|Chronic Renal Insufficiency|chronic renal insufficiency
224654|NCT02791906|Kidney Insufficiency, Chronic|kidney insufficiency, chronic
224655|NCT02791906|Cardiac Failure|cardiac failure
224656|NCT02791906|Congestive Heart Failure|congestive heart failure
224657|NCT02791906|Heart Decompensation|heart decompensation
224658|NCT02791906|Heart Failure, Congestive|heart failure, congestive
224659|NCT02791906|Myocardial Failure|myocardial failure
224660|NCT02791880|acute kidney injury|acute kidney injury
224661|NCT02791880|transcatheter aortic valve replacement|transcatheter aortic valve replacement
224662|NCT02791880|genomics|genomics
224663|NCT02791880|biomarker|biomarker
224664|NCT02791841|Reading|reading
224665|NCT02791841|Developmental Dyslexia,|developmental dyslexia,
224666|NCT02791841|Music|music
224667|NCT02791841|Rhythm|rhythm
224668|NCT02791841|Action Video Games|action video games
224669|NCT02791841|Hemisphere-Specific Stimulation|hemisphere-specific stimulation
224670|NCT02791815|selexipag|selexipag
224671|NCT02791815|pharmacokinetics|pharmacokinetics
224672|NCT02791815|midazolam|midazolam
224673|NCT02791802|Lipoprotein(a)|lipoprotein(a)
224674|NCT02791802|lipoprotein/lipid apheresis|lipoprotein/lipid apheresis
224675|NCT02791802|CV disease|cv disease
287276|NCT02419469|ALL|all
224676|NCT02791789|Autism Spectrum Disorder|autism spectrum disorder
224677|NCT02791789|SEMATIC|sematic
224678|NCT02791789|software|software
224679|NCT02791776|scoliosis|scoliosis
224680|NCT02791763|Renal Anemia|renal anemia
224681|NCT02791763|Japanese|japanese
224682|NCT02791763|chronic kidney disease|chronic kidney disease
224683|NCT02791763|Peritoneal dialysis|peritoneal dialysis
224684|NCT02791763|GSK1278863|gsk1278863
224685|NCT02791763|Non-dialysis|non-dialysis
224686|NCT02791750|hormone replacement therapy|hormone replacement therapy
224687|NCT02791750|breast cancer|breast cancer
224688|NCT02791750|follow up|follow up
224689|NCT02791737|Hematologic Malignancy|hematologic malignancy
224690|NCT02791737|Exercise|exercise
224691|NCT02791737|Decreased Physical Activity|decreased physical activity
224692|NCT02791711|Bronchiolitis|bronchiolitis
224693|NCT02791711|Continuous Positive Airway Pressure|continuous positive airway pressure
224694|NCT02791711|HFNC|hfnc
224695|NCT02791698|cortisol|cortisol
224696|NCT02791698|hair|hair
224697|NCT02791698|urinary|urinary
224698|NCT02791685|Cardiac Rehabilitation|cardiac rehabilitation
224699|NCT02791672|Perioperative Care|perioperative care
224700|NCT02791672|Breast Reconstruction|breast reconstruction
224701|NCT02791659|radiation exposure|radiation exposure
224702|NCT02791659|ERCP|ercp
224703|NCT02791659|prone|prone
224704|NCT02791659|left lateral decubitus|left lateral decubitus
224705|NCT02791607|Circulating tumor cells|circulating tumor cells
224706|NCT02791607|Head and neck cancer|head and neck cancer
224707|NCT02791607|Survival Prognosis|survival prognosis
224708|NCT02791607|P16Ink4A|p16ink4a
224710|NCT02791581|Breast Cancer|breast cancer
224711|NCT02791581|Fatigue|fatigue
224712|NCT02791581|Cardiovascular Events|cardiovascular events
224713|NCT02791555|pradaxa|pradaxa
224714|NCT02791555|warfarin|warfarin
224715|NCT02791542|Asthma|asthma
224716|NCT02791516|Osteoporosis.|osteoporosis.
224717|NCT02791516|Osteoporosis-Postmenopausal.|osteoporosis-postmenopausal.
224718|NCT02791516|Bone Diseases-Metabolic.|bone diseases-metabolic.
224719|NCT02791516|Bone Diseases.|bone diseases.
224720|NCT02791516|Musculoskeletal Diseases.|musculoskeletal diseases.
224721|NCT02791503|Irreversible electroporation (IRE|irreversible electroporation (ire
224722|NCT02791503|Stereotactic ablative radiotherapy (SABR|stereotactic ablative radiotherapy (sabr
224723|NCT02791503|Efficacy|efficacy
224724|NCT02791503|Tumor ablation|tumor ablation
224725|NCT02791503|Chemotherapy|chemotherapy
224726|NCT02791503|Locally advanced pancreatic cancer (LAPC)|locally advanced pancreatic cancer (lapc)
224727|NCT02791477|Attune|attune
224728|NCT02791464|Meditation|meditation
224729|NCT02791464|TM|tm
224730|NCT02791464|PTSD|ptsd
224731|NCT02791464|Trauma|trauma
224732|NCT02791464|Female Prisoners|female prisoners
224733|NCT02791451|COPD|copd
224734|NCT02791451|telemonitoring|telemonitoring
224735|NCT02791451|exacerbation|exacerbation
224736|NCT02791425|Brain-Computer Interface|brain-computer interface
224737|NCT02791425|Intratracheal intubation|intratracheal intubation
224738|NCT02791425|Mechanical ventilation|mechanical ventilation
224739|NCT02791425|Nonverbal communication|nonverbal communication
224740|NCT02791425|Critical illness|critical illness
224741|NCT02791425|Electroencephalography|electroencephalography
224742|NCT02791425|Visual Evoked Potential|visual evoked potential
224743|NCT02791412|left main|left main
224744|NCT02791412|unprotected|unprotected
224745|NCT02791412|percutaneous coronary intervention|percutaneous coronary intervention
224746|NCT02791412|coronary-artery bypass graft|coronary-artery bypass graft
224747|NCT02791399|opioid safety|opioid safety
224748|NCT02791399|opioid misuse|opioid misuse
224749|NCT02791399|opioid abuse|opioid abuse
224750|NCT02791399|patient-centered|patient-centered
224752|NCT02791399|opiate|opiate
224753|NCT02791399|chronic pain|chronic pain
224754|NCT02791399|primary care|primary care
224755|NCT02791399|Veteran|veteran
224756|NCT02791399|clinical care|clinical care
224757|NCT02791360|Brain|brain
224758|NCT02791360|Radiotherapy|radiotherapy
224759|NCT02791360|MRI|mri
224760|NCT02791360|Sequelae|sequelae
224761|NCT02791334|PDL1|pdl1
224762|NCT02791334|PD-L1|pd-l1
224763|NCT02791295|Type 2 diabetes|type 2 diabetes
224764|NCT02791295|lifestyle intervention|lifestyle intervention
224765|NCT02791295|insulin pump treatment|insulin pump treatment
224766|NCT02791295|body weight|body weight
224767|NCT02791295|body composition|body composition
224768|NCT02791282|Chronic Thromboembolic Pulmonary Hypertension (CTEPH)|chronic thromboembolic pulmonary hypertension (cteph)
224769|NCT02791282|MRI|mri
224770|NCT02791282|SPECT|spect
224771|NCT02791230|amyloidosis|amyloidosis
224772|NCT02791230|amyloid|amyloid
224773|NCT02791230|transthyretin|transthyretin
224774|NCT02791230|TTR|ttr
224775|NCT02791230|ATTR-CM|attr-cm
224776|NCT02791191|BACE inhibitor|bace inhibitor
224777|NCT02791100|height|height
224778|NCT02791100|weight|weight
224779|NCT02791100|diet|diet
224780|NCT02791100|complementary foods|complementary foods
224781|NCT02791100|protein|protein
224782|NCT02791100|calcium|calcium
224783|NCT02791009|HF|hf
224784|NCT02791009|HFrEF|hfref
224785|NCT02791009|HFpEF|hfpef
224786|NCT02791009|MRI|mri
224787|NCT02791009|biomarker|biomarker
224788|NCT02790996|sepsis|sepsis
224789|NCT02790996|neonate|neonate
224790|NCT02790996|vancomycin|vancomycin
224791|NCT02790983|Registry|registry
224792|NCT02790983|Spine|spine
224793|NCT02790983|Surgery|surgery
224794|NCT02790983|Medical Oncology|medical oncology
224795|NCT02790983|Radiation Oncology|radiation oncology
224796|NCT02790983|Neoplasms|neoplasms
224797|NCT02790944|Germline|germline
224798|NCT02790944|Pancreatic|pancreatic
224799|NCT02790944|Genetic Testing|genetic testing
224800|NCT02790931|diabetic foot|diabetic foot
224801|NCT02790931|therapeutic exercises|therapeutic exercises
224802|NCT02790931|foot|foot
224803|NCT02790931|preventive care|preventive care
224804|NCT02790931|rehabilitation|rehabilitation
224805|NCT02790931|Diabetic Neuropathy|diabetic neuropathy
224806|NCT02790918|Pulmonary Hypertension|pulmonary hypertension
224807|NCT02790918|MRI|mri
224808|NCT02790905|pregnant and post-partum women|pregnant and post-partum women
224809|NCT02790905|Validation questionnaires|validation questionnaires
224810|NCT02790905|Thai-Myanmar border|thai-myanmar border
224811|NCT02790892|type 1 diabetes|type 1 diabetes
224812|NCT02790892|type 2 diabetes|type 2 diabetes
224813|NCT02790892|children|children
224814|NCT02790892|adolescents|adolescents
224815|NCT02790892|young adults|young adults
224816|NCT02790892|youth|youth
224817|NCT02790892|transition|transition
224818|NCT02790892|art therapy|art therapy
224819|NCT02790892|behavioral therapy|behavioral therapy
224820|NCT02790879|Transitional care|transitional care
224821|NCT02790879|teenagers|teenagers
224822|NCT02790879|cystic fibrosis|cystic fibrosis
224823|NCT02790879|pulmonary function|pulmonary function
224824|NCT02790879|nutritional function|nutritional function
224825|NCT02790879|Patients who experiment a transition pediatric - adult care|patients who experiment a transition pediatric - adult care
224826|NCT02790866|Decision Aid|decision aid
224827|NCT02790866|Informed Decision Making|informed decision making
224828|NCT02790866|Shared Decision making|shared decision making
224829|NCT02790866|Screening|screening
224830|NCT02790840|Volunteers|volunteers
224831|NCT02790801|chronic heart failure|chronic heart failure
224832|NCT02790801|atrial fibrillation|atrial fibrillation
224833|NCT02790801|anticoagulant|anticoagulant
224834|NCT02790762|stem cells|stem cells
224835|NCT02790762|Mesenchymal Stem Cells|mesenchymal stem cells
224836|NCT02790762|Umbilical Cord-Mesenchymal Stem Cells|umbilical cord-mesenchymal stem cells
224837|NCT02790762|Pneumoconiosis|pneumoconiosis
224838|NCT02790749|Developmental hip dysplasia|developmental hip dysplasia
224839|NCT02790749|Intra-articular pathology|intra-articular pathology
224840|NCT02790749|Adult hip dysplasia|adult hip dysplasia
224841|NCT02790749|Labral tear, hip|labral tear, hip
224842|NCT02790749|Chondromalacia, hip|chondromalacia, hip
224843|NCT02790736|propranolol|propranolol
224844|NCT02790736|public speaking anxiety|public speaking anxiety
224845|NCT02790710|propanolol|propanolol
224846|NCT02790710|obsessive-compulsive disorder|obsessive-compulsive disorder
224847|NCT02790697|Indirect calorimetry|indirect calorimetry
224848|NCT02790697|ICALIC Study|icalic study
224849|NCT02790697|Energy expenditure|energy expenditure
224850|NCT02790697|VO2|vo2
224851|NCT02790697|VCO2|vco2
224852|NCT02790697|Respiratory quotient|respiratory quotient
224853|NCT02790658|Grumixama|grumixama
224854|NCT02790658|Urolithins|urolithins
224855|NCT02790658|Anthocyanins|anthocyanins
224856|NCT02790658|Metabolomic Approach|metabolomic approach
224857|NCT02790658|Ellagitannins|ellagitannins
224858|NCT02790658|Subjects|subjects
224859|NCT02790645|Type 1 diabetes|type 1 diabetes
224860|NCT02790645|Health technologies|health technologies
224861|NCT02790645|Continuous subcutaneous insulin infusion|continuous subcutaneous insulin infusion
224862|NCT02790645|Telemedicine|telemedicine
224863|NCT02790645|Glycemic variability|glycemic variability
224864|NCT02790645|Inflammatory markers,|inflammatory markers,
224865|NCT02790645|Oxidative stress|oxidative stress
224866|NCT02790645|Depression|depression
224867|NCT02790645|Quality of life|quality of life
224868|NCT02790645|Cost-effectiveness|cost-effectiveness
224869|NCT02790632|Aneurysm, Ruptured|aneurysm, ruptured
224870|NCT02790632|Nimodipine|nimodipine
224871|NCT02790632|Subarachnoid Hemorrhage|subarachnoid hemorrhage
224873|NCT02790606|Stenosis|stenosis
224874|NCT02790606|Restenosis|restenosis
224875|NCT02790606|Hemodialysis|hemodialysis
224876|NCT02790606|AV Graft|av graft
224877|NCT02790567|diagnostic performance|diagnostic performance
224878|NCT02790567|heparin-induced thrombocytopenia|heparin-induced thrombocytopenia
224879|NCT02790567|rapid immunological diagnostic method|rapid immunological diagnostic method
224880|NCT02790567|immunoassay|immunoassay
723541|NCT00534352|TMC114|tmc114
287542|NCT02418182|IVF|ivf
224881|NCT02790567|pretest scoring systems|pretest scoring systems
224882|NCT02790567|4Ts score|4ts score
224883|NCT02790567|HEP score|hep score
224884|NCT02790541|aging|aging
224885|NCT02790541|HBOT|hbot
224886|NCT02790541|reverse|reverse
224887|NCT02790541|angiogenesis|angiogenesis
224888|NCT02790541|elderly|elderly
224889|NCT02790541|mitochohndria|mitochohndria
224890|NCT02790528|statin|statin
224891|NCT02790528|vasospastic angina|vasospastic angina
224892|NCT02790476|Safe|safe
224893|NCT02790476|Prescribing|prescribing
224894|NCT02790476|Opioids|opioids
224895|NCT02790463|Allopurinol|allopurinol
224896|NCT02790398|Transdiagnostic treatment protocol|transdiagnostic treatment protocol
224897|NCT02790398|Transdiagnostic treatment protocol + PA component|transdiagnostic treatment protocol + pa component
224898|NCT02790372|Nursing homes|nursing homes
224899|NCT02790372|Norway|norway
224900|NCT02790359|Carbon dioxide|carbon dioxide
224902|NCT02790359|Colonoscopy|colonoscopy
224903|NCT02790346|hemiparesis|hemiparesis
224904|NCT02790346|deformity of the foot and ankle|deformity of the foot and ankle
224905|NCT02790320|Eribulin mesylate|eribulin mesylate
224906|NCT02790320|Halaven|halaven
224907|NCT02790320|Breast cancer|breast cancer
224908|NCT02790307|multiple sclerosis|multiple sclerosis
224909|NCT02790307|overactive bladder|overactive bladder
224910|NCT02790307|urinary incontinence|urinary incontinence
224911|NCT02790307|tibial nerve stimulation|tibial nerve stimulation
224912|NCT02790294|magnetic resonance imaging|magnetic resonance imaging
224913|NCT02790268|Cionni Ring|cionni ring
224914|NCT02790268|Ultrasound Biomicroscopy|ultrasound biomicroscopy
224915|NCT02790242|Mechanical Circulatory Support Device (MCSD)|mechanical circulatory support device (mcsd)
224916|NCT02790242|ventricular Assist Device (VAD)|ventricular assist device (vad)
224917|NCT02790229|rehabilitation, anti-gravity treadmill|rehabilitation, anti-gravity treadmill
224918|NCT02790216|Image guided brachytherapy|image guided brachytherapy
224919|NCT02790151|working memory, recollection training, transfer|working memory, recollection training, transfer
224920|NCT02790138|Drug Therapy|drug therapy
224921|NCT02790112|Body Mass Index|body mass index
224922|NCT02790112|Body Composition|body composition
224923|NCT02790112|Glucose Metabolism Disorders|glucose metabolism disorders
224924|NCT02790112|Bone Development|bone development
224925|NCT02790112|Gonadal Disorders|gonadal disorders
224926|NCT02790112|Fertility|fertility
224927|NCT02790112|Overweight|overweight
224928|NCT02790112|Obesity|obesity
224929|NCT02790112|Menarche|menarche
224930|NCT02790099|Pain|pain
224931|NCT02790099|Postoperative pain control|postoperative pain control
224932|NCT02790099|Rectus sheath block|rectus sheath block
224933|NCT02790099|Intrathecal morphine|intrathecal morphine
224934|NCT02790099|Caesarean section|caesarean section
224935|NCT02790086|hypothermia|hypothermia
224936|NCT02790086|prevalence|prevalence
224937|NCT02790086|perioperative|perioperative
224938|NCT02790086|anemia|anemia
224939|NCT02790086|myocardial injury|myocardial injury
224940|NCT02790086|troponin T|troponin t
224941|NCT02790086|noncardiac surgery|noncardiac surgery
224942|NCT02790073|Calciphylaxis|calciphylaxis
224943|NCT02790073|Calcific Uremic Arteriolopathy|calcific uremic arteriolopathy
224944|NCT02790073|Dialysis|dialysis
224945|NCT02790073|End Stage Renal Disease|end stage renal disease
224946|NCT02790073|Rare disease (ORPHA280062)|rare disease (orpha280062)
224947|NCT02790073|Calcification|calcification
224948|NCT02790073|Calcium Metabolism Disorders|calcium metabolism disorders
224949|NCT02790073|Calcinosis|calcinosis
224950|NCT02790073|Metabolic Diseases|metabolic diseases
224951|NCT02790060|diabetes|diabetes
224952|NCT02790047|Chronic Obstructive Pulmonary Disease|chronic obstructive pulmonary disease
224953|NCT02790047|Exercise Therapy|exercise therapy
224954|NCT02790047|Positive Expiratory Pressure|positive expiratory pressure
224955|NCT02790047|Physical Fitness|physical fitness
224956|NCT02790047|Quality of Life|quality of life
224957|NCT02790008|echocardiography|echocardiography
224958|NCT02790008|magnetic resonance imaging|magnetic resonance imaging
224959|NCT02790008|cardiopulmonary exercise test|cardiopulmonary exercise test
224960|NCT02789995|Intensive Care Unit - Acquired Weakness (ICU-AW)|intensive care unit - acquired weakness (icu-aw)
224961|NCT02789982|PTSD|ptsd
224962|NCT02789982|Trauma related disorders|trauma related disorders
224963|NCT02789982|Reconsolidation blockade|reconsolidation blockade
224964|NCT02789982|Paris attacks|paris attacks
224965|NCT02789956|Internal connection|internal connection
224966|NCT02789956|Cobalt/Chrome|cobalt/chrome
224967|NCT02789956|Cad-cam Framework|cad-cam framework
224968|NCT02789956|marginal bone level|marginal bone level
224969|NCT02789943|IHD Normal EF|ihd normal ef
224970|NCT02789930|Weight estimation|weight estimation
224971|NCT02789930|Patient safety|patient safety
224972|NCT02789917|ACS|acs
224973|NCT02789917|Triple-Therapy|triple-therapy
224974|NCT02789917|AF|af
224975|NCT02789917|oral anticoagulation (OAC)|oral anticoagulation (oac)
723542|NCT00534352|TMC125|tmc125
224976|NCT02789917|non-vitamin-K oral anticoagulant (NOAC)|non-vitamin-k oral anticoagulant (noac)
224977|NCT02789878|Neoadjuvant therapy|neoadjuvant therapy
224978|NCT02789878|High-risk Prostate Cancer|high-risk prostate cancer
224979|NCT02789865|Acute appendicitis|acute appendicitis
224980|NCT02789865|Endoscopic retrograde appendicitis therapy|endoscopic retrograde appendicitis therapy
224981|NCT02789865|Endoscopic retrograde appendicography|endoscopic retrograde appendicography
224982|NCT02789865|Endoscopic therapy|endoscopic therapy
224983|NCT02789865|Appendectomy|appendectomy
224984|NCT02789865|Antibiotic Therapy|antibiotic therapy
224985|NCT02789787|Cleft Lip|cleft lip
224986|NCT02789787|Palate|palate
224987|NCT02789787|Class III|class iii
224988|NCT02789787|Malocclusion|malocclusion
224989|NCT02789787|Protraction|protraction
224990|NCT02789761|Flow-mediated dilatation (FMD)|flow-mediated dilatation (fmd)
224991|NCT02789761|Vascular function|vascular function
224992|NCT02789761|cognitive function|cognitive function
224993|NCT02789735|Pregnancy|pregnancy
224994|NCT02789735|laser therapy|laser therapy
224995|NCT02789735|persistent pain|persistent pain
224996|NCT02789735|pelvic pain|pelvic pain
224997|NCT02789722|Mate|mate
224998|NCT02789722|Vascular protection|vascular protection
224999|NCT02789722|Endothelial function|endothelial function
225000|NCT02789722|Ilex paraguariensis|ilex paraguariensis
225001|NCT02789657|neoadjuvant breast cancer|neoadjuvant breast cancer
225002|NCT02789657|stage I-III breast cancer|stage i-iii breast cancer
225003|NCT02789657|HER 2 positive breast cancer|her 2 positive breast cancer
225004|NCT02789644|Ursodeoxycholic acid|ursodeoxycholic acid
225005|NCT02789644|Metabolomics/biomarker|metabolomics/biomarker
225006|NCT02789644|Pharmacokinetics|pharmacokinetics
225007|NCT02789605|Aphthous Stomatitis [C07.465.864.750]|aphthous stomatitis [c07.465.864.750]
225008|NCT02789592|REM Sleep Behavior Disorder|rem sleep behavior disorder
225009|NCT02789592|Parkinson Disease|parkinson disease
225010|NCT02789592|Randomized Controlled Trial|randomized controlled trial
225011|NCT02789592|Clinical Trial|clinical trial
225012|NCT02789592|Melatonin|melatonin
225013|NCT02789592|Clonazepam|clonazepam
225014|NCT02789579|prophylactic|prophylactic
225015|NCT02789579|Urinary Tract Infections|urinary tract infections
225016|NCT02789579|Minimally invasive upper tract lithotomy|minimally invasive upper tract lithotomy
225017|NCT02789566|Primaquine|primaquine
225018|NCT02789566|Pharmacokinetic|pharmacokinetic
225019|NCT02789553|Glucose digestion|glucose digestion
225020|NCT02789553|Bypass surgery|bypass surgery
225021|NCT02789553|C13-glucose tracer|c13-glucose tracer
225022|NCT02789553|Insulin secretion|insulin secretion
225023|NCT02789540|COPD symptoms|copd symptoms
225024|NCT02789527|healthy volunteers|healthy volunteers
225025|NCT02789514|esophagogastroduodenoscopy|esophagogastroduodenoscopy
225026|NCT02789514|paediatric|paediatric
225027|NCT02789501|Catheter|catheter
225028|NCT02789501|Dysfunctions|dysfunctions
225029|NCT02789501|Blood Stream Infections|blood stream infections
225030|NCT02789501|Haemodialysis|haemodialysis
225031|NCT02789501|Taurolidine|taurolidine
225032|NCT02789501|Tunneled|tunneled
225033|NCT02789436|halitosis|halitosis
225034|NCT02789436|chronic periodontitis|chronic periodontitis
225035|NCT02789436|probiotic|probiotic
225036|NCT02789410|Cesarean delivery|cesarean delivery
225037|NCT02789410|Analgesia|analgesia
225038|NCT02789410|Intrathecal opioids|intrathecal opioids
225039|NCT02789397|Granulomatous and lymphocytic interstitial lung disease|granulomatous and lymphocytic interstitial lung disease
225040|NCT02789397|common variable immunodeficiency|common variable immunodeficiency
225041|NCT02789397|Rituximab|rituximab
225042|NCT02789397|Azathioprine|azathioprine
225043|NCT02789397|primary immunodeficiency|primary immunodeficiency
225044|NCT02789397|GLIILD|gliild
225045|NCT02789397|CVID|cvid
225046|NCT02789384|soft-tissue sarcomas|soft-tissue sarcomas
225047|NCT02789384|CINSARC|cinsarc
225048|NCT02789384|biomarker|biomarker
225049|NCT02789384|efficacy|efficacy
225050|NCT02789384|pronostic|pronostic
225051|NCT02789371|EUS-FNA|eus-fna
225052|NCT02789371|modified wet suction technique|modified wet suction technique
225053|NCT02789371|dry suction technique|dry suction technique
225054|NCT02789358|cryotherapy|cryotherapy
225055|NCT02789345|T790M|t790m
225056|NCT02789345|epidermal growth factor receptor (EGFR)|epidermal growth factor receptor (egfr)
225057|NCT02789332|carboplatin|carboplatin
225058|NCT02789332|olaparib|olaparib
225059|NCT02789332|pCR|pcr
225060|NCT02789332|neoadjuvant|neoadjuvant
225061|NCT02789332|triple-negative|triple-negative
225062|NCT02789332|hormonreceptor-positive|hormonreceptor-positive
225063|NCT02789332|BRCA1/2|brca1/2
225064|NCT02789332|HRD, homologous recominant deficient|hrd, homologous recominant deficient
225065|NCT02789332|breast cancer|breast cancer
225066|NCT02789332|genetic testing (somatic and germline mutations)|genetic testing (somatic and germline mutations)
225067|NCT02789319|Blood Glucose Monitoring System|blood glucose monitoring system
225068|NCT02789319|BGMS|bgms
225069|NCT02789319|Diabetes|diabetes
225070|NCT02789319|Patient Use|patient use
723988|NCT00532480|fMRI|fmri
225071|NCT02789306|Preventive therapy|preventive therapy
225072|NCT02789306|Dental implants|dental implants
225073|NCT02789293|Glaucoma|glaucoma
225074|NCT02789293|Ultrasound|ultrasound
225075|NCT02789293|Ciliary body|ciliary body
225076|NCT02789267|Head and Neck Cancer|head and neck cancer
225077|NCT02789267|Quality of Life|quality of life
225078|NCT02789267|Dietary support|dietary support
225079|NCT02789254|acute myeloid leukemia|acute myeloid leukemia
225080|NCT02789254|Fms-like receptor tyrosine kinase (FLT3)|fms-like receptor tyrosine kinase (flt3)
225081|NCT02789254|stem cell transplantation|stem cell transplantation
225082|NCT02789254|complete remission|complete remission
225083|NCT02789254|CD135|cd135
225084|NCT02789254|antibodies|antibodies
225085|NCT02789254|Leukemia|leukemia
225086|NCT02789254|AML|aml
225087|NCT02789254|Fc-optimized|fc-optimized
225088|NCT02789241|Endotoxin|endotoxin
225089|NCT02789241|healthy|healthy
225090|NCT02789241|volunteers|volunteers
225091|NCT02789241|males|males
225092|NCT02789241|females|females
225093|NCT02789215|Child care food costs|child care food costs
225094|NCT02789215|Meal participation rates|meal participation rates
225095|NCT02789215|Child and Adult Care Food Program|child and adult care food program
225096|NCT02789202|dental caries|dental caries
225097|NCT02789202|deciduous tooth|deciduous tooth
225098|NCT02789176|Phenobarbital|phenobarbital
225099|NCT02789176|EEG|eeg
225100|NCT02789176|family impact|family impact
225101|NCT02789176|neurodevelopment|neurodevelopment
225102|NCT02789163|breast|breast
225103|NCT02789163|ultrasound|ultrasound
225104|NCT02789163|diagnostic exam|diagnostic exam
225105|NCT02789163|automated volume breast scanner|automated volume breast scanner
225106|NCT02789137|metastatic renal cell carcinoma|metastatic renal cell carcinoma
225107|NCT02789124|fluid responsiveness|fluid responsiveness
225108|NCT02789124|carotid artery flow time|carotid artery flow time
225109|NCT02789124|passive leg raise|passive leg raise
225110|NCT02789098|ST Elevation Myocardial Infarction|st elevation myocardial infarction
225111|NCT02789098|Ventricular remodeling|ventricular remodeling
225112|NCT02789098|Biomarkers|biomarkers
225113|NCT02789098|Coronary endothelial function|coronary endothelial function
225114|NCT02789098|Positron Emission Tomography|positron emission tomography
225115|NCT02789085|TENS|tens
225116|NCT02789085|ULF-TENS|ulf-tens
225117|NCT02789085|ANS|ans
225118|NCT02789085|Dentistry|dentistry
225119|NCT02789085|TMD|tmd
225120|NCT02789059|Becker muscular dystrophy|becker muscular dystrophy
225121|NCT02789059|Facioscapulohumeral dystrophy|facioscapulohumeral dystrophy
225122|NCT02789059|congenital myopathy|congenital myopathy
225123|NCT02789059|motor neurone diseases|motor neurone diseases
225124|NCT02789046|adult|adult
225125|NCT02789046|vascular access|vascular access
225126|NCT02789046|preoperative period|preoperative period
225127|NCT02789046|peripheral venous catheterization|peripheral venous catheterization
225128|NCT02789033|diabetic foot ulcers|diabetic foot ulcers
225129|NCT02789033|chitosan|chitosan
225130|NCT02789033|isosorbide dinitrate spray|isosorbide dinitrate spray
225131|NCT02789020|Rasagiline|rasagiline
225132|NCT02788981|triple-negative breast cancer|triple-negative breast cancer
225133|NCT02788981|advanced breast cancer|advanced breast cancer
225134|NCT02788981|nab-paclitaxel|nab-paclitaxel
225135|NCT02788981|mifepristone|mifepristone
225136|NCT02788981|glucocorticoid receptor-positive breast cancer|glucocorticoid receptor-positive breast cancer
225137|NCT02788968|Psychology and Cognitive Neuroscience of development|psychology and cognitive neuroscience of development
225138|NCT02788968|Adolescent and young adult healthy volunteers|adolescent and young adult healthy volunteers
225139|NCT02788968|Anatomical and functionally Magnetic Resonance Imaging (MRI)|anatomical and functionally magnetic resonance imaging (mri)
225140|NCT02788968|Conflict detection|conflict detection
225141|NCT02788968|Reasoning|reasoning
225142|NCT02788955|Protein|protein
225143|NCT02788955|Diet intervention|diet intervention
225144|NCT02788955|Muscle|muscle
225145|NCT02788955|Colorectal cancer|colorectal cancer
225146|NCT02788942|Port|port
225147|NCT02788942|Infection|infection
225148|NCT02788942|cholecystectomy|cholecystectomy
225149|NCT02788929|Percutaneous Transluminal Coronary Intervention|percutaneous transluminal coronary intervention
225150|NCT02788929|Cardiac Rehabilitation|cardiac rehabilitation
225151|NCT02788929|Fitbit Charge HR|fitbit charge hr
225152|NCT02788916|Drug Therapy|drug therapy
225153|NCT02788903|Obesity Counseling|obesity counseling
225154|NCT02788864|Forest ranger|forest ranger
225155|NCT02788864|P.falciparum|p.falciparum
225156|NCT02788864|P.vivax|p.vivax
225157|NCT02788864|Dihydroartemisinine-piperaquine (DP)|dihydroartemisinine-piperaquine (dp)
225158|NCT02788864|Primaquine|primaquine
225159|NCT02788851|Stimulant Medication|stimulant medication
225160|NCT02788851|Exercise|exercise
225161|NCT02788851|Functional Outcome|functional outcome
225162|NCT02788851|Effectiveness|effectiveness
225163|NCT02788851|Symptoms|symptoms
225164|NCT02788838|Magnetic Resonance Imaging|magnetic resonance imaging
225165|NCT02788838|Energy Intake|energy intake
287907|NCT02416466|CAR-T|car-t
225166|NCT02788838|Commercials|commercials
225167|NCT02788838|Children|children
225168|NCT02788799|ST Elevation|st elevation
225169|NCT02788799|LCX Artery|lcx artery
225170|NCT02788786|chlorhexidine|chlorhexidine
225171|NCT02788786|cetylpyridinium chloride|cetylpyridinium chloride
225172|NCT02788786|gingival crevicular fluid|gingival crevicular fluid
225173|NCT02788734|carpal tunnel syndrome|carpal tunnel syndrome
225174|NCT02788734|CTS|cts
225175|NCT02788734|inherited peripheral neuropathy|inherited peripheral neuropathy
225176|NCT02788734|Charcot-Marie-Tooth disease|charcot-marie-tooth disease
225177|NCT02788734|Hereditary Neuropathy|hereditary neuropathy
225178|NCT02788734|Pressure Palsies|pressure palsies
225179|NCT02788734|CMT|cmt
225180|NCT02788734|HNPP|hnpp
225181|NCT02788708|paclitaxel|paclitaxel
225182|NCT02788708|lenvatinib|lenvatinib
225183|NCT02788695|Visual Nonspecific|visual nonspecific
225184|NCT02788682|VDBP|vdbp
225185|NCT02788682|single nucleotide polymorphisms (SNPs)|single nucleotide polymorphisms (snps)
225186|NCT02788682|interferon based therapy|interferon based therapy
225187|NCT02788682|Egypt|egypt
225188|NCT02788656|heart failure|heart failure
225189|NCT02788656|neprilysin|neprilysin
225190|NCT02788656|implantable hemodynamic monitor|implantable hemodynamic monitor
225191|NCT02788656|angiotensin-receptor blocker|angiotensin-receptor blocker
225192|NCT02788656|angiotensin-converting enzyme inhibitor|angiotensin-converting enzyme inhibitor
225193|NCT02788604|psychosocial screening, quality of life|psychosocial screening, quality of life
225194|NCT02788552|Neurological|neurological
225195|NCT02788552|Diet and Nutrition|diet and nutrition
225196|NCT02788552|Mental Health|mental health
225197|NCT02788539|Chronic Pain|chronic pain
225198|NCT02788539|mhealth|mhealth
225199|NCT02788539|Integrative Medicine|integrative medicine
225200|NCT02788539|MBSR|mbsr
225201|NCT02788539|Mindfulness Based Stress Reduction|mindfulness based stress reduction
225202|NCT02788539|Web based|web based
225203|NCT02788539|Internet Based|internet based
225204|NCT02788526|Carcinoma,Hepatocellular|carcinoma,hepatocellular
225205|NCT02788526|Chemoembolization|chemoembolization
225206|NCT02788526|Adjuvant therapy|adjuvant therapy
225207|NCT02788526|Hepatocellular|hepatocellular
225208|NCT02788526|Microvessels invasion|microvessels invasion
225209|NCT02788500|Epidemiology|epidemiology
225210|NCT02788500|Sports medicine|sports medicine
225211|NCT02788500|Research protocol|research protocol
225212|NCT02788500|Athletic injuries|athletic injuries
225213|NCT02788500|Sports for persons with disabilities|sports for persons with disabilities
225214|NCT02788448|Percutaneous vascular closure device|percutaneous vascular closure device
225215|NCT02788448|Large hole closure device|large hole closure device
225216|NCT02788396|STEMI|stemi
225217|NCT02788396|PPCI|ppci
225218|NCT02788396|post-dilatation|post-dilatation
225219|NCT02788396|coronary microcirculation|coronary microcirculation
225220|NCT02788370|Positive expiratory pressure|positive expiratory pressure
225221|NCT02788370|Cardiopulmonary responses|cardiopulmonary responses
225222|NCT02788370|Exercise|exercise
225223|NCT02788370|Older people|older people
225224|NCT02788357|motor training|motor training
225225|NCT02788357|motor recovery|motor recovery
225226|NCT02788357|human|human
225227|NCT02788357|neuroplasticity|neuroplasticity
225228|NCT02788357|transcranial magnetic stimulation|transcranial magnetic stimulation
225229|NCT02788344|Observational study|observational study
225230|NCT02788344|Myocardial revascularization|myocardial revascularization
225231|NCT02788344|Thrombolytic therapy|thrombolytic therapy
225232|NCT02788344|Hospital mortality|hospital mortality
225233|NCT02788344|Hemorrhage|hemorrhage
225234|NCT02788344|Quality of health care|quality of health care
225235|NCT02788344|Angioplasty|angioplasty
225236|NCT02788318|Epilepsy|epilepsy
225237|NCT02788318|SUDEP|sudep
225238|NCT02788318|Serotonin|serotonin
225239|NCT02788292|acetylcysteine|acetylcysteine
225240|NCT02788292|three-dimensional reconstruction|three-dimensional reconstruction
225241|NCT02788292|autologous fat grafting|autologous fat grafting
225340|NCT02787668|carbohydrate-restriction|carbohydrate-restriction
225242|NCT02788279|Locally advanced or Metastatic colorectal adenocarcinoma|locally advanced or metastatic colorectal adenocarcinoma
225243|NCT02788266|Cervical lesion|cervical lesion
225244|NCT02788266|gingival recession|gingival recession
225245|NCT02788266|restorative materials|restorative materials
225246|NCT02788253|Mallampati|mallampati
225247|NCT02788253|Intubation difficult|intubation difficult
225248|NCT02788253|Mask ventilation difficult|mask ventilation difficult
225249|NCT02788227|Ebola Vaccine|ebola vaccine
225250|NCT02788214|Gastric Cancer|gastric cancer
225251|NCT02788214|Bacterial Risk Factors|bacterial risk factors
225252|NCT02788214|DNA Methylation|dna methylation
225253|NCT02788214|DNA Sequencing|dna sequencing
225254|NCT02788214|Biobank|biobank
225255|NCT02788201|COXEN|coxen
225256|NCT02788201|Bladder Cancer|bladder cancer
225257|NCT02788201|Molecular Profiles|molecular profiles
225258|NCT02788188|First in Human|first in human
225259|NCT02788188|Middle East Respiratory Syndrome (MERS)|middle east respiratory syndrome (mers)
225260|NCT02788188|Tc Bovine-Derived|tc bovine-derived
225261|NCT02788188|Transchromosomic Cattle|transchromosomic cattle
225262|NCT02788175|HIV Immune Therapy|hiv immune therapy
225263|NCT02788175|Monoclonal Antibody|monoclonal antibody
225264|NCT02788175|Integrin|integrin
225265|NCT02788149|Ultrasonography|ultrasonography
225266|NCT02788149|Submental|submental
225267|NCT02788149|Lateral Parapharyngeal wall|lateral parapharyngeal wall
225268|NCT02788149|Tongue base thickness|tongue base thickness
225269|NCT02788149|Polysomnography|polysomnography
225270|NCT02788123|De-Nol|de-nol
225271|NCT02788123|NSAID-induced gastropathy|nsaid-induced gastropathy
225272|NCT02788123|Pantoprazole|pantoprazole
225273|NCT02788123|Bismuth tripotassium dicitrate|bismuth tripotassium dicitrate
225274|NCT02788123|Russia|russia
225275|NCT02788097|blastocysts|blastocysts
225276|NCT02788097|progesterone|progesterone
225277|NCT02788097|implantation|implantation
225278|NCT02788097|artificial frozen embryo transfer|artificial frozen embryo transfer
225279|NCT02788084|Next Generation Sequencing|next generation sequencing
225280|NCT02788084|Cell free DNA|cell free dna
225281|NCT02788071|Irritable Bowel Syndrome|irritable bowel syndrome
225282|NCT02788071|Fecal Microbiota Transplantation|fecal microbiota transplantation
225283|NCT02788071|Microbiota|microbiota
225284|NCT02788058|Hypofractionated Radiotherapy|hypofractionated radiotherapy
225285|NCT02788058|EGFR Positive|egfr positive
225286|NCT02788058|Lung Adenocarcinoma|lung adenocarcinoma
225287|NCT02788058|Limited Metastases|limited metastases
225288|NCT02788019|Adductor canal block, nerve block|adductor canal block, nerve block
225289|NCT02787941|acute coronary syndrome|acute coronary syndrome
225290|NCT02787941|medication adherence|medication adherence
225291|NCT02787941|pharmacist-led interventions|pharmacist-led interventions
225292|NCT02787941|Vietnam|vietnam
225293|NCT02787915|dendritic cells|dendritic cells
225294|NCT02787915|cytotoxic T lymphocyte|cytotoxic t lymphocyte
225295|NCT02787915|DC vaccine|dc vaccine
225296|NCT02787863|Pneumococcal vaccine|pneumococcal vaccine
225297|NCT02787863|Polioxidonium|polioxidonium
225298|NCT02787837|metastatic Castration Resistant Prostate Cancer|metastatic castration resistant prostate cancer
225299|NCT02787837|Abiraterone Acetate|abiraterone acetate
225300|NCT02787837|Biomarkers|biomarkers
225301|NCT02787824|iron deficiency|iron deficiency
225302|NCT02787824|hemodialysis|hemodialysis
225303|NCT02787811|IUI|iui
225304|NCT02787811|Pregnancy rate|pregnancy rate
225305|NCT02787811|predictors|predictors
225306|NCT02787798|Nervous System|nervous system
225307|NCT02787798|Cardiac disease|cardiac disease
225308|NCT02787785|Subcutaneous|subcutaneous
225309|NCT02787785|Implantable Cardioverter Defibrillator|implantable cardioverter defibrillator
225310|NCT02787785|MADIT|madit
225311|NCT02787785|Diabetes|diabetes
225312|NCT02787785|Myocardial Infarction|myocardial infarction
225313|NCT02787759|stroke|stroke
225314|NCT02787759|walking|walking
225315|NCT02787759|balance|balance
225316|NCT02787759|exercise|exercise
225317|NCT02787746|AD|ad
225318|NCT02787746|Donepezil|donepezil
225319|NCT02787746|Safety|safety
225320|NCT02787733|performance|performance
225321|NCT02787733|recovery|recovery
225322|NCT02787720|Acute Respiratory Distress Syndrome|acute respiratory distress syndrome
225323|NCT02787720|Pulmonary Rehabilitation|pulmonary rehabilitation
225324|NCT02787720|Rehabilitation Plan|rehabilitation plan
225325|NCT02787720|Rehabilitation Techniques|rehabilitation techniques
225326|NCT02787720|Survivor|survivor
225327|NCT02787720|Randomized Controlled Trial|randomized controlled trial
225328|NCT02787707|Breast cancer|breast cancer
225329|NCT02787707|Traditional medicine|traditional medicine
225330|NCT02787707|Chemotherapy Induced Nausea and Vomiting|chemotherapy induced nausea and vomiting
225331|NCT02787707|Bunium Persicum|bunium persicum
225332|NCT02787707|Rhus Coriaria|rhus coriaria
225333|NCT02787694|stroke|stroke
225334|NCT02787694|walking|walking
225335|NCT02787694|balance|balance
225336|NCT02787694|exercise|exercise
225337|NCT02787668|childhood obesity|childhood obesity
225338|NCT02787668|Non-alcoholic fatty liver disease|non-alcoholic fatty liver disease
225339|NCT02787668|insulin resistance|insulin resistance
225341|NCT02787655|Aging|aging
225342|NCT02787642|Advanced soft-tissue sarcoma|advanced soft-tissue sarcoma
225343|NCT02787642|Unresectable Soft-tissue Sarcoma|unresectable soft-tissue sarcoma
225344|NCT02787629|D007440|d007440
225345|NCT02787590|Neurology|neurology
225346|NCT02787577|Sleep Duration|sleep duration
225347|NCT02787577|Sleep Quality|sleep quality
225348|NCT02787577|Body Composition|body composition
225349|NCT02787577|Energy Intake|energy intake
225350|NCT02787577|Energy Expenditure|energy expenditure
225351|NCT02787577|Energy Balance|energy balance
225352|NCT02787577|Cardiovascular Risk|cardiovascular risk
225353|NCT02787564|fruit, vegetables|fruit, vegetables
225354|NCT02787538|Rheumatoid Arthritis|rheumatoid arthritis
225355|NCT02787538|Decision Aids|decision aids
225356|NCT02787538|Biologics|biologics
225357|NCT02787512|ERCP|ercp
288158|NCT02415036|HCC|hcc
225358|NCT02787512|stent|stent
225359|NCT02787512|preoperative biliary drainage|preoperative biliary drainage
225360|NCT02787499|Drug resistance|drug resistance
225361|NCT02787499|Standard of care|standard of care
225362|NCT02787499|sub-saharan africa|sub-saharan africa
225363|NCT02787499|antiretroviral therapy|antiretroviral therapy
225364|NCT02787499|diagnostics|diagnostics
225365|NCT02787499|implementation|implementation
225366|NCT02787486|Down syndrome|down syndrome
225367|NCT02787486|Edwards syndrome|edwards syndrome
225368|NCT02787486|Patau syndrome|patau syndrome
225369|NCT02787486|Klinefelter syndrome|klinefelter syndrome
225370|NCT02787486|DiGeorge syndrome|digeorge syndrome
225371|NCT02787486|Chromosome Deletion|chromosome deletion
225372|NCT02787486|Aneuploidy|aneuploidy
225373|NCT02787473|Squamous cell lung cancer|squamous cell lung cancer
225374|NCT02787473|Pemetrexed|pemetrexed
225375|NCT02787473|Radiosensitivity|radiosensitivity
225376|NCT02787460|Parenting|parenting
225377|NCT02787460|Family Relations|family relations
225378|NCT02787460|Marriage|marriage
225379|NCT02787460|Relationships|relationships
225380|NCT02787447|Hypofractionated Radiotherapy|hypofractionated radiotherapy
225381|NCT02787447|Thymosin Alpha 1|thymosin alpha 1
225382|NCT02787447|Lung Adenocarcinoma|lung adenocarcinoma
225383|NCT02787447|Tyrosine Kinase Inhibitors|tyrosine kinase inhibitors
225384|NCT02787434|African american men|african american men
225385|NCT02787434|prostate cancer screening|prostate cancer screening
225386|NCT02787434|web-based decision aid|web-based decision aid
225387|NCT02787434|informed decision making|informed decision making
225388|NCT02787434|shared decision-making|shared decision-making
225389|NCT02787421|Reconstructive Surgery|reconstructive surgery
225390|NCT02787421|Rhinoplasty|rhinoplasty
225391|NCT02787382|cytomegalovirus|cytomegalovirus
225392|NCT02787382|TORCH|torch
225393|NCT02787382|prenatal diagnosis|prenatal diagnosis
225394|NCT02787382|congenital infections|congenital infections
225395|NCT02787382|fetal abnormalities|fetal abnormalities
225396|NCT02787382|echocardiography|echocardiography
225397|NCT02787382|myocardial deformation|myocardial deformation
225398|NCT02787369|Refractory Leukemia|refractory leukemia
225399|NCT02787369|Leukemia|leukemia
225400|NCT02787356|Skin Diseases, Erythema|skin diseases, erythema
225401|NCT02787330|pediatric cancer|pediatric cancer
225402|NCT02787330|psychosocial|psychosocial
225403|NCT02787330|siblings|siblings
225404|NCT02787317|bivalirudin|bivalirudin
225405|NCT02787317|myocardial injure|myocardial injure
225406|NCT02787304|NAFLD activity score|nafld activity score
225407|NCT02787304|ASBTi|asbti
225408|NCT02787304|MRI PDFF|mri pdff
225410|NCT02787304|NAFLD|nafld
225411|NCT02787304|liver disease|liver disease
225412|NCT02787304|ASBT|asbt
225413|NCT02787304|MRI proton density fat fraction|mri proton density fat fraction
225414|NCT02787304|nonalcoholic steatohepatitis|nonalcoholic steatohepatitis
225415|NCT02787304|apical sodium dependent bile acid transporter inhibitor|apical sodium dependent bile acid transporter inhibitor
225416|NCT02787304|fatty liver|fatty liver
225417|NCT02787304|NASH|nash
225418|NCT02787278|rtPA|rtpa
225419|NCT02787278|Intracranial hemorrhage|intracranial hemorrhage
225420|NCT02787265|High density spinal cord stimulation|high density spinal cord stimulation
225421|NCT02787265|Virtual expert registry|virtual expert registry
225422|NCT02787226|liposomal bupivacaine|liposomal bupivacaine
225423|NCT02787226|analgesia for total shoulder arthroplasty|analgesia for total shoulder arthroplasty
225424|NCT02787226|peripheral nerve blocks for total shoulder arthroplasty|peripheral nerve blocks for total shoulder arthroplasty
225425|NCT02787213|proteomics|proteomics
225426|NCT02787213|pregnancy|pregnancy
225427|NCT02787213|biomarkers|biomarkers
225428|NCT02787213|preterm birth|preterm birth
225429|NCT02787200|electroencephalogram (EEG),Human brain,Brain-Computer Interface|electroencephalogram (eeg),human brain,brain-computer interface
225430|NCT02787187|Standard lymphadenectomy|standard lymphadenectomy
225431|NCT02787187|extended lymphadenectomy|extended lymphadenectomy
225432|NCT02787187|pancreaticoduodenectomy|pancreaticoduodenectomy
225433|NCT02787174|Asthma|asthma
225434|NCT02787174|Medication adherence|medication adherence
225435|NCT02787174|Intervention study|intervention study
225436|NCT02787161|Chronic Kidney Disease|chronic kidney disease
225437|NCT02787161|Hemodialysis|hemodialysis
225438|NCT02787161|Hemodiafiltration|hemodiafiltration
225439|NCT02787161|Renal Replacement Therapy|renal replacement therapy
225440|NCT02787161|Physical Activity|physical activity
225441|NCT02787161|Accelerometer|accelerometer
225442|NCT02787148|cognitive behavioral therapy|cognitive behavioral therapy
225443|NCT02787148|psychotherapy|psychotherapy
225444|NCT02787148|cardiovascular health|cardiovascular health
225445|NCT02787148|psychoneuroimmunology|psychoneuroimmunology
225446|NCT02787135|Delusions|delusions
225447|NCT02787135|Schizophrenia|schizophrenia
225448|NCT02787135|Cognitive Behavior Therapy|cognitive behavior therapy
225449|NCT02787135|Emotion|emotion
225450|NCT02787135|Emotion regulation|emotion regulation
225451|NCT02787135|self-esteem|self-esteem
225452|NCT02787135|sleep quality|sleep quality
225453|NCT02787135|Efficacy of change|efficacy of change
225454|NCT02787122|Schizophrenia|schizophrenia
225455|NCT02787122|psychotic disorders|psychotic disorders
225456|NCT02787122|Cognitive Behavior Therapy|cognitive behavior therapy
225457|NCT02787122|emotion regulation|emotion regulation
225458|NCT02787122|self-esteem|self-esteem
225459|NCT02787122|randomized-controlled trial|randomized-controlled trial
225460|NCT02787109|Safety|safety
225461|NCT02787109|Immunogenicity|immunogenicity
225462|NCT02787109|Phase I|phase i
225463|NCT02787096|dynamic knee laxity measurement|dynamic knee laxity measurement
225464|NCT02787096|laxi-MRI|laxi-mri
225465|NCT02787096|partial anterior cruciate ligament tear|partial anterior cruciate ligament tear
225466|NCT02787083|Interstitial Cystitis|interstitial cystitis
225467|NCT02787044|influenza vaccine|influenza vaccine
225468|NCT02787044|cardiopulmonary hospitalization|cardiopulmonary hospitalization
225469|NCT02787044|heart failure|heart failure
225470|NCT02787044|myocardial infarction|myocardial infarction
225471|NCT02787044|clinical trial|clinical trial
225472|NCT02787031|hip fracture|hip fracture
225473|NCT02787031|geriatric|geriatric
225474|NCT02787031|epidemiology|epidemiology
225475|NCT02787031|practice variation|practice variation
225476|NCT02787031|anesthesia|anesthesia
225477|NCT02787018|Brachial plexus block|brachial plexus block
225478|NCT02787018|Ropivacaine|ropivacaine
225479|NCT02787018|Dexmedetomidine|dexmedetomidine
225480|NCT02787018|Dexamethasone|dexamethasone
225481|NCT02787018|Adjuvants, anesthesia|adjuvants, anesthesia
225482|NCT02787005|PD1|pd1
225483|NCT02787005|PD-1|pd-1
225484|NCT02787005|PDL1|pdl1
225485|NCT02787005|PD-L1|pd-l1
225486|NCT02786992|Misoprostol|misoprostol
225487|NCT02786992|Oxytocin|oxytocin
225488|NCT02786992|Carbetocin|carbetocin
225489|NCT02786992|Prevention|prevention
225490|NCT02786992|Post-partum hemorrhage|post-partum hemorrhage
225491|NCT02786979|Type 2 Diabetes Mellitus|type 2 diabetes mellitus
225492|NCT02786979|Arteriosclerosis|arteriosclerosis
225493|NCT02786979|beraprost|beraprost
225494|NCT02786979|Aspirin|aspirin
225495|NCT02786966|Cervical spine injuries|cervical spine injuries
225496|NCT02786966|Canadian C-spine Rule|canadian c-spine rule
225497|NCT02786966|Emergency Medical Services|emergency medical services
225498|NCT02786966|Paramedic|paramedic
225499|NCT02786966|Cervical spine fracture|cervical spine fracture
225500|NCT02786953|Sleep|sleep
225501|NCT02786953|Adherence|adherence
225502|NCT02786953|Diabetes Management|diabetes management
225503|NCT02786953|Adolescent|adolescent
225504|NCT02786940|remote|remote
225505|NCT02786940|cardiac monitoring|cardiac monitoring
225506|NCT02786940|mortality|mortality
225507|NCT02786927|HANDIHALER|handihaler
225508|NCT02786927|Dry Powder Inhaler|dry powder inhaler
225509|NCT02786927|COPD|copd
225510|NCT02786927|ELLIPTA|ellipta
225511|NCT02786927|Inhaler preference attributes|inhaler preference attributes
225512|NCT02786875|lifestyle|lifestyle
225513|NCT02786875|low glycemic index diet|low glycemic index diet
225514|NCT02786875|exercise|exercise
225515|NCT02786875|vitamin D|vitamin d
225516|NCT02786875|breast cancer|breast cancer
225517|NCT02786875|Mediterranean diet|mediterranean diet
225518|NCT02786862|mechanical ventilation|mechanical ventilation
225519|NCT02786862|independent ventilation|independent ventilation
225520|NCT02786862|ventilation/perfusion mismatch|ventilation/perfusion mismatch
225521|NCT02786862|thoracic anesthesia|thoracic anesthesia
225522|NCT02786849|Electric Stimulation|electric stimulation
225523|NCT02786849|Electric Stimulation Therapy|electric stimulation therapy
225524|NCT02786836|acute liver failure|acute liver failure
225525|NCT02786836|methacetin|methacetin
225526|NCT02786836|breath test|breath test
225527|NCT02786836|severe acute liver injury|severe acute liver injury
225528|NCT02786836|hepatic encephalopathy|hepatic encephalopathy
225529|NCT02786836|ALFSG Registry|alfsg registry
225530|NCT02786836|acetaminophen toxicity|acetaminophen toxicity
225531|NCT02786797|breast cancer|breast cancer
225532|NCT02786797|mindfulness-based stress reduction|mindfulness-based stress reduction
225533|NCT02786797|cognitive impairment|cognitive impairment
225534|NCT02786771|Stress Management|stress management
225535|NCT02786771|Mindfulness|mindfulness
225536|NCT02786771|Meditation|meditation
225537|NCT02786771|Stress Resilience|stress resilience
225538|NCT02786732|Psoriasis|psoriasis
225539|NCT02786719|Sargramostim|sargramostim
225540|NCT02786719|Cyclophosphamide|cyclophosphamide
225541|NCT02786719|Topotecan|topotecan
225542|NCT02786719|Cisplatin|cisplatin
225543|NCT02786719|Dexrazoxane|dexrazoxane
225544|NCT02786719|Doxorubicin|doxorubicin
225545|NCT02786719|Etoposide|etoposide
225546|NCT02786719|Filgrastim|filgrastim
225547|NCT02786719|Vincristine|vincristine
225548|NCT02786719|Mesna|mesna
225549|NCT02786706|Traumatic Brain Injury|traumatic brain injury
225550|NCT02786706|Intracranial Pressure|intracranial pressure
225551|NCT02786706|Ultrasonography|ultrasonography
225552|NCT02786706|Computer-Assisted Image Analysis|computer-assisted image analysis
225553|NCT02786706|Intracranial Hypertension|intracranial hypertension
225554|NCT02786706|Acute brain injuries|acute brain injuries
225555|NCT02786693|TEP-scan|tep-scan
225556|NCT02786654|Acute myocardial infarction|acute myocardial infarction
225557|NCT02786654|mortality|mortality
225558|NCT02786654|evidence-based care|evidence-based care
225559|NCT02786654|Myocardial Ischaemia National Audit Project|myocardial ischaemia national audit project
225560|NCT02786654|β blockers|β blockers
225561|NCT02786641|nasopharyngeal carcinoma|nasopharyngeal carcinoma
225562|NCT02786641|induction chemotherapy|induction chemotherapy
225563|NCT02786641|concurrent chemotherapy|concurrent chemotherapy
225564|NCT02786641|docetaxel|docetaxel
225565|NCT02786641|cisplatin|cisplatin
225566|NCT02786641|xeloda|xeloda
225567|NCT02786641|nomogram|nomogram
225568|NCT02786615|men who have sex with men (MSM)|men who have sex with men (msm)
225569|NCT02786589|Lung cancer Immunotherapy|lung cancer immunotherapy
225570|NCT02786589|Plasmodium vivax|plasmodium vivax
225571|NCT02786589|Immunotherapy|immunotherapy
225572|NCT02786576|Moderate to Severe Hidradenitis Suppurativa|moderate to severe hidradenitis suppurativa
225573|NCT02786576|Adalimumab|adalimumab
225574|NCT02786563|power doppler (PD)|power doppler (pd)
225575|NCT02786563|ultrasonographic (US)|ultrasonographic (us)
225576|NCT02786563|rheumatoid arthritis (RA)|rheumatoid arthritis (ra)
225577|NCT02786563|disease activity scale (DAS)|disease activity scale (das)
225578|NCT02786563|C-reactive protein (CRP)|c-reactive protein (crp)
225579|NCT02786550|Lower blepharoplasty, Botulinum toxin, Scar|lower blepharoplasty, botulinum toxin, scar
225580|NCT02786537|Hepatitis C|hepatitis c
225581|NCT02786524|Palliative Care|palliative care
225582|NCT02786524|Triage|triage
225583|NCT02786524|Symptom Evaluation|symptom evaluation
225584|NCT02786524|Chemotherapy|chemotherapy
225585|NCT02786524|Patient Distress|patient distress
225586|NCT02786498|Tibial Shaft|tibial shaft
225587|NCT02786498|Tibia|tibia
225588|NCT02786498|Femoral Shaft|femoral shaft
225589|NCT02786498|Femur|femur
225590|NCT02786498|Vitamin D|vitamin d
225591|NCT02786498|Fracture Healing|fracture healing
225592|NCT02786485|BPX-501|bpx-501
225593|NCT02786485|Rimiducid|rimiducid
225594|NCT02786485|AP1903|ap1903
225595|NCT02786485|Hematological malignancies|hematological malignancies
225596|NCT02786485|Hematologic diseases|hematologic diseases
225597|NCT02786485|Leukemias and Myelodysplastic Syndromes|leukemias and myelodysplastic syndromes
225598|NCT02786485|Lymphomas|lymphomas
225599|NCT02786485|Multiple myeloma|multiple myeloma
225600|NCT02786472|Bystander behaviors|bystander behaviors
225601|NCT02786472|Incoming students|incoming students
225602|NCT02786472|CampusSave|campussave
225603|NCT02786472|Prevention|prevention
225604|NCT02786472|Sexual Assault|sexual assault
225605|NCT02786472|Incapacitation|incapacitation
225606|NCT02786459|Prostate|prostate
225607|NCT02786459|Local Recurrence|local recurrence
225608|NCT02786459|Radical Prostatectomy|radical prostatectomy
225609|NCT02786446|Lidocaine gel|lidocaine gel
225610|NCT02786446|Extracorporeal shockwave lithotripsy|extracorporeal shockwave lithotripsy
225611|NCT02786446|Naproxen sodium|naproxen sodium
225612|NCT02786446|Pain score|pain score
225613|NCT02786420|pregnancy|pregnancy
225614|NCT02786420|magnetic resonance imaging|magnetic resonance imaging
225615|NCT02786420|environmental air pollutants|environmental air pollutants
225616|NCT02786407|overactive bladder|overactive bladder
225617|NCT02786407|Botulinum Toxin Type A for Injection|botulinum toxin type a for injection
225618|NCT02786368|Food Production|food production
225619|NCT02786368|Inadequacy|inadequacy
225620|NCT02786368|Dietary zinc|dietary zinc
225621|NCT02786368|Iron|iron
225622|NCT02786368|vitamin A|vitamin a
225623|NCT02786342|Hepatocellular Carcinoma|hepatocellular carcinoma
225624|NCT02786342|Sorafenib|sorafenib
225626|NCT02786342|Angiogenesis|angiogenesis
225627|NCT02786342|Polymorphisms|polymorphisms
225628|NCT02786329|colorectal cancer|colorectal cancer
225629|NCT02786329|TIVA|tiva
225630|NCT02786329|sevoflurane|sevoflurane
225631|NCT02786329|lidocaine|lidocaine
225632|NCT02786264|transcatheter aortic valve replacement|transcatheter aortic valve replacement
225633|NCT02786264|anesthesia|anesthesia
225634|NCT02786264|conscious sedation|conscious sedation
225635|NCT02786264|managed anesthesia care|managed anesthesia care
225636|NCT02786199|Hepatocellular Carcinoma(HCC)|hepatocellular carcinoma(hcc)
225637|NCT02786199|Ultrasound|ultrasound
225638|NCT02786199|Backscatter|backscatter
225639|NCT02786199|Differentiation grade|differentiation grade
225640|NCT02786199|Survival|survival
225641|NCT02786186|Psoriasis|psoriasis
225642|NCT02786186|Plaque Psoriasis|plaque psoriasis
225643|NCT02786186|Chronic Plaque Psoriasis|chronic plaque psoriasis
225644|NCT02786186|Cosentyx|cosentyx
225645|NCT02786186|Secukinumab|secukinumab
225646|NCT02786186|Moderate to severe plaque psoriasis|moderate to severe plaque psoriasis
225647|NCT02786186|PURE registry|pure registry
225648|NCT02786186|Registry|registry
225649|NCT02786173|PRIME|prime
225650|NCT02786173|PAD|pad
225651|NCT02786173|PVD|pvd
225652|NCT02786173|Observational|observational
225653|NCT02786173|CLI|cli
225654|NCT02786173|PRIME Registry|prime registry
225655|NCT02786147|Breast Cancer|breast cancer
225656|NCT02786147|Ovarian Cancer|ovarian cancer
225657|NCT02786147|B-RST|b-rst
225658|NCT02786121|hip replacement,|hip replacement,
225659|NCT02786121|rehabilitation,|rehabilitation,
225660|NCT02786121|early ambulation,|early ambulation,
225661|NCT02786108|left gastric artery|left gastric artery
225662|NCT02786108|embolization|embolization
225663|NCT02786108|obesity|obesity
225664|NCT02786095|Atrial fibrillation|atrial fibrillation
225665|NCT02786095|anti arrhythmic drug|anti arrhythmic drug
225666|NCT02786095|NOAC|noac
225667|NCT02786095|warfarin|warfarin
225668|NCT02786095|coumadin|coumadin
225669|NCT02786056|Respiratory Function Tests|respiratory function tests
225670|NCT02786056|Lung|lung
225671|NCT02785965|electroacupuncture|electroacupuncture
225672|NCT02785965|lifestyle modification|lifestyle modification
225673|NCT02785965|diet|diet
225674|NCT02785965|exercise|exercise
225675|NCT02785965|Dai Meridian|dai meridian
225676|NCT02785926|pesticide exposure|pesticide exposure
225677|NCT02785926|respiratory control|respiratory control
225678|NCT02785926|sleep|sleep
225679|NCT02785900|Antibodies, monoclonal|antibodies, monoclonal
225680|NCT02785900|Antibody drug conjugate|antibody drug conjugate
225681|NCT02785900|Antigens, cluster of differentiation 33 (CD33)|antigens, cluster of differentiation 33 (cd33)
225682|NCT02785900|Drug therapy|drug therapy
225683|NCT02785900|Immunotherapy|immunotherapy
225684|NCT02785887|Breast cancer|breast cancer
225685|NCT02785887|lung cancer|lung cancer
225686|NCT02785887|Gastrointestinal Cancer|gastrointestinal cancer
225687|NCT02785887|Ovarian cancer|ovarian cancer
225688|NCT02785887|Prostate cancer|prostate cancer
225689|NCT02785887|bladder cancer|bladder cancer
225690|NCT02785861|hormonal therapy|hormonal therapy
225691|NCT02785861|walking|walking
225692|NCT02785861|fatigue|fatigue
225693|NCT02785822|Reproductive Techniques, Assisted|reproductive techniques, assisted
225694|NCT02785809|Oral contraceptives|oral contraceptives
225695|NCT02785809|long-term use|long-term use
225696|NCT02785809|AMH|amh
225697|NCT02785809|Ovarian reserve parameters|ovarian reserve parameters
225698|NCT02785783|EndoRings™|endorings™
225699|NCT02785757|adenocarcinoma|adenocarcinoma
225700|NCT02785757|venous thromboembolism|venous thromboembolism
225701|NCT02785757|thrombin generation assay|thrombin generation assay
225702|NCT02785731|pelvic mass|pelvic mass
225703|NCT02785731|ovarian cancer|ovarian cancer
225704|NCT02785731|gynecological cancer|gynecological cancer
225705|NCT02785731|risk prediction|risk prediction
225706|NCT02785718|Contact system|contact system
225707|NCT02785718|Factor XI deficiency|factor xi deficiency
225708|NCT02785718|Factor XII deficiency|factor xii deficiency
225709|NCT02785718|Global haemostasis assays|global haemostasis assays
225710|NCT02785705|immunization|immunization
225711|NCT02785705|vaccine schedule|vaccine schedule
225712|NCT02785705|poliomyelitis|poliomyelitis
225713|NCT02785705|polio|polio
225714|NCT02785705|oral polio vaccine|oral polio vaccine
225715|NCT02785705|inactivated polio vaccine|inactivated polio vaccine
225716|NCT02785692|soft tissue sarcoma|soft tissue sarcoma
225717|NCT02785692|IMRT and sarcoma|imrt and sarcoma
225718|NCT02785692|preoperative highly conformal radiation therapy|preoperative highly conformal radiation therapy
225719|NCT02785692|soft tissue sarcoma and wound healing|soft tissue sarcoma and wound healing
225720|NCT02785692|postoperative complications|postoperative complications
225721|NCT02785692|treatment tolerance of soft tissue IMRT|treatment tolerance of soft tissue imrt
225722|NCT02785679|Allergy|allergy
225723|NCT02785679|Cow's milk|cow's milk
225724|NCT02785679|breast feeding|breast feeding
225725|NCT02785679|Cow's milk formula|cow's milk formula
225726|NCT02785679|prevention|prevention
225727|NCT02785666|Men who have sex with men|men who have sex with men
225728|NCT02785666|Elimination|elimination
225729|NCT02785653|sevoflurane|sevoflurane
225730|NCT02785653|rocuronium|rocuronium
225731|NCT02785653|intubation|intubation
225732|NCT02785627|Bone health|bone health
225733|NCT02785627|Bone microarchitecture|bone microarchitecture
225734|NCT02785627|Androgen deprivation therapy (ADT)|androgen deprivation therapy (adt)
225735|NCT02785588|MRI Scanner|mri scanner
225736|NCT02785588|NICU|nicu
225737|NCT02785562|PDL1 expression : Protein Death Ligand 1 expression .|pdl1 expression : protein death ligand 1 expression .
225738|NCT02785549|Acute diverticulitis|acute diverticulitis
225739|NCT02785549|Antibiotic|antibiotic
225740|NCT02785549|Outpatient treatment|outpatient treatment
225741|NCT02785536|minority health|minority health
225742|NCT02785536|social class|social class
225743|NCT02785536|healthcare disparities|healthcare disparities
225744|NCT02785536|tobacco use disorder|tobacco use disorder
225745|NCT02785497|Electrical stimulation|electrical stimulation
225746|NCT02785497|wound healing|wound healing
225747|NCT02785497|Polarity current|polarity current
225748|NCT02785497|Burn|burn
225749|NCT02785497|Chronic ulcer|chronic ulcer
225750|NCT02785484|Cigarette smoking|cigarette smoking
225751|NCT02785484|Smoking|smoking
225752|NCT02785484|Tobacco use|tobacco use
225753|NCT02785471|Suicide prevention|suicide prevention
225754|NCT02785471|men's mental health|men's mental health
225755|NCT02785471|depression|depression
225756|NCT02785471|suicide ideation and behaviors|suicide ideation and behaviors
225757|NCT02785419|Rehabilitation|rehabilitation
225758|NCT02785419|Upper Extremity|upper extremity
225759|NCT02785419|Physical Therapy|physical therapy
225760|NCT02785406|cocaine|cocaine
225761|NCT02785406|sleep|sleep
225762|NCT02785406|anxiety|anxiety
225763|NCT02785406|craving|craving
225764|NCT02785406|addiction|addiction
225765|NCT02785406|orexin|orexin
225766|NCT02785406|cue reactivity|cue reactivity
225767|NCT02785406|suvorexant|suvorexant
225768|NCT02785406|Belsomra|belsomra
225769|NCT02785393|Methamphetamine|methamphetamine
225770|NCT02785393|Dependence|dependence
225771|NCT02785341|adapted physical activity|adapted physical activity
225772|NCT02785328|Memory|memory
225773|NCT02785328|sleep|sleep
225774|NCT02785328|narcolepsy|narcolepsy
225775|NCT02785328|apnea|apnea
225776|NCT02785328|epilepsy|epilepsy
225777|NCT02785302|Pediatric|pediatric
225778|NCT02785302|HIV|hiv
225779|NCT02785302|Transition|transition
225780|NCT02785302|Adult Care|adult care
225781|NCT02785263|Anal cancer|anal cancer
225782|NCT02785263|Shared decision making|shared decision making
225783|NCT02785250|T cell activation|t cell activation
225784|NCT02785250|immunotherapy|immunotherapy
225785|NCT02785250|ovarian|ovarian
225786|NCT02785250|fallopian tube|fallopian tube
225787|NCT02785250|peritoneal|peritoneal
225788|NCT02785250|cancer|cancer
225789|NCT02785250|recurrent|recurrent
225790|NCT02785250|tumor|tumor
225791|NCT02785250|measurable|measurable
225792|NCT02785237|Drug-eluting stent|drug-eluting stent
225793|NCT02785237|OCT|oct
225794|NCT02785237|Re-endothelialization|re-endothelialization
225795|NCT02785146|Huaier Granule|huaier granule
225796|NCT02785146|After radical surgery|after radical surgery
225797|NCT02785146|Prevention of recurrence and metastasis|prevention of recurrence and metastasis
225798|NCT02785146|Efficacy and safety|efficacy and safety
225799|NCT02785120|Phase 2|phase 2
225800|NCT02785120|Efficacy|efficacy
225801|NCT02785120|Safety|safety
225802|NCT02785120|Ischemic Stroke|ischemic stroke
225803|NCT02785107|Exercise|exercise
225804|NCT02785107|Habit|habit
225805|NCT02785107|MVPA|mvpa
225806|NCT02785107|M-PAC|m-pac
225807|NCT02785107|Automaticity|automaticity
225808|NCT02785107|Physical Activity|physical activity
225809|NCT02785094|Caesarean Section Rate|caesarean section rate
225810|NCT02785094|Primigravida|primigravida
225811|NCT02785081|Thoracic epidural|thoracic epidural
225812|NCT02785081|Magnetic Resonance Imaging|magnetic resonance imaging
225813|NCT02785081|Children|children
225814|NCT02785068|Phase I|phase i
225815|NCT02785068|Cancer|cancer
225816|NCT02785068|EGFR|egfr
225817|NCT02785068|Metastatic Colorectal Cancer|metastatic colorectal cancer
225818|NCT02785068|Oncology|oncology
225819|NCT02785068|RAS/RAF Wild-Type|ras/raf wild-type
225820|NCT02785068|Nal-IRI|nal-iri
225821|NCT02785068|EGFR Inhibitor|egfr inhibitor
225822|NCT02785068|Oligoclonal Antibody|oligoclonal antibody
225823|NCT02785068|Nanoliposome|nanoliposome
225824|NCT02785068|Nanoliposomal Irinotecan|nanoliposomal irinotecan
225825|NCT02785016|Stress Urinary Incontinence|stress urinary incontinence
225826|NCT02785016|Suburethral Sling|suburethral sling
225827|NCT02785003|Colorectal Surgery|colorectal surgery
225828|NCT02785003|Acute Pain|acute pain
225829|NCT02785003|Pain|pain
225830|NCT02785003|post-operative pain|post-operative pain
225831|NCT02785003|ketamine|ketamine
225832|NCT02784938|Employment|employment
225833|NCT02784938|Mental Illness|mental illness
225834|NCT02784938|Photovoice|photovoice
225835|NCT02784912|Biomarkers|biomarkers
225836|NCT02784912|Ventricular Dysfunction|ventricular dysfunction
225837|NCT02784912|Ventricular Tachycardia|ventricular tachycardia
225838|NCT02784912|Electrical Storm|electrical storm
225839|NCT02784912|ST2|st2
225840|NCT02784912|Galectin-3|galectin-3
225841|NCT02784912|NT-proBNP|nt-probnp
225842|NCT02784912|Iron Deficiency|iron deficiency
225843|NCT02784912|hs-CRP|hs-crp
225844|NCT02784912|hs-TnT|hs-tnt
225845|NCT02784886|Placenta accreta|placenta accreta
225846|NCT02784886|previous caesarean|previous caesarean
225847|NCT02784886|placenta praevia|placenta praevia
225848|NCT02784886|Cell-free fetal DNA|cell-free fetal dna
225849|NCT02784886|Biological markers|biological markers
225850|NCT02784873|High intensity interval training|high intensity interval training
225851|NCT02784873|Coronary heart disease|coronary heart disease
225852|NCT02784873|Exercise training|exercise training
225853|NCT02784873|Cardiac rehabilitation|cardiac rehabilitation
225854|NCT02784873|Interval training|interval training
225855|NCT02784860|colonoscopy|colonoscopy
225856|NCT02784860|lidocaine|lidocaine
225857|NCT02784860|propofol|propofol
225858|NCT02784860|sedation|sedation
225859|NCT02784834|CLL|cll
225860|NCT02784834|cancer|cancer
225861|NCT02784834|DMF|dmf
225862|NCT02784834|SLL|sll
225863|NCT02784834|dimethylfumarate|dimethylfumarate
225864|NCT02784834|relapsed|relapsed
225865|NCT02784834|refractory|refractory
225866|NCT02784795|Notch Inhibitor|notch inhibitor
225867|NCT02784782|Spinal|spinal
225868|NCT02784782|Vertebral|vertebral
225869|NCT02784782|Burstfracture|burstfracture
225870|NCT02784782|Orthesis|orthesis
225871|NCT02784782|Brace|brace
225872|NCT02784782|Thoracolumbar|thoracolumbar
225873|NCT02784756|Quantiferon-CMV|quantiferon-cmv
225874|NCT02784756|solid organ transplant|solid organ transplant
225875|NCT02784756|CMV Disease|cmv disease
225876|NCT02784743|Wuchereria bancrofti|wuchereria bancrofti
225877|NCT02784743|Anopheles|anopheles
225878|NCT02784743|Albendazole|albendazole
225879|NCT02784743|Ivermectin|ivermectin
225880|NCT02784743|MDA|mda
225881|NCT02784730|breast cancer|breast cancer
225882|NCT02784730|chemotherapy|chemotherapy
225883|NCT02784730|peripherally inserted central catheter|peripherally inserted central catheter
225884|NCT02784730|implantable device|implantable device
225885|NCT02784730|randomized controlled trial|randomized controlled trial
225886|NCT02784730|iterative placement|iterative placement
225887|NCT02784730|Catheterization, Central Venous|catheterization, central venous
225888|NCT02784717|rivaroxaban,|rivaroxaban,
225889|NCT02784717|non-interventional,|non-interventional,
225890|NCT02784717|atrial fibrillation,|atrial fibrillation,
225891|NCT02784717|stroke prevention,|stroke prevention,
225892|NCT02784665|CSC|csc
225893|NCT02784665|Micropulse Laser|micropulse laser
225894|NCT02784665|Traditional Laser|traditional laser
225895|NCT02784639|KRAS/BRAF mutational status|kras/braf mutational status
225896|NCT02784626|Dexmedetomidine|dexmedetomidine
225897|NCT02784626|Propofol|propofol
225898|NCT02784626|Pain, Postoperative|pain, postoperative
225899|NCT02784600|Partial-thickness|partial-thickness
225900|NCT02784600|Full-thickness|full-thickness
225901|NCT02784587|stellate ganglion block|stellate ganglion block
225902|NCT02784587|cardiac surgery|cardiac surgery
225903|NCT02784574|Rehabilitation|rehabilitation
225904|NCT02784574|Aftercare|aftercare
225905|NCT02784561|allogeneic peripheral blood stem cell transplantation|allogeneic peripheral blood stem cell transplantation
225906|NCT02784561|conditioning regimen|conditioning regimen
225907|NCT02784561|acute leukemia|acute leukemia
225908|NCT02784561|relapsed/refractory|relapsed/refractory
225909|NCT02784535|norepinephrine transporter inhibitors|norepinephrine transporter inhibitors
225910|NCT02784509|Physical Activity|physical activity
225911|NCT02784509|Sedentary Behavior|sedentary behavior
225912|NCT02784509|Cardiometabolic Risk Factors|cardiometabolic risk factors
225913|NCT02784509|Childhood and Adolescence|childhood and adolescence
225914|NCT02784444|NASH|nash
225915|NCT02784405|percutaneous coronary intervention|percutaneous coronary intervention
225916|NCT02784405|stent implantation|stent implantation
225917|NCT02784379|Mastalgia|mastalgia
225918|NCT02784379|electromyography|electromyography
225919|NCT02784379|Pectoral|pectoral
225920|NCT02784366|Cancer immunotherapy|cancer immunotherapy
225921|NCT02784366|Ipilimumab|ipilimumab
225922|NCT02784353|Rehabilitation|rehabilitation
225923|NCT02784353|Quality of life|quality of life
225924|NCT02784353|Surgery|surgery
225925|NCT02784353|Hepatic neoplasms|hepatic neoplasms
225926|NCT02784353|Biliary tract neoplasms|biliary tract neoplasms
225927|NCT02784353|Pancreatic neoplasms|pancreatic neoplasms
225928|NCT02784340|Postoperative pain|postoperative pain
225929|NCT02784340|dexamethasone|dexamethasone
225930|NCT02784340|cesarean section|cesarean section
225931|NCT02784314|Clinically localized prostate cancer|clinically localized prostate cancer
225932|NCT02784314|Robotic-assisted prostatectomy|robotic-assisted prostatectomy
225933|NCT02784314|Laparoscopic prostatectomy|laparoscopic prostatectomy
225934|NCT02784314|Erectile function ;|erectile function ;
225935|NCT02784314|Cost efficacy study|cost efficacy study
225936|NCT02784288|head and neck neoplasms|head and neck neoplasms
225937|NCT02784288|HPV|hpv
225938|NCT02784288|human papilloma virus|human papilloma virus
225939|NCT02784288|de-escalation|de-escalation
225940|NCT02784288|low-risk|low-risk
225941|NCT02784288|oropharyngeal cancer|oropharyngeal cancer
225942|NCT02784262|Botulinum Toxin Type A|botulinum toxin type a
225943|NCT02784262|Block|block
225944|NCT02784262|Sphenopalatine Ganglion|sphenopalatine ganglion
225945|NCT02784249|Glaucoma|glaucoma
225946|NCT02784249|glaucoma surgery|glaucoma surgery
225947|NCT02784249|ab interno|ab interno
225948|NCT02784223|F18-choline|f18-choline
225949|NCT02784223|Surgery|surgery
225950|NCT02784223|Indeterminate|indeterminate
225951|NCT02784223|Thyroid node|thyroid node
225952|NCT02784210|Multiple Sclerosis|multiple sclerosis
225953|NCT02784210|Corticosteroids|corticosteroids
225954|NCT02784197|coronary angiography|coronary angiography
225955|NCT02784197|ventricular ejection fraction|ventricular ejection fraction
225956|NCT02784197|coronary artery disease|coronary artery disease
288903|NCT02410733|RNA|rna
225957|NCT02784184|Hypothalamic-pituitary-gonadal axis|hypothalamic-pituitary-gonadal axis
225958|NCT02784158|Non-small cell lung cancer|non-small cell lung cancer
225959|NCT02784158|Non-small cell lung carcinoma|non-small cell lung carcinoma
225960|NCT02784158|Epithelial lung cancer|epithelial lung cancer
225961|NCT02784158|Squamous cell carcinoma|squamous cell carcinoma
225962|NCT02784158|Large cell carcinoma|large cell carcinoma
225963|NCT02784158|Adenocarcinoma|adenocarcinoma
225964|NCT02784158|Anaplastic lymphoma kinase (ALK)|anaplastic lymphoma kinase (alk)
225965|NCT02784158|Carcinoma|carcinoma
225966|NCT02784158|Advanced Cancers|advanced cancers
225967|NCT02784158|Brigatinib|brigatinib
225968|NCT02784158|AP26113|ap26113
225969|NCT02784119|temporary porto-caval shunt|temporary porto-caval shunt
225970|NCT02784119|liver graft|liver graft
225971|NCT02784119|extended criteria donor|extended criteria donor
225972|NCT02784106|Rheumatoid Arthritis|rheumatoid arthritis
225973|NCT02784106|M2951|m2951
225974|NCT02784106|Bruton's Tyrosine Kinase (BTK)|bruton's tyrosine kinase (btk)
225975|NCT02784093|Chronic Constipation|chronic constipation
225976|NCT02784093|Fecal impaction|fecal impaction
225977|NCT02784093|Gastrografin|gastrografin
225978|NCT02784093|Randomized Controlled Trial|randomized controlled trial
225979|NCT02784080|Liver Transplantation|liver transplantation
225980|NCT02784080|HLA alloantibodies|hla alloantibodies
225981|NCT02784080|donor specific antibodies|donor specific antibodies
225982|NCT02784080|Mortality|mortality
225983|NCT02784080|Re-transplantation|re-transplantation
225984|NCT02784080|Rejection|rejection
225985|NCT02784080|Acute rejection|acute rejection
225986|NCT02784080|Chronic rejection|chronic rejection
225987|NCT02784080|Biliary complications|biliary complications
225988|NCT02784080|Biliary stricture|biliary stricture
225989|NCT02784080|Arterial thrombosis|arterial thrombosis
225990|NCT02784080|Arterial stenosis|arterial stenosis
225991|NCT02784080|Portal vein thrombosis|portal vein thrombosis
225992|NCT02784080|Fibrosis|fibrosis
225993|NCT02784080|Single antigen bead|single antigen bead
225994|NCT02784080|Cross-match|cross-match
225995|NCT02784041|knee arthroplasty|knee arthroplasty
225996|NCT02784041|adductor canal block|adductor canal block
225997|NCT02784041|periarticular infiltration|periarticular infiltration
225998|NCT02784028|Peritoneal Carcinomatosis|peritoneal carcinomatosis
225999|NCT02784028|SGM-101|sgm-101
226000|NCT02783989|Endothelial function|endothelial function
226001|NCT02783989|Inflammation|inflammation
226002|NCT02783989|Genes related to vascular risk|genes related to vascular risk
226003|NCT02783963|Coronary Artery Disease|coronary artery disease
226004|NCT02783963|Coronary Thrombosis|coronary thrombosis
226005|NCT02783963|Coronary Stenosis|coronary stenosis
226006|NCT02783963|Tomography, Optical Coherence|tomography, optical coherence
226007|NCT02783963|Magnetic Resonance Imaging|magnetic resonance imaging
226008|NCT02783950|Genomics|genomics
226009|NCT02783950|Adjuvant Treatment|adjuvant treatment
226010|NCT02783937|Premature|premature
226011|NCT02783937|Ovarian|ovarian
226012|NCT02783937|Failure|failure
226013|NCT02783937|Filgrastim|filgrastim
226014|NCT02783924|vitamin D|vitamin d
226015|NCT02783924|genomics|genomics
226016|NCT02783924|proteomics|proteomics
226017|NCT02783924|metabolomics|metabolomics
226018|NCT02783924|adipose tissue|adipose tissue
226019|NCT02783911|Clinical and Radiograph|clinical and radiograph
226020|NCT02783898|pre syncope, palpitations|pre syncope, palpitations
226021|NCT02783859|Children|children
226022|NCT02783859|Anti-Bacterial Agents|anti-bacterial agents
226023|NCT02783859|Indigenous Population|indigenous population
226024|NCT02783859|Hospitals|hospitals
226025|NCT02783846|Propofol|propofol
226026|NCT02783846|Dexmedetomidine|dexmedetomidine
226027|NCT02783846|Dose|dose
226028|NCT02783846|Bispectral index monitor|bispectral index monitor
226029|NCT02783833|malaria, induced blood stage model challenge|malaria, induced blood stage model challenge
226030|NCT02783820|malaria, single ascending dose,|malaria, single ascending dose,
226031|NCT02783794|BP-C1|bp-c1
226032|NCT02783794|Cis-coordinated complexes of platinum(II) with polymer of benzene polycarboxylic acids derived from lignin|cis-coordinated complexes of platinum(ii) with polymer of benzene polycarboxylic acids derived from lignin
226033|NCT02783794|Benzene polycarboxylic acids complex with cis-diammineplatinum(II)|benzene polycarboxylic acids complex with cis-diammineplatinum(ii)
226034|NCT02783794|Metastatic Breast Cancer|metastatic breast cancer
226035|NCT02783794|Platinum analogue|platinum analogue
226036|NCT02783794|Metronomic chemotherapy|metronomic chemotherapy
226037|NCT02783794|Breast cancer|breast cancer
226038|NCT02783794|Cisplatin|cisplatin
226137|NCT02783339|Stent assisted coiling|stent assisted coiling
226138|NCT02783326|Chronic Disease Obstructive Pulmonary|chronic disease obstructive pulmonary
226039|NCT02783794|Cis-diammineplatinum(II) complexed with a polymer containing benzene polycarboxylic acids derived from lignin|cis-diammineplatinum(ii) complexed with a polymer containing benzene polycarboxylic acids derived from lignin
226040|NCT02783781|Cardiac surgery (extracorporeal circulation; beating heart)|cardiac surgery (extracorporeal circulation; beating heart)
226041|NCT02783781|Biological data|biological data
289056|NCT02409914|PET|pet
226042|NCT02783781|Preoperative biological variables|preoperative biological variables
226043|NCT02783781|EuroSCORE II|euroscore ii
226044|NCT02783781|Risk prediction|risk prediction
226045|NCT02783768|E-cigarettes|e-cigarettes
226046|NCT02783768|COPD|copd
226047|NCT02783755|pain|pain
226048|NCT02783755|coping|coping
226049|NCT02783755|mhealth|mhealth
226050|NCT02783755|Breast cancer|breast cancer
226051|NCT02783742|provider-patient communication|provider-patient communication
226052|NCT02783742|coaching|coaching
226053|NCT02783742|feedback|feedback
226054|NCT02783742|burnout|burnout
226055|NCT02783729|E2006|e2006
226056|NCT02783729|Lemborexant|lemborexant
226057|NCT02783729|zolpidem tartrate|zolpidem tartrate
226058|NCT02783729|Ambien CR|ambien cr
226059|NCT02783729|Insomnia|insomnia
226060|NCT02783703|Hyperinsulinemia|hyperinsulinemia
226061|NCT02783664|Breast Cancer|breast cancer
226062|NCT02783664|BRCA1|brca1
226063|NCT02783664|BRCA2|brca2
226064|NCT02783664|stress|stress
226065|NCT02783664|gene testing|gene testing
226066|NCT02783664|genetic screening|genetic screening
226067|NCT02783664|psychological support|psychological support
226068|NCT02783664|State-Trait Anxiety Inventory|state-trait anxiety inventory
226069|NCT02783664|Cancer Worry Scale|cancer worry scale
226070|NCT02783664|Health Anxiety Inventory|health anxiety inventory
226071|NCT02783664|gene mutations|gene mutations
226072|NCT02783625|Duvelisib|duvelisib
226073|NCT02783625|Romidepsin|romidepsin
226074|NCT02783625|Bortezomib|bortezomib
226075|NCT02783625|16-042|16-042
226076|NCT02783573|dementia|dementia
226077|NCT02783573|brain diseases|brain diseases
226078|NCT02783573|neurodegenerative diseases|neurodegenerative diseases
226079|NCT02783573|central nervous system diseases|central nervous system diseases
226080|NCT02783573|nervous system diseases|nervous system diseases
226081|NCT02783573|mental disorders|mental disorders
226082|NCT02783573|delirium, dementia, amnestic, cognitive|delirium, dementia, amnestic, cognitive
226083|NCT02783573|tauopathies|tauopathies
226084|NCT02783573|memory|memory
226085|NCT02783573|amyloid|amyloid
226086|NCT02783560|Sleep|sleep
226087|NCT02783560|Electrodermal Activity|electrodermal activity
226088|NCT02783560|Mealtimes|mealtimes
226089|NCT02783534|Acupuncture|acupuncture
226090|NCT02783534|Primary Dysmenorrhea|primary dysmenorrhea
226091|NCT02783534|Randomized Controlled Trial|randomized controlled trial
226092|NCT02783534|Placebo Effect|placebo effect
226093|NCT02783521|Hispanic men|hispanic men
226094|NCT02783521|Weight loss|weight loss
226095|NCT02783521|Diet|diet
226096|NCT02783521|Physical activity|physical activity
226097|NCT02783521|Intervention|intervention
226098|NCT02783508|Labor analgesia|labor analgesia
226099|NCT02783508|Nitrous Oxide|nitrous oxide
226100|NCT02783508|Meperidine|meperidine
226101|NCT02783508|Multiparous|multiparous
226102|NCT02783508|Visual analogue scale|visual analogue scale
226103|NCT02783495|glioma|glioma
226104|NCT02783495|neurocognitive|neurocognitive
226105|NCT02783495|quality of life|quality of life
226106|NCT02783456|renal hemodynamic|renal hemodynamic
226107|NCT02783456|central hemodynamic|central hemodynamic
226108|NCT02783456|pilot study|pilot study
226109|NCT02783456|flight noise|flight noise
226110|NCT02783456|healthy participant|healthy participant
226111|NCT02783456|renal plasma flow|renal plasma flow
226112|NCT02783456|filtration fraction|filtration fraction
226113|NCT02783456|renal vascular resistance|renal vascular resistance
226114|NCT02783456|calculated intra glomerular pressure|calculated intra glomerular pressure
226115|NCT02783443|Anesthesia, glycocalyx, perfused boundary region|anesthesia, glycocalyx, perfused boundary region
226116|NCT02783430|Ketamine|ketamine
226117|NCT02783430|Palliative care|palliative care
226118|NCT02783430|Supportive care|supportive care
226119|NCT02783430|Early palliative care|early palliative care
226120|NCT02783430|Fast acting antidepressant|fast acting antidepressant
226121|NCT02783430|End of life care|end of life care
226122|NCT02783430|Cancer|cancer
226123|NCT02783430|psychological distress|psychological distress
226124|NCT02783430|antidepressant|antidepressant
226125|NCT02783430|serotonin norepinephrine reuptake inhibitors|serotonin norepinephrine reuptake inhibitors
226126|NCT02783417|Visceral fat|visceral fat
226127|NCT02783404|bacteraemia|bacteraemia
226128|NCT02783404|endocarditis|endocarditis
226129|NCT02783404|antibiotic prophylaxis|antibiotic prophylaxis
226130|NCT02783404|dentistry|dentistry
226131|NCT02783378|impedance metry|impedance metry
226132|NCT02783378|gaviscon|gaviscon
226133|NCT02783339|Next Generation Neuroform Stent System|next generation neuroform stent system
226134|NCT02783339|Intracranial|intracranial
226135|NCT02783339|Stent system|stent system
226136|NCT02783339|Saccular aneurysm|saccular aneurysm
226345|NCT02782078|clindamycin|clindamycin
226139|NCT02783326|Rehabilitation|rehabilitation
226140|NCT02783326|Physical Therapy|physical therapy
226141|NCT02783313|pathogen inactivation|pathogen inactivation
226142|NCT02783313|platelets|platelets
226143|NCT02783300|GSK3326595|gsk3326595
226144|NCT02783300|glioblastoma multiforme (GBM)|glioblastoma multiforme (gbm)
226145|NCT02783300|Solid tumor|solid tumor
226146|NCT02783300|Non-Hodgkin's lymphoma (NHL)|non-hodgkin's lymphoma (nhl)
226147|NCT02783300|breast cancer|breast cancer
226148|NCT02783300|bladder cancer|bladder cancer
226149|NCT02783300|dose escalation|dose escalation
226150|NCT02783287|Exercise adherence|exercise adherence
226151|NCT02783287|Medication adherence|medication adherence
226152|NCT02783287|Mobile health|mobile health
226153|NCT02783287|Cardiac rehabilitation|cardiac rehabilitation
226154|NCT02783261|radioembolization|radioembolization
226155|NCT02783261|hypertrophy|hypertrophy
226156|NCT02783261|Y90|y90
226157|NCT02783248|Percutaneous mitral commissurotomy|percutaneous mitral commissurotomy
226158|NCT02783248|Mitral Stenosis|mitral stenosis
226159|NCT02783235|VIA|via
226160|NCT02783235|Cervical Cancer|cervical cancer
226161|NCT02783235|Training|training
226162|NCT02783222|breast cancer|breast cancer
226163|NCT02783222|elderly patients|elderly patients
226164|NCT02783170|Tdap vaccine|tdap vaccine
226165|NCT02783170|Flu vaccine|flu vaccine
226166|NCT02783170|vaccines in pregnancy|vaccines in pregnancy
226167|NCT02783170|immunizations in pregnancy|immunizations in pregnancy
226168|NCT02783170|Whooping Cough|whooping cough
226169|NCT02783170|Pertussis|pertussis
226170|NCT02783170|Influenza|influenza
226171|NCT02783157|Autonomic|autonomic
226172|NCT02783157|Vagal nerve stimulation|vagal nerve stimulation
226173|NCT02783157|Postoperative atrial fibrillation|postoperative atrial fibrillation
226174|NCT02783144|Analgesia|analgesia
226175|NCT02783144|Dexamethasone|dexamethasone
226176|NCT02783144|Levobupivacaine|levobupivacaine
226177|NCT02783144|Ultrasound-guided|ultrasound-guided
226178|NCT02783144|Tranversus Abdominis|tranversus abdominis
226179|NCT02783131|inventions|inventions
226180|NCT02783131|Simulation Training|simulation training
226181|NCT02783131|Postpartum Haemorrhage|postpartum haemorrhage
226182|NCT02783131|Non Technical Skills|non technical skills
226183|NCT02783131|teamwork|teamwork
226184|NCT02783131|Crew Resource Management, Healthcare|crew resource management, healthcare
226185|NCT02783118|Depression|depression
226186|NCT02783118|Prevention|prevention
226187|NCT02783118|CBT|cbt
226188|NCT02783118|Smartphone app|smartphone app
226189|NCT02783105|Music therapy|music therapy
226190|NCT02783105|Paroxysmal sympathetic hyperactivity|paroxysmal sympathetic hyperactivity
226191|NCT02783105|Traumatic brain injury|traumatic brain injury
226192|NCT02783079|Breast Cancer|breast cancer
226193|NCT02783079|Prostate Cancer|prostate cancer
226194|NCT02783079|Colon Cancer|colon cancer
226195|NCT02783079|Lung Cancer|lung cancer
226196|NCT02783079|Gynecologic Cancer|gynecologic cancer
226197|NCT02783014|overactive bladder|overactive bladder
226198|NCT02782988|Olfaction|olfaction
226199|NCT02782988|CMV|cmv
226200|NCT02782962|nystagmus|nystagmus
226201|NCT02782962|vertigo|vertigo
226202|NCT02782962|unsteadiness|unsteadiness
226203|NCT02782962|emergency duplex ultrasonography|emergency duplex ultrasonography
226204|NCT02782936|Work of Breathing; Hypoxemia; Respiratory Acidosis; Respiratory effort|work of breathing; hypoxemia; respiratory acidosis; respiratory effort
226205|NCT02782923|Cervical Spine Surgery|cervical spine surgery
226206|NCT02782923|Simulation|simulation
226207|NCT02782897|intravenous immunoglobulin|intravenous immunoglobulin
226208|NCT02782897|intracerebral hemorrhage|intracerebral hemorrhage
226209|NCT02782897|perihematomal edema|perihematomal edema
226210|NCT02782884|post-operative pain|post-operative pain
226211|NCT02782871|Transfer|transfer
226212|NCT02782871|Intra-hospital|intra-hospital
226213|NCT02782871|Ventilator|ventilator
226214|NCT02782871|Manual ventilation|manual ventilation
226215|NCT02782871|Head and neck surgery|head and neck surgery
226216|NCT02782858|Multiple Sclerosis|multiple sclerosis
226217|NCT02782858|Multiple Sclerosis Relapsing-Remitting|multiple sclerosis relapsing-remitting
226218|NCT02782858|GNbAC1|gnbac1
226219|NCT02782858|MRI|mri
226220|NCT02782858|Monoclonal antibody|monoclonal antibody
226221|NCT02782858|Multiple Sclerosis associated retrovirus MSRV|multiple sclerosis associated retrovirus msrv
226222|NCT02782858|MS|ms
226223|NCT02782858|RRMS|rrms
226224|NCT02782858|HERV-W|herv-w
226225|NCT02782832|Neuromuscular|neuromuscular
226226|NCT02782832|Blockade|blockade
226227|NCT02782832|Surgery|surgery
226228|NCT02782819|Shock resuscitation|shock resuscitation
226229|NCT02782819|colloid|colloid
226230|NCT02782819|crystalloid|crystalloid
226231|NCT02782806|Noninvasive|noninvasive
226232|NCT02782806|Pulse|pulse
226233|NCT02782806|CO-Oximeter|co-oximeter
226234|NCT02782806|Validation|validation
226235|NCT02782793|Endoscopic|endoscopic
226236|NCT02782793|Mucosal|mucosal
226237|NCT02782793|Resection|resection
226238|NCT02782780|insomnia|insomnia
226239|NCT02782780|insomnia disorder|insomnia disorder
226240|NCT02782780|Gulf War Illness|gulf war illness
226241|NCT02782780|Chronic Multisymptom Illness|chronic multisymptom illness
226242|NCT02782728|intimate partner violence|intimate partner violence
226243|NCT02782728|reproductive coercion|reproductive coercion
226244|NCT02782728|women's health|women's health
226245|NCT02782728|relationship abuse|relationship abuse
226246|NCT02782702|Botulism Toxin|botulism toxin
226247|NCT02782663|Crohn's Disease|crohn's disease
226248|NCT02782663|Efficacy|efficacy
226249|NCT02782663|Safety|safety
226250|NCT02782663|Tolerability|tolerability
226251|NCT02782663|ABT-494|abt-494
226252|NCT02782650|Limits|limits
226253|NCT02782650|Prenatal Counseling|prenatal counseling
226254|NCT02782650|Decision-making|decision-making
226255|NCT02782650|Foetal Complications|foetal complications
226256|NCT02782650|Counseling|counseling
226257|NCT02782650|Viability|viability
226258|NCT02782637|limits of viability|limits of viability
226259|NCT02782637|Prenatal Counseling|prenatal counseling
226260|NCT02782637|Decision-making|decision-making
226261|NCT02782637|Viability|viability
226262|NCT02782637|Counseling|counseling
226263|NCT02782611|Happiness|happiness
226264|NCT02782611|Subjective Well-Being|subjective well-being
226265|NCT02782611|Psychological Flourishing|psychological flourishing
226266|NCT02782611|Well-Being|well-being
226267|NCT02782611|Health|health
226268|NCT02782611|Behavioral Change|behavioral change
226269|NCT02782611|Life Satisfaction|life satisfaction
226270|NCT02782611|Affect|affect
226271|NCT02782611|Emotion|emotion
226272|NCT02782611|Goals|goals
226273|NCT02782611|Meaning in Life|meaning in life
226274|NCT02782598|Negative|negative
226275|NCT02782598|Atrioventricular|atrioventricular
226276|NCT02782598|Hysteresis|hysteresis
226277|NCT02782598|Cardiac Resynchronization|cardiac resynchronization
226278|NCT02782598|MultiPoint|multipoint
226279|NCT02782585|neck pain|neck pain
226280|NCT02782585|Manual therapy|manual therapy
226281|NCT02782585|psychological interaction|psychological interaction
226282|NCT02782572|Exercise|exercise
226283|NCT02782572|Cardiac Rehabilitation|cardiac rehabilitation
226284|NCT02782572|Non-invasive ventilation|non-invasive ventilation
226285|NCT02782520|Cardiopulmonary bypass|cardiopulmonary bypass
226286|NCT02782520|Swan Ganz|swan ganz
226287|NCT02782520|Fluid expansion|fluid expansion
226288|NCT02782520|hypertonic saline solution|hypertonic saline solution
226289|NCT02782507|pilot study|pilot study
226290|NCT02782507|CBT trial|cbt trial
226291|NCT02782494|Latent tuberculosis infection, dialysis|latent tuberculosis infection, dialysis
226292|NCT02782468|Drug Therapy|drug therapy
226293|NCT02782442|cognitive training|cognitive training
226294|NCT02782429|ketamine|ketamine
226295|NCT02782429|Cardiac Surgery|cardiac surgery
226296|NCT02782429|Neurocognitive Disorders|neurocognitive disorders
226297|NCT02782416|Renal|renal
226298|NCT02782416|Latent|latent
226299|NCT02782416|Tuberculosis|tuberculosis
226300|NCT02782390|Stainless dental crown|stainless dental crown
226301|NCT02782390|Composite Resin|composite resin
226302|NCT02782390|Primary teeth|primary teeth
226303|NCT02782377|Faecal Incontinence|faecal incontinence
226304|NCT02782377|Obstructive Defaecation|obstructive defaecation
226305|NCT02782377|Rectal Prolapse|rectal prolapse
226306|NCT02782364|Faecal Incontinence|faecal incontinence
226307|NCT02782338|warfarin|warfarin
226308|NCT02782338|Voltaren eye drops|voltaren eye drops
226310|NCT02782312|Bronchiectasis|bronchiectasis
226311|NCT02782312|ICS+LABA|ics+laba
226312|NCT02782299|Decision aid|decision aid
226313|NCT02782299|Shared decision making|shared decision making
226314|NCT02782299|Older adult patients|older adult patients
226315|NCT02782299|Distal radius fracture|distal radius fracture
226316|NCT02782286|ketorolac|ketorolac
226317|NCT02782286|pain relieve|pain relieve
226318|NCT02782286|morphine|morphine
226319|NCT02782273|ketorolac|ketorolac
226320|NCT02782273|pain relieve|pain relieve
226321|NCT02782273|morphine|morphine
226322|NCT02782221|lipolysis|lipolysis
226323|NCT02782221|ATGL|atgl
226324|NCT02782182|Pancreatic ductal adenocarcinoma|pancreatic ductal adenocarcinoma
226325|NCT02782182|FOLFIRINOX|folfirinox
226326|NCT02782182|resectable pancreatic cancer|resectable pancreatic cancer
226327|NCT02782156|Process Evaluation|process evaluation
226328|NCT02782156|alcohol withdrawal syndrome|alcohol withdrawal syndrome
226329|NCT02782143|delirium detection|delirium detection
226330|NCT02782130|HIV|hiv
226331|NCT02782130|YMSM|ymsm
226332|NCT02782130|Trans women|trans women
226333|NCT02782130|ART Adherence|art adherence
226334|NCT02782130|Intervention|intervention
226335|NCT02782104|Depressive Disorder, Treatment-Resistant|depressive disorder, treatment-resistant
226336|NCT02782104|Esketamine|esketamine
226337|NCT02782104|JNJ-54135419|jnj-54135419
226338|NCT02782091|MET|met
226339|NCT02782091|Prognosis|prognosis
226340|NCT02782091|Cognition|cognition
226341|NCT02782091|Ecological|ecological
226342|NCT02782091|Executive function|executive function
226343|NCT02782078|osteoarticular infection|osteoarticular infection
226344|NCT02782078|rifampicin|rifampicin
226346|NCT02782078|enzymatic induction|enzymatic induction
226347|NCT02782078|antibiotherapy resistance|antibiotherapy resistance
289405|NCT02407782|Scabies|scabies
226348|NCT02782065|validation|validation
226349|NCT02782065|pediatrics|pediatrics
226350|NCT02782065|asthma severity|asthma severity
226351|NCT02782052|pulmonary arterial hypertension|pulmonary arterial hypertension
226352|NCT02782052|spirometry|spirometry
226353|NCT02782052|dynamic lung hyperinflation|dynamic lung hyperinflation
226354|NCT02782052|bronchodilator|bronchodilator
226355|NCT02782052|dyspnoea|dyspnoea
226356|NCT02782052|Idiopathic|idiopathic
226357|NCT02782052|heritable|heritable
226358|NCT02782052|PAH|pah
226359|NCT02782026|pulmonary hypertension|pulmonary hypertension
226360|NCT02782026|early detection|early detection
226361|NCT02782013|community acquired pneumonia|community acquired pneumonia
226362|NCT02782013|CAP|cap
226363|NCT02782013|disease progression|disease progression
226364|NCT02782000|dementia|dementia
226365|NCT02782000|early recognition|early recognition
226366|NCT02782000|general practitioner|general practitioner
226367|NCT02782000|training|training
226368|NCT02781935|unresectable colorectal liver metastasis|unresectable colorectal liver metastasis
226369|NCT02781935|diffusion weighted MRI|diffusion weighted mri
226370|NCT02781935|disappearing liver metastasis|disappearing liver metastasis
226371|NCT02781922|cardiac stem/progenitor cells|cardiac stem/progenitor cells
226372|NCT02781922|autologous cell therapy|autologous cell therapy
226373|NCT02781922|functional single ventricle|functional single ventricle
226374|NCT02781922|congenital heart disease|congenital heart disease
226375|NCT02781909|NSAIDS|nsaids
226376|NCT02781909|tuberculosis treatment|tuberculosis treatment
226377|NCT02781909|anti-inflammatories|anti-inflammatories
226378|NCT02781909|Host-directed therapies|host-directed therapies
226379|NCT02781909|TB|tb
226380|NCT02781896|TAVI|tavi
226381|NCT02781896|aortic valve bioprothesis|aortic valve bioprothesis
226382|NCT02781896|TAVI simplification|tavi simplification
226383|NCT02781896|aortic stenosis|aortic stenosis
226384|NCT02781896|rapid left ventricular pacing|rapid left ventricular pacing
226385|NCT02781896|TAVR|tavr
226386|NCT02781883|Liposomal Grb-2 treatment of AML or High Risk MDS|liposomal grb-2 treatment of aml or high risk mds
226387|NCT02781883|Liposomal Grb-2 with decitabine for AML or High Risk MDS|liposomal grb-2 with decitabine for aml or high risk mds
226388|NCT02781857|Exhaled Breath|exhaled breath
226389|NCT02781857|Mass Spectrometry|mass spectrometry
226390|NCT02781857|Fingerprinting|fingerprinting
226391|NCT02781818|hidradenitis|hidradenitis
226392|NCT02781818|intralesional|intralesional
226393|NCT02781818|triamcinolone|triamcinolone
226394|NCT02781779|Cardiac Implantable Electronic Device|cardiac implantable electronic device
226395|NCT02781779|Implant|implant
226396|NCT02781766|Haemophilia A|haemophilia a
226397|NCT02781766|prophylaxis|prophylaxis
226398|NCT02781766|thrombin generation assay|thrombin generation assay
226399|NCT02781766|factor VIII|factor viii
226400|NCT02781766|prophylactic therapy|prophylactic therapy
226401|NCT02781740|Continous Positive Airway Pressure|continous positive airway pressure
226402|NCT02781740|CPAP|cpap
226403|NCT02781740|Sham CPAP|sham cpap
226404|NCT02781740|CPAP withdrawal|cpap withdrawal
226405|NCT02781740|suboptimal CPAP|suboptimal cpap
226406|NCT02781727|Human Growth Hormone|human growth hormone
226407|NCT02781727|hGH|hgh
226408|NCT02781727|GHD|ghd
226409|NCT02781727|rHGH|rhgh
226410|NCT02781727|Pediatric Growth Hormone Deficiency|pediatric growth hormone deficiency
226411|NCT02781727|Long Acting Growth Hormone|long acting growth hormone
226412|NCT02781727|Somatropin|somatropin
226413|NCT02781727|Prodrug|prodrug
226414|NCT02781727|Growth Failure|growth failure
226415|NCT02781727|Growth Hormone Replacement Therapy|growth hormone replacement therapy
226416|NCT02781727|Sustained Release|sustained release
226417|NCT02781727|Sustained Release Growth Hormone|sustained release growth hormone
226418|NCT02781727|Growth Hormone Deficiency|growth hormone deficiency
226419|NCT02781714|contraception|contraception
226420|NCT02781714|postpartum period|postpartum period
226421|NCT02781714|mobile health|mobile health
226422|NCT02781714|mHealth|mhealth
226423|NCT02781714|Kenya|kenya
226424|NCT02781714|couples|couples
226425|NCT02781675|Diet|diet
226426|NCT02781675|Mediterranean|mediterranean
226427|NCT02781675|Cholesterol|cholesterol
226428|NCT02781675|Inflammation|inflammation
226429|NCT02781662|Safety|safety
226430|NCT02781662|Hospitalization|hospitalization
226431|NCT02781662|Older Persons|older persons
226432|NCT02781662|High-Risk|high-risk
226433|NCT02781649|Renal|renal
226434|NCT02781649|Transplants|transplants
226435|NCT02781649|Hepatitis C|hepatitis c
226436|NCT02781649|HCV-negative|hcv-negative
226437|NCT02781649|Infected|infected
226438|NCT02781649|Donors|donors
226439|NCT02781636|Efficacy|efficacy
226440|NCT02781636|Implantable|implantable
226441|NCT02781636|Wireless|wireless
226442|NCT02781636|Neuromodulation|neuromodulation
226443|NCT02781636|Device|device
226444|NCT02781636|Tibial|tibial
226445|NCT02781623|Quadriceps|quadriceps
226446|NCT02781623|Tibial Plateau|tibial plateau
226447|NCT02781623|Fracture|fracture
226448|NCT02781610|Cystic fibrosis|cystic fibrosis
226449|NCT02781610|Pulmonary exacerbation|pulmonary exacerbation
226450|NCT02781610|Antibiotic|antibiotic
226451|NCT02781610|Treatment duration|treatment duration
226452|NCT02781610|Lung infection|lung infection
226453|NCT02781610|Cystic Fibrosis Foundation|cystic fibrosis foundation
226454|NCT02781610|Cystic Fibrosis Foundation National Patient Registry|cystic fibrosis foundation national patient registry
226455|NCT02781597|Hemoptysis|hemoptysis
226456|NCT02781597|Tranexamic acid|tranexamic acid
226457|NCT02781597|VAS score|vas score
226458|NCT02781545|Child Development|child development
226459|NCT02781545|Psychomotor Performance|psychomotor performance
226460|NCT02781545|Newborns|newborns
226462|NCT02781493|Prucalopride|prucalopride
226463|NCT02781493|Polyethylene Glycol|polyethylene glycol
226464|NCT02781493|bowel preparation|bowel preparation
226465|NCT02781467|Acute Myeloid|acute myeloid
226466|NCT02781467|Leukemia|leukemia
226467|NCT02781467|PNK-007|pnk-007
226468|NCT02781467|Human IL-2|human il-2
226469|NCT02781467|RHIL-2|rhil-2
226470|NCT02781467|Fludarabine|fludarabine
226471|NCT02781467|Cyclophosphamide|cyclophosphamide
226472|NCT02781454|SALS|sals
226473|NCT02781454|Mexiletine|mexiletine
226474|NCT02781454|TMS|tms
226475|NCT02781454|NCS|ncs
226476|NCT02781402|Overweight BMI Individuals|overweight bmi individuals
226477|NCT02781402|Normal BMI Individuals|normal bmi individuals
226478|NCT02781402|Recovery Heart Rate|recovery heart rate
226479|NCT02781389|Basal cell carcinoma (BCC)|basal cell carcinoma (bcc)
226480|NCT02781389|advanced BCC (aBCC)|advanced bcc (abcc)
226481|NCT02781376|Primary Care|primary care
226482|NCT02781376|Computer Decision Support System|computer decision support system
226483|NCT02781376|Guidelines|guidelines
226484|NCT02781376|Snoring|snoring
226485|NCT02781363|thoracic ultrasound|thoracic ultrasound
226486|NCT02781363|children|children
226487|NCT02781363|efficacy|efficacy
226488|NCT02781363|emergency service|emergency service
226489|NCT02781350|high fat diet|high fat diet
226490|NCT02781350|insulinogenesis|insulinogenesis
226491|NCT02781350|Fiber|fiber
226492|NCT02781350|inflammation|inflammation
226493|NCT02781324|Ultrasonic Bone Scalpel|ultrasonic bone scalpel
226494|NCT02781324|Adolescent Idiopathic Scoliosis|adolescent idiopathic scoliosis
226495|NCT02781324|Posterior Spinal Fusion|posterior spinal fusion
226496|NCT02781324|Estimated Blood Loss|estimated blood loss
226497|NCT02781272|pelvic mass|pelvic mass
226498|NCT02781272|ovarian cancer|ovarian cancer
226499|NCT02781272|gynecological cancer|gynecological cancer
226500|NCT02781272|risk prediction|risk prediction
226501|NCT02781259|Sentinel Lymph Node Biopsy|sentinel lymph node biopsy
226502|NCT02781259|Fluorescence|fluorescence
226503|NCT02781259|Breast Neoplasms|breast neoplasms
226504|NCT02781259|Indocyanine Green|indocyanine green
226505|NCT02781220|MCI|mci
226506|NCT02781220|Dementia|dementia
226507|NCT02781220|amyloid PET|amyloid pet
226508|NCT02781220|physician diagnosis|physician diagnosis
226509|NCT02781220|Alzheimer's disease|alzheimer's disease
226510|NCT02781220|AD|ad
226511|NCT02781220|PET imaging|pet imaging
226512|NCT02781220|Appropriate Use Criteria|appropriate use criteria
226513|NCT02781220|patient-reported outcomes|patient-reported outcomes
226514|NCT02781220|patient adherence|patient adherence
226515|NCT02781207|syncope|syncope
226516|NCT02781207|point-of-care ultrasound|point-of-care ultrasound
226517|NCT02781181|Stenting|stenting
226518|NCT02781181|Protection device|protection device
226519|NCT02781181|EPD usage|epd usage
226520|NCT02781168|Premature newborn|premature newborn
226521|NCT02781168|Cortisol|cortisol
226522|NCT02781168|Stress|stress
226523|NCT02781155|Health related quality of life|health related quality of life
226524|NCT02781155|Moxibustion|moxibustion
226525|NCT02781155|Cancer|cancer
226526|NCT02781155|Chemotherapy|chemotherapy
226527|NCT02781155|Neutropenia|neutropenia
226528|NCT02781155|Anaemia|anaemia
226529|NCT02781155|Thrombocytopenia|thrombocytopenia
226530|NCT02781155|Self management|self management
226531|NCT02781155|Wellbeing|wellbeing
226532|NCT02781129|Memory|memory
226533|NCT02781129|Responsive Neurostimulator System|responsive neurostimulator system
226534|NCT02781090|HIV|hiv
226535|NCT02781090|Tobacco|tobacco
226536|NCT02781090|Cigarette|cigarette
226537|NCT02781090|Smoking|smoking
226538|NCT02781090|Social Network|social network
226539|NCT02781090|Internet|internet
226540|NCT02781090|Cessation|cessation
226541|NCT02781077|Stroke|stroke
226542|NCT02781077|walking competency|walking competency
226543|NCT02781077|Task-oriented exercise program|task-oriented exercise program
226544|NCT02781077|Exercise intensity|exercise intensity
226545|NCT02781012|Pancreatic Disease|pancreatic disease
226546|NCT02781012|Pancreas|pancreas
226547|NCT02781012|Borderline Resectable|borderline resectable
226548|NCT02781012|Pancreatic Cancer|pancreatic cancer
226549|NCT02781012|Pancreatitis|pancreatitis
226550|NCT02781012|Family history of pancreatic cancer|family history of pancreatic cancer
226551|NCT02781012|Healthy|healthy
226552|NCT02781012|Healthy at risk|healthy at risk
226553|NCT02780999|Osteoarthritis|osteoarthritis
226554|NCT02780999|hand|hand
226555|NCT02780999|orthotic|orthotic
226556|NCT02780999|rehabilitation|rehabilitation
226557|NCT02780986|female entertainment worker|female entertainment worker
226558|NCT02780986|heterosexual men|heterosexual men
226559|NCT02780986|entertainment establishment|entertainment establishment
226560|NCT02780986|condom use|condom use
226561|NCT02780986|sexually transmitted infection|sexually transmitted infection
226562|NCT02780986|Singapore|singapore
226563|NCT02780947|Ventricular tachycardia|ventricular tachycardia
226564|NCT02780947|Ablation|ablation
226565|NCT02780947|Myocardial Infarction|myocardial infarction
226566|NCT02780947|Heart Failure|heart failure
226567|NCT02780934|Pressure Dressing|pressure dressing
226568|NCT02780934|Post-operative Care|post-operative care
226569|NCT02780934|Simple Adhesive Dressing|simple adhesive dressing
226570|NCT02780934|Mohs|mohs
226571|NCT02780921|Prehabilitation|prehabilitation
226572|NCT02780921|Oesophageal cancer|oesophageal cancer
226573|NCT02780921|Gastric cancer|gastric cancer
226574|NCT02780921|Fitness|fitness
226575|NCT02780921|Preconditionning|preconditionning
226576|NCT02780921|two parallel arms|two parallel arms
226577|NCT02780895|Parkinson Disease|parkinson disease
226578|NCT02780895|stereotactic surgery|stereotactic surgery
226579|NCT02780895|human allogeneic fetal derived stem cells|human allogeneic fetal derived stem cells
226580|NCT02780882|Pasireotide|pasireotide
226581|NCT02780882|Ectopic ACTH|ectopic acth
226582|NCT02780882|SOM230|som230
226583|NCT02780882|ectopic ACTH-dependent Cushing's syndrome|ectopic acth-dependent cushing's syndrome
226584|NCT02780856|Caries Activity Demineralisation|caries activity demineralisation
226585|NCT02780856|Demineralisation|demineralisation
226586|NCT02780843|Stroke|stroke
226587|NCT02780843|Tomography, X-Ray Computed|tomography, x-ray computed
226588|NCT02780843|Magnetic Resonance Imaging|magnetic resonance imaging
226589|NCT02780843|Thrombolytic Therapy|thrombolytic therapy
226590|NCT02780830|Lymphoma|lymphoma
226591|NCT02780830|Diffuse Large B-Cell Lymphoma|diffuse large b-cell lymphoma
226592|NCT02780830|non-GCB Diffuse Large B-Cell Lymphoma|non-gcb diffuse large b-cell lymphoma
226593|NCT02780830|Relapsed or Refractory non-GCB Diffuse Large B-Cell Lymphoma|relapsed or refractory non-gcb diffuse large b-cell lymphoma
226594|NCT02780830|Vistusertib|vistusertib
226595|NCT02780830|AZD2014|azd2014
226596|NCT02780830|Ibrutinib|ibrutinib
226597|NCT02780830|Imbruvica|imbruvica
226598|NCT02780791|Infertility|infertility
226599|NCT02780791|Ovarian Failure, Premature|ovarian failure, premature
226600|NCT02780791|Ovarian Follicle|ovarian follicle
226601|NCT02780791|Ovary|ovary
226602|NCT02780791|Tissue Transplantation|tissue transplantation
226603|NCT02780791|Cryopreservation|cryopreservation
226604|NCT02780791|Pelvis|pelvis
226605|NCT02780791|Chemotherapy|chemotherapy
226606|NCT02780791|Pregnancy Rate|pregnancy rate
226607|NCT02780791|Folliculogenesis|folliculogenesis
226608|NCT02780791|Endometrium|endometrium
226609|NCT02780791|Estrogens|estrogens
226610|NCT02780791|Progestins|progestins
226611|NCT02780791|Follicle Stimulating Hormone|follicle stimulating hormone
226612|NCT02780791|Estradiol|estradiol
226613|NCT02780791|Progesterone|progesterone
226614|NCT02780791|Hormones|hormones
226615|NCT02780791|Maturation of Follicles|maturation of follicles
226616|NCT02780791|Pregnant Women|pregnant women
226617|NCT02780791|Premature Menopause|premature menopause
226618|NCT02780791|Ovarian Insufficiency|ovarian insufficiency
226619|NCT02780791|Ovarian Insufficiency, Premature|ovarian insufficiency, premature
226620|NCT02780791|Cytotoxic therapy|cytotoxic therapy
226621|NCT02780791|Fertility Protection|fertility protection
226622|NCT02780791|Reproductive Medicine|reproductive medicine
226623|NCT02780791|Reproductive Techniques|reproductive techniques
226624|NCT02780791|Reproductive Technology|reproductive technology
226625|NCT02780791|Cryotherapy|cryotherapy
226626|NCT02780791|Pregnancy|pregnancy
226627|NCT02780739|Psychological Tests|psychological tests
226628|NCT02780739|Neuropsychological Tests|neuropsychological tests
226629|NCT02780739|Transcranial Direct Current Stimulation|transcranial direct current stimulation
226630|NCT02780739|Exercise|exercise
226631|NCT02780739|Circuit-Based Exercise|circuit-based exercise
226632|NCT02780739|Video Games|video games
226633|NCT02780739|Magnetic Resonance Imaging|magnetic resonance imaging
226634|NCT02780739|Magnetic Resonance Spectroscopy|magnetic resonance spectroscopy
226635|NCT02780739|Cognition|cognition
226636|NCT02780739|Executive Function|executive function
226637|NCT02780739|Learning|learning
226638|NCT02780739|Problem Solving|problem solving
226639|NCT02780739|Transfer (Psychology)|transfer (psychology)
226640|NCT02780739|Decision Making|decision making
226641|NCT02780739|Brain|brain
226642|NCT02780739|Gray Matter|gray matter
226643|NCT02780739|White Matter|white matter
226644|NCT02780726|Peritoneal dialysis|peritoneal dialysis
226645|NCT02780726|Roxadustat|roxadustat
226646|NCT02780726|Renal anemia|renal anemia
226647|NCT02780726|ASP1517|asp1517
226648|NCT02780713|Breast cancer|breast cancer
226649|NCT02780713|Healthy volunteers|healthy volunteers
226650|NCT02780713|Pharmacokinetics|pharmacokinetics
226651|NCT02780713|AZD9496|azd9496
226652|NCT02780713|Safety|safety
226653|NCT02780713|Tolerability|tolerability
226654|NCT02780674|Polymyositis, dermatomyositis, Sjogren's syndrome, SLE, SSc|polymyositis, dermatomyositis, sjogren's syndrome, sle, ssc
226655|NCT02780648|stereotactic radiotherapy|stereotactic radiotherapy
226656|NCT02780648|pancreatic adenocarcinoma|pancreatic adenocarcinoma
226657|NCT02780635|family, caregiving, ptsd, couples|family, caregiving, ptsd, couples
226658|NCT02780609|autologous hematopoietic cell transplantation (HCT)|autologous hematopoietic cell transplantation (hct)
226659|NCT02780609|high-dose melphalan|high-dose melphalan
226660|NCT02780609|selinexor|selinexor
226661|NCT02780596|Infant|infant
226662|NCT02780596|Toddler|toddler
226663|NCT02780596|Primary Care|primary care
226664|NCT02780570|SVPE|svpe
226665|NCT02780570|intravenous immunoglobulin|intravenous immunoglobulin
226666|NCT02780570|plasmapheresis|plasmapheresis
226667|NCT02780557|Vocabulary|vocabulary
226668|NCT02780557|Book reading|book reading
226669|NCT02780557|Infancy|infancy
226670|NCT02780557|Parenting|parenting
226671|NCT02780544|Infant, premature|infant, premature
226672|NCT02780544|Pain|pain
226673|NCT02780544|Stress, physiological|stress, physiological
226674|NCT02780544|Stress, psychological|stress, psychological
226675|NCT02780544|skin-to-skin contact|skin-to-skin contact
226676|NCT02780518|oxygen|oxygen
226677|NCT02780518|carbon dioxide|carbon dioxide
226678|NCT02780492|Duchenne muscular dystrophy|duchenne muscular dystrophy
226679|NCT02780492|Natural history|natural history
226680|NCT02780492|Outcome measures|outcome measures
226681|NCT02780492|North Star Ambulatory Assessment (NSAA)|north star ambulatory assessment (nsaa)
226682|NCT02780492|6 minute walk distance (6MWD)|6 minute walk distance (6mwd)
226683|NCT02780492|Myoset|myoset
226684|NCT02780492|Exon skipping|exon skipping
226685|NCT02780479|Prednisone|prednisone
226686|NCT02780479|Dexamethasone|dexamethasone
226687|NCT02780479|Asthma exacerbation|asthma exacerbation
226688|NCT02780479|Hospitalized|hospitalized
226689|NCT02780466|Septic shock|septic shock
226690|NCT02780466|Endotracheal intubation|endotracheal intubation
226691|NCT02780466|Outcome|outcome
226692|NCT02780440|Post Stroke Recovery|post stroke recovery
226693|NCT02780440|Mirror Therapy|mirror therapy
226694|NCT02780440|Unimanual mirror therapy|unimanual mirror therapy
226695|NCT02780440|Bimanual mirror therapy|bimanual mirror therapy
226696|NCT02780440|Stroke|stroke
226697|NCT02780427|Dose-Response Relationship, Drug|dose-response relationship, drug
226698|NCT02780414|Hypertension|hypertension
226699|NCT02780414|Proteinuria|proteinuria
226700|NCT02780414|Thrombocytopenia|thrombocytopenia
226701|NCT02780414|Renal Insufficiency|renal insufficiency
226702|NCT02780414|Impaired Liver Function|impaired liver function
226703|NCT02780414|Pulmonary Edema|pulmonary edema
226704|NCT02780401|Stage I|stage i
226705|NCT02780401|Stage II|stage ii
226706|NCT02780401|Stage III|stage iii
226707|NCT02780388|MEDI4920, VIB4920, CD40L, RA, rheumatoid arthritis|medi4920, vib4920, cd40l, ra, rheumatoid arthritis
226708|NCT02780375|Transcriptional Responses|transcriptional responses
226709|NCT02780375|Radiation|radiation
226710|NCT02780323|Celecoxib|celecoxib
226711|NCT02780323|CELBESTA|celbesta
226712|NCT02780310|Lenvatinib|lenvatinib
226713|NCT02780310|15-327|15-327
226714|NCT02780297|primary hyperoxaluria|primary hyperoxaluria
226715|NCT02780297|Dent Disease|dent disease
226716|NCT02780297|enteric hyperoxaluria|enteric hyperoxaluria
226717|NCT02780297|cystinuria|cystinuria
226718|NCT02780297|Lowe Syndrome|lowe syndrome
226719|NCT02780297|Adenine phosphoribosyltransferase deficiency|adenine phosphoribosyltransferase deficiency
226720|NCT02780297|PH|ph
226721|NCT02780297|APRTd|aprtd
226722|NCT02780297|APRT|aprt
226723|NCT02780297|hyperoxaluria|hyperoxaluria
226724|NCT02780297|oxalate|oxalate
226725|NCT02780297|oxalosis|oxalosis
226726|NCT02780297|PH type 1|ph type 1
226727|NCT02780297|PH type 2|ph type 2
226728|NCT02780297|PH type 3|ph type 3
226729|NCT02780297|Dents|dents
226730|NCT02780297|Dent|dent
226731|NCT02780297|Dent 1|dent 1
226732|NCT02780297|Dent 2|dent 2
226733|NCT02780297|APRT deficiency|aprt deficiency
226734|NCT02780284|Gut Microbiota|gut microbiota
226735|NCT02780284|Butyrate|butyrate
226736|NCT02780284|Physical activity|physical activity
226737|NCT02780271|Breast Cancer|breast cancer
226738|NCT02780271|Cancer survivor|cancer survivor
226739|NCT02780271|e-communication|e-communication
226740|NCT02780271|diet and physical activity|diet and physical activity
226741|NCT02780271|fruits/vegetables daily servings|fruits/vegetables daily servings
226742|NCT02780271|energy density|energy density
226743|NCT02780245|Caesarean Section|caesarean section
226744|NCT02780245|Tranexamic Acid|tranexamic acid
226745|NCT02780245|Postpartum Hemorrhage|postpartum hemorrhage
226746|NCT02780245|Ecbolics|ecbolics
226747|NCT02780232|Depression|depression
226748|NCT02780232|Adolescence|adolescence
226749|NCT02780232|Prevention|prevention
226750|NCT02780232|Early intervention|early intervention
226751|NCT02780232|E-Mental Health|e-mental health
226752|NCT02780180|Aminopeptidase A inhibitor|aminopeptidase a inhibitor
226753|NCT02780180|Heart Failure|heart failure
226754|NCT02780180|Up-titration|up-titration
226755|NCT02780180|Dose-Response Relationship, Drug|dose-response relationship, drug
226756|NCT02780180|Pharmacokinetics|pharmacokinetics
226757|NCT02780180|Patient Safety|patient safety
226758|NCT02780180|Treatment Efficacy|treatment efficacy
226759|NCT02780167|Phase 2|phase 2
226760|NCT02780167|randomized|randomized
226761|NCT02780167|double-blind|double-blind
226762|NCT02780167|placebo|placebo
226763|NCT02780167|atopic dermatitis|atopic dermatitis
226764|NCT02780167|safety|safety
226765|NCT02780167|efficacy|efficacy
226766|NCT02780167|JAK|jak
226767|NCT02780167|janus kinase|janus kinase
226768|NCT02780167|moderate|moderate
226769|NCT02780167|severe|severe
226770|NCT02780154|7G8 clone|7g8 clone
226771|NCT02780154|NF54 strain|nf54 strain
226772|NCT02780154|Non-immune|non-immune
226773|NCT02780154|PCR|pcr
226774|NCT02780154|PfSPZ Challenge|pfspz challenge
226775|NCT02780154|Plasmodium falciparum|plasmodium falciparum
226776|NCT02780154|qPCR|qpcr
226777|NCT02780154|Sporozoites|sporozoites
226778|NCT02780141|Renal anemia|renal anemia
226779|NCT02780141|Roxadustat|roxadustat
226780|NCT02780141|ASP1517|asp1517
226781|NCT02780141|Hemodialysis|hemodialysis
226782|NCT02780128|neuroblastoma|neuroblastoma
226783|NCT02780128|cancer|cancer
226784|NCT02780128|genetic profiling|genetic profiling
226785|NCT02780128|ceritinib|ceritinib
226786|NCT02780128|ribociclib|ribociclib
226787|NCT02780128|trametinib|trametinib
226788|NCT02780128|HDM201|hdm201
226789|NCT02780102|ADHD|adhd
226790|NCT02780102|Cognitive-motor rehabilitation|cognitive-motor rehabilitation
226791|NCT02780102|Active Control Group|active control group
226792|NCT02780102|Stimulant Medication|stimulant medication
226793|NCT02780089|Metastatic|metastatic
226794|NCT02780089|Unresectable|unresectable
226795|NCT02780063|Dilation|dilation
226796|NCT02780063|Intraocular|intraocular
226797|NCT02780063|Ophthalmology|ophthalmology
226798|NCT02780050|cardiopulmonary resuscitation|cardiopulmonary resuscitation
226799|NCT02780050|manikins|manikins
226800|NCT02780050|physical fitness|physical fitness
226801|NCT02780024|Neo-Adjuvant Metformin|neo-adjuvant metformin
226802|NCT02780024|Neo-Adjuvant Temozolomide|neo-adjuvant temozolomide
226803|NCT02780024|Temozolomide and accelerated hypofractionation|temozolomide and accelerated hypofractionation
226804|NCT02780024|Metformin and accelerated hypofractionation|metformin and accelerated hypofractionation
226805|NCT02780024|Adjuvant Temozolomide|adjuvant temozolomide
226806|NCT02780024|Adjuvant Metformin|adjuvant metformin
226807|NCT02780011|CD30+|cd30+
226808|NCT02780011|Relapsed|relapsed
226809|NCT02780011|Refractory|refractory
226810|NCT02780011|ALCL|alcl
226811|NCT02779985|Lycium Barbarum|lycium barbarum
226812|NCT02779985|Energy expenditure|energy expenditure
226813|NCT02779985|Postprandial metabolism|postprandial metabolism
226814|NCT02779972|Cardiac Physiology|cardiac physiology
226815|NCT02779972|Physiology|physiology
226816|NCT02779933|Hospital-acquired Pneumonia|hospital-acquired pneumonia
226817|NCT02779933|Epidemiology|epidemiology
226818|NCT02779933|Risk Factors|risk factors
226819|NCT02779920|refractory gastroparesis|refractory gastroparesis
226820|NCT02779920|per oral pyloromyotomy|per oral pyloromyotomy
226821|NCT02779907|Paediatric|paediatric
226822|NCT02779907|Malawi|malawi
226823|NCT02779894|Sleep Apnea|sleep apnea
226824|NCT02779894|Communication Based Technology|communication based technology
226825|NCT02779894|ICT|ict
226826|NCT02779868|body composition|body composition
226827|NCT02779868|functional capacity|functional capacity
226828|NCT02779868|quality of life|quality of life
226829|NCT02779855|triple negative breast cancer (TNBC)|triple negative breast cancer (tnbc)
226830|NCT02779855|estrogen receptor|estrogen receptor
226831|NCT02779855|progesterone receptor|progesterone receptor
226832|NCT02779855|invasive ductal carcinoma|invasive ductal carcinoma
226833|NCT02779855|breast cancer tumors|breast cancer tumors
226834|NCT02779816|Diabetes Mellitus|diabetes mellitus
226835|NCT02779816|Arthritis|arthritis
226836|NCT02779790|Systematic Review and Meta-Analysis|systematic review and meta-analysis
226837|NCT02779790|Evidence-Based Medicine|evidence-based medicine
226838|NCT02779790|Evidence-Based Nutrition|evidence-based nutrition
226839|NCT02779790|Clinical Practice Guidelines|clinical practice guidelines
226840|NCT02779790|Liquid Meal Replacements|liquid meal replacements
226841|NCT02779790|Body Weight|body weight
226842|NCT02779790|Systolic Blood Pressure|systolic blood pressure
226843|NCT02779790|Diastolic Blood Pressure|diastolic blood pressure
226844|NCT02779790|Fasting Blood Glucose|fasting blood glucose
226845|NCT02779790|Fasting Blood Insulin|fasting blood insulin
226846|NCT02779790|HbA1c|hba1c
723989|NCT00532480|pictures|pictures
226847|NCT02779790|Total Cholesterol|total cholesterol
226848|NCT02779790|Triglycerides|triglycerides
226849|NCT02779790|LDL-C|ldl-c
226850|NCT02779790|HDL-C|hdl-c
226851|NCT02779790|Controlled Feeding Trials|controlled feeding trials
226852|NCT02779764|Hemodialysis|hemodialysis
226853|NCT02779764|ASP1517|asp1517
226854|NCT02779764|Roxadustat|roxadustat
226855|NCT02779764|Renal anemia|renal anemia
226856|NCT02779725|Symptom Management|symptom management
226857|NCT02779712|Remote ischaemic conditioning|remote ischaemic conditioning
226858|NCT02779686|Macular Degeneration|macular degeneration
226859|NCT02779686|Genetic testing|genetic testing
226860|NCT02779686|Age-Related Macular degeneration|age-related macular degeneration
226861|NCT02779686|Age-Related Maculopathies|age-related maculopathies
226862|NCT02779660|Atrial Fibrillation|atrial fibrillation
226863|NCT02779647|Overweight, obesity, play, physical activity, accelerometry.|overweight, obesity, play, physical activity, accelerometry.
226864|NCT02779608|malignant ascites|malignant ascites
226865|NCT02779582|Progesterone|progesterone
226866|NCT02779582|Menstrual Flow|menstrual flow
226867|NCT02779556|Health Literacy|health literacy
226868|NCT02779556|Diabetes|diabetes
226869|NCT02779543|In lab sleep studies|in lab sleep studies
226870|NCT02779517|upper extremity|upper extremity
226871|NCT02779517|stroke|stroke
226872|NCT02779517|rehabilitation|rehabilitation
226873|NCT02779517|robotics|robotics
226874|NCT02779517|telepresence|telepresence
226875|NCT02779517|elderly|elderly
226876|NCT02779517|aged|aged
226877|NCT02779517|Housing for the elderly|housing for the elderly
226878|NCT02779517|retirement|retirement
226879|NCT02779517|homes for the aged|homes for the aged
226880|NCT02779491|fruit and vegetables|fruit and vegetables
226881|NCT02779491|food intake|food intake
226882|NCT02779491|knowledge|knowledge
226883|NCT02779478|chronic obstructive pulmonary disease (COPD)|chronic obstructive pulmonary disease (copd)
226884|NCT02779478|cavitary|cavitary
226885|NCT02779478|nodular bronchiectatic disease|nodular bronchiectatic disease
226886|NCT02779478|NTM|ntm
226887|NCT02779465|vitamin D treatment|vitamin d treatment
226888|NCT02779465|chronic hepatitis B|chronic hepatitis b
226889|NCT02779452|neurodevelopment|neurodevelopment
226890|NCT02779452|electroencephalography|electroencephalography
226891|NCT02779452|gestational diabetes mellitus|gestational diabetes mellitus
226892|NCT02779452|omega 3 polyunsaturated fatty acids|omega 3 polyunsaturated fatty acids
226893|NCT02779426|Atopic dermatitis|atopic dermatitis
226894|NCT02779426|Text Messages|text messages
226895|NCT02779426|Health literacy|health literacy
226896|NCT02779400|INR|inr
226897|NCT02779400|coagulation|coagulation
226898|NCT02779400|vitamin K antagonist|vitamin k antagonist
226899|NCT02779387|GnRH-a|gnrh-a
226900|NCT02779387|endometriosis|endometriosis
226901|NCT02779387|efficiency|efficiency
226902|NCT02779374|ovarian insufficiency Bone Marrow|ovarian insufficiency bone marrow
226903|NCT02779361|green tea|green tea
226904|NCT02779361|steroid profile|steroid profile
226905|NCT02779348|Nebicapone|nebicapone
226906|NCT02779348|Warfarin|warfarin
226907|NCT02779335|tube-fed|tube-fed
226908|NCT02779335|Formula Tolerance|formula tolerance
226909|NCT02779335|Pediatric Patients|pediatric patients
226910|NCT02779322|gastric bypass|gastric bypass
226911|NCT02779322|hospital charges|hospital charges
226912|NCT02779322|mini gastric bypass|mini gastric bypass
226913|NCT02779309|Frail Older Adults|frail older adults
226914|NCT02779309|Mortality|mortality
226915|NCT02779309|Home Care|home care
226916|NCT02779309|Survival Analysis|survival analysis
226917|NCT02779309|Clinical Prediction Rule|clinical prediction rule
226918|NCT02779296|Cyanoacrylates|cyanoacrylates
226919|NCT02779296|Mammaplasty|mammaplasty
226920|NCT02779296|Mastectomy|mastectomy
226921|NCT02779257|hypoglycemia|hypoglycemia
226922|NCT02779244|Orthopedic|orthopedic
226923|NCT02779244|Post-operative|post-operative
226924|NCT02779244|Weight bearing|weight bearing
226925|NCT02779244|Range of motion|range of motion
226926|NCT02779218|Hemiplegia|hemiplegia
226927|NCT02779205|Cell therapy|cell therapy
226928|NCT02779205|Stromal Cells|stromal cells
226929|NCT02779205|Stem cells|stem cells
226930|NCT02779205|Adipose tissue|adipose tissue
226931|NCT02779205|Children|children
226932|NCT02779192|Acute Noise Induced Hearing Loss|acute noise induced hearing loss
226933|NCT02779192|Prevent Acute Noise Induced Hearing Loss|prevent acute noise induced hearing loss
226934|NCT02779166|hip arthroscopy|hip arthroscopy
226935|NCT02779153|SLE|sle
226936|NCT02779153|H.P. Acthar Gel|h.p. acthar gel
226937|NCT02779140|BoNT|bont
226938|NCT02779140|botulinum|botulinum
226939|NCT02779140|Botulism|botulism
226940|NCT02779140|Clostridium|clostridium
226941|NCT02779140|Neurotoxin|neurotoxin
226942|NCT02779140|NTM-1632|ntm-1632
226943|NCT02779127|Smoking|smoking
226944|NCT02779127|Endothelium|endothelium
226945|NCT02779127|Passive smoking|passive smoking
226946|NCT02779114|Rheumatoid Arthritis|rheumatoid arthritis
226947|NCT02779114|Remission|remission
226948|NCT02779114|Dose reduction|dose reduction
226949|NCT02779101|Central nervous system lymphoma|central nervous system lymphoma
226950|NCT02779101|Pembrolizumab|pembrolizumab
226951|NCT02779088|physical fitness,body composition,sarcopenia|physical fitness,body composition,sarcopenia
226952|NCT02779075|Sleeve Gastrectomy|sleeve gastrectomy
226953|NCT02779075|Roux-en-Y Gastric Bypass|roux-en-y gastric bypass
226954|NCT02779036|Stroke|stroke
226955|NCT02779036|task-oriented home exercise|task-oriented home exercise
226956|NCT02779036|walking competency|walking competency
226957|NCT02779036|Usual Physiotherapy care|usual physiotherapy care
226958|NCT02778997|Shunt|shunt
226959|NCT02778997|CSF|csf
226960|NCT02778997|Dysfunction|dysfunction
226961|NCT02778997|Complication|complication
226962|NCT02778984|Anesthesia|anesthesia
226963|NCT02778984|facial mask|facial mask
226964|NCT02778971|MCI|mci
226965|NCT02778971|Dementia|dementia
226966|NCT02778971|amyloid PET|amyloid pet
226967|NCT02778971|physician diagnosis|physician diagnosis
226968|NCT02778971|Alzheimer's disease|alzheimer's disease
226969|NCT02778971|AD|ad
226970|NCT02778971|PET imaging|pet imaging
226971|NCT02778971|Appropriate Use Criteria|appropriate use criteria
226972|NCT02778971|patient-reported outcomes|patient-reported outcomes
226973|NCT02778958|bariatric surgery|bariatric surgery
226974|NCT02778958|morbid obesity|morbid obesity
226975|NCT02778958|nonopioid analgesics|nonopioid analgesics
226976|NCT02778945|spinal surgery|spinal surgery
226977|NCT02778945|sugammadex|sugammadex
226978|NCT02778945|deep neuromuscular block|deep neuromuscular block
226979|NCT02778945|shear wave elastography|shear wave elastography
226980|NCT02778945|neuromuscular monitoring|neuromuscular monitoring
226981|NCT02778919|Endometriosis|endometriosis
226982|NCT02778906|Abatacept|abatacept
226983|NCT02778893|Conmana|conmana
226984|NCT02778893|Thalidomide|thalidomide
226985|NCT02778893|NSCLC|nsclc
226986|NCT02778893|EGFR mutation|egfr mutation
226987|NCT02778854|NSCLC|nsclc
226988|NCT02778854|liquid biopsy|liquid biopsy
226989|NCT02778854|driver mutation|driver mutation
226990|NCT02778828|linezolide|linezolide
226991|NCT02778828|tuberculosis|tuberculosis
226992|NCT02778828|MDR-TB|mdr-tb
226993|NCT02778802|Pulmonary Hypertension|pulmonary hypertension
226994|NCT02778802|Emphysema|emphysema
226995|NCT02778802|COPD|copd
226996|NCT02778776|Metformin|metformin
226997|NCT02778776|Agave Inulin|agave inulin
226998|NCT02778776|METS|mets
226999|NCT02778776|Inflammation parameters|inflammation parameters
227000|NCT02778776|Urodynamic parameters|urodynamic parameters
227001|NCT02778776|Prostate hyperplasia|prostate hyperplasia
227002|NCT02778763|Breast cancer|breast cancer
227004|NCT02778763|Neutropenia|neutropenia
227005|NCT02778750|Cystic Fibrosis (CF)|cystic fibrosis (cf)
227006|NCT02778737|ACT, CBT, Randomized controlled trial, Chronic Pain|act, cbt, randomized controlled trial, chronic pain
227007|NCT02778711|anti-IL-17|anti-il-17
227008|NCT02778711|secukinumab|secukinumab
227009|NCT02778672|bacterial pneumonia|bacterial pneumonia
227010|NCT02778672|children|children
227011|NCT02778672|diagnosing pneumonia|diagnosing pneumonia
227012|NCT02778672|thermal imaging|thermal imaging
227013|NCT02778633|Volume responsiveness mean systemic filling pressure|volume responsiveness mean systemic filling pressure
227014|NCT02778620|Volume responsiveness mean systemic filling pressure|volume responsiveness mean systemic filling pressure
227015|NCT02778607|Atypical Parkinsonism Syndrome (APS)|atypical parkinsonism syndrome (aps)
227016|NCT02778581|Cognitive Impairment, Alzheimer's Disease, Vegetal Oil|cognitive impairment, alzheimer's disease, vegetal oil
227017|NCT02778542|Automated Hovering|automated hovering
227018|NCT02778542|Remote Monitoring|remote monitoring
227019|NCT02778542|Bidirectional Text Messaging|bidirectional text messaging
227020|NCT02778529|stroke|stroke
227021|NCT02778529|amputees|amputees
227022|NCT02778529|spinal cord injuries|spinal cord injuries
227023|NCT02778529|cerebral palsy|cerebral palsy
227024|NCT02778529|robotics|robotics
227025|NCT02778529|rehabilitation|rehabilitation
227026|NCT02778503|Tooth, Deciduous|tooth, deciduous
227027|NCT02778503|Dentition, Permanent|dentition, permanent
227028|NCT02778503|Dental Atraumatic Restorative Treatment|dental atraumatic restorative treatment
227029|NCT02778503|Glass Ionomer Cements|glass ionomer cements
227030|NCT02778503|Dental Caries|dental caries
227031|NCT02778490|sleeve gastrectomy, bariatric surgery|sleeve gastrectomy, bariatric surgery
227032|NCT02778464|Inflammatory Bowel Disease|inflammatory bowel disease
227033|NCT02778464|Pregnancy|pregnancy
227034|NCT02778464|Stool markers|stool markers
227035|NCT02778464|Calprotectin|calprotectin
227036|NCT02778464|Faecal S100A12 (f-SA12)|faecal s100a12 (f-sa12)
227037|NCT02778464|Faecal calprotectin (f-Cp)|faecal calprotectin (f-cp)
227038|NCT02778425|partial splenic embolization|partial splenic embolization
227039|NCT02778412|Thyroid cancer|thyroid cancer
227040|NCT02778412|Thyroid nodules|thyroid nodules
227041|NCT02778412|Thyroid neoplasia|thyroid neoplasia
227042|NCT02778412|Thyroiditis|thyroiditis
227043|NCT02778399|Pelvic Pain|pelvic pain
227044|NCT02778399|Endometriosis|endometriosis
227045|NCT02778399|Dysmenorrhea|dysmenorrhea
227046|NCT02778399|Dyspareunia|dyspareunia
227047|NCT02778360|Attention deficit|attention deficit
227048|NCT02778360|Neurofeedback|neurofeedback
227049|NCT02778360|ADHD|adhd
227050|NCT02778360|Methylphenidate|methylphenidate
227051|NCT02778347|Palliative care|palliative care
227052|NCT02778347|Need assessment|need assessment
227053|NCT02778347|Tools|tools
227054|NCT02778347|Validity|validity
227055|NCT02778347|Quality of care|quality of care
227056|NCT02778308|Gallbladder cancer, adjuvant chemotherapy, gemcitabine|gallbladder cancer, adjuvant chemotherapy, gemcitabine
227057|NCT02778295|Fabry Disease|fabry disease
227058|NCT02778295|Biomarker|biomarker
227059|NCT02778269|ECG|ecg
227060|NCT02778269|CGM|cgm
227061|NCT02778269|Hypoglycaemia|hypoglycaemia
227062|NCT02778269|Sudden Cardiac Death|sudden cardiac death
227063|NCT02778256|depression, bipolar disorder|depression, bipolar disorder
227064|NCT02778230|fiber|fiber
227065|NCT02778230|gastrointestinal|gastrointestinal
227066|NCT02778230|microbiota|microbiota
227067|NCT02778191|Head and neck squamous cell carcinoma|head and neck squamous cell carcinoma
227068|NCT02778191|cisplatin|cisplatin
227069|NCT02778191|carboplatin|carboplatin
227070|NCT02778191|5-fluorouracil|5-fluorouracil
227071|NCT02778087|motor recovery|motor recovery
227072|NCT02778087|mirror therapy|mirror therapy
227073|NCT02778087|upper extremity|upper extremity
227074|NCT02778074|Internet Cognitive Behavioural Therapy|internet cognitive behavioural therapy
227075|NCT02778061|Intra Uterine Ball|intra uterine ball
227076|NCT02778061|IUD|iud
227077|NCT02778061|copper|copper
227078|NCT02778061|contraception|contraception
227079|NCT02778022|Child behavior disorders|child behavior disorders
227080|NCT02778022|Parent child relationship|parent child relationship
227081|NCT02778022|Primary care|primary care
227082|NCT02778009|Medical student|medical student
227083|NCT02778009|Activity Monitor|activity monitor
227084|NCT02778009|Medical school|medical school
227085|NCT02778009|Fitness|fitness
227086|NCT02777996|screening|screening
227087|NCT02777983|patient education|patient education
227088|NCT02777983|low back pain|low back pain
227089|NCT02777983|technology|technology
227090|NCT02777970|Acute pain|acute pain
227091|NCT02777970|Acute moderate to severe pain|acute moderate to severe pain
227092|NCT02777970|Postoperative pain|postoperative pain
227093|NCT02777970|Dexketoprofen Tramadol|dexketoprofen tramadol
227094|NCT02777970|Dexketoprofen trometamol|dexketoprofen trometamol
227095|NCT02777970|Tramadol hydrochloride|tramadol hydrochloride
227096|NCT02777970|Multimodal analgesia|multimodal analgesia
227097|NCT02777970|Third molar extraction|third molar extraction
227098|NCT02777970|Fixed drug combination|fixed drug combination
227099|NCT02777970|Paracetamol|paracetamol
227100|NCT02777970|Analgesics|analgesics
227101|NCT02777957|Echocardiography|echocardiography
227102|NCT02777957|Lung Transplantation|lung transplantation
227103|NCT02777944|motivation|motivation
227104|NCT02777944|attendance|attendance
227105|NCT02777918|food intake|food intake
227106|NCT02777905|late life|late life
227107|NCT02777905|mindfulness meditation|mindfulness meditation
227108|NCT02777879|Chronic Obstructive Pulmonary Disease (COPD)|chronic obstructive pulmonary disease (copd)
227109|NCT02777853|tea|tea
227110|NCT02777853|cardiovascular|cardiovascular
227111|NCT02777853|vascular|vascular
227112|NCT02777853|metabolism|metabolism
227113|NCT02777853|microcirculation|microcirculation
227114|NCT02777853|physical inactivity|physical inactivity
227115|NCT02777853|polyphenols|polyphenols
227116|NCT02777853|conduit artery|conduit artery
227117|NCT02777853|endothelial function|endothelial function
227118|NCT02777853|cerebrovascular|cerebrovascular
227119|NCT02777853|insulin sensitivity|insulin sensitivity
227120|NCT02777827|Abediterol|abediterol
227121|NCT02777827|Dry powder inhaler|dry powder inhaler
227122|NCT02777827|Pressured metered-dose inhaler|pressured metered-dose inhaler
227123|NCT02777827|Pharmacokinetic|pharmacokinetic
227124|NCT02777827|Pharmacodynamic|pharmacodynamic
227125|NCT02777827|Safety|safety
227126|NCT02777814|colorectal cancer|colorectal cancer
227127|NCT02777814|Entecavir|entecavir
227128|NCT02777814|Hepatitis B Carrier|hepatitis b carrier
227129|NCT02777801|gastric cancer|gastric cancer
227130|NCT02777801|hepatitis B carrier|hepatitis b carrier
227131|NCT02777801|entecavir|entecavir
227132|NCT02777788|Chinese Traditional Medicine|chinese traditional medicine
227133|NCT02777775|NF1|nf1
227134|NCT02777775|CNF|cnf
227135|NCT02777775|PNF|pnf
227136|NCT02777775|Skin Tumors|skin tumors
227137|NCT02777736|Lymphoma, B cell|lymphoma, b cell
227138|NCT02777736|Central nervous system relapse|central nervous system relapse
227139|NCT02777736|Methotrexate|methotrexate
227140|NCT02777736|Intrathecal chemotherapy|intrathecal chemotherapy
227141|NCT02777723|Dry Eye Syndrome|dry eye syndrome
227142|NCT02777723|Sodium Hyaluronate|sodium hyaluronate
227143|NCT02777723|CKD-350|ckd-350
227144|NCT02777697|cancer treatment protocols|cancer treatment protocols
227145|NCT02777697|chronic cancer pain|chronic cancer pain
227146|NCT02777697|cognitive function|cognitive function
227147|NCT02777697|quality of life|quality of life
227148|NCT02777697|anxiety|anxiety
227149|NCT02777697|depression|depression
227150|NCT02777684|Physical activity|physical activity
227151|NCT02777684|Knee osteoarthritis|knee osteoarthritis
227152|NCT02777684|Non pharmacological treatment|non pharmacological treatment
227153|NCT02777684|Qualitative study|qualitative study
227256|NCT02777112|job coach|job coach
227257|NCT02777099|remote ischemic postconditioning|remote ischemic postconditioning
227258|NCT02777099|autonomic function|autonomic function
227154|NCT02777658|Epidermal Growth Factor Receptor (EGFR), non-small cell lung cancer (NSCLC), EGFR T790M, EGFR Mutation-Positive Locally Advanced or Advanced NSCLC|epidermal growth factor receptor (egfr), non-small cell lung cancer (nsclc), egfr t790m, egfr mutation-positive locally advanced or advanced nsclc
227155|NCT02777619|Pharmacodynamic|pharmacodynamic
227156|NCT02777619|Dexmedetomidine|dexmedetomidine
227157|NCT02777619|Propofol|propofol
227158|NCT02777619|Target-controlled Infusion Intravenous Anesthesia|target-controlled infusion intravenous anesthesia
227159|NCT02777606|Severe Sepsis|severe sepsis
227160|NCT02777606|Sini Decoction|sini decoction
227161|NCT02777606|Immune Function|immune function
227162|NCT02777606|Mortality|mortality
227163|NCT02777580|Thrombolytic Therapy|thrombolytic therapy
227164|NCT02777580|Primary PCI|primary pci
227165|NCT02777554|Healthy Subjects|healthy subjects
227166|NCT02777554|Apremilast|apremilast
227167|NCT02777554|Pharmacokinetic|pharmacokinetic
227168|NCT02777541|early enteral nutrition|early enteral nutrition
227169|NCT02777541|children|children
227170|NCT02777541|percutaneous endoscopic gastrostomy|percutaneous endoscopic gastrostomy
227171|NCT02777515|electronic cigarette|electronic cigarette
227172|NCT02777489|obesity|obesity
227173|NCT02777489|perindopril|perindopril
227174|NCT02777489|carboxypeptidase D|carboxypeptidase d
227175|NCT02777489|genotyping|genotyping
227176|NCT02777489|theranostic|theranostic
227177|NCT02777450|low back pain|low back pain
227178|NCT02777450|physical examination|physical examination
227179|NCT02777450|local anesthesia|local anesthesia
227180|NCT02777437|Colonic Neoplasms|colonic neoplasms
227181|NCT02777437|Laparoscopic Surgery|laparoscopic surgery
227182|NCT02777437|Neoadjuvant chemotherapy|neoadjuvant chemotherapy
227184|NCT02777411|Vaccines|vaccines
227185|NCT02777411|Hand, Foot and Mouth Disease|hand, foot and mouth disease
227186|NCT02777411|EV71 enteroviruses vaccine|ev71 enteroviruses vaccine
227187|NCT02777398|Intra-spinal Canal|intra-spinal canal
227188|NCT02777398|Tumor|tumor
227189|NCT02777398|Minimal Invasive Surgery|minimal invasive surgery
227190|NCT02777398|Clinical Trial|clinical trial
227191|NCT02777398|Quadrant Channel|quadrant channel
227192|NCT02777385|Head and Neck|head and neck
227193|NCT02777385|Locally Advanced|locally advanced
227194|NCT02777385|Squamous Cell Carcinoma|squamous cell carcinoma
227195|NCT02777385|SCCHN|scchn
227196|NCT02777385|Untreated|untreated
227197|NCT02777385|High Risk|high risk
227198|NCT02777385|Intermediate Risk|intermediate risk
227199|NCT02777385|Radiation Therapy|radiation therapy
227200|NCT02777385|Cisplatin|cisplatin
227201|NCT02777372|Zoloft|zoloft
227202|NCT02777372|PMS|pms
227203|NCT02777372|Menses|menses
227204|NCT02777359|patent foramen ovale|patent foramen ovale
227205|NCT02777359|migraine|migraine
227206|NCT02777359|treatment|treatment
227207|NCT02777346|WOUNDS, PENETRATING|wounds, penetrating
227208|NCT02777346|CHILD, PRESCHOOL|child, preschool
227209|NCT02777346|CHILD|child
227210|NCT02777346|INFANT|infant
227211|NCT02777346|ADOLESCENT|adolescent
227212|NCT02777346|SUTURES|sutures
227213|NCT02777346|POLYGLACTIN 910|polyglactin 910
227214|NCT02777346|POLYPROPYLENES|polypropylenes
227215|NCT02777333|Simulation|simulation
227216|NCT02777333|Arthroscopy|arthroscopy
227217|NCT02777333|Motion analysis|motion analysis
227218|NCT02777320|Sciatica|sciatica
227219|NCT02777320|Ibuprofen|ibuprofen
227220|NCT02777320|Paracetamol|paracetamol
227221|NCT02777320|Emergency Medicine|emergency medicine
227222|NCT02777307|Laparoscopic|laparoscopic
227223|NCT02777307|Cholecistectomy|cholecistectomy
227224|NCT02777307|Collection|collection
227225|NCT02777307|Bleeding|bleeding
227226|NCT02777307|reoperation|reoperation
227227|NCT02777281|Shoulder Pain|shoulder pain
227228|NCT02777281|Wheelchair|wheelchair
227229|NCT02777281|Spinal Cord injury|spinal cord injury
227230|NCT02777242|Hypogonadism|hypogonadism
227231|NCT02777242|Testosterone enanthate|testosterone enanthate
227232|NCT02777216|RDN|rdn
227233|NCT02777203|morcellation|morcellation
227234|NCT02777203|myomectomy|myomectomy
227235|NCT02777203|hysterectomy|hysterectomy
227236|NCT02777190|misoprostol|misoprostol
227237|NCT02777190|cytotec|cytotec
227238|NCT02777190|cervical ripening|cervical ripening
227239|NCT02777190|labor, induced|labor, induced
227240|NCT02777190|active labor|active labor
227241|NCT02777138|Adipose tissue|adipose tissue
227242|NCT02777138|Inflammation|inflammation
227243|NCT02777138|Age Comparison|age comparison
227244|NCT02777138|Macrophages|macrophages
227245|NCT02777138|T-lymphocytes|t-lymphocytes
227246|NCT02777138|Adipose Progenitors|adipose progenitors
227247|NCT02777125|pediatrics|pediatrics
227248|NCT02777125|metered dose inhalers|metered dose inhalers
227249|NCT02777125|breath actuated nebulizers|breath actuated nebulizers
227250|NCT02777112|high-risk|high-risk
227251|NCT02777112|early prevention|early prevention
227252|NCT02777112|productivity|productivity
227253|NCT02777112|return on investment|return on investment
227254|NCT02777112|workplace|workplace
227255|NCT02777112|e-mental health program|e-mental health program
227259|NCT02777099|heart rate variability|heart rate variability
227260|NCT02777099|acute ischemic stroke|acute ischemic stroke
227261|NCT02777099|prognosis|prognosis
227262|NCT02777086|HIV|hiv
227263|NCT02777086|Risk Behaviors|risk behaviors
227264|NCT02777086|Decision-making|decision-making
227265|NCT02777073|Diabetic ketoacidosis|diabetic ketoacidosis
227266|NCT02777073|Insulin|insulin
227267|NCT02777073|Type 1 Diabetes|type 1 diabetes
227268|NCT02777073|glucose (sugar) control|glucose (sugar) control
227269|NCT02777073|SGLT-2 inhibitors|sglt-2 inhibitors
227270|NCT02777060|virtual reality|virtual reality
227271|NCT02777060|sensor-based balance training|sensor-based balance training
227272|NCT02777060|gait|gait
227273|NCT02777060|balance|balance
227274|NCT02777047|Thromboembolism|thromboembolism
227275|NCT02777047|Medication Safety|medication safety
227276|NCT02777047|Hospital-community collaboration|hospital-community collaboration
227277|NCT02777047|Pilot RCT|pilot rct
227278|NCT02777047|Telehealth|telehealth
227279|NCT02777034|Laparoscopy|laparoscopy
227280|NCT02777034|Enhanced Recovery|enhanced recovery
227281|NCT02777034|Fast-track|fast-track
227282|NCT02777021|Pediatric|pediatric
227283|NCT02777021|Acute Myeloid Leukemia|acute myeloid leukemia
227284|NCT02777021|Quality of Life|quality of life
227285|NCT02777021|Neutropenia Management|neutropenia management
227286|NCT02777021|Patient Centered Outcomes|patient centered outcomes
227287|NCT02777021|Chemotherapy|chemotherapy
227288|NCT02776982|Gastroesophageal reflux disease|gastroesophageal reflux disease
227289|NCT02776982|GERD|gerd
227290|NCT02776982|Barrett's Esophagus|barrett's esophagus
227291|NCT02776982|Esophageal adenocarcinoma|esophageal adenocarcinoma
227292|NCT02776969|Papillary Carcinoma|papillary carcinoma
227293|NCT02776969|Gene Hunting|gene hunting
227294|NCT02776969|Familial|familial
227295|NCT02776956|atrial fibrillation;left atrial function|atrial fibrillation;left atrial function
227296|NCT02776930|Injury Prediction|injury prediction
227297|NCT02776930|Return to Work|return to work
227298|NCT02776930|Injury Prevention|injury prevention
227299|NCT02776917|metastatic breast cancer|metastatic breast cancer
227300|NCT02776917|locally advanced, unresectable breast cancer|locally advanced, unresectable breast cancer
227301|NCT02776917|HER2/NEU negative|her2/neu negative
227302|NCT02776904|Concussion|concussion
227303|NCT02776904|Football player|football player
227304|NCT02776904|Movement assessment|movement assessment
227305|NCT02776904|Soccer player|soccer player
227306|NCT02776891|lymphoma|lymphoma
227307|NCT02776891|gallium citrate|gallium citrate
227308|NCT02776891|PET|pet
227309|NCT02776865|suprascapular nerve block|suprascapular nerve block
227310|NCT02776813|CD20+|cd20+
227311|NCT02776813|B-cell|b-cell
227312|NCT02776813|ACTR087|actr087
227313|NCT02776813|Relapsed|relapsed
227314|NCT02776813|Refractory|refractory
227315|NCT02776800|Wound|wound
227316|NCT02776800|Surgical Wound|surgical wound
227317|NCT02776800|Trauma Wound|trauma wound
227318|NCT02776800|Home Health Care|home health care
227319|NCT02776800|Home Health Nurse|home health nurse
227320|NCT02776800|Pressure Ulcer|pressure ulcer
227321|NCT02776800|Diabetic Foot Ulcer|diabetic foot ulcer
227322|NCT02776800|Venous Leg Ulcer|venous leg ulcer
227323|NCT02776800|Arterial Ulcer|arterial ulcer
227324|NCT02776800|Wound Dehiscence|wound dehiscence
227325|NCT02776800|Open Wound|open wound
227326|NCT02776774|spine|spine
227327|NCT02776748|Tenofovir disoproxil|tenofovir disoproxil
227328|NCT02776748|Pre-exposure prophylaxis|pre-exposure prophylaxis
227329|NCT02776748|Breastfeeding|breastfeeding
227330|NCT02776748|Emtricitabine|emtricitabine
227331|NCT02776748|Tenofovir|tenofovir
227332|NCT02776748|Post-partum|post-partum
227333|NCT02776748|HIV prevention|hiv prevention
227334|NCT02776748|Women|women
227335|NCT02776748|Pharmacokinetics|pharmacokinetics
227336|NCT02776722|Systematic Review and Meta-analysis|systematic review and meta-analysis
227337|NCT02776722|randomized controlled trial|randomized controlled trial
227338|NCT02776722|Evidence-Based Medicine|evidence-based medicine
227339|NCT02776722|carbohydrate metabolism|carbohydrate metabolism
227340|NCT02776722|postprandial|postprandial
227341|NCT02776722|glycemic response|glycemic response
227342|NCT02776722|glycemic control|glycemic control
227343|NCT02776722|insulin sensitivity|insulin sensitivity
227344|NCT02776722|beta-cell function|beta-cell function
227345|NCT02776722|sugars|sugars
227346|NCT02776722|fructose|fructose
227347|NCT02776722|allulose|allulose
227348|NCT02776722|tagatose|tagatose
227349|NCT02776722|sorbose|sorbose
227350|NCT02776696|Closed Loop|closed loop
227351|NCT02776696|Artificial Pancreas|artificial pancreas
227352|NCT02776644|renal cell carcinoma|renal cell carcinoma
227353|NCT02776644|sunitinib, pazopanib|sunitinib, pazopanib
227354|NCT02776644|temsirolimus|temsirolimus
227355|NCT02776644|sorafenib|sorafenib
227356|NCT02776644|everolimus|everolimus
227357|NCT02776644|interferon alpha|interferon alpha
227358|NCT02776644|interleukin 2|interleukin 2
227359|NCT02776592|Healthy Children|healthy children
227360|NCT02776579|Resistance Training; Muscle Strength|resistance training; muscle strength
227361|NCT02776566|Anticoagulation|anticoagulation
227362|NCT02776566|Anticoagulation Management|anticoagulation management
227363|NCT02776566|Self-Testing|self-testing
227364|NCT02776566|Self-Management|self-management
227365|NCT02776566|Warfarin|warfarin
227366|NCT02776566|Thromboembolism|thromboembolism
227367|NCT02776566|Blood Coagulation Disorders|blood coagulation disorders
227368|NCT02776566|Health Disparities|health disparities
227369|NCT02776566|Minorities|minorities
227370|NCT02776566|African American|african american
227371|NCT02776566|Hispanic|hispanic
227372|NCT02776566|Cardiovascular Disease|cardiovascular disease
227373|NCT02776566|Models of Anticoagulation Care|models of anticoagulation care
227374|NCT02776566|Tele-Health|tele-health
227375|NCT02776566|Home Self-Testing|home self-testing
227376|NCT02776527|Gastric cancer|gastric cancer
227377|NCT02776527|D2 Lymphadenectomy|d2 lymphadenectomy
227378|NCT02776527|postoprative adjuvant chemotherapy|postoprative adjuvant chemotherapy
227379|NCT02776527|Apatinib|apatinib
227380|NCT02776527|disease free survival|disease free survival
227381|NCT02776488|brain trauma, metabolic therapy|brain trauma, metabolic therapy
227382|NCT02776462|Eye Tracking|eye tracking
227383|NCT02776462|Concussion|concussion
227384|NCT02776462|Outcome Measures|outcome measures
227385|NCT02776410|sustainable healthy eating|sustainable healthy eating
227386|NCT02776410|consumer behaviour|consumer behaviour
227387|NCT02776410|consumer attitudes|consumer attitudes
227388|NCT02776384|Heart Failure|heart failure
227389|NCT02776384|Biomarkers|biomarkers
227390|NCT02776384|Echocardiography|echocardiography
227391|NCT02776384|Cardiopulmonary Function Tests|cardiopulmonary function tests
227392|NCT02776371|Helicobacter pylori|helicobacter pylori
227393|NCT02776371|Sequential therapy|sequential therapy
227394|NCT02776371|Modified non-clarithromycin triple therapy|modified non-clarithromycin triple therapy
227395|NCT02776345|calcific tendonitis|calcific tendonitis
227396|NCT02776345|rotator cuff calcific tendonitis|rotator cuff calcific tendonitis
227397|NCT02776332|breastfeeding|breastfeeding
227398|NCT02776332|premature infants|premature infants
227399|NCT02776332|manual expression|manual expression
227400|NCT02776319|Non-invasive brain stimulation|non-invasive brain stimulation
227401|NCT02776319|tobacco use disorder|tobacco use disorder
227402|NCT02776319|craving|craving
227403|NCT02776280|water|water
227404|NCT02776280|salt|salt
227405|NCT02776280|oral fluids|oral fluids
227406|NCT02776280|plaque|plaque
227407|NCT02776280|dental caries|dental caries
227408|NCT02776254|anti-retroviral therapy|anti-retroviral therapy
227409|NCT02776254|differentiated care|differentiated care
227410|NCT02776241|ADPKD|adpkd
227411|NCT02776241|total kidney volume|total kidney volume
227412|NCT02776241|kidney disease|kidney disease
227413|NCT02776189|Anaesthesia|anaesthesia
227415|NCT02776189|Brain|brain
227416|NCT02776176|enhanced recovery after surgery|enhanced recovery after surgery
227417|NCT02776176|hirschsprung disease|hirschsprung disease
227418|NCT02776163|Salivary Gland Tumors|salivary gland tumors
227419|NCT02776163|Head-an-Neck cancer|head-an-neck cancer
227420|NCT02776163|Concurrent Chemoradiotherapy|concurrent chemoradiotherapy
227421|NCT02776163|High-Risk|high-risk
227422|NCT02776163|Cisplatin|cisplatin
227423|NCT02776163|Docetaxel|docetaxel
227424|NCT02776150|probe melting curve|probe melting curve
227425|NCT02776150|Drug resistance|drug resistance
227426|NCT02776150|Tuberculosis, Pulmonary|tuberculosis, pulmonary
227427|NCT02776137|Docetaxel|docetaxel
227428|NCT02776137|Concurrent Chemoradiotherapy|concurrent chemoradiotherapy
227429|NCT02776137|High-Risk|high-risk
227430|NCT02776137|Squamous Cell Carcinoma|squamous cell carcinoma
227431|NCT02776137|Head-and-Neck Cancer|head-and-neck cancer
227432|NCT02776124|Nutritional status|nutritional status
227433|NCT02776124|nasopharyngeal carcinoma|nasopharyngeal carcinoma
227434|NCT02776124|Nutritional Counseling|nutritional counseling
227435|NCT02776124|concurrent chemoradiotherapy|concurrent chemoradiotherapy
227436|NCT02776124|oral nutritional supplements|oral nutritional supplements
227437|NCT02776111|Kidney Transplant|kidney transplant
227438|NCT02776098|Cystic Fibrosis|cystic fibrosis
227439|NCT02776098|Glucose Intolerance|glucose intolerance
227440|NCT02776098|Muscle Accrual|muscle accrual
227441|NCT02776098|Cystic Fibrosis-related Diabetes|cystic fibrosis-related diabetes
227442|NCT02776098|Healthy Controls|healthy controls
227443|NCT02776098|Healthy Participants|healthy participants
227444|NCT02776085|optic nerve sheath diameter|optic nerve sheath diameter
227445|NCT02776085|ultrasound|ultrasound
227446|NCT02776085|shunt failure|shunt failure
227447|NCT02776072|Tecfidera, DMF, dimethyl fumarate, Fingolimod, Glatiramer acetate, Teriflunomide, Gilenya, Copaxone, Aubagio|tecfidera, dmf, dimethyl fumarate, fingolimod, glatiramer acetate, teriflunomide, gilenya, copaxone, aubagio
227448|NCT02776059|survival|survival
227449|NCT02776059|pegfilgrastim|pegfilgrastim
227450|NCT02776059|cirrhosis, alcoholic|cirrhosis, alcoholic
227451|NCT02776046|Oxygen, surgical site infection, postoperative complication, recruitment maneuvers, open lung strategy|oxygen, surgical site infection, postoperative complication, recruitment maneuvers, open lung strategy
227452|NCT02776033|tolerability|tolerability
227453|NCT02776033|safety|safety
227454|NCT02776033|GSK2982772|gsk2982772
227455|NCT02776033|RIP1 kinase inhibitor|rip1 kinase inhibitor
227456|NCT02776033|psoriasis|psoriasis
227457|NCT02776007|Continuous Glucose Monitoring System|continuous glucose monitoring system
227458|NCT02775955|Pharmacokinetics|pharmacokinetics
227459|NCT02775929|Tenofovir disoproxil|tenofovir disoproxil
227460|NCT02775929|Emtricitabine|emtricitabine
227461|NCT02775929|Pre-exposure Prophylaxis|pre-exposure prophylaxis
227462|NCT02775929|Antiretroviral Therapy|antiretroviral therapy
227463|NCT02775929|HIV Prevention|hiv prevention
227464|NCT02775929|FTC TDF|ftc tdf
227465|NCT02775929|PrEP|prep
227466|NCT02775929|HIV Infected Partners|hiv infected partners
227467|NCT02775929|HIV Uninfected Partners|hiv uninfected partners
227468|NCT02775903|MEDI4736|medi4736
227469|NCT02775903|Durvalumab|durvalumab
227470|NCT02775903|Myelodysplastic Syndromes|myelodysplastic syndromes
227471|NCT02775903|Acute Myeloid Leukemia|acute myeloid leukemia
227472|NCT02775903|Hematopoietic Stem Cell Transplantation|hematopoietic stem cell transplantation
227473|NCT02775903|Azacitidine|azacitidine
227474|NCT02775903|Safety|safety
227475|NCT02775903|Efficacy|efficacy
227476|NCT02775903|PD-L1|pd-l1
227477|NCT02775877|PCOS|pcos
227478|NCT02775877|letrozole|letrozole
227479|NCT02775877|clomiphene|clomiphene
227480|NCT02775786|Pancreatic Adenocarcinoma|pancreatic adenocarcinoma
227481|NCT02775786|Pancreatic Cancer|pancreatic cancer
227482|NCT02775773|TXA|txa
227483|NCT02775773|PPH|pph
227484|NCT02775760|brain|brain
227485|NCT02775760|brain mapping|brain mapping
227486|NCT02775760|cognition|cognition
227487|NCT02775760|exercise|exercise
227488|NCT02775760|physical activity|physical activity
227489|NCT02775760|hippocampus|hippocampus
227490|NCT02775760|entorhinal cortex|entorhinal cortex
227491|NCT02775760|spatial navigation|spatial navigation
227492|NCT02775760|learning|learning
227493|NCT02775760|memory|memory
227494|NCT02775760|magnetic resonance imaging|magnetic resonance imaging
227495|NCT02775760|functional neuroimaging|functional neuroimaging
227496|NCT02775760|physical endurance|physical endurance
227497|NCT02775760|physical fitness|physical fitness
227498|NCT02775760|resistance training|resistance training
227499|NCT02775760|walking|walking
227500|NCT02775760|muscle stretching exercises|muscle stretching exercises
227501|NCT02775760|exercise test|exercise test
227502|NCT02775760|neuropsychological tests|neuropsychological tests
227503|NCT02775760|executive function|executive function
227504|NCT02775760|attention|attention
227505|NCT02775760|body composition|body composition
227506|NCT02775734|Polycystic Ovary Syndrome|polycystic ovary syndrome
227507|NCT02775734|N-acetyl-cysteine|n-acetyl-cysteine
227508|NCT02775734|Clomiphene citrate|clomiphene citrate
227509|NCT02775734|Clomiphene citrate resistant|clomiphene citrate resistant
227510|NCT02775734|Laparoscopic ovarian drilling|laparoscopic ovarian drilling
227511|NCT02775734|therapy|therapy
227512|NCT02775721|Nursing Education|nursing education
227513|NCT02775721|Weight Loss|weight loss
227514|NCT02775721|Gastrostomy Tube Care|gastrostomy tube care
227515|NCT02775695|pancreatic cancer|pancreatic cancer
227516|NCT02775695|Resectable Pancreatic Cancer|resectable pancreatic cancer
227517|NCT02775695|Doxycycline|doxycycline
227518|NCT02775695|Metakaryote cells|metakaryote cells
227519|NCT02775695|Eukaryotic cells|eukaryotic cells
227520|NCT02775695|Cancer Stem Cells|cancer stem cells
227521|NCT02775695|Targeted Cancer Stem Cell Therapy|targeted cancer stem cell therapy
227522|NCT02775695|Multi-metakaryocide therapy|multi-metakaryocide therapy
227523|NCT02775695|Doxycycline Hyclate|doxycycline hyclate
227524|NCT02775695|Tetracycline|tetracycline
227525|NCT02775682|epilepsy, dynamic cerebral autoregulation|epilepsy, dynamic cerebral autoregulation
227526|NCT02775669|noninvasive ICP monitoring|noninvasive icp monitoring
227527|NCT02775656|Cimzia®|cimzia®
227528|NCT02775656|CZP|czp
227529|NCT02775656|Pregnancy Follow up study|pregnancy follow up study
227530|NCT02775656|Autoimmune diseases|autoimmune diseases
227531|NCT02775656|Pregnancy outcomes|pregnancy outcomes
227532|NCT02775656|major congenital malformations|major congenital malformations
227533|NCT02775656|birth outcomes|birth outcomes
227534|NCT02775656|malformation|malformation
227535|NCT02775656|birth defect|birth defect
227536|NCT02775643|Melanoma|melanoma
227537|NCT02775643|Spitzoid Melanoma|spitzoid melanoma
227538|NCT02775643|Congenital Melanoma|congenital melanoma
227539|NCT02775643|Melanoma Arising in Giant Nevi|melanoma arising in giant nevi
227540|NCT02775643|Melanocytic lesions with indeterminate biological behavior|melanocytic lesions with indeterminate biological behavior
227541|NCT02775643|Pigment synthesizing melanomas|pigment synthesizing melanomas
227542|NCT02775604|fall risks at home|fall risks at home
227543|NCT02775604|video technology|video technology
227544|NCT02775604|home assessment|home assessment
227545|NCT02775578|heart failure|heart failure
227546|NCT02775578|coronary artery disease|coronary artery disease
227547|NCT02775578|biomarkers|biomarkers
227548|NCT02775578|Percutaneous Coronary Intervention, PCI|percutaneous coronary intervention, pci
227549|NCT02775578|Coronary Artery Bypass Grafting, CABG|coronary artery bypass grafting, cabg
227550|NCT02775552|Child Nutrition|child nutrition
227551|NCT02775552|Breastfeeding|breastfeeding
227552|NCT02775552|Complementary Feeding|complementary feeding
227553|NCT02775552|Infant and Young Child Feeding|infant and young child feeding
227554|NCT02775552|Social and Behavior Change Communication|social and behavior change communication
227555|NCT02775552|Ethiopia|ethiopia
227556|NCT02775539|Pulmonary hypertension|pulmonary hypertension
227557|NCT02775539|Mirabegron|mirabegron
227558|NCT02775539|Heart failure|heart failure
227559|NCT02775539|B3 adrenergic|b3 adrenergic
227560|NCT02775526|Mixed urinary incontinence|mixed urinary incontinence
227561|NCT02775526|Transobturator tape (TOT)|transobturator tape (tot)
227562|NCT02775526|Tension-Free Vaginal Tape (TVT)|tension-free vaginal tape (tvt)
227563|NCT02775526|Burch colposuspension|burch colposuspension
227564|NCT02775526|Urinary incontinence|urinary incontinence
227565|NCT02775500|pregnancy|pregnancy
227566|NCT02775500|apremilast|apremilast
227567|NCT02775500|Otezla|otezla
227568|NCT02775500|autoimmune disease|autoimmune disease
227569|NCT02775500|psoriatic arthritis|psoriatic arthritis
227570|NCT02775500|psoriasis|psoriasis
227571|NCT02775500|TNF|tnf
227572|NCT02775500|tumor necrosis factor|tumor necrosis factor
227573|NCT02775500|birth outcome|birth outcome
227574|NCT02775500|birth defect|birth defect
227575|NCT02775487|COPD|copd
227576|NCT02775487|Air quality|air quality
227577|NCT02775474|Methadone|methadone
227578|NCT02775474|Pain, Postoperative|pain, postoperative
227579|NCT02775474|Chronic Pain|chronic pain
227580|NCT02775474|Bariatric Surgery|bariatric surgery
227581|NCT02775461|Pancreas Cancer|pancreas cancer
227582|NCT02775461|Chronic Pancreatitis|chronic pancreatitis
227583|NCT02775461|Pancreatic Cyst|pancreatic cyst
227584|NCT02775461|BRCA1|brca1
227585|NCT02775461|BRCA2|brca2
227586|NCT02775461|Lynch Syndrome|lynch syndrome
227587|NCT02775461|Peutz-Jeghers syndrome|peutz-jeghers syndrome
227588|NCT02775461|ATM mutation|atm mutation
227589|NCT02775461|FAMMM Syndrome|fammm syndrome
227590|NCT02775461|Pancreatitis|pancreatitis
227591|NCT02775461|Family History of Pancreas Cancer|family history of pancreas cancer
227592|NCT02775461|Family History of Cancer|family history of cancer
227593|NCT02775448|Homeopathy|homeopathy
227594|NCT02775448|Carduus marianus|carduus marianus
227595|NCT02775448|Dyslipidemia|dyslipidemia
227596|NCT02775448|Climacteric|climacteric
227597|NCT02775448|Obesity|obesity
227598|NCT02775448|Triglycerides|triglycerides
227599|NCT02775448|Cholesterol|cholesterol
227600|NCT02775448|Insulin resistance|insulin resistance
227601|NCT02775448|LDL-cholesterol|ldl-cholesterol
227602|NCT02775448|HDL-cholesterol|hdl-cholesterol
227603|NCT02775435|PD1|pd1
227604|NCT02775435|PD-1|pd-1
227605|NCT02775435|PDL1|pdl1
227606|NCT02775435|PD-L1|pd-l1
227607|NCT02775383|National MDS Study|national mds study
227608|NCT02775383|MDS|mds
227609|NCT02775383|Idiopathic|idiopathic
227610|NCT02775383|cytopenia|cytopenia
227611|NCT02775383|cytopenias|cytopenias
227612|NCT02775383|ICUS|icus
227613|NCT02775383|MDS/MPN|mds/mpn
227614|NCT02775383|Myeloproliferative Neoplasm|myeloproliferative neoplasm
227615|NCT02775383|Biorepository|biorepository
227616|NCT02775344|Laparoscopy|laparoscopy
227617|NCT02775344|ovarian cystectomy|ovarian cystectomy
227618|NCT02775344|three dimension laparoscopy|three dimension laparoscopy
227619|NCT02775331|shift scheduling|shift scheduling
227620|NCT02775331|work-life interaction|work-life interaction
227621|NCT02775331|working time control|working time control
227622|NCT02775331|public sector|public sector
227623|NCT02775318|Stellate Ganglion|stellate ganglion
227624|NCT02775318|Digital Subtraction Angiography|digital subtraction angiography
227625|NCT02775318|Transcranial Doppler Ultrasonography|transcranial doppler ultrasonography
227626|NCT02775279|acute coronary syndrome, telomere length, predictive factor|acute coronary syndrome, telomere length, predictive factor
227627|NCT02775253|Brown adipose tissue|brown adipose tissue
227628|NCT02775253|Subcutaneous white adipose tissue|subcutaneous white adipose tissue
227629|NCT02775253|White adipose tissue|white adipose tissue
227630|NCT02775240|Maribavir|maribavir
227631|NCT02775214|Storz C-MAC|storz c-mac
227632|NCT02775214|direct laryngoscopy|direct laryngoscopy
227633|NCT02775214|pyloromyotomy|pyloromyotomy
726413|NCT00523133|naltrexone|naltrexone
227634|NCT02775214|rapid sequence|rapid sequence
227635|NCT02775201|plantaris|plantaris
227636|NCT02775201|Tendinopathy|tendinopathy
227637|NCT02775201|Achilles|achilles
227638|NCT02775201|Release|release
227639|NCT02775175|Ramadan|ramadan
227640|NCT02775175|Fasting|fasting
227641|NCT02775175|Nutrition|nutrition
227642|NCT02775175|Quality of Life|quality of life
227643|NCT02775136|brain injuries|brain injuries
227644|NCT02775136|neurological monitoring|neurological monitoring
227645|NCT02775084|n-3|n-3
227646|NCT02775084|Polyunsaturated|polyunsaturated
227647|NCT02775084|Fatty acids|fatty acids
227648|NCT02775084|Antigens|antigens
227649|NCT02775084|Cognition|cognition
227650|NCT02775084|CD4|cd4
227651|NCT02775045|EoE|eoe
227652|NCT02775032|advance care planning|advance care planning
227653|NCT02775032|general practice|general practice
227654|NCT02775032|family practice|family practice
227655|NCT02775032|palliative care|palliative care
227656|NCT02775032|end-of-life care|end-of-life care
227657|NCT02774967|root coverage|root coverage
227658|NCT02774967|gingival recession|gingival recession
227659|NCT02774967|periodontal surgery|periodontal surgery
227660|NCT02774954|Change the cycle|change the cycle
227661|NCT02774954|social learning theory|social learning theory
227662|NCT02774954|people who inject drugs|people who inject drugs
227663|NCT02774954|injection drug use|injection drug use
227664|NCT02774954|Information, Motivation, Behavior Skills Model|information, motivation, behavior skills model
227665|NCT02774954|Longitudinal cohort study|longitudinal cohort study
227666|NCT02774928|Pulmonary Hypertension|pulmonary hypertension
227667|NCT02774928|COPD|copd
227668|NCT02774928|ILD|ild
227669|NCT02774928|OSA|osa
227670|NCT02774902|Drug Therapy|drug therapy
227671|NCT02774889|Falls Prevention|falls prevention
227672|NCT02774889|Stepping On|stepping on
227673|NCT02774889|Health Promotion|health promotion
227674|NCT02774889|Implementation|implementation
227675|NCT02774889|Health Maintenance|health maintenance
227676|NCT02774876|Closed-loop system|closed-loop system
227677|NCT02774876|Artificial pancreas|artificial pancreas
227678|NCT02774876|Glucose control|glucose control
227679|NCT02774876|Meal|meal
227680|NCT02774850|Pediatric|pediatric
227681|NCT02774850|Neutropenia Management|neutropenia management
227682|NCT02774850|Acute Myeloid Leukemia|acute myeloid leukemia
227683|NCT02774850|Chart Abstraction|chart abstraction
227684|NCT02774850|Chemotherapy|chemotherapy
227685|NCT02774837|nucleoside analogues|nucleoside analogues
227686|NCT02774837|tenofovir|tenofovir
227687|NCT02774837|telbivudine|telbivudine
227688|NCT02774837|quantitative HBsAg|quantitative hbsag
227689|NCT02774837|combination therapy|combination therapy
227690|NCT02774798|Rectal Prolapse|rectal prolapse
227691|NCT02774798|Rectal Intussuception|rectal intussuception
227692|NCT02774759|Malignant neoplasms of female genital organs|malignant neoplasms of female genital organs
227693|NCT02774759|Endometrial cancer survivors|endometrial cancer survivors
227694|NCT02774759|Obese|obese
227695|NCT02774759|Weight loss intervention|weight loss intervention
227696|NCT02774759|Resistance training|resistance training
227697|NCT02774759|Aerobic exercise|aerobic exercise
227698|NCT02774759|Questionnaires|questionnaires
227699|NCT02774759|Surveys|surveys
227700|NCT02774759|Accelerometer|accelerometer
227701|NCT02774759|Fitness Test|fitness test
227702|NCT02774759|Telephone Coaching|telephone coaching
227703|NCT02774759|Video Chat Sessions|video chat sessions
227704|NCT02774707|Dry eye|dry eye
227705|NCT02774694|nociceptive flexion reflex|nociceptive flexion reflex
227706|NCT02774694|interventional pain management|interventional pain management
227707|NCT02774668|gender|gender
227708|NCT02774668|arterial stiffness|arterial stiffness
227709|NCT02774668|blood pressure|blood pressure
227710|NCT02774668|weight loss|weight loss
227711|NCT02774668|uric acid|uric acid
227712|NCT02774655|healthy volunteers|healthy volunteers
227713|NCT02774655|patient compliance|patient compliance
227714|NCT02774655|exercise|exercise
227715|NCT02774655|motivation|motivation
227716|NCT02774642|PTSD|ptsd
227717|NCT02774642|insomnia|insomnia
227718|NCT02774642|CBT-I|cbt-i
227719|NCT02774642|Prolonged Exposure|prolonged exposure
227720|NCT02774642|Veteran|veteran
227721|NCT02774629|food allergy|food allergy
227722|NCT02774629|skin prick test|skin prick test
227723|NCT02774629|atopy patch test|atopy patch test
227724|NCT02774590|Acne vulgaris|acne vulgaris
227725|NCT02774590|Rosacea|rosacea
227726|NCT02774577|Oxygen Consumption|oxygen consumption
227727|NCT02774577|Aged|aged
227728|NCT02774577|Whole Body Vibration|whole body vibration
227729|NCT02774551|Body composition|body composition
227730|NCT02774551|Muscle strength|muscle strength
227731|NCT02774551|Health related quality of life|health related quality of life
227732|NCT02774538|Cervical HPV infection|cervical hpv infection
227733|NCT02774538|Oral HPV infection|oral hpv infection
227734|NCT02774538|Sexually transmitted infection|sexually transmitted infection
227735|NCT02774525|child welfare system|child welfare system
291217|NCT02396940|3D|3d
227736|NCT02774525|parental substance use problem|parental substance use problem
227737|NCT02774525|child maltreatment|child maltreatment
227738|NCT02774525|parenting|parenting
227739|NCT02774408|backup ventilation|backup ventilation
227740|NCT02774408|preterm infants|preterm infants
227741|NCT02774408|functional residual capacity|functional residual capacity
227742|NCT02774408|chronic lung disease|chronic lung disease
227743|NCT02774382|Recurrence|recurrence
227744|NCT02774382|Infection|infection
227745|NCT02774369|cancer|cancer
227746|NCT02774369|insomnia|insomnia
227747|NCT02774369|sleep|sleep
227748|NCT02774369|physical exercise|physical exercise
227749|NCT02774369|aerobic|aerobic
227750|NCT02774369|cognitive-behavioral therapy|cognitive-behavioral therapy
227751|NCT02774369|self-help|self-help
227752|NCT02774369|RCT|rct
227753|NCT02774356|Brainstem|brainstem
227754|NCT02774356|Encoding|encoding
227755|NCT02774356|Pitch|pitch
227756|NCT02774304|elastance|elastance
227757|NCT02774304|fluid responsiveness|fluid responsiveness
227758|NCT02774265|Fracture|fracture
227759|NCT02774265|Prophylaxis|prophylaxis
227760|NCT02774226|Flow-Mediated Dilation|flow-mediated dilation
227761|NCT02774226|Kuvan|kuvan
227762|NCT02774226|Antioxidant|antioxidant
227763|NCT02774226|FEV1|fev1
227764|NCT02774187|Hepatocellular Carcinoma|hepatocellular carcinoma
227765|NCT02774187|Hepatic arterial infusion chemotherapy|hepatic arterial infusion chemotherapy
227766|NCT02774187|Sorafenib|sorafenib
227767|NCT02774174|Proximal Humerus|proximal humerus
227768|NCT02774109|low back pain|low back pain
227769|NCT02774109|fish oil|fish oil
227770|NCT02774109|omega 3|omega 3
227771|NCT02774096|Aortic dissection|aortic dissection
227772|NCT02774096|Cerebral and Spinal Protection|cerebral and spinal protection
227773|NCT02774096|Post-conditioning|post-conditioning
227774|NCT02774083|older people|older people
227775|NCT02774083|cognitive training|cognitive training
227776|NCT02774070|AAJ RA MRI synovitis|aaj ra mri synovitis
227777|NCT02774057|Captafer®|captafer®
227778|NCT02774057|Iron Sulfate|iron sulfate
227779|NCT02774057|Iron deficiency anemia|iron deficiency anemia
227780|NCT02774057|inflammatory bowel disease|inflammatory bowel disease
227781|NCT02774044|preterm neonates, surfactant|preterm neonates, surfactant
227782|NCT02774031|Anesthesia, Inhalation|anesthesia, inhalation
227783|NCT02774031|Laparoscopy|laparoscopy
227784|NCT02774031|Prostatectomy|prostatectomy
227785|NCT02774031|Cystectomy|cystectomy
227786|NCT02774031|Gynecologic Surgical Procedures|gynecologic surgical procedures
227787|NCT02774018|Mindfulness|mindfulness
227788|NCT02774018|Elderly|elderly
227789|NCT02774018|Psychopathology|psychopathology
227790|NCT02773992|Solitary Pulmonary Nodule|solitary pulmonary nodule
227791|NCT02773992|Itos|itos
227792|NCT02773992|lung cancer|lung cancer
227793|NCT02773979|challenge|challenge
227794|NCT02773979|malaria|malaria
227795|NCT02773979|P. falciparum|p. falciparum
227796|NCT02773979|PfSPZ|pfspz
227797|NCT02773979|sporozoites|sporozoites
227798|NCT02773979|vaccine|vaccine
227799|NCT02773953|CPAP|cpap
227800|NCT02773953|Telemonitoring|telemonitoring
227801|NCT02773927|Agave inulin|agave inulin
227802|NCT02773927|Adiponectin|adiponectin
227803|NCT02773927|Metabolic syndrome|metabolic syndrome
227804|NCT02773927|Metformin|metformin
227805|NCT02773927|Insulin resistance|insulin resistance
227806|NCT02773914|Activity of Daily Living (ADL)|activity of daily living (adl)
227807|NCT02773914|Comprehensive Geriatric Assessment|comprehensive geriatric assessment
227808|NCT02773914|Elderly|elderly
227809|NCT02773914|Frailty|frailty
227810|NCT02773914|Randomized controlled study|randomized controlled study
227811|NCT02773901|intracranial pressure|intracranial pressure
227812|NCT02773901|noninvasive monitoring|noninvasive monitoring
227813|NCT02773901|lumbar puncture|lumbar puncture
227814|NCT02773888|intracranial pressure|intracranial pressure
227815|NCT02773888|noninvasive monitoring|noninvasive monitoring
227816|NCT02773875|artificial pancreas|artificial pancreas
227817|NCT02773862|brain injuries|brain injuries
227818|NCT02773862|noninvasive monitoring|noninvasive monitoring
227819|NCT02773862|intracranial pressure|intracranial pressure
227820|NCT02773849|IFN|ifn
227821|NCT02773849|BCG-unresponsive|bcg-unresponsive
227822|NCT02773849|Non-Muscle Invasive Bladder Cancer|non-muscle invasive bladder cancer
227823|NCT02773836|tobacco use|tobacco use
227824|NCT02773836|e-cigarettes|e-cigarettes
227825|NCT02773836|public policy|public policy
227826|NCT02773836|ITC|itc
227827|NCT02773823|obesity|obesity
227828|NCT02773823|children|children
227829|NCT02773823|cardiovascular health|cardiovascular health
227830|NCT02773823|intervention study|intervention study
227831|NCT02773797|Sedation|sedation
227832|NCT02773797|Dexmedetomidine|dexmedetomidine
227833|NCT02773771|Muscle Atrophy|muscle atrophy
227834|NCT02773771|Critical Illness|critical illness
227835|NCT02773771|Ultrasound|ultrasound
227836|NCT02773771|beta-hydroxy-beta-methylbutyrate|beta-hydroxy-beta-methylbutyrate
291296|NCT02396420|BPH|bph
227837|NCT02773771|ICU|icu
227838|NCT02773680|respiration|respiration
227839|NCT02773680|monitoring, physiologic|monitoring, physiologic
227840|NCT02773680|diagnostic techniques, respiratory system|diagnostic techniques, respiratory system
227841|NCT02773654|shoulder|shoulder
227842|NCT02773654|motion|motion
227843|NCT02773654|measurement|measurement
227844|NCT02773654|healthy shoulder|healthy shoulder
227845|NCT02773654|shoulder motion|shoulder motion
227846|NCT02773602|Analgesia|analgesia
227847|NCT02773602|caudal analgesia|caudal analgesia
227848|NCT02773602|ropivacaine|ropivacaine
227849|NCT02773602|clonidine|clonidine
227850|NCT02773602|dexamethasone|dexamethasone
227851|NCT02773550|Multiple Myeloma|multiple myeloma
227852|NCT02773524|Metastatic|metastatic
227853|NCT02773524|Locally recurrent|locally recurrent
227854|NCT02773524|Oesophago-gastric junction|oesophago-gastric junction
227855|NCT02773524|Stomach|stomach
227856|NCT02773524|Adenocarcinoma|adenocarcinoma
227857|NCT02773524|Undifferentiated Carcinoma|undifferentiated carcinoma
227858|NCT02773472|colorectal|colorectal
227859|NCT02773472|electroacupuncture|electroacupuncture
227860|NCT02773472|laparoscopic surgery|laparoscopic surgery
227861|NCT02773446|ETEC|etec
227862|NCT02773446|Escherichia coli|escherichia coli
227863|NCT02773446|enteritis|enteritis
227864|NCT02773446|Challenge|challenge
227865|NCT02773446|CS6|cs6
227866|NCT02773446|Enterotoxigenic|enterotoxigenic
227867|NCT02773407|Undifferentiated febrile illness|undifferentiated febrile illness
227868|NCT02773407|Azithromycin|azithromycin
227869|NCT02773407|Cotrimoxazole|cotrimoxazole
227870|NCT02773407|Efficacy|efficacy
227871|NCT02773407|Enteric fever|enteric fever
227872|NCT02773407|Fever clearance time|fever clearance time
227873|NCT02773394|Hepatitis C Virus|hepatitis c virus
227874|NCT02773394|Observational|observational
227875|NCT02773394|Brazil|brazil
227876|NCT02773342|Invasive Pulmonal Aspergillosis|invasive pulmonal aspergillosis
227877|NCT02773342|Neutropenic Patients|neutropenic patients
227878|NCT02773342|Haematological Malignancies|haematological malignancies
227879|NCT02773342|Chest Computed Tomography|chest computed tomography
227880|NCT02773329|chemotherapy induced peripheral neuropathy|chemotherapy induced peripheral neuropathy
227881|NCT02773329|Cancer|cancer
227882|NCT02773329|game-based exercise|game-based exercise
227883|NCT02773329|exercise|exercise
227884|NCT02773329|wearable sensors|wearable sensors
227885|NCT02773329|balance|balance
227886|NCT02773329|falls|falls
227887|NCT02773329|virtual reality|virtual reality
227888|NCT02773303|Neurofeedback|neurofeedback
227889|NCT02773303|balance, postural|balance, postural
227890|NCT02773303|postural equilibrium|postural equilibrium
227891|NCT02773303|EEG|eeg
227892|NCT02773290|Aplastic Anemia|aplastic anemia
227893|NCT02773251|Postoperative adhesion|postoperative adhesion
227894|NCT02773251|Laparoscopy|laparoscopy
227895|NCT02773251|Adhesion barrier|adhesion barrier
227896|NCT02773225|non severe Aplastic Anemia,|non severe aplastic anemia,
227897|NCT02773186|postoperative|postoperative
227898|NCT02773186|behavioral changes|behavioral changes
227899|NCT02773173|Colorectal Laparoscopic Surgery|colorectal laparoscopic surgery
227900|NCT02773134|Post-operative Bracing|post-operative bracing
227901|NCT02773134|Rigid Lumbosacral Orthosis|rigid lumbosacral orthosis
227902|NCT02773134|Posterior Spine Fusion|posterior spine fusion
227903|NCT02773134|Quality of Life|quality of life
227904|NCT02773134|Lumbar Degenerative Conditions|lumbar degenerative conditions
227905|NCT02773121|Cognition|cognition
227906|NCT02773121|Learning|learning
227907|NCT02773121|Memory|memory
227908|NCT02773121|Executive Function|executive function
227909|NCT02773121|Attention|attention
227910|NCT02773121|Neuropsychological Tests|neuropsychological tests
227911|NCT02773121|Physical Activity|physical activity
227912|NCT02773121|Physical Fitness|physical fitness
227913|NCT02773121|Exercise|exercise
227914|NCT02773121|Resistance Training|resistance training
227915|NCT02773121|Walking|walking
227916|NCT02773121|Muscle Stretching Exercises|muscle stretching exercises
227917|NCT02773121|Exercise Test|exercise test
227918|NCT02773121|Balance|balance
227919|NCT02773121|Flexibility|flexibility
227920|NCT02773121|Body Composition|body composition
227921|NCT02773095|Novartis Access|novartis access
227922|NCT02773095|noncommunicable disease burden|noncommunicable disease burden
227923|NCT02773095|medicine availability and price|medicine availability and price
227924|NCT02773095|Kenya|kenya
227925|NCT02773082|Treatment-Resistant|treatment-resistant
227926|NCT02773082|Anxiety|anxiety
227927|NCT02773056|transfemoral|transfemoral
227928|NCT02773056|amputation|amputation
227929|NCT02773056|perspiration|perspiration
227930|NCT02773056|socket|socket
227931|NCT02773056|socket comfort|socket comfort
227932|NCT02773030|Multiple Myeloma|multiple myeloma
227933|NCT02773030|Relapsed|relapsed
227934|NCT02773030|Refractory|refractory
227935|NCT02773030|Pharmacokinetics|pharmacokinetics
227936|NCT02773030|Safety|safety
227937|NCT02773030|Efficacy|efficacy
227938|NCT02773030|CC-220|cc-220
227939|NCT02773030|Relapsed and refractory multiple myeloma|relapsed and refractory multiple myeloma
227940|NCT02773030|Dexamethasone|dexamethasone
227941|NCT02773030|Daratumumab|daratumumab
227942|NCT02773030|Bortezomib|bortezomib
227943|NCT02773017|sedation|sedation
227944|NCT02773017|age|age
227945|NCT02773017|dexmedetomidine|dexmedetomidine
227946|NCT02773004|Genomic test|genomic test
227947|NCT02773004|Chemotherapy decision|chemotherapy decision
227948|NCT02772978|decision making|decision making
227949|NCT02772978|impulsivity|impulsivity
227950|NCT02772926|Benfotiamine|benfotiamine
227951|NCT02772926|Advanced glycation end products|advanced glycation end products
227952|NCT02772926|Soluble receptor for AGEs|soluble receptor for ages
227953|NCT02772926|Endogenous secretory receptor for AGEs|endogenous secretory receptor for ages
227954|NCT02772900|Aging|aging
227955|NCT02772900|Beetroot|beetroot
227956|NCT02772900|Dietary Nitrate|dietary nitrate
227957|NCT02772900|Functional Food|functional food
227958|NCT02772900|Vascular Function|vascular function
227959|NCT02772887|pregnancy|pregnancy
227960|NCT02772887|type 2 diabetes|type 2 diabetes
227961|NCT02772887|asymmetric dimethylarginine|asymmetric dimethylarginine
227962|NCT02772887|L-arginine|l-arginine
227963|NCT02772887|L-citrulline|l-citrulline
227964|NCT02772887|placental growth factor (PlGF)|placental growth factor (plgf)
227965|NCT02772887|blood pressure|blood pressure
227966|NCT02772874|fecal incontinence|fecal incontinence
227967|NCT02772874|severity|severity
227968|NCT02772874|ultrasound|ultrasound
227969|NCT02772874|anorectal manometry|anorectal manometry
227970|NCT02772874|classification|classification
227972|NCT02772835|nHFOV|nhfov
227973|NCT02772835|Preterm|preterm
227974|NCT02772835|RDS|rds
227975|NCT02772835|CO2 Elimination|co2 elimination
227976|NCT02772809|stroke|stroke
227977|NCT02772809|hemiplegia|hemiplegia
227978|NCT02772809|rehabilitation|rehabilitation
227979|NCT02772809|robotics|robotics
227980|NCT02772809|neuroplasticity|neuroplasticity
227981|NCT02772796|Pharmacokinetics|pharmacokinetics
227982|NCT02772796|Healthy Volunteer Study|healthy volunteer study
227983|NCT02772783|brain|brain
227984|NCT02772783|fMRI|fmri
227985|NCT02772783|carbohydrate|carbohydrate
227986|NCT02772783|insulin clamp|insulin clamp
227987|NCT02772783|intake regulation|intake regulation
227988|NCT02772783|overweight|overweight
227989|NCT02772783|glycemic index|glycemic index
227990|NCT02772757|hearing loss|hearing loss
227991|NCT02772757|hearing aids|hearing aids
227992|NCT02772757|outcome assessment|outcome assessment
227993|NCT02772744|Hepatitis C virus genotype 4|hepatitis c virus genotype 4
227994|NCT02772744|Antiviral|antiviral
227995|NCT02772744|Virologic Response|virologic response
227996|NCT02772731|mastectomy|mastectomy
227997|NCT02772718|Hypoglycemia|hypoglycemia
227998|NCT02772705|Standardized Uptake Value|standardized uptake value
227999|NCT02772705|Diagnosis|diagnosis
228000|NCT02772679|Diabetes|diabetes
228001|NCT02772679|Treg|treg
228002|NCT02772679|Proluekin|proluekin
228003|NCT02772666|Relative afferent pupillary defect (RAPD)|relative afferent pupillary defect (rapd)
228004|NCT02772666|Multiple sclerosis|multiple sclerosis
228005|NCT02772666|Glaucoma|glaucoma
228006|NCT02772653|Microcirculation|microcirculation
228007|NCT02772653|Videomicroscopy|videomicroscopy
228008|NCT02772653|Spectroscopy, Near-Infrared|spectroscopy, near-infrared
228009|NCT02772653|B-Type Natriuretic Peptide|b-type natriuretic peptide
228010|NCT02772653|Thromboelastometry|thromboelastometry
228011|NCT02772653|Trauma|trauma
228012|NCT02772653|Resuscitation|resuscitation
228013|NCT02772653|Hypovolemic shock|hypovolemic shock
228014|NCT02772640|Hypercholesterolemia|hypercholesterolemia
228015|NCT02772640|Rosuvastatin|rosuvastatin
228016|NCT02772640|Statin|statin
228017|NCT02772640|Ezetimibe|ezetimibe
228018|NCT02772640|Compliance|compliance
228019|NCT02772640|Cholesterol|cholesterol
228020|NCT02772640|Secondary prevention|secondary prevention
228021|NCT02772640|Coronary artery disease|coronary artery disease
228022|NCT02772640|Cholesterol absorption inhibitor|cholesterol absorption inhibitor
228023|NCT02772627|Parkinson's disease, Nebicapone|parkinson's disease, nebicapone
228024|NCT02772614|Nebicapone, Parkinson's disease|nebicapone, parkinson's disease
228025|NCT02772601|ABBV-066|abbv-066
228026|NCT02772601|BI 655066|bi 655066
228027|NCT02772601|risankizumab|risankizumab
228028|NCT02772588|ARN-509|arn-509
228029|NCT02772588|Abiraterone|abiraterone
228030|NCT02772588|Leuprolide|leuprolide
228031|NCT02772588|Intensity-Modulated and Image-Guided Radiation Therapy|intensity-modulated and image-guided radiation therapy
228032|NCT02772588|15-334|15-334
228033|NCT02772588|apalutamide,|apalutamide,
228034|NCT02772588|JNJ-56021927|jnj-56021927
228035|NCT02772575|MOLECULAR PREDICTORS|molecular predictors
228036|NCT02772575|Hepatic trans-arterial embolization (TAE)|hepatic trans-arterial embolization (tae)
228037|NCT02772575|16-385|16-385
228038|NCT02772562|prostate cancer|prostate cancer
228039|NCT02772549|Diagnosis|diagnosis
228040|NCT02772536|Chronic Tinnitus Tinted Light Change in Perception|chronic tinnitus tinted light change in perception
228041|NCT02772523|Primary Prevention|primary prevention
228042|NCT02772510|Stroke|stroke
228043|NCT02772510|Rehabilitation|rehabilitation
228044|NCT02772510|Hand|hand
228045|NCT02772510|Game|game
228046|NCT02772510|Functional electrical stimulation|functional electrical stimulation
228047|NCT02772510|Virtual reality|virtual reality
228048|NCT02772497|DME|dme
228049|NCT02772497|Anti VEGF|anti vegf
228050|NCT02772497|VEGF trap|vegf trap
228051|NCT02772497|Diabetes|diabetes
228052|NCT02772497|Diabetic retinopathy|diabetic retinopathy
228053|NCT02772497|ZALTRAP|zaltrap
228054|NCT02772497|Ziv aflibercept|ziv aflibercept
228055|NCT02772484|noninvasive monitoring|noninvasive monitoring
228056|NCT02772471|intracranial pressure|intracranial pressure
228057|NCT02772471|noninvasive monitoring|noninvasive monitoring
228058|NCT02772458|Crohn's Disease|crohn's disease
228059|NCT02772458|gut brain axis|gut brain axis
228060|NCT02772458|reduced appetite|reduced appetite
228061|NCT02772445|Empowerment|empowerment
228062|NCT02772445|Caregiver|caregiver
228063|NCT02772432|resiliency training|resiliency training
228064|NCT02772432|parenting|parenting
228065|NCT02772432|special learning disability|special learning disability
228066|NCT02772406|ulcerative colitis|ulcerative colitis
228067|NCT02772406|colonoscopy|colonoscopy
228068|NCT02772406|Dysplasia|dysplasia
228069|NCT02772406|Diagnosis|diagnosis
228070|NCT02772367|cardiotoxicity|cardiotoxicity
228071|NCT02772367|16-025|16-025
228072|NCT02772354|Pediatric population, ablation|pediatric population, ablation
228073|NCT02772341|Asthma|asthma
228074|NCT02772341|Halotherapy|halotherapy
228075|NCT02772341|Airway hyper-reactivity|airway hyper-reactivity
228076|NCT02772341|Metacholine|metacholine
228077|NCT02772328|Testing|testing
228078|NCT02772328|Access|access
228079|NCT02772315|genomics|genomics
228080|NCT02772315|proteomics|proteomics
228081|NCT02772315|metabolomics|metabolomics
228082|NCT02772315|endocrine hypertension|endocrine hypertension
228083|NCT02772315|primary aldosteronism|primary aldosteronism
228084|NCT02772315|Cushing syndrom|cushing syndrom
228085|NCT02772315|pheochromocytoma|pheochromocytoma
228086|NCT02772289|Mesenchyme Stem Cells|mesenchyme stem cells
228087|NCT02772289|Cesarean Section|cesarean section
228088|NCT02772289|Scars|scars
228089|NCT02772276|Glomerular Filtration Rate|glomerular filtration rate
228090|NCT02772263|Paramedicine|paramedicine
228091|NCT02772263|Community Paramedic|community paramedic
228092|NCT02772263|Elderly|elderly
228093|NCT02772250|bowel preparation|bowel preparation
228094|NCT02772250|polyethylene glycol|polyethylene glycol
228095|NCT02772250|face-to-face re-education|face-to-face re-education
228096|NCT02772250|telephone re-education|telephone re-education
228097|NCT02772250|Boston Bowel Preparation Scale|boston bowel preparation scale
228098|NCT02772237|concussion|concussion
228099|NCT02772237|sports-related concussion|sports-related concussion
228100|NCT02772237|mTBI|mtbi
228101|NCT02772237|Riboflavin|riboflavin
228102|NCT02772237|Vitamin B2|vitamin b2
228103|NCT02772159|COPD|copd
228104|NCT02772159|ADME|adme
228105|NCT02772159|Healthy Normal Males|healthy normal males
228106|NCT02772159|Phase 1|phase 1
228107|NCT02772120|Infertility|infertility
228108|NCT02772120|In vitro fertilization|in vitro fertilization
228109|NCT02772120|Embryo transfer|embryo transfer
228110|NCT02772120|Blastocyst|blastocyst
228111|NCT02772120|Progesterone|progesterone
228112|NCT02772120|Crinone|crinone
228113|NCT02772107|Small Cell Lung Carcinoma|small cell lung carcinoma
228114|NCT02772094|glioblastoma multiforme|glioblastoma multiforme
228115|NCT02772094|glioblastoma|glioblastoma
228116|NCT02772094|newly diagnosed glioblastoma|newly diagnosed glioblastoma
228117|NCT02772094|immunotherapy|immunotherapy
228118|NCT02772094|dendritic cells|dendritic cells
228119|NCT02772094|grade IV astrocytoma|grade iv astrocytoma
228120|NCT02772094|oncology|oncology
228121|NCT02772094|neurology|neurology
228122|NCT02772094|glioma|glioma
228123|NCT02772094|brain tumor|brain tumor
228124|NCT02772094|ADCTA-G|adcta-g
228125|NCT02772055|Moxa smoke|moxa smoke
228126|NCT02772055|Moxibustion|moxibustion
228127|NCT02772055|Knee osteoarthritis|knee osteoarthritis
228128|NCT02772042|Manual Therapy|manual therapy
228129|NCT02772042|Physiotherapy|physiotherapy
228130|NCT02772042|Manipulation|manipulation
228131|NCT02771990|Back Pain|back pain
228132|NCT02771964|outcome assessment|outcome assessment
228133|NCT02771964|postoperative period|postoperative period
228134|NCT02771951|Childhood|childhood
228135|NCT02771951|Obesity|obesity
228136|NCT02771938|radiotherapy, breast cancer, DIEP flap|radiotherapy, breast cancer, diep flap
228137|NCT02771925|Gabapentin|gabapentin
228138|NCT02771925|Alcohol Dependence|alcohol dependence
228139|NCT02771899|Imaging, Three-Dimensional|imaging, three-dimensional
228141|NCT02771899|Scoliosis|scoliosis
228142|NCT02771886|mindfulness|mindfulness
228143|NCT02771886|urges|urges
228144|NCT02771886|adolescents|adolescents
228145|NCT02771886|risk behaviors|risk behaviors
228146|NCT02771886|therapy intervention|therapy intervention
228147|NCT02771860|denosumab|denosumab
228148|NCT02771860|RANKL-blockade|rankl-blockade
228149|NCT02771834|Postural balance|postural balance
228150|NCT02771834|Osteoporosis|osteoporosis
228151|NCT02771834|Postmenopause|postmenopause
228152|NCT02771834|Vitamin D|vitamin d
228153|NCT02771834|Kyfhosis|kyfhosis
228154|NCT02771834|Muscle strength|muscle strength
228155|NCT02771808|CABG|cabg
228156|NCT02771795|HER2|her2
228157|NCT02771795|Trastuzumab|trastuzumab
228158|NCT02771795|Biosimilar|biosimilar
228159|NCT02771795|Cancer|cancer
228160|NCT02771795|Breast|breast
228161|NCT02771795|Positive|positive
228162|NCT02771782|BCG|bcg
228163|NCT02771782|TDaP-IPV|tdap-ipv
228164|NCT02771782|DPT Vaccine|dpt vaccine
228165|NCT02771769|cell-free DNA|cell-free dna
228166|NCT02771769|copy number instability|copy number instability
228167|NCT02771769|liquid biopsy|liquid biopsy
228168|NCT02771769|cancer|cancer
228169|NCT02771756|Breast cancer|breast cancer
228170|NCT02771756|Lung cancer|lung cancer
228171|NCT02771756|Nutritional support|nutritional support
228172|NCT02771756|Safety|safety
228173|NCT02771756|Effectiveness|effectiveness
228174|NCT02771743|Neuroblastoma|neuroblastoma
228175|NCT02771743|High risk|high risk
228176|NCT02771743|Tandem high dose chemotherapy|tandem high dose chemotherapy
228177|NCT02771691|Adolescent|adolescent
228178|NCT02771652|Multiple Sclerosis|multiple sclerosis
228179|NCT02771652|Quality of Life|quality of life
228180|NCT02771652|exercise|exercise
228181|NCT02771652|internet|internet
228182|NCT02771639|Hip arthroplasty|hip arthroplasty
228183|NCT02771639|periprosthetic joint infection|periprosthetic joint infection
228184|NCT02771639|outcome|outcome
228185|NCT02771626|RCC|rcc
228186|NCT02771626|MEL|mel
228187|NCT02771626|NSCLC|nsclc
228188|NCT02771626|Immuno-Oncology|immuno-oncology
228189|NCT02771626|Tumor Metabolism|tumor metabolism
228190|NCT02771626|Glutaminase|glutaminase
228191|NCT02771626|Glutaminase Inhibitor|glutaminase inhibitor
228192|NCT02771613|Morbidity Mortality Review|morbidity mortality review
228193|NCT02771613|medical simulation|medical simulation
228194|NCT02771613|in situ simulation|in situ simulation
228195|NCT02771613|multi professional simulation|multi professional simulation
228196|NCT02771613|hospital adverse event|hospital adverse event
228197|NCT02771600|Procedural pain|procedural pain
228198|NCT02771600|Procedural anxiety|procedural anxiety
228199|NCT02771600|Pediatrics|pediatrics
228200|NCT02771600|Needle-related procedures|needle-related procedures
228201|NCT02771587|alcohol|alcohol
228202|NCT02771587|energy drink|energy drink
228203|NCT02771587|coagulability|coagulability
228204|NCT02771587|caffeine|caffeine
228205|NCT02771587|taurine|taurine
228206|NCT02771587|driving performance|driving performance
228207|NCT02771574|Bariatric surgery complications|bariatric surgery complications
228208|NCT02771574|Glucose Metabolism Disorders|glucose metabolism disorders
228209|NCT02771574|Exendin (9-39)|exendin (9-39)
228210|NCT02771574|GLP-1|glp-1
228211|NCT02771561|Patent Foramen Ovale|patent foramen ovale
228212|NCT02771561|Obstructive Sleep Apnea|obstructive sleep apnea
228213|NCT02771561|Apnea-Hypopnea Index|apnea-hypopnea index
228214|NCT02771561|Oxygen Desaturation Index|oxygen desaturation index
228215|NCT02771561|Epworth Sleepiness Scale|epworth sleepiness scale
228216|NCT02771561|Quality of life|quality of life
228217|NCT02771561|Continuous Positive Airway Pressure|continuous positive airway pressure
228218|NCT02771561|Obstructive Sleep Apnea-Hypopnea Syndrome|obstructive sleep apnea-hypopnea syndrome
228219|NCT02771561|Gore™ septal occluder device|gore™ septal occluder device
228220|NCT02771548|Knee injuries|knee injuries
228221|NCT02771548|Rehabilitation|rehabilitation
228222|NCT02771548|Return to sport|return to sport
228223|NCT02771548|Biomechanics|biomechanics
228224|NCT02771522|Caries, Acitivity, Demineralsiation|caries, acitivity, demineralsiation
228225|NCT02771509|CPB|cpb
228226|NCT02771509|Cardiac Surgery|cardiac surgery
228227|NCT02771509|Acute Kidney Injury|acute kidney injury
228228|NCT02771470|Gut microflora|gut microflora
228229|NCT02771470|Lung cancer|lung cancer
228230|NCT02771470|Chemotherapy|chemotherapy
228231|NCT02771470|Immunity|immunity
228232|NCT02771470|Nutrition|nutrition
228233|NCT02771457|Influximab|influximab
228234|NCT02771457|IFX|ifx
228235|NCT02771457|Remicade|remicade
228236|NCT02771418|Carotid endarterectomy|carotid endarterectomy
228237|NCT02771418|postoperative cognitive dysfunction|postoperative cognitive dysfunction
228238|NCT02771405|HCV-HCC-DAAs|hcv-hcc-daas
228239|NCT02771366|neuroinflammation|neuroinflammation
228240|NCT02771366|cognitive function|cognitive function
228241|NCT02771366|aging adults|aging adults
228242|NCT02771314|NSCLC|nsclc
228243|NCT02771314|AZD9291|azd9291
228244|NCT02771314|>= 2nd line|>= 2nd line
228245|NCT02771314|liquid biopsy|liquid biopsy
228246|NCT02771314|EGFR TKIs|egfr tkis
228247|NCT02771314|EGFR mutant|egfr mutant
726813|NCT00521729|Obesity|obesity
228248|NCT02771301|IDH1R132H Dendritic cell glioma|idh1r132h dendritic cell glioma
228249|NCT02771288|Kawasaki disease|kawasaki disease
228250|NCT02771288|optical coherence tomography|optical coherence tomography
228251|NCT02771288|multislice computed tomography|multislice computed tomography
228252|NCT02771275|Mitral Valve Repair|mitral valve repair
228253|NCT02771275|Transapical|transapical
228254|NCT02771275|Artificial Chordae|artificial chordae
228255|NCT02771249|Latent Tuberculosis Infection (LTBI)|latent tuberculosis infection (ltbi)
228256|NCT02771249|Antiretrovirals (ARVs)|antiretrovirals (arvs)
228257|NCT02771249|HIV|hiv
228258|NCT02771249|UGT1A1|ugt1a1
228259|NCT02771249|Drug-Drug Interaction (DDI)|drug-drug interaction (ddi)
228260|NCT02771236|Inherited Eye Disease|inherited eye disease
228261|NCT02771210|Active psoriatic arthritis|active psoriatic arthritis
228262|NCT02771210|Axial spondyloarthritides|axial spondyloarthritides
228263|NCT02771210|Subcutaneous|subcutaneous
228264|NCT02771210|Secukinumab in prefilled syringe|secukinumab in prefilled syringe
228265|NCT02771210|Enthesitis|enthesitis
228266|NCT02771210|Achilles tendon|achilles tendon
228267|NCT02771197|AML|aml
228268|NCT02771171|Pediatric Airway, Three-dimensional Imaging, CT Scan|pediatric airway, three-dimensional imaging, ct scan
228269|NCT02771158|critical care|critical care
228270|NCT02771158|shock, septic|shock, septic
228271|NCT02771158|sepsis|sepsis
228272|NCT02771158|hypotension|hypotension
228273|NCT02771158|midodrine|midodrine
228274|NCT02771093|Type 2, Diabetes, Diabetes Mellitus|type 2, diabetes, diabetes mellitus
228275|NCT02771041|Hip prothesis|hip prothesis
228276|NCT02771002|critically ill patients|critically ill patients
228277|NCT02771002|septic shock|septic shock
228278|NCT02771002|peripheral perfusion index|peripheral perfusion index
228279|NCT02771002|capillary refill time|capillary refill time
228280|NCT02771002|mottling score|mottling score
228281|NCT02771002|microcirculation|microcirculation
228282|NCT02770989|Cardiac Ablation|cardiac ablation
228283|NCT02770989|Safety|safety
228284|NCT02770989|Performance|performance
228285|NCT02770989|Laser|laser
228286|NCT02770963|discogenic|discogenic
228287|NCT02770963|Acupuncture Therapy|acupuncture therapy
228288|NCT02770963|randomized controlled trial|randomized controlled trial
228289|NCT02770950|Knee Osteoarthritis|knee osteoarthritis
228290|NCT02770937|laparoscopy, simulator|laparoscopy, simulator
228291|NCT02770924|cataract|cataract
228292|NCT02770924|phacoemulsification|phacoemulsification
228293|NCT02770924|AT LISA TRI TORIC|at lisa tri toric
228294|NCT02770924|IOL|iol
228295|NCT02770911|Rectal Carcinoma|rectal carcinoma
228296|NCT02770911|Laparoscopy|laparoscopy
228297|NCT02770911|Anastomotic Leak|anastomotic leak
228298|NCT02770911|Double-stapling technique|double-stapling technique
228299|NCT02770898|probation|probation
228300|NCT02770898|evidence-based|evidence-based
228301|NCT02770898|well-being|well-being
228302|NCT02770898|physical exercise|physical exercise
228303|NCT02770898|family well-being|family well-being
228304|NCT02770872|serum amyloid a|serum amyloid a
228305|NCT02770872|lipoprotein|lipoprotein
228306|NCT02770872|insulin resistance|insulin resistance
228307|NCT02770872|dyslipidemia|dyslipidemia
228308|NCT02770859|Achalasia|achalasia
228309|NCT02770833|Proteins (seafood and meat)|proteins (seafood and meat)
228310|NCT02770833|GI|gi
228311|NCT02770833|Energy expenditure|energy expenditure
228312|NCT02770833|Energy balance|energy balance
228313|NCT02770833|Thermogenesis (DIT)|thermogenesis (dit)
228314|NCT02770833|Appetite regulating hormones|appetite regulating hormones
228315|NCT02770833|Appetite sensations|appetite sensations
228316|NCT02770833|Glucose allostatis|glucose allostatis
228317|NCT02770833|Amino acid metabolism|amino acid metabolism
228318|NCT02770833|Satiety|satiety
228319|NCT02770833|Food preferences|food preferences
228320|NCT02770807|Ataxia Teleangiectasia|ataxia teleangiectasia
228321|NCT02770807|AT|at
228322|NCT02770807|EryDex system|erydex system
228323|NCT02770807|Dexamethasone|dexamethasone
228324|NCT02770807|Dexamethasone sodium phosphate|dexamethasone sodium phosphate
228325|NCT02770781|survivors|survivors
228326|NCT02770781|physical fitness|physical fitness
228327|NCT02770768|HSDD (Hypoactive Sexual Desire Disorder)|hsdd (hypoactive sexual desire disorder)
228328|NCT02770768|EEG (Electroencephalogram)|eeg (electroencephalogram)
228329|NCT02770742|patient satisfaction|patient satisfaction
228330|NCT02770742|unsedated colonoscopy|unsedated colonoscopy
228331|NCT02770742|intestinal diseases|intestinal diseases
228332|NCT02770729|intracameral moxifloxacin|intracameral moxifloxacin
228333|NCT02770729|endophthalmitis|endophthalmitis
228334|NCT02770729|Vigamox|vigamox
228335|NCT02770729|endothelial cell density|endothelial cell density
228336|NCT02770716|Type 1|type 1
228337|NCT02770677|Yoga|yoga
228338|NCT02770677|COPD|copd
228339|NCT02770677|rehabilitation|rehabilitation
228340|NCT02770651|optical coherence tomography|optical coherence tomography
228341|NCT02770651|everolimus-eluting stent|everolimus-eluting stent
228342|NCT02770651|zotarolimus-eluting stent|zotarolimus-eluting stent
228343|NCT02770638|Healthy|healthy
228344|NCT02770638|Sport|sport
228345|NCT02770638|Athlete|athlete
228346|NCT02770638|Male|male
228347|NCT02770638|University|university
228348|NCT02770638|Adults|adults
228349|NCT02770638|Rugby Football Union|rugby football union
228350|NCT02770638|Professional|professional
228351|NCT02770638|Competitive sport|competitive sport
228352|NCT02770638|Scoop Stretcher|scoop stretcher
228353|NCT02770638|Ferno Scoop Stretcher|ferno scoop stretcher
228354|NCT02770638|Long back spinal board|long back spinal board
228355|NCT02770638|Emergency Medical Services|emergency medical services
228356|NCT02770638|Long backboard|long backboard
228357|NCT02770638|Patient Extrication|patient extrication
228358|NCT02770638|Triple Immobilisation|triple immobilisation
228359|NCT02770638|Pre hospital Medicine|pre hospital medicine
228360|NCT02770638|Rigid Cervical Collar|rigid cervical collar
228361|NCT02770638|Pressure Testing|pressure testing
228362|NCT02770638|Tissue Pressure Testing|tissue pressure testing
228363|NCT02770638|Visual Analogue Scale|visual analogue scale
228364|NCT02770638|Pressure Sores|pressure sores
228365|NCT02770638|Pressure area damage|pressure area damage
228366|NCT02770638|Tissue Viability|tissue viability
228367|NCT02770638|Tissue Interface Pressure|tissue interface pressure
228368|NCT02770638|Comfort|comfort
228369|NCT02770638|Pain|pain
228370|NCT02770625|Type I Gaucher|type i gaucher
228371|NCT02770625|ISU302|isu302
228372|NCT02770625|Imiglucerase|imiglucerase
228373|NCT02770599|IBD|ibd
228374|NCT02770599|HRQoL|hrqol
228375|NCT02770599|QoC|qoc
228376|NCT02770599|Adherence|adherence
228377|NCT02770599|IBD nurse|ibd nurse
228378|NCT02770599|MDT|mdt
228379|NCT02770573|nano-hydroxyapatite|nano-hydroxyapatite
228380|NCT02770508|antiretroviral naive|antiretroviral naive
228381|NCT02770508|dual therapy|dual therapy
228382|NCT02770482|dementia|dementia
228383|NCT02770482|biomarkers|biomarkers
228384|NCT02770482|cerebrospinal fluid|cerebrospinal fluid
228385|NCT02770469|Breast Cancer|breast cancer
228386|NCT02770469|Korean Americans|korean americans
228387|NCT02770469|Survivorship|survivorship
228388|NCT02770469|Quality of Life|quality of life
228389|NCT02770469|Coping Skills|coping skills
228390|NCT02770469|Perceived Stress|perceived stress
228391|NCT02770456|fish oil, preterm birth, pregnancy, China, prevention|fish oil, preterm birth, pregnancy, china, prevention
228392|NCT02770443|Recovered LVEF|recovered lvef
228393|NCT02770443|DCM|dcm
228394|NCT02770391|HSD3B1 Genotype|hsd3b1 genotype
228395|NCT02770391|Steroid Metabolism|steroid metabolism
228396|NCT02770391|High-risk Prostate Cancer|high-risk prostate cancer
228397|NCT02770391|ARN-509|arn-509
228398|NCT02770378|Temozolomide|temozolomide
228399|NCT02770378|Recurrent Glioblastoma|recurrent glioblastoma
228400|NCT02770352|retrospective chart review|retrospective chart review
228401|NCT02770352|prospective chart review|prospective chart review
228402|NCT02770352|fistula formation and repair|fistula formation and repair
228403|NCT02770352|database|database
228404|NCT02770352|demographics of women with fistulas|demographics of women with fistulas
228405|NCT02770352|internationally accepted risks factors for fistula formation|internationally accepted risks factors for fistula formation
228406|NCT02770339|Pharmacogenomics|pharmacogenomics
228407|NCT02770339|Psychiatric crisis|psychiatric crisis
228408|NCT02770339|Drug overdose|drug overdose
228409|NCT02770339|Psychotropic medications|psychotropic medications
228410|NCT02770326|Safety of Stool Transplant|safety of stool transplant
228411|NCT02770326|Fecal Microbiota Transplantation (FMT)|fecal microbiota transplantation (fmt)
228412|NCT02770326|15-337|15-337
228413|NCT02770300|automatic|automatic
228414|NCT02770300|personalized|personalized
228415|NCT02770300|robotic therapy|robotic therapy
228416|NCT02770261|DP-R208|dp-r208
228417|NCT02770222|Pharmacokinetics|pharmacokinetics
228418|NCT02770196|Community-Supported Agriculture|community-supported agriculture
228419|NCT02770196|Local Food System|local food system
228420|NCT02770196|Vegetable|vegetable
228421|NCT02770196|Fruit|fruit
228422|NCT02770196|Childhood Obesity|childhood obesity
228423|NCT02770183|Myocardial stunning|myocardial stunning
228424|NCT02770183|Echocardiography, Transesophageal|echocardiography, transesophageal
228425|NCT02770183|Extracorporeal Circulation|extracorporeal circulation
228426|NCT02770144|Child Quality of Life|child quality of life
228427|NCT02770144|Financial Coaching|financial coaching
228428|NCT02770144|Socioeconomic Status|socioeconomic status
228429|NCT02770144|Social Determinants of Health|social determinants of health
228430|NCT02770131|hypercholesterolaemia|hypercholesterolaemia
228431|NCT02770131|lipid-lowering therapies|lipid-lowering therapies
228432|NCT02770118|sleep restriction|sleep restriction
228433|NCT02770118|obesity|obesity
228434|NCT02770118|brown adipose tissue|brown adipose tissue
228435|NCT02770105|L-theanine|l-theanine
228436|NCT02770105|caffeine|caffeine
228437|NCT02770105|selective attention|selective attention
228438|NCT02770105|fMRI|fmri
228439|NCT02770105|RVRT|rvrt
228440|NCT02770079|Insulin sensitivity|insulin sensitivity
228441|NCT02770053|Foraminal enlargement|foraminal enlargement
228442|NCT02770053|Root canal treatment|root canal treatment
228443|NCT02770040|Acute Severe Ulcerative Colitis|acute severe ulcerative colitis
228444|NCT02770040|Steroid Refractory Ulcerative Colitis|steroid refractory ulcerative colitis
228445|NCT02770027|Colon Surgery|colon surgery
228446|NCT02770027|blood viscosity|blood viscosity
228447|NCT02770014|Non-Small Cell Lung Cancer|non-small cell lung cancer
228448|NCT02770014|Epidermal Growth Factor Receptor|epidermal growth factor receptor
228449|NCT02770001|Admixture|admixture
228450|NCT02770001|African American|african american
228451|NCT02770001|African American Genetics|african american genetics
228452|NCT02769988|Adolescents|adolescents
228453|NCT02769988|Health Information Literacy|health information literacy
228454|NCT02769988|Health Education|health education
228455|NCT02769975|Endocrinology|endocrinology
228456|NCT02769975|Obesity|obesity
228457|NCT02769975|Pediatric|pediatric
228458|NCT02769975|Growth Disorder|growth disorder
228459|NCT02769975|Pubertal Development|pubertal development
228460|NCT02769962|PARP Inhibitor|parp inhibitor
228461|NCT02769962|Topoisomerase I (Top1)|topoisomerase i (top1)
228462|NCT02769962|Camptothecins|camptothecins
228463|NCT02769962|Nanoparticle Drug Conjugate|nanoparticle drug conjugate
228464|NCT02769962|Solid Tumors|solid tumors
228465|NCT02769949|Genetics|genetics
228466|NCT02769949|Metabolic|metabolic
228467|NCT02769949|Dysmorphic Syndromes|dysmorphic syndromes
228468|NCT02769949|Developmental Delay|developmental delay
228469|NCT02769949|Genetic Counseling|genetic counseling
228470|NCT02769936|Receptors|receptors
228471|NCT02769936|N-Methyl-D-Aspartate|n-methyl-d-aspartate
228472|NCT02769923|WestPharma ID-adapter|westpharma id-adapter
228473|NCT02769923|Star ID syringe|star id syringe
228474|NCT02769923|BCG needle syringe|bcg needle syringe
228475|NCT02769923|fractional dose IPV|fractional dose ipv
228476|NCT02769923|fIPV|fipv
228477|NCT02769923|polio|polio
228478|NCT02769923|Polio Endgame|polio endgame
228480|NCT02769884|artificial pancreas|artificial pancreas
228481|NCT02769832|Abraxane|abraxane
228482|NCT02769832|Albumin-bound Paclitaxel|albumin-bound paclitaxel
228483|NCT02769832|SCLC|sclc
228484|NCT02769832|Gemzar|gemzar
228485|NCT02769819|Flexible fiberscope|flexible fiberscope
228486|NCT02769754|LIVER|liver
228487|NCT02769754|RESECTION|resection
228488|NCT02769754|SURGERY|surgery
228489|NCT02769741|Cashew|cashew
228490|NCT02769741|Lipoprotein|lipoprotein
228491|NCT02769715|Removable partial dentures|removable partial dentures
228492|NCT02769715|partial edentulism|partial edentulism
228493|NCT02769702|Uveitis|uveitis
228494|NCT02769689|Multiple sclerosis|multiple sclerosis
228495|NCT02769689|Natalizumab|natalizumab
228496|NCT02769689|Fingolimod|fingolimod
228497|NCT02769689|Methylprednisolone|methylprednisolone
228498|NCT02769650|Coronary stenosis|coronary stenosis
228499|NCT02769650|Drug-eluting stent|drug-eluting stent
228500|NCT02769650|Coronary angioplasty with stenting|coronary angioplasty with stenting
228501|NCT02769650|Ischemic Heart Disease|ischemic heart disease
228502|NCT02769650|Chronic total occlusion|chronic total occlusion
228503|NCT02769650|Right coronary artery|right coronary artery
228504|NCT02769650|Stress-MRI|stress-mri
228505|NCT02769637|upper gastrointestinal tract|upper gastrointestinal tract
228506|NCT02769637|lung microbiota and inflammation|lung microbiota and inflammation
228507|NCT02769624|Congenital heart disease|congenital heart disease
228508|NCT02769598|Pain|pain
228509|NCT02769598|Nociception|nociception
228510|NCT02769598|Pediatric intensive care|pediatric intensive care
228511|NCT02769598|Pain assessment scale|pain assessment scale
228512|NCT02769598|ANI index|ani index
228513|NCT02769585|Obesity|obesity
228514|NCT02769585|Diabetes Mellitus, Type 2|diabetes mellitus, type 2
228515|NCT02769585|weight reduction|weight reduction
228516|NCT02769572|Knee osteoarthritis|knee osteoarthritis
228517|NCT02769572|moxibustion|moxibustion
228518|NCT02769572|diclofenac sodium gel|diclofenac sodium gel
228519|NCT02769520|squamous cell carcinoma head and neck|squamous cell carcinoma head and neck
228520|NCT02769520|pembrolizumab|pembrolizumab
228521|NCT02769520|cancer|cancer
228522|NCT02769520|SCCHN|scchn
228523|NCT02769494|Oral ulcer|oral ulcer
228524|NCT02769494|Crohn's disease|crohn's disease
228525|NCT02769468|Temperature-Probe Placement-preterm infant-case room|temperature-probe placement-preterm infant-case room
228526|NCT02769455|Food Labelling|food labelling
228527|NCT02769442|Intravenous|intravenous
228528|NCT02769442|Catheter|catheter
228529|NCT02769442|Puncture|puncture
228530|NCT02769442|Peripheral Catheterization|peripheral catheterization
228531|NCT02769442|First Stick Success|first stick success
228532|NCT02769442|Contamination|contamination
228533|NCT02769442|Terumo|terumo
228534|NCT02769442|SurFlash|surflash
228535|NCT02769416|spinal cord injury|spinal cord injury
228536|NCT02769416|traumatic brain injury|traumatic brain injury
228537|NCT02769403|Job Satisfaction|job satisfaction
228538|NCT02769403|Job Performance|job performance
228539|NCT02769403|Primary Care|primary care
228540|NCT02769390|Analgesia|analgesia
228541|NCT02769390|Bupivacaine|bupivacaine
228542|NCT02769390|Clonidine|clonidine
228543|NCT02769377|diabetes, glucometer, mobile-phone|diabetes, glucometer, mobile-phone
228544|NCT02769364|Advanced or Metastatic Breast Cancer|advanced or metastatic breast cancer
228545|NCT02769364|Eribulin|eribulin
228546|NCT02769351|volume overload|volume overload
228547|NCT02769351|heart failure|heart failure
228548|NCT02769351|cardiac decompensation|cardiac decompensation
228549|NCT02769351|ultrafiltration|ultrafiltration
228550|NCT02769338|Implementation|implementation
228551|NCT02769338|Quality Improvement|quality improvement
228552|NCT02769338|Stroke|stroke
228553|NCT02769338|Transient Ischemic Attack|transient ischemic attack
228554|NCT02769338|TIA|tia
228555|NCT02769338|Systems Redesign|systems redesign
228556|NCT02769338|QI Intervention|qi intervention
228557|NCT02769325|atropine|atropine
228558|NCT02769325|pain, postoperative|pain, postoperative
228559|NCT02769312|Quality of Life|quality of life
228560|NCT02769312|Post-Traumatic Stress Disorder|post-traumatic stress disorder
228561|NCT02769312|Transcranial Magnetic Stimulation|transcranial magnetic stimulation
228562|NCT02769312|Feasibility studies|feasibility studies
228563|NCT02769260|pyrosequencing|pyrosequencing
228564|NCT02769260|16S DNA gene|16s dna gene
228565|NCT02769260|Confocal Laser Scanning Microscope|confocal laser scanning microscope
228566|NCT02769260|bacterial viability|bacterial viability
228567|NCT02769260|bacterial diversity|bacterial diversity
228568|NCT02769247|naproxen|naproxen
228569|NCT02769247|lidocaine|lidocaine
228570|NCT02769247|intrauterine device|intrauterine device
228571|NCT02769247|IUD|iud
228572|NCT02769247|pain|pain
228573|NCT02769234|EEG|eeg
228574|NCT02769234|ERP|erp
228575|NCT02769234|Event-related Potentials|event-related potentials
228576|NCT02769234|Alzheimer's|alzheimer's
228577|NCT02769234|P300|p300
228578|NCT02769208|Air Pollution|air pollution
228579|NCT02769208|Air Filtration|air filtration
228580|NCT02769208|Exposure Assessment|exposure assessment
228581|NCT02769208|HEPA Filter|hepa filter
228582|NCT02769208|Electrostatic Precipitator|electrostatic precipitator
228583|NCT02769208|Cardiovascular Disease Biomarkers|cardiovascular disease biomarkers
228584|NCT02769208|Respiratory Disease Biomarkers|respiratory disease biomarkers
228585|NCT02769182|Older adults|older adults
228586|NCT02769182|falls|falls
228587|NCT02769182|cognition|cognition
228588|NCT02769182|smart phone|smart phone
228589|NCT02769169|Ranibizumab, regression of the polyps|ranibizumab, regression of the polyps
228590|NCT02769143|Postmenopausal|postmenopausal
228591|NCT02769143|Bone Density|bone density
228592|NCT02769143|Exercise|exercise
228593|NCT02769104|aromatase inhibitors|aromatase inhibitors
228594|NCT02769104|chemotherapy|chemotherapy
228595|NCT02769104|neoadjuvant|neoadjuvant
228596|NCT02769104|postmenopausal|postmenopausal
228597|NCT02769104|breast cancer|breast cancer
228598|NCT02769078|Anticoagulation|anticoagulation
228599|NCT02769065|Drug Therapy|drug therapy
228600|NCT02769052|endometriosis|endometriosis
228601|NCT02769052|dyspareunia|dyspareunia
228602|NCT02769052|physical therapy|physical therapy
228603|NCT02769052|sexuality|sexuality
228604|NCT02769052|transcutaneous electrical nerve stimulation|transcutaneous electrical nerve stimulation
228605|NCT02769013|Schistosoma haematobium plasmodium falciparum transmission|schistosoma haematobium plasmodium falciparum transmission
228606|NCT02768987|exercise|exercise
228607|NCT02768987|physical activity|physical activity
228608|NCT02768987|behavior modification|behavior modification
228609|NCT02768987|coping skills|coping skills
228610|NCT02768987|self management|self management
228611|NCT02768987|glycemic control|glycemic control
228612|NCT02768987|overweight|overweight
228613|NCT02768987|obesity|obesity
228614|NCT02768987|body composition|body composition
228615|NCT02768987|adherence|adherence
228616|NCT02768961|sofosbuvir|sofosbuvir
228617|NCT02768961|ledipasvir|ledipasvir
228618|NCT02768961|ribavirin|ribavirin
228619|NCT02768961|prisoner|prisoner
228620|NCT02768961|hepatitis c|hepatitis c
228621|NCT02768961|prevalence|prevalence
228622|NCT02768961|hepatitis b|hepatitis b
228623|NCT02768922|Telemedicine|telemedicine
228624|NCT02768922|Telerehabilitation|telerehabilitation
228625|NCT02768922|Speech and language therapy|speech and language therapy
228626|NCT02768883|Childhood asthma|childhood asthma
228627|NCT02768883|Latino|latino
228628|NCT02768870|Mitral Valve Repair|mitral valve repair
228629|NCT02768870|Transapical|transapical
228630|NCT02768870|Artificial Chordae|artificial chordae
228631|NCT02768844|Stochastic Resonance|stochastic resonance
228632|NCT02768844|Fetus/Newborn Infant|fetus/newborn infant
228633|NCT02768844|Drug Withdrawal|drug withdrawal
228634|NCT02768844|Substance Abuse|substance abuse
228635|NCT02768818|Maternal Obesity Complicating Pregnancy|maternal obesity complicating pregnancy
228636|NCT02768805|Influenza|influenza
228637|NCT02768805|Human|human
228638|NCT02768805|RNA Virus Infections|rna virus infections
228639|NCT02768805|Immunologic|immunologic
228640|NCT02768805|Immunogenic Factors|immunogenic factors
228641|NCT02768805|Physiological Effects of Drug|physiological effects of drug
228642|NCT02768805|Virus Diseases|virus diseases
228643|NCT02768805|Orthomyxoviridae Infections|orthomyxoviridae infections
228644|NCT02768805|Infection|infection
228645|NCT02768779|hair|hair
228646|NCT02768766|MEK inhibitor|mek inhibitor
228647|NCT02768766|Selumetinib|selumetinib
228648|NCT02768766|hyd-sulfate AZD6244|hyd-sulfate azd6244
228649|NCT02768766|Uveal melanoma|uveal melanoma
228650|NCT02768766|Melanoma|melanoma
228651|NCT02768753|Robotic thyroidectomy|robotic thyroidectomy
228652|NCT02768753|Robotic central neck dissection|robotic central neck dissection
228653|NCT02768753|Axillary bilateral-breast approach|axillary bilateral-breast approach
228654|NCT02768753|Bilateral axillo-breast approach|bilateral axillo-breast approach
228655|NCT02768727|neurocognitive function|neurocognitive function
228656|NCT02768727|neural inertia|neural inertia
228657|NCT02768727|xenon gas|xenon gas
228658|NCT02768714|Breast Cancer High risk Stage II or Stage III / IV|breast cancer high risk stage ii or stage iii / iv
228659|NCT02768701|Pembrolizumab|pembrolizumab
228660|NCT02768701|cyclophosphamide|cyclophosphamide
228661|NCT02768688|Human Brain|human brain
228662|NCT02768688|Magnetic Resonance Imaging (MRI)|magnetic resonance imaging (mri)
228663|NCT02768688|Dexmedetomidine|dexmedetomidine
228664|NCT02768688|Cerebral blood flow|cerebral blood flow
228665|NCT02768675|Kyphotic|kyphotic
228666|NCT02768675|Corrective Surgery|corrective surgery
228667|NCT02768675|Spinal fractures|spinal fractures
228668|NCT02768636|Omega-3, ANS, HRV, SDNN|omega-3, ans, hrv, sdnn
228669|NCT02768610|dexmedetomidine|dexmedetomidine
228670|NCT02768584|severe mental illness|severe mental illness
228671|NCT02768584|nursing|nursing
228672|NCT02768584|therapeutic alliance|therapeutic alliance
228673|NCT02768584|psychiatric diseases|psychiatric diseases
228674|NCT02768571|cerebrolysin, stroke, motor function|cerebrolysin, stroke, motor function
228675|NCT02768558|Lung Cancer|lung cancer
228677|NCT02768558|Nivolumab|nivolumab
228678|NCT02768545|Hepatitis C|hepatitis c
228679|NCT02768545|Ezetimibe|ezetimibe
228680|NCT02768545|Cholesterol|cholesterol
228681|NCT02768545|Enterohepatic Circulation|enterohepatic circulation
228682|NCT02768545|Bile|bile
228683|NCT02768545|Feces|feces
228684|NCT02768532|Crohn's disease|crohn's disease
228685|NCT02768532|Vedolizumab|vedolizumab
228686|NCT02768532|TNF (Tumor Necrosis Factor)|tnf (tumor necrosis factor)
228687|NCT02768532|Clinical response|clinical response
228688|NCT02768532|Clinical remission|clinical remission
228689|NCT02768519|Participants|participants
228690|NCT02768506|obesity, malabsorption, gastric bypass, SADI-S|obesity, malabsorption, gastric bypass, sadi-s
228691|NCT02768480|Diabetes|diabetes
228692|NCT02768480|phone calls|phone calls
228693|NCT02768480|glycemic control|glycemic control
228694|NCT02768467|Alloderm graft|alloderm graft
228695|NCT02768467|Allograft|allograft
228696|NCT02768467|Buccal Mucosa|buccal mucosa
228697|NCT02768454|broad-spectrum antimicrobial|broad-spectrum antimicrobial
228698|NCT02768454|antibiotics pharmacist|antibiotics pharmacist
228699|NCT02768428|Knowledge [K01.468]|knowledge [k01.468]
228700|NCT02768428|Video-Audio Media [V01.255.500]|video-audio media [v01.255.500]
228701|NCT02768428|Handbooks [V02.520]|handbooks [v02.520]
228702|NCT02768402|Mitral Valve Regurgitation|mitral valve regurgitation
228703|NCT02768402|Primary MR|primary mr
228704|NCT02768402|Secondary MR|secondary mr
228705|NCT02768402|MR|mr
228706|NCT02768402|Heart Failure|heart failure
228707|NCT02768402|Structural Heart|structural heart
228708|NCT02768402|Secondary Mitral Valve Regurgitation|secondary mitral valve regurgitation
228709|NCT02768402|Primary Mitral Valve Regurgitation|primary mitral valve regurgitation
228710|NCT02768402|Transseptal|transseptal
228711|NCT02768402|Transcatheter|transcatheter
228712|NCT02768389|Modified Atkins Diet|modified atkins diet
228713|NCT02768389|MAD|mad
228714|NCT02768389|Brain Tumor|brain tumor
228715|NCT02768389|Glioblastoma|glioblastoma
228716|NCT02768363|Immunotherapy|immunotherapy
228717|NCT02768363|Tumor vaccine|tumor vaccine
228718|NCT02768363|Immuno-oncology|immuno-oncology
228719|NCT02768363|Cytotoxicity|cytotoxicity
228720|NCT02768363|Prostate cancer|prostate cancer
228721|NCT02768363|Active Surveillance|active surveillance
228722|NCT02768350|lung collapse|lung collapse
228723|NCT02768350|ventilator hyper inflation|ventilator hyper inflation
228724|NCT02768350|hemodynamic responses|hemodynamic responses
228725|NCT02768350|ventilatory responses|ventilatory responses
228726|NCT02768350|trauma patients|trauma patients
228727|NCT02768337|brain metastasis|brain metastasis
228728|NCT02768337|operable brain metastasis|operable brain metastasis
228729|NCT02768324|sepsis|sepsis
228730|NCT02768324|Gastrointestinal Microbiome|gastrointestinal microbiome
228731|NCT02768324|Gut microbiota|gut microbiota
228732|NCT02768324|Gut Flora|gut flora
228733|NCT02768324|Intestinal Flora|intestinal flora
228734|NCT02768311|Instrumentation Post-operative pain Root canal preparation|instrumentation post-operative pain root canal preparation
228735|NCT02768298|Heart failure|heart failure
228736|NCT02768298|systolic heart failure|systolic heart failure
228737|NCT02768298|heart failure with reduced ejection fraction|heart failure with reduced ejection fraction
228738|NCT02768298|exercise capacity|exercise capacity
228739|NCT02768285|apical patency|apical patency
228740|NCT02768285|root canal treatment|root canal treatment
228741|NCT02768233|Medication-overuse Headache|medication-overuse headache
228742|NCT02768233|Educational Programme|educational programme
228743|NCT02768233|Personality Profiles|personality profiles
228744|NCT02768181|nutrition-specific behaviour change communication|nutrition-specific behaviour change communication
228745|NCT02768181|dietary supplements|dietary supplements
228746|NCT02768168|Dezocine|dezocine
228747|NCT02768168|Dexamethasone 21-phosphate|dexamethasone 21-phosphate
228748|NCT02768168|Pain|pain
228749|NCT02768168|Pruritus|pruritus
228750|NCT02768155|OA, Osteoarthritis, Knee|oa, osteoarthritis, knee
228751|NCT02768116|Active Transfer of Plaque|active transfer of plaque
228752|NCT02768103|upper extremity|upper extremity
228753|NCT02768103|spinal cord injury|spinal cord injury
228754|NCT02768103|surgical reconstruction|surgical reconstruction
228755|NCT02768103|MRI, functional|mri, functional
228756|NCT02768103|rehabilitation|rehabilitation
228757|NCT02768077|melatonin|melatonin
228758|NCT02768077|sleep disturbances|sleep disturbances
228759|NCT02768025|smoking cessation|smoking cessation
228760|NCT02768025|tobacco control|tobacco control
228761|NCT02768025|acupuncture|acupuncture
228762|NCT02768025|Korean Medicine|korean medicine
228763|NCT02768025|Traditional & Complementary Medicine|traditional & complementary medicine
228764|NCT02767999|Acute ischemic stroke|acute ischemic stroke
228765|NCT02767986|Health Disparities|health disparities
228766|NCT02767986|Mental Models|mental models
228767|NCT02767986|Hispanic|hispanic
228768|NCT02767986|Health Belief Model|health belief model
228769|NCT02767986|Cultural Consensus Theory|cultural consensus theory
228770|NCT02767986|Cancer Genetics|cancer genetics
228771|NCT02767986|Qualitative|qualitative
228772|NCT02767960|Tenascin-C|tenascin-c
228774|NCT02767908|Smoking Cessation|smoking cessation
228775|NCT02767869|Metabolic syndrome|metabolic syndrome
228776|NCT02767869|central obesity|central obesity
228777|NCT02767869|Banaba|banaba
228778|NCT02767869|insulin secretion|insulin secretion
228779|NCT02767869|insulin sensitivity|insulin sensitivity
228780|NCT02767804|ALK-positive NSCLC|alk-positive nsclc
228781|NCT02767778|Acute ischemic stroke|acute ischemic stroke
228782|NCT02767778|Neuroprotection|neuroprotection
228783|NCT02767778|Extremely low frequency magnetic fields|extremely low frequency magnetic fields
228784|NCT02767752|Resectable pancreatic cancer|resectable pancreatic cancer
228785|NCT02767752|Adjuvant|adjuvant
228786|NCT02767713|Cognition Disorders|cognition disorders
228787|NCT02767713|Cardiac Surgical Procedures|cardiac surgical procedures
228788|NCT02767713|dexamethasone|dexamethasone
228789|NCT02767687|Postoperative Care|postoperative care
228790|NCT02767687|Postoperative Period|postoperative period
228791|NCT02767687|Heart Surgery|heart surgery
228792|NCT02767674|R-Gemox|r-gemox
228793|NCT02767674|R-miniCHOP|r-minichop
228794|NCT02767674|elderly patients with diffuse large B cell lymphoma|elderly patients with diffuse large b cell lymphoma
228795|NCT02767661|metronomic capecitabine|metronomic capecitabine
228796|NCT02767661|aromatase inhibitor|aromatase inhibitor
228797|NCT02767661|first line treatment|first line treatment
228798|NCT02767661|metastatic breast cancer|metastatic breast cancer
228799|NCT02767648|cholestasis|cholestasis
228800|NCT02767648|neonatal|neonatal
228801|NCT02767648|infant|infant
228802|NCT02767596|Type 2 Diabetes Mellitus|type 2 diabetes mellitus
228803|NCT02767596|treatment|treatment
228804|NCT02767596|GLP-1|glp-1
228805|NCT02767583|Neuropathology|neuropathology
228806|NCT02767570|Osteoarthritis, Knee|osteoarthritis, knee
228807|NCT02767570|Arthritis|arthritis
228808|NCT02767570|Joint Diseases|joint diseases
228809|NCT02767570|Musculoskeletal Diseases|musculoskeletal diseases
228810|NCT02767570|Rheumatic Diseases|rheumatic diseases
228811|NCT02767544|laparoscopic hysterectomy|laparoscopic hysterectomy
228812|NCT02767544|postoperative pain|postoperative pain
228813|NCT02767544|local analgesia|local analgesia
228814|NCT02767544|vaginal wound|vaginal wound
228815|NCT02767479|eradication rates|eradication rates
228816|NCT02767479|rabeprazole|rabeprazole
228817|NCT02767479|esomeprazole|esomeprazole
228818|NCT02767453|Shoulder arthroplasty|shoulder arthroplasty
228819|NCT02767453|Closed suction drainage|closed suction drainage
228820|NCT02767453|Glenohumeral|glenohumeral
228821|NCT02767453|Drainage tube|drainage tube
228822|NCT02767427|Infection Control|infection control
228823|NCT02767427|Preoperative Care|preoperative care
228824|NCT02767427|Chlorhexidine|chlorhexidine
228825|NCT02767427|Pre-Surgical Wash|pre-surgical wash
228826|NCT02767427|Spine Surgery|spine surgery
228827|NCT02767427|Surgical site infections|surgical site infections
228828|NCT02767427|Cutaneous bacterial load on skin|cutaneous bacterial load on skin
228829|NCT02767401|PET-CT|pet-ct
228830|NCT02767401|Cardiac magnetic resonance (CMR) imaging|cardiac magnetic resonance (cmr) imaging
712520|NCT00579865|Quality of Life|quality of life
228831|NCT02767401|Major adverse cardiac events (MACEs)|major adverse cardiac events (maces)
228832|NCT02767401|coronary artery disease|coronary artery disease
228833|NCT02767375|Hepatocellular Carcinoma|hepatocellular carcinoma
228834|NCT02767375|Hepatic arterial infusion chemotherapy|hepatic arterial infusion chemotherapy
228835|NCT02767362|atorvastatin|atorvastatin
228836|NCT02767362|endometrium|endometrium
228837|NCT02767362|endometrial cancer|endometrial cancer
228838|NCT02767310|Bioequivalence|bioequivalence
228839|NCT02767310|two rosuvastatin-containing products|two rosuvastatin-containing products
228840|NCT02767284|Contrast Sensitivity|contrast sensitivity
228841|NCT02767284|Diagnostic Techniques, Ophthalmological|diagnostic techniques, ophthalmological
228842|NCT02767258|Dry eye|dry eye
228843|NCT02767258|Diseases of the eye and adnexa|diseases of the eye and adnexa
228844|NCT02767245|Thiamine|thiamine
228845|NCT02767245|Congestive heart failure|congestive heart failure
228846|NCT02767245|Atrial fibrillation|atrial fibrillation
228847|NCT02767245|Graves' disease|graves' disease
228848|NCT02767232|PHLO|phlo
228849|NCT02767232|deep vein thrombosis|deep vein thrombosis
228850|NCT02767232|deep venous thrombosis|deep venous thrombosis
228851|NCT02767232|blood clot|blood clot
228852|NCT02767232|catheter-directed thrombolysis|catheter-directed thrombolysis
228853|NCT02767232|thrombolysis|thrombolysis
228854|NCT02767232|post-thrombotic syndrome|post-thrombotic syndrome
228855|NCT02767232|PTS|pts
228856|NCT02767232|recombinant tissue plasminogen activator|recombinant tissue plasminogen activator
228857|NCT02767232|rt-PA|rt-pa
228858|NCT02767232|Activase|activase
228859|NCT02767232|Alteplase|alteplase
228860|NCT02767219|Ophthalmology|ophthalmology
228861|NCT02767206|Transnasal endoscopy|transnasal endoscopy
228862|NCT02767206|ultrathin endoscopes|ultrathin endoscopes
228863|NCT02767206|esophageal varices|esophageal varices
228864|NCT02767206|gastric varices|gastric varices
228865|NCT02767167|Cow's milk|cow's milk
228866|NCT02767167|Iodine|iodine
228867|NCT02767167|Selenium|selenium
228868|NCT02767167|Women|women
228869|NCT02767167|Child-bearing age|child-bearing age
228870|NCT02767154|extracorporeal circulation|extracorporeal circulation
228871|NCT02767141|Hunger|hunger
228872|NCT02767141|food insecurity|food insecurity
228873|NCT02767141|behaviors|behaviors
228874|NCT02767128|pharmacokinetics|pharmacokinetics
228875|NCT02767128|healthy adult volunteer|healthy adult volunteer
228876|NCT02767102|Mediterranean diet|mediterranean diet
228877|NCT02767102|indoleamine|indoleamine
228878|NCT02767102|nutraceuticals|nutraceuticals
228879|NCT02767102|nutrition|nutrition
228880|NCT02767102|oxidative stress|oxidative stress
228881|NCT02767089|Glucocorticoids, Biomarkers, Dissociated Agonist of the Glucocorticoid Receptor|glucocorticoids, biomarkers, dissociated agonist of the glucocorticoid receptor
228882|NCT02767076|paramedian spinal anesthesia|paramedian spinal anesthesia
228883|NCT02767076|real time|real time
228884|NCT02767076|ultrasound|ultrasound
228885|NCT02767076|knee surgeries|knee surgeries
228886|NCT02767076|conventional|conventional
228887|NCT02767050|DENTAL CARIES|dental caries
228888|NCT02767050|TOBACCO USERS|tobacco users
228889|NCT02767050|SMOKERS|smokers
228890|NCT02767050|SMOKELESS TOBACCO CHEWERS|smokeless tobacco chewers
228891|NCT02767011|surgical site infection|surgical site infection
228892|NCT02766985|FSHD|fshd
228893|NCT02766985|muscular dystrophy|muscular dystrophy
228894|NCT02766972|Intracranial Aneurysm|intracranial aneurysm
228895|NCT02766972|Surgical Clipping|surgical clipping
228896|NCT02766972|Rapid Ventricular Pacing|rapid ventricular pacing
228897|NCT02766959|chronic rhinosinusitis|chronic rhinosinusitis
228898|NCT02766959|airway physiology|airway physiology
228899|NCT02766959|taste receptors|taste receptors
228900|NCT02766959|tas2r|tas2r
228901|NCT02766959|epithelial biology|epithelial biology
228902|NCT02766959|upper respiratory disease|upper respiratory disease
228903|NCT02766946|Mechanical Ventilation|mechanical ventilation
228904|NCT02766933|tenofovir|tenofovir
228905|NCT02766933|hepatocellular carcinoma|hepatocellular carcinoma
228906|NCT02766933|cirrhosis|cirrhosis
228907|NCT02766881|Ductal Carcinoma in Situ|ductal carcinoma in situ
228908|NCT02766881|DSC|dsc
228909|NCT02766881|Breast Conserving Surgery|breast conserving surgery
228910|NCT02766855|cysteamine|cysteamine
228911|NCT02766855|nephropathic cystinosis|nephropathic cystinosis
228912|NCT02766855|cystine crystals|cystine crystals
228913|NCT02766842|SharkCore|sharkcore
228914|NCT02766842|ProCore|procore
228915|NCT02766829|spinal|spinal
228916|NCT02766829|anesthesia|anesthesia
228917|NCT02766829|sitting|sitting
228918|NCT02766829|cross leg|cross leg
228919|NCT02766829|spinal-bone contact|spinal-bone contact
228920|NCT02766738|residential aged care|residential aged care
228921|NCT02766738|mobility|mobility
228922|NCT02766738|social participation|social participation
228923|NCT02766738|functional capability|functional capability
228924|NCT02766712|catheter ablation|catheter ablation
228925|NCT02766712|atrial fibrillation|atrial fibrillation
228926|NCT02766699|Astrocytoma, Grade IV|astrocytoma, grade iv
228927|NCT02766699|Doxorubicin|doxorubicin
228928|NCT02766699|Glioblastoma|glioblastoma
228929|NCT02766699|Neoplasms|neoplasms
228930|NCT02766699|Neoplasms by Site|neoplasms by site
228931|NCT02766699|Antineoplastic Agents|antineoplastic agents
228932|NCT02766699|Drug Delivery Systems|drug delivery systems
228933|NCT02766699|Molecular Targeted Therapy|molecular targeted therapy
228934|NCT02766699|Nanoparticles|nanoparticles
228935|NCT02766699|Disease Progression|disease progression
228936|NCT02766699|Recurrence|recurrence
228937|NCT02766699|Brain Neoplasms|brain neoplasms
228938|NCT02766699|Immunotherapy|immunotherapy
228939|NCT02766699|Receptor, Epidermal Growth Factor|receptor, epidermal growth factor
228940|NCT02766699|Antibodies, Bispecific|antibodies, bispecific
228941|NCT02766686|Prostate cancer|prostate cancer
228942|NCT02766686|proton radiotherapy|proton radiotherapy
228943|NCT02766686|photon radiotherapy|photon radiotherapy
228944|NCT02766660|Thyroid ophthalmopathy|thyroid ophthalmopathy
228945|NCT02766660|optical coherence tomography|optical coherence tomography
228946|NCT02766647|Filgrastim|filgrastim
228947|NCT02766634|filgrastim|filgrastim
228948|NCT02766621|First in human, Phase 1, Healthy volunteers|first in human, phase 1, healthy volunteers
228949|NCT02766608|COPD|copd
228950|NCT02766582|Ovarian|ovarian
228951|NCT02766582|platinum|platinum
228952|NCT02766582|pembrolizumab|pembrolizumab
228953|NCT02766582|taxane|taxane
228954|NCT02766569|IRFACODE II, ASD closure, ASD device, erosion, arrhythmia|irfacode ii, asd closure, asd device, erosion, arrhythmia
228955|NCT02766543|prostate cancer|prostate cancer
228956|NCT02766543|high intensity transurethral ultrasound ablation|high intensity transurethral ultrasound ablation
228957|NCT02766543|MRI-guided|mri-guided
228958|NCT02766543|minimally invasive|minimally invasive
228959|NCT02766543|real-time temperature feedback control|real-time temperature feedback control
228960|NCT02766491|Stretching|stretching
228961|NCT02766465|Sickle Cell Disease|sickle cell disease
228962|NCT02766465|Young Adults|young adults
228963|NCT02766465|Phase II Trial|phase ii trial
228964|NCT02766465|Hematopoietic Cell Transplantation (HCT)|hematopoietic cell transplantation (hct)
228965|NCT02766465|Human Leukocyte Antigen (HLA)|human leukocyte antigen (hla)
228966|NCT02766400|Stroke|stroke
228967|NCT02766400|Rehabilitation|rehabilitation
228968|NCT02766400|Cognition|cognition
228969|NCT02766400|Disability|disability
228970|NCT02766400|Intervention|intervention
228971|NCT02766374|Asthma|asthma
228972|NCT02766374|Biofeedback|biofeedback
228973|NCT02766374|Heart rate variability biofeedback|heart rate variability biofeedback
228974|NCT02766374|Inhaled corticosteroids|inhaled corticosteroids
228975|NCT02766361|Bipolar disorder|bipolar disorder
228976|NCT02766361|Psychotherapy|psychotherapy
228977|NCT02766361|Cognitive rehabilitation|cognitive rehabilitation
228978|NCT02766348|DC-CTL, NSCLC|dc-ctl, nsclc
228979|NCT02766322|Alcohol metabolism|alcohol metabolism
228980|NCT02766322|Bariatric surgery|bariatric surgery
228981|NCT02766309|Self-assessment of health, Sf12-v2|self-assessment of health, sf12-v2
228982|NCT02766296|PTSD|ptsd
228983|NCT02766296|trauma|trauma
228984|NCT02766296|working memory|working memory
228985|NCT02766296|working memory training|working memory training
228986|NCT02766283|Children|children
228987|NCT02766283|Iodinated contrast agents|iodinated contrast agents
228988|NCT02766270|Grade II/III Glioma|grade ii/iii glioma
228989|NCT02766270|IDH|idh
228990|NCT02766270|TERT|tert
228991|NCT02766270|Chemoradiotherapy|chemoradiotherapy
228992|NCT02766270|Temozolomide|temozolomide
228993|NCT02766218|toddler obesity|toddler obesity
228994|NCT02766218|responsive feeding|responsive feeding
228995|NCT02766218|behavioral weight control|behavioral weight control
228996|NCT02766218|pregnancy weight gain|pregnancy weight gain
228997|NCT02766218|early life risk factors|early life risk factors
228998|NCT02766205|Embolic Stroke of Undetermined Source|embolic stroke of undetermined source
228999|NCT02766205|Atrial fibrillation|atrial fibrillation
229000|NCT02766205|prognostic score|prognostic score
229001|NCT02766192|ketamine|ketamine
229002|NCT02766192|mindfulness based cognitive therapy|mindfulness based cognitive therapy
229003|NCT02766192|PTSD|ptsd
229004|NCT02766192|trauma memory|trauma memory
229005|NCT02766192|memory extinction|memory extinction
229006|NCT02766192|memory re-consolidation|memory re-consolidation
229007|NCT02766192|metabolomics|metabolomics
229008|NCT02766192|TIMBER (Trauma Intervention using Mindfulness Based Extinction and Re-consolidation of trauma memories)|timber (trauma intervention using mindfulness based extinction and re-consolidation of trauma memories)
229009|NCT02766127|radiotherapy|radiotherapy
229010|NCT02766114|CTS|cts
229011|NCT02766114|Carpal tunnel syndrome|carpal tunnel syndrome
229012|NCT02766114|Carpal tunnel release|carpal tunnel release
229013|NCT02766114|Mini incision of carpal tunnel release|mini incision of carpal tunnel release
229014|NCT02766114|Cosmetic surgery of carpal tunnel syndrome|cosmetic surgery of carpal tunnel syndrome
229015|NCT02766114|endoscopic carpal tunnel surgery|endoscopic carpal tunnel surgery
229016|NCT02766114|Carpal Tunnel Release Through Mini Transverse Approach|carpal tunnel release through mini transverse approach
712521|NCT00579852|Lung|lung
229017|NCT02766114|Dr. Sayed Issa's Approach|dr. sayed issa's approach
229018|NCT02766114|CTRMTA|ctrmta
229019|NCT02766114|OCTR|octr
229020|NCT02766114|ECTR|ectr
229021|NCT02766114|Open Carpal Tunnel Release|open carpal tunnel release
229022|NCT02766114|Endoscopic Carpal Tunnel Release|endoscopic carpal tunnel release
229023|NCT02766114|Syria|syria
229024|NCT02766114|Cosmetic|cosmetic
229025|NCT02766114|Safety|safety
229026|NCT02766114|Rehabilitation,|rehabilitation,
229027|NCT02766114|Complications|complications
229028|NCT02766114|Surgery|surgery
229029|NCT02766114|Satisfaction|satisfaction
229030|NCT02766088|Dengue|dengue
229031|NCT02766088|Household|household
229032|NCT02766088|Southeast Asia|southeast asia
229033|NCT02766088|Latin America|latin america
229034|NCT02766088|Surveillance|surveillance
229035|NCT02766075|Transcatheter Aortic Valve Disease|transcatheter aortic valve disease
229036|NCT02766075|Supervised TAVR Exercise Program|supervised tavr exercise program
229037|NCT02766062|Postoperative cognitive dysfunction|postoperative cognitive dysfunction
229038|NCT02766062|metabolic syndrome|metabolic syndrome
229039|NCT02766062|propofol|propofol
229040|NCT02766062|sevoflurane|sevoflurane
229041|NCT02766049|HIV|hiv
229042|NCT02766049|immunotherapy|immunotherapy
229043|NCT02766049|clinical trial|clinical trial
229044|NCT02766049|dendritic cell|dendritic cell
229045|NCT02766036|Proteinuria|proteinuria
229046|NCT02766036|Propolis|propolis
229047|NCT02766036|Chronic Kidney Disease|chronic kidney disease
229048|NCT02766023|CTV-05|ctv-05
229049|NCT02766023|LACTIN-V|lactin-v
229050|NCT02766023|Lactobacillus|lactobacillus
229051|NCT02766023|MetroGel®|metrogel®
229052|NCT02766023|Vaginitis|vaginitis
229053|NCT02765997|AML|aml
229054|NCT02765997|ALL|all
229055|NCT02765997|MDS|mds
229056|NCT02765984|implantation site|implantation site
229057|NCT02765984|placental site|placental site
229058|NCT02765984|Doppler|doppler
229059|NCT02765971|chewing gums|chewing gums
229060|NCT02765971|laxatives|laxatives
229061|NCT02765971|bowel function|bowel function
229062|NCT02765945|Exercise|exercise
229063|NCT02765945|Osteoporosis|osteoporosis
229064|NCT02765945|Cytokines|cytokines
229065|NCT02765932|Hip|hip
229066|NCT02765932|Knee|knee
229067|NCT02765932|replacement|replacement
229068|NCT02765932|surgery|surgery
229069|NCT02765919|Carcinoma cervix|carcinoma cervix
229070|NCT02765919|RCT(randomised controlled trial)|rct(randomised controlled trial)
229071|NCT02765919|9 Gray|9 gray
229072|NCT02765919|Brachytherapy|brachytherapy
229073|NCT02765906|video|video
229074|NCT02765906|educational tool|educational tool
229075|NCT02765906|preeclampsia|preeclampsia
229076|NCT02765906|hypertension|hypertension
229077|NCT02765906|pregnancy|pregnancy
229078|NCT02765906|patient education|patient education
229079|NCT02765906|graphic card|graphic card
229080|NCT02765906|eclampsia|eclampsia
229081|NCT02765906|HELLP|hellp
229082|NCT02765906|anxiety|anxiety
229083|NCT02765906|anxiety assessment|anxiety assessment
229084|NCT02765906|STAI 6|stai 6
229085|NCT02765841|HoFH|hofh
229086|NCT02765815|TKA|tka
229087|NCT02765815|Knee replacement|knee replacement
229088|NCT02765815|Arthritis|arthritis
229089|NCT02765815|Knee|knee
229090|NCT02765776|Anti-HIV Drugs|anti-hiv drugs
229091|NCT02765776|Raltegravir Potassium|raltegravir potassium
229092|NCT02765776|Aged|aged
229093|NCT02765776|Retrospective Study|retrospective study
229094|NCT02765776|Medical Records|medical records
229095|NCT02765750|Emergence agitation|emergence agitation
229096|NCT02765711|ticagrelor|ticagrelor
229097|NCT02765711|acute coronary syndrome|acute coronary syndrome
229098|NCT02765698|Magnetic Resonance Imaging|magnetic resonance imaging
229099|NCT02765672|Combat Veterans|combat veterans
229100|NCT02765672|Automobile Driving|automobile driving
229101|NCT02765672|Fitness to Drive|fitness to drive
229102|NCT02765659|HIV|hiv
229103|NCT02765659|Prevention|prevention
229104|NCT02765659|Implementation|implementation
229105|NCT02765659|Community based participatory research|community based participatory research
229106|NCT02765620|Positron-Emission Tomography|positron-emission tomography
229107|NCT02765620|Response Criteria|response criteria
229108|NCT02765620|solid tumor|solid tumor
229109|NCT02765607|Blood circulation|blood circulation
229110|NCT02765607|Cardiac surgical procedures|cardiac surgical procedures
229111|NCT02765607|Homeostasis|homeostasis
229112|NCT02765594|Glomerulonephritis, IGA|glomerulonephritis, iga
229113|NCT02765594|Kidney Diseases|kidney diseases
229114|NCT02765594|Autoimmune Diseases|autoimmune diseases
229115|NCT02765594|Glomerulonephritis|glomerulonephritis
229116|NCT02765594|Nephritis|nephritis
229117|NCT02765594|Immune System Diseases|immune system diseases
229118|NCT02765594|Urologic Diseases|urologic diseases
229119|NCT02765594|Hydroxychloroquine|hydroxychloroquine
229120|NCT02765594|Anti-Infective Agents|anti-infective agents
229121|NCT02765594|Antimalarials|antimalarials
229122|NCT02765594|Antiparasitic Agents|antiparasitic agents
229123|NCT02765594|Antiprotozoal Agents|antiprotozoal agents
229124|NCT02765594|Antirheumatic Agents|antirheumatic agents
229125|NCT02765594|Enzyme Inhibitors|enzyme inhibitors
229126|NCT02765594|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action
229127|NCT02765594|Pharmacologic Actions|pharmacologic actions
229128|NCT02765594|Therapeutic Uses|therapeutic uses
229129|NCT02765594|interleukin-6|interleukin-6
229130|NCT02765594|interferon-alpha|interferon-alpha
229131|NCT02765594|tumor necrosis factor-alpha|tumor necrosis factor-alpha
229132|NCT02765581|Acupuncture|acupuncture
229133|NCT02765581|Migraine without aura|migraine without aura
229134|NCT02765581|Efficacy|efficacy
229135|NCT02765581|Randomized controlled trial|randomized controlled trial
229136|NCT02765581|Non-penetrating sham acupuncture|non-penetrating sham acupuncture
229137|NCT02765568|Coronary Artery Disease|coronary artery disease
229138|NCT02765568|Percutaneous Coronary Intervention (PCI)|percutaneous coronary intervention (pci)
229139|NCT02765542|Depression|depression
229141|NCT02765542|Interactive Voice Response|interactive voice response
229142|NCT02765542|Bolivia|bolivia
229143|NCT02765542|Mental health|mental health
229144|NCT02765529|Environmental Pollution|environmental pollution
229145|NCT02765529|Fine particles|fine particles
229146|NCT02765529|Biomarkers|biomarkers
229147|NCT02765529|Elderly|elderly
229148|NCT02765490|Hepatitis C, Chronic|hepatitis c, chronic
229149|NCT02765490|AL-335|al-335
229150|NCT02765490|Odalasvir|odalasvir
229151|NCT02765490|Simeprevir|simeprevir
229152|NCT02765490|ODV|odv
229153|NCT02765490|SMV|smv
229154|NCT02765490|ACH-3102|ach-3102
229155|NCT02765490|ACH-0143102|ach-0143102
229156|NCT02765490|TMC435|tmc435
229157|NCT02765477|Acute myocardial infarction|acute myocardial infarction
229158|NCT02765477|ST Elevation Myocardial Infarction|st elevation myocardial infarction
229159|NCT02765477|Acute Coronary Occlusion|acute coronary occlusion
229160|NCT02765477|Electrocardiogram|electrocardiogram
229161|NCT02765477|Ventricular Paced Rhythm|ventricular paced rhythm
229162|NCT02765477|Modified Sgarbossa Criteria|modified sgarbossa criteria
229163|NCT02765451|non-academic|non-academic
229164|NCT02765451|health institution|health institution
229165|NCT02765451|development|development
229166|NCT02765451|clinical research|clinical research
229167|NCT02765451|cancer|cancer
229168|NCT02765451|private hospital|private hospital
229169|NCT02765451|public hospital|public hospital
229170|NCT02765451|northwestern france|northwestern france
229171|NCT02765451|france|france
229172|NCT02765451|hospitals|hospitals
229173|NCT02765412|decision support|decision support
229174|NCT02765412|patient preferences|patient preferences
229175|NCT02765412|risk adjustment|risk adjustment
229176|NCT02765386|Cochlear implants|cochlear implants
229177|NCT02765386|Hybrid fittings|hybrid fittings
229178|NCT02765386|Cross-over frequency|cross-over frequency
229179|NCT02765373|aromatase inhibitors|aromatase inhibitors
229180|NCT02765373|lipid levels|lipid levels
229181|NCT02765360|EIT|eit
229182|NCT02765360|NIV|niv
229183|NCT02765308|Uveitis|uveitis
229184|NCT02765308|Glaucoma|glaucoma
229185|NCT02765308|Aqueous humor dynamics|aqueous humor dynamics
229186|NCT02765295|Hydrogen|hydrogen
229187|NCT02765295|Inhalation|inhalation
229188|NCT02765295|bronchiectasis|bronchiectasis
229189|NCT02765282|Deep brain stimulation (DBS)|deep brain stimulation (dbs)
229190|NCT02765282|Kinesia|kinesia
229191|NCT02765269|cancer pain|cancer pain
229192|NCT02765269|mobile applications|mobile applications
229193|NCT02765243|neuroblastoma|neuroblastoma
229194|NCT02765243|GD2|gd2
229195|NCT02765243|Chimeric antigen receptor|chimeric antigen receptor
229196|NCT02765243|Immunotherapy|immunotherapy
229197|NCT02765243|Cyclophosphamide|cyclophosphamide
229198|NCT02765243|Fludarabine|fludarabine
229199|NCT02765217|Antibiotic associated diarrhea|antibiotic associated diarrhea
229200|NCT02765217|Children|children
229201|NCT02765217|Prevention|prevention
229202|NCT02765217|Lactobacillus reuteri DSM 17938|lactobacillus reuteri dsm 17938
229203|NCT02765217|Probiotic|probiotic
229204|NCT02765191|Magnetic Resonance Imaging|magnetic resonance imaging
229205|NCT02765191|Norepinephrine|norepinephrine
229206|NCT02765191|Fluid Therapy|fluid therapy
229207|NCT02765191|Renal Circulation|renal circulation
229208|NCT02765165|Phase 1|phase 1
229209|NCT02765165|Phase 2|phase 2
229210|NCT02765165|Glioblastoma Multiforme|glioblastoma multiforme
229211|NCT02765165|Glioblastoma|glioblastoma
229212|NCT02765165|GBM|gbm
229213|NCT02765165|Brain Tumor|brain tumor
229214|NCT02765165|Brain Cancer|brain cancer
229215|NCT02765165|Tumor|tumor
229216|NCT02765165|Solid Tumor|solid tumor
229217|NCT02765165|Tumour|tumour
229218|NCT02765165|Lomustine|lomustine
229219|NCT02765165|CCNU|ccnu
229220|NCT02765165|CXCR4|cxcr4
229221|NCT02765165|Phase 1 Clinical Trial|phase 1 clinical trial
229222|NCT02765165|Phase 2 Clinical Trial|phase 2 clinical trial
229223|NCT02765152|exercise|exercise
229224|NCT02765152|rhythmic movement|rhythmic movement
229225|NCT02765152|discrete movement|discrete movement
229226|NCT02765100|Bipolar Disorder|bipolar disorder
229227|NCT02765100|Obesity|obesity
229228|NCT02765100|Depression|depression
229229|NCT02765074|subcutaneous tocilizumab|subcutaneous tocilizumab
229230|NCT02765074|High Resolution peripheral QCT (HR-pQCT)|high resolution peripheral qct (hr-pqct)
229231|NCT02765074|bone erosion|bone erosion
229232|NCT02765074|bone microarchitecture|bone microarchitecture
229233|NCT02765074|rheumatoid arthritis|rheumatoid arthritis
229234|NCT02765048|Adolescent girls|adolescent girls
229235|NCT02765048|Child welfare|child welfare
229236|NCT02765048|Trauma treatment|trauma treatment
229237|NCT02765048|PTSD|ptsd
229238|NCT02765048|Depression|depression
229239|NCT02765048|Social problem-solving|social problem-solving
229240|NCT02765009|Fluid overload|fluid overload
229241|NCT02765009|Multiple organ failure|multiple organ failure
229242|NCT02765009|Diuretics|diuretics
229243|NCT02765009|Fluid restriction|fluid restriction
229244|NCT02765009|Body weight|body weight
229245|NCT02764983|Combat Veterans|combat veterans
229246|NCT02764983|Automobile Driving|automobile driving
229247|NCT02764983|Fitness to Drive|fitness to drive
229248|NCT02764905|Diabetes|diabetes
229249|NCT02764905|Cognitive-physical rehabilitation|cognitive-physical rehabilitation
229250|NCT02764905|Self care management|self care management
229251|NCT02764879|Omega 3 fatty acids|omega 3 fatty acids
229252|NCT02764879|Root planning|root planning
229253|NCT02764879|chronic periodontitis|chronic periodontitis
229254|NCT02764866|Lung cancer|lung cancer
229255|NCT02764866|Sleep apnea|sleep apnea
229256|NCT02764866|Sleep disordered breathing|sleep disordered breathing
229257|NCT02764853|HIV|hiv
229258|NCT02764853|Black|black
229259|NCT02764853|African American|african american
229260|NCT02764853|Women|women
229261|NCT02764853|Cognitive Behavioral Therapy|cognitive behavioral therapy
229262|NCT02764853|Racism|racism
229263|NCT02764853|Stigma|stigma
229264|NCT02764853|Discrimination|discrimination
229265|NCT02764853|Gender related stressors|gender related stressors
229266|NCT02764853|Resilience|resilience
229267|NCT02764853|Behavioral Medicine|behavioral medicine
229268|NCT02764827|skin prick test|skin prick test
229269|NCT02764827|grass and weed pollens|grass and weed pollens
229270|NCT02764788|Auriculotherapy|auriculotherapy
229271|NCT02764762|Drug Therapy|drug therapy
229272|NCT02764749|vascular function|vascular function
229273|NCT02764749|endothelial function|endothelial function
229274|NCT02764749|polyphenols|polyphenols
229275|NCT02764697|Glaucoma associated with uveitis|glaucoma associated with uveitis
229276|NCT02764671|recombinant hepatitis B vaccine|recombinant hepatitis b vaccine
229277|NCT02764671|safety|safety
229278|NCT02764671|immunogenicity|immunogenicity
229279|NCT02764645|Cardiopulmonary Bypass|cardiopulmonary bypass
229280|NCT02764619|Upstream therapy, spironolactone|upstream therapy, spironolactone
229281|NCT02764619|Atrial remodelling|atrial remodelling
229282|NCT02764619|Modified look-locker inversion recover (MOLLI) sequences|modified look-locker inversion recover (molli) sequences
229283|NCT02764619|T1 mapping|t1 mapping
229284|NCT02764619|Diffuse myocardial fibrosis|diffuse myocardial fibrosis
229285|NCT02764606|Lung Cancer|lung cancer
229286|NCT02764606|Biomarkers|biomarkers
229287|NCT02764606|Bone|bone
229288|NCT02764606|Metastases|metastases
229289|NCT02764593|Head and Neck Squamous Cell Carcinoma|head and neck squamous cell carcinoma
229290|NCT02764593|HNSCC|hnscc
229291|NCT02764593|Nivolumab|nivolumab
229292|NCT02764554|Post-Marketing Surveillance|post-marketing surveillance
229293|NCT02764554|Lenvima|lenvima
229294|NCT02764554|Lenvatinib|lenvatinib
229295|NCT02764554|E7080|e7080
229296|NCT02764554|Differentiated thyroid carcinoma|differentiated thyroid carcinoma
229297|NCT02764554|Refractory to radioactive iodine|refractory to radioactive iodine
229298|NCT02764554|Progressive|progressive
229299|NCT02764554|locally recurrent|locally recurrent
229300|NCT02764554|metastatic|metastatic
229301|NCT02764541|Breast Cancer|breast cancer
229302|NCT02764541|Invasive Lobular Carcinoma|invasive lobular carcinoma
229303|NCT02764528|Hygiene|hygiene
229304|NCT02764515|Kunxian Capsule|kunxian capsule
229305|NCT02764515|efficacy|efficacy
229306|NCT02764515|rheumatoid arthritis|rheumatoid arthritis
229307|NCT02764515|Methotrexate|methotrexate
229308|NCT02764502|Epidural Identification pressure gauge|epidural identification pressure gauge
229309|NCT02764476|psychogenic|psychogenic
229310|NCT02764476|non-epileptic seizures|non-epileptic seizures
229311|NCT02764476|functional neurological symptom disorder|functional neurological symptom disorder
229312|NCT02764476|PNES|pnes
229313|NCT02764476|PMD|pmd
229314|NCT02764476|virtual reality|virtual reality
229315|NCT02764476|3D augmented reality|3d augmented reality
229316|NCT02764476|mirror therapy|mirror therapy
229317|NCT02764463|Fiber Reinforced Composites|fiber reinforced composites
229318|NCT02764463|Resin cements|resin cements
229319|NCT02764463|Survival|survival
229320|NCT02764450|composite|composite
229321|NCT02764450|restoration|restoration
229322|NCT02764450|polymerization|polymerization
229323|NCT02764424|Newborn|newborn
229324|NCT02764424|Heart Rate Variability (HRV)|heart rate variability (hrv)
229325|NCT02764424|Analgesic Nociception Index (ANI)|analgesic nociception index (ani)
229326|NCT02764424|Autonomous Nervous System (ANS)|autonomous nervous system (ans)
229327|NCT02764411|Capillary malformations|capillary malformations
229328|NCT02764411|Onrealtea|onrealtea
229329|NCT02764411|port-wine stain|port-wine stain
229330|NCT02764411|treatment|treatment
229331|NCT02764411|topical|topical
229332|NCT02764372|Arm rehabilitation|arm rehabilitation
229333|NCT02764372|Serious games|serious games
229334|NCT02764372|stroke|stroke
229335|NCT02764372|Multiple sclerosis|multiple sclerosis
229336|NCT02764346|Arthritis|arthritis
229337|NCT02764346|Self-management|self-management
229338|NCT02764346|Pain|pain
229339|NCT02764333|TPIV200/huFR-1|tpiv200/hufr-1
229340|NCT02764333|Anti-PD-L1|anti-pd-l1
229341|NCT02764333|vaccine|vaccine
229342|NCT02764333|16-011|16-011
229343|NCT02764294|anxiety|anxiety
229344|NCT02764294|pain|pain
229345|NCT02764294|satisfaction|satisfaction
229346|NCT02764294|cystoscopy|cystoscopy
229347|NCT02764294|music|music
229348|NCT02764294|video|video
229349|NCT02764294|stress ball|stress ball
229350|NCT02764294|nursing|nursing
229351|NCT02764268|Gastric Cancer|gastric cancer
229352|NCT02764268|Pharmacokinetics|pharmacokinetics
229353|NCT02764268|Dose titration|dose titration
229354|NCT02764242|insect sting allergy|insect sting allergy
229355|NCT02764242|recombinant venom allergen|recombinant venom allergen
229356|NCT02764203|Dark Chocolate|dark chocolate
229357|NCT02764203|Blood Pressure|blood pressure
229358|NCT02764203|Wearable Devices|wearable devices
229359|NCT02764203|Digital Health|digital health
229360|NCT02764164|TDCS|tdcs
229361|NCT02764151|GBM|gbm
229362|NCT02764151|malignant glioma|malignant glioma
229363|NCT02764151|glioma|glioma
229364|NCT02764151|anaplastic glioma|anaplastic glioma
229365|NCT02764151|astrocytoma|astrocytoma
229366|NCT02764151|IDO|ido
229367|NCT02764151|IDO1|ido1
229368|NCT02764151|PF-06840003|pf-06840003
229369|NCT02764138|poverty|poverty
229370|NCT02764138|discrimination|discrimination
229371|NCT02764125|Parkinson's Disease|parkinson's disease
229372|NCT02764125|Wearing-off|wearing-off
229373|NCT02764112|warfarin|warfarin
229374|NCT02764073|Heart failure|heart failure
229375|NCT02764073|Bioimpedance|bioimpedance
229376|NCT02764073|Lung ultrasonography|lung ultrasonography
229377|NCT02764060|Periodontitis|periodontitis
229378|NCT02764060|Tongue coating|tongue coating
229379|NCT02764060|Tongue cleaning|tongue cleaning
229380|NCT02764060|Bacterial load|bacterial load
229381|NCT02764047|Non-alcoholic Fatty Liver Disease|non-alcoholic fatty liver disease
229382|NCT02764047|Nonalcoholic Steatohepatitis|nonalcoholic steatohepatitis
229384|NCT02764047|NASH|nash
229385|NCT02764034|Low level Laser|low level laser
229386|NCT02764034|Tissue culture|tissue culture
229387|NCT02764034|Endometrial receptivity|endometrial receptivity
229388|NCT02764021|HbA1c|hba1c
229389|NCT02764021|Diabetes-Releated Complications|diabetes-releated complications
229390|NCT02764021|Diet, Low Carbohydrate|diet, low carbohydrate
229391|NCT02764021|Carbohydrate-Restricted Diet|carbohydrate-restricted diet
229392|NCT02764021|Diabetes Mellitus|diabetes mellitus
229393|NCT02764021|Metabolic Disorder|metabolic disorder
229394|NCT02764021|Glucose Metabolism Disorders|glucose metabolism disorders
229395|NCT02764021|Endocrine System Diseases|endocrine system diseases
229396|NCT02764008|Postoperative Analgesia|postoperative analgesia
229397|NCT02764008|Peritubal infiltration|peritubal infiltration
229398|NCT02764008|Ultrasound guided low thoracic paravertebral block|ultrasound guided low thoracic paravertebral block
229399|NCT02764008|Percutaneous Nephrolithotomy pain|percutaneous nephrolithotomy pain
229400|NCT02763995|HIV|hiv
229401|NCT02763995|pharmaceutical care|pharmaceutical care
229402|NCT02763995|older patients|older patients
229403|NCT02763995|cardiovascular risk|cardiovascular risk
229404|NCT02763995|pharmacotherapy follow up|pharmacotherapy follow up
229405|NCT02763982|left ventricular ejection fraction|left ventricular ejection fraction
229406|NCT02763982|peak oxygen uptake|peak oxygen uptake
229407|NCT02763982|respiratory muscles|respiratory muscles
229408|NCT02763982|quality of life|quality of life
229409|NCT02763956|Gelstix, Hydrogel|gelstix, hydrogel
229410|NCT02763930|Cardiovascular disease|cardiovascular disease
229411|NCT02763930|Blood pressure|blood pressure
229412|NCT02763930|Hypertension|hypertension
229413|NCT02763930|Dairy products|dairy products
229414|NCT02763930|Milk|milk
229415|NCT02763930|Cheese|cheese
229416|NCT02763891|Balance|balance
229417|NCT02763891|Mobility|mobility
229418|NCT02763891|Trunk control|trunk control
229419|NCT02763878|Uncut Roux-en-Y|uncut roux-en-y
229420|NCT02763878|Billroth II anastomosis|billroth ii anastomosis
229421|NCT02763878|Distal gastric cancer|distal gastric cancer
229422|NCT02763878|Nutrition status|nutrition status
229423|NCT02763878|Postoperative complications|postoperative complications
229424|NCT02763852|Parkinson's Disease|parkinson's disease
229425|NCT02763852|Nebicapone|nebicapone
229426|NCT02763839|Parkinson's disease|parkinson's disease
229427|NCT02763839|Nebicapone|nebicapone
229428|NCT02763826|Transcranial Direct Current Stimulation|transcranial direct current stimulation
229429|NCT02763826|tDCS|tdcs
229430|NCT02763800|Parkinson's disease|parkinson's disease
229431|NCT02763800|Nebicapone|nebicapone
229432|NCT02763774|coronary artery bypass|coronary artery bypass
229433|NCT02763774|sistemic inflammatory response syndrome|sistemic inflammatory response syndrome
229434|NCT02763774|left ventricular dysfunction|left ventricular dysfunction
229435|NCT02763774|postoperative complications|postoperative complications
229436|NCT02763774|physical fitness|physical fitness
229437|NCT02763735|Pulmonary arterial hypertension|pulmonary arterial hypertension
229438|NCT02763735|Right ventricle|right ventricle
229439|NCT02763735|Right ventricular function|right ventricular function
229440|NCT02763735|Metabolism|metabolism
229441|NCT02763735|Non-invasive imaging|non-invasive imaging
229442|NCT02763735|Healthy Subjects|healthy subjects
229443|NCT02763722|atopic dermatitis|atopic dermatitis
229444|NCT02763722|allergic contact dermatitis|allergic contact dermatitis
229445|NCT02763722|cosmetics|cosmetics
229446|NCT02763722|transepidermal water loos|transepidermal water loos
229447|NCT02763696|Metagenomics|metagenomics
229448|NCT02763696|Vaginal microflora|vaginal microflora
229449|NCT02763696|High-throughput sequencing|high-throughput sequencing
229450|NCT02763683|Parkinsons Disease|parkinsons disease
229451|NCT02763683|PET Imaging|pet imaging
229452|NCT02763683|PIB|pib
229453|NCT02763683|VAT|vat
229454|NCT02763683|Dementia|dementia
229455|NCT02763670|Heart failure|heart failure
229456|NCT02763670|patient education as topic|patient education as topic
229457|NCT02763670|patient care management|patient care management
229458|NCT02763657|fMRI|fmri
229459|NCT02763657|reasoning|reasoning
229460|NCT02763657|development|development
229461|NCT02763644|transplant associated microangiopathy|transplant associated microangiopathy
229462|NCT02763618|Neurofeedback|neurofeedback
229463|NCT02763618|theta/beta ratio|theta/beta ratio
229464|NCT02763618|multiple baseline|multiple baseline
229465|NCT02763605|Acanthamoeba Keratitis|acanthamoeba keratitis
229466|NCT02763605|in vivo confocal microscopic|in vivo confocal microscopic
229467|NCT02763592|Localized Neuropathic pain|localized neuropathic pain
229468|NCT02763592|5% lidocaine medicated plaster|5% lidocaine medicated plaster
229469|NCT02763592|Knee surgery|knee surgery
229470|NCT02763566|Hormone Receptor-Positive|hormone receptor-positive
229471|NCT02763566|HER2-Negative|her2-negative
229472|NCT02763566|CDK4|cdk4
229473|NCT02763566|CDK6|cdk6
229474|NCT02763553|Ketone Bodies|ketone bodies
229475|NCT02763553|Enteral Nutrition|enteral nutrition
229476|NCT02763553|Ketogenic Diet|ketogenic diet
229478|NCT02763540|Pathology|pathology
229479|NCT02763540|diagnosis|diagnosis
229480|NCT02763540|lung biopsy|lung biopsy
229481|NCT02763527|smoking cessation|smoking cessation
229482|NCT02763501|bariatric surgery|bariatric surgery
229483|NCT02763501|gastric bypass|gastric bypass
229484|NCT02763501|intestinal obstruction|intestinal obstruction
229485|NCT02763501|postoperative complication|postoperative complication
229486|NCT02763501|methods|methods
229487|NCT02763501|laparoscopy|laparoscopy
229488|NCT02763488|blood flow restriction training|blood flow restriction training
229489|NCT02763488|occlusion training|occlusion training
229490|NCT02763488|total knee arthroplasty|total knee arthroplasty
229491|NCT02763488|post-operative rehabilitation|post-operative rehabilitation
229492|NCT02763475|Killer Cells, Natural|killer cells, natural
229493|NCT02763475|Consolidation treatment|consolidation treatment
229494|NCT02763475|cytologic remission|cytologic remission
229495|NCT02763475|Haploidentical NK Cells|haploidentical nk cells
229496|NCT02763475|allogeneic|allogeneic
229497|NCT02763475|IL-2 Expanded NK Cells|il-2 expanded nk cells
229498|NCT02763462|Acute Febrile Illness|acute febrile illness
229499|NCT02763436|term infant, neonatal transition, cord clamping, NIRS, arterial oxygen saturation, regional cerebral oxygen saturation, cerebral blood volume|term infant, neonatal transition, cord clamping, nirs, arterial oxygen saturation, regional cerebral oxygen saturation, cerebral blood volume
229500|NCT02763423|umbilical cord stem cell|umbilical cord stem cell
229501|NCT02763423|diabetic ketoacidosis|diabetic ketoacidosis
229502|NCT02763371|high GI lunch|high gi lunch
229503|NCT02763371|low GI lunch|low gi lunch
229504|NCT02763358|obesity|obesity
229505|NCT02763358|weight loss|weight loss
229506|NCT02763332|Fibromyalgia|fibromyalgia
229507|NCT02763332|Efficacy|efficacy
229508|NCT02763332|Taping|taping
229509|NCT02763319|Diffuse Large B-cell Lymphoma|diffuse large b-cell lymphoma
229510|NCT02763319|bendamustine|bendamustine
229511|NCT02763319|rituximab|rituximab
229512|NCT02763319|combination therapy|combination therapy
229513|NCT02763319|CD19 monoclonal antibody|cd19 monoclonal antibody
229514|NCT02763319|transplant ineligible|transplant ineligible
229515|NCT02763293|pain|pain
229516|NCT02763293|effectiveness|effectiveness
229517|NCT02763293|manual therapy|manual therapy
229518|NCT02763267|Insulin sensitivity|insulin sensitivity
229519|NCT02763267|Insulin secretion|insulin secretion
229520|NCT02763267|Pregnancy|pregnancy
229521|NCT02763267|Placental proteins|placental proteins
229522|NCT02763254|Epstein-Barr Virus|epstein-barr virus
229523|NCT02763254|DLBCL|dlbcl
229524|NCT02763254|PTLD|ptld
229525|NCT02763254|EBV|ebv
229526|NCT02763254|CIVIC|civic
229527|NCT02763254|HL|hl
229528|NCT02763254|T cell|t cell
229529|NCT02763241|rhinitis|rhinitis
229530|NCT02763228|Physical Activity|physical activity
229531|NCT02763228|Breast Cancer|breast cancer
229532|NCT02763228|minority|minority
229533|NCT02763228|African American|african american
229534|NCT02763202|transition of care|transition of care
229535|NCT02763202|pragmatic clinical trial|pragmatic clinical trial
229536|NCT02763202|telemedicine|telemedicine
229537|NCT02763202|emergency medical technician|emergency medical technician
229538|NCT02763189|Mentoring|mentoring
229539|NCT02763189|Endotracheal Tube Exchange|endotracheal tube exchange
229540|NCT02763189|Training|training
229541|NCT02763176|hCG testing, multi-level pregnancy test|hcg testing, multi-level pregnancy test
229542|NCT02763150|Gestational Diabetes Prevention|gestational diabetes prevention
229543|NCT02763124|Pseudophakic|pseudophakic
229544|NCT02763111|ankylosing spondylitis|ankylosing spondylitis
229545|NCT02763111|interleukin 17|interleukin 17
229546|NCT02763111|monoclonal antibody|monoclonal antibody
229547|NCT02763098|cardiovascular responses|cardiovascular responses
229548|NCT02763098|analgesics opioid|analgesics opioid
229549|NCT02763098|remifentanil|remifentanil
229550|NCT02763046|Ankylosing Spondylitis|ankylosing spondylitis
229551|NCT02763046|NSAID|nsaid
229552|NCT02763046|ASAS|asas
229553|NCT02763046|Secukinumab|secukinumab
229554|NCT02763046|Subcutaneous|subcutaneous
229555|NCT02763020|high glycemic index, polyphenols, blood glucose, satiety|high glycemic index, polyphenols, blood glucose, satiety
229556|NCT02762994|interleukin 17|interleukin 17
229557|NCT02762994|monoclonal antibody|monoclonal antibody
229558|NCT02762994|psoriasis|psoriasis
229559|NCT02762981|CORT125134|cort125134
229560|NCT02762981|nabpaclitaxel|nabpaclitaxel
229561|NCT02762981|Triple-Negative Breast Cancer|triple-negative breast cancer
229562|NCT02762981|Ovarian Epithelial Cancer|ovarian epithelial cancer
229563|NCT02762981|GR Antagonist|gr antagonist
229564|NCT02762981|Glucocorticoid Receptor Antagonist|glucocorticoid receptor antagonist
229565|NCT02762981|Pancreatic Cancer|pancreatic cancer
229566|NCT02762981|Solid Tumors|solid tumors
229567|NCT02762955|adalimumab|adalimumab
229568|NCT02762955|biosimilar|biosimilar
229569|NCT02762955|BCD-057|bcd-057
229570|NCT02762955|psoriasis|psoriasis
229571|NCT02762955|tumor necrosis factor|tumor necrosis factor
229572|NCT02762955|monoclonal antibody|monoclonal antibody
229573|NCT02762942|cervical ripening|cervical ripening
229574|NCT02762942|misoprostol|misoprostol
229575|NCT02762942|supracervical balloon|supracervical balloon
229576|NCT02762942|Foley catheter|foley catheter
229577|NCT02762929|Analgesia|analgesia
229578|NCT02762929|Bunionectomy|bunionectomy
229579|NCT02762903|Shoulder arthroplasty|shoulder arthroplasty
229580|NCT02762903|Lesser Tuberosity Osteotomy|lesser tuberosity osteotomy
229581|NCT02762903|Subscapularis tenotomy|subscapularis tenotomy
229582|NCT02762864|aspirin|aspirin
229583|NCT02762864|ticagrelor|ticagrelor
229584|NCT02762864|clopidogrel|clopidogrel
229585|NCT02762851|Influenza|influenza
229586|NCT02762851|Vaccine|vaccine
229587|NCT02762851|Heart failure|heart failure
229588|NCT02762851|Vascular|vascular
229589|NCT02762799|neutrophil count|neutrophil count
229590|NCT02762799|filgrastim|filgrastim
229591|NCT02762799|granulocyte colony-stimulating factor|granulocyte colony-stimulating factor
229592|NCT02762747|Hernia, Inguinal|hernia, inguinal
229593|NCT02762747|Extraperitoneal Hernioplasty|extraperitoneal hernioplasty
229594|NCT02762747|Drain|drain
229595|NCT02762747|Mesh Repair|mesh repair
229596|NCT02762747|Laparoscopic|laparoscopic
229597|NCT02762734|adolescent|adolescent
229598|NCT02762734|suicide|suicide
229599|NCT02762721|FGFR2 fusion|fgfr2 fusion
229600|NCT02762721|iCCA|icca
229601|NCT02762721|mixed HCC-CCA|mixed hcc-cca
229602|NCT02762721|Intrahepatic Cholangiocarcinoma|intrahepatic cholangiocarcinoma
229603|NCT02762721|Mixed Hepatocellular Cholangiocarcinoma|mixed hepatocellular cholangiocarcinoma
229604|NCT02762721|Cholangiocarcinoma|cholangiocarcinoma
229605|NCT02762721|ArQule|arqule
229606|NCT02762708|Bariatric Surgery|bariatric surgery
229607|NCT02762708|Weight loss|weight loss
229608|NCT02762695|Hypertension|hypertension
229609|NCT02762695|Diabetes Mellitus, Type 2|diabetes mellitus, type 2
229610|NCT02762695|Case Management|case management
229611|NCT02762669|Uterine contraction|uterine contraction
229612|NCT02762669|Oxytocin desensitization|oxytocin desensitization
229613|NCT02762643|DP-R213|dp-r213
229614|NCT02762617|Healthy Volunteers|healthy volunteers
229615|NCT02762617|Women's Health|women's health
229616|NCT02762552|Stroke|stroke
229617|NCT02762552|Etiology|etiology
229618|NCT02762552|Recurrence|recurrence
229619|NCT02762552|Transcranial holter|transcranial holter
727063|NCT00520975|Trastuzumab|trastuzumab
229620|NCT02762552|Microembolic signals|microembolic signals
229621|NCT02762526|lipectomy|lipectomy
229622|NCT02762526|abdominoplasty|abdominoplasty
229623|NCT02762526|plethysmography optoelectronics|plethysmography optoelectronics
229624|NCT02762526|diaphragmatic mobility|diaphragmatic mobility
229625|NCT02762526|lung function|lung function
229626|NCT02762526|respiratory muscles|respiratory muscles
229627|NCT02762474|nab-paclitaxel|nab-paclitaxel
229628|NCT02762474|IMRT|imrt
229629|NCT02762474|esophageal cancer|esophageal cancer
229630|NCT02762461|Fertilization in Vitro|fertilization in vitro
229631|NCT02762461|Sperm Injections, Intracytoplasmic|sperm injections, intracytoplasmic
229632|NCT02762461|Endometriosis|endometriosis
229633|NCT02762422|endothelial function|endothelial function
229634|NCT02762422|iron stores|iron stores
229635|NCT02762422|red blood cell|red blood cell
229636|NCT02762422|blood donation|blood donation
229637|NCT02762409|critical care|critical care
229638|NCT02762409|reduction of depression syndrome|reduction of depression syndrome
229639|NCT02762409|anxiety|anxiety
229640|NCT02762409|quality of life|quality of life
229641|NCT02762409|post traumatic stress|post traumatic stress
229642|NCT02762409|discomforts|discomforts
229643|NCT02762396|Young ischemic stroke|young ischemic stroke
229644|NCT02762396|Risk factors|risk factors
229645|NCT02762396|Causes|causes
229646|NCT02762396|Consequences|consequences
229647|NCT02762370|osteoarthritis|osteoarthritis
229648|NCT02762370|knee|knee
229649|NCT02762370|pain|pain
229650|NCT02762370|diabetes|diabetes
229651|NCT02762370|intra-articular|intra-articular
229652|NCT02762370|injection|injection
229653|NCT02762370|corticosteroid|corticosteroid
229654|NCT02762357|Novosyn Quick|novosyn quick
229655|NCT02762357|Episiotomy|episiotomy
229656|NCT02762331|Vitamin C|vitamin c
229657|NCT02762331|Coronary Artery Bypass Grafting|coronary artery bypass grafting
229658|NCT02762331|Atrial Fibrillation|atrial fibrillation
229659|NCT02762331|Cardiac Valve Repair|cardiac valve repair
229660|NCT02762305|fall risk|fall risk
229661|NCT02762305|RSVP bone builders|rsvp bone builders
229662|NCT02762305|group exercise|group exercise
229663|NCT02762305|older adults|older adults
229664|NCT02762305|balance confidence|balance confidence
229665|NCT02762305|life satisfaction|life satisfaction
229666|NCT02762305|balance|balance
229667|NCT02762305|walking speed|walking speed
229668|NCT02762292|Mechanical ventilation|mechanical ventilation
229669|NCT02762292|Children|children
229670|NCT02762292|Work of breathing|work of breathing
229671|NCT02762279|Mechanical ventilation|mechanical ventilation
229672|NCT02762279|Children|children
229673|NCT02762279|Esophageal Pressure|esophageal pressure
229674|NCT02762279|Pleural Pressure|pleural pressure
229675|NCT02762240|Accreditation|accreditation
229676|NCT02762240|Certification|certification
229677|NCT02762240|General Practice|general practice
229678|NCT02762240|Family Medicine|family medicine
229679|NCT02762240|Randomized Controlled Trial|randomized controlled trial
229680|NCT02762227|CEUS|ceus
229682|NCT02762227|gallbladder cholesterol polyps|gallbladder cholesterol polyps
229683|NCT02762227|adenoma|adenoma
229684|NCT02762227|gallbladder cancer|gallbladder cancer
229685|NCT02762214|Uterin manipulator|uterin manipulator
229686|NCT02762214|Endometrial Cancer|endometrial cancer
229687|NCT02762214|Laparoscopy|laparoscopy
229688|NCT02762214|Robotic|robotic
229689|NCT02762188|wet ARMD|wet armd
229690|NCT02762188|VEGF|vegf
229691|NCT02762188|intra vitreal injections|intra vitreal injections
229692|NCT02762175|maxillomandibular advancement|maxillomandibular advancement
229693|NCT02762175|obstructive sleep apnea|obstructive sleep apnea
229694|NCT02762175|apnea-hypopnea index|apnea-hypopnea index
229695|NCT02762175|quality of life|quality of life
229696|NCT02762162|antiplatelet|antiplatelet
229697|NCT02762162|stent thrombosis|stent thrombosis
229698|NCT02762149|Tsui Test|tsui test
229699|NCT02762149|Labour|labour
229700|NCT02762149|Epidural catheter|epidural catheter
229701|NCT02762097|polyps|polyps
229702|NCT02762097|saline sonography|saline sonography
229703|NCT02762097|infertility|infertility
229704|NCT02762084|Gorlin Syndrome|gorlin syndrome
229705|NCT02762084|Basal Cell|basal cell
229706|NCT02762084|Nevus Syndrome|nevus syndrome
229707|NCT02762084|BCNS|bcns
229708|NCT02762084|nevoid basal cell carcinoma syndrome|nevoid basal cell carcinoma syndrome
229709|NCT02762084|Basal cell carcinoma|basal cell carcinoma
229710|NCT02762084|Hedgehog|hedgehog
229711|NCT02762084|Surgically Eligible Basal Cell Carcinomas|surgically eligible basal cell carcinomas
229712|NCT02762058|Acquired Brain Injury|acquired brain injury
229713|NCT02762058|Stroke Rehabilitation|stroke rehabilitation
229714|NCT02762045|Therapeutic Vaccine HIV Adenovirus type 5 vector|therapeutic vaccine hiv adenovirus type 5 vector
229715|NCT02762032|Skin Biopsy|skin biopsy
229716|NCT02762032|PrimaVie|primavie
229717|NCT02762032|Herbal Supplement|herbal supplement
229718|NCT02762019|Stomatitis|stomatitis
229719|NCT02762019|Laser|laser
229720|NCT02762019|Children|children
293681|NCT02382549|peptide|peptide
229721|NCT02762019|Chemotherapy|chemotherapy
229722|NCT02762019|Treatment|treatment
229723|NCT02762006|durvalumab|durvalumab
229724|NCT02762006|tremelimumab|tremelimumab
229725|NCT02762006|Phase Ib|phase ib
229726|NCT02762006|Locally Advanced|locally advanced
229727|NCT02761980|ibuprofen; acetaminophen; induced fever; fever|ibuprofen; acetaminophen; induced fever; fever
229728|NCT02761967|Physical activity|physical activity
229729|NCT02761967|Pregnancy|pregnancy
229730|NCT02761967|Childbirth|childbirth
229731|NCT02761967|Postpartum period|postpartum period
229732|NCT02761967|Exercise|exercise
229733|NCT02761954|regional anesthesia|regional anesthesia
229734|NCT02761954|caudal block|caudal block
229735|NCT02761928|Facet Joint|facet joint
229736|NCT02761928|Sacroiliac Joint|sacroiliac joint
229737|NCT02761928|Myofascial Trigger Point Pain|myofascial trigger point pain
229738|NCT02761928|Injectables|injectables
229739|NCT02761915|Neuroblastoma|neuroblastoma
229740|NCT02761915|Immunotherapy|immunotherapy
229741|NCT02761915|1RG-CART|1rg-cart
229742|NCT02761915|Cyclophosphamide|cyclophosphamide
229743|NCT02761915|Fludarabine|fludarabine
229744|NCT02761915|CAR T-cells|car t-cells
229745|NCT02761915|Anti-GD2|anti-gd2
229746|NCT02761915|GD2|gd2
229747|NCT02761915|CAR|car
229748|NCT02761915|Chimeric Antigen Receptor|chimeric antigen receptor
229749|NCT02761902|Children|children
229750|NCT02761902|Polysomnography|polysomnography
229751|NCT02761902|sleep|sleep
229752|NCT02761902|obstructive sleep apnea;|obstructive sleep apnea;
229753|NCT02761902|Chinese|chinese
229754|NCT02761863|Mesothelioma|mesothelioma
229755|NCT02761863|CD 74|cd 74
229756|NCT02761863|VEGF|vegf
229757|NCT02761824|Quality of Life|quality of life
229758|NCT02761824|Occupation|occupation
229759|NCT02761772|Preimplantation Factor|preimplantation factor
229760|NCT02761746|HIV|hiv
229761|NCT02761746|Adherence|adherence
229762|NCT02761746|Health Outcomes|health outcomes
229763|NCT02761733|Shared Decision Making|shared decision making
229764|NCT02761733|Case Management|case management
229765|NCT02761733|Decision Aid|decision aid
229766|NCT02761694|AKT1|akt1
229767|NCT02761694|AKT2|akt2
229768|NCT02761694|AKT3|akt3
229769|NCT02761694|PI3K|pi3k
229770|NCT02761694|solid tumors|solid tumors
229771|NCT02761694|cancer|cancer
229772|NCT02761694|ARQ 751|arq 751
229773|NCT02761694|ArQule|arqule
229774|NCT02761694|PTEN|pten
229775|NCT02761681|Acceptance and Commitment Therapy|acceptance and commitment therapy
229776|NCT02761681|Mindfulness|mindfulness
229878|NCT02761252|AQLQ|aqlq
229777|NCT02761681|Guided self-help|guided self-help
229778|NCT02761681|College students|college students
229779|NCT02761681|Focused Interviews|focused interviews
229780|NCT02761681|RCT Control Condition|rct control condition
229781|NCT02761681|RCT ACT-CL Condition|rct act-cl condition
229782|NCT02761668|Pathological tooth migration|pathological tooth migration
229783|NCT02761668|periodontal regenerative surgery|periodontal regenerative surgery
229784|NCT02761668|vertical infrabony defects|vertical infrabony defects
229785|NCT02761668|xenogeneic bone graft|xenogeneic bone graft
229786|NCT02761668|orthodontic therapy|orthodontic therapy
229787|NCT02761655|Dementia|dementia
229788|NCT02761655|Medication Adherence|medication adherence
229789|NCT02761655|Perspective Memory|perspective memory
229790|NCT02761590|intermuscular fat|intermuscular fat
229791|NCT02761590|circuit training|circuit training
229792|NCT02761590|adipokines|adipokines
229793|NCT02761590|inflammation|inflammation
229794|NCT02761590|computed tomography scan|computed tomography scan
229795|NCT02761577|Acetylcysteine|acetylcysteine
229796|NCT02761577|Sodium Bicarbonate|sodium bicarbonate
229797|NCT02761577|Lipocalins|lipocalins
229798|NCT02761577|Creatinine|creatinine
229799|NCT02761577|Blood Urea Nitrogen|blood urea nitrogen
229800|NCT02761564|Cardiac surgery|cardiac surgery
229801|NCT02761564|Blood transfusion|blood transfusion
229802|NCT02761564|ScvO2|scvo2
229803|NCT02761538|obesity|obesity
229804|NCT02761538|Overweight|overweight
229805|NCT02761538|ICTs|icts
229806|NCT02761538|Cost-effectiveness|cost-effectiveness
229807|NCT02761525|silver nanoparticles antimicrobial activity|silver nanoparticles antimicrobial activity
229808|NCT02761486|aspirin|aspirin
229809|NCT02761486|gut microbiome|gut microbiome
229810|NCT02761486|inflammation|inflammation
229811|NCT02761486|placebo|placebo
229812|NCT02761486|circulating biomarker|circulating biomarker
229813|NCT02761447|Motor control Laterality|motor control laterality
229814|NCT02761447|Pain Perception|pain perception
229815|NCT02761447|Lower Extremity|lower extremity
229816|NCT02761447|Complementary Therapies|complementary therapies
229817|NCT02761447|Physical Therapy Modalities|physical therapy modalities
229818|NCT02761434|copeptin|copeptin
229819|NCT02761434|vasopressin|vasopressin
229820|NCT02761434|dehydration|dehydration
229821|NCT02761434|insulin resistance|insulin resistance
229822|NCT02761434|Diabetes|diabetes
229823|NCT02761434|Glucose regulation|glucose regulation
229824|NCT02761421|IOPD|iopd
229825|NCT02761408|Head and neck cancer|head and neck cancer
229826|NCT02761408|Asian|asian
229827|NCT02761408|ALDH2|aldh2
229828|NCT02761369|food addiction|food addiction
229829|NCT02761369|obesity|obesity
229830|NCT02761369|deep TMS|deep tms
229832|NCT02761369|Food Stroop|food stroop
229833|NCT02761369|brain laterality|brain laterality
229835|NCT02761369|INP|inp
229836|NCT02761343|cardiac arrhythmia|cardiac arrhythmia
229837|NCT02761343|cardiac ablation|cardiac ablation
229838|NCT02761343|congenital cardiac disease|congenital cardiac disease
229839|NCT02761343|cardiac ablation lesions under Magnetic Resonance imaging|cardiac ablation lesions under magnetic resonance imaging
229840|NCT02761330|Anesthesia|anesthesia
229841|NCT02761330|Electroconvulsive therapy|electroconvulsive therapy
229842|NCT02761330|Delirium|delirium
229843|NCT02761330|Electroencephalography|electroencephalography
229844|NCT02761330|Seizures|seizures
229845|NCT02761330|Depression|depression
229846|NCT02761330|Ketamine|ketamine
229847|NCT02761330|Etomidate|etomidate
229848|NCT02761330|Physiological Effects of Drugs|physiological effects of drugs
229849|NCT02761330|Pharmacologic Actions|pharmacologic actions
229850|NCT02761330|Confusion|confusion
229851|NCT02761330|Mental Disorders|mental disorders
229852|NCT02761330|Neurobehavioral Manifestations|neurobehavioral manifestations
229853|NCT02761330|Signs and Symptoms|signs and symptoms
229854|NCT02761330|Neurologic Manifestations|neurologic manifestations
229855|NCT02761330|Cognitive Disorders|cognitive disorders
229856|NCT02761317|bowel preparation|bowel preparation
229857|NCT02761317|bisacodyl|bisacodyl
229858|NCT02761317|polyethyleneglycol|polyethyleneglycol
229859|NCT02761317|colorectal surgery|colorectal surgery
229860|NCT02761291|Nasopharyngeal carcinoma|nasopharyngeal carcinoma
229861|NCT02761291|EB virus|eb virus
229862|NCT02761291|metastasis|metastasis
229863|NCT02761291|recurrence|recurrence
229864|NCT02761291|cytolytic viral activation therapy|cytolytic viral activation therapy
229865|NCT02761291|gemcitabine|gemcitabine
229866|NCT02761291|valproic acid|valproic acid
229867|NCT02761291|ganciclovir|ganciclovir
229868|NCT02761291|valganciclovir|valganciclovir
229869|NCT02761265|Degenerative Adult Scoliosis|degenerative adult scoliosis
229870|NCT02761265|Gait Analysis|gait analysis
229871|NCT02761265|Balance Analysis|balance analysis
229872|NCT02761265|Biomechanics|biomechanics
229873|NCT02761265|Neuromuscular Control|neuromuscular control
229874|NCT02761265|Thoracolumbar Deformity|thoracolumbar deformity
229875|NCT02761252|Bilastine|bilastine
229876|NCT02761252|Montelukast|montelukast
229877|NCT02761252|total symptom score|total symptom score
229879|NCT02761239|cricopharyngeal muscle|cricopharyngeal muscle
229880|NCT02761239|innervation by EBSLN|innervation by ebsln
229881|NCT02761239|A prospective case-controlled study|a prospective case-controlled study
229882|NCT02761226|platform switching|platform switching
229883|NCT02761226|dental implant|dental implant
229884|NCT02761226|crestal bone level|crestal bone level
229885|NCT02761226|implant stability|implant stability
229886|NCT02761226|postoperative complication|postoperative complication
229887|NCT02761187|Drug Therapy|drug therapy
229888|NCT02761174|Vascular lesions|vascular lesions
229889|NCT02761174|inflammation|inflammation
229891|NCT02761161|PTSD|ptsd
229892|NCT02761161|Sleep|sleep
229893|NCT02761161|Refugee|refugee
229894|NCT02761161|IRT|irt
229895|NCT02761161|Mianserin|mianserin
229896|NCT02761148|white matter hyperintensity|white matter hyperintensity
229897|NCT02761148|brain network|brain network
229898|NCT02761148|MRI|mri
229899|NCT02761148|cognition|cognition
229900|NCT02761148|emotion|emotion
229901|NCT02761135|Biopsy technique|biopsy technique
229902|NCT02761135|Transrectal ultrasonography probe|transrectal ultrasonography probe
229903|NCT02761135|Side-fire|side-fire
229904|NCT02761135|Prostate cancer|prostate cancer
229905|NCT02761135|End-fire|end-fire
229906|NCT02761083|Eye surgery|eye surgery
229907|NCT02761083|Suture material|suture material
229908|NCT02761083|Novosyn Quick|novosyn quick
229909|NCT02761083|Vicryl Rapid|vicryl rapid
229910|NCT02761070|glioblastoma|glioblastoma
229911|NCT02761070|recurrent|recurrent
229912|NCT02761070|dose-dense temozolomide|dose-dense temozolomide
229913|NCT02761070|bevacizumab|bevacizumab
229914|NCT02761031|Heart rate variability|heart rate variability
229915|NCT02761031|Electrocardiography|electrocardiography
229916|NCT02761031|Observational study|observational study
229917|NCT02761031|Non-interventional study|non-interventional study
229918|NCT02761031|Risk assessment|risk assessment
229919|NCT02761031|Perioperative|perioperative
229920|NCT02761005|Eradication therapy|eradication therapy
229921|NCT02761005|Mutation of 23S rRNA of H. pylori|mutation of 23s rrna of h. pylori
229922|NCT02761005|Personalized therapy|personalized therapy
229923|NCT02760979|knee arthroplasty|knee arthroplasty
229924|NCT02760953|Bladder Cancer|bladder cancer
229925|NCT02760953|Cryoablation|cryoablation
229926|NCT02760940|Inflammatory bowel diseases|inflammatory bowel diseases
229927|NCT02760940|Anemia|anemia
229928|NCT02760940|Crohn's disease|crohn's disease
229929|NCT02760940|Ulcerative colitis|ulcerative colitis
229930|NCT02760940|Oral iron|oral iron
229931|NCT02760940|Quality of life|quality of life
229932|NCT02760914|adipose tissue|adipose tissue
229933|NCT02760914|inflammatory mediators|inflammatory mediators
229934|NCT02760914|gene expression|gene expression
229935|NCT02760875|Achilles Tendon Rupture|achilles tendon rupture
229936|NCT02760875|Conservative treatment|conservative treatment
229937|NCT02760875|early weight bearing|early weight bearing
229938|NCT02760875|Achilles Tendon Length|achilles tendon length
229939|NCT02760875|Ultrasound|ultrasound
229940|NCT02760875|Foot Pressure Mapping|foot pressure mapping
229941|NCT02760875|ATRA|atra
229942|NCT02760875|Heel Raise Work|heel raise work
229943|NCT02760836|Crohn's disease|crohn's disease
229944|NCT02760836|disease outcomes|disease outcomes
229945|NCT02760784|Achilles Tendon Rupture|achilles tendon rupture
229946|NCT02760784|Conservative treatment|conservative treatment
229947|NCT02760784|early weight bearing|early weight bearing
229948|NCT02760784|Dynamic|dynamic
229949|NCT02760784|ATRS|atrs
229950|NCT02760784|ATRA|atra
229951|NCT02760784|Heel Raise Work|heel raise work
229952|NCT02760771|THV (trans-catheter heart valve)|thv (trans-catheter heart valve)
229953|NCT02760771|severe aortic stenosis|severe aortic stenosis
229954|NCT02760771|pre-dilation|pre-dilation
229955|NCT02760771|rapid pacing|rapid pacing
229956|NCT02760771|BAV (balloon artery valvuloplasty|bav (balloon artery valvuloplasty
229957|NCT02760758|non-nucleoside inhibitor|non-nucleoside inhibitor
229958|NCT02760758|NNI|nni
229959|NCT02760758|HCV|hcv
229960|NCT02760758|DAA|daa
229961|NCT02760745|fever|fever
229962|NCT02760745|shivering|shivering
229963|NCT02760745|chills|chills
229964|NCT02760745|rigors|rigors
229965|NCT02760745|severe bacterial infection|severe bacterial infection
229966|NCT02760719|3% hypertonic solution|3% hypertonic solution
229967|NCT02760719|duration of hospitalisation|duration of hospitalisation
229968|NCT02760693|bipolar disorder, naturalistic cohort study,|bipolar disorder, naturalistic cohort study,
229969|NCT02760693|defined catchment area,long term treatment|defined catchment area,long term treatment
229970|NCT02760680|Chronic Heart Failure|chronic heart failure
229971|NCT02760680|Sleep-Disordered Breathing|sleep-disordered breathing
229972|NCT02760680|Peripheral Arterial Tone|peripheral arterial tone
229973|NCT02760667|Oropharyngeal cancer|oropharyngeal cancer
229974|NCT02760667|Laryngeal cancer|laryngeal cancer
229975|NCT02760641|obesity|obesity
229976|NCT02760641|low carbohydrate diet|low carbohydrate diet
229977|NCT02760641|metabolism|metabolism
229978|NCT02760641|body composition|body composition
229979|NCT02760641|visceral fat|visceral fat
229980|NCT02760641|older adults|older adults
229981|NCT02760641|insulin sensitivity|insulin sensitivity
229982|NCT02760615|Drug therapy|drug therapy
229983|NCT02760602|anti-amyloid|anti-amyloid
229984|NCT02760602|monoclonal antibody|monoclonal antibody
229985|NCT02760589|ACL tear|acl tear
229986|NCT02760589|ACL lesion|acl lesion
229987|NCT02760589|ACL reconstruction|acl reconstruction
229988|NCT02760589|InternalBrace|internalbrace
229989|NCT02760589|functional performance test|functional performance test
229990|NCT02760589|anterior cruciate ligament|anterior cruciate ligament
229991|NCT02760537|Liver Neoplasms|liver neoplasms
229992|NCT02760537|Hepatitis B|hepatitis b
229993|NCT02760537|Hepatitis B vaccination|hepatitis b vaccination
229994|NCT02760537|Asian Americans|asian americans
229995|NCT02760537|Lay health workers|lay health workers
229996|NCT02760537|Community health workers|community health workers
229997|NCT02760511|Randomized Controlled Trial|randomized controlled trial
229998|NCT02760511|Anthocyanin|anthocyanin
229999|NCT02760511|Antioxidants|antioxidants
230000|NCT02760485|Diffuse large B-cell lymphoma|diffuse large b-cell lymphoma
230001|NCT02760485|Relapsed Diffuse large B-cell lymphoma|relapsed diffuse large b-cell lymphoma
230002|NCT02760485|Refractory Diffuse large B-cell lymphoma|refractory diffuse large b-cell lymphoma
230003|NCT02760485|activated B cell|activated b cell
230004|NCT02760485|germinal center B-cell|germinal center b-cell
230005|NCT02760485|non-Hodgkin lymphoma|non-hodgkin lymphoma
230006|NCT02760485|JAK1 inhibitor|jak1 inhibitor
230007|NCT02760485|Bruton's tyrosine kinase (BTK) inhibitor|bruton's tyrosine kinase (btk) inhibitor
230008|NCT02760472|Retinopathy of Prematurity|retinopathy of prematurity
230009|NCT02760472|Preterm|preterm
230010|NCT02760472|Fatty acids|fatty acids
230011|NCT02760433|moderate Rheumatoid Arthritis|moderate rheumatoid arthritis
230012|NCT02760433|severe Rheumatoid Arthritis|severe rheumatoid arthritis
230013|NCT02760433|Olokizumab|olokizumab
230014|NCT02760407|moderate Rheumatoid Arthritis|moderate rheumatoid arthritis
230015|NCT02760407|severe Rheumatoid Arthritis|severe rheumatoid arthritis
230016|NCT02760407|subcutaneous|subcutaneous
230017|NCT02760407|Olokizumab|olokizumab
230018|NCT02760394|chronic ischemic heart disease|chronic ischemic heart disease
230019|NCT02760394|coronary bypass|coronary bypass
727064|NCT00520975|Bevacizumab|bevacizumab
230020|NCT02760394|refractory stable angina|refractory stable angina
230021|NCT02760394|HBOT|hbot
230022|NCT02760394|reperfusion|reperfusion
230023|NCT02760394|neoangiogenesis|neoangiogenesis
230024|NCT02760394|microvascular|microvascular
230025|NCT02760394|myocardial perfusion|myocardial perfusion
230026|NCT02760368|moderate Rheumatoid Arthritis|moderate rheumatoid arthritis
230027|NCT02760368|severe Rheumatoid Arthritis|severe rheumatoid arthritis
230028|NCT02760368|subcutaneous|subcutaneous
230029|NCT02760368|Olokizumab|olokizumab
230030|NCT02760342|Pharmacokinetics|pharmacokinetics
230031|NCT02760342|Metformin|metformin
230032|NCT02760342|Drug-drug interaction|drug-drug interaction
230033|NCT02760342|ASP015K|asp015k
230034|NCT02760329|asthma|asthma
230035|NCT02760329|COPD|copd
230036|NCT02760329|chronic obstructive pulmonary disease|chronic obstructive pulmonary disease
230037|NCT02760329|lung disease|lung disease
230038|NCT02760329|chronic airways disease|chronic airways disease
230039|NCT02760329|obstructive lung disease|obstructive lung disease
230040|NCT02760316|Healthy Volunteers|healthy volunteers
230041|NCT02760316|Obese|obese
230042|NCT02760316|Insulin Resistant Subjects|insulin resistant subjects
230043|NCT02760316|Rheumatoid Arthritis|rheumatoid arthritis
230044|NCT02760303|insulin dependent diabetes mellitus|insulin dependent diabetes mellitus
230045|NCT02760303|adolescents and young adults|adolescents and young adults
230046|NCT02760303|stress reduction|stress reduction
230047|NCT02760303|metabolic control|metabolic control
230048|NCT02760290|Forced Expiratory Volume in 1 second|forced expiratory volume in 1 second
230049|NCT02760290|Forced expiratory vital capacity|forced expiratory vital capacity
230050|NCT02760290|Peak expiratory flow|peak expiratory flow
230051|NCT02760277|Duchenne muscular dystrophy|duchenne muscular dystrophy
230052|NCT02760277|vamorolone|vamorolone
230053|NCT02760264|Duchenne Muscular Dystrophy|duchenne muscular dystrophy
230054|NCT02760264|vamorolone|vamorolone
230055|NCT02760251|immunomodulation|immunomodulation
230056|NCT02760238|myeloproliferative neoplasm|myeloproliferative neoplasm
230057|NCT02760238|myelodysplastic syndrome|myelodysplastic syndrome
230058|NCT02760238|registry|registry
230059|NCT02760238|leukemia|leukemia
230060|NCT02760238|Bone Marrow Diseases|bone marrow diseases
230061|NCT02760238|Hematologic Diseases|hematologic diseases
230062|NCT02760238|Neoplasms|neoplasms
230063|NCT02760225|Pembrolizumab|pembrolizumab
230064|NCT02760225|PET imaging|pet imaging
230065|NCT02760225|Melanoma|melanoma
230066|NCT02760225|Non-small cell lung cancer|non-small cell lung cancer
230067|NCT02760212|Shockwave therapy|shockwave therapy
230068|NCT02760212|fMRI|fmri
230069|NCT02760212|blood biomarkers|blood biomarkers
230070|NCT02760173|verticality perception|verticality perception
230071|NCT02760147|Pressure Support Ventilation|pressure support ventilation
230167|NCT02759588|immunotherapy|immunotherapy
230072|NCT02760134|Super-Mini Percutaneous Nephrolithotomy(SMP)|super-mini percutaneous nephrolithotomy(smp)
230073|NCT02760134|Renal Pelvic Pressure|renal pelvic pressure
230074|NCT02760121|Acetazolamide|acetazolamide
230075|NCT02760121|Methazolamide|methazolamide
230076|NCT02760121|Control of breathing|control of breathing
230077|NCT02760121|Hypoxic pulmonary vasoconstriction|hypoxic pulmonary vasoconstriction
230078|NCT02760108|Early onset Parkinson's disease|early onset parkinson's disease
230079|NCT02760108|Familial Parkinson's disease|familial parkinson's disease
230080|NCT02760108|Parkinson's disease|parkinson's disease
230081|NCT02760108|Genetics|genetics
230082|NCT02760095|environmental enteric dysfunction|environmental enteric dysfunction
230083|NCT02760095|environmental enteropathy|environmental enteropathy
230084|NCT02760095|zinc|zinc
230085|NCT02760095|vitamin A|vitamin a
230086|NCT02760095|Bangladesh|bangladesh
230087|NCT02760082|Multiple Sclerosis|multiple sclerosis
230088|NCT02760082|Qualitative study|qualitative study
230089|NCT02760082|Motivation|motivation
230090|NCT02760056|Thyroid hormone|thyroid hormone
230091|NCT02760056|Remyelination|remyelination
230092|NCT02760004|Depression|depression
230093|NCT02759991|Hepatitis E virus|hepatitis e virus
230094|NCT02759991|Viral Hepatitis Vaccines|viral hepatitis vaccines
230095|NCT02759978|Imaging|imaging
230096|NCT02759978|Computed Tomography|computed tomography
230097|NCT02759978|Magnetic Resonance Imaging|magnetic resonance imaging
230098|NCT02759978|Positron Emission Tomography|positron emission tomography
230099|NCT02759978|Leukocyte Scintigraphy|leukocyte scintigraphy
230100|NCT02759978|Microbiological diagnostics|microbiological diagnostics
230101|NCT02759978|Sonication|sonication
230102|NCT02759978|Drug Monitoring|drug monitoring
230103|NCT02759978|Cardiac Surgery|cardiac surgery
230104|NCT02759952|retinitis pigmentosa|retinitis pigmentosa
230105|NCT02759952|PDE6A|pde6a
230106|NCT02759952|gene therapy trial|gene therapy trial
230107|NCT02759939|Shared Decision-Making|shared decision-making
230108|NCT02759939|Patient-Provider Communication|patient-provider communication
230109|NCT02759926|Healthy volunteers|healthy volunteers
230110|NCT02759926|Obesity|obesity
230111|NCT02759926|Bitter|bitter
230112|NCT02759913|neuromuscular diseases|neuromuscular diseases
230113|NCT02759848|COPD, tuberculosis, mortality|copd, tuberculosis, mortality
230114|NCT02759835|EGFR Tyrosine Kinase Inhibitors|egfr tyrosine kinase inhibitors
230115|NCT02759835|T790M Mutation|t790m mutation
230116|NCT02759835|Local Ablative Therapies|local ablative therapies
230117|NCT02759835|Oligoprogressive Disease|oligoprogressive disease
230118|NCT02759835|Acquired Resistance|acquired resistance
230119|NCT02759822|Haploidentical Hematopoietic Stem Cell Transplantation|haploidentical hematopoietic stem cell transplantation
230120|NCT02759822|Partially Matched Hematopoietic Stem Cell Transplantation|partially matched hematopoietic stem cell transplantation
230121|NCT02759822|Post-transplant Cyclophosphamide|post-transplant cyclophosphamide
230122|NCT02759822|Hematopoietic Stem Cell Transplantation|hematopoietic stem cell transplantation
230123|NCT02759783|Radiotherapy|radiotherapy
230124|NCT02759783|oligometastases|oligometastases
230125|NCT02759783|SBRT|sbrt
230126|NCT02759757|Kinesio Taping|kinesio taping
230127|NCT02759757|Low back Pain|low back pain
230128|NCT02759757|Electromyographic|electromyographic
230129|NCT02759757|EMG|emg
230130|NCT02759744|Thermal Ablation|thermal ablation
230131|NCT02759744|Localized Prostate Cancer|localized prostate cancer
230132|NCT02759744|Medtronic-Visualase|medtronic-visualase
230133|NCT02759744|Thermal Damage|thermal damage
230134|NCT02759744|PSA Levels|psa levels
230135|NCT02759731|Murine Models|murine models
230136|NCT02759731|Rheumatoid Arthritis|rheumatoid arthritis
230137|NCT02759731|Corticosteroids|corticosteroids
230138|NCT02759731|Systemic Therapy|systemic therapy
230139|NCT02759731|Inflammatory Cytokines|inflammatory cytokines
230140|NCT02759718|pancreatic neuroendocrine tumor|pancreatic neuroendocrine tumor
230141|NCT02759718|chromogranin A|chromogranin a
230142|NCT02759705|fertility|fertility
230143|NCT02759705|sexuality|sexuality
230144|NCT02759705|male|male
230145|NCT02759705|exstrophy-epispadias complex|exstrophy-epispadias complex
230146|NCT02759705|bladder exstrophy|bladder exstrophy
230147|NCT02759705|epispadias|epispadias
230148|NCT02759666|PARP|parp
230149|NCT02759666|advanced solid tumor|advanced solid tumor
230150|NCT02759640|c-Met kinase inhibitor|c-met kinase inhibitor
230151|NCT02759640|Advanced solid tumors|advanced solid tumors
230152|NCT02759627|Rehabilitation|rehabilitation
230153|NCT02759627|Gait|gait
230154|NCT02759627|Ambulation|ambulation
230155|NCT02759627|Exercise Therapy|exercise therapy
230156|NCT02759627|Physical Exertion|physical exertion
230157|NCT02759627|Motor Skills|motor skills
230158|NCT02759601|HDAC Inhibitor|hdac inhibitor
230159|NCT02759601|Tefinostat|tefinostat
230160|NCT02759601|Inflammation|inflammation
230161|NCT02759601|Hepatocellular Carcinoma|hepatocellular carcinoma
230162|NCT02759601|Cancer associated Inflammation in Hepatocellular Carcinoma|cancer associated inflammation in hepatocellular carcinoma
230163|NCT02759588|GL-ONC1|gl-onc1
230164|NCT02759588|oncolytic virus|oncolytic virus
230165|NCT02759588|virotherapy|virotherapy
230166|NCT02759588|Viral therapy|viral therapy
230168|NCT02759588|immune therapy|immune therapy
230169|NCT02759588|vaccinia|vaccinia
230170|NCT02759588|vaccinia virus|vaccinia virus
230171|NCT02759588|Genelux|genelux
230172|NCT02759588|ovarian cancer|ovarian cancer
230173|NCT02759588|platinum resistant|platinum resistant
230174|NCT02759588|platinum refractory|platinum refractory
230175|NCT02759588|peritoneal carcinomatosis|peritoneal carcinomatosis
230176|NCT02759588|fallopian cancer|fallopian cancer
230177|NCT02759588|cancer|cancer
230178|NCT02759588|abdominal cancer|abdominal cancer
230179|NCT02759588|imaging|imaging
230180|NCT02759588|carcinoma|carcinoma
230181|NCT02759588|DNA virus|dna virus
230182|NCT02759588|neoplasms|neoplasms
230183|NCT02759588|neoplasms by histological type|neoplasms by histological type
230184|NCT02759588|neoplasms, Glandular and Epithelial|neoplasms, glandular and epithelial
230185|NCT02759588|Poxviridae infections|poxviridae infections
230186|NCT02759588|Virus diseases|virus diseases
230187|NCT02759588|recurrent ovarian cancer|recurrent ovarian cancer
230188|NCT02759588|intermediate platinum-sensitive|intermediate platinum-sensitive
230189|NCT02759549|Radiation Therapy|radiation therapy
230190|NCT02759523|Magnetic Resonance Imaging|magnetic resonance imaging
230191|NCT02759523|Portion Size|portion size
230192|NCT02759523|Energy Intake|energy intake
230193|NCT02759510|cardiac output|cardiac output
230194|NCT02759510|norepinephrin|norepinephrin
230195|NCT02759510|cesarean section|cesarean section
230196|NCT02759484|CHWs|chws
230197|NCT02759484|Health Education|health education
230198|NCT02759484|Disease Self Management|disease self management
230199|NCT02759445|alcohol induced cardiomyopathy|alcohol induced cardiomyopathy
230200|NCT02759445|myocardial deformation imaging|myocardial deformation imaging
230201|NCT02759432|high-intensity interval training|high-intensity interval training
230202|NCT02759432|adolescents|adolescents
230203|NCT02759432|physical fitness|physical fitness
230204|NCT02759432|quality of life|quality of life
230205|NCT02759432|school-based intervention|school-based intervention
230206|NCT02759367|Nutrition|nutrition
230207|NCT02759367|Potassium|potassium
230208|NCT02759354|Immune response|immune response
230209|NCT02759328|Stroke|stroke
230210|NCT02759328|Rehabilitation|rehabilitation
230211|NCT02759328|Serious games|serious games
230212|NCT02759328|Virtual reality|virtual reality
230213|NCT02759328|Xbox Kinect™|xbox kinect™
230214|NCT02759302|MRI|mri
230215|NCT02759302|LGMD|lgmd
230216|NCT02759302|POMT2|pomt2
230217|NCT02759289|Arsenic|arsenic
230218|NCT02759276|Nailfold Videocapillaroscopy|nailfold videocapillaroscopy
230219|NCT02759276|Venous Occlusion Plethysmography|venous occlusion plethysmography
230220|NCT02759276|Endothelial Function|endothelial function
230221|NCT02759276|Microcirculation|microcirculation
230222|NCT02759276|Inflammatory Biomarkers|inflammatory biomarkers
230223|NCT02759185|PTSD|ptsd
230224|NCT02759185|marijuana|marijuana
230225|NCT02759185|cannabis|cannabis
230226|NCT02759185|sleep|sleep
230227|NCT02759185|THC|thc
230228|NCT02759185|CBD|cbd
230229|NCT02759172|Suicide prevention|suicide prevention
230230|NCT02759172|Jail|jail
230231|NCT02759120|Idiopathic Pulmonary Fibrosis|idiopathic pulmonary fibrosis
230232|NCT02759120|IPF|ipf
230233|NCT02759120|pulmonary fibrosis|pulmonary fibrosis
230234|NCT02759120|antimicrobial therapy|antimicrobial therapy
230235|NCT02759120|doxycycline|doxycycline
230236|NCT02759120|co-trimoxazole|co-trimoxazole
230237|NCT02759094|GERD|gerd
230238|NCT02759094|Implantable medical device|implantable medical device
230239|NCT02759094|RefluxStop|refluxstop
230240|NCT02759094|Reflux|reflux
230241|NCT02759094|Gastroesophageal Reflux|gastroesophageal reflux
230242|NCT02759094|Laparoscopy|laparoscopy
230243|NCT02759094|pH-Monitoring|ph-monitoring
230244|NCT02759094|PPI proton pump inhibitors|ppi proton pump inhibitors
230245|NCT02759068|vegetative state|vegetative state
230246|NCT02759068|minimally conscious state|minimally conscious state
230247|NCT02759068|music|music
230248|NCT02759068|preference|preference
230249|NCT02758990|Food|food
230250|NCT02758990|Nutrigenomics|nutrigenomics
230251|NCT02758990|Precision Medicine|precision medicine
230252|NCT02758990|Pharmacogenetics|pharmacogenetics
230253|NCT02758990|Lifestyle|lifestyle
230254|NCT02758977|Colorectal liver metastases|colorectal liver metastases
230255|NCT02758977|Liver Surgery|liver surgery
230256|NCT02758977|ALPPS|alpps
230257|NCT02758977|Two Stage Hepatectomy|two stage hepatectomy
230258|NCT02758977|Surgical Oncology|surgical oncology
230259|NCT02758977|Hepatectomy|hepatectomy
230260|NCT02758964|TAVR|tavr
230261|NCT02758964|TAVI|tavi
230262|NCT02758964|Transcatheter Aortic Valve Replacement|transcatheter aortic valve replacement
230263|NCT02758964|Intracranial Embolism|intracranial embolism
230264|NCT02758951|Colorectal Neoplasms|colorectal neoplasms
230265|NCT02758951|Peritoneal Neoplasms|peritoneal neoplasms
230266|NCT02758951|Cytoreduction Surgical Procedures|cytoreduction surgical procedures
230267|NCT02758951|Hyperthermia, Induced|hyperthermia, induced
230268|NCT02758951|Neoadjuvant Therapy|neoadjuvant therapy
230269|NCT02758951|Adjuvant Chemotherapy|adjuvant chemotherapy
230270|NCT02758951|Bevacizumab|bevacizumab
230271|NCT02758951|Randomized Controlled Trial|randomized controlled trial
230272|NCT02758951|Mortality|mortality
230273|NCT02758951|Progression-Free Survival|progression-free survival
230274|NCT02758899|Anterior cervical discectomy|anterior cervical discectomy
230275|NCT02758899|Anterior cervical fusion|anterior cervical fusion
230276|NCT02758860|Colonoscopy|colonoscopy
230277|NCT02758860|Diverticular disease of the colon|diverticular disease of the colon
230278|NCT02758860|Classification|classification
230279|NCT02758847|critical lower limb ischemia with tissue loss|critical lower limb ischemia with tissue loss
230280|NCT02758834|Preterm Infants|preterm infants
230281|NCT02758834|Phytosterols|phytosterols
230282|NCT02758834|Parenteral Nutrition|parenteral nutrition
230283|NCT02758821|C-reactive protein|c-reactive protein
230284|NCT02758821|antibiotic|antibiotic
230285|NCT02758795|protein|protein
230286|NCT02758795|inflammation|inflammation
230287|NCT02758795|anti-inflammatory agents|anti-inflammatory agents
230288|NCT02758743|smoking|smoking
230289|NCT02758743|tobacco|tobacco
230290|NCT02758743|smoking cessation|smoking cessation
230291|NCT02758730|GBA mutation|gba mutation
230292|NCT02758704|Intubation|intubation
230293|NCT02758704|Neonatal|neonatal
230294|NCT02758704|Teaching|teaching
230295|NCT02758704|Stress|stress
230296|NCT02758704|Simulation|simulation
230297|NCT02758691|memory|memory
230298|NCT02758691|insulin|insulin
230299|NCT02758678|P-selectin|p-selectin
230300|NCT02758678|Lung Cancer|lung cancer
230301|NCT02758678|Raman Spectroscopy|raman spectroscopy
230302|NCT02758665|CLL|cll
230303|NCT02758665|chronic lymphocytic leukemia|chronic lymphocytic leukemia
230304|NCT02758665|ibrutinib|ibrutinib
230305|NCT02758665|venetoclax|venetoclax
230306|NCT02758665|obinutuzumab|obinutuzumab
230307|NCT02758665|TP53 Deletion|tp53 deletion
230308|NCT02758652|chemoresistance|chemoresistance
230309|NCT02758652|miRNA|mirna
230310|NCT02758652|microRNA|microrna
294459|NCT02378402|MRS|mrs
230311|NCT02758639|parental cancer|parental cancer
230312|NCT02758639|children psychosocial adjustment|children psychosocial adjustment
230313|NCT02758639|psychosocial intervention|psychosocial intervention
230314|NCT02758574|acute pulmonary embolism|acute pulmonary embolism
230315|NCT02758574|submassive pulmonary embolism|submassive pulmonary embolism
230316|NCT02758574|thrombolysis|thrombolysis
230317|NCT02758574|catheter directed thrombolysis|catheter directed thrombolysis
230318|NCT02758574|ultrasound assisted thrombolysis|ultrasound assisted thrombolysis
230319|NCT02758561|decisional aid|decisional aid
230320|NCT02758561|workshops|workshops
230321|NCT02758561|urinary incontinence|urinary incontinence
230322|NCT02758561|pelvic organ prolapse|pelvic organ prolapse
230323|NCT02758561|pelvic floor dysfunction|pelvic floor dysfunction
230324|NCT02758561|decisional conflict|decisional conflict
230325|NCT02758548|Total IgE measurement|total ige measurement
230326|NCT02758548|Novel Point-of-care test device|novel point-of-care test device
230327|NCT02758548|atopic conditions|atopic conditions
230328|NCT02758548|in vitro diagnostic test|in vitro diagnostic test
230329|NCT02758522|Diabetes Mellitus|diabetes mellitus
230330|NCT02758522|Hospital Hyperglycemia|hospital hyperglycemia
230331|NCT02758496|Autism, chart review, transcranial magnetic stimulation (TMS)|autism, chart review, transcranial magnetic stimulation (tms)
230332|NCT02758470|Muscle Fatigue|muscle fatigue
230333|NCT02758470|Acetazolamide|acetazolamide
230334|NCT02758470|Methazolamide|methazolamide
230335|NCT02758457|cad/cam|cad/cam
230336|NCT02758457|dental porcelain|dental porcelain
230337|NCT02758457|zirconia|zirconia
230338|NCT02758457|press on metal|press on metal
230339|NCT02758444|environmental enteric dysfunction|environmental enteric dysfunction
230340|NCT02758444|environmental enteropathy|environmental enteropathy
230341|NCT02758444|zinc absorption|zinc absorption
230342|NCT02758444|Bangladesh|bangladesh
230343|NCT02758444|toddlers|toddlers
230344|NCT02758444|zinc isotope|zinc isotope
230345|NCT02758431|testosterone|testosterone
230346|NCT02758418|Adjustment disorders online|adjustment disorders online
230347|NCT02758418|Psychological Treatments|psychological treatments
230348|NCT02758418|Information and Communication Technologies|information and communication technologies
230349|NCT02758418|Internet|internet
230350|NCT02758405|Epidural|epidural
230351|NCT02758405|Labor analgesia|labor analgesia
230352|NCT02758405|Programmed intermittent epidural bolus|programmed intermittent epidural bolus
230353|NCT02758392|Healthy|healthy
230354|NCT02758392|JNJ-61178104|jnj-61178104
230355|NCT02758392|Placebo|placebo
230356|NCT02758392|Safety|safety
230357|NCT02758379|coronary artery disease|coronary artery disease
230358|NCT02758379|calcified lesions|calcified lesions
230359|NCT02758379|lithotripsy|lithotripsy
230360|NCT02758366|glioblastoma multiforme|glioblastoma multiforme
230361|NCT02758366|high grade glioma|high grade glioma
230362|NCT02758366|diffuse intrinsic pontine glioma|diffuse intrinsic pontine glioma
230363|NCT02758366|DIPG|dipg
230364|NCT02758366|doxorubicin|doxorubicin
230365|NCT02758366|temozolomide|temozolomide
230366|NCT02758366|malignant glioma|malignant glioma
230367|NCT02758366|Brainstem Glioma|brainstem glioma
230368|NCT02758366|diffuse spinal glioma|diffuse spinal glioma
230369|NCT02758366|bilateral thalamic glioma|bilateral thalamic glioma
230370|NCT02758366|Anaplastic Astrocytoma|anaplastic astrocytoma
230371|NCT02758366|Gliomatosis Cerebri|gliomatosis cerebri
230372|NCT02758366|Midline Diffuse Glioma|midline diffuse glioma
230373|NCT02758353|Malaria in Pregnancy|malaria in pregnancy
230374|NCT02758353|Nigeria|nigeria
230375|NCT02758353|Sulfadoxine-Pyrimethamine|sulfadoxine-pyrimethamine
230376|NCT02758353|Scale up|scale up
230377|NCT02758353|Primary Health Care|primary health care
230378|NCT02758340|induction of labor|induction of labor
230379|NCT02758340|misoprostol|misoprostol
230380|NCT02758340|foley's balloon catheter|foley's balloon catheter
230381|NCT02758327|Tear Osmolarity|tear osmolarity
230382|NCT02758327|Keratitis Sicca|keratitis sicca
230383|NCT02758327|Ocular Surface Disease|ocular surface disease
230384|NCT02758327|TheraTears|theratears
230385|NCT02758314|PD-1|pd-1
230386|NCT02758314|PD-L1|pd-l1
230387|NCT02758314|NSCLC|nsclc
230388|NCT02758288|Kidney transplant|kidney transplant
230389|NCT02758288|BK Viremia|bk viremia
230390|NCT02758288|BK Nephropathy|bk nephropathy
230391|NCT02758275|Medication adherence|medication adherence
230392|NCT02758275|Patient compliance|patient compliance
230393|NCT02758275|Diabetes mellitus, Type 2|diabetes mellitus, type 2
230394|NCT02758275|Hypertension|hypertension
230395|NCT02758275|Nursing|nursing
230396|NCT02758275|Nursing process|nursing process
230397|NCT02758275|Teaching|teaching
230398|NCT02758275|Randomized controlled trial|randomized controlled trial
230399|NCT02758210|Bradycardia|bradycardia
230400|NCT02758210|Atrial Tachyarrhythmia|atrial tachyarrhythmia
230401|NCT02758210|Smart Phone|smart phone
230402|NCT02758210|Tablet|tablet
230403|NCT02758197|Mindfulness|mindfulness
230404|NCT02758197|Chronic Pain|chronic pain
230405|NCT02758197|Quality of Life|quality of life
230406|NCT02758197|Immune Function|immune function
230407|NCT02758197|Cancer survivors|cancer survivors
230408|NCT02758197|Disability|disability
230409|NCT02758132|Castrate-resistant prostate cancer with bone metastases|castrate-resistant prostate cancer with bone metastases
230410|NCT02758106|chest wall oscillation|chest wall oscillation
230411|NCT02758106|acute respiratory failure|acute respiratory failure
230412|NCT02758106|airway secretion|airway secretion
230413|NCT02758080|Personalized medicine|personalized medicine
230414|NCT02758080|Next generation sequencing|next generation sequencing
230415|NCT02758041|Acne|acne
230416|NCT02758028|Youth|youth
230417|NCT02758028|Adventure-based training|adventure-based training
230418|NCT02758028|WhatsApp messages|whatsapp messages
230419|NCT02758015|betaine|betaine
230420|NCT02758015|betaine hydrochloride|betaine hydrochloride
230421|NCT02758015|healthy volunteer|healthy volunteer
230422|NCT02758015|gastric pH|gastric ph
230423|NCT02758002|atrial fibrillation ablation|atrial fibrillation ablation
230424|NCT02758002|ablation|ablation
230425|NCT02758002|atrial fibrillation rotors|atrial fibrillation rotors
230426|NCT02757989|Low risk MDS|low risk mds
230427|NCT02757989|Transplantation|transplantation
230428|NCT02757963|Screening tool|screening tool
230429|NCT02757963|International Prostate Symptom Score|international prostate symptom score
230430|NCT02757963|Lower urinary tract symptoms|lower urinary tract symptoms
230432|NCT02757963|BPE|bpe
230433|NCT02757963|Benign prostatic enlargement|benign prostatic enlargement
230434|NCT02757963|Benign prostatic obstruction|benign prostatic obstruction
230435|NCT02757963|LUTS|luts
230436|NCT02757963|Benign prostatic hyperplasia|benign prostatic hyperplasia
230437|NCT02757963|IPSS|ipss
230438|NCT02757963|BPH|bph
230439|NCT02757950|exposed and unexposed cohorts|exposed and unexposed cohorts
230440|NCT02757950|post-marketing, maternal immunization|post-marketing, maternal immunization
230441|NCT02757950|neonate related Adverse Events|neonate related adverse events
230442|NCT02757950|Congenital anomaly|congenital anomaly
230443|NCT02757950|RefortrixTM|refortrixtm
230444|NCT02757950|Pregnancy related Adverse Events|pregnancy related adverse events
230445|NCT02757937|Medication Adherence|medication adherence
230446|NCT02757937|Self-efficacy|self-efficacy
230447|NCT02757937|Behavior|behavior
230448|NCT02757937|Diabetes|diabetes
230449|NCT02757937|Diabetes Mellitus|diabetes mellitus
230450|NCT02757911|XCGD|xcgd
230451|NCT02757898|Red Blood Cell (RBC) transfusion|red blood cell (rbc) transfusion
230452|NCT02757898|Biotin labeled red blood cells|biotin labeled red blood cells
230453|NCT02757885|bone marrow transplant|bone marrow transplant
230454|NCT02757872|Hypertension|hypertension
230455|NCT02757872|Kidney Diseases|kidney diseases
230456|NCT02757872|Vitamin D|vitamin d
230457|NCT02757872|Omega 3 fatty acids|omega 3 fatty acids
230458|NCT02757846|Radiomics|radiomics
230459|NCT02757846|prognosis|prognosis
230460|NCT02757846|medical images|medical images
230461|NCT02757846|Hepatocellular carcinoma|hepatocellular carcinoma
230462|NCT02757820|anesthesia; airway; laryngeal mask airway; I-gel; Air-Q|anesthesia; airway; laryngeal mask airway; i-gel; air-q
230463|NCT02757807|Erectile Dysfunction|erectile dysfunction
230464|NCT02757781|Patient empowerment|patient empowerment
230465|NCT02757781|Patient involvement|patient involvement
230466|NCT02757781|Patient participation|patient participation
230467|NCT02757781|Healthcare professional attitudes|healthcare professional attitudes
230468|NCT02757781|Chronic diseases|chronic diseases
230469|NCT02757768|Myrbetriq|myrbetriq
230470|NCT02757768|Lower Urinary Tract Symptoms|lower urinary tract symptoms
230471|NCT02757768|Benign Prostatic Hyperplasia|benign prostatic hyperplasia
230472|NCT02757768|Overactive Bladder|overactive bladder
230473|NCT02757768|Betmiga|betmiga
230474|NCT02757768|Mirabegron|mirabegron
230475|NCT02757768|Tamsulosin Hydrochloride|tamsulosin hydrochloride
230476|NCT02757742|sudden cardiac death|sudden cardiac death
230477|NCT02757742|ventricular arrhythmias|ventricular arrhythmias
230478|NCT02757742|cardiopathy|cardiopathy
230479|NCT02757742|late gadolinium enhancement|late gadolinium enhancement
230480|NCT02757716|addiction remission|addiction remission
230481|NCT02757716|addiction transfer|addiction transfer
230482|NCT02757703|somatostatin|somatostatin
230483|NCT02757703|variceal bleeding|variceal bleeding
230484|NCT02757703|terlipressin|terlipressin
230485|NCT02757664|achilles|achilles
230486|NCT02757664|tendinopathy|tendinopathy
230487|NCT02757664|Physical Therapy Modalities|physical therapy modalities
230488|NCT02757664|High-Energy Shock Waves|high-energy shock waves
230489|NCT02757612|laser diode, pain|laser diode, pain
230490|NCT02757586|chronic lymphocytic leukemia|chronic lymphocytic leukemia
230491|NCT02757586|XPO1|xpo1
230492|NCT02757586|in vitro|in vitro
230493|NCT02757586|in vivo|in vivo
230494|NCT02757560|saturated fat|saturated fat
230495|NCT02757560|acute insulin resistance|acute insulin resistance
230496|NCT02757560|insulin suppression test|insulin suppression test
230497|NCT02757560|dietary fatty acids|dietary fatty acids
727261|NCT00520026|suicide|suicide
230498|NCT02757521|Bipolar Depressive Disorder|bipolar depressive disorder
230499|NCT02757521|Treatment- Resistant Bipolar Disorder|treatment- resistant bipolar disorder
230500|NCT02757521|Nitrous Oxide|nitrous oxide
230501|NCT02757495|sevoflurane emergence agitation|sevoflurane emergence agitation
230502|NCT02757495|caudal dexmedetomidine|caudal dexmedetomidine
230503|NCT02757482|Patient training|patient training
230504|NCT02757482|Warfarin|warfarin
230505|NCT02757482|International Normalized Ratio|international normalized ratio
230506|NCT02757482|Nursing|nursing
230507|NCT02757456|exercise|exercise
230508|NCT02757456|hemodialysis|hemodialysis
230509|NCT02757456|pulse wave velocity|pulse wave velocity
230510|NCT02757456|micro RNAs|micro rnas
230511|NCT02757443|Phosphocreatine|phosphocreatine
230512|NCT02757443|Creatine Phosphate|creatine phosphate
230513|NCT02757443|Neoton|neoton
230514|NCT02757443|Phosphate, Creatine|phosphate, creatine
230515|NCT02757443|Phosphorylcreatine|phosphorylcreatine
230516|NCT02757404|botulinum toxin|botulinum toxin
230517|NCT02757404|spasticity|spasticity
230518|NCT02757404|injection technique|injection technique
230519|NCT02757404|neuronox|neuronox
230520|NCT02757404|meditoxin|meditoxin
230521|NCT02757378|Pain|pain
230522|NCT02757378|Brain|brain
230523|NCT02757378|Plasticity|plasticity
230524|NCT02757378|Education|education
230525|NCT02757378|Manual Therapy|manual therapy
230526|NCT02757378|Straight Leg Raise|straight leg raise
230527|NCT02757378|Remapping|remapping
230528|NCT02757365|aspirin|aspirin
230529|NCT02757352|ankylosing|ankylosing
230530|NCT02757352|nonradiographic spondyloarthritis|nonradiographic spondyloarthritis
230531|NCT02757339|neurobiology|neurobiology
230532|NCT02757339|PTSD|ptsd
230533|NCT02757339|DID|did
230534|NCT02757326|sphingosine kinase 2 inhibitor|sphingosine kinase 2 inhibitor
230535|NCT02757326|sphingosine kinase 2|sphingosine kinase 2
230536|NCT02757326|SK2 inhibitor|sk2 inhibitor
230537|NCT02757326|SK2|sk2
230538|NCT02757313|marijuana|marijuana
230539|NCT02757313|driving|driving
230540|NCT02757313|THC|thc
230541|NCT02757313|cannabis|cannabis
230542|NCT02757313|intoxication|intoxication
230543|NCT02757313|MRI|mri
230544|NCT02757287|Ovarian stimulation|ovarian stimulation
230545|NCT02757287|LH inhibition|lh inhibition
230546|NCT02757274|Urologic Surgical Procedure|urologic surgical procedure
230547|NCT02757274|Male|male
230548|NCT02757261|Bruxism|bruxism
230549|NCT02757261|Child|child
230550|NCT02757261|Occlusal splint|occlusal splint
230551|NCT02757261|Bite force|bite force
230552|NCT02757261|Acunpuncture|acunpuncture
230553|NCT02757261|Laser|laser
230554|NCT02757261|Muscle actvity|muscle actvity
230555|NCT02757261|Salivary Cortisol|salivary cortisol
230556|NCT02757235|chronic subdural hematoma|chronic subdural hematoma
230557|NCT02757235|irrigation|irrigation
230558|NCT02757235|recurrence|recurrence
230559|NCT02757235|burr hole evacuation|burr hole evacuation
230560|NCT02757235|temperature|temperature
230561|NCT02757209|ASTHMA|asthma
230562|NCT02757209|COPD|copd
230563|NCT02757209|budesonide|budesonide
230564|NCT02757209|formoterol|formoterol
230565|NCT02757209|Salmeterol|salmeterol
230566|NCT02757209|Fluticasone|fluticasone
230567|NCT02757209|Spiromax|spiromax
230568|NCT02757209|DPI|dpi
230569|NCT02757209|Diskus|diskus
230570|NCT02757196|Immune Thrombocytopenia|immune thrombocytopenia
230571|NCT02757196|Rituximab|rituximab
230572|NCT02757196|methylprednisolone|methylprednisolone
230573|NCT02757157|Hydrotherapy|hydrotherapy
230574|NCT02757157|Walking|walking
230575|NCT02757131|Mobility|mobility
230576|NCT02757131|Elderly|elderly
230577|NCT02757131|Hospitalized patient|hospitalized patient
230578|NCT02757118|Cardiac Surgery, blood viscosity|cardiac surgery, blood viscosity
230579|NCT02757092|Pulmonary rehabilitation|pulmonary rehabilitation
230580|NCT02757092|lung cancer|lung cancer
230581|NCT02757092|Thoracoscopy|thoracoscopy
230582|NCT02757079|Melatonin|melatonin
230583|NCT02757079|NPC-15|npc-15
230584|NCT02757079|Sleep disorders|sleep disorders
230585|NCT02757079|Neurodevelopmental disorder|neurodevelopmental disorder
230586|NCT02757079|Sleep latency|sleep latency
230587|NCT02757079|DSM-5|dsm-5
230588|NCT02757066|Melatonin|melatonin
230589|NCT02757066|NPC-15|npc-15
230590|NCT02757066|Sleep disorders|sleep disorders
230591|NCT02757066|Autism spectrum disorders|autism spectrum disorders
230592|NCT02757066|DSM-5|dsm-5
230593|NCT02757053|Brain Concussion|brain concussion
230594|NCT02757053|Brain Injuries|brain injuries
230595|NCT02757053|Diffuse Axonal Injury|diffuse axonal injury
230596|NCT02757053|Football|football
230597|NCT02757053|Head Protective Devices|head protective devices
230598|NCT02757053|Magnetic Resonance Imaging|magnetic resonance imaging
230599|NCT02757053|Helmet|helmet
230600|NCT02757053|Third party add-on|third party add-on
230601|NCT02757040|chronic lymphocytic leukemia|chronic lymphocytic leukemia
230602|NCT02757040|ibrutinib|ibrutinib
230603|NCT02757040|arsenic trioxide|arsenic trioxide
727262|NCT00520026|prevention|prevention
230604|NCT02757040|phosphatidylinositol 3-kinase|phosphatidylinositol 3-kinase
230605|NCT02757027|CABG surgery|cabg surgery
230606|NCT02757027|blood viscosity|blood viscosity
230607|NCT02757001|Retrievable Inferior Vena Cava Filters|retrievable inferior vena cava filters
230608|NCT02757001|Pulmonary Embolism|pulmonary embolism
230609|NCT02756949|HIV|hiv
230610|NCT02756949|Viral load|viral load
230611|NCT02756949|CD4 count|cd4 count
230612|NCT02756949|mHealth|mhealth
230613|NCT02756949|Smartphone|smartphone
230614|NCT02756949|Linkage to care|linkage to care
230615|NCT02756949|Retention in care|retention in care
230616|NCT02756949|Antiretroviral treatment|antiretroviral treatment
230617|NCT02756949|Randomized controlled trial|randomized controlled trial
230618|NCT02756949|Johannesburg|johannesburg
230619|NCT02756949|Mobile app|mobile app
230620|NCT02756949|Treatment adherence|treatment adherence
230621|NCT02756923|Male Infertility|male infertility
230622|NCT02756923|Spermatogonial stem cell|spermatogonial stem cell
230623|NCT02756910|open abdominal surgery|open abdominal surgery
230624|NCT02756910|anesthesia, general|anesthesia, general
230625|NCT02756845|Non CNS Tumor|non cns tumor
230626|NCT02756832|Drug Therapy|drug therapy
230627|NCT02756819|Drug Therapy|drug therapy
230628|NCT02756806|Tattoo removal, Picosecond Laser, Q-switched Laser|tattoo removal, picosecond laser, q-switched laser
230629|NCT02756780|Remission|remission
230630|NCT02756780|Carer|carer
230631|NCT02756780|Psychological|psychological
230632|NCT02756780|Bereaved|bereaved
230633|NCT02756780|Cancer|cancer
230634|NCT02756780|Breast|breast
230635|NCT02756780|Prostate|prostate
230636|NCT02756780|Colorectal|colorectal
230637|NCT02756780|Music|music
230638|NCT02756741|Cirrhosis|cirrhosis
230639|NCT02756741|hepatitis B virus|hepatitis b virus
230640|NCT02756741|Alcohol|alcohol
230641|NCT02756741|varices|varices
230642|NCT02756702|TKA|tka
230643|NCT02756702|TKR|tkr
230644|NCT02756702|All-Poly|all-poly
230645|NCT02756702|posterior stabilized|posterior stabilized
230646|NCT02756689|Mechanical cervical ripening|mechanical cervical ripening
230647|NCT02756689|Transcervical catheter|transcervical catheter
230648|NCT02756689|Foley catheter for labor induction|foley catheter for labor induction
230649|NCT02756689|Cervical ripening|cervical ripening
230650|NCT02756689|Induction of labor|induction of labor
230651|NCT02756676|Parkinson Disease|parkinson disease
230652|NCT02756676|Quality of Life|quality of life
230653|NCT02756676|Rehabilitation|rehabilitation
230654|NCT02756663|multiple myeloma|multiple myeloma
230655|NCT02756663|MM|mm
230656|NCT02756663|relapsed|relapsed
230657|NCT02756663|relapsed and refractory|relapsed and refractory
230658|NCT02756663|panobinostat|panobinostat
230659|NCT02756663|LBH589|lbh589
230660|NCT02756663|histone deacetylase inhibitor|histone deacetylase inhibitor
230661|NCT02756663|carfilzomib|carfilzomib
230662|NCT02756663|proteasome inhibitor|proteasome inhibitor
230663|NCT02756650|Behcet Disease|behcet disease
230664|NCT02756650|Inflammation|inflammation
230665|NCT02756650|Immune system|immune system
230666|NCT02756650|Arthritis|arthritis
230667|NCT02756611|Oncology|oncology
230668|NCT02756611|Chronic Lymphocytic Leukemia|chronic lymphocytic leukemia
230669|NCT02756611|17p Deletion|17p deletion
230670|NCT02756611|TP53 Mutation|tp53 mutation
230671|NCT02756611|Relapsed|relapsed
230672|NCT02756611|Refractory|refractory
230773|NCT02755857|Prophylaxis|prophylaxis
230673|NCT02756611|B-Cell receptor inhibitor|b-cell receptor inhibitor
230674|NCT02756598|sufentanil|sufentanil
230675|NCT02756598|propofol|propofol
230676|NCT02756598|personality/stress test|personality/stress test
230677|NCT02756598|fast-track|fast-track
230678|NCT02756585|computed tomography|computed tomography
230679|NCT02756585|perfusion imaging|perfusion imaging
230680|NCT02756585|brain death|brain death
230681|NCT02756585|traumatic brain injury|traumatic brain injury
230682|NCT02756559|sepsis|sepsis
230683|NCT02756559|microRNAs|micrornas
230684|NCT02756520|chronic kidney disease, pre-dialytic|chronic kidney disease, pre-dialytic
230685|NCT02756520|Ketosteril, keto-acids|ketosteril, keto-acids
230686|NCT02756520|diet, protein-restricted|diet, protein-restricted
230687|NCT02756520|renal function|renal function
230688|NCT02756507|anxiety symptoms|anxiety symptoms
230689|NCT02756507|depression symptoms|depression symptoms
230690|NCT02756507|internalizing symptoms|internalizing symptoms
230691|NCT02756468|pancreatic cancer|pancreatic cancer
230692|NCT02756468|procalcitonin|procalcitonin
230693|NCT02756455|gastric cancer|gastric cancer
230694|NCT02756455|procalcitonin|procalcitonin
230695|NCT02756429|atrial fibrillation|atrial fibrillation
230696|NCT02756429|stroke|stroke
230697|NCT02756429|thromboembolism|thromboembolism
230698|NCT02756429|inflammation|inflammation
230699|NCT02756416|Reversible Cerebral Vasoconstriction Syndrome (RCVS)|reversible cerebral vasoconstriction syndrome (rcvs)
230700|NCT02756416|Arterial spin labeling (ASL) MRI|arterial spin labeling (asl) mri
230701|NCT02756390|Insomnia cancer Survivor|insomnia cancer survivor
230702|NCT02756364|Drug Therapy|drug therapy
230703|NCT02756325|Azoospermia, IVF, MRI|azoospermia, ivf, mri
230704|NCT02756299|Sleep Apnea|sleep apnea
230705|NCT02756299|Positive Airway Pressure|positive airway pressure
230706|NCT02756299|Patient Education|patient education
230707|NCT02756286|Electroencephalography|electroencephalography
230708|NCT02756286|Attention|attention
230709|NCT02756273|ileostomy|ileostomy
230710|NCT02756273|morbidity|morbidity
230711|NCT02756273|colorectal surgery|colorectal surgery
230712|NCT02756247|Buparlisib|buparlisib
230713|NCT02756247|BKM120|bkm120
230714|NCT02756247|Ibrutinib|ibrutinib
230715|NCT02756247|16-009|16-009
230716|NCT02756221|symptoms|symptoms
230717|NCT02756208|vaccine|vaccine
230718|NCT02756208|healthy volunteer|healthy volunteer
230719|NCT02756195|Patient safety|patient safety
230720|NCT02756195|adverse events|adverse events
230721|NCT02756195|pediatric surgery|pediatric surgery
230722|NCT02756195|quality improvement|quality improvement
230723|NCT02756195|health systems|health systems
230724|NCT02756195|observational study|observational study
230725|NCT02756195|non-routine event|non-routine event
230726|NCT02756195|National Surgical Improvement Program|national surgical improvement program
230727|NCT02756169|Obesity|obesity
230728|NCT02756169|Breastfeeding|breastfeeding
230729|NCT02756169|Grow up|grow up
230730|NCT02756169|Milk composition|milk composition
230731|NCT02756169|Mexico|mexico
230732|NCT02756156|interscalene|interscalene
230733|NCT02756156|infraclavicular|infraclavicular
230734|NCT02756156|humerus surgery|humerus surgery
230735|NCT02756143|fetal heart|fetal heart
230736|NCT02756143|cesarean section|cesarean section
230737|NCT02756143|exercise|exercise
230738|NCT02756143|pregnancy|pregnancy
230739|NCT02756091|Intracranial Artery Dissection|intracranial artery dissection
230740|NCT02756091|IAD|iad
230741|NCT02756091|Stroke|stroke
230742|NCT02756091|Observational Study|observational study
230743|NCT02756065|Bipolar|bipolar
230744|NCT02756065|schizophrenia|schizophrenia
230745|NCT02756065|schizoaffective|schizoaffective
230746|NCT02756026|Breast milk|breast milk
230747|NCT02756026|mineral|mineral
230748|NCT02756026|vitamin|vitamin
230749|NCT02756013|chemotherapy dosing|chemotherapy dosing
230750|NCT02756013|Body surface area|body surface area
230751|NCT02756013|BSA|bsa
230752|NCT02756013|paclitaxel|paclitaxel
230753|NCT02756013|carboplatin|carboplatin
230754|NCT02756013|dose dense|dose dense
230755|NCT02756000|myocardial infarction|myocardial infarction
230756|NCT02756000|percutaneous coronary intervention|percutaneous coronary intervention
230757|NCT02756000|multivessel coronary artery disease|multivessel coronary artery disease
230758|NCT02756000|dobutamine stress echocardiography|dobutamine stress echocardiography
230759|NCT02755974|Chronic Obstructive Pulmonary Disease|chronic obstructive pulmonary disease
230760|NCT02755961|End-stage renal disease|end-stage renal disease
230761|NCT02755961|Phosphate binders|phosphate binders
230762|NCT02755961|Hyperphosphatemia|hyperphosphatemia
230763|NCT02755961|Dietary education|dietary education
230764|NCT02755948|Influenza|influenza
230765|NCT02755948|Respiratory Syncytial Virus Infections|respiratory syncytial virus infections
230766|NCT02755948|RSV A Memphis 37|rsv a memphis 37
230767|NCT02755922|Mesenchymal Stem Cells|mesenchymal stem cells
230768|NCT02755922|Treatment|treatment
230769|NCT02755909|Cardiac surgery, anxiety, education|cardiac surgery, anxiety, education
230770|NCT02755883|Physical activity|physical activity
230771|NCT02755883|non-small lung cancer|non-small lung cancer
230772|NCT02755883|positive affect|positive affect
230774|NCT02755857|Bioavailability|bioavailability
230775|NCT02755857|Pharmacokinetics|pharmacokinetics
230776|NCT02755844|endometrial carcinomas|endometrial carcinomas
230777|NCT02755844|metronomic cyclophosphamide|metronomic cyclophosphamide
230778|NCT02755844|metformin|metformin
230779|NCT02755844|olaparib|olaparib
230780|NCT02755844|dose-escalation study|dose-escalation study
230781|NCT02755831|OSA|osa
230782|NCT02755831|pregnancy|pregnancy
230783|NCT02755831|adverse pregnancy outcomes|adverse pregnancy outcomes
230784|NCT02755831|continuous positive airway pressure|continuous positive airway pressure
230785|NCT02755831|preeclampsia|preeclampsia
230786|NCT02755831|gestational diabetes|gestational diabetes
230787|NCT02755818|high density lipoprotein (HDL)|high density lipoprotein (hdl)
230788|NCT02755818|lipid|lipid
230789|NCT02755818|insulin resistance|insulin resistance
230790|NCT02755818|glomerular filtration rate (GFR)|glomerular filtration rate (gfr)
230791|NCT02755818|obesity|obesity
230792|NCT02755805|Stroke|stroke
230793|NCT02755805|Rehabilitation|rehabilitation
230794|NCT02755805|Cognition|cognition
230795|NCT02755805|Intervention|intervention
230796|NCT02755805|Strategy training|strategy training
230797|NCT02755792|Mild Cognitive Impairment|mild cognitive impairment
230798|NCT02755792|Cognitive training|cognitive training
230799|NCT02755792|Calligraphy|calligraphy
230800|NCT02755792|Emotional calmness|emotional calmness
230801|NCT02755792|Working memory|working memory
230802|NCT02755753|Rebamipide|rebamipide
230803|NCT02755740|female|female
230804|NCT02755688|atrial fibrillation|atrial fibrillation
230805|NCT02755688|catheter ablation|catheter ablation
230806|NCT02755688|thoracoscopic surgical ablation|thoracoscopic surgical ablation
230807|NCT02755688|long standing persistent atrial fibrillation|long standing persistent atrial fibrillation
230808|NCT02755662|Obstructive Sleep Apnea Syndrome|obstructive sleep apnea syndrome
230809|NCT02755662|mandibular repositioning device|mandibular repositioning device
230810|NCT02755636|Health Behavior Change|health behavior change
230811|NCT02755636|Primary Health Care|primary health care
230812|NCT02755636|Patient Participation|patient participation
230813|NCT02755636|Provider-Patient Communication|provider-patient communication
230814|NCT02755636|Cluster-Randomized Trial|cluster-randomized trial
230815|NCT02755636|Mobile Health|mobile health
230816|NCT02755610|Peritoneal Dialysis|peritoneal dialysis
230817|NCT02755610|Checklist|checklist
230818|NCT02755597|relapsed/refractory multiple myeloma|relapsed/refractory multiple myeloma
230819|NCT02755597|relapsed multiple myeloma|relapsed multiple myeloma
230820|NCT02755597|refractory multiple myeloma|refractory multiple myeloma
230821|NCT02755597|multiple myeloma|multiple myeloma
230822|NCT02755584|Aging|aging
230823|NCT02755584|Senescent Cells|senescent cells
230824|NCT02755532|Pharmacokinetics|pharmacokinetics
230825|NCT02755532|Bupivacaine|bupivacaine
230826|NCT02755532|Axillary brachial plexus block|axillary brachial plexus block
230827|NCT02755519|primary aldosteronism|primary aldosteronism
230828|NCT02755519|confirmatory test|confirmatory test
230829|NCT02755519|hypertension|hypertension
230830|NCT02755506|Ultrasound elastography|ultrasound elastography
230831|NCT02755506|Thoracic lesions|thoracic lesions
230832|NCT02755506|EBUS-TBNA|ebus-tbna
230833|NCT02755480|bone marrow transplant|bone marrow transplant
230834|NCT02755480|infection|infection
230835|NCT02755480|computed tomography|computed tomography
230836|NCT02755480|radiation dose|radiation dose
230837|NCT02755441|Diagnosis|diagnosis
230838|NCT02755441|Prognosis|prognosis
230839|NCT02755441|Biomarker|biomarker
230840|NCT02755415|Rehabilitation|rehabilitation
230841|NCT02755415|Robotic|robotic
230842|NCT02755415|Gait|gait
230843|NCT02755415|Quality of Life|quality of life
230844|NCT02755389|Tracheal intubation|tracheal intubation
230845|NCT02755389|High flow nasal oxygen|high flow nasal oxygen
230846|NCT02755389|Airway management|airway management
230847|NCT02755389|Apneic oxygenation|apneic oxygenation
230848|NCT02755363|COPD|copd
230849|NCT02755363|residual volume|residual volume
230850|NCT02755363|osteopathy|osteopathy
230851|NCT02755363|hyperinflation|hyperinflation
230852|NCT02755350|PrEP|prep
230853|NCT02755350|HIV Prevention|hiv prevention
230854|NCT02755350|combination prevention|combination prevention
230855|NCT02755350|demonstration project|demonstration project
230856|NCT02755337|adenocarcinoma|adenocarcinoma
230857|NCT02755337|non-adenocarcinoma|non-adenocarcinoma
230858|NCT02755298|Treatment Outcome|treatment outcome
230859|NCT02755298|Acetazolamide|acetazolamide
230860|NCT02755272|Triple Negative Breast Cancer|triple negative breast cancer
230861|NCT02755259|Acetazolamide|acetazolamide
230862|NCT02755259|Hemodynamics|hemodynamics
230863|NCT02755246|subjective cognitive decline|subjective cognitive decline
230864|NCT02755246|dementia|dementia
230865|NCT02755246|lifestyle|lifestyle
230866|NCT02755246|polyamine|polyamine
230867|NCT02755246|memory|memory
230868|NCT02755246|elderly|elderly
230869|NCT02755246|prevention|prevention
230870|NCT02755246|treatment|treatment
230871|NCT02755246|dietary supplement|dietary supplement
230872|NCT02755246|Polyamine-enriched diet|polyamine-enriched diet
230873|NCT02755194|pharmacokinetics|pharmacokinetics
230874|NCT02755194|Drug-in-milk|drug-in-milk
230875|NCT02755194|breastfeeding|breastfeeding
230876|NCT02755194|drug safety|drug safety
230877|NCT02755194|population pharmacokinetics|population pharmacokinetics
230878|NCT02755155|acute circulatory failure requiring norepinephrine|acute circulatory failure requiring norepinephrine
230879|NCT02755155|SIRS|sirs
230880|NCT02755155|Albumin, therapeutic|albumin, therapeutic
230881|NCT02755116|Nausea|nausea
230882|NCT02755116|Vomiting|vomiting
230883|NCT02755103|Mindfulness|mindfulness
230884|NCT02755103|Comorbid PTSD and SUD|comorbid ptsd and sud
230885|NCT02755103|Meditation|meditation
230886|NCT02755090|nitrous|nitrous
230887|NCT02755090|pain|pain
230888|NCT02755077|Anesthesia induction|anesthesia induction
230889|NCT02755077|Airway|airway
230890|NCT02755077|Mask ventilation|mask ventilation
230891|NCT02755038|postmenopausal women|postmenopausal women
230892|NCT02755038|scalp hair|scalp hair
230893|NCT02755038|estrogen|estrogen
230894|NCT02755038|progesterone|progesterone
230895|NCT02755025|Sepsis|sepsis
230896|NCT02755025|SOFA score|sofa score
230897|NCT02755025|Automated calculation|automated calculation
230898|NCT02755012|Maternal Health|maternal health
230899|NCT02755012|Guatemala|guatemala
230900|NCT02755012|Indigenous Population|indigenous population
230901|NCT02755012|Stunting|stunting
230902|NCT02755012|Food Insecurity|food insecurity
230903|NCT02755012|Poverty|poverty
230904|NCT02755012|Social Support|social support
230905|NCT02755012|Maternal Autonomy|maternal autonomy
230906|NCT02755012|Paternal Support|paternal support
230907|NCT02755012|Cortisol Rhythm|cortisol rhythm
230908|NCT02754986|heart rate variability|heart rate variability
230909|NCT02754960|Gastrointestinal bleeding|gastrointestinal bleeding
230910|NCT02754960|Vascular malformation|vascular malformation
230911|NCT02754960|Angiodysplasia|angiodysplasia
230912|NCT02754960|Thalidomide|thalidomide
230913|NCT02754947|Assessment and Consultation Team (ACT)|assessment and consultation team (act)
230914|NCT02754947|Rapid Response Team (RRT)|rapid response team (rrt)
230915|NCT02754947|Perioperative complications|perioperative complications
230916|NCT02754947|Respiratory insufficiency|respiratory insufficiency
230917|NCT02754947|ASA status|asa status
230918|NCT02754934|chronic|chronic
230919|NCT02754895|acute coronary syndrome|acute coronary syndrome
230920|NCT02754895|health behavior|health behavior
230921|NCT02754895|factorial design|factorial design
230922|NCT02754895|positive psychology|positive psychology
230923|NCT02754882|NSCLC|nsclc
230924|NCT02754882|bevacizumab|bevacizumab
230925|NCT02754882|avastin|avastin
230926|NCT02754778|arterial stiffness|arterial stiffness
230927|NCT02754778|preeclampsia|preeclampsia
230928|NCT02754778|HELLP-syndrome|hellp-syndrome
230929|NCT02754778|pulse wave velocity|pulse wave velocity
230930|NCT02754778|advanced glycation endproducts|advanced glycation endproducts
230931|NCT02754778|skin autofluorescence|skin autofluorescence
230932|NCT02754778|conditional workout|conditional workout
230933|NCT02754778|postpartum|postpartum
230934|NCT02754778|cardiovascular risk|cardiovascular risk
230935|NCT02754778|pregnancy|pregnancy
230936|NCT02754778|vicorder|vicorder
230937|NCT02754778|age reader|age reader
230938|NCT02754752|Malignant neoplasm of breast|malignant neoplasm of breast
230939|NCT02754752|Electro-acupuncture|electro-acupuncture
230940|NCT02754752|Questionnaires|questionnaires
230941|NCT02754752|Surveys|surveys
230942|NCT02754752|Standard of care|standard of care
230943|NCT02754752|Chronic Pain|chronic pain
230944|NCT02754739|Pravastatin|pravastatin
230945|NCT02754739|Insulin Resistance|insulin resistance
230946|NCT02754700|Anterior Cruciate Ligament|anterior cruciate ligament
230947|NCT02754687|male contraception|male contraception
230948|NCT02754687|healthy men|healthy men
230949|NCT02754687|androgen|androgen
230950|NCT02754687|Nortestosterone|nortestosterone
230951|NCT02754687|Dodecylcarbonate|dodecylcarbonate
230952|NCT02754687|11-Beta|11-beta
230953|NCT02754687|11β|11β
230954|NCT02754687|contraception|contraception
230955|NCT02754661|Polyps; Capsule endoscopy; CT Colonography; Colonoscopy; Average risk patients for colorectal cancer screening|polyps; capsule endoscopy; ct colonography; colonoscopy; average risk patients for colorectal cancer screening
230956|NCT02754635|Abnormal first or second trimester biochemical markers|abnormal first or second trimester biochemical markers
230957|NCT02754635|maternal and perinatal morbidity/mortality|maternal and perinatal morbidity/mortality
230958|NCT02754622|Rehabilitation|rehabilitation
230959|NCT02754609|Celiac Disease|celiac disease
230960|NCT02754609|Necator americanus|necator americanus
230961|NCT02754609|Helminths|helminths
230962|NCT02754609|Autoimmunity|autoimmunity
230963|NCT02754609|Clinical Trials, Phase I|clinical trials, phase i
230964|NCT02754609|Randomized Controlled Trial|randomized controlled trial
230965|NCT02754583|trachoma|trachoma
230966|NCT02754583|soil transmitted helminths|soil transmitted helminths
230967|NCT02754583|sanitation|sanitation
230968|NCT02754583|face washing|face washing
230969|NCT02754583|antibiotics|antibiotics
230970|NCT02754570|Open-angle glaucoma|open-angle glaucoma
230971|NCT02754570|Ocular hypertension|ocular hypertension
230972|NCT02754570|Latanoprost|latanoprost
230973|NCT02754570|Pilocarpine|pilocarpine
230974|NCT02754531|Cole formula|cole formula
230975|NCT02754531|Pediatric patients|pediatric patients
230976|NCT02754531|intubation|intubation
230977|NCT02754531|Ultrasonography|ultrasonography
230978|NCT02754531|Endotracheal tube|endotracheal tube
230979|NCT02754531|uncuffed|uncuffed
230980|NCT02754531|pediatric|pediatric
230981|NCT02754505|Keywords: intensive care, muscle wasting, discharge, neuromuscular weakness, mobilization|keywords: intensive care, muscle wasting, discharge, neuromuscular weakness, mobilization
230982|NCT02754453|Weight Regain|weight regain
230983|NCT02754453|Group Treatment|group treatment
230984|NCT02754453|Weight Loss|weight loss
230985|NCT02754427|Surveillance|surveillance
230986|NCT02754427|Physiotherapy|physiotherapy
230987|NCT02754427|Arm morbidity|arm morbidity
230988|NCT02754414|platelets|platelets
230989|NCT02754414|transfusion|transfusion
230990|NCT02754414|cold storage|cold storage
230991|NCT02754414|apheresis|apheresis
230992|NCT02754401|public health|public health
230993|NCT02754401|periodontitis|periodontitis
230994|NCT02754401|self-reported questionnaire|self-reported questionnaire
230995|NCT02754388|LDCT, screening, health behavior, psychological factors|ldct, screening, health behavior, psychological factors
230996|NCT02754375|biological markers|biological markers
230997|NCT02754375|rTMS|rtms
230998|NCT02754362|Poly-ICLC and bevacizumab|poly-iclc and bevacizumab
230999|NCT02754362|humanized monoclonal antibody|humanized monoclonal antibody
231000|NCT02754349|pulse wave velocity|pulse wave velocity
231001|NCT02754349|augmentation index|augmentation index
231002|NCT02754349|central pulse pressure|central pulse pressure
231003|NCT02754310|Education, medical|education, medical
231004|NCT02754310|Simulation Training|simulation training
231005|NCT02754297|Neuroendocrine tumors|neuroendocrine tumors
231006|NCT02754297|Personalized|personalized
231007|NCT02754297|Peptide receptor radionuclide therapy|peptide receptor radionuclide therapy
231008|NCT02754297|PRRT|prrt
231009|NCT02754297|177Lu-DOTATATE|177lu-dotatate
231010|NCT02754297|177Lu-octreotate|177lu-octreotate
231011|NCT02754245|multicenter study|multicenter study
231012|NCT02754245|emergency department|emergency department
231013|NCT02754245|overcrowding status|overcrowding status
231014|NCT02754245|estimation tool|estimation tool
231015|NCT02754245|validation|validation
231016|NCT02754232|Physical training|physical training
231017|NCT02754232|Telemedicine|telemedicine
231018|NCT02754232|Daily activities|daily activities
231019|NCT02754232|Cross sectoral|cross sectoral
231020|NCT02754219|Diabetes Mellitus, Type II|diabetes mellitus, type ii
231021|NCT02754193|Venous-Arterial ExtraCorporeal Membrane Oxygenation|venous-arterial extracorporeal membrane oxygenation
231022|NCT02754180|adjuvant|adjuvant
231023|NCT02754180|pancreatic cancer|pancreatic cancer
231024|NCT02754180|R1 resection|r1 resection
231025|NCT02754180|positive lymph nodes|positive lymph nodes
231026|NCT02754167|Hepcidin|hepcidin
231027|NCT02754167|hemoglobin|hemoglobin
231028|NCT02754167|iron|iron
231029|NCT02754167|anemia of chronic disease|anemia of chronic disease
231030|NCT02754089|Body weight changes|body weight changes
231031|NCT02754089|Medicine, Traditional|medicine, traditional
231032|NCT02754089|Herbal medicine|herbal medicine
231033|NCT02754089|Rhus|rhus
231034|NCT02754089|Waist Circumference|waist circumference
231035|NCT02754089|Waist-Hip Ratio|waist-hip ratio
231036|NCT02754089|Body mass index|body mass index
231037|NCT02754076|Sanfilippo Syndrome Type B|sanfilippo syndrome type b
231038|NCT02754024|Stemless shoulder prosthesis|stemless shoulder prosthesis
231039|NCT02754011|HER2 negative|her2 negative
231040|NCT02754011|Locally advanced or metastatic|locally advanced or metastatic
231041|NCT02753998|Stenosis of arteriovenous fistula|stenosis of arteriovenous fistula
231042|NCT02753998|Angioplasty|angioplasty
231043|NCT02753998|Paclitaxel-Coated Balloon Angioplasty|paclitaxel-coated balloon angioplasty
231044|NCT02753920|voiding trial|voiding trial
231045|NCT02753920|prolapse|prolapse
231046|NCT02753894|Dose-finding|dose-finding
231047|NCT02753894|Hemodialysis|hemodialysis
231048|NCT02753894|ASP1585|asp1585
231049|NCT02753894|Chronic kidney disease|chronic kidney disease
231050|NCT02753868|Intradialytic exercise|intradialytic exercise
231051|NCT02753868|Cardiac and arterial function|cardiac and arterial function
231052|NCT02753842|Sexually Transmitted Infections|sexually transmitted infections
231053|NCT02753842|Condoms|condoms
231054|NCT02753842|Contraceptive Devices|contraceptive devices
231055|NCT02753842|HIV|hiv
231056|NCT02753816|Tranexamic Acid|tranexamic acid
231057|NCT02753816|Burn|burn
231058|NCT02753816|Surgery|surgery
231059|NCT02753816|Tangential|tangential
231060|NCT02753816|Excision|excision
231061|NCT02753790|Brain|brain
231062|NCT02753790|Metastasis|metastasis
231063|NCT02753790|IMRT|imrt
231064|NCT02753790|Radiation|radiation
231065|NCT02753790|Cancer|cancer
231066|NCT02753790|Hippocampus|hippocampus
231067|NCT02753790|Intensity modulated radiotherapy|intensity modulated radiotherapy
231068|NCT02753790|Quality of life|quality of life
231069|NCT02753790|QOL|qol
231070|NCT02753712|Small airway disease|small airway disease
231072|NCT02753699|Chronic hepatitis C|chronic hepatitis c
231073|NCT02753686|HR+ HER2|hr+ her2
231074|NCT02753686|pre/postmenopausal|pre/postmenopausal
231075|NCT02753686|men|men
231076|NCT02753686|advanced breast cancer|advanced breast cancer
231077|NCT02753686|non steroidal aromatase inhibitor (NSAI) exposure|non steroidal aromatase inhibitor (nsai) exposure
231078|NCT02753686|metastatic|metastatic
231079|NCT02753686|endocrine therapy|endocrine therapy
231080|NCT02753686|targeted therapy|targeted therapy
231081|NCT02753686|prospective|prospective
231082|NCT02753686|observational|observational
231083|NCT02753686|registry|registry
231084|NCT02753686|real world setting|real world setting
231085|NCT02753686|non-interventional|non-interventional
231086|NCT02753686|Canadian|canadian
231087|NCT02753673|Breast Conserving Therapy|breast conserving therapy
231088|NCT02753673|Reported Outcomes Instrument|reported outcomes instrument
231089|NCT02753673|16-325|16-325
231090|NCT02753660|spinal, anesthesia, pendant, spinal-bone contact, puncture|spinal, anesthesia, pendant, spinal-bone contact, puncture
231091|NCT02753608|exhaled breath condensate|exhaled breath condensate
231092|NCT02753608|volatile organic compounds|volatile organic compounds
231093|NCT02753595|PEGylated Recombinant Human Hyaluronidase|pegylated recombinant human hyaluronidase
727263|NCT00520026|lithium|lithium
231094|NCT02753595|Eribulin Mesylate|eribulin mesylate
231095|NCT02753595|E7389|e7389
231096|NCT02753595|PEGPH20|pegph20
231097|NCT02753595|Human Epidermal Growth Factor Receptor 2-Negative|human epidermal growth factor receptor 2-negative
231098|NCT02753595|High-Hyaluronan|high-hyaluronan
231099|NCT02753582|Elderly, pre-frail, SOD|elderly, pre-frail, sod
231100|NCT02753569|Magnetic Resonance Imaging|magnetic resonance imaging
231101|NCT02753569|PET/CT|pet/ct
231102|NCT02753569|non-small cell lung cancer|non-small cell lung cancer
231103|NCT02753556|Chronic Obstructive Pulmonary Disease|chronic obstructive pulmonary disease
231104|NCT02753556|COPD|copd
231105|NCT02753556|ScreenFlow|screenflow
231106|NCT02753556|Screening|screening
231107|NCT02753556|Lung Disease|lung disease
231108|NCT02753556|Mobile Health|mobile health
231109|NCT02753556|Peak Flow Meter|peak flow meter
231110|NCT02753556|Usability|usability
231111|NCT02753517|hepatobiliary scintigraphy|hepatobiliary scintigraphy
231112|NCT02753517|extended hepatectomy|extended hepatectomy
231113|NCT02753517|volumetry|volumetry
231114|NCT02753504|Dyslipidemia|dyslipidemia
231115|NCT02753491|short interview, diabetes, lifestyle changes, primary care|short interview, diabetes, lifestyle changes, primary care
231116|NCT02753478|hypothermia|hypothermia
231117|NCT02753465|Rectal Neoplasms|rectal neoplasms
231118|NCT02753465|anastomosis|anastomosis
231119|NCT02753465|OS|os
231120|NCT02753465|DFS|dfs
231121|NCT02753465|LCA|lca
231122|NCT02753465|laparoscopic surgery|laparoscopic surgery
231123|NCT02753452|youth|youth
231124|NCT02753452|disability|disability
231125|NCT02753452|transition|transition
231126|NCT02753452|life skills|life skills
231127|NCT02753452|adolescence|adolescence
231128|NCT02753413|Vaccine|vaccine
231129|NCT02753413|Safety|safety
231130|NCT02753413|Reactogenicity|reactogenicity
231131|NCT02753413|Respiratory syncytial virus (RSV)|respiratory syncytial virus (rsv)
231132|NCT02753387|mouthwash|mouthwash
231133|NCT02753387|head and neck cancer|head and neck cancer
231134|NCT02753387|chlorhexidine|chlorhexidine
231135|NCT02753387|pathogens germs|pathogens germs
231136|NCT02753374|cystic fibrosis, Chinese, children|cystic fibrosis, chinese, children
231137|NCT02753361|Ultrasound|ultrasound
231138|NCT02753361|regional blockade|regional blockade
231139|NCT02753361|lipoma|lipoma
231140|NCT02753335|CRPS, graded motor imagery, desensitization, fMRI, DMN|crps, graded motor imagery, desensitization, fmri, dmn
231141|NCT02753322|Dual task training|dual task training
231142|NCT02753322|Dual task interference|dual task interference
231143|NCT02753322|Sub-acute stroke|sub-acute stroke
231144|NCT02753322|Physiotherapy training|physiotherapy training
231145|NCT02753322|Community ambulation|community ambulation
231146|NCT02753322|Balance|balance
231147|NCT02753309|BCG|bcg
231148|NCT02753309|Rapamycin|rapamycin
231149|NCT02753296|Cancer|cancer
231150|NCT02753296|Fertility Preservation|fertility preservation
231151|NCT02753296|Patient Decision Aid|patient decision aid
231152|NCT02753283|Bone loss|bone loss
231399|NCT02751723|cancer disease|cancer disease
231153|NCT02753283|Frail Geriatric Patients|frail geriatric patients
231154|NCT02753283|Nursing Home Patients|nursing home patients
231155|NCT02753283|Long-term Care Patients|long-term care patients
231156|NCT02753283|Osteoporosis|osteoporosis
231157|NCT02753283|Osteoporotic Fractures|osteoporotic fractures
231158|NCT02753257|stroke|stroke
231159|NCT02753257|stroke mimic|stroke mimic
231160|NCT02753244|Cognitive VideoGames|cognitive videogames
231161|NCT02753179|Bilateral vestibular hypofunction|bilateral vestibular hypofunction
231162|NCT02753179|Video Head Impulse Test|video head impulse test
231163|NCT02753179|Covert-saccades|covert-saccades
231164|NCT02753179|Quality of life|quality of life
231165|NCT02753179|Dynamic visual acuity|dynamic visual acuity
231166|NCT02753166|PTSD (Post Traumatic Stress Disorder)|ptsd (post traumatic stress disorder)
231167|NCT02753166|Emergency Department|emergency department
231168|NCT02753127|Colorectal Neoplasms|colorectal neoplasms
231169|NCT02753127|Colonic Diseases|colonic diseases
231170|NCT02753127|Digestive System Diseases|digestive system diseases
231171|NCT02753127|Digestive System Neoplasms|digestive system neoplasms
231172|NCT02753127|Gastrointestinal Diseases|gastrointestinal diseases
231173|NCT02753127|Gastrointestinal Neoplasms|gastrointestinal neoplasms
231174|NCT02753127|Intestinal Diseases|intestinal diseases
231175|NCT02753127|Intestinal Neoplasms|intestinal neoplasms
231176|NCT02753127|Neoplasms|neoplasms
231177|NCT02753127|Neoplasms by Histologic Type|neoplasms by histologic type
231178|NCT02753127|Neoplasms by Site|neoplasms by site
231179|NCT02753127|Neoplasms, Glandular and Epithelial|neoplasms, glandular and epithelial
231180|NCT02753127|Rectal Diseases|rectal diseases
231181|NCT02753114|Ketamine|ketamine
231182|NCT02753114|Intranasal|intranasal
231183|NCT02753114|Emergency Medical Services|emergency medical services
231184|NCT02753114|Pain|pain
231185|NCT02753114|Analgesia|analgesia
231186|NCT02753101|Positron Emission Tomography|positron emission tomography
231187|NCT02753101|Magnetic Resonance Imaging|magnetic resonance imaging
231188|NCT02753101|PET/MRI|pet/mri
231189|NCT02753101|sigma-1 receptor|sigma-1 receptor
231190|NCT02753101|radiopharmaceutical|radiopharmaceutical
231191|NCT02753101|complex regional pain syndrome|complex regional pain syndrome
231192|NCT02753101|sciatica|sciatica
231193|NCT02753101|chronic pain|chronic pain
231194|NCT02753088|Equivalence|equivalence
231195|NCT02753088|BCD-063|bcd-063
231196|NCT02753088|Copaxone-Teva|copaxone-teva
231198|NCT02753049|AIDS|aids
231199|NCT02753049|Adolescent|adolescent
231200|NCT02753049|Adherence|adherence
231201|NCT02753049|Retention|retention
231202|NCT02753049|mHealth|mhealth
231203|NCT02753036|cognition|cognition
231204|NCT02753036|chemotherapy|chemotherapy
231205|NCT02753036|polyneuropathy|polyneuropathy
231206|NCT02753036|paclitaxel|paclitaxel
231207|NCT02753036|cancer|cancer
231208|NCT02753036|chemobrain|chemobrain
231209|NCT02752984|Peripherally inserted central venous catheter|peripherally inserted central venous catheter
231210|NCT02752932|Head and neck cancer|head and neck cancer
231211|NCT02752932|Patient derived Xenograft|patient derived xenograft
231212|NCT02752932|Chemotherapy|chemotherapy
231213|NCT02752932|Metastases|metastases
231214|NCT02752906|Meningitis|meningitis
231215|NCT02752906|Meningococcal Meningitis|meningococcal meningitis
231216|NCT02752906|Meningococcal Infections|meningococcal infections
231217|NCT02752906|MenACYW conjugate vaccine|menacyw conjugate vaccine
231218|NCT02752906|Licensed Meningococcal Conjugate Vaccine (MCV4)|licensed meningococcal conjugate vaccine (mcv4)
231219|NCT02752893|estrogen|estrogen
231220|NCT02752893|estrogen receptor|estrogen receptor
231221|NCT02752893|ER+|er+
231222|NCT02752893|HER2|her2
231223|NCT02752893|HER2-|her2-
231224|NCT02752893|HER2-negative|her2-negative
231225|NCT02752893|xenograft|xenograft
231226|NCT02752893|co-clinical|co-clinical
231227|NCT02752893|mice|mice
231228|NCT02752893|patient-derived xenograft|patient-derived xenograft
231229|NCT02752893|patient-derived|patient-derived
231230|NCT02752893|breast cancer|breast cancer
231231|NCT02752893|precision medicine|precision medicine
231232|NCT02752893|personalized medicine|personalized medicine
231233|NCT02752867|traditional Chinese medicine granules|traditional chinese medicine granules
231234|NCT02752867|Cognitive Impairment|cognitive impairment
231235|NCT02752867|Acute cerebral infraction|acute cerebral infraction
231236|NCT02752867|treatment|treatment
231237|NCT02752854|pain scores|pain scores
231238|NCT02752854|pressure algometer|pressure algometer
231239|NCT02752854|healthy volunteer adults|healthy volunteer adults
231240|NCT02752802|Contrast Media|contrast media
231241|NCT02752802|Angiography|angiography
231242|NCT02752789|alloantibodies|alloantibodies
231243|NCT02752789|donor specific antibodies (DSA)-preformed, de novo|donor specific antibodies (dsa)-preformed, de novo
231244|NCT02752789|self-antigens|self-antigens
231245|NCT02752789|chronic allograft function|chronic allograft function
231246|NCT02752776|secukinumab|secukinumab
231247|NCT02752776|AIN457|ain457
231248|NCT02752776|Moderate to severe plaque psoriasis|moderate to severe plaque psoriasis
231249|NCT02752776|immune-mediated systemic disease|immune-mediated systemic disease
231250|NCT02752776|scaly patches|scaly patches
231251|NCT02752776|papules|papules
231252|NCT02752776|plaques|plaques
231253|NCT02752776|itching|itching
231254|NCT02752763|Dry eye|dry eye
231255|NCT02752763|isotretinoin, AS|isotretinoin, as
231256|NCT02752763|Autologous serum|autologous serum
231257|NCT02752724|major depressive disorder|major depressive disorder
231258|NCT02752724|electroconvulsive therapy|electroconvulsive therapy
231259|NCT02752724|metabolomics|metabolomics
231260|NCT02752724|treatment resistant depression|treatment resistant depression
231261|NCT02752724|anesthesiology|anesthesiology
231262|NCT02752724|ketamine|ketamine
231263|NCT02752724|prospective randomized clinical trial|prospective randomized clinical trial
231264|NCT02752711|Minor head trauma|minor head trauma
231265|NCT02752711|Children|children
231266|NCT02752711|Clinical decision rule|clinical decision rule
231267|NCT02752685|Nab-Paclitaxel|nab-paclitaxel
231268|NCT02752685|Abraxane|abraxane
231269|NCT02752685|MK-3475|mk-3475
231270|NCT02752672|dithranol|dithranol
231271|NCT02752672|therapeutic mechanisms|therapeutic mechanisms
231272|NCT02752659|Monitoring|monitoring
231273|NCT02752646|cataract|cataract
231274|NCT02752633|Xanthine dehydrogenase inhibitor treatment, pharmacotherapy|xanthine dehydrogenase inhibitor treatment, pharmacotherapy
231275|NCT02752620|osteopathic manipulative treatment|osteopathic manipulative treatment
231276|NCT02752620|Chronic nonspecific low back pain|chronic nonspecific low back pain
231277|NCT02752620|low back pain|low back pain
231278|NCT02752594|probiotic|probiotic
231279|NCT02752594|mutans streptococci|mutans streptococci
231280|NCT02752594|bacillus coagulans|bacillus coagulans
231281|NCT02752594|caries|caries
231282|NCT02752581|suction drain|suction drain
231283|NCT02752581|knee arthroscopy|knee arthroscopy
231284|NCT02752581|knee pain|knee pain
231285|NCT02752555|Oligoasthenoteratozoospermia|oligoasthenoteratozoospermia
231286|NCT02752555|Male factor managment|male factor managment
727264|NCT00520026|suicidality|suicidality
295742|NCT02370849|S-1|s-1
231287|NCT02752555|Intacytoplasmic sperm injection|intacytoplasmic sperm injection
231288|NCT02752529|Liver Transplantation|liver transplantation
231289|NCT02752529|Individualized Therapy|individualized therapy
231290|NCT02752529|Polymorphism|polymorphism
231291|NCT02752477|Opioid-sparing|opioid-sparing
231292|NCT02752464|Weight Loss|weight loss
231293|NCT02752464|Health Status Disparities|health status disparities
231294|NCT02752438|high frequency oscillatory ventilation|high frequency oscillatory ventilation
231295|NCT02752438|rescue|rescue
231296|NCT02752438|newborn|newborn
231297|NCT02752425|Speech disorders|speech disorders
231298|NCT02752425|Speech therapy|speech therapy
231299|NCT02752425|Visual feedback|visual feedback
231300|NCT02752425|Buccopharyngeal surgery|buccopharyngeal surgery
231301|NCT02752425|Central nervous system damage|central nervous system damage
231302|NCT02752373|GTC Seizures|gtc seizures
231303|NCT02752360|intestinal reconstruction|intestinal reconstruction
231304|NCT02752360|end to end anastomosis|end to end anastomosis
231305|NCT02752321|patient discharge|patient discharge
231306|NCT02752321|patient engagement|patient engagement
231307|NCT02752321|patient satisfaction|patient satisfaction
231308|NCT02752321|continuity of patient care|continuity of patient care
231309|NCT02752321|hospital discharge|hospital discharge
231310|NCT02752321|health technology|health technology
231311|NCT02752321|eDischarge|edischarge
231312|NCT02752321|multimedia|multimedia
231313|NCT02752321|mobile applications|mobile applications
231314|NCT02752321|software applications|software applications
231315|NCT02752321|portable electronic applications|portable electronic applications
231316|NCT02752282|Family Planning|family planning
231317|NCT02752282|LNG-IUS|lng-ius
231318|NCT02752282|Health Education|health education
231319|NCT02752256|tissue plasminogen activator|tissue plasminogen activator
231320|NCT02752243|acute leukemia|acute leukemia
231321|NCT02752243|myelodysplastic syndrome (MDS)|myelodysplastic syndrome (mds)
231322|NCT02752243|Stem Cell Transplantation|stem cell transplantation
231323|NCT02752230|Post operative pain|post operative pain
231324|NCT02752230|Bariatric Surgery|bariatric surgery
231325|NCT02752204|Relapsed|relapsed
231326|NCT02752204|Refractory|refractory
231327|NCT02752204|Lymphoma|lymphoma
231328|NCT02752191|ferumoxytol|ferumoxytol
231329|NCT02752178|Depression|depression
231330|NCT02752178|Major depressive disorder|major depressive disorder
231331|NCT02752178|MDD|mdd
231332|NCT02752152|Counseling|counseling
231333|NCT02752152|Reminder|reminder
231334|NCT02752152|Early diagnosis|early diagnosis
231335|NCT02752139|Sleep Disorders|sleep disorders
231336|NCT02752139|Cerebral Hemodynamics|cerebral hemodynamics
231337|NCT02752139|Dynamic Cerebral Auto-Regulation|dynamic cerebral auto-regulation
231338|NCT02752139|Stroke|stroke
231339|NCT02752126|Esophageal sparing|esophageal sparing
231340|NCT02752126|Conventional radiotherapy|conventional radiotherapy
231341|NCT02752126|Palliative radiation|palliative radiation
231342|NCT02752126|Central lung tumors|central lung tumors
231343|NCT02752113|diabetes mellitus type 2|diabetes mellitus type 2
231344|NCT02752113|Metformin|metformin
231345|NCT02752113|Micro- and macrocirculation|micro- and macrocirculation
231346|NCT02752113|HbA1c >= 7%|hba1c >= 7%
231347|NCT02752100|Lower Extremity Arterial Occlusive Disease|lower extremity arterial occlusive disease
231348|NCT02752100|Interventional Therapy|interventional therapy
231349|NCT02752074|Melanoma|melanoma
231350|NCT02752074|Metastatic Melanoma|metastatic melanoma
231351|NCT02752035|AML|aml
231352|NCT02752035|ASP2215|asp2215
231353|NCT02752035|Newly Diagnosed AML|newly diagnosed aml
231354|NCT02752035|gilteritinib|gilteritinib
231355|NCT02752035|Acute Myeloid Leukemia (AML)|acute myeloid leukemia (aml)
231356|NCT02752035|FLT3|flt3
231357|NCT02752022|e-cigarettes|e-cigarettes
231358|NCT02752022|nitrosamines|nitrosamines
231359|NCT02752022|smoking cessation|smoking cessation
231360|NCT02752009|Breast Cancer|breast cancer
231361|NCT02752009|Armpit lymph nodes Cancer|armpit lymph nodes cancer
231362|NCT02751996|Chronic Hepatitis|chronic hepatitis
231363|NCT02751996|HBV|hbv
231364|NCT02751996|Double blind|double blind
231365|NCT02751983|Suicide|suicide
231366|NCT02751983|Psychiatric Rehabilitation|psychiatric rehabilitation
231367|NCT02751983|Acceptance and Commitment Therapy|acceptance and commitment therapy
231368|NCT02751983|Brief Psychotherapy|brief psychotherapy
231369|NCT02751983|Inpatients|inpatients
231370|NCT02751970|Dental adhesive|dental adhesive
231371|NCT02751970|adhesive systems|adhesive systems
231372|NCT02751970|Dental Restoration Failure|dental restoration failure
231373|NCT02751944|exercise-induced|exercise-induced
231374|NCT02751944|joint pain|joint pain
231375|NCT02751944|joint stiffness|joint stiffness
231376|NCT02751944|post-menopausal|post-menopausal
231377|NCT02751944|women|women
231378|NCT02751944|cartilage turnover|cartilage turnover
231379|NCT02751944|CTX-II|ctx-ii
231380|NCT02751931|Pediatrics|pediatrics
231381|NCT02751931|Urodynamics|urodynamics
231382|NCT02751931|Mirabegron|mirabegron
231383|NCT02751931|Phase 3|phase 3
295849|NCT02370316|MRI|mri
231384|NCT02751931|Neurogenic Detrusor Overactivity|neurogenic detrusor overactivity
231385|NCT02751918|Mesothelin-expressing platinum-resistant cancer|mesothelin-expressing platinum-resistant cancer
231386|NCT02751814|Childcare Center Regulations|childcare center regulations
231387|NCT02751814|Physical Activity|physical activity
231388|NCT02751814|Sedentary Behavior|sedentary behavior
231389|NCT02751814|Screen-time Behavior|screen-time behavior
231390|NCT02751788|childcare center regulations|childcare center regulations
231391|NCT02751788|physical activity|physical activity
231392|NCT02751788|sedentary behavior|sedentary behavior
231393|NCT02751788|screen-time behavior|screen-time behavior
231394|NCT02751775|Childcare center regulations|childcare center regulations
231395|NCT02751775|Physical Activity|physical activity
231396|NCT02751775|Sedentary Behavior|sedentary behavior
231397|NCT02751775|Screen-Time Behavior|screen-time behavior
231398|NCT02751775|Focus groups|focus groups
231400|NCT02751723|palliative care|palliative care
231401|NCT02751723|palliative therapy|palliative therapy
231402|NCT02751723|cancer|cancer
231403|NCT02751723|patient´s needs|patient´s needs
231404|NCT02751723|patient care|patient care
231405|NCT02751723|disease burden|disease burden
231406|NCT02751684|Rapid Sequence Induction|rapid sequence induction
231407|NCT02751684|European|european
231408|NCT02751684|Evaluation|evaluation
231409|NCT02751684|EUROpE RSI|europe rsi
231410|NCT02751684|Standards|standards
231411|NCT02751684|RSI|rsi
231412|NCT02751645|Pediatric|pediatric
231413|NCT02751645|Cardiac|cardiac
231414|NCT02751645|Surgery|surgery
231415|NCT02751632|Ultra High Risk of Psychosis|ultra high risk of psychosis
231416|NCT02751632|Prodrome|prodrome
231417|NCT02751632|Clinical High Risk of Psychosis|clinical high risk of psychosis
231418|NCT02751619|Pre-emptive analgesia|pre-emptive analgesia
231419|NCT02751619|Post-thoracotomy pain|post-thoracotomy pain
231420|NCT02751619|Lidocaine patch|lidocaine patch
231421|NCT02751606|Ferumoxtran|ferumoxtran
231422|NCT02751606|MRI Scans|mri scans
231423|NCT02751593|pregnancy|pregnancy
231424|NCT02751593|Immune Thrombocytopenia|immune thrombocytopenia
231425|NCT02751593|dexamethasone|dexamethasone
231426|NCT02751528|Breast Cancer|breast cancer
231427|NCT02751528|Breast Cancer male|breast cancer male
231428|NCT02751528|Breast Neoplasms|breast neoplasms
231429|NCT02751528|Breast Neoplasms male|breast neoplasms male
231430|NCT02751528|Vaccine|vaccine
231431|NCT02751528|HER2|her2
231432|NCT02751528|Metastatic|metastatic
231433|NCT02751528|Locally Advanced|locally advanced
231434|NCT02751528|Unresectable|unresectable
231435|NCT02751528|Solid Tumor|solid tumor
231436|NCT02751528|Phase 1|phase 1
231437|NCT02751528|Cancer Vaccine|cancer vaccine
231438|NCT02751502|Children|children
231439|NCT02751502|Pediatrics|pediatrics
231440|NCT02751502|Arm|arm
231441|NCT02751502|Upper limb|upper limb
231442|NCT02751502|bimanual training|bimanual training
231443|NCT02751502|physical training|physical training
231444|NCT02751437|preterm|preterm
231445|NCT02751437|arginine|arginine
231446|NCT02751437|immune function|immune function
231447|NCT02751437|nutrition|nutrition
231448|NCT02751424|Multidrug-resistant|multidrug-resistant
231449|NCT02751424|Gram negative bacterial infection|gram negative bacterial infection
231450|NCT02751424|Safety|safety
231451|NCT02751424|Pharmacokinetic|pharmacokinetic
231452|NCT02751333|Esophageal stricture|esophageal stricture
231453|NCT02751333|Esophageal leak|esophageal leak
231454|NCT02751333|Esophageal perforation|esophageal perforation
231455|NCT02751333|Esophageal fistula|esophageal fistula
231456|NCT02751333|Endostitch|endostitch
231457|NCT02751333|Esophageal stent|esophageal stent
231458|NCT02751307|metformin|metformin
231459|NCT02751307|clozapine|clozapine
231460|NCT02751307|schizophrenia|schizophrenia
231461|NCT02751307|metabolic traits|metabolic traits
231462|NCT02751294|Healthy Volunteer|healthy volunteer
231463|NCT02751294|Malaria|malaria
231464|NCT02751294|Pharmacokinetics|pharmacokinetics
231465|NCT02751294|Tafenoquine|tafenoquine
231466|NCT02751281|pneumatic|pneumatic
231467|NCT02751281|ultra-sonic|ultra-sonic
231468|NCT02751281|percutaneous nephrolithotomy|percutaneous nephrolithotomy
231469|NCT02751268|infraorbital nerve block|infraorbital nerve block
231470|NCT02751268|infratrochlear nerve block|infratrochlear nerve block
231471|NCT02751268|septorhinoplasty|septorhinoplasty
231472|NCT02751268|general anesthesia|general anesthesia
231473|NCT02751268|postoperative analgesia|postoperative analgesia
231474|NCT02751242|Diuretic Resistance|diuretic resistance
231475|NCT02751242|Emergency Medicine|emergency medicine
231476|NCT02751229|Mental illness|mental illness
231477|NCT02751229|adolescents|adolescents
231478|NCT02751229|intervention|intervention
231479|NCT02751229|stigma|stigma
231480|NCT02751229|disclosure|disclosure
231481|NCT02751229|secrecy|secrecy
231482|NCT02751216|high frequency / high density spinal cord stimulation|high frequency / high density spinal cord stimulation
231483|NCT02751216|EEG|eeg
295963|NCT02369536|NAFLD|nafld
231484|NCT02751216|conditioned pain modulation|conditioned pain modulation
231485|NCT02751177|KRAS gene mutation|kras gene mutation
231486|NCT02751177|NRAS gene mutation|nras gene mutation
231487|NCT02751177|BRAF gene mutation|braf gene mutation
231488|NCT02751138|Immune phenotype|immune phenotype
231489|NCT02751138|Cytokines|cytokines
231490|NCT02751138|Genetic aberration|genetic aberration
231491|NCT02751138|Overall survival|overall survival
231492|NCT02751138|Progression free survival|progression free survival
231493|NCT02751125|Mesenchymal stem cells|mesenchymal stem cells
231494|NCT02751125|bone augmentation|bone augmentation
231495|NCT02751125|bone regeneration|bone regeneration
231496|NCT02751086|minimally invasive surgery|minimally invasive surgery
231497|NCT02751086|gastrectomy|gastrectomy
231498|NCT02751086|robotic surgery|robotic surgery
231499|NCT02751086|laparoscopic surgery|laparoscopic surgery
231500|NCT02751086|laparoscopy|laparoscopy
231501|NCT02751086|robot-assisted|robot-assisted
231502|NCT02751086|robotic|robotic
231503|NCT02751086|robotic gastrectomy|robotic gastrectomy
231504|NCT02751086|laparoscopic gastrectomy|laparoscopic gastrectomy
231505|NCT02751086|minimally invasive gastrectomy|minimally invasive gastrectomy
231506|NCT02751073|Microbiota|microbiota
231507|NCT02751073|Proteome|proteome
231508|NCT02751034|Wrinkle Severity Rating Scale|wrinkle severity rating scale
231509|NCT02751034|Global Aesthetic Improvement Scale|global aesthetic improvement scale
231510|NCT02751034|Hyaluronic acid filler|hyaluronic acid filler
231511|NCT02751034|filler|filler
231512|NCT02751034|Nasolabial Fold|nasolabial fold
231513|NCT02750995|myelodysplastic syndrome|myelodysplastic syndrome
231514|NCT02750995|acute myeloid leukemia|acute myeloid leukemia
231515|NCT02750995|azacitidine|azacitidine
231516|NCT02750995|peptide vaccine|peptide vaccine
231517|NCT02750995|cancer testis antigen|cancer testis antigen
231518|NCT02750995|cancer vaccine|cancer vaccine
231519|NCT02750995|immunotherapy|immunotherapy
231520|NCT02750995|combination therapy|combination therapy
231521|NCT02750995|NY-ESO-1|ny-eso-1
231522|NCT02750995|PRAME|prame
231523|NCT02750995|MAGE-A3|mage-a3
231524|NCT02750995|WT-1|wt-1
231525|NCT02750995|vaccine|vaccine
231526|NCT02750969|tinnitus|tinnitus
231527|NCT02750969|lidocain patch|lidocain patch
231528|NCT02750956|endocan protein|endocan protein
231529|NCT02750956|VEGF A|vegf a
231530|NCT02750956|TNF-alpha|tnf-alpha
231531|NCT02750956|after treatment|after treatment
231532|NCT02750930|Extension|extension
231533|NCT02750930|Long-term Safety|long-term safety
231534|NCT02750930|Pharmacodynamics|pharmacodynamics
231535|NCT02750930|Albiglutide|albiglutide
231536|NCT02750930|Type 2 Diabetes Mellitus|type 2 diabetes mellitus
231537|NCT02750917|postoperative pain|postoperative pain
231538|NCT02750917|lornoxicam|lornoxicam
231539|NCT02750917|etoricoxib|etoricoxib
231540|NCT02750917|total knee arthroplasty|total knee arthroplasty
231541|NCT02750904|Smoking Cessation|smoking cessation
231542|NCT02750904|Acceptance & Commitment Therapy|acceptance & commitment therapy
231543|NCT02750904|Cognitive Behavioral Therapy|cognitive behavioral therapy
231544|NCT02750904|Bipolar Disorder|bipolar disorder
231545|NCT02750891|high grade glioma|high grade glioma
231546|NCT02750891|HGG|hgg
231547|NCT02750891|DIPG|dipg
231548|NCT02750878|Urinary Incontinence, Stress [C13.351.968.934.814.500]|urinary incontinence, stress [c13.351.968.934.814.500]
231549|NCT02750865|biomedical technology|biomedical technology
231550|NCT02750865|palliative care|palliative care
231551|NCT02750800|Rheumatoid arthritis|rheumatoid arthritis
231552|NCT02750800|Ankylosing spondylitis|ankylosing spondylitis
231553|NCT02750800|Psoriatic arthritis|psoriatic arthritis
231554|NCT02750800|Psoriasis|psoriasis
231555|NCT02750800|Crohn's disease|crohn's disease
231556|NCT02750800|Ulcerative colitis|ulcerative colitis
231557|NCT02750800|Patient support program|patient support program
231558|NCT02750800|Quality of life|quality of life
231559|NCT02750800|Patient related outcomes|patient related outcomes
231560|NCT02750800|Observational study|observational study
231561|NCT02750800|Adalimumab|adalimumab
231562|NCT02750800|Humira|humira
231563|NCT02750800|Adherence|adherence
231564|NCT02750800|Health-related quality of life|health-related quality of life
231565|NCT02750800|Healthcare resource utilization|healthcare resource utilization
231566|NCT02750800|Disease activity|disease activity
231567|NCT02750800|Treatment satisfaction|treatment satisfaction
231568|NCT02750800|Workability|workability
231569|NCT02750722|Exercise|exercise
231570|NCT02750722|Lung diffusion capacity|lung diffusion capacity
231571|NCT02750722|Sputum viscoelasticity|sputum viscoelasticity
231572|NCT02750722|Lung disease|lung disease
231573|NCT02750709|HT-1|ht-1
231574|NCT02750709|Tyrosinemia|tyrosinemia
231575|NCT02750709|Nitisinone|nitisinone
231576|NCT02750709|Bioequivalence|bioequivalence
231577|NCT02750709|Healthy Volunteer|healthy volunteer
231578|NCT02750709|Orfadin|orfadin
231579|NCT02750696|Acetaminophen|acetaminophen
231580|NCT02750696|Analgesia|analgesia
231581|NCT02750696|Codeine|codeine
231582|NCT02750696|Drug Combinations|drug combinations
231583|NCT02750696|Endodontics|endodontics
231584|NCT02750696|Periapical abscess|periapical abscess
231585|NCT02750696|Randomized Controlled Trial|randomized controlled trial
231586|NCT02750696|Tramadol|tramadol
231587|NCT02750696|Visual analog scale|visual analog scale
231588|NCT02750683|inotropic effect, norepinephrine, septic shock,|inotropic effect, norepinephrine, septic shock,
231589|NCT02750670|Lymphoma|lymphoma
231590|NCT02750670|Non-Hodgkin's|non-hodgkin's
231591|NCT02750670|CD20+|cd20+
231592|NCT02750670|Obinutuzumab|obinutuzumab
231593|NCT02750670|GDP Chemotherapy|gdp chemotherapy
231594|NCT02750670|Refractory and aggressive non-Hodgkin lymphoma|refractory and aggressive non-hodgkin lymphoma
231595|NCT02750631|depression|depression
231596|NCT02750631|melatonin|melatonin
231597|NCT02750631|light therapy|light therapy
231598|NCT02750631|Wake Therapy|wake therapy
231599|NCT02750631|chronobiology|chronobiology
231600|NCT02750592|Ankylosing Spondylitis|ankylosing spondylitis
231601|NCT02750592|secukinumab|secukinumab
231602|NCT02750592|AIN457H|ain457h
231603|NCT02750592|SpondyloArthritis|spondyloarthritis
231604|NCT02750540|Tenofovir enema|tenofovir enema
231605|NCT02750501|CF, EPI, diabetes, PERT, LCPUFA, DHA, EPA, Omega-3 index|cf, epi, diabetes, pert, lcpufa, dha, epa, omega-3 index
231606|NCT02750423|Cardiology|cardiology
231607|NCT02750423|Surgery|surgery
231608|NCT02750397|HIV|hiv
231609|NCT02750397|Kidney Transplant|kidney transplant
231610|NCT02750397|Liver Transplant|liver transplant
231611|NCT02750397|Transplant|transplant
231612|NCT02750371|Cavernous sinus meningioma|cavernous sinus meningioma
231613|NCT02750371|Pituitary adenoma|pituitary adenoma
231614|NCT02750371|Hippocampus|hippocampus
231615|NCT02750371|Irradiation|irradiation
231616|NCT02750371|Autobiographical memory|autobiographical memory
231617|NCT02750358|Enzalutamide|enzalutamide
231618|NCT02750358|15-307|15-307
231619|NCT02750345|HT-1|ht-1
231620|NCT02750345|Tyrosinemia|tyrosinemia
231621|NCT02750345|Nitisinone|nitisinone
231622|NCT02750345|Bioavailability|bioavailability
231623|NCT02750345|Healthy Volunteer|healthy volunteer
231624|NCT02750345|Food-Effect|food-effect
231625|NCT02750332|HT-1|ht-1
231626|NCT02750332|Tyrosinemia|tyrosinemia
231627|NCT02750332|Nitisinone|nitisinone
231628|NCT02750332|Bioavailability|bioavailability
231629|NCT02750332|Healthy Volunteer|healthy volunteer
231630|NCT02750332|Food-Effect|food-effect
231631|NCT02750319|Amiodarone|amiodarone
231632|NCT02750319|N-Acetylcysteine|n-acetylcysteine
231633|NCT02750319|16-307|16-307
231634|NCT02750293|vitamin D|vitamin d
231635|NCT02750293|blood pressure|blood pressure
231636|NCT02750293|serum lipids|serum lipids
231637|NCT02750293|glucose metabolism|glucose metabolism
231638|NCT02750293|muscle function|muscle function
231639|NCT02750293|arterial stiffness|arterial stiffness
231640|NCT02750293|depression|depression
231641|NCT02750293|psoriasis|psoriasis
231642|NCT02750293|sleep|sleep
231643|NCT02750293|bone density|bone density
231644|NCT02750267|Type 1 Diabetes Mellitus (T1DM)|type 1 diabetes mellitus (t1dm)
231645|NCT02750267|Artificial Pancreas Project (APP)|artificial pancreas project (app)
231646|NCT02750267|Diabetes Assistant (DiAs)|diabetes assistant (dias)
231647|NCT02750267|Closed-Loop Control (CLC)|closed-loop control (clc)
231648|NCT02750267|Continuous Glucose Monitor|continuous glucose monitor
231649|NCT02750267|Pediatric|pediatric
231650|NCT02750267|Insulin Pump|insulin pump
231651|NCT02750241|active video game|active video game
231652|NCT02750241|mHealth|mhealth
231653|NCT02750241|cancer survivor|cancer survivor
231654|NCT02750241|women's health|women's health
231655|NCT02750241|breast cancer|breast cancer
231656|NCT02750241|physical activity|physical activity
231657|NCT02750241|support group|support group
231658|NCT02750241|survivorship|survivorship
231659|NCT02750215|MET exon 14 skipping|met exon 14 skipping
231660|NCT02750215|Stage IV non-small cell lung cancer NSCLC|stage iv non-small cell lung cancer nsclc
231661|NCT02750202|Genital warts|genital warts
231662|NCT02750202|HPV types|hpv types
231663|NCT02750202|HPV vaccine|hpv vaccine
231664|NCT02750202|Cervical cytology|cervical cytology
231665|NCT02750202|Therapeutic vaccine|therapeutic vaccine
231666|NCT02750202|Quadrivalent HPV vaccine|quadrivalent hpv vaccine
231667|NCT02750176|Rehabilitation|rehabilitation
231668|NCT02750176|Closed chain exercises|closed chain exercises
231669|NCT02750137|Tetracaine|tetracaine
231670|NCT02750124|participation|participation
231671|NCT02750124|self sampling|self sampling
231672|NCT02750124|Screening|screening
231673|NCT02750098|Diabetes Mellitus, Cataract, Aqueous humor|diabetes mellitus, cataract, aqueous humor
231674|NCT02750085|Hemophilia A|hemophilia a
231675|NCT02750085|pharmacokinetics|pharmacokinetics
231677|NCT02750020|Telephone survey|telephone survey
231678|NCT02749955|HIV prevention|hiv prevention
231679|NCT02749955|Pre exposure prophylaxis|pre exposure prophylaxis
231680|NCT02749955|Men who have sex with men|men who have sex with men
231681|NCT02749955|Partner services|partner services
231682|NCT02749955|Linkage to care|linkage to care
296216|NCT02368054|LiDCO|lidco
231683|NCT02749955|Seronegative|seronegative
231684|NCT02749955|Sexually transmitted diseases|sexually transmitted diseases
231685|NCT02749942|Diabetes|diabetes
231686|NCT02749942|Remote Ischemic Conditioning|remote ischemic conditioning
231687|NCT02749942|Neuropathy|neuropathy
231688|NCT02749942|Angiopathy|angiopathy
231689|NCT02749929|Distal radius fracture, Low Level Laser Therapy|distal radius fracture, low level laser therapy
231690|NCT02749916|SWI|swi
231691|NCT02749916|MP-RAGE|mp-rage
231692|NCT02749916|DANTE T1-SPACE|dante t1-space
231693|NCT02749877|Pediatric Cancer|pediatric cancer
231694|NCT02749877|Training|training
231695|NCT02749877|Working Memory|working memory
231696|NCT02749877|Physical Activity|physical activity
231697|NCT02749877|Brain Tumor|brain tumor
231698|NCT02749877|Physical Exercise|physical exercise
231699|NCT02749864|Hepatitis|hepatitis
231700|NCT02749864|Prevalence|prevalence
231701|NCT02749864|Epidemiology|epidemiology
231702|NCT02749864|Infectious diseases|infectious diseases
231703|NCT02749851|pregnancy|pregnancy
231704|NCT02749851|growth restriction|growth restriction
231705|NCT02749838|Cancer|cancer
231706|NCT02749838|Genomic testing|genomic testing
231707|NCT02749838|Genetic testing|genetic testing
231708|NCT02749838|Molecular screening|molecular screening
231709|NCT02749838|Molecular Profiling|molecular profiling
231710|NCT02749838|Biomarker|biomarker
231711|NCT02749838|Biopsy|biopsy
231712|NCT02749838|Tumor sampling|tumor sampling
231713|NCT02749838|Registry|registry
231714|NCT02749825|Prostate|prostate
231715|NCT02749825|Cancer|cancer
231716|NCT02749825|Trelstar|trelstar
231717|NCT02749760|Ulnar collateral ligament|ulnar collateral ligament
231718|NCT02749760|elbow injuries|elbow injuries
231719|NCT02749760|dynamic elbow stabilizers|dynamic elbow stabilizers
231720|NCT02749760|Tommy John's procedure|tommy john's procedure
231721|NCT02749760|elbow injuries in pitchers|elbow injuries in pitchers
231722|NCT02749747|Menopause|menopause
231723|NCT02749747|nonhormonal treatment|nonhormonal treatment
231724|NCT02749747|sulpiride|sulpiride
231725|NCT02749734|Human embryo stem cell derived retinal pigment epitheliums|human embryo stem cell derived retinal pigment epitheliums
231726|NCT02749734|Subretinal transplantation|subretinal transplantation
231727|NCT02749734|Wet Age related Macular degeneration|wet age related macular degeneration
231728|NCT02749734|Stargardt's macular dystrophy|stargardt's macular dystrophy
231729|NCT02749721|depression|depression
231730|NCT02749721|brain network activation|brain network activation
231731|NCT02749721|vortioxetine|vortioxetine
231732|NCT02749708|IRX5183|irx5183
231733|NCT02749708|relapsed/refractory AML|relapsed/refractory aml
231734|NCT02749708|high-risk MDS|high-risk mds
231735|NCT02749695|menopause, climacteric syndrome, insomnia, placental extract|menopause, climacteric syndrome, insomnia, placental extract
231736|NCT02749682|Nyhus classification|nyhus classification
231737|NCT02749682|constipation severity scale|constipation severity scale
231738|NCT02749682|groin hernia|groin hernia
231739|NCT02749669|Inappropriate hospitalization|inappropriate hospitalization
231740|NCT02749669|elderly|elderly
231741|NCT02749669|mild or moderate cognitive impairment|mild or moderate cognitive impairment
231742|NCT02749669|qualitative research|qualitative research
231743|NCT02749669|economic evaluation|economic evaluation
231744|NCT02749656|Scalp psoriasis|scalp psoriasis
231745|NCT02749656|0.25% Desoximetasone cream|0.25% desoximetasone cream
231746|NCT02749591|stroke rehabilitation|stroke rehabilitation
231747|NCT02749591|spasticity|spasticity
231748|NCT02749591|Botulinum toxin type A injection|botulinum toxin type a injection
231749|NCT02749591|robot-assisted therapy|robot-assisted therapy
231750|NCT02749591|mirror therapy|mirror therapy
231751|NCT02749591|randomized controlled trial|randomized controlled trial
231752|NCT02749565|asthma|asthma
231753|NCT02749565|fibrocyte|fibrocyte
231754|NCT02749565|airway remodeling|airway remodeling
231755|NCT02749565|OSA|osa
231756|NCT02749565|hypoxia|hypoxia
231757|NCT02749539|Mastectomy|mastectomy
231758|NCT02749539|Shoulder Pain|shoulder pain
231759|NCT02749539|ROM|rom
231760|NCT02749539|Kinesio Tape|kinesio tape
231761|NCT02749526|Recombinant human endostatin，Endo|recombinant human endostatin，endo
231762|NCT02749500|Motor control|motor control
231763|NCT02749487|Critical Care|critical care
231764|NCT02749487|Neutrophils|neutrophils
231765|NCT02749487|Lymphocytes|lymphocytes
231766|NCT02749461|preterm infants|preterm infants
231767|NCT02749461|pain|pain
231768|NCT02749461|assessment|assessment
231769|NCT02749461|contextual factors|contextual factors
231770|NCT02749461|diagnostic accuracy|diagnostic accuracy
231771|NCT02749435|Digital disease management tool|digital disease management tool
231772|NCT02749435|Type 2 diabetes mellitus/ T2DM|type 2 diabetes mellitus/ t2dm
231773|NCT02749435|HbA1c|hba1c
231774|NCT02749435|Standard care|standard care
231775|NCT02749435|PRO questionnaires|pro questionnaires
231776|NCT02749435|Smart phone/ personal computer with internet access|smart phone/ personal computer with internet access
728337|NCT00515320|children|children
231777|NCT02749422|cognitive dysfunction|cognitive dysfunction
231778|NCT02749422|memory loss|memory loss
231779|NCT02749422|non-invasive transcranial magnetic stimulation (TMS)|non-invasive transcranial magnetic stimulation (tms)
231780|NCT02749422|rTMS|rtms
231781|NCT02749422|Magstim Rapid2|magstim rapid2
231782|NCT02749357|gait|gait
231783|NCT02749357|robotic orthosis|robotic orthosis
231784|NCT02749344|Frozen Embryo Transfer, Progesterone, Endometrium|frozen embryo transfer, progesterone, endometrium
231785|NCT02749318|Behavior Modification|behavior modification
231786|NCT02749318|Genetic Testing|genetic testing
231787|NCT02749318|Risk Management|risk management
231788|NCT02749318|Oral Health Care|oral health care
231789|NCT02749292|rituximab|rituximab
231790|NCT02749292|maintenance|maintenance
231791|NCT02749292|remission|remission
231792|NCT02749266|chiropractic, cognition|chiropractic, cognition
231793|NCT02749253|Post Traumatic Stress Disorder (PTSD)|post traumatic stress disorder (ptsd)
231794|NCT02749253|Sudarshan Kriya Yoga (SKY)|sudarshan kriya yoga (sky)
231795|NCT02749227|Clinically non-functioning pituitary adenomas (CNFAs)|clinically non-functioning pituitary adenomas (cnfas)
231796|NCT02749227|silent corticotroph adenomas|silent corticotroph adenomas
231797|NCT02749201|Obesity|obesity
231798|NCT02749201|sleeve gastrectomy|sleeve gastrectomy
231799|NCT02749188|Urine Specimen Collection/methods|urine specimen collection/methods
231800|NCT02749188|Infant|infant
231801|NCT02749188|Newborn|newborn
231802|NCT02749188|Feasibility Studies|feasibility studies
231803|NCT02749188|Bladder stimulation|bladder stimulation
231804|NCT02749175|cricoid pressure|cricoid pressure
231805|NCT02749149|Cardiac|cardiac
231806|NCT02749149|Surgery|surgery
231807|NCT02749149|Frailty|frailty
231808|NCT02749149|Frail|frail
231809|NCT02749149|Patients|patients
231810|NCT02749149|Recovery|recovery
231811|NCT02749149|Morbidity|morbidity
231812|NCT02749149|Outcomes|outcomes
231813|NCT02749149|Mortality|mortality
231814|NCT02749149|Heart|heart
231815|NCT02749149|Perioperative|perioperative
231816|NCT02749149|Disability|disability
231817|NCT02749149|WHODAS|whodas
231818|NCT02749136|Pancreatic adenocarcinoma|pancreatic adenocarcinoma
231819|NCT02749136|Borderline resectable|borderline resectable
231820|NCT02749136|Neoadjuvant chemotherapy|neoadjuvant chemotherapy
231821|NCT02749136|FOLFIRINOX|folfirinox
231822|NCT02749110|Mass screening|mass screening
231823|NCT02749110|Family medicine|family medicine
231824|NCT02749110|Human Papillomavirus DNA tests|human papillomavirus dna tests
231825|NCT02749110|Papanicolaou test|papanicolaou test
231826|NCT02749110|Early detection of cancer/methods*|early detection of cancer/methods*
231827|NCT02749110|Specimen Handling/methods*|specimen handling/methods*
231828|NCT02749110|Patient compliance|patient compliance
231829|NCT02749110|Adult|adult
231830|NCT02749110|Female|female
231831|NCT02749110|Humans|humans
231832|NCT02749110|Randomized controlled trial|randomized controlled trial
231833|NCT02749084|chronic graft versus host disease|chronic graft versus host disease
231834|NCT02749084|T regulatory cell|t regulatory cell
231835|NCT02749058|capsulectomy|capsulectomy
231836|NCT02749058|capsulotomy|capsulotomy
231837|NCT02749019|BBN-RGD|bbn-rgd
231838|NCT02749019|GRPR|grpr
231839|NCT02749019|integrin αvβ3|integrin αvβ3
231840|NCT02749006|Bipolar disorder|bipolar disorder
231841|NCT02749006|Depression|depression
231842|NCT02749006|intermittent Theta-Burst Stimulation (rTMS)|intermittent theta-burst stimulation (rtms)
231843|NCT02749006|neuromodulatory technique|neuromodulatory technique
231844|NCT02748967|Healthy|healthy
231845|NCT02748967|ExPEC4V|expec4v
231846|NCT02748967|JNJ-63871860|jnj-63871860
231847|NCT02748967|Safety|safety
231848|NCT02748941|unstable/stable atherosclerotic plaque|unstable/stable atherosclerotic plaque
231849|NCT02748941|HITS|hits
231850|NCT02748941|GSM|gsm
231851|NCT02748941|CEUS|ceus
231852|NCT02748941|HR MRI|hr mri
231853|NCT02748941|mi-RNA|mi-rna
231854|NCT02748915|Cochlear Implant|cochlear implant
231855|NCT02748915|ECAP|ecap
231856|NCT02748915|EABR|eabr
231857|NCT02748915|perceptual levels|perceptual levels
231858|NCT02748915|hearing performances|hearing performances
231859|NCT02748902|Verruca vulgaris|verruca vulgaris
231860|NCT02748902|Common warts|common warts
231861|NCT02748902|Verruca|verruca
231862|NCT02748902|Warts|warts
231863|NCT02748902|Papilloma virus|papilloma virus
231864|NCT02748902|ingenol mebutate 0.05% gel|ingenol mebutate 0.05% gel
231865|NCT02748902|hands|hands
231866|NCT02748889|SCLC|sclc
231867|NCT02748889|Small Cell|small cell
231868|NCT02748889|Lung Cancer|lung cancer
231869|NCT02748889|MPDL3280A|mpdl3280a
231870|NCT02748889|atezolizumab|atezolizumab
231871|NCT02748863|psoriasis|psoriasis
231872|NCT02748863|secukinumab|secukinumab
231873|NCT02748863|pre-filled syringes|pre-filled syringes
231874|NCT02748850|apheresis patients|apheresis patients
231875|NCT02748824|Age- Related Macular Degeneration; Diabetic Retinopathy; Glaucoma; Cataract|age- related macular degeneration; diabetic retinopathy; glaucoma; cataract
231876|NCT02748811|elderly|elderly
231877|NCT02748811|intervention study|intervention study
231878|NCT02748811|geriatrics|geriatrics
231879|NCT02748811|chemotherapy|chemotherapy
231880|NCT02748772|Anti-angiogenesis Drugs|anti-angiogenesis drugs
231881|NCT02748772|Advanced Colorectal Cancer|advanced colorectal cancer
231882|NCT02748772|Endostar|endostar
231883|NCT02748772|Thalidomide|thalidomide
231884|NCT02748772|Vascular Endothelial Growth Factor A|vascular endothelial growth factor a
231885|NCT02748759|Continous Passive Motion|continous passive motion
231886|NCT02748759|Manual Physical Therapy|manual physical therapy
231887|NCT02748759|Range of Motion, Articular|range of motion, articular
231888|NCT02748759|Anterior Cruciate Ligament Reconstruction|anterior cruciate ligament reconstruction
231889|NCT02748759|Rehabilitation|rehabilitation
231890|NCT02748759|Kaltenborn Manual Therapy|kaltenborn manual therapy
231891|NCT02748746|Lymphedema|lymphedema
231892|NCT02748746|Electric Impedance|electric impedance
231893|NCT02748746|Breast Cancer|breast cancer
231894|NCT02748733|Adapted APD|adapted apd
231895|NCT02748733|Dialytic Sodium Removal|dialytic sodium removal
231896|NCT02748733|Ultrafiltration|ultrafiltration
231897|NCT02748733|Clearance rate|clearance rate
231898|NCT02748733|Intraperitoneal pressure|intraperitoneal pressure
231899|NCT02748720|Premature|premature
231900|NCT02748720|Respiratory Function Monitor|respiratory function monitor
231901|NCT02748694|Drug Therapy|drug therapy
231902|NCT02748681|obstructive sleep apnea|obstructive sleep apnea
231903|NCT02748681|CPAP|cpap
231904|NCT02748681|stroke|stroke
231905|NCT02748681|telemedicine|telemedicine
231906|NCT02748681|neurorehabilitation|neurorehabilitation
231907|NCT02748681|systolic blood pressure|systolic blood pressure
231908|NCT02748629|inguinal hernia|inguinal hernia
231909|NCT02748629|mesh|mesh
231910|NCT02748629|lichtenstein|lichtenstein
231911|NCT02748629|hernia repair|hernia repair
231912|NCT02748629|selfgripping mesh|selfgripping mesh
231913|NCT02748616|Colitis|colitis
231914|NCT02748616|Bile|bile
231915|NCT02748577|Migraines|migraines
231916|NCT02748577|Pain responses|pain responses
231917|NCT02748551|Gastric cancer|gastric cancer
231918|NCT02748551|locally advanced gastric cancer|locally advanced gastric cancer
231919|NCT02748551|laparoscopic surgery|laparoscopic surgery
231920|NCT02748551|laparoscopic procedure|laparoscopic procedure
231921|NCT02748551|comparison laparoscopic with open procedure|comparison laparoscopic with open procedure
231922|NCT02748551|multicenter trials|multicenter trials
231923|NCT02748486|schizophrenia|schizophrenia
231924|NCT02748486|randomized controlled trial|randomized controlled trial
231925|NCT02748486|metacognitive training|metacognitive training
231926|NCT02748486|single sessions|single sessions
231927|NCT02748473|Pilates exercises|pilates exercises
231928|NCT02748473|pelvic floor muscle contraction|pelvic floor muscle contraction
231929|NCT02748434|iPro2 Continuous Blood Glucose Recorder|ipro2 continuous blood glucose recorder
231930|NCT02748434|Subclinical|subclinical
231931|NCT02748421|retina surgery|retina surgery
231932|NCT02748421|image guided surgery|image guided surgery
231933|NCT02748421|optical coherence tomography assisted|optical coherence tomography assisted
231934|NCT02748369|TCA cycle flux|tca cycle flux
231935|NCT02748369|in vivo measurements|in vivo measurements
231936|NCT02748369|Stable isotopes|stable isotopes
231937|NCT02748369|Arteriovenous balance|arteriovenous balance
231938|NCT02748369|Metabolome|metabolome
231939|NCT02748369|Proteome|proteome
231940|NCT02748369|Exosomes|exosomes
231941|NCT02748356|Spina Bifida|spina bifida
231942|NCT02748356|Spinal Cord Injury|spinal cord injury
231943|NCT02748317|Spina Bifida|spina bifida
231944|NCT02748317|Spinal Cord Injury|spinal cord injury
231945|NCT02748317|Lower Urinary Tract Symptoms|lower urinary tract symptoms
231946|NCT02748317|Probiotics|probiotics
231947|NCT02748317|Intermittent Catheterization|intermittent catheterization
231948|NCT02748291|Sedentary|sedentary
231949|NCT02748291|Knee osteoarthritis|knee osteoarthritis
231950|NCT02748291|Knee pain|knee pain
231951|NCT02748291|Gonarthritis|gonarthritis
231952|NCT02748291|Arthritis|arthritis
231953|NCT02748291|Walking|walking
231954|NCT02748291|Pedometer|pedometer
231955|NCT02748291|Physical Activity|physical activity
231956|NCT02748291|Activities of Daily Function|activities of daily function
231957|NCT02748291|Department of Health Physical Activity Guidelines|department of health physical activity guidelines
231958|NCT02748291|Improve pain|improve pain
231959|NCT02748291|Decrease pain|decrease pain
231960|NCT02748291|Improve function|improve function
231961|NCT02748291|Increase function|increase function
231962|NCT02748291|Activity Monitoring|activity monitoring
231963|NCT02748291|Monitoring, Ambulatory/instrumentation|monitoring, ambulatory/instrumentation
231964|NCT02748278|subfertility|subfertility
231965|NCT02748278|In-vitro fertilization|in-vitro fertilization
231966|NCT02748239|diabetes self-management education|diabetes self-management education
231967|NCT02748239|insulin therapy|insulin therapy
231968|NCT02748174|Migraine|migraine
231969|NCT02748174|Curelator|curelator
231970|NCT02748161|Hepatocellular carcinoma|hepatocellular carcinoma
231971|NCT02748161|DEB-TACE|deb-tace
231972|NCT02748161|QED|qed
231973|NCT02748148|Medication Therapy Management|medication therapy management
231974|NCT02748148|Pharmacogenomics|pharmacogenomics
231975|NCT02748122|Adolescents|adolescents
231976|NCT02748122|Insulin|insulin
231977|NCT02748122|T2DM|t2dm
231978|NCT02748109|Physical Therapy|physical therapy
231979|NCT02748109|Balance Disorder|balance disorder
231980|NCT02748109|Concussion|concussion
231981|NCT02748109|Mild Traumatic Brain Injury|mild traumatic brain injury
231982|NCT02748096|Unicompartmental Knee Replacement|unicompartmental knee replacement
231983|NCT02748096|Patient Specific Instrumentation|patient specific instrumentation
231984|NCT02748083|tDCS|tdcs
231985|NCT02748083|schizophrenia|schizophrenia
231986|NCT02748083|cognition|cognition
231987|NCT02748083|fMRI|fmri
231988|NCT02748031|Congenital cataracts|congenital cataracts
231989|NCT02748031|Opacity location|opacity location
231990|NCT02748031|Opacity shape|opacity shape
231991|NCT02748031|Classification|classification
231992|NCT02748031|Clinical applicability|clinical applicability
231993|NCT02748005|Fenugreek seed extract|fenugreek seed extract
231994|NCT02748005|testosterone|testosterone
231995|NCT02748005|protodioscin|protodioscin
231996|NCT02748005|hypogonadism|hypogonadism
231997|NCT02747979|hemodialysis|hemodialysis
231998|NCT02747979|hyperparathyroidism|hyperparathyroidism
231999|NCT02747979|refractory pruritus|refractory pruritus
232000|NCT02747979|ostalgia|ostalgia
232001|NCT02747979|insomnia|insomnia
232002|NCT02747979|CVD incidence|cvd incidence
232003|NCT02747979|life quality|life quality
232004|NCT02747966|access flow|access flow
232005|NCT02747966|access recirculation|access recirculation
232006|NCT02747966|cardiac output|cardiac output
232007|NCT02747966|cardiac index|cardiac index
232008|NCT02747966|hemodialysis|hemodialysis
232009|NCT02747927|Drug therapy|drug therapy
232010|NCT02747901|KINESIOTAPING|kinesiotaping
232011|NCT02747901|COLD THERAPY|cold therapy
232012|NCT02747901|FUNCTIONAL PERFORMANCE|functional performance
232013|NCT02747888|Thyroid|thyroid
232014|NCT02747875|pediatric|pediatric
232015|NCT02747875|cardiac bypass surgery|cardiac bypass surgery
232016|NCT02747875|methadone|methadone
232017|NCT02747875|fentanyl|fentanyl
232018|NCT02747875|morphine|morphine
232019|NCT02747862|Attenuated Familial Adenomatous Polyposis|attenuated familial adenomatous polyposis
232020|NCT02747862|AFAP|afap
232021|NCT02747862|Deleterious Familial Adenomatous Polyposis|deleterious familial adenomatous polyposis
232022|NCT02747862|FAP|fap
232023|NCT02747862|Chart review|chart review
232024|NCT02747797|Advanced Cancer|advanced cancer
232025|NCT02747797|Lucitanib (E3810)|lucitanib (e3810)
232026|NCT02747797|Fibroblast Growth Factor Receptor|fibroblast growth factor receptor
232027|NCT02747797|FGFR|fgfr
232028|NCT02747797|Vascular Endothelial Growth Factor Receptor|vascular endothelial growth factor receptor
232029|NCT02747797|VEGFR|vegfr
232030|NCT02747797|Platelet Derived Growth Factor Receptor|platelet derived growth factor receptor
232031|NCT02747797|PDGFR|pdgfr
232032|NCT02747797|metastatic malignancy|metastatic malignancy
232033|NCT02747784|cognitive dysfunction|cognitive dysfunction
232034|NCT02747784|cognitive training|cognitive training
232035|NCT02747771|effectiveness|effectiveness
232036|NCT02747771|trichotillomania|trichotillomania
232037|NCT02747771|hair pulling|hair pulling
232038|NCT02747771|habit reversal training|habit reversal training
232039|NCT02747771|acceptance and commitment therapy|acceptance and commitment therapy
232040|NCT02747771|cognitive behavioral therapy|cognitive behavioral therapy
232041|NCT02747758|neuropathic pain|neuropathic pain
232042|NCT02747758|neuralgia|neuralgia
232043|NCT02747758|tDCS|tdcs
232044|NCT02747758|transcranial direct current stimulation|transcranial direct current stimulation
232045|NCT02747745|Caregivers|caregivers
232046|NCT02747745|Case Management|case management
232047|NCT02747745|Community Dwelling|community dwelling
232048|NCT02747706|peer mentor|peer mentor
232049|NCT02747706|health coach|health coach
232050|NCT02747706|parent support|parent support
232051|NCT02747706|parent mentor|parent mentor
232052|NCT02747680|type 1 diabetes|type 1 diabetes
232053|NCT02747680|hypoglycemia unawareness|hypoglycemia unawareness
232054|NCT02747680|healthy control|healthy control
232055|NCT02747667|iol dislocation|iol dislocation
232056|NCT02747667|iol complication|iol complication
232057|NCT02747667|intraocular lens|intraocular lens
232058|NCT02747667|Implant or Graft|implant or graft
232059|NCT02747667|Eye|eye
232060|NCT02747654|NAT2 genotype guided dosing|nat2 genotype guided dosing
232061|NCT02747628|Transdermal nicotine|transdermal nicotine
232062|NCT02747628|Transdermal melatonin|transdermal melatonin
232063|NCT02747628|Postoperative pain|postoperative pain
232361|NCT02745470|appetite|appetite
232064|NCT02747628|Laparoscopic cholecystectomy|laparoscopic cholecystectomy
400506|NCT01866579|Retinal Nerve Fiber Layer Thickness, Optical Coherence Tomography, Ethambutol optic neuropathy|retinal nerve fiber layer thickness, optical coherence tomography, ethambutol optic neuropathy
400507|NCT01866553|CML|cml
232065|NCT02747615|Preoperative autologous blood donation, allogeneic blood transfusion, parenteral iron, tranexamic acid, revision total hip arthroplasty, hemoglobin, hematocrit|preoperative autologous blood donation, allogeneic blood transfusion, parenteral iron, tranexamic acid, revision total hip arthroplasty, hemoglobin, hematocrit
232066|NCT02747602|Healthy volunteers|healthy volunteers
232067|NCT02747602|Caprylic triglyceride oil|caprylic triglyceride oil
232068|NCT02747602|AC-1204|ac-1204
232069|NCT02747602|Pharmacokinetic|pharmacokinetic
232070|NCT02747602|Ketone body|ketone body
232071|NCT02747576|Childhood Cancer Survivor|childhood cancer survivor
232072|NCT02747576|Social-cognition|social-cognition
232073|NCT02747576|Healthy Volunteers|healthy volunteers
232074|NCT02747563|prostate cancer|prostate cancer
232075|NCT02747563|PSA|psa
232076|NCT02747563|digital rectal examination|digital rectal examination
232077|NCT02747472|GIP|gip
232078|NCT02747472|GIP receptor antagonist|gip receptor antagonist
232079|NCT02747446|fructose, triglyceride, oral glucose tolerance|fructose, triglyceride, oral glucose tolerance
232080|NCT02747433|robot-assisted therapy|robot-assisted therapy
232081|NCT02747433|task-oriented training|task-oriented training
232082|NCT02747433|motor learning|motor learning
232083|NCT02747433|cognitive strategy training|cognitive strategy training
232084|NCT02747420|Posterior Tibial Nerve Stimulation, Bladder|posterior tibial nerve stimulation, bladder
232085|NCT02747368|Wet age-related macular degeneration|wet age-related macular degeneration
232086|NCT02747368|Age-related macular degeneration|age-related macular degeneration
232087|NCT02747368|Ocusweep|ocusweep
232088|NCT02747368|Driving health|driving health
232089|NCT02747368|Visual field|visual field
232090|NCT02747368|Contrast sensitivity|contrast sensitivity
232091|NCT02747342|Metastatic castration-resistant prostate cancer|metastatic castration-resistant prostate cancer
232092|NCT02747329|BuMA Supreme|buma supreme
232093|NCT02747329|Xience V/Prime|xience v/prime
232094|NCT02747329|OCT|oct
232095|NCT02747329|neointima formation|neointima formation
232096|NCT02747316|Iron bioavailability|iron bioavailability
232097|NCT02747316|Hepcidin|hepcidin
232098|NCT02747316|Iron absorption|iron absorption
232099|NCT02747303|brain metastases|brain metastases
232100|NCT02747303|Stereotactic Radiosurgery|stereotactic radiosurgery
232101|NCT02747290|BBN-RGD|bbn-rgd
232102|NCT02747290|PET|pet
232103|NCT02747290|integrin αvβ3|integrin αvβ3
232104|NCT02747290|GRPR|grpr
232105|NCT02747264|eRAPID|erapid
232106|NCT02747264|PRO|pro
232107|NCT02747264|PROM|prom
232108|NCT02747264|Adverse event|adverse event
232109|NCT02747264|QTool|qtool
232110|NCT02747264|CTCAE|ctcae
232111|NCT02747251|"Shoulder Impingement Syndrome[Mesh]"|"shoulder impingement syndrome[mesh]"
232112|NCT02747251|"Rehabilitation[Mesh]"|"rehabilitation[mesh]"
232113|NCT02747251|"Exercise[Mesh]"|"exercise[mesh]"
232114|NCT02747251|"Rotator Cuff[Mesh]"|"rotator cuff[mesh]"
232115|NCT02747238|Pregnancy|pregnancy
232116|NCT02747238|Epidural|epidural
232117|NCT02747238|Labor|labor
232118|NCT02747225|electrical properties|electrical properties
232119|NCT02747225|malignant tissues|malignant tissues
232120|NCT02747225|in vivo|in vivo
232121|NCT02747212|electrical properties|electrical properties
232122|NCT02747212|malignant tissues|malignant tissues
232123|NCT02747212|ex vivo|ex vivo
232124|NCT02747199|SYNERGY|synergy
232125|NCT02747199|Neointimal formation|neointimal formation
232126|NCT02747199|OCT|oct
232127|NCT02747199|coronary angioscopy|coronary angioscopy
232128|NCT02747199|coronary artery disease|coronary artery disease
232129|NCT02747186|lidocaine, jaw|lidocaine, jaw
232130|NCT02747173|metastatic, bone metastases|metastatic, bone metastases
232131|NCT02747160|Cancer|cancer
232132|NCT02747160|Anxiety|anxiety
232133|NCT02747160|Cognitive behavior therapy|cognitive behavior therapy
232134|NCT02747160|Elderly|elderly
232135|NCT02747160|Caregivers|caregivers
232136|NCT02747121|External inspections|external inspections
232137|NCT02747108|Veterans|veterans
232138|NCT02747108|Type 2 Diabetes Mellitus|type 2 diabetes mellitus
232139|NCT02747108|Prediabetes|prediabetes
232140|NCT02747108|Decision-making|decision-making
232141|NCT02747108|Motivation|motivation
232142|NCT02747108|Health Promotion|health promotion
232143|NCT02747108|Prevention and Control|prevention and control
232144|NCT02747095|CT|ct
232145|NCT02747095|Spectral Images|spectral images
232146|NCT02747082|endodontic retreatment|endodontic retreatment
232147|NCT02747082|sodium hypochlorite|sodium hypochlorite
232148|NCT02747082|chlorhexidine|chlorhexidine
232149|NCT02747082|calcium hydroxide|calcium hydroxide
232150|NCT02747082|Retreatment|retreatment
232151|NCT02747069|Heart rate|heart rate
232152|NCT02747069|Electronic Stethoscope|electronic stethoscope
232153|NCT02747069|Electrocardiogram|electrocardiogram
232154|NCT02747069|Resuscitation|resuscitation
232155|NCT02747030|Central retinal vein occlusion|central retinal vein occlusion
232156|NCT02747030|Retinal endovascular surgery|retinal endovascular surgery
232157|NCT02747030|Retinal vein cannulation|retinal vein cannulation
232158|NCT02747030|Ocriplasmin|ocriplasmin
232159|NCT02747017|transplant|transplant
232556|NCT02744469|outcome|outcome
232160|NCT02746965|magnetic seizure therapy|magnetic seizure therapy
232161|NCT02746965|randomized controlled trials|randomized controlled trials
232162|NCT02746965|schizophrenia|schizophrenia
232163|NCT02746965|cognition|cognition
232164|NCT02746939|program evaluation|program evaluation
232165|NCT02746939|health literacy|health literacy
232167|NCT02746939|nutrition|nutrition
232168|NCT02746939|education|education
232169|NCT02746913|Pelvic, Urodynamic, Vaginal Wall|pelvic, urodynamic, vaginal wall
232170|NCT02746874|Total Knee Replacement, Replacement of the knee joint,|total knee replacement, replacement of the knee joint,
232171|NCT02746861|peer mentor|peer mentor
232172|NCT02746861|peer supporter|peer supporter
232173|NCT02746861|peer coach|peer coach
232174|NCT02746861|peer-to-peer mentoring|peer-to-peer mentoring
232175|NCT02746848|cornea epithelium healing Amniotic Membrane Eye Drop|cornea epithelium healing amniotic membrane eye drop
232176|NCT02746835|physical condition|physical condition
232177|NCT02746835|self-efficacy|self-efficacy
232178|NCT02746835|fall risk|fall risk
232179|NCT02746835|exercise program|exercise program
232180|NCT02746822|acute myocardial infarction,|acute myocardial infarction,
232181|NCT02746822|thrombus aspiration|thrombus aspiration
232182|NCT02746679|Asherman syndrome|asherman syndrome
232183|NCT02746679|Mindfulness|mindfulness
232184|NCT02746679|Anxiety|anxiety
232185|NCT02746679|Depression|depression
232186|NCT02746679|Quality of Life|quality of life
232187|NCT02746653|Fascia Closure Device, hernia,|fascia closure device, hernia,
232188|NCT02746614|adaptive behavior|adaptive behavior
232189|NCT02746614|motor proficiency|motor proficiency
232190|NCT02746614|psychomotor therapy|psychomotor therapy
232191|NCT02746614|intellectual disability|intellectual disability
232192|NCT02746588|miscarriage|miscarriage
232193|NCT02746588|uterine abnormalities|uterine abnormalities
232194|NCT02746588|Chronic infection|chronic infection
232195|NCT02746562|Assisted reproduction|assisted reproduction
232196|NCT02746562|In vitro fertilisation|in vitro fertilisation
232197|NCT02746562|Frozen embryo transfer (FET)|frozen embryo transfer (fet)
232198|NCT02746536|COPD|copd
232199|NCT02746536|Inspiratory capacity|inspiratory capacity
232200|NCT02746536|Exercise|exercise
232201|NCT02746523|NHL|nhl
232202|NCT02746523|Concussion|concussion
232203|NCT02746523|Biomarkers|biomarkers
232204|NCT02746497|Menopause|menopause
232205|NCT02746497|Hot flushes|hot flushes
232206|NCT02746497|Acupuncture|acupuncture
232207|NCT02746497|Randomized controlled trial|randomized controlled trial
232208|NCT02746458|Blood Flow Restriction|blood flow restriction
232209|NCT02746458|Muscle Weakness|muscle weakness
232210|NCT02746458|Physical therapy techniques|physical therapy techniques
232211|NCT02746458|closed femoral fracture injuries|closed femoral fracture injuries
232212|NCT02746445|Autism|autism
232213|NCT02746445|ASD|asd
232214|NCT02746445|Autism Spectrum Disorder|autism spectrum disorder
232215|NCT02746432|CRC-Insulin|crc-insulin
232216|NCT02746354|Chronic Pain|chronic pain
232217|NCT02746354|Analgesics, Opioid|analgesics, opioid
232218|NCT02746354|Primary Health Care|primary health care
232219|NCT02746276|malnutrition|malnutrition
232220|NCT02746276|antibiotics|antibiotics
232221|NCT02746276|antimicrobial resistance|antimicrobial resistance
232222|NCT02746276|pharmacokinetics|pharmacokinetics
232223|NCT02746263|Elective total knee arthroplasty|elective total knee arthroplasty
232224|NCT02746237|Serotonin|serotonin
232225|NCT02746237|Pulmonary Arterial Hypertension|pulmonary arterial hypertension
232226|NCT02746237|Pharmacokinetics|pharmacokinetics
232227|NCT02746237|Phase 1|phase 1
232228|NCT02746237|Healthy Volunteers|healthy volunteers
232229|NCT02746224|Colorectal cancer|colorectal cancer
232230|NCT02746224|Colorectal surgery|colorectal surgery
232231|NCT02746211|immunology|immunology
232232|NCT02746211|pathogenicity|pathogenicity
232233|NCT02746198|Probiotics, Antibiotics, AAD, Helicobacter p.|probiotics, antibiotics, aad, helicobacter p.
232234|NCT02746185|cancer|cancer
232235|NCT02746185|venous thromboembolism|venous thromboembolism
232236|NCT02746185|low-molecular weight heparin|low-molecular weight heparin
232237|NCT02746185|rivaroxaban|rivaroxaban
232238|NCT02746172|cochlear implants|cochlear implants
232239|NCT02746172|Mapping|mapping
232240|NCT02746172|in-situ audiometry|in-situ audiometry
232241|NCT02746107|shared decision making|shared decision making
232242|NCT02746107|oral anticoagulant|oral anticoagulant
232243|NCT02746107|atrial fibrillation|atrial fibrillation
232244|NCT02746107|stroke|stroke
232245|NCT02746107|decision to treat|decision to treat
232246|NCT02746081|BAY1436032|bay1436032
232247|NCT02746081|Solid tumors|solid tumors
232248|NCT02746081|IDH1|idh1
232249|NCT02746081|Cancer|cancer
232250|NCT02746081|Safety|safety
232251|NCT02746081|Tolerability|tolerability
232252|NCT02746081|Pharmacokinetics|pharmacokinetics
232253|NCT02746081|Pharmacodynamics|pharmacodynamics
232254|NCT02746081|Efficacy|efficacy
232255|NCT02746081|Food-effect|food-effect
232256|NCT02746068|Bone Marrow Lesions|bone marrow lesions
232257|NCT02746068|AXS02|axs02
232258|NCT02746068|Axsome|axsome
232259|NCT02746068|Knee OA|knee oa
232260|NCT02746068|Osteoarthritis|osteoarthritis
232261|NCT02746042|chronic rhinosinusitis|chronic rhinosinusitis
232262|NCT02746042|Sinupret extract|sinupret extract
232263|NCT02746042|herbal medicinal product|herbal medicinal product
232264|NCT02746003|drinking water|drinking water
232265|NCT02746003|salinity|salinity
232266|NCT02745990|erythropoietin|erythropoietin
232267|NCT02745990|preterm|preterm
232268|NCT02745990|brain injury|brain injury
232269|NCT02745990|cerebral palsy|cerebral palsy
232270|NCT02745990|PVL|pvl
232271|NCT02745951|cardiopulmonary bypass|cardiopulmonary bypass
232272|NCT02745951|cardioplegia|cardioplegia
232273|NCT02745951|cardioprotection|cardioprotection
232274|NCT02745951|coronary artery bypass graft surgery|coronary artery bypass graft surgery
232275|NCT02745951|heliox|heliox
232276|NCT02745938|Exercise test|exercise test
232277|NCT02745938|GDF-15|gdf-15
232278|NCT02745938|Growth and Differentiation Factor 15|growth and differentiation factor 15
232279|NCT02745925|Iron bioavailability|iron bioavailability
232280|NCT02745925|Inflammation|inflammation
232281|NCT02745925|Hepcidin|hepcidin
232282|NCT02745925|Iron absorption|iron absorption
232283|NCT02745912|Drug Therapy|drug therapy
232285|NCT02745899|cow milk|cow milk
232286|NCT02745899|pulmonary function testing|pulmonary function testing
232287|NCT02745899|children|children
232288|NCT02745899|mucus|mucus
232289|NCT02745860|selexipag|selexipag
232290|NCT02745860|pharmacokinetics|pharmacokinetics
232291|NCT02745821|coronary flow reserve|coronary flow reserve
232292|NCT02745821|fractional flow reserve|fractional flow reserve
232293|NCT02745821|diabetes mellitus|diabetes mellitus
232294|NCT02745821|coronary artery disease|coronary artery disease
232295|NCT02745821|percutaneous coronary intervention|percutaneous coronary intervention
232296|NCT02745821|coronary physiology|coronary physiology
232297|NCT02745821|index of microcirculatory resistance|index of microcirculatory resistance
232298|NCT02745795|Motivational interview|motivational interview
232299|NCT02745795|adolescents|adolescents
232300|NCT02745795|obesity|obesity
232301|NCT02745795|overweight|overweight
232302|NCT02745795|physical activity|physical activity
232303|NCT02745795|diet|diet
232304|NCT02745782|Pulpitis|pulpitis
232305|NCT02745782|Syncope|syncope
232306|NCT02745782|Trigeminal Cardio-Reflex|trigeminal cardio-reflex
232307|NCT02745756|Children|children
232308|NCT02745756|Cancer|cancer
232309|NCT02745756|High-risk neuroblastoma|high-risk neuroblastoma
232310|NCT02745743|Phase 1|phase 1
232311|NCT02745743|Dose escalation|dose escalation
232312|NCT02745743|Dose expansion|dose expansion
232313|NCT02745743|Positive transcription elongation factor b inhibitor|positive transcription elongation factor b inhibitor
232314|NCT02745743|Cyclin-dependent kinase 9 inhibitor|cyclin-dependent kinase 9 inhibitor
232315|NCT02745717|Severe aplastic anemia|severe aplastic anemia
232316|NCT02745717|immunosuppressive therapy|immunosuppressive therapy
232317|NCT02745717|cord blood transfusion|cord blood transfusion
232318|NCT02745704|chronic hepatitis B|chronic hepatitis b
232319|NCT02745704|peginterferon alfa|peginterferon alfa
232320|NCT02745691|quality of life|quality of life
232321|NCT02745691|psychometric validation|psychometric validation
232322|NCT02745691|international field study|international field study
232323|NCT02745691|patient-reported outcome (PRO)|patient-reported outcome (pro)
232324|NCT02745678|Enema|enema
232325|NCT02745678|Ulcerative Colitis|ulcerative colitis
232326|NCT02745652|median nerve|median nerve
232327|NCT02745652|wrist joint|wrist joint
232328|NCT02745652|carpal tunnel|carpal tunnel
232329|NCT02745639|rectal cancer|rectal cancer
232330|NCT02745639|radiotherapy|radiotherapy
232331|NCT02745639|chemotherapy|chemotherapy
232332|NCT02745639|VMAT|vmat
232333|NCT02745639|toxicity|toxicity
232334|NCT02745600|RFA|rfa
232335|NCT02745600|Liver|liver
232336|NCT02745600|Ablation Techniques|ablation techniques
232337|NCT02745600|Treatment Simulation|treatment simulation
232338|NCT02745600|Computer assisted therapy|computer assisted therapy
232339|NCT02745574|should and upper abdominal pain, post-laparoscopy|should and upper abdominal pain, post-laparoscopy
232340|NCT02745561|Endostatin|endostatin
232341|NCT02745561|Oxaliplatin|oxaliplatin
232342|NCT02745561|Esophageal Cancer|esophageal cancer
232343|NCT02745561|chemoradiotherapy|chemoradiotherapy
232344|NCT02745548|Lung Cancer|lung cancer
232345|NCT02745548|NSCLC (Non Small Cell Lung Cancer)|nsclc (non small cell lung cancer)
232346|NCT02745548|SABR (Stereotactic ablative radiotherapy)|sabr (stereotactic ablative radiotherapy)
232347|NCT02745535|Hepatitis C relapse|hepatitis c relapse
232348|NCT02745522|Placebo effect|placebo effect
232349|NCT02745522|Working memory|working memory
232350|NCT02745509|Extensive Intraoperative Peritoneal Lavage|extensive intraoperative peritoneal lavage
232351|NCT02745509|EIPL|eipl
232352|NCT02745509|Gastric Cancer|gastric cancer
232353|NCT02745496|Image-guided biopsy|image-guided biopsy
232354|NCT02745496|Tumour detection|tumour detection
232355|NCT02745496|Diagnostic|diagnostic
232356|NCT02745496|Biomarkers|biomarkers
232357|NCT02745483|RFA|rfa
232358|NCT02745470|lean/obese diabetes mellitus|lean/obese diabetes mellitus
232359|NCT02745470|functional MRI|functional mri
232360|NCT02745470|GLP-1|glp-1
232362|NCT02745470|activation of brain|activation of brain
232363|NCT02745470|connectivity|connectivity
232364|NCT02745444|Living kidney transplantation|living kidney transplantation
232365|NCT02745444|Chronic kidney disease|chronic kidney disease
232366|NCT02745444|Acute kidney injury|acute kidney injury
232367|NCT02745431|Likeability|likeability
232368|NCT02745431|Being liked|being liked
232369|NCT02745405|Weight Stigma|weight stigma
232370|NCT02745405|Cortisol Reactivity|cortisol reactivity
232371|NCT02745405|Eating Behavior|eating behavior
232372|NCT02745392|migraine|migraine
232373|NCT02745392|migraine headache|migraine headache
232374|NCT02745392|acute migraine|acute migraine
232375|NCT02745392|acute migraine headache|acute migraine headache
232376|NCT02745353|Cancer|cancer
232377|NCT02745353|Constipation|constipation
232378|NCT02745353|Opioid|opioid
232379|NCT02745327|oral vaccination|oral vaccination
232380|NCT02745327|nutrition|nutrition
232381|NCT02745314|Aortic Stenosis, Frailty, Elderly, moertality|aortic stenosis, frailty, elderly, moertality
232382|NCT02745275|Peer Education|peer education
232383|NCT02745275|Health Coaches|health coaches
232384|NCT02745275|Community Dwelling Seniors|community dwelling seniors
232385|NCT02745275|Health Literacy|health literacy
232386|NCT02745275|Health Education|health education
232387|NCT02745275|Healthy Ageing|healthy ageing
232388|NCT02745236|Atrial Fibrillation|atrial fibrillation
232389|NCT02745236|Health Related Quality of Life|health related quality of life
232390|NCT02745236|Nurse Practitioner|nurse practitioner
232391|NCT02745236|Sustainable Models of Healthcare|sustainable models of healthcare
232392|NCT02745236|Patient Satisfaction|patient satisfaction
232393|NCT02745171|Parkinson's disease|parkinson's disease
232394|NCT02745171|Quality of life|quality of life
232395|NCT02745171|Functional mobility|functional mobility
232396|NCT02745171|Follow up|follow up
232397|NCT02745158|Fibrodysplasia ossificans progressiva|fibrodysplasia ossificans progressiva
232398|NCT02745158|FOP|fop
232399|NCT02745158|International FOP Association|international fop association
232400|NCT02745158|Patient Advocacy Group|patient advocacy group
232401|NCT02745158|Patient Registry|patient registry
232402|NCT02745158|Natural History|natural history
232403|NCT02745158|Patient-Reported Outcomes|patient-reported outcomes
232404|NCT02745158|Observational Database|observational database
232405|NCT02745158|Bone Morphogenetic Protein|bone morphogenetic protein
232406|NCT02745158|BMP|bmp
232407|NCT02745158|Bone Growth|bone growth
232408|NCT02745158|Joint|joint
232409|NCT02745158|Mobility|mobility
232410|NCT02745158|Flare-Up|flare-up
232411|NCT02745158|Heterotopic Ossification|heterotopic ossification
232412|NCT02745158|Ectopic Bone|ectopic bone
232413|NCT02745158|Osteochondroma|osteochondroma
232414|NCT02745158|Hallux Valgus|hallux valgus
232415|NCT02745158|ALK2|alk2
232416|NCT02745158|ACVR1|acvr1
232417|NCT02745158|Activin A|activin a
232418|NCT02745158|IFOPA|ifopa
232419|NCT02745158|Activin A Receptor Type I|activin a receptor type i
232420|NCT02745158|Activin Receptor-like Kinase-2|activin receptor-like kinase-2
232421|NCT02745145|Double-Blind Method|double-blind method
232422|NCT02745145|Interstitial Lung Diseases|interstitial lung diseases
232423|NCT02745145|Systemic Scleroderma|systemic scleroderma
232424|NCT02745145|Abituzumab|abituzumab
232425|NCT02745145|Mycophenolate|mycophenolate
232426|NCT02745145|Efficacy, Safety|efficacy, safety
232427|NCT02745132|Chronic, Cognition Disorders|chronic, cognition disorders
232428|NCT02745132|Neurocognition Disorders|neurocognition disorders
232429|NCT02745132|Cognitive Impairments|cognitive impairments
232430|NCT02745132|Diffusion Magnetic Resonance Imaging|diffusion magnetic resonance imaging
232431|NCT02745132|MRI functional|mri functional
232432|NCT02745132|Verbal fluency|verbal fluency
232433|NCT02745106|Chronic thromboembolic pulmonary hypertension, Navigation system, Ablation|chronic thromboembolic pulmonary hypertension, navigation system, ablation
232434|NCT02745093|Abortion induced|abortion induced
232435|NCT02745093|Patient Acceptance of Healthcare|patient acceptance of healthcare
232436|NCT02745093|safety|safety
232437|NCT02745093|effectiveness|effectiveness
232438|NCT02745093|misoprostol|misoprostol
232439|NCT02745093|mifepristone|mifepristone
232440|NCT02745080|Psoriatic Arthritis|psoriatic arthritis
232441|NCT02745080|secukinumab|secukinumab
232442|NCT02745080|adalimumab|adalimumab
232443|NCT02745080|monoclonal antibody|monoclonal antibody
232444|NCT02745080|CASPAR|caspar
232445|NCT02745054|oral anticoagulants|oral anticoagulants
232446|NCT02745054|bleeding|bleeding
232447|NCT02745054|anticoagulation reversal|anticoagulation reversal
232448|NCT02745041|Fibrinogen|fibrinogen
232449|NCT02745041|Cryoprecipitate|cryoprecipitate
232450|NCT02745028|delayed gastric emptying|delayed gastric emptying
232451|NCT02745028|children|children
232452|NCT02745028|monosodium glutamate|monosodium glutamate
232453|NCT02745015|periodontitis|periodontitis
232454|NCT02745015|diabetes|diabetes
232455|NCT02745015|HbA1c|hba1c
232456|NCT02745015|inflammation|inflammation
232457|NCT02745002|Bronchoscopy|bronchoscopy
232458|NCT02745002|Bronchoscopes|bronchoscopes
232459|NCT02744989|Schizophrenia|schizophrenia
232460|NCT02744989|Transcranial direct-current stimulation (tDCS)|transcranial direct-current stimulation (tdcs)
232461|NCT02744989|Sham|sham
232462|NCT02744989|Positive and Negative Syndrome Scale (PANSS)|positive and negative syndrome scale (panss)
232463|NCT02744989|Functional Magnetic Resonance Imaging (fRMI)|functional magnetic resonance imaging (frmi)
232464|NCT02744989|Brain-Derived-Neurotrophic Factor (BDNF)|brain-derived-neurotrophic factor (bdnf)
232465|NCT02744976|Coronary artery disease|coronary artery disease
232466|NCT02744976|Atherosclerosis|atherosclerosis
232467|NCT02744976|Prediabetes|prediabetes
232468|NCT02744976|Intravascular ultrasound|intravascular ultrasound
232469|NCT02744976|Insulin resistance|insulin resistance
232470|NCT02744976|Percutaneous coronary intervention|percutaneous coronary intervention
232471|NCT02744976|Metformin|metformin
232472|NCT02744950|pulley|pulley
232473|NCT02744950|scalp defects|scalp defects
232474|NCT02744911|speech problems|speech problems
232475|NCT02744898|uterus|uterus
232476|NCT02744898|gynecological|gynecological
232477|NCT02744898|corpus uteri|corpus uteri
232478|NCT02744872|lung transplantation|lung transplantation
232479|NCT02744872|chronic renal insufficiency|chronic renal insufficiency
232480|NCT02744859|Decision Making|decision making
232481|NCT02744859|Consumption|consumption
232482|NCT02744859|Economics|economics
232483|NCT02744846|antibiotics|antibiotics
232484|NCT02744846|children|children
232485|NCT02744846|pediatric|pediatric
232486|NCT02744846|body mass index|body mass index
232487|NCT02744846|Observational Study|observational study
232488|NCT02744846|Comparative Effectiveness Research|comparative effectiveness research
232489|NCT02744846|Obesity|obesity
232490|NCT02744846|Growth Trajectory|growth trajectory
232491|NCT02744846|Cohort Study|cohort study
232492|NCT02744846|Electronic Medical Record|electronic medical record
232493|NCT02744846|Qualitative Research|qualitative research
232494|NCT02744833|DVT|dvt
232495|NCT02744807|intrauterine adhesions|intrauterine adhesions
232496|NCT02744807|Chronic endometritis|chronic endometritis
232497|NCT02744807|infections|infections
232498|NCT02744807|Hysteroscopy|hysteroscopy
232499|NCT02744781|Muscular Atrophy|muscular atrophy
232500|NCT02744781|Asymmetry|asymmetry
232501|NCT02744781|Athletes|athletes
232502|NCT02744768|Acute Lymphoblastic Leukemia, adult, dasatinib, blinatumomab|acute lymphoblastic leukemia, adult, dasatinib, blinatumomab
232503|NCT02744716|intrauterine balloon|intrauterine balloon
232504|NCT02744716|uterine endometrial repair|uterine endometrial repair
232505|NCT02744716|intrauterine adhesion|intrauterine adhesion
232506|NCT02744716|aspirin|aspirin
232507|NCT02744690|Eye Disease|eye disease
232508|NCT02744690|Intraocular Pressure|intraocular pressure
232509|NCT02744690|Visual Acuity|visual acuity
232510|NCT02744690|Trabeculectomy|trabeculectomy
232511|NCT02744677|Tetralogy of Fallot|tetralogy of fallot
232512|NCT02744677|Aortic Valve Defect/Disease Resulting in Ross Procedure|aortic valve defect/disease resulting in ross procedure
232513|NCT02744677|Pulmonary Atresia|pulmonary atresia
232514|NCT02744677|Pulmonary Stenosis|pulmonary stenosis
232515|NCT02744677|Truncus Arteriosus|truncus arteriosus
232516|NCT02744677|Transposition of the Great Arteries|transposition of the great arteries
232517|NCT02744677|Transcatheter pulmonary valve implantation|transcatheter pulmonary valve implantation
232518|NCT02744677|Transcatheter pulmonary valve replacement|transcatheter pulmonary valve replacement
232519|NCT02744677|TPV|tpv
232520|NCT02744677|TPVR|tpvr
232521|NCT02744677|TPVI|tpvi
232522|NCT02744664|Lung Neoplasms|lung neoplasms
232523|NCT02744664|EGFR mutation|egfr mutation
232524|NCT02744664|Cryotherapy|cryotherapy
232525|NCT02744664|Icotinib|icotinib
232526|NCT02744638|bacterial vaginosis|bacterial vaginosis
232527|NCT02744638|probiotics|probiotics
232528|NCT02744638|Amsel Score|amsel score
232529|NCT02744638|Nugent Score|nugent score
232530|NCT02744599|Feasibility trial|feasibility trial
232531|NCT02744586|Sexually transmitted infections|sexually transmitted infections
232532|NCT02744586|Neglected tropical diseases|neglected tropical diseases
232533|NCT02744586|Non-communicable diseases|non-communicable diseases
232534|NCT02744534|Prostate Cancer|prostate cancer
232535|NCT02744534|Imaging Technology|imaging technology
232536|NCT02744534|Oncology|oncology
232537|NCT02744534|Prostate Biopsy|prostate biopsy
232538|NCT02744508|palonosetron, dexamethasone, PONV (postoperative nausea and vomiting)|palonosetron, dexamethasone, ponv (postoperative nausea and vomiting)
232539|NCT02744495|cardiac surgery|cardiac surgery
232540|NCT02744495|corticoids|corticoids
232541|NCT02744495|droperidol|droperidol
232542|NCT02744495|antiemetics|antiemetics
232543|NCT02744495|Postoperative Vomiting|postoperative vomiting
232544|NCT02744495|Postoperative Nausea|postoperative nausea
232545|NCT02744495|Postoperative Emesis|postoperative emesis
232546|NCT02744495|prophylaxis|prophylaxis
232547|NCT02744469|Tuberculosis|tuberculosis
232548|NCT02744469|population structure|population structure
232549|NCT02744469|implications|implications
232550|NCT02744469|lineages|lineages
232551|NCT02744469|spoligotyping|spoligotyping
232552|NCT02744469|sputum|sputum
232553|NCT02744469|resistance|resistance
232554|NCT02744469|culture|culture
232555|NCT02744469|diagnostics|diagnostics
232557|NCT02744469|new/retreatment patient|new/retreatment patient
232558|NCT02744456|Hydrochlorothiazide tablet|hydrochlorothiazide tablet
232559|NCT02744456|Norvasc|norvasc
232560|NCT02744456|Cozaar|cozaar
232561|NCT02744456|amlodipine besylate tablets|amlodipine besylate tablets
232562|NCT02744456|losartan potassium tablets|losartan potassium tablets
232563|NCT02744456|Hypertension|hypertension
232564|NCT02744456|High Blood Pressure|high blood pressure
232565|NCT02744430|Medical expulsive therapy|medical expulsive therapy
232566|NCT02744430|ureteral stone|ureteral stone
232567|NCT02744430|stent pain|stent pain
232568|NCT02744417|smoking cessation|smoking cessation
232569|NCT02744417|tobacco|tobacco
232570|NCT02744417|periodontal|periodontal
232571|NCT02744417|subgingival microorganisms|subgingival microorganisms
232572|NCT02744352|infraclavicular brachial plexus block|infraclavicular brachial plexus block
232573|NCT02744352|quality of recovery score|quality of recovery score
232574|NCT02744352|pain score|pain score
232575|NCT02744352|disability assessment of shoulder and hand questionnaire|disability assessment of shoulder and hand questionnaire
232576|NCT02744339|PH-HFpEF|ph-hfpef
232577|NCT02744300|Gestational diabetes mellitus (GDM) in most recent pregnancy|gestational diabetes mellitus (gdm) in most recent pregnancy
232578|NCT02744287|prostate stem cell antigen|prostate stem cell antigen
232579|NCT02744287|BPX-601|bpx-601
232580|NCT02744287|AP1903|ap1903
232581|NCT02744287|CAR T|car t
232582|NCT02744287|PSCA-CAR|psca-car
232583|NCT02744287|Hormone-refractory prostate cancer|hormone-refractory prostate cancer
232584|NCT02744287|rimiducid|rimiducid
232585|NCT02744287|gastric cancer|gastric cancer
232586|NCT02744287|gastroesophageal junction cancer|gastroesophageal junction cancer
232587|NCT02744287|pancreatic cancer|pancreatic cancer
232588|NCT02744274|acupuncture|acupuncture
232589|NCT02744274|chemotherapy|chemotherapy
232590|NCT02744274|peripheral neuropathy|peripheral neuropathy
232591|NCT02744274|randomized clinical trial|randomized clinical trial
232592|NCT02744274|numbness|numbness
232594|NCT02744261|STI|sti
232595|NCT02744261|Primary Prevention|primary prevention
232596|NCT02744261|Topical Microbicides|topical microbicides
232597|NCT02744261|User Experience|user experience
232598|NCT02744261|Drug Delivery Systems|drug delivery systems
232599|NCT02744248|Magnetic Resonance Imaging (MRI)|magnetic resonance imaging (mri)
232600|NCT02744196|rheumatoid arthritis|rheumatoid arthritis
232601|NCT02744196|rheumatism|rheumatism
232602|NCT02744196|Acellbia|acellbia
232603|NCT02744196|methotrexate|methotrexate
232604|NCT02744196|biologic therapy|biologic therapy
232605|NCT02744196|monoclonal antibody|monoclonal antibody
232606|NCT02744196|rituximab|rituximab
232607|NCT02744183|Exercise|exercise
232608|NCT02744183|Fasted|fasted
232609|NCT02744183|Glucose|glucose
232610|NCT02744183|Energy Balance|energy balance
232611|NCT02744170|COPD|copd
232612|NCT02744170|Incremental Shuttle Walk Test|incremental shuttle walk test
232613|NCT02744170|Endurance Shuttle Walk Test|endurance shuttle walk test
232614|NCT02744170|oxygen therapy|oxygen therapy
232615|NCT02744131|PCOS|pcos
232616|NCT02744131|Metformin|metformin
232617|NCT02744131|OCP|ocp
232618|NCT02744131|metabolic parameters|metabolic parameters
232619|NCT02744118|Media Use|media use
232620|NCT02744092|Rivaroxaban (Xarelto)|rivaroxaban (xarelto)
232621|NCT02744092|Apixaban (Eliquis)|apixaban (eliquis)
232622|NCT02744092|Edoxaban (Savaysa)|edoxaban (savaysa)
232623|NCT02744092|Dabigatran (Pradaxa)|dabigatran (pradaxa)
232624|NCT02744092|Warfarin (Coumadin)|warfarin (coumadin)
232625|NCT02744092|Low molecular weight heparin (LMWH)|low molecular weight heparin (lmwh)
232626|NCT02744079|diet|diet
232627|NCT02744079|dietary intervention|dietary intervention
232628|NCT02744079|carbohydrate restriction|carbohydrate restriction
232629|NCT02744079|low carbohydrate|low carbohydrate
232630|NCT02744079|fat restriction|fat restriction
232631|NCT02744079|low fat|low fat
232632|NCT02744079|cancer|cancer
232633|NCT02744079|breast cancer|breast cancer
232634|NCT02744079|pre-surgical window|pre-surgical window
232635|NCT02744079|biomarker|biomarker
232636|NCT02744040|HIV reservoir|hiv reservoir
232637|NCT02744040|alcohol|alcohol
232638|NCT02744040|ART|art
232639|NCT02744027|Generalized Lymphatic Anomaly|generalized lymphatic anomaly
232640|NCT02744027|Kaposiform Lymphangiomatosis|kaposiform lymphangiomatosis
232641|NCT02744027|Dynamic Contrast Enhanced Magnetic Resonance Lymphangiogram|dynamic contrast enhanced magnetic resonance lymphangiogram
232642|NCT02744027|Magnetic Resonance Imaging|magnetic resonance imaging
232643|NCT02743988|cerebral oxygenation|cerebral oxygenation
232644|NCT02743988|NIRS|nirs
232645|NCT02743988|near-infrared spectroscopy|near-infrared spectroscopy
232646|NCT02743988|bradycardia|bradycardia
232647|NCT02743988|hypoxemia|hypoxemia
232648|NCT02743988|cerebral perfusion|cerebral perfusion
232649|NCT02743988|cardiac output|cardiac output
232650|NCT02743988|apnea|apnea
232651|NCT02743988|desaturation|desaturation
232652|NCT02743988|oxygen saturation target range|oxygen saturation target range
232653|NCT02743949|Drug therapy|drug therapy
232654|NCT02743910|preoperative|preoperative
232655|NCT02743910|neoadjuvant|neoadjuvant
232656|NCT02743910|plasma tumor DNA|plasma tumor dna
232657|NCT02743910|ptDNA|ptdna
232658|NCT02743897|end-stage renal disease|end-stage renal disease
232659|NCT02743871|FIH, Pharmacokinetics, Pharmacodynamics, Safety, Tolerability, Atopic Dermatitis, Chronic Rhinosinusitis, Nasal Polyps|fih, pharmacokinetics, pharmacodynamics, safety, tolerability, atopic dermatitis, chronic rhinosinusitis, nasal polyps
232660|NCT02743858|Lymphedema|lymphedema
232661|NCT02743858|Surveillance Program|surveillance program
232662|NCT02743858|Axillary Lymph Node Dissection|axillary lymph node dissection
232663|NCT02743858|16-220|16-220
232664|NCT02743845|Rare|rare
232665|NCT02743845|Undiagnosed|undiagnosed
232666|NCT02743845|Orphan Disease|orphan disease
232667|NCT02743845|Genomic Sequencing|genomic sequencing
232668|NCT02743832|Surgery, Oral|surgery, oral
232669|NCT02743832|Tumor budding|tumor budding
232670|NCT02743819|Melanoma|melanoma
232671|NCT02743819|Pembrolizumab|pembrolizumab
232672|NCT02743819|Ipilimumab|ipilimumab
232673|NCT02743806|Drug Therapy|drug therapy
232674|NCT02743793|single organ liver or kidney allograft|single organ liver or kidney allograft
232675|NCT02743793|operationally tolerant allograft recipients|operationally tolerant allograft recipients
232676|NCT02743793|longitudinal follow-up|longitudinal follow-up
232677|NCT02743780|Ocular Hypertension|ocular hypertension
232678|NCT02743780|Open-Angle Glaucoma|open-angle glaucoma
232679|NCT02743780|POAG|poag
232680|NCT02743780|Glaucoma|glaucoma
232681|NCT02743767|Airway management|airway management
232682|NCT02743767|General anaesthesia|general anaesthesia
232683|NCT02743767|Critical incidents|critical incidents
232684|NCT02743767|Complications|complications
232685|NCT02743741|Somatostatin Receptor Positive Neuroendocrine Tumors|somatostatin receptor positive neuroendocrine tumors
232686|NCT02743728|perinatal stroke|perinatal stroke
232687|NCT02743728|transcranial magnetic stimulation|transcranial magnetic stimulation
232688|NCT02743728|magnetic resonance imaging|magnetic resonance imaging
232689|NCT02743728|diffusion tensor imaging|diffusion tensor imaging
232690|NCT02743728|non-invasive brain stimulation|non-invasive brain stimulation
232691|NCT02743728|infant|infant
232692|NCT02743715|Obsessive-Compulsive Disorder|obsessive-compulsive disorder
232693|NCT02743715|Transcranial direct current stimulation|transcranial direct current stimulation
232694|NCT02743715|Neuromodulation|neuromodulation
232695|NCT02743702|Effectiveness|effectiveness
232696|NCT02743702|Physical therapy modalities|physical therapy modalities
232697|NCT02743702|neuromuscular diseases|neuromuscular diseases
232698|NCT02743689|Postoperative|postoperative
232699|NCT02743689|Cardiac surgery|cardiac surgery
232700|NCT02743676|Avian Influenza|avian influenza
232701|NCT02743663|pediatric|pediatric
232702|NCT02743663|lung ventilation inhomogeneity|lung ventilation inhomogeneity
232703|NCT02743663|preschool|preschool
232704|NCT02743663|asthma|asthma
232705|NCT02743663|wheeze|wheeze
232706|NCT02743650|Low Serum Bicarbonate Level|low serum bicarbonate level
232707|NCT02743650|Sodium Bicarbonate|sodium bicarbonate
232708|NCT02743637|Cancer|cancer
232709|NCT02743637|Oncology|oncology
232710|NCT02743637|Solid Tumors|solid tumors
232711|NCT02743637|Phase 1|phase 1
232712|NCT02743637|SDX-7320|sdx-7320
232713|NCT02743637|SynDevRx|syndevrx
232714|NCT02743637|MetAP2|metap2
232715|NCT02743637|Breast|breast
232716|NCT02743637|Post menopausal|post menopausal
232717|NCT02743637|Colorectal|colorectal
232718|NCT02743637|Pancreatic|pancreatic
232719|NCT02743637|Ovarian|ovarian
232720|NCT02743637|Endometrial|endometrial
232721|NCT02743637|Esophageal|esophageal
232722|NCT02743637|Lung|lung
232723|NCT02743637|Renal|renal
232724|NCT02743637|Prostate|prostate
232725|NCT02743637|Liver|liver
232726|NCT02743611|BPX-701|bpx-701
232727|NCT02743611|AP1903|ap1903
232728|NCT02743611|rimiducid|rimiducid
232729|NCT02743611|AML|aml
232730|NCT02743611|MDS|mds
232731|NCT02743611|relapsed AML|relapsed aml
232732|NCT02743611|uveal melanoma|uveal melanoma
232733|NCT02743611|PRAME|prame
232734|NCT02743598|HIV infection|hiv infection
232735|NCT02743598|Diabetes Mellitus type 2|diabetes mellitus type 2
232736|NCT02743598|Obesity|obesity
232737|NCT02743598|Neurocognitive function|neurocognitive function
232738|NCT02743572|premature infant|premature infant
232739|NCT02743572|anemia|anemia
232740|NCT02743572|iron-fortification|iron-fortification
232741|NCT02743572|parenteral nutrition|parenteral nutrition
232742|NCT02743572|randomized controlled trial|randomized controlled trial
232743|NCT02743546|B-Cell, Malignancy|b-cell, malignancy
232744|NCT02743546|Lymphoma, Large B-Cell, Diffuse|lymphoma, large b-cell, diffuse
232745|NCT02743546|Lymphoma, Mantle-Cell|lymphoma, mantle-cell
232746|NCT02743546|Lymphoma, Follicular|lymphoma, follicular
297646|NCT02359812|Arm|arm
232747|NCT02743546|Lymphocytic, Chronic, B-Cell|lymphocytic, chronic, b-cell
232748|NCT02743546|JNJ-64052781|jnj-64052781
232749|NCT02743546|Ibrutinib|ibrutinib
232750|NCT02743533|cardiovascular diseases, prognosis|cardiovascular diseases, prognosis
232751|NCT02743520|sleep apnea|sleep apnea
232752|NCT02743481|Pesticide|pesticide
232753|NCT02743481|Agriculture|agriculture
232754|NCT02743481|Cancer|cancer
232755|NCT02743481|Childhood|childhood
232756|NCT02743481|Leukemia|leukemia
232757|NCT02743468|Bronchoscopy|bronchoscopy
232758|NCT02743468|Pollutants|pollutants
232759|NCT02743468|Human Pulmonary Cells|human pulmonary cells
232760|NCT02743468|Macrophage Function|macrophage function
232761|NCT02743468|Soluble Epoxide Hydrolase|soluble epoxide hydrolase
232762|NCT02743455|Fever|fever
232763|NCT02743455|Immunogenicity|immunogenicity
232764|NCT02743455|MVA-BN|mva-bn
232765|NCT02743455|Reactogenicity|reactogenicity
232766|NCT02743455|Vaccine|vaccine
232767|NCT02743455|Yellow|yellow
232768|NCT02743429|ch14.18/CHO|ch14.18/cho
232769|NCT02743429|neuroblastoma|neuroblastoma
232770|NCT02743429|long term infusion|long term infusion
232771|NCT02743416|Screening|screening
232772|NCT02743416|Stroke prevention|stroke prevention
232773|NCT02743416|Cost effectiveness|cost effectiveness
232774|NCT02743390|blood pressure|blood pressure
232775|NCT02743390|inflammation|inflammation
232776|NCT02743390|tumor Necrosis Factor-alpha|tumor necrosis factor-alpha
232777|NCT02743377|GsI+/-|gsi+/-
232778|NCT02743377|Camp|camp
232779|NCT02743377|GNAS|gnas
232780|NCT02743351|Cell Transplants|cell transplants
232781|NCT02743351|Hematopoietic Cell Transplant|hematopoietic cell transplant
232782|NCT02743351|HSCT|hsct
232783|NCT02743351|Hematologic Malignancies|hematologic malignancies
232784|NCT02743351|Hematologic Malignancy|hematologic malignancy
232785|NCT02743351|Acute Myeloid Leukemia|acute myeloid leukemia
232786|NCT02743351|Acute Lymphoblastic Leukemia|acute lymphoblastic leukemia
232787|NCT02743351|ALL|all
232788|NCT02743351|AML|aml
232789|NCT02743351|Myelodysplastic Syndrome|myelodysplastic syndrome
232790|NCT02743351|MDS|mds
232791|NCT02743351|Allogeneic|allogeneic
232792|NCT02743351|CML|cml
232793|NCT02743351|Stem Cell Transplant|stem cell transplant
232794|NCT02743351|Transplant|transplant
232795|NCT02743351|aGvHD|agvhd
232796|NCT02743351|Acute graft-versus-host Disease|acute graft-versus-host disease
232797|NCT02743338|Sleep Restriction|sleep restriction
232798|NCT02743338|Sleep Compression|sleep compression
232799|NCT02743338|Cognitive Behavioral Therapy|cognitive behavioral therapy
232800|NCT02743312|Balance-Based Torso-Weighting|balance-based torso-weighting
232801|NCT02743312|Physical Activity|physical activity
232802|NCT02743312|Neurorehabilitation|neurorehabilitation
232803|NCT02743286|sedentary behavior|sedentary behavior
232804|NCT02743286|sitting|sitting
232805|NCT02743286|feasibility|feasibility
232806|NCT02743286|endothelial function|endothelial function
232807|NCT02743286|metabolism|metabolism
232808|NCT02743260|phenotype|phenotype
232809|NCT02743260|transporter|transporter
232810|NCT02743260|cocktail|cocktail
232811|NCT02743247|Healthy volunteer|healthy volunteer
232812|NCT02743221|metastatic|metastatic
232813|NCT02743221|colorectal|colorectal
232814|NCT02743221|cancer|cancer
232815|NCT02743221|untreated|untreated
232816|NCT02743221|first-line|first-line
232817|NCT02743221|S95005 (Trifluridine/tipiracil)|s95005 (trifluridine/tipiracil)
232818|NCT02743221|bevacizumab|bevacizumab
232819|NCT02743221|capecitabine|capecitabine
232820|NCT02743208|Arthroplasty, Replacement, Hip|arthroplasty, replacement, hip
232821|NCT02743208|Surgical Procedures, Operative|surgical procedures, operative
232822|NCT02743208|Hip Prosthesis|hip prosthesis
232823|NCT02743169|Geographic Information Systems|geographic information systems
232824|NCT02743169|Spatial Analysis|spatial analysis
232825|NCT02743169|Emergency Medical Services|emergency medical services
232826|NCT02743156|IVUS|ivus
232827|NCT02743156|Acute Renal Failure|acute renal failure
232828|NCT02743156|Angioplasty|angioplasty
232829|NCT02743156|stent|stent
232830|NCT02743156|contrast|contrast
232831|NCT02743156|percutaneous coronary intervention|percutaneous coronary intervention
232832|NCT02743156|intravascular ultrasound|intravascular ultrasound
232833|NCT02743143|Exercise therapy|exercise therapy
232834|NCT02743143|Cardiovascular disease|cardiovascular disease
232835|NCT02743143|Risk|risk
232836|NCT02743130|Berries|berries
232837|NCT02743130|Blackcurrant (Ribes nigrum)|blackcurrant (ribes nigrum)
232838|NCT02743130|Lingonberry (Vaccinium vitis-idaea)|lingonberry (vaccinium vitis-idaea)
232839|NCT02743130|Sucrose|sucrose
232840|NCT02743130|Inverted sugar|inverted sugar
232841|NCT02743130|Postprandial glucose response|postprandial glucose response
232842|NCT02743130|Postprandial insulin response|postprandial insulin response
232843|NCT02743117|Trivalent|trivalent
232844|NCT02743117|Influenza|influenza
232845|NCT02743117|FluMist Quadrivalent|flumist quadrivalent
232846|NCT02743117|Vaccine|vaccine
232847|NCT02743117|Prevention|prevention
232848|NCT02743117|Healthy|healthy
232849|NCT02743117|Monovalent|monovalent
232850|NCT02743091|heart failure|heart failure
232851|NCT02743091|survival|survival
232852|NCT02743091|end-stage kidney disease|end-stage kidney disease
232853|NCT02743078|Glioblastoma|glioblastoma
232854|NCT02743078|Glioma|glioma
232855|NCT02743078|Gliosarcoma|gliosarcoma
232856|NCT02743078|Optune|optune
232857|NCT02743078|TTFields|ttfields
232858|NCT02743065|HepaSphere|hepasphere
232859|NCT02743039|Low income|low income
232860|NCT02743039|Education|education
232861|NCT02743039|Poverty|poverty
232862|NCT02743039|Children|children
232863|NCT02743039|Parents|parents
232864|NCT02743039|Head Start|head start
232865|NCT02743000|fMRI|fmri
232866|NCT02743000|emotion conflict task|emotion conflict task
232867|NCT02743000|monetary incentive delay|monetary incentive delay
232868|NCT02742974|Trauma|trauma
232869|NCT02742974|Minimally Invasive Hemodynamic Monitoring|minimally invasive hemodynamic monitoring
232870|NCT02742974|Perioperative|perioperative
232871|NCT02742974|Complications|complications
232872|NCT02742974|Hemodynamics|hemodynamics
232873|NCT02742974|Operative procedures|operative procedures
232874|NCT02742961|orthopedics|orthopedics
232875|NCT02742961|anesthesiology|anesthesiology
232876|NCT02742961|nerve block|nerve block
232877|NCT02742961|length of stay|length of stay
232878|NCT02742961|Patient readmission|patient readmission
232879|NCT02742948|elective caesarean section|elective caesarean section
232880|NCT02742948|antibiotics|antibiotics
232881|NCT02742948|endometritis|endometritis
232882|NCT02742922|self harm|self harm
232883|NCT02742922|culturally adapted therapy|culturally adapted therapy
232884|NCT02742922|problem solving therapy|problem solving therapy
232885|NCT02742922|low and middle income countries|low and middle income countries
232886|NCT02742896|Erectile dysfunction|erectile dysfunction
232887|NCT02742896|cognitive function|cognitive function
232888|NCT02742870|Diffusion MRI|diffusion mri
232889|NCT02742870|ADC histograms|adc histograms
232890|NCT02742870|Adnexal tumor|adnexal tumor
232891|NCT02742844|phase I/IIa|phase i/iia
232892|NCT02742844|mesenchymal stem cells|mesenchymal stem cells
232893|NCT02742844|ABCB5+|abcb5+
232894|NCT02742844|APZ2|apz2
232895|NCT02742844|chronic venous ulcer|chronic venous ulcer
232896|NCT02742844|varicose ulcer|varicose ulcer
232897|NCT02742844|skin ulcer|skin ulcer
232898|NCT02742844|advanced therapy medicinal product|advanced therapy medicinal product
232899|NCT02742844|APZ2-II-01|apz2-ii-01
232900|NCT02742844|autologous use|autologous use
232901|NCT02742844|somatic cell therapy|somatic cell therapy
232902|NCT02742818|forced-air warming|forced-air warming
232903|NCT02742818|hypothermia|hypothermia
232904|NCT02742818|endovascular surgery|endovascular surgery
232905|NCT02742818|blanket|blanket
232906|NCT02742805|hives|hives
232907|NCT02742792|sleep apnea|sleep apnea
232908|NCT02742792|elderly|elderly
232909|NCT02742792|exercise|exercise
232910|NCT02742766|Dose escalation study|dose escalation study
232911|NCT02742766|Safety|safety
232912|NCT02742766|Pharmacodynamics|pharmacodynamics
232913|NCT02742766|Pharmacokinetics|pharmacokinetics
232914|NCT02742766|GSK3008356|gsk3008356
232915|NCT02742766|Tolerability|tolerability
232916|NCT02742753|Otitis|otitis
232917|NCT02742753|Vaccine|vaccine
232918|NCT02742753|Sweden|sweden
232919|NCT02742753|Database|database
232920|NCT02742675|prostate cancer|prostate cancer
232921|NCT02742675|androgen deprivation therapy|androgen deprivation therapy
232922|NCT02742675|local treatment|local treatment
232923|NCT02742662|Obesity|obesity
232924|NCT02742662|Overweight|overweight
232925|NCT02742662|Prediabetes|prediabetes
232926|NCT02742662|Smartphone application|smartphone application
232927|NCT02742662|Technology|technology
232928|NCT02742662|Weight Loss|weight loss
232929|NCT02742662|Lifestyle Intervention|lifestyle intervention
232930|NCT02742623|Cancer|cancer
232931|NCT02742623|Deep Venous Thrombosis|deep venous thrombosis
232932|NCT02742623|Pulmonary Embolism|pulmonary embolism
232933|NCT02742584|cough stress test|cough stress test
232934|NCT02742584|urodynamics|urodynamics
232935|NCT02742584|pad test|pad test
232936|NCT02742571|Biological evaluation of denutrition|biological evaluation of denutrition
232937|NCT02742571|Denutrition|denutrition
232938|NCT02742571|PINI score|pini score
232939|NCT02742558|cholera vaccine|cholera vaccine
232940|NCT02742558|randomized trial|randomized trial
232941|NCT02742558|immunogenicity|immunogenicity
232942|NCT02742506|Brain-damaged|brain-damaged
232943|NCT02742506|Disorders of consciousness|disorders of consciousness
232944|NCT02742506|Post-coma|post-coma
232945|NCT02742506|consciousness|consciousness
232946|NCT02742506|coma|coma
232947|NCT02742506|vegetative state|vegetative state
232948|NCT02742506|minimally conscious state|minimally conscious state
232949|NCT02742506|music|music
232950|NCT02742506|P300|p300
232951|NCT02742493|relapse|relapse
232952|NCT02742493|irregularity|irregularity
232953|NCT02742493|recession|recession
232954|NCT02742493|retention|retention
232955|NCT02742480|stroke|stroke
232956|NCT02742480|oral anticoagulants|oral anticoagulants
232957|NCT02742480|cardioembolic|cardioembolic
232958|NCT02742454|Umbilical Cord Clamping|umbilical cord clamping
232959|NCT02742454|Intraventricular Hemorrhage|intraventricular hemorrhage
232960|NCT02742454|Extremely Preterm Infants|extremely preterm infants
232961|NCT02742337|Epigenetic|epigenetic
232962|NCT02742324|efficacy|efficacy
232963|NCT02742324|safety|safety
233159|NCT02740686|COPD|copd
232964|NCT02742298|Neuromuscular Ultrasound|neuromuscular ultrasound
232965|NCT02742298|Electrical Impedance Myography|electrical impedance myography
232966|NCT02742285|antimalarials|antimalarials
232967|NCT02742285|blood samples|blood samples
232968|NCT02742285|drug concentrations|drug concentrations
232969|NCT02742285|pharmacokinetics|pharmacokinetics
232970|NCT02742285|lumefantrine|lumefantrine
232971|NCT02742285|healthy volunteers|healthy volunteers
232972|NCT02742233|Diabetes|diabetes
232973|NCT02742233|Wound Healing|wound healing
232974|NCT02742233|Dipeptidyl Peptidase 4 Inhibition|dipeptidyl peptidase 4 inhibition
232975|NCT02742220|intermittent claudication|intermittent claudication
232976|NCT02742220|exercise|exercise
232977|NCT02742220|blood pressure|blood pressure
232978|NCT02742220|cardiovascular system|cardiovascular system
232979|NCT02742194|ginger obesity|ginger obesity
232980|NCT02742194|ginger inflammation|ginger inflammation
232981|NCT02742194|treatment of obesity|treatment of obesity
232982|NCT02742155|Family Research|family research
232983|NCT02742116|Expanded carrier screening|expanded carrier screening
232984|NCT02742090|CLL|cll
232985|NCT02742025|Coronary Angiography|coronary angiography
232986|NCT02742012|electroencephalogram|electroencephalogram
232987|NCT02742012|hemodynamic monitoring|hemodynamic monitoring
232988|NCT02742012|respiratory monitoring|respiratory monitoring
232989|NCT02741986|risk assessment|risk assessment
232990|NCT02741986|sepsis|sepsis
232991|NCT02741986|acute kidney injury (AKI)|acute kidney injury (aki)
232992|NCT02741973|Yoga|yoga
232993|NCT02741973|Stress|stress
232994|NCT02741973|Adolescents|adolescents
232995|NCT02741973|School|school
232996|NCT02741973|Children|children
232997|NCT02741960|metformin|metformin
232998|NCT02741960|systemic lupus erythematosus|systemic lupus erythematosus
232999|NCT02741947|Parkinson|parkinson
233000|NCT02741947|Therapeutic Equivalence|therapeutic equivalence
233001|NCT02741947|Levodopa|levodopa
233002|NCT02741895|Biosensing Techniques|biosensing techniques
233003|NCT02741895|Patient Readmission|patient readmission
233004|NCT02741882|Microcephaly|microcephaly
233005|NCT02741882|zika Virus|zika virus
233006|NCT02741882|Case-control study|case-control study
233007|NCT02741869|Staphylococcus aureus; nare carriage|staphylococcus aureus; nare carriage
233008|NCT02741804|Memory|memory
233009|NCT02741791|AXS-05|axs-05
233010|NCT02741791|Major Depressive Disorder|major depressive disorder
233011|NCT02741791|Treatment Resistant Depression|treatment resistant depression
233012|NCT02741791|TRD|trd
233013|NCT02741791|MDD|mdd
233014|NCT02741791|Axsome|axsome
233015|NCT02741791|NMDA receptor|nmda receptor
233016|NCT02741791|Refractory depression|refractory depression
233017|NCT02741791|Resistant depression|resistant depression
233018|NCT02741791|Depression|depression
233019|NCT02741778|Esophagogastric Junction|esophagogastric junction
233020|NCT02741778|Adenocarcinoma|adenocarcinoma
233021|NCT02741778|Cardia|cardia
233022|NCT02741765|Transcranial Magnetic Stimulation|transcranial magnetic stimulation
233023|NCT02741765|Exercise|exercise
233024|NCT02741765|Brain Plasticity|brain plasticity
233025|NCT02741752|histomorphometry|histomorphometry
233026|NCT02741739|Drug concentration|drug concentration
233027|NCT02741739|REGN1033|regn1033
233028|NCT02741739|blood|blood
233029|NCT02741700|Adherence|adherence
233030|NCT02741700|Disparities|disparities
233031|NCT02741700|Patient Outcomes|patient outcomes
233032|NCT02741687|stress hyperglycemia|stress hyperglycemia
233033|NCT02741687|blood glucose|blood glucose
233034|NCT02741674|Observational Study|observational study
233035|NCT02741674|Comparative Effectiveness Research|comparative effectiveness research
233036|NCT02741648|Red Blood Cell Transfusion|red blood cell transfusion
233037|NCT02741648|Digestive tract problems|digestive tract problems
233038|NCT02741648|Extremely Low Birth Weight|extremely low birth weight
233039|NCT02741622|Exercise therapy|exercise therapy
233040|NCT02741609|Borrelia|borrelia
233041|NCT02741609|spirochetes|spirochetes
233042|NCT02741609|culture|culture
233043|NCT02741609|immunostaining|immunostaining
233044|NCT02741596|DX-2930(SHP643)|dx-2930(shp643)
233045|NCT02741596|Dyax|dyax
233046|NCT02741596|Hereditary Angioedema|hereditary angioedema
233047|NCT02741557|Fixed-dose Combination (FDC)|fixed-dose combination (fdc)
233048|NCT02741557|Bioequivalence|bioequivalence
233049|NCT02741557|Dolutegravir|dolutegravir
233050|NCT02741557|Rilpivirine|rilpivirine
233051|NCT02741544|Second primary cancers|second primary cancers
233052|NCT02741544|Cataracts|cataracts
233053|NCT02741544|Newly-diagnosed multiple myeloma|newly-diagnosed multiple myeloma
233054|NCT02741544|Revlimid capsules|revlimid capsules
233055|NCT02741518|obesity|obesity
233056|NCT02741518|FMT|fmt
233057|NCT02741505|cerebrospinal fluid (CSF)|cerebrospinal fluid (csf)
233058|NCT02741505|sleep|sleep
233059|NCT02741505|Obstructive Sleep Apnea (OSA)|obstructive sleep apnea (osa)
233060|NCT02741505|Sleep Disordered Breathing (SDB)|sleep disordered breathing (sdb)
233061|NCT02741505|Period Limb Movement during Sleep (PLMS)|period limb movement during sleep (plms)
233062|NCT02741479|dancers|dancers
233160|NCT02740686|Exercise|exercise
233063|NCT02741440|Spinocerebellar Ataxia|spinocerebellar ataxia
233064|NCT02741427|Tooth discoloration|tooth discoloration
233065|NCT02741427|Toothpaste|toothpaste
233066|NCT02741427|Tooth bleaching|tooth bleaching
233067|NCT02741427|Clinical trial|clinical trial
233068|NCT02741414|Helicobacter pylori|helicobacter pylori
233069|NCT02741414|Antibiotic resistance|antibiotic resistance
233070|NCT02741414|Sequencing|sequencing
233071|NCT02741414|Mechanism|mechanism
233072|NCT02741401|Complementary therapies|complementary therapies
233073|NCT02741401|Massage|massage
233074|NCT02741401|Gastrointestinal cancer|gastrointestinal cancer
233075|NCT02741388|selinexor|selinexor
233076|NCT02741388|lymphoma|lymphoma
233077|NCT02741388|inhibitor of nuclear export|inhibitor of nuclear export
233078|NCT02741362|Type III hypersensitivity autoimmune disease|type iii hypersensitivity autoimmune disease
233079|NCT02741349|Atrial fibrillation|atrial fibrillation
233080|NCT02741349|Risk score|risk score
233081|NCT02741323|HIV-infected with end-stage kidney disease|hiv-infected with end-stage kidney disease
233082|NCT02741297|Spinal Cord Stimulation|spinal cord stimulation
233083|NCT02741297|Chronic Pain|chronic pain
233084|NCT02741232|analgesics, opioids|analgesics, opioids
233085|NCT02741232|pectoral block|pectoral block
233086|NCT02741206|psycho-education|psycho-education
233087|NCT02741206|maternal depression|maternal depression
233088|NCT02741206|Reach Out Stay Strong Essentials|reach out stay strong essentials
233089|NCT02741193|Transcranial magnet stimulation (nTMS)|transcranial magnet stimulation (ntms)
233090|NCT02741193|Brainsight Neuronavigation|brainsight neuronavigation
233091|NCT02741193|Electromyography|electromyography
233092|NCT02741193|EMG|emg
233093|NCT02741167|peritoneal surface malignancies|peritoneal surface malignancies
233094|NCT02741167|cytoreductive surgery|cytoreductive surgery
233095|NCT02741167|hyperthermic intraperitoneal chemotherapy|hyperthermic intraperitoneal chemotherapy
233096|NCT02741154|aromataze inhibitor, poor responder ,induction|aromataze inhibitor, poor responder ,induction
233097|NCT02741128|Dengue Fever|dengue fever
233098|NCT02741128|Dengue Hemorrhagic Fever|dengue hemorrhagic fever
233099|NCT02741128|Human Immunodeficiency Virus|human immunodeficiency virus
233100|NCT02741128|CYD Dengue Vaccine|cyd dengue vaccine
233101|NCT02741115|Fontan|fontan
233102|NCT02741115|Maximal Oxygen Consumption|maximal oxygen consumption
233103|NCT02741115|Vascular Function|vascular function
233104|NCT02741115|EndoPAT|endopat
233105|NCT02741115|Myocardial Performance|myocardial performance
233106|NCT02741102|Infertility|infertility
233107|NCT02741102|AUFI|aufi
233108|NCT02741089|Analgosedation|analgosedation
233109|NCT02741089|Internal Quality Assurance|internal quality assurance
233110|NCT02741063|oxytocin|oxytocin
233111|NCT02741063|attentional bias|attentional bias
233112|NCT02741063|Autism|autism
233113|NCT02741011|Cone-Beam Computed Tomography|cone-beam computed tomography
233114|NCT02741011|Mentally Handicapped|mentally handicapped
233115|NCT02740998|Microbiome|microbiome
233116|NCT02740998|Progestin|progestin
233117|NCT02740998|Long-acting contraception|long-acting contraception
233118|NCT02740985|AZD4635|azd4635
233119|NCT02740985|durvalumab|durvalumab
233120|NCT02740985|oleclumab|oleclumab
233121|NCT02740985|docetaxel|docetaxel
233122|NCT02740985|non-small cell lung cancer|non-small cell lung cancer
233123|NCT02740985|advanced solid malignancies|advanced solid malignancies
233124|NCT02740985|prostate cancer|prostate cancer
233125|NCT02740985|colorectal cancer|colorectal cancer
233126|NCT02740985|abiraterone acetate|abiraterone acetate
233127|NCT02740985|enzalutamide|enzalutamide
233128|NCT02740933|Brain Tumor Surgery|brain tumor surgery
233129|NCT02740868|Magnetic Resonance Imaging,cystic fibrosis,asthma,healthy|magnetic resonance imaging,cystic fibrosis,asthma,healthy
233130|NCT02740855|sclerotherapy|sclerotherapy
233131|NCT02740855|ethanol|ethanol
233132|NCT02740855|pulmonal hypertension|pulmonal hypertension
233133|NCT02740790|Human papillomavirus|human papillomavirus
233134|NCT02740790|vaccine|vaccine
233135|NCT02740790|cervical infection|cervical infection
233136|NCT02740790|cervical cancer|cervical cancer
233137|NCT02740764|Functional autonomy level|functional autonomy level
233138|NCT02740764|Lawton Instrumental Activities of Daily Living|lawton instrumental activities of daily living
233139|NCT02740764|Cognitive disorders|cognitive disorders
233140|NCT02740764|Potentially inappropriate medication|potentially inappropriate medication
233141|NCT02740764|elderly|elderly
233142|NCT02740764|Optimization of drug prescribing|optimization of drug prescribing
233143|NCT02740738|Knee Arthroplasty|knee arthroplasty
233144|NCT02740738|Hip Arthroplasty|hip arthroplasty
233145|NCT02740725|Amblyopia|amblyopia
233146|NCT02740725|Interaction Binocular Treatment (I-BiTTM)|interaction binocular treatment (i-bittm)
233147|NCT02740725|Patch Therapy|patch therapy
233148|NCT02740712|rucaparib|rucaparib
233149|NCT02740712|CO-338|co-338
233150|NCT02740712|Clovis|clovis
233151|NCT02740712|Clovis Oncology|clovis oncology
233152|NCT02740712|PARP Inhibitor|parp inhibitor
233153|NCT02740712|Drug-Drug Interaction|drug-drug interaction
233154|NCT02740699|Cholesterol|cholesterol
233155|NCT02740699|Heart Disease|heart disease
233156|NCT02740699|CT Scan|ct scan
233157|NCT02740699|Crestor|crestor
233158|NCT02740699|Lipitor|lipitor
233161|NCT02740686|Immunity|immunity
233162|NCT02740686|Inflammation|inflammation
233163|NCT02740686|Biomarkers|biomarkers
233164|NCT02740660|Albuterol|albuterol
233165|NCT02740660|Caffeine|caffeine
233166|NCT02740660|Lean Body Mass|lean body mass
233167|NCT02740660|Fat Mass|fat mass
233169|NCT02740634|LPA|lpa
233170|NCT02740595|nicotine|nicotine
233171|NCT02740595|endothelial function|endothelial function
233172|NCT02740595|oxidative stress|oxidative stress
233173|NCT02740569|scleroderma|scleroderma
233174|NCT02740569|sleep apnea|sleep apnea
233175|NCT02740569|pulmonary disease|pulmonary disease
233176|NCT02740556|Hepatitis C|hepatitis c
233177|NCT02740556|Adherence|adherence
233178|NCT02740556|Adheretech|adheretech
233179|NCT02740556|HepCure|hepcure
233180|NCT02740556|Telehealth|telehealth
233181|NCT02740556|Health apps|health apps
233182|NCT02740543|World Trade Center|world trade center
233183|NCT02740543|WTC|wtc
233184|NCT02740543|Induced Sputum|induced sputum
233185|NCT02740543|Exhaled Breath Condensate|exhaled breath condensate
233186|NCT02740504|Respiration rate|respiration rate
233187|NCT02740465|ACE|ace
233188|NCT02740465|Anxiety|anxiety
233189|NCT02740465|COPD|copd
233190|NCT02740452|Rupture|rupture
233191|NCT02740452|Anterior Cruciate Ligament (ACL)|anterior cruciate ligament (acl)
233192|NCT02740452|Laxity knee|laxity knee
233193|NCT02740452|Instability knee|instability knee
233194|NCT02740400|Endobronchial ultrasonography|endobronchial ultrasonography
233195|NCT02740400|guided sheath|guided sheath
233196|NCT02740400|diagnosis|diagnosis
233197|NCT02740400|accuracy|accuracy
233198|NCT02740400|complication|complication
233199|NCT02740374|ROTEM|rotem
233200|NCT02740374|Thromboelastometry|thromboelastometry
233201|NCT02740374|spine surgery|spine surgery
233202|NCT02740374|allogenic blood transfusion|allogenic blood transfusion
233203|NCT02740374|blood loss|blood loss
233204|NCT02740374|red blood cell transfusion|red blood cell transfusion
233205|NCT02740335|anticoagulant reversal|anticoagulant reversal
233206|NCT02740335|urgent surgery|urgent surgery
233207|NCT02740335|invasive procedures|invasive procedures
233208|NCT02740335|vitamin K|vitamin k
233209|NCT02740335|prothrombin complex concentrate|prothrombin complex concentrate
233210|NCT02740335|four-factor prothrombin complex concentrate (4F-PCC)|four-factor prothrombin complex concentrate (4f-pcc)
233211|NCT02740322|Hum Test, Weber test, audiogram|hum test, weber test, audiogram
233212|NCT02740309|inflammatory bowel disease|inflammatory bowel disease
233213|NCT02740309|childhood chronic disease|childhood chronic disease
233214|NCT02740309|adolescent depression|adolescent depression
233215|NCT02740309|adolescent anxiety|adolescent anxiety
233216|NCT02740309|integrated brief behavioral therapy|integrated brief behavioral therapy
233217|NCT02740309|adolescent psychosocial risks|adolescent psychosocial risks
233218|NCT02740309|adolescent chronic disease|adolescent chronic disease
233219|NCT02740309|childhood depression|childhood depression
233220|NCT02740309|childhood anxiety|childhood anxiety
233221|NCT02740309|childhood psychosocial risks|childhood psychosocial risks
233222|NCT02740283|Gestational Diabetes Mellitus|gestational diabetes mellitus
233223|NCT02740283|Oral Glucose Tolerance Test|oral glucose tolerance test
233224|NCT02740270|advanced solid tumors|advanced solid tumors
233225|NCT02740270|lymphomas|lymphomas
233226|NCT02740270|GWN323|gwn323
233227|NCT02740270|PDR001|pdr001
233228|NCT02740270|advanced malignancies|advanced malignancies
233229|NCT02740270|anti-GITR|anti-gitr
233230|NCT02740270|anti-PD-1|anti-pd-1
233231|NCT02740270|adults|adults
233232|NCT02740231|viscosupplement|viscosupplement
233233|NCT02740231|osteoarthritis|osteoarthritis
233234|NCT02740231|knee|knee
233235|NCT02740231|intra-articular injection|intra-articular injection
233236|NCT02740231|arthritis|arthritis
233237|NCT02740231|degenerative|degenerative
233238|NCT02740218|Psoriasis|psoriasis
233239|NCT02740218|Apremilast|apremilast
233240|NCT02740218|APPRECIATE|appreciate
233241|NCT02740218|Dermatology|dermatology
233242|NCT02740218|Retrospective|retrospective
233243|NCT02740218|Observational|observational
233244|NCT02740205|Patients with Enteral Feeding|patients with enteral feeding
233245|NCT02740179|Eplerenone|eplerenone
233246|NCT02740179|Cardiovascular Disease|cardiovascular disease
728338|NCT00515320|adolescent|adolescent
233247|NCT02740179|Mineralocorticoid Receptor Antagonist|mineralocorticoid receptor antagonist
233248|NCT02740179|Coronary Vasculature|coronary vasculature
233249|NCT02740179|Myocardial Inflammation|myocardial inflammation
233250|NCT02740179|Myocardial Fibrosis|myocardial fibrosis
233251|NCT02740179|Atherosclerosis|atherosclerosis
233252|NCT02740179|Aldosterone|aldosterone
233253|NCT02740166|Esophageal Varices; propranolol; banding ligation|esophageal varices; propranolol; banding ligation
233254|NCT02740140|chronic coinfection|chronic coinfection
233255|NCT02740127|Malignant neoplasms of male genital organs|malignant neoplasms of male genital organs
233256|NCT02740127|Adult Penile Prosthesis Surgery|adult penile prosthesis surgery
233257|NCT02740127|Caudal nerve block|caudal nerve block
233258|NCT02740127|CNB|cnb
233259|NCT02740127|General anesthesia|general anesthesia
233260|NCT02740127|GA|ga
233261|NCT02740127|Ropivacaine|ropivacaine
233262|NCT02740127|Naropin|naropin
233263|NCT02740127|Epinephrine|epinephrine
233264|NCT02740127|Decadron|decadron
233265|NCT02740127|Dexamethasone|dexamethasone
233266|NCT02740127|Clonidine|clonidine
233267|NCT02740127|Propofol|propofol
233268|NCT02740127|Diprivan|diprivan
233269|NCT02740114|Malignant neoplasms of female genital organs|malignant neoplasms of female genital organs
233270|NCT02740114|Open gynecologic surgery|open gynecologic surgery
233271|NCT02740114|Local wound infiltration|local wound infiltration
233272|NCT02740114|Gynecologic cancer|gynecologic cancer
233273|NCT02740114|Bupivacaine|bupivacaine
233274|NCT02740114|Liposomal Bupivacaine|liposomal bupivacaine
233275|NCT02740114|Oxycodone|oxycodone
233276|NCT02740114|ETH-Oxydose [DSC]|eth-oxydose [dsc]
233277|NCT02740114|OxyContin|oxycontin
233278|NCT02740114|OxyIR|oxyir
233279|NCT02740114|Roxicodone|roxicodone
233280|NCT02740114|Questionnaires|questionnaires
233281|NCT02740114|Surveys|surveys
233282|NCT02740114|MD Anderson Symptom Inventory|md anderson symptom inventory
233283|NCT02740114|MDASI|mdasi
233284|NCT02740114|Pill diary|pill diary
233285|NCT02740114|Medication log|medication log
233286|NCT02740101|oxytocin|oxytocin
233287|NCT02740101|social reward|social reward
233288|NCT02740101|social punishment|social punishment
233289|NCT02740075|Mechanical versus hand ventilation|mechanical versus hand ventilation
233290|NCT02740075|Transport ventilation|transport ventilation
233291|NCT02740049|Epithelial Cells|epithelial cells
233292|NCT02740010|MIOL|miol
233293|NCT02740010|extended depth of focus|extended depth of focus
233294|NCT02740010|cataract|cataract
233295|NCT02740010|visual acuity|visual acuity
233296|NCT02740010|halos|halos
233297|NCT02739984|diabetes|diabetes
233298|NCT02739984|type 2 diabetes|type 2 diabetes
233299|NCT02739984|high blood cholesterol|high blood cholesterol
233300|NCT02739984|hypercholesterolemia|hypercholesterolemia
233301|NCT02739984|mixed dyslipidemia|mixed dyslipidemia
233302|NCT02739984|high cholesterol|high cholesterol
233303|NCT02739984|statin intolerant|statin intolerant
233304|NCT02739945|Ulnar Nerve Compression, Cubital Tunnel|ulnar nerve compression, cubital tunnel
233305|NCT02739932|Attenuated Psychotic Symptoms|attenuated psychotic symptoms
233306|NCT02739919|Kidney stones|kidney stones
233307|NCT02739919|Renal Calculi|renal calculi
233308|NCT02739880|Vaginal discomfort|vaginal discomfort
233309|NCT02739880|Vaginal dryness|vaginal dryness
233310|NCT02739867|occult cancer|occult cancer
233311|NCT02739867|venous thromboembolism|venous thromboembolism
233312|NCT02739867|tumor-educated platelets|tumor-educated platelets
233313|NCT02739867|platelet RNA profiling|platelet rna profiling
233314|NCT02739867|early diagnosis|early diagnosis
233315|NCT02739867|screening|screening
233316|NCT02739854|trauma|trauma
233317|NCT02739854|atelectasis|atelectasis
233318|NCT02739841|hemodynamic response|hemodynamic response
233319|NCT02739828|Quality of life|quality of life
233320|NCT02739815|Caesarean Section|caesarean section
233321|NCT02739815|Tranexamic Acid|tranexamic acid
233322|NCT02739815|Postpartum Hemorrhage|postpartum hemorrhage
233323|NCT02739815|Ecbolics|ecbolics
233324|NCT02739789|tDCS rejection affect mood fMRI|tdcs rejection affect mood fmri
233325|NCT02739763|PfSPZ|pfspz
233326|NCT02739763|Semi-immune adults|semi-immune adults
233327|NCT02739763|Kenya|kenya
233328|NCT02739763|challenge|challenge
233329|NCT02739763|CHMI|chmi
233330|NCT02739763|malaria|malaria
233331|NCT02739737|Bias|bias
233332|NCT02739737|Orthopedics|orthopedics
233333|NCT02739737|Peer Review|peer review
233334|NCT02739698|ovarian cancer|ovarian cancer
233335|NCT02739659|prostate carcinoma|prostate carcinoma
233336|NCT02739659|carbon-ion radiotherapy|carbon-ion radiotherapy
233337|NCT02739659|efficacy|efficacy
233338|NCT02739659|toxicity|toxicity
233339|NCT02739633|Chemotherapy|chemotherapy
233340|NCT02739633|Gemcitabine|gemcitabine
233341|NCT02739633|Recurrent and metastatic adenocarcinoma of the pancreas|recurrent and metastatic adenocarcinoma of the pancreas
233342|NCT02739633|Genexol-PM|genexol-pm
233343|NCT02739633|Paclitaxel|paclitaxel
233344|NCT02739607|emotional disorders|emotional disorders
233345|NCT02739607|internet-delivered intervention|internet-delivered intervention
233346|NCT02739607|anxiety|anxiety
233347|NCT02739607|depression|depression
233348|NCT02739607|transdiagnostic|transdiagnostic
233349|NCT02739568|EDS|eds
233350|NCT02739568|OSA|osa
233351|NCT02739555|Osteoid osteoma|osteoid osteoma
233352|NCT02739555|Bisphophonates|bisphophonates
233353|NCT02739542|Radiologically Isolated Syndrome (RIS)|radiologically isolated syndrome (ris)
233354|NCT02739490|physiotherapeutic techniques|physiotherapeutic techniques
233355|NCT02739490|pelvis|pelvis
233356|NCT02739490|Muscle strength|muscle strength
233357|NCT02739477|Favipiravir|favipiravir
233358|NCT02739477|Tolerance|tolerance
233359|NCT02739477|Survivor|survivor
233360|NCT02739477|Ebola Virus|ebola virus
233361|NCT02739477|Genital reservoir|genital reservoir
233362|NCT02739477|Guinea|guinea
233363|NCT02739464|Burn|burn
233364|NCT02739464|Exercise|exercise
233365|NCT02739464|Ergometer|ergometer
233366|NCT02739464|MP-10|mp-10
233367|NCT02739451|immunocompromized patients|immunocompromized patients
233368|NCT02739451|critically ill patients|critically ill patients
233369|NCT02739438|Pulmonary inflammation|pulmonary inflammation
233370|NCT02739438|Endothelial dysfunction|endothelial dysfunction
233371|NCT02739438|Electronic Cigarettes|electronic cigarettes
233372|NCT02739425|Sentinel lymph node biopsy (SLNB)|sentinel lymph node biopsy (slnb)
233373|NCT02739425|Superparamagnetic iron oxide (SPIO) tracer|superparamagnetic iron oxide (spio) tracer
233374|NCT02739399|phenylephrine|phenylephrine
233375|NCT02739399|alpha mimetics|alpha mimetics
233376|NCT02739399|pulse pressure variation|pulse pressure variation
233377|NCT02739399|venous return|venous return
233378|NCT02739347|tDCS|tdcs
233379|NCT02739347|cognitive control|cognitive control
233380|NCT02739347|working memory|working memory
233381|NCT02739347|EEG|eeg
233382|NCT02739347|gamma oscillations|gamma oscillations
233383|NCT02739321|Autism|autism
233384|NCT02739321|ASD|asd
233385|NCT02739321|Sleep|sleep
233386|NCT02739321|Mattress|mattress
233387|NCT02739308|proprioception|proprioception
233388|NCT02739308|ankle sprain|ankle sprain
233389|NCT02739308|fencing|fencing
233390|NCT02739269|ovarian response|ovarian response
233391|NCT02739269|anti-Mullerian hormone|anti-mullerian hormone
233392|NCT02739269|antral follicle count|antral follicle count
233393|NCT02739256|voiding trial|voiding trial
233394|NCT02739256|pelvic organ prolapse|pelvic organ prolapse
233395|NCT02739256|post-operative catheterization|post-operative catheterization
233396|NCT02739204|Celecoxib|celecoxib
233397|NCT02739204|Relapse-free OSCC patient|relapse-free oscc patient
233398|NCT02739204|Recurrence|recurrence
233399|NCT02739204|Survival|survival
233400|NCT02739204|Prognosis|prognosis
233401|NCT02739191|NPWT|npwt
233402|NCT02739165|Acute exacerbations|acute exacerbations
233403|NCT02739165|Idiopathic pulmonary fibrosis|idiopathic pulmonary fibrosis
233404|NCT02739165|Recombinant human soluble thrombomodulin|recombinant human soluble thrombomodulin
233405|NCT02739165|ART-123|art-123
233406|NCT02739152|Sepsis|sepsis
233407|NCT02739152|Severe sepsis|severe sepsis
233408|NCT02739152|Infections|infections
233409|NCT02739152|Worsening|worsening
233410|NCT02739126|Diagnosis|diagnosis
233411|NCT02739100|pharmacokinetics|pharmacokinetics
233412|NCT02739100|bioequivalence|bioequivalence
233413|NCT02739087|radiation free cardiac catheterization|radiation free cardiac catheterization
233414|NCT02739061|pathogenesis|pathogenesis
233415|NCT02739061|cognitive behavioral group therapy|cognitive behavioral group therapy
233416|NCT02738996|Diabetes|diabetes
233417|NCT02738996|Sedentary Lifestyle|sedentary lifestyle
233418|NCT02738983|Non-small cell lung cancer|non-small cell lung cancer
233419|NCT02738983|epidermal growth factor receptor tyrosine kinase inhibitor (EGFR-TKI)|epidermal growth factor receptor tyrosine kinase inhibitor (egfr-tki)
233420|NCT02738983|Radiotherapy|radiotherapy
233421|NCT02738983|wild type|wild type
233422|NCT02738931|dolutegravir|dolutegravir
233423|NCT02738931|lamivudine|lamivudine
233424|NCT02738931|Bioavailability|bioavailability
233425|NCT02738931|fixed dose combinations|fixed dose combinations
233426|NCT02738918|Renal Transplant|renal transplant
233427|NCT02738918|Anti HLA antibodies|anti hla antibodies
233428|NCT02738918|Humoral rejection|humoral rejection
233429|NCT02738892|Pregnancy|pregnancy
233430|NCT02738892|Stillbirth|stillbirth
233431|NCT02738892|Preterm birth|preterm birth
233432|NCT02738866|breast cancer|breast cancer
233433|NCT02738866|Metastatic Breast Cancer|metastatic breast cancer
233434|NCT02738866|palbociclib|palbociclib
233435|NCT02738866|fulvestrant|fulvestrant
233436|NCT02738814|emergence agitation|emergence agitation
233437|NCT02738814|emergence delirium|emergence delirium
233438|NCT02738814|PAED scale|paed scale
233439|NCT02738814|The Modified Aldrete Scoring System|the modified aldrete scoring system
233440|NCT02738814|treatment|treatment
233441|NCT02738814|pediatric|pediatric
233442|NCT02738814|sevoflurane|sevoflurane
233443|NCT02738801|Idiopathic Pulmonary Fibrosis|idiopathic pulmonary fibrosis
233444|NCT02738801|GLPG1690|glpg1690
233445|NCT02738801|Autotaxin|autotaxin
233446|NCT02738788|airway|airway
233447|NCT02738788|airway changes|airway changes
233448|NCT02738788|MMS|mms
233449|NCT02738788|prone position|prone position
233450|NCT02738788|Trendelenburg position|trendelenburg position
233451|NCT02738775|multiple sclerosis|multiple sclerosis
233452|NCT02738762|intensive care|intensive care
233453|NCT02738762|glutamine|glutamine
233454|NCT02738762|length of stay|length of stay
233455|NCT02738749|sudden cardiac death, sodium channel splicing variant|sudden cardiac death, sodium channel splicing variant
233456|NCT02738723|Limited-stage small cell lung cancer|limited-stage small cell lung cancer
233457|NCT02738723|Stereotactic body radiation therapy|stereotactic body radiation therapy
233458|NCT02738723|Intensity modulated radiation therapy|intensity modulated radiation therapy
233459|NCT02738723|Radiation|radiation
233460|NCT02738723|Chemotherapy|chemotherapy
233461|NCT02738697|Carcinoma,Hepatocellular|carcinoma,hepatocellular
233462|NCT02738697|Adjuvant chemotherapy|adjuvant chemotherapy
233463|NCT02738697|Microvessels invasion|microvessels invasion
233464|NCT02738697|Survival|survival
233465|NCT02738697|Recurrence|recurrence
233466|NCT02738684|lung cancer|lung cancer
233467|NCT02738684|adenocarcinoma|adenocarcinoma
233468|NCT02738684|EGFR|egfr
233469|NCT02738684|plasma free nucleic acids|plasma free nucleic acids
233470|NCT02738671|functional MRI|functional mri
233471|NCT02738671|olfactory function|olfactory function
233472|NCT02738671|bariatric surgery|bariatric surgery
233473|NCT02738658|Coronary microcirculatory dysfunction|coronary microcirculatory dysfunction
233474|NCT02738658|Coronary endothelium dysfunction|coronary endothelium dysfunction
233475|NCT02738619|allergic rhinitis|allergic rhinitis
233476|NCT02738619|immunotherapy|immunotherapy
233477|NCT02738619|vitamin D|vitamin d
233478|NCT02738554|HBV|hbv
233479|NCT02738554|treatment cessation|treatment cessation
233480|NCT02738554|HBsAg|hbsag
233481|NCT02738554|HBcrAg|hbcrag
233482|NCT02738554|nucleoside analogue|nucleoside analogue
233483|NCT02738554|entecavir|entecavir
233484|NCT02738554|tenofovir|tenofovir
233485|NCT02738502|HIV|hiv
233486|NCT02738502|prevention of mother-to-child transmission|prevention of mother-to-child transmission
233487|NCT02738502|Ritonavir boosted darunavir monotherapy|ritonavir boosted darunavir monotherapy
233488|NCT02738489|PD-1/PD-L1 advanced Melanoma immunotherapy|pd-1/pd-l1 advanced melanoma immunotherapy
233489|NCT02738463|ferritin LBW|ferritin lbw
233490|NCT02738450|cognitive decline|cognitive decline
233491|NCT02738437|osteogenesis|osteogenesis
233492|NCT02738437|Positron-Emission Tomography|positron-emission tomography
233493|NCT02738437|Radiostereometric analysis|radiostereometric analysis
233494|NCT02738424|Low Back Pain|low back pain
233495|NCT02738424|MRI|mri
233496|NCT02738372|Chronic Pain|chronic pain
233497|NCT02738372|Biopsychosocial Factors|biopsychosocial factors
233498|NCT02738372|Shoulder pain|shoulder pain
233499|NCT02738372|Prognosis|prognosis
233500|NCT02738372|Central Nervous System Sensitization|central nervous system sensitization
233501|NCT02738359|colon cancer|colon cancer
233502|NCT02738359|rectum cancer|rectum cancer
233503|NCT02738359|colonoscopy|colonoscopy
233504|NCT02738359|fecal immunological test|fecal immunological test
233505|NCT02738359|colon capsule|colon capsule
233506|NCT02738346|Small Cell Lung Cancer|small cell lung cancer
233507|NCT02738346|Topotecan|topotecan
233508|NCT02738346|Etoposide|etoposide
233509|NCT02738307|High Altitude|high altitude
233510|NCT02738307|Attention|attention
233511|NCT02738307|Cognitive Function|cognitive function
233512|NCT02738307|Acclimatization|acclimatization
233513|NCT02738307|Sleep|sleep
233514|NCT02738255|Obstructive sleep apnea|obstructive sleep apnea
233515|NCT02738255|Mouth breathing|mouth breathing
233516|NCT02738255|Apnea-Hypopnea Index (AHI)|apnea-hypopnea index (ahi)
233517|NCT02738242|Functional Electrical Stimulation|functional electrical stimulation
233518|NCT02738242|Upper motor neuron injury or disease|upper motor neuron injury or disease
233519|NCT02738242|Drop foot|drop foot
233520|NCT02738242|Thigh muscle weakness|thigh muscle weakness
233521|NCT02738203|Pain Management|pain management
233522|NCT02738203|IUD insertion|iud insertion
233523|NCT02738190|albumin|albumin
233524|NCT02738190|fresh frozen plasma|fresh frozen plasma
233525|NCT02738190|extracorporeal circulation|extracorporeal circulation
233526|NCT02738190|cardiovascular surgery|cardiovascular surgery
233527|NCT02738190|pediatric population|pediatric population
233528|NCT02738177|misopristol|misopristol
233529|NCT02738177|effox|effox
233530|NCT02738177|cervical ripening|cervical ripening
233531|NCT02738138|HCV Genotype 3|hcv genotype 3
233532|NCT02738138|Non-cirrhotic|non-cirrhotic
233533|NCT02738138|HCV Genotype 1|hcv genotype 1
233534|NCT02738138|HCV Genotype 6|hcv genotype 6
233535|NCT02738138|Human Immunodeficiency Virus (HIV) Infection|human immunodeficiency virus (hiv) infection
233536|NCT02738138|HCV Genotype 5|hcv genotype 5
233537|NCT02738138|HCV Treatment Naive|hcv treatment naive
233538|NCT02738138|HCV Genotype 4|hcv genotype 4
233539|NCT02738138|HCV Treatment Experienced|hcv treatment experienced
233540|NCT02738138|HCV Genotype 2|hcv genotype 2
712522|NCT00579839|PreTerm Birth|preterm birth
298608|NCT02354313|ASCT|asct
233541|NCT02738138|Hepatitis C Virus (HCV) Infection|hepatitis c virus (hcv) infection
233542|NCT02738138|Compensated Cirrhosis|compensated cirrhosis
233543|NCT02738125|Adalimumab|adalimumab
233544|NCT02738125|Ulcerative Colitis|ulcerative colitis
233545|NCT02738125|SOTHIS|sothis
233546|NCT02738125|Effectiveness|effectiveness
233547|NCT02738086|Amputation|amputation
233548|NCT02738086|Physical Activity|physical activity
233549|NCT02738086|Rehabilitation|rehabilitation
233550|NCT02738034|Hypertension|hypertension
233551|NCT02738034|Cognition|cognition
233552|NCT02738034|Computerized Training|computerized training
233553|NCT02738034|Cogmed|cogmed
233554|NCT02738021|Psychosocial|psychosocial
233555|NCT02738021|Psychotherapy|psychotherapy
233556|NCT02738021|Maternal|maternal
233557|NCT02737995|Iron deficiency|iron deficiency
233558|NCT02737982|coronary heart disease|coronary heart disease
233559|NCT02737982|gender|gender
233560|NCT02737982|platelet|platelet
233561|NCT02737982|microvascular dysfunction|microvascular dysfunction
233562|NCT02737982|sexual hormones|sexual hormones
233662|NCT02737358|smoking|smoking
233563|NCT02737982|cardiac magnetic resonance|cardiac magnetic resonance
233564|NCT02737982|percutaneous coronary interventions|percutaneous coronary interventions
233565|NCT02737969|Transesophageal Echocardiography/angiography (TEE/Angio)|transesophageal echocardiography/angiography (tee/angio)
233566|NCT02737943|Skin graft|skin graft
233567|NCT02737943|Burn|burn
233568|NCT02737943|MEBO|mebo
233569|NCT02737943|Wound dressing|wound dressing
233570|NCT02737943|Wound care|wound care
233571|NCT02737943|Raw Area|raw area
233572|NCT02737930|Acute ischemic stroke|acute ischemic stroke
233573|NCT02737930|Homonymous hemianopia|homonymous hemianopia
233574|NCT02737930|Homonymous quadrantanopia|homonymous quadrantanopia
233575|NCT02737930|Visual field loss|visual field loss
233576|NCT02737930|Post-stroke recovery|post-stroke recovery
233577|NCT02737930|Fluoxetine|fluoxetine
233578|NCT02737930|Selective serotonin reuptake inhibitor|selective serotonin reuptake inhibitor
233579|NCT02737904|Muscle spasticity|muscle spasticity
233580|NCT02737865|Focal nodular hyperplasia|focal nodular hyperplasia
233581|NCT02737865|Ultrasonography|ultrasonography
233582|NCT02737865|Superb-Microvascular imaging|superb-microvascular imaging
233583|NCT02737865|Contrast-enhanced ultrasonography|contrast-enhanced ultrasonography
233584|NCT02737813|isobaric marcaine|isobaric marcaine
233585|NCT02737813|hyperbaric marcaine|hyperbaric marcaine
233586|NCT02737787|Second or Greater Remission|second or greater remission
233587|NCT02737787|WT1 Analog Peptide Vaccine|wt1 analog peptide vaccine
233588|NCT02737787|Montanide|montanide
233589|NCT02737787|GM-CSF|gm-csf
233590|NCT02737787|Nivolumab|nivolumab
233591|NCT02737787|15-247|15-247
233592|NCT02737774|Icotinib|icotinib
233593|NCT02737774|chemotherapy|chemotherapy
233594|NCT02737774|EGFR|egfr
233595|NCT02737761|Heart Failure|heart failure
233596|NCT02737761|Positive Psychology|positive psychology
233597|NCT02737761|Adherence to Health Behaviors|adherence to health behaviors
233598|NCT02737748|Donor Site Wounds|donor site wounds
233599|NCT02737696|prescription opioid|prescription opioid
233600|NCT02737696|prevention|prevention
233601|NCT02737696|computer-based|computer-based
233602|NCT02737696|adolescent|adolescent
233603|NCT02737683|Disease|disease
233604|NCT02737683|anxiety|anxiety
233605|NCT02737683|depression|depression
233606|NCT02737683|combine|combine
233607|NCT02737683|negative emotional states|negative emotional states
233608|NCT02737683|functional dyspepsia|functional dyspepsia
233609|NCT02737657|Canagliflozin|canagliflozin
233610|NCT02737657|Metformin|metformin
233611|NCT02737657|Diabetes Mellitus, Type 2|diabetes mellitus, type 2
233612|NCT02737657|INVOKANA|invokana
233613|NCT02737657|Sulfonylurea|sulfonylurea
233614|NCT02737644|Congenital Heart Disease|congenital heart disease
233615|NCT02737644|Key Nutritional Factors|key nutritional factors
233616|NCT02737644|conception|conception
233617|NCT02737644|pregnant|pregnant
233618|NCT02737605|Esketamine|esketamine
233619|NCT02737605|Healthy|healthy
233620|NCT02737605|Pharmacokinetics|pharmacokinetics
233621|NCT02737605|Electrocardiogram|electrocardiogram
233622|NCT02737605|Repolarization|repolarization
233623|NCT02737579|cardiac catheterization|cardiac catheterization
233624|NCT02737579|cardiac MRI|cardiac mri
233625|NCT02737566|Smoking Cessation|smoking cessation
233626|NCT02737566|Financial Incentives|financial incentives
233627|NCT02737566|Contingency Management|contingency management
233628|NCT02737566|Vulnerable Populations|vulnerable populations
233629|NCT02737566|Medically Uninsured|medically uninsured
233630|NCT02737566|Medicaid|medicaid
233631|NCT02737527|ultrasound|ultrasound
233632|NCT02737527|lumbar sympathetic block|lumbar sympathetic block
233633|NCT02737514|adenoma detection rate|adenoma detection rate
233634|NCT02737514|colonoscopy|colonoscopy
233635|NCT02737514|water exchange|water exchange
233636|NCT02737501|Non-small cell lung cancer|non-small cell lung cancer
298733|NCT02353650|Q10|q10
233637|NCT02737501|Non-small cell lung carcinoma|non-small cell lung carcinoma
233638|NCT02737501|Epithelial lung cancer|epithelial lung cancer
233639|NCT02737501|Squamous cell carcinoma|squamous cell carcinoma
233640|NCT02737501|Large cell carcinoma|large cell carcinoma
233641|NCT02737501|Adenocarcinoma|adenocarcinoma
233642|NCT02737501|Carcinoma|carcinoma
233643|NCT02737501|Anaplastic Lymphoma Kinase (ALK)|anaplastic lymphoma kinase (alk)
233644|NCT02737501|Advanced Cancers|advanced cancers
233645|NCT02737501|Brigatinib|brigatinib
233646|NCT02737501|AP26113|ap26113
233647|NCT02737488|Therapy|therapy
233648|NCT02737488|Trauma Systems Therapy|trauma systems therapy
233649|NCT02737410|Resilience|resilience
233650|NCT02737410|Coping|coping
233651|NCT02737410|Psychosomatic|psychosomatic
233652|NCT02737410|Hypnosis|hypnosis
233653|NCT02737410|Construct Validation|construct validation
233654|NCT02737384|Combined immunodeficiencies|combined immunodeficiencies
233655|NCT02737384|hematopoietic stem cell transplantation|hematopoietic stem cell transplantation
233656|NCT02737384|CD45RA|cd45ra
233657|NCT02737384|primitive immunodeficiencies|primitive immunodeficiencies
233658|NCT02737384|pediatric transplantation|pediatric transplantation
233659|NCT02737384|CD45RA depletion|cd45ra depletion
233660|NCT02737358|nicotine|nicotine
233663|NCT02737358|cessation|cessation
233664|NCT02737358|N-acetylcysteine|n-acetylcysteine
233666|NCT02737358|pharmacotherapy|pharmacotherapy
233667|NCT02737358|relapse|relapse
233668|NCT02737358|tobacco use disorder|tobacco use disorder
233669|NCT02737345|fibrinolysis|fibrinolysis
233670|NCT02737345|liver transplant|liver transplant
233671|NCT02737345|thromboelastometry|thromboelastometry
233672|NCT02737319|Contrast,nephropathy, angioplasty, stable coronary|contrast,nephropathy, angioplasty, stable coronary
233673|NCT02737306|RIC Allogeneic Stem-Cell Transplantation|ric allogeneic stem-cell transplantation
233674|NCT02737280|infant|infant
233675|NCT02737280|high flow nasal cannulae|high flow nasal cannulae
233676|NCT02737280|oxygen therapy|oxygen therapy
233677|NCT02737280|bronchiolitis|bronchiolitis
233678|NCT02737267|Genetics|genetics
233679|NCT02737267|Polymorphism|polymorphism
233680|NCT02737267|Epigenetics|epigenetics
233681|NCT02737267|Metagenomics|metagenomics
233682|NCT02737267|Metabolomics|metabolomics
233683|NCT02737267|Metabolic syndrome conditions|metabolic syndrome conditions
233684|NCT02737267|Precision nutrition|precision nutrition
233685|NCT02737254|Attachment|attachment
233686|NCT02737254|Oxytocin|oxytocin
233687|NCT02737254|Cognitive bias modification|cognitive bias modification
233688|NCT02737254|Middle childhood|middle childhood
233689|NCT02737241|Prostate|prostate
233690|NCT02737241|Laser|laser
233691|NCT02737241|Enucleation|enucleation
233692|NCT02737202|LAM|lam
233693|NCT02737189|Basilar Artery Occlusion|basilar artery occlusion
233694|NCT02737189|Ischemic Stroke|ischemic stroke
233695|NCT02737189|Mechanical Embolectomy|mechanical embolectomy
233696|NCT02737176|Smoking Cessation|smoking cessation
233697|NCT02737176|Mouth Diseases|mouth diseases
233698|NCT02737176|Periodontal Diseases|periodontal diseases
233699|NCT02737176|Leukoplakia|leukoplakia
233700|NCT02737176|Keratosis|keratosis
233701|NCT02737176|Implant|implant
233702|NCT02737176|Lichen Planus|lichen planus
233703|NCT02737163|Programmable shunts|programmable shunts
233704|NCT02737163|Strata valve|strata valve
233705|NCT02737124|Acetaminophen|acetaminophen
233706|NCT02737124|Surgery|surgery
233707|NCT02737124|Meniscectomy|meniscectomy
233708|NCT02737098|PTSD|ptsd
233709|NCT02737098|virtual care|virtual care
233710|NCT02737098|implementation|implementation
233711|NCT02737098|telepsychiatry|telepsychiatry
233712|NCT02737098|telepsychology|telepsychology
233713|NCT02737085|CD19-targeted CAR-T Cell|cd19-targeted car-t cell
233714|NCT02737085|CD20-targeted CAR-T Cell|cd20-targeted car-t cell
233715|NCT02737085|Diffuse Large B Cell Lymphoma|diffuse large b cell lymphoma
233716|NCT02737072|immuno-oncology|immuno-oncology
233717|NCT02737046|Adult T-cell Leukemia-Lymphoma|adult t-cell leukemia-lymphoma
233718|NCT02737046|ATLL|atll
233719|NCT02737033|ADHD|adhd
233720|NCT02737033|Adults|adults
233721|NCT02737033|Treatment|treatment
233722|NCT02737033|Rhodiola|rhodiola
233723|NCT02737020|ADHD|adhd
233724|NCT02737020|Adults|adults
233725|NCT02737020|Treatment|treatment
233726|NCT02737020|Rhodiola rosea|rhodiola rosea
233727|NCT02737007|Malaria|malaria
233728|NCT02737007|Microdose|microdose
233729|NCT02737007|GSK3191607|gsk3191607
233730|NCT02736994|edentulous|edentulous
233731|NCT02736994|patients|patients
233732|NCT02736994|with full|with full
233733|NCT02736981|Obesity|obesity
233734|NCT02736981|Weight Loss|weight loss
233735|NCT02736981|Young Adults|young adults
233736|NCT02736968|Amebic|amebic
233737|NCT02736968|Auranofin|auranofin
233738|NCT02736968|GI Protozoa|gi protozoa
233739|NCT02736968|Giardiasis|giardiasis
233740|NCT02736968|Reprofiled|reprofiled
728339|NCT00515320|Fluoxetine|fluoxetine
298868|NCT02352766|FNA|fna
233741|NCT02736890|Botulinum Toxin A|botulinum toxin a
233742|NCT02736890|Neuropathic pain|neuropathic pain
233743|NCT02736890|Spinal cord injury|spinal cord injury
233744|NCT02736890|Pain management|pain management
233745|NCT02736890|Rehabilitation|rehabilitation
233746|NCT02736877|keratoconus|keratoconus
233747|NCT02736877|bullous keratopathy|bullous keratopathy
233748|NCT02736877|corneal dystrophy|corneal dystrophy
233749|NCT02736851|disability|disability
233750|NCT02736851|home|home
233751|NCT02736851|stretching exercises|stretching exercises
233752|NCT02736838|Pressure|pressure
233753|NCT02736838|Pressure Ulcer|pressure ulcer
233754|NCT02736838|Skin perfusion|skin perfusion
233755|NCT02736838|Skin oxygenation|skin oxygenation
233756|NCT02736812|Randomized controlled trial|randomized controlled trial
233757|NCT02736812|Lyophilized Plasma|lyophilized plasma
233758|NCT02736812|Advanced Trauma Life Support Care|advanced trauma life support care
233759|NCT02736786|proton|proton
233760|NCT02736773|Guided Bone|guided bone
233761|NCT02736773|Pre-implant referred|pre-implant referred
233762|NCT02736773|Regeneration|regeneration
233763|NCT02736747|Stroke|stroke
233764|NCT02736747|Muscle Spasticity|muscle spasticity
233765|NCT02736747|Cryotherapy|cryotherapy
233766|NCT02736747|Gait|gait
233767|NCT02736747|Muscle Weakness|muscle weakness
233768|NCT02736747|Proprioception|proprioception
233769|NCT02736708|Primary sclerosing cholangitis|primary sclerosing cholangitis
233770|NCT02736695|PPA|ppa
233771|NCT02736669|weight loss|weight loss
233772|NCT02736669|body weight|body weight
233773|NCT02736669|behavioral|behavioral
233774|NCT02736643|LDCT, screening|ldct, screening
233775|NCT02736630|general anaesthesia|general anaesthesia
233776|NCT02736630|elective surgery|elective surgery
233777|NCT02736630|national epidemiology|national epidemiology
233778|NCT02736630|turkey|turkey
233779|NCT02736565|metastatic|metastatic
233780|NCT02736565|askin tumor|askin tumor
233781|NCT02736565|neuroectodermal tumor|neuroectodermal tumor
233782|NCT02736565|pNET|pnet
233783|NCT02736565|sarcoma|sarcoma
233784|NCT02736565|soft tissue|soft tissue
233785|NCT02736565|ESFT|esft
233786|NCT02736565|Immunotherapy|immunotherapy
233787|NCT02736552|Gastric cancer|gastric cancer
233788|NCT02736552|Adjuvant chemotherapy|adjuvant chemotherapy
233789|NCT02736552|S-1|s-1
233790|NCT02736552|D2 resection|d2 resection
233791|NCT02736526|moderate intermittent exotropia|moderate intermittent exotropia
233792|NCT02736526|surgical treatment|surgical treatment
233793|NCT02736526|observation|observation
233794|NCT02736513|Tagrisso|tagrisso
233795|NCT02736513|AZD9291|azd9291
233796|NCT02736513|EGFRm|egfrm
233797|NCT02736513|brain metastases|brain metastases
233798|NCT02736513|NSCLC|nsclc
233799|NCT02736500|neuroendocrine tumors|neuroendocrine tumors
233800|NCT02736500|gastro entero pancreatic neuroendocrine tumors|gastro entero pancreatic neuroendocrine tumors
233801|NCT02736500|Radioisotope therapy|radioisotope therapy
233802|NCT02736500|177Lu-DOTATATE|177lu-dotatate
233803|NCT02736500|METRONOMIC CAPECITABINE|metronomic capecitabine
233804|NCT02736487|Air Pollution|air pollution
233805|NCT02736487|Exposure Assessment|exposure assessment
233806|NCT02736487|Filtration|filtration
233807|NCT02736487|Cardiovascular Outcomes|cardiovascular outcomes
233808|NCT02736487|Respiratory Outcomes|respiratory outcomes
233809|NCT02736487|Short-term Intervention|short-term intervention
233810|NCT02736461|Orbital fractures|orbital fractures
233811|NCT02736461|Strabismus|strabismus
233812|NCT02736461|Predicting factors|predicting factors
233813|NCT02736461|orbital floor fractures|orbital floor fractures
233814|NCT02736448|GEP-NET tumors|gep-net tumors
233815|NCT02736448|Lu-PRRT|lu-prrt
233816|NCT02736448|177Lutethium - Peptide Receptor Radionuclide Therapy|177lutethium - peptide receptor radionuclide therapy
233817|NCT02736448|gastro-entero-pancreatic neuroendocrine tumors|gastro-entero-pancreatic neuroendocrine tumors
233818|NCT02736448|18-FDG Positron Emission Tomography (PET) positive|18-fdg positron emission tomography (pet) positive
233819|NCT02736448|low dose of capecitabine|low dose of capecitabine
233820|NCT02736435|Magnetic Resonance Guided High Intensity Focused Ultrasound|magnetic resonance guided high intensity focused ultrasound
233821|NCT02736435|MR-HIFU|mr-hifu
233822|NCT02736435|Fibroids|fibroids
233823|NCT02736435|Leuprolide Acetate|leuprolide acetate
233824|NCT02736357|Lymphoma|lymphoma
233825|NCT02736357|Cohort|cohort
233826|NCT02736357|non-Hodgkin|non-hodgkin
233827|NCT02736344|coronary luminal diameter|coronary luminal diameter
233828|NCT02736344|lesions|lesions
233829|NCT02736344|vessels|vessels
233830|NCT02736331|Cognitive performance|cognitive performance
233831|NCT02736331|Metabolic control|metabolic control
233832|NCT02736331|Pharmacokinetic profile|pharmacokinetic profile
233833|NCT02736331|Anthocyanins|anthocyanins
233834|NCT02736305|ovarian|ovarian
233835|NCT02736305|regorafenib|regorafenib
233836|NCT02736305|platinum resistant|platinum resistant
233837|NCT02736305|clear cell|clear cell
233838|NCT02736305|endometrioid|endometrioid
233839|NCT02736266|Muscle-invasive|muscle-invasive
233840|NCT02736266|Urothelial bladder carcinoma|urothelial bladder carcinoma
233841|NCT02736266|Neoadjuvant therapy|neoadjuvant therapy
233842|NCT02736266|Radical cystectomy|radical cystectomy
233843|NCT02736253|foot amputation|foot amputation
233844|NCT02736253|Osteomyelitis|osteomyelitis
233845|NCT02736253|Diabetic Foot|diabetic foot
233846|NCT02736227|liver transplantation|liver transplantation
233847|NCT02736227|immunosuppression|immunosuppression
233848|NCT02736227|everolimus|everolimus
233849|NCT02736227|tacrolimus|tacrolimus
233850|NCT02736227|kidney function|kidney function
233851|NCT02736227|liver function|liver function
233852|NCT02736227|biomarkers|biomarkers
233853|NCT02736188|GNE Myopathy|gne myopathy
233854|NCT02736188|GNEM|gnem
233855|NCT02736188|Nonaka|nonaka
233856|NCT02736188|Hereditary Inclusion Body Myopathy|hereditary inclusion body myopathy
233857|NCT02736188|HIBM|hibm
233858|NCT02736188|DMRV|dmrv
233859|NCT02736188|QSM|qsm
233860|NCT02736162|Perampanel|perampanel
233861|NCT02736162|E2007|e2007
233862|NCT02736162|Phase 4|phase 4
233863|NCT02736162|Fycompa|fycompa
233864|NCT02736136|maternal parenting self-efficacy|maternal parenting self-efficacy
233865|NCT02736136|parental stress|parental stress
233866|NCT02736136|maternal sensitivity|maternal sensitivity
233867|NCT02736136|mother-infant bond|mother-infant bond
233868|NCT02736110|Osteoarthritis, knee|osteoarthritis, knee
233869|NCT02736084|optimism|optimism
233870|NCT02736084|positive affect|positive affect
233871|NCT02736084|adherence|adherence
233872|NCT02736084|health behavior|health behavior
233873|NCT02736084|diabetes|diabetes
233874|NCT02736006|Alveolo-capillar membrane|alveolo-capillar membrane
233875|NCT02736006|decompression illness|decompression illness
233876|NCT02736006|diving|diving
233877|NCT02736006|occupational|occupational
233878|NCT02735993|Celution|celution
233879|NCT02735993|ADRC|adrc
233880|NCT02735993|Heart Failure|heart failure
233881|NCT02735993|Device|device
233882|NCT02735980|SCLC|sclc
233883|NCT02735980|LY2606368|ly2606368
233884|NCT02735980|CHK1|chk1
233885|NCT02735915|Immunogenicity|immunogenicity
233886|NCT02735915|Safety|safety
233887|NCT02735915|Long term follow-up|long term follow-up
233888|NCT02735915|Adults|adults
233889|NCT02735915|Herpes zoster|herpes zoster
233890|NCT02735902|antivitamins K|antivitamins k
233891|NCT02735902|direct oral anti-coagulant|direct oral anti-coagulant
233892|NCT02735876|Bruton tyrosine kinase inhibitor|bruton tyrosine kinase inhibitor
233893|NCT02735876|Btk|btk
233894|NCT02735876|ACP-196|acp-196
233895|NCT02735876|Mantle Cell Lymphoma|mantle cell lymphoma
233896|NCT02735876|MCL|mcl
233897|NCT02735811|Implantable defibrillator|implantable defibrillator
233898|NCT02735811|Cardiomyopathies|cardiomyopathies
233899|NCT02735720|thoracic endovascular aortic repair|thoracic endovascular aortic repair
233900|NCT02735720|endograft|endograft
233901|NCT02735720|cardiac remodelling|cardiac remodelling
233902|NCT02735720|thoracic aortic aneurysm|thoracic aortic aneurysm
233903|NCT02735720|penetrating aortic ulcer|penetrating aortic ulcer
233904|NCT02735720|MRI|mri
233905|NCT02735707|Pneumonia|pneumonia
233906|NCT02735707|Lung Diseases|lung diseases
233907|NCT02735707|Respiratory Tract Diseases|respiratory tract diseases
233908|NCT02735707|Respiratory Tract Infections|respiratory tract infections
233909|NCT02735707|Anti-Bacterial Agents|anti-bacterial agents
233910|NCT02735707|Moxifloxacin|moxifloxacin
233911|NCT02735707|Levofloxacin|levofloxacin
233912|NCT02735707|Cephalosporins|cephalosporins
233913|NCT02735707|Antibiotics|antibiotics
233914|NCT02735707|Hydrocortisone 17-butyrate 21-propionate|hydrocortisone 17-butyrate 21-propionate
233915|NCT02735707|Hydrocortisone acetate|hydrocortisone acetate
233916|NCT02735707|Cortisol succinate|cortisol succinate
233917|NCT02735707|Hydrocortisone|hydrocortisone
233918|NCT02735707|Anti-Infective Agents|anti-infective agents
233919|NCT02735694|Sleep apnea|sleep apnea
233920|NCT02735694|Hypoglossal Nerve|hypoglossal nerve
233921|NCT02735694|N-methyl-D-aspartate receptors|n-methyl-d-aspartate receptors
233922|NCT02735694|Cycloserine|cycloserine
233923|NCT02735694|Short-term potentiation|short-term potentiation
233924|NCT02735668|Shoulder Pain|shoulder pain
233925|NCT02735668|Pattern Motor|pattern motor
233926|NCT02735668|Physical Therapy Modalities|physical therapy modalities
233927|NCT02735668|Breast Cancer Treatment|breast cancer treatment
233928|NCT02735655|endoscopy|endoscopy
233929|NCT02735655|Education|education
233930|NCT02735655|capsule endoscopy|capsule endoscopy
233931|NCT02735655|Cholangiopancreatography, Endoscopic Retrograde|cholangiopancreatography, endoscopic retrograde
233932|NCT02735655|esophagogastroduodenoscopy|esophagogastroduodenoscopy
233933|NCT02735655|colonoscopy|colonoscopy
233934|NCT02735655|Double-Balloon Enteroscopy|double-balloon enteroscopy
233935|NCT02735655|Global status|global status
233936|NCT02735655|unmet need|unmet need
233937|NCT02735616|heart rate variability|heart rate variability
233938|NCT02735616|stroke|stroke
233939|NCT02735577|Alcohol|alcohol
233940|NCT02735577|Craving|craving
233941|NCT02735577|Functional MRI|functional mri
233942|NCT02735577|Cognitive control|cognitive control
233943|NCT02735577|Risky decision-making|risky decision-making
233944|NCT02735577|Disulfiram|disulfiram
233945|NCT02735564|Weight Loss|weight loss
233946|NCT02735564|Magnetic Resonance Imaging|magnetic resonance imaging
233947|NCT02735564|gut microbiota|gut microbiota
233948|NCT02735551|LARC|larc
233949|NCT02735551|IUD|iud
233950|NCT02735551|Contraceptive Implant|contraceptive implant
233951|NCT02735551|Contraception|contraception
233952|NCT02735551|Community college|community college
233953|NCT02735525|telemedicine|telemedicine
233954|NCT02735525|smartphone|smartphone
233955|NCT02735499|onabotulinum toxin A|onabotulinum toxin a
233956|NCT02735499|Urinary bladder|urinary bladder
233957|NCT02735499|EMDA|emda
233958|NCT02735499|iontophoresis|iontophoresis
233959|NCT02735499|electrophoresis|electrophoresis
233960|NCT02735499|Urinary incontinence|urinary incontinence
233961|NCT02735486|Ginger|ginger
233962|NCT02735486|blood pressure|blood pressure
233963|NCT02735486|flow mediated dilatation|flow mediated dilatation
233964|NCT02735434|Health anxiety|health anxiety
233965|NCT02735434|illness anxiety disorder|illness anxiety disorder
233966|NCT02735434|ACT|act
233967|NCT02735434|internet|internet
233968|NCT02735421|acne|acne
233969|NCT02735421|scars|scars
233970|NCT02735395|Periodontal Diseases|periodontal diseases
233971|NCT02735395|Metronidazole|metronidazole
233972|NCT02735395|Amoxicillin|amoxicillin
233973|NCT02735395|Chronic periodontitis|chronic periodontitis
233974|NCT02735395|Root Planing|root planing
233975|NCT02735382|Translational Medical Research|translational medical research
233976|NCT02735382|Clinical Practice Guidelines|clinical practice guidelines
233977|NCT02735382|Electronic Health Records|electronic health records
233978|NCT02735382|Smoking|smoking
233979|NCT02735382|Tobacco|tobacco
233980|NCT02735382|Quitline|quitline
233981|NCT02735330|CCP|ccp
233982|NCT02735317|Nasopharyngeal carcinoma (NPC)|nasopharyngeal carcinoma (npc)
233983|NCT02735317|radiotherapy|radiotherapy
233984|NCT02735317|oral mucositis (OM)|oral mucositis (om)
233985|NCT02735291|Leukemia CAR-T|leukemia car-t
233986|NCT02735265|Rehabilitation|rehabilitation
233987|NCT02735265|Virtual reality|virtual reality
233988|NCT02735252|Castration Resistant|castration resistant
233989|NCT02735252|Metastatic|metastatic
233990|NCT02735239|Oesophageal Cancer|oesophageal cancer
233991|NCT02735239|Oesophageal adenocarcinoma|oesophageal adenocarcinoma
233992|NCT02735239|Oesophageal squamous cell carcinoma|oesophageal squamous cell carcinoma
233993|NCT02735239|Immunotherapy|immunotherapy
233994|NCT02735239|Cytotoxic T-lymphocyte-associated protein 4 (CTLA-4)|cytotoxic t-lymphocyte-associated protein 4 (ctla-4)
233995|NCT02735239|Programmed cell death protein 1 (PD-1)|programmed cell death protein 1 (pd-1)
233996|NCT02735239|Programmed death ligand 1 (PD-L1)|programmed death ligand 1 (pd-l1)
233997|NCT02735226|stroke|stroke
233998|NCT02735226|Shanghai Healthcare|shanghai healthcare
233999|NCT02735226|Healthcare Quality, Access, and Evaluation|healthcare quality, access, and evaluation
234000|NCT02735213|Central Serous Choroidopathy|central serous choroidopathy
234001|NCT02735213|Micropulse Laser Treatment|micropulse laser treatment
234002|NCT02735213|Traditional laser Treatment|traditional laser treatment
234003|NCT02735213|optical coherence tomography|optical coherence tomography
234004|NCT02735174|Telehealth|telehealth
234005|NCT02735174|Sensor cap|sensor cap
234006|NCT02735174|School based care|school based care
234007|NCT02735174|Community health|community health
234008|NCT02735174|AsthmaTreatSmart Application|asthmatreatsmart application
234009|NCT02735161|Sarcoidosis|sarcoidosis
234010|NCT02735161|Fatigue|fatigue
234011|NCT02735161|Exercise|exercise
234012|NCT02735148|Postural balance|postural balance
234013|NCT02735148|Accidental falls|accidental falls
234014|NCT02735148|Rehabilitation|rehabilitation
234015|NCT02735148|Cerebrovascular Accident|cerebrovascular accident
234016|NCT02735148|Walking|walking
234017|NCT02735148|Mobility limitation|mobility limitation
234018|NCT02735135|bedridden|bedridden
234019|NCT02735109|VIN|vin
234020|NCT02735096|Bilateral Vestibular Hypofunction|bilateral vestibular hypofunction
234021|NCT02735096|Unilateral Vestibular Hypofunction|unilateral vestibular hypofunction
234022|NCT02735096|Imbalance|imbalance
234023|NCT02735070|Common cold treatment|common cold treatment
234024|NCT02735057|oesophagus cancer|oesophagus cancer
234025|NCT02735031|Glucagon-Like Peptide 1|glucagon-like peptide 1
234026|NCT02735031|Impaired hypoglycemic awareness|impaired hypoglycemic awareness
234027|NCT02734992|Migraines|migraines
234028|NCT02734992|Tension-type Headache|tension-type headache
234029|NCT02734992|Acceptance|acceptance
234030|NCT02734979|lymphedema|lymphedema
234031|NCT02734979|edema|edema
234032|NCT02734966|Drug-Induced|drug-induced
234033|NCT02734966|Acute Liver Injury|acute liver injury
234034|NCT02734953|Inhaled nitric oxide|inhaled nitric oxide
234035|NCT02734953|Exercise|exercise
234036|NCT02734953|6 minute walk test|6 minute walk test
234037|NCT02734953|CardioMems|cardiomems
234038|NCT02734927|schizophrenia|schizophrenia
234039|NCT02734927|motivation|motivation
234040|NCT02734927|executive control|executive control
234041|NCT02734901|polyphenols|polyphenols
234042|NCT02734901|vascular function|vascular function
234043|NCT02734901|endothelial function|endothelial function
234044|NCT02734901|raspberry|raspberry
234045|NCT02734888|arterial inflammation|arterial inflammation
234046|NCT02734888|electronic cigarettes|electronic cigarettes
234047|NCT02734888|PET scan|pet scan
234048|NCT02734875|anticoagulants|anticoagulants
234049|NCT02734875|NOACs|noacs
234050|NCT02734875|warfarin|warfarin
234051|NCT02734875|randomized designed delay|randomized designed delay
234052|NCT02734875|intervention|intervention
234053|NCT02734875|machine learning algorithm|machine learning algorithm
234054|NCT02734875|primary care|primary care
234055|NCT02734862|mycoses|mycoses
234056|NCT02734810|Exocrine Pancreatic Insufficiency|exocrine pancreatic insufficiency
234057|NCT02734810|Cystic Fibrosis|cystic fibrosis
234058|NCT02734810|Liprotamase|liprotamase
234059|NCT02734810|Pancreatic Enzyme Replacement Therapy (PERT)|pancreatic enzyme replacement therapy (pert)
234060|NCT02734771|DLBCL|dlbcl
234061|NCT02734745|diabetes type 1|diabetes type 1
234062|NCT02734745|flash glucose monitoring|flash glucose monitoring
234063|NCT02734732|Prostate|prostate
234064|NCT02734732|Biopsy|biopsy
234065|NCT02734732|Infection|infection
234066|NCT02734732|Prophylaxis|prophylaxis
234067|NCT02734732|Antibiotic|antibiotic
234068|NCT02734693|Attention-Deficit Hyperactivity Disorder (ADHD)|attention-deficit hyperactivity disorder (adhd)
234069|NCT02734680|Pancreatic cancer|pancreatic cancer
235252|NCT02727361|Dystonia|dystonia
234070|NCT02734680|Intraoperative radiotherapy(IORT)|intraoperative radiotherapy(iort)
234071|NCT02734680|Postoperative radiochemotherapy|postoperative radiochemotherapy
234072|NCT02734654|oxidative stress|oxidative stress
234073|NCT02734654|lung lobectomy|lung lobectomy
234074|NCT02734615|LSZ102|lsz102
234075|NCT02734615|LEE011|lee011
234076|NCT02734615|ribociclib|ribociclib
234077|NCT02734615|Kisqali|kisqali
234078|NCT02734615|BYL719|byl719
234079|NCT02734615|alpelisib|alpelisib
234080|NCT02734615|ER+ breast cancer|er+ breast cancer
234081|NCT02734615|advanced ER+ breast cancer|advanced er+ breast cancer
234082|NCT02734615|metastatic ER+ breast cancer|metastatic er+ breast cancer
234083|NCT02734615|SERD|serd
234084|NCT02734615|SERM|serm
234085|NCT02734615|fulvestrant|fulvestrant
234086|NCT02734615|tamoxifen|tamoxifen
234087|NCT02734615|aromatase inhibitor|aromatase inhibitor
234088|NCT02734615|ESR1|esr1
234089|NCT02734615|mtESR1|mtesr1
234090|NCT02734615|wtESR1|wtesr1
234091|NCT02734615|estrogen receptor|estrogen receptor
234092|NCT02734615|endocrine therapy|endocrine therapy
234093|NCT02734602|depression|depression
234094|NCT02734602|post-traumatic stress disorder|post-traumatic stress disorder
234095|NCT02734602|sv2a|sv2a
234096|NCT02734602|ketamine|ketamine
234098|NCT02734589|Ulcerative Colitis|ulcerative colitis
234099|NCT02734589|Nutrition|nutrition
234100|NCT02734589|microbiome|microbiome
234101|NCT02734576|Venous Sinus Stenting|venous sinus stenting
234102|NCT02734576|Dural Sinus Stenting|dural sinus stenting
234103|NCT02734550|Sepsis|sepsis
234104|NCT02734550|Invasive Candida Infection|invasive candida infection
234105|NCT02734550|Biomarker|biomarker
234106|NCT02734550|(1,3)-β-D-glucan|(1,3)-β-d-glucan
234107|NCT02734550|Antifungal therapy|antifungal therapy
234108|NCT02734550|Intensive care medicine|intensive care medicine
234109|NCT02734550|Critically ill|critically ill
234110|NCT02734524|Natural killer cells|natural killer cells
234111|NCT02734524|NSCLC|nsclc
234112|NCT02734524|NCT|nct
234113|NCT02734524|Combined therapy|combined therapy
234114|NCT02734485|Progressive supranuclear palsy|progressive supranuclear palsy
234115|NCT02734485|Deep transcranial magnetic stimulation|deep transcranial magnetic stimulation
234116|NCT02734472|blood pressure|blood pressure
234117|NCT02734472|Hypertrophy, Left Ventricular|hypertrophy, left ventricular
234118|NCT02734472|Vascular Stiffness|vascular stiffness
234119|NCT02734472|Proteinuria|proteinuria
234120|NCT02734472|Carotid Artery Diseases|carotid artery diseases
234121|NCT02734446|Bronchial Inflammation|bronchial inflammation
234122|NCT02734446|Asthma|asthma
234123|NCT02734446|Childhood Asthma Control Test (C-ACT)|childhood asthma control test (c-act)
234124|NCT02734446|Asthma Exacerbations|asthma exacerbations
234125|NCT02734433|Advanced solid tumors|advanced solid tumors
234126|NCT02734433|Asian subjects|asian subjects
234127|NCT02734433|Developmental Phase I|developmental phase i
234128|NCT02734420|Dental caries|dental caries
234129|NCT02734420|PDT|pdt
234130|NCT02734420|LLLT|lllt
234131|NCT02734420|pediatric dentistry|pediatric dentistry
234132|NCT02734394|exercise|exercise
234133|NCT02734394|body composition|body composition
234134|NCT02734394|metabolism|metabolism
234135|NCT02734394|nutrition|nutrition
234136|NCT02734381|elderly patients|elderly patients
234137|NCT02734381|prevalence|prevalence
234138|NCT02734381|emergency department use|emergency department use
234139|NCT02734381|main presenting disease|main presenting disease
234140|NCT02734355|atrial fibrillation|atrial fibrillation
234141|NCT02734355|catheter ablation|catheter ablation
234142|NCT02734355|left atrium|left atrium
234143|NCT02734355|mechanical function|mechanical function
234144|NCT02734355|contractility|contractility
234145|NCT02734329|Nephron sparing surgery|nephron sparing surgery
234146|NCT02734329|Zero ischemia|zero ischemia
234147|NCT02734329|Warm ischemia|warm ischemia
234148|NCT02734329|Laparoscopic|laparoscopic
234149|NCT02734329|Radiofrequency ablation|radiofrequency ablation
234150|NCT02734329|Microwave ablation|microwave ablation
234151|NCT02734303|Dietary Radioactivity|dietary radioactivity
234152|NCT02734303|Dietary Assessment|dietary assessment
234153|NCT02734303|Retrospective Recall|retrospective recall
234154|NCT02734303|Focus Group|focus group
234155|NCT02734290|metastatic|metastatic
234156|NCT02734290|Human epidermal growth factor receptor 2 (HER2) negative breast cancer|human epidermal growth factor receptor 2 (her2) negative breast cancer
234157|NCT02734290|Estrogen Receptor (ER) negative breast cancer|estrogen receptor (er) negative breast cancer
234158|NCT02734290|Progesterone Receptor (PR) negative breast cancer|progesterone receptor (pr) negative breast cancer
234159|NCT02734290|Immunotherapy|immunotherapy
234160|NCT02734290|Breast Cancer|breast cancer
234161|NCT02734277|Insulin|insulin
234162|NCT02734277|Glucose Intolerance|glucose intolerance
234163|NCT02734277|Prior ITN027AI Study Participants-NCT00129259|prior itn027ai study participants-nct00129259
234164|NCT02734277|Prior ITN045AI Study Participants-NCT00965458|prior itn045ai study participants-nct00965458
234165|NCT02734251|Healthy mood|healthy mood
234166|NCT02734251|Stress management|stress management
234167|NCT02734251|Relora|relora
234168|NCT02734251|Healthy subjects|healthy subjects
234169|NCT02734225|total knee replacement|total knee replacement
234170|NCT02734225|total knee arthroplasty|total knee arthroplasty
234171|NCT02734225|rehabilitation|rehabilitation
234172|NCT02734225|physical therapy|physical therapy
234173|NCT02734225|balance|balance
234174|NCT02734212|Stigmatization|stigmatization
234175|NCT02734199|Birth Control|birth control
234176|NCT02734199|Contraception|contraception
234177|NCT02734199|IUD|iud
234178|NCT02734186|Filariasis|filariasis
234179|NCT02734186|Schistosoma Mansoni|schistosoma mansoni
234180|NCT02734186|Coinfection|coinfection
234181|NCT02734160|immunotherapy|immunotherapy
234182|NCT02734160|check point inhibitors|check point inhibitors
234183|NCT02734160|transforming growth factor (TGF)-beta R1 kinase inhibitor|transforming growth factor (tgf)-beta r1 kinase inhibitor
234184|NCT02734134|Periprosthetic joint infection|periprosthetic joint infection
234185|NCT02734121|breast cancer|breast cancer
234186|NCT02734121|breast reconstruction|breast reconstruction
234187|NCT02734121|shared decision making|shared decision making
234188|NCT02734121|decision support intervention|decision support intervention
234189|NCT02734108|Sever anorexia nervosa|sever anorexia nervosa
234190|NCT02734082|stroke|stroke
234191|NCT02734082|ischemia|ischemia
234192|NCT02734082|Berne|berne
234193|NCT02734069|carboplatin|carboplatin
234194|NCT02734043|bundled payment|bundled payment
234195|NCT02734030|Anterior Knee Pain Syndrome|anterior knee pain syndrome
234196|NCT02734030|Quadriceps Femoris|quadriceps femoris
234197|NCT02734030|Muscle Inhibition|muscle inhibition
234198|NCT02734030|Interpolated Twitch Technique|interpolated twitch technique
234199|NCT02734030|Muscle Architecture|muscle architecture
234200|NCT02734030|Single Leg Squat|single leg squat
234201|NCT02734030|Women Knee Pain|women knee pain
234202|NCT02734004|MEDIOLA|mediola
234203|NCT02734004|Olaparib|olaparib
234204|NCT02734004|MEDI4736|medi4736
234205|NCT02734004|Bevacizumab|bevacizumab
234206|NCT02734004|Ovarian cancer|ovarian cancer
234207|NCT02734004|Breast cancer|breast cancer
234208|NCT02734004|Small Cell Lung Cancer|small cell lung cancer
234209|NCT02734004|Gastric Cancer|gastric cancer
234210|NCT02734004|Phase I/II, Adults|phase i/ii, adults
234211|NCT02734004|PDL-1|pdl-1
234212|NCT02733978|Ozone oxygen|ozone oxygen
234213|NCT02733978|ulcer healing|ulcer healing
234214|NCT02733965|clinical pharmacy consultations|clinical pharmacy consultations
234215|NCT02733965|oral anti-cancer therapy|oral anti-cancer therapy
234216|NCT02733965|serious adverse events|serious adverse events
234217|NCT02733965|medication reconciliation|medication reconciliation
234218|NCT02733939|technology|technology
234219|NCT02733939|informal care|informal care
234220|NCT02733939|caregiver burden|caregiver burden
234221|NCT02733913|atrial fibrillation|atrial fibrillation
234222|NCT02733913|pulmonary vein isolation|pulmonary vein isolation
234223|NCT02733913|heart rate turbulence|heart rate turbulence
234224|NCT02733913|baroreflex sensitivity|baroreflex sensitivity
234225|NCT02733900|aseptic osteonecrosis|aseptic osteonecrosis
234226|NCT02733900|femoral head|femoral head
234227|NCT02733900|micro scanner|micro scanner
234228|NCT02733900|Raman spectrometry|raman spectrometry
234229|NCT02733900|MRI|mri
234230|NCT02733861|dental implant|dental implant
234231|NCT02733861|stability|stability
234232|NCT02733861|implant stability quotient|implant stability quotient
234233|NCT02733848|Roux-en-Y gastric bypass|roux-en-y gastric bypass
234234|NCT02733848|Hypoglycemia|hypoglycemia
234235|NCT02733848|Creon|creon
234236|NCT02733822|opiate|opiate
234237|NCT02733822|heroin|heroin
234238|NCT02733822|opioid|opioid
234239|NCT02733822|overdose|overdose
234240|NCT02733822|naloxone|naloxone
234241|NCT02733809|Hepatocellular Carcinoma|hepatocellular carcinoma
234242|NCT02733809|Sorafenib|sorafenib
234243|NCT02733796|zika virus|zika virus
234244|NCT02733796|semen analysis|semen analysis
234245|NCT02733796|sexual transmission|sexual transmission
234246|NCT02733757|Clonidine|clonidine
234247|NCT02733757|Sub-Tenon's and Peribulbar block|sub-tenon's and peribulbar block
234248|NCT02733757|IOP|iop
234249|NCT02733757|OPP|opp
234250|NCT02733757|OPA|opa
234251|NCT02733744|Stem cell transplant|stem cell transplant
234252|NCT02733744|fecal microbiota transplantation|fecal microbiota transplantation
234253|NCT02733718|Necrotizing enterocolitis|necrotizing enterocolitis
234254|NCT02733718|Transfusion|transfusion
234255|NCT02733718|Mesenteric Oxygenisation|mesenteric oxygenisation
234256|NCT02733705|Pain|pain
234257|NCT02733705|TRUS biopsy|trus biopsy
234258|NCT02733692|HIV|hiv
234259|NCT02733692|STDs|stds
234260|NCT02733692|web-based app|web-based app
234261|NCT02733692|women|women
234262|NCT02733666|Absorbable screw|absorbable screw
234263|NCT02733666|Internal fixation|internal fixation
234264|NCT02733666|Children|children
234265|NCT02733653|Superficial Femoral Artery|superficial femoral artery
234266|NCT02733653|Proximal Popliteal Artery|proximal popliteal artery
234267|NCT02733653|Endovascular therapy|endovascular therapy
234268|NCT02733653|Atherectomy|atherectomy
236048|NCT02722954|malignancy|malignancy
234269|NCT02733601|breast cancer epidemiology algeria registry|breast cancer epidemiology algeria registry
234270|NCT02733588|hypoglycemia|hypoglycemia
234271|NCT02733588|glucagon|glucagon
234272|NCT02733588|glucose metabolism disorders|glucose metabolism disorders
234273|NCT02733588|hormones|hormones
234274|NCT02733588|gastrointestinal agents|gastrointestinal agents
234275|NCT02733588|bariatric surgery|bariatric surgery
234276|NCT02733588|incretins|incretins
234277|NCT02733536|endotracheal intubation|endotracheal intubation
234278|NCT02733536|trauma|trauma
234279|NCT02733536|paramedic|paramedic
234280|NCT02733510|kidney transplantation|kidney transplantation
234281|NCT02733510|subclinical rejection|subclinical rejection
234282|NCT02733510|steroid pulse therapy|steroid pulse therapy
234283|NCT02733497|sympathectomy, sympathicotomy, heart rate variability,|sympathectomy, sympathicotomy, heart rate variability,
234284|NCT02733484|Obesity,Probiotics,Treatment|obesity,probiotics,treatment
234285|NCT02733471|Lidocaine|lidocaine
234286|NCT02733471|Endoscopy|endoscopy
234287|NCT02733471|Tolerance|tolerance
234288|NCT02733393|Thoracotomy|thoracotomy
234289|NCT02733393|Postoperative|postoperative
234290|NCT02733393|Lidocaine|lidocaine
234291|NCT02733393|Sphenopalatine Ganglion Block|sphenopalatine ganglion block
234292|NCT02733380|Diffuse Large B-Cell Lymphoma|diffuse large b-cell lymphoma
234293|NCT02733380|Relapsed and refractory|relapsed and refractory
234294|NCT02733380|Histone deacetylase inhibitor|histone deacetylase inhibitor
234295|NCT02733380|Chidamide|chidamide
234296|NCT02733341|Adenosine Diphosphate|adenosine diphosphate
234297|NCT02733341|Cardiovascular Magnetic Resonance (CMR)|cardiovascular magnetic resonance (cmr)
234298|NCT02733341|Index of microvascular resistance (IMR)|index of microvascular resistance (imr)
234299|NCT02733341|Vasodilator stimulated phosphoprotein phosphorylation (VASP)|vasodilator stimulated phosphoprotein phosphorylation (vasp)
234300|NCT02733341|Pharmacodynamic|pharmacodynamic
234301|NCT02733341|Antiplatelet|antiplatelet
234302|NCT02733341|Myocardial Infarction (MI)|myocardial infarction (mi)
234303|NCT02733341|Cangrelor|cangrelor
234304|NCT02733341|Ticagrelor|ticagrelor
234305|NCT02733341|Coronary artery bypass graft (CABG)|coronary artery bypass graft (cabg)
234306|NCT02733341|Primary percutaneous coronary intervention (PPCI)|primary percutaneous coronary intervention (ppci)
234307|NCT02733328|Cardio-pulmonary bypass (CPB)|cardio-pulmonary bypass (cpb)
234308|NCT02733328|renal replacement therapy (RRT)|renal replacement therapy (rrt)
234309|NCT02733328|enzyme-linked immunosorbent assay (ELISA)|enzyme-linked immunosorbent assay (elisa)
234310|NCT02733263|gut microbiota|gut microbiota
234311|NCT02733263|fiber|fiber
234312|NCT02733263|diet quality|diet quality
234313|NCT02733263|immunity|immunity
234314|NCT02733250|NSCLC|nsclc
234315|NCT02733250|Pembrolizumab|pembrolizumab
234316|NCT02733250|Nab-paclitaxel|nab-paclitaxel
234317|NCT02733237|oxytocin|oxytocin
234318|NCT02733237|infidelity|infidelity
234319|NCT02733224|lenalidomide adherence MEMS|lenalidomide adherence mems
234320|NCT02733211|Closed Loop|closed loop
234321|NCT02733185|chelation|chelation
234322|NCT02733172|Vulvodynia|vulvodynia
234323|NCT02733172|Endophenotypes|endophenotypes
234324|NCT02733172|functional MRI|functional mri
234325|NCT02733159|Performance Status 2|performance status 2
234326|NCT02733159|Pembrolizumab|pembrolizumab
234327|NCT02733159|MK-3475|mk-3475
234328|NCT02733133|Testosterone|testosterone
234329|NCT02733133|AndroGel|androgel
299598|NCT02348437|Repair|repair
234330|NCT02733133|Transference|transference
234331|NCT02733133|Women|women
234332|NCT02733133|Children|children
234333|NCT02733107|Non-small Cell Lung Cancer|non-small cell lung cancer
234334|NCT02733107|Apatinib|apatinib
234335|NCT02733107|Etoposide|etoposide
234336|NCT02733081|Long Acting Reversible Contraception|long acting reversible contraception
234337|NCT02733081|Intrauterine Device (IUD)|intrauterine device (iud)
234338|NCT02733081|Intrauterine Device (IUD) Insertion|intrauterine device (iud) insertion
234339|NCT02733081|Family Planning|family planning
234340|NCT02733081|International Family Planning|international family planning
234341|NCT02733055|Postural Equilibrium|postural equilibrium
234342|NCT02733055|Musculoskeletal Equilibrium|musculoskeletal equilibrium
234343|NCT02733055|Eye Movements|eye movements
234344|NCT02733055|Saccades|saccades
234345|NCT02733055|Pursuit, Smooth|pursuit, smooth
234346|NCT02733042|Lymphoma|lymphoma
234347|NCT02733042|Chronic Lymphocytic Leukemia|chronic lymphocytic leukemia
234348|NCT02733042|Durvalumab|durvalumab
234349|NCT02733042|Anti-PD-L1 Antibody|anti-pd-l1 antibody
234350|NCT02733042|MEDI4736|medi4736
234351|NCT02733042|Immune Checkpoint|immune checkpoint
234352|NCT02733042|Lymphatic Disease|lymphatic disease
234353|NCT02733042|B-Cell Malignancies|b-cell malignancies
234354|NCT02733042|Abscopal Effect|abscopal effect
234355|NCT02733042|Lenalidomide|lenalidomide
234356|NCT02733042|Bendamustine|bendamustine
234357|NCT02733042|Rituximab|rituximab
234358|NCT02733042|Ibrutinib|ibrutinib
234359|NCT02733042|Lymphoma, B-Cell|lymphoma, b-cell
234360|NCT02733042|Lymphoma, Non Hodgkin,|lymphoma, non hodgkin,
234361|NCT02733042|Hodgkin Disease|hodgkin disease
234362|NCT02733042|Leukemia, Lymphocytic, Chronic, B-Cell,|leukemia, lymphocytic, chronic, b-cell,
236049|NCT02722954|metastatic|metastatic
234363|NCT02733042|Lymphoma, Follicular|lymphoma, follicular
234364|NCT02733042|Lymphoma, Diffuse Large B-Cell|lymphoma, diffuse large b-cell
234365|NCT02733042|Lymphoma, Mantle Cell|lymphoma, mantle cell
234366|NCT02733042|Lymphoma, Small Lymphocytic|lymphoma, small lymphocytic
234367|NCT02733042|Immune System Diseases|immune system diseases
234368|NCT02733042|Immunoproliferative Disorders|immunoproliferative disorders
234369|NCT02733042|Lymphoproliferative Disorders|lymphoproliferative disorders
234370|NCT02733003|Implementation Science|implementation science
234371|NCT02733003|HIV|hiv
234372|NCT02733003|Sexual Risk|sexual risk
234373|NCT02733003|Sexually Transmitted Diseases|sexually transmitted diseases
234374|NCT02733003|Substance Abuse|substance abuse
234375|NCT02733003|Violence and Victimization|violence and victimization
234376|NCT02733003|Linkage to care|linkage to care
234377|NCT02733003|Gender-based Violence|gender-based violence
234378|NCT02733003|Antiretroviral Therapy (ART)|antiretroviral therapy (art)
234379|NCT02732990|Training|training
234380|NCT02732990|One-legged exercise|one-legged exercise
234381|NCT02732990|Peripheral blood flow|peripheral blood flow
234382|NCT02732990|Cardiac function|cardiac function
234383|NCT02732990|Muscle metaboreflex|muscle metaboreflex
234384|NCT02732964|satisfaction|satisfaction
234385|NCT02732938|CCR2i, nab-paclitaxel, Abraxane, gemcitabine, pancreas|ccr2i, nab-paclitaxel, abraxane, gemcitabine, pancreas
234386|NCT02732925|Vertebral Compression Fracture|vertebral compression fracture
234387|NCT02732925|Balloon Kyphoplasty|balloon kyphoplasty
234388|NCT02732925|Conservative treatment|conservative treatment
234389|NCT02732925|Sham procedure|sham procedure
234390|NCT02732925|VCFs|vcfs
234391|NCT02732925|Multiple Myeloma|multiple myeloma
234392|NCT02732912|falls|falls
234393|NCT02732912|sleep|sleep
234394|NCT02732899|AMD|amd
234395|NCT02732886|foam dressing|foam dressing
234396|NCT02732860|personalized patient-derived xenografts (pPDX)|personalized patient-derived xenografts (ppdx)
234397|NCT02732860|molecular profiling|molecular profiling
234398|NCT02732860|epigenetic analysis|epigenetic analysis
234399|NCT02732860|drug sensitivity testing|drug sensitivity testing
234400|NCT02732860|triple negative|triple negative
234401|NCT02732860|metastatic|metastatic
234402|NCT02732860|serous|serous
234403|NCT02732847|Respiratory infections|respiratory infections
234404|NCT02732847|Primary care|primary care
234405|NCT02732847|Antibiotics|antibiotics
234406|NCT02732847|Delayed prescriptions|delayed prescriptions
234407|NCT02732834|Clinician-Patient Communication|clinician-patient communication
234408|NCT02732834|16-001|16-001
234409|NCT02732821|Gastroparesis|gastroparesis
234410|NCT02732821|G-POEM|g-poem
234411|NCT02732821|Gastric Per Oral Endoscopic Myotomy|gastric per oral endoscopic myotomy
234412|NCT02732808|Double stimulations|double stimulations
234413|NCT02732808|luteal-phase ovarian stimulation|luteal-phase ovarian stimulation
234414|NCT02732808|poor ovarian response|poor ovarian response
234415|NCT02732782|Achilles tendon|achilles tendon
234416|NCT02732782|isometric muscle training|isometric muscle training
234417|NCT02732782|competitive sports|competitive sports
234418|NCT02732782|strength training|strength training
234419|NCT02732782|eccentric exercise|eccentric exercise
234420|NCT02732782|isometric exercise|isometric exercise
234421|NCT02732782|chronic condition|chronic condition
234422|NCT02732782|regeneration|regeneration
234423|NCT02732782|tendon|tendon
234424|NCT02732782|tendon properties|tendon properties
234425|NCT02732782|tendinopathy|tendinopathy
234426|NCT02732782|tendinosis|tendinosis
234427|NCT02732782|intervention|intervention
234428|NCT02732782|training load|training load
234429|NCT02732782|high performance sports|high performance sports
234430|NCT02732756|ADHD|adhd
234431|NCT02732756|Sleep|sleep
234432|NCT02732756|Attention|attention
234433|NCT02732756|Adolescence|adolescence
234434|NCT02732743|childhod constipation|childhod constipation
234435|NCT02732730|ART (Antir-retroviral therapy)|art (antir-retroviral therapy)
234436|NCT02732730|PrEP (Pre-Exposure Prophylaxis)|prep (pre-exposure prophylaxis)
234437|NCT02732730|DAIDS (Division of AIDS)|daids (division of aids)
234438|NCT02732730|HPTN (HIV Prevention Trials Network)|hptn (hiv prevention trials network)
234439|NCT02732704|Aortic Valve Disease|aortic valve disease
234440|NCT02732704|Aortic Regurgitation|aortic regurgitation
234441|NCT02732704|Aortic Insufficiency|aortic insufficiency
234442|NCT02732691|Aortic Valve Disease|aortic valve disease
234443|NCT02732691|Aortic Valve Stenosis|aortic valve stenosis
234444|NCT02732613|Laryngeal Mask Airway|laryngeal mask airway
234445|NCT02732613|Body weight|body weight
234446|NCT02732613|Complication|complication
234447|NCT02732600|Veterans|veterans
234448|NCT02732600|Veterans Health|veterans health
234449|NCT02732600|Patient Compliance|patient compliance
234450|NCT02732600|Primary Health Care|primary health care
234451|NCT02732600|Health Care Providers|health care providers
234452|NCT02732600|Health Promotion|health promotion
234453|NCT02732522|misoprostol|misoprostol
234454|NCT02732522|induction of labor|induction of labor
234455|NCT02732522|sublingual|sublingual
234456|NCT02732496|Attention-Deficit/Hyperactivity Disorder|attention-deficit/hyperactivity disorder
234457|NCT02732496|Tourette Syndrome|tourette syndrome
234458|NCT02732496|Working Memory Training|working memory training
234459|NCT02732483|gastric cancer|gastric cancer
234460|NCT02732483|bleeding|bleeding
234461|NCT02732483|gastrointestinal hemorrhage|gastrointestinal hemorrhage
234462|NCT02732470|Systemic Lupus Erythematous|systemic lupus erythematous
234464|NCT02732470|Quality of life|quality of life
234465|NCT02732457|HIV|hiv
234466|NCT02732457|Persistence|persistence
234467|NCT02732457|Reservoirs|reservoirs
234468|NCT02732457|Stem Cell Transplant|stem cell transplant
234469|NCT02732457|Functional Cure|functional cure
234470|NCT02732444|Erythrocytes Membranes Stability|erythrocytes membranes stability
234471|NCT02732444|Oxidative Stress|oxidative stress
234472|NCT02732444|Chronic Obstructive Pulmonary Disease (COPD)|chronic obstructive pulmonary disease (copd)
234473|NCT02732444|Advanced Pulmonary Disease (APD)|advanced pulmonary disease (apd)
234474|NCT02732444|Long-Term Home Oxygen Therapy (LTOT)|long-term home oxygen therapy (ltot)
234475|NCT02732418|CI-contraceptive injection|ci-contraceptive injection
234476|NCT02732418|DMPA-Depot medroxyprogesterone acetate|dmpa-depot medroxyprogesterone acetate
234477|NCT02732418|MPA-Medroxyprogesterone Acetate|mpa-medroxyprogesterone acetate
234478|NCT02732418|subQ-subcutaneous|subq-subcutaneous
234479|NCT02732379|Postoperative Nausea and Vomiting|postoperative nausea and vomiting
234480|NCT02732379|Aromatherapy|aromatherapy
234481|NCT02732379|Quality of Health Care|quality of health care
234482|NCT02732366|aged [MeSH term]|aged [mesh term]
234483|NCT02732366|exercise [MeSH term]|exercise [mesh term]
234484|NCT02732340|triple-branched stent graft|triple-branched stent graft
234485|NCT02732340|the occluded rate of false lumen|the occluded rate of false lumen
234486|NCT02732275|Adult T-cell leukemia-lymphoma (ATL)|adult t-cell leukemia-lymphoma (atl)
234487|NCT02732275|Peripheral T-cell lymphoma (PTCL)|peripheral t-cell lymphoma (ptcl)
234488|NCT02732262|acute pain|acute pain
234489|NCT02732262|postoperative|postoperative
234490|NCT02732262|surgery|surgery
234491|NCT02732249|Helicobacter pylori|helicobacter pylori
234492|NCT02732249|Clarithromycin|clarithromycin
234493|NCT02732249|Amoxicillin|amoxicillin
234494|NCT02732249|Metronidazole|metronidazole
234495|NCT02732249|Eradication|eradication
234496|NCT02732236|marginal zone lymphoma|marginal zone lymphoma
234497|NCT02732236|Cohort|cohort
234498|NCT02732236|Rituximab|rituximab
234499|NCT02732236|HBV|hbv
234500|NCT02732223|Atherosclerosis|atherosclerosis
234501|NCT02732223|omega 3|omega 3
234502|NCT02732223|plant sterols|plant sterols
234503|NCT02732223|polyphenols|polyphenols
234504|NCT02732184|AML|aml
234505|NCT02732184|MDS|mds
234506|NCT02732158|Novel laboratory methods|novel laboratory methods
234507|NCT02732145|Three-Vulvar-Rings|three-vulvar-rings
234508|NCT02732145|Three-Rings-Vulvoscopy|three-rings-vulvoscopy
234509|NCT02732145|N-S-P scheme|n-s-p scheme
234510|NCT02732145|Vulvoscopy Index|vulvoscopy index
234511|NCT02732145|Vulvar Dermatosis|vulvar dermatosis
234512|NCT02732145|Vulvar Lichen Sclerosus|vulvar lichen sclerosus
234513|NCT02732145|Lichen Planus|lichen planus
234514|NCT02732145|Lichen Simplex Chronicus|lichen simplex chronicus
234515|NCT02732145|Vulvodynia|vulvodynia
728439|NCT00515060|Stimuli|stimuli
234516|NCT02732145|Provoked Vestibulodynia|provoked vestibulodynia
234517|NCT02732145|Vulvar Vestibulitis|vulvar vestibulitis
234518|NCT02732145|Vulvar Diseases|vulvar diseases
234519|NCT02732119|HR-positive|hr-positive
234520|NCT02732119|HER2-negative|her2-negative
234521|NCT02732119|Advanced breast cancer|advanced breast cancer
234522|NCT02732119|LEE011|lee011
234523|NCT02732119|ribociclib|ribociclib
234524|NCT02732119|everolimus|everolimus
234525|NCT02732119|Afinitor|afinitor
234526|NCT02732119|exemestane|exemestane
234527|NCT02732119|Aromasin|aromasin
234528|NCT02732119|CDK|cdk
234529|NCT02732119|CDK4|cdk4
234530|NCT02732119|CDK6|cdk6
234531|NCT02732119|CDK4/6|cdk4/6
234532|NCT02732119|CDK4/6 inhibitor|cdk4/6 inhibitor
234533|NCT02732119|Phase III|phase iii
234534|NCT02732119|ER-positive|er-positive
234535|NCT02732119|PR-positive|pr-positive
234536|NCT02732119|Postmenopausal|postmenopausal
234537|NCT02732106|ADRCs, cell characterization|adrcs, cell characterization
234538|NCT02732080|primary percutaneous coronary intervention|primary percutaneous coronary intervention
234539|NCT02732080|microvascular obstruction|microvascular obstruction
234540|NCT02732080|myocardial edema|myocardial edema
234541|NCT02732080|microvascular resistance|microvascular resistance
234542|NCT02732080|acute myocardial infarction|acute myocardial infarction
234543|NCT02732067|Anesthesia|anesthesia
234544|NCT02732054|HBV vaccination, immunity|hbv vaccination, immunity
234545|NCT02732002|shoulder|shoulder
234546|NCT02732002|rotator cuff- injury|rotator cuff- injury
234547|NCT02732002|management|management
234548|NCT02732002|rehabilitation model|rehabilitation model
234549|NCT02731976|Gluten-Free diet|gluten-free diet
234550|NCT02731976|Healthy individuals|healthy individuals
234551|NCT02731963|Outcomes|outcomes
234552|NCT02731963|Bowel preparation|bowel preparation
234553|NCT02731950|Sternotomy , cardiac surgery , pain|sternotomy , cardiac surgery , pain
234554|NCT02731924|Appendicitis|appendicitis
234555|NCT02731924|Ultrasound|ultrasound
234556|NCT02731924|Emergency Department|emergency department
234557|NCT02731872|COPD|copd
234558|NCT02731872|oxygen treatment|oxygen treatment
234559|NCT02731872|quality of life|quality of life
234560|NCT02731846|Efficacy|efficacy
234561|NCT02731846|Triple therapy|triple therapy
234562|NCT02731846|Parallel|parallel
234563|NCT02731846|Respiratory|respiratory
234564|NCT02731820|potassium citrate|potassium citrate
234565|NCT02731807|TA-65|ta-65
234566|NCT02731807|Telemorase|telemorase
234567|NCT02731807|Dietary Supplement|dietary supplement
234568|NCT02731794|cardiopulmonary bypass|cardiopulmonary bypass
234569|NCT02731794|coronary artery bypass grafting|coronary artery bypass grafting
234570|NCT02731794|inflammatory response|inflammatory response
234571|NCT02731794|cardiac dysfunction|cardiac dysfunction
234572|NCT02731781|OUTCOME|outcome
234573|NCT02731781|PROGNOSIS|prognosis
234574|NCT02731781|PEDIATRIC HEAd injury|pediatric head injury
234575|NCT02731781|CT SCAN|ct scan
234576|NCT02731755|Oats|oats
234577|NCT02731755|Phenolic acid|phenolic acid
234578|NCT02731755|FMD|fmd
234579|NCT02731755|LDI|ldi
234580|NCT02731755|Avenanthramide|avenanthramide
234581|NCT02731729|Ipilimumab|ipilimumab
234582|NCT02731729|Nivolumab|nivolumab
234583|NCT02731729|Stage III-IV Melanoma|stage iii-iv melanoma
234584|NCT02731729|Progressed or Relapsed on PD-1 Inhibitor Therapy|progressed or relapsed on pd-1 inhibitor therapy
234585|NCT02731729|16-043|16-043
234586|NCT02731703|overdenture|overdenture
234587|NCT02731703|overlay|overlay
234588|NCT02731703|implant supported|implant supported
234589|NCT02731703|denture|denture
234590|NCT02731703|dental prosthesis|dental prosthesis
234591|NCT02731703|maxillary|maxillary
234592|NCT02731690|GNE Myopathy|gne myopathy
234593|NCT02731690|Nonaka|nonaka
234594|NCT02731690|GNEM|gnem
234595|NCT02731690|Hereditary Inclusion Body Myopathy|hereditary inclusion body myopathy
234596|NCT02731690|HIBM|hibm
234597|NCT02731690|DMRV|dmrv
234598|NCT02731690|QSM|qsm
234599|NCT02731664|Irritable bowel syndrome|irritable bowel syndrome
234600|NCT02731664|Functional dyspepsia|functional dyspepsia
234601|NCT02731664|Gastric emptying|gastric emptying
234602|NCT02731664|Gastrointestinal peptide hormones|gastrointestinal peptide hormones
234603|NCT02731638|cornea|cornea
234604|NCT02731638|ulcer|ulcer
234605|NCT02731638|fungal|fungal
234606|NCT02731638|keratitis|keratitis
234607|NCT02731625|Kettlebell training|kettlebell training
234608|NCT02731625|High-intensity interval training|high-intensity interval training
234609|NCT02731612|Bipolar Disorder|bipolar disorder
234610|NCT02731612|Cognition|cognition
234611|NCT02731612|Euthymic|euthymic
234612|NCT02731612|Lurasidone|lurasidone
234613|NCT02731599|Parkinson Disease|parkinson disease
234614|NCT02731599|treadmill|treadmill
234615|NCT02731599|Rehabilitation|rehabilitation
234616|NCT02731586|Dental Implants|dental implants
234617|NCT02731586|Allogenic mesenchymal stem cells|allogenic mesenchymal stem cells
234618|NCT02731586|osseointegration|osseointegration
728440|NCT00515060|Pain|pain
234619|NCT02731586|primary stability|primary stability
234620|NCT02731586|resonance frequency analysis|resonance frequency analysis
234621|NCT02731586|RFA|rfa
234622|NCT02731586|implants and stem cells|implants and stem cells
234623|NCT02731586|use of stem cells|use of stem cells
234624|NCT02731586|stem cells|stem cells
234625|NCT02731573|Mediastenitis|mediastenitis
234626|NCT02731560|Pakistan, Rituximab|pakistan, rituximab
234627|NCT02731560|RA|ra
234628|NCT02731521|MRS Biomarkers|mrs biomarkers
234629|NCT02731508|Transcranial Direct Current Stimulation|transcranial direct current stimulation
234630|NCT02731508|Neuroplasticity|neuroplasticity
234631|NCT02731482|Bronchiectasis|bronchiectasis
234632|NCT02731482|Rehabilitation|rehabilitation
234633|NCT02731482|Quality of Life|quality of life
234634|NCT02731482|Physiotherapy Specialty|physiotherapy specialty
234635|NCT02731456|high altitude|high altitude
234636|NCT02731456|cognition|cognition
234637|NCT02731456|sleep|sleep
234638|NCT02731443|dreaming|dreaming
234639|NCT02731443|epilepsy|epilepsy
234640|NCT02731443|neurosurgery|neurosurgery
234641|NCT02731443|temporal lobectomy|temporal lobectomy
234642|NCT02731378|erythropoietin|erythropoietin
234643|NCT02731378|iron supplementation|iron supplementation
234644|NCT02731378|inadequately responsive|inadequately responsive
234645|NCT02731378|chemotherapy-induced anaemia|chemotherapy-induced anaemia
234646|NCT02731365|Parkinson's Disease|parkinson's disease
234647|NCT02731300|Transcranial direct current stimulation|transcranial direct current stimulation
234648|NCT02731300|Cathodal stimulation|cathodal stimulation
234649|NCT02731300|Childhood Pharmacoresistant epilepsy|childhood pharmacoresistant epilepsy
234650|NCT02731300|Lennox-Gastaut syndrome|lennox-gastaut syndrome
234651|NCT02731235|Stroke|stroke
234652|NCT02731235|stroke, acute|stroke, acute
234653|NCT02731235|Cerebral small vessel disease|cerebral small vessel disease
234654|NCT02731222|CEAP classification|ceap classification
234655|NCT02731222|CVD: Chronic Venous Disease|cvd: chronic venous disease
234656|NCT02731222|Onychodystrophy|onychodystrophy
234657|NCT02731222|Body Mass Index|body mass index
234658|NCT02731196|exercise|exercise
234659|NCT02731196|lumbar microdiscectomy|lumbar microdiscectomy
234660|NCT02731183|Fecal Microbiota Transplantation|fecal microbiota transplantation
234661|NCT02731183|Chronic intestinal pseudo obstruction|chronic intestinal pseudo obstruction
234662|NCT02731183|Efficacy and safety|efficacy and safety
234663|NCT02731170|Parkinson Disease|parkinson disease
234664|NCT02731170|Advanced Stages|advanced stages
234665|NCT02731170|Rehabilitation|rehabilitation
234666|NCT02731144|Loss of Physical Function|loss of physical function
234667|NCT02731118|glaucoma|glaucoma
234668|NCT02731118|intraocular pressure lowering treatment|intraocular pressure lowering treatment
234669|NCT02731118|antisectory factor (AF)|antisectory factor (af)
234670|NCT02731118|Salovum|salovum
234671|NCT02731105|acne|acne
234672|NCT02731105|vulgaris|vulgaris
234673|NCT02731105|Clindamycin|clindamycin
234674|NCT02731105|Tretinoin|tretinoin
234675|NCT02731105|Adapalen|adapalen
234676|NCT02731105|Benzoylperoxid|benzoylperoxid
234677|NCT02731105|Epiduo|epiduo
234678|NCT02731105|Acnatac|acnatac
234679|NCT02731092|lactoferrin|lactoferrin
234680|NCT02731092|very low birth weight infants|very low birth weight infants
234681|NCT02731092|preterm infants|preterm infants
234682|NCT02731079|Sleeve gastrectomy stapler Covidien Ethicon bleeding leak|sleeve gastrectomy stapler covidien ethicon bleeding leak
234683|NCT02731053|Depression|depression
234684|NCT02731053|Prevention|prevention
234685|NCT02731053|Adolescents|adolescents
234686|NCT02731053|School|school
234687|NCT02731053|Effectiveness|effectiveness
234688|NCT02731014|Dry Needling|dry needling
234689|NCT02730975|pharmacokinetics|pharmacokinetics
234690|NCT02730975|food-effect|food-effect
234691|NCT02730975|fat diet|fat diet
234692|NCT02730975|abiraterone acetate|abiraterone acetate
234693|NCT02730949|D-Chiro-Inositol, type 1 diabetes|d-chiro-inositol, type 1 diabetes
234694|NCT02730923|Clinical Trials, Randomized|clinical trials, randomized
234695|NCT02730923|Clinical Trial, Phase I|clinical trial, phase i
234696|NCT02730923|Clinical Trial, Phase II|clinical trial, phase ii
234697|NCT02730923|Multicenter Trials|multicenter trials
234698|NCT02730923|Aromatase Inhibitors|aromatase inhibitors
234699|NCT02730923|mTOR kinase inhibitor|mtor kinase inhibitor
234700|NCT02730910|Bioavailability|bioavailability
234701|NCT02730910|adults|adults
234702|NCT02730897|Surgery|surgery
234703|NCT02730897|Thoracotomy|thoracotomy
234704|NCT02730897|VATS|vats
234705|NCT02730884|Leukemia|leukemia
234706|NCT02730884|Myelofibrosis|myelofibrosis
234708|NCT02730884|Anemia|anemia
234709|NCT02730884|Splenomegaly|splenomegaly
234710|NCT02730884|Post-polycythemia vera MF|post-polycythemia vera mf
234711|NCT02730884|post-PV|post-pv
234712|NCT02730884|post-essential thrombocythemia MF|post-essential thrombocythemia mf
234713|NCT02730884|post-ET|post-et
234714|NCT02730884|Rigosertib|rigosertib
234715|NCT02730884|ON 01910.Na|on 01910.na
234716|NCT02730884|Questionnaire|questionnaire
234717|NCT02730884|Survey|survey
728541|NCT00514566|Closure|closure
300101|NCT02345629|Pain|pain
234718|NCT02730858|Metastatic Breast Cancer|metastatic breast cancer
234719|NCT02730858|Palliative Care|palliative care
234720|NCT02730858|Breast Cancer|breast cancer
234721|NCT02730858|End of life|end of life
234722|NCT02730858|Health service research|health service research
234723|NCT02730845|Elective|elective
234724|NCT02730845|local anesthesia|local anesthesia
234725|NCT02730845|knee arthroscopy|knee arthroscopy
234726|NCT02730845|Dexmedetomidine|dexmedetomidine
234727|NCT02730793|Cystic Fibrosis|cystic fibrosis
234728|NCT02730793|P. aeruginosa (PA)|p. aeruginosa (pa)
234729|NCT02730754|Mood Disorders|mood disorders
234730|NCT02730754|Illness Perception|illness perception
234731|NCT02730754|Primary Care|primary care
234732|NCT02730754|Medication Adherence|medication adherence
234733|NCT02730741|diarrhoea|diarrhoea
234734|NCT02730741|metfomin|metfomin
234735|NCT02730741|type 2 diabetes|type 2 diabetes
234736|NCT02730741|microbiota|microbiota
234737|NCT02730728|adductor canal block|adductor canal block
234738|NCT02730728|tinetti score|tinetti score
234739|NCT02730728|time to up and go test|time to up and go test
234740|NCT02730728|Ambulation distance|ambulation distance
234741|NCT02730728|pain score|pain score
234742|NCT02730728|quality of recovery score|quality of recovery score
234743|NCT02730689|DP-R207|dp-r207
234744|NCT02730689|Rosuvastatin|rosuvastatin
234745|NCT02730689|Ezetimibe|ezetimibe
234746|NCT02730676|electronic cigarettes|electronic cigarettes
234747|NCT02730676|e-cigarette|e-cigarette
234748|NCT02730676|combustible cigarette|combustible cigarette
234749|NCT02730676|cigarette|cigarette
234750|NCT02730676|menthol|menthol
234751|NCT02730676|cig-alike|cig-alike
234752|NCT02730676|subjective measures|subjective measures
234753|NCT02730676|pharmacokinetics|pharmacokinetics
234754|NCT02730676|craving|craving
234755|NCT02730663|Endoscopic ultrasound guided transluminal drainage|endoscopic ultrasound guided transluminal drainage
234756|NCT02730650|FACE-Q|face-q
234757|NCT02730650|Platelet Rich Therapy|platelet rich therapy
234758|NCT02730650|PRT|prt
234759|NCT02730624|piperacillin/tazobactam|piperacillin/tazobactam
234760|NCT02730624|critically ill|critically ill
234761|NCT02730624|severe sepsis|severe sepsis
234762|NCT02730624|septic shock|septic shock
234763|NCT02730611|Vertical sleeve gastrectomy|vertical sleeve gastrectomy
234764|NCT02730611|Metabolic syndrome|metabolic syndrome
234765|NCT02730611|Disorder of Bile Acid and Cholesterol Metabolism|disorder of bile acid and cholesterol metabolism
234766|NCT02730611|Cholangiocarcinoma|cholangiocarcinoma
234767|NCT02730611|Hepatocellular carcinoma|hepatocellular carcinoma
234768|NCT02730585|C-reactive protein|c-reactive protein
234769|NCT02730572|Attention Deficit Hyperactivity Disorder|attention deficit hyperactivity disorder
234770|NCT02730572|Methylphenidate|methylphenidate
234771|NCT02730559|Motivational Interviewing|motivational interviewing
234772|NCT02730533|endoscopic submucosal dissection|endoscopic submucosal dissection
234773|NCT02730533|proton pump inhibitor|proton pump inhibitor
234774|NCT02730533|bleeding|bleeding
234775|NCT02730520|respiratory disease|respiratory disease
234776|NCT02730520|allergen sensitization|allergen sensitization
234778|NCT02730520|skin tests|skin tests
234779|NCT02730520|air allergens|air allergens
234780|NCT02730494|mycosis|mycosis
234781|NCT02730494|Candidiasis|candidiasis
234782|NCT02730494|Lcr35®|lcr35®
234783|NCT02730494|Lcr Regenerans®|lcr regenerans®
234784|NCT02730455|Stroke|stroke
234785|NCT02730351|Fluticasone furoate|fluticasone furoate
234786|NCT02730351|activity monitoring|activity monitoring
234787|NCT02730351|Vilanterol|vilanterol
234788|NCT02730351|Cross-over|cross-over
234789|NCT02730351|exercise-induced bronchoconstriction|exercise-induced bronchoconstriction
234790|NCT02730351|exercise challenge|exercise challenge
234791|NCT02730351|double-dummy|double-dummy
234792|NCT02730351|asthma|asthma
234793|NCT02730351|spirometry|spirometry
234794|NCT02730351|fluticasone propionate|fluticasone propionate
234795|NCT02730338|Castrate resistant|castrate resistant
234796|NCT02730338|Exercise|exercise
234797|NCT02730338|Metastatic|metastatic
234798|NCT02730338|Prostate cancer|prostate cancer
234799|NCT02730325|CDI|cdi
234800|NCT02730325|C. diff|c. diff
234801|NCT02730325|Ulcerative Colitis|ulcerative colitis
234802|NCT02730325|UC|uc
234803|NCT02730325|IBD|ibd
234804|NCT02730325|Inflammatory Bowel Disease|inflammatory bowel disease
234805|NCT02730312|AML|aml
234806|NCT02730312|B-ALL|b-all
234807|NCT02730312|BPDCN|bpdcn
234808|NCT02730312|CML|cml
234809|NCT02730312|Blast Crisis|blast crisis
234810|NCT02730286|human activity|human activity
234811|NCT02730286|International Classification of Functioning|international classification of functioning
234812|NCT02730260|Directive coaching|directive coaching
234813|NCT02730260|Nondirective coaching|nondirective coaching
234814|NCT02730260|smoking cessation quitline|smoking cessation quitline
234815|NCT02730260|social support|social support
234816|NCT02730247|ramucirumab|ramucirumab
234817|NCT02730247|docetaxel|docetaxel
234818|NCT02730221|Administrative workload|administrative workload
234819|NCT02730221|Patient data management system|patient data management system
234820|NCT02730221|Intensive Care Unit|intensive care unit
234821|NCT02730221|Work sampling method|work sampling method
234822|NCT02730221|Nursing Activity Score|nursing activity score
234823|NCT02730182|postural control|postural control
234824|NCT02730182|high altitude|high altitude
234825|NCT02730169|Hypogonadotropic|hypogonadotropic
234826|NCT02730169|hypogonadism|hypogonadism
234827|NCT02730169|testosterone|testosterone
234828|NCT02730143|Altitude|altitude
234829|NCT02730143|Nocturnal breathing pattern|nocturnal breathing pattern
234830|NCT02730130|Pembrolizumab|pembrolizumab
234831|NCT02730130|Radiotherapy|radiotherapy
234832|NCT02730130|16-032|16-032
234833|NCT02730117|Acute kidney injury|acute kidney injury
234834|NCT02730117|Furosemide stress test|furosemide stress test
234835|NCT02730117|critical care|critical care
234836|NCT02730078|Mood Disorders|mood disorders
234837|NCT02730078|Self Care|self care
234838|NCT02730078|Primary Care|primary care
234839|NCT02730065|Cerebral small vessel disease|cerebral small vessel disease
234840|NCT02730065|Lifestyle modification|lifestyle modification
234841|NCT02730065|Physical activity|physical activity
234842|NCT02730065|Primary prevention|primary prevention
234843|NCT02730065|Aerobic dance|aerobic dance
234844|NCT02730065|Cognition|cognition
234845|NCT02730065|Depression|depression
234846|NCT02730065|Activities of daily living|activities of daily living
234847|NCT02730065|Cerebral autoregulation|cerebral autoregulation
234848|NCT02730052|Blood pressure control|blood pressure control
234849|NCT02730052|Hypertension|hypertension
234850|NCT02730052|Office blood pressure|office blood pressure
234851|NCT02730052|Self-measured blood pressure,|self-measured blood pressure,
234852|NCT02730052|Telemonitoring|telemonitoring
234853|NCT02730039|Cancer Care Providers|cancer care providers
234854|NCT02730039|Psychotherapy|psychotherapy
234855|NCT02730039|15-321|15-321
234856|NCT02730026|Ketofrofen|ketofrofen
234857|NCT02730026|Omeprazole|omeprazole
234858|NCT02730026|Lower Third Molar|lower third molar
234859|NCT02730026|Oral Surgery|oral surgery
234860|NCT02730013|Older adults|older adults
234861|NCT02730013|Square stepping exercise|square stepping exercise
234862|NCT02730013|Mind-motor exercise|mind-motor exercise
234863|NCT02730013|Long-term care|long-term care
234864|NCT02730013|Global cognitive functioning|global cognitive functioning
234865|NCT02730000|Dental Atraumatic Restorative Treatment|dental atraumatic restorative treatment
234866|NCT02730000|Primary Teeth|primary teeth
234867|NCT02730000|Clinical Efficacy|clinical efficacy
234868|NCT02730000|Cost Analysis|cost analysis
234869|NCT02730000|Glass Ionomer Cement|glass ionomer cement
234870|NCT02729987|online|online
234871|NCT02729987|internet|internet
234872|NCT02729987|CBT|cbt
234873|NCT02729987|Stress|stress
234874|NCT02729987|Work|work
234875|NCT02729987|Internet based treatment|internet based treatment
234876|NCT02729974|thromboelastography|thromboelastography
234877|NCT02729935|Parecoxib|parecoxib
234878|NCT02729935|Bladder Discomfort|bladder discomfort
234879|NCT02729909|Drug therapy|drug therapy
234880|NCT02729870|Ketones|ketones
234881|NCT02729870|Gastroenteritis|gastroenteritis
234882|NCT02729844|Incidence|incidence
234883|NCT02729844|Risk factors|risk factors
234884|NCT02729844|Outcome|outcome
234885|NCT02729831|decision making|decision making
234886|NCT02729831|decision aids|decision aids
234887|NCT02729831|decision quality instruments|decision quality instruments
234888|NCT02729831|osteoarthritis|osteoarthritis
234889|NCT02729831|shared decision making|shared decision making
234890|NCT02729818|Retina|retina
234891|NCT02729818|Microperimetry|microperimetry
234892|NCT02729818|Visual Fields|visual fields
234893|NCT02729805|ketamine|ketamine
234894|NCT02729805|chronic pain|chronic pain
234895|NCT02729805|mastectomy|mastectomy
234896|NCT02729805|acute pain|acute pain
234897|NCT02729792|depression|depression
234898|NCT02729792|treatment resistance|treatment resistance
234899|NCT02729792|biomarkers|biomarkers
234900|NCT02729792|repetitive transcranial magnetic stimulation|repetitive transcranial magnetic stimulation
234901|NCT02729766|Hyponatremia|hyponatremia
234902|NCT02729766|SGLT2 inhibitor|sglt2 inhibitor
234903|NCT02729740|Penumbra Smart coils|penumbra smart coils
234904|NCT02729740|PC 400|pc 400
234905|NCT02729740|AV malformations|av malformations
234906|NCT02729740|AV fistulae|av fistulae
234907|NCT02729740|POD|pod
234908|NCT02729688|Venous insufficiency|venous insufficiency
234909|NCT02729688|Compression|compression
234910|NCT02729688|Bandaging|bandaging
234911|NCT02729675|fruit & vegetable, market, education, worksite, food access|fruit & vegetable, market, education, worksite, food access
234912|NCT02729597|neuromuscular disorders|neuromuscular disorders
234913|NCT02729597|MRI|mri
234914|NCT02729597|white matter|white matter
234915|NCT02729597|brain|brain
234916|NCT02729597|myotonic dystrophy|myotonic dystrophy
234917|NCT02729558|brain metastases|brain metastases
300350|NCT02344420|CRT|crt
234918|NCT02729558|radiotherapy|radiotherapy
234919|NCT02729558|resection|resection
234920|NCT02729545|acupuncture|acupuncture
234921|NCT02729545|LH/FSH|lh/fsh
234922|NCT02729545|total testosterone (TT)|total testosterone (tt)
234923|NCT02729545|polycystic ovarian syndrome(PCOS)|polycystic ovarian syndrome(pcos)
234924|NCT02729532|Extra-pulmonary tuberculosis|extra-pulmonary tuberculosis
234925|NCT02729532|multiple drug resistant tuberculosis|multiple drug resistant tuberculosis
234926|NCT02729532|mycobacterium tuberculosis|mycobacterium tuberculosis
234927|NCT02729532|human immunodeficiency virus|human immunodeficiency virus
234928|NCT02729506|hepatocellular carcinoma|hepatocellular carcinoma
234929|NCT02729506|transarterial radioembolization|transarterial radioembolization
234930|NCT02729506|chemoembolization chemoembolization|chemoembolization chemoembolization
234931|NCT02729506|clinical trial|clinical trial
234932|NCT02729493|Liver Cancer CAR-T|liver cancer car-t
234933|NCT02729467|Healthy|healthy
234934|NCT02729467|JNJ-53718678|jnj-53718678
234935|NCT02729467|Itraconazole|itraconazole
234936|NCT02729467|Rifampicin|rifampicin
234937|NCT02729467|Pharmacokinetics|pharmacokinetics
234938|NCT02729428|Aging|aging
234939|NCT02729428|White Matter Hyperintensity Volume|white matter hyperintensity volume
234940|NCT02729428|Default Mode Network Connectivity|default mode network connectivity
234941|NCT02729428|Cognitive Function|cognitive function
234942|NCT02729428|Cardiorespiratory Fitness|cardiorespiratory fitness
234943|NCT02729428|Magnetic Resonance Imaging|magnetic resonance imaging
234944|NCT02729415|Hair Diseases|hair diseases
234945|NCT02729415|Alopecia|alopecia
234946|NCT02729402|Adults|adults
234947|NCT02729389|Social Status|social status
234948|NCT02729389|Hispanics|hispanics
234949|NCT02729389|Energy Balance|energy balance
234950|NCT02729389|Stress|stress
234951|NCT02729376|Healthy Volunteers|healthy volunteers
234952|NCT02729337|technology|technology
234953|NCT02729337|adolescent|adolescent
234954|NCT02729337|developing country|developing country
234955|NCT02729337|hiv prevention|hiv prevention
234956|NCT02729337|mHealth|mhealth
234957|NCT02729324|nasopharyngeal carcinoma (NPC)|nasopharyngeal carcinoma (npc)
234958|NCT02729324|radiation dermatitis|radiation dermatitis
234959|NCT02729324|intensity modulated radiation therapy (IMRT)|intensity modulated radiation therapy (imrt)
234960|NCT02729311|exercise|exercise
234961|NCT02729311|function|function
234962|NCT02729311|quality of life|quality of life
234963|NCT02729311|caregiver|caregiver
234964|NCT02729298|Tolero|tolero
234965|NCT02729298|Phase 1a / 1b|phase 1a / 1b
234966|NCT02729298|First in human|first in human
234967|NCT02729298|Solid Tumors with immunotherapy progression|solid tumors with immunotherapy progression
234968|NCT02729298|AXL inhibitor|axl inhibitor
234969|NCT02729298|Advanced Malignancy|advanced malignancy
234970|NCT02729298|Cancer|cancer
234971|NCT02729298|EGFR+ NSCLC with progression on ≤2 lines of oral TKIs|egfr+ nsclc with progression on ≤2 lines of oral tkis
234972|NCT02729298|BRAF-Mutated CRC|braf-mutated crc
234973|NCT02729298|KRAS-Mutated CRC|kras-mutated crc
234974|NCT02729298|NRAS-Mutated CRC|nras-mutated crc
234975|NCT02729298|Persistent/Recurrent Ovarian Cancer|persistent/recurrent ovarian cancer
234976|NCT02729298|BRAF-Mutated Melanoma with immunotherapy progression|braf-mutated melanoma with immunotherapy progression
234977|NCT02729259|VRD|vrd
234978|NCT02729233|mucosal barrier function|mucosal barrier function
234979|NCT02729220|Aging|aging
234980|NCT02729220|Oxidative stress|oxidative stress
234981|NCT02729220|Proteases|proteases
234982|NCT02729220|Bronchoscopy|bronchoscopy
234983|NCT02729207|NSAID Patch|nsaid patch
234984|NCT02729168|Rabies|rabies
234985|NCT02729168|Vaccine|vaccine
234986|NCT02729168|Safety|safety
234987|NCT02729168|INDIRAB|indirab
234988|NCT02729168|Vietnam|vietnam
234989|NCT02729155|Ischemic Preconditioning|ischemic preconditioning
234990|NCT02729155|Postconditioning|postconditioning
234991|NCT02729155|Angioplasty|angioplasty
234992|NCT02729155|Angiography|angiography
234993|NCT02729155|Contrast-Induced Nephropathy|contrast-induced nephropathy
234994|NCT02729142|HRpQCT|hrpqct
234995|NCT02729142|transplant|transplant
234996|NCT02729142|bone microarchitecture|bone microarchitecture
234997|NCT02729129|Diesel exhaust|diesel exhaust
234998|NCT02729129|Air pollution|air pollution
234999|NCT02729129|Intervention|intervention
235000|NCT02729129|Plethysmography|plethysmography
235001|NCT02729116|Extended-Spectrum ß-lactamase-producing Escherichia coli|extended-spectrum ß-lactamase-producing escherichia coli
235002|NCT02729116|Extended-Spectrum ß-lactamase-producing Klebsiella pneumoniae|extended-spectrum ß-lactamase-producing klebsiella pneumoniae
235003|NCT02729116|Kidney Transplantation|kidney transplantation
235004|NCT02729116|Urinary Tract Infections|urinary tract infections
235005|NCT02729090|Peripheral Arterial Disease, exercise|peripheral arterial disease, exercise
235006|NCT02729064|Intranasal Insulin|intranasal insulin
235007|NCT02729064|Insulin concentration|insulin concentration
235008|NCT02729064|Blood glucose|blood glucose
235009|NCT02729064|Cerebro Spinal Fluid insulin|cerebro spinal fluid insulin
300475|NCT02343458|COPD|copd
235010|NCT02729064|Intraoperative blood glucose|intraoperative blood glucose
235011|NCT02729064|Cardiac Surgery|cardiac surgery
235012|NCT02729064|Thoracic Surgery|thoracic surgery
235013|NCT02729051|Chronic Obstructive Pulmonary Disease (COPD)|chronic obstructive pulmonary disease (copd)
235014|NCT02729051|fluticasone furoate/umeclidinium bromide/vilanterol (FF/UMEC/VI)|fluticasone furoate/umeclidinium bromide/vilanterol (ff/umec/vi)
235015|NCT02729051|Umeclidinium bromide (UMEC)|umeclidinium bromide (umec)
235016|NCT02729051|Closed triple therapy|closed triple therapy
235017|NCT02729051|Placebo|placebo
235018|NCT02729051|Open triple therapy|open triple therapy
235019|NCT02729051|fluticasone furoate/vilanterol (FF/VI)|fluticasone furoate/vilanterol (ff/vi)
235020|NCT02729038|Normal Renal Function|normal renal function
235021|NCT02729038|end stage renal disease (ESRD)|end stage renal disease (esrd)
235022|NCT02729038|Pharmacokinetics|pharmacokinetics
235023|NCT02729038|Gepotidacin|gepotidacin
235024|NCT02729038|Renal Impairment|renal impairment
235025|NCT02729025|Hyperlipidemia|hyperlipidemia
235026|NCT02729025|Dyslipidemia|dyslipidemia
235027|NCT02729025|Proprotein convertase subtilisin/kexin type 9 (PCSK9) Inhibition|proprotein convertase subtilisin/kexin type 9 (pcsk9) inhibition
235028|NCT02729025|Arterial Wall Inflamation|arterial wall inflamation
235029|NCT02729025|Elevated lipoprotein a|elevated lipoprotein a
235030|NCT02729012|Children|children
235031|NCT02728999|Trendelenburg position|trendelenburg position
235032|NCT02728999|Robotic assisted gynecologic procedures|robotic assisted gynecologic procedures
235033|NCT02728999|benign gynecologic conditions|benign gynecologic conditions
235034|NCT02728986|Costs and Cost Analysis|costs and cost analysis
235035|NCT02728986|Humans|humans
235036|NCT02728986|Health Care Costs|health care costs
235037|NCT02728986|varicose ulcer|varicose ulcer
235038|NCT02728986|Compression Bandages|compression bandages
235039|NCT02728973|colorectal resection|colorectal resection
235040|NCT02728973|enhanced recovery after surgery|enhanced recovery after surgery
235041|NCT02728973|Postoperative Complications|postoperative complications
235042|NCT02728973|length of hospital stay|length of hospital stay
235043|NCT02728947|Parkinson's Disease|parkinson's disease
235044|NCT02728934|Rheumatoid Arthritis|rheumatoid arthritis
235045|NCT02728934|Golimumab|golimumab
235046|NCT02728934|Infliximab|infliximab
235047|NCT02728895|Drug Therapy|drug therapy
235048|NCT02728882|Lymphoma CAR-T|lymphoma car-t
235049|NCT02728843|Parkinson's disease|parkinson's disease
235050|NCT02728843|Deferiprone|deferiprone
235051|NCT02728830|gynecologic cancers|gynecologic cancers
235052|NCT02728830|mullerian cancers|mullerian cancers
235053|NCT02728830|tumoral immunoprofile|tumoral immunoprofile
235054|NCT02728817|Vascular access|vascular access
235055|NCT02728817|Hemodialysis|hemodialysis
235056|NCT02728817|Arteriovenous fistula|arteriovenous fistula
235057|NCT02728817|Stenosis|stenosis
235058|NCT02728817|Failure|failure
235060|NCT02728726|Postoperative respiratory depression|postoperative respiratory depression
235061|NCT02728726|Neuromuscular Agents|neuromuscular agents
235062|NCT02728713|Cranial manipulation|cranial manipulation
235063|NCT02728713|Visual function|visual function
235064|NCT02728687|peripheral neuropathy|peripheral neuropathy
235065|NCT02728687|Diabetes|diabetes
235066|NCT02728687|Pain|pain
235067|NCT02728674|COPD|copd
235068|NCT02728674|Breathlessness|breathlessness
235069|NCT02728674|Symptom|symptom
235070|NCT02728674|Opioids|opioids
235071|NCT02728674|Gender bias|gender bias
235072|NCT02728648|Pain Management|pain management
235073|NCT02728648|Pharmacokinetics|pharmacokinetics
235074|NCT02728648|Pharmacodynamics|pharmacodynamics
235075|NCT02728635|Adipose tissue, epigenetic, abdominal gluteal fat|adipose tissue, epigenetic, abdominal gluteal fat
235076|NCT02728622|ovarian cancer|ovarian cancer
235077|NCT02728622|platinum-resistant|platinum-resistant
235078|NCT02728622|endocrine treatment|endocrine treatment
235079|NCT02728622|chemotherapy|chemotherapy
235080|NCT02728622|tamoxifen|tamoxifen
235081|NCT02728583|Plant sterols|plant sterols
235082|NCT02728583|Fish oil|fish oil
235083|NCT02728583|Blood lipids|blood lipids
235084|NCT02728570|flavonoids|flavonoids
235085|NCT02728570|insulin resistance|insulin resistance
235086|NCT02728570|plasma lipids|plasma lipids
235087|NCT02728570|intestinal microbiome|intestinal microbiome
235088|NCT02728570|intestinal inflammation|intestinal inflammation
235089|NCT02728570|subclinical inflammation|subclinical inflammation
235090|NCT02728557|Therapeutic alliance|therapeutic alliance
235091|NCT02728557|Psychotherapy|psychotherapy
235092|NCT02728557|Psychodynamic psychotherapy|psychodynamic psychotherapy
235093|NCT02728557|supportive-expressive treatment|supportive-expressive treatment
235094|NCT02728557|Process research|process research
235095|NCT02728557|Attachment theory|attachment theory
235096|NCT02728557|Attachment orientation|attachment orientation
235097|NCT02728557|Mechanism of change in psychotherapy|mechanism of change in psychotherapy
235098|NCT02728466|flavanols|flavanols
235099|NCT02728466|cocoa procyanidins|cocoa procyanidins
235100|NCT02728466|vascular function|vascular function
235101|NCT02728466|endothelial function|endothelial function
235102|NCT02728427|Suprapubic Catheterization|suprapubic catheterization
235103|NCT02728427|Transurethral Catheterization|transurethral catheterization
235104|NCT02728427|Rectal Cancer|rectal cancer
235105|NCT02728427|Laparoscopic Surgery|laparoscopic surgery
235106|NCT02728414|Diabetes Mellitus, Type 2, Probiotics, Treatment|diabetes mellitus, type 2, probiotics, treatment
235107|NCT02728401|inflammation|inflammation
235108|NCT02728401|sepsis|sepsis
235109|NCT02728401|pediatric|pediatric
235110|NCT02728401|transcripts|transcripts
235111|NCT02728401|serum proteins|serum proteins
235112|NCT02728401|cardiopulmonary bypass|cardiopulmonary bypass
235114|NCT02728388|Neurofibroma|neurofibroma
235115|NCT02728388|Neurofibromatosis Type 1|neurofibromatosis type 1
235116|NCT02728362|tibial shaft fractures|tibial shaft fractures
235117|NCT02728284|Magnetic Resonance Imaging (MRI)|magnetic resonance imaging (mri)
235118|NCT02728219|Recurrent Hepatocellular Carcinoma|recurrent hepatocellular carcinoma
235119|NCT02728219|transcatheter arterial chemoembolization|transcatheter arterial chemoembolization
235120|NCT02728219|AFP conversion|afp conversion
235121|NCT02728193|treatments|treatments
235122|NCT02728193|hepatocellular carcinoma|hepatocellular carcinoma
235123|NCT02728180|Acute Ischemic Stroke|acute ischemic stroke
235124|NCT02728180|Xingnaojing injection|xingnaojing injection
235125|NCT02728180|Randomized Controlled Trial|randomized controlled trial
235126|NCT02728180|Traditional Chinese Medicine|traditional chinese medicine
235127|NCT02728167|Hepatectomy|hepatectomy
235128|NCT02728167|Liver metastasis|liver metastasis
235129|NCT02728167|High-Intensity Focused Ultrasound|high-intensity focused ultrasound
235130|NCT02728167|Liver metastases (LM) requiring surgery|liver metastases (lm) requiring surgery
235131|NCT02728154|pre-clinical diastolic dysfunction (pre-HFpEF)|pre-clinical diastolic dysfunction (pre-hfpef)
235132|NCT02728128|Milrinone|milrinone
235133|NCT02728115|Huntington's Disease|huntington's disease
235134|NCT02728115|Stem Cell|stem cell
235135|NCT02728115|Dental Pulp Stem Cells|dental pulp stem cells
235136|NCT02728102|Multiple Myeloma|multiple myeloma
235137|NCT02728102|Lenalidomide|lenalidomide
235138|NCT02728102|Maintenance Therapy|maintenance therapy
235139|NCT02728102|Hematologic Disorders|hematologic disorders
235140|NCT02728102|Vaccine|vaccine
235141|NCT02728102|GM-CSF|gm-csf
235142|NCT02728102|Transplant|transplant
235143|NCT02728102|Anti-Myeloma Agents|anti-myeloma agents
235144|NCT02728076|Breast Cancer|breast cancer
235145|NCT02728076|Accelerated Partial Breast Irradiation|accelerated partial breast irradiation
235146|NCT02728037|Myofascial Trigger Points|myofascial trigger points
235147|NCT02728037|Myofascial Pain|myofascial pain
235148|NCT02728037|Intramuscular Anesthetic Injection|intramuscular anesthetic injection
235149|NCT02727998|PTSD|ptsd
235150|NCT02727972|depression|depression
235151|NCT02727972|bipolar|bipolar
235152|NCT02727972|post-traumatic stress disorder|post-traumatic stress disorder
235153|NCT02727972|mood disorders|mood disorders
235154|NCT02727972|PET|pet
235155|NCT02727972|mGluRr|mglurr
235156|NCT02727972|glutamate system|glutamate system
235157|NCT02727972|MRI|mri
235158|NCT02727959|UC|uc
235159|NCT02727959|CD|cd
235160|NCT02727959|IBD|ibd
235161|NCT02727894|Screening|screening
235162|NCT02727894|pTNM|ptnm
235163|NCT02727894|Metastasis|metastasis
235164|NCT02727894|Chemotherapy|chemotherapy
235165|NCT02727894|Resection Margins|resection margins
235166|NCT02727894|Colorectal Cancer|colorectal cancer
235167|NCT02727881|AMD, CNV, choroidal neovascularization, retinal eye disease|amd, cnv, choroidal neovascularization, retinal eye disease
235168|NCT02727855|Cholera|cholera
235169|NCT02727855|Vaccine|vaccine
235170|NCT02727855|Strategy|strategy
235171|NCT02727842|cochlear implant|cochlear implant
235172|NCT02727842|Sound Processor|sound processor
235173|NCT02727777|Lymphoma|lymphoma
235174|NCT02727777|Relapsed Lymphoma|relapsed lymphoma
235175|NCT02727777|MLN0128|mln0128
235176|NCT02727777|Blood sugar|blood sugar
235177|NCT02727777|Glucometer|glucometer
235178|NCT02727777|TK228|tk228
235179|NCT02727764|Arthritis|arthritis
235180|NCT02727764|Gene therapy|gene therapy
235181|NCT02727764|Phase Ib|phase ib
235182|NCT02727764|Intra-articular|intra-articular
235183|NCT02727738|Hyperthyroidism|hyperthyroidism
235184|NCT02727738|Methimazole|methimazole
235185|NCT02727738|Selenium|selenium
235186|NCT02727712|coronary artery bypass graft|coronary artery bypass graft
235187|NCT02727712|thoracic paravertebral block|thoracic paravertebral block
235188|NCT02727699|Dementia|dementia
235189|NCT02727699|Alzheimer's Disease|alzheimer's disease
235190|NCT02727699|Xanamem|xanamem
235191|NCT02727699|UE2343|ue2343
235192|NCT02727699|Cortisol|cortisol
235193|NCT02727699|XanADu|xanadu
235194|NCT02727699|Actinogen|actinogen
235195|NCT02727699|11β-HSD1|11β-hsd1
235196|NCT02727699|11-beta-Hydroxysteroid Dehydrogenase Type 1|11-beta-hydroxysteroid dehydrogenase type 1
235197|NCT02727699|Mild Alzheimer's Disease|mild alzheimer's disease
235198|NCT02727699|Cognitive Impairments|cognitive impairments
729790|NCT00510302|Survey|survey
235199|NCT02727686|transsphenoidal pituitary surgery|transsphenoidal pituitary surgery
235200|NCT02727673|cancer stem cells|cancer stem cells
235201|NCT02727660|COPD|copd
235202|NCT02727647|Moderate hemophilia A|moderate hemophilia a
235203|NCT02727647|Severe hemophilia A|severe hemophilia a
235204|NCT02727647|Intermediate dose prophylaxis|intermediate dose prophylaxis
235205|NCT02727647|Low dose prophylaxis|low dose prophylaxis
235206|NCT02727634|Hemodynamics|hemodynamics
235207|NCT02727634|Echocardiography, Doppler, Pulsed|echocardiography, doppler, pulsed
235208|NCT02727621|Dexmedetomidine|dexmedetomidine
235209|NCT02727621|Cardiac|cardiac
235210|NCT02727621|Coronary Artery Bypass Grapht|coronary artery bypass grapht
235211|NCT02727621|Sedation|sedation
235212|NCT02727621|Propofol|propofol
235213|NCT02727621|Intravenous Anesthetics|intravenous anesthetics
235214|NCT02727582|MDR|mdr
235215|NCT02727556|skin conductance response|skin conductance response
235216|NCT02727556|facial muscle activity|facial muscle activity
235217|NCT02727556|heart rate variability|heart rate variability
235218|NCT02727556|eyetracking|eyetracking
235219|NCT02727543|Hypertension|hypertension
235220|NCT02727543|mHealth|mhealth
235221|NCT02727543|Medication Non-adherence|medication non-adherence
235222|NCT02727530|Infant Colic|infant colic
235223|NCT02727530|Manual Therapy|manual therapy
235224|NCT02727530|Effectiveness|effectiveness
235225|NCT02727517|Resuscitation|resuscitation
235226|NCT02727517|Cord clamping|cord clamping
235227|NCT02727504|Aortic valve stenosis|aortic valve stenosis
235228|NCT02727504|low flow|low flow
235229|NCT02727504|dobutamine stress echocardiography|dobutamine stress echocardiography
235230|NCT02727491|opioid analgesics,|opioid analgesics,
235231|NCT02727491|opioid consumption|opioid consumption
235232|NCT02727491|adverse effects|adverse effects
235233|NCT02727491|postoperative pain|postoperative pain
235234|NCT02727491|tonsillectomy|tonsillectomy
235235|NCT02727478|Balance|balance
235236|NCT02727478|Rehabilitation|rehabilitation
235237|NCT02727478|Exercise|exercise
235238|NCT02727478|basal ganglia|basal ganglia
235239|NCT02727478|Gait|gait
235240|NCT02727478|Training|training
235241|NCT02727478|physical activity|physical activity
235242|NCT02727439|microvascular function|microvascular function
235243|NCT02727439|laser Doppler flowmetry|laser doppler flowmetry
235244|NCT02727439|exercise|exercise
235245|NCT02727426|microvascular function|microvascular function
235246|NCT02727426|laser Doppler flowmetry|laser doppler flowmetry
235247|NCT02727426|high salt diet|high salt diet
235248|NCT02727374|Fear to Fall|fear to fall
235249|NCT02727374|Geriatric|geriatric
235250|NCT02727374|Rehabilitation|rehabilitation
235251|NCT02727374|Psychology|psychology
235253|NCT02727361|Binding potential|binding potential
235254|NCT02727361|FEOBV|feobv
235255|NCT02727348|femoral sciatic block spinal diabetic foot haemodynamic pain|femoral sciatic block spinal diabetic foot haemodynamic pain
235256|NCT02727335|Non-squamous non-small cell lung cancer|non-squamous non-small cell lung cancer
235257|NCT02727335|crizotinib|crizotinib
235258|NCT02727309|Apatinib|apatinib
235259|NCT02727309|Second-line Treatment|second-line treatment
235260|NCT02727309|Hepatocellular Cancer|hepatocellular cancer
235261|NCT02727309|TACE|tace
235262|NCT02727283|Healthy volunteer|healthy volunteer
235263|NCT02727283|Safety|safety
235264|NCT02727283|Pharmacokinetics|pharmacokinetics
235265|NCT02727283|Dose escalation|dose escalation
235266|NCT02727283|GSK3179106|gsk3179106
235267|NCT02727283|Rearranged during Transfection|rearranged during transfection
235268|NCT02727283|Irritable Bowel Syndrome|irritable bowel syndrome
235269|NCT02727283|Adults|adults
235270|NCT02727270|Movement disorders|movement disorders
235271|NCT02727270|Metabolic Stress|metabolic stress
235272|NCT02727257|Parkinson's disease|parkinson's disease
235273|NCT02727257|rehabilitation|rehabilitation
235274|NCT02727257|attention|attention
235275|NCT02727257|executive functions|executive functions
235276|NCT02727244|Pain Catastrophizing Scale|pain catastrophizing scale
235277|NCT02727231|closed loop glucose control|closed loop glucose control
235278|NCT02727231|hypoglycemia|hypoglycemia
235279|NCT02727231|type 1 diabetes|type 1 diabetes
235280|NCT02727231|HbA1C<7.5%|hba1c<7.5%
235281|NCT02727166|intestinal gas|intestinal gas
235282|NCT02727166|functional gut symptoms|functional gut symptoms
235283|NCT02727166|intestinal sensitivity|intestinal sensitivity
235284|NCT02727166|intestinal motility|intestinal motility
235285|NCT02727153|Colonic cancer|colonic cancer
235286|NCT02727153|E.R.A.S. programs|e.r.a.s. programs
235287|NCT02727153|Safety|safety
235288|NCT02727114|skin thickness|skin thickness
235289|NCT02727114|high-frequency ultrasound|high-frequency ultrasound
235290|NCT02727101|Focal epilepsy, Perampanel|focal epilepsy, perampanel
235291|NCT02727088|Dental Pulp Disease|dental pulp disease
235292|NCT02727088|Endodontics|endodontics
235293|NCT02727088|Pulp Capping|pulp capping
235294|NCT02727088|Pulpotomy|pulpotomy
235295|NCT02727088|Pulpectomy|pulpectomy
235296|NCT02727075|Occult Gastrointestinal Bleeding|occult gastrointestinal bleeding
730288|NCT00508872|Oxaliplatin|oxaliplatin
235297|NCT02727075|Iron Deficiency Anemia|iron deficiency anemia
235298|NCT02727075|Aged 75 Years and Older|aged 75 years and older
235299|NCT02727062|pain|pain
235300|NCT02727062|radiation|radiation
235301|NCT02727062|head and neck cancer|head and neck cancer
235302|NCT02727062|smartphone pain app|smartphone pain app
235303|NCT02727062|OM Pain App|om pain app
235304|NCT02727023|Healthy|healthy
235305|NCT02727010|Motor disability|motor disability
235306|NCT02727010|Motor impairment|motor impairment
235307|NCT02727010|Pregnancy|pregnancy
235308|NCT02727010|Parenthood|parenthood
235309|NCT02727010|Child psychology|child psychology
235310|NCT02726984|stroke|stroke
235311|NCT02726984|carotid plaque|carotid plaque
235312|NCT02726984|18F-sodium fluoride PET/MR|18f-sodium fluoride pet/mr
235313|NCT02726971|Intrauterine Adhesion|intrauterine adhesion
235314|NCT02726971|Oestrogen Artificial Periodic Therapy|oestrogen artificial periodic therapy
235315|NCT02726958|aortic valve replacement|aortic valve replacement
235316|NCT02726958|percutaneous valve|percutaneous valve
235317|NCT02726958|blood glucose variability|blood glucose variability
235318|NCT02726958|TAVI|tavi
235319|NCT02726932|Peritonitis|peritonitis
235320|NCT02726932|Inflammatory Markers|inflammatory markers
235321|NCT02726932|Patient Outcome Assessment|patient outcome assessment
235322|NCT02726932|Classification|classification
235323|NCT02726932|Multiple Organ Failure|multiple organ failure
235324|NCT02726932|Intraabdominal Infections|intraabdominal infections
235325|NCT02726919|focal epilepsy|focal epilepsy
235326|NCT02726919|clobazam|clobazam
235327|NCT02726906|Alzheimer's disease|alzheimer's disease
235328|NCT02726906|Mild Cognitive Impairment|mild cognitive impairment
235329|NCT02726906|Brain Imaging|brain imaging
235330|NCT02726867|refractory status epilepticus|refractory status epilepticus
235331|NCT02726867|levetiracetam|levetiracetam
235332|NCT02726867|lacosamide|lacosamide
235333|NCT02726867|ketamine|ketamine
235334|NCT02726841|Thoracic aorta|thoracic aorta
235335|NCT02726841|Abdominal aorta|abdominal aorta
235336|NCT02726841|Stents|stents
235337|NCT02726789|nucleic acid polymer REP 2139 HBsAg hepatitis B|nucleic acid polymer rep 2139 hbsag hepatitis b
235338|NCT02726763|Transcranial Direct Current Stimulation (tDCS)|transcranial direct current stimulation (tdcs)
235339|NCT02726763|Cognitive Training|cognitive training
235340|NCT02726763|16-034|16-034
235341|NCT02726750|Monoclonal gammopathy of unknown significance|monoclonal gammopathy of unknown significance
235342|NCT02726750|MGUS|mgus
235343|NCT02726750|Smoldering multiple myeloma|smoldering multiple myeloma
235344|NCT02726750|SMM|smm
235345|NCT02726750|Asymptomatic monoclonal gammopathies|asymptomatic monoclonal gammopathies
235346|NCT02726750|Biomarker testing|biomarker testing
235347|NCT02726750|Blood collection|blood collection
235348|NCT02726750|Blood draw|blood draw
236050|NCT02722954|Demcizumab|demcizumab
235349|NCT02726737|inferior alveolar nerve block|inferior alveolar nerve block
235350|NCT02726737|irreversible pulpitis|irreversible pulpitis
235351|NCT02726737|local anesthesia|local anesthesia
235352|NCT02726737|sodium bicarbonate|sodium bicarbonate
235353|NCT02726724|Stress-Resident performance-Observers|stress-resident performance-observers
235354|NCT02726685|respiratory training|respiratory training
235355|NCT02726685|functional performance|functional performance
235356|NCT02726672|inspiratory muscles|inspiratory muscles
235357|NCT02726672|multiple sclerosis|multiple sclerosis
235358|NCT02726672|rehabilitation|rehabilitation
235359|NCT02726646|Local Drug Delivery|local drug delivery
235360|NCT02726646|Antibiotics|antibiotics
235361|NCT02726646|Doxycycline|doxycycline
235362|NCT02726646|Smokers|smokers
235363|NCT02726646|Chronic Periodontitis|chronic periodontitis
235364|NCT02726620|Decision support|decision support
235365|NCT02726620|Decision Support Systems, Clinical|decision support systems, clinical
235366|NCT02726620|Decision Support Techniques|decision support techniques
235367|NCT02726620|Hypotension|hypotension
235368|NCT02726620|Intraoperative Hypotension|intraoperative hypotension
235369|NCT02726620|Acute Kidney Injury|acute kidney injury
235370|NCT02726620|Postoperative Mortality|postoperative mortality
235371|NCT02726620|Blood Pressure|blood pressure
235372|NCT02726607|Prevention of mother-to-child transmission (PMTCT)|prevention of mother-to-child transmission (pmtct)
235373|NCT02726607|Kenya|kenya
235374|NCT02726607|HITSystem 2.0|hitsystem 2.0
235375|NCT02726607|retention through PMTCT cascade of care|retention through pmtct cascade of care
235376|NCT02726607|Early Infant Diagnosis|early infant diagnosis
235377|NCT02726607|eHealth system-level intervention|ehealth system-level intervention
235378|NCT02726594|Magnetic Resonance Imaging, Patient Satisfaction|magnetic resonance imaging, patient satisfaction
235379|NCT02726568|EGFR-TKI|egfr-tki
235380|NCT02726568|NSCLC|nsclc
235381|NCT02726568|Icotinib|icotinib
235382|NCT02726568|SRS|srs
235383|NCT02726568|radiotherapy|radiotherapy
235384|NCT02726555|Red yeast rice|red yeast rice
235385|NCT02726555|Atorvastatin|atorvastatin
235386|NCT02726555|Mild cardiovascular disease|mild cardiovascular disease
235387|NCT02726542|obesity|obesity
235388|NCT02726542|adolescence|adolescence
235389|NCT02726542|fatty liver|fatty liver
235390|NCT02726542|growth hormone|growth hormone
235391|NCT02726516|Performance|performance
235392|NCT02726503|anaplastic thyroid cancer, lenvatinib|anaplastic thyroid cancer, lenvatinib
235393|NCT02726490|gestational diabetes, pregnancy, diabetes|gestational diabetes, pregnancy, diabetes
235394|NCT02726464|Platelet-rich Plasma|platelet-rich plasma
235395|NCT02726464|Cell-Derived Microparticles|cell-derived microparticles
235396|NCT02726464|Pain Management|pain management
235397|NCT02726464|Blood Platelets|blood platelets
235398|NCT02726464|Therapeutics|therapeutics
235399|NCT02726464|Inflammation|inflammation
235400|NCT02726464|ThromboLUX|thrombolux
235401|NCT02726464|Dynamic Light Scattering|dynamic light scattering
235402|NCT02726425|Diabetes self management|diabetes self management
235403|NCT02726425|Second Life platform|second life platform
235404|NCT02726425|Medical group visits|medical group visits
235405|NCT02726399|Ramucirumab|ramucirumab
235406|NCT02726399|Trastuzumab|trastuzumab
235407|NCT02726399|Capecitabine|capecitabine
235408|NCT02726399|Cisplatin|cisplatin
235409|NCT02726399|HER2-Positive|her2-positive
235410|NCT02726399|15-301|15-301
235411|NCT02726360|Communication|communication
235412|NCT02726360|15-316|15-316
235413|NCT02726360|Physician|physician
235414|NCT02726360|Use|use
235415|NCT02726360|Non-English|non-english
235416|NCT02726360|Language Skills|language skills
235417|NCT02726334|Metastatic|metastatic
235418|NCT02726308|Dexamethasone|dexamethasone
235419|NCT02726308|Super-hydration|super-hydration
235420|NCT02726308|Laparoscopic Cholecystectomy|laparoscopic cholecystectomy
235421|NCT02726308|Nausea|nausea
235422|NCT02726308|Vomiting|vomiting
235423|NCT02726308|Postoperative|postoperative
235424|NCT02726269|Helicobacter Pylory infections|helicobacter pylory infections
235425|NCT02726269|Levofloxacin|levofloxacin
235426|NCT02726269|Antibiotic resistance|antibiotic resistance
235427|NCT02726269|Clarithromycin|clarithromycin
235428|NCT02726269|Mutations|mutations
235429|NCT02726269|Fluorescence|fluorescence
235430|NCT02726269|Hybridization|hybridization
235431|NCT02726256|Diabetes|diabetes
235432|NCT02726256|DM complication|dm complication
235433|NCT02726243|Inflammatory bowel disease|inflammatory bowel disease
235434|NCT02726243|Crohn's Disease|crohn's disease
235435|NCT02726243|Ulcerative Colitis|ulcerative colitis
235436|NCT02726243|colorectal cancer|colorectal cancer
235437|NCT02726243|primary sclerosing cholangitis|primary sclerosing cholangitis
235438|NCT02726217|CareSmarts|caresmarts
235439|NCT02726217|SMS-based mobile|sms-based mobile
235440|NCT02726178|Apnea|apnea
235441|NCT02726178|bradycardia|bradycardia
235442|NCT02726178|immunization|immunization
235443|NCT02726178|inflammation|inflammation
235444|NCT02726178|preterms|preterms
235445|NCT02726152|Diagnostic laparoscopy|diagnostic laparoscopy
235446|NCT02726152|Acute appendicitis|acute appendicitis
236256|NCT02721628|Keratoconus|keratoconus
235447|NCT02726152|Appendiceal stump|appendiceal stump
235448|NCT02726139|Factor VIII|factor viii
235449|NCT02726139|inhibitor|inhibitor
235450|NCT02726139|assay|assay
235451|NCT02726126|Transdermal fentanyl|transdermal fentanyl
235452|NCT02726126|Transdermal melatonin|transdermal melatonin
235453|NCT02726126|Postoperative pain|postoperative pain
235454|NCT02726126|lumber laminectomy|lumber laminectomy
235455|NCT02726126|Relief|relief
235456|NCT02726113|prostate cancer|prostate cancer
235457|NCT02726113|vitamin D|vitamin d
235458|NCT02726100|Telemedicine|telemedicine
235459|NCT02726100|Diabetes Mellitus, Type 2|diabetes mellitus, type 2
235460|NCT02726100|Decision Support Systems, Clinical|decision support systems, clinical
235461|NCT02726100|Family Health Promoter|family health promoter
235462|NCT02726100|Primary Health Care|primary health care
235463|NCT02726087|Ministernotomy|ministernotomy
235464|NCT02726087|aortic valve stenosis|aortic valve stenosis
235465|NCT02726087|quality of life|quality of life
235466|NCT02726087|satisfaction|satisfaction
235467|NCT02726087|cardiac surgery|cardiac surgery
235468|NCT02726074|epilepsy|epilepsy
235469|NCT02726074|partial-onset seizures|partial-onset seizures
235470|NCT02726074|secondarily generalized seizures|secondarily generalized seizures
235471|NCT02726035|Self-injurious behavior|self-injurious behavior
235472|NCT02726035|Self mutilation|self mutilation
235473|NCT02726035|naltrexone|naltrexone
235474|NCT02725996|Hepatocellular Carcinoma|hepatocellular carcinoma
235475|NCT02725996|Natural Killer cells|natural killer cells
235476|NCT02725983|Gingivitis|gingivitis
235477|NCT02725983|Oral Hygiene|oral hygiene
235478|NCT02725983|Intra oral camera|intra oral camera
235479|NCT02725983|Self regulation|self regulation
235480|NCT02725983|bleeding|bleeding
235481|NCT02725970|HEALTH|health
235482|NCT02725970|barriers|barriers
235483|NCT02725970|facilitators|facilitators
235485|NCT02725970|BMI|bmi
235486|NCT02725970|Public Schools|public schools
235487|NCT02725957|Bioblast|bioblast
235488|NCT02725944|Cryptogenic stroke|cryptogenic stroke
235489|NCT02725944|Occult paroxysmal atrial fibrillation|occult paroxysmal atrial fibrillation
730289|NCT00508872|Eloxatin|eloxatin
235490|NCT02725931|Chronic obstructive pulmonary disease|chronic obstructive pulmonary disease
235491|NCT02725931|COPD|copd
235492|NCT02725931|Pulmonary rehabilitation|pulmonary rehabilitation
235493|NCT02725931|Physical activity|physical activity
235494|NCT02725931|Exercise|exercise
235495|NCT02725918|NSCLC|nsclc
235496|NCT02725918|EGFR-TKI failure|egfr-tki failure
235497|NCT02725918|chemotherapy|chemotherapy
235498|NCT02725905|Weight Management Counseling|weight management counseling
235499|NCT02725905|Medical School Education|medical school education
235500|NCT02725892|lung cancer epidemiology algeria registry|lung cancer epidemiology algeria registry
235501|NCT02725866|Observational Study|observational study
235502|NCT02725866|Sustained Virological Response|sustained virological response
235503|NCT02725866|Chronic Hepatitis C genotype 1|chronic hepatitis c genotype 1
235504|NCT02725866|Chronic Hepatitis C|chronic hepatitis c
235505|NCT02725866|Ombitasvir/paritaprevir/ritonavir ± dasabuvir|ombitasvir/paritaprevir/ritonavir ± dasabuvir
235506|NCT02725866|Chronic Hepatitis C genotype 4|chronic hepatitis c genotype 4
235507|NCT02725853|Transcranial Direct Current Stimulation|transcranial direct current stimulation
235508|NCT02725853|Arm Training|arm training
235509|NCT02725853|Virtual Reality Exposure Therapy|virtual reality exposure therapy
235510|NCT02725840|pulmonary vasculature|pulmonary vasculature
235511|NCT02725840|radiation late effects|radiation late effects
235512|NCT02725840|proton therapy|proton therapy
235513|NCT02725814|Sucrose|sucrose
235514|NCT02725814|Effectiveness|effectiveness
235515|NCT02725814|Healthcare Delivery|healthcare delivery
235516|NCT02725814|Neonates|neonates
235517|NCT02725814|Nursing|nursing
235518|NCT02725775|Orange Juice, Polyphenol, Cognition|orange juice, polyphenol, cognition
235519|NCT02725762|Dry AMD|dry amd
235520|NCT02725762|Vision Loss|vision loss
235521|NCT02725762|AMD|amd
235522|NCT02725749|shoulder|shoulder
235523|NCT02725749|low level laser therapy|low level laser therapy
235524|NCT02725749|exercises|exercises
235525|NCT02725710|uterine aspiration|uterine aspiration
235526|NCT02725658|Neoadjuvant Therapy|neoadjuvant therapy
235527|NCT02725658|Diffuse Optical Spectroscopic Imaging|diffuse optical spectroscopic imaging
235528|NCT02725658|DOSI|dosi
235529|NCT02725658|Neoadjuvant Chemotherapy|neoadjuvant chemotherapy
235530|NCT02725645|Surface electromyography|surface electromyography
235531|NCT02725645|children|children
235532|NCT02725645|backpack|backpack
235533|NCT02725632|Sodium channel|sodium channel
235534|NCT02725632|splicing variant|splicing variant
235535|NCT02725632|sleep apnea syndrome|sleep apnea syndrome
235536|NCT02725606|Neutropenia|neutropenia
235537|NCT02725606|Breast Cancer|breast cancer
235538|NCT02725606|GW003|gw003
235539|NCT02725593|Diabetes Mellitus|diabetes mellitus
235540|NCT02725593|Dapagliflozin|dapagliflozin
235541|NCT02725593|Placebo|placebo
235542|NCT02725593|Insulin resistance|insulin resistance
235543|NCT02725593|Metabolic Diseases|metabolic diseases
235544|NCT02725580|Neuronal ceroid lipofuscinosis|neuronal ceroid lipofuscinosis
235545|NCT02725580|NCL|ncl
235546|NCT02725580|Gene Transfer|gene transfer
235547|NCT02725541|HER2 equivocal|her2 equivocal
235548|NCT02725541|Trastuzumab emtansine|trastuzumab emtansine
235549|NCT02725541|Breast cancer|breast cancer
235550|NCT02725502|T1DM|t1dm
235551|NCT02725502|Linagliptin|linagliptin
235552|NCT02725502|mix meal test|mix meal test
235553|NCT02725489|Vigil|vigil
235554|NCT02725489|durvalumab|durvalumab
235555|NCT02725489|MEDI4736|medi4736
235556|NCT02725489|PD-L1|pd-l1
235557|NCT02725489|anti PD-L1|anti pd-l1
235558|NCT02725489|immunotherapy|immunotherapy
235559|NCT02725489|PD-L1 inhibitor|pd-l1 inhibitor
235560|NCT02725489|breast cancer|breast cancer
235561|NCT02725489|ovarian cancer|ovarian cancer
235562|NCT02725489|fallopian tube cancer|fallopian tube cancer
235563|NCT02725489|primary peritoneal cancer|primary peritoneal cancer
235564|NCT02725489|uterine cancer|uterine cancer
235565|NCT02725489|cervical cancer|cervical cancer
235566|NCT02725489|endometrial cancer|endometrial cancer
235567|NCT02725463|vestibular|vestibular
235568|NCT02725463|implant|implant
235569|NCT02725463|prosthesis|prosthesis
235570|NCT02725463|labyrinth|labyrinth
235571|NCT02725463|ototoxicity|ototoxicity
235572|NCT02725463|gentamicin|gentamicin
235573|NCT02725463|oscillopsia|oscillopsia
235574|NCT02725463|disequilibrium|disequilibrium
235575|NCT02725463|dizziness|dizziness
235576|NCT02725463|vestibulopathy|vestibulopathy
235577|NCT02725463|inner ear|inner ear
235578|NCT02725450|Motor Imagery|motor imagery
235579|NCT02725450|Fine motor skills|fine motor skills
235580|NCT02725450|Disabled|disabled
235581|NCT02725411|Chronic low back pain|chronic low back pain
235582|NCT02725411|Chronic pain|chronic pain
235583|NCT02725398|Buscopan|buscopan
235584|NCT02725398|probe-based confocal laser endomicroscopy|probe-based confocal laser endomicroscopy
235585|NCT02725398|Imaging Quality|imaging quality
235586|NCT02725385|No Evidence of Disease|no evidence of disease
235587|NCT02725372|Pulmonary Arterial Hypertension|pulmonary arterial hypertension
235588|NCT02725372|PAH|pah
235589|NCT02725372|Inhaled Nitric Oxide|inhaled nitric oxide
235590|NCT02725372|iNO|ino
235591|NCT02725372|long term oxygen therapy|long term oxygen therapy
235592|NCT02725372|oxygen therapy|oxygen therapy
235593|NCT02725359|Thyroidectomy pain|thyroidectomy pain
235594|NCT02725359|Tizanidine|tizanidine
235595|NCT02725359|Postoperative analgesia|postoperative analgesia
235596|NCT02725359|Ultrasound guided Superficial cervical plexus block|ultrasound guided superficial cervical plexus block
235597|NCT02725346|Surgical Planning Solution|surgical planning solution
235598|NCT02725346|Acromioplasty|acromioplasty
235599|NCT02725346|Shoulder Surgery|shoulder surgery
235600|NCT02725346|Critical Shoulder Angle|critical shoulder angle
235601|NCT02725333|Glenohumeral stabilization|glenohumeral stabilization
235602|NCT02725333|Computer tomography|computer tomography
235603|NCT02725333|Subtle or minor instability|subtle or minor instability
235604|NCT02725333|Unstable painful shoulder|unstable painful shoulder
235605|NCT02725333|Apprehension|apprehension
235606|NCT02725333|Dislocation|dislocation
235607|NCT02725333|Subluxation|subluxation
235608|NCT02725333|Kinematics modeling|kinematics modeling
235609|NCT02725333|Biomechanics|biomechanics
235610|NCT02725333|Motion capture|motion capture
235611|NCT02725333|3D simulation|3d simulation
235612|NCT02725320|rotator cuff|rotator cuff
235613|NCT02725320|shoulder reconstruction|shoulder reconstruction
235614|NCT02725294|exacerbation|exacerbation
235615|NCT02725294|access to care|access to care
235616|NCT02725294|telemedicine|telemedicine
235617|NCT02725268|Drug Therapy|drug therapy
235618|NCT02725229|Postoperative pain|postoperative pain
235619|NCT02725229|Parasternal block|parasternal block
235620|NCT02725229|Sternotomy|sternotomy
235621|NCT02725229|TENS|tens
235622|NCT02725203|Cardiovascular risk management|cardiovascular risk management
235623|NCT02725203|behaviour change techniques|behaviour change techniques
235624|NCT02725203|self-management|self-management
235625|NCT02725203|physical activity|physical activity
235626|NCT02725203|nurse-led|nurse-led
235627|NCT02725203|behaviour change wheel|behaviour change wheel
235628|NCT02725203|primary care|primary care
235629|NCT02725203|clustered RCT|clustered rct
235630|NCT02725177|Ocular Sarcoidosis|ocular sarcoidosis
235631|NCT02725164|oxygen|oxygen
235632|NCT02725164|nitrous oxide|nitrous oxide
235633|NCT02725164|sevoflurane|sevoflurane
235634|NCT02725164|carbon dioxide|carbon dioxide
235635|NCT02725164|endotracheal tube|endotracheal tube
235636|NCT02725164|respiration|respiration
235637|NCT02725151|inferior vena cava ultrasound|inferior vena cava ultrasound
235638|NCT02725151|acute|acute
235639|NCT02725151|heart failure|heart failure
235640|NCT02725151|management|management
235641|NCT02725151|decompensation|decompensation
235642|NCT02725138|Helicobacter pylori|helicobacter pylori
235643|NCT02725138|probiotic|probiotic
235644|NCT02725138|bacterial density|bacterial density
235645|NCT02725125|Stomach Cancer CAR-T|stomach cancer car-t
235646|NCT02725099|STEMI|stemi
235647|NCT02725060|POTS|pots
235648|NCT02725060|Orthostatic Intolerance|orthostatic intolerance
235649|NCT02725060|Orthostatic Tachycardia|orthostatic tachycardia
235650|NCT02725047|Osteoarthritis, Knee|osteoarthritis, knee
235651|NCT02725047|Cryotherapy|cryotherapy
235652|NCT02725047|Thermotherapy|thermotherapy
235653|NCT02725047|Hypothermia|hypothermia
235654|NCT02725047|Knee|knee
235655|NCT02725047|Physiotherapy|physiotherapy
235656|NCT02725021|tobacco prevention|tobacco prevention
235657|NCT02725008|Asthma|asthma
235658|NCT02725008|Pediatric|pediatric
235659|NCT02725008|Emergency Department|emergency department
235660|NCT02725008|Dexamethasone|dexamethasone
235661|NCT02725008|Steroid|steroid
235662|NCT02724982|Self esteem|self esteem
235663|NCT02724982|Body mass index|body mass index
235664|NCT02724969|text messaging|text messaging
235665|NCT02724969|short message service|short message service
235666|NCT02724956|supraglottic airway device (SGAD) insertion|supraglottic airway device (sgad) insertion
235667|NCT02724956|SGAD|sgad
235668|NCT02724956|ventilation and intubation|ventilation and intubation
235669|NCT02724956|gastric drainage channel|gastric drainage channel
235670|NCT02724956|fiberoptic assessment|fiberoptic assessment
235671|NCT02724943|child obesity|child obesity
235672|NCT02724943|primary prevention|primary prevention
235673|NCT02724943|primary care|primary care
235674|NCT02724943|weight management|weight management
235675|NCT02724943|child overweight|child overweight
235677|NCT02724930|low back pain, chronic pain, cognitive behavior therapy|low back pain, chronic pain, cognitive behavior therapy
235678|NCT02724904|Allogeneic hematopoietic stem cell transplantation|allogeneic hematopoietic stem cell transplantation
235679|NCT02724904|CNS Non-Hodgkin lymphoma|cns non-hodgkin lymphoma
235680|NCT02724891|Pelvic Floor Dysfunction|pelvic floor dysfunction
235681|NCT02724878|Kidney Cancer|kidney cancer
235682|NCT02724865|Oral Appliance Therapy|oral appliance therapy
235683|NCT02724852|MMR|mmr
235684|NCT02724852|vaccination|vaccination
235685|NCT02724852|HIV|hiv
235686|NCT02724852|Serologic response|serologic response
235687|NCT02724826|Expectations|expectations
235688|NCT02724826|Outcomes|outcomes
235689|NCT02724826|Qigong|qigong
235690|NCT02724826|Exercise therapy|exercise therapy
235691|NCT02724826|Disability|disability
235692|NCT02724826|Neck movements,|neck movements,
235693|NCT02724800|Insomnia|insomnia
235694|NCT02724800|Veterans|veterans
235695|NCT02724800|Cognitive Behavioral Therapy for Insomnia|cognitive behavioral therapy for insomnia
235696|NCT02724800|Brief Behavioral Treatment for Insomnia|brief behavioral treatment for insomnia
235697|NCT02724800|Comparative Effectiveness Research|comparative effectiveness research
235698|NCT02724787|Post-traumatic stress disorder|post-traumatic stress disorder
235699|NCT02724787|Veterans|veterans
235700|NCT02724787|Aggression|aggression
235701|NCT02724787|Emotion regulation|emotion regulation
235702|NCT02724774|infants|infants
235703|NCT02724774|mental health|mental health
235704|NCT02724774|postpartum period|postpartum period
235705|NCT02724748|Aggression|aggression
235706|NCT02724748|Mental Health|mental health
235707|NCT02724748|Education, Continuing|education, continuing
235708|NCT02724735|Depression|depression
235709|NCT02724735|Major Depressive Disorder (MDD)|major depressive disorder (mdd)
235710|NCT02724735|Major Depressive Disorder|major depressive disorder
235711|NCT02724735|Neurogenesis|neurogenesis
235712|NCT02724735|Synaptogenesis|synaptogenesis
235713|NCT02724735|NSI-189|nsi-189
235714|NCT02724735|Neuralstem|neuralstem
235715|NCT02724722|melamine|melamine
235716|NCT02724722|phthalate|phthalate
235717|NCT02724709|Automatic Data Processing|automatic data processing
235718|NCT02724709|Three-Dimensional Echocardiography|three-dimensional echocardiography
235719|NCT02724709|Aortic Valve|aortic valve
235720|NCT02724683|ascites|ascites
235721|NCT02724683|drainage|drainage
235722|NCT02724683|catheter|catheter
235723|NCT02724683|symptoms|symptoms
235724|NCT02724683|management|management
235725|NCT02724683|quality of life|quality of life
235726|NCT02724683|malignant|malignant
235727|NCT02724683|cancer|cancer
235728|NCT02724657|Child|child
235729|NCT02724657|Breathing exercises|breathing exercises
235730|NCT02724631|Clogged enteral access devices|clogged enteral access devices
235731|NCT02724631|Occluded enteral access device|occluded enteral access device
235732|NCT02724631|Enteral nutrition|enteral nutrition
235733|NCT02724631|Enteral access device|enteral access device
235734|NCT02724631|Tube Feeding|tube feeding
235735|NCT02724631|Gastric Feeding Tubes|gastric feeding tubes
235736|NCT02724618|Curcumin|curcumin
235737|NCT02724618|Protection, Radiation|protection, radiation
235738|NCT02724618|Controlled Clinical Trials, Randomized|controlled clinical trials, randomized
235739|NCT02724618|Radiation Therapy|radiation therapy
235740|NCT02724618|Prostate Cancer|prostate cancer
235741|NCT02724605|RBCS,|rbcs,
235742|NCT02724605|Transfusion,|transfusion,
235743|NCT02724605|Pediatric|pediatric
235744|NCT02724605|Changes|changes
235745|NCT02724566|Type 2 diabetic volunteers|type 2 diabetic volunteers
235746|NCT02724527|Cystic Fibrosis|cystic fibrosis
235747|NCT02724527|N91115|n91115
235748|NCT02724527|Cavosonstat|cavosonstat
235749|NCT02724488|Advanced cancer|advanced cancer
235750|NCT02724488|Advanced solid tumors|advanced solid tumors
235751|NCT02724488|Phase I clinical trial candidates|phase i clinical trial candidates
235752|NCT02724488|Phase II clinical trial candidates|phase ii clinical trial candidates
235753|NCT02724488|Phase III clinical trial candidates|phase iii clinical trial candidates
235754|NCT02724488|Head and Neck|head and neck
235755|NCT02724488|Melanoma|melanoma
235756|NCT02724488|Upper Aerodigestive cancer|upper aerodigestive cancer
235757|NCT02724488|Oral Cavity|oral cavity
235758|NCT02724488|Immune Checkpoint Inhibitors|immune checkpoint inhibitors
235759|NCT02724488|ICIs|icis
235760|NCT02724488|ctDNA|ctdna
235761|NCT02724488|Whole Exome Sequencing|whole exome sequencing
235762|NCT02724488|Molecular Profiling|molecular profiling
235763|NCT02724475|Laser Ablation|laser ablation
235764|NCT02724475|Portal Vein Tumor|portal vein tumor
235765|NCT02724475|Thrombus|thrombus
235766|NCT02724462|smoking cessation|smoking cessation
235767|NCT02724462|app for quitting smoking|app for quitting smoking
235768|NCT02724449|IAD|iad
235769|NCT02724449|Fecal incontinence|fecal incontinence
235770|NCT02724436|Yittrium-90|yittrium-90
235771|NCT02724436|Hepatocellular Carcinoma|hepatocellular carcinoma
235772|NCT02724423|epilepsy|epilepsy
235773|NCT02724423|seizure|seizure
235774|NCT02724410|appendectomy|appendectomy
235775|NCT02724397|Colon cancer|colon cancer
235776|NCT02724397|Diagnosis|diagnosis
235777|NCT02724397|Adenoma|adenoma
235778|NCT02724397|Serrated lesions|serrated lesions
235779|NCT02724358|Carcinoma|carcinoma
235780|NCT02724358|Hepatocellular|hepatocellular
235781|NCT02724358|Notch1|notch1
235782|NCT02724345|Cell keratin 18|cell keratin 18
235783|NCT02724332|Aspartate beta hydroxylase|aspartate beta hydroxylase
235784|NCT02724332|transcatheter arterial chemoembolization|transcatheter arterial chemoembolization
235785|NCT02724319|percutaneous coronary intervention|percutaneous coronary intervention
235786|NCT02724319|clopidogrel|clopidogrel
235787|NCT02724319|loss-of-function allele|loss-of-function allele
235788|NCT02724267|131I-chTNT-1/B treatment|131i-chtnt-1/b treatment
235789|NCT02724254|Genital warts|genital warts
235790|NCT02724254|HPV types|hpv types
235791|NCT02724254|Sexually Transmitted Disease|sexually transmitted disease
235792|NCT02724254|Papillomavirus Infections|papillomavirus infections
235793|NCT02724254|Viral Disease|viral disease
235794|NCT02724254|Anogenital warts|anogenital warts
235795|NCT02724254|AGW|agw
235796|NCT02724254|HPV6|hpv6
235797|NCT02724254|HPV11|hpv11
235798|NCT02724254|Human papillomavirus infection|human papillomavirus infection
235799|NCT02724254|HPV|hpv
235800|NCT02724254|Aviragen Therapeutics, Inc.|aviragen therapeutics, inc.
235801|NCT02724254|Aviragen Therapeutics|aviragen therapeutics
235802|NCT02724254|Aviragen|aviragen
235803|NCT02724241|nicotine|nicotine
235804|NCT02724241|autonomic tone|autonomic tone
235805|NCT02724241|oxidative stress|oxidative stress
235806|NCT02724228|Achondroplasia|achondroplasia
235807|NCT02724228|Dwarfism|dwarfism
235808|NCT02724228|Bone Diseases, Developmental|bone diseases, developmental
235809|NCT02724228|Bone Diseases|bone diseases
235810|NCT02724215|Subarachnoid hemorrhage|subarachnoid hemorrhage
235811|NCT02724215|Sleep Apnea|sleep apnea
235812|NCT02724202|Curcumin|curcumin
235813|NCT02724202|5FU|5fu
235814|NCT02724202|5-fluorouracil|5-fluorouracil
235815|NCT02724202|Adracil|adracil
235816|NCT02724202|5FU Resistant|5fu resistant
235817|NCT02724202|Metastatic Colon Cancer|metastatic colon cancer
235818|NCT02724202|Colon Cancer|colon cancer
235819|NCT02724189|electronic pre-assessment|electronic pre-assessment
235820|NCT02724189|preoperative assessment|preoperative assessment
235821|NCT02724163|Acute Myeloid Leukaemia|acute myeloid leukaemia
235822|NCT02724163|Children|children
235823|NCT02724163|Gemtuzumab ozogamicin|gemtuzumab ozogamicin
235824|NCT02724163|Liposomal daunorubicin|liposomal daunorubicin
235825|NCT02724163|Mitoxantrone|mitoxantrone
235826|NCT02724163|Randomised controlled trial|randomised controlled trial
235827|NCT02724163|Risk stratification|risk stratification
235828|NCT02724163|Minimal residual disease|minimal residual disease
235829|NCT02724163|Stem cell transplant|stem cell transplant
235830|NCT02724150|Gastroduodenal Ulcer|gastroduodenal ulcer
235831|NCT02724150|Marginal Ulcer|marginal ulcer
235832|NCT02724150|Peptic Ulcer Hemorrhage|peptic ulcer hemorrhage
235833|NCT02724150|Peptic Ulcer|peptic ulcer
235834|NCT02724137|Total Knee Replacement|total knee replacement
235835|NCT02724137|Physical Therapy|physical therapy
235836|NCT02724137|Fitbit®|fitbit®
235837|NCT02724124|exercise muscle stretching|exercise muscle stretching
235838|NCT02724124|electromyography|electromyography
235839|NCT02724111|Neuromuscular blockade|neuromuscular blockade
235840|NCT02724111|Surgical rating scale|surgical rating scale
235841|NCT02724111|Rocuronium|rocuronium
235842|NCT02724111|Sugammadex|sugammadex
235843|NCT02724111|Spinal surgery|spinal surgery
235844|NCT02724111|General anesthesia|general anesthesia
235845|NCT02724098|Palliative Therapy|palliative therapy
235846|NCT02724072|Thoracic Surgery|thoracic surgery
235847|NCT02724072|Aortic Arch|aortic arch
235848|NCT02724072|Frozen Elephant Trunk|frozen elephant trunk
235849|NCT02724072|Performance Goal|performance goal
235850|NCT02724046|Neisseria meningitidis|neisseria meningitidis
235851|NCT02724046|Ciprofloxacin|ciprofloxacin
235852|NCT02724046|Chemoprevention|chemoprevention
235853|NCT02724033|post operative nausea vomiting|post operative nausea vomiting
235854|NCT02724033|Inner ear surgery|inner ear surgery
235855|NCT02724020|Drug therapy|drug therapy
235856|NCT02724007|Trauma|trauma
235857|NCT02724007|India|india
235858|NCT02724007|ICISS|iciss
235859|NCT02723994|B-cell acute lymphoblastic leukemia (ALL)|b-cell acute lymphoblastic leukemia (all)
235860|NCT02723994|pediatric|pediatric
235861|NCT02723994|multi-agent chemotherapy|multi-agent chemotherapy
235862|NCT02723994|JAK inhibitor|jak inhibitor
235863|NCT02723981|Stent , COMBO Stent, anticoagulation|stent , combo stent, anticoagulation
235864|NCT02723955|ICOS receptor agonist antibody|icos receptor agonist antibody
235865|NCT02723955|Pembrolizumab|pembrolizumab
235866|NCT02723955|KEYNOTE-478|keynote-478
235867|NCT02723955|GSK3359609|gsk3359609
235868|NCT02723955|Cohort expansion|cohort expansion
235869|NCT02723955|Dose escalation|dose escalation
235870|NCT02723942|glypican-3(GPC3)|glypican-3(gpc3)
235871|NCT02723942|chimeric antigen receptor-modified T cell(CAR-T)|chimeric antigen receptor-modified t cell(car-t)
235872|NCT02723942|hepatocellular carcinoma(HCC)|hepatocellular carcinoma(hcc)
235873|NCT02723929|transcranial direct current stimulation|transcranial direct current stimulation
235874|NCT02723929|transcranial ultrasound|transcranial ultrasound
235875|NCT02723929|non-invasive brain stimulation|non-invasive brain stimulation
235876|NCT02723916|Parents|parents
235877|NCT02723916|Child|child
235878|NCT02723916|Preschool|preschool
235879|NCT02723916|eHealth|ehealth
235880|NCT02723903|somatization symptom score|somatization symptom score
235881|NCT02723903|SSS checklist|sss checklist
235882|NCT02723903|coronary angiography|coronary angiography
235883|NCT02723903|Patient Health Questionnaire|patient health questionnaire
235884|NCT02723903|Generalized Anxiety Disorder 7-items|generalized anxiety disorder 7-items
235885|NCT02723877|TNBC|tnbc
235886|NCT02723864|Pharmacodynamic|pharmacodynamic
235887|NCT02723864|DNA Damage Repair|dna damage repair
235888|NCT02723864|BRCA Null|brca null
235889|NCT02723864|Apoptosis|apoptosis
235890|NCT02723864|Combination Therapy|combination therapy
235891|NCT02723838|Bladder|bladder
235892|NCT02723838|Cancer|cancer
235893|NCT02723838|REOLYSIN®|reolysin®
235894|NCT02723838|Gemcitabine|gemcitabine
235895|NCT02723838|Cisplatin|cisplatin
235896|NCT02723838|Reovirus|reovirus
235897|NCT02723838|Oncolytic virus|oncolytic virus
235898|NCT02723825|Distal tibia|distal tibia
235899|NCT02723825|fractures|fractures
235900|NCT02723825|epiphyses|epiphyses
235901|NCT02723825|children|children
235902|NCT02723812|Influenza|influenza
235903|NCT02723812|GCFLU|gcflu
235904|NCT02723812|vaccine|vaccine
235905|NCT02723812|Vietnam|vietnam
235906|NCT02723799|Hope|hope
235907|NCT02723786|Delayed Graft Function|delayed graft function
235908|NCT02723786|Renal Transplantation|renal transplantation
235909|NCT02723786|Prevention|prevention
235910|NCT02723786|GSK1070806|gsk1070806
235911|NCT02723773|Efficacy|efficacy
235912|NCT02723773|Immunogenicity|immunogenicity
235913|NCT02723773|Safety|safety
235914|NCT02723773|Adults|adults
235915|NCT02723773|Herpes zoster|herpes zoster
235916|NCT02723747|myocardial ischemia|myocardial ischemia
235917|NCT02723747|magnetic resonance imaging|magnetic resonance imaging
235918|NCT02723747|perfusion|perfusion
235919|NCT02723747|software|software
235920|NCT02723734|Decipher®|decipher®
235921|NCT02723734|African-American men|african-american men
235922|NCT02723734|prostate|prostate
235923|NCT02723734|low risk PCa|low risk pca
235924|NCT02723734|intermediate risk PCa|intermediate risk pca
235925|NCT02723734|genomic classifier (GC)|genomic classifier (gc)
235926|NCT02723721|Lentigo maligna|lentigo maligna
235927|NCT02723695|Cochlear implant|cochlear implant
235928|NCT02723695|Perception|perception
235929|NCT02723695|Posture|posture
235930|NCT02723695|Quality of life|quality of life
235931|NCT02723669|Relative Bioavailability|relative bioavailability
235932|NCT02723656|smoking|smoking
235933|NCT02723656|cancer|cancer
235934|NCT02723656|cancer registry|cancer registry
235935|NCT02723656|smoking cessation|smoking cessation
235936|NCT02723643|Hypertension|hypertension
235937|NCT02723643|Essential hypertension|essential hypertension
235938|NCT02723643|Blood pressure|blood pressure
235939|NCT02723643|Cardiovascular diseases|cardiovascular diseases
235940|NCT02723630|Bioequivalence|bioequivalence
235941|NCT02723630|Lenvatinib|lenvatinib
235942|NCT02723630|Healthy Volunteers|healthy volunteers
235943|NCT02723630|Lenvima|lenvima
235944|NCT02723630|E7080|e7080
235945|NCT02723591|FK506|fk506
235946|NCT02723591|Kidney Transplantation|kidney transplantation
235947|NCT02723591|Tacrolimus|tacrolimus
235948|NCT02723591|Astagraf XL|astagraf xl
235949|NCT02723552|preeclampsia|preeclampsia
235950|NCT02723552|young adult hypertension|young adult hypertension
235951|NCT02723552|preterm birth|preterm birth
236457|NCT02720211|thin films|thin films
235952|NCT02723526|Metastatic Hormone-Sensitive Prostate Cancer；circulating tumor cells；Prognosis；Liquid biopsy|metastatic hormone-sensitive prostate cancer；circulating tumor cells；prognosis；liquid biopsy
235953|NCT02723513|Proton MRI|proton mri
235954|NCT02723513|Noble Gas MRI|noble gas mri
235955|NCT02723513|Pulmonary Function|pulmonary function
235956|NCT02723500|Magnetic Resonance Imaging|magnetic resonance imaging
235957|NCT02723500|Pulmonary Function|pulmonary function
235958|NCT02723487|TAP block|tap block
235959|NCT02723487|pediatric|pediatric
235960|NCT02723487|Laparoscopic|laparoscopic
235961|NCT02723487|postoperative pain|postoperative pain
235962|NCT02723474|Magnetic Resonance Imaging|magnetic resonance imaging
235963|NCT02723474|Pulmonary Function|pulmonary function
235964|NCT02723396|Parkinson's disease|parkinson's disease
235965|NCT02723396|Sleep Benefit|sleep benefit
235966|NCT02723383|alcoholism|alcoholism
235967|NCT02723383|intensive care|intensive care
235968|NCT02723383|Baclofen|baclofen
235969|NCT02723383|restlessness|restlessness
235970|NCT02723383|Delirium tremens|delirium tremens
235971|NCT02723383|Alcohol withdrawal syndrome|alcohol withdrawal syndrome
235972|NCT02723370|Quality of Healthcare|quality of healthcare
235973|NCT02723370|Colorectal neoplasms|colorectal neoplasms
235974|NCT02723370|Health Literacy|health literacy
235975|NCT02723370|Teach-Back Communication|teach-back communication
235976|NCT02723370|Evidence Based Practice|evidence based practice
235977|NCT02723370|Colonoscopy|colonoscopy
235978|NCT02723357|Financial Coaching|financial coaching
235979|NCT02723357|Mental Health|mental health
235980|NCT02723357|Social Determinants|social determinants
235981|NCT02723357|Medical-Financial Partnership|medical-financial partnership
235982|NCT02723357|Toxic Stress|toxic stress
235983|NCT02723344|PTSD|ptsd
235984|NCT02723344|Mild TBI|mild tbi
235985|NCT02723344|Probiotic|probiotic
235986|NCT02723344|Inflammation|inflammation
235987|NCT02723331|Stereotactic Body Radiation Therapy|stereotactic body radiation therapy
235988|NCT02723331|Perioperative Therapy|perioperative therapy
235989|NCT02723331|Resectable Pancreas Ductal Adenocarcinoma|resectable pancreas ductal adenocarcinoma
235990|NCT02723331|Borderline Resectable Pancreas Ductal Adenocarcinoma|borderline resectable pancreas ductal adenocarcinoma
235991|NCT02723331|Nab-paclitaxel|nab-paclitaxel
235992|NCT02723331|Abraxane|abraxane
235993|NCT02723331|Gemcitabine|gemcitabine
235994|NCT02723331|Neoadjuvant Therapy|neoadjuvant therapy
235995|NCT02723331|Adjuvant Therapy|adjuvant therapy
235996|NCT02723318|Cognition|cognition
235997|NCT02723318|Financial Coaching|financial coaching
235998|NCT02723318|Social Determinants of Health|social determinants of health
235999|NCT02723318|Socioeconomic Status|socioeconomic status
236000|NCT02723305|Klinefelter syndrome|klinefelter syndrome
236001|NCT02723305|XXY|xxy
236002|NCT02723305|Sex chromosome aneuploidy|sex chromosome aneuploidy
236003|NCT02723305|sex chromosome variation|sex chromosome variation
236004|NCT02723305|hypogonadism|hypogonadism
236005|NCT02723305|cardiometabolic|cardiometabolic
236006|NCT02723305|body composition|body composition
236007|NCT02723305|exercise capacity|exercise capacity
236008|NCT02723279|Urgency-frequency Syndrome|urgency-frequency syndrome
236009|NCT02723279|Electrical Pudendal Nerve Stimulation|electrical pudendal nerve stimulation
236010|NCT02723279|Tolterodine Tartrate|tolterodine tartrate
236011|NCT02723266|American Indian, Alaska Native Adolescents|american indian, alaska native adolescents
236012|NCT02723266|Preconception Counseling|preconception counseling
236013|NCT02723266|Reproductive Health|reproductive health
236014|NCT02723266|Gestational Diabetes Mellitus|gestational diabetes mellitus
236015|NCT02723253|rectal cancer|rectal cancer
236016|NCT02723253|radiotherapy|radiotherapy
236017|NCT02723253|chemotherapy|chemotherapy
236018|NCT02723253|Raltitrexed|raltitrexed
236019|NCT02723253|Oxaliplatin|oxaliplatin
236020|NCT02723240|NUC-3373|nuc-3373
236021|NCT02723240|Dose escalation|dose escalation
236022|NCT02723240|Nucleotide Analogue|nucleotide analogue
236023|NCT02723227|Parenting Stress|parenting stress
236024|NCT02723227|Stress|stress
236025|NCT02723227|Social Determinants|social determinants
236026|NCT02723227|Socioeconomic status|socioeconomic status
236027|NCT02723227|Financial Coaching|financial coaching
236028|NCT02723175|Fibromyalgia|fibromyalgia
236029|NCT02723175|Pain|pain
236030|NCT02723136|Smartphone|smartphone
236031|NCT02723136|Internship|internship
236032|NCT02723136|Internal Medicine|internal medicine
236033|NCT02723123|CPAP|cpap
236034|NCT02723123|NIPPV|nippv
236035|NCT02723123|Extubation failure|extubation failure
236036|NCT02723123|Cardiorespiratory behaviour|cardiorespiratory behaviour
236037|NCT02723123|NIV-NAVA|niv-nava
236038|NCT02723110|Type 2 Diabetes Risk|type 2 diabetes risk
236039|NCT02723084|Hepatitis C Virus|hepatitis c virus
236040|NCT02723084|Non-cirrhotic|non-cirrhotic
236041|NCT02723084|Hepatitis C Genotype 2|hepatitis c genotype 2
236042|NCT02723084|Chronic Hepatitis C Virus|chronic hepatitis c virus
236043|NCT02723084|Hepatitis C|hepatitis c
236044|NCT02723058|Depression|depression
236045|NCT02723058|Homelessness|homelessness
236046|NCT02723058|Primary care|primary care
236047|NCT02723006|Drug Therapy|drug therapy
236051|NCT02722954|Pembrolizumab|pembrolizumab
236052|NCT02722954|Phase 1b|phase 1b
236053|NCT02722941|autologous hematopoietic cell transplant (HCT)|autologous hematopoietic cell transplant (hct)
236054|NCT02722941|autologous|autologous
236055|NCT02722928|Postoperative pneumocephalus|postoperative pneumocephalus
236056|NCT02722928|Fraction of inspired oxygen|fraction of inspired oxygen
236057|NCT02722928|Intracranial surgery|intracranial surgery
236058|NCT02722915|fMRI|fmri
236059|NCT02722915|neurofeedback|neurofeedback
236060|NCT02722915|hallucination|hallucination
236061|NCT02722915|schizophrenia|schizophrenia
236062|NCT02722902|Metabolic flexibility|metabolic flexibility
236063|NCT02722902|Insulin sensitivity|insulin sensitivity
236064|NCT02722889|Ascending aorta|ascending aorta
236065|NCT02722889|Elongation of the aorta|elongation of the aorta
236066|NCT02722889|Type A dissection|type a dissection
236067|NCT02722889|Aortic rupture|aortic rupture
236068|NCT02722889|Aortic length|aortic length
236069|NCT02722876|Rehabilitation|rehabilitation
236070|NCT02722876|Cross-education|cross-education
236071|NCT02722850|breast cancer|breast cancer
236072|NCT02722850|cancer survivorship|cancer survivorship
236073|NCT02722850|dietary intake|dietary intake
236074|NCT02722850|physical activity|physical activity
236075|NCT02722850|quality of life|quality of life
236076|NCT02722824|motor symptoms|motor symptoms
236077|NCT02722811|Etanercept|etanercept
236078|NCT02722811|Osteoarthritis Of Knee|osteoarthritis of knee
236079|NCT02722811|TNF-α|tnf-α
236080|NCT02722811|IL-1α|il-1α
236081|NCT02722811|Subcutaneous Injection|subcutaneous injection
236082|NCT02722785|Exercise training|exercise training
236083|NCT02722785|Surgical complications|surgical complications
236084|NCT02722785|Cancer prognosis|cancer prognosis
236085|NCT02722785|Muscle function|muscle function
236086|NCT02722785|Body composition|body composition
236087|NCT02722785|Pulmonary function|pulmonary function
236088|NCT02722785|Quality of life|quality of life
236089|NCT02722772|Intra-Articular Injection|intra-articular injection
236090|NCT02722772|Etanercept|etanercept
236091|NCT02722772|TNF-α|tnf-α
236092|NCT02722772|IL-1|il-1
236093|NCT02722772|Osteoarthritis of Knee|osteoarthritis of knee
236094|NCT02722746|Epidural Analgesia|epidural analgesia
236095|NCT02722733|Hodgkin's lymphoma|hodgkin's lymphoma
236096|NCT02722733|Non-Hodgkin's lymphoma|non-hodgkin's lymphoma
236097|NCT02722733|mobilization|mobilization
236098|NCT02722733|G-CSF|g-csf
236099|NCT02722733|filgrastim|filgrastim
236100|NCT02722733|cytosine arabinoside|cytosine arabinoside
236101|NCT02722733|autologous stem cell transplantation|autologous stem cell transplantation
236102|NCT02722720|Carotid atherosclerosis|carotid atherosclerosis
236103|NCT02722720|Carotid stenosis|carotid stenosis
236104|NCT02722720|Ischemic attack|ischemic attack
236105|NCT02722720|Stroke|stroke
236106|NCT02722720|Carotid stenting|carotid stenting
236107|NCT02722720|Transradial approach|transradial approach
236108|NCT02722720|Transfemoral approach|transfemoral approach
236109|NCT02722720|Bleeding|bleeding
236110|NCT02722720|Thromboembolism|thromboembolism
236111|NCT02722720|Embolism|embolism
236112|NCT02722720|Neurocognitive disorders|neurocognitive disorders
236114|NCT02722668|ALL|all
236115|NCT02722668|CML|cml
236116|NCT02722668|CLL|cll
236117|NCT02722668|SLL|sll
236118|NCT02722655|Pediatrics|pediatrics
236119|NCT02722629|COPD|copd
236120|NCT02722629|Respiratory Aspiration|respiratory aspiration
236121|NCT02722629|COPD acute exacerbation|copd acute exacerbation
236122|NCT02722616|Ultrasound|ultrasound
236123|NCT02722590|Epilepsy|epilepsy
236124|NCT02722590|Partial-onset seizures|partial-onset seizures
236125|NCT02722590|secondarily generalized seizures|secondarily generalized seizures
236126|NCT02722551|Mitral|mitral
236127|NCT02722551|Regurgitation|regurgitation
236128|NCT02722551|Insufficiency|insufficiency
236129|NCT02722551|Degenerative|degenerative
236130|NCT02722551|Functional|functional
236131|NCT02722551|Primary|primary
236132|NCT02722551|Secondary|secondary
236133|NCT02722551|Organic|organic
236134|NCT02722551|Transcatheter|transcatheter
236135|NCT02722551|TMVR|tmvr
236136|NCT02722551|TMVI|tmvi
236137|NCT02722551|Heart valve|heart valve
236138|NCT02722551|Mitral valve|mitral valve
236139|NCT02722551|Transapical|transapical
236140|NCT02722551|Transfemoral|transfemoral
236141|NCT02722551|Transeptal|transeptal
236142|NCT02722551|Severe|severe
236143|NCT02722525|ADT|adt
236144|NCT02722525|Prostate cancer|prostate cancer
236145|NCT02722499|Diabetes Mellitus, Type 2|diabetes mellitus, type 2
236146|NCT02722499|Diabetes Mellitus, Adult-Onset|diabetes mellitus, adult-onset
236147|NCT02722499|Diabetes Mellitus, Non-Insulin-Dependent|diabetes mellitus, non-insulin-dependent
236148|NCT02722499|Diabetes Mellitus, Noninsulin Dependent|diabetes mellitus, noninsulin dependent
236149|NCT02722499|Diabetes Mellitus, Type II|diabetes mellitus, type ii
236150|NCT02722499|African American|african american
236151|NCT02722499|Blacks|blacks
236152|NCT02722499|non-Hispanic Blacks|non-hispanic blacks
236153|NCT02722499|Randomized Control Trial|randomized control trial
236458|NCT02720146|Dry eye|dry eye
236154|NCT02722499|Controlled Clinical Trial|controlled clinical trial
236155|NCT02722499|Behavioral Research|behavioral research
236156|NCT02722499|Behavioral Medicine|behavioral medicine
236157|NCT02722421|efavirenz|efavirenz
236158|NCT02722421|levonorgestrel|levonorgestrel
236159|NCT02722421|contraceptive implant|contraceptive implant
236160|NCT02722408|LDL-C|ldl-c
236161|NCT02722408|Lipid Regulator|lipid regulator
236162|NCT02722382|Chronic Kidney Disease|chronic kidney disease
236163|NCT02722291|presbyopia|presbyopia
236164|NCT02722265|Essential hypertension|essential hypertension
236165|NCT02722265|Long-term treatment|long-term treatment
236166|NCT02722265|Mineralocorticoid receptor antagonist|mineralocorticoid receptor antagonist
236167|NCT02722252|In Vitro Fertilization with ICSI|in vitro fertilization with icsi
236168|NCT02722239|Xigduo;|xigduo;
236169|NCT02722239|bioequivalence;|bioequivalence;
236170|NCT02722239|crossover;|crossover;
236171|NCT02722239|Russia|russia
236172|NCT02722226|High fidelity simulation|high fidelity simulation
236173|NCT02722226|Sedation|sedation
236174|NCT02722226|Medical education|medical education
236175|NCT02722200|fMRI obesity|fmri obesity
236176|NCT02722148|Eosinophilic Esophagitis|eosinophilic esophagitis
236177|NCT02722148|Diet Elimination Therapy|diet elimination therapy
236178|NCT02722122|Cystic Fibrosis|cystic fibrosis
236179|NCT02722122|CF|cf
236180|NCT02722122|AIR DNase™|air dnase™
236181|NCT02722122|Digestive System Diseases|digestive system diseases
236182|NCT02722122|Genetic Diseases, Inborn|genetic diseases, inborn
236183|NCT02722122|Infant, New born, Diseases|infant, new born, diseases
236184|NCT02722122|Lung diseases|lung diseases
236185|NCT02722122|Pancreatic Diseases|pancreatic diseases
236186|NCT02722122|Respiratory Tract Diseases|respiratory tract diseases
236187|NCT02722096|arteriovenous fistula|arteriovenous fistula
236188|NCT02722096|regional anesthesia|regional anesthesia
236189|NCT02722096|local anesthesia|local anesthesia
236190|NCT02722096|early complication|early complication
236191|NCT02722031|intensive care|intensive care
236192|NCT02722031|prevalence|prevalence
236193|NCT02722031|hypoxemia|hypoxemia
236194|NCT02722031|ARDS|ards
236195|NCT02722005|Health related quality of life|health related quality of life
236196|NCT02722005|Financial Coaching|financial coaching
236197|NCT02722005|Medical Financial Partnership|medical financial partnership
236198|NCT02722005|Social Determinants of Health|social determinants of health
236199|NCT02722005|Socioeconomic status|socioeconomic status
236200|NCT02721966|Assessment of spondyloarthritis international society (ASAS)|assessment of spondyloarthritis international society (asas)
236201|NCT02721966|ASAS|asas
236202|NCT02721966|axial|axial
236203|NCT02721966|Psoriatic Arthritis (PsA)|psoriatic arthritis (psa)
236204|NCT02721966|PsA|psa
236205|NCT02721966|Magnetic resonance imaging (MRI)|magnetic resonance imaging (mri)
236206|NCT02721966|MRI|mri
236207|NCT02721927|refugees|refugees
236208|NCT02721927|Syrian|syrian
236209|NCT02721927|cost|cost
236210|NCT02721927|visit|visit
236211|NCT02721914|low-back pain|low-back pain
236212|NCT02721914|massage therapy|massage therapy
236213|NCT02721914|Gymnastics|gymnastics
236214|NCT02721914|disability|disability
236215|NCT02721901|Gastrointestinal Disorders|gastrointestinal disorders
236216|NCT02721901|Nutrition|nutrition
236217|NCT02721901|Behavioral|behavioral
236218|NCT02721862|gallstones|gallstones
236219|NCT02721862|cholelithiasis|cholelithiasis
236220|NCT02721862|sleeve gastrectomy|sleeve gastrectomy
236221|NCT02721797|hypermobility|hypermobility
236222|NCT02721797|collagen|collagen
236223|NCT02721797|joint|joint
236224|NCT02721797|hyperflexation|hyperflexation
236225|NCT02721784|MRI|mri
236226|NCT02721784|Radiotherapy|radiotherapy
236227|NCT02721758|Motivational Interviewing|motivational interviewing
236228|NCT02721758|Health Behavior|health behavior
236229|NCT02721758|Cardiac Rehabilitation|cardiac rehabilitation
236230|NCT02721719|Ulcerative Colitis|ulcerative colitis
236231|NCT02721719|UC|uc
236232|NCT02721719|Vedolizumab|vedolizumab
236233|NCT02721719|Entyvio|entyvio
236234|NCT02721719|Inflammatory Bowl Disease|inflammatory bowl disease
236235|NCT02721719|IBD|ibd
236236|NCT02721719|T-Lymphocytes, Regulatory|t-lymphocytes, regulatory
236237|NCT02721706|Nutrition assessment|nutrition assessment
236238|NCT02721706|inpatients|inpatients
236239|NCT02721706|cost-benefit analysis|cost-benefit analysis
236240|NCT02721706|quality of life|quality of life
236241|NCT02721706|body composition|body composition
236242|NCT02721706|mass screening|mass screening
236243|NCT02721693|Troponin|troponin
236244|NCT02721693|Exercise|exercise
236245|NCT02721667|Blood pressure|blood pressure
236246|NCT02721667|Telemonitoring|telemonitoring
236247|NCT02721667|Case management|case management
236248|NCT02721667|Seniors|seniors
236249|NCT02721654|Plasma-Lyte|plasma-lyte
236250|NCT02721654|Sodium chloride|sodium chloride
236251|NCT02721654|Saline|saline
236252|NCT02721654|Fluid resuscitation|fluid resuscitation
236253|NCT02721654|Intravenous fluid therapy|intravenous fluid therapy
236254|NCT02721654|Critically ill|critically ill
236255|NCT02721654|Critical care|critical care
236257|NCT02721615|intra spinal pressure|intra spinal pressure
236258|NCT02721615|spinal cord perfusion pressure|spinal cord perfusion pressure
236259|NCT02721615|microdialysis|microdialysis
236260|NCT02721615|duroplasty|duroplasty
236261|NCT02721537|Brain Nicotinamide Adenine Dinucleotide (NAD+)|brain nicotinamide adenine dinucleotide (nad+)
236262|NCT02721537|Adenosine Triphosphate (ATP) Depletion|adenosine triphosphate (atp) depletion
236263|NCT02721537|Polyadenosine Diphosphate-Ribosepolymerase (PARP) Activation|polyadenosine diphosphate-ribosepolymerase (parp) activation
236264|NCT02721524|Ring Annuloplasty|ring annuloplasty
236265|NCT02721524|Suture Annuloplasty|suture annuloplasty
236266|NCT02721524|Functional Tricuspid Regurgitation|functional tricuspid regurgitation
236267|NCT02721498|Respiratory Physiotherapy|respiratory physiotherapy
236268|NCT02721498|Airway clearance techniques|airway clearance techniques
236269|NCT02721498|Outcome measures|outcome measures
236270|NCT02721485|Ringer's Lactate|ringer's lactate
236271|NCT02721485|Normal Saline|normal saline
236272|NCT02721485|resuscitation fluids|resuscitation fluids
236273|NCT02721485|hypovolemia|hypovolemia
236274|NCT02721459|unresectable melanoma|unresectable melanoma
236275|NCT02721459|stage III melanoma|stage iii melanoma
236276|NCT02721459|stage IV melanoma|stage iv melanoma
236277|NCT02721459|AJCC melanoma staging|ajcc melanoma staging
236278|NCT02721459|American Joint Committee on Cancer (AJCC)|american joint committee on cancer (ajcc)
236279|NCT02721459|BRAF V600 E mutation|braf v600 e mutation
236280|NCT02721459|BRAF V600 K mutation|braf v600 k mutation
236281|NCT02721394|Challenging Behaviour|challenging behaviour
236282|NCT02721394|Functional Communication Training|functional communication training
236283|NCT02721394|Positive Behavioural Support|positive behavioural support
236284|NCT02721394|Family carer training|family carer training
236285|NCT02721381|Autism Spectrum Disorder|autism spectrum disorder
236286|NCT02721381|Parent training|parent training
236287|NCT02721381|Telehealth|telehealth
236288|NCT02721381|RCT|rct
236289|NCT02721355|Chronic gastritis|chronic gastritis
236290|NCT02721355|Gastric ulcer|gastric ulcer
236291|NCT02721355|Helicobacter pylori|helicobacter pylori
236292|NCT02721355|IgY|igy
236293|NCT02721342|Chronic proteinuric nephropathies|chronic proteinuric nephropathies
236294|NCT02721329|Obstructive Sleep Apnea|obstructive sleep apnea
236295|NCT02721329|OSA|osa
236296|NCT02721329|Insomnia|insomnia
236297|NCT02721329|CPAP|cpap
236298|NCT02721329|SensAwake|sensawake
236299|NCT02721290|Knee surgery|knee surgery
236300|NCT02721277|Parenteral nutrition, Total|parenteral nutrition, total
236301|NCT02721277|Infant, newborn|infant, newborn
236302|NCT02721277|Cholestasis|cholestasis
236303|NCT02721277|Enterocolitis, Necrotizing|enterocolitis, necrotizing
236304|NCT02721251|exercise|exercise
236305|NCT02721251|weight loss|weight loss
236306|NCT02721251|sleep apnea|sleep apnea
236307|NCT02721212|Robotic|robotic
236308|NCT02721212|Stroke|stroke
236309|NCT02721212|Upper Limb Rehabilitation|upper limb rehabilitation
236310|NCT02721186|Malaria|malaria
236311|NCT02721186|Plasmodium|plasmodium
236312|NCT02721186|Mass drug administration|mass drug administration
236313|NCT02721186|Malaria elimination|malaria elimination
236314|NCT02721186|Zanzibar|zanzibar
236315|NCT02721186|Dihydroartemisinin-Piperaquine|dihydroartemisinin-piperaquine
236316|NCT02721186|Single low dose Primaquine|single low dose primaquine
236317|NCT02721173|Tazarotene|tazarotene
236318|NCT02721173|Adapalene|adapalene
236319|NCT02721173|Clindamycin|clindamycin
236320|NCT02721160|performance-based financing|performance-based financing
236321|NCT02721160|malnutrition|malnutrition
236322|NCT02721160|impact evaluation|impact evaluation
236323|NCT02721108|Mindfulness|mindfulness
236324|NCT02721108|Headspace|headspace
236325|NCT02721108|Psychological approaches|psychological approaches
236326|NCT02721108|Progressive muscle relaxation|progressive muscle relaxation
236327|NCT02721082|tobacco treatment|tobacco treatment
236328|NCT02721069|Seizures|seizures
236329|NCT02721069|Epilepsy|epilepsy
236330|NCT02721043|Personalized vaccine|personalized vaccine
236331|NCT02721043|Poly-ICLC|poly-iclc
236332|NCT02721043|Immunotherapy|immunotherapy
236333|NCT02721043|Cancer|cancer
236334|NCT02721030|Heartfailure|heartfailure
236335|NCT02721030|1-year mortality|1-year mortality
236336|NCT02721030|heartfailure quality of life|heartfailure quality of life
236337|NCT02721030|sub-Saharan Africa|sub-saharan africa
236338|NCT02721017|Nuss|nuss
236339|NCT02721017|Nuss Procedure|nuss procedure
236340|NCT02721017|pectus excavatum|pectus excavatum
236341|NCT02721017|cryoanalgesia|cryoanalgesia
236342|NCT02721004|Rheumatoid arthritis|rheumatoid arthritis
236343|NCT02721004|RoActemra|roactemra
236344|NCT02721004|Tocilizumab|tocilizumab
236345|NCT02720965|Pain Acute|pain acute
236346|NCT02720965|Orthopedic Surgery|orthopedic surgery
236347|NCT02720965|Satisfaction Nerve Blocks|satisfaction nerve blocks
236348|NCT02720913|Time|time
236349|NCT02720913|COR-KNOT|cor-knot
236350|NCT02720913|Standard|standard
236351|NCT02720913|Cost|cost
236352|NCT02720887|pregnant women|pregnant women
236353|NCT02720887|nanoparticles|nanoparticles
236354|NCT02720887|amniotic fluid|amniotic fluid
236355|NCT02720861|RNF213 rs112735431 Gene|rnf213 rs112735431 gene
236356|NCT02720861|Acute Non-embolic ischemic stroke|acute non-embolic ischemic stroke
236357|NCT02720848|double-balloon enteroscopy|double-balloon enteroscopy
236358|NCT02720809|micronutrients|micronutrients
236359|NCT02720809|blood pressure|blood pressure
236360|NCT02720809|allergy|allergy
236361|NCT02720809|lung function|lung function
236363|NCT02720796|TumorGraft|tumorgraft
236364|NCT02720796|Patient derived xenograft|patient derived xenograft
236365|NCT02720796|sarcoma|sarcoma
236366|NCT02720783|Pharmacokinetics|pharmacokinetics
236367|NCT02720783|Econazole nitrate 150mg|econazole nitrate 150mg
236368|NCT02720783|Benzydamine HCl 6mg|benzydamine hcl 6mg
236369|NCT02720783|Vaginal pessary|vaginal pessary
236370|NCT02720783|Tolerability|tolerability
236371|NCT02720770|growth hormone|growth hormone
236372|NCT02720718|Gastric Bypass Status for Obesity Complicating Pregnancy, Childbirth and the Puerperium|gastric bypass status for obesity complicating pregnancy, childbirth and the puerperium
236373|NCT02720718|Laparoscopy|laparoscopy
236374|NCT02720718|Suture Techniques|suture techniques
236375|NCT02720718|Sutures|sutures
236376|NCT02720705|sevoflurane emergence agitation|sevoflurane emergence agitation
236377|NCT02720692|Pain|pain
236378|NCT02720692|Analgesia|analgesia
236379|NCT02720692|N1539|n1539
236380|NCT02720692|Phase 3|phase 3
236381|NCT02720679|Genetics|genetics
236382|NCT02720679|Whole genome sequencing|whole genome sequencing
730594|NCT00507975|birth|birth
302241|NCT02333058|ALL|all
236383|NCT02720679|Pediatrics and hematology|pediatrics and hematology
236384|NCT02720627|acne|acne
236385|NCT02720627|cortexolone|cortexolone
236386|NCT02720627|anti-androgen|anti-androgen
236387|NCT02720614|accelerated hypofractionated radiotherapy|accelerated hypofractionated radiotherapy
236388|NCT02720614|three-dimensional conformal radiation therapy|three-dimensional conformal radiation therapy
236389|NCT02720614|concurrent radiochemotherapy|concurrent radiochemotherapy
236390|NCT02720601|irinotecan|irinotecan
236391|NCT02720601|capecitabine|capecitabine
236392|NCT02720601|gemcitabine|gemcitabine
236393|NCT02720601|biliary tract cancer|biliary tract cancer
236394|NCT02720601|gallbladder cancer|gallbladder cancer
236395|NCT02720601|second-line|second-line
236396|NCT02720575|Vitamin D|vitamin d
236397|NCT02720575|Bioavailability|bioavailability
236398|NCT02720575|Fortified Bread|fortified bread
236399|NCT02720536|Anemia.|anemia.
236400|NCT02720536|Myelodysplastic Syndrome|myelodysplastic syndrome
236401|NCT02720536|Thalassemia|thalassemia
236402|NCT02720536|Film coated tablet|film coated tablet
236403|NCT02720523|rheumatoid arthritis|rheumatoid arthritis
236404|NCT02720523|ABT-494|abt-494
236405|NCT02720523|Japanese|japanese
236406|NCT02720523|Antirheumatic agents|antirheumatic agents
236407|NCT02720510|multiple myeloma|multiple myeloma
236408|NCT02720510|farydak|farydak
236409|NCT02720510|panobinostat|panobinostat
236410|NCT02720510|LBH589|lbh589
236411|NCT02720510|ASCT|asct
236412|NCT02720510|transplant|transplant
236413|NCT02720471|local analgesia|local analgesia
236414|NCT02720471|total hip replacement|total hip replacement
236415|NCT02720471|local infiltrations|local infiltrations
236416|NCT02720458|Hypnotics withdrawal in insomniac patients|hypnotics withdrawal in insomniac patients
236417|NCT02720458|Cognitive-Behavioural Therapy (CBT)|cognitive-behavioural therapy (cbt)
236418|NCT02720458|Internet-delivered self-help program|internet-delivered self-help program
236419|NCT02720458|Sleep restriction|sleep restriction
236420|NCT02720458|Stimulus control|stimulus control
236421|NCT02720458|Half-life benzodiazepine|half-life benzodiazepine
236422|NCT02720458|Z-drug|z-drug
236423|NCT02720445|Alzheimer's Disease|alzheimer's disease
236424|NCT02720445|Nicotine|nicotine
236425|NCT02720445|Transdermal Patch|transdermal patch
236426|NCT02720432|early intervention, infant|early intervention, infant
236427|NCT02720419|drug eluting stent|drug eluting stent
236428|NCT02720419|percutaneous coronary intervention|percutaneous coronary intervention
236429|NCT02720419|real world|real world
236431|NCT02720380|Physical Therapy Specialty|physical therapy specialty
236432|NCT02720380|Breathing Exercises|breathing exercises
236433|NCT02720380|Child|child
236434|NCT02720380|Clinical Trail|clinical trail
236435|NCT02720302|Overweight|overweight
236436|NCT02720302|Children|children
236437|NCT02720302|Treatment|treatment
236438|NCT02720302|Prevention|prevention
236439|NCT02720302|Lifestyle intervention|lifestyle intervention
236440|NCT02720289|injury prevention|injury prevention
236441|NCT02720276|stroke|stroke
236442|NCT02720276|exercise|exercise
236443|NCT02720276|walking|walking
236444|NCT02720276|mobility|mobility
236445|NCT02720263|Schizophrenia|schizophrenia
236446|NCT02720263|ASP4345|asp4345
236447|NCT02720250|omega-3 fatty acids, microcirculation, laser Doppler flowmetry, lipid profile|omega-3 fatty acids, microcirculation, laser doppler flowmetry, lipid profile
236448|NCT02720237|Alcohol use|alcohol use
236449|NCT02720237|HIV|hiv
236450|NCT02720237|Viral Load|viral load
236451|NCT02720237|ART|art
236452|NCT02720211|headache|headache
236453|NCT02720211|photophobia|photophobia
236454|NCT02720211|migraine|migraine
236455|NCT02720211|light sensitivity|light sensitivity
236456|NCT02720211|tints|tints
236459|NCT02720133|ramadan fasting|ramadan fasting
236460|NCT02720133|variation of biochemical parameters|variation of biochemical parameters
236461|NCT02720133|variation of hematological parameters|variation of hematological parameters
236462|NCT02720133|verify now assay|verify now assay
236463|NCT02720107|fingolimod|fingolimod
236464|NCT02720107|Biomarker|biomarker
236465|NCT02720107|Multiple sclerosis|multiple sclerosis
236466|NCT02720107|Relapsing-remitting multiple sclerosis|relapsing-remitting multiple sclerosis
236467|NCT02720094|Pre-Exposure Prophylaxis|pre-exposure prophylaxis
236468|NCT02720094|PrEP|prep
236470|NCT02720068|PD-1|pd-1
236471|NCT02720068|PDL1|pdl1
236472|NCT02720068|PD-L1|pd-l1
236473|NCT02720055|Distal Radius Fracture|distal radius fracture
236474|NCT02720055|Outcomes|outcomes
236475|NCT02720055|Psychological Intervention|psychological intervention
236476|NCT02720029|aspiration|aspiration
236477|NCT02720029|reflux|reflux
236478|NCT02720016|Post Traumatic Stress Disorder|post traumatic stress disorder
236479|NCT02720016|Marital Therapy|marital therapy
236480|NCT02720016|Veterans|veterans
236481|NCT02720016|Telemedicine|telemedicine
236482|NCT02720016|Couples|couples
236483|NCT02720003|Atherosclerosis|atherosclerosis
236484|NCT02720003|Superficial Femoral Artery|superficial femoral artery
236485|NCT02720003|Proximal Popliteal Artery|proximal popliteal artery
236486|NCT02719990|VRS-317|vrs-317
236487|NCT02719990|Long Acting Growth Hormone|long acting growth hormone
236488|NCT02719990|Versartis|versartis
236489|NCT02719990|somavaratan|somavaratan
236490|NCT02719990|Growth Hormone Deficiency|growth hormone deficiency
236491|NCT02719990|Adult Growth Hormone Deficiency|adult growth hormone deficiency
236492|NCT02719990|AGHD|aghd
236493|NCT02719990|Growth Hormone Replacement|growth hormone replacement
236494|NCT02719990|Growth Hormone Replacement Therapy|growth hormone replacement therapy
236495|NCT02719990|XTEN|xten
236496|NCT02719964|Cognitive Training|cognitive training
236497|NCT02719964|Traumatic Brain Injury|traumatic brain injury
236498|NCT02719964|Video Games|video games
236499|NCT02719951|autism|autism
236500|NCT02719951|fragile X syndrome (FXS)|fragile x syndrome (fxs)
236501|NCT02719951|PET (Positron Emission Tomography)|pet (positron emission tomography)
236502|NCT02719951|glutamate|glutamate
236503|NCT02719925|magnesium deficiency|magnesium deficiency
236504|NCT02719925|stress psycological|stress psycological
236505|NCT02719925|sleep duration and quality|sleep duration and quality
236506|NCT02719925|mineral water rich in magnesium|mineral water rich in magnesium
236507|NCT02719899|NLRP3 Inflammasome|nlrp3 inflammasome
236508|NCT02719899|Sirtuin 3|sirtuin 3
236509|NCT02719899|T-Cell Polarity|t-cell polarity
236510|NCT02719899|Caloric Restriction|caloric restriction
236511|NCT02719873|obesity , pregnancy , maternal and fetal outcome|obesity , pregnancy , maternal and fetal outcome
236512|NCT02719847|Lung cancer|lung cancer
236513|NCT02719847|Non-Small Cell Lung|non-small cell lung
236514|NCT02719847|NSCLC|nsclc
236515|NCT02719847|Suspected non small cell lung cancer|suspected non small cell lung cancer
236516|NCT02719847|Endobronchial ultrasound-guided transbronchial needle aspiration|endobronchial ultrasound-guided transbronchial needle aspiration
236517|NCT02719847|EBUS-TBNA|ebus-tbna
236518|NCT02719821|Hematopoietic Stem Cell Transplantation|hematopoietic stem cell transplantation
236519|NCT02719821|Fatigue|fatigue
236520|NCT02719821|Insomnia|insomnia
236521|NCT02719821|Depression|depression
236522|NCT02719821|Behavioral Intervention|behavioral intervention
236523|NCT02719808|Vertical infection transmission|vertical infection transmission
236524|NCT02719808|Tenofovir|tenofovir
236525|NCT02719795|Breast Neoplasms|breast neoplasms
236526|NCT02719795|Nerve block|nerve block
236527|NCT02719795|Anesthesia|anesthesia
236528|NCT02719769|Positive Blood Culture|positive blood culture
236529|NCT02719743|children|children
236530|NCT02719743|H5N1|h5n1
236531|NCT02719743|observer-blind|observer-blind
236532|NCT02719743|Influenza|influenza
236533|NCT02719743|dose-ranging|dose-ranging
236534|NCT02719717|VATS lobectomy|vats lobectomy
236535|NCT02719717|vascular sealing|vascular sealing
236536|NCT02719717|energy|energy
236537|NCT02719717|pulmonary artery|pulmonary artery
236538|NCT02719691|MLN0128|mln0128
236539|NCT02719691|Dual TORC1/2 Inhibitor|dual torc1/2 inhibitor
236540|NCT02719691|MLN8237|mln8237
236541|NCT02719691|Aurora A inhibitor|aurora a inhibitor
236542|NCT02719691|Alisertib|alisertib
236543|NCT02719691|Triple-Negative Breast Cancer|triple-negative breast cancer
236544|NCT02719665|peripheral arterial disease|peripheral arterial disease
236545|NCT02719665|claudication|claudication
236546|NCT02719665|PAD|pad
236547|NCT02719665|Vascular Disease|vascular disease
236548|NCT02719665|Vascular Occlusion|vascular occlusion
236549|NCT02719665|Vacular Calcification|vacular calcification
236550|NCT02719665|intermittent claudication|intermittent claudication
236551|NCT02719665|Osteoarthritis|osteoarthritis
236552|NCT02719652|intracranial atherosclerotic disease（ICAD）|intracranial atherosclerotic disease（icad）
236553|NCT02719652|vulnerable plaque|vulnerable plaque
236554|NCT02719652|high-resolution magnetic resonance imaging （HR-MRI）|high-resolution magnetic resonance imaging （hr-mri）
236555|NCT02719626|senior|senior
236556|NCT02719626|nutrition|nutrition
236557|NCT02719626|home delivered meals|home delivered meals
236558|NCT02719626|food safety|food safety
236559|NCT02719626|emergency prep|emergency prep
236560|NCT02719600|Virtual Reality|virtual reality
236561|NCT02719587|saliva|saliva
236562|NCT02719587|omega-3|omega-3
236563|NCT02719574|AML|aml
236564|NCT02719574|MDS|mds
236565|NCT02719574|IDH1|idh1
236566|NCT02719574|IDH|idh
236567|NCT02719535|corneal reshaping therapy|corneal reshaping therapy
236568|NCT02719535|corneal biomechanics|corneal biomechanics
236569|NCT02719483|Children|children
236570|NCT02719483|Spasticity|spasticity
236571|NCT02719483|Extracorporeal shock wave therapy|extracorporeal shock wave therapy
236572|NCT02719483|Cerebral palsy|cerebral palsy
236573|NCT02719483|Gross motor function|gross motor function
236574|NCT02719470|Cognition Impairment|cognition impairment
236575|NCT02719470|Rehabilitation|rehabilitation
236576|NCT02719470|Parkinson's Disease|parkinson's disease
236577|NCT02719457|Exercise testing|exercise testing
236578|NCT02719457|COPD|copd
236579|NCT02719457|Upper and Lower limb exercise|upper and lower limb exercise
236580|NCT02719418|Thromboembolism|thromboembolism
236581|NCT02719418|Venous Thrombosis|venous thrombosis
236582|NCT02719418|Embolism and Thrombosis|embolism and thrombosis
236583|NCT02719418|Chronic Renal Diseases|chronic renal diseases
236584|NCT02719418|Kidney Failure, Chronic|kidney failure, chronic
236585|NCT02719418|Renal Failure, Chronic|renal failure, chronic
236586|NCT02719418|Venous Thromboembolism|venous thromboembolism
236587|NCT02719418|Tinzaparin|tinzaparin
236588|NCT02719418|Innohep|innohep
236589|NCT02719418|Heparin, Low-Molecular-Weight|heparin, low-molecular-weight
236590|NCT02719405|milk|milk
236591|NCT02719405|allergy|allergy
236592|NCT02719405|tolerance|tolerance
236593|NCT02719327|Alzheimer's disease|alzheimer's disease
236594|NCT02719327|Cerebrospinal fluid|cerebrospinal fluid
236595|NCT02719327|brain blood flow|brain blood flow
236596|NCT02719327|cognition|cognition
236597|NCT02719327|icosapent ethyl|icosapent ethyl
236598|NCT02719327|Vascepa|vascepa
236599|NCT02719327|omega-3 fatty acids|omega-3 fatty acids
236600|NCT02719327|eicosapentaenoic acid|eicosapentaenoic acid
236601|NCT02719262|Melamine|melamine
236602|NCT02719262|Renal damage|renal damage
236603|NCT02719262|Workplace intervention|workplace intervention
236604|NCT02719249|ESRD|esrd
236605|NCT02719249|Fabry disease|fabry disease
236606|NCT02719236|Coxarthrosis|coxarthrosis
236607|NCT02719236|Hip arthroplasty|hip arthroplasty
236608|NCT02719236|Direct Anterior Approach|direct anterior approach
236609|NCT02719236|Direct Lateral Approach|direct lateral approach
236610|NCT02719223|Intradialytic hypotension|intradialytic hypotension
236611|NCT02719223|hemodynamic parameters|hemodynamic parameters
236612|NCT02719223|Hemodiafiltration|hemodiafiltration
236613|NCT02719223|NICAS device (non-invasive cardiac system)|nicas device (non-invasive cardiac system)
236614|NCT02719158|Acute otitis media with tympanostomy tubes|acute otitis media with tympanostomy tubes
236615|NCT02719158|OTIPRIO|otiprio
236616|NCT02719145|micro RNA|micro rna
236617|NCT02719145|asthma|asthma
236618|NCT02719145|COPD|copd
236619|NCT02719132|Diabetes Mellitus type 2, dapagliflozin, quality of life|diabetes mellitus type 2, dapagliflozin, quality of life
236620|NCT02719106|real world data|real world data
236621|NCT02719106|percutaneous coronary intervention|percutaneous coronary intervention
236622|NCT02719106|drug eluting stent|drug eluting stent
236623|NCT02719093|Infertility Male|infertility male
236624|NCT02719093|Receptors FSH|receptors fsh
236625|NCT02719093|Varicocele|varicocele
236626|NCT02719093|FSH therapy|fsh therapy
236627|NCT02719080|anaesthetists, surgeons, stress, burnout|anaesthetists, surgeons, stress, burnout
236628|NCT02719067|neuropsychological function|neuropsychological function
236629|NCT02719067|neuroimage|neuroimage
236630|NCT02719067|developmental changes|developmental changes
236631|NCT02719054|Depression|depression
236632|NCT02719054|Child Development|child development
236633|NCT02719054|Stimulation|stimulation
236634|NCT02719054|CBT|cbt
236635|NCT02719054|Bangladesh|bangladesh
236636|NCT02719015|Melanoma|melanoma
236637|NCT02719015|Refractory Metastatic Melanoma|refractory metastatic melanoma
236638|NCT02719015|rAd.CD40L|rad.cd40l
236639|NCT02719015|ISF35|isf35
236640|NCT02719015|Intratumoral|intratumoral
236641|NCT02719015|IT|it
236642|NCT02719015|Pembrolizumab|pembrolizumab
236643|NCT02719015|Keytruda|keytruda
236644|NCT02719015|MK-3475|mk-3475
236645|NCT02719015|SCH-900475|sch-900475
236646|NCT02719015|MM|mm
236647|NCT02718989|H-reflex|h-reflex
236648|NCT02718989|TENS|tens
236649|NCT02718989|Tone|tone
236650|NCT02718976|Hip surgery anesthesia|hip surgery anesthesia
236651|NCT02718976|Perioperative analgesia|perioperative analgesia
236652|NCT02718950|Brown Adipose Tissue|brown adipose tissue
236653|NCT02718950|Hypothalamic Activation|hypothalamic activation
236654|NCT02718950|Non-shivering Thermogenesis|non-shivering thermogenesis
236655|NCT02718950|Basal Metabolic Rate|basal metabolic rate
236656|NCT02718950|Liraglutide|liraglutide
236657|NCT02718950|Victoza|victoza
236658|NCT02718950|Body Composition|body composition
236659|NCT02718950|Body weight|body weight
236660|NCT02718950|Adipose Tissue Biopsy|adipose tissue biopsy
236661|NCT02718937|Viral diseases|viral diseases
236662|NCT02718937|Antiviral|antiviral
236663|NCT02718937|Paramyxoviridae infections|paramyxoviridae infections
236664|NCT02718937|RSV|rsv
236665|NCT02718937|Aviragen Therapeutics, Inc.|aviragen therapeutics, inc.
236666|NCT02718937|Aviragen Therapeutics|aviragen therapeutics
236667|NCT02718937|Aviragen|aviragen
236668|NCT02718924|Thromboelastometry|thromboelastometry
236669|NCT02718924|pregnancy|pregnancy
236670|NCT02718924|obesity|obesity
236671|NCT02718898|genital|genital
236672|NCT02718885|inulin-type fructans|inulin-type fructans
236673|NCT02718885|hemodialysis|hemodialysis
236674|NCT02718885|gut microbiome|gut microbiome
236675|NCT02718885|mineral and bone disorder|mineral and bone disorder
236676|NCT02718859|advanced pancreatic cancer|advanced pancreatic cancer
236677|NCT02718859|nature killer cell|nature killer cell
236678|NCT02718859|irreversible electroporation|irreversible electroporation
236679|NCT02718833|Multiple Myeloma|multiple myeloma
236681|NCT02718807|Patient Care|patient care
236682|NCT02718807|Education|education
236683|NCT02718794|Simulation Training [I02.903.847]|simulation training [i02.903.847]
236684|NCT02718794|Problem-Based Learning [F02.463.425.720]|problem-based learning [f02.463.425.720]
236685|NCT02718794|Airway Management [E02.041]|airway management [e02.041]
236686|NCT02718755|Hematologic malignancy|hematologic malignancy
236687|NCT02718755|Relapsed and refractory hematologic malignancies|relapsed and refractory hematologic malignancies
236688|NCT02718755|Acute myeloid leukemia|acute myeloid leukemia
236689|NCT02718755|AML|aml
236690|NCT02718755|Acute lymphoblastic leukemia|acute lymphoblastic leukemia
236691|NCT02718755|ALL|all
236692|NCT02718755|Burkitt's leukemia/lymphoma|burkitt's leukemia/lymphoma
236693|NCT02718755|Prolymphocytic leukemia|prolymphocytic leukemia
236694|NCT02718755|Biphenotypic acute leukemia|biphenotypic acute leukemia
236695|NCT02718755|Blast-phase of chronic myeloid leukemia|blast-phase of chronic myeloid leukemia
236696|NCT02718755|CML|cml
236697|NCT02718755|B-cell lymphoma|b-cell lymphoma
236698|NCT02718755|Richter's transformation of chronic lymphocytic leukemia|richter's transformation of chronic lymphocytic leukemia
236699|NCT02718755|CLL|cll
236700|NCT02718755|Fludarabine|fludarabine
236701|NCT02718755|Fludarabine phosphate|fludarabine phosphate
236702|NCT02718755|Fludara|fludara
236703|NCT02718755|Cytarabine|cytarabine
236704|NCT02718755|Ara-C|ara-c
236705|NCT02718755|Cytosar|cytosar
236706|NCT02718755|DepoCyt|depocyt
236707|NCT02718755|Cytosine arabinosine hydrochloride|cytosine arabinosine hydrochloride
236708|NCT02718729|Anastomotic leakage|anastomotic leakage
236709|NCT02718729|Rectal cancer|rectal cancer
236710|NCT02718729|Laparoscopic|laparoscopic
236711|NCT02718729|Rectal resection|rectal resection
236712|NCT02718716|ITP|itp
236713|NCT02718690|H-Reflex|h-reflex
236714|NCT02718690|Current Density|current density
236715|NCT02718690|TENS|tens
236716|NCT02718651|ALK rearrangement|alk rearrangement
236717|NCT02718651|Circulating tumor DNA|circulating tumor dna
236718|NCT02718651|Plasma DNA|plasma dna
236719|NCT02718651|Non-small cell lung cancer|non-small cell lung cancer
236720|NCT02718651|Tyrosine kinase inhibitors|tyrosine kinase inhibitors
236721|NCT02718625|Pressure Ulcers|pressure ulcers
236722|NCT02718625|Bed sores|bed sores
236723|NCT02718625|Long-term care|long-term care
236724|NCT02718625|Nursing home|nursing home
236725|NCT02718612|Uraemic Sarcopenia|uraemic sarcopenia
236726|NCT02718612|Sarcopenic Obesity|sarcopenic obesity
236727|NCT02718586|Myokines|myokines
236728|NCT02718586|Protein Energy Wasting|protein energy wasting
236729|NCT02718586|Hemodialysis|hemodialysis
236730|NCT02718573|Hepatitis C|hepatitis c
236731|NCT02718573|Interferon-free|interferon-free
236732|NCT02718573|DDA's|dda's
236733|NCT02718547|Diabetes mellitus|diabetes mellitus
236734|NCT02718547|Diabetic macular edema|diabetic macular edema
236735|NCT02718547|Intra ocular pressure|intra ocular pressure
236736|NCT02718547|Ocular perfusion pressure|ocular perfusion pressure
236737|NCT02718547|Retinal perfusion|retinal perfusion
236738|NCT02718521|contrast-induced nephropathy|contrast-induced nephropathy
236739|NCT02718521|hydration therapy combined with intravenous infusion of isosorbide|hydration therapy combined with intravenous infusion of isosorbide
236740|NCT02718521|percutaneous coronary intervention|percutaneous coronary intervention
236741|NCT02718469|Ebola|ebola
236742|NCT02718469|VSV|vsv
236743|NCT02718469|Vesicular Stomatitis Virus|vesicular stomatitis virus
236744|NCT02718469|Vaccine|vaccine
236745|NCT02718469|Zaire|zaire
236746|NCT02718417|untreated epithelial ovarian|untreated epithelial ovarian
236747|NCT02718417|fallopian tube|fallopian tube
236748|NCT02718417|primary peritoneal cancer|primary peritoneal cancer
236749|NCT02718404|MR-HIFU|mr-hifu
236750|NCT02718404|bone metastases|bone metastases
236751|NCT02718404|pain treatment|pain treatment
236752|NCT02718391|Intradermal Autologous Dendritic Cell Vaccine|intradermal autologous dendritic cell vaccine
236753|NCT02718391|Malignant Melanoma|malignant melanoma
236754|NCT02718391|Adjuvant|adjuvant
236755|NCT02718391|vaccin|vaccin
236756|NCT02718391|therapy|therapy
236757|NCT02718391|randomized trial|randomized trial
236758|NCT02718391|observation|observation
236759|NCT02718378|safety|safety
236760|NCT02718378|pharmacokinetics|pharmacokinetics
236761|NCT02718378|pharmacodynamics|pharmacodynamics
236762|NCT02718378|randomized|randomized
236763|NCT02718365|Lung Neoplasms|lung neoplasms
236764|NCT02718365|Surgery|surgery
236765|NCT02718365|VATS|vats
236766|NCT02718365|GGO|ggo
236767|NCT02718365|GGN|ggn
236768|NCT02718365|Segmentectomy|segmentectomy
236769|NCT02718365|Wedge Resection|wedge resection
236770|NCT02718365|Prognosis|prognosis
236771|NCT02718313|intraventricular conduction delay|intraventricular conduction delay
236772|NCT02718300|Primary myelofibrosis (PMF)|primary myelofibrosis (pmf)
236773|NCT02718300|post-polycythemia vera myelofibrosis (PPV-MF)|post-polycythemia vera myelofibrosis (ppv-mf)
236774|NCT02718300|post-essential thrombocythemia myelofibrosis (PET-MF)|post-essential thrombocythemia myelofibrosis (pet-mf)
236775|NCT02718300|myeloproliferative neoplasms (MPNs)|myeloproliferative neoplasms (mpns)
302739|NCT02330094|SAH|sah
236776|NCT02718300|phosphoinositide 3-kinase (PI3K) inhibitor|phosphoinositide 3-kinase (pi3k) inhibitor
236777|NCT02718300|Janus kinase (JAK) inhibitor|janus kinase (jak) inhibitor
236778|NCT02718287|language development|language development
236779|NCT02718287|socio-emotional development|socio-emotional development
236780|NCT02718287|cognitive development|cognitive development
236781|NCT02718287|motor skills|motor skills
236782|NCT02718274|HIV self-testing|hiv self-testing
236783|NCT02718274|Malawi|malawi
236784|NCT02718274|HIV|hiv
236785|NCT02718248|self-harm|self-harm
236786|NCT02718248|problem-solving therapy|problem-solving therapy
236787|NCT02718248|emergency department|emergency department
236788|NCT02718248|e-therapy|e-therapy
236789|NCT02718248|suicide prevention|suicide prevention
236790|NCT02718222|Post-partum intrauterine device (PPIUD)|post-partum intrauterine device (ppiud)
236791|NCT02718157|Polymerase Chain Reaction (PCR)|polymerase chain reaction (pcr)
236792|NCT02718157|GBS|gbs
236793|NCT02718157|Streptococcus agalactiae|streptococcus agalactiae
236794|NCT02718157|Antepartum women|antepartum women
236795|NCT02718144|dose-escalation|dose-escalation
236796|NCT02718144|safety|safety
236797|NCT02718144|dose-limiting toxicity|dose-limiting toxicity
236798|NCT02718131|Tibial Pseudarthrosis|tibial pseudarthrosis
236799|NCT02718105|KIR HLA-C|kir hla-c
236800|NCT02718105|ART|art
236801|NCT02718066|HBI-8000|hbi-8000
236802|NCT02718066|Nivolumab|nivolumab
236803|NCT02718066|Melanoma|melanoma
236804|NCT02718066|Renal Cell Carcinoma|renal cell carcinoma
236805|NCT02718066|Non-Small Cell Lung Cancer|non-small cell lung cancer
236806|NCT02718027|Alport Syndrome|alport syndrome
236807|NCT02718027|Biomarker|biomarker
236808|NCT02718014|Non Surgical Therapy|non surgical therapy
236809|NCT02718001|Mitral|mitral
236810|NCT02718001|Regurgitation|regurgitation
236811|NCT02718001|Insufficiency|insufficiency
236812|NCT02718001|Degenerative|degenerative
236813|NCT02718001|Functional|functional
236814|NCT02718001|Primary|primary
236815|NCT02718001|Secondary|secondary
236816|NCT02718001|Organic|organic
236817|NCT02718001|Transcatheter|transcatheter
236818|NCT02718001|TMVR|tmvr
236819|NCT02718001|TMVI|tmvi
236820|NCT02718001|Heart Valve|heart valve
236821|NCT02718001|Mitral Valve|mitral valve
236822|NCT02718001|Transseptal|transseptal
236823|NCT02718001|Trans-Septal|trans-septal
236824|NCT02718001|Transeptal|transeptal
236825|NCT02718001|Severe|severe
236826|NCT02717988|rheumatoid arthritis|rheumatoid arthritis
236827|NCT02717988|healthy volunteers|healthy volunteers
236828|NCT02717988|moderately to severely active|moderately to severely active
236829|NCT02717975|Urinary retention|urinary retention
236830|NCT02717975|trial removal of catheter|trial removal of catheter
236831|NCT02717975|valve|valve
236832|NCT02717962|Glioma|glioma
236833|NCT02717962|Glioblastoma|glioblastoma
236834|NCT02717962|Glioblastoma multiforme|glioblastoma multiforme
236835|NCT02717962|GBM|gbm
236836|NCT02717962|brain tumor|brain tumor
236837|NCT02717962|brain cancer|brain cancer
236838|NCT02717962|recurrent brain tumor|recurrent brain tumor
236839|NCT02717962|recurrent brain cancer|recurrent brain cancer
236840|NCT02717962|refractory brain tumor|refractory brain tumor
236841|NCT02717962|refractory brain cancer|refractory brain cancer
236842|NCT02717962|recurrent GBM|recurrent gbm
236843|NCT02717962|refractory GBM|refractory gbm
236844|NCT02717962|recurrent glioma|recurrent glioma
236845|NCT02717962|refractory glioma|refractory glioma
236846|NCT02717962|recurrent glioblastoma|recurrent glioblastoma
236847|NCT02717962|refractory glioblastoma|refractory glioblastoma
236848|NCT02717962|recurrent glioblastoma multiforme|recurrent glioblastoma multiforme
236849|NCT02717962|refractory glioblastoma multiforme|refractory glioblastoma multiforme
236850|NCT02717962|failed bevacizumab|failed bevacizumab
236851|NCT02717962|temodar failure|temodar failure
236852|NCT02717962|temozolomide failure|temozolomide failure
236853|NCT02717962|adjuvant therapy|adjuvant therapy
236854|NCT02717949|hepatitis C|hepatitis c
236855|NCT02717949|low-grade lymphoma|low-grade lymphoma
236856|NCT02717936|squamous cell carcinoma|squamous cell carcinoma
236857|NCT02717936|dermatosurgery|dermatosurgery
236858|NCT02717936|immunohistochemistry|immunohistochemistry
236859|NCT02717923|metastatic colorectal cancer|metastatic colorectal cancer
236860|NCT02717923|maintenance treatment|maintenance treatment
236861|NCT02717923|cetuximab|cetuximab
236862|NCT02717910|Games|games
236863|NCT02717910|Adolescent|adolescent
236864|NCT02717910|Health education|health education
236865|NCT02717910|Smoking|smoking
236866|NCT02717910|Health literacy|health literacy
236867|NCT02717884|AML|aml
236868|NCT02717884|MDS|mds
236869|NCT02717884|relapsed|relapsed
236870|NCT02717884|trans-retinoic acid ATRA|trans-retinoic acid atra
236871|NCT02717884|epigenetic treatment|epigenetic treatment
236872|NCT02717884|non-M3 AML blasts|non-m3 aml blasts
236873|NCT02717884|tranylcypromine TCP|tranylcypromine tcp
236874|NCT02717884|LSD1|lsd1
236875|NCT02717884|refractory|refractory
236876|NCT02717871|Collagen cross-linking, PACK-CXL, infectious keratitis, CXL.|collagen cross-linking, pack-cxl, infectious keratitis, cxl.
236877|NCT02717845|varus malignment|varus malignment
236878|NCT02717845|osteoarthritis|osteoarthritis
236879|NCT02717845|knee|knee
236880|NCT02717819|Sarcopenia|sarcopenia
236881|NCT02717819|Muscular atrophy|muscular atrophy
236882|NCT02717819|Frailty|frailty
236883|NCT02717819|Acute illness|acute illness
236884|NCT02717819|Ageing|ageing
236885|NCT02717819|Protein supplementation|protein supplementation
236886|NCT02717819|Whey protein|whey protein
236887|NCT02717819|Resistance training|resistance training
236888|NCT02717819|Strength training|strength training
236889|NCT02717767|pneumonia|pneumonia
236890|NCT02717767|diagnosis|diagnosis
236891|NCT02717767|prognosis|prognosis
236892|NCT02717767|tracheal aspirate|tracheal aspirate
236893|NCT02717767|bronchoalveolar lavage|bronchoalveolar lavage
236894|NCT02717663|Reinforcement|reinforcement
236895|NCT02717663|Walking|walking
236896|NCT02717663|Exercise|exercise
236897|NCT02717663|Built Environment|built environment
236898|NCT02717663|Adaptive|adaptive
236899|NCT02717663|Financial incentive|financial incentive
236900|NCT02717663|Walkability|walkability
236901|NCT02717650|Exercise Testing|exercise testing
236902|NCT02717650|Maximal Exercise Testing|maximal exercise testing
236903|NCT02717650|Maximal Exercise Capacity|maximal exercise capacity
236904|NCT02717650|Peak Exercise Capacity|peak exercise capacity
236905|NCT02717650|Adults|adults
236906|NCT02717650|Step Tests|step tests
236907|NCT02717637|oxycodone, caesarean, spinal anesthesia|oxycodone, caesarean, spinal anesthesia
236908|NCT02717624|Bruton Tyrosine Kinase Inhibitor|bruton tyrosine kinase inhibitor
236909|NCT02717624|BTK|btk
236910|NCT02717624|Mantle Cell Lymphoma|mantle cell lymphoma
236911|NCT02717624|MCL|mcl
236912|NCT02717624|Acalabrutinib|acalabrutinib
236913|NCT02717624|ACE-LY-106|ace-ly-106
236914|NCT02717611|Chronic Lymphocytic Leukemia|chronic lymphocytic leukemia
236915|NCT02717611|Ibrutinib Intolerant|ibrutinib intolerant
236916|NCT02717598|cold snare polypectomy|cold snare polypectomy
236917|NCT02717598|hot snare polypectomy|hot snare polypectomy
236918|NCT02717585|Continuous Positive Airway Pressure therapy|continuous positive airway pressure therapy
236919|NCT02717585|Chronic Pain|chronic pain
236920|NCT02717585|Sleep Disturbance|sleep disturbance
236921|NCT02717559|Anterior cruciate ligament / injuries|anterior cruciate ligament / injuries
236922|NCT02717559|Anterior cruciate ligament / surgery|anterior cruciate ligament / surgery
236923|NCT02717559|knee injuries / surgery|knee injuries / surgery
236924|NCT02717559|outcomes research|outcomes research
236925|NCT02717559|prospective studies|prospective studies
236926|NCT02717559|osteoarthritis|osteoarthritis
236927|NCT02717546|Distal Tibia Fracture Screw|distal tibia fracture screw
236928|NCT02717520|glass hybrid|glass hybrid
236929|NCT02717520|composite|composite
236930|NCT02717494|PPV-23|ppv-23
236931|NCT02717494|PCV-10|pcv-10
236932|NCT02717494|HIV|hiv
236933|NCT02717494|Immunization|immunization
236934|NCT02717494|Pregnancy|pregnancy
236935|NCT02717455|Diffuse Intrinsic Pontine Glioma|diffuse intrinsic pontine glioma
236936|NCT02717442|Meniere's Disease|meniere's disease
236937|NCT02717442|Vertigo|vertigo
236938|NCT02717416|upper gastrointestinal bleeding|upper gastrointestinal bleeding
236939|NCT02717416|endoscopic hemostasis|endoscopic hemostasis
236940|NCT02717416|hemostatic powder|hemostatic powder
236941|NCT02717403|Chronic Disease Management|chronic disease management
236942|NCT02717403|Rheumatoid Arthritis|rheumatoid arthritis
236943|NCT02717403|Facebook|facebook
236944|NCT02717403|Social networking|social networking
236945|NCT02717403|Internet|internet
236946|NCT02717403|Questionnaires|questionnaires
236947|NCT02717403|Surveys|surveys
236948|NCT02717403|Phone interview|phone interview
236949|NCT02717390|Reading|reading
236950|NCT02717390|Early Childhood development|early childhood development
236951|NCT02717390|Talking|talking
236952|NCT02717390|Playing|playing
236953|NCT02717390|Praising|praising
236954|NCT02717390|Safety|safety
236955|NCT02717390|Injury prevention|injury prevention
236956|NCT02717377|Micro bouts|micro bouts
236957|NCT02717377|Physical Activity|physical activity
236958|NCT02717338|blood donor|blood donor
236959|NCT02717338|retention|retention
236960|NCT02717338|motivation|motivation
236961|NCT02717338|self-determination theory|self-determination theory
236962|NCT02717247|tRNS|trns
236963|NCT02717247|Food addiction,|food addiction,
236964|NCT02717247|Obesity|obesity
236965|NCT02717247|Craving|craving
236966|NCT02717247|functional magnetic resonance imaging (fMRI)|functional magnetic resonance imaging (fmri)
236967|NCT02717182|self management program|self management program
236968|NCT02717182|patient education|patient education
236969|NCT02717182|self care program|self care program
236970|NCT02717169|health promotion|health promotion
236971|NCT02717169|health action process|health action process
236972|NCT02717169|activity tracker|activity tracker
236973|NCT02717169|sleep regulation|sleep regulation
236974|NCT02717143|Acute myocarditis|acute myocarditis
236975|NCT02717143|Dilated cardiomyopathy|dilated cardiomyopathy
236976|NCT02717143|Magnetic resonance imaging|magnetic resonance imaging
236977|NCT02717117|Motility|motility
236978|NCT02717117|MRI|mri
236979|NCT02717117|Gut peptides|gut peptides
236980|NCT02717117|Feeding|feeding
236981|NCT02717104|femoropopliteal|femoropopliteal
236982|NCT02717078|diet|diet
236983|NCT02717078|carbohydrate|carbohydrate
236984|NCT02717078|protein|protein
236985|NCT02717078|glucose|glucose
236986|NCT02717078|type 2 diabetes mellitus|type 2 diabetes mellitus
236987|NCT02717065|Neuromodulation|neuromodulation
236988|NCT02717065|Noninvasive|noninvasive
236989|NCT02717065|Plasticity|plasticity
236990|NCT02717065|Hearing|hearing
236991|NCT02717065|Hyperacusis|hyperacusis
236992|NCT02717013|Muscle|muscle
236993|NCT02717013|Bone|bone
236994|NCT02717013|Fat|fat
236995|NCT02716974|Lupron|lupron
236996|NCT02716974|Bicalutamide|bicalutamide
236997|NCT02716974|Docetaxel|docetaxel
236998|NCT02716896|cystectomy|cystectomy
236999|NCT02716896|radiation|radiation
237000|NCT02716896|chemotherapy|chemotherapy
237001|NCT02716883|keratitis|keratitis
237002|NCT02716883|AMT|amt
237003|NCT02716883|bacterial keratitis|bacterial keratitis
237004|NCT02716883|medication|medication
237005|NCT02716870|Systematic review and meta-analysis|systematic review and meta-analysis
237006|NCT02716870|Evidence-based medicine (EBM)|evidence-based medicine (ebm)
237007|NCT02716870|Evidence-based nutrition (EBN)|evidence-based nutrition (ebn)
237008|NCT02716870|Clinical practice guidelines|clinical practice guidelines
237009|NCT02716870|Clinical trials|clinical trials
237010|NCT02716870|Dietary sugars|dietary sugars
237011|NCT02716870|Fructose|fructose
237012|NCT02716870|High fructose corn syrup|high fructose corn syrup
237013|NCT02716870|Fruit|fruit
237014|NCT02716870|Isocaloric|isocaloric
237015|NCT02716870|Hypercaloric|hypercaloric
237016|NCT02716870|Cardiometabolic risk factors|cardiometabolic risk factors
237017|NCT02716870|Triglycerides|triglycerides
237018|NCT02716870|Cholesterol|cholesterol
237019|NCT02716870|Glycemic control|glycemic control
237020|NCT02716870|Insulin resistance|insulin resistance
237021|NCT02716870|Body weight|body weight
237022|NCT02716870|Uric acid|uric acid
237023|NCT02716870|Blood pressure|blood pressure
237024|NCT02716870|Fatty liver|fatty liver
237025|NCT02716870|Fasting|fasting
237026|NCT02716870|Postprandial|postprandial
237027|NCT02716844|Osteoporosis|osteoporosis
237028|NCT02716844|Clinic Pilates Exercise|clinic pilates exercise
237029|NCT02716844|Kinesiophobia|kinesiophobia
237030|NCT02716844|Pain|pain
237031|NCT02716831|Bulimia Nervosa|bulimia nervosa
237032|NCT02716831|Eating Disorders|eating disorders
237033|NCT02716831|Binge Eating|binge eating
237034|NCT02716831|Bulimia|bulimia
237035|NCT02716831|Purging|purging
237036|NCT02716818|Glucocorticoid therapy|glucocorticoid therapy
237037|NCT02716805|autologous stem cell transplant|autologous stem cell transplant
237038|NCT02716805|HDT/ASCT|hdt/asct
237039|NCT02716805|CTLA-4|ctla-4
237040|NCT02716805|PD-L1|pd-l1
237041|NCT02716805|peripheral blood mononuclear cells|peripheral blood mononuclear cells
237042|NCT02716805|PBMC|pbmc
237043|NCT02716805|ASCT|asct
237044|NCT02716766|Sorafenib|sorafenib
237045|NCT02716766|Drug Therapy|drug therapy
237046|NCT02716740|Post-obesity surgery|post-obesity surgery
237047|NCT02716740|Leucine-enriched amino acid supplementation|leucine-enriched amino acid supplementation
237048|NCT02716740|Anabolic substance|anabolic substance
237049|NCT02716740|Physical training|physical training
237050|NCT02716740|Muscular mass|muscular mass
237051|NCT02716740|Loss of weight|loss of weight
237052|NCT02716714|Korean|korean
237053|NCT02716701|Exercise|exercise
237054|NCT02716688|Esophageal cancer|esophageal cancer
237055|NCT02716688|Radiotherapy|radiotherapy
237056|NCT02716688|elder|elder
237057|NCT02716688|S-1|s-1
237058|NCT02716675|HIV-1 Infections|hiv-1 infections
237059|NCT02716649|Trauma|trauma
237060|NCT02716649|ICISS|iciss
237061|NCT02716649|India|india
237062|NCT02716649|ICD-10|icd-10
237063|NCT02716597|albumin, septic shock|albumin, septic shock
237064|NCT02716571|Healthy Subjects|healthy subjects
237065|NCT02716571|Healthy Participants|healthy participants
237066|NCT02716545|Gastrointestinal vascular malformation|gastrointestinal vascular malformation
237067|NCT02716545|Endoscopic Therapy|endoscopic therapy
237068|NCT02716519|Diabetes|diabetes
237069|NCT02716519|diabetic foot ulcer|diabetic foot ulcer
237070|NCT02716519|foot sore|foot sore
237071|NCT02716519|type 2 diabetes|type 2 diabetes
237072|NCT02716519|type 1 diabetes|type 1 diabetes
237073|NCT02716519|DFU|dfu
237074|NCT02716519|pressure ulcers|pressure ulcers
237075|NCT02716519|bed sores|bed sores
237076|NCT02716506|POP surgery|pop surgery
237077|NCT02716493|Telerehabilitation|telerehabilitation
237078|NCT02716480|Nutrition|nutrition
237079|NCT02716480|Physical activity|physical activity
237080|NCT02716480|Bariatric surgery|bariatric surgery
237081|NCT02716480|Obesity|obesity
237082|NCT02716480|Health technology|health technology
237083|NCT02716480|Health-connected devices|health-connected devices
237084|NCT02716467|nursing|nursing
237085|NCT02716467|intercessory prayer|intercessory prayer
237086|NCT02716467|spirituality|spirituality
237087|NCT02716467|clinical trials|clinical trials
237088|NCT02716454|Early surgery|early surgery
237089|NCT02716454|Crohn's disease|crohn's disease
237090|NCT02716454|Step-up therapy|step-up therapy
237091|NCT02716415|neonates|neonates
237092|NCT02716415|infants|infants
237093|NCT02716402|Cyanotic congenital heart disease|cyanotic congenital heart disease
237094|NCT02716402|pulmonary thrombosis|pulmonary thrombosis
237095|NCT02716402|cerebral thrombosis|cerebral thrombosis
237096|NCT02716376|Head and neck neoplasms|head and neck neoplasms
237097|NCT02716376|Radiotherapy|radiotherapy
237098|NCT02716376|Otitis media|otitis media
237099|NCT02716337|human milk target fortification|human milk target fortification
237100|NCT02716324|Attention-Deficit/Hyperactivity Disorder|attention-deficit/hyperactivity disorder
237101|NCT02716324|Shared-Decision Making|shared-decision making
237102|NCT02716324|Care Manager|care manager
237103|NCT02716324|Children|children
237104|NCT02716324|Parents|parents
237105|NCT02716324|Teachers|teachers
237106|NCT02716311|EGFR|egfr
237107|NCT02716311|Lung Cancer|lung cancer
237108|NCT02716285|Irritable Bowel Syndrome|irritable bowel syndrome
237109|NCT02716285|Abdominal pain|abdominal pain
237110|NCT02716285|Targeted Delivery|targeted delivery
237111|NCT02716285|Peppermint oil|peppermint oil
237112|NCT02716272|mesothelioma|mesothelioma
237113|NCT02716272|immunotherapy|immunotherapy
237114|NCT02716272|nivolumab|nivolumab
237115|NCT02716272|ipilimumab|ipilimumab
237116|NCT02716259|Periodontitis|periodontitis
237117|NCT02716259|Cardiovascular diseases|cardiovascular diseases
237118|NCT02716259|Bacteremia|bacteremia
237119|NCT02716259|Scaling and root planing|scaling and root planing
237120|NCT02716259|Flow-mediated dilation|flow-mediated dilation
237121|NCT02716259|carotid intima-media thickness|carotid intima-media thickness
237122|NCT02716259|Porphyromonas gingivalis|porphyromonas gingivalis
237123|NCT02716259|Aggregatibacter actinomycetemcomitans|aggregatibacter actinomycetemcomitans
237124|NCT02716246|MPS IIIA|mps iiia
237125|NCT02716246|Sanfilippo|sanfilippo
237126|NCT02716246|Gene Therapy|gene therapy
237127|NCT02716220|DREAMS 2G|dreams 2g
237128|NCT02716220|Scaffold|scaffold
237129|NCT02716220|Drug Eluting Absorbable Metal Scaffold|drug eluting absorbable metal scaffold
237130|NCT02716220|Coronary Artery Disease|coronary artery disease
237131|NCT02716207|Stereotactic Body Radiotherapy (SBRT)|stereotactic body radiotherapy (sbrt)
237132|NCT02716207|CyberKnife|cyberknife
237133|NCT02716207|Dose Escalation|dose escalation
237134|NCT02716181|Atopic Dermatitis|atopic dermatitis
237135|NCT02716181|Topical therapy|topical therapy
237136|NCT02716168|Cancer|cancer
237137|NCT02716168|tele-health|tele-health
237138|NCT02716168|Shared care|shared care
237139|NCT02716168|Continuity|continuity
237140|NCT02716116|NSCLC|nsclc
237141|NCT02716116|EGFR|egfr
237142|NCT02716116|HER2|her2
237143|NCT02716116|human epidermal growth factor receptor 2|human epidermal growth factor receptor 2
237144|NCT02716116|exon 20 insertions|exon 20 insertions
237145|NCT02716116|exon 19 deletions|exon 19 deletions
237146|NCT02716116|exon 21 substitution|exon 21 substitution
237147|NCT02716116|T790M|t790m
237148|NCT02716116|ErbB-2|erbb-2
237149|NCT02716116|Epidermal Growth Factor Receptor|epidermal growth factor receptor
237150|NCT02716103|AL amyloidosis, systemic primary amyloidosis|al amyloidosis, systemic primary amyloidosis
237151|NCT02716064|chronic conditions, self-management, PHR|chronic conditions, self-management, phr
237152|NCT02716038|Non-Small Cell Lung Cancer|non-small cell lung cancer
237153|NCT02716038|Non-Small-Cell Lung Carcinoma|non-small-cell lung carcinoma
237154|NCT02716038|Nonsmall Cell Lung Cancer|nonsmall cell lung cancer
237155|NCT02716038|NSCLC|nsclc
237156|NCT02716012|Oligonucleotide|oligonucleotide
237157|NCT02716012|RNA|rna
237158|NCT02716012|saRNA|sarna
237159|NCT02716012|Fibrosis|fibrosis
237160|NCT02716012|Cirrhosis|cirrhosis
237161|NCT02715986|ECT|ect
237162|NCT02715986|Diffusion Tensor Imaging (DTI)|diffusion tensor imaging (dti)
237163|NCT02715986|fMRI|fmri
237164|NCT02715947|Psoriasis Vulgaris|psoriasis vulgaris
237165|NCT02715947|Methotrexate|methotrexate
237166|NCT02715934|Diabetes Education|diabetes education
237167|NCT02715934|Chronic Disease Management|chronic disease management
237168|NCT02715934|Health Care Delivery|health care delivery
237169|NCT02715934|Patient-Centered Medical Home|patient-centered medical home
237170|NCT02715934|Primary Care|primary care
237171|NCT02715895|Infant|infant
237172|NCT02715895|Growth|growth
237173|NCT02715895|Body Weight Changes|body weight changes
237174|NCT02715895|Infant Formula|infant formula
237175|NCT02715895|Randomized Controlled Trial|randomized controlled trial
237176|NCT02715882|Colorectal cancer|colorectal cancer
237177|NCT02715882|TLR5|tlr5
237178|NCT02715882|Immunotherapy|immunotherapy
303260|NCT02327065|EUS|eus
237179|NCT02715869|Myocardial Preconditioning, inotropic score|myocardial preconditioning, inotropic score
237180|NCT02715856|Bone metastases|bone metastases
237181|NCT02715856|Intramedullary nailing surgery|intramedullary nailing surgery
237183|NCT02715856|Physical tasks|physical tasks
237184|NCT02715856|Surveys|surveys
237185|NCT02715856|Questionnaires|questionnaires
237186|NCT02715856|Smartphone|smartphone
237187|NCT02715856|Tablet|tablet
237188|NCT02715856|Telemedicine|telemedicine
237189|NCT02715856|Telemonitoring|telemonitoring
237190|NCT02715843|CD20|cd20
237191|NCT02715843|immunotoxin|immunotoxin
237192|NCT02715843|NHL|nhl
237193|NCT02715843|non-Hodgkin's lymphoma|non-hodgkin's lymphoma
237194|NCT02715843|lymphoma|lymphoma
237195|NCT02715843|cancer|cancer
237196|NCT02715843|antibodies|antibodies
237197|NCT02715843|immunotherapy|immunotherapy
237198|NCT02715843|safety|safety
237199|NCT02715843|pharmacokinetics|pharmacokinetics
237200|NCT02715843|MT-3724|mt-3724
237201|NCT02715843|relapsed|relapsed
237202|NCT02715843|refractory|refractory
237203|NCT02715830|angioplasty|angioplasty
237204|NCT02715830|infrapopliteal arteries|infrapopliteal arteries
237205|NCT02715817|Stroke|stroke
237206|NCT02715817|Hemiparesis|hemiparesis
237207|NCT02715817|Physical Therapy|physical therapy
237208|NCT02715817|Virtual Reality Exposure Therapy|virtual reality exposure therapy
237209|NCT02715817|Video Games|video games
237210|NCT02715804|Pancreatic ductal adenocarcinoma (PDA)|pancreatic ductal adenocarcinoma (pda)
237211|NCT02715804|Pancreatic ductal carcinoma|pancreatic ductal carcinoma
237212|NCT02715804|PEGylated Recombinant Human Hyaluronidase (PEGPH20)|pegylated recombinant human hyaluronidase (pegph20)
237213|NCT02715804|Nab-paclitaxel|nab-paclitaxel
237214|NCT02715804|Gemcitabine|gemcitabine
237215|NCT02715804|Metastatic|metastatic
237216|NCT02715804|Stage IV|stage iv
237217|NCT02715791|Self-Management|self-management
237218|NCT02715791|Health Connectors|health connectors
237219|NCT02715791|Volunteers|volunteers
237220|NCT02715791|Technology|technology
237221|NCT02715791|Interprofessional team|interprofessional team
237222|NCT02715791|Chronic disease|chronic disease
237223|NCT02715791|Self-efficacy|self-efficacy
237224|NCT02715791|Patient-centredness|patient-centredness
237225|NCT02715791|Community Engagement|community engagement
237226|NCT02715739|Trauma|trauma
237227|NCT02715739|India|india
237228|NCT02715739|ICISS|iciss
237229|NCT02715713|Autonomic neuropathy, Testosterone Deficiency|autonomic neuropathy, testosterone deficiency
237230|NCT02715661|blood flow|blood flow
237231|NCT02715661|brain health|brain health
237232|NCT02715661|exercise|exercise
237233|NCT02715661|endothelial activation|endothelial activation
237234|NCT02715596|head and neck|head and neck
237235|NCT02715596|eicosapentanoic acid|eicosapentanoic acid
237236|NCT02715596|body composition|body composition
237237|NCT02715570|Aspergillus species|aspergillus species
237238|NCT02715570|Filamentous fungi|filamentous fungi
237239|NCT02715570|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors
237240|NCT02715570|Anti-Infective Agents|anti-infective agents
237241|NCT02715570|Antifungal Agents|antifungal agents
237242|NCT02715570|Enzyme Inhibitors|enzyme inhibitors
237243|NCT02715570|Aspergillosis|aspergillosis
237244|NCT02715570|Allergic Bronchopulmonary|allergic bronchopulmonary
237245|NCT02715570|Asthma|asthma
237246|NCT02715544|Intervention|intervention
237247|NCT02715544|Physical activity|physical activity
237248|NCT02715544|Eating habit|eating habit
237249|NCT02715544|Connectedness to nature|connectedness to nature
237250|NCT02715518|Acute ST-segment elevation myocardial infarction|acute st-segment elevation myocardial infarction
237251|NCT02715518|Acute myocardial infarction|acute myocardial infarction
237252|NCT02715518|Fractional flow reserve|fractional flow reserve
237253|NCT02715518|Percutaneous coronary intervention|percutaneous coronary intervention
237254|NCT02715518|Multivessel disease|multivessel disease
237255|NCT02715518|STEMI|stemi
237256|NCT02715518|NSTEMI|nstemi
237257|NCT02715505|Hurler syndrome, MLD, Krabbe, cALD, Hematopoietic Stem Cell Transplantation (HSCT)|hurler syndrome, mld, krabbe, cald, hematopoietic stem cell transplantation (hsct)
237258|NCT02715453|Frailty|frailty
237259|NCT02715453|Acute myocardial infarction|acute myocardial infarction
237260|NCT02715440|Benzodiazepines|benzodiazepines
237261|NCT02715440|drugs|drugs
237262|NCT02715440|withdrawal|withdrawal
237263|NCT02715440|nursing home|nursing home
237265|NCT02715440|therapy elderly|therapy elderly
237266|NCT02715440|Adverse Effect|adverse effect
237267|NCT02715440|pharmacokinetics|pharmacokinetics
237268|NCT02715440|Decreased Drug Tolerance|decreased drug tolerance
237269|NCT02715375|asthma environment|asthma environment
237270|NCT02715362|immunotherapy GPC3 CAR-T HCC|immunotherapy gpc3 car-t hcc
237271|NCT02715349|schizophrenia|schizophrenia
237272|NCT02715349|psychoeducation|psychoeducation
237273|NCT02715349|Vietnam|vietnam
237274|NCT02715336|In vitro fertilization|in vitro fertilization
237275|NCT02715336|IVF|ivf
237276|NCT02715336|Assisted Reproductive Technologies|assisted reproductive technologies
237277|NCT02715336|ART|art
237278|NCT02715336|OHSS|ohss
237279|NCT02715336|Ovarian hyperstimulation|ovarian hyperstimulation
237280|NCT02715336|dual triggering|dual triggering
237281|NCT02715336|GnRH|gnrh
237282|NCT02715323|dry eye|dry eye
237283|NCT02715323|immunological profile|immunological profile
237284|NCT02715323|autoimmune|autoimmune
237285|NCT02715297|glioblastoma|glioblastoma
237286|NCT02715297|GBM|gbm
237287|NCT02715297|radiotherapy|radiotherapy
237288|NCT02715297|Re-irradiation|re-irradiation
237289|NCT02715297|progression|progression
237290|NCT02715284|Metastatic solid tumors|metastatic solid tumors
237291|NCT02715284|Advanced solid tumors|advanced solid tumors
237292|NCT02715284|anti-PD-1|anti-pd-1
237293|NCT02715284|TSR-042|tsr-042
237294|NCT02715284|Immunotherapy|immunotherapy
237295|NCT02715284|PD-1|pd-1
237296|NCT02715284|Endometrial|endometrial
237297|NCT02715284|Non-small cell lung cancer, NSCLC|non-small cell lung cancer, nsclc
237298|NCT02715284|MSI-High|msi-high
237299|NCT02715284|Dostarlimab|dostarlimab
237300|NCT02715284|dMMR|dmmr
237301|NCT02715245|home rehabilitation|home rehabilitation
237302|NCT02715245|Primary Health Care|primary health care
237303|NCT02715245|Physiotherapy|physiotherapy
237304|NCT02715245|chronic disease|chronic disease
237305|NCT02715206|rural adolescents, substance use, prevention, adaptation|rural adolescents, substance use, prevention, adaptation
237306|NCT02715154|Epidural Anaesthesia|epidural anaesthesia
237307|NCT02715154|Cesarean Section|cesarean section
237308|NCT02715154|Dexmedetomidine|dexmedetomidine
237309|NCT02715141|surveillance, molecular stool testing|surveillance, molecular stool testing
237310|NCT02715115|Autism|autism
237311|NCT02715115|Rett's syndrome|rett's syndrome
237312|NCT02715115|Rett disorder|rett disorder
237313|NCT02715115|Rett's disorder|rett's disorder
237314|NCT02715115|Ataxia|ataxia
237315|NCT02715102|lung cancer|lung cancer
237316|NCT02715102|lung neoplasms|lung neoplasms
237317|NCT02715102|lung nodules|lung nodules
237318|NCT02715102|screening tests for cancer|screening tests for cancer
237319|NCT02715089|NGS|ngs
237320|NCT02715089|Liver Neoplasms|liver neoplasms
237321|NCT02715089|Biliary Tract Neoplasms|biliary tract neoplasms
237322|NCT02715089|Hepatobiliary Neoplasms|hepatobiliary neoplasms
237323|NCT02715076|Thoracic Surgery|thoracic surgery
237324|NCT02715076|Thoracic surgery, Video assisted|thoracic surgery, video assisted
237325|NCT02715076|Open Abdominal Surgery|open abdominal surgery
237326|NCT02715076|Anesthesia, General|anesthesia, general
237327|NCT02715050|phototherapy|phototherapy
237328|NCT02715050|photobiostimulation|photobiostimulation
237329|NCT02715050|muscle training|muscle training
237330|NCT02715050|muscular adaptation|muscular adaptation
237331|NCT02715037|fusobacterium necrophorum|fusobacterium necrophorum
237332|NCT02715037|acute tonsillitis|acute tonsillitis
237333|NCT02715037|peritonsillar cellulitis|peritonsillar cellulitis
237334|NCT02715037|infectious mononucleosis|infectious mononucleosis
237335|NCT02715037|microbiology|microbiology
237336|NCT02715037|antibody development|antibody development
237337|NCT02715024|Tamsulosin|tamsulosin
237338|NCT02715024|Solifenacin|solifenacin
237339|NCT02715024|Lower urinary tract symptoms|lower urinary tract symptoms
237340|NCT02715024|Overactive bladder|overactive bladder
237341|NCT02715011|Leukemia, Myeloid, Acute|leukemia, myeloid, acute
237342|NCT02715011|JNJ-63709178|jnj-63709178
237343|NCT02714998|ectopic pregnancy|ectopic pregnancy
237344|NCT02714998|ovarian reserve|ovarian reserve
237345|NCT02714998|salpingectomy|salpingectomy
237346|NCT02714998|methotrexate|methotrexate
237347|NCT02714985|chikungunya virus|chikungunya virus
237348|NCT02714985|RT-PCR|rt-pcr
237349|NCT02714985|urine|urine
237350|NCT02714985|diagnosis|diagnosis
237351|NCT02714946|Thyroid Nodule|thyroid nodule
237352|NCT02714946|Percutaneous radiofrequency ablation (RFA)|percutaneous radiofrequency ablation (rfa)
237353|NCT02714946|Percutaneous laser ablation (LA)|percutaneous laser ablation (la)
237354|NCT02714933|pulmonary|pulmonary
237355|NCT02714933|parenchyma|parenchyma
237356|NCT02714933|MRI sequence Advanced ZTE|mri sequence advanced zte
237357|NCT02714933|chest computed tomography|chest computed tomography
237358|NCT02714920|DNA Repair Enzyme Signature|dna repair enzyme signature
237359|NCT02714920|instrinsic radio- or chemo-resistance|instrinsic radio- or chemo-resistance
237360|NCT02714920|treatment-induced radio- or chemo-resistance|treatment-induced radio- or chemo-resistance
237361|NCT02714894|magnetic resonance imaging|magnetic resonance imaging
237362|NCT02714894|magnetic resonance spectroscopy|magnetic resonance spectroscopy
237363|NCT02714868|repeated measures|repeated measures
237364|NCT02714868|matched comparison|matched comparison
237365|NCT02714868|manualized intervention|manualized intervention
237366|NCT02714868|self-determination|self-determination
237367|NCT02714868|participation|participation
237368|NCT02714868|advocacy|advocacy
237369|NCT02714868|problem-solving|problem-solving
237370|NCT02714868|commuinity participation|commuinity participation
237371|NCT02714868|occupational therapy|occupational therapy
237372|NCT02714868|environment|environment
712523|NCT00579839|PreTerm Neonate|preterm neonate
237373|NCT02714829|Injectable Ceramics Bone Graft Substitute Containing rhBMP-2|injectable ceramics bone graft substitute containing rhbmp-2
237374|NCT02714790|Acute Myeloid Leukemia|acute myeloid leukemia
237375|NCT02714790|Minimal Residual Disease|minimal residual disease
237376|NCT02714790|Wilms Tumor|wilms tumor
237377|NCT02714777|General anesthesia|general anesthesia
237378|NCT02714777|Autonomic nervous system|autonomic nervous system
237379|NCT02714777|Children|children
237380|NCT02714764|Alexander Disease|alexander disease
237381|NCT02714738|Brachial plexus block|brachial plexus block
237382|NCT02714738|Regional anesthesia|regional anesthesia
237383|NCT02714738|Ultrasound|ultrasound
237384|NCT02714725|Dexmedetomidine|dexmedetomidine
237385|NCT02714725|Microcirculation|microcirculation
237386|NCT02714725|On Pump|on pump
237387|NCT02714725|CABG|cabg
237388|NCT02714686|Fertility|fertility
237389|NCT02714686|Total Contraception Prevalence Rate|total contraception prevalence rate
237390|NCT02714686|Family planning methods|family planning methods
237391|NCT02714686|Birth Control|birth control
237392|NCT02714686|Mass Media Campaign|mass media campaign
237393|NCT02714686|Demand for contraception|demand for contraception
237394|NCT02714686|Modern Contraception Prevalence Rate|modern contraception prevalence rate
237395|NCT02714686|Birth intervals|birth intervals
237396|NCT02714647|motor learning|motor learning
237397|NCT02714647|attention|attention
237398|NCT02714647|priming|priming
237399|NCT02714647|rehabilitation|rehabilitation
237400|NCT02714621|Magnetic Resonance Imaging (MRI)|magnetic resonance imaging (mri)
237401|NCT02714621|High Intensity Focused Ultrasound (HIFU)|high intensity focused ultrasound (hifu)
237402|NCT02714621|Focused Ultrasound Surgery|focused ultrasound surgery
237403|NCT02714595|cefiderocol|cefiderocol
237404|NCT02714595|Bloodstream infections (BSI)|bloodstream infections (bsi)
237405|NCT02714595|Complicated urinary tract infection (cUTI)|complicated urinary tract infection (cuti)
237406|NCT02714595|Ventilator associated pneumonia (VAP)|ventilator associated pneumonia (vap)
237407|NCT02714595|Hospital acquired pneumonia (HAP)|hospital acquired pneumonia (hap)
237408|NCT02714595|Sepsis|sepsis
237409|NCT02714595|multi-drug resistant pathogens|multi-drug resistant pathogens
237410|NCT02714595|S-649266|s-649266
237411|NCT02714595|Gram-negative pathogens|gram-negative pathogens
237412|NCT02714595|Healthcare-associated pneumonia (HCAP)|healthcare-associated pneumonia (hcap)
237413|NCT02714595|carbapenem resistant pathogens|carbapenem resistant pathogens
237414|NCT02714582|Shift report|shift report
237415|NCT02714582|Bedside|bedside
237416|NCT02714582|Nursing|nursing
237417|NCT02714582|Matched controlled trial|matched controlled trial
237418|NCT02714582|Mixed method|mixed method
237419|NCT02714582|Patient participation|patient participation
237420|NCT02714556|Lung volume|lung volume
237421|NCT02714556|Lung Clearance Index|lung clearance index
237422|NCT02714556|Functional Residual Capacity|functional residual capacity
237423|NCT02714556|Respiratory function|respiratory function
237424|NCT02714543|OSMF|osmf
237425|NCT02714543|Aloevera|aloevera
237426|NCT02714543|Hydrocortisone|hydrocortisone
237427|NCT02714543|Hyaluronidase|hyaluronidase
237428|NCT02714504|Prophylaxis|prophylaxis
237554|NCT02713893|Benzydamine HCl 0.12%|benzydamine hcl 0.12%
237429|NCT02714465|Hyperbaric Oxygen Therapy; Gamma Knife Radiosurgery|hyperbaric oxygen therapy; gamma knife radiosurgery
237430|NCT02714452|Person-centred care|person-centred care
237431|NCT02714452|Thriving|thriving
237432|NCT02714452|Satisfaction with care|satisfaction with care
237433|NCT02714452|Residential aged care|residential aged care
237434|NCT02714452|Caring environment|caring environment
237435|NCT02714439|Malignant neoplasms of female genital organs|malignant neoplasms of female genital organs
237436|NCT02714439|Cervical Cancer Prevention|cervical cancer prevention
237437|NCT02714439|Abnormal Pap test|abnormal pap test
237438|NCT02714439|Positive HPV test|positive hpv test
237439|NCT02714439|History of cervical dysplasia|history of cervical dysplasia
237440|NCT02714439|Colposcopy|colposcopy
237441|NCT02714439|Proflavine|proflavine
237442|NCT02714439|Proflavine hemisulfate|proflavine hemisulfate
237443|NCT02714439|High-Resolution Microendoscopy|high-resolution microendoscopy
237444|NCT02714439|HRME|hrme
237445|NCT02714439|Human papillomavirus|human papillomavirus
237446|NCT02714426|Cognitive Aging|cognitive aging
237447|NCT02714426|Attention|attention
237448|NCT02714426|Mindfulness|mindfulness
237449|NCT02714413|D-allulose|d-allulose
237450|NCT02714413|Caucasian|caucasian
237451|NCT02714413|African American|african american
237452|NCT02714400|Obstructive Sleep Apnea|obstructive sleep apnea
237453|NCT02714400|Arousal threshold|arousal threshold
237454|NCT02714400|Venlafaxine|venlafaxine
237455|NCT02714387|Non traumatic acute brain injury|non traumatic acute brain injury
237456|NCT02714374|GL-ONC1|gl-onc1
237457|NCT02714374|Solid Organ Cancer|solid organ cancer
237458|NCT02714374|Cancer|cancer
237459|NCT02714374|Surgery|surgery
237460|NCT02714374|Oncolytic Virus|oncolytic virus
237461|NCT02714374|Soliris|soliris
237462|NCT02714374|Metastatic melanoma|metastatic melanoma
237463|NCT02714374|Esophageal and gastric adenocarcinoma (Stage III/IV)|esophageal and gastric adenocarcinoma (stage iii/iv)
237464|NCT02714374|Cholangiocarcinoma|cholangiocarcinoma
237465|NCT02714374|Pancreatic adenocarcinoma|pancreatic adenocarcinoma
237466|NCT02714374|Gallbladder cancer|gallbladder cancer
237467|NCT02714374|Colorectal cancer (Stage IV)|colorectal cancer (stage iv)
237468|NCT02714374|High-grade mucinous appendix cancer|high-grade mucinous appendix cancer
237469|NCT02714374|High-grade gastrointestinal neuroendocrine cancer|high-grade gastrointestinal neuroendocrine cancer
237470|NCT02714374|Mesothelioma|mesothelioma
237471|NCT02714374|High-grade soft tissue sarcoma|high-grade soft tissue sarcoma
237472|NCT02714374|Stage III or IV|stage iii or iv
237473|NCT02714361|Iron deficiency|iron deficiency
237474|NCT02714361|Vitamin D|vitamin d
237475|NCT02714361|Iron absorption|iron absorption
237476|NCT02714361|Hepcidin|hepcidin
237477|NCT02714348|Helminth infection|helminth infection
237478|NCT02714348|Vaccination|vaccination
237479|NCT02714322|Adalimumab|adalimumab
237480|NCT02714322|Biologics|biologics
237481|NCT02714322|Biosimilar|biosimilar
237482|NCT02714309|Postprandial glycemia|postprandial glycemia
237483|NCT02714309|Metabolic health measures|metabolic health measures
237484|NCT02714296|colon preparation for endoscopy|colon preparation for endoscopy
237485|NCT02714296|enteral feeding|enteral feeding
237486|NCT02714296|sip feeding|sip feeding
237487|NCT02714296|nutridrink|nutridrink
237488|NCT02714296|nutridrink compact protein|nutridrink compact protein
237489|NCT02714283|nontuberculous mycobacteria|nontuberculous mycobacteria
237490|NCT02714283|corticosteroids|corticosteroids
237491|NCT02714283|macrolides|macrolides
237492|NCT02714283|antibiotics|antibiotics
237493|NCT02714205|Hot flash|hot flash
237494|NCT02714153|Lead extraction|lead extraction
237495|NCT02714153|Superior Vena Cava Tear|superior vena cava tear
237496|NCT02714153|Pacemaker/Defibrillator lead extraction|pacemaker/defibrillator lead extraction
237497|NCT02714127|Human Papillomavirus|human papillomavirus
237498|NCT02714127|Biomarker|biomarker
237499|NCT02714127|Self-sampling|self-sampling
237500|NCT02714127|First-void urine|first-void urine
237501|NCT02714127|Cervicovaginal fluid|cervicovaginal fluid
237502|NCT02714127|Colposcopy|colposcopy
237503|NCT02714114|Antibodies|antibodies
237504|NCT02714114|Vaccination|vaccination
237505|NCT02714114|Self-sampling|self-sampling
237506|NCT02714114|First-void urine|first-void urine
237507|NCT02714114|Serum|serum
237508|NCT02714088|High-intensity interval training|high-intensity interval training
237509|NCT02714088|Functional fitness|functional fitness
237510|NCT02714088|Quality of life|quality of life
237511|NCT02714088|Older adults|older adults
237512|NCT02714062|Adolescent Obesity|adolescent obesity
237513|NCT02714062|Childhood Obesity|childhood obesity
237514|NCT02714062|Qsymia|qsymia
237515|NCT02714062|Pharmacokinetics|pharmacokinetics
237516|NCT02714062|VI-0521|vi-0521
237517|NCT02714062|Phentermine|phentermine
237518|NCT02714062|Topiramate|topiramate
237519|NCT02714049|hypoactive sexual desire disorder|hypoactive sexual desire disorder
237520|NCT02714049|Addyi|addyi
237521|NCT02714049|flibanserin|flibanserin
237522|NCT02714049|low sexual desire|low sexual desire
237523|NCT02714049|HSDD|hsdd
237524|NCT02714036|ALS|als
237525|NCT02714010|EGFR-TKI|egfr-tki
237526|NCT02714010|whole brain radiotherapy|whole brain radiotherapy
237527|NCT02714010|brain metastasis|brain metastasis
237528|NCT02714010|non-small cell lung cancer|non-small cell lung cancer
237529|NCT02713984|HER2 CAR-T|her2 car-t
237530|NCT02713984|safety|safety
237531|NCT02713984|efficiency|efficiency
237532|NCT02713984|refractory and relapsed cancer|refractory and relapsed cancer
237533|NCT02713971|Rehabilitation|rehabilitation
237534|NCT02713971|Balance|balance
237535|NCT02713971|Gait|gait
237536|NCT02713971|Biofeedback|biofeedback
237537|NCT02713958|Telerehabilitation|telerehabilitation
237538|NCT02713958|Elbow fractures|elbow fractures
237539|NCT02713958|Arthrolysis|arthrolysis
237540|NCT02713958|MediTouch|meditouch
237541|NCT02713958|Occupational Therapy|occupational therapy
237542|NCT02713958|Active exercises|active exercises
237543|NCT02713945|Simvastatin|simvastatin
237544|NCT02713945|Ras|ras
237545|NCT02713945|MAPK|mapk
237546|NCT02713932|Aortic valve stenosis|aortic valve stenosis
237547|NCT02713932|Aortic valve regurgitation|aortic valve regurgitation
237548|NCT02713932|Transcatheter aortic valve implantation|transcatheter aortic valve implantation
237549|NCT02713919|Cancer|cancer
237550|NCT02713919|Outpatients|outpatients
237551|NCT02713919|Family Caregivers|family caregivers
237552|NCT02713893|Pharmacokinetics|pharmacokinetics
237553|NCT02713893|Econazole nitrate 1%|econazole nitrate 1%
237555|NCT02713893|Intravaginal cream|intravaginal cream
237556|NCT02713893|Antimycotic|antimycotic
237557|NCT02713893|Tolerability|tolerability
237558|NCT02713880|Amyloid Neuropathies|amyloid neuropathies
237559|NCT02713880|Biomarker|biomarker
237560|NCT02713854|Subfertility|subfertility
237561|NCT02713854|In-vitro fertilization|in-vitro fertilization
237562|NCT02713854|BAP-EB|bap-eb
237563|NCT02713854|Endometrial epithelial cells|endometrial epithelial cells
730900|NCT00506857|Leukemia|leukemia
237564|NCT02713854|Repeated implantation failure|repeated implantation failure
237565|NCT02713828|gpNMB-Expressing Squamous Cell Carcinoma of the Lung|gpnmb-expressing squamous cell carcinoma of the lung
237566|NCT02713828|Stage IIIb|stage iiib
237567|NCT02713828|Stage IV|stage iv
237568|NCT02713828|Advanced Squamous Cell Cancer of the Lung|advanced squamous cell cancer of the lung
237569|NCT02713828|Metastatic Squamous Cell Cancer of the Lung|metastatic squamous cell cancer of the lung
237570|NCT02713828|gpNMB-Expressing|gpnmb-expressing
237571|NCT02713828|Glembatumumab Vedotin|glembatumumab vedotin
237572|NCT02713815|Amphetamine-type stimulants|amphetamine-type stimulants
237573|NCT02713815|prefrontal-striatal circuits|prefrontal-striatal circuits
237574|NCT02713815|rTMS|rtms
237575|NCT02713815|Glutamate/GABA|glutamate/gaba
237576|NCT02713815|motivational and cognitive intervention|motivational and cognitive intervention
237577|NCT02713789|ED|ed
237578|NCT02713776|High-Output Enterostomy|high-output enterostomy
237579|NCT02713776|Pasireotide|pasireotide
237580|NCT02713776|Somatostatin Analogues|somatostatin analogues
237581|NCT02713763|Sunitinib|sunitinib
237582|NCT02713750|Combined Oral Contraceptives|combined oral contraceptives
237583|NCT02713750|Highly Active Antiretroviral Therapy|highly active antiretroviral therapy
237584|NCT02713750|Hormonal Contraception|hormonal contraception
237585|NCT02713750|Human Immunodeficiency Virus|human immunodeficiency virus
237586|NCT02713750|Intrauterine Device|intrauterine device
237587|NCT02713750|Pharmacokinetic|pharmacokinetic
237588|NCT02713750|Sexually Transmitted Diseases|sexually transmitted diseases
237589|NCT02713750|Reproductive Health|reproductive health
237590|NCT02713737|hypoxemia|hypoxemia
237591|NCT02713737|high-flow|high-flow
237592|NCT02713737|atrial fibrillation|atrial fibrillation
237593|NCT02713737|sleep|sleep
237594|NCT02713711|Psoriasis|psoriasis
237595|NCT02713711|balneotherapy|balneotherapy
237596|NCT02713711|phototherapy|phototherapy
237597|NCT02713711|balneophototherapy|balneophototherapy
237598|NCT02713698|Anaesthetics|anaesthetics
237599|NCT02713698|Intravenous|intravenous
237600|NCT02713698|Propofol|propofol
237601|NCT02713698|Pharmacokinetics|pharmacokinetics
237602|NCT02713698|Pharmacodynamics|pharmacodynamics
237603|NCT02713698|Propofol pharmacokinetic-pharmacodynamic model|propofol pharmacokinetic-pharmacodynamic model
237604|NCT02713685|regional anesthesia|regional anesthesia
237605|NCT02713685|lower limb surgery|lower limb surgery
237606|NCT02713685|Bupivacaine|bupivacaine
237607|NCT02713659|Literacy|literacy
237608|NCT02713659|Child Development|child development
237609|NCT02713659|Reading|reading
237610|NCT02713646|MRI|mri
237611|NCT02713646|Virtual Endoscopy|virtual endoscopy
237612|NCT02713646|Pain Measurement|pain measurement
237613|NCT02713620|HBV vaccination, immunity|hbv vaccination, immunity
237614|NCT02713581|Proximal venous thromboembolism|proximal venous thromboembolism
237615|NCT02713568|Macrosomia|macrosomia
237616|NCT02713568|Magnetic Resonance- Estimated Fetal Weight|magnetic resonance- estimated fetal weight
237617|NCT02713568|Ultrasound-Estimated Fetal Weight|ultrasound-estimated fetal weight
237618|NCT02713568|Large-for-date fetus|large-for-date fetus
237619|NCT02713529|Solid Tumor|solid tumor
237620|NCT02713529|Pancreatic Cancer|pancreatic cancer
237621|NCT02713529|Colorectal Cancer|colorectal cancer
237622|NCT02713529|Non-Small Cell Lung Cancer|non-small cell lung cancer
237623|NCT02713516|Anxiety|anxiety
237624|NCT02713516|OCD|ocd
237625|NCT02713516|Obsessive Compulsive Disorder|obsessive compulsive disorder
237626|NCT02713516|Generalized Anxiety|generalized anxiety
237627|NCT02713516|Social Phobia|social phobia
237628|NCT02713516|Separation Anxiety|separation anxiety
237629|NCT02713516|GAD|gad
237630|NCT02713516|Youth|youth
237631|NCT02713516|Teen|teen
237632|NCT02713516|Therapy|therapy
237633|NCT02713451|Oxygen|oxygen
237634|NCT02713438|Physical activity|physical activity
237635|NCT02713438|Planning|planning
237636|NCT02713438|Implementation intention|implementation intention
237637|NCT02713438|Quality of life|quality of life
237638|NCT02713438|Body weight|body weight
237639|NCT02713425|Anxiety|anxiety
237640|NCT02713425|Social Phobia|social phobia
237641|NCT02713425|Separation Anxiety|separation anxiety
237642|NCT02713425|Generalized Anxiety|generalized anxiety
237643|NCT02713425|GAD|gad
237644|NCT02713425|Phobia|phobia
237645|NCT02713425|video game|video game
237646|NCT02713425|teen|teen
237647|NCT02713425|youth|youth
237648|NCT02713425|child|child
237649|NCT02713425|adolescent|adolescent
237650|NCT02713347|Quality of Life|quality of life
237651|NCT02713347|Symptom Assessment|symptom assessment
237652|NCT02713347|Palliative Care|palliative care
237653|NCT02713347|Disease Management|disease management
237654|NCT02713347|Delivery of Health Care|delivery of health care
237655|NCT02713347|Advance Care Planning|advance care planning
237656|NCT02713334|Decision Making|decision making
237657|NCT02713334|Communication|communication
237658|NCT02713334|16-080|16-080
237659|NCT02713321|diabetes|diabetes
237660|NCT02713321|vulnerable populations|vulnerable populations
237661|NCT02713321|comorbidity|comorbidity
237662|NCT02713321|patient-centered outcomes research|patient-centered outcomes research
237663|NCT02713321|Medicaid reform|medicaid reform
237664|NCT02713321|health disparities|health disparities
237665|NCT02713295|Moderate Plaque Psoriasis|moderate plaque psoriasis
237666|NCT02713295|Severe Plaque Psoriasis|severe plaque psoriasis
237667|NCT02713295|Plaque Psoriasis|plaque psoriasis
237668|NCT02713282|Schizophrenia|schizophrenia
237669|NCT02713282|R092670|r092670
237670|NCT02713282|Paliperidone Palmitate|paliperidone palmitate
237671|NCT02713269|Secondary Malignant Neoplasm of Vertebral Column|secondary malignant neoplasm of vertebral column
237672|NCT02713269|Spine Metastases|spine metastases
237673|NCT02713269|Epidural spinal cord compression|epidural spinal cord compression
237674|NCT02713269|Stereotactic spine radiosurgery|stereotactic spine radiosurgery
237675|NCT02713269|SSRS|ssrs
237676|NCT02713269|Thermal ablation|thermal ablation
237677|NCT02713269|Symptom questionnaire|symptom questionnaire
237678|NCT02713269|Surveys|surveys
237679|NCT02713256|Graves' disease|graves' disease
237680|NCT02713256|Hyperthyroidism|hyperthyroidism
237681|NCT02713256|CFZ533|cfz533
237682|NCT02713256|TSH|tsh
237683|NCT02713243|Primary bile acid diarrhea,|primary bile acid diarrhea,
237684|NCT02713243|FXR agonist,|fxr agonist,
237685|NCT02713243|bile acid malabsorption.|bile acid malabsorption.
237686|NCT02713217|depressive disorder|depressive disorder
237687|NCT02713217|alcohol-related disorders|alcohol-related disorders
237688|NCT02713217|telemedicine|telemedicine
237689|NCT02713217|rural health|rural health
237690|NCT02713217|collaborative care|collaborative care
237691|NCT02713217|post-traumatic stress disorder (PTSD)|post-traumatic stress disorder (ptsd)
237692|NCT02713191|Bronchoscopy|bronchoscopy
237693|NCT02713191|Sedation|sedation
237694|NCT02713191|Dexmedetomidine|dexmedetomidine
237695|NCT02713165|Gut Microbiota|gut microbiota
237696|NCT02713139|vaginal|vaginal
237697|NCT02713139|discharge|discharge
237698|NCT02713139|women|women
237699|NCT02713048|Cardiac arrest|cardiac arrest
237700|NCT02713048|Troponin I|troponin i
237701|NCT02713048|coronary anatomy|coronary anatomy
237702|NCT02713022|DEXA Scan|dexa scan
237703|NCT02713022|15-235|15-235
237704|NCT02713009|Maternal body weight|maternal body weight
237705|NCT02713009|Vitamin D|vitamin d
237706|NCT02713009|Pregnancy|pregnancy
237707|NCT02712996|Traumatic Brain Injury|traumatic brain injury
237708|NCT02712996|Attention Deficit|attention deficit
237709|NCT02712996|TBI|tbi
237710|NCT02712996|Vyvanse|vyvanse
237711|NCT02712983|Inhaled tobramycin; tobramycin inhalation powder; bronchiectasis; pulmonary Pseudomonas aeruginosa infection; dose-finding study|inhaled tobramycin; tobramycin inhalation powder; bronchiectasis; pulmonary pseudomonas aeruginosa infection; dose-finding study
237712|NCT02712918|Depression|depression
237713|NCT02712918|Inpatient|inpatient
237714|NCT02712918|Acute|acute
237715|NCT02712918|Brief Behavioral Activation Treatment for Depression|brief behavioral activation treatment for depression
237716|NCT02712905|Acute myeloid leukemia (AML)|acute myeloid leukemia (aml)
237717|NCT02712905|myelodysplastic syndrome (MDS)|myelodysplastic syndrome (mds)
237718|NCT02712905|small cell lung cancer (SCLC)|small cell lung cancer (sclc)
237719|NCT02712905|myelofibrosis (MF)|myelofibrosis (mf)
237720|NCT02712905|solid tumor, lysine-specific demethylase 1 (LSD1) inhibitor|solid tumor, lysine-specific demethylase 1 (lsd1) inhibitor
237721|NCT02712840|Single embryo transfer|single embryo transfer
237722|NCT02712840|Freeze-all|freeze-all
237723|NCT02712840|Fresh|fresh
237724|NCT02712840|Vitrification|vitrification
237725|NCT02712840|Clinical Pregnancy|clinical pregnancy
237726|NCT02712840|Blastocyst|blastocyst
237727|NCT02712827|self-gripping mesh, fibrin glue, total extraperitoneal|self-gripping mesh, fibrin glue, total extraperitoneal
237728|NCT02712801|HIV|hiv
237729|NCT02712801|antiretroviral treatment|antiretroviral treatment
237730|NCT02712801|child|child
237731|NCT02712801|testing|testing
237732|NCT02712788|Subarachnoid Hemorrhage|subarachnoid hemorrhage
237733|NCT02712788|Cerebral Vasospasm|cerebral vasospasm
237734|NCT02712788|Milrinone|milrinone
237735|NCT02712788|Hyperdynamic Therapy|hyperdynamic therapy
237736|NCT02712762|immunological profiles|immunological profiles
237737|NCT02712749|Binaural Beat|binaural beat
237738|NCT02712749|Elderly|elderly
237739|NCT02712749|preoperative medication|preoperative medication
237740|NCT02712749|postoperative merphine consumption|postoperative merphine consumption
237741|NCT02712749|postoperative pain|postoperative pain
237742|NCT02712736|Primary Sclerosing Cholangitis|primary sclerosing cholangitis
237743|NCT02712723|ER+, HER2-negative breast cancer|er+, her2-negative breast cancer
237744|NCT02712723|Stage II or III|stage ii or iii
237745|NCT02712723|Letrozole|letrozole
237746|NCT02712723|Femara|femara
237747|NCT02712723|Ribociclib|ribociclib
237748|NCT02712723|LEE011|lee011
237749|NCT02712723|Neo-adjuvant|neo-adjuvant
237848|NCT02712177|interaction|interaction
237750|NCT02712710|knee, osteoarthritis, brace|knee, osteoarthritis, brace
237751|NCT02712697|liver-kidney yin deficiency syndrome|liver-kidney yin deficiency syndrome
237752|NCT02712697|primary severe IgA nephropathy|primary severe iga nephropathy
730901|NCT00506857|MDS|mds
237753|NCT02712697|Lee's grade Ⅲ|lee's grade ⅲ
237754|NCT02712671|Cost-Benefit Analysis|cost-benefit analysis
237755|NCT02712671|Quality of Life|quality of life
237756|NCT02712593|Healthy participants|healthy participants
237757|NCT02712593|Dietary supplement|dietary supplement
237758|NCT02712593|Bioavailability|bioavailability
237759|NCT02712593|Niagen™|niagen™
237760|NCT02712593|Nicotinamide riboside|nicotinamide riboside
237761|NCT02712593|N-methylnicotinamide|n-methylnicotinamide
237762|NCT02712580|pediatric burns|pediatric burns
237763|NCT02712580|deep dermal wounds|deep dermal wounds
237764|NCT02712580|wound healing|wound healing
237765|NCT02712580|ChildPain Measurement|childpain measurement
237766|NCT02712580|Treatment Outcome Wound Healing/physiology|treatment outcome wound healing/physiology
237767|NCT02712580|wireless electric stimulation|wireless electric stimulation
237768|NCT02712580|wireless current stimulation|wireless current stimulation
237769|NCT02712580|wireless technology|wireless technology
237770|NCT02712580|children|children
237771|NCT02712580|conservative treatment|conservative treatment
237772|NCT02712580|deep dermal scalds|deep dermal scalds
237773|NCT02712580|humans|humans
237774|NCT02712580|deep dermal burns|deep dermal burns
237775|NCT02712580|burns|burns
237776|NCT02712580|wound healing process|wound healing process
237777|NCT02712554|Pain|pain
237778|NCT02712554|Nausea|nausea
237779|NCT02712554|Vomiting|vomiting
237780|NCT02712541|Caregiver burden Index|caregiver burden index
237781|NCT02712528|bispectral index|bispectral index
237782|NCT02712528|extubation|extubation
237783|NCT02712528|recovery|recovery
237784|NCT02712528|remifentanil|remifentanil
237785|NCT02712489|HAART-treated participants|haart-treated participants
237787|NCT02712489|Therapeutic immunization|therapeutic immunization
237788|NCT02712476|Mannitol|mannitol
237789|NCT02712476|Furosemid|furosemid
237790|NCT02712476|Brain Relaxation|brain relaxation
237791|NCT02712463|Schizophrenia|schizophrenia
237792|NCT02712463|Oral antipsychotics|oral antipsychotics
237793|NCT02712463|Long acting Injectable antipsychotics|long acting injectable antipsychotics
237794|NCT02712450|geriatric|geriatric
237795|NCT02712450|emergency|emergency
237796|NCT02712450|clinical pathway|clinical pathway
237797|NCT02712450|regulation|regulation
237798|NCT02712450|SAMU|samu
237799|NCT02712450|training|training
237800|NCT02712437|Insomnia|insomnia
237801|NCT02712437|Quality of Life|quality of life
237802|NCT02712437|Cognitive behavioral therapy|cognitive behavioral therapy
237803|NCT02712424|Vaccine|vaccine
237804|NCT02712372|AZD4831 oral suspension|azd4831 oral suspension
237805|NCT02712372|Healthy male subjects|healthy male subjects
237806|NCT02712372|Safety|safety
237807|NCT02712372|Tolerability|tolerability
237808|NCT02712372|Pharmacokinetics|pharmacokinetics
237809|NCT02712372|Pharmacodynamics|pharmacodynamics
237810|NCT02712359|Havrix|havrix
237811|NCT02712359|Cross-sectional seroprevalence survey|cross-sectional seroprevalence survey
237812|NCT02712359|Panama|panama
237813|NCT02712359|Long-term persistence|long-term persistence
237814|NCT02712359|Hepatitis|hepatitis
237815|NCT02712346|Sickle Cell Anemia|sickle cell anemia
237816|NCT02712346|Sickle Cell Thalassemia|sickle cell thalassemia
237817|NCT02712346|Sickle Beta Thalassemia|sickle beta thalassemia
237818|NCT02712346|Proteinuria|proteinuria
237819|NCT02712346|Sickle nephropathy|sickle nephropathy
237820|NCT02712333|PM2.5|pm2.5
237821|NCT02712333|air purification|air purification
237822|NCT02712333|randomized controlled trial|randomized controlled trial
237823|NCT02712333|metabolomics|metabolomics
237824|NCT02712333|Metabolites|metabolites
237825|NCT02712333|exhaled nitric oxide|exhaled nitric oxide
237826|NCT02712320|Prostate Neoplasm Cancer Carcinoma|prostate neoplasm cancer carcinoma
237827|NCT02712320|Safety Extension|safety extension
237828|NCT02712294|pulmonary hypertension|pulmonary hypertension
237829|NCT02712294|peripheral muscle electrostimulation|peripheral muscle electrostimulation
237830|NCT02712294|capacity of the exercises|capacity of the exercises
237831|NCT02712294|quality of life|quality of life
237832|NCT02712281|Food Selectivity|food selectivity
237833|NCT02712281|Autism MEAL Plan|autism meal plan
237834|NCT02712281|Parent Education|parent education
237835|NCT02712268|Polypharmacy|polypharmacy
237836|NCT02712268|Clinical decision-making|clinical decision-making
237837|NCT02712255|Physical activity|physical activity
237838|NCT02712255|Quality of life|quality of life
237839|NCT02712255|Planning|planning
237840|NCT02712255|Implementation intentions|implementation intentions
237841|NCT02712255|Cardiovascular disease|cardiovascular disease
237842|NCT02712255|Diabetes|diabetes
237843|NCT02712203|Measles vaccine|measles vaccine
237844|NCT02712203|Priorix|priorix
237845|NCT02712203|Priorix-Tetra|priorix-tetra
237846|NCT02712203|Age at vaccination|age at vaccination
237847|NCT02712177|vaccine safety|vaccine safety
237849|NCT02712164|Split-thickness skin graft|split-thickness skin graft
237850|NCT02712164|STSG|stsg
237851|NCT02712164|donor site|donor site
237852|NCT02712164|negative-pressure wound therapy|negative-pressure wound therapy
237853|NCT02712164|NPWT|npwt
237854|NCT02712164|dressing|dressing
237855|NCT02712151|transversus abdominal plane block|transversus abdominal plane block
237856|NCT02712138|Gilbert Syndrome|gilbert syndrome
237857|NCT02712138|Biomarker|biomarker
237858|NCT02712060|Ehlers-Danlos Syndrome|ehlers-danlos syndrome
237859|NCT02712060|Obstructive Sleep Apnea|obstructive sleep apnea
237860|NCT02712060|Prevalence|prevalence
237861|NCT02712060|Children|children
237862|NCT02712060|Pediatric|pediatric
237863|NCT02712060|Adolescents|adolescents
237864|NCT02712047|Fluticasone furoate/vilanterol|fluticasone furoate/vilanterol
237865|NCT02712047|Asthma|asthma
237866|NCT02712047|fraction of exhaled nitric oxide|fraction of exhaled nitric oxide
237867|NCT02712047|cross-over|cross-over
237868|NCT02712034|Medication-assisted treatment (MAT)|medication-assisted treatment (mat)
237869|NCT02712034|Buprenorphine|buprenorphine
237870|NCT02712034|Methadone|methadone
237871|NCT02712034|Naltrexone|naltrexone
237872|NCT02712021|Cerebral Palsy|cerebral palsy
237873|NCT02712021|Lycra|lycra
237874|NCT02712021|Motor Function|motor function
237875|NCT02712021|Static Balance|static balance
237876|NCT02711995|botulinum toxin|botulinum toxin
237877|NCT02711995|injection augmentation|injection augmentation
237878|NCT02711995|essential voice tremor|essential voice tremor
237879|NCT02711956|Metastatic Castration-Resistant Prostate Cancer (mCRPC)|metastatic castration-resistant prostate cancer (mcrpc)
237880|NCT02711956|Phase 1b/2a|phase 1b/2a
237881|NCT02711956|Prostate Cancer|prostate cancer
237882|NCT02711956|Pharmacokinetics (PK)|pharmacokinetics (pk)
237883|NCT02711956|ZEN003694|zen003694
237884|NCT02711956|ZEN-3694|zen-3694
237885|NCT02711956|Metastatic Castrate-Resistant Prostate Cancer|metastatic castrate-resistant prostate cancer
237886|NCT02711956|BET inhibitor (BETi)|bet inhibitor (beti)
237887|NCT02711956|Bromodomain|bromodomain
237888|NCT02711956|Pharmacodynamics (PD)|pharmacodynamics (pd)
237889|NCT02711956|Enzalutamide|enzalutamide
237890|NCT02711956|XTANDI|xtandi
237891|NCT02711956|MDV3100|mdv3100
237892|NCT02711956|Epigenetics|epigenetics
237893|NCT02711930|intra-ocular pressure|intra-ocular pressure
237894|NCT02711930|prone ventilation|prone ventilation
237895|NCT02711917|Propofol|propofol
237896|NCT02711917|Sevoflurane|sevoflurane
237897|NCT02711917|Etomidate|etomidate
237898|NCT02711917|Rocuronium|rocuronium
237900|NCT02711917|Closed loop infusion system|closed loop infusion system
237901|NCT02711904|Extubation|extubation
237902|NCT02711904|Cough|cough
237903|NCT02711904|Target Controlled Anesthesia (TACAN)|target controlled anesthesia (tacan)
237904|NCT02711891|fingerstick|fingerstick
237905|NCT02711891|opioid|opioid
237906|NCT02711891|heelstick|heelstick
237907|NCT02711891|loperamide|loperamide
237908|NCT02711891|topical opioid|topical opioid
237909|NCT02711826|graft inflammation|graft inflammation
237910|NCT02711826|Treg|treg
237911|NCT02711826|polyclonally expanded Tregs (polyTregs)|polyclonally expanded tregs (polytregs)
237912|NCT02711826|calcineurin inhibitors (CNIs)|calcineurin inhibitors (cnis)
237913|NCT02711826|mTOR inhibitors|mtor inhibitors
237914|NCT02711787|Hand|hand
237915|NCT02711787|Paralysis|paralysis
237916|NCT02711787|Stroke|stroke
237917|NCT02711722|Neurally adjusted ventilatory assist|neurally adjusted ventilatory assist
237918|NCT02711709|Intra-abdominal sepsis|intra-abdominal sepsis
237919|NCT02711709|Surgical ICU|surgical icu
237920|NCT02711696|Celiac Disease,|celiac disease,
237921|NCT02711696|Gluten Free Diet|gluten free diet
237922|NCT02711696|Gluten contamination|gluten contamination
237923|NCT02711670|nephrolithiasis|nephrolithiasis
237924|NCT02711670|calcium stones|calcium stones
237925|NCT02711670|kidney stones|kidney stones
237926|NCT02711670|hypercalciuria|hypercalciuria
237927|NCT02711670|thiazide|thiazide
237928|NCT02711657|Fibrocytes|fibrocytes
237929|NCT02711657|Interstitial Lung Diseases|interstitial lung diseases
237930|NCT02711657|Rheumatoid Arthritis|rheumatoid arthritis
237931|NCT02711657|Asthma|asthma
237932|NCT02711644|Pregnancy|pregnancy
237933|NCT02711644|Prenatal|prenatal
237934|NCT02711644|Nutrition|nutrition
237935|NCT02711631|coronary angioplasty|coronary angioplasty
237936|NCT02711631|cardiac rehabilitation|cardiac rehabilitation
237937|NCT02711631|coronary artery bypass graft|coronary artery bypass graft
237938|NCT02711605|ultrasound|ultrasound
237940|NCT02711592|Orthopaedic Pain Management|orthopaedic pain management
237941|NCT02711566|Rehabilitation|rehabilitation
237942|NCT02711566|Robot-assisted therapy|robot-assisted therapy
237943|NCT02711501|post-operative pain|post-operative pain
237944|NCT02711501|diode laser|diode laser
237945|NCT02711488|school-based intervention|school-based intervention
237946|NCT02711488|sedentary behavior|sedentary behavior
237947|NCT02711488|physical activity|physical activity
237948|NCT02711488|sugar sweetened beverages|sugar sweetened beverages
237949|NCT02711462|Healthy Subjects|healthy subjects
237950|NCT02711449|acute surgery|acute surgery
237951|NCT02711449|laparoscopy|laparoscopy
237952|NCT02711371|addiction|addiction
237953|NCT02711371|cannabis|cannabis
237955|NCT02711345|LTT462|ltt462
237956|NCT02711345|ERK|erk
237957|NCT02711345|MAPK|mapk
237958|NCT02711345|solid tumor|solid tumor
237959|NCT02711267|Open Flow Microperfusion|open flow microperfusion
237960|NCT02711241|Gastroenteritis|gastroenteritis
237961|NCT02711241|Analgesia|analgesia
237962|NCT02711241|Emergency department|emergency department
237963|NCT02711189|Addiction|addiction
237964|NCT02711189|Oxytocin|oxytocin
237965|NCT02711189|Functional Magnetic Resonance Imaging (fMRI)|functional magnetic resonance imaging (fmri)
237966|NCT02711189|Alcohol|alcohol
237967|NCT02711189|Cue Reactivity|cue reactivity
237968|NCT02711137|Solid tumor|solid tumor
237969|NCT02711137|lymphoma|lymphoma
237970|NCT02711137|leukemia|leukemia
237971|NCT02711137|AML|aml
237972|NCT02711137|myelodysplastic syndrome (MDS)|myelodysplastic syndrome (mds)
237973|NCT02711137|multiple myeloma|multiple myeloma
237974|NCT02711137|myeloproliferative neoplasm (MPN)|myeloproliferative neoplasm (mpn)
237975|NCT02711137|MDS/MPN|mds/mpn
237976|NCT02711137|myelofibrosis (MF)|myelofibrosis (mf)
237977|NCT02711137|pancreatic cancer|pancreatic cancer
237978|NCT02711137|colorectal cancer|colorectal cancer
237979|NCT02711137|non-small cell lung cancer|non-small cell lung cancer
237980|NCT02711137|prostate cancer|prostate cancer
237981|NCT02711137|breast cancer|breast cancer
237982|NCT02711137|ovarian cancer|ovarian cancer
237983|NCT02711137|glioblastoma multiforme (GBM)|glioblastoma multiforme (gbm)
237984|NCT02711137|NUT midline carcinoma|nut midline carcinoma
237985|NCT02711137|non-Hodgkin lymphoma|non-hodgkin lymphoma
237986|NCT02711137|diffuse large B-cell lymphoma (DLBCL)|diffuse large b-cell lymphoma (dlbcl)
237987|NCT02711137|double-hit|double-hit
237988|NCT02711137|triple-hit|triple-hit
237989|NCT02711137|myc|myc
237990|NCT02711137|bromodomain and extra-terminal (BET) inhibitor|bromodomain and extra-terminal (bet) inhibitor
237991|NCT02711124|hemoglobin A1c|hemoglobin a1c
237992|NCT02711124|coronary artery bypass grafting|coronary artery bypass grafting
237993|NCT02711124|impedance aggregometry|impedance aggregometry
237994|NCT02711124|platelet reactivity|platelet reactivity
237995|NCT02711124|clinical outcomes|clinical outcomes
237996|NCT02711098|cardiac arrest|cardiac arrest
237997|NCT02711098|hypothermia|hypothermia
237998|NCT02711098|critical care|critical care
237999|NCT02711059|hyperparathyroidism|hyperparathyroidism
238000|NCT02711059|insulin resistance|insulin resistance
238001|NCT02711020|Depressive symptoms|depressive symptoms
238002|NCT02711020|Fibromyalgia|fibromyalgia
238003|NCT02711020|Cognitive Behavioral Therapy|cognitive behavioral therapy
238004|NCT02711020|Personal Constructs Therapy|personal constructs therapy
238005|NCT02711020|Differential Efficacy|differential efficacy
238006|NCT02711007|osteosarcoma|osteosarcoma
238007|NCT02711007|metastasis|metastasis
238008|NCT02711007|advanced|advanced
238009|NCT02711007|apatinib|apatinib
238010|NCT02710994|Immediate release omeprazole|immediate release omeprazole
238011|NCT02710994|Integrated gastric acidity|integrated gastric acidity
238012|NCT02710981|Sildenafil vaginal gel|sildenafil vaginal gel
238013|NCT02710981|endometrium|endometrium
238014|NCT02710981|clomiphene|clomiphene
238015|NCT02710981|anovulation|anovulation
238016|NCT02710968|FETO|feto
238017|NCT02710916|Optical Coherence Tomography|optical coherence tomography
238018|NCT02710916|Intraocular pressure|intraocular pressure
238019|NCT02710916|Optic Nerve Head|optic nerve head
238020|NCT02710916|Nerve fiber layer|nerve fiber layer
238021|NCT02710916|Bruch Membrane Opening -Minimum Rim Width|bruch membrane opening -minimum rim width
238022|NCT02710903|Periodontitis|periodontitis
238023|NCT02710903|SNP|snp
238024|NCT02710903|Pathogenesis|pathogenesis
238025|NCT02710903|IL29|il29
238026|NCT02710903|IL28B|il28b
238027|NCT02710890|Epilepsy|epilepsy
238028|NCT02710890|pediatric|pediatric
238029|NCT02710890|intravenous|intravenous
238030|NCT02710890|children|children
238031|NCT02710890|Lacosamide|lacosamide
238032|NCT02710890|VIMPAT®|vimpat®
238033|NCT02710890|seizure|seizure
238034|NCT02710877|epidural analgesia|epidural analgesia
238035|NCT02710877|patient controlled analgesia|patient controlled analgesia
238036|NCT02710877|obstetric outcome|obstetric outcome
238037|NCT02710864|Cytomegalovirus|cytomegalovirus
238038|NCT02710851|human papillomavirus vaccine|human papillomavirus vaccine
238039|NCT02710851|condylomata acuminata|condylomata acuminata
238040|NCT02710838|Early gastric cancer|early gastric cancer
238041|NCT02710838|Infrared endoscope|infrared endoscope
238042|NCT02710799|Endocrinology|endocrinology
238043|NCT02710799|Referral list|referral list
238044|NCT02710799|Teleconsultation|teleconsultation
238045|NCT02710799|Telemedicine|telemedicine
238046|NCT02710799|Cluster randomized clinical trial|cluster randomized clinical trial
238047|NCT02710773|Gait|gait
238048|NCT02710773|Randomized controlled trial|randomized controlled trial
238049|NCT02710773|Chronic Stroke|chronic stroke
238050|NCT02710773|Treadmill training|treadmill training
238051|NCT02710760|Biomarkers|biomarkers
238052|NCT02710760|Child Nutrition Sciences|child nutrition sciences
238053|NCT02710760|Economics, Behavioral|economics, behavioral
238054|NCT02710747|warfarin|warfarin
238055|NCT02710747|Chinese patients|chinese patients
238056|NCT02710747|heart valve replacement|heart valve replacement
238057|NCT02710734|Urothelial|urothelial
238058|NCT02710721|Fasting|fasting
238059|NCT02710721|Prostatic Neoplasms|prostatic neoplasms
238060|NCT02710721|Complementary Therapies|complementary therapies
238061|NCT02710721|Urology|urology
238062|NCT02710708|birth control,|birth control,
238063|NCT02710708|contraceptives safety,|contraceptives safety,
238064|NCT02710708|contraceptives efficacy,|contraceptives efficacy,
238065|NCT02710708|moderate acne vulgaris|moderate acne vulgaris
238066|NCT02710682|Lateral Epicondylitis of the elbow|lateral epicondylitis of the elbow
238067|NCT02710682|Tendon Fenestration|tendon fenestration
238068|NCT02710682|Minimally invasive Surgery|minimally invasive surgery
238069|NCT02710682|Ultrasound-guided procedure|ultrasound-guided procedure
238070|NCT02710682|Ultrasonography|ultrasonography
238071|NCT02710682|Elastography|elastography
238072|NCT02710669|ablation|ablation
238073|NCT02710656|Atherosclerosis|atherosclerosis
238074|NCT02710656|SFA|sfa
238075|NCT02710656|Poplitea|poplitea
238076|NCT02710656|Drug coated balloon|drug coated balloon
238077|NCT02710656|Angioplasty|angioplasty
238078|NCT02710656|Restenosis|restenosis
238079|NCT02710656|Peripheral artery disease (PAD)|peripheral artery disease (pad)
238080|NCT02710643|Follicular|follicular
238081|NCT02710643|Lymphoma|lymphoma
238082|NCT02710643|Grade 1|grade 1
238083|NCT02710643|Grade 2|grade 2
238084|NCT02710643|Grade 3A|grade 3a
238085|NCT02710604|chronic hepatitis B(CHB)|chronic hepatitis b(chb)
238086|NCT02710591|Rimeporide|rimeporide
238087|NCT02710578|Alcohol impaired driving|alcohol impaired driving
238088|NCT02710578|Driving simulation|driving simulation
238089|NCT02710578|Residual effects of alcohol|residual effects of alcohol
238090|NCT02710578|Acute psychomotor effects of alcohol|acute psychomotor effects of alcohol
238091|NCT02710578|Young drivers|young drivers
238092|NCT02710565|Endo bronchial ultrasound|endo bronchial ultrasound
238093|NCT02710565|Trans bronchial needle aspiration|trans bronchial needle aspiration
238094|NCT02710565|Cell line|cell line
238095|NCT02710565|Lung cancer|lung cancer
238096|NCT02710552|arterial hypertension|arterial hypertension
238097|NCT02710552|antihypertensive drugs|antihypertensive drugs
238098|NCT02710539|arterial hypertension|arterial hypertension
238099|NCT02710539|antihypertensive drugs|antihypertensive drugs
238100|NCT02710513|beta-glucans|beta-glucans
238101|NCT02710513|gut microbiota|gut microbiota
238102|NCT02710513|p-cresyl sulphate (pCS)|p-cresyl sulphate (pcs)
238103|NCT02710513|indoxyl sulphate (IS)|indoxyl sulphate (is)
238104|NCT02710513|short-chain fatty acid (SCFA)|short-chain fatty acid (scfa)
238105|NCT02710500|LGMD2B|lgmd2b
238106|NCT02710500|Limb Girdle Muscular Dystrophy|limb girdle muscular dystrophy
238107|NCT02710500|Miyoshi|miyoshi
238108|NCT02710500|Gene Transfer|gene transfer
238109|NCT02710500|Dysferlin|dysferlin
238110|NCT02710487|Parkinson's disease, Sleep Benefit|parkinson's disease, sleep benefit
238111|NCT02710474|preterm birth|preterm birth
238112|NCT02710474|NICU|nicu
238113|NCT02710474|neonatal|neonatal
238114|NCT02710474|kangaroo care|kangaroo care
238115|NCT02710474|separation stress|separation stress
238116|NCT02710474|family nurture|family nurture
238117|NCT02710474|maternal confidence|maternal confidence
238118|NCT02710474|maternal competence|maternal competence
238119|NCT02710474|calming cycle|calming cycle
238120|NCT02710474|infant neurodevelopment|infant neurodevelopment
238121|NCT02710474|infant psychological development|infant psychological development
238122|NCT02710474|mother-infant co-regulation|mother-infant co-regulation
238123|NCT02710474|post-partum depression|post-partum depression
238124|NCT02710461|Polyphenols|polyphenols
238125|NCT02710461|Grape|grape
238126|NCT02710461|Pomegranate|pomegranate
238127|NCT02710461|Metabolic syndrome|metabolic syndrome
238128|NCT02710461|Abdominal obesity|abdominal obesity
238129|NCT02710461|Postprandial glucose|postprandial glucose
238130|NCT02710461|Insulin resistance|insulin resistance
238131|NCT02710435|Coronary Sinus|coronary sinus
238132|NCT02710435|Reducer|reducer
238133|NCT02710435|Refractory Angina|refractory angina
238134|NCT02710435|Angina Pectoris|angina pectoris
238135|NCT02710435|Angina Pectoris, Stable|angina pectoris, stable
238136|NCT02710435|Chronic Stable Angina|chronic stable angina
238137|NCT02710435|Persistent Angina|persistent angina
238138|NCT02710435|Neovasc Reducer System|neovasc reducer system
238139|NCT02710435|Refractory Angina Pectoris|refractory angina pectoris
238140|NCT02710435|Coronary Sinus Narrowing|coronary sinus narrowing
238141|NCT02710435|Reversible Ischemic Heart Disease|reversible ischemic heart disease
238142|NCT02710435|Chronic Angina|chronic angina
238143|NCT02710435|End Stage Angina|end stage angina
238144|NCT02710435|Coronary Sinus Reduction|coronary sinus reduction
238145|NCT02710435|Coronary Sinus Reducer|coronary sinus reducer
238146|NCT02710435|Chronic Refractory Angina|chronic refractory angina
238147|NCT02710435|Chronic Refractory Angina Pectoris|chronic refractory angina pectoris
238148|NCT02710422|Prostate Cancer|prostate cancer
238149|NCT02710422|Amniotic Membrane Placement|amniotic membrane placement
238150|NCT02710422|Robotic Assisted Radical Prostatectomy|robotic assisted radical prostatectomy
238151|NCT02710422|RARP|rarp
238152|NCT02710422|Human Amniotic Membrane Allograft|human amniotic membrane allograft
238153|NCT02710409|safety, immunogenicity , quadrivalent influenza vaccine|safety, immunogenicity , quadrivalent influenza vaccine
238154|NCT02710396|Carcinoma, Non-Small-Cell Lung|carcinoma, non-small-cell lung
238155|NCT02710396|Non-Small Cell Lung Cancer|non-small cell lung cancer
238156|NCT02710396|Non-Small-Cell Lung Carcinoma|non-small-cell lung carcinoma
238157|NCT02710396|Nonsmall Cell Lung Cancer|nonsmall cell lung cancer
238158|NCT02710396|NSCLC|nsclc
238159|NCT02710396|Cancer of Neck|cancer of neck
238160|NCT02710396|Neoplasms, Head and Neck|neoplasms, head and neck
238161|NCT02710396|Cancer of the Head|cancer of the head
238162|NCT02710396|Cancer of the Head and Neck|cancer of the head and neck
238163|NCT02710396|Head, Neck Neoplasms|head, neck neoplasms
238164|NCT02710396|Bladder Cancer|bladder cancer
238165|NCT02710396|Bladder Neoplasms|bladder neoplasms
238166|NCT02710396|Malignant Tumor of Urinary Bladder|malignant tumor of urinary bladder
238167|NCT02710396|Urinary Bladder Cancer|urinary bladder cancer
238168|NCT02710396|Esophageal Squamous Cell Carcinoma|esophageal squamous cell carcinoma
238169|NCT02710396|Carcinoma, Transitional Cell|carcinoma, transitional cell
238170|NCT02710383|Cystic Fibrosis|cystic fibrosis
238171|NCT02710383|Biomarker|biomarker
238172|NCT02710370|Bariatric Surgery|bariatric surgery
238173|NCT02710370|Gastric Bypass|gastric bypass
238174|NCT02710370|Obesity/surgery|obesity/surgery
238175|NCT02710370|Endoscopy, Digestive System|endoscopy, digestive system
238176|NCT02710370|Blood Glucose/metabolism|blood glucose/metabolism
238177|NCT02710370|Diabetes Mellitus, Experimental/metabolism|diabetes mellitus, experimental/metabolism
238178|NCT02710370|Energy Metabolism|energy metabolism
238179|NCT02710370|Glucose/metabolism|glucose/metabolism
238180|NCT02710370|Jejunum/metabolism|jejunum/metabolism
238181|NCT02710370|Metabolomics|metabolomics
238182|NCT02710370|Gene Expression|gene expression
238183|NCT02710357|Mandibular Prosthesis Implantation|mandibular prosthesis implantation
238184|NCT02710357|Prostheses and Implants|prostheses and implants
238185|NCT02710357|Denture, Complete, Lower|denture, complete, lower
238186|NCT02710318|Immunizations|immunizations
238187|NCT02710318|Immunization Information System (IIS)|immunization information system (iis)
238188|NCT02710318|Immunization notifications|immunization notifications
238189|NCT02710279|Psychiatry|psychiatry
238190|NCT02710279|Depressive disorder|depressive disorder
238191|NCT02710279|Suicide|suicide
238192|NCT02710266|Synthetic Protease Inhibitor|synthetic protease inhibitor
238193|NCT02710266|Hepatectomy|hepatectomy
238194|NCT02710266|Postoperative Complications|postoperative complications
238195|NCT02710214|Hot flash|hot flash
238196|NCT02710214|Estrogen|estrogen
238197|NCT02710214|Women|women
238198|NCT02710149|CAR-T|car-t
238199|NCT02710149|Leukemia|leukemia
238200|NCT02710149|Lymphoma|lymphoma
238201|NCT02710136|Asthma|asthma
238202|NCT02710136|Glycerinated German cockroach allergenic extract|glycerinated german cockroach allergenic extract
238203|NCT02710136|Cockroach Nasal Allergen Challenge|cockroach nasal allergen challenge
238204|NCT02710058|support group|support group
238205|NCT02710058|15-246|15-246
238206|NCT02710058|The Arab American Breast Cancer Education and Referral Program (AMBER)|the arab american breast cancer education and referral program (amber)
238207|NCT02710045|Immunity, Innate|immunity, innate
238208|NCT02710045|Immunity, Non-Specific|immunity, non-specific
238209|NCT02710045|Antibodies|antibodies
238210|NCT02710045|Cytokines|cytokines
238211|NCT02710045|Immunity, Cellular|immunity, cellular
238212|NCT02710032|Transgender women|transgender women
238213|NCT02710032|HIV Pre-Exposure Prophylaxis|hiv pre-exposure prophylaxis
238214|NCT02710032|Adherence|adherence
238215|NCT02710032|Peru|peru
238216|NCT02710032|Social Networks|social networks
238217|NCT02710019|substance use|substance use
238218|NCT02710019|psychosis|psychosis
238219|NCT02710019|youth|youth
238220|NCT02710019|video game|video game
238221|NCT02710006|Uterus|uterus
238222|NCT02710006|Ultrasound|ultrasound
238223|NCT02709980|Brain Injury|brain injury
238224|NCT02709980|Insomnia|insomnia
238225|NCT02709980|Sleep|sleep
238226|NCT02709941|Obstructive Sleep Apnea|obstructive sleep apnea
238227|NCT02709941|Inspiratory Muscle Strength Training|inspiratory muscle strength training
238228|NCT02709941|Baroreceptor Sensitivity|baroreceptor sensitivity
238229|NCT02709941|Blood Pressure|blood pressure
238230|NCT02709928|Multiple ascending dose|multiple ascending dose
238231|NCT02709850|ANGPTL-3|angptl-3
238232|NCT02709837|bioavailability|bioavailability
238233|NCT02709837|amino acid|amino acid
238234|NCT02709837|carnosine|carnosine
238235|NCT02709837|lycopene|lycopene
238236|NCT02709837|mastication|mastication
238237|NCT02709837|meat|meat
238238|NCT02709798|Shenfu Injection|shenfu injection
238239|NCT02709798|Reperfusion Injury|reperfusion injury
238240|NCT02709798|Myocardial Protection|myocardial protection
238241|NCT02709798|Percutaneous Coronary Intervention|percutaneous coronary intervention
238242|NCT02709746|paediatric patients|paediatric patients
238243|NCT02709733|Virtual Reality|virtual reality
238244|NCT02709733|Negative Symptoms|negative symptoms
238245|NCT02709720|Lung Cancer|lung cancer
238246|NCT02709720|Cancer Lung Disease|cancer lung disease
238247|NCT02709720|NORA|nora
238248|NCT02709720|GECP 15/02|gecp 15/02
238249|NCT02709720|Metronomic administration|metronomic administration
238250|NCT02709707|Diabetes, Blood Sugar|diabetes, blood sugar
238251|NCT02709681|Sickle Cell Disease|sickle cell disease
238252|NCT02709681|Hydroxyurea|hydroxyurea
238253|NCT02709668|MTHFR depression vitamins Homocysteine|mthfr depression vitamins homocysteine
238254|NCT02709655|paediatric|paediatric
238255|NCT02709616|Glioblastoma|glioblastoma
238256|NCT02709616|DC vaccine|dc vaccine
238257|NCT02709616|tumor antigen|tumor antigen
238258|NCT02709616|personalized vaccine|personalized vaccine
238259|NCT02709551|corporate health management|corporate health management
238260|NCT02709551|hrv|hrv
238261|NCT02709551|mindfulness|mindfulness
238262|NCT02709525|hyaluronic acid|hyaluronic acid
238263|NCT02709525|bone repair|bone repair
238264|NCT02709525|dental socket|dental socket
238265|NCT02709525|cone beam computed tomography|cone beam computed tomography
238266|NCT02709512|Malignant Pleural Mesothelioma|malignant pleural mesothelioma
238267|NCT02709486|Osteoarthritis, pain, tanezumab.|osteoarthritis, pain, tanezumab.
238268|NCT02709473|propofol|propofol
238269|NCT02709473|remifentanil|remifentanil
238270|NCT02709473|rocuronium|rocuronium
238271|NCT02709460|hematoma|hematoma
238272|NCT02709460|complication|complication
238273|NCT02709460|hysterectomy|hysterectomy
238274|NCT02709447|Intimate Partner Violence|intimate partner violence
238275|NCT02709447|Juvenile Delinquency|juvenile delinquency
238276|NCT02709447|Sexual Behavior|sexual behavior
238277|NCT02709421|post-Endoscopic Retrograde cholangiopancreatography pancreatitis|post-endoscopic retrograde cholangiopancreatography pancreatitis
238278|NCT02709421|Risk factors|risk factors
238279|NCT02709421|Indomethacin|indomethacin
238280|NCT02709408|Carbapenem resistance|carbapenem resistance
238281|NCT02709408|Enterobacteriaceae|enterobacteriaceae
238282|NCT02709408|Acinetobacter baumannii|acinetobacter baumannii
238283|NCT02709408|Bloodstream infections|bloodstream infections
238284|NCT02709408|Intrabdominal infections|intrabdominal infections
238285|NCT02709408|Urinary tract infections|urinary tract infections
238286|NCT02709408|Pneumonia|pneumonia
238287|NCT02709408|Risk factors|risk factors
238288|NCT02709408|Outcome|outcome
238289|NCT02709408|Hospitalised patients|hospitalised patients
238290|NCT02709408|Mortality|mortality
238291|NCT02709408|Clinical response|clinical response
238292|NCT02709408|Length of hospital stay|length of hospital stay
238293|NCT02709369|HIRREM|hirrem
238294|NCT02709369|Neuro-technology|neuro-technology
238295|NCT02709369|Closed-loop|closed-loop
238296|NCT02709369|Acoustic stimulation|acoustic stimulation
238297|NCT02709369|Allostatic|allostatic
238298|NCT02709369|heart rate variability|heart rate variability
238299|NCT02709369|baroreflex sensitivity|baroreflex sensitivity
238300|NCT02709369|traumatic brain injury|traumatic brain injury
238301|NCT02709369|sports concussion|sports concussion
238302|NCT02709369|PTSD|ptsd
238303|NCT02709369|hot flashes|hot flashes
238304|NCT02709369|headache|headache
238305|NCT02709369|insomnia|insomnia
238306|NCT02709304|urinary catheter discomfort|urinary catheter discomfort
238307|NCT02709278|BCG|bcg
238308|NCT02709278|Aerosol|aerosol
238309|NCT02709278|Tuberculosis|tuberculosis
238310|NCT02709278|Challenge|challenge
238311|NCT02709226|Brain Tumor|brain tumor
238312|NCT02709226|Astrocytoma|astrocytoma
238313|NCT02709226|GBM|gbm
238314|NCT02709226|Radiation Therapy|radiation therapy
238315|NCT02709213|Inflammatory chronic bowel disease|inflammatory chronic bowel disease
238316|NCT02709213|ICBD|icbd
238317|NCT02709213|Colorectal cancer|colorectal cancer
238318|NCT02709213|Infectious colitis|infectious colitis
238319|NCT02709187|DP-R208|dp-r208
238320|NCT02709174|Pulmonary Embolism|pulmonary embolism
238321|NCT02709174|Pregnancy|pregnancy
238322|NCT02709174|D-Dimer|d-dimer
238323|NCT02709161|neurofeedback|neurofeedback
238324|NCT02709161|major depressive disorder|major depressive disorder
238325|NCT02709161|amygdala|amygdala
238326|NCT02709148|Parkinson's Disease|parkinson's disease
238327|NCT02709070|highly-purified CTL|highly-purified ctl
238328|NCT02709044|Acute pancreatitis|acute pancreatitis
238329|NCT02709044|Fluid resuscitation|fluid resuscitation
238330|NCT02709044|Crystalloids|crystalloids
238331|NCT02709031|Cicletanine|cicletanine
238332|NCT02709031|Magnesium|magnesium
238333|NCT02709031|Metabolic disease|metabolic disease
238334|NCT02709018|posttraumatic stress disorder|posttraumatic stress disorder
238335|NCT02709018|losartan|losartan
238336|NCT02709018|angiotensin receptor blocker|angiotensin receptor blocker
238337|NCT02709005|Bacterial Vaginosis|bacterial vaginosis
238338|NCT02709005|Monolaurin Vaginal Gel|monolaurin vaginal gel
238339|NCT02708992|Azithromycin|azithromycin
238340|NCT02708992|Cefixime|cefixime
238341|NCT02708992|Duration|duration
238342|NCT02708992|High-Dose|high-dose
238343|NCT02708992|Neisseria gonorrhoeae|neisseria gonorrhoeae
238344|NCT02708992|Pharmacokinetics|pharmacokinetics
238345|NCT02708992|Susceptibility|susceptibility
238346|NCT02708979|Stress|stress
238347|NCT02708979|Eating|eating
238348|NCT02708966|Gymnema Sylvestre|gymnema sylvestre
238349|NCT02708966|Glycemic control|glycemic control
238350|NCT02708927|social integration|social integration
238351|NCT02708927|cognitive impairment|cognitive impairment
238352|NCT02708927|emotional processing|emotional processing
238353|NCT02708927|quality of life|quality of life
238354|NCT02708901|Autism Spectrum Disorder|autism spectrum disorder
238355|NCT02708901|Probiotic Vivomixx®|probiotic vivomixx®
238356|NCT02708901|Gastrointestinal Symptoms|gastrointestinal symptoms
238357|NCT02708901|Gut-Brain Axis|gut-brain axis
238358|NCT02708901|Endophenotypes|endophenotypes
238359|NCT02708888|Trunk|trunk
238360|NCT02708888|Biomechanical Phenomena|biomechanical phenomena
238361|NCT02708888|Gait|gait
238362|NCT02708888|Electromyography|electromyography
238363|NCT02708888|Rehabilitation|rehabilitation
238364|NCT02708888|Balance|balance
238365|NCT02708875|Microvascular|microvascular
238366|NCT02708875|Insulin resistance|insulin resistance
238367|NCT02708875|Mixed Meal|mixed meal
238368|NCT02708875|Glucose tolerance|glucose tolerance
238369|NCT02708823|Postoperative delirium|postoperative delirium
238370|NCT02708823|Risk assessment|risk assessment
238371|NCT02708823|Clinical screening tool|clinical screening tool
238372|NCT02708823|Tablet computer|tablet computer
238373|NCT02708810|radiosurgery (RS)|radiosurgery (rs)
238374|NCT02708810|trigeminal neuralgia (TGN)|trigeminal neuralgia (tgn)
238375|NCT02708797|Cerebral autoregulation|cerebral autoregulation
238376|NCT02708797|MRI|mri
238377|NCT02708797|VBM|vbm
238378|NCT02708797|Doppler Transcranial|doppler transcranial
238379|NCT02708784|Glykogen storage disease type 2)|glykogen storage disease type 2)
238380|NCT02708784|Dystrophia Myotonica|dystrophia myotonica
238381|NCT02708784|Muscular disorders|muscular disorders
238382|NCT02708784|MR-imaging|mr-imaging
238383|NCT02708784|Muscle strength|muscle strength
238384|NCT02708784|Myopathies|myopathies
238385|NCT02708745|communication|communication
238386|NCT02708745|immunization|immunization
238387|NCT02708719|COPD|copd
238388|NCT02708719|MID|mid
238389|NCT02708719|1-minute sit-to-stand-test|1-minute sit-to-stand-test
238390|NCT02708706|adhesive capsulitis|adhesive capsulitis
238391|NCT02708706|hyaluronic acid|hyaluronic acid
238392|NCT02708667|non-small cell lung cancer|non-small cell lung cancer
238393|NCT02708667|crizotinib|crizotinib
238394|NCT02708667|hepatic toxicity|hepatic toxicity
238395|NCT02708654|Remote monitoring|remote monitoring
238396|NCT02708654|Incentives|incentives
238397|NCT02708628|scar prevention|scar prevention
238398|NCT02708628|sectio|sectio
238399|NCT02708628|extract of allium cepae|extract of allium cepae
238400|NCT02708628|allantoin|allantoin
238401|NCT02708628|heparin|heparin
238402|NCT02708602|β2-adrenergic receptor|β2-adrenergic receptor
238403|NCT02708602|genetic polymorphisms|genetic polymorphisms
238404|NCT02708602|labor progress|labor progress
238405|NCT02708563|meconium|meconium
238406|NCT02708563|neonatal resuscitation|neonatal resuscitation
238407|NCT02708498|Palliative care|palliative care
238408|NCT02708498|Frail elderly|frail elderly
238409|NCT02708498|Comorbidity|comorbidity
238410|NCT02708498|Staff Development|staff development
238411|NCT02708498|Nursing Homes|nursing homes
238412|NCT02708472|Generalized Anxiety Disorder|generalized anxiety disorder
238413|NCT02708472|synchronized Transcranial Magnetic Stimulation|synchronized transcranial magnetic stimulation
238414|NCT02708472|Anxiety|anxiety
238415|NCT02708472|Neurostimulation|neurostimulation
238416|NCT02708472|TMS|tms
238417|NCT02708446|Second Trimester|second trimester
238418|NCT02708446|Abortion|abortion
238419|NCT02708446|Misoprostol|misoprostol
238420|NCT02708446|Sublingual|sublingual
238421|NCT02708446|Buccal|buccal
238422|NCT02708433|lidocaine, jaw|lidocaine, jaw
238423|NCT02708420|Glidescope|glidescope
238424|NCT02708420|Cardiovascular surgery|cardiovascular surgery
238425|NCT02708420|Macintosh Laryngoscope|macintosh laryngoscope
238426|NCT02708420|Hemodynamic response|hemodynamic response
238427|NCT02708420|Anesthesia|anesthesia
238428|NCT02708381|Population 70 years and older|population 70 years and older
238429|NCT02708381|Geriatric|geriatric
238430|NCT02708381|Oncogeriatric|oncogeriatric
238431|NCT02708381|Senior adult|senior adult
238432|NCT02708368|Chronic Kidney Disease - Mineral Bone Disorder (CKD-MBD)|chronic kidney disease - mineral bone disorder (ckd-mbd)
238433|NCT02708329|Coronary stenosis|coronary stenosis
238434|NCT02708329|Drug-eluting stent|drug-eluting stent
238435|NCT02708329|Coronary angioplasty with stenting|coronary angioplasty with stenting
238436|NCT02708329|Ischemic Heart Disease|ischemic heart disease
238437|NCT02708329|Chronic total occlusion|chronic total occlusion
238438|NCT02708329|Bifurcational lesion|bifurcational lesion
238439|NCT02708329|Bifurcational stenting|bifurcational stenting
238440|NCT02708303|Esophageal Reflux|esophageal reflux
238441|NCT02708303|Gastric Acid Reflux|gastric acid reflux
238442|NCT02708303|Gastric Acid Reflux Disease|gastric acid reflux disease
238443|NCT02708303|Gastro-Esophageal Reflux|gastro-esophageal reflux
238444|NCT02708303|Gastro-oesophageal Reflux|gastro-oesophageal reflux
238445|NCT02708303|Gastroesophageal Reflux Disease|gastroesophageal reflux disease
238446|NCT02708303|Reflux, Gastroesophageal|reflux, gastroesophageal
238447|NCT02708303|Esophageal Hernia|esophageal hernia
238448|NCT02708303|Hernia, Esophageal|hernia, esophageal
238449|NCT02708303|Hernia, Paraesophageal|hernia, paraesophageal
238450|NCT02708303|Hiatal Hernia|hiatal hernia
238451|NCT02708303|Sliding Hiatal Hernia|sliding hiatal hernia
238452|NCT02708303|Sliding Esophageal Hernia|sliding esophageal hernia
238453|NCT02708303|Hernia, Hiatus|hernia, hiatus
238454|NCT02708303|Paraesophageal Hiatal Hernia|paraesophageal hiatal hernia
238455|NCT02708303|Questionnaires|questionnaires
238456|NCT02708277|intrauterine contraceptive device|intrauterine contraceptive device
238457|NCT02708277|intrauterine balloon|intrauterine balloon
238458|NCT02708238|Infantile colics|infantile colics
238459|NCT02708199|Drug resistance malaria|drug resistance malaria
238460|NCT02708199|Myanmar Artemisinin Resistance Containment Zone|myanmar artemisinin resistance containment zone
238461|NCT02708199|Asymptomatic malaria|asymptomatic malaria
238462|NCT02708199|Serology|serology
238463|NCT02708186|Dementia with Lewy bodies|dementia with lewy bodies
238464|NCT02708186|Lewy bodies|lewy bodies
238465|NCT02708186|REM sleep behavior disorder|rem sleep behavior disorder
238466|NCT02708186|Parkinson's disease dementia|parkinson's disease dementia
238467|NCT02708173|vaccine|vaccine
238468|NCT02708173|safety|safety
238469|NCT02708134|Chest compressions|chest compressions
238470|NCT02708134|Cardiopulmonary Resuscitation|cardiopulmonary resuscitation
238471|NCT02708069|Autism Spectrum Disorder|autism spectrum disorder
238472|NCT02708056|Sugammadex|sugammadex
238473|NCT02708056|Rocuronium|rocuronium
238474|NCT02708056|Infant patients|infant patients
238475|NCT02708017|Subcostal TAP block|subcostal tap block
238476|NCT02708017|Posterior TAP block|posterior tap block
238477|NCT02708017|Ultrasound|ultrasound
238478|NCT02708017|Laparoscopic cholecystectomy|laparoscopic cholecystectomy
238479|NCT02707991|Continuity of Patient Care|continuity of patient care
238480|NCT02707991|Treatment Cascade|treatment cascade
238481|NCT02707978|Dementia|dementia
238482|NCT02707978|Brain Diseases|brain diseases
238483|NCT02707978|Central Nervous System Diseases|central nervous system diseases
238484|NCT02707978|Mild Cognitive Impairment|mild cognitive impairment
238485|NCT02707978|tauopathies|tauopathies
238486|NCT02707978|Neurodegenerative Disease|neurodegenerative disease
238487|NCT02707965|Generic brittle|generic brittle
238488|NCT02707965|Anti-epileptic drug|anti-epileptic drug
238489|NCT02707965|Bioequivalence|bioequivalence
238490|NCT02707952|Compensated cirrhosis|compensated cirrhosis
238491|NCT02707952|Non-cirrhotic|non-cirrhotic
238492|NCT02707952|Renal impairment|renal impairment
238493|NCT02707952|Hepatitis C virus (HCV)|hepatitis c virus (hcv)
238494|NCT02707952|Hepatitis C|hepatitis c
238495|NCT02707952|Chronic Hepatitis C|chronic hepatitis c
238496|NCT02707952|Hepatitis C Genotype 1|hepatitis c genotype 1
238497|NCT02707952|Hepatitis C Genotype 2|hepatitis c genotype 2
238498|NCT02707952|Hepatitis C Genotype 3|hepatitis c genotype 3
238499|NCT02707952|Hepatitis C Genotype 4|hepatitis c genotype 4
238500|NCT02707952|Hepatitis C Genotype 5|hepatitis c genotype 5
238501|NCT02707952|Hepatitis C Genotype 6|hepatitis c genotype 6
238502|NCT02707952|DAA-experienced|daa-experienced
238503|NCT02707900|Vorinostat|vorinostat
238504|NCT02707900|AGS-004|ags-004
238505|NCT02707900|HIV virus|hiv virus
238506|NCT02707900|AIDS|aids
238507|NCT02707887|Mental Disorders|mental disorders
238508|NCT02707887|Mood Disorders|mood disorders
238509|NCT02707887|Behavioral Activation|behavioral activation
238511|NCT02707861|Resistant|resistant
238512|NCT02707861|Salvage|salvage
238513|NCT02707861|ibalizumab|ibalizumab
238514|NCT02707861|antibody|antibody
238515|NCT02707861|AIDS|aids
238516|NCT02707835|Edema,taping,ultrasound|edema,taping,ultrasound
238517|NCT02707822|tacrolimus|tacrolimus
238518|NCT02707822|pharmacokinetics|pharmacokinetics
238519|NCT02707822|gene polymorphism|gene polymorphism
238520|NCT02707822|clinical factors|clinical factors
238521|NCT02707796|oxygen reserve index, partial oxygen pressure, hemicolectomy|oxygen reserve index, partial oxygen pressure, hemicolectomy
238522|NCT02707783|stable and unstable angina|stable and unstable angina
238523|NCT02707783|bioresorbable vascular scaffold|bioresorbable vascular scaffold
238524|NCT02707783|BVS|bvs
238525|NCT02707783|PCI|pci
238526|NCT02707770|COPD, pulmonary rehabilitation, ambulatory oxygen therapy|copd, pulmonary rehabilitation, ambulatory oxygen therapy
238527|NCT02707757|Haemodialysis|haemodialysis
238528|NCT02707757|Anaemia|anaemia
238529|NCT02707757|Iron|iron
238530|NCT02707757|Erythropoeitin stimulating agents|erythropoeitin stimulating agents
238531|NCT02707744|Heart Failure|heart failure
238532|NCT02707744|Atrial Fibrillation|atrial fibrillation
238533|NCT02707744|Ambulatory ECG monitor|ambulatory ecg monitor
238534|NCT02707718|sepsis|sepsis
238535|NCT02707718|biomarker|biomarker
238536|NCT02707718|prognostic|prognostic
238537|NCT02707718|emergency department|emergency department
238538|NCT02707718|diagnosis|diagnosis
238539|NCT02707692|HIV|hiv
238540|NCT02707692|AIDS|aids
238541|NCT02707692|Immune Stimulation|immune stimulation
238542|NCT02707692|HIV Reservoir|hiv reservoir
238543|NCT02707679|Knee|knee
238544|NCT02707679|Mobilization|mobilization
238545|NCT02707679|Taping|taping
238546|NCT02707679|Function|function
238547|NCT02707679|Balance|balance
238548|NCT02707666|resectable malignant pleural mesothelioma|resectable malignant pleural mesothelioma
238549|NCT02707666|Pembrolizumab|pembrolizumab
238550|NCT02707627|Pediatric|pediatric
238551|NCT02707627|Laser|laser
238552|NCT02707627|Burn|burn
238553|NCT02707627|Scar|scar
238554|NCT02707627|Photothermolysis|photothermolysis
238555|NCT02707601|HIV|hiv
238556|NCT02707601|HCV|hcv
238557|NCT02707601|Antiretroviral therapy|antiretroviral therapy
238558|NCT02707601|HCV direct acting antiviral(s) (DAA)|hcv direct acting antiviral(s) (daa)
238559|NCT02707588|Determine the tolerance and efficacy of Pembrolizumab|determine the tolerance and efficacy of pembrolizumab
238560|NCT02707575|Keratin|keratin
238561|NCT02707575|Ranibizumab|ranibizumab
238562|NCT02707562|Cystic fibrosis G551D mutation|cystic fibrosis g551d mutation
238563|NCT02707562|GLPG1837|glpg1837
238564|NCT02707549|crystalloid solutions|crystalloid solutions
238565|NCT02707549|acid-base imbalance|acid-base imbalance
238566|NCT02707549|water-electrolyte Imbalance|water-electrolyte imbalance
238567|NCT02707523|RSV|rsv
238568|NCT02707523|respiratory support|respiratory support
238569|NCT02707523|RSV induced respiratory failure|rsv induced respiratory failure
238570|NCT02707510|logotherapy|logotherapy
238571|NCT02707510|cognitive behavior therapy|cognitive behavior therapy
238572|NCT02707510|metastatic breast cancer|metastatic breast cancer
238573|NCT02707497|sepsis|sepsis
238574|NCT02707497|severe thrombocytopenia|severe thrombocytopenia
238575|NCT02707497|recombinant human thrombopoietin|recombinant human thrombopoietin
238576|NCT02707497|platelets|platelets
238577|NCT02707497|28-day mortality|28-day mortality
238578|NCT02707484|Gastrointestinal vascular malformation|gastrointestinal vascular malformation
238579|NCT02707484|thalidomide|thalidomide
238580|NCT02707484|Small intestinal bleeding|small intestinal bleeding
238581|NCT02707458|apolipoprotein E|apolipoprotein e
238582|NCT02707458|Alzheimer|alzheimer
238583|NCT02707458|pre-clinical|pre-clinical
238584|NCT02707458|pre-symptomatic|pre-symptomatic
238585|NCT02707458|dose-finding|dose-finding
238586|NCT02707458|prevention|prevention
238587|NCT02707432|Cardiovascular Diseases|cardiovascular diseases
238588|NCT02707432|Community-Based Participatory Research|community-based participatory research
238589|NCT02707432|African Americans|african americans
238590|NCT02707419|Total knee replacement|total knee replacement
238591|NCT02707419|Action observation treatment|action observation treatment
238592|NCT02707419|Rehabilitation|rehabilitation
238593|NCT02707393|stem cell transplantation|stem cell transplantation
238594|NCT02707393|pediatrics|pediatrics
238595|NCT02707354|GVHD|gvhd
238596|NCT02707354|confocal endomicroscopy|confocal endomicroscopy
238597|NCT02707341|psoriasis|psoriasis
238598|NCT02707341|disease registry|disease registry
238599|NCT02707328|Gemcitabine|gemcitabine
238600|NCT02707328|Gemzar|gemzar
238601|NCT02707328|CyberKnife|cyberknife
238602|NCT02707328|Cyber knife|cyber knife
238603|NCT02707328|CK|ck
238604|NCT02707328|abraxane|abraxane
238605|NCT02707328|nab-paclitaxel|nab-paclitaxel
238606|NCT02707315|Cyber Knife|cyber knife
238607|NCT02707315|CyberKnife|cyberknife
238608|NCT02707315|Stereotactic Radiosurgery|stereotactic radiosurgery
238609|NCT02707315|CK|ck
238610|NCT02707276|Bipolar Depression|bipolar depression
238611|NCT02707276|Geriatric|geriatric
238612|NCT02707276|Low Field Magnetic Stimulation|low field magnetic stimulation
238613|NCT02707263|heparin|heparin
238614|NCT02707250|pethidine|pethidine
238615|NCT02707250|laparoscopic cholecystectomy|laparoscopic cholecystectomy
238616|NCT02707250|bupivacaine|bupivacaine
238617|NCT02707224|DP-R208|dp-r208
238618|NCT02707172|Diethylhexyl Phthalate|diethylhexyl phthalate
238619|NCT02707172|Hand hygiene|hand hygiene
238620|NCT02707172|Soaps|soaps
238621|NCT02707172|N-of-1 design|n-of-1 design
238622|NCT02707172|Cross-Over Studies|cross-over studies
238623|NCT02707159|Circulating tumor cells|circulating tumor cells
238624|NCT02707159|Nab-paclitaxel|nab-paclitaxel
238625|NCT02707159|Metastatic pancreatic cancer|metastatic pancreatic cancer
238626|NCT02707159|Gemcitabine|gemcitabine
238627|NCT02707120|PRGF, Neurotrophic Keratitis, platelet rich plasma, PRP|prgf, neurotrophic keratitis, platelet rich plasma, prp
238628|NCT02707094|back|back
238629|NCT02707094|pain|pain
238630|NCT02707094|chronic|chronic
238631|NCT02707068|Quality of Life|quality of life
238632|NCT02707068|Self-help intervention|self-help intervention
238633|NCT02707055|Alcohol Consumption|alcohol consumption
238634|NCT02707055|Alcohol Treatment|alcohol treatment
238635|NCT02707055|Alcoholism|alcoholism
238636|NCT02707055|Ghrelin|ghrelin
238637|NCT02707055|Ghrelin Antagonism|ghrelin antagonism
238638|NCT02707042|Microbiome|microbiome
238639|NCT02707042|Amoxicillin|amoxicillin
238640|NCT02707042|Azithromycin|azithromycin
238641|NCT02707042|Metagenome|metagenome
238642|NCT02707042|Metabolic|metabolic
238643|NCT02707029|Screening Protocol|screening protocol
238644|NCT02707029|Pain|pain
238645|NCT02707029|Phenotypes|phenotypes
238646|NCT02707016|Emergence delirium|emergence delirium
238647|NCT02707016|Sevoflurane|sevoflurane
238648|NCT02707016|Pediatric anesthesia|pediatric anesthesia
238649|NCT02707003|Post-operative respiratory distress|post-operative respiratory distress
238650|NCT02706977|Ophthalmology|ophthalmology
238651|NCT02706964|metastasis|metastasis
238652|NCT02706964|3D imaging|3d imaging
238653|NCT02706964|early detection|early detection
238654|NCT02706951|Musculoskeletal Disease|musculoskeletal disease
238655|NCT02706951|Arthritis|arthritis
238656|NCT02706951|Joint Disease|joint disease
238657|NCT02706951|anti-inflammatory agents|anti-inflammatory agents
238658|NCT02706951|antirheumatic agents|antirheumatic agents
238659|NCT02706938|Gastroesophageal reflux disease|gastroesophageal reflux disease
238660|NCT02706938|Head of bed elevation|head of bed elevation
238661|NCT02706938|Quality of life|quality of life
238662|NCT02706938|Nocturnal symptoms|nocturnal symptoms
238663|NCT02706938|Lifestyle measures|lifestyle measures
238664|NCT02706912|Stroke|stroke
238665|NCT02706912|Hemiparesis|hemiparesis
238666|NCT02706912|Activities of Daily Living|activities of daily living
238667|NCT02706912|Virtual World|virtual world
238668|NCT02706912|Occupational Therapy|occupational therapy
238669|NCT02706899|Antibody-Drug Conjugate CD33 Antigen|antibody-drug conjugate cd33 antigen
238670|NCT02706886|PH1|ph1
238671|NCT02706886|Primary Hyperoxaluria|primary hyperoxaluria
238672|NCT02706886|RNAi therapeutic|rnai therapeutic
238673|NCT02706886|siRNA|sirna
238674|NCT02706886|AGT|agt
238675|NCT02706873|Musculoskeletal disease|musculoskeletal disease
238676|NCT02706873|Arthritis|arthritis
238677|NCT02706873|Joint disease|joint disease
238678|NCT02706873|Anti-inflammatory agents|anti-inflammatory agents
238679|NCT02706873|Antirheumatic agents|antirheumatic agents
238680|NCT02706847|Musculoskeletal Disease|musculoskeletal disease
238681|NCT02706847|Arthritis|arthritis
238682|NCT02706847|Joint Disease|joint disease
238683|NCT02706847|Anti-inflammatory agents|anti-inflammatory agents
238684|NCT02706847|Antirheumatic agents|antirheumatic agents
238685|NCT02706834|Drug therapy|drug therapy
238686|NCT02706821|prediabetes|prediabetes
238687|NCT02706821|blood glucose|blood glucose
238688|NCT02706821|clinical trial|clinical trial
238689|NCT02706808|chronic kidney disease|chronic kidney disease
238690|NCT02706808|hemodialysis|hemodialysis
238691|NCT02706808|conservative treatment|conservative treatment
238692|NCT02706808|resistance starch|resistance starch
238693|NCT02706795|Cervical dystonia|cervical dystonia
238694|NCT02706795|Spasmodic torticollis|spasmodic torticollis
238695|NCT02706704|Intravitreal Adalimumab|intravitreal adalimumab
238696|NCT02706704|Subcutaneous Adalimumab|subcutaneous adalimumab
238697|NCT02706678|FK506|fk506
238698|NCT02706678|Renal transplant recipients|renal transplant recipients
238699|NCT02706678|cyclosporin|cyclosporin
238700|NCT02706665|Anesthetics|anesthetics
238701|NCT02706665|Propofol|propofol
238702|NCT02706665|Electroencephalography|electroencephalography
238703|NCT02706665|SEDline monitor|sedline monitor
238704|NCT02706652|Screening|screening
238705|NCT02706652|Genotype|genotype
238706|NCT02706652|Drug Dosing|drug dosing
238707|NCT02706652|Trial Selection|trial selection
238708|NCT02706639|Biospecimen Procurement|biospecimen procurement
238709|NCT02706639|Laboratory Research Specimens|laboratory research specimens
238710|NCT02706639|Sample Collection|sample collection
238711|NCT02706639|Rare Diseases|rare diseases
238712|NCT02706587|Critical illness polyneuropathy|critical illness polyneuropathy
238713|NCT02706587|Neuromuscular Electrical Stimulation|neuromuscular electrical stimulation
238714|NCT02706574|Eye Tracking|eye tracking
238715|NCT02706574|Blood-based Biomarkers|blood-based biomarkers
238716|NCT02706574|CSF-based Biomarkers|csf-based biomarkers
238717|NCT02706574|Magnetic Resonance Imaging|magnetic resonance imaging
238718|NCT02706574|Computed Tomography Scan|computed tomography scan
238719|NCT02706574|Outcome Measures|outcome measures
238720|NCT02706561|15-317|15-317
238721|NCT02706548|occupational therapy|occupational therapy
238722|NCT02706548|medication adherence|medication adherence
238723|NCT02706548|intervention studies|intervention studies
238724|NCT02706535|Itraconazole|itraconazole
238725|NCT02706535|Rifampicin|rifampicin
238726|NCT02706535|Pharmacokinetics|pharmacokinetics
238727|NCT02706535|Cross-over|cross-over
238728|NCT02706496|aging of elderly|aging of elderly
238729|NCT02706496|falling prevention|falling prevention
238730|NCT02706496|electroencephalography|electroencephalography
238731|NCT02706496|postural control|postural control
238732|NCT02706496|biomechanics|biomechanics
238733|NCT02706470|recurrent miscarriage; immunology|recurrent miscarriage; immunology
238734|NCT02706457|intensive care|intensive care
238735|NCT02706457|functionality|functionality
238736|NCT02706405|PD-L1|pd-l1
238737|NCT02706405|immunotherapy|immunotherapy
238738|NCT02706405|non-Hodgkin lymphoma|non-hodgkin lymphoma
238739|NCT02706353|Melanoma|melanoma
238740|NCT02706353|Metastatic Melanoma|metastatic melanoma
238741|NCT02706353|Intratumoral APX005M|intratumoral apx005m
238742|NCT02706353|Pembrolizumab|pembrolizumab
238743|NCT02706353|Keytruda|keytruda
238744|NCT02706353|MK-3475|mk-3475
238745|NCT02706353|SCH-900475|sch-900475
238746|NCT02706327|orthotic insoles|orthotic insoles
238747|NCT02706327|pain|pain
238748|NCT02706327|quality of life|quality of life
238749|NCT02706327|athletic performance|athletic performance
238750|NCT02706301|colorectal cancer survivor|colorectal cancer survivor
238751|NCT02706301|cancer pain|cancer pain
238752|NCT02706301|psychological distress|psychological distress
238753|NCT02706301|coping skills training|coping skills training
238754|NCT02706301|symptom management|symptom management
238755|NCT02706301|cancer survivorship|cancer survivorship
238756|NCT02706210|Mild Cognitive Impairment|mild cognitive impairment
238757|NCT02706210|Diffusion Tensor Imaging|diffusion tensor imaging
238758|NCT02706197|Electron Paramagnetic Resonance|electron paramagnetic resonance
238759|NCT02706197|Hypoxia|hypoxia
238760|NCT02706197|OxyChip|oxychip
238761|NCT02706184|gastric cancer|gastric cancer
238762|NCT02706184|colorectal cancer|colorectal cancer
238763|NCT02706184|chemotherapy induced diarrhea|chemotherapy induced diarrhea
238764|NCT02706184|5-Fluoruracil|5-fluoruracil
238765|NCT02706184|chemotherapeutic remedy|chemotherapeutic remedy
238766|NCT02706145|social norms|social norms
238767|NCT02706145|youth violence|youth violence
238768|NCT02706145|media|media
238769|NCT02706132|Mesenchymal stromal cells|mesenchymal stromal cells
238770|NCT02706132|Liver Transplantation|liver transplantation
238771|NCT02706132|ABO blood group|abo blood group
238772|NCT02706119|total parenteral nutrition|total parenteral nutrition
238773|NCT02706119|glargine insulin|glargine insulin
238774|NCT02706119|insulin|insulin
238775|NCT02706080|Antithrombotic agents|antithrombotic agents
238776|NCT02706080|VKA|vka
238777|NCT02706080|Direct Oral Anticoagulant|direct oral anticoagulant
238778|NCT02706080|Antiplatelet|antiplatelet
238779|NCT02706080|Bleeding|bleeding
238780|NCT02706080|Emergency|emergency
238781|NCT02706041|Exploratory Lap (Ex Lap)|exploratory lap (ex lap)
238782|NCT02706041|Damage Control Laparotomy (DCL)|damage control laparotomy (dcl)
238783|NCT02706041|Definitive|definitive
238784|NCT02706028|underwater ultrasound|underwater ultrasound
238785|NCT02706028|rheumatoid arthritis|rheumatoid arthritis
238786|NCT02706015|Headache|headache
238787|NCT02706015|Aura|aura
238788|NCT02706015|Migraine|migraine
238789|NCT02705937|xerostomia, Saliva, iatrogenic oral dryness, dairy product|xerostomia, saliva, iatrogenic oral dryness, dairy product
238790|NCT02705898|alcohol use disorders|alcohol use disorders
238791|NCT02705898|physical activity|physical activity
238792|NCT02705898|women's health|women's health
238793|NCT02705885|IgY|igy
238794|NCT02705885|Periodontitis|periodontitis
238795|NCT02705885|Porphyromonas gingivalis|porphyromonas gingivalis
238796|NCT02705885|gingipains|gingipains
238797|NCT02705885|Efficacy|efficacy
238798|NCT02705872|Epidural|epidural
238799|NCT02705872|Programmed intermittent boluses|programmed intermittent boluses
238800|NCT02705872|Cesarian section|cesarian section
238801|NCT02705872|Instrumented delivery|instrumented delivery
238802|NCT02705846|BRCA1|brca1
238803|NCT02705846|BRCA2|brca2
238804|NCT02705846|Lynch Syndrome|lynch syndrome
238805|NCT02705820|Metastatic, Lung Cancer, Switch, Maintenance, Pembrolizumab.|metastatic, lung cancer, switch, maintenance, pembrolizumab.
238806|NCT02705807|Pulmonary Arterial Hypertension (PAH)|pulmonary arterial hypertension (pah)
238807|NCT02705807|safety|safety
238808|NCT02705807|FLOLAN|flolan
238809|NCT02705807|New Thermostable Formulation|new thermostable formulation
238810|NCT02705807|dose adjustment|dose adjustment
238811|NCT02705807|reformulated diluents|reformulated diluents
238812|NCT02705807|currently marketed diluent|currently marketed diluent
238813|NCT02705794|intubation, laryngoscopy|intubation, laryngoscopy
238814|NCT02705768|Neuron-specific enolase (NSE)|neuron-specific enolase (nse)
238815|NCT02705768|Carbamazepine|carbamazepine
238816|NCT02705768|Oxcarbazepine|oxcarbazepine
238817|NCT02705755|Neurogenic Orthostatic Hypotension (nOH)|neurogenic orthostatic hypotension (noh)
238818|NCT02705755|Multiple System Atrophy (MSA)|multiple system atrophy (msa)
238819|NCT02705755|Pure Autonomic Failure|pure autonomic failure
238820|NCT02705755|Parkinson Disease(PD)|parkinson disease(pd)
238821|NCT02705755|nOH|noh
238822|NCT02705755|MSA|msa
238823|NCT02705755|PD|pd
238824|NCT02705755|PAF|paf
238825|NCT02705755|Orthostatic Hypotension|orthostatic hypotension
238826|NCT02705755|ampreloxetine|ampreloxetine
238827|NCT02705755|TD-9855|td-9855
238828|NCT02705742|Mesenchymal stem cells|mesenchymal stem cells
238829|NCT02705742|Liver cirrhosis|liver cirrhosis
238830|NCT02705742|Hepatitis C|hepatitis c
238831|NCT02705729|dental caries|dental caries
238832|NCT02705729|proximal surfaces|proximal surfaces
238833|NCT02705729|posterior teeth|posterior teeth
238834|NCT02705729|carious lesions|carious lesions
238835|NCT02705729|tooth diseases|tooth diseases
238836|NCT02705729|dental restorations|dental restorations
238837|NCT02705729|glass-ionomer|glass-ionomer
238838|NCT02705664|Onychomycosis|onychomycosis
239340|NCT02702479|Fructose|fructose
238839|NCT02705612|Cervical cancer|cervical cancer
238840|NCT02705612|cisplatin|cisplatin
238841|NCT02705612|nimotuzumab|nimotuzumab
238842|NCT02705599|Ischemic stroke|ischemic stroke
238843|NCT02705599|High resolution MRI|high resolution mri
238844|NCT02705599|Perfusion|perfusion
238845|NCT02705599|Mechanism|mechanism
238846|NCT02705586|Movement disorders|movement disorders
238847|NCT02705586|Metabolic Stress|metabolic stress
238848|NCT02705547|Friedreich Ataxia|friedreich ataxia
238849|NCT02705534|Hepatitis C|hepatitis c
238850|NCT02705534|Cirrhosis|cirrhosis
238851|NCT02705534|Sofosbuvir|sofosbuvir
238852|NCT02705534|Ledipasvir|ledipasvir
238853|NCT02705534|Ribavirin|ribavirin
238854|NCT02705521|shoulder|shoulder
238855|NCT02705521|impingement|impingement
238856|NCT02705521|rehabilitation|rehabilitation
238857|NCT02705521|physiotherapy|physiotherapy
238858|NCT02705521|gamification|gamification
238859|NCT02705521|activation|activation
238860|NCT02705521|engagement|engagement
238861|NCT02705508|extranodal natural killer/T-cell lymphoma|extranodal natural killer/t-cell lymphoma
238862|NCT02705508|nasal type|nasal type
238863|NCT02705508|chemotherapy|chemotherapy
238864|NCT02705508|radiotherapy|radiotherapy
238865|NCT02705482|Advanced solid tumors|advanced solid tumors
238866|NCT02705482|MEDI0562|medi0562
238867|NCT02705482|durvalumab|durvalumab
238868|NCT02705482|tremelimumab|tremelimumab
238869|NCT02705482|OX40|ox40
238870|NCT02705482|PD-L1|pd-l1
238871|NCT02705482|CTLA-4|ctla-4
238872|NCT02705482|immuno-oncology|immuno-oncology
238873|NCT02705482|Cancer|cancer
238874|NCT02705469|Metastatic Castration-Resistant Prostate Cancer (mCRPC)|metastatic castration-resistant prostate cancer (mcrpc)
238875|NCT02705469|Phase 1|phase 1
238876|NCT02705469|Prostate Cancer|prostate cancer
238877|NCT02705469|Pharmacokinetics (PK)|pharmacokinetics (pk)
238878|NCT02705469|ZEN003694|zen003694
238879|NCT02705469|ZEN-3694|zen-3694
238880|NCT02705469|Metastatic Castrate-Resistant Prostate Cancer|metastatic castrate-resistant prostate cancer
238881|NCT02705469|BET inhibitor (BETi)|bet inhibitor (beti)
238882|NCT02705469|Bromodomain|bromodomain
238883|NCT02705469|Pharmacodynamics (PD)|pharmacodynamics (pd)
238884|NCT02705469|Epigenetics|epigenetics
238885|NCT02705456|Dental Caries|dental caries
238886|NCT02705456|Tooth Paste|tooth paste
238887|NCT02705456|Orthodontics|orthodontics
238888|NCT02705456|Fluorides|fluorides
238889|NCT02705417|arteriovenous fistula|arteriovenous fistula
238890|NCT02705417|colour Doppler|colour doppler
238891|NCT02705417|physical examination|physical examination
238892|NCT02705417|renal dialysis|renal dialysis
238893|NCT02705417|retrospective studies|retrospective studies
238894|NCT02705404|multifocal|multifocal
238895|NCT02705404|genetic|genetic
238896|NCT02705404|bronchoalveolar carcinoma|bronchoalveolar carcinoma
238897|NCT02705404|adenocarcinoma in situ|adenocarcinoma in situ
238898|NCT02705404|ground glass opacity|ground glass opacity
238899|NCT02705404|next generation sequencing|next generation sequencing
238900|NCT02705378|Intensive care unit|intensive care unit
238901|NCT02705378|ICU|icu
238902|NCT02705378|Critical Illness|critical illness
238903|NCT02705378|Constipation|constipation
238904|NCT02705365|Lung Screening|lung screening
238905|NCT02705365|Low-Dose Computer Tomography|low-dose computer tomography
238906|NCT02705365|Patient Navigation|patient navigation
238907|NCT02705352|Skin graft|skin graft
238908|NCT02705352|5-Fluorouracil|5-fluorouracil
238909|NCT02705352|Periocular reconstruction|periocular reconstruction
238910|NCT02705313|neuroendocrine tumors|neuroendocrine tumors
238911|NCT02705313|177Lu-DOTA0-Tyr3-Octreotate|177lu-dota0-tyr3-octreotate
238912|NCT02705313|PRRT|prrt
238913|NCT02705287|vitamin D|vitamin d
238914|NCT02705287|half life|half life
238915|NCT02705287|kinetics|kinetics
238916|NCT02705261|child|child
238917|NCT02705261|behavior therapy|behavior therapy
238918|NCT02705261|cognitive therapy|cognitive therapy
238919|NCT02705261|parent|parent
238920|NCT02705261|anxiety|anxiety
238921|NCT02705222|Abnormal uterine bleeding|abnormal uterine bleeding
238922|NCT02705222|Dilatation and curettage|dilatation and curettage
238923|NCT02705222|Hysteroscopy|hysteroscopy
238924|NCT02705196|oncolytic|oncolytic
238925|NCT02705196|adenovirus|adenovirus
238926|NCT02705196|pancreatic|pancreatic
238927|NCT02705196|cancer|cancer
238928|NCT02705196|LOKON|lokon
238929|NCT02705196|LOAd703|load703
238930|NCT02705183|surgical treatment|surgical treatment
238931|NCT02705183|post-operative radiotherapy|post-operative radiotherapy
238932|NCT02705183|quality of life|quality of life
238933|NCT02705183|complications|complications
238934|NCT02705183|survival|survival
238935|NCT02705183|long bones|long bones
238936|NCT02705170|index of microvascular resistance|index of microvascular resistance
238937|NCT02705157|long bones|long bones
238938|NCT02705157|survival|survival
238939|NCT02705157|prognosis|prognosis
238940|NCT02705157|treatment|treatment
238941|NCT02705157|quality of life|quality of life
238942|NCT02705131|Cervical radiculopathy|cervical radiculopathy
239934|NCT02698878|GLUT4|glut4
238943|NCT02705131|Balance chiropractic therapy|balance chiropractic therapy
238944|NCT02705118|radiofrequency ablation|radiofrequency ablation
238945|NCT02705118|image fusion|image fusion
238946|NCT02705105|Metastatic Solid Tumors|metastatic solid tumors
238947|NCT02705105|Advanced Solid Tumors|advanced solid tumors
238948|NCT02705105|KW-0761|kw-0761
238949|NCT02705105|ONO-4538/BMS-936558|ono-4538/bms-936558
238950|NCT02705105|Anti-tumor|anti-tumor
238951|NCT02705105|Mogamulizumab|mogamulizumab
238952|NCT02705105|Nivolumab|nivolumab
238953|NCT02705105|Oncology|oncology
238954|NCT02705105|HCC|hcc
238955|NCT02705105|Hepatocellular carcinoma|hepatocellular carcinoma
238956|NCT02705053|Diabetes Mellitus, Type 1|diabetes mellitus, type 1
238957|NCT02705053|Artificial Pancreas|artificial pancreas
238958|NCT02705053|Autoimmune Diseases|autoimmune diseases
238959|NCT02705053|Diabetes Mellitus|diabetes mellitus
238960|NCT02705053|Hyperglycemia|hyperglycemia
238961|NCT02705053|Hypoglycemia|hypoglycemia
238962|NCT02705040|male osteoporosis|male osteoporosis
238963|NCT02705040|miRNA|mirna
238964|NCT02705040|biomarker|biomarker
238965|NCT02705014|pituitary stalk interruption syndrome|pituitary stalk interruption syndrome
238966|NCT02705014|pulsatile GnRH therapy|pulsatile gnrh therapy
238967|NCT02705014|hypogonadotropic hypogonadism|hypogonadotropic hypogonadism
238968|NCT02705014|hypopituitarism|hypopituitarism
238969|NCT02704975|Dry Needling, Shoulder Stabilization|dry needling, shoulder stabilization
238970|NCT02704962|schizophrenia|schizophrenia
238971|NCT02704962|olanzapine|olanzapine
238972|NCT02704962|trifluoperazine|trifluoperazine
238973|NCT02704962|antipsychotic polypharmacy|antipsychotic polypharmacy
238974|NCT02704949|Urolithiasis|urolithiasis
238975|NCT02704949|Fluoroscopy|fluoroscopy
238976|NCT02704949|Radiation|radiation
238977|NCT02704949|Ureteroscopy|ureteroscopy
238978|NCT02704923|Atropine|atropine
238979|NCT02704923|Pneumonia|pneumonia
238980|NCT02704923|Ventilator|ventilator
238981|NCT02704923|Adults|adults
238982|NCT02704923|Intensive care unit.|intensive care unit.
238983|NCT02704871|SeptiCyte|septicyte
238984|NCT02704858|recurrent glioblastoma|recurrent glioblastoma
238985|NCT02704858|recurrent GBM|recurrent gbm
238986|NCT02704845|Inflammatory back pain|inflammatory back pain
238987|NCT02704845|Ankylosing spondylitis|ankylosing spondylitis
238988|NCT02704845|Non-specific low back pain|non-specific low back pain
238989|NCT02704845|Pain experience|pain experience
238990|NCT02704845|Disability|disability
238991|NCT02704845|Behavioural|behavioural
238992|NCT02704845|Psychological|psychological
238993|NCT02704845|Biopsychosocial|biopsychosocial
238994|NCT02704845|Pain profiles|pain profiles
238995|NCT02704832|Geriatric oncology|geriatric oncology
238996|NCT02704832|Intervention|intervention
238997|NCT02704832|Case management|case management
238998|NCT02704819|Decision Support System|decision support system
238999|NCT02704819|Dizziness|dizziness
239000|NCT02704819|Vertigo|vertigo
239001|NCT02704819|Balance|balance
239002|NCT02704780|Retained placenta|retained placenta
239003|NCT02704780|Misoprostol|misoprostol
239004|NCT02704780|double blind|double blind
239005|NCT02704780|Randomization|randomization
239006|NCT02704780|Haemorrhage|haemorrhage
239007|NCT02704715|postoperative pain|postoperative pain
239008|NCT02704715|general anesthesia|general anesthesia
239009|NCT02704702|Fimasartan|fimasartan
239010|NCT02704676|CA-125|ca-125
239011|NCT02704676|Pre-Eclampsia|pre-eclampsia
239012|NCT02704663|adnexal mass|adnexal mass
239013|NCT02704663|laparoscopy|laparoscopy
239014|NCT02704663|removal route|removal route
239015|NCT02704663|postoperative pain|postoperative pain
239016|NCT02704637|vasospasm|vasospasm
239017|NCT02704624|Crohn Disease|crohn disease
239018|NCT02704624|Fatigue|fatigue
239019|NCT02704624|Osteopenia|osteopenia
239020|NCT02704624|Exercise Tolerance|exercise tolerance
239021|NCT02704624|Vitamin d|vitamin d
239022|NCT02704585|Neonatal resuscitation|neonatal resuscitation
239023|NCT02704585|Pulse oximetry|pulse oximetry
239024|NCT02704572|Herpes zoster vaccine|herpes zoster vaccine
239025|NCT02704572|cell-mediated immunity|cell-mediated immunity
239026|NCT02704533|Plasmodium falciparum|plasmodium falciparum
239027|NCT02704533|PfSPZ Vaccine|pfspz vaccine
239028|NCT02704533|PfSPZ Challenge (NF54)|pfspz challenge (nf54)
239029|NCT02704533|PfSPZ Challenge (7G8)|pfspz challenge (7g8)
239030|NCT02704533|CHMI|chmi
239031|NCT02704520|Rectal Cancer|rectal cancer
239032|NCT02704520|Magnetic Resonance Imaging|magnetic resonance imaging
239033|NCT02704520|Chemoradiotherapy|chemoradiotherapy
239034|NCT02704520|Chemotherapy|chemotherapy
239035|NCT02704520|Diagnostic Imaging|diagnostic imaging
239036|NCT02704507|tretinoin|tretinoin
239037|NCT02704507|topical steroid|topical steroid
239038|NCT02704507|irritation|irritation
239039|NCT02704507|retinoid induced irritation|retinoid induced irritation
239040|NCT02704494|Resveratrol|resveratrol
239041|NCT02704494|Diabetes mellitus|diabetes mellitus
239042|NCT02704494|Diabetes complications|diabetes complications
239043|NCT02704494|Diabetic nephropathies|diabetic nephropathies
239044|NCT02704494|Proteinuria|proteinuria
239045|NCT02704494|Albuminuria|albuminuria
239046|NCT02704494|renal insufficiency|renal insufficiency
239047|NCT02704481|mifepristone|mifepristone
239048|NCT02704481|misoprostol|misoprostol
239049|NCT02704481|medical abortion|medical abortion
239050|NCT02704468|CAVI|cavi
239051|NCT02704468|FGF-21|fgf-21
239052|NCT02704468|arterial stiffness|arterial stiffness
239053|NCT02704468|renal transplant|renal transplant
239054|NCT02704455|children|children
239055|NCT02704442|anesthesiology|anesthesiology
239056|NCT02704442|ophthalmology|ophthalmology
239057|NCT02704416|Ventricular arrhythmias|ventricular arrhythmias
239058|NCT02704416|aborted cardiac arrest|aborted cardiac arrest
239059|NCT02704416|cardiac death|cardiac death
239060|NCT02704403|Elafibranor|elafibranor
239061|NCT02704403|NASH|nash
239062|NCT02704403|Nonalcoholic steatohepatitis|nonalcoholic steatohepatitis
239063|NCT02704403|Fatty liver disease|fatty liver disease
239064|NCT02704403|Fibrosis|fibrosis
239065|NCT02704390|ORADUR®-Methylphenidate|oradur®-methylphenidate
239066|NCT02704377|Prostate Cancer Survivor|prostate cancer survivor
239067|NCT02704338|Autoimmune Diseases, Treg|autoimmune diseases, treg
239068|NCT02704325|DMD|dmd
239069|NCT02704325|Duchenne Muscular Dystrophy|duchenne muscular dystrophy
239070|NCT02704273|MTM|mtm
239071|NCT02704273|XLMTM|xlmtm
239072|NCT02704208|Antiretroviral Therapy|antiretroviral therapy
239073|NCT02704208|Medication Adherence|medication adherence
239074|NCT02704208|Technology-based Intervention|technology-based intervention
239075|NCT02704195|Parkinson disease|parkinson disease
239076|NCT02704195|Deep brain stimulation|deep brain stimulation
239077|NCT02704195|Freezing of Gait|freezing of gait
239078|NCT02704182|Arthroplasties, Knee Replacement|arthroplasties, knee replacement
239079|NCT02704169|head and neck cancer|head and neck cancer
239080|NCT02704169|H&N cancer|h&n cancer
239081|NCT02704156|Stereotactic body radiation therapy|stereotactic body radiation therapy
239082|NCT02704156|CyberKnife|cyberknife
239083|NCT02704156|Initial treatment|initial treatment
239084|NCT02704130|Therapeutic Embolization|therapeutic embolization
239085|NCT02704130|Ablation Techniques|ablation techniques
239086|NCT02704130|Transarterial Embolization|transarterial embolization
239087|NCT02704130|TAE|tae
239088|NCT02704130|Microwave Ablation|microwave ablation
239089|NCT02704130|MWA|mwa
239090|NCT02704104|topical hemostat|topical hemostat
239091|NCT02704104|self-assembling peptide barrier|self-assembling peptide barrier
239092|NCT02704065|amyloidosis|amyloidosis
239093|NCT02704065|renal transplantation|renal transplantation
239094|NCT02704026|Body composition|body composition
239095|NCT02704026|Nutritional status|nutritional status
239096|NCT02704013|Neurotrophins|neurotrophins
239097|NCT02704013|Nerve Growth Factor|nerve growth factor
239098|NCT02704013|Brain-Derived Neurotrophic Factor|brain-derived neurotrophic factor
239099|NCT02704013|Urinary Biomarkers|urinary biomarkers
239100|NCT02704013|Urodynamics|urodynamics
239101|NCT02704013|Anticholinergics|anticholinergics
239102|NCT02704013|Children|children
239103|NCT02703961|CCRT|ccrt
239104|NCT02703961|adjuvant chemotherapy|adjuvant chemotherapy
239105|NCT02703961|cisplatin and docetaxel|cisplatin and docetaxel
239106|NCT02703909|morbid obesity|morbid obesity
239107|NCT02703909|laparoscopic surgery|laparoscopic surgery
239108|NCT02703909|neuromuscular blockade|neuromuscular blockade
239109|NCT02703896|g a, bile reflux. PPIs, H2RAs, prokinetic agents|g a, bile reflux. ppis, h2ras, prokinetic agents
239110|NCT02703831|adult spine deformity|adult spine deformity
239111|NCT02703831|time-driven activity-based costing|time-driven activity-based costing
239112|NCT02703831|three-column posterior osteotomy|three-column posterior osteotomy
239113|NCT02703805|Community program|community program
239114|NCT02703805|Wellness|wellness
239115|NCT02703805|Exercise|exercise
239116|NCT02703805|Physical Activity|physical activity
239117|NCT02703805|Education|education
239118|NCT02703805|Stroke|stroke
239119|NCT02703805|Self-management|self-management
239120|NCT02703779|Multiple Myeloma|multiple myeloma
239121|NCT02703779|Bortezomib|bortezomib
239122|NCT02703779|Autologous|autologous
239123|NCT02703779|Stem Cell|stem cell
239124|NCT02703779|Purging|purging
239125|NCT02703779|In-vivo purging|in-vivo purging
239126|NCT02703779|Ex-vivo purging|ex-vivo purging
239127|NCT02703779|Leukapheresis|leukapheresis
239128|NCT02703779|Contaminated|contaminated
239129|NCT02703779|Stem Cell Harvest|stem cell harvest
239130|NCT02703779|Stem Cell Transplant|stem cell transplant
239131|NCT02703779|Transplantation|transplantation
239132|NCT02703727|polypharmacy|polypharmacy
239133|NCT02703727|polymedication check|polymedication check
239134|NCT02703727|anticoagulation treatment|anticoagulation treatment
239135|NCT02703714|Advanced|advanced
239136|NCT02703714|Locally-advanced|locally-advanced
239137|NCT02703714|Not eligible for resection|not eligible for resection
239138|NCT02703714|Prior chemotherapy treatment|prior chemotherapy treatment
239139|NCT02703701|Patient Satisfaction|patient satisfaction
239140|NCT02703701|Emergency Department efficiency|emergency department efficiency
239141|NCT02703662|Biologic mesh|biologic mesh
239142|NCT02703662|abdominal wall reconstruction|abdominal wall reconstruction
240231|NCT02697136|Low apoA-I|low apoa-i
239143|NCT02703649|Aromatase inhibitor|aromatase inhibitor
239144|NCT02703649|induction of ovulation|induction of ovulation
239145|NCT02703636|Alzheimer's disease|alzheimer's disease
239146|NCT02703610|Pain|pain
239147|NCT02703610|Elderly|elderly
239148|NCT02703597|Cigarette Smoking Behavior|cigarette smoking behavior
239149|NCT02703597|Smoking curiosity|smoking curiosity
239150|NCT02703597|Smoking Cessation|smoking cessation
239151|NCT02703597|Smoking Prevention|smoking prevention
239152|NCT02703597|Health improvement|health improvement
239153|NCT02703597|Smoking prevention interactive experience|smoking prevention interactive experience
239154|NCT02703597|ASPIRE|aspire
239155|NCT02703597|Game-based social activities|game-based social activities
239156|NCT02703597|GSA's|gsa's
239157|NCT02703597|Surveys|surveys
239158|NCT02703597|Questionnaires|questionnaires
239159|NCT02703597|Interviews|interviews
239160|NCT02703584|Double trigger|double trigger
239161|NCT02703571|Trametinib|trametinib
239162|NCT02703571|Ribociclib|ribociclib
239163|NCT02703571|LEE011|lee011
239164|NCT02703571|TMT212|tmt212
239165|NCT02703571|advanced solid tumors|advanced solid tumors
239166|NCT02703545|familial pancreas cancer|familial pancreas cancer
239167|NCT02703545|pancreatic cyst|pancreatic cyst
239168|NCT02703532|Therapy|therapy
239169|NCT02703532|Rehabilitation|rehabilitation
239170|NCT02703532|Caregiver|caregiver
239171|NCT02703519|cesarean section, repeat|cesarean section, repeat
239172|NCT02703519|uterine scar tissue|uterine scar tissue
239173|NCT02703519|transvaginal ultrasound|transvaginal ultrasound
239174|NCT02703519|uterine rupture|uterine rupture
239175|NCT02703519|placenta accreta|placenta accreta
239176|NCT02703519|placenta percreta|placenta percreta
239177|NCT02703519|placenta increta|placenta increta
239178|NCT02703467|Exhaled hydrogen sulphide|exhaled hydrogen sulphide
239179|NCT02703428|Abdominal|abdominal
239180|NCT02703428|Aortic|aortic
239181|NCT02703428|Aneurysm|aneurysm
239182|NCT02703415|immune|immune
239183|NCT02703415|interleukin|interleukin
239184|NCT02703415|tramadol|tramadol
239185|NCT02703415|postoperartive analgesia|postoperartive analgesia
239186|NCT02703415|pediatric|pediatric
239187|NCT02703415|caudal bupivacaine|caudal bupivacaine
239188|NCT02703402|low back pain|low back pain
239189|NCT02703402|physical exercise and quality of life|physical exercise and quality of life
239190|NCT02703389|knowledge translation|knowledge translation
239191|NCT02703389|antimicrobial stewardship|antimicrobial stewardship
239192|NCT02703311|Valtech Cardio|valtech cardio
239193|NCT02703311|Cardioband|cardioband
239194|NCT02703311|Mitral Valve|mitral valve
239195|NCT02703298|Advanced Solid Malignancy|advanced solid malignancy
239196|NCT02703298|Safety and Tolerability|safety and tolerability
239197|NCT02703298|Tumor Response|tumor response
239198|NCT02703298|Oncology|oncology
239199|NCT02703272|Lymphoma, Non-Hodgkin|lymphoma, non-hodgkin
239200|NCT02703272|Ibrutinib|ibrutinib
239201|NCT02703272|JNJ-54179060|jnj-54179060
239202|NCT02703246|Hysterectomy, Vaginal|hysterectomy, vaginal
239203|NCT02703246|Hysterectomy, Abdominal|hysterectomy, abdominal
239204|NCT02703220|sleep apnea|sleep apnea
239205|NCT02703220|chemoresponsiveness|chemoresponsiveness
239206|NCT02703220|cerebrovascular response|cerebrovascular response
239207|NCT02703220|hyperoxia|hyperoxia
239208|NCT02703220|acetazolamide|acetazolamide
239209|NCT02703220|finasteride|finasteride
239210|NCT02703220|apneic threshold|apneic threshold
239211|NCT02703220|carbon-dioxide reserve|carbon-dioxide reserve
239212|NCT02703207|obstructive sleep apnea|obstructive sleep apnea
239213|NCT02703207|COPD|copd
239214|NCT02703207|Overlap syndrome|overlap syndrome
239215|NCT02703207|quality of life|quality of life
239216|NCT02703207|neurocognitive function|neurocognitive function
239217|NCT02703207|sleepiness|sleepiness
239218|NCT02703207|elderly|elderly
239219|NCT02703194|IgG4-related disease|igg4-related disease
239220|NCT02703194|IgG4-related sclerosing cholangitis|igg4-related sclerosing cholangitis
239221|NCT02703194|Mikulicz disease|mikulicz disease
239222|NCT02703194|Pancreatitis|pancreatitis
239223|NCT02703194|Retroperitoneal fibrosis|retroperitoneal fibrosis
239224|NCT02703194|Lymphadenopathy|lymphadenopathy
239225|NCT02703181|Safety|safety
239226|NCT02703181|Dose Escalation|dose escalation
239227|NCT02703181|Repeat Dosing|repeat dosing
239228|NCT02703181|Epelsiban|epelsiban
239229|NCT02703181|Pharmacokinetics|pharmacokinetics
239230|NCT02703181|Healthy Women Volunteers|healthy women volunteers
239231|NCT02703181|Tolerability|tolerability
239232|NCT02703181|Oxytocin|oxytocin
239233|NCT02703168|Dental implants|dental implants
239234|NCT02703142|esophagogastrostomy|esophagogastrostomy
239235|NCT02703142|gastric conduit ischemia|gastric conduit ischemia
239236|NCT02703142|endoscopy|endoscopy
239237|NCT02703129|Migraine|migraine
239238|NCT02703129|Diet quality|diet quality
239239|NCT02703129|Nutritional intervention|nutritional intervention
239240|NCT02703129|Severity of disease|severity of disease
239241|NCT02703129|Depressive symptoms|depressive symptoms
239243|NCT02703116|Substance Use|substance use
239244|NCT02703103|cardiopulmonary resuscitation|cardiopulmonary resuscitation
239245|NCT02703103|chest compression|chest compression
239247|NCT02703103|simulation|simulation
239248|NCT02703064|Furocyst|furocyst
239249|NCT02703064|PCOS|pcos
239250|NCT02703038|cardiogenic shock|cardiogenic shock
239251|NCT02703038|observatory|observatory
239252|NCT02703025|Obesity, green coffee bean extract, weight management|obesity, green coffee bean extract, weight management
239253|NCT02702973|Characteristic analysis|characteristic analysis
239254|NCT02702960|FL-HCC|fl-hcc
239255|NCT02702960|living donor liver transplant|living donor liver transplant
239256|NCT02702960|HLA matched first degree relative|hla matched first degree relative
239257|NCT02702960|Milan Criteria|milan criteria
239258|NCT02702960|Ephraim Fuchs|ephraim fuchs
239259|NCT02702960|Fibrolamellar Cancer Foundation|fibrolamellar cancer foundation
239260|NCT02702960|fibrolamellar|fibrolamellar
239261|NCT02702960|non-fibrolamellar|non-fibrolamellar
239262|NCT02702947|BPH|bph
239263|NCT02702947|Prunus Domestica extract|prunus domestica extract
239264|NCT02702882|Fenugreek seed extract, hypogonadism, protodioscin, testosterone|fenugreek seed extract, hypogonadism, protodioscin, testosterone
239265|NCT02702869|cleft lip|cleft lip
239266|NCT02702869|cleft palate|cleft palate
239267|NCT02702869|cleft lip and palate|cleft lip and palate
239268|NCT02702869|cleft alveolus|cleft alveolus
239269|NCT02702869|multidisciplinary team|multidisciplinary team
239270|NCT02702869|interdisciplinary team|interdisciplinary team
239271|NCT02702856|Prostate Cancer|prostate cancer
239272|NCT02702856|Gleason Grade|gleason grade
239273|NCT02702856|Prostatic Neoplasms|prostatic neoplasms
239274|NCT02702817|Alzheimer's disease, biomarkers, cognitive decline, pre-clinical|alzheimer's disease, biomarkers, cognitive decline, pre-clinical
239275|NCT02702791|Physical activity|physical activity
239276|NCT02702791|Pulmonary rehabilitation|pulmonary rehabilitation
239277|NCT02702791|COPD|copd
239278|NCT02702778|Polymyalgia Rheumatica (PMR)|polymyalgia rheumatica (pmr)
239279|NCT02702765|sCD163|scd163
239280|NCT02702765|liver cirrhosis|liver cirrhosis
239281|NCT02702765|disease severity|disease severity
239282|NCT02702752|Heart diseases stromal differentiation factor alpha 1|heart diseases stromal differentiation factor alpha 1
239283|NCT02702713|bioactive|bioactive
239284|NCT02702713|enriched foods|enriched foods
239285|NCT02702713|anthocyanins (AC)|anthocyanins (ac)
239286|NCT02702713|beta-glucans (BG)|beta-glucans (bg)
239287|NCT02702713|docosahexaenoic acid (DHA)|docosahexaenoic acid (dha)
239288|NCT02702687|Asthma|asthma
239289|NCT02702687|Childhood Asthma|childhood asthma
239290|NCT02702687|Bronchial Diseases|bronchial diseases
239291|NCT02702687|Immune System Diseases|immune system diseases
239292|NCT02702687|Lung Diseases|lung diseases
239293|NCT02702687|Lung Diseases, Obstructive|lung diseases, obstructive
239294|NCT02702687|Respiratory Tract Diseases|respiratory tract diseases
239295|NCT02702687|Peak Flow Meter|peak flow meter
239296|NCT02702687|Symptom Perception|symptom perception
239297|NCT02702687|Illness Representation|illness representation
239298|NCT02702661|Fascia Iliaca Block|fascia iliaca block
239299|NCT02702661|Local Anaesthetic Infiltration|local anaesthetic infiltration
239300|NCT02702661|Hip Arthroscopy|hip arthroscopy
239301|NCT02702648|healthy subjects|healthy subjects
239302|NCT02702648|first-in-man|first-in-man
239303|NCT02702648|safety|safety
239304|NCT02702622|bananas|bananas
239305|NCT02702622|biofortified|biofortified
239306|NCT02702622|carotenoids|carotenoids
239307|NCT02702622|vitamin A|vitamin a
239308|NCT02702583|Myelosuppressive Chemotherapy|myelosuppressive chemotherapy
239309|NCT02702583|Febrile Neutropenia|febrile neutropenia
239310|NCT02702583|Solid Tumors|solid tumors
239311|NCT02702583|Dental Infection|dental infection
239312|NCT02702583|Oral Infection|oral infection
239313|NCT02702557|Frail Elderly|frail elderly
239314|NCT02702557|Elastic Band Exercises|elastic band exercises
239315|NCT02702557|Unsupervised Exercises|unsupervised exercises
239316|NCT02702557|Monitoring Technology|monitoring technology
239317|NCT02702557|Bandcizer|bandcizer
239318|NCT02702557|Adherence|adherence
239319|NCT02702557|Feasibility|feasibility
239320|NCT02702531|Laparoscopic Surgery|laparoscopic surgery
239321|NCT02702531|FloShield Defogging and Cleaning System|floshield defogging and cleaning system
239322|NCT02702531|Clearify Defogging and Cleaning System|clearify defogging and cleaning system
239323|NCT02702531|gynecologic|gynecologic
305989|NCT02312531|HBV|hbv
239324|NCT02702518|rhDNase I, Pulmozyme, oGVHD, Dry Eye|rhdnase i, pulmozyme, ogvhd, dry eye
239325|NCT02702505|Pulp|pulp
239326|NCT02702505|pulpotomies|pulpotomies
239327|NCT02702505|mineral trioxide aggregate|mineral trioxide aggregate
239328|NCT02702492|PAK4|pak4
239329|NCT02702492|KPT-9274|kpt-9274
239330|NCT02702492|Karyopharm|karyopharm
239332|NCT02702492|solid tumors|solid tumors
239333|NCT02702492|NAMPT|nampt
239334|NCT02702479|Systematic review and meta-analysis|systematic review and meta-analysis
239335|NCT02702479|Evidence-based medicine (EBM)|evidence-based medicine (ebm)
239336|NCT02702479|Evidence-based nutrition (EBN)|evidence-based nutrition (ebn)
239337|NCT02702479|Clinical practice guidelines|clinical practice guidelines
239338|NCT02702479|Clinical trials|clinical trials
239339|NCT02702479|Dietary sugars|dietary sugars
239341|NCT02702479|High fructose corn syrup|high fructose corn syrup
239342|NCT02702479|Isocaloric|isocaloric
239343|NCT02702479|Hypercaloric|hypercaloric
239344|NCT02702479|Cardiometabolic Risk Factors|cardiometabolic risk factors
239345|NCT02702479|Triglycerides|triglycerides
239346|NCT02702479|Cholesterol|cholesterol
239347|NCT02702479|Glycemic control|glycemic control
239348|NCT02702479|Body weight|body weight
239349|NCT02702479|Uric acid|uric acid
239350|NCT02702479|Blood pressure|blood pressure
239351|NCT02702479|Fatty liver|fatty liver
239352|NCT02702479|Fasting|fasting
239353|NCT02702479|Postprandial|postprandial
239354|NCT02702466|Upper limb musculoskeletal disorders|upper limb musculoskeletal disorders
239355|NCT02702466|Spa treatment|spa treatment
239356|NCT02702466|Randomized controlled trials|randomized controlled trials
239357|NCT02702466|Education|education
239358|NCT02702466|Self- management|self- management
239359|NCT02702466|Self-care|self-care
239360|NCT02702466|Exercise|exercise
239361|NCT02702466|Non pharmacological treatment|non pharmacological treatment
239362|NCT02702440|Systematic review and meta-analysis|systematic review and meta-analysis
239363|NCT02702440|Sugars|sugars
239364|NCT02702440|Liquid calories|liquid calories
239365|NCT02702440|Solid calories|solid calories
239366|NCT02702440|Clinical trials|clinical trials
239367|NCT02702440|Body weight|body weight
239368|NCT02702440|Body Mass Index|body mass index
239369|NCT02702440|Evidence-base nutrition (EBN)|evidence-base nutrition (ebn)
239370|NCT02702440|Evidence-base medicine (EBM)|evidence-base medicine (ebm)
239371|NCT02702440|Clinical practice guidelines|clinical practice guidelines
239372|NCT02702427|viral infections post HSCT, virus-specific T-cells|viral infections post hsct, virus-specific t-cells
239373|NCT02702414|PD1|pd1
239374|NCT02702414|PD-1|pd-1
239375|NCT02702414|PDL1|pdl1
239376|NCT02702414|PD-L1|pd-l1
239377|NCT02702401|PD1|pd1
239378|NCT02702401|PD-1|pd-1
239379|NCT02702401|PDL1|pdl1
239380|NCT02702401|PD-L1|pd-l1
239381|NCT02702388|Lenvatinib|lenvatinib
239382|NCT02702388|E7080|e7080
239383|NCT02702388|Iodine-131 Refractory Differentiated Thyroid Cancer|iodine-131 refractory differentiated thyroid cancer
239384|NCT02702388|Lenvima|lenvima
239385|NCT02702388|Phase 2|phase 2
239386|NCT02702388|RR-DTC|rr-dtc
239387|NCT02702375|Systematic review and meta-analysis|systematic review and meta-analysis
239388|NCT02702375|Evidence-based medicine (EBM)|evidence-based medicine (ebm)
239389|NCT02702375|Evidence-based nutrition (EBN)|evidence-based nutrition (ebn)
239390|NCT02702375|Clinical practice guidelines|clinical practice guidelines
239391|NCT02702375|Prospective cohort studies|prospective cohort studies
239392|NCT02702375|Dietary sugars|dietary sugars
239393|NCT02702375|Fructose|fructose
239394|NCT02702375|Sucrose|sucrose
239395|NCT02702375|High fructose corn syrup|high fructose corn syrup
239396|NCT02702375|HFCS|hfcs
239397|NCT02702375|Cohort studies|cohort studies
239398|NCT02702375|Prospective studies|prospective studies
239399|NCT02702375|Diabetes Mellitus|diabetes mellitus
239400|NCT02702375|Metabolic syndrome|metabolic syndrome
239401|NCT02702375|Coronary heart disease|coronary heart disease
239402|NCT02702375|Stroke|stroke
239403|NCT02702375|Hypertension|hypertension
239404|NCT02702375|Gout|gout
239405|NCT02702362|disorders of consciousness|disorders of consciousness
239406|NCT02702362|minimally conscious state|minimally conscious state
239407|NCT02702362|traumatic brain injury|traumatic brain injury
239408|NCT02702362|stroke|stroke
239409|NCT02702362|transcranial direct current stimulation|transcranial direct current stimulation
239410|NCT02702323|hepatocellular carcinoma|hepatocellular carcinoma
239411|NCT02702323|pulmonary metastasis|pulmonary metastasis
239412|NCT02702323|Apatinib|apatinib
239413|NCT02702323|efficacy|efficacy
239414|NCT02702323|safety|safety
239415|NCT02702297|Preterm premature rupture of the membranes|preterm premature rupture of the membranes
239416|NCT02702297|PPROM|pprom
239417|NCT02702297|PROM|prom
239418|NCT02702297|fetal membranes|fetal membranes
239419|NCT02702297|premature rupture|premature rupture
239420|NCT02702297|neonatal early onset sepsis|neonatal early onset sepsis
239421|NCT02702297|amniotic fluid|amniotic fluid
730902|NCT00506857|Lymphoma|lymphoma
306111|NCT02311686|Ethanol|ethanol
239422|NCT02702297|amniotic infection|amniotic infection
239423|NCT02702297|fetal inflammatory response syndrome|fetal inflammatory response syndrome
239424|NCT02702297|adverse neonatal outcome|adverse neonatal outcome
239425|NCT02702297|FIRS|firs
239426|NCT02702284|Advance Directives|advance directives
239427|NCT02702284|Healthcare power of attorney|healthcare power of attorney
239428|NCT02702258|mindfulness|mindfulness
239429|NCT02702258|blood pressure|blood pressure
239430|NCT02702258|hypertension|hypertension
239431|NCT02702258|prehypertension|prehypertension
239432|NCT02702206|Shoulder pain|shoulder pain
239433|NCT02702206|subdeltoid bursitis|subdeltoid bursitis
239434|NCT02702206|subacromial bursitis|subacromial bursitis
239435|NCT02702206|intra-bursa injection|intra-bursa injection
239436|NCT02702167|brain stimulation|brain stimulation
239437|NCT02702167|rTMS|rtms
239438|NCT02702154|brain stimulation|brain stimulation
239439|NCT02702154|rTMS|rtms
240431|NCT02696070|Pain|pain
239440|NCT02702141|Non-hodgkin lymphoma|non-hodgkin lymphoma
239441|NCT02702141|Antibody-drug conjugate|antibody-drug conjugate
239442|NCT02702141|CD19|cd19
239443|NCT02702141|Diffuse large B-cell lymphoma|diffuse large b-cell lymphoma
239444|NCT02702141|DLBCL|dlbcl
239445|NCT02702141|Grade 3 follicular lymphoma|grade 3 follicular lymphoma
239446|NCT02702128|Bleeding perioperative|bleeding perioperative
239447|NCT02702128|EXACYL|exacyl
239448|NCT02702128|Oorthognathism surgery|oorthognathism surgery
239449|NCT02702128|Hematoma|hematoma
239450|NCT02702115|Mucopolysaccharidosis I|mucopolysaccharidosis i
239451|NCT02702115|MPS I|mps i
239452|NCT02702115|Hurler-Scheie syndrome|hurler-scheie syndrome
239453|NCT02702115|Gene Therapy|gene therapy
239454|NCT02702115|Gene Editing|gene editing
239455|NCT02702115|Zinc Finger|zinc finger
239456|NCT02702115|SB-318|sb-318
239457|NCT02702115|Rare|rare
239458|NCT02702115|Genetic|genetic
239459|NCT02702115|DNA|dna
239460|NCT02702115|Sangamo|sangamo
239461|NCT02702115|Genome editing|genome editing
239462|NCT02702115|Empowers|empowers
239463|NCT02702115|ZFN|zfn
239464|NCT02702115|Hurler|hurler
239465|NCT02702115|Gene Specific Targeted Insertion|gene specific targeted insertion
239466|NCT02702076|Apomorphine|apomorphine
239467|NCT02702050|Physiotherapy|physiotherapy
239468|NCT02702050|Mechanical Stimulation|mechanical stimulation
239469|NCT02702050|Mastectomy Scar|mastectomy scar
239470|NCT02702024|efficacy|efficacy
239471|NCT02702024|double incision technique|double incision technique
239472|NCT02702024|uterus preserving surgery|uterus preserving surgery
239473|NCT02701998|Ischemic Stroke|ischemic stroke
239474|NCT02701998|Transient Ischemic Attack|transient ischemic attack
239475|NCT02701998|Physical Activity|physical activity
239476|NCT02701998|Sedentary Behavior|sedentary behavior
239477|NCT02701998|Lifestyle|lifestyle
239478|NCT02701998|Behavior|behavior
239479|NCT02701959|Nitric oxide|nitric oxide
239480|NCT02701959|Dietary intervention trail|dietary intervention trail
239481|NCT02701946|Blood loss|blood loss
239482|NCT02701946|Total knee arthroplasty|total knee arthroplasty
239483|NCT02701946|Bandage|bandage
239484|NCT02701946|Dressing|dressing
239485|NCT02701920|Premature Birth|premature birth
239486|NCT02701920|Infant|infant
239487|NCT02701920|Heart rate|heart rate
239488|NCT02701881|Femoropopliteal Artery|femoropopliteal artery
239489|NCT02701881|Drug-eluting Stent|drug-eluting stent
239490|NCT02701881|Endovascular Therapy|endovascular therapy
239491|NCT02701868|Infant Formula|infant formula
239492|NCT02701829|taxi cab drivers|taxi cab drivers
239493|NCT02701829|high blood pressure|high blood pressure
239494|NCT02701829|16-038|16-038
239495|NCT02701816|Peripheral Artery Disease|peripheral artery disease
239496|NCT02701816|Femoropopliteal Artery|femoropopliteal artery
239497|NCT02701816|Nitinol Stent|nitinol stent
239498|NCT02701816|Restenosis|restenosis
239499|NCT02701777|spike timing dependant plasticity|spike timing dependant plasticity
239500|NCT02701764|laser-assisted in situ keratomileusis|laser-assisted in situ keratomileusis
239501|NCT02701764|dry eye symptoms|dry eye symptoms
239502|NCT02701764|LASIK|lasik
239503|NCT02701764|prevention|prevention
239504|NCT02701712|magnetic resonance|magnetic resonance
239505|NCT02701712|external beam radiotherapy|external beam radiotherapy
239506|NCT02701712|brachytherapy|brachytherapy
239507|NCT02701712|radiotherapy|radiotherapy
239508|NCT02701699|Lung Cancer|lung cancer
239509|NCT02701699|FAZA PET Imaging|faza pet imaging
239510|NCT02701699|Lung Radiotherapy|lung radiotherapy
239511|NCT02701686|smoking cessation|smoking cessation
239512|NCT02701673|Refractory or Relapsed Lymphoma|refractory or relapsed lymphoma
239513|NCT02701673|Busulfan|busulfan
239514|NCT02701673|Busulfex|busulfex
239515|NCT02701673|Myleran|myleran
239516|NCT02701673|Caphosol|caphosol
239517|NCT02701673|Glutamine|glutamine
239518|NCT02701673|Enterex|enterex
239519|NCT02701673|Glutapak-10|glutapak-10
239520|NCT02701673|NutreStore|nutrestore
239521|NCT02701673|Resource|resource
239522|NCT02701673|GlutaSolve|glutasolve
239523|NCT02701673|Sympt-X-G.I.|sympt-x-g.i.
239524|NCT02701673|Sympt-X|sympt-x
239525|NCT02701673|Pyridoxine|pyridoxine
239526|NCT02701673|Belinostat|belinostat
239527|NCT02701673|Azacitidine|azacitidine
239528|NCT02701673|5-azacytidine|5-azacytidine
239529|NCT02701673|5-aza|5-aza
239530|NCT02701673|Azacytidine|azacytidine
239531|NCT02701673|Vidaza|vidaza
239532|NCT02701673|5-AZC|5-azc
239533|NCT02701673|AZA-CR|aza-cr
239534|NCT02701673|Ladakamycin|ladakamycin
239535|NCT02701673|Gemcitabine|gemcitabine
239536|NCT02701673|Gemcitabine Hydrochloride|gemcitabine hydrochloride
239537|NCT02701673|Gemzar|gemzar
239538|NCT02701673|Stem cell transplant|stem cell transplant
239539|NCT02701673|SCT|sct
239540|NCT02701673|Melphalan|melphalan
239541|NCT02701673|Alkeran|alkeran
239542|NCT02701660|Pharmaceutical Care|pharmaceutical care
239543|NCT02701660|Adherence|adherence
239544|NCT02701660|Polypharmacy|polypharmacy
239545|NCT02701660|e-Health|e-health
239546|NCT02701660|opioid substitution therapy|opioid substitution therapy
239547|NCT02701647|Transcranial Magnetic Stimulation|transcranial magnetic stimulation
239548|NCT02701647|metaplasticity|metaplasticity
239549|NCT02701647|gait training|gait training
239550|NCT02701634|Chronic Graft Versus Host Disease (cGVHD)|chronic graft versus host disease (cgvhd)
239551|NCT02701634|newly diagnosed cGVHD|newly diagnosed cgvhd
239552|NCT02701634|immune reconstitution|immune reconstitution
239553|NCT02701634|Immune System Diseases|immune system diseases
239554|NCT02701634|allogeneic stem cell transplantation|allogeneic stem cell transplantation
239555|NCT02701634|SYK inhibitor|syk inhibitor
239556|NCT02701621|Parkinson's disease, aquatic therapy, balance, MIRT|parkinson's disease, aquatic therapy, balance, mirt
239557|NCT02701517|conditioning treatment|conditioning treatment
239558|NCT02701517|alemtuzumab|alemtuzumab
239559|NCT02701517|allogeneic hematopoietic stem cell transplantation|allogeneic hematopoietic stem cell transplantation
239560|NCT02701517|chronic lymphoproliferative disorders|chronic lymphoproliferative disorders
239561|NCT02701504|sleep apnea|sleep apnea
239562|NCT02701504|coronary artery bypass grafting|coronary artery bypass grafting
239563|NCT02701504|outcomes|outcomes
239564|NCT02701465|Shoulder|shoulder
239565|NCT02701465|Exercise therapy|exercise therapy
239566|NCT02701452|GnRH agonist triggering|gnrh agonist triggering
239567|NCT02701426|Macrosomia|macrosomia
239568|NCT02701426|Weight gain|weight gain
239569|NCT02701426|Participation|participation
239570|NCT02701426|Adhesion|adhesion
239571|NCT02701426|Physical activity|physical activity
239572|NCT02701426|Nutrition|nutrition
239573|NCT02701413|Apex M|apex m
239574|NCT02701413|Postpartum|postpartum
239575|NCT02701413|Pelvic Floor rehabilitation|pelvic floor rehabilitation
239576|NCT02701387|bone implant interaction|bone implant interaction
239577|NCT02701387|implant stability|implant stability
239578|NCT02701387|resonance frequency analysis (RFA)|resonance frequency analysis (rfa)
239579|NCT02701387|implant stability quotient (ISQ)|implant stability quotient (isq)
239580|NCT02701374|TRK-700|trk-700
239581|NCT02701374|Post-Herpetic Neuralgia|post-herpetic neuralgia
239582|NCT02701361|mindfulness|mindfulness
239583|NCT02701361|critical illness|critical illness
239584|NCT02701361|intensive care unit|intensive care unit
239585|NCT02701361|mindfulness-based stress reduction|mindfulness-based stress reduction
239586|NCT02701348|neoadjuvant endocrine|neoadjuvant endocrine
239587|NCT02701335|Osteoarthritis|osteoarthritis
239588|NCT02701335|Hand|hand
239589|NCT02701335|Rehabilitation|rehabilitation
239590|NCT02701322|Velopharyngeal Insufficiency|velopharyngeal insufficiency
239591|NCT02701322|Fluoroscopy|fluoroscopy
239592|NCT02701309|Iron deficiency|iron deficiency
239593|NCT02701309|Child|child
239594|NCT02701309|Infancy|infancy
239595|NCT02701309|Preschool children|preschool children
239596|NCT02701309|iron deficiency anemia|iron deficiency anemia
239597|NCT02701296|Infiltration between popliteal artery and capsule of knee (iPACK)|infiltration between popliteal artery and capsule of knee (ipack)
239598|NCT02701270|Glycemic Index|glycemic index
239599|NCT02701270|Dietary Fiber|dietary fiber
239600|NCT02701257|Bionic Pancreas|bionic pancreas
239601|NCT02701257|Insulin|insulin
239602|NCT02701257|Glucagon|glucagon
239603|NCT02701257|Continuous Glucose Monitor|continuous glucose monitor
239604|NCT02701244|Infiltrating Ductal Carcinoma|infiltrating ductal carcinoma
239605|NCT02701244|Ductal Carcinoma In Situ|ductal carcinoma in situ
239606|NCT02701244|Brachytherapy|brachytherapy
239607|NCT02701244|Breast Neoplasms|breast neoplasms
239608|NCT02701244|Breast Diseases|breast diseases
239609|NCT02701244|Neoplasms|neoplasms
239610|NCT02701244|Neoplasms by Site|neoplasms by site
239611|NCT02701231|lung cancer|lung cancer
239612|NCT02701231|Low-frequency rotating magnetic therapy system|low-frequency rotating magnetic therapy system
239613|NCT02701231|systemic anti-tumor therapy|systemic anti-tumor therapy
239614|NCT02701218|Canalith repositioning procedure (CRP)|canalith repositioning procedure (crp)
239615|NCT02701218|BPPV|bppv
239616|NCT02701205|Plaque Psoriasis|plaque psoriasis
239617|NCT02701205|Skin Disease|skin disease
239618|NCT02701192|coccygodynia|coccygodynia
239619|NCT02701192|coccygectomy|coccygectomy
239620|NCT02701192|coccyx|coccyx
239621|NCT02701179|Lignocaine|lignocaine
239622|NCT02701166|Pruritus|pruritus
239623|NCT02701166|itch|itch
239624|NCT02701166|cholestasis|cholestasis
239625|NCT02701075|peripheral neuropathy|peripheral neuropathy
239626|NCT02701075|traumatic tissue injury|traumatic tissue injury
239627|NCT02701075|radiculopathy|radiculopathy
239628|NCT02701036|sporadic ataxia|sporadic ataxia
239629|NCT02701036|MSAc|msac
239630|NCT02701036|SAOA|saoa
239631|NCT02701036|multiple system atrophy of cerebellar type|multiple system atrophy of cerebellar type
239632|NCT02701036|natural history|natural history
239633|NCT02701010|behavioral therapy|behavioral therapy
239634|NCT02701010|overactive bladder|overactive bladder
239635|NCT02701010|urinary incontinence|urinary incontinence
239636|NCT02700958|Remote ischemic preconditioning|remote ischemic preconditioning
239637|NCT02700958|Contrast-induced Nephropathy|contrast-induced nephropathy
239638|NCT02700958|Stable coronary artery disease|stable coronary artery disease
239639|NCT02700958|Lower extremity arterial disease|lower extremity arterial disease
240724|NCT02694133|aphasia|aphasia
239640|NCT02700958|Low molecular weight metabolites|low molecular weight metabolites
239641|NCT02700958|Functional properties of arteries|functional properties of arteries
239642|NCT02700932|non-invasive|non-invasive
239643|NCT02700906|Lateral epicondylitis|lateral epicondylitis
239644|NCT02700906|tennis elbow|tennis elbow
239645|NCT02700906|Lidocaine|lidocaine
239646|NCT02700906|corticosteroid|corticosteroid
239647|NCT02700880|wearable cardioverter defibrillator|wearable cardioverter defibrillator
239648|NCT02700880|ischemic cardiomyopathy|ischemic cardiomyopathy
239649|NCT02700880|new onset heart failure|new onset heart failure
239650|NCT02700880|sudden cardiac death|sudden cardiac death
239651|NCT02700867|intraosseous access|intraosseous access
239652|NCT02700867|cardiopulmonary resuscitation|cardiopulmonary resuscitation
239653|NCT02700867|paramedic|paramedic
239654|NCT02700867|simulation|simulation
239655|NCT02700867|cadaver|cadaver
239656|NCT02700854|Hypothermia treatment|hypothermia treatment
239657|NCT02700854|Hypocapnia|hypocapnia
239658|NCT02700854|Inhaled CO2|inhaled co2
239659|NCT02700854|Neuroprotection|neuroprotection
239660|NCT02700828|Hypothermia treatment|hypothermia treatment
239661|NCT02700828|Circulatory failure|circulatory failure
239662|NCT02700828|Neonatal hypotension|neonatal hypotension
239663|NCT02700828|Relative adrenal insufficiency|relative adrenal insufficiency
239664|NCT02700828|Hydrocortisone supplementation|hydrocortisone supplementation
239665|NCT02700802|food insecurity|food insecurity
239666|NCT02700802|informal caregiver health|informal caregiver health
239667|NCT02700802|clinic-to-community linkages|clinic-to-community linkages
239668|NCT02700802|community resources|community resources
239669|NCT02700789|diagnostic accuracy|diagnostic accuracy
239670|NCT02700789|double decidual sac sign|double decidual sac sign
239671|NCT02700789|intrauterine pregnancy|intrauterine pregnancy
239672|NCT02700776|screening mammogram|screening mammogram
239673|NCT02700776|GP88|gp88
239674|NCT02700776|breast cancer|breast cancer
239675|NCT02700763|Brain metastasis|brain metastasis
239676|NCT02700737|cardiovascular modeling|cardiovascular modeling
239677|NCT02700737|aortic coarctation|aortic coarctation
239678|NCT02700737|virtual stenting|virtual stenting
239679|NCT02700698|Mitochondria|mitochondria
239680|NCT02700698|women|women
239681|NCT02700698|muscle|muscle
239682|NCT02700698|PBMC|pbmc
239683|NCT02700672|Ageing|ageing
239684|NCT02700672|Cognition|cognition
239685|NCT02700672|Executive Function|executive function
239686|NCT02700672|Gait|gait
239687|NCT02700620|emotional eating|emotional eating
239688|NCT02700620|restrictive eating|restrictive eating
239689|NCT02700620|body dissatisfaction|body dissatisfaction
239690|NCT02700607|cerebral aneurysm, coiling embolization, blood viscosity|cerebral aneurysm, coiling embolization, blood viscosity
239691|NCT02700555|colorectal cancer|colorectal cancer
239692|NCT02700555|diabetes|diabetes
239693|NCT02700555|metabolic parameters|metabolic parameters
239694|NCT02700555|Surveillance|surveillance
239695|NCT02700542|asthma|asthma
239696|NCT02700542|pest management|pest management
239697|NCT02700503|Diabetes prevention|diabetes prevention
239698|NCT02700503|type 2 diabetes|type 2 diabetes
239699|NCT02700503|prediabetes|prediabetes
239700|NCT02700503|family|family
239701|NCT02700477|Type-2 Diabetic|type-2 diabetic
239702|NCT02700477|HbA1c|hba1c
239704|NCT02700477|PPBS|ppbs
239705|NCT02700477|C-peptide|c-peptide
239706|NCT02700451|IV acetaminophen|iv acetaminophen
239707|NCT02700451|IV Ketorolac|iv ketorolac
239708|NCT02700451|Post-operative analgesia|post-operative analgesia
239709|NCT02700451|Opioid use|opioid use
239710|NCT02700425|Wide QRS|wide qrs
239711|NCT02700425|Ventricular Dyssynchrony|ventricular dyssynchrony
239712|NCT02700399|Rehabilitation|rehabilitation
239713|NCT02700386|Breast|breast
239714|NCT02700386|Cancer|cancer
239715|NCT02700386|Hypofractionated|hypofractionated
239716|NCT02700386|Node-Positive Breast Cancer|node-positive breast cancer
239717|NCT02700386|Radiation Therapy|radiation therapy
239718|NCT02700386|Comprehensive Radiation Therapy|comprehensive radiation therapy
239719|NCT02700360|EC-18|ec-18
239720|NCT02700360|Hematology|hematology
239721|NCT02700360|Cancer|cancer
239722|NCT02700360|Neutropenia|neutropenia
239723|NCT02700334|Prediabetes|prediabetes
239724|NCT02700334|Impaired fasting glucose|impaired fasting glucose
239725|NCT02700334|Hyperglycemia|hyperglycemia
239726|NCT02700334|Impaired glucose tolerance|impaired glucose tolerance
239727|NCT02700334|Glucose intolerance|glucose intolerance
239728|NCT02700334|Dapagliflozin|dapagliflozin
239729|NCT02700334|Sodium glucose cotransporter 2 inhibitor|sodium glucose cotransporter 2 inhibitor
239730|NCT02700334|SGLT2|sglt2
239731|NCT02700321|non severely hypoxemic respiratory failure|non severely hypoxemic respiratory failure
239732|NCT02700321|preoxygenation|preoxygenation
239733|NCT02700321|crash induction|crash induction
239734|NCT02700308|Solid tumors|solid tumors
239735|NCT02700308|Spine metastasis|spine metastasis
239736|NCT02700308|Vertebroplasty|vertebroplasty
239737|NCT02700308|kyphoplasty|kyphoplasty
239738|NCT02700308|randomization|randomization
239739|NCT02700295|Orthokeratology|orthokeratology
239740|NCT02700282|Cystic fibrosis|cystic fibrosis
239741|NCT02700282|Backpack carrying|backpack carrying
239742|NCT02700282|Respiratory function|respiratory function
239743|NCT02700282|Children|children
239744|NCT02700256|surgery|surgery
239745|NCT02700256|15-315|15-315
239746|NCT02700243|Cystic Fibrosis|cystic fibrosis
239747|NCT02700243|Exercise|exercise
239748|NCT02700243|Fitbit|fitbit
239749|NCT02700217|Donor Nephrectomy|donor nephrectomy
239750|NCT02700139|Myopia control, aspheric lenses, children|myopia control, aspheric lenses, children
239751|NCT02700126|propofol|propofol
239752|NCT02700126|total intravenous anesthesia|total intravenous anesthesia
239753|NCT02700126|cerebral aneurysm|cerebral aneurysm
239754|NCT02700126|single nucleotide polymorphism|single nucleotide polymorphism
239755|NCT02700087|Laryngomalacia|laryngomalacia
239756|NCT02700061|Induced Constraint Therapy|induced constraint therapy
239757|NCT02700061|Robotic Occupational Therapy|robotic occupational therapy
239758|NCT02700061|Neuroplasticity|neuroplasticity
239759|NCT02700048|type 1 diabetes|type 1 diabetes
239760|NCT02700048|hypoglycemia|hypoglycemia
239761|NCT02700048|hypoglycemia unawareness|hypoglycemia unawareness
239762|NCT02700035|Intervention|intervention
239763|NCT02700035|Prevention|prevention
239764|NCT02700035|Randomized Controlled Trial|randomized controlled trial
239765|NCT02700035|Bii-Zin-Da-De-Dah|bii-zin-da-de-dah
239766|NCT02700022|Lineberger Comprehensive Cancer Center|lineberger comprehensive cancer center
239767|NCT02700022|Alisertib|alisertib
239768|NCT02699905|Sepsis|sepsis
239769|NCT02699905|Septic Shock|septic shock
239770|NCT02699905|Multiple Organ Dysfunction|multiple organ dysfunction
239771|NCT02699905|FFA2|ffa2
239772|NCT02699905|GPR43|gpr43
239773|NCT02699866|Small diameter implant|small diameter implant
239774|NCT02699840|Meningitis|meningitis
239775|NCT02699840|Meningococcal Meningitis|meningococcal meningitis
239776|NCT02699840|Meningococcal Infections|meningococcal infections
239777|NCT02699840|Menactra®|menactra®
239778|NCT02699840|Meningococcal Vaccine|meningococcal vaccine
239779|NCT02699827|Levobupivacaine|levobupivacaine
239780|NCT02699827|Magnesium|magnesium
239781|NCT02699827|Preeclampsia|preeclampsia
239782|NCT02699827|Epidural|epidural
239783|NCT02699814|Depression|depression
239784|NCT02699814|Children|children
239785|NCT02699814|Anxiety|anxiety
239786|NCT02699775|Botulinum toxin injections|botulinum toxin injections
239787|NCT02699775|Stroke|stroke
239788|NCT02699775|3D motion analysis|3d motion analysis
239789|NCT02699775|Gait pattern|gait pattern
239790|NCT02699762|self rehabilitation|self rehabilitation
239791|NCT02699762|stroke|stroke
239792|NCT02699762|botulinum toxin injection|botulinum toxin injection
239793|NCT02699762|arm functions|arm functions
239794|NCT02699749|Drug Therapy|drug therapy
239795|NCT02699736|HIV|hiv
239796|NCT02699736|HIV-1|hiv-1
239797|NCT02699736|Hepatitis C|hepatitis c
239798|NCT02699736|HCV|hcv
239799|NCT02699736|prospective|prospective
239800|NCT02699736|cohort|cohort
239801|NCT02699736|coinfection|coinfection
239802|NCT02699671|Bioresorbable Vascular Scaffold|bioresorbable vascular scaffold
239803|NCT02699671|Routine Clinical Practice|routine clinical practice
239804|NCT02699671|Angioplasty, Transluminal, Percutaneous Coronary|angioplasty, transluminal, percutaneous coronary
239805|NCT02699671|Coronary Artery Disease|coronary artery disease
239806|NCT02699671|drug eluting stent|drug eluting stent
239807|NCT02699671|acute myocardial infarction|acute myocardial infarction
239808|NCT02699658|levofloxacin|levofloxacin
239809|NCT02699658|population pharmacokinetics|population pharmacokinetics
239810|NCT02699658|pharmacodynamics|pharmacodynamics
239811|NCT02699645|Blood Pressure (BP)|blood pressure (bp)
239812|NCT02699645|Stroke|stroke
239813|NCT02699632|Survey|survey
239814|NCT02699619|Undisplaced|undisplaced
239815|NCT02699606|Tumor|tumor
239816|NCT02699606|Fibroblast Growth Factor Receptor (FGFR)|fibroblast growth factor receptor (fgfr)
239817|NCT02699606|Non-Small Cell Lung Cancer (NSCLC)|non-small cell lung cancer (nsclc)
239818|NCT02699606|Erdafitinib|erdafitinib
239819|NCT02699606|Urothelial Cancer|urothelial cancer
239820|NCT02699606|Esophageal Cancer|esophageal cancer
239821|NCT02699606|Cholangiocarcinoma|cholangiocarcinoma
239822|NCT02699580|Biodegradable collagen implant|biodegradable collagen implant
239823|NCT02699580|scleral thinning|scleral thinning
239824|NCT02699580|strabismus surgery|strabismus surgery
239825|NCT02699567|taste perception|taste perception
239826|NCT02699567|individual differences|individual differences
239827|NCT02699567|fat|fat
239828|NCT02699567|genetics|genetics
239829|NCT02699541|Diabetes Self-Management Education|diabetes self-management education
239830|NCT02699541|Behavioural change theory|behavioural change theory
239831|NCT02699541|IMB model|imb model
239832|NCT02699541|Diabetes Type 2|diabetes type 2
239833|NCT02699515|MSB0011359C|msb0011359c
239834|NCT02699476|NFL|nfl
239835|NCT02699476|veterans|veterans
239836|NCT02699476|cognitive training|cognitive training
239837|NCT02699476|TBI|tbi
239838|NCT02699476|concussion|concussion
239839|NCT02699437|Preeclampsia|preeclampsia
239840|NCT02699437|Antiphospholipid Antibodies|antiphospholipid antibodies
239841|NCT02699411|ligament anterior cruciate , dry needling, physioterapy, propioception, knee arthroplasty, vastus medialis.|ligament anterior cruciate , dry needling, physioterapy, propioception, knee arthroplasty, vastus medialis.
239842|NCT02699385|Gastroenteritis|gastroenteritis
239843|NCT02699385|Domperidone|domperidone
239844|NCT02699385|Pediatric participants|pediatric participants
239845|NCT02699372|Healthy Volunteers|healthy volunteers
239846|NCT02699359|concussion|concussion
239847|NCT02699359|mild traumatic brain injuries|mild traumatic brain injuries
239848|NCT02699346|concussion|concussion
239849|NCT02699346|mild traumatic brain injuries|mild traumatic brain injuries
239850|NCT02699320|Short bowel syndrome|short bowel syndrome
239851|NCT02699320|Intestinal microbiota|intestinal microbiota
239852|NCT02699320|immune|immune
239853|NCT02699307|physical activity|physical activity
239854|NCT02699294|Pain Threshold|pain threshold
239855|NCT02699294|Pectoralis Minor|pectoralis minor
239856|NCT02699294|Proprioceptive Neuromuscular Facilitation (PNF) Stretching|proprioceptive neuromuscular facilitation (pnf) stretching
239857|NCT02699294|Physiotherapy|physiotherapy
239858|NCT02699294|Rehabilitation|rehabilitation
239859|NCT02699242|Fiberoptic intubation Training Simulation Performance|fiberoptic intubation training simulation performance
239860|NCT02699216|Macular Degeneration|macular degeneration
239861|NCT02699216|Eye Diseases|eye diseases
239862|NCT02699216|Retinal Degeneration|retinal degeneration
239863|NCT02699216|Retinal Diseases|retinal diseases
239864|NCT02699190|Leukodystrophy|leukodystrophy
239865|NCT02699190|White Matter Disease|white matter disease
239866|NCT02699190|Whole Genome Sequencing|whole genome sequencing
239868|NCT02699177|ciliary beat frequency,|ciliary beat frequency,
239869|NCT02699164|non surgical spinal decompression therapy|non surgical spinal decompression therapy
239870|NCT02699164|deep friction massage|deep friction massage
239871|NCT02699164|exercise|exercise
239872|NCT02699099|Children|children
239873|NCT02699099|Infants|infants
239874|NCT02699099|SB257049|sb257049
239875|NCT02699099|Malaria|malaria
239876|NCT02699099|Immunogenicity|immunogenicity
239877|NCT02699099|Surveillance|surveillance
239878|NCT02699099|Efficacy|efficacy
239879|NCT02699099|Safety|safety
239880|NCT02699099|Africa|africa
239881|NCT02699099|Plasmodium falciparum|plasmodium falciparum
239882|NCT02699086|ADHD|adhd
239883|NCT02699073|colorectal cancer|colorectal cancer
239884|NCT02699073|metastatic|metastatic
239885|NCT02699073|regorafenib|regorafenib
239886|NCT02699073|CHOI criteria|choi criteria
239887|NCT02699073|RECIST criteria|recist criteria
239888|NCT02699060|GERD|gerd
239889|NCT02699060|Barrett`s esophagus|barrett`s esophagus
239890|NCT02699060|macrophage|macrophage
239891|NCT02699060|FSSG questionnaire|fssg questionnaire
239892|NCT02699047|Gastrointestinal cancer|gastrointestinal cancer
239893|NCT02699047|Fish oil|fish oil
239894|NCT02699047|Oxidative stress|oxidative stress
239895|NCT02699047|Inflammation|inflammation
239896|NCT02699047|Quality of life|quality of life
239897|NCT02699047|Nutritional status|nutritional status
239898|NCT02699047|Colorectal cancer|colorectal cancer
239899|NCT02699047|Stomach cancer|stomach cancer
239900|NCT02699047|Chemotherapy|chemotherapy
239901|NCT02699047|polyunsaturated fatty acids n-3|polyunsaturated fatty acids n-3
239902|NCT02699034|real-time MRI|real-time mri
239903|NCT02699034|electrophysiology study|electrophysiology study
239904|NCT02699034|atrial flutter ablation|atrial flutter ablation
239905|NCT02699034|active tracking|active tracking
239906|NCT02699008|clopidogrel；antiplatelet therapy|clopidogrel；antiplatelet therapy
239907|NCT02698982|elderly|elderly
239908|NCT02698982|postoperative cognitive dysfunction|postoperative cognitive dysfunction
239909|NCT02698982|postoperative delirium|postoperative delirium
730903|NCT00506857|Myeloma|myeloma
306800|NCT02307682|AMD|amd
239910|NCT02698982|depth of anesthesia|depth of anesthesia
239911|NCT02698982|intraoperative blood pressure monitoring|intraoperative blood pressure monitoring
239912|NCT02698969|Sugammadex|sugammadex
239913|NCT02698969|Post-operative residual curarization|post-operative residual curarization
239914|NCT02698969|Diaphragm Ultrasonography|diaphragm ultrasonography
239915|NCT02698956|SAPIEN 3 THV|sapien 3 thv
239916|NCT02698956|TAVI|tavi
239917|NCT02698956|Transfemoral|transfemoral
239918|NCT02698956|Transaortic|transaortic
239919|NCT02698956|Transapical|transapical
239920|NCT02698956|Aortic valve|aortic valve
239921|NCT02698943|cataract; intraocular lens; posterior capsule opacification; glistening; ENVISTA|cataract; intraocular lens; posterior capsule opacification; glistening; envista
239922|NCT02698930|Infective endocarditis|infective endocarditis
239923|NCT02698930|acute kidney injury|acute kidney injury
239924|NCT02698930|dexmedetomidine|dexmedetomidine
239925|NCT02698917|Out-of-Hospital Cardiac Arrest|out-of-hospital cardiac arrest
239926|NCT02698917|Resuscitation|resuscitation
239927|NCT02698917|Hypoxia-Ischemia, Brain|hypoxia-ischemia, brain
239928|NCT02698904|Chronic Obstructive Pulmonary Disease (COPD)|chronic obstructive pulmonary disease (copd)
239929|NCT02698904|Relaxation Technique|relaxation technique
239930|NCT02698904|Anxiety|anxiety
239931|NCT02698891|Early Stage Breast Cancer|early stage breast cancer
239932|NCT02698878|Lupin Protein|lupin protein
239933|NCT02698878|Glucose Metabolism|glucose metabolism
239935|NCT02698878|Muscle Unloading|muscle unloading
239936|NCT02698878|Neuromuscular Electrical Stimulation|neuromuscular electrical stimulation
239937|NCT02698852|Drug eluting stents|drug eluting stents
239938|NCT02698852|Interventional Cardiology|interventional cardiology
239939|NCT02698839|Drug eluting stents|drug eluting stents
239940|NCT02698839|Interventional Cardiology|interventional cardiology
239941|NCT02698826|Cardiac Arrest, Hyperoxia, Ischemia-reperfusion Injury, Reactive Oxygen Species, Oxidative Stress, Neuropsychological Tests|cardiac arrest, hyperoxia, ischemia-reperfusion injury, reactive oxygen species, oxidative stress, neuropsychological tests
239942|NCT02698761|Vaso-Occlusive Crises|vaso-occlusive crises
239943|NCT02698761|Sickle Cell Disease|sickle cell disease
239944|NCT02698761|Decreasing Length of Stay|decreasing length of stay
239945|NCT02698761|Comprehensive Care Plan|comprehensive care plan
239946|NCT02698748|Chloroquine|chloroquine
239947|NCT02698748|Malaria Elimination|malaria elimination
239948|NCT02698748|P.falciparum|p.falciparum
239949|NCT02698748|Clinical Trial|clinical trial
239950|NCT02698748|Mozambique|mozambique
239951|NCT02698748|Adults|adults
239952|NCT02698709|Keratoconus|keratoconus
239953|NCT02698709|Corneal Topography|corneal topography
239954|NCT02698709|Diagnosis|diagnosis
239955|NCT02698709|Keratomileusis, Laser In Situ|keratomileusis, laser in situ
239956|NCT02698696|Cognitive Remediation|cognitive remediation
239957|NCT02698696|Mood disorders|mood disorders
239958|NCT02698696|Neuropsychology|neuropsychology
239959|NCT02698683|Nutrition|nutrition
239960|NCT02698683|Lymphocyte Count|lymphocyte count
239961|NCT02698683|Immunoparalysis|immunoparalysis
239962|NCT02698683|nutritional status of septic patients|nutritional status of septic patients
239963|NCT02698670|Cardiac Arrhythmias|cardiac arrhythmias
239964|NCT02698670|Cardiovascular Disease|cardiovascular disease
239965|NCT02698670|Radiofrequency Ablation|radiofrequency ablation
239966|NCT02698670|Cardiac Mapping|cardiac mapping
239967|NCT02698657|Rheumatoid arthritis (RA)|rheumatoid arthritis (ra)
239968|NCT02698657|Methotrexate|methotrexate
239969|NCT02698657|ASP5094|asp5094
239970|NCT02698631|Catheter Ablation|catheter ablation
239971|NCT02698631|Radiofrequency|radiofrequency
239972|NCT02698631|Fibrosis|fibrosis
239973|NCT02698631|Late-gadolinium enhanced MRI|late-gadolinium enhanced mri
239974|NCT02698618|Diabetes|diabetes
239975|NCT02698618|IMR|imr
239976|NCT02698618|Microcirculation|microcirculation
239977|NCT02698618|Ticagrelor|ticagrelor
239978|NCT02698618|CFR|cfr
239979|NCT02698618|FFR|ffr
239980|NCT02698618|Coronary microcirculation|coronary microcirculation
239981|NCT02698592|atrial flutter|atrial flutter
239982|NCT02698592|ablation|ablation
239983|NCT02698592|Thermocool SF catheter|thermocool sf catheter
239984|NCT02698579|Adrenoleukodystrophy|adrenoleukodystrophy
239985|NCT02698579|X-linked Adrenoleukodystrophy|x-linked adrenoleukodystrophy
239986|NCT02698579|Hematopoietic Stem Cells|hematopoietic stem cells
239987|NCT02698553|Major depressive disorder|major depressive disorder
239988|NCT02698553|Extended release Bupropion|extended release bupropion
239989|NCT02698527|lidocaine|lidocaine
239990|NCT02698501|Asthma|asthma
239991|NCT02698501|Airway hyperresponsiveness|airway hyperresponsiveness
239992|NCT02698501|TSLP|tslp
239993|NCT02698501|Mast cell|mast cell
239994|NCT02698501|Eosinophil|eosinophil
239995|NCT02698475|Psoriasis|psoriasis
239996|NCT02698475|Ustekinumab|ustekinumab
239997|NCT02698475|STELARA|stelara
239998|NCT02698462|Advanced neoplasia|advanced neoplasia
239999|NCT02698462|Colorectal cancer|colorectal cancer
240000|NCT02698462|Population screening|population screening
240001|NCT02698462|Family history|family history
240002|NCT02698436|Acne|acne
240003|NCT02698371|composite resins|composite resins
240004|NCT02698371|dental restoration|dental restoration
240005|NCT02698371|adhesives|adhesives
240006|NCT02698371|non-carious cervical lesions|non-carious cervical lesions
240007|NCT02698371|clinical effectiveness|clinical effectiveness
240008|NCT02698371|Adhese universal|adhese universal
240009|NCT02698371|Futurabond U|futurabond u
240010|NCT02698371|Futurabond DC|futurabond dc
240011|NCT02698371|self-etch|self-etch
240012|NCT02698371|multimode/universal|multimode/universal
240013|NCT02698371|clinical trial|clinical trial
240014|NCT02698358|Peripheral artery disease, Iliac artery, nitinol stent, restenosis|peripheral artery disease, iliac artery, nitinol stent, restenosis
240015|NCT02698345|Popliteal artery disease, drug-eluting balloon, angioplasty|popliteal artery disease, drug-eluting balloon, angioplasty
240016|NCT02698319|Triage|triage
240017|NCT02698319|Systematic Triage|systematic triage
240018|NCT02698280|Bevacizumab|bevacizumab
240019|NCT02698280|Nimustine|nimustine
240020|NCT02698280|Pathology, Molecular|pathology, molecular
240021|NCT02698241|Cardiac Resynchronization Therapy Defibrillator (CRT-D)|cardiac resynchronization therapy defibrillator (crt-d)
240022|NCT02698241|heart failure|heart failure
240023|NCT02698241|integrated diagnostics|integrated diagnostics
240024|NCT02698241|chronic medication management|chronic medication management
240025|NCT02698228|anesthesia|anesthesia
240026|NCT02698202|Tomosynthesis,sensitivity,specificity,screening,mammography|tomosynthesis,sensitivity,specificity,screening,mammography
240027|NCT02698176|OTX015|otx015
240028|NCT02698176|MK-8628|mk-8628
240029|NCT02698163|Root Canal Therapy|root canal therapy
240030|NCT02698150|Mitral regurgitation|mitral regurgitation
240031|NCT02698150|Mitraclip|mitraclip
240032|NCT02698150|Remote monitoring|remote monitoring
240033|NCT02698150|Wearables|wearables
240034|NCT02698111|nasopharyngeal carcinoma,donafeinib|nasopharyngeal carcinoma,donafeinib
240035|NCT02698098|Malaysia|malaysia
240036|NCT02698098|Asia|asia
240037|NCT02698098|Southeast Asia|southeast asia
240038|NCT02698098|Compulsory Drug Detention Centers|compulsory drug detention centers
240039|NCT02698098|Compulsory Centers for Drug Users|compulsory centers for drug users
240040|NCT02698098|Methadone|methadone
240041|NCT02698098|Drug Relapse|drug relapse
240042|NCT02698098|Drug and Narcotic Control|drug and narcotic control
240043|NCT02698098|Opiate Substitution Treatment|opiate substitution treatment
240044|NCT02698098|Prisons|prisons
240045|NCT02698085|carpal tunnel syndrome|carpal tunnel syndrome
240046|NCT02698085|physiotherapy|physiotherapy
240047|NCT02698085|manual therapy|manual therapy
240048|NCT02698072|Stiffness|stiffness
240049|NCT02698072|Pain|pain
240050|NCT02698072|Disfunction|disfunction
240051|NCT02698046|Heart failure|heart failure
240052|NCT02698046|Iron|iron
240053|NCT02698046|Anemia|anemia
240054|NCT02698046|Chronic disease|chronic disease
240055|NCT02698033|food allergy|food allergy
240056|NCT02698033|peanut|peanut
240057|NCT02698033|food challenge|food challenge
240058|NCT02698020|Newborn|newborn
240059|NCT02698020|Anesthesia|anesthesia
240060|NCT02698020|Oxygen|oxygen
240061|NCT02698020|Hyperoxia|hyperoxia
240062|NCT02697994|Sterile Water Injection|sterile water injection
240063|NCT02697994|Midwifery|midwifery
240064|NCT02697981|sleeve gastrectomy|sleeve gastrectomy
240065|NCT02697929|Rocuronium|rocuronium
240066|NCT02697916|aspirin|aspirin
240067|NCT02697916|ACSD|acsd
240068|NCT02697916|PCORI|pcori
240069|NCT02697903|Creatine kinase supplementation|creatine kinase supplementation
240070|NCT02697903|C-reactive protein|c-reactive protein
240071|NCT02697903|resistance training|resistance training
240072|NCT02697903|Pomegranate supplementation|pomegranate supplementation
240073|NCT02697903|pomegranate juice|pomegranate juice
240074|NCT02697903|muscle damage response|muscle damage response
240075|NCT02697786|Aortic valve surgery|aortic valve surgery
240076|NCT02697773|osteoarthritis of the knee|osteoarthritis of the knee
240077|NCT02697773|osteoarthritis of the hip|osteoarthritis of the hip
240078|NCT02697773|nerve growth factor inhibitor|nerve growth factor inhibitor
240079|NCT02697773|tanezumab|tanezumab
240080|NCT02697760|cadmium-zinc-telluride，CZT cameras|cadmium-zinc-telluride，czt cameras
240081|NCT02697760|myocardial blood flow，MBF|myocardial blood flow，mbf
240082|NCT02697760|myocardial flow reserve，MFR|myocardial flow reserve，mfr
240083|NCT02697747|Ultrasound|ultrasound
240084|NCT02697747|Palpation|palpation
240085|NCT02697747|Analgesia|analgesia
240086|NCT02697747|Epidural|epidural
240087|NCT02697734|Cushing's disease|cushing's disease
240088|NCT02697734|LCI699|lci699
240089|NCT02697734|osilodrostat|osilodrostat
240090|NCT02697734|Pituitary Gland|pituitary gland
240091|NCT02697734|Adrenocorticotropic|adrenocorticotropic
240092|NCT02697734|Hormone|hormone
240093|NCT02697734|ACTH|acth
240095|NCT02697721|Caregivers|caregivers
240096|NCT02697721|Behavioral symptoms|behavioral symptoms
240097|NCT02697721|Dementia|dementia
240098|NCT02697721|Alzheimer disease|alzheimer disease
240099|NCT02697721|Physical activity|physical activity
306994|NCT02306668|Dry eye|dry eye
240100|NCT02697721|Depressive symptoms|depressive symptoms
240101|NCT02697721|Powerful Tools for Caregivers|powerful tools for caregivers
240102|NCT02697721|Chronic Disease Self-Management Program|chronic disease self-management program
240103|NCT02697695|chronic inflammation|chronic inflammation
240104|NCT02697695|fatty liver index|fatty liver index
240105|NCT02697669|Heart failure|heart failure
240106|NCT02697669|myocardial perfusion|myocardial perfusion
240107|NCT02697669|single-photon emission tomography|single-photon emission tomography
240108|NCT02697643|clinical decision support|clinical decision support
240109|NCT02697643|substance use|substance use
240110|NCT02697643|opioid|opioid
240111|NCT02697630|Uveal melanoma|uveal melanoma
240112|NCT02697591|Solid tumor|solid tumor
240113|NCT02697591|adenocarcinoma of the endometrium|adenocarcinoma of the endometrium
240114|NCT02697591|melanoma, non-small cell lung cancer (NSCLC)|melanoma, non-small cell lung cancer (nsclc)
240115|NCT02697591|renal cell carcinoma (RCC)|renal cell carcinoma (rcc)
240116|NCT02697591|glucocorticoid-induced tumor necrosis factor receptor (GITR)|glucocorticoid-induced tumor necrosis factor receptor (gitr)
240117|NCT02697565|childhood obesity|childhood obesity
240118|NCT02697565|obesity|obesity
240119|NCT02697565|prevention|prevention
240120|NCT02697565|nutrition|nutrition
240121|NCT02697565|health|health
240122|NCT02697565|preschool|preschool
240123|NCT02697565|childcare|childcare
240124|NCT02697565|role model|role model
240125|NCT02697565|pediatric obesity|pediatric obesity
240126|NCT02697565|weight|weight
240127|NCT02697565|overweight|overweight
240128|NCT02697565|early childhood|early childhood
240129|NCT02697565|train the trainer|train the trainer
240130|NCT02697526|radial artery|radial artery
240131|NCT02697526|occlusion|occlusion
240132|NCT02697526|functional|functional
240133|NCT02697526|complications|complications
240134|NCT02697526|consequences|consequences
240135|NCT02697487|Depression|depression
240136|NCT02697487|Cohort|cohort
240137|NCT02697474|Hepatitis B|hepatitis b
240138|NCT02697474|DTaP-IPV-Hep B-PRP-T Hexavalent Vaccine|dtap-ipv-hep b-prp-t hexavalent vaccine
240139|NCT02697474|Euvax-B®|euvax-b®
240140|NCT02697474|Hexaxim®|hexaxim®
240141|NCT02697474|Infanrix® hexa|infanrix® hexa
240142|NCT02697435|Chronic Low Back Pain|chronic low back pain
240143|NCT02697435|Aged|aged
240144|NCT02697435|Elderly|elderly
240145|NCT02697435|Primary Care|primary care
240146|NCT02697435|Assessment|assessment
240147|NCT02697435|Lumbar|lumbar
240148|NCT02697435|Spinal Stenosis|spinal stenosis
240149|NCT02697435|Hip Osteoarthritis|hip osteoarthritis
240150|NCT02697435|Myofascial Pain Syndrome|myofascial pain syndrome
240151|NCT02697435|Fibromyalgia|fibromyalgia
240152|NCT02697435|Depression|depression
240153|NCT02697435|Maladaptive Coping|maladaptive coping
240154|NCT02697435|Lumbar Spinal Stenosis|lumbar spinal stenosis
240155|NCT02697435|Insomnia|insomnia
240156|NCT02697435|Sacroiliac Joint Pain|sacroiliac joint pain
240157|NCT02697435|Lateral Hip and Thigh Pain|lateral hip and thigh pain
240158|NCT02697435|Anxiety|anxiety
240159|NCT02697435|Dementia|dementia
240160|NCT02697435|Recent Leg Length Discrepancy|recent leg length discrepancy
240161|NCT02697422|Smoking (tobacco use)|smoking (tobacco use)
240162|NCT02697422|Peer health coach|peer health coach
240163|NCT02697422|Systolic blood pressure|systolic blood pressure
240164|NCT02697422|Framingham Cardiovascular risk score|framingham cardiovascular risk score
240165|NCT02697422|Lipid|lipid
240166|NCT02697422|Health related quality of life|health related quality of life
240167|NCT02697422|Health care utilization|health care utilization
240168|NCT02697422|Medication adherence|medication adherence
240169|NCT02697422|Physical activity|physical activity
240170|NCT02697422|Nutrition|nutrition
240171|NCT02697422|Alcohol use|alcohol use
240172|NCT02697422|Stress management|stress management
240173|NCT02697396|Social Marketing Campaign|social marketing campaign
240174|NCT02697396|Mexican American Children|mexican american children
240175|NCT02697396|16-069|16-069
240176|NCT02697383|Ixazomib (MLN9708)|ixazomib (mln9708)
240177|NCT02697383|Dexamethasone|dexamethasone
240178|NCT02697383|15-294|15-294
240179|NCT02697370|Haemophilia A prophylaxis pharmacokinetic dosing|haemophilia a prophylaxis pharmacokinetic dosing
240180|NCT02697357|Emotion Regulation Therapy|emotion regulation therapy
240181|NCT02697357|Distress Among Caregivers|distress among caregivers
240182|NCT02697357|15-219|15-219
240183|NCT02697331|Short cervix, twins, progesterone|short cervix, twins, progesterone
240184|NCT02697305|Insulin response|insulin response
240185|NCT02697305|Incretin effect|incretin effect
240186|NCT02697305|GLP-1|glp-1
240187|NCT02697305|GIP|gip
240188|NCT02697305|Valine|valine
240189|NCT02697305|Leucine|leucine
240190|NCT02697305|Isoleucine|isoleucine
240191|NCT02697305|Branched chain amino acids|branched chain amino acids
240192|NCT02697292|Intravenous Immunoglobulin|intravenous immunoglobulin
240193|NCT02697292|VGKC|vgkc
240194|NCT02697292|Autoimmune epilepsy|autoimmune epilepsy
240195|NCT02697292|Gamumex-C|gamumex-c
240196|NCT02697279|Abscess|abscess
240197|NCT02697279|Loop|loop
240198|NCT02697279|Drainage|drainage
240199|NCT02697253|Roux-en-Y Bariatric Surgery|roux-en-y bariatric surgery
240200|NCT02697253|Psychosocial Variables|psychosocial variables
240201|NCT02697253|Behavioral Variables|behavioral variables
240202|NCT02697253|Weight Loss|weight loss
240203|NCT02697253|Food Intake|food intake
240204|NCT02697253|GLP-1|glp-1
240205|NCT02697253|Reinforcing Value of Food|reinforcing value of food
240206|NCT02697253|Exendin 9-39|exendin 9-39
240207|NCT02697240|sickle cell disease|sickle cell disease
240208|NCT02697240|citrulline|citrulline
240209|NCT02697214|commercial heart rate monitors|commercial heart rate monitors
240210|NCT02697214|accuracy|accuracy
240211|NCT02697214|ECG|ecg
240212|NCT02697214|varying degrees of exertion|varying degrees of exertion
240213|NCT02697201|Mitochondrial Dynamics|mitochondrial dynamics
240214|NCT02697201|Insulin Resistance|insulin resistance
240215|NCT02697188|testosterone|testosterone
240216|NCT02697188|male hypogonadism|male hypogonadism
240217|NCT02697188|low testosterone|low testosterone
240218|NCT02697175|live video-colposcopy|live video-colposcopy
240219|NCT02697175|cervical dysplasia|cervical dysplasia
240220|NCT02697175|anxiety|anxiety
240221|NCT02697175|randomized controlled trial|randomized controlled trial
240222|NCT02697175|colposcopy|colposcopy
240223|NCT02697162|Intermittent catheterisation|intermittent catheterisation
240224|NCT02697162|Antiseptic|antiseptic
240225|NCT02697162|Octenidine chloride|octenidine chloride
240226|NCT02697162|Children|children
240227|NCT02697149|ERCP|ercp
240228|NCT02697149|nonradiation-to-endoscopist|nonradiation-to-endoscopist
240229|NCT02697149|gallstones|gallstones
240230|NCT02697136|Low HDL|low hdl
240232|NCT02697136|ABCA-1 mutations|abca-1 mutations
240233|NCT02697136|ApoA-I mutations|apoa-i mutations
240234|NCT02697123|Venous Thrombosis|venous thrombosis
240235|NCT02697123|Pregnancy|pregnancy
240236|NCT02697123|postpartum|postpartum
240237|NCT02697123|antepartum|antepartum
240238|NCT02697110|Cognition|cognition
240239|NCT02697110|Brain Stimulation|brain stimulation
240240|NCT02697110|Early Child Development|early child development
240241|NCT02697097|Hip Muscle Strength|hip muscle strength
240242|NCT02697097|FAI|fai
240243|NCT02697071|Ketamine|ketamine
240244|NCT02697071|Migraine|migraine
240245|NCT02697071|Headache|headache
240246|NCT02697071|Emergency Department|emergency department
240247|NCT02697045|Schizophrenia|schizophrenia
240248|NCT02697045|Quality of Life|quality of life
240249|NCT02697045|Functionality|functionality
240250|NCT02697045|Long Acting Injectable|long acting injectable
240251|NCT02697045|Aripiprazole|aripiprazole
240252|NCT02697045|Naturalistic|naturalistic
240253|NCT02697045|Open-label|open-label
240254|NCT02697045|Single Arm|single arm
240255|NCT02697045|Uncontrolled Study|uncontrolled study
240256|NCT02697032|FDHT|fdht
240257|NCT02697032|PET|pet
240258|NCT02697032|Breast cancer|breast cancer
240259|NCT02697032|Bicalutamide|bicalutamide
240260|NCT02697019|Nonsuicidal Self-Injury (NSSI), Deliberate Self-Harm (DSH), Self-harm, Self-injury|nonsuicidal self-injury (nssi), deliberate self-harm (dsh), self-harm, self-injury
240261|NCT02696980|obesity|obesity
240262|NCT02696980|asthma|asthma
240263|NCT02696967|Apelin|apelin
240264|NCT02696967|CLR325|clr325
240265|NCT02696967|Chronic heart failure|chronic heart failure
240266|NCT02696954|Artemether-lumefantrine|artemether-lumefantrine
240267|NCT02696954|Amodiaquine|amodiaquine
240268|NCT02696954|Primaquine|primaquine
240269|NCT02696902|Pseudomonas aeruginosa, Pneumonia|pseudomonas aeruginosa, pneumonia
240270|NCT02696889|Infertility|infertility
240271|NCT02696889|Premature Ovarian Failure|premature ovarian failure
240272|NCT02696889|Stem Cells|stem cells
240273|NCT02696889|Amenorrhea|amenorrhea
240274|NCT02696889|Low Ovarian Reserve|low ovarian reserve
240275|NCT02696889|Ovarian Insufficiency|ovarian insufficiency
240276|NCT02696889|Premature menopause|premature menopause
240277|NCT02696889|Premature Ovarian Insufficiency|premature ovarian insufficiency
240278|NCT02696876|Cartilage|cartilage
240279|NCT02696876|Mesenchymal stromal cell|mesenchymal stromal cell
240280|NCT02696876|Microfracture|microfracture
240281|NCT02696876|Knee|knee
240282|NCT02696876|Defect|defect
240283|NCT02696876|Injury|injury
240284|NCT02696876|Stem cell|stem cell
240285|NCT02696876|Autologous|autologous
240286|NCT02696876|Minimally manipulated|minimally manipulated
240287|NCT02696850|sinusitis|sinusitis
240288|NCT02696850|rhinosinusitis|rhinosinusitis
240289|NCT02696850|rhinitis|rhinitis
240290|NCT02696850|nasal lavage|nasal lavage
240291|NCT02696811|cancer|cancer
240292|NCT02696811|inflammation|inflammation
240293|NCT02696811|dietary intervention trial|dietary intervention trial
240294|NCT02696798|Ankylosing Spondylitis|ankylosing spondylitis
240295|NCT02696785|Ankylosing Spondylitis|ankylosing spondylitis
240296|NCT02696759|Breast|breast
240297|NCT02696759|Cancer|cancer
240298|NCT02696733|TURBT|turbt
240299|NCT02696733|ultrasound guided|ultrasound guided
240300|NCT02696733|ONB|onb
240301|NCT02696733|interadductor approach|interadductor approach
240302|NCT02696720|lidocaine|lidocaine
240303|NCT02696720|phantom limb pain (PLP)|phantom limb pain (plp)
240304|NCT02696720|Primary/secondary scar hyperalgesia|primary/secondary scar hyperalgesia
240305|NCT02696707|cardiac toxicities|cardiac toxicities
240306|NCT02696668|multisensory exercises|multisensory exercises
240307|NCT02696668|group-based balance exercise programme|group-based balance exercise programme
240308|NCT02696655|transplantation|transplantation
240309|NCT02696642|mesothelin-expressing advanced solid cancers|mesothelin-expressing advanced solid cancers
240310|NCT02696629|Ventilatory control|ventilatory control
240311|NCT02696629|Obstructive sleep apnea|obstructive sleep apnea
240312|NCT02696629|Loop gain|loop gain
240313|NCT02696629|Upper airway|upper airway
240314|NCT02696629|Surgery|surgery
240315|NCT02696603|Health app research|health app research
240316|NCT02696603|mHealth research|mhealth research
240317|NCT02696603|Mobile health research|mobile health research
240318|NCT02696603|Mobile application health research|mobile application health research
240319|NCT02696564|COPD|copd
240320|NCT02696564|emphysema|emphysema
240321|NCT02696564|HRCT|hrct
240322|NCT02696564|losartan|losartan
240323|NCT02696551|Medical education|medical education
240324|NCT02696551|Spondyloarthritis|spondyloarthritis
240325|NCT02696551|Physician action|physician action
240326|NCT02696538|Fall risk|fall risk
240327|NCT02696538|Rehabiliation|rehabiliation
240328|NCT02696538|Physical Therapy|physical therapy
240329|NCT02696538|Functional Gait Assessment|functional gait assessment
240330|NCT02696538|mini-Balance Evaluation Systems Test|mini-balance evaluation systems test
240331|NCT02696538|Berg Balance Scale|berg balance scale
240332|NCT02696538|Psychometric properties|psychometric properties
240333|NCT02696538|Validity|validity
240334|NCT02696538|Inter-rater reliability|inter-rater reliability
240335|NCT02696538|Montreal Cognitive Assessment|montreal cognitive assessment
240336|NCT02696525|Circulating Tumor DNA|circulating tumor dna
240337|NCT02696525|Lung cancer|lung cancer
240338|NCT02696525|lead time|lead time
240339|NCT02696512|Severe Disorders of Consciousness (SDOC)|severe disorders of consciousness (sdoc)
240340|NCT02696512|Coma|coma
240341|NCT02696512|Vegetative State|vegetative state
240342|NCT02696512|Minimally Conscious State|minimally conscious state
240343|NCT02696499|Uremic pruritus|uremic pruritus
240344|NCT02696499|Pruritus|pruritus
240345|NCT02696499|Chronic itch|chronic itch
240346|NCT02696499|Itch|itch
240347|NCT02696499|Hemodialysis|hemodialysis
240348|NCT02696499|End-stage renal disease|end-stage renal disease
240349|NCT02696473|Bioavailability|bioavailability
240350|NCT02696473|Polyacetylenes|polyacetylenes
240351|NCT02696473|Falcarinol|falcarinol
240352|NCT02696473|Falcarindiol|falcarindiol
240353|NCT02696473|Falcarindiol-3-acetate|falcarindiol-3-acetate
240354|NCT02696473|Carrot|carrot
240355|NCT02696473|Biological Availability|biological availability
240356|NCT02696460|debridement|debridement
240357|NCT02696460|analgesia|analgesia
240358|NCT02696447|Radiation therapy|radiation therapy
240359|NCT02696447|Thrombosis|thrombosis
240360|NCT02696434|naltrexone|naltrexone
240361|NCT02696434|VIVITROL|vivitrol
240362|NCT02696434|buprenorphine|buprenorphine
240363|NCT02696434|opioid|opioid
240364|NCT02696434|addiction|addiction
240365|NCT02696408|Mucositis|mucositis
240366|NCT02696408|Low level laser therapy|low level laser therapy
240367|NCT02696408|Autograft|autograft
240368|NCT02696408|Allograft|allograft
240369|NCT02696382|Veterans|veterans
240370|NCT02696382|Progressive High Intensity Physical Therapy|progressive high intensity physical therapy
240371|NCT02696382|Gait Speed|gait speed
240372|NCT02696382|Acute Hospitalization|acute hospitalization
240373|NCT02696382|Hospital Associated Deconditioning|hospital associated deconditioning
240374|NCT02696356|HLA-A*02|hla-a*02
240375|NCT02696343|somatosensory stimulation|somatosensory stimulation
240376|NCT02696343|orocutaneous|orocutaneous
240377|NCT02696343|gene expression|gene expression
240378|NCT02696291|Dengue|dengue
240379|NCT02696291|Arbovirus Infections|arbovirus infections
240380|NCT02696291|Flaviviridae Infections|flaviviridae infections
240381|NCT02696291|Flavivirus Infections|flavivirus infections
240382|NCT02696291|Hemorrhagic Fevers, Viral|hemorrhagic fevers, viral
240383|NCT02696291|RNA Virus Infections|rna virus infections
240384|NCT02696291|Virus Diseases|virus diseases
240385|NCT02696291|Pharmaceutical Solutions|pharmaceutical solutions
240386|NCT02696291|Pharmacologic Actions|pharmacologic actions
240387|NCT02696291|Therapeutic Uses|therapeutic uses
240388|NCT02696278|gut microbiota|gut microbiota
240389|NCT02696278|obesity|obesity
240390|NCT02696278|toddlers|toddlers
240391|NCT02696278|fiber|fiber
240392|NCT02696278|unsaturated fats|unsaturated fats
240393|NCT02696265|Atrial Fibrillation|atrial fibrillation
240394|NCT02696265|Complex Fractionated Atrial Electrocardiograms|complex fractionated atrial electrocardiograms
240395|NCT02696265|Pulmonary Vein Isolation|pulmonary vein isolation
240396|NCT02696265|Ablation|ablation
240397|NCT02696265|CFAE/spatiotemporal dispersion guided ablation|cfae/spatiotemporal dispersion guided ablation
240398|NCT02696252|Endocrine System Diseases|endocrine system diseases
240399|NCT02696252|Glucose Metabolism Disorders|glucose metabolism disorders
240400|NCT02696252|Metabolic Diseases|metabolic diseases
240401|NCT02696239|vaginal cuff closure|vaginal cuff closure
240402|NCT02696239|Robotic Hysterectomy|robotic hysterectomy
240403|NCT02696200|Concussion|concussion
240404|NCT02696187|Pulmonary Disease, Chronic Obstructive|pulmonary disease, chronic obstructive
240405|NCT02696187|Feasibility|feasibility
240406|NCT02696187|Health promotion tool|health promotion tool
240407|NCT02696187|Self management|self management
240408|NCT02696187|Evidence based care|evidence based care
240409|NCT02696187|Knowledge transfer|knowledge transfer
240410|NCT02696187|Implementation|implementation
240411|NCT02696161|platelet rich plasma|platelet rich plasma
240412|NCT02696161|Perineural injection therapy|perineural injection therapy
240413|NCT02696135|hypertrophic cardiomyopathy|hypertrophic cardiomyopathy
240414|NCT02696135|clinical outcomes|clinical outcomes
240415|NCT02696135|multi-omics|multi-omics
240416|NCT02696135|risk stratification|risk stratification
240417|NCT02696122|Pain, postoperative|pain, postoperative
240418|NCT02696122|Hernia, abdominal|hernia, abdominal
240419|NCT02696122|Anesthesia, spinal|anesthesia, spinal
240420|NCT02696122|Anesthesia, local|anesthesia, local
240421|NCT02696122|Anesthesia, general|anesthesia, general
240422|NCT02696122|Quality of life|quality of life
240423|NCT02696122|Anesthesia recovery period|anesthesia recovery period
240424|NCT02696122|Personal satisfaction|personal satisfaction
240425|NCT02696122|Postoperative complications|postoperative complications
240426|NCT02696122|Quality of recovery|quality of recovery
240427|NCT02696109|Transition age youth|transition age youth
240428|NCT02696109|Mental health|mental health
240429|NCT02696109|Mental health services|mental health services
240430|NCT02696109|Engagement|engagement
240432|NCT02696070|Diabetic Neuropathy|diabetic neuropathy
240433|NCT02696070|Pulsed Electromagnetic Energy Field|pulsed electromagnetic energy field
240434|NCT02696070|PEMF|pemf
240435|NCT02696070|PPDN|ppdn
240436|NCT02696044|Gastrointestinal Disorders|gastrointestinal disorders
240437|NCT02696031|non-radiographic spondyloarthritis|non-radiographic spondyloarthritis
240438|NCT02696031|axial spondyloarthritis|axial spondyloarthritis
240439|NCT02696031|Ankylosing Spondylitis|ankylosing spondylitis
240440|NCT02696018|Diaphragm|diaphragm
240441|NCT02696018|Ultrasound|ultrasound
240442|NCT02696018|Critically ill patients|critically ill patients
240443|NCT02695992|Rate control in atrial fibrillation|rate control in atrial fibrillation
240444|NCT02695992|Beta blockers|beta blockers
240445|NCT02695992|Calcium channel blockers|calcium channel blockers
240446|NCT02695992|Permanent atrial fibrillation|permanent atrial fibrillation
240447|NCT02695992|Management of atrial fibrillation|management of atrial fibrillation
240448|NCT02695992|Atrial fibrillation and biomarkers|atrial fibrillation and biomarkers
240449|NCT02695992|Arrhythmias, cardiac|arrhythmias, cardiac
240450|NCT02695992|Heart Diseases|heart diseases
240451|NCT02695992|Pathological processes|pathological processes
240452|NCT02695992|Diltiazem|diltiazem
240453|NCT02695992|Metoprolol|metoprolol
240454|NCT02695992|Adrenergic Agents|adrenergic agents
240455|NCT02695992|Adrenergic Antagonists|adrenergic antagonists
240456|NCT02695992|Adrenergic beta-1 Receptor Antagonists|adrenergic beta-1 receptor antagonists
240457|NCT02695992|Adrenergic beta-Antagonists|adrenergic beta-antagonists
240458|NCT02695992|Anti-Arrhythmia Agents|anti-arrhythmia agents
240459|NCT02695992|Antihypertensive Agents|antihypertensive agents
240460|NCT02695992|Autonomic Agents|autonomic agents
240461|NCT02695992|Cardiovascular Agents|cardiovascular agents
240462|NCT02695992|Membrane Transport Modulators|membrane transport modulators
240463|NCT02695992|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action
240464|NCT02695992|Neurotransmitter Agents|neurotransmitter agents
240465|NCT02695992|Peripheral Nervous System Agents|peripheral nervous system agents
240466|NCT02695992|Physiological Effects of Drugs|physiological effects of drugs
240467|NCT02695992|Sympatholytics|sympatholytics
240468|NCT02695992|Therapeutic Uses|therapeutic uses
240469|NCT02695992|Vasodilator Agents|vasodilator agents
240470|NCT02695992|Troponins|troponins
240471|NCT02695992|NT-proBNP|nt-probnp
240472|NCT02695992|Biomarkers|biomarkers
240473|NCT02695953|PTSD|ptsd
240474|NCT02695953|biomarker|biomarker
240475|NCT02695953|Cognitive Processing Therapy|cognitive processing therapy
240476|NCT02695914|Inflammatory markers|inflammatory markers
240477|NCT02695901|Plaque index|plaque index
240478|NCT02695901|Melaleuca alternifolia oil.|melaleuca alternifolia oil.
240479|NCT02695901|Nanoparticles|nanoparticles
240480|NCT02695875|Fibromyalgia|fibromyalgia
240481|NCT02695875|Pain|pain
240482|NCT02695875|Postural balance|postural balance
240483|NCT02695875|Physical therapy|physical therapy
240484|NCT02695875|Aquatic therapy|aquatic therapy
240485|NCT02695849|Non-small cell lung cancer (NSCLC)|non-small cell lung cancer (nsclc)
240486|NCT02695836|Audit and Feedback|audit and feedback
240487|NCT02695836|Nursing Homes|nursing homes
240488|NCT02695836|Organizational Context|organizational context
240489|NCT02695836|Quality Improvement|quality improvement
240490|NCT02695836|Care Aides|care aides
240491|NCT02695836|Leadership|leadership
240492|NCT02695836|Resident Assessment Instrument (RAI)|resident assessment instrument (rai)
240493|NCT02695836|Alberta Context Tool (ACT)|alberta context tool (act)
240494|NCT02695823|intracranial hypertension|intracranial hypertension
240495|NCT02695823|liver transplantation|liver transplantation
240496|NCT02695823|transcranial Doppler|transcranial doppler
240497|NCT02695823|optic nerve sheath diameter|optic nerve sheath diameter
240498|NCT02695797|Intractable cryptogenic epilepsy with autoimmune antibody|intractable cryptogenic epilepsy with autoimmune antibody
240499|NCT02695797|Immunotherapy|immunotherapy
240500|NCT02695771|bladder tumors|bladder tumors
240501|NCT02695771|urinary tumors|urinary tumors
240502|NCT02695771|non-muscle invasive bladder tumors|non-muscle invasive bladder tumors
240503|NCT02695771|NMIBC|nmibc
240504|NCT02695732|Esophageal and Gastric Varices|esophageal and gastric varices
240505|NCT02695732|Primary Prophylaxis|primary prophylaxis
240506|NCT02695732|Carvedilol|carvedilol
240507|NCT02695732|Endoscopy|endoscopy
240508|NCT02695719|Drug therapy|drug therapy
240509|NCT02695706|Diabetes|diabetes
240510|NCT02695706|Skin acceptability|skin acceptability
240511|NCT02695706|Clinical Research|clinical research
240512|NCT02695680|Lung Cancer|lung cancer
240513|NCT02695680|SBRT|sbrt
240514|NCT02695680|Motion Management|motion management
240515|NCT02695641|Arteriovenous Fistula|arteriovenous fistula
240516|NCT02695641|Arteriovenous Graft|arteriovenous graft
240517|NCT02695641|Bevacizumab|bevacizumab
240518|NCT02695641|Hemodialysis|hemodialysis
240519|NCT02695641|VEGF|vegf
240520|NCT02695641|Avastin|avastin
240521|NCT02695615|cesarean operation|cesarean operation
240522|NCT02695615|Spielberger State Trait Anxiety Inventory|spielberger state trait anxiety inventory
240523|NCT02695615|pain|pain
240524|NCT02695563|Amniocentesis|amniocentesis
240525|NCT02695524|Rehabilitation|rehabilitation
240526|NCT02695524|Shoulder|shoulder
240527|NCT02695498|migraine with aura|migraine with aura
240528|NCT02695498|migraine without aura|migraine without aura
240529|NCT02695498|pain|pain
240530|NCT02695498|controls|controls
240531|NCT02695498|mind-body|mind-body
240532|NCT02695485|dorsal digital island flap|dorsal digital island flap
240533|NCT02695485|sensory reconstruction|sensory reconstruction
240534|NCT02695472|Depression|depression
240535|NCT02695472|Major Depressive Disorder (MDD)|major depressive disorder (mdd)
240536|NCT02695472|Major Depressive Disorder|major depressive disorder
240537|NCT02695472|Neurogenesis|neurogenesis
240538|NCT02695472|Synaptogenesis|synaptogenesis
240539|NCT02695472|NSI-189|nsi-189
240540|NCT02695472|Neuralstem|neuralstem
240541|NCT02695433|Pre-diabetes|pre-diabetes
240542|NCT02695433|Metabolic syndrome|metabolic syndrome
240543|NCT02695433|Matsuda composite index of insulin sensitivity (MISI)|matsuda composite index of insulin sensitivity (misi)
240544|NCT02695433|Blood glucose|blood glucose
240545|NCT02695433|Insulin response|insulin response
240546|NCT02695433|HbA1c|hba1c
240547|NCT02695433|Lipid|lipid
240548|NCT02695433|Inflammation|inflammation
240549|NCT02695420|Heart Failure|heart failure
240550|NCT02695407|artery cannulation|artery cannulation
240551|NCT02695407|haemodynamic monitoring|haemodynamic monitoring
240552|NCT02695342|Balance|balance
240553|NCT02695342|Falls|falls
240554|NCT02695342|Exercise|exercise
240555|NCT02695342|COPD|copd
240556|NCT02695329|navigation system|navigation system
240557|NCT02695329|palm-sized|palm-sized
240558|NCT02695329|total knee arthroplasty|total knee arthroplasty
240559|NCT02695316|Migrants|migrants
240560|NCT02695316|Communication Barriers|communication barriers
240561|NCT02695316|Maternal Health Services|maternal health services
240562|NCT02695316|Health Services Needs and Demand|health services needs and demand
240563|NCT02695316|Access to Health Care|access to health care
240564|NCT02695316|Professional-Patient Relations|professional-patient relations
240565|NCT02695316|Eritrea|eritrea
240566|NCT02695316|Kosovo|kosovo
240567|NCT02695316|Switzerland|switzerland
240568|NCT02695277|Atrial Fibrillation|atrial fibrillation
240569|NCT02695277|Persistent and Longstanding Persistent AF|persistent and longstanding persistent af
240570|NCT02695277|Hybrid Procedure|hybrid procedure
240571|NCT02695277|Catheter Ablation|catheter ablation
240572|NCT02695264|intracranial pressure|intracranial pressure
240573|NCT02695264|intracranial hypertension|intracranial hypertension
240574|NCT02695264|severe traumatic brain injury|severe traumatic brain injury
240575|NCT02695199|Doppler Ultrasound|doppler ultrasound
240576|NCT02695199|Laparoscopic|laparoscopic
240577|NCT02695199|Microscopic Subinguinal Varicocelectomy|microscopic subinguinal varicocelectomy
240578|NCT02695186|Intestinal metaplasia|intestinal metaplasia
240579|NCT02695186|Metabolic syndrome|metabolic syndrome
240580|NCT02695186|Oxidative stress|oxidative stress
240581|NCT02695108|Scapula|scapula
240582|NCT02695108|Neck|neck
240583|NCT02695108|Pain|pain
240584|NCT02695108|Therapy|therapy
240585|NCT02695108|Kinematic|kinematic
240586|NCT02695069|Complete Placenta Previa|complete placenta previa
240587|NCT02695069|Random Placenta Margin Incision|random placenta margin incision
240588|NCT02695069|Cesarean Section|cesarean section
240589|NCT02695069|Hemorrhage|hemorrhage
240590|NCT02694991|surgery|surgery
240591|NCT02694991|outcome|outcome
240592|NCT02694991|pain|pain
240593|NCT02694991|osteopathic manipulative treatment|osteopathic manipulative treatment
240594|NCT02694978|iron deficiency anemia|iron deficiency anemia
240595|NCT02694978|IDA|ida
240596|NCT02694978|ferumoxytol|ferumoxytol
240597|NCT02694978|ferric carboxymaltose|ferric carboxymaltose
240598|NCT02694978|FCM|fcm
240599|NCT02694978|Injectafer|injectafer
240600|NCT02694978|Feraheme|feraheme
240601|NCT02694978|Ferinject|ferinject
240602|NCT02694926|adrenal crisis|adrenal crisis
240603|NCT02694926|education programme|education programme
240604|NCT02694887|Capillary blood|capillary blood
240605|NCT02694887|Venous blood|venous blood
240606|NCT02694887|Lactate|lactate
240607|NCT02694887|Emergency Department|emergency department
240608|NCT02694874|Adjunctive treatment|adjunctive treatment
240609|NCT02694874|Severe malaria|severe malaria
240610|NCT02694861|Angina Pectoris|angina pectoris
240611|NCT02694861|Angina, Stable|angina, stable
240612|NCT02694861|Chest Pain|chest pain
240613|NCT02694796|Web and smartphone-based physical activity program|web and smartphone-based physical activity program
240614|NCT02694796|Connected devices|connected devices
240615|NCT02694796|Balneotherapy|balneotherapy
240616|NCT02694783|JC VIRUS|jc virus
240617|NCT02694783|Progressive Multifocal Encephalopathy (PML)|progressive multifocal encephalopathy (pml)
240618|NCT02694770|aGvHD|agvhd
240619|NCT02694770|GvHD|gvhd
240620|NCT02694770|sr-aGvHD|sr-agvhd
240621|NCT02694770|biologics|biologics
240622|NCT02694770|monoclonal antibody|monoclonal antibody
240623|NCT02694757|Ostom-i|ostom-i
240624|NCT02694757|OIA device|oia device
240625|NCT02694744|Treatment of Hyperkalemia|treatment of hyperkalemia
240626|NCT02694744|Hyperkalemia|hyperkalemia
240627|NCT02694744|Potassium|potassium
240628|NCT02694744|Chronic Kidney Disease|chronic kidney disease
240629|NCT02694731|Craving|craving
240630|NCT02694731|Mobile Apps|mobile apps
240631|NCT02694705|Oxygen Inhalation Therapy|oxygen inhalation therapy
240632|NCT02694705|Intubation|intubation
240633|NCT02694705|Emergency Medicine|emergency medicine
240634|NCT02694679|social networks, maternal and child health, global health|social networks, maternal and child health, global health
240635|NCT02694653|C/section, Acetaminophen|c/section, acetaminophen
240636|NCT02694640|Breast cancer|breast cancer
240637|NCT02694640|Exercise|exercise
240638|NCT02694640|Physical activity|physical activity
240639|NCT02694640|Community volunteers|community volunteers
240640|NCT02694640|Peer mentors|peer mentors
240641|NCT02694640|Peer coaches|peer coaches
240642|NCT02694640|Social support|social support
240643|NCT02694640|Exercise maintenance|exercise maintenance
240644|NCT02694627|gender, caregiving, MNCH, violence, sexual and reproductive health, parenting|gender, caregiving, mnch, violence, sexual and reproductive health, parenting
240645|NCT02694614|weight loss|weight loss
240646|NCT02694614|individualised dietary coaching|individualised dietary coaching
240647|NCT02694614|smartphone-assisted dietary coaching|smartphone-assisted dietary coaching
240648|NCT02694614|health behavior change|health behavior change
240649|NCT02694601|Ketones|ketones
240650|NCT02694601|Glucose|glucose
240651|NCT02694601|Caffeine|caffeine
240652|NCT02694588|Vedolizumab|vedolizumab
240653|NCT02694588|Infliximab|infliximab
240654|NCT02694562|Metastatic Colorectal Carcinoma|metastatic colorectal carcinoma
240655|NCT02694549|Vascular Closure Devices|vascular closure devices
240656|NCT02694549|Catheterization Closure Devices|catheterization closure devices
240657|NCT02694549|Vascular Access Devices|vascular access devices
240658|NCT02694523|Psoriasis|psoriasis
240659|NCT02694523|Skin Diseases|skin diseases
240660|NCT02694523|Skin Diseases, Papulosquamous|skin diseases, papulosquamous
240661|NCT02694523|Adalimumab|adalimumab
240662|NCT02694523|Anti-Inflammatory Agents|anti-inflammatory agents
240663|NCT02694523|ABBV-066|abbv-066
240664|NCT02694523|BI 655066|bi 655066
240665|NCT02694523|Risankizumab|risankizumab
240666|NCT02694510|Preterm infants|preterm infants
240667|NCT02694510|Oxidative stress|oxidative stress
240668|NCT02694510|Parenteral nutrition|parenteral nutrition
240669|NCT02694497|transmission|transmission
240670|NCT02694497|women|women
240671|NCT02694497|genital|genital
240672|NCT02694497|anorectal|anorectal
240673|NCT02694484|Cytomegalovirus|cytomegalovirus
240674|NCT02694484|Stool sample|stool sample
240675|NCT02694484|Healthy Volunteers|healthy volunteers
240676|NCT02694484|Fecal microbiota transplant|fecal microbiota transplant
240677|NCT02694471|Ageing|ageing
240678|NCT02694471|Physical inactivity|physical inactivity
240679|NCT02694471|Functional decline|functional decline
240680|NCT02694471|Reconditioning|reconditioning
240681|NCT02694458|Vancomycin|vancomycin
240682|NCT02694458|Children|children
240683|NCT02694458|Infection|infection
240684|NCT02694458|Antibiotic|antibiotic
240685|NCT02694458|Methicillin-resistant Staphylococcus aureus (MRSA)|methicillin-resistant staphylococcus aureus (mrsa)
240686|NCT02694458|Population-based pharmacokinetic modeling|population-based pharmacokinetic modeling
240687|NCT02694458|Pharmacokinetics|pharmacokinetics
240688|NCT02694458|Pharmacodynamics|pharmacodynamics
240689|NCT02694458|Bayesian approach|bayesian approach
240690|NCT02694458|Therapeutic drug monitoring|therapeutic drug monitoring
240691|NCT02694432|high blood pressure, systolic, diastolic|high blood pressure, systolic, diastolic
240692|NCT02694432|complementary therapies, meditation|complementary therapies, meditation
240693|NCT02694419|endometrium|endometrium
240694|NCT02694406|Diagnosis|diagnosis
240695|NCT02694367|genetic basis|genetic basis
240696|NCT02694341|Management|management
240697|NCT02694328|Alkermes|alkermes
240698|NCT02694328|ALKS 3831|alks 3831
240699|NCT02694328|Samidorphan|samidorphan
240700|NCT02694328|Schizophrenia|schizophrenia
240701|NCT02694328|Olanzapine|olanzapine
240702|NCT02694328|Weight|weight
240703|NCT02694302|Stroke|stroke
240704|NCT02694250|cervical|cervical
240705|NCT02694250|fusion|fusion
240706|NCT02694250|radiculopathy|radiculopathy
240707|NCT02694250|DTRAX|dtrax
240708|NCT02694224|breast cancer|breast cancer
240709|NCT02694224|triple negative|triple negative
240710|NCT02694224|neoadjuvant|neoadjuvant
240711|NCT02694211|work related stress|work related stress
240712|NCT02694185|Medication Adherence|medication adherence
240713|NCT02694185|Randomized Controlled Trial|randomized controlled trial
240714|NCT02694185|Veterans|veterans
240715|NCT02694172|diabetes mellitus type 2|diabetes mellitus type 2
240716|NCT02694172|healthy subjects|healthy subjects
240717|NCT02694172|human microbiome|human microbiome
240718|NCT02694172|cereal bar|cereal bar
240719|NCT02694146|platelet-rich plasma (PRP)|platelet-rich plasma (prp)
240720|NCT02694146|hyaluronic acid (Hylan G-F 20).|hyaluronic acid (hylan g-f 20).
240721|NCT02694146|NSAIDs|nsaids
240722|NCT02694146|WOMAC|womac
240723|NCT02694133|telerehabilitation|telerehabilitation
240725|NCT02694133|speech therapy|speech therapy
240726|NCT02694133|rehabilitation device|rehabilitation device
240727|NCT02694133|visual action therapy|visual action therapy
240728|NCT02694133|naming drills|naming drills
240729|NCT02694094|cholesterol|cholesterol
240730|NCT02694094|seizure|seizure
240731|NCT02694094|epilepsy|epilepsy
240732|NCT02694094|ketogenic|ketogenic
240733|NCT02694094|diet|diet
240734|NCT02694081|reflux|reflux
240735|NCT02694081|residue|residue
240736|NCT02694081|Gastric stasis|gastric stasis
240737|NCT02694081|Emptying time|emptying time
240738|NCT02694068|Peritoneal Dialysis|peritoneal dialysis
240739|NCT02694068|Genetic|genetic
240740|NCT02694068|Peritoneal Membrane|peritoneal membrane
240741|NCT02694068|Peritoneal Equilibrium Test|peritoneal equilibrium test
240742|NCT02694068|Ultrafiltration Capacity|ultrafiltration capacity
240743|NCT02694068|End Stage Renal Disease (ESRD)|end stage renal disease (esrd)
240744|NCT02694055|Community Health Workers|community health workers
240745|NCT02694055|Community Case Management|community case management
240746|NCT02694055|Proactive Case Detection|proactive case detection
240747|NCT02694055|Under-five Child Mortality|under-five child mortality
240748|NCT02694055|Access to Health Care|access to health care
240749|NCT02694042|Pediatric inflammatory bowel disease|pediatric inflammatory bowel disease
240750|NCT02694042|Crohn's disease|crohn's disease
240751|NCT02694042|Ulcerative colitis|ulcerative colitis
240752|NCT02694042|Web-based teaching and support|web-based teaching and support
240753|NCT02694042|disease self-management|disease self-management
240754|NCT02694042|peer support|peer support
240755|NCT02694016|Remote ischemic preconditioning|remote ischemic preconditioning
240756|NCT02694016|Neuroprotection|neuroprotection
240757|NCT02694003|Autism Spectrum Disorder (ASD)|autism spectrum disorder (asd)
240758|NCT02694003|Fetal Alcohol Spectrum Disorder (FASD)|fetal alcohol spectrum disorder (fasd)
240759|NCT02694003|Cerebral Palsy (CP)|cerebral palsy (cp)
240760|NCT02694003|Attention-Deficit/Hyperactivity Disorder (ADHD)|attention-deficit/hyperactivity disorder (adhd)
240761|NCT02694003|Behavioural Insomnia|behavioural insomnia
240762|NCT02694003|Neurodevelopmental Disorders|neurodevelopmental disorders
240763|NCT02693990|Tumor lining the brain|tumor lining the brain
240764|NCT02693990|Meningioma|meningioma
240765|NCT02693990|Brain Tumor|brain tumor
240766|NCT02693977|OSA|osa
240767|NCT02693977|sleep apnea|sleep apnea
240768|NCT02693977|AT|at
240769|NCT02693977|adenotonsillectomy|adenotonsillectomy
240770|NCT02693977|pediatric|pediatric
240771|NCT02693964|Type 1 Diabetes|type 1 diabetes
240772|NCT02693964|Menopause|menopause
240773|NCT02693964|Cardiovascular Risk|cardiovascular risk
240774|NCT02693964|Bone Density|bone density
240775|NCT02693951|gastric varices|gastric varices
240776|NCT02693951|endoscopic injection of tissue adhesive|endoscopic injection of tissue adhesive
240777|NCT02693938|diabetes|diabetes
240778|NCT02693938|menstrual cycle|menstrual cycle
240779|NCT02693938|insulin|insulin
240780|NCT02693912|efferocytosis|efferocytosis
240781|NCT02693912|macrophage|macrophage
240782|NCT02693873|Osteoarthritis, Hip|osteoarthritis, hip
240783|NCT02693873|Osteoarthritis, Knee|osteoarthritis, knee
240784|NCT02693873|Patient Education|patient education
240785|NCT02693873|Exercise, Neuromuscular|exercise, neuromuscular
240786|NCT02693873|Disease Management|disease management
240787|NCT02693873|Evidence-Based Health Care|evidence-based health care
240788|NCT02693873|Pilot Study|pilot study
240789|NCT02693847|HCV|hcv
240790|NCT02693847|HIV|hiv
240791|NCT02693847|Liver cirrhosis|liver cirrhosis
240792|NCT02693847|Hepatocellular carcinoma|hepatocellular carcinoma
240793|NCT02693847|Liver transplant|liver transplant
240794|NCT02693847|Liver stiffness|liver stiffness
240795|NCT02693847|Transient elastography|transient elastography
240796|NCT02693834|foot drop|foot drop
240797|NCT02693834|Subacute stroke|subacute stroke
240798|NCT02693834|AFO|afo
240799|NCT02693834|gait symmetry|gait symmetry
240800|NCT02693834|Gait endurance|gait endurance
240801|NCT02693821|Gabapentin|gabapentin
240802|NCT02693821|prevention|prevention
240803|NCT02693821|incidence|incidence
240804|NCT02693808|Temporal hollowing|temporal hollowing
240805|NCT02693808|Lateral orbital wall decompression|lateral orbital wall decompression
240806|NCT02693808|Thyroid eye disease|thyroid eye disease
240807|NCT02693795|myocardial infarction|myocardial infarction
240808|NCT02693795|left ventricular remodeling|left ventricular remodeling
240809|NCT02693782|Fibre|fibre
240810|NCT02693782|Wheat Bran Extract|wheat bran extract
240811|NCT02693782|Microbiota|microbiota
240812|NCT02693782|Microbiota metabolites|microbiota metabolites
240813|NCT02693782|Gastrointestinal tolerance|gastrointestinal tolerance
240814|NCT02693743|suicidality|suicidality
240815|NCT02693743|rTMS|rtms
240816|NCT02693743|suicide ideation|suicide ideation
240817|NCT02693730|Irritable Bowel Syndrome|irritable bowel syndrome
240819|NCT02693730|Ulcerative Colitis|ulcerative colitis
240820|NCT02693730|UC|uc
240821|NCT02693730|Inflammatory Bowel Disease|inflammatory bowel disease
240822|NCT02693730|IBD|ibd
240823|NCT02693730|Healthy Control|healthy control
240824|NCT02693730|HC|hc
240825|NCT02693730|Visceral Pain|visceral pain
240827|NCT02693730|Neuroimaging|neuroimaging
240828|NCT02693730|fMRI|fmri
240829|NCT02693730|resting state|resting state
240830|NCT02693730|structural MRI|structural mri
240831|NCT02693730|functional MRI|functional mri
240832|NCT02693730|diffusion tensor imaging|diffusion tensor imaging
240833|NCT02693730|MR Spectroscopy|mr spectroscopy
240834|NCT02693678|Proprioception|proprioception
240835|NCT02693678|Doms|doms
240836|NCT02693678|Pain|pain
240837|NCT02693678|Massage|massage
240838|NCT02693678|Diathermy|diathermy
240839|NCT02693665|pediatric advance care planning|pediatric advance care planning
240840|NCT02693665|adolescent|adolescent
240841|NCT02693665|family|family
240842|NCT02693665|palliative care|palliative care
240843|NCT02693665|end of life|end of life
240844|NCT02693665|communication|communication
240845|NCT02693665|decision making|decision making
240846|NCT02693665|surrogate decision maker|surrogate decision maker
240847|NCT02693665|health care proxy|health care proxy
240848|NCT02693665|intervention|intervention
240849|NCT02693665|randomized clinical trial|randomized clinical trial
240850|NCT02693665|cancer|cancer
240851|NCT02693665|quality of life|quality of life
240852|NCT02693665|spiritual|spiritual
240853|NCT02693665|religion|religion
240854|NCT02693665|treatment congruence|treatment congruence
240855|NCT02693665|treatment preferences|treatment preferences
240856|NCT02693665|FAmily CEntered (FACE) Advance Care Planning|family centered (face) advance care planning
240857|NCT02693639|PANX1|panx1
240858|NCT02693639|Infection|infection
240859|NCT02693639|Liver transplantation|liver transplantation
240860|NCT02693626|mobile phone-based text message interventions|mobile phone-based text message interventions
240861|NCT02693626|'Happy Quit'|'happy quit'
240862|NCT02693626|smoking cessation|smoking cessation
240863|NCT02693613|Drug-drug interaction|drug-drug interaction
240864|NCT02693613|Kremezin|kremezin
240865|NCT02693613|Pharmacokinetics|pharmacokinetics
240866|NCT02693613|ASP1517|asp1517
240867|NCT02693600|Total Trapeziectomy|total trapeziectomy
240868|NCT02693600|Partial Trapeziectomy|partial trapeziectomy
240869|NCT02693600|Ligamentoplasty|ligamentoplasty
240870|NCT02693574|Helicobacter pylori|helicobacter pylori
240871|NCT02693574|Helicobacter Infections|helicobacter infections
240872|NCT02693574|Proton Pump Inhibitors|proton pump inhibitors
240873|NCT02693561|Self-help book|self-help book
240874|NCT02693561|Deep breathing|deep breathing
240875|NCT02693548|Familial Hypercholesterolaemia|familial hypercholesterolaemia
240876|NCT02693548|Prognosis|prognosis
240877|NCT02693548|Cardiovascular disease|cardiovascular disease
240878|NCT02693535|cancer|cancer
240879|NCT02693535|off-label|off-label
240880|NCT02693535|precision medicine|precision medicine
240881|NCT02693535|targeted therapy|targeted therapy
240882|NCT02693496|ResearchKit|researchkit
240883|NCT02693496|CT screening|ct screening
240884|NCT02693496|Early Diagnosis|early diagnosis
240885|NCT02693496|Lung Cancer|lung cancer
240886|NCT02693392|Fenugreek seed extract|fenugreek seed extract
240887|NCT02693392|HbA1c|hba1c
240888|NCT02693392|Blood glucose|blood glucose
240889|NCT02693379|cervical cancer|cervical cancer
240890|NCT02693379|HPV|hpv
240891|NCT02693379|VIA|via
240892|NCT02693379|screening|screening
240893|NCT02693379|smartphone|smartphone
240894|NCT02693379|telemedicine|telemedicine
240895|NCT02693366|bone marrow cells, stem cells, cell therapy|bone marrow cells, stem cells, cell therapy
240896|NCT02693366|Glomerulosclerosis, Focal Segmental|glomerulosclerosis, focal segmental
240897|NCT02693366|Renal Insufficiency, Chronic|renal insufficiency, chronic
240898|NCT02693327|Gut Microbiome|gut microbiome
240899|NCT02693327|Mental Disorder|mental disorder
240900|NCT02693327|Dysbiosis|dysbiosis
240901|NCT02693314|Jarro-Dophilus|jarro-dophilus
240902|NCT02693314|probiotic|probiotic
240903|NCT02693314|microbiota|microbiota
240904|NCT02693314|gastrointestinal|gastrointestinal
240905|NCT02693301|Asthma|asthma
240906|NCT02693301|Respiratory symptoms|respiratory symptoms
240907|NCT02693301|Exercise program|exercise program
240908|NCT02693301|Functional capacity|functional capacity
240909|NCT02693301|Body composition|body composition
240910|NCT02693288|Wrist fracture|wrist fracture
240911|NCT02693288|postoperative pain|postoperative pain
240912|NCT02693288|local anesthesia|local anesthesia
240913|NCT02693275|Community Sampling|community sampling
240914|NCT02693262|defibrillator|defibrillator
240915|NCT02693262|heart failure|heart failure
240916|NCT02693262|ICD|icd
240917|NCT02693262|CRT-D|crt-d
240918|NCT02693262|cardiac resynchronization therapy|cardiac resynchronization therapy
240919|NCT02693262|rate response|rate response
240920|NCT02693262|CLS|cls
240921|NCT02693262|closed-loop stimulation|closed-loop stimulation
240922|NCT02693262|accelerometer|accelerometer
240923|NCT02693262|chronotropic incompetence|chronotropic incompetence
240924|NCT02693249|accidents|accidents
240925|NCT02693249|adolescents|adolescents
240926|NCT02693249|children|children
240927|NCT02693249|posttraumatic cognitions|posttraumatic cognitions
240928|NCT02693223|stroke|stroke
240929|NCT02693197|Hepatic Impairment|hepatic impairment
240930|NCT02693145|HIV/AIDS|hiv/aids
240931|NCT02693145|re-engagement in care|re-engagement in care
240932|NCT02693145|data to care|data to care
240933|NCT02693132|Obesity|obesity
240934|NCT02693132|Exercise|exercise
240935|NCT02693119|LHON|lhon
240936|NCT02693119|Ocuvia™|ocuvia™
240937|NCT02693119|elamipretide|elamipretide
240938|NCT02693119|MTP-131|mtp-131
240939|NCT02693041|Probiotics|probiotics
240940|NCT02693041|inflammation|inflammation
240941|NCT02693041|immunological response|immunological response
240942|NCT02693041|preterm birth|preterm birth
240943|NCT02693041|preeclampsia|preeclampsia
240944|NCT02693028|Microbiome|microbiome
240945|NCT02693028|probiotic|probiotic
240946|NCT02692976|Castration-resistant prostate cancer|castration-resistant prostate cancer
240947|NCT02692976|Dendritic Cells|dendritic cells
240948|NCT02692976|Immunotherapy|immunotherapy
240949|NCT02692976|Vaccines|vaccines
240950|NCT02692937|Neurosurgical Procedures|neurosurgical procedures
240951|NCT02692937|Nerve Block|nerve block
240952|NCT02692937|Exercise therapy|exercise therapy
240953|NCT02692937|Physical Therapy Specialty|physical therapy specialty
240954|NCT02692924|Pregnancy Complications|pregnancy complications
240955|NCT02692924|Ultrasound|ultrasound
240956|NCT02692911|Gallbaldder|gallbaldder
240957|NCT02692911|Cancer|cancer
240958|NCT02692911|Gallstones|gallstones
240959|NCT02692911|Cholecystectomy|cholecystectomy
240960|NCT02692911|Inflammation|inflammation
240961|NCT02692898|Brain Tumor|brain tumor
240962|NCT02692898|Molecular Pathology|molecular pathology
240963|NCT02692898|Clinical Data|clinical data
240964|NCT02692898|Imaging Data|imaging data
240965|NCT02692885|Phenotype|phenotype
240966|NCT02692885|Adipose Tissue|adipose tissue
240967|NCT02692885|Brown Adipose Tissue|brown adipose tissue
240968|NCT02692872|Alpha Thalassemia|alpha thalassemia
240969|NCT02692872|Double Deletion|double deletion
240970|NCT02692846|CONNECTIVE TISSUE DISEASES|connective tissue diseases
240971|NCT02692846|Cardiovascular Disease|cardiovascular disease
240972|NCT02692846|Elastin Gene Mutation|elastin gene mutation
240973|NCT02692846|Multisystem Developmental Disorder|multisystem developmental disorder
240974|NCT02692833|Telomere|telomere
240975|NCT02692833|Telomerase|telomerase
240976|NCT02692833|DNA methylation|dna methylation
240977|NCT02692833|Cell aging|cell aging
240978|NCT02692833|Thoracic Surgery|thoracic surgery
240979|NCT02692820|Preterm|preterm
240980|NCT02692820|Probiotic|probiotic
240981|NCT02692807|hip arthroscopy|hip arthroscopy
240982|NCT02692807|femoroacetabular impingement|femoroacetabular impingement
240983|NCT02692807|exercise therapy after hip arthroscopy|exercise therapy after hip arthroscopy
240984|NCT02692807|rehabilitation after hip arthroscopy|rehabilitation after hip arthroscopy
240985|NCT02692794|sinusitis|sinusitis
240986|NCT02692794|oximetry|oximetry
240987|NCT02692794|paranasal sinus diseases|paranasal sinus diseases
240988|NCT02692781|Obesity|obesity
240989|NCT02692768|total shoulder arthroplasty|total shoulder arthroplasty
240990|NCT02692768|total shoulder replacement|total shoulder replacement
240991|NCT02692768|adult|adult
240992|NCT02692768|reverse shoulder arthroplasty|reverse shoulder arthroplasty
240993|NCT02692755|African American|african american
240994|NCT02692742|Chemotherapy|chemotherapy
240995|NCT02692742|Chemotherapy-induced Neutropenia|chemotherapy-induced neutropenia
240996|NCT02692742|Supportive Care|supportive care
240997|NCT02692742|Myelosuppression|myelosuppression
240998|NCT02692742|CIN|cin
240999|NCT02692703|HCV Treatment Experienced|hcv treatment experienced
241000|NCT02692703|Hepatitis C|hepatitis c
241001|NCT02692703|HCV Genotype 3|hcv genotype 3
241002|NCT02692703|Without cirrhosis|without cirrhosis
241003|NCT02692703|Non-cirrhotic|non-cirrhotic
241004|NCT02692703|HCV Genotype 2|hcv genotype 2
241005|NCT02692703|Renal Transplant|renal transplant
241006|NCT02692703|HCV Treatment Naive|hcv treatment naive
241007|NCT02692703|Post transplant|post transplant
241008|NCT02692703|HCV Genotype 6|hcv genotype 6
241009|NCT02692703|Liver Transplant|liver transplant
241010|NCT02692703|HCV Genotype 5|hcv genotype 5
241011|NCT02692703|HCV Genotype 4|hcv genotype 4
241012|NCT02692703|Kidney Transplant|kidney transplant
241013|NCT02692703|HCV Genotype 1|hcv genotype 1
241014|NCT02692677|Healthy|healthy
241015|NCT02692677|JNJ-42756493|jnj-42756493
241016|NCT02692664|iliac side branch|iliac side branch
241017|NCT02692651|vancomycin|vancomycin
241018|NCT02692651|fidaxomicin|fidaxomicin
241019|NCT02692651|CDI|cdi
241020|NCT02692651|diarrhea|diarrhea
241021|NCT02692599|live attenuated mumps vaccine|live attenuated mumps vaccine
241022|NCT02692599|safety|safety
241023|NCT02692599|immunogenicity|immunogenicity
241024|NCT02692599|infant|infant
241025|NCT02692586|Thromboembolism|thromboembolism
241026|NCT02692586|Thrombectomy|thrombectomy
241027|NCT02692586|Right Heart Strain|right heart strain
241028|NCT02692586|Submassive PE|submassive pe
241029|NCT02692586|Right Ventricle Dysfunction|right ventricle dysfunction
241030|NCT02692586|Massive PE|massive pe
241031|NCT02692560|Sedentary time|sedentary time
241032|NCT02692560|Sit-to-stand transitions|sit-to-stand transitions
241033|NCT02692534|Anesthesia|anesthesia
241034|NCT02692534|Cocaine Use|cocaine use
241035|NCT02692508|cardiovascular MRI|cardiovascular mri
241036|NCT02692508|apical hypertrophic cardiomyopathy|apical hypertrophic cardiomyopathy
241037|NCT02692508|giant negative T-wave|giant negative t-wave
241038|NCT02692508|wall thickness|wall thickness
241039|NCT02692508|Nuclear Magnetic Resonance|nuclear magnetic resonance
241040|NCT02692508|Early Diagnosis|early diagnosis
241041|NCT02692508|Prognosis|prognosis
241042|NCT02692495|body odor|body odor
241043|NCT02692495|halitosis|halitosis
241044|NCT02692495|dysbiosis|dysbiosis
241045|NCT02692495|leaky gut|leaky gut
241046|NCT02692495|microbiome|microbiome
241047|NCT02692495|PATM|patm
241048|NCT02692495|breath odor|breath odor
241049|NCT02692469|Bariatric Surgery, Obesity, Laparoscopy|bariatric surgery, obesity, laparoscopy
241050|NCT02692443|Congenital Heart Disease|congenital heart disease
241051|NCT02692443|Magnetic Brain Resonance|magnetic brain resonance
241052|NCT02692443|CHD|chd
241053|NCT02692443|MRI|mri
241054|NCT02692443|Neurodevelopmental|neurodevelopmental
241055|NCT02692430|Portosystemic Shunt|portosystemic shunt
241056|NCT02692430|Hepatic encephalopathy|hepatic encephalopathy
241057|NCT02692430|Portal hypertension|portal hypertension
241058|NCT02692430|Liver cirrhosis|liver cirrhosis
241059|NCT02692417|hypoactive desire disorder|hypoactive desire disorder
241060|NCT02692417|female sexual dysfunction|female sexual dysfunction
241061|NCT02692417|genital arousal disorder|genital arousal disorder
241062|NCT02692417|sexual|sexual
241063|NCT02692417|dysfunction|dysfunction
241064|NCT02692417|female|female
241065|NCT02692417|arousal|arousal
241066|NCT02692417|electrical stimulation|electrical stimulation
241067|NCT02692417|transcutaneous electrical stimulation|transcutaneous electrical stimulation
241068|NCT02692417|women|women
241069|NCT02692404|Postpartum Depression|postpartum depression
241070|NCT02692404|Perinatal Depression|perinatal depression
241071|NCT02692404|Pregnancy|pregnancy
241072|NCT02692404|Anesthesia|anesthesia
241073|NCT02692404|Obstetric|obstetric
241074|NCT02692404|Pain|pain
241075|NCT02692404|Analgesia|analgesia
241076|NCT02692404|Epidural|epidural
241077|NCT02692404|Midwife|midwife
241078|NCT02692404|Infant Development|infant development
241079|NCT02692404|Pain Management|pain management
241080|NCT02692391|Acute pancreatitis|acute pancreatitis
241081|NCT02692391|Indomethacin|indomethacin
241082|NCT02692391|Organ failure|organ failure
241083|NCT02692391|Prevention|prevention
241084|NCT02692378|Haemodialysis|haemodialysis
241085|NCT02692378|sodium bicarbonate|sodium bicarbonate
241086|NCT02692378|potassium|potassium
241087|NCT02692378|arrhythmia|arrhythmia
241088|NCT02692378|muscle|muscle
241089|NCT02692378|symptoms|symptoms
241090|NCT02692339|Relapsed Multiple Myeloma|relapsed multiple myeloma
241091|NCT02692339|Refractory Multiple Myeloma|refractory multiple myeloma
241092|NCT02692339|Lenalidomide|lenalidomide
241093|NCT02692339|Dexamethasone|dexamethasone
241094|NCT02692339|Observational Study|observational study
241095|NCT02692339|Safety of Len/Dex|safety of len/dex
241096|NCT02692326|intrahepatic cholestasis|intrahepatic cholestasis
241097|NCT02692326|infant newborn|infant newborn
241098|NCT02692326|cyclic parenteral nutrition|cyclic parenteral nutrition
241099|NCT02692313|epinephrine|epinephrine
241100|NCT02692313|counterregulation|counterregulation
241101|NCT02692313|dose responses|dose responses
241102|NCT02692300|anesthesia|anesthesia
241103|NCT02692300|delirium|delirium
241104|NCT02692300|surgery|surgery
241105|NCT02692300|electroencephalography|electroencephalography
241106|NCT02692300|burst suppression|burst suppression
241107|NCT02692300|PTSD|ptsd
241108|NCT02692300|anxiety|anxiety
241109|NCT02692300|depression|depression
241110|NCT02692300|falls|falls
241111|NCT02692274|Point-of-care diagnostics|point-of-care diagnostics
241112|NCT02692274|Rural primary health care|rural primary health care
241113|NCT02692274|Access|access
241114|NCT02692274|Need|need
241115|NCT02692274|Usage|usage
241116|NCT02692274|Maternal Health|maternal health
241117|NCT02692235|carnitine|carnitine
241118|NCT02692222|pulse pressure variation monitoring|pulse pressure variation monitoring
241119|NCT02692222|Captesia|captesia
241120|NCT02692222|cardiac output monitoring|cardiac output monitoring
241121|NCT02692209|Mammography|mammography
241122|NCT02692196|Neurofeedback|neurofeedback
241123|NCT02692196|Emotion processing|emotion processing
241124|NCT02692196|Real-time|real-time
241125|NCT02692196|fMRI|fmri
241126|NCT02692183|Parkinson's disease|parkinson's disease
241128|NCT02692183|EEG|eeg
241129|NCT02692183|FUS|fus
241130|NCT02692183|BNA|bna
241131|NCT02692183|Essential tremor|essential tremor
241132|NCT02692131|Left Ventricle strain, speckle strain|left ventricle strain, speckle strain
241133|NCT02692105|prostate adenocarcinoma|prostate adenocarcinoma
241134|NCT02692105|intermediate risk group|intermediate risk group
241135|NCT02692105|brachytherapy|brachytherapy
241136|NCT02692105|High Dose Rate vs Low Dose Rate|high dose rate vs low dose rate
241137|NCT02692105|Quality of Life|quality of life
241138|NCT02692092|Complications|complications
241139|NCT02692092|Arthroplasty, Hip Replacement|arthroplasty, hip replacement
241140|NCT02692092|Arthroplasty, Knee Replacement|arthroplasty, knee replacement
241141|NCT02692079|Angiogenesis|angiogenesis
241142|NCT02692079|Bilateral infrabony defect|bilateral infrabony defect
241143|NCT02692079|Flap surgery|flap surgery
241144|NCT02692079|Titanium-prepared, platelet-rich ﬁbrin|titanium-prepared, platelet-rich ﬁbrin
241145|NCT02692040|obesity|obesity
241146|NCT02692040|diabetes mellitus|diabetes mellitus
241147|NCT02692040|glucagon-like peptide-1|glucagon-like peptide-1
241148|NCT02692027|Community-based initiation of antiretroviral therapy|community-based initiation of antiretroviral therapy
241149|NCT02692027|Home-based HIV testing and counseling|home-based hiv testing and counseling
241150|NCT02692027|Lesotho|lesotho
241151|NCT02692027|Sub-sahara Africa|sub-sahara africa
241152|NCT02692027|antiretroviral therapy|antiretroviral therapy
241153|NCT02692027|AIDS|aids
241154|NCT02692027|Test and treat|test and treat
241155|NCT02691988|Inhaled corticosteroids|inhaled corticosteroids
241156|NCT02691988|General practice|general practice
241157|NCT02691988|Primary care|primary care
241158|NCT02691988|Pharmacotherapy|pharmacotherapy
241159|NCT02691936|Genitourinary symptoms of menopause|genitourinary symptoms of menopause
241160|NCT02691936|Menopause|menopause
241161|NCT02691936|Atrophic vaginitis|atrophic vaginitis
241162|NCT02691923|High Grade Glioma|high grade glioma
241163|NCT02691923|Low Grade Glioma|low grade glioma
241164|NCT02691923|Brain Tumor|brain tumor
241165|NCT02691910|malaria|malaria
241166|NCT02691910|Plasmodium vivax|plasmodium vivax
241167|NCT02691910|treatment|treatment
241168|NCT02691910|Chloroquine|chloroquine
241169|NCT02691910|Primaquine|primaquine
241170|NCT02691897|Diabetes mellitus|diabetes mellitus
241171|NCT02691897|Melatonin|melatonin
241172|NCT02691897|Blood Glucose|blood glucose
241173|NCT02691897|Therapeutics|therapeutics
241174|NCT02691897|Pineal gland|pineal gland
241175|NCT02691884|Heart Rate, Fetal|heart rate, fetal
241176|NCT02691884|Electronic Fetal Monitoring|electronic fetal monitoring
241177|NCT02691884|Transducers, Pressure|transducers, pressure
241178|NCT02691858|Intussusception|intussusception
241179|NCT02691819|jailed-balloon technique|jailed-balloon technique
241180|NCT02691754|Paracetamol|paracetamol
241181|NCT02691754|PPI|ppi
241182|NCT02691754|Opioids|opioids
241183|NCT02691754|NSAID|nsaid
241184|NCT02691754|Drug Prescription|drug prescription
241185|NCT02691702|Multiple Ascending Dose Study|multiple ascending dose study
241186|NCT02691702|Safety and Tolerability|safety and tolerability
241187|NCT02691702|Pharmacokinetics|pharmacokinetics
241188|NCT02691702|Pharmacodynamics|pharmacodynamics
241189|NCT02691702|Melatonin|melatonin
241190|NCT02691702|Plasma|plasma
241191|NCT02691702|Dim Light Melatonin Onset|dim light melatonin onset
241192|NCT02691676|crystalloids, fluid therapy, Plasmalyte, Ringerfundin|crystalloids, fluid therapy, plasmalyte, ringerfundin
241193|NCT02691663|Geriatric|geriatric
241194|NCT02691663|bicarbonate|bicarbonate
241195|NCT02691650|serum cholinesterase|serum cholinesterase
241196|NCT02691650|plasma cholinesterase|plasma cholinesterase
241197|NCT02691650|pseudocholinesterase|pseudocholinesterase
241198|NCT02691650|systemic inflammation|systemic inflammation
241199|NCT02691650|SIRS|sirs
241200|NCT02691650|polytrauma|polytrauma
241201|NCT02691637|Helicobacter pylori infection|helicobacter pylori infection
241202|NCT02691637|Eradication treatment|eradication treatment
241203|NCT02691637|Reversibility|reversibility
241204|NCT02691637|atrophic gastritis|atrophic gastritis
241205|NCT02691637|intestinal metaplasia|intestinal metaplasia
241206|NCT02691624|Lymphedema of Upper Arm|lymphedema of upper arm
241207|NCT02691624|Breast cancer|breast cancer
241208|NCT02691624|Breast cancer-related Lymphedema|breast cancer-related lymphedema
241209|NCT02691624|Lymphoscintigraphy|lymphoscintigraphy
241210|NCT02691546|Chronic Kidney Diseases|chronic kidney diseases
241211|NCT02691546|Older|older
241212|NCT02691546|Geriatric assessment|geriatric assessment
241213|NCT02691546|Biomarkers|biomarkers
241214|NCT02691533|Acute|acute
241215|NCT02691520|Treatment Resistant Depression|treatment resistant depression
241216|NCT02691507|Eczema, Itchy Skin|eczema, itchy skin
241217|NCT02691494|Elagolix|elagolix
241218|NCT02691494|Elagolix Sodium|elagolix sodium
241219|NCT02691494|Heavy uterine bleeding|heavy uterine bleeding
241220|NCT02691494|Heavy menstrual bleeding (HMB)|heavy menstrual bleeding (hmb)
241221|NCT02691494|Leiomyomata|leiomyomata
241222|NCT02691494|Menorrhagia|menorrhagia
241223|NCT02691494|ABT-620|abt-620
241224|NCT02691494|Elagolix + E2/NETA (Elagolix + Norethindrone acetate)|elagolix + e2/neta (elagolix + norethindrone acetate)
241225|NCT02691468|one lung ventilation|one lung ventilation
241226|NCT02691468|double lumen endobronchial tube|double lumen endobronchial tube
241227|NCT02691468|displacement|displacement
241228|NCT02691468|Fiberoptic bronchoscope|fiberoptic bronchoscope
241229|NCT02691442|Peripheral nerve block|peripheral nerve block
241230|NCT02691429|Vitreoretinal surgery|vitreoretinal surgery
241231|NCT02691429|euterpe oleracea|euterpe oleracea
241232|NCT02691429|chromovitrectomy|chromovitrectomy
241233|NCT02691325|ELLIPTA|ellipta
241234|NCT02691325|GSK2269557|gsk2269557
241235|NCT02691325|Tolerability|tolerability
241236|NCT02691325|Safety|safety
241237|NCT02691325|Dry powder Inhaler (DPI)|dry powder inhaler (dpi)
241238|NCT02691325|Pharmacokinetics|pharmacokinetics
241239|NCT02691312|type 1 diabetes|type 1 diabetes
241240|NCT02691312|retinopathy|retinopathy
241241|NCT02691299|NSCLC|nsclc
241242|NCT02691260|obesity|obesity
241243|NCT02691260|behavioral intervention|behavioral intervention
241244|NCT02691260|diet|diet
241245|NCT02691247|T1DM|t1dm
241246|NCT02691247|Type 1 Diabetes Mellitus|type 1 diabetes mellitus
241247|NCT02691247|T regulatory cell|t regulatory cell
241248|NCT02691247|Immunotherapy|immunotherapy
241249|NCT02691247|Cell therapy|cell therapy
241250|NCT02691247|T-Reg|t-reg
241251|NCT02691221|Suicidal behavior, Mobile Application, Mobile Health Tool|suicidal behavior, mobile application, mobile health tool
241252|NCT02691208|acupuncture|acupuncture
241253|NCT02691208|breast cancer|breast cancer
241254|NCT02691208|rehabilitation|rehabilitation
241255|NCT02691208|pain|pain
241256|NCT02691195|Ultrasound|ultrasound
241257|NCT02691195|Serratus Plane Block|serratus plane block
241258|NCT02691195|Quality of recovery|quality of recovery
241259|NCT02691156|Hematofluorometer|hematofluorometer
241260|NCT02691130|influenza|influenza
241261|NCT02691130|vaccine|vaccine
241262|NCT02691130|universal|universal
241263|NCT02691130|peptide|peptide
241264|NCT02691130|prime|prime
241265|NCT02691130|boost|boost
241266|NCT02691130|HAI|hai
241267|NCT02691130|CMI|cmi
241268|NCT02691130|UNISEC|unisec
241269|NCT02691117|Alopecia Areata|alopecia areata
241270|NCT02691117|Garlic concentrate|garlic concentrate
241271|NCT02691052|pancreatic cancer|pancreatic cancer
241272|NCT02691052|metastatic|metastatic
241273|NCT02691026|MPNST|mpnst
241274|NCT02691026|Pembrolizumab|pembrolizumab
241275|NCT02691000|depression|depression
241276|NCT02691000|depressive symptoms|depressive symptoms
241277|NCT02691000|stage b heart failure|stage b heart failure
241278|NCT02691000|bright white light|bright white light
241279|NCT02691000|light therapy|light therapy
241280|NCT02690987|tobacco|tobacco
241281|NCT02690987|GLP1|glp1
241282|NCT02690987|ghrelin|ghrelin
241283|NCT02690987|alcohol|alcohol
241284|NCT02690987|appetite|appetite
241285|NCT02690987|reward|reward
241286|NCT02690987|addiction|addiction
241287|NCT02690987|hormone|hormone
241288|NCT02690987|cigarette|cigarette
241289|NCT02690987|fMRI|fmri
241290|NCT02690974|HFrEF,|hfref,
241291|NCT02690974|ACEi,|acei,
241292|NCT02690974|ACE inhibitor,|ace inhibitor,
241293|NCT02690974|ARBs,|arbs,
241294|NCT02690974|systolic heart failure,|systolic heart failure,
241295|NCT02690974|chronic heart failure,|chronic heart failure,
241296|NCT02690974|CHF,|chf,
241297|NCT02690974|reduced EF,|reduced ef,
241298|NCT02690974|Ejection Fraction|ejection fraction
241299|NCT02690961|Healthy|healthy
241300|NCT02690935|grass pollen|grass pollen
241301|NCT02690935|homeopathy|homeopathy
241302|NCT02690935|placebo|placebo
241303|NCT02690935|quality of life|quality of life
241304|NCT02690909|Uncontrolled Hypertension|uncontrolled hypertension
241305|NCT02690909|Resistant Hypertension|resistant hypertension
241306|NCT02690909|Renal Denervation|renal denervation
241307|NCT02690896|caregiver burden|caregiver burden
241308|NCT02690896|caregiver support groups|caregiver support groups
241309|NCT02690870|tamoxifen|tamoxifen
241310|NCT02690870|clomiphene|clomiphene
241311|NCT02690870|mild stimulation|mild stimulation
241312|NCT02690870|poor ovarian response|poor ovarian response
241313|NCT02690870|clinical pregnancy rate|clinical pregnancy rate
241314|NCT02690831|Asthma|asthma
241315|NCT02690831|Inspiratory Muscle Training|inspiratory muscle training
241316|NCT02690831|Manual Therapies|manual therapies
241317|NCT02690818|Tuberculosis|tuberculosis
241318|NCT02690818|Latent Tuberculosis|latent tuberculosis
241320|NCT02690818|Adherence|adherence
241321|NCT02690818|Medication|medication
241322|NCT02690792|Healthy|healthy
241323|NCT02690792|NAFLD|nafld
241324|NCT02690792|NASH|nash
241325|NCT02690792|Liver Metabolism|liver metabolism
241326|NCT02690792|Vitamin E|vitamin e
241327|NCT02690766|Cancer|cancer
241328|NCT02690766|Breast Cancer|breast cancer
241329|NCT02690766|Endometrial cancer,|endometrial cancer,
241330|NCT02690766|Type 2 Diabetes|type 2 diabetes
241331|NCT02690753|Repositioning|repositioning
241332|NCT02690753|Incontinence care|incontinence care
241333|NCT02690753|Prevention|prevention
241334|NCT02690740|titrated quantitative conjunctival provocation test|titrated quantitative conjunctival provocation test
241335|NCT02690727|Fasting|fasting
241336|NCT02690727|Fed condition|fed condition
241337|NCT02690727|Pharmacokinetics|pharmacokinetics
241338|NCT02690701|psoriasis|psoriasis
241339|NCT02690701|plaque psoriasis|plaque psoriasis
241340|NCT02690701|secukinumab|secukinumab
241341|NCT02690701|AIN457|ain457
241342|NCT02690701|biologic|biologic
241343|NCT02690701|monoclonal antibody|monoclonal antibody
241344|NCT02690701|aortic vascular inflammation|aortic vascular inflammation
241345|NCT02690688|Pulse Pressure Variation|pulse pressure variation
241347|NCT02690688|Pneumoperitoneum|pneumoperitoneum
241348|NCT02690688|Abdominal surgery|abdominal surgery
241349|NCT02690675|Neurodevelopment|neurodevelopment
241350|NCT02690675|Bayley Scale|bayley scale
241351|NCT02690675|Growth|growth
241352|NCT02690675|Iron fortification|iron fortification
241353|NCT02690662|Obesity|obesity
241354|NCT02690662|Kidney stones|kidney stones
241355|NCT02690662|Diet|diet
241356|NCT02690649|anticoagulants|anticoagulants
241357|NCT02690649|Personal Health Records|personal health records
241358|NCT02690623|hospitalist|hospitalist
241359|NCT02690623|pediatric inpatient care|pediatric inpatient care
241360|NCT02690610|EBUS, Mediastinal lesions, Mediastinal lymph node|ebus, mediastinal lesions, mediastinal lymph node
241361|NCT02690597|Anxiety analogic visual scale|anxiety analogic visual scale
241362|NCT02690597|Pain|pain
241363|NCT02690597|State Trait Inventory anxiety scale|state trait inventory anxiety scale
241364|NCT02690597|Anxiety|anxiety
241365|NCT02690584|Psychotherapy|psychotherapy
241366|NCT02690571|Air Pollution|air pollution
241367|NCT02690571|Biodiesel exhaust|biodiesel exhaust
241368|NCT02690571|Bronchoscopy|bronchoscopy
241369|NCT02690571|Metabolomics|metabolomics
241370|NCT02690558|muscle-invasive|muscle-invasive
241371|NCT02690545|CAR T cells|car t cells
241372|NCT02690545|CD30|cd30
241373|NCT02690545|Lymphoma|lymphoma
241374|NCT02690545|T Lymphocytes|t lymphocytes
241375|NCT02690532|Celiac|celiac
241376|NCT02690532|Gluten|gluten
241377|NCT02690532|Sensitivity|sensitivity
241378|NCT02690532|Permeability|permeability
241379|NCT02690532|Non-celiac gluten intolerance|non-celiac gluten intolerance
241380|NCT02690532|Gastrointestinal Diseases|gastrointestinal diseases
241381|NCT02690532|Digestive System Diseases|digestive system diseases
241382|NCT02690519|Cystic fibrosis S1251N mutation|cystic fibrosis s1251n mutation
241383|NCT02690519|GLPG1837|glpg1837
241384|NCT02690506|pregabalin|pregabalin
241385|NCT02690506|spinal anesthesia|spinal anesthesia
241386|NCT02690480|fulvestrant|fulvestrant
241387|NCT02690480|palbociclib|palbociclib
241388|NCT02690480|metastases|metastases
241389|NCT02690480|postmenopausal|postmenopausal
241390|NCT02690480|breast cancer|breast cancer
241391|NCT02690480|hormone receptor positive|hormone receptor positive
241392|NCT02690467|Insulin therapy|insulin therapy
241393|NCT02690467|Needle|needle
241394|NCT02690454|ticagrelor|ticagrelor
241395|NCT02690454|ticagrelor active metabolite (AR-C124910XX)|ticagrelor active metabolite (ar-c124910xx)
241396|NCT02690454|platelet function tests|platelet function tests
241397|NCT02690454|the flow cytometric VASP assay|the flow cytometric vasp assay
241398|NCT02690454|the VerifyNow® device|the verifynow® device
241399|NCT02690454|the Multiplate® analyzer|the multiplate® analyzer
241400|NCT02690454|pharmacokinetics|pharmacokinetics
241401|NCT02690454|pharmacodynamics|pharmacodynamics
241402|NCT02690454|Multiplate® ADPtest|multiplate® adptest
241403|NCT02690454|VerifyNow® PRUTest™|verifynow® prutest™
241404|NCT02690454|Platelet VASP/P2Y12 assay|platelet vasp/p2y12 assay
241405|NCT02690441|GAD|gad
241406|NCT02690441|CBT|cbt
241407|NCT02690441|Physical exercise|physical exercise
241408|NCT02690441|Older adults|older adults
241409|NCT02690428|Hyperthermia, Induced|hyperthermia, induced
241410|NCT02690428|Laser Coagulation|laser coagulation
241411|NCT02690428|Laser Therapy|laser therapy
241412|NCT02690389|Acupuncture|acupuncture
241413|NCT02690389|Flumazenil|flumazenil
241414|NCT02690389|Narcotrend|narcotrend
241415|NCT02690389|General Anaesthesia|general anaesthesia
241416|NCT02690389|Sedation|sedation
241417|NCT02690337|Advanced solid malignant tumors|advanced solid malignant tumors
241418|NCT02690337|phase 1|phase 1
241419|NCT02690337|oncology|oncology
241420|NCT02690337|refractory|refractory
241421|NCT02690337|no standard treatment|no standard treatment
241422|NCT02690272|kidney transplant|kidney transplant
241423|NCT02690272|psychic process|psychic process
241424|NCT02690259|Sentinel Lymph Node Biopsy|sentinel lymph node biopsy
241425|NCT02690233|endothelial dysfunction|endothelial dysfunction
241426|NCT02690233|surgery|surgery
241427|NCT02690233|cardiovascular complications|cardiovascular complications
241428|NCT02690233|EndoPat|endopat
241429|NCT02690233|myocardial injury|myocardial injury
241430|NCT02690233|myocardial infarction|myocardial infarction
241431|NCT02690220|polypropylene mesh|polypropylene mesh
241432|NCT02690220|prolapse|prolapse
241433|NCT02690220|cystocele|cystocele
241434|NCT02690220|surgical mesh|surgical mesh
241435|NCT02690207|Herpes Zoster|herpes zoster
241436|NCT02690207|Safety|safety
241437|NCT02690207|Adults|adults
241438|NCT02690207|Cross-vaccination|cross-vaccination
241439|NCT02690194|Buddhify|buddhify
241440|NCT02690194|Stress|stress
241441|NCT02690194|Anxiety|anxiety
241442|NCT02690194|Relaxation Technique|relaxation technique
241443|NCT02690168|Fasting|fasting
241444|NCT02690168|Carbon-13 Magnetic Resonance Spectroscopy|carbon-13 magnetic resonance spectroscopy
241445|NCT02690168|Neuroimaging|neuroimaging
241446|NCT02690155|Non-valvular atrial fibrillation (NVAF)|non-valvular atrial fibrillation (nvaf)
241447|NCT02690155|Prevention|prevention
241448|NCT02690155|Stroke|stroke
241449|NCT02690129|progesterone|progesterone
241450|NCT02690129|threatened abortion|threatened abortion
241451|NCT02690116|Meditative movement|meditative movement
241452|NCT02690116|Breast cancer survivors|breast cancer survivors
241453|NCT02690116|Qigong|qigong
241454|NCT02690116|Tai Chi Easy|tai chi easy
241455|NCT02690116|Fatigue|fatigue
241456|NCT02690103|Arabinoxylan|arabinoxylan
241458|NCT02690103|Viremia|viremia
241459|NCT02690103|Biobran|biobran
241460|NCT02690103|PEG interferon|peg interferon
241461|NCT02690090|Deep Vein Thrombosis|deep vein thrombosis
241462|NCT02690090|Prophylaxis|prophylaxis
241463|NCT02690090|Critically ill adults|critically ill adults
241464|NCT02690077|Patient Satisfaction|patient satisfaction
241465|NCT02690077|Earlier Family Bond Initiation|earlier family bond initiation
241466|NCT02690077|Maternal and Neonatal Outcomes|maternal and neonatal outcomes
241467|NCT02690064|Endothelial Function|endothelial function
241468|NCT02690064|Maximal Exercise Capacity|maximal exercise capacity
241469|NCT02690064|Flow Mediated Dilation|flow mediated dilation
241470|NCT02690064|Antioxidant|antioxidant
241471|NCT02690064|FEV1|fev1
241472|NCT02690038|AECOPD|aecopd
241473|NCT02690038|COPD|copd
241474|NCT02689999|Gastroesophageal Reflux Disease (GERD), GERD, impedence|gastroesophageal reflux disease (gerd), gerd, impedence
241475|NCT02689986|Cold agglutinin|cold agglutinin
241476|NCT02689986|Cold agglutinin disease|cold agglutinin disease
241477|NCT02689986|Anemia|anemia
241478|NCT02689986|Hemolytic|hemolytic
241479|NCT02689986|Autoimmune|autoimmune
241480|NCT02689986|Bendamustine|bendamustine
241481|NCT02689986|Rituximab|rituximab
241482|NCT02689973|adolescence|adolescence
241483|NCT02689973|body fat|body fat
241484|NCT02689973|physical activity|physical activity
241485|NCT02689973|psychosocial intervention|psychosocial intervention
241486|NCT02689973|self-efficacy|self-efficacy
241487|NCT02689973|planning|planning
241488|NCT02689960|addison disease|addison disease
241489|NCT02689960|adrenal crisis|adrenal crisis
241490|NCT02689960|prednisone|prednisone
241491|NCT02689934|hypercholesterolemia|hypercholesterolemia
241492|NCT02689934|bifidobacterium longum BB536|bifidobacterium longum bb536
241493|NCT02689934|red yeast rice|red yeast rice
241494|NCT02689934|monacolin K|monacolin k
241495|NCT02689934|lactoflorene colesterolo|lactoflorene colesterolo
241496|NCT02689908|Thorax CT|thorax ct
241497|NCT02689908|Low Dose|low dose
241498|NCT02689908|Body Mass Index|body mass index
241499|NCT02689908|Neck Circumference|neck circumference
241500|NCT02689895|adolescents|adolescents
241501|NCT02689895|second line treatment failure|second line treatment failure
241502|NCT02689895|adherence|adherence
241503|NCT02689895|drug resistance|drug resistance
241504|NCT02689882|nicotinamide riboside|nicotinamide riboside
241505|NCT02689882|nicotinamide ribonucleoside|nicotinamide ribonucleoside
241506|NCT02689882|Nicotinamide-Adenine Dinucleotide|nicotinamide-adenine dinucleotide
241507|NCT02689869|indolent lymphoma|indolent lymphoma
241508|NCT02689869|novel agents|novel agents
241509|NCT02689869|chemotherapy free treatment|chemotherapy free treatment
241510|NCT02689869|ibrutinib|ibrutinib
241511|NCT02689869|obinutuzumab|obinutuzumab
241512|NCT02689869|GA101|ga101
241513|NCT02689843|Inflammation|inflammation
241514|NCT02689843|Complement system proteins|complement system proteins
241515|NCT02689843|Homocysteine|homocysteine
241516|NCT02689843|C-Reactive Protein|c-reactive protein
241517|NCT02689843|Cyproterone|cyproterone
241518|NCT02689843|Ethinyl Estradiol|ethinyl estradiol
241519|NCT02689843|Androgen Antagonists|androgen antagonists
241520|NCT02689843|Metformin|metformin
241521|NCT02689843|Thiazolidinediones|thiazolidinediones
241522|NCT02689843|Pioglitazone|pioglitazone
241523|NCT02689817|Pressure ulcer|pressure ulcer
241524|NCT02689817|Monitoring|monitoring
241525|NCT02689817|Pressure|pressure
241526|NCT02689817|Physiologic feedback|physiologic feedback
241527|NCT02689804|Emergency contraception|emergency contraception
241528|NCT02689791|Appetite|appetite
241529|NCT02689791|Food Intake|food intake
241530|NCT02689791|Satiety Hormones|satiety hormones
241531|NCT02689778|Pirfenidone|pirfenidone
241532|NCT02689778|Diabetic nephropathy|diabetic nephropathy
241533|NCT02689752|mass balance|mass balance
241534|NCT02689752|14C|14c
241535|NCT02689713|Burn Pain|burn pain
241536|NCT02689713|Hyperalgesia|hyperalgesia
241537|NCT02689713|TRPV1|trpv1
241538|NCT02689713|OLAMs|olams
241539|NCT02689700|Human Cytomegalovirus|human cytomegalovirus
241540|NCT02689700|Varicella Zoster Virus|varicella zoster virus
241541|NCT02689700|Materno-fetal antibody transfer|materno-fetal antibody transfer
241542|NCT02689700|Pregnancy|pregnancy
241543|NCT02689700|Gestational age|gestational age
241544|NCT02689622|Hematology|hematology
241545|NCT02689622|Elderly|elderly
241546|NCT02689622|High Risk Myelodysplastic Syndrome|high risk myelodysplastic syndrome
241547|NCT02689609|Nasopharyngeal carcinoma|nasopharyngeal carcinoma
241548|NCT02689609|Intensity-modulated radiation therapy|intensity-modulated radiation therapy
241549|NCT02689609|Hypothyroidism|hypothyroidism
241550|NCT02689609|Predictors|predictors
241551|NCT02689583|Helicobacter pylori|helicobacter pylori
241552|NCT02689583|Antibiotic resistance|antibiotic resistance
241553|NCT02689583|Sequencing|sequencing
241554|NCT02689583|Mechanism|mechanism
241555|NCT02689583|Cause|cause
241556|NCT02689570|type 1 diabetes|type 1 diabetes
241557|NCT02689570|coronary artery calcifications|coronary artery calcifications
241558|NCT02689570|diastolic dysfunction|diastolic dysfunction
241559|NCT02689570|adipokines|adipokines
241560|NCT02689570|visceral adipose tissue|visceral adipose tissue
241561|NCT02689544|exercise muscle stretching|exercise muscle stretching
241562|NCT02689544|range of motion|range of motion
241563|NCT02689544|dynamometer of muscle strength|dynamometer of muscle strength
241564|NCT02689544|electromyography|electromyography
241565|NCT02689518|AMD|amd
241566|NCT02689518|Wet AMD|wet amd
241567|NCT02689518|Macular degeneration|macular degeneration
241568|NCT02689518|Wet macular degeneration|wet macular degeneration
241569|NCT02689518|Neovascularization|neovascularization
241570|NCT02689518|Retina|retina
241571|NCT02689518|Retinal degeneration|retinal degeneration
241572|NCT02689479|Clinical Islet Transplantation|clinical islet transplantation
241573|NCT02689479|Positron Emission Tomography (PET) Computed Tomography (CT) imaging|positron emission tomography (pet) computed tomography (ct) imaging
241574|NCT02689466|Adult|adult
241575|NCT02689466|Acetylcholine|acetylcholine
241576|NCT02689466|Movement Disorder|movement disorder
241577|NCT02689466|Magnetic Resonance Imaging (MRI)|magnetic resonance imaging (mri)
241578|NCT02689466|PET Imaging|pet imaging
241579|NCT02689453|T-cell Lymphoproliferative Disorder|t-cell lymphoproliferative disorder
241580|NCT02689453|CD4/CD25 Expressing T-cells in Blood and Lymphoid Tissues|cd4/cd25 expressing t-cells in blood and lymphoid tissues
241581|NCT02689453|Anti-CD52 Monoclonal Antibody|anti-cd52 monoclonal antibody
241582|NCT02689453|Antibody Dependent Cellular Cytotoxicity|antibody dependent cellular cytotoxicity
241583|NCT02689427|Androgen Receptor positive TNBC|androgen receptor positive tnbc
241584|NCT02689414|Atherosclerosis|atherosclerosis
241585|NCT02689401|Esophageal Cancer|esophageal cancer
241586|NCT02689401|lymph nodes tumor|lymph nodes tumor
241587|NCT02689388|analgesia|analgesia
241588|NCT02689388|regional analgesia|regional analgesia
241589|NCT02689388|femoral nerve block|femoral nerve block
241590|NCT02689388|older persons|older persons
241591|NCT02689388|frail|frail
241592|NCT02689362|Diabetes Mellitus Type 2|diabetes mellitus type 2
241593|NCT02689349|hearing|hearing
241594|NCT02689349|implant|implant
241595|NCT02689349|moderate degree|moderate degree
241596|NCT02689349|severe degree|severe degree
241597|NCT02689310|Wound Care|wound care
241598|NCT02689310|Medical Grade Honey|medical grade honey
241599|NCT02689310|Pressure Ulcers|pressure ulcers
241600|NCT02689284|Stomach Cancer|stomach cancer
241601|NCT02689284|Gastroesophageal Junction|gastroesophageal junction
241602|NCT02689284|Gastric Cancer|gastric cancer
241603|NCT02689284|Cancer of the Stomach|cancer of the stomach
241604|NCT02689284|Cancer of Stomach|cancer of stomach
241605|NCT02689284|Stomach|stomach
241606|NCT02689284|Pembrolizumab|pembrolizumab
241607|NCT02689284|Keytruda|keytruda
241608|NCT02689284|HER2+|her2+
241610|NCT02689284|HER2 positive|her2 positive
241611|NCT02689284|Metastatic|metastatic
241612|NCT02689284|Margetuximab|margetuximab
241613|NCT02689284|Immunotherapy|immunotherapy
241614|NCT02689284|Trastuzumab|trastuzumab
241615|NCT02689284|Human epidermal growth factor receptor 2|human epidermal growth factor receptor 2
241616|NCT02689284|Human epidermal growth factor receptor 2-positive|human epidermal growth factor receptor 2-positive
241617|NCT02689284|gastroesophageal junction cancer|gastroesophageal junction cancer
241618|NCT02689284|Pembro|pembro
241619|NCT02689284|PD-L1|pd-l1
241620|NCT02689284|PD-1|pd-1
241621|NCT02689284|PD|pd
241622|NCT02689284|Tumor|tumor
241623|NCT02689284|Cancer|cancer
241624|NCT02689271|MRI|mri
241625|NCT02689271|Magnetic resonance imaging|magnetic resonance imaging
241626|NCT02689271|Biomarkers|biomarkers
241627|NCT02689271|Fluidics|fluidics
241628|NCT02689271|Diffusion MRI|diffusion mri
241629|NCT02689219|Antigens, CD30, Embryonal Germ Cell Tumors|antigens, cd30, embryonal germ cell tumors
241630|NCT02689206|Chronic kidney disease|chronic kidney disease
241631|NCT02689206|Efficacy|efficacy
241632|NCT02689206|Erythropoiesis-stimulating agent|erythropoiesis-stimulating agent
241633|NCT02689206|GSK1278863|gsk1278863
241634|NCT02689206|Safety|safety
241635|NCT02689206|Hemodialysis-dependent anemia|hemodialysis-dependent anemia
241636|NCT02689206|Pharmacokinetics|pharmacokinetics
241637|NCT02689193|Proteomics|proteomics
241638|NCT02689193|Rapid Diagnostic Test|rapid diagnostic test
241639|NCT02689193|Salmonellosis|salmonellosis
241640|NCT02689180|heart failure|heart failure
241641|NCT02689180|diuretics|diuretics
241642|NCT02689180|furosemide|furosemide
241643|NCT02689167|renal cell carcinoma|renal cell carcinoma
241644|NCT02689167|sunitinib|sunitinib
241645|NCT02689167|metastatic|metastatic
241646|NCT02689167|schedule|schedule
241647|NCT02689167|toxicity|toxicity
241648|NCT02689167|safety|safety
241649|NCT02689154|Pediatric Obesity|pediatric obesity
241650|NCT02689154|Food Addiction|food addiction
241651|NCT02689154|Mobile Health (mHealth)|mobile health (mhealth)
241652|NCT02689154|Weight Management|weight management
241653|NCT02689141|chronic lymphocytic leukemia CLL|chronic lymphocytic leukemia cll
241654|NCT02689141|untreated chronic lymphocytic leukemia|untreated chronic lymphocytic leukemia
241655|NCT02689141|relapsed chronic lymphocytic leukemia|relapsed chronic lymphocytic leukemia
241656|NCT02689141|refractory chronic lymphocytic leukemia|refractory chronic lymphocytic leukemia
241657|NCT02689128|Anesthesia|anesthesia
241658|NCT02689128|postoperative|postoperative
241659|NCT02689128|nausea|nausea
241660|NCT02689128|vomiting|vomiting
241661|NCT02689115|Nuclear factor Kappa B|nuclear factor kappa b
241662|NCT02689115|IKK epsilon|ikk epsilon
241663|NCT02689102|Optical coherence tomography|optical coherence tomography
241664|NCT02689102|Confocal laser endomicroscopy|confocal laser endomicroscopy
241665|NCT02689076|Patient transfer|patient transfer
241666|NCT02689076|Patient care management|patient care management
241667|NCT02689076|Health information exchange|health information exchange
241668|NCT02689063|Analgesic|analgesic
241669|NCT02689024|Nerve block|nerve block
241670|NCT02689024|Analgesia|analgesia
241671|NCT02689011|Total Knee Arthroplasty|total knee arthroplasty
241672|NCT02689011|Femoral Nerve Block|femoral nerve block
241673|NCT02689011|Epidural Analgesia|epidural analgesia
241674|NCT02689011|Urinary Retention|urinary retention
241675|NCT02689011|Lumbar Epidural|lumbar epidural
241676|NCT02688998|HER2 negative|her2 negative
241677|NCT02688959|motor attention training|motor attention training
241678|NCT02688959|exercise|exercise
241679|NCT02688959|tai chi|tai chi
241680|NCT02688959|ADHD|adhd
241681|NCT02688855|Bone Growth Stimulator|bone growth stimulator
241682|NCT02688855|Ankle Fracture|ankle fracture
241683|NCT02688829|Sirolimus eluting stents|sirolimus eluting stents
241684|NCT02688829|percutaneous coronary intervention|percutaneous coronary intervention
241685|NCT02688829|First in man|first in man
241686|NCT02688816|visual inspection with acetic acid|visual inspection with acetic acid
241687|NCT02688816|Xpert HPV|xpert hpv
241688|NCT02688816|OncoE6|oncoe6
241689|NCT02688816|screening|screening
241690|NCT02688803|HER2 Negative|her2 negative
241691|NCT02688790|Dalbavancin|dalbavancin
241692|NCT02688790|DALVANCE®|dalvance®
241693|NCT02688790|Suspected or Confirmed Bacterial Infection|suspected or confirmed bacterial infection
241694|NCT02688777|Rehabilitation|rehabilitation
241695|NCT02688777|Gait|gait
241696|NCT02688777|Postural Balance|postural balance
241697|NCT02688777|Exercise|exercise
241698|NCT02688777|Accidental Falls|accidental falls
241699|NCT02688777|Kinesiology, Applied|kinesiology, applied
241700|NCT02688764|PA21|pa21
241701|NCT02688764|phosphate binder|phosphate binder
241702|NCT02688712|IIA|iia
241703|NCT02688712|Xeloda|xeloda
241704|NCT02688712|radiation therapy|radiation therapy
241705|NCT02688712|LY2157299|ly2157299
241706|NCT02688712|tumor resection|tumor resection
241707|NCT02688712|capecitabine|capecitabine
241708|NCT02688712|5FU|5fu
241709|NCT02688712|Fluorouracil|fluorouracil
241710|NCT02688712|IIB|iib
241711|NCT02688712|IIC|iic
241712|NCT02688712|IV|iv
241713|NCT02688712|neoadjuvant|neoadjuvant
241714|NCT02688712|Rectal cancer|rectal cancer
241715|NCT02688712|Immunotherapy|immunotherapy
241716|NCT02688660|Pediatrics|pediatrics
241717|NCT02688660|Neuroimaging|neuroimaging
241718|NCT02688647|Pulmonary Fibrosis|pulmonary fibrosis
241719|NCT02688647|Fibrosis|fibrosis
241720|NCT02688647|Idiopathic Interstitial Pneumonias|idiopathic interstitial pneumonias
241721|NCT02688647|Lung Diseases|lung diseases
241722|NCT02688634|Cleft Palate Surgery|cleft palate surgery
241723|NCT02688634|Antibiotic treatment|antibiotic treatment
241724|NCT02688621|weight loss|weight loss
241725|NCT02688621|financial incentives|financial incentives
241726|NCT02688621|internet weight loss|internet weight loss
241727|NCT02688595|Infant, Newborn|infant, newborn
241728|NCT02688595|Ultrasonography|ultrasonography
241729|NCT02688582|Target Controlled Infusion|target controlled infusion
241730|NCT02688582|Pharmacokinetics|pharmacokinetics
241731|NCT02688582|Cefepime|cefepime
241732|NCT02688582|critically ill patients|critically ill patients
241733|NCT02688556|KCS|kcs
241734|NCT02688556|dry eye|dry eye
241735|NCT02688556|cyclosporine|cyclosporine
241736|NCT02688543|radio frequency treatment|radio frequency treatment
241737|NCT02688543|genicular nerves|genicular nerves
241738|NCT02688543|osteoarthritis of the knee|osteoarthritis of the knee
241739|NCT02688504|labelled medicines|labelled medicines
241740|NCT02688504|drivers involved in serious and non-serious road accidents|drivers involved in serious and non-serious road accidents
241741|NCT02688504|relevance and effectiveness of pictograms on medicines packaging|relevance and effectiveness of pictograms on medicines packaging
241742|NCT02688478|Phthalate|phthalate
241743|NCT02688478|Dibutylphthalate (DBP)|dibutylphthalate (dbp)
241744|NCT02688478|Airway responsiveness|airway responsiveness
241745|NCT02688478|Allergies|allergies
241746|NCT02688452|strenuous exercise|strenuous exercise
241747|NCT02688452|muscle soreness|muscle soreness
241748|NCT02688413|Virtual reality|virtual reality
241749|NCT02688413|Stroke|stroke
241750|NCT02688413|Neurorehabilitation|neurorehabilitation
241751|NCT02688413|Upper-limb rehabilitation|upper-limb rehabilitation
241752|NCT02688413|Training games|training games
241753|NCT02688400|Osteoarthritis|osteoarthritis
241754|NCT02688400|Knee|knee
241755|NCT02688400|Osteoarthritis, Knee|osteoarthritis, knee
241756|NCT02688400|Diacerein|diacerein
241757|NCT02688400|Celecoxib|celecoxib
241758|NCT02688400|Phase III|phase iii
241759|NCT02688400|Phase IV|phase iv
241760|NCT02688400|Phase III-IV|phase iii-iv
241761|NCT02688400|Canada|canada
241762|NCT02688400|Spain|spain
241763|NCT02688400|Austria|austria
241764|NCT02688400|Czech Republic|czech republic
241765|NCT02688400|WOMAC|womac
241766|NCT02688387|Ambrisentan|ambrisentan
241767|NCT02688387|Bioavailability|bioavailability
241768|NCT02688387|Tadalafil|tadalafil
241769|NCT02688387|Fixed Dose combination|fixed dose combination
241770|NCT02688322|sulbactam|sulbactam
241771|NCT02688322|pharmacokinetics|pharmacokinetics
241772|NCT02688322|pharmacodynamics|pharmacodynamics
241773|NCT02688322|Acinetobacter infections|acinetobacter infections
241774|NCT02688257|Magnetic Resonance Imaging|magnetic resonance imaging
241775|NCT02688257|Ultrasound|ultrasound
241776|NCT02688257|Breast Cancer|breast cancer
241777|NCT02688244|complicated appendicitis|complicated appendicitis
241778|NCT02688244|laparoscopic appendectomy|laparoscopic appendectomy
241779|NCT02688244|irrigation|irrigation
241780|NCT02688244|suction|suction
241781|NCT02688244|abdominal abscess|abdominal abscess
241782|NCT02688231|Multiple Sclerosis|multiple sclerosis
241783|NCT02688231|Upper limb rehabilitation|upper limb rehabilitation
241784|NCT02688218|exercise|exercise
241785|NCT02688218|artificial pancreas|artificial pancreas
241786|NCT02688218|hypoglycemia|hypoglycemia
241787|NCT02688218|type 1 diabetes|type 1 diabetes
241788|NCT02688205|Cyriax's functional examination|cyriax's functional examination
241789|NCT02688205|Ultrasound|ultrasound
241790|NCT02688205|Correlation|correlation
241791|NCT02688205|Resisted test|resisted test
241792|NCT02688153|Aortic Valve Replacement|aortic valve replacement
241793|NCT02688153|Aortic Stenosis|aortic stenosis
241794|NCT02688153|EDWARDS INTUITY|edwards intuity
241795|NCT02688140|APL|apl
241796|NCT02688140|acute promyelocytic leukemia (M3)|acute promyelocytic leukemia (m3)
241797|NCT02688140|high-risk acute promyelocytic leukemia (APL/AML M3)|high-risk acute promyelocytic leukemia (apl/aml m3)
241798|NCT02688140|acute myeloid leukemia with t(15;17)(q22;q12)|acute myeloid leukemia with t(15;17)(q22;q12)
241799|NCT02688140|newly diagnosed|newly diagnosed
241800|NCT02688140|high-risk|high-risk
241801|NCT02688127|obstetric bleeding placenta previa|obstetric bleeding placenta previa
241802|NCT02688075|Diabetes Mellitus Type 2|diabetes mellitus type 2
241803|NCT02688075|Canagliflozin|canagliflozin
241804|NCT02688075|Observational Study|observational study
241805|NCT02688036|Limited Disease Small Cell Lung Cancer|limited disease small cell lung cancer
241806|NCT02688036|concurrent chemoradiotherapy|concurrent chemoradiotherapy
241807|NCT02688036|dose fractionation|dose fractionation
241808|NCT02688023|5-fluorouracil|5-fluorouracil
241809|NCT02688023|Irinotecan|irinotecan
241810|NCT02688023|Oxaliplatin|oxaliplatin
241811|NCT02688023|Colorectal cancer|colorectal cancer
241812|NCT02688023|neoadjuvant|neoadjuvant
241813|NCT02688023|chemotherapy|chemotherapy
241814|NCT02688010|noise|noise
241815|NCT02688010|sound|sound
241816|NCT02688010|cycled light|cycled light
241817|NCT02688010|preterm infants|preterm infants
241818|NCT02688010|neonatal care|neonatal care
241819|NCT02688010|growth|growth
241820|NCT02688010|visual development|visual development
241821|NCT02687984|Schizophrenia|schizophrenia
241822|NCT02687984|Long-acting Risperidone|long-acting risperidone
241823|NCT02687984|Atrigel|atrigel
241824|NCT02687958|GEP/ NEC|gep/ nec
241825|NCT02687932|Functional Mitral Regurgitation|functional mitral regurgitation
241826|NCT02687932|Ischemic Mitral Regurgitation|ischemic mitral regurgitation
241827|NCT02687919|diet (gluten-free)|diet (gluten-free)
241828|NCT02687919|diet therapy|diet therapy
241829|NCT02687919|quality of life|quality of life
241830|NCT02687893|Sleep|sleep
241831|NCT02687893|Exercise|exercise
241832|NCT02687867|Non-valvular atrial fibrillation (NVAF)|non-valvular atrial fibrillation (nvaf)
241833|NCT02687867|Prevention|prevention
241834|NCT02687867|Stroke|stroke
241835|NCT02687854|Non-valvular atrial fibrillation (NVAF)|non-valvular atrial fibrillation (nvaf)
241836|NCT02687854|Prevention|prevention
241837|NCT02687854|Stroke|stroke
241838|NCT02687841|acute kidney injury|acute kidney injury
241839|NCT02687841|indoxylsulfate|indoxylsulfate
241840|NCT02687841|p-cresol|p-cresol
241841|NCT02687841|AST-120|ast-120
241842|NCT02687828|Intestinal Behcet's disease (BD)|intestinal behcet's disease (bd)
241843|NCT02687828|Adalimumab|adalimumab
241844|NCT02687828|Safety|safety
241945|NCT02686996|carnosine|carnosine
241845|NCT02687828|Effectiveness|effectiveness
241846|NCT02687828|AMORE study|amore study
241847|NCT02687815|Vitamin D, severe asthma exacerbations, children|vitamin d, severe asthma exacerbations, children
241848|NCT02687802|respiratory mechanics|respiratory mechanics
241849|NCT02687802|Respiratory Insufficiency|respiratory insufficiency
241850|NCT02687802|artificial, ventilation|artificial, ventilation
241851|NCT02687789|Bacterial Vaginosis|bacterial vaginosis
241852|NCT02687789|BV|bv
241853|NCT02687776|Copeptin, human|copeptin, human
241854|NCT02687763|vaccines|vaccines
241855|NCT02687763|ProQuad|proquad
241856|NCT02687763|immunosuppressed|immunosuppressed
241857|NCT02687763|solid organ transplant|solid organ transplant
241858|NCT02687763|MMRV|mmrv
241859|NCT02687737|Tongue|tongue
241860|NCT02687737|Genioglossus|genioglossus
241861|NCT02687737|genioglossus recruitment|genioglossus recruitment
241862|NCT02687711|Non-interventional (NIS)|non-interventional (nis)
241863|NCT02687711|Epilepsy|epilepsy
241864|NCT02687711|Partial Onset Seizures (POS)|partial onset seizures (pos)
241865|NCT02687711|add-on therapy|add-on therapy
241866|NCT02687685|Skin to Skin Contact|skin to skin contact
241867|NCT02687685|Infant, Newborn|infant, newborn
241868|NCT02687607|Endovascular|endovascular
241869|NCT02687607|Brain aneurysm|brain aneurysm
241870|NCT02687607|Ruptured aneurysm|ruptured aneurysm
241871|NCT02687542|Parkinson Disease|parkinson disease
241872|NCT02687542|Motor Fluctuation|motor fluctuation
241873|NCT02687529|Tuberculosis|tuberculosis
241874|NCT02687529|TB|tb
241875|NCT02687516|Treatment|treatment
241876|NCT02687516|Child|child
241877|NCT02687516|Obesity|obesity
241878|NCT02687516|Behavioral treatment|behavioral treatment
241879|NCT02687503|Immune system|immune system
241880|NCT02687503|Probiotics|probiotics
241881|NCT02687464|Pediatric Surgery|pediatric surgery
241882|NCT02687464|Pediatrics|pediatrics
241883|NCT02687464|Randomized controlled trial,|randomized controlled trial,
241884|NCT02687464|Antibiotics|antibiotics
241885|NCT02687464|Cost effectiveness|cost effectiveness
241886|NCT02687451|Surgical Pain|surgical pain
241887|NCT02687451|Acute Post-Surgical Pain|acute post-surgical pain
241888|NCT02687438|Steroid-eluting implant Mometasone Furoate|steroid-eluting implant mometasone furoate
241889|NCT02687425|Pioglitazone|pioglitazone
241890|NCT02687425|Chronic Myeloid Leukemia|chronic myeloid leukemia
241891|NCT02687412|Fast-track surgery|fast-track surgery
241892|NCT02687412|Gynecological oncology|gynecological oncology
241893|NCT02687412|Hospitalization post-operation|hospitalization post-operation
241894|NCT02687412|Complication|complication
241895|NCT02687399|knee arthroplasty|knee arthroplasty
241896|NCT02687386|Recurrent|recurrent
241897|NCT02687386|Refractory|refractory
241898|NCT02687373|Plasmodium falciparum|plasmodium falciparum
241899|NCT02687373|PfSPZ Vaccine|pfspz vaccine
241900|NCT02687360|Methadone|methadone
241901|NCT02687308|Prostatic cancer|prostatic cancer
241902|NCT02687308|Radical prostatectomy|radical prostatectomy
241903|NCT02687308|Minimally invasive prostate cancer surgery|minimally invasive prostate cancer surgery
241904|NCT02687282|Modified Mallampati score|modified mallampati score
241905|NCT02687282|Cesarean delivery|cesarean delivery
241906|NCT02687269|myocardial protection|myocardial protection
241907|NCT02687269|coronary artery bypass grafting|coronary artery bypass grafting
241908|NCT02687243|pediatrics|pediatrics
241909|NCT02687243|anxiety|anxiety
241910|NCT02687243|anesthesia|anesthesia
241911|NCT02687243|preoperative|preoperative
241912|NCT02687217|PerioperativeHyperoxygenation|perioperativehyperoxygenation
241913|NCT02687217|Wound Site Infection|wound site infection
241914|NCT02687217|Appendicitis|appendicitis
241915|NCT02687191|safety, maximum tolerated dose, modified continual reassessment method, intracerebral, hemorrhage, hematoma|safety, maximum tolerated dose, modified continual reassessment method, intracerebral, hemorrhage, hematoma
241916|NCT02687113|ablation|ablation
241917|NCT02687113|fusion|fusion
241918|NCT02687100|intubation|intubation
241919|NCT02687100|intensive care|intensive care
241920|NCT02687100|cardiac surgery|cardiac surgery
241921|NCT02687100|sore throat|sore throat
241922|NCT02687087|Radiotherapy Induced Xerostomia (RIX)|radiotherapy induced xerostomia (rix)
241923|NCT02687074|HFNC|hfnc
241924|NCT02687074|Respiratory Failure|respiratory failure
241925|NCT02687074|Intubation|intubation
241926|NCT02687074|Mortality|mortality
241927|NCT02687061|Recall study|recall study
241928|NCT02687061|Lost to follow-up|lost to follow-up
241929|NCT02687048|mindful meditation|mindful meditation
241930|NCT02687035|S3iCAP|s3icap
241931|NCT02687035|SAPIEN 3|sapien 3
241932|NCT02687035|Transfemoral|transfemoral
241933|NCT02687035|Commander|commander
241934|NCT02687035|Certitude|certitude
241935|NCT02687035|TAVR|tavr
241936|NCT02687035|TAVI|tavi
241937|NCT02687035|Aortic stenosis|aortic stenosis
241938|NCT02687035|THV|thv
241939|NCT02687035|Transcatheter Heart Valve|transcatheter heart valve
241940|NCT02687035|TVT|tvt
241941|NCT02687035|TVTR|tvtr
241942|NCT02687009|colon cancer|colon cancer
241943|NCT02687009|Wnt pathway|wnt pathway
241944|NCT02687009|Frizzled|frizzled
241946|NCT02686996|Insulin sensitivity|insulin sensitivity
241947|NCT02686996|low grade inflammation|low grade inflammation
241948|NCT02686996|Oxidative stress|oxidative stress
241949|NCT02686996|Advanced glycation|advanced glycation
241950|NCT02686996|Type 2 diabetes|type 2 diabetes
241951|NCT02686996|Cardiovascular disease|cardiovascular disease
241952|NCT02686970|Family|family
241953|NCT02686970|Quality|quality
241954|NCT02686970|Validate|validate
241956|NCT02686944|GIST|gist
241957|NCT02686931|Developmental delayed|developmental delayed
241958|NCT02686931|Orthopedic disease|orthopedic disease
241959|NCT02686931|Longitudinal study|longitudinal study
241960|NCT02686892|Inflamatory bowel disease|inflamatory bowel disease
241961|NCT02686892|Crohns disease|crohns disease
241962|NCT02686892|ulcerative colitis|ulcerative colitis
241963|NCT02686892|incidence|incidence
241964|NCT02686892|epidemiology|epidemiology
241965|NCT02686879|hyperopes|hyperopes
241966|NCT02686879|axial length|axial length
241967|NCT02686879|peripheral defocus|peripheral defocus
241968|NCT02686853|Intrathecal administration|intrathecal administration
241969|NCT02686853|Liposomal amphotericin B|liposomal amphotericin b
241970|NCT02686853|Without Acquired Immune Deficiency Syndrome|without acquired immune deficiency syndrome
241971|NCT02686814|Valvular heart disease|valvular heart disease
241972|NCT02686814|Severe aortic stenosis|severe aortic stenosis
241973|NCT02686814|Aortic valve replacement|aortic valve replacement
241974|NCT02686801|nutrition|nutrition
241975|NCT02686801|prematurity|prematurity
241976|NCT02686801|body composition|body composition
241977|NCT02686788|multiple sclerosis|multiple sclerosis
241978|NCT02686788|relapsing remitting|relapsing remitting
241979|NCT02686788|nonsteroidal anti-inflammatory drug|nonsteroidal anti-inflammatory drug
241980|NCT02686788|contrast enhancing lesions|contrast enhancing lesions
241981|NCT02686762|NASH|nash
241982|NCT02686736|internet-based educational intervention|internet-based educational intervention
241983|NCT02686736|risky sexual behaviors|risky sexual behaviors
241984|NCT02686736|prevention|prevention
241985|NCT02686723|ACL injury|acl injury
241986|NCT02686723|Return to sport|return to sport
241987|NCT02686723|Motion analysis|motion analysis
241988|NCT02686723|Isokinetic evaluation|isokinetic evaluation
241989|NCT02686723|Risk factor|risk factor
241990|NCT02686697|L-Carnosine|l-carnosine
241991|NCT02686697|Schizophrenia|schizophrenia
241992|NCT02686697|Psychosis|psychosis
241993|NCT02686697|Cognition|cognition
241994|NCT02686671|Bursitis|bursitis
241995|NCT02686671|Injections|injections
241996|NCT02686671|Shoulder Pain|shoulder pain
241997|NCT02686658|Geographic Atrophy (GA)|geographic atrophy (ga)
241998|NCT02686658|Dry age-related macular degeneration|dry age-related macular degeneration
241999|NCT02686658|AMD|amd
242000|NCT02686658|Zimura|zimura
242001|NCT02686658|Anti-inflammatory|anti-inflammatory
242002|NCT02686658|complement factor C5 inhibitor|complement factor c5 inhibitor
242003|NCT02686658|ARC1905|arc1905
242004|NCT02686658|avacincaptad pegol|avacincaptad pegol
242005|NCT02686645|Fecal Microbiota Transplantation|fecal microbiota transplantation
242006|NCT02686632|Denture Stomatitis|denture stomatitis
242007|NCT02686632|Denture Erythematous Stomatitis|denture erythematous stomatitis
242008|NCT02686632|Prosthesis Stomatitis|prosthesis stomatitis
242009|NCT02686632|Oral Candidiasis|oral candidiasis
242010|NCT02686632|Palatal inflammation|palatal inflammation
242011|NCT02686593|Clofarabine|clofarabine
242012|NCT02686593|Acute Myeloid Leukemia|acute myeloid leukemia
242013|NCT02686567|transanal drainage tube|transanal drainage tube
242014|NCT02686567|anastomotic leakage|anastomotic leakage
242015|NCT02686567|laparoscopic anterior resection|laparoscopic anterior resection
242016|NCT02686567|rectal cancer|rectal cancer
242017|NCT02686554|Biomarker|biomarker
242018|NCT02686528|total hip arthroplasty|total hip arthroplasty
242019|NCT02686528|hip precautions|hip precautions
242020|NCT02686528|posterior approach|posterior approach
242021|NCT02686515|balance|balance
242022|NCT02686476|Empagliflozin, Fatty Liver Disease|empagliflozin, fatty liver disease
242023|NCT02686463|malignant ovarian cancer|malignant ovarian cancer
242024|NCT02686463|laparoscopy|laparoscopy
242025|NCT02686463|laparotomy|laparotomy
242026|NCT02686437|shoulder dysfunction|shoulder dysfunction
242027|NCT02686437|kinesiology tape|kinesiology tape
242028|NCT02686437|rehabilitation|rehabilitation
242029|NCT02686424|MAGE-A3 protein|mage-a3 protein
242030|NCT02686424|NY-ESO-1 protein|ny-eso-1 protein
242031|NCT02686424|WT1 Proteins|wt1 proteins
242032|NCT02686424|PRAME protein|prame protein
242033|NCT02686411|Benign neoplasms|benign neoplasms
242034|NCT02686411|In situ neoplasms|in situ neoplasms
242035|NCT02686411|Malignant neoplasms of independent (primary) multiple sites|malignant neoplasms of independent (primary) multiple sites
242036|NCT02686411|Consult with palliative care doctor|consult with palliative care doctor
242037|NCT02686411|Palliative care unit|palliative care unit
242038|NCT02686411|PCU|pcu
242039|NCT02686411|Questionnaires|questionnaires
242040|NCT02686411|Surveys|surveys
242041|NCT02686398|Influenza Vaccines|influenza vaccines
242042|NCT02686398|MF59 oil emulsion|mf59 oil emulsion
242043|NCT02686398|End Stage Renal Failure on Dialysis|end stage renal failure on dialysis
242044|NCT02686372|hepatocellular carcinoma|hepatocellular carcinoma
242045|NCT02686359|physiology|physiology
242046|NCT02686359|pain|pain
242047|NCT02686359|analgesia|analgesia
242048|NCT02686359|saliva|saliva
242049|NCT02686359|opiorphin|opiorphin
242050|NCT02686346|Relapsed|relapsed
242051|NCT02686346|Refractory|refractory
242052|NCT02686333|Meditation|meditation
242053|NCT02686333|Dialysis|dialysis
242054|NCT02686320|Rheumatoid arthritis|rheumatoid arthritis
242055|NCT02686320|Elderly|elderly
242056|NCT02686320|infections|infections
242057|NCT02686320|cardio-vascular disease|cardio-vascular disease
242058|NCT02686320|osteoporosis|osteoporosis
242059|NCT02686320|cancer|cancer
242060|NCT02686268|Amyotrophic Lateral Sclerosis|amyotrophic lateral sclerosis
242061|NCT02686268|ALS|als
242062|NCT02686268|C9ORF72 gene mutation|c9orf72 gene mutation
242063|NCT02686268|Chromosome 9 open reading frame 72 protein|chromosome 9 open reading frame 72 protein
242064|NCT02686268|Natural history|natural history
242065|NCT02686268|Biomarkers|biomarkers
242066|NCT02686268|Amyotrophic Lateral Sclerosis, Familial|amyotrophic lateral sclerosis, familial
242067|NCT02686268|Amyotrophic Lateral Sclerosis, Sporadic|amyotrophic lateral sclerosis, sporadic
242068|NCT02686268|Frontotemporal Dementia-Amyotrophic Lateral Sclerosis|frontotemporal dementia-amyotrophic lateral sclerosis
242069|NCT02686242|cesarean section|cesarean section
242070|NCT02686242|spinal anesthesia|spinal anesthesia
242071|NCT02686242|general anesthesia|general anesthesia
242072|NCT02686229|Low grade glioma, registry, neurosurgery, brain tumor|low grade glioma, registry, neurosurgery, brain tumor
242073|NCT02686216|F-18 THK-5351 PET|f-18 thk-5351 pet
242074|NCT02686190|Alzheimer; luxtherapy, sleep disturbance, behaviour disturbance|alzheimer; luxtherapy, sleep disturbance, behaviour disturbance
242075|NCT02686177|Type 2 diabetes|type 2 diabetes
242076|NCT02686177|Angiogenesis|angiogenesis
242077|NCT02686177|Liraglutide|liraglutide
242078|NCT02686177|Glucagon like peptide 1 receptor agonist|glucagon like peptide 1 receptor agonist
242079|NCT02686164|Lenvatinib|lenvatinib
242080|NCT02686164|Lenvima|lenvima
242081|NCT02686164|E7080|e7080
242082|NCT02686164|Phase 1|phase 1
242083|NCT02686164|Solid tumors|solid tumors
242084|NCT02686164|Midazolam|midazolam
242085|NCT02686164|CYP3A4|cyp3a4
242086|NCT02686151|Letrozole|letrozole
242087|NCT02686151|OHSS|ohss
242088|NCT02686099|Rigid Fixation|rigid fixation
242089|NCT02686099|Sternal Plating|sternal plating
242090|NCT02686099|Sternal Closure|sternal closure
242091|NCT02686099|Sternalock|sternalock
242092|NCT02686073|BMI|bmi
242093|NCT02686073|progress of labor|progress of labor
242094|NCT02686073|nulliparous women|nulliparous women
242095|NCT02686047|Knee osteoarthritis|knee osteoarthritis
242096|NCT02686047|Hyaluronic acid|hyaluronic acid
242097|NCT02686047|Viscosupplementation|viscosupplementation
242098|NCT02686034|Migraine|migraine
242099|NCT02686034|Non-invasive vagus nerve stimulation|non-invasive vagus nerve stimulation
242100|NCT02686034|Vagus nerve stimulation|vagus nerve stimulation
242101|NCT02686034|Vagal nerve stimulation|vagal nerve stimulation
242102|NCT02686034|gammaCore|gammacore
242103|NCT02686034|episodic migraine|episodic migraine
242104|NCT02685982|Unipolar|unipolar
242105|NCT02685982|Depression|depression
242106|NCT02685982|Depressive Disorder|depressive disorder
242107|NCT02685982|Behavioural Symptoms|behavioural symptoms
242108|NCT02685982|Mood Disorder|mood disorder
242109|NCT02685982|Adjunctive Therapy|adjunctive therapy
242110|NCT02685982|Music Therapy|music therapy
242111|NCT02685982|Brain Stimulation|brain stimulation
242112|NCT02685969|Prevention|prevention
242113|NCT02685969|Positron Emission Tomography|positron emission tomography
242114|NCT02685930|invasive mechanical ventilation|invasive mechanical ventilation
242115|NCT02685878|urinary continence|urinary continence
242116|NCT02685878|prevalence of depression|prevalence of depression
242117|NCT02685878|reproductive outcomes|reproductive outcomes
242118|NCT02685878|quality of life|quality of life
242119|NCT02685878|HIV status|hiv status
242120|NCT02685878|obstetric fistula|obstetric fistula
242121|NCT02685865|pancreatic fluid collection; pancreatic necrosis; stent;|pancreatic fluid collection; pancreatic necrosis; stent;
242122|NCT02685839|frailty syndrome, Intelligent POWER Rehabilitation Cluster Machine, Internet of Things, wearable|frailty syndrome, intelligent power rehabilitation cluster machine, internet of things, wearable
242123|NCT02685826|Open-label|open-label
242124|NCT02685826|Phase 1/2|phase 1/2
242125|NCT02685826|Durvalumab|durvalumab
242126|NCT02685826|MEDI4736|medi4736
242127|NCT02685826|Lenalidomide (Len)|lenalidomide (len)
242128|NCT02685826|Dexamethasone (dex)|dexamethasone (dex)
242129|NCT02685826|Multiple Myeloma|multiple myeloma
242130|NCT02685826|Newly-Diagnosed (NDMM)|newly-diagnosed (ndmm)
242131|NCT02685826|Transplant Non-eligible (TNE)|transplant non-eligible (tne)
242132|NCT02685826|PD-L1|pd-l1
242133|NCT02685826|Durvalumab (DURVA)|durvalumab (durva)
242134|NCT02685813|Ultra sound|ultra sound
242135|NCT02685813|birth defects|birth defects
242136|NCT02685787|Care-giver burden|care-giver burden
242137|NCT02685787|Dementia|dementia
242138|NCT02685787|Alzheimer's disease|alzheimer's disease
242139|NCT02685787|Care-giver depression|care-giver depression
242140|NCT02685787|Care-giver anxiety|care-giver anxiety
242141|NCT02685709|Octreotide Capsules|octreotide capsules
242142|NCT02685709|Acromegaly|acromegaly
242143|NCT02685709|Somatostatin|somatostatin
242144|NCT02685709|Mpowered|mpowered
242145|NCT02685709|OOC-ACM-302|ooc-acm-302
242146|NCT02685683|Crohn's Disease|crohn's disease
242147|NCT02685683|GED-0301|ged-0301
242148|NCT02685683|Open-label|open-label
242149|NCT02685683|Pharmacodynamic|pharmacodynamic
242150|NCT02685683|Mongersen|mongersen
242151|NCT02685644|endometrioma|endometrioma
242152|NCT02685644|laparoscopy|laparoscopy
242153|NCT02685644|anti-mullerian hormone|anti-mullerian hormone
242154|NCT02685644|ovarian reserve|ovarian reserve
242155|NCT02685631|Hepatocellular carcinoma|hepatocellular carcinoma
242156|NCT02685631|Colorectal cancer|colorectal cancer
242157|NCT02685631|Neuroendocrine tumor|neuroendocrine tumor
242158|NCT02685631|Cholangiocarcinoma|cholangiocarcinoma
242159|NCT02685631|Breast cancer|breast cancer
242160|NCT02685631|Tumor of unknown primary|tumor of unknown primary
242161|NCT02685631|Pancreatic cancer|pancreatic cancer
242162|NCT02685605|Glioblastoma|glioblastoma
242163|NCT02685605|Intraoperative Radiotherapy|intraoperative radiotherapy
242164|NCT02685605|Radiotherapy Dose Escalation|radiotherapy dose escalation
242165|NCT02685592|Lentigo Maligna|lentigo maligna
242166|NCT02685592|Photodynamic Therapy|photodynamic therapy
242167|NCT02685592|Hyperspectral Imaging|hyperspectral imaging
242168|NCT02685566|Mammography|mammography
242169|NCT02685540|Anesthesia|anesthesia
242170|NCT02685540|mortality|mortality
242172|NCT02685514|Graves' disease|graves' disease
242173|NCT02685514|treatment|treatment
242174|NCT02685475|Diabetes mellitus|diabetes mellitus
242175|NCT02685475|Axillary brachial plexus block|axillary brachial plexus block
242176|NCT02685475|Block duration|block duration
242177|NCT02685475|Time-to-first pain|time-to-first pain
242178|NCT02685475|Postoperative analgesia|postoperative analgesia
242179|NCT02685449|diabetes type 1|diabetes type 1
242180|NCT02685449|insulin pump|insulin pump
242181|NCT02685449|prandial insulin requirement|prandial insulin requirement
242182|NCT02685449|pure protein meal|pure protein meal
242183|NCT02685449|high protein meal|high protein meal
242184|NCT02685449|square bolus|square bolus
242185|NCT02685449|square-wave bolus|square-wave bolus
242186|NCT02685449|insulin bolus|insulin bolus
242187|NCT02685449|dietary protein|dietary protein
242188|NCT02685423|Amblyopia|amblyopia
242189|NCT02685423|Lazy Eye|lazy eye
242190|NCT02685423|Anisometropia|anisometropia
242191|NCT02685384|healthcare access|healthcare access
242192|NCT02685384|healthcare utilization|healthcare utilization
242193|NCT02685384|health expenditures|health expenditures
242194|NCT02685384|preventive services|preventive services
242195|NCT02685384|biomarkers|biomarkers
242196|NCT02685358|Stress Disorders, Post-traumatic|stress disorders, post-traumatic
242197|NCT02685358|Primary Health Care|primary health care
242198|NCT02685358|Mobile Applications|mobile applications
242199|NCT02685358|Veterans|veterans
242200|NCT02685345|Type 2 Diabetes Mellitus|type 2 diabetes mellitus
242201|NCT02685345|sitagliptin|sitagliptin
242202|NCT02685345|adult|adult
242203|NCT02685345|Phase 2|phase 2
242204|NCT02685280|rechargeable neurostimulators|rechargeable neurostimulators
242205|NCT02685254|Group Therapy|group therapy
242206|NCT02685254|Structured Skills Training|structured skills training
242207|NCT02685254|Dialectic Behavioural Therapy|dialectic behavioural therapy
242208|NCT02685241|Exhaled breath|exhaled breath
242209|NCT02685241|Biomarker|biomarker
242210|NCT02685215|intensive care unit|intensive care unit
242211|NCT02685215|muscular dystrophy|muscular dystrophy
242212|NCT02685215|mortality|mortality
242213|NCT02685215|prognosis|prognosis
242214|NCT02685215|tracheostomy|tracheostomy
242215|NCT02685202|orofacial pain|orofacial pain
242216|NCT02685202|sleep-disordered breathing|sleep-disordered breathing
242217|NCT02685202|temporomandibular disorder|temporomandibular disorder
242218|NCT02685202|oral appliance|oral appliance
242219|NCT02685202|upper airway collapse|upper airway collapse
242220|NCT02685176|hypothermia|hypothermia
242221|NCT02685176|rewarming|rewarming
242222|NCT02685176|non-shivering|non-shivering
242223|NCT02685150|Endoscopic Tri-Modal Imaging|endoscopic tri-modal imaging
242224|NCT02685150|Gastric juice|gastric juice
242225|NCT02685150|Functional dyspepsia|functional dyspepsia
242226|NCT02685150|Acid reflux disease|acid reflux disease
242227|NCT02685150|Bile reflux|bile reflux
242228|NCT02685137|Kernicterus|kernicterus
242229|NCT02685137|Neonatal Jaundice|neonatal jaundice
242230|NCT02685137|Newborn Jaundice|newborn jaundice
242231|NCT02685137|Hyperbilirubinemia|hyperbilirubinemia
242232|NCT02685137|Stannsoporfin|stannsoporfin
242233|NCT02685111|Breast cancer|breast cancer
242234|NCT02685111|Adjuvant|adjuvant
242235|NCT02685111|Docetaxel|docetaxel
242236|NCT02685111|Adriamycin|adriamycin
242237|NCT02685111|Cyclophosphamide|cyclophosphamide
242238|NCT02685111|Neutropenia|neutropenia
242239|NCT02685111|Filgrastim|filgrastim
242240|NCT02685111|Pegfilgrastim|pegfilgrastim
242241|NCT02685098|Stem cells|stem cells
242242|NCT02685098|MSCs|mscs
242243|NCT02685098|Mesenchymal|mesenchymal
242244|NCT02685098|Amputation|amputation
242245|NCT02685098|BKA|bka
242246|NCT02685098|below knee amputation|below knee amputation
242247|NCT02685098|CHAMP|champ
242248|NCT02685098|AKA|aka
242249|NCT02685098|Above Knee Amputation|above knee amputation
242250|NCT02685098|Stromal cells|stromal cells
242251|NCT02685098|bone marrow stem cell injection|bone marrow stem cell injection
242252|NCT02685098|Allogeneic|allogeneic
242253|NCT02685072|Smoking Cessation|smoking cessation
242254|NCT02685072|Nicotine Cessation|nicotine cessation
242255|NCT02685059|breast cancer|breast cancer
242256|NCT02685059|Medi4736|medi4736
242257|NCT02685059|Anti PD-L1|anti pd-l1
242258|NCT02685059|Nab-Paclitaxel|nab-paclitaxel
242259|NCT02685059|Placebo|placebo
242260|NCT02685059|triple negative|triple negative
242261|NCT02685033|Osteomyelitis|osteomyelitis
242262|NCT02685033|dalbavancin|dalbavancin
242263|NCT02685033|antibiotic|antibiotic
242264|NCT02685020|Healthy|healthy
242265|NCT02685020|Human Immunodeficiency Virus|human immunodeficiency virus
242266|NCT02685020|adenovirus serotype 26|adenovirus serotype 26
242267|NCT02685020|Ad26.Mos.HIV|ad26.mos.hiv
242268|NCT02685020|Vaccine|vaccine
242269|NCT02685020|Placebo|placebo
242270|NCT02685020|Glycoprotein|glycoprotein
242271|NCT02685020|IPCAVD010|ipcavd010
242272|NCT02685007|minimal invasive surgery|minimal invasive surgery
242273|NCT02684994|Trauma|trauma
242274|NCT02684994|Sexual assault|sexual assault
242275|NCT02684994|Sexual abuse|sexual abuse
242276|NCT02684994|Physical assault|physical assault
242277|NCT02684994|Physical abuse|physical abuse
242278|NCT02684994|PTSD|ptsd
242279|NCT02684994|Interpersonal Violence|interpersonal violence
242280|NCT02684994|Women|women
242281|NCT02684955|cardiac arrest|cardiac arrest
242282|NCT02684955|near-infrared spectroscopy|near-infrared spectroscopy
242283|NCT02684955|automated infrared pupillometry|automated infrared pupillometry
242284|NCT02684955|prognostication|prognostication
242285|NCT02684942|Meperidine|meperidine
242286|NCT02684942|Fentanyl|fentanyl
242287|NCT02684942|Pain management|pain management
242288|NCT02684942|brachytherapy|brachytherapy
242289|NCT02684929|insulin resistance|insulin resistance
242290|NCT02684929|bcaa|bcaa
242291|NCT02684929|mitochondrial biogenesis|mitochondrial biogenesis
242292|NCT02684916|Chiropractic spinal manipulation|chiropractic spinal manipulation
242293|NCT02684916|Children|children
242294|NCT02684916|Pediatric|pediatric
242295|NCT02684916|Headache|headache
242296|NCT02684903|Child Abuse|child abuse
242297|NCT02684903|Parent Child Interaction Therapy (PCIT)|parent child interaction therapy (pcit)
242298|NCT02684903|Evidenced Based Intervention|evidenced based intervention
242299|NCT02684903|Self-control|self-control
242300|NCT02684877|Fatigue|fatigue
242301|NCT02684877|Quality of life|quality of life
242302|NCT02684877|Critically ill patients|critically ill patients
242303|NCT02684864|biomarker|biomarker
242304|NCT02684864|inflammation|inflammation
242305|NCT02684864|knee|knee
242306|NCT02684864|prognosis|prognosis
242307|NCT02684838|Gliadel, Carmustine wafer implant|gliadel, carmustine wafer implant
242308|NCT02684825|Stroke|stroke
242309|NCT02684825|ischemic stroke|ischemic stroke
242310|NCT02684825|atrial fibrillation|atrial fibrillation
242311|NCT02684825|continuous cardiac monitoring|continuous cardiac monitoring
242312|NCT02684825|insertable cardiac monitoring|insertable cardiac monitoring
242313|NCT02684825|implantable loop recorder|implantable loop recorder
242314|NCT02684825|antithrombotics|antithrombotics
242315|NCT02684825|anticoagulants|anticoagulants
242316|NCT02684825|stroke subtype|stroke subtype
242317|NCT02684825|atherothrombotic stroke|atherothrombotic stroke
242318|NCT02684825|lacunar stroke|lacunar stroke
242319|NCT02684812|antifibrinolytic therapy|antifibrinolytic therapy
242320|NCT02684812|recurrent bleeding|recurrent bleeding
242321|NCT02684812|tranexamic acid|tranexamic acid
242322|NCT02684773|Hemodialysis|hemodialysis
242323|NCT02684773|Left Ventricular Mass|left ventricular mass
242324|NCT02684773|Cardiac Magnetic resonance Imaging|cardiac magnetic resonance imaging
242325|NCT02684760|Inflammatory Bowel Disease|inflammatory bowel disease
242326|NCT02684747|Healthy Volunteers|healthy volunteers
242327|NCT02684747|Sports Medicine|sports medicine
242328|NCT02684747|Athletes|athletes
242329|NCT02684747|Anti-doping|anti-doping
242330|NCT02684734|Ulcerative Colitis|ulcerative colitis
242331|NCT02684734|UC|uc
242332|NCT02684734|Cytomegalovirus|cytomegalovirus
242333|NCT02684734|CMV|cmv
242334|NCT02684721|rehabilitation|rehabilitation
242335|NCT02684721|physical capacity|physical capacity
242336|NCT02684721|quality of life|quality of life
242337|NCT02684695|Magnetic resonance imaging|magnetic resonance imaging
242338|NCT02684695|Imaging biomarker|imaging biomarker
242339|NCT02684695|Diffusion-weighted imaging|diffusion-weighted imaging
242340|NCT02684682|Toothbrushing|toothbrushing
242341|NCT02684682|Gingivitis|gingivitis
242342|NCT02684682|Dental Plaque|dental plaque
242343|NCT02684682|Periodontal Diseases|periodontal diseases
242344|NCT02684682|Clinical Trial|clinical trial
242345|NCT02684669|burn injury|burn injury
242346|NCT02684669|controlled trial|controlled trial
242347|NCT02684669|latent sensitization|latent sensitization
242348|NCT02684669|naloxone|naloxone
242349|NCT02684669|secondary hyperalgesia|secondary hyperalgesia
242350|NCT02684669|volunteers|volunteers
242351|NCT02684656|Oxalate|oxalate
242352|NCT02684656|Inflammation|inflammation
242353|NCT02684656|Hemodiafiltration|hemodiafiltration
242354|NCT02684656|Hemodialysis|hemodialysis
242355|NCT02684656|Oxalate Blood Sample|oxalate blood sample
242356|NCT02684643|individualised therapy|individualised therapy
242357|NCT02684643|hyperphosphatemia|hyperphosphatemia
242358|NCT02684643|hemodialysis|hemodialysis
242359|NCT02684643|clinical trials|clinical trials
242360|NCT02684643|restricted phosphate diet|restricted phosphate diet
242361|NCT02684643|phosphate binders|phosphate binders
242362|NCT02684565|pre-diabetes|pre-diabetes
242363|NCT02684565|blood glucose regulation|blood glucose regulation
242364|NCT02684565|branching chain amino acids|branching chain amino acids
242365|NCT02684565|diabetes|diabetes
242366|NCT02684565|lower blood sugar|lower blood sugar
242367|NCT02684513|Well-being|well-being
242368|NCT02684513|Quality of Recovery|quality of recovery
242369|NCT02684513|Maternal complications|maternal complications
242370|NCT02684500|aSAH|asah
242371|NCT02684487|vitamin D|vitamin d
242372|NCT02684487|vitamin D3|vitamin d3
242373|NCT02684487|sepsis|sepsis
242374|NCT02684487|severe sepsis|severe sepsis
242375|NCT02684487|critical illness|critical illness
242376|NCT02684487|ICU|icu
242377|NCT02684396|Drug therapy|drug therapy
242378|NCT02684383|Dengue Vaccine|dengue vaccine
242379|NCT02684370|Psoriasis|psoriasis
242380|NCT02684370|Skin Diseases|skin diseases
242381|NCT02684370|Skin Diseases, Papulosquamous|skin diseases, papulosquamous
242382|NCT02684370|ustekinumab|ustekinumab
242383|NCT02684370|Dermatologic Agents|dermatologic agents
242384|NCT02684370|ABBV-066|abbv-066
242385|NCT02684370|BI 655066|bi 655066
242386|NCT02684370|risankizumab|risankizumab
242387|NCT02684357|ABBV-066|abbv-066
242388|NCT02684357|BI 655066|bi 655066
242389|NCT02684357|risankizumab|risankizumab
242390|NCT02684344|Post-Operative Urinary Retention|post-operative urinary retention
242391|NCT02684292|PD1|pd1
242392|NCT02684292|PD-1|pd-1
242393|NCT02684292|PDL1|pdl1
242394|NCT02684292|PD-L1|pd-l1
242395|NCT02684266|neoplasm, Cycline-Dependent Kinase|neoplasm, cycline-dependent kinase
242396|NCT02684253|Nivolumab|nivolumab
242397|NCT02684253|Stereotactic Body Radiotherapy (SBRT)|stereotactic body radiotherapy (sbrt)
242398|NCT02684253|15-253|15-253
242399|NCT02684214|food security|food security
242400|NCT02684201|Phantom Limb|phantom limb
242401|NCT02684201|Upper Amputee|upper amputee
242402|NCT02684201|Electrodes|electrodes
242403|NCT02684201|Implant|implant
242404|NCT02684201|Pain|pain
242405|NCT02684175|Audiometry|audiometry
242406|NCT02684175|Cochlear Implants|cochlear implants
242407|NCT02684175|Adult|adult
242408|NCT02684175|Telemedicine|telemedicine
242409|NCT02684175|Health Services Accessibility|health services accessibility
242410|NCT02684175|Rural Population|rural population
242411|NCT02684175|Technology Assessment, Biomedical|technology assessment, biomedical
242412|NCT02684149|Intensive care|intensive care
242413|NCT02684149|Arterial puncture|arterial puncture
242414|NCT02684149|Cross-over|cross-over
242415|NCT02684149|Relational touch|relational touch
242416|NCT02684149|Pain|pain
242417|NCT02684136|insomnia|insomnia
242418|NCT02684136|fibromyalgia|fibromyalgia
242419|NCT02684136|polysomnography|polysomnography
242420|NCT02684136|pain management|pain management
242421|NCT02684123|Alopecia areata|alopecia areata
242422|NCT02684097|Alopecia, Alopecia Totalis, Alopecia Universalis|alopecia, alopecia totalis, alopecia universalis
242423|NCT02684084|Diabetic Macular Edema|diabetic macular edema
242424|NCT02684084|Ozurdex|ozurdex
242425|NCT02684084|Lucentis|lucentis
242426|NCT02684071|medulloblastoma, ependymoma, AT/RT, embryonal|medulloblastoma, ependymoma, at/rt, embryonal
242427|NCT02684058|Malignant glioma|malignant glioma
242428|NCT02684058|BRAF mutant positive|braf mutant positive
242429|NCT02684058|High grade glioma|high grade glioma
242430|NCT02684058|Low grade glioma|low grade glioma
242431|NCT02684058|Dabrafenib|dabrafenib
242432|NCT02684058|Trametinib|trametinib
242433|NCT02684058|Pediatrics|pediatrics
242434|NCT02684058|Brain neoplasma|brain neoplasma
242435|NCT02684032|PI3K (phosphoinositide 3-kinase)|pi3k (phosphoinositide 3-kinase)
242436|NCT02684032|mTOR (mechanistic target of rapamycin)|mtor (mechanistic target of rapamycin)
242437|NCT02684032|PI3K/mTOR|pi3k/mtor
242438|NCT02684032|metastatic breast cancer (MBC)|metastatic breast cancer (mbc)
242439|NCT02684032|ER+ (estrogen receptor positive)|er+ (estrogen receptor positive)
242440|NCT02684032|HER2- (human epidermal growth factor receptor 2 negative)|her2- (human epidermal growth factor receptor 2 negative)
242441|NCT02684019|Endoscopic retrograde cholangiopancreatography|endoscopic retrograde cholangiopancreatography
242442|NCT02684019|sedation|sedation
242443|NCT02684019|dexmedetomidine|dexmedetomidine
242444|NCT02684019|propofol|propofol
242445|NCT02684019|Magnesium sulphate|magnesium sulphate
242446|NCT02684019|Bispectral index monitoring|bispectral index monitoring
242447|NCT02684006|Cancer|cancer
242448|NCT02684006|renal cell cancer|renal cell cancer
242449|NCT02684006|kidney disease|kidney disease
242450|NCT02684006|kidney neoplasms|kidney neoplasms
242451|NCT02684006|axitinib, sunitinib|axitinib, sunitinib
242452|NCT02683915|Acute kidney injury|acute kidney injury
242453|NCT02683915|Perinatal asphyxia|perinatal asphyxia
242454|NCT02683915|Therapeutic hypothermia|therapeutic hypothermia
242455|NCT02683915|Serum NGAL|serum ngal
242456|NCT02683915|Serum cystatin-C|serum cystatin-c
242457|NCT02683902|prediabetes|prediabetes
242458|NCT02683902|tDCS|tdcs
242459|NCT02683902|transcranial direct current stimulation|transcranial direct current stimulation
242460|NCT02683902|obesity|obesity
242461|NCT02683902|diabetes|diabetes
242462|NCT02683876|body odor, malodor, halitosis|body odor, malodor, halitosis
242463|NCT02683837|Intraoperative Neurophysiological Monitoring|intraoperative neurophysiological monitoring
242464|NCT02683837|Reflex, Pupillary|reflex, pupillary
242465|NCT02683837|remifentanil|remifentanil
242466|NCT02683811|adolescence|adolescence
242467|NCT02683811|prevention|prevention
242468|NCT02683811|wellbeing|wellbeing
242469|NCT02683811|evaluation|evaluation
242470|NCT02683811|effectiveness|effectiveness
242471|NCT02683811|school-based program|school-based program
242472|NCT02683798|Weight loss maintenance|weight loss maintenance
242473|NCT02683785|Pain intensity|pain intensity
242474|NCT02683785|Hand Osteoarthritis|hand osteoarthritis
242475|NCT02683785|GSK3196165|gsk3196165
242476|NCT02683785|AUSCAN|auscan
242477|NCT02683785|GM-CSF|gm-csf
242478|NCT02683785|Numerical Rating Scale|numerical rating scale
242479|NCT02683772|NIV, NIPPV, ventilation|niv, nippv, ventilation
242480|NCT02683746|Pharmacodynamics|pharmacodynamics
242481|NCT02683746|Safety|safety
242482|NCT02683746|Albiglutide|albiglutide
242483|NCT02683746|Tolerability|tolerability
242484|NCT02683746|Type 2 Diabetes Mellitus|type 2 diabetes mellitus
309989|NCT02290106|obesity|obesity
242485|NCT02683746|Efficacy|efficacy
242486|NCT02683707|Percutaneous Coronary Intervention|percutaneous coronary intervention
242487|NCT02683707|Blood Platelets|blood platelets
242488|NCT02683707|Fentanyl|fentanyl
242489|NCT02683694|Epiretinal membrane|epiretinal membrane
242490|NCT02683694|lamellar holes of the macula|lamellar holes of the macula
242491|NCT02683694|macular holes|macular holes
242492|NCT02683694|vitreomacular traction syndrome|vitreomacular traction syndrome
242493|NCT02683668|Inhalers|inhalers
242494|NCT02683668|Tiotropium|tiotropium
242495|NCT02683629|Parkinson's Disease|parkinson's disease
242496|NCT02683629|Xenotransplantation|xenotransplantation
242497|NCT02683629|choroid plexus|choroid plexus
242498|NCT02683603|colistin|colistin
242499|NCT02683603|aerosol|aerosol
242500|NCT02683603|ventilator associated pneumonia|ventilator associated pneumonia
242501|NCT02683603|nephrotoxicity|nephrotoxicity
242502|NCT02683603|intravenous|intravenous
242503|NCT02683590|Sternectomie|sternectomie
242504|NCT02683590|Ceramic Implant|ceramic implant
242505|NCT02683590|Bones Tumors|bones tumors
242506|NCT02683538|RFA|rfa
242507|NCT02683525|Allogeneic|allogeneic
242508|NCT02683525|Sitagliptin|sitagliptin
242509|NCT02683499|Tooth preparation|tooth preparation
242510|NCT02683499|Prosthodontics|prosthodontics
242511|NCT02683447|Continuing Medical Education|continuing medical education
242512|NCT02683447|Simulation|simulation
242513|NCT02683447|Non-technical Skills|non-technical skills
242514|NCT02683447|Crisis Resource Management|crisis resource management
242515|NCT02683434|soccer|soccer
242516|NCT02683421|Rheumatoid arthritis|rheumatoid arthritis
242517|NCT02683421|Tilmanocept|tilmanocept
242518|NCT02683421|Imaging|imaging
242519|NCT02683395|PLX51107|plx51107
242520|NCT02683395|Acute Myeloid Leukemia|acute myeloid leukemia
242521|NCT02683395|Myelodysplastic Syndrome|myelodysplastic syndrome
242522|NCT02683395|Non-Hodgkin's Lymphoma|non-hodgkin's lymphoma
242523|NCT02683369|Non-anemic Iron Deficiency, Iron Supplementation|non-anemic iron deficiency, iron supplementation
242524|NCT02683356|Percutaneous Coronary Intervention|percutaneous coronary intervention
242525|NCT02683356|Stents|stents
242526|NCT02683330|PD|pd
242527|NCT02683330|Parkinson's|parkinson's
242528|NCT02683317|DHA|dha
242529|NCT02683317|Retinopathy of Prematurity|retinopathy of prematurity
242530|NCT02683291|Kidney transplantation|kidney transplantation
242531|NCT02683291|sirolimus|sirolimus
242532|NCT02683291|cytomegalovirus|cytomegalovirus
242533|NCT02683291|aged|aged
242534|NCT02683252|Magnetic resonance imaging|magnetic resonance imaging
242535|NCT02683252|perfusion|perfusion
242536|NCT02683252|quantitative|quantitative
242537|NCT02683213|fluoxetine|fluoxetine
242538|NCT02683213|outcome|outcome
242539|NCT02683213|depression|depression
242540|NCT02683213|plasticity|plasticity
242541|NCT02683187|insulin secretion|insulin secretion
242542|NCT02683187|GLP-1|glp-1
242543|NCT02683187|alpha cell|alpha cell
242544|NCT02683187|paracrine effect|paracrine effect
242545|NCT02683187|Glucagon-Like Peptide 1|glucagon-like peptide 1
242546|NCT02683174|syncope|syncope
242547|NCT02683122|Organ dysfunction scores|organ dysfunction scores
242548|NCT02683122|Pneumonia, Ventilator-Associated|pneumonia, ventilator-associated
242549|NCT02683122|Intensive care units|intensive care units
242550|NCT02683070|Catheter-related bladder discomfort|catheter-related bladder discomfort
242551|NCT02683070|Pudendal nerve block|pudendal nerve block
242552|NCT02683070|Tramadol|tramadol
242553|NCT02683070|Randomized controlled trial|randomized controlled trial
242554|NCT02683070|catheter-related bladder discomfort prevention|catheter-related bladder discomfort prevention
242555|NCT02683044|Erectile dysfunction|erectile dysfunction
242556|NCT02683044|Low-Density Shock Waves|low-density shock waves
242557|NCT02683044|Randomized Clinical Trial|randomized clinical trial
242558|NCT02683031|fertilization arrest|fertilization arrest
242559|NCT02683031|Cleavage failure|cleavage failure
242560|NCT02683031|Embryonic development|embryonic development
242561|NCT02683031|Calcium ionophore|calcium ionophore
242562|NCT02683005|treatment|treatment
242563|NCT02683005|pharmacokinetics|pharmacokinetics
242564|NCT02682979|therapeutic limitation code|therapeutic limitation code
242565|NCT02682979|emergency unit admittance|emergency unit admittance
242566|NCT02682966|troponin|troponin
242567|NCT02682966|coronary artery disease|coronary artery disease
242568|NCT02682966|pulmonary embolism|pulmonary embolism
242569|NCT02682966|Computed Tomography Angiography|computed tomography angiography
242570|NCT02682966|postoperative myocardial injury|postoperative myocardial injury
242571|NCT02682927|seizure|seizure
242572|NCT02682927|tonic-atonic|tonic-atonic
242573|NCT02682927|clonic|clonic
242574|NCT02682927|epilepsy|epilepsy
242575|NCT02682927|myoclonic|myoclonic
242576|NCT02682927|encephalopathy|encephalopathy
242577|NCT02682914|Psychological distress|psychological distress
242578|NCT02682914|Stroke etiology|stroke etiology
242579|NCT02682914|Young patients|young patients
242580|NCT02682888|brain functional connectivity changes|brain functional connectivity changes
242581|NCT02682862|tiotropium|tiotropium
242582|NCT02682862|olodaterol|olodaterol
242583|NCT02682862|smoker|smoker
242584|NCT02682862|cigarette|cigarette
242585|NCT02682862|bronchodilator|bronchodilator
242586|NCT02682836|physical activity|physical activity
242587|NCT02682836|chemotherapy|chemotherapy
242588|NCT02682836|fatigue|fatigue
242589|NCT02682810|HIV|hiv
242590|NCT02682810|point-of-care HIV diagnosis|point-of-care hiv diagnosis
242591|NCT02682810|Alere Q|alere q
242592|NCT02682810|diagnostic|diagnostic
242593|NCT02682810|children|children
242594|NCT02682771|gastroplasty, breathing exercices, positive pressure|gastroplasty, breathing exercices, positive pressure
242595|NCT02682758|xenon|xenon
242596|NCT02682758|transpulmonary pressure|transpulmonary pressure
242597|NCT02682758|electrical impedance tomography|electrical impedance tomography
242598|NCT02682758|tidal volume|tidal volume
242599|NCT02682758|esophageal pressure measurement|esophageal pressure measurement
242600|NCT02682732|Acute Myeloid Leukemia|acute myeloid leukemia
242601|NCT02682732|PET/CT Scan|pet/ct scan
242602|NCT02682719|Natriuretic peptide, brain|natriuretic peptide, brain
242603|NCT02682719|Diabetes Mellitus, Type 2|diabetes mellitus, type 2
242604|NCT02682719|Hypertension|hypertension
242605|NCT02682719|Cardiovascular prevention|cardiovascular prevention
242606|NCT02682719|Left atrial volume index|left atrial volume index
242607|NCT02682719|Angiotensin receptor neprilysin inhibitor|angiotensin receptor neprilysin inhibitor
242608|NCT02682719|LCZ696|lcz696
242609|NCT02682719|Valsartan|valsartan
242610|NCT02682719|Sacubitril|sacubitril
242611|NCT02682706|brown adipose tissue|brown adipose tissue
242612|NCT02682706|magnetic resonance imaging|magnetic resonance imaging
242613|NCT02682706|energy expenditure|energy expenditure
242614|NCT02682706|non-shivering thermogenesis|non-shivering thermogenesis
242615|NCT02682680|diabetes|diabetes
242616|NCT02682680|hyperlipidaemia|hyperlipidaemia
242617|NCT02682680|colesevelam|colesevelam
242618|NCT02682680|ezetimibe|ezetimibe
242619|NCT02682680|LDL cholesterol|ldl cholesterol
242620|NCT02682680|glycated hemoglobin|glycated hemoglobin
242621|NCT02682667|Apheresis Products|apheresis products
242622|NCT02682667|Immunological|immunological
242623|NCT02682667|Diverse Malignan|diverse malignan
242624|NCT02682667|Premalignant|premalignant
242625|NCT02682667|Protein|protein
242626|NCT02682654|Pain|pain
242627|NCT02682654|Ankle|ankle
242628|NCT02682654|Knee|knee
242629|NCT02682654|Brace|brace
242630|NCT02682615|Cardiac Index|cardiac index
242631|NCT02682615|Noninvasive|noninvasive
242632|NCT02682615|esCCO|escco
242633|NCT02682615|PiCCO|picco
242634|NCT02682615|Thermodilution|thermodilution
242635|NCT02682602|total hip arthroplasty|total hip arthroplasty
242636|NCT02682589|Complete Mesocolic Excision|complete mesocolic excision
242637|NCT02682589|locally advanced Colon Cancer|locally advanced colon cancer
242638|NCT02682589|Laparoscopic|laparoscopic
242639|NCT02682576|brachial artery ultrasound imaging|brachial artery ultrasound imaging
242640|NCT02682576|flow-mediated dilation|flow-mediated dilation
242641|NCT02682576|endothelium|endothelium
242743|NCT02682069|fluorescence imaging|fluorescence imaging
242844|NCT02681289|infant|infant
242642|NCT02682563|SGLT-2 inhibition, Renal, Cardiovascular, Type 2 diabetes, forxiga, dapagliflozin|sglt-2 inhibition, renal, cardiovascular, type 2 diabetes, forxiga, dapagliflozin
242643|NCT02682550|polytrauma|polytrauma
242644|NCT02682550|hemorrhagic shock|hemorrhagic shock
242645|NCT02682550|sepsis|sepsis
242646|NCT02682550|MODS|mods
242647|NCT02682537|Resting energy expenditure|resting energy expenditure
242648|NCT02682537|Calorie requirements|calorie requirements
242649|NCT02682537|Indirect Calorimetry|indirect calorimetry
242650|NCT02682511|Ifetroban|ifetroban
242651|NCT02682511|Scleroderma|scleroderma
242652|NCT02682511|Systemic Sclerosis|systemic sclerosis
242653|NCT02682498|Knee Arthroplasty, Total|knee arthroplasty, total
242654|NCT02682498|Liposomal Bupivicaine|liposomal bupivicaine
242655|NCT02682485|Rectal Cancer|rectal cancer
242656|NCT02682485|low anterior resection|low anterior resection
242657|NCT02682485|SES|ses
242658|NCT02682485|SES-DTA|ses-dta
242659|NCT02682485|anastomotic leak|anastomotic leak
242660|NCT02682485|anastomotic healing|anastomotic healing
242661|NCT02682485|intestinal healing|intestinal healing
242662|NCT02682485|anastomosis|anastomosis
242663|NCT02682459|Extracapillary glomerulonephritis|extracapillary glomerulonephritis
242664|NCT02682459|crescentic glomerulonephritis|crescentic glomerulonephritis
242665|NCT02682459|rapidly progressive renal failure|rapidly progressive renal failure
242666|NCT02682459|chronic kidney disease|chronic kidney disease
242667|NCT02682459|ACE-inhibitors|ace-inhibitors
242668|NCT02682459|fibrosis|fibrosis
242669|NCT02682446|Early gastric cancer|early gastric cancer
242670|NCT02682446|endoscopic submucosal dissection|endoscopic submucosal dissection
242671|NCT02682446|serum pepsinogen|serum pepsinogen
242672|NCT02682446|Helicobacter pylori|helicobacter pylori
242673|NCT02682407|IgAN|igan
242674|NCT02682407|MN|mn
242675|NCT02682407|C3 Glomerulopathy|c3 glomerulopathy
242676|NCT02682407|Lupus Nephritis|lupus nephritis
242677|NCT02682394|Cancer of pancreas|cancer of pancreas
242678|NCT02682394|steatosis|steatosis
242679|NCT02682394|MRI|mri
242680|NCT02682381|Teduglutide|teduglutide
242681|NCT02682381|pediatric|pediatric
242682|NCT02682381|GLP-2|glp-2
242683|NCT02682381|parenteral support|parenteral support
242684|NCT02682381|Short Bowel Syndrome|short bowel syndrome
242685|NCT02682381|short gut syndrome|short gut syndrome
242686|NCT02682381|short gut|short gut
242687|NCT02682381|SBS|sbs
242688|NCT02682381|parenteral nutrition|parenteral nutrition
242689|NCT02682368|Surgeon performed ultrasound|surgeon performed ultrasound
242690|NCT02682368|Point of care ultrasound|point of care ultrasound
242691|NCT02682329|Peroxide|peroxide
242692|NCT02682316|undergoing laparotomy|undergoing laparotomy
242693|NCT02682316|15-309|15-309
242694|NCT02682303|Adhesive elastic bandaging|adhesive elastic bandaging
242695|NCT02682303|balance|balance
242696|NCT02682303|posturography|posturography
242697|NCT02682290|SPUTUM|sputum
242698|NCT02682290|RHEOLOGY|rheology
242699|NCT02682277|obesity|obesity
242700|NCT02682277|body weight|body weight
242701|NCT02682277|overweight|overweight
242702|NCT02682277|weight loss|weight loss
242703|NCT02682277|polyglucosamine|polyglucosamine
242704|NCT02682277|L112|l112
242705|NCT02682277|caloric restriction|caloric restriction
242706|NCT02682277|physical activity|physical activity
242707|NCT02682264|acne|acne
242708|NCT02682251|Cardiac Resynchronization Therapy Devices|cardiac resynchronization therapy devices
242709|NCT02682251|Cardiac Resynchronization Therapy|cardiac resynchronization therapy
242710|NCT02682225|Esketamine|esketamine
242711|NCT02682225|Placebo|placebo
242712|NCT02682225|Racemic ketamine|racemic ketamine
242713|NCT02682225|Pharmacokinetics|pharmacokinetics
242714|NCT02682212|Pelvic floor|pelvic floor
242715|NCT02682212|obstetrics|obstetrics
242716|NCT02682212|perineal tear|perineal tear
242717|NCT02682212|physiotherapy|physiotherapy
242718|NCT02682186|Prosthetic breast surgery|prosthetic breast surgery
242719|NCT02682186|Locoregional anesthesia|locoregional anesthesia
242720|NCT02682186|Pectoral nerve block|pectoral nerve block
242721|NCT02682186|Pain|pain
242722|NCT02682186|Postoperative analgesia|postoperative analgesia
242723|NCT02682160|bariatric surgery|bariatric surgery
242724|NCT02682134|Sore Throat|sore throat
242725|NCT02682134|Intubation|intubation
242726|NCT02682134|Xylocaine|xylocaine
242727|NCT02682134|Dexamethasone|dexamethasone
242728|NCT02682108|Hepatitis B|hepatitis b
242729|NCT02682108|Hepatitis C|hepatitis c
242730|NCT02682108|Fibrosis, Liver|fibrosis, liver
242731|NCT02682108|Magnetic Resonance Imaging|magnetic resonance imaging
242732|NCT02682095|Hypertension|hypertension
242733|NCT02682095|Blood Pressure Control|blood pressure control
242734|NCT02682095|Adherence|adherence
242735|NCT02682095|Mixed Methods|mixed methods
242736|NCT02682082|Pancreatic cancer|pancreatic cancer
242737|NCT02682082|Pain Management|pain management
242738|NCT02682082|Celiac plexus neurolysis|celiac plexus neurolysis
242739|NCT02682082|Bupivacaine|bupivacaine
242740|NCT02682082|Palliative treatment|palliative treatment
242741|NCT02682069|Diabetic foot ulcer|diabetic foot ulcer
242742|NCT02682069|venous leg ulcer|venous leg ulcer
242744|NCT02682069|wound imaging|wound imaging
242745|NCT02682056|Pediatrics|pediatrics
242746|NCT02682056|Endocrinology|endocrinology
242747|NCT02682056|Adolescent|adolescent
242748|NCT02682056|Microneedle|microneedle
242749|NCT02682030|Airway Clearance Devices|airway clearance devices
242750|NCT02682030|High Frequency Chest Compression Devices|high frequency chest compression devices
242751|NCT02682030|Cough Assist|cough assist
242752|NCT02682017|Seaweed|seaweed
242753|NCT02682017|Pork|pork
242754|NCT02682017|Fucoidan|fucoidan
242755|NCT02682017|Laminarin|laminarin
242756|NCT02682017|Functional Food|functional food
242757|NCT02682017|Antioxidant activity|antioxidant activity
242758|NCT02681913|Cardioplegia|cardioplegia
242759|NCT02681913|Cardiac Surgery|cardiac surgery
242760|NCT02681913|Adenosine|adenosine
242761|NCT02681913|Therapeutic Uses|therapeutic uses
242762|NCT02681913|Intermittent warm blood cardioplegia|intermittent warm blood cardioplegia
242763|NCT02681913|Minimally Invasive Surgery|minimally invasive surgery
242764|NCT02681913|minimally invasive mitral valve plasty (mini-MPL)|minimally invasive mitral valve plasty (mini-mpl)
242765|NCT02681913|minimally invasive mitral valve replacement (mini-MVR)|minimally invasive mitral valve replacement (mini-mvr)
242766|NCT02681874|dietary pattern|dietary pattern
242767|NCT02681874|stress|stress
242768|NCT02681874|nutrition|nutrition
242769|NCT02681874|health|health
242770|NCT02681874|obesity|obesity
242771|NCT02681874|children|children
242772|NCT02681874|minority|minority
242773|NCT02681874|pre-schoolers|pre-schoolers
242774|NCT02681861|Pharmacodynamics|pharmacodynamics
242775|NCT02681861|Pharmacokinetics|pharmacokinetics
242776|NCT02681861|ASP6294|asp6294
242777|NCT02681861|Maximum tolerated dose|maximum tolerated dose
242778|NCT02681861|Healthy subjects|healthy subjects
310362|NCT02288104|CT|ct
242779|NCT02681848|Primary care attendance|primary care attendance
242780|NCT02681848|All-cause|all-cause
242781|NCT02681848|Cause specific|cause specific
242782|NCT02681848|Hospital attendance|hospital attendance
242783|NCT02681822|Genome-wide association studies|genome-wide association studies
242784|NCT02681822|Environmental factors|environmental factors
242785|NCT02681822|Behavioral Assessment|behavioral assessment
242786|NCT02681822|Pathway analysis|pathway analysis
242787|NCT02681783|aflibercept|aflibercept
242788|NCT02681770|kidney transplantation|kidney transplantation
242789|NCT02681770|adherence|adherence
242790|NCT02681770|quality of life|quality of life
242791|NCT02681770|couples|couples
242792|NCT02681770|fundamental frequency|fundamental frequency
242793|NCT02681770|communication|communication
242794|NCT02681770|social support|social support
242795|NCT02681757|pediatric hand burn|pediatric hand burn
242796|NCT02681757|pediatric foot burn|pediatric foot burn
242797|NCT02681757|mepitel Ag|mepitel ag
242798|NCT02681757|soft cast technique for burn wound heaing|soft cast technique for burn wound heaing
242799|NCT02681718|A1C≥9%|a1c≥9%
242800|NCT02681718|minorities|minorities
242801|NCT02681718|economically disadvantaged|economically disadvantaged
242802|NCT02681692|colonoscopy|colonoscopy
242803|NCT02681692|colonoscopy education|colonoscopy education
242804|NCT02681692|magnetic endoscope imaging|magnetic endoscope imaging
242805|NCT02681692|Colonic Diseases|colonic diseases
242806|NCT02681666|FODMAP Diet|fodmap diet
242807|NCT02681666|Bowel Habit|bowel habit
242808|NCT02681666|Rome IV Criteria|rome iv criteria
242809|NCT02681666|Mindfulness|mindfulness
242810|NCT02681666|Abdominal pain|abdominal pain
242811|NCT02681666|Irritable Bowel Syndrome|irritable bowel syndrome
242812|NCT02681653|Statins|statins
242813|NCT02681653|Septic Shock|septic shock
242814|NCT02681614|Imaging|imaging
242815|NCT02681614|Prostate|prostate
242816|NCT02681614|Multiparametric MRI|multiparametric mri
242817|NCT02681614|brachytherapy|brachytherapy
242818|NCT02681601|Diet, Food, and Nutrition|diet, food, and nutrition
242819|NCT02681588|diabetes, obesity, skinfold, newborn|diabetes, obesity, skinfold, newborn
242820|NCT02681562|olaparib|olaparib
242821|NCT02681510|medication tolerability|medication tolerability
242822|NCT02681497|canagliflozin|canagliflozin
242823|NCT02681497|diabetes|diabetes
242824|NCT02681497|SGLT2|sglt2
242825|NCT02681497|real-world data|real-world data
242826|NCT02681471|Monopolar|monopolar
242827|NCT02681471|Bipolar|bipolar
242828|NCT02681471|TURP syndrome|turp syndrome
242829|NCT02681471|hyponatremia|hyponatremia
242830|NCT02681432|HIPEC|hipec
242831|NCT02681432|ovarian cancer|ovarian cancer
242832|NCT02681432|peritoneal carcinomatosis|peritoneal carcinomatosis
242833|NCT02681393|Physical activity, brochures, telephone support, stroke|physical activity, brochures, telephone support, stroke
242834|NCT02681380|simulated patient|simulated patient
242835|NCT02681380|Balint|balint
242836|NCT02681380|empathy|empathy
242837|NCT02681380|medical student|medical student
242838|NCT02681367|Recurrent implantation failure|recurrent implantation failure
242839|NCT02681367|Freeze all policy|freeze all policy
242840|NCT02681367|endometrial receptivity|endometrial receptivity
242841|NCT02681367|implantation|implantation
242842|NCT02681367|clinical outcome|clinical outcome
242843|NCT02681354|elderly|elderly
242845|NCT02681289|risk|risk
242846|NCT02681289|rehabilitation|rehabilitation
242847|NCT02681276|Irrigation during root canal treatment|irrigation during root canal treatment
242848|NCT02681276|Sodium Hypochlorite|sodium hypochlorite
242849|NCT02681250|Zirconium|zirconium
242850|NCT02681250|Randomized Controlled Trial|randomized controlled trial
242851|NCT02681250|Dental Implants|dental implants
242852|NCT02681250|Dental Material|dental material
242853|NCT02681250|Titanium|titanium
242854|NCT02681211|migraine headache|migraine headache
242855|NCT02681211|acupuncture|acupuncture
242856|NCT02681198|Healthy|healthy
242857|NCT02681198|Lofexidine|lofexidine
242858|NCT02681198|Paroxetine|paroxetine
242859|NCT02681198|Volunteer|volunteer
242860|NCT02681172|CSF|csf
242861|NCT02681172|Alzheimer's Disease (AD) and related dementia|alzheimer's disease (ad) and related dementia
242862|NCT02681172|HAS recommendations|has recommendations
242863|NCT02681159|Anesthesia|anesthesia
242864|NCT02681146|education|education
242865|NCT02681146|physiotherapy|physiotherapy
242866|NCT02681133|Physical activity level|physical activity level
242867|NCT02681133|Knee osteoarthritis|knee osteoarthritis
242868|NCT02681133|Non pharmacological treatment|non pharmacological treatment
242869|NCT02681133|Survey|survey
242870|NCT02681133|Socio-demographic, clinical variables|socio-demographic, clinical variables
242871|NCT02681133|Barriers, facilitators Fears and beliefs|barriers, facilitators fears and beliefs
242872|NCT02681133|Function|function
242873|NCT02681120|Biomarkers|biomarkers
242874|NCT02681120|Breast imaging|breast imaging
242875|NCT02681107|Radiation therapy|radiation therapy
242876|NCT02681107|Accelerated partial breast irradiation (APBI)|accelerated partial breast irradiation (apbi)
310511|NCT02287116|BPD|bpd
242877|NCT02681107|Breast conserving surgery|breast conserving surgery
242878|NCT02681107|Stage 1|stage 1
242879|NCT02681094|Diabetes Mellitus Type 2,|diabetes mellitus type 2,
242880|NCT02681094|saxagliptin,|saxagliptin,
242881|NCT02681094|dapagliflozin,|dapagliflozin,
242882|NCT02681094|metformin|metformin
242883|NCT02681081|Neuroplasticity|neuroplasticity
242884|NCT02681068|Fecal microbiota transplantation (FMT)|fecal microbiota transplantation (fmt)
242885|NCT02681068|Clostridium difficile associated diarrhea (CDAD)|clostridium difficile associated diarrhea (cdad)
242886|NCT02681055|NASH|nash
242887|NCT02681055|NAFLD|nafld
242888|NCT02681029|Cleavage stage blastocyst transfer cryopreservation|cleavage stage blastocyst transfer cryopreservation
242889|NCT02681016|Calypso|calypso
242890|NCT02681016|Xience|xience
242891|NCT02681016|Coronary stenosis|coronary stenosis
242892|NCT02681016|Drug-eluting stent|drug-eluting stent
242893|NCT02681016|Coronary angioplasty with stenting|coronary angioplasty with stenting
242894|NCT02681016|Ischemic Heart Disease|ischemic heart disease
242895|NCT02680977|Mucuna pruriens|mucuna pruriens
242896|NCT02680977|Levodopa|levodopa
242897|NCT02680951|Pediatric|pediatric
242898|NCT02680951|Adolescent|adolescent
242899|NCT02680912|Bi syndrome|bi syndrome
242900|NCT02680899|science education|science education
242901|NCT02680899|health promotion|health promotion
242902|NCT02680899|mental health promotion|mental health promotion
242903|NCT02680899|stigmatization|stigmatization
242904|NCT02680899|behavioral intervention|behavioral intervention
242905|NCT02680886|Rapid Absorbable Suture Material|rapid absorbable suture material
242906|NCT02680886|Children / Adults|children / adults
242907|NCT02680886|Novosyn Quick|novosyn quick
242908|NCT02680873|type 2 diabetes , obesity , SASI|type 2 diabetes , obesity , sasi
242909|NCT02680847|Pediatric|pediatric
242910|NCT02680847|pain indication|pain indication
242911|NCT02680847|controlled release oxycodone|controlled release oxycodone
242912|NCT02680834|venous stasis ulcer|venous stasis ulcer
242913|NCT02680834|wound|wound
242914|NCT02680834|chronic venous insufficiency|chronic venous insufficiency
242915|NCT02680821|Laxity|laxity
242916|NCT02680821|Knee|knee
242917|NCT02680821|Rupture|rupture
242918|NCT02680821|ALL|all
242919|NCT02680795|UGT1A1*28|ugt1a1*28
242920|NCT02680795|Belinostat|belinostat
242921|NCT02680795|beleodaq|beleodaq
242922|NCT02680795|wild type genotypes|wild type genotypes
242923|NCT02680795|heterozygous genotypes|heterozygous genotypes
242924|NCT02680795|homozygous genotypes|homozygous genotypes
242925|NCT02680782|Healthy Volunteers|healthy volunteers
242926|NCT02680782|Comparison|comparison
242927|NCT02680782|Once-Daily|once-daily
242928|NCT02680782|Twice-Daily|twice-daily
242929|NCT02680782|X4P-001|x4p-001
242930|NCT02680756|Iron Deficiency|iron deficiency
242931|NCT02680756|Anaemia|anaemia
242932|NCT02680756|Crohn's Disease|crohn's disease
242933|NCT02680756|Deficiency Diseases|deficiency diseases
242934|NCT02680756|Inflammatory Bowel Diseases|inflammatory bowel diseases
242935|NCT02680756|Intestinal Diseases|intestinal diseases
242936|NCT02680730|Autonomic nervous system|autonomic nervous system
242937|NCT02680730|Auditory processing disorder|auditory processing disorder
242938|NCT02680730|Social behavior|social behavior
242939|NCT02680691|infratentorial stroke|infratentorial stroke
242940|NCT02680691|robot|robot
242941|NCT02680691|postural balance|postural balance
242942|NCT02680691|Rehabilitation|rehabilitation
242943|NCT02680652|CVID|cvid
242944|NCT02680652|Common Variable Immune Deficiency|common variable immune deficiency
242945|NCT02680639|High-Frequency Ventilation|high-frequency ventilation
242946|NCT02680639|Biphasic Continuous Positive Airway Pressure|biphasic continuous positive airway pressure
242947|NCT02680613|Behaviour Change|behaviour change
242948|NCT02680613|Secondary Prevention|secondary prevention
242949|NCT02680613|mHealth|mhealth
242950|NCT02680587|Prostate Cancer|prostate cancer
242951|NCT02680587|Stereotactic Body Radiation Therapy|stereotactic body radiation therapy
242952|NCT02680587|Stereotactic Ablative Radiotherapy|stereotactic ablative radiotherapy
242953|NCT02680587|Oligometastasis|oligometastasis
242954|NCT02680574|vadadustat|vadadustat
242955|NCT02680574|AKB-6548|akb-6548
242956|NCT02680574|Chronic kidney disease|chronic kidney disease
242957|NCT02680574|anemia|anemia
242958|NCT02680574|CKD|ckd
242959|NCT02680574|chronic renal insufficiency|chronic renal insufficiency
242960|NCT02680574|renal impairment|renal impairment
242961|NCT02680574|erythropoietin|erythropoietin
242962|NCT02680574|kidney|kidney
242963|NCT02680574|renal|renal
242964|NCT02680574|oral anemia treatment|oral anemia treatment
242965|NCT02680574|hemoglobin|hemoglobin
242966|NCT02680574|hypoxia-inducible factor|hypoxia-inducible factor
242967|NCT02680574|HIF|hif
242968|NCT02680574|hypoxia-inducible factor prolyl-hydroxylase inhibitor|hypoxia-inducible factor prolyl-hydroxylase inhibitor
242969|NCT02680574|HIF-PHI|hif-phi
242970|NCT02680574|efficacy|efficacy
242971|NCT02680574|safety|safety
242972|NCT02680574|Phase 3|phase 3
242973|NCT02680574|cardiovascular|cardiovascular
310610|NCT02286531|PET|pet
242974|NCT02680574|NDD-CKD|ndd-ckd
242975|NCT02680548|ankle pain|ankle pain
242976|NCT02680548|foot pain|foot pain
242977|NCT02680548|methylprednisolone|methylprednisolone
242978|NCT02680548|neuropathic pain|neuropathic pain
242979|NCT02680522|Parkinson's disease|parkinson's disease
242980|NCT02680522|Heart Rate Variability|heart rate variability
242981|NCT02680522|Physiotherapy|physiotherapy
242982|NCT02680496|Robot-Assistance|robot-assistance
242983|NCT02680496|Gait [MeSH]|gait [mesh]
242984|NCT02680496|Energy Consumption|energy consumption
242985|NCT02680496|Cardiorespiratory Load|cardiorespiratory load
242986|NCT02680496|Stroke [MeSH]|stroke [mesh]
242987|NCT02680483|Atrial fibrillation|atrial fibrillation
242988|NCT02680483|Registry|registry
242989|NCT02680483|Middle East|middle east
242990|NCT02680483|Jordan|jordan
242991|NCT02680483|risk factors|risk factors
242992|NCT02680483|in hospital management|in hospital management
242993|NCT02680483|long term management|long term management
242994|NCT02680470|Tuberculosis|tuberculosis
242995|NCT02680470|Management|management
242996|NCT02680470|Observed therapy|observed therapy
242997|NCT02680444|Mindfulness|mindfulness
242998|NCT02680444|Primary Promotion|primary promotion
242999|NCT02680444|Mental Health|mental health
243000|NCT02680444|Well-being|well-being
243001|NCT02680444|Positive Reappraisal|positive reappraisal
243002|NCT02680392|Pulsed and Continuous Radiofrequency Treatment|pulsed and continuous radiofrequency treatment
243003|NCT02680392|Continuous adductor canal block|continuous adductor canal block
243004|NCT02680392|Postoperative pain|postoperative pain
243005|NCT02680392|Functional recovery|functional recovery
243006|NCT02680392|Total Knee Joint Replacement|total knee joint replacement
243007|NCT02680379|Fragile X Syndrome|fragile x syndrome
243008|NCT02680379|Autism|autism
243009|NCT02680379|FMR1|fmr1
243010|NCT02680379|FRAXA|fraxa
243011|NCT02680340|Total Hip Arthroplasty THA|total hip arthroplasty tha
243012|NCT02680314|unripe cervix|unripe cervix
243013|NCT02680301|Wet Wraps|wet wraps
243014|NCT02680301|Topical Steroid|topical steroid
243015|NCT02680288|Psychostimulant, Craving, Cocaine.|psychostimulant, craving, cocaine.
243016|NCT02680275|Chronic endometritis|chronic endometritis
243017|NCT02680275|Miscarriage|miscarriage
243018|NCT02680275|Infertility|infertility
243019|NCT02680262|HPV self-sampling, cervical cancer screening|hpv self-sampling, cervical cancer screening
243020|NCT02680249|Safety, Bioavailability and Pharmacokinetics|safety, bioavailability and pharmacokinetics
243021|NCT02680236|Pain|pain
243022|NCT02680236|Cancer|cancer
243023|NCT02680236|Chemotherapy|chemotherapy
243024|NCT02680236|Anxiety|anxiety
243025|NCT02680236|Depression|depression
243026|NCT02680236|Isolation|isolation
243027|NCT02680197|COPD|copd
243028|NCT02680184|Malignant Melanoma|malignant melanoma
243029|NCT02680184|Stage IV Skin Melanoma|stage iv skin melanoma
243030|NCT02680171|Cognitive Rehabilitation|cognitive rehabilitation
243031|NCT02680171|Prism Adaptation|prism adaptation
243032|NCT02680171|Stroke|stroke
243033|NCT02680171|Spatial Neglect|spatial neglect
243034|NCT02680145|Pessary|pessary
243035|NCT02680145|Prolapse|prolapse
243036|NCT02680145|Cystocele|cystocele
243037|NCT02680106|Nanofibers|nanofibers
243038|NCT02680106|Dressing|dressing
243039|NCT02680106|Donor site|donor site
243040|NCT02680106|Polycaprolactone|polycaprolactone
243041|NCT02680067|Healthy Individual|healthy individual
243042|NCT02680067|Lymphatic Transport|lymphatic transport
243043|NCT02680067|Near InfraRed|near infrared
243044|NCT02680067|Imaging|imaging
243045|NCT02680067|Indocyanine Green|indocyanine green
243046|NCT02680067|ICG|icg
243047|NCT02680067|NIR|nir
243048|NCT02680067|NIR-ICG|nir-icg
243049|NCT02680067|MSImager|msimager
243050|NCT02680067|rheumatoid arthritis|rheumatoid arthritis
243051|NCT02680015|PEERS|peers
243052|NCT02680015|friendships|friendships
243053|NCT02680015|brain|brain
243054|NCT02679989|Insulin sensitivity|insulin sensitivity
243055|NCT02679989|Weight loss|weight loss
243056|NCT02679989|Intermittent fasting|intermittent fasting
243057|NCT02679989|Sympathetic nervous system|sympathetic nervous system
243058|NCT02679950|Next generation genome sequencing|next generation genome sequencing
243059|NCT02679950|Late relapse|late relapse
243060|NCT02679950|Genetic profiles|genetic profiles
243061|NCT02679937|U.S. Military|u.s. military
243062|NCT02679937|Overweight|overweight
243063|NCT02679937|Obesity|obesity
243064|NCT02679937|Service Members|service members
243065|NCT02679937|Prevention|prevention
243066|NCT02679911|Onychomycosis|onychomycosis
243067|NCT02679898|Arterial function|arterial function
243068|NCT02679898|Whole-body vibration training|whole-body vibration training
243069|NCT02679898|Aortic blood pressures|aortic blood pressures
243070|NCT02679898|Wave reflection|wave reflection
243071|NCT02679898|Muscle strength|muscle strength
243072|NCT02679898|Endothelial function|endothelial function
243073|NCT02679898|Blood flow|blood flow
243074|NCT02679872|Non-technical skills|non-technical skills
310727|NCT02285855|XRT|xrt
243075|NCT02679872|Patient safety|patient safety
243076|NCT02679872|Video-assisted thoracoscopic surgery|video-assisted thoracoscopic surgery
243077|NCT02679872|Operating theatre team|operating theatre team
243078|NCT02679872|Operating room|operating room
243079|NCT02679859|Natriuretic Peptide, Brain|natriuretic peptide, brain
243080|NCT02679859|Surgery|surgery
243081|NCT02679846|withdrawal of antiepileptic drugs|withdrawal of antiepileptic drugs
243082|NCT02679846|monitoring VEEG|monitoring veeg
243083|NCT02679846|safety|safety
243084|NCT02679846|adverse event|adverse event
243085|NCT02679846|standardized protocol|standardized protocol
243086|NCT02679833|Cobalamin biomarkers|cobalamin biomarkers
243087|NCT02679833|Anemia|anemia
243088|NCT02679833|Vegan diet|vegan diet
243089|NCT02679833|Subclinical|subclinical
243090|NCT02679833|Metabolic functional markers|metabolic functional markers
243091|NCT02679833|Holotranscobalamin|holotranscobalamin
243092|NCT02679833|Methylmalonic acid|methylmalonic acid
243093|NCT02679755|Hormone receptor positive advanced breast cancer|hormone receptor positive advanced breast cancer
243094|NCT02679742|beta hydroxy beta methylbutyrate|beta hydroxy beta methylbutyrate
243095|NCT02679742|older people|older people
243096|NCT02679742|muscle mass|muscle mass
243097|NCT02679742|muscle strength|muscle strength
243098|NCT02679742|post-acute|post-acute
243099|NCT02679729|inhaled dose|inhaled dose
243100|NCT02679729|intravenous dose|intravenous dose
243101|NCT02679729|healthy subjects|healthy subjects
243102|NCT02679729|safety|safety
243103|NCT02679729|tolerability|tolerability
243104|NCT02679729|pharmacokinetics|pharmacokinetics
243105|NCT02679729|AZD5634|azd5634
243106|NCT02679729|jet nebulizer|jet nebulizer
243107|NCT02679677|Chronic obstructive pulmonary disease|chronic obstructive pulmonary disease
243108|NCT02679677|Randomized controlled trial|randomized controlled trial
243109|NCT02679677|Physical activity|physical activity
243110|NCT02679638|breast cancer|breast cancer
243111|NCT02679638|treatment choice|treatment choice
243112|NCT02679638|factor|factor
243113|NCT02679638|perception|perception
243114|NCT02679573|Pneumonia|pneumonia
243115|NCT02679560|femur fracture, hip fracture, exparel, liposomal bupivacaine|femur fracture, hip fracture, exparel, liposomal bupivacaine
243116|NCT02679547|Appendix|appendix
243117|NCT02679547|Breastfeeding|breastfeeding
243118|NCT02679547|Adult|adult
243119|NCT02679534|pain|pain
243120|NCT02679534|thoracic surgery|thoracic surgery
243121|NCT02679534|massage|massage
243122|NCT02679521|Extracorporeal Shock Wave Therapy|extracorporeal shock wave therapy
243123|NCT02679521|Painful Heel|painful heel
243124|NCT02679521|Plantar fasciitis|plantar fasciitis
243125|NCT02679508|Esophagitis|esophagitis
243126|NCT02679495|early gastric cancer|early gastric cancer
243127|NCT02679495|lifestyle|lifestyle
243128|NCT02679482|Primary Open Angle Glaucoma|primary open angle glaucoma
243129|NCT02679482|Selective Laser Trabeculoplasty|selective laser trabeculoplasty
243130|NCT02679482|Pattern Scan Laser Trabeculoplasty|pattern scan laser trabeculoplasty
243131|NCT02679443|Lung Adenocarcinoma|lung adenocarcinoma
243132|NCT02679443|Non-squamous NSCLC|non-squamous nsclc
243133|NCT02679443|Chemotherapy|chemotherapy
243134|NCT02679443|Pemetrexed|pemetrexed
243135|NCT02679443|Vitamin B12|vitamin b12
243136|NCT02679443|Folate|folate
243137|NCT02679443|Supplementation|supplementation
243138|NCT02679443|Cytopenia|cytopenia
243139|NCT02679417|Aminotransferase|aminotransferase
243140|NCT02679417|Fibrosis, liver|fibrosis, liver
243141|NCT02679417|Anthropometry|anthropometry
243142|NCT02679417|Exercise|exercise
243143|NCT02679404|Biological aortic valves|biological aortic valves
243144|NCT02679404|Mechanical aortic valves|mechanical aortic valves
243145|NCT02679404|Aortic conduits|aortic conduits
243146|NCT02679404|Sutureless Aortic Valve|sutureless aortic valve
243147|NCT02679391|Abdominoplasty|abdominoplasty
243148|NCT02679391|Early complications|early complications
243149|NCT02679391|Guidelines|guidelines
243150|NCT02679391|Sequelae|sequelae
243151|NCT02679391|bariatric patients|bariatric patients
243152|NCT02679326|Therapeutic ultrasound, Treatment, Plantar fasciitis|therapeutic ultrasound, treatment, plantar fasciitis
243153|NCT02679300|Chronic Low Back Pain|chronic low back pain
243154|NCT02679300|Virtual Reality|virtual reality
243155|NCT02679300|Serious Gaming|serious gaming
243156|NCT02679300|Exercise Therapy|exercise therapy
243157|NCT02679300|Distraction|distraction
243158|NCT02679287|Closed-Loop Control (CLC)|closed-loop control (clc)
243159|NCT02679287|Sensor-Augmented Therapy (SAP)|sensor-augmented therapy (sap)
243160|NCT02679287|USS Virginia|uss virginia
243161|NCT02679287|Continuous Glucose Monitor (CGM)|continuous glucose monitor (cgm)
243162|NCT02679287|Insulin Pump|insulin pump
243163|NCT02679287|Artificial Pancreas (AP)|artificial pancreas (ap)
243164|NCT02679274|Aging, Frailty, Hypogonadism|aging, frailty, hypogonadism
243165|NCT02679261|Aortic dilation|aortic dilation
243166|NCT02679261|Statins|statins
243167|NCT02679261|Aortic degeneration|aortic degeneration
243168|NCT02679248|Pre-hypertension|pre-hypertension
243169|NCT02679248|Mild hypertension|mild hypertension
243170|NCT02679248|Dietary supplement|dietary supplement
243171|NCT02679248|Efficacy|efficacy
243172|NCT02679248|Nitric oxide|nitric oxide
243173|NCT02679248|Neo40 Daily|neo40 daily
243174|NCT02679170|ALK+|alk+
243175|NCT02679157|Posttraumatic stress disorder|posttraumatic stress disorder
243176|NCT02679157|Depression|depression
243177|NCT02679157|Anxiety|anxiety
243178|NCT02679157|ADL|adl
243179|NCT02679157|Health-related quality of life|health-related quality of life
243180|NCT02679157|ICU survivorship|icu survivorship
243181|NCT02679131|relapsed/refractory solid tumors|relapsed/refractory solid tumors
243182|NCT02679131|beleodaq|beleodaq
243183|NCT02679131|renal impairment|renal impairment
243184|NCT02679131|belinostat|belinostat
243185|NCT02679131|hematological malignancies|hematological malignancies
243186|NCT02679118|intestinal perforation|intestinal perforation
243187|NCT02679118|bariatric surgery|bariatric surgery
243188|NCT02679118|gastric bypass|gastric bypass
243189|NCT02679118|gastric perforation|gastric perforation
243190|NCT02679118|colonic perforation|colonic perforation
243191|NCT02679092|Induced Abortion|induced abortion
243192|NCT02679092|Mifepristone|mifepristone
243193|NCT02679092|Dilation and Evacuation|dilation and evacuation
243194|NCT02679092|Cervical Preparation|cervical preparation
243195|NCT02679092|Osmotic Dilators|osmotic dilators
243196|NCT02679092|Misoprostol|misoprostol
243197|NCT02678962|Multifocal Intraocular Lenses|multifocal intraocular lenses
243198|NCT02678962|bilateral implantation|bilateral implantation
243199|NCT02678897|Abortion, Drug-Induced|abortion, drug-induced
243200|NCT02678897|Pain Management|pain management
243328|NCT02677922|Azacitidine|azacitidine
243201|NCT02678884|Head and Neck Squamous Cell Carcinoma|head and neck squamous cell carcinoma
243202|NCT02678884|Radiation therapy|radiation therapy
243203|NCT02678884|Head and Neck Cancers|head and neck cancers
243204|NCT02678871|Aortic Valve Stenosis|aortic valve stenosis
243205|NCT02678871|Left atrial appendage|left atrial appendage
243206|NCT02678858|social cognition|social cognition
243207|NCT02678858|social skills|social skills
243208|NCT02678858|cognitive remediation|cognitive remediation
243209|NCT02678858|functional outcome|functional outcome
243210|NCT02678858|treatment adherence|treatment adherence
243211|NCT02678767|HIV|hiv
243212|NCT02678767|Dementia|dementia
243213|NCT02678767|Neuroimaging|neuroimaging
243214|NCT02678702|Sleep|sleep
243215|NCT02678702|Depression|depression
243216|NCT02678702|Comorbid Insomnia|comorbid insomnia
243217|NCT02678702|Cognitive Behavioral Therapy|cognitive behavioral therapy
243218|NCT02678702|Sleep Restriction|sleep restriction
243219|NCT02678702|Stimulus Control therapy|stimulus control therapy
243220|NCT02678702|Relaxation|relaxation
243221|NCT02678676|Drug Therapy|drug therapy
243222|NCT02678663|Colon polyp|colon polyp
243223|NCT02678663|Polypectomy|polypectomy
243224|NCT02678663|Cold snare|cold snare
243225|NCT02678663|Endoscopic mucosal resection|endoscopic mucosal resection
243226|NCT02678650|Volatile Anesthetics|volatile anesthetics
243227|NCT02678650|MicroRNA|microrna
243228|NCT02678650|Off-pump Coronary Artery Bypass Surgery|off-pump coronary artery bypass surgery
243229|NCT02678650|Internal Mammary Artery|internal mammary artery
243230|NCT02678650|Ascending Aorta|ascending aorta
243231|NCT02678637|MRI|mri
243232|NCT02678637|CCSA|ccsa
243233|NCT02678637|Contractile Cross Sectional Area|contractile cross sectional area
243234|NCT02678637|Strength|strength
243235|NCT02678637|Calf muscle|calf muscle
243236|NCT02678611|Healthy participants|healthy participants
243237|NCT02678611|Dietary supplement|dietary supplement
243238|NCT02678611|Safety|safety
243239|NCT02678611|Tolerability|tolerability
243240|NCT02678611|Older Adults|older adults
243241|NCT02678611|Basis|basis
243242|NCT02678611|Nicotinamide riboside|nicotinamide riboside
243243|NCT02678611|Pterostilbene|pterostilbene
243244|NCT02678598|Micafungin|micafungin
243245|NCT02678598|Candida|candida
243246|NCT02678598|Aspergillosis|aspergillosis
243247|NCT02678598|Antifungal|antifungal
243248|NCT02678572|uveal liver PHP hepatic perfusion chemosaturation Delcath|uveal liver php hepatic perfusion chemosaturation delcath
243249|NCT02678559|Alveolar recruitment manoeuvre|alveolar recruitment manoeuvre
243250|NCT02678559|Lung recruitment|lung recruitment
243251|NCT02678559|Preload dependency|preload dependency
243252|NCT02678559|Cardiac surgery|cardiac surgery
243253|NCT02678559|Transoesophageal echocardiography|transoesophageal echocardiography
243254|NCT02678546|Traditional Chinese Medicine|traditional chinese medicine
243255|NCT02678533|Fanconi Anemia|fanconi anemia
243256|NCT02678533|CD34+ cells mobilization|cd34+ cells mobilization
243257|NCT02678533|G-CSF|g-csf
243258|NCT02678533|Plerixafor|plerixafor
243259|NCT02678533|gene therapy|gene therapy
243260|NCT02678520|Prostate Cancer|prostate cancer
243261|NCT02678520|Post Operative|post operative
243262|NCT02678520|Radiation|radiation
243263|NCT02678520|Prostatectomy|prostatectomy
243264|NCT02678520|3-D CRT|3-d crt
243265|NCT02678520|IMRT|imrt
243266|NCT02678520|RT|rt
243267|NCT02678520|CRT|crt
243268|NCT02678520|Conformal Radiation Therapy|conformal radiation therapy
243269|NCT02678520|Intensity Modulated Radiation Therapy|intensity modulated radiation therapy
243270|NCT02678520|Hormone|hormone
243271|NCT02678520|Surgery|surgery
243272|NCT02678520|Hormonal Therapy|hormonal therapy
243273|NCT02678494|Spinal Cord Injury|spinal cord injury
243274|NCT02678481|multiparametric magnetic resonance imaging|multiparametric magnetic resonance imaging
243275|NCT02678481|MR-targeted prostate biopsy|mr-targeted prostate biopsy
243276|NCT02678481|saturation TRUS-guided prostate biopsy|saturation trus-guided prostate biopsy
243277|NCT02678455|Dengue Virus|dengue virus
243278|NCT02678416|comparison|comparison
243279|NCT02678403|peripheral artery disease|peripheral artery disease
243280|NCT02678403|transcutaneous electrical nerve stimulation|transcutaneous electrical nerve stimulation
243281|NCT02678403|walking ability|walking ability
243282|NCT02678403|endothelial function|endothelial function
243283|NCT02678364|Vitamin D-biofortified eggs|vitamin d-biofortified eggs
243284|NCT02678364|Vitamin D status|vitamin d status
243285|NCT02678364|RCT|rct
243286|NCT02678312|Pediatric Heart failure,|pediatric heart failure,
243287|NCT02678312|systemic left ventricle,|systemic left ventricle,
243288|NCT02678312|reduced ejection fraction|reduced ejection fraction
243289|NCT02678286|Abdominoplasty|abdominoplasty
243290|NCT02678286|Pain|pain
243291|NCT02678286|Analgesia|analgesia
243292|NCT02678286|N1539|n1539
243293|NCT02678286|Phase 3|phase 3
243294|NCT02678273|population|population
243295|NCT02678273|Singapore|singapore
243296|NCT02678260|Advanced malignancies|advanced malignancies
243297|NCT02678260|PDR001|pdr001
243298|NCT02678260|Japanese patients|japanese patients
243299|NCT02678260|adults|adults
243300|NCT02678247|prosthesis|prosthesis
243301|NCT02678247|prosthetic socket|prosthetic socket
243302|NCT02678247|transfemoral amputation|transfemoral amputation
243303|NCT02678247|socket comfort|socket comfort
243304|NCT02678247|gait biomechanics|gait biomechanics
243305|NCT02678156|Dura mater substitute|dura mater substitute
243306|NCT02678156|Graft|graft
243307|NCT02678156|Lyoplant|lyoplant
243308|NCT02678156|Lyostypt|lyostypt
243309|NCT02678156|Lyoplant onlay|lyoplant onlay
243310|NCT02678156|Xenograft|xenograft
243311|NCT02678130|Intervertebral disc degeneration|intervertebral disc degeneration
243312|NCT02678130|Bone Disease|bone disease
243313|NCT02678130|Musculoskeletal disease|musculoskeletal disease
243314|NCT02678130|Spinal disease|spinal disease
243315|NCT02678104|Dry Socket|dry socket
243316|NCT02678104|Honey|honey
243317|NCT02678104|Tooth Extraction|tooth extraction
243318|NCT02678078|cancer|cancer
243319|NCT02678078|diagnosis|diagnosis
243320|NCT02678078|biopsy|biopsy
243321|NCT02678078|chemotherapy drugs|chemotherapy drugs
243322|NCT02678078|tumor|tumor
243323|NCT02678052|Drug therapy|drug therapy
243324|NCT02677961|sarcoma|sarcoma
243325|NCT02677961|registry|registry
243326|NCT02677922|Acute Myeloid Leukemia|acute myeloid leukemia
243327|NCT02677922|Leukemia|leukemia
243329|NCT02677922|AG-120|ag-120
243330|NCT02677922|AG-221|ag-221
243331|NCT02677909|Parenteral Nutrition|parenteral nutrition
243332|NCT02677909|Critical Care|critical care
243333|NCT02677896|Androgen Deprivation Therapy (ADT)|androgen deprivation therapy (adt)
243334|NCT02677896|Metastatic hormone sensitive prostate cancer|metastatic hormone sensitive prostate cancer
243335|NCT02677896|Xtandi|xtandi
243336|NCT02677896|Enzalutamide|enzalutamide
243337|NCT02677870|Saproterin dihydrochloride|saproterin dihydrochloride
243338|NCT02677870|Kuvan|kuvan
243339|NCT02677870|Amish|amish
243340|NCT02677831|Physical functioning|physical functioning
243341|NCT02677831|Neuropsychiatric Disorders|neuropsychiatric disorders
243342|NCT02677831|Frailty|frailty
243343|NCT02677818|Plasma Factor VIII Levels|plasma factor viii levels
243344|NCT02677818|Ischemic stroke|ischemic stroke
243345|NCT02677818|Antithrombotic therapy|antithrombotic therapy
243346|NCT02677818|Bleeding|bleeding
243347|NCT02677766|Occupational Therapy|occupational therapy
243348|NCT02677766|Complex patients|complex patients
243349|NCT02677766|Randomized controlled trial|randomized controlled trial
243350|NCT02677766|Occupational performance problem|occupational performance problem
243351|NCT02677766|Rehabilitation Complexity Scale|rehabilitation complexity scale
243352|NCT02677740|MRI|mri
243353|NCT02677740|MRS|mrs
243354|NCT02677740|rTMS|rtms
243355|NCT02677727|Cisplatin-based chemotherapy|cisplatin-based chemotherapy
243356|NCT02677727|Chemotherapy-induced peripheral neuropathy|chemotherapy-induced peripheral neuropathy
243357|NCT02677688|systemic lupus erythematosus|systemic lupus erythematosus
243358|NCT02677688|autologous anti-EBV CTL|autologous anti-ebv ctl
243359|NCT02677688|adoptive therapy|adoptive therapy
243360|NCT02677688|phase 1 -2|phase 1 -2
243361|NCT02677662|Diesel exhaust|diesel exhaust
243362|NCT02677662|Oxidative stress|oxidative stress
243363|NCT02677662|Systemic inflammation|systemic inflammation
243364|NCT02677662|Air pollution|air pollution
712524|NCT00579839|High risk pregnancy|high risk pregnancy
243365|NCT02677649|cranberry, microbiome, polyphenols, healthy|cranberry, microbiome, polyphenols, healthy
243366|NCT02677636|Dermatitis, Atopic|dermatitis, atopic
243367|NCT02677636|Eczema|eczema
243368|NCT02677636|Dermatitis|dermatitis
243369|NCT02677636|Pruritus|pruritus
243370|NCT02677636|Genetic Diseases, Inborn|genetic diseases, inborn
243371|NCT02677636|Hypersensitivity|hypersensitivity
243372|NCT02677636|Hypersensitivity, Immediate|hypersensitivity, immediate
243373|NCT02677636|Immune System Diseases|immune system diseases
243374|NCT02677636|Skin Diseases, Eczematous|skin diseases, eczematous
243375|NCT02677636|Skin Diseases, Genetic|skin diseases, genetic
243376|NCT02677636|Skin Diseases|skin diseases
243377|NCT02677636|Itching|itching
243378|NCT02677636|Rash|rash
243379|NCT02677636|Steroid|steroid
243380|NCT02677610|Dermatitis, Atopic|dermatitis, atopic
243381|NCT02677610|Eczema|eczema
243382|NCT02677610|Dermatitis|dermatitis
243383|NCT02677610|Pruritus|pruritus
243384|NCT02677610|Genetic Diseases, Inborn|genetic diseases, inborn
243385|NCT02677610|Hypersensitivity|hypersensitivity
243386|NCT02677610|Hypersensitivity, Immediate|hypersensitivity, immediate
243387|NCT02677610|Immune System Diseases|immune system diseases
243388|NCT02677610|Skin Diseases, Eczematous|skin diseases, eczematous
243389|NCT02677610|Skin Diseases, Genetic|skin diseases, genetic
243390|NCT02677610|Skin Diseases|skin diseases
243391|NCT02677610|Itching|itching
243392|NCT02677610|Rash|rash
243393|NCT02677610|Steroid|steroid
243394|NCT02677584|caffeine|caffeine
243395|NCT02677584|apnea|apnea
243396|NCT02677584|preterm infant|preterm infant
243397|NCT02677558|Pregnancy|pregnancy
243398|NCT02677558|Obesity|obesity
243399|NCT02677558|Echocardiography|echocardiography
243400|NCT02677519|ADHD|adhd
243401|NCT02677519|children|children
243402|NCT02677519|methylphenidate|methylphenidate
243403|NCT02677506|elbow|elbow
243404|NCT02677480|Microflora|microflora
243405|NCT02677480|Probiotics|probiotics
243406|NCT02677480|Hyposalivation|hyposalivation
243407|NCT02677480|Lactobacilli|lactobacilli
243408|NCT02677480|Mutans streptococci|mutans streptococci
243409|NCT02677480|pH-rising components|ph-rising components
243410|NCT02677454|Blood Glucose|blood glucose
243411|NCT02677454|Blood Glucose Self-Monitoring|blood glucose self-monitoring
243412|NCT02677428|Veterans|veterans
243413|NCT02677428|world wide web|world wide web
243414|NCT02677428|Counseling|counseling
243415|NCT02677428|Workman's Compensation|workman's compensation
243416|NCT02677415|Ischemic Stroke|ischemic stroke
243417|NCT02677415|Anesthesia|anesthesia
243418|NCT02677415|Endovascular Procedures|endovascular procedures
243419|NCT02677402|femoral vein|femoral vein
243420|NCT02677402|saphenous vein|saphenous vein
243421|NCT02677402|hydrostatic pressure|hydrostatic pressure
243422|NCT02677402|temperature|temperature
243423|NCT02677402|recovery|recovery
243424|NCT02677363|Elderly|elderly
243425|NCT02677363|Older|older
243426|NCT02677363|Adults|adults
243427|NCT02677363|Resistant Exercise|resistant exercise
243428|NCT02677363|Strength Training|strength training
243429|NCT02677363|Cognitive function|cognitive function
243430|NCT02677324|Waldenstrom Macroglobulinemia|waldenstrom macroglobulinemia
243431|NCT02677324|WM|wm
243432|NCT02677272|Nursing home|nursing home
243433|NCT02677272|emergency department|emergency department
243434|NCT02677272|inappropriate transfer|inappropriate transfer
243435|NCT02677272|elderly|elderly
243436|NCT02677259|luteal phase|luteal phase
243437|NCT02677259|estradiol|estradiol
243438|NCT02677259|pregnancy rate|pregnancy rate
243439|NCT02677246|Bone marrow transplantation|bone marrow transplantation
243440|NCT02677246|Children|children
243441|NCT02677246|Bone complications|bone complications
243442|NCT02677246|Denosumab.|denosumab.
243443|NCT02677181|ATG|atg
243444|NCT02677181|Matched sibling donor|matched sibling donor
243445|NCT02677181|peripheral blood stem cell transplantation|peripheral blood stem cell transplantation
243446|NCT02677168|obstructive sleep apnea|obstructive sleep apnea
243447|NCT02677168|sleep apnea|sleep apnea
243449|NCT02677168|cNEP|cnep
243450|NCT02677168|continuous negative external pressure|continuous negative external pressure
243451|NCT02677155|Follicular lymphoma|follicular lymphoma
243452|NCT02677155|Intranodal therapy|intranodal therapy
243453|NCT02677155|Autologous dendritic cells|autologous dendritic cells
243454|NCT02677155|Rituximab|rituximab
243455|NCT02677155|Immunotherapy|immunotherapy
243456|NCT02677155|Cancer vaccine|cancer vaccine
243457|NCT02677155|Anti-PD1|anti-pd1
243458|NCT02677155|Pembrolizumab|pembrolizumab
243459|NCT02677155|Radiotherapy|radiotherapy
243460|NCT02677142|pediatric|pediatric
243461|NCT02677142|Childhood Brain Tumour Survivors|childhood brain tumour survivors
243462|NCT02677142|Social Skills Rating System|social skills rating system
243463|NCT02677142|social skills intervention program (SSIP)|social skills intervention program (ssip)
243464|NCT02677103|Radial shock wave therapy,calcific tendinitis, ultrasound guidance|radial shock wave therapy,calcific tendinitis, ultrasound guidance
243465|NCT02677090|Fiber tolerability|fiber tolerability
243466|NCT02677090|Children|children
243467|NCT02677077|RRMS|rrms
243468|NCT02677077|MRI|mri
243469|NCT02677064|Allogeneic Hematopoietic Stem Cell Transplantation|allogeneic hematopoietic stem cell transplantation
243470|NCT02677064|Identify Barriers|identify barriers
243471|NCT02677064|16-024|16-024
243472|NCT02677025|HIV|hiv
243473|NCT02677025|Sexual Risk|sexual risk
243474|NCT02677025|Sexually Transmitted Diseases|sexually transmitted diseases
243475|NCT02677025|Substance Abuse|substance abuse
243476|NCT02677025|Violence and Victimization|violence and victimization
243477|NCT02676986|Primary Breast Cancer|primary breast cancer
243478|NCT02676986|ER|er
243479|NCT02676986|AR|ar
243480|NCT02676986|TNBC|tnbc
243481|NCT02676973|pelvic organ prolapse|pelvic organ prolapse
243482|NCT02676973|POP|pop
243483|NCT02676973|vault prolapse|vault prolapse
243484|NCT02676973|cystocele|cystocele
243485|NCT02676973|vaginal prolapse|vaginal prolapse
243486|NCT02676973|post-hysterectomy vaginal prolapse|post-hysterectomy vaginal prolapse
243487|NCT02676921|sinus membrane|sinus membrane
243488|NCT02676921|osteogenic|osteogenic
243489|NCT02676908|endovenous ablation|endovenous ablation
243490|NCT02676908|laser|laser
243491|NCT02676908|radiofrequency|radiofrequency
243492|NCT02676908|stockings|stockings
243493|NCT02676882|Depressive Disorder|depressive disorder
243494|NCT02676882|Depression|depression
243495|NCT02676882|Antidepressants|antidepressants
243496|NCT02676882|Pregnancy|pregnancy
243497|NCT02676882|Folate|folate
243498|NCT02676882|Dietary Supplements|dietary supplements
243499|NCT02676882|Omega-3 Fatty Acids|omega-3 fatty acids
243500|NCT02676882|Women's Health|women's health
243501|NCT02676882|Vitamins|vitamins
243502|NCT02676856|acute myeloid leukemia|acute myeloid leukemia
243503|NCT02676856|hematopoietic stem cell microtransplantation|hematopoietic stem cell microtransplantation
243504|NCT02676817|colitis|colitis
243505|NCT02676817|endoscopy|endoscopy
243506|NCT02676804|Exercise|exercise
243507|NCT02676778|Peripheral T-cell lymphoma|peripheral t-cell lymphoma
243508|NCT02676778|Cutaneous T-cell lymphoma|cutaneous t-cell lymphoma
243509|NCT02676778|E7777|e7777
243510|NCT02676778|Phase 2|phase 2
243511|NCT02676765|Allergic rhinitis|allergic rhinitis
243512|NCT02676765|Immunotherapy, Allergen|immunotherapy, allergen
243513|NCT02676765|Sublingual Immunotherapy|sublingual immunotherapy
243514|NCT02676752|head and neck cancer|head and neck cancer
243515|NCT02676752|lymphedema and fibrosis|lymphedema and fibrosis
243516|NCT02676726|extraperitoneal|extraperitoneal
243517|NCT02676726|transperitoneal|transperitoneal
243518|NCT02676726|laparoscopic aortic lymphadenectomy|laparoscopic aortic lymphadenectomy
243519|NCT02676726|endometrial cancer|endometrial cancer
243520|NCT02676726|ovarian cancer|ovarian cancer
243521|NCT02676726|surgical staging|surgical staging
243522|NCT02676713|Traditional Chinese Medicine|traditional chinese medicine
243523|NCT02676713|Chinese Herbal|chinese herbal
243524|NCT02676700|Urinary stress incontinence|urinary stress incontinence
243525|NCT02676700|pelvic floor muscle|pelvic floor muscle
243526|NCT02676700|Kaatsu training|kaatsu training
243527|NCT02676687|surgery, noneloquent area|surgery, noneloquent area
243528|NCT02676661|peri-implant disease|peri-implant disease
243529|NCT02676661|risk factors|risk factors
243530|NCT02676661|prevalence|prevalence
243531|NCT02676622|Crohn's Disease|crohn's disease
243532|NCT02676622|Autologous Hematopoietic Stem cell Transplant|autologous hematopoietic stem cell transplant
243533|NCT02676622|Cyclophosphamide|cyclophosphamide
243534|NCT02676622|IL-2|il-2
243535|NCT02676622|Aldesleukin|aldesleukin
243536|NCT02676622|Proleukin|proleukin
243537|NCT02676622|PCDAI|pcdai
243538|NCT02676609|Type 1 diabetes|type 1 diabetes
243539|NCT02676609|Smart phone application|smart phone application
243540|NCT02676609|carbohydrate counting|carbohydrate counting
243541|NCT02676609|meal insulin dose|meal insulin dose
243542|NCT02676583|pain|pain
243543|NCT02676583|tonsillectomy|tonsillectomy
243544|NCT02676583|tonsillar fossa|tonsillar fossa
243545|NCT02676583|suture|suture
243546|NCT02676583|tonsil fossa closure|tonsil fossa closure
243547|NCT02676544|Prostate Artery Embolization (PAE)|prostate artery embolization (pae)
243548|NCT02676544|Benign Prostatic Hyperplasia (BPH)|benign prostatic hyperplasia (bph)
243549|NCT02676544|Lower Urinary Tract Symptoms (LUTS)|lower urinary tract symptoms (luts)
243550|NCT02676544|PAE|pae
243551|NCT02676544|BPH|bph
243552|NCT02676544|LUTS|luts
243553|NCT02676544|Prostate Artery Embolization|prostate artery embolization
243554|NCT02676544|Embospheres|embospheres
243555|NCT02676531|Walking Meditation|walking meditation
243556|NCT02676531|Vascular Function|vascular function
243557|NCT02676531|Flow-mediated dilatation|flow-mediated dilatation
243558|NCT02676531|Breast Cancer Patients|breast cancer patients
243559|NCT02676531|Anthracyclines Chemotherapy|anthracyclines chemotherapy
243560|NCT02676518|polycystic ovary syndrome|polycystic ovary syndrome
243561|NCT02676518|Serum anti-Mullerian hormone|serum anti-mullerian hormone
243562|NCT02676518|glucose intolerance|glucose intolerance
243563|NCT02676518|metabolic syndrome|metabolic syndrome
243564|NCT02676466|Mobility|mobility
243565|NCT02676440|Oral Health|oral health
243566|NCT02676401|Diabetic Nephropathy|diabetic nephropathy
243567|NCT02676388|Slow Transit Constipation|slow transit constipation
243568|NCT02676388|Freeze-dried, Capsulized FMT|freeze-dried, capsulized fmt
243569|NCT02676388|Fresh FMT|fresh fmt
243570|NCT02676349|mFolfirinox|mfolfirinox
243571|NCT02676349|Chemoradiotherapy|chemoradiotherapy
243572|NCT02676349|Neoadjuvant treatment|neoadjuvant treatment
243573|NCT02676349|Borderline|borderline
243574|NCT02676336|FBC|fbc
243575|NCT02676336|cyclic mastalgia|cyclic mastalgia
243576|NCT02676336|breast discomfort|breast discomfort
243577|NCT02676323|Maximum tolerated dose|maximum tolerated dose
243578|NCT02676323|Childhood leukemia|childhood leukemia
243579|NCT02676323|Hematological malignancies|hematological malignancies
243580|NCT02676297|inhalation|inhalation
243581|NCT02676297|anticholinergic|anticholinergic
243582|NCT02676258|silicone hydrogel daily disposable soft contact lens|silicone hydrogel daily disposable soft contact lens
243583|NCT02676245|Prenatal Education|prenatal education
243584|NCT02676245|Residual Specimens|residual specimens
243585|NCT02676232|Online Intervention|online intervention
243586|NCT02676232|Recurrent Abdominal Pain|recurrent abdominal pain
243587|NCT02676232|Children|children
243588|NCT02676193|Tobacco Smoking|tobacco smoking
243589|NCT02676193|Cigarettes|cigarettes
243590|NCT02676193|Packaging|packaging
243591|NCT02676193|Text messaging|text messaging
243592|NCT02676193|Graphic Images|graphic images
243593|NCT02676193|Sensor-Based Assessments|sensor-based assessments
243594|NCT02676167|HIV prevention|hiv prevention
243595|NCT02676167|men who have sex with men|men who have sex with men
243596|NCT02676167|pre-exposure prophylaxis|pre-exposure prophylaxis
243597|NCT02676167|PrEP|prep
243598|NCT02676167|Greece|greece
243599|NCT02676167|people who inject drugs|people who inject drugs
243600|NCT02676154|Episodic Hypertension|episodic hypertension
243601|NCT02676154|Spinal Cord Injury|spinal cord injury
243602|NCT02676154|Traumatic Spinal Cord Injury|traumatic spinal cord injury
243603|NCT02676154|Blood Pressure|blood pressure
243604|NCT02676154|Fesoterodine|fesoterodine
243605|NCT02676154|Neurogenic Detrusor Overactivity|neurogenic detrusor overactivity
243606|NCT02676154|Autonomic Dysreflexia|autonomic dysreflexia
243607|NCT02676154|Urodynamic Studies|urodynamic studies
243608|NCT02676154|24 Hour Ambulatory Blood Pressure Monitoring|24 hour ambulatory blood pressure monitoring
243609|NCT02676154|Cerebral Blood Flow|cerebral blood flow
243610|NCT02676128|HIV|hiv
243611|NCT02676128|Medication Adherence|medication adherence
243612|NCT02676128|Mobile Health|mobile health
243613|NCT02676115|Cosmetic Wound Healing|cosmetic wound healing
243614|NCT02676115|anterior cruciate ligament (ACL)|anterior cruciate ligament (acl)
243615|NCT02676102|barber shops|barber shops
243616|NCT02676102|organ transplant|organ transplant
243617|NCT02676102|transplants|transplants
243618|NCT02676102|organ donor registration|organ donor registration
243619|NCT02676089|Asthma, Anticholinergics, Triple combination|asthma, anticholinergics, triple combination
243620|NCT02676076|asthma, anticholinergics, triple combination|asthma, anticholinergics, triple combination
243621|NCT02676063|predictive factors|predictive factors
243622|NCT02676063|neurodevelopmental disabilities|neurodevelopmental disabilities
243623|NCT02676011|Atropine|atropine
243624|NCT02676011|Succinycholine|succinycholine
243625|NCT02676011|Laparoscopy|laparoscopy
243626|NCT02676011|Gynecology|gynecology
243627|NCT02675985|Physical Therapy, early intervention|physical therapy, early intervention
243628|NCT02675972|stroke, blood pressure, prognosis|stroke, blood pressure, prognosis
243629|NCT02675959|stem cell transplantation|stem cell transplantation
243630|NCT02675959|sickle cell disease|sickle cell disease
243631|NCT02675959|haploidentical|haploidentical
243632|NCT02675959|defibrotide|defibrotide
243633|NCT02675946|WNT inhibitor|wnt inhibitor
243634|NCT02675920|surveillance|surveillance
243635|NCT02675920|ultrasonography|ultrasonography
243636|NCT02675920|computed tomography|computed tomography
243637|NCT02675907|Bunion|bunion
243638|NCT02675907|Bunionectomy|bunionectomy
243639|NCT02675907|Pain|pain
243640|NCT02675907|Analgesia|analgesia
243641|NCT02675907|N1539|n1539
243642|NCT02675907|Phase 3|phase 3
243643|NCT02675894|RFA|rfa
243644|NCT02675881|RFA|rfa
243645|NCT02675868|noradrenaline|noradrenaline
243646|NCT02675868|vasopressin|vasopressin
243647|NCT02675868|phenylephrine|phenylephrine
243648|NCT02675868|endotoxemia|endotoxemia
243649|NCT02675868|Lipopolysaccharide|lipopolysaccharide
243650|NCT02675868|vasopressor|vasopressor
243651|NCT02675855|Grafix|grafix
243652|NCT02675829|HER2 mutant|her2 mutant
243653|NCT02675829|HER2 amplified|her2 amplified
243654|NCT02675829|Ado-Trastuzumab Emtansine|ado-trastuzumab emtansine
243655|NCT02675829|15-335|15-335
243656|NCT02675816|Obstructive Sleep Apnea|obstructive sleep apnea
243657|NCT02675816|OSA|osa
243658|NCT02675816|neurostimulation|neurostimulation
243659|NCT02675816|hypoglossal nerve|hypoglossal nerve
243660|NCT02675816|tongue|tongue
730904|NCT00506857|Fludarabine|fludarabine
243661|NCT02675816|upper airway stimulation|upper airway stimulation
243662|NCT02675816|surgery|surgery
243663|NCT02675803|Rheumatoid arthritis|rheumatoid arthritis
243664|NCT02675790|hydroxyurea|hydroxyurea
243665|NCT02675790|sub-Saharan Africa|sub-saharan africa
243666|NCT02675790|secondary stroke prevention|secondary stroke prevention
243667|NCT02675777|Alcohol misuse|alcohol misuse
243668|NCT02675777|Unhealthy alcohol use|unhealthy alcohol use
243669|NCT02675777|Alcoholism|alcoholism
243670|NCT02675777|Alcohol dependence|alcohol dependence
243671|NCT02675777|Alcohol abuse|alcohol abuse
243672|NCT02675777|Risky drinking|risky drinking
243673|NCT02675764|hand function|hand function
243674|NCT02675751|myopia|myopia
243675|NCT02675673|Enteral Feeding|enteral feeding
243676|NCT02675673|G-Tube|g-tube
243677|NCT02675673|GJ Tube|gj tube
243678|NCT02675660|kinetic data|kinetic data
243679|NCT02675660|volunteers|volunteers
243680|NCT02675608|vaccine efficacy|vaccine efficacy
243681|NCT02675608|inflammation|inflammation
243682|NCT02675608|aging|aging
243683|NCT02675608|Type 2 Diabetes Mellitus|type 2 diabetes mellitus
243684|NCT02675608|flu vaccine|flu vaccine
243685|NCT02675569|Vascular access|vascular access
243686|NCT02675569|Hemodialysis|hemodialysis
243687|NCT02675569|Kidney failure|kidney failure
243688|NCT02675569|Catheter|catheter
243689|NCT02675569|Fistula|fistula
243690|NCT02675556|Depression|depression
243691|NCT02675530|NMDA|nmda
243692|NCT02675530|glutamate|glutamate
243693|NCT02675530|schizophrenia|schizophrenia
243694|NCT02675504|scary scale|scary scale
243695|NCT02675491|Advanced solid tumor|advanced solid tumor
243696|NCT02675491|DS-6051b|ds-6051b
243697|NCT02675491|ROS1|ros1
243698|NCT02675491|NTRK|ntrk
243699|NCT02675491|refractory to standard therapy|refractory to standard therapy
243700|NCT02675491|no standard therapy|no standard therapy
243701|NCT02675478|AML|aml
243702|NCT02675478|phase 1|phase 1
243703|NCT02675478|oncology|oncology
243704|NCT02675465|Pompe, rhGAA|pompe, rhgaa
243705|NCT02675426|Musculoskeletal Disease|musculoskeletal disease
243706|NCT02675426|Arthritis|arthritis
243707|NCT02675426|Joint Disease|joint disease
243708|NCT02675426|Anti-inflammatory agents|anti-inflammatory agents
243709|NCT02675426|Antirheumatic agents|antirheumatic agents
243710|NCT02675413|Cerebral Spinal Fluid|cerebral spinal fluid
243711|NCT02675413|Dimethyl Fumarate|dimethyl fumarate
243712|NCT02675413|Tecfidera|tecfidera
243713|NCT02675413|Multiple Sclerosis|multiple sclerosis
243714|NCT02675413|Relapsing MS|relapsing ms
243715|NCT02675413|RRMS|rrms
243716|NCT02675413|Mechanism of Action|mechanism of action
243717|NCT02675400|ADHD|adhd
243719|NCT02675400|Attention Deficit/Hyperactivity Disorder|attention deficit/hyperactivity disorder
243720|NCT02675400|Attention|attention
243721|NCT02675400|Hyperactivity|hyperactivity
243722|NCT02675374|Cardiac surgery|cardiac surgery
243723|NCT02675374|cardiopulmonary bypass|cardiopulmonary bypass
243724|NCT02675374|dexchlorpheniramine|dexchlorpheniramine
243725|NCT02675374|H1 blockers|h1 blockers
243726|NCT02675374|norepinephrine|norepinephrine
243727|NCT02675374|histamine release|histamine release
243728|NCT02675361|Transfer to adult care|transfer to adult care
243729|NCT02675361|Continuity of patient care|continuity of patient care
243730|NCT02675361|Transition program|transition program
243731|NCT02675335|Diabetic foot ulcer, Sitagliptin|diabetic foot ulcer, sitagliptin
243732|NCT02675296|outcome|outcome
243733|NCT02675283|Point of care test|point of care test
243734|NCT02675283|Diagnosis|diagnosis
243735|NCT02675283|Case finding|case finding
243736|NCT02675257|Diabetes mellitus|diabetes mellitus
243737|NCT02675257|Affective disorders|affective disorders
243738|NCT02675257|Depressive symptoms|depressive symptoms
243739|NCT02675257|Diabetes distress|diabetes distress
243740|NCT02675257|Hyperglycaemia|hyperglycaemia
243741|NCT02675257|Dysglycaemia|dysglycaemia
243742|NCT02675257|Glycaemic control|glycaemic control
243743|NCT02675257|Self-care behaviour|self-care behaviour
243744|NCT02675257|Quality of Life|quality of life
243745|NCT02675257|Diabetes acceptance|diabetes acceptance
243847|NCT02674711|Neck Pain|neck pain
243746|NCT02675257|Diabetes complications|diabetes complications
243747|NCT02675257|Low-grade inflammation|low-grade inflammation
243748|NCT02675257|Inflammatory markers|inflammatory markers
243749|NCT02675257|Stress reactivity|stress reactivity
243750|NCT02675257|Health-care costs|health-care costs
243751|NCT02675244|Tricuspid Valve Regurgitation|tricuspid valve regurgitation
243752|NCT02675192|sarcopenia|sarcopenia
243753|NCT02675192|elderly|elderly
243754|NCT02675192|muscle biopsy|muscle biopsy
243755|NCT02675166|Childhood cancer|childhood cancer
243756|NCT02675166|Sequels|sequels
243757|NCT02675166|Complications|complications
243758|NCT02675166|Surgery|surgery
243759|NCT02675166|Radiotherapy|radiotherapy
243760|NCT02675166|Chemotherapy|chemotherapy
243761|NCT02675166|Cancer|cancer
243762|NCT02675153|Inflammatory Bowel Disease|inflammatory bowel disease
243763|NCT02675153|stenosis|stenosis
243764|NCT02675153|sirolimus|sirolimus
243765|NCT02675153|rapamycin|rapamycin
243766|NCT02675153|stricture|stricture
243767|NCT02675114|Sapien 3|sapien 3
243768|NCT02675114|cardiovascular disease|cardiovascular disease
243769|NCT02675114|heart disease|heart disease
243770|NCT02675114|aortic stenosis|aortic stenosis
243771|NCT02675114|SAVR|savr
243772|NCT02675114|TAVR|tavr
243773|NCT02675088|Extensive Stage Small Cell Lung Cancer|extensive stage small cell lung cancer
243774|NCT02675088|thoracic radiotherapy|thoracic radiotherapy
243775|NCT02675088|radiotherapy regimen|radiotherapy regimen
243776|NCT02675075|Amyotrophic Lateral Sclerosis|amyotrophic lateral sclerosis
243777|NCT02675075|Voice|voice
243778|NCT02675075|Voice Quality|voice quality
243779|NCT02675075|Total Lung Capacity|total lung capacity
243780|NCT02675062|Accelerometry|accelerometry
243781|NCT02675062|Osteoarthritis|osteoarthritis
243782|NCT02675062|Habitual physical activity|habitual physical activity
243783|NCT02675062|Sedentary behaviour|sedentary behaviour
243784|NCT02675062|Knee arthroplasty|knee arthroplasty
243785|NCT02675049|Intranasal|intranasal
243786|NCT02675049|Dexmedetomidine|dexmedetomidine
243787|NCT02675049|Anaesthesia|anaesthesia
243788|NCT02675049|Breast Lumpectomy|breast lumpectomy
243789|NCT02675036|ectopiccanine teeth, impacted teeth, tooth eruption, orthodontics|ectopiccanine teeth, impacted teeth, tooth eruption, orthodontics
243790|NCT02674997|Goal setting|goal setting
243791|NCT02674997|Feasibility|feasibility
243792|NCT02674997|Standardized Goal Attainment Scaling menu for Hemophilia (GAS-Hem)|standardized goal attainment scaling menu for hemophilia (gas-hem)
243793|NCT02674997|Patient reported outcome (PRO)|patient reported outcome (pro)
243794|NCT02674997|Goal attainment scaling (GAS)|goal attainment scaling (gas)
243795|NCT02674958|endothelial progenitor cells|endothelial progenitor cells
243796|NCT02674958|aspirin|aspirin
243797|NCT02674958|acetylsalicylic acid|acetylsalicylic acid
243798|NCT02674958|alcohol septal ablation|alcohol septal ablation
243799|NCT02674945|fitbit|fitbit
243800|NCT02674945|activity tracker|activity tracker
243801|NCT02674945|sleep|sleep
243802|NCT02674945|quality of life|quality of life
243803|NCT02674919|Repeated-sprint ability|repeated-sprint ability
243804|NCT02674919|Nordic Hamstring exercise|nordic hamstring exercise
243805|NCT02674919|Eccentric hamstring muscle strength|eccentric hamstring muscle strength
243806|NCT02674893|BMI>27|bmi>27
243807|NCT02674893|Treatment with Liraglutide|treatment with liraglutide
243808|NCT02674841|Adolescent|adolescent
243809|NCT02674841|Physical therapy modalities|physical therapy modalities
243810|NCT02674841|Exercise intervention|exercise intervention
243811|NCT02674841|Auditive feedback|auditive feedback
243812|NCT02674841|Visual feedback|visual feedback
243813|NCT02674815|Exercise|exercise
243814|NCT02674815|Preoperative|preoperative
243815|NCT02674815|High Intensity Interval Training|high intensity interval training
243816|NCT02674815|Colorectal|colorectal
243817|NCT02674815|Thoracic|thoracic
243818|NCT02674815|Postoperative|postoperative
243819|NCT02674802|Reinfection|reinfection
243820|NCT02674802|Eradication therapy|eradication therapy
243821|NCT02674802|C-urea breath test|c-urea breath test
243822|NCT02674802|Helicobacter Pylori|helicobacter pylori
243823|NCT02674789|Exercise|exercise
243824|NCT02674789|Athletes|athletes
243825|NCT02674789|Ionized Magnesium|ionized magnesium
243826|NCT02674789|Variation|variation
243827|NCT02674789|Blood|blood
243828|NCT02674763|Acute Myeloid Leukemia|acute myeloid leukemia
243829|NCT02674763|AML|aml
243830|NCT02674763|IMGN779|imgn779
243831|NCT02674763|ImmunoGen|immunogen
243832|NCT02674763|Phase 1|phase 1
243833|NCT02674763|Relapsed|relapsed
243834|NCT02674763|Refractory|refractory
243835|NCT02674763|CD33|cd33
243836|NCT02674763|Dose Escalation|dose escalation
243837|NCT02674763|Dose Expansion|dose expansion
243838|NCT02674750|DLBCL|dlbcl
243839|NCT02674750|MYC|myc
243840|NCT02674724|Resistance Training|resistance training
243841|NCT02674724|Postural Balance|postural balance
243842|NCT02674724|Exercise|exercise
243843|NCT02674711|patient education|patient education
243844|NCT02674711|low back pain|low back pain
243845|NCT02674711|post-surgical pain|post-surgical pain
243846|NCT02674711|chronic opioid use|chronic opioid use
243848|NCT02674672|VenaTech® Retrievable Vena Cava Filter|venatech® retrievable vena cava filter
243850|NCT02674672|efficacy|efficacy
243851|NCT02674659|resistance training, PCSK9, coronary artery bypass|resistance training, pcsk9, coronary artery bypass
243852|NCT02674633|ADHD|adhd
243853|NCT02674594|Anticoagulation|anticoagulation
243854|NCT02674568|SCLC|sclc
243855|NCT02674568|Small Cell Lung Cancer|small cell lung cancer
243856|NCT02674568|DLL#|dll#
243857|NCT02674568|Relapsed|relapsed
243858|NCT02674568|Refractory|refractory
243859|NCT02674555|Phase 1|phase 1
243860|NCT02674555|Metabolism|metabolism
243861|NCT02674555|Excretion|excretion
243862|NCT02674555|Absorption|absorption
243863|NCT02674555|[14C]-radioactivity|[14c]-radioactivity
243864|NCT02674555|Pharmacokinetics|pharmacokinetics
243865|NCT02674555|naquotinib|naquotinib
243866|NCT02674555|Oncology|oncology
243867|NCT02674542|Family planning|family planning
243868|NCT02674542|Birth spacing|birth spacing
243869|NCT02674529|Depression|depression
243870|NCT02674529|Neuroimaging biomarkers|neuroimaging biomarkers
243871|NCT02674529|MDD|mdd
243872|NCT02674529|Neurofeedback|neurofeedback
243873|NCT02674516|antisocial behavior|antisocial behavior
243874|NCT02674516|aggression|aggression
243875|NCT02674516|transcranial direct current stimulation|transcranial direct current stimulation
243876|NCT02674516|dorsolateral prefrontal cortex|dorsolateral prefrontal cortex
243877|NCT02674516|associated risk factors|associated risk factors
243878|NCT02674503|Walking|walking
243879|NCT02674503|Hospitalization|hospitalization
243880|NCT02674503|Randomized controlled trial|randomized controlled trial
243881|NCT02674490|aphasia, language|aphasia, language
243882|NCT02674373|gastric cancer|gastric cancer
243883|NCT02674373|biomarker|biomarker
243884|NCT02674373|Circulating tumor DNA|circulating tumor dna
243885|NCT02674373|Chemotherapy|chemotherapy
243886|NCT02674373|Prognosis|prognosis
243887|NCT02674373|Predictive|predictive
243888|NCT02674334|orthopedic procedures|orthopedic procedures
243889|NCT02674321|Tourette Syndrome|tourette syndrome
243890|NCT02674321|adolescents|adolescents
243891|NCT02674308|Drug therapy|drug therapy
243892|NCT02674295|Healthy|healthy
243893|NCT02674295|JNJ-54135419|jnj-54135419
243894|NCT02674295|Esketamine|esketamine
243895|NCT02674282|anterior cruciate ligament reconstruction|anterior cruciate ligament reconstruction
243896|NCT02674282|anterior cruciate ligament|anterior cruciate ligament
243897|NCT02674282|sports medicine|sports medicine
243898|NCT02674282|soccer|soccer
243899|NCT02674282|maximum oxygen uptake|maximum oxygen uptake
243900|NCT02674282|return to play|return to play
243901|NCT02674269|Overactive bladder|overactive bladder
243902|NCT02674269|Botox|botox
243903|NCT02674269|TC-3 Gel|tc-3 gel
243904|NCT02674269|Intravesical|intravesical
243905|NCT02674269|UroGen Pharma|urogen pharma
243906|NCT02674269|Botulinum Toxin|botulinum toxin
243907|NCT02674269|Urgency|urgency
243908|NCT02674269|OAB|oab
243909|NCT02674269|Incontinence|incontinence
243910|NCT02674269|I-QOL|i-qol
243911|NCT02674269|KHQ|khq
243912|NCT02674269|TBS|tbs
243913|NCT02674269|RTG|rtg
243914|NCT02674256|health|health
243915|NCT02674256|age between 18 to 60 years old|age between 18 to 60 years old
243916|NCT02674256|no history of gastrointestinal symptoms or complaints|no history of gastrointestinal symptoms or complaints
243917|NCT02674243|Malignant pleural effusion|malignant pleural effusion
243918|NCT02674243|Pleurodesis|pleurodesis
243919|NCT02674243|Talc|talc
243920|NCT02674243|Iodopovidone solution|iodopovidone solution
243921|NCT02674243|Povidone-iodine|povidone-iodine
243922|NCT02674204|Statin therapy|statin therapy
243923|NCT02674204|trastuzumab|trastuzumab
243924|NCT02674191|miniplates ,molar intrusion, hyperdivergent|miniplates ,molar intrusion, hyperdivergent
243925|NCT02674139|post placental-caesarean-IUD|post placental-caesarean-iud
243926|NCT02674126|Cardiac Surgery|cardiac surgery
243927|NCT02674126|Maternal sound|maternal sound
243928|NCT02674126|Cortisol|cortisol
243929|NCT02674126|Blood sugar|blood sugar
243930|NCT02674126|Stress|stress
243931|NCT02674061|PD1|pd1
243932|NCT02674061|PD-1|pd-1
243933|NCT02674061|PDL1|pdl1
243934|NCT02674061|PD-L1|pd-l1
243935|NCT02674035|Abdominoplasty|abdominoplasty
243936|NCT02674035|Sutures|sutures
243937|NCT02674035|Abdominal deformities|abdominal deformities
243938|NCT02674035|Plication|plication
243939|NCT02674035|Monofilament nylon suture|monofilament nylon suture
243940|NCT02674035|Barbed suture|barbed suture
243941|NCT02674022|Maternal Health|maternal health
243942|NCT02674022|Autistic Disorder|autistic disorder
243943|NCT02674022|Metabolism|metabolism
243944|NCT02674022|Folic Acid|folic acid
243945|NCT02673996|antibody|antibody
243946|NCT02673996|autoimmune|autoimmune
243947|NCT02673996|adrenergic|adrenergic
243948|NCT02673996|autonomic|autonomic
243949|NCT02673983|Intestinal|intestinal
243950|NCT02673983|Biopsy|biopsy
243951|NCT02673983|full thickness|full thickness
243952|NCT02673983|endoscopic|endoscopic
243953|NCT02673970|Melanoma|melanoma
243954|NCT02673931|Open Heart Surgery|open heart surgery
243955|NCT02673931|Organ protection|organ protection
243956|NCT02673918|Rehabilitation|rehabilitation
243957|NCT02673918|Home-Based Intervention|home-based intervention
243958|NCT02673905|nasal chondrocytes|nasal chondrocytes
243959|NCT02673905|articular chondral lesions|articular chondral lesions
243960|NCT02673905|tissue engineering|tissue engineering
243961|NCT02673905|femoral condyle|femoral condyle
243962|NCT02673905|trochlea|trochlea
243963|NCT02673892|discharge|discharge
243964|NCT02673892|transitions|transitions
243965|NCT02673892|patient experience|patient experience
243966|NCT02673866|Diabetic Peripheral Neuropathic Pain (DPNP)|diabetic peripheral neuropathic pain (dpnp)
243967|NCT02673866|Diabetes|diabetes
243968|NCT02673866|Pregabalin|pregabalin
243969|NCT02673866|Spontaneous Pain|spontaneous pain
243970|NCT02673866|Hyperalgesia|hyperalgesia
243971|NCT02673866|Allodynia|allodynia
243972|NCT02673866|Average Daily Pain Score (ADPS)|average daily pain score (adps)
243973|NCT02673866|Pain Associated Sleep Interference|pain associated sleep interference
243974|NCT02673853|Supraglottic airway|supraglottic airway
243975|NCT02673853|Mini-dose atracurium|mini-dose atracurium
243976|NCT02673853|Postoperative residual paralysis|postoperative residual paralysis
243977|NCT02673840|dengue fever|dengue fever
243978|NCT02673840|dengue hemorrhagic fever|dengue hemorrhagic fever
243979|NCT02673840|ketotifen|ketotifen
243980|NCT02673840|vascular leakage|vascular leakage
243981|NCT02673840|pleural effusion|pleural effusion
243982|NCT02673840|plasma leakage|plasma leakage
243983|NCT02673801|Referral and Consultation|referral and consultation
243984|NCT02673801|Orthopedics|orthopedics
243985|NCT02673775|Macrophage|macrophage
243986|NCT02673749|Lactose maldigestion|lactose maldigestion
243987|NCT02673749|Dairy intolerance|dairy intolerance
243988|NCT02673749|Intolerance to milk|intolerance to milk
243989|NCT02673749|Intolerance to dairy|intolerance to dairy
243990|NCT02673749|Milk intolerance|milk intolerance
243991|NCT02673749|GI disorder|gi disorder
243992|NCT02673749|Lactose metabolism|lactose metabolism
243993|NCT02673749|GI symptoms after dairy ingestion|gi symptoms after dairy ingestion
243994|NCT02673736|PLX73086|plx73086
243995|NCT02673736|Synovitis, Pigmented Villonodular|synovitis, pigmented villonodular
243996|NCT02673736|Tenosynovial Giant Cell Tumor|tenosynovial giant cell tumor
243997|NCT02673736|Joint Diseases|joint diseases
243998|NCT02673736|Neoplasms|neoplasms
243999|NCT02673736|Synovitis|synovitis
244000|NCT02673723|docozine|docozine
244001|NCT02673697|Sutureless valve|sutureless valve
244002|NCT02673658|infant development, early intervention|infant development, early intervention
244003|NCT02673645|Educational Achievement|educational achievement
244004|NCT02673632|Anti-Müllerian hormone|anti-müllerian hormone
244005|NCT02673632|Ovarian stimulation|ovarian stimulation
244006|NCT02673632|Polycystic ovary syndrome|polycystic ovary syndrome
244007|NCT02673632|Intracytoplasmic sperm injection|intracytoplasmic sperm injection
244008|NCT02673619|Topical|topical
244009|NCT02673619|Palmar Hyperhidrosis|palmar hyperhidrosis
244010|NCT02673619|Umeclidinium|umeclidinium
244011|NCT02673593|Safety|safety
244012|NCT02673593|Pharmacokinetics|pharmacokinetics
244013|NCT02673593|Food Effect|food effect
244014|NCT02673554|Glucose-dependent Insulinotropic Polypeptide (GIP)|glucose-dependent insulinotropic polypeptide (gip)
244015|NCT02673554|Glucagon-Like Peptide 1 (GLP-1)|glucagon-like peptide 1 (glp-1)
244016|NCT02673554|Incretin|incretin
244017|NCT02673554|Insulin secretion|insulin secretion
244018|NCT02673554|Tachyphylaxis|tachyphylaxis
244019|NCT02673528|appendectomy|appendectomy
244020|NCT02673528|laparoscopy|laparoscopy
244021|NCT02673528|laparoscopic assisted appendectomy|laparoscopic assisted appendectomy
244022|NCT02673528|cost utility|cost utility
244023|NCT02673515|Alternate Day Fasting|alternate day fasting
244024|NCT02673502|Carbohydrate drink|carbohydrate drink
244025|NCT02673502|Post operative complication|post operative complication
244026|NCT02673502|insulin resistance|insulin resistance
244027|NCT02673502|Fasting blood glucose|fasting blood glucose
244028|NCT02673437|Acute coronary syndrome|acute coronary syndrome
244029|NCT02673411|elastography|elastography
244030|NCT02673411|ultrasonography|ultrasonography
244031|NCT02673372|Geriatric, Pain, Ketamine, Emergency Medicine|geriatric, pain, ketamine, emergency medicine
244032|NCT02673359|Preterm labor|preterm labor
244033|NCT02673359|Short cervix|short cervix
244034|NCT02673359|Progesterone|progesterone
244035|NCT02673359|Cervical cerclage|cervical cerclage
244036|NCT02673333|Pembrolizumab|pembrolizumab
244037|NCT02673333|15-286|15-286
244038|NCT02673320|Acute Traumatic Cervical Central Cord Syndrom Injury|acute traumatic cervical central cord syndrom injury
244039|NCT02673320|Delay of Surgery|delay of surgery
244040|NCT02673320|Decompressive Surgery|decompressive surgery
244041|NCT02673320|Canal Stenosis|canal stenosis
244042|NCT02673320|Schneider Syndrom|schneider syndrom
244043|NCT02673320|Quality of life|quality of life
244044|NCT02673320|Functional Outcome|functional outcome
244045|NCT02673281|walnuts|walnuts
244046|NCT02673281|brain|brain
244047|NCT02673281|appetite|appetite
244048|NCT02673281|energy intake|energy intake
244049|NCT02673281|obesity|obesity
244050|NCT02673255|Plasma|plasma
244051|NCT02673255|Plasma Donor|plasma donor
244052|NCT02673255|Plasma Donation|plasma donation
244053|NCT02673255|Tetanus|tetanus
244054|NCT02673255|Td|td
244055|NCT02673255|Immunoglobulin|immunoglobulin
244056|NCT02673255|Hyper-immunization|hyper-immunization
244057|NCT02673229|Santyl|santyl
244058|NCT02673229|Burn|burn
244059|NCT02673229|Partial Thickness Burn|partial thickness burn
244060|NCT02673229|Second Degree Burn|second degree burn
244061|NCT02673229|Minor Burn Bacitracin|minor burn bacitracin
244062|NCT02673229|Scar Appearance|scar appearance
244063|NCT02673203|glucose monitoring|glucose monitoring
244064|NCT02673203|hunger levels|hunger levels
244065|NCT02673203|food intake|food intake
244066|NCT02673177|robot-assisted total mesorectal excision(RTME)|robot-assisted total mesorectal excision(rtme)
244067|NCT02673177|laparoscopic total mesorectal excision(LTME)|laparoscopic total mesorectal excision(ltme)
244068|NCT02673177|urinary function|urinary function
244069|NCT02673177|sexual function|sexual function
244070|NCT02673177|sphincter- preservation|sphincter- preservation
244071|NCT02673177|low rectal cancer|low rectal cancer
244072|NCT02673164|Heart failure|heart failure
244073|NCT02673164|stem cell|stem cell
244074|NCT02673164|adipose derived stem cell|adipose derived stem cell
244075|NCT02673164|Stem cell therapy|stem cell therapy
244076|NCT02673164|ischemic heart disease|ischemic heart disease
244077|NCT02673125|Preimplantation Genetic Screening|preimplantation genetic screening
244078|NCT02673112|Concussion|concussion
244079|NCT02673112|mild traumatic brain injury|mild traumatic brain injury
244080|NCT02673112|post concussion syndrome|post concussion syndrome
244081|NCT02673112|child|child
244082|NCT02673099|HDF online|hdf online
244083|NCT02673099|ESRD|esrd
244084|NCT02673099|Hemodialysis|hemodialysis
244085|NCT02673099|oxidative stress|oxidative stress
244086|NCT02673099|quality of life|quality of life
244087|NCT02673099|Hemodialysis treatment|hemodialysis treatment
244088|NCT02673086|retroclavicular approach|retroclavicular approach
244089|NCT02673086|coracoid approach|coracoid approach
244090|NCT02673086|ultrasound|ultrasound
244091|NCT02673086|upper limb surgery|upper limb surgery
244092|NCT02673086|needle visibility|needle visibility
244093|NCT02673086|infraclavicular brachial plexus block|infraclavicular brachial plexus block
244094|NCT02673073|Heart failure|heart failure
244095|NCT02673073|patient's diary|patient's diary
244096|NCT02673073|self awareness|self awareness
244097|NCT02672995|stereotactic radiosurgery,Bevacizumab|stereotactic radiosurgery,bevacizumab
244098|NCT02672969|smoke evacuation system|smoke evacuation system
244099|NCT02672969|surgical smoke|surgical smoke
244100|NCT02672943|Parkinson disease|parkinson disease
244101|NCT02672943|Autonomic nervous system|autonomic nervous system
244102|NCT02672943|MicroRNA|microrna
244103|NCT02672943|Inflammation|inflammation
244104|NCT02672943|Oxidative stress|oxidative stress
244105|NCT02672943|noradrenergic network|noradrenergic network
244106|NCT02672943|Rehabilitation treatment|rehabilitation treatment
244107|NCT02672930|calcium gluconate|calcium gluconate
244108|NCT02672930|hyperpotassemia treatment|hyperpotassemia treatment
244109|NCT02672917|CA19-9 Positive Malignancies|ca19-9 positive malignancies
244110|NCT02672904|vocal cord|vocal cord
244111|NCT02672904|carcinoma|carcinoma
244112|NCT02672904|ktp laser|ktp laser
244113|NCT02672904|co2 laser|co2 laser
244114|NCT02672904|endoscopic surgery|endoscopic surgery
244115|NCT02672891|Postpartum Hemorrhage|postpartum hemorrhage
244116|NCT02672891|Uterine Tamponade|uterine tamponade
244117|NCT02672891|Condom Catheter|condom catheter
244118|NCT02672878|In-stent restenosis|in-stent restenosis
244119|NCT02672878|Bioresorbable vascular scaffold|bioresorbable vascular scaffold
244121|NCT02672878|Drug-eluting stent|drug-eluting stent
244122|NCT02672878|Coronary angiography|coronary angiography
244123|NCT02672852|ABBV-066|abbv-066
244124|NCT02672852|BI 655066|bi 655066
244125|NCT02672852|risankizumab|risankizumab
244126|NCT02672813|Pectoral nerve I and II blocks|pectoral nerve i and ii blocks
244127|NCT02672813|Breast surgery|breast surgery
244128|NCT02672813|Ropivacaine|ropivacaine
244129|NCT02672813|Postoperative opioid consumption|postoperative opioid consumption
244130|NCT02672787|Antihypertensive adherence|antihypertensive adherence
244131|NCT02672787|Emergency medicine|emergency medicine
244132|NCT02672787|Antihypertensives|antihypertensives
244133|NCT02672748|garden|garden
244134|NCT02672748|Native American|native american
244135|NCT02672748|BMI|bmi
244136|NCT02672748|Emotional health|emotional health
244137|NCT02672748|Physical health|physical health
244138|NCT02672735|corrective exercise program|corrective exercise program
244139|NCT02672735|movement efficiency|movement efficiency
244140|NCT02672722|This term was found doing the MeSH search and is the only thing that fits since we will be working with healthy subjects with no conditions.|this term was found doing the mesh search and is the only thing that fits since we will be working with healthy subjects with no conditions.
244141|NCT02672709|Factor Xa Inhibitors|factor xa inhibitors
244142|NCT02672709|Renal Dialysis|renal dialysis
244143|NCT02672696|Navigation|navigation
244144|NCT02672696|Gamma Nail|gamma nail
244145|NCT02672657|Health-Related Quality of life|health-related quality of life
244147|NCT02672657|Elderly|elderly
244148|NCT02672657|Caregivers|caregivers
244149|NCT02672618|heart failure|heart failure
244150|NCT02672618|infrared thermal imaging|infrared thermal imaging
244151|NCT02672592|Metabolic syndrome X|metabolic syndrome x
244152|NCT02672592|Hypogonadism|hypogonadism
244153|NCT02672592|Testosterone|testosterone
244154|NCT02672592|Inflammation|inflammation
244155|NCT02672592|Obesity|obesity
244156|NCT02672566|Fetal Growth Retardation|fetal growth retardation
244157|NCT02672566|enoxaparin|enoxaparin
244158|NCT02672553|Aortic Valve Replacement|aortic valve replacement
244159|NCT02672553|Minimal Invasive Sternotomy|minimal invasive sternotomy
244160|NCT02672540|Sickle Cell|sickle cell
244161|NCT02672540|Anemia|anemia
244162|NCT02672540|VOC|voc
244163|NCT02672540|Vaso occlusive crisis|vaso occlusive crisis
244164|NCT02672501|immunotherapy|immunotherapy
244165|NCT02672501|CAR-T|car-t
244166|NCT02672501|leukemia|leukemia
244167|NCT02672449|Prostate cancer|prostate cancer
244168|NCT02672449|Carbon ions|carbon ions
244169|NCT02672449|Radiobiology|radiobiology
244170|NCT02672449|Radiotherapy|radiotherapy
244171|NCT02672436|Diabetic Foot Ulcer|diabetic foot ulcer
244172|NCT02672436|Diabetes Mellitus|diabetes mellitus
244173|NCT02672436|Wound Healing|wound healing
244174|NCT02672397|Epidural|epidural
244175|NCT02672397|Ethnicity|ethnicity
244176|NCT02672397|Education|education
244177|NCT02672397|Labor|labor
244178|NCT02672397|obstetrical analgesia|obstetrical analgesia
244179|NCT02672384|Intensive care unit|intensive care unit
244180|NCT02672384|Invasive mechanical ventilation|invasive mechanical ventilation
244181|NCT02672384|Chronic periodontitis|chronic periodontitis
244182|NCT02672384|Point of Care P. gingivalis test|point of care p. gingivalis test
244183|NCT02672358|Non-Small-Cell Lung Cancer|non-small-cell lung cancer
244184|NCT02672358|NSCLC|nsclc
244185|NCT02672358|dabrafenib|dabrafenib
244186|NCT02672358|trametinib|trametinib
244187|NCT02672358|Japanese patients|japanese patients
244188|NCT02672358|BRAF V600E mutation positive metastatic|braf v600e mutation positive metastatic
244189|NCT02672358|stage IV|stage iv
244190|NCT02672345|Sevoflurane|sevoflurane
244191|NCT02672345|MicroRNAs|micrornas
244192|NCT02672345|Inflammatory Response|inflammatory response
244193|NCT02672345|Cytokines|cytokines
244194|NCT02672345|Anesthetics, Inhalation|anesthetics, inhalation
244195|NCT02672345|Macrophage Inflammatory Proteins|macrophage inflammatory proteins
244196|NCT02672267|AMI, hBMMSCs, stem cells,|ami, hbmmscs, stem cells,
244197|NCT02672241|Radiation Therapy|radiation therapy
244198|NCT02672241|Brainstem Tumor in Children|brainstem tumor in children
244199|NCT02672202|Chronic Pain|chronic pain
244200|NCT02672202|Pain Modulation Profile|pain modulation profile
244201|NCT02672202|CPM|cpm
244202|NCT02672202|acute post operative pain|acute post operative pain
244203|NCT02672189|Climacteric symptoms|climacteric symptoms
244204|NCT02672189|Menopause|menopause
244205|NCT02672189|Breast Cancer Survivors|breast cancer survivors
244206|NCT02672189|Internet-based|internet-based
244207|NCT02672189|Cognitive behavioral therapy|cognitive behavioral therapy
244208|NCT02672189|Psychosocial intervention|psychosocial intervention
244209|NCT02672176|Diabetes mellitus|diabetes mellitus
244210|NCT02672176|Motivational Interviewing|motivational interviewing
244211|NCT02672176|Mobile Health Technology|mobile health technology
244212|NCT02672176|Patient-generated Health Data (PGHD)|patient-generated health data (pghd)
244213|NCT02672163|autologous micrografts|autologous micrografts
244214|NCT02672163|heart failure|heart failure
244215|NCT02672163|coronary artery bypass surgery|coronary artery bypass surgery
244216|NCT02672163|cell therapy|cell therapy
244217|NCT02672163|atrial appendage|atrial appendage
244218|NCT02672163|epicardial cell delivery|epicardial cell delivery
244219|NCT02672150|evidence-based practice implementation|evidence-based practice implementation
244220|NCT02672150|system change|system change
244221|NCT02672150|interagency collaboration|interagency collaboration
244222|NCT02672150|substance use|substance use
244223|NCT02672150|treatment services|treatment services
244224|NCT02672150|data-driven decision making|data-driven decision making
244225|NCT02672150|juvenile justice|juvenile justice
244226|NCT02672150|adolescents|adolescents
244227|NCT02672150|justice-involved youth|justice-involved youth
244228|NCT02672150|cluster randomized trial|cluster randomized trial
244229|NCT02672137|myocardial infarction|myocardial infarction
244230|NCT02672137|knowledge transfer|knowledge transfer
244231|NCT02672137|acute coronary syndromes|acute coronary syndromes
244232|NCT02672020|pheochromocytoma|pheochromocytoma
244233|NCT02672020|paraganglioma|paraganglioma
244234|NCT02672020|adrenocortical carcinoma|adrenocortical carcinoma
244235|NCT02672007|Respiratory rate measurement methods.|respiratory rate measurement methods.
244236|NCT02671994|Geriatric Assessment|geriatric assessment
244237|NCT02671994|G8 screening|g8 screening
244238|NCT02671994|Oncologic treatment|oncologic treatment
244239|NCT02671968|CGM|cgm
244240|NCT02671968|hypoglycemic events|hypoglycemic events
244241|NCT02671955|Advanced Cancer|advanced cancer
244242|NCT02671955|JNJ-61610588|jnj-61610588
244243|NCT02671942|roflumilast|roflumilast
244244|NCT02671916|QoL and Survival one year after ICU stay|qol and survival one year after icu stay
244245|NCT02671864|Incretin-based therapy|incretin-based therapy
244246|NCT02671864|GLP1|glp1
244247|NCT02671864|Angiogenesis Inflammation|angiogenesis inflammation
244248|NCT02671864|Hypoglycaemic treatment|hypoglycaemic treatment
244249|NCT02671851|Thoracic Paravertebral Blocks|thoracic paravertebral blocks
244250|NCT02671851|Ultrasound Guidance|ultrasound guidance
244251|NCT02671851|Reduction Mammoplasty|reduction mammoplasty
244252|NCT02671851|Time to First Pain|time to first pain
244253|NCT02671851|Postoperative Analgesia|postoperative analgesia
244254|NCT02671825|Pharmacokinetics|pharmacokinetics
244255|NCT02671812|dental implant|dental implant
244256|NCT02671812|patient satisfaction|patient satisfaction
244257|NCT02671812|treatment outcome|treatment outcome
244258|NCT02671812|cytokine profile|cytokine profile
244259|NCT02671812|risk factor|risk factor
244260|NCT02671812|risk predictor|risk predictor
244261|NCT02671786|Severe Acute Malnutrition|severe acute malnutrition
244262|NCT02671786|Severe Underweight|severe underweight
244263|NCT02671786|IAP Grade III-IV|iap grade iii-iv
244264|NCT02671786|Severe Stunting|severe stunting
244265|NCT02671786|Village Health Workers|village health workers
244266|NCT02671786|MAHAN RUTF & MAHAN Vit-Mim mix|mahan rutf & mahan vit-mim mix
244267|NCT02671773|Microbiota|microbiota
244268|NCT02671760|Short-term insomnia|short-term insomnia
244269|NCT02671760|difficulty sleeping|difficulty sleeping
244270|NCT02671760|sedative|sedative
244271|NCT02671760|hypnotic|hypnotic
244272|NCT02671734|endoscopy|endoscopy
244273|NCT02671682|Immunoadsorption|immunoadsorption
244274|NCT02671682|Plasmapheresis|plasmapheresis
244275|NCT02671656|Uricemia|uricemia
244276|NCT02671630|Cognitive function|cognitive function
244277|NCT02671630|Depression|depression
244278|NCT02671630|Quality of life|quality of life
244279|NCT02671630|Community-based computerized cognitive training program|community-based computerized cognitive training program
244280|NCT02671630|Randomized controlled trial|randomized controlled trial
244281|NCT02671617|Abdominal Cavity|abdominal cavity
244282|NCT02671617|Aged|aged
244283|NCT02671604|acute renal failure|acute renal failure
244284|NCT02671604|prostatectomy|prostatectomy
244285|NCT02671604|minimal invasive surgery|minimal invasive surgery
244286|NCT02671578|nitrous oxide|nitrous oxide
244287|NCT02671578|conscious sedation|conscious sedation
244288|NCT02671578|pain|pain
244289|NCT02671578|anxiety|anxiety
244290|NCT02671565|Intraarticular hyaluronic acid injections|intraarticular hyaluronic acid injections
244291|NCT02671565|Total knee replacement|total knee replacement
244292|NCT02671565|Observational study|observational study
244293|NCT02671565|Intraarticular corticosteroid injections|intraarticular corticosteroid injections
244294|NCT02671565|Comparative effectiveness|comparative effectiveness
244295|NCT02671539|gene therapy|gene therapy
244296|NCT02671539|hereditary retinal degeneration|hereditary retinal degeneration
244297|NCT02671539|rAAV2.REP1|raav2.rep1
244298|NCT02671513|Melanoma|melanoma
244299|NCT02671513|Cycline-Dependent Kinase|cycline-dependent kinase
244300|NCT02671487|Problem Behavior|problem behavior
244301|NCT02671487|Aggression|aggression
244302|NCT02671487|Posttraumatic Stress Disorder|posttraumatic stress disorder
244303|NCT02671487|Adolescents|adolescents
244304|NCT02671448|Homebound|homebound
244305|NCT02671448|Homecare|homecare
244306|NCT02671448|15-022|15-022
244307|NCT02671435|Colorectal, colon, CRC, solid tumors, check point inhibitors, immunotherapy, metastatic|colorectal, colon, crc, solid tumors, check point inhibitors, immunotherapy, metastatic
244308|NCT02671396|Virtual Reality|virtual reality
244309|NCT02671396|Postural Stability|postural stability
244310|NCT02671396|Balance Training|balance training
244311|NCT02671396|Parkinson's Disease|parkinson's disease
244312|NCT02671383|Antiretroviral Agents|antiretroviral agents
244313|NCT02671383|Treatment|treatment
244314|NCT02671383|Viral Load|viral load
244315|NCT02671357|pancreatic surgery; neoplasms|pancreatic surgery; neoplasms
244316|NCT02671318|cytomegalovirus|cytomegalovirus
244317|NCT02671318|sirolimus|sirolimus
244318|NCT02671318|cytomegalovirus recurrence|cytomegalovirus recurrence
244319|NCT02671318|kidney transplant|kidney transplant
244320|NCT02671318|conversion|conversion
244321|NCT02671305|delayed cord clamping|delayed cord clamping
244322|NCT02671305|cord milking|cord milking
244323|NCT02671305|bedside neonatal resuscitation|bedside neonatal resuscitation
244324|NCT02671292|Loss of Control Eating|loss of control eating
244325|NCT02671292|Binge Eating|binge eating
244326|NCT02671292|Obesity|obesity
244327|NCT02671292|Prevention|prevention
244328|NCT02671292|Interpersonal Psychotherapy|interpersonal psychotherapy
244329|NCT02671292|Adolescent|adolescent
244330|NCT02671266|Oxytocin|oxytocin
244331|NCT02671266|Body dysmorphic disorder|body dysmorphic disorder
244332|NCT02671266|Obsessive-compulsive disorder|obsessive-compulsive disorder
244333|NCT02671240|Parkinson disease|parkinson disease
244334|NCT02671240|behavioral addiction|behavioral addiction
244335|NCT02671240|akinéto-rigid syndrome|akinéto-rigid syndrome
244336|NCT02671240|dopamine agonist|dopamine agonist
244337|NCT02671214|guar gum|guar gum
244338|NCT02671214|konjac mannan|konjac mannan
244339|NCT02671214|blood glucose|blood glucose
244340|NCT02671214|legume flour|legume flour
244341|NCT02671188|C-C chemokine receptor|c-c chemokine receptor
244342|NCT02671188|Psoriatic arthritis|psoriatic arthritis
244343|NCT02671188|Chemokine (C-C motif) ligand 20|chemokine (c-c motif) ligand 20
244344|NCT02671188|Monoclonal antibody|monoclonal antibody
244345|NCT02671188|psoriasis|psoriasis
730905|NCT00506857|Fludara|fludara
244346|NCT02671188|Humanized Immunoglobulin G|humanized immunoglobulin g
244347|NCT02671162|Pruritus|pruritus
244348|NCT02671162|End-Stage Renal Disease|end-stage renal disease
244349|NCT02671110|weight loss treatment|weight loss treatment
244351|NCT02671084|Sevoflurane|sevoflurane
244352|NCT02671084|Ck-MB|ck-mb
244353|NCT02671071|Cervix Cancer|cervix cancer
244354|NCT02671058|bioavailability|bioavailability
244355|NCT02671045|lung cancer|lung cancer
244356|NCT02671045|genomic profile|genomic profile
244357|NCT02671045|targeted therapy|targeted therapy
244358|NCT02671045|FoundationOne|foundationone
244359|NCT02671032|Cochlear Prosthesis Implantation|cochlear prosthesis implantation
244360|NCT02670980|Retina Implant|retina implant
244361|NCT02670980|Visual Prosthesis|visual prosthesis
244362|NCT02670941|aromatherapy|aromatherapy
244363|NCT02670941|chemotherapy|chemotherapy
244364|NCT02670941|ginger|ginger
244365|NCT02670941|lavender|lavender
244366|NCT02670941|orange|orange
244367|NCT02670941|jojoba|jojoba
244368|NCT02670941|essential oils|essential oils
244369|NCT02670941|cancer|cancer
244370|NCT02670928|Diabetes|diabetes
244371|NCT02670928|lifestyle change|lifestyle change
244372|NCT02670928|weight management|weight management
244373|NCT02670928|control of glycemic in HbA1C and FPG|control of glycemic in hba1c and fpg
244374|NCT02670850|Mild Cognitive Impairment|mild cognitive impairment
244375|NCT02670850|Family caregiver|family caregiver
244376|NCT02670850|Intervention program|intervention program
244377|NCT02670850|Elders|elders
244378|NCT02670811|Hypertension|hypertension
244379|NCT02670811|Fermented Milk|fermented milk
244380|NCT02670811|Clinical Study|clinical study
244381|NCT02670811|Randomized|randomized
244382|NCT02670811|Double-blind|double-blind
244383|NCT02670798|neuromuscular|neuromuscular
244384|NCT02670798|scoliosis|scoliosis
244385|NCT02670772|Antiretroviral Agents|antiretroviral agents
244386|NCT02670746|Pancreatic Cancer|pancreatic cancer
244387|NCT02670746|Observational|observational
244388|NCT02670746|Nab-Paclitaxel|nab-paclitaxel
244389|NCT02670746|Abraxane|abraxane
244390|NCT02670746|ABI-007|abi-007
244391|NCT02670746|Gemcitabine|gemcitabine
244392|NCT02670746|Non-interventional|non-interventional
244393|NCT02670746|Netherlands|netherlands
244394|NCT02670746|Quality of Life|quality of life
244395|NCT02670733|mechanical ventilation|mechanical ventilation
244396|NCT02670733|positive end-expiratory pressure|positive end-expiratory pressure
244397|NCT02670720|BCX4161|bcx4161
244398|NCT02670720|avoralstat|avoralstat
244400|NCT02670720|hereditary angioedema|hereditary angioedema
244401|NCT02670720|prophylaxis|prophylaxis
244402|NCT02670707|vinblastine|vinblastine
244403|NCT02670707|prednisone|prednisone
244404|NCT02670707|cytarabine|cytarabine
244405|NCT02670707|Langerhans Cell Histiocytosis (LCH)|langerhans cell histiocytosis (lch)
244406|NCT02670694|Rett Syndrome|rett syndrome
244407|NCT02670694|Prader-Willi Syndrome|prader-willi syndrome
244408|NCT02670694|Angelman Syndrome|angelman syndrome
244409|NCT02670694|Sleep Problems|sleep problems
244410|NCT02670681|Exercise|exercise
244411|NCT02670681|Aerobic Exercise|aerobic exercise
244412|NCT02670668|BRCA1/2;Mutations;Neoadjuvant chemotherapy;TNBC|brca1/2;mutations;neoadjuvant chemotherapy;tnbc
244413|NCT02670655|Ablative fractional laser|ablative fractional laser
244414|NCT02670655|Iontophoresis|iontophoresis
244415|NCT02670655|Actinic keratosis|actinic keratosis
244416|NCT02670655|Photodynamic therapy|photodynamic therapy
244417|NCT02670629|Pediatric orthopedics|pediatric orthopedics
244418|NCT02670577|stage I|stage i
244419|NCT02670577|stage II|stage ii
244420|NCT02670577|HER2 positive|her2 positive
244421|NCT02670577|Triple Negative|triple negative
244422|NCT02670564|pharmacogenetics|pharmacogenetics
244423|NCT02670564|busulfan|busulfan
244424|NCT02670564|treosulfan|treosulfan
244425|NCT02670564|hematopoietic stem cell transplantation|hematopoietic stem cell transplantation
244426|NCT02670564|fludarabine|fludarabine
244427|NCT02670564|pediatric patients|pediatric patients
244428|NCT02670564|TBI|tbi
244429|NCT02670564|leukemia|leukemia
244430|NCT02670564|leukemia, lymphoid|leukemia, lymphoid
244431|NCT02670564|precursor cell lymphoblastic Leukemia-Lymphoma|precursor cell lymphoblastic leukemia-lymphoma
244432|NCT02670564|Immune System disease|immune system disease
244433|NCT02670564|Immunoproliferative Disorders|immunoproliferative disorders
244434|NCT02670564|stem cell transplantation|stem cell transplantation
244435|NCT02670564|children and adolescent|children and adolescent
244436|NCT02670564|high risk acute lymphoblastic leukemia|high risk acute lymphoblastic leukemia
244437|NCT02670564|NCT01949129 add-on|nct01949129 add-on
244438|NCT02670564|ALL SCTped FORUM|all sctped forum
244439|NCT02670525|Recurrent, Refractory, or High Risk Leukemias|recurrent, refractory, or high risk leukemias
244440|NCT02670525|Matched targeted therapy|matched targeted therapy
244441|NCT02670512|End-Stage Renal Disease|end-stage renal disease
244442|NCT02670512|Peritoneal Dialysis|peritoneal dialysis
244443|NCT02670512|Telehomecare|telehomecare
244444|NCT02670512|Telehome Monitoring|telehome monitoring
244445|NCT02670486|Overactive bladder|overactive bladder
312482|NCT02275702|QoR-40|qor-40
244446|NCT02670486|Urge urinary incontinence|urge urinary incontinence
244447|NCT02670486|Urodynamics|urodynamics
244448|NCT02670408|Heart transplant|heart transplant
244449|NCT02670408|global gene expression|global gene expression
244450|NCT02670408|molecular diagnostics|molecular diagnostics
244451|NCT02670395|Healthy|healthy
244452|NCT02670395|JNJ-54416076|jnj-54416076
244453|NCT02670395|Ascending Dose|ascending dose
244454|NCT02670369|Sedentary time|sedentary time
244455|NCT02670369|Sit-to-stand transitions|sit-to-stand transitions
244456|NCT02670356|fish oil|fish oil
244458|NCT02670356|DHA|dha
244459|NCT02670356|krill oil|krill oil
244460|NCT02670356|Metabolic Syndrome|metabolic syndrome
244461|NCT02670330|Amicus Therapeutics|amicus therapeutics
244462|NCT02670330|Scioderm, Inc.|scioderm, inc.
244463|NCT02670330|Simplex|simplex
244464|NCT02670330|Recessive Dystrophic|recessive dystrophic
244465|NCT02670330|Junctional non-Herlitz|junctional non-herlitz
244466|NCT02670330|Epidermolysis Bullosa|epidermolysis bullosa
244467|NCT02670330|SD-101 6%|sd-101 6%
244468|NCT02670330|SD-101-6.0|sd-101-6.0
244469|NCT02670330|Allantoin 6%|allantoin 6%
244470|NCT02670330|Zorblisa|zorblisa
244471|NCT02670317|DLBCL|dlbcl
244472|NCT02670317|large B cell lymphoma|large b cell lymphoma
244473|NCT02670317|NHL|nhl
244474|NCT02670304|letrozole|letrozole
244475|NCT02670304|ovarian hyperstimulating syndrome|ovarian hyperstimulating syndrome
244476|NCT02670291|auditory hallucinations|auditory hallucinations
244477|NCT02670291|schizophrenia|schizophrenia
244478|NCT02670291|cTBS|ctbs
244479|NCT02670291|noninvasive brain stimulation|noninvasive brain stimulation
244480|NCT02670265|malnutrition|malnutrition
244481|NCT02670265|parenteral nutrition|parenteral nutrition
244482|NCT02670265|weight loss|weight loss
244483|NCT02670265|pancreatic cancer|pancreatic cancer
244484|NCT02670265|biliary tract cancer|biliary tract cancer
244485|NCT02670265|quality of life|quality of life
244486|NCT02670226|Amyotrophic Lateral Sclerosis|amyotrophic lateral sclerosis
244487|NCT02670226|Muscle metabolism|muscle metabolism
244488|NCT02670226|Metabolomics|metabolomics
244489|NCT02670226|Transcriptomics|transcriptomics
244490|NCT02670200|psychooncology|psychooncology
244491|NCT02670200|mental health support|mental health support
244492|NCT02670200|ICBT|icbt
244493|NCT02670200|supportive treatment for cancer patients|supportive treatment for cancer patients
244494|NCT02670200|depression|depression
244495|NCT02670200|online-therapy|online-therapy
244496|NCT02670200|Psycho-oncological support via internet|psycho-oncological support via internet
244497|NCT02670200|internet-delivered cognitive behavior medicine|internet-delivered cognitive behavior medicine
244498|NCT02670187|MERS CoV|mers cov
244499|NCT02670187|MERS-CoV|mers-cov
244500|NCT02670187|Middle East Respiratory Syndrome|middle east respiratory syndrome
244501|NCT02670187|MERS|mers
244502|NCT02670187|DNA Vaccine|dna vaccine
244503|NCT02670174|Shoulder impingement syndrome|shoulder impingement syndrome
244504|NCT02670174|Overhead athletes|overhead athletes
244505|NCT02670174|Kinetic chain|kinetic chain
244506|NCT02670174|Exercise treatment|exercise treatment
244507|NCT02670148|Chiropractic Manipulative Therapy|chiropractic manipulative therapy
244508|NCT02670148|Low back pain|low back pain
244509|NCT02670148|Trunk muscle strength|trunk muscle strength
244510|NCT02670148|Balance|balance
244511|NCT02670148|Active military personnel|active military personnel
244512|NCT02670122|Hepatocellular Carcinoma|hepatocellular carcinoma
244513|NCT02670122|TACE|tace
244514|NCT02670096|acetazolamide|acetazolamide
244515|NCT02670096|Treatment Emergent Sleep Disordered Breathing|treatment emergent sleep disordered breathing
244516|NCT02670096|Sleep Apnea|sleep apnea
244517|NCT02670031|Hypertensive Heart Disease|hypertensive heart disease
244518|NCT02670031|Hypertension|hypertension
244519|NCT02670031|Left Ventricular Hypertrophy|left ventricular hypertrophy
244520|NCT02670031|Myocardial Fibrosis|myocardial fibrosis
244521|NCT02670031|Cardiovascular Magnetic Resonance Imaging|cardiovascular magnetic resonance imaging
244522|NCT02669992|Ileostomy|ileostomy
244523|NCT02669979|elderly|elderly
244524|NCT02669979|oral care|oral care
244525|NCT02669966|Kidney Transplantation|kidney transplantation
244526|NCT02669940|Ombitasvir|ombitasvir
244527|NCT02669940|Dasabuvir|dasabuvir
244528|NCT02669940|Paritaprevir|paritaprevir
244529|NCT02669927|hip surgery|hip surgery
244530|NCT02669927|frail older people|frail older people
244531|NCT02669901|Opioid-Related Disorders|opioid-related disorders
244532|NCT02669901|Naloxone|naloxone
244533|NCT02669901|Harm Reduction|harm reduction
244534|NCT02669901|Drug Overdose Deaths|drug overdose deaths
244535|NCT02669901|Opioid Misuse|opioid misuse
244536|NCT02669901|Naloxone Coprescribing|naloxone coprescribing
244537|NCT02669901|Universal Precautions|universal precautions
244538|NCT02669901|Opioid Substance Use Disorder|opioid substance use disorder
244539|NCT02669888|Indigo Naturalis|indigo naturalis
244540|NCT02669888|Atopic Dermatitis|atopic dermatitis
244541|NCT02669888|TCM|tcm
244542|NCT02669823|Diagnosis|diagnosis
244543|NCT02669797|Childhood Obesity|childhood obesity
244544|NCT02669797|Ecological Momentary Intervention|ecological momentary intervention
244545|NCT02669797|Video Feedback|video feedback
244546|NCT02669771|Xtandi|xtandi
244547|NCT02669771|MDV3100|mdv3100
244548|NCT02669771|long term use|long term use
244549|NCT02669771|enzalutamide|enzalutamide
244550|NCT02669758|Alkermes|alkermes
244551|NCT02669758|ALKS 3831|alks 3831
244552|NCT02669758|Samidorphan|samidorphan
244553|NCT02669758|Schizophrenia|schizophrenia
244554|NCT02669758|Safety|safety
244555|NCT02669745|Chinese women|chinese women
244556|NCT02669745|Breast cancer|breast cancer
244557|NCT02669732|Type 2 Diabetes Mellitus|type 2 diabetes mellitus
244558|NCT02669732|Adult|adult
244559|NCT02669732|Developmental Phase II|developmental phase ii
244560|NCT02669719|Lung Cancer|lung cancer
244561|NCT02669719|Chemotherapy|chemotherapy
244562|NCT02669719|Immunotherapy|immunotherapy
244563|NCT02669693|Olives, oleuropein|olives, oleuropein
244564|NCT02669667|MEDI9314|medi9314
244565|NCT02669667|Safety|safety
244566|NCT02669667|Tolerability|tolerability
244567|NCT02669667|Pharmacokinetics|pharmacokinetics
244568|NCT02669667|Immunogenicity|immunogenicity
244569|NCT02669641|Steatosis, Fatty liver, Steatohepatitis|steatosis, fatty liver, steatohepatitis
244570|NCT02669615|multiple myeloma|multiple myeloma
244571|NCT02669615|Melphalan HCl|melphalan hcl
244572|NCT02669615|Autologous Transplantation|autologous transplantation
244573|NCT02669602|Nutritional epidemiology|nutritional epidemiology
244574|NCT02669602|Prospective|prospective
244575|NCT02669589|CRRT|crrt
244576|NCT02669589|AKI|aki
244577|NCT02669589|anticoagulation|anticoagulation
244578|NCT02669589|KDIGO|kdigo
244579|NCT02669576|Breast cancer|breast cancer
244580|NCT02669576|meopausal syptoms|meopausal syptoms
244581|NCT02669576|mind body medecine|mind body medecine
244582|NCT02669576|yoga|yoga
244583|NCT02669576|acupuncture|acupuncture
244584|NCT02669550|Fiberoptic bronchoscope|fiberoptic bronchoscope
244585|NCT02669550|Disposcope endoscope|disposcope endoscope
244586|NCT02669550|Awake orotracheal intubation|awake orotracheal intubation
244587|NCT02669511|DLBCL|dlbcl
244588|NCT02669485|ICG|icg
244589|NCT02669485|colectomy|colectomy
244590|NCT02669485|anastomotic leak|anastomotic leak
244591|NCT02669485|anastomotic leakage rate|anastomotic leakage rate
244592|NCT02669485|surgical decision|surgical decision
244593|NCT02669459|Cervical Intraepithelial Neoplasia|cervical intraepithelial neoplasia
244594|NCT02669459|Imiquimod|imiquimod
244595|NCT02669459|Human papillomavirus|human papillomavirus
244596|NCT02669459|quality of life|quality of life
244597|NCT02669459|biological markers|biological markers
244598|NCT02669446|Non interventional study|non interventional study
244599|NCT02669446|Ectoin|ectoin
244600|NCT02669446|Lozenges|lozenges
244601|NCT02669446|pharyngitis|pharyngitis
244602|NCT02669433|Dementia with Lewy bodies|dementia with lewy bodies
244603|NCT02669433|Lewy bodies|lewy bodies
244604|NCT02669433|intepirdine|intepirdine
244605|NCT02669433|RVT-101|rvt-101
244606|NCT02669433|dementia|dementia
244607|NCT02669381|Phenylalanine|phenylalanine
244608|NCT02669381|Direct Amino Acid Oxidation|direct amino acid oxidation
244609|NCT02669381|Stable isotopes|stable isotopes
244610|NCT02669355|White coat physician attire|white coat physician attire
244611|NCT02669342|Infection|infection
244612|NCT02669342|Urinary Catheter|urinary catheter
244613|NCT02669342|Sharklet|sharklet
244614|NCT02669316|diet|diet
244615|NCT02669303|Subacromial injection|subacromial injection
244616|NCT02669303|methylprednisolone|methylprednisolone
244617|NCT02669303|treatment|treatment
244618|NCT02669303|Platelet-rich plasma|platelet-rich plasma
244619|NCT02669264|Loncastuximab tesirine|loncastuximab tesirine
244620|NCT02669251|Optimal Biologic Dose|optimal biologic dose
244621|NCT02669251|Safety|safety
244622|NCT02669251|Chronic Graft-Versus-Host Disease (cGVHD)|chronic graft-versus-host disease (cgvhd)
244623|NCT02669251|Inflammatory Lung Disease|inflammatory lung disease
244624|NCT02669251|FEV1|fev1
244625|NCT02669225|18 F florbetaben|18 f florbetaben
244626|NCT02669225|Sleep Deprivation|sleep deprivation
244627|NCT02669225|rested wakefulness|rested wakefulness
244628|NCT02669225|glymphatic system|glymphatic system
244629|NCT02669212|Chronic Fatigue Syndrome|chronic fatigue syndrome
244630|NCT02669212|Lyme Disease|lyme disease
244631|NCT02669212|Healthy Volunteers|healthy volunteers
244632|NCT02669212|Movement Disorder|movement disorder
244633|NCT02669186|analgesia|analgesia
244634|NCT02669186|cancer|cancer
244635|NCT02669186|natural killer cell|natural killer cell
244636|NCT02669186|opioid|opioid
245938|NCT02661425|IBS|ibs
244637|NCT02669173|Myeloid derived suppressor cells|myeloid derived suppressor cells
244638|NCT02669173|brain tumor|brain tumor
244639|NCT02669173|MDSC|mdsc
244640|NCT02669173|GBM|gbm
244641|NCT02669173|recurrent|recurrent
244642|NCT02669160|Motorized Orthotic Devices|motorized orthotic devices
244643|NCT02669160|Minors|minors
244644|NCT02669160|CP (Cerebral Palsy)|cp (cerebral palsy)
244645|NCT02669160|Exoskeleton Device|exoskeleton device
244646|NCT02669134|cardiac resynchronization therapy|cardiac resynchronization therapy
244647|NCT02669134|optimization|optimization
244648|NCT02669134|heart failure|heart failure
244649|NCT02669134|reverse left ventricular remodeling|reverse left ventricular remodeling
244650|NCT02669121|Drug therapy|drug therapy
244651|NCT02669108|testis|testis
244652|NCT02669108|spermatogenesis|spermatogenesis
244653|NCT02669082|Drug Therapy|drug therapy
244654|NCT02669069|Bi-modal neuromodulation|bi-modal neuromodulation
244655|NCT02669017|Loncastuximab tesirine|loncastuximab tesirine
244656|NCT02669004|Analgesia, Epidural,Pain, Postoperative|analgesia, epidural,pain, postoperative
244657|NCT02668991|Autism Spectrum Disorder|autism spectrum disorder
244658|NCT02668991|Janssen Autism Knowledge Engine|janssen autism knowledge engine
244659|NCT02668991|Autism Behavior Inventory|autism behavior inventory
244660|NCT02668978|lung surgery|lung surgery
244661|NCT02668978|air leak|air leak
244662|NCT02668978|prevention|prevention
244663|NCT02668965|Clinical pregnancy rate|clinical pregnancy rate
244664|NCT02668913|gynaecology|gynaecology
244665|NCT02668913|Oncology|oncology
244666|NCT02668900|Feasibility trial|feasibility trial
244667|NCT02668900|Cardiovascular disease|cardiovascular disease
244668|NCT02668900|Decision Support|decision support
244669|NCT02668900|Patient Decision Aid|patient decision aid
244670|NCT02668900|implantable cardioverter defibrillator|implantable cardioverter defibrillator
244671|NCT02668900|implantable cardioverter defibrillator replacement|implantable cardioverter defibrillator replacement
244672|NCT02668874|Pit and Fissure sealants|pit and fissure sealants
244673|NCT02668874|Isolation|isolation
244674|NCT02668874|permanent teeth|permanent teeth
244675|NCT02668874|children|children
244676|NCT02668874|Isolite®|isolite®
244677|NCT02668874|Dental caries|dental caries
244678|NCT02668848|Stroke|stroke
244679|NCT02668848|Dehydration|dehydration
244680|NCT02668848|Fluid therapy|fluid therapy
244681|NCT02668770|Advanced Cancers|advanced cancers
244682|NCT02668770|Melanoma|melanoma
244683|NCT02668770|Advanced solid malignancies|advanced solid malignancies
244684|NCT02668770|Metastatic|metastatic
244685|NCT02668770|MGN1703|mgn1703
244686|NCT02668770|Ipilimumab|ipilimumab
244687|NCT02668770|Yervoy|yervoy
244688|NCT02668770|BMS-734016|bms-734016
244689|NCT02668770|MDX010|mdx010
244690|NCT02668770|Refractory|refractory
244691|NCT02668770|Relapsed|relapsed
244692|NCT02668718|radiotherapy, adjuvant|radiotherapy, adjuvant
244693|NCT02668718|prostatectomy|prostatectomy
244694|NCT02668692|LEO 80185 gel, calcipotriol, betamethasone|leo 80185 gel, calcipotriol, betamethasone
244695|NCT02668679|Dream Doctors|dream doctors
244696|NCT02668679|Medical Clown|medical clown
244697|NCT02668679|Pediatrics|pediatrics
244698|NCT02668679|Sedation|sedation
244699|NCT02668679|Endoscopy|endoscopy
244700|NCT02668666|Palbociclib|palbociclib
244701|NCT02668666|Tamoxifen|tamoxifen
244702|NCT02668666|CDK4/6 Inhibitor|cdk4/6 inhibitor
244703|NCT02668653|Newly diagnosed Acute Myeloid Leukemia|newly diagnosed acute myeloid leukemia
244704|NCT02668653|FLT3-ITD positive|flt3-itd positive
244705|NCT02668653|Chemotherapy|chemotherapy
244706|NCT02668653|Induction chemotherapy|induction chemotherapy
244707|NCT02668653|Consolidation chemotherapy|consolidation chemotherapy
244708|NCT02668653|Maintenance chemotherapy|maintenance chemotherapy
244709|NCT02668653|Quizartinib|quizartinib
244710|NCT02668653|Receptor tyrosine kinase inhibitor|receptor tyrosine kinase inhibitor
244711|NCT02668653|Feline McDonough sarcoma (FMS)-like tyrosine kinase 3|feline mcdonough sarcoma (fms)-like tyrosine kinase 3
244712|NCT02668653|AC220|ac220
244713|NCT02668653|FLT3-ITD|flt3-itd
244714|NCT02668653|AML|aml
244715|NCT02668640|Quality of life (QOL)|quality of life (qol)
244716|NCT02668640|Rheumatoid arthritis (RA)|rheumatoid arthritis (ra)
244717|NCT02668640|Work productivity|work productivity
244718|NCT02668640|Adalimumab|adalimumab
244719|NCT02668627|Stroke|stroke
244720|NCT02668627|Collateral status|collateral status
244721|NCT02668627|Endovascular treatment|endovascular treatment
244722|NCT02668614|Detection|detection
244723|NCT02668601|Gestational Diabetes Mellitus|gestational diabetes mellitus
244724|NCT02668601|Childhood Obesity|childhood obesity
244725|NCT02668601|Offspring|offspring
244726|NCT02668575|Pulmonary Cystic Fibrosis|pulmonary cystic fibrosis
244727|NCT02668562|acute coronary syndrome|acute coronary syndrome
244728|NCT02668562|coronary artery bypass surgery|coronary artery bypass surgery
244729|NCT02668562|ticagrelor|ticagrelor
244730|NCT02668562|antiplatelet therapy|antiplatelet therapy
244731|NCT02668562|platelet function testing|platelet function testing
244732|NCT02668536|sunscreen|sunscreen
244733|NCT02668536|melanoma|melanoma
244938|NCT02667327|Granexin gel|granexin gel
244734|NCT02668536|improved protection from uv rays|improved protection from uv rays
244735|NCT02668523|Presbyopia|presbyopia
244736|NCT02668523|Corneal Inlay|corneal inlay
244737|NCT02668523|Pseudophakic|pseudophakic
244738|NCT02668523|Pseudophakia|pseudophakia
244739|NCT02668510|Heel Pain|heel pain
244740|NCT02668510|extracorporeal shock wave therapy|extracorporeal shock wave therapy
244741|NCT02668510|ESWT|eswt
244742|NCT02668510|shock wave|shock wave
244743|NCT02668510|Soldiers|soldiers
244744|NCT02668510|Platelet rich plasma|platelet rich plasma
244745|NCT02668510|PRP|prp
244746|NCT02668510|Autologous conditioned plasma|autologous conditioned plasma
244747|NCT02668510|Military|military
244748|NCT02668497|Movement disorders|movement disorders
244749|NCT02668497|Botulinum toxin type A|botulinum toxin type a
244750|NCT02668497|Tremor|tremor
244751|NCT02668497|Kinematics|kinematics
244752|NCT02668484|TAVI|tavi
244753|NCT02668484|trans-femoral|trans-femoral
244754|NCT02668484|Sapien|sapien
244755|NCT02668484|Lotus|lotus
244756|NCT02668445|Concurrent|concurrent
244757|NCT02668445|muscle|muscle
244758|NCT02668445|glycogen|glycogen
244759|NCT02668445|molecular|molecular
244760|NCT02668406|Blood infection, melioidosis, rapid diagnostic test|blood infection, melioidosis, rapid diagnostic test
244761|NCT02668380|Apatinib|apatinib
244762|NCT02668380|metastatic gastric cancer|metastatic gastric cancer
244763|NCT02668380|Non-interventionalStudy|non-interventionalstudy
244764|NCT02668367|Viral Diseases|viral diseases
244765|NCT02668367|Antiviral|antiviral
244766|NCT02668367|Paramyxoviridae Infections|paramyxoviridae infections
244767|NCT02668367|RSV|rsv
244768|NCT02668367|Respiratory Syncytial Virus|respiratory syncytial virus
244769|NCT02668367|Aviragen Therapeutics, Inc.|aviragen therapeutics, inc.
244770|NCT02668367|Aviragen Therapeutics|aviragen therapeutics
244771|NCT02668367|Aviragen|aviragen
244772|NCT02668354|Childhood Cancer|childhood cancer
244773|NCT02668354|Pediatric Oncology|pediatric oncology
244774|NCT02668354|Infant tumors|infant tumors
244775|NCT02668302|Steroid-eluting sinus implant|steroid-eluting sinus implant
244776|NCT02668302|Mometasone furoate|mometasone furoate
244777|NCT02668302|Endoscopic sinus surgery|endoscopic sinus surgery
244778|NCT02668276|Prostatic neoplasms|prostatic neoplasms
244779|NCT02668276|Oncotype DX|oncotype dx
244780|NCT02668276|Treatment Decisions|treatment decisions
244781|NCT02668263|Breast cancer|breast cancer
244782|NCT02668263|mastectomy|mastectomy
244783|NCT02668263|seromas|seromas
244784|NCT02668211|osteoarthritis|osteoarthritis
244785|NCT02668211|radiostereometric analysis|radiostereometric analysis
244786|NCT02668211|correction of functional deformity|correction of functional deformity
244787|NCT02668211|procedures|procedures
244788|NCT02668211|total hip arthroplasty|total hip arthroplasty
244789|NCT02668211|musculoskeletal diseases|musculoskeletal diseases
244790|NCT02668198|Endoscopic mucosal resection, residual polyp, near focus imaging|endoscopic mucosal resection, residual polyp, near focus imaging
244791|NCT02668172|pegvisomant|pegvisomant
244792|NCT02668172|pasireotide LAR|pasireotide lar
244793|NCT02668172|long acting somatostatin analogues|long acting somatostatin analogues
244794|NCT02668146|essential tremor|essential tremor
244795|NCT02668146|Perampanel|perampanel
244796|NCT02668146|clinical trial|clinical trial
244797|NCT02668133|zinc deficiency|zinc deficiency
244798|NCT02668133|zinc absorption|zinc absorption
244799|NCT02668120|chronic histiocytic intervillositis|chronic histiocytic intervillositis
244800|NCT02668120|serum alkaline phosphatase|serum alkaline phosphatase
244801|NCT02668120|placenta|placenta
244802|NCT02668120|case-control study|case-control study
244803|NCT02668094|propofol|propofol
244804|NCT02668094|lidocaine|lidocaine
244805|NCT02668094|pregabalin|pregabalin
244806|NCT02668081|Endoscopic sphincterotomy|endoscopic sphincterotomy
244807|NCT02668081|Endoscopic papillary balloon dilation|endoscopic papillary balloon dilation
244808|NCT02668081|Metagenomics|metagenomics
244809|NCT02668068|Pneumoconiosis|pneumoconiosis
244810|NCT02668068|Mesenchymal Stem Cells|mesenchymal stem cells
244811|NCT02668068|whole-lung lavage (WLL)|whole-lung lavage (wll)
244812|NCT02668055|TB4|tb4
244813|NCT02668055|Difficult to heal|difficult to heal
244814|NCT02668029|Oxygen therapy|oxygen therapy
244815|NCT02668016|cardiovascular diseases|cardiovascular diseases
244816|NCT02668016|hyperlipidemias|hyperlipidemias
244817|NCT02668003|Prevention trial|prevention trial
244818|NCT02668003|Cognitive Behaviour Therapy|cognitive behaviour therapy
244819|NCT02668003|CWP|cwp
244820|NCT02668003|Chronic widespread pain|chronic widespread pain
244821|NCT02668003|RCT|rct
244822|NCT02668003|Fibromyalgia|fibromyalgia
244823|NCT02668003|Prevention|prevention
244824|NCT02667990|metatarsalgia|metatarsalgia
244825|NCT02667990|pedobar|pedobar
244826|NCT02667990|foot|foot
244827|NCT02667990|stiletto|stiletto
244828|NCT02667990|insoles|insoles
244829|NCT02667977|fluids, pediatric, gastroenteritis|fluids, pediatric, gastroenteritis
244830|NCT02667951|Elderly|elderly
244831|NCT02667951|Dementia|dementia
244832|NCT02667951|Intervention program|intervention program
244833|NCT02667925|ovarian cancer|ovarian cancer
244834|NCT02667925|intraperitoneal chemotherapy|intraperitoneal chemotherapy
244835|NCT02667912|Hypertension, Endovascular Procedures, Catheter Ablation, Renal Artery|hypertension, endovascular procedures, catheter ablation, renal artery
312999|NCT02272686|SCT|sct
244836|NCT02667899|disorders of consciousness|disorders of consciousness
244837|NCT02667899|deep brain stimulation|deep brain stimulation
244838|NCT02667899|transcranial magnetic stimulation|transcranial magnetic stimulation
244839|NCT02667860|intracorporeal anastomosis|intracorporeal anastomosis
244840|NCT02667860|laparoscopic colectomy|laparoscopic colectomy
244841|NCT02667860|outcomes|outcomes
244842|NCT02667860|length of stay|length of stay
244843|NCT02667860|analgesia|analgesia
244844|NCT02667860|aesthetic|aesthetic
244845|NCT02667860|extracorporeal anastomosis|extracorporeal anastomosis
244846|NCT02667860|laparoscopic|laparoscopic
244847|NCT02667847|preoperative anxiety assessment|preoperative anxiety assessment
244848|NCT02667847|levels of preoperative anxiety using two different scales|levels of preoperative anxiety using two different scales
244849|NCT02667834|social cognition|social cognition
244850|NCT02667834|cognitive remediation|cognitive remediation
244851|NCT02667782|Mindfulness-based interventions|mindfulness-based interventions
244852|NCT02667782|Dementia|dementia
244853|NCT02667782|Caregiving|caregiving
244854|NCT02667782|Burden|burden
244855|NCT02667782|Stress|stress
244856|NCT02667782|Anxiety|anxiety
244857|NCT02667782|Depression|depression
244858|NCT02667782|Community care|community care
244859|NCT02667756|biomarker|biomarker
244860|NCT02667756|inflammation|inflammation
244861|NCT02667756|prognosis|prognosis
244862|NCT02667756|knee|knee
244863|NCT02667743|NSCLC|nsclc
244864|NCT02667743|Paclitaxel Micelles for Injection|paclitaxel micelles for injection
244865|NCT02667691|superoxyde dismutase|superoxyde dismutase
244866|NCT02667691|melon concentrate|melon concentrate
244867|NCT02667691|oxydative stress|oxydative stress
244868|NCT02667691|overweight women|overweight women
244869|NCT02667665|Alzheimer's Disease Dementia|alzheimer's disease dementia
244870|NCT02667652|T2DM|t2dm
244871|NCT02667652|RYGB|rygb
244873|NCT02667639|safety|safety
244874|NCT02667639|tolerability|tolerability
244875|NCT02667639|RPH-104|rph-104
244876|NCT02667639|RPH104|rph104
244877|NCT02667639|Anti-IL1 beta|anti-il1 beta
244878|NCT02667639|Anti-IL1|anti-il1
244879|NCT02667626|Breast cancer survivor|breast cancer survivor
244880|NCT02667626|Cancer survivorship|cancer survivorship
244881|NCT02667626|Survivorship care plan|survivorship care plan
244882|NCT02667626|Vaginal dryness|vaginal dryness
244883|NCT02667626|Vulvovaginal atrophy|vulvovaginal atrophy
244884|NCT02667626|Vasomotor symptom|vasomotor symptom
244885|NCT02667626|Infertility|infertility
244886|NCT02667626|Family planning|family planning
244887|NCT02667613|motor skill learning|motor skill learning
244888|NCT02667613|functional changes|functional changes
244889|NCT02667613|neuroplastic changes|neuroplastic changes
244890|NCT02667600|Cesarean|cesarean
244891|NCT02667600|Blood Loss|blood loss
244892|NCT02667600|Triton|triton
244893|NCT02667574|basal cell carcinoma|basal cell carcinoma
244894|NCT02667574|surgery|surgery
244895|NCT02667574|stage|stage
244896|NCT02667574|vismodegib|vismodegib
244897|NCT02667548|percutaneous coronary intervention|percutaneous coronary intervention
244898|NCT02667509|Evolutionary Model|evolutionary model
244899|NCT02667483|Duchenne muscular dystrophy|duchenne muscular dystrophy
244900|NCT02667483|DMD|dmd
244901|NCT02667483|Oligonucleotides, Antisense|oligonucleotides, antisense
244902|NCT02667483|Exon skipping|exon skipping
244903|NCT02667470|Solifenacin|solifenacin
244904|NCT02667470|Overactive bladder|overactive bladder
244905|NCT02667431|SUI|sui
244906|NCT02667418|Clostridium|clostridium
244907|NCT02667418|Difficile|difficile
244908|NCT02667418|Fidaxomicin|fidaxomicin
244909|NCT02667418|Vancomycin|vancomycin
244910|NCT02667418|Recurrent|recurrent
244911|NCT02667418|Pulse|pulse
244912|NCT02667418|Taper|taper
244913|NCT02667392|Stroke|stroke
244914|NCT02667392|Gait|gait
244915|NCT02667392|Walking|walking
244916|NCT02667392|Rehabilitation|rehabilitation
244917|NCT02667392|Exercise|exercise
244918|NCT02667392|Exercise Therapy|exercise therapy
244919|NCT02667392|Physical Therapy Modalities|physical therapy modalities
244920|NCT02667392|Exercise Movement Techniques|exercise movement techniques
244921|NCT02667379|Cat|cat
244922|NCT02667379|allergy|allergy
244923|NCT02667379|dander|dander
244924|NCT02667379|Fel d 1|fel d 1
244925|NCT02667379|Felis domesticus|felis domesticus
244926|NCT02667366|mild and moderate depression|mild and moderate depression
244927|NCT02667353|electroconvulsive|electroconvulsive
244928|NCT02667353|hippocampus|hippocampus
244929|NCT02667353|elderly|elderly
244930|NCT02667353|working mechanism|working mechanism
244931|NCT02667340|exercise|exercise
244932|NCT02667340|carbohydrate|carbohydrate
244933|NCT02667340|Superstarch|superstarch
244934|NCT02667327|diabetic foot ulcer|diabetic foot ulcer
244935|NCT02667327|diabetic complications|diabetic complications
244936|NCT02667327|diabetes|diabetes
244937|NCT02667327|wound healing|wound healing
244939|NCT02667327|FirstString Research|firststring research
244940|NCT02667314|Cognition|cognition
244941|NCT02667314|Cognitive Aging|cognitive aging
244942|NCT02667314|Dementia|dementia
244943|NCT02667314|Neurocognitive Disorders|neurocognitive disorders
244944|NCT02667314|Cognitive Therapy|cognitive therapy
244945|NCT02667314|Cognitive Reserve|cognitive reserve
244946|NCT02667314|Cognitive Enrichment|cognitive enrichment
244947|NCT02667314|Jigsaw Puzzles|jigsaw puzzles
244948|NCT02667275|seborrheic keratosis|seborrheic keratosis
244949|NCT02667249|cholecystectomy, check list|cholecystectomy, check list
244950|NCT02667236|seborrheic keratosis|seborrheic keratosis
244951|NCT02667223|pharmacokinetics|pharmacokinetics
244952|NCT02667223|pharmacodynamics|pharmacodynamics
244953|NCT02667223|RN316|rn316
244954|NCT02667223|recombinant human hyaluronidase|recombinant human hyaluronidase
244955|NCT02667145|hand osteoarthritis|hand osteoarthritis
244956|NCT02667145|self care program|self care program
244957|NCT02667145|assistive tecnology|assistive tecnology
244958|NCT02667132|Granulomatous, Mastitis|granulomatous, mastitis
244959|NCT02667132|C17.800.090.968.400|c17.800.090.968.400
244960|NCT02667132|C13.703.844.603.400|c13.703.844.603.400
244961|NCT02667093|Acute Leukemia|acute leukemia
244962|NCT02667093|Acute Myeloid Leukemia|acute myeloid leukemia
244963|NCT02667093|AML|aml
244964|NCT02667080|Semen quality|semen quality
244965|NCT02667080|Sexual Abstinence|sexual abstinence
244966|NCT02667080|sperm motility|sperm motility
244967|NCT02667080|DNA fragmentation|dna fragmentation
244968|NCT02667015|Substance Use Disorders|substance use disorders
244969|NCT02667015|Anxiety|anxiety
244970|NCT02667015|Anxiety Sensitivity|anxiety sensitivity
244971|NCT02667015|Brief Intervention|brief intervention
244972|NCT02667015|Treatment|treatment
244973|NCT02666989|Depression|depression
244974|NCT02666989|Placebo|placebo
244975|NCT02666989|Open-label|open-label
244976|NCT02666989|Clinical practice|clinical practice
244977|NCT02666976|Gastroesophageal reflux, proton pump inhibitors, ilaprazole|gastroesophageal reflux, proton pump inhibitors, ilaprazole
244978|NCT02666963|RTA 901|rta 901
244979|NCT02666963|RTA 901 capsules|rta 901 capsules
244980|NCT02666898|Residual disease|residual disease
244981|NCT02666885|Personalized Medicine|personalized medicine
244982|NCT02666885|Radiation Oncology|radiation oncology
244983|NCT02666885|Functional Imaging|functional imaging
244984|NCT02666885|Biomarker|biomarker
244985|NCT02666885|Decision Support System|decision support system
244986|NCT02666885|Radiomics|radiomics
244987|NCT02666872|Vaccination|vaccination
244988|NCT02666872|Infant|infant
244989|NCT02666872|Parents|parents
244990|NCT02666872|Intention|intention
244991|NCT02666846|UVB Pain Model|uvb pain model
244992|NCT02666846|PK|pk
244993|NCT02666846|Topical|topical
244994|NCT02666846|NSAIDs|nsaids
244995|NCT02666833|Skin Cancer|skin cancer
244996|NCT02666833|Basal Cell Carcinoma|basal cell carcinoma
244997|NCT02666833|Squamous Cell Carcinoma|squamous cell carcinoma
244998|NCT02666833|Mohs Surgery|mohs surgery
244999|NCT02666833|Imaging|imaging
245000|NCT02666807|NF-κB|nf-κb
245001|NCT02666807|Ginger|ginger
245002|NCT02666794|analgesia|analgesia
245003|NCT02666794|fetal bradycardia|fetal bradycardia
245004|NCT02666794|hypertonic uterine|hypertonic uterine
245005|NCT02666781|OSA, Surgery, Postoperative, Rostral Fluid Shift|osa, surgery, postoperative, rostral fluid shift
245006|NCT02666755|Lung Neoplasms digital polymerase chain reaction|lung neoplasms digital polymerase chain reaction
245007|NCT02666716|pharmacokinetics|pharmacokinetics
245008|NCT02666716|fluconazole|fluconazole
245009|NCT02666716|invasive fungal infection|invasive fungal infection
245010|NCT02666716|candidiasis|candidiasis
245011|NCT02666716|intensive care unit|intensive care unit
245012|NCT02666703|cardiac surgery|cardiac surgery
245013|NCT02666703|systemic inflammatory response|systemic inflammatory response
245014|NCT02666703|immunoadsorption|immunoadsorption
245015|NCT02666677|polytrauma, emergency medicine|polytrauma, emergency medicine
245016|NCT02666664|hyperlipidemia|hyperlipidemia
245017|NCT02666664|cholesterol|cholesterol
245018|NCT02666664|heterozygous familial hypercholesterolemia|heterozygous familial hypercholesterolemia
245019|NCT02666664|atherosclerotic cardiovascular disease|atherosclerotic cardiovascular disease
245020|NCT02666664|ASCVD|ascvd
245021|NCT02666664|HeFH|hefh
245022|NCT02666664|LDL|ldl
245023|NCT02666638|Magnetic Resonance Imaging (MRI)|magnetic resonance imaging (mri)
245024|NCT02666612|Patients|patients
245025|NCT02666599|F-18-FDG|f-18-fdg
245026|NCT02666599|neoplasm|neoplasm
245027|NCT02666599|probe|probe
245028|NCT02666599|positron|positron
245029|NCT02666599|diagnosis|diagnosis
245030|NCT02666599|surgery|surgery
245031|NCT02666599|radioguided surgery|radioguided surgery
245032|NCT02666573|drug therapy|drug therapy
245033|NCT02666573|Photosensitizing Agents|photosensitizing agents
245034|NCT02666573|therapeutic use|therapeutic use
245035|NCT02666560|Auditory Cueing|auditory cueing
245036|NCT02666560|Gait|gait
245037|NCT02666547|68Ga-NODAGA-RGD|68ga-nodaga-rgd
245038|NCT02666547|18F-FDG|18f-fdg
245039|NCT02666547|18F-FET|18f-fet
245040|NCT02666547|PET/CT|pet/ct
245041|NCT02666547|neoangiogenesis|neoangiogenesis
245042|NCT02666534|Ablative fractional laser|ablative fractional laser
245043|NCT02666534|microinvasive squamous cell carcinoma|microinvasive squamous cell carcinoma
245044|NCT02666534|photodynamic therapy|photodynamic therapy
245045|NCT02666521|Primary Health Care|primary health care
245046|NCT02666508|plaque identifying toothpaste|plaque identifying toothpaste
245047|NCT02666508|plaque score|plaque score
245048|NCT02666508|C-reactive protein|c-reactive protein
245049|NCT02666495|Schema Therapy|schema therapy
245050|NCT02666482|smoking|smoking
245051|NCT02666482|stop smoking|stop smoking
245052|NCT02666482|tobacco use cessation|tobacco use cessation
245053|NCT02666469|Hyperbaric oxygen treatment, rehabilitation|hyperbaric oxygen treatment, rehabilitation
245054|NCT02666443|brachial plexus|brachial plexus
245055|NCT02666443|supraclavicular|supraclavicular
245056|NCT02666443|duration|duration
245057|NCT02666443|dexamethasone|dexamethasone
245058|NCT02666443|block|block
245059|NCT02666417|Iron fortification|iron fortification
245060|NCT02666417|Anemia|anemia
245061|NCT02666417|Iron Deficiency|iron deficiency
245062|NCT02666417|Iron Absorption|iron absorption
245063|NCT02666417|Prebiotics|prebiotics
245064|NCT02666417|Stable isotopes|stable isotopes
245065|NCT02666404|Volume Resuscitation|volume resuscitation
245066|NCT02666404|Shock|shock
245067|NCT02666404|Body Impedance Measurement|body impedance measurement
245068|NCT02666404|Renal Resistive Index|renal resistive index
245069|NCT02666404|Acute Kidney Injury|acute kidney injury
245070|NCT02666404|Renal Replacement Therapy|renal replacement therapy
245071|NCT02666365|anesthesia|anesthesia
245072|NCT02666365|surgical antimicrobial prophylaxis|surgical antimicrobial prophylaxis
245073|NCT02666365|surgical site infections|surgical site infections
245074|NCT02666339|Hortitherapy|hortitherapy
245075|NCT02666339|Care-garden|care-garden
245076|NCT02666339|Anxiety|anxiety
245077|NCT02666339|Therapeutic alliance|therapeutic alliance
245078|NCT02666326|Acute Coronary Syndrome|acute coronary syndrome
245079|NCT02666326|Prehospital emergency care|prehospital emergency care
245080|NCT02666326|Biological markers|biological markers
245081|NCT02666326|Copeptin|copeptin
245082|NCT02666326|Troponin|troponin
245083|NCT02666326|Rule-out|rule-out
245084|NCT02666326|Point-of-Care systems|point-of-care systems
245085|NCT02666326|Infarction|infarction
245086|NCT02666326|Cardiovascular Diseases|cardiovascular diseases
245087|NCT02666326|Heart Diseases|heart diseases
245088|NCT02666326|Ischemia|ischemia
245089|NCT02666326|Myocardial Ischemia|myocardial ischemia
245090|NCT02666326|copeptins|copeptins
245091|NCT02666326|Troponin T|troponin t
245092|NCT02666326|Diagnostic Techniques (Cardiovascular)|diagnostic techniques (cardiovascular)
245093|NCT02666326|High sensitivity troponin|high sensitivity troponin
245094|NCT02666300|Postoperative sore throat,Anesthesia|postoperative sore throat,anesthesia
245095|NCT02666287|Fluticasone furoate|fluticasone furoate
245096|NCT02666287|Chronic obstructive pulmonary disease|chronic obstructive pulmonary disease
245097|NCT02666287|Batefenterol|batefenterol
245098|NCT02666287|Dry Powder Inhaler|dry powder inhaler
245099|NCT02666287|Respiratory|respiratory
245100|NCT02666287|Pharmacokinetics|pharmacokinetics
245101|NCT02666287|Ellipta|ellipta
245102|NCT02666287|Healthy Subjects|healthy subjects
245103|NCT02666274|carbapenem resistance|carbapenem resistance
245104|NCT02666274|bacterial carriage|bacterial carriage
245105|NCT02666274|multi-drug resistant gram negative bacteria|multi-drug resistant gram negative bacteria
245106|NCT02666222|hearing loss|hearing loss
245107|NCT02666222|sensorineural|sensorineural
245108|NCT02666222|hearing implant|hearing implant
245109|NCT02666209|Multiple Myeloma|multiple myeloma
245110|NCT02666209|Relapsed Multiple Myeloma|relapsed multiple myeloma
245111|NCT02666209|Refractory Multiple Myeloma|refractory multiple myeloma
245112|NCT02666183|cancer|cancer
245113|NCT02666183|caregiver|caregiver
245114|NCT02666183|videoconferencing|videoconferencing
245115|NCT02666157|atrial fibrillation|atrial fibrillation
245116|NCT02666157|stroke|stroke
245117|NCT02666157|systemic embolism|systemic embolism
245118|NCT02666157|bleeding|bleeding
245119|NCT02666157|oral anticoagulant|oral anticoagulant
245120|NCT02666118|pain|pain
245121|NCT02666118|pain management|pain management
245122|NCT02666118|shoulder repair|shoulder repair
245123|NCT02666118|nerve blockade|nerve blockade
245124|NCT02666118|regional anesthesia|regional anesthesia
245125|NCT02666118|pediatrics|pediatrics
245126|NCT02666105|NSCLC|nsclc
245127|NCT02666092|IgE|ige
245128|NCT02666092|Immunoelectrophoresis|immunoelectrophoresis
245129|NCT02666092|Western Blot|western blot
245130|NCT02666092|ImmunoCAP|immunocap
245131|NCT02666079|Wide local excision (WLE) for breast cancer|wide local excision (wle) for breast cancer
245132|NCT02666027|Fluid monitoring|fluid monitoring
245133|NCT02666014|PONV|ponv
245134|NCT02666014|nausea|nausea
245135|NCT02666014|vomiting|vomiting
245136|NCT02666014|sugammadex|sugammadex
245137|NCT02666014|neostigmine|neostigmine
712525|NCT00579839|Preterm Baby|preterm baby
245138|NCT02665988|Transcranial Direct Current Stimulation|transcranial direct current stimulation
245139|NCT02665975|Tinnitus treatment|tinnitus treatment
245140|NCT02665975|Internet-intervention|internet-intervention
245141|NCT02665975|CBT|cbt
245142|NCT02665962|newly diagnosed patients|newly diagnosed patients
245143|NCT02665936|epidural analgesia|epidural analgesia
245144|NCT02665871|vaccine|vaccine
245145|NCT02665871|safety|safety
245146|NCT02665871|intranasal administration|intranasal administration
245147|NCT02665806|Ciclesonide|ciclesonide
245148|NCT02665806|Fluticasone propionate|fluticasone propionate
245149|NCT02665806|Nasal Polyposis|nasal polyposis
245150|NCT02665806|Chronic Sinuitis|chronic sinuitis
245151|NCT02665806|Chronic rhinosinusitis|chronic rhinosinusitis
245152|NCT02665793|Peanut allergy|peanut allergy
245153|NCT02665793|Food allergy|food allergy
245154|NCT02665793|Thresholds|thresholds
245155|NCT02665793|Anaphylaxis|anaphylaxis
245156|NCT02665780|halitosis, periodontal debridement, chemotherapeutics|halitosis, periodontal debridement, chemotherapeutics
245157|NCT02665767|Telesonography, Appendix|telesonography, appendix
245158|NCT02665754|Allergic rhinitis|allergic rhinitis
245159|NCT02665754|Injection, intralymphatic|injection, intralymphatic
245160|NCT02665754|Immunotherapy|immunotherapy
245161|NCT02665754|Dermatophagoides farinae|dermatophagoides farinae
245162|NCT02665754|Dermatophagoides pteronyssinus|dermatophagoides pteronyssinus
245163|NCT02665754|Dogs|dogs
245164|NCT02665754|Cats|cats
245165|NCT02665741|distal colonoscope attachments, colon cancer screening, screening colonoscopy, adenoma detection|distal colonoscope attachments, colon cancer screening, screening colonoscopy, adenoma detection
245166|NCT02665715|Reactive hypoglycemia|reactive hypoglycemia
245167|NCT02665715|Hyperinsulinaemia|hyperinsulinaemia
245168|NCT02665715|Diet|diet
245169|NCT02665715|Glucagon-like Peptide-1|glucagon-like peptide-1
245170|NCT02665715|Glucagon|glucagon
245171|NCT02665715|Peptide YY|peptide yy
245172|NCT02665715|Ghrelin|ghrelin
245173|NCT02665689|Diabetic Macular Edema, Ranibizumab, Visual Acuity, Diabetic Control|diabetic macular edema, ranibizumab, visual acuity, diabetic control
245174|NCT02665676|Childhood Cancer|childhood cancer
245175|NCT02665676|Pediatric Oncology|pediatric oncology
245176|NCT02665676|Embryonal Neoplasms|embryonal neoplasms
245177|NCT02665676|Embryonic Neoplasms|embryonic neoplasms
245178|NCT02665676|Embryonic Tumors|embryonic tumors
245179|NCT02665676|Embryonal Tumors|embryonal tumors
245180|NCT02665624|Bowel cleansing|bowel cleansing
245181|NCT02665624|Colonoscopy|colonoscopy
245182|NCT02665624|Stewed apricot juice|stewed apricot juice
245183|NCT02665624|Senna|senna
245184|NCT02665598|Posterior Reversible Encephalopathy Syndrome,Prognosis|posterior reversible encephalopathy syndrome,prognosis
245185|NCT02665585|carotid disease|carotid disease
245186|NCT02665585|stroke|stroke
245187|NCT02665585|stent|stent
245188|NCT02665585|carotid stenting|carotid stenting
245189|NCT02665572|renal transplantation|renal transplantation
245190|NCT02665572|defunctionalized bladder|defunctionalized bladder
245191|NCT02665572|bladder recycling|bladder recycling
245192|NCT02665559|HIV|hiv
245193|NCT02665559|Hypogonadism|hypogonadism
245194|NCT02665559|Metabolic Syndrom|metabolic syndrom
245195|NCT02665559|Reservoirs|reservoirs
245196|NCT02665559|Osteodensitometry|osteodensitometry
245197|NCT02665559|Erectil dysfonction|erectil dysfonction
245198|NCT02665559|Depression|depression
245199|NCT02665546|Dyspnea|dyspnea
245200|NCT02665546|pulmonary hypertension|pulmonary hypertension
245201|NCT02665546|Histiocytosis Langerhans cells|histiocytosis langerhans cells
245202|NCT02665546|exercise test|exercise test
245203|NCT02665533|pain measurement|pain measurement
245204|NCT02665533|edema|edema
245205|NCT02665533|trismus|trismus
245206|NCT02665520|stem cells injections|stem cells injections
245207|NCT02665520|erectile dysfunction|erectile dysfunction
245208|NCT02665507|Photobiomodulation|photobiomodulation
245209|NCT02665507|Aviation|aviation
245210|NCT02665481|Exercise|exercise
245211|NCT02665481|Mindfulness|mindfulness
245212|NCT02665481|Education|education
245213|NCT02665481|Elderly|elderly
245214|NCT02665468|Supported adoption|supported adoption
245215|NCT02665468|Secure messaging|secure messaging
245216|NCT02665468|Patient aligned care team (PACT)|patient aligned care team (pact)
245217|NCT02665468|My HealtheVet Coordinator|my healthevet coordinator
245218|NCT02665455|Diabetes Mellitus|diabetes mellitus
245219|NCT02665455|Sensing Technology|sensing technology
245220|NCT02665442|Esophageal Stylet|esophageal stylet
245221|NCT02665442|EsoSure|esosure
245222|NCT02665442|Atrial Fibrillation|atrial fibrillation
245223|NCT02665442|Catheter Ablation|catheter ablation
245224|NCT02665442|Mechanical esophageal displacement|mechanical esophageal displacement
245225|NCT02665429|Emergency Medicine|emergency medicine
245226|NCT02665390|lung cancer|lung cancer
245227|NCT02665390|Percutaneous cryoablation|percutaneous cryoablation
245228|NCT02665390|treatment of medically inoperable|treatment of medically inoperable
245229|NCT02665338|transcranial magnetic stimulation|transcranial magnetic stimulation
245230|NCT02665338|fMRI|fmri
245231|NCT02665338|cue craving|cue craving
245232|NCT02665325|TSH-suppressive therapy|tsh-suppressive therapy
245233|NCT02665325|cognitive function|cognitive function
245234|NCT02665312|cardiotoxicity|cardiotoxicity
245235|NCT02665312|fluoropyrimidine|fluoropyrimidine
245236|NCT02665312|colorectal cancer|colorectal cancer
245237|NCT02665299|colon cancer|colon cancer
245238|NCT02665299|colon polyps|colon polyps
245239|NCT02665299|colon adenomas|colon adenomas
245240|NCT02665299|colonoscopy|colonoscopy
245241|NCT02665299|circulating tumor DNA|circulating tumor dna
245242|NCT02665234|Dry Eye|dry eye
245243|NCT02665221|Multiple Sclerosis|multiple sclerosis
245244|NCT02665221|erythema|erythema
245245|NCT02665208|cigarettes|cigarettes
245246|NCT02665208|smoking|smoking
245247|NCT02665208|opiate-dependence|opiate-dependence
245248|NCT02665208|alcohol|alcohol
245249|NCT02665208|detoxification|detoxification
245250|NCT02665182|orchitis|orchitis
245251|NCT02665182|testicular diseases|testicular diseases
245252|NCT02665169|Postural Balance|postural balance
245253|NCT02665169|Cost-Benefit Analysis|cost-benefit analysis
245254|NCT02665169|Morbidity|morbidity
245255|NCT02665169|Exercise|exercise
245256|NCT02665143|acute myeloid leukemia|acute myeloid leukemia
245257|NCT02665130|COPD|copd
245258|NCT02665130|Pulmonary rehabilitation|pulmonary rehabilitation
245259|NCT02665117|Hypokalemia|hypokalemia
245260|NCT02665117|Isoprostanes|isoprostanes
245261|NCT02665117|Insulin resistance|insulin resistance
245262|NCT02665117|Aldosterone|aldosterone
245263|NCT02665117|Hepatic fat|hepatic fat
245264|NCT02665117|Muscle Magnesium|muscle magnesium
245265|NCT02665117|Liver fat|liver fat
245266|NCT02665104|Cerebral oxygen saturation|cerebral oxygen saturation
245267|NCT02665104|TCD|tcd
245268|NCT02665104|NIRS|nirs
245269|NCT02665104|Carotid endarterectomy|carotid endarterectomy
245270|NCT02665078|Lung Cancer|lung cancer
245271|NCT02665065|Acute Myeloid Leukemia|acute myeloid leukemia
245272|NCT02665065|Leukemia, Acute Myeloid|leukemia, acute myeloid
245273|NCT02665065|Myeloid Leukemia, Acute|myeloid leukemia, acute
245274|NCT02665065|Bone Marrow Cell Transplant|bone marrow cell transplant
245275|NCT02665065|Transplant, Bone Marrow|transplant, bone marrow
245276|NCT02665065|HCT|hct
245277|NCT02665065|HSCT|hsct
245278|NCT02665065|Refractory AML|refractory aml
245279|NCT02665065|Relapsed AML|relapsed aml
245280|NCT02665065|BC8|bc8
245281|NCT02665065|I-131|i-131
245282|NCT02665065|Iomab|iomab
245283|NCT02665065|Iomab-B|iomab-b
245284|NCT02665065|CD45|cd45
245285|NCT02665065|Iodine|iodine
245286|NCT02665065|Iodine-131|iodine-131
245287|NCT02665065|131-I|131-i
245288|NCT02665065|AML|aml
245289|NCT02665065|BMT|bmt
245290|NCT02665065|Radioimmunotherapy|radioimmunotherapy
245291|NCT02665052|Rehabilitation|rehabilitation
245292|NCT02665052|Motor Recovery|motor recovery
245293|NCT02665052|upper extremity|upper extremity
245294|NCT02664987|pain management, pain control, cancer|pain management, pain control, cancer
245295|NCT02664961|TRC105|trc105
245296|NCT02664961|CD105|cd105
245297|NCT02664961|Endoglin|endoglin
245298|NCT02664961|Angiogenesis inhibitor|angiogenesis inhibitor
245299|NCT02664961|GTN|gtn
245300|NCT02664961|Bevacizumab|bevacizumab
245301|NCT02664961|Avastin|avastin
245302|NCT02664948|early follow-up|early follow-up
245303|NCT02664948|geriatrics|geriatrics
245304|NCT02664935|NSCLC|nsclc
245305|NCT02664935|Lung Cancer|lung cancer
245306|NCT02664935|Adenocarcinoma|adenocarcinoma
245307|NCT02664935|Matrix|matrix
245308|NCT02664935|SMP2|smp2
245309|NCT02664935|Umbrella Trial Design|umbrella trial design
245310|NCT02664935|Multi-arm|multi-arm
245311|NCT02664922|Electrophysiology|electrophysiology
245312|NCT02664922|Anesthetics|anesthetics
245313|NCT02664909|Hip Hemiarthroplasty|hip hemiarthroplasty
245314|NCT02664909|Tranexamic Acid|tranexamic acid
245315|NCT02664909|Topical|topical
245316|NCT02664909|Blood Transfusion|blood transfusion
245317|NCT02664896|Knee pain|knee pain
245318|NCT02664896|Knee Osteoarthritis|knee osteoarthritis
245319|NCT02664870|synovial fluid|synovial fluid
245320|NCT02664870|biomarkers|biomarkers
245321|NCT02664857|Vitamin D|vitamin d
245322|NCT02664857|Postoperative Pain|postoperative pain
245323|NCT02664857|Mental Motor Retardation|mental motor retardation
245324|NCT02664844|Obesity|obesity
245325|NCT02664844|Appetite regulation|appetite regulation
245326|NCT02664844|Insulin sensitivity|insulin sensitivity
245327|NCT02664844|Adolescents|adolescents
245328|NCT02664844|Exercise|exercise
245329|NCT02664831|cardiac arrest|cardiac arrest
245330|NCT02664831|inflammation|inflammation
245331|NCT02664831|immune|immune
245332|NCT02664831|neuregulin|neuregulin
245333|NCT02664831|lipids|lipids
245334|NCT02664831|lymphocyte|lymphocyte
245335|NCT02664818|Heart failure|heart failure
245336|NCT02664818|China|china
245337|NCT02664818|Registry|registry
245338|NCT02664818|Characteristic|characteristic
245339|NCT02664818|Outcome|outcome
245340|NCT02664792|Non-small cell lung carcinoma|non-small cell lung carcinoma
245341|NCT02664792|PET/CT|pet/ct
245342|NCT02664792|18F-FDG|18f-fdg
245343|NCT02664766|Heavy drinking|heavy drinking
245344|NCT02664766|Heavy drinking cessation|heavy drinking cessation
245345|NCT02664766|Alcohol abuse|alcohol abuse
245937|NCT02661425|IBS-D|ibs-d
245346|NCT02664766|alcohol use disorder|alcohol use disorder
245347|NCT02664740|Phage Therapy|phage therapy
245348|NCT02664727|alcohol|alcohol
245349|NCT02664727|alcohol abuse|alcohol abuse
245350|NCT02664727|alcohol dependence|alcohol dependence
245351|NCT02664727|alcohol use disorder|alcohol use disorder
245352|NCT02664727|heavy drinking|heavy drinking
245353|NCT02664727|alcohol abuse cessation|alcohol abuse cessation
245354|NCT02664714|physiotherapy, perineometer, adherence|physiotherapy, perineometer, adherence
245355|NCT02664688|spondylolisthesis|spondylolisthesis
245356|NCT02664688|low back pain|low back pain
245357|NCT02664688|stabilization exercise|stabilization exercise
245358|NCT02664662|Breast cancer|breast cancer
245359|NCT02664662|Health literacy|health literacy
245360|NCT02664662|Tailored education|tailored education
245361|NCT02664662|Rehabilitation|rehabilitation
245362|NCT02664662|International Classification of Functioning, Disability and Health|international classification of functioning, disability and health
245363|NCT02664649|TAVR|tavr
245364|NCT02664649|Apixaban|apixaban
245365|NCT02664649|Anticoagulant|anticoagulant
245366|NCT02664649|VKA|vka
245367|NCT02664649|Antiplatelet therapy|antiplatelet therapy
245368|NCT02664649|Aortic stenosis|aortic stenosis
245369|NCT02664610|hypertension treatment|hypertension treatment
245370|NCT02664610|stroke prevention|stroke prevention
245371|NCT02664597|ADNEXMR SCORING system|adnexmr scoring system
245372|NCT02664597|MRI|mri
245373|NCT02664597|adnexal masses|adnexal masses
245374|NCT02664519|Chronic Kidney Disease|chronic kidney disease
245375|NCT02664519|Functional sympatholysis|functional sympatholysis
245376|NCT02664519|Exercise training|exercise training
245377|NCT02664519|Exercise intolerance|exercise intolerance
245378|NCT02664519|Handgrip exercise|handgrip exercise
245379|NCT02664519|Near infrared spectroscopy|near infrared spectroscopy
245380|NCT02664519|Lower body negative pressure|lower body negative pressure
245381|NCT02664493|kidney transplantation|kidney transplantation
245382|NCT02664493|subclinical borderline rejection|subclinical borderline rejection
245383|NCT02664493|steroid pulse therapy|steroid pulse therapy
245384|NCT02664480|Salivary Alpha-amylase|salivary alpha-amylase
245385|NCT02664480|ovulation|ovulation
245386|NCT02664454|Elderly|elderly
245387|NCT02664454|Health care organization|health care organization
245388|NCT02664454|Primary care|primary care
245389|NCT02664441|Obesity|obesity
245390|NCT02664441|Drug intervention|drug intervention
245391|NCT02664441|Children|children
245392|NCT02664441|Adolescents|adolescents
245393|NCT02664441|Young adults|young adults
245394|NCT02664441|Hypothalamic lesion|hypothalamic lesion
245395|NCT02664441|Change of weight status|change of weight status
245396|NCT02664441|Food intake|food intake
245397|NCT02664441|Energy expenditure|energy expenditure
245398|NCT02664441|Hormonal changes|hormonal changes
245399|NCT02664441|Glucagon-like peptide-1 agonist|glucagon-like peptide-1 agonist
245400|NCT02664441|Bydureon|bydureon
245401|NCT02664441|Weight Loss|weight loss
245402|NCT02664441|Energy balance|energy balance
245403|NCT02664415|Human Monoclonal Antibody|human monoclonal antibody
245404|NCT02664402|Palliative Care|palliative care
245405|NCT02664402|Pain|pain
245406|NCT02664402|Community Health|community health
245407|NCT02664376|sarcopenia|sarcopenia
245408|NCT02664376|geriatry|geriatry
245409|NCT02664311|Pulmonary Vein Isolation|pulmonary vein isolation
245410|NCT02664311|Jet Ventilation|jet ventilation
245411|NCT02664311|Atrial Fibrillation|atrial fibrillation
245412|NCT02664298|severely atrophic jaw|severely atrophic jaw
245413|NCT02664298|cranial bone-graft|cranial bone-graft
245414|NCT02664298|dental implants|dental implants
245415|NCT02664298|immediate loading|immediate loading
245416|NCT02664298|augmentation maxilla/mandible|augmentation maxilla/mandible
245417|NCT02664298|sinus-floor elevation/sinuslift|sinus-floor elevation/sinuslift
245418|NCT02664298|dental prosthesis|dental prosthesis
245419|NCT02664298|implant supported|implant supported
245420|NCT02664298|provisional implants|provisional implants
245421|NCT02664298|temporary implants|temporary implants
245422|NCT02664298|one-stage surgery|one-stage surgery
245423|NCT02664298|alveolar ridge augmentation|alveolar ridge augmentation
245424|NCT02664298|maxilla|maxilla
245425|NCT02664259|Endobronchial ultrasonography|endobronchial ultrasonography
245426|NCT02664259|Peripheral pulmonary lesions|peripheral pulmonary lesions
245427|NCT02664259|Ultrathin bronchoscopy|ultrathin bronchoscopy
245428|NCT02664246|contrast-induced nephropathy|contrast-induced nephropathy
245429|NCT02664246|Percutaneous coronary intervention|percutaneous coronary intervention
245430|NCT02664246|risk factors|risk factors
245431|NCT02664246|incidence|incidence
245432|NCT02664233|Diabetes|diabetes
245433|NCT02664233|Diabetes Mellitus, Type 2|diabetes mellitus, type 2
245434|NCT02664233|obesity|obesity
245435|NCT02664233|self-monitoring|self-monitoring
245436|NCT02664233|goal setting|goal setting
245437|NCT02664233|mobile health|mobile health
245438|NCT02664233|connected health|connected health
245439|NCT02664220|Povidone-iodine irrigation|povidone-iodine irrigation
245440|NCT02664207|Myelomeningocele repair|myelomeningocele repair
245441|NCT02664207|Open Neural Tube Defect|open neural tube defect
245442|NCT02664207|BMI of 35-40 kg/m2,|bmi of 35-40 kg/m2,
245443|NCT02664207|Open Fetal Surgery|open fetal surgery
245444|NCT02664207|Elevated body mass index|elevated body mass index
245445|NCT02664194|Hypothermia|hypothermia
245446|NCT02664194|Rewarming|rewarming
245447|NCT02664194|Myocardial Infarction|myocardial infarction
245448|NCT02664194|Percutaneous Cornonary Intervention|percutaneous cornonary intervention
245449|NCT02664181|Cancer|cancer
245450|NCT02664181|Nivolumab|nivolumab
245451|NCT02664181|Decitabine|decitabine
245452|NCT02664181|Tetrahydrouridine|tetrahydrouridine
245453|NCT02664155|Renal insufficiency|renal insufficiency
245454|NCT02664155|Direct oral anticoagulants (DOA)|direct oral anticoagulants (doa)
245455|NCT02664155|Deep Vein Thrombosis (DVT)|deep vein thrombosis (dvt)
245456|NCT02664155|Pulmonary Embolism (PE)|pulmonary embolism (pe)
245457|NCT02664155|Venous Thromboembolism (VTE)|venous thromboembolism (vte)
245458|NCT02664155|Heparins|heparins
245459|NCT02664142|General Surgery|general surgery
245460|NCT02664142|Child|child
245461|NCT02664142|Anaesthesia|anaesthesia
245462|NCT02664142|Depth of anaesthesia|depth of anaesthesia
245463|NCT02664142|BIS monitoring|bis monitoring
245464|NCT02664129|schizophrenia|schizophrenia
245465|NCT02664129|awareness|awareness
245466|NCT02664129|insight|insight
245467|NCT02664129|video|video
245468|NCT02664129|self-observation|self-observation
245469|NCT02664116|Severe Migraine Headache|severe migraine headache
245470|NCT02664090|acute respiratory distress syndrome|acute respiratory distress syndrome
245471|NCT02664090|prone ventilation|prone ventilation
245472|NCT02664090|trans-esophageal doppler|trans-esophageal doppler
245473|NCT02664077|NSABP|nsabp
245474|NCT02664077|Colon cancer|colon cancer
245475|NCT02664077|Regorafenib|regorafenib
245476|NCT02664077|Stage III|stage iii
245477|NCT02664077|Adjuvant therapy|adjuvant therapy
245478|NCT02664064|prediabetes, weight loss, behavior modification|prediabetes, weight loss, behavior modification
245479|NCT02664038|AUD|aud
245480|NCT02664038|Neuropsychology|neuropsychology
245481|NCT02664038|Cognitive Remediation|cognitive remediation
245482|NCT02664025|teaching vaginal examination|teaching vaginal examination
245483|NCT02664012|adoption|adoption
245484|NCT02664012|electronic cigarettes|electronic cigarettes
245485|NCT02664012|e-cigarettes|e-cigarettes
245486|NCT02664012|menthol|menthol
245487|NCT02664012|combustible cigarettes|combustible cigarettes
245488|NCT02664012|nicotine polacrilex|nicotine polacrilex
245489|NCT02664012|own brand cigarette|own brand cigarette
245490|NCT02664012|subjective measures|subjective measures
245491|NCT02664012|pharmacokinetics|pharmacokinetics
245492|NCT02664012|pharmacodynamics|pharmacodynamics
245493|NCT02664012|cigarette|cigarette
245494|NCT02663999|dose proportionality|dose proportionality
245495|NCT02663999|diazepam nasal spray|diazepam nasal spray
245496|NCT02663986|Organization, Time Management, and Planning (OTMP)|organization, time management, and planning (otmp)
245497|NCT02663973|Breast cancer|breast cancer
245498|NCT02663960|Regional citrate anticoagulation|regional citrate anticoagulation
245499|NCT02663960|Protocol|protocol
245500|NCT02663960|Filter lifespan|filter lifespan
245501|NCT02663947|ventriculoperitoneal shunt|ventriculoperitoneal shunt
245502|NCT02663947|optic nerve sheath diameter|optic nerve sheath diameter
245503|NCT02663947|intracranial pressure|intracranial pressure
245504|NCT02663934|HIV, AIDS, Cognition, Memory, Exercise, Stretching|hiv, aids, cognition, memory, exercise, stretching
245505|NCT02663921|Fitzpatrick Skin-Type|fitzpatrick skin-type
245506|NCT02663921|Melanin|melanin
245507|NCT02663921|Ultraviolet Light (UV)|ultraviolet light (uv)
245508|NCT02663882|smoking|smoking
245509|NCT02663882|self control|self control
245510|NCT02663804|Total Knee Arthroplasty|total knee arthroplasty
245511|NCT02663804|Patient Satisfaction|patient satisfaction
245512|NCT02663804|PROMs|proms
245513|NCT02663804|Implant Design|implant design
245514|NCT02663791|Alcohol|alcohol
245515|NCT02663791|Aortic stiffness|aortic stiffness
245516|NCT02663791|Arterial stiffness|arterial stiffness
245517|NCT02663791|Pulse wave velocity|pulse wave velocity
245518|NCT02663791|Longitudinal|longitudinal
245519|NCT02663752|deferasirox|deferasirox
245520|NCT02663752|MDS|mds
245521|NCT02663752|RNA expression|rna expression
245522|NCT02663752|predictive biomarker|predictive biomarker
245523|NCT02663739|Stanford type B aortic dissection|stanford type b aortic dissection
245524|NCT02663739|Malperfusion|malperfusion
245525|NCT02663739|Rupture|rupture
245526|NCT02663739|Acute disease|acute disease
245527|NCT02663739|Endovascular procedures|endovascular procedures
245528|NCT02663726|Physically inactive|physically inactive
245529|NCT02663726|Older adults|older adults
245530|NCT02663713|Pharmacodynamics|pharmacodynamics
245531|NCT02663713|Ticagrelor|ticagrelor
245532|NCT02663713|Clopidogrel|clopidogrel
245533|NCT02663713|MI|mi
245534|NCT02663700|Adults|adults
245535|NCT02663700|Burkina Faso|burkina faso
245536|NCT02663700|malaria|malaria
245537|NCT02663700|PfSPZ Vaccine|pfspz vaccine
245538|NCT02663700|Placebo|placebo
245539|NCT02663700|Randomized|randomized
245540|NCT02663674|CAP|cap
245541|NCT02663674|Coccidioidomycosis|coccidioidomycosis
245542|NCT02663674|Community Acquired Pneumonia|community acquired pneumonia
245543|NCT02663674|FLEET|fleet
245544|NCT02663674|Fluconazole|fluconazole
245545|NCT02663674|Parent Study of 16-0008|parent study of 16-0008
245546|NCT02663674|Pneumonia|pneumonia
245547|NCT02663674|Valley Fever|valley fever
245548|NCT02663661|Diabetes Mellitus, Type 1 (T1DM)|diabetes mellitus, type 1 (t1dm)
245549|NCT02663661|TrialNet|trialnet
245550|NCT02663661|Pathway to Prevention (PTP)|pathway to prevention (ptp)
245551|NCT02663661|First and second degree relatives of persons with T1DM|first and second degree relatives of persons with t1dm
245552|NCT02663661|Insulin-glucagon-glucose (IGG)|insulin-glucagon-glucose (igg)
245553|NCT02663661|Immunological risk to develop T1DM|immunological risk to develop t1dm
245554|NCT02663648|myeloproliferative disorders|myeloproliferative disorders
245555|NCT02663648|cell cycle regulatory protein|cell cycle regulatory protein
245556|NCT02663609|Cushing's Syndrome|cushing's syndrome
245557|NCT02663609|Mifepristone|mifepristone
245558|NCT02663609|Adrenal|adrenal
245559|NCT02663609|Retrospective|retrospective
245560|NCT02663609|Chart Review|chart review
245561|NCT02663596|Pediatric|pediatric
245562|NCT02663596|Continuous Renal Replacement Therapy|continuous renal replacement therapy
245563|NCT02663596|Dialysis|dialysis
245564|NCT02663596|Therapeutic drug monitoring|therapeutic drug monitoring
245565|NCT02663596|Pharmacokinetics|pharmacokinetics
245566|NCT02663596|Pharmacodynamics|pharmacodynamics
245567|NCT02663583|Oropharynx squamous cell carcinoma|oropharynx squamous cell carcinoma
245568|NCT02663583|OPSCC|opscc
245569|NCT02663583|Actigraph accelerometer|actigraph accelerometer
245570|NCT02663583|MD Anderson Symptom Inventory - Head and Neck module|md anderson symptom inventory - head and neck module
245571|NCT02663583|MDASI-HN|mdasi-hn
245572|NCT02663583|Intensity-Modulated Proton Therapy|intensity-modulated proton therapy
245573|NCT02663583|IMPT|impt
245574|NCT02663583|TransOral Robotic Surgery|transoral robotic surgery
245575|NCT02663583|TORS|tors
245576|NCT02663583|Surveys|surveys
245577|NCT02663583|Questionnaires|questionnaires
245578|NCT02663557|stroke, blood pressure, prognosis|stroke, blood pressure, prognosis
245579|NCT02663544|Diabetes|diabetes
245580|NCT02663544|Metabolic syndrome|metabolic syndrome
245581|NCT02663544|Obesity|obesity
245582|NCT02663544|NAFLD|nafld
245583|NCT02663518|T-Cell|t-cell
245584|NCT02663518|CTCL|ctcl
245585|NCT02663518|PTCL|ptcl
245586|NCT02663518|ALL|all
245587|NCT02663518|Rituximab|rituximab
245588|NCT02663518|Nivolumab|nivolumab
245589|NCT02663518|TTI-621|tti-621
245590|NCT02663518|Solid Tumor|solid tumor
245591|NCT02663518|Hematologic Malignancies|hematologic malignancies
245592|NCT02663518|Lymphoma|lymphoma
245593|NCT02663518|Cutaneous T-Cell Lymphoma|cutaneous t-cell lymphoma
245594|NCT02663518|Peripheral T-Cell Lymphoma|peripheral t-cell lymphoma
245595|NCT02663518|Acute Lymphoblastic Leukemia|acute lymphoblastic leukemia
245596|NCT02663518|CD47|cd47
245597|NCT02663492|Acupuncture|acupuncture
245598|NCT02663492|electrical stimulation of acupoints|electrical stimulation of acupoints
245599|NCT02663492|chemotherapy|chemotherapy
245600|NCT02663492|Diyu Shengbai Pian|diyu shengbai pian
245601|NCT02663492|nursing care|nursing care
245602|NCT02663466|pilonidal sinus|pilonidal sinus
245603|NCT02663466|Limberg flap|limberg flap
245604|NCT02663466|off-midline closure concept|off-midline closure concept
245605|NCT02663466|recurrence|recurrence
245606|NCT02663453|preterm|preterm
245607|NCT02663453|parenteral nutrition|parenteral nutrition
245608|NCT02663453|cholestasis|cholestasis
245609|NCT02663453|fish oil|fish oil
245610|NCT02663427|pepsinogen Ⅰ|pepsinogen ⅰ
245611|NCT02663427|pepsinogen Ⅱ|pepsinogen ⅱ
245612|NCT02663427|gastric cancer screening|gastric cancer screening
245613|NCT02663427|helicobacter pylori|helicobacter pylori
245614|NCT02663427|gastrin|gastrin
245615|NCT02663375|TAVI|tavi
245616|NCT02663375|Aortic Stenosis|aortic stenosis
245617|NCT02663375|Transcatheter aortic valve replacement|transcatheter aortic valve replacement
245618|NCT02663375|Transcatheter aortic valve implantation|transcatheter aortic valve implantation
245619|NCT02663375|Transapical Access|transapical access
245620|NCT02663362|magnetic resonance imaging|magnetic resonance imaging
245621|NCT02663362|magnetic resonance spectroscopy|magnetic resonance spectroscopy
245622|NCT02663336|masked hypertension, chronic kidney disease|masked hypertension, chronic kidney disease
245623|NCT02663323|Coronary Artery Disease|coronary artery disease
245624|NCT02663323|MeRes-1 Extend|meres-1 extend
245625|NCT02663323|MeRes100|meres100
245626|NCT02663323|Sirolimus Eluting Bioresorbable Vascular Scaffold System|sirolimus eluting bioresorbable vascular scaffold system
245627|NCT02663310|spinal cord injury|spinal cord injury
245628|NCT02663310|Kunming Locomotor Scale|kunming locomotor scale
245629|NCT02663310|surgical decompression|surgical decompression
245630|NCT02663310|untethering|untethering
245631|NCT02663310|weight bearing rehabilitation|weight bearing rehabilitation
245632|NCT02663297|CAR T cells|car t cells
245633|NCT02663297|CD30|cd30
245634|NCT02663297|Lymphoma|lymphoma
245635|NCT02663297|T Lymphocytes|t lymphocytes
245636|NCT02663245|Type 2 diabetes mellitus|type 2 diabetes mellitus
245637|NCT02663245|glycemic control|glycemic control
245638|NCT02663232|V600 BRAF mutation|v600 braf mutation
245639|NCT02663232|Metastatic melanoma|metastatic melanoma
245641|NCT02663219|ART|art
245642|NCT02663219|CCM|ccm
245643|NCT02663219|DAIDS|daids
245644|NCT02663219|HPTN|hptn
245645|NCT02663219|ACA|aca
245646|NCT02663219|PAF|paf
245647|NCT02663219|PEP|pep
245648|NCT02663219|RDS|rds
245649|NCT02663206|spastic esophageal disorders|spastic esophageal disorders
245650|NCT02663206|achalasia|achalasia
245651|NCT02663206|diffuse esophageal spasm|diffuse esophageal spasm
245652|NCT02663206|hypercontractile (jackhammer) esophagus|hypercontractile (jackhammer) esophagus
245653|NCT02663206|Botulinum toxin injection|botulinum toxin injection
245654|NCT02663206|peroral endoscopic myotomy|peroral endoscopic myotomy
245655|NCT02663193|Prostate Cancer|prostate cancer
245656|NCT02663193|Observational study|observational study
245657|NCT02663193|Enzalutamide|enzalutamide
245658|NCT02663193|Abiraterone Acetate|abiraterone acetate
245659|NCT02663193|Prednisone|prednisone
245660|NCT02663193|Tolerability|tolerability
245661|NCT02663154|Aromatherapy|aromatherapy
245662|NCT02663102|Safety|safety
245663|NCT02663102|Post-marketing|post-marketing
245664|NCT02663102|Korea|korea
245665|NCT02663102|Drug utilization study|drug utilization study
245666|NCT02663102|Fluarix Tetra|fluarix tetra
245667|NCT02663089|total radioactivity|total radioactivity
245668|NCT02663089|[14C]-GSK961081|[14c]-gsk961081
245669|NCT02663089|Pharmacokinetics|pharmacokinetics
245670|NCT02663089|Chronic Obstructive Pulmonary Disease (COPD)|chronic obstructive pulmonary disease (copd)
245671|NCT02663089|Microtracer|microtracer
245672|NCT02663063|Complementary and alternative medicine|complementary and alternative medicine
245673|NCT02663063|Hospice Palliative Care|hospice palliative care
245674|NCT02663050|Dysmenorrhea|dysmenorrhea
245675|NCT02663050|kinesio tape|kinesio tape
245676|NCT02663037|Segmentation|segmentation
245677|NCT02663037|Health needs|health needs
245678|NCT02662985|Power Doppler Ultrasonography, Psoriatic Arthritis, Enthesitis, Synovitis, Outcome Measures in Rheumatology, Spondyloarthritis Research Consortium of Canada|power doppler ultrasonography, psoriatic arthritis, enthesitis, synovitis, outcome measures in rheumatology, spondyloarthritis research consortium of canada
245679|NCT02662972|Nerve block|nerve block
245680|NCT02662972|Sphenopalatine Ganglion Block|sphenopalatine ganglion block
245681|NCT02662972|Botulinum Toxins, Type A|botulinum toxins, type a
245682|NCT02662959|Chemotherapy, metastatic gastric cancer, irinotecan|chemotherapy, metastatic gastric cancer, irinotecan
245683|NCT02662907|Head and Neck Cancer|head and neck cancer
245684|NCT02662907|Post-radiotherapy H&N cancer survivors|post-radiotherapy h&n cancer survivors
245685|NCT02662907|Aspiration|aspiration
245686|NCT02662907|Expiratory muscle strength training|expiratory muscle strength training
245687|NCT02662907|EMST|emst
245688|NCT02662907|Dysphagia therapy|dysphagia therapy
245689|NCT02662907|Modified barium swallow|modified barium swallow
245690|NCT02662907|Neurocognitive exams|neurocognitive exams
245691|NCT02662907|Questionnaires|questionnaires
245692|NCT02662907|Surveys|surveys
245693|NCT02662907|Digital Manometer|digital manometer
245694|NCT02662868|Breast cancer|breast cancer
245695|NCT02662868|Metastasis|metastasis
245696|NCT02662842|infusion set|infusion set
245697|NCT02662842|continuous subcutaneous insulin infusion|continuous subcutaneous insulin infusion
245698|NCT02662829|Lesotho|lesotho
245699|NCT02662829|tuberculosis|tuberculosis
245700|NCT02662829|TB|tb
245701|NCT02662829|HIV|hiv
245702|NCT02662829|adherence|adherence
245703|NCT02662829|community-based intervention|community-based intervention
245704|NCT02662829|retention|retention
245705|NCT02662816|Glutathione|glutathione
245706|NCT02662816|Liver|liver
245707|NCT02662816|Muscle|muscle
245708|NCT02662816|Proton magnetic resonance spectroscopy|proton magnetic resonance spectroscopy
245709|NCT02662816|Healthy human|healthy human
245710|NCT02662803|Generalized Anxiety Disorder|generalized anxiety disorder
245712|NCT02662803|physical exercise|physical exercise
245713|NCT02662803|aerobe exercise|aerobe exercise
245714|NCT02662803|mental disorder|mental disorder
245715|NCT02662803|high-intensive aerobe exercise|high-intensive aerobe exercise
245716|NCT02662777|esophageal anastomosis leakage|esophageal anastomosis leakage
245717|NCT02662777|endoscopic vacuum therapy|endoscopic vacuum therapy
245718|NCT02662777|esophageal perforation|esophageal perforation
245719|NCT02662777|upper gastrointestinal tract|upper gastrointestinal tract
245720|NCT02662777|esophageal leak|esophageal leak
245721|NCT02662777|endoscopy|endoscopy
245722|NCT02662738|Blood glucose|blood glucose
245723|NCT02662725|melanoma|melanoma
245724|NCT02662725|brain metastasis|brain metastasis
245725|NCT02662725|stereotactic radiosurgery|stereotactic radiosurgery
245726|NCT02662725|Ipilimumab|ipilimumab
245727|NCT02662725|survival|survival
245728|NCT02662725|safety|safety
245729|NCT02662725|efficacy|efficacy
245730|NCT02662712|Healthy|healthy
245731|NCT02662712|Hepatitis, Chronic|hepatitis, chronic
245732|NCT02662712|JNJ-56136379|jnj-56136379
245733|NCT02662712|Placebo|placebo
245734|NCT02662699|Anemia|anemia
245735|NCT02662699|Hematologic Diseases|hematologic diseases
245736|NCT02662699|Erythrocytes|erythrocytes
245737|NCT02662699|Hemoglobin|hemoglobin
245738|NCT02662699|Hemolytic|hemolytic
245739|NCT02662686|Embryo Implantation|embryo implantation
245740|NCT02662686|Mitochondrial genes|mitochondrial genes
245741|NCT02662686|Mitochondrial DNA|mitochondrial dna
245742|NCT02662686|MitoScore|mitoscore
245743|NCT02662686|Embryo selection|embryo selection
245744|NCT02662686|Embryo viability|embryo viability
245745|NCT02662686|Embryo biomarker|embryo biomarker
245746|NCT02662686|Diagnosis of embryo viability in euploids embryos|diagnosis of embryo viability in euploids embryos
245747|NCT02662673|HIFU|hifu
245748|NCT02662673|Prostate Cancer|prostate cancer
245749|NCT02662673|Focal|focal
245750|NCT02662673|Quality of life|quality of life
245751|NCT02662673|Index study|index study
245752|NCT02662647|demethylating agent|demethylating agent
245753|NCT02662647|lymphocyte infusion|lymphocyte infusion
245754|NCT02662634|NSCLC|nsclc
245755|NCT02662634|resectable|resectable
245756|NCT02662634|non-small cell lung cancer|non-small cell lung cancer
245757|NCT02662634|immunotherapy|immunotherapy
245758|NCT02662634|autologous|autologous
245759|NCT02662634|dendritic cell|dendritic cell
245760|NCT02662621|personalized care|personalized care
245761|NCT02662621|early diagnosis|early diagnosis
245762|NCT02662621|ovarian cancer|ovarian cancer
245763|NCT02662621|breast cancer|breast cancer
245764|NCT02662621|lung cancer|lung cancer
245765|NCT02662621|Early Detection|early detection
245766|NCT02662621|Cancer [E01.390.500]|cancer [e01.390.500]
245767|NCT02662608|Brontictuzumab|brontictuzumab
245768|NCT02662595|mHealth|mhealth
245769|NCT02662595|mobile phones|mobile phones
245770|NCT02662595|measles vaccination|measles vaccination
245771|NCT02662582|Chronic Obstructive Pulmonary Disease|chronic obstructive pulmonary disease
245772|NCT02662582|CK-2127107|ck-2127107
245773|NCT02662582|COPD|copd
245774|NCT02662543|rotavirus,|rotavirus,
245775|NCT02662543|acute gastroenteritis|acute gastroenteritis
245776|NCT02662543|vaccination|vaccination
245777|NCT02662543|Estonia|estonia
245778|NCT02662543|impact|impact
245779|NCT02662543|severity scales|severity scales
245780|NCT02662517|Neurotrophins|neurotrophins
245781|NCT02662517|Stem Cells|stem cells
245782|NCT02662517|Prematurity|prematurity
245783|NCT02662504|mesothelioma|mesothelioma
245784|NCT02662504|multimodal treatment|multimodal treatment
245785|NCT02662504|PDT|pdt
245786|NCT02662504|pleura|pleura
245787|NCT02662478|Laparoscopic gastric resection|laparoscopic gastric resection
245788|NCT02662478|gastrointestinal stromal tumor|gastrointestinal stromal tumor
245789|NCT02662478|laparoscopic surgery|laparoscopic surgery
245790|NCT02662465|Interventional|interventional
245791|NCT02662465|Treatment|treatment
245792|NCT02662465|Laser|laser
245793|NCT02662439|Heart Failure|heart failure
245794|NCT02662439|Bioimpedance analysis|bioimpedance analysis
245795|NCT02662439|Fluid overload|fluid overload
245796|NCT02662426|Seasonal Influenza|seasonal influenza
245797|NCT02662426|Lingdancao|lingdancao
245798|NCT02662426|RCT|rct
245799|NCT02662361|peri-implant disease; risk factors; prevalence|peri-implant disease; risk factors; prevalence
245800|NCT02662322|Communication|communication
245801|NCT02662322|Confusion|confusion
245802|NCT02662322|Intravenous Catheterization|intravenous catheterization
245803|NCT02662322|Comfort|comfort
245804|NCT02662309|Muscle invasive bladder cancer|muscle invasive bladder cancer
245805|NCT02662309|Transitional cell carcinoma|transitional cell carcinoma
245806|NCT02662283|IGA Nephropathy|iga nephropathy
245807|NCT02662283|proteinurien|proteinurien
245808|NCT02662283|Reh-acteoside|reh-acteoside
245809|NCT02662283|Prednisolone|prednisolone
245810|NCT02662270|Fibromyalgia|fibromyalgia
245811|NCT02662270|QEEG|qeeg
245812|NCT02662270|Brain activity|brain activity
245813|NCT02662270|fMRI|fmri
245814|NCT02662270|Diagnosis|diagnosis
245815|NCT02662257|Sevoflurane|sevoflurane
245816|NCT02662257|Propofol|propofol
245817|NCT02662257|Aged|aged
245818|NCT02662257|Neoplasm|neoplasm
245819|NCT02662257|Surgical Procedure, Operative|surgical procedure, operative
245820|NCT02662257|Delirium|delirium
245821|NCT02662257|Postoperative Complications|postoperative complications
245822|NCT02662257|Postoperative Cognitive Dysfunction|postoperative cognitive dysfunction
245823|NCT02662231|Surgical Site Infection|surgical site infection
245824|NCT02662231|General Surgery|general surgery
245825|NCT02662231|Laparotomy|laparotomy
245826|NCT02662231|Outcome and Process Assessment (Health Care)|outcome and process assessment (health care)
245827|NCT02662231|Developing Countries|developing countries
245828|NCT02662231|International Cooperation|international cooperation
245829|NCT02662231|Specialties, Surgical|specialties, surgical
245830|NCT02662231|Developed Countries|developed countries
245831|NCT02662231|Quality of Health Care|quality of health care
245832|NCT02662179|Elderly patients|elderly patients
245833|NCT02662179|Onco-geriatrics|onco-geriatrics
245834|NCT02662179|Fried criteria|fried criteria
245835|NCT02662166|bladder cancer|bladder cancer
245836|NCT02662166|MRI|mri
245837|NCT02662166|TUR-BT|tur-bt
245838|NCT02662166|cystectomy|cystectomy
245839|NCT02662166|chemotherapy|chemotherapy
245840|NCT02662075|alternative tobacco products (ATPs)|alternative tobacco products (atps)
245841|NCT02662075|electronic cigarettes|electronic cigarettes
245842|NCT02662062|Non-metastatic muscle invasive bladder cancer|non-metastatic muscle invasive bladder cancer
245843|NCT02662023|Healthy Human Volunteers|healthy human volunteers
245844|NCT02662010|AGEs|ages
245845|NCT02662010|glycemic control|glycemic control
245846|NCT02662010|T2DM|t2dm
245847|NCT02661997|Tai Chi|tai chi
245848|NCT02661997|Wellness|wellness
245849|NCT02661997|Mind-body|mind-body
245850|NCT02661997|Gulf War Illness|gulf war illness
245851|NCT02661997|Gulf War Veteran's Illness|gulf war veteran's illness
245852|NCT02661997|GWVI|gwvi
245853|NCT02661984|FeNO, exhaled nitric oxide|feno, exhaled nitric oxide
245854|NCT02661958|acne vulgaris|acne vulgaris
245855|NCT02661958|acne|acne
245856|NCT02661945|near focus with narrow band imaging|near focus with narrow band imaging
245857|NCT02661945|tumor margin|tumor margin
245858|NCT02661945|indigocarmine chromoendoscopy|indigocarmine chromoendoscopy
245859|NCT02661932|Fertility preservation|fertility preservation
245860|NCT02661932|letrozole|letrozole
245861|NCT02661932|Ovarian stimulation|ovarian stimulation
245862|NCT02661919|Epilepsy|epilepsy
245863|NCT02661919|Seizure|seizure
245864|NCT02661919|Seizures|seizures
245865|NCT02661919|Mattress monitor|mattress monitor
245866|NCT02661919|Bed monitor|bed monitor
245867|NCT02661919|Bed alarm|bed alarm
245868|NCT02661919|Generalized tonic-clonic seizure|generalized tonic-clonic seizure
245869|NCT02661919|GTC|gtc
245870|NCT02661893|Healthy|healthy
245871|NCT02661893|JNJ-42847922|jnj-42847922
245872|NCT02661893|Rifampin|rifampin
245873|NCT02661893|Pharmacokinetics|pharmacokinetics
245874|NCT02661867|Childbirth|childbirth
245875|NCT02661867|Pelvic organ prolapse|pelvic organ prolapse
245876|NCT02661867|Urinary incontinence|urinary incontinence
245877|NCT02661867|Fecal incontinence|fecal incontinence
245878|NCT02661854|Rhinitis / Rhinoconjunctivitis|rhinitis / rhinoconjunctivitis
245879|NCT02661854|Vaccine|vaccine
245880|NCT02661854|Immunotherapy|immunotherapy
245881|NCT02661854|Mite|mite
245882|NCT02661854|Allergy|allergy
245883|NCT02661828|Tapering Antidepressant Regimen|tapering antidepressant regimen
245884|NCT02661828|Antidepressant Discontinuation Syndrome|antidepressant discontinuation syndrome
245885|NCT02661789|Mental health|mental health
245886|NCT02661789|Brain Imaging|brain imaging
245887|NCT02661789|Steroid hormones|steroid hormones
245888|NCT02661789|Serotonin|serotonin
245889|NCT02661789|PET|pet
245890|NCT02661789|MRI|mri
245891|NCT02661789|fMRI|fmri
245892|NCT02661789|human|human
245893|NCT02661789|gender|gender
245894|NCT02661789|risk model|risk model
245895|NCT02661776|natural killer cell|natural killer cell
245896|NCT02661776|head and neck cancer|head and neck cancer
245897|NCT02661776|opioid|opioid
245898|NCT02661763|Rheumatic heart disease|rheumatic heart disease
245899|NCT02661750|Cleansing the colon|cleansing the colon
245900|NCT02661711|Macular Oedema Retinitis Pigmentosa|macular oedema retinitis pigmentosa
245901|NCT02661685|Cancer immunotherapy|cancer immunotherapy
245902|NCT02661685|IFN-γ-producing killer dendritic cell-like cells|ifn-γ-producing killer dendritic cell-like cells
245903|NCT02661685|Natural killer cells|natural killer cells
245904|NCT02661672|Intracranial hemorrhage|intracranial hemorrhage
245905|NCT02661672|Neurosurgery|neurosurgery
245906|NCT02661659|mesothelioma|mesothelioma
245907|NCT02661659|multipeptide vaccine|multipeptide vaccine
245908|NCT02661659|S-588210|s-588210
245909|NCT02661646|Chronic Swelling|chronic swelling
245910|NCT02661646|Leg Lymphedema|leg lymphedema
245911|NCT02661646|Primary Lymphedema|primary lymphedema
245912|NCT02661646|Secondary Lymphedema|secondary lymphedema
245913|NCT02661633|Concussion|concussion
245914|NCT02661633|Mild Traumatic Brain Injury|mild traumatic brain injury
245915|NCT02661633|Sport Related Concussion|sport related concussion
245916|NCT02661620|REDAPT Femoral System modular stem implant|redapt femoral system modular stem implant
245917|NCT02661620|Total Hip arthroplasty revision|total hip arthroplasty revision
245918|NCT02661594|TQT|tqt
245919|NCT02661594|amisulpride|amisulpride
245920|NCT02661594|volunteer|volunteer
245921|NCT02661594|ECG|ecg
245922|NCT02661581|Diabetes|diabetes
245923|NCT02661581|Peer Leader Support|peer leader support
245924|NCT02661529|Shunt|shunt
245925|NCT02661529|Echocardiogram|echocardiogram
245926|NCT02661490|Norovirus|norovirus
245927|NCT02661464|Healthy|healthy
245928|NCT02661464|Ebola viruses|ebola viruses
245929|NCT02661464|Ebola virus disease (EVD)|ebola virus disease (evd)
245930|NCT02661464|Filoviruses|filoviruses
245931|NCT02661464|Safety|safety
245932|NCT02661464|Human adenovirus serotype 26 (Ad26) expressing the Ebola virus Mayinga variant glycoprotein (Ad26.ZEBOV)|human adenovirus serotype 26 (ad26) expressing the ebola virus mayinga variant glycoprotein (ad26.zebov)
245933|NCT02661464|Modified Vaccinia Virus Ankara ‐ Bavarian Nordic Filo‐vector (MVA‐BN Filo)|modified vaccinia virus ankara ‐ bavarian nordic filo‐vector (mva‐bn filo)
245934|NCT02661464|Hemorrhagic fever|hemorrhagic fever
245935|NCT02661451|Valve|valve
245936|NCT02661438|Usability Test|usability test
245939|NCT02661412|immediate loading|immediate loading
245940|NCT02661412|biological stability|biological stability
245941|NCT02661412|mechanical stability|mechanical stability
245942|NCT02661412|long-term|long-term
245943|NCT02661412|marginal bone level|marginal bone level
245944|NCT02661412|maxilla|maxilla
245945|NCT02661412|immediate placement|immediate placement
245946|NCT02661412|dental implant|dental implant
245947|NCT02661412|fibre-reinforced provisional fixed prosthesis|fibre-reinforced provisional fixed prosthesis
245948|NCT02661399|CIPN|cipn
245949|NCT02661373|Antimalarial|antimalarial
245950|NCT02661373|First-in-Human|first-in-human
245951|NCT02661373|Pharmacokinetic|pharmacokinetic
245952|NCT02661360|swaddling|swaddling
245953|NCT02661347|First Episode|first episode
245954|NCT02661347|Schizophreniform|schizophreniform
245955|NCT02661347|Schizoaffective Disorder|schizoaffective disorder
245956|NCT02661347|Psychosis|psychosis
245957|NCT02661347|Schizophrenia|schizophrenia
245958|NCT02661347|tDCS|tdcs
245959|NCT02661347|Risperidone|risperidone
245960|NCT02661347|Anti-psychotic medication|anti-psychotic medication
245961|NCT02661334|creatine|creatine
245962|NCT02661334|creatine monohydrate|creatine monohydrate
245963|NCT02661334|supplement|supplement
245964|NCT02661334|exercise|exercise
245965|NCT02661334|fitness|fitness
245966|NCT02661256|pharyngeal swallow|pharyngeal swallow
245967|NCT02661256|airway compromise|airway compromise
245968|NCT02661256|NICU|nicu
245969|NCT02661243|Sjogren's Syndrome|sjogren's syndrome
245970|NCT02661243|Dental Implants|dental implants
245971|NCT02661230|exergaming|exergaming
245972|NCT02661230|intensive care unit|intensive care unit
245973|NCT02661230|feasibility acceptability|feasibility acceptability
245974|NCT02661230|heart|heart
245975|NCT02661230|brain function|brain function
245976|NCT02661217|Acute decompensated heart failure|acute decompensated heart failure
245977|NCT02661217|Reduced ejection fraction|reduced ejection fraction
245978|NCT02661217|Pre-discharge treatment|pre-discharge treatment
245979|NCT02661217|Post-discharge treatment|post-discharge treatment
245980|NCT02661217|Angiotensin receptor neprilysine inhibitor|angiotensin receptor neprilysine inhibitor
245981|NCT02661217|HFrEF|hfref
245982|NCT02661191|asthma|asthma
245983|NCT02661191|vitamin D|vitamin d
245984|NCT02661191|exacerbations|exacerbations
245985|NCT02661191|airway obstruction|airway obstruction
245986|NCT02661178|Parasitic Diseases|parasitic diseases
245987|NCT02661178|Helminthiasis|helminthiasis
245988|NCT02661178|Nematode Infections|nematode infections
245989|NCT02661178|Secernentea Infections|secernentea infections
245990|NCT02661178|Spirurida Infections|spirurida infections
245991|NCT02661178|Filariasis|filariasis
245992|NCT02661178|Skin Diseases, Parasitic|skin diseases, parasitic
245993|NCT02661178|Skin and Connective Tissue Diseases|skin and connective tissue diseases
245994|NCT02661178|Skin Diseases|skin diseases
245995|NCT02661178|Skin Diseases, Infectious|skin diseases, infectious
245996|NCT02661178|Depsipeptides|depsipeptides
245997|NCT02661178|Emodepside|emodepside
245998|NCT02661178|Neglected disease|neglected disease
245999|NCT02661178|Africa|africa
246000|NCT02661178|New drug|new drug
246001|NCT02661178|Oral drug|oral drug
246002|NCT02661178|Parasite|parasite
246003|NCT02661178|Anthelmintic drug|anthelmintic drug
246004|NCT02661178|Cyclooctadepsipeptide|cyclooctadepsipeptide
246005|NCT02661178|Single ascending dose|single ascending dose
246006|NCT02661178|Volunteers|volunteers
246007|NCT02661178|Phase 1|phase 1
246008|NCT02661178|Safety|safety
246009|NCT02661178|Tolerability|tolerability
246010|NCT02661178|Pharmacokinetics|pharmacokinetics
246011|NCT02661178|Relative bioavailability|relative bioavailability
246012|NCT02661178|Onchocerciasis|onchocerciasis
246013|NCT02661139|bisphosphonates and/or targeted therapy by monoclonal antibodies|bisphosphonates and/or targeted therapy by monoclonal antibodies
246014|NCT02661139|jaw reconstruction|jaw reconstruction
246015|NCT02661139|prosthetic rehabilitation|prosthetic rehabilitation
246016|NCT02661139|quality of life|quality of life
246017|NCT02661100|Vaccine|vaccine
246018|NCT02661100|NY-ESO-1|ny-eso-1
246019|NCT02661100|DEC-205|dec-205
246020|NCT02661100|Poly-ICLC|poly-iclc
246021|NCT02661100|Pembrolizumab|pembrolizumab
246022|NCT02661100|Cancer|cancer
246023|NCT02661087|submucosal myoma|submucosal myoma
246024|NCT02661087|hysteroscopic resection|hysteroscopic resection
246025|NCT02661087|bipolar energy|bipolar energy
246026|NCT02661087|monopolar energy|monopolar energy
246027|NCT02661074|Fisherman|fisherman
246028|NCT02661074|Fish industry|fish industry
246029|NCT02661061|ketamine|ketamine
246030|NCT02661061|glutamate|glutamate
246031|NCT02661061|relapse prevention|relapse prevention
246032|NCT02661035|AML|aml
246033|NCT02661035|ALL|all
246034|NCT02661035|CML|cml
246035|NCT02661035|MDS|mds
246036|NCT02661035|CLL|cll
246037|NCT02661035|SLL|sll
246038|NCT02661035|NHL|nhl
246039|NCT02661009|NSCLC|nsclc
246040|NCT02661009|EGFR|egfr
246041|NCT02661009|EGFR-TKI|egfr-tki
246042|NCT02661009|PCR|pcr
246043|NCT02660970|Iberogast|iberogast
246044|NCT02660970|Acupressure|acupressure
246045|NCT02660970|gut-brain-axis|gut-brain-axis
246046|NCT02660957|Smoking cessation|smoking cessation
246047|NCT02660931|Pediatrics|pediatrics
246048|NCT02660905|HIV-HCV co-infected|hiv-hcv co-infected
246049|NCT02660905|HCV|hcv
246050|NCT02660905|HIV|hiv
246051|NCT02660905|Hep C|hep c
246052|NCT02660905|Hepatitis C|hepatitis c
246053|NCT02660905|HCV positive|hcv positive
246054|NCT02660892|IAAO|iaao
246055|NCT02660892|Threonine|threonine
246056|NCT02660892|Children|children
246057|NCT02660879|Education|education
246058|NCT02660879|Inhaler|inhaler
246059|NCT02660866|intermittent claudication|intermittent claudication
246060|NCT02660866|randomized controlled trial|randomized controlled trial
246061|NCT02660853|Exacerbations|exacerbations
246062|NCT02660814|Chemerin|chemerin
246063|NCT02660814|Interleukin-6|interleukin-6
246064|NCT02660814|Gingival crevicular fluid|gingival crevicular fluid
246065|NCT02660801|spinal manipulation|spinal manipulation
246066|NCT02660801|spinal mobilization|spinal mobilization
246067|NCT02660801|spinal stiffness|spinal stiffness
246068|NCT02660788|6-24 months overdue|6-24 months overdue
246069|NCT02660788|screening mammography|screening mammography
246070|NCT02660775|schizophrenia|schizophrenia
246071|NCT02660736|Albiglutide|albiglutide
246072|NCT02660736|Randomized|randomized
246073|NCT02660736|Pharmacokinetics|pharmacokinetics
246074|NCT02660736|GSK716155|gsk716155
246075|NCT02660736|Bioequivalence study|bioequivalence study
246076|NCT02660723|M01.774.500|m01.774.500
246077|NCT02660723|Volunteers|volunteers
246078|NCT02660710|single arm phase 2|single arm phase 2
246079|NCT02660710|safety and efficacy|safety and efficacy
246080|NCT02660710|R-CHOP|r-chop
246081|NCT02660697|socket preservation, implant site development|socket preservation, implant site development
246082|NCT02660684|Prograf|prograf
246083|NCT02660684|Graft versus host disease|graft versus host disease
246084|NCT02660684|Hematopoietic stem cell transplantation|hematopoietic stem cell transplantation
246085|NCT02660684|Prophylaxis|prophylaxis
246086|NCT02660684|Peripheral hematopoietic stem cell transplantation|peripheral hematopoietic stem cell transplantation
246087|NCT02660645|Cysview|cysview
246088|NCT02660645|Hexaminolevulinate|hexaminolevulinate
246089|NCT02660645|Hexvix|hexvix
246090|NCT02660645|NMIBC|nmibc
246091|NCT02660645|BLCC|blcc
246092|NCT02660645|Blue Light Cystoscopy with Cysview|blue light cystoscopy with cysview
246093|NCT02660645|Cystoscopy|cystoscopy
246094|NCT02660645|TURBT|turbt
246095|NCT02660645|TUR|tur
246096|NCT02660645|Fluorescent cystoscopy|fluorescent cystoscopy
246097|NCT02660645|Non-muscle invasive bladder cancer (NMIBC)|non-muscle invasive bladder cancer (nmibc)
246098|NCT02660645|Transurethral resection (TUR)|transurethral resection (tur)
246099|NCT02660593|Diabetes Mellitus|diabetes mellitus
246100|NCT02660593|Chinese medicine|chinese medicine
246101|NCT02660593|exercise|exercise
246102|NCT02660593|diet|diet
246103|NCT02660580|Adalimumab|adalimumab
246104|NCT02660580|MSB11022|msb11022
246105|NCT02660580|Psoriasis|psoriasis
246106|NCT02660580|Phase III|phase iii
246107|NCT02660567|postpartum hemorrhage|postpartum hemorrhage
246108|NCT02660567|PPH|pph
246109|NCT02660567|atonic|atonic
246110|NCT02660567|new maneuver|new maneuver
246111|NCT02660554|Pneumonia|pneumonia
246112|NCT02660554|Methicillin-Resistant Staphylococcus aureus|methicillin-resistant staphylococcus aureus
246113|NCT02660554|Polymerase Chain Reaction|polymerase chain reaction
246114|NCT02660554|Intensive care units|intensive care units
246115|NCT02660554|Drug Resistance|drug resistance
246116|NCT02660541|Dressing for burn wounds|dressing for burn wounds
246117|NCT02660515|complete articular distal radius fracture|complete articular distal radius fracture
246118|NCT02660515|wrist arthroscopy|wrist arthroscopy
246119|NCT02660489|CRTH2 antagonist|crth2 antagonist
246120|NCT02660489|Prostaglandin D2 receptor|prostaglandin d2 receptor
246121|NCT02660489|Anti-Asthmatic Agents|anti-asthmatic agents
246122|NCT02660489|OC459|oc459
246123|NCT02660489|Allergic asthma|allergic asthma
246124|NCT02660489|Eosinophilia|eosinophilia
246125|NCT02660476|Diet|diet
246126|NCT02660476|Middle East and North Africa country|middle east and north africa country
246127|NCT02660476|Health|health
246128|NCT02660476|Complication|complication
732046|NCT00503035|colonoscopy|colonoscopy
246129|NCT02660476|Cardiovascular disease|cardiovascular disease
246130|NCT02660476|Obesity|obesity
246131|NCT02660476|Stress|stress
246132|NCT02660476|Obstructive Sleep Apnoea (OSA)|obstructive sleep apnoea (osa)
246133|NCT02660463|incidence|incidence
246134|NCT02660463|risk factors|risk factors
246135|NCT02660437|COPD|copd
246136|NCT02660437|Carbon dioxide partial pressure (pCO2)|carbon dioxide partial pressure (pco2)
246137|NCT02660437|Cerebral blood flow (CBF)|cerebral blood flow (cbf)
246138|NCT02660437|Cognitive dysfunction|cognitive dysfunction
246139|NCT02660437|Mild/Moderate Cognitive Impairment (MCI)|mild/moderate cognitive impairment (mci)
246140|NCT02660437|Pulmonary Rehabilitation (PR)|pulmonary rehabilitation (pr)
246141|NCT02660437|Standardized Mini Mental State Examination (SMMSE)|standardized mini mental state examination (smmse)
246341|NCT02659410|Organic solvents|organic solvents
246142|NCT02660437|Addenbrooke's Cognitive Examination (ACE-R)|addenbrooke's cognitive examination (ace-r)
246143|NCT02660437|Montreal Cognitive Assessment (MoCA)|montreal cognitive assessment (moca)
246144|NCT02660437|Telephone Interview for Cognitive Status (TICS)|telephone interview for cognitive status (tics)
246145|NCT02660437|Stroop test (Reaction Time)|stroop test (reaction time)
246146|NCT02660411|Sevoflurane|sevoflurane
246147|NCT02660411|Propofol|propofol
246148|NCT02660411|Aged|aged
246149|NCT02660411|Neoplasm|neoplasm
246150|NCT02660411|Surgical Procedure, Operative|surgical procedure, operative
246151|NCT02660411|Long-term survival|long-term survival
246152|NCT02660385|pain|pain
246153|NCT02660385|insomnia|insomnia
246154|NCT02660385|cardiac failure|cardiac failure
246155|NCT02660385|sleep|sleep
246156|NCT02660385|fatigue|fatigue
246157|NCT02660385|heart disease|heart disease
246158|NCT02660385|anxiety|anxiety
246159|NCT02660385|actigraphy|actigraphy
246160|NCT02660385|psychomotor vigilance|psychomotor vigilance
246161|NCT02660385|six minute walk|six minute walk
246162|NCT02660385|depression|depression
246163|NCT02660385|cognitive behavioral therapy|cognitive behavioral therapy
246164|NCT02660385|self-management|self-management
246165|NCT02660385|self-care|self-care
246166|NCT02660346|IL-10|il-10
246167|NCT02660346|MRSA|mrsa
246168|NCT02660346|Bacteremia|bacteremia
246169|NCT02660333|Obesity|obesity
246170|NCT02660333|Inflammation|inflammation
246171|NCT02660333|Nutritional status|nutritional status
246172|NCT02660333|Prebiotic|prebiotic
246173|NCT02660333|Synbiotic|synbiotic
246174|NCT02660307|stress|stress
246175|NCT02660307|work|work
246176|NCT02660307|employees|employees
246177|NCT02660307|mindfulness|mindfulness
246178|NCT02660307|depression|depression
246179|NCT02660307|anxiety|anxiety
246180|NCT02660268|Clinical pathway|clinical pathway
246181|NCT02660268|Infection|infection
246182|NCT02660268|Hip|hip
246183|NCT02660268|Prosthesis|prosthesis
246184|NCT02660255|CBD|cbd
246185|NCT02660255|Epidiolex|epidiolex
246186|NCT02660255|Myoclonic|myoclonic
246187|NCT02660255|Brain Disease|brain disease
246188|NCT02660255|Central Nervous System Disease|central nervous system disease
246189|NCT02660255|GWP42003|gwp42003
246190|NCT02660242|T1D|t1d
246191|NCT02660242|Type 1 Diabetes|type 1 diabetes
246192|NCT02660242|Mini-dose Glucagon|mini-dose glucagon
246193|NCT02660242|Adults|adults
246194|NCT02660242|Exercise|exercise
246195|NCT02660242|Hypoglycemia|hypoglycemia
246196|NCT02660229|Intravenous injection in cancer pain|intravenous injection in cancer pain
246197|NCT02660216|minimally invasive|minimally invasive
246198|NCT02660216|le fort I osteotomy|le fort i osteotomy
246199|NCT02660216|3D virtual treatment planning|3d virtual treatment planning
246200|NCT02660216|accuracy|accuracy
246201|NCT02660203|chest physiotherapy|chest physiotherapy
246202|NCT02660203|post operative period|post operative period
246203|NCT02660203|forced expiration|forced expiration
246204|NCT02660203|pleural drainage duration|pleural drainage duration
246205|NCT02660164|Concussion|concussion
246206|NCT02660125|ICSI|icsi
246207|NCT02660125|endometrial injury|endometrial injury
246208|NCT02660125|implantation rate|implantation rate
246209|NCT02660086|Weight|weight
246210|NCT02660086|Prevention|prevention
246211|NCT02660086|Food choice|food choice
246212|NCT02660086|Nutrition|nutrition
246213|NCT02660086|Behavior change|behavior change
246214|NCT02660086|Behavioral economics|behavioral economics
246215|NCT02660086|Feedback|feedback
246216|NCT02660086|Incentives|incentives
246217|NCT02660060|Pramipexole|pramipexole
246218|NCT02660060|Bioequivalence|bioequivalence
246219|NCT02660060|Pharmacokinetics|pharmacokinetics
246220|NCT02660047|South Asian descent|south asian descent
246221|NCT02660034|Dose Escalation|dose escalation
246222|NCT02660034|Dose Expansion|dose expansion
246223|NCT02660034|BGB-A317|bgb-a317
246224|NCT02660034|BGB-290|bgb-290
246225|NCT02660021|three-dimensional virtual treatment planning|three-dimensional virtual treatment planning
246226|NCT02660021|orthognathic surgery|orthognathic surgery
246227|NCT02659995|glycemic variability|glycemic variability
246228|NCT02659995|infection|infection
246229|NCT02659956|Multiple Sclerosis|multiple sclerosis
246230|NCT02659956|Longitudinal Prospective Follow-Up|longitudinal prospective follow-up
246231|NCT02659943|Gene Therapy|gene therapy
246232|NCT02659943|Adoptive T Cell Therapy|adoptive t cell therapy
246233|NCT02659943|Allogeneic Stem Cell Transplantation|allogeneic stem cell transplantation
246234|NCT02659943|T-cell infusion|t-cell infusion
246235|NCT02659943|Residual Malignancy|residual malignancy
246236|NCT02659930|HIV|hiv
246237|NCT02659930|AIDS|aids
246238|NCT02659930|Multicentric Castleman Disease|multicentric castleman disease
246239|NCT02659917|glass-ionomer cement|glass-ionomer cement
246240|NCT02659917|atraumatic restorative treatment|atraumatic restorative treatment
246241|NCT02659917|pit and fissure sealants|pit and fissure sealants
246242|NCT02659904|Free gingival graft|free gingival graft
246243|NCT02659904|Palatal donor site healing|palatal donor site healing
246342|NCT02659397|LDL-cholesterol|ldl-cholesterol
246244|NCT02659878|Takotsubo cardiomyopathy;NT-proBNP;urine metanephrine|takotsubo cardiomyopathy;nt-probnp;urine metanephrine
246245|NCT02659852|Hilar malignant biliary obstruction|hilar malignant biliary obstruction
246246|NCT02659852|bilateral metal stent|bilateral metal stent
246247|NCT02659852|stent in stent|stent in stent
246248|NCT02659852|side by side|side by side
246249|NCT02659839|Cancer|cancer
246250|NCT02659839|Intensive care unit|intensive care unit
246251|NCT02659839|Mortality|mortality
246252|NCT02659826|Transcutaneous spinal direct current stimulation|transcutaneous spinal direct current stimulation
246253|NCT02659826|Transcranial Magnetic Stimulation|transcranial magnetic stimulation
246254|NCT02659826|Gait Training|gait training
246255|NCT02659826|Central Nervous System Excitability|central nervous system excitability
246256|NCT02659826|Healthy|healthy
246257|NCT02659813|Orthodontic wires|orthodontic wires
246258|NCT02659774|Smoking cessation interventions|smoking cessation interventions
246259|NCT02659761|Human Immunodeficiency Virus|human immunodeficiency virus
246260|NCT02659761|Injection drug use|injection drug use
246261|NCT02659761|Single-tablet antiretroviral treatment|single-tablet antiretroviral treatment
246262|NCT02659761|Dolutegravir|dolutegravir
246263|NCT02659761|Tolerability|tolerability
246264|NCT02659761|Adherence|adherence
246265|NCT02659761|Efficacy|efficacy
246266|NCT02659748|Bioactive fatty acids|bioactive fatty acids
246267|NCT02659748|Insulin sensitivity|insulin sensitivity
246268|NCT02659748|Diet|diet
246269|NCT02659748|Milk fat|milk fat
246270|NCT02659748|Lipid metabolism|lipid metabolism
246271|NCT02659748|Inflammation markers|inflammation markers
246272|NCT02659748|Fecal microbiota composition|fecal microbiota composition
246273|NCT02659735|Influenza A virus|influenza a virus
246274|NCT02659735|JNJ-63623872|jnj-63623872
246275|NCT02659735|Healthy|healthy
246276|NCT02659722|INTERVERTEBRAL DISC DEGENERATION|intervertebral disc degeneration
246277|NCT02659722|Bone Disease|bone disease
246278|NCT02659722|Musculoskeletal disease|musculoskeletal disease
246279|NCT02659722|Spinal disease|spinal disease
246280|NCT02659709|Glaucoma|glaucoma
246281|NCT02659709|Smartphone|smartphone
246282|NCT02659709|Tablet|tablet
246283|NCT02659709|Application|application
246284|NCT02659709|Eye Drops|eye drops
246285|NCT02659631|P-cadherin|p-cadherin
246286|NCT02659631|PF-06671008|pf-06671008
246287|NCT02659631|solid tumors|solid tumors
246288|NCT02659631|lung cancer|lung cancer
246289|NCT02659631|breast cancer|breast cancer
246290|NCT02659631|colorectal cancer|colorectal cancer
246291|NCT02659631|NSCLC|nsclc
246292|NCT02659631|TNBC|tnbc
246293|NCT02659631|CRC|crc
246294|NCT02659631|neoplasms|neoplasms
246295|NCT02659631|Triple negative breast cancer|triple negative breast cancer
246296|NCT02659631|Non-small cell lung cancer|non-small cell lung cancer
246297|NCT02659618|Asthma|asthma
246298|NCT02659605|pre-term birth|pre-term birth
246299|NCT02659605|delayed cord clamping|delayed cord clamping
246300|NCT02659605|skin to skin|skin to skin
246301|NCT02659592|fertility preservation|fertility preservation
246302|NCT02659592|ovarian tissue transplantation|ovarian tissue transplantation
246303|NCT02659592|ovarian endocrine function|ovarian endocrine function
246304|NCT02659592|assisted reproductive technology|assisted reproductive technology
246305|NCT02659592|pregnancy and live birth|pregnancy and live birth
246306|NCT02659579|Shared Book Reading|shared book reading
246307|NCT02659579|Vocabulary|vocabulary
246308|NCT02659579|Language Development|language development
246309|NCT02659579|Young Children|young children
246310|NCT02659579|Randomised Control Trial|randomised control trial
246311|NCT02659566|Markers|markers
246312|NCT02659566|Parasitemia|parasitemia
246313|NCT02659566|Coartem|coartem
246314|NCT02659566|Plasmodium|plasmodium
246315|NCT02659566|Infection|infection
246316|NCT02659553|Liver Transplantation - Steatosis - Fatty Liver|liver transplantation - steatosis - fatty liver
246317|NCT02659540|Ipilimumab|ipilimumab
246318|NCT02659540|Nivolumab|nivolumab
246319|NCT02659540|Radiotherapy|radiotherapy
246320|NCT02659514|Poziotinib|poziotinib
246321|NCT02659514|Metastatic Breast Cancer|metastatic breast cancer
246322|NCT02659514|HER2-positive|her2-positive
246323|NCT02659514|Pan-HER inhibitor|pan-her inhibitor
246324|NCT02659501|Breast reconstruction|breast reconstruction
246325|NCT02659501|Bupivacaine|bupivacaine
246326|NCT02659501|Liposomal bupivacaine|liposomal bupivacaine
246327|NCT02659501|Postoperative analgesia|postoperative analgesia
246328|NCT02659462|Repaired Congenital Heart Disease|repaired congenital heart disease
246329|NCT02659462|Cardio Pulmonary Exercise Testing|cardio pulmonary exercise testing
246330|NCT02659462|Fontan|fontan
246331|NCT02659462|Fontan Palliation|fontan palliation
246332|NCT02659462|functional capacity|functional capacity
246333|NCT02659449|hands|hands
246334|NCT02659436|Cognitive Behavioural Therapy|cognitive behavioural therapy
246335|NCT02659423|Bystanding behaviors|bystanding behaviors
246336|NCT02659423|Campus|campus
246337|NCT02659423|Prevention|prevention
246338|NCT02659423|Sexual Assault|sexual assault
246339|NCT02659423|CampusSave|campussave
246340|NCT02659410|Physiologically based pharmacokinetic modeling|physiologically based pharmacokinetic modeling
246343|NCT02659397|Hypercholesterolemia|hypercholesterolemia
246344|NCT02659397|ETC-1002|etc-1002
246345|NCT02659397|Adenosine triphosphate citrate lyase|adenosine triphosphate citrate lyase
246346|NCT02659397|Atorvastatin|atorvastatin
246347|NCT02659358|Advanced solid malignancy|advanced solid malignancy
246348|NCT02659358|Activity monitor|activity monitor
246349|NCT02659358|Biosensor|biosensor
246351|NCT02659358|Patient Reported Outcomes (PRO)|patient reported outcomes (pro)
246352|NCT02659358|Stage 3/4 cancer|stage 3/4 cancer
246353|NCT02659358|Performance Status|performance status
246354|NCT02659358|Eastern Cooperative Oncology Group Performance Status (ECOG-PS)|eastern cooperative oncology group performance status (ecog-ps)
246355|NCT02659345|Art Therapy|art therapy
246356|NCT02659345|Chemotherapy|chemotherapy
246357|NCT02659319|Child overweight|child overweight
246358|NCT02659319|Child obesity|child obesity
246359|NCT02659319|Family dynamics|family dynamics
246360|NCT02659319|Peer relationships|peer relationships
246361|NCT02659319|Family intervention|family intervention
246362|NCT02659319|School intervention|school intervention
246363|NCT02659319|Parenting|parenting
246364|NCT02659293|Multiple myeloma|multiple myeloma
246365|NCT02659293|stem-cell transplant|stem-cell transplant
246366|NCT02659293|Symptomatic myeloma|symptomatic myeloma
246367|NCT02659293|lenalidomide|lenalidomide
246368|NCT02659293|carfilzomib|carfilzomib
246369|NCT02659293|dexamethasone|dexamethasone
246370|NCT02659280|telerehabilitation|telerehabilitation
246371|NCT02659267|Health Promotion|health promotion
246372|NCT02659267|Physical Activity|physical activity
246373|NCT02659267|Eating habits|eating habits
246374|NCT02659267|Health System|health system
246375|NCT02659267|Users from Health Academy Program|users from health academy program
246376|NCT02659254|Drug-Eluting Stents,Absorbable Implants,Stents|drug-eluting stents,absorbable implants,stents
246377|NCT02659215|Hyaluronic Acid|hyaluronic acid
246378|NCT02659215|Cartilage Repair|cartilage repair
246379|NCT02659215|Knee|knee
246380|NCT02659202|Exercise|exercise
246381|NCT02659202|Heart Failure|heart failure
246382|NCT02659202|Blood Pressure|blood pressure
246383|NCT02659163|cardiometabolic risk|cardiometabolic risk
246384|NCT02659163|obesity|obesity
246385|NCT02659163|mHealth|mhealth
246386|NCT02659163|health behaviors|health behaviors
246387|NCT02659150|tocilizumab|tocilizumab
246388|NCT02659150|subcutaneous injection|subcutaneous injection
246389|NCT02659150|rheumatoid arthritis|rheumatoid arthritis
246390|NCT02659150|plaque inflammation|plaque inflammation
246391|NCT02659150|atherosclerotic plaque|atherosclerotic plaque
246392|NCT02659150|joint inflammation|joint inflammation
246393|NCT02659150|FDG-PET|fdg-pet
246394|NCT02659150|PET-MR|pet-mr
246395|NCT02659150|ACTEMRA|actemra
246396|NCT02659137|LBBB|lbbb
246397|NCT02659137|TAVI|tavi
246398|NCT02659124|facial laser|facial laser
246399|NCT02659124|fraction ablative resurfacing|fraction ablative resurfacing
246400|NCT02659124|total ablative resurfacing|total ablative resurfacing
246401|NCT02659124|EpiFix|epifix
246402|NCT02659124|rhytides|rhytides
246403|NCT02659124|wrinkles|wrinkles
246404|NCT02659124|AmnioFix|amniofix
246405|NCT02659111|Exercise Therapy|exercise therapy
246406|NCT02659098|Best Corrected Visual Acuity|best corrected visual acuity
246407|NCT02659098|Geographic Atrophy|geographic atrophy
246408|NCT02659098|Macular Degeneration|macular degeneration
246409|NCT02659098|CNTO 2476|cnto 2476
246410|NCT02659085|Depressive Disorder, Major|depressive disorder, major
246411|NCT02659085|Antidepressive Agents/adverse effects|antidepressive agents/adverse effects
246412|NCT02659085|Depressive Disorder, Major/drug therapy|depressive disorder, major/drug therapy
246413|NCT02659085|Infusions, Intravenous|infusions, intravenous
246414|NCT02659085|Ketamine/administration & dosage*|ketamine/administration & dosage*
246415|NCT02659085|Ketamine/adverse effects|ketamine/adverse effects
246416|NCT02659085|Treatment Outcome|treatment outcome
246417|NCT02659085|Electroconvulsive therapy|electroconvulsive therapy
246418|NCT02659046|Traumatic Brain Injury|traumatic brain injury
246419|NCT02659033|microbiota|microbiota
246420|NCT02659033|resistant bacteria|resistant bacteria
246421|NCT02659007|yoga|yoga
246422|NCT02659007|balance|balance
246423|NCT02658968|Radioimmunotherapy|radioimmunotherapy
246424|NCT02658968|Lu-177|lu-177
246425|NCT02658968|Phase I study|phase i study
246426|NCT02658968|Betalutin|betalutin
246427|NCT02658968|ARC|arc
246428|NCT02658968|Antibody Radionuclide Conjugate|antibody radionuclide conjugate
246429|NCT02658968|HH1|hh1
246430|NCT02658968|Rituximab|rituximab
246431|NCT02658968|177Lu-DOTA-HH1|177lu-dota-hh1
246432|NCT02658968|Lilotomab|lilotomab
246433|NCT02658968|Lutetium (177Lu)-lilotomab satetraxetan|lutetium (177lu)-lilotomab satetraxetan
246434|NCT02658968|Additional relevant MeSH terms:|additional relevant mesh terms:
246435|NCT02658968|Lymphoma|lymphoma
246436|NCT02658968|Lymphoma, Non-Hodgkin|lymphoma, non-hodgkin
246437|NCT02658968|Immune System Diseases|immune system diseases
246438|NCT02658968|Immunoproliferative Disorders|immunoproliferative disorders
246439|NCT02658968|Diffuse Large B-Cell Lymphoma|diffuse large b-cell lymphoma
246440|NCT02658968|Lymphatic Diseases|lymphatic diseases
246441|NCT02658968|Lymphoproliferative Disorders|lymphoproliferative disorders
246442|NCT02658968|Neoplasms|neoplasms
246443|NCT02658968|Neoplasms by Histologic Type|neoplasms by histologic type
246444|NCT02658968|DLBCL|dlbcl
246445|NCT02658968|Refractory DLBCL|refractory dlbcl
246446|NCT02658968|Relapsed DLBCL|relapsed dlbcl
246447|NCT02658955|Abdominal wall closure|abdominal wall closure
246448|NCT02658942|renal stones|renal stones
246449|NCT02658942|lower calyx|lower calyx
246450|NCT02658942|Ureteroscopy|ureteroscopy
246451|NCT02658942|Shockwave lithotripsy|shockwave lithotripsy
246452|NCT02658942|Holmium laser|holmium laser
246453|NCT02658942|Adult|adult
246454|NCT02658942|Kidney|kidney
246455|NCT02658929|Multiple Myeloma|multiple myeloma
246456|NCT02658929|Efficacy and Safety|efficacy and safety
246457|NCT02658929|bb2121|bb2121
246458|NCT02658929|CAR T Cell|car t cell
246459|NCT02658929|BCMA|bcma
246460|NCT02658903|Foley|foley
246461|NCT02658903|Infection|infection
246462|NCT02658903|Hospital acquired|hospital acquired
246463|NCT02658903|catheter associated|catheter associated
246464|NCT02658903|urinary|urinary
246465|NCT02658877|Xolair|xolair
246466|NCT02658877|corticosteroids|corticosteroids
246467|NCT02658877|asthma|asthma
246468|NCT02658877|long-acting beta-agonists|long-acting beta-agonists
246469|NCT02658864|lafutidine tablet|lafutidine tablet
246470|NCT02658864|pharmacokinetics|pharmacokinetics
246471|NCT02658864|food|food
246472|NCT02658864|safety|safety
246473|NCT02658864|healthy subjects|healthy subjects
246474|NCT02658851|lymphocele|lymphocele
246475|NCT02658851|pelvic lymph node dissection|pelvic lymph node dissection
246476|NCT02658851|robotic assisted radical prostatectomy|robotic assisted radical prostatectomy
246477|NCT02658851|PLND|plnd
246478|NCT02658851|RARP|rarp
246479|NCT02658851|prostatectomy|prostatectomy
246480|NCT02658851|Patel|patel
246481|NCT02658825|Healthy|healthy
246482|NCT02658825|JNJ-63623872|jnj-63623872
246483|NCT02658825|Moxifloxacin|moxifloxacin
246484|NCT02658799|periodontitis|periodontitis
246485|NCT02658799|anti-inflammatory agents|anti-inflammatory agents
246486|NCT02658760|Femoral Fractures|femoral fractures
246487|NCT02658721|Systemic Tramadol|systemic tramadol
246488|NCT02658721|Adjunct Tramadol|adjunct tramadol
246489|NCT02658721|Lidocain|lidocain
246490|NCT02658695|ICSI|icsi
246491|NCT02658695|embryo transfer|embryo transfer
246492|NCT02658695|air bubbles depth|air bubbles depth
246493|NCT02658669|Insomnia|insomnia
246494|NCT02658669|Injury, Brain, Traumatic Mild|injury, brain, traumatic mild
246495|NCT02658656|Exoskeleton|exoskeleton
246496|NCT02658643|biliodigestive anastomosis techniques|biliodigestive anastomosis techniques
246497|NCT02658630|arm rehabilitation|arm rehabilitation
246498|NCT02658630|recovery of function|recovery of function
246499|NCT02658617|Empathy|empathy
246500|NCT02658617|Interoceptive Awareness|interoceptive awareness
246501|NCT02658617|fMRI|fmri
246502|NCT02658617|MRS|mrs
246503|NCT02658591|Food intake|food intake
246504|NCT02658591|Satiety|satiety
246505|NCT02658591|Appetite|appetite
246506|NCT02658591|Glycemia|glycemia
246507|NCT02658591|Faba bean|faba bean
246508|NCT02658591|Protein|protein
246509|NCT02658591|Snack|snack
246510|NCT02658565|Intraoperative Consultation|intraoperative consultation
246511|NCT02658552|HIFU|hifu
246512|NCT02658552|Benign thyroid nodule|benign thyroid nodule
246513|NCT02658552|Low risk|low risk
246514|NCT02658552|New treatment|new treatment
246515|NCT02658539|Body fat distribution|body fat distribution
246516|NCT02658539|Bone mineral density|bone mineral density
246517|NCT02658539|Dual-energy x-ray absorptiometry|dual-energy x-ray absorptiometry
246518|NCT02658526|cognition|cognition
246519|NCT02658526|anesthesia|anesthesia
246520|NCT02658526|surgery|surgery
246521|NCT02658526|stress|stress
246522|NCT02658526|child|child
246523|NCT02658500|early infant feeding|early infant feeding
246524|NCT02658500|infant intestinal flora|infant intestinal flora
246525|NCT02658500|infant health|infant health
246526|NCT02658474|Chronic pain|chronic pain
246527|NCT02658474|Acceptance and Commitment Therapy|acceptance and commitment therapy
246528|NCT02658474|Multidisciplinary treatment|multidisciplinary treatment
246529|NCT02658474|Group treatment|group treatment
246530|NCT02658435|Malaria|malaria
246531|NCT02658435|Retinal|retinal
246532|NCT02658435|Ophthalmic|ophthalmic
246533|NCT02658435|Plasmodium. vivax|plasmodium. vivax
246534|NCT02658435|Tafenoquine|tafenoquine
246535|NCT02658435|Pharmacodynamic|pharmacodynamic
246536|NCT02658409|CCIV|cciv
246537|NCT02658409|quadrivalent cell-culture based influenza vaccine|quadrivalent cell-culture based influenza vaccine
246538|NCT02658409|Influenza vaccine|influenza vaccine
246539|NCT02658409|Vaccination|vaccination
246540|NCT02658396|Multiple Myeloma|multiple myeloma
246541|NCT02658396|Relapsed Multiple Myeloma|relapsed multiple myeloma
246542|NCT02658396|Refractory Multiple Myeloma|refractory multiple myeloma
246543|NCT02658370|physical exercises|physical exercises
246643|NCT02657915|FF-VEP|ff-vep
246544|NCT02658370|physical therapy|physical therapy
246545|NCT02658370|Wii game console|wii game console
246546|NCT02658370|patients perspective|patients perspective
246547|NCT02658344|Stem cell|stem cell
246548|NCT02658344|adipose tissue derived mesenchymal stem cell|adipose tissue derived mesenchymal stem cell
246549|NCT02658344|osteoarthritis|osteoarthritis
246550|NCT02658344|degenerative arthritis|degenerative arthritis
246551|NCT02658344|biostar|biostar
246552|NCT02658344|Rbio|rbio
246553|NCT02658331|Ebola Virus Disease|ebola virus disease
246554|NCT02658331|Rapid Diagnosis|rapid diagnosis
246555|NCT02658331|Point of care|point of care
246556|NCT02658331|Molecular platform|molecular platform
246557|NCT02658318|peri- and postoperative complications|peri- and postoperative complications
246558|NCT02658318|airway obstruction|airway obstruction
246559|NCT02658318|adapted Furlow palatoplasty|adapted furlow palatoplasty
246560|NCT02658305|transoral approach|transoral approach
246561|NCT02658305|transbuccal approach|transbuccal approach
246562|NCT02658305|postoperative complications|postoperative complications
246563|NCT02658292|fungus|fungus
246564|NCT02658292|antifungal|antifungal
246565|NCT02658292|skin infection|skin infection
246566|NCT02658292|hair infection|hair infection
246567|NCT02658292|dermatophyte|dermatophyte
246568|NCT02658292|scalp|scalp
246569|NCT02658292|skin|skin
246570|NCT02658292|eyebrows|eyebrows
246571|NCT02658292|eyelashes|eyelashes
246572|NCT02658292|hair|hair
246573|NCT02658292|Trichophyton|trichophyton
246574|NCT02658292|Microsporum|microsporum
246575|NCT02658292|Endothrix|endothrix
246576|NCT02658292|spores|spores
246577|NCT02658279|Pembrolizumab (MK-3475)|pembrolizumab (mk-3475)
246578|NCT02658279|15-227|15-227
246579|NCT02658279|Hypermutator Phenotype|hypermutator phenotype
246580|NCT02658266|resistance training|resistance training
246581|NCT02658266|adult|adult
246582|NCT02658266|muscle strength|muscle strength
246583|NCT02658266|muscle endurance|muscle endurance
246584|NCT02658266|muscle metabolism|muscle metabolism
246585|NCT02658253|Placental malaria vaccine|placental malaria vaccine
246586|NCT02658253|Plasmodium|plasmodium
246587|NCT02658253|PRIMALVAC|primalvac
246588|NCT02658240|Nerve block|nerve block
246589|NCT02658240|Periarticular infiltration|periarticular infiltration
246590|NCT02658240|Ropivacaine|ropivacaine
246591|NCT02658240|Pain|pain
246592|NCT02658214|durvalumab, tremelimumab, metastatic, solid tumors, immuno-oncology, first-line chemotherapy, esophageal, pancreatic|durvalumab, tremelimumab, metastatic, solid tumors, immuno-oncology, first-line chemotherapy, esophageal, pancreatic
246593|NCT02658188|Restless legs syndrome patients|restless legs syndrome patients
246594|NCT02658188|ASP8825|asp8825
246595|NCT02658188|XP13512|xp13512
246596|NCT02658110|Postprandial glycemia|postprandial glycemia
246597|NCT02658110|Metabolic health measures|metabolic health measures
246598|NCT02658097|Lung Cancer|lung cancer
246599|NCT02658097|pembrolizumab|pembrolizumab
246600|NCT02658097|focal radiation|focal radiation
246601|NCT02658097|RT|rt
246602|NCT02658084|HER2-Positive|her2-positive
246603|NCT02658084|Metastatic Breast Cancer|metastatic breast cancer
246604|NCT02658071|exfoliative glaucoma|exfoliative glaucoma
246605|NCT02658071|cataract|cataract
246606|NCT02658071|ocular pressure|ocular pressure
246607|NCT02658058|Ultrasound|ultrasound
246608|NCT02658058|Spinal anesthesia|spinal anesthesia
246609|NCT02658058|Elderly|elderly
246610|NCT02658058|Landmark|landmark
246611|NCT02658045|oxygen saturation|oxygen saturation
246612|NCT02658045|monitoring|monitoring
246613|NCT02658045|oximeter|oximeter
246614|NCT02658019|Hepatocellular Carcinoma|hepatocellular carcinoma
246615|NCT02658019|Advanced Hepatocellular Carcinoma|advanced hepatocellular carcinoma
246616|NCT02658019|Unresectable Hepatocellular Carcinoma|unresectable hepatocellular carcinoma
246617|NCT02658006|Near Infrared Spectroscopy|near infrared spectroscopy
246618|NCT02658006|Ultrasonography|ultrasonography
246619|NCT02658006|Hepatic vein Doppler|hepatic vein doppler
246620|NCT02658006|Portal vein Doppler|portal vein doppler
246621|NCT02658006|Lung ultrasound|lung ultrasound
246622|NCT02658006|Positive fluid balance|positive fluid balance
246623|NCT02658006|Mixed venous saturation|mixed venous saturation
246624|NCT02657993|Breast Neoplasms|breast neoplasms
246625|NCT02657993|Aromatase Inhibitors|aromatase inhibitors
246626|NCT02657993|Musculoskeletal Pain|musculoskeletal pain
246627|NCT02657993|Hypnosis|hypnosis
246628|NCT02657993|Medication Adherence|medication adherence
246629|NCT02657993|Cost-Benefit Analysis|cost-benefit analysis
246630|NCT02657993|Treatment Outcomes|treatment outcomes
246631|NCT02657980|Major Depressive Disorder|major depressive disorder
246632|NCT02657980|tDCS|tdcs
246633|NCT02657980|MDD|mdd
246634|NCT02657980|transcranial Direct Current Stimulation|transcranial direct current stimulation
246635|NCT02657954|Homeless persons|homeless persons
246636|NCT02657954|Veterans|veterans
246637|NCT02657954|Mental disorders|mental disorders
246638|NCT02657954|Cognition|cognition
246639|NCT02657954|Rehabilitation|rehabilitation
246640|NCT02657941|Schizophrenia|schizophrenia
246641|NCT02657941|Obesity|obesity
246642|NCT02657941|Metabolic Syndrome|metabolic syndrome
246644|NCT02657915|mfVEP|mfvep
246645|NCT02657915|Human anti-LINGO-1|human anti-lingo-1
246646|NCT02657915|BIIB033|biib033
246647|NCT02657915|AON|aon
246648|NCT02657889|PARP inhibitor|parp inhibitor
246649|NCT02657889|PD-1|pd-1
246650|NCT02657889|Niraparib|niraparib
246651|NCT02657889|Pembrolizumab|pembrolizumab
246652|NCT02657889|Keynote|keynote
246653|NCT02657889|TOPACIO|topacio
246654|NCT02657837|CF|cf
246655|NCT02657837|Multiple Breath Washout|multiple breath washout
246656|NCT02657837|Lung Clearance Index|lung clearance index
246657|NCT02657837|Pediatrics|pediatrics
246658|NCT02657824|Ejection fraction|ejection fraction
246659|NCT02657824|mitral valve|mitral valve
246660|NCT02657824|e-point septal separation|e-point septal separation
246661|NCT02657811|Time-Lapse Imaging|time-lapse imaging
246662|NCT02657811|Embryo Culture Techniques|embryo culture techniques
246663|NCT02657811|Fertilization in Vitro|fertilization in vitro
246664|NCT02657811|Embryology|embryology
246665|NCT02657811|Assisted Reproductive Techniques|assisted reproductive techniques
246666|NCT02657811|Infertility|infertility
246667|NCT02657811|Preimplantation diagnosis|preimplantation diagnosis
246668|NCT02657772|Target Ultra coils|target ultra coils
246669|NCT02657772|small aneurysms|small aneurysms
246670|NCT02657746|blood pressure monitoring|blood pressure monitoring
246671|NCT02657746|high blood pressure|high blood pressure
246672|NCT02657746|cardiovascular disease|cardiovascular disease
246673|NCT02657746|Antihypertensive agents|antihypertensive agents
246674|NCT02657746|Non-pharmacological treatment|non-pharmacological treatment
246675|NCT02657746|community health care workers|community health care workers
246676|NCT02657746|cost-effectiveness|cost-effectiveness
246677|NCT02657733|Respiratory Conditions for Adults|respiratory conditions for adults
246678|NCT02657720|Respiratory Conditions for Adults|respiratory conditions for adults
246679|NCT02657707|stent|stent
246680|NCT02657707|stenosis|stenosis
246681|NCT02657707|artery|artery
246682|NCT02657707|carotid|carotid
246683|NCT02657668|Irritable Bowel Syndrome|irritable bowel syndrome
246684|NCT02657668|Emotion Focused Therapy|emotion focused therapy
246685|NCT02657668|Stress|stress
246686|NCT02657668|Resilience|resilience
246687|NCT02657668|Coping Strategies|coping strategies
246688|NCT02657655|Parkinson's Disease|parkinson's disease
246689|NCT02657655|Dyskinesia|dyskinesia
246690|NCT02657655|Tremor|tremor
246691|NCT02657655|Symptom Management|symptom management
246692|NCT02657655|Technology|technology
246693|NCT02657655|Wearable Sensors|wearable sensors
246694|NCT02657655|Continuous Monitoring|continuous monitoring
246695|NCT02657655|Mobility|mobility
246696|NCT02657642|drug related problems, elderly|drug related problems, elderly
246697|NCT02657603|Peripheral Nerve Blocks|peripheral nerve blocks
246698|NCT02657577|Women|women
246699|NCT02657577|Infants and Children|infants and children
246700|NCT02657551|Thyroid Cancer|thyroid cancer
246701|NCT02657538|Interproximal caries|interproximal caries
246702|NCT02657538|Enamel caries|enamel caries
246703|NCT02657538|Caries detection|caries detection
246704|NCT02657538|Caries diagnostics|caries diagnostics
246705|NCT02657538|Near-infrared light transillumination|near-infrared light transillumination
246706|NCT02657538|DIAGNOcam|diagnocam
246707|NCT02657512|Rivaroxaban, pharmacokinetics, activated charcoal, poisoning|rivaroxaban, pharmacokinetics, activated charcoal, poisoning
246708|NCT02657499|healthcare access|healthcare access
246709|NCT02657499|utilization|utilization
246710|NCT02657499|expenditures|expenditures
246711|NCT02657499|preventive services|preventive services
246712|NCT02657486|BGJ398|bgj398
246713|NCT02657486|15-090|15-090
246714|NCT02657460|chemotherapy|chemotherapy
246715|NCT02657460|microparticle|microparticle
246716|NCT02657460|malignant pleural effusion|malignant pleural effusion
246717|NCT02657447|Radioimmunotherapy|radioimmunotherapy
246718|NCT02657447|Lu-177|lu-177
246719|NCT02657447|Phase I study|phase i study
246720|NCT02657447|Betalutin|betalutin
246722|NCT02657447|Antibody Radionuclide Conjugate|antibody radionuclide conjugate
246723|NCT02657447|HH1|hh1
246724|NCT02657447|Rituximab|rituximab
246725|NCT02657447|177Lu-DOTA-HH1|177lu-dota-hh1
246726|NCT02657447|Lymphoma|lymphoma
246727|NCT02657447|Lymphoma Non-Hodgkin|lymphoma non-hodgkin
246728|NCT02657447|Immune System Diseases|immune system diseases
246729|NCT02657447|Follicular Lymphoma|follicular lymphoma
246730|NCT02657447|Marginal Zone Lymphoma|marginal zone lymphoma
246731|NCT02657447|Lymphoplasmacytoid|lymphoplasmacytoid
246732|NCT02657447|Lymphatic Diseases|lymphatic diseases
246733|NCT02657447|Lymphoproliferative Disorders|lymphoproliferative disorders
246734|NCT02657447|Neoplasms|neoplasms
246735|NCT02657447|Neoplasms by Histological Type|neoplasms by histological type
246736|NCT02657447|Small Lymphocytic Lymphoma|small lymphocytic lymphoma
246737|NCT02657447|Classical Mantle Cell Lymphoma|classical mantle cell lymphoma
246738|NCT02657447|Lilotomab|lilotomab
246739|NCT02657447|Lutetium (177Lu) lilotomab satetraxetan|lutetium (177lu) lilotomab satetraxetan
246740|NCT02657382|Biofeedback|biofeedback
246741|NCT02657382|Myocardial Imaging|myocardial imaging
246742|NCT02657369|Lenvatinib|lenvatinib
246849|NCT02656771|Hip|hip
246743|NCT02657369|Thyroid Cancer, Anaplastic|thyroid cancer, anaplastic
246744|NCT02657369|Lenvima|lenvima
246745|NCT02657369|E7080|e7080
246746|NCT02657356|Pulmonary Hypertension|pulmonary hypertension
246747|NCT02657356|Pulmonary Arterial Hypertension|pulmonary arterial hypertension
246748|NCT02657356|Connective Tissue Disease-Associated Pulmonary Arterial Hypertension|connective tissue disease-associated pulmonary arterial hypertension
246749|NCT02657356|Bardoxolone methyl|bardoxolone methyl
246750|NCT02657356|PAH|pah
246751|NCT02657356|RTA 402|rta 402
246752|NCT02657356|6-minute walk distance|6-minute walk distance
246753|NCT02657343|Breast Cancer With Positive HER2|breast cancer with positive her2
246754|NCT02657330|Locally Advanced|locally advanced
246755|NCT02657330|Metastatic|metastatic
246756|NCT02657317|chronic pain|chronic pain
246757|NCT02657317|pain management|pain management
246758|NCT02657317|trauma|trauma
246759|NCT02657317|ptsd|ptsd
246760|NCT02657317|tbi|tbi
246761|NCT02657317|opioid medication|opioid medication
246762|NCT02657304|Sleep Apnea|sleep apnea
246763|NCT02657304|CPAP|cpap
246764|NCT02657278|Peripheral arterial disease,|peripheral arterial disease,
246765|NCT02657278|Cardipulmonary Exercise Test|cardipulmonary exercise test
246766|NCT02657252|telangiectasis|telangiectasis
246767|NCT02657252|varicose veins|varicose veins
246768|NCT02657252|veins|veins
246769|NCT02657252|glucose|glucose
246770|NCT02657252|sclerotherapy|sclerotherapy
246771|NCT02657239|Physical Function|physical function
246772|NCT02657213|Diabetes, Type 1|diabetes, type 1
246773|NCT02657213|Hypoglycemia|hypoglycemia
246774|NCT02657213|Insulin Infusion Systems|insulin infusion systems
246775|NCT02657200|miscarriage|miscarriage
246776|NCT02657200|Flanders|flanders
246777|NCT02657200|spontaneous abortion|spontaneous abortion
246778|NCT02657200|KAP|kap
246779|NCT02657200|midwives|midwives
246780|NCT02657174|third molar|third molar
246781|NCT02657174|auriculotherapy|auriculotherapy
246782|NCT02657174|inflammation|inflammation
246783|NCT02657174|pain|pain
246784|NCT02657122|Single ascending dose|single ascending dose
246785|NCT02657122|SAD|sad
246786|NCT02657122|multiple ascending dose|multiple ascending dose
246787|NCT02657122|MAD|mad
246788|NCT02657122|Phase 1|phase 1
246789|NCT02657122|first-in-human|first-in-human
246790|NCT02657122|volunteers|volunteers
246791|NCT02657122|TD-1473|td-1473
246792|NCT02657109|valve replacement|valve replacement
246793|NCT02657109|physical therapy|physical therapy
246794|NCT02657109|early mobilization|early mobilization
246795|NCT02657096|Chronic Periodontitis|chronic periodontitis
246796|NCT02657096|Hybenx|hybenx
246797|NCT02657096|Desiccant agent|desiccant agent
246798|NCT02657096|Healing|healing
246799|NCT02657096|Microbiology|microbiology
246800|NCT02657096|Periodontal Diseases|periodontal diseases
246801|NCT02657096|Periodontitis|periodontitis
246802|NCT02657096|Split-mouth clinical Study|split-mouth clinical study
246803|NCT02657070|Stroke|stroke
246804|NCT02657070|learned non-use|learned non-use
246805|NCT02657070|Virtual Reality|virtual reality
246806|NCT02657070|Hemiparesis|hemiparesis
246807|NCT02657057|neuromodulation|neuromodulation
246808|NCT02657057|electrical estimulation|electrical estimulation
246809|NCT02657057|percutaneous|percutaneous
246810|NCT02657057|transcutaneous|transcutaneous
246811|NCT02657057|OAB|oab
246812|NCT02657044|EMR|emr
246813|NCT02657044|ESD|esd
246814|NCT02657044|endoscopic mucosal resection|endoscopic mucosal resection
246815|NCT02657044|endoscopic submucosal resection|endoscopic submucosal resection
246816|NCT02657044|colorectal adenomas|colorectal adenomas
246817|NCT02657031|Headache, Migraine|headache, migraine
246818|NCT02656992|Bronchiectasis|bronchiectasis
246819|NCT02656992|High-intensity inspiratory muscle training|high-intensity inspiratory muscle training
246820|NCT02656979|Glaucoma|glaucoma
246821|NCT02656979|Blood flow|blood flow
246822|NCT02656979|Pseudoexfoliation|pseudoexfoliation
246823|NCT02656979|Intraocular pressure|intraocular pressure
246824|NCT02656979|Brain perfusion|brain perfusion
246825|NCT02656979|Magnetic Resonance Imaging|magnetic resonance imaging
246826|NCT02656953|VDU workers|vdu workers
246827|NCT02656953|VDU lenses|vdu lenses
246828|NCT02656953|Neck complaints|neck complaints
246829|NCT02656953|Visual complaints|visual complaints
246830|NCT02656940|obesity|obesity
246831|NCT02656940|lipids|lipids
246832|NCT02656940|energy expenditure|energy expenditure
246833|NCT02656940|gene expression|gene expression
246834|NCT02656927|Spinal Cord Injury|spinal cord injury
246835|NCT02656927|Yoga|yoga
246836|NCT02656927|Psychological Flexibility|psychological flexibility
246837|NCT02656927|Mindfulness|mindfulness
246838|NCT02656927|Pain|pain
246839|NCT02656849|Solid Tumor|solid tumor
246840|NCT02656823|ANKYLOS|ankylos
246841|NCT02656823|Simplant|simplant
246842|NCT02656823|maxilla|maxilla
246843|NCT02656823|edentulous|edentulous
246844|NCT02656823|short implants|short implants
246845|NCT02656797|Leishmania major|leishmania major
246846|NCT02656797|Leishmania tropica|leishmania tropica
246847|NCT02656797|Amphotericin B|amphotericin b
246848|NCT02656771|THA|tha
246850|NCT02656771|arthroplasties|arthroplasties
246851|NCT02656745|Smoking|smoking
246852|NCT02656745|Cigarette Smoking|cigarette smoking
246853|NCT02656745|Tobacco Smoking|tobacco smoking
246854|NCT02656745|Nicotine|nicotine
246855|NCT02656745|Drug|drug
246856|NCT02656745|Addiction|addiction
246857|NCT02656745|Tobacco|tobacco
246858|NCT02656719|tracheostomy|tracheostomy
246859|NCT02656719|complications|complications
246860|NCT02656719|ultrasound|ultrasound
246861|NCT02656719|bronchoscopy|bronchoscopy
246862|NCT02656706|Adjuvant melanoma|adjuvant melanoma
246863|NCT02656706|Advanced melanoma|advanced melanoma
246864|NCT02656693|Weight Reduction Programs|weight reduction programs
246865|NCT02656693|Weight Loss Programs|weight loss programs
246866|NCT02656693|Obesity|obesity
246867|NCT02656667|COPD pulmonary rehabilitation|copd pulmonary rehabilitation
246868|NCT02656667|neuromuscular electrical stimulation|neuromuscular electrical stimulation
246869|NCT02656667|sit to stand test COPD|sit to stand test copd
246870|NCT02656667|quadriceps strengthening|quadriceps strengthening
246871|NCT02656602|Computer Assisted Instruction|computer assisted instruction
246872|NCT02656602|Patient Counselling|patient counselling
246873|NCT02656602|Endoscopy|endoscopy
246874|NCT02656589|breast cancer|breast cancer
246875|NCT02656589|herceptin|herceptin
246876|NCT02656589|microRNA|microrna
246877|NCT02656576|Human Papillomavirus|human papillomavirus
246878|NCT02656576|oropharynx biopsy|oropharynx biopsy
246879|NCT02656576|tonsillar lesion|tonsillar lesion
246880|NCT02656550|Uterine Transplant|uterine transplant
246882|NCT02656550|Rokitansky Syndrome|rokitansky syndrome
246883|NCT02656524|Metastatic colorectal cancer|metastatic colorectal cancer
246884|NCT02656511|immediate antiretroviral therapy|immediate antiretroviral therapy
246885|NCT02656511|hyperacute infection|hyperacute infection
246886|NCT02656498|Tau, neurodegeneration, positron emission computed tomography|tau, neurodegeneration, positron emission computed tomography
246887|NCT02656472|Pediatric Cardiac surgery|pediatric cardiac surgery
246888|NCT02656472|Inflammatory response|inflammatory response
246889|NCT02656472|Tranexamic acid|tranexamic acid
246890|NCT02656472|Epsilon Aminocaproic Acid|epsilon aminocaproic acid
246891|NCT02656459|gene expression|gene expression
246892|NCT02656446|Neuraxial|neuraxial
246893|NCT02656446|Ultrasound|ultrasound
246894|NCT02656433|QEEG|qeeg
246895|NCT02656433|ERP|erp
246896|NCT02656433|tRNS|trns
246897|NCT02656433|Brain injury|brain injury
246898|NCT02656433|Motor Impairment|motor impairment
246899|NCT02656433|Transcranial Brain non-invasive stimulation|transcranial brain non-invasive stimulation
246900|NCT02656433|electroencephalogram|electroencephalogram
246901|NCT02656407|Functional Ultrasound|functional ultrasound
246902|NCT02656407|Intraoperative|intraoperative
246903|NCT02656407|Brain|brain
246904|NCT02656407|Doppler|doppler
246905|NCT02656407|Ultrasound|ultrasound
246906|NCT02656394|ocular surface disease|ocular surface disease
246907|NCT02656394|glaucoma medications|glaucoma medications
246908|NCT02656381|Sarcoidosis|sarcoidosis
246909|NCT02656381|Behcet's Disease|behcet's disease
246910|NCT02656381|Natural History Study|natural history study
246911|NCT02656381|Biological Specimens|biological specimens
246912|NCT02656381|Immune System|immune system
246913|NCT02656355|Gait Initiation|gait initiation
246914|NCT02656355|Freezing of gait|freezing of gait
246915|NCT02656355|Balance training|balance training
246916|NCT02656355|Anticipatory postural adjustments|anticipatory postural adjustments
246917|NCT02656342|OCD|ocd
246918|NCT02656329|Heart Failure (HF)|heart failure (hf)
246919|NCT02656329|Single photon emission computer tomography scan (SPECT)|single photon emission computer tomography scan (spect)
712526|NCT00579839|Premature Baby|premature baby
246920|NCT02656329|Implantable cardioverter defibrillator (ICD)|implantable cardioverter defibrillator (icd)
246921|NCT02656329|Left Ventricular ejection fraction (LVEF)|left ventricular ejection fraction (lvef)
246922|NCT02656329|New York Health Association (NYHA)|new york health association (nyha)
246923|NCT02656329|Metaiodobenzylguanidine (mIBG)|metaiodobenzylguanidine (mibg)
246924|NCT02656329|123I-iobenguane|123i-iobenguane
246925|NCT02656329|Heart-to-mediastinal ratio (H/M)|heart-to-mediastinal ratio (h/m)
246926|NCT02656329|ADMIRE-ICD (AdreView Myocardial Imaging for Risk Evaluation - Implantable Cardioverter Defibrillator|admire-icd (adreview myocardial imaging for risk evaluation - implantable cardioverter defibrillator
246927|NCT02656329|All-cause mortality|all-cause mortality
246928|NCT02656329|Cardiac mortality|cardiac mortality
246929|NCT02656251|biofilms|biofilms
246930|NCT02656251|cross over trial|cross over trial
246931|NCT02656251|chlorhexidine|chlorhexidine
246932|NCT02656238|CTEPH|cteph
246933|NCT02656238|Balloon pulmonary angioplasty|balloon pulmonary angioplasty
246934|NCT02656238|Chronic thromboembolic pulmonary hypertension|chronic thromboembolic pulmonary hypertension
246935|NCT02656238|Pulmonary endarterectomy|pulmonary endarterectomy
246936|NCT02656238|BPA|bpa
246937|NCT02656238|PEA|pea
246938|NCT02656225|postpartum anemia|postpartum anemia
246939|NCT02656225|hemoglobin|hemoglobin
246940|NCT02656225|iron metabolism|iron metabolism
246941|NCT02656225|Traditional Chinese Medicine|traditional chinese medicine
246942|NCT02656225|Ejiao|ejiao
246943|NCT02656212|epicatechin|epicatechin
246944|NCT02656212|pre-diabetes|pre-diabetes
246945|NCT02656199|Diaphragm|diaphragm
246946|NCT02656199|Ventilators, Mechanical|ventilators, mechanical
246947|NCT02656173|Tamsulosin|tamsulosin
246948|NCT02656173|Overactive bladder|overactive bladder
246949|NCT02656173|Benign prostatic hypertrophy|benign prostatic hypertrophy
246950|NCT02656173|Mirabegron|mirabegron
246951|NCT02656147|Leukemia|leukemia
246952|NCT02656147|Lymphoma|lymphoma
246953|NCT02656147|CAR γδT|car γδt
246954|NCT02656134|Familial Adenomatous Polyposis|familial adenomatous polyposis
246955|NCT02656121|PCOS, vitamin D|pcos, vitamin d
246956|NCT02656082|Discoid lupus erythematosus|discoid lupus erythematosus
246957|NCT02656082|Intradermal injection of etanercept|intradermal injection of etanercept
246958|NCT02656017|kidney disease|kidney disease
246959|NCT02656017|polycystic kidney disease|polycystic kidney disease
246960|NCT02656017|autosomal dominant kidney disease|autosomal dominant kidney disease
246961|NCT02656017|kidney cysts|kidney cysts
246962|NCT02656017|PKD|pkd
246963|NCT02656004|Eucalyptus|eucalyptus
246964|NCT02656004|Autonomic nervous system|autonomic nervous system
246965|NCT02656004|Isometric resistance exercise|isometric resistance exercise
246966|NCT02655991|Stress Disorders, Post-Traumatic|stress disorders, post-traumatic
246967|NCT02655991|Ambulatory Care|ambulatory care
246968|NCT02655991|Telemedicine|telemedicine
246969|NCT02655991|Remote Consultation|remote consultation
246970|NCT02655991|Health Services Accessibility|health services accessibility
246971|NCT02655965|Breast cancer|breast cancer
246972|NCT02655965|lumpectomy|lumpectomy
246973|NCT02655965|mastectomy|mastectomy
246974|NCT02655965|PECS bloc|pecs bloc
246975|NCT02655939|Gonarthrosis|gonarthrosis
246976|NCT02655926|OCD|ocd
246977|NCT02655926|DBS|dbs
246978|NCT02655926|Deep Brain Stimulation|deep brain stimulation
246979|NCT02655913|Sodium ascorbate|sodium ascorbate
246980|NCT02655913|Non-Small-Cell Lung cancer|non-small-cell lung cancer
246981|NCT02655913|Oncothermia|oncothermia
246982|NCT02655913|Immune function|immune function
246983|NCT02655913|Life quality|life quality
246984|NCT02655913|Tumor marker|tumor marker
246985|NCT02655913|Survival time|survival time
246986|NCT02655900|Obstetric anal sphincter injury,|obstetric anal sphincter injury,
246987|NCT02655900|Ultrasound diagnosis|ultrasound diagnosis
246988|NCT02655887|Vernacular|vernacular
246989|NCT02655887|Iliofemoral Occlusive Disease|iliofemoral occlusive disease
246990|NCT02655874|Seasonal Influenza|seasonal influenza
246991|NCT02655874|Antibody response|antibody response
246992|NCT02655874|Influenza Vaccines|influenza vaccines
246993|NCT02655874|Hemagglutination Inhibition|hemagglutination inhibition
246994|NCT02655874|Elderly|elderly
246995|NCT02655874|immunosenescence|immunosenescence
246996|NCT02655874|Tropics|tropics
246997|NCT02655848|Popeye|popeye
246998|NCT02655848|Long Head Biceps Tendon|long head biceps tendon
246999|NCT02655848|Arthroscopy|arthroscopy
247000|NCT02655848|Functional result|functional result
247001|NCT02655835|mindfulness|mindfulness
247002|NCT02655835|meditation|meditation
247003|NCT02655835|internet|internet
247004|NCT02655822|NSCLC|nsclc
247005|NCT02655822|MEL|mel
247006|NCT02655822|RCC|rcc
247007|NCT02655822|TNBC|tnbc
247008|NCT02655822|Triple Negative Breast Neoplasms|triple negative breast neoplasms
247009|NCT02655822|Neoplasms|neoplasms
247010|NCT02655822|CRC|crc
247011|NCT02655822|Lung Cancer|lung cancer
247012|NCT02655822|Kidney Cancer|kidney cancer
247013|NCT02655822|Colon Cancer|colon cancer
247014|NCT02655822|Rectal Cancer|rectal cancer
247015|NCT02655822|Skin Cancer|skin cancer
247016|NCT02655822|Breast Cancer|breast cancer
247017|NCT02655822|mCRPC|mcrpc
247018|NCT02655822|Prostate Cancer|prostate cancer
247019|NCT02655796|Accidental Falls|accidental falls
247020|NCT02655796|Risk Assessment|risk assessment
247021|NCT02655796|Frail Elderly|frail elderly
247022|NCT02655783|induction of labor|induction of labor
247023|NCT02655744|Neurobehavioral Assessment|neurobehavioral assessment
247024|NCT02655744|Radiotherapy (RT)|radiotherapy (rt)
247025|NCT02655744|Chemotherapy|chemotherapy
247026|NCT02655744|Neurotoxicity|neurotoxicity
247027|NCT02655718|ACS|acs
247028|NCT02655718|Non obstructive coronary atherosclerosis|non obstructive coronary atherosclerosis
247029|NCT02655705|Cyclosporine|cyclosporine
247030|NCT02655705|Methotrexate|methotrexate
247031|NCT02655692|PTSD|ptsd
247032|NCT02655692|Ketamine|ketamine
247033|NCT02655692|Veteran|veteran
247034|NCT02655692|Military|military
247035|NCT02655692|Clinical Trial|clinical trial
247036|NCT02655679|Eczema|eczema
247037|NCT02655640|illness perceptions|illness perceptions
247038|NCT02655627|Type 2 DM|type 2 dm
247039|NCT02655627|internet based exercise training|internet based exercise training
247040|NCT02655627|group exercise training|group exercise training
247041|NCT02655627|glycemic control|glycemic control
247042|NCT02655575|dizziness|dizziness
247043|NCT02655575|cognitive therapy|cognitive therapy
247044|NCT02655575|primary care|primary care
247045|NCT02655575|vestibular rehabilitation|vestibular rehabilitation
247046|NCT02655575|chronic|chronic
247047|NCT02655484|COPD|copd
247048|NCT02655484|noninvasive ventilation|noninvasive ventilation
247049|NCT02655484|exercise|exercise
247050|NCT02655484|CO2 rebreathing|co2 rebreathing
247051|NCT02655458|Multiple Myeloma|multiple myeloma
247052|NCT02655458|Induction Therapy|induction therapy
247053|NCT02655458|Autologous Stem Cell Transplant|autologous stem cell transplant
247054|NCT02655458|ASCT|asct
247055|NCT02655458|Auto-SCT|auto-sct
247056|NCT02655419|cIAIs in hospitalized adults|ciais in hospitalized adults
247057|NCT02655406|Foam sclerotherapy|foam sclerotherapy
247058|NCT02655406|Compression|compression
247060|NCT02655367|oats|oats
247061|NCT02655367|porridge|porridge
247062|NCT02655367|satiety|satiety
247063|NCT02655367|GI hormones|gi hormones
247064|NCT02655367|processing|processing
247065|NCT02655341|Dehydration|dehydration
247066|NCT02655341|Primary PCI|primary pci
247067|NCT02655341|Acute Myocardial Infarction|acute myocardial infarction
247068|NCT02655341|Bioimpedance|bioimpedance
247069|NCT02655341|Renal Angiography|renal angiography
247070|NCT02655328|asthma|asthma
247071|NCT02655328|athlete|athlete
247072|NCT02655315|Parkinson|parkinson
247073|NCT02655315|Deferiprone|deferiprone
247074|NCT02655315|Chelation|chelation
247075|NCT02655302|Interleukin-17|interleukin-17
247076|NCT02655302|Interleukin-22|interleukin-22
247077|NCT02655302|Microbiota|microbiota
247078|NCT02655302|Exacerbations|exacerbations
247079|NCT02655302|Immunity|immunity
247080|NCT02655302|Mucosal|mucosal
247081|NCT02655276|microencapsulated glycine|microencapsulated glycine
247082|NCT02655276|attentional performance|attentional performance
247083|NCT02655276|motoric activity|motoric activity
247084|NCT02655276|hyperactivity|hyperactivity
247085|NCT02655237|Drug Therapy|drug therapy
247086|NCT02655224|Drug Therapy|drug therapy
247087|NCT02655198|refractory childhood epilepsy|refractory childhood epilepsy
247088|NCT02655198|Lennox Gastaut syndrome|lennox gastaut syndrome
247089|NCT02655198|fenfluramine|fenfluramine
247090|NCT02655198|anti-epileptic treatment|anti-epileptic treatment
247091|NCT02655185|Lipids|lipids
247092|NCT02655185|Atrial Fibrillation|atrial fibrillation
247093|NCT02655185|Heart Failure|heart failure
247094|NCT02655172|Schizophrenia, affordance,|schizophrenia, affordance,
247095|NCT02655172|perception-action binding,|perception-action binding,
247096|NCT02655172|stimulus-response-compatibility|stimulus-response-compatibility
247097|NCT02655159|Breast Cancer|breast cancer
247098|NCT02655159|Metastatic breast cancer|metastatic breast cancer
247099|NCT02655159|nab-paclitaxel|nab-paclitaxel
247100|NCT02655159|Abraxane|abraxane
247101|NCT02655159|Observational|observational
247102|NCT02655159|Retrospective|retrospective
247103|NCT02655159|AMBER|amber
247104|NCT02655146|Frozen embryo transfer,luteal support, GnRHa|frozen embryo transfer,luteal support, gnrha
247105|NCT02655120|Femoral head necrosis|femoral head necrosis
247106|NCT02655120|Autologous Bone Marrow|autologous bone marrow
247107|NCT02655120|BMP7|bmp7
247108|NCT02655107|blood gas monitoring|blood gas monitoring
247109|NCT02655107|non-invasive|non-invasive
247110|NCT02655107|hemoglobin|hemoglobin
247111|NCT02655094|minimal-invasive surgery, mitral valve|minimal-invasive surgery, mitral valve
247112|NCT02655081|Urinary diversion|urinary diversion
247113|NCT02655081|Bladder Neoplasm|bladder neoplasm
247114|NCT02655081|Nutritional Supplement|nutritional supplement
247115|NCT02655081|Cystectomy|cystectomy
247116|NCT02655068|Head and Neck Cancer|head and neck cancer
247117|NCT02655068|Definitive Therapy|definitive therapy
247118|NCT02655068|Positron Emission Tomography - Computed Tomography (PET/CT)|positron emission tomography - computed tomography (pet/ct)
247119|NCT02655068|Computed Tomography (CT)|computed tomography (ct)
247120|NCT02655055|apheresis|apheresis
247121|NCT02655055|citrate anticoagulation|citrate anticoagulation
247122|NCT02655055|blood donor|blood donor
247123|NCT02655055|bone|bone
247124|NCT02655016|Ovarian Cancer|ovarian cancer
247125|NCT02655016|PARP Inhibitor|parp inhibitor
247126|NCT02655016|HRD|hrd
247127|NCT02655016|HRD positive|hrd positive
247128|NCT02655016|PRIMA|prima
247129|NCT02655016|PRIMA Clinical Trial|prima clinical trial
247130|NCT02655016|PRIMA Study|prima study
247131|NCT02655003|behavioral symptoms|behavioral symptoms
247132|NCT02655003|psychological symptoms|psychological symptoms
247133|NCT02655003|dementia|dementia
247134|NCT02655003|neuropsychiatric symptoms|neuropsychiatric symptoms
247135|NCT02654990|multiple myeloma|multiple myeloma
247136|NCT02654990|relapsed or relapsed/refractory|relapsed or relapsed/refractory
247137|NCT02654990|LBH589|lbh589
247138|NCT02654990|panobinostat|panobinostat
247139|NCT02654990|bortezomib|bortezomib
247140|NCT02654990|dexamethasone|dexamethasone
247141|NCT02654951|Stroke|stroke
247142|NCT02654951|Rehabilitation Robotics|rehabilitation robotics
247143|NCT02654951|Bimanual|bimanual
247144|NCT02654951|Compensatory movements|compensatory movements
247145|NCT02654951|Hemiplegia|hemiplegia
247146|NCT02654951|Kinematics|kinematics
247147|NCT02654951|Reaching|reaching
247148|NCT02654951|Trunk|trunk
247149|NCT02654938|prostate cancer|prostate cancer
247150|NCT02654938|adenovirus|adenovirus
247151|NCT02654938|TLR5|tlr5
247152|NCT02654938|immunotherapy|immunotherapy
247153|NCT02654912|malaria|malaria
247154|NCT02654912|elimination|elimination
247155|NCT02654912|surveillance and response|surveillance and response
247156|NCT02654912|dihydroartemisinin+piperaquine|dihydroartemisinin+piperaquine
247157|NCT02654899|Healthy subjects|healthy subjects
247158|NCT02654899|Single Ascending Dose|single ascending dose
247159|NCT02654899|Hyperlipidemia|hyperlipidemia
247160|NCT02654899|Dyslipidemia|dyslipidemia
247161|NCT02654886|exercise|exercise
247162|NCT02654886|Pompe disease|pompe disease
247163|NCT02654886|Pompe|pompe
247164|NCT02654873|histopathology|histopathology
247165|NCT02654873|gallbladder|gallbladder
247166|NCT02654873|specimen|specimen
247167|NCT02654847|vasopressor|vasopressor
247168|NCT02654847|blood pressure|blood pressure
247169|NCT02654847|Cesarean section|cesarean section
247170|NCT02654847|spinal anesthesia|spinal anesthesia
247171|NCT02654821|Melanoma|melanoma
247172|NCT02654821|TCR|tcr
247173|NCT02654808|Gynecology|gynecology
247174|NCT02654808|Laparoscopy|laparoscopy
247175|NCT02654808|Pneumoperitoneum|pneumoperitoneum
247176|NCT02654808|CO2 absorption|co2 absorption
247177|NCT02654782|Lactated Ringer's|lactated ringer's
247178|NCT02654782|Human Albumin|human albumin
247179|NCT02654756|Risk Assessment|risk assessment
247180|NCT02654704|Personalized Medicine|personalized medicine
247181|NCT02654704|Precision Medicine|precision medicine
247182|NCT02654691|Chemotherapy|chemotherapy
247183|NCT02654639|Metastatic Colorectal Cancer|metastatic colorectal cancer
247184|NCT02654639|Advanced Colorectal Cancer|advanced colorectal cancer
247185|NCT02654600|cardiac surgery|cardiac surgery
247186|NCT02654600|thoracopulmonary compliance|thoracopulmonary compliance
247187|NCT02654587|Non-Small-Cell Lung Cancer|non-small-cell lung cancer
247188|NCT02654587|NSCLC|nsclc
247189|NCT02654587|Immunotherapy|immunotherapy
247190|NCT02654587|Cancer vaccine|cancer vaccine
247191|NCT02654587|Metastasis|metastasis
247192|NCT02654574|Alzheimer's disease or related disorders|alzheimer's disease or related disorders
247193|NCT02654574|Functional autonomy level|functional autonomy level
247194|NCT02654574|Lawton Instrumental Activities of Daily Living|lawton instrumental activities of daily living
247195|NCT02654574|The Functional autonomy level|the functional autonomy level
247196|NCT02654561|Severe sepsis|severe sepsis
247197|NCT02654561|Disseminated intravascular coagulation|disseminated intravascular coagulation
247198|NCT02654561|Unfractionated heparin|unfractionated heparin
247199|NCT02654535|Systematic review and meta-analysis|systematic review and meta-analysis
247200|NCT02654535|Evidence-based medicine (EBM)|evidence-based medicine (ebm)
247201|NCT02654535|Evidence-based nutrition (EBN)|evidence-based nutrition (ebn)
247202|NCT02654535|Clinical practice guidelines|clinical practice guidelines
247203|NCT02654535|Clinical trials|clinical trials
247204|NCT02654535|Tree Nuts|tree nuts
247205|NCT02654535|Peanuts|peanuts
247206|NCT02654535|Body weight|body weight
247207|NCT02654535|Prospective cohort studies|prospective cohort studies
247208|NCT02654496|Gut Microbiota|gut microbiota
247209|NCT02654496|Weight Regain|weight regain
247210|NCT02654496|Gastric Bypass|gastric bypass
247211|NCT02654457|Immunohistochemical|immunohistochemical
247212|NCT02654457|Ki-67|ki-67
247213|NCT02654457|Breast cancer|breast cancer
247214|NCT02654457|IHC|ihc
247215|NCT02654444|Immunohistochemical (IHC)|immunohistochemical (ihc)
247216|NCT02654444|Her2/Neu|her2/neu
315980|NCT02255097|PD1|pd1
247217|NCT02654444|Breast cancer|breast cancer
247218|NCT02654431|Immunohistochemical (IHC)|immunohistochemical (ihc)
247219|NCT02654431|ER/PR|er/pr
247220|NCT02654431|Breast cancer|breast cancer
247221|NCT02654418|colonic polyps ≥20 mm,|colonic polyps ≥20 mm,
247222|NCT02654418|adenomas|adenomas
247223|NCT02654418|polyps|polyps
247224|NCT02654405|HDAC inhibitors|hdac inhibitors
247225|NCT02654405|Inflammation|inflammation
247226|NCT02654392|Omega-3|omega-3
247227|NCT02654392|Omega-6|omega-6
247228|NCT02654392|Exercise Performance|exercise performance
247229|NCT02654366|Syringe exchange|syringe exchange
247230|NCT02654366|HIV risk reduction|hiv risk reduction
247231|NCT02654366|Drug-free community support|drug-free community support
247232|NCT02654353|Persistent atrial fibrillation, catheter ablation, outcome|persistent atrial fibrillation, catheter ablation, outcome
247233|NCT02654340|Tuberous sclerosis complex|tuberous sclerosis complex
247234|NCT02654340|Biomarker|biomarker
247235|NCT02654327|Extracorporeal|extracorporeal
247236|NCT02654327|Acute Respiratory Distress Syndrome|acute respiratory distress syndrome
247237|NCT02654327|Protective Lung Ventilation|protective lung ventilation
247238|NCT02654327|Ventilator Induced Lung Injury|ventilator induced lung injury
247239|NCT02654327|Carbon Dioxide Removal|carbon dioxide removal
247240|NCT02654327|Lung|lung
247241|NCT02654327|Lung Injury|lung injury
247242|NCT02654314|prevention; delirium; in-patients; melatonin,|prevention; delirium; in-patients; melatonin,
247243|NCT02654301|Xylose|xylose
247244|NCT02654301|prediabetes|prediabetes
247245|NCT02654301|postprandial hyperglycemia|postprandial hyperglycemia
247246|NCT02654301|glucose|glucose
247247|NCT02654288|pancreatic cancer|pancreatic cancer
247248|NCT02654288|gemcitabine|gemcitabine
247249|NCT02654288|chemotherapy|chemotherapy
247250|NCT02654288|immunoglobulin G 4|immunoglobulin g 4
247251|NCT02654249|Hemorrhoids grade III and IV|hemorrhoids grade iii and iv
247252|NCT02654249|transanal hemorrhoidal dearterialization|transanal hemorrhoidal dearterialization
247253|NCT02654249|hemorroidectomy|hemorroidectomy
247254|NCT02654249|THD|thd
247255|NCT02654249|LigaSure|ligasure
247256|NCT02654223|Rhinitis / Rhinoconjunctivitis|rhinitis / rhinoconjunctivitis
247257|NCT02654223|Vaccine|vaccine
247258|NCT02654223|Immunotherapy|immunotherapy
247259|NCT02654223|Grass pollen|grass pollen
247260|NCT02654223|Allergy|allergy
247261|NCT02654210|birth cohort|birth cohort
247262|NCT02654210|infectious diseases|infectious diseases
247263|NCT02654210|microbiome|microbiome
247264|NCT02654210|immune system|immune system
247265|NCT02654210|immune response|immune response
247266|NCT02654184|Right lateral|right lateral
247267|NCT02654184|Induction|induction
247268|NCT02654184|Children|children
247269|NCT02654184|Anesthesia|anesthesia
247270|NCT02654171|RSV|rsv
247271|NCT02654171|AK0529|ak0529
247272|NCT02654158|acute upper respiratory infection|acute upper respiratory infection
247273|NCT02654145|mepolizumab|mepolizumab
247274|NCT02654145|Omalizumab|omalizumab
247275|NCT02654145|SGRQ|sgrq
247276|NCT02654145|severe eosinophilic asthma|severe eosinophilic asthma
247277|NCT02654145|ACQ|acq
247278|NCT02654145|exacerbations|exacerbations
247279|NCT02654106|multiple brain metastases|multiple brain metastases
247280|NCT02654106|large brain metastases|large brain metastases
247281|NCT02654106|meningeal metastases|meningeal metastases
247282|NCT02654106|fractionated stereotactic radiotherapy|fractionated stereotactic radiotherapy
247283|NCT02654106|temozolomide|temozolomide
247284|NCT02654054|Elagolix|elagolix
247285|NCT02654054|Elagolix Sodium|elagolix sodium
247286|NCT02654054|Heavy Uterine Bleeding|heavy uterine bleeding
247287|NCT02654054|Heavy Menstrual Bleeding|heavy menstrual bleeding
247288|NCT02654054|Leiomyomata|leiomyomata
247289|NCT02654054|Menorrhagia|menorrhagia
247290|NCT02654054|ABT-620|abt-620
247291|NCT02654054|Elagolix + E2/NETA|elagolix + e2/neta
247292|NCT02654054|Elagolix + Norethindrone Acetate|elagolix + norethindrone acetate
247293|NCT02654054|HMB|hmb
247294|NCT02654015|intracranial hemorrhage|intracranial hemorrhage
247295|NCT02654015|neurosurgery|neurosurgery
247296|NCT02653963|Steroid, Triamcinolone, Ahmed Glaucoma valve|steroid, triamcinolone, ahmed glaucoma valve
247297|NCT02653937|IBS|ibs
247298|NCT02653937|MUPS|mups
247299|NCT02653937|FSS|fss
247300|NCT02653937|shigyakusan|shigyakusan
247301|NCT02653937|Katsumi's points|katsumi's points
247302|NCT02653937|Nakatani's N line|nakatani's n line
247303|NCT02653924|Suture|suture
247304|NCT02653924|bacteria|bacteria
247305|NCT02653911|Acupuncture|acupuncture
247306|NCT02653898|Malaria|malaria
247307|NCT02653898|Antimalarials|antimalarials
247308|NCT02653898|Malaria Elimination|malaria elimination
247309|NCT02653898|Mass Drug Administration|mass drug administration
247310|NCT02653898|Malaria Prophylaxis|malaria prophylaxis
247311|NCT02653898|Mobile population|mobile population
247312|NCT02653898|Drug resistance|drug resistance
247313|NCT02653898|Focused screening and treatment|focused screening and treatment
247314|NCT02653898|Monthly Malaria Prophylaxis|monthly malaria prophylaxis
247315|NCT02653898|Mass screening and treatment|mass screening and treatment
247316|NCT02653898|Primaquine|primaquine
247317|NCT02653898|Malaria transmission|malaria transmission
247318|NCT02653898|Permethrin insecticide|permethrin insecticide
247319|NCT02653898|Thai-Cambodian border|thai-cambodian border
247320|NCT02653898|Cambodia|cambodia
247321|NCT02653898|AFRIMS|afrims
247322|NCT02653885|cardiac surgery|cardiac surgery
247323|NCT02653885|open heart surgery|open heart surgery
247324|NCT02653885|hemogram|hemogram
247325|NCT02653872|Non-randomized|non-randomized
247326|NCT02653872|Verapamil|verapamil
247327|NCT02653872|Itraconazole|itraconazole
247328|NCT02653872|Diltiazem|diltiazem
247329|NCT02653872|Safety|safety
247330|NCT02653872|Tolerability|tolerability
247331|NCT02653872|Pharmacokinetics|pharmacokinetics
247332|NCT02653859|CTC|ctc
247333|NCT02653859|PCR|pcr
247334|NCT02653833|Becker|becker
247335|NCT02653833|Muscular Dystrophy|muscular dystrophy
247336|NCT02653833|Skeletal Muscle|skeletal muscle
247337|NCT02653833|blood flow|blood flow
247338|NCT02653833|Ultrasound|ultrasound
247339|NCT02653807|manual therapy|manual therapy
247340|NCT02653807|osteopathy|osteopathy
247341|NCT02653807|mobilization with movement|mobilization with movement
247342|NCT02653807|ankle|ankle
247343|NCT02653807|stiffness|stiffness
247344|NCT02653794|Juvenile Subjects'characteristics|juvenile subjects'characteristics
247345|NCT02653768|Osteoarthritis, Knee|osteoarthritis, knee
247346|NCT02653768|Exercise|exercise
247347|NCT02653755|Breast Cancer Radiation|breast cancer radiation
247348|NCT02653755|Radiotherapy for Favorable-Risk Breast cancer|radiotherapy for favorable-risk breast cancer
247837|NCT02650674|SDS|sds
247349|NCT02653755|Radiotherapy Omission|radiotherapy omission
247350|NCT02653729|cognitive behaviour therapy|cognitive behaviour therapy
247351|NCT02653729|first episode|first episode
247352|NCT02653716|New Orleans Intervention Model|new orleans intervention model
247353|NCT02653716|Case Management|case management
247354|NCT02653716|Maltreatment|maltreatment
247355|NCT02653716|Child|child
247356|NCT02653664|Chronic Pain|chronic pain
247357|NCT02653664|Sleep|sleep
247358|NCT02653651|Ketamine|ketamine
247359|NCT02653651|Lidocaine|lidocaine
247360|NCT02653651|Nephrectomy|nephrectomy
247361|NCT02653651|Chronic pain|chronic pain
247362|NCT02653638|Cerebral Vasodilator Function|cerebral vasodilator function
247363|NCT02653638|White Matter Hyperintensity Volume|white matter hyperintensity volume
247364|NCT02653638|Default Mode Network Connectivity|default mode network connectivity
247365|NCT02653638|Cognitive Function|cognitive function
247366|NCT02653638|Cardiorespiratory Fitness|cardiorespiratory fitness
247367|NCT02653638|Aging|aging
247368|NCT02653625|Primary Sclerosing Cholangitis|primary sclerosing cholangitis
247369|NCT02653612|surgery|surgery
247370|NCT02653612|folate receptor|folate receptor
247371|NCT02653586|resilience|resilience
247372|NCT02653586|prevention program|prevention program
247373|NCT02653586|body image|body image
247374|NCT02653586|self esteem|self esteem
247375|NCT02653573|young adult|young adult
247376|NCT02653560|Potassium|potassium
247377|NCT02653560|Magnesium|magnesium
247378|NCT02653560|Citrate|citrate
247379|NCT02653560|DASH|dash
247380|NCT02653547|tinnitus|tinnitus
247381|NCT02653547|transcranial random noise stimulation|transcranial random noise stimulation
247382|NCT02653547|rTMS|rtms
247383|NCT02653547|multisite stimulation|multisite stimulation
247384|NCT02653547|non-invasive brain stimulation|non-invasive brain stimulation
247385|NCT02653534|Kangaroo Mother Care in community|kangaroo mother care in community
247386|NCT02653534|mortality|mortality
247387|NCT02653521|Esophageal Cancer|esophageal cancer
247388|NCT02653521|Adaptive Radiation Therapy|adaptive radiation therapy
247389|NCT02653508|BMI: Body Mass Index|bmi: body mass index
247390|NCT02653508|obesity|obesity
247391|NCT02653508|adolescents|adolescents
247392|NCT02653508|overweight|overweight
247393|NCT02653508|CI:confidence interval|ci:confidence interval
247394|NCT02653508|CDC: Center Disease Control|cdc: center disease control
247395|NCT02653482|heart failure|heart failure
247396|NCT02653482|dapagliflozin|dapagliflozin
247397|NCT02653482|SGLT-2 inhibitors|sglt-2 inhibitors
247398|NCT02653456|excimer laser|excimer laser
247399|NCT02653456|percutaneous catheter|percutaneous catheter
247400|NCT02653456|photoablation|photoablation
247401|NCT02653456|chronic total occlusion|chronic total occlusion
247402|NCT02653456|symptomatic infrainguinal lower extremity vascular disease|symptomatic infrainguinal lower extremity vascular disease
247403|NCT02653443|INTERCEPT|intercept
247404|NCT02653443|Platelet|platelet
247405|NCT02653443|Pathogen Inactivation|pathogen inactivation
247406|NCT02653443|Platelets Components Stored|platelets components stored
247407|NCT02653443|Therapeutic Efficacy|therapeutic efficacy
247408|NCT02653430|obesity|obesity
247409|NCT02653430|BMI|bmi
247410|NCT02653430|efficacy|efficacy
247411|NCT02653430|bariatric surgery|bariatric surgery
247412|NCT02653430|gut flora|gut flora
247413|NCT02653430|fMRI|fmri
732047|NCT00503035|Biopsy|biopsy
316211|NCT02253628|Gastrin|gastrin
247414|NCT02653391|Fuchs' Corneal Endothelial Dystrophy|fuchs' corneal endothelial dystrophy
247415|NCT02653391|FCED|fced
247416|NCT02653391|Ocuvia™|ocuvia™
247417|NCT02653391|MTP-131|mtp-131
247418|NCT02653352|randomized controlled trials|randomized controlled trials
247419|NCT02653352|soft drinks|soft drinks
247420|NCT02653352|hypercholesterolemia|hypercholesterolemia
247421|NCT02653352|serum cholesterol|serum cholesterol
247422|NCT02653352|blood glucose|blood glucose
247423|NCT02653352|overweight|overweight
247424|NCT02653352|carbonated beverages|carbonated beverages
247425|NCT02653339|traditional Chinese medicine|traditional chinese medicine
247426|NCT02653339|Loratadine|loratadine
247427|NCT02653339|questionnaire survey|questionnaire survey
247428|NCT02653326|Tertiary Prevention|tertiary prevention
247429|NCT02653326|Telerehabilitation|telerehabilitation
247430|NCT02653287|Fatigue, Physical Activity, Lupus|fatigue, physical activity, lupus
247431|NCT02653274|MRI|mri
247432|NCT02653274|blood glucose|blood glucose
247433|NCT02653274|satiety|satiety
247434|NCT02653274|breakfast|breakfast
247435|NCT02653274|porridge|porridge
247436|NCT02653274|grains|grains
247437|NCT02653261|tranexamic acid|tranexamic acid
247438|NCT02653261|Transurethral Resection of the Prostate (TURP)|transurethral resection of the prostate (turp)
247439|NCT02653261|Transurethral Resection of a Bladder Tumor (TURBT)|transurethral resection of a bladder tumor (turbt)
247440|NCT02653261|Hemorrhage|hemorrhage
247441|NCT02653261|Blood Transfusion|blood transfusion
247442|NCT02653222|Ethanol Sympathicolysis|ethanol sympathicolysis
247443|NCT02653222|Computer Tomography guidance|computer tomography guidance
247444|NCT02653222|Denervation|denervation
247445|NCT02653222|Kidney Transplantation|kidney transplantation
247446|NCT02653222|Dialysis|dialysis
247447|NCT02653209|Type 2 diabetes|type 2 diabetes
247448|NCT02653209|Stratification|stratification
247449|NCT02653209|Biomarkers|biomarkers
247450|NCT02653209|Pharmacogenetics|pharmacogenetics
247451|NCT02653209|SGLT2 inhibitors|sglt2 inhibitors
247452|NCT02653209|Thiazolidinediones|thiazolidinediones
247453|NCT02653209|DPP4 inhibitors|dpp4 inhibitors
247454|NCT02653170|acute stroke|acute stroke
247455|NCT02653170|care transitions|care transitions
247456|NCT02653170|patient engagement|patient engagement
247457|NCT02653170|patient education|patient education
247458|NCT02653170|caregivers|caregivers
247459|NCT02653170|social workers|social workers
247460|NCT02653157|multidrug resistance|multidrug resistance
247462|NCT02653157|infections, gram-negative bacilli|infections, gram-negative bacilli
247463|NCT02653157|ventilator-associated pneumonia|ventilator-associated pneumonia
247464|NCT02653157|ventilator-associated tracheobronchitis|ventilator-associated tracheobronchitis
247465|NCT02653157|gram-negative bacilli colonization|gram-negative bacilli colonization
247466|NCT02653144|post operative pain, Dexmedetomidine, Regional anesthesia|post operative pain, dexmedetomidine, regional anesthesia
247467|NCT02653131|Short bowel syndrome|short bowel syndrome
247468|NCT02653105|High risk of cancer, BRCA1 or 2 mutation, Olfactomedine 4|high risk of cancer, brca1 or 2 mutation, olfactomedine 4
247469|NCT02653066|recruitment|recruitment
247470|NCT02653040|Lighting|lighting
247471|NCT02653040|Inpatients|inpatients
247472|NCT02653040|Recovery|recovery
247473|NCT02653040|Sleep|sleep
247474|NCT02653027|Genetics|genetics
247475|NCT02652988|tDCS|tdcs
247476|NCT02652988|chronic pain|chronic pain
247477|NCT02652988|fibromyalgia|fibromyalgia
247478|NCT02652923|ultrasound contrast agent|ultrasound contrast agent
247479|NCT02652923|lymphosonography|lymphosonography
247480|NCT02652923|breast cancer|breast cancer
247481|NCT02652897|bleeding|bleeding
247482|NCT02652897|clotting tests|clotting tests
247483|NCT02652897|neurosurgery|neurosurgery
247484|NCT02652897|clotting time|clotting time
247485|NCT02652897|maximum clot firmness|maximum clot firmness
247486|NCT02652897|kinetics|kinetics
247487|NCT02652897|lysis|lysis
247488|NCT02652897|primary hemostasis|primary hemostasis
247489|NCT02652897|platelet dysfunction|platelet dysfunction
247490|NCT02652897|coagulation|coagulation
247491|NCT02652884|transient hypoparathyroidism|transient hypoparathyroidism
247492|NCT02652884|steroids|steroids
247493|NCT02652884|total thyroidectomy|total thyroidectomy
247494|NCT02652871|Leukemia|leukemia
247495|NCT02652871|Acute Myeloid Leukemia|acute myeloid leukemia
247497|NCT02652871|Relapsed or Refractory|relapsed or refractory
247498|NCT02652871|Acute myelogenous leukemia|acute myelogenous leukemia
247499|NCT02652871|LY2510924|ly2510924
247500|NCT02652871|Idarubicin|idarubicin
247501|NCT02652871|Idamycin|idamycin
247502|NCT02652871|Cytarabine|cytarabine
247503|NCT02652871|Ara-C|ara-c
247504|NCT02652871|Cytosar|cytosar
247505|NCT02652871|DepoCyt|depocyt
247506|NCT02652871|Cytosine Arabinosine Hydrochloride|cytosine arabinosine hydrochloride
247507|NCT02652819|Chronic Kidney Disease|chronic kidney disease
247508|NCT02652806|Chronic Kidney Disease|chronic kidney disease
247509|NCT02652780|Leber Hereditary Optic Neuropathy|leber hereditary optic neuropathy
247510|NCT02652780|Leber Hereditary Optic Atrophy|leber hereditary optic atrophy
247511|NCT02652780|Heredity Optic Atrophy|heredity optic atrophy
247512|NCT02652780|Eye Diseases|eye diseases
247513|NCT02652780|Hereditary Eye Diseases|hereditary eye diseases
247514|NCT02652780|Inborn Genetic Disease|inborn genetic disease
247515|NCT02652780|Genetic Therapy|genetic therapy
247516|NCT02652780|Intravitreal Injections|intravitreal injections
247517|NCT02652780|Mitochondrial Disease|mitochondrial disease
247518|NCT02652780|AAV2 Vectors|aav2 vectors
247519|NCT02652780|Nervous System Diseases|nervous system diseases
247520|NCT02652780|Neurodegenerative Disease|neurodegenerative disease
247521|NCT02652780|Heredodegenerative Disorders of the Nervous System|heredodegenerative disorders of the nervous system
247522|NCT02652767|Leber Hereditary Optic Neuropathy|leber hereditary optic neuropathy
247523|NCT02652767|Leber Hereditary Optic Atrophy|leber hereditary optic atrophy
247524|NCT02652767|Heredity Optic Atrophy|heredity optic atrophy
247525|NCT02652767|Eye Diseases|eye diseases
247526|NCT02652767|Hereditary Eye Diseases|hereditary eye diseases
247527|NCT02652767|Inborn Genetic Disease|inborn genetic disease
247528|NCT02652767|Genetic Therapy|genetic therapy
247529|NCT02652767|Intravitreal Injections|intravitreal injections
247530|NCT02652767|Mitochondrial Disease|mitochondrial disease
247531|NCT02652767|AAV2 Vectors|aav2 vectors
247532|NCT02652767|Nervous System Diseases|nervous system diseases
247533|NCT02652767|Neurodegenerative Disease|neurodegenerative disease
247534|NCT02652767|Heredodegenerative Disorders of the Nervous System|heredodegenerative disorders of the nervous system
247535|NCT02652754|Granexin|granexin
247536|NCT02652754|diabetic foot ulcers|diabetic foot ulcers
247537|NCT02652754|pharmacokinetic study|pharmacokinetic study
247538|NCT02652754|FirstString Research|firststring research
247539|NCT02652702|circular stapler-assisted colostomy|circular stapler-assisted colostomy
247540|NCT02652689|pulmonary embolism|pulmonary embolism
247541|NCT02652689|pulmonary disease|pulmonary disease
247542|NCT02652689|Lung Doppler signals|lung doppler signals
247543|NCT02652676|Infant Cardiac Transplantation|infant cardiac transplantation
247544|NCT02652676|End-stage Idiopathic Dilated Cardiomyopathy|end-stage idiopathic dilated cardiomyopathy
247545|NCT02652676|Mechanical Circulatory Device|mechanical circulatory device
247546|NCT02652676|End Stage Dilated Left Ventriculopathy|end stage dilated left ventriculopathy
247547|NCT02652676|Acute-on-Chronic Left Ventricular Failure|acute-on-chronic left ventricular failure
247548|NCT02652663|colorectal cancer|colorectal cancer
247549|NCT02652663|liver|liver
247550|NCT02652663|MRI|mri
247551|NCT02652663|contrast|contrast
247552|NCT02652663|gadoxetic acid|gadoxetic acid
247553|NCT02652650|Healthy|healthy
247554|NCT02652650|JNJ-63623872|jnj-63623872
247555|NCT02652650|Ethinylestradiol|ethinylestradiol
247556|NCT02652650|Norethindrone|norethindrone
247557|NCT02652611|Screw Removal vs. Non-screw removal|screw removal vs. non-screw removal
247558|NCT02652611|Complications|complications
247559|NCT02652611|SI Screw Stabilization|si screw stabilization
247560|NCT02652585|Alcoholism|alcoholism
247561|NCT02652585|alcohol self-administration|alcohol self-administration
247562|NCT02652572|Granexin|granexin
247563|NCT02652572|venous leg ulcer|venous leg ulcer
247564|NCT02652572|pharmacokinetic study|pharmacokinetic study
247565|NCT02652572|FirstString Research|firststring research
247566|NCT02652559|Chronic Obstructive Pulmonary Disease|chronic obstructive pulmonary disease
247567|NCT02652559|Non-invasive ventilation|non-invasive ventilation
247568|NCT02652559|Home initiation|home initiation
247569|NCT02652546|HIV/AIDS|hiv/aids
247570|NCT02652546|Immune Activation|immune activation
247571|NCT02652546|Anti-Inflammatory|anti-inflammatory
247572|NCT02652546|TNF|tnf
247573|NCT02652546|Phosphodieterase Inhibitor|phosphodieterase inhibitor
247574|NCT02652520|Kidney transplantation|kidney transplantation
247575|NCT02652520|Organ preservation|organ preservation
247576|NCT02652507|Sedation|sedation
247577|NCT02652507|MRI|mri
247578|NCT02652507|Dexmedetomidine|dexmedetomidine
247579|NCT02652507|Ketamine|ketamine
247580|NCT02652507|General anesthesia|general anesthesia
247581|NCT02652507|MRI of Brain|mri of brain
247582|NCT02652507|MRI of Brain/Spine|mri of brain/spine
247583|NCT02652494|Psoriasis|psoriasis
247584|NCT02652494|Observational|observational
247585|NCT02652494|Apremilast|apremilast
247586|NCT02652494|APRIL|april
247587|NCT02652494|Non-Interventional|non-interventional
247588|NCT02652494|The Netherlands|the netherlands
247589|NCT02652455|cutaneous|cutaneous
247590|NCT02652455|unresectable|unresectable
247591|NCT02652455|mucosal metastatic stage III/IV melanoma|mucosal metastatic stage iii/iv melanoma
247592|NCT02652442|dizziness|dizziness
247593|NCT02652442|postural balance|postural balance
247594|NCT02652442|rehabilitation|rehabilitation
247595|NCT02652429|PAH|pah
247596|NCT02652429|Pulmonary Arterial Hypertension|pulmonary arterial hypertension
247597|NCT02652429|Inhaled Nitric Oxide|inhaled nitric oxide
247598|NCT02652429|iNO|ino
247599|NCT02652403|Denture, Complete|denture, complete
247600|NCT02652403|Mouth, Edentulous|mouth, edentulous
247601|NCT02652351|Stem cell|stem cell
247602|NCT02652351|Human Umbilical Cord Mesenchymal Stem Cell|human umbilical cord mesenchymal stem cell
247603|NCT02652351|Mesenchymal Stem Cell|mesenchymal stem cell
247604|NCT02652351|Hepatic Cirrhosis|hepatic cirrhosis
247605|NCT02652338|heart rhythm disturbances and symptoms|heart rhythm disturbances and symptoms
247606|NCT02652338|dietary supplement|dietary supplement
247607|NCT02652312|Dexmedetomidine|dexmedetomidine
247608|NCT02652312|Desflurane|desflurane
247609|NCT02652312|Bispectral Index BIS|bispectral index bis
247610|NCT02652299|Fibrocytes|fibrocytes
247611|NCT02652299|Synovial biopsy|synovial biopsy
247612|NCT02652286|VATS|vats
247613|NCT02652286|Energy sealing|energy sealing
247614|NCT02652247|trauma|trauma
247615|NCT02652247|ventilator|ventilator
247616|NCT02652247|surgical ICU|surgical icu
247617|NCT02652208|decision making|decision making
247618|NCT02652208|decision aids|decision aids
247619|NCT02652208|shared decision making|shared decision making
247620|NCT02652208|stable angina|stable angina
247621|NCT02652208|cardiology|cardiology
247622|NCT02652195|Neural correlates|neural correlates
247623|NCT02652195|oxytocin administration|oxytocin administration
247624|NCT02652156|transversus abdominis plane|transversus abdominis plane
247625|NCT02652156|postoperative|postoperative
247626|NCT02652156|pain|pain
247627|NCT02652143|in vivo culture|in vivo culture
247628|NCT02652130|GVHD, Graft versus Host Disease|gvhd, graft versus host disease
247629|NCT02652104|Advanced|advanced
247630|NCT02652104|Deep brain stimulation|deep brain stimulation
247631|NCT02652091|Adherence|adherence
247632|NCT02652091|Persistence|persistence
247633|NCT02652091|Patient satisfaction|patient satisfaction
247634|NCT02652065|Psoriasis|psoriasis
247635|NCT02652065|Microcirculation|microcirculation
247636|NCT02652065|TRPV1|trpv1
247637|NCT02652026|dental root planing and scaling|dental root planing and scaling
247638|NCT02652026|periodontal disease|periodontal disease
247639|NCT02652026|type 2 diabetes mellitus|type 2 diabetes mellitus
247839|NCT02650674|Nutrition|nutrition
247640|NCT02652026|glycosylated hemoglobin A|glycosylated hemoglobin a
247641|NCT02651974|neoplasm|neoplasm
247642|NCT02651974|colorectal|colorectal
247643|NCT02651974|cancer|cancer
247644|NCT02651974|uninsured|uninsured
247645|NCT02651974|FIT|fit
247646|NCT02651974|fecal immunochemical test|fecal immunochemical test
247647|NCT02651961|Total hip prosthesis|total hip prosthesis
247648|NCT02651961|Total knee prosthesis|total knee prosthesis
247649|NCT02651961|Chronic infection|chronic infection
247650|NCT02651961|One stage exchange|one stage exchange
247651|NCT02651961|Two stage exchange|two stage exchange
247652|NCT02651961|Cost-effectiveness|cost-effectiveness
247653|NCT02651935|Respiration, Artificial|respiration, artificial
247654|NCT02651935|weaning|weaning
247655|NCT02651935|critical care|critical care
247656|NCT02651922|Nervous restlessness|nervous restlessness
247657|NCT02651922|Pascoflair|pascoflair
247658|NCT02651922|Passiflora incarnata|passiflora incarnata
247659|NCT02651922|Benzodiazepine|benzodiazepine
247660|NCT02651883|Cervical cancer screening|cervical cancer screening
247661|NCT02651883|HPV testing|hpv testing
247662|NCT02651883|Self-collection|self-collection
247663|NCT02651870|Hypertension|hypertension
247664|NCT02651844|Progesterone receptor isoforms|progesterone receptor isoforms
247665|NCT02651844|Antiprogestins|antiprogestins
247666|NCT02651844|Mifepristone|mifepristone
247667|NCT02651844|Neoadjuvant|neoadjuvant
247668|NCT02651844|Breast cancer|breast cancer
247669|NCT02651831|ICMs|icms
247670|NCT02651831|Immune checkpoint modulators|immune checkpoint modulators
247671|NCT02651818|Goiter|goiter
247672|NCT02651818|Thyroid disease|thyroid disease
247673|NCT02651818|Struma|struma
247674|NCT02651805|Palliative Care|palliative care
247675|NCT02651805|Respiratory Secretion|respiratory secretion
247676|NCT02651792|ketamine|ketamine
247677|NCT02651792|propofol|propofol
247678|NCT02651792|pethidine|pethidine
247679|NCT02651792|ERCP|ercp
247680|NCT02651792|endoscopist|endoscopist
247681|NCT02651740|Rifaximin|rifaximin
247682|NCT02651740|Fecal microbiota transplantation|fecal microbiota transplantation
247683|NCT02651740|Gut microbiota|gut microbiota
247684|NCT02651675|LDL Receptors|ldl receptors
247685|NCT02651675|Gene therapy|gene therapy
247686|NCT02651675|Metabolic Diseases|metabolic diseases
247687|NCT02651675|Rare diseases|rare diseases
247688|NCT02651675|Genetic Diseases|genetic diseases
247689|NCT02651675|Atherosclerosis|atherosclerosis
247690|NCT02651675|cardiovascular disease|cardiovascular disease
247691|NCT02651610|PPHM 1401|pphm 1401
247692|NCT02651610|bavituximab|bavituximab
247693|NCT02651610|Peregrine|peregrine
247694|NCT02651610|Breast Cancer|breast cancer
247695|NCT02651610|HER-2 Negative|her-2 negative
247696|NCT02651610|HER2 Negative|her2 negative
247697|NCT02651597|Oatmeal|oatmeal
247698|NCT02651597|Beta glucan|beta glucan
247699|NCT02651597|Postprandial Glycemic Response|postprandial glycemic response
247700|NCT02651597|Blood Glucose|blood glucose
247701|NCT02651571|Knee|knee
247702|NCT02651571|Replacement|replacement
247703|NCT02651571|Prosthesis|prosthesis
247704|NCT02651571|Mobile-bearing|mobile-bearing
247705|NCT02651532|Confocal Laser Endomicroscopy|confocal laser endomicroscopy
247706|NCT02651532|inflammation|inflammation
247707|NCT02651532|Irritable Bowel Syndrome|irritable bowel syndrome
247708|NCT02651519|bispectral index|bispectral index
247709|NCT02651519|regional cerebral oxygen saturation|regional cerebral oxygen saturation
247710|NCT02651519|Stellate-ganglion block|stellate-ganglion block
247711|NCT02651506|Lung cancer biopsy|lung cancer biopsy
247712|NCT02651506|Electromagnetic Navigation Bronchoscopy|electromagnetic navigation bronchoscopy
247713|NCT02651506|Transthoracic Needle Biopsy|transthoracic needle biopsy
247714|NCT02651480|Diet, Vegetarian|diet, vegetarian
247715|NCT02651480|Diet, Fat-Restricted|diet, fat-restricted
247716|NCT02651480|Quality of Life|quality of life
247717|NCT02651480|Glycemic Index|glycemic index
247718|NCT02651454|metabolic syndrome|metabolic syndrome
247719|NCT02651454|Daesiho-tang|daesiho-tang
247720|NCT02651454|Taeeumjowi-tang|taeeumjowi-tang
247721|NCT02651454|Korean medicine|korean medicine
247722|NCT02651441|D-CIK|d-cik
247723|NCT02651441|lung cancer|lung cancer
247724|NCT02651428|Kidney Failure, Chronic|kidney failure, chronic
247725|NCT02651428|Catheter-Related Infections|catheter-related infections
247726|NCT02651428|Central Venous Catheter|central venous catheter
247727|NCT02651415|Metastatic colorectal cancer|metastatic colorectal cancer
247728|NCT02651415|Metastatic colorectal carcinoma|metastatic colorectal carcinoma
247729|NCT02651415|mCRC|mcrc
247730|NCT02651415|Regorafenib|regorafenib
247731|NCT02651415|Stivarga|stivarga
247732|NCT02651415|Perindopril|perindopril
247733|NCT02651415|Perindopril erbumine|perindopril erbumine
247734|NCT02651415|Coversyl|coversyl
247735|NCT02651402|Anxiety Disorders|anxiety disorders
247736|NCT02651402|Internalizing|internalizing
247737|NCT02651402|Anxiety|anxiety
247738|NCT02651389|Digital Orthoptic Platform|digital orthoptic platform
247739|NCT02651389|Vision test|vision test
247740|NCT02651376|Immunodeficiency|immunodeficiency
247838|NCT02650674|cereal product|cereal product
247741|NCT02651376|Allogenic Mononuclear Cell Transplantation|allogenic mononuclear cell transplantation
247742|NCT02651350|Drug-induced Liver Injury|drug-induced liver injury
247743|NCT02651350|Recurrence|recurrence
247744|NCT02651350|Methylprednisolone|methylprednisolone
247745|NCT02651285|G-CSF|g-csf
247746|NCT02651285|BLASTOCYST|blastocyst
247748|NCT02651272|Pulmonary Hypertension|pulmonary hypertension
247749|NCT02651272|Sickle Cell Disease|sickle cell disease
247750|NCT02651272|Pulmonary Arterial Hypertension|pulmonary arterial hypertension
247751|NCT02651272|Macitentan|macitentan
247752|NCT02651194|Treatment-naïve|treatment-naïve
247753|NCT02651194|HCV Gentoype 2|hcv gentoype 2
247754|NCT02651194|Non-cirrhotic|non-cirrhotic
247755|NCT02651194|Chronic Hepatitis C|chronic hepatitis c
247756|NCT02651194|HCV Gentoype 5|hcv gentoype 5
247757|NCT02651194|HCV Gentoype 4|hcv gentoype 4
247758|NCT02651194|HCV Gentoype 6|hcv gentoype 6
247759|NCT02651194|HCV Gentoype 1|hcv gentoype 1
247760|NCT02651194|Compensated cirrhotic|compensated cirrhotic
247761|NCT02651194|Treatment-experienced|treatment-experienced
247762|NCT02651194|HCV Gentoype 3|hcv gentoype 3
247763|NCT02651168|Diabetic Macular Edema|diabetic macular edema
247764|NCT02651168|Ocular Cytokines|ocular cytokines
247765|NCT02651168|aflibercept|aflibercept
247766|NCT02651168|ranibizumab|ranibizumab
247767|NCT02651155|Drug therapy|drug therapy
247768|NCT02651129|noise|noise
247769|NCT02651129|obstetric|obstetric
247770|NCT02651129|operating rooms|operating rooms
247771|NCT02651116|cough, acute cough, pediatric, Dextromethorphan Hydrobromide, antitussive, ambulatory cough recording device|cough, acute cough, pediatric, dextromethorphan hydrobromide, antitussive, ambulatory cough recording device
247772|NCT02651090|contraindication for CECT|contraindication for cect
247773|NCT02651090|contraindication for CEMRI|contraindication for cemri
247774|NCT02651090|liver pathology|liver pathology
247775|NCT02651090|renal failure|renal failure
247776|NCT02651090|contrast enhanced ultrasound|contrast enhanced ultrasound
247777|NCT02651090|sonazoid|sonazoid
247778|NCT02651077|Endometriosis, chemical contaminants, BFRs|endometriosis, chemical contaminants, bfrs
247779|NCT02651064|Supplemental Nutrition Assistance Program (SNAP)|supplemental nutrition assistance program (snap)
247780|NCT02651064|fruits and vegetables|fruits and vegetables
247781|NCT02651064|price incentive|price incentive
247782|NCT02651051|Postprandial glycemia|postprandial glycemia
247783|NCT02651051|Metabolic health measures|metabolic health measures
247784|NCT02650973|Bioequivalence|bioequivalence
247785|NCT02650947|Sucralose|sucralose
247786|NCT02650947|Insulin Secretion|insulin secretion
247787|NCT02650947|Insulin Sensitivity|insulin sensitivity
247788|NCT02650947|Incretin|incretin
247789|NCT02650947|Gut Microbiota|gut microbiota
247790|NCT02650947|Food and Eating Behaviour|food and eating behaviour
247791|NCT02650947|Healthy Volunteers|healthy volunteers
247792|NCT02650934|STEMI, Heart Failure, Inflammation, Haptoglobin Polymorphisms, Adverse Remodeling, Genetics, GWAS, MRI|stemi, heart failure, inflammation, haptoglobin polymorphisms, adverse remodeling, genetics, gwas, mri
247793|NCT02650908|Lesion|lesion
316778|NCT02250820|TTE|tte
247794|NCT02650908|Meniscus|meniscus
247795|NCT02650908|Avivement|avivement
247796|NCT02650908|Suturing area|suturing area
247797|NCT02650882|Respiratory muscles|respiratory muscles
247798|NCT02650882|athletic performance|athletic performance
247799|NCT02650882|handball|handball
247800|NCT02650869|Necrotizing Enterocolitis|necrotizing enterocolitis
247801|NCT02650869|probiotics|probiotics
247802|NCT02650869|very low birth weight|very low birth weight
247803|NCT02650856|Blood loss|blood loss
247804|NCT02650856|Tranexamic acid|tranexamic acid
247805|NCT02650856|Platelet rich plasma|platelet rich plasma
247806|NCT02650856|Total knee arthroplasty|total knee arthroplasty
247807|NCT02650843|Parkinsonism|parkinsonism
247808|NCT02650843|DAT Dopamine transporter|dat dopamine transporter
247809|NCT02650843|SPECT|spect
247810|NCT02650830|type 2 diabetes|type 2 diabetes
247811|NCT02650830|prediabetes|prediabetes
247812|NCT02650830|bile acids profile|bile acids profile
247813|NCT02650830|GLP-1|glp-1
247814|NCT02650830|FGF-19|fgf-19
247815|NCT02650804|Cancer|cancer
247816|NCT02650804|Advanced Pancreatic Cancer|advanced pancreatic cancer
247817|NCT02650778|Breast Cancer|breast cancer
247818|NCT02650778|Automated whole breast ultrasound|automated whole breast ultrasound
247819|NCT02650778|BI-RADS category 3 lesions|bi-rads category 3 lesions
247820|NCT02650765|Brain injury|brain injury
247821|NCT02650765|Head injury|head injury
247822|NCT02650765|Computed tomography|computed tomography
247823|NCT02650765|Emergency department|emergency department
247824|NCT02650752|Lapatinib|lapatinib
247825|NCT02650752|Capecitabine|capecitabine
247826|NCT02650752|HER2|her2
247827|NCT02650752|15-278|15-278
247828|NCT02650687|Postoperative Cognitive Dysfunction|postoperative cognitive dysfunction
247829|NCT02650687|Elderly, geriatric|elderly, geriatric
247830|NCT02650687|Anesthesia|anesthesia
247831|NCT02650687|Anesthetic depth|anesthetic depth
247832|NCT02650687|Bispectral index monitor|bispectral index monitor
247833|NCT02650687|Function|function
247834|NCT02650687|Recovery after surgery|recovery after surgery
247835|NCT02650687|Surgery|surgery
247836|NCT02650674|glycemic & insulin response|glycemic & insulin response
247840|NCT02650674|Carbohydrate|carbohydrate
247841|NCT02650674|Absorption|absorption
247842|NCT02650674|Intestine|intestine
247843|NCT02650661|Cancer survivors|cancer survivors
247844|NCT02650648|Humanized Anti-GD2 Antibody Hu3F8|humanized anti-gd2 antibody hu3f8
247845|NCT02650648|Allogeneic Natural Killer Cells|allogeneic natural killer cells
247846|NCT02650648|rIL-2|ril-2
247847|NCT02650648|15-272|15-272
247848|NCT02650622|Metabolism|metabolism
247849|NCT02650622|Genetics|genetics
247850|NCT02650622|Metabolomics|metabolomics
247851|NCT02650622|Genomics|genomics
247852|NCT02650609|chronic subdural hematomas|chronic subdural hematomas
247853|NCT02650609|surgical treatment|surgical treatment
247854|NCT02650609|corticosteroids|corticosteroids
247855|NCT02650570|Cancer|cancer
247856|NCT02650570|Cachexia|cachexia
247857|NCT02650557|coronary slow flow|coronary slow flow
247858|NCT02650557|P-wave dispersion|p-wave dispersion
247859|NCT02650544|Carcinoma, Non-Small-Cell Lung|carcinoma, non-small-cell lung
247860|NCT02650544|Depression|depression
247861|NCT02650544|mirtazapine|mirtazapine
247862|NCT02650544|patients health questionnaire (PHQ-9)|patients health questionnaire (phq-9)
247863|NCT02650531|Follow up studies|follow up studies
247864|NCT02650531|Risk factors|risk factors
247865|NCT02650518|Catheter-Associated Urinary Tract Infections|catheter-associated urinary tract infections
247866|NCT02650518|Antimicrobial Stewardship|antimicrobial stewardship
247867|NCT02650518|Short-Course Antimicrobials|short-course antimicrobials
247868|NCT02650492|Hyperthermia, Induced|hyperthermia, induced
247869|NCT02650492|Laser Coagulation|laser coagulation
247870|NCT02650492|Laser Therapy|laser therapy
247871|NCT02650453|Stent|stent
247872|NCT02650453|Angioplasty|angioplasty
247873|NCT02650453|Endophlebectomy|endophlebectomy
247874|NCT02650440|robotics|robotics
247875|NCT02650440|locomotion|locomotion
247876|NCT02650440|gait|gait
247877|NCT02650440|walking|walking
247878|NCT02650440|rehabilitation|rehabilitation
247879|NCT02650414|Biological: CART 22|biological: cart 22
247880|NCT02650401|TRK|trk
247881|NCT02650401|Tyrosine kinase|tyrosine kinase
247882|NCT02650401|NTRK|ntrk
247883|NCT02650401|NTRK1|ntrk1
247884|NCT02650401|NTRK2|ntrk2
247885|NCT02650401|NTRK3|ntrk3
247886|NCT02650401|ROS1|ros1
247887|NCT02650401|ALK|alk
247888|NCT02650401|Pediatric|pediatric
247889|NCT02650401|Relapsed|relapsed
247890|NCT02650401|Refractory|refractory
247891|NCT02650401|Solid Tumor|solid tumor
247892|NCT02650401|Metastatic Cancer|metastatic cancer
247893|NCT02650401|Gene rearrangement|gene rearrangement
247894|NCT02650401|Neuroblastoma|neuroblastoma
247895|NCT02650401|Infantile fibrosarcoma|infantile fibrosarcoma
247896|NCT02650401|Secretory breast cancer|secretory breast cancer
247897|NCT02650401|Congenital mesoblastic nephroma|congenital mesoblastic nephroma
247898|NCT02650401|Pontine glioma|pontine glioma
247899|NCT02650401|Brain tumors|brain tumors
247900|NCT02650401|CNS tumors|cns tumors
247901|NCT02650401|Sarcoma|sarcoma
247902|NCT02650401|Ewing sarcoma|ewing sarcoma
247903|NCT02650401|Glial tumors|glial tumors
247904|NCT02650401|Salivary Gland Cancer (MASC)|salivary gland cancer (masc)
247905|NCT02650401|Papillary thyroid cancer|papillary thyroid cancer
247906|NCT02650401|Medulloblastoma|medulloblastoma
247907|NCT02650401|Wilms tumor (anaplastic)|wilms tumor (anaplastic)
247908|NCT02650362|spinal cord stimulation|spinal cord stimulation
247909|NCT02650362|resting state functional magnetic resonance|resting state functional magnetic resonance
247910|NCT02650362|voxel-based magnetic resonance morphometry|voxel-based magnetic resonance morphometry
247911|NCT02650349|spinal cord stimulation|spinal cord stimulation
247912|NCT02650349|resting state functional magnetic resonance|resting state functional magnetic resonance
247913|NCT02650349|voxel-based magnetic resonance morphometry|voxel-based magnetic resonance morphometry
247914|NCT02650297|Lymphedema secondary to breast cancer|lymphedema secondary to breast cancer
247915|NCT02650297|Breast cancer|breast cancer
247916|NCT02650297|Body image|body image
247917|NCT02650271|adjuvant|adjuvant
247918|NCT02650271|entecavir|entecavir
247919|NCT02650271|hepatocellular carcinoma|hepatocellular carcinoma
247920|NCT02650271|hepatic resection|hepatic resection
247921|NCT02650245|breath|breath
247922|NCT02650245|gastroenterology|gastroenterology
247923|NCT02650245|ammonia|ammonia
247924|NCT02650245|blood|blood
247925|NCT02650245|protein|protein
247926|NCT02650245|cirrhosis|cirrhosis
247927|NCT02650245|encephalopathy|encephalopathy
247928|NCT02650232|Volunteers|volunteers
247929|NCT02650206|diabetes|diabetes
247930|NCT02650206|macrophage|macrophage
247931|NCT02650206|inflammation|inflammation
247932|NCT02650206|adipose tissue|adipose tissue
247933|NCT02650206|weight loss|weight loss
247934|NCT02650206|liraglutide|liraglutide
247935|NCT02650193|HSP-130 Phase 1-2 Study in patients with Breast cancer|hsp-130 phase 1-2 study in patients with breast cancer
247936|NCT02650180|Rehabilitation|rehabilitation
247937|NCT02650154|sedation|sedation
247938|NCT02650154|children|children
247939|NCT02650154|infants|infants
247940|NCT02650154|ketamine|ketamine
247941|NCT02650154|neurotoxicity|neurotoxicity
247942|NCT02650128|Coronary Artery Disease|coronary artery disease
247943|NCT02650128|Calcified Coronary Lesions|calcified coronary lesions
247944|NCT02650128|Coronary Arterial Stenosis|coronary arterial stenosis
247945|NCT02650089|Resistance Exercise|resistance exercise
247946|NCT02650089|Postexercise Hypotension|postexercise hypotension
247947|NCT02650089|Sympathovagal balance|sympathovagal balance
247948|NCT02650089|Professor|professor
247949|NCT02650011|Chronic liver disease|chronic liver disease
247950|NCT02650011|Liver cirrhosis|liver cirrhosis
247951|NCT02649998|Fursemide|fursemide
247952|NCT02649998|Isosorbide Dinitrate|isosorbide dinitrate
247953|NCT02649998|Heart Decompensation|heart decompensation
247954|NCT02649998|Clinical Trials, Randomized|clinical trials, randomized
247955|NCT02649998|Clinical Efficacy|clinical efficacy
247956|NCT02649972|Cobimetinib|cobimetinib
247958|NCT02649959|Autism|autism
247959|NCT02649946|ESRD|esrd
247960|NCT02649946|Stenosis|stenosis
247961|NCT02649946|Restenosis|restenosis
247962|NCT02649946|Hemodialysis|hemodialysis
247963|NCT02649946|AV Fistula|av fistula
247964|NCT02649946|Arteriovenous (AV)|arteriovenous (av)
247965|NCT02649933|pregnancy|pregnancy
247966|NCT02649933|obstructive sleep apnea|obstructive sleep apnea
247967|NCT02649920|unfavorable cervix|unfavorable cervix
247968|NCT02649920|obese pregnant women|obese pregnant women
247969|NCT02649894|malignant pleural effusion|malignant pleural effusion
247970|NCT02649881|macrophage|macrophage
247971|NCT02649881|vulnerable coronary plaque|vulnerable coronary plaque
247972|NCT02649868|Radio-Opaque Bland Beads|radio-opaque bland beads
247973|NCT02649868|Thermal Ablation|thermal ablation
247974|NCT02649868|Transarterial Embolization|transarterial embolization
247975|NCT02649855|PSA|psa
247976|NCT02649855|Vaccine|vaccine
247977|NCT02649855|Immunotherapy|immunotherapy
247978|NCT02649855|Immune Response|immune response
247979|NCT02649855|Androgen Deprivation Therapy|androgen deprivation therapy
247980|NCT02649829|dendritic cell vaccination|dendritic cell vaccination
247981|NCT02649829|chemo-immunotherapy|chemo-immunotherapy
247982|NCT02649829|Wilms' tumor 1 (WT1)|wilms' tumor 1 (wt1)
247983|NCT02649816|Pit and fissure sealants|pit and fissure sealants
247984|NCT02649816|Dental Caries|dental caries
247985|NCT02649816|Prevention|prevention
247986|NCT02649816|Dental undergraduate students|dental undergraduate students
247987|NCT02649816|patient's caries risk|patient's caries risk
247988|NCT02649803|pediatric|pediatric
247989|NCT02649803|asthma control|asthma control
247990|NCT02649803|community|community
247991|NCT02649790|Multiple Myeloma|multiple myeloma
247992|NCT02649790|Karyopharm|karyopharm
247993|NCT02649790|KPT-8602|kpt-8602
247994|NCT02649790|MM|mm
247995|NCT02649790|Phase 1|phase 1
712527|NCT00579839|Cord Clamping|cord clamping
316964|NCT02249832|CVA|cva
247996|NCT02649790|Relapsed/ Refractory Multiple Myeloma|relapsed/ refractory multiple myeloma
247997|NCT02649790|Myelodysplastic Syndrome|myelodysplastic syndrome
247998|NCT02649790|MDS|mds
247999|NCT02649790|Metastatic Castration Resistant Prostate Cancer|metastatic castration resistant prostate cancer
248000|NCT02649790|mCRPC|mcrpc
248001|NCT02649790|CRC|crc
248002|NCT02649790|Metastatic Colorectal Cancer|metastatic colorectal cancer
248003|NCT02649777|oxidative stress|oxidative stress
248004|NCT02649751|Cystic Fibrosis|cystic fibrosis
248005|NCT02649751|Roscovitine|roscovitine
248006|NCT02649751|Seliciclib|seliciclib
248007|NCT02649751|CYC202|cyc202
248008|NCT02649738|keratoconus|keratoconus
248009|NCT02649738|corneal tissue inlay|corneal tissue inlay
248010|NCT02649699|Primary Brain Cancer|primary brain cancer
248011|NCT02649673|lung carcinoma|lung carcinoma
248012|NCT02649673|topotecan|topotecan
248013|NCT02649673|Hycamtin|hycamtin
248014|NCT02649673|ovarian neoplasms|ovarian neoplasms
248015|NCT02649673|LCL161|lcl161
248016|NCT02649673|IAP inhibitors|iap inhibitors
248017|NCT02649660|Fabry Disease|fabry disease
248018|NCT02649660|Platelets|platelets
248019|NCT02649660|Lipidomics|lipidomics
248020|NCT02649660|Sphingolipids|sphingolipids
248021|NCT02649660|α-Galactosidase A|α-galactosidase a
248022|NCT02649660|Globotriaosylceramide|globotriaosylceramide
248023|NCT02649660|Gb3|gb3
248024|NCT02649660|GL-3|gl-3
248025|NCT02649660|CD77|cd77
248026|NCT02649660|Alpha-galactosidase|alpha-galactosidase
248027|NCT02649660|Platelet activation|platelet activation
248028|NCT02649660|Lysosomal storage disease|lysosomal storage disease
248029|NCT02649660|LysoGb3|lysogb3
248030|NCT02649660|Spingosine-1-Phosphate|spingosine-1-phosphate
248031|NCT02649660|Platelet function|platelet function
248032|NCT02649660|CD62P|cd62p
248033|NCT02649660|P-selectin|p-selectin
248034|NCT02649647|Rectal cancer|rectal cancer
248035|NCT02649647|Neoadjuvant therapy|neoadjuvant therapy
248036|NCT02649647|Chemoradiotherapy|chemoradiotherapy
248037|NCT02649647|Resection margin|resection margin
248038|NCT02649647|Bowel function|bowel function
248039|NCT02649647|Anastomosis|anastomosis
248040|NCT02649634|Motivational Interviewing|motivational interviewing
248041|NCT02649634|Obesity|obesity
248042|NCT02649634|Weight Loss|weight loss
248043|NCT02649634|Behavioral Medicine|behavioral medicine
248044|NCT02649621|Limbal Stem Cell Deficiency Amniotic Membrane Extract Eye Drop in vivo cultivation|limbal stem cell deficiency amniotic membrane extract eye drop in vivo cultivation
248045|NCT02649595|Homeless|homeless
248046|NCT02649595|Homelessness|homelessness
248047|NCT02649595|Respite care|respite care
248048|NCT02649595|EQ-5D|eq-5d
248049|NCT02649595|Quality of life questionnaire|quality of life questionnaire
248050|NCT02649595|Economic evaluation|economic evaluation
248051|NCT02649595|Cost-utility analysis|cost-utility analysis
248052|NCT02649582|Dendritic cells|dendritic cells
248053|NCT02649582|Chemoimmunotherapy|chemoimmunotherapy
248054|NCT02649582|Adjuvant therapy|adjuvant therapy
248055|NCT02649556|Candidate modified risk tobacco product|candidate modified risk tobacco product
248056|NCT02649556|Conventional cigarette|conventional cigarette
248057|NCT02649556|Exposure response|exposure response
248058|NCT02649556|Smoking|smoking
248059|NCT02649556|Tobacco Heating System|tobacco heating system
248060|NCT02649543|Surgical Wound Infection|surgical wound infection
248061|NCT02649543|Negative-Pressure Wound Therapy|negative-pressure wound therapy
248062|NCT02649543|Wound Closure Techniques|wound closure techniques
248063|NCT02649543|Laparotomy.|laparotomy.
248064|NCT02649543|Abdominal Wound Closure Techniques|abdominal wound closure techniques
248065|NCT02649517|decompensated heart failure|decompensated heart failure
248066|NCT02649517|ischemic heart disease|ischemic heart disease
248067|NCT02649517|inflammatory cardiomyopathy|inflammatory cardiomyopathy
248068|NCT02649491|Radiotherapy|radiotherapy
248069|NCT02649491|Chemotherapy|chemotherapy
248070|NCT02649491|Metabonomics|metabonomics
248071|NCT02649491|Electronic Sensing|electronic sensing
248072|NCT02649491|GI Toxicity|gi toxicity
248073|NCT02649452|Whole body Vibration|whole body vibration
248074|NCT02649439|Vaccine|vaccine
248075|NCT02649439|PSA|psa
248076|NCT02649439|Surveillance|surveillance
248077|NCT02649439|Immunotherapy|immunotherapy
248078|NCT02649426|denervation|denervation
248079|NCT02649426|resistant hypertension|resistant hypertension
248080|NCT02649426|essential hypertension|essential hypertension
248081|NCT02649361|Anlotinib|anlotinib
248082|NCT02649348|gastric neoplasm|gastric neoplasm
248083|NCT02649348|metabolic syndrome|metabolic syndrome
248084|NCT02649348|prehabilitation|prehabilitation
248085|NCT02649348|pre-operative exercise|pre-operative exercise
248086|NCT02649348|laparoscopic radical gastrectomy|laparoscopic radical gastrectomy
248087|NCT02649335|Non selective beta blockers|non selective beta blockers
248088|NCT02649335|Ascites|ascites
248089|NCT02649309|Ischemic Preconditioning|ischemic preconditioning
248090|NCT02649309|Postconditioning|postconditioning
248091|NCT02649309|Angioplasty|angioplasty
248092|NCT02649270|Tolerability|tolerability
248093|NCT02649270|Safety|safety
248094|NCT02649270|Pharmacokinetic Study|pharmacokinetic study
248095|NCT02649270|preliminary pharmacodynamic study|preliminary pharmacodynamic study
248096|NCT02649270|Humanized Anti-CD6 Monoclonal Antibody(T1h)|humanized anti-cd6 monoclonal antibody(t1h)
248097|NCT02649257|IOL rotation|iol rotation
248098|NCT02649257|capsular tension ring|capsular tension ring
248099|NCT02649257|IOL rotational stability|iol rotational stability
248100|NCT02649218|QGE031|qge031
248101|NCT02649218|chronic|chronic
248102|NCT02649218|spontaneous|spontaneous
248103|NCT02649218|Urticaria|urticaria
248104|NCT02649218|CSU|csu
248105|NCT02649218|adults|adults
248106|NCT02649218|Safety|safety
248107|NCT02649192|Children|children
248108|NCT02649192|Vitamin Supplements|vitamin supplements
248109|NCT02649192|Influenza virus vaccine|influenza virus vaccine
248110|NCT02649166|Essential tremor|essential tremor
248111|NCT02649166|Kinetic tremor|kinetic tremor
248112|NCT02649166|Intention tremor|intention tremor
248113|NCT02649140|24-hour urine|24-hour urine
248114|NCT02649140|Calcium oxalate|calcium oxalate
248115|NCT02649140|Vinegar|vinegar
248116|NCT02649127|exercise|exercise
248117|NCT02649127|biomarker|biomarker
248118|NCT02649088|microcirculation|microcirculation
248119|NCT02649088|tissue oxygenation|tissue oxygenation
248120|NCT02649088|outcome|outcome
248121|NCT02649075|IBD|ibd
248122|NCT02649075|Inflammatory Bowel Disease|inflammatory bowel disease
248123|NCT02649075|Crohn's|crohn's
248124|NCT02649075|Crohns|crohns
248125|NCT02649075|SBI|sbi
248126|NCT02649075|Serum-derived bovine immunoglobulin / protein isolate|serum-derived bovine immunoglobulin / protein isolate
248127|NCT02649075|EnteraGam|enteragam
248128|NCT02649010|Type 1 Diabetes|type 1 diabetes
248129|NCT02649010|Type 2 Diabetes|type 2 diabetes
248130|NCT02649010|Enlite 3 Sensor|enlite 3 sensor
248131|NCT02649010|Continuous Glucose Monitoring|continuous glucose monitoring
248132|NCT02648997|Atypical Meningioma|atypical meningioma
248133|NCT02648997|Anaplastic Meningioma|anaplastic meningioma
248134|NCT02648984|Pulmonary vascular disease|pulmonary vascular disease
248135|NCT02648971|knee|knee
248136|NCT02648971|arthroscopy|arthroscopy
248137|NCT02648971|portal|portal
248138|NCT02648971|meniscus|meniscus
248139|NCT02648971|cartilage injury|cartilage injury
248140|NCT02648932|Acute Myeloid Leukemia (AML)|acute myeloid leukemia (aml)
248141|NCT02648932|High-Risk Myelodysplastic Syndrome (MDS)|high-risk myelodysplastic syndrome (mds)
248142|NCT02648932|hematopoietic cell transplantation|hematopoietic cell transplantation
248143|NCT02648932|haplo-cord search|haplo-cord search
248144|NCT02648932|matched unrelated donor search|matched unrelated donor search
248145|NCT02648893|iron|iron
248146|NCT02648893|zinc|zinc
248147|NCT02648893|vitamin A|vitamin a
248148|NCT02648893|biofortified|biofortified
248149|NCT02648893|efficacy|efficacy
248150|NCT02648893|India|india
248151|NCT02648893|infant|infant
248152|NCT02648893|trial|trial
248153|NCT02648880|Exercise|exercise
248154|NCT02648880|Physical Activity|physical activity
248155|NCT02648841|gastric cancer|gastric cancer
248156|NCT02648841|adjuvant chemo-radiotherapy|adjuvant chemo-radiotherapy
248157|NCT02648828|Judgment|judgment
248158|NCT02648828|risk assessment|risk assessment
248159|NCT02648828|clinical deterioration|clinical deterioration
248160|NCT02648828|cardiac arrest|cardiac arrest
248161|NCT02648828|Rothman Index|rothman index
248162|NCT02648815|Necrotizing pancreatitis|necrotizing pancreatitis
248163|NCT02648815|Sepsis|sepsis
248164|NCT02648815|Infection|infection
248165|NCT02648815|Drainage|drainage
248166|NCT02648802|breast-conserving surgery(BCS)|breast-conserving surgery(bcs)
248167|NCT02648802|Cavity shave margin|cavity shave margin
248168|NCT02648802|Proportion of positive margins|proportion of positive margins
248169|NCT02648789|Primary oral cancer|primary oral cancer
248170|NCT02648789|DNA methylation|dna methylation
248171|NCT02648789|Recurrence oral cancer|recurrence oral cancer
248172|NCT02648776|hypnotic agents|hypnotic agents
248173|NCT02648776|sleep disorders|sleep disorders
248174|NCT02648776|elderly|elderly
248175|NCT02648750|self-management|self-management
248176|NCT02648750|rehabilitation|rehabilitation
248177|NCT02648737|Parkinson's disease|parkinson's disease
248178|NCT02648737|Cognitive Behavioural therapy|cognitive behavioural therapy
248179|NCT02648737|generalized anxiety disorder|generalized anxiety disorder
248180|NCT02648737|social phobia|social phobia
248181|NCT02648737|cerebral connectivity|cerebral connectivity
248182|NCT02648724|Advanced Solid Tumor Malignancies|advanced solid tumor malignancies
248183|NCT02648724|MET Gene Amplification|met gene amplification
248184|NCT02648724|MET Amplification|met amplification
248185|NCT02648724|Wild-type|wild-type
248186|NCT02648724|NSCLC|nsclc
248187|NCT02648724|METex14del|metex14del
248188|NCT02648724|Non-Small Cell Lung Carcinoma|non-small cell lung carcinoma
248189|NCT02648711|solid tumors|solid tumors
248190|NCT02648698|chronic endometritis|chronic endometritis
248191|NCT02648698|CD138|cd138
248192|NCT02648685|post prandial glucose (PPG)|post prandial glucose (ppg)
248193|NCT02648685|basal blood glucose (BBG)|basal blood glucose (bbg)
248194|NCT02648685|overall glycaemia|overall glycaemia
248195|NCT02648633|Brain Cancer|brain cancer
248196|NCT02648633|Immunotherapy|immunotherapy
248197|NCT02648633|Nivolumab|nivolumab
248198|NCT02648633|Radiosurgery|radiosurgery
248199|NCT02648633|Gamma Knife|gamma knife
248200|NCT02648620|Paclitaxel|paclitaxel
248201|NCT02648620|Percutaneous Transluminal Angioplasty|percutaneous transluminal angioplasty
248202|NCT02648620|PAD|pad
248203|NCT02648620|Peripheral Artery Disease|peripheral artery disease
248204|NCT02648620|Pharmacokinetics|pharmacokinetics
248205|NCT02648607|Pelvic Girdle Pain|pelvic girdle pain
248206|NCT02648607|Chronic Pelvic Girdle Pain|chronic pelvic girdle pain
248207|NCT02648607|Symphysis Pubis Dysfunction|symphysis pubis dysfunction
248208|NCT02648607|Sacroiliac Joint Dysfunction|sacroiliac joint dysfunction
248209|NCT02648607|Physiotherapy|physiotherapy
248210|NCT02648607|Physical Therapy|physical therapy
248211|NCT02648607|Orthoses|orthoses
248212|NCT02648607|Orthosis|orthosis
248213|NCT02648607|Orthotic Devices|orthotic devices
248214|NCT02648594|lung|lung
248215|NCT02648594|thoracoscopy|thoracoscopy
248216|NCT02648594|hook wire localization|hook wire localization
248217|NCT02648581|Behçet|behçet
248218|NCT02648581|ulcers|ulcers
248219|NCT02648581|uveitis|uveitis
248220|NCT02648581|ustekinumab|ustekinumab
248221|NCT02648581|biologics|biologics
248222|NCT02648568|Sleepwalking|sleepwalking
248223|NCT02648568|sleep terrors|sleep terrors
248224|NCT02648568|arousal disorders|arousal disorders
248225|NCT02648568|F513 (CIM-10)|f513 (cim-10)
248226|NCT02648568|F514 (CIM-10)|f514 (cim-10)
248227|NCT02648529|Benign childhood epilepsy with centro-temporal spikes|benign childhood epilepsy with centro-temporal spikes
248228|NCT02648529|rolandic epilepsy|rolandic epilepsy
248229|NCT02648529|brain development|brain development
248230|NCT02648529|DTI|dti
248231|NCT02648529|functional MRI|functional mri
248232|NCT02648529|structural MRI|structural mri
248233|NCT02648529|idiopathic focal epilepsy|idiopathic focal epilepsy
248234|NCT02648529|cryptogenic epilepsy of childhood|cryptogenic epilepsy of childhood
248235|NCT02648516|Immune Reconstitution|immune reconstitution
248236|NCT02648516|Allogenic HLA-Mismatched Mononuclear Cells Transplantation|allogenic hla-mismatched mononuclear cells transplantation
248237|NCT02648503|Sugammadex|sugammadex
248238|NCT02648503|Post-operative Quality Recovery Scale (PQRS)|post-operative quality recovery scale (pqrs)
248239|NCT02648490|metastatic or recurrent epithelial cancer|metastatic or recurrent epithelial cancer
248240|NCT02648464|Hydroxychloroquine|hydroxychloroquine
248241|NCT02648464|anti-inflammatory|anti-inflammatory
248242|NCT02648464|Myocardial infarction|myocardial infarction
248243|NCT02648464|cardiovascular diseases|cardiovascular diseases
248244|NCT02648438|AZD7594|azd7594
248245|NCT02648438|Bioavailability|bioavailability
248246|NCT02648438|Healthy male subjects|healthy male subjects
248247|NCT02648438|Safety|safety
248248|NCT02648438|Tolerability|tolerability
248249|NCT02648438|Pharmacokinetics|pharmacokinetics
248250|NCT02648438|Monodose inhaler|monodose inhaler
248251|NCT02648438|Multiple-dose dry powder inhaler|multiple-dose dry powder inhaler
248252|NCT02648425|ASLAN001|aslan001
248253|NCT02648425|Varlitinib|varlitinib
248254|NCT02648399|thyroid carcinoma|thyroid carcinoma
248255|NCT02648399|center lymph node dissection|center lymph node dissection
248256|NCT02648360|exercise|exercise
248257|NCT02648360|diet|diet
248258|NCT02648360|patients, underserved|patients, underserved
248259|NCT02648360|text messaging|text messaging
248260|NCT02648347|vadadustat|vadadustat
248261|NCT02648347|AKB-6548|akb-6548
248262|NCT02648347|Chronic kidney disease|chronic kidney disease
248263|NCT02648347|anemia|anemia
248264|NCT02648347|CKD|ckd
248265|NCT02648347|chronic renal insufficiency|chronic renal insufficiency
248266|NCT02648347|renal impairment|renal impairment
248267|NCT02648347|erythropoietin|erythropoietin
248268|NCT02648347|kidney|kidney
248269|NCT02648347|renal|renal
248270|NCT02648347|oral anemia treatment|oral anemia treatment
248271|NCT02648347|hemoglobin|hemoglobin
248272|NCT02648347|hypoxia-inducible factor|hypoxia-inducible factor
248273|NCT02648347|HIF|hif
248274|NCT02648347|hypoxia-inducible factor prolyl-hydroxylase inhibitor|hypoxia-inducible factor prolyl-hydroxylase inhibitor
248275|NCT02648347|HIF-PHI|hif-phi
248276|NCT02648347|efficacy|efficacy
248277|NCT02648347|safety|safety
248278|NCT02648347|Phase 3|phase 3
248279|NCT02648347|cardiovascular|cardiovascular
248280|NCT02648347|NDD-CKD|ndd-ckd
248281|NCT02648334|Drug-Coated Balloon|drug-coated balloon
248282|NCT02648334|Superficial Femoral artery|superficial femoral artery
248283|NCT02648334|popliteal peripheral Artery|popliteal peripheral artery
248284|NCT02648321|Motivational Interviewing|motivational interviewing
248285|NCT02648321|Exercise|exercise
248286|NCT02648308|Education, Medical|education, medical
248287|NCT02648282|vaccine|vaccine
248288|NCT02648282|immunotherapy|immunotherapy
248289|NCT02648282|antibody|antibody
248290|NCT02648282|PD-1|pd-1
248291|NCT02648282|radiation|radiation
248292|NCT02648256|Pneumocystis jirovecii|pneumocystis jirovecii
248293|NCT02648256|Polymerase Chain Reaction|polymerase chain reaction
248294|NCT02648256|Oropharyngeal Rinse|oropharyngeal rinse
248295|NCT02648243|Qatar|qatar
248296|NCT02648243|Acute Coronary Syndrome|acute coronary syndrome
248297|NCT02648243|Pharmacist|pharmacist
248298|NCT02648243|Medication burden|medication burden
248299|NCT02648243|Mortality|mortality
248300|NCT02648243|Readmission|readmission
248301|NCT02648243|Adherence|adherence
248302|NCT02648243|Impact|impact
248303|NCT02648230|Ischemia|ischemia
248304|NCT02648230|Fractional Flow Reserve|fractional flow reserve
248305|NCT02648230|Stent|stent
248306|NCT02648191|Obesity|obesity
248307|NCT02648191|Bariatric Surgery|bariatric surgery
248308|NCT02648191|No invasive intra-auricular vagus nerve stimulation|no invasive intra-auricular vagus nerve stimulation
248309|NCT02648191|Weight loss|weight loss
248310|NCT02648191|Autonomic nervous system|autonomic nervous system
248311|NCT02648113|Myocardial Infarction|myocardial infarction
248312|NCT02648113|Anemia|anemia
248313|NCT02648113|Blood Transfusion|blood transfusion
248314|NCT02648100|Muscle invasive bladder cancer|muscle invasive bladder cancer
248315|NCT02648100|Basal subtype|basal subtype
248316|NCT02648100|Anti-EGFR treatment|anti-egfr treatment
248317|NCT02648100|Nanostring|nanostring
248318|NCT02648074|asthma|asthma
248319|NCT02648074|eosinophils|eosinophils
248320|NCT02648074|airway smooth muscle|airway smooth muscle
248321|NCT02648074|airway remodelling|airway remodelling
248322|NCT02648074|integrins|integrins
248323|NCT02648074|cytokines|cytokines
248324|NCT02648061|Blood circulation|blood circulation
248325|NCT02648061|Follow-up studies|follow-up studies
248326|NCT02648061|Biological markers|biological markers
248327|NCT02648061|Hemodynamics|hemodynamics
248328|NCT02648048|Idiopathic Pulmonary Fibrosis|idiopathic pulmonary fibrosis
248329|NCT02648048|Vismodegib|vismodegib
248330|NCT02648048|Pirfenidone|pirfenidone
248331|NCT02648022|Care Integration|care integration
248332|NCT02648022|Hepatitis C|hepatitis c
248333|NCT02648022|Substance Use Disorder|substance use disorder
248334|NCT02648022|PTSD|ptsd
248335|NCT02647970|Energy metabolism|energy metabolism
248336|NCT02647957|acute ischemic stroke|acute ischemic stroke
248337|NCT02647957|quality|quality
248338|NCT02647905|type 1 diabetes|type 1 diabetes
248339|NCT02647905|type 2 diabetes|type 2 diabetes
248340|NCT02647905|CGM|cgm
248341|NCT02647905|implantable|implantable
248342|NCT02647905|accuracy|accuracy
248343|NCT02647905|longevity|longevity
248344|NCT02647866|4083-002|4083-002
248345|NCT02647866|Intestinal Diseases|intestinal diseases
248346|NCT02647866|Ulcerative Colitis|ulcerative colitis
248347|NCT02647866|UC|uc
248348|NCT02647866|Mayo Clinic Scoring|mayo clinic scoring
248349|NCT02647866|Gastrointestinal Tract|gastrointestinal tract
248350|NCT02647840|dysphonia|dysphonia
248351|NCT02647840|voice therapy|voice therapy
248352|NCT02647827|Acupuncture|acupuncture
248353|NCT02647827|Metformin|metformin
248354|NCT02647827|Glucose metabolism|glucose metabolism
248355|NCT02647827|Hba1c|hba1c
248356|NCT02647814|Parent activation|parent activation
248357|NCT02647814|Text-messages|text-messages
248358|NCT02647814|LEP|lep
248359|NCT02647814|Latino populations|latino populations
248360|NCT02647814|pediatrics|pediatrics
248361|NCT02647801|Network approach|network approach
248362|NCT02647801|mindfulness|mindfulness
248363|NCT02647801|self-control|self-control
248364|NCT02647801|ambulatory assessment|ambulatory assessment
248365|NCT02647788|Pain, Postoperative|pain, postoperative
248366|NCT02647775|Thoracoscopic surgery|thoracoscopic surgery
248367|NCT02647723|Omega-3|omega-3
248368|NCT02647723|Fatty acid|fatty acid
248369|NCT02647723|docosahexaenoic|docosahexaenoic
248370|NCT02647723|Pregnant|pregnant
248371|NCT02647723|neurodevelopment|neurodevelopment
248372|NCT02647723|stress|stress
248373|NCT02647723|urban|urban
248374|NCT02647723|african-american|african-american
248375|NCT02647723|supplement|supplement
248376|NCT02647723|nutrition|nutrition
248377|NCT02647723|mental health|mental health
248378|NCT02647710|HIV Prevention|hiv prevention
248379|NCT02647710|Juvenile Justice|juvenile justice
248380|NCT02647710|Sexual Health|sexual health
248381|NCT02647710|Evidence Based Intervention|evidence based intervention
248382|NCT02647697|UCB3491|ucb3491
248383|NCT02647697|Phase 1|phase 1
248384|NCT02647697|Pharmacokinetics|pharmacokinetics
248385|NCT02647697|Radiprodil|radiprodil
248386|NCT02647697|Healthy volunteers|healthy volunteers
248387|NCT02647684|Cancer|cancer
248388|NCT02647684|Parenting|parenting
248389|NCT02647684|Self-directed Triple P|self-directed triple p
248390|NCT02647671|Colon polyp|colon polyp
248391|NCT02647671|Colorectal cancer|colorectal cancer
248392|NCT02647671|Chemoprevention|chemoprevention
248393|NCT02647671|Natural product|natural product
248394|NCT02647658|acute low back pain|acute low back pain
248395|NCT02647658|primary care|primary care
248396|NCT02647658|psychologically informed physical therapy|psychologically informed physical therapy
248397|NCT02647658|cluster randomized pragmatic trial|cluster randomized pragmatic trial
248398|NCT02647658|comparative effectiveness|comparative effectiveness
248399|NCT02647658|secondary prevention|secondary prevention
248400|NCT02647632|HCV genotype 1 or 4|hcv genotype 1 or 4
248401|NCT02647632|failure to DAA|failure to daa
248402|NCT02647619|Primary Dd disase|primary dd disase
248403|NCT02647619|MCP joint|mcp joint
248404|NCT02647580|Growth|growth
248405|NCT02647580|Children|children
248406|NCT02647580|Appetite-regulating hormones|appetite-regulating hormones
248407|NCT02647580|Gut Microbiota|gut microbiota
248408|NCT02647567|Cognitive|cognitive
248409|NCT02647567|Aerobic Exercise|aerobic exercise
248410|NCT02647567|Performance|performance
248411|NCT02647554|sepsis|sepsis
248412|NCT02647554|septic shock|septic shock
248413|NCT02647554|Ulinastatin|ulinastatin
248414|NCT02647554|adult|adult
248415|NCT02647554|China|china
248416|NCT02647541|Children|children
248417|NCT02647541|Congenital heart disease|congenital heart disease
248418|NCT02647541|Nutritional status|nutritional status
248419|NCT02647541|Bioelectrical impedance|bioelectrical impedance
248420|NCT02647476|immunonutrition|immunonutrition
248421|NCT02647476|gastric cancer|gastric cancer
248422|NCT02647476|enteral nutrition|enteral nutrition
248423|NCT02647463|Attachment|attachment
248424|NCT02647463|Cortisol|cortisol
248425|NCT02647463|Parent sensitivity|parent sensitivity
248426|NCT02647411|Prevalence|prevalence
248427|NCT02647411|Myopia|myopia
248428|NCT02647398|Cancer survivors|cancer survivors
248429|NCT02647398|training|training
248430|NCT02647398|exercise|exercise
248431|NCT02647398|cancer-related fatigue|cancer-related fatigue
248432|NCT02647385|serratus anterior plane block|serratus anterior plane block
248433|NCT02647385|pectoral nerve block|pectoral nerve block
248434|NCT02647385|breast surgery|breast surgery
248435|NCT02647385|cancer|cancer
248436|NCT02647385|analgesia|analgesia
248437|NCT02647385|inflammatory cytokines|inflammatory cytokines
248438|NCT02647372|parkinson|parkinson
248439|NCT02647372|deep brain stimulation|deep brain stimulation
248440|NCT02647372|globus pallidus|globus pallidus
248441|NCT02647372|subthalamic nucleus|subthalamic nucleus
248442|NCT02647320|type 2 diabetes mellitus|type 2 diabetes mellitus
248443|NCT02647320|interventional|interventional
248444|NCT02647320|double blind|double blind
248445|NCT02647320|phase 2|phase 2
248446|NCT02647281|Single dose|single dose
248447|NCT02647281|Multiple ascending doses (MAD)|multiple ascending doses (mad)
248448|NCT02647281|Pharmacokinetics|pharmacokinetics
248450|NCT02647281|GSK3389404|gsk3389404
248451|NCT02647281|Tolerability|tolerability
248452|NCT02647268|Uterine contraction|uterine contraction
248453|NCT02647268|Oxytocin|oxytocin
248454|NCT02647268|Magnesium sulphate|magnesium sulphate
248455|NCT02647255|crescentic IgA nephropathy|crescentic iga nephropathy
248456|NCT02647255|plasma exchange treatment or plasmapheresis|plasma exchange treatment or plasmapheresis
248457|NCT02647255|randomized controlled trial|randomized controlled trial
248458|NCT02647255|intensive immunosuppressive treatment|intensive immunosuppressive treatment
248459|NCT02647255|methylprednisolone pulse|methylprednisolone pulse
248460|NCT02647216|Mindfulness Based Cognitive Therapy (MBCT)|mindfulness based cognitive therapy (mbct)
248461|NCT02647216|anxiety|anxiety
248462|NCT02647216|depression|depression
248463|NCT02647203|Fluoride toothpaste|fluoride toothpaste
248464|NCT02647203|Root caries|root caries
248465|NCT02647203|Randomized clinical trial|randomized clinical trial
248466|NCT02647190|Erwinia Chrysanthemi Asparaginase|erwinia chrysanthemi asparaginase
248467|NCT02647190|15-107|15-107
248468|NCT02647164|Non-small-cell lung carcinoma|non-small-cell lung carcinoma
248469|NCT02647164|Circulating tumor cells|circulating tumor cells
248470|NCT02647151|Acid Methyl Aminolevulinate (MAL)|acid methyl aminolevulinate (mal)
248471|NCT02647151|Aminolevulinic Gel (ALA) and Actinic Keratosis|aminolevulinic gel (ala) and actinic keratosis
248472|NCT02647112|Bladder cancer|bladder cancer
248473|NCT02647112|Urine|urine
248474|NCT02647112|Methylation|methylation
248475|NCT02647099|Aspirin|aspirin
248476|NCT02647099|PI3K signaling pathway|pi3k signaling pathway
248477|NCT02647086|Eczema|eczema
248478|NCT02647073|Mobile Monitoring|mobile monitoring
248479|NCT02647073|Post-Opioid Consumption|post-opioid consumption
248480|NCT02647073|Vital Signs|vital signs
248481|NCT02647060|cardiopulmonary exercise testing|cardiopulmonary exercise testing
248482|NCT02647060|right ventricle function|right ventricle function
248483|NCT02647060|cardio output|cardio output
248484|NCT02647060|pulmonary hypertension|pulmonary hypertension
248485|NCT02647060|quality of life|quality of life
248486|NCT02647047|spinal analgesia|spinal analgesia
248487|NCT02647047|epidural analgesia|epidural analgesia
248488|NCT02647047|laparotomic liver resection|laparotomic liver resection
248489|NCT02647047|ERAS|eras
248490|NCT02647047|length of stay|length of stay
248491|NCT02647021|physical therapy|physical therapy
248492|NCT02647021|cancer rehabilitation|cancer rehabilitation
248493|NCT02647021|exercise|exercise
248494|NCT02647008|outpatient hysteroscopy, TENS|outpatient hysteroscopy, tens
248495|NCT02646982|Alzheimer's disease|alzheimer's disease
248496|NCT02646982|Vascular function|vascular function
248497|NCT02646982|Neuroinflammation|neuroinflammation
248498|NCT02646956|Sweet Taste|sweet taste
248499|NCT02646956|Psychophysics|psychophysics
248500|NCT02646956|Genetics|genetics
248501|NCT02646956|Diet|diet
248502|NCT02646956|Age|age
248503|NCT02646956|Nonnutritive Sweetener|nonnutritive sweetener
248504|NCT02646943|Cohort|cohort
248505|NCT02646943|Biomarkers|biomarkers
248506|NCT02646943|Cardiomyopathy|cardiomyopathy
248507|NCT02646930|chronic endometritis|chronic endometritis
248508|NCT02646930|invitro fertilization|invitro fertilization
248509|NCT02646930|spontaneous abortion|spontaneous abortion
248510|NCT02646891|Rotavirus Vaccine|rotavirus vaccine
248511|NCT02646878|Type 1 Diabetes|type 1 diabetes
248512|NCT02646878|Type 2 Diabetes|type 2 diabetes
248513|NCT02646878|Harmony Sensor|harmony sensor
248514|NCT02646878|Continuous Glucose Monitoring|continuous glucose monitoring
248515|NCT02646878|CGM|cgm
248516|NCT02646865|social phobia|social phobia
248517|NCT02646865|compassion|compassion
248518|NCT02646865|shame|shame
248519|NCT02646839|Acute Lymphoblastic Leukemia (ALL)|acute lymphoblastic leukemia (all)
248520|NCT02646839|Acute Myeloid Leukemia (AML)|acute myeloid leukemia (aml)
248521|NCT02646839|Myelodysplastic Syndrome (MDS)|myelodysplastic syndrome (mds)
248522|NCT02646839|KIR-Favorable|kir-favorable
248523|NCT02646839|Haploidentical Transplantation|haploidentical transplantation
248524|NCT02646839|Allogeneic Hematopoietic Cell Transplantation|allogeneic hematopoietic cell transplantation
248525|NCT02646800|Micafungin|micafungin
248526|NCT02646800|Antifungal|antifungal
248527|NCT02646800|Candidiasis|candidiasis
248528|NCT02646800|Aspergillosis|aspergillosis
248529|NCT02646774|Aspergillosis|aspergillosis
248530|NCT02646774|Antifungal|antifungal
248531|NCT02646774|Micafungin|micafungin
248532|NCT02646748|Advanced|advanced
248533|NCT02646670|diabetic macular edema|diabetic macular edema
248534|NCT02646670|aflibercept|aflibercept
248535|NCT02646670|ranibizumab|ranibizumab
248536|NCT02646605|Depression|depression
248537|NCT02646605|AIDS|aids
248538|NCT02646605|HIV|hiv
248539|NCT02646579|Orthopedics|orthopedics
248540|NCT02646527|dignity, end of life, existential, treatment|dignity, end of life, existential, treatment
248541|NCT02646514|Cholangiocarcinoma, radiofrequency ablation, metal stent|cholangiocarcinoma, radiofrequency ablation, metal stent
248542|NCT02646488|cholesterol|cholesterol
248543|NCT02646488|smoking|smoking
248544|NCT02646488|aspirin|aspirin
248545|NCT02646488|chronic care model|chronic care model
248546|NCT02646475|renin-angiotensin system|renin-angiotensin system
248547|NCT02646475|angiotensin|angiotensin
248548|NCT02646475|insulin resistance|insulin resistance
248549|NCT02646475|blood pressure|blood pressure
248550|NCT02646462|pancreas adenocarcinoma, lymph node metastases|pancreas adenocarcinoma, lymph node metastases
248551|NCT02646449|Major Depressive Disorder|major depressive disorder
248552|NCT02646449|Alcohol Use Disorder|alcohol use disorder
248553|NCT02646436|unplanned peritoneal dialysis|unplanned peritoneal dialysis
248554|NCT02646436|unplanned heamodialysis|unplanned heamodialysis
248555|NCT02646423|Trial of labor after cesarean|trial of labor after cesarean
248556|NCT02646423|Elective repeat cesarean delivery|elective repeat cesarean delivery
248557|NCT02646423|Decision tool|decision tool
248558|NCT02646423|Shared decision making|shared decision making
248559|NCT02646410|malaria|malaria
248560|NCT02646410|seasonal malaria chemoprevention|seasonal malaria chemoprevention
248561|NCT02646410|immunity|immunity
248562|NCT02646410|resistance|resistance
248563|NCT02646410|sulfadoxine-pyrimethamine|sulfadoxine-pyrimethamine
248564|NCT02646410|amodiaquine|amodiaquine
248565|NCT02646410|delivery method|delivery method
248566|NCT02646397|glomerular filtration rate|glomerular filtration rate
248567|NCT02646397|hypertension|hypertension
248568|NCT02646345|Checklist|checklist
248569|NCT02646345|Mortality|mortality
248570|NCT02646345|Latin America|latin america
248571|NCT02646345|Surgery|surgery
248572|NCT02646345|Morbidity|morbidity
248573|NCT02646332|Helicobacter pylori|helicobacter pylori
248574|NCT02646332|Eradication rate|eradication rate
248575|NCT02646306|shoulder|shoulder
248576|NCT02646306|proprioception|proprioception
248577|NCT02646306|movement|movement
248578|NCT02646306|reaching|reaching
248579|NCT02646280|Low back pain|low back pain
248580|NCT02646280|interoceptive awareness|interoceptive awareness
248581|NCT02646280|motor imagery|motor imagery
248582|NCT02646280|massage|massage
248583|NCT02646267|Atrial fibrillation|atrial fibrillation
248584|NCT02646267|Dabigatran|dabigatran
248585|NCT02646267|Warfarin|warfarin
248586|NCT02646267|Anticoagulation|anticoagulation
248587|NCT02646267|Elderly|elderly
248588|NCT02646254|tetralogy of fallot, cardioplegia|tetralogy of fallot, cardioplegia
248589|NCT02646241|stomach neoplasm|stomach neoplasm
248590|NCT02646241|biopsy|biopsy
712528|NCT00579839|Milking the cord|milking the cord
248591|NCT02646150|Magnetic Resonance perfusion imaging|magnetic resonance perfusion imaging
248592|NCT02646150|distal perfusion|distal perfusion
248593|NCT02646150|Critical Limb Ischemia|critical limb ischemia
248594|NCT02646150|endovascular revascularization|endovascular revascularization
248595|NCT02646124|benzodiazepine|benzodiazepine
248596|NCT02646111|"Hepatitis C Virus"|"hepatitis c virus"
248597|NCT02646111|"Triple Therapy"|"triple therapy"
248598|NCT02646111|"PI Failure"|"pi failure"
248599|NCT02646111|"Genotype 1"|"genotype 1"
248600|NCT02646098|NHL|nhl
248601|NCT02646098|mantle cell lymphoma|mantle cell lymphoma
248602|NCT02646098|diffuse large B-cell lymphoma|diffuse large b-cell lymphoma
248603|NCT02646072|diabetes mellitus|diabetes mellitus
248604|NCT02646072|aqueous humor|aqueous humor
248605|NCT02646072|inflammatory cytokines|inflammatory cytokines
248606|NCT02646072|cystoid macular edema, postoperative|cystoid macular edema, postoperative
248607|NCT02646072|nonsteroidal anti-inflammatory drugs|nonsteroidal anti-inflammatory drugs
248608|NCT02646046|Cardiopulmonary Resuscitation|cardiopulmonary resuscitation
248609|NCT02646046|Emergency Medical Services|emergency medical services
248610|NCT02646046|Cell phones|cell phones
248611|NCT02646046|Simulation Training|simulation training
248612|NCT02646033|Intraocular Pressure, Trendelenburg position|intraocular pressure, trendelenburg position
248613|NCT02646020|pruritus|pruritus
248614|NCT02646020|Non-small Cell Lung Cancer|non-small cell lung cancer
248615|NCT02646020|Receptor, Epidermal Growth Factor|receptor, epidermal growth factor
248616|NCT02646020|tyrosine kinase inhibitor|tyrosine kinase inhibitor
248617|NCT02646007|Autologous Cell therapy Kienböck's disease|autologous cell therapy kienböck's disease
248618|NCT02646007|bone marrow derived mesenchymal stromal/stem cell|bone marrow derived mesenchymal stromal/stem cell
248619|NCT02645994|Closed Loop Anesthesia Delivery System|closed loop anesthesia delivery system
248620|NCT02645994|Target Controlled Infusion|target controlled infusion
248621|NCT02645981|Donafeinb|donafeinb
248622|NCT02645981|Sorafenib|sorafenib
248623|NCT02645981|Phase 3|phase 3
248624|NCT02645981|Overall Survival|overall survival
248625|NCT02645968|Pneumology|pneumology
248626|NCT02645968|Registry|registry
248627|NCT02645968|EXCITING|exciting
248628|NCT02645968|Interstitial lung disease|interstitial lung disease
248629|NCT02645968|ILD|ild
248630|NCT02645942|Carnitine|carnitine
248631|NCT02645942|placebo|placebo
248632|NCT02645942|risk factors|risk factors
248633|NCT02645916|Cold Hypersensitivity in the Hands|cold hypersensitivity in the hands
248634|NCT02645916|Korean medicine|korean medicine
248635|NCT02645916|DSGOST|dsgost
248636|NCT02645903|transversus abdominis plane block|transversus abdominis plane block
248637|NCT02645903|living liver transplantation|living liver transplantation
248638|NCT02645903|postoperative analgesia|postoperative analgesia
248639|NCT02645890|Benign Prostatic Hyperplasia|benign prostatic hyperplasia
248640|NCT02645890|Healthy Male Volunteer|healthy male volunteer
248641|NCT02645890|Tamsulosin|tamsulosin
248642|NCT02645890|Tadalafil|tadalafil
248643|NCT02645877|Pre-hospital Care|pre-hospital care
248644|NCT02645877|Diseases Spectrum|diseases spectrum
248645|NCT02645877|Call Demands|call demands
248646|NCT02645877|Emergency Response Time|emergency response time
248647|NCT02645864|Esophageal squamous cell carcinoma|esophageal squamous cell carcinoma
248648|NCT02645864|Apatinib|apatinib
248649|NCT02645864|Irinotecan|irinotecan
248650|NCT02645851|Fluid Therapy|fluid therapy
248651|NCT02645851|Plasma Substitutes|plasma substitutes
248652|NCT02645851|Fluid Balance|fluid balance
248653|NCT02645838|Motivational Interviewing|motivational interviewing
248654|NCT02645838|Smoking Cessation|smoking cessation
248655|NCT02645825|superficial adenopathy - echography|superficial adenopathy - echography
248656|NCT02645812|Fatigue|fatigue
248657|NCT02645812|Brief Fatigue Inventory (BFI)|brief fatigue inventory (bfi)
248658|NCT02645812|Primary care|primary care
248659|NCT02645812|General Practitioners|general practitioners
248660|NCT02645786|thyroid neoplasms|thyroid neoplasms
248661|NCT02645786|heart|heart
248662|NCT02645786|thyroxine|thyroxine
248663|NCT02645786|thyrotoxicosis|thyrotoxicosis
248664|NCT02645708|RIRS|rirs
248665|NCT02645708|EPVL|epvl
248666|NCT02645708|PDI(Percussion,Diuresis,Inversion)|pdi(percussion,diuresis,inversion)
248667|NCT02645708|Randomized Controlled Trial|randomized controlled trial
248668|NCT02645695|Pulmonary Rehabilitation|pulmonary rehabilitation
248669|NCT02645695|Chest Physiotherapy|chest physiotherapy
248670|NCT02645695|High Frequency Chest Wall Oscillation|high frequency chest wall oscillation
248671|NCT02645682|central venous catheter (CVC)|central venous catheter (cvc)
248672|NCT02645682|catheter-related bloodstream infection (CRBSI)|catheter-related bloodstream infection (crbsi)
248673|NCT02645682|catheter-related thrombosis (CRT)|catheter-related thrombosis (crt)
248674|NCT02645656|Oral Submucous Fibrosis|oral submucous fibrosis
248675|NCT02645656|Curcumin|curcumin
248676|NCT02645643|medical students|medical students
248677|NCT02645643|professionalism|professionalism
248678|NCT02645643|medical education|medical education
248679|NCT02645643|study emotion|study emotion
248680|NCT02645630|Cervical spine|cervical spine
248681|NCT02645630|Spinal manipulation|spinal manipulation
248682|NCT02645604|Artemisinin Combination Therapy (ACT)|artemisinin combination therapy (act)
248683|NCT02645591|Prostate cancer|prostate cancer
248684|NCT02645591|Dehydrated human amnion/chorion membrane|dehydrated human amnion/chorion membrane
248685|NCT02645591|dHACM|dhacm
248686|NCT02645591|Robotic assisted laparoscopic radical prostatectomy|robotic assisted laparoscopic radical prostatectomy
248687|NCT02645591|RARP|rarp
248688|NCT02645591|AmnioFix®|amniofix®
248689|NCT02645591|Sexual function score|sexual function score
248690|NCT02645591|Neurovascular bundle inflammation|neurovascular bundle inflammation
248691|NCT02645591|Questionnaire|questionnaire
248692|NCT02645591|Survey|survey
248693|NCT02645578|Coma|coma
248694|NCT02645578|traumatic brain injury|traumatic brain injury
248695|NCT02645578|median nerve stimulation|median nerve stimulation
248696|NCT02645552|Traumatic brain injury|traumatic brain injury
248697|NCT02645539|Heart failure|heart failure
248698|NCT02645539|Bridge-to-transplant|bridge-to-transplant
248699|NCT02645539|circulatory support|circulatory support
248701|NCT02645539|IABP|iabp
248702|NCT02645513|mHealth|mhealth
248703|NCT02645513|text message|text message
248704|NCT02645513|case management|case management
248705|NCT02645500|Physical Activity|physical activity
248706|NCT02645500|Family well-being|family well-being
248707|NCT02645448|Resistance Exercise|resistance exercise
248708|NCT02645448|Diabetes Mellitus|diabetes mellitus
248709|NCT02645448|Heart Rate Variability|heart rate variability
248710|NCT02645409|Fluorescence|fluorescence
248711|NCT02645409|Imaging|imaging
248712|NCT02645409|Partial nephrectomy|partial nephrectomy
248713|NCT02645409|Radical nephrectomy|radical nephrectomy
248714|NCT02645396|Cytomegalovirus|cytomegalovirus
248715|NCT02645383|Pattern scan laser|pattern scan laser
248716|NCT02645383|Proliferative diabetic retinopathy|proliferative diabetic retinopathy
248717|NCT02645383|Pain|pain
248718|NCT02645370|Migraine|migraine
248719|NCT02645370|Danzhen|danzhen
248720|NCT02645370|Topiramate|topiramate
248721|NCT02645370|Headache diary APP|headache diary app
248722|NCT02645370|preventive treatment|preventive treatment
248723|NCT02645357|Oncology Patients|oncology patients
248724|NCT02645357|evidence-based|evidence-based
248725|NCT02645357|computerized|computerized
248726|NCT02645357|decision|decision
248727|NCT02645357|support system|support system
248728|NCT02645357|linked|linked
248729|NCT02645357|electronic health records|electronic health records
248730|NCT02645344|Unilateral neglect|unilateral neglect
248731|NCT02645344|Right hemiplegia|right hemiplegia
248732|NCT02645318|Circulating Tumor DNA|circulating tumor dna
248733|NCT02645318|Lung cancer|lung cancer
248734|NCT02645318|Targeted sequencing|targeted sequencing
248735|NCT02645305|Safety and Efficacy|safety and efficacy
248736|NCT02645305|Adipose stem cells|adipose stem cells
248737|NCT02645305|Stem Cell therapy|stem cell therapy
248738|NCT02645279|newborn|newborn
248739|NCT02645279|MRI|mri
248740|NCT02645279|oral 30% glucose|oral 30% glucose
248741|NCT02645253|Safety|safety
248742|NCT02645253|Pharmacokinetics|pharmacokinetics
248743|NCT02645253|Pharmacodynamics|pharmacodynamics
248744|NCT02645253|Glucocorticoid receptor modulator|glucocorticoid receptor modulator
248745|NCT02645253|Healthy male subjects|healthy male subjects
248746|NCT02645201|probiotic|probiotic
248747|NCT02645188|Electromyography|electromyography
248748|NCT02645188|Exercise|exercise
248749|NCT02645175|Paclitaxel|paclitaxel
248750|NCT02645175|docetaxel|docetaxel
248751|NCT02645175|vinorelbine|vinorelbine
248752|NCT02645175|eribulin|eribulin
248753|NCT02645162|Pakistan|pakistan
248754|NCT02645162|Early Child Development, Care and Education|early child development, care and education
248755|NCT02645162|Youth Leaders|youth leaders
248756|NCT02645149|Metastatic Melanoma|metastatic melanoma
248757|NCT02645149|Molecular Testing|molecular testing
248758|NCT02645149|Targeted Therapy|targeted therapy
248759|NCT02645123|spinal mobilization|spinal mobilization
248760|NCT02645123|manual therapy|manual therapy
248761|NCT02645123|gait analysis|gait analysis
248762|NCT02645123|low back pain|low back pain
248763|NCT02645123|chronic|chronic
248764|NCT02645097|Adult|adult
248765|NCT02645097|nerve blocks in foot and ankle surgery|nerve blocks in foot and ankle surgery
248766|NCT02645097|saphenous|saphenous
248767|NCT02645071|physical activity|physical activity
248768|NCT02645071|family well being,|family well being,
248769|NCT02645071|health|health
248770|NCT02645058|Ureterorenoscopy|ureterorenoscopy
248771|NCT02645058|extracorporeal shock waves lithotripsy|extracorporeal shock waves lithotripsy
248772|NCT02645045|Dry eye|dry eye
248773|NCT02645045|Lipiview|lipiview
248774|NCT02645045|Tear Lipid Layer|tear lipid layer
248775|NCT02645045|meibomian gland dysfunction|meibomian gland dysfunction
248776|NCT02645032|Typhoid conjugate vaccine|typhoid conjugate vaccine
248777|NCT02645032|Vi-DT|vi-dt
248778|NCT02645032|Safety|safety
248779|NCT02645032|Immunogenicuty|immunogenicuty
248780|NCT02645006|falls|falls
248781|NCT02645006|elderly|elderly
248782|NCT02645006|Exercise,Physical|exercise,physical
248783|NCT02645006|vitamin d|vitamin d
248784|NCT02645006|home hazards|home hazards
248785|NCT02645006|mediterranean diet|mediterranean diet
248786|NCT02645006|body mass index|body mass index
248787|NCT02645006|lower extremity exercise movement technics|lower extremity exercise movement technics
248788|NCT02645006|vitamin D intake|vitamin d intake
248789|NCT02645006|Short Physical Performance Battery (SPPB o Test de Guralnik)|short physical performance battery (sppb o test de guralnik)
248790|NCT02644980|Target Controlled Infusion|target controlled infusion
248791|NCT02644967|ILLUMINATE- 204|illuminate- 204
248792|NCT02644954|psoriasis|psoriasis
248793|NCT02644954|Metformin|metformin
248794|NCT02644928|Chronic kidney disease|chronic kidney disease
248795|NCT02644928|Bariatric Surgery Candidate|bariatric surgery candidate
248796|NCT02644928|Caloric restriction|caloric restriction
248797|NCT02644915|ischemia-reperfusion(I/R) injury|ischemia-reperfusion(i/r) injury
248798|NCT02644915|Edaravone|edaravone
248799|NCT02644902|Avatar assisted cascade training and supervision|avatar assisted cascade training and supervision
248800|NCT02644902|maternal depression|maternal depression
248801|NCT02644902|postconflict|postconflict
248802|NCT02644902|THP|thp
248803|NCT02644889|Epidermal growth factor receptor(EGFR)|epidermal growth factor receptor(egfr)
248804|NCT02644889|NSCLC|nsclc
248805|NCT02644876|Postoperative pulmonary complications|postoperative pulmonary complications
248806|NCT02644876|Selective anticholinergic bronchodilator|selective anticholinergic bronchodilator
248807|NCT02644876|High risk patients|high risk patients
248808|NCT02644876|Postoperative period|postoperative period
248809|NCT02644876|Postoperative complications|postoperative complications
248810|NCT02644824|Congenital Heart Disease (CHD)|congenital heart disease (chd)
248811|NCT02644824|Cardiopulmonary Bypass (CPB)|cardiopulmonary bypass (cpb)
248812|NCT02644824|Cardiac Index|cardiac index
248813|NCT02644824|Hemodynamics|hemodynamics
248814|NCT02644824|Pediatrics|pediatrics
248815|NCT02644811|Miniscrew|miniscrew
248816|NCT02644811|Temporary anchorage device (TAD)|temporary anchorage device (tad)
248817|NCT02644811|mini-implants|mini-implants
248818|NCT02644811|Miniscrew implant (MSI)|miniscrew implant (msi)
248819|NCT02644798|ARDS|ards
248820|NCT02644798|Gene polymorphism|gene polymorphism
248821|NCT02644785|cardiac by-pass|cardiac by-pass
248822|NCT02644785|protamine|protamine
248823|NCT02644785|tryptase|tryptase
248824|NCT02644785|hypotension|hypotension
248825|NCT02644785|anaphylaxis|anaphylaxis
248826|NCT02644772|Acute Exacerbation of COPD|acute exacerbation of copd
248827|NCT02644772|Clinical problems in COPD|clinical problems in copd
248828|NCT02644759|Stem Cells|stem cells
248829|NCT02644759|Transplantation|transplantation
248830|NCT02644759|Immunomodulation|immunomodulation
248831|NCT02644759|CD34|cd34
248832|NCT02644759|CD133|cd133
248833|NCT02644759|ClinicMACS|clinicmacs
248834|NCT02644746|degenerative lumbar spinal stenosis|degenerative lumbar spinal stenosis
248835|NCT02644746|acupuncture|acupuncture
248836|NCT02644746|randomized controlled trial|randomized controlled trial
248837|NCT02644668|Reldesemtiv|reldesemtiv
248838|NCT02644655|Recurrent B-Cell Tumor|recurrent b-cell tumor
248839|NCT02644655|Refractory B-Cell Tumor|refractory b-cell tumor
248840|NCT02644655|New Cluster of Differentiation Antigen 19-chimeric Antigen Receptor T Cells|new cluster of differentiation antigen 19-chimeric antigen receptor t cells
248841|NCT02644655|safety|safety
248842|NCT02644655|prognosis|prognosis
248843|NCT02644616|tolvaptan|tolvaptan
248844|NCT02644616|safety and efficacy|safety and efficacy
248845|NCT02644616|left heart valves replacement|left heart valves replacement
248846|NCT02644603|Enhanced Recovery After Surgery|enhanced recovery after surgery
248847|NCT02644603|hepatocellular carcinoma|hepatocellular carcinoma
248848|NCT02644590|Melatonin|melatonin
248849|NCT02644590|Nocturnal Hypertension|nocturnal hypertension
248850|NCT02644590|Type 1 Diabetes Melitus|type 1 diabetes melitus
248851|NCT02644577|Metformin|metformin
248852|NCT02644577|antipsychotic-induced metabolic syndrome|antipsychotic-induced metabolic syndrome
248853|NCT02644577|bipolar disorder|bipolar disorder
248854|NCT02644564|Soft tissue shoulder injury|soft tissue shoulder injury
248855|NCT02644564|Rotator cuff tear|rotator cuff tear
248856|NCT02644564|Ultrasonography|ultrasonography
248857|NCT02644538|HBsAg clearance|hbsag clearance
248858|NCT02644525|Cameroon|cameroon
248859|NCT02644525|Filaricidal|filaricidal
248860|NCT02644525|Randomized|randomized
248861|NCT02644525|Blinded|blinded
248862|NCT02644525|Diethylcarbamazine|diethylcarbamazine
248863|NCT02644434|Percutaneous Coronary Intervention|percutaneous coronary intervention
248864|NCT02644434|Coronary Bifurcation Intervention|coronary bifurcation intervention
248865|NCT02644434|Randomized Clinical Trial|randomized clinical trial
248866|NCT02644421|Neuropathic Pain|neuropathic pain
248867|NCT02644421|Sciatica|sciatica
248868|NCT02644408|Chemoradiotherapy|chemoradiotherapy
248869|NCT02644408|Esophageal Squamous Cancer|esophageal squamous cancer
248870|NCT02644408|Megestrol|megestrol
248871|NCT02644382|breast cancer|breast cancer
248872|NCT02644382|decision making|decision making
248873|NCT02644382|surgery|surgery
248874|NCT02644382|qualitative|qualitative
248875|NCT02644317|Motor development delay|motor development delay
248876|NCT02644317|balance|balance
248877|NCT02644317|flatfoot|flatfoot
248878|NCT02644317|shoe insert|shoe insert
248879|NCT02644291|medulloblastoma|medulloblastoma
248880|NCT02644291|Diffuse Intrinsic Pontine Glioma (DIPG)|diffuse intrinsic pontine glioma (dipg)
248881|NCT02644291|high grade glioma|high grade glioma
248882|NCT02644291|glioblastoma|glioblastoma
248883|NCT02644291|brain stem malignant glioma|brain stem malignant glioma
248884|NCT02644278|VX15-984-001|vx15-984-001
248885|NCT02644278|VX-984|vx-984
248886|NCT02644278|M9831|m9831
248887|NCT02644278|Advanced Solid Tumor|advanced solid tumor
248888|NCT02644278|Pegylated liposomal doxorubicin|pegylated liposomal doxorubicin
248889|NCT02644265|Acute acquired brain injury|acute acquired brain injury
248890|NCT02644265|Disorders of consciousness|disorders of consciousness
248891|NCT02644265|Traumatic brain injury|traumatic brain injury
248892|NCT02644265|Non-traumatic brain injury|non-traumatic brain injury
248893|NCT02644265|Anoxic-ischemic encephalopathy|anoxic-ischemic encephalopathy
248894|NCT02644265|Stroke|stroke
248895|NCT02644265|Vegetative state|vegetative state
248896|NCT02644265|Minimal conscious state|minimal conscious state
248897|NCT02644265|Locked-in syndrome|locked-in syndrome
248898|NCT02644265|Functional magnetic resonance imaging|functional magnetic resonance imaging
248899|NCT02644265|Electroencephalography|electroencephalography
248900|NCT02644174|Obesity|obesity
248901|NCT02644174|Lung function test|lung function test
248902|NCT02644174|Bariatric surgery|bariatric surgery
248903|NCT02644161|stroke|stroke
248904|NCT02644161|depression|depression
248905|NCT02644161|stroke sequelae|stroke sequelae
248906|NCT02644161|acupuncture|acupuncture
248907|NCT02644161|DCEAS|dceas
248908|NCT02644161|CAI|cai
248909|NCT02644161|LAS|las
248910|NCT02644135|Healthy volunteer|healthy volunteer
248911|NCT02644122|advanced cancer|advanced cancer
248912|NCT02644122|metastatic cancer|metastatic cancer
248913|NCT02644122|Squamous Cell Carcinoma of the Head and Neck|squamous cell carcinoma of the head and neck
248914|NCT02644122|SCCHN|scchn
248915|NCT02644122|gene mutation|gene mutation
248916|NCT02644122|PIK3R1, PIK3R5 and PIK3AP1|pik3r1, pik3r5 and pik3ap1
248917|NCT02644122|PIK3CG|pik3cg
248918|NCT02644122|AKT and mTOR|akt and mtor
248919|NCT02644122|PIK3CA gene|pik3ca gene
248920|NCT02644122|PI-3 kinase inhibitor|pi-3 kinase inhibitor
248921|NCT02644122|PI-3 kinase pathway genes|pi-3 kinase pathway genes
248922|NCT02644096|Rehabilitation|rehabilitation
248923|NCT02644096|RCT|rct
248924|NCT02644096|User Involvement|user involvement
248925|NCT02644096|Self-Rated Health|self-rated health
248926|NCT02644070|Alveolar bone loss|alveolar bone loss
248927|NCT02644070|Alveoloplasty|alveoloplasty
248928|NCT02644070|Bone remodeling|bone remodeling
248929|NCT02644070|Xenograft|xenograft
248930|NCT02644070|Tooth socket|tooth socket
248931|NCT02644070|Dental implant|dental implant
248932|NCT02644044|Progressive multiple sclerosis|progressive multiple sclerosis
248933|NCT02644044|methotrexate|methotrexate
248934|NCT02644031|Instrumentation|instrumentation
248935|NCT02644031|Post-operative pain|post-operative pain
248936|NCT02644031|Root canal preparation|root canal preparation
248937|NCT02644018|Ingavirin|ingavirin
248938|NCT02644018|Common Cold|common cold
248939|NCT02644018|Influenza|influenza
248940|NCT02644018|Acute Respiratory Viral Infections|acute respiratory viral infections
248941|NCT02644018|pediatric clinical trial|pediatric clinical trial
248942|NCT02644018|Imidazolyl ethanamide pentandioic acid|imidazolyl ethanamide pentandioic acid
248943|NCT02643979|Ketamine|ketamine
248944|NCT02643979|Propofol|propofol
248945|NCT02643979|Ketofol|ketofol
248946|NCT02643979|Obese|obese
248947|NCT02643979|Upper gastrointestinal endoscopy|upper gastrointestinal endoscopy
248948|NCT02643979|Sedation|sedation
248949|NCT02643979|Bariatric|bariatric
248950|NCT02643966|whole breast ultrasound|whole breast ultrasound
248951|NCT02643966|digital breast tomosynthesis|digital breast tomosynthesis
248952|NCT02643966|breast density|breast density
248953|NCT02643966|breast cancer screening|breast cancer screening
248954|NCT02643953|Maternal Health|maternal health
248955|NCT02643953|Maternal Mortality|maternal mortality
248956|NCT02643953|Global Health|global health
248957|NCT02643953|RCT|rct
248958|NCT02643940|Percutaneous Coronary Intervention (PCI)|percutaneous coronary intervention (pci)
248959|NCT02643940|Chronic Total Occlusion (CTO)|chronic total occlusion (cto)
248960|NCT02643940|Cardiac MRI|cardiac mri
248961|NCT02643940|Instantaneous wave-free ratio (iFR)|instantaneous wave-free ratio (ifr)
248962|NCT02643875|myopia control|myopia control
248963|NCT02643875|orthokeratology|orthokeratology
248964|NCT02643823|Human Umbilical Cord Mesenchymal Stem Cell|human umbilical cord mesenchymal stem cell
248965|NCT02643823|Mesenchymal Stem Cell|mesenchymal stem cell
248966|NCT02643823|Rheumatoid Arthritis|rheumatoid arthritis
248967|NCT02643810|exercise training|exercise training
248968|NCT02643797|diabetes|diabetes
248969|NCT02643797|medical assistant|medical assistant
248970|NCT02643797|health coach|health coach
318207|NCT02244073|ICU|icu
248971|NCT02643797|glycemic control|glycemic control
248972|NCT02643797|pragmatic trial|pragmatic trial
248973|NCT02643784|acute ischemic stroke|acute ischemic stroke
248974|NCT02643771|Dental Scaling|dental scaling
248975|NCT02643771|Blood Glucose|blood glucose
248976|NCT02643771|Hemoglobin A, Glycosylated|hemoglobin a, glycosylated
248977|NCT02643758|Myopia control, bifocal soft contact lenses, children|myopia control, bifocal soft contact lenses, children
248978|NCT02643745|acute kidney injury|acute kidney injury
248979|NCT02643745|cardiac surgery|cardiac surgery
248980|NCT02643732|Activity|activity
248981|NCT02643719|migraine|migraine
248982|NCT02643719|topiramate|topiramate
248983|NCT02643706|Aldehyde dehydrogenase 2|aldehyde dehydrogenase 2
248984|NCT02643706|contrast induced nephropathy|contrast induced nephropathy
248985|NCT02643706|Gene polymorphism|gene polymorphism
248986|NCT02643693|Conventional cigarette|conventional cigarette
248987|NCT02643693|Nicotine lactate delivery system|nicotine lactate delivery system
248988|NCT02643693|e-cigarette|e-cigarette
248989|NCT02643693|VUSE|vuse
248990|NCT02643693|Combustible cigarette|combustible cigarette
248991|NCT02643680|Biocellulose|biocellulose
248992|NCT02643680|Silk sericin|silk sericin
248993|NCT02643680|Polyhexamethylene biguanide|polyhexamethylene biguanide
248994|NCT02643680|Split thickness skin graft donor site|split thickness skin graft donor site
248995|NCT02643667|Radical prostatectomy (RP)|radical prostatectomy (rp)
248996|NCT02643654|interleukin-1alpha|interleukin-1alpha
248997|NCT02643641|Grass pollen allergy|grass pollen allergy
248998|NCT02643641|subcutaneous immunotherapy|subcutaneous immunotherapy
248999|NCT02643641|allergy vaccine|allergy vaccine
249000|NCT02643641|dose regimen|dose regimen
249001|NCT02643615|Visual Evoked Potentials|visual evoked potentials
249002|NCT02643589|haploidentical hematopoietic Stem Cell Transplantation Antithymocyte globulin|haploidentical hematopoietic stem cell transplantation antithymocyte globulin
249003|NCT02643589|acute graft-versus-host disease|acute graft-versus-host disease
249004|NCT02643589|antithymocyte globulin|antithymocyte globulin
249005|NCT02643563|Brachial Plexus Block|brachial plexus block
249006|NCT02643563|Anesthetics, Local|anesthetics, local
249007|NCT02643524|Adult|adult
249008|NCT02643524|CAM boot|cam boot
249009|NCT02643524|controlled ankle movement|controlled ankle movement
249010|NCT02643498|Stereotactic Body Radiotherapy (SBRT)|stereotactic body radiotherapy (sbrt)
249011|NCT02643498|15-109|15-109
249012|NCT02643472|neonate|neonate
249013|NCT02643472|newborn|newborn
249014|NCT02643472|neonatal intensive care unit|neonatal intensive care unit
249015|NCT02643472|NICU|nicu
249016|NCT02643472|NICU discharge|nicu discharge
249017|NCT02643472|parent navigator|parent navigator
249018|NCT02643472|peer to peer|peer to peer
249019|NCT02643472|peer coaching|peer coaching
249020|NCT02643459|Triage|triage
249021|NCT02643459|Risk stratification|risk stratification
249022|NCT02643459|Acute care|acute care
249023|NCT02643459|suPAR|supar
249024|NCT02643446|Poliovirus Vaccine, Inactivated|poliovirus vaccine, inactivated
249025|NCT02643446|Poliovirus Vaccine, Oral|poliovirus vaccine, oral
249026|NCT02643446|Immunity|immunity
249027|NCT02643446|Seroconversion|seroconversion
249028|NCT02643433|Immunogenicity|immunogenicity
249029|NCT02643433|Coadministration|coadministration
249030|NCT02643433|Measles|measles
249031|NCT02643433|Rubella|rubella
249032|NCT02643433|Japanese encephalitis|japanese encephalitis
249033|NCT02643433|Vaccine|vaccine
249034|NCT02643420|Neutropenia|neutropenia
249035|NCT02643420|Breast Cancer|breast cancer
249036|NCT02643420|Long-acting Myeloid Growth Factor|long-acting myeloid growth factor
249037|NCT02643420|Early Stage Breast Cancer|early stage breast cancer
249038|NCT02643420|Docetaxel + Cyclophosphamide (TC) chemotherapy|docetaxel + cyclophosphamide (tc) chemotherapy
249039|NCT02643407|squamous cell carcinoma|squamous cell carcinoma
249040|NCT02643407|nedaplatin|nedaplatin
249041|NCT02643407|cisplatin|cisplatin
249042|NCT02643407|docetaxel|docetaxel
249043|NCT02643394|Acetaminophen|acetaminophen
249044|NCT02643394|Postoperative pain|postoperative pain
249045|NCT02643394|Sinus Surgery|sinus surgery
249046|NCT02643381|etomidate|etomidate
249047|NCT02643381|ketamine|ketamine
249048|NCT02643381|endotracheal intubation|endotracheal intubation
249049|NCT02643381|anesthesia induction medications|anesthesia induction medications
249050|NCT02643368|Polio|polio
249051|NCT02643368|Inactivated polio vaccine|inactivated polio vaccine
249052|NCT02643368|oral polio vaccine|oral polio vaccine
249053|NCT02643368|monovalent type 2 oral polio vaccine|monovalent type 2 oral polio vaccine
249054|NCT02643355|Narcotic Withdrawal|narcotic withdrawal
249055|NCT02643355|Opiate Withdrawal|opiate withdrawal
249056|NCT02643355|Emergency Department|emergency department
249057|NCT02643342|myopia control|myopia control
249058|NCT02643342|orthokeratology|orthokeratology
249059|NCT02643303|Durvalumab|durvalumab
249060|NCT02643303|MEDI4736|medi4736
249061|NCT02643303|Tremelimumab|tremelimumab
249062|NCT02643303|PolyICLC|polyiclc
249063|NCT02643303|Hiltonol|hiltonol
249064|NCT02643303|Locally Recurrent Breast Cancer|locally recurrent breast cancer
249065|NCT02643303|Metastatic Melanoma|metastatic melanoma
249066|NCT02643303|In Situ|in situ
249067|NCT02643303|CTLA-4 Antibody|ctla-4 antibody
249068|NCT02643303|PD-L1 Antibody|pd-l1 antibody
249069|NCT02643303|TLR3 Agonist|tlr3 agonist
249070|NCT02643303|CTCL|ctcl
249071|NCT02643290|Adult Scoliosis|adult scoliosis
249072|NCT02643290|Pain Management|pain management
249073|NCT02643290|Orthosis|orthosis
249074|NCT02643264|insula|insula
249075|NCT02643264|alcohol addiction|alcohol addiction
249076|NCT02643264|transcranial magnetic stimulation|transcranial magnetic stimulation
249077|NCT02643251|Diabetes Mellitus|diabetes mellitus
249078|NCT02643251|Pain|pain
249079|NCT02643251|Foot Pain|foot pain
249080|NCT02643251|Neuropathy|neuropathy
249081|NCT02643160|Trunk Training|trunk training
249082|NCT02643160|Motor Function|motor function
249083|NCT02643147|Heart Failure|heart failure
249084|NCT02643147|Renal Failure|renal failure
249085|NCT02643147|Biomarker guided-therapy|biomarker guided-therapy
249086|NCT02643147|Loop diuretics|loop diuretics
249087|NCT02643147|Carbohydrate antigen 125|carbohydrate antigen 125
249088|NCT02643134|ESWL|eswl
249089|NCT02643134|EPVL|epvl
249090|NCT02643134|PDI(Percussion,Diuresis,Inversion)|pdi(percussion,diuresis,inversion)
249091|NCT02643134|Randomized Controlled Trial(RCT)|randomized controlled trial(rct)
249092|NCT02643108|Lateral episiotomy|lateral episiotomy
249093|NCT02643108|Obstetrical anal sphincter injury|obstetrical anal sphincter injury
249094|NCT02643108|Vacuum extraction|vacuum extraction
249095|NCT02643108|Anal incontinence|anal incontinence
249096|NCT02643069|Frailty|frailty
249097|NCT02643069|Frailty tools|frailty tools
249098|NCT02643069|Clinical settings|clinical settings
249099|NCT02643069|Disability|disability
249100|NCT02643069|Quality of life|quality of life
249101|NCT02643069|Functional Autonomy|functional autonomy
249102|NCT02643043|Next Generation Sequencing|next generation sequencing
249103|NCT02643043|Genomic Analysis|genomic analysis
249104|NCT02643017|cognitive function|cognitive function
249105|NCT02643017|desflurane|desflurane
249106|NCT02643017|dexmedetomidine|dexmedetomidine
249107|NCT02642978|minimally invasive surgery|minimally invasive surgery
249108|NCT02642978|colorectal liver metastasis|colorectal liver metastasis
249109|NCT02642978|robotic surgery|robotic surgery
249110|NCT02642978|Patients with resectable colorectal liver metastasis|patients with resectable colorectal liver metastasis
249111|NCT02642952|arterial stiffness, central hemodynamics|arterial stiffness, central hemodynamics
249112|NCT02642926|menorrhagia|menorrhagia
249113|NCT02642926|higham PBAC score|higham pbac score
249114|NCT02642926|endometrial ablation|endometrial ablation
249115|NCT02642926|bipolar energy|bipolar energy
249116|NCT02642926|monopolar energy|monopolar energy
249117|NCT02642913|Enzalutamide|enzalutamide
249118|NCT02642913|Sorafenib|sorafenib
249119|NCT02642913|15-279|15-279
249120|NCT02642900|Complete denture|complete denture
249121|NCT02642900|Candida spp|candida spp
249122|NCT02642900|Photodynamic therapy|photodynamic therapy
249123|NCT02642887|gingival recession|gingival recession
249124|NCT02642887|tunnel technique|tunnel technique
249125|NCT02642887|Miller Class I and II|miller class i and ii
249126|NCT02642835|mesh|mesh
249127|NCT02642835|pelvic organ prolapse|pelvic organ prolapse
249128|NCT02642822|Cytomegalovirus|cytomegalovirus
249129|NCT02642796|Percutaneous Electric Nerve Stimulation|percutaneous electric nerve stimulation
249130|NCT02642796|Lumbosacral plexus|lumbosacral plexus
249131|NCT02642796|surgical wound|surgical wound
249132|NCT02642796|postoperative analgesia|postoperative analgesia
249133|NCT02642796|transcutaneous electrical stimulation|transcutaneous electrical stimulation
249134|NCT02642783|laxatives|laxatives
249135|NCT02642783|sensory evaluation|sensory evaluation
249136|NCT02642783|acceptability|acceptability
249137|NCT02642783|colonoscopy|colonoscopy
249138|NCT02642770|Transesophageal echocardiography, Speckle tracking strain|transesophageal echocardiography, speckle tracking strain
249139|NCT02642757|alcohol drinking|alcohol drinking
249140|NCT02642757|hazardous alcohol use|hazardous alcohol use
249141|NCT02642757|risky alcohol consumption|risky alcohol consumption
249142|NCT02642757|heavy alcohol consumption|heavy alcohol consumption
249143|NCT02642731|total knee arthroplasty|total knee arthroplasty
249144|NCT02642731|Kidney function|kidney function
249145|NCT02642731|Renal markers|renal markers
249146|NCT02642718|preemptive analgesia|preemptive analgesia
249147|NCT02642718|postoperative pain|postoperative pain
249148|NCT02642718|NSAIDs|nsaids
249149|NCT02642718|ketorolac|ketorolac
249150|NCT02642718|abdominal hysterectomy|abdominal hysterectomy
249151|NCT02642692|ACL reconstruction|acl reconstruction
249152|NCT02642692|Single bundle|single bundle
249153|NCT02642692|Clinical results|clinical results
249154|NCT02642692|Soccer players|soccer players
249155|NCT02642679|Split-thickness skin graft, donor site, chitosan, dressing|split-thickness skin graft, donor site, chitosan, dressing
249156|NCT02642666|Attention|attention
249157|NCT02642666|Hyperactivity|hyperactivity
249158|NCT02642666|Impulsivity|impulsivity
249159|NCT02642666|Yoga|yoga
249160|NCT02642666|Preschool|preschool
249161|NCT02642653|Fra(X) Syndrome|fra(x) syndrome
249162|NCT02642653|Trinucleotide Repeat Expansion|trinucleotide repeat expansion
249163|NCT02642653|Fragile X Syndrome|fragile x syndrome
249164|NCT02642653|Fragile X Mental Retardation Syndrome|fragile x mental retardation syndrome
249165|NCT02642653|Intellectual Disability|intellectual disability
249166|NCT02642653|Parent Implemented Language Intervention (PILI)|parent implemented language intervention (pili)
249167|NCT02642653|FXS|fxs
249168|NCT02642653|Mental Retardation, X-linked|mental retardation, x-linked
249169|NCT02642653|Genetic Diseases, X-linked|genetic diseases, x-linked
249170|NCT02642653|Neurobehavioral Manifestations|neurobehavioral manifestations
249171|NCT02642653|Chromosome Disorders|chromosome disorders
249172|NCT02642601|indomethacin, ICSI, difficult embryo transfer|indomethacin, icsi, difficult embryo transfer
249173|NCT02642562|Intravenous iron|intravenous iron
249174|NCT02642562|PROBE design|probe design
249175|NCT02642536|Veteran|veteran
249176|NCT02642523|natriuretic peptide|natriuretic peptide
249177|NCT02642523|insulin|insulin
249178|NCT02642523|lipolysis|lipolysis
249179|NCT02642523|hormones|hormones
249180|NCT02642523|metabolism|metabolism
249181|NCT02642497|postoperative analgesia|postoperative analgesia
249182|NCT02642497|ketamine|ketamine
249183|NCT02642497|total thyroidectomy|total thyroidectomy
249184|NCT02642471|sentinel lymph node|sentinel lymph node
249185|NCT02642471|pelvic lymphadenectomy|pelvic lymphadenectomy
249186|NCT02642471|cervical carcinoma|cervical carcinoma
249187|NCT02642471|surgery|surgery
249188|NCT02642471|radiotherapy|radiotherapy
249189|NCT02642445|Renal sympathetic denervation;hypertension|renal sympathetic denervation;hypertension
249190|NCT02642432|HCV Genotype 1|hcv genotype 1
249191|NCT02642432|HCV Genotype 4|hcv genotype 4
249192|NCT02642432|HCV Genotype 2|hcv genotype 2
249193|NCT02642432|Cirrhotic|cirrhotic
249194|NCT02642432|Interferon-Free|interferon-free
249195|NCT02642432|Compensated Cirrhosis|compensated cirrhosis
249196|NCT02642432|HCV Genotype 5|hcv genotype 5
249197|NCT02642432|Hepatitis C|hepatitis c
249198|NCT02642432|HCV Genotype 6|hcv genotype 6
249199|NCT02642393|SURE-PD3|sure-pd3
249200|NCT02642393|Parkinson's disease|parkinson's disease
249201|NCT02642393|PD|pd
249202|NCT02642393|Inosine|inosine
249203|NCT02642393|Urate|urate
249204|NCT02642393|Parkinson Study Group (PSG)|parkinson study group (psg)
249205|NCT02642380|ITP|itp
249206|NCT02642380|high-dose dexamethasone|high-dose dexamethasone
249207|NCT02642328|VO2Max|vo2max
249208|NCT02642328|Aerobic Exercise|aerobic exercise
249209|NCT02642328|Physical Conditioning|physical conditioning
249210|NCT02642302|VO2Max|vo2max
249211|NCT02642302|Aerobic Exercise|aerobic exercise
249212|NCT02642302|Physical Conditioning|physical conditioning
249213|NCT02642289|Probiotics|probiotics
249214|NCT02642276|exercise training|exercise training
249215|NCT02642250|safety|safety
249216|NCT02642250|efficacy|efficacy
249217|NCT02642237|Fluenz|fluenz
249218|NCT02642237|innate immune response|innate immune response
249219|NCT02642237|endotoxin tolerance|endotoxin tolerance
249220|NCT02642237|priming|priming
249221|NCT02642224|Violence|violence
249222|NCT02642224|firearm|firearm
249223|NCT02642224|guns|guns
249224|NCT02642224|homicide|homicide
249226|NCT02642224|injury|injury
249227|NCT02642198|NiBP|nibp
249228|NCT02642185|microwave|microwave
249229|NCT02642185|ablation|ablation
249230|NCT02642185|resection|resection
249231|NCT02642185|liver|liver
249232|NCT02642185|colorectal|colorectal
249233|NCT02642185|survival|survival
249234|NCT02642185|metastasis|metastasis
249235|NCT02642172|Inulin, OFS (oligofructose)|inulin, ofs (oligofructose)
249236|NCT02642107|nasopharyngeal carcinoma|nasopharyngeal carcinoma
249237|NCT02642107|elective neck irradiation|elective neck irradiation
249238|NCT02642081|NSAIDs|nsaids
249239|NCT02642081|Heart failure|heart failure
249240|NCT02642081|Acute kidney injury|acute kidney injury
249241|NCT02642068|Drug-naïve Adult ADHD|drug-naïve adult adhd
249242|NCT02642068|Neuropsychology|neuropsychology
249243|NCT02642068|Neurophysiology|neurophysiology
249244|NCT02642068|Neuroimaging|neuroimaging
249245|NCT02642068|Follow-up|follow-up
249246|NCT02642055|ADHD|adhd
249247|NCT02642055|Neurofeedback|neurofeedback
249248|NCT02642055|Biofeedback|biofeedback
249249|NCT02642055|Neuro+|neuro+
249250|NCT02642055|Go/no-go|go/no-go
249251|NCT02642055|Attention training|attention training
249252|NCT02642029|time perception|time perception
249253|NCT02642029|executive function|executive function
249254|NCT02642029|psychosis|psychosis
249255|NCT02642029|mood symptoms|mood symptoms
249256|NCT02642016|KTN0158|ktn0158
249257|NCT02642016|Advanced Cancer|advanced cancer
249258|NCT02642016|Phase 1|phase 1
249259|NCT02642016|Monoclonal Antibody|monoclonal antibody
249260|NCT02642016|Safety and Pharmacokinetics|safety and pharmacokinetics
249261|NCT02641925|Metabolic syndrome|metabolic syndrome
249262|NCT02641925|gastric cancer|gastric cancer
318624|NCT02241967|TKA|tka
249263|NCT02641925|omentectomy|omentectomy
249264|NCT02641899|Adult|adult
249265|NCT02641899|Male|male
249266|NCT02641899|Female|female
249267|NCT02641899|Volunteers|volunteers
249268|NCT02641886|traditional Chinese medicine granules|traditional chinese medicine granules
249269|NCT02641886|Cognitive Impairment|cognitive impairment
249270|NCT02641886|Acute cerebral infraction|acute cerebral infraction
249271|NCT02641886|prevention|prevention
249272|NCT02641873|metastatic Colorectal Cancer|metastatic colorectal cancer
249273|NCT02641873|mCRC|mcrc
249274|NCT02641847|triple negative breast cancer|triple negative breast cancer
249275|NCT02641847|mRNA-lncRNA signature|mrna-lncrna signature
249276|NCT02641847|chemotherapy|chemotherapy
249277|NCT02641847|high risk|high risk
249278|NCT02641834|diet|diet
249279|NCT02641834|vegetarian|vegetarian
249280|NCT02641834|cardiovascular risk|cardiovascular risk
249281|NCT02641795|cochlear implantation|cochlear implantation
249282|NCT02641795|robotics|robotics
249283|NCT02641795|image guidance|image guidance
249284|NCT02641782|High Risk Neuroblastoma|high risk neuroblastoma
249285|NCT02641756|HIV reservoir|hiv reservoir
249286|NCT02641756|phylogenetic analysis|phylogenetic analysis
249287|NCT02641756|sequencing|sequencing
249288|NCT02641730|Guselkumab|guselkumab
249289|NCT02641730|CNTO 1959|cnto 1959
249290|NCT02641730|Placebo|placebo
249291|NCT02641730|Palmoplantar Pustulosis|palmoplantar pustulosis
249292|NCT02641717|patient-collected|patient-collected
249293|NCT02641717|self-collected|self-collected
249294|NCT02641717|vaginitis|vaginitis
249295|NCT02641717|vaginosis, bacterial|vaginosis, bacterial
249296|NCT02641717|candidiasis|candidiasis
249297|NCT02641717|trichomonas|trichomonas
249298|NCT02641717|vaginal discharge|vaginal discharge
249299|NCT02641678|Atrial Fibrillation|atrial fibrillation
249300|NCT02641678|stroke|stroke
249301|NCT02641678|implantable cardiac monitor|implantable cardiac monitor
249302|NCT02641678|automated ECG analysis|automated ecg analysis
249303|NCT02641652|paroxysmal hypertension|paroxysmal hypertension
249304|NCT02641652|pseudopheochromocytoma|pseudopheochromocytoma
249305|NCT02641626|cardiac arrest|cardiac arrest
249306|NCT02641626|survival|survival
249307|NCT02641626|neurologic prognosis|neurologic prognosis
249308|NCT02641626|coronariography|coronariography
249309|NCT02641626|hypothermia|hypothermia
249310|NCT02641587|Smoking|smoking
249311|NCT02641587|Cigarettes|cigarettes
249312|NCT02641587|Reduced exposure|reduced exposure
249313|NCT02641587|Confinement|confinement
249314|NCT02641587|Ambulatory|ambulatory
249315|NCT02641587|Carbon Heated Tobacco Product|carbon heated tobacco product
249316|NCT02641561|Pancreatitis|pancreatitis
249317|NCT02641561|ERCP|ercp
249318|NCT02641561|Indomethacin|indomethacin
249319|NCT02641561|Lactated ringer's|lactated ringer's
249321|NCT02641522|Type 1 diabetes|type 1 diabetes
249322|NCT02641496|Obstructive Sleep Apnea|obstructive sleep apnea
249323|NCT02641496|PTSD|ptsd
249324|NCT02641496|Posttraumatic Stress Disorder|posttraumatic stress disorder
249325|NCT02641496|Cognitive Behavioral Therapy|cognitive behavioral therapy
249326|NCT02641496|Continuous Positive Airway Pressure|continuous positive airway pressure
249327|NCT02641496|CPAP|cpap
249328|NCT02641496|Cognition|cognition
249329|NCT02641496|Memory|memory
249330|NCT02641496|Quality of Life|quality of life
249331|NCT02641496|Self Efficacy|self efficacy
249332|NCT02641496|CBT|cbt
249333|NCT02641496|OSA|osa
249334|NCT02641496|Sleep Apnea|sleep apnea
249335|NCT02641496|Education|education
249336|NCT02641496|Psychotherapy|psychotherapy
249337|NCT02641496|Post Traumatic Stress Disorder|post traumatic stress disorder
249338|NCT02641496|Post-Traumatic Stress Disorder|post-traumatic stress disorder
249339|NCT02641496|Therapy|therapy
249340|NCT02641457|rubeosis iridis|rubeosis iridis
249341|NCT02641457|glaucoma|glaucoma
249342|NCT02641457|ranibizumab|ranibizumab
249343|NCT02641457|aflibercept|aflibercept
249344|NCT02641431|radiofrequency ablation|radiofrequency ablation
249345|NCT02641431|mapping|mapping
249346|NCT02641431|sudden death|sudden death
249347|NCT02641431|syncope|syncope
249348|NCT02641418|Exercise|exercise
249349|NCT02641405|Gait analysis|gait analysis
249350|NCT02641405|Proprioceptive focal stimulation|proprioceptive focal stimulation
249351|NCT02641405|Parkinson|parkinson
249352|NCT02641392|Crohn's Disease|crohn's disease
249353|NCT02641392|GED 0301|ged 0301
249354|NCT02641392|Mongersen|mongersen
249355|NCT02641392|Safety|safety
249356|NCT02641392|Irritable Bowel Disease|irritable bowel disease
249357|NCT02641353|Apremilast|apremilast
249358|NCT02641353|Healthy volunteers|healthy volunteers
249359|NCT02641353|Bioavailability|bioavailability
249360|NCT02641353|Food effect|food effect
249361|NCT02641353|Pharmacokinetic|pharmacokinetic
249362|NCT02641327|Inhospital patients|inhospital patients
249363|NCT02641314|Recurrent Neuroblastoma|recurrent neuroblastoma
249364|NCT02641301|obesity|obesity
249365|NCT02641301|Roux-en-Y-gastric bypass|roux-en-y-gastric bypass
318709|NCT02241525|Lung|lung
249366|NCT02641301|pharmacokinetics|pharmacokinetics
249367|NCT02641301|Pain|pain
249368|NCT02641301|morphine|morphine
249369|NCT02641275|Parental stress|parental stress
249370|NCT02641275|Muscular Dystrophies|muscular dystrophies
249371|NCT02641275|Coping|coping
249372|NCT02641275|Parental support|parental support
249373|NCT02641262|Myocardial Infarction|myocardial infarction
249374|NCT02641262|Angioplasty, Balloon, Coronary|angioplasty, balloon, coronary
249375|NCT02641262|Drug Therapy|drug therapy
249376|NCT02641236|Hematopoietic Stem Cell Transplantation (HSCT)|hematopoietic stem cell transplantation (hsct)
249377|NCT02641236|Acute GVH Disease|acute gvh disease
249378|NCT02641210|Chronic periodontitis|chronic periodontitis
249379|NCT02641210|Hepcidin|hepcidin
249380|NCT02641210|Hemoglobin|hemoglobin
249381|NCT02641210|Inflammation|inflammation
249382|NCT02641197|flow-mediated dilation|flow-mediated dilation
249383|NCT02641197|AngioDefender|angiodefender
249384|NCT02641197|device precision|device precision
249385|NCT02641197|repeatability|repeatability
249386|NCT02641197|reproducibility|reproducibility
249387|NCT02641197|cardiovascular diseases|cardiovascular diseases
249388|NCT02641184|Myocardial Infarction|myocardial infarction
249389|NCT02641184|Cardiovascular Diseases|cardiovascular diseases
249390|NCT02641184|Heart Diseases|heart diseases
249391|NCT02641184|Infarction|infarction
249392|NCT02641184|Diabetes|diabetes
249393|NCT02641158|HIV|hiv
249394|NCT02641158|Hepatitis C|hepatitis c
249395|NCT02641158|Substance users|substance users
249396|NCT02641158|Drug users|drug users
249397|NCT02641145|amyloidosis|amyloidosis
249398|NCT02641145|F-18 florbetapir|f-18 florbetapir
249399|NCT02641145|Positron emission tomography|positron emission tomography
249400|NCT02641145|cardiac magnetic resonance imaging|cardiac magnetic resonance imaging
249401|NCT02641119|Albumin|albumin
249402|NCT02641119|Resuscitation|resuscitation
249403|NCT02641106|Telemedicine|telemedicine
249404|NCT02641106|Mobile Phone|mobile phone
249405|NCT02641106|Adherence|adherence
249406|NCT02641106|Latent Tuberculosis Infection|latent tuberculosis infection
249407|NCT02641106|Directly Observed Therapy|directly observed therapy
249408|NCT02641106|Video DOT|video dot
249409|NCT02641041|Japanese|japanese
249410|NCT02641041|Single Ascending Dose (SAD)|single ascending dose (sad)
249411|NCT02641041|Multiple Ascending Dose (MAD)|multiple ascending dose (mad)
249412|NCT02641015|UTI|uti
249413|NCT02641002|CC-90002|cc-90002
249414|NCT02641002|Monoclonal|monoclonal
249415|NCT02641002|Antibody|antibody
249416|NCT02641002|CD47|cd47
249417|NCT02641002|Hematologic Cancers|hematologic cancers
249418|NCT02641002|Acute Myeloid Leukemia|acute myeloid leukemia
249419|NCT02641002|AML|aml
249420|NCT02641002|Myelodysplastic syndrome|myelodysplastic syndrome
249421|NCT02641002|MDS|mds
249422|NCT02641002|Blood disorder|blood disorder
249423|NCT02640989|Influenza Vaccine|influenza vaccine
249424|NCT02640989|Safety|safety
249425|NCT02640989|Immunogenicity|immunogenicity
249426|NCT02640976|in vitro fertilization|in vitro fertilization
249427|NCT02640976|controlled ovarian hyperstimulation|controlled ovarian hyperstimulation
249428|NCT02640976|poor ovarian response|poor ovarian response
249429|NCT02640976|estrogen receptor 2 gene polymorphism|estrogen receptor 2 gene polymorphism
249430|NCT02640976|follicle stimulating hormone receptor gene polymorphism|follicle stimulating hormone receptor gene polymorphism
249431|NCT02640976|anti-mullerian hormone|anti-mullerian hormone
249432|NCT02640963|exercise|exercise
249433|NCT02640963|older adults|older adults
249434|NCT02640963|physical performance|physical performance
249435|NCT02640937|Staphylococcus epidermidis|staphylococcus epidermidis
249436|NCT02640937|biofilm formation|biofilm formation
249437|NCT02640937|antibiotic resistance|antibiotic resistance
249438|NCT02640937|Orthopaedic device related infections|orthopaedic device related infections
249439|NCT02640937|risk factor|risk factor
249440|NCT02640924|Hepatocellular carcinoma|hepatocellular carcinoma
249441|NCT02640924|Proton therapy|proton therapy
249442|NCT02640924|Radiation therapy|radiation therapy
249443|NCT02640924|Switching control radiofrequency ablation|switching control radiofrequency ablation
249444|NCT02640872|sarcopenia|sarcopenia
249445|NCT02640872|sarcopenic obesity|sarcopenic obesity
249446|NCT02640872|osteoporosis|osteoporosis
249447|NCT02640872|fracture|fracture
249448|NCT02640872|cardiovascular disease|cardiovascular disease
249449|NCT02640872|mortality|mortality
249450|NCT02640846|Levosimendan|levosimendan
249451|NCT02640846|Milrinone|milrinone
249452|NCT02640846|Myocardial strain|myocardial strain
249453|NCT02640846|Septic cardiomyopathy|septic cardiomyopathy
249454|NCT02640846|Norepinephrine|norepinephrine
249455|NCT02640833|Refractory Lymphoma|refractory lymphoma
249456|NCT02640833|Relapsed Leukemia|relapsed leukemia
249457|NCT02640820|HPV|hpv
249458|NCT02640820|Verruca Vulgaris|verruca vulgaris
249459|NCT02640807|sepsis lymphocytopenia IL-7|sepsis lymphocytopenia il-7
249460|NCT02640807|immune reconstitution|immune reconstitution
249461|NCT02640794|Transcatheter aortic valve implantation|transcatheter aortic valve implantation
249462|NCT02640794|Antithrombotic treatment|antithrombotic treatment
249463|NCT02640794|Clopidogrel|clopidogrel
249464|NCT02640794|Aspirin/acetylsalicylic acid|aspirin/acetylsalicylic acid
249465|NCT02640794|Myocardial Infarction|myocardial infarction
249466|NCT02640794|Ischemic stroke|ischemic stroke
249467|NCT02640794|Major bleeding|major bleeding
249468|NCT02640768|in-hospital diabetes|in-hospital diabetes
249469|NCT02640768|clinical and management model|clinical and management model
249470|NCT02640755|Radiolabelled|radiolabelled
249471|NCT02640729|Lewy body dementia|lewy body dementia
249472|NCT02640729|Dementia with Lewy bodies|dementia with lewy bodies
249473|NCT02640729|Parkinson's disease dementia|parkinson's disease dementia
249474|NCT02640729|Lewy bodies|lewy bodies
249475|NCT02640729|Visual hallucinations|visual hallucinations
249476|NCT02640690|Stress Disorders, Post-traumatic|stress disorders, post-traumatic
249477|NCT02640690|Yoga|yoga
249478|NCT02640690|Cognitive Therapy|cognitive therapy
249479|NCT02640690|Chronic Pain|chronic pain
249480|NCT02640690|Veterans|veterans
249481|NCT02640690|cytokines|cytokines
249482|NCT02640690|acoustic startle reflex|acoustic startle reflex
249483|NCT02640664|open-label, long-term, extension study|open-label, long-term, extension study
249484|NCT02640664|intravitreal ranibizumab|intravitreal ranibizumab
249485|NCT02640664|laser ablation therapy|laser ablation therapy
249486|NCT02640664|retinopathy of prematurity|retinopathy of prematurity
249487|NCT02640664|preterm infants|preterm infants
249488|NCT02640664|RAINBOW|rainbow
249489|NCT02640638|Racial disparities|racial disparities
249490|NCT02640625|HIV|hiv
249491|NCT02640625|Probiotics|probiotics
249492|NCT02640625|Microbiota|microbiota
249493|NCT02640625|Mucosal immunology|mucosal immunology
249494|NCT02640625|Gut biopsy|gut biopsy
249495|NCT02640599|Vestibular|vestibular
249496|NCT02640599|Rehabilitation|rehabilitation
249497|NCT02640560|Children|children
249498|NCT02640560|Allergy|allergy
249499|NCT02640560|Peanuts|peanuts
249500|NCT02640560|Hazelnuts|hazelnuts
249501|NCT02640560|Walnuts|walnuts
249502|NCT02640560|Mollusks|mollusks
249503|NCT02640560|Shellfish|shellfish
249504|NCT02640560|Food|food
249505|NCT02640547|Chronic Hepatitis C|chronic hepatitis c
249506|NCT02640547|Dasabuvir|dasabuvir
249507|NCT02640547|Paritaprevir/r/Ombitasvir|paritaprevir/r/ombitasvir
249508|NCT02640547|Observational Study|observational study
249509|NCT02640547|Quality of Life|quality of life
249510|NCT02640547|Fibrosis|fibrosis
249511|NCT02640547|Cirrhosis|cirrhosis
249512|NCT02640547|Work Ability|work ability
249513|NCT02640534|Prostate cancer|prostate cancer
249514|NCT02640534|Cancer of the prostate|cancer of the prostate
249515|NCT02640534|Metformin|metformin
249516|NCT02640534|Enzalutamide|enzalutamide
249517|NCT02640534|Xtandi|xtandi
249518|NCT02640534|castration resistant prostate cancer|castration resistant prostate cancer
249519|NCT02640534|phase II|phase ii
249520|NCT02640534|Androgen deprivation therapy|androgen deprivation therapy
249521|NCT02640495|Treatment Efficacy|treatment efficacy
249522|NCT02640495|drug resistance|drug resistance
249523|NCT02640495|Artemisinin|artemisinin
249524|NCT02640482|Treatment-Naive|treatment-naive
249525|NCT02640482|Hepatitis C Virus Genotype 2|hepatitis c virus genotype 2
249526|NCT02640482|Sofosbuvir (SOF)-Experienced|sofosbuvir (sof)-experienced
249527|NCT02640482|Treatment-Experienced|treatment-experienced
249528|NCT02640482|Non-cirrhotic|non-cirrhotic
249529|NCT02640469|chlorhexidine|chlorhexidine
249530|NCT02640469|sterility|sterility
249531|NCT02640469|sterile hands|sterile hands
249532|NCT02640456|retropharyngeal abscess|retropharyngeal abscess
249533|NCT02640456|parapharyngeal abscess|parapharyngeal abscess
249534|NCT02640456|peritonsillar abscess|peritonsillar abscess
249535|NCT02640456|bacteriology|bacteriology
249536|NCT02640456|Fusobacterium necrophorum|fusobacterium necrophorum
249537|NCT02640417|Nucleotides (uridine, cytidine)|nucleotides (uridine, cytidine)
249538|NCT02640417|Vitamin B1|vitamin b1
249539|NCT02640417|Vitamin B6|vitamin b6
249540|NCT02640417|Vitamin B12|vitamin b12
249541|NCT02640404|Meningitis|meningitis
249542|NCT02640404|Meningococcal Meningitis|meningococcal meningitis
249543|NCT02640404|Meningococcal Infections|meningococcal infections
249544|NCT02640404|Menactra®|menactra®
249545|NCT02640404|Meningococcal Vaccine|meningococcal vaccine
249546|NCT02640391|Ulcerative colitis|ulcerative colitis
249547|NCT02640391|fecal calprotectin|fecal calprotectin
249548|NCT02640391|mucosal healing|mucosal healing
249549|NCT02640365|cancer|cancer
249550|NCT02640365|GERCOR|gercor
249551|NCT02640365|unresectable|unresectable
249552|NCT02640365|MM-398|mm-398
249553|NCT02640365|CPT-11|cpt-11
249554|NCT02640365|colorectal|colorectal
249555|NCT02640365|non colorectal|non colorectal
249556|NCT02640326|Urinary Catheterization|urinary catheterization
249557|NCT02640326|Randomized Controlled Trial|randomized controlled trial
249558|NCT02640326|Thoracic Surgery, Video-Assisted|thoracic surgery, video-assisted
249559|NCT02640326|Quality Improvement|quality improvement
249560|NCT02640326|Evidence-Based Practice|evidence-based practice
249561|NCT02640326|Post-operative complications|post-operative complications
249562|NCT02640313|18F-fluormethylcholine|18f-fluormethylcholine
249563|NCT02640313|[F18] choline|[f18] choline
249564|NCT02640313|[F18] fluormethylcholine|[f18] fluormethylcholine
249565|NCT02640300|antipsychotics, clozapine, schizophrenia, switching strategy|antipsychotics, clozapine, schizophrenia, switching strategy
249566|NCT02640274|Practise Patterns, Nurses'|practise patterns, nurses'
249567|NCT02640274|Directive Counseling|directive counseling
249568|NCT02640274|Self Care|self care
249569|NCT02640261|r-hLH|r-hlh
249570|NCT02640261|Cytokines|cytokines
249571|NCT02640261|Follicular Fluid|follicular fluid
249572|NCT02640235|Hemostasis|hemostasis
249573|NCT02640235|Oxidized Cellulose Strip|oxidized cellulose strip
249574|NCT02640235|Traumacel|traumacel
249575|NCT02640235|Traumastem|traumastem
249576|NCT02640235|Cardiothoracic Surgery|cardiothoracic surgery
249577|NCT02640235|General Surgery|general surgery
249578|NCT02640235|Vascular Surgery|vascular surgery
249579|NCT02640196|Laryngoscope|laryngoscope
249580|NCT02640196|Macintosh|macintosh
249581|NCT02640196|Glidescope|glidescope
249582|NCT02640196|King Vision|king vision
249583|NCT02640196|Airtraq|airtraq
249584|NCT02640196|Double Lumen Tube|double lumen tube
249585|NCT02640157|interferon free|interferon free
249586|NCT02640157|Hepatitis C|hepatitis c
249587|NCT02640157|daclatasvir|daclatasvir
249588|NCT02640157|Sovaldi|sovaldi
249590|NCT02640157|Hepatitis C Virus|hepatitis c virus
249591|NCT02640157|Hepatitis C Genotype 3|hepatitis c genotype 3
249592|NCT02640157|Hep C|hep c
249593|NCT02640157|sofosbuvir|sofosbuvir
249594|NCT02640157|Chronic Hepatitis C|chronic hepatitis c
249595|NCT02640157|Daklinza|daklinza
249596|NCT02640144|Hyaluronic acid|hyaluronic acid
249597|NCT02640144|Knee arthroscopy|knee arthroscopy
249598|NCT02640144|pain reduction|pain reduction
249599|NCT02640144|swelling|swelling
249600|NCT02640144|osteoarthritis|osteoarthritis
249601|NCT02640144|cartilage lesion|cartilage lesion
249602|NCT02640144|rehabilitation following knee arthroscopy|rehabilitation following knee arthroscopy
249603|NCT02640144|Hyaluronic acid injection|hyaluronic acid injection
249604|NCT02640131|prostate cancer|prostate cancer
249605|NCT02640131|radical prostatectomy|radical prostatectomy
249606|NCT02640131|survivorship|survivorship
249607|NCT02640131|quality of life|quality of life
249608|NCT02640131|erectile dysfunction|erectile dysfunction
249609|NCT02640131|sexual dysfunction|sexual dysfunction
249610|NCT02640131|feasibility study|feasibility study
249611|NCT02640079|Cognitive behavioral therapy|cognitive behavioral therapy
249612|NCT02640079|Laboratory pain responsivity|laboratory pain responsivity
249613|NCT02640014|Food allergy|food allergy
249614|NCT02640014|Health-related quality of life (HRQL)|health-related quality of life (hrql)
249615|NCT02640014|Quality-adjusted life-years (QALYs)|quality-adjusted life-years (qalys)
249616|NCT02640014|Oral immunotherapy (OIT)|oral immunotherapy (oit)
249617|NCT02640014|Cow´s milk allergy (CMA)|cow´s milk allergy (cma)
249618|NCT02640014|Milk oral immunotherapy (MOIT)|milk oral immunotherapy (moit)
249619|NCT02639988|type 2 diabetes mellitus|type 2 diabetes mellitus
249620|NCT02639988|Rheumatoid arthritis|rheumatoid arthritis
249621|NCT02639975|Adenosine A3 receptor antagonist|adenosine a3 receptor antagonist
249622|NCT02639962|culprit lesion|culprit lesion
249623|NCT02639962|arteriosclerosis|arteriosclerosis
249624|NCT02639962|cardiac CT|cardiac ct
249625|NCT02639923|TBI|tbi
249626|NCT02639923|microRNA|microrna
249627|NCT02639923|S-100B|s-100b
249628|NCT02639910|CD19|cd19
249629|NCT02639910|MOR208|mor208
249630|NCT02639910|MOR00208|mor00208
249632|NCT02639910|SLL|sll
249633|NCT02639910|COSMOS|cosmos
249634|NCT02639910|tafasitamab|tafasitamab
249635|NCT02639871|Huntington disease|huntington disease
249636|NCT02639871|Neuroimaging metabolic biomarker|neuroimaging metabolic biomarker
249637|NCT02639832|Triple Negative Breast Cancer|triple negative breast cancer
249638|NCT02639832|Breast Cancer|breast cancer
249639|NCT02639832|Natural Killer Cells|natural killer cells
249640|NCT02639832|BRCA Mutation|brca mutation
249641|NCT02639819|Intracerebral Hemorrhage|intracerebral hemorrhage
249642|NCT02639819|Stroke|stroke
249643|NCT02639819|Cerebrovascular|cerebrovascular
249644|NCT02639806|stroke|stroke
249645|NCT02639806|endovascular|endovascular
249646|NCT02639806|thrombectomy|thrombectomy
249647|NCT02639806|ischemic stroke|ischemic stroke
249648|NCT02639806|general anesthetic|general anesthetic
249649|NCT02639806|local anesthetic|local anesthetic
249650|NCT02639806|recanalization|recanalization
249651|NCT02639793|arrhythmias, quality of life|arrhythmias, quality of life
249652|NCT02639767|Pemetrexed|pemetrexed
249653|NCT02639767|Cisplatin|cisplatin
249654|NCT02639767|Intensity Modulated Radiation Therapy|intensity modulated radiation therapy
249655|NCT02639767|15-304|15-304
249656|NCT02639741|Melatonin|melatonin
249657|NCT02639741|Vitamin C|vitamin c
249658|NCT02639741|Morphine consumption|morphine consumption
712529|NCT00579813|obesity|obesity
249659|NCT02639728|Bowel surgery|bowel surgery
249660|NCT02639728|Postoperative bowel recovery|postoperative bowel recovery
249661|NCT02639702|Clozapine|clozapine
249662|NCT02639702|Dosing|dosing
249663|NCT02639702|Once daily|once daily
249664|NCT02639702|Regimen|regimen
249665|NCT02639702|Schizophrenia|schizophrenia
249666|NCT02639689|Deficits of foot relievers of central origin|deficits of foot relievers of central origin
249667|NCT02639689|Walkaide|walkaide
249668|NCT02639676|Infant|infant
249669|NCT02639676|Bronchopulmonary Dysplasia|bronchopulmonary dysplasia
249670|NCT02639676|Premature|premature
249671|NCT02639650|gestational trophoblastic tumor|gestational trophoblastic tumor
249672|NCT02639650|paclitaxel|paclitaxel
249673|NCT02639650|cisplatin|cisplatin
249674|NCT02639650|carboplatin|carboplatin
249675|NCT02639650|chemotherapy|chemotherapy
249676|NCT02639637|Type 2 Diabetes Mellitus|type 2 diabetes mellitus
249677|NCT02639637|Sitagliptin|sitagliptin
249678|NCT02639637|Dipeptidyl Peptidase IV Inhibitors|dipeptidyl peptidase iv inhibitors
249679|NCT02639637|Angiotensin Converting Enzyme Inhibitors|angiotensin converting enzyme inhibitors
249680|NCT02639637|Enalaprilat|enalaprilat
249681|NCT02639637|Neuropeptide Y|neuropeptide y
249682|NCT02639624|hemodialysis|hemodialysis
249683|NCT02639624|kidney|kidney
249684|NCT02639624|dialysis|dialysis
249685|NCT02639611|Breast Expanders|breast expanders
249686|NCT02639598|chronic migraine|chronic migraine
249687|NCT02639598|prophylaxis|prophylaxis
249688|NCT02639598|flunarizine|flunarizine
249689|NCT02639598|topiramate|topiramate
249690|NCT02639585|daclatasvir|daclatasvir
249691|NCT02639585|asunaprevir|asunaprevir
249692|NCT02639533|fibromyalgia|fibromyalgia
249693|NCT02639533|pregabalin|pregabalin
249694|NCT02639533|cortical excitability|cortical excitability
249695|NCT02639533|functional near infrared spectroscopy|functional near infrared spectroscopy
249696|NCT02639520|Uncomplicated urinary tract infection|uncomplicated urinary tract infection
249697|NCT02639481|traumatic brain injury|traumatic brain injury
249698|NCT02639481|stroke|stroke
249699|NCT02639481|disorders of consciousness|disorders of consciousness
249700|NCT02639481|rehabilitation|rehabilitation
249701|NCT02639481|robotic rehabilitation device|robotic rehabilitation device
249702|NCT02639416|severe acute malnutrition|severe acute malnutrition
249703|NCT02639416|polymeric therapeutic formula|polymeric therapeutic formula
249704|NCT02639416|elemental therapeutic formula|elemental therapeutic formula
249705|NCT02639403|Rectal cancer|rectal cancer
249706|NCT02639403|Radiotherapy|radiotherapy
249707|NCT02639403|Occlusion|occlusion
249708|NCT02639390|Robotics|robotics
249709|NCT02639390|upper extremity|upper extremity
249710|NCT02639390|neurorehabilitation|neurorehabilitation
249711|NCT02639390|movement therapy|movement therapy
249712|NCT02639377|Dental Implantation|dental implantation
249713|NCT02639377|Chlorhexidine gluconate|chlorhexidine gluconate
249714|NCT02639338|Chronic|chronic
249715|NCT02639325|Brain Tumor|brain tumor
249716|NCT02639325|Brain Cancer|brain cancer
249717|NCT02639325|Seizure Disorder|seizure disorder
249718|NCT02639325|Seizures|seizures
249719|NCT02639312|Cranofacial|cranofacial
249720|NCT02639312|Microsomia|microsomia
249721|NCT02639312|Mandibular|mandibular
249722|NCT02639312|Facial Defects|facial defects
249723|NCT02639312|Hasburg Jaw|hasburg jaw
249724|NCT02639299|Subjects|subjects
249725|NCT02639299|Venipuncture|venipuncture
249726|NCT02639299|Research|research
249727|NCT02639299|Evaluate|evaluate
249728|NCT02639299|Recruit|recruit
249729|NCT02639286|Lipodystrophy|lipodystrophy
249730|NCT02639286|Hypertriglyceridemia|hypertriglyceridemia
249731|NCT02639273|Nalmefene|nalmefene
249732|NCT02639273|fMRI|fmri
249733|NCT02639273|Incentive Salience|incentive salience
249734|NCT02639273|Reward Processing|reward processing
249735|NCT02639273|Aversive Event Processing|aversive event processing
249736|NCT02639260|Nephrotic Syndrome|nephrotic syndrome
249737|NCT02639260|Glomerular Filtration Rate|glomerular filtration rate
249738|NCT02639260|Sialic Acid|sialic acid
249739|NCT02639260|Proteinuria|proteinuria
249740|NCT02639247|Chronic|chronic
249741|NCT02639208|Breast Cancer I|breast cancer i
249742|NCT02639208|Breast Cancer Stage II|breast cancer stage ii
249743|NCT02639208|Breast Cancer Stage III|breast cancer stage iii
249744|NCT02639182|Axitinib|axitinib
249745|NCT02639182|Metastatic Renal Cell Carcinoma|metastatic renal cell carcinoma
249746|NCT02639182|AGS-16C3F|ags-16c3f
249747|NCT02639169|music therapy|music therapy
249748|NCT02639169|Distress|distress
249749|NCT02639169|Mood|mood
249750|NCT02639169|HSCT|hsct
249751|NCT02639130|Gastric Inhibitory Polypeptide (GIP)|gastric inhibitory polypeptide (gip)
249752|NCT02639130|Glucagon-Like Peptide 1 (GLP-1)|glucagon-like peptide 1 (glp-1)
249753|NCT02639130|DPP-4 inhibition; Exendin [9-39]|dpp-4 inhibition; exendin [9-39]
249754|NCT02639130|Gastric emptying|gastric emptying
249755|NCT02639130|Glucagon|glucagon
249756|NCT02639130|Incretin|incretin
249757|NCT02639130|Insulin Secretion|insulin secretion
249758|NCT02639130|Normal glucose-tolerant|normal glucose-tolerant
319205|NCT02239211|PSC|psc
249759|NCT02639117|basal cell carcinoma, photodynamic therapy, vismodegib|basal cell carcinoma, photodynamic therapy, vismodegib
249760|NCT02639104|neck pain|neck pain
249761|NCT02639104|cervical lordosis|cervical lordosis
249762|NCT02639104|long thoracic nerve|long thoracic nerve
249763|NCT02639091|Phase 1|phase 1
249764|NCT02639091|Solid tumors|solid tumors
249765|NCT02639091|Mesothelioma|mesothelioma
249766|NCT02639091|Lung cancer|lung cancer
249767|NCT02639091|Pemetrexed|pemetrexed
249768|NCT02639091|Cisplatin|cisplatin
249769|NCT02639078|Single ascending dose|single ascending dose
249770|NCT02639078|volunteers|volunteers
249771|NCT02639078|Phase 1|phase 1
249772|NCT02639078|first-in-human|first-in-human
249773|NCT02639078|TD-0714|td-0714
249774|NCT02639065|Durvalumab|durvalumab
249775|NCT02639065|MEDI4736|medi4736
249776|NCT02639065|PD-L1 inhibitor|pd-l1 inhibitor
249777|NCT02639052|Itch|itch
249778|NCT02639052|Botox|botox
249779|NCT02639052|Healthy Volunteers|healthy volunteers
249780|NCT02638987|Dry needling|dry needling
249781|NCT02638987|office workers|office workers
249782|NCT02638987|myofascial pain|myofascial pain
249783|NCT02638987|electromyography|electromyography
249784|NCT02638961|heart failure with preserved ejection fraction|heart failure with preserved ejection fraction
249785|NCT02638961|physical therapy|physical therapy
249786|NCT02638961|exercise capacity|exercise capacity
249787|NCT02638961|quality of life|quality of life
249788|NCT02638935|Virtual Touch Tissue Imaging|virtual touch tissue imaging
249789|NCT02638935|VTIQ|vtiq
249790|NCT02638935|Elastography|elastography
249791|NCT02638935|Breast Cancer|breast cancer
249792|NCT02638935|BI-RADS|bi-rads
249793|NCT02638935|Differentiation of breast lesions|differentiation of breast lesions
249794|NCT02638935|Breast Lesion|breast lesion
249795|NCT02638909|Gastrointestinal malignancies|gastrointestinal malignancies
249796|NCT02638896|Ankylosing Spondylitis|ankylosing spondylitis
249797|NCT02638896|Etanercept|etanercept
249798|NCT02638896|Sulfasalazine|sulfasalazine
249799|NCT02638896|Efficacy|efficacy
249800|NCT02638896|Safety|safety
249801|NCT02638896|dose|dose
249802|NCT02638896|reduction|reduction
249803|NCT02638857|Recurrence Hepatocellular Carcinoma|recurrence hepatocellular carcinoma
249804|NCT02638857|Advanced Hepatocellular Carcinoma|advanced hepatocellular carcinoma
249805|NCT02638857|Dendritic Cell -Precision Multiple Antigen T Cells|dendritic cell -precision multiple antigen t cells
249806|NCT02638857|Transcatheter Arterial Chemoembolization|transcatheter arterial chemoembolization
249807|NCT02638844|echocardiography|echocardiography
249808|NCT02638831|Pain|pain
249809|NCT02638831|Gonarthrosis|gonarthrosis
249810|NCT02638831|Low Back Pain|low back pain
249811|NCT02638831|Ketorolac Tromethamine|ketorolac tromethamine
249812|NCT02638831|Ketoprofen|ketoprofen
249813|NCT02638818|pancreaticoduodenectomy|pancreaticoduodenectomy
249814|NCT02638818|Whipple|whipple
249815|NCT02638779|Septic shock|septic shock
249816|NCT02638779|severe trauma|severe trauma
249817|NCT02638779|severe burn|severe burn
249818|NCT02638779|major surgery|major surgery
249819|NCT02638779|immunosuppression|immunosuppression
249820|NCT02638779|Healthcare-Associated Infections|healthcare-associated infections
249821|NCT02638766|metastatic|metastatic
249822|NCT02638766|unresectable|unresectable
249823|NCT02638766|KIT/PDGFR wild type GIST|kit/pdgfr wild type gist
249824|NCT02638753|non specific chronic low back pain|non specific chronic low back pain
249825|NCT02638753|education on pain neurophysiology|education on pain neurophysiology
249826|NCT02638753|education on pain biology|education on pain biology
249827|NCT02638753|education on pain neuroscience|education on pain neuroscience
249828|NCT02638753|hypnosis|hypnosis
249829|NCT02638727|vascular disease|vascular disease
249830|NCT02638727|endothelial function|endothelial function
249831|NCT02638727|L-Citrulline|l-citrulline
249832|NCT02638714|Optic Neuropathies|optic neuropathies
249833|NCT02638714|Stem Cell Therapy|stem cell therapy
249834|NCT02638675|financial health incentives|financial health incentives
249835|NCT02638675|physical activity|physical activity
249836|NCT02638675|behavioral economics|behavioral economics
249837|NCT02638675|randomized control trial|randomized control trial
249838|NCT02638675|workplace health|workplace health
249839|NCT02638649|lung ultrasound|lung ultrasound
249840|NCT02638636|Cognitive behavior therapy|cognitive behavior therapy
249841|NCT02638636|Randomized controlled trial|randomized controlled trial
249842|NCT02638636|Exposure therapy|exposure therapy
249843|NCT02638636|Fibromyalgia|fibromyalgia
249844|NCT02638623|Knee Arthroplasty|knee arthroplasty
249845|NCT02638623|Hip Arthroplasty|hip arthroplasty
249846|NCT02638584|Ilaprazole|ilaprazole
249847|NCT02638584|Gastric Adenoma|gastric adenoma
249848|NCT02638584|Early Gastric Cancer|early gastric cancer
249849|NCT02638584|Endoscopic Submucosal Dissection|endoscopic submucosal dissection
249851|NCT02638532|Fat Pad Atrophy|fat pad atrophy
249852|NCT02638532|Foot|foot
249853|NCT02638532|Feet|feet
249854|NCT02638532|Heel|heel
249855|NCT02638532|Forefoot|forefoot
249856|NCT02638506|Headaches, Migraines, Fentanyl|headaches, migraines, fentanyl
249857|NCT02638493|HIV|hiv
249858|NCT02638493|tenofovir-emtricitabine|tenofovir-emtricitabine
249859|NCT02638493|antiretroviral therapy|antiretroviral therapy
249860|NCT02638493|Prevention|prevention
249861|NCT02638493|tenofovir alafenamide|tenofovir alafenamide
249862|NCT02638454|Exercise|exercise
249863|NCT02638454|Anabolic Resistance|anabolic resistance
249864|NCT02638454|Skeletal Muscle|skeletal muscle
249865|NCT02638454|microRNA|microrna
249866|NCT02638441|psychological health|psychological health
249867|NCT02638441|women|women
249868|NCT02638441|anxiety|anxiety
249869|NCT02638441|depression|depression
249870|NCT02638415|HVPG|hvpg
249871|NCT02638402|glycosylation|glycosylation
249872|NCT02638402|mucin|mucin
249873|NCT02638402|receptor tyrosin kinases|receptor tyrosin kinases
249874|NCT02638402|ovarian cancer|ovarian cancer
249875|NCT02638402|endometrial cancer|endometrial cancer
249876|NCT02638376|Keraroconus|keraroconus
249877|NCT02638376|keratectasia|keratectasia
249878|NCT02638376|treatment|treatment
249879|NCT02638350|lung ultrasound|lung ultrasound
249880|NCT02638350|Pulmonary Edema|pulmonary edema
249881|NCT02638350|Respiratory Distress Syndrome|respiratory distress syndrome
249882|NCT02638337|Vulvo-vaginal Atrophy|vulvo-vaginal atrophy
249883|NCT02638337|menopause|menopause
249884|NCT02638259|Biosimilars|biosimilars
249885|NCT02638259|Rheumatoid Arthritis|rheumatoid arthritis
249886|NCT02638259|Etanercept|etanercept
249887|NCT02638233|CHC|chc
249888|NCT02638233|IVDA (intravenous drug abuse)|ivda (intravenous drug abuse)
249889|NCT02638233|Hepatitis C|hepatitis c
249890|NCT02638233|Sofosbuvir|sofosbuvir
249891|NCT02638233|Ledipasvir|ledipasvir
249892|NCT02638233|Opiate Substitution Therapy|opiate substitution therapy
249893|NCT02638220|Cerebrotendinous Xanthomatosis|cerebrotendinous xanthomatosis
249894|NCT02638220|CTX Prevalence Study|ctx prevalence study
249895|NCT02638220|CTX|ctx
249896|NCT02638220|Idiopathic Bilateral Cataracts|idiopathic bilateral cataracts
249897|NCT02638220|Cataracts|cataracts
249898|NCT02638220|Bilateral Cataracts|bilateral cataracts
249899|NCT02638220|Early-Onset Idiopathic Bilateral Cataracts|early-onset idiopathic bilateral cataracts
249900|NCT02638220|Observational Study|observational study
249901|NCT02638220|Ophthalmology|ophthalmology
249902|NCT02638207|Chronic Inflammatory Demyelinating Poly Neuropathy (CIDP)|chronic inflammatory demyelinating poly neuropathy (cidp)
249903|NCT02638194|Chronic Obstructive Pulmonary Disease (COPD)|chronic obstructive pulmonary disease (copd)
249904|NCT02638194|smoking|smoking
249905|NCT02638194|secondhand smoke|secondhand smoke
249906|NCT02638181|matrix metalloproteinase 13|matrix metalloproteinase 13
249907|NCT02638181|tissue inhibitor of metalloproteinases 3|tissue inhibitor of metalloproteinases 3
249908|NCT02638181|calcium-sensing receptor|calcium-sensing receptor
249909|NCT02638181|trabecular meshwork|trabecular meshwork
249910|NCT02638181|open-angle glaucoma|open-angle glaucoma
249911|NCT02638142|loop diuretic|loop diuretic
249912|NCT02638142|heart failure|heart failure
249913|NCT02638142|renal dysfunction|renal dysfunction
249914|NCT02638142|congestion signs|congestion signs
249915|NCT02638142|BNP|bnp
249916|NCT02638129|Drug therapy|drug therapy
249917|NCT02638116|Ibrutinib|ibrutinib
249918|NCT02638116|Proton pump inhibitors|proton pump inhibitors
249919|NCT02638116|Pharmacokinetics|pharmacokinetics
249920|NCT02638116|Drug Interaction|drug interaction
249921|NCT02638090|advanced lung cancer|advanced lung cancer
249922|NCT02638090|immune therapy naive|immune therapy naive
249923|NCT02638090|immune therapy pre-treated|immune therapy pre-treated
249924|NCT02638090|NSCLC|nsclc
249925|NCT02638090|Stage IV lung cancer|stage iv lung cancer
249926|NCT02638090|pembrolizumab|pembrolizumab
249927|NCT02638090|vorinostat|vorinostat
249928|NCT02638090|immunogenicity|immunogenicity
249929|NCT02638077|Differentiated Thyroid Cancer|differentiated thyroid cancer
249930|NCT02638077|the initial management|the initial management
249931|NCT02638051|Peritoneal Carcinomatosis|peritoneal carcinomatosis
249932|NCT02638051|Malignant Ascites|malignant ascites
249933|NCT02638051|Modulated Electro-Hyperthermia|modulated electro-hyperthermia
249934|NCT02638051|Traditional Chinese Medicine|traditional chinese medicine
249935|NCT02637960|VA106483, fedovapagon, BPH, nocturia, EQUINOC|va106483, fedovapagon, bph, nocturia, equinoc
249936|NCT02637921|bed rest|bed rest
249937|NCT02637921|bone metabolism|bone metabolism
249938|NCT02637908|Mindfulness|mindfulness
249939|NCT02637908|Parents|parents
249940|NCT02637908|Families|families
249941|NCT02637895|PTSD,|ptsd,
249942|NCT02637895|trauma|trauma
249943|NCT02637895|stress disorder|stress disorder
249944|NCT02637895|post-traumatic stress disorder|post-traumatic stress disorder
249945|NCT02637895|anxiety disorder|anxiety disorder
249946|NCT02637869|Health Expenditures|health expenditures
249947|NCT02637869|Prospective Payment System|prospective payment system
249948|NCT02637869|Health Care Utilization|health care utilization
249949|NCT02637869|Health Care Quality, Access, and Evaluation|health care quality, access, and evaluation
249950|NCT02637843|radial|radial
249951|NCT02637843|angiography|angiography
249952|NCT02637843|angioplasty|angioplasty
249953|NCT02637843|randomized|randomized
249954|NCT02637843|sheath|sheath
249955|NCT02637843|slender|slender
249956|NCT02637791|Stroke|stroke
249957|NCT02637791|Rehabilitation|rehabilitation
249958|NCT02637791|Virtual Reality|virtual reality
249959|NCT02637778|nutrient profiles|nutrient profiles
249960|NCT02637778|menu plans|menu plans
249961|NCT02637778|n-3 LC-PUFA|n-3 lc-pufa
249962|NCT02637778|SFA|sfa
249963|NCT02637778|MUFA|mufa
249964|NCT02637778|PUFA|pufa
249965|NCT02637778|cardiovascular risk|cardiovascular risk
249966|NCT02637765|Breast Cancer|breast cancer
249967|NCT02637765|Physical Activity|physical activity
249968|NCT02637765|Quality of life|quality of life
249969|NCT02637752|Pediatric Obesity|pediatric obesity
249970|NCT02637752|Body Mass Index|body mass index
249971|NCT02637752|Dentistry|dentistry
249972|NCT02637739|hysteroscope|hysteroscope
249973|NCT02637726|Total intravenous anesthesia|total intravenous anesthesia
249974|NCT02637726|Target Controlled Infusion|target controlled infusion
249975|NCT02637726|Propofol|propofol
249976|NCT02637726|Bispectral index|bispectral index
249977|NCT02637726|Children|children
249978|NCT02637713|GERD|gerd
249979|NCT02637713|sleeve gastrectomy|sleeve gastrectomy
249980|NCT02637713|reflux|reflux
249981|NCT02637713|morbidly obese|morbidly obese
249982|NCT02637700|Small Fiber Neuropathy|small fiber neuropathy
249983|NCT02637700|Painful Neuropathy|painful neuropathy
249984|NCT02637700|Intravenous Immunoglobulin Therapy|intravenous immunoglobulin therapy
249985|NCT02637687|Advanced solid tumors|advanced solid tumors
249986|NCT02637687|Central nervous system (CNS) tumor|central nervous system (cns) tumor
249987|NCT02637687|Extra-cranial tumor|extra-cranial tumor
249988|NCT02637687|Infantile fibrosarcoma (IFS)|infantile fibrosarcoma (ifs)
249989|NCT02637687|Neurotrophic tyrosine receptor kinase (NTRK)|neurotrophic tyrosine receptor kinase (ntrk)
249990|NCT02637687|NTRK1|ntrk1
249991|NCT02637687|NTRK2|ntrk2
249992|NCT02637687|NTRK3|ntrk3
249993|NCT02637687|Fusion Positive|fusion positive
249994|NCT02637687|TRK fusion|trk fusion
249995|NCT02637687|TRKA|trka
249996|NCT02637687|TRKB|trkb
249997|NCT02637687|TRKC|trkc
249998|NCT02637687|ETV6|etv6
249999|NCT02637674|allotransplantation|allotransplantation
250000|NCT02637661|earlobe crease|earlobe crease
250001|NCT02637661|acute myocardial infarction|acute myocardial infarction
250002|NCT02637661|risk factor|risk factor
250003|NCT02637635|Mammaplasty|mammaplasty
250004|NCT02637635|Transplantation, Autologous|transplantation, autologous
250005|NCT02637635|Mastectomy|mastectomy
250006|NCT02637635|Breast Implants|breast implants
250007|NCT02637635|Radiotherapy, Adjuvant|radiotherapy, adjuvant
250008|NCT02637622|conjoint analysis|conjoint analysis
250009|NCT02637622|stated-preference methods|stated-preference methods
250010|NCT02637622|patient centered outcome research (PCOR)|patient centered outcome research (pcor)
250011|NCT02637622|community-based participatory research (CBPR)|community-based participatory research (cbpr)
250012|NCT02637622|patient preference|patient preference
250013|NCT02637622|diabetes|diabetes
250014|NCT02637609|conjoint analysis|conjoint analysis
250015|NCT02637609|stated-preference methods|stated-preference methods
250016|NCT02637609|patient centered outcome research (PCOR)|patient centered outcome research (pcor)
250017|NCT02637609|community-based participatory research (CBPR)|community-based participatory research (cbpr)
250018|NCT02637609|patient priority|patient priority
250019|NCT02637609|diabetes|diabetes
250020|NCT02637583|conjugate vaccine|conjugate vaccine
250021|NCT02637583|polysaccharide vaccine|polysaccharide vaccine
250022|NCT02637570|healthy male athletes|healthy male athletes
250023|NCT02637570|18-35 years old|18-35 years old
250024|NCT02637531|IPI-549|ipi-549
250025|NCT02637531|Phase 1|phase 1
250524|NCT02634801|Fumaderm|fumaderm
250026|NCT02637531|Advanced Solid Tumor|advanced solid tumor
250027|NCT02637531|Non-small cell lung cancer|non-small cell lung cancer
250028|NCT02637531|Melanoma|melanoma
250029|NCT02637531|PI3K|pi3k
250030|NCT02637531|Squamous Cell Cancer of the Head and Neck|squamous cell cancer of the head and neck
250031|NCT02637531|Triple Negative Breast Cancer|triple negative breast cancer
250032|NCT02637531|Adrenocortical Carcinoma|adrenocortical carcinoma
250033|NCT02637531|Mesothelioma|mesothelioma
250034|NCT02637531|High-circulating myeloid-derived suppressor cells (MDSCs)|high-circulating myeloid-derived suppressor cells (mdscs)
250035|NCT02637518|Frailty|frailty
250036|NCT02637518|Frailty screening tools|frailty screening tools
250037|NCT02637518|Clinical settings|clinical settings
250038|NCT02637518|Social settings|social settings
250039|NCT02637518|Geriatrics|geriatrics
250040|NCT02637518|Functional autonomy|functional autonomy
250041|NCT02637518|Disability|disability
250042|NCT02637505|Articular cartilage|articular cartilage
250043|NCT02637505|Focal cartilage injury|focal cartilage injury
250044|NCT02637505|Focal cartilage injury in the knee|focal cartilage injury in the knee
250045|NCT02637505|Knee cartilage|knee cartilage
250046|NCT02637505|Microfracture|microfracture
250047|NCT02637505|Debridement|debridement
250048|NCT02637492|Critical limb ischaemia|critical limb ischaemia
250049|NCT02637492|Peripheral occlusive arterial disease|peripheral occlusive arterial disease
250050|NCT02637492|Clinical prediction|clinical prediction
250051|NCT02637492|Ankle pressure|ankle pressure
250052|NCT02637492|Transcutaneous oxygen pressure|transcutaneous oxygen pressure
250053|NCT02637492|Toe pressure|toe pressure
250054|NCT02637492|Microcirculation|microcirculation
250055|NCT02637453|Paroxysmal Atrial Fibrillation;Additional Linear Ablation|paroxysmal atrial fibrillation;additional linear ablation
250056|NCT02637427|Fresh frozen plasma|fresh frozen plasma
250057|NCT02637427|Bleeding|bleeding
250058|NCT02637414|Stress|stress
250059|NCT02637414|Well-being|well-being
250060|NCT02637414|Positive psychology|positive psychology
250061|NCT02637388|Appetite|appetite
250062|NCT02637388|Beta-glucans|beta-glucans
250063|NCT02637388|Energy Intake|energy intake
250064|NCT02637388|Glucagon-Like Peptide 1|glucagon-like peptide 1
250065|NCT02637388|Glucose|glucose
250066|NCT02637388|Insulin|insulin
250067|NCT02637388|Incretins|incretins
250068|NCT02637375|triple-negative breast cancer|triple-negative breast cancer
250069|NCT02637336|Therapies. Autonomic nervous system. Cardiovascular stress|therapies. autonomic nervous system. cardiovascular stress
250070|NCT02637323|osteoarthritis|osteoarthritis
250071|NCT02637323|knee|knee
250072|NCT02637323|pain|pain
250073|NCT02637323|corticosteroid|corticosteroid
250074|NCT02637323|intra-articular|intra-articular
250075|NCT02637323|injection|injection
250076|NCT02637284|Healthy volunteers|healthy volunteers
250077|NCT02637271|Calorie restriction|calorie restriction
250078|NCT02637271|Meal replacement|meal replacement
250079|NCT02637271|fMRI|fmri
250080|NCT02637271|Food-cue reactivity|food-cue reactivity
250081|NCT02637271|Obesity|obesity
250082|NCT02637258|optic nerve sheath diameter|optic nerve sheath diameter
250083|NCT02637258|neurological outcome|neurological outcome
250084|NCT02637258|OHCA|ohca
250085|NCT02637245|diabetic macular edema|diabetic macular edema
250086|NCT02637245|diabetic retinopathy|diabetic retinopathy
250087|NCT02637206|Healthy Japanese|healthy japanese
250088|NCT02637206|GSK2894512|gsk2894512
250089|NCT02637206|skin safety|skin safety
250090|NCT02637180|osteoporosis|osteoporosis
250091|NCT02637180|fracture|fracture
250092|NCT02637180|liaison service|liaison service
250093|NCT02637167|Heart failure|heart failure
250094|NCT02637167|inflammation|inflammation
250095|NCT02637167|rifaximin|rifaximin
250096|NCT02637167|Saccharomyces boulardii|saccharomyces boulardii
250097|NCT02637167|gut microbiota|gut microbiota
250098|NCT02637154|Adolescent|adolescent
250099|NCT02637154|Type 1 diabetes|type 1 diabetes
250100|NCT02637154|Metabolic control|metabolic control
250101|NCT02637154|Motivational interviewing|motivational interviewing
250102|NCT02637141|celiac|celiac
250103|NCT02637141|gluten|gluten
250104|NCT02637141|IL-15|il-15
250105|NCT02637141|AMG 714|amg 714
250106|NCT02637128|MALARIA, FALCIPARUM|malaria, falciparum
250107|NCT02637128|MALAWI|malawi
250108|NCT02637128|ARTEMETHER-LUMEFANTRINE|artemether-lumefantrine
250109|NCT02637128|ARTESUNATE-AMODIAQUINE|artesunate-amodiaquine
250110|NCT02637115|Gut microbiota|gut microbiota
250111|NCT02637115|Akkermansia muciniphila|akkermansia muciniphila
250112|NCT02637076|Xyrem|xyrem
250113|NCT02637076|narcolepsy with cataplexy|narcolepsy with cataplexy
250114|NCT02637076|positron emission tomography|positron emission tomography
250115|NCT02637076|dopamine|dopamine
250116|NCT02637063|Lifestyle behavior change|lifestyle behavior change
250117|NCT02637050|Type IV Pulmonary Hypertension|type iv pulmonary hypertension
250118|NCT02637050|Chronic Thromboembolic Pulmonary Hypertension|chronic thromboembolic pulmonary hypertension
250119|NCT02637050|CTEPH|cteph
250120|NCT02637037|dapagliflozin/metformin XR 5/500 mg|dapagliflozin/metformin xr 5/500 mg
250121|NCT02637037|dapagliflozin/metformin XR10/1000 mg|dapagliflozin/metformin xr10/1000 mg
250122|NCT02637037|bioequivalence|bioequivalence
250123|NCT02637037|fixed dose combination tablets|fixed dose combination tablets
250124|NCT02637037|pharmacokinetic|pharmacokinetic
250125|NCT02637037|type 2 Diabetes Mellitus (T2DM)|type 2 diabetes mellitus (t2dm)
250126|NCT02637037|safety|safety
250127|NCT02637024|Breast Cancer|breast cancer
250128|NCT02637024|DCIS|dcis
250129|NCT02637024|Radiotherapy|radiotherapy
250130|NCT02637024|Partial breast irradiation|partial breast irradiation
250131|NCT02637024|Radiation fractions|radiation fractions
250132|NCT02637011|acute respiratory distress syndrome|acute respiratory distress syndrome
250133|NCT02637011|intensive care medicine|intensive care medicine
250134|NCT02637011|critical illness|critical illness
250135|NCT02637011|long-term outcomes|long-term outcomes
250136|NCT02637011|quality of life|quality of life
250137|NCT02637011|return to work|return to work
250138|NCT02637011|quality of care|quality of care
250139|NCT02636972|TLR2|tlr2
250140|NCT02636972|TLR4|tlr4
250141|NCT02636972|Biomarker|biomarker
250142|NCT02636972|TLR responsiveness|tlr responsiveness
250143|NCT02636972|Peripheral blood responsiveness|peripheral blood responsiveness
250144|NCT02636972|Inflammatory pain|inflammatory pain
250145|NCT02636933|Asthma|asthma
250146|NCT02636933|Allergic Rhinitis|allergic rhinitis
250147|NCT02636933|Children|children
250148|NCT02636933|Atopy|atopy
250149|NCT02636920|Asthma|asthma
250150|NCT02636920|Children|children
250151|NCT02636855|Solid and Hematological Malignancies|solid and hematological malignancies
250152|NCT02636855|Screening|screening
250153|NCT02636855|Metastatic|metastatic
250154|NCT02636855|Previously Treated|previously treated
250155|NCT02636855|NY-ESO-1|ny-eso-1
250156|NCT02636855|MAGE A10|mage a10
250157|NCT02636855|MAGE-A4|mage-a4
250158|NCT02636842|Schizophrenia|schizophrenia
250159|NCT02636842|Schizoaffective Disorder|schizoaffective disorder
250160|NCT02636842|Aripiprazole Lauroxil|aripiprazole lauroxil
250161|NCT02636842|Aripiprazole|aripiprazole
250162|NCT02636842|ALKS 9072|alks 9072
250163|NCT02636842|Alkermes|alkermes
250164|NCT02636803|trichuris|trichuris
250165|NCT02636803|hookworms|hookworms
250166|NCT02636803|Ascaris|ascaris
250167|NCT02636777|low back pain|low back pain
250168|NCT02636777|chronic pain|chronic pain
250169|NCT02636777|self-management|self-management
250170|NCT02636777|longitudinal study|longitudinal study
250171|NCT02636777|predictive modelling|predictive modelling
250172|NCT02636751|Prehabilitation|prehabilitation
250173|NCT02636751|Telemedicine|telemedicine
250174|NCT02636751|Osteoarthritis|osteoarthritis
250175|NCT02636751|Arthroplasty|arthroplasty
250176|NCT02636751|Hip|hip
250177|NCT02636751|Knee|knee
250178|NCT02636725|Advanced Alveolar Soft Part Sarcoma|advanced alveolar soft part sarcoma
250179|NCT02636725|ASPS|asps
250180|NCT02636725|Soft Tissue Sarcomas|soft tissue sarcomas
250181|NCT02636725|STS|sts
250182|NCT02636725|Alveolar Soft Part Sarcoma|alveolar soft part sarcoma
250183|NCT02636686|DMD|dmd
250184|NCT02636686|Duchenne Muscular Dystrophy|duchenne muscular dystrophy
250185|NCT02636686|Drisapersen|drisapersen
250186|NCT02636686|Kyndrisa|kyndrisa
250187|NCT02636686|exon-skipping|exon-skipping
250188|NCT02636686|exon-51|exon-51
250189|NCT02636686|BMN-051-302|bmn-051-302
250190|NCT02636686|051-302|051-302
250191|NCT02636660|Critical care|critical care
250192|NCT02636660|Mechanical Ventilation|mechanical ventilation
250193|NCT02636660|Quality of Life|quality of life
250194|NCT02636660|Stressors|stressors
250195|NCT02636660|Nursing Sensitive Outcomes|nursing sensitive outcomes
250196|NCT02636660|Nursing|nursing
250197|NCT02636647|hepatic encephalopathy|hepatic encephalopathy
250198|NCT02636647|fecal transplant|fecal transplant
250199|NCT02636647|cirrhosis|cirrhosis
250200|NCT02636634|diagnostic strategy|diagnostic strategy
250201|NCT02636634|brain metastases|brain metastases
250202|NCT02636634|radiation necrosis|radiation necrosis
250203|NCT02636634|relapse|relapse
250204|NCT02636634|PET-FET and MSR|pet-fet and msr
250205|NCT02636634|radiosurgery|radiosurgery
250206|NCT02636621|Fatigue|fatigue
250207|NCT02636621|excessive daytime sleepiness|excessive daytime sleepiness
250208|NCT02636621|flow limitation|flow limitation
250209|NCT02636608|Chronic Hepatitis C|chronic hepatitis c
250210|NCT02636608|Dasabuvir|dasabuvir
250211|NCT02636608|Paritaprevir/r/Ombitasvir|paritaprevir/r/ombitasvir
250212|NCT02636608|Observational Study|observational study
250213|NCT02636608|Quality of Life|quality of life
250214|NCT02636608|Fibrosis|fibrosis
250215|NCT02636608|Cirrhosis|cirrhosis
250216|NCT02636608|Work Ability|work ability
250217|NCT02636595|Hepatitis C Genotype 4|hepatitis c genotype 4
250218|NCT02636595|Hepatitis C|hepatitis c
250219|NCT02636595|Chronic Hepatitis C|chronic hepatitis c
250220|NCT02636595|Hepatitis C Genotype 6|hepatitis c genotype 6
250221|NCT02636595|Hepatitis C Genotype 5|hepatitis c genotype 5
250222|NCT02636556|thymoma|thymoma
250223|NCT02636556|thymic carcinoma|thymic carcinoma
250224|NCT02636556|chemoradiotherapy|chemoradiotherapy
250225|NCT02636556|inoperable|inoperable
250226|NCT02636543|genetic diagnosis|genetic diagnosis
250227|NCT02636543|information|information
250228|NCT02636543|letter model|letter model
250229|NCT02636517|Fecal Microbiota transplant|fecal microbiota transplant
250230|NCT02636504|Pulp vitality|pulp vitality
250231|NCT02636504|Pulp testing|pulp testing
250232|NCT02636439|Diastolic heart failure|diastolic heart failure
250233|NCT02636439|Heart Failure|heart failure
250234|NCT02636439|Elderly|elderly
250235|NCT02636439|Obesity|obesity
250236|NCT02636426|phase I study|phase i study
250237|NCT02636426|sorafenib|sorafenib
250238|NCT02636426|high-dose schedule|high-dose schedule
250239|NCT02636426|pharmacokinetics|pharmacokinetics
250240|NCT02636426|drug monitoring|drug monitoring
250241|NCT02636400|Infertility|infertility
250242|NCT02636400|endometriosis|endometriosis
250243|NCT02636348|Calcium|calcium
250244|NCT02636348|Vitamin D|vitamin d
250245|NCT02636309|ergonomics|ergonomics
250246|NCT02636309|multifaceted intervention|multifaceted intervention
250247|NCT02636309|industry|industry
250248|NCT02636309|physiotherapy|physiotherapy
250249|NCT02636309|physical exercises|physical exercises
250250|NCT02636309|workplace|workplace
250251|NCT02636309|acupuncture|acupuncture
250252|NCT02636309|work|work
250253|NCT02636309|quality of life|quality of life
250254|NCT02636309|absenteeism|absenteeism
250255|NCT02636309|efficiency|efficiency
250256|NCT02636309|musculoskeletal pain|musculoskeletal pain
250257|NCT02636309|WMSD|wmsd
250258|NCT02636296|Pilates method|pilates method
250259|NCT02636296|elderly|elderly
250260|NCT02636296|postural balance|postural balance
250261|NCT02636257|Silicone Nasolacrimal Intubation|silicone nasolacrimal intubation
250262|NCT02636257|Dacryocystorhinostomy|dacryocystorhinostomy
250263|NCT02636231|Endostar|endostar
250264|NCT02636231|IMRT|imrt
250265|NCT02636231|recurrent|recurrent
250266|NCT02636231|NPC|npc
250267|NCT02636218|Ketamine|ketamine
250268|NCT02636192|Sodium-glucose co-transporter 2 inhibitors|sodium-glucose co-transporter 2 inhibitors
250269|NCT02636192|Diabetes Mellitus, Type 2|diabetes mellitus, type 2
250270|NCT02636179|In Vitro Fertilization, follow-up of children|in vitro fertilization, follow-up of children
250271|NCT02636166|Pregnancy|pregnancy
250272|NCT02636153|phosphorus,dietary|phosphorus,dietary
250273|NCT02636153|circadian rhythm|circadian rhythm
250274|NCT02636153|phosphorus|phosphorus
250275|NCT02636088|Phase II study, clinical trial|phase ii study, clinical trial
250276|NCT02636062|Coronary disease|coronary disease
250277|NCT02636062|Coronary artery disease (CAD)|coronary artery disease (cad)
250278|NCT02636062|Endothelial dysfunction|endothelial dysfunction
250279|NCT02636062|Coronary artery calcium (CAC)|coronary artery calcium (cac)
250280|NCT02636049|pharmacokinetics|pharmacokinetics
250281|NCT02636049|healthy adult volunteer|healthy adult volunteer
250282|NCT02635997|osteoporosis|osteoporosis
250283|NCT02635997|ibandronate|ibandronate
250284|NCT02635997|vitamine D|vitamine d
250285|NCT02635997|calcium|calcium
250286|NCT02635997|bone mineral density|bone mineral density
250287|NCT02635997|health-related quality of life|health-related quality of life
250288|NCT02635971|transcatheter arterial infusion|transcatheter arterial infusion
250289|NCT02635971|randomized controlled trial|randomized controlled trial
250290|NCT02635971|chemotherapy|chemotherapy
250291|NCT02635958|Body Mass Index|body mass index
250292|NCT02635958|BMI|bmi
250293|NCT02635958|InBody|inbody
250294|NCT02635958|iDXA|idxa
250295|NCT02635958|validation|validation
250296|NCT02635945|adenosine A1 receptor antagonist|adenosine a1 receptor antagonist
250297|NCT02635945|adenosine receptor modulator|adenosine receptor modulator
250298|NCT02635945|COPD|copd
250299|NCT02635945|asthma|asthma
250300|NCT02635919|Nicotine addiction|nicotine addiction
250301|NCT02635919|Cigarette smoking|cigarette smoking
250302|NCT02635919|Smoking cessation|smoking cessation
250303|NCT02635919|Quit smoking|quit smoking
250304|NCT02635906|BED REST|bed rest
250305|NCT02635906|CORONARY ANGIOPLASTY|coronary angioplasty
250306|NCT02635893|SCI|sci
250307|NCT02635867|vital pulp|vital pulp
250308|NCT02635867|reversible pulpitis|reversible pulpitis
250309|NCT02635867|pulp capping|pulp capping
250310|NCT02635867|deep cavity|deep cavity
250311|NCT02635867|Management of Deep Dental Caries|management of deep dental caries
250312|NCT02635854|leukocyte and platelet aggregates|leukocyte and platelet aggregates
250313|NCT02635854|platelet activation|platelet activation
250314|NCT02635841|Pantothenate Kinase-Associated Neurodegeneration|pantothenate kinase-associated neurodegeneration
250315|NCT02635841|PKAN|pkan
250316|NCT02635841|Neurodegeneration with Brain Iron Accumulation|neurodegeneration with brain iron accumulation
250317|NCT02635841|NBIA|nbia
250318|NCT02635841|Deferiprone|deferiprone
250319|NCT02635841|Ferriprox|ferriprox
250320|NCT02635828|Palonosetron|palonosetron
250321|NCT02635828|Craniotomy|craniotomy
250322|NCT02635828|Nausea|nausea
250323|NCT02635828|Vomiting|vomiting
250324|NCT02635802|remifentanil|remifentanil
250325|NCT02635802|analgesia|analgesia
250326|NCT02635802|intensive care units|intensive care units
250327|NCT02635789|Sirolimus|sirolimus
250328|NCT02635789|Skin lesions|skin lesions
250329|NCT02635789|TSC|tsc
250330|NCT02635789|Tuberous Sclerosis Complex|tuberous sclerosis complex
250331|NCT02635789|NPC-12G|npc-12g
250332|NCT02635789|Angiofibroma|angiofibroma
250333|NCT02635789|Hypomelanotic macule|hypomelanotic macule
250334|NCT02635789|Plaque|plaque
250335|NCT02635776|AR101 (Characterized Peanut Allergen)|ar101 (characterized peanut allergen)
250336|NCT02635776|Characterized Peanut Allergen|characterized peanut allergen
250337|NCT02635776|CPNA (Characterized Peanut Allergen)|cpna (characterized peanut allergen)
250338|NCT02635776|OIT (oral immunotherapy)|oit (oral immunotherapy)
250339|NCT02635776|Oral Immunotherapy|oral immunotherapy
250340|NCT02635776|Peanut Allergy|peanut allergy
250341|NCT02635776|Allergy|allergy
250342|NCT02635776|Peanut-Allergic Children|peanut-allergic children
250343|NCT02635776|Peanut-Allergic Adults|peanut-allergic adults
250344|NCT02635776|Desensitization|desensitization
250345|NCT02635763|nerve block|nerve block
250346|NCT02635763|general anesthesia|general anesthesia
250347|NCT02635763|hip fracture|hip fracture
250348|NCT02635763|recovery|recovery
250349|NCT02635724|Acute uncomplicated|acute uncomplicated
250350|NCT02635724|Elderly|elderly
250351|NCT02635685|Atrial fibrillation|atrial fibrillation
250352|NCT02635685|Stroke|stroke
250353|NCT02635685|Clinical Decision Support|clinical decision support
250354|NCT02635685|Anticoagulants|anticoagulants
250355|NCT02635672|Solid tumors|solid tumors
250356|NCT02635672|Aggressive non-hodgkin's lymphoma (NHL)|aggressive non-hodgkin's lymphoma (nhl)
250357|NCT02635659|food intake, satiety, satiation, nutrients, ileal brake|food intake, satiety, satiation, nutrients, ileal brake
250358|NCT02635633|partial epilepsy|partial epilepsy
250359|NCT02635633|unifocal neocortical|unifocal neocortical
250360|NCT02635633|treatment resistant|treatment resistant
250361|NCT02635633|transcranial magnetic stimulation|transcranial magnetic stimulation
250362|NCT02635633|thetaburst stimulation|thetaburst stimulation
250363|NCT02635620|e-cigarette, electronic cigarette, lung function|e-cigarette, electronic cigarette, lung function
250364|NCT02635607|GnRH antagonist|gnrh antagonist
250365|NCT02635607|fixed protocol|fixed protocol
250366|NCT02635607|flexible protocol|flexible protocol
250367|NCT02635542|Postoperative Pulmonary Complications|postoperative pulmonary complications
250368|NCT02635542|Residual Neuromuscular Blockade|residual neuromuscular blockade
250369|NCT02635542|Cardiac Surgical Procedures|cardiac surgical procedures
250370|NCT02635503|colorectal cancer|colorectal cancer
250371|NCT02635503|laparoscopic surgery|laparoscopic surgery
250372|NCT02635503|natural orifice specimen extraction|natural orifice specimen extraction
250373|NCT02635503|Inflammatory response|inflammatory response
250374|NCT02635490|prophylactic antibiotics, urinary tract infection.|prophylactic antibiotics, urinary tract infection.
250375|NCT02635451|vitamin c|vitamin c
250376|NCT02635451|Preterm Premature Rupture of Membranes|preterm premature rupture of membranes
250377|NCT02635438|Oropharyngeal Candidiasis|oropharyngeal candidiasis
250378|NCT02635412|Placenta|placenta
250379|NCT02635412|Accreta|accreta
250380|NCT02635412|Morbidly|morbidly
250381|NCT02635412|Adherent Placenta|adherent placenta
250382|NCT02635399|pancreaticoduodenectomy, delayed gastric emptying, duodenojejunopexy|pancreaticoduodenectomy, delayed gastric emptying, duodenojejunopexy
250383|NCT02635386|PCOS|pcos
250384|NCT02635386|GLP1 agonists|glp1 agonists
250385|NCT02635386|SGLT2 inhibitors|sglt2 inhibitors
250386|NCT02635373|Calciphylaxis|calciphylaxis
250387|NCT02635373|Rare disease (ORPHA280062)|rare disease (orpha280062)
250388|NCT02635373|Renal insufficiency|renal insufficiency
250389|NCT02635373|ESRD|esrd
250390|NCT02635373|Calcification|calcification
250391|NCT02635373|Chronic kidney disease|chronic kidney disease
250392|NCT02635373|Dialysis|dialysis
250393|NCT02635373|Vascular disease|vascular disease
250394|NCT02635360|advanced|advanced
250395|NCT02635360|cervical cancer|cervical cancer
250396|NCT02635360|pembrolizumab|pembrolizumab
250397|NCT02635360|chemoradiation|chemoradiation
250398|NCT02635360|immunotherapy|immunotherapy
250399|NCT02635347|Remote ischemic preconditioning|remote ischemic preconditioning
250400|NCT02635347|Remote ischemic perconditioning|remote ischemic perconditioning
250401|NCT02635347|Remote ischemic postconditioning|remote ischemic postconditioning
250402|NCT02635347|Remote ischemic conditioning|remote ischemic conditioning
250403|NCT02635347|Orthotopic liver transplant|orthotopic liver transplant
250404|NCT02635347|Brain Death Organ Donor|brain death organ donor
250405|NCT02635321|MRI|mri
250406|NCT02635321|LGMD|lgmd
250407|NCT02635321|GMPPB|gmppb
250408|NCT02635308|hip fracture|hip fracture
250409|NCT02635308|physical function|physical function
250410|NCT02635308|muscle function|muscle function
250411|NCT02635308|symmetry|symmetry
250412|NCT02635295|Clinical practicum|clinical practicum
250413|NCT02635295|Nursing student|nursing student
250414|NCT02635295|Nurse teacher|nurse teacher
250415|NCT02635295|Mobile technology|mobile technology
250416|NCT02635295|Cooperation|cooperation
250417|NCT02635295|Nurse competence|nurse competence
250418|NCT02635269|Ergometry|ergometry
250419|NCT02635269|Stable isotope tracers|stable isotope tracers
250420|NCT02635256|hypofractionation|hypofractionation
250421|NCT02635256|prostate cancer|prostate cancer
250422|NCT02635256|radiotherapy|radiotherapy
250423|NCT02635230|Atrial Fibrillations|atrial fibrillations
250424|NCT02635230|Heart Valve Prostheses|heart valve prostheses
250425|NCT02635230|Acute Coronary Syndromes|acute coronary syndromes
250426|NCT02635230|Percutaneous Coronary Revascularization|percutaneous coronary revascularization
250427|NCT02635230|Coronary Artery Bypass Grafting|coronary artery bypass grafting
250428|NCT02635230|Coronary Artery Diseases|coronary artery diseases
250429|NCT02635230|Myocardial Infarction|myocardial infarction
250430|NCT02635230|Ischemic stroke|ischemic stroke
250431|NCT02635230|Bleeding|bleeding
250432|NCT02635230|Thrombosis|thrombosis
250433|NCT02635230|Myocardial Ischemia|myocardial ischemia
250434|NCT02635230|Heart Diseases|heart diseases
250435|NCT02635230|Cardiovascular Diseases|cardiovascular diseases
250436|NCT02635230|Embolism and Thrombosis|embolism and thrombosis
250437|NCT02635230|Platelet Aggregation Inhibitors|platelet aggregation inhibitors
250438|NCT02635230|Aspirin|aspirin
250439|NCT02635230|Clopidogrel|clopidogrel
250440|NCT02635230|Ticagrelor|ticagrelor
250441|NCT02635230|Prasugrel|prasugrel
250442|NCT02635230|Antithrombotic treatment|antithrombotic treatment
250443|NCT02635230|Oral anticoagulation|oral anticoagulation
250444|NCT02635230|Warfarin|warfarin
250445|NCT02635230|Dabigatran etexilate mesylate|dabigatran etexilate mesylate
250446|NCT02635230|Apixaban|apixaban
250447|NCT02635230|Rivaroxaban|rivaroxaban
250448|NCT02635230|Direct Factor Xa Inhibitors|direct factor xa inhibitors
250449|NCT02635230|Direct Thrombin Inhibitors|direct thrombin inhibitors
250450|NCT02635217|Colonoscopy|colonoscopy
250451|NCT02635217|Esophagogastroduodenoscopy|esophagogastroduodenoscopy
250452|NCT02635217|Patient satisfaction|patient satisfaction
250453|NCT02635217|Bidirectional endoscopies|bidirectional endoscopies
250454|NCT02635191|Helicobacter pylori|helicobacter pylori
250455|NCT02635191|Therapy|therapy
250456|NCT02635191|Children|children
250457|NCT02635139|meal skipping|meal skipping
250458|NCT02635139|isocaloric diet|isocaloric diet
250459|NCT02635139|macronutrient oxidation|macronutrient oxidation
250460|NCT02635139|glucose homeostasis|glucose homeostasis
250461|NCT02635139|arterial stiffness|arterial stiffness
250462|NCT02635113|balance|balance
250463|NCT02635113|gait|gait
250464|NCT02635113|falls|falls
250465|NCT02635113|sensory deficits|sensory deficits
250466|NCT02635113|vibration|vibration
250467|NCT02635113|visual acuity|visual acuity
250468|NCT02635113|dizziness|dizziness
250469|NCT02635113|postural control|postural control
250470|NCT02635113|proprioceptive function|proprioceptive function
250471|NCT02635113|stereoacuity|stereoacuity
250472|NCT02635113|depth perception|depth perception
250473|NCT02635113|vestibular dysfunction|vestibular dysfunction
250474|NCT02635100|Sleep Disordered Breathing|sleep disordered breathing
250475|NCT02635100|Sleep Apnea|sleep apnea
250476|NCT02635048|Percutaneous nephrolithotomy|percutaneous nephrolithotomy
250477|NCT02635048|Kidney stones|kidney stones
250478|NCT02635048|Efficacy|efficacy
250479|NCT02635048|Safety|safety
250480|NCT02635022|Fracture|fracture
250481|NCT02635022|Sarcopenia|sarcopenia
250482|NCT02635022|Osteoporosis|osteoporosis
250483|NCT02635022|Care management|care management
250484|NCT02635022|Medication adherence|medication adherence
250485|NCT02634983|COPD|copd
250486|NCT02634983|Smokers|smokers
250487|NCT02634983|Ex-smokers|ex-smokers
250488|NCT02634970|wet AMD, ranibizumab, aflibercept, neovascularization|wet amd, ranibizumab, aflibercept, neovascularization
250489|NCT02634957|phonomicrosurgery|phonomicrosurgery
250490|NCT02634957|benign vocal fold lesions|benign vocal fold lesions
250491|NCT02634957|voice rest|voice rest
250492|NCT02634957|vhi-10|vhi-10
250493|NCT02634957|CPP|cpp
250494|NCT02634944|Concussion|concussion
250495|NCT02634944|Vestibular|vestibular
250496|NCT02634944|Ocular-Motor|ocular-motor
250497|NCT02634931|Sirolimus|sirolimus
250498|NCT02634931|Skin lesions|skin lesions
250499|NCT02634931|TSC|tsc
250500|NCT02634931|Tuberous Sclerosis Complex|tuberous sclerosis complex
250501|NCT02634931|NPC-12G|npc-12g
250502|NCT02634931|Angiofibroma|angiofibroma
250503|NCT02634931|Hypomelanotic Macule|hypomelanotic macule
250504|NCT02634931|Plaque|plaque
250505|NCT02634918|ultrasound,|ultrasound,
250506|NCT02634918|ultrasonography|ultrasonography
250507|NCT02634918|hemophilic joint|hemophilic joint
250508|NCT02634918|Doppler|doppler
250509|NCT02634905|atopic dermatitis|atopic dermatitis
250510|NCT02634905|Therapeutic patient education|therapeutic patient education
250511|NCT02634905|pediatric dermatology|pediatric dermatology
250512|NCT02634892|Sacral|sacral
250513|NCT02634892|Overlay Mattress|overlay mattress
250514|NCT02634892|Cooling|cooling
250515|NCT02634866|hypertension|hypertension
250516|NCT02634866|exercise|exercise
250517|NCT02634866|diastolic heart failure|diastolic heart failure
250518|NCT02634853|Dry Eye|dry eye
250519|NCT02634840|inferior alveolar nerve|inferior alveolar nerve
250520|NCT02634840|neurosensory disturbance|neurosensory disturbance
250521|NCT02634840|bilateral sagittal spilt osteotomy|bilateral sagittal spilt osteotomy
250522|NCT02634840|mandibular surgery|mandibular surgery
250523|NCT02634840|neurosensory function|neurosensory function
250525|NCT02634788|Post-Surgical Pain|post-surgical pain
250526|NCT02634788|Bunionectomy|bunionectomy
250527|NCT02634775|Pediatrics|pediatrics
250528|NCT02634775|Nephrology|nephrology
250529|NCT02634775|Dialysis|dialysis
250530|NCT02634749|Nordic countries|nordic countries
250531|NCT02634749|Eating behavior|eating behavior
250532|NCT02634749|Human microbiome|human microbiome
250533|NCT02634749|Child nutrition|child nutrition
250534|NCT02634749|Metabolic profile|metabolic profile
250535|NCT02634749|Body composition|body composition
250536|NCT02634710|soft tissue sarcoma|soft tissue sarcoma
250537|NCT02634697|Atrial Fibrillation|atrial fibrillation
250538|NCT02634697|Relaxation Response Resiliency Program Intervention|relaxation response resiliency program intervention
250539|NCT02634697|AF Symptom Severity and Burden|af symptom severity and burden
732257|NCT00502229|Metformin|metformin
250540|NCT02634697|Stress, Anxiety, Depression and Hostility|stress, anxiety, depression and hostility
250541|NCT02634697|Quality of Life|quality of life
250543|NCT02634697|QOL|qol
250544|NCT02634697|3RP|3rp
250545|NCT02634684|Schizophrenia|schizophrenia
250546|NCT02634684|Schizoaffective Disorder|schizoaffective disorder
250547|NCT02634684|Mental Disorders|mental disorders
250548|NCT02634684|Anti-Dyskinesia Agents|anti-dyskinesia agents
250549|NCT02634684|Antiparkinson Agents|antiparkinson agents
250550|NCT02634684|Central Nervous System Agents|central nervous system agents
250551|NCT02634684|Dopamine Agents|dopamine agents
250552|NCT02634684|Excitatory Amino Acid Agents|excitatory amino acid agents
250553|NCT02634684|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists
250554|NCT02634684|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action
250555|NCT02634684|Neurotransmitter Agents|neurotransmitter agents
250556|NCT02634684|Pharmacologic Actions|pharmacologic actions
250557|NCT02634684|Physiological Effects of Drugs|physiological effects of drugs
250558|NCT02634684|Therapeutic Uses|therapeutic uses
250559|NCT02634684|Prepulse inhibition|prepulse inhibition
250560|NCT02634684|Neurocognition|neurocognition
250561|NCT02634684|Working memory|working memory
250562|NCT02634684|Dextroamphetamine|dextroamphetamine
250563|NCT02634684|MATRICS Consensus Cognitive Battery|matrics consensus cognitive battery
250564|NCT02634684|Pharmacologic Augmentation of Cognitive Therapies|pharmacologic augmentation of cognitive therapies
250565|NCT02634684|Sensory discrimination learning|sensory discrimination learning
250566|NCT02634684|Targeted Cognitive Training|targeted cognitive training
250567|NCT02634684|rs4680 polymorphism of catechol-O-methyltransferase (COMT)|rs4680 polymorphism of catechol-o-methyltransferase (comt)
250568|NCT02634671|schizophrenia|schizophrenia
250569|NCT02634671|Facial emotions|facial emotions
250570|NCT02634619|urethral stricture|urethral stricture
250571|NCT02634606|Cholesterol|cholesterol
250572|NCT02634593|nutrition|nutrition
250573|NCT02634580|Japanese|japanese
250574|NCT02634580|High cholesterol|high cholesterol
250575|NCT02634580|Treatment of high cholesterol|treatment of high cholesterol
250576|NCT02634580|Lowering cholesterol|lowering cholesterol
250577|NCT02634580|Lowering high cholesterol|lowering high cholesterol
250578|NCT02634580|Hypercholesterolemia|hypercholesterolemia
250579|NCT02634580|Statin intolerant|statin intolerant
250580|NCT02634528|intermediate-acting human isophane insulin, biosimilar|intermediate-acting human isophane insulin, biosimilar
250581|NCT02634515|soluble human insulin, biosimilar|soluble human insulin, biosimilar
250582|NCT02634502|radiofrequency|radiofrequency
250583|NCT02634502|chemotherapy|chemotherapy
250584|NCT02634502|microRNA|microrna
250585|NCT02634489|Bladder outlet obstruction|bladder outlet obstruction
250586|NCT02634489|Overactive bladder|overactive bladder
250587|NCT02634489|Urinary incontinence|urinary incontinence
250588|NCT02634489|Omnic OCAS®|omnic ocas®
250589|NCT02634489|Vesicare®|vesicare®
250590|NCT02634489|Tamsulosin hydrochloride|tamsulosin hydrochloride
250591|NCT02634489|Solifenacin succinate|solifenacin succinate
250592|NCT02634476|Alcohol|alcohol
250593|NCT02634476|Substance use disorder|substance use disorder
250594|NCT02634476|cognitive bias|cognitive bias
250595|NCT02634476|behavioral intervention|behavioral intervention
250596|NCT02634476|computerised training|computerised training
250597|NCT02634463|Immunoassay|immunoassay
250598|NCT02634463|Antipsychotic|antipsychotic
250599|NCT02634463|Aripiprazole|aripiprazole
250600|NCT02634463|Olanzapine|olanzapine
250601|NCT02634463|Paliperidone|paliperidone
250602|NCT02634463|Risperidone|risperidone
250603|NCT02634450|HIV|hiv
250604|NCT02634450|Diagnostic|diagnostic
250605|NCT02634450|children|children
250606|NCT02634424|Hemophilia A|hemophilia a
250607|NCT02634424|Prophylaxy|prophylaxy
250608|NCT02634424|Pharmacokinetic|pharmacokinetic
250609|NCT02634424|Bayesian|bayesian
250610|NCT02634411|Ventilator Associated|ventilator associated
250611|NCT02634411|Pneumonia|pneumonia
250612|NCT02634411|Antibiotic treatment|antibiotic treatment
250613|NCT02634411|Pseudomonas aeruginosa|pseudomonas aeruginosa
250614|NCT02634372|Bipolar Disorder|bipolar disorder
250615|NCT02634372|Traumatic event|traumatic event
250616|NCT02634372|Eye Movement Desensitization Reprocessing|eye movement desensitization reprocessing
250617|NCT02634372|Supportive therapy|supportive therapy
250618|NCT02634372|Relapse prevention|relapse prevention
250619|NCT02634346|Alkermes|alkermes
250620|NCT02634346|ALKS 3831|alks 3831
250621|NCT02634346|Samidorphan|samidorphan
250622|NCT02634346|Schizophrenia|schizophrenia
250623|NCT02634346|Acute Exacerbation of Schizophrenia|acute exacerbation of schizophrenia
250624|NCT02634333|anti-vascular endothelial growth factor|anti-vascular endothelial growth factor
250625|NCT02634333|nonproliferative diabetic retinopathy|nonproliferative diabetic retinopathy
250626|NCT02634320|Alkermes|alkermes
250627|NCT02634320|ARISTADA|aristada
250628|NCT02634320|Aripiprazole Lauroxil|aripiprazole lauroxil
250629|NCT02634320|Schizophrenia|schizophrenia
250630|NCT02634307|Multiple Sclerosis|multiple sclerosis
250631|NCT02634307|MS|ms
732869|NCT00500240|Lymphoma|lymphoma
250632|NCT02634307|Relapsing Remitting Multiple Sclerosis|relapsing remitting multiple sclerosis
250633|NCT02634307|RRMS|rrms
250634|NCT02634307|dimethyl fumarate|dimethyl fumarate
250635|NCT02634307|DMF|dmf
250636|NCT02634294|Hematological Neoplasms|hematological neoplasms
250637|NCT02634294|recurrence|recurrence
250638|NCT02634294|Hematopoietic Stem Cell Transplantation|hematopoietic stem cell transplantation
250639|NCT02634294|peginterferon alfa-2b|peginterferon alfa-2b
250640|NCT02634294|Graft vs Host Disease|graft vs host disease
250641|NCT02634268|randomized controlled trial|randomized controlled trial
250642|NCT02634268|diet|diet
250643|NCT02634268|exercise|exercise
250644|NCT02634268|obesity|obesity
250645|NCT02634268|overweight|overweight
250646|NCT02634268|chronic obstructive pulmonary disease|chronic obstructive pulmonary disease
250647|NCT02634268|lifestyle|lifestyle
250648|NCT02634255|rocuronium|rocuronium
250649|NCT02634255|onset time|onset time
250650|NCT02634255|anxiety|anxiety
250651|NCT02634242|Si Wu Tang|si wu tang
250652|NCT02634242|antioxidation|antioxidation
250653|NCT02634242|anthropometric measurements|anthropometric measurements
250654|NCT02634242|liver|liver
250655|NCT02634242|skin|skin
250656|NCT02634229|monogenic diabetes|monogenic diabetes
250657|NCT02634229|MODY|mody
250658|NCT02634229|beta-cell|beta-cell
250659|NCT02634229|insulin secretion|insulin secretion
250660|NCT02634216|Hyperglycemia|hyperglycemia
250661|NCT02634216|Capros|capros
250662|NCT02634216|Type 1 Diabetes|type 1 diabetes
250663|NCT02634203|Chronic Thromboembolic Pulmonary Hypertension|chronic thromboembolic pulmonary hypertension
250664|NCT02634203|Balloon Pulmonary Angioplasty|balloon pulmonary angioplasty
250665|NCT02634203|Riociguat|riociguat
250666|NCT02634190|Cervical cancer screening|cervical cancer screening
250667|NCT02634190|High risk Human Papillomavirus|high risk human papillomavirus
250668|NCT02634190|Aptima HPV Assay|aptima hpv assay
250669|NCT02634177|Genotyping|genotyping
250670|NCT02634177|Genecept Assay™|genecept assay™
250671|NCT02634164|leucine|leucine
250672|NCT02634164|isoleucine|isoleucine
250673|NCT02634151|LDL‐C|ldl‐c
250674|NCT02634151|Lipid Regulator|lipid regulator
250675|NCT02634138|Peripheral Vascular Disease|peripheral vascular disease
250676|NCT02634138|Critical Limb Ischaemia|critical limb ischaemia
250677|NCT02634112|anastomotic leakage|anastomotic leakage
250678|NCT02634112|rectal cancer surgery|rectal cancer surgery
250679|NCT02634112|anastomotic leakage predictive score|anastomotic leakage predictive score
250680|NCT02634099|major pediatric surgery|major pediatric surgery
250681|NCT02634099|hemoglobin measurement|hemoglobin measurement
250682|NCT02634086|Coronary artery disease|coronary artery disease
250683|NCT02634086|Percutaneous coronary intervention|percutaneous coronary intervention
250684|NCT02634086|Coronary artery bypass graft|coronary artery bypass graft
250685|NCT02634086|Medication therapy|medication therapy
250686|NCT02634073|Lamivudine|lamivudine
250687|NCT02634073|Safety|safety
250688|NCT02634073|Sorbitol|sorbitol
250689|NCT02634073|Pharmacokinetics|pharmacokinetics
250690|NCT02634060|adalimumab|adalimumab
250691|NCT02634060|fecal calprotectin|fecal calprotectin
250692|NCT02634060|home based|home based
250693|NCT02634047|transesophageal echocardiography|transesophageal echocardiography
250694|NCT02634047|videolaryngoscope|videolaryngoscope
250695|NCT02634047|oropharyngeal injury|oropharyngeal injury
250696|NCT02634008|Pangenotypic|pangenotypic
250697|NCT02634008|Treatment|treatment
250698|NCT02633956|Non-alcoholic Fatty Liver Disease|non-alcoholic fatty liver disease
250699|NCT02633956|NAFLD|nafld
250700|NCT02633956|Fatty Liver Disease|fatty liver disease
250701|NCT02633956|NASH|nash
250702|NCT02633930|helicobacter pylori|helicobacter pylori
250703|NCT02633930|berberine-containing quadruple therapy|berberine-containing quadruple therapy
250704|NCT02633930|clarithromycin-containing quadruple therapy|clarithromycin-containing quadruple therapy
250705|NCT02633917|Low back pain|low back pain
250706|NCT02633917|Motor control|motor control
250707|NCT02633917|Joint mobilization|joint mobilization
250708|NCT02633904|Hip Dislocation|hip dislocation
250709|NCT02633904|Congenital|congenital
250710|NCT02633904|osteotomy|osteotomy
250711|NCT02633904|Femur Head Necrosis|femur head necrosis
250712|NCT02633891|neuropathies|neuropathies
250713|NCT02633891|metabolic diseases|metabolic diseases
250714|NCT02633891|nervous system diseases|nervous system diseases
250715|NCT02633891|peripheral nervous system diseases|peripheral nervous system diseases
250716|NCT02633878|Threatened Miscarriage|threatened miscarriage
250717|NCT02633878|The First Trimester|the first trimester
250718|NCT02633878|Micronized Progesterone|micronized progesterone
250719|NCT02633878|Chinese Herbal Medicine|chinese herbal medicine
250720|NCT02633878|Live Birth|live birth
250721|NCT02633865|patient characteristics|patient characteristics
250722|NCT02633852|Diabetic Macular Edema (DME)|diabetic macular edema (dme)
250723|NCT02633852|Aflibercept (EYLEA)|aflibercept (eylea)
250724|NCT02633839|Adults|adults
250725|NCT02633826|alloreactive T cell|alloreactive t cell
250726|NCT02633826|donor-specific antibody|donor-specific antibody
250727|NCT02633813|Bioequivalence|bioequivalence
250728|NCT02633813|Tinea pedis|tinea pedis
250729|NCT02633813|Naftin|naftin
250730|NCT02633800|Squamous cell cancer of the head and neck|squamous cell cancer of the head and neck
250731|NCT02633800|Squamous cell carcinoma|squamous cell carcinoma
250732|NCT02633800|Head and neck cancer|head and neck cancer
250733|NCT02633800|Neoplasms by site|neoplasms by site
250734|NCT02633787|Meningitis|meningitis
250735|NCT02633787|Meningococcal Meningitis|meningococcal meningitis
250736|NCT02633787|Meningococcal Infections|meningococcal infections
250737|NCT02633787|Menactra®|menactra®
250738|NCT02633761|Fetal death|fetal death
250739|NCT02633761|mifepristone|mifepristone
250740|NCT02633761|misoprostol|misoprostol
250741|NCT02633735|Clinical Decision Support|clinical decision support
250742|NCT02633696|Clinical trial|clinical trial
250743|NCT02633696|Phase I|phase i
250744|NCT02633696|Healthy volunteers|healthy volunteers
250745|NCT02633696|Clinical Pharmacology|clinical pharmacology
250746|NCT02633696|Bioavailability|bioavailability
250747|NCT02633696|Silybin|silybin
250748|NCT02633696|Liver Trasplantation|liver trasplantation
250749|NCT02633683|Restless Legs Syndrome|restless legs syndrome
250750|NCT02633683|RLS|rls
250751|NCT02633657|Restless Legs Syndrome|restless legs syndrome
250752|NCT02633657|RLS|rls
250753|NCT02633644|Heart Failure|heart failure
250754|NCT02633644|Cardiovascular Diseases|cardiovascular diseases
250755|NCT02633644|Heart Diseases|heart diseases
250756|NCT02633592|High Resolution Anorectal Manometry|high resolution anorectal manometry
250757|NCT02633592|Magnetic Resonance Imaging|magnetic resonance imaging
250758|NCT02633592|Balloon Expulsion|balloon expulsion
250759|NCT02633592|Position|position
250760|NCT02633579|Healthy volunteers|healthy volunteers
250761|NCT02633566|Flatfoot|flatfoot
250762|NCT02633566|orthoses|orthoses
250763|NCT02633566|children|children
250764|NCT02633553|thymoma|thymoma
250765|NCT02633553|adjuvant radiotherapy|adjuvant radiotherapy
250766|NCT02633553|complete resection|complete resection
250767|NCT02633540|T1a Larynx Cancer|t1a larynx cancer
250768|NCT02633540|T2a Larynx Cancer|t2a larynx cancer
250769|NCT02633514|thymoma|thymoma
250770|NCT02633514|thymic carcinoma|thymic carcinoma
250771|NCT02633514|adjuvant radiotherapy|adjuvant radiotherapy
250772|NCT02633514|adjuvant radiochemotherapy|adjuvant radiochemotherapy
250773|NCT02633514|incomplete resection|incomplete resection
250774|NCT02633475|interleukin-10|interleukin-10
250775|NCT02633475|Polymorphism, Single Nucleotide|polymorphism, single nucleotide
250776|NCT02633449|tDCS|tdcs
250777|NCT02633449|cognitive behavioral therapy|cognitive behavioral therapy
250778|NCT02633436|esophageal cancer|esophageal cancer
250779|NCT02633436|SLC1A5|slc1a5
250780|NCT02633423|Cardiopulmonary bypass|cardiopulmonary bypass
250781|NCT02633423|Mechanical ventilation|mechanical ventilation
250782|NCT02633423|Expiratory Flow Limitation|expiratory flow limitation
250783|NCT02633423|Best PEEP|best peep
250784|NCT02633397|SCD|scd
250785|NCT02633397|Sickle Cell Disease|sickle cell disease
250786|NCT02633397|Riociguat|riociguat
250787|NCT02633397|Adempas|adempas
250788|NCT02633384|Parenteral nutrition associated cholestasis|parenteral nutrition associated cholestasis
250789|NCT02633384|Intravenous lipid emulsions|intravenous lipid emulsions
250790|NCT02633384|Surgical neonates|surgical neonates
250791|NCT02633384|Congenital gastrointestinal abnormalities|congenital gastrointestinal abnormalities
250792|NCT02633358|Acute myocardial infarction, cardiogenic shock|acute myocardial infarction, cardiogenic shock
250793|NCT02633319|Parenting|parenting
250794|NCT02633319|Child maltreatment|child maltreatment
250795|NCT02633319|Economic strengthening|economic strengthening
250796|NCT02633319|Early childhood development|early childhood development
250797|NCT02633319|Cluster randomized controlled trial|cluster randomized controlled trial
250798|NCT02633319|Pilot evaluation|pilot evaluation
250799|NCT02633306|trigeminal region pain|trigeminal region pain
250800|NCT02633293|Treprostinil|treprostinil
250801|NCT02633293|PH|ph
250802|NCT02633293|ILD|ild
250803|NCT02633293|CPFE|cpfe
250804|NCT02633293|6 Minute Walk Test|6 minute walk test
250805|NCT02633267|social anxiety|social anxiety
250806|NCT02633267|unemployment|unemployment
250807|NCT02633267|cognitive behavioral therapy|cognitive behavioral therapy
250808|NCT02633267|group therapy|group therapy
250809|NCT02633267|work|work
250810|NCT02633267|vocation|vocation
250811|NCT02633241|pediatrics|pediatrics
250812|NCT02633241|sedation|sedation
250813|NCT02633241|dexmedetomidine|dexmedetomidine
250814|NCT02633241|propofol|propofol
250815|NCT02633241|MRI|mri
250816|NCT02633228|Multifocal Intraocular Lens|multifocal intraocular lens
250817|NCT02633228|Binocular Trifocality|binocular trifocality
250818|NCT02633228|Cataract Surgery|cataract surgery
250819|NCT02633228|Spectacle Independence|spectacle independence
250820|NCT02633228|Intermediate Vision|intermediate vision
250821|NCT02633228|Photopic Vision|photopic vision
250822|NCT02633228|Mesopic Vision|mesopic vision
250823|NCT02633228|Scotopic Vision|scotopic vision
250824|NCT02633228|Binocular Vision|binocular vision
250825|NCT02633215|motor recovery|motor recovery
250826|NCT02633215|neuroplasticity|neuroplasticity
250827|NCT02633215|chronic|chronic
250828|NCT02633215|human|human
250829|NCT02633215|sensory|sensory
250830|NCT02633202|Nasopharyngeal carcinoma|nasopharyngeal carcinoma
250831|NCT02633202|Concurrent chemoradiotherapy|concurrent chemoradiotherapy
250832|NCT02633202|intermediate risk|intermediate risk
250833|NCT02633202|intensity-modulated radiotherapy|intensity-modulated radiotherapy
250834|NCT02633189|stage IV|stage iv
250835|NCT02633189|stage IIIB|stage iiib
250836|NCT02633189|EGFR mutation|egfr mutation
250837|NCT02633189|non-squamous|non-squamous
250838|NCT02633189|liquid biopsy|liquid biopsy
250839|NCT02633189|erlotinib|erlotinib
250840|NCT02633189|bevacizumab|bevacizumab
250841|NCT02633163|Systemic Lupus Erythematosus|systemic lupus erythematosus
250842|NCT02633163|Stem Cell|stem cell
250843|NCT02633163|Lupus|lupus
250844|NCT02633150|Obesity|obesity
250845|NCT02633150|insulinoresistant|insulinoresistant
250846|NCT02633150|menopausal women|menopausal women
250847|NCT02633150|polyphenol|polyphenol
250848|NCT02633137|Lenalidomide|lenalidomide
250849|NCT02633137|15-196|15-196
250850|NCT02633124|Premature infants|premature infants
250851|NCT02633124|Catheter-related bacteremia|catheter-related bacteremia
250852|NCT02633124|Infusion device|infusion device
250853|NCT02633124|Neonatal intensive care|neonatal intensive care
250854|NCT02633124|Central Venous Catheter|central venous catheter
250855|NCT02633124|Drug Infusion Systems|drug infusion systems
250856|NCT02633111|DNA Sequencing|dna sequencing
250857|NCT02633111|15-180|15-180
250858|NCT02633098|Artesunate|artesunate
250859|NCT02633098|Artemisinins|artemisinins
250860|NCT02633098|Antimalarial|antimalarial
250861|NCT02633098|Neoadjuvant|neoadjuvant
250862|NCT02633098|Pre-operative|pre-operative
250863|NCT02633085|Unicompartment Knee Replacement|unicompartment knee replacement
250864|NCT02633072|Multifocal Intraocular Lens|multifocal intraocular lens
250865|NCT02633072|Binocular Trifocality|binocular trifocality
250866|NCT02633072|Cataract Surgery|cataract surgery
250867|NCT02633072|Spectacle Independence|spectacle independence
250868|NCT02633072|Intermediate Vision|intermediate vision
250869|NCT02633072|Photopic Vision|photopic vision
250870|NCT02633072|Mesopic Vision|mesopic vision
250871|NCT02633072|Scotopic Vision|scotopic vision
250872|NCT02633072|Binocular Vision|binocular vision
250873|NCT02633046|FSGS|fsgs
250874|NCT02633046|primary FSGS|primary fsgs
250875|NCT02633046|idiopathic FSGS|idiopathic fsgs
250876|NCT02633033|Multiple Sclerosis|multiple sclerosis
250877|NCT02633033|Relapsing-Remitting|relapsing-remitting
250878|NCT02633033|Acthar|acthar
250879|NCT02633033|Corticotropin|corticotropin
250880|NCT02633033|MS|ms
250881|NCT02632981|Interleukin-32|interleukin-32
250882|NCT02632981|periodontitis|periodontitis
250883|NCT02632955|arteriovenous fistula|arteriovenous fistula
250884|NCT02632955|hemodialysis|hemodialysis
250885|NCT02632955|drug coated balloon|drug coated balloon
250886|NCT02632942|arteriovenous fistula|arteriovenous fistula
250887|NCT02632942|hemodialysis|hemodialysis
250888|NCT02632942|maturation|maturation
250889|NCT02632929|foot ulcer, diabetic|foot ulcer, diabetic
250890|NCT02632929|wound healing|wound healing
250891|NCT02632929|diabetic foot ulcer|diabetic foot ulcer
250892|NCT02632877|pirfenidone|pirfenidone
250893|NCT02632877|Modified oxide diallyl disulfide (MODD)|modified oxide diallyl disulfide (modd)
250894|NCT02632877|ketanserin|ketanserin
250895|NCT02632877|diabetic foot ulcer|diabetic foot ulcer
250896|NCT02632851|inhalation|inhalation
250897|NCT02632851|isotonic saline|isotonic saline
250898|NCT02632851|NaCl solution 0.9 %|nacl solution 0.9 %
250899|NCT02632851|Ectoin|ectoin
250900|NCT02632851|bronchitis|bronchitis
250901|NCT02632851|respiratory tract infection|respiratory tract infection
250902|NCT02632838|Hypertension|hypertension
250903|NCT02632838|mHealth|mhealth
250904|NCT02632838|underserved community|underserved community
250905|NCT02632825|Nasal High Flow|nasal high flow
250906|NCT02632825|gas exchange|gas exchange
250907|NCT02632825|newborn|newborn
250908|NCT02632799|Nasal High Flow|nasal high flow
250909|NCT02632799|CPAP|cpap
250910|NCT02632799|airway pressure|airway pressure
250911|NCT02632799|newborn|newborn
250912|NCT02632786|amyloidosis|amyloidosis
250913|NCT02632786|ntprobnp|ntprobnp
250914|NCT02632786|NEOD001|neod001
250915|NCT02632786|Prothena|prothena
250916|NCT02632786|PRONTO|pronto
250917|NCT02632786|amyloid|amyloid
250918|NCT02632786|plasma cell dyscrasia|plasma cell dyscrasia
250919|NCT02632786|immunotherapy|immunotherapy
250920|NCT02632773|Language Intervention|language intervention
250921|NCT02632773|Parent-Mediated Intervention|parent-mediated intervention
250922|NCT02632734|alveolar bone preservation|alveolar bone preservation
250923|NCT02632734|coral grafting device|coral grafting device
250924|NCT02632708|Acute Myeloid Leukemia|acute myeloid leukemia
250925|NCT02632708|AML|aml
250926|NCT02632708|Untreated AML|untreated aml
250927|NCT02632708|De novo AML|de novo aml
250928|NCT02632708|Secondary AML|secondary aml
250929|NCT02632708|Newly diagnosed AML|newly diagnosed aml
250930|NCT02632708|IDH1|idh1
250931|NCT02632708|IDH2|idh2
250932|NCT02632708|Induction therapy|induction therapy
250933|NCT02632708|Consolidation therapy|consolidation therapy
250934|NCT02632708|IDH|idh
250935|NCT02632682|probe-based confocal laser endomicroscopy|probe-based confocal laser endomicroscopy
250936|NCT02632669|Focal brachytherapy|focal brachytherapy
250937|NCT02632669|Seed implant|seed implant
250938|NCT02632669|Quality of life|quality of life
250939|NCT02632669|Toxicity|toxicity
250940|NCT02632643|TMD|tmd
250941|NCT02632643|HYPERTONIA|hypertonia
250942|NCT02632643|PARAFUNCTIONS|parafunctions
250943|NCT02632643|SENSORIMOTOR APPROACH|sensorimotor approach
250944|NCT02632630|Peripheral Parenteral Nutrition|peripheral parenteral nutrition
250945|NCT02632630|Oral nutritional supplementation|oral nutritional supplementation
250946|NCT02632630|Acute Care hospitals|acute care hospitals
250947|NCT02632617|Heart Valve Diseases|heart valve diseases
250948|NCT02632617|Coronary Artery Disease|coronary artery disease
250949|NCT02632617|Computed Tomographic Angiography|computed tomographic angiography
250950|NCT02632617|Preoperative Procedure|preoperative procedure
250951|NCT02632565|osteoarthritis|osteoarthritis
250952|NCT02632565|lidocaine|lidocaine
250953|NCT02632565|pain|pain
250954|NCT02632565|ultrasound|ultrasound
250955|NCT02632552|care transition|care transition
250956|NCT02632552|technology|technology
250957|NCT02632552|chronic heart failure|chronic heart failure
250958|NCT02632552|chronic obstructive pulmonary disease|chronic obstructive pulmonary disease
250959|NCT02632552|virtual nurse|virtual nurse
250960|NCT02632552|texting|texting
250961|NCT02632552|informatics|informatics
250962|NCT02632552|Veterans|veterans
250963|NCT02632539|ventilator associated pneumonia|ventilator associated pneumonia
250964|NCT02632539|Subglottic Secretion Drainage|subglottic secretion drainage
250965|NCT02632539|manual air-impingement operation|manual air-impingement operation
250966|NCT02632526|AZD5718 oral suspension crystalline|azd5718 oral suspension crystalline
250967|NCT02632526|AZD5718 oral suspension amorphous|azd5718 oral suspension amorphous
250968|NCT02632526|Single ascending dose/multiple ascending dose (SAD/MAD)|single ascending dose/multiple ascending dose (sad/mad)
250969|NCT02632526|Placebo-controlled|placebo-controlled
250970|NCT02632526|Safety|safety
250971|NCT02632526|Tolerability|tolerability
250972|NCT02632526|Pharmacokinetics|pharmacokinetics
250973|NCT02632526|Pharmacodynamics|pharmacodynamics
250974|NCT02632513|continuous ultrasonic irrigation, syringe irrigation|continuous ultrasonic irrigation, syringe irrigation
250975|NCT02632500|Cardio-Pulmonary Resuscitation|cardio-pulmonary resuscitation
250976|NCT02632500|Cardiac Arrest|cardiac arrest
250977|NCT02632500|Training|training
250978|NCT02632474|HIV Infections|hiv infections
250979|NCT02632474|Tenofovir|tenofovir
250980|NCT02632474|Efavirenz|efavirenz
250981|NCT02632461|Diet|diet
250982|NCT02632461|Weight Loss|weight loss
250983|NCT02632461|Tracking|tracking
250984|NCT02632461|Calories|calories
250985|NCT02632448|Metastatic cancer|metastatic cancer
250986|NCT02632448|Advanced cancer|advanced cancer
250987|NCT02632448|Recurrent cancer|recurrent cancer
250988|NCT02632448|Colorectal neoplasms|colorectal neoplasms
250989|NCT02632448|Triple negative breast cancer|triple negative breast cancer
250990|NCT02632448|Ovarian neoplasms|ovarian neoplasms
250991|NCT02632448|Colon neoplasms|colon neoplasms
250992|NCT02632448|Rectal neoplasms|rectal neoplasms
250993|NCT02632448|Triple negative breast neoplasms|triple negative breast neoplasms
250994|NCT02632448|Gastrointestinal stromal tumor|gastrointestinal stromal tumor
250995|NCT02632448|Pancreatic Neoplasms|pancreatic neoplasms
250996|NCT02632448|Pancreatic Cancer|pancreatic cancer
250997|NCT02632435|HER2 positive|her2 positive
250998|NCT02632422|walk|walk
250999|NCT02632422|rehabilitation|rehabilitation
251000|NCT02632422|strength|strength
251001|NCT02632422|movement|movement
251002|NCT02632422|spinal cord trauma|spinal cord trauma
251003|NCT02632422|spinal cord injury|spinal cord injury
251004|NCT02632383|Diabetes type 1|diabetes type 1
251005|NCT02632383|Transition|transition
251006|NCT02632383|Telemedicine|telemedicine
251007|NCT02632383|mHealth app|mhealth app
251008|NCT02632383|Youth|youth
251009|NCT02632383|Self-management|self-management
251010|NCT02632370|Malignant Gliomas|malignant gliomas
251011|NCT02632370|5-ALA|5-ala
251012|NCT02632370|tumor resection|tumor resection
251013|NCT02632370|malignant tumor|malignant tumor
251014|NCT02632357|Neurodynamics|neurodynamics
251015|NCT02632344|Laryngeal papilloma, recurrent|laryngeal papilloma, recurrent
251016|NCT02632344|Respiratory papillomatosis|respiratory papillomatosis
251017|NCT02632344|Juvenile-onset recurrent respiratory papillomatosis|juvenile-onset recurrent respiratory papillomatosis
251018|NCT02632344|Human papillomavirus|human papillomavirus
251019|NCT02632344|Virally-related diseases|virally-related diseases
251020|NCT02632331|Food effect|food effect
251021|NCT02632331|Pharmacokinetics|pharmacokinetics
251022|NCT02632331|ASP8825|asp8825
251023|NCT02632331|XP13512|xp13512
251024|NCT02632305|unresectable biliary tract cancer|unresectable biliary tract cancer
251025|NCT02632305|nab-paclitaxel|nab-paclitaxel
251026|NCT02632305|cisplatin|cisplatin
251027|NCT02632305|gemcitabine|gemcitabine
251028|NCT02632279|Parkinson's disease|parkinson's disease
251029|NCT02632279|Deep Brain Stimulation|deep brain stimulation
251030|NCT02632279|Subthalamic nucleus|subthalamic nucleus
251031|NCT02632279|Tryptophan depletion|tryptophan depletion
251032|NCT02632279|Serotonin|serotonin
251033|NCT02632266|prematurity|prematurity
251034|NCT02632266|growth|growth
251035|NCT02632266|nutrition|nutrition
251036|NCT02632266|human milk fortifier|human milk fortifier
251037|NCT02632253|exercise therapy|exercise therapy
251038|NCT02632253|GUCH|guch
251039|NCT02632253|ventricular ejection fraction|ventricular ejection fraction
251040|NCT02632253|HIIT|hiit
251041|NCT02632253|MICE|mice
251042|NCT02632240|gingival recession|gingival recession
251043|NCT02632240|mucogingival surgery|mucogingival surgery
251044|NCT02632240|collagen matrix|collagen matrix
251045|NCT02632240|connective tissue graft|connective tissue graft
251046|NCT02632240|tunnel technique|tunnel technique
251047|NCT02632214|Face processing|face processing
251048|NCT02632214|asymmetry|asymmetry
251049|NCT02632214|deaf|deaf
251050|NCT02632214|fMRI|fmri
251051|NCT02632201|gastric cancer|gastric cancer
251052|NCT02632201|liver metastasis|liver metastasis
251053|NCT02632201|PIK-HER2 cells|pik-her2 cells
251054|NCT02632201|dendritic cell-precision multiple antigen T cells|dendritic cell-precision multiple antigen t cells
251055|NCT02632188|Recurrence|recurrence
251056|NCT02632188|Metastasis|metastasis
251057|NCT02632188|liver cancer|liver cancer
251058|NCT02632175|Ulcerative Colitis|ulcerative colitis
251059|NCT02632149|PINS Vagus Nerve Stimulator|pins vagus nerve stimulator
251060|NCT02632136|Laparoscopic|laparoscopic
251061|NCT02632136|TAP Block|tap block
251062|NCT02632136|Total extra peritoneal Inguinal hernia repair|total extra peritoneal inguinal hernia repair
251063|NCT02632123|idiopathic pulmonary fibrosis|idiopathic pulmonary fibrosis
251064|NCT02632123|outcome|outcome
251065|NCT02632123|prognosis|prognosis
251066|NCT02632123|survival|survival
251067|NCT02632110|Actinic Keratosis|actinic keratosis
251068|NCT02632097|inguinal hernia|inguinal hernia
251069|NCT02632097|mesh fixation|mesh fixation
251070|NCT02632097|glue|glue
251071|NCT02632097|cyanoacrylate|cyanoacrylate
251072|NCT02632097|Lichtenstein|lichtenstein
251073|NCT02632097|ambulatory surgery|ambulatory surgery
251074|NCT02632071|Breast Cancer|breast cancer
251075|NCT02632071|Breast Carcinoma|breast carcinoma
251076|NCT02632071|Breast tumors|breast tumors
251077|NCT02632071|Cancer of the Breast|cancer of the breast
251078|NCT02632071|Malignant tumor of the breast|malignant tumor of the breast
251079|NCT02632071|Metastatic Breast Cancer|metastatic breast cancer
251080|NCT02632071|Unresectable breast cancer|unresectable breast cancer
251081|NCT02632045|Breast Neoplasms|breast neoplasms
251082|NCT02632045|Breast Cancer|breast cancer
251083|NCT02632045|Breast Carcinoma|breast carcinoma
251084|NCT02632045|Breast tumors|breast tumors
251085|NCT02632045|Cancer of the Breast|cancer of the breast
251086|NCT02632032|Type 1 diabetes|type 1 diabetes
251087|NCT02632032|children|children
251088|NCT02632032|diabetes camps|diabetes camps
251089|NCT02632032|glycemic control|glycemic control
251090|NCT02632019|advanced biliary tract malignant tumor|advanced biliary tract malignant tumor
251091|NCT02632019|dendritic cell|dendritic cell
251092|NCT02632019|precision T cell for neo-antigen|precision t cell for neo-antigen
251093|NCT02632006|PIK-PD-1 Cells|pik-pd-1 cells
251094|NCT02632006|dendritic cell-precision multiple antigen T cells|dendritic cell-precision multiple antigen t cells
251095|NCT02632006|advanced hepatocellular carcinoma|advanced hepatocellular carcinoma
251096|NCT02631993|Psoralen|psoralen
251098|NCT02631993|Time-to-treatment|time-to-treatment
251099|NCT02631993|GVL|gvl
251100|NCT02631980|Hepcidin|hepcidin
251101|NCT02631967|Crohn disease|crohn disease
251102|NCT02631967|ileocecal resection|ileocecal resection
251103|NCT02631967|anastomosis|anastomosis
251104|NCT02631967|Kono|kono
251105|NCT02631928|biphasic human insulin|biphasic human insulin
251106|NCT02631928|biosimilar|biosimilar
251107|NCT02631902|Community-based intervention|community-based intervention
251108|NCT02631902|Exercise program|exercise program
251109|NCT02631902|Dietary intervention program|dietary intervention program
251110|NCT02631902|Health promotion|health promotion
251111|NCT02631902|Subjective well-being|subjective well-being
251112|NCT02631902|Cardiovascular risk|cardiovascular risk
251113|NCT02631876|Epithelial ovarian cancer|epithelial ovarian cancer
251114|NCT02631876|Fallopian tube cancer|fallopian tube cancer
251310|NCT02630862|vitamin E|vitamin e
251115|NCT02631876|Primary peritoneal cancer|primary peritoneal cancer
251116|NCT02631876|IMGN853|imgn853
251117|NCT02631876|ADC|adc
251118|NCT02631876|Antibody drug conjugate|antibody drug conjugate
251119|NCT02631876|ImmunoGen|immunogen
251120|NCT02631876|Antibody|antibody
733441|NCT00499278|surgery|surgery
320968|NCT02231086|HIPEC|hipec
251121|NCT02631876|Folate receptor alpha|folate receptor alpha
251122|NCT02631876|mirvetuximab soravtansine|mirvetuximab soravtansine
251123|NCT02631876|Phase 3|phase 3
251124|NCT02631876|platinum-resistant|platinum-resistant
251125|NCT02631850|Constraint-induced movement therapy|constraint-induced movement therapy
251126|NCT02631850|gaming|gaming
251127|NCT02631850|virtual reality|virtual reality
251128|NCT02631850|upper extremity|upper extremity
251129|NCT02631850|CI therapy|ci therapy
251130|NCT02631850|rehabilitation|rehabilitation
251131|NCT02631850|stroke|stroke
251132|NCT02631850|hemiparesis|hemiparesis
251133|NCT02631850|therapy|therapy
251134|NCT02631837|NOTES|notes
251135|NCT02631837|Laparoscopic surgery|laparoscopic surgery
251136|NCT02631824|fragility fractures|fragility fractures
251137|NCT02631824|hip fractures|hip fractures
251138|NCT02631824|augmentation|augmentation
251139|NCT02631824|tip-apex distance|tip-apex distance
251140|NCT02631811|acute leukaemia|acute leukaemia
251141|NCT02631811|supportive / palliative care|supportive / palliative care
251142|NCT02631785|ANXIETY|anxiety
251143|NCT02631785|CBT|cbt
251144|NCT02631785|fMRI|fmri
251145|NCT02631785|Fear conditioning|fear conditioning
251146|NCT02631785|Fear extinction|fear extinction
251147|NCT02631759|Acute intraCerebral Haemorrhage, Epileptic seizures, Lévétiracetam|acute intracerebral haemorrhage, epileptic seizures, lévétiracetam
251148|NCT02631720|Chronic Lung Allograft Dysfunction (CLAD)|chronic lung allograft dysfunction (clad)
251149|NCT02631720|Restrictive chronic lung allograft dysfunction (RCLAD)|restrictive chronic lung allograft dysfunction (rclad)
251150|NCT02631720|Bronchiolitis Obliterans Syndrome (BOS)|bronchiolitis obliterans syndrome (bos)
251151|NCT02631720|CLAD risk factors|clad risk factors
251152|NCT02631720|observational study|observational study
251153|NCT02631668|iron deficiency anemia, vitamin C, ferrous succinate|iron deficiency anemia, vitamin c, ferrous succinate
251154|NCT02631629|Vitamin D|vitamin d
251155|NCT02631629|Fortification|fortification
251156|NCT02631616|Prostatic Neoplasma, Castration-Resistant|prostatic neoplasma, castration-resistant
251157|NCT02631616|neuroendocrine differentiation|neuroendocrine differentiation
251158|NCT02631616|68Ga-DOTATET|68ga-dotatet
251159|NCT02631616|PET/CT|pet/ct
251160|NCT02631590|intra-hepatic biliary system|intra-hepatic biliary system
251161|NCT02631590|extra-hepatic biliary system|extra-hepatic biliary system
251162|NCT02631590|gall bladder|gall bladder
251163|NCT02631590|advanced biliary cancer|advanced biliary cancer
251164|NCT02631590|unresectable|unresectable
251165|NCT02631590|locally advanced|locally advanced
251166|NCT02631590|metastatic disease|metastatic disease
251167|NCT02631564|mCRC;TACE;hepatic infusion;raltitrexed|mcrc;tace;hepatic infusion;raltitrexed
251168|NCT02631551|Seasonal Allergic Rhinitis|seasonal allergic rhinitis
251169|NCT02631538|Subcutaneous|subcutaneous
251170|NCT02631538|Rituximab|rituximab
251171|NCT02631538|Intravenous|intravenous
251172|NCT02631538|Safety|safety
251173|NCT02631538|Efficacy|efficacy
251174|NCT02631538|Sjogren's syndrome|sjogren's syndrome
251175|NCT02631538|Belimumab|belimumab
251176|NCT02631525|Airway extubation|airway extubation
251177|NCT02631525|Anesthesia Recovery Period|anesthesia recovery period
251178|NCT02631525|Desflurane|desflurane
251179|NCT02631525|Propofol|propofol
251180|NCT02631525|Intravenous anesthesia|intravenous anesthesia
251181|NCT02631525|Balanced Anesthesia|balanced anesthesia
251182|NCT02631499|Circulating Tumor Cells|circulating tumor cells
251183|NCT02631499|Hepatoectomy|hepatoectomy
251184|NCT02631499|TACE|tace
251185|NCT02631499|prognosis|prognosis
251186|NCT02631499|relapse|relapse
251187|NCT02631499|Chemoembolization, Therapeutic|chemoembolization, therapeutic
251188|NCT02631486|Rotator Cuff Tears|rotator cuff tears
251189|NCT02631447|Metastatic Melanoma|metastatic melanoma
251190|NCT02631447|BRAF mutation|braf mutation
251191|NCT02631408|spinal fusion|spinal fusion
251192|NCT02631408|topical antibiotics|topical antibiotics
251193|NCT02631408|vancomycin|vancomycin
251194|NCT02631408|surgical site infection|surgical site infection
251195|NCT02631395|Exercise movement techniques|exercise movement techniques
251196|NCT02631382|wet cupping Saudi Arabia|wet cupping saudi arabia
251197|NCT02631343|Kangaroo mother care in the community|kangaroo mother care in the community
251198|NCT02631330|Geriatric Assessment|geriatric assessment
251199|NCT02631330|Physical Education and Training|physical education and training
251200|NCT02631317|acute ischemic stroke|acute ischemic stroke
251201|NCT02631317|intravenous rt-PA thrombolysis|intravenous rt-pa thrombolysis
251202|NCT02631317|process reengineering|process reengineering
251203|NCT02631317|door-to-needle time|door-to-needle time
251204|NCT02631304|Postoperative delirium|postoperative delirium
251205|NCT02631304|Cholinesterase activity|cholinesterase activity
251206|NCT02631304|Buturylcholinesterase activity|buturylcholinesterase activity
251207|NCT02631304|Acetylcholinesterase activity|acetylcholinesterase activity
251208|NCT02631304|Elderly patients|elderly patients
251209|NCT02631304|Cardiac surgery|cardiac surgery
251210|NCT02631265|Type 1 diabetes|type 1 diabetes
251211|NCT02631265|Exercise|exercise
251212|NCT02631265|Hypoglycemia|hypoglycemia
251213|NCT02631265|Insulin pump|insulin pump
251214|NCT02631252|Leukemia|leukemia
251215|NCT02631252|Acute Myelogenous|acute myelogenous
251216|NCT02631252|Phase I|phase i
251217|NCT02631252|Mitoxantrone|mitoxantrone
251218|NCT02631252|Etoposide|etoposide
251219|NCT02631252|Hydroxychloroquine|hydroxychloroquine
251220|NCT02631252|Relapsed|relapsed
251221|NCT02631252|Autophagy inhibitor|autophagy inhibitor
251222|NCT02631252|AML|aml
251223|NCT02631252|Relapsed AML|relapsed aml
251224|NCT02631200|Advance Care Planning|advance care planning
251225|NCT02631200|Palliative care|palliative care
251226|NCT02631200|Frail Elderly|frail elderly
251227|NCT02631200|Renal Dialysis|renal dialysis
251228|NCT02631187|Grade 2 retraction of the pars tensa of the tympanic membrane|grade 2 retraction of the pars tensa of the tympanic membrane
251229|NCT02631187|Grade 3 retraction of the pars tensa of the tympanic membrane|grade 3 retraction of the pars tensa of the tympanic membrane
251230|NCT02631135|Dexmedetomidine|dexmedetomidine
251231|NCT02631135|cognitive functions|cognitive functions
251232|NCT02631135|MMSE|mmse
251233|NCT02631122|Retroclavicular|retroclavicular
251234|NCT02631122|Supraclavicular|supraclavicular
251235|NCT02631122|Diagphram|diagphram
251236|NCT02631122|hemiparesis|hemiparesis
251237|NCT02631122|nerve block|nerve block
251238|NCT02631122|regional anesthesia|regional anesthesia
251239|NCT02631122|anesthesiology|anesthesiology
251240|NCT02631109|Pegaspargase|pegaspargase
251241|NCT02631109|hemophagocytic lymphohistiocytosis|hemophagocytic lymphohistiocytosis
251242|NCT02631109|Epstein Barr virus|epstein barr virus
251243|NCT02631070|Luspatercept|luspatercept
251244|NCT02631070|Transfusion dependent|transfusion dependent
251245|NCT02631070|Lower risk|lower risk
251246|NCT02631070|Low risk|low risk
251247|NCT02631070|Myelodysplastic Syndromes|myelodysplastic syndromes
251248|NCT02631070|ESA refractory|esa refractory
251249|NCT02631070|ESA intolerant|esa intolerant
251250|NCT02631070|ESA ineligible|esa ineligible
251251|NCT02631070|ACE-536|ace-536
251252|NCT02631070|Anemia|anemia
251253|NCT02631070|Ring Sideroblasts|ring sideroblasts
251254|NCT02631070|Require Red Blood Cell Transfusions|require red blood cell transfusions
251255|NCT02631070|MEDALIST|medalist
251256|NCT02631070|MDS|mds
251257|NCT02631070|IPSS-R very low/IPSS-R low/IPSS-R intermediate|ipss-r very low/ipss-r low/ipss-r intermediate
251258|NCT02631044|JCAR017|jcar017
251259|NCT02631044|chimeric antigen receptor|chimeric antigen receptor
251260|NCT02631044|non-Hodgkin lymphoma|non-hodgkin lymphoma
251261|NCT02631044|CAR|car
251262|NCT02631044|CAR T cells|car t cells
251263|NCT02631044|autologous T cell therapy|autologous t cell therapy
251264|NCT02631044|cell therapy|cell therapy
251265|NCT02631044|NHL|nhl
251266|NCT02631031|Chronokinetics|chronokinetics
251267|NCT02631031|chronodynamics|chronodynamics
251268|NCT02631031|chronopharmacology|chronopharmacology
251269|NCT02631031|valsartan|valsartan
251270|NCT02631005|systemic lupus erythematosus|systemic lupus erythematosus
251271|NCT02631005|exercise|exercise
251272|NCT02630992|ear infections|ear infections
251273|NCT02630992|antibiotics|antibiotics
251274|NCT02630992|antibiotic resistance|antibiotic resistance
251275|NCT02630992|pediatrics|pediatrics
251276|NCT02630992|infants|infants
251277|NCT02630992|children|children
251278|NCT02630992|amoxicillin-clavulanate|amoxicillin-clavulanate
251279|NCT02630966|Drug therapy|drug therapy
251280|NCT02630966|Fistulizing Crohn´s disease|fistulizing crohn´s disease
251281|NCT02630966|Perianal Fistula|perianal fistula
251282|NCT02630953|Physical Activity|physical activity
251283|NCT02630953|Latinas|latinas
251284|NCT02630953|Spanish-language|spanish-language
251285|NCT02630953|Text-Message|text-message
251286|NCT02630953|English-language|english-language
251287|NCT02630953|Exercise|exercise
251288|NCT02630927|Safety and Tolerability|safety and tolerability
251289|NCT02630927|Pharmacokinetic Study|pharmacokinetic study
251290|NCT02630927|Healthy Volunteer|healthy volunteer
251291|NCT02630927|Pyruvate Kinase|pyruvate kinase
251292|NCT02630927|Rare Genetic|rare genetic
251293|NCT02630914|Epicardial surgical removal|epicardial surgical removal
251294|NCT02630914|Closure of the left atrial|closure of the left atrial
251295|NCT02630914|Left atrial appendage (LAA)|left atrial appendage (laa)
251296|NCT02630888|Bipolar Disorder|bipolar disorder
251297|NCT02630888|Memantine|memantine
251298|NCT02630888|Lithium|lithium
251299|NCT02630888|Aripiprazole|aripiprazole
251300|NCT02630888|Quetiapine|quetiapine
251301|NCT02630888|Central Nervous System Agents|central nervous system agents
251302|NCT02630888|Therapeutic Uses|therapeutic uses
251303|NCT02630888|Pharmacologic Actions|pharmacologic actions
251304|NCT02630888|Psychotropic Drugs|psychotropic drugs
251305|NCT02630888|Cognitive effect of drugs|cognitive effect of drugs
251306|NCT02630862|oxidative stress|oxidative stress
251307|NCT02630862|atherosclerosis|atherosclerosis
251308|NCT02630862|carotid stenosis|carotid stenosis
251309|NCT02630862|oxysterols|oxysterols
251311|NCT02630862|lipid peroxidation|lipid peroxidation
251312|NCT02630862|antioxidants|antioxidants
251314|NCT02630862|dipyridamole|dipyridamole
251315|NCT02630836|mesenchymal stromal cells|mesenchymal stromal cells
251316|NCT02630836|stem cells|stem cells
251317|NCT02630836|elderly|elderly
251318|NCT02630836|allogeneic|allogeneic
251319|NCT02630836|bone marrow|bone marrow
251320|NCT02630836|bone regeneration|bone regeneration
251321|NCT02630836|fracture|fracture
251322|NCT02630797|Bone Health|bone health
251323|NCT02630797|Calcium|calcium
251324|NCT02630797|Osteoporosis|osteoporosis
251325|NCT02630797|Polyphenolics|polyphenolics
251326|NCT02630784|Non-invasive ventilation|non-invasive ventilation
251327|NCT02630784|NIV ventilator|niv ventilator
251328|NCT02630784|Exhalation by a calibrated leak|exhalation by a calibrated leak
251329|NCT02630784|ICU ventilator|icu ventilator
251330|NCT02630784|Respiratory acidosis|respiratory acidosis
251331|NCT02630784|ICU|icu
251332|NCT02630758|depression|depression
251333|NCT02630758|yoga|yoga
251334|NCT02630758|mindfulness|mindfulness
251335|NCT02630745|endodontic treatment|endodontic treatment
251336|NCT02630745|open flap debridement|open flap debridement
251337|NCT02630732|Back School|back school
251338|NCT02630732|Brain School|brain school
251339|NCT02630732|Lumbar surgery|lumbar surgery
251340|NCT02630732|Education|education
251341|NCT02630719|headache|headache
251342|NCT02630628|Lupus Nephritis|lupus nephritis
251343|NCT02630628|mycophenolate mofetil|mycophenolate mofetil
251344|NCT02630628|tacrolimus|tacrolimus
251345|NCT02630615|Circulating tumor cells|circulating tumor cells
251346|NCT02630589|tinnitus|tinnitus
251347|NCT02630589|auditory brainstem implant|auditory brainstem implant
251348|NCT02630589|electrical stimulation|electrical stimulation
251349|NCT02630576|electromyography|electromyography
251350|NCT02630576|neuromuscular blockade|neuromuscular blockade
251351|NCT02630550|Cardiac output|cardiac output
251352|NCT02630550|Intraoperative Monitoring|intraoperative monitoring
251353|NCT02630550|Echocardiography, Transesophageal|echocardiography, transesophageal
251354|NCT02630550|Vascular cross-clamping|vascular cross-clamping
251355|NCT02630550|Endarterectomy|endarterectomy
251356|NCT02630550|Monitoring, Physiologic/instrumentation|monitoring, physiologic/instrumentation
251357|NCT02630550|Cardiography, Impedance|cardiography, impedance
251358|NCT02630537|Cytomegalovirus|cytomegalovirus
251359|NCT02630537|Epstein- Barr virus|epstein- barr virus
251360|NCT02630537|Cell-mediated immunity|cell-mediated immunity
251361|NCT02630537|T-Track® CMV|t-track® cmv
251362|NCT02630537|T-Track® EBV|t-track® ebv
251363|NCT02630537|hemodialysis|hemodialysis
251364|NCT02630537|ELISpot|elispot
251365|NCT02630498|pain|pain
251366|NCT02630498|surgical|surgical
251367|NCT02630498|brachial plexus|brachial plexus
251368|NCT02630485|Randomized Controlled Trial|randomized controlled trial
251369|NCT02630459|Migraine Prevention|migraine prevention
251370|NCT02630459|Headache|headache
251371|NCT02630459|Prophylaxis|prophylaxis
251372|NCT02630446|respite care|respite care
251373|NCT02630446|effectiveness|effectiveness
251374|NCT02630446|cost-effectiveness|cost-effectiveness
251375|NCT02630446|support|support
251376|NCT02630446|caregiver|caregiver
251377|NCT02630446|dementia|dementia
251378|NCT02630446|community-based|community-based
251379|NCT02630433|Biliary pancreatitis|biliary pancreatitis
251380|NCT02630433|Cholecystectomy|cholecystectomy
251381|NCT02630394|sickle cell disease|sickle cell disease
251382|NCT02630394|acute chest syndrome|acute chest syndrome
251383|NCT02630381|high-energy shock waves|high-energy shock waves
251384|NCT02630368|Advanced Soft-tissue Sarcoma|advanced soft-tissue sarcoma
251385|NCT02630368|Advanced Breast Cancer|advanced breast cancer
251386|NCT02630368|Maximum Tolerated Dose|maximum tolerated dose
251387|NCT02630368|Efficacy and safety|efficacy and safety
251388|NCT02630342|Mock Scanner|mock scanner
251389|NCT02630342|Child Life Specialist|child life specialist
251390|NCT02630342|Patient Preparation|patient preparation
251391|NCT02630342|Child, Preschool|child, preschool
251392|NCT02630342|Child|child
251393|NCT02630342|Anxiety|anxiety
251394|NCT02630342|Human|human
251395|NCT02630342|Anesthesia, General|anesthesia, general
251396|NCT02630329|NOTES|notes
251397|NCT02630329|Benign adnexal disease|benign adnexal disease
251398|NCT02630329|Laparoscopy|laparoscopy
251399|NCT02630316|Treprostinil|treprostinil
251400|NCT02630316|PH|ph
251401|NCT02630316|ILD|ild
251402|NCT02630316|CPFE|cpfe
251403|NCT02630316|6 Minute Walk Test|6 minute walk test
251404|NCT02630303|light emitting diode-red light|light emitting diode-red light
251405|NCT02630303|LED-RL|led-rl
251406|NCT02630303|high fluence|high fluence
251407|NCT02630303|skin fibrosis|skin fibrosis
251408|NCT02630303|wound healing|wound healing
251409|NCT02630303|scar|scar
251410|NCT02630303|keloid|keloid
251411|NCT02630303|RCT|rct
251412|NCT02630290|Brachial plexus block|brachial plexus block
251413|NCT02630290|Dexmedetomidine|dexmedetomidine
251414|NCT02630290|Ropivacaine|ropivacaine
321357|NCT02229487|GLP-1|glp-1
251415|NCT02630290|ultrasound-guided nerve block|ultrasound-guided nerve block
251416|NCT02630290|supraclavicular brachial plexus block|supraclavicular brachial plexus block
251417|NCT02630277|Proliferative Diabetic Retinopathy|proliferative diabetic retinopathy
251418|NCT02630277|High Risk PDR|high risk pdr
251419|NCT02630277|aflibercept|aflibercept
251420|NCT02630277|regression of retinal neovascularization|regression of retinal neovascularization
251421|NCT02630264|clinical trial|clinical trial
251422|NCT02630264|Recombinant Human Endostatin Adenovirus|recombinant human endostatin adenovirus
251423|NCT02630264|randomized|randomized
251424|NCT02630251|Cancer|cancer
251425|NCT02630251|Safety|safety
251426|NCT02630251|GSK2820151|gsk2820151
251427|NCT02630251|Dose escalation|dose escalation
251428|NCT02630251|Tolerability|tolerability
251429|NCT02630251|Pharmacodynamics|pharmacodynamics
251430|NCT02630251|Pharmacokinetics|pharmacokinetics
251431|NCT02630238|Exercise|exercise
251432|NCT02630238|Amino Acids, Branched-Chain|amino acids, branched-chain
251433|NCT02630225|case management|case management
251434|NCT02630225|motivational interviewing|motivational interviewing
251435|NCT02630212|Aortic dissection|aortic dissection
251436|NCT02630212|Aldehyde dehydrogenase 2 polymorphism|aldehyde dehydrogenase 2 polymorphism
251437|NCT02630212|Risk factor|risk factor
251438|NCT02630212|aldehyde dehydrogenase 2|aldehyde dehydrogenase 2
251439|NCT02630173|endodontic treatment|endodontic treatment
251440|NCT02630173|scaling|scaling
251441|NCT02630173|root planning|root planning
251442|NCT02630147|Late preterm|late preterm
251443|NCT02630147|Vanilla|vanilla
251444|NCT02630147|Hypoxic intermittent events|hypoxic intermittent events
251446|NCT02630108|TACE|tace
251447|NCT02630108|Thermal Ablation|thermal ablation
251448|NCT02630108|Safety/Efficacy|safety/efficacy
251449|NCT02630095|anticoagulation|anticoagulation
251450|NCT02630082|HIV Preventive Vaccine|hiv preventive vaccine
251451|NCT02630082|HIV Seronegativity|hiv seronegativity
251452|NCT02630082|Immune Response, Mucosal|immune response, mucosal
251453|NCT02630069|amphetamine type stimulant|amphetamine type stimulant
251454|NCT02630069|adolescents|adolescents
251455|NCT02630056|radiotherapy hematologic toxicity pelvic bone marrow|radiotherapy hematologic toxicity pelvic bone marrow
251456|NCT02630004|Mucositis|mucositis
251457|NCT02630004|Head and Neck cancer|head and neck cancer
251458|NCT02630004|Chemoradiation|chemoradiation
251459|NCT02629991|Prader-Willi Syndrome (PWS)|prader-willi syndrome (pws)
251460|NCT02629991|Hyperphagia|hyperphagia
251461|NCT02629978|pulmonary|pulmonary
251462|NCT02629978|lung|lung
251463|NCT02629978|cancer|cancer
251464|NCT02629978|carcinoma|carcinoma
251465|NCT02629978|nodule|nodule
251466|NCT02629978|malignant|malignant
251467|NCT02629978|radiofrequency ablation|radiofrequency ablation
251468|NCT02629978|RFA|rfa
251469|NCT02629952|glucose tolerance|glucose tolerance
251470|NCT02629952|type 2 diabetes|type 2 diabetes
251471|NCT02629952|blueberry tea|blueberry tea
251472|NCT02629900|Weight Loss|weight loss
251473|NCT02629900|Intermittent fasting|intermittent fasting
251474|NCT02629887|supraglottic airway|supraglottic airway
251475|NCT02629887|neonatal resuscitation|neonatal resuscitation
251476|NCT02629887|ventilation|ventilation
251477|NCT02629887|term infant|term infant
251478|NCT02629874|EA-230|ea-230
251479|NCT02629874|Inflammatory response|inflammatory response
251480|NCT02629874|Kidney Injury|kidney injury
251481|NCT02629874|Endotoxemia|endotoxemia
251482|NCT02629848|Drug therapy|drug therapy
251483|NCT02629796|Biomarker|biomarker
251484|NCT02629796|CIDP|cidp
251485|NCT02629796|IVIG|ivig
251486|NCT02629796|treatment response|treatment response
251487|NCT02629757|High-grade glioma|high-grade glioma
251488|NCT02629757|chemotherapy|chemotherapy
251489|NCT02629757|β-elemene|β-elemene
251490|NCT02629731|foot|foot
251491|NCT02629731|ankle|ankle
251492|NCT02629731|osteoarthritis|osteoarthritis
251493|NCT02629731|flat foot|flat foot
251494|NCT02629718|neoadjuvant chemotherapy|neoadjuvant chemotherapy
251495|NCT02629718|radical surgery|radical surgery
251496|NCT02629718|cervical carcinoma|cervical carcinoma
251497|NCT02629653|carotid endarterectomy|carotid endarterectomy
251498|NCT02629653|stroke|stroke
251499|NCT02629653|hypothermia|hypothermia
251500|NCT02629653|endovascular cooling|endovascular cooling
251501|NCT02629640|vCJD|vcjd
251502|NCT02629640|prion disease|prion disease
251503|NCT02629640|dementia|dementia
251504|NCT02629640|old-age|old-age
251505|NCT02629640|surveillance|surveillance
251506|NCT02629640|brain banking|brain banking
251507|NCT02629640|public health|public health
251508|NCT02629627|Conjugated Linoleic Acid|conjugated linoleic acid
251509|NCT02629627|Leucine|leucine
251510|NCT02629627|visceral fat area|visceral fat area
251511|NCT02629627|Epicardial Fat|epicardial fat
251512|NCT02629627|Hemodinamic Parameters|hemodinamic parameters
251513|NCT02629601|physical activity|physical activity
251514|NCT02629601|financial incentives|financial incentives
251515|NCT02629601|behavioral economics|behavioral economics
251516|NCT02629588|Coma|coma
251517|NCT02629588|Persistent Vegetative State|persistent vegetative state
251518|NCT02629588|Sensory Stimulation|sensory stimulation
251519|NCT02629497|platelets|platelets
251520|NCT02629497|12-lipoxygenase|12-lipoxygenase
251521|NCT02629497|fatty acids|fatty acids
251522|NCT02629497|DGLA|dgla
251523|NCT02629497|DHA|dha
251524|NCT02629497|EPA|epa
251525|NCT02629497|12-LOX|12-lox
251526|NCT02629484|echocardiography|echocardiography
251527|NCT02629484|hip fracture|hip fracture
251528|NCT02629484|surgery|surgery
251529|NCT02629484|outcomes|outcomes
251530|NCT02629432|MRI|mri
251531|NCT02629432|COPD|copd
251532|NCT02629419|STAT3 deficient Hyper IgE syndrome|stat3 deficient hyper ige syndrome
251533|NCT02629419|Gain of function STAT1 defects|gain of function stat1 defects
251534|NCT02629419|Autoimmune polyendocrinopathy-candidiasis-ectodermal dystrophy (APECED)|autoimmune polyendocrinopathy-candidiasis-ectodermal dystrophy (apeced)
251535|NCT02629419|IL-17/IL-22 autoantibodies from thymoma|il-17/il-22 autoantibodies from thymoma
251536|NCT02629419|Job's Syndrome (Hyperimmunoglobulin E Syndrome, Buckley Syndrome)|job's syndrome (hyperimmunoglobulin e syndrome, buckley syndrome)
251537|NCT02629406|HIF|hif
251538|NCT02629406|hypoxia|hypoxia
251539|NCT02629406|chemoreflex|chemoreflex
251540|NCT02629406|baroreflex|baroreflex
251541|NCT02629406|MIR210|mir210
251542|NCT02629393|Molybdenum Cofactor Deficiency (MoCD)|molybdenum cofactor deficiency (mocd)
251543|NCT02629393|Molybdenum Cofactor (MoCo) biosynthesis|molybdenum cofactor (moco) biosynthesis
251544|NCT02629393|sulfite oxidase (SO)|sulfite oxidase (so)
251545|NCT02629393|S sulfocysteine (SSC)|s sulfocysteine (ssc)
251546|NCT02629393|xanthine oxidoreductase|xanthine oxidoreductase
251547|NCT02629393|aldehyde oxidase|aldehyde oxidase
251548|NCT02629380|meniscectomy|meniscectomy
251549|NCT02629380|hyaluronic acid|hyaluronic acid
251550|NCT02629380|intra-op injection|intra-op injection
251551|NCT02629380|randomized controlled trial|randomized controlled trial
251552|NCT02629380|placebo|placebo
251553|NCT02629341|woman osteopenia osteoporosis enriched calcium vit D yogurt|woman osteopenia osteoporosis enriched calcium vit d yogurt
251554|NCT02629328|CardioCel|cardiocel
251555|NCT02629328|FDA cleared|fda cleared
251556|NCT02629328|Tri-leaflet repair|tri-leaflet repair
251557|NCT02629328|Aortic valves|aortic valves
251558|NCT02629289|HSP-130|hsp-130
251559|NCT02629289|Pharmacodynamic and Pharmacokinetic equivalence|pharmacodynamic and pharmacokinetic equivalence
251560|NCT02629289|Pegfilgrastim|pegfilgrastim
251561|NCT02629276|neck pain|neck pain
251562|NCT02629276|arm pain|arm pain
251563|NCT02629276|neurodynamic tests|neurodynamic tests
251564|NCT02629276|quantitative sensory testing|quantitative sensory testing
251565|NCT02629276|somatosensory profile|somatosensory profile
251566|NCT02629250|proximal femoral fracture|proximal femoral fracture
251567|NCT02629250|goal-directed therapy|goal-directed therapy
251568|NCT02629250|myocardial injury|myocardial injury
251569|NCT02629250|supernormal oxygen delivery|supernormal oxygen delivery
251570|NCT02629250|elders|elders
251571|NCT02629250|stroke volume maximization|stroke volume maximization
251572|NCT02629237|glaucoma surgery|glaucoma surgery
251573|NCT02629237|educational intervention|educational intervention
251574|NCT02629237|satisfaction|satisfaction
251575|NCT02629237|rural|rural
251576|NCT02629224|Impaired renal function|impaired renal function
251577|NCT02629224|Haemodialysis|haemodialysis
251578|NCT02629224|ASP8825|asp8825
251579|NCT02629224|XP13512|xp13512
251580|NCT02629211|Inflammatory Bowel Diseases|inflammatory bowel diseases
251581|NCT02629211|Colitis, Ulcerative|colitis, ulcerative
251582|NCT02629211|Crohn Disease|crohn disease
251583|NCT02629211|Single-Balloon Enteroscopy|single-balloon enteroscopy
251584|NCT02629211|NaviAid AB™ Device|naviaid ab™ device
251585|NCT02629211|NaviAid AB™ Procedure|naviaid ab™ procedure
251586|NCT02629211|AB Device|ab device
251587|NCT02629211|Pediatric IBD|pediatric ibd
251588|NCT02629211|Pediatric Enteroscopy|pediatric enteroscopy
251589|NCT02629198|Vitamin D|vitamin d
251590|NCT02629185|Bone|bone
251591|NCT02629185|Vitamin D|vitamin d
251592|NCT02629185|Cardiovascular|cardiovascular
251593|NCT02629172|Hepatitis C Virus (HCV)|hepatitis c virus (hcv)
251594|NCT02629172|Paritaprevir|paritaprevir
251595|NCT02629172|Ombitasvir|ombitasvir
251596|NCT02629172|Ritonavir|ritonavir
251597|NCT02629172|Genotype 1|genotype 1
251598|NCT02629159|Musculoskeletal disease|musculoskeletal disease
251599|NCT02629159|Arthritis|arthritis
251600|NCT02629159|Joint disease|joint disease
251601|NCT02629159|Anti-inflammatory agents|anti-inflammatory agents
251602|NCT02629159|Antirheumatic agents|antirheumatic agents
251603|NCT02629146|Midazolam|midazolam
251604|NCT02629146|Fentanyl|fentanyl
251605|NCT02629133|Intimate Partner Violence|intimate partner violence
251606|NCT02629133|Sheltered Battered Women|sheltered battered women
251607|NCT02629133|Substance Use|substance use
251608|NCT02629120|The National Marrow Donor Program (NMDP)|the national marrow donor program (nmdp)
251609|NCT02629120|Matched Unrelated Donor (MUD)|matched unrelated donor (mud)
251610|NCT02629120|HLA Matched Related Donor|hla matched related donor
251612|NCT02629107|Functional Magnetic Resonance Imaging (fMRI)|functional magnetic resonance imaging (fmri)
251820|NCT02628067|PD-L1|pd-l1
251613|NCT02629107|Electroencephalogram (EEG)|electroencephalogram (eeg)
251614|NCT02629094|Hepatic Steatosis|hepatic steatosis
251615|NCT02629094|Cardiac Steatosis|cardiac steatosis
251616|NCT02629094|Aldosterone|aldosterone
251617|NCT02629094|Eplerenone|eplerenone
251618|NCT02629094|Mineralcorticoid Receptor|mineralcorticoid receptor
251619|NCT02629081|heartburn|heartburn
251620|NCT02629081|GERD|gerd
251621|NCT02629081|NERD|nerd
251622|NCT02629081|non-erosive reflux disease|non-erosive reflux disease
251623|NCT02629068|Adolescent|adolescent
251624|NCT02629068|Social Support|social support
251625|NCT02629068|Social Media|social media
251626|NCT02629068|Parents|parents
251627|NCT02629068|Shame|shame
251628|NCT02629068|Stigma|stigma
251629|NCT02629055|Non-invasive ventilation|non-invasive ventilation
251630|NCT02629055|Respiratory electromyography|respiratory electromyography
251631|NCT02629042|Anesthesia|anesthesia
251632|NCT02629042|Corticosteroids|corticosteroids
251633|NCT02629042|Dental Emergency|dental emergency
251634|NCT02629042|Irreversible Pulpitis|irreversible pulpitis
251635|NCT02629042|Mandibulae|mandibulae
251636|NCT02629042|Pain Management|pain management
251637|NCT02629042|Partial Endodontic Treatment|partial endodontic treatment
251638|NCT02629003|Positron Emission Tomography|positron emission tomography
251639|NCT02629003|Serotonin|serotonin
251640|NCT02629003|5-HT2A|5-ht2a
251641|NCT02629003|Radioligand|radioligand
251642|NCT02629003|Radiation dosimetry|radiation dosimetry
251643|NCT02629003|Radiation dosage|radiation dosage
251644|NCT02628964|smoking|smoking
251645|NCT02628964|cigarettes|cigarettes
251646|NCT02628938|Halitosis|halitosis
251647|NCT02628938|Oral Malodor|oral malodor
251648|NCT02628938|Miswak|miswak
251649|NCT02628938|Salvadora Persica|salvadora persica
251650|NCT02628925|mass screening|mass screening
251651|NCT02628925|Nursing diagnosis|nursing diagnosis
251652|NCT02628925|Psychiatric Status Rating Scale|psychiatric status rating scale
251653|NCT02628912|Cardiopulmonary Fitness|cardiopulmonary fitness
251654|NCT02628912|Long-Term Survivors|long-term survivors
251655|NCT02628912|15-277|15-277
251656|NCT02628912|HPV|hpv
251657|NCT02628912|Survivors|survivors
251658|NCT02628886|maternal and neonatal pneumococcal conjugate vaccination|maternal and neonatal pneumococcal conjugate vaccination
251659|NCT02628886|pneumococcal carriage|pneumococcal carriage
251660|NCT02628873|HSG|hsg
251661|NCT02628873|HyCoSy|hycosy
251662|NCT02628873|Contraception|contraception
251663|NCT02628873|Essure|essure
251664|NCT02628873|Saline Infused sonography|saline infused sonography
251665|NCT02628873|SIS|sis
251666|NCT02628873|Air bubbles|air bubbles
251667|NCT02628860|ferric carboxymaltose|ferric carboxymaltose
251668|NCT02628860|Ferinject®|ferinject®
251669|NCT02628860|pancreatoduodenectomy|pancreatoduodenectomy
251670|NCT02628847|stroke|stroke
251671|NCT02628847|rehabilitation|rehabilitation
251672|NCT02628847|motor skills|motor skills
251673|NCT02628847|sildenafil citrate|sildenafil citrate
251674|NCT02628847|White matter|white matter
251675|NCT02628834|Loading|loading
251676|NCT02628834|Gait|gait
251677|NCT02628834|Multiple Sclerosis|multiple sclerosis
251678|NCT02628834|Manual Therapy|manual therapy
251679|NCT02628808|autism|autism
251680|NCT02628808|asperger|asperger
251681|NCT02628808|Pervasive Developmental Disorder No Otherwise Specify|pervasive developmental disorder no otherwise specify
251682|NCT02628808|gene|gene
251683|NCT02628808|polymorphism|polymorphism
251684|NCT02628808|mutation|mutation
251685|NCT02628795|total hip arthroplasty|total hip arthroplasty
251686|NCT02628795|total knee arthroplasty|total knee arthroplasty
251687|NCT02628782|large bore endovascular catheterization procedures|large bore endovascular catheterization procedures
251688|NCT02628782|Vascular Closure Device|vascular closure device
251689|NCT02628769|Solithromycin|solithromycin
251690|NCT02628769|Chronic Obstructive Pulmonary Disease|chronic obstructive pulmonary disease
251691|NCT02628769|Inflammation|inflammation
251692|NCT02628769|Macrolide|macrolide
251693|NCT02628730|Atrial Fibrillation|atrial fibrillation
251694|NCT02628730|Ablation|ablation
251695|NCT02628730|Pulmonary vein isolation|pulmonary vein isolation
251696|NCT02628730|Ablation Index|ablation index
251697|NCT02628717|Hepatitis C|hepatitis c
251698|NCT02628717|sofosbuvir|sofosbuvir
251699|NCT02628717|ledipasvir|ledipasvir
251700|NCT02628717|daclatasvir|daclatasvir
251701|NCT02628717|simeprevir|simeprevir
251702|NCT02628704|Karyopharm|karyopharm
251703|NCT02628704|selinexor|selinexor
251704|NCT02628704|KPT-330|kpt-330
251705|NCT02628704|multiple myeloma|multiple myeloma
251706|NCT02628704|SCORE|score
251707|NCT02628678|Prebiotic|prebiotic
251708|NCT02628678|FOS|fos
251709|NCT02628678|fructooligosaccharide|fructooligosaccharide
251710|NCT02628678|polyglycan|polyglycan
251711|NCT02628678|microbiome|microbiome
251712|NCT02628678|microbiota|microbiota
251713|NCT02628678|Healthy Volunteers|healthy volunteers
251714|NCT02628652|Microbiome|microbiome
251715|NCT02628652|FOS|fos
251716|NCT02628652|polyglycan|polyglycan
251717|NCT02628652|prebiotic|prebiotic
251718|NCT02628652|Healthy Volunteers|healthy volunteers
251719|NCT02628626|Incontinence|incontinence
251720|NCT02628626|Diarrhea|diarrhea
251721|NCT02628626|Bile acid|bile acid
251722|NCT02628626|Microbiome|microbiome
251723|NCT02628613|Breast cancer|breast cancer
251724|NCT02628613|Neoadjuvant chemotherapy|neoadjuvant chemotherapy
251725|NCT02628613|TEKT4|tekt4
251726|NCT02628600|ALIS|alis
251727|NCT02628600|ARIKAYCE|arikayce
251728|NCT02628587|Acute Coronary Syndrome|acute coronary syndrome
251729|NCT02628587|Clopidogrel|clopidogrel
251730|NCT02628587|Platelet reactivity|platelet reactivity
251731|NCT02628574|Metastatic|metastatic
251732|NCT02628574|Stage III or IV|stage iii or iv
251733|NCT02628574|recurrent|recurrent
251734|NCT02628574|refractory|refractory
251735|NCT02628574|solid tumors|solid tumors
251736|NCT02628535|B7-H3-expressing neoplasms|b7-h3-expressing neoplasms
251737|NCT02628522|ADRC|adrc
251738|NCT02628522|Celution|celution
251739|NCT02628509|Acquired Von Willebrand|acquired von willebrand
251740|NCT02628509|Trans aortic valve replacement|trans aortic valve replacement
251741|NCT02628509|mechanical circulatory support|mechanical circulatory support
251742|NCT02628470|Cervical pain, cervicalgia|cervical pain, cervicalgia
251743|NCT02628457|occupation ratio|occupation ratio
251744|NCT02628457|pseudoatrophy|pseudoatrophy
251745|NCT02628444|Dengue Fever|dengue fever
251746|NCT02628444|Dengue virus|dengue virus
251747|NCT02628444|Dengue Hemorrhagic Fever|dengue hemorrhagic fever
251748|NCT02628444|CYD Dengue Vaccine|cyd dengue vaccine
251749|NCT02628418|Rehabilitation|rehabilitation
251750|NCT02628418|Robotics|robotics
251751|NCT02628392|Type 2 Diabetes Mellitus|type 2 diabetes mellitus
251752|NCT02628392|Adult|adult
251753|NCT02628392|Developmental Phase II|developmental phase ii
251754|NCT02628379|Genomic Testing|genomic testing
251755|NCT02628379|Cancer of Unknown Primary|cancer of unknown primary
251756|NCT02628379|CUP|cup
251757|NCT02628366|Cluster randomized Controlled Trial|cluster randomized controlled trial
251758|NCT02628366|Personalized Dialysate Temperature|personalized dialysate temperature
251759|NCT02628366|Cooler Dialysate Temperature|cooler dialysate temperature
251760|NCT02628366|Mortality|mortality
251761|NCT02628366|Cardiovascular Events|cardiovascular events
251762|NCT02628366|Myocardial Infarction|myocardial infarction
251763|NCT02628366|Ischemic Stroke|ischemic stroke
251764|NCT02628366|Congestive Heart Failure|congestive heart failure
251765|NCT02628366|Dialysis Solutions|dialysis solutions
251766|NCT02628353|Cardiovascular diseases|cardiovascular diseases
251767|NCT02628353|endothelial function|endothelial function
251768|NCT02628353|systolic blood pressure|systolic blood pressure
251769|NCT02628353|metabolomics|metabolomics
251770|NCT02628353|cardiovascular risk factor|cardiovascular risk factor
251771|NCT02628353|bioavailability|bioavailability
251772|NCT02628353|phenolic compounds|phenolic compounds
251773|NCT02628353|hypertension|hypertension
251774|NCT02628327|glaucoma care|glaucoma care
251775|NCT02628327|quality of life|quality of life
251776|NCT02628327|patient satisfaction|patient satisfaction
251777|NCT02628301|Obesity|obesity
251778|NCT02628301|Type 2 Diabetes Mellitus|type 2 diabetes mellitus
251779|NCT02628301|Hypercaloric diet|hypercaloric diet
251780|NCT02628301|Microcirculation|microcirculation
251781|NCT02628301|Microvascular dysfunction|microvascular dysfunction
251782|NCT02628301|Insulin Resistance|insulin resistance
251783|NCT02628301|Insulin Sensitivity|insulin sensitivity
251784|NCT02628301|Insulin signaling|insulin signaling
251785|NCT02628262|Macular hole|macular hole
251786|NCT02628236|Actinic keratosis|actinic keratosis
251787|NCT02628223|glaucoma|glaucoma
251788|NCT02628223|Elevated IOP|elevated iop
251789|NCT02628223|Selective Laser Trabeculoplasty|selective laser trabeculoplasty
251790|NCT02628223|SLT|slt
251791|NCT02628223|open angle glaucoma|open angle glaucoma
251792|NCT02628223|ocular hypertension|ocular hypertension
251793|NCT02628223|Glaucoma, Open Angle, Pseudo-exfoliative|glaucoma, open angle, pseudo-exfoliative
251794|NCT02628223|pigment dispersion syndrome|pigment dispersion syndrome
251795|NCT02628223|Pseudoexfoliation|pseudoexfoliation
251796|NCT02628223|IOP ≥ 21 mmHg|iop ≥ 21 mmhg
251797|NCT02628158|Epiretinal membrane|epiretinal membrane
251798|NCT02628145|Sarcopenia|sarcopenia
251799|NCT02628145|aging|aging
251800|NCT02628145|resistance training|resistance training
251801|NCT02628145|physical functioning|physical functioning
251802|NCT02628132|triple negative|triple negative
251803|NCT02628132|breast cancer|breast cancer
251804|NCT02628132|durvalumab|durvalumab
251805|NCT02628132|paclitaxel|paclitaxel
251806|NCT02628132|safety|safety
251807|NCT02628132|efficacy|efficacy
251808|NCT02628132|PD-L1|pd-l1
251809|NCT02628132|PD-1|pd-1
251810|NCT02628132|Metastatic|metastatic
251811|NCT02628132|AstraZeneca|astrazeneca
251812|NCT02628132|MEDI4736|medi4736
251813|NCT02628119|Hemodialysis|hemodialysis
251814|NCT02628119|vascular access|vascular access
251815|NCT02628119|access flow|access flow
251816|NCT02628080|Hypoxia|hypoxia
251817|NCT02628067|PD1|pd1
251818|NCT02628067|PDL1|pdl1
251819|NCT02628067|PD-1|pd-1
251822|NCT02628067|microsatellite instability|microsatellite instability
251823|NCT02628067|MMR|mmr
251824|NCT02628067|mismatch repair|mismatch repair
251825|NCT02628067|anal carcinoma|anal carcinoma
251826|NCT02628067|anal cancer|anal cancer
251827|NCT02628067|biliary adenocarcinoma|biliary adenocarcinoma
251828|NCT02628067|biliary cancer|biliary cancer
251829|NCT02628067|cholangiocarcinoma|cholangiocarcinoma
251830|NCT02628067|bile duct cancer|bile duct cancer
251831|NCT02628067|neuroendocrine tumor|neuroendocrine tumor
251832|NCT02628067|carcinoid tumor|carcinoid tumor
251833|NCT02628067|endometrial carcinoma|endometrial carcinoma
251834|NCT02628067|endometrial cancer|endometrial cancer
251835|NCT02628067|cervical carcinoma|cervical carcinoma
251836|NCT02628067|cervical cancer|cervical cancer
251837|NCT02628067|vulvar carcinoma|vulvar carcinoma
251838|NCT02628067|vulvar cancer|vulvar cancer
251839|NCT02628067|small cell lung carcinoma|small cell lung carcinoma
251840|NCT02628067|small cell lung cancer|small cell lung cancer
251841|NCT02628067|SCLC|sclc
251842|NCT02628067|mesothelioma|mesothelioma
251843|NCT02628067|thyroid carcinoma|thyroid carcinoma
251844|NCT02628067|thyroid cancer|thyroid cancer
251845|NCT02628067|salivary gland carcinoma|salivary gland carcinoma
251846|NCT02628067|salivary gland cancer|salivary gland cancer
251847|NCT02628067|salivary cancer|salivary cancer
251848|NCT02628067|parotid gland cancer|parotid gland cancer
251849|NCT02628067|advanced solid tumors|advanced solid tumors
251850|NCT02628054|PSG|psg
251851|NCT02628054|Typhoid Vaccine|typhoid vaccine
251852|NCT02628054|Depression|depression
251853|NCT02628054|Inflammation|inflammation
251854|NCT02628041|High-Dose-Rate Brachytherapy|high-dose-rate brachytherapy
251855|NCT02628041|HDR Monotherapy|hdr monotherapy
251856|NCT02628041|LDR monotherapy|ldr monotherapy
251857|NCT02628015|Theory of Mind|theory of mind
251858|NCT02628015|Very Low Birthweight Infants|very low birthweight infants
251859|NCT02628002|antigravity treadmill|antigravity treadmill
251860|NCT02628002|bruce protocol|bruce protocol
251861|NCT02628002|stress myocardial perfusion imaging|stress myocardial perfusion imaging
251862|NCT02628002|single photon emission computed tomography|single photon emission computed tomography
251863|NCT02628002|cardiac catheterization|cardiac catheterization
251864|NCT02628002|[E01.370.370.380.500]|[e01.370.370.380.500]
251865|NCT02628002|[E01.370.370.380.250]|[e01.370.370.380.250]
251866|NCT02628002|[E01.370.370.380.140]|[e01.370.370.380.140]
251867|NCT02627937|Pediatric obstructive sleep apnea/hypopnea syndrome|pediatric obstructive sleep apnea/hypopnea syndrome
251868|NCT02627937|Polysomnography|polysomnography
251869|NCT02627924|Rheumatoid Arthritis|rheumatoid arthritis
251870|NCT02627924|Work productivity|work productivity
251871|NCT02627924|patient-reported QoL(Quality of Life)|patient-reported qol(quality of life)
251872|NCT02627898|Green tea extract|green tea extract
251873|NCT02627898|Arterial stiffness|arterial stiffness
251874|NCT02627898|PWVao|pwvao
251875|NCT02627885|internet treatment|internet treatment
251876|NCT02627885|cognitive behavioral therapy|cognitive behavioral therapy
251877|NCT02627885|level of functioning|level of functioning
251878|NCT02627885|quality of life|quality of life
251879|NCT02627833|induced Sputum|induced sputum
251880|NCT02627833|lung clearance index|lung clearance index
251881|NCT02627833|miRNA|mirna
251882|NCT02627833|inflammation|inflammation
251883|NCT02627833|chronic lung disease|chronic lung disease
251884|NCT02627820|Senile|senile
251885|NCT02627820|ATTRwt|attrwt
251886|NCT02627820|wild-type transthyretin amyloidosis|wild-type transthyretin amyloidosis
251887|NCT02627807|Nasopharyngeal carcinoma|nasopharyngeal carcinoma
251888|NCT02627807|Intensity modulated radiotherapy|intensity modulated radiotherapy
251889|NCT02627807|Clinical target volume|clinical target volume
251890|NCT02627807|Clinical trial|clinical trial
251891|NCT02627794|Middle Meatus|middle meatus
251892|NCT02627794|Synechiae|synechiae
251893|NCT02627794|Endoscopic Sinus Surgery|endoscopic sinus surgery
251894|NCT02627794|Silastic spacer|silastic spacer
251895|NCT02627794|Restora™ steroid eluting MM spacer|restora™ steroid eluting mm spacer
251896|NCT02627781|acute appendicitis|acute appendicitis
251897|NCT02627781|Alvarado Score|alvarado score
251898|NCT02627781|negative appendectomy|negative appendectomy
251899|NCT02627781|right abdominal pain|right abdominal pain
251900|NCT02627768|STELARA|stelara
251901|NCT02627768|Psoriatic Arthritis|psoriatic arthritis
251902|NCT02627768|Ustekinumab|ustekinumab
251903|NCT02627755|videolaryngoscopy|videolaryngoscopy
251904|NCT02627755|difficult airway management|difficult airway management
251905|NCT02627716|Psychiatric advanced directives|psychiatric advanced directives
251906|NCT02627716|Joint crisis plan|joint crisis plan
251907|NCT02627716|Schizophrenia|schizophrenia
251908|NCT02627716|Primary care|primary care
251909|NCT02627677|CML|cml
251910|NCT02627677|CP-CML|cp-cml
251911|NCT02627677|Leukemia|leukemia
251912|NCT02627677|Leukemia, Myeloid|leukemia, myeloid
251913|NCT02627677|Leukemia, Myelogenous, Chronic, BCR-ABL Positive|leukemia, myelogenous, chronic, bcr-abl positive
251914|NCT02627677|Neoplasms by Histologic Type|neoplasms by histologic type
251915|NCT02627677|Neoplasms|neoplasms
251916|NCT02627677|Myeloproliferative Disorders|myeloproliferative disorders
251917|NCT02627677|Bone Marrow Diseases|bone marrow diseases
251918|NCT02627677|Hematologic Diseases|hematologic diseases
251919|NCT02627664|Idiopathic early|idiopathic early
251920|NCT02627664|Parkinson's Disease|parkinson's disease
251921|NCT02627638|osteopathy|osteopathy
251922|NCT02627638|complementary therapy|complementary therapy
251923|NCT02627638|symptoms in cancer patients|symptoms in cancer patients
251924|NCT02627625|inhalation|inhalation
251925|NCT02627625|anticholinergic|anticholinergic
251926|NCT02627612|veteran|veteran
251927|NCT02627612|mentorship|mentorship
251928|NCT02627612|Iraq/Afghanistan|iraq/afghanistan
251929|NCT02627612|treatment|treatment
251930|NCT02627612|PTSD|ptsd
251931|NCT02627612|Suicide|suicide
251932|NCT02627612|Criminal Activity|criminal activity
251933|NCT02627599|COPD|copd
251934|NCT02627599|LTOT|ltot
251935|NCT02627599|Long-Term Oxygen Therapy|long-term oxygen therapy
251936|NCT02627599|Oxygen Conserving Device|oxygen conserving device
251937|NCT02627599|Quality of Life|quality of life
251938|NCT02627599|Six Minute Walk Distance|six minute walk distance
251939|NCT02627599|Portable Oxygen Source|portable oxygen source
251940|NCT02627599|Oxygen Saturation|oxygen saturation
251941|NCT02627599|Breath Responsive Variable Bolus Oxygen Conserving Device|breath responsive variable bolus oxygen conserving device
251942|NCT02627599|BRVB-OCD|brvb-ocd
251943|NCT02627599|Pulse Oximetry|pulse oximetry
251944|NCT02627586|exercise therapy|exercise therapy
251945|NCT02627586|left ventricular remodeling|left ventricular remodeling
251946|NCT02627586|ventricular ejection fraction|ventricular ejection fraction
251947|NCT02627586|high-intensity interval training|high-intensity interval training
251948|NCT02627573|Cyclophosphamide|cyclophosphamide
251949|NCT02627573|Thymoglobulin|thymoglobulin
251950|NCT02627573|Myelodysplastic Syndromes|myelodysplastic syndromes
251951|NCT02627573|Immunosuppressive Agents|immunosuppressive agents
251952|NCT02627573|Immune System Diseases|immune system diseases
251953|NCT02627573|Busulfan|busulfan
251954|NCT02627573|Fludarabine|fludarabine
251955|NCT02627573|Tacrolimus|tacrolimus
251956|NCT02627573|Mycophenolate mofetil|mycophenolate mofetil
251957|NCT02627573|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating
251958|NCT02627573|Myeloablative Agonists|myeloablative agonists
251959|NCT02627573|Hematopoietic Stem Cell Transplantation|hematopoietic stem cell transplantation
251960|NCT02627573|Allogeneic Transplantation|allogeneic transplantation
251961|NCT02627573|Leukemia, Chronic Myeloid|leukemia, chronic myeloid
251962|NCT02627573|Leukemia, Myeloid, Chronic, Atypical, BCR-ABL Negative|leukemia, myeloid, chronic, atypical, bcr-abl negative
251963|NCT02627560|Administration, topical|administration, topical
251964|NCT02627560|Tranexamic acid|tranexamic acid
251965|NCT02627560|Postoperative care|postoperative care
251966|NCT02627560|Mastectomy|mastectomy
251967|NCT02627547|Flavanones|flavanones
251968|NCT02627547|Endurance-trained athletes|endurance-trained athletes
251969|NCT02627547|Biological availability|biological availability
251970|NCT02627534|Photodynamic therapy|photodynamic therapy
251971|NCT02627534|Ultrasonic debridement|ultrasonic debridement
251972|NCT02627534|Chronic periodontitis|chronic periodontitis
251973|NCT02627534|Type 2 diabetes|type 2 diabetes
251974|NCT02627508|Autism Spectrum Disorder|autism spectrum disorder
251975|NCT02627508|Autism|autism
251976|NCT02627508|Pregnenolone|pregnenolone
251977|NCT02627495|maladaptive plasticity|maladaptive plasticity
251978|NCT02627495|Limb amputation|limb amputation
251979|NCT02627495|phantom limb pain|phantom limb pain
251980|NCT02627495|tDCS|tdcs
251981|NCT02627495|non-invasive brain stimulation|non-invasive brain stimulation
251982|NCT02627469|Microbiota|microbiota
251983|NCT02627469|aged|aged
251984|NCT02627469|oral health|oral health
251985|NCT02627456|Malaria|malaria
251986|NCT02627456|Cryopreserved|cryopreserved
251987|NCT02627456|Infection|infection
251988|NCT02627456|Human|human
251989|NCT02627456|Immunization|immunization
251990|NCT02627417|ITP|itp
251991|NCT02627417|Dapsone|dapsone
251992|NCT02627404|Bipolar disorders|bipolar disorders
251993|NCT02627404|Genetic|genetic
251994|NCT02627404|Biomarkers|biomarkers
251995|NCT02627404|Circadian rhythm|circadian rhythm
251996|NCT02627391|Aortic valve|aortic valve
251997|NCT02627391|Stenosis|stenosis
251998|NCT02627391|Surgery|surgery
251999|NCT02627365|ART|art
252000|NCT02627365|mobile messaging|mobile messaging
252001|NCT02627365|behaviour|behaviour
252002|NCT02627365|motivation|motivation
252003|NCT02627352|Glaucoma|glaucoma
252004|NCT02627352|Micropulse Transscleral Cyclophotocoagulation|micropulse transscleral cyclophotocoagulation
252005|NCT02627352|Intraocular Pressure|intraocular pressure
252006|NCT02627339|Contrast Sensitivity|contrast sensitivity
252007|NCT02627326|chlorhexidine|chlorhexidine
252008|NCT02627326|endodontic treatment|endodontic treatment
252009|NCT02627313|Feasibility Studies|feasibility studies
252010|NCT02627300|PID|pid
252011|NCT02627261|residual disease|residual disease
252012|NCT02627235|Physical Activity|physical activity
252013|NCT02627235|Cancer Prevention|cancer prevention
252014|NCT02627222|Pro-vitamin A|pro-vitamin a
252016|NCT02627222|Vitamin A deficiency|vitamin a deficiency
252017|NCT02627222|Retinol Isotope Dilution|retinol isotope dilution
252018|NCT02627222|Preschool children|preschool children
252019|NCT02627222|Nigeria|nigeria
252020|NCT02627209|Angiotensin converting enzyme|angiotensin converting enzyme
252021|NCT02627209|Lysozyme|lysozyme
252022|NCT02627209|Ankylosing spondylitis|ankylosing spondylitis
252023|NCT02627209|Behcet's disease|behcet's disease
252024|NCT02627209|Sarcoidosis|sarcoidosis
252025|NCT02627209|Syphilis|syphilis
252026|NCT02627209|Tuberculosis|tuberculosis
252027|NCT02627209|Ocular inflammation|ocular inflammation
252028|NCT02627183|Atrial Fibrillation|atrial fibrillation
252029|NCT02627170|Adults|adults
252030|NCT02627144|Metastatic renal cell carcinoma|metastatic renal cell carcinoma
252031|NCT02627144|Avastin|avastin
252032|NCT02627144|Bevacizumab|bevacizumab
252033|NCT02627131|Autism|autism
252034|NCT02627131|Stem Cells|stem cells
252035|NCT02627105|weight loss|weight loss
252036|NCT02627105|red meats|red meats
252037|NCT02627105|obesity|obesity
252038|NCT02627105|lean body mass|lean body mass
252039|NCT02627105|body composition|body composition
252040|NCT02627105|dietary protein|dietary protein
252041|NCT02627066|Exercise|exercise
252042|NCT02627066|Nutrition|nutrition
252043|NCT02627066|Hemodialysis|hemodialysis
252044|NCT02627014|Chronic Migraine|chronic migraine
252045|NCT02627014|Temporomandibular Disorders|temporomandibular disorders
252046|NCT02627014|Physical Therapy|physical therapy
252047|NCT02627014|Manual Therapy|manual therapy
252048|NCT02627014|Home physical Therapy|home physical therapy
252049|NCT02626988|Diet Diversity|diet diversity
252050|NCT02626988|Biodiversity|biodiversity
252051|NCT02626988|Agrobiodiversity|agrobiodiversity
252052|NCT02626988|Nutrition|nutrition
252053|NCT02626988|Vietnam|vietnam
252054|NCT02626975|knee|knee
252055|NCT02626975|short hamstring autograft|short hamstring autograft
252056|NCT02626975|ligament|ligament
252057|NCT02626975|MRI|mri
252058|NCT02626962|melanoma|melanoma
252059|NCT02626949|HIV|hiv
252060|NCT02626949|AIDS|aids
252061|NCT02626949|Mindfulness|mindfulness
252062|NCT02626949|Mindfulness-based stress reduction|mindfulness-based stress reduction
252063|NCT02626949|Stress|stress
252064|NCT02626949|Intervention|intervention
252065|NCT02626949|Inflammation|inflammation
252066|NCT02626936|Type 1 diabetes|type 1 diabetes
252067|NCT02626936|Artificial pancreas|artificial pancreas
252068|NCT02626936|Closed-loop system|closed-loop system
252069|NCT02626936|Postprandial glucose control|postprandial glucose control
252070|NCT02626936|Hypoglycemia|hypoglycemia
252071|NCT02626936|Insulin|insulin
252072|NCT02626936|Glucagon|glucagon
252073|NCT02626910|Disability|disability
252074|NCT02626910|Activity of Daily Living|activity of daily living
252075|NCT02626910|Patient Satisfaction|patient satisfaction
252076|NCT02626897|Sarcoidosis|sarcoidosis
252077|NCT02626897|Daily activity|daily activity
252078|NCT02626897|Exercise|exercise
252079|NCT02626897|Accelerometer|accelerometer
252080|NCT02626845|Granulomatosis with Polyangiitis|granulomatosis with polyangiitis
252081|NCT02626845|Wegener's Granulomatosis|wegener's granulomatosis
252082|NCT02626845|GPA|gpa
252083|NCT02626845|Rituximab|rituximab
252084|NCT02626845|Rituxan|rituxan
252085|NCT02626845|ENT GPA|ent gpa
252086|NCT02626832|vasopressin|vasopressin
252087|NCT02626832|AVP|avp
252088|NCT02626832|NMDA|nmda
252089|NCT02626832|osmolality|osmolality
252090|NCT02626819|Obesity|obesity
252091|NCT02626819|Weight Management|weight management
252092|NCT02626819|Primary Care|primary care
252093|NCT02626819|Health Coach|health coach
252094|NCT02626819|iPad|ipad
252095|NCT02626819|Goal Setting|goal setting
252096|NCT02626819|5As|5as
252097|NCT02626819|technology|technology
252098|NCT02626806|exercise test|exercise test
252099|NCT02626806|HS -troponin|hs -troponin
252100|NCT02626806|Coronary artery disease|coronary artery disease
252101|NCT02626793|Plaque psoriasis|plaque psoriasis
252102|NCT02626793|Apremilast|apremilast
252103|NCT02626793|Otezla®|otezla®
252104|NCT02626793|LAPIS-Pso|lapis-pso
252105|NCT02626793|Observational|observational
252106|NCT02626793|CC-10004|cc-10004
252107|NCT02626793|non-interventional|non-interventional
252108|NCT02626793|Germany|germany
252109|NCT02626767|high-intensity interval training|high-intensity interval training
252110|NCT02626767|adolescents|adolescents
252111|NCT02626767|school-based exercise|school-based exercise
252112|NCT02626767|cardiometabolic health|cardiometabolic health
322229|NCT02225574|CML|cml
252113|NCT02626754|Sunitinib, 2/1 schedule, Renal cell carcinoma|sunitinib, 2/1 schedule, renal cell carcinoma
252114|NCT02626702|immune modulators|immune modulators
252115|NCT02626702|IVF outcomes|ivf outcomes
252116|NCT02626702|relationship|relationship
252117|NCT02626689|Beta-Thalassemia|beta-thalassemia
252118|NCT02626689|Quality of Life|quality of life
252119|NCT02626689|Healthcare Utilization|healthcare utilization
252120|NCT02626689|Transfusion dependent (TD) β-thalassemia|transfusion dependent (td) β-thalassemia
252121|NCT02626689|Non-transfusion dependent β-thalassemia|non-transfusion dependent β-thalassemia
252122|NCT02626689|Standard of care|standard of care
252123|NCT02626689|TransQoL|transqol
252124|NCT02626689|SF36v2|sf36v2
252125|NCT02626689|Fact-An|fact-an
252126|NCT02626689|NTD beta-thalassemia PRO|ntd beta-thalassemia pro
252127|NCT02626676|renal dialysis, hyperphosphatemia, educational programme|renal dialysis, hyperphosphatemia, educational programme
252128|NCT02626637|children with cancer|children with cancer
252129|NCT02626637|fatigue|fatigue
252130|NCT02626637|physical activity|physical activity
252131|NCT02626598|facial wrinkles|facial wrinkles
252132|NCT02626598|photoaging|photoaging
252133|NCT02626585|rhinoplasty|rhinoplasty
252134|NCT02626585|postrhinoplasty taping|postrhinoplasty taping
252135|NCT02626585|edema|edema
252136|NCT02626585|draping|draping
252137|NCT02626585|postoperative edema|postoperative edema
252138|NCT02626585|nasal skin thickness|nasal skin thickness
252139|NCT02626585|supratip fullness|supratip fullness
252140|NCT02626585|postoperative swelling|postoperative swelling
252141|NCT02626533|Cytokines|cytokines
252142|NCT02626507|ER+/HER2|er+/her2
252143|NCT02626481|Multiple Myeloma|multiple myeloma
252144|NCT02626481|Cancer|cancer
252145|NCT02626481|refractory|refractory
252146|NCT02626481|daratumumab|daratumumab
252147|NCT02626455|Clinical trial, Phase III|clinical trial, phase iii
252148|NCT02626455|Phosphatidylinositol-3-kinase|phosphatidylinositol-3-kinase
252149|NCT02626455|Non-Hodgkin's lymphoma|non-hodgkin's lymphoma
252150|NCT02626455|Indolent B-cell non-Hodgkin's lymphoma|indolent b-cell non-hodgkin's lymphoma
252151|NCT02626442|Cognition|cognition
252152|NCT02626442|Exercise|exercise
252153|NCT02626416|Telemedicine|telemedicine
252154|NCT02626403|vegetative state|vegetative state
252155|NCT02626403|minimally conscious state|minimally conscious state
252156|NCT02626403|disorder of consciousness|disorder of consciousness
252157|NCT02626403|transcranial current direct stimulation|transcranial current direct stimulation
252158|NCT02626403|non invasive brain stimulation|non invasive brain stimulation
252159|NCT02626403|neuromodulation|neuromodulation
252160|NCT02626377|Informal caregivers|informal caregivers
252161|NCT02626377|Elderly|elderly
252162|NCT02626377|Quality of life|quality of life
252163|NCT02626377|Cost effectiveness|cost effectiveness
252164|NCT02626377|Cohort study|cohort study
252165|NCT02626377|Randomized study|randomized study
252166|NCT02626351|postnatal|postnatal
252167|NCT02626299|Preterm birth, very low birth weight|preterm birth, very low birth weight
252168|NCT02626286|HIV|hiv
252169|NCT02626286|Men who have sex with men|men who have sex with men
252170|NCT02626273|obesity|obesity
252171|NCT02626273|adolescents|adolescents
252172|NCT02626273|physical activity|physical activity
252173|NCT02626273|adipocytes|adipocytes
252174|NCT02626273|osteocytes|osteocytes
252175|NCT02626273|weight loss|weight loss
252176|NCT02626273|bone|bone
252177|NCT02626273|fat|fat
252178|NCT02626247|elderly|elderly
252179|NCT02626234|cMET, INC280, rosuvastatin, digoxin|cmet, inc280, rosuvastatin, digoxin
252180|NCT02626208|Contraceptive vaginal ring|contraceptive vaginal ring
252181|NCT02626195|malnutrition|malnutrition
252182|NCT02626195|nutrition|nutrition
252183|NCT02626195|nutritional support|nutritional support
252184|NCT02626195|hepatobiliary pancreatic cancer|hepatobiliary pancreatic cancer
252185|NCT02626195|hepatobiliary pancreatic surgery|hepatobiliary pancreatic surgery
252186|NCT02626169|15-epi-lipoxin A4|15-epi-lipoxin a4
252187|NCT02626169|inflammation|inflammation
252188|NCT02626169|atherosclerosis|atherosclerosis
252189|NCT02626156|post healed venous leg ulcer|post healed venous leg ulcer
252190|NCT02626156|posted healed diabetic foot ulcer|posted healed diabetic foot ulcer
252191|NCT02626104|lactoferrin|lactoferrin
252192|NCT02626104|clostridium difficile|clostridium difficile
252193|NCT02626104|antibiotic associated diarrhoea|antibiotic associated diarrhoea
252194|NCT02626104|children|children
252195|NCT02626104|antibiotic therapy|antibiotic therapy
252196|NCT02626104|diarrhoea|diarrhoea
252197|NCT02626091|Anastomotic perfusion|anastomotic perfusion
252198|NCT02626091|ICG Fluorescence|icg fluorescence
252199|NCT02626091|Enhanced reality|enhanced reality
252200|NCT02626091|Left-sided colonic resection|left-sided colonic resection
252201|NCT02626078|Malnutrition|malnutrition
252202|NCT02626078|Food practices|food practices
252203|NCT02626078|Elderly|elderly
252204|NCT02626078|Nursing Home|nursing home
252205|NCT02626078|Aging|aging
252206|NCT02626078|Nutritional status|nutritional status
252207|NCT02626078|Quality of life|quality of life
252208|NCT02626065|Melanoma|melanoma
252209|NCT02626065|Anti-PD1 monoclonal antibodies|anti-pd1 monoclonal antibodies
252210|NCT02626065|Immune modulation|immune modulation
252211|NCT02626065|BRAF|braf
252212|NCT02626052|Skull vibration induced nystagmus test|skull vibration induced nystagmus test
252213|NCT02626052|mastoid vibration test|mastoid vibration test
252214|NCT02626039|Metastatic Breast Cancer|metastatic breast cancer
252215|NCT02626039|CTCs|ctcs
252216|NCT02626039|cfDNA|cfdna
252217|NCT02626039|genomics|genomics
252218|NCT02626039|somatic mutations|somatic mutations
252219|NCT02626000|Recurrent Metastatic Squamous Cell Carcinoma Head and Neck|recurrent metastatic squamous cell carcinoma head and neck
252220|NCT02625987|Appendicectomy, wound complications, skin closure|appendicectomy, wound complications, skin closure
252222|NCT02625961|PDL1|pdl1
252223|NCT02625961|PD-L1|pd-l1
252224|NCT02625961|PD-1|pd-1
252225|NCT02625948|Intracerebral Hemorrhage|intracerebral hemorrhage
252226|NCT02625948|tranexamic acid|tranexamic acid
252227|NCT02625948|spot sign|spot sign
252228|NCT02625935|Prosigna|prosigna
252229|NCT02625935|estrogen receptor positive|estrogen receptor positive
252230|NCT02625935|node negative|node negative
252231|NCT02625935|HER2 negative|her2 negative
252232|NCT02625922|Serelaxin,|serelaxin,
252233|NCT02625922|Chronic heart failure,|chronic heart failure,
252234|NCT02625922|Spiroergometry,|spiroergometry,
252235|NCT02625922|Troponin,|troponin,
252236|NCT02625922|New York Heart Association (NYHA) functional Class II/III,|new york heart association (nyha) functional class ii/iii,
252237|NCT02625922|Left ventricular ejection fraction,|left ventricular ejection fraction,
252238|NCT02625896|Aviation|aviation
252239|NCT02625896|Parachuting|parachuting
252240|NCT02625883|Resuscitation, quality of life|resuscitation, quality of life
252363|NCT02625246|lung|lung
252241|NCT02625857|Prostatic Neoplasms, Castration-Resistant|prostatic neoplasms, castration-resistant
252242|NCT02625857|JNJ-64041809|jnj-64041809
252243|NCT02625857|Listeria monocytogenes|listeria monocytogenes
252244|NCT02625831|ficolin-3|ficolin-3
252245|NCT02625831|anti-ficolin-3 antibodies|anti-ficolin-3 antibodies
252246|NCT02625831|lupus nephritis|lupus nephritis
252247|NCT02625831|Lupus Erythematosus, Systemic|lupus erythematosus, systemic
252248|NCT02625831|biomarker|biomarker
252249|NCT02625818|Emergency Services, Psychiatric|emergency services, psychiatric
252250|NCT02625818|Prognosis|prognosis
252251|NCT02625818|Biological markers|biological markers
252252|NCT02625818|Anxiety|anxiety
252253|NCT02625818|Panic|panic
252254|NCT02625818|Psychomotor Agitation|psychomotor agitation
252255|NCT02625818|Self-injurious Behavior|self-injurious behavior
252256|NCT02625792|Post ESD ulcer|post esd ulcer
252257|NCT02625792|Bleeding|bleeding
252258|NCT02625792|Prophylaxis|prophylaxis
252259|NCT02625779|Bipolar depression|bipolar depression
252260|NCT02625779|Cytidine|cytidine
252261|NCT02625779|Creatine|creatine
252262|NCT02625779|Magnetic resonance spectroscopy|magnetic resonance spectroscopy
252263|NCT02625766|Operative vs. Non-operative|operative vs. non-operative
252264|NCT02625766|LC pelvic fracture|lc pelvic fracture
252265|NCT02625766|Complications|complications
252266|NCT02625753|photorefractive keratectomy|photorefractive keratectomy
252267|NCT02625753|pain|pain
252268|NCT02625753|analgesia|analgesia
252269|NCT02625753|opioid|opioid
252270|NCT02625727|knee osteoarthritis|knee osteoarthritis
252271|NCT02625727|hyaluronic acid|hyaluronic acid
252272|NCT02625727|corticosteroid|corticosteroid
252273|NCT02625727|intra-articular injection|intra-articular injection
252274|NCT02625727|therapeutic effect|therapeutic effect
252275|NCT02625701|operative mortality|operative mortality
252276|NCT02625701|myocardial infarct, arrhythmia, heart failure, stroke|myocardial infarct, arrhythmia, heart failure, stroke
252277|NCT02625701|pneumonia, atelectasis, acute lung injury|pneumonia, atelectasis, acute lung injury
252278|NCT02625701|surgical site infection|surgical site infection
252279|NCT02625701|acute kidney injury|acute kidney injury
252280|NCT02625701|body weight|body weight
252281|NCT02625662|muscular dystrophy|muscular dystrophy
252282|NCT02625662|natural history|natural history
252283|NCT02625662|genetic profilling|genetic profilling
252284|NCT02625649|Roux-en-Y gastric bypass|roux-en-y gastric bypass
252285|NCT02625649|obesity|obesity
252286|NCT02625649|type 2 diabetes mellitus|type 2 diabetes mellitus
252287|NCT02625649|diabetic nephropathy|diabetic nephropathy
252288|NCT02625649|diabetic retinopathy|diabetic retinopathy
252289|NCT02625623|Avelumab|avelumab
252290|NCT02625623|Gastric cancer|gastric cancer
252291|NCT02625623|Gastroesophageal junction adenocarcinoma|gastroesophageal junction adenocarcinoma
252292|NCT02625610|Avelumab|avelumab
252293|NCT02625610|Cancer|cancer
252294|NCT02625610|Unresectable|unresectable
252295|NCT02625610|Locally advanced|locally advanced
252296|NCT02625610|Metastatic|metastatic
252297|NCT02625610|Adenocarcinoma of the stomach|adenocarcinoma of the stomach
252298|NCT02625610|Gastro-esophageal junction|gastro-esophageal junction
252299|NCT02625584|Shared Book Reading|shared book reading
733735|NCT00498199|nystagmus|nystagmus
252300|NCT02625584|Dialogic Reading|dialogic reading
252301|NCT02625584|Language Development|language development
252302|NCT02625584|Syntax|syntax
252303|NCT02625584|Vocabulary|vocabulary
252304|NCT02625584|Young Children|young children
252305|NCT02625584|Randomised Control Trial|randomised control trial
252306|NCT02625584|Language Intervention|language intervention
252307|NCT02625558|riociguat|riociguat
252308|NCT02625558|saph|saph
252309|NCT02625558|sarcoidosis|sarcoidosis
252310|NCT02625558|sarcoidosis associated pulmonary hypertension|sarcoidosis associated pulmonary hypertension
252311|NCT02625532|Controlled Ovarian stimulation|controlled ovarian stimulation
252312|NCT02625532|Follicular phase|follicular phase
252313|NCT02625532|Luteal phase|luteal phase
252314|NCT02625532|Reproductive Techniques, Assisted|reproductive techniques, assisted
252315|NCT02625519|Controlled ovarian stimulation|controlled ovarian stimulation
252316|NCT02625519|Follicle-stimulating hormone|follicle-stimulating hormone
252317|NCT02625519|Receptor N680S follicle-stimulating hormone receptor (FSHR)|receptor n680s follicle-stimulating hormone receptor (fshr)
252318|NCT02625519|Gene polymorphism|gene polymorphism
252319|NCT02625519|Oocyte donors|oocyte donors
252320|NCT02625493|Percutaneous coronary intervention|percutaneous coronary intervention
252321|NCT02625493|Patient Preference|patient preference
252322|NCT02625493|Radial access|radial access
252323|NCT02625493|Femoral access|femoral access
252324|NCT02625493|Coronary angiography|coronary angiography
252325|NCT02625493|Shared decision making|shared decision making
252326|NCT02625467|Keratoconus|keratoconus
252327|NCT02625454|Acetaminophen|acetaminophen
252328|NCT02625454|Labor|labor
252329|NCT02625454|Intrapartum Fever|intrapartum fever
252330|NCT02625454|Maternal Fever|maternal fever
252331|NCT02625454|Fetal Tachycardia|fetal tachycardia
252332|NCT02625454|Intravenous Acetaminophen|intravenous acetaminophen
252333|NCT02625441|Breast cancer|breast cancer
252334|NCT02625441|docetaxel|docetaxel
252335|NCT02625441|pertuzumab|pertuzumab
252336|NCT02625441|trastuzumab|trastuzumab
252337|NCT02625441|HER2|her2
252338|NCT02625402|decision making|decision making
252339|NCT02625402|decision aids|decision aids
252340|NCT02625402|decision quality instruments|decision quality instruments
252341|NCT02625402|osteoarthritis|osteoarthritis
252342|NCT02625402|shared decision making|shared decision making
252343|NCT02625389|scheduled for selective transarterial catheterization|scheduled for selective transarterial catheterization
252344|NCT02625363|Glycemic Index|glycemic index
252345|NCT02625363|Water Intake|water intake
252346|NCT02625363|Glycemic Response|glycemic response
252347|NCT02625350|instant noodle|instant noodle
252348|NCT02625350|water content|water content
252349|NCT02625350|glycemic index|glycemic index
252350|NCT02625350|serving method|serving method
252351|NCT02625298|periapical diseases|periapical diseases
252352|NCT02625298|dental injuries|dental injuries
252353|NCT02625298|MTA|mta
252354|NCT02625272|hand-assisted laparoscopic surgery|hand-assisted laparoscopic surgery
252355|NCT02625272|right colon cancer|right colon cancer
252356|NCT02625272|complete mesocolic excision|complete mesocolic excision
252357|NCT02625272|no touch isolation|no touch isolation
252358|NCT02625272|recurrence|recurrence
252359|NCT02625272|overall survival|overall survival
252360|NCT02625259|Drug therapy|drug therapy
252361|NCT02625246|bronchiectasis|bronchiectasis
252362|NCT02625246|mesenchymal stem cell|mesenchymal stem cell
252364|NCT02625246|pulmonary|pulmonary
252365|NCT02625246|interstitial lung disease|interstitial lung disease
252366|NCT02625207|Maraviroc, CYP3A5, pharmacokinetics, pharmacogenomics|maraviroc, cyp3a5, pharmacokinetics, pharmacogenomics
252367|NCT02625181|Decision support|decision support
252368|NCT02625181|Prediction models|prediction models
252369|NCT02625181|PONV|ponv
252370|NCT02625181|prophylaxis|prophylaxis
252371|NCT02625181|Decision Support Systems, Clinical|decision support systems, clinical
252372|NCT02625181|Decision Support Techniques|decision support techniques
252373|NCT02625168|Afatinib|afatinib
252374|NCT02625168|Erlotinib|erlotinib
252375|NCT02625168|Metastatic non-small cell lung cancer|metastatic non-small cell lung cancer
252376|NCT02625168|Efficacy|efficacy
252377|NCT02625168|Safety|safety
252378|NCT02625155|Pharmacogenomics|pharmacogenomics
252379|NCT02625155|Urine Drug Testing|urine drug testing
252380|NCT02625155|antidepressants|antidepressants
252381|NCT02625155|benzodiazepines|benzodiazepines
252382|NCT02625155|opioids|opioids
252383|NCT02625155|muscle relaxants|muscle relaxants
252384|NCT02625155|non-steroidal anti-inflammatory agents|non-steroidal anti-inflammatory agents
252385|NCT02625155|TDRAE|tdrae
252386|NCT02625142|Morning Rounds|morning rounds
252387|NCT02625142|Patient-centered Care|patient-centered care
252388|NCT02625142|Hospital Medicine|hospital medicine
252389|NCT02625142|Pediatrics|pediatrics
252390|NCT02625142|Hospitals, Pediatric|hospitals, pediatric
252391|NCT02625116|Cohort|cohort
252392|NCT02625103|Schizophrenia, Clozapine, TDM, Serum Concentration|schizophrenia, clozapine, tdm, serum concentration
252393|NCT02625090|Drug-resistance|drug-resistance
252394|NCT02625090|focal epilepsy|focal epilepsy
252395|NCT02625090|partial-onset seizures|partial-onset seizures
252396|NCT02625077|Valvuloplasty|valvuloplasty
252397|NCT02625077|Fundoplication|fundoplication
252398|NCT02625077|Acid reflux|acid reflux
252399|NCT02625077|GERD|gerd
252400|NCT02625077|Reflux disease|reflux disease
252401|NCT02625077|Hiatal hernia|hiatal hernia
252402|NCT02625064|ARDS|ards
252403|NCT02625064|biomarkers|biomarkers
252404|NCT02625064|proteomic|proteomic
252405|NCT02625012|Ultraviolet Therapy|ultraviolet therapy
252406|NCT02625012|Vitiligo|vitiligo
252407|NCT02625012|Melanocytes|melanocytes
252408|NCT02625012|Pigmentation|pigmentation
252409|NCT02624999|Head and Neck Cancer|head and neck cancer
252410|NCT02624999|SCCHN|scchn
252411|NCT02624999|R/M SCCHN|r/m scchn
252412|NCT02624999|Carcinoma|carcinoma
252413|NCT02624973|neoadjuvant treatment|neoadjuvant treatment
252414|NCT02624973|personalized medicine|personalized medicine
252416|NCT02624895|"metastatic colorectal cancer gene RAS not mutated WILD TYPE"|"metastatic colorectal cancer gene ras not mutated wild type"
252417|NCT02624882|blistering distal dactylitis|blistering distal dactylitis
252418|NCT02624882|Streptococcus pyogenes|streptococcus pyogenes
252419|NCT02624882|antibiotics|antibiotics
252420|NCT02624869|Hypercholesterolemia|hypercholesterolemia
252421|NCT02624869|Elevated Cholesterol|elevated cholesterol
252422|NCT02624869|High Cholesterol|high cholesterol
252423|NCT02624869|PCSK9 mutations|pcsk9 mutations
252424|NCT02624869|Severe Familial Hypercholesterolemia|severe familial hypercholesterolemia
252425|NCT02624869|evolocumab|evolocumab
252426|NCT02624869|Repatha|repatha
252427|NCT02624869|Heterozygous Familial Hypercholesterolemia|heterozygous familial hypercholesterolemia
252428|NCT02624869|Homozygous Familial Hypercholesterolemia|homozygous familial hypercholesterolemia
252429|NCT02624869|Pediatric|pediatric
252430|NCT02624869|Paediatric|paediatric
252431|NCT02624856|primary total knee arthroplasty|primary total knee arthroplasty
252432|NCT02624856|liposomal bupivacaine|liposomal bupivacaine
252433|NCT02624804|Diabetes|diabetes
252434|NCT02624791|astigmatism, contact lens, driving|astigmatism, contact lens, driving
252435|NCT02624765|RCT A: Fetal Atrial Flutter without Hydrops|rct a: fetal atrial flutter without hydrops
252436|NCT02624765|RCT B: Fetal Supraventricular Tachycardia without Hydrops|rct b: fetal supraventricular tachycardia without hydrops
252437|NCT02624765|RCT C: Fetal Supraventricular Tachycardia with Hydrops|rct c: fetal supraventricular tachycardia with hydrops
252438|NCT02624752|Oral Nutrition Supplementation|oral nutrition supplementation
252439|NCT02624726|1st line|1st line
252440|NCT02624726|FOLFIRI|folfiri
252441|NCT02624726|Aflibercept|aflibercept
252442|NCT02624726|mCRC|mcrc
252443|NCT02624713|eating disorder|eating disorder
252444|NCT02624713|childhood obesity|childhood obesity
252445|NCT02624713|family based treatment|family based treatment
252446|NCT02624700|ER-negative|er-negative
252447|NCT02624700|PgR-negative|pgr-negative
252448|NCT02624700|Human epidermal growth factor receptor 2 (HER2-negative)|human epidermal growth factor receptor 2 (her2-negative)
252449|NCT02624700|Triple Negative Breast Cancer|triple negative breast cancer
252450|NCT02624700|HER2-negative|her2-negative
252451|NCT02624661|Trigeminal ganglion|trigeminal ganglion
252452|NCT02624661|Glycerol|glycerol
252453|NCT02624661|Nerve block|nerve block
252454|NCT02624648|Sexual Dysfunction|sexual dysfunction
252455|NCT02624648|Postmenopausal women|postmenopausal women
252456|NCT02624648|Sexual desire|sexual desire
252457|NCT02624635|Manual Therapy|manual therapy
252458|NCT02624635|Pain|pain
252459|NCT02624635|Hip|hip
252460|NCT02624635|Muscle Strength|muscle strength
252461|NCT02624622|omphalitis|omphalitis
252462|NCT02624622|neonate|neonate
252463|NCT02624622|developing countries|developing countries
252464|NCT02624596|OCD|ocd
252465|NCT02624583|Fasting|fasting
252466|NCT02624583|Clopidogrel|clopidogrel
252467|NCT02624570|AML|aml
252468|NCT02624570|FLT3|flt3
252469|NCT02624570|ITD|itd
252470|NCT02624570|TKD|tkd
252471|NCT02624570|acute myeloid leukemia|acute myeloid leukemia
252472|NCT02624570|induction|induction
252473|NCT02624570|consolidation|consolidation
252474|NCT02624570|continuation|continuation
252475|NCT02624570|EAP|eap
252476|NCT02624570|ETP|etp
252477|NCT02624570|midostaurin|midostaurin
252478|NCT02624570|PKC412|pkc412
252479|NCT02624557|Hepatic impairment|hepatic impairment
252480|NCT02624557|Healthy volunteers|healthy volunteers
252481|NCT02624557|Clinical pharmacology study|clinical pharmacology study
252482|NCT02624557|BYL719|byl719
252483|NCT02624557|alpelisib|alpelisib
252484|NCT02624531|NACT|nact
252485|NCT02624531|Cervical cancer|cervical cancer
252486|NCT02624531|Fertility sparing|fertility sparing
252487|NCT02624531|Pregnancy|pregnancy
252488|NCT02624531|Treatment Strategy|treatment strategy
252489|NCT02624479|Pharmacokinetics|pharmacokinetics
252490|NCT02624466|Pediatrics|pediatrics
252491|NCT02624466|Nephrology|nephrology
252492|NCT02624466|Dialysis|dialysis
252493|NCT02624453|cryptococcus|cryptococcus
252494|NCT02624453|IMMY LFA|immy lfa
252495|NCT02624453|meningitis|meningitis
252496|NCT02624453|antigen|antigen
252497|NCT02624440|Multiple Myeloma|multiple myeloma
252498|NCT02624440|Infection|infection
252499|NCT02624440|Clarithromycin|clarithromycin
252500|NCT02624440|Trimethoprim-Sulfamethoxazole Combination|trimethoprim-sulfamethoxazole combination
252501|NCT02624427|Glaucoma|glaucoma
252502|NCT02624427|Intraocular Pressure|intraocular pressure
252503|NCT02624388|Genistein|genistein
252504|NCT02624388|Soy|soy
252505|NCT02624388|Chemotherapy side-effects|chemotherapy side-effects
252506|NCT02624388|Pediatric Cancer|pediatric cancer
252507|NCT02624388|Isoflavone|isoflavone
252508|NCT02624362|Odor|odor
252509|NCT02624362|trigger|trigger
252510|NCT02624362|inflammation|inflammation
252511|NCT02624362|nocebo|nocebo
252512|NCT02624336|periodontal disease|periodontal disease
252513|NCT02624336|caries|caries
252514|NCT02624323|ultrasonography|ultrasonography
252515|NCT02624323|catheterization|catheterization
252516|NCT02624323|central line|central line
252517|NCT02624323|mechanical ventilation|mechanical ventilation
252518|NCT02624323|intensive care|intensive care
252519|NCT02624323|axillary vein|axillary vein
252520|NCT02624323|jugular vein|jugular vein
252521|NCT02624323|randomization|randomization
252522|NCT02624297|Coronary artery disease|coronary artery disease
252523|NCT02624297|Chemoreceptors|chemoreceptors
252524|NCT02624297|Sympathetic nerve activity|sympathetic nerve activity
252525|NCT02624297|Exercise|exercise
252526|NCT02624271|gastric cancer|gastric cancer
252527|NCT02624271|gastric precancerous lesions|gastric precancerous lesions
252528|NCT02624271|blood test|blood test
252529|NCT02624232|Anorectal malformation|anorectal malformation
252530|NCT02624232|Anorectal atresia|anorectal atresia
252531|NCT02624232|anorectal stenosis|anorectal stenosis
252532|NCT02624232|Follow-Up Studies|follow-up studies
252533|NCT02624219|A/H5N8|a/h5n8
252534|NCT02624219|AS03|as03
252535|NCT02624219|Controlled|controlled
252536|NCT02624219|Double-Blind|double-blind
252537|NCT02624219|Immunogenicity|immunogenicity
252538|NCT02624219|Inactivated|inactivated
252539|NCT02624219|Influenza|influenza
252540|NCT02624219|MF59|mf59
252541|NCT02624219|Monovalent|monovalent
252542|NCT02624219|Randomized|randomized
252543|NCT02624219|Reactogenicity|reactogenicity
252544|NCT02624219|Safety|safety
252545|NCT02624219|Trial|trial
252546|NCT02624219|Vaccine|vaccine
252547|NCT02624193|Treatment Adherence|treatment adherence
252548|NCT02624193|Mental Health|mental health
252549|NCT02624193|Well-being|well-being
252550|NCT02624193|Emerging Adults|emerging adults
252551|NCT02624193|Youth|youth
252552|NCT02624128|head and neck cancer|head and neck cancer
252553|NCT02624128|valproic acid|valproic acid
252554|NCT02624128|recurrent|recurrent
252555|NCT02624128|metastatic|metastatic
252556|NCT02624102|Major depressive disorder|major depressive disorder
252557|NCT02624102|Cognitive behavioral therapy|cognitive behavioral therapy
252558|NCT02624102|Trial based cognitive therapy|trial based cognitive therapy
252559|NCT02624102|Behavioral activation|behavioral activation
252560|NCT02624076|unexplained infertility|unexplained infertility
252561|NCT02624076|Acupuncture|acupuncture
252562|NCT02624050|ACEI|acei
252563|NCT02624050|ARB|arb
252564|NCT02624050|Hypotension|hypotension
252565|NCT02624050|General Anesthesia|general anesthesia
252566|NCT02624050|Methohexital|methohexital
252567|NCT02624050|Propofol|propofol
252568|NCT02624037|Inflammatory Bowel Disease, Ulcerative Colitis|inflammatory bowel disease, ulcerative colitis
252569|NCT02624037|Crohn's Disease|crohn's disease
252570|NCT02624037|Pharmacokinetics, Individualized Dosage, Dashboard System|pharmacokinetics, individualized dosage, dashboard system
252571|NCT02624037|Remicade, Infliximab|remicade, infliximab
252572|NCT02623998|Diabetes|diabetes
252573|NCT02623998|Insulin|insulin
252574|NCT02623998|Glargine|glargine
252575|NCT02623998|Metformin|metformin
252576|NCT02623998|Sitagliptin|sitagliptin
252577|NCT02623998|Diet|diet
252578|NCT02623998|Excercise|excercise
252579|NCT02623998|Lifestyle|lifestyle
252580|NCT02623972|inflammatory breast cancer|inflammatory breast cancer
252581|NCT02623972|Human Epidermal Growth Factor 2 Negative Carcinoma of Breast|human epidermal growth factor 2 negative carcinoma of breast
252582|NCT02623959|Advanced Cancers|advanced cancers
252583|NCT02623959|Malignant pleural effusions|malignant pleural effusions
252584|NCT02623959|MPE|mpe
252585|NCT02623959|Indwelling pleural catheter|indwelling pleural catheter
252586|NCT02623959|IPC|ipc
252587|NCT02623959|Questionnaires|questionnaires
252588|NCT02623959|Surveys|surveys
252589|NCT02623959|Fentanyl patch|fentanyl patch
252590|NCT02623959|Fentanyl by vein|fentanyl by vein
252591|NCT02623959|Sublimaze|sublimaze
252592|NCT02623959|Doxycycline|doxycycline
252593|NCT02623959|Vibramycin|vibramycin
252594|NCT02623959|Periostat|periostat
252595|NCT02623959|Doryx|doryx
252596|NCT02623959|:Phone calls|:phone calls
252597|NCT02623946|motor evoked potentials|motor evoked potentials
252598|NCT02623933|HDR monotherapy|hdr monotherapy
252599|NCT02623933|MRI guidance|mri guidance
252600|NCT02623933|Intraprostatic lesion|intraprostatic lesion
252601|NCT02623933|dose paining|dose paining
252602|NCT02623894|Vascular aging.|vascular aging.
252603|NCT02623894|Arterial stiffness.|arterial stiffness.
252604|NCT02623894|Lifestyles.|lifestyles.
252605|NCT02623894|Vascular structure.|vascular structure.
252606|NCT02623894|Telomere length,|telomere length,
252607|NCT02623894|Psychological factors.|psychological factors.
252608|NCT02623894|Inflammatory factors.|inflammatory factors.
252609|NCT02623894|Oxidative stress|oxidative stress
252610|NCT02623881|Cervical pessary|cervical pessary
252611|NCT02623881|Vaginal progesterone|vaginal progesterone
252612|NCT02623881|Twins|twins
252613|NCT02623881|Premature birth|premature birth
252614|NCT02623855|Parks|parks
252615|NCT02623855|Well-being|well-being
252616|NCT02623855|Stress|stress
252617|NCT02623855|Physical Activity|physical activity
252619|NCT02623855|Greenspace|greenspace
252620|NCT02623842|urinary incontinence|urinary incontinence
252621|NCT02623842|woman|woman
252622|NCT02623842|radiofrequency|radiofrequency
252623|NCT02623829|scar prophylaxis|scar prophylaxis
252624|NCT02623829|Botulinum Toxin|botulinum toxin
252625|NCT02623764|Alzheimer´s disease|alzheimer´s disease
252626|NCT02623764|Lewy body dementia|lewy body dementia
252627|NCT02623764|Parkinson dementia|parkinson dementia
252628|NCT02623764|EEG|eeg
252629|NCT02623764|Cholinergic index|cholinergic index
252630|NCT02623725|Dengue Fever|dengue fever
252631|NCT02623725|Dengue virus|dengue virus
252632|NCT02623725|Dengue Hemorrhagic Fever|dengue hemorrhagic fever
252633|NCT02623725|CYD Dengue Vaccine|cyd dengue vaccine
252634|NCT02623699|IONIS-SOD1Rx|ionis-sod1rx
252635|NCT02623699|SOD1|sod1
252636|NCT02623699|ALS|als
252637|NCT02623686|Sleep|sleep
252638|NCT02623686|ICU|icu
252639|NCT02623686|Massage Therapy|massage therapy
252640|NCT02623686|Inhalation Patch|inhalation patch
252641|NCT02623660|Inflammation|inflammation
252642|NCT02623660|Edema|edema
252643|NCT02623660|Arthroplasty|arthroplasty
252644|NCT02623660|Rehabilitation|rehabilitation
252645|NCT02623660|Replacement|replacement
252646|NCT02623660|Knee|knee
252647|NCT02623660|Total Knee Replacement|total knee replacement
252648|NCT02623660|Pain, Postoperative|pain, postoperative
252649|NCT02623660|Exercise Therapy|exercise therapy
252650|NCT02623660|Therapeutics|therapeutics
252651|NCT02623660|Early Ambulation|early ambulation
252652|NCT02623660|Myofunctional Therapy|myofunctional therapy
252653|NCT02623660|Electric Stimulation Therapy|electric stimulation therapy
252654|NCT02623660|Orthopedic Procedures|orthopedic procedures
252655|NCT02623660|Wound Healing|wound healing
252656|NCT02623660|Total Knee Arthroplasty|total knee arthroplasty
252657|NCT02623634|Cuff leak test, relative factors|cuff leak test, relative factors
252658|NCT02623608|type 2 diabetes risk|type 2 diabetes risk
252659|NCT02623608|cardiovascular disease risk|cardiovascular disease risk
252660|NCT02623595|non-small cell lung cancer|non-small cell lung cancer
252661|NCT02623595|Granulocyte-Macrophage Colony-Stimulating Factor|granulocyte-macrophage colony-stimulating factor
252662|NCT02623595|Stereotactic body radiotherapy|stereotactic body radiotherapy
252663|NCT02623595|abscopal effect|abscopal effect
252664|NCT02623595|safety|safety
252665|NCT02623595|immunotherapy|immunotherapy
252666|NCT02623556|diagnosis of tuberculosis|diagnosis of tuberculosis
252667|NCT02623556|ESAT6-CFP10|esat6-cfp10
252668|NCT02623556|skin test|skin test
252669|NCT02623556|diagnostic test|diagnostic test
252670|NCT02623530|Nursing|nursing
252671|NCT02623530|Nursing education research|nursing education research
252672|NCT02623530|Critical thinking|critical thinking
252673|NCT02623530|Decision Making|decision making
252674|NCT02623517|CIED|cied
252675|NCT02623517|AF|af
252676|NCT02623517|arrhythmia|arrhythmia
252677|NCT02623517|atrial fibrillation|atrial fibrillation
252678|NCT02623517|cardiac device|cardiac device
252679|NCT02623517|pacemaker|pacemaker
252680|NCT02623517|defibrillator|defibrillator
252681|NCT02623504|Carbamazepine|carbamazepine
252682|NCT02623504|Equetro|equetro
252683|NCT02623504|Bipolar I Disorder|bipolar i disorder
252684|NCT02623504|Bipolar I Disorder in Children|bipolar i disorder in children
252685|NCT02623491|JNJ-55375515|jnj-55375515
252686|NCT02623491|Healthy|healthy
252687|NCT02623491|Placebo|placebo
252688|NCT02623439|hematologic malignancies|hematologic malignancies
252689|NCT02623426|uveitic macular edema|uveitic macular edema
252690|NCT02623426|uveitis|uveitis
252691|NCT02623400|preterm birth|preterm birth
252692|NCT02623400|perinatal stress|perinatal stress
252693|NCT02623400|growth and development|growth and development
252694|NCT02623387|paravertebral block|paravertebral block
252695|NCT02623348|dialysis|dialysis
252696|NCT02623348|end-stage renal disease|end-stage renal disease
252697|NCT02623335|patient decision making|patient decision making
252698|NCT02623335|surgical decision making|surgical decision making
252699|NCT02623335|question prompt list|question prompt list
323055|NCT02222272|cml|cml
252700|NCT02623335|shared decision making|shared decision making
252701|NCT02623335|decision support techniques|decision support techniques
252702|NCT02623257|Non-small Cell Lung Cancer|non-small cell lung cancer
252703|NCT02623257|circulating tumor DNA|circulating tumor dna
252704|NCT02623257|amplification refractory mutation system|amplification refractory mutation system
252705|NCT02623244|ovarian endometrioma|ovarian endometrioma
252706|NCT02623244|lower urinary tract symptoms|lower urinary tract symptoms
252707|NCT02623244|sexual dysfunction|sexual dysfunction
252708|NCT02623244|gastrointestinal symptoms|gastrointestinal symptoms
252709|NCT02623218|traumatic brain injury|traumatic brain injury
252710|NCT02623218|acupuncture|acupuncture
252711|NCT02623218|transcranial doppler ultrasound|transcranial doppler ultrasound
252712|NCT02623166|Pneumonia|pneumonia
252713|NCT02623166|Fever|fever
252714|NCT02623166|Diarrhoea|diarrhoea
252715|NCT02623140|Coronary drug eluting stents|coronary drug eluting stents
252716|NCT02623140|Outcomes|outcomes
252717|NCT02623127|Thymic carcinoma|thymic carcinoma
252718|NCT02623127|Sunitinib|sunitinib
252719|NCT02623127|Metastatic|metastatic
252720|NCT02623127|Recurrent|recurrent
252721|NCT02623101|Reflectance confocal microscopy|reflectance confocal microscopy
252722|NCT02623101|Basal cell carcinoma|basal cell carcinoma
252723|NCT02623101|Biopsy|biopsy
252724|NCT02623101|Diagnostics|diagnostics
252725|NCT02623088|Obstructive Sleep Apnea|obstructive sleep apnea
252726|NCT02623088|Endothelial dysfunction|endothelial dysfunction
252727|NCT02623088|Arterial stiffness|arterial stiffness
252728|NCT02623088|PAP therapies|pap therapies
252729|NCT02623049|New oral anticoagulants|new oral anticoagulants
252730|NCT02623049|Blood levels|blood levels
252731|NCT02623049|Octogenarians|octogenarians
252732|NCT02623036|chronotherapy|chronotherapy
252733|NCT02623036|angiotensin converting enzyme inhibitors|angiotensin converting enzyme inhibitors
252734|NCT02623036|ambulatory blood pressure monitoring|ambulatory blood pressure monitoring
252735|NCT02623010|Primary CNS lymphoma|primary cns lymphoma
252736|NCT02623010|Ibrutinib|ibrutinib
252737|NCT02623010|Elderly|elderly
252738|NCT02623010|Maintenance|maintenance
252739|NCT02622997|HPV self-sampling|hpv self-sampling
252740|NCT02622971|phototherapy|phototherapy
252741|NCT02622971|cryotherapy|cryotherapy
252742|NCT02622971|exercise|exercise
252743|NCT02622971|fatigue|fatigue
252744|NCT02622971|recovery|recovery
252745|NCT02622958|Social Anxiety Disorder|social anxiety disorder
252746|NCT02622958|Social Phobia|social phobia
252747|NCT02622958|Performance Anxiety|performance anxiety
252748|NCT02622958|Social Anxiety|social anxiety
252749|NCT02622958|Anxiety|anxiety
252750|NCT02622906|Gastrointestinal angiodysplasia|gastrointestinal angiodysplasia
252751|NCT02622906|Pasireotide|pasireotide
252752|NCT02622906|Gastrointestinal bleeding|gastrointestinal bleeding
252753|NCT02622867|Lactobacillus plantarum|lactobacillus plantarum
252754|NCT02622867|Maltodextrin|maltodextrin
252755|NCT02622867|Probiotics|probiotics
252756|NCT02622867|Randomized Controlled Trial|randomized controlled trial
252757|NCT02622854|plasma exchange|plasma exchange
252758|NCT02622854|hypertriglyceridemia|hypertriglyceridemia
252759|NCT02622841|First in man|first in man
252760|NCT02622841|Spinal metastases|spinal metastases
252761|NCT02622841|Stereotactic bodyradiotherapy|stereotactic bodyradiotherapy
252762|NCT02622841|Palliative care|palliative care
252763|NCT02622841|Safety|safety
252764|NCT02622841|Surgical stabilisation|surgical stabilisation
252765|NCT02622828|wheelchairs|wheelchairs
252766|NCT02622828|social participation|social participation
252767|NCT02622815|Hypercoagulation|hypercoagulation
252768|NCT02622815|Thrombosis|thrombosis
252769|NCT02622815|Cancer Risk Assessment|cancer risk assessment
252770|NCT02622815|Cancer Prognosis|cancer prognosis
252771|NCT02622802|ex-vivo placenta perfusion|ex-vivo placenta perfusion
252772|NCT02622802|transplacental transfer|transplacental transfer
252773|NCT02622802|paracetamol|paracetamol
252774|NCT02622802|erythromycin|erythromycin
252775|NCT02622802|azithromycin|azithromycin
252776|NCT02622789|Spinal alignment|spinal alignment
252777|NCT02622789|Kinematics|kinematics
252778|NCT02622789|Pilates|pilates
252779|NCT02622789|Physical Therapy|physical therapy
252780|NCT02622763|Tolerogenic Dendritic Cells|tolerogenic dendritic cells
252781|NCT02622750|triple-branched stent graft|triple-branched stent graft
252782|NCT02622750|total arch replace|total arch replace
252783|NCT02622750|the occluded rate of false lumen|the occluded rate of false lumen
252784|NCT02622737|Parkinson disease|parkinson disease
252785|NCT02622737|Accidental Falls|accidental falls
252786|NCT02622737|Exercise therapy|exercise therapy
252787|NCT02622737|Virtual Reality Exposure Therapy|virtual reality exposure therapy
252788|NCT02622724|ARDS, human|ards, human
252789|NCT02622724|Acute Respiratory Distress Syndrome|acute respiratory distress syndrome
252790|NCT02622724|Respiratory Insufficiency|respiratory insufficiency
252791|NCT02622711|breast cancer|breast cancer
252792|NCT02622711|obesity|obesity
252793|NCT02622711|weight control|weight control
323193|NCT02221596|MRS|mrs
252794|NCT02622711|exercise and physical fitness|exercise and physical fitness
252795|NCT02622672|Antioxidation|antioxidation
252796|NCT02622672|Anti-inflammation|anti-inflammation
252797|NCT02622672|Blood glucose|blood glucose
252798|NCT02622672|Blood lipids|blood lipids
252799|NCT02622659|acute upper respiratory infection|acute upper respiratory infection
252800|NCT02622620|dynamic contrast-enhanced MR imaging|dynamic contrast-enhanced mr imaging
252801|NCT02622620|three-dimensional arterial spin labeling|three-dimensional arterial spin labeling
252802|NCT02622620|diffusion-weighted imaging|diffusion-weighted imaging
252804|NCT02622607|Prevention|prevention
252805|NCT02622607|lung cancer|lung cancer
252806|NCT02622529|Awake craniotomy|awake craniotomy
252807|NCT02622529|Psychological consequences|psychological consequences
252808|NCT02622529|Fear and Anxiety|fear and anxiety
252809|NCT02622516|Rehabilitation|rehabilitation
252810|NCT02622516|Physical Therapy Specialty|physical therapy specialty
252811|NCT02622516|Postural Balance|postural balance
252812|NCT02622516|Vertigo|vertigo
252813|NCT02622516|Dizziness|dizziness
252814|NCT02622438|FSHD|fshd
252815|NCT02622438|Usual care performed at Montpellier hospital|usual care performed at montpellier hospital
252816|NCT02622438|Muscle function|muscle function
252817|NCT02622438|Antioxidants|antioxidants
252818|NCT02622438|Oxidative stress|oxidative stress
252819|NCT02622438|Quality of life|quality of life
252820|NCT02622438|Physical activities, development of food-based dietary guidelines|physical activities, development of food-based dietary guidelines
252821|NCT02622438|Co-morbidity|co-morbidity
252822|NCT02622425|Carotenoid|carotenoid
252823|NCT02622425|Bacillus|bacillus
252824|NCT02622425|Microbiota|microbiota
252825|NCT02622425|Cardiovascular health|cardiovascular health
252826|NCT02622412|Quality of Life|quality of life
252827|NCT02622412|Palliative Therapy|palliative therapy
252828|NCT02622412|Outpatient Services|outpatient services
252829|NCT02622386|Psoriasis|psoriasis
252830|NCT02622373|Pea Pod|pea pod
252831|NCT02622373|Body composition|body composition
252832|NCT02622308|Arterial leg ulcers|arterial leg ulcers
252833|NCT02622308|Intermittent Negative Pressure|intermittent negative pressure
252834|NCT02622308|Peripheral Circulation|peripheral circulation
252835|NCT02622308|Wound healing|wound healing
252836|NCT02622308|Peripheral blood flow|peripheral blood flow
252837|NCT02622295|metabolism|metabolism
252838|NCT02622295|glucose|glucose
252839|NCT02622295|osteoporosis|osteoporosis
252840|NCT02622295|secondary health conditions|secondary health conditions
252841|NCT02622295|quality of life|quality of life
252842|NCT02622295|standing|standing
252843|NCT02622295|electrical stimulation|electrical stimulation
252844|NCT02622295|diabetes|diabetes
252845|NCT02622295|insulin|insulin
252846|NCT02622295|skeletal muscle|skeletal muscle
252847|NCT02622282|physical activity|physical activity
252848|NCT02622282|physical inactivity|physical inactivity
252849|NCT02622282|PAD|pad
252850|NCT02622282|Diabetes|diabetes
252851|NCT02622282|High blood pressure|high blood pressure
252852|NCT02622282|High cholesterol|high cholesterol
252853|NCT02622282|Smoking|smoking
252854|NCT02622269|Urography|urography
252855|NCT02622269|Radiation dosage|radiation dosage
252856|NCT02622269|image enhancement|image enhancement
252857|NCT02622256|Social Media|social media
252858|NCT02622256|Twitter|twitter
252859|NCT02622256|Hypertension|hypertension
252860|NCT02622256|Cardiovascular|cardiovascular
252861|NCT02622256|CVD|cvd
252862|NCT02622256|HTN|htn
252863|NCT02622230|Uygur Medicine|uygur medicine
252864|NCT02622217|anesthesiology|anesthesiology
252865|NCT02622217|non technical kills|non technical kills
252866|NCT02622191|Glaucoma|glaucoma
252867|NCT02622191|Optical Coherence Tomography|optical coherence tomography
252868|NCT02622191|Primary Open Angle Glaucoma|primary open angle glaucoma
252869|NCT02622191|Visual Field|visual field
252870|NCT02622165|health promotion|health promotion
252871|NCT02622165|nutrition|nutrition
252872|NCT02622165|intervention|intervention
252873|NCT02622165|adolescents|adolescents
252874|NCT02622165|serious game|serious game
252875|NCT02622152|Right lateral|right lateral
252876|NCT02622152|Oxygenation|oxygenation
252877|NCT02622152|Cardiac|cardiac
252878|NCT02622152|Congenital|congenital
252879|NCT02622152|Pediatric|pediatric
252880|NCT02622152|Postoperative|postoperative
252881|NCT02622139|Photoacoustics|photoacoustics
252882|NCT02622139|Optoacoustics|optoacoustics
252883|NCT02622139|Ultrasound|ultrasound
252884|NCT02622126|Preloading|preloading
252885|NCT02622126|Colloid|colloid
252886|NCT02622126|Cesarean section|cesarean section
252887|NCT02622126|D-dimer|d-dimer
252888|NCT02622126|Hypotension|hypotension
252889|NCT02622113|insulin resistance|insulin resistance
252890|NCT02622100|Bioresorbable Vascular Scaffold|bioresorbable vascular scaffold
252891|NCT02622100|Routine Clinical Practice|routine clinical practice
252892|NCT02622100|Angioplasty, Transluminal, Percutaneous Coronary|angioplasty, transluminal, percutaneous coronary
252893|NCT02622100|Coronary Artery Disease|coronary artery disease
252894|NCT02622100|drug eluting stent|drug eluting stent
252896|NCT02622074|PD-1|pd-1
252897|NCT02622074|PDL1|pdl1
252898|NCT02622074|PD-L1|pd-l1
252899|NCT02622074|Triple Negative Breast Cancer|triple negative breast cancer
252900|NCT02622048|Mental Health|mental health
252901|NCT02622048|Psychosis|psychosis
252902|NCT02622048|Parent|parent
252903|NCT02622035|Child Feeding|child feeding
252904|NCT02622022|randomised|randomised
252905|NCT02622022|placebo controlled|placebo controlled
252906|NCT02622022|clinical trial|clinical trial
252907|NCT02622009|stable COPD; bronchoalveolar lavage; biopsy; HRV; RSV|stable copd; bronchoalveolar lavage; biopsy; hrv; rsv
252908|NCT02621996|Surface Electromyography|surface electromyography
252909|NCT02621996|Hypotonia|hypotonia
252910|NCT02621996|Patient Positioning|patient positioning
252911|NCT02621983|Schizophrenia|schizophrenia
252912|NCT02621983|Exercise|exercise
252913|NCT02621983|Cognition|cognition
252914|NCT02621905|Prophylaxis|prophylaxis
252915|NCT02621905|Steady-State|steady-state
252916|NCT02621905|Bioavailability|bioavailability
252917|NCT02621866|hypertension|hypertension
252918|NCT02621866|ultraviolet|ultraviolet
252919|NCT02621853|Steatosis|steatosis
252920|NCT02621827|vitamin D|vitamin d
252921|NCT02621827|Africa|africa
252922|NCT02621814|Infant|infant
252923|NCT02621814|Growth|growth
252924|NCT02621814|Body Weight Changes|body weight changes
252925|NCT02621814|Infant Formula|infant formula
252926|NCT02621814|Randomized Controlled Trial|randomized controlled trial
252927|NCT02621788|mind/body medicine|mind/body medicine
252928|NCT02621788|3RP|3rp
252929|NCT02621788|stress management|stress management
252930|NCT02621788|resident burnout|resident burnout
252931|NCT02621775|Stress management|stress management
252932|NCT02621775|Cognitive behavioural therapy (CBT)|cognitive behavioural therapy (cbt)
252933|NCT02621775|Self-help|self-help
252934|NCT02621775|e-health|e-health
252935|NCT02621775|Adjustment disorder with anxiety|adjustment disorder with anxiety
252936|NCT02621736|children|children
252937|NCT02621736|desmopressin|desmopressin
252938|NCT02621736|copeptin|copeptin
252939|NCT02621723|Preventability|preventability
252940|NCT02621697|dual task|dual task
252941|NCT02621697|aging|aging
252942|NCT02621671|Healthy Volunteers|healthy volunteers
252943|NCT02621658|Colorectal Cancer|colorectal cancer
252944|NCT02621658|Colonoscopy|colonoscopy
252945|NCT02621658|Adenoma Detection Rate|adenoma detection rate
252946|NCT02621658|Bowel Preparation|bowel preparation
252947|NCT02621658|Time to Cecal Intubation|time to cecal intubation
252948|NCT02621645|monochorionic|monochorionic
252949|NCT02621645|TRAP|trap
252950|NCT02621645|acardiac twin|acardiac twin
252951|NCT02621632|Compression therapy|compression therapy
252952|NCT02621619|Older adults|older adults
252953|NCT02621619|Elderly|elderly
252954|NCT02621619|Acute pain|acute pain
252955|NCT02621619|IV acetaminophen|iv acetaminophen
252956|NCT02621619|IV hydromorphone|iv hydromorphone
252957|NCT02621619|Analgesia|analgesia
252958|NCT02621619|Adjunctive analgesia|adjunctive analgesia
252959|NCT02621593|Meibomian Gland Dysfunction|meibomian gland dysfunction
252960|NCT02621593|Dry eye symptoms|dry eye symptoms
252961|NCT02621593|Intense Pulsed Light|intense pulsed light
252962|NCT02621580|Panretinal Photocoagulation|panretinal photocoagulation
252963|NCT02621554|Memory|memory
252964|NCT02621554|Resveratrol|resveratrol
252965|NCT02621554|elderly|elderly
252966|NCT02621554|cognition|cognition
252967|NCT02621541|neuroendocrine tumor|neuroendocrine tumor
252968|NCT02621541|pancreas|pancreas
252969|NCT02621541|diagnosis|diagnosis
252970|NCT02621541|positron emission tomography|positron emission tomography
252971|NCT02621528|CeraFlex occluder|ceraflex occluder
252972|NCT02621515|Nivolumab|nivolumab
252973|NCT02621515|Brain metastasis|brain metastasis
252974|NCT02621515|Melanoma|melanoma
252975|NCT02621502|Quinoa|quinoa
252976|NCT02621502|Satiety|satiety
252977|NCT02621502|Visual analogue scale|visual analogue scale
252978|NCT02621502|Cross-over studies|cross-over studies
252979|NCT02621489|Glucagon-like peptide-1|glucagon-like peptide-1
252980|NCT02621489|Endothelialization|endothelialization
252981|NCT02621489|Cardiac Function|cardiac function
252982|NCT02621489|Exenatide|exenatide
252983|NCT02621489|Optical Coherence Tomography|optical coherence tomography
252984|NCT02621450|chronic renal failure|chronic renal failure
252985|NCT02621450|hypertension|hypertension
252986|NCT02621450|ampulatory blood pressure|ampulatory blood pressure
252987|NCT02621437|pain|pain
252988|NCT02621437|quality of life|quality of life
252989|NCT02621437|osteopathy|osteopathy
252990|NCT02621437|oncology|oncology
252991|NCT02621437|surgery|surgery
252992|NCT02621437|breast|breast
252993|NCT02621424|dementia|dementia
252994|NCT02621424|Mild Cognitive Impairment (MCI)|mild cognitive impairment (mci)
252995|NCT02621424|RTMS|rtms
252996|NCT02621424|CVLT|cvlt
252997|NCT02621411|Substance abuse|substance abuse
252998|NCT02621411|Emergency operation|emergency operation
252999|NCT02621411|Preoperative screen|preoperative screen
253000|NCT02621320|Vitamin D|vitamin d
253001|NCT02621320|Exercise Performance|exercise performance
253002|NCT02621320|Wheelchair Athletes|wheelchair athletes
253003|NCT02621320|Indoor sports|indoor sports
253004|NCT02621320|Wingate|wingate
253005|NCT02621320|Isokinetic Dynamometer|isokinetic dynamometer
253006|NCT02621307|postprandial glycemia|postprandial glycemia
253007|NCT02621307|subjective appetite|subjective appetite
253008|NCT02621307|Salba|salba
253009|NCT02621307|Flax|flax
253010|NCT02621294|Protein|protein
253011|NCT02621294|indicator amino acid oxidation method|indicator amino acid oxidation method
253012|NCT02621294|athletes|athletes
253013|NCT02621281|hypothermic machine perfusion|hypothermic machine perfusion
253014|NCT02621281|Kidney Transplantation|kidney transplantation
253015|NCT02621281|Delayed graft function|delayed graft function
253016|NCT02621281|perfusion pressure|perfusion pressure
253017|NCT02621216|percutaneous coronary intervention|percutaneous coronary intervention
253018|NCT02621190|circulating tumor cells|circulating tumor cells
253019|NCT02621190|predictive factor|predictive factor
253020|NCT02621151|combination therapy|combination therapy
253021|NCT02621151|immunotherapy|immunotherapy
253022|NCT02621151|immune checkpoint inhibition|immune checkpoint inhibition
253023|NCT02621099|handheld gamma camera|handheld gamma camera
253024|NCT02621086|Oligosaccharide, Tolerability,|oligosaccharide, tolerability,
253025|NCT02621073|lower extremity|lower extremity
253026|NCT02621073|status-post ORIF|status-post orif
253027|NCT02621060|Chlorogenic acid|chlorogenic acid
253028|NCT02621060|Control glucose|control glucose
253029|NCT02621060|Insulin Secretion|insulin secretion
253030|NCT02621060|Insulin Sensitivity|insulin sensitivity
253031|NCT02621047|Healthy volunteer|healthy volunteer
253032|NCT02621047|Alectinib|alectinib
253033|NCT02621047|Hepatic impairment|hepatic impairment
253034|NCT02621034|Root canal treatment|root canal treatment
253035|NCT02621034|pain|pain
253036|NCT02621034|endodontic instruments|endodontic instruments
253037|NCT02621021|Melanoma|melanoma
253038|NCT02621021|Skin Cancer|skin cancer
253039|NCT02621021|Immunotherapy|immunotherapy
253040|NCT02621021|Cell Therapy|cell therapy
253041|NCT02621008|diabetes|diabetes
253042|NCT02621008|hypertension|hypertension
253043|NCT02621008|obesity|obesity
253044|NCT02621008|mobile phone|mobile phone
253045|NCT02621008|stress|stress
253046|NCT02621008|healthy living|healthy living
253047|NCT02621008|pre-diabetes|pre-diabetes
253048|NCT02620995|hypertension|hypertension
253049|NCT02620995|endothelial dysfunction|endothelial dysfunction
253050|NCT02620995|erectile dysfunction|erectile dysfunction
253051|NCT02620995|sildenafil|sildenafil
253052|NCT02620982|Shockwave|shockwave
253053|NCT02620982|vascular ED|vascular ed
253054|NCT02620982|Organic ED|organic ed
253055|NCT02620969|Paediatrics|paediatrics
253056|NCT02620969|Haemodialysis|haemodialysis
253057|NCT02620969|Kinetics|kinetics
253058|NCT02620943|Anemia|anemia
253059|NCT02620943|Pregnancy Outcome|pregnancy outcome
253060|NCT02620943|Pregnancy|pregnancy
253061|NCT02620943|Dietary Diversity|dietary diversity
253062|NCT02620943|Birth Weight|birth weight
253063|NCT02620930|Sleep Disorders|sleep disorders
253064|NCT02620930|Sleep Apnea|sleep apnea
253065|NCT02620930|Apnea-Hypopnea Index (AHI)|apnea-hypopnea index (ahi)
253066|NCT02620930|Respiratory Disturbance Index (RDI)|respiratory disturbance index (rdi)
253067|NCT02620917|type 1 diabetes|type 1 diabetes
253068|NCT02620917|CSII|csii
253069|NCT02620904|mifepristone|mifepristone
253070|NCT02620904|randomized controlled trial|randomized controlled trial
253071|NCT02620904|vaginal delivery|vaginal delivery
253072|NCT02620904|progesterone receptor modulator|progesterone receptor modulator
253073|NCT02620904|induction of labor|induction of labor
253074|NCT02620891|helium oxygen mixture|helium oxygen mixture
253075|NCT02620891|Meconium aspiration syndrome|meconium aspiration syndrome
253076|NCT02620878|Artificial pancreas|artificial pancreas
253077|NCT02620878|SAP therapy|sap therapy
253078|NCT02620878|children|children
253079|NCT02620878|adolescents|adolescents
253080|NCT02620878|type 1 diabetes|type 1 diabetes
253081|NCT02620852|Breast screening|breast screening
253082|NCT02620852|mammography|mammography
253083|NCT02620852|prevention|prevention
253084|NCT02620852|risk assessment|risk assessment
253085|NCT02620852|DCIS|dcis
253086|NCT02620852|Breast cancer|breast cancer
253087|NCT02620852|Wisdom|wisdom
253088|NCT02620839|CDKN2A-p16 Positive|cdkn2a-p16 positive
253089|NCT02620839|Locally Advanced Solid Neoplasm|locally advanced solid neoplasm
253090|NCT02620839|Metastatic Malignant Solid Neoplasm|metastatic malignant solid neoplasm
253091|NCT02620813|acne|acne
253092|NCT02620813|sebaceous gland|sebaceous gland
253093|NCT02620813|lipid|lipid
253094|NCT02620813|sebum|sebum
253095|NCT02620800|Metastatic Pancreatic Cancer|metastatic pancreatic cancer
253096|NCT02620800|Adenocarcinoma|adenocarcinoma
323498|NCT02220309|PTSD|ptsd
253097|NCT02620800|Open-label|open-label
253098|NCT02620800|Phase 1/2|phase 1/2
253099|NCT02620800|Metronomic|metronomic
253100|NCT02620800|Chemotherapy|chemotherapy
253101|NCT02620800|ABI-007|abi-007
253102|NCT02620800|nab-paclitaxel|nab-paclitaxel
253103|NCT02620800|Abraxane|abraxane
253104|NCT02620800|gemcitabine|gemcitabine
253105|NCT02620800|Gemzar|gemzar
253106|NCT02620800|bevacizumab|bevacizumab
253107|NCT02620800|Avastin|avastin
253108|NCT02620800|5-Fluorouracil (5-FU)|5-fluorouracil (5-fu)
253109|NCT02620800|leucovorin|leucovorin
253110|NCT02620800|oxaliplatin|oxaliplatin
253111|NCT02620800|Eloxatin|eloxatin
253112|NCT02620735|Exercise, health coaching, RCT, telehealth,|exercise, health coaching, rct, telehealth,
253113|NCT02620722|tourniquet|tourniquet
253114|NCT02620722|safety|safety
253115|NCT02620722|personalized|personalized
253116|NCT02620722|surgery|surgery
253117|NCT02620709|Native Hawaiians|native hawaiians
253118|NCT02620709|Community-based participatory research|community-based participatory research
253119|NCT02620709|Health disparities|health disparities
253120|NCT02620709|Minority populations|minority populations
253121|NCT02620709|Chronic disease|chronic disease
253122|NCT02620683|lidocaine, jaw|lidocaine, jaw
253123|NCT02620670|Physical Activity|physical activity
253124|NCT02620670|Glycemic Variability|glycemic variability
253125|NCT02620644|no retinopathy|no retinopathy
253126|NCT02620631|Morphine|morphine
253127|NCT02620631|TKA|tka
253128|NCT02620631|Pain|pain
253129|NCT02620631|TKR|tkr
253130|NCT02620631|Arthroplasty|arthroplasty
253131|NCT02620618|Safety|safety
253132|NCT02620618|Efficacy|efficacy
253133|NCT02620618|intravitreal infliximab|intravitreal infliximab
253134|NCT02620618|ocular behcets|ocular behcets
253135|NCT02620618|refractory posterior uveitis|refractory posterior uveitis
253136|NCT02620605|Cabergoline|cabergoline
253137|NCT02620605|Ovarian Hyper Stimulation Syndrome (OHSS)|ovarian hyper stimulation syndrome (ohss)
253138|NCT02620592|Healthy Subject|healthy subject
253139|NCT02620592|ZYDPLA1|zydpla1
253140|NCT02620592|DPPIV inhibitor|dppiv inhibitor
253141|NCT02620592|Pharmacokinetics|pharmacokinetics
253142|NCT02620592|Safety|safety
253143|NCT02620579|Personalized Pharmaceutical|personalized pharmaceutical
253144|NCT02620579|Personalized Education|personalized education
253145|NCT02620566|caudal block|caudal block
253146|NCT02620566|local wound infiltration|local wound infiltration
253147|NCT02620566|hernia repair|hernia repair
253148|NCT02620553|Type 1 Diabetes|type 1 diabetes
253149|NCT02620553|Diabetes|diabetes
253150|NCT02620553|Autoimmune Diabetes|autoimmune diabetes
253151|NCT02620540|Broselow Tape|broselow tape
253152|NCT02620540|Weight estimation|weight estimation
253153|NCT02620540|Patient safety|patient safety
253154|NCT02620527|Circulating Tumor DNA|circulating tumor dna
253155|NCT02620527|Cancer|cancer
253156|NCT02620527|Neoplasms|neoplasms
253157|NCT02620527|Genomic Testing|genomic testing
253158|NCT02620527|FoundationOne|foundationone
253159|NCT02620527|Cell Free DNA|cell free dna
253160|NCT02620527|ctDNA|ctdna
253161|NCT02620527|cfDNA|cfdna
253162|NCT02620514|Digestive Disease and Disorders|digestive disease and disorders
253163|NCT02620514|Inflammation|inflammation
253164|NCT02620501|EGD|egd
253165|NCT02620501|topical lidocaine|topical lidocaine
253166|NCT02620501|recovery time|recovery time
253167|NCT02620501|intravenous sedation|intravenous sedation
253168|NCT02620488|Pain Perception|pain perception
253169|NCT02620488|Autonomic Nervous System|autonomic nervous system
253170|NCT02620488|Sickle Cell Disease|sickle cell disease
253171|NCT02620488|Hypnosis|hypnosis
253172|NCT02620488|Guided Imagery|guided imagery
253173|NCT02620462|Postural Balance|postural balance
253174|NCT02620462|Pain|pain
253175|NCT02620462|Gait|gait
253176|NCT02620462|Physical Activity Level|physical activity level
253177|NCT02620449|phosphorus|phosphorus
253178|NCT02620449|fibroblast growth factor 23|fibroblast growth factor 23
253179|NCT02620449|diet|diet
253180|NCT02620436|Maternal & Child Health|maternal & child health
253181|NCT02620436|Mother Shelters|mother shelters
253182|NCT02620436|Maternity Waiting Homes|maternity waiting homes
253183|NCT02620423|Pancreatic|pancreatic
253184|NCT02620423|Cancer|cancer
253185|NCT02620423|REOLYSIN®|reolysin®
253186|NCT02620423|Chemotherapy|chemotherapy
253187|NCT02620423|Pembrolizumab|pembrolizumab
253188|NCT02620423|KEYTRUDA®|keytruda®
253189|NCT02620423|Pelareorep|pelareorep
253190|NCT02620423|Reovirus|reovirus
253191|NCT02620423|Oncolytic virus|oncolytic virus
253192|NCT02620410|OAB|oab
253193|NCT02620384|Metolazone|metolazone
253194|NCT02620384|Heart Failure|heart failure
253195|NCT02620358|Mechanical Ventilation|mechanical ventilation
253196|NCT02620358|Weaning|weaning
253197|NCT02620345|Fibroids|fibroids
253198|NCT02620319|bronchoscopy|bronchoscopy
253199|NCT02620319|polydioxanone|polydioxanone
253200|NCT02620319|absorbable implants|absorbable implants
253201|NCT02620319|stents|stents
253202|NCT02620280|Triple Negative Breast Cancer|triple negative breast cancer
253203|NCT02620267|Mismatch Negativity|mismatch negativity
253204|NCT02620267|Transcranial Direct Current Stimulation|transcranial direct current stimulation
253205|NCT02620267|MMN|mmn
253206|NCT02620267|tDCS|tdcs
253207|NCT02620254|mastocytosis|mastocytosis
253208|NCT02620254|cutaneous mastocytosis|cutaneous mastocytosis
253209|NCT02620254|urticaria pigmentosa|urticaria pigmentosa
253210|NCT02620254|telangiectasia macularis eruptiva perstans (TMEP)|telangiectasia macularis eruptiva perstans (tmep)
253211|NCT02620254|diffuse cutaneous mastocytosis|diffuse cutaneous mastocytosis
253212|NCT02620254|solitary cutaneous mastocytosis|solitary cutaneous mastocytosis
253213|NCT02620254|systemic mastocytosis|systemic mastocytosis
253214|NCT02620254|indolent systemic mastocytosis|indolent systemic mastocytosis
253215|NCT02620254|smoldering systemic mastocytosis|smoldering systemic mastocytosis
253216|NCT02620254|aggressive systemic mastocytosis|aggressive systemic mastocytosis
253217|NCT02620254|systemic mastocytosis with associated clonal hematologic non-mast cell lineage disease|systemic mastocytosis with associated clonal hematologic non-mast cell lineage disease
253218|NCT02620254|mast cell leukemia|mast cell leukemia
253219|NCT02620241|gastro-oesophageal reflux|gastro-oesophageal reflux
253220|NCT02620241|intrapulmonary percussive ventilation|intrapulmonary percussive ventilation
253221|NCT02620241|positioning|positioning
253222|NCT02620228|Bioimpedance|bioimpedance
253223|NCT02620228|Biopsy|biopsy
253224|NCT02620228|Liver tumour|liver tumour
253225|NCT02620228|Biopsy needle guidance|biopsy needle guidance
253226|NCT02620202|Troponin|troponin
253227|NCT02620202|Myocardial infarction|myocardial infarction
253228|NCT02620150|HIV|hiv
253229|NCT02620150|AIDS|aids
253230|NCT02620150|Depression|depression
253231|NCT02620150|SSRI|ssri
253232|NCT02620150|Escitalopram|escitalopram
253233|NCT02620150|Immunity|immunity
253234|NCT02620085|Graves' disease|graves' disease
253235|NCT02620085|Hyperthyroidism|hyperthyroidism
253236|NCT02620085|Personality traits|personality traits
253237|NCT02620072|Type 1 diabetes|type 1 diabetes
253238|NCT02620072|T1D|t1d
253239|NCT02620072|diabetes mellitus|diabetes mellitus
253240|NCT02620072|oral insulin|oral insulin
253241|NCT02620072|oral tolerance|oral tolerance
253242|NCT02620072|autoantigen|autoantigen
253243|NCT02620072|self tolerance|self tolerance
253244|NCT02620072|prevention|prevention
253245|NCT02620072|at risk for developing type 1 diabetes|at risk for developing type 1 diabetes
253246|NCT02620072|juvenile diabetes|juvenile diabetes
253247|NCT02620072|dysglycemia|dysglycemia
253248|NCT02620059|Postpartum Period|postpartum period
253249|NCT02620046|Drug therapy|drug therapy
253250|NCT02620033|Prostatectomy|prostatectomy
253251|NCT02620033|Yoga therapy|yoga therapy
253252|NCT02620033|Health related quality of life|health related quality of life
253253|NCT02620007|Adult|adult
253254|NCT02620007|AIEC|aiec
253255|NCT02619994|Multidrug-resistant tuberculosis|multidrug-resistant tuberculosis
253256|NCT02619994|Linezolid|linezolid
253257|NCT02619994|Delamanid|delamanid
253258|NCT02619994|Multicenter randomized trial|multicenter randomized trial
253259|NCT02619994|Non-inferiority|non-inferiority
253260|NCT02619994|Shorter regimen|shorter regimen
253261|NCT02619968|Chronic renal failure|chronic renal failure
253262|NCT02619968|Arteriovenous fistula|arteriovenous fistula
253263|NCT02619968|Isometric exercises|isometric exercises
253264|NCT02619968|Vascular endothelium|vascular endothelium
253265|NCT02619955|hepcidin deficiency|hepcidin deficiency
253266|NCT02619955|genetic|genetic
253267|NCT02619955|except C282Y Homozygosity|except c282y homozygosity
253268|NCT02619942|Right colon cancer, Survival, Laparoscopic surgery|right colon cancer, survival, laparoscopic surgery
253269|NCT02619929|Oral Vinorelbine|oral vinorelbine
253270|NCT02619929|Advanced Non-Small-Cell Lung Cancer|advanced non-small-cell lung cancer
253271|NCT02619929|Metastatic Breast Cancer|metastatic breast cancer
253272|NCT02619916|Cancer|cancer
253273|NCT02619916|Depression|depression
253274|NCT02619916|MBCT|mbct
253275|NCT02619916|CBT|cbt
253276|NCT02619890|Adult Glioma|adult glioma
253277|NCT02619890|MRI|mri
253278|NCT02619838|Double Arthrodesis|double arthrodesis
253279|NCT02619838|Triple Arthrodesis|triple arthrodesis
253280|NCT02619838|Subtalar Arthrodesis|subtalar arthrodesis
253281|NCT02619825|Child|child
253282|NCT02619799|magnesium sulphate|magnesium sulphate
253283|NCT02619799|intrathecal route|intrathecal route
253284|NCT02619799|midazolam|midazolam
253285|NCT02619773|Colorectal Surgery|colorectal surgery
253286|NCT02619760|Percutaneous Coronary Intervention|percutaneous coronary intervention
253287|NCT02619760|Platelet Aggregation Inhibitors|platelet aggregation inhibitors
253288|NCT02619747|pH monitoring|ph monitoring
253289|NCT02619734|Cell Therapy|cell therapy
253290|NCT02619734|Sickle cell disease|sickle cell disease
253291|NCT02619734|Autologous implantation|autologous implantation
253292|NCT02619734|Mesenchymal stromal cell|mesenchymal stromal cell
253293|NCT02619734|Edothelial Progenitor cell|edothelial progenitor cell
253294|NCT02619721|PINS SNS OAB|pins sns oab
253295|NCT02619708|immersive preoperative experience|immersive preoperative experience
253296|NCT02619695|ketoprofen|ketoprofen
253297|NCT02619695|gel|gel
253298|NCT02619695|low back pain|low back pain
253299|NCT02619695|emergency department|emergency department
253300|NCT02619669|Neoadjuvant|neoadjuvant
253301|NCT02619669|TAK-228 (MLN0128)|tak-228 (mln0128)
253302|NCT02619669|Letrozole|letrozole
253303|NCT02619669|ER+|er+
253304|NCT02619669|HER2-|her2-
253305|NCT02619656|PEG|peg
253306|NCT02619656|CO2 insufflation|co2 insufflation
253307|NCT02619656|Room Air insufflation|room air insufflation
253308|NCT02619656|pneumoperitoneum|pneumoperitoneum
253309|NCT02619617|Cluster Headache|cluster headache
253310|NCT02619617|Patient Diary collection of headache pain|patient diary collection of headache pain
253311|NCT02619578|Transcutaneous electric acupoint stimulation (TEAS)|transcutaneous electric acupoint stimulation (teas)
253312|NCT02619578|gynecological laparoscopic surgery|gynecological laparoscopic surgery
253313|NCT02619578|QoQ-40|qoq-40
253314|NCT02619578|MMSE|mmse
253315|NCT02619578|VAS|vas
253316|NCT02619565|Myelodysplastic syndromes|myelodysplastic syndromes
253317|NCT02619565|mutations|mutations
253318|NCT02619565|overall survival|overall survival
253319|NCT02619565|prognosis|prognosis
253320|NCT02619513|Paravertebral Blocks|paravertebral blocks
253321|NCT02619513|Dexmedetomidine|dexmedetomidine
253322|NCT02619513|Analgesia|analgesia
253323|NCT02619513|Inflammatory response|inflammatory response
253324|NCT02619513|Thoracotomy|thoracotomy
253325|NCT02619474|Parent Satisfaction|parent satisfaction
253326|NCT02619474|Patient Satisfaction|patient satisfaction
253327|NCT02619474|Whiteboard|whiteboard
253328|NCT02619474|Communication|communication
253329|NCT02619448|inoperable|inoperable
253330|NCT02619448|Solitary [T1bN0, T2aN0, T2bN0] lesion measuring 2-7 cm|solitary [t1bn0, t2an0, t2bn0] lesion measuring 2-7 cm
253331|NCT02619435|RAS-mutant|ras-mutant
253332|NCT02619422|Cardiac rehabilitation programs|cardiac rehabilitation programs
253333|NCT02619422|Adherence to secondary preventive measures|adherence to secondary preventive measures
253334|NCT02619422|Acute coronary syndrome|acute coronary syndrome
253335|NCT02619422|More intensive cardiac rehabilitation program in less time|more intensive cardiac rehabilitation program in less time
253336|NCT02619396|radiofrequency power|radiofrequency power
253337|NCT02619396|lesion size index|lesion size index
253338|NCT02619396|esophageal temperature alerts|esophageal temperature alerts
253339|NCT02619383|HBOT|hbot
253340|NCT02619383|hyperbaric oxygen|hyperbaric oxygen
253341|NCT02619383|DCE|dce
253342|NCT02619383|ED|ed
253343|NCT02619383|erectile dysfunction|erectile dysfunction
253344|NCT02619370|advance care planning|advance care planning
253345|NCT02619370|advance directive|advance directive
253346|NCT02619370|caregiving|caregiving
253347|NCT02619357|Asthma|asthma
253348|NCT02619357|wearable physical activity monitor|wearable physical activity monitor
253349|NCT02619357|step counts|step counts
253350|NCT02619357|Exercise|exercise
253351|NCT02619357|energy expenditure|energy expenditure
253352|NCT02619357|COPD|copd
253353|NCT02619357|indirect calorimetry|indirect calorimetry
253354|NCT02619318|Balancing Everyday Life (BEL)|balancing everyday life (bel)
253355|NCT02619318|activity-based lifestyle intervention|activity-based lifestyle intervention
253356|NCT02619318|standard occupational therapy|standard occupational therapy
253357|NCT02619292|cancer survivor|cancer survivor
253358|NCT02619292|immune function|immune function
253359|NCT02619266|Cancer Anorexia Cachexia Syndrome|cancer anorexia cachexia syndrome
253360|NCT02619266|Acupuncture|acupuncture
253361|NCT02619266|Megestrol acetate|megestrol acetate
253362|NCT02619266|Poor Appetite|poor appetite
253363|NCT02619266|Anorexia|anorexia
253364|NCT02619266|Randomized Controlled Trial|randomized controlled trial
253365|NCT02619253|Immunotherapy|immunotherapy
253366|NCT02619253|Safety|safety
253367|NCT02619253|Pharmacodynamics|pharmacodynamics
253368|NCT02619253|Efficacy|efficacy
253369|NCT02619214|Oxidative Stress|oxidative stress
253370|NCT02619214|Oxygen|oxygen
253371|NCT02619214|General Anesthesia|general anesthesia
253372|NCT02619201|vomiting in children|vomiting in children
253373|NCT02619201|ondansetron|ondansetron
253374|NCT02619201|metoclopramide|metoclopramide
253375|NCT02619201|antiemetics|antiemetics
253376|NCT02619188|Nutrition|nutrition
253377|NCT02619188|Hyperemesis gravidarum|hyperemesis gravidarum
253378|NCT02619188|Prealbumin|prealbumin
253379|NCT02619188|Questionnaire|questionnaire
253380|NCT02619162|breast cancer non metastatic|breast cancer non metastatic
253381|NCT02619162|adjuvant letrozole|adjuvant letrozole
253382|NCT02619162|Nintedanib BIFF1120|nintedanib biff1120
253383|NCT02619136|Blood Transfusion|blood transfusion
253384|NCT02619123|breast density|breast density
253385|NCT02619123|breast cancer|breast cancer
253386|NCT02619123|risk-based screening|risk-based screening
253387|NCT02619123|Tailored breast cancer screening|tailored breast cancer screening
253388|NCT02619123|premenopausal women|premenopausal women
253389|NCT02619110|Chronic Stroke|chronic stroke
253390|NCT02619110|cardiopulmonary|cardiopulmonary
253391|NCT02619110|Berg Balance Scale (BBS)|berg balance scale (bbs)
253392|NCT02619084|Tourette Syndrome|tourette syndrome
253393|NCT02619084|Subthalamic Nucleus|subthalamic nucleus
253394|NCT02619084|STN|stn
253395|NCT02619084|Deep Brain Stimulation|deep brain stimulation
253396|NCT02619084|DBS|dbs
253397|NCT02619084|Tic|tic
253398|NCT02619084|Obsessive-compulsive disorders|obsessive-compulsive disorders
253399|NCT02619071|acute myeloid leukemia- refractory AML- relapsed AML- precision medecine-|acute myeloid leukemia- refractory aml- relapsed aml- precision medecine-
253400|NCT02619058|NKT|nkt
253401|NCT02619058|metastatic melanoma|metastatic melanoma
253402|NCT02619032|remifentanil|remifentanil
253403|NCT02619032|fentanyl|fentanyl
253404|NCT02619032|dental surgery|dental surgery
253405|NCT02619006|Anemia, Iron-Deficiency|anemia, iron-deficiency
253406|NCT02619006|Myelination|myelination
253407|NCT02619006|Ferritin|ferritin
253408|NCT02619006|Umbilical cord clamping|umbilical cord clamping
253409|NCT02619006|Umbilical Cord Milking|umbilical cord milking
253410|NCT02619006|Placental Transfusion|placental transfusion
253411|NCT02619006|Brain Development|brain development
253412|NCT02618993|mandibular nerve block|mandibular nerve block
253413|NCT02618993|mandibular osteotomy|mandibular osteotomy
253414|NCT02618980|acute coronary syndrome|acute coronary syndrome
253415|NCT02618980|gastrointestinal bleeding|gastrointestinal bleeding
253416|NCT02618980|endoscopy|endoscopy
253417|NCT02618967|Lupus|lupus
253418|NCT02618967|Healthy Volunteer|healthy volunteer
253419|NCT02618967|Safety Study|safety study
253420|NCT02618967|Placebo Control|placebo control
253421|NCT02618967|Phase 1|phase 1
253819|NCT02616276|Cognition|cognition
253422|NCT02618954|Rheumatoid arthritis|rheumatoid arthritis
253423|NCT02618954|Articular ultrasound|articular ultrasound
253424|NCT02618954|Synovitis|synovitis
253425|NCT02618954|Relapse risk|relapse risk
253426|NCT02618928|HCV|hcv
253427|NCT02618928|Chronic Hepatitis C|chronic hepatitis c
253428|NCT02618915|gene therapy|gene therapy
253429|NCT02618915|Hemophilia B|hemophilia b
253430|NCT02618902|patient safety|patient safety
253431|NCT02618902|tolerogenic dendritic cells|tolerogenic dendritic cells
253432|NCT02618902|tolDC|toldc
253433|NCT02618850|metabolic response|metabolic response
253434|NCT02618850|chemotherapy|chemotherapy
253435|NCT02618850|PET|pet
253436|NCT02618837|NSTEMI|nstemi
253437|NCT02618837|NSTEACS|nsteacs
253438|NCT02618837|prasugrel|prasugrel
253439|NCT02618837|ticagrelor|ticagrelor
253440|NCT02618837|Downstream versus Upstream strategy|downstream versus upstream strategy
253441|NCT02618811|sarcopenia|sarcopenia
253442|NCT02618811|myosteatosis|myosteatosis
253443|NCT02618811|enhanced recovery after surgery|enhanced recovery after surgery
253444|NCT02618811|colorectal cancer|colorectal cancer
253445|NCT02618811|minimally invasive surgery|minimally invasive surgery
253446|NCT02618811|complications|complications
253447|NCT02618798|chronic liver disease|chronic liver disease
253448|NCT02618798|CLD|cld
253449|NCT02618798|platelet function|platelet function
253450|NCT02618785|Hysterosalpingography|hysterosalpingography
253451|NCT02618785|antispasmodic drug|antispasmodic drug
253452|NCT02618785|infertile women|infertile women
253453|NCT02618772|Pediatrics|pediatrics
253454|NCT02618772|Laceration|laceration
253455|NCT02618772|Anxiety|anxiety
253456|NCT02618772|Anti-Anxiety Agents|anti-anxiety agents
253457|NCT02618746|Telemonitoring|telemonitoring
253458|NCT02618746|Home Rehabilitation|home rehabilitation
253459|NCT02618746|Exacerbations|exacerbations
253460|NCT02618746|Physical Activity|physical activity
253461|NCT02618746|COPD|copd
253462|NCT02618720|Antimicrobial prophylaxis|antimicrobial prophylaxis
253463|NCT02618720|Colorectal surgery|colorectal surgery
253464|NCT02618720|Surgical Site Infection|surgical site infection
253465|NCT02618720|Postoperative morbidity|postoperative morbidity
253466|NCT02618707|Lactate|lactate
253467|NCT02618707|Congenital cardiac defect|congenital cardiac defect
253468|NCT02618707|CPB|cpb
253469|NCT02618707|Pediatric|pediatric
253470|NCT02618694|adrenal|adrenal
253471|NCT02618694|supra-renal|supra-renal
253472|NCT02618694|adrenalectomy|adrenalectomy
253473|NCT02618694|retroperitoneoscopy|retroperitoneoscopy
253474|NCT02618694|posterior retroperitoneoscopy|posterior retroperitoneoscopy
253475|NCT02618694|Laparoscopic adrenalectomy|laparoscopic adrenalectomy
253476|NCT02618681|earlobe crease|earlobe crease
253477|NCT02618681|acute myocardial infarction|acute myocardial infarction
253478|NCT02618655|TBDs；diagnosis|tbds；diagnosis
253479|NCT02618642|muscle contraction|muscle contraction
253480|NCT02618642|electrodiagnostic|electrodiagnostic
253481|NCT02618642|i/t curve|i/t curve
253482|NCT02618603|Stroke|stroke
253483|NCT02618603|Should pain|should pain
253484|NCT02618603|Botulinum Toxin|botulinum toxin
253485|NCT02618590|non-small cell lung cancer|non-small cell lung cancer
253486|NCT02618590|EGFR mutant type|egfr mutant type
253487|NCT02618590|first/second line EGFR-TKI|first/second line egfr-tki
253488|NCT02618577|Anticoagulation|anticoagulation
253489|NCT02618577|atrial high rate episodes|atrial high rate episodes
253490|NCT02618577|Atrial Fibrillation|atrial fibrillation
253491|NCT02618577|VKA|vka
253492|NCT02618577|NOAC|noac
253493|NCT02618551|Thermoplasty|thermoplasty
253494|NCT02618551|Severe asthma|severe asthma
253495|NCT02618551|Dynamic hyperinflation|dynamic hyperinflation
253496|NCT02618499|birth|birth
253497|NCT02618499|oxytocin|oxytocin
253498|NCT02618499|placental transfusion|placental transfusion
253499|NCT02618499|umbilical cord clamping|umbilical cord clamping
253500|NCT02618473|Coronary computed tomography angiography|coronary computed tomography angiography
253501|NCT02618473|motion artifacts|motion artifacts
253502|NCT02618473|motion correction algorithm|motion correction algorithm
253503|NCT02618473|diagnostic utility|diagnostic utility
253504|NCT02618460|Non-contrast enhanced MRI|non-contrast enhanced mri
253505|NCT02618460|healthy volunteers|healthy volunteers
253506|NCT02618460|renal diffusion|renal diffusion
253507|NCT02618460|renal perfusion|renal perfusion
253508|NCT02618369|High Intensity Focused Ultrasound|high intensity focused ultrasound
253509|NCT02618317|renal dialysis|renal dialysis
253510|NCT02618304|Meibomian gland dysfunction|meibomian gland dysfunction
253511|NCT02618304|Lipiview|lipiview
253512|NCT02618304|Tear Lipid Layer|tear lipid layer
253513|NCT02618291|primary health care|primary health care
253514|NCT02618265|stroke|stroke
253515|NCT02618265|secondary prevention|secondary prevention
253516|NCT02618265|platelet response polymorphism|platelet response polymorphism
253517|NCT02618265|mobile terminal|mobile terminal
253518|NCT02618252|difficult IV access|difficult iv access
253519|NCT02618252|ultrasound|ultrasound
253520|NCT02618252|veinviewer|veinviewer
253521|NCT02618252|near infrared device|near infrared device
253522|NCT02618239|intestinal gas|intestinal gas
253523|NCT02618239|Healthy subjects|healthy subjects
253524|NCT02618239|microbiota|microbiota
253525|NCT02618239|prebiotics|prebiotics
253526|NCT02618226|Traumatic Brain Injury|traumatic brain injury
253527|NCT02618226|TBI|tbi
253528|NCT02618226|Optic nerve ultrasound|optic nerve ultrasound
253529|NCT02618226|ONUS|onus
253530|NCT02618226|Intracranial pressure|intracranial pressure
253531|NCT02618226|ICP|icp
253532|NCT02618226|Intracranial hypertension|intracranial hypertension
253533|NCT02618213|Continuous Positive Airway Pressure|continuous positive airway pressure
253534|NCT02618213|High Flow Oxygenation therapy|high flow oxygenation therapy
253535|NCT02618213|Bronchiolitis|bronchiolitis
253536|NCT02618213|Children|children
253537|NCT02618200|Prostate cancer|prostate cancer
253538|NCT02618200|Computer-Aided Diagnosis|computer-aided diagnosis
253539|NCT02618161|EBRT and HDR Brachytherapy|ebrt and hdr brachytherapy
253540|NCT02618109|B acute lymphoblastic leukemia|b acute lymphoblastic leukemia
253541|NCT02618109|leukemia relapse|leukemia relapse
253542|NCT02618109|pediatric onco-hematology|pediatric onco-hematology
253543|NCT02618096|membrane sweeping|membrane sweeping
253544|NCT02618096|dinoprostone|dinoprostone
253545|NCT02618096|multiparas|multiparas
253546|NCT02618096|labor induction|labor induction
253547|NCT02618096|cesarean delivery|cesarean delivery
253548|NCT02618044|Gastroesophageal reflux|gastroesophageal reflux
253549|NCT02618044|Obesity|obesity
253550|NCT02618044|Esophageal manometry|esophageal manometry
253551|NCT02618044|24 H impedance pH-monitoring|24 h impedance ph-monitoring
253552|NCT02618044|Laparoscopic Roux-en-Y Gastric Bypass|laparoscopic roux-en-y gastric bypass
253553|NCT02618031|capillary index score|capillary index score
253554|NCT02618031|acute ischemic stroke|acute ischemic stroke
253555|NCT02618031|collateral circulation|collateral circulation
253556|NCT02618031|cerebral ischemia|cerebral ischemia
253557|NCT02618031|diagnostic imaging|diagnostic imaging
253558|NCT02618018|astigmatism|astigmatism
253559|NCT02618018|toric intraocular lens|toric intraocular lens
253560|NCT02618005|Astronauts|astronauts
253561|NCT02618005|Probiotics|probiotics
253562|NCT02618005|Immune function|immune function
253563|NCT02618005|Intestinal microbiota|intestinal microbiota
253564|NCT02617966|Retina|retina
253565|NCT02617966|Retinal Degeneration|retinal degeneration
253566|NCT02617966|Retinitis Pigmentosa|retinitis pigmentosa
253567|NCT02617966|Stargardt's Disease|stargardt's disease
253568|NCT02617966|Dark Adaptation|dark adaptation
253569|NCT02617953|Tinnitus|tinnitus
253570|NCT02617953|EEG|eeg
253571|NCT02617953|ERP|erp
253572|NCT02617940|dental caries|dental caries
253573|NCT02617940|primary tooth|primary tooth
253574|NCT02617940|resin-based sealants|resin-based sealants
253575|NCT02617914|ARDS|ards
253576|NCT02617914|PEEP|peep
253577|NCT02617914|ECMO|ecmo
253578|NCT02617901|Bone age|bone age
253579|NCT02617901|Greulich & Pyle|greulich & pyle
253580|NCT02617901|TW3|tw3
253581|NCT02617901|Radiography|radiography
253582|NCT02617901|Dual energy x-ray absorptiometry|dual energy x-ray absorptiometry
253583|NCT02617888|radiation|radiation
253584|NCT02617888|cardiac computed tomography|cardiac computed tomography
253585|NCT02617888|CCTA|ccta
253586|NCT02617888|breast shielding|breast shielding
253587|NCT02617888|Myocardial perfusion scintigraphy|myocardial perfusion scintigraphy
253588|NCT02617888|MPS|mps
253589|NCT02617888|Invasive coronary angiography|invasive coronary angiography
253590|NCT02617888|ICA|ica
253591|NCT02617875|Pre-hospital|pre-hospital
253592|NCT02617875|Emergency medical system|emergency medical system
253593|NCT02617875|Telemedicine|telemedicine
253594|NCT02617875|Tele consultation|tele consultation
253595|NCT02617875|Remote treatment|remote treatment
253596|NCT02617862|Diagnostic imaging|diagnostic imaging
253597|NCT02617862|Retina|retina
253598|NCT02617862|Pediatrics|pediatrics
253599|NCT02617810|Healthy|healthy
253600|NCT02617810|JNJ-42847922|jnj-42847922
253601|NCT02617810|Midazolam|midazolam
253602|NCT02617810|Warfarin|warfarin
253603|NCT02617810|Pharmacokinetics|pharmacokinetics
253604|NCT02617797|Urinary Stress Incontinence|urinary stress incontinence
253605|NCT02617797|Radiofrequency|radiofrequency
253606|NCT02617797|Women|women
253607|NCT02617758|Healthy|healthy
253608|NCT02617758|Bioequivalence Study|bioequivalence study
253609|NCT02617758|JNJ-35685-AAA-G021|jnj-35685-aaa-g021
253610|NCT02617758|DURAGESIC|duragesic
253611|NCT02617745|Stupp protocol, glioblastoma, thrombocytopenia|stupp protocol, glioblastoma, thrombocytopenia
253612|NCT02617732|glucose variability|glucose variability
253613|NCT02617732|continuous glucose mornitoring system|continuous glucose mornitoring system
253614|NCT02617732|traditional Chinese medicine|traditional chinese medicine
253615|NCT02617706|Anorectal surgeries|anorectal surgeries
253616|NCT02617706|infection|infection
253617|NCT02617706|topical oxygen|topical oxygen
253618|NCT02617680|Desflurane|desflurane
253619|NCT02617680|end tidal concentration|end tidal concentration
253620|NCT02617680|age|age
253621|NCT02617680|anesthesia|anesthesia
253622|NCT02617641|Secondary Prevention|secondary prevention
253623|NCT02617641|Walking|walking
253624|NCT02617641|Health Behavior|health behavior
253625|NCT02617641|Internet|internet
253627|NCT02617641|Computer-Assisted Instruction|computer-assisted instruction
253628|NCT02617641|Multicenter Study|multicenter study
253629|NCT02617641|Randomized Controlled Trial|randomized controlled trial
253630|NCT02617641|Intervention Studies|intervention studies
253631|NCT02617641|Motivation|motivation
253632|NCT02617641|Self Efficacy|self efficacy
253633|NCT02617641|Theory, Nursing|theory, nursing
253634|NCT02617641|Theory, Psychological|theory, psychological
253635|NCT02617641|Nursing Research|nursing research
253636|NCT02617628|opioid addiction|opioid addiction
253637|NCT02617615|MB-110|mb-110
253638|NCT02617602|Congenital heart defect|congenital heart defect
253639|NCT02617602|Cardiopulmonary bypass|cardiopulmonary bypass
253640|NCT02617602|Goal directed therapy|goal directed therapy
253641|NCT02617602|Acute heart failure|acute heart failure
253642|NCT02617563|spondylolisthesis|spondylolisthesis
253643|NCT02617563|CD Horizon® Spinal Systems|cd horizon® spinal systems
253644|NCT02617563|minimal invasive|minimal invasive
253645|NCT02617563|Spinal Fusion|spinal fusion
253646|NCT02617563|MAST procedure|mast procedure
253647|NCT02617563|Lumbar fusion|lumbar fusion
253648|NCT02617524|dedicated sheath|dedicated sheath
253649|NCT02617498|living donor liver transplantation|living donor liver transplantation
253650|NCT02617459|Safety|safety
253651|NCT02617459|efficacy|efficacy
253652|NCT02617459|Levobetaxolol eye drops|levobetaxolol eye drops
253653|NCT02617459|Chinese patients|chinese patients
253654|NCT02617446|safety|safety
253655|NCT02617446|efficacy|efficacy
253656|NCT02617446|istaroxime|istaroxime
253657|NCT02617407|Dental Plaque|dental plaque
253658|NCT02617407|Gingivitis|gingivitis
253659|NCT02617407|Bacterial Infection|bacterial infection
253660|NCT02617407|Oral Hygiene|oral hygiene
253661|NCT02617407|HSCT|hsct
253662|NCT02617407|Oral Microbiome|oral microbiome
253663|NCT02617407|Gut Microbiome|gut microbiome
253664|NCT02617407|Blood Microbiome|blood microbiome
253665|NCT02617368|Keratoconus, Corneal crosslinking, Fourier Analysis of Topographic Data|keratoconus, corneal crosslinking, fourier analysis of topographic data
253666|NCT02617342|Intervention|intervention
253667|NCT02617342|Autism Spectrum Disorder|autism spectrum disorder
253668|NCT02617342|Social Skills|social skills
253669|NCT02617329|Extracorporeal shock wave therapy (ESWT), Neck Pain|extracorporeal shock wave therapy (eswt), neck pain
253670|NCT02617316|running speeds, strike patterns|running speeds, strike patterns
253671|NCT02617303|elderly|elderly
253672|NCT02617303|accidental falls|accidental falls
253673|NCT02617303|osteoporosis|osteoporosis
253674|NCT02617303|fractures|fractures
253675|NCT02617303|Primary Care|primary care
253676|NCT02617303|Randomized clinical trial|randomized clinical trial
253677|NCT02617303|Otago exercise programme|otago exercise programme
253678|NCT02617290|Coronary Artery Disease (CAD)|coronary artery disease (cad)
253679|NCT02617290|Percutaneous Coronary Intervention (PCI)|percutaneous coronary intervention (pci)
253680|NCT02617277|AZD1775|azd1775
253681|NCT02617277|MEDI4736|medi4736
253682|NCT02617277|AZD1775 + MEDI4736|azd1775 + medi4736
253683|NCT02617277|Advanced Solid Tumours|advanced solid tumours
253684|NCT02617277|Adavosertib|adavosertib
253685|NCT02617277|Durvalumab|durvalumab
253686|NCT02617238|arterial stiffness|arterial stiffness
253687|NCT02617238|cardiovascular risk|cardiovascular risk
253688|NCT02617238|cardiovascular events|cardiovascular events
253689|NCT02617238|renal events|renal events
253690|NCT02617212|dental implant|dental implant
253691|NCT02617212|bone preservation|bone preservation
253692|NCT02617212|definitive abutment|definitive abutment
253693|NCT02617212|one abutment one time|one abutment one time
253694|NCT02617199|epidural anesthesia|epidural anesthesia
253695|NCT02617199|pain management|pain management
253696|NCT02617199|microcirculation|microcirculation
253697|NCT02617160|Insulin Pump Treatment|insulin pump treatment
253698|NCT02617160|Type 1 Diabetes|type 1 diabetes
253699|NCT02617160|Insulin Pump Setting|insulin pump setting
253700|NCT02617160|Pump Advisor|pump advisor
253701|NCT02617108|uterine septum|uterine septum
253702|NCT02617108|intrauterine adhesions|intrauterine adhesions
253703|NCT02617108|Foley balloon|foley balloon
253704|NCT02617082|breast cancer|breast cancer
253705|NCT02617082|partial breast irradiation|partial breast irradiation
253706|NCT02617082|DCIS|dcis
253707|NCT02617069|Atrial fibrillation|atrial fibrillation
253708|NCT02617069|botulinum toxin|botulinum toxin
253709|NCT02617056|electrodermal response|electrodermal response
253710|NCT02617043|breast cancer|breast cancer
253711|NCT02617043|hypofractionated whole breast irradiation|hypofractionated whole breast irradiation
253712|NCT02617017|Parkinson disease|parkinson disease
253713|NCT02617017|Levodopa induce dyskinesia|levodopa induce dyskinesia
253714|NCT02616952|Stress urinary incontinence|stress urinary incontinence
253715|NCT02616952|Chinese Herb|chinese herb
253716|NCT02616952|Traditional Chinese medicine|traditional chinese medicine
253717|NCT02616952|Pelvic floor muscle training|pelvic floor muscle training
253718|NCT02616939|Multidetector computed tomography|multidetector computed tomography
253719|NCT02616926|hepatocellular carcinoma|hepatocellular carcinoma
253720|NCT02616926|hepatectomy|hepatectomy
253721|NCT02616926|transarterial chemoembolization|transarterial chemoembolization
253722|NCT02616926|radiofrequency ablation|radiofrequency ablation
253723|NCT02616874|HIV infection|hiv infection
253724|NCT02616874|Early treatment|early treatment
253725|NCT02616874|Romidepsin|romidepsin
253726|NCT02616874|HDACi|hdaci
253727|NCT02616874|Therapeutic Vaccines|therapeutic vaccines
253728|NCT02616874|HIVconsv|hivconsv
253729|NCT02616874|HIV reservoir|hiv reservoir
253730|NCT02616874|Population PK/PD analysis|population pk/pd analysis
253731|NCT02616848|Everolimus|everolimus
253732|NCT02616848|eribulin|eribulin
253733|NCT02616822|hypertension|hypertension
253734|NCT02616822|endothelium|endothelium
253735|NCT02616822|resveratrol|resveratrol
253736|NCT02616822|clinical trials|clinical trials
253737|NCT02616783|HIV 1 Infection|hiv 1 infection
253738|NCT02616783|HIV|hiv
253739|NCT02616783|Virologically-Suppressed|virologically-suppressed
253740|NCT02616744|aromatase inhibitors|aromatase inhibitors
253741|NCT02616744|breast cancer|breast cancer
253742|NCT02616744|bone mineral density|bone mineral density
253743|NCT02616692|HCC|hcc
253744|NCT02616692|Patient preferences|patient preferences
253745|NCT02616666|Type 2 diabetes mellitus|type 2 diabetes mellitus
253746|NCT02616666|Randomised|randomised
253747|NCT02616666|Pragmatic|pragmatic
253748|NCT02616666|Standard of Care|standard of care
253749|NCT02616666|Dapagliflozin|dapagliflozin
253750|NCT02616666|FORXIGA|forxiga
253751|NCT02616640|Multiple Myeloma|multiple myeloma
253752|NCT02616640|Relapsed|relapsed
253753|NCT02616640|Refractory|refractory
253754|NCT02616640|MEDI4736|medi4736
253755|NCT02616640|Durvalumab|durvalumab
253756|NCT02616640|Pomalidomide (POM)|pomalidomide (pom)
253757|NCT02616640|Dexamethasone (DEX)|dexamethasone (dex)
253759|NCT02616627|bone mineral density|bone mineral density
253760|NCT02616627|chronic dialysis|chronic dialysis
253761|NCT02616627|end-stage renal disease|end-stage renal disease
253762|NCT02616627|body composition analysis|body composition analysis
253763|NCT02616627|sarcopenia|sarcopenia
253764|NCT02616588|advanced stage cancer,|advanced stage cancer,
253765|NCT02616588|patient navigator,|patient navigator,
253766|NCT02616588|social work|social work
253767|NCT02616575|home care|home care
253768|NCT02616575|monitoring system|monitoring system
253769|NCT02616575|risk assessment|risk assessment
253770|NCT02616575|telehealth|telehealth
253771|NCT02616536|Flipped classroom|flipped classroom
253772|NCT02616536|Teaching methods|teaching methods
253773|NCT02616536|Knowledge gain|knowledge gain
253774|NCT02616523|dexmedetomidine|dexmedetomidine
253775|NCT02616523|lidocaine|lidocaine
253776|NCT02616523|neuropathic pain|neuropathic pain
253777|NCT02616523|laparoscopic intestine resection|laparoscopic intestine resection
253778|NCT02616523|cognitive function|cognitive function
253779|NCT02616497|aspirin|aspirin
253780|NCT02616497|triflusal|triflusal
253781|NCT02616497|antiplatelet drugs|antiplatelet drugs
253782|NCT02616497|atherothrombosis|atherothrombosis
253783|NCT02616497|secondary prevention|secondary prevention
253784|NCT02616497|bleeding|bleeding
253785|NCT02616484|Sodium Dichloroacetate|sodium dichloroacetate
253786|NCT02616484|Treatment of PDCD with Dichloroacetate|treatment of pdcd with dichloroacetate
253787|NCT02616471|Cheese|cheese
253788|NCT02616471|Dairy|dairy
253789|NCT02616471|Saturated fat|saturated fat
253790|NCT02616471|Blood lipid concentrations|blood lipid concentrations
253791|NCT02616471|Lipoprotein particle size|lipoprotein particle size
253792|NCT02616471|Metabolic Syndrome|metabolic syndrome
253793|NCT02616471|Insulin sensitivity|insulin sensitivity
253794|NCT02616471|Blood glucose concentrations|blood glucose concentrations
253795|NCT02616445|Xanamem|xanamem
253796|NCT02616432|Tomosynthesis|tomosynthesis
253797|NCT02616432|Digital Breast Tomosynthesis (DBT)|digital breast tomosynthesis (dbt)
253798|NCT02616432|Breast Imaging|breast imaging
253799|NCT02616432|Full-field digital mammography|full-field digital mammography
253800|NCT02616432|Breast screening|breast screening
253801|NCT02616419|Emergency Department|emergency department
253802|NCT02616419|Procedural pain|procedural pain
253803|NCT02616419|Procedural anxiety|procedural anxiety
253804|NCT02616419|Needle-related procedures|needle-related procedures
253805|NCT02616419|Clinical Nursing Research|clinical nursing research
253806|NCT02616419|Nursing practice|nursing practice
253807|NCT02616419|Non-pharmacological method|non-pharmacological method
253808|NCT02616406|recovery of function|recovery of function
253809|NCT02616380|Quality of life (QOL)|quality of life (qol)
253810|NCT02616380|Work productivity|work productivity
253811|NCT02616380|Rheumatoid arthritis (RA)|rheumatoid arthritis (ra)
253812|NCT02616354|Pharmacokinetics; pharmacodynamic; imipenem; sepsis|pharmacokinetics; pharmacodynamic; imipenem; sepsis
253813|NCT02616315|Drug therapy|drug therapy
253814|NCT02616302|Drug therapy|drug therapy
253815|NCT02616276|Glycemic Index|glycemic index
253816|NCT02616276|Postprandial Period|postprandial period
253817|NCT02616276|Vascular Stiffness|vascular stiffness
253818|NCT02616276|Blood glucose|blood glucose
253820|NCT02616237|Chinese population|chinese population
253821|NCT02616237|acupressure|acupressure
253822|NCT02616237|physical activity|physical activity
253823|NCT02616237|nutrition|nutrition
253824|NCT02616237|Facebook|facebook
253825|NCT02616198|glass ionomers|glass ionomers
253826|NCT02616198|surface coating|surface coating
253827|NCT02616198|clinical trial|clinical trial
253828|NCT02616120|Herbal therapy|herbal therapy
253829|NCT02616120|Parkinson's Disease|parkinson's disease
253830|NCT02616120|Non-motor Symptoms|non-motor symptoms
253831|NCT02616120|Randomized controlled trial|randomized controlled trial
253832|NCT02616107|Caregiver|caregiver
253833|NCT02616107|Self-management|self-management
253834|NCT02616107|Care options|care options
253835|NCT02616107|Goals of care|goals of care
253836|NCT02616107|Breast cancer|breast cancer
253837|NCT02616107|Palliative care|palliative care
253838|NCT02616081|Urinary Bladder|urinary bladder
253839|NCT02616081|Neurogenic|neurogenic
253840|NCT02616081|Quality of Life|quality of life
253841|NCT02616081|Spinal cord injury|spinal cord injury
253842|NCT02616081|incontinence|incontinence
253843|NCT02616081|Bladder|bladder
253844|NCT02616042|Centella asiatica|centella asiatica
253845|NCT02616042|bamboo salt|bamboo salt
253846|NCT02616042|dentifrice|dentifrice
253847|NCT02616003|Morbid Obesity|morbid obesity
253848|NCT02616003|Giant Obese|giant obese
253849|NCT02616003|Preoperative Procedure|preoperative procedure
253850|NCT02616003|Liraglutide|liraglutide
253851|NCT02616003|Leucine|leucine
253852|NCT02615977|Pavlovian conditioning, Operant conditioning|pavlovian conditioning, operant conditioning
253853|NCT02615977|Pavlovian-to-instrumental transfer|pavlovian-to-instrumental transfer
253854|NCT02615977|Functional imaging|functional imaging
253855|NCT02615977|Relapse risk|relapse risk
253856|NCT02615977|Behavioural Intervention|behavioural intervention
253857|NCT02615951|Regulatory B cells (Breg)|regulatory b cells (breg)
253858|NCT02615951|Genes|genes
253859|NCT02615951|Cell surface proteins|cell surface proteins
253860|NCT02615951|Nutrient transporters|nutrient transporters
253861|NCT02615951|Chemokine receptors|chemokine receptors
253862|NCT02615899|Older Adults, Falls|older adults, falls
253863|NCT02615886|rice bran|rice bran
253864|NCT02615886|infants|infants
253865|NCT02615886|stool metabolome|stool metabolome
253866|NCT02615886|stool microbiome|stool microbiome
253867|NCT02615886|dietary intervention|dietary intervention
253868|NCT02615873|Parkinson's Disease|parkinson's disease
253869|NCT02615873|Fluctuating Parkinson's Disease|fluctuating parkinson's disease
253870|NCT02615873|Carbidopa|carbidopa
253871|NCT02615873|Levodopa|levodopa
253872|NCT02615873|Accordion|accordion
253873|NCT02615860|HIV-infection|hiv-infection
253874|NCT02615860|anal cancer (AC)|anal cancer (ac)
253875|NCT02615860|anal cancer prevention|anal cancer prevention
253876|NCT02615860|anal dysplasia|anal dysplasia
253877|NCT02615860|anal intraepithelial neoplasia (AIN)|anal intraepithelial neoplasia (ain)
253878|NCT02615860|human papillomavirus (HPV)|human papillomavirus (hpv)
253879|NCT02615860|HPV-induced anal cancer precursor lesions|hpv-induced anal cancer precursor lesions
253880|NCT02615860|electrocautery (ECA)|electrocautery (eca)
253881|NCT02615860|topical trichloroacetic acid (TCA) treatment.|topical trichloroacetic acid (tca) treatment.
253882|NCT02615704|Brilique treatment adherence via electronic device application (APP)|brilique treatment adherence via electronic device application (app)
253883|NCT02615678|neuropathy|neuropathy
253884|NCT02615678|peripheral|peripheral
253885|NCT02615678|chemotherapy|chemotherapy
253886|NCT02615678|breast cancer|breast cancer
253887|NCT02615665|NK-cells|nk-cells
253888|NCT02615665|T-cells|t-cells
253889|NCT02615639|HPDC-T cells|hpdc-t cells
253890|NCT02615639|CHB|chb
253891|NCT02615639|immuno therapy|immuno therapy
253892|NCT02615626|Visfatin|visfatin
253893|NCT02615626|GCF|gcf
253894|NCT02615626|serum|serum
253895|NCT02615626|Non-surgical Periodontal Treatment.|non-surgical periodontal treatment.
253896|NCT02615613|Hedonics, Ghrelin, Hunger|hedonics, ghrelin, hunger
253897|NCT02615600|tinnitus|tinnitus
253898|NCT02615600|transcranial random noise stimulation|transcranial random noise stimulation
253899|NCT02615600|tRNS|trns
253900|NCT02615600|auditory cortex|auditory cortex
253901|NCT02615600|non-invasive brain stimulation|non-invasive brain stimulation
253902|NCT02615587|non-valvular Atrial Fibrillation|non-valvular atrial fibrillation
253903|NCT02615561|Safety|safety
253904|NCT02615561|Efficacy|efficacy
253905|NCT02615561|Atopic dermatitis|atopic dermatitis
253906|NCT02615561|Cosmetic products|cosmetic products
253907|NCT02615548|exercises|exercises
253908|NCT02615535|traumatic brain injury|traumatic brain injury
253909|NCT02615522|primary TKR|primary tkr
253910|NCT02615509|Mammography|mammography
253911|NCT02615509|Tomosynthesis|tomosynthesis
253912|NCT02615496|Health Care Surveys|health care surveys
253913|NCT02615496|Vascular Endothelial Growth Factor|vascular endothelial growth factor
253914|NCT02615470|Pneumococcal Vaccines|pneumococcal vaccines
253915|NCT02615470|Shingles|shingles
253916|NCT02615470|Pharmacy|pharmacy
253917|NCT02615470|Vaccine|vaccine
253918|NCT02615470|Immunization|immunization
253919|NCT02615444|Metabolic Syndrome X|metabolic syndrome x
253920|NCT02615444|Overweight|overweight
253921|NCT02615444|Waist Circumference|waist circumference
253922|NCT02615444|Blood Pressure|blood pressure
253923|NCT02615444|Cholesterol|cholesterol
253924|NCT02615444|Oat beta glucan|oat beta glucan
253925|NCT02615392|RCT|rct
253926|NCT02615392|Park Prescription|park prescription
253927|NCT02615392|Park Use|park use
253928|NCT02615392|Physical Activity|physical activity
253929|NCT02615392|Health Promotion|health promotion
253930|NCT02615392|Health Behavior|health behavior
253931|NCT02615392|Mental Well-Being|mental well-being
253932|NCT02615392|Body composition|body composition
253933|NCT02615392|Blood levels|blood levels
253934|NCT02615392|Accelerometry|accelerometry
253935|NCT02615392|Improving general physical and mental health|improving general physical and mental health
253936|NCT02615379|instrumented spinal fusion|instrumented spinal fusion
253937|NCT02615379|infection|infection
253938|NCT02615379|topical oxygen|topical oxygen
253939|NCT02615340|delirium|delirium
253940|NCT02615340|melatonin|melatonin
253941|NCT02615340|pharmacokinetics|pharmacokinetics
253942|NCT02615340|feasibility|feasibility
253943|NCT02615340|prevention|prevention
253944|NCT02615327|Fiber|fiber
253945|NCT02615327|Polydextrose|polydextrose
253946|NCT02615327|Glycemic Index|glycemic index
253947|NCT02615314|migraine|migraine
253948|NCT02615314|benign paroxysmal positional vertigo|benign paroxysmal positional vertigo
253949|NCT02615288|Vitamin D|vitamin d
253950|NCT02615275|Head and Neck Cancer|head and neck cancer
253951|NCT02615275|Bioelectrical impedance analysis|bioelectrical impedance analysis
253952|NCT02615275|BIA|bia
253953|NCT02615275|Eight-electrode BIA device|eight-electrode bia device
253954|NCT02615275|SECA mBCA|seca mbca
253955|NCT02615275|Computed tomography|computed tomography
253956|NCT02615275|CT|ct
253957|NCT02615275|Positron emission tomography|positron emission tomography
253958|NCT02615275|PET|pet
253959|NCT02615275|Symptom questionnaire|symptom questionnaire
253960|NCT02615275|Survey|survey
253961|NCT02615275|Radiation therapy|radiation therapy
253962|NCT02615275|RT|rt
253963|NCT02615275|XRT|xrt
253964|NCT02615262|Pediatric cardiac surgery|pediatric cardiac surgery
253965|NCT02615262|Dexamethasone|dexamethasone
253966|NCT02615262|Steroids|steroids
253967|NCT02615262|Cardiopulmonary bypass|cardiopulmonary bypass
253968|NCT02615262|Congenital heart defects|congenital heart defects
253969|NCT02615262|Infants|infants
253970|NCT02615197|PTSD|ptsd
253971|NCT02615197|Multi-diagnostic|multi-diagnostic
253972|NCT02615197|Dialectical Behavior Therapy|dialectical behavior therapy
253973|NCT02615197|Prolonged Exposure Therapy|prolonged exposure therapy
253974|NCT02615184|Drug therapy|drug therapy
253975|NCT02615158|Feeding practices|feeding practices
253976|NCT02615158|Diet|diet
253977|NCT02615158|Physical activity|physical activity
253978|NCT02615158|Prevention|prevention
253979|NCT02615145|Chronic Hepatitis C|chronic hepatitis c
253980|NCT02615145|Dasabuvir|dasabuvir
733736|NCT00498186|Rotigotine|rotigotine
324664|NCT02214784|SUI|sui
253981|NCT02615145|Ombitasvir+Paritaprevir+Ritonavir|ombitasvir+paritaprevir+ritonavir
253982|NCT02615145|Observational Study|observational study
253983|NCT02615145|Quality of life|quality of life
253984|NCT02615145|Work-ability|work-ability
253985|NCT02615145|Fibrosis|fibrosis
253986|NCT02615145|Cirrhosis|cirrhosis
253987|NCT02615119|heartbeat|heartbeat
253988|NCT02615119|respiration|respiration
253989|NCT02615119|interoception|interoception
253990|NCT02615119|anxiety|anxiety
253991|NCT02615119|eating|eating
253992|NCT02615106|Radiation Therapy|radiation therapy
253993|NCT02615106|Neuroblastoma|neuroblastoma
253994|NCT02615067|Diagnostic|diagnostic
253995|NCT02615067|Active surveillance|active surveillance
253996|NCT02615067|Very low risk|very low risk
253997|NCT02615067|Imaging|imaging
253998|NCT02615067|PSMA|psma
253999|NCT02615067|SPECT/CT|spect/ct
254000|NCT02615067|99mTc|99mtc
254001|NCT02615067|Newly Diagnosed|newly diagnosed
254002|NCT02615067|Prostatectomy|prostatectomy
254003|NCT02615067|Biopsy|biopsy
254004|NCT02615054|Cardiovascular Impairment|cardiovascular impairment
254005|NCT02615054|15-258|15-258
254006|NCT02615041|Meropenem|meropenem
254007|NCT02615041|Ventilator-Associated Pneumonia|ventilator-associated pneumonia
254008|NCT02615041|population pharmacokinetics|population pharmacokinetics
254009|NCT02615041|pharmacokinetics|pharmacokinetics
254010|NCT02615041|pharmacodynamics|pharmacodynamics
254011|NCT02615028|Force plate, Balance ability|force plate, balance ability
254012|NCT02615015|Deoxyribonuclease|deoxyribonuclease
254013|NCT02615002|Cognition|cognition
254014|NCT02615002|mild Alzheimer's disease|mild alzheimer's disease
254015|NCT02615002|Sleep|sleep
254016|NCT02614989|Tremor|tremor
254017|NCT02614989|Thalamotomy|thalamotomy
254018|NCT02614963|Irritable Bowel Syndrome|irritable bowel syndrome
254019|NCT02614963|Clostridium Butyricum|clostridium butyricum
254020|NCT02614911|Early Onset Entheropathy|early onset entheropathy
254021|NCT02614833|Hormone receptor positive|hormone receptor positive
254522|NCT02611635|VKA|vka
254022|NCT02614820|Ischemic preconditioning|ischemic preconditioning
254024|NCT02614820|efficacy|efficacy
254025|NCT02614820|DMD|dmd
254026|NCT02614807|Dietary Supplement|dietary supplement
254027|NCT02614794|Tucatinib|tucatinib
254028|NCT02614794|Capecitabine|capecitabine
254029|NCT02614794|Trastuzumab|trastuzumab
254030|NCT02614794|Xeloda|xeloda
254031|NCT02614794|Herceptin|herceptin
254032|NCT02614794|Breast Cancer|breast cancer
254033|NCT02614794|ARRY-380|arry-380
254034|NCT02614794|ONT-380|ont-380
254035|NCT02614794|HER2 Positive Breast Carcinoma|her2 positive breast carcinoma
254036|NCT02614794|HER2 Positive Locally Advanced Breast Cancer|her2 positive locally advanced breast cancer
254037|NCT02614794|HER-2 Positive Breast Cancer|her-2 positive breast cancer
254038|NCT02614794|HER-2 Positive Breast Carcinoma|her-2 positive breast carcinoma
254039|NCT02614794|HER-2 Positive Locally Advanced Breast Cancer|her-2 positive locally advanced breast cancer
254040|NCT02614794|Recurrent Breast Carcinoma|recurrent breast carcinoma
254041|NCT02614794|Stage IV Breast Cancer|stage iv breast cancer
254042|NCT02614794|Metastatic Breast Cancer|metastatic breast cancer
254043|NCT02614794|Breast Carcinoma|breast carcinoma
254044|NCT02614794|Metastatic Malignant Neoplasm in the Brain|metastatic malignant neoplasm in the brain
254045|NCT02614794|Brain Metastases in Breast Cancer|brain metastases in breast cancer
254046|NCT02614794|Asymptomatic Brain Metastases in Breast Cancer|asymptomatic brain metastases in breast cancer
254047|NCT02614794|Low Symptomatic Brain Metastases in Breast Cancer|low symptomatic brain metastases in breast cancer
254048|NCT02614768|Glucose Monitoring System|glucose monitoring system
254049|NCT02614755|Older Adults Volunteers|older adults volunteers
254050|NCT02614755|Seniors|seniors
254051|NCT02614755|Brain Performance Test|brain performance test
254052|NCT02614729|High Protein|high protein
254053|NCT02614729|Satiety|satiety
254054|NCT02614729|Appetite Control|appetite control
254055|NCT02614729|Protein Distribution|protein distribution
254056|NCT02614729|Cognitive Function|cognitive function
254057|NCT02614729|Ad libitum Food Intake|ad libitum food intake
254058|NCT02614729|Obesity prevention|obesity prevention
254059|NCT02614729|Obesity treatment|obesity treatment
254060|NCT02614703|Barrett's Esophagus|barrett's esophagus
254061|NCT02614703|Acetic Acid Chromoendoscopy|acetic acid chromoendoscopy
254062|NCT02614690|Fracture of the upper limb|fracture of the upper limb
254063|NCT02614677|Disability Evaluation System|disability evaluation system
254064|NCT02614677|SF-12|sf-12
254065|NCT02614677|ICF model|icf model
254066|NCT02614612|Acute Graft Versus Host Disease|acute graft versus host disease
254067|NCT02614599|ADD|add
254068|NCT02614599|ADHD|adhd
254069|NCT02614599|Proteins|proteins
254070|NCT02614599|Dietary|dietary
254071|NCT02614599|Nutrition|nutrition
254072|NCT02614599|QEEG|qeeg
254073|NCT02614599|ERP|erp
254074|NCT02614599|ICA|ica
254075|NCT02614586|Drug Therapy|drug therapy
254076|NCT02614573|Dependent|dependent
254077|NCT02614573|Aged, 80 and over|aged, 80 and over
254078|NCT02614573|Aged|aged
254079|NCT02614560|acute myeloid leukemia|acute myeloid leukemia
254080|NCT02614560|AML|aml
254081|NCT02614560|antibody-drug conjugate|antibody-drug conjugate
254082|NCT02614534|HIPEC|hipec
254083|NCT02614521|Pulmonary veins ablation|pulmonary veins ablation
254084|NCT02614521|Paroxysmal atrial fibrillation|paroxysmal atrial fibrillation
254085|NCT02614482|Children|children
254086|NCT02614482|Antimuscarinics|antimuscarinics
254087|NCT02614482|Antocholinergics|antocholinergics
254088|NCT02614482|Overactive bladder|overactive bladder
254089|NCT02614443|Depression|depression
254090|NCT02614443|Anxiety|anxiety
254091|NCT02614443|Stress|stress
254092|NCT02614443|Online interventions|online interventions
254093|NCT02614443|University students|university students
254094|NCT02614443|CBT|cbt
254095|NCT02614430|Rehabilitation|rehabilitation
254096|NCT02614430|Prediction|prediction
254097|NCT02614430|Inflammation|inflammation
254098|NCT02614404|Plasmodium falciparum|plasmodium falciparum
254099|NCT02614404|Uncomplicated malarial|uncomplicated malarial
254100|NCT02614404|imatinib mesylate|imatinib mesylate
254101|NCT02614404|antimalarials|antimalarials
254102|NCT02614391|Procedural pain|procedural pain
254103|NCT02614391|Phlebotomy|phlebotomy
254104|NCT02614391|Distraction|distraction
254105|NCT02614391|Videogame|videogame
254106|NCT02614391|Computer tablet|computer tablet
254107|NCT02614391|Child|child
254108|NCT02614378|abortive effect|abortive effect
254109|NCT02614326|Depression|depression
254110|NCT02614326|Cognitive risk factors|cognitive risk factors
254111|NCT02614326|Autobiographical memory|autobiographical memory
254112|NCT02614326|Cognitive bias|cognitive bias
254113|NCT02614326|Relapse prevention|relapse prevention
254114|NCT02614313|Fructose|fructose
254115|NCT02614313|Irritable Bowel Syndrome|irritable bowel syndrome
254116|NCT02614313|Breath test|breath test
254117|NCT02614313|Placebo|placebo
254118|NCT02614300|pulmonary rehabilitation|pulmonary rehabilitation
254119|NCT02614300|chest physiotherapy|chest physiotherapy
254120|NCT02614300|non-cystic fibrosis bronchiectasis|non-cystic fibrosis bronchiectasis
254121|NCT02614300|exercise tolerance|exercise tolerance
254122|NCT02614300|bronchiectasis|bronchiectasis
254123|NCT02614300|respiratory therapy|respiratory therapy
254124|NCT02614287|prevention|prevention
254125|NCT02614287|prophylaxis|prophylaxis
254126|NCT02614287|headache|headache
254127|NCT02614274|knee|knee
254128|NCT02614274|pain|pain
254129|NCT02614274|osteoarthritis|osteoarthritis
254130|NCT02614274|nutraceutical|nutraceutical
254131|NCT02614274|nutrition|nutrition
254132|NCT02614274|supplement|supplement
254133|NCT02614274|non-surgical|non-surgical
254134|NCT02614274|biomarker|biomarker
254135|NCT02614274|joint health|joint health
254136|NCT02614261|prevention|prevention
254137|NCT02614261|prophylaxis|prophylaxis
254138|NCT02614261|headache|headache
254139|NCT02614235|Cardiac Arrhythmia|cardiac arrhythmia
254140|NCT02614235|Syncope|syncope
254141|NCT02614235|Ambulatory Electrocardiography Monitoring|ambulatory electrocardiography monitoring
254142|NCT02614222|Computer Assisted Instrument Guidance (CAIG)|computer assisted instrument guidance (caig)
254143|NCT02614222|Peripheral Nerve Block|peripheral nerve block
254144|NCT02614222|Clear Guide ONE|clear guide one
254145|NCT02614222|Needle path|needle path
254146|NCT02614222|Needle Guidance|needle guidance
254147|NCT02614222|Ultrasound|ultrasound
254148|NCT02614209|ED|ed
254149|NCT02614209|BNP|bnp
254150|NCT02614196|prevention|prevention
254151|NCT02614196|prophylaxis|prophylaxis
254152|NCT02614196|headache|headache
254153|NCT02614183|prevention|prevention
254154|NCT02614183|prophylaxis|prophylaxis
254155|NCT02614183|headache|headache
254156|NCT02614157|rectal cancer|rectal cancer
254157|NCT02614157|lateral lymph node dissection|lateral lymph node dissection
254158|NCT02614157|neoadjuvant chemoradiation|neoadjuvant chemoradiation
254159|NCT02614157|total mesorectal excision|total mesorectal excision
254160|NCT02614157|surgery|surgery
254161|NCT02614157|recurrence|recurrence
254162|NCT02614157|metastasis|metastasis
254163|NCT02614157|overall survival|overall survival
254164|NCT02614144|Hospital Acquired Pneumonia|hospital acquired pneumonia
254165|NCT02614144|Mortality|mortality
254166|NCT02614118|Endodontic treatment|endodontic treatment
254167|NCT02614118|non steroid|non steroid
254168|NCT02614118|pain|pain
254169|NCT02614118|pre medication|pre medication
254170|NCT02614092|Mild Cognitive Impairment|mild cognitive impairment
254171|NCT02614092|memory impairment|memory impairment
254172|NCT02614092|Physical Activity|physical activity
254173|NCT02614092|Exercise|exercise
254174|NCT02614092|Cognitive Training|cognitive training
254175|NCT02614092|Veterans|veterans
254176|NCT02614092|Older Adults|older adults
254177|NCT02614079|lumbago|lumbago
254178|NCT02614079|low back pain|low back pain
254179|NCT02614079|leg pain|leg pain
254180|NCT02614040|crystalloid|crystalloid
254181|NCT02614040|acute kidney injury|acute kidney injury
733737|NCT00498186|Neupro®|neupro®
324881|NCT02213926|Btk|btk
254182|NCT02614001|breathing training, congestive heart failure, stroke|breathing training, congestive heart failure, stroke
254183|NCT02613988|Glioblastoma|glioblastoma
254184|NCT02613988|MRI|mri
254185|NCT02613988|standard treatment|standard treatment
254186|NCT02613949|fibromyalgia|fibromyalgia
254187|NCT02613949|pain|pain
254188|NCT02613949|stimulation|stimulation
254189|NCT02613936|traumatic brain injury|traumatic brain injury
254190|NCT02613936|post concussive symptoms|post concussive symptoms
254191|NCT02613936|depression|depression
254192|NCT02613936|executive dysfunction|executive dysfunction
254193|NCT02613936|brain stimulation|brain stimulation
254194|NCT02613923|Breast Cancer|breast cancer
254195|NCT02613923|GO! to sleep|go! to sleep
254196|NCT02613923|sleep|sleep
254197|NCT02613910|Ofatumumab|ofatumumab
254198|NCT02613910|Pemphigus Vulgaris|pemphigus vulgaris
254199|NCT02613910|Long-Term Extension Study|long-term extension study
254200|NCT02613845|Postoperative delirium|postoperative delirium
254201|NCT02613845|Cardiac surgery|cardiac surgery
254202|NCT02613845|Cardiopulmonary bypass|cardiopulmonary bypass
254203|NCT02613845|Risk factor|risk factor
254204|NCT02613832|Noncooperative patients|noncooperative patients
254205|NCT02613806|Dexmedetomidine|dexmedetomidine
254206|NCT02613806|Coughing Response|coughing response
254207|NCT02613806|Postoperative Recovery Quality|postoperative recovery quality
254208|NCT02613806|Thyroid Surgery|thyroid surgery
254209|NCT02613793|Preterm pre-eclampsia|preterm pre-eclampsia
254210|NCT02613793|Neurological dysfunction|neurological dysfunction
254211|NCT02613793|Saccadic reaction time|saccadic reaction time
254212|NCT02613728|Colorectal cancer|colorectal cancer
254213|NCT02613728|Colorectal cancer surgery|colorectal cancer surgery
254214|NCT02613728|Polyp(s)|polyp(s)
254215|NCT02613728|Accelerated Enhanced Recovery|accelerated enhanced recovery
254216|NCT02613728|RecoverMI|recovermi
254217|NCT02613728|Fluid diary|fluid diary
254218|NCT02613728|Questionnaires|questionnaires
254219|NCT02613728|Surveys|surveys
254220|NCT02613728|RecoverMI device|recovermi device
254221|NCT02613715|Flavonoids|flavonoids
254222|NCT02613715|Anthocyanins|anthocyanins
254223|NCT02613715|Blackberry Juice|blackberry juice
254523|NCT02611583|TENS|tens
254224|NCT02613715|Bioavailability|bioavailability
254226|NCT02613702|Free gingival graft|free gingival graft
254227|NCT02613702|keratinized gingival tissue|keratinized gingival tissue
254228|NCT02613689|smokeless tobacco, text message, tobacco cessation, tobacco|smokeless tobacco, text message, tobacco cessation, tobacco
254229|NCT02613637|lung cancer|lung cancer
254230|NCT02613637|registry study|registry study
254231|NCT02613637|Biological Disease Profile|biological disease profile
254232|NCT02613624|KMC in community|kmc in community
254233|NCT02613559|Neovascular Age-Related Macular Degeneration, Subfoveal CNV, TK001|neovascular age-related macular degeneration, subfoveal cnv, tk001
254234|NCT02613546|cognitive-behavioral psychotherapy|cognitive-behavioral psychotherapy
254235|NCT02613546|Sexual Dysfunctions|sexual dysfunctions
254236|NCT02613546|Women|women
254237|NCT02613520|PfSPZ Vaccine|pfspz vaccine
254238|NCT02613520|Plasmodium falciparum|plasmodium falciparum
254239|NCT02613494|clozapine|clozapine
254240|NCT02613494|hypersalivation|hypersalivation
254241|NCT02613494|refractory schizophrenia|refractory schizophrenia
254242|NCT02613468|Pregnancy|pregnancy
254243|NCT02613468|Low birth weight|low birth weight
254244|NCT02613468|Gingivitis|gingivitis
254245|NCT02613468|Inflammation|inflammation
254246|NCT02613468|Periodontitis|periodontitis
254247|NCT02613390|Epidural metastasis|epidural metastasis
254248|NCT02613390|Magnetic resonance imaging|magnetic resonance imaging
254249|NCT02613390|MRI|mri
254250|NCT02613390|Guidance system|guidance system
254251|NCT02613390|Spinal surgery|spinal surgery
254252|NCT02613390|Questionnaires|questionnaires
254253|NCT02613390|Surveys|surveys
254379|NCT02612636|Mechanical ventilation|mechanical ventilation
254254|NCT02613377|Transfusion-related acute lung injury, Red Blood Cell|transfusion-related acute lung injury, red blood cell
254255|NCT02613351|Exercise Tolerance|exercise tolerance
254256|NCT02613351|Lung Diseases, Obstructive|lung diseases, obstructive
254257|NCT02613325|Melanoma|melanoma
254258|NCT02613325|Imaging|imaging
254259|NCT02613325|Pigmented Lesions|pigmented lesions
254260|NCT02613325|Melanoma Management|melanoma management
254261|NCT02613247|Viscosupplementation|viscosupplementation
254262|NCT02613247|Hyaluronic acid|hyaluronic acid
254263|NCT02613247|Synvisc|synvisc
254264|NCT02613247|Synvisc-One|synvisc-one
254265|NCT02613247|Patellofemoral pain syndrome|patellofemoral pain syndrome
254266|NCT02613247|PFPS|pfps
254267|NCT02613247|Anterior knee pain|anterior knee pain
254268|NCT02613247|Runner's knee|runner's knee
254269|NCT02613234|Epilepsy|epilepsy
254270|NCT02613234|128-Channel EEG|128-channel eeg
254271|NCT02613234|Dipole Localization|dipole localization
254272|NCT02613234|Transcranial Direct Current Stimulation|transcranial direct current stimulation
254273|NCT02613221|Metastatic colorectal cancer, Panitumumab, TAS-102|metastatic colorectal cancer, panitumumab, tas-102
254274|NCT02613195|Ischemia-Reperfusion Injury|ischemia-reperfusion injury
254275|NCT02613195|oxidative stress|oxidative stress
254276|NCT02613195|organ preservation|organ preservation
254277|NCT02613195|Hydrogen|hydrogen
254278|NCT02613195|Kidney Transplantation|kidney transplantation
254279|NCT02613169|M. tuberculosis infection|m. tuberculosis infection
254280|NCT02613169|isoniazid|isoniazid
254281|NCT02613169|HIV-exposed infants|hiv-exposed infants
254282|NCT02613156|laparoscopic|laparoscopic
254283|NCT02613156|hepatocellular carcinoma|hepatocellular carcinoma
254284|NCT02613156|recurrence|recurrence
254285|NCT02613143|malignant glaucoma|malignant glaucoma
254286|NCT02613143|zonulo-hyaloido-vitrectomy|zonulo-hyaloido-vitrectomy
254287|NCT02613091|volunteers|volunteers
254288|NCT02613078|Children|children
254289|NCT02613078|Functional Abdominal Pain Syndrome|functional abdominal pain syndrome
254290|NCT02613078|Irritable Bowel Syndrome|irritable bowel syndrome
254291|NCT02613078|Gut-Directed Hypnotherapy|gut-directed hypnotherapy
254292|NCT02613078|Probiotic|probiotic
254293|NCT02613065|Ad libitum|ad libitum
254294|NCT02613065|Energy balance|energy balance
254295|NCT02613065|Protein|protein
254296|NCT02613039|oral contraceptives|oral contraceptives
254297|NCT02613039|female sexuality|female sexuality
254298|NCT02613026|Breast tumor|breast tumor
254299|NCT02613026|Neoadjuvant chemotherapy|neoadjuvant chemotherapy
254300|NCT02613026|Pathological complete remission|pathological complete remission
254302|NCT02612987|Internet based|internet based
254303|NCT02612974|Qurse mafasil|qurse mafasil
254304|NCT02612974|leech therapy|leech therapy
254305|NCT02612974|Hirudinaria granulosa|hirudinaria granulosa
254306|NCT02612961|Mechanically ventilated patients|mechanically ventilated patients
254307|NCT02612961|Normal Saline|normal saline
254308|NCT02612961|Tracheostomy Tube Suctioning|tracheostomy tube suctioning
254309|NCT02612922|Influenza|influenza
254310|NCT02612909|Avian Influenza|avian influenza
254311|NCT02612909|A/H5N1 vaccine|a/h5n1 vaccine
254312|NCT02612909|IVAC|ivac
254313|NCT02612896|Taenia solium|taenia solium
254314|NCT02612896|control|control
254315|NCT02612896|elimination|elimination
254316|NCT02612896|One Health|one health
254317|NCT02612883|Flux measurement|flux measurement
254318|NCT02612870|Breast Cancer|breast cancer
254319|NCT02612870|Sentinel Node|sentinel node
254320|NCT02612870|Sentinel Node Biopsy|sentinel node biopsy
254321|NCT02612870|Breast Surgery|breast surgery
254322|NCT02612857|dermatomyositis|dermatomyositis
254323|NCT02612857|IMO-8400|imo-8400
254324|NCT02612857|Pioneer|pioneer
254325|NCT02612818|coelioscopy|coelioscopy
254326|NCT02612766|celiac disease|celiac disease
254327|NCT02612766|oat|oat
254328|NCT02612766|gluten free diet|gluten free diet
254329|NCT02612753|Aphasia|aphasia
254330|NCT02612753|Speaking therapy|speaking therapy
254331|NCT02612753|Language therapy|language therapy
254332|NCT02612753|transcranial Direct current stimulation|transcranial direct current stimulation
254333|NCT02612740|Bio Oss|bio oss
254334|NCT02612740|critical-size defect|critical-size defect
254335|NCT02612740|bone grafting|bone grafting
254336|NCT02612740|cyst|cyst
254337|NCT02612740|CT bone analysis|ct bone analysis
254338|NCT02612740|alveolar bone|alveolar bone
254339|NCT02612727|Hyperbilirubinemia, Neonatal|hyperbilirubinemia, neonatal
254340|NCT02612714|diabetes|diabetes
254341|NCT02612714|hypercholesterolemia|hypercholesterolemia
254342|NCT02612714|sexual dysfunction|sexual dysfunction
254343|NCT02612714|statin|statin
254344|NCT02612714|testosterone|testosterone
254345|NCT02612701|Myocardial perfusion|myocardial perfusion
254346|NCT02612701|Electronic cigarettes|electronic cigarettes
254347|NCT02612701|Cigarettes|cigarettes
254348|NCT02612701|Cigarette smoking|cigarette smoking
254349|NCT02612688|Advance Care Planning|advance care planning
254350|NCT02612688|Advance Directives|advance directives
254351|NCT02612688|Alzheimer Disease|alzheimer disease
254352|NCT02612688|Dementia|dementia
254353|NCT02612688|Do-Not-Resuscitate Orders|do-not-resuscitate orders
254354|NCT02612688|Enteral Nutrition|enteral nutrition
254355|NCT02612688|Heart Failure|heart failure
254356|NCT02612688|Hospices|hospices
254357|NCT02612688|Hospitalization|hospitalization
254358|NCT02612688|Instructional Films and Videos|instructional films and videos
254359|NCT02612688|Intubation|intubation
254360|NCT02612688|Nursing Homes|nursing homes
254361|NCT02612688|Parenteral Nutrition|parenteral nutrition
254362|NCT02612688|Pragmatic Clinical Trials|pragmatic clinical trials
254363|NCT02612688|Pulmonary Disease, Chronic Obstructive|pulmonary disease, chronic obstructive
254364|NCT02612688|Randomized Controlled Trials|randomized controlled trials
254365|NCT02612688|Resuscitation Orders|resuscitation orders
254366|NCT02612688|Skilled Nursing Facilities|skilled nursing facilities
254367|NCT02612662|AZD4076|azd4076
254368|NCT02612662|Healthy male subjects|healthy male subjects
254369|NCT02612662|Safety|safety
254370|NCT02612662|Subcutaneous|subcutaneous
254371|NCT02612662|Tolerability|tolerability
254372|NCT02612649|Irritable bowel syndrome|irritable bowel syndrome
254373|NCT02612649|YM060|ym060
254374|NCT02612649|Ramosetron|ramosetron
254375|NCT02612649|Survey|survey
254376|NCT02612636|Delirium|delirium
254377|NCT02612636|Ear Plug|ear plug
254378|NCT02612636|Eye Mask|eye mask
254380|NCT02612636|Sleep|sleep
254381|NCT02612597|before and after bedrest|before and after bedrest
254382|NCT02612597|healthy untrained|healthy untrained
254383|NCT02612597|before and after exercise training|before and after exercise training
254384|NCT02612558|Warm antibody autoimmune hemolytic anemia (AIHA)|warm antibody autoimmune hemolytic anemia (aiha)
254385|NCT02612545|Plasmodium Falciparum|plasmodium falciparum
254386|NCT02612545|Artemisinin Combination Therapy|artemisinin combination therapy
254387|NCT02612545|Triple Artemisinin Combination Therapy|triple artemisinin combination therapy
254388|NCT02612545|Piperaquine|piperaquine
254389|NCT02612545|Mefloquine|mefloquine
254390|NCT02612493|obesity surgery|obesity surgery
254391|NCT02612493|type I diabetes|type i diabetes
254392|NCT02612493|weight loss|weight loss
254393|NCT02612493|insulin dosage|insulin dosage
254394|NCT02612493|postsurgery metabolic changes|postsurgery metabolic changes
254395|NCT02612480|endotoxin|endotoxin
254396|NCT02612480|LPS|lps
254397|NCT02612480|ticagrelor|ticagrelor
254398|NCT02612480|clopidogrel|clopidogrel
254399|NCT02612480|acetylsalicyclic acid|acetylsalicyclic acid
254400|NCT02612480|placebo|placebo
254401|NCT02612467|start back tool|start back tool
254402|NCT02612467|stratified care|stratified care
254403|NCT02612467|targeted treatment|targeted treatment
254404|NCT02612454|Eczema|eczema
254405|NCT02612441|stroke|stroke
254406|NCT02612389|COPD|copd
254407|NCT02612389|Qigong|qigong
254408|NCT02612389|ANS|ans
254409|NCT02612389|Meditative Movement|meditative movement
254410|NCT02612389|Flight Attendants|flight attendants
254411|NCT02612389|Secondhand Smoke|secondhand smoke
254412|NCT02612389|Nicotine|nicotine
254413|NCT02612389|Blood Pressure|blood pressure
254414|NCT02612389|6 minute walk test|6 minute walk test
254415|NCT02612363|septic shock|septic shock
254416|NCT02612363|sedation|sedation
254417|NCT02612363|microcirculation|microcirculation
254418|NCT02612350|ctDNA|ctdna
254419|NCT02612350|high risk for developing cancer|high risk for developing cancer
254420|NCT02612350|Plasma|plasma
254421|NCT02612350|Relative Risk|relative risk
254422|NCT02612350|Early Detection of Cancer|early detection of cancer
254423|NCT02612350|Cancer Screening Tests|cancer screening tests
254424|NCT02612350|Cancer Screening|cancer screening
254425|NCT02612337|Meniere's Disease|meniere's disease
254426|NCT02612337|Vertigo|vertigo
254427|NCT02612324|adolescents|adolescents
254428|NCT02612324|teen pregnancy prevention|teen pregnancy prevention
254429|NCT02612324|sexually transmitted infections prevention|sexually transmitted infections prevention
254430|NCT02612324|place-based programs|place-based programs
254431|NCT02612324|health education|health education
254432|NCT02612298|Essential Hypertension|essential hypertension
254433|NCT02612298|Arotinolol|arotinolol
254434|NCT02612298|Morning Blood Pressure|morning blood pressure
254435|NCT02612233|Pain|pain
254436|NCT02612220|liver resection|liver resection
254437|NCT02612181|dexmedetomidine|dexmedetomidine
254438|NCT02612181|microcirculation|microcirculation
254439|NCT02612181|septic shock|septic shock
254440|NCT02612168|Diagnosis|diagnosis
254441|NCT02612168|skin imaging|skin imaging
254442|NCT02612155|Hypoxic-ischemic encephalopathy|hypoxic-ischemic encephalopathy
254443|NCT02612155|autologous cord blood cells|autologous cord blood cells
254444|NCT02612155|newborn infants|newborn infants
254445|NCT02612129|NPC1|npc1
254446|NCT02612129|Niemann-Pick Type C|niemann-pick type c
254447|NCT02612129|Niemann-Pick|niemann-pick
254448|NCT02612129|arimoclomol|arimoclomol
254449|NCT02612129|lysosomal storage disorder|lysosomal storage disorder
254450|NCT02612129|lysosomal storage disease|lysosomal storage disease
254451|NCT02612129|NPC2|npc2
254452|NCT02612129|NP-C|np-c
254453|NCT02612103|Biochemical markers|biochemical markers
254454|NCT02612090|Nutrition|nutrition
254455|NCT02612090|Polyphenols|polyphenols
254456|NCT02612090|Berries|berries
254457|NCT02612090|Lipid Panels|lipid panels
254458|NCT02612051|patients|patients
254459|NCT02612051|FTIH|ftih
254460|NCT02612051|healthy volunteers|healthy volunteers
254461|NCT02612051|GSK3008348|gsk3008348
254462|NCT02612051|[18F]-FBA-A20FMDV2|[18f]-fba-a20fmdv2
254463|NCT02612051|Idiopathic Pulmonary Fibrosis|idiopathic pulmonary fibrosis
254464|NCT02612051|PET|pet
254465|NCT02612038|Obstructive sleep apnea|obstructive sleep apnea
254466|NCT02612038|Expiratory flow limitation|expiratory flow limitation
254467|NCT02612012|breast cancer|breast cancer
254468|NCT02612012|positive sentinel lymph nodes|positive sentinel lymph nodes
254469|NCT02612012|axillary radiotherapy|axillary radiotherapy
254470|NCT02611999|Physicians' ordering behavior with price information|physicians' ordering behavior with price information
254471|NCT02611986|Airway management|airway management
254472|NCT02611986|video laryngoscope|video laryngoscope
254473|NCT02611973|Essential Thrombocythemia|essential thrombocythemia
254474|NCT02611973|Aspirin|aspirin
254475|NCT02611960|PD-1|pd-1
254476|NCT02611960|PD1|pd1
254477|NCT02611960|PD-L1|pd-l1
254478|NCT02611960|PDL1|pdl1
254479|NCT02611947|emphysema|emphysema
254480|NCT02611947|airway remodelling|airway remodelling
254481|NCT02611947|multidetector computed tomography|multidetector computed tomography
254482|NCT02611921|Ketamine|ketamine
254483|NCT02611921|Social Impairment|social impairment
254484|NCT02611921|Autism|autism
254485|NCT02611921|Autistic Disorder|autistic disorder
254486|NCT02611908|CLL|cll
254487|NCT02611908|cancer|cancer
254488|NCT02611908|obinutuzumab|obinutuzumab
254489|NCT02611908|ibrutinib|ibrutinib
254490|NCT02611908|SLL|sll
254491|NCT02611895|Aviremic HIV-1 infected patients|aviremic hiv-1 infected patients
254492|NCT02611895|HAART|haart
254493|NCT02611895|Integrase inhibitor Raltegravir|integrase inhibitor raltegravir
254494|NCT02611895|Ongoing HIV infection|ongoing hiv infection
254495|NCT02611856|twin to twin,|twin to twin,
254496|NCT02611856|transfusion syndrome|transfusion syndrome
254497|NCT02611843|peer support|peer support
254498|NCT02611843|web-based treatment|web-based treatment
254499|NCT02611843|veterans|veterans
254500|NCT02611843|PTSD|ptsd
254501|NCT02611843|Substance Use Disorders|substance use disorders
254502|NCT02611830|Drug therapy|drug therapy
254503|NCT02611817|Drug therapy|drug therapy
254504|NCT02611791|Treatment by Pulsed Radio Frequency, Collagen, Female|treatment by pulsed radio frequency, collagen, female
254505|NCT02611713|Advanced Parkinson's Disease|advanced parkinson's disease
254506|NCT02611713|Duodopa/Duopa|duodopa/duopa
254507|NCT02611713|carbidopa levodopa enteral suspension (CLES)|carbidopa levodopa enteral suspension (cles)
254508|NCT02611713|levodopa-carbidopa intestinal gel (LCIG)|levodopa-carbidopa intestinal gel (lcig)
254509|NCT02611713|OFF time|off time
254510|NCT02611713|motor and non-motor symptoms|motor and non-motor symptoms
254511|NCT02611713|dyskinesia|dyskinesia
254512|NCT02611713|tremor|tremor
254513|NCT02611713|Quality of Life|quality of life
254514|NCT02611713|Observational|observational
254515|NCT02611713|Long-term|long-term
254516|NCT02611713|Caregiver Burden|caregiver burden
254517|NCT02611713|effectiveness|effectiveness
254518|NCT02611713|fluctuations|fluctuations
254519|NCT02611635|non-valvular Atrial Fibrillation|non-valvular atrial fibrillation
254520|NCT02611635|Patient treatment preference|patient treatment preference
254521|NCT02611635|NOAC|noac
254524|NCT02611570|Lung cancer|lung cancer
254525|NCT02611570|Low dose computed tomography|low dose computed tomography
254526|NCT02611570|Screening|screening
254527|NCT02611570|Non-smoker|non-smoker
254528|NCT02611570|Gender issue|gender issue
254529|NCT02611557|MRI|mri
254530|NCT02611557|lymphedema|lymphedema
254531|NCT02611557|manual lymphatic drainage|manual lymphatic drainage
254532|NCT02611544|Fear of Cancer Recurrence|fear of cancer recurrence
254533|NCT02611544|Fear of Cancer Return|fear of cancer return
254534|NCT02611544|Breast Cancer Survivor|breast cancer survivor
254535|NCT02611544|Breast Cancer Remission|breast cancer remission
254536|NCT02611518|Healthy|healthy
254537|NCT02611518|JNJ-54861911|jnj-54861911
254538|NCT02611518|Rosuvastatin|rosuvastatin
254539|NCT02611518|Metformin|metformin
254540|NCT02611505|Healthy|healthy
254541|NCT02611505|Esketamine|esketamine
254542|NCT02611505|Hepatic Impairment|hepatic impairment
254543|NCT02611505|Pharmacokinetics|pharmacokinetics
254544|NCT02611479|patient reported outcomes|patient reported outcomes
254545|NCT02611466|Osteoarthritis|osteoarthritis
254546|NCT02611466|ASP7962|asp7962
254547|NCT02611453|choledocholithiasis|choledocholithiasis
254548|NCT02611453|ERCP|ercp
254549|NCT02611453|cholangiography|cholangiography
254550|NCT02611453|biliary stricture|biliary stricture
254551|NCT02611453|bile ducts|bile ducts
254552|NCT02611453|carbon dioxide|carbon dioxide
254553|NCT02611440|ischemic stroke|ischemic stroke
254554|NCT02611440|medication adherence|medication adherence
254555|NCT02611440|cardiovascular disease prevention|cardiovascular disease prevention
254556|NCT02611427|spine|spine
254557|NCT02611427|lumbar|lumbar
254558|NCT02611427|postoperative|postoperative
254559|NCT02611427|physical activity|physical activity
254560|NCT02611414|functional dyspepsia|functional dyspepsia
254561|NCT02611414|tDCS|tdcs
254562|NCT02611401|multiple sclerosis|multiple sclerosis
254563|NCT02611401|depression|depression
254564|NCT02611401|mindfulness|mindfulness
254565|NCT02611336|Left Ventricular Hypertrophy|left ventricular hypertrophy
254566|NCT02611336|Diastolic Dysfunction|diastolic dysfunction
254567|NCT02611336|Myocardial Fibrosis|myocardial fibrosis
254568|NCT02611336|Acromegaly|acromegaly
254569|NCT02611297|Cryoprobes|cryoprobes
254570|NCT02611297|Cryobiopsy|cryobiopsy
254571|NCT02611297|Transbronchial lung biopsy|transbronchial lung biopsy
254572|NCT02611284|Beractant|beractant
254573|NCT02611284|Feasibility Studies|feasibility studies
254574|NCT02611284|Infant, Premature|infant, premature
254575|NCT02611284|Noninvasive Ventilation|noninvasive ventilation
254576|NCT02611258|Left Ventricular Hypertrophy|left ventricular hypertrophy
254577|NCT02611258|Diastolic Dysfunction|diastolic dysfunction
254578|NCT02611258|Myocardial Fibrosis|myocardial fibrosis
254579|NCT02611258|Cushing's Syndrome|cushing's syndrome
254580|NCT02611245|Thoracic Duct|thoracic duct
254581|NCT02611245|Sentinel lymph node biopsy|sentinel lymph node biopsy
254582|NCT02611232|Diabetes Type 1|diabetes type 1
254583|NCT02611232|Diabetes, Insulin-Dependent|diabetes, insulin-dependent
254584|NCT02611232|Liraglutide|liraglutide
254585|NCT02611232|Preclinical Type 1 Diabetes|preclinical type 1 diabetes
254586|NCT02611232|GLP-1 Analogue|glp-1 analogue
254587|NCT02611206|rTMS|rtms
254588|NCT02611167|mesenchymal stem cells|mesenchymal stem cells
254589|NCT02611154|Healthy Volunteers|healthy volunteers
254590|NCT02611154|Sports Medicine|sports medicine
254591|NCT02611154|Men's Health|men's health
254592|NCT02611154|Athletes|athletes
254593|NCT02611154|Anti-Doping|anti-doping
254594|NCT02611141|Retromolar Intubation|retromolar intubation
254595|NCT02611115|Pulmonary Embolism|pulmonary embolism
254596|NCT02611115|Multidetector Computed Tomography|multidetector computed tomography
254597|NCT02611115|Radiation Dosage|radiation dosage
254598|NCT02611115|Contrast Media|contrast media
254599|NCT02611115|Individualized Medicine|individualized medicine
254600|NCT02611089|Muscle connective tissue|muscle connective tissue
254601|NCT02611089|Small leucine-rich proteoglycans|small leucine-rich proteoglycans
254602|NCT02611089|Limb development|limb development
254603|NCT02611076|smoking cessation|smoking cessation
254604|NCT02611076|self-help|self-help
254605|NCT02611076|Spanish language|spanish language
254606|NCT02611063|allogeneic stem cell transplant|allogeneic stem cell transplant
254607|NCT02611050|patient decision aid|patient decision aid
254608|NCT02611050|multi-vessel coronary artery disease|multi-vessel coronary artery disease
254609|NCT02611037|MPM|mpm
254610|NCT02611037|Unresectable|unresectable
254611|NCT02611037|Respiratory|respiratory
254612|NCT02611037|Intrathoracic|intrathoracic
254613|NCT02611037|Transarterial|transarterial
254614|NCT02611037|Chemoperfusion|chemoperfusion
254615|NCT02611024|lurbinectedin|lurbinectedin
254616|NCT02611024|PM01183|pm01183
254617|NCT02611024|tumors|tumors
254618|NCT02611024|cancer|cancer
254619|NCT02611024|Pharma Mar|pharma mar
254620|NCT02611011|Congo Red Dot Test|congo red dot test
254621|NCT02610985|Imaging, Three-Dimensional|imaging, three-dimensional
254622|NCT02610985|Hysterectomy|hysterectomy
254623|NCT02610985|laparoscopic hysterectomy|laparoscopic hysterectomy
255134|NCT02607891|Epidiolex|epidiolex
254624|NCT02610972|Congo Red test GV-005|congo red test gv-005
254625|NCT02610946|pediatric|pediatric
254626|NCT02610946|adolescent|adolescent
254627|NCT02610946|compliance|compliance
254628|NCT02610933|vascular calcification|vascular calcification
254629|NCT02610933|hemodialysis|hemodialysis
254630|NCT02610933|rivaroxaban|rivaroxaban
254631|NCT02610933|vitamin K2|vitamin k2
254632|NCT02610894|postoperative symptom management|postoperative symptom management
254633|NCT02610894|symptom management|symptom management
254634|NCT02610894|mHealth application|mhealth application
254635|NCT02610868|Cerebral Palsy|cerebral palsy
254636|NCT02610868|ALS|als
254637|NCT02610868|Stroke|stroke
254638|NCT02610868|Neuroleptics|neuroleptics
254639|NCT02610803|stroke|stroke
254640|NCT02610803|ischemic stroke|ischemic stroke
254641|NCT02610803|recurrent stroke|recurrent stroke
254642|NCT02610803|atrial fibrillation|atrial fibrillation
254643|NCT02610803|premature atrial complexes|premature atrial complexes
254644|NCT02610803|heart rhythm monitoring|heart rhythm monitoring
254645|NCT02610803|cardiac telemetry|cardiac telemetry
254646|NCT02610790|connected bracelets, footsteps|connected bracelets, footsteps
254647|NCT02610777|Drug Therapy|drug therapy
254648|NCT02610764|Circulating Tumor Cells|circulating tumor cells
254649|NCT02610764|Response evaluation|response evaluation
254650|NCT02610751|Maternal Smoking|maternal smoking
254651|NCT02610751|Female Fetal Testosterone|female fetal testosterone
254652|NCT02610751|Anogenital Distance|anogenital distance
254653|NCT02610751|Maternal Testosterone|maternal testosterone
254654|NCT02610751|Maternal Cotinine|maternal cotinine
254655|NCT02610712|ketamine|ketamine
254656|NCT02610712|treatment-resistant|treatment-resistant
254657|NCT02610712|depression|depression
254658|NCT02610712|spectroscopy|spectroscopy
254659|NCT02610712|neuroinflammation|neuroinflammation
254660|NCT02610686|Plasmodium vivax|plasmodium vivax
254661|NCT02610686|recurrence|recurrence
254662|NCT02610686|drug resistance|drug resistance
254663|NCT02610634|Parkinson's disease|parkinson's disease
254664|NCT02610634|Older adults|older adults
254665|NCT02610634|Vision|vision
254666|NCT02610634|Cognition|cognition
254667|NCT02610634|Visual cues|visual cues
254668|NCT02610634|Eye-tracking|eye-tracking
254669|NCT02610634|Gait|gait
254670|NCT02610634|Saccades|saccades
254671|NCT02610634|Dual task|dual task
254672|NCT02610634|Visual sampling|visual sampling
254673|NCT02610621|Clinically node negative|clinically node negative
254674|NCT02610621|T1 and T2 invasive breast cancer|t1 and t2 invasive breast cancer
254675|NCT02610595|Idiopathic Membranous Nephropathy|idiopathic membranous nephropathy
254676|NCT02610595|Jianpiyiqi Recipe|jianpiyiqi recipe
254677|NCT02610595|Huoxuejiedu Recipe|huoxuejiedu recipe
254678|NCT02610595|Effectiveness|effectiveness
254679|NCT02610595|Safety|safety
254680|NCT02610582|CNGA3-linked|cnga3-linked
254681|NCT02610569|Colonic capsule|colonic capsule
254682|NCT02610569|ulcerative colitis|ulcerative colitis
254683|NCT02610569|mucosal healing|mucosal healing
254684|NCT02610569|endoscopic score|endoscopic score
254685|NCT02610556|NPC|npc
254686|NCT02610556|concurrent chemotherapy|concurrent chemotherapy
254687|NCT02610556|docetaxel|docetaxel
254688|NCT02610556|cisplatin|cisplatin
254689|NCT02610543|Primary Sjögren's Syndrome|primary sjögren's syndrome
254690|NCT02610530|type 2 diabetes|type 2 diabetes
254691|NCT02610530|metabolic surgery|metabolic surgery
254692|NCT02610530|medical treatment|medical treatment
254693|NCT02610517|Hazardous alcohol use|hazardous alcohol use
254694|NCT02610517|Computer based intervention (CBI)|computer based intervention (cbi)
254695|NCT02610517|Pharmacotherapy|pharmacotherapy
254696|NCT02610504|degenerative arthritis|degenerative arthritis
254697|NCT02610465|Computed Tomography|computed tomography
254698|NCT02610465|Image Reconstruction|image reconstruction
254699|NCT02610465|Iterative Reconstruction|iterative reconstruction
254700|NCT02610452|clown therapy|clown therapy
254701|NCT02610387|tDCS|tdcs
254702|NCT02610387|stroke|stroke
254703|NCT02610387|Spasticity|spasticity
254704|NCT02610374|Gut microbiota composition|gut microbiota composition
254705|NCT02610348|Hepatitis B|hepatitis b
254706|NCT02610348|Hexaxim®|hexaxim®
254707|NCT02610348|Hexyon®|hexyon®
254708|NCT02610348|Hexacima®|hexacima®
254709|NCT02610348|Prevnar®|prevnar®
254710|NCT02610348|DTaP-IPV-HB-Hib hexavalent vaccine|dtap-ipv-hb-hib hexavalent vaccine
254711|NCT02610335|lumbar spinal stenosis|lumbar spinal stenosis
254712|NCT02610309|family-based crisis intervention|family-based crisis intervention
254713|NCT02610309|adolescent suicide|adolescent suicide
254714|NCT02610283|AKI|aki
254715|NCT02610270|Sport|sport
254716|NCT02610270|fatty acid|fatty acid
254717|NCT02610270|omega 3|omega 3
254718|NCT02610257|Parkinson's disease|parkinson's disease
254719|NCT02610257|Freezing of gait|freezing of gait
254720|NCT02610257|Motor blocks|motor blocks
254721|NCT02610257|Somatosensory|somatosensory
254722|NCT02610257|Proprioception|proprioception
254723|NCT02610257|Muscle vibration|muscle vibration
254724|NCT02610257|Handwriting|handwriting
254725|NCT02610231|Parkinson's disease|parkinson's disease
254726|NCT02610231|Moderate to Severe Parkinson's Disease|moderate to severe parkinson's disease
254727|NCT02610218|Cell free DNA|cell free dna
254728|NCT02610218|Circulating tumor cell|circulating tumor cell
254729|NCT02610218|Therapeutic efficacy|therapeutic efficacy
254730|NCT02610205|Caring touch|caring touch
254731|NCT02610205|Tactile massage|tactile massage
254732|NCT02610205|Healing touch|healing touch
254733|NCT02610192|Autologous Protein Solution|autologous protein solution
254734|NCT02610192|Patellofemoral Osteoarthritis|patellofemoral osteoarthritis
254735|NCT02610192|Female|female
254736|NCT02610114|Assisted reproductive technology (ART)|assisted reproductive technology (art)
254737|NCT02610114|zygotes|zygotes
254738|NCT02610114|Z-score (Zygote Score)|z-score (zygote score)
254739|NCT02610114|Infertility|infertility
254740|NCT02610101|Specific Carbohydrate Diet|specific carbohydrate diet
254741|NCT02610101|Diet|diet
254742|NCT02610101|Nutrition|nutrition
254743|NCT02610088|Diabetes|diabetes
254744|NCT02610088|Atherosclerosis|atherosclerosis
254745|NCT02610088|Cardiovascular disease|cardiovascular disease
254746|NCT02610088|Endothelial dysfunction|endothelial dysfunction
254747|NCT02610088|Vascular function|vascular function
254748|NCT02610088|Dapagliflozin|dapagliflozin
254749|NCT02610088|Gliclazide|gliclazide
254750|NCT02610075|AZD1775|azd1775
254751|NCT02610075|Metastatic solid tumors|metastatic solid tumors
254752|NCT02610075|Ovarian cancer|ovarian cancer
254753|NCT02610062|AML|aml
254754|NCT02610062|Acute Myeloid Leukemia|acute myeloid leukemia
254755|NCT02610049|PTSD|ptsd
254756|NCT02610036|diabetes|diabetes
254757|NCT02610036|foot ulcer|foot ulcer
254758|NCT02610010|NPC|npc
254759|NCT02610010|concurrent chemotherapy|concurrent chemotherapy
254760|NCT02610010|IMRT|imrt
254761|NCT02610010|stage II|stage ii
254762|NCT02609997|Intraocular lens|intraocular lens
254763|NCT02609984|immunotherapy|immunotherapy
254764|NCT02609984|CMB305|cmb305
254765|NCT02609984|LV305|lv305
254766|NCT02609984|GLA-SE|gla-se
254767|NCT02609984|Atezolizumab|atezolizumab
254768|NCT02609984|NY-ESO-1|ny-eso-1
254769|NCT02609971|Anterior cruciate ligament|anterior cruciate ligament
254770|NCT02609971|Neuromuscular Performance and balance|neuromuscular performance and balance
254771|NCT02609945|Migraine attacks|migraine attacks
254772|NCT02609932|Interferon-gamma|interferon-gamma
254773|NCT02609932|innate immunity|innate immunity
733939|NCT00497302|women|women
254774|NCT02609919|study of contrast reaction in children under 2 years of age|study of contrast reaction in children under 2 years of age
254775|NCT02609919|safety|safety
254776|NCT02609906|proximal humerus|proximal humerus
254777|NCT02609906|AO 11-A3 fracture|ao 11-a3 fracture
254778|NCT02609906|MultiLoc|multiloc
254779|NCT02609906|Philos augmented|philos augmented
254780|NCT02609893|HCV|hcv
254781|NCT02609880|Psycho-Oncology|psycho-oncology
254782|NCT02609880|Psychoneuroimmunology|psychoneuroimmunology
254783|NCT02609880|Cognitive Behavioral Therapy|cognitive behavioral therapy
254784|NCT02609880|Gynecologic Cancer|gynecologic cancer
254785|NCT02609880|Insomnia|insomnia
254786|NCT02609880|Pain|pain
254787|NCT02609880|Distress|distress
254788|NCT02609880|Cortisol|cortisol
254789|NCT02609880|Cytokines|cytokines
254790|NCT02609854|herniated disc|herniated disc
254791|NCT02609854|sustained acoustic medicine|sustained acoustic medicine
254792|NCT02609854|ultrasound|ultrasound
254793|NCT02609854|CLBP|clbp
254794|NCT02609828|Metastatic cancer bone pain|metastatic cancer bone pain
254795|NCT02609828|Multiple myeloma|multiple myeloma
254796|NCT02609789|Systemic Lupus Erythematosus|systemic lupus erythematosus
254797|NCT02609789|JNJ-55920839|jnj-55920839
254798|NCT02609789|Healthy Volunteers|healthy volunteers
254799|NCT02609789|CNTO 6358|cnto 6358
254800|NCT02609776|Non-Small-Cell Lung Cancer|non-small-cell lung cancer
254801|NCT02609776|JNJ-61186372|jnj-61186372
254802|NCT02609776|First-in-Human|first-in-human
254803|NCT02609776|Human Bispecific Epidermal Growth Factor Receptor (EGFR)|human bispecific epidermal growth factor receptor (egfr)
254804|NCT02609776|c-Mesenchymal-Epithelial Transition (cMet) Antibody|c-mesenchymal-epithelial transition (cmet) antibody
254805|NCT02609776|JNJ372|jnj372
254806|NCT02609776|Exon 20|exon 20
254807|NCT02609776|Exon 20 insertion|exon 20 insertion
254808|NCT02609776|Tyrosine Kinase Inhibitor (TKI) Resistant|tyrosine kinase inhibitor (tki) resistant
254809|NCT02609776|TKI Resistance|tki resistance
254810|NCT02609776|EGFR C797s|egfr c797s
254811|NCT02609776|Met Amplification|met amplification
254812|NCT02609776|Met + EGFR bispecific|met + egfr bispecific
254813|NCT02609737|Radiolabeled Somatostatin Antagonists|radiolabeled somatostatin antagonists
254814|NCT02609737|68Ga-DOTA-JR11|68ga-dota-jr11
254815|NCT02609737|177Lu-DOTA-JR11|177lu-dota-jr11
254816|NCT02609737|Pet scan|pet scan
254817|NCT02609737|CT scan|ct scan
254818|NCT02609737|15-161|15-161
254819|NCT02609724|breast cancer|breast cancer
254820|NCT02609724|lymphedema|lymphedema
254821|NCT02609724|manual lymph drainage|manual lymph drainage
254822|NCT02609724|near infrared fluorescence imaging|near infrared fluorescence imaging
254823|NCT02609698|Stent|stent
254824|NCT02609698|Polymer-free|polymer-free
255135|NCT02607891|Stiripentol|stiripentol
254825|NCT02609698|Antiplatelet therapy|antiplatelet therapy
254826|NCT02609698|Clopidogrel|clopidogrel
254827|NCT02609698|DES|des
254828|NCT02609698|DAPT|dapt
254829|NCT02609685|Thyroid cancer|thyroid cancer
254830|NCT02609685|Active surveillance|active surveillance
254831|NCT02609685|PTMC|ptmc
254832|NCT02609672|Exercise|exercise
254833|NCT02609672|Resilience|resilience
254834|NCT02609659|Chronic Hepatitis C Infection|chronic hepatitis c infection
254835|NCT02609646|Anti-Infective Agents|anti-infective agents
254836|NCT02609646|Pharmacokinetics|pharmacokinetics
254837|NCT02609646|Critically ill patients|critically ill patients
254838|NCT02609594|human amniotic membrane|human amniotic membrane
254839|NCT02609594|compression therapy|compression therapy
254840|NCT02609594|venous leg ulcer|venous leg ulcer
254841|NCT02609581|Non Interventional Study|non interventional study
254842|NCT02609581|NIS|nis
254843|NCT02609581|sublingual immunotherapy|sublingual immunotherapy
254844|NCT02609581|allergen|allergen
254845|NCT02609581|Mites|mites
254846|NCT02609568|Children|children
254847|NCT02609568|Head injury|head injury
254848|NCT02609568|Salivary biomarker|salivary biomarker
254849|NCT02609568|Trauma Brain Injury|trauma brain injury
254850|NCT02609555|TEM|tem
254851|NCT02609555|Rectopexy|rectopexy
254852|NCT02609555|rectal prolapse|rectal prolapse
254853|NCT02609542|oral language|oral language
254854|NCT02609542|STOL|stol
254855|NCT02609542|memory|memory
254856|NCT02609542|eye tracking|eye tracking
254857|NCT02609529|Irritable Bowel Syndrome|irritable bowel syndrome
254858|NCT02609529|Pediatrics|pediatrics
254859|NCT02609529|Nutrition|nutrition
254860|NCT02609516|Multimorbidity|multimorbidity
254861|NCT02609516|Health inequalities|health inequalities
254862|NCT02609516|Ageing|ageing
254863|NCT02609516|Mortality|mortality
254864|NCT02609477|Recreational stimulant users|recreational stimulant users
254865|NCT02609477|Recreational Drug Users|recreational drug users
254866|NCT02609451|quality of life|quality of life
254867|NCT02609451|feasibility|feasibility
254868|NCT02609451|safety|safety
254869|NCT02609451|protective ileostomy closure|protective ileostomy closure
254870|NCT02609438|worksite|worksite
254871|NCT02609438|intervention|intervention
254872|NCT02609438|sitting|sitting
254873|NCT02609399|Influenza|influenza
254874|NCT02609399|Antiviral treatment|antiviral treatment
254875|NCT02609399|Emergency department|emergency department
254876|NCT02609399|Influenza therapeutics|influenza therapeutics
254877|NCT02609399|Rapid influenza testing|rapid influenza testing
254878|NCT02609386|Head and Neck Neoplasms|head and neck neoplasms
254879|NCT02609386|Immunotherapy|immunotherapy
254880|NCT02609386|Cancer|cancer
254881|NCT02609386|Oral Cavity|oral cavity
254882|NCT02609373|shiftwork|shiftwork
254883|NCT02609373|sleep hygiene|sleep hygiene
254884|NCT02609373|prevention|prevention
254885|NCT02609373|intervention|intervention
254886|NCT02609373|occupational|occupational
254887|NCT02609373|biological|biological
254888|NCT02609373|breast cancer|breast cancer
254889|NCT02609373|lifestyle|lifestyle
254890|NCT02609360|Acute Respiratory Failure|acute respiratory failure
254891|NCT02609360|ARDS|ards
254892|NCT02609360|ECMO|ecmo
254893|NCT02609360|Lung transplantation|lung transplantation
254894|NCT02609360|Acid-Base Equilibrium|acid-base equilibrium
254895|NCT02609347|Manual Therapy|manual therapy
254896|NCT02609347|Ankle Fracture|ankle fracture
254897|NCT02609347|Hindfoot Fracture|hindfoot fracture
254898|NCT02609321|Paravertebral|paravertebral
254899|NCT02609321|Single injection|single injection
254900|NCT02609321|Breast surgery|breast surgery
254901|NCT02609321|Analgesia|analgesia
254902|NCT02609308|ankle sprain|ankle sprain
254903|NCT02609308|platelet-rich plasma|platelet-rich plasma
254904|NCT02609308|ankle injuries|ankle injuries
254905|NCT02609295|α-linolenic acid|α-linolenic acid
254906|NCT02609295|perilla oil|perilla oil
254907|NCT02609295|aPTT|aptt
254908|NCT02609295|Collagen-epinephrine closure time|collagen-epinephrine closure time
254909|NCT02609295|Lp-PLA2|lp-pla2
254910|NCT02609282|Sedentary behaviour|sedentary behaviour
254911|NCT02609282|sitting|sitting
254912|NCT02609282|workplace|workplace
254913|NCT02609282|prompts|prompts
254914|NCT02609256|Intracranial hypertension|intracranial hypertension
254915|NCT02609256|cerebral herniation|cerebral herniation
254916|NCT02609256|Stereotactic infarct tissue aspiration|stereotactic infarct tissue aspiration
254917|NCT02609256|fatality|fatality
254918|NCT02609256|disability|disability
254919|NCT02609243|prediabetes|prediabetes
254920|NCT02609243|diabetes mellitus type 2|diabetes mellitus type 2
254921|NCT02609243|obesity|obesity
254922|NCT02609243|NAFLD|nafld
254923|NCT02609243|dyslipoproteinemia|dyslipoproteinemia
254924|NCT02609217|elective|elective
254925|NCT02609217|cesarean|cesarean
254926|NCT02609204|Pattern Electroretinogram (PERG)|pattern electroretinogram (perg)
254927|NCT02609204|Flash Electroretinogram (FERG)|flash electroretinogram (ferg)
254928|NCT02609178|artificial crown|artificial crown
254929|NCT02609178|biomorphic|biomorphic
254930|NCT02609178|functional generated path|functional generated path
254931|NCT02609178|muscle-action theory|muscle-action theory
254932|NCT02609178|anatomic theory|anatomic theory
254933|NCT02609126|osteoarthritis|osteoarthritis
254934|NCT02609126|knee|knee
254935|NCT02609113|Carpal Tunnel Syndrome|carpal tunnel syndrome
254936|NCT02609074|bone substitute|bone substitute
254937|NCT02609074|CPC|cpc
254938|NCT02609074|rhBMP-2|rhbmp-2
254939|NCT02609048|PBC|pbc
254940|NCT02609022|Myasthenia Gravis|myasthenia gravis
254941|NCT02609022|CV-MG01 therapeutic vaccine|cv-mg01 therapeutic vaccine
254942|NCT02609022|Acetylcholine receptor mimetic peptides|acetylcholine receptor mimetic peptides
254943|NCT02609022|Safety|safety
254944|NCT02609022|Immunogenic response|immunogenic response
254945|NCT02609022|First-in-Human|first-in-human
254946|NCT02609022|Proof-of-Concept|proof-of-concept
254947|NCT02609022|Myasterix|myasterix
254948|NCT02609009|Back Pain|back pain
254949|NCT02609009|Adolescent Idiopathic Scoliosis|adolescent idiopathic scoliosis
254950|NCT02609009|Spinal Manipulation|spinal manipulation
254951|NCT02608983|Seaweed|seaweed
254952|NCT02608983|Hydrocolloid|hydrocolloid
254953|NCT02608983|Functional Food|functional food
254954|NCT02608983|Dietary Fibre|dietary fibre
254955|NCT02608983|Prebiotic|prebiotic
254956|NCT02608983|Low molecular weight polysaccharides|low molecular weight polysaccharides
254957|NCT02608983|Alginate|alginate
254958|NCT02608983|Agar|agar
254959|NCT02608983|HYFFI|hyffi
254960|NCT02608983|Low molecular weight seaweed derived hydrocolloids as functional food ingredients|low molecular weight seaweed derived hydrocolloids as functional food ingredients
254961|NCT02608983|subjects|subjects
254962|NCT02608931|delta-9-tetrahydrocannabinol (THC)|delta-9-tetrahydrocannabinol (thc)
254963|NCT02608892|Breastfeeding|breastfeeding
254964|NCT02608892|Skin to skin care|skin to skin care
254965|NCT02608892|Sucrose|sucrose
254966|NCT02608892|Newborn screening|newborn screening
254967|NCT02608892|Blood test|blood test
254968|NCT02608892|Neonate|neonate
254969|NCT02608892|Infant|infant
254970|NCT02608892|Knowledge translation|knowledge translation
254971|NCT02608879|proinflammatory cytokines|proinflammatory cytokines
254972|NCT02608879|microbiome|microbiome
254973|NCT02608879|radiation therapy|radiation therapy
733940|NCT00497289|n-3 PUFA|n-3 pufa
254974|NCT02608866|stereotactic ablative radiotherapy|stereotactic ablative radiotherapy
254975|NCT02608866|spine metastasis|spine metastasis
254976|NCT02608840|slow-wave sleep|slow-wave sleep
254977|NCT02608840|cognition|cognition
254978|NCT02608840|auditory stimulation|auditory stimulation
254979|NCT02608827|Hypertension; slow breathing; sympathetic nerve activity|hypertension; slow breathing; sympathetic nerve activity
254980|NCT02608788|postoperative sore throat|postoperative sore throat
254981|NCT02608788|American Society of Anesthesiologists status|american society of anesthesiologists status
254982|NCT02608788|general anesthesia|general anesthesia
254983|NCT02608788|post-anesthesia care unit(PACU)|post-anesthesia care unit(pacu)
254984|NCT02608775|ANI|ani
254985|NCT02608775|SPI|spi
254986|NCT02608775|Autonomic balance|autonomic balance
254987|NCT02608775|Nociception measurement|nociception measurement
254988|NCT02608762|Pediatric brain tumors|pediatric brain tumors
254989|NCT02608762|Radiation therapy|radiation therapy
254990|NCT02608762|Neurobehavioral functions|neurobehavioral functions
254991|NCT02608762|Proton radiotherapy|proton radiotherapy
254992|NCT02608749|Osteoporosis|osteoporosis
254993|NCT02608749|Fall|fall
254994|NCT02608749|Fracture|fracture
254995|NCT02608749|Sacopenia|sacopenia
254996|NCT02608749|Body Composition|body composition
254997|NCT02608736|head and neck squamous cell carcinoma|head and neck squamous cell carcinoma
254998|NCT02608736|histone deacetylases|histone deacetylases
254999|NCT02608736|valproic acid|valproic acid
255000|NCT02608736|acetylation|acetylation
255001|NCT02608736|chemoprevention|chemoprevention
255002|NCT02608736|DNA methyltransferase|dna methyltransferase
255003|NCT02608736|methylation|methylation
255004|NCT02608723|shock wave|shock wave
255005|NCT02608723|plantar fasciitis|plantar fasciitis
255006|NCT02608723|placebo effect|placebo effect
255007|NCT02608723|nocebo effect|nocebo effect
255008|NCT02608684|immunotherapy|immunotherapy
255009|NCT02608684|platinum-resistant ovarian cancer|platinum-resistant ovarian cancer
255010|NCT02608684|immune checkpoint inhibitors|immune checkpoint inhibitors
255011|NCT02608671|Episiotomy|episiotomy
255012|NCT02608671|continuous suture|continuous suture
255013|NCT02608671|Skin adhesive tape|skin adhesive tape
255014|NCT02608658|Cirrhosis|cirrhosis
255015|NCT02608658|Ascites|ascites
255016|NCT02608658|SBP|sbp
255017|NCT02608632|Renal denervation|renal denervation
255018|NCT02608632|Ablation|ablation
255019|NCT02608619|18F-fluorocholine|18f-fluorocholine
255020|NCT02608619|Pet imaging|pet imaging
255021|NCT02608619|Biopsy|biopsy
255022|NCT02608619|15-268|15-268
255023|NCT02608580|pediatric hospital care|pediatric hospital care
255024|NCT02608580|adult hospital care|adult hospital care
255025|NCT02608580|sickle cell disease|sickle cell disease
255026|NCT02608554|Polycystic ovary sybdrome|polycystic ovary sybdrome
255027|NCT02608554|Taichi|taichi
255136|NCT02607891|Valproate|valproate
255028|NCT02608541|Multiple Rib Fractures, Frail Chest|multiple rib fractures, frail chest
255029|NCT02608476|acne|acne
255030|NCT02608463|neuropathic pain|neuropathic pain
255031|NCT02608463|pregnancy|pregnancy
255032|NCT02608450|acne|acne
255033|NCT02608437|melanoma|melanoma
255034|NCT02608437|ipilimumab|ipilimumab
255035|NCT02608437|SGI-110|sgi-110
255036|NCT02608424|Foot mechanical stimulation|foot mechanical stimulation
255037|NCT02608424|Autonomic nervous system|autonomic nervous system
255038|NCT02608424|Inflammation|inflammation
255039|NCT02608424|Parkinson's disease|parkinson's disease
255040|NCT02608424|Spectral analysis|spectral analysis
255041|NCT02608424|Heart rate variability|heart rate variability
255042|NCT02608424|Blood pressure variability|blood pressure variability
255043|NCT02608398|obesity|obesity
255044|NCT02608398|weight-loss|weight-loss
255045|NCT02608398|metabonomics|metabonomics
255046|NCT02608398|gut microbiome|gut microbiome
255047|NCT02608372|Seaweed|seaweed
255048|NCT02608372|Insulin|insulin
255049|NCT02608372|Glucose tolerance|glucose tolerance
255050|NCT02608372|C-peptide|c-peptide
255051|NCT02608372|Appetide|appetide
255052|NCT02608372|Metabolomics|metabolomics
255053|NCT02608359|Post-Marketing Surveillance|post-marketing surveillance
255054|NCT02608359|Abiraterone Acetate|abiraterone acetate
255055|NCT02608359|Zytiga|zytiga
255056|NCT02608346|Circulating tumor DNA|circulating tumor dna
255057|NCT02608346|BRCA1 mutation|brca1 mutation
255058|NCT02608346|Circulating tumor cells|circulating tumor cells
255059|NCT02608333|Early intervention|early intervention
255060|NCT02608333|ESDM|esdm
255061|NCT02608333|behavioral and developmental intervention|behavioral and developmental intervention
255062|NCT02608320|Healthy|healthy
255063|NCT02608320|JNJ-35685-AAA-G016|jnj-35685-aaa-g016
255064|NCT02608320|JNJ-35685-AAA-G021|jnj-35685-aaa-g021
255065|NCT02608320|DURAGESIC|duragesic
255066|NCT02608320|Fentanyl|fentanyl
255067|NCT02608307|Treatment Decision-Making|treatment decision-making
255068|NCT02608307|Adolescents and Young Adult Oncology|adolescents and young adult oncology
255069|NCT02608294|stroke|stroke
255070|NCT02608294|gait|gait
255071|NCT02608294|balance|balance
255072|NCT02608281|Spectral Mammography|spectral mammography
255073|NCT02608281|Dual energy|dual energy
255074|NCT02608281|Contrast enhanced|contrast enhanced
255075|NCT02608268|Solid tumors|solid tumors
255076|NCT02608268|Melanoma|melanoma
255077|NCT02608268|Non small cell lung cancer|non small cell lung cancer
255078|NCT02608268|NSCLC|nsclc
255079|NCT02608268|Renal cell carcinoma|renal cell carcinoma
255080|NCT02608268|RCC|rcc
255081|NCT02608268|Phase I-Ib/II|phase i-ib/ii
255082|NCT02608268|MBG453|mbg453
255083|NCT02608268|PDR001|pdr001
255084|NCT02608268|Checkpoint inhibitor|checkpoint inhibitor
255085|NCT02608268|PD-1|pd-1
255086|NCT02608268|TIM-3|tim-3
255087|NCT02608164|Healthy adults|healthy adults
255088|NCT02608151|neurodevelopement|neurodevelopement
255089|NCT02608151|Very preterm infant|very preterm infant
255090|NCT02608138|iodine|iodine
255091|NCT02608138|urine|urine
255092|NCT02608138|children|children
255093|NCT02608138|schools|schools
255094|NCT02608138|cognitive performance|cognitive performance
255095|NCT02608138|salt fortification|salt fortification
255096|NCT02608125|FGFR|fgfr
255097|NCT02608099|Atrial fibrillation|atrial fibrillation
255098|NCT02608099|Non-valvular atrial fibrillation|non-valvular atrial fibrillation
255099|NCT02608099|Catheter ablation|catheter ablation
255100|NCT02608099|Apixaban|apixaban
255101|NCT02608099|Warfarin|warfarin
255102|NCT02608099|Harvard Clinical Research Institute|harvard clinical research institute
255103|NCT02608086|PTSD|ptsd
255104|NCT02608086|Trauma|trauma
255105|NCT02608086|Emergency|emergency
255106|NCT02608086|RCT|rct
255107|NCT02608086|Psychological First Aid|psychological first aid
255108|NCT02608021|Alzheimer's Disease|alzheimer's disease
255109|NCT02608021|MRI|mri
255110|NCT02608008|3D-Ultrasound|3d-ultrasound
255111|NCT02608008|Live X-rays|live x-rays
255112|NCT02608008|EchoNavigator System|echonavigator system
255113|NCT02607982|Esophageal cancer|esophageal cancer
255114|NCT02607982|Concurrent chemoradiotherapy|concurrent chemoradiotherapy
255115|NCT02607982|Oxaliplatin|oxaliplatin
255116|NCT02607982|Paclitaxel|paclitaxel
255117|NCT02607982|Survival|survival
255118|NCT02607982|Toxicity|toxicity
255119|NCT02607969|Deformational Plagiocephaly,Treatment,Compliance|deformational plagiocephaly,treatment,compliance
255120|NCT02607956|HIV|hiv
255121|NCT02607943|acute stroke|acute stroke
255122|NCT02607943|hyperglycemia|hyperglycemia
255123|NCT02607943|regular insulin|regular insulin
255124|NCT02607943|long-acting insulin|long-acting insulin
255125|NCT02607930|HIV|hiv
255126|NCT02607917|Cardiovascular Disease|cardiovascular disease
255127|NCT02607904|Cannabidiol|cannabidiol
255128|NCT02607904|GWP42003-P|gwp42003-p
255129|NCT02607904|Epidiolex|epidiolex
255130|NCT02607904|Stiripentol|stiripentol
255131|NCT02607904|Valproate|valproate
255132|NCT02607891|Cannabidiol|cannabidiol
255133|NCT02607891|GWP42003-P|gwp42003-p
255137|NCT02607878|Cardiac arrest|cardiac arrest
255138|NCT02607878|Coma|coma
255139|NCT02607878|Prognosis|prognosis
255140|NCT02607878|Automated pupillometry|automated pupillometry
255141|NCT02607878|EEG|eeg
255142|NCT02607878|Evoked potentials|evoked potentials
255391|NCT02606110|chemotherapy induced|chemotherapy induced
255143|NCT02607878|Targeted Temperature Management (TTM)|targeted temperature management (ttm)
255144|NCT02607852|Patient Reported Outcomes Measure|patient reported outcomes measure
255145|NCT02607852|Burns|burns
255146|NCT02607839|lipid handling by the gut and liver|lipid handling by the gut and liver
255147|NCT02607813|LXH254, CRAF, MAPK, solid tumor, PDR001|lxh254, craf, mapk, solid tumor, pdr001
255148|NCT02607800|Chronic Hepatitis C Infection|chronic hepatitis c infection
255149|NCT02607787|Exercise Rehabilitation|exercise rehabilitation
255150|NCT02607774|Plaque psoriasis|plaque psoriasis
255151|NCT02607774|disease-drug-drug-interaction|disease-drug-drug-interaction
255152|NCT02607774|midazolam|midazolam
255153|NCT02607774|secukinumab|secukinumab
255154|NCT02607761|infertility|infertility
255155|NCT02607761|fertility awareness|fertility awareness
255156|NCT02607761|health interventions|health interventions
255157|NCT02607761|young adults|young adults
255158|NCT02607748|18F-NaF PET|18f-naf pet
255159|NCT02607748|18F-sodium fluoride PET|18f-sodium fluoride pet
255160|NCT02607748|Coronary CTA|coronary cta
255161|NCT02607735|Chronic Hepatitis C Infection|chronic hepatitis c infection
255162|NCT02607644|Intubation|intubation
255163|NCT02607644|Ventilation|ventilation
255164|NCT02607644|Cardiac arrest|cardiac arrest
255165|NCT02607644|prehospital|prehospital
255166|NCT02607644|Laryngeal Masks|laryngeal masks
255167|NCT02607644|Laryngeal Tube|laryngeal tube
255168|NCT02607644|airway management|airway management
255169|NCT02607631|Thymic epithelial tumors|thymic epithelial tumors
255170|NCT02607631|Pembrolizumab|pembrolizumab
255171|NCT02607605|lung cancer|lung cancer
255172|NCT02607605|leptomeningeal metastases|leptomeningeal metastases
255173|NCT02607605|cell-free DNA|cell-free dna
255174|NCT02607592|Non-Small-Cell Lung cancer|non-small-cell lung cancer
255175|NCT02607592|overall toxicity value|overall toxicity value
255176|NCT02607566|Diabetes|diabetes
255177|NCT02607566|Yoga|yoga
255178|NCT02607566|Walking|walking
255179|NCT02607566|Stress|stress
255180|NCT02607566|exercise|exercise
255181|NCT02607566|glycemic control|glycemic control
255182|NCT02607540|Chemoradiotherapy|chemoradiotherapy
255183|NCT02607540|Esophageal Squamous Cancer|esophageal squamous cancer
255184|NCT02607540|Cisplatin-5-fluorouracil|cisplatin-5-fluorouracil
255185|NCT02607501|coil embolization|coil embolization
255186|NCT02607501|bifurcation|bifurcation
255187|NCT02607488|Obese patients|obese patients
255188|NCT02607488|Undergoing bariatric surgery|undergoing bariatric surgery
255189|NCT02607475|telesonography|telesonography
255190|NCT02607475|ultrasound|ultrasound
255191|NCT02607475|robotic telesonography|robotic telesonography
255192|NCT02607449|Tuberculosis|tuberculosis
255193|NCT02607449|Multi-drug resistant TB|multi-drug resistant tb
255194|NCT02607449|TB treatment|tb treatment
255195|NCT02607410|Type 2 diabetes|type 2 diabetes
255196|NCT02607410|sitagliptin|sitagliptin
255197|NCT02607410|NPH insulin|nph insulin
255198|NCT02607410|GLP-1|glp-1
255199|NCT02607371|Patient treatment preference|patient treatment preference
255200|NCT02607371|Non-valvular Atrial Fibrillation|non-valvular atrial fibrillation
255201|NCT02607371|NOAC|noac
255202|NCT02607371|VKA|vka
255203|NCT02607358|Clopidogrel|clopidogrel
255204|NCT02607358|acetacylic acid|acetacylic acid
255205|NCT02607358|antiplatelet therapy|antiplatelet therapy
255206|NCT02607358|HOTPR|hotpr
255207|NCT02607358|VerifyNow|verifynow
255208|NCT02607332|single-center|single-center
255209|NCT02607332|prospective|prospective
255210|NCT02607332|single-arm|single-arm
255211|NCT02607332|open-label|open-label
255212|NCT02607332|phase II|phase ii
255213|NCT02607319|Recurrent Implantation Failure|recurrent implantation failure
255214|NCT02607319|Implantation|implantation
255215|NCT02607319|low molecular weight heparin|low molecular weight heparin
255216|NCT02607319|In vitro Fertilization|in vitro fertilization
255217|NCT02607319|Assisted Reproductive Technology|assisted reproductive technology
255218|NCT02607319|Pregnancy|pregnancy
255219|NCT02607293|Polycystic Ovary Syndrome|polycystic ovary syndrome
255220|NCT02607293|Gonadotropin releasing hormone agonist (GnRH-a)|gonadotropin releasing hormone agonist (gnrh-a)
255221|NCT02607293|Gonal-f|gonal-f
255222|NCT02607293|Assisted Reproductive Technology|assisted reproductive technology
255223|NCT02607280|Diabetic peripheral neuropathic pain|diabetic peripheral neuropathic pain
255224|NCT02607280|post-herpetic neuralgia|post-herpetic neuralgia
255225|NCT02607280|renal impairment|renal impairment
255226|NCT02607267|EOSS|eoss
255227|NCT02607267|Metabolic Surgery|metabolic surgery
255228|NCT02607267|postoperative outcome|postoperative outcome
255229|NCT02607267|30 - day mortality|30 - day mortality
255230|NCT02607241|drug-coated balloon|drug-coated balloon
255231|NCT02607241|bioresorbable scaffold|bioresorbable scaffold
255232|NCT02607241|fractional flow reserve|fractional flow reserve
255525|NCT02605265|UGT1A1|ugt1a1
255233|NCT02607241|optical coherence tomography|optical coherence tomography
255234|NCT02607150|Spinal Fusion|spinal fusion
255235|NCT02607150|Cerebral Oxygenation|cerebral oxygenation
255236|NCT02607150|Blood Transfusion|blood transfusion
255237|NCT02607124|DIPG|dipg
255238|NCT02607111|Dalteparin|dalteparin
255239|NCT02607111|Dosage|dosage
255240|NCT02607111|Home Hemodialysis|home hemodialysis
255241|NCT02607072|APREMEC, aspirin, colorectal cancer, adjuvant therapy, recurrence, metastasis, survival|apremec, aspirin, colorectal cancer, adjuvant therapy, recurrence, metastasis, survival
255242|NCT02607046|rehabilitation|rehabilitation
255243|NCT02607046|exercise training|exercise training
255244|NCT02607033|Exercise|exercise
255245|NCT02607033|Weight Loss|weight loss
255246|NCT02607033|Mobility Limitation|mobility limitation
255247|NCT02607007|Dairy|dairy
255248|NCT02607007|Post-prandial Glycemia|post-prandial glycemia
255249|NCT02607007|Satiety|satiety
255250|NCT02607007|Food Intake|food intake
255251|NCT02607007|Insulin|insulin
255252|NCT02607007|Milk|milk
255253|NCT02607007|Greek yogurt|greek yogurt
255254|NCT02607007|Cheese|cheese
255255|NCT02607007|Soy beverage|soy beverage
255256|NCT02606994|oral mucositis|oral mucositis
255257|NCT02606994|chemotherapy|chemotherapy
255258|NCT02606994|toothpaste|toothpaste
255259|NCT02606981|Water treatment|water treatment
255260|NCT02606981|Child growth|child growth
255261|NCT02606981|Enteric infection|enteric infection
255262|NCT02606955|Bioimpedance|bioimpedance
255263|NCT02606955|Dry weight|dry weight
255264|NCT02606955|Hemodialysis|hemodialysis
255265|NCT02606955|Resistance|resistance
255266|NCT02606942|chondromalacia patellae (CMP)|chondromalacia patellae (cmp)
255267|NCT02606942|patella|patella
255268|NCT02606916|Once-daily Simultaneous Modulated Accelerated Radiotherapy|once-daily simultaneous modulated accelerated radiotherapy
255270|NCT02606916|DDP|ddp
255271|NCT02606916|elderly patients|elderly patients
255272|NCT02606890|Magnetic Resonance Imaging|magnetic resonance imaging
255273|NCT02606890|Stroke Lesion Pattern|stroke lesion pattern
255274|NCT02606890|Atrial Fibrillation|atrial fibrillation
255275|NCT02606890|Stroke|stroke
255276|NCT02606851|Proton Pump Inhibitor, GERD, GERD Q|proton pump inhibitor, gerd, gerd q
255277|NCT02606799|Esophagectomy Inflammation Hemoperfusion Cytokines|esophagectomy inflammation hemoperfusion cytokines
255278|NCT02606786|stabilization exercises|stabilization exercises
255279|NCT02606773|vitamin C supplementation|vitamin c supplementation
255280|NCT02606760|Nail psoriasis|nail psoriasis
255281|NCT02606747|DPN|dpn
255282|NCT02606747|fall|fall
255283|NCT02606747|fMRI|fmri
255284|NCT02606747|balance|balance
255285|NCT02606721|Food Hypersensitivity|food hypersensitivity
255286|NCT02606721|Oral Food Challenge|oral food challenge
255287|NCT02606721|Skin Prick Test|skin prick test
255288|NCT02606721|Food Biomarkers|food biomarkers
255289|NCT02606695|Spine Surgery Patients|spine surgery patients
255290|NCT02606682|Phase 1|phase 1
255291|NCT02606682|Safety|safety
255292|NCT02606682|Tolerability|tolerability
255293|NCT02606682|Pharmacokinetics|pharmacokinetics
255294|NCT02606682|Parkinson's Disease|parkinson's disease
255295|NCT02606630|Relapsing multiple sclerosis|relapsing multiple sclerosis
255296|NCT02606617|Mosapride|mosapride
255297|NCT02606617|blood glucose|blood glucose
255298|NCT02606617|serum lipid|serum lipid
255299|NCT02606604|Functional Electrical Stimulation|functional electrical stimulation
255300|NCT02606604|Cycling|cycling
255301|NCT02606591|Electroencephalograph|electroencephalograph
255302|NCT02606591|EEG|eeg
255303|NCT02606591|Hair sample|hair sample
255304|NCT02606591|Cognitive tests|cognitive tests
255305|NCT02606591|Cortisol analysis|cortisol analysis
255306|NCT02606591|Brain activity|brain activity
255307|NCT02606591|Stress hormones|stress hormones
255308|NCT02606552|drug eluting stent|drug eluting stent
255309|NCT02606552|atrial appendage closure|atrial appendage closure
255310|NCT02606539|gestaional trophoblastic neoplasm|gestaional trophoblastic neoplasm
255311|NCT02606539|hystrectomy|hystrectomy
255312|NCT02606539|chemotherapy|chemotherapy
255313|NCT02606539|methotrxate|methotrxate
255314|NCT02606513|Computed Tomography Urography|computed tomography urography
255315|NCT02606513|Magnetic Resonance Urography|magnetic resonance urography
255316|NCT02606487|CF|cf
255317|NCT02606487|Exacerbation|exacerbation
255318|NCT02606487|Hyerpolarized xenon MRI|hyerpolarized xenon mri
255319|NCT02606487|Pediatrics|pediatrics
255320|NCT02606487|Lung Clearance Index|lung clearance index
255321|NCT02606461|Advanced unresectable dedifferentiated liposarcoma|advanced unresectable dedifferentiated liposarcoma
255322|NCT02606461|selinexor|selinexor
255323|NCT02606461|KCP-330|kcp-330
255324|NCT02606461|Karyopharm|karyopharm
255325|NCT02606461|Phase 2 / 3|phase 2 / 3
255326|NCT02606461|dedifferentiated liposarcoma|dedifferentiated liposarcoma
255327|NCT02606461|Liposarcoma|liposarcoma
255328|NCT02606448|pain control|pain control
255329|NCT02606448|patient satisfaction|patient satisfaction
255330|NCT02606448|liposomal bupivacaine|liposomal bupivacaine
255331|NCT02606448|Anterior cruciate ligament reconstruction|anterior cruciate ligament reconstruction
255523|NCT02605265|Neoadjuvant Chemoradiation|neoadjuvant chemoradiation
255332|NCT02606422|transcranial direct current stimulation (tDCS)|transcranial direct current stimulation (tdcs)
255333|NCT02606422|neurodegeneration|neurodegeneration
255334|NCT02606422|language therapy|language therapy
255335|NCT02606422|Primary Progressive Aphasia (PPA)|primary progressive aphasia (ppa)
255336|NCT02606370|Unstable Shoes;Trunk muscles;Lumbar lordosis;Low Back Pain|unstable shoes;trunk muscles;lumbar lordosis;low back pain
255337|NCT02606318|Occupational Therapy|occupational therapy
255338|NCT02606318|Quality of Life|quality of life
255339|NCT02606305|Epithelial ovarian cancer|epithelial ovarian cancer
255340|NCT02606305|Fallopian tube cancer|fallopian tube cancer
255341|NCT02606305|Primary peritoneal cancer|primary peritoneal cancer
255342|NCT02606305|IMGN853|imgn853
255343|NCT02606305|ADC|adc
255344|NCT02606305|Antibody drug conjugate|antibody drug conjugate
255345|NCT02606305|ImmunoGen|immunogen
255346|NCT02606305|Antibody|antibody
255347|NCT02606305|Phase 1|phase 1
255348|NCT02606305|Folate receptor alpha|folate receptor alpha
255349|NCT02606253|loop diuretics|loop diuretics
255350|NCT02606253|thiazide diuretics|thiazide diuretics
255351|NCT02606253|vasopressin antagonists|vasopressin antagonists
255352|NCT02606253|diuretic resistance|diuretic resistance
255353|NCT02606253|heart failure|heart failure
255354|NCT02606227|Pregnant smokers|pregnant smokers
255355|NCT02606227|smoking cessation|smoking cessation
255356|NCT02606227|financial incentives|financial incentives
255357|NCT02606227|control group|control group
255358|NCT02606227|randomized study|randomized study
255359|NCT02606214|Tuberculosis|tuberculosis
255360|NCT02606214|TBA-354|tba-354
255361|NCT02606214|Pulmonary Tuberculosis|pulmonary tuberculosis
255362|NCT02606214|TB|tb
255363|NCT02606201|stress urinary incontinence|stress urinary incontinence
255364|NCT02606201|intrinsic sphincter deficiency|intrinsic sphincter deficiency
255365|NCT02606201|myofiber|myofiber
255366|NCT02606201|autologous|autologous
255367|NCT02606201|skeletal muscle precursor cells|skeletal muscle precursor cells
255368|NCT02606201|autologous serum|autologous serum
255369|NCT02606188|Modified High-flow nasal cannula|modified high-flow nasal cannula
255370|NCT02606188|Bronchoscopy|bronchoscopy
255371|NCT02606188|Oxygen therapy|oxygen therapy
255372|NCT02606175|health literacy|health literacy
255373|NCT02606175|patient medication knowledge|patient medication knowledge
255374|NCT02606175|kidney transplantation|kidney transplantation
255375|NCT02606175|medication adherence|medication adherence
255376|NCT02606175|kidney transplant|kidney transplant
255377|NCT02606175|renal transplantation|renal transplantation
255378|NCT02606149|Lung cancer|lung cancer
255379|NCT02606149|chemotherapy outcome|chemotherapy outcome
255380|NCT02606149|ethics|ethics
255381|NCT02606149|information|information
255382|NCT02606136|Duchenne|duchenne
255383|NCT02606136|muscular|muscular
255384|NCT02606136|dystrophy|dystrophy
255385|NCT02606136|DMD|dmd
255386|NCT02606136|non-ambulatory|non-ambulatory
255387|NCT02606123|Prostate Cancer|prostate cancer
255388|NCT02606123|Metastatic castration-resistant prostate cancer|metastatic castration-resistant prostate cancer
255389|NCT02606110|ReBuilder|rebuilder
255390|NCT02606110|breast cancer|breast cancer
255392|NCT02606084|Renal Impairment|renal impairment
255393|NCT02606084|Healthy|healthy
255394|NCT02606084|Esketamine|esketamine
255395|NCT02606071|cardiac resynchronization therapy|cardiac resynchronization therapy
255396|NCT02606071|multipoint left ventricular pacing|multipoint left ventricular pacing
255397|NCT02606045|menorrhagia|menorrhagia
255398|NCT02606045|VWD|vwd
255399|NCT02606032|Fecal Microbiota Transplant|fecal microbiota transplant
255400|NCT02606032|Antibiotics|antibiotics
255401|NCT02606019|Pentraxin 3|pentraxin 3
255402|NCT02606019|Vascular Endothelial Growth Factor|vascular endothelial growth factor
255403|NCT02606019|dengue|dengue
255404|NCT02606006|Physical Therapy Modalities|physical therapy modalities
255405|NCT02606006|Motivation|motivation
255406|NCT02606006|Patient Participation|patient participation
255407|NCT02606006|Animal Assisted Therapy|animal assisted therapy
255408|NCT02605993|complement inhibitor|complement inhibitor
255409|NCT02605967|PDR001,|pdr001,
255410|NCT02605967|nasopharyngeal cancer,|nasopharyngeal cancer,
255411|NCT02605967|moderately differentiated/undifferentiated,|moderately differentiated/undifferentiated,
255412|NCT02605967|locally advanced,|locally advanced,
255413|NCT02605967|recurrent or metastatic NPC,|recurrent or metastatic npc,
255414|NCT02605967|after first- line platinum-based therapy|after first- line platinum-based therapy
255415|NCT02605954|HIV 1 Infection|hiv 1 infection
255416|NCT02605954|HIV|hiv
255417|NCT02605954|Virologically-Suppressed|virologically-suppressed
255418|NCT02605954|Antiretroviral agents|antiretroviral agents
255419|NCT02605941|DNA methylation|dna methylation
255420|NCT02605941|Cervical cancer|cervical cancer
255421|NCT02605928|Arthritis|arthritis
255422|NCT02605928|Bioimpedance|bioimpedance
255423|NCT02605928|Glucocorticoid|glucocorticoid
255424|NCT02605928|Intra-articular injection|intra-articular injection
255425|NCT02605928|Needle Guidance|needle guidance
255426|NCT02605902|Chronic tic disorders|chronic tic disorders
255427|NCT02605902|Tourette syndrome|tourette syndrome
255524|NCT02605265|Irinotecan|irinotecan
255428|NCT02605876|anterior cruciate ligament reconstruction|anterior cruciate ligament reconstruction
255429|NCT02605863|Enzalutamide|enzalutamide
255430|NCT02605863|Non-Muscle Invasive Bladder Cancer|non-muscle invasive bladder cancer
255431|NCT02605863|Androgen Deprivation Therapy|androgen deprivation therapy
255432|NCT02605850|heart health|heart health
255433|NCT02605811|limited small cell lung cancer|limited small cell lung cancer
255434|NCT02605811|brain metastases|brain metastases
255435|NCT02605811|prophylactic cranial radiotherapy|prophylactic cranial radiotherapy
255436|NCT02605811|temozolomide|temozolomide
255437|NCT02605785|PSP|psp
255438|NCT02605733|Premature infant|premature infant
255439|NCT02605733|Amplitude integrated EEG|amplitude integrated eeg
255440|NCT02605733|Near-infrared spectroscopy|near-infrared spectroscopy
255441|NCT02605707|Endothelial Progenitor Cells|endothelial progenitor cells
255442|NCT02605707|Transplantation|transplantation
255443|NCT02605707|Stroke|stroke
255444|NCT02605681|midkine|midkine
255445|NCT02605681|endothelial injury|endothelial injury
255446|NCT02605681|sepsis|sepsis
255447|NCT02605681|angiotensin-converting enzyme|angiotensin-converting enzyme
255448|NCT02605681|angiotensin II|angiotensin ii
255449|NCT02605668|Anxiety Disorders|anxiety disorders
255450|NCT02605668|Extinction Learning|extinction learning
255451|NCT02605668|Optimized Extinction|optimized extinction
255452|NCT02605668|Behavioral Therapy|behavioral therapy
255453|NCT02605668|Massed Confrontation|massed confrontation
255454|NCT02605668|Social Anxiety Disorder|social anxiety disorder
255455|NCT02605668|Specific Phobia|specific phobia
255456|NCT02605668|Panic Disorder|panic disorder
255457|NCT02605668|Agoraphobia|agoraphobia
255458|NCT02605655|obesity|obesity
255459|NCT02605655|hyperlipidemia|hyperlipidemia
255460|NCT02605655|hyperglycemia|hyperglycemia
255461|NCT02605642|CT-P13|ct-p13
255462|NCT02605642|Inflectra|inflectra
255463|NCT02605642|Remsima|remsima
255464|NCT02605642|Remicade|remicade
255465|NCT02605642|Infliximab|infliximab
255466|NCT02605642|Observational|observational
255467|NCT02605642|Follow-up|follow-up
255468|NCT02605642|Safety|safety
255469|NCT02605603|Gaucher Type 1, Gaucher Type 2, Gaucher Type 3|gaucher type 1, gaucher type 2, gaucher type 3
255470|NCT02605577|late preterm infants|late preterm infants
255471|NCT02605577|nutrition|nutrition
255472|NCT02605577|systemic management|systemic management
255473|NCT02605525|IgAN|igan
255474|NCT02605512|Radiotherapy|radiotherapy
255475|NCT02605512|Echocardiography|echocardiography
255476|NCT02605512|Strain strain rate|strain strain rate
255477|NCT02605512|Coronary computed tomography angiography|coronary computed tomography angiography
255478|NCT02605512|Segments of coronary arteries|segments of coronary arteries
255479|NCT02605512|Subclinical functional and anatomical cardiac lesions|subclinical functional and anatomical cardiac lesions
255480|NCT02605512|Biomarkers|biomarkers
255481|NCT02605512|Heart dosimetry|heart dosimetry
255482|NCT02605486|palbociclib|palbociclib
255483|NCT02605486|bicalutamide|bicalutamide
255484|NCT02605486|AR(+)|ar(+)
255485|NCT02605486|15-207|15-207
255486|NCT02605460|Bone Marrow Transplantation|bone marrow transplantation
255487|NCT02605460|Conditioning Regimen|conditioning regimen
255488|NCT02605434|Parkinson's Disease|parkinson's disease
255489|NCT02605434|Fluctuating Parkinson's Disease|fluctuating parkinson's disease
255490|NCT02605434|Advanced Parkinson's Disease|advanced parkinson's disease
255491|NCT02605434|Carbidopa|carbidopa
255492|NCT02605434|Levodopa|levodopa
255493|NCT02605434|Accordion|accordion
255494|NCT02605434|Accordance|accordance
255495|NCT02605421|High-risk neuroblastoma|high-risk neuroblastoma
255496|NCT02605421|Neuroblastoma|neuroblastoma
255497|NCT02605421|Myeloablative chemotherapy|myeloablative chemotherapy
255498|NCT02605421|Myeloablative consolidation chemotherapy|myeloablative consolidation chemotherapy
255499|NCT02605421|Autologous peripheral blood stem cell rescue|autologous peripheral blood stem cell rescue
255500|NCT02605421|PBSC|pbsc
255501|NCT02605421|Autologous stem cell rescue|autologous stem cell rescue
255502|NCT02605395|Bioequivalence|bioequivalence
255503|NCT02605395|Fed condition|fed condition
255504|NCT02605395|PARIET 20 mg|pariet 20 mg
255505|NCT02605395|IDIAZOLE 20mg|idiazole 20mg
255506|NCT02605395|Rabeprazole|rabeprazole
255507|NCT02605382|Dental Implantation|dental implantation
255508|NCT02605382|Chlorhexidine gluconate|chlorhexidine gluconate
255509|NCT02605356|Radium-223 dichloride|radium-223 dichloride
255510|NCT02605356|bortezomib|bortezomib
255511|NCT02605356|dexamethasone|dexamethasone
255512|NCT02605356|early relapsed multiple myeloma|early relapsed multiple myeloma
255513|NCT02605356|combination therapy multiple myeloma|combination therapy multiple myeloma
255514|NCT02605343|PGx|pgx
255515|NCT02605343|pharmacogenetic testing|pharmacogenetic testing
255516|NCT02605343|Pain Management|pain management
255517|NCT02605343|AltheaDx|altheadx
255518|NCT02605343|Post-Operative Pain Management|post-operative pain management
255519|NCT02605317|Emergency Physicians|emergency physicians
255520|NCT02605317|Consulting Physicians|consulting physicians
255521|NCT02605317|WhatsApp|whatsapp
255522|NCT02605278|Primary Health Care, Patient Education, Care Managament|primary health care, patient education, care managament
255526|NCT02605252|Chronic hepatitis B|chronic hepatitis b
255527|NCT02605252|Peginterferon alfa-2b|peginterferon alfa-2b
255528|NCT02605252|Nucleotide analogue|nucleotide analogue
255529|NCT02605200|Diabetes|diabetes
255530|NCT02605200|Endocrinology|endocrinology
255531|NCT02605200|Pediatrics|pediatrics
255532|NCT02605187|cesarean|cesarean
255533|NCT02605187|postoperative pain|postoperative pain
255534|NCT02605187|patient choice|patient choice
255535|NCT02605161|Blood brain barrier|blood brain barrier
255536|NCT02605161|movement disorder|movement disorder
255537|NCT02605161|deep brain stimulation|deep brain stimulation
255538|NCT02605161|essential tremor|essential tremor
255539|NCT02605161|cervical dystonia|cervical dystonia
255540|NCT02605161|magnetic resonance imaging|magnetic resonance imaging
255541|NCT02605161|neostriatum|neostriatum
255542|NCT02605148|Islet autoimmunity|islet autoimmunity
255543|NCT02605148|gluten free diet|gluten free diet
255544|NCT02605148|prediabetes|prediabetes
255545|NCT02605148|prevention|prevention
255546|NCT02605148|type 1 diabetes|type 1 diabetes
255547|NCT02605148|glucose tolerance test|glucose tolerance test
255548|NCT02605122|pneumonia|pneumonia
255549|NCT02605122|macrolide|macrolide
255550|NCT02605122|pediatric|pediatric
255551|NCT02605109|MERS-CoV|mers-cov
255552|NCT02605109|Infection control|infection control
255553|NCT02605109|Case-control studies|case-control studies
255554|NCT02605096|suspected scaphoid fracture|suspected scaphoid fracture
255555|NCT02605083|Cancer|cancer
255556|NCT02605083|Neoplasm|neoplasm
255557|NCT02605083|Solid Tumor|solid tumor
255558|NCT02605083|Breast|breast
255559|NCT02605083|Head and Neck|head and neck
255560|NCT02605083|Lung|lung
255561|NCT02605083|Pancreatic|pancreatic
255562|NCT02605083|Hepatic|hepatic
255563|NCT02605083|Melanoma|melanoma
326618|NCT02205593|eczema|eczema
255564|NCT02605083|Colon|colon
255565|NCT02605083|Renal|renal
255566|NCT02605083|Thyroid|thyroid
255567|NCT02605083|Prostate|prostate
255568|NCT02605083|Ovarian|ovarian
255569|NCT02605083|MNK1|mnk1
255570|NCT02605083|MNK2|mnk2
255571|NCT02605083|eIF4E|eif4e
255572|NCT02605005|interscalene block, general anesthesia, shoulder arthroscopy, cerebral oxygen saturation, beach chair position|interscalene block, general anesthesia, shoulder arthroscopy, cerebral oxygen saturation, beach chair position
255573|NCT02604992|Comparative Bioavailability|comparative bioavailability
255574|NCT02604966|P. falciparum|p. falciparum
255575|NCT02604966|resistance to artemisinin|resistance to artemisinin
255576|NCT02604966|Central Vietnam|central vietnam
255577|NCT02604953|glaucoma|glaucoma
255578|NCT02604953|VEP|vep
255579|NCT02604953|PERG|perg
255580|NCT02604953|SD-tVEP|sd-tvep
255581|NCT02604953|ss-PERG|ss-perg
255582|NCT02604940|Postoperative narcotic requirements|postoperative narcotic requirements
255583|NCT02604940|Dexmedetomidine|dexmedetomidine
255584|NCT02604940|Bariatric Surgery|bariatric surgery
255585|NCT02604901|medication adherence|medication adherence
255586|NCT02604901|community pharmacies|community pharmacies
255587|NCT02604901|screening and brief intervention|screening and brief intervention
255588|NCT02604888|Baldness|baldness
255589|NCT02604888|Alopecia Areata|alopecia areata
255590|NCT02604888|Alopecia|alopecia
255591|NCT02604888|Hair loss|hair loss
255592|NCT02604784|Pressurized Intra Peritoneal Air-flow Chemotherapy (PIPAC)|pressurized intra peritoneal air-flow chemotherapy (pipac)
255593|NCT02604784|Chemotherapy|chemotherapy
255594|NCT02604784|Peritoneal Carcinomatosis|peritoneal carcinomatosis
255595|NCT02604758|Alcoholics [M01.066]|alcoholics [m01.066]
255596|NCT02604745|degenerative mitral regurgitation|degenerative mitral regurgitation
255597|NCT02604667|Biomarkers|biomarkers
255598|NCT02604667|Mechanisms|mechanisms
255599|NCT02604667|Transcranial Doppler|transcranial doppler
255600|NCT02604641|skin rejuvenation|skin rejuvenation
255601|NCT02604641|anti-ageing effects|anti-ageing effects
255602|NCT02604641|minimal erythema dose|minimal erythema dose
255603|NCT02604641|dermis structure|dermis structure
255604|NCT02604641|physiological skin condition|physiological skin condition
255605|NCT02604641|wrinkling|wrinkling
255606|NCT02604641|dry skin|dry skin
255607|NCT02604628|Pneumonia|pneumonia
255608|NCT02604628|Antibiotic Stewardship|antibiotic stewardship
255609|NCT02604628|Stepped wedge|stepped wedge
255610|NCT02604628|Antibiotic|antibiotic
255611|NCT02604615|Chemoradiotherapy|chemoradiotherapy
255612|NCT02604615|Esophageal Squamous Cancer|esophageal squamous cancer
255613|NCT02604615|Capecitabine and oxaliplatin|capecitabine and oxaliplatin
255614|NCT02604615|Chinese|chinese
255615|NCT02604615|Randomized Controlled Trials|randomized controlled trials
255616|NCT02604602|PPH|pph
255617|NCT02604589|Catheters, Indwelling|catheters, indwelling
255618|NCT02604589|Infusion Pumps|infusion pumps
255619|NCT02604589|Anesthesia, Local|anesthesia, local
255620|NCT02604589|Analgesia, Patient-Controlled|analgesia, patient-controlled
255621|NCT02604589|Bupivacaine|bupivacaine
255622|NCT02604576|functional dyspepsia|functional dyspepsia
255623|NCT02604524|Type 1 Diabetes Mellitus (T1DM)|type 1 diabetes mellitus (t1dm)
255624|NCT02604524|Artificial Pancreas (AP)|artificial pancreas (ap)
255721|NCT02604004|LC-MS/MS|lc-ms/ms
255625|NCT02604524|Sensor-Augmented Pump (SAP) Therapy|sensor-augmented pump (sap) therapy
255626|NCT02604524|Closed Loop Control|closed loop control
255627|NCT02604524|Insulin Pump|insulin pump
255628|NCT02604524|Continuous Glucose Monitor (CGM)|continuous glucose monitor (cgm)
255629|NCT02604511|Waldenstrom's Macroglobulinemia|waldenstrom's macroglobulinemia
255630|NCT02604485|Hypoglycemia|hypoglycemia
255631|NCT02604485|Congenital Hyperinsulinism|congenital hyperinsulinism
255632|NCT02604472|Nasopharyngeal carcinoma|nasopharyngeal carcinoma
255633|NCT02604472|induction chemotherapy|induction chemotherapy
255634|NCT02604472|concurrent chemoradiotherapy|concurrent chemoradiotherapy
255635|NCT02604446|Arthroplasty, Replacement, Knee|arthroplasty, replacement, knee
255636|NCT02604446|Analgesics|analgesics
255637|NCT02604446|Administration and dosage|administration and dosage
255638|NCT02604446|Knee|knee
255639|NCT02604446|Postoperational care|postoperational care
255640|NCT02604446|Pain management|pain management
255641|NCT02604433|ACE-536|ace-536
255642|NCT02604433|Safety|safety
255643|NCT02604433|Efficacy|efficacy
255644|NCT02604433|Placebo|placebo
255645|NCT02604433|Red Blood Cell Transfusions|red blood cell transfusions
255646|NCT02604433|Beta -Thalassemia|beta -thalassemia
255647|NCT02604394|Rheolytic Thrombectomy|rheolytic thrombectomy
255648|NCT02604394|Percutaneous Coronary Intervention|percutaneous coronary intervention
255649|NCT02604394|Angioplasty|angioplasty
255650|NCT02604394|Cardiac Magnetic Resonance Imaging|cardiac magnetic resonance imaging
255651|NCT02604394|Myocardial Salvage Index|myocardial salvage index
255652|NCT02604394|STEMI, ST elevation Myocardial Infarction|stemi, st elevation myocardial infarction
255653|NCT02604394|Corrected TIMI Frame Count, cTFC|corrected timi frame count, ctfc
255654|NCT02604394|Index of microcirculatory resistance, thermodilution, IMR|index of microcirculatory resistance, thermodilution, imr
255655|NCT02604381|Osteoarthritis|osteoarthritis
255656|NCT02604381|Knee|knee
255657|NCT02604381|Glucosamine Sulfate|glucosamine sulfate
255658|NCT02604381|Ginkgo Biloba|ginkgo biloba
255659|NCT02604381|WOMAC|womac
255660|NCT02604381|Joint Health Wellness|joint health wellness
255661|NCT02604381|Interleukin-1-beta|interleukin-1-beta
255662|NCT02604368|hemoglobin SS|hemoglobin ss
255663|NCT02604368|hemoglobin SC|hemoglobin sc
255664|NCT02604368|hemoglobin S/β°-thalassemia|hemoglobin s/β°-thalassemia
255665|NCT02604329|low level laser therapy|low level laser therapy
255666|NCT02604329|oral mucositis|oral mucositis
255667|NCT02604329|child|child
255668|NCT02604316|Overweight and Obesity|overweight and obesity
255669|NCT02604316|Appetite|appetite
255670|NCT02604316|Gut hormones and obesity|gut hormones and obesity
255671|NCT02604316|Arabinoxylan, Beta-Glucan|arabinoxylan, beta-glucan
255672|NCT02604316|SmartPill|smartpill
255673|NCT02604303|Abdominal Aortic Aneurysm|abdominal aortic aneurysm
255674|NCT02604303|RhoA|rhoa
255675|NCT02604303|Biomarker|biomarker
255676|NCT02604290|Kinesio taping|kinesio taping
255677|NCT02604290|Neuromuscular taping|neuromuscular taping
255678|NCT02604290|Targeted treatment|targeted treatment
255679|NCT02604290|Chronic low back pain|chronic low back pain
255680|NCT02604290|Randomised controlled trial|randomised controlled trial
255681|NCT02604277|Psychology|psychology
255682|NCT02604238|Pulmonary Embolism at intermediate risk|pulmonary embolism at intermediate risk
255683|NCT02604225|Anaethesiology|anaethesiology
255684|NCT02604186|Spasticity|spasticity
255685|NCT02604186|Botulinum Toxin|botulinum toxin
255686|NCT02604186|Hereditary Spastic Paraplegia|hereditary spastic paraplegia
255687|NCT02604134|silver nitrate|silver nitrate
255688|NCT02604134|children|children
255689|NCT02604134|dental caries|dental caries
255690|NCT02604134|medical management|medical management
255691|NCT02604134|quality of life|quality of life
255692|NCT02604121|oral cavity|oral cavity
255693|NCT02604121|cancerous and precancerous lesions|cancerous and precancerous lesions
255694|NCT02604108|physical activity|physical activity
255695|NCT02604108|healthy diet|healthy diet
255696|NCT02604095|Acanthosis nigricans|acanthosis nigricans
255697|NCT02604095|Obesity|obesity
255698|NCT02604069|Breast reconstruction|breast reconstruction
255699|NCT02604069|Breast cancer|breast cancer
255700|NCT02604069|Microsurgery|microsurgery
255701|NCT02604069|Continuous flap monitor|continuous flap monitor
255702|NCT02604043|supraglottic pH|supraglottic ph
255703|NCT02604017|HCV GT1|hcv gt1
255704|NCT02604017|Non-cirrhotic|non-cirrhotic
255705|NCT02604017|RBV Free|rbv free
255706|NCT02604017|Without cirrhosis|without cirrhosis
255707|NCT02604017|Chronic Hepatitis C|chronic hepatitis c
255708|NCT02604017|Hepatitis C Genotype 1 (GT1)|hepatitis c genotype 1 (gt1)
255709|NCT02604017|IFN free|ifn free
255710|NCT02604017|Hepatitis C|hepatitis c
255711|NCT02604017|Ribavirin Free|ribavirin free
255712|NCT02604017|Interferon (IFN) Free|interferon (ifn) free
255713|NCT02604017|HCV|hcv
255714|NCT02604017|Hepatitis C virus|hepatitis c virus
255715|NCT02604017|DAA|daa
255716|NCT02604004|lamivudine|lamivudine
255717|NCT02604004|bioequivalence test|bioequivalence test
255718|NCT02604004|pharmacokinetics|pharmacokinetics
255719|NCT02604004|high-performance liquid chromatography|high-performance liquid chromatography
255720|NCT02604004|3TC|3tc
255722|NCT02604004|mass spectrometry|mass spectrometry
255723|NCT02603991|children and adolescents|children and adolescents
255724|NCT02603991|Prospective cohort study|prospective cohort study
255725|NCT02603991|vagus nerve stimulation|vagus nerve stimulation
255726|NCT02603991|PINS|pins
255727|NCT02603952|Influenza|influenza
255728|NCT02603952|Influenza A|influenza a
255729|NCT02603952|Flu|flu
255730|NCT02603952|Flu A|flu a
255731|NCT02603939|Pain|pain
255732|NCT02603939|Magnetic resonance imaging|magnetic resonance imaging
255733|NCT02603913|Pre-eclampsia|pre-eclampsia
255734|NCT02603913|Pregnancy induced hypertension|pregnancy induced hypertension
255735|NCT02603913|Preterm birth|preterm birth
255736|NCT02603913|Intra-uterine growth restriction|intra-uterine growth restriction
255737|NCT02603913|Oxidative stress|oxidative stress
255738|NCT02603900|Adductor Canal Catheter|adductor canal catheter
255739|NCT02603900|Arthroplasty, Replacement, Knee|arthroplasty, replacement, knee
255740|NCT02603900|Local infiltration of analgesia|local infiltration of analgesia
255741|NCT02603874|Fluoroscopy|fluoroscopy
255742|NCT02603874|Spinal Fusion|spinal fusion
255743|NCT02603874|Wrong Level Surgery|wrong level surgery
255744|NCT02603848|Inguinal surgery|inguinal surgery
255745|NCT02603848|Hernia Repair|hernia repair
255746|NCT02603848|Orchidopexy|orchidopexy
255747|NCT02603848|Hydrocele|hydrocele
255748|NCT02603848|Pediatric|pediatric
255749|NCT02603848|Post-operative pain|post-operative pain
255750|NCT02603848|Morphine sulfate|morphine sulfate
255751|NCT02603848|Ibuprofen|ibuprofen
255752|NCT02603835|SSO2 Therapy|sso2 therapy
255753|NCT02603835|Acute myocardial infarction|acute myocardial infarction
255754|NCT02603835|Anterior myocardial infarction|anterior myocardial infarction
255755|NCT02603835|SuperSaturated oxygen delivery|supersaturated oxygen delivery
255756|NCT02603835|Left main coronary artery|left main coronary artery
255757|NCT02603835|Myocardial infarction|myocardial infarction
255758|NCT02603835|Heart attack|heart attack
255759|NCT02603835|Percutaneous coronary intervention|percutaneous coronary intervention
255760|NCT02603835|Cardiac catheterization laboratory|cardiac catheterization laboratory
255761|NCT02603835|PCI|pci
255762|NCT02603835|Stent|stent
255763|NCT02603835|Stenting|stenting
255764|NCT02603835|Stents|stents
255765|NCT02603835|Angioplasty|angioplasty
255766|NCT02603835|LMCA|lmca
255767|NCT02603835|Delivery of supersaturated oxygen (SSO2) therapy for the treatment of anterior acute myocardial infarction|delivery of supersaturated oxygen (sso2) therapy for the treatment of anterior acute myocardial infarction
255768|NCT02603796|3-Dimensional|3-dimensional
255769|NCT02603796|continuous positive airway pressure|continuous positive airway pressure
255770|NCT02603796|nasal changes|nasal changes
255771|NCT02603757|Vitamin D|vitamin d
255772|NCT02603744|Premature ovarian failure adipose derived stromal cells intraovarian injection|premature ovarian failure adipose derived stromal cells intraovarian injection
255773|NCT02603718|Stroke|stroke
255774|NCT02603718|On-line EEG|on-line eeg
255775|NCT02603718|BEI index|bei index
255776|NCT02603718|Attention|attention
255777|NCT02603718|Rehabilitation|rehabilitation
255778|NCT02603705|chronic pain|chronic pain
255779|NCT02603705|opioid|opioid
255780|NCT02603705|oxycodone|oxycodone
255781|NCT02603705|non cancer pain|non cancer pain
255782|NCT02603705|moderate to severe|moderate to severe
255783|NCT02603692|Newly diagnosed brain tumor|newly diagnosed brain tumor
255784|NCT02603692|Progressive brain tumor|progressive brain tumor
255785|NCT02603692|PROMIS|promis
255786|NCT02603692|Quality of life|quality of life
255787|NCT02603679|Cyclin-Dependent Kinase Inhibitor p16|cyclin-dependent kinase inhibitor p16
255788|NCT02603666|cystic fibrosis|cystic fibrosis
255789|NCT02603666|elastography|elastography
255790|NCT02603666|liver biopsy|liver biopsy
255791|NCT02603614|Chronic Heart Failure|chronic heart failure
255792|NCT02603614|Renal Insufficiency|renal insufficiency
255793|NCT02603614|Natriuretic Peptides|natriuretic peptides
255794|NCT02603614|Cenderitide|cenderitide
255795|NCT02603601|Randomized controlled trial|randomized controlled trial
255796|NCT02603601|Mindfulness|mindfulness
255797|NCT02603601|Obesity|obesity
255798|NCT02603588|Acupuncture|acupuncture
255799|NCT02603588|Sphenopalatine ganglion|sphenopalatine ganglion
255800|NCT02603588|Nasal ventilation|nasal ventilation
255801|NCT02603588|Neuropeptides|neuropeptides
255802|NCT02603575|Caspofungin|caspofungin
255803|NCT02603575|corticosteroids|corticosteroids
255804|NCT02603575|Pneumocystis Pneumonia|pneumocystis pneumonia
255805|NCT02603575|Immunocompromised|immunocompromised
255806|NCT02603575|Non-HIV|non-hiv
255807|NCT02603575|respiratory failure|respiratory failure
255808|NCT02603562|FSHD|fshd
255809|NCT02603536|Text Messaging|text messaging
255810|NCT02603536|Harm Reduction|harm reduction
255811|NCT02603523|accidental falls|accidental falls
255812|NCT02603523|older people|older people
255813|NCT02603523|dance|dance
255814|NCT02603523|randomized controlled trial|randomized controlled trial
255815|NCT02603497|ASP015K|asp015k
255816|NCT02603497|impaired renal function|impaired renal function
255817|NCT02603497|Pharmacokinetics|pharmacokinetics
255818|NCT02603471|HIV+|hiv+
255819|NCT02603471|Alcohol dependence|alcohol dependence
255820|NCT02603471|Mobile Technology|mobile technology
255821|NCT02603458|Schizophrenia|schizophrenia
255822|NCT02603458|Naurex|naurex
255823|NCT02603458|Intravenous Treatment|intravenous treatment
255824|NCT02603458|NRX-1074|nrx-1074
255825|NCT02603445|BCL201|bcl201
255826|NCT02603445|idelalisib|idelalisib
255827|NCT02603445|Follicular lymphoma|follicular lymphoma
255828|NCT02603445|FL|fl
255829|NCT02603445|mantle cell lymphoma|mantle cell lymphoma
255830|NCT02603445|MCL|mcl
255831|NCT02603432|Bladder cancer|bladder cancer
255832|NCT02603432|Urologic neoplasms|urologic neoplasms
255833|NCT02603432|urothelial carcinoma|urothelial carcinoma
255834|NCT02603432|PD-L1|pd-l1
255835|NCT02603432|programmed cell death protein|programmed cell death protein
255836|NCT02603432|maintenance treatment|maintenance treatment
255837|NCT02603419|classical Hodgkins Lymphoma (relapsed/refractory)|classical hodgkins lymphoma (relapsed/refractory)
255838|NCT02603419|post-allogeneic HSCT|post-allogeneic hsct
255839|NCT02603419|anti PD-L1|anti pd-l1
255840|NCT02603419|Phase 1|phase 1
255841|NCT02603419|PK|pk
255842|NCT02603419|Receptor occupancy|receptor occupancy
255843|NCT02603419|Immunophenotypic biomarkers|immunophenotypic biomarkers
255844|NCT02603393|COPD, QVA149|copd, qva149
255845|NCT02603380|Delirium|delirium
255846|NCT02603380|Feasibility study|feasibility study
255847|NCT02603380|software application|software application
255848|NCT02603380|qualitative|qualitative
255849|NCT02603328|Cerebral cavernous malformation|cerebral cavernous malformation
327054|NCT02203773|AML|aml
255850|NCT02603328|Statins|statins
255851|NCT02603328|MRI|mri
255852|NCT02603328|Permeability|permeability
255853|NCT02603328|Quantitative susceptibility mapping|quantitative susceptibility mapping
255854|NCT02603302|rectal cancer|rectal cancer
255855|NCT02603302|radiotherapy|radiotherapy
255856|NCT02603302|escalated dose|escalated dose
255857|NCT02603302|interval|interval
255858|NCT02603276|hypercholesterolemia|hypercholesterolemia
255859|NCT02603276|dietary supplements|dietary supplements
255860|NCT02603276|red yeast rice|red yeast rice
255861|NCT02603276|plant sterols|plant sterols
255862|NCT02603263|social norms|social norms
255863|NCT02603263|healthy eating|healthy eating
255864|NCT02603263|vegetables|vegetables
255865|NCT02603263|field study|field study
255866|NCT02603250|Anemia|anemia
255867|NCT02603250|Iron deficiency|iron deficiency
255868|NCT02603250|noninvasive anemia screening|noninvasive anemia screening
255869|NCT02603211|breast cancer|breast cancer
255870|NCT02603198|third molar|third molar
255871|NCT02603198|tooth extraction|tooth extraction
255872|NCT02603198|impacted tooth|impacted tooth
255873|NCT02603185|Phase 1, Healthy subjects|phase 1, healthy subjects
255874|NCT02603172|GSK3039294|gsk3039294
255875|NCT02603172|GSK2315698|gsk2315698
255876|NCT02603172|systemic amyloidosis|systemic amyloidosis
255877|NCT02603172|CPHPC|cphpc
255878|NCT02603172|dose-escalation|dose-escalation
255879|NCT02603159|Chemoradiotherapy|chemoradiotherapy
255880|NCT02603159|Esophageal Squamous Cancer|esophageal squamous cancer
255881|NCT02603159|Capecitabine|capecitabine
255882|NCT02603146|RA prevention|ra prevention
255883|NCT02603146|hydroxychloroquine (HCQ)|hydroxychloroquine (hcq)
255884|NCT02603146|anti-CCP3|anti-ccp3
255885|NCT02603133|healthcare|healthcare
255886|NCT02603133|burnout|burnout
255887|NCT02603133|resilience|resilience
255888|NCT02603133|fatigue|fatigue
255889|NCT02603133|NICU|nicu
255890|NCT02603133|safety culture|safety culture
255891|NCT02603133|quality of care|quality of care
255892|NCT02603081|Meniere's|meniere's
255893|NCT02603081|hearing loss|hearing loss
255894|NCT02603081|vertigo|vertigo
255895|NCT02603081|tinnitus|tinnitus
255896|NCT02603081|ebselen|ebselen
255897|NCT02603055|Safety|safety
255898|NCT02603055|immunogenicity|immunogenicity
255899|NCT02603055|Hepatitis E|hepatitis e
255900|NCT02603042|Hypophosphatasia Disease|hypophosphatasia disease
255901|NCT02603042|Biomarker|biomarker
255902|NCT02603029|skin rejuvenation|skin rejuvenation
255903|NCT02603029|anti-ageing effects|anti-ageing effects
255904|NCT02603029|minimal erythema dose|minimal erythema dose
255905|NCT02603029|dermis structure|dermis structure
255906|NCT02603029|physiological skin condition|physiological skin condition
255907|NCT02603029|wrinkling|wrinkling
255908|NCT02603016|Clinical Nutrition|clinical nutrition
255909|NCT02603003|Circulating tumor cells(CTCs)|circulating tumor cells(ctcs)
255910|NCT02603003|Traditional Chinese Medicine(TCM)|traditional chinese medicine(tcm)
255911|NCT02603003|Myeloid-derived suppressor cells(MDSCs)|myeloid-derived suppressor cells(mdscs)
255912|NCT02602990|Cerebral|cerebral
255913|NCT02602990|Arteriovenous|arteriovenous
255914|NCT02602990|Malformation|malformation
255915|NCT02602990|Embolization|embolization
255916|NCT02602990|Endovascular|endovascular
255917|NCT02602977|inflammation|inflammation
255918|NCT02602977|remote ischemic preconditioning|remote ischemic preconditioning
255919|NCT02602938|aspirin|aspirin
255920|NCT02602938|circulating tumor cells|circulating tumor cells
255921|NCT02602938|metastatic breast cancer|metastatic breast cancer
256023|NCT02602418|working memory training|working memory training
255922|NCT02602938|metastatic colorectal cancer|metastatic colorectal cancer
255923|NCT02602899|PINS|pins
255924|NCT02602899|Deep Brain Stimulator|deep brain stimulator
255925|NCT02602899|Refractory Epilepsy|refractory epilepsy
255926|NCT02602899|Anterior Thalamic Nucleus|anterior thalamic nucleus
255927|NCT02602860|SV2A|sv2a
255928|NCT02602860|Levetiracetam|levetiracetam
255929|NCT02602860|Brivaracetam|brivaracetam
255930|NCT02602860|PET|pet
255931|NCT02602847|Liver transplantation|liver transplantation
255932|NCT02602847|HBV|hbv
255933|NCT02602847|cccDNA|cccdna
255934|NCT02602834|exercise test|exercise test
255935|NCT02602834|biological markers|biological markers
255936|NCT02602808|acute pancreatitis|acute pancreatitis
255937|NCT02602808|non-coding RNA|non-coding rna
255938|NCT02602808|biological markers|biological markers
255939|NCT02602808|receiver operating characteristic curve|receiver operating characteristic curve
255940|NCT02602808|post-ERCP pancreatitis|post-ercp pancreatitis
255941|NCT02602795|Opiate Dependence|opiate dependence
255942|NCT02602795|Sexually Transmitted Diseases|sexually transmitted diseases
255943|NCT02602795|HIV|hiv
255944|NCT02602795|Extended release naltrexone|extended release naltrexone
255945|NCT02602756|Choroid Melanoma|choroid melanoma
255946|NCT02602743|sedation|sedation
255947|NCT02602743|remifentanyl|remifentanyl
255948|NCT02602743|pediatric patient|pediatric patient
255949|NCT02602743|colonoscopy|colonoscopy
255950|NCT02602730|Cigarette smoking|cigarette smoking
255951|NCT02602730|Smoking, Tobacco|smoking, tobacco
255952|NCT02602730|postpartum|postpartum
255953|NCT02602730|internet|internet
255954|NCT02602730|interactive|interactive
255955|NCT02602730|coach|coach
255956|NCT02602717|follicular origin|follicular origin
255957|NCT02602691|Heart transplantation|heart transplantation
255958|NCT02602691|AlloMap® gene expression profiling test|allomap® gene expression profiling test
255959|NCT02602691|Medico-economic study|medico-economic study
255960|NCT02602678|Children.|children.
255961|NCT02602678|prone position|prone position
255962|NCT02602678|acute viral bronchiolitis|acute viral bronchiolitis
255963|NCT02602678|syncytial virus|syncytial virus
255964|NCT02602678|work of breathing|work of breathing
255965|NCT02602678|intrinsic PEEP|intrinsic peep
255966|NCT02602665|catheter placement|catheter placement
255967|NCT02602652|geometric mean titer|geometric mean titer
255968|NCT02602652|seroprotection|seroprotection
255969|NCT02602652|live attenuated chimeric JE vaccine|live attenuated chimeric je vaccine
255970|NCT02602652|JE-CV|je-cv
255971|NCT02602652|SA14-14-2 vaccine|sa14-14-2 vaccine
255972|NCT02602626|Human Papillomavirus|human papillomavirus
255973|NCT02602626|HPV|hpv
255974|NCT02602626|Postpartum|postpartum
255975|NCT02602587|acute myeloid leukemia|acute myeloid leukemia
255976|NCT02602587|Dendrogenin A|dendrogenin a
255977|NCT02602587|5,6-cholesterol epoxide|5,6-cholesterol epoxide
255978|NCT02602587|6-oxo-cholestane-3beta|6-oxo-cholestane-3beta
255979|NCT02602587|5alpha-diol|5alpha-diol
255980|NCT02602587|cholesterol epoxide hydrolase|cholesterol epoxide hydrolase
255981|NCT02602587|oxysterols|oxysterols
255982|NCT02602574|Cholangiopancreatography, Endoscopic Retrograde|cholangiopancreatography, endoscopic retrograde
255983|NCT02602574|Pancreatitis|pancreatitis
255984|NCT02602574|Heat-Shock Proteins|heat-shock proteins
255985|NCT02602574|Pentraxin 3 protein|pentraxin 3 protein
255986|NCT02602574|C-Reactive Protein|c-reactive protein
255987|NCT02602574|procalcitonin|procalcitonin
255988|NCT02602574|Interleukin-1 beta|interleukin-1 beta
255989|NCT02602574|Leukocytes, Mononuclear|leukocytes, mononuclear
255990|NCT02602574|Killer Cells, Natural|killer cells, natural
255991|NCT02602574|natural-killer group 2, member D receptor|natural-killer group 2, member d receptor
255992|NCT02602561|HMB|hmb
255993|NCT02602561|beta-hydroxy-beta-methylbutyrate|beta-hydroxy-beta-methylbutyrate
255994|NCT02602561|ACL|acl
255995|NCT02602561|surgery|surgery
255996|NCT02602561|muscle mass|muscle mass
255997|NCT02602548|Propionibacterium acnes|propionibacterium acnes
255998|NCT02602548|shoulder surgery|shoulder surgery
255999|NCT02602548|infection|infection
256000|NCT02602496|Diet|diet
256001|NCT02602496|Whole grain|whole grain
256002|NCT02602496|Fruits|fruits
256003|NCT02602496|Vegetables|vegetables
256004|NCT02602496|Gut health|gut health
256005|NCT02602496|Anti-inflammatory|anti-inflammatory
256006|NCT02602483|temporomandibular|temporomandibular
256007|NCT02602483|joint|joint
256008|NCT02602483|pain|pain
256009|NCT02602483|ibuprofen|ibuprofen
256010|NCT02602483|magnesium|magnesium
256011|NCT02602483|vitamin C|vitamin c
256012|NCT02602457|Atrial Fibrillation|atrial fibrillation
256013|NCT02602444|ticagrelor|ticagrelor
256014|NCT02602444|STEMI|stemi
256015|NCT02602444|NSTEMI|nstemi
256016|NCT02602444|pharmacokinetics|pharmacokinetics
256017|NCT02602444|pharmacodynamics|pharmacodynamics
256018|NCT02602431|laser|laser
256019|NCT02602431|third molar|third molar
256020|NCT02602431|low laser|low laser
256021|NCT02602431|inflammatory response|inflammatory response
256022|NCT02602418|Human Immunodeficiency Virus (HIV)|human immunodeficiency virus (hiv)
256129|NCT02601820|Liver|liver
256024|NCT02602418|brain function|brain function
256025|NCT02602418|functional magnetic resonance imaging (fMRI)|functional magnetic resonance imaging (fmri)
256026|NCT02602405|Outcome Assessment (Health Care)|outcome assessment (health care)
256027|NCT02602405|Return to work|return to work
256028|NCT02602405|Registries|registries
256029|NCT02602405|Norway|norway
256030|NCT02602392|Self management|self management
256031|NCT02602392|Education|education
256032|NCT02602392|Children|children
256033|NCT02602392|Caregivers|caregivers
256034|NCT02602392|Health Care Providers|health care providers
256035|NCT02602379|Pain|pain
256036|NCT02602379|Monitoring|monitoring
256037|NCT02602379|Analgesia Nociception Index|analgesia nociception index
256038|NCT02602379|NoL|nol
256039|NCT02602379|Nociception Level|nociception level
256040|NCT02602379|Remifentanil|remifentanil
256041|NCT02602366|HIV|hiv
256042|NCT02602366|DCE|dce
256043|NCT02602366|MPT|mpt
256044|NCT02602366|Microbicide|microbicide
256045|NCT02602327|radioembolization|radioembolization
256046|NCT02602327|Yttrium-90|yttrium-90
256047|NCT02602327|90Y|90y
256048|NCT02602327|Resin microspheres|resin microspheres
256049|NCT02602327|Tas-102|tas-102
256050|NCT02602327|Lonsurf|lonsurf
256051|NCT02602327|SIR-Sphere|sir-sphere
734341|NCT00495872|SU011248|su011248
256052|NCT02602314|Chronic myeloid leukemia|chronic myeloid leukemia
256053|NCT02602314|Nilotinib|nilotinib
256054|NCT02602314|Imatinib|imatinib
256055|NCT02602301|oxytocin|oxytocin
256056|NCT02602223|Alveolar Ridge Augmentation|alveolar ridge augmentation
256057|NCT02602223|Tooth Socket|tooth socket
256058|NCT02602223|Guided Tissue Regeneration|guided tissue regeneration
256059|NCT02602223|Membranes|membranes
256060|NCT02602210|cirrhosis|cirrhosis
256061|NCT02602210|liver|liver
256062|NCT02602210|corticosteroids|corticosteroids
256063|NCT02602210|hypotension|hypotension
256064|NCT02602210|sepsis|sepsis
256065|NCT02602210|cortisol|cortisol
256066|NCT02602197|Paracetamol|paracetamol
256067|NCT02602197|Dexketoprofen|dexketoprofen
256068|NCT02602197|postoperative pain|postoperative pain
256069|NCT02602197|septoplasty|septoplasty
256070|NCT02602184|skin regeneration|skin regeneration
256071|NCT02602184|re-epithelialization|re-epithelialization
256072|NCT02602184|split thickness wounds|split thickness wounds
256073|NCT02602184|Abdominoplasty|abdominoplasty
256074|NCT02602158|breath test|breath test
256075|NCT02602158|lipid emulsions|lipid emulsions
256076|NCT02602158|MRI|mri
256077|NCT02602158|gastric emptying|gastric emptying
256078|NCT02602145|femoral|femoral
256079|NCT02602145|popliteal|popliteal
256080|NCT02602145|stent|stent
256081|NCT02602145|modeling|modeling
256082|NCT02602145|flexion|flexion
256083|NCT02602132|INDWELLING URINARY CATHETER|indwelling urinary catheter
256084|NCT02602132|CLAMPING|clamping
256085|NCT02602132|REMOVAL|removal
256086|NCT02602106|Aquatic activities|aquatic activities
256087|NCT02602106|Aerobic exercise|aerobic exercise
256088|NCT02602106|Resistance exercise|resistance exercise
256089|NCT02602106|Pregnancy|pregnancy
256090|NCT02602106|Maternal weight gain|maternal weight gain
256091|NCT02602106|birthweight|birthweight
256092|NCT02602093|Lumbar Disk Herniation|lumbar disk herniation
256093|NCT02602093|Percutaneous Transforaminal Endoscopic Discectomy|percutaneous transforaminal endoscopic discectomy
256094|NCT02602093|Micro Discectomy|micro discectomy
256095|NCT02602093|Minimal Invasive Spine Surgery|minimal invasive spine surgery
256096|NCT02602054|persistent ductus arteriosus|persistent ductus arteriosus
256097|NCT02602054|preterm infants|preterm infants
256098|NCT02602054|surgical treatment|surgical treatment
256099|NCT02602054|pharmacological treatment|pharmacological treatment
256100|NCT02602028|Familial Mediterranean Fever|familial mediterranean fever
256101|NCT02602028|Colchicine|colchicine
256102|NCT02602002|Remifentanil, Pharmacodynamic Pain assessments, Intravenous, South Korea|remifentanil, pharmacodynamic pain assessments, intravenous, south korea
256103|NCT02601976|PegInterferon alpha-2a|peginterferon alpha-2a
256104|NCT02601976|Ribavirin|ribavirin
256105|NCT02601976|Hepatitis C Virus|hepatitis c virus
256106|NCT02601976|Sustained Virological Response|sustained virological response
256107|NCT02601976|End of Treatment Response|end of treatment response
256108|NCT02601976|Unipeg|unipeg
256109|NCT02601976|Ribazole|ribazole
256110|NCT02601924|Anesthesia|anesthesia
256111|NCT02601924|injection|injection
256112|NCT02601924|pain|pain
256113|NCT02601924|pressure massage|pressure massage
256114|NCT02601924|topical gel|topical gel
256115|NCT02601911|Failure|failure
256116|NCT02601911|Injection|injection
256117|NCT02601911|Ketorolac|ketorolac
256118|NCT02601911|Premedication|premedication
256119|NCT02601885|Relapsing-remitting|relapsing-remitting
256120|NCT02601885|Secondary progressive|secondary progressive
256121|NCT02601885|Relapsing forms|relapsing forms
256122|NCT02601833|Caries|caries
256123|NCT02601833|Cavity|cavity
256124|NCT02601820|patient-reported outcomes|patient-reported outcomes
256125|NCT02601820|observational|observational
256126|NCT02601820|HCV|hcv
256127|NCT02601820|Hepatitis C|hepatitis c
256128|NCT02601820|Liver Disease|liver disease
256130|NCT02601820|Infectious Disease|infectious disease
256131|NCT02601820|PROs|pros
256132|NCT02601807|Back|back
256133|NCT02601807|Pain|pain
256134|NCT02601807|PSWT|pswt
256135|NCT02601807|ActiPatch|actipatch
256136|NCT02601807|Pulsed shortwave therapy|pulsed shortwave therapy
256137|NCT02601794|Breast Cancer|breast cancer
256138|NCT02601794|mHealth|mhealth
256139|NCT02601794|Mindfulness|mindfulness
256140|NCT02601794|Complementary Therapies|complementary therapies
256141|NCT02601781|Bioresorbable Vascular Scaffold (BVS)|bioresorbable vascular scaffold (bvs)
256142|NCT02601781|STEMI|stemi
256143|NCT02601781|Primary PCI|primary pci
256144|NCT02601768|ASD II|asd ii
256145|NCT02601768|transcatheter closure|transcatheter closure
256146|NCT02601768|percutaneous closure|percutaneous closure
256147|NCT02601768|3D TEE|3d tee
256148|NCT02601768|balloon-sizing|balloon-sizing
256149|NCT02601742|zinc|zinc
256150|NCT02601742|Duration|duration
256151|NCT02601729|Type 1 diabetes|type 1 diabetes
256152|NCT02601729|real-time continuous glucose monitoring|real-time continuous glucose monitoring
256153|NCT02601729|observational study|observational study
256154|NCT02601729|insulin pump|insulin pump
256155|NCT02601729|Belgium|belgium
256156|NCT02601716|Plasmodium falciparum|plasmodium falciparum
256157|NCT02601716|PfSPZ Vaccine|pfspz vaccine
256158|NCT02601716|Sporozoites|sporozoites
256159|NCT02601716|Controlled Human Malaria Infection|controlled human malaria infection
256160|NCT02601690|Rye Grass|rye grass
256161|NCT02601690|Ragweed|ragweed
256163|NCT02601690|House Dust Mite|house dust mite
256164|NCT02601677|Obsessive Compulsive Disorder|obsessive compulsive disorder
256165|NCT02601677|Deep Brain Stimulation|deep brain stimulation
256166|NCT02601677|Nucleus accumbens|nucleus accumbens
256167|NCT02601651|Totally Extraperitoneal Inguinal Hernioplasty|totally extraperitoneal inguinal hernioplasty
256168|NCT02601651|Lidocaine infusion|lidocaine infusion
256169|NCT02601651|Postoperative opioid consumption|postoperative opioid consumption
256170|NCT02601625|Tolerability|tolerability
256171|NCT02601625|Anifrolumab|anifrolumab
256172|NCT02601625|Subcutaneous injection|subcutaneous injection
256173|NCT02601625|Intravenous infusion|intravenous infusion
256174|NCT02601599|Smoking Cessation|smoking cessation
256175|NCT02601599|Tobacco Use Cessation|tobacco use cessation
256176|NCT02601599|Motivational Interviewing|motivational interviewing
256177|NCT02601599|Students, Medical|students, medical
256178|NCT02601599|Randomized Controlled Trial|randomized controlled trial
256179|NCT02601560|Coronary Artery Disease|coronary artery disease
256180|NCT02601560|CAD|cad
256181|NCT02601547|Positron-Emission Tomography|positron-emission tomography
256182|NCT02601547|chemotherapy-induced brain damage|chemotherapy-induced brain damage
256183|NCT02601547|neuro-cognitive function alteration|neuro-cognitive function alteration
256184|NCT02601534|sedentary behaviour|sedentary behaviour
256185|NCT02601534|physical activity|physical activity
256186|NCT02601508|deep NM block|deep nm block
256187|NCT02601508|Surgeon's satisfaction|surgeon's satisfaction
256188|NCT02601508|bridion|bridion
256189|NCT02601482|Glycemic control|glycemic control
256190|NCT02601482|exercise|exercise
256191|NCT02601482|Interval Training|interval training
256192|NCT02601456|Amputation, Traumatic|amputation, traumatic
256193|NCT02601456|Biomechanics|biomechanics
256194|NCT02601456|Asymmetry|asymmetry
256195|NCT02601456|Amputee Running|amputee running
256196|NCT02601456|Prolonged Effort|prolonged effort
256197|NCT02601417|Cholangitis|cholangitis
256198|NCT02601417|Bile culture|bile culture
256199|NCT02601391|STEPPS-HI|stepps-hi
256200|NCT02601391|personality disorder|personality disorder
256201|NCT02601391|evaluation|evaluation
256202|NCT02601391|forensic|forensic
256203|NCT02601378|Uveal melanoma|uveal melanoma
256204|NCT02601378|Metastatic uveal melanoma|metastatic uveal melanoma
256205|NCT02601378|Phase I|phase i
256206|NCT02601378|LXS196|lxs196
256207|NCT02601378|PKC inhibitor|pkc inhibitor
256208|NCT02601378|HDM201|hdm201
256209|NCT02601378|HDM2 inhibitor|hdm2 inhibitor
256210|NCT02601378|dose escalation|dose escalation
256211|NCT02601339|spectroscopy, Near-Infrared|spectroscopy, near-infrared
256212|NCT02601300|Ulcerative Colitis|ulcerative colitis
256213|NCT02601300|GED-0301|ged-0301
256214|NCT02601300|Mongersen|mongersen
256215|NCT02601300|Efficacy|efficacy
256216|NCT02601300|Safety|safety
256217|NCT02601261|pregnant|pregnant
256218|NCT02601261|gestational ages|gestational ages
256219|NCT02601261|hospitalized|hospitalized
256220|NCT02601261|problem of pregnancy|problem of pregnancy
256221|NCT02601248|safety, PK|safety, pk
256222|NCT02601235|nasal congestion|nasal congestion
256223|NCT02601222|chronic eczema|chronic eczema
256224|NCT02601222|efficacy and safety|efficacy and safety
256225|NCT02601222|Runzao zhiyang capsule|runzao zhiyang capsule
256226|NCT02601196|Leiomyoma|leiomyoma
256227|NCT02601196|Infertility|infertility
256228|NCT02601196|IVF|ivf
256229|NCT02601196|Ulipristal acetate|ulipristal acetate
256230|NCT02601183|brain temperture，thrombolysis，early diagnosis|brain temperture，thrombolysis，early diagnosis
256231|NCT02601170|Platelet Rich Plasma|platelet rich plasma
256232|NCT02601170|Hemophilia|hemophilia
256233|NCT02601170|Hemophilic arthropathy|hemophilic arthropathy
256234|NCT02601157|stent|stent
256235|NCT02601157|polymer|polymer
256236|NCT02601157|antiplatelet therapy|antiplatelet therapy
256237|NCT02601157|clopidogrel|clopidogrel
256238|NCT02601144|DBS|dbs
256239|NCT02601144|VFS|vfs
256240|NCT02601144|FOG|fog
256241|NCT02601131|platelet count|platelet count
256242|NCT02601131|platelet transfusion|platelet transfusion
256243|NCT02601131|complement factors|complement factors
256244|NCT02601131|endothelial markers|endothelial markers
256245|NCT02601131|stem cell transplantation|stem cell transplantation
256246|NCT02601105|gotu kola|gotu kola
256247|NCT02601105|centella asiatica|centella asiatica
256248|NCT02601092|Mini Gastric Bypass|mini gastric bypass
256249|NCT02601092|Roux-en-Y Gastric Bypass|roux-en-y gastric bypass
256250|NCT02601092|RCT|rct
256251|NCT02601079|Biopsy|biopsy
256252|NCT02601079|Diagnostics|diagnostics
256253|NCT02601079|Genetic analysis|genetic analysis
256254|NCT02601066|LMNA|lmna
256255|NCT02601066|Sudden Death|sudden death
256256|NCT02601066|Neuromuscular|neuromuscular
256257|NCT02601040|Safety|safety
256258|NCT02601040|Immunogenicity|immunogenicity
256259|NCT02601040|Vaccine|vaccine
256260|NCT02601040|Hepatitis A|hepatitis a
256261|NCT02601014|Hormone-Resistant Prostate Cancer|hormone-resistant prostate cancer
256262|NCT02601014|Prostate Carcinoma Metastatic in the Bone|prostate carcinoma metastatic in the bone
256263|NCT02600988|Graft-Versus-Host-Disease|graft-versus-host-disease
256264|NCT02600988|post-allogeneic transplant|post-allogeneic transplant
256265|NCT02600988|haematopoietic progenitors|haematopoietic progenitors
256266|NCT02600936|venous outflow obstruction|venous outflow obstruction
256267|NCT02600936|peripheral venous disease|peripheral venous disease
256268|NCT02600936|vein stent|vein stent
256269|NCT02600936|Wallstent|wallstent
256270|NCT02600936|registry|registry
256271|NCT02600936|May Thurner|may thurner
256272|NCT02600923|palbociclib, ibrance, breast cancer|palbociclib, ibrance, breast cancer
256273|NCT02600910|Manual Wheelchair|manual wheelchair
256274|NCT02600910|Shoulder injury|shoulder injury
256275|NCT02600910|Shoulder function|shoulder function
256276|NCT02600910|rotator cuff|rotator cuff
256277|NCT02600910|Tendinopathy|tendinopathy
256278|NCT02600910|Spinal cord injury|spinal cord injury
256279|NCT02600910|Shoulder pain|shoulder pain
256280|NCT02600910|Shoulder impingement|shoulder impingement
256281|NCT02600871|Abscess|abscess
256282|NCT02600871|Antiseptic|antiseptic
256283|NCT02600871|Provodine|provodine
256284|NCT02600871|Povidone-Iodine|povidone-iodine
256285|NCT02600819|End stage renal disease|end stage renal disease
256286|NCT02600819|Hemodialysis|hemodialysis
256287|NCT02600819|Open-label|open-label
256288|NCT02600819|HIV-1 Infection|hiv-1 infection
256289|NCT02600806|Community-acquired pneumonia|community-acquired pneumonia
256290|NCT02600806|Procalcitonin|procalcitonin
256291|NCT02600806|Outpatients|outpatients
256292|NCT02600806|Outcomes|outcomes
256293|NCT02600806|Azithromycin|azithromycin
256294|NCT02600806|Fluoroquinolones|fluoroquinolones
256295|NCT02600780|Febuxostat|febuxostat
256296|NCT02600780|Efficacy|efficacy
256297|NCT02600780|Safety|safety
256298|NCT02600780|Allopurinol|allopurinol
256299|NCT02600780|Hyperuricemia|hyperuricemia
256300|NCT02600780|Zurig|zurig
256301|NCT02600780|Getz Pharma|getz pharma
256302|NCT02600754|older adults, depressive symptoms, psychosocial treatment|older adults, depressive symptoms, psychosocial treatment
256303|NCT02600741|Schizophrenia|schizophrenia
256304|NCT02600741|Caregiver|caregiver
256305|NCT02600741|Psycho-education and skills training|psycho-education and skills training
256306|NCT02600741|Paliperidone Palmitate|paliperidone palmitate
256307|NCT02600741|Oral Antipsychotic|oral antipsychotic
256308|NCT02600728|Parkinson Disease|parkinson disease
256309|NCT02600728|Gait|gait
256310|NCT02600728|cues|cues
256311|NCT02600728|memory|memory
256312|NCT02600728|training|training
256313|NCT02600702|Home base exercise|home base exercise
256314|NCT02600689|Pulmonary rehab|pulmonary rehab
256315|NCT02600689|Exergame|exergame
256316|NCT02600689|Home-based|home-based
256317|NCT02600637|stroke|stroke
256318|NCT02600637|depression|depression
256319|NCT02600637|anxiety|anxiety
256320|NCT02600637|mindfulness|mindfulness
256321|NCT02600637|meditation|meditation
256322|NCT02600572|balance, postural|balance, postural
256323|NCT02600572|postural equilibrium|postural equilibrium
256324|NCT02600572|mental speed|mental speed
256325|NCT02600572|isometric exercise|isometric exercise
256326|NCT02600572|eccentric exercise|eccentric exercise
256327|NCT02600559|Otitis media|otitis media
256328|NCT02600559|Ear infection|ear infection
256329|NCT02600559|Tympanostomy tubes|tympanostomy tubes
256330|NCT02600533|minority group recruitment|minority group recruitment
256331|NCT02600533|stages of implementation|stages of implementation
256332|NCT02600533|clinical trials education|clinical trials education
256333|NCT02600481|standard-pressure pneumoperitoneum|standard-pressure pneumoperitoneum
256334|NCT02600481|prolonged pneumoperitoneum|prolonged pneumoperitoneum
256335|NCT02600481|myocardial injuries|myocardial injuries
256336|NCT02600481|troponin T(TnT)|troponin t(tnt)
256337|NCT02600481|Trendelenburg position|trendelenburg position
256338|NCT02600481|chest CT scan|chest ct scan
256339|NCT02600481|low-pressure pneumoperitoneum|low-pressure pneumoperitoneum
256340|NCT02600481|robot-assisted surgery|robot-assisted surgery
256341|NCT02600442|Neoadjuvant Therapy|neoadjuvant therapy
256342|NCT02600442|Chemotherapy|chemotherapy
256343|NCT02600442|Positron-Emission Tomography|positron-emission tomography
256344|NCT02600442|PET-CT|pet-ct
256346|NCT02600442|Fluorodeoxyglucose|fluorodeoxyglucose
256347|NCT02600442|Diagnosis|diagnosis
256348|NCT02600442|Prognosis|prognosis
256349|NCT02600442|Pathological complete response|pathological complete response
256350|NCT02600442|molecular biology|molecular biology
256351|NCT02600442|proliferation genes|proliferation genes
256352|NCT02600429|Neurotrophic Keratopathy|neurotrophic keratopathy
256354|NCT02600403|Visual Evoked Potentials|visual evoked potentials
256355|NCT02600403|Optical Coherence Tomography|optical coherence tomography
256356|NCT02600403|Visual Fields|visual fields
256357|NCT02600390|Leg Ulcer|leg ulcer
256358|NCT02600390|LU|lu
256359|NCT02600390|SANGUINATE|sanguinate
256360|NCT02600390|QOL|qol
256361|NCT02600390|SCD|scd
256362|NCT02600390|Sickle Cell Disease|sickle cell disease
256363|NCT02600390|Sickle Cell|sickle cell
256364|NCT02600390|Anemia|anemia
256365|NCT02600390|Leg Wound|leg wound
256366|NCT02600390|Leg|leg
256367|NCT02600390|Skin Lesion|skin lesion
256368|NCT02600364|Aneurysm|aneurysm
256369|NCT02600364|intracerebral|intracerebral
256370|NCT02600364|stroke|stroke
256371|NCT02600364|p64|p64
256372|NCT02600351|Hepatitis C Virus (HCV)|hepatitis c virus (hcv)
256373|NCT02600351|Ledipasvir/Sofosbuvir|ledipasvir/sofosbuvir
256374|NCT02600351|Ribavirin|ribavirin
256375|NCT02600338|Systematic review and meta-analysis|systematic review and meta-analysis
256376|NCT02600338|Evidence-based medicine (EBM)|evidence-based medicine (ebm)
256377|NCT02600338|Evidence-based nutrition (EBN)|evidence-based nutrition (ebn)
256378|NCT02600338|Clinical practice guidelines|clinical practice guidelines
256379|NCT02600338|Clinical trials|clinical trials
256380|NCT02600338|Legumes|legumes
256381|NCT02600338|Beans, peas, chickpeas, lentils, soy, peanuts, lupins|beans, peas, chickpeas, lentils, soy, peanuts, lupins
256382|NCT02600338|Cardiometabolic risk factors|cardiometabolic risk factors
256383|NCT02600338|Blood pressure|blood pressure
256384|NCT02600325|Acute Hepatitis C|acute hepatitis c
256385|NCT02600325|Human Immunodeficiency virus|human immunodeficiency virus
256386|NCT02600325|Grazoprevir|grazoprevir
256387|NCT02600325|Elbasvir|elbasvir
256388|NCT02600286|Physical medicine and rehabilitation|physical medicine and rehabilitation
256389|NCT02600286|Neurology|neurology
256390|NCT02600260|thrombophilia|thrombophilia
256391|NCT02600260|thrombosis|thrombosis
256392|NCT02600260|Pregnancy, High-Risk|pregnancy, high-risk
256393|NCT02600260|venous thrombosis|venous thrombosis
256394|NCT02600260|enoxaparin|enoxaparin
256395|NCT02600260|risk assessment|risk assessment
256396|NCT02600260|deep vein thrombosis|deep vein thrombosis
256397|NCT02600260|pulmonary embolism|pulmonary embolism
256398|NCT02600260|hospitalization|hospitalization
256399|NCT02600247|Total knee arthroplasty|total knee arthroplasty
256400|NCT02600247|Duloxetine|duloxetine
256401|NCT02600221|ACOS|acos
256402|NCT02600195|Intensive Care, Neonatal|intensive care, neonatal
256403|NCT02600195|Nosocomial Infections|nosocomial infections
256404|NCT02600195|Quality Improvement|quality improvement
256405|NCT02600182|Thoracic surgery|thoracic surgery
256406|NCT02600182|Non-invasive ventilation|non-invasive ventilation
256407|NCT02600182|Physiotherapy|physiotherapy
256408|NCT02600143|Melanoma|melanoma
256409|NCT02600143|Colitis|colitis
256410|NCT02600143|Ipilimumab|ipilimumab
256411|NCT02600143|Nivolumab|nivolumab
256412|NCT02600143|Pembrolizumab|pembrolizumab
256413|NCT02600091|Anxiety|anxiety
256414|NCT02600091|Depression|depression
256415|NCT02600091|Type 1 Diabetes|type 1 diabetes
256416|NCT02600091|Mindfulness-based Cognitive Therapy|mindfulness-based cognitive therapy
256417|NCT02600091|Glycaemic control|glycaemic control
256418|NCT02600078|hypoxia|hypoxia
256419|NCT02600078|ataxia|ataxia
256420|NCT02600013|incomplete motor SCI|incomplete motor sci
256421|NCT02600013|robotic gait training|robotic gait training
256422|NCT02600013|exoskeleton|exoskeleton
256423|NCT02600013|rehabilitation tool|rehabilitation tool
256424|NCT02600013|EKSO-GT|ekso-gt
256425|NCT02599961|Glut 1 DS|glut 1 ds
256426|NCT02599935|Nutritional status|nutritional status
256427|NCT02599935|MNA|mna
256428|NCT02599935|GSA|gsa
256429|NCT02599909|Tumor Microenvironment|tumor microenvironment
256430|NCT02599909|100 Trillion Microbial Cells|100 trillion microbial cells
256431|NCT02599909|Liver Tumors|liver tumors
256432|NCT02599909|Intestinal Microbiota|intestinal microbiota
256433|NCT02599909|Immune Regulation|immune regulation
256434|NCT02599896|Dose Escalation|dose escalation
256435|NCT02599896|HIV Prevention|hiv prevention
256436|NCT02599896|Broadly HIV-1 Neutralizing Activity|broadly hiv-1 neutralizing activity
256437|NCT02599896|Open-Label|open-label
256438|NCT02599896|Half-Life|half-life
256439|NCT02599883|Chronic Obstructive Pulmonary Disease|chronic obstructive pulmonary disease
256440|NCT02599883|Diagnostic Imaging|diagnostic imaging
256441|NCT02599883|Disease Management|disease management
256442|NCT02599883|Clinical Decision Support Systems|clinical decision support systems
256443|NCT02599883|Cost-Utility Analysis|cost-utility analysis
256444|NCT02599870|PGx|pgx
256445|NCT02599870|pharmacogenetic testing|pharmacogenetic testing
256446|NCT02599870|IDgenetix|idgenetix
256447|NCT02599870|Pain Management|pain management
256448|NCT02599870|AltheaDx|altheadx
256449|NCT02599870|Post-Operative Pain Management|post-operative pain management
256450|NCT02599844|acute kidney injury|acute kidney injury
256451|NCT02599831|Electrical pudendal nerve stimulation|electrical pudendal nerve stimulation
256452|NCT02599831|Pelvic floor muscle training|pelvic floor muscle training
256453|NCT02599831|Transanal electrical stimulation|transanal electrical stimulation
256454|NCT02599831|Post radical prostatectomy incontinence|post radical prostatectomy incontinence
327757|NCT02200679|SRS|srs
256455|NCT02599831|Comparative study|comparative study
256456|NCT02599792|Safety and Pharmacokinetics|safety and pharmacokinetics
256457|NCT02599779|Renal cell cancer|renal cell cancer
256458|NCT02599779|SBRT|sbrt
256459|NCT02599779|Pembrolizumab|pembrolizumab
256460|NCT02599766|animal assisted intervention, brain injury, rehabilitation|animal assisted intervention, brain injury, rehabilitation
256461|NCT02599740|Blood glucose|blood glucose
256462|NCT02599727|balance, postural|balance, postural
256463|NCT02599727|postural equilibrium|postural equilibrium
256464|NCT02599727|heart rate|heart rate
256465|NCT02599727|blood pressure|blood pressure
256466|NCT02599727|pulse oxygenation|pulse oxygenation
256467|NCT02599727|mental speed|mental speed
256468|NCT02599714|AZD2014|azd2014
256469|NCT02599714|Palbociclib|palbociclib
256470|NCT02599714|Fulvestrant|fulvestrant
256471|NCT02599714|Hormonal Therapy|hormonal therapy
256472|NCT02599714|Estrogen Receptor Positive|estrogen receptor positive
256473|NCT02599714|Breast Cancer|breast cancer
256474|NCT02599701|Delta Sleep|delta sleep
256475|NCT02599701|Growth Hormone|growth hormone
256476|NCT02599701|IGF-1|igf-1
256477|NCT02599675|Muscle|muscle
256478|NCT02599675|Vitamin D|vitamin d
256479|NCT02599675|Strength|strength
256480|NCT02599675|Endurance|endurance
256481|NCT02599675|Muscle fiber|muscle fiber
256482|NCT02599662|Cancer|cancer
256483|NCT02599662|Intraoperative Radiation Therapy - IORT|intraoperative radiation therapy - iort
256484|NCT02599649|Myelodysplastic syndrome|myelodysplastic syndrome
256485|NCT02599649|MDS|mds
256486|NCT02599649|Low or intermediate-1 MDS|low or intermediate-1 mds
256487|NCT02599649|High Risk MDS|high risk mds
256488|NCT02599649|Lirilumab|lirilumab
256489|NCT02599649|Nivolumab|nivolumab
256490|NCT02599649|BMS-936558|bms-936558
256491|NCT02599649|Opdivo|opdivo
256492|NCT02599649|Azacitidine|azacitidine
256493|NCT02599649|5-azacytidine|5-azacytidine
256494|NCT02599649|5-aza|5-aza
256495|NCT02599649|Vidaza|vidaza
256496|NCT02599649|5-AZC|5-azc
256497|NCT02599649|AZA-CR|aza-cr
256498|NCT02599649|Ladakamycin|ladakamycin
256499|NCT02599649|NSC-102816|nsc-102816
256500|NCT02599649|Azacytidine|azacytidine
256501|NCT02599623|Incarcerated|incarcerated
256502|NCT02599623|Anesthesia|anesthesia
256503|NCT02599623|Hernia|hernia
256504|NCT02599610|labor, vaginal examination, transperineal ultrasound, pain, anxiety|labor, vaginal examination, transperineal ultrasound, pain, anxiety
256505|NCT02599584|behaviour|behaviour
256506|NCT02599558|EOE|eoe
256507|NCT02599532|Apixaban|apixaban
256508|NCT02599532|Pharmacokinetics|pharmacokinetics
256509|NCT02599532|Pharmacodynamics|pharmacodynamics
256510|NCT02599506|breast cancer|breast cancer
256511|NCT02599506|fear of recurrence|fear of recurrence
256512|NCT02599506|longitudinal study|longitudinal study
256513|NCT02599506|radiation therapy|radiation therapy
256514|NCT02599506|emotional concerns|emotional concerns
256515|NCT02599506|trajectory|trajectory
256516|NCT02599506|psychological constructs|psychological constructs
256517|NCT02599506|diary keeping|diary keeping
256518|NCT02599480|HFpEF|hfpef
256519|NCT02599480|left ventricular hypertrophy|left ventricular hypertrophy
256520|NCT02599480|cardiac remodeling,|cardiac remodeling,
256521|NCT02599467|Nerve Pain|nerve pain
256522|NCT02599467|Electromyography|electromyography
256523|NCT02599467|Median Nerve|median nerve
256524|NCT02599467|Breast Neoplasms|breast neoplasms
256525|NCT02599415|psoriasis patients referred to receive TL01 NB-UVB therapy|psoriasis patients referred to receive tl01 nb-uvb therapy
256526|NCT02599389|in-stent restenosis; drug-coated balloons; Excimer Laser, cost effectiveness study, quality of life|in-stent restenosis; drug-coated balloons; excimer laser, cost effectiveness study, quality of life
256527|NCT02599350|Ventilation|ventilation
256528|NCT02599350|Gas exchange|gas exchange
256529|NCT02599350|V/Q ratio|v/q ratio
256530|NCT02599350|Requirement for mechanical ventilation|requirement for mechanical ventilation
256531|NCT02599337|bioequivalence|bioequivalence
256532|NCT02599311|pelvic organ prolapse|pelvic organ prolapse
256533|NCT02599298|sleep|sleep
256534|NCT02599298|treatment|treatment
256535|NCT02599259|Stroke|stroke
256536|NCT02599259|Oral anticoagulants|oral anticoagulants
256537|NCT02599259|NOAC|noac
256538|NCT02599259|wireless monitoring|wireless monitoring
256539|NCT02599259|Warfarin|warfarin
256540|NCT02599259|Xarelto|xarelto
256541|NCT02599259|compliance|compliance
256542|NCT02599259|adherence|adherence
256543|NCT02599259|monitoring|monitoring
256544|NCT02599259|directly observed therapy|directly observed therapy
256545|NCT02599259|DOT|dot
256546|NCT02599259|mobile device|mobile device
256547|NCT02599259|electronic monitoring|electronic monitoring
256548|NCT02599259|artificial intelligence|artificial intelligence
256549|NCT02599259|oral anticoagulation therapy|oral anticoagulation therapy
256550|NCT02599259|adherence monitoring methods|adherence monitoring methods
256551|NCT02599259|nonadherence|nonadherence
256552|NCT02599259|non-adherence|non-adherence
734656|NCT00494767|hunger|hunger
256553|NCT02599246|Home ventilator|home ventilator
256554|NCT02599246|FiO2|fio2
256555|NCT02599246|O2|o2
256556|NCT02599246|NIV|niv
256557|NCT02599246|COPD|copd
256558|NCT02599233|pain trajectory|pain trajectory
256559|NCT02599181|Perineural cathether|perineural cathether
256560|NCT02599181|Catheter infection|catheter infection
256561|NCT02599168|dexmedetomidine|dexmedetomidine
256562|NCT02599168|propofol|propofol
256563|NCT02599168|BIS|bis
256564|NCT02599168|CLADS|clads
256565|NCT02599155|crystalloid|crystalloid
256566|NCT02599155|colloid|colloid
256567|NCT02599155|children|children
256568|NCT02599155|infant|infant
256569|NCT02599155|cardiac surgery|cardiac surgery
256570|NCT02599142|radiotherapy immobilisation|radiotherapy immobilisation
256571|NCT02599142|open-face shells|open-face shells
256572|NCT02599129|Alopecia areata|alopecia areata
256573|NCT02599116|cytoreductive surgery|cytoreductive surgery
256574|NCT02599116|hyperthermic intraperitoneal chemotherapy|hyperthermic intraperitoneal chemotherapy
256575|NCT02599116|microbiome|microbiome
256576|NCT02599090|Glioblastoma|glioblastoma
256577|NCT02599090|Gliosarcoma|gliosarcoma
256578|NCT02599090|Brain Cancer|brain cancer
256579|NCT02599090|Sorafenib|sorafenib
256580|NCT02599090|Temozolomide|temozolomide
256581|NCT02599090|Radiation|radiation
256582|NCT02599090|Radiotherapy|radiotherapy
256583|NCT02599090|XRT|xrt
256584|NCT02599077|oral contraceptives|oral contraceptives
256585|NCT02599077|endometrioma|endometrioma
256586|NCT02599077|dienogest|dienogest
256587|NCT02599064|Age-related macular degeneration|age-related macular degeneration
256588|NCT02599064|RXI-109|rxi-109
256589|NCT02599064|NVAMD|nvamd
256590|NCT02599064|Retinal scarring|retinal scarring
256591|NCT02599064|Subretinal scarring|subretinal scarring
256592|NCT02599064|Retinal fibrosis|retinal fibrosis
256593|NCT02599064|Subretinal fibrosis|subretinal fibrosis
256594|NCT02599064|Eye diseases|eye diseases
256595|NCT02599038|NAFLD|nafld
256596|NCT02599038|NASH|nash
256597|NCT02599038|Serine|serine
256598|NCT02599038|Glutathione|glutathione
256599|NCT02599025|Cerebral palsy|cerebral palsy
256600|NCT02599025|passive cycling|passive cycling
256601|NCT02599025|autonomic control system|autonomic control system
256602|NCT02598986|glycemic index, pita bread, phosphorus, potassium, magnesium|glycemic index, pita bread, phosphorus, potassium, magnesium
256603|NCT02598973|Parkinson Disease|parkinson disease
256604|NCT02598973|exercise|exercise
256605|NCT02598947|posterior shoulder tightness|posterior shoulder tightness
256606|NCT02598947|shoulder impingement syndrome|shoulder impingement syndrome
256607|NCT02598947|Glenohumeral joint|glenohumeral joint
256608|NCT02598947|exercise|exercise
256609|NCT02598921|Assisted reproductive technology|assisted reproductive technology
256610|NCT02598882|Elderly|elderly
256611|NCT02598882|Videogame|videogame
256612|NCT02598882|energy expenditure|energy expenditure
256613|NCT02598882|electromyography|electromyography
256614|NCT02598882|rehabilitation|rehabilitation
256615|NCT02598869|Triamcinolone acetonide|triamcinolone acetonide
256616|NCT02598856|Emergency Treatment|emergency treatment
256617|NCT02598856|Morphine Derivates|morphine derivates
256618|NCT02598856|Heroin|heroin
256619|NCT02598856|Antidotes|antidotes
256620|NCT02598856|Administration, Intravenous|administration, intravenous
256621|NCT02598856|Pharmacology|pharmacology
256622|NCT02598856|Naloxone|naloxone
256623|NCT02598856|Healthy volunteers|healthy volunteers
256624|NCT02598856|Administration, intramuscular|administration, intramuscular
256625|NCT02598856|Administration, intranasal|administration, intranasal
256626|NCT02598830|Cachexia|cachexia
256627|NCT02598830|Vitamin D|vitamin d
256628|NCT02598830|Muscle|muscle
256629|NCT02598830|Strength training|strength training
256630|NCT02598804|Physical activity level|physical activity level
256631|NCT02598804|Knee osteoarthritis|knee osteoarthritis
256632|NCT02598804|Randomized controlled trials|randomized controlled trials
256633|NCT02598804|Alternate month design study|alternate month design study
256634|NCT02598804|Self-management|self-management
256635|NCT02598804|Self-care|self-care
256730|NCT02598362|clearance|clearance
256636|NCT02598804|Education and exercise in knee osteoarthritis|education and exercise in knee osteoarthritis
256637|NCT02598804|Education|education
256638|NCT02598804|Non pharmacological treatment|non pharmacological treatment
256639|NCT02598791|incretin hormones|incretin hormones
256640|NCT02598791|GIP|gip
256641|NCT02598791|GLP-1|glp-1
256642|NCT02598765|Glaucoma|glaucoma
256643|NCT02598765|Trabeculectomy|trabeculectomy
256644|NCT02598765|Eye Disease|eye disease
256645|NCT02598765|Intraocular Pressure|intraocular pressure
256646|NCT02598765|Visual Acuity|visual acuity
256647|NCT02598752|functional performance testing|functional performance testing
256648|NCT02598752|exercise fitness testing|exercise fitness testing
256649|NCT02598752|15-274|15-274
256650|NCT02598739|Physical exercise|physical exercise
256651|NCT02598739|Psoriatic arthritis|psoriatic arthritis
256652|NCT02598739|Quality of life|quality of life
256653|NCT02598700|total hip arthroplasty|total hip arthroplasty
256654|NCT02598700|imaging|imaging
256655|NCT02598700|arthritis|arthritis
256656|NCT02598700|surgical technique|surgical technique
256657|NCT02598674|acute kidney injury|acute kidney injury
256658|NCT02598661|Myelodysplastic Syndromes|myelodysplastic syndromes
256659|NCT02598661|Imetelstat|imetelstat
256660|NCT02598661|GRN163L|grn163l
256661|NCT02598661|Relapsed/refractory to ESAs|relapsed/refractory to esas
256662|NCT02598661|Transfusion dependent|transfusion dependent
256663|NCT02598648|FXR|fxr
256664|NCT02598648|RIPK3|ripk3
256665|NCT02598648|Neonates|neonates
256666|NCT02598648|Acute Respiratory Distress Syndrome|acute respiratory distress syndrome
256667|NCT02598648|Acute Lung Injury|acute lung injury
256668|NCT02598635|Cholecalciferol|cholecalciferol
256669|NCT02598635|peritoneal dialysis|peritoneal dialysis
256670|NCT02598635|FGF23|fgf23
256671|NCT02598635|Calcium|calcium
256672|NCT02598635|Phosphorus|phosphorus
256673|NCT02598609|Adverse event|adverse event
256674|NCT02598609|Neonatal Intensive Care Unit|neonatal intensive care unit
256675|NCT02598609|Catheter-related Bloodstream Infection (CRBSI) nos|catheter-related bloodstream infection (crbsi) nos
256676|NCT02598609|Extravasation injury|extravasation injury
256677|NCT02598609|Medication error|medication error
256678|NCT02598609|Central venous catheter complication|central venous catheter complication
256679|NCT02598609|Unprogrammed extubation|unprogrammed extubation
256680|NCT02598596|Refractory gout|refractory gout
256681|NCT02598596|Chronic gout|chronic gout
256682|NCT02598583|Paroxysmal Nocturnal Hemoglobinuria|paroxysmal nocturnal hemoglobinuria
256683|NCT02598583|PNH|pnh
256684|NCT02598583|complement inhibitor|complement inhibitor
256685|NCT02598570|Relapsed Lymphoma|relapsed lymphoma
256686|NCT02598570|Phosphoinositide 3-kinase (PI3K) Inhibitor|phosphoinositide 3-kinase (pi3k) inhibitor
256687|NCT02598570|Duvelisib|duvelisib
256688|NCT02598570|Japanese|japanese
256689|NCT02598570|Refractory Lymphoma|refractory lymphoma
256690|NCT02598518|Integrating Combined Therapies|integrating combined therapies
256691|NCT02598518|Alcohol Use Disorder|alcohol use disorder
256692|NCT02598518|Mental Health Disorder|mental health disorder
256693|NCT02598492|Mechanical Ventilator|mechanical ventilator
256694|NCT02598479|Cancer|cancer
256695|NCT02598479|Insulin Potentiation Low Dose Chemotherapy|insulin potentiation low dose chemotherapy
256696|NCT02598479|IPT|ipt
256697|NCT02598479|IPTLD|iptld
256698|NCT02598479|Nutrition therapy|nutrition therapy
256699|NCT02598427|Breast Cancer|breast cancer
256700|NCT02598427|HER2 Positive|her2 positive
256701|NCT02598427|HER2+|her2+
256702|NCT02598427|Brain Metastases|brain metastases
256703|NCT02598427|Metastatic Breast Cancer|metastatic breast cancer
256704|NCT02598427|Intrathecal Treatment|intrathecal treatment
256705|NCT02598427|Lumbar Puncture|lumbar puncture
256706|NCT02598427|Pertuzumab|pertuzumab
256707|NCT02598427|Trastuzumab|trastuzumab
256708|NCT02598427|Advanced Breast Cancer|advanced breast cancer
256709|NCT02598427|Duke University|duke university
256710|NCT02598414|Colorectal Disease|colorectal disease
256711|NCT02598414|Robotic Surgery|robotic surgery
256712|NCT02598414|Indocyanine Green Fluorescence Imaging|indocyanine green fluorescence imaging
256713|NCT02598414|Anastomotic Leak|anastomotic leak
256714|NCT02598414|Short-term Outcomes|short-term outcomes
256715|NCT02598388|Healthy|healthy
256716|NCT02598388|Vaccine|vaccine
256717|NCT02598388|Ebola viruses|ebola viruses
256718|NCT02598388|Ebola virus disease (EVD)|ebola virus disease (evd)
256719|NCT02598388|Filoviruses|filoviruses
256720|NCT02598388|Hemorrhagic fever|hemorrhagic fever
256721|NCT02598388|Monovalent vaccine|monovalent vaccine
256722|NCT02598388|Human adenovirus serotype 26 (Ad26) encoding the Ebola virus Mayinga variant glycoprotein (Ad26.ZEBOV)|human adenovirus serotype 26 (ad26) encoding the ebola virus mayinga variant glycoprotein (ad26.zebov)
256723|NCT02598388|Modified Vaccinia Virus Ankara - Bavarian Nordic (MVA-BN) Filo-vector|modified vaccinia virus ankara - bavarian nordic (mva-bn) filo-vector
256724|NCT02598388|Safety|safety
256725|NCT02598388|Immunogenicity|immunogenicity
256726|NCT02598375|Early reached target enteral nutrition in PICU feeding intolerance IFABP|early reached target enteral nutrition in picu feeding intolerance ifabp
256727|NCT02598362|ciprofloxacin|ciprofloxacin
256728|NCT02598362|pharmacokinetics|pharmacokinetics
256729|NCT02598362|excretion|excretion
256731|NCT02598362|infant|infant
256732|NCT02598362|children|children
256733|NCT02598362|adolescent|adolescent
256734|NCT02598349|Unresectable|unresectable
256735|NCT02598349|Borderline resectable|borderline resectable
256736|NCT02598336|Structured Light Plethysmography|structured light plethysmography
256737|NCT02598336|Spirometry|spirometry
256738|NCT02598336|Pneumotachograph|pneumotachograph
256739|NCT02598297|Early Myelofibrosis|early myelofibrosis
256740|NCT02598297|high molecular risk mutations.|high molecular risk mutations.
256741|NCT02598297|Ruxolitinib|ruxolitinib
256742|NCT02598297|INC424|inc424
256743|NCT02598297|High molecular risk mutations|high molecular risk mutations
256744|NCT02598297|HMR|hmr
256745|NCT02598284|Preventive measures|preventive measures
256746|NCT02598284|Quality Improvement|quality improvement
256747|NCT02598271|Acute Kidney Injury|acute kidney injury
256748|NCT02598271|Cardiac Surgery|cardiac surgery
256749|NCT02598258|Sauna|sauna
256750|NCT02598258|Cold water bath|cold water bath
256751|NCT02598245|urinary incontinence, CESA, VASA, TOT, TVT|urinary incontinence, cesa, vasa, tot, tvt
256752|NCT02598219|Sentinel node|sentinel node
256753|NCT02598206|food effect|food effect
256754|NCT02598206|healthy volunteers|healthy volunteers
256755|NCT02598206|pharmacokinetics|pharmacokinetics
256756|NCT02598206|CCR2i|ccr2i
256757|NCT02598141|Protheses, nails, screws or plates|protheses, nails, screws or plates
256758|NCT02598115|collaborative pharmaceutical care|collaborative pharmaceutical care
256759|NCT02598089|Seasonal Influenza|seasonal influenza
256760|NCT02598089|Trivalent Vaccine|trivalent vaccine
256761|NCT02598089|Inactivated Vaccine|inactivated vaccine
256762|NCT02598050|postoperative health outcomes|postoperative health outcomes
256763|NCT02598050|older surgical patients|older surgical patients
256764|NCT02598037|Obesity|obesity
256765|NCT02598037|Polymorphism|polymorphism
256766|NCT02598037|Hormones|hormones
256767|NCT02597985|Frailty|frailty
256768|NCT02597959|ergonomic risk factors|ergonomic risk factors
256769|NCT02597959|allied health professionals|allied health professionals
256770|NCT02597959|surgical care|surgical care
256771|NCT02597881|natural history|natural history
256772|NCT02597868|therapy|therapy
256773|NCT02597868|Capecitabine|capecitabine
256774|NCT02597868|breast cancer|breast cancer
256775|NCT02597842|Postoperative nausea and vomiting|postoperative nausea and vomiting
256776|NCT02597842|TEAS|teas
256777|NCT02597829|Inflammatory Bowel Disease|inflammatory bowel disease
256778|NCT02597829|Mucosal Healing|mucosal healing
256779|NCT02597829|Certolizumab pegol|certolizumab pegol
256780|NCT02597803|Dry Eye Syndrome|dry eye syndrome
256781|NCT02597803|Dry Eye|dry eye
256782|NCT02597803|DES|des
256783|NCT02597790|endothelial function|endothelial function
256784|NCT02597790|cardiovascular risk|cardiovascular risk
256785|NCT02597790|HIV|hiv
256786|NCT02597790|Hepatitis C|hepatitis c
256787|NCT02597790|metabolic disease|metabolic disease
256788|NCT02597790|inflammation|inflammation
256789|NCT02597764|Diaphragmatic breathing (DB)|diaphragmatic breathing (db)
256790|NCT02597764|Bladder and bowel disorders (BBD)|bladder and bowel disorders (bbd)
256791|NCT02597764|Autonomic nervous system (ANS)|autonomic nervous system (ans)
256792|NCT02597764|Heart rate variability (HRV)|heart rate variability (hrv)
256793|NCT02597764|Deep breathing|deep breathing
256794|NCT02597764|Randomized controlled trial (RCT)|randomized controlled trial (rct)
256795|NCT02597751|DCD|dcd
256796|NCT02597751|Neuroimaging|neuroimaging
256797|NCT02597751|Rehabilitation|rehabilitation
256798|NCT02597725|Urodynamics|urodynamics
256799|NCT02597725|Late effects|late effects
256800|NCT02597725|Urinary Incontinence|urinary incontinence
256801|NCT02597712|acid reflux|acid reflux
256802|NCT02597712|intragastric pH|intragastric ph
256803|NCT02597712|gastrin|gastrin
256804|NCT02597712|hypergastrinemia|hypergastrinemia
256805|NCT02597699|Termination of pregnancy|termination of pregnancy
256806|NCT02597699|Feticide|feticide
256807|NCT02597699|Fetal pain|fetal pain
256808|NCT02597699|Remifentanil Ultiva®|remifentanil ultiva®
256809|NCT02597699|Fetal asystole|fetal asystole
256810|NCT02597699|Fetopathologic analysis|fetopathologic analysis
256811|NCT02597660|patellar tendinopathy|patellar tendinopathy
256812|NCT02597660|somatropin|somatropin
256813|NCT02597660|jumper's knee|jumper's knee
256814|NCT02597647|immunology|immunology
256815|NCT02597647|Microbiota|microbiota
256816|NCT02597582|LigaSure|ligasure
256817|NCT02597582|Neck dissection|neck dissection
256818|NCT02597582|Operative duration|operative duration
256819|NCT02597582|Postoperative drainage|postoperative drainage
256820|NCT02597582|Postoperative pain|postoperative pain
256821|NCT02597569|stroke|stroke
256822|NCT02597569|Cognitive Orientation to daily Occupational Performance|cognitive orientation to daily occupational performance
256823|NCT02597569|health services accessibility|health services accessibility
256824|NCT02597569|cognitive impairment|cognitive impairment
256825|NCT02597569|rehabilitation|rehabilitation
256826|NCT02597569|integrated knowledge translation|integrated knowledge translation
256827|NCT02597569|interrupted time series|interrupted time series
256828|NCT02597569|The CO-OP Approach|the co-op approach
256829|NCT02597556|Albendazole|albendazole
256830|NCT02597556|Ancylostoma duodenale|ancylostoma duodenale
256831|NCT02597556|Ascariasis lumbricoides|ascariasis lumbricoides
256832|NCT02597556|Coinfection|coinfection
256833|NCT02597556|Diarrhea|diarrhea
256834|NCT02597556|Helminths|helminths
256835|NCT02597556|Necator americanus|necator americanus
256836|NCT02597556|Microbiota|microbiota
256837|NCT02597556|Trichuris trichiura|trichuris trichiura
256838|NCT02597543|heart transplantation|heart transplantation
256839|NCT02597543|cardiac MRI|cardiac mri
256840|NCT02597543|graft rejection|graft rejection
256841|NCT02597543|nonspecific allograft dysfunction|nonspecific allograft dysfunction
256842|NCT02597543|allograft vasculopathy|allograft vasculopathy
256843|NCT02597530|TEAS|teas
256844|NCT02597530|anesthesia|anesthesia
256845|NCT02597517|gastritis|gastritis
256846|NCT02597517|chromoendoscopy|chromoendoscopy
256847|NCT02597517|magnification|magnification
256848|NCT02597517|Helicobacter pylori|helicobacter pylori
256849|NCT02597517|Atrophic gastritis|atrophic gastritis
256850|NCT02597491|Smoking,|smoking,
256851|NCT02597491|Smoking cessation|smoking cessation
256852|NCT02597491|Sequential, multiple assignment, randomized trials (SMART)|sequential, multiple assignment, randomized trials (smart)
256853|NCT02597491|Lung cancer screening|lung cancer screening
256854|NCT02597478|Advanced Cancers|advanced cancers
256855|NCT02597478|Fentanyl Sublingual Spray|fentanyl sublingual spray
256856|NCT02597478|Fentanyl SL Spray|fentanyl sl spray
256857|NCT02597478|FSS|fss
256858|NCT02597478|Questionnaires|questionnaires
256859|NCT02597478|Surveys|surveys
256860|NCT02597478|Mental Abilities Test|mental abilities test
256861|NCT02597478|Phone Call|phone call
256862|NCT02597478|Shuttle Walk Test|shuttle walk test
256863|NCT02597452|breast lump|breast lump
256864|NCT02597452|breast exam|breast exam
256865|NCT02597452|breast cancer screening|breast cancer screening
256866|NCT02597452|breast lump detection|breast lump detection
256867|NCT02597439|Ultra-high risk|ultra-high risk
256868|NCT02597439|UHR|uhr
256869|NCT02597439|psychosis|psychosis
256870|NCT02597426|Nasopharyngeal Carcinoma|nasopharyngeal carcinoma
256871|NCT02597426|Intensity-Modulated Radiotherapy|intensity-modulated radiotherapy
256872|NCT02597426|Post treatment|post treatment
256873|NCT02597374|Electroencephalography|electroencephalography
256874|NCT02597374|mu rhythm|mu rhythm
256875|NCT02597374|Sensorimotor Cortex|sensorimotor cortex
256876|NCT02597374|Unilateral Cerebral Palsy|unilateral cerebral palsy
256877|NCT02597374|Child|child
256878|NCT02597361|Ehlers-Danlos syndrome, vascular type|ehlers-danlos syndrome, vascular type
256879|NCT02597361|Type 2 Angiotensin Receptor Blockers|type 2 angiotensin receptor blockers
256880|NCT02597348|Liver|liver
256881|NCT02597348|Metastasis|metastasis
256882|NCT02597348|Colorectal cancer|colorectal cancer
256883|NCT02597348|Liver transplantation|liver transplantation
256884|NCT02597335|Glioma|glioma
256885|NCT02597335|IDH1/IDH2 mutation|idh1/idh2 mutation
256886|NCT02597335|Spectroscopy MRI|spectroscopy mri
256887|NCT02597335|D-2-hydroxyglutarate|d-2-hydroxyglutarate
256888|NCT02597335|Free circulating DNA|free circulating dna
256889|NCT02597322|Axitinib|axitinib
256890|NCT02597322|T2a Renal tumor|t2a renal tumor
256891|NCT02597322|organ confined tumors|organ confined tumors
256892|NCT02597322|nephron sparing surgery|nephron sparing surgery
256893|NCT02597322|nephron sparing procedure|nephron sparing procedure
256894|NCT02597322|radical nephrectomy|radical nephrectomy
256895|NCT02597283|Bifurcation lesions|bifurcation lesions
256896|NCT02597283|Percutaneous coronary intervention|percutaneous coronary intervention
256897|NCT02597283|Randomized controlled trial|randomized controlled trial
256898|NCT02597270|Hepatitis C virus|hepatitis c virus
256899|NCT02597257|Lidocaine infusion therapy|lidocaine infusion therapy
256900|NCT02597244|Lumbar foraminal stenosis|lumbar foraminal stenosis
256901|NCT02597231|Delirium|delirium
256902|NCT02597231|Melatonin|melatonin
256903|NCT02597218|Hepatectomy|hepatectomy
256904|NCT02597218|Prophylaxis|prophylaxis
256905|NCT02597205|Medical adherence|medical adherence
256906|NCT02597205|Lifestyle modification|lifestyle modification
256907|NCT02597205|Mobile Health|mobile health
256908|NCT02597205|Secondary Prevention|secondary prevention
256909|NCT02597192|gingivitis|gingivitis
256910|NCT02597192|gingival inflammation|gingival inflammation
256911|NCT02597192|probiotics|probiotics
256912|NCT02597192|Bacillus|bacillus
256913|NCT02597075|Colorectal Cancer|colorectal cancer
256914|NCT02597075|Metastatic Colorectal Cancer|metastatic colorectal cancer
256915|NCT02597075|Physical Activity|physical activity
256916|NCT02597075|Quality of life|quality of life
256917|NCT02597036|Advanced, Angiopoietin|advanced, angiopoietin
256918|NCT02596997|Adenovirus Brincidofovir|adenovirus brincidofovir
256919|NCT02596984|Intensive Care Unit|intensive care unit
256920|NCT02596984|Shock|shock
256921|NCT02596984|Antifungal agent|antifungal agent
256922|NCT02596984|Pharmacokinetics|pharmacokinetics
256923|NCT02596984|Sepsis|sepsis
256924|NCT02596932|Intrapartum|intrapartum
256925|NCT02596893|Crohn's Disease|crohn's disease
256926|NCT02596893|GED-0301|ged-0301
256927|NCT02596893|Mongersen|mongersen
256928|NCT02596893|IBD|ibd
256929|NCT02596893|Safety|safety
256930|NCT02596893|Efficacy|efficacy
256931|NCT02596880|Hepatitis C|hepatitis c
256932|NCT02596880|Cirrhosis|cirrhosis
256933|NCT02596880|Sofosbuvir|sofosbuvir
256934|NCT02596880|Daclatasvir|daclatasvir
256935|NCT02596880|Ribavirin|ribavirin
256936|NCT02596867|B adrenergic pathway|b adrenergic pathway
256937|NCT02596867|B Blocker|b blocker
256938|NCT02596841|Lung diffusing capacity|lung diffusing capacity
256939|NCT02596841|Idiopathic Interstitial Pneumonias|idiopathic interstitial pneumonias
256940|NCT02596828|molecular targeted therapy|molecular targeted therapy
256941|NCT02596828|protein kinase inhibitor|protein kinase inhibitor
256942|NCT02596828|mTOR Inhibitor|mtor inhibitor
256943|NCT02596828|cytostatic topoisomerase-I-inhibitor|cytostatic topoisomerase-i-inhibitor
256944|NCT02596828|temozolomide|temozolomide
256945|NCT02596828|irinotecan|irinotecan
256946|NCT02596828|dasatinib|dasatinib
256947|NCT02596828|rapamycin|rapamycin
256948|NCT02596802|Fetoscopic Endoluminal Tracheal Occlusion|fetoscopic endoluminal tracheal occlusion
256949|NCT02596802|Congenital Diaphragmatic Hernia|congenital diaphragmatic hernia
256950|NCT02596763|Off-label prescription|off-label prescription
256951|NCT02596763|Alcoholism|alcoholism
256952|NCT02596763|Pharmacovigilance|pharmacovigilance
256953|NCT02596763|Pharmacoepidemiology|pharmacoepidemiology
256954|NCT02596763|Baclofen|baclofen
256955|NCT02596737|health|health
256956|NCT02596737|work|work
256957|NCT02596737|lifestyle|lifestyle
256958|NCT02596737|behavior|behavior
256959|NCT02596737|management|management
256960|NCT02596737|stress|stress
256961|NCT02596737|physical activity|physical activity
256962|NCT02596737|nutrition|nutrition
256963|NCT02596737|mortality|mortality
256964|NCT02596737|morbidity|morbidity
256965|NCT02596737|public health|public health
256966|NCT02596724|Breast Cancer|breast cancer
256967|NCT02596724|Neoadjuvant therapy for breast cancer|neoadjuvant therapy for breast cancer
256968|NCT02596711|Cancer Prevention|cancer prevention
256969|NCT02596711|Tobacco Use Cessation|tobacco use cessation
256970|NCT02596711|Nicotine Patch|nicotine patch
256971|NCT02596711|NRT|nrt
256972|NCT02596711|Questionnaires|questionnaires
256973|NCT02596711|Surveys|surveys
256974|NCT02596711|Carbon Monoxide Test|carbon monoxide test
256975|NCT02596711|CO|co
256976|NCT02596711|Health Education|health education
256977|NCT02596711|Handouts|handouts
256978|NCT02596711|Pamphlets|pamphlets
256979|NCT02596711|Counseling sessions|counseling sessions
256980|NCT02596698|Mood Disorder|mood disorder
256981|NCT02596672|physical activity|physical activity
256982|NCT02596672|older adults|older adults
256983|NCT02596672|retirement homes|retirement homes
256984|NCT02596672|walking|walking
256985|NCT02596672|feasibility study|feasibility study
256986|NCT02596659|lateral epicondylosis|lateral epicondylosis
256987|NCT02596659|lateral epicondylitis|lateral epicondylitis
256988|NCT02596659|shockwave|shockwave
256989|NCT02596659|sonoelastography|sonoelastography
256990|NCT02596659|tennis elbow|tennis elbow
256991|NCT02596659|pain intensity|pain intensity
256992|NCT02596659|grip strength|grip strength
256993|NCT02596659|upper limb function|upper limb function
256994|NCT02596659|stiffness of common extensor tendon|stiffness of common extensor tendon
256995|NCT02596620|Helicobacter pylori|helicobacter pylori
256996|NCT02596620|Proton pump inhibitor|proton pump inhibitor
256997|NCT02596620|Eradication|eradication
256998|NCT02596607|ischemic stroke, acute phase, thrombolysis, management times|ischemic stroke, acute phase, thrombolysis, management times
256999|NCT02596594|IUGR|iugr
257000|NCT02596594|severe IUGR|severe iugr
257001|NCT02596594|brain sparing|brain sparing
257002|NCT02596594|fetal nutrition|fetal nutrition
257003|NCT02596594|Prolongation|prolongation
257004|NCT02596594|pregnancy|pregnancy
257005|NCT02596594|neonatal outcome|neonatal outcome
257006|NCT02596581|periodontitis|periodontitis
257007|NCT02596581|diabetes mellitus|diabetes mellitus
257008|NCT02596581|chemerin|chemerin
257009|NCT02596581|interleukin-6|interleukin-6
257010|NCT02596503|young adults|young adults
257011|NCT02596503|adolescents|adolescents
257012|NCT02596490|Non-Small Cell Lung Cancer|non-small cell lung cancer
257013|NCT02596490|NSCLC|nsclc
257014|NCT02596490|Couples-based meditation program|couples-based meditation program
257015|NCT02596490|Couples-based cancer-related discussion program|couples-based cancer-related discussion program
257016|NCT02596490|Questionnaires|questionnaires
257017|NCT02596490|Surveys|surveys
257018|NCT02596490|Metastatic lung cancer|metastatic lung cancer
257019|NCT02596490|Quality of life|quality of life
257020|NCT02596490|QOL|qol
257021|NCT02596477|Heart failure|heart failure
257022|NCT02596412|children|children
257023|NCT02596412|botulinum toxin|botulinum toxin
257024|NCT02596412|augmented reality|augmented reality
257025|NCT02596412|Pain|pain
257026|NCT02596399|Healthy volunteers|healthy volunteers
257027|NCT02596399|DSTA4637S|dsta4637s
257028|NCT02596360|Antinociception|antinociception
257029|NCT02596360|Freeze-induced hyperalgesia model|freeze-induced hyperalgesia model
257030|NCT02596360|Dextromethorphan|dextromethorphan
257031|NCT02596360|NMDA-receptors|nmda-receptors
257032|NCT02596360|Pharmacogenetic|pharmacogenetic
257033|NCT02596360|CYP3A4 gene|cyp3a4 gene
257034|NCT02596360|MDR1 gene|mdr1 gene
257035|NCT02596334|HIV-1 infected patient|hiv-1 infected patient
257036|NCT02596334|monotherapy|monotherapy
257037|NCT02596334|dolutegravir|dolutegravir
257038|NCT02596321|House Dust Mite|house dust mite
257039|NCT02596308|Plague vaccine|plague vaccine
257040|NCT02596308|Immunogenicity|immunogenicity
257041|NCT02596308|Safety|safety
257042|NCT02596282|neonatal male circumcision|neonatal male circumcision
257043|NCT02596282|Clinical officers vs Nurse midwives|clinical officers vs nurse midwives
257044|NCT02596282|Rakai, Uganda|rakai, uganda
257045|NCT02596282|acceptability and safety of neonatal male circumcision|acceptability and safety of neonatal male circumcision
257046|NCT02596243|CIN2, CIN2/3, CIN3|cin2, cin2/3, cin3
257047|NCT02596243|Cervical Intraepithelial Neoplasia|cervical intraepithelial neoplasia
257048|NCT02596243|High-Risk HPV|high-risk hpv
257049|NCT02596243|HPV infection|hpv infection
257050|NCT02596243|precancer Diseases|precancer diseases
257051|NCT02596243|Double Blind|double blind
257052|NCT02596243|Safety/Efficacy|safety/efficacy
257053|NCT02596217|ABBV-066|abbv-066
257054|NCT02596217|BI 655066|bi 655066
257055|NCT02596217|risankizumab|risankizumab
257056|NCT02596165|validation|validation
257057|NCT02596165|pulse wave analysis|pulse wave analysis
257058|NCT02596165|blood pressure monitoring|blood pressure monitoring
257059|NCT02596152|balance|balance
257060|NCT02596152|strength|strength
257061|NCT02596152|barriers towards exercise|barriers towards exercise
257062|NCT02596152|quality of life|quality of life
257063|NCT02596152|body dissatisfaction|body dissatisfaction
257064|NCT02596152|executive functions|executive functions
257065|NCT02596152|eating behavior|eating behavior
257066|NCT02596152|fitness|fitness
257067|NCT02596126|Polypill|polypill
257068|NCT02596126|Prevention of Secondary Cardiovascular Disease|prevention of secondary cardiovascular disease
257069|NCT02596126|Cardiovascular Disease|cardiovascular disease
257070|NCT02596126|Myocardial Infarction|myocardial infarction
257071|NCT02596126|Cardiovascular Combination Polypill AAR|cardiovascular combination polypill aar
257072|NCT02596126|Cardiovascular Disease in the Elderly|cardiovascular disease in the elderly
257073|NCT02596126|Adherence|adherence
257074|NCT02596126|SECURE|secure
257075|NCT02596126|Elderly|elderly
257076|NCT02596126|Secondary Cardiovascular Disease|secondary cardiovascular disease
257077|NCT02596126|Secondary Cardiovascular Prevention|secondary cardiovascular prevention
257078|NCT02596126|Randomized Cardiovascular Trial|randomized cardiovascular trial
257079|NCT02596126|Randomized Trial|randomized trial
257080|NCT02596126|Cardiovascular Polypill|cardiovascular polypill
257081|NCT02596113|colorectal cancer|colorectal cancer
257082|NCT02596113|genes involved in carcinogenesis of the colon|genes involved in carcinogenesis of the colon
257083|NCT02596113|screening colorectal cancer|screening colorectal cancer
257084|NCT02596100|Bioequivalence|bioequivalence
257085|NCT02596009|COPD|copd
257086|NCT02596009|Cachexia due to chronic obstructive pulmonary disease|cachexia due to chronic obstructive pulmonary disease
257087|NCT02596009|wasting syndrome|wasting syndrome
257088|NCT02596009|Loss of weight|loss of weight
257089|NCT02596009|muscle atrophy|muscle atrophy
257090|NCT02596009|loss of body mass|loss of body mass
257091|NCT02596009|signficant loss of appetite|signficant loss of appetite
257092|NCT02596009|cachectic syndrome|cachectic syndrome
257094|NCT02595983|Familial Amyloidotic Polyneuropathy|familial amyloidotic polyneuropathy
257095|NCT02595983|ATTR Amyloidosis|attr amyloidosis
257096|NCT02595983|Orthotopic Liver Transplant|orthotopic liver transplant
257097|NCT02595983|RNAi therapeutic|rnai therapeutic
257098|NCT02595970|Psoriasis|psoriasis
257099|NCT02595970|Secukinumab|secukinumab
257100|NCT02595970|Simplified Psoriasis Index|simplified psoriasis index
257101|NCT02595970|CAIN457A|cain457a
257102|NCT02595970|AIN457AFR01|ain457afr01
257103|NCT02595970|AIN457A|ain457a
257104|NCT02595970|Skin condition|skin condition
257105|NCT02595970|skin disease|skin disease
257106|NCT02595970|itching condition|itching condition
257107|NCT02595970|psoriasis vulgaris|psoriasis vulgaris
257108|NCT02595970|relapsing/remitting psoriasis|relapsing/remitting psoriasis
257109|NCT02595970|immune-mediated systemic disease|immune-mediated systemic disease
257110|NCT02595970|skin lesions|skin lesions
257111|NCT02595970|red skin lesions|red skin lesions
257112|NCT02595970|scaly patches|scaly patches
257113|NCT02595970|papules|papules
257114|NCT02595970|plaques|plaques
257115|NCT02595970|itching|itching
257116|NCT02595957|Return of Results|return of results
257117|NCT02595957|Exome Sequencing|exome sequencing
257118|NCT02595957|Secondary Findings|secondary findings
257119|NCT02595853|Upper GastroIntestinal bleeding, endoscopy, Hemospray|upper gastrointestinal bleeding, endoscopy, hemospray
257120|NCT02595827|Pediatrics|pediatrics
257121|NCT02595827|Epidemiology|epidemiology
257122|NCT02595827|Fever|fever
257123|NCT02595827|Democratic Republic of the Congo|democratic republic of the congo
257124|NCT02595827|Randomized Controlled Trial|randomized controlled trial
257125|NCT02595814|Registry|registry
257126|NCT02595814|Heart failure|heart failure
257127|NCT02595814|Hospitalized|hospitalized
257128|NCT02595814|Global|global
257129|NCT02595814|Morbidity|morbidity
257130|NCT02595814|Mortality|mortality
257131|NCT02595814|Quality of life|quality of life
257132|NCT02595814|AHF|ahf
257133|NCT02595775|endoscopy measures|endoscopy measures
257134|NCT02595775|audit and feedback|audit and feedback
257135|NCT02595775|quality improvement|quality improvement
257136|NCT02595775|randomized controlled trial|randomized controlled trial
257137|NCT02595775|Colonoscopy|colonoscopy
257138|NCT02595710|Cryptogenic Chronic Hepatitis|cryptogenic chronic hepatitis
257139|NCT02595710|Bartonellosis|bartonellosis
257140|NCT02595684|Obesity|obesity
257141|NCT02595684|Tadalfil|tadalfil
257142|NCT02595684|Insulin secretion|insulin secretion
257143|NCT02595684|Insulin sensitivity|insulin sensitivity
257144|NCT02595671|Digital coaching|digital coaching
257145|NCT02595671|Sustainable weight loss|sustainable weight loss
257146|NCT02595671|Self-determination theory|self-determination theory
257147|NCT02595671|Obesity|obesity
257148|NCT02595671|Overweight|overweight
257149|NCT02595671|Diet|diet
257150|NCT02595671|Physical activity|physical activity
257151|NCT02595645|colorectal adenoma|colorectal adenoma
257152|NCT02595645|colorectal cancer|colorectal cancer
257153|NCT02595645|next generation sequencing|next generation sequencing
257154|NCT02595645|liquid biopsy|liquid biopsy
257155|NCT02595645|screening colonoscopy|screening colonoscopy
257156|NCT02595645|surveillance strategies|surveillance strategies
257157|NCT02595619|AKI|aki
257158|NCT02595619|Extracorporeal Carbon Dioxide Removal|extracorporeal carbon dioxide removal
257159|NCT02595619|Renal Replacement Therapy|renal replacement therapy
257160|NCT02595619|Mechanical Ventilation|mechanical ventilation
257161|NCT02595606|dry eye syndromes|dry eye syndromes
257162|NCT02595606|diabetes mellitus|diabetes mellitus
257163|NCT02595593|Trauma|trauma
257164|NCT02595593|Rib Plate|rib plate
257165|NCT02595593|Rib Fixation|rib fixation
257166|NCT02595580|Blood Glucose Self-Monitoring|blood glucose self-monitoring
257167|NCT02595567|Liver disease|liver disease
257168|NCT02595567|Pleural effusion|pleural effusion
257169|NCT02595554|Cervical cancer, Stage IIB, Neoadjuvant chemotherapy|cervical cancer, stage iib, neoadjuvant chemotherapy
257170|NCT02595541|pediatric|pediatric
257171|NCT02595541|cardiac|cardiac
257172|NCT02595541|sildenfil|sildenfil
257173|NCT02595541|milrinone|milrinone
257174|NCT02595541|pulmonary hypertension|pulmonary hypertension
257175|NCT02595489|Leukodystrophy|leukodystrophy
257176|NCT02595489|ABCD1|abcd1
257177|NCT02595489|Demyelination|demyelination
257178|NCT02595489|Inflammation|inflammation
257179|NCT02595489|ALD|ald
257180|NCT02595489|Vitamin D|vitamin d
257181|NCT02595489|Oxidative Stress|oxidative stress
257182|NCT02595489|X- linked|x- linked
257183|NCT02595489|Adrenoleukodystrophy|adrenoleukodystrophy
257184|NCT02595476|analgesia|analgesia
257185|NCT02595476|pupillometry|pupillometry
257186|NCT02595476|general anesthesia|general anesthesia
257187|NCT02595450|Non-small cell lung cancer|non-small cell lung cancer
257188|NCT02595437|dialysis|dialysis
257189|NCT02595437|pediatric|pediatric
257190|NCT02595437|chronic kidney disease|chronic kidney disease
257191|NCT02595411|Children|children
257192|NCT02595411|Rehabilitation|rehabilitation
257193|NCT02595411|Upper Limb|upper limb
257194|NCT02595411|Assessments|assessments
257195|NCT02595411|Outcome Measures|outcome measures
257196|NCT02595398|Uveitis|uveitis
257197|NCT02595398|UME|ume
257198|NCT02595398|Posterior Uveitis|posterior uveitis
257199|NCT02595398|Anterior Uveitis|anterior uveitis
257200|NCT02595398|Intermediate Uveitis|intermediate uveitis
257201|NCT02595398|Panuveitis|panuveitis
257202|NCT02595398|Non-infectious Uveitis|non-infectious uveitis
257203|NCT02595398|Triamcinolone|triamcinolone
257204|NCT02595398|Choroid|choroid
257205|NCT02595398|Choroidal Injection|choroidal injection
257206|NCT02595398|Suprachoroidal|suprachoroidal
257207|NCT02595398|Microneedle|microneedle
257208|NCT02595398|Microinjection|microinjection
257209|NCT02595359|endophthalmitis|endophthalmitis
257210|NCT02595359|antibiotic therapy|antibiotic therapy
257211|NCT02595359|cataract surgery|cataract surgery
257212|NCT02595359|prevention|prevention
257213|NCT02595333|repeat cesarean section|repeat cesarean section
257214|NCT02595333|pain|pain
257215|NCT02595320|breast, gastrointestinal,capecitabine, cancer, metastatic|breast, gastrointestinal,capecitabine, cancer, metastatic
257216|NCT02595307|Risk Recall|risk recall
257217|NCT02595307|Pamphlet|pamphlet
257218|NCT02595307|Brochure|brochure
257219|NCT02595307|Patient satisfaction|patient satisfaction
257220|NCT02595307|Informed Consent|informed consent
257221|NCT02595281|Ovarian Carcinoma|ovarian carcinoma
257222|NCT02595281|neoadjuvant|neoadjuvant
257223|NCT02595281|ROMA|roma
257224|NCT02595281|Ca125|ca125
257225|NCT02595281|HE4|he4
257226|NCT02595281|biomarker|biomarker
257227|NCT02595268|Healthy|healthy
257228|NCT02595268|Pitavastatin|pitavastatin
257229|NCT02595268|JNJ-63623872|jnj-63623872
257230|NCT02595255|chemotherapy/GnRH analogues/lymphoma/children/fertility|chemotherapy/gnrh analogues/lymphoma/children/fertility
257231|NCT02595203|Bioavailability|bioavailability
257232|NCT02595190|Sacral perineurial cysts(Tarlov Cysts)|sacral perineurial cysts(tarlov cysts)
257233|NCT02595190|Resting state functional magnetic resonance imaging (rfMRI)|resting state functional magnetic resonance imaging (rfmri)
257234|NCT02595190|VAS|vas
257235|NCT02595190|Medicine conservative treatment|medicine conservative treatment
257236|NCT02595190|Surgical treatment|surgical treatment
257237|NCT02595177|multifocal IOL|multifocal iol
257238|NCT02595177|monovision|monovision
257239|NCT02595177|hybrid monovision|hybrid monovision
257240|NCT02595177|spectacles independence|spectacles independence
257241|NCT02595151|Probe-based confocal laser endomicroscopy|probe-based confocal laser endomicroscopy
257242|NCT02595151|chronic atrophic antral gastritis|chronic atrophic antral gastritis
257243|NCT02595151|microcirculatory dynamics|microcirculatory dynamics
257244|NCT02595138|zoledronic acid|zoledronic acid
257245|NCT02595138|triple-negative breast cancer|triple-negative breast cancer
257246|NCT02595138|adjuvant treatment|adjuvant treatment
257247|NCT02595125|intrauterine device|intrauterine device
257248|NCT02595125|contraceptive method|contraceptive method
257249|NCT02595125|direct technique|direct technique
257250|NCT02595125|torpedo technique|torpedo technique
257251|NCT02595125|verbal numeric scale|verbal numeric scale
257252|NCT02595112|staphylococcal infections|staphylococcal infections
257253|NCT02595112|nasal carriage|nasal carriage
257254|NCT02595112|nasal cavity|nasal cavity
257255|NCT02595112|Staphylococcus aureus|staphylococcus aureus
257256|NCT02595060|acute lung injury, molgramostim, GM-CSF, pneumonia, barrier restoration|acute lung injury, molgramostim, gm-csf, pneumonia, barrier restoration
257257|NCT02595047|Self-regeneration, in vivo tissue prefabrication,|self-regeneration, in vivo tissue prefabrication,
257258|NCT02595021|Total or subtotal colectomy|total or subtotal colectomy
257259|NCT02595021|Ovarian cancer|ovarian cancer
257260|NCT02595021|Complications|complications
257261|NCT02595021|One-year disease-free survival|one-year disease-free survival
257262|NCT02595021|Stage IIIc|stage iiic
257263|NCT02595021|Stage IV|stage iv
257264|NCT02594982|Delirium|delirium
257265|NCT02594982|intensive care nursing|intensive care nursing
257266|NCT02594982|Acute acquired brain injury|acute acquired brain injury
257267|NCT02594982|neurointensive care|neurointensive care
257268|NCT02594982|Intensive care delirium screening checklist|intensive care delirium screening checklist
257269|NCT02594982|Confusion Assessment Method for the ICU|confusion assessment method for the icu
257270|NCT02594969|atopic dermatitis|atopic dermatitis
257271|NCT02594956|nasogastric decompression|nasogastric decompression
257272|NCT02594943|Diagnostics|diagnostics
257273|NCT02594943|Biopsy|biopsy
257274|NCT02594943|Diffuse gastric cancer|diffuse gastric cancer
257275|NCT02594930|synovial biopsy|synovial biopsy
257276|NCT02594930|knee arthroplasty|knee arthroplasty
257277|NCT02594930|infection|infection
257278|NCT02594904|G6PD Deficiency|g6pd deficiency
257279|NCT02594904|Neonatal Hyperbilirubinemia|neonatal hyperbilirubinemia
257280|NCT02594904|Yinzhihuang Oral Liquid|yinzhihuang oral liquid
257281|NCT02594904|Indirect Bilirubin|indirect bilirubin
257282|NCT02594891|cholangitis|cholangitis
257283|NCT02594891|endoscopic retrograde cholangiopancreatography|endoscopic retrograde cholangiopancreatography
257284|NCT02594891|complication|complication
257285|NCT02594878|Chronic non-bacterial osteomyelitis|chronic non-bacterial osteomyelitis
257286|NCT02594878|Chronic recurrent multifocal osteomyelitis|chronic recurrent multifocal osteomyelitis
257287|NCT02594878|Non- bacterial osteomyelitis|non- bacterial osteomyelitis
257288|NCT02594878|SAPHO syndrome|sapho syndrome
257289|NCT02594878|Whole body MRI|whole body mri
257290|NCT02594878|Pamidronate|pamidronate
257291|NCT02594878|Inflammatory bone disease|inflammatory bone disease
257292|NCT02594878|Autoinflammatory disease|autoinflammatory disease
257293|NCT02594865|Enteral Nutrition|enteral nutrition
257294|NCT02594865|Continuous Glucose Monitoring|continuous glucose monitoring
257295|NCT02594839|interstitial lung disease|interstitial lung disease
257296|NCT02594839|idiopathic interstitial pneumonia|idiopathic interstitial pneumonia
257297|NCT02594839|idiopathic pulmonary fibrosis|idiopathic pulmonary fibrosis
257298|NCT02594839|stem cells|stem cells
257299|NCT02594800|Atherosclerotic Intracranial Arterial Stenosis|atherosclerotic intracranial arterial stenosis
257300|NCT02594800|Intensive Rosuvastatin Therapy|intensive rosuvastatin therapy
257301|NCT02594800|Computed Tomography Perfusion (CTP)|computed tomography perfusion (ctp)
257302|NCT02594735|Juvenile dermatomyositis|juvenile dermatomyositis
257303|NCT02594735|inflammatory myopathies|inflammatory myopathies
257304|NCT02594735|Orencia|orencia
257305|NCT02594735|Abatacept|abatacept
257306|NCT02594722|COPD|copd
257307|NCT02594722|Functional Electrical Stimulation Cycling|functional electrical stimulation cycling
257308|NCT02594722|Pulmonary Rehabilitation|pulmonary rehabilitation
257309|NCT02594696|Major depression and Cancer|major depression and cancer
257310|NCT02594696|Schizophrenia and Cancer|schizophrenia and cancer
257311|NCT02594696|Bipolar disorder and Cancer|bipolar disorder and cancer
257312|NCT02594696|Lung Cancer|lung cancer
257313|NCT02594696|Breast Cancer|breast cancer
257314|NCT02594696|Head and Neck cancer|head and neck cancer
257315|NCT02594696|GI cancer|gi cancer
257316|NCT02594696|Schizophrenia|schizophrenia
257317|NCT02594696|Bipolar disorder|bipolar disorder
257318|NCT02594670|acupoints|acupoints
257319|NCT02594670|insomnia|insomnia
257320|NCT02594670|acupuncture|acupuncture
257321|NCT02594670|randomized controlled trial|randomized controlled trial
257322|NCT02594657|Eccentric|eccentric
257323|NCT02594657|Ergometer|ergometer
257324|NCT02594657|Pedal rate|pedal rate
257325|NCT02594657|Oxygen consumption|oxygen consumption
257326|NCT02594657|Only health volunteers|only health volunteers
257327|NCT02594631|Urethral stones|urethral stones
257328|NCT02594631|Acute Cacular urinary retention|acute cacular urinary retention
257329|NCT02594631|Extracorporeal Shock Wave Lithotripsy (ESWL)|extracorporeal shock wave lithotripsy (eswl)
257330|NCT02594631|Visual lithotripsy|visual lithotripsy
257331|NCT02594631|bladder stone|bladder stone
257332|NCT02594592|Osteoporosis|osteoporosis
257333|NCT02594592|Osteoporosis Self-Assessment Tool|osteoporosis self-assessment tool
257334|NCT02594592|One-Minute Osteoporosis Risk Test|one-minute osteoporosis risk test
257336|NCT02594566|Cytomegalovirus|cytomegalovirus
257337|NCT02594566|Vaccine|vaccine
257338|NCT02594566|Congenital Infection|congenital infection
257339|NCT02594553|Antibiotics|antibiotics
257340|NCT02594553|Children|children
257341|NCT02594553|General Practitioner|general practitioner
257342|NCT02594553|GP|gp
257343|NCT02594553|After-hours care|after-hours care
257344|NCT02594553|Out-of-hours care|out-of-hours care
257345|NCT02594553|Booklet|booklet
257346|NCT02594553|Primary Health Care|primary health care
257347|NCT02594553|Child|child
257348|NCT02594527|Older people|older people
257349|NCT02594527|Physical activity|physical activity
257350|NCT02594527|Hospital|hospital
257351|NCT02594514|cardiovascular risk|cardiovascular risk
257352|NCT02594514|metabolic profile|metabolic profile
257353|NCT02594488|Myocardial infarction|myocardial infarction
257354|NCT02594488|Autonomic nervous system|autonomic nervous system
257355|NCT02594488|Risk stratification|risk stratification
257356|NCT02594488|Implantable cardiac monitor|implantable cardiac monitor
257357|NCT02594488|Sudden cardiac death|sudden cardiac death
257358|NCT02594488|ECG|ecg
257359|NCT02594475|endoscopic retrograde cholangiopancreatography, position|endoscopic retrograde cholangiopancreatography, position
257360|NCT02594462|contraception|contraception
257361|NCT02594462|Anemia, Sickle Cell|anemia, sickle cell
257362|NCT02594449|Pharmacodynamic Study of BCS|pharmacodynamic study of bcs
257363|NCT02594436|Actinic Keratosis|actinic keratosis
257364|NCT02594436|topical|topical
257365|NCT02594436|ingenol mebutate|ingenol mebutate
257366|NCT02594436|Picato®|picato®
257367|NCT02594384|Phase 1|phase 1
257368|NCT02594384|Safety|safety
257369|NCT02594384|Apilimod dimesylate|apilimod dimesylate
257370|NCT02594384|Pharmacokinetics|pharmacokinetics
257371|NCT02594384|Non-Hodgkin Lymphoma|non-hodgkin lymphoma
257372|NCT02594384|Chronic lymphocytic leukemia|chronic lymphocytic leukemia
257373|NCT02594358|Caffeine|caffeine
257374|NCT02594332|eosinophilic asthma|eosinophilic asthma
257375|NCT02594332|mepolizumab|mepolizumab
257376|NCT02594332|treatment|treatment
257377|NCT02594306|drug addiction|drug addiction
257378|NCT02594306|Heroin|heroin
257379|NCT02594306|craving|craving
257380|NCT02594306|event related potential|event related potential
257381|NCT02594306|crystal methamphetamine|crystal methamphetamine
257382|NCT02594267|PTCL|ptcl
257383|NCT02594267|Peripheral T-Cell Lymphoma|peripheral t-cell lymphoma
257384|NCT02594267|Folotyn|folotyn
257385|NCT02594267|Pralatrexate|pralatrexate
257386|NCT02594267|CHOP|chop
257387|NCT02594241|Ventral hernia|ventral hernia
257388|NCT02594241|Abdominal wall reconstruction|abdominal wall reconstruction
257389|NCT02594241|Enhanced recovery after surgery|enhanced recovery after surgery
257390|NCT02594241|Steroid|steroid
257391|NCT02594215|AKT1|akt1
257392|NCT02594215|Overgrowth|overgrowth
257393|NCT02594202|Specimen Collection|specimen collection
257394|NCT02594202|Carcinogenesis|carcinogenesis
257395|NCT02594202|Prognostic Biomarkers|prognostic biomarkers
257396|NCT02594202|Molecular Mechanims|molecular mechanims
257397|NCT02594202|Cell Lines|cell lines
257398|NCT02594189|Influenza A|influenza a
257399|NCT02594189|H3N2|h3n2
257400|NCT02594189|Challenge Model|challenge model
257401|NCT02594189|Influenza|influenza
257402|NCT02594189|Human Challenge|human challenge
257403|NCT02594176|Osteoarthritis|osteoarthritis
257404|NCT02594176|Pain|pain
257405|NCT02594176|NSAID|nsaid
257406|NCT02594176|Sequessome|sequessome
257407|NCT02594137|Decompressive craniectomy|decompressive craniectomy
257408|NCT02594137|Brain Edema|brain edema
257409|NCT02594124|SMA|sma
257410|NCT02594124|SMN|smn
257411|NCT02594124|SMNRx|smnrx
257412|NCT02594124|ISIS-SMNRx|isis-smnrx
257413|NCT02594124|ISIS-SMN Rx|isis-smn rx
257414|NCT02594124|ISIS 396443|isis 396443
257415|NCT02594124|SHINE|shine
257416|NCT02594124|IONIS-SMNRx|ionis-smnrx
257417|NCT02594124|IONIS-SMN Rx|ionis-smn rx
257418|NCT02594124|Spinraza|spinraza
257419|NCT02594124|nusinersen|nusinersen
257420|NCT02594111|inflammation|inflammation
257421|NCT02594111|percutaneous coronary intervention|percutaneous coronary intervention
257422|NCT02594111|coronary artery disease|coronary artery disease
257423|NCT02594111|colchicine|colchicine
257424|NCT02594098|Atopic dermatitis|atopic dermatitis
257425|NCT02594098|extrinsic atopic dermatitis|extrinsic atopic dermatitis
257426|NCT02594098|intrinsic atopic dermatitis|intrinsic atopic dermatitis
257427|NCT02594059|endothelial function, idiopathic pulmonary fibrosis|endothelial function, idiopathic pulmonary fibrosis
257428|NCT02594020|suspected caries|suspected caries
257429|NCT02594020|initial enamel lesions|initial enamel lesions
257430|NCT02594007|telehealth|telehealth
257431|NCT02594007|heart failure|heart failure
257432|NCT02593994|Onyx|onyx
257433|NCT02593994|drug eluting stent|drug eluting stent
257434|NCT02593994|Routine Clinical Practice|routine clinical practice
257435|NCT02593994|Angioplasty, Transluminal, Percutaneous Coronary|angioplasty, transluminal, percutaneous coronary
257436|NCT02593994|Coronary Artery Disease|coronary artery disease
257437|NCT02593981|sleep|sleep
257438|NCT02593981|fruit|fruit
257439|NCT02593981|honey|honey
257440|NCT02593981|geriatric|geriatric
257441|NCT02593929|squamous cell carcinoma|squamous cell carcinoma
257442|NCT02593929|head and neck cancer|head and neck cancer
257443|NCT02593929|operable|operable
257444|NCT02593903|Antibiotic Prophylaxis|antibiotic prophylaxis
257445|NCT02593890|Breast Cancer|breast cancer
257446|NCT02593890|Breast Surgery|breast surgery
257447|NCT02593890|Mastectomy|mastectomy
257448|NCT02593890|Lumpectomy|lumpectomy
257449|NCT02593890|Post-operative|post-operative
257450|NCT02593890|Bra|bra
257451|NCT02593890|Lingerie|lingerie
257452|NCT02593890|Body Image|body image
257453|NCT02593890|Psycho-social|psycho-social
257454|NCT02593890|Impact|impact
257455|NCT02593877|Trauma|trauma
257456|NCT02593877|Hemostasis|hemostasis
257457|NCT02593877|Resuscitation|resuscitation
257458|NCT02593877|Coagulopathy|coagulopathy
257459|NCT02593877|Transfusion|transfusion
257460|NCT02593851|Respiratory Syncytial Virus Infections|respiratory syncytial virus infections
257461|NCT02593851|JNJ-53718678|jnj-53718678
257462|NCT02593851|Placebo|placebo
257463|NCT02593851|Infants|infants
257464|NCT02593812|Learning|learning
257465|NCT02593812|Practice|practice
257466|NCT02593799|Liver cirrhosis|liver cirrhosis
257467|NCT02593799|Esophageal and Gastric Varices|esophageal and gastric varices
257468|NCT02593799|Endoscopy|endoscopy
257469|NCT02593773|Interferon gamma|interferon gamma
257470|NCT02593747|Allergy|allergy
257471|NCT02593708|HER2+|her2+
257472|NCT02593695|Anorexia Nervosa|anorexia nervosa
257473|NCT02593695|Deep Brain Stimulation|deep brain stimulation
257474|NCT02593695|Nucleus accumbens|nucleus accumbens
257475|NCT02593656|protein ingestion|protein ingestion
257476|NCT02593656|resistance exercise|resistance exercise
257477|NCT02593656|interval exercise|interval exercise
257478|NCT02593656|stretching exercise|stretching exercise
257479|NCT02593656|endurance exercise|endurance exercise
257480|NCT02593643|Major Depressive Disorder|major depressive disorder
257481|NCT02593643|Bipolar Disorder|bipolar disorder
257482|NCT02593643|Depression|depression
257483|NCT02593643|Suicide|suicide
257484|NCT02593643|Suicidal Ideation|suicidal ideation
257485|NCT02593643|Ketamine|ketamine
257486|NCT02593643|Midazolam|midazolam
257487|NCT02593643|Inpatients|inpatients
257488|NCT02593617|Energy Drinks|energy drinks
257489|NCT02593617|Alcohol Drinking|alcohol drinking
257490|NCT02593617|Substance Use|substance use
257491|NCT02593604|Hidradenitis suppurativa|hidradenitis suppurativa
257492|NCT02593604|Wide excision|wide excision
257493|NCT02593604|Quality of Life|quality of life
257494|NCT02593604|Sexual Function|sexual function
257495|NCT02593539|APDS|apds
257496|NCT02593539|Safety|safety
257497|NCT02593539|Pharmacokinetics|pharmacokinetics
257498|NCT02593539|GSK2269557|gsk2269557
257499|NCT02593539|PASLI|pasli
257500|NCT02593513|Embryo Transfer|embryo transfer
257501|NCT02593513|Embryo Selection Criteria for Implantation|embryo selection criteria for implantation
257502|NCT02593513|Assisted Reproductive Technology|assisted reproductive technology
257503|NCT02593500|Bioequivalence, budesonide,|bioequivalence, budesonide,
257504|NCT02593487|Coronary Artery Disease|coronary artery disease
257505|NCT02593487|Hyperlipidemia|hyperlipidemia
257506|NCT02593487|Rosuvastatin|rosuvastatin
257507|NCT02593487|Lipoproteins|lipoproteins
257508|NCT02593487|high-density lipoprotein|high-density lipoprotein
257509|NCT02593487|HDL2|hdl2
257510|NCT02593474|Adolescent|adolescent
257511|NCT02593474|Youth|youth
257512|NCT02593461|Embryo Transfer|embryo transfer
257513|NCT02593461|Embryo Selection Criteria for Implantation|embryo selection criteria for implantation
257514|NCT02593461|Assisted Reproductive Technology|assisted reproductive technology
257515|NCT02593448|Cardiopulmonary Bypass|cardiopulmonary bypass
257516|NCT02593448|Anoxia|anoxia
257517|NCT02593435|BRCA1/2 gene mutation|brca1/2 gene mutation
257518|NCT02593435|Breast Cancer|breast cancer
257519|NCT02593435|Chinese high risk group|chinese high risk group
257520|NCT02593422|ovarian cancer|ovarian cancer
257521|NCT02593422|expressive writing|expressive writing
257522|NCT02593422|writing interventions|writing interventions
257523|NCT02593422|psychosocial support|psychosocial support
257525|NCT02593409|pre-exposure prophylaxis (PrEP)|pre-exposure prophylaxis (prep)
257526|NCT02593409|immune response|immune response
734657|NCT00494767|weight loss|weight loss
257527|NCT02593396|sexual dysfunctions|sexual dysfunctions
257528|NCT02593396|erectile dysfunctions|erectile dysfunctions
257529|NCT02593396|hypoactive sexual desire dysfunctions|hypoactive sexual desire dysfunctions
257530|NCT02593383|safety|safety
257531|NCT02593383|efficacy|efficacy
257532|NCT02593370|Hip surgery anesthesia|hip surgery anesthesia
257533|NCT02593370|Perioperative analgesia|perioperative analgesia
257534|NCT02593357|endothelial function|endothelial function
257535|NCT02593357|COPD|copd
257536|NCT02593357|pulmonary function|pulmonary function
257537|NCT02593344|asthma, endothelial function|asthma, endothelial function
257538|NCT02593318|energy metabolism|energy metabolism
257539|NCT02593318|oxaloacetate|oxaloacetate
257540|NCT02593305|nitrate|nitrate
257541|NCT02593305|blood flow|blood flow
257542|NCT02593305|blood pressure|blood pressure
257543|NCT02593305|vascular function|vascular function
257544|NCT02593305|hypoxia|hypoxia
257545|NCT02593292|Clinical pathway|clinical pathway
257546|NCT02593292|Electronic Health Records|electronic health records
257547|NCT02593292|Maternal Health Services & administration|maternal health services & administration
257548|NCT02593292|Patient Access to Records|patient access to records
257549|NCT02593292|Patient Satisfaction|patient satisfaction
257550|NCT02593292|Prenatal Care/methods|prenatal care/methods
257551|NCT02593279|Asthma|asthma
257552|NCT02593279|phenotype|phenotype
257553|NCT02593279|small|small
257554|NCT02593279|airway|airway
257555|NCT02593279|proximal|proximal
257556|NCT02593279|dysfunction|dysfunction
257557|NCT02593266|Prevention|prevention
257558|NCT02593266|Family|family
257559|NCT02593266|Intervention|intervention
257560|NCT02593266|Depression|depression
257561|NCT02593266|Children|children
257562|NCT02593253|Quality Improvement|quality improvement
257563|NCT02593253|Quality Indicators, Health Care|quality indicators, health care
257564|NCT02593253|Hospital Medicine|hospital medicine
257565|NCT02593240|Energy|energy
257566|NCT02593240|Presenteeism|presenteeism
257567|NCT02593240|Absenteeism|absenteeism
257568|NCT02593240|Cardiometabolic health|cardiometabolic health
257569|NCT02593240|Obesity|obesity
257570|NCT02593240|Overweight|overweight
257571|NCT02593240|Weight Loss|weight loss
257572|NCT02593240|Quality of Life|quality of life
257573|NCT02593240|Weight Control|weight control
257574|NCT02593240|Eating Behavior|eating behavior
257575|NCT02593240|Food Cravings|food cravings
257576|NCT02593240|Hunger|hunger
257577|NCT02593240|Worksite Wellness|worksite wellness
257578|NCT02593227|TNBC|tnbc
257579|NCT02593214|Condoms, Female|condoms, female
257580|NCT02593214|Contraception, Barrier|contraception, barrier
257581|NCT02593136|Vitamins|vitamins
257582|NCT02593136|Public Health|public health
257583|NCT02593136|Nutrition|nutrition
257584|NCT02593123|Donor Type (Matched Related Donor or Matched Unrelated Donor)|donor type (matched related donor or matched unrelated donor)
257585|NCT02593084|Resistance Training|resistance training
257586|NCT02593084|Exercise|exercise
257587|NCT02593084|Walking|walking
257588|NCT02593084|Safety|safety
257589|NCT02593084|Feasibility Studies|feasibility studies
257590|NCT02593058|Anhedonia|anhedonia
257591|NCT02593058|Apathy|apathy
257592|NCT02593058|Negative symptoms|negative symptoms
257593|NCT02593058|Anticipatory pleasure|anticipatory pleasure
257594|NCT02593058|Savoring|savoring
257595|NCT02593032|hemoglobin A1c protein, human > 7.5|hemoglobin a1c protein, human > 7.5
257596|NCT02593006|Joint Diseases|joint diseases
257597|NCT02593006|Juvenile Arthritis|juvenile arthritis
257598|NCT02593006|treatment|treatment
257599|NCT02593006|biologic therapy|biologic therapy
257600|NCT02593006|comparative effectiveness|comparative effectiveness
257601|NCT02592967|Carcinoma, Non-Small-Cell Lung|carcinoma, non-small-cell lung
257602|NCT02592967|JNJ-64041757|jnj-64041757
257603|NCT02592967|Listeria monocytogenes|listeria monocytogenes
257604|NCT02592928|eHealth|ehealth
257605|NCT02592928|Spirometry|spirometry
257606|NCT02592928|Lung Function|lung function
257607|NCT02592928|Primary Care|primary care
257608|NCT02592928|Telehealth|telehealth
257609|NCT02592928|Integrated Care|integrated care
257610|NCT02592902|recurrent respiratory papillomatosis|recurrent respiratory papillomatosis
257611|NCT02592902|extra oesophageal reflux|extra oesophageal reflux
257612|NCT02592902|laryngeal cyst|laryngeal cyst
257613|NCT02592902|phonosurgery|phonosurgery
257614|NCT02592902|oesophageal impedance|oesophageal impedance
257615|NCT02592889|MITRAL REGURGITATION|mitral regurgitation
257616|NCT02592876|Antibodies, Monoclonal|antibodies, monoclonal
257617|NCT02592876|Antibody-Drug Conjugate|antibody-drug conjugate
257618|NCT02592876|Antigens, CD19|antigens, cd19
257619|NCT02592876|Autologous Stem Cell Transplant|autologous stem cell transplant
257620|NCT02592876|Drug Therapy|drug therapy
257621|NCT02592876|Follicular Lymphoma Grade 3b|follicular lymphoma grade 3b
257622|NCT02592876|Hematologic Diseases|hematologic diseases
257623|NCT02592876|Immune System Diseases|immune system diseases
257624|NCT02592876|Immunoproliferative Disorders|immunoproliferative disorders
257625|NCT02592876|Immunotherapy|immunotherapy
329250|NCT02193646|ADR|adr
257626|NCT02592876|Lymphatic Diseases|lymphatic diseases
257627|NCT02592876|Lymphoma|lymphoma
257628|NCT02592876|Lymphoma, B-Cell|lymphoma, b-cell
257629|NCT02592876|Lymphoma, Large B-Cell, Diffuse|lymphoma, large b-cell, diffuse
257630|NCT02592876|Lymphoma, Non-Hodgkin|lymphoma, non-hodgkin
257631|NCT02592876|Monomethylauristatin F|monomethylauristatin f
257632|NCT02592876|Neoplasms|neoplasms
257633|NCT02592876|Neoplasms by Histologic Type|neoplasms by histologic type
257634|NCT02592876|Transformed Lymphoma / DLBCL|transformed lymphoma / dlbcl
257635|NCT02592876|Rituximab|rituximab
257636|NCT02592876|Ifosfamide|ifosfamide
257637|NCT02592876|Carboplatin|carboplatin
257638|NCT02592876|Etoposide|etoposide
257639|NCT02592850|Osteopathic manipulative treatment|osteopathic manipulative treatment
257640|NCT02592850|Frequent Episodic Tension-Type Headache|frequent episodic tension-type headache
257641|NCT02592850|Randomized Controlled Trial|randomized controlled trial
257642|NCT02592837|Endobronchial ultrasound|endobronchial ultrasound
257643|NCT02592837|EBUS|ebus
257644|NCT02592837|TBNA|tbna
257645|NCT02592837|Mediastinal ymphadenopathy|mediastinal ymphadenopathy
257646|NCT02592837|Hilar lymphadenopathy|hilar lymphadenopathy
257647|NCT02592837|Lung cancer|lung cancer
257648|NCT02592824|glutamate, heart failure, coronary artery bypass surgery|glutamate, heart failure, coronary artery bypass surgery
257649|NCT02592811|Cholangiopancreatography|cholangiopancreatography
257650|NCT02592811|therapeutic strategy|therapeutic strategy
257651|NCT02592811|Endoscopic Retrograde|endoscopic retrograde
257652|NCT02592772|menthol|menthol
257653|NCT02592772|nicotine|nicotine
257654|NCT02592772|reduced nicotine|reduced nicotine
257655|NCT02592772|smoking|smoking
257656|NCT02592772|cigarette|cigarette
257657|NCT02592772|cigarettes|cigarettes
257658|NCT02592772|men smoking|men smoking
257659|NCT02592772|smoking research|smoking research
257660|NCT02592772|nicotine dependence|nicotine dependence
257661|NCT02592720|Acute Coronary Syndromes|acute coronary syndromes
257662|NCT02592720|Fractional Flow Reserve|fractional flow reserve
257663|NCT02592720|Percutaneous Coronary Intervention|percutaneous coronary intervention
257664|NCT02592681|menstrual migraine|menstrual migraine
257665|NCT02592681|acupuncture|acupuncture
257666|NCT02592681|acupressure|acupressure
257667|NCT02592655|tourniquet|tourniquet
257668|NCT02592655|arterial|arterial
257669|NCT02592655|pre-hospital|pre-hospital
257670|NCT02592655|SOFTT-W|softt-w
257671|NCT02592655|Battle Wrap|battle wrap
257672|NCT02592655|windlass|windlass
257673|NCT02592655|exsanguination|exsanguination
257674|NCT02592655|hemorrhage|hemorrhage
257675|NCT02592655|amputation|amputation
257676|NCT02592642|lumbar spinal stenosis|lumbar spinal stenosis
257677|NCT02592642|neurogenic claudication|neurogenic claudication
257678|NCT02592642|non-operative|non-operative
257679|NCT02592642|treatment|treatment
257680|NCT02592642|outcomes|outcomes
257681|NCT02592642|clinical trial|clinical trial
257682|NCT02592629|subacromial injection|subacromial injection
257683|NCT02592629|rotator cuff disease|rotator cuff disease
257684|NCT02592629|steroid injection|steroid injection
257685|NCT02592616|Exercise|exercise
257686|NCT02592616|Appetite|appetite
257687|NCT02592616|Energy intake|energy intake
257688|NCT02592603|Serrated lesions|serrated lesions
257689|NCT02592603|Surveillance|surveillance
257690|NCT02592603|Colorectal cancer|colorectal cancer
257691|NCT02592603|Endocuff|endocuff
257692|NCT02592603|Sessile serrated adenoma|sessile serrated adenoma
257693|NCT02592603|Colonoscopy|colonoscopy
257694|NCT02592590|Exercise|exercise
257695|NCT02592590|Physical Activity|physical activity
257696|NCT02592590|Smartphone|smartphone
257697|NCT02592590|Technology|technology
257698|NCT02592577|Previously Treated|previously treated
257699|NCT02592577|Cell Therapy|cell therapy
257700|NCT02592577|T Cell Therapy|t cell therapy
257701|NCT02592577|MAGE-A10|mage-a10
257702|NCT02592577|Immuno-oncology|immuno-oncology
257703|NCT02592577|T Cell Receptor|t cell receptor
257704|NCT02592577|Metastatic|metastatic
257705|NCT02592564|Magnetic Resonance Imaging|magnetic resonance imaging
257706|NCT02592564|Cognitive Behavior Therapy|cognitive behavior therapy
257707|NCT02592564|Telomerase|telomerase
257708|NCT02592564|Telomere Length, Mean Leukocyte|telomere length, mean leukocyte
257709|NCT02592538|Biliary duct carcinoma;|biliary duct carcinoma;
257710|NCT02592538|radiofrequency ablation|radiofrequency ablation
257711|NCT02592538|S-1|s-1
257712|NCT02592512|Hypoxia|hypoxia
257713|NCT02592512|hypercapnia|hypercapnia
257714|NCT02592499|HM III|hm iii
257715|NCT02592499|survival|survival
257716|NCT02592499|LVAD|lvad
257717|NCT02592486|quadrivalent influenza vaccine|quadrivalent influenza vaccine
257718|NCT02592486|23-valent pneumococcal vaccine|23-valent pneumococcal vaccine
257719|NCT02592486|immunogenicity|immunogenicity
257720|NCT02592473|Prostate Artery Embolization (PAE)|prostate artery embolization (pae)
257912|NCT02591459|Autism|autism
257721|NCT02592473|Benign Prostatic Hyperplasia (BPH)|benign prostatic hyperplasia (bph)
735568|NCT00491192|Outcome|outcome
257722|NCT02592473|Lower Urinary Tract Symptoms (LUTS)|lower urinary tract symptoms (luts)
257724|NCT02592473|PAE|pae
257725|NCT02592473|LUTS|luts
257726|NCT02592473|Prostatic Artery Embolization|prostatic artery embolization
257727|NCT02592447|CML|cml
257728|NCT02592447|chronic phase CML|chronic phase cml
257729|NCT02592447|leukemia|leukemia
257730|NCT02592434|Arthritis|arthritis
257731|NCT02592434|Pediatric|pediatric
257732|NCT02592434|Long-term|long-term
257733|NCT02592434|JIA|jia
257734|NCT02592434|polyarticular|polyarticular
257735|NCT02592434|CP-690,550|cp-690,550
257736|NCT02592434|tofacitinib|tofacitinib
257737|NCT02592434|Xeljanz|xeljanz
257738|NCT02592395|pancreatic adenocarcinoma|pancreatic adenocarcinoma
257739|NCT02592395|electrochemotherapy|electrochemotherapy
257740|NCT02592395|electroporation|electroporation
257741|NCT02592395|radiogenomics|radiogenomics
257742|NCT02592395|imaging|imaging
257743|NCT02592395|magnetic resonance spectroscopy|magnetic resonance spectroscopy
257744|NCT02592356|Full-body dual-energy x-ray absorptiometry|full-body dual-energy x-ray absorptiometry
257745|NCT02592356|DXA|dxa
257746|NCT02592356|Body measurement|body measurement
257747|NCT02592356|Weight of participant|weight of participant
257748|NCT02592356|Questionnaires|questionnaires
257749|NCT02592356|Surveys|surveys
257750|NCT02592356|Chemotherapy|chemotherapy
257751|NCT02592356|Advanced Cancers|advanced cancers
257752|NCT02592356|Endocrine Tumor|endocrine tumor
257753|NCT02592343|fecal microbiota transplantation|fecal microbiota transplantation
257754|NCT02592343|lyophilized|lyophilized
257755|NCT02592330|LSCD treatment|lscd treatment
257756|NCT02592330|Limbal Stem Cell Deficiency|limbal stem cell deficiency
257757|NCT02592330|CALEC|calec
257758|NCT02592330|Cultivated Autologous Limbal Epithelial Cell Transplantation|cultivated autologous limbal epithelial cell transplantation
257759|NCT02592330|Corneal epithelial stem cells|corneal epithelial stem cells
257760|NCT02592330|Corneal scarring|corneal scarring
257761|NCT02592330|Corneal opacity|corneal opacity
257762|NCT02592330|Chemical injury eye|chemical injury eye
257763|NCT02592330|Thermal injury eye|thermal injury eye
257764|NCT02592330|Autologous stem cell|autologous stem cell
257765|NCT02592330|Epithelial defect|epithelial defect
257766|NCT02592330|Corneal cloudiness|corneal cloudiness
257767|NCT02592330|Occular burn|occular burn
257768|NCT02592330|Occular injury|occular injury
257769|NCT02592330|Autograft|autograft
257770|NCT02592330|CLAU|clau
257771|NCT02592330|Conjunctival Limbal Autograft|conjunctival limbal autograft
257772|NCT02592330|LSCD research|lscd research
257773|NCT02592330|Chronic contact lens wear|chronic contact lens wear
257774|NCT02592330|Chronic keratoconjunctivitis|chronic keratoconjunctivitis
257775|NCT02592330|Corneal conjunctivalization|corneal conjunctivalization
257776|NCT02592330|Corneal fibrovascular pannus|corneal fibrovascular pannus
257777|NCT02592330|Corneal neovascularization|corneal neovascularization
257778|NCT02592330|Corneal regeneration|corneal regeneration
257779|NCT02592330|Infectious keratitus|infectious keratitus
257780|NCT02592330|Limbal epithelial stem cell deficiency LESC|limbal epithelial stem cell deficiency lesc
257781|NCT02592330|Ocular injury drug toxicity|ocular injury drug toxicity
257782|NCT02592330|Ocular surface disorder|ocular surface disorder
257783|NCT02592330|Neovascularization pannus|neovascularization pannus
257784|NCT02592330|Neurotrophic keratitis|neurotrophic keratitis
257785|NCT02592330|Occular surface Inflammation|occular surface inflammation
257786|NCT02592330|Eye injury ionizing radiation|eye injury ionizing radiation
257787|NCT02592330|Eye injury ultraviolet radiation|eye injury ultraviolet radiation
257788|NCT02592330|Corneal pannus|corneal pannus
257789|NCT02592330|Corneal wound healing|corneal wound healing
257790|NCT02592330|Neurotrophic keratopathy|neurotrophic keratopathy
257791|NCT02592330|LSCD trial|lscd trial
257792|NCT02592317|JNJ-56021927|jnj-56021927
257793|NCT02592317|Prostatic Neoplasms, Castration-Resistant|prostatic neoplasms, castration-resistant
257794|NCT02592291|Mobile health|mobile health
257795|NCT02592291|Apps|apps
257796|NCT02592291|Applications|applications
257797|NCT02592291|Smart phone|smart phone
257798|NCT02592291|mHealth|mhealth
257799|NCT02592291|Chronic and Complex Conditions|chronic and complex conditions
257800|NCT02592291|Self-Management|self-management
257801|NCT02592291|Self-Care|self-care
257802|NCT02592278|Dental Caries|dental caries
257803|NCT02592278|Fluoride Varnish|fluoride varnish
257804|NCT02592278|Preschool child|preschool child
257805|NCT02592278|Prevention|prevention
257806|NCT02592239|Functional brain MRI|functional brain mri
257807|NCT02592239|functional dyspepsia|functional dyspepsia
257808|NCT02592239|hedonic response|hedonic response
257809|NCT02592200|Female|female
257810|NCT02592200|Constipation|constipation
257811|NCT02592200|Lactobacillus gasseri DSM 27123|lactobacillus gasseri dsm 27123
257812|NCT02592200|Probiotics|probiotics
257813|NCT02592187|Life-logging|life-logging
257814|NCT02592187|Cognitive Training|cognitive training
257815|NCT02592187|Mild Cognitive Impairment|mild cognitive impairment
257816|NCT02592187|Memory|memory
735671|NCT00490750|Myotomy|myotomy
257817|NCT02592187|Information and communications technology (ICT) in healthcare|information and communications technology (ict) in healthcare
257818|NCT02592187|Portable camera|portable camera
257819|NCT02592135|Acute Cardiac Insufficiency|acute cardiac insufficiency
257820|NCT02592135|Acute Heart Failure|acute heart failure
257821|NCT02592122|Mechanical ventilation|mechanical ventilation
257822|NCT02592122|Chronic obstructive pulmonary disease|chronic obstructive pulmonary disease
257823|NCT02592122|Airway resistance|airway resistance
257824|NCT02592122|Bronchial dilation test|bronchial dilation test
257825|NCT02592109|Complementary Feeding Recommendation|complementary feeding recommendation
257826|NCT02592109|Linear Programming|linear programming
257827|NCT02592109|Nutritional Status|nutritional status
257828|NCT02592109|Omega-3 Fatty Acids|omega-3 fatty acids
257829|NCT02592109|Malondialdehyde|malondialdehyde
257830|NCT02592109|alpha-Tocopherol|alpha-tocopherol
257831|NCT02592096|safety and bioavailability|safety and bioavailability
257832|NCT02592083|Neoadjuvant Therapy|neoadjuvant therapy
257833|NCT02592083|Cyclin-Dependent Kinase Inhibitor p16|cyclin-dependent kinase inhibitor p16
257834|NCT02592044|pain|pain
257835|NCT02592044|anxiety|anxiety
257836|NCT02592044|Catheterization, Peripheral|catheterization, peripheral
257837|NCT02592005|pollution|pollution
257838|NCT02591979|Sleep Apnea Syndrome|sleep apnea syndrome
257839|NCT02591979|Primary Health Care|primary health care
257840|NCT02591940|cardiovascular modeling|cardiovascular modeling
257841|NCT02591940|aortic coarctation|aortic coarctation
257842|NCT02591940|aortic valve disease|aortic valve disease
257843|NCT02591927|myocardial infarction|myocardial infarction
257844|NCT02591927|glucose-insulin-potassium|glucose-insulin-potassium
257845|NCT02591901|Spinal Cord Injuries|spinal cord injuries
257846|NCT02591901|Multiple Sclerosis|multiple sclerosis
257847|NCT02591901|Transverse Myelitis|transverse myelitis
257848|NCT02591901|Neurogenic Bladder Dysfunction|neurogenic bladder dysfunction
257849|NCT02591901|Feasibility Study|feasibility study
257850|NCT02591901|Urinary Tract Infection|urinary tract infection
257851|NCT02591875|Cardiac Catheter Ablation|cardiac catheter ablation
257852|NCT02591875|Cardiac Arrhythmias|cardiac arrhythmias
257853|NCT02591875|Atrial Flutter|atrial flutter
257854|NCT02591836|LDL‐C|ldl‐c
257855|NCT02591836|Lipid Regulator|lipid regulator
257856|NCT02591797|pain|pain
257857|NCT02591797|Infant Behavior|infant behavior
257858|NCT02591797|Heart rate|heart rate
257859|NCT02591797|Dental Anxiety|dental anxiety
257860|NCT02591784|nimotuzumab esophageal radiotherapy|nimotuzumab esophageal radiotherapy
257861|NCT02591771|Adrenaline|adrenaline
257862|NCT02591771|Extra Corporeal Life Support|extra corporeal life support
257863|NCT02591771|Inotropes|inotropes
257864|NCT02591758|Hexo-Skin|hexo-skin
257865|NCT02591758|Hexoskin|hexoskin
257866|NCT02591758|NOVA-SKIN|nova-skin
257867|NCT02591758|angina|angina
257868|NCT02591758|biometric vest|biometric vest
257869|NCT02591706|Single missing tooth|single missing tooth
257870|NCT02591706|Implants|implants
257871|NCT02591706|Peri-implant bone remodeling|peri-implant bone remodeling
257872|NCT02591706|Bone thickness|bone thickness
257873|NCT02591706|Thickness of soft tissue|thickness of soft tissue
257874|NCT02591693|Family Caregivers|family caregivers
257875|NCT02591693|Occupational Therapy|occupational therapy
257876|NCT02591693|Activities of Daily Living|activities of daily living
257877|NCT02591667|Colorectal cancer|colorectal cancer
257878|NCT02591667|Peritoneal metastasis|peritoneal metastasis
257879|NCT02591667|Neoadjuvant chemotherapy|neoadjuvant chemotherapy
257880|NCT02591667|5-Fluorouracil|5-fluorouracil
257881|NCT02591667|Oxaliplatin|oxaliplatin
257882|NCT02591667|Irinotecan|irinotecan
257883|NCT02591667|Bevacizumab|bevacizumab
257884|NCT02591667|Histopathological response|histopathological response
257885|NCT02591654|FLT|flt
257886|NCT02591654|Pembrolizumab|pembrolizumab
257887|NCT02591654|Metastatic Melanoma|metastatic melanoma
257888|NCT02591654|MK-3475|mk-3475
257889|NCT02591641|pre-hospital transport|pre-hospital transport
257890|NCT02591641|shear force|shear force
257891|NCT02591641|tissue interface pressure|tissue interface pressure
257892|NCT02591628|Hypertension|hypertension
257893|NCT02591628|Thiazide diuretics|thiazide diuretics
257894|NCT02591589|Hyperoxia|hyperoxia
257895|NCT02591589|Delirium|delirium
257896|NCT02591589|Normoxic|normoxic
257897|NCT02591589|t-MoCA|t-moca
257898|NCT02591576|Diabetes|diabetes
257899|NCT02591576|ST-elevation myocardial infarction (STEMI)|st-elevation myocardial infarction (stemi)
257900|NCT02591576|non-STEMI|non-stemi
257901|NCT02591576|Excess mortality|excess mortality
257902|NCT02591576|Relative survival|relative survival
257903|NCT02591550|chronic cough|chronic cough
257904|NCT02591550|cough reflex sensitivity|cough reflex sensitivity
257905|NCT02591550|transient receptor potential vanilloid 1|transient receptor potential vanilloid 1
257906|NCT02591550|transient receptor potential ankyrin 1|transient receptor potential ankyrin 1
257907|NCT02591498|cognitive training|cognitive training
257908|NCT02591485|PTSD prevention|ptsd prevention
257909|NCT02591485|Acute stress disorder|acute stress disorder
257910|NCT02591485|Attention training|attention training
257911|NCT02591485|Cognitive bias modification|cognitive bias modification
257913|NCT02591446|TMS|tms
257914|NCT02591446|Autism Spectrum Disorders|autism spectrum disorders
257915|NCT02591446|Plasticity|plasticity
257916|NCT02591407|Continuous Epidural Analgesia|continuous epidural analgesia
257917|NCT02591407|Transversus Abdominis Plane block|transversus abdominis plane block
257918|NCT02591381|urinary stress incontinence|urinary stress incontinence
257919|NCT02591355|Platelet Rich Plasma|platelet rich plasma
257920|NCT02591355|Hair Loss|hair loss
257921|NCT02591342|femoral neck fracture|femoral neck fracture
257922|NCT02591342|hip arthroplasty|hip arthroplasty
257923|NCT02591342|complication|complication
257924|NCT02591342|periprosthetic femoral fracture|periprosthetic femoral fracture
257925|NCT02591316|nutrition|nutrition
257926|NCT02591316|physical activity|physical activity
257927|NCT02591316|breast cancer survivor|breast cancer survivor
257928|NCT02591316|cognition|cognition
257929|NCT02591303|Insomnia|insomnia
257930|NCT02591303|Stress|stress
257931|NCT02591303|Real-life stressful events|real-life stressful events
257932|NCT02591290|Meningitis|meningitis
257933|NCT02591290|Meningococcal Meningitis|meningococcal meningitis
257934|NCT02591290|Meningococcal Infections|meningococcal infections
257935|NCT02591290|Menactra®|menactra®
257936|NCT02591290|Meningococcal Vaccine|meningococcal vaccine
257937|NCT02591277|Hepatitis C virus|hepatitis c virus
257938|NCT02591277|observational|observational
257939|NCT02591277|post-marketing|post-marketing
257940|NCT02591277|ledipasvir/sofosbuvir|ledipasvir/sofosbuvir
257941|NCT02591277|Japan|japan
257942|NCT02591238|smoking|smoking
257943|NCT02591238|melatonin|melatonin
257944|NCT02591238|vascular injury|vascular injury
257945|NCT02591225|left atrial thrombus size|left atrial thrombus size
257946|NCT02591225|transesophageale echocardiography|transesophageale echocardiography
257947|NCT02591225|silent cerebral embolism|silent cerebral embolism
257948|NCT02591212|Bystanding behaviors|bystanding behaviors
257949|NCT02591212|Campus|campus
257950|NCT02591212|Prevention|prevention
257951|NCT02591212|Sexual Assault|sexual assault
257952|NCT02591212|CampusSave|campussave
257953|NCT02591173|Autonomic|autonomic
257954|NCT02591173|Hypertension|hypertension
257955|NCT02591173|Renin-Angiotensin System|renin-angiotensin system
257956|NCT02591134|weight loss|weight loss
257957|NCT02591134|NNS|nns
257958|NCT02591134|beverages|beverages
257959|NCT02591134|diet|diet
257960|NCT02591134|appetite|appetite
257961|NCT02591134|satiety|satiety
257962|NCT02591134|weight control|weight control
257963|NCT02591108|train of four|train of four
257964|NCT02591108|neuromuscular blockade|neuromuscular blockade
257965|NCT02591108|surgery|surgery
257966|NCT02591069|Vagus nerve stimulation|vagus nerve stimulation
257967|NCT02591069|vegetative state|vegetative state
257968|NCT02591069|minimally conscious state|minimally conscious state
257969|NCT02591069|akinetic mutism|akinetic mutism
257970|NCT02591069|consciousness|consciousness
257971|NCT02591069|connectivity|connectivity
257972|NCT02591043|Pelvic|pelvic
257973|NCT02591043|Treatment Outcome|treatment outcome
257974|NCT02591030|Bile Duct Cancer|bile duct cancer
257975|NCT02591030|phase II/III|phase ii/iii
257976|NCT02591030|Modified folfirinox|modified folfirinox
257977|NCT02591030|Gemcis|gemcis
257978|NCT02591004|Neuroprotection|neuroprotection
257979|NCT02591004|calcium channel blockers|calcium channel blockers
257980|NCT02591004|magnesium sulhate|magnesium sulhate
257981|NCT02591004|Middle cerebral artery doppler|middle cerebral artery doppler
257982|NCT02590978|gallstone pancreatitis|gallstone pancreatitis
257983|NCT02590978|mild acute pancreatitis|mild acute pancreatitis
257984|NCT02590978|adult|adult
257985|NCT02590952|safety, PK|safety, pk
257986|NCT02590926|Fractional Flow Reserve, Myocardial|fractional flow reserve, myocardial
257987|NCT02590913|fructose|fructose
257988|NCT02590913|metabolism|metabolism
257989|NCT02590913|acute|acute
257990|NCT02590900|pharmacokinetics|pharmacokinetics
257991|NCT02590900|pregnancy|pregnancy
257992|NCT02590900|oral contraceptives|oral contraceptives
257993|NCT02590900|oestradiol|oestradiol
257994|NCT02590874|Mild Cognitive Impairment|mild cognitive impairment
257995|NCT02590874|Cognition|cognition
257996|NCT02590874|Memory|memory
257997|NCT02590874|Depression|depression
257998|NCT02590874|Depressive disorder|depressive disorder
257999|NCT02590874|Antidepressive agents|antidepressive agents
258000|NCT02590874|Duloxetine|duloxetine
258001|NCT02590874|Cymbalta|cymbalta
258002|NCT02590874|Selective serotonin and norepinephrine uptake inhibitors|selective serotonin and norepinephrine uptake inhibitors
258003|NCT02590861|Partial Dentures|partial dentures
258004|NCT02590861|Dental Implants|dental implants
258005|NCT02590861|Quality of Life|quality of life
258006|NCT02590861|Partial Edentulism|partial edentulism
258007|NCT02590848|Walnut intake|walnut intake
258008|NCT02590848|Brain development|brain development
258009|NCT02590848|Nutritional intervention|nutritional intervention
258010|NCT02590848|Healthy adolescents|healthy adolescents
258011|NCT02590835|Adult patients|adult patients
258012|NCT02590835|Patient demand for orthodontic treatment|patient demand for orthodontic treatment
258013|NCT02590822|Diabetes|diabetes
258014|NCT02590822|T2DM|t2dm
258015|NCT02590822|young adults|young adults
258016|NCT02590822|heart|heart
258017|NCT02590822|weight loss|weight loss
258018|NCT02590822|MRI|mri
258019|NCT02590822|exercise|exercise
258020|NCT02590822|diastolic function|diastolic function
258021|NCT02590809|Left ventricular obstruction|left ventricular obstruction
258022|NCT02590796|Delirium|delirium
258023|NCT02590796|Inattention|inattention
258024|NCT02590796|Medical device|medical device
258025|NCT02590796|Software application|software application
258026|NCT02590796|Validation study|validation study
258027|NCT02590796|Diagnosis|diagnosis
258028|NCT02590796|Dementia|dementia
258029|NCT02590783|treatment|treatment
258030|NCT02590757|non-invasive ventilation|non-invasive ventilation
258031|NCT02590757|non-invasive neurally adjusted ventilatory assist|non-invasive neurally adjusted ventilatory assist
258032|NCT02590757|nasal continuous positive airway pressure|nasal continuous positive airway pressure
258033|NCT02590744|Emergence Agitation|emergence agitation
258034|NCT02590744|eye patch|eye patch
258035|NCT02590744|preschool children|preschool children
258036|NCT02590653|STEMI|stemi
258037|NCT02590653|myocardial strain|myocardial strain
258038|NCT02590653|atorvastatin|atorvastatin
258039|NCT02590627|Parasite clearance, Treatment failure|parasite clearance, treatment failure
258040|NCT02590601|PPCM|ppcm
258041|NCT02590601|Bromocriptine|bromocriptine
258042|NCT02590601|Peripartum cardiomyopathy|peripartum cardiomyopathy
258043|NCT02590588|IgM-associated AL amyloidosis|igm-associated al amyloidosis
258044|NCT02590575|extracorporeal CO2 removal|extracorporeal co2 removal
258045|NCT02590575|renal replacement therapy|renal replacement therapy
258046|NCT02590575|Prismalung|prismalung
258047|NCT02590575|ARDS|ards
258048|NCT02590575|hypercapnia|hypercapnia
258049|NCT02590575|Changes in the arterial pCO2 value|changes in the arterial pco2 value
258050|NCT02590575|ventilated|ventilated
258051|NCT02590575|Hypercapnic|hypercapnic
258052|NCT02590549|Keratoconus|keratoconus
258053|NCT02590549|riboflavin|riboflavin
258054|NCT02590549|corneal collagen crosslinking|corneal collagen crosslinking
258055|NCT02590549|intrasromal ring|intrasromal ring
258056|NCT02590536|Sildenafil|sildenafil
258057|NCT02590536|Fetal growth Restriction|fetal growth restriction
258058|NCT02590536|Umbilical Artery Doppler|umbilical artery doppler
258059|NCT02590510|Intrathecal chemotherapy|intrathecal chemotherapy
258060|NCT02590471|Angioplasty with stenting of the superficial femoral artery|angioplasty with stenting of the superficial femoral artery
258061|NCT02590471|Fasciotomy in Hunter's channel|fasciotomy in hunter's channel
258062|NCT02590471|Breakage of stent|breakage of stent
258063|NCT02590458|Breast Cancer|breast cancer
258064|NCT02590458|Short Breast MRI Scan|short breast mri scan
258065|NCT02590458|SBMRI|sbmri
258066|NCT02590458|Routine MRI|routine mri
258067|NCT02590458|High risk for breast cancer|high risk for breast cancer
258068|NCT02590458|Screening|screening
258069|NCT02590432|Immunogenicity|immunogenicity
258070|NCT02590432|Irritable Bowel Syndrome with Constipation|irritable bowel syndrome with constipation
258071|NCT02590432|Chronic Idiopathic Constipation|chronic idiopathic constipation
258072|NCT02590432|Linaclotide|linaclotide
258073|NCT02590432|Linzess|linzess
258074|NCT02590406|Morbid Obesity|morbid obesity
258075|NCT02590406|Bariatric Surgery|bariatric surgery
258076|NCT02590406|Pre-Oxygenation|pre-oxygenation
258077|NCT02590406|Anesthesia Induction|anesthesia induction
258078|NCT02590406|Positive pressure ventilation|positive pressure ventilation
258079|NCT02590406|Non hypoxic apnea time|non hypoxic apnea time
258080|NCT02590406|Positive-Pressure Respiration|positive-pressure respiration
258081|NCT02590406|Anesthesia, General|anesthesia, general
258082|NCT02590393|Nicotine addiction|nicotine addiction
258083|NCT02590393|Cigarette smoking|cigarette smoking
258084|NCT02590393|E-cigarettes|e-cigarettes
258085|NCT02590380|Adolescent|adolescent
258086|NCT02590380|paediatric|paediatric
258087|NCT02590380|pediatric|pediatric
258088|NCT02590380|scoliosis|scoliosis
258089|NCT02590380|spine deformity|spine deformity
258090|NCT02590367|oxaliplatin-induced peripheral neuropathy|oxaliplatin-induced peripheral neuropathy
258091|NCT02590367|HD6610 granule|hd6610 granule
258092|NCT02590367|colorectal cancer|colorectal cancer
258093|NCT02590354|Treatment interruption|treatment interruption
258094|NCT02590354|functional cure|functional cure
258095|NCT02590341|myocarditis|myocarditis
258096|NCT02590341|children|children
258097|NCT02590341|adolescents|adolescents
258098|NCT02590341|registry|registry
258099|NCT02590341|multi-center|multi-center
258100|NCT02590341|pediatric|pediatric
258101|NCT02590341|heart failure|heart failure
258102|NCT02590341|inflammatory heart disease|inflammatory heart disease
258103|NCT02590341|inflammatory cardiomyopathy|inflammatory cardiomyopathy
258104|NCT02590328|Neonatal Screening|neonatal screening
258105|NCT02590328|Severe Combined Immunodeficiency|severe combined immunodeficiency
258106|NCT02590328|Immunologic Deficiency Syndromes|immunologic deficiency syndromes
258107|NCT02590328|DNA Repair-Deficiency Disorders|dna repair-deficiency disorders
258108|NCT02590328|T-cell Receptor Excision Circle|t-cell receptor excision circle
258109|NCT02590315|BC|bc
258110|NCT02590302|Clinical pathway|clinical pathway
258111|NCT02590302|Mental Health|mental health
258112|NCT02590302|Emergency Department|emergency department
258113|NCT02590302|Paediatric|paediatric
258114|NCT02590302|Risk assessment|risk assessment
258115|NCT02590302|Service integration|service integration
258116|NCT02590302|Transitions in care|transitions in care
258117|NCT02590302|Implementation|implementation
258118|NCT02590302|Scoring tools|scoring tools
258119|NCT02590302|Clinical Pathway Evaluation|clinical pathway evaluation
258120|NCT02590276|frontotemporal Dementia|frontotemporal dementia
258121|NCT02590276|Amyotrophic lateral sclerosis|amyotrophic lateral sclerosis
258122|NCT02590276|Biomarkers|biomarkers
258123|NCT02590276|brain Imaging PET|brain imaging pet
258124|NCT02590263|WHO grade III|who grade iii
258125|NCT02590263|WHO grade IV|who grade iv
258126|NCT02590263|Glioblastoma|glioblastoma
258127|NCT02590237|Laryngoscopy|laryngoscopy
258128|NCT02590237|Video Laryngoscopy|video laryngoscopy
258129|NCT02590211|experimental study|experimental study
258130|NCT02590211|cognitive mechanisms|cognitive mechanisms
258131|NCT02590211|poker|poker
258132|NCT02590211|cognitive remediation therapy|cognitive remediation therapy
258133|NCT02590133|Refractory Nasopharyngeal Carcinoma, Endostar, 5-Fu|refractory nasopharyngeal carcinoma, endostar, 5-fu
258134|NCT02590081|Normal saline|normal saline
258135|NCT02590081|Destrose 5%|destrose 5%
258136|NCT02590081|Blood pressure|blood pressure
258137|NCT02590081|Interdialytic weight gain|interdialytic weight gain
258138|NCT02590081|thirst level|thirst level
258139|NCT02590081|End Stage Renal Failure|end stage renal failure
258140|NCT02589990|health|health
258141|NCT02589990|muscle strength|muscle strength
258142|NCT02589990|exercise genomics|exercise genomics
258143|NCT02589977|magnetic resonance imaging|magnetic resonance imaging
258144|NCT02589977|positron-emission tomography|positron-emission tomography
258145|NCT02589977|echocardiography|echocardiography
258146|NCT02589977|myocardial blood flow|myocardial blood flow
258147|NCT02589977|energy metabolism|energy metabolism
258148|NCT02589964|probiotics|probiotics
258149|NCT02589964|antibiotic associated diarrhea|antibiotic associated diarrhea
258150|NCT02589964|clostridium difficile|clostridium difficile
258151|NCT02589938|hypopharyngeal cancer|hypopharyngeal cancer
258152|NCT02589938|laryngeal cancer|laryngeal cancer
258153|NCT02589938|lip and oral cavity cancer|lip and oral cavity cancer
258154|NCT02589938|nasopharyngeal cancer|nasopharyngeal cancer
258155|NCT02589938|oropharyngeal cancer|oropharyngeal cancer
258156|NCT02589938|paranasal sinus and nasal cavity cancer|paranasal sinus and nasal cavity cancer
258157|NCT02589938|salivary gland cancer|salivary gland cancer
258158|NCT02589938|radiation toxicity|radiation toxicity
258159|NCT02589938|xerostomia|xerostomia
258160|NCT02589938|long-term effects of cancer treatment|long-term effects of cancer treatment
258161|NCT02589938|oral complications of radiation therapy|oral complications of radiation therapy
258162|NCT02589925|deep brain stimulation|deep brain stimulation
258163|NCT02589925|subthalamic nucleus|subthalamic nucleus
258164|NCT02589925|Nucleus basalis Meynert|nucleus basalis meynert
258165|NCT02589886|Self-help|self-help
258166|NCT02589886|Education|education
258167|NCT02589886|e-Health|e-health
258168|NCT02589873|Lifestyle Intervention|lifestyle intervention
258169|NCT02589873|Workplace|workplace
258170|NCT02589873|Diabetes Prevention|diabetes prevention
258171|NCT02589860|Stem Cell Transplantation|stem cell transplantation
258172|NCT02589847|Clostridium difficile|clostridium difficile
258173|NCT02589847|C diff|c diff
258174|NCT02589847|CDI|cdi
258175|NCT02589847|CDAD|cdad
258176|NCT02589847|Fecal transplant|fecal transplant
258177|NCT02589847|Fecal Microbiota transplant|fecal microbiota transplant
258178|NCT02589847|diarrhea|diarrhea
258179|NCT02589847|FMT|fmt
258180|NCT02589847|microbiota restoration therapy|microbiota restoration therapy
258181|NCT02589847|microbiota suspension|microbiota suspension
258182|NCT02589847|fecal bacteriotherapy|fecal bacteriotherapy
258183|NCT02589847|C diff diarrhea|c diff diarrhea
258184|NCT02589808|pre-operative|pre-operative
258185|NCT02589808|transthoracic echocardiography|transthoracic echocardiography
258186|NCT02589808|handheld|handheld
258187|NCT02589795|safety|safety
258188|NCT02589795|immunogenicity|immunogenicity
258189|NCT02589795|HIV vaccine|hiv vaccine
258190|NCT02589782|bedaquiline|bedaquiline
258191|NCT02589782|Nitroimidazoles|nitroimidazoles
258192|NCT02589782|diarylquinolines|diarylquinolines
258193|NCT02589782|linezolid|linezolid
258194|NCT02589782|clofazimine|clofazimine
258195|NCT02589782|pretomanid|pretomanid
258196|NCT02589782|moxifloxacin|moxifloxacin
258197|NCT02589756|obesity|obesity
258198|NCT02589756|persistent organic pollutants|persistent organic pollutants
258199|NCT02589756|metabolic syndrome|metabolic syndrome
258200|NCT02589743|clinical trial|clinical trial
258201|NCT02589743|pit and fissure sealants|pit and fissure sealants
258202|NCT02589743|tooth eruption|tooth eruption
258203|NCT02589743|retention|retention
258204|NCT02589743|adhesive system|adhesive system
258205|NCT02589743|intermediary layer|intermediary layer
258206|NCT02589730|Smartphone app|smartphone app
258207|NCT02589730|diabetic management|diabetic management
258208|NCT02589730|lifestyle behaviors|lifestyle behaviors
258209|NCT02589730|medication management|medication management
258210|NCT02589678|AIDS|aids
258211|NCT02589678|Immunology|immunology
258212|NCT02589678|Public Health|public health
258213|NCT02589678|Female sex workers|female sex workers
258214|NCT02589678|Single mothers|single mothers
258215|NCT02589665|IL-23 antibody|il-23 antibody
258216|NCT02589652|Pegylated interferon|pegylated interferon
258217|NCT02589652|Entecavir|entecavir
258218|NCT02589600|Bone loss|bone loss
258219|NCT02589600|Frail Geriatric Women|frail geriatric women
258220|NCT02589600|Nursing Home Patients|nursing home patients
258221|NCT02589600|Long-term Care Patients|long-term care patients
258222|NCT02589600|Osteoporosis|osteoporosis
258223|NCT02589600|Osteoporotic Fractures|osteoporotic fractures
258224|NCT02589561|hearing loss|hearing loss
258225|NCT02589561|hearing aids|hearing aids
258226|NCT02589548|Hodgkin Lymphoma|hodgkin lymphoma
258227|NCT02589548|Hodgkin Disease|hodgkin disease
258228|NCT02589509|Event-related potentials|event-related potentials
258229|NCT02589509|Attention|attention
258230|NCT02589509|Cognitive rehabilitation|cognitive rehabilitation
258231|NCT02589509|Independent activities of daily living|independent activities of daily living
258232|NCT02589470|cognitive rehabilitation|cognitive rehabilitation
258233|NCT02589470|memory|memory
258234|NCT02589470|epilepsy|epilepsy
258235|NCT02589457|Chronic Hepatitis B virus, HIV-1 infection|chronic hepatitis b virus, hiv-1 infection
258236|NCT02589457|Healthy Male Volunteer|healthy male volunteer
258237|NCT02589457|Tenofovir Disoproxil Fumarate|tenofovir disoproxil fumarate
258238|NCT02589444|Clinical Endocrinology|clinical endocrinology
258239|NCT02589444|Immunology|immunology
258240|NCT02589444|Inflammation|inflammation
258241|NCT02589444|Microbiology|microbiology
258242|NCT02589444|Respiratory Disorders|respiratory disorders
258243|NCT02589444|Vitamins|vitamins
258244|NCT02589431|hypothalamo pituitary adrenal axis|hypothalamo pituitary adrenal axis
258245|NCT02589418|Manual acupuncture|manual acupuncture
258246|NCT02589418|Experimental dental pain|experimental dental pain
258247|NCT02589418|Psychophysics|psychophysics
258248|NCT02589418|Autonomic nervous system|autonomic nervous system
258249|NCT02589418|Subjective pain ratings|subjective pain ratings
258250|NCT02589379|postoperative pancreatic fistula|postoperative pancreatic fistula
258251|NCT02589379|soft and hard pancreas|soft and hard pancreas
258252|NCT02589366|Lymphoseek|lymphoseek
258253|NCT02589366|endometrial cancer|endometrial cancer
258254|NCT02589366|sentinel lymph node|sentinel lymph node
258255|NCT02589366|lymph node dissection|lymph node dissection
258256|NCT02589275|TNX-102 SL|tnx-102 sl
258257|NCT02589275|bedtime|bedtime
258258|NCT02589275|sublingual|sublingual
258259|NCT02589275|3-month|3-month
258260|NCT02589275|long term safety|long term safety
258261|NCT02589275|long term efficacy|long term efficacy
258262|NCT02589275|Fibromyalgia|fibromyalgia
258263|NCT02589236|Cystic Fibrosis|cystic fibrosis
258264|NCT02589236|N91115|n91115
258265|NCT02589236|Cavosonstat|cavosonstat
258266|NCT02589223|multisensory stimulation|multisensory stimulation
258267|NCT02589210|Diabetes Mellitus|diabetes mellitus
258268|NCT02589210|Foot Disease|foot disease
258269|NCT02589210|Foot Ulcer|foot ulcer
258270|NCT02589197|osteoarthritis|osteoarthritis
258271|NCT02589197|correction of functional deformity|correction of functional deformity
258272|NCT02589197|procedures|procedures
258273|NCT02589197|traumatic osteoarthritis|traumatic osteoarthritis
258274|NCT02589197|degenerative osteoarthritis|degenerative osteoarthritis
258275|NCT02589197|total knee arthroplasty|total knee arthroplasty
258276|NCT02589197|Healthy Volunteers|healthy volunteers
258277|NCT02589197|electromyography|electromyography
258278|NCT02589197|Musculoskeletal Diseases|musculoskeletal diseases
258279|NCT02589184|balance, postural|balance, postural
258280|NCT02589184|postural equilibrium|postural equilibrium
258281|NCT02589184|pain scale|pain scale
258282|NCT02589184|range of motion|range of motion
258283|NCT02589145|Blood And Marrow Transplantation|blood and marrow transplantation
258284|NCT02589145|Diffuse large B-cell lymphoma|diffuse large b-cell lymphoma
258285|NCT02589145|DLBCL|dlbcl
258286|NCT02589145|Busulfan|busulfan
258287|NCT02589145|Busulfex|busulfex
258288|NCT02589145|Myleran|myleran
258289|NCT02589145|Lenalidomide|lenalidomide
258290|NCT02589145|CC-5013|cc-5013
258291|NCT02589145|Revlimid|revlimid
258292|NCT02589145|Vorinostat|vorinostat
258293|NCT02589145|SAHA|saha
258294|NCT02589145|Suberoylanilide Hydroxamic Acid|suberoylanilide hydroxamic acid
258295|NCT02589145|MSK-390|msk-390
258296|NCT02589145|Zolinza|zolinza
258297|NCT02589145|Gemcitabine|gemcitabine
258298|NCT02589145|Gemcitabine Hydrochloride|gemcitabine hydrochloride
258299|NCT02589145|Gemzar|gemzar
258300|NCT02589145|Melphalan|melphalan
258301|NCT02589145|Alkeran|alkeran
258302|NCT02589145|Rituximab|rituximab
258303|NCT02589145|Rituxan|rituxan
258304|NCT02589145|Dexamethasone|dexamethasone
258305|NCT02589145|Decadron|decadron
258306|NCT02589145|Glutamine|glutamine
258307|NCT02589145|Enterex|enterex
258308|NCT02589145|Glutapack-10|glutapack-10
258309|NCT02589145|NutreStore|nutrestore
258310|NCT02589145|Resource|resource
258311|NCT02589145|GlutaSolve|glutasolve
258312|NCT02589145|Sympt-X G.I.|sympt-x g.i.
258313|NCT02589145|Symptx-X|symptx-x
258314|NCT02589145|Pyridoxine|pyridoxine
258315|NCT02589145|Enoxaparin|enoxaparin
258316|NCT02589145|Lovenox Injection|lovenox injection
258317|NCT02589145|Palifermin|palifermin
258318|NCT02589145|Kepivance|kepivance
258319|NCT02589119|cryptoglandular|cryptoglandular
258320|NCT02589119|perianal fistula|perianal fistula
258321|NCT02589119|cryptoglandular perianal fistulas|cryptoglandular perianal fistulas
258322|NCT02589106|Anisotropic Textile Braces|anisotropic textile braces
258323|NCT02589093|Analgesia|analgesia
258324|NCT02589093|Monitoring|monitoring
258325|NCT02589093|Analgesia Nociception Index|analgesia nociception index
258326|NCT02589093|ANI|ani
258327|NCT02589093|PhysioDoloris|physiodoloris
258328|NCT02589093|Pain|pain
258329|NCT02589041|intraneural sciatic block|intraneural sciatic block
258330|NCT02589028|diabetes mellitus|diabetes mellitus
258331|NCT02589028|incretin hormone|incretin hormone
258332|NCT02589028|glucose level|glucose level
258333|NCT02589028|GLP-1|glp-1
258334|NCT02589028|GIP|gip
258335|NCT02589028|premeal protein|premeal protein
258336|NCT02589015|morbid obesity|morbid obesity
258337|NCT02589015|neck circumference|neck circumference
258338|NCT02589015|difficult mask ventilation|difficult mask ventilation
258339|NCT02589015|difficult laryngoscopy|difficult laryngoscopy
258340|NCT02589002|sucralose|sucralose
258341|NCT02589002|insulin sensitivity|insulin sensitivity
258342|NCT02589002|beta-cell response|beta-cell response
258343|NCT02589002|appetite regulating hormone|appetite regulating hormone
258344|NCT02588976|Activated clotting time|activated clotting time
258345|NCT02588976|Sonoclot|sonoclot
258346|NCT02588963|upper respiratory tract infections|upper respiratory tract infections
258347|NCT02588963|lower respiratory tract infections|lower respiratory tract infections
258348|NCT02588963|health promotion|health promotion
258349|NCT02588963|respiratory physiotherapy|respiratory physiotherapy
258350|NCT02588963|infant|infant
258351|NCT02588937|Entecavir, EntecaBell ODT., Hepatitis B|entecavir, entecabell odt., hepatitis b
258352|NCT02588924|Parkinson Disease|parkinson disease
258353|NCT02588924|ENVIRONMENTAL AND OCCUPATIONAL EXPOSURE TO METALS|environmental and occupational exposure to metals
258354|NCT02588911|Radiofrequency Catheter Ablation|radiofrequency catheter ablation
258355|NCT02588911|Operative Surgical Procedure|operative surgical procedure
258356|NCT02588911|Saphenous Vein|saphenous vein
258357|NCT02588885|physical therapy|physical therapy
258358|NCT02588885|psychotherapy|psychotherapy
258359|NCT02588885|dysfunctional sexual behavior|dysfunctional sexual behavior
258360|NCT02588885|pelvic pain|pelvic pain
258361|NCT02588885|posttraumatic stress|posttraumatic stress
258362|NCT02588885|PTSD|ptsd
258363|NCT02588885|chronic pain|chronic pain
258364|NCT02588872|platelet-rich plasma|platelet-rich plasma
258365|NCT02588872|hyaluronic acid|hyaluronic acid
258366|NCT02588859|T2DM, Diabetes|t2dm, diabetes
258367|NCT02588846|Prostate|prostate
258368|NCT02588846|Radiotherapy|radiotherapy
258369|NCT02588846|IGRT|igrt
258370|NCT02588846|VMAT|vmat
258371|NCT02588846|Image-guided radiation therapy|image-guided radiation therapy
258372|NCT02588846|Volumetric modulated arc therapy|volumetric modulated arc therapy
258373|NCT02588846|Adaptive radiotherapy|adaptive radiotherapy
258374|NCT02588820|HIV|hiv
258375|NCT02588794|sepsis, acute kidney injury , CytoSorb|sepsis, acute kidney injury , cytosorb
258376|NCT02588768|Low-level laser therapy|low-level laser therapy
258377|NCT02588768|Light emitting diodes|light emitting diodes
258378|NCT02588768|Rugby|rugby
258379|NCT02588768|Field test|field test
258380|NCT02588768|Photobiomodulation|photobiomodulation
258381|NCT02588755|Chemoembolization|chemoembolization
258382|NCT02588755|Therapeutic|therapeutic
258383|NCT02588755|Tegafur|tegafur
258384|NCT02588742|elderly ICU patients|elderly icu patients
258385|NCT02588729|Gestational diabetes|gestational diabetes
258386|NCT02588729|app|app
258387|NCT02588729|RCT|rct
258388|NCT02588729|diet|diet
258389|NCT02588729|physical activity|physical activity
258636|NCT02587156|Amino acid|amino acid
258390|NCT02588716|Hepatectomy, Surgical Blood Loss, terlipressin|hepatectomy, surgical blood loss, terlipressin
258391|NCT02588677|Amyotrophic Lateral Sclerosis (ALS) - masitinib|amyotrophic lateral sclerosis (als) - masitinib
258392|NCT02588664|Early Supported Discharge|early supported discharge
258393|NCT02588651|Lymphoma|lymphoma
258394|NCT02588651|Leukemia|leukemia
735672|NCT00490737|ESRD|esrd
330255|NCT02189395|NPH|nph
258395|NCT02588651|Brentuximab Vedotin|brentuximab vedotin
258396|NCT02588638|NGS|ngs
258397|NCT02588638|Quality of life|quality of life
258398|NCT02588638|Diagnosis|diagnosis
258399|NCT02588638|Rare disease|rare disease
258400|NCT02588638|Next-generation sequencing|next-generation sequencing
258401|NCT02588612|Immuno-oncology|immuno-oncology
258402|NCT02588612|Cell Therapy|cell therapy
258403|NCT02588612|NY-ESO-1|ny-eso-1
258404|NCT02588612|T Cell Therapy|t cell therapy
258800|NCT02586207|Oropharynx|oropharynx
258405|NCT02588612|Previously Treated|previously treated
258406|NCT02588612|T Cell Receptor|t cell receptor
258407|NCT02588586|HIV|hiv
258408|NCT02588586|3BNC117|3bnc117
258409|NCT02588586|Broadly neutralizing antibody|broadly neutralizing antibody
258410|NCT02588560|lymphoma, hepatitis C virus, chemotherapy|lymphoma, hepatitis c virus, chemotherapy
258411|NCT02588547|Shivering|shivering
258412|NCT02588547|Granisetron|granisetron
258413|NCT02588547|Spinal|spinal
258414|NCT02588547|Cesarean section|cesarean section
258415|NCT02588534|etanercept, healthy subject,open-label, randomized, auto-injection, bioequivalence, pharmacokinetic|etanercept, healthy subject,open-label, randomized, auto-injection, bioequivalence, pharmacokinetic
258416|NCT02588508|perineal tear|perineal tear
258417|NCT02588508|pain|pain
258418|NCT02588508|pelvic floor|pelvic floor
258419|NCT02588508|Labour|labour
258420|NCT02588495|Ultrasound|ultrasound
258421|NCT02588495|Gastric area|gastric area
258422|NCT02588495|Accuracy|accuracy
258423|NCT02588495|Aspirate|aspirate
258424|NCT02588482|electroencephalography (EEG)|electroencephalography (eeg)
258425|NCT02588482|mismatch negativity (MMN)|mismatch negativity (mmn)
258426|NCT02588469|pediatric obesity|pediatric obesity
258427|NCT02588469|obstructive sleep apnea|obstructive sleep apnea
258428|NCT02588469|physical exercise|physical exercise
258429|NCT02588469|compression socks|compression socks
258430|NCT02588469|rostral fluid shift|rostral fluid shift
258431|NCT02588391|premature birth; executive function; preschool|premature birth; executive function; preschool
258432|NCT02588365|Attention Deficit Hyperactivity Disorder; executive function; preschool|attention deficit hyperactivity disorder; executive function; preschool
258433|NCT02588339|Hematologic disorder|hematologic disorder
258434|NCT02588339|allogeneic hematopoietic cell transplantation|allogeneic hematopoietic cell transplantation
258435|NCT02588326|Bioequivalence|bioequivalence
258436|NCT02588326|Suspension nasal spray|suspension nasal spray
258437|NCT02588326|Mometasone furoate|mometasone furoate
258438|NCT02588326|Pharmacokinetics|pharmacokinetics
258439|NCT02588326|Particle size distribution|particle size distribution
258440|NCT02588274|Chronic prostatitis|chronic prostatitis
258441|NCT02588274|chronic pelvic pain syndrome|chronic pelvic pain syndrome
258442|NCT02588274|acupuncture|acupuncture
258443|NCT02588274|placebo needle|placebo needle
258444|NCT02588274|randomized controlled trial|randomized controlled trial
258445|NCT02588261|erlotinib|erlotinib
258446|NCT02588261|EGFR mutation|egfr mutation
258447|NCT02588261|naquotinib|naquotinib
258448|NCT02588261|Non-small cell lung cancer (NSCLC)|non-small cell lung cancer (nsclc)
258449|NCT02588261|ASP8273|asp8273
258450|NCT02588261|gefitinib|gefitinib
258451|NCT02588248|Colon Cancer|colon cancer
258452|NCT02588248|Colonic Polyps|colonic polyps
258453|NCT02588248|L-Menthol|l-menthol
258454|NCT02588248|C-Mint|c-mint
258455|NCT02588183|atrial fibrillation|atrial fibrillation
258456|NCT02588183|catheter ablation|catheter ablation
258457|NCT02588183|pulmonary vein|pulmonary vein
258458|NCT02588183|cryoenergy|cryoenergy
258459|NCT02588183|cryoablation|cryoablation
258460|NCT02588183|ArcticFront|arcticfront
258461|NCT02588157|Rapid sequence induction intubation|rapid sequence induction intubation
258462|NCT02588157|McGrath X-Blade|mcgrath x-blade
258463|NCT02588157|Glidescope|glidescope
258464|NCT02588157|Macintosh|macintosh
258465|NCT02588144|Parkinson's disease|parkinson's disease
258466|NCT02588144|freezing of gait|freezing of gait
258467|NCT02588144|deep brain stimulation|deep brain stimulation
258468|NCT02588144|substantia nigra pars reticulata|substantia nigra pars reticulata
258469|NCT02588144|subthalamic nucleus|subthalamic nucleus
258470|NCT02588131|tremelimumab|tremelimumab
258471|NCT02588131|anti-PD-L1 MEDI4736 (Durvalumab)|anti-pd-l1 medi4736 (durvalumab)
258472|NCT02588131|malignant mesothelioma|malignant mesothelioma
258473|NCT02588105|Phase I, open label study; safety and efficacy of AZD0156; ATM inhibitor|phase i, open label study; safety and efficacy of azd0156; atm inhibitor
258474|NCT02588092|Camidanlumab tesirine|camidanlumab tesirine
258475|NCT02588079|Dental Fear|dental fear
258476|NCT02588079|Dental Phobia|dental phobia
258477|NCT02588079|Internet based cognitive behavioral therapy|internet based cognitive behavioral therapy
258478|NCT02588079|specific phobia|specific phobia
258479|NCT02588079|children and adolescents anxiety|children and adolescents anxiety
258480|NCT02588079|Self Efficacy|self efficacy
258481|NCT02588040|Chronic Lateral Epicondylitis|chronic lateral epicondylitis
258482|NCT02588040|Leukocyte- and Platelet-Rich Plasma|leukocyte- and platelet-rich plasma
258483|NCT02588040|Recover-L-PRP|recover-l-prp
330392|NCT02188901|HCC|hcc
258484|NCT02587988|Erectile dysfunction & Hypertension|erectile dysfunction & hypertension
258485|NCT02587949|acute cerebrovascular stroke|acute cerebrovascular stroke
258486|NCT02587936|Chronic|chronic
258487|NCT02587936|Risk prediction model|risk prediction model
258488|NCT02587936|Quality Improvement (QI)|quality improvement (qi)
258489|NCT02587936|Pragmatic trial|pragmatic trial
258490|NCT02587936|Cluster randomization|cluster randomization
258491|NCT02587936|Collaborative care|collaborative care
258492|NCT02587936|clinical informatics|clinical informatics
258493|NCT02587936|Chronic kidney disease|chronic kidney disease
258494|NCT02587936|hypertension|hypertension
258495|NCT02587936|high BP|high bp
258496|NCT02587936|diabetes|diabetes
258497|NCT02587897|Ultrasonography|ultrasonography
258498|NCT02587897|Nerve Conduction Velocity|nerve conduction velocity
258499|NCT02587897|Ergonomics|ergonomics
258500|NCT02587897|Work Related Injury|work related injury
258501|NCT02587897|Cumulative Trauma Disorders|cumulative trauma disorders
258502|NCT02587884|Recurrence|recurrence
258503|NCT02587884|Microvascular Invasion|microvascular invasion
258504|NCT02587884|Aspartate beta-hydroxylase|aspartate beta-hydroxylase
258505|NCT02587858|NBIA|nbia
258506|NCT02587858|PKAN|pkan
258507|NCT02587858|brain iron|brain iron
258508|NCT02587858|Neurodegeneration with Brain Iron Accumulation|neurodegeneration with brain iron accumulation
258509|NCT02587858|Hallervorden Spatz Syndrome|hallervorden spatz syndrome
258510|NCT02587858|Pantothenate Kinase Associated Neurodegeneration|pantothenate kinase associated neurodegeneration
258511|NCT02587858|PLAN|plan
258512|NCT02587858|INAD|inad
258513|NCT02587858|PLA2G6-associated neurodegeneration|pla2g6-associated neurodegeneration
258514|NCT02587858|BPAN|bpan
258515|NCT02587858|Beta-propeller Protein-associated neurodegenration|beta-propeller protein-associated neurodegenration
258516|NCT02587858|WDR45|wdr45
258517|NCT02587858|PLA2G6|pla2g6
258518|NCT02587845|total hip arthroplasty|total hip arthroplasty
258519|NCT02587845|transexamic acid|transexamic acid
258520|NCT02587832|cpap|cpap
258521|NCT02587832|HHHFNC|hhhfnc
258522|NCT02587832|RDS|rds
258523|NCT02587832|ELBW|elbw
258524|NCT02587806|RRMS|rrms
258525|NCT02587793|Hepatocellular Carcinoma|hepatocellular carcinoma
258526|NCT02587793|primary culture|primary culture
258527|NCT02587793|fine-needle aspiration|fine-needle aspiration
258528|NCT02587793|cancer-associated fibroblast|cancer-associated fibroblast
258529|NCT02587741|type 2 diabetes mellitus|type 2 diabetes mellitus
258530|NCT02587741|Diabetic Retinopathy|diabetic retinopathy
258531|NCT02587741|glucose fluctuation|glucose fluctuation
258532|NCT02587741|oxidative stress|oxidative stress
258533|NCT02587741|Insulin|insulin
258534|NCT02587741|Oral drugs|oral drugs
258535|NCT02587728|Carpal Tunnel Syndrome|carpal tunnel syndrome
258536|NCT02587728|Amyloidosis|amyloidosis
258537|NCT02587715|RRMS|rrms
258538|NCT02587702|Term Infants|term infants
258539|NCT02587624|atrial fibrillation|atrial fibrillation
258540|NCT02587624|catheter ablation|catheter ablation
258541|NCT02587624|remote magnetic navigation|remote magnetic navigation
258542|NCT02587598|leukemia|leukemia
258543|NCT02587598|myelodysplastic syndrome (MDS)|myelodysplastic syndrome (mds)
258544|NCT02587598|myelodysplastic/myeloproliferative neoplasms (MDS/MPN)|myelodysplastic/myeloproliferative neoplasms (mds/mpn)
258545|NCT02587598|myelofibrosis (MF)|myelofibrosis (mf)
258546|NCT02587598|lymphoproliferative disorders|lymphoproliferative disorders
258547|NCT02587598|acute myeloid leukemia (AML)|acute myeloid leukemia (aml)
258548|NCT02587598|lymphomas|lymphomas
258549|NCT02587598|multiple myeloma (MM)|multiple myeloma (mm)
258550|NCT02587598|PIM kinases|pim kinases
258551|NCT02587559|physical therapy|physical therapy
258552|NCT02587546|laryngeal carcinoma|laryngeal carcinoma
258553|NCT02587546|bilateral vocal cord paralysis|bilateral vocal cord paralysis
258554|NCT02587546|laryngotracheal stenosis|laryngotracheal stenosis
258555|NCT02587546|laser treatment|laser treatment
258556|NCT02587546|decannulation|decannulation
258557|NCT02587546|voice|voice
258558|NCT02587546|swallowing|swallowing
258559|NCT02587533|Baroreflex|baroreflex
258560|NCT02587533|Chemoreflex|chemoreflex
258561|NCT02587533|Autonomic nervous system|autonomic nervous system
258562|NCT02587533|Sympathetic activity|sympathetic activity
258563|NCT02587533|Muscle sympathetic nerve activity (MSNA)|muscle sympathetic nerve activity (msna)
258564|NCT02587533|Microneurography|microneurography
258565|NCT02587533|Electrical baroreflex stimulation|electrical baroreflex stimulation
258566|NCT02587533|Resistant hypertension|resistant hypertension
258567|NCT02587533|Device-based therapy|device-based therapy
258568|NCT02587520|Tetanus|tetanus
258569|NCT02587520|Diphtheria|diphtheria
258570|NCT02587520|Pertussis|pertussis
258571|NCT02587520|SP0173|sp0173
258572|NCT02587520|Tdap vaccine|tdap vaccine
258573|NCT02587481|Acute coronary syndrom|acute coronary syndrom
258574|NCT02587481|Chronic obstructive pulmonary disease|chronic obstructive pulmonary disease
258575|NCT02587481|Myocardial infarction|myocardial infarction
258576|NCT02587481|Blood based biomarkers|blood based biomarkers
258577|NCT02587468|phenolics|phenolics
258578|NCT02587468|absorption|absorption
258579|NCT02587468|fruit & vegetable concentrate|fruit & vegetable concentrate
258580|NCT02587468|Bioavailability of phenolic compounds|bioavailability of phenolic compounds
258581|NCT02587455|Non-small cell carcinoma|non-small cell carcinoma
258582|NCT02587442|Acute Radiation Syndrome|acute radiation syndrome
258583|NCT02587442|ARS|ars
258584|NCT02587442|Amifostine|amifostine
258585|NCT02587442|Radio-protectants|radio-protectants
258586|NCT02587416|Pharmacokinetics|pharmacokinetics
258587|NCT02587416|Lipid Regulator|lipid regulator
258588|NCT02587390|Pharmacokinetics|pharmacokinetics
258589|NCT02587390|Lipid Regulator|lipid regulator
258590|NCT02587364|Pharmacokinetics|pharmacokinetics
258591|NCT02587364|Lipid Regulator|lipid regulator
258697|NCT02586844|Molecular profiling|molecular profiling
258592|NCT02587351|Chronic Obstructive Pulmonary Disease|chronic obstructive pulmonary disease
258593|NCT02587351|COPD|copd
258594|NCT02587351|Exacerbation|exacerbation
258595|NCT02587351|Lung function|lung function
258596|NCT02587351|Cardiac|cardiac
258597|NCT02587351|Cardiovascular|cardiovascular
258598|NCT02587351|Beta blockers|beta blockers
258599|NCT02587351|Metoprolol succinate|metoprolol succinate
258600|NCT02587351|Smoking|smoking
258601|NCT02587338|Subjective Memory Impairment|subjective memory impairment
258602|NCT02587338|tDCS|tdcs
258603|NCT02587338|NIRS|nirs
258604|NCT02587338|Cognitive Training|cognitive training
258605|NCT02587338|Working Memory|working memory
258606|NCT02587286|mHealth|mhealth
258607|NCT02587286|Telemedicine|telemedicine
258608|NCT02587286|Randomized Controlled Trial|randomized controlled trial
258609|NCT02587286|Glucose control|glucose control
258610|NCT02587273|Critical care|critical care
258611|NCT02587273|Intensive Care|intensive care
258612|NCT02587273|Fentanyl|fentanyl
258613|NCT02587273|Pharmacokinetics|pharmacokinetics
258614|NCT02587273|Multiple Organ Failure|multiple organ failure
258615|NCT02587260|P2Y12 inhibitors|p2y12 inhibitors
258616|NCT02587260|Acute Coronary Syndrome (ACS)|acute coronary syndrome (acs)
258617|NCT02587260|Endothelial function|endothelial function
258618|NCT02587260|Adenosine measurement in human subject|adenosine measurement in human subject
258619|NCT02587260|Endopath|endopath
258620|NCT02587234|motor recovery|motor recovery
258621|NCT02587234|chronic|chronic
258622|NCT02587234|human|human
258623|NCT02587234|sensory|sensory
258624|NCT02587234|afferent input|afferent input
258625|NCT02587234|motor training|motor training
258626|NCT02587208|circumcision|circumcision
258627|NCT02587208|plastibell|plastibell
258628|NCT02587208|infants|infants
258629|NCT02587208|open sleeve|open sleeve
258630|NCT02587195|Multiple Sclerosis|multiple sclerosis
258631|NCT02587169|liposarcoma|liposarcoma
258632|NCT02587169|leiomyosarcoma|leiomyosarcoma
258633|NCT02587169|retroperitoneum|retroperitoneum
258634|NCT02587169|chondrosarcoma|chondrosarcoma
258635|NCT02587156|Required dietary protein|required dietary protein
258637|NCT02587156|Splanchnic extraction|splanchnic extraction
258638|NCT02587130|intractable pain|intractable pain
258639|NCT02587130|pressure ulcer|pressure ulcer
258640|NCT02587130|bed sore|bed sore
258641|NCT02587130|palliative medicine|palliative medicine
258642|NCT02587130|ketamine|ketamine
258643|NCT02587130|pain management|pain management
258644|NCT02587117|Antioxidant|antioxidant
258645|NCT02587117|Lycopene|lycopene
258646|NCT02587117|Prednisolone|prednisolone
258647|NCT02587104|Diabetes Mellitus|diabetes mellitus
258648|NCT02587104|Foot Diseases|foot diseases
258649|NCT02587104|Foot Ulcer|foot ulcer
258650|NCT02587078|Haemodynamic stabilization|haemodynamic stabilization
258651|NCT02587052|biopsy-proven acute rejection|biopsy-proven acute rejection
258652|NCT02587052|graft loss|graft loss
258653|NCT02587052|graft survival|graft survival
258654|NCT02587039|delirium|delirium
258656|NCT02587039|valve|valve
258657|NCT02587039|graft|graft
258658|NCT02587039|surgery|surgery
258659|NCT02587039|coronary|coronary
258660|NCT02587026|Biorepository|biorepository
258661|NCT02587026|Precision Genomics|precision genomics
258662|NCT02587000|adenomyosis|adenomyosis
258663|NCT02587000|ulipristal acetate|ulipristal acetate
258664|NCT02587000|sonography|sonography
258665|NCT02587000|Magnetic resonance imaging [MRI]|magnetic resonance imaging [mri]
258666|NCT02587000|Pictorial Blood-loss Assessment Chart [PBAC]|pictorial blood-loss assessment chart [pbac]
258667|NCT02586987|Selumetinib|selumetinib
258668|NCT02586987|Tremelimumab|tremelimumab
258669|NCT02586987|MEDI4736|medi4736
258670|NCT02586987|Safety|safety
258671|NCT02586987|Tolerability|tolerability
258672|NCT02586987|Pharmacokinetics|pharmacokinetics
258673|NCT02586987|Patients with advanced solid tumours|patients with advanced solid tumours
258674|NCT02586987|Disease progression|disease progression
258675|NCT02586974|CO2 insufflation|co2 insufflation
258676|NCT02586974|robot assisted radical prostatectomy|robot assisted radical prostatectomy
258677|NCT02586974|laparoscopy|laparoscopy
258678|NCT02586974|hypothermia|hypothermia
258679|NCT02586974|cytokine response|cytokine response
258680|NCT02586961|randomized prospective study|randomized prospective study
258681|NCT02586961|complication rate|complication rate
258682|NCT02586961|bronchiolitis|bronchiolitis
258683|NCT02586961|children|children
258684|NCT02586948|extracorporeal CO2 removal|extracorporeal co2 removal
258686|NCT02586935|Autism|autism
258687|NCT02586909|Alzheimer's disease|alzheimer's disease
258688|NCT02586909|RVT-101|rvt-101
258689|NCT02586909|donepezil|donepezil
258690|NCT02586883|Dilation of the Bronchi|dilation of the bronchi
258691|NCT02586883|Bronchial potential difference|bronchial potential difference
258692|NCT02586883|Dilation of the Bronchi (DDB)|dilation of the bronchi (ddb)
258693|NCT02586857|Glioblastoma Multiforme|glioblastoma multiforme
258694|NCT02586857|GBM|gbm
258695|NCT02586844|NET|net
258696|NCT02586844|PanNET|pannet
258698|NCT02586844|Transcriptome sequencing|transcriptome sequencing
258699|NCT02586831|Diabetes Mellitus, Type 1|diabetes mellitus, type 1
258700|NCT02586831|Hypoglycemia|hypoglycemia
258701|NCT02586831|Autoimmune Diseases|autoimmune diseases
258702|NCT02586831|Diabetes Mellitus|diabetes mellitus
258703|NCT02586805|DX-2930|dx-2930
258704|NCT02586805|Hereditary Angioedema|hereditary angioedema
258705|NCT02586805|Dyax|dyax
258706|NCT02586792|Influenza,Open-Label, Vaccine, Intramusclar, H7N7, H7N9, Non-adjuvanted, sub-study|influenza,open-label, vaccine, intramusclar, h7n7, h7n9, non-adjuvanted, sub-study
258707|NCT02586779|Referral and consultation|referral and consultation
258708|NCT02586779|emergency department|emergency department
258709|NCT02586779|WhatsApp|whatsapp
258710|NCT02586766|Youth Violence|youth violence
258711|NCT02586727|Radiation Retinopathy|radiation retinopathy
258712|NCT02586727|aflibercept|aflibercept
258713|NCT02586688|child depression|child depression
258714|NCT02586688|depression|depression
258715|NCT02586688|Transcranial Magnetic Stimulation|transcranial magnetic stimulation
258716|NCT02586688|Adolescent Major Depressive Disorder|adolescent major depressive disorder
258717|NCT02586688|TMS|tms
258718|NCT02586688|adolescent depression|adolescent depression
258719|NCT02586675|ER+ breast cancer|er+ breast cancer
258720|NCT02586675|PR+ breast cancer|pr+ breast cancer
258721|NCT02586675|hormone receptor positive|hormone receptor positive
258722|NCT02586675|HER2- breast cancer|her2- breast cancer
258723|NCT02586675|HER2 negative|her2 negative
258724|NCT02586675|locally advanced|locally advanced
258725|NCT02586675|metastatic|metastatic
258726|NCT02586662|scapular dyskinesis|scapular dyskinesis
258727|NCT02586662|kinematics|kinematics
258728|NCT02586649|tiotropium bromide|tiotropium bromide
258729|NCT02586636|Metformin|metformin
258730|NCT02586636|OCT1|oct1
258731|NCT02586623|Parkinson's Disease|parkinson's disease
258732|NCT02586623|Multiple System Atrophy|multiple system atrophy
258733|NCT02586623|Pure Autonomic Failure|pure autonomic failure
258734|NCT02586623|Primary Autonomic Failure|primary autonomic failure
258735|NCT02586623|Dopamine Beta Hydroxylase Deficiency|dopamine beta hydroxylase deficiency
258736|NCT02586610|Pembrolizumab|pembrolizumab
258737|NCT02586610|Chemoradiation|chemoradiation
258738|NCT02586610|Anti-PD-1 Antibody|anti-pd-1 antibody
258739|NCT02586610|MK-3475|mk-3475
258740|NCT02586597|Stroke|stroke
258741|NCT02586597|PAS|pas
258742|NCT02586597|TMS|tms
258743|NCT02586597|cortical excitability|cortical excitability
258744|NCT02586597|plasticity|plasticity
258745|NCT02586584|Patient-Reported Outcome, Antiretroviral Therapy|patient-reported outcome, antiretroviral therapy
258746|NCT02586571|Body Composition|body composition
258747|NCT02586571|Breast Feeding|breast feeding
258748|NCT02586571|Growth|growth
258749|NCT02586571|Infant|infant
258750|NCT02586571|Milk, Human|milk, human
258751|NCT02586571|Nutritional Sciences|nutritional sciences
258752|NCT02586571|Weaning|weaning
258753|NCT02586532|Detection|detection
258754|NCT02586532|Cancer|cancer
258755|NCT02586532|Antibody|antibody
258756|NCT02586532|Biopsy|biopsy
258757|NCT02586532|Registry|registry
258758|NCT02586519|wearable technology|wearable technology
258759|NCT02586519|Orpyx|orpyx
258760|NCT02586519|SurroSense Rx|surrosense rx
258761|NCT02586519|smart insole|smart insole
258762|NCT02586519|TCC|tcc
258763|NCT02586519|total contact cast|total contact cast
258764|NCT02586519|insole|insole
258765|NCT02586519|removable cast walker|removable cast walker
258766|NCT02586519|RCW|rcw
258767|NCT02586506|correct use of inhaler|correct use of inhaler
258768|NCT02586506|dose left|dose left
258769|NCT02586506|ease of use|ease of use
258770|NCT02586506|ELLIPTA|ellipta
258771|NCT02586506|Asthma|asthma
258772|NCT02586493|Placebo|placebo
258773|NCT02586493|ELLIPTA inhaler|ellipta inhaler
258774|NCT02586493|Correct use|correct use
258775|NCT02586493|COPD|copd
258776|NCT02586493|Ease of use|ease of use
258777|NCT02586480|bradycardia|bradycardia
258778|NCT02586454|Transmuscular quadratus lumborum block, total abdominal hysterectomy|transmuscular quadratus lumborum block, total abdominal hysterectomy
258779|NCT02586441|Bispectral index (BIS)|bispectral index (bis)
258780|NCT02586441|EEG|eeg
258781|NCT02586441|Depth of anesthesia|depth of anesthesia
258782|NCT02586415|endovascular|endovascular
258783|NCT02586415|endovascular procedure|endovascular procedure
258784|NCT02586415|Mechanical Thrombectomy|mechanical thrombectomy
258785|NCT02586402|ESAs CKD|esas ckd
258786|NCT02586363|Entecavir|entecavir
258787|NCT02586363|Food effect|food effect
258788|NCT02586363|Cavir Tab 0.5mg|cavir tab 0.5mg
258789|NCT02586363|Baraclude Tab. 0.5mg|baraclude tab. 0.5mg
258790|NCT02586285|S-Adenosyl Methionine|s-adenosyl methionine
258791|NCT02586285|Recurrence|recurrence
258792|NCT02586272|Embryo Transfer|embryo transfer
258793|NCT02586272|assisted reproductive technology|assisted reproductive technology
258794|NCT02586246|CDP870|cdp870
258795|NCT02586246|Rheumatoid arthritis|rheumatoid arthritis
258796|NCT02586246|Long-term|long-term
258797|NCT02586207|Larynx|larynx
258798|NCT02586207|Squamous Cell|squamous cell
258799|NCT02586207|Oral cavity|oral cavity
258801|NCT02586207|Hypopharynx|hypopharynx
258802|NCT02586194|Impaired hepatic function|impaired hepatic function
258803|NCT02586194|Pharmacokinetics|pharmacokinetics
258804|NCT02586194|ASP015K|asp015k
258805|NCT02586168|Insulin Resistance|insulin resistance
258806|NCT02586168|Lipid Regulator|lipid regulator
258807|NCT02586142|spasticity|spasticity
258808|NCT02586142|claw toe|claw toe
258809|NCT02586142|ultrasounds guidance|ultrasounds guidance
258810|NCT02586142|botulinum toxin|botulinum toxin
258811|NCT02586142|stretching exercise|stretching exercise
258812|NCT02586090|Pediatric Obesity|pediatric obesity
258813|NCT02586090|Lifestyle Intervention|lifestyle intervention
258814|NCT02586090|Family-based Intervention|family-based intervention
258815|NCT02586090|Motivational Interviewing|motivational interviewing
258816|NCT02586064|posttraumatic stress disorder|posttraumatic stress disorder
258817|NCT02586064|Veterans|veterans
258818|NCT02586064|Psychotherapy|psychotherapy
258819|NCT02586064|Randomized Controlled Trial|randomized controlled trial
258820|NCT02585999|Hormonal contraception, hormone pharmacokinetics|hormonal contraception, hormone pharmacokinetics
258821|NCT02585973|AZD1775|azd1775
258822|NCT02585973|Cisplatin|cisplatin
258823|NCT02585973|Head and Neck Squamous Cell Carcinoma|head and neck squamous cell carcinoma
258824|NCT02585973|HNSCC|hnscc
258825|NCT02585973|Chemoradiotherapy|chemoradiotherapy
258826|NCT02585973|Radiotherapy|radiotherapy
258827|NCT02585973|CRT|crt
258828|NCT02585947|Non-Hodgkin's Lymphoma|non-hodgkin's lymphoma
258829|NCT02585947|Tenofovir|tenofovir
258830|NCT02585934|Alzheimer's disease|alzheimer's disease
258831|NCT02585934|RVT-101|rvt-101
258832|NCT02585934|donepezil|donepezil
258833|NCT02585934|intepirdine|intepirdine
258834|NCT02585934|dementia|dementia
258835|NCT02585921|Urban Health|urban health
258836|NCT02585895|LDL-C Apheresis|ldl-c apheresis
258837|NCT02585895|Hypercholesterolemia|hypercholesterolemia
258838|NCT02585895|Elevated Cholesterol|elevated cholesterol
258839|NCT02585895|High Cholesterol|high cholesterol
258840|NCT02585895|PCSK9 mutations|pcsk9 mutations
258841|NCT02585895|Severe Familial Hypercholesterolemia|severe familial hypercholesterolemia
258842|NCT02585895|evolocumab|evolocumab
258843|NCT02585895|Repatha|repatha
258844|NCT02585869|Lipid Regulator|lipid regulator
258845|NCT02585869|TG|tg
258846|NCT02585856|Biliary duct carcinoma|biliary duct carcinoma
258847|NCT02585856|Photodynamic therapy|photodynamic therapy
258848|NCT02585843|Heart Failure|heart failure
258849|NCT02585843|Mineralocorticoid receptor antagonists|mineralocorticoid receptor antagonists
258850|NCT02585843|Loop diuretic resistance|loop diuretic resistance
258851|NCT02585817|Cardiac Implantable Electronic Devices|cardiac implantable electronic devices
258852|NCT02585804|FSGS, SGLT2, chronic kidney disease, GFR, proteinuria|fsgs, sglt2, chronic kidney disease, gfr, proteinuria
258853|NCT02585791|electronic cigarette|electronic cigarette
258854|NCT02585791|airway inflammation|airway inflammation
258855|NCT02585791|nasal potential difference|nasal potential difference
258856|NCT02585726|Varicose Veins|varicose veins
258857|NCT02585726|Great Saphenous Vein|great saphenous vein
258858|NCT02585726|Venous Insufficiency|venous insufficiency
258859|NCT02585700|Grippe|grippe
258860|NCT02585700|Human Flu|human flu
258861|NCT02585700|Human influenza|human influenza
258862|NCT02585687|Liver Perfusion MRI, Hepatocellular carcinoma|liver perfusion mri, hepatocellular carcinoma
258863|NCT02585622|Diabetic Kidney Disease|diabetic kidney disease
258864|NCT02585622|Mesenchymal Stromal Cells (MSC)|mesenchymal stromal cells (msc)
258865|NCT02585622|immune response|immune response
258866|NCT02585622|allogeneic|allogeneic
258867|NCT02585622|disease progression|disease progression
258868|NCT02585609|Sleep|sleep
258869|NCT02585583|Deep Brain|deep brain
258870|NCT02585583|Essential tremor|essential tremor
258871|NCT02585583|Parkinson Disease|parkinson disease
258872|NCT02585583|Tremor|tremor
258873|NCT02585583|Radiosurgery|radiosurgery
258874|NCT02585583|Thalamotomy|thalamotomy
258875|NCT02585583|deep brain stimulation|deep brain stimulation
258876|NCT02585583|DBS|dbs
258877|NCT02585583|intractable, drug resistant, invalidating tremor|intractable, drug resistant, invalidating tremor
330897|NCT02186743|IBS|ibs
258878|NCT02585570|shoulder|shoulder
258879|NCT02585570|phenylephrine|phenylephrine
258880|NCT02585570|hypotension|hypotension
258881|NCT02585544|genital prolapse|genital prolapse
258882|NCT02585544|day-care management|day-care management
258883|NCT02585544|vaginal route|vaginal route
258884|NCT02585544|prosthetic reinforcement|prosthetic reinforcement
258885|NCT02585531|Bronchiolitis|bronchiolitis
258886|NCT02585531|Dexamethasone|dexamethasone
258887|NCT02585531|Epinephrine|epinephrine
258888|NCT02585531|Hypertonic saline|hypertonic saline
258889|NCT02585427|Diabetes|diabetes
258890|NCT02585427|Obesity|obesity
258891|NCT02585427|metabolic disorders|metabolic disorders
258892|NCT02585388|pretreated metastatic breast cancer|pretreated metastatic breast cancer
258893|NCT02585362|palliative|palliative
258894|NCT02585336|Sugar-Sweetened beverages|sugar-sweetened beverages
258895|NCT02585336|Metabolic health|metabolic health
258896|NCT02585336|Soft drinks|soft drinks
258897|NCT02585323|Physical activity|physical activity
258997|NCT02584530|ultrasound|ultrasound
258898|NCT02585323|Osteoarthritis|osteoarthritis
258899|NCT02585323|Knee|knee
258900|NCT02585323|Exercise|exercise
258901|NCT02585323|Arthritis|arthritis
258902|NCT02585310|PRBC transfusion|prbc transfusion
258903|NCT02585310|CABGs|cabgs
258904|NCT02585245|Hospital Nutrition screens|hospital nutrition screens
258905|NCT02585232|Behavioral sciences|behavioral sciences
258906|NCT02585232|Counseling|counseling
258907|NCT02585232|Intervention Studies|intervention studies
258908|NCT02585232|Cognitive Behavioral Therapy|cognitive behavioral therapy
258909|NCT02585232|Telemedicine|telemedicine
258910|NCT02585232|Mindfulness|mindfulness
258911|NCT02585206|Mobile Phone|mobile phone
258912|NCT02585206|Text Messaging|text messaging
258913|NCT02585206|Internet|internet
258914|NCT02585206|Tobacco Use|tobacco use
258915|NCT02585180|Ventilator-associated pneumonia|ventilator-associated pneumonia
258916|NCT02585180|Surveillance|surveillance
258917|NCT02585180|Subglottic-secretions|subglottic-secretions
258918|NCT02585180|Critically ill patients|critically ill patients
258919|NCT02585180|Prevention|prevention
258920|NCT02585167|VAAFT|vaaft
258921|NCT02585167|anal fistula|anal fistula
258922|NCT02585167|sphincter reconstruction|sphincter reconstruction
258923|NCT02585154|Deep Brain Stimulation|deep brain stimulation
258924|NCT02585128|Delirium|delirium
258925|NCT02585128|Transcatheter Aortic Valve Implantation|transcatheter aortic valve implantation
258926|NCT02585128|Elderly|elderly
258927|NCT02585102|Vegetables|vegetables
258928|NCT02585089|Hypertension|hypertension
258929|NCT02585089|active biopeptide|active biopeptide
258930|NCT02585089|cardiovascular pathophysiology|cardiovascular pathophysiology
258931|NCT02585089|angiotensin converting enzyme inhibition|angiotensin converting enzyme inhibition
258932|NCT02585089|cured-pork ham|cured-pork ham
258933|NCT02585076|Stroke prevention|stroke prevention
258934|NCT02585076|Risk assessment|risk assessment
258935|NCT02585063|independent prescribing,|independent prescribing,
258936|NCT02585063|optometrist|optometrist
258937|NCT02585063|acute care|acute care
258938|NCT02585050|do not attempt resuscitation|do not attempt resuscitation
258939|NCT02585050|neurological outcome|neurological outcome
258940|NCT02585050|live discharged ratio|live discharged ratio
258941|NCT02585024|smoking|smoking
258942|NCT02585024|cytisine|cytisine
258943|NCT02585024|Pharmacokinetics|pharmacokinetics
258944|NCT02585011|Hemiarthroplasty|hemiarthroplasty
258945|NCT02585011|Anesthesia, Local|anesthesia, local
258946|NCT02585011|Pain, Postoperative|pain, postoperative
258947|NCT02584972|Postural control|postural control
258948|NCT02584972|Gait|gait
258949|NCT02584972|Children|children
258950|NCT02584972|Autism Spectrum Disorder|autism spectrum disorder
258951|NCT02584933|ALK|alk
258952|NCT02584933|Malignancies|malignancies
258953|NCT02584907|Critically ill|critically ill
258954|NCT02584907|Diet|diet
258955|NCT02584907|Blood glucose|blood glucose
258956|NCT02584894|Stress Disorders, Post-Traumatic|stress disorders, post-traumatic
258957|NCT02584894|trauma exposure|trauma exposure
258958|NCT02584894|Repeated transcranial magnetic stimulation|repeated transcranial magnetic stimulation
258959|NCT02584855|Spondyloarthritis|spondyloarthritis
258960|NCT02584855|Spondylarthropathy|spondylarthropathy
258961|NCT02584816|BRV-PV|brv-pv
258962|NCT02584816|Rotavirus vaccine|rotavirus vaccine
258963|NCT02584816|lot-to-lot consistency|lot-to-lot consistency
258964|NCT02584816|interference with routine immunization|interference with routine immunization
258965|NCT02584790|Nasopharyngeal carcinoma|nasopharyngeal carcinoma
258966|NCT02584790|Narrow band imaging|narrow band imaging
258967|NCT02584777|Post-essential thrombocythemia myelofibrosis|post-essential thrombocythemia myelofibrosis
258968|NCT02584777|Post-Polycythemia Vera Myelofibrosis|post-polycythemia vera myelofibrosis
258969|NCT02584738|Asthma|asthma
258970|NCT02584738|Exacerbation|exacerbation
258971|NCT02584738|Nebulization|nebulization
258972|NCT02584738|Magnesium|magnesium
258973|NCT02584738|Pediatric|pediatric
258974|NCT02584725|Tranexamic Acid|tranexamic acid
258975|NCT02584725|Total Joint Arthroplasty|total joint arthroplasty
258976|NCT02584725|Intraoperative Blood Loss|intraoperative blood loss
258977|NCT02584660|Rivaroxaban|rivaroxaban
258978|NCT02584660|JNJ39039039|jnj39039039
258979|NCT02584660|Pulmonary embolism|pulmonary embolism
258980|NCT02584647|Unresectable|unresectable
258981|NCT02584634|Non-Small Cell Lung Cancer|non-small cell lung cancer
258982|NCT02584634|NSCLC|nsclc
258983|NCT02584634|ALK|alk
258984|NCT02584634|avelumab|avelumab
258985|NCT02584634|crizotinib|crizotinib
258986|NCT02584634|PF-06463922|pf-06463922
258987|NCT02584595|Tachycardia|tachycardia
258988|NCT02584595|Ventricular Tachycardia|ventricular tachycardia
258989|NCT02584595|Cardiac Arrhythmias|cardiac arrhythmias
258990|NCT02584595|Cardiovascular Diseases|cardiovascular diseases
258991|NCT02584595|Heart Diseases|heart diseases
258992|NCT02584582|Glucagon|glucagon
258993|NCT02584582|Glukagon-like peptide-1 (GLP-1)|glukagon-like peptide-1 (glp-1)
258994|NCT02584582|GLP-1 receptor agonist (GLP-1RA)|glp-1 receptor agonist (glp-1ra)
258995|NCT02584582|Incretins|incretins
258996|NCT02584569|Drug therapy|drug therapy
258998|NCT02584530|PICC line|picc line
258999|NCT02584530|neonate|neonate
259000|NCT02584517|Vasculitis|vasculitis
259001|NCT02584517|Autoimmune disease|autoimmune disease
259002|NCT02584517|Connective tissue disease|connective tissue disease
259003|NCT02584517|Polymyalgia rheumatica|polymyalgia rheumatica
259004|NCT02584517|Musculoskeletal Diseases|musculoskeletal diseases
259005|NCT02584517|Immune disorder|immune disorder
259006|NCT02584517|Rheumatic disease|rheumatic disease
259007|NCT02584504|Non-statin LMT|non-statin lmt
259008|NCT02584504|Low dose statin|low dose statin
259009|NCT02584478|Dual receptor Tyrosine Kinase Inhibitor|dual receptor tyrosine kinase inhibitor
259010|NCT02584478|Anti-angiogenic therapy|anti-angiogenic therapy
259011|NCT02584478|Combination Therapy|combination therapy
259012|NCT02584439|ivabradine|ivabradine
259013|NCT02584439|heart rate|heart rate
259014|NCT02584439|aging|aging
259015|NCT02584439|visco-elasticity|visco-elasticity
259016|NCT02584426|Cefazolin|cefazolin
259017|NCT02584400|prostatic tumors|prostatic tumors
259018|NCT02584400|[18F]HX4 Pet imaging|[18f]hx4 pet imaging
259019|NCT02584400|hypoxia|hypoxia
259020|NCT02584400|phase II trial|phase ii trial
259021|NCT02584400|esophageal tumors|esophageal tumors
259022|NCT02584400|rectal tumors|rectal tumors
259023|NCT02584400|brain metastases|brain metastases
259024|NCT02584400|primary brain tumors|primary brain tumors
259025|NCT02584374|iliac vein compression|iliac vein compression
259026|NCT02584361|Hearing loss|hearing loss
259027|NCT02584361|Cochlear implant|cochlear implant
259028|NCT02584348|ultrasound, antrum, pulmonary aspiration, emergency surgery|ultrasound, antrum, pulmonary aspiration, emergency surgery
259029|NCT02584335|wound treatment|wound treatment
259030|NCT02584335|lidocaine|lidocaine
259031|NCT02584335|pain reduction|pain reduction
259032|NCT02584335|local anesthetic|local anesthetic
259033|NCT02584283|Liver Transplantation|liver transplantation
259034|NCT02584283|Donation after Circulatory Death|donation after circulatory death
259035|NCT02584283|Machine Perfusion|machine perfusion
259036|NCT02584270|palatal drop prosthesis|palatal drop prosthesis
259037|NCT02584231|Desmopressin|desmopressin
259038|NCT02584231|Paediatrics|paediatrics
259039|NCT02584231|urinary concentration test|urinary concentration test
259040|NCT02584205|inspiratory muscle training|inspiratory muscle training
259041|NCT02584205|obstructive sleep apnea|obstructive sleep apnea
259042|NCT02584205|functional capacity|functional capacity
259043|NCT02584179|mpMRI, significant cancer|mpmri, significant cancer
259044|NCT02584166|Morbidity|morbidity
259045|NCT02584166|Mortality|mortality
259046|NCT02584166|conferences|conferences
259047|NCT02584166|human science|human science
259048|NCT02584153|Hernia|hernia
259049|NCT02584153|Ventral|ventral
259050|NCT02584153|Incisional|incisional
259051|NCT02584153|Abdominal|abdominal
259052|NCT02584153|Herniorrhaphy|herniorrhaphy
259053|NCT02584153|Recurrence|recurrence
259054|NCT02584153|laparotomy|laparotomy
259055|NCT02584153|prevention|prevention
259056|NCT02584140|PrEP|prep
259057|NCT02584140|Pre-exposure Prophylaxis|pre-exposure prophylaxis
259058|NCT02584140|HIV Prevention|hiv prevention
259059|NCT02584127|Smoking|smoking
259060|NCT02584127|cessation|cessation
259061|NCT02584127|Internet program|internet program
259062|NCT02584101|Acceptance and Commitment Therapy|acceptance and commitment therapy
259063|NCT02584088|NovaSure|novasure
259064|NCT02584088|Ablation|ablation
259065|NCT02584088|Menorrhagia|menorrhagia
259066|NCT02584088|Endometrium|endometrium
259067|NCT02584049|Osteopathic treatment|osteopathic treatment
259068|NCT02584049|Care-induced Pain|care-induced pain
259069|NCT02584049|Pain|pain
259070|NCT02584049|Elderly|elderly
259071|NCT02584036|influenza|influenza
259072|NCT02584036|vaccine|vaccine
259073|NCT02584036|public health|public health
259074|NCT02584036|preventable disease|preventable disease
259075|NCT02584036|vaccine history|vaccine history
259076|NCT02584036|point-of-care|point-of-care
259077|NCT02584023|ultrasonography|ultrasonography
259078|NCT02584023|infant|infant
259079|NCT02584023|perioperative period|perioperative period
259080|NCT02584023|general anesthesia|general anesthesia
259081|NCT02584010|Postoperative scars|postoperative scars
259082|NCT02584010|Cicatrix|cicatrix
259083|NCT02584010|Cicatrization|cicatrization
259084|NCT02583997|To suture or not to suture....|to suture or not to suture....
259085|NCT02583997|Tooth extraction|tooth extraction
259086|NCT02583997|Third molar|third molar
259087|NCT02583971|Direct current cardioversion|direct current cardioversion
259088|NCT02583971|Medical management|medical management
259089|NCT02583971|Atrial fibrillation ablation|atrial fibrillation ablation
259090|NCT02583945|acute kidney injury|acute kidney injury
259091|NCT02583945|hemodynamic stabilisation|hemodynamic stabilisation
259092|NCT02583945|nephrotoxic medication|nephrotoxic medication
259093|NCT02583932|Randomized controlled trial|randomized controlled trial
259094|NCT02583932|Psychological|psychological
259095|NCT02583932|Meaning|meaning
259096|NCT02583932|Existential|existential
259097|NCT02583932|Quality of life|quality of life
259098|NCT02583932|Intervention|intervention
259099|NCT02583932|Cancer|cancer
259100|NCT02583932|Advanced disease|advanced disease
259101|NCT02583932|New diagnosis|new diagnosis
259102|NCT02583880|nutritional status|nutritional status
259103|NCT02583880|malnutrition|malnutrition
259104|NCT02583880|energy intake|energy intake
259105|NCT02583880|caloric deficit|caloric deficit
259107|NCT02583880|hospital|hospital
259108|NCT02583880|enteral nutrition|enteral nutrition
259109|NCT02583880|parenteral nutrition|parenteral nutrition
259110|NCT02583880|nutrition|nutrition
259111|NCT02583854|Coronary angiography|coronary angiography
259112|NCT02583854|Transradial|transradial
259113|NCT02583854|Patient experience|patient experience
259114|NCT02583854|VAS|vas
259115|NCT02583854|Compression device|compression device
259116|NCT02583802|MHD|mhd
259117|NCT02583802|ear pills|ear pills
259118|NCT02583802|Shengmai capsule|shengmai capsule
259119|NCT02583802|Chinese medicine treatment|chinese medicine treatment
259120|NCT02583776|continuous glucose monitoring (cgm)|continuous glucose monitoring (cgm)
259121|NCT02583776|neonatal hypoglycemia|neonatal hypoglycemia
259122|NCT02583776|very low birth weight infants (VLBWI)|very low birth weight infants (vlbwi)
259123|NCT02583776|preterm infants|preterm infants
259124|NCT02583763|pro-brain natriuretic peptide (1-76)|pro-brain natriuretic peptide (1-76)
259125|NCT02583763|Insulin-Like Growth Factor Binding Proteins|insulin-like growth factor binding proteins
259126|NCT02583763|Insulin-Like Growth Factor I|insulin-like growth factor i
259127|NCT02583763|Echocardiography|echocardiography
259128|NCT02583763|Velocity Vector Imaging|velocity vector imaging
259129|NCT02583763|Heart Function Tests|heart function tests
259130|NCT02583750|glucose metabolism|glucose metabolism
259131|NCT02583750|sleep deprivation|sleep deprivation
259132|NCT02583737|bone|bone
259133|NCT02583737|maxillary sinus|maxillary sinus
259134|NCT02583672|Gaucher Disease|gaucher disease
259135|NCT02583672|GD1|gd1
259136|NCT02583672|N-acetylcysteine|n-acetylcysteine
259137|NCT02583672|glutathione|glutathione
259138|NCT02583672|GSH|gsh
259139|NCT02583659|Gastric cancer|gastric cancer
259140|NCT02583659|First-line chemotherapy|first-line chemotherapy
259141|NCT02583659|Biomarker|biomarker
259142|NCT02583646|Obesity|obesity
259143|NCT02583646|Puberty|puberty
259144|NCT02583646|Ultrasound|ultrasound
259145|NCT02583646|Pediatric|pediatric
259146|NCT02583620|high myopia|high myopia
259147|NCT02583568|breast cancer|breast cancer
259148|NCT02583568|image-guided surgery|image-guided surgery
259149|NCT02583555|Quality of Life|quality of life
259150|NCT02583555|Health Care Utilization|health care utilization
259151|NCT02583542|breast|breast
259152|NCT02583542|lung|lung
259153|NCT02583542|squamous|squamous
259154|NCT02583542|KRAS|kras
259155|NCT02583542|AZD|azd
259156|NCT02583542|selumetinib|selumetinib
259157|NCT02583529|Parkinson Disease|parkinson disease
259158|NCT02583529|Neurogenic Overactive Bladder|neurogenic overactive bladder
259159|NCT02583529|Posterior Tibial Nerve Electrostimulation|posterior tibial nerve electrostimulation
259160|NCT02583503|Total knee arthroplasty|total knee arthroplasty
259161|NCT02583503|Total knee replacement|total knee replacement
259162|NCT02583503|TKA|tka
259163|NCT02583503|TKR|tkr
259164|NCT02583490|Electroconvulsive Therapy|electroconvulsive therapy
259165|NCT02583490|Low Pulse Amplitude Focal Electroconvulsive Therapy|low pulse amplitude focal electroconvulsive therapy
259166|NCT02583490|ECT|ect
259167|NCT02583490|Depression|depression
259168|NCT02583490|Suicidal Ideation|suicidal ideation
259169|NCT02583477|Pancreatic Ductal Adenocarcinoma, PDAC, immunotherapy, PDL1, AZD5069, MEDI4736|pancreatic ductal adenocarcinoma, pdac, immunotherapy, pdl1, azd5069, medi4736
259170|NCT02583438|Gut Microbiota|gut microbiota
259171|NCT02583438|inflammatory marker|inflammatory marker
259172|NCT02583438|Glucose and lipid metabolism|glucose and lipid metabolism
735673|NCT00490737|dialysis|dialysis
259173|NCT02583399|Pediatric (Birth to less than 6 months of age)|pediatric (birth to less than 6 months of age)
259174|NCT02583399|Pain|pain
259175|NCT02583399|Fever|fever
259176|NCT02583386|mobility|mobility
259177|NCT02583386|falls|falls
259178|NCT02583386|fall prevention|fall prevention
259179|NCT02583386|gait and balance|gait and balance
259180|NCT02583386|automatic fall detector|automatic fall detector
259181|NCT02583373|Pneumonia|pneumonia
259182|NCT02583373|Streptococcus pneumoniae|streptococcus pneumoniae
259183|NCT02583373|Pneumolysin|pneumolysin
259184|NCT02583360|Infant|infant
259185|NCT02583360|Feeding difficulties|feeding difficulties
259186|NCT02583360|Dysphagia|dysphagia
259187|NCT02583334|acupuncture|acupuncture
259188|NCT02583334|fibromyalgia|fibromyalgia
259189|NCT02583334|rheumatism|rheumatism
259190|NCT02583334|clinical trial|clinical trial
259191|NCT02583321|chlorhexidine gluconate|chlorhexidine gluconate
259192|NCT02583321|oral care|oral care
259193|NCT02583321|mechanical ventilation|mechanical ventilation
259194|NCT02583321|critically ill patients|critically ill patients
259195|NCT02583321|tracheal secretions|tracheal secretions
259196|NCT02583321|subglottic secretions|subglottic secretions
259197|NCT02583308|Ventilator-associated pneumonia|ventilator-associated pneumonia
259198|NCT02583308|Surveillance|surveillance
259395|NCT02582138|nutrition|nutrition
259199|NCT02583308|Subglottic-secretions|subglottic-secretions
259200|NCT02583308|Critically ill patients|critically ill patients
259201|NCT02583308|Prevention|prevention
259202|NCT02583295|Awareness|awareness
259203|NCT02583295|Cardiac Surgery|cardiac surgery
259204|NCT02583295|Maternal|maternal
259205|NCT02583295|Pediatric|pediatric
259206|NCT02583295|Sound|sound
259207|NCT02583295|Music|music
259208|NCT02583256|Influenza Vaccine|influenza vaccine
259209|NCT02583256|MF59 adjuvant|mf59 adjuvant
259210|NCT02583243|Opioid dependence|opioid dependence
259211|NCT02583243|HIV/AIDS|hiv/aids
259212|NCT02583243|Hepatitis C|hepatitis c
259213|NCT02583243|Severe mental illness|severe mental illness
259214|NCT02583243|Injection Drug Use|injection drug use
259215|NCT02583230|Antidepressant Medication|antidepressant medication
259216|NCT02583230|Adherence|adherence
259217|NCT02583230|Mobile Smartphone Intervention|mobile smartphone intervention
259218|NCT02583230|Telemedicine|telemedicine
259219|NCT02583230|Primary Care|primary care
259220|NCT02583217|Laryngeal mask|laryngeal mask
259221|NCT02583217|Ketamine|ketamine
259222|NCT02583217|Remifentanyl|remifentanyl
259223|NCT02583165|advanced solid tumors|advanced solid tumors
259224|NCT02583165|immunotherapy|immunotherapy
259225|NCT02583165|immuno-oncology|immuno-oncology
259226|NCT02583139|Children, Moderate and/or highly emetogenic chemotherapy|children, moderate and/or highly emetogenic chemotherapy
259227|NCT02583126|Teenager|teenager
259228|NCT02583126|moderate and/or highly emetogenic chemotherapy|moderate and/or highly emetogenic chemotherapy
259229|NCT02583113|Total Knee Replacement|total knee replacement
259230|NCT02583113|Unicompartment Knee Replacement|unicompartment knee replacement
259231|NCT02583087|Barrett esophagus|barrett esophagus
259232|NCT02583087|Esophageal adenocarcinoma|esophageal adenocarcinoma
259233|NCT02583087|Endoscopic submucosal dissection|endoscopic submucosal dissection
259234|NCT02583074|deep brain stimulation|deep brain stimulation
259235|NCT02583074|Subthalamic Nucleus|subthalamic nucleus
259236|NCT02583074|dystonia|dystonia
259237|NCT02583035|cancer|cancer
259238|NCT02583035|geriatric|geriatric
259239|NCT02582996|Headache|headache
259240|NCT02582996|Aura|aura
259241|NCT02582996|Migraine|migraine
259242|NCT02582996|Moderate to Severe|moderate to severe
259243|NCT02582957|ARDS|ards
259244|NCT02582957|Shock Lung|shock lung
259245|NCT02582957|Acute Chest Syndrome|acute chest syndrome
259246|NCT02582957|Respiratory Distress Syndrome, Adult|respiratory distress syndrome, adult
259247|NCT02582957|Respiratory insufficiency|respiratory insufficiency
259248|NCT02582957|Trauma|trauma
259249|NCT02582918|Randomized Controlled Trial|randomized controlled trial
259250|NCT02582918|Mass Screening|mass screening
259251|NCT02582905|Alcohol Use Disorder|alcohol use disorder
259252|NCT02582905|Bipolar Disorder|bipolar disorder
259253|NCT02582905|Mood|mood
259254|NCT02582905|Alcohol craving|alcohol craving
259255|NCT02582905|Pregnenolone|pregnenolone
259256|NCT02582905|Citicoline|citicoline
259257|NCT02582879|Chronic Lymphocytic Leukemia|chronic lymphocytic leukemia
259258|NCT02582879|CLL|cll
259259|NCT02582879|Small Lymphocytic Leukemia|small lymphocytic leukemia
259260|NCT02582879|SLL|sll
259261|NCT02582866|Lacosamide|lacosamide
259262|NCT02582866|Vimpat|vimpat
259263|NCT02582866|Epilepsy|epilepsy
259264|NCT02582866|Partial onset seizures|partial onset seizures
259265|NCT02582866|Tonic-clonic seizures|tonic-clonic seizures
259266|NCT02582866|Monotherapy|monotherapy
259267|NCT02582866|AED|aed
259268|NCT02582853|GBS|gbs
259269|NCT02582853|AIDP|aidp
259270|NCT02582853|Spinal fluid|spinal fluid
259271|NCT02582853|sCD163|scd163
737360|NCT00484185|Efficacy|efficacy
259272|NCT02582840|Japanese patients with type 1 diabetes with inadequate glycemic control on insulin|japanese patients with type 1 diabetes with inadequate glycemic control on insulin
259273|NCT02582827|Advanced Solid Tumors|advanced solid tumors
259274|NCT02582827|solid tumor|solid tumor
259275|NCT02582827|lymphoma|lymphoma
259276|NCT02582814|Japanese patients with type 1 diabetes with inadequate glycemic control on insulin|japanese patients with type 1 diabetes with inadequate glycemic control on insulin
259277|NCT02582801|PET/CT|pet/ct
259278|NCT02582801|Alfatide Ⅱ|alfatide ⅱ
259279|NCT02582801|breast cancer|breast cancer
259280|NCT02582762|Nail gel|nail gel
259281|NCT02582762|Nail surface abnormality|nail surface abnormality
259282|NCT02582762|Efficacy|efficacy
259283|NCT02582749|Androgen Deprivation Therapy|androgen deprivation therapy
259284|NCT02582749|Androgen Receptor Antagonist|androgen receptor antagonist
259285|NCT02582749|Radium-223 Dichloride|radium-223 dichloride
259286|NCT02582749|Placebo|placebo
259287|NCT02582736|Antipsychotics|antipsychotics
259288|NCT02582736|Drug side effects|drug side effects
259289|NCT02582736|Psychosis|psychosis
259290|NCT02582736|Hyperglycemic emergencies|hyperglycemic emergencies
259291|NCT02582736|Diabetes|diabetes
259292|NCT02582736|Epidemiology|epidemiology
259293|NCT02582736|Database research|database research
259294|NCT02582736|CNODES|cnodes
259295|NCT02582697|Germ Cell|germ cell
259296|NCT02582697|Intermediate and poor-risk metastatic germ cell tumours|intermediate and poor-risk metastatic germ cell tumours
259297|NCT02582671|Real World Effectiveness|real world effectiveness
259298|NCT02582671|Observational Study|observational study
259299|NCT02582671|Sustained Virologic Response|sustained virologic response
259300|NCT02582671|Chronic Hepatitis C|chronic hepatitis c
259301|NCT02582671|Chronic Hepatitis C genotype 1|chronic hepatitis c genotype 1
259302|NCT02582671|Ombitasvir/paritaprevir/ritonavir ± dasabuvir|ombitasvir/paritaprevir/ritonavir ± dasabuvir
259303|NCT02582658|Paritaprevir|paritaprevir
259304|NCT02582658|Dasabuvir|dasabuvir
259305|NCT02582658|Ombitasvir|ombitasvir
259306|NCT02582658|Chronic Hepatitis C|chronic hepatitis c
259307|NCT02582658|HCV|hcv
259308|NCT02582645|impaction|impaction
259309|NCT02582645|impacted canine|impacted canine
259310|NCT02582645|palatally|palatally
259311|NCT02582645|open window|open window
259312|NCT02582645|closed window|closed window
259313|NCT02582645|management|management
259314|NCT02582632|Hepatitis C Virus|hepatitis c virus
259315|NCT02582632|Interferon-Free|interferon-free
259316|NCT02582632|Ribavirin-Free|ribavirin-free
259317|NCT02582632|Hepatitis C|hepatitis c
259318|NCT02582632|Hepatitis C Genotype 1b|hepatitis c genotype 1b
259319|NCT02582619|Spinal Cord Injury and Employment|spinal cord injury and employment
259320|NCT02582606|Insulin Resistance|insulin resistance
259321|NCT02582606|Meal pattern|meal pattern
259322|NCT02582606|Obese|obese
259323|NCT02582593|Cognitive Aging|cognitive aging
259324|NCT02582593|Neuromodulation|neuromodulation
259325|NCT02582593|Low Level Light Therapy|low level light therapy
259326|NCT02582593|Near Infrared Light|near infrared light
259327|NCT02582593|Neurostimulation|neurostimulation
259328|NCT02582580|pelvic floor|pelvic floor
259329|NCT02582580|perineal trauma|perineal trauma
259330|NCT02582580|physiotherapy|physiotherapy
259331|NCT02582580|perineal integrity|perineal integrity
259332|NCT02582567|Pregnant Women|pregnant women
259333|NCT02582567|Quality of Life|quality of life
259334|NCT02582567|Exercise|exercise
259335|NCT02582567|Sleep|sleep
259336|NCT02582567|Fetal Research|fetal research
259337|NCT02582567|Diet, Mediterranean|diet, mediterranean
259338|NCT02582567|Physical Fitness|physical fitness
259339|NCT02582567|Oxidative stress|oxidative stress
259340|NCT02582567|Inflammation|inflammation
259341|NCT02582528|cognitive remediation|cognitive remediation
259342|NCT02582528|cognition|cognition
259343|NCT02582528|youth|youth
259344|NCT02582528|mental health|mental health
259345|NCT02582528|functional outcome|functional outcome
259346|NCT02582515|d-cycloserine|d-cycloserine
259347|NCT02582515|comprehensive behavioral intervention for tics|comprehensive behavioral intervention for tics
259348|NCT02582515|habit reversal training|habit reversal training
259349|NCT02582502|Hyperbaric Oxygen|hyperbaric oxygen
259350|NCT02582502|HBOT|hbot
259351|NCT02582502|Hyperbaric Chamber|hyperbaric chamber
259352|NCT02582502|Pressurized Oxygen|pressurized oxygen
259353|NCT02582489|Mesenchymal stem cells|mesenchymal stem cells
259354|NCT02582489|Bone marrow aspirate concentrate|bone marrow aspirate concentrate
259355|NCT02582476|Hypokalemic Periodic Paralysis|hypokalemic periodic paralysis
259356|NCT02582476|Bumetanide|bumetanide
259357|NCT02582476|Periodic Paralysis|periodic paralysis
259358|NCT02582463|Risk Assessment|risk assessment
259359|NCT02582463|Hospitals|hospitals
259360|NCT02582463|Pharmacists|pharmacists
259361|NCT02582463|Medication Systems|medication systems
259362|NCT02582463|Patient Selection|patient selection
259363|NCT02582463|Prognosis research|prognosis research
259364|NCT02582450|Haemophilia|haemophilia
259365|NCT02582450|Adherence of Treatment|adherence of treatment
259366|NCT02582450|Knowledge of Illness|knowledge of illness
259367|NCT02582450|Medical-patient Relationship|medical-patient relationship
259368|NCT02582450|Illness Behavior|illness behavior
259369|NCT02582450|Treatment Difficulties|treatment difficulties
259370|NCT02582450|Veritas|veritas
259371|NCT02582437|Minimum Alveolar Concentration|minimum alveolar concentration
259372|NCT02582411|Healthy Subjects|healthy subjects
259373|NCT02582385|Amyotrophic lateral sclerosis (ALS)|amyotrophic lateral sclerosis (als)
259374|NCT02582385|Cytokines|cytokines
259375|NCT02582385|Neuropathology|neuropathology
259376|NCT02582359|Acute Myeloid Leukemia|acute myeloid leukemia
259377|NCT02582346|MRI|mri
259378|NCT02582346|Neurography|neurography
259379|NCT02582346|Tractography|tractography
259380|NCT02582346|Pelvic nerves|pelvic nerves
259381|NCT02582203|Ceftaroline fosamil|ceftaroline fosamil
259382|NCT02582203|Vancomycin|vancomycin
259383|NCT02582203|Acute bacterial skin and skin structure infections|acute bacterial skin and skin structure infections
259384|NCT02582203|Methicillin-resistant S. aureus|methicillin-resistant s. aureus
259385|NCT02582190|electrical cardioversion|electrical cardioversion
259386|NCT02582190|persistent atrial fibrillation|persistent atrial fibrillation
259387|NCT02582177|Fungal infection|fungal infection
259388|NCT02582177|Skin infection|skin infection
259389|NCT02582177|Dermatophytoses|dermatophytoses
259390|NCT02582164|Optical Coherence Tomography (OCT)|optical coherence tomography (oct)
259391|NCT02582164|Swept Source OCT|swept source oct
259392|NCT02582138|physical frailty|physical frailty
259393|NCT02582138|sarcopenia|sarcopenia
259394|NCT02582138|exercise|exercise
259396|NCT02582138|information and communications technology|information and communications technology
259397|NCT02582125|ONO-4538|ono-4538
259398|NCT02582125|Advanced non-small cell lung cancer|advanced non-small cell lung cancer
259399|NCT02582047|influenza vaccine|influenza vaccine
259400|NCT02582047|pneumococcal vaccine|pneumococcal vaccine
259401|NCT02582047|simultaneous vaccination|simultaneous vaccination
259402|NCT02582034|Optimized Dosimetry versus standard Dosimetry|optimized dosimetry versus standard dosimetry
259403|NCT02582034|Internal Radiation Therapy|internal radiation therapy
259404|NCT02582021|Microvascular Coronary Dysfunction (MCD)|microvascular coronary dysfunction (mcd)
259405|NCT02582021|Magnetic resonance imaging (MRI)|magnetic resonance imaging (mri)
259406|NCT02582021|Coronary angiography|coronary angiography
259407|NCT02582021|Coronary Vascular Dysfunction (CVD)|coronary vascular dysfunction (cvd)
259408|NCT02581995|Diabetic macular edema|diabetic macular edema
259409|NCT02581995|Intravitreal injection|intravitreal injection
259410|NCT02581982|Urothelial cancer|urothelial cancer
259411|NCT02581982|Bladder cancer|bladder cancer
259412|NCT02581982|Immunotherapy|immunotherapy
259413|NCT02581982|Paclitaxel|paclitaxel
259414|NCT02581969|Hemophilia A, Congenital|hemophilia a, congenital
259415|NCT02581956|Immunology|immunology
259416|NCT02581891|Neovascular age-related macular degeneration|neovascular age-related macular degeneration
259417|NCT02581891|nAMD)|namd)
259418|NCT02581878|Thorium-227|thorium-227
259419|NCT02581878|BAY1862864 Injection|bay1862864 injection
259420|NCT02581878|Safety|safety
259421|NCT02581878|Pharmacokinetics|pharmacokinetics
259422|NCT02581878|CD22|cd22
259423|NCT02581878|Radioimmunotherapy|radioimmunotherapy
259424|NCT02581839|eribulin|eribulin
259425|NCT02581839|central nervous system|central nervous system
259426|NCT02581839|CNS|cns
259427|NCT02581839|Eribulin Mesylate|eribulin mesylate
259428|NCT02581839|Halaven|halaven
259429|NCT02581813|Bone health|bone health
259430|NCT02581813|Body composition|body composition
259431|NCT02581813|Dairy foods|dairy foods
259432|NCT02581813|Exercise|exercise
259433|NCT02581813|inflammation|inflammation
259434|NCT02581813|nutrition intervention|nutrition intervention
259435|NCT02581813|weight management|weight management
259436|NCT02581774|induction|induction
259437|NCT02581774|cesarean delivery|cesarean delivery
259438|NCT02581761|Hemodynamically stable women >18 years old|hemodynamically stable women >18 years old
259439|NCT02581761|with abnormal plateauing serum βHCG|with abnormal plateauing serum βhcg
259440|NCT02581735|Haemophilia|haemophilia
259441|NCT02581735|Adherence|adherence
259442|NCT02581735|Prophylaxis treatment|prophylaxis treatment
259443|NCT02581735|Quality of Life|quality of life
259444|NCT02581735|Illness Behavior|illness behavior
259445|NCT02581735|Veritas-Pro questionnaire|veritas-pro questionnaire
259446|NCT02581735|uPatient|upatient
259447|NCT02581722|PrePex, Male Circumcision, HIV Prevention, Adolescents|prepex, male circumcision, hiv prevention, adolescents
259448|NCT02581709|Feasibility study|feasibility study
259449|NCT02581709|Cognition|cognition
259450|NCT02581709|Chemotherapy|chemotherapy
259451|NCT02581709|Neoplasms|neoplasms
259452|NCT02581670|oligometastatic breast cancer|oligometastatic breast cancer
259453|NCT02581618|ischemic preconditioning|ischemic preconditioning
259454|NCT02581618|myocardial injury|myocardial injury
259455|NCT02581618|percutaneous coronary intervention|percutaneous coronary intervention
259456|NCT02581592|Hepatic Impairment|hepatic impairment
259457|NCT02581592|Hepatitis|hepatitis
259458|NCT02581592|Liver Cirrhosis|liver cirrhosis
259459|NCT02581579|Tuberculosis|tuberculosis
259460|NCT02581579|Tregs|tregs
259461|NCT02581579|Tolerance|tolerance
259462|NCT02581579|Probiotic|probiotic
259463|NCT02581579|Mycobacteria|mycobacteria
259464|NCT02581540|Troponin|troponin
259465|NCT02581540|High Sensitivity Troponin T|high sensitivity troponin t
259466|NCT02581540|MACE|mace
259467|NCT02581540|risk stratification|risk stratification
259468|NCT02581540|suspected cardiac chest pain|suspected cardiac chest pain
259469|NCT02581540|Acute Coronary Syndrome|acute coronary syndrome
259470|NCT02581540|GRACE|grace
259471|NCT02581540|TIMI|timi
259472|NCT02581540|HEART|heart
259473|NCT02581514|decision algorithm|decision algorithm
259474|NCT02581501|Xeloda|xeloda
259475|NCT02581501|Gemcitabine|gemcitabine
259476|NCT02581501|Abraxane|abraxane
259477|NCT02581501|Pancreatic Cancer|pancreatic cancer
259478|NCT02581501|Metastatic Cancer|metastatic cancer
259479|NCT02581501|Phase I|phase i
259480|NCT02581501|5-FU|5-fu
259481|NCT02581501|Capecitabine|capecitabine
259482|NCT02581501|Gemzar|gemzar
259483|NCT02581501|NAB-Paclitaxel|nab-paclitaxel
259484|NCT02581501|Chemotherapy|chemotherapy
259485|NCT02581488|Diabetes|diabetes
259486|NCT02581488|diabetic foot ulcer|diabetic foot ulcer
259487|NCT02581488|foot sore|foot sore
259488|NCT02581488|type 2 diabetes|type 2 diabetes
259489|NCT02581488|type 1 diabetes|type 1 diabetes
259490|NCT02581488|neuropathy|neuropathy
259491|NCT02581488|DFU|dfu
259492|NCT02581475|Adenoma detection rate|adenoma detection rate
259493|NCT02581475|Colonoscopy|colonoscopy
259494|NCT02581475|Withdrawal time|withdrawal time
259495|NCT02581449|omega-3 fatty acids|omega-3 fatty acids
259496|NCT02581449|hemodialysis|hemodialysis
259497|NCT02581449|oxidative stress|oxidative stress
259498|NCT02581449|dyslipidemia|dyslipidemia
259499|NCT02581436|Prediction test|prediction test
259500|NCT02581436|genetic transcription profile|genetic transcription profile
259501|NCT02581436|Transplant follow-up|transplant follow-up
259502|NCT02581436|Chronic index|chronic index
259503|NCT02581436|Graft Function|graft function
259504|NCT02581410|Zostavax®|zostavax®
259505|NCT02581410|≥ 65 years of age|≥ 65 years of age
259506|NCT02581410|Herpes Zoster|herpes zoster
259507|NCT02581410|Shingles|shingles
259508|NCT02581410|Immunogenicity|immunogenicity
259509|NCT02581410|Safety|safety
259510|NCT02581397|cough|cough
259511|NCT02581397|expectorant|expectorant
259512|NCT02581397|upper respiratory tract infections|upper respiratory tract infections
259513|NCT02581397|respiratory tract infections|respiratory tract infections
259514|NCT02581397|antitussive agents|antitussive agents
259515|NCT02581384|Ewing Sarcoma|ewing sarcoma
259516|NCT02581384|Rhabdomyosarcoma|rhabdomyosarcoma
259517|NCT02581384|Wilms Tumor|wilms tumor
259518|NCT02581384|Rhabdomyosarcoma of Mediastinum|rhabdomyosarcoma of mediastinum
259519|NCT02581384|Ewing's Sarcoma Metastatic|ewing's sarcoma metastatic
259520|NCT02581384|Ewing Family of Tumors|ewing family of tumors
259521|NCT02581384|Ewing's Tumor Metastatic|ewing's tumor metastatic
259522|NCT02581384|Osteosarcoma, Metastatic|osteosarcoma, metastatic
259523|NCT02581384|Osteosarcoma in Children|osteosarcoma in children
259524|NCT02581384|Rhabdoid Tumor|rhabdoid tumor
259525|NCT02581384|Lung Metastasis|lung metastasis
259526|NCT02581384|Radiation for Children|radiation for children
259527|NCT02581384|SBRT for children|sbrt for children
259528|NCT02581384|Stereotactic Body Radiotherapy|stereotactic body radiotherapy
259529|NCT02581384|Pulmonary Metastasis|pulmonary metastasis
259530|NCT02581384|Lung Metastasis in Children|lung metastasis in children
259531|NCT02581384|Pulmonary Metastasis in Children|pulmonary metastasis in children
259532|NCT02581384|Comfort Care|comfort care
259533|NCT02581384|Palliative Care|palliative care
259534|NCT02581371|Cerebrolysin|cerebrolysin
259535|NCT02581371|neuroplasticity|neuroplasticity
259536|NCT02581371|upper limb|upper limb
259537|NCT02581371|middle cerebral artery|middle cerebral artery
259538|NCT02581371|NBS|nbs
259539|NCT02581371|navigation brain stimulation|navigation brain stimulation
259540|NCT02581371|paretic limb|paretic limb
259541|NCT02581371|stroke|stroke
259542|NCT02581371|ischemic stroke|ischemic stroke
259543|NCT02581371|rehabilitation|rehabilitation
259544|NCT02581371|Frenchay Arm Test|frenchay arm test
259545|NCT02581371|NBS eXimia Nexstim|nbs eximia nexstim
259546|NCT02581371|Barthel index|barthel index
259547|NCT02581358|scoliosis|scoliosis
259548|NCT02581358|spinal deformity|spinal deformity
259549|NCT02581358|Cobb angle|cobb angle
259550|NCT02581358|assessment|assessment
259551|NCT02581358|ultrasound|ultrasound
259552|NCT02581345|Moderate to severe chronic plaque psoriasis|moderate to severe chronic plaque psoriasis
259553|NCT02581345|Psoriasis|psoriasis
259554|NCT02581332|behavioral intervention|behavioral intervention
259555|NCT02581254|Snare|snare
259556|NCT02581254|Polypectomy|polypectomy
259557|NCT02581241|QT interval prolongation|qt interval prolongation
259558|NCT02581215|mFOLFIRINOX|mfolfirinox
259559|NCT02581215|Ramucirumab|ramucirumab
737361|NCT00484172|Obesity|obesity
259560|NCT02581202|antiretroviral therapy|antiretroviral therapy
259561|NCT02581189|Chronic Hepatitis C|chronic hepatitis c
259562|NCT02581189|Effectiveness|effectiveness
259563|NCT02581189|Influence of adherence|influence of adherence
259564|NCT02581189|Patient reported outcomes|patient reported outcomes
259565|NCT02581189|Ombitasvir/paritaprevir/ritonavir ± dasabuvir|ombitasvir/paritaprevir/ritonavir ± dasabuvir
259566|NCT02581189|Chronic Hepatitis C genotype 1|chronic hepatitis c genotype 1
259567|NCT02581189|Chronic Hepatitis C genotype 4|chronic hepatitis c genotype 4
259568|NCT02581163|Effectiveness|effectiveness
259569|NCT02581163|Influence of adherence|influence of adherence
259570|NCT02581163|Patient reported outcomes|patient reported outcomes
259571|NCT02581163|Ombitasvir/paritaprevir/ritonavir ± dasabuvir|ombitasvir/paritaprevir/ritonavir ± dasabuvir
259572|NCT02581163|Chronic Hepatitis C genotype 1|chronic hepatitis c genotype 1
259573|NCT02581163|Chronic Hepatitis C genotype 4|chronic hepatitis c genotype 4
259574|NCT02581150|Outpatient hospitalization|outpatient hospitalization
259575|NCT02581150|Randomized trial|randomized trial
259576|NCT02581150|Peripheral arterial disease|peripheral arterial disease
259577|NCT02581150|Endovascular treatment|endovascular treatment
259578|NCT02581150|Health Economics|health economics
259579|NCT02581124|JTZ-951|jtz-951
259580|NCT02581124|Lapatinib|lapatinib
259581|NCT02581124|Pharmacokinetics|pharmacokinetics
259582|NCT02581085|Tocotrienol|tocotrienol
259583|NCT02581085|Vitamin E|vitamin e
259584|NCT02581059|Regorafenib|regorafenib
259585|NCT02581059|American Ginseng|american ginseng
259586|NCT02581059|Fatigue|fatigue
259587|NCT02581020|Hepatitis C|hepatitis c
259588|NCT02581020|Follow-up|follow-up
259589|NCT02581020|Observation|observation
259590|NCT02581020|Japanese|japanese
259591|NCT02581007|CML|cml
259592|NCT02581007|AML|aml
259593|NCT02581007|MDS|mds
259594|NCT02581007|ALL|all
259595|NCT02581007|CLL/CPL|cll/cpl
259596|NCT02581007|HD|hd
259597|NCT02581007|NHL|nhl
259598|NCT02581007|MPS|mps
259599|NCT02581007|CMML|cmml
259600|NCT02581007|MM|mm
259601|NCT02580994|Extended Disease Small Cell Lung Cancer|extended disease small cell lung cancer
259602|NCT02580994|phase II|phase ii
259603|NCT02580994|randomized|randomized
259604|NCT02580994|pembrolizumab|pembrolizumab
259605|NCT02580994|cross-over|cross-over
259606|NCT02580994|etoposide|etoposide
259607|NCT02580994|cisplatin|cisplatin
259608|NCT02580994|carboplatin|carboplatin
259609|NCT02580994|rechallenge|rechallenge
259610|NCT02580981|Cancer|cancer
259611|NCT02580981|Oncology|oncology
259612|NCT02580981|Acute Lymphoblastic Leukemia|acute lymphoblastic leukemia
259613|NCT02580981|ALL|all
259614|NCT02580981|Genomics|genomics
259615|NCT02580981|Genetics|genetics
259616|NCT02580981|Sequencing|sequencing
259617|NCT02580981|DNA|dna
259618|NCT02580981|RNA|rna
259619|NCT02580981|Ph-like|ph-like
259620|NCT02580968|Electroacupuncture therapy|electroacupuncture therapy
259621|NCT02580968|Migraine|migraine
259622|NCT02580968|Acupuncture Therapy|acupuncture therapy
259623|NCT02580929|Radiotherapy|radiotherapy
259624|NCT02580929|General Surgery|general surgery
259625|NCT02580916|non-melanoma skin cancer|non-melanoma skin cancer
259626|NCT02580916|outcome assessment|outcome assessment
259627|NCT02580916|quality of life|quality of life
259628|NCT02580877|oral insulin|oral insulin
259629|NCT02580838|Stroke|stroke
259630|NCT02580838|Spasticity|spasticity
259631|NCT02580838|OnabotulinumtoxinA|onabotulinumtoxina
259632|NCT02580825|Childhood obesity|childhood obesity
259633|NCT02580825|Ground reaction force|ground reaction force
259634|NCT02580825|Knee pain|knee pain
259635|NCT02580812|Perinatal listeriosis|perinatal listeriosis
259636|NCT02580812|Neurological impairment|neurological impairment
259637|NCT02580812|Sepsis|sepsis
259638|NCT02580812|Prematurity|prematurity
259639|NCT02580812|Neurotropism|neurotropism
259640|NCT02580812|Listeria monocytogenes|listeria monocytogenes
259641|NCT02580812|Intellectual Quotient|intellectual quotient
259642|NCT02580773|Sickle cell disease|sickle cell disease
259643|NCT02580773|Anemia|anemia
259644|NCT02580773|Rare disease|rare disease
259645|NCT02580773|Reanimation|reanimation
259646|NCT02580773|Prophylactic anticoagulation|prophylactic anticoagulation
259647|NCT02580760|Silicone|silicone
259648|NCT02580760|Transgender|transgender
259649|NCT02580760|Dermatology|dermatology
259650|NCT02580760|Blood contamination|blood contamination
259651|NCT02580760|Adverse event after injection|adverse event after injection
259652|NCT02580734|burning mouth syndrome|burning mouth syndrome
259653|NCT02580734|treatment|treatment
259654|NCT02580734|oral chronic pain|oral chronic pain
259655|NCT02580721|mucosal tissue thickness|mucosal tissue thickness
259656|NCT02580721|dental implant|dental implant
259657|NCT02580721|marginal bone loss|marginal bone loss
259658|NCT02580721|soft tissue|soft tissue
259659|NCT02580643|Autologous Protein Solution|autologous protein solution
259660|NCT02580643|Osteoarthritis|osteoarthritis
259661|NCT02580643|Intra-articular Injection|intra-articular injection
737527|NCT00483717|Migraine|migraine
259662|NCT02580630|Strength training, injection, glucocorticoid|strength training, injection, glucocorticoid
259663|NCT02580565|sickle cell disease|sickle cell disease
259664|NCT02580552|Cutaneous T-cell Lymphoma|cutaneous t-cell lymphoma
259665|NCT02580552|CTCL|ctcl
259666|NCT02580552|Mycosis Fungoides|mycosis fungoides
259667|NCT02580552|Chronic lymphocytic leukemia|chronic lymphocytic leukemia
259669|NCT02580552|Diffuse large B-cell lymphoma|diffuse large b-cell lymphoma
259670|NCT02580552|DLBCL|dlbcl
259671|NCT02580552|Adult T-cell leukemia/lymphoma|adult t-cell leukemia/lymphoma
259672|NCT02580552|ATLL|atll
259673|NCT02580539|Allogeneic Transplantation|allogeneic transplantation
259674|NCT02580539|T cell|t cell
259675|NCT02580539|Epstein-Barr Virus|epstein-barr virus
259676|NCT02580513|Circadian Rhythm|circadian rhythm
259677|NCT02580513|Circadian Misalignment|circadian misalignment
259678|NCT02580513|Insulin Sensitivity|insulin sensitivity
259679|NCT02580500|Epidural anesthesia|epidural anesthesia
259680|NCT02580500|Spinal anesthesia|spinal anesthesia
259681|NCT02580500|pilonidal dermoid sinus|pilonidal dermoid sinus
259682|NCT02580487|acute appendicitis|acute appendicitis
259683|NCT02580487|pain management|pain management
259684|NCT02580487|analgesics|analgesics
259685|NCT02580487|pediatric patients|pediatric patients
259686|NCT02580487|laparoscopy|laparoscopy
259687|NCT02580487|open surgery|open surgery
259688|NCT02580461|family caregivers|family caregivers
259689|NCT02580461|cancer|cancer
259690|NCT02580461|exercise intervention|exercise intervention
259691|NCT02580461|center based|center based
259692|NCT02580448|Breast Cancer|breast cancer
259693|NCT02580448|Breast|breast
259694|NCT02580448|Advanced Breast Cancer|advanced breast cancer
259695|NCT02580448|Metastatic Breast Cancer|metastatic breast cancer
259696|NCT02580448|CYP17|cyp17
259697|NCT02580448|Male Breast Cancer|male breast cancer
259698|NCT02580448|Triple Negative Cancer|triple negative cancer
259699|NCT02580448|ER+ Breast Cancer|er+ breast cancer
259700|NCT02580435|multiple sclerosis|multiple sclerosis
259701|NCT02580435|microbiome|microbiome
259702|NCT02580435|prediction|prediction
259704|NCT02580422|Echocardiography|echocardiography
259705|NCT02580409|health care utilization|health care utilization
259706|NCT02580409|health care costs|health care costs
259707|NCT02580383|Radiofrequency ablation|radiofrequency ablation
259708|NCT02580383|RF-MB|rf-mb
259709|NCT02580383|Lumbar RF|lumbar rf
259710|NCT02580383|Facet joint syndrome|facet joint syndrome
259711|NCT02580383|Multifidus twitching|multifidus twitching
259712|NCT02580383|Sensory stimulation|sensory stimulation
259713|NCT02580370|REALISE 1|realise 1
259714|NCT02580357|Connective tissue graft|connective tissue graft
259715|NCT02580357|Gingival recession|gingival recession
259716|NCT02580357|Low level laser therapy|low level laser therapy
259717|NCT02580305|SUVN-502|suvn-502
259718|NCT02580305|5-HT6|5-ht6
259719|NCT02580305|Phase 2|phase 2
259720|NCT02580305|Cognition|cognition
259721|NCT02580305|Donepezil|donepezil
259722|NCT02580305|Memantine|memantine
259723|NCT02580305|Alzheimer's Disease|alzheimer's disease
259724|NCT02580305|Triple Combination|triple combination
259725|NCT02580305|Proof of Concept (POC)|proof of concept (poc)
259726|NCT02580279|Breast Neoplasms|breast neoplasms
259727|NCT02580279|prevention & control|prevention & control
259728|NCT02580279|Epigallocatechin gallate|epigallocatechin gallate
259729|NCT02580279|Dermatitis|dermatitis
259730|NCT02580266|Kidney|kidney
259731|NCT02580266|Diabetes|diabetes
259732|NCT02580240|septic shock|septic shock
259733|NCT02580240|hydrocortisone|hydrocortisone
259734|NCT02580240|mortality|mortality
259735|NCT02580227|Tranexamic Acid|tranexamic acid
259736|NCT02580227|Blood Transfusions|blood transfusions
259737|NCT02580188|Neuromuscular blockade|neuromuscular blockade
259738|NCT02580188|Sugammadex|sugammadex
259739|NCT02580188|Laparoscopic surgery|laparoscopic surgery
259740|NCT02580188|Intra abdominal pressure alarm|intra abdominal pressure alarm
259741|NCT02580136|Esthesioneuroblastoma|esthesioneuroblastoma
259742|NCT02580136|Tumor|tumor
259743|NCT02580136|Skull Base Surgery|skull base surgery
259744|NCT02580136|Sinonasal Cancer|sinonasal cancer
259745|NCT02580110|no specific condition|no specific condition
259746|NCT02580097|Arterial Spin Labeling|arterial spin labeling
259747|NCT02580097|Ischemic stroke|ischemic stroke
259748|NCT02580097|Collateral Circulation|collateral circulation
259749|NCT02580097|Perfusion imaging|perfusion imaging
259750|NCT02580084|atherosclerosis of the peripheral arteries|atherosclerosis of the peripheral arteries
259751|NCT02580084|Aorta-femoral Bypass|aorta-femoral bypass
259752|NCT02580084|Hybrid Intervention|hybrid intervention
259753|NCT02580084|Iliac Arteries With Stenting and Plasty of the Common Femoral Artery|iliac arteries with stenting and plasty of the common femoral artery
259754|NCT02580084|plastic arteries with lesions of the common femoral artery and deep femoral artery|plastic arteries with lesions of the common femoral artery and deep femoral artery
259755|NCT02580071|Hematopoietic Stem Cell Transplant|hematopoietic stem cell transplant
259756|NCT02580071|Chinese Herbal Medicine|chinese herbal medicine
259757|NCT02580071|immune reconstitution|immune reconstitution
259758|NCT02580071|clinical trial|clinical trial
259759|NCT02580071|ALL|all
259760|NCT02580071|AML|aml
259761|NCT02580058|platinum resistant|platinum resistant
259762|NCT02580058|platinum refractory|platinum refractory
259763|NCT02580045|metastatic cancer|metastatic cancer
259764|NCT02580045|lumbar puncture|lumbar puncture
259765|NCT02580045|advanced cancer|advanced cancer
259766|NCT02580045|brain metastases|brain metastases
259767|NCT02580045|chemotherapy|chemotherapy
259768|NCT02580045|endocrine therapy|endocrine therapy
259769|NCT02580045|HER2 targeted therapy|her2 targeted therapy
259770|NCT02580045|immune therapy|immune therapy
259771|NCT02580045|anti-cancer therapy|anti-cancer therapy
259772|NCT02580045|blood brain barrier|blood brain barrier
259773|NCT02580045|pharmacokinetics|pharmacokinetics
259774|NCT02580045|Duke University|duke university
259775|NCT02580045|brain metastasis|brain metastasis
259776|NCT02580019|Cellular therapy|cellular therapy
259777|NCT02580019|Stroke|stroke
259778|NCT02580019|Neuronal Plasticity|neuronal plasticity
259779|NCT02580019|Recovery|recovery
259780|NCT02580019|umbilical cord mesenchymal stem cells|umbilical cord mesenchymal stem cells
259781|NCT02580019|Transplantation|transplantation
259782|NCT02580019|Cardiovascular Diseases|cardiovascular diseases
259783|NCT02580019|Ischemia|ischemia
259784|NCT02580019|Brain Infarction|brain infarction
259785|NCT02580019|Brain Ischemia|brain ischemia
259786|NCT02580019|Cerebrovascular Disorders|cerebrovascular disorders
259787|NCT02579993|Cornea|cornea
259788|NCT02579993|Limbal stem cell|limbal stem cell
259789|NCT02579980|Dynamic Contrast Enhanced MRI|dynamic contrast enhanced mri
259790|NCT02579980|Diffusion Weighted MRI|diffusion weighted mri
259791|NCT02579980|Magnetic Resonance Imaging (MRI)|magnetic resonance imaging (mri)
259792|NCT02579967|Haploidentical|haploidentical
259793|NCT02579967|Autoimmunity|autoimmunity
259794|NCT02579967|Immune Dysregulation|immune dysregulation
259795|NCT02579967|Congenital|congenital
259796|NCT02579967|Opportunistic Infection|opportunistic infection
259797|NCT02579941|Hyperfibrinolysis|hyperfibrinolysis
259798|NCT02579941|Pregnant women at term|pregnant women at term
259799|NCT02579941|Tranexamic acid|tranexamic acid
259800|NCT02579928|Ketamine|ketamine
259801|NCT02579928|Depression|depression
259802|NCT02579928|Major Depressive Disorder|major depressive disorder
259803|NCT02579928|Anxiety|anxiety
259804|NCT02579928|School refusal|school refusal
259805|NCT02579928|Suicide|suicide
259806|NCT02579928|Generalized Anxiety|generalized anxiety
259807|NCT02579928|Suicidal Ideation|suicidal ideation
259808|NCT02579902|Irritable Bowel Syndrome|irritable bowel syndrome
259809|NCT02579902|inflammation|inflammation
259810|NCT02579902|oxidative stress|oxidative stress
259811|NCT02579902|clinical signs|clinical signs
259812|NCT02579902|vitamin D3|vitamin d3
259813|NCT02579889|Closed Loop Stimulation|closed loop stimulation
259814|NCT02579889|Atrial Fibrillation|atrial fibrillation
259815|NCT02579889|Stroke|stroke
259816|NCT02579889|Heart Failure|heart failure
259817|NCT02579889|Pacemaker|pacemaker
259818|NCT02579889|ICD|icd
259819|NCT02579876|Milk Allergy|milk allergy
259820|NCT02579876|Viaskin Milk|viaskin milk
259821|NCT02579876|Epicutaneous ImmunoTherapy (EPIT)|epicutaneous immunotherapy (epit)
259822|NCT02579876|Eosinophilic Esophagitis|eosinophilic esophagitis
259823|NCT02579876|Milk-Induced Eosinophilic Esophagitis|milk-induced eosinophilic esophagitis
259824|NCT02579863|PD1|pd1
259825|NCT02579863|PD-1|pd-1
259826|NCT02579863|PD-L1|pd-l1
259827|NCT02579863|PDL1|pdl1
259828|NCT02579850|COPD|copd
259829|NCT02579850|COPD Exacerbation|copd exacerbation
259830|NCT02579850|EXACT-PRO|exact-pro
259831|NCT02579837|screening|screening
259832|NCT02579824|Myeloma|myeloma
259833|NCT02579824|Relapsed and/or Refractory|relapsed and/or refractory
259834|NCT02579824|Multiple Myeloma|multiple myeloma
259835|NCT02579824|MM|mm
259836|NCT02579824|DS-3032b|ds-3032b
259837|NCT02579811|Kidney|kidney
259838|NCT02579811|Cancer|cancer
259839|NCT02579811|Axitinib|axitinib
259840|NCT02579811|Pd-1 inhibitor|pd-1 inhibitor
259841|NCT02579811|Pd-L1 inhibitor|pd-l1 inhibitor
259842|NCT02579798|Bariatric surgery|bariatric surgery
259843|NCT02579798|Post-surgery hypoxemia|post-surgery hypoxemia
259844|NCT02579798|Obesity|obesity
259845|NCT02579785|Family Planning|family planning
259846|NCT02579785|Abortion|abortion
259847|NCT02579785|mHealth|mhealth
259848|NCT02579785|Behaviour Change Communication|behaviour change communication
259849|NCT02579785|Menstrual Regulation|menstrual regulation
259850|NCT02579785|Postabortion|postabortion
259851|NCT02579785|Bangladesh|bangladesh
259852|NCT02579759|PXT3003|pxt3003
259853|NCT02579746|hypertension|hypertension
259854|NCT02579746|immigrant|immigrant
259855|NCT02579746|dietary intervention|dietary intervention
259856|NCT02579746|lifestyle modification|lifestyle modification
259857|NCT02579720|Recurrent Grass Pollen Allergy|recurrent grass pollen allergy
259858|NCT02579720|Pollinex® Quattro|pollinex® quattro
259859|NCT02579707|Healthy Volunteers|healthy volunteers
332155|NCT02180061|PD1|pd1
259860|NCT02579681|Cognition|cognition
259861|NCT02579681|Tecfidera|tecfidera
259862|NCT02579681|RRMS|rrms
259863|NCT02579681|BG00012|bg00012
259864|NCT02579642|Moderate to severe depression|moderate to severe depression
259865|NCT02579642|Monopolar|monopolar
259866|NCT02579642|Bipolar|bipolar
259867|NCT02579642|Ketamine|ketamine
259868|NCT02579642|ECT|ect
259869|NCT02579642|Electroconvulsive therapy|electroconvulsive therapy
259870|NCT02579642|NMDA|nmda
259871|NCT02579629|Analgesia|analgesia
259872|NCT02579629|Cesarean section|cesarean section
259873|NCT02579629|Opiates|opiates
259874|NCT02579616|Lenvatinib|lenvatinib
259875|NCT02579616|E7080|e7080
259876|NCT02579616|Unresectable biliary tract cancer|unresectable biliary tract cancer
259877|NCT02579616|BTC|btc
259878|NCT02579616|Gemcitabine-based combination chemotherapy|gemcitabine-based combination chemotherapy
259879|NCT02579616|Lenvima|lenvima
259880|NCT02579538|Total Knee Arthroplasty|total knee arthroplasty
259881|NCT02579538|Thoracotomy|thoracotomy
259882|NCT02579538|Mastectomy|mastectomy
259883|NCT02579538|Video-Assisted Thoracoscopic Surgery (VATS)|video-assisted thoracoscopic surgery (vats)
259884|NCT02579538|Persistent Pain|persistent pain
259885|NCT02579538|Cognitive Flexibility|cognitive flexibility
259886|NCT02579525|septic shock|septic shock
259887|NCT02579525|tissue perfusion|tissue perfusion
259888|NCT02579525|macrocirculatory|macrocirculatory
259889|NCT02579525|mean arterial pressure|mean arterial pressure
259890|NCT02579525|vasopressor use|vasopressor use
259891|NCT02579525|days alive free of organ support|days alive free of organ support
259892|NCT02579499|Coronary artery disease|coronary artery disease
259893|NCT02579499|LDL choelsterol|ldl choelsterol
259894|NCT02579499|Statin|statin
259895|NCT02579473|Continuous dopaminergic stimulation|continuous dopaminergic stimulation
259896|NCT02579460|Barrett's esophagus|barrett's esophagus
259897|NCT02579460|Gastroesophageal Reflux Disease|gastroesophageal reflux disease
259898|NCT02579434|CYP3A|cyp3a
259899|NCT02579408|NAFLD|nafld
259900|NCT02579408|LDLT|ldlt
259901|NCT02579408|steatosis|steatosis
259902|NCT02579408|CAP|cap
259903|NCT02579408|transient elastography|transient elastography
259904|NCT02579382|HBV|hbv
259905|NCT02579382|Hepatitis|hepatitis
259906|NCT02579382|Liver Disease|liver disease
259907|NCT02579369|Epidermolysis Bullosa|epidermolysis bullosa
259908|NCT02579369|stem cell|stem cell
259909|NCT02579317|Baroreflex mechanism|baroreflex mechanism
259910|NCT02579317|Alcohol Use Disorder|alcohol use disorder
259911|NCT02579317|Substance Use Disorder|substance use disorder
259912|NCT02579317|Heart Rate Variability|heart rate variability
259913|NCT02579317|Breathing|breathing
259914|NCT02579291|Stroke|stroke
259915|NCT02579291|Dry needling|dry needling
259916|NCT02579291|Spasticity|spasticity
259917|NCT02579291|Motor function|motor function
259918|NCT02579291|Stabilometry|stabilometry
259919|NCT02579278|EMVI|emvi
259920|NCT02579278|Extramural Venous Invasion|extramural venous invasion
259921|NCT02579278|mrEMVI|mremvi
259922|NCT02579278|Rectal Cancer|rectal cancer
259923|NCT02579278|ctDNA|ctdna
259924|NCT02579278|Neoplasm DNA|neoplasm dna
259925|NCT02579278|MRI|mri
259926|NCT02579265|Parenteral nutrition|parenteral nutrition
259927|NCT02579265|Neonates|neonates
259928|NCT02579265|Infants|infants
259929|NCT02579265|Lipid emulsions|lipid emulsions
259930|NCT02579265|Intravenous|intravenous
259931|NCT02579252|vaccine|vaccine
259932|NCT02579252|tau protein|tau protein
259933|NCT02579252|active|active
259934|NCT02579252|immunization|immunization
259935|NCT02579252|KLH|klh
259936|NCT02579252|immunotherapy|immunotherapy
259937|NCT02579252|tau|tau
259938|NCT02579239|LGMD2B|lgmd2b
259939|NCT02579239|FSHD|fshd
259940|NCT02579226|AZD2811|azd2811
259941|NCT02579226|Advanced solid tumours|advanced solid tumours
259942|NCT02579226|Small-cell lung cancer|small-cell lung cancer
259943|NCT02579213|electronic nose|electronic nose
259944|NCT02579213|abnormal fetal karyotype|abnormal fetal karyotype
259945|NCT02579161|Percutaneous Nephrolithotomy|percutaneous nephrolithotomy
259946|NCT02579161|Kidney Stones|kidney stones
259947|NCT02579161|Antibiotics|antibiotics
259948|NCT02579148|erectile dysfunction|erectile dysfunction
259949|NCT02579148|stem cell|stem cell
259950|NCT02579148|collagen scaffold|collagen scaffold
259951|NCT02579135|Condoms|condoms
259952|NCT02579135|Sexual Abstinence|sexual abstinence
259953|NCT02579135|Sexual Communication|sexual communication
259954|NCT02579122|Reviparin|reviparin
259955|NCT02579122|Bridging|bridging
259956|NCT02579122|Phenprocoumon|phenprocoumon
259957|NCT02579096|Gout|gout
259958|NCT02579096|Allopurinol|allopurinol
259959|NCT02579096|Febuxostat|febuxostat
259960|NCT02579096|CKD|ckd
259961|NCT02579070|Diabetic Foot|diabetic foot
259962|NCT02579070|foot temperature|foot temperature
259963|NCT02579070|diabetic foot ulcer|diabetic foot ulcer
259964|NCT02579057|Congestive heart failure|congestive heart failure
259965|NCT02579057|Furosemide|furosemide
259966|NCT02579031|Percutaneous Coronary Intervention|percutaneous coronary intervention
259967|NCT02579031|Stents|stents
259968|NCT02579031|Drug-Eluting Stents|drug-eluting stents
259969|NCT02579031|Coronary Artery Disease|coronary artery disease
259970|NCT02579031|Acute Coronary Syndrome|acute coronary syndrome
259971|NCT02579018|Anorexia Nervosa|anorexia nervosa
259972|NCT02579018|Exercise|exercise
259973|NCT02579018|Healthy Adults|healthy adults
259974|NCT02579018|Physical Activity|physical activity
259975|NCT02579005|Radiation|radiation
259976|NCT02579005|Immune response|immune response
259977|NCT02579005|Anti-tumor|anti-tumor
259978|NCT02579005|Lung Cancer|lung cancer
259979|NCT02578992|intubating stylet|intubating stylet
259980|NCT02578992|head and neck position|head and neck position
259981|NCT02578979|atrial fibrillation|atrial fibrillation
259982|NCT02578979|ischemic stroke|ischemic stroke
259983|NCT02578979|electrocardiogram|electrocardiogram
259984|NCT02578979|holter|holter
259985|NCT02578966|Early Childhood Caries|early childhood caries
259986|NCT02578966|Randomized clinical trial|randomized clinical trial
259987|NCT02578966|Motivational Interviewing|motivational interviewing
259988|NCT02578953|Bioequivalence|bioequivalence
259989|NCT02578953|Fasted state|fasted state
259990|NCT02578953|Japanese male healthy subjects|japanese male healthy subjects
259991|NCT02578953|Dutasteride|dutasteride
259992|NCT02578914|allergic conjunctivitis|allergic conjunctivitis
259993|NCT02578914|seasonal allergies|seasonal allergies
259994|NCT02578914|ragweed allergy|ragweed allergy
259995|NCT02578914|grass allergy|grass allergy
259996|NCT02578914|tree allergy|tree allergy
259997|NCT02578914|NS2|ns2
259998|NCT02578914|Aldeyra|aldeyra
259999|NCT02578901|Thrombocytopenia|thrombocytopenia
260000|NCT02578901|Tranexamic Acid|tranexamic acid
260001|NCT02578901|TXA|txa
260002|NCT02578901|Chemotherapy induced thrombocytopenia|chemotherapy induced thrombocytopenia
260003|NCT02578875|Sequence Technique|sequence technique
260004|NCT02578875|Infectious Disease|infectious disease
260005|NCT02578875|Pathogen Detection|pathogen detection
260006|NCT02578875|Diagnostic|diagnostic
260007|NCT02578836|Weight Loss|weight loss
260008|NCT02578836|Overweight|overweight
260009|NCT02578836|Endoscopic treatment for obesity|endoscopic treatment for obesity
260010|NCT02578823|Targeted Temperature Management(TTM)|targeted temperature management(ttm)
260011|NCT02578823|in-hospital cardiac arrest(IHCA)|in-hospital cardiac arrest(ihca)
260012|NCT02578823|restoration of spontaneous circulation(ROSC)|restoration of spontaneous circulation(rosc)
260013|NCT02578823|unconsciousness|unconsciousness
260014|NCT02578823|brain injury|brain injury
260015|NCT02578797|Castration-Resistant Prostate Cancer (CRPC)|castration-resistant prostate cancer (crpc)
260016|NCT02578797|Prostatic Neoplasms|prostatic neoplasms
260017|NCT02578797|Genital Diseases, Male|genital diseases, male
260018|NCT02578797|Genital Neoplasms, Male|genital neoplasms, male
260019|NCT02578797|Neoplasms|neoplasms
260020|NCT02578797|Neoplasms by Site|neoplasms by site
260021|NCT02578797|Prostatic Diseases|prostatic diseases
260022|NCT02578797|Urogenital Neoplasms|urogenital neoplasms
260023|NCT02578784|Dialysis|dialysis
260024|NCT02578758|Transdiagnostic Internet-based Protocol|transdiagnostic internet-based protocol
260025|NCT02578758|Positive affect regulation|positive affect regulation
260026|NCT02578706|HIV|hiv
260027|NCT02578706|Aspirin|aspirin
260028|NCT02578706|Clopidogrel|clopidogrel
260029|NCT02578706|Platelet|platelet
260030|NCT02578706|Inflammation|inflammation
260031|NCT02578706|Cardiovascular disease|cardiovascular disease
260032|NCT02578706|Arachidonic acid|arachidonic acid
260033|NCT02578706|Cyclooxygenase inhibitor|cyclooxygenase inhibitor
260034|NCT02578706|ADP inhibitor|adp inhibitor
260035|NCT02578706|Immune activation|immune activation
260036|NCT02578706|Monocyte|monocyte
260037|NCT02578706|Coagulation|coagulation
260038|NCT02578706|Thrombogenicity|thrombogenicity
260039|NCT02578680|PD1|pd1
260040|NCT02578680|PD-1|pd-1
260041|NCT02578680|PDL1|pdl1
260042|NCT02578680|PD-L1|pd-l1
260043|NCT02578680|Non-Small-Cell Lung Cancer|non-small-cell lung cancer
260044|NCT02578641|Nasopharyngeal Carcinoma (NPC)|nasopharyngeal carcinoma (npc)
260045|NCT02578641|NPC|npc
260046|NCT02578641|immunotherapy|immunotherapy
260047|NCT02578641|Nasopharyngeal Cancer|nasopharyngeal cancer
260048|NCT02578641|Nose Cancer|nose cancer
260049|NCT02578641|Cell therapy|cell therapy
260050|NCT02578641|Head and Neck Cancer|head and neck cancer
260051|NCT02578641|Cytotoxic T cells|cytotoxic t cells
260052|NCT02578641|chemotherapy|chemotherapy
260053|NCT02578641|Epstein-Barr Virus|epstein-barr virus
260054|NCT02578576|Diagnostic Techniques|diagnostic techniques
260055|NCT02578576|Digestive System|digestive system
260056|NCT02578550|Immunodeficiency Virus Type 1, Human|immunodeficiency virus type 1, human
260057|NCT02578550|Darunavir|darunavir
260058|NCT02578550|Cobicistat|cobicistat
260059|NCT02578550|Emtricitabine|emtricitabine
260060|NCT02578550|Tenofovir alafenamide|tenofovir alafenamide
260061|NCT02578550|Healthy participants|healthy participants
260062|NCT02578537|Ticagrelor|ticagrelor
260063|NCT02578537|Pharmacokinetics|pharmacokinetics
260064|NCT02578537|NSTE-ACS|nste-acs
260065|NCT02578537|CKD|ckd
260066|NCT02578524|cataract satisfaction|cataract satisfaction
260067|NCT02578511|Acute Lymphoblastic Leukemia in Complete Remission|acute lymphoblastic leukemia in complete remission
260068|NCT02578511|Lymphoblastic Lymphoma in Complete Remission|lymphoblastic lymphoma in complete remission
260069|NCT02578511|Mixed Phenotype Acute Leukemia in Complete Remission|mixed phenotype acute leukemia in complete remission
260070|NCT02578511|IXAZOMIB|ixazomib
260071|NCT02578511|POMP/D|pomp/d
260072|NCT02578511|Phase I|phase i
260073|NCT02578511|Early Phase|early phase
260074|NCT02578511|Acute Lymphoblastic Leukemia|acute lymphoblastic leukemia
260075|NCT02578511|Lymphoblastic Lymphoma|lymphoblastic lymphoma
260076|NCT02578511|Mixed Phenotype Acute Leukemia|mixed phenotype acute leukemia
260077|NCT02578511|ALL|all
260078|NCT02578498|glucagon|glucagon
260079|NCT02578498|Carbohydrate diet|carbohydrate diet
260080|NCT02578472|Healthy|healthy
260081|NCT02578472|JNJ-42847922|jnj-42847922
260082|NCT02578472|zolpidem|zolpidem
260083|NCT02578472|Placebo|placebo
260084|NCT02578459|Cancer pain|cancer pain
260085|NCT02578459|Intrathecal therapy|intrathecal therapy
260086|NCT02578459|Pain|pain
260087|NCT02578459|Pancreatic cancer|pancreatic cancer
260088|NCT02578433|Mindful Self Compassion short form|mindful self compassion short form
260089|NCT02578433|Progressive Muscle Relaxation|progressive muscle relaxation
260090|NCT02578394|Gout|gout
260091|NCT02578394|Kidney|kidney
260092|NCT02578394|Depo-Medrone|depo-medrone
260093|NCT02578394|Anakinra|anakinra
260094|NCT02578381|pressure wire|pressure wire
260095|NCT02578381|coronary angiogram|coronary angiogram
260096|NCT02578381|validation|validation
260097|NCT02578368|gastric cancer|gastric cancer
260098|NCT02578368|perioperative|perioperative
260099|NCT02578368|FLOT|flot
260100|NCT02578368|limited metastatic|limited metastatic
260101|NCT02578368|GEJ cancer|gej cancer
260102|NCT02578355|Atherosclerosis|atherosclerosis
260103|NCT02578355|Coronary Artery Disease|coronary artery disease
260104|NCT02578355|Cardiovascular Disease|cardiovascular disease
260105|NCT02578355|Coronary Computed Tomographic Angiography|coronary computed tomographic angiography
260106|NCT02578355|CCTA|ccta
260107|NCT02578355|Myocardial Infarction|myocardial infarction
260108|NCT02578355|MI|mi
260109|NCT02578355|OPeRA|opera
260110|NCT02578329|Mediterranean diet|mediterranean diet
260111|NCT02578329|blood fatty acid|blood fatty acid
260112|NCT02578329|Coronary Artery Disease|coronary artery disease
260113|NCT02578316|Advanced Solid Tumors|advanced solid tumors
260114|NCT02578316|Lymphomas|lymphomas
260115|NCT02578303|sleep apnea|sleep apnea
260116|NCT02578303|phase-contrast MRI|phase-contrast mri
260117|NCT02578303|cerebral blood flow|cerebral blood flow
260118|NCT02578303|vascular risk factor|vascular risk factor
260119|NCT02578303|dementia|dementia
260120|NCT02578290|decision support systems|decision support systems
260121|NCT02578290|clinical|clinical
260122|NCT02578238|Korea|korea
260123|NCT02578238|Humira|humira
260124|NCT02578238|Pediatric Crohn's Disease|pediatric crohn's disease
260125|NCT02578225|Heart|heart
260126|NCT02578225|Chronic|chronic
260127|NCT02578225|Failure|failure
260128|NCT02578225|MI|mi
260129|NCT02578225|real life|real life
260130|NCT02578225|Turkey|turkey
260131|NCT02578160|pain|pain
260132|NCT02578160|infant behaviour|infant behaviour
260133|NCT02578160|heart rate|heart rate
260134|NCT02578160|dental anxiety|dental anxiety
260135|NCT02578147|risky sexual behavior|risky sexual behavior
260136|NCT02578147|early intervention|early intervention
260137|NCT02578147|adolescent pregnancy|adolescent pregnancy
260138|NCT02578121|Relapsed|relapsed
260139|NCT02578121|Response Rate|response rate
260140|NCT02578121|Progression free|progression free
260141|NCT02578082|Renal Impairment|renal impairment
260142|NCT02578082|Renal Insufficiency|renal insufficiency
260143|NCT02578069|Ischemic Stroke|ischemic stroke
260144|NCT02578069|Intracranial Stenting|intracranial stenting
260145|NCT02578056|pelvic organ prolapse|pelvic organ prolapse
260146|NCT02578056|urinary incontinence|urinary incontinence
260147|NCT02578017|Sickle Cell Disease|sickle cell disease
260148|NCT02578017|Hydroxyurea|hydroxyurea
260149|NCT02578017|Adherence|adherence
260150|NCT02578004|Difficult|difficult
260151|NCT02578004|environmental, microbial, immunological and genetic factors|environmental, microbial, immunological and genetic factors
260152|NCT02578004|significantly different|significantly different
260153|NCT02577965|ST segment Elevation Myocardial Infarction|st segment elevation myocardial infarction
260154|NCT02577965|Optical Coherence Tomography|optical coherence tomography
260155|NCT02577965|Percutaneous Coronary Intervention|percutaneous coronary intervention
260156|NCT02577965|Thrombus histopathology|thrombus histopathology
260157|NCT02577965|Gender differences|gender differences
260158|NCT02577952|lipodystrophy|lipodystrophy
260159|NCT02577952|lipodystrophy, congenital generalized|lipodystrophy, congenital generalized
260160|NCT02577952|Berardinelli-Seip Congenital Lipodystrophy|berardinelli-seip congenital lipodystrophy
260161|NCT02577952|Congenital generalized lipodystrophy|congenital generalized lipodystrophy
260162|NCT02577952|generalized lipodystrophy|generalized lipodystrophy
260163|NCT02577952|lipodystrophy, familial partial|lipodystrophy, familial partial
260164|NCT02577952|partial lipodystrophy|partial lipodystrophy
260165|NCT02577952|lipodystrophy, partial, acquired|lipodystrophy, partial, acquired
260166|NCT02577952|acquired lipodystrophy|acquired lipodystrophy
260167|NCT02577913|contraception|contraception
260168|NCT02577913|contraceptive patch|contraceptive patch
260169|NCT02577913|Levonorgestrel|levonorgestrel
260170|NCT02577913|gestodene|gestodene
260171|NCT02577913|safety|safety
260172|NCT02577900|foot ulcer and honey and silver|foot ulcer and honey and silver
260173|NCT02577861|limbal stem cells deficinecy, LSCD, ocular burn|limbal stem cells deficinecy, lscd, ocular burn
260174|NCT02577848|Glucagon-like peptide-1|glucagon-like peptide-1
260175|NCT02577848|Non-ST-segment elevation myocardial infarction|non-st-segment elevation myocardial infarction
260176|NCT02577848|Left ventricular ejection fraction|left ventricular ejection fraction
260177|NCT02577835|Hypertension|hypertension
260178|NCT02577835|Arterial Stiffness|arterial stiffness
260179|NCT02577835|Ambulatory blood pressure|ambulatory blood pressure
260180|NCT02577796|radial artery spasm|radial artery spasm
260181|NCT02577796|radial artery occlusion|radial artery occlusion
260182|NCT02577796|radial access|radial access
260183|NCT02577783|Doxorubicin Hydrochloride|doxorubicin hydrochloride
260184|NCT02577770|Acupuncture|acupuncture
260185|NCT02577770|caffeine|caffeine
260186|NCT02577770|pain|pain
260187|NCT02577757|Languages network|languages network
260188|NCT02577757|Functional MRI|functional mri
260189|NCT02577744|Electrical Impedance Tomography|electrical impedance tomography
260190|NCT02577731|Trauma|trauma
260191|NCT02577705|food insecurity|food insecurity
260192|NCT02577705|adverse childhood experiences|adverse childhood experiences
260193|NCT02577705|violence exposure|violence exposure
260194|NCT02577705|trauma|trauma
260195|NCT02577705|poverty|poverty
260196|NCT02577705|TANF|tanf
260197|NCT02577705|assets|assets
260198|NCT02577705|depression|depression
260199|NCT02577705|randomized control trial|randomized control trial
260200|NCT02577679|Dentistry|dentistry
260201|NCT02577653|balance, postural|balance, postural
260202|NCT02577653|postural equilibrium|postural equilibrium
260203|NCT02577614|Cardiopulmonary Bypass|cardiopulmonary bypass
260204|NCT02577614|Aortic Valve Repair|aortic valve repair
260205|NCT02577614|Coronary Re-Implantation|coronary re-implantation
260206|NCT02577614|Deep Hypothermic Circulatory Arrest|deep hypothermic circulatory arrest
260207|NCT02577614|Factor VIII Inhibitor Bypass Activity|factor viii inhibitor bypass activity
260208|NCT02577614|Transfusion|transfusion
260209|NCT02577601|Emergency contraception|emergency contraception
260210|NCT02577601|Birth Control Pills|birth control pills
260211|NCT02577588|p53 Antigen|p53 antigen
260212|NCT02577588|T cell therapy|t cell therapy
260213|NCT02577588|autologous|autologous
260214|NCT02577588|Adoptive Cellular Immunotherapy|adoptive cellular immunotherapy
260215|NCT02577575|Oxytocin|oxytocin
260216|NCT02577575|Syntocinon|syntocinon
260217|NCT02577575|Social Cognition|social cognition
260218|NCT02577575|Schizophrenia|schizophrenia
260219|NCT02577549|Knee Pain|knee pain
260220|NCT02577549|Exercise|exercise
260221|NCT02577549|Diet|diet
260222|NCT02577549|Weight Loss|weight loss
260223|NCT02577536|Pregnancy outcome|pregnancy outcome
260224|NCT02577536|Neonatal outcome|neonatal outcome
260225|NCT02577536|Birth weight|birth weight
260226|NCT02577536|Weight gain|weight gain
260227|NCT02577536|Physical disability|physical disability
260228|NCT02577510|Lateral Femoral Cutaneous Nerve Block|lateral femoral cutaneous nerve block
260229|NCT02577510|Meralgia Parasthetica|meralgia parasthetica
260230|NCT02577510|nerve stimulator|nerve stimulator
260231|NCT02577510|ultrasound|ultrasound
260232|NCT02577484|Fractional Flow Reserve|fractional flow reserve
260233|NCT02577484|Rapid Exchange|rapid exchange
260234|NCT02577484|Catheter|catheter
260235|NCT02577471|Constipation|constipation
260236|NCT02577471|pregnancy|pregnancy
260237|NCT02577471|delivery|delivery
260238|NCT02577432|spinal anesthesia|spinal anesthesia
260239|NCT02577419|breast milk|breast milk
260240|NCT02577419|chylothorax|chylothorax
260241|NCT02577419|infants|infants
260242|NCT02577419|cardiac surgery|cardiac surgery
260243|NCT02577419|modified fat breast milk|modified fat breast milk
260244|NCT02577406|AG-221|ag-221
260245|NCT02577406|CC-90007|cc-90007
260246|NCT02577406|Efficacy|efficacy
260247|NCT02577406|Safety|safety
260248|NCT02577406|Leukemia|leukemia
260249|NCT02577406|Acute myeloid meukemia|acute myeloid meukemia
260250|NCT02577406|Isocitrate dehydrogenase 2 mutation|isocitrate dehydrogenase 2 mutation
260251|NCT02577406|Enasidenib|enasidenib
260252|NCT02577393|Lung Neoplasms|lung neoplasms
260253|NCT02577393|esophagitis|esophagitis
260254|NCT02577393|Prevention & Control|prevention & control
260255|NCT02577393|Epigallocatechin Gallate|epigallocatechin gallate
332650|NCT02177526|CT|ct
260256|NCT02577367|Hypothyroidism|hypothyroidism
260257|NCT02577367|Tube Feeding|tube feeding
260258|NCT02577341|Nimotuzumab, Chemoradiotherapy,Squamous Cell Lung Cancer|nimotuzumab, chemoradiotherapy,squamous cell lung cancer
260259|NCT02577302|Chronic Tibial nerve stimulation|chronic tibial nerve stimulation
260260|NCT02577302|Wireless PNS|wireless pns
260261|NCT02577302|neuromodulation|neuromodulation
260262|NCT02577289|simultaneous implantation|simultaneous implantation
260263|NCT02577289|Dental implant|dental implant
260264|NCT02577289|Open sinus Lifting|open sinus lifting
260265|NCT02577289|PRF|prf
260266|NCT02577289|platelet rich fibrin (PRF)|platelet rich fibrin (prf)
260267|NCT02577276|stroke|stroke
260268|NCT02577276|remote monitoring|remote monitoring
260269|NCT02577276|hemiparesis|hemiparesis
260270|NCT02577250|ketamine|ketamine
260271|NCT02577250|stress disorders, post-traumatic|stress disorders, post-traumatic
260272|NCT02577250|stress disorders, traumatic|stress disorders, traumatic
260273|NCT02577250|anxiety disorders|anxiety disorders
260274|NCT02577250|mental disorders|mental disorders
260275|NCT02577250|adjuvants, anesthesia|adjuvants, anesthesia
260276|NCT02577250|analgesics|analgesics
260277|NCT02577250|anesthetics|anesthetics
260278|NCT02577250|anesthetics, dissociative|anesthetics, dissociative
260279|NCT02577250|anesthetics, general|anesthetics, general
260280|NCT02577250|anesthetics, intravenous|anesthetics, intravenous
260281|NCT02577250|excitatory amino acid agents|excitatory amino acid agents
260282|NCT02577250|excitatory amino acid antagonists|excitatory amino acid antagonists
260283|NCT02577250|hypnotics and sedatives|hypnotics and sedatives
260284|NCT02577250|molecular mechanisms of pharmacological action|molecular mechanisms of pharmacological action
260285|NCT02577250|neurotransmitter agents|neurotransmitter agents
260286|NCT02577250|peripheral nervous system agents|peripheral nervous system agents
260287|NCT02577250|pharmacologic actions|pharmacologic actions
260288|NCT02577250|physiological effects of drugs|physiological effects of drugs
260289|NCT02577250|psychotropic drugs|psychotropic drugs
260290|NCT02577250|sensory system agents|sensory system agents
260291|NCT02577250|central nervous system agents|central nervous system agents
260292|NCT02577250|central nervous system depressants|central nervous system depressants
260293|NCT02577250|depression|depression
260294|NCT02577250|depressive disorder|depressive disorder
260807|NCT02574520|opioid|opioid
260295|NCT02577250|depressive disorder, treatment-resistant|depressive disorder, treatment-resistant
260296|NCT02577250|behavioral symptoms|behavioral symptoms
260297|NCT02577250|mood disorders|mood disorders
260298|NCT02577250|therapeutic uses|therapeutic uses
260299|NCT02577237|caregiver|caregiver
260300|NCT02577237|simulation|simulation
260301|NCT02577224|Patient-led care|patient-led care
260302|NCT02577224|Botulinum toxin|botulinum toxin
260303|NCT02577224|Dystonia|dystonia
260304|NCT02577224|Randomised controlled trial|randomised controlled trial
260305|NCT02577224|Acceptability|acceptability
260306|NCT02577211|Critically ill|critically ill
260307|NCT02577211|Enteral nutrition|enteral nutrition
260308|NCT02577172|Testicular cancer|testicular cancer
260309|NCT02577172|Physical Exercise|physical exercise
260310|NCT02577172|Chemotherapy|chemotherapy
260311|NCT02577159|sodium-glucose cotransporter 2 inhibitor|sodium-glucose cotransporter 2 inhibitor
260312|NCT02577159|Diabetes Mellitus, Type 2|diabetes mellitus, type 2
260313|NCT02577159|dyslipidemia|dyslipidemia
260314|NCT02577159|remnants|remnants
260315|NCT02577159|apolipoprotein B-48|apolipoprotein b-48
260316|NCT02577146|stone|stone
260317|NCT02577146|ureter|ureter
260318|NCT02577146|ultrasound|ultrasound
260319|NCT02577133|colic|colic
260320|NCT02577133|probiotic|probiotic
260321|NCT02577133|Lactobacillus reuteri|lactobacillus reuteri
260322|NCT02577133|prevention|prevention
260323|NCT02577120|Epiceram|epiceram
260324|NCT02577120|Ceramiseal|ceramiseal
260325|NCT02577107|Age-related macular degeneration,|age-related macular degeneration,
260326|NCT02577107|ranibizumab,|ranibizumab,
260327|NCT02577107|conbercept,|conbercept,
260328|NCT02577107|plasma VEGF|plasma vegf
260329|NCT02577107|PK|pk
260330|NCT02577094|CD22 positive- lymphoblastic leukemia-RIT-Yttrium|cd22 positive- lymphoblastic leukemia-rit-yttrium
260331|NCT02577055|Multiple leiomyoma|multiple leiomyoma
260332|NCT02577055|Uterine Artery Embolization|uterine artery embolization
260333|NCT02577055|Surgery|surgery
260334|NCT02577055|childbearing age|childbearing age
260335|NCT02577055|Fertility|fertility
260336|NCT02577055|Noninferiority trial|noninferiority trial
260337|NCT02577042|Raltegravir|raltegravir
260338|NCT02577042|protease inhibitors|protease inhibitors
260339|NCT02577042|darunavir|darunavir
260340|NCT02577042|inflammation|inflammation
260341|NCT02577042|statins|statins
260342|NCT02577042|comorbidities|comorbidities
260343|NCT02576990|PD1|pd1
260344|NCT02576990|PD-1|pd-1
260345|NCT02576990|PDL1|pdl1
260346|NCT02576990|PD-L1|pd-l1
260347|NCT02576977|PDL1|pdl1
260348|NCT02576977|PD1|pd1
260349|NCT02576977|Multiple Myeloma|multiple myeloma
260350|NCT02576938|Atopic Eczema|atopic eczema
260351|NCT02576912|Cannabis|cannabis
260352|NCT02576912|Marijuana|marijuana
260353|NCT02576912|THC|thc
260354|NCT02576912|Pregnenolone|pregnenolone
260355|NCT02576912|Psychotic Disorders|psychotic disorders
260356|NCT02576912|PREG|preg
260357|NCT02576899|smoking cessation|smoking cessation
260358|NCT02576899|posttraumatic stress disorder|posttraumatic stress disorder
260359|NCT02576899|tobacco|tobacco
260360|NCT02576899|treatment|treatment
260361|NCT02576899|smoking|smoking
260362|NCT02576899|mindfulness|mindfulness
260363|NCT02576899|acceptance|acceptance
260364|NCT02576899|functioning|functioning
260365|NCT02576886|supine|supine
260366|NCT02576886|prone|prone
260367|NCT02576886|myocardial perfusion imaging|myocardial perfusion imaging
260368|NCT02576886|radiation exposure|radiation exposure
260369|NCT02576886|pre-screening tool|pre-screening tool
260370|NCT02576873|Survival|survival
260371|NCT02576873|Hemodiafiltration|hemodiafiltration
260372|NCT02576873|End-stage renal disease|end-stage renal disease
260373|NCT02576873|Hemodialysis|hemodialysis
260374|NCT02576821|Amnesia, Alzheimer, hippocampal sclerosis, fronto-temporal lobar degeneration|amnesia, alzheimer, hippocampal sclerosis, fronto-temporal lobar degeneration
260375|NCT02576795|Haemophilia A|haemophilia a
260376|NCT02576795|Gene Therapy|gene therapy
260377|NCT02576795|Clotting Disorders|clotting disorders
260378|NCT02576795|Blood Disorder|blood disorder
260379|NCT02576795|Blood Coagulation Disorders, Inherited|blood coagulation disorders, inherited
260380|NCT02576795|Blood Coagulation Disorders|blood coagulation disorders
260381|NCT02576795|Hematologic Diseases|hematologic diseases
260382|NCT02576795|Coagulation Protein Disorders|coagulation protein disorders
260383|NCT02576795|Hemorrhagic Disorders|hemorrhagic disorders
260384|NCT02576795|Genetic Diseases, Inborn|genetic diseases, inborn
260385|NCT02576795|Factor VIII|factor viii
260386|NCT02576795|Coagulants|coagulants
260387|NCT02576795|AAV5 vector|aav5 vector
260388|NCT02576782|regional anesthesia|regional anesthesia
260389|NCT02576782|dexamethasone|dexamethasone
260390|NCT02576782|bupivacaine|bupivacaine
260391|NCT02576782|femoral|femoral
260392|NCT02576782|sciatic|sciatic
260393|NCT02576769|Basal cell carcinoma|basal cell carcinoma
260394|NCT02576769|Pigmentation|pigmentation
260395|NCT02576769|Melanocyte|melanocyte
260396|NCT02576769|Melanin|melanin
260397|NCT02576769|Skin cancer|skin cancer
261397|NCT02571504|Memory|memory
260398|NCT02576756|Risk on aspiration|risk on aspiration
260399|NCT02576756|Postoperative|postoperative
260400|NCT02576756|Difficult Intubation|difficult intubation
260401|NCT02576743|Stroke|stroke
260402|NCT02576743|AVM|avm
260403|NCT02576743|Aneurysm|aneurysm
260404|NCT02576717|MS|ms
260405|NCT02576717|RMS|rms
260406|NCT02576717|Multiple Sclerosis|multiple sclerosis
260407|NCT02576717|Relapsing Multiple Sclerosis|relapsing multiple sclerosis
260408|NCT02576691|cardiac arrest|cardiac arrest
260409|NCT02576691|percutaneous coronary intervention|percutaneous coronary intervention
260410|NCT02576691|cardiogenic shock|cardiogenic shock
260411|NCT02576691|outcome|outcome
260412|NCT02576678|Psoriasis|psoriasis
260413|NCT02576678|Moderate to Severe Plaque Psoriasis|moderate to severe plaque psoriasis
260414|NCT02576678|Plaque Psoriasis|plaque psoriasis
260415|NCT02576678|CC-10004|cc-10004
260416|NCT02576678|Apremilast|apremilast
260417|NCT02576678|Pharmacokinetics|pharmacokinetics
260418|NCT02576678|Open-label|open-label
260419|NCT02576678|Safety|safety
260420|NCT02576678|Pediatric|pediatric
260421|NCT02576665|Anaplastic Astrocytoma, Glioblastoma|anaplastic astrocytoma, glioblastoma
260422|NCT02576652|bone biopsy|bone biopsy
260423|NCT02576652|tetracycline|tetracycline
260424|NCT02576652|demeclocycline|demeclocycline
260425|NCT02576652|total hip replacement|total hip replacement
260426|NCT02576639|Alzheimer's Disease,|alzheimer's disease,
260427|NCT02576639|Amyloid Beta,|amyloid beta,
260428|NCT02576639|cerebrospinal fluid,|cerebrospinal fluid,
260429|NCT02576639|beta secretase|beta secretase
260430|NCT02576626|Nebulizer|nebulizer
260431|NCT02576626|DPI|dpi
260432|NCT02576626|COPD|copd
260433|NCT02576626|indacaterol|indacaterol
260434|NCT02576626|ipratropium|ipratropium
260435|NCT02576626|glycopyrronium|glycopyrronium
260436|NCT02576626|salbutamol|salbutamol
260437|NCT02576626|Breezhaler|breezhaler
260438|NCT02576626|Nebuliser|nebuliser
260439|NCT02576626|Hyperinflation|hyperinflation
260440|NCT02576626|Dyspnea|dyspnea
260441|NCT02576626|SABA|saba
260442|NCT02576626|short-acting muscarinic antagonists (SAMA)|short-acting muscarinic antagonists (sama)
260443|NCT02576626|long-acting beta2-agonist (LABA)|long-acting beta2-agonist (laba)
260444|NCT02576626|LAMA|lama
260445|NCT02576626|FEV1|fev1
260446|NCT02576574|Avelumab|avelumab
260447|NCT02576574|MSB0010718C|msb0010718c
260448|NCT02576574|Non-Small Cell Lung Cancer|non-small cell lung cancer
260449|NCT02576561|human papillomavirus|human papillomavirus
260450|NCT02576561|Cervical Intraepithelial Neoplasia|cervical intraepithelial neoplasia
260451|NCT02576561|Cold Knife Conization|cold knife conization
260452|NCT02576561|hysterectomy|hysterectomy
260453|NCT02576561|Loop Electrosurgical Excision Procedure|loop electrosurgical excision procedure
260454|NCT02576561|LEEP|leep
260455|NCT02576561|HSIL|hsil
260456|NCT02576561|High-Grade Squamous Intraepithelial Lesion|high-grade squamous intraepithelial lesion
260457|NCT02576496|phase 1 clinical trial|phase 1 clinical trial
260458|NCT02576496|multiple myeloma|multiple myeloma
260459|NCT02576496|Hodgkin's lymphoma|hodgkin's lymphoma
260460|NCT02576496|peripheral T-cell lymphoma|peripheral t-cell lymphoma
260461|NCT02576496|cutaneous T-cell lymphoma|cutaneous t-cell lymphoma
260462|NCT02576496|T-cell Prolymphocytic Leukemia|t-cell prolymphocytic leukemia
260463|NCT02576496|tinostamustine|tinostamustine
260464|NCT02576470|swallowing|swallowing
260465|NCT02576470|stroke|stroke
260466|NCT02576470|dysphagia|dysphagia
260467|NCT02576470|deglutition|deglutition
260468|NCT02576431|Non-small cell lung cancer|non-small cell lung cancer
260469|NCT02576431|Thyroid cancer|thyroid cancer
260470|NCT02576431|Sarcoma|sarcoma
260471|NCT02576431|Colorectal cancer|colorectal cancer
260472|NCT02576431|Salivary gland cancer|salivary gland cancer
260473|NCT02576431|Biliary cancer|biliary cancer
260474|NCT02576431|Central nervous system (CNS) tumor|central nervous system (cns) tumor
260475|NCT02576431|Neurotrophic tyrosine receptor kinase (NTRK)|neurotrophic tyrosine receptor kinase (ntrk)
260476|NCT02576431|NTRK1|ntrk1
260477|NCT02576431|NTRK2|ntrk2
260478|NCT02576431|NTRK3|ntrk3
260479|NCT02576431|Fusion Positive|fusion positive
260480|NCT02576431|TRK fusion|trk fusion
260481|NCT02576431|TRKA|trka
260482|NCT02576431|TRKB|trkb
260483|NCT02576431|TRKC|trkc
260484|NCT02576431|ETV6|etv6
260485|NCT02576418|Partosure TTD test|partosure ttd test
260486|NCT02576418|CL|cl
260487|NCT02576418|ART|art
260488|NCT02576418|SN|sn
260489|NCT02576418|SP|sp
260490|NCT02576418|PPV|ppv
260491|NCT02576418|NPV|npv
260492|NCT02576379|Helicopter Emergency Medical System|helicopter emergency medical system
260493|NCT02576379|Mortality|mortality
260494|NCT02576379|Labour market affiliation|labour market affiliation
260495|NCT02576379|Modified Rankin Scale|modified rankin scale
260496|NCT02576327|Lymphoma|lymphoma
260497|NCT02576327|Aprepitant|aprepitant
260498|NCT02576327|Chemotherapy-induced nausea and vomiting (CINV)|chemotherapy-induced nausea and vomiting (cinv)
260499|NCT02576327|Autologous Hematopoietic Stem Cell Transplantation|autologous hematopoietic stem cell transplantation
261699|NCT02569827|Celgosivir|celgosivir
260500|NCT02576327|Hematological Malignancies|hematological malignancies
260501|NCT02576301|AML|aml
260502|NCT02576301|MDS|mds
260503|NCT02576288|Sitagliptin|sitagliptin
260504|NCT02576288|Brachial artery flow mediated dilation|brachial artery flow mediated dilation
260505|NCT02576288|Carotid stiffness|carotid stiffness
260506|NCT02576288|Pro-inflammatory|pro-inflammatory
260507|NCT02576288|Pro-atherogenic|pro-atherogenic
260508|NCT02576288|M1 macrophages|m1 macrophages
260509|NCT02576275|Phase 3|phase 3
260510|NCT02576275|iNHL|inhl
260511|NCT02576275|Follicular Lymphoma|follicular lymphoma
260512|NCT02576275|FL|fl
260513|NCT02576275|PI3K|pi3k
260514|NCT02576275|Small Lymphocytic Lymphoma|small lymphocytic lymphoma
260515|NCT02576275|SLL|sll
260516|NCT02576275|Marginal Zone Lymphoma|marginal zone lymphoma
260517|NCT02576275|MZL|mzl
260518|NCT02576249|osteoarthritis|osteoarthritis
260519|NCT02576249|injection|injection
260520|NCT02576249|steroid|steroid
260521|NCT02576249|anesthetic|anesthetic
260522|NCT02576236|Naïve patient|naïve patient
260523|NCT02576236|Suspicion of H pylori infection|suspicion of h pylori infection
260524|NCT02576236|Endoscopy|endoscopy
260525|NCT02576236|Antibiotics therapeutic strategies|antibiotics therapeutic strategies
260526|NCT02576236|Urea breath test|urea breath test
260527|NCT02576223|Peripheral Nerve Blocks|peripheral nerve blocks
260528|NCT02576197|mild to moderate|mild to moderate
260529|NCT02576197|probiotic|probiotic
260530|NCT02576184|Incisional hernia|incisional hernia
260531|NCT02576184|Stoma|stoma
260532|NCT02576184|rectal cancer|rectal cancer
260533|NCT02576184|synthetic mesh|synthetic mesh
260534|NCT02576184|biologic mesh|biologic mesh
260535|NCT02576171|cognitive behavioral therapy;|cognitive behavioral therapy;
260536|NCT02576171|guided self-help|guided self-help
260537|NCT02576171|adolescent|adolescent
260538|NCT02576067|Atherosclerotic cardiovascular disease|atherosclerotic cardiovascular disease
260539|NCT02576067|Inflammation reduction|inflammation reduction
260540|NCT02576041|driving simulator|driving simulator
260541|NCT02576028|Total Hip Replacement|total hip replacement
260542|NCT02576028|Manipulation Therapy|manipulation therapy
260543|NCT02576002|Pulmonary Arterial Hypertension|pulmonary arterial hypertension
260544|NCT02575989|Trauma|trauma
260545|NCT02575989|Prehospital|prehospital
260546|NCT02575989|Hypothermia|hypothermia
260547|NCT02575976|Rehabilitation|rehabilitation
260548|NCT02575976|Coronary artery disease|coronary artery disease
260549|NCT02575976|Patient Education|patient education
737528|NCT00483717|Ketorolac|ketorolac
333018|NCT02175251|AHRS|ahrs
260550|NCT02575976|Randomized Controlled Trial|randomized controlled trial
260551|NCT02575976|Protocol|protocol
260552|NCT02575937|low glycemic diet|low glycemic diet
260553|NCT02575937|diabetes|diabetes
260554|NCT02575924|media|media
260555|NCT02575924|blastocyst|blastocyst
260556|NCT02575924|male infertility|male infertility
260557|NCT02575924|poor responders|poor responders
260558|NCT02575924|pgs|pgs
260559|NCT02575859|HIPEC|hipec
260560|NCT02575859|peritoneal lavage|peritoneal lavage
260561|NCT02575833|Angina|angina
260562|NCT02575833|Stable Angina|stable angina
260563|NCT02575833|Cardiovascular Disease|cardiovascular disease
260564|NCT02575833|Exercise-induced Angina|exercise-induced angina
260565|NCT02575807|Ovarian cancer|ovarian cancer
260566|NCT02575807|Fallopian cancer|fallopian cancer
260567|NCT02575807|Primary peritoneal cancer|primary peritoneal cancer
260568|NCT02575755|Azithromycin|azithromycin
260569|NCT02575755|Piperaquine|piperaquine
260570|NCT02575755|IPTp|iptp
260571|NCT02575755|Pharmacokinetics|pharmacokinetics
260572|NCT02575755|Efficacy|efficacy
260573|NCT02575729|carpal tunnel syndrome|carpal tunnel syndrome
260574|NCT02575729|local steroid injection|local steroid injection
260575|NCT02575729|sonography|sonography
260576|NCT02575729|sonography-guided|sonography-guided
260577|NCT02575716|McGrath®|mcgrath®
260578|NCT02575716|Videolaryngoscope|videolaryngoscope
260579|NCT02575716|intubating condition|intubating condition
260580|NCT02575716|muscle relaxant|muscle relaxant
260581|NCT02575716|intubation|intubation
260582|NCT02575690|spirulina, placebo, obesity,antihypertensive treatment|spirulina, placebo, obesity,antihypertensive treatment
260583|NCT02575677|labor pain|labor pain
260584|NCT02575677|oxycodone|oxycodone
260585|NCT02575664|Pain|pain
260586|NCT02575664|Arthroplasty|arthroplasty
260587|NCT02575664|Buprenorphine|buprenorphine
260588|NCT02575651|PARP|parp
260589|NCT02575651|Advanced Solid Malignancies|advanced solid malignancies
260590|NCT02575651|Fluzoparib|fluzoparib
260591|NCT02575651|Ovarian Cancer|ovarian cancer
260592|NCT02575651|BRCA|brca
260593|NCT02575625|Liver steatosis|liver steatosis
260594|NCT02575625|Steatohepatitis|steatohepatitis
260595|NCT02575625|Fibroscan|fibroscan
260596|NCT02575599|Self-management|self-management
260597|NCT02575599|web-based|web-based
260598|NCT02575599|quantitative approach|quantitative approach
260599|NCT02575586|Trigger Points|trigger points
260600|NCT02575586|Dry needling|dry needling
260601|NCT02575586|Torque|torque
260602|NCT02575586|H-Reflex|h-reflex
260603|NCT02575573|resuscitation decision|resuscitation decision
260604|NCT02575560|Progression-Free Survival|progression-free survival
260605|NCT02575547|Nutritional Status|nutritional status
260606|NCT02575547|Locoregionally Advanced Nasopharyngeal Carcinoma|locoregionally advanced nasopharyngeal carcinoma
260607|NCT02575534|anti-arrhythmic therapy|anti-arrhythmic therapy
260608|NCT02575482|SUVN-D4010|suvn-d4010
260609|NCT02575482|serotonin 4 (5-HT4) receptor|serotonin 4 (5-ht4) receptor
260610|NCT02575482|first in human|first in human
260611|NCT02575482|safety|safety
260612|NCT02575482|pharmacokinetics|pharmacokinetics
260613|NCT02575482|tolerability|tolerability
260614|NCT02575482|single dose|single dose
260615|NCT02575482|repeat dose|repeat dose
260616|NCT02575417|advance care planning|advance care planning
260617|NCT02575417|end-of-life care|end-of-life care
260618|NCT02575417|health games|health games
260619|NCT02575417|Family caregivers|family caregivers
260620|NCT02575417|Advance directives|advance directives
260621|NCT02575404|Metastatic|metastatic
260622|NCT02575404|Keytruda|keytruda
260623|NCT02575404|pembrolizumab|pembrolizumab
260624|NCT02575404|GR-MD-02|gr-md-02
260625|NCT02575404|Galactoarabino-rhamnogalacturonate|galactoarabino-rhamnogalacturonate
260626|NCT02575404|Immunotherapy|immunotherapy
260627|NCT02575391|L-Glutamine|l-glutamine
260628|NCT02575391|chemotherapy|chemotherapy
260629|NCT02575391|radiotherapy|radiotherapy
260630|NCT02575391|therapeutic toxicity|therapeutic toxicity
260631|NCT02575378|Metastatic Colorectal Cancer|metastatic colorectal cancer
260632|NCT02575378|Maintenance Treatment|maintenance treatment
260633|NCT02575378|Chinese Traditional Medicine|chinese traditional medicine
260634|NCT02575378|Clinical Trial|clinical trial
260635|NCT02575378|efficacy|efficacy
260636|NCT02575378|safety|safety
260637|NCT02575365|RRMS,|rrms,
260638|NCT02575365|Cognition,|cognition,
260639|NCT02575365|brain,|brain,
260640|NCT02575365|Fingolimod,|fingolimod,
260641|NCT02575365|Multiple Sclerosis,|multiple sclerosis,
260642|NCT02575365|neurodegeneration,|neurodegeneration,
260643|NCT02575365|Brain atrophy,|brain atrophy,
260644|NCT02575365|gray matter atrophy,|gray matter atrophy,
260645|NCT02575365|thalamic atrophy,|thalamic atrophy,
260646|NCT02575365|biomarkers,|biomarkers,
260647|NCT02575365|BICAMS Battery,|bicams battery,
260648|NCT02575352|Bone Substitute|bone substitute
260649|NCT02575352|Calcium Phosphate Cement|calcium phosphate cement
260650|NCT02575352|GRAFTYS|graftys
260651|NCT02575352|GRAFTYS®HBS|graftys®hbs
260652|NCT02575352|GRAFTYS®QUICKSET|graftys®quickset
260653|NCT02575352|Bone void filler|bone void filler
260654|NCT02575352|Bone growth|bone growth
260655|NCT02575352|Registry|registry
260656|NCT02575352|Bone defect|bone defect
260657|NCT02575352|Revision arthroplasty|revision arthroplasty
260658|NCT02575352|Arthrodesis|arthrodesis
260659|NCT02575339|MLN0128|mln0128
260660|NCT02575339|Sapanisertib|sapanisertib
260661|NCT02575339|TORC1/2 inhibitor|torc1/2 inhibitor
260662|NCT02575339|INK128|ink128
260663|NCT02575339|Nexavar|nexavar
260664|NCT02575339|Sorafenib|sorafenib
260665|NCT02575326|Asthma, Body Mass Idex, BMI, Overweight, Obesity|asthma, body mass idex, bmi, overweight, obesity
260666|NCT02575313|L-Glutamine|l-glutamine
260667|NCT02575313|chemotherapy|chemotherapy
260668|NCT02575313|radiotherapy|radiotherapy
260669|NCT02575313|therapeutic toxicity|therapeutic toxicity
260670|NCT02575300|neuroendocrine tumors (NETs)|neuroendocrine tumors (nets)
260671|NCT02575300|gastroenteropancreatic NETs|gastroenteropancreatic nets
260672|NCT02575300|pancreatic NETs|pancreatic nets
260673|NCT02575300|gastrointestinal (GI) tract NET|gastrointestinal (gi) tract net
260674|NCT02575300|advanced carcinoid tumors|advanced carcinoid tumors
260675|NCT02575274|Peri-implantitis|peri-implantitis
260676|NCT02575274|Peri-implant disease|peri-implant disease
260677|NCT02575274|Dental implants|dental implants
260678|NCT02575274|Guided bone regeneration|guided bone regeneration
260679|NCT02575261|CAR-T cell immunotherapy|car-t cell immunotherapy
260680|NCT02575261|EphA2|epha2
260681|NCT02575261|malignant glioma|malignant glioma
260682|NCT02575248|dienogest|dienogest
260683|NCT02575248|infertility|infertility
260684|NCT02575248|endometriosis|endometriosis
260685|NCT02575235|Sarcopenia|sarcopenia
260686|NCT02575235|Cetylpyridinium chloride|cetylpyridinium chloride
260687|NCT02575222|Immunotherapy|immunotherapy
260688|NCT02575222|PD-1|pd-1
260689|NCT02575222|anti-PD-1|anti-pd-1
260690|NCT02575222|antibody|antibody
260691|NCT02575222|Kidney Cancer|kidney cancer
260692|NCT02575222|RCC|rcc
260693|NCT02575222|non-metastatic|non-metastatic
260694|NCT02575196|Cardiac arrest|cardiac arrest
260695|NCT02575196|Cardiopulmonary Resuscitation|cardiopulmonary resuscitation
260696|NCT02575196|CPR|cpr
260697|NCT02575196|cerebral blood flow|cerebral blood flow
260698|NCT02575196|cerebral perfusion|cerebral perfusion
260699|NCT02575183|Waterpipe smoking|waterpipe smoking
260700|NCT02575183|Nicotine dependence|nicotine dependence
260701|NCT02575183|Smoking cessation|smoking cessation
260702|NCT02575183|Varinecline, Chantix therapy|varinecline, chantix therapy
260703|NCT02575183|Behavioral therapy|behavioral therapy
260704|NCT02575170|amino acid|amino acid
260705|NCT02575170|cesarean delivery|cesarean delivery
260706|NCT02575170|hypothermia|hypothermia
260707|NCT02575131|satiety|satiety
260708|NCT02575131|overweight|overweight
260709|NCT02575131|breakfast|breakfast
260710|NCT02575131|ecological validity|ecological validity
260711|NCT02575105|Bispectral Index Hydrocephalus|bispectral index hydrocephalus
260712|NCT02575092|Hyperhomocysteinemia|hyperhomocysteinemia
260713|NCT02575092|Coronary angiography|coronary angiography
260714|NCT02575092|Percutaneous coronary intervention|percutaneous coronary intervention
260715|NCT02575092|Hypertension|hypertension
260716|NCT02575092|Contrast-induced nephropathy|contrast-induced nephropathy
260717|NCT02575066|pazopanib|pazopanib
260718|NCT02575066|radiotherapy|radiotherapy
260719|NCT02575053|latex allergy|latex allergy
260720|NCT02575053|latex hypersensitivity|latex hypersensitivity
260721|NCT02575053|powder free latex surgical gloves|powder free latex surgical gloves
260722|NCT02575053|latex safe protocol|latex safe protocol
260723|NCT02575001|Type 1 diabetes|type 1 diabetes
260724|NCT02575001|Children and adolescents|children and adolescents
260725|NCT02575001|Stress|stress
260726|NCT02575001|Genetic factors|genetic factors
260727|NCT02575001|Psychological background|psychological background
260728|NCT02574988|drug allergy|drug allergy
260729|NCT02574988|drug hypersensitivity|drug hypersensitivity
260730|NCT02574988|adverse drug reactions|adverse drug reactions
260731|NCT02574988|severe cutaneous adverse reactions|severe cutaneous adverse reactions
260732|NCT02574949|radiation|radiation
260733|NCT02574949|fluoroscopy|fluoroscopy
260734|NCT02574949|diagnostic|diagnostic
260735|NCT02574936|karydakis modification|karydakis modification
260736|NCT02574936|pilonidal sinus|pilonidal sinus
260737|NCT02574936|complication|complication
260738|NCT02574923|Cerebral Palsy|cerebral palsy
260739|NCT02574923|Stem Cells|stem cells
260740|NCT02574871|Stress|stress
260741|NCT02574871|Chronic stress|chronic stress
260742|NCT02574871|Perceived stress|perceived stress
260743|NCT02574871|Psychological distress|psychological distress
260744|NCT02574832|Pain|pain
260745|NCT02574832|Surgery|surgery
260746|NCT02574832|Pregnancy|pregnancy
260747|NCT02574832|Anesthesia|anesthesia
260748|NCT02574819|opioid-induced constipation|opioid-induced constipation
260749|NCT02574806|BNP|bnp
260750|NCT02574806|Reference values|reference values
260751|NCT02574806|Newborn|newborn
260752|NCT02574806|Ventricular function|ventricular function
260753|NCT02574806|Stress|stress
260754|NCT02574806|Pediatrics|pediatrics
260755|NCT02574806|Biomarkers|biomarkers
260756|NCT02574793|Glucose Fluctuation|glucose fluctuation
260757|NCT02574793|GH-Secreting Adenoma|gh-secreting adenoma
260758|NCT02574793|Cushing Syndrome|cushing syndrome
260759|NCT02574780|lymphedema|lymphedema
260760|NCT02574780|complex physical therapy|complex physical therapy
260761|NCT02574780|muscle strength|muscle strength
260762|NCT02574767|Weight gain, Fatty Acids, Omega-3|weight gain, fatty acids, omega-3
260763|NCT02574754|warfarin|warfarin
260764|NCT02574754|pharmacokinetics|pharmacokinetics
260765|NCT02574754|bioequivalence|bioequivalence
260766|NCT02574754|healthy volunteer|healthy volunteer
260767|NCT02574728|Pediatrics|pediatrics
260768|NCT02574728|Brain Tumors|brain tumors
260769|NCT02574728|Neuroblastoma|neuroblastoma
260770|NCT02574728|Osteosarcoma|osteosarcoma
260771|NCT02574728|Ewing's Sarcoma|ewing's sarcoma
260772|NCT02574728|Rhabdomyosarcoma|rhabdomyosarcoma
260773|NCT02574728|Wilms Tumors|wilms tumors
260774|NCT02574728|Soft Tissue Sarcomas|soft tissue sarcomas
260775|NCT02574702|superficial surgical site infection|superficial surgical site infection
260776|NCT02574702|loop ileostomy|loop ileostomy
260777|NCT02574702|Ileostomy closure|ileostomy closure
260778|NCT02574689|Physical Activity|physical activity
260779|NCT02574689|Cancer Prevention|cancer prevention
260780|NCT02574637|MEDI2070|medi2070
260781|NCT02574637|inflammatory bowel disease|inflammatory bowel disease
260782|NCT02574637|moderate to severe Crohn's Disease|moderate to severe crohn's disease
260783|NCT02574637|IL-23|il-23
260784|NCT02574598|PDL1|pdl1
260785|NCT02574598|monoclonal antibody|monoclonal antibody
260786|NCT02574585|Spinal cord injury|spinal cord injury
260787|NCT02574585|Paraplegia|paraplegia
260788|NCT02574585|Stem cells|stem cells
260789|NCT02574585|Mesenchymal cells|mesenchymal cells
260790|NCT02574572|Spinal cord injury|spinal cord injury
260791|NCT02574572|Mesenchymal cells|mesenchymal cells
260792|NCT02574572|Stem cells|stem cells
260793|NCT02574559|Caregiver|caregiver
260794|NCT02574559|Stress|stress
260795|NCT02574559|Depression|depression
260796|NCT02574559|Autism Spectrum Disorder|autism spectrum disorder
260797|NCT02574559|Compassion Meditation|compassion meditation
260798|NCT02574546|Mastectomy|mastectomy
260799|NCT02574533|Immunotherapy|immunotherapy
260800|NCT02574533|PD-1 inhibitor|pd-1 inhibitor
260801|NCT02574533|Keytruda|keytruda
260802|NCT02574533|checkpoint inhibitor|checkpoint inhibitor
260803|NCT02574533|vaccine|vaccine
260804|NCT02574533|FANG|fang
260805|NCT02574533|Vigil|vigil
260806|NCT02574520|Post-operative pain|post-operative pain
260808|NCT02574520|opioid reduction|opioid reduction
260809|NCT02574520|laparoscopic cholecystectomy|laparoscopic cholecystectomy
260810|NCT02574520|laparoscopic surgery|laparoscopic surgery
260811|NCT02574520|bupivacaine|bupivacaine
260812|NCT02574520|extended release|extended release
260813|NCT02574520|locally acting analgesic|locally acting analgesic
260814|NCT02574507|breast cancer|breast cancer
260815|NCT02574507|weight management|weight management
260816|NCT02574507|couples|couples
260817|NCT02574507|symptom management|symptom management
260818|NCT02574481|atherosclerosis|atherosclerosis
260819|NCT02574481|Superficial Femoral Artery (SFA)|superficial femoral artery (sfa)
260820|NCT02574481|Proximal Popliteal Artery (PPA)|proximal popliteal artery (ppa)
260821|NCT02574481|lower extremities|lower extremities
260822|NCT02574481|stenting|stenting
260823|NCT02574481|paclitaxel|paclitaxel
260824|NCT02574468|Dexamethasone|dexamethasone
260825|NCT02574468|Direct pulp capping|direct pulp capping
260826|NCT02574468|MTA|mta
260827|NCT02574468|pulpotomy|pulpotomy
260828|NCT02574442|cervical intraepithelial neoplasia grade 1|cervical intraepithelial neoplasia grade 1
260829|NCT02574442|cervical intraepithelial neoplasia grade 2|cervical intraepithelial neoplasia grade 2
260830|NCT02574442|cervical intraepithelial neoplasia grade 3|cervical intraepithelial neoplasia grade 3
260831|NCT02574442|adenocarcinoma in situ|adenocarcinoma in situ
260832|NCT02574429|Borderline Personality Disorder|borderline personality disorder
260833|NCT02574429|Posttraumatic Stress Disorder|posttraumatic stress disorder
260834|NCT02574429|Cognitive Processing Therapy|cognitive processing therapy
260835|NCT02574429|Group Therapy|group therapy
260836|NCT02574429|Comorbidity|comorbidity
260837|NCT02574429|Dialectical Behavior Therapy|dialectical behavior therapy
260838|NCT02574416|Health behaviour|health behaviour
260839|NCT02574416|Health outcomes|health outcomes
260840|NCT02574416|Diet quality|diet quality
260841|NCT02574416|Physical function|physical function
260842|NCT02574416|Lifestyle|lifestyle
260843|NCT02574416|Older adults|older adults
260844|NCT02574403|atypical hemolytic uremic syndrome (aHUS)|atypical hemolytic uremic syndrome (ahus)
260845|NCT02574403|eculizumab discontinuation|eculizumab discontinuation
260846|NCT02574390|ALS|als
260847|NCT02574390|stem cell|stem cell
260848|NCT02574390|biomarker|biomarker
260849|NCT02574390|disease progression|disease progression
260850|NCT02574364|abdomen CT|abdomen ct
260851|NCT02574364|open appendicectomy|open appendicectomy
260852|NCT02574312|Mechanical Axis Alignment|mechanical axis alignment
260853|NCT02574312|Knee Arthroplasty, Total|knee arthroplasty, total
260854|NCT02574299|dyslexia|dyslexia
260855|NCT02574299|training|training
260856|NCT02574299|auditory rehabilitation|auditory rehabilitation
260857|NCT02574299|hearing loss|hearing loss
260858|NCT02574299|evoked potentials|evoked potentials
260859|NCT02574299|dichotic|dichotic
260860|NCT02574299|plasticity|plasticity
260861|NCT02574299|noise|noise
260862|NCT02574247|Audiology|audiology
260863|NCT02574247|Auditory Pathways|auditory pathways
260864|NCT02574247|Auditory Perception|auditory perception
260865|NCT02574247|Brain Stem|brain stem
260866|NCT02574247|Cochlea|cochlea
260867|NCT02574247|Ear, Inner|ear, inner
260868|NCT02574247|Efferent Pathways|efferent pathways
260869|NCT02574247|Hair Cells, Auditory, Outer|hair cells, auditory, outer
260870|NCT02574247|Learning|learning
260871|NCT02574247|Neurons, Efferent|neurons, efferent
260872|NCT02574247|Speech Perception|speech perception
260873|NCT02574234|Postoperative cognitive disorders POCD|postoperative cognitive disorders pocd
260874|NCT02574234|inflammation|inflammation
260875|NCT02574234|Surgery|surgery
260876|NCT02574208|Adult outpatients|adult outpatients
260877|NCT02574208|Paris, France|paris, france
260878|NCT02574195|Diabetes Mellitus|diabetes mellitus
260879|NCT02574195|microvascular complications|microvascular complications
260880|NCT02574195|macrovascular complications|macrovascular complications
260881|NCT02574195|epidemiology|epidemiology
260882|NCT02574195|Russia|russia
260883|NCT02574182|Mild Cognitive Impairment|mild cognitive impairment
260884|NCT02574182|Magnetic Resonance Imaging|magnetic resonance imaging
260885|NCT02574169|Alveolar Recruitment Maneuvers (ARM)|alveolar recruitment maneuvers (arm)
260886|NCT02574169|Continuous Positive Airway Pressure (CPAP)|continuous positive airway pressure (cpap)
260887|NCT02574169|Extended Sigh (eSigh)|extended sigh (esigh)
260888|NCT02574143|Prognosis|prognosis
260889|NCT02574143|Prospective Study|prospective study
260890|NCT02574143|Quality of Life|quality of life
260891|NCT02574143|Radiology|radiology
260892|NCT02574143|Rehabilitation|rehabilitation
260893|NCT02574143|Registry;|registry;
260894|NCT02574143|Signs and Symptoms|signs and symptoms
260895|NCT02574143|Therapy|therapy
260896|NCT02574143|Bronchiectiasis|bronchiectiasis
260897|NCT02574143|Diagnosis|diagnosis
260898|NCT02574143|Epidemiology|epidemiology
260899|NCT02574143|Etiology|etiology
260900|NCT02574143|Longitudinal Study|longitudinal study
260901|NCT02574143|Microbiology|microbiology
260902|NCT02574104|Intensive Care Units, Neonatal|intensive care units, neonatal
260903|NCT02574104|Patient simulation|patient simulation
262102|NCT02567708|Efficacy|efficacy
260904|NCT02574104|Interdisciplinary Communication|interdisciplinary communication
260905|NCT02574104|Human factors|human factors
260906|NCT02574104|Hazard Analysis and Critical Control Points|hazard analysis and critical control points
260907|NCT02574091|EGFR inhibitor|egfr inhibitor
260908|NCT02574091|topical agent|topical agent
260909|NCT02574091|psoriasis|psoriasis
260910|NCT02574091|phase 1|phase 1
260911|NCT02574065|crying|crying
260912|NCT02574065|colicky|colicky
260913|NCT02574065|infants|infants
260914|NCT02574065|Lactobacillus reuteri DSM 17938|lactobacillus reuteri dsm 17938
260915|NCT02574052|Menu Labelling;|menu labelling;
260916|NCT02574052|Nutrition Education;|nutrition education;
260917|NCT02574052|dietary assessment tools;|dietary assessment tools;
260918|NCT02574039|volunteers|volunteers
260919|NCT02574039|oat|oat
260920|NCT02574039|phenolic acid|phenolic acid
260921|NCT02574039|bioavailability|bioavailability
260922|NCT02574026|MEG|meg
260923|NCT02574026|EEG|eeg
260924|NCT02574026|MRI|mri
260925|NCT02574026|Brain mapping|brain mapping
260926|NCT02574026|functional imaging|functional imaging
260927|NCT02574026|brain computer interface|brain computer interface
260928|NCT02573974|undernutrition|undernutrition
260929|NCT02573974|gastrointestinal cancer|gastrointestinal cancer
260930|NCT02573974|skeletal muscle|skeletal muscle
260931|NCT02573974|energy metabolism|energy metabolism
260932|NCT02573948|People who inject drugs|people who inject drugs
260933|NCT02573948|Vietnam|vietnam
260934|NCT02573948|Community support groups|community support groups
260935|NCT02573935|Multiple Myeloma|multiple myeloma
260936|NCT02573935|Clarithromycin|clarithromycin
260937|NCT02573935|Induction Chemotherapy|induction chemotherapy
260938|NCT02573935|Transplantation, Autologous|transplantation, autologous
260939|NCT02573922|constipation|constipation
260940|NCT02573922|opioid|opioid
260941|NCT02573922|Oxycodone|oxycodone
260942|NCT02573922|Oxycodone-naloxone|oxycodone-naloxone
260943|NCT02573922|spine surgery|spine surgery
260944|NCT02573896|relapsed refractory neuroblastoma|relapsed refractory neuroblastoma
260945|NCT02573883|Vulva|vulva
260946|NCT02573883|Lichen Sclerosus|lichen sclerosus
260947|NCT02573883|Fractionated Carbon Dioxide Laser|fractionated carbon dioxide laser
260948|NCT02573883|Mona Lisa Laser|mona lisa laser
260949|NCT02573883|Clobetasol Proprionate|clobetasol proprionate
260950|NCT02573883|Vulvodynia|vulvodynia
260951|NCT02573870|COPD|copd
260952|NCT02573870|DPI|dpi
260953|NCT02573870|Batefenterol|batefenterol
260954|NCT02573870|Fluticasone Furoate|fluticasone furoate
260955|NCT02573857|Induced blood stage malaria|induced blood stage malaria
260956|NCT02573857|Transmission|transmission
260957|NCT02573857|Gametocytemia|gametocytemia
260958|NCT02573844|irritable bowel syndrome|irritable bowel syndrome
260959|NCT02573844|abdominal pain|abdominal pain
260960|NCT02573844|rome III criteria|rome iii criteria
260961|NCT02573844|abdominal distension|abdominal distension
260962|NCT02573844|consistency of stools|consistency of stools
260963|NCT02573844|stool frequency|stool frequency
260964|NCT02573844|meteorism|meteorism
260965|NCT02573844|flatulence|flatulence
260966|NCT02573844|abdominal discomfort|abdominal discomfort
260967|NCT02573844|proklama|proklama
260968|NCT02573844|probiotics|probiotics
260969|NCT02573844|alga klamath|alga klamath
260970|NCT02573844|aphanizomenon flos-aquae|aphanizomenon flos-aquae
260971|NCT02573844|prebiotics|prebiotics
260972|NCT02573844|colitis ulcerosa|colitis ulcerosa
260973|NCT02573831|labor|labor
260974|NCT02573831|pain|pain
260975|NCT02573831|oxycodone|oxycodone
260976|NCT02573831|placenta|placenta
260977|NCT02573818|sedation for EGD and colonoscopy procedures|sedation for egd and colonoscopy procedures
260978|NCT02573805|nocturnal penile tumescence and rigidity|nocturnal penile tumescence and rigidity
260979|NCT02573805|erectile dysfunction|erectile dysfunction
260980|NCT02573805|Chinese males|chinese males
260981|NCT02573792|First onset of optical neuritis|first onset of optical neuritis
260982|NCT02573779|human milk|human milk
260983|NCT02573779|enteral nutrition|enteral nutrition
260984|NCT02573779|microbiome|microbiome
260985|NCT02573779|Microbiota|microbiota
260986|NCT02573766|Neurofeedback training|neurofeedback training
260987|NCT02573766|EEG|eeg
260988|NCT02573766|electroencephalograph|electroencephalograph
260989|NCT02573766|Questionnaires|questionnaires
260990|NCT02573766|Surveys|surveys
260991|NCT02573766|Chemotherapy-Induced Peripheral Neuropathy|chemotherapy-induced peripheral neuropathy
260992|NCT02573766|CIPN|cipn
260993|NCT02573740|Mild Cognitive Impairment|mild cognitive impairment
260994|NCT02573740|Alzheimer's Disease|alzheimer's disease
260995|NCT02573714|Ketamine|ketamine
260996|NCT02573714|Intranasal|intranasal
260997|NCT02573714|Pain crisis|pain crisis
260998|NCT02573714|Vasoocclusive Pain|vasoocclusive pain
260999|NCT02573714|Sickle cell disease|sickle cell disease
261000|NCT02573701|Schizophrenia|schizophrenia
261001|NCT02573701|Adolescents|adolescents
261002|NCT02573701|Treatment|treatment
261003|NCT02573701|Guidelines|guidelines
261004|NCT02573688|Obesity|obesity
261005|NCT02573688|Metabolic Syndrome X|metabolic syndrome x
261006|NCT02573688|Interdisciplinary Studies|interdisciplinary studies
261007|NCT02573675|hemodialysis|hemodialysis
261008|NCT02573675|peritoneal dialysis|peritoneal dialysis
261009|NCT02573662|Metabolic complications|metabolic complications
261010|NCT02573662|Type 2 diabetes|type 2 diabetes
261011|NCT02573662|Sedentary lifestyle|sedentary lifestyle
261012|NCT02573662|Low grade inflammation|low grade inflammation
261013|NCT02573662|Lipid metabolism|lipid metabolism
261014|NCT02573662|Glucose metabolism|glucose metabolism
261015|NCT02573662|Bone metabolism|bone metabolism
261016|NCT02573662|Physical inactivity|physical inactivity
261017|NCT02573623|Immunology diagnosis test|immunology diagnosis test
261018|NCT02573623|Children|children
261020|NCT02573571|single nucleotide polymorphisms|single nucleotide polymorphisms
261021|NCT02573571|cytokines|cytokines
261022|NCT02573571|microbiome|microbiome
261023|NCT02573545|liver|liver
261024|NCT02573532|myocardial ischemia/diagnosis|myocardial ischemia/diagnosis
261025|NCT02573532|myocardial ischemia/epidemiology|myocardial ischemia/epidemiology
261026|NCT02573532|perioperative|perioperative
261027|NCT02573532|perioperative complications/diagnosis|perioperative complications/diagnosis
261028|NCT02573532|prognosis|prognosis
261029|NCT02573519|11C Donepezil PET/CT scan|11c donepezil pet/ct scan
261030|NCT02573519|3D-Transit|3d-transit
261031|NCT02573519|Diabetes Mellitus|diabetes mellitus
261032|NCT02573519|Gastrointestinal motility disorder|gastrointestinal motility disorder
261033|NCT02573519|Diabetic autonomic neuropathy|diabetic autonomic neuropathy
261034|NCT02573506|Non-small cell lung cancer|non-small cell lung cancer
261035|NCT02573506|Split-course Chemoradiotherapy|split-course chemoradiotherapy
261036|NCT02573480|youth violence, intervention, emergency medicine|youth violence, intervention, emergency medicine
261037|NCT02573467|sporadic inclusion body myositis,|sporadic inclusion body myositis,
261038|NCT02573467|muscle wasting,|muscle wasting,
261039|NCT02573467|extension study,|extension study,
261041|NCT02573467|bimagrumab,|bimagrumab,
261042|NCT02573428|Autism Spectrum Disorder|autism spectrum disorder
261043|NCT02573428|Eye Gaze|eye gaze
261044|NCT02573428|Remote Eye Gaze Tracking|remote eye gaze tracking
261045|NCT02573428|Autism|autism
261046|NCT02573402|electric stimulation|electric stimulation
261047|NCT02573402|urodynamic study|urodynamic study
261048|NCT02573389|pancreatic fistula, pancreatectomy, endoscopic stenting, pancreatic stenting, distal pancreatectomy|pancreatic fistula, pancreatectomy, endoscopic stenting, pancreatic stenting, distal pancreatectomy
261049|NCT02573376|HIV|hiv
261050|NCT02573376|Hepatitis C|hepatitis c
261051|NCT02573376|Drug Abuse|drug abuse
261052|NCT02573376|Hepatitis C Virus|hepatitis c virus
261053|NCT02573376|sofosbuvir|sofosbuvir
261054|NCT02573376|ledipasvir|ledipasvir
261055|NCT02573376|pharmacology|pharmacology
261056|NCT02573376|pharmacokinetics|pharmacokinetics
261057|NCT02573324|Newly Diagnosed Glioblastoma|newly diagnosed glioblastoma
261058|NCT02573324|Epithelial Growth Factor Receptor (EGFR)|epithelial growth factor receptor (egfr)
261059|NCT02573324|Temozolomide|temozolomide
261060|NCT02573324|ABT-414|abt-414
261061|NCT02573324|Radiology Therapy Oncology Group|radiology therapy oncology group
261062|NCT02573324|Antibody Drug Conjugate|antibody drug conjugate
261063|NCT02573324|Brain Tumor|brain tumor
261064|NCT02573324|Brain Tumor Group|brain tumor group
261065|NCT02573324|EGFRvIII|egfrviii
261066|NCT02573324|EGFR Amplified|egfr amplified
261067|NCT02573324|First Line Therapy|first line therapy
261068|NCT02573324|Brain Cancer|brain cancer
261069|NCT02573298|cryotherapy|cryotherapy
261070|NCT02573298|power Doppler score|power doppler score
261071|NCT02573298|synovial fluid cytokines|synovial fluid cytokines
261072|NCT02573298|pain VAS|pain vas
261073|NCT02573259|efficacy|efficacy
261074|NCT02573259|safety|safety
261075|NCT02573259|pharmacokinetics|pharmacokinetics
261076|NCT02573259|pharmacodynamics|pharmacodynamics
261077|NCT02573259|open label|open label
261078|NCT02573259|dose response|dose response
261079|NCT02573259|multiple ascending dose|multiple ascending dose
261080|NCT02573259|immunogenicity|immunogenicity
261081|NCT02573259|recommended phase 2 dose|recommended phase 2 dose
261082|NCT02573259|subcutaneous|subcutaneous
261083|NCT02573246|neurostimulation|neurostimulation
261084|NCT02573246|cognitive restructuring|cognitive restructuring
261085|NCT02573246|TMS|tms
261086|NCT02573246|emotion regulation|emotion regulation
261087|NCT02573246|MRI|mri
261088|NCT02573246|Emotional Memory Task|emotional memory task
261089|NCT02573246|Reappraisal|reappraisal
261090|NCT02573246|Distraction|distraction
261091|NCT02573194|Appetite|appetite
261092|NCT02573194|Amino acids|amino acids
261093|NCT02573194|Protein Source|protein source
261094|NCT02573168|Pharmacogenomic|pharmacogenomic
261095|NCT02573168|Pharmacogenomic Testing|pharmacogenomic testing
261096|NCT02573168|Pharmacogenomics|pharmacogenomics
261097|NCT02573168|Genetic Testing|genetic testing
261098|NCT02573168|Genetics|genetics
261099|NCT02573168|GeneSight|genesight
261100|NCT02573168|Enhanced GeneSight|enhanced genesight
261101|NCT02573168|Psychotropic|psychotropic
261102|NCT02573155|Pharmacokinetics|pharmacokinetics
261103|NCT02573155|Pharmacodynamics|pharmacodynamics
261105|NCT02573155|Safety|safety
261106|NCT02573155|Tolerability|tolerability
261107|NCT02573155|mild persistent asthma|mild persistent asthma
261108|NCT02573155|moderate to severe COPD|moderate to severe copd
261109|NCT02573142|obesity|obesity
261110|NCT02573142|treatment|treatment
261111|NCT02573142|community|community
261112|NCT02573142|integrated|integrated
261113|NCT02573129|cardiovascular disease risk|cardiovascular disease risk
261114|NCT02573129|Mediterranean diet|mediterranean diet
261115|NCT02573129|red meat|red meat
261116|NCT02573116|obstructive sleep apnea|obstructive sleep apnea
261117|NCT02573116|endothelial dysfunction|endothelial dysfunction
261118|NCT02573116|periodontitis|periodontitis
261119|NCT02573090|Occlusal caries|occlusal caries
261120|NCT02573090|Resin based fissure sealant|resin based fissure sealant
261121|NCT02573090|Composite resin restoration|composite resin restoration
261122|NCT02573090|Effectiveness|effectiveness
261123|NCT02573090|Longevity|longevity
261124|NCT02573077|Hyponatremia due to SIADH|hyponatremia due to siadh
261125|NCT02573077|Cancer|cancer
261126|NCT02573038|Aflibercept|aflibercept
261127|NCT02573038|choroidal neovascularization|choroidal neovascularization
261128|NCT02573038|angioid streaks|angioid streaks
261129|NCT02573038|young patient|young patient
261130|NCT02572999|Aged|aged
261131|NCT02572999|Frail|frail
261132|NCT02572999|Functional decline|functional decline
261133|NCT02572999|Impairment|impairment
261134|NCT02572999|valvular heart disease|valvular heart disease
261135|NCT02572999|Cohort|cohort
261136|NCT02572999|risk factors|risk factors
261137|NCT02572947|Dolutegravir|dolutegravir
261138|NCT02572947|HIV infection|hiv infection
261139|NCT02572947|Anti-Retroviral Agents|anti-retroviral agents
261140|NCT02572947|HIV Integrase Inhibitors|hiv integrase inhibitors
261141|NCT02572947|Integrase Inhibitors|integrase inhibitors
261142|NCT02572947|Pharmacologic Actions|pharmacologic actions
261143|NCT02572947|Therapeutic Uses|therapeutic uses
261144|NCT02572934|Testicular cancer|testicular cancer
261145|NCT02572934|Survivorship|survivorship
261146|NCT02572934|late adverse treatment effects|late adverse treatment effects
261147|NCT02572921|Positive Psychotherapy|positive psychotherapy
261148|NCT02572921|Depression|depression
261149|NCT02572921|Happiness|happiness
261150|NCT02572908|wheat, IBS, gluten, ATI|wheat, ibs, gluten, ati
261151|NCT02572895|Cranberry|cranberry
261152|NCT02572895|Proanthocyanidins|proanthocyanidins
261153|NCT02572895|Urinary catabolites|urinary catabolites
261154|NCT02572882|hemodialysis|hemodialysis
261155|NCT02572882|p-inulin|p-inulin
261156|NCT02572882|gut microbiome|gut microbiome
261157|NCT02572869|Mandible Reconstruction|mandible reconstruction
261158|NCT02572869|Fibula Osteomyocutaneous Free Flaps|fibula osteomyocutaneous free flaps
261159|NCT02572869|Quality of Life|quality of life
261161|NCT02572856|Feasibility|feasibility
261162|NCT02572856|continuous glucose monitor|continuous glucose monitor
261163|NCT02572856|surgery|surgery
261164|NCT02572843|NSCLC|nsclc
261165|NCT02572843|lung cancer|lung cancer
261166|NCT02572843|MEDI4736|medi4736
261167|NCT02572843|non-small cell lung cancer|non-small cell lung cancer
261168|NCT02572843|immunotherapy|immunotherapy
261169|NCT02572843|anti-PD-L1|anti-pd-l1
261170|NCT02572830|Reconsolidation|reconsolidation
261171|NCT02572830|EMDR|emdr
261172|NCT02572830|PTSD|ptsd
261173|NCT02572817|Anti-Influenza Immune Plasma|anti-influenza immune plasma
261174|NCT02572804|bladder cancer-cystectomy|bladder cancer-cystectomy
261175|NCT02572804|rectus sheath catheter|rectus sheath catheter
261176|NCT02572804|epidural|epidural
261177|NCT02572713|Parkinson's Disease|parkinson's disease
261178|NCT02572713|alpha-synuclein|alpha-synuclein
261179|NCT02572713|biomarker|biomarker
261180|NCT02572687|metastatic|metastatic
261181|NCT02572687|advanced|advanced
261182|NCT02572687|immuno-oncology|immuno-oncology
261183|NCT02572687|vascular endothelial growth factor (VEGF)|vascular endothelial growth factor (vegf)
261184|NCT02572687|angiogenesis|angiogenesis
261185|NCT02572687|PD-1|pd-1
261186|NCT02572687|PD-L1|pd-l1
261187|NCT02572674|Bipolar disorder|bipolar disorder
261188|NCT02572674|relapse risk factors|relapse risk factors
261189|NCT02572674|prospective follow up|prospective follow up
261190|NCT02572661|Radiotherapy, Sentinel Node Mapping, Spect|radiotherapy, sentinel node mapping, spect
261191|NCT02572648|Cardiomyopathy|cardiomyopathy
261192|NCT02572648|Magnetic Resonance Imaging (MRI)|magnetic resonance imaging (mri)
261193|NCT02572635|Pneumococcal Infection|pneumococcal infection
261194|NCT02572635|Phase I|phase i
261195|NCT02572635|Immunogenicity|immunogenicity
261196|NCT02572635|Safety|safety
261197|NCT02572635|Vaccination|vaccination
261198|NCT02572622|exercise|exercise
261199|NCT02572622|deep friction massage|deep friction massage
261200|NCT02572622|spinal decompression|spinal decompression
261201|NCT02572622|non-surgical spinal decompression|non-surgical spinal decompression
261202|NCT02572596|Hematopoietic Stem Cell Mobilization|hematopoietic stem cell mobilization
261203|NCT02572596|Thrombopoietin|thrombopoietin
261204|NCT02572583|Reconciling Exterior and Interior Therapy|reconciling exterior and interior therapy
261205|NCT02572583|Influenza|influenza
261206|NCT02572570|Adult dental care|adult dental care
261207|NCT02572557|Spray Cryotherapy|spray cryotherapy
261208|NCT02572544|young healthy adults|young healthy adults
261209|NCT02572544|single pinhole glasses|single pinhole glasses
261210|NCT02572544|multiple pinhole glasses|multiple pinhole glasses
261211|NCT02572531|Lactobacillus reuteri|lactobacillus reuteri
261212|NCT02572531|Wound Healing|wound healing
261213|NCT02572531|Third Molar|third molar
261214|NCT02572531|Postoperative Complications|postoperative complications
261215|NCT02572518|immunity yellow fever vaccine|immunity yellow fever vaccine
261216|NCT02572505|HIV-Discordant|hiv-discordant
261217|NCT02572505|Preexposure Prophylaxis|preexposure prophylaxis
261218|NCT02572492|Multiple Myeloma|multiple myeloma
261219|NCT02572492|Recurrence|recurrence
261220|NCT02572492|Carfilzomib|carfilzomib
261221|NCT02572492|Salvage Therapy|salvage therapy
261222|NCT02572492|Transplantation, Autologous|transplantation, autologous
261223|NCT02572479|fatty acids, amyotrophic lateral sclerosis, nutrient status|fatty acids, amyotrophic lateral sclerosis, nutrient status
261224|NCT02572466|high-sensitive troponin-I|high-sensitive troponin-i
261225|NCT02572466|End-stage renal disease|end-stage renal disease
261226|NCT02572466|hemodialysis|hemodialysis
261227|NCT02572440|Aortic arch surgery; Blood conservation; aPRP|aortic arch surgery; blood conservation; aprp
261228|NCT02572401|Human immunodeficiency virus|human immunodeficiency virus
261229|NCT02572401|Sexually transmitted disease|sexually transmitted disease
261230|NCT02572401|Behavioral intervention|behavioral intervention
261231|NCT02572401|Randomized controlled trial|randomized controlled trial
261232|NCT02572401|Text messages|text messages
261233|NCT02572401|Social cognitive theory|social cognitive theory
261234|NCT02572401|Theory of planned behavior|theory of planned behavior
261235|NCT02572401|Sexual behavior|sexual behavior
261236|NCT02572401|African Americans|african americans
261237|NCT02572401|Men|men
261238|NCT02572349|Healthy Subjects|healthy subjects
261239|NCT02572310|total knee arthroplasty|total knee arthroplasty
261240|NCT02572297|epilepsy|epilepsy
261241|NCT02572297|SUDEP|sudep
261242|NCT02572297|SpO2|spo2
261243|NCT02572284|Stereotactic Body Radiation Therapy (SBRT)|stereotactic body radiation therapy (sbrt)
261244|NCT02572284|High Risk Prostate Cancer|high risk prostate cancer
261245|NCT02572284|Preoperative SBRT|preoperative sbrt
261246|NCT02572284|Prostate Adenocarcinoma|prostate adenocarcinoma
261247|NCT02572284|Prostatectomy|prostatectomy
261248|NCT02572284|Quality of Life|quality of life
261249|NCT02572271|Autologous augmentation|autologous augmentation
261250|NCT02572271|Mastopexy|mastopexy
261251|NCT02572271|Massive weight loss|massive weight loss
261252|NCT02572245|Healthy Subjects|healthy subjects
261253|NCT02572245|Device|device
261254|NCT02572245|PK|pk
261255|NCT02572245|Phase 1|phase 1
261256|NCT02572245|Bioequivalence|bioequivalence
261257|NCT02572245|Adalimumab|adalimumab
261258|NCT02572245|Single Dose|single dose
261259|NCT02572193|achalasia|achalasia
261260|NCT02572193|surgery|surgery
261261|NCT02572167|Monomethyl auristatin E|monomethyl auristatin e
261262|NCT02572167|Antigens, CD30|antigens, cd30
261263|NCT02572167|Antibody-Drug Conjugate|antibody-drug conjugate
261264|NCT02572167|Antibodies, Monoclonal|antibodies, monoclonal
261265|NCT02572167|Immunotherapy|immunotherapy
261266|NCT02572167|Autologous stem cell transplant|autologous stem cell transplant
261267|NCT02572115|After-Hours Care|after-hours care
261268|NCT02572115|Primary Care|primary care
261269|NCT02572115|Emergency Medical Services/utilization|emergency medical services/utilization
261270|NCT02572115|Denmark|denmark
261271|NCT02572115|Questionnaires|questionnaires
261272|NCT02572115|Patient Satisfaction|patient satisfaction
261273|NCT02572115|Patient feeling of safety|patient feeling of safety
261274|NCT02572115|Triage/standards|triage/standards
261275|NCT02572115|Referral and Consultation/statistics & numerical data|referral and consultation/statistics & numerical data
261276|NCT02572115|Humans|humans
261277|NCT02572115|Male|male
261278|NCT02572115|Female|female
261279|NCT02572115|Hotlines|hotlines
261280|NCT02572115|telenursing|telenursing
261281|NCT02572115|Night Care/utilization|night care/utilization
261282|NCT02572115|postal service|postal service
261284|NCT02572102|Blood Pressure|blood pressure
261285|NCT02572102|Energy Drinks|energy drinks
261286|NCT02572102|Panax Ginseng|panax ginseng
261287|NCT02572037|Premature ejaculation|premature ejaculation
261288|NCT02572037|Dapoxetine|dapoxetine
261289|NCT02572037|local anaesthetics|local anaesthetics
261290|NCT02572037|nerve electrophysiology|nerve electrophysiology
261291|NCT02572011|Lower limb amputation|lower limb amputation
261292|NCT02572011|Transtibial|transtibial
261293|NCT02572011|Balance|balance
261294|NCT02572011|Postural Control|postural control
261295|NCT02572011|Limits of Stability|limits of stability
261296|NCT02572011|Rehabilitation|rehabilitation
261297|NCT02572011|Home-based intervention|home-based intervention
261298|NCT02572011|Nintendo Wii|nintendo wii
261299|NCT02572011|Balance Board|balance board
261300|NCT02571985|Zenith aortoiliac aneurysm|zenith aortoiliac aneurysm
261301|NCT02571985|iliac aneurysm|iliac aneurysm
261302|NCT02571985|branch|branch
261303|NCT02571985|connections|connections
261304|NCT02571985|endovascular graft|endovascular graft
261305|NCT02571985|graft-iliac bifurcation|graft-iliac bifurcation
261306|NCT02571985|Aneurysm|aneurysm
261307|NCT02571985|Vascular Diseases|vascular diseases
261308|NCT02571985|Cardiovascular Diseases|cardiovascular diseases
261309|NCT02571972|dorzolamide-timolol|dorzolamide-timolol
261310|NCT02571972|topical aqueous suppression|topical aqueous suppression
261311|NCT02571972|neovascular age-related macular degeneration|neovascular age-related macular degeneration
261312|NCT02571972|macular edema|macular edema
261313|NCT02571972|intravitreal injection|intravitreal injection
261314|NCT02571972|anti-vascular endothelial growth factor|anti-vascular endothelial growth factor
261315|NCT02571959|Obesity|obesity
261316|NCT02571959|Pharmacology|pharmacology
261317|NCT02571959|Amoxicillin-Potassium Clavulanate Combination|amoxicillin-potassium clavulanate combination
261318|NCT02571933|Pediatrics|pediatrics
261319|NCT02571933|Pain Scale|pain scale
261320|NCT02571933|Faces Pain Scale - Revised|faces pain scale - revised
261321|NCT02571933|Cameroon|cameroon
261322|NCT02571920|cardiac surgery|cardiac surgery
261323|NCT02571920|cardiac output|cardiac output
261324|NCT02571907|Zenith aortoiliac aneurysm|zenith aortoiliac aneurysm
261325|NCT02571907|Iliac aneurysm|iliac aneurysm
261326|NCT02571907|Branch|branch
261327|NCT02571907|Connections|connections
261328|NCT02571907|Endovascular graft|endovascular graft
261329|NCT02571907|Graft-iliac bifurcation|graft-iliac bifurcation
261330|NCT02571907|Aneurysm|aneurysm
261331|NCT02571907|Vascular Diseases|vascular diseases
261332|NCT02571907|Cardiovascular Diseases|cardiovascular diseases
261333|NCT02571881|constipation|constipation
261334|NCT02571881|oxycodone|oxycodone
261335|NCT02571881|caesarean section|caesarean section
261336|NCT02571855|insomnia|insomnia
261337|NCT02571855|Pharmacokinetics|pharmacokinetics
261338|NCT02571855|Safety|safety
261339|NCT02571855|Pharmacodynamics|pharmacodynamics
261340|NCT02571855|Healthy|healthy
261341|NCT02571842|Recurrent IgA nephropathy|recurrent iga nephropathy
261342|NCT02571842|Rituximab|rituximab
261343|NCT02571829|Liposarcoma|liposarcoma
261344|NCT02571829|Soft tissue sarcoma|soft tissue sarcoma
261345|NCT02571829|CDK4|cdk4
261346|NCT02571829|CDK6|cdk6
261347|NCT02571829|LEE011|lee011
261348|NCT02571829|ribociclib|ribociclib
261349|NCT02571816|Hepatic Impairment|hepatic impairment
261350|NCT02571816|Mild Hepatic Impairment|mild hepatic impairment
261351|NCT02571816|Healthy|healthy
261352|NCT02571816|ASP2215|asp2215
261353|NCT02571816|Moderate Hepatic Impairment|moderate hepatic impairment
261354|NCT02571803|coronary artery disease|coronary artery disease
261355|NCT02571803|atherosclerosis|atherosclerosis
261356|NCT02571803|DASH diet|dash diet
261357|NCT02571790|Patient with Generalized Anxiety Disorders|patient with generalized anxiety disorders
261358|NCT02571777|Asthma|asthma
261359|NCT02571725|Ovarian cancer|ovarian cancer
261360|NCT02571725|Fallopian tube cancer|fallopian tube cancer
261361|NCT02571725|Peritoneal cancer|peritoneal cancer
261362|NCT02571725|PARP|parp
261363|NCT02571725|BRCA|brca
261364|NCT02571725|Immunotherapy|immunotherapy
261365|NCT02571725|Olaparib|olaparib
261366|NCT02571725|Tremelimumab|tremelimumab
261367|NCT02571725|CTLA4|ctla4
261368|NCT02571673|Survivorship|survivorship
261369|NCT02571673|Quality of Life|quality of life
261370|NCT02571673|HN-STAR web-based|hn-star web-based
261371|NCT02571673|15-245|15-245
261372|NCT02571660|vitamin d levels|vitamin d levels
261373|NCT02571660|exacerbation of asthma|exacerbation of asthma
261374|NCT02571660|asthma control|asthma control
261375|NCT02571634|intranasal fentanyl|intranasal fentanyl
261376|NCT02571634|conscious sedation|conscious sedation
261377|NCT02571608|Type 2 diabetes mellitus, Metformin, peri-operative|type 2 diabetes mellitus, metformin, peri-operative
261378|NCT02571595|HIV - Human Immunodeficiency Virus|hiv - human immunodeficiency virus
261379|NCT02571595|digital cognitive behavioural therapy for insomnia (dCBT-I)|digital cognitive behavioural therapy for insomnia (dcbt-i)
261380|NCT02571595|insomnia|insomnia
261381|NCT02571595|cognitive Impairment|cognitive impairment
261382|NCT02571595|concentration|concentration
261383|NCT02571595|productivity|productivity
261384|NCT02571582|Predictors of mortality|predictors of mortality
261385|NCT02571543|Ibuprofen|ibuprofen
261386|NCT02571543|IVF|ivf
261387|NCT02571543|minimal stimulation|minimal stimulation
261388|NCT02571543|modified natural-cycle|modified natural-cycle
261389|NCT02571543|nonsteroidal anti-inflammatory drug (NSAID)|nonsteroidal anti-inflammatory drug (nsaid)
261390|NCT02571543|Anti-Inflammatory Agents, Non-Steroidal/therapeutic use|anti-inflammatory agents, non-steroidal/therapeutic use
261391|NCT02571543|Oocyte Retrieval|oocyte retrieval
261392|NCT02571543|Ovarian Follicle/drug effects|ovarian follicle/drug effects
261393|NCT02571517|Respiratory viral infection.|respiratory viral infection.
261394|NCT02571517|Respiratory syncytial virus bronchiolitis|respiratory syncytial virus bronchiolitis
261395|NCT02571517|METHYLPREDNISOLONE SODIUM SUCCINATE|methylprednisolone sodium succinate
261396|NCT02571504|HIV - Human Immunodeficiency Virus|hiv - human immunodeficiency virus
261398|NCT02571504|Concentration|concentration
261399|NCT02571478|Military Couples|military couples
261400|NCT02571478|Marriage|marriage
261401|NCT02571478|Primary Care|primary care
261402|NCT02571478|Marriage Intervention|marriage intervention
261403|NCT02571478|Air Force|air force
261404|NCT02571465|functional hemodynamic parameter|functional hemodynamic parameter
261405|NCT02571465|passive leg raising|passive leg raising
261406|NCT02571465|stroke volume variation|stroke volume variation
261407|NCT02571465|pulse pressure variation|pulse pressure variation
261408|NCT02571452|Veteran|veteran
261409|NCT02571452|Insomnia|insomnia
261410|NCT02571452|Primary Healthcare|primary healthcare
261411|NCT02571439|TAP block, post-cesarean analgesia|tap block, post-cesarean analgesia
261412|NCT02571413|animated cartoon-aided teaching|animated cartoon-aided teaching
261413|NCT02571413|oral presentation|oral presentation
261414|NCT02571413|allergic rhinitis|allergic rhinitis
261415|NCT02571413|intranasal corticosteroid|intranasal corticosteroid
261416|NCT02571413|how to use intranasal corticosteroid|how to use intranasal corticosteroid
261417|NCT02571400|Risk|risk
261418|NCT02571400|Opioid analgesics|opioid analgesics
261419|NCT02571400|Opioid-related disorders|opioid-related disorders
261420|NCT02571400|Surgery|surgery
261421|NCT02571400|Post-operative care|post-operative care
261422|NCT02571400|Post-operative period|post-operative period
261423|NCT02571400|Post-operative complications|post-operative complications
261424|NCT02571400|Opioid Use disorders|opioid use disorders
261425|NCT02571400|Pain, post-operative|pain, post-operative
261426|NCT02571400|Opiate Addiction|opiate addiction
261427|NCT02571387|Motivation|motivation
261428|NCT02571387|Impulsive eating|impulsive eating
261429|NCT02571387|Mindfulness|mindfulness
261430|NCT02571387|Self-help|self-help
261431|NCT02571387|Physical activity|physical activity
261432|NCT02571387|Weight-loss|weight-loss
261433|NCT02571374|symbiotic|symbiotic
261434|NCT02571374|colorectal cancer|colorectal cancer
334148|NCT02168712|Safety|safety
261435|NCT02571361|Acetaminophen|acetaminophen
261436|NCT02571361|Ibuprofen|ibuprofen
261437|NCT02571361|Arthroplasty, Replacement, Hip|arthroplasty, replacement, hip
261438|NCT02571309|Self-management|self-management
261439|NCT02571309|Asthma|asthma
261440|NCT02571309|Patient education|patient education
261441|NCT02571309|Health literacy|health literacy
261442|NCT02571309|Health-related quality of life|health-related quality of life
261443|NCT02571309|Asthma control|asthma control
261444|NCT02571309|Adherence|adherence
261445|NCT02571296|Preterm Birth|preterm birth
261446|NCT02571296|Oral Micronized Progesterone|oral micronized progesterone
261447|NCT02571283|Total Knee Arthroplasty|total knee arthroplasty
261448|NCT02571283|Total Knee Replacement|total knee replacement
261449|NCT02571283|Exparel|exparel
261450|NCT02571283|Cocktail Injection|cocktail injection
261451|NCT02571283|Pain Management|pain management
261452|NCT02571270|Exercise|exercise
261453|NCT02571270|quality of life|quality of life
261454|NCT02571270|healthy|healthy
261455|NCT02571270|cardiac remodeling|cardiac remodeling
261456|NCT02571257|LDL-C|ldl-c
261457|NCT02571257|Lipid Regulator|lipid regulator
261458|NCT02571244|Tobacco Use Disorder|tobacco use disorder
261459|NCT02571244|Hospitalized patients|hospitalized patients
261460|NCT02571244|Text message|text message
261461|NCT02571244|Motivational Interview|motivational interview
261462|NCT02571244|Substance-Related Disorders|substance-related disorders
261463|NCT02571244|Behaviors and Mental Disorders|behaviors and mental disorders
261464|NCT02571218|atrial fibrillation|atrial fibrillation
261465|NCT02571218|mapping|mapping
261466|NCT02571218|substrate|substrate
261467|NCT02571218|ablation|ablation
261468|NCT02571205|testosterone|testosterone
261469|NCT02571205|pubertal delay|pubertal delay
261470|NCT02571192|ADME|adme
261471|NCT02571179|Labor pain|labor pain
261472|NCT02571179|Fentanyl|fentanyl
261473|NCT02571179|Transmucosal|transmucosal
261474|NCT02571153|Intravenous anesthesia|intravenous anesthesia
261475|NCT02571153|Postoperative nausea vomiting|postoperative nausea vomiting
261476|NCT02571153|Postoperative pain|postoperative pain
261477|NCT02571153|Patient satisfaction|patient satisfaction
261478|NCT02571153|Quality of health care|quality of health care
261479|NCT02571153|Ketamine|ketamine
261480|NCT02571114|Glycemic Responses|glycemic responses
261481|NCT02571114|Metabolic Responses|metabolic responses
261482|NCT02571114|Males|males
261483|NCT02571114|Females|females
261484|NCT02571101|Clomipramine|clomipramine
261485|NCT02571101|Premature ejaculation|premature ejaculation
261486|NCT02571101|CDFR0812|cdfr0812
261487|NCT02571101|Sildenafil|sildenafil
261488|NCT02571088|Sickle Cell Hemoglobin C Disease|sickle cell hemoglobin c disease
261489|NCT02571088|Sports Training|sports training
261490|NCT02571088|Hemoglobin S Disease|hemoglobin s disease
261491|NCT02571088|Lactate|lactate
261492|NCT02571075|auricular|auricular
261493|NCT02571075|acupuncture|acupuncture
261494|NCT02571075|pain|pain
261495|NCT02571062|bioequivalence|bioequivalence
261496|NCT02571036|Gastrointestinal stromal tumors (GIST)|gastrointestinal stromal tumors (gist)
262201|NCT02567032|Oxytocin|oxytocin
261497|NCT02571036|systemic mastocytosis (SM)|systemic mastocytosis (sm)
261498|NCT02571036|PDGFR-alpha|pdgfr-alpha
261499|NCT02571036|KIT|kit
261500|NCT02571036|mast cell leukemia (MCL)|mast cell leukemia (mcl)
261501|NCT02571036|mast cell disease (MCD)|mast cell disease (mcd)
261502|NCT02571036|DCC-2618|dcc-2618
261503|NCT02571036|melanoma|melanoma
261504|NCT02571036|aggressive systemic mastocytosis (ASM)|aggressive systemic mastocytosis (asm)
261505|NCT02571036|soft tissue sarcoma (STS)|soft tissue sarcoma (sts)
261506|NCT02571036|germ cell tumors|germ cell tumors
261507|NCT02571036|penile cancer|penile cancer
261508|NCT02571036|non-small cell lung carcinoma (NSCLC)|non-small cell lung carcinoma (nsclc)
261509|NCT02571036|renal impairment|renal impairment
261510|NCT02571036|malignant gliomas|malignant gliomas
261511|NCT02571023|Skull Base Trauma|skull base trauma
261512|NCT02571023|microscope surgery|microscope surgery
261513|NCT02571023|neuroendoscope surgery|neuroendoscope surgery
261514|NCT02571010|static mechanical allodynia|static mechanical allodynia
261515|NCT02571010|somatosensory rehabilitation|somatosensory rehabilitation
261516|NCT02571010|vibrotactile stimulation|vibrotactile stimulation
261517|NCT02570997|Alzheimer's Disease|alzheimer's disease
261518|NCT02570997|Mild Cognitive Impairment|mild cognitive impairment
261519|NCT02570971|mannitol|mannitol
261520|NCT02570971|treatment|treatment
261521|NCT02570958|robotic surgery|robotic surgery
261522|NCT02570958|indocyanine green|indocyanine green
261523|NCT02570958|electromagnetic navigational bronchoscopy|electromagnetic navigational bronchoscopy
261524|NCT02570932|Adult Autologous Bone Marrow Mesenchymal Cells Expanded|adult autologous bone marrow mesenchymal cells expanded
261525|NCT02570932|chronic spinal cord injury (SCI)|chronic spinal cord injury (sci)
261526|NCT02570919|Prostate cancer|prostate cancer
261527|NCT02570919|IGRT|igrt
261528|NCT02570919|Hypofractionation|hypofractionation
261529|NCT02570919|Extreme|extreme
261530|NCT02570919|Single Fraction|single fraction
261531|NCT02570919|Urethral Sparing|urethral sparing
261533|NCT02570893|Esophageal cancer;adjuvant therapy;chemotherapy;radiotherapy|esophageal cancer;adjuvant therapy;chemotherapy;radiotherapy
261534|NCT02570867|glaucoma|glaucoma
261535|NCT02570867|brain function|brain function
261536|NCT02570867|fMRI|fmri
261537|NCT02570854|Anemia|anemia
261538|NCT02570841|Heat pain threshold|heat pain threshold
261539|NCT02570841|Cold pain threshold|cold pain threshold
261540|NCT02570841|Mechanical pain threshold|mechanical pain threshold
261541|NCT02570841|High dose Capsaicin|high dose capsaicin
261542|NCT02570828|healthy neonate, tachypnea, thermal imaging, pneumonia|healthy neonate, tachypnea, thermal imaging, pneumonia
261543|NCT02570815|lung cancer|lung cancer
261544|NCT02570815|segmentectomy|segmentectomy
261545|NCT02570815|robotic surgery|robotic surgery
261546|NCT02570815|near-infrared fluorescent|near-infrared fluorescent
261547|NCT02570815|IC-GREEN|ic-green
261548|NCT02570815|indocyanine green|indocyanine green
261549|NCT02570815|early-stage lung cancer|early-stage lung cancer
261550|NCT02570776|Helicobacter pylori|helicobacter pylori
261551|NCT02570776|UBT|ubt
261552|NCT02570776|Sensitivity|sensitivity
261553|NCT02570776|specificity|specificity
261554|NCT02570776|prevalence|prevalence
261555|NCT02570763|neurostimulation|neurostimulation
261556|NCT02570763|comorbidity|comorbidity
261557|NCT02570763|tDCS|tdcs
261558|NCT02570763|CBT|cbt
261559|NCT02570763|anxiety|anxiety
261560|NCT02570763|alcohol|alcohol
261561|NCT02570711|Acalabrutinib|acalabrutinib
261562|NCT02570685|Gratitude Intervention|gratitude intervention
261563|NCT02570685|positive emotion|positive emotion
261564|NCT02570685|friendships|friendships
261565|NCT02570685|positive psychology|positive psychology
261566|NCT02570685|life satisfaction|life satisfaction
261567|NCT02570659|WAD|wad
261568|NCT02570659|Whiplash|whiplash
261569|NCT02570659|Information Video|information video
261570|NCT02570633|Migraine|migraine
261571|NCT02570633|Ginger|ginger
261572|NCT02570633|Prophylactic treatment|prophylactic treatment
261573|NCT02570594|Cognition|cognition
261574|NCT02570594|Autobiographical|autobiographical
261575|NCT02570594|memoryCognitive|memorycognitive
261576|NCT02570594|remediation|remediation
261577|NCT02570581|volonteeres|volonteeres
261578|NCT02570568|Venepuncture|venepuncture
261579|NCT02570568|Transillumination|transillumination
261580|NCT02570555|driving|driving
261581|NCT02570542|CD34+ Cell Dose|cd34+ cell dose
261582|NCT02570542|Autologous Stem Cell Transplantation|autologous stem cell transplantation
261583|NCT02570542|15-193|15-193
261584|NCT02570529|Pancreatic cancer|pancreatic cancer
261585|NCT02570529|Chemoradiotherapy|chemoradiotherapy
261586|NCT02570529|Gastrointestinal toxicity|gastrointestinal toxicity
261587|NCT02570529|Albis|albis
261588|NCT02570516|Indigo carmine chromoendoscopy|indigo carmine chromoendoscopy
261589|NCT02570516|Narrow band imaging|narrow band imaging
261590|NCT02570516|Colonoscopy|colonoscopy
261591|NCT02570490|fusidic acid|fusidic acid
261592|NCT02570490|skin infection|skin infection
261593|NCT02570451|cognitive impairment|cognitive impairment
261594|NCT02570451|post surgical outcomes|post surgical outcomes
261595|NCT02570451|elective joint replacement surgery|elective joint replacement surgery
261596|NCT02570438|postoperative outcomes|postoperative outcomes
261597|NCT02570438|older surgical patients|older surgical patients
261598|NCT02570386|In-vitro fertilization|in-vitro fertilization
261599|NCT02570386|frozen thawed embryo transfer|frozen thawed embryo transfer
261600|NCT02570386|fresh embryo transfer|fresh embryo transfer
261601|NCT02570373|Healthy|healthy
261602|NCT02570373|Guselkumab|guselkumab
261603|NCT02570347|Snake Envenomation|snake envenomation
261604|NCT02570347|Antibiotic Prophylaxis|antibiotic prophylaxis
261605|NCT02570347|Viperidae|viperidae
261606|NCT02570334|early ART|early art
261607|NCT02570334|neurocognitive evaluation|neurocognitive evaluation
261608|NCT02570321|Cornea|cornea
261609|NCT02570321|Ulcer|ulcer
261610|NCT02570321|Infectious keratitis|infectious keratitis
261611|NCT02570321|Bacterial|bacterial
261612|NCT02570321|Fungal|fungal
261613|NCT02570295|Army|army
261614|NCT02570295|Sport|sport
261615|NCT02570295|Physical Fitness|physical fitness
261616|NCT02570295|Injuries|injuries
261617|NCT02570295|Psychological Tests|psychological tests
261618|NCT02570295|Attrition|attrition
261619|NCT02570282|Female|female
261620|NCT02570256|stroke|stroke
261621|NCT02570256|upper extremity|upper extremity
261622|NCT02570256|motor exploration|motor exploration
261623|NCT02570256|error augmentation|error augmentation
261624|NCT02570256|robotic rehabilitation|robotic rehabilitation
261625|NCT02570243|heparin|heparin
261626|NCT02570243|radial artery|radial artery
261627|NCT02570230|Thoracotomy|thoracotomy
261628|NCT02570230|Postoperative pain|postoperative pain
261629|NCT02570230|Ketamine|ketamine
261630|NCT02570217|NCPAP, High Flow Nasal Cannula, pretem infants, NICU|ncpap, high flow nasal cannula, pretem infants, nicu
261631|NCT02570178|clinical trial|clinical trial
261632|NCT02570178|accidental falls|accidental falls
261633|NCT02570178|postural balance|postural balance
261634|NCT02570178|elderly|elderly
261635|NCT02570178|primary Health Care|primary health care
261636|NCT02570165|efficacy|efficacy
261637|NCT02570165|dry powder inhaler|dry powder inhaler
261638|NCT02570165|vilanterol|vilanterol
261639|NCT02570165|batefenterol|batefenterol
261640|NCT02570152|Dengue|dengue
261641|NCT02570152|Non-laboratory confirmed dengue (non-LCD)|non-laboratory confirmed dengue (non-lcd)
261642|NCT02570152|Acute febrile illness (AFI)|acute febrile illness (afi)
261643|NCT02570152|Laboratory confirmed dengue (LCD)|laboratory confirmed dengue (lcd)
261644|NCT02570126|Immunogenicity|immunogenicity
261645|NCT02570126|Varicella|varicella
261646|NCT02570126|Safety|safety
261647|NCT02570126|Human serum albumin|human serum albumin
261648|NCT02570126|Healthy children|healthy children
261649|NCT02570126|12 to 23 months|12 to 23 months
261650|NCT02570100|Cancer Stem Cells|cancer stem cells
261651|NCT02570087|Coronary ChronicTotal Occlusion|coronary chronictotal occlusion
261652|NCT02570087|Coronary Angioplasty|coronary angioplasty
261653|NCT02570087|Reduced Ejection Fraction|reduced ejection fraction
261654|NCT02570061|recruitment|recruitment
261655|NCT02570061|comprehension|comprehension
261656|NCT02570061|satisfaction|satisfaction
261657|NCT02570061|informed consent|informed consent
261658|NCT02570061|telephone|telephone
261659|NCT02570035|Mirabegron|mirabegron
261660|NCT02570035|Overactive Bladder|overactive bladder
261661|NCT02570035|Cardiovascular Disease|cardiovascular disease
261662|NCT02570022|Pain control|pain control
261663|NCT02570022|liposomal bupivacaine|liposomal bupivacaine
261664|NCT02570022|exparel|exparel
261665|NCT02570022|shoulder arthroplasty|shoulder arthroplasty
261666|NCT02570009|couples|couples
261667|NCT02570009|weight loss treatment|weight loss treatment
261668|NCT02570009|home environment|home environment
261669|NCT02569970|Epilepsy|epilepsy
261670|NCT02569970|SUDEP|sudep
261671|NCT02569970|fluoxetine|fluoxetine
261672|NCT02569970|placebo|placebo
261673|NCT02569970|SpO2|spo2
261674|NCT02569918|Neuroplasticity|neuroplasticity
261675|NCT02569918|Sensory Feedback|sensory feedback
261676|NCT02569918|Transcutaneous electrical stimulation|transcutaneous electrical stimulation
261677|NCT02569918|Robotic hand|robotic hand
261678|NCT02569905|flurbiprofen|flurbiprofen
261679|NCT02569905|Parecoxib sodium|parecoxib sodium
261680|NCT02569905|Postoperative Shivering|postoperative shivering
261681|NCT02569879|Boostrix™|boostrix™
261682|NCT02569879|Bagota|bagota
261683|NCT02569879|maternal vaccination|maternal vaccination
261684|NCT02569879|Pertussis|pertussis
261685|NCT02569879|Mortality|mortality
261686|NCT02569879|Morbidity|morbidity
261687|NCT02569866|plastic surgery|plastic surgery
261688|NCT02569866|mammaplasty|mammaplasty
261689|NCT02569866|wound infection|wound infection
261690|NCT02569866|prophylaxis|prophylaxis
261691|NCT02569827|Uncomplicated Dengue Fever|uncomplicated dengue fever
261692|NCT02569827|Treatment|treatment
261693|NCT02569827|Phase Ib/IIa|phase ib/iia
261694|NCT02569827|single centre|single centre
261695|NCT02569827|double-blind|double-blind
261696|NCT02569827|placebo-controlled|placebo-controlled
261697|NCT02569827|parallel-group dose ranging trial|parallel-group dose ranging trial
261698|NCT02569827|Modipafant|modipafant
261700|NCT02569788|re-irradiation|re-irradiation
261701|NCT02569788|carbon ion radiotherapy|carbon ion radiotherapy
261702|NCT02569775|Cerebral Palsy|cerebral palsy
261703|NCT02569775|Stem Cells|stem cells
261704|NCT02569762|Non-Nutritive Sweeteners|non-nutritive sweeteners
261705|NCT02569762|Artificial Sweeteners|artificial sweeteners
261706|NCT02569762|Glucose Metabolism|glucose metabolism
261707|NCT02569762|Microbiota|microbiota
261708|NCT02569762|Dysbiosis|dysbiosis
261709|NCT02569671|Dental Implants, Single-Tooth|dental implants, single-tooth
261710|NCT02569645|Rectal cancer|rectal cancer
261711|NCT02569645|Rosuvastatin|rosuvastatin
261712|NCT02569632|Meningococcal Vaccines|meningococcal vaccines
261713|NCT02569632|Neisseria Meningitidis|neisseria meningitidis
261714|NCT02569632|Factor H-binding Protein|factor h-binding protein
261715|NCT02569619|Physical Activity|physical activity
261716|NCT02569619|Mental Health|mental health
261717|NCT02569619|Physical Exercise|physical exercise
261718|NCT02569619|Mental disorder|mental disorder
261719|NCT02569619|Promotion|promotion
261720|NCT02569606|consumption of blood|consumption of blood
261721|NCT02569606|consumption of coagulation products|consumption of coagulation products
261722|NCT02569606|coagulation algorithm|coagulation algorithm
261723|NCT02569606|trauma related transfusion|trauma related transfusion
261724|NCT02569580|anti-lice treatment|anti-lice treatment
261725|NCT02569567|Smart-Shear Wave(SSW)|smart-shear wave(ssw)
261726|NCT02569567|Transient Elastography(TE)|transient elastography(te)
261727|NCT02569567|Liver cirrhosis|liver cirrhosis
261728|NCT02569554|PF-06463922|pf-06463922
261729|NCT02569554|rabeprazole|rabeprazole
261730|NCT02569554|proton pump inhibitor (PPI)|proton pump inhibitor (ppi)
261731|NCT02569554|pharmacokinetics(PK)|pharmacokinetics(pk)
261732|NCT02569554|food effect|food effect
261733|NCT02569541|fusidic acid|fusidic acid
261734|NCT02569541|prosthetic joint infections|prosthetic joint infections
261735|NCT02569541|bone infections|bone infections
261736|NCT02569541|osteomyelitis|osteomyelitis
261737|NCT02569528|atrial fibrillation|atrial fibrillation
261738|NCT02569528|anticoagulation|anticoagulation
261739|NCT02569476|BGB-3111|bgb-3111
261740|NCT02569476|Obinutuzumab|obinutuzumab
261741|NCT02569476|B-cell|b-cell
261742|NCT02569476|Lymphoma|lymphoma
261743|NCT02569476|Leukemia|leukemia
261744|NCT02569476|Therapeutic uses|therapeutic uses
261745|NCT02569450|Surgery|surgery
261746|NCT02569450|Performance|performance
261747|NCT02569450|Outcome|outcome
261748|NCT02569450|Control chart|control chart
261749|NCT02569437|doxycycline|doxycycline
261750|NCT02569437|oral methylprednisone|oral methylprednisone
261751|NCT02569437|sinusitis with nasal polyps|sinusitis with nasal polyps
261752|NCT02569424|PEEP level|peep level
261753|NCT02569424|Trendelenburg position|trendelenburg position
261754|NCT02569424|cross-sectional area of the jugular and subclavian veins|cross-sectional area of the jugular and subclavian veins
261755|NCT02569424|central venous catheter|central venous catheter
261756|NCT02569398|Alzheimer disease|alzheimer disease
261757|NCT02569398|Atabecestat|atabecestat
261758|NCT02569398|Dementia|dementia
261759|NCT02569385|Weaning TTE|weaning tte
261760|NCT02569385|patients in prolonged weaning|patients in prolonged weaning
261761|NCT02569346|Triumeq|triumeq
261762|NCT02569346|Pharmacokinetics|pharmacokinetics
261763|NCT02569346|Crushing|crushing
261764|NCT02569346|Drip feed|drip feed
261765|NCT02569333|ulcerative colitis|ulcerative colitis
261766|NCT02569333|inflammatory bowel disease|inflammatory bowel disease
261767|NCT02569333|education|education
261768|NCT02569333|patient-reported outcomes|patient-reported outcomes
261769|NCT02569307|At Risk of Mental State|at risk of mental state
261770|NCT02569307|Prodromal Phase|prodromal phase
261771|NCT02569307|Psychosis|psychosis
261772|NCT02569294|group interventions|group interventions
261773|NCT02569294|emotional distress|emotional distress
261774|NCT02569294|breast cancer|breast cancer
261775|NCT02569294|yoga|yoga
261776|NCT02569294|hypnosis|hypnosis
261777|NCT02569294|cognitive-behavioral therapy|cognitive-behavioral therapy
261778|NCT02569281|Subacromial pain syndrome|subacromial pain syndrome
261779|NCT02569281|Eccentric exercise|eccentric exercise
261780|NCT02569281|Pressure pain|pressure pain
261781|NCT02569281|US-guided percutaneous electrolysis|us-guided percutaneous electrolysis
261782|NCT02569268|Arteriosclerosis|arteriosclerosis
261783|NCT02569268|Vascular function|vascular function
261784|NCT02569268|Vascular disease early detection system|vascular disease early detection system
261785|NCT02569229|children|children
261786|NCT02569229|cystic fibrosis|cystic fibrosis
261787|NCT02569229|glucose intolerance|glucose intolerance
261788|NCT02569229|continuous glucose measurement|continuous glucose measurement
261789|NCT02569216|Electrical Inhibition|electrical inhibition
261790|NCT02569216|Preterm Birth|preterm birth
261791|NCT02569216|Premature Birth|premature birth
261792|NCT02569216|Preterm Labor|preterm labor
261793|NCT02569216|Premature Labor|premature labor
261794|NCT02569216|tocolytic|tocolytic
261795|NCT02569216|uterus|uterus
261796|NCT02569177|myocardial infarction|myocardial infarction
261797|NCT02569177|cardiac surgery|cardiac surgery
261798|NCT02569177|troponin|troponin
261799|NCT02569177|heart-type fatty acid binding protein|heart-type fatty acid binding protein
261800|NCT02569138|Balance|balance
261801|NCT02569138|Footwear|footwear
261802|NCT02569138|Shoes|shoes
261803|NCT02569138|Falls|falls
261804|NCT02569125|segmental overgrowth syndrome|segmental overgrowth syndrome
261805|NCT02569099|stroke survivors|stroke survivors
261806|NCT02569099|caregivers|caregivers
261807|NCT02569099|burden of care|burden of care
261808|NCT02569099|quality of life|quality of life
261809|NCT02569099|function|function
261810|NCT02569099|community reintegration|community reintegration
261811|NCT02569099|caregiver training|caregiver training
261812|NCT02569086|Sepsis|sepsis
261813|NCT02569086|Therapeutic Drug Monitoring|therapeutic drug monitoring
261814|NCT02569086|Beta-lactams|beta-lactams
261815|NCT02569086|Pharmacokinetics|pharmacokinetics
261816|NCT02569073|Functional Chest Pain|functional chest pain
261817|NCT02569073|Non-Cardiac Chest Pain|non-cardiac chest pain
261818|NCT02569073|Esophageal Hypersensitivity|esophageal hypersensitivity
261819|NCT02569060|diabetes mellitus|diabetes mellitus
261820|NCT02569060|community intervention|community intervention
261821|NCT02569060|intervention|intervention
261822|NCT02569060|randomized|randomized
261823|NCT02569060|dietary intervention|dietary intervention
261824|NCT02569060|self-management support|self-management support
261825|NCT02569060|food bank|food bank
261826|NCT02569047|Atraumatic Restorative Treatment|atraumatic restorative treatment
261827|NCT02569047|Occlusoproximal|occlusoproximal
261828|NCT02569047|Primary Teeth|primary teeth
261829|NCT02569047|Glass Ionomer Cements|glass ionomer cements
261830|NCT02569047|Hall Technique|hall technique
261831|NCT02569021|Parkinsons Disease|parkinsons disease
261832|NCT02569021|Essential Tremor|essential tremor
261833|NCT02569021|DBS|dbs
261834|NCT02569021|Depp Brain Stimulation|depp brain stimulation
261835|NCT02569008|Fluid Challenge|fluid challenge
261836|NCT02569008|Mean systemic filling pressure|mean systemic filling pressure
261837|NCT02569008|Fluid therapy|fluid therapy
261838|NCT02568995|postoperative pain|postoperative pain
261839|NCT02568995|morphine|morphine
261840|NCT02568995|total hip arthroplasty|total hip arthroplasty
261841|NCT02568995|femoral nerve block|femoral nerve block
261842|NCT02568982|Cushing's disease|cushing's disease
261843|NCT02568982|Quality of life|quality of life
261844|NCT02568982|Metabolic|metabolic
261845|NCT02568982|patients with Cushing's disease|patients with cushing's disease
261846|NCT02568982|cardiovascular|cardiovascular
261847|NCT02568982|thromboembolic|thromboembolic
261848|NCT02568982|bone complications|bone complications
261849|NCT02568969|Cardiosurgery, lactate|cardiosurgery, lactate
261850|NCT02568943|multiple myelome, MM, expanded treatment, panobinostat, bortezomib, dexamethasone, relapsed, refractory, LBH589|multiple myelome, mm, expanded treatment, panobinostat, bortezomib, dexamethasone, relapsed, refractory, lbh589
261851|NCT02568930|quality of life heart failure mechanical support transplant|quality of life heart failure mechanical support transplant
261852|NCT02568917|Dental Atraumatic Restorative Treatment|dental atraumatic restorative treatment
261853|NCT02568917|Composite Resins|composite resins
261854|NCT02568917|Primary Teeth|primary teeth
261855|NCT02568917|Permanent Teeth|permanent teeth
261856|NCT02568917|Clinical Effectiveness|clinical effectiveness
261857|NCT02568917|Cost Analysis|cost analysis
261858|NCT02568878|Depression|depression
261859|NCT02568878|Anxiety|anxiety
261860|NCT02568878|Methamphetamine dependence|methamphetamine dependence
261861|NCT02568852|D-dimer|d-dimer
261862|NCT02568852|Fibrinogen|fibrinogen
261863|NCT02568852|Laparoscopic cholecystectomy|laparoscopic cholecystectomy
261864|NCT02568839|Neoadjuvant therapy|neoadjuvant therapy
261865|NCT02568826|Low Back Pain|low back pain
261866|NCT02568826|Muscle relaxant|muscle relaxant
261867|NCT02568813|epilepsy|epilepsy
261868|NCT02568813|depression|depression
261869|NCT02568813|mood disorder|mood disorder
261870|NCT02568813|anxiety|anxiety
261871|NCT02568813|cyclothymia|cyclothymia
261872|NCT02568813|Behavioral neuropsychiatric features|behavioral neuropsychiatric features
261873|NCT02568787|NAFLD|nafld
261874|NCT02568787|cytokines|cytokines
261875|NCT02568787|interleukin (IL)|interleukin (il)
261876|NCT02568787|interferon (IFN)|interferon (ifn)
261877|NCT02568787|liver function test (LFTS)|liver function test (lfts)
261878|NCT02568787|nutrition|nutrition
261879|NCT02568787|bran arabinoxylan compound (RBAC)|bran arabinoxylan compound (rbac)
261880|NCT02568787|tumor necrosis factor -- type I receptor (TNF-RI)|tumor necrosis factor -- type i receptor (tnf-ri)
261881|NCT02568787|TNF-RII (tumor necrosis factor -- type II receptor (TNF-RII)|tnf-rii (tumor necrosis factor -- type ii receptor (tnf-rii)
261882|NCT02568774|Post-stroke|post-stroke
261883|NCT02568761|Snoring|snoring
261884|NCT02568761|Sleep apnea|sleep apnea
261885|NCT02568761|Obstructive sleep apnea|obstructive sleep apnea
261886|NCT02568761|Speech therapy|speech therapy
261887|NCT02568761|Injection snoreplasty|injection snoreplasty
261888|NCT02568761|Ethanol|ethanol
261889|NCT02568761|Oropharyngeal exercises|oropharyngeal exercises
261890|NCT02568735|Dexketoprofen|dexketoprofen
261891|NCT02568735|Etoricoxib|etoricoxib
261892|NCT02568735|hip arthroplasty|hip arthroplasty
261893|NCT02568735|pain|pain
261894|NCT02568722|Renal replacement therapy|renal replacement therapy
261895|NCT02568722|Acute kidney injury|acute kidney injury
261896|NCT02568722|Dialysis|dialysis
261897|NCT02568722|Hemodialysis|hemodialysis
261898|NCT02568722|Critical illness|critical illness
261899|NCT02568709|Oxytocin|oxytocin
261900|NCT02568709|Syntocinon|syntocinon
261901|NCT02568709|Social Cognition|social cognition
261902|NCT02568709|Schizophrenia|schizophrenia
261903|NCT02568709|Magnetoencephalography (MEG)|magnetoencephalography (meg)
261904|NCT02568696|kidney transplantation|kidney transplantation
261905|NCT02568696|renal transplantation|renal transplantation
261906|NCT02568696|fibrinolysis|fibrinolysis
261907|NCT02568696|cell mediated rejection|cell mediated rejection
261908|NCT02568696|coagulation|coagulation
261909|NCT02568696|delayed graft function|delayed graft function
261910|NCT02568696|Halloran criteria|halloran criteria
261911|NCT02568696|graft rejection|graft rejection
261912|NCT02568696|thrombin generation|thrombin generation
261913|NCT02568696|fibrin generation|fibrin generation
261914|NCT02568683|DLBCL|dlbcl
261915|NCT02568683|Relapsed|relapsed
261916|NCT02568683|Refractory|refractory
261917|NCT02568644|Migraine|migraine
261918|NCT02568644|Ginger|ginger
261919|NCT02568644|Acute treatment|acute treatment
261920|NCT02568631|Autistic Disorder|autistic disorder
261921|NCT02568618|Military|military
261922|NCT02568618|Genomics|genomics
261923|NCT02568618|Pain|pain
261924|NCT02568605|Dietary intervention|dietary intervention
261925|NCT02568605|Prebiotic fibre|prebiotic fibre
261926|NCT02568605|Weight loss|weight loss
261927|NCT02568605|Gut microbiota|gut microbiota
261928|NCT02568605|Obesity|obesity
261929|NCT02568605|Liver fat|liver fat
261930|NCT02568605|Hepatic fibrosis|hepatic fibrosis
261931|NCT02568540|Hepatitis C|hepatitis c
261932|NCT02568540|Smartphone|smartphone
261933|NCT02568540|app|app
261934|NCT02568540|Tracker|tracker
261935|NCT02568540|C Tracker|c tracker
261936|NCT02568527|LSCD|lscd
261937|NCT02568527|SLET|slet
261938|NCT02568527|Donor Human Amniotic Membrane (hAM)|donor human amniotic membrane (ham)
261939|NCT02568527|PLGA|plga
261940|NCT02568514|mhealth|mhealth
261941|NCT02568514|text messaging|text messaging
261942|NCT02568514|secure text messaging|secure text messaging
261943|NCT02568514|communication|communication
261944|NCT02568501|diabetes|diabetes
261945|NCT02568501|adolescent|adolescent
261946|NCT02568501|young adult|young adult
261947|NCT02568501|behavioral economics|behavioral economics
261948|NCT02568501|financial incentives|financial incentives
261949|NCT02568501|social incentives|social incentives
261950|NCT02568475|nursing home residents, decision aid, acute care transfers|nursing home residents, decision aid, acute care transfers
261951|NCT02568462|Stents|stents
261952|NCT02568462|Angioplasty|angioplasty
261953|NCT02568462|Coronary Vessels|coronary vessels
261954|NCT02568462|Coronary Artery Disease|coronary artery disease
261955|NCT02568462|Angina Pectoris|angina pectoris
261956|NCT02568462|Myocardial Ischemia|myocardial ischemia
261957|NCT02568462|Myocardial Infarction|myocardial infarction
261958|NCT02568462|Myocardial Revascularization|myocardial revascularization
261959|NCT02568410|Mast Cells|mast cells
261960|NCT02568410|Blood Platelets|blood platelets
261961|NCT02568410|cardiac surgical procedures|cardiac surgical procedures
261962|NCT02568371|biobank|biobank
261963|NCT02568371|DNA|dna
261964|NCT02568371|genetic|genetic
261965|NCT02568371|young adults|young adults
261966|NCT02568371|cohort study|cohort study
261967|NCT02568345|Dose-Response Relationship|dose-response relationship
261968|NCT02568345|Drug|drug
261969|NCT02568345|Obesity|obesity
261970|NCT02568345|Cyclodextrins|cyclodextrins
261971|NCT02568267|Entrectinib|entrectinib
261972|NCT02568267|RXDX-101|rxdx-101
261973|NCT02568267|TrkA|trka
261974|NCT02568267|TrkB|trkb
261975|NCT02568267|TrkC|trkc
261976|NCT02568267|NTRK1|ntrk1
261977|NCT02568267|NTRK2|ntrk2
261978|NCT02568267|NTRK3|ntrk3
261979|NCT02568267|ROS1|ros1
261980|NCT02568267|ALK|alk
261981|NCT02568267|Trk Fusions|trk fusions
261982|NCT02568267|NTRK Gene Rearrangements|ntrk gene rearrangements
261983|NCT02568267|ROS1 Fusions|ros1 fusions
261984|NCT02568267|ROS1 Gene Rearrangements|ros1 gene rearrangements
261985|NCT02568267|ALK Fusions|alk fusions
261986|NCT02568267|ALK Gene Rearrangements|alk gene rearrangements
261987|NCT02568267|Basket study|basket study
261988|NCT02568267|Non-small cell lung cancer|non-small cell lung cancer
261989|NCT02568267|Colorectal cancer|colorectal cancer
261990|NCT02568267|Salivary gland cancers|salivary gland cancers
261991|NCT02568267|Primary brain tumors|primary brain tumors
261992|NCT02568267|Melanoma|melanoma
261993|NCT02568267|Sarcomas|sarcomas
261994|NCT02568267|Papillary thyroid cancer|papillary thyroid cancer
261995|NCT02568267|Renal cell cancer|renal cell cancer
261996|NCT02568267|Pancreatic cancer|pancreatic cancer
261997|NCT02568267|Breast cancer|breast cancer
261998|NCT02568267|Cholangiocarcinoma|cholangiocarcinoma
261999|NCT02568267|Head & Neck cancers|head & neck cancers
262000|NCT02568267|Ovarian cancer|ovarian cancer
262001|NCT02568267|Neuroendocrine tumors|neuroendocrine tumors
262002|NCT02568267|Anaplastic Large Cell Lymphoma|anaplastic large cell lymphoma
262003|NCT02568241|Interferon Alfa-2b|interferon alfa-2b
262004|NCT02568241|Relapse|relapse
262005|NCT02568241|Donor lymphocyte infusion|donor lymphocyte infusion
262006|NCT02568228|Triacylglycerols|triacylglycerols
262007|NCT02568228|Omega-3 fatty acids|omega-3 fatty acids
262008|NCT02568228|Krill oil|krill oil
262009|NCT02568228|Fish|fish
262010|NCT02568228|Healthy Volunteers|healthy volunteers
262011|NCT02568215|HIV-1 Infections|hiv-1 infections
262012|NCT02568189|Sepsis|sepsis
262013|NCT02568189|Gastroenteritis|gastroenteritis
262014|NCT02568189|Dehydration|dehydration
262015|NCT02568189|Ultrasound|ultrasound
262016|NCT02568189|Ultrasonography|ultrasonography
262017|NCT02568189|Inferior Vena Cava|inferior vena cava
262018|NCT02568176|Healthy|healthy
262019|NCT02568176|Pharmacokinetics|pharmacokinetics
262020|NCT02568176|Esketamine|esketamine
262021|NCT02568176|JNJ-54135419|jnj-54135419
262022|NCT02568176|Midazolam|midazolam
262023|NCT02568176|Bupropion|bupropion
262024|NCT02568137|mobile health|mobile health
262025|NCT02568137|Behavior change|behavior change
262026|NCT02568137|Africa|africa
262027|NCT02568124|Tranexamic acid|tranexamic acid
262028|NCT02568124|Cyklokapron|cyklokapron
262029|NCT02568124|Conservative management|conservative management
262030|NCT02568124|Medical management|medical management
262031|NCT02568111|erythema|erythema
262032|NCT02568111|PLEGRIDY|plegridy
262033|NCT02568111|injection site reaction (ISR)|injection site reaction (isr)
262034|NCT02568111|MS|ms
262035|NCT02568111|RRMS|rrms
262036|NCT02568098|Drug combination|drug combination
262037|NCT02568098|Ivermectin|ivermectin
262038|NCT02568098|Primaquine|primaquine
262039|NCT02568098|Dihydroartemisinin-Piperaquine|dihydroartemisinin-piperaquine
262040|NCT02568098|Albendazole|albendazole
262041|NCT02568098|Pharmacokinetics|pharmacokinetics
262042|NCT02568098|Mosquito-Lethal Effect|mosquito-lethal effect
262043|NCT02568098|Healthy adult subject|healthy adult subject
262044|NCT02568072|exercise|exercise
262045|NCT02568072|cardiac remodelling|cardiac remodelling
262046|NCT02568072|left ventricular non-compaction cardiomyopathy|left ventricular non-compaction cardiomyopathy
262047|NCT02568046|Metastatic Colorectal Cancer|metastatic colorectal cancer
262048|NCT02567981|chronic undernutrition|chronic undernutrition
262049|NCT02567981|anemia|anemia
262050|NCT02567981|micronutrient supplement|micronutrient supplement
262051|NCT02567955|HPV vaccines, interchangeable use|hpv vaccines, interchangeable use
262052|NCT02567877|hypothyroidism|hypothyroidism
262053|NCT02567877|deiodinase polymorphism|deiodinase polymorphism
262054|NCT02567877|cognitive function|cognitive function
262055|NCT02567877|thyroidectomy|thyroidectomy
262056|NCT02567877|levothyroxine|levothyroxine
262057|NCT02567851|Brentuximab Vedotin|brentuximab vedotin
262058|NCT02567851|PET scans|pet scans
262059|NCT02567851|Lymphoma|lymphoma
262060|NCT02567825|ear infection|ear infection
262061|NCT02567825|antibiotics|antibiotics
262062|NCT02567825|infants|infants
262063|NCT02567825|children|children
262064|NCT02567825|pediatrics|pediatrics
262065|NCT02567825|tympanostomy tubes|tympanostomy tubes
262066|NCT02567799|Lung Neoplasms|lung neoplasms
262067|NCT02567773|Itraconazole|itraconazole
262068|NCT02567773|GSK2881078|gsk2881078
262069|NCT02567773|CYP3A4|cyp3a4
262070|NCT02567773|Selective Androgen Receptor Modulator|selective androgen receptor modulator
262071|NCT02567773|Safety|safety
262072|NCT02567773|Pharmacokinetics|pharmacokinetics
262073|NCT02567773|Tolerability|tolerability
262074|NCT02567760|MP1|mp1
262075|NCT02567760|cognitive enhancing effect|cognitive enhancing effect
262076|NCT02567760|menopausal women|menopausal women
262077|NCT02567747|Colombia|colombia
262078|NCT02567747|otitis|otitis
262079|NCT02567747|Database|database
262080|NCT02567747|pneumonia|pneumonia
262081|NCT02567734|irreversible electroporation|irreversible electroporation
262082|NCT02567734|ablation|ablation
262083|NCT02567734|neoplasms|neoplasms
262084|NCT02567734|cancer|cancer
262085|NCT02567734|carcinoma|carcinoma
262086|NCT02567734|NanoKnife|nanoknife
262087|NCT02567734|Ablation Techniques|ablation techniques
262088|NCT02567721|Post-authorisation safety study (PASS)|post-authorisation safety study (pass)
262089|NCT02567721|Adverse Drug Reaction Reporting Systems|adverse drug reaction reporting systems
262090|NCT02567721|Post marketing product surveillance|post marketing product surveillance
262091|NCT02567721|European Medicines Agency (EMA)|european medicines agency (ema)
262092|NCT02567721|Influenza Vaccine|influenza vaccine
262093|NCT02567721|Computerized Medical Record System|computerized medical record system
262094|NCT02567721|United Kingdom|united kingdom
262095|NCT02567721|Primary Health Care|primary health care
262096|NCT02567708|GSK2269557|gsk2269557
262097|NCT02567708|Asthma|asthma
262098|NCT02567708|Pharmacokinetics|pharmacokinetics
262099|NCT02567708|Safety|safety
262100|NCT02567708|Adults|adults
262101|NCT02567708|DISKUS Dry Powder Inhaler|diskus dry powder inhaler
262103|NCT02567682|anemia, sickle cell|anemia, sickle cell
262104|NCT02567669|radiotherapy|radiotherapy
262105|NCT02567656|CTCL|ctcl
262106|NCT02567656|PTCL|ptcl
262107|NCT02567656|RP6530|rp6530
262108|NCT02567643|Brain|brain
262109|NCT02567643|CNS|cns
262110|NCT02567643|Metastases|metastases
262111|NCT02567617|Polyphenols, Prostaglandin E2, hormonal contraceptives|polyphenols, prostaglandin e2, hormonal contraceptives
262112|NCT02567591|pre liver transplantation patients|pre liver transplantation patients
262113|NCT02567552|endometrial receptivity|endometrial receptivity
262114|NCT02567552|endometrial predecidualization|endometrial predecidualization
262115|NCT02567552|endometrial genomics|endometrial genomics
262116|NCT02567552|endometrial receptivity array|endometrial receptivity array
262117|NCT02567526|food and fluid intake|food and fluid intake
262118|NCT02567526|nursing home residents|nursing home residents
262119|NCT02567526|staffing|staffing
262120|NCT02567513|food and fluid intake|food and fluid intake
262121|NCT02567513|nursing homes|nursing homes
262122|NCT02567500|emotional|emotional
262123|NCT02567500|auditory hallucinations|auditory hallucinations
262124|NCT02567500|non-psychotic children|non-psychotic children
262125|NCT02567474|chronic lung disease|chronic lung disease
262126|NCT02567461|dual antiplatelet therapy|dual antiplatelet therapy
262127|NCT02567461|clopidogrel|clopidogrel
262128|NCT02567461|aspirin|aspirin
262129|NCT02567461|edoxaban|edoxaban
738243|NCT00480974|Hydroxyurea|hydroxyurea
262130|NCT02567448|Obstructive Sleep Apnea|obstructive sleep apnea
262131|NCT02567448|Chronic Obstructive Pulmonary Disease|chronic obstructive pulmonary disease
262132|NCT02567448|Overlap syndrome|overlap syndrome
262133|NCT02567448|Pcrit|pcrit
262134|NCT02567448|Critical closing pressure|critical closing pressure
262135|NCT02567383|head and neck cancer|head and neck cancer
262136|NCT02567383|hyperthermia, Thermotron RF-8|hyperthermia, thermotron rf-8
262137|NCT02567383|radiotherapy|radiotherapy
262138|NCT02567370|Schizophrenia or Schizoaffective Disorder|schizophrenia or schizoaffective disorder
262139|NCT02567357|change triggered temper outbursts|change triggered temper outbursts
262140|NCT02567357|parent training|parent training
262141|NCT02567357|autism|autism
262142|NCT02567357|intellectual disability|intellectual disability
262143|NCT02567357|Prader-Willi syndrome|prader-willi syndrome
262144|NCT02567357|Fragile X syndrome|fragile x syndrome
262145|NCT02567357|web-based training|web-based training
262146|NCT02567357|Down syndrome|down syndrome
262147|NCT02567344|Cannabis|cannabis
262148|NCT02567344|rTMS|rtms
262149|NCT02567344|Craving|craving
262150|NCT02567344|Decision making|decision making
262151|NCT02567318|Pain|pain
262152|NCT02567318|Secondary hyperalgesia|secondary hyperalgesia
262153|NCT02567318|Healthy volunteers|healthy volunteers
262154|NCT02567318|Magnetic Resonance Imaging|magnetic resonance imaging
262155|NCT02567292|Digestive Disease and Disorders|digestive disease and disorders
262156|NCT02567292|Neonatal|neonatal
262157|NCT02567292|Pediatric Disorders|pediatric disorders
262158|NCT02567253|Cytoreductive surgery|cytoreductive surgery
262159|NCT02567253|(H)ipec|(h)ipec
262160|NCT02567253|Ovarian cancer|ovarian cancer
262161|NCT02567253|Cisplatin|cisplatin
262162|NCT02567253|Peritoneal carcinomatosis|peritoneal carcinomatosis
262163|NCT02567253|Pharmacokinetics|pharmacokinetics
262164|NCT02567253|Pharmacodynamics|pharmacodynamics
262165|NCT02567214|dyspnea|dyspnea
262166|NCT02567214|exercise|exercise
262167|NCT02567214|shuttle test|shuttle test
262168|NCT02567214|long-acting β2-agonists|long-acting β2-agonists
262169|NCT02567214|longacting muscarinic antagonist|longacting muscarinic antagonist
262170|NCT02567214|indacaterol|indacaterol
262171|NCT02567214|glycopyrronium|glycopyrronium
262172|NCT02567214|tiotropium|tiotropium
262173|NCT02567201|Voluntary attention|voluntary attention
262174|NCT02567201|Electroencephalogram|electroencephalogram
262175|NCT02567201|Brain-computer interface|brain-computer interface
262176|NCT02567201|Disorders of consciousness|disorders of consciousness
262177|NCT02567162|Intracerebral hemorrhage|intracerebral hemorrhage
262178|NCT02567162|Hemorrhagic stroke|hemorrhagic stroke
262179|NCT02567162|Intraparenchymal hemorrhage|intraparenchymal hemorrhage
262180|NCT02567162|Cerebrovascular disease|cerebrovascular disease
262181|NCT02567162|Stroke|stroke
262182|NCT02567149|Wart|wart
262183|NCT02567110|Mid-life Depression|mid-life depression
262184|NCT02567110|Bipolar Disorder|bipolar disorder
262185|NCT02567110|DSM-5 MDE|dsm-5 mde
262186|NCT02567110|Inflammation|inflammation
262187|NCT02567110|CNS Glutamate|cns glutamate
262188|NCT02567084|Bone substitute|bone substitute
262189|NCT02567084|benign bone cyst|benign bone cyst
262190|NCT02567084|ceramic|ceramic
262191|NCT02567084|remodelling|remodelling
262192|NCT02567071|C-section|c-section
262193|NCT02567071|Microbiota|microbiota
262194|NCT02567058|Achilles tendon|achilles tendon
262195|NCT02567045|Immunochemical fecal occult blood test|immunochemical fecal occult blood test
262196|NCT02567045|Colonoscopy|colonoscopy
262197|NCT02567045|Screening uptake|screening uptake
262198|NCT02567045|Screening participation|screening participation
262199|NCT02567045|Familiar risk|familiar risk
262200|NCT02567045|Colorectal Cancer|colorectal cancer
262202|NCT02567032|Syntocinon|syntocinon
262203|NCT02567032|Social Cognition|social cognition
262204|NCT02567032|Schizophrenia|schizophrenia
262205|NCT02567032|Psychosis|psychosis
262206|NCT02567032|Schizoaffective Disorder|schizoaffective disorder
262207|NCT02567032|Schizophreniform Disorder|schizophreniform disorder
262208|NCT02567032|Psychotic Disorders|psychotic disorders
262209|NCT02567006|vaccines|vaccines
262210|NCT02567006|reminders|reminders
262211|NCT02567006|immunization timeliness|immunization timeliness
262212|NCT02567006|vaccine coverage|vaccine coverage
262213|NCT02566980|depression|depression
262214|NCT02566980|mood disorder|mood disorder
262215|NCT02566980|post-partum depression|post-partum depression
262216|NCT02566980|suicidality|suicidality
262217|NCT02566980|post-partum suicidality|post-partum suicidality
262218|NCT02566980|perinatal depression|perinatal depression
262219|NCT02566980|perinatal mood disorder|perinatal mood disorder
262220|NCT02566980|inflammation|inflammation
262221|NCT02566980|kynurenine pathway|kynurenine pathway
262222|NCT02566980|glutamate|glutamate
262223|NCT02566954|radiology|radiology
262224|NCT02566954|3D measurement|3d measurement
262225|NCT02566954|lower limb|lower limb
262226|NCT02566941|critical illness polyneuropathy|critical illness polyneuropathy
262227|NCT02566941|critical illness myopathy|critical illness myopathy
335213|NCT02163616|PPH|pph
262228|NCT02566941|neuromuscular electrical stimulation|neuromuscular electrical stimulation
262229|NCT02566941|intensive care unit acquired weakness|intensive care unit acquired weakness
262230|NCT02566941|prevention of critical illness polyneuropathy|prevention of critical illness polyneuropathy
262231|NCT02566928|Methicillin-Resistant Staphylococcus aureus|methicillin-resistant staphylococcus aureus
262232|NCT02566928|Recurrence|recurrence
262233|NCT02566928|Practice Based Research Network|practice based research network
262234|NCT02566928|Community Health Workers/Promotoras|community health workers/promotoras
262235|NCT02566928|Decolonization and Decontamination|decolonization and decontamination
262236|NCT02566928|Staphylococcal Skin Infections|staphylococcal skin infections
262237|NCT02566928|Household Transmission|household transmission
262238|NCT02566889|Pediatric Inflammatory Bowel Disease|pediatric inflammatory bowel disease
262239|NCT02566889|Infliximab|infliximab
262240|NCT02566889|Pediatric Participants|pediatric participants
262241|NCT02566889|Pediatric Ulcerative Colitis|pediatric ulcerative colitis
262242|NCT02566889|Pediatric Crohn's Disease|pediatric crohn's disease
262243|NCT02566889|Dose Escalation|dose escalation
262244|NCT02566876|Children|children
262245|NCT02566876|Abdominal Pain|abdominal pain
262246|NCT02566876|Functional Dyspepsia|functional dyspepsia
262247|NCT02566876|Irritable Bowel Syndrome|irritable bowel syndrome
262248|NCT02566876|Quality of Life|quality of life
262249|NCT02566863|dexmedetomidine|dexmedetomidine
262250|NCT02566863|heart rate|heart rate
262251|NCT02566863|heart rate variability|heart rate variability
262252|NCT02566837|ultrasound|ultrasound
262253|NCT02566837|Electrical stimulation guidance|electrical stimulation guidance
262254|NCT02566837|botulinum toxin|botulinum toxin
262255|NCT02566772|Prostate Cancer|prostate cancer
262256|NCT02566759|Drug therapy|drug therapy
262257|NCT02566733|remifentanil|remifentanil
262258|NCT02566720|amantadine|amantadine
262259|NCT02566720|tractography|tractography
262260|NCT02566720|mri|mri
262261|NCT02566720|coma|coma
262262|NCT02566720|abi|abi
262263|NCT02566720|tbi|tbi
262264|NCT02566720|traumatic brain injury|traumatic brain injury
262265|NCT02566720|acquired brain injury|acquired brain injury
262266|NCT02566668|Asthma|asthma
262267|NCT02566668|Severe Asthma|severe asthma
262268|NCT02566668|IL-10|il-10
262269|NCT02566668|IL-27|il-27
262270|NCT02566668|IL-13|il-13
262271|NCT02566668|Epithelial Cells|epithelial cells
262272|NCT02566668|T lymphocytes|t lymphocytes
262273|NCT02566668|Interferon-g|interferon-g
262274|NCT02566629|microbiota community|microbiota community
262275|NCT02566629|IBS|ibs
262276|NCT02566603|ITP|itp
262277|NCT02566603|Thrombocytopenia|thrombocytopenia
262278|NCT02566577|Chronic anemia|chronic anemia
262279|NCT02566577|Cardiopulmonary testing|cardiopulmonary testing
262280|NCT02566577|Transfusion-dependent anemia|transfusion-dependent anemia
262281|NCT02566551|Prostatic artery embolization|prostatic artery embolization
262282|NCT02566551|Transurethral resection of the prostate|transurethral resection of the prostate
262283|NCT02566538|Cohort study|cohort study
262284|NCT02566538|psychometric tests|psychometric tests
262285|NCT02566538|cognitive function|cognitive function
262286|NCT02566538|cardiovascular risk|cardiovascular risk
262287|NCT02566538|prediction algorithm|prediction algorithm
262288|NCT02566525|CytoSorb device|cytosorb device
262289|NCT02566525|Plasma free hemoglobin|plasma free hemoglobin
262290|NCT02566525|inflammation|inflammation
262291|NCT02566525|extracorporeal bypass|extracorporeal bypass
262292|NCT02566512|Tracheostomy|tracheostomy
262293|NCT02566512|weaning|weaning
262294|NCT02566512|respiratory failure|respiratory failure
262295|NCT02566512|cough strength|cough strength
262296|NCT02566499|Medical imaging|medical imaging
262297|NCT02566499|Microwaves|microwaves
262298|NCT02566473|Patient reported outcomes|patient reported outcomes
262299|NCT02566473|Osteoarthritis|osteoarthritis
262300|NCT02566473|Total joint replacement|total joint replacement
262301|NCT02566460|Lactate clearance|lactate clearance
262302|NCT02566460|systemic central venous oxygen saturation|systemic central venous oxygen saturation
262303|NCT02566460|septic shock|septic shock
262304|NCT02566460|haemodynamic therapy|haemodynamic therapy
262305|NCT02566434|Dietary Supplements|dietary supplements
262306|NCT02566395|Stem Cell Transplantation|stem cell transplantation
262307|NCT02566395|Haploidentical Donors|haploidentical donors
262308|NCT02566369|Efficacy|efficacy
262309|NCT02566369|Safety|safety
262310|NCT02566369|Acne vulgaris|acne vulgaris
262311|NCT02566356|Oxytocin|oxytocin
262312|NCT02566356|Syntocinon|syntocinon
262313|NCT02566356|Social Cognition|social cognition
262314|NCT02566356|Schizophrenia|schizophrenia
262315|NCT02566356|Functional Magnetic Resonance Imaging (fMRI)|functional magnetic resonance imaging (fmri)
262316|NCT02566343|Spirometry|spirometry
262317|NCT02566343|Exercise Test|exercise test
262318|NCT02566343|Blood Gas Analysis|blood gas analysis
262319|NCT02566343|Respiratory Function Tests|respiratory function tests
712530|NCT00579813|inflammation|inflammation
262320|NCT02566343|Diagnostic Techniques, Respiratory System|diagnostic techniques, respiratory system
262321|NCT02566343|Surgical Procedures, Operative|surgical procedures, operative
262322|NCT02566330|EndoBarrier|endobarrier
262323|NCT02566330|Duodenojejunal Bypass Liner|duodenojejunal bypass liner
262324|NCT02566291|laryngeal mask|laryngeal mask
262325|NCT02566291|airway leakage|airway leakage
262326|NCT02566291|airway morbidity|airway morbidity
262327|NCT02566278|Obstructive Sleep Apnea|obstructive sleep apnea
262328|NCT02566278|Pcrit|pcrit
262329|NCT02566278|Upper airway collapsibility|upper airway collapsibility
262330|NCT02566265|influenza|influenza
262331|NCT02566265|multiple myeloma|multiple myeloma
262332|NCT02566265|Waldenstrom's macroglobulinemia|waldenstrom's macroglobulinemia
262333|NCT02566252|Safety|safety
262334|NCT02566252|tolerability|tolerability
262335|NCT02566239|aging|aging
262336|NCT02566239|ORCATECH|orcatech
262337|NCT02566239|Oregon Center for Aging & Technology|oregon center for aging & technology
262338|NCT02566239|Life Lab|life lab
262339|NCT02566239|Living Lab|living lab
262340|NCT02566239|in-home assessment|in-home assessment
262341|NCT02566239|technology and aging|technology and aging
262342|NCT02566213|volunteers|volunteers
262343|NCT02566200|Acute coronary syndrome|acute coronary syndrome
262344|NCT02566200|Cardiology|cardiology
262345|NCT02566174|Cancer Caregivers|cancer caregivers
262346|NCT02566174|Cancer Patients|cancer patients
262347|NCT02566174|Role Adjustment|role adjustment
262348|NCT02566174|Mutuality|mutuality
262349|NCT02566174|Well-Being|well-being
262350|NCT02566161|Genetics|genetics
262351|NCT02566161|Genomics|genomics
262352|NCT02566148|Life-event survey|life-event survey
262353|NCT02566148|observational survey among migrants in France|observational survey among migrants in france
262354|NCT02566135|C-LMA|c-lma
262355|NCT02566135|I-gel|i-gel
262356|NCT02566135|ventilating bougie|ventilating bougie
262357|NCT02566135|intubation|intubation
262358|NCT02566096|major abdominal cancer|major abdominal cancer
262359|NCT02566070|Enteral feeding|enteral feeding
262360|NCT02566070|Continuous gastric feeding|continuous gastric feeding
262361|NCT02566070|Bolus gastric feeding|bolus gastric feeding
262362|NCT02566044|Cystic Fibrosis|cystic fibrosis
262363|NCT02566031|COPD|copd
262364|NCT02566031|open-label|open-label
262365|NCT02566031|QVA149|qva149
262366|NCT02566031|symptomatic|symptomatic
262367|NCT02566031|tiotropium|tiotropium
262368|NCT02566018|elderly|elderly
262369|NCT02566005|Misoprostol|misoprostol
262370|NCT02566005|Induction|induction
262371|NCT02566005|Foley|foley
262372|NCT02565992|Pembrolizumab|pembrolizumab
262373|NCT02565992|Coxsackievirus A21|coxsackievirus a21
262374|NCT02565992|melanoma|melanoma
262375|NCT02565992|CAVATAK|cavatak
262376|NCT02565992|CVA21|cva21
262377|NCT02565992|checkpoint inhibitor|checkpoint inhibitor
262378|NCT02565979|Resveratrol|resveratrol
262379|NCT02565979|Diabetes Mellitus, Type 2|diabetes mellitus, type 2
262380|NCT02565979|Insulin Resistance|insulin resistance
262381|NCT02565979|Metabolic Diseases|metabolic diseases
262382|NCT02565979|Glucose Metabolism Disorders|glucose metabolism disorders
262383|NCT02565953|Vascular access devices obstruction|vascular access devices obstruction
262384|NCT02565927|Trachea|trachea
262385|NCT02565927|Stent|stent
262386|NCT02565927|Intraluminal brachytherapy|intraluminal brachytherapy
262387|NCT02565888|Hepatitis C|hepatitis c
262389|NCT02565888|atazanavir|atazanavir
262390|NCT02565888|ritonavir|ritonavir
262391|NCT02565888|daclatasvir|daclatasvir
262392|NCT02565888|cobicistat|cobicistat
262393|NCT02565875|Efficiency, Organizational|efficiency, organizational
262394|NCT02565875|Simulation|simulation
262395|NCT02565875|Communication|communication
262396|NCT02565875|Laparoscopy|laparoscopy
262397|NCT02565875|Medical Education|medical education
262398|NCT02565862|HCV|hcv
262399|NCT02565862|Diabetes Mellitus|diabetes mellitus
262400|NCT02565862|Daclatasvir|daclatasvir
262401|NCT02565862|Metformin|metformin
262402|NCT02565862|drug-drug interaction|drug-drug interaction
262403|NCT02565862|pharmacokinetics|pharmacokinetics
262404|NCT02565836|Vitamin K 1|vitamin k 1
262405|NCT02565836|prothrombin complex concentrates|prothrombin complex concentrates
262406|NCT02565836|warfarin|warfarin
262407|NCT02565823|Exercise|exercise
262408|NCT02565797|Decubitus Ulcer, Peri-operative, support surface, alternating pressure, neurosurgery|decubitus ulcer, peri-operative, support surface, alternating pressure, neurosurgery
262409|NCT02565771|Childhood cancer|childhood cancer
262410|NCT02565771|Cancer|cancer
262411|NCT02565771|Sequels|sequels
262412|NCT02565771|Surgery|surgery
262413|NCT02565771|Complications|complications
262414|NCT02565771|Chemotherapy|chemotherapy
262415|NCT02565771|Radiotherapy|radiotherapy
262416|NCT02565758|Cancer|cancer
262417|NCT02565758|Advanced Solid Tumors|advanced solid tumors
262418|NCT02565758|Neoplasm|neoplasm
262419|NCT02565758|Undifferentiated pleomorphic sarcoma|undifferentiated pleomorphic sarcoma
262420|NCT02565758|squamous cell carcinoma of the head and neck|squamous cell carcinoma of the head and neck
262421|NCT02565758|carcinoma of the breast|carcinoma of the breast
262422|NCT02565758|antibody drug conjugate|antibody drug conjugate
262423|NCT02565745|Prevention|prevention
262424|NCT02565745|Pressure ulcers|pressure ulcers
262425|NCT02565745|Clinical trial|clinical trial
262426|NCT02565745|Nursing|nursing
262427|NCT02565706|Fruit, vegetables, income, WIC program, farmers' market|fruit, vegetables, income, wic program, farmers' market
262428|NCT02565680|acute urticaria|acute urticaria
262429|NCT02565680|glucocorticoids|glucocorticoids
262430|NCT02565680|antihistamines|antihistamines
262431|NCT02565680|prurit|prurit
262432|NCT02565680|itch score|itch score
262433|NCT02565680|rash|rash
262434|NCT02565667|low rectal carcinoma|low rectal carcinoma
262435|NCT02565667|anastomosis|anastomosis
262436|NCT02565667|anterior rectal resection|anterior rectal resection
262437|NCT02565654|Irritable bowel syndrome(IBS)|irritable bowel syndrome(ibs)
262438|NCT02565654|Small intestinal bacterial overgrowth (SIBO)|small intestinal bacterial overgrowth (sibo)
262439|NCT02565654|Rifaximin|rifaximin
262440|NCT02565602|Calcium metabolism|calcium metabolism
262441|NCT02565602|Osteoporosis|osteoporosis
262442|NCT02565602|Postmenopausal women|postmenopausal women
262443|NCT02565576|CFZ533, Myasthenia Gravis|cfz533, myasthenia gravis
262444|NCT02565563|EMDR|emdr
262445|NCT02565563|Mechanisms|mechanisms
262446|NCT02565563|Eye Movement Desensitisation Reprocessing|eye movement desensitisation reprocessing
262447|NCT02565550|Microbiota Community|microbiota community
262448|NCT02565550|FODMAPs|fodmaps
262450|NCT02565524|schizophrenia|schizophrenia
262451|NCT02565524|early dissociative disorder|early dissociative disorder
262452|NCT02565524|genetic|genetic
262453|NCT02565511|Randomization, Placebo controlled, Parallel-group, APOE4 Homozygotes, Preclinical Alzheimer's Disease (AD), Aβ lowering|randomization, placebo controlled, parallel-group, apoe4 homozygotes, preclinical alzheimer's disease (ad), aβ lowering
262454|NCT02565498|Soft tissue sarcoma|soft tissue sarcoma
262455|NCT02565498|Extremity|extremity
262456|NCT02565498|Preoperative radiotherapy|preoperative radiotherapy
262457|NCT02565498|Postoperative radiotherapy|postoperative radiotherapy
262458|NCT02565485|pulse pressure|pulse pressure
262459|NCT02565485|fetal heart rate|fetal heart rate
262460|NCT02565485|epidural analgesia|epidural analgesia
262461|NCT02565485|hypotension|hypotension
262462|NCT02565485|preload|preload
262463|NCT02565485|fluid bolus|fluid bolus
262464|NCT02565485|central hypovolemia|central hypovolemia
262465|NCT02565459|Mesenchymal stromal cells|mesenchymal stromal cells
262466|NCT02565459|kidney transplantation|kidney transplantation
262467|NCT02565459|tolerance|tolerance
262468|NCT02565433|brain metastases|brain metastases
262469|NCT02565433|Gamma Knife|gamma knife
262470|NCT02565433|Radiosurgery|radiosurgery
262471|NCT02565433|Quality of Life|quality of life
262472|NCT02565355|Pediatric Gastroenterology|pediatric gastroenterology
262473|NCT02565342|Clavicle|clavicle
262474|NCT02565303|cesarean delivery|cesarean delivery
262475|NCT02565303|ropivacaine|ropivacaine
262476|NCT02565303|minimum effective dose|minimum effective dose
262477|NCT02565303|dose-response relationship|dose-response relationship
262478|NCT02565303|intrathecal|intrathecal
262479|NCT02565303|intervertebral space|intervertebral space
262480|NCT02565290|polyunsaturated fatty acid|polyunsaturated fatty acid
262481|NCT02565290|fetal ductus arteriosus|fetal ductus arteriosus
262482|NCT02565290|inflammation|inflammation
262483|NCT02565251|sepsis|sepsis
262484|NCT02565251|hemodynamic monitoring|hemodynamic monitoring
262485|NCT02565251|septic shock|septic shock
262486|NCT02565251|volemic resuscitation|volemic resuscitation
262487|NCT02565251|fluid resuscitation|fluid resuscitation
262488|NCT02565212|Montelukast|montelukast
262489|NCT02565212|Sniffin' Sticks test|sniffin' sticks test
262490|NCT02565212|allergic rhinitis|allergic rhinitis
262491|NCT02565212|mometasone furoate|mometasone furoate
262492|NCT02565199|Transcranial Magnetic Stimulation|transcranial magnetic stimulation
262493|NCT02565173|glaucoma|glaucoma
262494|NCT02565173|primary open-angle glaucoma|primary open-angle glaucoma
262495|NCT02565173|ocular hypertension|ocular hypertension
262496|NCT02565173|adenosine agonist|adenosine agonist
262497|NCT02565173|eye drop|eye drop
262498|NCT02565173|trabodenoson|trabodenoson
262499|NCT02565173|trabecular meshwork|trabecular meshwork
262500|NCT02565160|Osteoarthritis|osteoarthritis
262501|NCT02565160|Septic Arthritis|septic arthritis
262502|NCT02565147|STEMI, infarct size, CMR, bivalirudin|stemi, infarct size, cmr, bivalirudin
262503|NCT02565121|Olfactory perception|olfactory perception
262504|NCT02565121|Adrenal cortex hormones|adrenal cortex hormones
262505|NCT02565121|Steroids|steroids
262506|NCT02565121|Education|education
262507|NCT02565108|Cannabidiol|cannabidiol
262508|NCT02565108|GWP42003-P|gwp42003-p
262509|NCT02565108|Clobazam|clobazam
262510|NCT02565108|Epidiolex|epidiolex
262511|NCT02565108|CBD|cbd
262512|NCT02565082|Hemostatic potential|hemostatic potential
262513|NCT02565082|Sickle cell disease|sickle cell disease
262514|NCT02565082|Thrombin generation test|thrombin generation test
262515|NCT02565056|Acceptance and Commitment Therapy|acceptance and commitment therapy
335523|NCT02162329|EEG|eeg
262516|NCT02565043|Negative Pressure Wound Therapy|negative pressure wound therapy
262517|NCT02565030|Chronic thromboembolic Pulmonary Hypertension|chronic thromboembolic pulmonary hypertension
262518|NCT02565030|Distal Chronic thromboembolic Pulmonary Hypertension|distal chronic thromboembolic pulmonary hypertension
262519|NCT02565030|Proximal Chronic thromboembolic Pulmonary Hypertension|proximal chronic thromboembolic pulmonary hypertension
262520|NCT02565030|Operable disease|operable disease
262521|NCT02565030|In-operable disease|in-operable disease
262522|NCT02565030|Pulmonary Endarterectomy|pulmonary endarterectomy
262523|NCT02565030|PH specific targeted therapy|ph specific targeted therapy
262648|NCT02564315|Tobacco|tobacco
262524|NCT02565030|Phosphodiesterase type 5 Inhibitors|phosphodiesterase type 5 inhibitors
262525|NCT02565030|Endothelin Receptor Antagonist|endothelin receptor antagonist
262526|NCT02565030|Prostacyclin analogues|prostacyclin analogues
262527|NCT02565030|Soluble Guanylate cyclase stimulator|soluble guanylate cyclase stimulator
262528|NCT02565030|Sildenafil|sildenafil
262529|NCT02565030|Tadalafil|tadalafil
262530|NCT02565030|Bosentan|bosentan
262531|NCT02565030|Ambrisentan|ambrisentan
262532|NCT02565030|Macitentan|macitentan
262533|NCT02565030|Iloprost|iloprost
262534|NCT02565030|Riociguat|riociguat
262535|NCT02565030|Idiopathic Pulmonary Arterial Hypertension|idiopathic pulmonary arterial hypertension
262536|NCT02565017|IBM Watson|ibm watson
262537|NCT02565017|Clinical Decision Support System|clinical decision support system
262538|NCT02565017|Patient Preferences|patient preferences
262539|NCT02565017|15-226|15-226
262540|NCT02565004|Genetic|genetic
262541|NCT02565004|Sample Collection|sample collection
262542|NCT02564991|Alcoholism|alcoholism
262543|NCT02564991|MRI|mri
262544|NCT02564991|Structural MRI|structural mri
262545|NCT02564991|Cerebellum|cerebellum
262546|NCT02564978|Age-Related Macular Degeneration|age-related macular degeneration
262547|NCT02564978|Age-Related Macular Degeneration (AMD)|age-related macular degeneration (amd)
262548|NCT02564978|Geographic Atrophy|geographic atrophy
262549|NCT02564978|Minocycline|minocycline
262550|NCT02564978|Atrophic Macular Degeneration|atrophic macular degeneration
262551|NCT02564965|Acute Necrotizing Pancreatitis|acute necrotizing pancreatitis
262552|NCT02564965|Walled-Off Pancreatic Necrosis|walled-off pancreatic necrosis
262553|NCT02564952|Cannabidiol (CBD)|cannabidiol (cbd)
262554|NCT02564952|GWP42003-P|gwp42003-p
262555|NCT02564952|Clobazam|clobazam
262556|NCT02564952|Epidiolex|epidiolex
262557|NCT02564939|prevention|prevention
262558|NCT02564926|DM|dm
262559|NCT02564913|tongue diagnosis|tongue diagnosis
262560|NCT02564913|heart rate variability|heart rate variability
262561|NCT02564913|nailfold videocapillaroscopy|nailfold videocapillaroscopy
262562|NCT02564900|Advanced solid tumors|advanced solid tumors
262563|NCT02564900|phase 1|phase 1
262564|NCT02564900|oncology|oncology
262565|NCT02564900|HER2|her2
262566|NCT02564900|Antibody drug conjugate (ADC)|antibody drug conjugate (adc)
262567|NCT02564887|dysphagia|dysphagia
262568|NCT02564887|oral pharyngeal cancer|oral pharyngeal cancer
262569|NCT02564887|Iowa Oral Performance Instrument (IOPI)|iowa oral performance instrument (iopi)
262570|NCT02564887|IOPI|iopi
262571|NCT02564861|pharmacokinetics|pharmacokinetics
262572|NCT02564848|Clinical T1-2N0 ER+|clinical t1-2n0 er+
262573|NCT02564848|Invasive breast cancer|invasive breast cancer
262574|NCT02564848|estrogen-positive|estrogen-positive
262575|NCT02564822|migraine disorders|migraine disorders
262576|NCT02564822|cortical excitability|cortical excitability
262577|NCT02564822|transcranial magnetic stimulation|transcranial magnetic stimulation
262578|NCT02564822|electroencephalography|electroencephalography
262579|NCT02564796|Erythropoetin|erythropoetin
262580|NCT02564796|Cyanotic Heart Disease|cyanotic heart disease
262581|NCT02564796|Transfusion|transfusion
262582|NCT02564796|Congenital Heart Disease|congenital heart disease
262583|NCT02564731|children|children
262584|NCT02564731|prognosis|prognosis
262585|NCT02564718|Pediatric|pediatric
262586|NCT02564679|bariatric surgery|bariatric surgery
262587|NCT02564679|sleeve gastrectomy|sleeve gastrectomy
262880|NCT02563002|PD1|pd1
262588|NCT02564666|hepatocellular carcinoma|hepatocellular carcinoma
262589|NCT02564666|sorafenib|sorafenib
262590|NCT02564666|telephone counseling|telephone counseling
262591|NCT02564640|videolaryngoscope|videolaryngoscope
262592|NCT02564640|direct laryngoscope|direct laryngoscope
262593|NCT02564640|hemodynamic changes|hemodynamic changes
262594|NCT02564640|elderly patients|elderly patients
262595|NCT02564601|intervention|intervention
262596|NCT02564601|cognition|cognition
262597|NCT02564601|aging|aging
262598|NCT02564601|piano training|piano training
262599|NCT02564601|computer brain training|computer brain training
262600|NCT02564575|Ebolavirus|ebolavirus
262601|NCT02564562|PF-06463922|pf-06463922
262602|NCT02564562|[14C]PF-06463922|[14c]pf-06463922
262603|NCT02564562|Human ADME|human adme
262604|NCT02564562|Radiolabel|radiolabel
262605|NCT02564562|Mass Balance|mass balance
262606|NCT02564562|Pharmacokinetics|pharmacokinetics
262607|NCT02564549|low risk prostate cancer|low risk prostate cancer
262608|NCT02564523|Healthy|healthy
262609|NCT02564523|Vaccine|vaccine
262610|NCT02564523|Ebola viruses|ebola viruses
262611|NCT02564523|Ebola virus disease (EVD)|ebola virus disease (evd)
262612|NCT02564523|Filoviruses|filoviruses
262613|NCT02564523|Hemorrhagic fever|hemorrhagic fever
262614|NCT02564523|Monovalent vaccine|monovalent vaccine
262615|NCT02564523|Human adenovirus serotype 26 (Ad26) expressing the Ebola virus Mayinga variant glycoprotein (Ad26.ZEBOV)|human adenovirus serotype 26 (ad26) expressing the ebola virus mayinga variant glycoprotein (ad26.zebov)
262616|NCT02564523|Modified Vaccinia Virus Ankara - Bavarian Nordic (MVA-BN) Filo-vector|modified vaccinia virus ankara - bavarian nordic (mva-bn) filo-vector
262617|NCT02564523|Safety|safety
262618|NCT02564523|Immunogenicity|immunogenicity
262619|NCT02564523|Inserm, Centre Muraz|inserm, centre muraz
262620|NCT02564484|Cancer Therapy|cancer therapy
262621|NCT02564484|Pharmacogenomics|pharmacogenomics
262622|NCT02564484|Drug Response|drug response
262623|NCT02564484|Genetic Variants|genetic variants
262624|NCT02564484|Vincristine-Induced Neuropathy|vincristine-induced neuropathy
262625|NCT02564484|Cancer Survivor|cancer survivor
262626|NCT02564432|amputee|amputee
262627|NCT02564354|Cystic Fibrosis|cystic fibrosis
262628|NCT02564354|CF|cf
262629|NCT02564354|ΔF508|δf508
262630|NCT02564354|CFTR|cftr
262631|NCT02564354|QR-010|qr-010
262632|NCT02564354|antisense oligonucleotide|antisense oligonucleotide
262633|NCT02564354|RNA therapy|rna therapy
262634|NCT02564354|F508del|f508del
262635|NCT02564354|NPD|npd
262636|NCT02564354|nasal potential difference|nasal potential difference
262637|NCT02564341|HIV Infection|hiv infection
262638|NCT02564341|Pain|pain
262639|NCT02564341|Collaborative Care|collaborative care
262640|NCT02564341|Chronic Opioid Therapy|chronic opioid therapy
262641|NCT02564341|Addiction|addiction
262642|NCT02564341|Analgesics, Opioid|analgesics, opioid
262643|NCT02564328|Stroke|stroke
262644|NCT02564328|Bone Marrow Mesenchymal Stem Cell|bone marrow mesenchymal stem cell
262645|NCT02564328|Transplantation|transplantation
262646|NCT02564315|Smoking|smoking
262647|NCT02564315|Cessation|cessation
262649|NCT02564315|Relapse|relapse
262651|NCT02564302|Atrial Fibrillation|atrial fibrillation
262652|NCT02564302|MUSE Headband|muse headband
262653|NCT02564302|Mindfulness|mindfulness
262654|NCT02564289|microvesicles, microparticles|microvesicles, microparticles
262655|NCT02564289|Plethysmography|plethysmography
262656|NCT02564289|Snus|snus
262657|NCT02564289|Arterial Stiffness|arterial stiffness
262658|NCT02564289|EPC|epc
262659|NCT02564276|Indocyanine Green|indocyanine green
262660|NCT02564276|Sentinel Lymph Node Biopsy|sentinel lymph node biopsy
262661|NCT02564263|Programmed Cell Death-1 (PD1, PD-1)|programmed cell death-1 (pd1, pd-1)
262662|NCT02564263|Programmed Death-Ligand 1 (PDL1, PD-L1)|programmed death-ligand 1 (pdl1, pd-l1)
262663|NCT02564263|Programmed Death-Ligand 2 (PDL2, PD-L2)|programmed death-ligand 2 (pdl2, pd-l2)
262664|NCT02564263|Gene expression profiling (GEP)|gene expression profiling (gep)
262665|NCT02564237|Group A streptococcal|group a streptococcal
262666|NCT02564198|relapsed pediatric solid tumors|relapsed pediatric solid tumors
262667|NCT02564198|unspecified childhood solid tumor|unspecified childhood solid tumor
262668|NCT02564198|brain and central nervous system tumors|brain and central nervous system tumors
262669|NCT02564159|malnutrition|malnutrition
262670|NCT02564159|muscle ultrasound|muscle ultrasound
262671|NCT02564159|intensive care unit|intensive care unit
262672|NCT02564159|mechanical ventilation|mechanical ventilation
262673|NCT02564159|albumin|albumin
262674|NCT02564159|prealbumin|prealbumin
262675|NCT02564159|nutrition|nutrition
262676|NCT02564055|Vehicle-Controlled|vehicle-controlled
262677|NCT02564055|GSK2894512|gsk2894512
262678|NCT02564055|Double blind|double blind
262679|NCT02564055|Dose-finding|dose-finding
262680|NCT02564055|Atopic Dermatitis|atopic dermatitis
262681|NCT02564042|Double blind|double blind
262682|NCT02564042|Dose-finding|dose-finding
262683|NCT02564042|Vehicle-Controlled|vehicle-controlled
262684|NCT02564042|GSK2894512|gsk2894512
262685|NCT02564042|Plaque Psoriasis|plaque psoriasis
262686|NCT02563977|Breast reconstruction|breast reconstruction
262780|NCT02563613|physical exercise|physical exercise
262687|NCT02563977|Deep inferior epigastric perforator flap|deep inferior epigastric perforator flap
262688|NCT02563977|Abdominal wall morbidity|abdominal wall morbidity
262689|NCT02563977|Plastic and reconstructive surgery|plastic and reconstructive surgery
262690|NCT02563964|Myocardial infarction|myocardial infarction
262691|NCT02563964|vulnerable plaque|vulnerable plaque
262692|NCT02563964|Positron emission tomography (PET)|positron emission tomography (pet)
262693|NCT02563964|Cardiac magnetic resonance imaging (CMR)|cardiac magnetic resonance imaging (cmr)
262694|NCT02563964|Biomarkers|biomarkers
262695|NCT02563951|Nausea|nausea
262696|NCT02563951|Vomiting|vomiting
262697|NCT02563951|Chemotherapy|chemotherapy
262698|NCT02563951|Radiation therapy|radiation therapy
262699|NCT02563925|Brain Irradiation|brain irradiation
262700|NCT02563925|Tremelimumab|tremelimumab
262701|NCT02563925|15-038|15-038
262702|NCT02563912|Children|children
262703|NCT02563912|resuscitation|resuscitation
262704|NCT02563912|simulation|simulation
262705|NCT02563912|medication error|medication error
262706|NCT02563899|Primary Axillary Hyperhidrosis|primary axillary hyperhidrosis
262707|NCT02563899|GSK573719|gsk573719
262708|NCT02563899|Hyperhidrosis Disease Severity Scale (HDSS)|hyperhidrosis disease severity scale (hdss)
262709|NCT02563899|Topical|topical
262710|NCT02563899|PRO|pro
262711|NCT02563899|Hyperhidrosis Symptom Severity Measure (HSSM)|hyperhidrosis symptom severity measure (hssm)
262712|NCT02563899|Umeclidinium|umeclidinium
262713|NCT02563860|Treatment trial|treatment trial
262714|NCT02563860|Lovastatin|lovastatin
262715|NCT02563821|Termination of pregancy|termination of pregancy
262716|NCT02563821|Third trimester|third trimester
262717|NCT02563821|Programmed intermittent epidural bolus|programmed intermittent epidural bolus
262718|NCT02563821|Continuous epidural infusion|continuous epidural infusion
262719|NCT02563821|Epidural analgesia|epidural analgesia
262720|NCT02563821|Legally induced abortion|legally induced abortion
262721|NCT02563795|Spinal anesthesia|spinal anesthesia
262722|NCT02563795|Cesarean|cesarean
262723|NCT02563795|Maternal hypotension|maternal hypotension
262724|NCT02563769|Cocaine|cocaine
262725|NCT02563769|Clavulanic Acid|clavulanic acid
262726|NCT02563756|Medial gonarthritis, knee osteoarthritis,|medial gonarthritis, knee osteoarthritis,
262727|NCT02563756|Muscle function, muscle mass, muscle atrophy|muscle function, muscle mass, muscle atrophy
262728|NCT02563756|Total knee arthroplasty (TKA)|total knee arthroplasty (tka)
262729|NCT02563756|Unicondylar knee arthroplasty (UKA)|unicondylar knee arthroplasty (uka)
262730|NCT02563756|Total knee replacement (TKR)|total knee replacement (tkr)
262731|NCT02563756|Unicondylar knee replacement (UKR)|unicondylar knee replacement (ukr)
262732|NCT02563756|Health-related quality of life (HRQoL)|health-related quality of life (hrqol)
262733|NCT02563756|Patient related outcome measurements (PROMs)|patient related outcome measurements (proms)
262734|NCT02563743|Sick-leave|sick-leave
262735|NCT02563743|Return to work|return to work
262736|NCT02563743|Occupational health|occupational health
262737|NCT02563743|Common mental disorder|common mental disorder
262738|NCT02563743|Depression|depression
262739|NCT02563743|Anxiety disorders|anxiety disorders
262740|NCT02563743|Adjustment disorders|adjustment disorders
262741|NCT02563743|Problem solving therapy|problem solving therapy
262742|NCT02563743|Occupational Health Services|occupational health services
262743|NCT02563743|Randomized controlled trial|randomized controlled trial
262744|NCT02563743|Intervention studies|intervention studies
262745|NCT02563743|Occupational stress|occupational stress
262746|NCT02563730|Cryobiopsy|cryobiopsy
262747|NCT02563730|lung biopsy|lung biopsy
262748|NCT02563730|interstitial lung disease|interstitial lung disease
262749|NCT02563717|Resuscitation|resuscitation
262750|NCT02563717|Positive-Pressure Respiration|positive-pressure respiration
262751|NCT02563717|Infant, Extremely Premature|infant, extremely premature
262752|NCT02563717|Continuous Positive Airway Pressure|continuous positive airway pressure
262753|NCT02563717|Intubation|intubation
262754|NCT02563704|Artesunate|artesunate
262755|NCT02563704|Quinine|quinine
262756|NCT02563704|Efficacy|efficacy
262757|NCT02563704|Malaria|malaria
262758|NCT02563704|Children|children
262759|NCT02563704|Cameroon|cameroon
262760|NCT02563652|Abdomen/surgery|abdomen/surgery
262761|NCT02563652|Biological markers|biological markers
262762|NCT02563652|Length of stay|length of stay
262763|NCT02563652|Postoperative care|postoperative care
262764|NCT02563652|Anesthesia recovery period|anesthesia recovery period
262765|NCT02563652|Prognosis|prognosis
262766|NCT02563639|newly diagnosed|newly diagnosed
262767|NCT02563639|paroxysmal|paroxysmal
262768|NCT02563639|persistent|persistent
262769|NCT02563626|coronary artery aneurysm|coronary artery aneurysm
262770|NCT02563626|prognosis|prognosis
262771|NCT02563626|outcomes|outcomes
262772|NCT02563626|management|management
262773|NCT02563626|incidence|incidence
262774|NCT02563626|heart failure|heart failure
262775|NCT02563626|acute coronary syndrome|acute coronary syndrome
262776|NCT02563626|death|death
262777|NCT02563613|community-based intervention|community-based intervention
262778|NCT02563613|family holistic health|family holistic health
262779|NCT02563613|positive psychology|positive psychology
262879|NCT02563015|Lean Mass|lean mass
262781|NCT02563613|healthy diet|healthy diet
262782|NCT02563587|Laughter|laughter
262783|NCT02563587|children|children
262784|NCT02563587|postoperative|postoperative
262785|NCT02563587|pain|pain
262786|NCT02563587|anxiety|anxiety
262787|NCT02563587|cortisol|cortisol
262788|NCT02563574|Alcohol and brain function|alcohol and brain function
262789|NCT02563574|HIV and brain function|hiv and brain function
262790|NCT02563574|Motivational Interviewing|motivational interviewing
262791|NCT02563561|Bladder Cancer|bladder cancer
262792|NCT02563561|Non-muscle invasive bladder cancer|non-muscle invasive bladder cancer
262793|NCT02563561|Apaziquone|apaziquone
262794|NCT02563561|TURBT|turbt
262795|NCT02563561|Stage Ta, G1-G2|stage ta, g1-g2
262796|NCT02563522|non healing ulcers|non healing ulcers
262797|NCT02563522|VM202|vm202
262798|NCT02563522|Diabetic ulcers|diabetic ulcers
262799|NCT02563522|foot ulcers|foot ulcers
262800|NCT02563509|HIV|hiv
262801|NCT02563509|cellular immunity therapy|cellular immunity therapy
262802|NCT02563509|functional cure|functional cure
262803|NCT02563496|pharmacokinetic|pharmacokinetic
262804|NCT02563496|pediatric|pediatric
262805|NCT02563496|Tafenoquine|tafenoquine
262806|NCT02563496|Plasmodium vivax Malaria|plasmodium vivax malaria
262807|NCT02563496|G6PD deficiency|g6pd deficiency
262808|NCT02563483|caregivers|caregivers
262809|NCT02563483|anxiety|anxiety
262810|NCT02563483|depression|depression
262811|NCT02563483|yoga|yoga
262812|NCT02563483|meditation|meditation
262813|NCT02563483|stress|stress
262814|NCT02563457|diabetic patients|diabetic patients
262815|NCT02563457|periodontal treatment|periodontal treatment
262816|NCT02563457|glycaemic control|glycaemic control
262817|NCT02563444|Diagnostic (Biopsy) or Therapeutic Procedure (Infiltration, Ablation)|diagnostic (biopsy) or therapeutic procedure (infiltration, ablation)
262818|NCT02563431|shoulder pain|shoulder pain
262819|NCT02563431|prevention program|prevention program
262820|NCT02563418|video oculography|video oculography
262821|NCT02563405|alpha receptor blocker|alpha receptor blocker
262822|NCT02563405|uric acid|uric acid
262823|NCT02563405|CCB|ccb
262824|NCT02563405|blood pressure variability|blood pressure variability
262825|NCT02563366|kidney transplantation|kidney transplantation
262826|NCT02563366|mesenchymal stem cell therapy|mesenchymal stem cell therapy
262827|NCT02563366|poor early graft function|poor early graft function
262828|NCT02563366|delayed graft function|delayed graft function
262829|NCT02563366|ischemia reperfusion injury|ischemia reperfusion injury
262830|NCT02563366|donation after cardiac death|donation after cardiac death
262831|NCT02563353|whole body vibration|whole body vibration
262832|NCT02563353|PTH|pth
262833|NCT02563340|kidney transplantation|kidney transplantation
262834|NCT02563340|antibody-mediated rejection|antibody-mediated rejection
262835|NCT02563340|mesenchymal stem cell therapy|mesenchymal stem cell therapy
262836|NCT02563340|donor specific antibody|donor specific antibody
262837|NCT02563340|acute rejection|acute rejection
262838|NCT02563314|Noninvasive Ventilation|noninvasive ventilation
262839|NCT02563314|Pulmonary Disease|pulmonary disease
262840|NCT02563314|Chronic Obstructive|chronic obstructive
262841|NCT02563314|Renal Doppler|renal doppler
262842|NCT02563314|Oxygen|oxygen
262843|NCT02563314|Hypercapnia|hypercapnia
262844|NCT02563288|esmolol|esmolol
262845|NCT02563288|dexmedetomidine|dexmedetomidine
262846|NCT02563288|opioids|opioids
262847|NCT02563197|Device study|device study
262848|NCT02563197|Peak inspiratory flow rate|peak inspiratory flow rate
262849|NCT02563197|Non-cystic fibrosis bronchiectasis|non-cystic fibrosis bronchiectasis
262850|NCT02563197|T-326 Inhaler|t-326 inhaler
262851|NCT02563171|visceral adipose-specific serpin|visceral adipose-specific serpin
262852|NCT02563171|intelectin 1 (omentin)|intelectin 1 (omentin)
262853|NCT02563171|Tumor Necrosis Factor-alpha|tumor necrosis factor-alpha
262854|NCT02563158|liver resection|liver resection
262855|NCT02563158|blood inflow control|blood inflow control
262856|NCT02563158|ischemia-reperfusion injury|ischemia-reperfusion injury
262857|NCT02563158|inflammatory response|inflammatory response
262858|NCT02563158|randomized controlled trial|randomized controlled trial
262859|NCT02563145|Real-time fMRI feedback|real-time fmri feedback
262860|NCT02563132|colonoscopy|colonoscopy
262861|NCT02563132|carbon dioxide|carbon dioxide
262862|NCT02563132|inflammatory bowel disease|inflammatory bowel disease
262863|NCT02563093|Influenza|influenza
262864|NCT02563093|Fluzone® Quadrivalent, Influenza Vaccine|fluzone® quadrivalent, influenza vaccine
262865|NCT02563093|Fluzone® Intradermal Quadrivalent, Influenza Vaccine|fluzone® intradermal quadrivalent, influenza vaccine
262866|NCT02563093|Fluzone® High Dose, Influenza Vaccine|fluzone® high dose, influenza vaccine
262867|NCT02563080|exocrine insufficiency|exocrine insufficiency
262868|NCT02563080|acute pancreatitis|acute pancreatitis
262869|NCT02563080|severe|severe
262870|NCT02563080|moderately severe|moderately severe
262871|NCT02563067|Asthma|asthma
262872|NCT02563067|QAW039|qaw039
262873|NCT02563028|Visual Evoked Potentials|visual evoked potentials
262874|NCT02563028|Microdiscectomy|microdiscectomy
262875|NCT02563028|SightSaver|sightsaver
262876|NCT02563015|Infant|infant
262877|NCT02563015|Vitamin D|vitamin d
262878|NCT02563015|Deficiency|deficiency
262881|NCT02563002|PDL1|pdl1
262882|NCT02563002|PD-L1|pd-l1
262883|NCT02562924|MEDIHONEY|medihoney
262884|NCT02562924|Chronic Rhinosinusitis With Nasal Polyposis|chronic rhinosinusitis with nasal polyposis
262885|NCT02562924|Functional Endoscopic Sinus Surgery|functional endoscopic sinus surgery
262886|NCT02562911|cystic fibrosis|cystic fibrosis
262887|NCT02562911|menstrual cycle|menstrual cycle
262888|NCT02562911|puberty|puberty
262889|NCT02562885|Benign epilepsy with centro-temporal spikes|benign epilepsy with centro-temporal spikes
262890|NCT02562885|Continuous spike waves in slow wave sleep|continuous spike waves in slow wave sleep
262891|NCT02562885|Electroencephalography|electroencephalography
262892|NCT02562885|Sleep, slow wave|sleep, slow wave
262893|NCT02562872|Controlled|controlled
262895|NCT02562872|Malaria|malaria
262896|NCT02562872|Infection|infection
262897|NCT02562872|Healthy|healthy
262898|NCT02562872|Volunteer|volunteer
262899|NCT02562846|electroconvulsive therapy|electroconvulsive therapy
262900|NCT02562846|response prediction|response prediction
262901|NCT02562846|cognitive side effects|cognitive side effects
262902|NCT02562833|Osteoarthritis|osteoarthritis
262903|NCT02562833|Self-management|self-management
262904|NCT02562833|Multi-Component Exercise|multi-component exercise
262905|NCT02562807|Urinary Incontinence|urinary incontinence
262906|NCT02562807|Urinary Incontinence, Stress|urinary incontinence, stress
262907|NCT02562807|Lower Urinary Tract Symptoms|lower urinary tract symptoms
262908|NCT02562794|refugee|refugee
262909|NCT02562781|postoperative complications|postoperative complications
262910|NCT02562781|postoperative cognitive dysfunction|postoperative cognitive dysfunction
262911|NCT02562781|oxygen|oxygen
262912|NCT02562755|Hepatocellular Carcinoma (HCC)|hepatocellular carcinoma (hcc)
262913|NCT02562755|Pexastimogene Devacirepvec (Pexa-Vec)|pexastimogene devacirepvec (pexa-vec)
262914|NCT02562755|Sorafenib|sorafenib
262915|NCT02562755|GM-CSF therapy|gm-csf therapy
262916|NCT02562755|Thymidine Kinase-Deactivated Vaccinia Virus|thymidine kinase-deactivated vaccinia virus
262917|NCT02562755|Oncology|oncology
262918|NCT02562755|Recombinant Vaccinia Virus|recombinant vaccinia virus
262919|NCT02562755|Oncolytic Virus Therapy|oncolytic virus therapy
262920|NCT02562755|Oncolytic virotherapy|oncolytic virotherapy
262921|NCT02562742|Hepatitis C virus|hepatitis c virus
262922|NCT02562742|observational|observational
262923|NCT02562742|post-marketing|post-marketing
262924|NCT02562742|sofosbuvir|sofosbuvir
262925|NCT02562742|Infection|infection
262926|NCT02562729|Cervical cancer; Nerve-sparing hysterectomy; simplified|cervical cancer; nerve-sparing hysterectomy; simplified
262927|NCT02562690|Coronary Artery Disease|coronary artery disease
262928|NCT02562690|Myocardial Ischemia|myocardial ischemia
262929|NCT02562690|Arterial Occlusive Diseases|arterial occlusive diseases
262930|NCT02562690|Coronary Thrombosis|coronary thrombosis
262931|NCT02562651|STEMI, adverse LVR (left ventricular remodeling), MMPs, Doxycycline|stemi, adverse lvr (left ventricular remodeling), mmps, doxycycline
262932|NCT02562638|NPO|npo
262933|NCT02562638|NBM|nbm
262934|NCT02562638|pre-procedure|pre-procedure
262935|NCT02562638|cardiac|cardiac
262936|NCT02562599|Induction Chemotherapy|induction chemotherapy
262937|NCT02562599|Concurrent Chemoradiotherapy|concurrent chemoradiotherapy
262938|NCT02562586|Suction|suction
262939|NCT02562586|Arthroplasty|arthroplasty
262940|NCT02562586|Replacement|replacement
262941|NCT02562586|Hip|hip
262942|NCT02562534|ECG|ecg
262943|NCT02562534|MRI|mri
262944|NCT02562534|rythm troubles|rythm troubles
262945|NCT02562534|conductive troubles|conductive troubles
262946|NCT02562534|ECG artifacts|ecg artifacts
262947|NCT02562534|Database|database
262948|NCT02562508|Human Papilloma Virus 16|human papilloma virus 16
262949|NCT02562508|Human Papilloma Virus 18|human papilloma virus 18
262950|NCT02562508|vaccine|vaccine
262951|NCT02562508|adolescent girl|adolescent girl
262952|NCT02562508|bridging trial|bridging trial
262953|NCT02562508|non-inferiority|non-inferiority
262954|NCT02562495|severe cerebral pathology|severe cerebral pathology
262955|NCT02562495|Ultrasound|ultrasound
262956|NCT02562495|thickness of the quadriceps|thickness of the quadriceps
262957|NCT02562482|Antibody Response|antibody response
262958|NCT02562482|Immune Response|immune response
262959|NCT02562482|Healthy Volunteer|healthy volunteer
262960|NCT02562482|Vaccine-Mediated Protection|vaccine-mediated protection
262961|NCT02562482|Chikungunya Virus|chikungunya virus
262962|NCT02562482|Vaccines, Virus-like Particles|vaccines, virus-like particles
262963|NCT02562456|Dental Atraumatic Restorative Treatment|dental atraumatic restorative treatment
262964|NCT02562456|Composite Resins|composite resins
262965|NCT02562456|Primary Teeth|primary teeth
262966|NCT02562456|Clinical Efficacy|clinical efficacy
262967|NCT02562456|Cost Analysis|cost analysis
262968|NCT02562443|Myelodysplastic Syndrome|myelodysplastic syndrome
262969|NCT02562443|MDS|mds
262970|NCT02562430|Placebo response|placebo response
262971|NCT02562391|atrial fibrillation|atrial fibrillation
262972|NCT02562391|ablation|ablation
262973|NCT02562391|thoracoscopy|thoracoscopy
262974|NCT02562391|left atrial appendage|left atrial appendage
262975|NCT02562365|adjuvent chemotherapy|adjuvent chemotherapy
262976|NCT02562365|ovarian cancer|ovarian cancer
262977|NCT02562352|polypharmacy|polypharmacy
262978|NCT02562352|multimorbidity|multimorbidity
262979|NCT02562352|randomized controlled trial|randomized controlled trial
262980|NCT02562352|drug discontinuation|drug discontinuation
262981|NCT02562352|patient preference|patient preference
262982|NCT02562352|eHealth|ehealth
262983|NCT02562274|Menopause|menopause
262984|NCT02562274|Cognitive impairment|cognitive impairment
262985|NCT02562274|Working memory|working memory
262986|NCT02562274|Bone formation markers|bone formation markers
262987|NCT02562274|Osteoporosis|osteoporosis
262988|NCT02562261|sepsis|sepsis
262989|NCT02562261|platelet|platelet
262990|NCT02562261|platelet reactivity|platelet reactivity
262991|NCT02562261|P2Y12|p2y12
262992|NCT02562235|Pulmonary arterial hypertension|pulmonary arterial hypertension
262993|NCT02562222|migraine disorders|migraine disorders
262994|NCT02562222|transcranial direct current stimulation|transcranial direct current stimulation
262995|NCT02562222|electric stimulation therapy|electric stimulation therapy
262996|NCT02562222|pain|pain
262997|NCT02562222|rehabilitation|rehabilitation
262998|NCT02562209|Obesity|obesity
262999|NCT02562209|Abdominal adiposity|abdominal adiposity
263000|NCT02562209|High protein diet|high protein diet
263001|NCT02562196|migraine disorders|migraine disorders
263002|NCT02562196|transcranial direct current stimulation|transcranial direct current stimulation
263003|NCT02562196|electric stimulation therapy|electric stimulation therapy
263004|NCT02562196|pain|pain
263005|NCT02562170|breast|breast
263006|NCT02562170|reconstruction|reconstruction
263007|NCT02562170|mesh|mesh
263008|NCT02562170|acellular dermal matrix|acellular dermal matrix
263009|NCT02562131|PET-MR|pet-mr
263010|NCT02562131|recidive|recidive
263011|NCT02562131|PET/MR imaging|pet/mr imaging
263012|NCT02562131|18F-Fluciclovine|18f-fluciclovine
263013|NCT02562131|radical treatment|radical treatment
263014|NCT02562131|recurrence|recurrence
263015|NCT02562105|Intensive care unit|intensive care unit
263016|NCT02562105|Hematological malignancy|hematological malignancy
263017|NCT02562105|Acute respiratory failure|acute respiratory failure
263018|NCT02562105|Prognosis|prognosis
263019|NCT02562105|Mechanical ventilation|mechanical ventilation
263020|NCT02562092|AIDS|aids
263021|NCT02562092|Health Promotion|health promotion
263022|NCT02562079|T lymphocyte|t lymphocyte
263023|NCT02562079|OX40/OX40L|ox40/ox40l
263024|NCT02562040|Pediatrics|pediatrics
263025|NCT02562040|Primary Snoring|primary snoring
263026|NCT02562040|Adenotonsillectomy|adenotonsillectomy
263027|NCT02562001|Spinal Cord Injuries|spinal cord injuries
263028|NCT02562001|gait training|gait training
263029|NCT02562001|robotic|robotic
263030|NCT02562001|Lokomat|lokomat
263031|NCT02562001|Transcranial Magnetic Stimulation|transcranial magnetic stimulation
263032|NCT02562001|transcranial direct-current stimulation|transcranial direct-current stimulation
263033|NCT02562001|Electroencephalography|electroencephalography
263034|NCT02562001|Functional near-infrared spectroscopy|functional near-infrared spectroscopy
263035|NCT02561975|Double pulmonary diffusing capacity to carbon monoxyd (CO) associated to nitric oxide (NO)|double pulmonary diffusing capacity to carbon monoxyd (co) associated to nitric oxide (no)
263036|NCT02561975|Evolution of membrane and capillar damages|evolution of membrane and capillar damages
263037|NCT02561975|Early pronostic value of congenital heart disease|early pronostic value of congenital heart disease
263038|NCT02561962|Multiple Myeloma|multiple myeloma
263039|NCT02561962|Relapsed Multiple Myeloma|relapsed multiple myeloma
263040|NCT02561962|Refractory Multiple Myeloma|refractory multiple myeloma
263041|NCT02561949|Depression/therapy|depression/therapy
263042|NCT02561949|Developing Countries|developing countries
263043|NCT02561949|Interpersonal Relations|interpersonal relations
263044|NCT02561949|Life Change Events|life change events
263045|NCT02561949|Psychotherapy, group|psychotherapy, group
263046|NCT02561949|Resilience, Psychological|resilience, psychological
263047|NCT02561949|Sierra Leone|sierra leone
263048|NCT02561949|Survivors/psychology|survivors/psychology
263049|NCT02561949|Social Adjustment|social adjustment
263050|NCT02561949|Social Behavior|social behavior
263051|NCT02561949|War|war
263052|NCT02561936|Healthy|healthy
263053|NCT02561936|EUDRANT|eudrant
263054|NCT02561936|Rilpivirine|rilpivirine
263055|NCT02561923|Healthy|healthy
263056|NCT02561923|Rivaroxaban|rivaroxaban
263057|NCT02561923|XARELTO|xarelto
263058|NCT02561910|Inguinal hernia repair|inguinal hernia repair
263059|NCT02561910|laparoscopic inguinal hernia repair|laparoscopic inguinal hernia repair
263060|NCT02561910|TAPP|tapp
263061|NCT02561871|Ad26.RSV.FA2 (JNJ-61187165-AAA)|ad26.rsv.fa2 (jnj-61187165-aaa)
263062|NCT02561871|Ad35.RSV.FA2 (JNJ-61187191-AAA)|ad35.rsv.fa2 (jnj-61187191-aaa)
263063|NCT02561871|Healthy participants|healthy participants
263064|NCT02561858|Renal Ammonium ;uric acid|renal ammonium ;uric acid
263065|NCT02561845|Effectiveness of statins, on lipid goal attainment and lipid parameters in Percutaneous Coronary Intervention patients|effectiveness of statins, on lipid goal attainment and lipid parameters in percutaneous coronary intervention patients
263066|NCT02561832|breast cancer|breast cancer
263067|NCT02561819|Short Bowel Syndrome|short bowel syndrome
263068|NCT02561819|Congenital Short Bowel Syndrome|congenital short bowel syndrome
263069|NCT02561819|Body Composition|body composition
263561|NCT02558920|Isocaloric|isocaloric
263070|NCT02561819|Parenteral Nutrition|parenteral nutrition
263071|NCT02561819|Intestinal Failure|intestinal failure
263072|NCT02561780|Mental Health Knowledge|mental health knowledge
263073|NCT02561780|Stigma|stigma
263074|NCT02561780|Mental Health Literacy|mental health literacy
263075|NCT02561767|kidney transplantation|kidney transplantation
263076|NCT02561767|mesenchymal stem cell|mesenchymal stem cell
263077|NCT02561767|donation after citizen's death|donation after citizen's death
336259|NCT02158988|HIPEC|hipec
263078|NCT02561767|ischemia reperfusion injury|ischemia reperfusion injury
263079|NCT02561767|renal function recovery|renal function recovery
263080|NCT02561754|Diet|diet
263081|NCT02561754|Obesity|obesity
263082|NCT02561754|Adolescents|adolescents
263083|NCT02561754|Intellectual and Developmental Disability|intellectual and developmental disability
263084|NCT02561728|Helmet|helmet
263085|NCT02561728|Hangar|hangar
263086|NCT02561728|P-Pod|p-pod
263087|NCT02561728|Plagiocephaly|plagiocephaly
263088|NCT02561728|Surgery|surgery
263089|NCT02561715|Parkinson's|parkinson's
263090|NCT02561715|Anosognosia|anosognosia
263091|NCT02561715|DBS|dbs
263092|NCT02561715|Deep Brain Surgery|deep brain surgery
263093|NCT02561689|Occlusal caries|occlusal caries
263094|NCT02561689|Resin fissure sealant|resin fissure sealant
263095|NCT02561689|Longevity|longevity
263096|NCT02561689|Effectiveness|effectiveness
263097|NCT02561676|Mindfulness|mindfulness
263098|NCT02561676|Spinal Cord Injury|spinal cord injury
263099|NCT02561663|microcirculation|microcirculation
263100|NCT02561663|blood pressure|blood pressure
263101|NCT02561663|pulse wave analysis|pulse wave analysis
263102|NCT02561663|pulse wave velocity|pulse wave velocity
263103|NCT02561637|Case management|case management
263104|NCT02561624|mHealth|mhealth
263105|NCT02561624|Text message|text message
263106|NCT02561611|Pedal Desk|pedal desk
263107|NCT02561611|Workplace Intervention|workplace intervention
263108|NCT02561611|Physical Activity|physical activity
263109|NCT02561611|Energy Expenditure|energy expenditure
263110|NCT02561546|concurrent|concurrent
263111|NCT02561520|platelet rich plasma|platelet rich plasma
263112|NCT02561520|platelet poor plasma|platelet poor plasma
263113|NCT02561520|ocular GVHD|ocular gvhd
263114|NCT02561455|Advanced solid tumors|advanced solid tumors
263115|NCT02561455|Acute myeloid leukemia|acute myeloid leukemia
263116|NCT02561455|gilteritinib|gilteritinib
263117|NCT02561455|ASP2215|asp2215
263118|NCT02561416|Fibromyalgia syndrome|fibromyalgia syndrome
263119|NCT02561416|Mindfulness (MBSR)|mindfulness (mbsr)
263120|NCT02561416|Neuroimaging|neuroimaging
263121|NCT02561416|Cytokines|cytokines
263122|NCT02561416|Randomized Controlled Trial|randomized controlled trial
263123|NCT02561416|Cost-effectiveness|cost-effectiveness
263124|NCT02561416|Psychoeducation (FibroQol)|psychoeducation (fibroqol)
263125|NCT02561403|traumatic brain injury (TBI)|traumatic brain injury (tbi)
263126|NCT02561403|aging|aging
263127|NCT02561403|cognitive training|cognitive training
263128|NCT02561403|Cognitive Aging|cognitive aging
263129|NCT02561377|resistance training|resistance training
263130|NCT02561377|Prediabetic state|prediabetic state
263131|NCT02561377|Metabolomics|metabolomics
263132|NCT02561364|Fetal Biophysical Profile|fetal biophysical profile
263133|NCT02561351|bronchial asthma|bronchial asthma
263134|NCT02561351|fractional exhaled nitric oxide (FeNO)|fractional exhaled nitric oxide (feno)
263135|NCT02561351|asthma exacerbation|asthma exacerbation
263136|NCT02561338|GKA,T2DM,HMS5552|gka,t2dm,hms5552
263137|NCT02561325|Blood pressure|blood pressure
263138|NCT02561325|Sodium Chloride|sodium chloride
263139|NCT02561325|Sodium Bicarbonate|sodium bicarbonate
263140|NCT02561299|Drug-coated Balloons|drug-coated balloons
263141|NCT02561299|Calcified Lesions|calcified lesions
263142|NCT02561299|Orbital Atherectomy|orbital atherectomy
263143|NCT02561299|Below the Knee|below the knee
263144|NCT02561299|Paclitaxel|paclitaxel
263145|NCT02561299|Lutonix 014 Drug-coated Balloon|lutonix 014 drug-coated balloon
263146|NCT02561286|Human immunodeficiency virus|human immunodeficiency virus
263147|NCT02561286|Sexually transmitted disease|sexually transmitted disease
263148|NCT02561286|Men who have sex with men|men who have sex with men
263149|NCT02561286|African Americans|african americans
263150|NCT02561286|Behavioral intervention|behavioral intervention
263151|NCT02561286|Randomized controlled trial|randomized controlled trial
263152|NCT02561286|Sexual behavior|sexual behavior
263153|NCT02561286|Mediation analysis|mediation analysis
263154|NCT02561286|Social cognitive theory|social cognitive theory
263155|NCT02561286|Theory of planned behavior|theory of planned behavior
263156|NCT02561247|Acute Kidney Injury|acute kidney injury
263157|NCT02561247|Continuous Renal Replacement Therapy|continuous renal replacement therapy
263158|NCT02561247|Blood Urea Nitrogen (BUN)|blood urea nitrogen (bun)
263159|NCT02561247|Prismaflex|prismaflex
263160|NCT02561247|Pediatric|pediatric
263161|NCT02561221|primary care|primary care
263162|NCT02561221|pragmatic trial|pragmatic trial
263163|NCT02561221|weight loss|weight loss
263164|NCT02561221|overweight|overweight
263165|NCT02561221|diet|diet
263166|NCT02561221|physical activity|physical activity
263167|NCT02561221|PCORI|pcori
263168|NCT02561208|Patient adherence|patient adherence
263169|NCT02561208|Mobile Health|mobile health
263170|NCT02561208|HPV DNA Tests|hpv dna tests
263171|NCT02561208|Self-collected|self-collected
263172|NCT02561195|Clostridium difficile, Vaccine.|clostridium difficile, vaccine.
263173|NCT02561169|antiviral|antiviral
263174|NCT02561169|oseltamivir|oseltamivir
336486|NCT02158026|IVF|ivf
263175|NCT02561156|Drug therapy|drug therapy
263176|NCT02561143|cachexia|cachexia
263177|NCT02561143|nutrition supplementation|nutrition supplementation
263178|NCT02561143|IAtta|iatta
263179|NCT02561143|palliative care|palliative care
263180|NCT02561143|quality of life|quality of life
263181|NCT02561130|Diabetes|diabetes
263182|NCT02561130|Insulin|insulin
263183|NCT02561130|Glargine|glargine
263184|NCT02561130|Metformin|metformin
263185|NCT02561130|Forxiga|forxiga
263186|NCT02561130|Diet|diet
263187|NCT02561130|Exercise|exercise
263188|NCT02561130|Lifestyle|lifestyle
263189|NCT02561104|cataract|cataract
263190|NCT02561104|phacoemulsification|phacoemulsification
263191|NCT02561104|laser-assisted surgery|laser-assisted surgery
263192|NCT02561104|femtosecond laser|femtosecond laser
263193|NCT02561091|Deafness|deafness
263194|NCT02561091|Hearing Loss, Sensorineural|hearing loss, sensorineural
263195|NCT02561091|Ear Diseases|ear diseases
263196|NCT02561091|Hearing Disorders|hearing disorders
263197|NCT02561091|Otorhinolaryngologic Diseases|otorhinolaryngologic diseases
263198|NCT02561091|Sensation Disorders|sensation disorders
263199|NCT02561091|Signs and Symptoms|signs and symptoms
263200|NCT02561091|Hearing and Speech impairment|hearing and speech impairment
263201|NCT02561091|Hearing Loss, Unilateral|hearing loss, unilateral
263202|NCT02561078|insulin pumps|insulin pumps
263203|NCT02561078|concentrated insulin|concentrated insulin
263204|NCT02561078|OmniPod|omnipod
263205|NCT02561065|Health Lifestyle|health lifestyle
263206|NCT02561065|Lifestyle Risk Reduction|lifestyle risk reduction
263207|NCT02561065|Health Behavior|health behavior
263208|NCT02561065|Sedentary Lifestyle|sedentary lifestyle
263209|NCT02561065|Intervention Studies|intervention studies
263210|NCT02561065|Cardiovascular risk in office workers|cardiovascular risk in office workers
263211|NCT02561065|Motivational Interview|motivational interview
263212|NCT02561065|Preventive health services|preventive health services
263213|NCT02561065|Health education|health education
263214|NCT02561065|Physical activity|physical activity
263215|NCT02561065|Dietary behaviour intervention|dietary behaviour intervention
263216|NCT02561065|Workplace|workplace
263217|NCT02561026|Frozen plasma|frozen plasma
263218|NCT02561026|INR|inr
263219|NCT02561026|procedures|procedures
263220|NCT02561000|Platelets|platelets
263221|NCT02561000|Platelet Aggregation Inhibitors|platelet aggregation inhibitors
263222|NCT02561000|Protease-Activated Receptor 1|protease-activated receptor 1
263223|NCT02561000|Hemorrhage|hemorrhage
263224|NCT02560961|Kinesio Taping|kinesio taping
263225|NCT02560961|Soccer|soccer
263226|NCT02560961|Hop Test|hop test
263227|NCT02560961|Vertical Jump|vertical jump
263228|NCT02560935|primary stroke prevention|primary stroke prevention
263229|NCT02560935|hydroxyurea|hydroxyurea
263230|NCT02560935|low income country|low income country
263231|NCT02560935|sub-Saharan Africa|sub-saharan africa
263232|NCT02560922|Osteoarthritis|osteoarthritis
263233|NCT02560922|Knee Osteoarthritis|knee osteoarthritis
263234|NCT02560922|Hip Osteoarthritis|hip osteoarthritis
263235|NCT02560896|Family|family
263236|NCT02560896|History|history
263237|NCT02560896|Pancreas|pancreas
263238|NCT02560896|Cancer|cancer
263239|NCT02560896|Genetic|genetic
263240|NCT02560883|Hairy Cell|hairy cell
263241|NCT02560857|Quantiferon-Monitor|quantiferon-monitor
263242|NCT02560857|organ rejection|organ rejection
263243|NCT02560857|global immunity|global immunity
263244|NCT02560831|Osteoarthritis|osteoarthritis
263245|NCT02560831|Therapeutic exercises|therapeutic exercises
263246|NCT02560831|Pain|pain
263247|NCT02560831|Muscle strength|muscle strength
263248|NCT02560831|Postural balance|postural balance
263249|NCT02560818|splice profiles of messenger RNA|splice profiles of messenger rna
263250|NCT02560779|TRC105|trc105
263251|NCT02560779|CD105|cd105
263252|NCT02560779|Endoglin|endoglin
263253|NCT02560779|Angiogenesis inhibitor|angiogenesis inhibitor
263254|NCT02560779|HCC|hcc
263255|NCT02560779|TKI|tki
263256|NCT02560779|Tyrosine Kinase Inhibitor|tyrosine kinase inhibitor
263257|NCT02560779|Sorafenib|sorafenib
263258|NCT02560779|Nexavar|nexavar
263259|NCT02560766|Restless Leg Syndrome|restless leg syndrome
263260|NCT02560766|RLS|rls
263261|NCT02560727|Inflammatory Bowel Diseases|inflammatory bowel diseases
263262|NCT02560727|Fecal Microbiota Transplantation|fecal microbiota transplantation
263263|NCT02560727|transendoscopic enteral tubing|transendoscopic enteral tubing
263264|NCT02560714|sacroiliac joint fusion|sacroiliac joint fusion
263265|NCT02560714|SIJ Fusion|sij fusion
263266|NCT02560714|SI Joint|si joint
263267|NCT02560714|SIJ|sij
263268|NCT02560701|high-deductible health plans|high-deductible health plans
263269|NCT02560701|medication adherence|medication adherence
263270|NCT02560688|drug interaction|drug interaction
263271|NCT02560688|clopidogrel|clopidogrel
263272|NCT02560688|healthy subjects|healthy subjects
263273|NCT02560675|Whiplash Injury Pain|whiplash injury pain
263274|NCT02560675|Chronic Pain|chronic pain
263275|NCT02560675|TBI|tbi
263276|NCT02560662|Breast cancer, physical exercise, recovery|breast cancer, physical exercise, recovery
263277|NCT02560636|Muscle Invasive|muscle invasive
263278|NCT02560636|Metastatic|metastatic
263279|NCT02560636|Advanced|advanced
263280|NCT02560623|Barrett's|barrett's
263281|NCT02560623|esophagus|esophagus
263282|NCT02560623|reflux|reflux
263283|NCT02560623|esophageal adenocarcinoma|esophageal adenocarcinoma
263284|NCT02560597|epilepsy|epilepsy
263285|NCT02560597|epilepsia partialis continua|epilepsia partialis continua
263286|NCT02560597|status epilepticus|status epilepticus
263287|NCT02560597|treatment resistant|treatment resistant
263288|NCT02560597|repetitive transcranial magnetic stimulation|repetitive transcranial magnetic stimulation
263289|NCT02560584|Non-muscle invasive bladder cancer|non-muscle invasive bladder cancer
263290|NCT02560584|NMIBC|nmibc
263291|NCT02560584|Cysview|cysview
263292|NCT02560558|Immunosuppression|immunosuppression
263293|NCT02560558|Transplantation Immunology|transplantation immunology
263294|NCT02560532|aneurysmal subarachnoid hemorrhage|aneurysmal subarachnoid hemorrhage
263295|NCT02560532|cerebral vasospasm|cerebral vasospasm
263296|NCT02560532|clazosentan|clazosentan
263297|NCT02560519|human serum albumin solution|human serum albumin solution
263298|NCT02560519|Cardiopulmonary Bypass|cardiopulmonary bypass
263299|NCT02560493|BMIz|bmiz
263300|NCT02560493|Exergaming|exergaming
263301|NCT02560493|Cardiovascular Disease|cardiovascular disease
263302|NCT02560480|groin pain, groin injury, magnetic resonance imaging|groin pain, groin injury, magnetic resonance imaging
263303|NCT02560454|Cognitive Remediation|cognitive remediation
263304|NCT02560454|Working Memory Training|working memory training
263305|NCT02560454|Cognitive training|cognitive training
263306|NCT02560428|Mixed Methods|mixed methods
263307|NCT02560428|Cardiovascular Health|cardiovascular health
263308|NCT02560428|Implementation Evaluation|implementation evaluation
263309|NCT02560428|Cardiovascular Prevention Screening|cardiovascular prevention screening
263310|NCT02560415|Autism Spectrum Disorder|autism spectrum disorder
263311|NCT02560415|Serious Game|serious game
263312|NCT02560415|Controlled trial|controlled trial
263313|NCT02560415|Denver model|denver model
263314|NCT02560402|Glomerular hyperfiltration|glomerular hyperfiltration
263315|NCT02560402|Renal Resistive Index (RRI)|renal resistive index (rri)
263316|NCT02560389|Posttraumatic Stress Disorder|posttraumatic stress disorder
263317|NCT02560389|functional Magnetic Resonance Imaging|functional magnetic resonance imaging
263318|NCT02560389|Levodopa (L-DOPA)|levodopa (l-dopa)
263319|NCT02560389|Exposure Therapy|exposure therapy
263320|NCT02560389|Fear Extinction|fear extinction
263321|NCT02560376|PET/CT|pet/ct
263322|NCT02560376|glucagon-like peptide-1 receptor (GLP-1R) imaging|glucagon-like peptide-1 receptor (glp-1r) imaging
263323|NCT02560363|AZD9977|azd9977
263324|NCT02560363|Safety|safety
263325|NCT02560363|Tolerability|tolerability
263326|NCT02560363|Pharmacokinetics|pharmacokinetics
263327|NCT02560363|Food effect|food effect
263328|NCT02560363|AZD9977 capsules|azd9977 capsules
263329|NCT02560363|AZD9977 suspension|azd9977 suspension
263330|NCT02560350|adipose-derived stem cells|adipose-derived stem cells
263331|NCT02560350|small intestinal submucosa|small intestinal submucosa
263332|NCT02560350|adipocyte-containing hypodermis|adipocyte-containing hypodermis
263333|NCT02560337|Ovarian cancer|ovarian cancer
263334|NCT02560337|Relapse|relapse
263335|NCT02560337|Recurrence|recurrence
263336|NCT02560337|Chemotherapy resistance|chemotherapy resistance
263337|NCT02560324|Ramelteon|ramelteon
263338|NCT02560324|Nicotine|nicotine
263339|NCT02560324|Nicotine dependence|nicotine dependence
263340|NCT02560324|Insomnia|insomnia
263341|NCT02560324|Tobacco Dependence|tobacco dependence
263342|NCT02560285|Risk assessment|risk assessment
263343|NCT02560285|Mortality|mortality
263344|NCT02560285|Morbidity|morbidity
263345|NCT02560285|Risk factor|risk factor
263346|NCT02560272|vaccine|vaccine
263347|NCT02560272|haemophilus influenzae type b|haemophilus influenzae type b
263348|NCT02560259|knee pain|knee pain
263349|NCT02560246|Microbiome|microbiome
263350|NCT02560233|Neurofeedback|neurofeedback
263351|NCT02560233|Stress|stress
263352|NCT02560233|fMRI|fmri
263353|NCT02560233|Real-time fMRI Neurofeedback|real-time fmri neurofeedback
263354|NCT02560233|Anterior cingulate cortex|anterior cingulate cortex
263355|NCT02560233|Hypothalamic-pituitary-adrenal axis|hypothalamic-pituitary-adrenal axis
263356|NCT02560233|Cortisol|cortisol
263357|NCT02560233|EEG|eeg
263358|NCT02560233|Heart rate variability|heart rate variability
263359|NCT02560233|Blood pressure|blood pressure
263360|NCT02560233|Simultaneous EEG/fMRI|simultaneous eeg/fmri
263361|NCT02560181|recurrent prostate cancer, HDR whole gland salvage|recurrent prostate cancer, hdr whole gland salvage
263362|NCT02560168|Coronary artery disease|coronary artery disease
263363|NCT02560168|iECG|iecg
263364|NCT02560168|MyoVista|myovista
263365|NCT02560168|Heart Test Labs|heart test labs
263366|NCT02560168|Wavelet analysis|wavelet analysis
263367|NCT02560168|Surface electrocardiogram|surface electrocardiogram
263368|NCT02560155|Orthopedic surgery|orthopedic surgery
263369|NCT02560155|Surgical site infection|surgical site infection
336622|NCT02157324|Btk|btk
263370|NCT02560155|Decolonization|decolonization
263371|NCT02560155|Staphylococcus aureus|staphylococcus aureus
263372|NCT02560129|recovery|recovery
263374|NCT02560129|clinic|clinic
263375|NCT02560129|survivor|survivor
263376|NCT02560129|physical function|physical function
263377|NCT02560116|Pulmonary artery systolic pressure|pulmonary artery systolic pressure
263378|NCT02560116|Optison|optison
263379|NCT02560090|Diabetes|diabetes
263380|NCT02560077|cognitive|cognitive
263381|NCT02560077|memory|memory
263382|NCT02560077|physical fitness|physical fitness
263383|NCT02560077|psychological fitness|psychological fitness
263384|NCT02560077|elderly|elderly
263385|NCT02560077|middle aged|middle aged
263386|NCT02560051|Prostate Cancer|prostate cancer
263387|NCT02560051|Advanced|advanced
263388|NCT02560051|Local Failures|local failures
263389|NCT02560038|Urothelial Cancer|urothelial cancer
263390|NCT02560038|Bladder Cancer|bladder cancer
263391|NCT02560038|Metastatic|metastatic
263392|NCT02560025|Acute Myeloid Leukemia|acute myeloid leukemia
263393|NCT02560012|Renal Cell Carcinoma|renal cell carcinoma
263394|NCT02560012|RCC|rcc
263395|NCT02560012|Personalized therapy|personalized therapy
263396|NCT02560012|targeted inhibitors|targeted inhibitors
263397|NCT02559999|Healthy Volunteers|healthy volunteers
263398|NCT02559999|Pain|pain
263399|NCT02559999|EEG|eeg
263400|NCT02559973|Buprenorphine|buprenorphine
263401|NCT02559973|opioid use disorder|opioid use disorder
263402|NCT02559921|Recombinant Human Rabies Immunoglobin (rhRIG)|recombinant human rabies immunoglobin (rhrig)
263403|NCT02559869|Biofluid|biofluid
263404|NCT02559869|ALS|als
263405|NCT02559869|MRI|mri
263406|NCT02559869|PET|pet
263407|NCT02559869|Imaging|imaging
263408|NCT02559869|Biomarkers|biomarkers
263409|NCT02559869|Amyotrophic Lateral Sclerosis|amyotrophic lateral sclerosis
263410|NCT02559869|TRACK ALS|track als
263411|NCT02559869|pathology|pathology
263412|NCT02559843|pomegranate|pomegranate
263413|NCT02559843|diabetes|diabetes
263414|NCT02559843|oxidative stress|oxidative stress
263415|NCT02559817|Irritable Bowel Syndrome with Constipation in children|irritable bowel syndrome with constipation in children
263416|NCT02559817|Linzess|linzess
263417|NCT02559791|Reslizumab|reslizumab
263418|NCT02559791|Eosinophils|eosinophils
263419|NCT02559791|Asthma|asthma
263420|NCT02559791|Airway inflammation|airway inflammation
263421|NCT02559791|Prednisone|prednisone
263422|NCT02559765|physiotherapy|physiotherapy
263423|NCT02559765|progressive multiple sclerosis|progressive multiple sclerosis
263424|NCT02559765|rehabilitation|rehabilitation
263425|NCT02559765|rehabilitation services|rehabilitation services
263426|NCT02559739|Stroke|stroke
263427|NCT02559739|Ischemic Attack, Transient|ischemic attack, transient
263428|NCT02559739|Cardiovascular Diseases|cardiovascular diseases
263429|NCT02559739|Sleep Apnea Syndromes|sleep apnea syndromes
263430|NCT02559739|Sleep Initiation and Maintenance Disorders|sleep initiation and maintenance disorders
263431|NCT02559739|Insomnia|insomnia
263432|NCT02559739|Restless Legs Syndrome|restless legs syndrome
263433|NCT02559739|Sleep Deprivation|sleep deprivation
263434|NCT02559726|Hypertrophic cardiomyopathy, hyper-synchronicity, outflow-tract obstruction, dual chamber pacing|hypertrophic cardiomyopathy, hyper-synchronicity, outflow-tract obstruction, dual chamber pacing
263435|NCT02559713|Lactation|lactation
263436|NCT02559713|Lactating Women|lactating women
263437|NCT02559713|Vedolizumab|vedolizumab
263438|NCT02559713|Colitis Ulcerative|colitis ulcerative
263439|NCT02559713|Crohn Disease|crohn disease
263440|NCT02559713|Crohn's|crohn's
263441|NCT02559700|Healthy Ageing|healthy ageing
263442|NCT02559687|Programmed Cell Death-1 (PD-1, PD1)|programmed cell death-1 (pd-1, pd1)
263443|NCT02559687|Programmed Cell Death-Ligand 1 (PD-L1, PDL1)|programmed cell death-ligand 1 (pd-l1, pdl1)
263444|NCT02559687|Programmed Cell Death-Ligand 2 (PD-L2, PDL2)|programmed cell death-ligand 2 (pd-l2, pdl2)
263445|NCT02559674|Pancreas|pancreas
263446|NCT02559674|Pancreatic|pancreatic
263447|NCT02559674|Cancer|cancer
263448|NCT02559674|Advanced Pancreatic Cancer|advanced pancreatic cancer
263449|NCT02559674|Immunotherapy|immunotherapy
263450|NCT02559674|Immunotherapeutic|immunotherapeutic
263451|NCT02559674|Interleukin-15|interleukin-15
263452|NCT02559674|Gemcitabine|gemcitabine
263453|NCT02559674|Nab-paclitaxel|nab-paclitaxel
263454|NCT02559674|Solid Tumor|solid tumor
263455|NCT02559674|Metastatic Disease|metastatic disease
263456|NCT02559674|Combination Immunotherapy|combination immunotherapy
263457|NCT02559583|Multiple Myeloma|multiple myeloma
263458|NCT02559583|chronic lymphocytic leukemia|chronic lymphocytic leukemia
263459|NCT02559583|Non-Hodgkin lymphoma|non-hodgkin lymphoma
263460|NCT02559570|Functional constipation in children|functional constipation in children
263461|NCT02559570|LINZESS|linzess
263462|NCT02559518|Cerebellum|cerebellum
263463|NCT02559518|Transcranial Direct Current Stimulation|transcranial direct current stimulation
263464|NCT02559518|Repetitive Transcranial Magnetic Stimulation|repetitive transcranial magnetic stimulation
263465|NCT02559518|Motor Learning|motor learning
712531|NCT00579813|diabetes|diabetes
263466|NCT02559518|Serial Reaction Time Task|serial reaction time task
263467|NCT02559518|HandwritingTask|handwritingtask
263468|NCT02559505|natural influenza infection|natural influenza infection
263469|NCT02559505|live attenuated influenza vaccination (LAIV)|live attenuated influenza vaccination (laiv)
263470|NCT02559505|inactivated influenza vaccination (IIV)|inactivated influenza vaccination (iiv)
263471|NCT02559505|infants|infants
263472|NCT02559505|children|children
263473|NCT02559466|pharmaco-resistant depressed patients|pharmaco-resistant depressed patients
263474|NCT02559427|sleep apnea|sleep apnea
263475|NCT02559427|Venous Insufficiency|venous insufficiency
263476|NCT02559427|SPA treatment|spa treatment
263477|NCT02559401|Eloquent cortex|eloquent cortex
263478|NCT02559349|Stereotactic Body Radiotherapy|stereotactic body radiotherapy
263479|NCT02559349|SBRT|sbrt
263480|NCT02559336|Palliative Care|palliative care
263481|NCT02559336|Cancer|cancer
263482|NCT02559336|Health Services Research|health services research
263483|NCT02559310|Pneumonia|pneumonia
263484|NCT02559310|CABP|cabp
263486|NCT02559310|Community acquired bacterial pneumonia|community acquired bacterial pneumonia
263487|NCT02559297|Regulatory T cells|regulatory t cells
263488|NCT02559297|Sevoflurane|sevoflurane
263489|NCT02559297|Desflurane|desflurane
263490|NCT02559297|Cytokines|cytokines
263491|NCT02559297|Flow cytometry|flow cytometry
263492|NCT02559297|Living Donor Kidney Transplant|living donor kidney transplant
263493|NCT02559284|Saline Solution, Isotonic / Administration & dosage|saline solution, isotonic / administration & dosage
263494|NCT02559284|Therapeutic Irrigation / methods|therapeutic irrigation / methods
263495|NCT02559284|Postoperative Care / methods|postoperative care / methods
263496|NCT02559284|Quality of life|quality of life
263497|NCT02559180|Diabetes|diabetes
263498|NCT02559180|Macular Edema|macular edema
263499|NCT02559180|Diabetic Retinopathy|diabetic retinopathy
263500|NCT02559141|haemodynamic optimization|haemodynamic optimization
263501|NCT02559141|cardiac index|cardiac index
263502|NCT02559141|non-invasive|non-invasive
263503|NCT02559141|pulse pressure variation|pulse pressure variation
263504|NCT02559128|Insulin Resistance|insulin resistance
263505|NCT02559128|Chronic Heart Failure|chronic heart failure
263506|NCT02559128|Type 2 Diabetes|type 2 diabetes
263507|NCT02559128|Endothelial Dysfunction|endothelial dysfunction
263508|NCT02559115|68Ga-RM2|68ga-rm2
263509|NCT02559115|PET/CT scan|pet/ct scan
263510|NCT02559115|Gastrin Releasing Peptide Receptor (GRPr)|gastrin releasing peptide receptor (grpr)
263511|NCT02559115|14-146|14-146
263512|NCT02559102|Dexmedetomidine sedation|dexmedetomidine sedation
263513|NCT02559102|General anaesthesia|general anaesthesia
263514|NCT02559102|Neurodevelopment|neurodevelopment
263515|NCT02559102|Infants|infants
263516|NCT02559102|Neonates|neonates
263517|NCT02559076|Overweight|overweight
263518|NCT02559076|Obesity|obesity
263519|NCT02559076|Preschool children|preschool children
263520|NCT02559076|United Arab Emirates|united arab emirates
263521|NCT02559076|Dietary patterns|dietary patterns
263522|NCT02559076|BMI z-scores|bmi z-scores
263523|NCT02559063|cognitive training|cognitive training
263524|NCT02559063|speed of processing|speed of processing
263525|NCT02559063|neuroplasticity|neuroplasticity
263526|NCT02559063|cognitive aging|cognitive aging
263527|NCT02559037|acupuncture|acupuncture
263528|NCT02559037|moxibustion|moxibustion
263529|NCT02559037|intestinal microbiota|intestinal microbiota
263530|NCT02559037|Mucosal immunity|mucosal immunity
263531|NCT02559024|Metastatic colorectal cancer|metastatic colorectal cancer
263532|NCT02559024|liver lesion|liver lesion
263533|NCT02559024|anti-OX40 antibody|anti-ox40 antibody
263534|NCT02559024|MEDI6469|medi6469
263535|NCT02559024|Immunotherapy|immunotherapy
263536|NCT02559011|Arrhythmias, Cardiac|arrhythmias, cardiac
263537|NCT02559011|Transcatheter Aortic Valve implantation|transcatheter aortic valve implantation
263538|NCT02559011|Aortic Valve Stenosis|aortic valve stenosis
263539|NCT02558985|Pulmonary Compliance|pulmonary compliance
263540|NCT02558985|Casting|casting
263541|NCT02558972|Postural Tachycardia Syndrome (POTS)|postural tachycardia syndrome (pots)
263542|NCT02558972|Vasovagal Syncope (VVS)|vasovagal syncope (vvs)
263543|NCT02558972|Fainting|fainting
263544|NCT02558972|Orthostatic Intolerance|orthostatic intolerance
263545|NCT02558972|Droxidopa|droxidopa
263546|NCT02558972|Northera|northera
263547|NCT02558933|Fetal Alcohol Syndrome|fetal alcohol syndrome
263548|NCT02558933|Prenatal exposure|prenatal exposure
263549|NCT02558933|Biomarkers|biomarkers
263550|NCT02558933|Oxidative stress|oxidative stress
263551|NCT02558933|Epigallocatechin gallate|epigallocatechin gallate
263552|NCT02558920|Systematic review and meta-analysis|systematic review and meta-analysis
263553|NCT02558920|Evidence-based medicine (EBM)|evidence-based medicine (ebm)
263554|NCT02558920|Evidence-based nutrition (EBN)|evidence-based nutrition (ebn)
263555|NCT02558920|Clinical practice guidelines|clinical practice guidelines
263556|NCT02558920|Clinical trials|clinical trials
263557|NCT02558920|Dietary sugars|dietary sugars
263558|NCT02558920|Fructose|fructose
263559|NCT02558920|Sucrose|sucrose
712532|NCT00579800|Vibrant-DE|vibrant-de
263560|NCT02558920|High fructose corn syrup|high fructose corn syrup
263562|NCT02558920|Hypercaloric|hypercaloric
263563|NCT02558920|Body weight|body weight
263564|NCT02558920|Prospective cohort studies|prospective cohort studies
263565|NCT02558907|geriatrics|geriatrics
263566|NCT02558907|cancer|cancer
263567|NCT02558907|MMS test|mms test
263568|NCT02558907|MoCA test|moca test
263569|NCT02558907|cognitive evaluation|cognitive evaluation
263570|NCT02558894|Pancreatic Ductal Adenocarcinoma, PDAC|pancreatic ductal adenocarcinoma, pdac
263571|NCT02558881|screening|screening
263572|NCT02558881|colorectal cancer|colorectal cancer
263573|NCT02558881|colon capsule|colon capsule
263574|NCT02558881|virtual colonoscopy|virtual colonoscopy
263575|NCT02558855|Thrust Joint Manipulation|thrust joint manipulation
263576|NCT02558855|Non-thrust Joint Manipulation|non-thrust joint manipulation
263577|NCT02558855|Transversus Abdominis|transversus abdominis
263578|NCT02558829|Adult Growth Hormone Deficiency|adult growth hormone deficiency
263579|NCT02558803|HPV Vaccinations|hpv vaccinations
263580|NCT02558803|Quadrivalent Vaccine|quadrivalent vaccine
263581|NCT02558790|Attention Deficit/Hyperactivity Disorder|attention deficit/hyperactivity disorder
263582|NCT02558790|ADHD|adhd
263583|NCT02558790|Attention Deficit Disorder|attention deficit disorder
263584|NCT02558790|ADD|add
263585|NCT02558790|Magnesium|magnesium
263586|NCT02558777|Delirium|delirium
263587|NCT02558777|Pilot Study|pilot study
263588|NCT02558777|Nurse intervention|nurse intervention
263589|NCT02558777|Hospitalization|hospitalization
263590|NCT02558751|pneumococcal conjugate vaccine|pneumococcal conjugate vaccine
263591|NCT02558751|aging HIV|aging hiv
263592|NCT02558738|dermatitis and irritations at the outer ear canal|dermatitis and irritations at the outer ear canal
263593|NCT02558738|prevention of subacute otitis externa|prevention of subacute otitis externa
263594|NCT02558712|screening|screening
263595|NCT02558712|tele-ophthalmology|tele-ophthalmology
263596|NCT02558686|trigger points|trigger points
263597|NCT02558686|disability|disability
263598|NCT02558686|post-dry needling soreness|post-dry needling soreness
263599|NCT02558686|eccentric exercise|eccentric exercise
263600|NCT02558673|Trimethylamine-N-oxide|trimethylamine-n-oxide
263601|NCT02558673|Biomarkers|biomarkers
263602|NCT02558673|Production|production
263603|NCT02558673|Metabolism|metabolism
263604|NCT02558673|Gut microbiome|gut microbiome
263605|NCT02558673|Healthy|healthy
263606|NCT02558660|Supplemental Nutrition Incentive Program (SNAP)|supplemental nutrition incentive program (snap)
263607|NCT02558660|economic incentive|economic incentive
263608|NCT02558647|therapy|therapy
263609|NCT02558647|CBT-I|cbt-i
263610|NCT02558647|internet-based|internet-based
263611|NCT02558647|online|online
263612|NCT02558647|short-term benefits|short-term benefits
263613|NCT02558647|medium-term outcomes|medium-term outcomes
263614|NCT02558647|health resource use|health resource use
263615|NCT02558647|sick leave|sick leave
263616|NCT02558621|Robotic Spinal Fusion Surgery|robotic spinal fusion surgery
263617|NCT02558608|Prime Spontaneous Pneumothorax|prime spontaneous pneumothorax
263618|NCT02558608|recurrence|recurrence
263619|NCT02558595|PKD|pkd
263620|NCT02558595|Kidney disease|kidney disease
263621|NCT02558595|Vitamin B3|vitamin b3
263622|NCT02558582|Pulmonary arterial hypertension|pulmonary arterial hypertension
263623|NCT02558582|Chronic thromboembolic pulmonary hypertension|chronic thromboembolic pulmonary hypertension
263624|NCT02558582|Rehabilitation|rehabilitation
263625|NCT02558582|Oxygen|oxygen
263626|NCT02558569|fentanyl, scalp block|fentanyl, scalp block
263627|NCT02558556|Laparoscopic cholecystectomy (LC)|laparoscopic cholecystectomy (lc)
263628|NCT02558556|Indocyanine green (ICG)|indocyanine green (icg)
263629|NCT02558556|Near-Infrared Fluorescence Imaging (NIRF)|near-infrared fluorescence imaging (nirf)
263630|NCT02558556|Critical View of Safety (CVS)|critical view of safety (cvs)
263631|NCT02558517|Systemic Lupus Erythematosus|systemic lupus erythematosus
263632|NCT02558517|Corticosteroids|corticosteroids
263633|NCT02558517|Chronic disease|chronic disease
263634|NCT02558491|Type 1 Diabetes Mellitus (T1DM)|type 1 diabetes mellitus (t1dm)
263635|NCT02558491|Artificial Pancreas Project (APP)|artificial pancreas project (app)
263636|NCT02558491|Diabetes Assistant (DiAs)|diabetes assistant (dias)
263637|NCT02558491|Insulin Pump|insulin pump
263638|NCT02558491|Continuous Glucose Monitor|continuous glucose monitor
263639|NCT02558491|Exercise|exercise
263640|NCT02558491|Glucose Variability|glucose variability
263641|NCT02558491|Decision Support System|decision support system
263642|NCT02558491|Multiple Daily Injections (MDI)|multiple daily injections (mdi)
263643|NCT02558478|Whole exome sequencing|whole exome sequencing
263644|NCT02558465|Xarelto, rivaroxaban, VTE, PE, DVT, Japan, PMS, SDUI|xarelto, rivaroxaban, vte, pe, dvt, japan, pms, sdui
263645|NCT02558452|elderly kidney transplant recipient|elderly kidney transplant recipient
263646|NCT02558452|registry|registry
263647|NCT02558452|tacrolimus once daily|tacrolimus once daily
263648|NCT02558426|Chronic Venous Disease|chronic venous disease
263649|NCT02558426|Estrogen receptors|estrogen receptors
263650|NCT02558426|GPER|gper
263651|NCT02558413|Viral Diseases|viral diseases
263652|NCT02558413|Antiviral|antiviral
263653|NCT02558413|Paramyxoviridae Infections|paramyxoviridae infections
263654|NCT02558413|RSV|rsv
263655|NCT02558413|Respiratory Syncytial Virus|respiratory syncytial virus
263656|NCT02558413|Aviragen Therapeutics, Inc.|aviragen therapeutics, inc.
263657|NCT02558413|Aviragen Therapeutics|aviragen therapeutics
263658|NCT02558413|Aviragen|aviragen
263659|NCT02558348|Dual receptor Tyrosine Kinase Inhibitor|dual receptor tyrosine kinase inhibitor
263660|NCT02558348|Anti-angiogenic therapy|anti-angiogenic therapy
263661|NCT02558257|Advanced Cancers|advanced cancers
263662|NCT02558257|Survey|survey
263663|NCT02558257|Questionnaire|questionnaire
263664|NCT02558244|Childhood Cancer|childhood cancer
263665|NCT02558244|Image-defined Risk Factors|image-defined risk factors
263666|NCT02558244|Pediatric Oncology|pediatric oncology
263668|NCT02558192|Probiotics|probiotics
263669|NCT02558192|nosocomial infection prevention|nosocomial infection prevention
263670|NCT02558192|pediatrics|pediatrics
263671|NCT02558166|Acute Kidney Injury (AKI)|acute kidney injury (aki)
263672|NCT02558166|Renal Resistive Index (RRI)|renal resistive index (rri)
263673|NCT02558153|drug eluting balloon|drug eluting balloon
263674|NCT02558153|percutaneous balloon angioplasty|percutaneous balloon angioplasty
263675|NCT02558127|asthma|asthma
263676|NCT02558127|cystic fibrosis|cystic fibrosis
263677|NCT02558101|Screening|screening
263678|NCT02558101|Early detection|early detection
263679|NCT02558101|Health inequality|health inequality
263680|NCT02558101|Uptake|uptake
263681|NCT02558088|salmeterol|salmeterol
263682|NCT02558088|pharmacokinetics|pharmacokinetics
263683|NCT02558088|doping|doping
263684|NCT02558088|beta2-agonists|beta2-agonists
263685|NCT02558088|long-acting beta2-agonists|long-acting beta2-agonists
263686|NCT02558062|Ventilator Associated Pneumonia|ventilator associated pneumonia
263687|NCT02558062|Distal lung|distal lung
263688|NCT02558049|Patient decision aid|patient decision aid
263689|NCT02558036|Head Neck Position Videolaryngoscopy|head neck position videolaryngoscopy
263690|NCT02558023|PRE-ECLAMPSIA|pre-eclampsia
263691|NCT02558023|URAPIDIL|urapidil
263692|NCT02558023|NICARDIPINE|nicardipine
263693|NCT02558010|Methadone|methadone
263694|NCT02558010|Gabapentin|gabapentin
263695|NCT02558010|Postoperative Pain|postoperative pain
263696|NCT02558010|Posterior Spinal Fusion|posterior spinal fusion
263697|NCT02558010|Pediatric|pediatric
263698|NCT02557997|HIV reservoir|hiv reservoir
263699|NCT02557997|HIV-1 DNA|hiv-1 dna
263700|NCT02557997|Immune activation|immune activation
263701|NCT02557997|Monocyte function|monocyte function
263702|NCT02557997|Activation biomarkers|activation biomarkers
263703|NCT02557984|Dopamine|dopamine
263704|NCT02557984|Opioid|opioid
263705|NCT02557984|Reward|reward
263706|NCT02557958|COPD, pulmonary disease|copd, pulmonary disease
263707|NCT02557932|PPI standard triple therapy|ppi standard triple therapy
263708|NCT02557932|Bismuth quadruple therapy|bismuth quadruple therapy
263709|NCT02557932|Helicobacter|helicobacter
263710|NCT02557906|Acellular dermal matrix|acellular dermal matrix
263711|NCT02557906|ADM|adm
263712|NCT02557906|SurgiMend|surgimend
263713|NCT02557906|Breast reconstruction|breast reconstruction
263714|NCT02557906|Immediate breast reconstruction|immediate breast reconstruction
263715|NCT02557906|Autologous reconstruction|autologous reconstruction
263716|NCT02557906|Biological mesh|biological mesh
263717|NCT02557867|dexmedetomidine|dexmedetomidine
263718|NCT02557867|pharmacokinetic|pharmacokinetic
263719|NCT02557867|obesity|obesity
263720|NCT02557841|Cerebellum|cerebellum
263721|NCT02557841|Transcranial Direct Current Stimulation|transcranial direct current stimulation
263722|NCT02557841|Motor Learning|motor learning
263723|NCT02557841|Serial Reaction Time Task|serial reaction time task
263724|NCT02557841|Handwriting|handwriting
263725|NCT02557815|Repetitive Transcranial Magnetic Stimulation|repetitive transcranial magnetic stimulation
263726|NCT02557815|Emotion Regulation|emotion regulation
263727|NCT02557815|Craving|craving
263728|NCT02557789|Absolute bioavailability|absolute bioavailability
263729|NCT02557789|Pharmacokinetics|pharmacokinetics
263730|NCT02557776|BRCA1|brca1
263731|NCT02557776|BRCA2|brca2
263732|NCT02557776|hereditary breast cancer|hereditary breast cancer
263733|NCT02557776|genetic counseling|genetic counseling
263734|NCT02557763|Oxford UKA|oxford uka
263735|NCT02557763|anterior knee pain|anterior knee pain
263736|NCT02557763|lateral facet of patella|lateral facet of patella
263737|NCT02557750|Childhood Cancer|childhood cancer
263738|NCT02557750|Pediatric Oncology|pediatric oncology
263739|NCT02557737|stroke|stroke
263740|NCT02557737|upper extremity|upper extremity
263741|NCT02557737|spasticity|spasticity
263742|NCT02557737|botulinum toxin|botulinum toxin
263743|NCT02557737|ultrasonography|ultrasonography
263744|NCT02557737|electric stimulation|electric stimulation
263745|NCT02557711|spasticity|spasticity
263746|NCT02557711|stroke|stroke
263747|NCT02557711|ultrasound elastography|ultrasound elastography
263748|NCT02557711|acoustic radiation force impulse|acoustic radiation force impulse
263749|NCT02557659|Low Profile|low profile
263750|NCT02557659|Abdominal Aortic Aneurysms|abdominal aortic aneurysms
263751|NCT02557659|Endovascular|endovascular
263752|NCT02557594|Hepatitis B|hepatitis b
263753|NCT02557568|nasal carriage|nasal carriage
263754|NCT02557568|Staphylococcus aureus|staphylococcus aureus
263755|NCT02557568|hemodialysis patients|hemodialysis patients
263756|NCT02557542|Varicose Veins; One Stop Clinic|varicose veins; one stop clinic
263757|NCT02557529|Head and Neck Cancer|head and neck cancer
263758|NCT02557529|Concomitant chemoradiotherapy|concomitant chemoradiotherapy
263759|NCT02557529|Exercise Training|exercise training
263760|NCT02557529|Progressive Resistance Training|progressive resistance training
263761|NCT02557529|Weight loss|weight loss
263762|NCT02557529|Lean Body Mass|lean body mass
263763|NCT02557529|Body Composition|body composition
263764|NCT02557503|TACE; oxaliplatin; fluorouracil; liver cancer|tace; oxaliplatin; fluorouracil; liver cancer
263765|NCT02557490|TACE; hepatic artery infusion; oxaliplatin; raltitrexed|tace; hepatic artery infusion; oxaliplatin; raltitrexed
263766|NCT02557464|semantic memory|semantic memory
263767|NCT02557464|eye movements|eye movements
263768|NCT02557464|reading|reading
263769|NCT02557438|Bone|bone
263770|NCT02557438|Child Health|child health
263771|NCT02557438|Nutrition|nutrition
263772|NCT02557425|malaria|malaria
263773|NCT02557425|infant|infant
263774|NCT02557425|pregnancy|pregnancy
263775|NCT02557425|prophylaxis|prophylaxis
263776|NCT02557425|dihyroartemisinin-piperaquine|dihyroartemisinin-piperaquine
263777|NCT02557425|sulfadoxine-pyrimethamine|sulfadoxine-pyrimethamine
263778|NCT02557425|behavior|behavior
263779|NCT02557425|neurodevelopment|neurodevelopment
263780|NCT02557425|cognitive|cognitive
263781|NCT02557399|Clindamycin|clindamycin
263782|NCT02557399|Gel|gel
263783|NCT02557399|Benzoyl Peroxide|benzoyl peroxide
263784|NCT02557399|Acne Vulgaris|acne vulgaris
263785|NCT02557386|Cruciate ligament surgery|cruciate ligament surgery
263786|NCT02557386|Adductor canal|adductor canal
263787|NCT02557386|Nerve block|nerve block
263788|NCT02557373|rice bran|rice bran
263789|NCT02557373|infants|infants
263790|NCT02557373|stool metabolome and microbiome|stool metabolome and microbiome
263791|NCT02557373|dietary intervention|dietary intervention
263792|NCT02557360|liver injury|liver injury
263793|NCT02557360|detoxification|detoxification
263794|NCT02557360|S-adenosyl-L-methionine|s-adenosyl-l-methionine
263795|NCT02557360|quality of life|quality of life
263796|NCT02557334|Strawberry Powder|strawberry powder
263797|NCT02557334|Cardiovascular Disease Risk Factors|cardiovascular disease risk factors
263798|NCT02557269|Pollenosis|pollenosis
263799|NCT02557269|Congestion|congestion
263800|NCT02557269|Mucoadhesive Treatment|mucoadhesive treatment
263801|NCT02557269|Nasal Decongestant|nasal decongestant
263802|NCT02557269|Nasal Antihistamine|nasal antihistamine
263803|NCT02557269|Nasal Corticosteroid|nasal corticosteroid
263804|NCT02557256|Childhood Cancer|childhood cancer
263805|NCT02557256|Abdominal Tumors|abdominal tumors
263806|NCT02557256|Pelvic Tumors|pelvic tumors
263807|NCT02557256|Pediatric Oncology|pediatric oncology
263808|NCT02557243|Childhood Cancer|childhood cancer
263809|NCT02557243|Soft Tissue Tumors|soft tissue tumors
263810|NCT02557243|Bone Tumors|bone tumors
263811|NCT02557243|Extremity Tumor|extremity tumor
263812|NCT02557243|Pediatric Oncology|pediatric oncology
263813|NCT02557230|Childhood Cancer|childhood cancer
263814|NCT02557230|Genitourinary tumors|genitourinary tumors
263815|NCT02557230|urogenital tumors|urogenital tumors
263816|NCT02557230|Pediatric Oncology|pediatric oncology
263817|NCT02557204|nasogastric tube insertion|nasogastric tube insertion
263818|NCT02557204|Video laryngoscope|video laryngoscope
263819|NCT02557204|success rate|success rate
263820|NCT02557165|Muscle regeneration|muscle regeneration
263821|NCT02557113|cement leakage|cement leakage
263822|NCT02557113|cement augmentation|cement augmentation
263823|NCT02557113|vertebral body fracture|vertebral body fracture
263824|NCT02557113|vertebral cavity|vertebral cavity
263825|NCT02557113|vertebroplasty|vertebroplasty
263826|NCT02557048|Childhood Cancer|childhood cancer
263827|NCT02557048|Head and Neck Tumors|head and neck tumors
263828|NCT02557048|Pediatric Oncology|pediatric oncology
263829|NCT02557022|Systematic review and meta-analysis|systematic review and meta-analysis
263830|NCT02557022|Evidence-based medicine (EBM)|evidence-based medicine (ebm)
263831|NCT02557022|Evidence-based nutrition (EBN)|evidence-based nutrition (ebn)
263832|NCT02557022|Clinical practice guidelines|clinical practice guidelines
263833|NCT02557022|Glycemic index|glycemic index
263834|NCT02557022|Glycemic load|glycemic load
263835|NCT02557022|Body weight|body weight
263836|NCT02557022|Cardiovascular risk factors|cardiovascular risk factors
263837|NCT02557022|Cardiovascular disease|cardiovascular disease
263838|NCT02557009|Hemodynamics|hemodynamics
263839|NCT02557009|Central Venous Pressure|central venous pressure
263840|NCT02557009|Pulmonary Artery Pressure|pulmonary artery pressure
263841|NCT02557009|Cardiac Output|cardiac output
263842|NCT02556983|Appendicitis|appendicitis
263843|NCT02556983|Tomography, X-Ray Computed|tomography, x-ray computed
263844|NCT02556983|Receiver operating characteristic (ROC) Curve|receiver operating characteristic (roc) curve
263845|NCT02556983|Computer Simulation|computer simulation
263846|NCT02556944|Depth of focus|depth of focus
263847|NCT02556931|immunosuppression|immunosuppression
263848|NCT02556931|nonmyeloablative|nonmyeloablative
263849|NCT02556931|non-myeloablative|non-myeloablative
263850|NCT02556931|allogeneic|allogeneic
263851|NCT02556931|tacrolimus|tacrolimus
263852|NCT02556931|peripheral blood|peripheral blood
263853|NCT02556931|cyclophosphamide|cyclophosphamide
263854|NCT02556931|mycophenolate mofetil|mycophenolate mofetil
263855|NCT02556918|Coronary artery bypass graft surgery (CABG)|coronary artery bypass graft surgery (cabg)
263856|NCT02556918|Type 2 Diabetes|type 2 diabetes
263857|NCT02556905|Multiple Myeloma|multiple myeloma
263858|NCT02556905|Revlimid|revlimid
263859|NCT02556905|Lenalidomide|lenalidomide
263860|NCT02556905|Observational|observational
263862|NCT02556905|Post Marketing Surveillance[PMS]|post marketing surveillance[pms]
263863|NCT02556892|Lymphocytic Leukemia|lymphocytic leukemia
263864|NCT02556892|Ibrutinib|ibrutinib
263865|NCT02556892|PCI-32765|pci-32765
263866|NCT02556892|JNJ-54179060|jnj-54179060
263867|NCT02556879|Liver transplantation|liver transplantation
263868|NCT02556879|Graft failure|graft failure
263869|NCT02556879|Donor specific antibodies|donor specific antibodies
263870|NCT02556853|Ultrasound|ultrasound
263871|NCT02556853|Double lumen tube|double lumen tube
263872|NCT02556840|Monogenic diabetes|monogenic diabetes
263873|NCT02556840|maturity-onset diabetes of the young|maturity-onset diabetes of the young
263874|NCT02556840|MODY|mody
263875|NCT02556840|Pregnancy|pregnancy
263876|NCT02556840|Gestational diabetes|gestational diabetes
263877|NCT02556840|Glucokinase|glucokinase
263878|NCT02556840|Insulin therapy during pregnancy|insulin therapy during pregnancy
264006|NCT02556242|insecticide|insecticide
263879|NCT02556840|Evaluation of fetal growth by ultrasonography measurements|evaluation of fetal growth by ultrasonography measurements
263880|NCT02556827|demodex|demodex
263881|NCT02556827|oxidative stress|oxidative stress
263882|NCT02556827|reflectance confocal microscopy|reflectance confocal microscopy
263883|NCT02556814|ITP|itp
263884|NCT02556814|Caffeic Acid|caffeic acid
263885|NCT02556814|dexamethasone|dexamethasone
263886|NCT02556801|Sublingual immunotherapy|sublingual immunotherapy
263887|NCT02556801|Dose range finding|dose range finding
263888|NCT02556801|Grass pollen|grass pollen
263889|NCT02556801|Allergic rhinitis/rhinoconjunctivitis|allergic rhinitis/rhinoconjunctivitis
263890|NCT02556801|Immunogenicity|immunogenicity
263891|NCT02556788|Efficacy|efficacy
263892|NCT02556788|Safety|safety
263893|NCT02556788|Acne vulgaris|acne vulgaris
263894|NCT02556762|Esophageal cancer|esophageal cancer
263895|NCT02556762|Simultaneous modulated accelerated boost|simultaneous modulated accelerated boost
263896|NCT02556762|Standard dose radiotherapy|standard dose radiotherapy
263897|NCT02556762|Chemotherapy|chemotherapy
263898|NCT02556762|Survival|survival
263899|NCT02556749|Cranberries|cranberries
263900|NCT02556749|blood pressure|blood pressure
263901|NCT02556749|cholesterol|cholesterol
263902|NCT02556749|SphygmoCor|sphygmocor
263903|NCT02556736|gene therapy|gene therapy
263904|NCT02556736|optogenetics|optogenetics
263905|NCT02556736|channelrhodopsin|channelrhodopsin
263906|NCT02556736|retina|retina
263907|NCT02556736|retinitis pigmentosa|retinitis pigmentosa
263908|NCT02556710|Osteoarthritis|osteoarthritis
263909|NCT02556710|Osteoarthritis of the Knee|osteoarthritis of the knee
263910|NCT02556684|Breast-Specific Gamma Imaging|breast-specific gamma imaging
263911|NCT02556684|Locally Advanced Breast Cancer|locally advanced breast cancer
263912|NCT02556684|Neoadjuvant Chemotherapy|neoadjuvant chemotherapy
263913|NCT02556684|BSGI|bsgi
263914|NCT02556658|Smartpilot View|smartpilot view
263915|NCT02556658|Hip fracture surgery|hip fracture surgery
263916|NCT02556658|Depth of anaesthesia|depth of anaesthesia
263917|NCT02556658|Intraoperative hypotension|intraoperative hypotension
263918|NCT02556658|Quality of anaesthesia|quality of anaesthesia
263919|NCT02556645|Combat|combat
263920|NCT02556645|Psychological Treatment|psychological treatment
263921|NCT02556645|Military|military
263922|NCT02556645|Psychotherapy|psychotherapy
263923|NCT02556645|Trauma|trauma
263924|NCT02556645|Posttraumatic Stress|posttraumatic stress
263925|NCT02556645|Posttraumatic Stress Disorder|posttraumatic stress disorder
263926|NCT02556619|Liver Cancer|liver cancer
263927|NCT02556619|Randomized Control Trial|randomized control trial
263928|NCT02556619|Palliative Care|palliative care
263929|NCT02556619|Liver Cell Carcinoma|liver cell carcinoma
263930|NCT02556619|Palliative Therapy|palliative therapy
263931|NCT02556606|ketamine|ketamine
263932|NCT02556606|depression|depression
263933|NCT02556606|treatment resistant|treatment resistant
263934|NCT02556606|treatment resistant depression|treatment resistant depression
263935|NCT02556606|late life depression|late life depression
263936|NCT02556606|depression in the elderly|depression in the elderly
263937|NCT02556606|geriatric depression|geriatric depression
263938|NCT02556593|Non-Small Cell Lung Cancer|non-small cell lung cancer
263939|NCT02556593|IMRT|imrt
263940|NCT02556593|erlotinib|erlotinib
263941|NCT02556593|whole-brain radiotherapy|whole-brain radiotherapy
263942|NCT02556580|albumin|albumin
263943|NCT02556580|surgery|surgery
263944|NCT02556580|inflammation|inflammation
263945|NCT02556580|volume kinetics|volume kinetics
263946|NCT02556567|Sleep patterns|sleep patterns
263947|NCT02556567|Physical activity|physical activity
263948|NCT02556567|Fitbit|fitbit
263949|NCT02556515|CMC1|cmc1
263950|NCT02556515|arthritis|arthritis
263951|NCT02556515|degenerative arthritis|degenerative arthritis
263952|NCT02556515|thumb|thumb
263953|NCT02556515|interpositional arthroplasty|interpositional arthroplasty
263954|NCT02556515|total joint replacement|total joint replacement
263955|NCT02556489|immunological memory|immunological memory
263956|NCT02556476|critical care|critical care
263957|NCT02556476|intensive care|intensive care
263958|NCT02556476|health related quality of life|health related quality of life
263959|NCT02556476|cost benefit analysis|cost benefit analysis
263960|NCT02556463|MEDI9197|medi9197
263961|NCT02556463|TLR 7/8 Agonist|tlr 7/8 agonist
263962|NCT02556463|Durvalumab|durvalumab
263963|NCT02556463|MEDI4736|medi4736
263964|NCT02556463|Imfinzi|imfinzi
263965|NCT02556437|Subcutaneous immunoglobulin|subcutaneous immunoglobulin
263966|NCT02556437|MMN|mmn
263967|NCT02556424|Ophthalmology|ophthalmology
263968|NCT02556424|Uveitic macular edema|uveitic macular edema
263969|NCT02556424|Triamcinolone subconjunctival injection|triamcinolone subconjunctival injection
263970|NCT02556424|Dexamethasone intraocular implant|dexamethasone intraocular implant
263971|NCT02556372|AIH|aih
263972|NCT02556372|JKB-122|jkb-122
263973|NCT02556372|autoimmune|autoimmune
263974|NCT02556372|hepatitis|hepatitis
263975|NCT02556346|CD20|cd20
263976|NCT02556346|immunotoxin|immunotoxin
263977|NCT02556346|CLL|cll
263978|NCT02556346|SLL|sll
263979|NCT02556346|leukemia|leukemia
263980|NCT02556346|lymphocytic lymphoma|lymphocytic lymphoma
263981|NCT02556346|lymphocytic leukemia|lymphocytic leukemia
263982|NCT02556346|MT-3724|mt-3724
263983|NCT02556346|relapsed|relapsed
263984|NCT02556346|refractory|refractory
263985|NCT02556346|immunotherapy|immunotherapy
263986|NCT02556346|cancer|cancer
263987|NCT02556346|antibodies|antibodies
263988|NCT02556346|safety|safety
263989|NCT02556346|pharmacokinetics|pharmacokinetics
263990|NCT02556333|TAF|taf
263991|NCT02556333|F/TAF|f/taf
263992|NCT02556333|antiretroviral therapy|antiretroviral therapy
263993|NCT02556333|TDF|tdf
263994|NCT02556333|directly observed therapy|directly observed therapy
263995|NCT02556294|HIV risk behavior|hiv risk behavior
263996|NCT02556268|Single-Dose, Open-Label, Non-Blinded, Non-Placebo-|single-dose, open-label, non-blinded, non-placebo-
263997|NCT02556268|Controlled, Stratified Design|controlled, stratified design
263998|NCT02556255|Peripheral Arterial Disease|peripheral arterial disease
263999|NCT02556255|Peripheral Artery Disease|peripheral artery disease
264000|NCT02556255|PAD|pad
264001|NCT02556255|Atherosclerosis|atherosclerosis
264002|NCT02556255|Arterial Occlusive Diseases|arterial occlusive diseases
264003|NCT02556255|Peripheral Vascular Diseases|peripheral vascular diseases
264004|NCT02556255|PVD|pvd
264005|NCT02556242|vector control|vector control
264007|NCT02556229|Aflibercept|aflibercept
264008|NCT02556229|inflammatory choroidal neovascularization|inflammatory choroidal neovascularization
264009|NCT02556229|young patient|young patient
264010|NCT02556216|bone biopsy; bone density|bone biopsy; bone density
264011|NCT02556203|TAVR|tavr
264012|NCT02556203|TAVI|tavi
264013|NCT02556203|Transfemoral aortic valve implantation|transfemoral aortic valve implantation
264014|NCT02556177|TBI|tbi
264015|NCT02556177|MR|mr
264016|NCT02556177|mTBI|mtbi
264017|NCT02556177|NFL|nfl
264018|NCT02556177|MRI|mri
264019|NCT02556164|Electroacupuncture|electroacupuncture
264020|NCT02556164|Body Worn Sensor|body worn sensor
264021|NCT02556164|Gait|gait
264022|NCT02556164|Balance|balance
264023|NCT02556138|Intragastric Balloon|intragastric balloon
264024|NCT02556138|ORBERA Intragastric Balloon|orbera intragastric balloon
264025|NCT02556138|Weight Loss|weight loss
264026|NCT02556138|BMI >35|bmi >35
264027|NCT02556125|SCI|sci
264028|NCT02556125|Respiratory impairment|respiratory impairment
264029|NCT02556125|Diaphragm pacing|diaphragm pacing
264030|NCT02556125|Diaphragm stimulation|diaphragm stimulation
264031|NCT02556073|asthma control|asthma control
264032|NCT02556073|adherence|adherence
264033|NCT02556073|asthma self management plan|asthma self management plan
264034|NCT02556073|airway inflammation|airway inflammation
264035|NCT02556060|ketamine use disorder|ketamine use disorder
264036|NCT02556060|lamotrigine|lamotrigine
264037|NCT02556060|craving|craving
264038|NCT02556008|Children|children
264039|NCT02556008|Epilepsy|epilepsy
264040|NCT02556008|Cannabidiol|cannabidiol
264041|NCT02555995|AMD|amd
264042|NCT02555995|OCT|oct
264043|NCT02555982|Essential Head tremor|essential head tremor
264044|NCT02555982|Botulinum toxin injections|botulinum toxin injections
264045|NCT02555982|Quality of life|quality of life
264046|NCT02555982|Embarrassment assessment|embarrassment assessment
264047|NCT02555956|Macular grid|macular grid
264048|NCT02555956|Subthreshold|subthreshold
264049|NCT02555956|diabetic macular edema|diabetic macular edema
264050|NCT02555956|decrease in visual acuity|decrease in visual acuity
264051|NCT02555930|HIV|hiv
264052|NCT02555930|Sensory Neuropathy|sensory neuropathy
264053|NCT02555891|Prescriptions|prescriptions
264054|NCT02555891|Epidemiology|epidemiology
264055|NCT02555891|Health Administration Databases|health administration databases
264056|NCT02555891|Elderly|elderly
264057|NCT02555891|STOPP/START criteria|stopp/start criteria
264058|NCT02555878|Cancer|cancer
264059|NCT02555878|Rivaroxaban|rivaroxaban
264060|NCT02555878|Venous thromboembolism|venous thromboembolism
264061|NCT02555865|etiology|etiology
264062|NCT02555865|children|children
264063|NCT02555852|Proton Pump Inhibitors|proton pump inhibitors
264064|NCT02555852|Pneumonia|pneumonia
264065|NCT02555852|NSAIDs|nsaids
264066|NCT02555852|Histamine H2 Antagonists|histamine h2 antagonists
264067|NCT02555852|Drug safety|drug safety
264068|NCT02555839|Relapsed Multiple Myeloma|relapsed multiple myeloma
264069|NCT02555839|Refractory Multiple Myeloma|refractory multiple myeloma
264070|NCT02555839|Pomalidomide|pomalidomide
264071|NCT02555839|Imnovid|imnovid
264072|NCT02555839|Non-interventional|non-interventional
264073|NCT02555813|Metastatic Pancreatic Cancer|metastatic pancreatic cancer
264074|NCT02555813|nab-Paclitaxel|nab-paclitaxel
264075|NCT02555813|Gemcitabine|gemcitabine
264076|NCT02555813|Non-interventional|non-interventional
264077|NCT02555800|Laryngeal papillomatosis|laryngeal papillomatosis
264078|NCT02555800|Cidofovir|cidofovir
264079|NCT02555800|Bevacizumab|bevacizumab
264080|NCT02555800|Recurrent respiratory papillomatosis|recurrent respiratory papillomatosis
264081|NCT02555787|FK506E|fk506e
264082|NCT02555787|Tacrolimus|tacrolimus
264083|NCT02555787|Observational|observational
264084|NCT02555787|Kidney transplantation|kidney transplantation
264085|NCT02555787|Advagraf|advagraf
264086|NCT02555774|subjective memory impairment|subjective memory impairment
264087|NCT02555774|cognitive training|cognitive training
264088|NCT02555735|pancreatic cancer|pancreatic cancer
264089|NCT02555696|Metastatic Breast Cancer|metastatic breast cancer
264090|NCT02555696|nab-paclitaxel|nab-paclitaxel
264091|NCT02555696|Abraxane|abraxane
264092|NCT02555683|Asthma|asthma
264093|NCT02555683|QAW039|qaw039
264094|NCT02555670|Muscles|muscles
264095|NCT02555670|Intensive Care|intensive care
264096|NCT02555670|Tomography, X-Ray Computed|tomography, x-ray computed
264097|NCT02555670|Electric Impedance|electric impedance
264098|NCT02555657|PD1|pd1
264099|NCT02555657|PD-1|pd-1
264100|NCT02555657|PDL1|pdl1
264101|NCT02555657|PD-LI|pd-li
264102|NCT02555644|cancer|cancer
264103|NCT02555631|type 2 diabetes|type 2 diabetes
264104|NCT02555631|prevention|prevention
264105|NCT02555631|men|men
264106|NCT02555618|Vaccine|vaccine
264107|NCT02555605|children|children
264108|NCT02555605|dexmedetomidine|dexmedetomidine
264109|NCT02555605|magnetic resonance imaging scans|magnetic resonance imaging scans
264110|NCT02555605|deep sedation|deep sedation
264111|NCT02555605|adverse respiratory events|adverse respiratory events
264112|NCT02555553|Cognitive behavioral therapy guided self-help|cognitive behavioral therapy guided self-help
264113|NCT02555553|Mobile Mental Health|mobile mental health
264114|NCT02555553|Binge Eating|binge eating
264115|NCT02555553|Cognitive Behavioral Therapy|cognitive behavioral therapy
264116|NCT02555553|Eating Disorder Treatment|eating disorder treatment
264117|NCT02555553|Self-monitoring|self-monitoring
264118|NCT02555553|Eating Disorders|eating disorders
264119|NCT02555553|Ecological Momentary Intervention|ecological momentary intervention
264120|NCT02555501|children|children
264121|NCT02555501|cancer|cancer
264122|NCT02555501|stomatitis|stomatitis
264123|NCT02555501|clinical trial|clinical trial
264124|NCT02555501|laser therapy, low-level|laser therapy, low-level
264125|NCT02555501|methylene blue|methylene blue
264126|NCT02555501|photochemotherapy|photochemotherapy
264127|NCT02555475|Hepatitis C|hepatitis c
264128|NCT02555475|primary care|primary care
264129|NCT02555397|Prostate Cancer|prostate cancer
264130|NCT02555397|Locally Recurrent|locally recurrent
264131|NCT02555397|Gene Therapy|gene therapy
264132|NCT02555397|IL-12|il-12
264133|NCT02555397|Adenovirus|adenovirus
264134|NCT02555371|Severe eosinophilic asthma|severe eosinophilic asthma
264135|NCT02555371|mepolizumab|mepolizumab
264136|NCT02555371|asthma exacerbation|asthma exacerbation
264137|NCT02555358|Resectable advanced gastric cancer|resectable advanced gastric cancer
264138|NCT02555345|classic asthma, cough variant asthma,eosinophilic bronchitis|classic asthma, cough variant asthma,eosinophilic bronchitis
264139|NCT02555319|Pulmonary Valve|pulmonary valve
264140|NCT02555319|Transcatheter Pulmonary Valve|transcatheter pulmonary valve
264141|NCT02555319|Congenital Heart Disease|congenital heart disease
264142|NCT02555306|Macular Degeneration|macular degeneration
264143|NCT02555293|Liver resection|liver resection
264144|NCT02555293|fibrosis|fibrosis
264145|NCT02555293|inflammation|inflammation
264146|NCT02555293|Rifaximin|rifaximin
264147|NCT02555267|geriatric assessment|geriatric assessment
264148|NCT02555267|diffuse large B-cell lymphoma|diffuse large b-cell lymphoma
264149|NCT02555267|activity of daily living|activity of daily living
264150|NCT02555267|instrumental activity of daily living|instrumental activity of daily living
264151|NCT02555267|Charlson's comorbidity index|charlson's comorbidity index
264152|NCT02555254|cardiac arrest|cardiac arrest
264153|NCT02555254|targeted temperature management|targeted temperature management
264154|NCT02555254|hypothermia induced|hypothermia induced
264155|NCT02555254|shockable rhythm|shockable rhythm
264156|NCT02555241|ASD, Children|asd, children
264157|NCT02555228|simethicone|simethicone
264158|NCT02555228|gastroscopy|gastroscopy
264159|NCT02555228|McNalley score|mcnalley score
264160|NCT02555215|Pediatrics|pediatrics
264161|NCT02555202|dyspnea|dyspnea
264162|NCT02555163|bladder cancer, laser|bladder cancer, laser
264163|NCT02555137|chronic thromboembolic pulmonary hypertension|chronic thromboembolic pulmonary hypertension
264164|NCT02555137|pulmonary embolism|pulmonary embolism
264165|NCT02555137|pulmonary hypertension|pulmonary hypertension
264166|NCT02555137|screening|screening
264167|NCT02555137|echocardiography|echocardiography
264168|NCT02555124|Healthy|healthy
264169|NCT02555124|JNJ-42847922|jnj-42847922
264170|NCT02555111|thrombosis|thrombosis
264171|NCT02555072|Yellow Fever Vaccine, immunity evolution|yellow fever vaccine, immunity evolution
264172|NCT02555059|Ciprofloxacin|ciprofloxacin
264173|NCT02555059|Japan|japan
264174|NCT02555059|Post-marketing surveillance|post-marketing surveillance
264175|NCT02555046|Spectroscopy, Near-Infrared|spectroscopy, near-infrared
264176|NCT02555046|Endovascular Procedures|endovascular procedures
264177|NCT02555046|Local Anesthesia|local anesthesia
264178|NCT02555046|General Anesthesia|general anesthesia
264179|NCT02555033|Instability resistance training|instability resistance training
264180|NCT02555033|unstable surface|unstable surface
264181|NCT02555033|elderly people|elderly people
264182|NCT02554994|ASPRA cohort|aspra cohort
264183|NCT02554994|multifactorial intervention|multifactorial intervention
264184|NCT02554994|Medicaid services|medicaid services
264185|NCT02554994|Geriatric disorder|geriatric disorder
264186|NCT02554994|Short Physical Performance Battery|short physical performance battery
264187|NCT02554929|Social Anxiety Disorder|social anxiety disorder
264188|NCT02554929|Selective Mutism|selective mutism
264190|NCT02554929|preschool anxiety disorders|preschool anxiety disorders
264191|NCT02554916|Mobility decline|mobility decline
264192|NCT02554903|LVAD|lvad
264193|NCT02554890|Acute|acute
264194|NCT02554890|Heart Failure|heart failure
264195|NCT02554890|reduced ejection fraction|reduced ejection fraction
264196|NCT02554890|NTproBNP|ntprobnp
264197|NCT02554890|Heart failure with reduced ejection fraction (HFREF)|heart failure with reduced ejection fraction (hfref)
264198|NCT02554838|Specific phobia|specific phobia
264199|NCT02554838|Fear of Falling|fear of falling
264200|NCT02554838|Life-space area|life-space area
264201|NCT02554812|anti PD-L1|anti pd-l1
264202|NCT02554812|anti 4-1BB|anti 4-1bb
264203|NCT02554812|OX40 agonist|ox40 agonist
264204|NCT02554812|anti M-CSF|anti m-csf
264205|NCT02554812|TLR9 agonist|tlr9 agonist
264206|NCT02554812|Non-small cell lung cancer (NSCLC)|non-small cell lung cancer (nsclc)
264207|NCT02554812|melanoma|melanoma
264208|NCT02554812|squamous cell carcinoma of head and neck (SCCHN)|squamous cell carcinoma of head and neck (scchn)
264209|NCT02554812|triple negative breast cancer (TNBC)|triple negative breast cancer (tnbc)
264210|NCT02554812|gastric cancer|gastric cancer
264211|NCT02554812|Small cell lung cancer (SCLC)|small cell lung cancer (sclc)
264212|NCT02554812|bladder cancer|bladder cancer
264213|NCT02554812|platinum resistant ovarian cancer|platinum resistant ovarian cancer
264214|NCT02554812|TGCT/PVNS|tgct/pvns
264215|NCT02554786|QMF149, Mometasone furoate (MF), asthma|qmf149, mometasone furoate (mf), asthma
264216|NCT02554773|Hemophilia|hemophilia
264217|NCT02554773|RNAi therapeutic|rnai therapeutic
264218|NCT02554721|Healthy Volunteers|healthy volunteers
264219|NCT02554708|Aneurysm|aneurysm
264220|NCT02554708|bifurcation|bifurcation
264221|NCT02554708|wide neck|wide neck
264222|NCT02554708|pCONus|pconus
264223|NCT02554708|intracerebral|intracerebral
264224|NCT02554708|stroke|stroke
264225|NCT02554695|adrenergic|adrenergic
264226|NCT02554682|Adolescent Health|adolescent health
264227|NCT02554682|Sexual Health|sexual health
264228|NCT02554682|Parent-Teen Communication|parent-teen communication
264229|NCT02554682|Teen Driving|teen driving
264230|NCT02554682|Alcohol Prevention|alcohol prevention
264231|NCT02554669|Blood glucose (indicated by interstitial glucose)|blood glucose (indicated by interstitial glucose)
264232|NCT02554669|Markers of systemic inflammation|markers of systemic inflammation
264233|NCT02554643|intermittent exercise|intermittent exercise
264234|NCT02554643|continuous exercise|continuous exercise
264235|NCT02554643|blood glucose|blood glucose
264236|NCT02554643|intramyocellular lipids|intramyocellular lipids
264237|NCT02554643|diabetes|diabetes
712533|NCT00579800|IDEAL|ideal
264238|NCT02554643|gene expression|gene expression
264239|NCT02554617|healthy people|healthy people
264240|NCT02554617|fractional exhaled nitric oxide (FeNo)|fractional exhaled nitric oxide (feno)
264241|NCT02554617|factors|factors
264242|NCT02554604|HDL|hdl
264243|NCT02554604|Preeclampsia|preeclampsia
264244|NCT02554604|saliva|saliva
264245|NCT02554578|mHealth|mhealth
264246|NCT02554578|multidisciplinary team|multidisciplinary team
264247|NCT02554578|immunosuppressive medication|immunosuppressive medication
264248|NCT02554578|pharmaceutical care|pharmaceutical care
264249|NCT02554578|adherence|adherence
264250|NCT02554578|heart transplant|heart transplant
264251|NCT02554578|recipients|recipients
264252|NCT02554565|Patients with cervical cancer|patients with cervical cancer
264253|NCT02554552|Osteoarthritis|osteoarthritis
264254|NCT02554526|hemophilia A|hemophilia a
264255|NCT02554526|inhibitor|inhibitor
264256|NCT02554526|bypassing therapy|bypassing therapy
264257|NCT02554526|factor VIII|factor viii
264258|NCT02554513|Apraxia of Speech|apraxia of speech
264259|NCT02554513|Treatment|treatment
264260|NCT02554487|stroke|stroke
264261|NCT02554487|sleep disordered breathing|sleep disordered breathing
264262|NCT02554487|sleep apnea|sleep apnea
264263|NCT02554487|infarct volume|infarct volume
264264|NCT02554487|penumbra|penumbra
264265|NCT02554474|Physical activity|physical activity
264266|NCT02554474|Exercise|exercise
264267|NCT02554474|Rheumatoid|rheumatoid
264268|NCT02554474|Arthritis|arthritis
264269|NCT02554474|Lupus|lupus
264270|NCT02554474|SLE|sle
264271|NCT02554448|Circulating Tumor Cells|circulating tumor cells
264272|NCT02554448|rectal Neoplasms|rectal neoplasms
264273|NCT02554448|neoadjuvant otherapy|neoadjuvant otherapy
264274|NCT02554435|physical activity|physical activity
264275|NCT02554435|activity monitor|activity monitor
264276|NCT02554435|older adults|older adults
264277|NCT02554435|5 A's counseling|5 a's counseling
264278|NCT02554409|Fluzone Quadrivalent Intradermal Influenza Vaccine|fluzone quadrivalent intradermal influenza vaccine
264279|NCT02554409|Pregnancy Registry|pregnancy registry
264280|NCT02554409|Influenza|influenza
264281|NCT02554396|ophthalmology|ophthalmology
264282|NCT02554396|vision|vision
264283|NCT02554396|ocular|ocular
264284|NCT02554383|pediatrics|pediatrics
264285|NCT02554383|antibiotics|antibiotics
264286|NCT02554383|placebo|placebo
264287|NCT02554344|CIN3|cin3
264288|NCT02554344|Squamous CIN3|squamous cin3
264289|NCT02554331|Gait|gait
264290|NCT02554331|REM sleep behavior disorder|rem sleep behavior disorder
264291|NCT02554331|Parkinson's disease|parkinson's disease
264292|NCT02554331|Follow-up|follow-up
264293|NCT02554318|Tempeh|tempeh
264294|NCT02554318|Body weight|body weight
264295|NCT02554318|Handgrip strength|handgrip strength
264296|NCT02554318|6MWT|6mwt
264297|NCT02554318|Supplementation|supplementation
264298|NCT02554318|Wasting|wasting
264299|NCT02554305|efficacy and safety of fusion Oxygenation System|efficacy and safety of fusion oxygenation system
264300|NCT02554305|isolated Coronary Artery Bypass Grafting|isolated coronary artery bypass grafting
264301|NCT02554305|Bypass Grafting|bypass grafting
264302|NCT02554227|Spondylodiscitis|spondylodiscitis
264303|NCT02554227|erosive osteochondrosis|erosive osteochondrosis
264304|NCT02554227|infection|infection
264305|NCT02554227|cytokine profiles|cytokine profiles
264306|NCT02554227|lumbar, thoracic spine|lumbar, thoracic spine
264307|NCT02554227|suPAR|supar
264308|NCT02554201|pudendal nerve modulation|pudendal nerve modulation
264309|NCT02554201|transanal/transvaginal electrical stimulation|transanal/transvaginal electrical stimulation
264310|NCT02554188|Dietary Intervention|dietary intervention
264311|NCT02554188|Fasting-mimicking|fasting-mimicking
264312|NCT02554188|Influenza Vaccines|influenza vaccines
264313|NCT02554175|Propofol|propofol
264314|NCT02554175|Schnider model|schnider model
264315|NCT02554162|Satiety, appetite, wholegrain rye|satiety, appetite, wholegrain rye
264316|NCT02554149|total hip|total hip
264317|NCT02554149|stem version|stem version
264318|NCT02554149|replacement|replacement
264319|NCT02554149|hip|hip
264320|NCT02554097|laparoscopic transcystic common bile duct exploration|laparoscopic transcystic common bile duct exploration
264321|NCT02554097|laparoscopic common bile duct exploration|laparoscopic common bile duct exploration
264322|NCT02554097|endoscopic sphincterotomy,|endoscopic sphincterotomy,
264323|NCT02554097|cost-effective analysis|cost-effective analysis
264324|NCT02554058|Spinal cord injury|spinal cord injury
264325|NCT02554058|rehabilitation|rehabilitation
264326|NCT02554058|cycling|cycling
264327|NCT02554032|antegrade cerebral perfusion|antegrade cerebral perfusion
264328|NCT02554032|innominate artery cannulation|innominate artery cannulation
264329|NCT02554032|axillary artery cannulation|axillary artery cannulation
264330|NCT02554032|aortic surgery|aortic surgery
264331|NCT02554032|deep hypothermic circulatory arrest|deep hypothermic circulatory arrest
264332|NCT02554019|SLE, Lupus|sle, lupus
264333|NCT02554019|IL10, IL-10, BT063, BT-063|il10, il-10, bt063, bt-063
264334|NCT02553993|Stroke|stroke
264335|NCT02553993|Cognition|cognition
264336|NCT02553993|Exergames|exergames
264337|NCT02553993|Weight shifting|weight shifting
264338|NCT02553993|Balance|balance
264339|NCT02553993|Rehabilitation|rehabilitation
264340|NCT02553980|Physical activity|physical activity
264341|NCT02553980|Information technology|information technology
264342|NCT02553980|Middle-aged|middle-aged
264343|NCT02553980|Health promotion|health promotion
264344|NCT02553967|functional Magnetic Resonance Imaging (fMRI)|functional magnetic resonance imaging (fmri)
264345|NCT02553967|Breast reconstructive surgery|breast reconstructive surgery
264346|NCT02553967|Breast Q questionnaire|breast q questionnaire
264347|NCT02553954|Mechanisms of Senescence|mechanisms of senescence
264348|NCT02553954|Senescence markers|senescence markers
264349|NCT02553915|Omega-3|omega-3
264350|NCT02553915|EPA|epa
264351|NCT02553915|Depression|depression
264352|NCT02553915|Overweight|overweight
264353|NCT02553915|Inflammation|inflammation
264354|NCT02553915|Eicosapentaenoic acid|eicosapentaenoic acid
264355|NCT02553902|Positional therapy|positional therapy
264356|NCT02553902|MAD|mad
264357|NCT02553902|Oral appliance|oral appliance
264358|NCT02553902|Sleep position trainer|sleep position trainer
264359|NCT02553902|POSA|posa
264360|NCT02553876|neurostimulation|neurostimulation
264361|NCT02553876|dorsal root ganglion|dorsal root ganglion
264362|NCT02553876|hand pain|hand pain
264363|NCT02553876|upper limb pain|upper limb pain
264364|NCT02553863|chemotherapy induced peripheral neuropathy|chemotherapy induced peripheral neuropathy
264365|NCT02553863|acupuncture|acupuncture
264366|NCT02553863|pain|pain
264367|NCT02553863|cost-effectiveness|cost-effectiveness
264368|NCT02553837|Healthy Volunteers|healthy volunteers
264369|NCT02553824|binge eating|binge eating
264370|NCT02553824|bulimia nervosa|bulimia nervosa
264371|NCT02553824|binge eating disorder|binge eating disorder
264372|NCT02553824|eating disorder treatment|eating disorder treatment
264373|NCT02553811|carpal tunnel syndrome|carpal tunnel syndrome
264374|NCT02553811|clinical examination|clinical examination
264375|NCT02553811|diagnosis|diagnosis
264376|NCT02553811|clinical trial|clinical trial
264377|NCT02553811|median nerve compression|median nerve compression
264378|NCT02553811|accuracy|accuracy
264379|NCT02553811|ultrasonography|ultrasonography
264380|NCT02553811|electromyography|electromyography
264381|NCT02553811|electrodiagnostic testing|electrodiagnostic testing
264382|NCT02553785|BioVentrix|bioventrix
264383|NCT02553785|Revivent|revivent
264384|NCT02553785|Revivent TC|revivent tc
264385|NCT02553759|observed action|observed action
264386|NCT02553759|range of motion|range of motion
264387|NCT02553759|mirror neuron|mirror neuron
264388|NCT02553746|Ultrasound|ultrasound
264389|NCT02553746|Spinal anesthesia|spinal anesthesia
264390|NCT02553746|Epidural anesthesia|epidural anesthesia
264391|NCT02553733|Dietary nitrate supplementation|dietary nitrate supplementation
264392|NCT02553733|Beetroot juice|beetroot juice
264393|NCT02553720|Post thrombotic syndrome|post thrombotic syndrome
264394|NCT02553720|Chronic venous insufficiency|chronic venous insufficiency
264395|NCT02553694|OSA, Apnea|osa, apnea
264396|NCT02553668|Proteomics|proteomics
264397|NCT02553668|Oxygen|oxygen
264398|NCT02553668|Pathways|pathways
264399|NCT02553642|Tumor Mutation|tumor mutation
264400|NCT02553642|Nivolumab|nivolumab
264401|NCT02553642|Nivolumab plus Ipilimumab|nivolumab plus ipilimumab
264402|NCT02553642|Predicted Neo-antigen Burden|predicted neo-antigen burden
264403|NCT02553642|15-126|15-126
264404|NCT02553590|Non Interventional Study|non interventional study
264405|NCT02553590|NIS|nis
264406|NCT02553590|sublingual immunotherapy|sublingual immunotherapy
264407|NCT02553590|allergen|allergen
264408|NCT02553590|tree|tree
264409|NCT02553590|birch|birch
264410|NCT02553590|alder|alder
264411|NCT02553577|prenatal|prenatal
264412|NCT02553577|cytokines|cytokines
264413|NCT02553538|cancer screening|cancer screening
264414|NCT02553538|patient navigation|patient navigation
264415|NCT02553525|Deep Brain Stimulation|deep brain stimulation
264416|NCT02553525|Movement Disorders|movement disorders
264417|NCT02553525|Parkinson Disease|parkinson disease
264418|NCT02553525|Essential Tremor|essential tremor
264419|NCT02553525|Subthalamic Nucleus|subthalamic nucleus
264420|NCT02553525|Globus Pallidus|globus pallidus
264421|NCT02553525|Thalamus|thalamus
264422|NCT02553525|Tremor|tremor
264423|NCT02553525|Bradykinesia|bradykinesia
264424|NCT02553525|Temporal Pattern|temporal pattern
264425|NCT02553525|Electrical Stimulation|electrical stimulation
264426|NCT02553525|Neuromodulation|neuromodulation
264427|NCT02553525|PD|pd
264428|NCT02553525|ET|et
264429|NCT02553525|MS|ms
264430|NCT02553525|STN|stn
264431|NCT02553525|GPi|gpi
264432|NCT02553525|DBS|dbs
264433|NCT02553525|Nervous System Diseases|nervous system diseases
264434|NCT02553525|Neurodegenerative Diseases|neurodegenerative diseases
264435|NCT02553499|Solid tumor|solid tumor
264436|NCT02553499|PD1|pd1
264437|NCT02553499|PD-L1|pd-l1
264438|NCT02553499|PDL1|pdl1
264439|NCT02553486|adoption|adoption
264440|NCT02553486|children|children
264441|NCT02553486|quality of life|quality of life
264442|NCT02553460|Infants|infants
264443|NCT02553434|pigtail catheter|pigtail catheter
264444|NCT02553434|small-bore catheter|small-bore catheter
264445|NCT02553434|trauma|trauma
264446|NCT02553434|hemothorax|hemothorax
264447|NCT02553421|infiltration|infiltration
264448|NCT02553421|extravasation|extravasation
264449|NCT02553421|peripheral intravenous therapy|peripheral intravenous therapy
264450|NCT02553356|Female Subjects|female subjects
264451|NCT02553343|Influenza|influenza
264452|NCT02553343|High-Dose Quadrivalent Influenza Vaccine|high-dose quadrivalent influenza vaccine
264453|NCT02553343|High-Dose Trivalent Influenza Vaccine|high-dose trivalent influenza vaccine
264454|NCT02553330|Hair loss|hair loss
264455|NCT02553330|alopecia areata|alopecia areata
264456|NCT02553330|alopecia totalis|alopecia totalis
264457|NCT02553330|alopecia universalis|alopecia universalis
264458|NCT02553330|JAK inhibitors|jak inhibitors
264459|NCT02553330|topical hair growth|topical hair growth
264460|NCT02553278|abdominoplasty|abdominoplasty
264461|NCT02553265|Familial dysautonomia (HSAN III)|familial dysautonomia (hsan iii)
264462|NCT02553265|Norepinephrine|norepinephrine
264463|NCT02553265|Sympathetic nervous system|sympathetic nervous system
264464|NCT02553265|Autonomic nervous system|autonomic nervous system
264465|NCT02553265|Blood pressure variability|blood pressure variability
264466|NCT02553265|Hypertension|hypertension
264467|NCT02553265|Carbidopa/Lodosyn|carbidopa/lodosyn
264468|NCT02553265|Afferent baroreflex failure|afferent baroreflex failure
264469|NCT02553265|Clinical trial|clinical trial
264470|NCT02553252|post traumatic stress disorder (PTSD)|post traumatic stress disorder (ptsd)
264471|NCT02553252|Sudarshan Kriya Yoga (SKY)|sudarshan kriya yoga (sky)
264472|NCT02553239|Atrial Fibrillation|atrial fibrillation
264473|NCT02553239|Paroxysmal|paroxysmal
264474|NCT02553239|Cryoablation|cryoablation
264475|NCT02553226|Active phase of labour|active phase of labour
264476|NCT02553226|Discontinuation|discontinuation
264477|NCT02553226|Caesarean section|caesarean section
264478|NCT02553200|intubated patients|intubated patients
264479|NCT02553200|secretion clearance|secretion clearance
264480|NCT02553200|lung function|lung function
264481|NCT02553200|breathing exercise|breathing exercise
264482|NCT02553161|Depression|depression
264483|NCT02553148|prevalence|prevalence
264484|NCT02553148|epidemiology|epidemiology
264485|NCT02553148|palliative care|palliative care
264486|NCT02553148|pediatric|pediatric
264487|NCT02553135|choroideremia, gene therapy|choroideremia, gene therapy
264488|NCT02553122|Blood Loss|blood loss
264489|NCT02553122|Tranexamic Acid|tranexamic acid
264490|NCT02553122|Evicel|evicel
264491|NCT02553109|small paraclinoid|small paraclinoid
264492|NCT02553096|exacerbations|exacerbations
264493|NCT02553096|self-management support|self-management support
264494|NCT02553096|software application|software application
264495|NCT02553031|Application of MR-PET|application of mr-pet
264496|NCT02553005|Acupuncture|acupuncture
264497|NCT02553005|Rheumatoid Arthritis|rheumatoid arthritis
264498|NCT02553005|Quality of life|quality of life
264499|NCT02553005|Hand Strength|hand strength
264500|NCT02552979|atopic dermatitis|atopic dermatitis
264501|NCT02552979|atopic patch test|atopic patch test
264502|NCT02552927|PDA|pda
264503|NCT02552927|Jaundice|jaundice
264504|NCT02552927|Phototherapy|phototherapy
264505|NCT02552914|Colli-Pee|colli-pee
264506|NCT02552914|STI|sti
264507|NCT02552914|first-void urine|first-void urine
264508|NCT02552901|hepatic|hepatic
264509|NCT02552901|liver|liver
264510|NCT02552901|LFT|lft
264511|NCT02552901|hepatic assessment|hepatic assessment
264512|NCT02552901|ICG dye|icg dye
264513|NCT02552901|indocyanine green dye|indocyanine green dye
264514|NCT02552901|Diagnostic Green|diagnostic green
264515|NCT02552901|Pulsion|pulsion
264516|NCT02552901|Akorn|akorn
264517|NCT02552901|Cardiox|cardiox
264518|NCT02552901|anazen|anazen
264519|NCT02552901|essence|essence
264520|NCT02552901|dye detection monitor|dye detection monitor
264521|NCT02552901|Earpads|earpads
264522|NCT02552901|flow sensor|flow sensor
264523|NCT02552901|scaphoid fossa|scaphoid fossa
264524|NCT02552901|liver disease|liver disease
264525|NCT02552901|acute hepatic failure|acute hepatic failure
264526|NCT02552901|AHF|ahf
264527|NCT02552901|NASH|nash
264528|NCT02552901|hepatitis C|hepatitis c
264529|NCT02552901|cirrhosis|cirrhosis
264530|NCT02552901|MELD|meld
264531|NCT02552901|pulse dye densitometry|pulse dye densitometry
264532|NCT02552901|liver transplant|liver transplant
264533|NCT02552901|fluorescence|fluorescence
264534|NCT02552901|near infra-red|near infra-red
264535|NCT02552901|serial blood draws|serial blood draws
264536|NCT02552901|PDR|pdr
264537|NCT02552901|plasma disappearance rate|plasma disappearance rate
264538|NCT02552901|R15|r15
264539|NCT02552901|k coefficient|k coefficient
264540|NCT02552901|transcutaneously|transcutaneously
264541|NCT02552901|liver donor|liver donor
264542|NCT02552901|liver dysfunction|liver dysfunction
264543|NCT02552901|Child-Pugh|child-pugh
264544|NCT02552901|AST|ast
264545|NCT02552901|ALT|alt
264546|NCT02552901|GGT|ggt
264547|NCT02552901|alk phos|alk phos
264548|NCT02552901|prothrombin time|prothrombin time
264549|NCT02552901|albumin|albumin
264550|NCT02552901|serum ICG|serum icg
264551|NCT02552901|liver function tests|liver function tests
264552|NCT02552888|Endothelial Dysfunction|endothelial dysfunction
264553|NCT02552888|Inflammation|inflammation
264554|NCT02552875|Acceleromyography|acceleromyography
264555|NCT02552875|staircase phenomenon|staircase phenomenon
264556|NCT02552875|tetanic stimulation|tetanic stimulation
264557|NCT02552797|Shared Decision Making|shared decision making
264558|NCT02552797|CAMHS|camhs
264559|NCT02552758|violence|violence
264560|NCT02552758|PET|pet
264561|NCT02552758|omega-3 fatty acid|omega-3 fatty acid
264562|NCT02552758|schizophrenia|schizophrenia
264563|NCT02552758|patient|patient
264564|NCT02552719|Injustice Experience|injustice experience
264565|NCT02552719|Questionnaire|questionnaire
264566|NCT02552719|Validation|validation
264567|NCT02552719|German translation|german translation
264568|NCT02552706|probiotics|probiotics
264569|NCT02552706|preterm very low birth weight infants|preterm very low birth weight infants
264570|NCT02552706|necrotizing enterocolitis|necrotizing enterocolitis
264571|NCT02552706|gut microflora|gut microflora
264572|NCT02552706|TLR|tlr
264573|NCT02552706|NF-KB|nf-kb
264574|NCT02552706|inflammatory factors|inflammatory factors
264575|NCT02552693|Enhancing retention|enhancing retention
264576|NCT02552680|Work-Related Musculoskeletal Disorders|work-related musculoskeletal disorders
264577|NCT02552680|Quality of life|quality of life
264578|NCT02552680|Health Education|health education
264579|NCT02552667|Asthma|asthma
264580|NCT02552667|Allergic rhinitis|allergic rhinitis
264581|NCT02552628|Wilson's Disease|wilson's disease
264582|NCT02552628|Deep Brain Stimulation|deep brain stimulation
264583|NCT02552628|dystonia|dystonia
264584|NCT02552615|scoliosis, verticality perception, body symmetry|scoliosis, verticality perception, body symmetry
264585|NCT02552602|HIV|hiv
264586|NCT02552602|Multivitamins|multivitamins
264587|NCT02552589|clinical trial, phase III|clinical trial, phase iii
264588|NCT02552589|plaque index|plaque index
264589|NCT02552589|gingivitis index|gingivitis index
264590|NCT02552589|fluoride|fluoride
264591|NCT02552589|toothpaste|toothpaste
264592|NCT02552550|squamous cell carcinoma of the oropharynx|squamous cell carcinoma of the oropharynx
264593|NCT02552550|swallowing, speech|swallowing, speech
264594|NCT02552550|quality of life|quality of life
264595|NCT02552524|pathological gambling|pathological gambling
264596|NCT02552524|rTMS|rtms
264597|NCT02552524|cognitive tests|cognitive tests
264598|NCT02552524|autonomic nervous system|autonomic nervous system
264599|NCT02552524|craving|craving
264600|NCT02552472|Asthma|asthma
264601|NCT02552472|Inhaler Use|inhaler use
264602|NCT02552472|Adherence|adherence
264603|NCT02552472|Chronic Obstructive Pulmonary Disease|chronic obstructive pulmonary disease
264604|NCT02552459|dexmedetomidine|dexmedetomidine
264605|NCT02552459|patient controlled analgesia|patient controlled analgesia
264606|NCT02552433|nutritional deficiencies|nutritional deficiencies
264607|NCT02552433|plastic surgery|plastic surgery
264608|NCT02552433|post-bariatric|post-bariatric
264609|NCT02552433|protein|protein
264610|NCT02552433|skin surplus|skin surplus
264611|NCT02552420|infrared thermal imaging|infrared thermal imaging
264612|NCT02552420|deep venous thrombosis|deep venous thrombosis
264613|NCT02552407|thrombectomy|thrombectomy
264614|NCT02552407|acute coronary syndromes|acute coronary syndromes
264615|NCT02552407|percutaneous coronary intervention|percutaneous coronary intervention
264616|NCT02552407|STEMI|stemi
264617|NCT02552381|Cancer|cancer
264618|NCT02552381|Thromboembolic event|thromboembolic event
264619|NCT02552381|Fibrin Structure|fibrin structure
264620|NCT02552381|LMWH|lmwh
264621|NCT02552368|Stroke Rehabilitation|stroke rehabilitation
264622|NCT02552368|BCI|bci
264623|NCT02552368|Stroke|stroke
264624|NCT02552368|Upper Extremity Rehabilitation|upper extremity rehabilitation
264625|NCT02552368|paresis|paresis
264626|NCT02552368|hemiparesis|hemiparesis
264627|NCT02552329|mild cognitive impairment|mild cognitive impairment
264628|NCT02552329|Tai Chi|tai chi
264629|NCT02552329|cognitive functions|cognitive functions
264630|NCT02552316|microbiome|microbiome
264631|NCT02552316|bacteria|bacteria
264632|NCT02552316|NB-UVB Phototherapy|nb-uvb phototherapy
264633|NCT02552316|light therapy|light therapy
264634|NCT02552277|Diabetic|diabetic
264635|NCT02552277|PDA-002|pda-002
264636|NCT02552277|Placenta-Derived Cells|placenta-derived cells
264637|NCT02552277|Peripheral neuropathy|peripheral neuropathy
264638|NCT02552277|Neuropathy|neuropathy
264639|NCT02552277|Double-Blind|double-blind
264640|NCT02552277|Safety|safety
264641|NCT02552277|Efficacy|efficacy
264642|NCT02552277|Human Placenta-derived Cells|human placenta-derived cells
264643|NCT02552238|Lumason|lumason
264644|NCT02552238|Dobutamine stress echo|dobutamine stress echo
264645|NCT02552238|stress echo|stress echo
264646|NCT02552238|coronary artery disease|coronary artery disease
264647|NCT02552225|laryngeal sensory neuropathy, chronic laryngeal neuropathy|laryngeal sensory neuropathy, chronic laryngeal neuropathy
264648|NCT02552212|Axial Spondyloarthritis|axial spondyloarthritis
264649|NCT02552212|axSpA|axspa
264650|NCT02552212|Ankylosing Spondylitis|ankylosing spondylitis
264651|NCT02552212|Anti TNF-alpha|anti tnf-alpha
264652|NCT02552212|Certolizumab Pegol|certolizumab pegol
264653|NCT02552212|Nr-axSpA|nr-axspa
264654|NCT02552212|Non-radiographic|non-radiographic
264655|NCT02552212|Spondylarthropathies|spondylarthropathies
264656|NCT02552212|Arthritis|arthritis
264657|NCT02552212|Spinal Diseases|spinal diseases
264753|NCT02551679|Autologous|autologous
264658|NCT02552212|Immunosuppressive Agents|immunosuppressive agents
264659|NCT02552160|Chronic Obstructive Pulmonary Disease|chronic obstructive pulmonary disease
264660|NCT02552160|Fixed-dose Combination|fixed-dose combination
264661|NCT02552160|LAMA/LABA (Long Acting Beta2-Agonists / Long Acting Muscarinic Antagonists)|lama/laba (long acting beta2-agonists / long acting muscarinic antagonists)
264662|NCT02552160|Inhaler|inhaler
264663|NCT02552160|Aclidinium/Formoterol|aclidinium/formoterol
264664|NCT02552160|Glycopyrronium/Indacaterol|glycopyrronium/indacaterol
264665|NCT02552160|Umeclidinium/Vilanterol|umeclidinium/vilanterol
264666|NCT02552147|Autism spectrum disorder|autism spectrum disorder
264667|NCT02552147|Aggression|aggression
264668|NCT02552147|Irritability|irritability
264669|NCT02552147|Nicotine|nicotine
264670|NCT02552147|Nicotinic acetylcholine receptor|nicotinic acetylcholine receptor
264671|NCT02552147|Nicotinic agonist|nicotinic agonist
264672|NCT02552147|Adult autism|adult autism
264673|NCT02552134|Access to physical activity resources, community based exercise programme, sports-clubs, health resort,|access to physical activity resources, community based exercise programme, sports-clubs, health resort,
264674|NCT02552121|ovary cancer|ovary cancer
264675|NCT02552121|cervix cancer|cervix cancer
264676|NCT02552121|endometrium cancer|endometrium cancer
264677|NCT02552121|bladder cancer|bladder cancer
264678|NCT02552121|prostate cancer (CRPC)|prostate cancer (crpc)
264679|NCT02552121|esophagus cancer|esophagus cancer
264680|NCT02552121|lung cancer (NSCLC)|lung cancer (nsclc)
264681|NCT02552108|Cognitive-behavioural therapy|cognitive-behavioural therapy
264682|NCT02552056|Child Adolescent Mental Integration PHC Traditional Healers|child adolescent mental integration phc traditional healers
264683|NCT02552043|Cystic fibrosis|cystic fibrosis
264684|NCT02552043|Exercise capacity|exercise capacity
264685|NCT02552043|Interactive gaming console|interactive gaming console
264686|NCT02552043|Pulmonary rehabilitation|pulmonary rehabilitation
264687|NCT02552017|adenoma detection rate|adenoma detection rate
264688|NCT02552017|Endocuff|endocuff
264689|NCT02552017|Endocuff Vision|endocuff vision
264690|NCT02552017|colonoscopy|colonoscopy
264691|NCT02552017|bowel cancer screening|bowel cancer screening
264692|NCT02552017|bowel cancer|bowel cancer
264693|NCT02552004|pCLE|pcle
264694|NCT02552004|Digestive surgery|digestive surgery
264695|NCT02552004|Endocrine surgery|endocrine surgery
264696|NCT02551991|Pancreatic cancer|pancreatic cancer
264697|NCT02551991|MM-398|mm-398
264698|NCT02551991|Metastatic pancreatic cancer|metastatic pancreatic cancer
264699|NCT02551991|First line pancreatic cancer treatment|first line pancreatic cancer treatment
264700|NCT02551978|obesity|obesity
264701|NCT02551978|child|child
264702|NCT02551978|primary prevention|primary prevention
264703|NCT02551978|serious game|serious game
264704|NCT02551978|nutrition|nutrition
264705|NCT02551978|physical activity|physical activity
264706|NCT02551978|psychosocial|psychosocial
264707|NCT02551978|stress|stress
264708|NCT02551978|knowledge|knowledge
264709|NCT02551978|diet|diet
264710|NCT02551965|Cancer|cancer
264711|NCT02551965|Patient|patient
264712|NCT02551965|Oncology|oncology
264713|NCT02551965|Caregiver|caregiver
264714|NCT02551952|Games|games
264715|NCT02551952|Cognitive Tests|cognitive tests
264716|NCT02551952|General Anesthesia|general anesthesia
264717|NCT02551952|Surgery|surgery
264718|NCT02551913|Psychological Theory|psychological theory
264719|NCT02551913|adolescents|adolescents
264720|NCT02551900|Type 2 Diabetes|type 2 diabetes
264721|NCT02551900|Vascular Function|vascular function
264722|NCT02551900|Water Exercise|water exercise
264723|NCT02551900|Warm Water|warm water
264724|NCT02551900|Cold Water|cold water
264725|NCT02551887|HPV Vaccinations|hpv vaccinations
264726|NCT02551887|Quadrivalent Vaccine|quadrivalent vaccine
264727|NCT02551848|Movement disorders|movement disorders
264728|NCT02551848|Botulinum toxin type A|botulinum toxin type a
264729|NCT02551848|Kinematics|kinematics
264730|NCT02551835|ODIN|odin
264731|NCT02551835|Meta-analysis|meta-analysis
264732|NCT02551835|Cholecalciferol|cholecalciferol
264733|NCT02551835|25(OH)D|25(oh)d
264734|NCT02551835|Subgroup effects|subgroup effects
264735|NCT02551822|Urge Urinary Incontinence, sacral neuromodulation|urge urinary incontinence, sacral neuromodulation
264736|NCT02551796|lenticule extraction|lenticule extraction
264737|NCT02551796|laser in situ keratomileusis|laser in situ keratomileusis
264738|NCT02551796|femtosecond laser-assisted laser in situ keratomileusis|femtosecond laser-assisted laser in situ keratomileusis
264739|NCT02551796|tear|tear
264740|NCT02551796|inflammatory mediators|inflammatory mediators
264741|NCT02551783|urethral stricture|urethral stricture
264742|NCT02551783|urethroplasty|urethroplasty
264743|NCT02551783|buccal mucosa|buccal mucosa
264744|NCT02551783|graft|graft
264745|NCT02551757|Rehabilitation|rehabilitation
264746|NCT02551757|Continuous Positive Airway Pressure|continuous positive airway pressure
264747|NCT02551744|histamine-2 receptor antagonist|histamine-2 receptor antagonist
264748|NCT02551744|proton pump inhibitor|proton pump inhibitor
264749|NCT02551744|thienopyridine|thienopyridine
264750|NCT02551744|clopidogrel|clopidogrel
264751|NCT02551744|prevention|prevention
264752|NCT02551679|Stem cells|stem cells
264754|NCT02551679|Vascular disease|vascular disease
264755|NCT02551679|Peripheral arterial disease|peripheral arterial disease
264756|NCT02551679|Regenerative medicine|regenerative medicine
264757|NCT02551679|Amputation|amputation
264758|NCT02551653|Idiopathic Pulmonary Arterial Hypertension|idiopathic pulmonary arterial hypertension
264759|NCT02551653|Biodistribution|biodistribution
264760|NCT02551653|Positron Emission Tomography|positron emission tomography
264761|NCT02551653|[11C]-GSK2256098|[11c]-gsk2256098
264762|NCT02551653|Healthy subjects|healthy subjects
264763|NCT02551614|lipopolysaccharide|lipopolysaccharide
264764|NCT02551614|COPD|copd
264765|NCT02551614|neutrophil|neutrophil
264766|NCT02551601|subfoveal choroidal thickness|subfoveal choroidal thickness
264767|NCT02551601|optical coherence tomography|optical coherence tomography
264768|NCT02551601|enhanced depth imaging|enhanced depth imaging
264769|NCT02551588|fibrosis|fibrosis
264770|NCT02551588|Magnetic resonance imaging|magnetic resonance imaging
264771|NCT02551549|Subjects|subjects
264772|NCT02551536|Allergic rhinitis|allergic rhinitis
264773|NCT02551536|montelukast|montelukast
264774|NCT02551536|fexofenadine|fexofenadine
264775|NCT02551536|levocetrizine|levocetrizine
264776|NCT02551510|Skin Adhesive|skin adhesive
264777|NCT02551510|Suture|suture
264778|NCT02551510|Port Incisions|port incisions
264779|NCT02551497|volunteer drug interaction study|volunteer drug interaction study
264780|NCT02551471|Locally advanced rectal cancer|locally advanced rectal cancer
264781|NCT02551471|Fixed primary rectal cancer|fixed primary rectal cancer
264782|NCT02551471|Pelvic recurrence|pelvic recurrence
264783|NCT02551471|Benchmarking France Australia|benchmarking france australia
264784|NCT02551432|pembrolizumab|pembrolizumab
264785|NCT02551432|paclitaxel|paclitaxel
264786|NCT02551419|mild cognitive impairment|mild cognitive impairment
264787|NCT02551419|ketones|ketones
264788|NCT02551419|medium chain triglycerides|medium chain triglycerides
264789|NCT02551419|Positron emission tomography|positron emission tomography
264790|NCT02551419|magnetic resonance imaging|magnetic resonance imaging
264791|NCT02551419|cognition|cognition
264792|NCT02551419|brain|brain
264793|NCT02551419|neuroimaging|neuroimaging
264794|NCT02551406|nocturnal hypoventilation|nocturnal hypoventilation
264795|NCT02551406|capno-oxymetry|capno-oxymetry
264796|NCT02551393|Older adults|older adults
264797|NCT02551393|Home Blood Pressure Monitoring|home blood pressure monitoring
264798|NCT02551367|letrozole|letrozole
264799|NCT02551354|Labor, Obstetric|labor, obstetric
264800|NCT02551354|pain|pain
264801|NCT02551354|pupil diameter|pupil diameter
264802|NCT02551354|Visual Analogic Scale (VAS)|visual analogic scale (vas)
264803|NCT02551341|prostatectomy|prostatectomy
264804|NCT02551341|robotic|robotic
264805|NCT02551315|Intra-cortical pore volume|intra-cortical pore volume
264806|NCT02551315|HR-pQCT|hr-pqct
264807|NCT02551315|DXA|dxa
264808|NCT02551315|bone mineral density|bone mineral density
264809|NCT02551315|bone turnover markers|bone turnover markers
264810|NCT02551315|urinary pentosidine|urinary pentosidine
264811|NCT02551289|MRI|mri
264812|NCT02551289|Gluten|gluten
264813|NCT02551289|Imaging|imaging
264814|NCT02551289|Enteropathy-Associated T-Cell Lymphoma|enteropathy-associated t-cell lymphoma
264815|NCT02551263|Breast Cancer|breast cancer
264816|NCT02551263|Eribulin|eribulin
264817|NCT02551263|HER2-negative|her2-negative
264818|NCT02551263|hormone-resistant|hormone-resistant
264819|NCT02551263|inoperable|inoperable
264820|NCT02551263|recurrent metastatic|recurrent metastatic
264821|NCT02551250|hepatocellular carcinoma|hepatocellular carcinoma
264822|NCT02551250|surveillance|surveillance
264823|NCT02551250|liver cirrhosis|liver cirrhosis
264824|NCT02551250|ultrasonography|ultrasonography
264825|NCT02551250|magnetic resonance imaging|magnetic resonance imaging
264826|NCT02551237|Elderly patient|elderly patient
264827|NCT02551237|Radiotherapy|radiotherapy
264828|NCT02551237|Radio chemotherapy|radio chemotherapy
264829|NCT02551237|Neoadjuvant treatment|neoadjuvant treatment
264830|NCT02551224|COPD|copd
264831|NCT02551198|polyethylene glycol with ascorbic acid|polyethylene glycol with ascorbic acid
264832|NCT02551198|oral sulfate solution|oral sulfate solution
264833|NCT02551198|bowel preparation|bowel preparation
712534|NCT00579800|MRI|mri
338507|NCT02148250|U 500|u 500
264834|NCT02551159|programmed cell death ligand 1 (PD-L1), MEDI4736, Cytotoxic T-lymphocyte-associated antigen 4 {CTLA-4}, PFS, SCCHN|programmed cell death ligand 1 (pd-l1), medi4736, cytotoxic t-lymphocyte-associated antigen 4 {ctla-4}, pfs, scchn
264835|NCT02551133|Dexamethasone|dexamethasone
264836|NCT02551133|mastectomy|mastectomy
264837|NCT02551133|persistent surgical pain|persistent surgical pain
264838|NCT02551120|Idiopathic hypoparathyroidism|idiopathic hypoparathyroidism
264839|NCT02551120|Autosomal dominant hypocalcaemia|autosomal dominant hypocalcaemia
264840|NCT02551120|Pseudohypoparathyroidism|pseudohypoparathyroidism
264841|NCT02551120|Quality of Life|quality of life
264842|NCT02551120|Bone Mineral Density|bone mineral density
264843|NCT02551120|Muscle strength|muscle strength
264844|NCT02551120|Cardiovascular indices|cardiovascular indices
264845|NCT02551055|Drug Therapy|drug therapy
264846|NCT02551042|Digital Ulcers|digital ulcers
264847|NCT02551042|Raynauds Phenomenon|raynauds phenomenon
264848|NCT02551042|Factor XIII|factor xiii
264849|NCT02551029|Magnetic Resonance Imaging|magnetic resonance imaging
264850|NCT02551029|Brainstem|brainstem
264851|NCT02551029|Solitary Nucleus|solitary nucleus
264852|NCT02551029|Visceral Nervous System|visceral nervous system
264853|NCT02551029|Transient Receptor Potential Channels|transient receptor potential channels
264854|NCT02550977|Contraception|contraception
264855|NCT02550977|Transdermal contraceptive patch|transdermal contraceptive patch
264856|NCT02550977|Safety|safety
264857|NCT02550977|Efficacy|efficacy
264858|NCT02550977|Pharmacokinetic|pharmacokinetic
264859|NCT02550964|Autoimmune Disease|autoimmune disease
264860|NCT02550964|Rheumatoid Arthritis|rheumatoid arthritis
264861|NCT02550964|Systemic Lupus Erythematosus|systemic lupus erythematosus
264862|NCT02550964|Hydroxychloroquine(HCQ)|hydroxychloroquine(hcq)
264863|NCT02550964|Chloroquine(CQ)|chloroquine(cq)
264864|NCT02550964|Toxic Maculopathy|toxic maculopathy
264865|NCT02550925|Cancer survivors|cancer survivors
264866|NCT02550886|Work Burden|work burden
264867|NCT02550886|Ambulatory Orthopedic Surgery|ambulatory orthopedic surgery
264868|NCT02550886|Anesthesiology|anesthesiology
264869|NCT02550886|Perioperative Care|perioperative care
264870|NCT02550860|intravenous fat emulsions|intravenous fat emulsions
264871|NCT02550860|parenteral nutrition|parenteral nutrition
264872|NCT02550860|skin barrier function|skin barrier function
264873|NCT02550860|essential fatty acids|essential fatty acids
264874|NCT02550860|transepidermal water loss|transepidermal water loss
264875|NCT02550847|MR/PET|mr/pet
264876|NCT02550847|pancreatic cancer|pancreatic cancer
264877|NCT02550834|Core stability|core stability
264878|NCT02550834|Indoors curling exercises|indoors curling exercises
264879|NCT02550834|Motivation|motivation
264880|NCT02550821|Physical activity levels|physical activity levels
264881|NCT02550821|Bronchiectasis|bronchiectasis
264882|NCT02550782|perineural dexmedetomidine|perineural dexmedetomidine
264883|NCT02550782|infraclavicular perineural catheter|infraclavicular perineural catheter
264884|NCT02550782|postoperative analgesia|postoperative analgesia
264885|NCT02550769|Transanal NOTES|transanal notes
264886|NCT02550769|Transanal TME|transanal tme
264887|NCT02550769|Laparoscopic Low Anterior Resection|laparoscopic low anterior resection
264888|NCT02550769|Surgery|surgery
264889|NCT02550743|Stage II|stage ii
264890|NCT02550743|Stage III|stage iii
264891|NCT02550743|Stage IV|stage iv
264892|NCT02550743|metastatic|metastatic
264893|NCT02550717|Low-dose Acetylsalicylic Acid,|low-dose acetylsalicylic acid,
264894|NCT02550717|Bleeding,|bleeding,
264895|NCT02550717|The Health Improvement Network (THIN),|the health improvement network (thin),
264896|NCT02550717|Cardiovascular|cardiovascular
264897|NCT02550717|Secondary prevention of cardiovascular events|secondary prevention of cardiovascular events
264898|NCT02550704|Irritable Bowel syndrome|irritable bowel syndrome
264899|NCT02550704|Intestinal permeability|intestinal permeability
264900|NCT02550704|Visceral hypersensitivity|visceral hypersensitivity
264901|NCT02550704|Low grade inflammation|low grade inflammation
264902|NCT02550678|Untreated nBCC|untreated nbcc
264903|NCT02550678|Low-Risk|low-risk
264904|NCT02550665|Alzheimer's disease|alzheimer's disease
264905|NCT02550665|donepezil|donepezil
264906|NCT02550626|delirium|delirium
264907|NCT02550626|alpha synucleinopathy|alpha synucleinopathy
264908|NCT02550626|spine surgery|spine surgery
264909|NCT02550613|MR/PET, hepatocellular carcinoma, HCC|mr/pet, hepatocellular carcinoma, hcc
264910|NCT02550600|ARDS|ards
264911|NCT02550600|Acute lung impairment|acute lung impairment
264912|NCT02550600|Extracorporeal lung assist|extracorporeal lung assist
264913|NCT02550600|ECMO|ecmo
264914|NCT02550600|ECLA|ecla
264915|NCT02550600|Murray-score|murray-score
264916|NCT02550600|SOFA-score|sofa-score
264917|NCT02550587|Patient Satisfaction|patient satisfaction
264918|NCT02550587|anesthesia Care|anesthesia care
264919|NCT02550561|Posterior tibial nerve stimulation|posterior tibial nerve stimulation
264920|NCT02550561|PTNS|ptns
264921|NCT02550561|IC|ic
264922|NCT02550548|Incretins|incretins
264923|NCT02550548|GLP-1|glp-1
264924|NCT02550548|GIP|gip
338645|NCT02147847|Aging|aging
264925|NCT02550548|hyperglycemic clamp|hyperglycemic clamp
264926|NCT02550548|Glucagon|glucagon
264927|NCT02550535|Gene Therapy|gene therapy
264928|NCT02550535|WT1 TCR|wt1 tcr
264929|NCT02550535|Gene modified T cels|gene modified t cels
264930|NCT02550522|without associated head injury|without associated head injury
264931|NCT02550509|stroke|stroke
264932|NCT02550509|Botulinum toxin|botulinum toxin
264933|NCT02550509|Muscle alterations|muscle alterations
264934|NCT02550483|Healthy volunteers|healthy volunteers
264935|NCT02550444|Clonidine|clonidine
264936|NCT02550444|Anesthesia, Obstetrical|anesthesia, obstetrical
264937|NCT02550379|Social Anxiety|social anxiety
264938|NCT02550379|Social Phobia|social phobia
264939|NCT02550379|Depression|depression
264940|NCT02550379|Emotion Recognition Training|emotion recognition training
264941|NCT02550366|Cardiac MRI|cardiac mri
264942|NCT02550366|Accelerate imaging|accelerate imaging
264943|NCT02550366|coronary artery disease|coronary artery disease
264944|NCT02550353|lenticule extraction|lenticule extraction
265047|NCT02549833|glioma|glioma
265147|NCT02549326|Vitamin D|vitamin d
264945|NCT02550353|femtosecond laser-assisted laser in situ keratomileusis|femtosecond laser-assisted laser in situ keratomileusis
264946|NCT02550353|tear|tear
264947|NCT02550353|inflammatory mediators|inflammatory mediators
264948|NCT02550340|Arrhythmia|arrhythmia
264949|NCT02550340|Alcohol|alcohol
264950|NCT02550340|ECG|ecg
264951|NCT02550327|resectable|resectable
264952|NCT02550327|potentially resectable|potentially resectable
264953|NCT02550327|Pancreatic adenocarcinoma|pancreatic adenocarcinoma
264954|NCT02550327|PDAC|pdac
264955|NCT02550301|mean platelet volume|mean platelet volume
264956|NCT02550262|Epidural|epidural
264957|NCT02550262|Labor analgesia|labor analgesia
264958|NCT02550262|Programmed intermittent epidural bolus|programmed intermittent epidural bolus
264959|NCT02550236|Children|children
264960|NCT02550236|Obesity|obesity
264961|NCT02550236|Pregnancy|pregnancy
264962|NCT02550236|Growth|growth
264963|NCT02550236|Lifestyle|lifestyle
264964|NCT02550236|Metabolic and cardiovascular health|metabolic and cardiovascular health
264965|NCT02550236|Birth|birth
264966|NCT02550236|Development|development
264967|NCT02550210|Breast Conserving Surgery|breast conserving surgery
264968|NCT02550210|Breast Imaging|breast imaging
264969|NCT02550210|Breast Diagnostics|breast diagnostics
264970|NCT02550197|Influenza|influenza
264971|NCT02550197|Quadrivalent influenza vaccine|quadrivalent influenza vaccine
264972|NCT02550197|Trivalent influenza vaccine|trivalent influenza vaccine
264973|NCT02550184|Patients with symptoms of acute respiratory problems|patients with symptoms of acute respiratory problems
264974|NCT02550171|Biobank|biobank
264975|NCT02550171|Genetics|genetics
264976|NCT02550171|DNA|dna
264977|NCT02550171|Cohort|cohort
264978|NCT02550171|normal control|normal control
264979|NCT02550158|Crohn's Disease|crohn's disease
264980|NCT02550158|Ulcerative Colitis|ulcerative colitis
264981|NCT02550158|Educational program|educational program
264982|NCT02550158|Inflammatory Bowel Disease|inflammatory bowel disease
264983|NCT02550158|Psycho-pedagogic score|psycho-pedagogic score
264984|NCT02550158|IBD|ibd
264985|NCT02550145|Hyperinsulinemic|hyperinsulinemic
264986|NCT02550145|post-bariatric surgery|post-bariatric surgery
264987|NCT02550132|electromyography|electromyography
264988|NCT02550132|biomechanical phenomena|biomechanical phenomena
264989|NCT02550132|dose-response relationship|dose-response relationship
264990|NCT02550132|musculoskeletal manipulations|musculoskeletal manipulations
264991|NCT02550132|spinal manipulation|spinal manipulation
264992|NCT02550106|CHRONIC SPONTANEOUS URTICARIA, OMALIZUMAB, URTICARIA CONTROL TEST|chronic spontaneous urticaria, omalizumab, urticaria control test
264993|NCT02550093|Volunteers|volunteers
264994|NCT02550067|HIV infection|hiv infection
264995|NCT02550067|DepoLevonorgestrel|depolevonorgestrel
264996|NCT02550067|Contraception|contraception
264997|NCT02550067|DMPA|dmpa
264998|NCT02550067|Copper IUD|copper iud
264999|NCT02550067|Levonorgestrel implant|levonorgestrel implant
265000|NCT02550067|IUD|iud
265001|NCT02550041|Bronchitis aspergillus|bronchitis aspergillus
265002|NCT02550041|cystic fibrosis|cystic fibrosis
265003|NCT02550028|Neonates|neonates
265004|NCT02550028|Seizure|seizure
265005|NCT02550015|Exercise training|exercise training
265006|NCT02550015|Oxygen consumption|oxygen consumption
265007|NCT02549989|LY3023414|ly3023414
265008|NCT02549989|15-079|15-079
265009|NCT02549989|Persistent Endometrial Cancer|persistent endometrial cancer
265010|NCT02549976|Crohn's Disease|crohn's disease
265011|NCT02549976|Digestive Damage|digestive damage
265012|NCT02549976|Lemann Index|lemann index
265013|NCT02549950|Accelerated orthodontic tooth movement (AOTM)|accelerated orthodontic tooth movement (aotm)
265014|NCT02549950|Peizo-corticission|peizo-corticission
265015|NCT02549937|biliary|biliary
265016|NCT02549937|pancreatic|pancreatic
265017|NCT02549937|neuroendocrine|neuroendocrine
265018|NCT02549937|carcinoid|carcinoid
265019|NCT02549937|PNET|pnet
265020|NCT02549937|EP-NET|ep-net
265021|NCT02549937|extrapancreatic|extrapancreatic
265022|NCT02549937|sarcoma|sarcoma
265023|NCT02549937|soft tissue sarcoma|soft tissue sarcoma
265024|NCT02549937|STS|sts
265025|NCT02549937|BTC|btc
265026|NCT02549924|Resveratrol|resveratrol
265027|NCT02549924|Glycemic Variability|glycemic variability
265028|NCT02549924|MAGE|mage
265029|NCT02549911|chemotherapy|chemotherapy
265030|NCT02549911|surgery|surgery
265031|NCT02549911|Surgically-Created Resection Cavity|surgically-created resection cavity
265032|NCT02549911|Adverse Reaction to Drug|adverse reaction to drug
265033|NCT02549885|Migraine disorders|migraine disorders
265034|NCT02549885|Muscle stretching exercises|muscle stretching exercises
265035|NCT02549872|Dementia|dementia
265036|NCT02549872|Validity|validity
265037|NCT02549872|Mortality|mortality
265038|NCT02549872|Electronic health records|electronic health records
265039|NCT02549859|DBS|dbs
265040|NCT02549859|Low frequency stimulation|low frequency stimulation
265041|NCT02549859|Dysphagia|dysphagia
265042|NCT02549859|Freezing of gait|freezing of gait
265043|NCT02549833|low-grade glioma|low-grade glioma
265044|NCT02549833|WHO grade II|who grade ii
265045|NCT02549833|vaccine|vaccine
265046|NCT02549833|immunotherapy|immunotherapy
265048|NCT02549820|Congenital Diaphragmatic Hernia|congenital diaphragmatic hernia
265049|NCT02549820|Tracheal Occlusion|tracheal occlusion
265050|NCT02549807|Vascular hemiplegia|vascular hemiplegia
265051|NCT02549807|2D ultrasound|2d ultrasound
265052|NCT02549807|Muscle elasticity|muscle elasticity
265053|NCT02549807|Pennation angle|pennation angle
265054|NCT02549794|low concentration contrast agent|low concentration contrast agent
265055|NCT02549794|Low dose contrast agent|low dose contrast agent
265056|NCT02549794|computed tomography|computed tomography
265057|NCT02549781|pathological gambler|pathological gambler
265058|NCT02549781|Go-Nogo test|go-nogo test
265059|NCT02549768|Dexmedetomidine|dexmedetomidine
265060|NCT02549768|Pituitary|pituitary
265061|NCT02549768|Transsphenoidal|transsphenoidal
265062|NCT02549768|Cortisol|cortisol
265063|NCT02549742|Electrochemotherapy|electrochemotherapy
265064|NCT02549742|head neck cancer|head neck cancer
265065|NCT02549742|bleomycin|bleomycin
265066|NCT02549716|Acetaminophen|acetaminophen
265067|NCT02549716|interleukin-6|interleukin-6
265068|NCT02549716|interleukin-1|interleukin-1
265069|NCT02549716|thromboxane A2|thromboxane a2
265070|NCT02549703|multiple sclerosis|multiple sclerosis
265071|NCT02549703|progressive multiple sclerosis|progressive multiple sclerosis
265072|NCT02549703|mitochondria|mitochondria
265073|NCT02549703|neurodegeneration|neurodegeneration
265074|NCT02549690|IVF, Testosterone gel, DHEA, poor responder.|ivf, testosterone gel, dhea, poor responder.
265075|NCT02549664|Hypertrophic Cardiomyopathy (HCM)|hypertrophic cardiomyopathy (hcm)
265076|NCT02549664|Long QT Syndrome (LQTS)|long qt syndrome (lqts)
265077|NCT02549651|DLBCL|dlbcl
265078|NCT02549651|MEDI4736|medi4736
265079|NCT02549651|durvalumab|durvalumab
265080|NCT02549651|tremelimumab|tremelimumab
265081|NCT02549651|AZD9150|azd9150
265082|NCT02549651|anti-PD-L1|anti-pd-l1
265083|NCT02549651|anti-CTLA-4|anti-ctla-4
265084|NCT02549651|immunotherapy|immunotherapy
265085|NCT02549651|IMTC|imtc
265086|NCT02549651|STAT3|stat3
265087|NCT02549625|Single right ventricular failure|single right ventricular failure
265088|NCT02549612|Conductive hearing loss|conductive hearing loss
265089|NCT02549612|middle ear pressure equalization|middle ear pressure equalization
265090|NCT02549612|middle ear effusion|middle ear effusion
265091|NCT02549599|Digital and mobile health|digital and mobile health
265092|NCT02549599|Sexual and reproductive health|sexual and reproductive health
265093|NCT02549599|Adolescents and young adults|adolescents and young adults
265094|NCT02549586|solid organ transplant|solid organ transplant
265095|NCT02549586|immune tolerance|immune tolerance
265096|NCT02549586|autologous stem cell transplant|autologous stem cell transplant
265097|NCT02549586|blood and marrow transplant|blood and marrow transplant
265098|NCT02549586|autoimmune disease|autoimmune disease
265099|NCT02549573|Motor Symptoms|motor symptoms
265100|NCT02549573|Parkinson's disease|parkinson's disease
265101|NCT02549573|Apokyn|apokyn
265102|NCT02549573|Apomorphine|apomorphine
265103|NCT02549573|PD|pd
265104|NCT02549560|tDCS|tdcs
265105|NCT02549560|Cardiac Surgery|cardiac surgery
265106|NCT02549547|anxiety|anxiety
265107|NCT02549547|depression|depression
265108|NCT02549547|exercise|exercise
265109|NCT02549547|group|group
265110|NCT02549547|group medical visit|group medical visit
265111|NCT02549547|mood disorder|mood disorder
265112|NCT02549547|physical activity|physical activity
265113|NCT02549547|primary care|primary care
265114|NCT02549534|Taxane|taxane
265115|NCT02549534|Neuropathy|neuropathy
265116|NCT02549534|Chemotherapy-Induced Peripheral Neuropathy (CIPN)|chemotherapy-induced peripheral neuropathy (cipn)
265117|NCT02549534|Breast Cancer|breast cancer
265118|NCT02549534|Local skin heating|local skin heating
265119|NCT02549534|Axon reflex|axon reflex
265120|NCT02549534|Axon flare|axon flare
712535|NCT00579800|Breast|breast
265121|NCT02549534|Total Neuropathy Score (TNS)|total neuropathy score (tns)
265122|NCT02549534|Laser Doppler Flowmetry (LDF)|laser doppler flowmetry (ldf)
265123|NCT02549534|Laser Speckle Contrast Imaging (LSCI)|laser speckle contrast imaging (lsci)
265124|NCT02549534|Full-field laser perfusion imaging (FLPI)|full-field laser perfusion imaging (flpi)
265125|NCT02549534|Paclitaxel|paclitaxel
265126|NCT02549534|Taxol|taxol
265127|NCT02549521|calcium|calcium
265128|NCT02549521|magnesium|magnesium
265129|NCT02549521|vitamin D|vitamin d
265130|NCT02549521|bone turnover markers|bone turnover markers
265131|NCT02549482|Central volume deficit|central volume deficit
265132|NCT02549482|Head-up tilt|head-up tilt
265133|NCT02549482|Systolic pressure variation|systolic pressure variation
265134|NCT02549456|natural orifice surgery|natural orifice surgery
265135|NCT02549456|natural orifice specimen extraction|natural orifice specimen extraction
265136|NCT02549456|taTME|tatme
265137|NCT02549443|Catabolic response|catabolic response
265138|NCT02549443|Amino Acids|amino acids
265139|NCT02549443|Insulin|insulin
265140|NCT02549430|Advanced breast cancer|advanced breast cancer
265141|NCT02549430|Postmenopausal|postmenopausal
265142|NCT02549430|ER positive|er positive
265143|NCT02549430|Her2 negative|her2 negative
265144|NCT02549378|microcirculation|microcirculation
265145|NCT02549378|confocal microscopy|confocal microscopy
265146|NCT02549378|hypocapnia|hypocapnia
265148|NCT02549313|brain lesion|brain lesion
265149|NCT02549313|intracranial pressure|intracranial pressure
265150|NCT02549313|cerebral perfusion pressure|cerebral perfusion pressure
265151|NCT02549300|connective tissue massage|connective tissue massage
265152|NCT02549300|adolescent tension-type headache|adolescent tension-type headache
265153|NCT02549274|Cervicalgia|cervicalgia
265154|NCT02549274|self-rehabilitation|self-rehabilitation
265155|NCT02549274|physiotherapy|physiotherapy
265156|NCT02549261|nimotuzumab|nimotuzumab
265157|NCT02549261|non-small cell lung cancer|non-small cell lung cancer
265158|NCT02549261|radiochemotherapy|radiochemotherapy
265159|NCT02549261|stage IIIA/IIIB non-small cell lung cancer|stage iiia/iiib non-small cell lung cancer
265160|NCT02549248|Interstitial Lung Diseases|interstitial lung diseases
265161|NCT02549248|nanoparticles|nanoparticles
265162|NCT02549248|lung|lung
265163|NCT02549248|broncho-alveolar lavage|broncho-alveolar lavage
265164|NCT02549248|bronchial washings|bronchial washings
265165|NCT02549235|IVF/ICSI|ivf/icsi
265166|NCT02549235|Infertility|infertility
265167|NCT02549235|Septate uterus|septate uterus
265168|NCT02549235|3D|3d
265169|NCT02549235|Ultrasound|ultrasound
265170|NCT02549235|Arcuate uterus|arcuate uterus
265171|NCT02549222|pathogen reduction|pathogen reduction
265172|NCT02549222|INTERCEPT|intercept
265173|NCT02549222|platelet|platelet
265174|NCT02549222|pulmonary|pulmonary
265175|NCT02549222|ARDS|ards
265176|NCT02549222|hematology|hematology
265177|NCT02549222|oncology|oncology
265178|NCT02549222|assisted ventilation|assisted ventilation
265179|NCT02549222|transfusion of platelet components|transfusion of platelet components
265180|NCT02549222|hematology-oncology patients|hematology-oncology patients
265181|NCT02549209|Pembrolizumab|pembrolizumab
265182|NCT02549209|Keytruda|keytruda
265183|NCT02549209|Anti-Programmed [Cell] Death Protein 1 (PD-1) Antibody|anti-programmed [cell] death protein 1 (pd-1) antibody
265184|NCT02549209|Carboplatin|carboplatin
265185|NCT02549209|Paclitaxel|paclitaxel
265186|NCT02549183|Spinal Cord Stimulation|spinal cord stimulation
265187|NCT02549170|Autoimmune Diseases|autoimmune diseases
265188|NCT02549170|Polyneuropathies|polyneuropathies
265189|NCT02549170|Nervous System Diseases|nervous system diseases
265190|NCT02549170|Peripheral Nervous System Diseases|peripheral nervous system diseases
265191|NCT02549170|Polyradiculoneuropathy|polyradiculoneuropathy
265192|NCT02549170|Autoimmune Diseases of the Nervous System|autoimmune diseases of the nervous system
265193|NCT02549170|Immunoglobulins|immunoglobulins
265194|NCT02549170|Immune System Diseases|immune system diseases
265195|NCT02549170|Demyelinating Diseases|demyelinating diseases
265196|NCT02549170|Polyradiculoneuropathy, Chronic Inflammatory Demyelinating|polyradiculoneuropathy, chronic inflammatory demyelinating
265197|NCT02549170|Neuromuscular Diseases|neuromuscular diseases
265198|NCT02549144|HDL biochemical composition and function|hdl biochemical composition and function
265199|NCT02549105|EMLA CREAM|emla cream
265200|NCT02549105|LIDOCAINE INFILTERATION|lidocaine infilteration
265201|NCT02549105|PAIN RELIEF|pain relief
265202|NCT02549092|levodopa-carbidopa intestinal gel|levodopa-carbidopa intestinal gel
265203|NCT02549092|levodopa|levodopa
265204|NCT02549092|carbidopa|carbidopa
265205|NCT02549092|Advanced Parkinson's Disease|advanced parkinson's disease
265206|NCT02549092|Non-Motor Symptom Scale NMSS|non-motor symptom scale nmss
265207|NCT02549092|Parkinson's Disease Sleep Scale PDSS-2|parkinson's disease sleep scale pdss-2
265208|NCT02549092|efficacy|efficacy
265209|NCT02549066|cardiopulmonary bypass|cardiopulmonary bypass
265210|NCT02549066|renal blood flow|renal blood flow
265211|NCT02549066|renal function|renal function
265212|NCT02549066|renal oxygenation|renal oxygenation
265213|NCT02549001|Onychomycosis|onychomycosis
265214|NCT02549001|Nail fungus|nail fungus
265215|NCT02548975|Cardiac surgery|cardiac surgery
265216|NCT02548975|Risk factors|risk factors
265217|NCT02548975|Postoperative delirium|postoperative delirium
265218|NCT02548962|Multiple Myeloma|multiple myeloma
265219|NCT02548962|Bruton's Tyrosine Kinase|bruton's tyrosine kinase
265220|NCT02548962|PCI-32765|pci-32765
265221|NCT02548962|Pomalidomide|pomalidomide
265222|NCT02548962|Dexamethasone|dexamethasone
265223|NCT02548962|Relapsed Refractory Multiple Myeloma|relapsed refractory multiple myeloma
265224|NCT02548962|Ibrutinib|ibrutinib
265225|NCT02548936|Cholesterol, LDL|cholesterol, ldl
265226|NCT02548936|Carotid Intima-Media Thickness|carotid intima-media thickness
265227|NCT02548936|Atherosclerosis|atherosclerosis
265228|NCT02548936|Ezetimibe, Simvastatin Drug Combination|ezetimibe, simvastatin drug combination
265229|NCT02548936|Lupus Erythematosus, Systemic|lupus erythematosus, systemic
265230|NCT02548897|Parkinson's Disease with Freezing of Gait Symptoms|parkinson's disease with freezing of gait symptoms
265231|NCT02548858|Perineorrhaphy|perineorrhaphy
265232|NCT02548858|Pelvic organ prolapse|pelvic organ prolapse
265233|NCT02548858|Vaginal or abdominal reconstruction|vaginal or abdominal reconstruction
265234|NCT02548858|Body image|body image
265235|NCT02548845|hyponatremia|hyponatremia
265236|NCT02548845|SIADH|siadh
265237|NCT02548845|Oncologic patients|oncologic patients
265238|NCT02548832|Berberine|berberine
265239|NCT02548832|Bezafibrate|bezafibrate
265240|NCT02548806|Clonidine|clonidine
265241|NCT02548793|Cardiac Arrest|cardiac arrest
265242|NCT02548793|CPR|cpr
265243|NCT02548793|Family-centered Care|family-centered care
265244|NCT02548793|Health Literacy|health literacy
265245|NCT02548793|Health Education|health education
265246|NCT02548793|Education Dissemination|education dissemination
265247|NCT02548780|unresectable|unresectable
265248|NCT02548767|High fructose corn syrup|high fructose corn syrup
265249|NCT02548767|Sugar|sugar
265250|NCT02548754|atrial fibrillation|atrial fibrillation
265251|NCT02548754|neuromodulation|neuromodulation
265252|NCT02548754|inflammation|inflammation
265253|NCT02548741|Metformin|metformin
265254|NCT02548741|diabetes|diabetes
265255|NCT02548741|type 2 diabetes|type 2 diabetes
265256|NCT02548741|diabetes complications|diabetes complications
265257|NCT02548741|methylglyoxal|methylglyoxal
265258|NCT02548741|Prediabetes|prediabetes
265259|NCT02548728|Opioid Dependence|opioid dependence
265260|NCT02548728|Opioid Withdrawal|opioid withdrawal
265261|NCT02548728|Opioid|opioid
265262|NCT02548728|Oxytocin|oxytocin
265263|NCT02548728|OT (oxytocin)|ot (oxytocin)
265264|NCT02548728|Intranasal administration|intranasal administration
265265|NCT02548715|thyroxine|thyroxine
265266|NCT02548715|Otolaryngology|otolaryngology
265267|NCT02548702|Sport|sport
265268|NCT02548702|type 2 diabetes|type 2 diabetes
265269|NCT02548702|community intervention programme|community intervention programme
265270|NCT02548702|Fit4life|fit4life
265271|NCT02548702|Exercise|exercise
265272|NCT02548689|alopecia|alopecia
265273|NCT02548689|hair loss|hair loss
265274|NCT02548663|amyotrophic lateral sclerosis|amyotrophic lateral sclerosis
265275|NCT02548663|sport therapy|sport therapy
265276|NCT02548663|osteopathic manual treatment|osteopathic manual treatment
265277|NCT02548663|muscle oxidative metabolism|muscle oxidative metabolism
265278|NCT02548650|myocardial infarction|myocardial infarction
265279|NCT02548650|diabetes mellitus|diabetes mellitus
265280|NCT02548650|vorapaxar|vorapaxar
265281|NCT02548650|peripheral arterial disease|peripheral arterial disease
265282|NCT02548585|MEDI0382, diabetes|medi0382, diabetes
265283|NCT02548572|Transcorneal Electrical Stimulation|transcorneal electrical stimulation
265284|NCT02548572|TES|tes
265285|NCT02548572|Retinitis Pigmentosa|retinitis pigmentosa
265286|NCT02548572|RP|rp
265287|NCT02548416|Atelectasis|atelectasis
265288|NCT02548416|Positive End-Expiratory Pressure|positive end-expiratory pressure
265289|NCT02548416|Oxygenation|oxygenation
265290|NCT02548416|Anaesthesia|anaesthesia
265291|NCT02548416|Computed tomography|computed tomography
265292|NCT02548403|Bowel preparation|bowel preparation
265293|NCT02548403|Simethicone|simethicone
265294|NCT02548403|Polyethylene glycol with ascorbic acid|polyethylene glycol with ascorbic acid
265295|NCT02548390|Phase 1/1b|phase 1/1b
265296|NCT02548390|open-label|open-label
265297|NCT02548390|dose-escalation|dose-escalation
265298|NCT02548390|pharmacokinetics|pharmacokinetics
265299|NCT02548390|solid tumor|solid tumor
265300|NCT02548390|metastatic cancer|metastatic cancer
265301|NCT02548390|chemotherapy|chemotherapy
265302|NCT02548390|nano formulation|nano formulation
265303|NCT02548390|alkylator|alkylator
265304|NCT02548377|Head and Neck Neoplasms|head and neck neoplasms
265305|NCT02548377|Surgical Flaps|surgical flaps
265306|NCT02548377|Ischemic Preconditioning|ischemic preconditioning
265307|NCT02548377|Hemostasis|hemostasis
265308|NCT02548377|Thrombosis|thrombosis
265309|NCT02548377|Immune System|immune system
265310|NCT02548377|Reperfusion Injury|reperfusion injury
265311|NCT02548364|Vitamin D|vitamin d
265312|NCT02548364|Myocardial Infarction|myocardial infarction
265313|NCT02548364|Ventricular remodeling|ventricular remodeling
265314|NCT02548364|Biomarkers|biomarkers
265315|NCT02548351|Non Alcoholic Steatohepatitis, fatty liver disease, NASH|non alcoholic steatohepatitis, fatty liver disease, nash
265316|NCT02548312|Readers' perceptions|readers' perceptions
265317|NCT02548299|Diabetes|diabetes
265318|NCT02548299|Cooking|cooking
265319|NCT02548299|Nutrition|nutrition
265320|NCT02548299|Lifestyle Medicine|lifestyle medicine
265321|NCT02548286|Hypertension|hypertension
265322|NCT02548286|Healthy male volunteer|healthy male volunteer
265323|NCT02548286|Candesartan, Amlodipine|candesartan, amlodipine
265324|NCT02548273|Corneal endothelium|corneal endothelium
265325|NCT02548273|phacoemulsification|phacoemulsification
265326|NCT02548247|Stool frequency|stool frequency
265327|NCT02548247|Bowel motor function|bowel motor function
265328|NCT02548247|Orafti® Inulin|orafti® inulin
265329|NCT02548247|Dietary Fiber|dietary fiber
265330|NCT02548234|Stroke|stroke
265331|NCT02548234|Randomized control trial|randomized control trial
265332|NCT02548234|Mirror therapy|mirror therapy
265333|NCT02548234|Bilateral arm training|bilateral arm training
265334|NCT02548234|Comparative efficacy research|comparative efficacy research
265335|NCT02548234|Neurorehabilitation|neurorehabilitation
265336|NCT02548221|Thoracentesis|thoracentesis
265337|NCT02548221|Pleural Effusions|pleural effusions
265338|NCT02548221|Transthoracic echocardiogram|transthoracic echocardiogram
265339|NCT02548221|Lung volume measurements|lung volume measurements
265340|NCT02548195|GEMOX|gemox
265341|NCT02548195|intrahepatic cholangiocarcinoma|intrahepatic cholangiocarcinoma
265342|NCT02548195|adjuvant therapy|adjuvant therapy
265343|NCT02548195|oxaliplatin|oxaliplatin
265344|NCT02548195|gemcitabine|gemcitabine
265345|NCT02548195|capecitabine|capecitabine
265346|NCT02548195|curative surgery|curative surgery
265347|NCT02548169|Dendritic Cell Vaccine|dendritic cell vaccine
265348|NCT02548169|FOLFIRINOX|folfirinox
265349|NCT02548169|nab-paclitaxel|nab-paclitaxel
265350|NCT02548169|gemcitabine|gemcitabine
265351|NCT02548117|Testosterone therapy|testosterone therapy
265352|NCT02548117|erythrocytosis|erythrocytosis
265353|NCT02548117|finasteride|finasteride
265354|NCT02548091|non invasive ventilation|non invasive ventilation
265355|NCT02548091|reperfusion pulmonary edema|reperfusion pulmonary edema
265356|NCT02548091|chronic thrombolic pulmonary hypertension|chronic thrombolic pulmonary hypertension
265357|NCT02548091|pulmonary artery angioplasty|pulmonary artery angioplasty
265358|NCT02548078|Protection against Ebola Zaire virus|protection against ebola zaire virus
265359|NCT02548065|Fibromyalgia Syndrome|fibromyalgia syndrome
265360|NCT02548065|Balneotherapy|balneotherapy
265361|NCT02548065|Vetriolo Water|vetriolo water
265362|NCT02548052|retinoic acid receptor-related orphan receptor (ROR) gamma inverse agonist|retinoic acid receptor-related orphan receptor (ror) gamma inverse agonist
265363|NCT02548052|Plaque type psoriasis|plaque type psoriasis
265364|NCT02548052|psoriasis plaque test|psoriasis plaque test
265365|NCT02548052|Topical|topical
265366|NCT02548052|GSK2981278|gsk2981278
265367|NCT02548039|Anovulatory|anovulatory
265368|NCT02548039|Clomiphene|clomiphene
265369|NCT02548026|meal frequency|meal frequency
265370|NCT02548026|eating frequency|eating frequency
265371|NCT02548026|ingestive frequency|ingestive frequency
265372|NCT02548026|positive energy balance|positive energy balance
265373|NCT02548026|satiety|satiety
265374|NCT02548026|appetite|appetite
265375|NCT02548026|hunger|hunger
265376|NCT02547987|breast cancer|breast cancer
265377|NCT02547987|triple negative|triple negative
265378|NCT02547987|TNBC|tnbc
265379|NCT02547987|triple negative breast cancer|triple negative breast cancer
265380|NCT02547974|Safety|safety
265381|NCT02547974|Immunogenicity|immunogenicity
265382|NCT02547974|Reactogenicity|reactogenicity
265383|NCT02547961|breast cancer|breast cancer
265384|NCT02547961|HER2|her2
265385|NCT02547961|CAR-T cell|car-t cell
265386|NCT02547948|CD19|cd19
265387|NCT02547948|CAR T Cells|car t cells
265388|NCT02547948|Lymphoma|lymphoma
265389|NCT02547922|lupus, nephritis, randomized, placebo, anifrolumab, safety, efficacy, adult|lupus, nephritis, randomized, placebo, anifrolumab, safety, efficacy, adult
265390|NCT02547896|codeine|codeine
265391|NCT02547896|diclofenac|diclofenac
265392|NCT02547896|impacted third molar tooth|impacted third molar tooth
265393|NCT02547883|Statins|statins
265394|NCT02547883|Elderly|elderly
265395|NCT02547883|Mortality|mortality
265396|NCT02547883|Quality of life|quality of life
265397|NCT02547883|Randomized trial|randomized trial
265398|NCT02547883|Cost effectiveness study|cost effectiveness study
265399|NCT02547883|Primary care|primary care
265400|NCT02547870|Rilpivirine|rilpivirine
265401|NCT02547870|Healthy participants|healthy participants
265402|NCT02547857|Pelvic ultrasound|pelvic ultrasound
265403|NCT02547857|Transvaginal ultrasound|transvaginal ultrasound
265404|NCT02547818|Early stage AD|early stage ad
265406|NCT02547818|aMCI|amci
265407|NCT02547818|prodromal|prodromal
265408|NCT02547818|Memory loss|memory loss
265409|NCT02547818|Memory problems|memory problems
265410|NCT02547818|Aging|aging
265411|NCT02547818|Early Alzheimer's Disease|early alzheimer's disease
265412|NCT02547818|Early AD|early ad
265413|NCT02547805|Urine Oxalate|urine oxalate
265414|NCT02547805|Nephrolithiasis|nephrolithiasis
265415|NCT02547805|Kidney Stones|kidney stones
265416|NCT02547805|Hyperoxaluria|hyperoxaluria
265417|NCT02547805|Enteric Hyperoxaluria|enteric hyperoxaluria
265418|NCT02547805|Idiopathic Hyperoxaluria|idiopathic hyperoxaluria
265419|NCT02547805|Urological Diseases|urological diseases
265420|NCT02547805|Kidney Diseases|kidney diseases
265421|NCT02547805|Supersaturation|supersaturation
265422|NCT02547805|Dietary Oxalate|dietary oxalate
265423|NCT02547792|Influenza B|influenza b
265424|NCT02547779|crystalloid|crystalloid
265425|NCT02547779|acute kidney injury|acute kidney injury
265426|NCT02547766|Ventricular Assist Device|ventricular assist device
265427|NCT02547766|Recovery of Function|recovery of function
265428|NCT02547753|Tooth extraction|tooth extraction
265429|NCT02547753|Antibiotic prophylaxis|antibiotic prophylaxis
265430|NCT02547753|Postoperative complications|postoperative complications
265431|NCT02547740|macula|macula
265432|NCT02547740|visual fields|visual fields
265433|NCT02547740|optical coherence tomography|optical coherence tomography
265434|NCT02547740|glaucoma progression|glaucoma progression
265435|NCT02547740|retinal ganglion cells|retinal ganglion cells
265436|NCT02547727|rabies vaccination|rabies vaccination
265437|NCT02547714|cyclosporine A|cyclosporine a
265438|NCT02547610|MR/PET in the evaluation|mr/pet in the evaluation
265439|NCT02547610|patients|patients
265440|NCT02547597|Beta-blockers|beta-blockers
265441|NCT02547597|Anti-anginal effect|anti-anginal effect
265442|NCT02547597|Lipid metabolism|lipid metabolism
265443|NCT02547597|Glucose metabolism|glucose metabolism
265444|NCT02547571|Outpatient|outpatient
265445|NCT02547558|Indacaterol|indacaterol
265446|NCT02547558|Pulmonary gas exchange|pulmonary gas exchange
265447|NCT02547558|Long-acting bronchodilators|long-acting bronchodilators
265448|NCT02547532|COPD|copd
265449|NCT02547532|alpha-1 antitrypsin deficiency|alpha-1 antitrypsin deficiency
265450|NCT02547532|microbioma|microbioma
265451|NCT02547519|Type 1 diabetes|type 1 diabetes
265452|NCT02547519|T1D|t1d
265453|NCT02547519|diabetes mellitus|diabetes mellitus
265454|NCT02547519|oral insulin|oral insulin
265455|NCT02547519|oral tolerance|oral tolerance
265456|NCT02547519|autoantigen|autoantigen
265457|NCT02547519|self tolerance|self tolerance
265458|NCT02547519|prevention|prevention
265459|NCT02547519|at risk for developing type 1 diabetes|at risk for developing type 1 diabetes
265460|NCT02547519|juvenile diabetes|juvenile diabetes
265461|NCT02547506|cardiorespiratory fitness|cardiorespiratory fitness
265462|NCT02547506|group exercise|group exercise
265463|NCT02547493|Vaccination against Pneumococcal|vaccination against pneumococcal
265464|NCT02547493|Naïve Abatacept patients|naïve abatacept patients
265465|NCT02547480|liver|liver
265466|NCT02547480|metastatic|metastatic
265467|NCT02547467|mortality|mortality
265468|NCT02547415|Pain, Chronic|pain, chronic
265469|NCT02547415|children|children
265470|NCT02547376|Telomeres|telomeres
265471|NCT02547376|Telomerase|telomerase
265472|NCT02547376|Alternative lengthening of Telomeres Mechanism|alternative lengthening of telomeres mechanism
265473|NCT02547285|biomechanics of walking|biomechanics of walking
265474|NCT02547285|footwear|footwear
265475|NCT02547272|Intensive care|intensive care
265476|NCT02547272|S Aureus|s aureus
265477|NCT02547259|schizophrenia|schizophrenia
265478|NCT02547259|memory|memory
265479|NCT02547259|pain|pain
265480|NCT02547246|bulimia|bulimia
265481|NCT02547246|repetitive transcranial magnetic stimulation (rTMS)|repetitive transcranial magnetic stimulation (rtms)
265482|NCT02547194|coronary artery bypass grafting|coronary artery bypass grafting
265483|NCT02547194|saphenous vein|saphenous vein
265484|NCT02547194|no-touch technique|no-touch technique
265485|NCT02547181|Fracture|fracture
265486|NCT02547181|Follow-up|follow-up
265487|NCT02547181|metacarpal|metacarpal
265488|NCT02547168|Atrial Fibrillation|atrial fibrillation
265489|NCT02547168|Symptomatic Atrial Fibrillation|symptomatic atrial fibrillation
265490|NCT02547168|Asymptomatic Atrial Fibrillation|asymptomatic atrial fibrillation
265491|NCT02547168|Lung Resection|lung resection
265492|NCT02547168|Ambulatory Cardiac Monitor|ambulatory cardiac monitor
265493|NCT02547142|Prospective Pre-Post Evaluation|prospective pre-post evaluation
265494|NCT02547142|Early Palliative care|early palliative care
265495|NCT02547142|FACT-E questionnaire|fact-e questionnaire
265496|NCT02547142|HADS questionnaire|hads questionnaire
265497|NCT02547142|Patient Health Questionnaire-9 (PHQ-9)|patient health questionnaire-9 (phq-9)
265498|NCT02547103|Chlorhexidine gluconate|chlorhexidine gluconate
265499|NCT02547103|Mupirocin ointment|mupirocin ointment
265500|NCT02547103|Normal saline|normal saline
265501|NCT02547103|Peritonitis|peritonitis
265502|NCT02547103|Peritoneal dialysis|peritoneal dialysis
265503|NCT02547064|intubation|intubation
265504|NCT02547064|stylet|stylet
265505|NCT02547064|videolaryngoscope|videolaryngoscope
265506|NCT02547038|Helicobacter pylori|helicobacter pylori
265507|NCT02547038|Eradication rate|eradication rate
265508|NCT02547025|Helicobacter pylori|helicobacter pylori
265509|NCT02547025|third-line therapy|third-line therapy
265510|NCT02547025|antibiotic susceptibility|antibiotic susceptibility
265511|NCT02547025|Eradication|eradication
265512|NCT02547012|Helicobacter pylori|helicobacter pylori
265513|NCT02547012|Eradication rate|eradication rate
265514|NCT02547012|Rescue treatment|rescue treatment
265515|NCT02546999|Botulinum Toxins, Type A|botulinum toxins, type a
265516|NCT02546999|Walking|walking
265517|NCT02546986|CC-486|cc-486
265518|NCT02546986|Azacitidine|azacitidine
265519|NCT02546986|Oral azacitidine|oral azacitidine
265520|NCT02546986|Methyltransferase inhibitor|methyltransferase inhibitor
265521|NCT02546986|Hypomethylation|hypomethylation
265522|NCT02546986|Hypomethylating agent|hypomethylating agent
265523|NCT02546986|Epigenetic|epigenetic
265524|NCT02546986|MK-3475|mk-3475
265525|NCT02546986|Pembrolizumab|pembrolizumab
265526|NCT02546986|Keytruda|keytruda
265527|NCT02546986|PD-1|pd-1
265528|NCT02546986|PD-L1|pd-l1
265529|NCT02546986|ImmunotherapyAdvanced non-small cell lung cancer|immunotherapyadvanced non-small cell lung cancer
265530|NCT02546986|Metastatic non-small cell lung cancer|metastatic non-small cell lung cancer
265531|NCT02546986|Non-small cell lung cancer|non-small cell lung cancer
265532|NCT02546986|NSCLC|nsclc
265533|NCT02546986|Merck Pembrolizumab (Keynote-117)|merck pembrolizumab (keynote-117)
265534|NCT02546960|Healthy|healthy
265535|NCT02546960|JNJ-63871860|jnj-63871860
265536|NCT02546960|ExPEC4V|expec4v
265537|NCT02546947|Respiratory Distress Syndrome, Adult|respiratory distress syndrome, adult
265538|NCT02546947|Neuromuscular Blocking Agents|neuromuscular blocking agents
265539|NCT02546947|Atracurium|atracurium
265540|NCT02546947|Mechanical ventilation|mechanical ventilation
265541|NCT02546947|ARDS|ards
265542|NCT02546947|partial pressure of oxygen(PaO2) /inspired oxygen (FiO2) < 200|partial pressure of oxygen(pao2) /inspired oxygen (fio2) < 200
265543|NCT02546947|Positive End Expiratory Pressure (PEEP) > 5 since less than 48 hrs|positive end expiratory pressure (peep) > 5 since less than 48 hrs
265544|NCT02546934|triple negative breast cancer|triple negative breast cancer
265545|NCT02546934|fine line chemotherapy|fine line chemotherapy
265546|NCT02546921|IgE antibody|ige antibody
265547|NCT02546921|Folate receptor|folate receptor
265548|NCT02546921|Cancer Immunotherapy|cancer immunotherapy
265549|NCT02546921|First in class|first in class
265550|NCT02546908|Prostatic Neoplasms|prostatic neoplasms
265551|NCT02546908|Non-interventional|non-interventional
265552|NCT02546908|Observational|observational
265553|NCT02546895|head and neck cancer patients|head and neck cancer patients
265554|NCT02546895|clinical data|clinical data
265555|NCT02546895|tissue collection|tissue collection
265556|NCT02546895|prospective registration|prospective registration
265557|NCT02546895|patients|patients
265558|NCT02546882|stromal vascular fraction|stromal vascular fraction
265559|NCT02546882|skin graft|skin graft
265560|NCT02546843|rocuronium|rocuronium
265561|NCT02546843|sugammadex|sugammadex
265562|NCT02546843|pediatric anesthesia|pediatric anesthesia
265563|NCT02546843|cisatracurium|cisatracurium
265564|NCT02546843|surgical conditions|surgical conditions
265565|NCT02546817|Treatment|treatment
265566|NCT02546817|Tx|tx
265567|NCT02546817|Prevent|prevent
265568|NCT02546778|Radio frequency|radio frequency
265569|NCT02546778|Female|female
265570|NCT02546778|Humans|humans
265571|NCT02546778|Esthetics|esthetics
265572|NCT02546765|analgesics|analgesics
265573|NCT02546765|cardiac surgery|cardiac surgery
265574|NCT02546765|sedation|sedation
265575|NCT02546739|Leukemia|leukemia
265576|NCT02546739|Lymphoma|lymphoma
265577|NCT02546739|CAR T|car t
265578|NCT02546726|heat therapy|heat therapy
265579|NCT02546726|steam-room|steam-room
265580|NCT02546726|aerobic exercise|aerobic exercise
265581|NCT02546726|hypertension|hypertension
265582|NCT02546726|multiple behavior change|multiple behavior change
265583|NCT02546726|lifestyle modification|lifestyle modification
265584|NCT02546713|dental implants|dental implants
265585|NCT02546687|Anastomotic Leak|anastomotic leak
265586|NCT02546687|Esophagectomy Gastric Pull-up|esophagectomy gastric pull-up
265587|NCT02546674|Chronic Myeloid Leukemia|chronic myeloid leukemia
265588|NCT02546674|Nilotinib|nilotinib
265589|NCT02546674|Molecular Response|molecular response
265590|NCT02546674|MR4.5|mr4.5
265591|NCT02546661|Durvalumab|durvalumab
265592|NCT02546661|Olaparib|olaparib
265593|NCT02546661|Vistusertib|vistusertib
265594|NCT02546661|Selumetinib|selumetinib
265595|NCT02546661|Muscle invasive bladder cancer|muscle invasive bladder cancer
265596|NCT02546661|MIBC|mibc
265597|NCT02546661|BISCAY|biscay
265598|NCT02546661|MEDI4736|medi4736
265599|NCT02546661|AZD4547|azd4547
265600|NCT02546661|AZD2281|azd2281
265601|NCT02546661|AZD1775|azd1775
265602|NCT02546661|AZD2014|azd2014
265603|NCT02546661|AZD9150|azd9150
265604|NCT02546661|AZD6244|azd6244
265605|NCT02546622|Factor|factor
265606|NCT02546622|Coagulation|coagulation
265607|NCT02546622|Inhibitor|inhibitor
265608|NCT02546622|HTC|htc
265609|NCT02546622|Bleeding|bleeding
265610|NCT02546557|CABG|cabg
265611|NCT02546557|Coronary Artery Bypass Grafting|coronary artery bypass grafting
265612|NCT02546544|Linsitinib|linsitinib
265613|NCT02546544|anti-IGF-1R/IR|anti-igf-1r/ir
265614|NCT02546544|Ewing Sarcoma|ewing sarcoma
265615|NCT02546544|dual IGF-1R/IR inhibition|dual igf-1r/ir inhibition
265616|NCT02546544|Relapsed Ewing Sarcoma|relapsed ewing sarcoma
265617|NCT02546544|Refractory Ewing Sarcoma|refractory ewing sarcoma
265618|NCT02546544|Metastatic Ewing Sarcoma|metastatic ewing sarcoma
265619|NCT02546518|Conductive hearing loss|conductive hearing loss
265620|NCT02546518|Middle ear effusion|middle ear effusion
265621|NCT02546518|Middle ear pressure equalization|middle ear pressure equalization
265622|NCT02546505|Consumer behavior|consumer behavior
265623|NCT02546505|Nutrition Labeling|nutrition labeling
265624|NCT02546479|Mortality|mortality
265625|NCT02546479|Radiation|radiation
265626|NCT02546479|Spine deformities|spine deformities
265627|NCT02546466|low back pain|low back pain
265628|NCT02546466|functional taping|functional taping
265629|NCT02546466|balance|balance
265630|NCT02546466|posture|posture
265631|NCT02546466|rehabilitation|rehabilitation
265632|NCT02546466|psychosocial factors|psychosocial factors
265633|NCT02546466|minimal intervention strategy|minimal intervention strategy
265634|NCT02546453|high risk solid tumor pediatric, genetic alteration, Metastatic solid tumor pediatric|high risk solid tumor pediatric, genetic alteration, metastatic solid tumor pediatric
265635|NCT02546414|Platelet count/spleen diameter ratio|platelet count/spleen diameter ratio
265636|NCT02546414|China|china
265637|NCT02546375|Bosutinib|bosutinib
265638|NCT02546375|chronic myeloid leukaemia|chronic myeloid leukaemia
265639|NCT02546375|retrospective|retrospective
265640|NCT02546375|observational|observational
265641|NCT02546349|chronic obstructive pulmonary disease|chronic obstructive pulmonary disease
265642|NCT02546349|airway inflammation|airway inflammation
265643|NCT02546349|eosinophilic airway inflammation|eosinophilic airway inflammation
265644|NCT02546349|exhaled nitric oxide|exhaled nitric oxide
265645|NCT02546336|Ultrasound Guidance|ultrasound guidance
265646|NCT02546336|Cooled Radiofrequency|cooled radiofrequency
265647|NCT02546336|Hip Denervation|hip denervation
265648|NCT02546323|Rosuvastatin 20 mg treatment, Carotid Intima-Media Thickness, Chinese subjects, Subclinical atherosclerosis|rosuvastatin 20 mg treatment, carotid intima-media thickness, chinese subjects, subclinical atherosclerosis
265649|NCT02546297|LAMA,ICS+LABA,LAMA+LABA|lama,ics+laba,lama+laba
265650|NCT02546284|CMML|cmml
265651|NCT02546258|Fungal Nail|fungal nail
265652|NCT02546232|locally advanced breast cancer|locally advanced breast cancer
265653|NCT02546232|metastatic breast cancer|metastatic breast cancer
265654|NCT02546219|eosinophilic esophagitis|eosinophilic esophagitis
265655|NCT02546219|EoE|eoe
265656|NCT02546219|integrins|integrins
265657|NCT02546206|Bifidobacterium|bifidobacterium
265658|NCT02546206|Gingivitis|gingivitis
265659|NCT02546206|Gingival crevicular fluid|gingival crevicular fluid
265660|NCT02546206|Interleukin-1beta|interleukin-1beta
265661|NCT02546206|Probiotics|probiotics
265662|NCT02546180|Patient education|patient education
265663|NCT02546180|Preoperative anxiety|preoperative anxiety
265664|NCT02546154|Iron|iron
265665|NCT02546154|Anaemia|anaemia
265666|NCT02546154|Anaemia, Iron-Deficiency|anaemia, iron-deficiency
265667|NCT02546154|Kidney Diseases|kidney diseases
265668|NCT02546154|Inflammatory Bowel Diseases|inflammatory bowel diseases
265669|NCT02546154|Fatigue|fatigue
265670|NCT02546076|Keloid|keloid
265671|NCT02546076|Hypertrophic scars|hypertrophic scars
265672|NCT02546076|Er-YAG Lasers|er-yag lasers
265673|NCT02546050|Gut microbiota|gut microbiota
265674|NCT02546050|metformin|metformin
265675|NCT02546050|Metabolism|metabolism
265676|NCT02546050|Metagenomics|metagenomics
265677|NCT02546050|Metabolomics|metabolomics
265678|NCT02546037|coagulation|coagulation
265679|NCT02546037|haemodialysis|haemodialysis
265680|NCT02546024|Major depressive disorder|major depressive disorder
265681|NCT02546024|late-onset|late-onset
265682|NCT02546024|treatment response|treatment response
265683|NCT02546024|predictors|predictors
265684|NCT02546024|moderators|moderators
265685|NCT02545998|Telehealthcare|telehealthcare
265686|NCT02545985|sirolimus|sirolimus
265687|NCT02545985|coronary stent|coronary stent
265688|NCT02545985|Prolim|prolim
265689|NCT02545972|immunosuppression|immunosuppression
265690|NCT02545959|Intrathecal Rituximab|intrathecal rituximab
265691|NCT02545959|intrathecal chemotherapy|intrathecal chemotherapy
265692|NCT02545959|cerebrospinal fluid|cerebrospinal fluid
265693|NCT02545959|lumbar puncture|lumbar puncture
265694|NCT02545959|Physiological Effects of Drugs|physiological effects of drugs
265695|NCT02545959|Rituximab|rituximab
265696|NCT02545946|traditional incision and drainage|traditional incision and drainage
265697|NCT02545946|minimally invasive incision and drainage|minimally invasive incision and drainage
265698|NCT02545946|vessel loop|vessel loop
265699|NCT02545946|emergency department|emergency department
265700|NCT02545946|pediatrics|pediatrics
265701|NCT02545933|prasugrel|prasugrel
265702|NCT02545933|ticagrelor|ticagrelor
265703|NCT02545933|vorapaxar|vorapaxar
265704|NCT02545920|haemodialysis|haemodialysis
265705|NCT02545920|hypotension|hypotension
265706|NCT02545907|Amyloidosis|amyloidosis
265707|NCT02545907|AL Amyloidosis|al amyloidosis
265708|NCT02545855|myAIRVO2|myairvo2
265709|NCT02545855|high-flow nasal cannula therapy|high-flow nasal cannula therapy
265710|NCT02545855|home oxygen therapy|home oxygen therapy
265711|NCT02545855|HOT|hot
265712|NCT02545790|coarctation of aorta|coarctation of aorta
265713|NCT02545790|aortic stenosis|aortic stenosis
265714|NCT02545790|biomarkers|biomarkers
265715|NCT02545790|cardiac hypertrophy|cardiac hypertrophy
265716|NCT02545777|Acute gouty arthritis|acute gouty arthritis
265717|NCT02545777|tonifying spleen and descending the turbid|tonifying spleen and descending the turbid
265718|NCT02545777|soaking|soaking
265719|NCT02545777|wet wrapping|wet wrapping
265720|NCT02545764|Gait Analysis|gait analysis
265721|NCT02545764|Knee Adduction Moment|knee adduction moment
265722|NCT02545764|Physiotherapy|physiotherapy
265723|NCT02545764|Obesity|obesity
265724|NCT02545751|Esophageal cancer|esophageal cancer
265725|NCT02545751|Metastatic esophageal cancer|metastatic esophageal cancer
265726|NCT02545751|Radiotherapy|radiotherapy
265727|NCT02545751|Thymalfasin|thymalfasin
265728|NCT02545751|ZADAXIN's®|zadaxin's®
265729|NCT02545751|Stereotactic Body Radiation Therapy|stereotactic body radiation therapy
265730|NCT02545725|Colorectal Cancer|colorectal cancer
265731|NCT02545725|Quality of life|quality of life
265732|NCT02545725|Questionnaires|questionnaires
265733|NCT02545712|Ethanol|ethanol
265734|NCT02545712|Propylene glycol|propylene glycol
265735|NCT02545712|Benzyl alcohol|benzyl alcohol
265736|NCT02545712|Acesulfam potassium|acesulfam potassium
265737|NCT02545712|Aspartame|aspartame
265738|NCT02545712|Glycerin|glycerin
265739|NCT02545712|Sorbitol|sorbitol
265740|NCT02545712|Methyl-p-hydroxybenzoate|methyl-p-hydroxybenzoate
265741|NCT02545712|Propanyl-p-hydroxybenzoate|propanyl-p-hydroxybenzoate
265742|NCT02545712|Patients|patients
265744|NCT02545699|Polyp|polyp
265745|NCT02545699|CRC|crc
265746|NCT02545699|Colonoscopy|colonoscopy
265747|NCT02545699|Detection Yield|detection yield
265748|NCT02545673|Intervention Studies|intervention studies
265749|NCT02545673|Access to Health Care|access to health care
265750|NCT02545673|Social Stigma|social stigma
265751|NCT02545673|Social Support|social support
265752|NCT02545634|probiotic|probiotic
265753|NCT02545634|ADHD|adhd
265754|NCT02545634|anxiety|anxiety
265755|NCT02545634|digestive health|digestive health
265756|NCT02545634|children|children
265757|NCT02545634|attention deficit|attention deficit
265758|NCT02545634|gut brain axis|gut brain axis
265759|NCT02545634|nutritional supplement|nutritional supplement
265760|NCT02545634|microbiome|microbiome
265761|NCT02545621|Receptor for advanced glycation end products (RAGE)|receptor for advanced glycation end products (rage)
265762|NCT02545621|Acute respiratory distress syndrome (ARDS)|acute respiratory distress syndrome (ards)
265763|NCT02545621|Monocyte/Macrophage activation|monocyte/macrophage activation
265764|NCT02545621|Fluorescence-Activated Cell Sorting (FACS) analysis|fluorescence-activated cell sorting (facs) analysis
265765|NCT02545621|Thioredoxin interacting protein (TXNIP)|thioredoxin interacting protein (txnip)
265766|NCT02545621|NOD-like receptor family, pyrin domain containing 3 (NLRP3)|nod-like receptor family, pyrin domain containing 3 (nlrp3)
265767|NCT02545621|Inflammasome|inflammasome
265768|NCT02545595|General anaesthesia|general anaesthesia
265769|NCT02545595|Curarization with rocuronium|curarization with rocuronium
265770|NCT02545556|Liver Cancer|liver cancer
265771|NCT02545556|HepaSphere|hepasphere
265772|NCT02545556|cryosurgery|cryosurgery
265773|NCT02545530|renal dialysis|renal dialysis
265774|NCT02545530|hypertension|hypertension
265775|NCT02545530|clonidine|clonidine
265776|NCT02545517|Rabies disease|rabies disease
265777|NCT02545517|Pre-exposure (PrEP) or post exposure prophylaxis (PEP)|pre-exposure (prep) or post exposure prophylaxis (pep)
265778|NCT02545517|Long-term Immunogenicity|long-term immunogenicity
265779|NCT02545504|Gastroesophageal junction (GEJ)|gastroesophageal junction (gej)
265780|NCT02545504|Stomach cancer|stomach cancer
265781|NCT02545491|CCD|ccd
265782|NCT02545491|Child development|child development
265783|NCT02545491|daycare|daycare
265784|NCT02545491|caregiver|caregiver
265785|NCT02545478|septic shock|septic shock
265786|NCT02545478|infection|infection
265787|NCT02545478|inflammation|inflammation
265788|NCT02545478|pathologic process|pathologic process
265789|NCT02545478|biomarkers|biomarkers
265790|NCT02545465|Pulmonary Arterial Hypertension|pulmonary arterial hypertension
265791|NCT02545465|Inoperable Chronic Thromboembolic Pulmonary Hypertension|inoperable chronic thromboembolic pulmonary hypertension
265792|NCT02545465|Persistent Chronic Thromboembolic Pulmonary Hypertension|persistent chronic thromboembolic pulmonary hypertension
265793|NCT02545465|Recurrent Chronic Thromboembolic Pulmonary Hypertension|recurrent chronic thromboembolic pulmonary hypertension
265794|NCT02545465|Switch of therapy|switch of therapy
265795|NCT02545465|Titration phase|titration phase
265796|NCT02545465|Retrospective chart review|retrospective chart review
265797|NCT02545439|Alkermes|alkermes
265798|NCT02545439|Samidorphan|samidorphan
265799|NCT02545439|ALKS 5461|alks 5461
265800|NCT02545439|Healthy Volunteer|healthy volunteer
265801|NCT02545439|Pharmacokinetics|pharmacokinetics
265802|NCT02545426|myocardial stunning|myocardial stunning
265803|NCT02545426|dialysate calcium concentration|dialysate calcium concentration
265804|NCT02545426|nutritional status|nutritional status
265805|NCT02545426|hemodinamic|hemodinamic
265806|NCT02545426|hemodialysis|hemodialysis
265807|NCT02545374|chronic wound|chronic wound
265808|NCT02545374|tablet|tablet
265809|NCT02545374|telemedicine|telemedicine
265810|NCT02545374|wounds consultation|wounds consultation
265811|NCT02545374|Smartphone|smartphone
265812|NCT02545296|In-vitro Diagnostics|in-vitro diagnostics
265813|NCT02545296|paediatrics|paediatrics
265814|NCT02545270|Surgery, Laparoscopic|surgery, laparoscopic
265815|NCT02545270|surgical rating scale|surgical rating scale
265816|NCT02545257|Aged people|aged people
265817|NCT02545257|Home care|home care
265818|NCT02545257|Drug related problems, DRPs|drug related problems, drps
265819|NCT02545257|Coordinated medication management model|coordinated medication management model
265820|NCT02545244|Gingivitis, Black Tea, Green Tea,Chlorhexidine, Biofilm,|gingivitis, black tea, green tea,chlorhexidine, biofilm,
265821|NCT02545218|Perineum. Perineorraphy. Pelvic floor exercise.|perineum. perineorraphy. pelvic floor exercise.
265822|NCT02545205|Rehabilitation|rehabilitation
265823|NCT02545205|Robotics|robotics
265824|NCT02545192|PTSD|ptsd
265825|NCT02545166|Stroke|stroke
265826|NCT02545166|Purines|purines
265827|NCT02545166|SMARTChip|smartchip
265828|NCT02545166|Ischaemia|ischaemia
265829|NCT02545166|Carotid endarterectomy|carotid endarterectomy
265830|NCT02545166|Biosensor|biosensor
265831|NCT02545140|risk factors|risk factors
265832|NCT02545140|screening|screening
265833|NCT02545140|adolescents|adolescents
265834|NCT02545127|inadequate milk production|inadequate milk production
265835|NCT02545114|Hyponatremia|hyponatremia
265836|NCT02545114|SIADH, stroke|siadh, stroke
265837|NCT02545114|SAH; ICH|sah; ich
265838|NCT02545114|AIS|ais
265839|NCT02545101|Hyponatremia due to SIADH|hyponatremia due to siadh
265840|NCT02545101|tolvaptan|tolvaptan
265841|NCT02545088|Rehabilitation|rehabilitation
265842|NCT02545088|Robotics|robotics
265843|NCT02545049|Type 2 Diabetes|type 2 diabetes
265844|NCT02545049|Kidney diseases|kidney diseases
265845|NCT02545036|chronic kidney disease|chronic kidney disease
265846|NCT02545036|Daycare|daycare
265847|NCT02545036|Traditional Chinese Medicine(TCM)|traditional chinese medicine(tcm)
265848|NCT02544984|prophylactic macrolides|prophylactic macrolides
265849|NCT02544984|RSV|rsv
265850|NCT02544984|chronic lung disease|chronic lung disease
265851|NCT02544984|respiratory infections|respiratory infections
265852|NCT02544958|Enlarged pores|enlarged pores
265853|NCT02544958|Er:YAG laser|er:yag laser
265854|NCT02544945|Radiotherapy|radiotherapy
265855|NCT02544932|anticoagulant|anticoagulant
265856|NCT02544932|atherosclerosis|atherosclerosis
265857|NCT02544932|endothelium|endothelium
265858|NCT02544919|SMOF|smof
265859|NCT02544919|neurological complications|neurological complications
265860|NCT02544919|neurotoxicity|neurotoxicity
265861|NCT02544919|liver transplantation|liver transplantation
265862|NCT02544919|Lipid emulsions|lipid emulsions
265863|NCT02544906|recipients|recipients
265864|NCT02544880|HNSCC|hnscc
265865|NCT02544880|Head and Neck Squamous Cell Carcinoma|head and neck squamous cell carcinoma
265866|NCT02544880|Tadalafil|tadalafil
265867|NCT02544880|PDE5 Inhibition|pde5 inhibition
265868|NCT02544880|Anti-MUC1 Vaccine|anti-muc1 vaccine
265869|NCT02544880|Recurrent Head and Neck Squamous Cell Carcinoma|recurrent head and neck squamous cell carcinoma
265870|NCT02544880|Recurrent HNSCC|recurrent hnscc
265871|NCT02544880|Second primary site disease stage III|second primary site disease stage iii
265872|NCT02544880|Second primary site disease stage IV|second primary site disease stage iv
265873|NCT02544880|Anti-Influenza Vaccine|anti-influenza vaccine
265874|NCT02544854|Pharmacokinetics, pharmacodynamics, propofol, pediatrics|pharmacokinetics, pharmacodynamics, propofol, pediatrics
265875|NCT02544828|Osteoarthritis|osteoarthritis
265876|NCT02544828|knee arthroplasty|knee arthroplasty
265877|NCT02544828|iron|iron
265878|NCT02544815|digoxin, eficacy, safety|digoxin, eficacy, safety
265879|NCT02544776|pco|pco
265880|NCT02544776|Amlodipine|amlodipine
265881|NCT02544737|Esophageal cancer|esophageal cancer
265882|NCT02544737|Metastatic esophageal cancer|metastatic esophageal cancer
265883|NCT02544737|Apatinib|apatinib
265884|NCT02544724|Relapsed|relapsed
265885|NCT02544724|Refractory|refractory
265886|NCT02544724|DLBCL|dlbcl
265887|NCT02544724|Chemotherapy|chemotherapy
265888|NCT02544711|Pelvis|pelvis
265889|NCT02544711|Surgical resection|surgical resection
265890|NCT02544711|Patient specific instrument|patient specific instrument
265891|NCT02544698|vaccine|vaccine
265892|NCT02544698|safety|safety
265893|NCT02544685|Febrile neutropenia|febrile neutropenia
265894|NCT02544685|Synbiotic|synbiotic
265895|NCT02544685|Probiotic|probiotic
265896|NCT02544685|Prebiotic|prebiotic
265897|NCT02544685|Safety|safety
265898|NCT02544685|Cancer|cancer
265899|NCT02544685|Oncology|oncology
265900|NCT02544685|Chemotherapy|chemotherapy
265901|NCT02544685|Symbiotic|symbiotic
265902|NCT02544659|Treatment|treatment
265903|NCT02544659|Bisphosphonates|bisphosphonates
265904|NCT02544659|Response rate|response rate
265905|NCT02544646|trabeculectomy|trabeculectomy
265906|NCT02544633|Mirati|mirati
265907|NCT02544633|MGCD265|mgcd265
265908|NCT02544633|MET|met
265909|NCT02544633|NSCLC|nsclc
265910|NCT02544607|Ketamine|ketamine
265911|NCT02544607|Depression|depression
265912|NCT02544607|Anxious Depression|anxious depression
265913|NCT02544607|MRI|mri
265914|NCT02544568|high fat|high fat
265915|NCT02544568|high protein|high protein
265916|NCT02544568|high carbohydrate|high carbohydrate
265917|NCT02544568|insulin|insulin
265918|NCT02544568|glucose|glucose
265919|NCT02544555|Peripheral arterial disease|peripheral arterial disease
265920|NCT02544555|Atherosclerosis|atherosclerosis
265921|NCT02544555|Intraluminal approach|intraluminal approach
265922|NCT02544555|Subintimal approach|subintimal approach
265923|NCT02544542|Mild Hypothermia|mild hypothermia
265924|NCT02544542|Hypoxic-Ischemic Encephalopathy|hypoxic-ischemic encephalopathy
265925|NCT02544516|Schizophrenia|schizophrenia
265926|NCT02544516|motor and sensory perceptions|motor and sensory perceptions
265927|NCT02544490|Sepsis|sepsis
265928|NCT02544490|MicroRNAs|micrornas
265929|NCT02544490|Diagnosis|diagnosis
265930|NCT02544490|Prognosis|prognosis
265931|NCT02544464|osteoarthritis|osteoarthritis
265932|NCT02544464|knee arthroplasty|knee arthroplasty
265933|NCT02544464|iron|iron
265934|NCT02544412|Mindfulness|mindfulness
265935|NCT02544412|School Teachers|school teachers
265936|NCT02544412|preservice teachers|preservice teachers
266134|NCT02543294|HF|hf
265937|NCT02544412|teacher education|teacher education
265938|NCT02544399|Bone microarchitecture|bone microarchitecture
265939|NCT02544399|Playing golf|playing golf
265940|NCT02544399|Walkers|walkers
265941|NCT02544386|bone microarchitecture|bone microarchitecture
265942|NCT02544386|hemiplegia|hemiplegia
265943|NCT02544373|OSA|osa
265944|NCT02544373|Obstructive Sleep Apnea|obstructive sleep apnea
265945|NCT02544373|Cognition|cognition
265946|NCT02544373|Cognitive Dysfunction|cognitive dysfunction
265947|NCT02544373|Memory|memory
265948|NCT02544373|Positive Aiway Pressure|positive aiway pressure
265949|NCT02544373|CPAP|cpap
265950|NCT02544373|MS|ms
265951|NCT02544360|photoaging mobile apps|photoaging mobile apps
265952|NCT02544360|adolescent smoking|adolescent smoking
265953|NCT02544360|tobacco prevention|tobacco prevention
265954|NCT02544360|school-based prevention|school-based prevention
265955|NCT02544360|adolescent health|adolescent health
265956|NCT02544360|school health|school health
265957|NCT02544360|smoking|smoking
265958|NCT02544360|tobacco|tobacco
265959|NCT02544347|vaspin|vaspin
265960|NCT02544347|omentin|omentin
265961|NCT02544347|diabetes mellitus|diabetes mellitus
265962|NCT02544347|chronic periodontitis|chronic periodontitis
265963|NCT02544347|tumor-necrosis factor alfa|tumor-necrosis factor alfa
265964|NCT02544347|gingival crevicular fluid|gingival crevicular fluid
265965|NCT02544334|Rheumatoid arthritis|rheumatoid arthritis
265966|NCT02544334|Metagenome|metagenome
265967|NCT02544334|microbiome|microbiome
265968|NCT02544308|Solitary, Bone|solitary, bone
265969|NCT02544282|Analgesics|analgesics
265970|NCT02544282|Opioid|opioid
265971|NCT02544282|Mastectomy|mastectomy
265972|NCT02544282|Segmental Mastectomy|segmental mastectomy
265973|NCT02544282|Pecs II|pecs ii
265974|NCT02544269|Lumbosacral plexus blockade|lumbosacral plexus blockade
265975|NCT02544269|Continuous spinal anesthesia|continuous spinal anesthesia
265976|NCT02544269|Hemodynamics|hemodynamics
265977|NCT02544256|Microcirculation|microcirculation
265978|NCT02544256|Mild Hypothermia, Induced|mild hypothermia, induced
265979|NCT02544256|Subarachnoid Hemorrhage, Aneurysmal|subarachnoid hemorrhage, aneurysmal
265980|NCT02544256|Aneurysmal Clipping|aneurysmal clipping
265981|NCT02544256|Vasospasms|vasospasms
265982|NCT02544230|granulocyte transfusions|granulocyte transfusions
265983|NCT02544191|azoospermia nonobstructive|azoospermia nonobstructive
265984|NCT02544191|male infertility|male infertility
265985|NCT02544178|radiotherapy|radiotherapy
265986|NCT02544178|neurocognitive defect|neurocognitive defect
265987|NCT02544178|leukoencephalopathy|leukoencephalopathy
265988|NCT02544165|smoking|smoking
265989|NCT02544165|caffeine intake|caffeine intake
265990|NCT02544165|haemodynamic parameters|haemodynamic parameters
265991|NCT02544165|Advanced Glycation End Products (AGEs)|advanced glycation end products (ages)
265992|NCT02544165|Non-invasive measurements devices|non-invasive measurements devices
265993|NCT02544087|fire-heat syndrome|fire-heat syndrome
265994|NCT02544087|blood stasis syndrome|blood stasis syndrome
265995|NCT02544087|method of clearing heat|method of clearing heat
265996|NCT02544087|method of promoting blood circulation|method of promoting blood circulation
712536|NCT00579800|07-091|07-091
265997|NCT02544061|NM-IL-12, HemaMax, Safety, Stoma Takedown, Wound closure|nm-il-12, hemamax, safety, stoma takedown, wound closure
265998|NCT02544048|Immune|immune
265999|NCT02544048|Parasitemia|parasitemia
266000|NCT02544048|Menactra|menactra
266001|NCT02544048|Polymerase Chain Reaction (PCR)|polymerase chain reaction (pcr)
266002|NCT02544048|Coartem|coartem
266003|NCT02544035|Childhood Growth and Development|childhood growth and development
266004|NCT02544035|Development|development
266005|NCT02544022|Pain Scale|pain scale
266006|NCT02544022|QOL|qol
266007|NCT02544022|Tool Validation|tool validation
266008|NCT02544022|Cognitive Interviews|cognitive interviews
266009|NCT02544009|Energy Expenditure|energy expenditure
266010|NCT02544009|Obesity|obesity
266011|NCT02544009|Behavioral Weight Loss Treatment|behavioral weight loss treatment
266012|NCT02543996|Sample Collection|sample collection
266013|NCT02543996|Laboratory Research Specimens|laboratory research specimens
266014|NCT02543996|Biospecimen Procurement|biospecimen procurement
266015|NCT02543996|Rare Diseases|rare diseases
266016|NCT02543983|Neurobiology|neurobiology
266017|NCT02543983|Suicide|suicide
266018|NCT02543983|Ketamine|ketamine
266019|NCT02543983|Major Depression Disorder|major depression disorder
266020|NCT02543983|Biomarkers|biomarkers
266021|NCT02543957|ERCP|ercp
266022|NCT02543957|Cholangitis|cholangitis
266023|NCT02543957|Bacteremia|bacteremia
266024|NCT02543957|Antibiotics|antibiotics
266025|NCT02543931|turmeric|turmeric
266026|NCT02543931|curcumin|curcumin
266027|NCT02543931|curcuminoids|curcuminoids
266028|NCT02543931|arthritis|arthritis
266029|NCT02543931|methotrexate|methotrexate
266030|NCT02543892|Vaccine|vaccine
266031|NCT02543879|AML|aml
266032|NCT02543879|BET Inhibitor|bet inhibitor
266033|NCT02543879|FT-1101|ft-1101
266034|NCT02543879|Acute Leukemia|acute leukemia
266035|NCT02543879|Myelodysplastic Syndrome|myelodysplastic syndrome
266036|NCT02543879|NHL|nhl
266037|NCT02543879|Non-Hodgkin Lymphoma|non-hodgkin lymphoma
266038|NCT02543840|Quality Improvement|quality improvement
266039|NCT02543840|Organization of Services|organization of services
266040|NCT02543840|Implementation|implementation
266041|NCT02543827|Vaccine|vaccine
266042|NCT02543827|Recurrent Urinary Tract Infections (RUTI)|recurrent urinary tract infections (ruti)
266043|NCT02543788|optic neuritis|optic neuritis
266044|NCT02543788|vision|vision
266045|NCT02543788|quality of life|quality of life
266046|NCT02543788|pathophysiology|pathophysiology
266047|NCT02543775|Cervical Cancer|cervical cancer
266048|NCT02543775|Sentinel Lymph Node|sentinel lymph node
266049|NCT02543775|Lymphadenectomy|lymphadenectomy
266050|NCT02543762|Chromoendoscopy|chromoendoscopy
266051|NCT02543762|Ulcerative Colitis|ulcerative colitis
266052|NCT02543762|Crohn disease|crohn disease
266053|NCT02543762|Colorectal Neoplasia|colorectal neoplasia
266054|NCT02543749|CML|cml
266055|NCT02543749|DC vaccine|dc vaccine
266056|NCT02543723|medication adherence, telehealth strategies, nurse coaching|medication adherence, telehealth strategies, nurse coaching
266057|NCT02543684|glycemic response|glycemic response
266058|NCT02543684|diabetes|diabetes
266059|NCT02543684|insulinemic response|insulinemic response
266060|NCT02543684|mixed meals|mixed meals
266061|NCT02543684|glycemic index|glycemic index
266062|NCT02543671|vitamin D status|vitamin d status
266063|NCT02543671|25-hydroxyvitamin D|25-hydroxyvitamin d
266064|NCT02543671|cheese|cheese
266065|NCT02543671|Randomized controlled trial|randomized controlled trial
266066|NCT02543671|postmenopausal women|postmenopausal women
266067|NCT02543671|enriched|enriched
266068|NCT02543671|vitamin D3|vitamin d3
266069|NCT02543658|Acute Pancreatitis|acute pancreatitis
266070|NCT02543658|Intra-abdominal hypertension|intra-abdominal hypertension
266071|NCT02543658|Abdominal compartment syndrome|abdominal compartment syndrome
266072|NCT02543658|Curative Effect|curative effect
266073|NCT02543658|Security|security
266074|NCT02543658|Neostigmine|neostigmine
266075|NCT02543632|heart failure|heart failure
266076|NCT02543632|parachute|parachute
266077|NCT02543632|partitioning device|partitioning device
266078|NCT02543593|tDCS|tdcs
266079|NCT02543580|mastectomy|mastectomy
266080|NCT02543580|transcutaneous electrical acupoint stimulation|transcutaneous electrical acupoint stimulation
266081|NCT02543580|acute pain|acute pain
266082|NCT02543580|chronic pain|chronic pain
266083|NCT02543567|Ebola viruses|ebola viruses
266084|NCT02543567|Ebola virus disease (EVD)|ebola virus disease (evd)
266085|NCT02543567|Filoviruses|filoviruses
266086|NCT02543567|Monovalent vaccine|monovalent vaccine
266087|NCT02543567|Safety|safety
266088|NCT02543567|Immunogenicity|immunogenicity
266089|NCT02543567|Ebola vaccine|ebola vaccine
266090|NCT02543567|Human adenovirus serotype 26 (Ad26) expressing the Ebola virus Mayinga variant glycoprotein (Ad26.ZEBOV)|human adenovirus serotype 26 (ad26) expressing the ebola virus mayinga variant glycoprotein (ad26.zebov)
266091|NCT02543567|Modified Vaccinia Virus Ankara ‐ Bavarian Nordic Filo‐vector (MVA‐BN Filo)|modified vaccinia virus ankara ‐ bavarian nordic filo‐vector (mva‐bn filo)
266092|NCT02543567|Healthy participants|healthy participants
266093|NCT02543541|Palliative Care|palliative care
266094|NCT02543541|Supportive Care|supportive care
266095|NCT02543541|Caregiver|caregiver
266096|NCT02543541|Phase I|phase i
266097|NCT02543515|following hysteroscopy|following hysteroscopy
266098|NCT02543502|Periodontitis|periodontitis
266099|NCT02543502|atherosclerosis|atherosclerosis
266100|NCT02543502|Heart Disease|heart disease
266101|NCT02543476|PD-L1 status, biomarkers, prevalence, SCCHN, overall survival|pd-l1 status, biomarkers, prevalence, scchn, overall survival
266102|NCT02543450|Chronic stroke|chronic stroke
266103|NCT02543450|Participation|participation
266104|NCT02543450|Walking ability|walking ability
266105|NCT02543385|S Ketamine|s ketamine
266106|NCT02543385|Morphine|morphine
266107|NCT02543385|Consumption|consumption
266108|NCT02543372|concerned significant other|concerned significant other
266109|NCT02543372|problem gambling|problem gambling
266110|NCT02543372|internet-delivered cognitive-behavioral therapy|internet-delivered cognitive-behavioral therapy
266111|NCT02543372|behavioral couples therapy|behavioral couples therapy
266112|NCT02543359|Training|training
266113|NCT02543359|Implementation|implementation
266114|NCT02543359|Community-Based Mental Health Services|community-based mental health services
266115|NCT02543359|Parent-Child Interaction Therapy|parent-child interaction therapy
266116|NCT02543359|Children|children
266117|NCT02543333|Acute Asthma,|acute asthma,
266118|NCT02543307|Hip Replacement|hip replacement
266119|NCT02543307|Spinal Diseases|spinal diseases
266120|NCT02543307|Rotator Cuff Reconstruction|rotator cuff reconstruction
266121|NCT02543307|Nursing|nursing
266122|NCT02543307|Nurse-led|nurse-led
266123|NCT02543307|Pathways|pathways
266124|NCT02543307|Patient Satisfaction|patient satisfaction
266125|NCT02543307|Quality of Nursing Care|quality of nursing care
266126|NCT02543294|Heart Failure|heart failure
266127|NCT02543294|Echocardiogram|echocardiogram
266128|NCT02543294|ECHO|echo
266129|NCT02543294|Electrocardiogram|electrocardiogram
266130|NCT02543294|ECG|ecg
266131|NCT02543294|Questionnaire|questionnaire
266132|NCT02543294|Survey|survey
266133|NCT02543294|Telephone Follow-Up|telephone follow-up
266259|NCT02542384|Ventral Hernia repair|ventral hernia repair
266135|NCT02543294|Cancer treatment induced left ventricular dysfunction|cancer treatment induced left ventricular dysfunction
266136|NCT02543294|CILVD|cilvd
266137|NCT02543294|Left ventricular ejection fraction|left ventricular ejection fraction
266138|NCT02543294|LVEF|lvef
266139|NCT02543268|Ebola viruses|ebola viruses
266140|NCT02543268|Ebola virus disease (EVD)|ebola virus disease (evd)
266141|NCT02543268|Filoviruses|filoviruses
266142|NCT02543268|Monovalent vaccine|monovalent vaccine
266143|NCT02543268|Safety|safety
266144|NCT02543268|Immunogenicity|immunogenicity
266145|NCT02543268|Human adenovirus serotype 26 (Ad26) expressing the Ebola virus Mayinga variant glycoprotein (Ad26.ZEBOV)|human adenovirus serotype 26 (ad26) expressing the ebola virus mayinga variant glycoprotein (ad26.zebov)
266146|NCT02543268|Modified Vaccinia Virus Ankara ‐ Bavarian Nordic Filo‐vector (MVA‐BN Filo)|modified vaccinia virus ankara ‐ bavarian nordic filo‐vector (mva‐bn filo)
266147|NCT02543268|Healthy participants|healthy participants
266148|NCT02543255|High risk|high risk
266149|NCT02543242|Urinary Incontinence|urinary incontinence
266150|NCT02543242|Stress Urinary Incontinence|stress urinary incontinence
266151|NCT02543242|Urge Incontinence|urge incontinence
266152|NCT02543242|Mixed Urinary Incontience|mixed urinary incontience
266153|NCT02543242|Female Pelvic Health|female pelvic health
266154|NCT02543216|fatty acids, FADS gene, genotype, diet|fatty acids, fads gene, genotype, diet
266155|NCT02543203|Relaxation|relaxation
266156|NCT02543190|Care Transition|care transition
266157|NCT02543190|Readmission|readmission
266158|NCT02543190|Rehospitalization|rehospitalization
266159|NCT02543177|NSTEMI, CKD|nstemi, ckd
266160|NCT02543164|Glycemic Index|glycemic index
266161|NCT02543164|glycemic response|glycemic response
266162|NCT02543151|Biliary stricture|biliary stricture
266163|NCT02543151|Cholangioscopy|cholangioscopy
266164|NCT02543151|Spyglass|spyglass
266165|NCT02543151|Liver transplant|liver transplant
266166|NCT02543125|very low birth weight|very low birth weight
266167|NCT02543125|respiratory distress|respiratory distress
266168|NCT02543125|NHFOV|nhfov
266169|NCT02543125|NIPPV|nippv
266170|NCT02543099|endothelial function|endothelial function
266171|NCT02543099|policosanol|policosanol
266172|NCT02543099|efficacy|efficacy
266173|NCT02543099|safety|safety
266174|NCT02543086|Phase 1, malaria, inoculum, P. falciparum, KAE609, Piperaquine|phase 1, malaria, inoculum, p. falciparum, kae609, piperaquine
266175|NCT02543021|Colitis|colitis
266176|NCT02543021|Dysplasia|dysplasia
266177|NCT02543021|Chromoendoscopy|chromoendoscopy
266178|NCT02543008|Asymptomatic individuals|asymptomatic individuals
266179|NCT02542982|tDCS|tdcs
266180|NCT02542982|motor recovery|motor recovery
266181|NCT02542956|Tummy tuck (abdominoplasty)|tummy tuck (abdominoplasty)
266182|NCT02542956|Breast Surgery|breast surgery
266183|NCT02542930|Non-small cell lung cancer|non-small cell lung cancer
266184|NCT02542930|Metastatic Non-small cell lung cancer|metastatic non-small cell lung cancer
266185|NCT02542930|Radiotherapy|radiotherapy
266186|NCT02542930|Thymalfasin|thymalfasin
266187|NCT02542930|ZADAXIN's®|zadaxin's®
266188|NCT02542891|e-health|e-health
266189|NCT02542891|depressive disorder|depressive disorder
266190|NCT02542891|cost-effectiveness|cost-effectiveness
266191|NCT02542891|Cognitive behavioral treatment|cognitive behavioral treatment
266192|NCT02542878|myofascial release|myofascial release
266193|NCT02542878|back extensors endurance|back extensors endurance
266194|NCT02542878|foam roller|foam roller
266195|NCT02542878|sport|sport
266196|NCT02542852|HIV-1|hiv-1
266197|NCT02542839|Botulinum Toxin|botulinum toxin
266198|NCT02542839|Transcranial Magnetic Stimulation|transcranial magnetic stimulation
266199|NCT02542826|Pulmonary Rehabilitation|pulmonary rehabilitation
266200|NCT02542826|3-minute constant rate shuttle walk test|3-minute constant rate shuttle walk test
266201|NCT02542826|3-minute constant rate step test|3-minute constant rate step test
266202|NCT02542826|Dyspnea|dyspnea
266203|NCT02542813|Pharmacokinetics|pharmacokinetics
266204|NCT02542813|safety|safety
266205|NCT02542813|tolerability|tolerability
266206|NCT02542813|oxytocin|oxytocin
266207|NCT02542787|MS|ms
266208|NCT02542787|Spasticity|spasticity
266209|NCT02542787|VSN16R|vsn16r
266210|NCT02542774|Diabetes mellitus|diabetes mellitus
266211|NCT02542774|Stroke|stroke
266212|NCT02542774|Myocardial infarction|myocardial infarction
266213|NCT02542774|Stable angina pectoris|stable angina pectoris
266214|NCT02542774|Heart failure|heart failure
266215|NCT02542774|Quality of care|quality of care
266216|NCT02542748|norepinephrine|norepinephrine
266217|NCT02542748|ephedrine|ephedrine
266218|NCT02542722|lifestyle modification|lifestyle modification
266219|NCT02542722|olive oil|olive oil
266220|NCT02542722|Mediterranean diet|mediterranean diet
266221|NCT02542683|congenital heart diseases|congenital heart diseases
266222|NCT02542683|cognition|cognition
266223|NCT02542683|adaptive behavior|adaptive behavior
266224|NCT02542683|physical activity|physical activity
266225|NCT02542683|neurodevelopment|neurodevelopment
266226|NCT02542644|Fuchs' Endothelial Dystrophy, DMEK|fuchs' endothelial dystrophy, dmek
266227|NCT02542618|Depression|depression
266228|NCT02542618|Treatment|treatment
266229|NCT02542618|IBSR|ibsr
266231|NCT02542605|Migraine|migraine
266232|NCT02542605|Headache|headache
266233|NCT02542605|Migraine Headache|migraine headache
266234|NCT02542605|Headache, Migraine|headache, migraine
266235|NCT02542605|Amgen|amgen
266236|NCT02542592|Glucocorticoids|glucocorticoids
266237|NCT02542592|Immune Signaling|immune signaling
266238|NCT02542592|Recovery|recovery
266239|NCT02542592|Hip arthroplasty, total|hip arthroplasty, total
266240|NCT02542579|Helicobacter pylori|helicobacter pylori
266241|NCT02542579|Dyspepsia|dyspepsia
266242|NCT02542540|Osteogenesis Imperfecta|osteogenesis imperfecta
266243|NCT02542540|physical exercise training|physical exercise training
266244|NCT02542540|Wii|wii
266245|NCT02542540|muscular strength|muscular strength
266246|NCT02542514|PCNSL|pcnsl
266247|NCT02542514|IOL|iol
266248|NCT02542462|mechanisms for intussusception|mechanisms for intussusception
266249|NCT02542462|rotavirus vaccine|rotavirus vaccine
266250|NCT02542449|Green tea|green tea
266251|NCT02542449|weight maintenance|weight maintenance
266252|NCT02542449|obesity|obesity
266253|NCT02542449|fat mass|fat mass
266254|NCT02542384|abdominal surgery|abdominal surgery
266255|NCT02542384|laparoscopy|laparoscopy
266256|NCT02542384|Hysterectomy|hysterectomy
266257|NCT02542384|Prostatectomy|prostatectomy
266258|NCT02542384|Hemi-colectomy|hemi-colectomy
266260|NCT02542384|CR845|cr845
266261|NCT02542384|analgesic|analgesic
266262|NCT02542384|kappa opioid|kappa opioid
266263|NCT02542384|partial bowel resection|partial bowel resection
266264|NCT02542384|difelikefalin|difelikefalin
266266|NCT02542371|Atherosclerosis|atherosclerosis
266267|NCT02542371|Tilmanocept|tilmanocept
266268|NCT02542345|Cardiac Multislice CT|cardiac multislice ct
266269|NCT02542345|MRI coronarography|mri coronarography
266270|NCT02542332|lung cancer screening|lung cancer screening
266271|NCT02542332|statistical background|statistical background
266272|NCT02542306|Blood loss|blood loss
266273|NCT02542306|coagulopathy|coagulopathy
266274|NCT02542306|fibrinogen concentrate|fibrinogen concentrate
266275|NCT02542306|transfusion|transfusion
266276|NCT02542293|NSCLC|nsclc
266277|NCT02542293|PDL1|pdl1
266278|NCT02542293|TMB|tmb
266279|NCT02542293|MEDI4736|medi4736
266280|NCT02542293|Durvalumab|durvalumab
266281|NCT02542293|Tremelimumab|tremelimumab
266282|NCT02542293|OS|os
266283|NCT02542267|Bare Metal Stent|bare metal stent
266284|NCT02542267|In-Stent Restenosis|in-stent restenosis
266285|NCT02542241|Open abdomen|open abdomen
266286|NCT02542241|hypertonic saline solution|hypertonic saline solution
266287|NCT02542241|intensive care|intensive care
266288|NCT02542228|Immune Deficiency, antibody|immune deficiency, antibody
266289|NCT02542228|Quality of Life survey|quality of life survey
266290|NCT02542176|Metabolic Syndrome|metabolic syndrome
266291|NCT02542176|Grape|grape
266292|NCT02542176|HDL|hdl
266293|NCT02542176|Lipoproteins|lipoproteins
266294|NCT02542137|Small cell lung cancer|small cell lung cancer
266295|NCT02542137|Metastatic small cell lung cancer|metastatic small cell lung cancer
266296|NCT02542137|ZADAXIN|zadaxin
266297|NCT02542137|radiotherapy|radiotherapy
266298|NCT02542137|Thymalfasin|thymalfasin
266299|NCT02542124|CTCL|ctcl
266300|NCT02542124|Total Skin Electron Beam Therapy (TSEBT)|total skin electron beam therapy (tsebt)
266301|NCT02542124|Mycosis fungoides|mycosis fungoides
266302|NCT02542124|Sézary syndrome|sézary syndrome
266303|NCT02542124|recombinant human Interleukin-12 (rHuIL-12)|recombinant human interleukin-12 (rhuil-12)
266304|NCT02542124|T Cell|t cell
266305|NCT02542111|diffuse large b-cell lymphoma|diffuse large b-cell lymphoma
266306|NCT02542085|incisional hernia|incisional hernia
266307|NCT02542085|laparoscopic repair|laparoscopic repair
266308|NCT02542085|hybrid repair|hybrid repair
266309|NCT02542085|seroma|seroma
266310|NCT02542085|recurrent hernia|recurrent hernia
266311|NCT02542033|postprandial glycemia; apple juice; sugar reduction; glucose oxidase|postprandial glycemia; apple juice; sugar reduction; glucose oxidase
266312|NCT02542007|intracoronary stent|intracoronary stent
266313|NCT02542007|drug eluting stent|drug eluting stent
266314|NCT02542007|sirolimus|sirolimus
266315|NCT02542007|endothelial progenitor cells|endothelial progenitor cells
266316|NCT02541981|Heart transplant|heart transplant
266317|NCT02541981|renal insufficiency|renal insufficiency
266318|NCT02541955|Rheumatoid arthritis (RA)|rheumatoid arthritis (ra)
266319|NCT02541955|Musculoskeletal ultrasound (MSUS)|musculoskeletal ultrasound (msus)
266320|NCT02541929|Alzheimer's disease|alzheimer's disease
266321|NCT02541929|Docosahexaenoic acid|docosahexaenoic acid
266322|NCT02541929|brain health|brain health
266323|NCT02541929|memory|memory
266324|NCT02541929|fish oil|fish oil
266325|NCT02541929|cognition|cognition
266326|NCT02541929|DHA|dha
266327|NCT02541929|omega 3 fatty acid|omega 3 fatty acid
266328|NCT02541929|brain|brain
266329|NCT02541916|Transplantation Tolerance|transplantation tolerance
266330|NCT02541916|Immune Tolerance|immune tolerance
266331|NCT02541916|Transplantation|transplantation
266332|NCT02541916|Liver Transplantation|liver transplantation
266333|NCT02541916|Biological Markers|biological markers
266334|NCT02541916|Gene Expression|gene expression
266335|NCT02541916|Immunosuppression|immunosuppression
266336|NCT02541916|Immunology|immunology
266337|NCT02541916|Multiplex Polymerase Chain Reaction|multiplex polymerase chain reaction
266338|NCT02541916|Real-Time Polymerase Chain Reaction|real-time polymerase chain reaction
266339|NCT02541903|Epidermal growth factor receptor (EGFR),|epidermal growth factor receptor (egfr),
266340|NCT02541903|Human Papillomavirus (HPV)|human papillomavirus (hpv)
266341|NCT02541903|Penile squamous cell carcinoma (PSCC)|penile squamous cell carcinoma (pscc)
266342|NCT02541903|Gilotrif|gilotrif
266343|NCT02541890|Rehabilitation|rehabilitation
266344|NCT02541890|Return to Work|return to work
266345|NCT02541864|Helicobacter pylori|helicobacter pylori
266346|NCT02541864|Hybrid therapy|hybrid therapy
266347|NCT02541864|Bismuth containing quadruple therapy|bismuth containing quadruple therapy
266348|NCT02541864|Eradication|eradication
266349|NCT02541838|Autonomic Neuropathy|autonomic neuropathy
266350|NCT02541838|diabetes|diabetes
266351|NCT02541838|balance control|balance control
266352|NCT02541825|transjugular intrahepatic portosystemic shunt|transjugular intrahepatic portosystemic shunt
266353|NCT02541812|Obsessive-Compulsive Disorder|obsessive-compulsive disorder
266354|NCT02541812|Transcranial Magnetic Stimulation|transcranial magnetic stimulation
266355|NCT02541812|Error processing|error processing
266356|NCT02541799|informed consent|informed consent
266357|NCT02541799|telemedicine|telemedicine
266358|NCT02541799|research methods|research methods
266359|NCT02541786|dexlansoprazole MR|dexlansoprazole mr
266360|NCT02541786|rabeprazole|rabeprazole
266361|NCT02541786|Helicobacter pylori|helicobacter pylori
266362|NCT02541786|triple therapy|triple therapy
266363|NCT02541773|Chronic Heart Failure|chronic heart failure
266364|NCT02541773|Cardiac Resynchronization Therapy|cardiac resynchronization therapy
266365|NCT02541773|Vascular Biomarker|vascular biomarker
266366|NCT02541773|miRNA|mirna
266367|NCT02541773|Extracellular Matrix|extracellular matrix
266368|NCT02541773|Brain Natruetic Peptide|brain natruetic peptide
266369|NCT02541773|Growth Degradation Factor-15|growth degradation factor-15
266370|NCT02541773|Body Composition|body composition
266371|NCT02541734|SPECT|spect
266372|NCT02541734|radiopeptides|radiopeptides
266373|NCT02541734|gelofusine|gelofusine
266374|NCT02541734|Beta cell|beta cell
266375|NCT02541695|Experimental challenge trial|experimental challenge trial
266376|NCT02541669|Drug therapy|drug therapy
266377|NCT02541656|Preload dependence indices|preload dependence indices
266378|NCT02541656|pulse pressure variation|pulse pressure variation
266379|NCT02541656|plethysmographic waveform of pulse oximetry variation|plethysmographic waveform of pulse oximetry variation
266380|NCT02541656|stroke volume variation|stroke volume variation
266381|NCT02541656|laparoscopy|laparoscopy
266382|NCT02541656|pneumoperitoneum|pneumoperitoneum
738244|NCT00480948|infant|infant
266383|NCT02541643|Relapsed/Refractory Multiple Myeloma|relapsed/refractory multiple myeloma
266384|NCT02541630|Mindfulness|mindfulness
266385|NCT02541591|post cardiac arrest|post cardiac arrest
266386|NCT02541591|hemodynamics|hemodynamics
266387|NCT02541578|stroke, acute; gait, complexity|stroke, acute; gait, complexity
266388|NCT02541552|Knee arthroscopy|knee arthroscopy
266389|NCT02541552|Quadriceps weakness|quadriceps weakness
266390|NCT02541552|ropivacaine|ropivacaine
266391|NCT02541552|saphenous nerve block|saphenous nerve block
266392|NCT02541552|Adductor canal|adductor canal
266393|NCT02541526|amphetamine type stimulant dependence|amphetamine type stimulant dependence
266394|NCT02541526|mirtazepine|mirtazepine
266395|NCT02541513|paliparidone|paliparidone
266396|NCT02541513|amphetamine type stimulant dependence|amphetamine type stimulant dependence
266397|NCT02541500|minocycline|minocycline
266398|NCT02541500|amphetamine type stimulant dependence|amphetamine type stimulant dependence
266399|NCT02541474|Controlled trial|controlled trial
266400|NCT02541474|Matched|matched
266401|NCT02541474|Before-After design|before-after design
266402|NCT02541474|Prospective|prospective
266403|NCT02541474|complex interventions|complex interventions
266404|NCT02541461|Body composition measurement|body composition measurement
266405|NCT02541461|Lipid profile|lipid profile
266406|NCT02541461|Weight loss|weight loss
266407|NCT02541461|Gastrectomy|gastrectomy
266408|NCT02541435|Radiotherapy|radiotherapy
266409|NCT02541435|Biological markers|biological markers
266410|NCT02541435|Magnetic resonance imaging|magnetic resonance imaging
266411|NCT02541435|Echocardiography|echocardiography
266412|NCT02541435|Tomography, X-Ray Computed|tomography, x-ray computed
266413|NCT02541435|Risk factors|risk factors
266414|NCT02541435|Heart|heart
266415|NCT02541435|Quality of Life|quality of life
266416|NCT02541409|directly observed therapy|directly observed therapy
266417|NCT02541409|sofosbuvir|sofosbuvir
266418|NCT02541409|ribavirin|ribavirin
266419|NCT02541409|pegylated interferon|pegylated interferon
266420|NCT02541409|resource-limited setting|resource-limited setting
266421|NCT02541396|Bunion|bunion
266422|NCT02541396|Bunionectomy|bunionectomy
266423|NCT02541383|Untreated Multiple Myeloma|untreated multiple myeloma
266424|NCT02541383|daratumumab|daratumumab
266425|NCT02541357|Colorectal Surgery|colorectal surgery
266426|NCT02541331|IgE-dependent asthma|ige-dependent asthma
266427|NCT02541318|peri-menopausal women|peri-menopausal women
266428|NCT02541318|sleep disturbances|sleep disturbances
266429|NCT02541318|Dao-in exercise|dao-in exercise
266430|NCT02541318|body constitution|body constitution
266431|NCT02541305|falls prevention|falls prevention
266432|NCT02541305|proprioception|proprioception
266433|NCT02541305|physical condition|physical condition
266434|NCT02541266|Imaging|imaging
266435|NCT02541266|Questionnaire|questionnaire
266436|NCT02541240|resilience|resilience
266437|NCT02541240|optimism|optimism
266438|NCT02541240|stress|stress
266439|NCT02541240|coping|coping
266440|NCT02541240|curriculum|curriculum
266441|NCT02541201|Plant sterols|plant sterols
266442|NCT02541201|Low-Density Lipoprotein Cholesterol|low-density lipoprotein cholesterol
266443|NCT02541201|Phytosterols|phytosterols
266444|NCT02541188|Breast cancer|breast cancer
266445|NCT02541175|Electrocardiography|electrocardiography
266446|NCT02541175|Automation|automation
266447|NCT02541175|Arrhythmias, Cardiac|arrhythmias, cardiac
266448|NCT02541175|Atrial Fibrillation|atrial fibrillation
266449|NCT02541175|Atrial Flutter|atrial flutter
266450|NCT02541175|Atrial Premature Complexes|atrial premature complexes
266451|NCT02541175|Esophagus|esophagus
266452|NCT02541136|exercise|exercise
266453|NCT02541136|resilience|resilience
266454|NCT02541136|physiotherapy|physiotherapy
266455|NCT02541136|fMRI|fmri
266456|NCT02541123|Traumatic Brain Injury|traumatic brain injury
266457|NCT02541123|Head Injury|head injury
266458|NCT02541084|Age-related macular degeneration|age-related macular degeneration
266459|NCT02541084|Caregiver burden|caregiver burden
266460|NCT02541084|Anti-vascular endothelial growth factor (VEGF) therapy|anti-vascular endothelial growth factor (vegf) therapy
266461|NCT02541058|Velocardiofacial Syndrome|velocardiofacial syndrome
266462|NCT02541058|Shprintzen Syndrome|shprintzen syndrome
266463|NCT02541058|Conotruncal Defects|conotruncal defects
266464|NCT02541058|Chromosomal Abnormalities|chromosomal abnormalities
266465|NCT02541058|22q, 22q.11.2|22q, 22q.11.2
266466|NCT02541058|deletion|deletion
266467|NCT02541058|duplication|duplication
266468|NCT02541045|non-alcoholic steatohepatitis|non-alcoholic steatohepatitis
266469|NCT02541045|metadoxine|metadoxine
266470|NCT02541045|efficacy|efficacy
266471|NCT02541045|therapy|therapy
266472|NCT02541019|C23.888.821.712.700|c23.888.821.712.700
266473|NCT02541006|FEV1|fev1
266475|NCT02541006|AUC 0-24|auc 0-24
266476|NCT02541006|bronchodilator efficacy|bronchodilator efficacy
266477|NCT02541006|tiotropium|tiotropium
266478|NCT02540993|Type 2 Diabetes|type 2 diabetes
266479|NCT02540993|Kidney diseases|kidney diseases
266480|NCT02540967|Contrast enhancement in the following MR imaging|contrast enhancement in the following mr imaging
266481|NCT02540967|Brain and spine|brain and spine
266482|NCT02540967|Body and extremities|body and extremities
266483|NCT02540967|Gadobutrol|gadobutrol
266484|NCT02540954|Age-related macular degeneration (AMD)|age-related macular degeneration (amd)
266485|NCT02540954|Eylea treatment|eylea treatment
266486|NCT02540954|Treat and Extend|treat and extend
266487|NCT02540954|Intravitreal|intravitreal
266488|NCT02540902|Knee replacement|knee replacement
266489|NCT02540902|Knee arthroplasty|knee arthroplasty
266490|NCT02540902|All-polyethylene tibia|all-polyethylene tibia
266491|NCT02540902|Bone density|bone density
266492|NCT02540863|myofascial pain syndrome|myofascial pain syndrome
266493|NCT02540863|exercise therapy|exercise therapy
266494|NCT02540863|randomized controlled trial|randomized controlled trial
266495|NCT02540850|septin 9|septin 9
266496|NCT02540850|SEPT9|sept9
266497|NCT02540850|colorectal cancer|colorectal cancer
266498|NCT02540850|CRC|crc
266499|NCT02540850|screening|screening
266500|NCT02540850|methylation|methylation
266501|NCT02540850|adenoma|adenoma
266502|NCT02540850|polyps|polyps
266503|NCT02540850|FIT|fit
266504|NCT02540850|FOBT|fobt
266505|NCT02540850|colonoscopy|colonoscopy
266506|NCT02540824|Apatinib|apatinib
266507|NCT02540824|RET|ret
266508|NCT02540824|gene fusion|gene fusion
266509|NCT02540824|Non-small Cell Lung Cancer|non-small cell lung cancer
266510|NCT02540798|Anxiety|anxiety
266511|NCT02540798|Urodynamics|urodynamics
266512|NCT02540798|Symptom reproducibility|symptom reproducibility
266513|NCT02540798|Lower urinary tract symptoms|lower urinary tract symptoms
266514|NCT02540798|Women|women
266515|NCT02540785|Refractive Surgical Procedures|refractive surgical procedures
266516|NCT02540785|small-incision lenticule extraction|small-incision lenticule extraction
266517|NCT02540785|lenticule extraction|lenticule extraction
266518|NCT02540785|inflammatory mediators|inflammatory mediators
266519|NCT02540772|Confabulations|confabulations
266520|NCT02540772|Neuropsychological rehabilitation|neuropsychological rehabilitation
266521|NCT02540772|Memory|memory
266522|NCT02540759|Buglossoides arvensis|buglossoides arvensis
266523|NCT02540759|vegetable oil|vegetable oil
266524|NCT02540759|omega-3 fatty acids|omega-3 fatty acids
266525|NCT02540759|participants|participants
266526|NCT02540746|Emotional Dysregulation|emotional dysregulation
266527|NCT02540746|Early Intervention|early intervention
266528|NCT02540746|Youth Mental Health|youth mental health
266529|NCT02540746|Staging|staging
266530|NCT02540746|Motivational Enhancement|motivational enhancement
266531|NCT02540746|Family Connections|family connections
266532|NCT02540746|Family Skills Training|family skills training
266533|NCT02540733|cerebral infarction|cerebral infarction
266534|NCT02540733|diabetes|diabetes
266535|NCT02540733|rehabilitation|rehabilitation
266536|NCT02540733|MRI|mri
266537|NCT02540681|Transtibial amputation|transtibial amputation
266538|NCT02540681|Prosthetic fit|prosthetic fit
266539|NCT02540681|Prosthetic alignment|prosthetic alignment
266540|NCT02540655|Stem Cells|stem cells
266541|NCT02540655|Adult Stem Cells|adult stem cells
266542|NCT02540655|Spinocerebellar Ataxia|spinocerebellar ataxia
266543|NCT02540655|Steminent|steminent
266544|NCT02540629|Cardiopulmonary resuscitation|cardiopulmonary resuscitation
266545|NCT02540629|Emergency Medicine|emergency medicine
266546|NCT02540616|MdDS|mdds
266547|NCT02540616|TES|tes
266548|NCT02540616|TMS|tms
266549|NCT02540590|microcirculation|microcirculation
266550|NCT02540590|wound healing|wound healing
266551|NCT02540590|tunnel technique|tunnel technique
266552|NCT02540590|gingival recession|gingival recession
266553|NCT02540590|Mucograft|mucograft
266554|NCT02540590|laser speckle contrast analyzer|laser speckle contrast analyzer
266555|NCT02540538|Adjuvants, immunologic|adjuvants, immunologic
266556|NCT02540538|Interleukin-2|interleukin-2
266557|NCT02540538|Hepatitis B vaccines|hepatitis b vaccines
266558|NCT02540538|Non-responders|non-responders
266559|NCT02540525|stress incontinence|stress incontinence
266560|NCT02540525|transobturator sling|transobturator sling
266561|NCT02540525|single-incision mini-sling|single-incision mini-sling
266562|NCT02540499|lung cancer|lung cancer
266563|NCT02540499|breath hold|breath hold
266564|NCT02540499|radiotherapy|radiotherapy
266565|NCT02540486|Type 2 diabetes|type 2 diabetes
266566|NCT02540486|T2DM|t2dm
266567|NCT02540473|Resilience|resilience
266568|NCT02540447|Liver transplantation|liver transplantation
266569|NCT02540447|Graft rinse|graft rinse
266570|NCT02540447|Ischemia reperfusion injury|ischemia reperfusion injury
266571|NCT02540434|Hypofibrinogenemia|hypofibrinogenemia
266572|NCT02540434|ROTEM|rotem
266573|NCT02540434|Cardiac Surgery|cardiac surgery
266574|NCT02540434|Concentrated Fibrinogen|concentrated fibrinogen
266575|NCT02540421|cervical intraepithelial neoplasia|cervical intraepithelial neoplasia
266576|NCT02540421|human papillomavirus|human papillomavirus
266577|NCT02540421|conization|conization
266578|NCT02540408|Occupational COPD|occupational copd
266579|NCT02540408|Pathophysiology|pathophysiology
266580|NCT02540408|Exercise limitation|exercise limitation
266581|NCT02540408|Pulmonary hyperinflation|pulmonary hyperinflation
266582|NCT02540408|Arterial stiffness|arterial stiffness
266583|NCT02540395|Kidney transplantation|kidney transplantation
266584|NCT02540395|Immunosuppression|immunosuppression
266585|NCT02540395|IFN-γ|ifn-γ
266586|NCT02540382|TIPS|tips
266587|NCT02540382|Hepatocellular Carcinoma|hepatocellular carcinoma
266588|NCT02540382|Portasystemic Shunt|portasystemic shunt
266589|NCT02540369|Diabetic macular edema|diabetic macular edema
266590|NCT02540369|Wet Age-related macular degeneration|wet age-related macular degeneration
266591|NCT02540343|Translation|translation
266592|NCT02540343|Validation|validation
266593|NCT02540343|Orebro-G|orebro-g
266594|NCT02540291|E7046|e7046
266595|NCT02540291|Advanced malignancies|advanced malignancies
266596|NCT02540291|malignancies|malignancies
266597|NCT02540265|Bunion|bunion
266598|NCT02540265|Bunionectomy|bunionectomy
266599|NCT02540265|Pain|pain
266600|NCT02540265|Analgesia|analgesia
266601|NCT02540265|N1539|n1539
266602|NCT02540252|Lower Limb Amputation|lower limb amputation
266603|NCT02540252|Nutrition|nutrition
266604|NCT02540252|Eating|eating
266605|NCT02540252|Inflammation|inflammation
266606|NCT02540252|Nursing|nursing
266607|NCT02540226|Tranexamic Acid|tranexamic acid
266608|NCT02540226|Total Knee Arthroplasty|total knee arthroplasty
266609|NCT02540226|Total Knee Replacement|total knee replacement
266610|NCT02540187|haemophilia|haemophilia
266611|NCT02540187|TFPI|tfpi
266612|NCT02540187|thrombin generation|thrombin generation
266613|NCT02540187|hemorrhagic score|hemorrhagic score
266614|NCT02540174|alcohol and tobacco consumption|alcohol and tobacco consumption
266615|NCT02540174|addiction treatment|addiction treatment
266616|NCT02540161|Sym004|sym004
266617|NCT02540161|Glioblastoma|glioblastoma
266618|NCT02540161|Desjardins|desjardins
266619|NCT02540161|Pro00063483|pro00063483
266620|NCT02540161|Symphogen|symphogen
266621|NCT02540161|Duke Cancer Institute|duke cancer institute
266622|NCT02540135|high grade glioma|high grade glioma
266623|NCT02540135|glioblastoma multiforme|glioblastoma multiforme
266624|NCT02540135|anaplastic astrocytoma|anaplastic astrocytoma
266625|NCT02540135|flourescein|flourescein
266626|NCT02540135|flourescence-guided surgery|flourescence-guided surgery
266627|NCT02540135|intraoperative MRI|intraoperative mri
266628|NCT02540135|iMRI|imri
266629|NCT02540109|Stroke|stroke
266630|NCT02540109|Anomia|anomia
266631|NCT02540096|mental practice|mental practice
266632|NCT02540096|motor imagery|motor imagery
266633|NCT02540096|hemiparesis|hemiparesis
266634|NCT02540096|stroke|stroke
266635|NCT02540096|gait|gait
266636|NCT02540096|mobility|mobility
266637|NCT02540070|Adductor canal Block|adductor canal block
266638|NCT02540070|ultrasound|ultrasound
266639|NCT02540070|periarticular injections|periarticular injections
266640|NCT02540070|Dexmedetomidine|dexmedetomidine
266641|NCT02540018|DEB, drug-eluting balloon, Paclitaxel, peripheral artery disease|deb, drug-eluting balloon, paclitaxel, peripheral artery disease
266642|NCT02539979|IV Paracetamol|iv paracetamol
266643|NCT02539979|Radiofrequency Lesion/Ablation of medial branch nerve|radiofrequency lesion/ablation of medial branch nerve
266644|NCT02539979|Preventative Pain Management|preventative pain management
266645|NCT02539940|Below-the-knee|below-the-knee
266646|NCT02539914|Virtual reality|virtual reality
266647|NCT02539914|Motor and cognitive rehabilitation|motor and cognitive rehabilitation
266648|NCT02539914|Positive emotion stimuli|positive emotion stimuli
266649|NCT02539901|cochlear implant|cochlear implant
266650|NCT02539901|Developmental Psychology|developmental psychology
266651|NCT02539901|cognitive development|cognitive development
266652|NCT02539901|communicative development|communicative development
266653|NCT02539901|perceptual development|perceptual development
266654|NCT02539901|deaf child|deaf child
266655|NCT02539875|Effectiveness of quit immediately (QI) and cut down to quit (CDTQ) interventions in achieving smoking abstinence|effectiveness of quit immediately (qi) and cut down to quit (cdtq) interventions in achieving smoking abstinence
266656|NCT02539862|Insomnia|insomnia
266657|NCT02539862|behavioral and cognitive therapies|behavioral and cognitive therapies
266658|NCT02539836|children's obesity|children's obesity
266659|NCT02539836|gut microbiome|gut microbiome
266660|NCT02539836|body mass index|body mass index
266661|NCT02539836|fruit and vegetable fermentation extraction|fruit and vegetable fermentation extraction
266662|NCT02539836|dietary nutrition intervention|dietary nutrition intervention
266663|NCT02539784|stimulation|stimulation
266664|NCT02539771|vaso-occlusive crisis|vaso-occlusive crisis
266665|NCT02539771|obstructive sleep apnea|obstructive sleep apnea
266666|NCT02539771|priapism|priapism
266667|NCT02539758|acute angle closure|acute angle closure
266668|NCT02539758|ocular massage|ocular massage
266669|NCT02539745|vitamin D|vitamin d
266670|NCT02539745|primary open- angle glaucoma|primary open- angle glaucoma
266671|NCT02539732|Weaning|weaning
266672|NCT02539732|Spontaneous breathing trial|spontaneous breathing trial
266673|NCT02539732|Neurally-adjusted ventilator assist|neurally-adjusted ventilator assist
266674|NCT02539732|Electrical activity of the diaphragm|electrical activity of the diaphragm
266675|NCT02539719|Platinum-Resistant|platinum-resistant
266676|NCT02539719|Refractory|refractory
266677|NCT02539680|Phosphate transporter|phosphate transporter
266678|NCT02539680|CKD|ckd
266679|NCT02539680|duodenal biopsies|duodenal biopsies
266680|NCT02539602|High school|high school
266681|NCT02539602|Longitudnal|longitudnal
266682|NCT02539602|Sexual initiation|sexual initiation
266683|NCT02539602|Contraception|contraception
266684|NCT02539602|Adolescents|adolescents
266685|NCT02539602|Pregnancy prevention|pregnancy prevention
266686|NCT02539602|Sexual health|sexual health
266687|NCT02539576|pharmacokinetics|pharmacokinetics
266688|NCT02539576|Healthy subjects|healthy subjects
266689|NCT02539576|Abacavir/dolutegravir/lamivudine|abacavir/dolutegravir/lamivudine
266690|NCT02539576|Japanese|japanese
266691|NCT02539576|Fixed-dose combination|fixed-dose combination
266692|NCT02539576|safety|safety
266693|NCT02539563|labor duration|labor duration
266694|NCT02539550|PF-06266047|pf-06266047
266695|NCT02539550|safety|safety
266696|NCT02539550|tolerability|tolerability
266697|NCT02539550|pharmacokinetics|pharmacokinetics
266698|NCT02539550|first-in-human|first-in-human
266699|NCT02539550|healthy volunteers|healthy volunteers
266700|NCT02539550|PDE4|pde4
266701|NCT02539550|phosphodiesterase-4|phosphodiesterase-4
266702|NCT02539537|locally advanced pancreatic carcinoma|locally advanced pancreatic carcinoma
266703|NCT02539537|FOLFIRINOX|folfirinox
266704|NCT02539524|clinical impact|clinical impact
266705|NCT02539524|anxiety|anxiety
266706|NCT02539524|quality of life|quality of life
266707|NCT02539524|Yoga|yoga
266708|NCT02539498|Primary Hyperparathyroidism|primary hyperparathyroidism
266709|NCT02539498|Parathyroid Hormone|parathyroid hormone
266710|NCT02539498|High-Resolution peripheral Quantitative Computed Tomography|high-resolution peripheral quantitative computed tomography
266711|NCT02539498|Bone densitometry|bone densitometry
266712|NCT02539498|Bone microarchitecture|bone microarchitecture
266713|NCT02539446|Aging|aging
266714|NCT02539446|External focus|external focus
266715|NCT02539446|Internal focus|internal focus
266716|NCT02539446|Attention|attention
266717|NCT02539446|Posture balance|posture balance
266718|NCT02539446|Parkinson's disease|parkinson's disease
266719|NCT02539407|β-lactam antibiotics|β-lactam antibiotics
266720|NCT02539407|Children|children
266721|NCT02539407|Anti-infectives|anti-infectives
266722|NCT02539407|Aminoglycosides, glycopeptides|aminoglycosides, glycopeptides
266723|NCT02539407|Fluoroquinolone|fluoroquinolone
266724|NCT02539407|Fungal|fungal
266725|NCT02539407|Antiviral|antiviral
266726|NCT02539394|Anterior Cervical Discectomy and Fusion|anterior cervical discectomy and fusion
266727|NCT02539394|Dysphagia|dysphagia
266728|NCT02539394|ACDF|acdf
266729|NCT02539368|CT-P13|ct-p13
266730|NCT02539368|Inflectra|inflectra
266731|NCT02539368|Remicade|remicade
266732|NCT02539368|Infliximab|infliximab
266733|NCT02539368|Observational|observational
266734|NCT02539368|Follow-up|follow-up
266735|NCT02539368|Safety|safety
266736|NCT02539368|Effectiveness|effectiveness
266737|NCT02539355|Insulin resistance|insulin resistance
266738|NCT02539355|Diabetes|diabetes
266739|NCT02539355|Cancer|cancer
266740|NCT02539355|Obesity|obesity
266741|NCT02539355|Inflammation|inflammation
266742|NCT02539342|Oral Mucositis|oral mucositis
266743|NCT02539342|Cancer|cancer
266744|NCT02539342|Chemotherapy|chemotherapy
266745|NCT02539329|neuropathy|neuropathy
266746|NCT02539329|antibodies antiFGFR3|antibodies antifgfr3
266747|NCT02539329|Biological diagnostic criteria|biological diagnostic criteria
266748|NCT02539316|Parenteral Nutrition|parenteral nutrition
266749|NCT02539290|Unexplained infertility|unexplained infertility
266750|NCT02539290|Infertility|infertility
266751|NCT02539290|Tubal flushing|tubal flushing
266752|NCT02539290|Uterine flushing|uterine flushing
266753|NCT02539290|Live birth|live birth
266754|NCT02539290|Pregnancy|pregnancy
266755|NCT02539290|Randomized controlled trial|randomized controlled trial
266756|NCT02539290|Saline|saline
266757|NCT02539290|Physiological saline|physiological saline
266758|NCT02539264|All patients registered for A PSG|all patients registered for a psg
266759|NCT02539264|polysomnography|polysomnography
266760|NCT02539251|Early Child Development|early child development
266761|NCT02539251|Ages and Stages Questionnaire _3|ages and stages questionnaire _3
266762|NCT02539251|Validation|validation
266763|NCT02539238|Medical Education|medical education
266764|NCT02539238|cardiopulmonary resuscitation|cardiopulmonary resuscitation
266765|NCT02539238|feedback|feedback
266766|NCT02539238|cost-effectiveness analysis|cost-effectiveness analysis
266767|NCT02539212|microwave|microwave
266768|NCT02539212|radiofrequency|radiofrequency
266769|NCT02539212|ablation|ablation
266770|NCT02539160|coronary artery disease|coronary artery disease
266771|NCT02539160|diabetes mellitus|diabetes mellitus
266772|NCT02539160|chronic kidney disease|chronic kidney disease
266773|NCT02539160|ticagrelor|ticagrelor
266774|NCT02539147|lipopolysaccharide|lipopolysaccharide
266775|NCT02539147|sepsis|sepsis
266776|NCT02539147|caspase-4 and -5|caspase-4 and -5
266777|NCT02539147|monocytes|monocytes
266778|NCT02539147|IL-1β and IL-1α|il-1β and il-1α
266779|NCT02539134|Drug therapy|drug therapy
266780|NCT02539121|Labor|labor
266781|NCT02539121|Acupuncture|acupuncture
266782|NCT02539121|Postpartum hemorrhage|postpartum hemorrhage
266783|NCT02539121|Placental expulsion time|placental expulsion time
266784|NCT02539121|Postpartum blood loss|postpartum blood loss
266785|NCT02539108|Influenza|influenza
266786|NCT02539108|Influenza virus vaccine|influenza virus vaccine
266787|NCT02539108|Fluzone® Quadrivalent Influenza Vaccine (No Preservative)|fluzone® quadrivalent influenza vaccine (no preservative)
266788|NCT02539095|intra-articular injection|intra-articular injection
266789|NCT02539095|intra-articular collagen injection|intra-articular collagen injection
266790|NCT02539095|collagen|collagen
266791|NCT02539095|knee joint pain|knee joint pain
266792|NCT02539082|collagen|collagen
266793|NCT02539082|collagen injection|collagen injection
266794|NCT02539082|plantar fasciitis|plantar fasciitis
266795|NCT02539069|cartilage defects|cartilage defects
266796|NCT02539069|Chondron|chondron
266797|NCT02539069|Autologous cultured Chondrocyte|autologous cultured chondrocyte
266798|NCT02539069|arthroscopy|arthroscopy
266799|NCT02539056|cartilage defects|cartilage defects
266800|NCT02539056|Chondron|chondron
266801|NCT02539056|Autologous cultured Chondrocyte|autologous cultured chondrocyte
266802|NCT02539043|Lipolysis|lipolysis
266803|NCT02539043|Subcutaneous Fat, Abdominal/metabolism|subcutaneous fat, abdominal/metabolism
266804|NCT02539043|Subcutaneous Fat, Abdominal/ultrasonography|subcutaneous fat, abdominal/ultrasonography
266805|NCT02539043|High-Intensity Focused Ultrasound Ablation/methods|high-intensity focused ultrasound ablation/methods
266806|NCT02539043|Waist Circumference|waist circumference
266807|NCT02539043|Pilot Projects|pilot projects
266808|NCT02539043|Subcutaneous Fat|subcutaneous fat
266809|NCT02539043|High-Intensity Focused Ultrasound Ablation|high-intensity focused ultrasound ablation
266810|NCT02539043|Adiposity|adiposity
266811|NCT02539030|Cartilage defect of knee|cartilage defect of knee
266812|NCT02539030|microfracture|microfracture
266813|NCT02539030|modified microfracture|modified microfracture
266814|NCT02539030|collagen|collagen
266815|NCT02539017|cellular immune therapy|cellular immune therapy
266816|NCT02539017|triple negative breast cancer|triple negative breast cancer
266817|NCT02539017|adjuvant therapy|adjuvant therapy
266818|NCT02539004|kidney stones|kidney stones
266819|NCT02539004|ureteral stones|ureteral stones
266820|NCT02538991|Bulkamid|bulkamid
266821|NCT02538991|Tension-Free Vaginal Tape|tension-free vaginal tape
266822|NCT02538991|Women|women
266824|NCT02538965|Lenalidomide|lenalidomide
266825|NCT02538965|Revlimid|revlimid
266826|NCT02538965|Pediatric|pediatric
266827|NCT02538965|Relapsed or Refractory|relapsed or refractory
266828|NCT02538965|Acute Myeloid Leukemia|acute myeloid leukemia
266829|NCT02538965|Leukemia|leukemia
266830|NCT02538952|GeneXpert|genexpert
266831|NCT02538952|Tuberculosis|tuberculosis
266832|NCT02538952|Human immunodeficiency virus|human immunodeficiency virus
266833|NCT02538952|Diagnostic accuracy|diagnostic accuracy
266834|NCT02538952|Impact|impact
266835|NCT02538939|Calcific tendinitis, Shoulder, Needle lavage, Sodium thiosulfate|calcific tendinitis, shoulder, needle lavage, sodium thiosulfate
266836|NCT02538913|Exercise|exercise
266837|NCT02538913|Pelvic floor|pelvic floor
266838|NCT02538913|Prehabilitation|prehabilitation
266839|NCT02538913|Fecal incontinence|fecal incontinence
266840|NCT02538913|Urinary incontinence|urinary incontinence
266841|NCT02538913|Sexual dysfunction, physiological|sexual dysfunction, physiological
266842|NCT02538900|peripheral arterial disease, peripheral artery disease, PAD, exercise|peripheral arterial disease, peripheral artery disease, pad, exercise
266843|NCT02538822|aortic aneurysm|aortic aneurysm
266844|NCT02538822|thoracic ascending aorta|thoracic ascending aorta
266845|NCT02538822|ATA|ata
266846|NCT02538822|dynamic imaging|dynamic imaging
266847|NCT02538822|mechanical testing|mechanical testing
266848|NCT02538796|Anorexia Nervosa|anorexia nervosa
266849|NCT02538796|Cognition|cognition
266850|NCT02538796|Conscious|conscious
266851|NCT02538796|Non-Conscious|non-conscious
266852|NCT02538705|Diabetic foot syndrome|diabetic foot syndrome
266853|NCT02538705|Ulcers|ulcers
266854|NCT02538679|transversus abdominis plane block|transversus abdominis plane block
266855|NCT02538679|tap block|tap block
266856|NCT02538679|regional anesthesia|regional anesthesia
266857|NCT02538679|colorectal surgery|colorectal surgery
266858|NCT02538653|glycemic & insulin response, SDS, cereal product, Nutrition|glycemic & insulin response, sds, cereal product, nutrition
266859|NCT02538640|Nutrition, glycemic response, cereal products|nutrition, glycemic response, cereal products
266860|NCT02538627|Heregulin-positive|heregulin-positive
266861|NCT02538627|EGFR|egfr
266862|NCT02538627|ErbB3|erbb3
266863|NCT02538627|Phase I|phase i
266864|NCT02538627|Oncology|oncology
266865|NCT02538627|Cancer|cancer
266866|NCT02538627|IGF-1|igf-1
266867|NCT02538627|MEKinhibitor|mekinhibitor
266868|NCT02538627|IGF-1R inhibitor|igf-1r inhibitor
266869|NCT02538627|KRAS|kras
266870|NCT02538627|NRAS|nras
266871|NCT02538601|Post Traumatic Stress Disorder|post traumatic stress disorder
266872|NCT02538601|PTSD|ptsd
266873|NCT02538601|Cigarette Smoking|cigarette smoking
266874|NCT02538601|Lower Respiratory Symptoms|lower respiratory symptoms
266875|NCT02538601|Cognitive Behavioral Therapy|cognitive behavioral therapy
266876|NCT02538601|CBT|cbt
266877|NCT02538601|Transdiagnostic Treatments|transdiagnostic treatments
266878|NCT02538601|World Trade Center|world trade center
266879|NCT02538588|Healthy Volunteers|healthy volunteers
266880|NCT02538575|Cystic Fibrosis|cystic fibrosis
266881|NCT02538575|Adults|adults
266882|NCT02538575|6-minute walk test|6-minute walk test
266883|NCT02538497|NBO|nbo
266884|NCT02538497|The Newborn Behavioral Observation|the newborn behavioral observation
266885|NCT02538497|postpartum depression|postpartum depression
266886|NCT02538497|postnatal depression|postnatal depression
266887|NCT02538497|child development|child development
266888|NCT02538497|parent-child interaction|parent-child interaction
266889|NCT02538458|Saline Solution, Hypertonic (3 %)|saline solution, hypertonic (3 %)
266890|NCT02538458|Infant|infant
266891|NCT02538445|Schizophrenia|schizophrenia
266892|NCT02538445|Memory|memory
266893|NCT02538445|Cognition|cognition
266894|NCT02538432|Disease Progression|disease progression
266895|NCT02538432|Non-Responsive Disease|non-responsive disease
266896|NCT02538432|Advanced Disease|advanced disease
266897|NCT02538406|Adenoma|adenoma
266898|NCT02538406|withdrawal time|withdrawal time
266899|NCT02538406|Colonoscopy|colonoscopy
266900|NCT02538380|Lung cancer|lung cancer
266901|NCT02538380|Adrenal gland metastasis|adrenal gland metastasis
266902|NCT02538354|Riboflavin (vitamin B2)|riboflavin (vitamin b2)
266903|NCT02538354|Faecalibacterium prausnitzii|faecalibacterium prausnitzii
266904|NCT02538328|laparoscopy|laparoscopy
266905|NCT02538328|obesity|obesity
266906|NCT02538328|harmonic scalpel|harmonic scalpel
266907|NCT02538328|ligasure|ligasure
266908|NCT02538315|[18F]FODPA, Parkinson's, PET/CT, Stem Cell transplantation|[18f]fodpa, parkinson's, pet/ct, stem cell transplantation
266909|NCT02538302|Minirin|minirin
266910|NCT02538302|Oxybutynin|oxybutynin
266911|NCT02538302|Nocturnal enuresis|nocturnal enuresis
266912|NCT02538289|Dyspnea|dyspnea
266913|NCT02538289|Palliative Care|palliative care
266914|NCT02538289|Heart Failure|heart failure
266915|NCT02538289|Chronic Pulmonary Disease|chronic pulmonary disease
266916|NCT02538289|Opioids|opioids
266917|NCT02538276|carotid endarterectomy, carotid stenosis, carotid stenting|carotid endarterectomy, carotid stenosis, carotid stenting
266918|NCT02538250|Oral nutritional supplement|oral nutritional supplement
266919|NCT02538250|supplementation|supplementation
266920|NCT02538250|adult patients|adult patients
266921|NCT02538224|Periodontitis|periodontitis
266922|NCT02538224|doxycycline/ketoprofen topical gel therapeutic|doxycycline/ketoprofen topical gel therapeutic
266923|NCT02538198|lenalidomide (CC-5013)|lenalidomide (cc-5013)
266924|NCT02538198|maintenance|maintenance
266925|NCT02538198|15-129|15-129
266926|NCT02538172|Cell-mediated immunity|cell-mediated immunity
266927|NCT02538172|Antiviral prophylaxis|antiviral prophylaxis
266928|NCT02538172|Transplantation|transplantation
266929|NCT02538159|Non-tunneled Central venous catheter|non-tunneled central venous catheter
266930|NCT02538159|Bacteraemia|bacteraemia
266931|NCT02538159|Peripherally inserted central venous catheter|peripherally inserted central venous catheter
266932|NCT02538146|pain|pain
266933|NCT02538146|depression|depression
266934|NCT02538146|cytokines|cytokines
266935|NCT02538146|well-being|well-being
266936|NCT02538133|99mTc-Exametazime (HMPAO)-Labeled Leukocytes|99mtc-exametazime (hmpao)-labeled leukocytes
266937|NCT02538133|suspected subdiaphragmatic vascular prosthesis infection|suspected subdiaphragmatic vascular prosthesis infection
266938|NCT02538133|diagnosis|diagnosis
266939|NCT02538094|Cognitive Enhancement|cognitive enhancement
266940|NCT02538094|tDCS|tdcs
266941|NCT02538094|stimulation|stimulation
266942|NCT02538094|MS|ms
266943|NCT02538094|Multiple Sclerosis|multiple sclerosis
266944|NCT02538094|Encephalitis|encephalitis
266945|NCT02538081|schizophrenia|schizophrenia
266946|NCT02538081|olanzapine|olanzapine
266947|NCT02538081|risperidone|risperidone
266948|NCT02538081|alpha 7 nicotinic receptors|alpha 7 nicotinic receptors
266949|NCT02538081|cognition|cognition
266950|NCT02538068|Purpose in Life|purpose in life
266951|NCT02538068|Self-determination|self-determination
266952|NCT02538068|Physical activity|physical activity
266953|NCT02538068|Self-monitoring|self-monitoring
266954|NCT02538068|Behavior change|behavior change
266955|NCT02538055|Community Health Workers|community health workers
266956|NCT02538055|Diabetes Mellitus|diabetes mellitus
266957|NCT02538055|Chronic Pain|chronic pain
266958|NCT02538029|Dual tasking|dual tasking
266959|NCT02538016|Cystinuria|cystinuria
266960|NCT02538016|Kidney Stones|kidney stones
266961|NCT02537964|chlorhexidine|chlorhexidine
266962|NCT02537951|autofluorescent flavoprotein imaging, capsaicin|autofluorescent flavoprotein imaging, capsaicin
266963|NCT02537925|COX-2 inhibitors|cox-2 inhibitors
266964|NCT02537925|radiosensitivity|radiosensitivity
266965|NCT02537925|nasopharyngeal carcinoma|nasopharyngeal carcinoma
266966|NCT02537912|peanut skin|peanut skin
266967|NCT02537912|body fat|body fat
266968|NCT02537912|blood glucose|blood glucose
266969|NCT02537912|waistline|waistline
266970|NCT02537912|body weight|body weight
266971|NCT02537886|PCOR|pcor
266972|NCT02537873|Cocaine Use Disorder|cocaine use disorder
266973|NCT02537847|Sitafloxacin|sitafloxacin
266974|NCT02537847|Extended-Spectrum ß-lactamase-producing Escherichia coli|extended-spectrum ß-lactamase-producing escherichia coli
266975|NCT02537847|Treatment for Acute Pyelonephritis|treatment for acute pyelonephritis
266976|NCT02537847|Ertapenem|ertapenem
266977|NCT02537795|Deep Brain Stimulation|deep brain stimulation
266978|NCT02537795|Anterior Capsulotomy|anterior capsulotomy
266979|NCT02537782|Cardiac Resynchronisation Therapy|cardiac resynchronisation therapy
266980|NCT02537782|Heart Failure|heart failure
266981|NCT02537782|Left ventricular dyssynchrony|left ventricular dyssynchrony
266982|NCT02537782|Echocardiography|echocardiography
266983|NCT02537782|Apical rocking|apical rocking
266984|NCT02537782|Septal flash|septal flash
266985|NCT02537769|LVAD|lvad
266986|NCT02537769|Tricuspid regurgitation|tricuspid regurgitation
266987|NCT02537769|Heart failure|heart failure
266988|NCT02537769|Transplant|transplant
266989|NCT02537769|3D transesophageal echocardiography (TEE)|3d transesophageal echocardiography (tee)
266990|NCT02537769|2D transesophageal echocardiography (TEE)|2d transesophageal echocardiography (tee)
266991|NCT02537769|Mild|mild
266992|NCT02537769|Moderate|moderate
266993|NCT02537743|Patient Reported Outcomes|patient reported outcomes
266994|NCT02537704|Obesity|obesity
266995|NCT02537704|Translational|translational
266996|NCT02537704|Diabetes Prevention Program|diabetes prevention program
266997|NCT02537704|Group Lifestyle Balance Program|group lifestyle balance program
266998|NCT02537652|Central blood pressure|central blood pressure
266999|NCT02537652|Transient ischaemic attack|transient ischaemic attack
267000|NCT02537639|Simulator in transesophageal echocardiography|simulator in transesophageal echocardiography
267001|NCT02537613|Chronic Lymphocytic Leukemia|chronic lymphocytic leukemia
267002|NCT02537600|BRAF mutation|braf mutation
267003|NCT02537600|Brain metastasis|brain metastasis
267004|NCT02537600|Cobimetinib + Vemurafenib combination treatment|cobimetinib + vemurafenib combination treatment
267005|NCT02537587|Blood glucose|blood glucose
267006|NCT02537587|Blood insulin|blood insulin
267007|NCT02537587|Humans|humans
267008|NCT02537587|Postprandial|postprandial
267009|NCT02537587|Carbohydrate|carbohydrate
267010|NCT02537587|Protein|protein
267011|NCT02537587|Resistant starch|resistant starch
267012|NCT02537587|Sugar|sugar
267013|NCT02537574|Alkermes|alkermes
267014|NCT02537574|Buprenorphine|buprenorphine
267015|NCT02537574|Naltrexone|naltrexone
267016|NCT02537574|Vivitrol|vivitrol
267017|NCT02537574|Opioid Use|opioid use
267018|NCT02537574|Opiates|opiates
267019|NCT02537574|Dependence|dependence
267020|NCT02537574|Abuse|abuse
267021|NCT02537574|Heroin|heroin
267022|NCT02537574|Painkillers|painkillers
267023|NCT02537574|Substance Abuse|substance abuse
267024|NCT02537496|Alzheimer's Disease|alzheimer's disease
267025|NCT02537496|Brain stimulation|brain stimulation
267026|NCT02537496|Transcranial Magnetic Stimulation|transcranial magnetic stimulation
267027|NCT02537496|Neuroplasticity|neuroplasticity
267028|NCT02537496|cognitive enhancement|cognitive enhancement
267029|NCT02537496|TMS-EEG|tms-eeg
267030|NCT02537496|rTMS|rtms
267031|NCT02537496|PAS|pas
267032|NCT02537431|KRN23|krn23
267033|NCT02537431|Fibroblast growth factor 23 (FGF23)|fibroblast growth factor 23 (fgf23)
267034|NCT02537431|XLH|xlh
267035|NCT02537431|X-linked Hypophosphatemia|x-linked hypophosphatemia
267036|NCT02537379|Hepatitis C virus|hepatitis c virus
267037|NCT02537379|observational|observational
267038|NCT02537379|post-marketing|post-marketing
267039|NCT02537379|sofosbuvir|sofosbuvir
267040|NCT02537353|Upper gastrointestinal bleeding|upper gastrointestinal bleeding
267041|NCT02537353|Hemospray|hemospray
267042|NCT02537353|Endoscopic hemostasis|endoscopic hemostasis
267043|NCT02537340|PET/MR|pet/mr
267044|NCT02537340|MRI|mri
267045|NCT02537340|Rectal cancer|rectal cancer
267046|NCT02537340|EMVI|emvi
267047|NCT02537340|FDG|fdg
267048|NCT02537327|Recurrent caries|recurrent caries
267049|NCT02537327|Secondary caries|secondary caries
267050|NCT02537327|Dental composite|dental composite
267051|NCT02537327|Dental amalgam|dental amalgam
267052|NCT02537314|Normal Body Weight|normal body weight
267053|NCT02537301|Endoscopic Retrograde Cholangiopancreatography|endoscopic retrograde cholangiopancreatography
267054|NCT02537301|social networking|social networking
267055|NCT02537301|group chat|group chat
267056|NCT02537288|VA106483|va106483
267057|NCT02537288|fedovapagon|fedovapagon
267058|NCT02537288|males|males
267059|NCT02537288|females|females
267060|NCT02537288|moxifloxacin|moxifloxacin
267061|NCT02537288|TQT|tqt
267062|NCT02537288|QT/QTC|qt/qtc
267063|NCT02537288|ECG|ecg
267064|NCT02537288|Nocturia|nocturia
267065|NCT02537262|carbohydrate|carbohydrate
739248|NCT00477152|hyaluronan|hyaluronan
267066|NCT02537262|quality of recovery(QOR) 40|quality of recovery(qor) 40
267067|NCT02537262|enhanced recovery after surgery(ERAS)|enhanced recovery after surgery(eras)
267068|NCT02537249|dexmedetomidine|dexmedetomidine
267069|NCT02537249|quality of recovery|quality of recovery
267070|NCT02537236|Omega-3 Fatty Acids|omega-3 fatty acids
267071|NCT02537236|Therapeutic Lifestyle Changes|therapeutic lifestyle changes
267072|NCT02537236|Human Immunodeficiency Virus|human immunodeficiency virus
267073|NCT02537236|Cardiac Risk|cardiac risk
267074|NCT02537236|Dyslipidemia|dyslipidemia
267075|NCT02537171|Apatinib|apatinib
267076|NCT02537171|Locally Advanced Gastric Cancer|locally advanced gastric cancer
267077|NCT02537171|Metastatic Gastric Cancer|metastatic gastric cancer
267078|NCT02537158|sorafenib|sorafenib
267079|NCT02537158|transcatheter arterial chemoembolization|transcatheter arterial chemoembolization
267080|NCT02537158|hepatocellular carcinoma|hepatocellular carcinoma
267081|NCT02537158|microvascular invasion|microvascular invasion
267082|NCT02537145|compliance|compliance
267083|NCT02537145|do-it-yourself methodology|do-it-yourself methodology
267084|NCT02537145|pilot|pilot
267085|NCT02537145|human microbiome|human microbiome
267086|NCT02537132|Non Invasive Ventilation (NIV)|non invasive ventilation (niv)
267087|NCT02537132|Amyotrophic Lateral sclerosis (ALS)|amyotrophic lateral sclerosis (als)
267088|NCT02537132|adaptation|adaptation
267089|NCT02537132|home care|home care
267090|NCT02537106|Brain Tumors|brain tumors
267091|NCT02537106|Microcirculation|microcirculation
267092|NCT02537106|Osmotherapy|osmotherapy
267093|NCT02537106|Hypertonic NaCl|hypertonic nacl
267094|NCT02537106|Natremia|natremia
267095|NCT02537080|Postoperative cognitive dysfunction|postoperative cognitive dysfunction
267096|NCT02537080|Nimodipin|nimodipin
267097|NCT02537080|Anesthesia|anesthesia
267098|NCT02537067|a partial cartilage defect of ankle|a partial cartilage defect of ankle
267099|NCT02537067|Chondron|chondron
267100|NCT02537067|Autologus Chondrocyte|autologus chondrocyte
267101|NCT02537054|Choroidal neovascularization|choroidal neovascularization
267102|NCT02537054|Angioid streaks|angioid streaks
267103|NCT02537054|Pseudoxanthoma Elasticum|pseudoxanthoma elasticum
267104|NCT02537054|vascular endothelial growth factor|vascular endothelial growth factor
267105|NCT02537054|aflibercept|aflibercept
267106|NCT02537028|MSC2364447C|msc2364447c
267107|NCT02537028|Phase 1|phase 1
267108|NCT02537028|BTK inhibitor|btk inhibitor
267109|NCT02537028|Systemic Lupus Erythematosus|systemic lupus erythematosus
267110|NCT02537028|M2951|m2951
267111|NCT02537028|Lupus|lupus
267112|NCT02537002|PF-05230907|pf-05230907
267113|NCT02537002|Pharmacokinetics|pharmacokinetics
267114|NCT02537002|Pharmacodynamic|pharmacodynamic
267115|NCT02537002|Immunogenicity|immunogenicity
267116|NCT02536989|peptic ulcer bleeding|peptic ulcer bleeding
267117|NCT02536989|blood clot|blood clot
267118|NCT02536989|dose|dose
267119|NCT02536976|mirabegron|mirabegron
267120|NCT02536950|bionic pancreas|bionic pancreas
267121|NCT02536950|closed-loop control|closed-loop control
267122|NCT02536950|artificial pancreas|artificial pancreas
267123|NCT02536885|Postoperative cognitive dysfunction|postoperative cognitive dysfunction
267124|NCT02536885|Blood pressure|blood pressure
267125|NCT02536885|Anesthesia|anesthesia
267126|NCT02536872|infection overactive bladder|infection overactive bladder
267127|NCT02536846|Healthy volunteers|healthy volunteers
267128|NCT02536846|antipsychotic drugs|antipsychotic drugs
267129|NCT02536846|brain metabolism|brain metabolism
267130|NCT02536833|OA|oa
267131|NCT02536833|Samumed|samumed
267132|NCT02536781|Anthocyanin|anthocyanin
267133|NCT02536781|Inflammation|inflammation
267134|NCT02536781|Orthodontic treatment|orthodontic treatment
267135|NCT02536768|Medication adherence|medication adherence
267136|NCT02536768|ART|art
267137|NCT02536768|Counseling|counseling
267138|NCT02536768|Adherence Guidelines for Chronic Diseases (HIV, TB and NCDs)|adherence guidelines for chronic diseases (hiv, tb and ncds)
267139|NCT02536742|Breast Cancer|breast cancer
267140|NCT02536742|Metastatic|metastatic
267141|NCT02536742|HER2 negative|her2 negative
267142|NCT02536742|Palbociclib|palbociclib
267143|NCT02536716|Dental Implant|dental implant
267144|NCT02536690|propofol|propofol
267145|NCT02536690|midazolam|midazolam
267146|NCT02536690|remifentanil|remifentanil
267147|NCT02536690|combination|combination
267148|NCT02536690|synergic|synergic
267149|NCT02536690|pharmacodynamics|pharmacodynamics
267150|NCT02536690|Loss of consciousness|loss of consciousness
267151|NCT02536677|Acute Chest Pain|acute chest pain
267152|NCT02536677|Acute Coronary Syndrome|acute coronary syndrome
267153|NCT02536677|Evaluation and Management|evaluation and management
267154|NCT02536677|Decision Aid|decision aid
267155|NCT02536677|Healthcare Utilization|healthcare utilization
267156|NCT02536651|validation studies, patient-reported outcome measures|validation studies, patient-reported outcome measures
267157|NCT02536638|urine protein|urine protein
267158|NCT02536638|pregnancy|pregnancy
267159|NCT02536638|pyelonephritis|pyelonephritis
267160|NCT02536638|kidney infection|kidney infection
267161|NCT02536625|everolimus|everolimus
267162|NCT02536625|NK|nk
267163|NCT02536625|metastatic|metastatic
267164|NCT02536612|Motivation|motivation
267165|NCT02536612|Behavioral Economics|behavioral economics
267166|NCT02536612|Conditional Economic Incentives|conditional economic incentives
267167|NCT02536612|Conditional cash transfers|conditional cash transfers
267168|NCT02536612|Contingency management|contingency management
267169|NCT02536599|Febrile Neutropenia|febrile neutropenia
267170|NCT02536599|Childhood Cancer|childhood cancer
267171|NCT02536599|Pediatric Oncology|pediatric oncology
267172|NCT02536599|Fever|fever
267173|NCT02536599|Neutropenia|neutropenia
267174|NCT02536573|Total hip replacement|total hip replacement
267175|NCT02536560|intestinal microbiota|intestinal microbiota
267176|NCT02536560|antibiotics|antibiotics
267177|NCT02536560|infant|infant
267178|NCT02536560|allergy|allergy
267179|NCT02536547|Clinical pulmonary infection score|clinical pulmonary infection score
267180|NCT02536547|sepsis|sepsis
267181|NCT02536547|lung ultrasound|lung ultrasound
267182|NCT02536547|ventilator-associated pneumonia|ventilator-associated pneumonia
267183|NCT02536534|Pulmonary Arterial Hypertension (PAH)|pulmonary arterial hypertension (pah)
267184|NCT02536534|Chronic Thromboembolic Pulmonary Hypertension (CTEPH)|chronic thromboembolic pulmonary hypertension (cteph)
267185|NCT02536456|screening|screening
267186|NCT02536456|counseling|counseling
267187|NCT02536456|follow-up|follow-up
267188|NCT02536456|cardiovascular disease|cardiovascular disease
267189|NCT02536456|population-based project|population-based project
267190|NCT02536456|China|china
267191|NCT02536443|heart failure|heart failure
267192|NCT02536443|prognosis|prognosis
267193|NCT02536443|clinical characteristics|clinical characteristics
267194|NCT02536430|Infra alveolar nerve block|infra alveolar nerve block
267195|NCT02536430|Ketorolac|ketorolac
267196|NCT02536430|Success rate|success rate
267197|NCT02536417|Melatonin|melatonin
267198|NCT02536417|Delirium prevention|delirium prevention
267199|NCT02536417|End-of-life|end-of-life
267200|NCT02536352|Fluoride Supplementation|fluoride supplementation
267201|NCT02536352|Prenatal Vitamin|prenatal vitamin
267202|NCT02536352|Pregnancy Nutrition|pregnancy nutrition
267203|NCT02536352|Prenatal Nutrition|prenatal nutrition
267204|NCT02536287|secondary hyperparathyroidism|secondary hyperparathyroidism
267205|NCT02536287|total parathyroidectomy|total parathyroidectomy
267206|NCT02536287|autotransplantation|autotransplantation
267207|NCT02536287|morbidity|morbidity
267208|NCT02536287|recurrence|recurrence
267209|NCT02536287|postoperative hypocalcemia|postoperative hypocalcemia
267210|NCT02536261|Prolactinoma|prolactinoma
267211|NCT02536261|dopamine agonist|dopamine agonist
267212|NCT02536261|withdrawal|withdrawal
267213|NCT02536261|cavernous sinus|cavernous sinus
267214|NCT02536248|sitagliptin|sitagliptin
267215|NCT02536248|diabetes|diabetes
268013|NCT02531204|Bixalomer|bixalomer
267216|NCT02536248|inflammation|inflammation
267217|NCT02536196|Cerebral protection, aortic stenosis, transcatheter aortic valve implantation, TAVI, TriGuard, Keystone Heart|cerebral protection, aortic stenosis, transcatheter aortic valve implantation, tavi, triguard, keystone heart
267218|NCT02536183|Solid tumors|solid tumors
267219|NCT02536183|relapsed pediatric solid tumors|relapsed pediatric solid tumors
267220|NCT02536183|high intensity focused ultrasound|high intensity focused ultrasound
267221|NCT02536183|Lyso-thermosensitive liposomal doxorubicin|lyso-thermosensitive liposomal doxorubicin
267222|NCT02536183|ThermoDox|thermodox
267223|NCT02536183|relapsed sarcoma|relapsed sarcoma
267224|NCT02536183|Ewing Sarcoma family of tumors|ewing sarcoma family of tumors
267225|NCT02536183|Osteosarcoma|osteosarcoma
267226|NCT02536183|Neuroblastoma|neuroblastoma
267227|NCT02536183|Wilms Tumor|wilms tumor
267228|NCT02536183|Hepatic Tumor|hepatic tumor
267229|NCT02536183|Germ Cell Tumors|germ cell tumors
267230|NCT02536170|Arginine Therapy|arginine therapy
267231|NCT02536157|Volar plate|volar plate
267232|NCT02536157|Splint|splint
267233|NCT02536157|Proximal interphalangeal joint|proximal interphalangeal joint
267234|NCT02536157|Palmar plate|palmar plate
267235|NCT02536157|Hyperextension injury|hyperextension injury
267236|NCT02536144|colon capsule|colon capsule
267237|NCT02536144|magnetic|magnetic
267238|NCT02536144|maneuverability|maneuverability
267239|NCT02536144|colonoscopy|colonoscopy
267240|NCT02536131|Psychosomatics|psychosomatics
267241|NCT02536131|Gastroenterology|gastroenterology
267242|NCT02536131|Psychoneuroimmunology|psychoneuroimmunology
267243|NCT02536105|Attention Deficit Hyperactivity Disorder|attention deficit hyperactivity disorder
267244|NCT02536105|ADHD|adhd
267245|NCT02536053|[E04.100.814.603]|[e04.100.814.603]
267246|NCT02536040|silver diamine fluoride|silver diamine fluoride
267247|NCT02536040|diammine silver fluoride|diammine silver fluoride
267248|NCT02536040|children|children
267249|NCT02536027|continuous venovenous hemofiltration|continuous venovenous hemofiltration
267250|NCT02536027|neutrophil gelatinase-associated lipocalin|neutrophil gelatinase-associated lipocalin
267251|NCT02536027|sepsis|sepsis
267252|NCT02536027|acute kidney injury|acute kidney injury
267253|NCT02536014|Dexmedetomidine|dexmedetomidine
739249|NCT00477152|rHuPH20|rhuph20
267254|NCT02536014|pneumoperitoneum|pneumoperitoneum
267255|NCT02536014|trendelenburg position|trendelenburg position
267256|NCT02536014|QTc interval|qtc interval
267257|NCT02536014|Tp-e interval|tp-e interval
267258|NCT02536014|robotic prostatectomy|robotic prostatectomy
267259|NCT02536001|Vaginal mesh|vaginal mesh
267260|NCT02536001|Total vaginal length|total vaginal length
267261|NCT02536001|Quality of life|quality of life
267262|NCT02535988|Colorectal Cancer|colorectal cancer
267263|NCT02535988|Metastatic Colorectal Cancer|metastatic colorectal cancer
267264|NCT02535988|ZADAXIN|zadaxin
267265|NCT02535988|Abscopal Effect|abscopal effect
267266|NCT02535988|Radiotherapy|radiotherapy
267267|NCT02535962|PFAPA|pfapa
267268|NCT02535936|Cerebral Palsy|cerebral palsy
267269|NCT02535923|Schizophrenia and Disorders with Psychotic Feature|schizophrenia and disorders with psychotic feature
267270|NCT02535923|Mental Disorders|mental disorders
267271|NCT02535923|Insomnia Disorder|insomnia disorder
267272|NCT02535910|vitamin D3|vitamin d3
267273|NCT02535910|25(OH)D3|25(oh)d3
267274|NCT02535910|vitamin D status|vitamin d status
267275|NCT02535910|risk factors of cardiovascular diease|risk factors of cardiovascular diease
267276|NCT02535884|Huntington Disease|huntington disease
267277|NCT02535884|DBS|dbs
267278|NCT02535884|Chorea|chorea
267279|NCT02535858|Anxiety|anxiety
267280|NCT02535832|Rheumatoid Arthritis|rheumatoid arthritis
267281|NCT02535819|Cataract surgery|cataract surgery
267282|NCT02535806|Relapsed, Refractory|relapsed, refractory
267283|NCT02535767|Primaquine|primaquine
267284|NCT02535741|Knee Replacement|knee replacement
267285|NCT02535741|Arthroplasty|arthroplasty
267286|NCT02535728|Frail Elderly|frail elderly
267287|NCT02535728|Cardiac Surgical Procedure|cardiac surgical procedure
267288|NCT02535728|Risk Assessment|risk assessment
267289|NCT02535728|Quality of Life|quality of life
267290|NCT02535715|Oral Insulin|oral insulin
267291|NCT02535702|fMRI|fmri
267292|NCT02535702|EEG|eeg
267293|NCT02535689|Anti-DNA Antibody|anti-dna antibody
267294|NCT02535689|Tofacitinib|tofacitinib
267295|NCT02535689|Lupus|lupus
267296|NCT02535689|Safety|safety
267297|NCT02535676|schizophrenia|schizophrenia
267298|NCT02535676|transcranial stimulation|transcranial stimulation
267299|NCT02535663|rhamnogalacturonan|rhamnogalacturonan
267300|NCT02535663|Natural killer cell activity|natural killer cell activity
267301|NCT02535663|interleukin-12|interleukin-12
267302|NCT02535663|interferon-gamma|interferon-gamma
267303|NCT02535663|immune function|immune function
267304|NCT02535663|inflammatory|inflammatory
267305|NCT02535572|Electroconvulsive Therapy|electroconvulsive therapy
267306|NCT02535546|Chronic obstructive pulmonary disease (COPD)|chronic obstructive pulmonary disease (copd)
267307|NCT02535546|Streptococcus pneumoniae|streptococcus pneumoniae
267308|NCT02535546|Pneumonia|pneumonia
267309|NCT02535546|Pneumococcal conjugate vaccine-13 (PCV-13)|pneumococcal conjugate vaccine-13 (pcv-13)
269020|NCT02524899|SPD|spd
267310|NCT02535546|Pneumococcal polysaccharide vaccine-23 (PPV-23)|pneumococcal polysaccharide vaccine-23 (ppv-23)
267311|NCT02535546|Pneumococcal vaccine|pneumococcal vaccine
267312|NCT02535533|Kidney cancer|kidney cancer
267313|NCT02535533|Selenium (Se)|selenium (se)
267314|NCT02535507|pyrotinib|pyrotinib
267315|NCT02535507|HER2|her2
267316|NCT02535507|Non-small Cell Lung Cancer|non-small cell lung cancer
267317|NCT02535507|Phase II|phase ii
267318|NCT02535481|epidermal graft|epidermal graft
267319|NCT02535481|suction blister|suction blister
267320|NCT02535481|blister graft|blister graft
267321|NCT02535481|suction graft|suction graft
267322|NCT02535481|Epidermis/su, tr [Surgery, Transplantation]|epidermis/su, tr [surgery, transplantation]
267323|NCT02535390|cognitive remediation|cognitive remediation
267324|NCT02535390|vocational outcomes|vocational outcomes
267325|NCT02535377|Cryodamage|cryodamage
267326|NCT02535377|microarrays|microarrays
267327|NCT02535377|Insemination|insemination
267328|NCT02535377|sperm|sperm
267329|NCT02535364|acute lymphoblastic leukemia|acute lymphoblastic leukemia
267331|NCT02535364|chimeric antigen receptor|chimeric antigen receptor
267332|NCT02535364|CAR|car
267333|NCT02535364|CAR T cells|car t cells
267334|NCT02535364|JCAR015|jcar015
267335|NCT02535364|autologous T cell therapy|autologous t cell therapy
267336|NCT02535364|cell therapy|cell therapy
267337|NCT02535351|Clear cell Metastatic renal cell carcinoma|clear cell metastatic renal cell carcinoma
267338|NCT02535351|Cytoreductive nephrectomy|cytoreductive nephrectomy
267339|NCT02535351|First line treatment|first line treatment
267340|NCT02535299|telomere-telomerase|telomere-telomerase
267341|NCT02535299|Par-4|par-4
267342|NCT02535299|GLP-1|glp-1
267343|NCT02535299|metformin|metformin
267344|NCT02535273|dexmedetomidine|dexmedetomidine
267345|NCT02535273|prone position|prone position
267346|NCT02535273|spine surgery|spine surgery
267347|NCT02535273|Minimally invasive|minimally invasive
267348|NCT02535273|local anesthesia|local anesthesia
267349|NCT02535260|Pregnancy|pregnancy
267350|NCT02535221|Premenopausal Patients|premenopausal patients
712537|NCT00579787|cervical cancer|cervical cancer
267351|NCT02535221|Estrogen Receptor-Positive HER2 negative|estrogen receptor-positive her2 negative
267352|NCT02535169|at risk for type 2 diabetes|at risk for type 2 diabetes
267353|NCT02535169|currently has type 2 diabetes|currently has type 2 diabetes
267354|NCT02535078|IMCgp100|imcgp100
267355|NCT02535078|gp100|gp100
267356|NCT02535078|metastatic cutaneous melanoma|metastatic cutaneous melanoma
267357|NCT02535078|checkpoint inhibitor|checkpoint inhibitor
267358|NCT02535078|PD-1|pd-1
267359|NCT02535078|PD-L1|pd-l1
267360|NCT02535078|CTLA-4|ctla-4
267361|NCT02535078|durvalumab|durvalumab
267362|NCT02535078|tremelimumab|tremelimumab
267363|NCT02535065|Low Profile|low profile
267364|NCT02535065|Abdominal Aortic Aneurysms|abdominal aortic aneurysms
267365|NCT02535065|Endovascular|endovascular
267366|NCT02535039|Elderly|elderly
267367|NCT02535039|cognitive retention disorder|cognitive retention disorder
267368|NCT02535039|methylprednisolone|methylprednisolone
267369|NCT02534974|Critical care|critical care
267370|NCT02534974|Trauma patients|trauma patients
267371|NCT02534961|Hepatocellular carcinoma|hepatocellular carcinoma
267372|NCT02534961|Radiofrequency ablation|radiofrequency ablation
267373|NCT02534961|Antibiotics|antibiotics
267374|NCT02534948|mindfulness|mindfulness
267375|NCT02534948|MABT|mabt
267376|NCT02534948|social anxiety|social anxiety
267377|NCT02534948|mindfulness and acceptance|mindfulness and acceptance
267378|NCT02534948|group therapy|group therapy
267379|NCT02534935|Phase 2 Immunogenicity|phase 2 immunogenicity
267380|NCT02534935|Safety|safety
267381|NCT02534935|Tolerability Study|tolerability study
267382|NCT02534935|rLP2086 Vaccine|rlp2086 vaccine
267383|NCT02534935|Healthy Toddlers|healthy toddlers
267384|NCT02534935|Neisseria meningitidis|neisseria meningitidis
267385|NCT02534935|Duration of Immunogenicity|duration of immunogenicity
267386|NCT02534909|PNH|pnh
267387|NCT02534870|Volunteer|volunteer
267388|NCT02534857|randomized double blinded study|randomized double blinded study
267389|NCT02534857|live birth rate|live birth rate
267390|NCT02534857|IVF treatment|ivf treatment
267391|NCT02534857|brief incubation of oocytes and sperm|brief incubation of oocytes and sperm
267392|NCT02534844|Niemann-Pick Type C1 (NPC1) Disease|niemann-pick type c1 (npc1) disease
267393|NCT02534844|neurologic disease|neurologic disease
267394|NCT02534844|gross motor dysfunction|gross motor dysfunction
267395|NCT02534844|fine motor dysfunction|fine motor dysfunction
267396|NCT02534844|dysphagia|dysphagia
267397|NCT02534844|swallowing problems|swallowing problems
267398|NCT02534844|cognitive dysfunction|cognitive dysfunction
267399|NCT02534844|gait abnormalities|gait abnormalities
267400|NCT02534844|pediatrics|pediatrics
267401|NCT02534727|Pharmacokinetic-Moedeling|pharmacokinetic-moedeling
267402|NCT02534727|Tuberculosis|tuberculosis
267403|NCT02534727|Therapeutic Drug Monitoring|therapeutic drug monitoring
267404|NCT02534727|Drug-Levels|drug-levels
267405|NCT02534727|Caseum|caseum
267406|NCT02534701|stroke|stroke
267407|NCT02534701|clot retrieval system|clot retrieval system
267408|NCT02534701|recanalization|recanalization
267409|NCT02534649|Molecular profiling|molecular profiling
267410|NCT02534649|Genomic alteration|genomic alteration
267411|NCT02534649|Advanced cancer|advanced cancer
267412|NCT02534610|preemptive|preemptive
267413|NCT02534610|postoperative pain|postoperative pain
267414|NCT02534610|etoricoxib|etoricoxib
267415|NCT02534584|acute kidney injury|acute kidney injury
267416|NCT02534584|outcome|outcome
267417|NCT02534584|mortality|mortality
267418|NCT02534584|care-bundle|care-bundle
267419|NCT02534558|MicroRNA-29|microrna-29
267420|NCT02534558|shoulder stiffness|shoulder stiffness
267421|NCT02534558|mir-29a|mir-29a
267422|NCT02534545|Intracranial atherosclerotic stenosis|intracranial atherosclerotic stenosis
267423|NCT02534545|ischemia|ischemia
267424|NCT02534545|remote ischemic conditioning|remote ischemic conditioning
267425|NCT02534545|stroke|stroke
267426|NCT02534532|Atrial fibrillation screening|atrial fibrillation screening
267427|NCT02534506|Advanced malignant tumors|advanced malignant tumors
267428|NCT02534506|Metastatic malignant tumors|metastatic malignant tumors
267429|NCT02534480|Amyloid|amyloid
267430|NCT02534415|Antiinflammatory|antiinflammatory
267431|NCT02534415|Gingiva|gingiva
267432|NCT02534415|Hyaluronic acid|hyaluronic acid
267433|NCT02534415|Palate|palate
267434|NCT02534415|Transplants|transplants
267435|NCT02534415|Wound healing|wound healing
267436|NCT02534402|Biomarkers|biomarkers
267437|NCT02534402|Genomics|genomics
267438|NCT02534402|Prednisone|prednisone
267439|NCT02534389|rectal cancer|rectal cancer
267440|NCT02534389|inflammation|inflammation
267441|NCT02534389|omega-3|omega-3
267442|NCT02534389|fish oil|fish oil
267443|NCT02534389|nutritional status|nutritional status
267444|NCT02534376|prostatectomy, cholesterol, statin|prostatectomy, cholesterol, statin
267445|NCT02534363|Cognition|cognition
267446|NCT02534363|Psychosis|psychosis
267447|NCT02534363|Antipsychotic Agents|antipsychotic agents
267448|NCT02534363|Treatment|treatment
267449|NCT02534363|Effectiveness|effectiveness
267450|NCT02534363|Aripiprazole|aripiprazole
267451|NCT02534363|Quetiapine|quetiapine
267452|NCT02534363|Ziprasidone|ziprasidone
267453|NCT02534363|Neurocognition|neurocognition
267454|NCT02534350|Respiratory Syncytial Virus (RSV)|respiratory syncytial virus (rsv)
267455|NCT02534350|Antiviral|antiviral
267456|NCT02534350|Lung Transplant|lung transplant
267457|NCT02534324|Hypertension|hypertension
267458|NCT02534324|Emergency|emergency
267459|NCT02534298|single sided deafness.|single sided deafness.
267460|NCT02534298|Auditory plasticity|auditory plasticity
267461|NCT02534298|Asymmetrical hearing loss|asymmetrical hearing loss
267462|NCT02534298|Cochlear implants|cochlear implants
267463|NCT02534298|Inter hemispheric asymmetry|inter hemispheric asymmetry
267464|NCT02534298|Lateralization index|lateralization index
267465|NCT02534298|Dichotic hearing|dichotic hearing
267466|NCT02534285|Anesthesia, Inhalation|anesthesia, inhalation
267467|NCT02534285|Hearing|hearing
267468|NCT02534285|Noise, Occupational|noise, occupational
267469|NCT02534246|Core tissue biopsy|core tissue biopsy
267470|NCT02534246|Core needle biopsy|core needle biopsy
267471|NCT02534246|EUS|eus
267472|NCT02534246|Fine needle biopsy|fine needle biopsy
267473|NCT02534246|Fine needle aspiration|fine needle aspiration
267474|NCT02534233|barrett's esophagus with dysplasia|barrett's esophagus with dysplasia
267475|NCT02534233|early esophageal cancer|early esophageal cancer
267476|NCT02534220|Toothbrushing|toothbrushing
267477|NCT02534220|Oral hygiene|oral hygiene
267478|NCT02534220|Dental hygiene|dental hygiene
267479|NCT02534194|Gestation|gestation
267480|NCT02534194|Premature|premature
267481|NCT02534194|Infants|infants
267482|NCT02534181|Refeeding Syndrome|refeeding syndrome
267483|NCT02534181|Cancer|cancer
267484|NCT02534168|genetic polymorphisms|genetic polymorphisms
267485|NCT02534155|MitraClip®|mitraclip®
267486|NCT02534155|MR|mr
267487|NCT02534155|DMR|dmr
267488|NCT02534155|high-risk patients|high-risk patients
267489|NCT02534155|mitral regurgitation|mitral regurgitation
267490|NCT02534155|surgery|surgery
267491|NCT02534155|intermediate risk patients|intermediate risk patients
267492|NCT02534129|breast cancer|breast cancer
267493|NCT02534129|radiation|radiation
267494|NCT02534129|dermatitis|dermatitis
267495|NCT02534116|abdominal reconstruction|abdominal reconstruction
267496|NCT02534090|Premature|premature
267497|NCT02534090|Preterm|preterm
267498|NCT02534090|Necrotizing|necrotizing
267499|NCT02534090|Enterocolitis|enterocolitis
267500|NCT02534090|NIRS|nirs
267501|NCT02534077|omegaven|omegaven
267502|NCT02534077|cholestasis|cholestasis
267503|NCT02534077|parenteral nutrition associated liver disease|parenteral nutrition associated liver disease
267504|NCT02534064|Menopause|menopause
267505|NCT02534064|Osteoporosis|osteoporosis
267506|NCT02534064|Hip fractures|hip fractures
267507|NCT02534064|vitamin D deficiency|vitamin d deficiency
267508|NCT02534051|clinical care path|clinical care path
267509|NCT02534051|care pathway|care pathway
267510|NCT02534051|obesity|obesity
267511|NCT02534051|pregnancy|pregnancy
267512|NCT02534038|Disinhibition|disinhibition
267513|NCT02533986|Berry|berry
267514|NCT02533986|Inflammation|inflammation
267515|NCT02533986|Cognition|cognition
267516|NCT02533986|Polyphenols|polyphenols
267517|NCT02533986|Appetite|appetite
267518|NCT02533986|Glucose metabolism|glucose metabolism
267519|NCT02533960|Registry of Acute Stroke Under Novel Oral Anticoagulants|registry of acute stroke under novel oral anticoagulants
267520|NCT02533947|Allogeneic Stem Cell Transplantation|allogeneic stem cell transplantation
267521|NCT02533947|Hematological Malignancies|hematological malignancies
267522|NCT02533947|Exercise Intervention|exercise intervention
267523|NCT02533947|Cognitive Function|cognitive function
267525|NCT02533947|Randomized Controlled Trial|randomized controlled trial
267526|NCT02533934|HIV|hiv
267527|NCT02533934|Hepatitis C|hepatitis c
267528|NCT02533934|Liver Disease|liver disease
267529|NCT02533934|HCV Treatment|hcv treatment
267530|NCT02533934|transplant|transplant
267531|NCT02533921|Palliative Care|palliative care
267532|NCT02533921|Parkinson's Disease|parkinson's disease
267533|NCT02533869|low-dose computed tomography|low-dose computed tomography
267534|NCT02533817|Fructose|fructose
267535|NCT02533817|Insulin|insulin
267536|NCT02533817|Postprandial lipemia|postprandial lipemia
267537|NCT02533817|Ambulatory blood pressure|ambulatory blood pressure
267538|NCT02533817|Ethnicity|ethnicity
267539|NCT02533804|health|health
267540|NCT02533804|wellness|wellness
267541|NCT02533804|life expectancy|life expectancy
267542|NCT02533804|quality of life|quality of life
267543|NCT02533804|performance|performance
267544|NCT02533804|religion|religion
267545|NCT02533804|skin|skin
267546|NCT02533804|cardiovascular|cardiovascular
267547|NCT02533804|joints|joints
267548|NCT02533804|bone|bone
267549|NCT02533804|respiration|respiration
267550|NCT02533804|pain|pain
267551|NCT02533804|nervous system diseases|nervous system diseases
267552|NCT02533804|oral health|oral health
267553|NCT02533804|behavior|behavior
267554|NCT02533804|child|child
267555|NCT02533804|depression|depression
267556|NCT02533804|mood|mood
267557|NCT02533804|panic|panic
267558|NCT02533804|sleep|sleep
267559|NCT02533804|stress|stress
267560|NCT02533804|nutrition|nutrition
267561|NCT02533804|exercise|exercise
267562|NCT02533804|life change events|life change events
267563|NCT02533804|personality|personality
267564|NCT02533804|employment|employment
267565|NCT02533804|social networking|social networking
267566|NCT02533804|time management|time management
267567|NCT02533804|residence characteristics|residence characteristics
267568|NCT02533791|Safety|safety
267569|NCT02533791|immunogenicity|immunogenicity
267570|NCT02533791|Ebola vaccine|ebola vaccine
267571|NCT02533791|boosting|boosting
267572|NCT02533765|Cisplatin-resistant|cisplatin-resistant
267573|NCT02533765|Neoplasms, Germ Cell and Embryonal|neoplasms, germ cell and embryonal
267574|NCT02533765|Salvage treatment|salvage treatment
267575|NCT02533765|olaparib|olaparib
267576|NCT02533752|Left Atrial Appendage Closure|left atrial appendage closure
267577|NCT02533752|Watchman device|watchman device
267578|NCT02533752|LAA Closure|laa closure
267579|NCT02533726|Bed Sores|bed sores
267580|NCT02533726|Bedsores|bedsores
267581|NCT02533726|Decubitus Ulcer|decubitus ulcer
267582|NCT02533726|Pressure Sore|pressure sore
267583|NCT02533713|rehabilitation|rehabilitation
267584|NCT02533713|bone strength|bone strength
267585|NCT02533713|quality of life|quality of life
267586|NCT02533687|prostate|prostate
267587|NCT02533687|transurethral resection|transurethral resection
267588|NCT02533687|bipolar|bipolar
267589|NCT02533687|monopolar|monopolar
267590|NCT02533661|Effectiveness|effectiveness
267591|NCT02533661|Genes|genes
267592|NCT02533661|Intervention|intervention
267593|NCT02533661|Neurodevelopment|neurodevelopment
267594|NCT02533661|Prematurity|prematurity
267595|NCT02533661|Preschool Age|preschool age
267596|NCT02533648|Type 2 diabetes mellitus, oxidative stress|type 2 diabetes mellitus, oxidative stress
267597|NCT02533648|insulin sensitivity|insulin sensitivity
267598|NCT02533648|insulin resistance|insulin resistance
267599|NCT02533648|mitochondrial dysfunction|mitochondrial dysfunction
267600|NCT02533648|skeletal muscle|skeletal muscle
267601|NCT02533648|xanthine oxidase|xanthine oxidase
267602|NCT02533648|allopurinol|allopurinol
267603|NCT02533622|progressive mobility|progressive mobility
267604|NCT02533583|pulse oximetry|pulse oximetry
267605|NCT02533583|clinical assessment|clinical assessment
267606|NCT02533583|neonate|neonate
267607|NCT02533583|lung disease|lung disease
267608|NCT02533570|Lupus|lupus
267609|NCT02533557|brachial plexus block|brachial plexus block
267610|NCT02533557|nerve stimulator|nerve stimulator
267611|NCT02533557|ultrasound|ultrasound
267612|NCT02533544|tenofovir disoproxil fumarate|tenofovir disoproxil fumarate
267613|NCT02533505|Respiratory|respiratory
267614|NCT02533505|COPD|copd
267615|NCT02533505|O2 Consumption|o2 consumption
267616|NCT02533492|total knee replacement|total knee replacement
267617|NCT02533492|vicryl plus|vicryl plus
267618|NCT02533492|surgical site infection|surgical site infection
267619|NCT02533453|Type 2 Diabetes Mellitus, T2DM, GLP-1, GLP-1 Once weekly, Exenatide|type 2 diabetes mellitus, t2dm, glp-1, glp-1 once weekly, exenatide
267620|NCT02533414|kidney stone|kidney stone
267621|NCT02533414|retrograde intrarenal surgery|retrograde intrarenal surgery
267622|NCT02533414|ureteral access sheath|ureteral access sheath
267623|NCT02533414|kidney function|kidney function
267624|NCT02533388|transcutaneous electrical acupoint stimulation|transcutaneous electrical acupoint stimulation
267625|NCT02533388|stress response|stress response
267626|NCT02533375|efficacy|efficacy
267627|NCT02533375|safety|safety
267628|NCT02533349|laryngopharyngeal reflux disease|laryngopharyngeal reflux disease
267629|NCT02533349|prokinetics|prokinetics
267630|NCT02533349|proton pump inhibitor|proton pump inhibitor
267631|NCT02533336|Malaria control|malaria control
267880|NCT02532023|IL-6|il-6
267632|NCT02533336|Insecticide treated durable Wall Liners|insecticide treated durable wall liners
267633|NCT02533336|Malaria incidence|malaria incidence
267634|NCT02533336|Randomized Trial|randomized trial
267635|NCT02533323|NK/T-cell lymphoma|nk/t-cell lymphoma
267636|NCT02533323|induction chemotherapy|induction chemotherapy
267637|NCT02533323|survival|survival
267638|NCT02533310|Specific phobia|specific phobia
267639|NCT02533310|Exposure therapy|exposure therapy
267640|NCT02533310|Virtual reality|virtual reality
267641|NCT02533310|Randomized controlled trial|randomized controlled trial
267642|NCT02533297|standardization,|standardization,
267643|NCT02533297|performance clinical skills|performance clinical skills
267644|NCT02533297|nursing|nursing
267645|NCT02533297|learning curve|learning curve
267646|NCT02533271|rectal cancer|rectal cancer
267647|NCT02533271|short-term radiotherapy|short-term radiotherapy
267648|NCT02533271|neoadjuvant chemotherapy|neoadjuvant chemotherapy
267649|NCT02533271|total mesorectal excision|total mesorectal excision
267650|NCT02533258|advanced renal cell carcinoma, disease progression, sunitinib, interferon alpha|advanced renal cell carcinoma, disease progression, sunitinib, interferon alpha
739554|NCT00476151|DPN|dpn
267651|NCT02533245|Exercise Training|exercise training
267652|NCT02533245|Quality of Life|quality of life
267653|NCT02533245|Patient Reported Outcomes|patient reported outcomes
267654|NCT02533245|Organ Transplantation|organ transplantation
267655|NCT02533232|Schizophrenia|schizophrenia
267656|NCT02533232|Anti-inflammatory|anti-inflammatory
267657|NCT02533232|Clozapine|clozapine
267658|NCT02533232|Minocycline|minocycline
267659|NCT02533232|Psychosis NOS|psychosis nos
267660|NCT02533219|Hyperinsulinemic hypoglycemia|hyperinsulinemic hypoglycemia
267661|NCT02533219|PET/CT|pet/ct
267662|NCT02533219|PET/MRI|pet/mri
267663|NCT02533219|[18F]-DOPA|[18f]-dopa
267664|NCT02533219|PET/MR|pet/mr
267665|NCT02533219|Congenital Hyperinsulinism|congenital hyperinsulinism
267666|NCT02533193|enhanced recovery after surgery protocal|enhanced recovery after surgery protocal
267667|NCT02533193|laparoscopic hepatectomy|laparoscopic hepatectomy
267668|NCT02533180|Liver allograft recipient|liver allograft recipient
267669|NCT02533180|Immunosuppression withdrawal|immunosuppression withdrawal
267670|NCT02533180|Calcineurin inhibitor (CNI) based immunosuppression|calcineurin inhibitor (cni) based immunosuppression
267671|NCT02533180|Living Donor (of the Respective Liver Transplant Recipient)|living donor (of the respective liver transplant recipient)
267672|NCT02533141|Investigation of the changes of flicker induced vasodilatation before, during and after withdrawal of therapy with simvastatin|investigation of the changes of flicker induced vasodilatation before, during and after withdrawal of therapy with simvastatin
267673|NCT02533128|Intraoperative blood pressure|intraoperative blood pressure
267674|NCT02533128|Triple low|triple low
267675|NCT02533128|Anesthetic overdose|anesthetic overdose
267676|NCT02533128|Major adverse cardiac events (MACE)|major adverse cardiac events (mace)
267677|NCT02533128|Myocardial injury after noncardiac surgery (MINS)|myocardial injury after noncardiac surgery (mins)
267678|NCT02533128|Perioperative risk stratification|perioperative risk stratification
267679|NCT02533128|Brain-type natriuretic peptide (BNP)|brain-type natriuretic peptide (bnp)
267680|NCT02533128|High-sensitivity cardiac Troponin I (hs-cTnI)|high-sensitivity cardiac troponin i (hs-ctni)
267681|NCT02533115|VYXEOS|vyxeos
267682|NCT02533102|Pharmacokinetics|pharmacokinetics
267683|NCT02533102|E7050|e7050
267684|NCT02533102|Healthy Subjects|healthy subjects
267685|NCT02533050|obstructive sleep apnea|obstructive sleep apnea
267686|NCT02533050|acute coronary event|acute coronary event
267687|NCT02533050|cognitive functions|cognitive functions
267688|NCT02533050|Continuous positive airway pressure night|continuous positive airway pressure night
267689|NCT02533011|Sepsis|sepsis
267690|NCT02533011|Heparin Binding Protein|heparin binding protein
267691|NCT02532998|Pharmacodynamics|pharmacodynamics
267692|NCT02532998|AZD9977|azd9977
267693|NCT02532998|Safety|safety
267694|NCT02532998|Tolerability|tolerability
267695|NCT02532998|Pharmacokinetics|pharmacokinetics
267696|NCT02532998|Eplerenone|eplerenone
267697|NCT02532998|Fludrocortisone|fludrocortisone
267698|NCT02532985|Gastrointestinal tolerability|gastrointestinal tolerability
267699|NCT02532985|dietary fiber|dietary fiber
267700|NCT02532985|clinical trial|clinical trial
267701|NCT02532985|healthy subjects|healthy subjects
267702|NCT02532933|Replacement, Knee|replacement, knee
267703|NCT02532920|Natural history|natural history
267704|NCT02532920|Atopic dermatitis|atopic dermatitis
267705|NCT02532920|Atopic march|atopic march
267706|NCT02532907|HCV|hcv
267707|NCT02532894|endothelial dysfunction|endothelial dysfunction
267708|NCT02532894|microvesicles|microvesicles
267709|NCT02532894|endothelial progenitor cells|endothelial progenitor cells
267710|NCT02532894|electronic cigarettes|electronic cigarettes
267711|NCT02532842|Schizophrenia|schizophrenia
267712|NCT02532842|Paliperidone palmitate|paliperidone palmitate
267713|NCT02532816|stunting|stunting
267714|NCT02532816|indonesia|indonesia
267715|NCT02532803|Cancer|cancer
267716|NCT02532803|Rectum|rectum
267717|NCT02532803|Rectal Cancer|rectal cancer
267718|NCT02532803|Polyps|polyps
267719|NCT02532790|Mild proteinuria|mild proteinuria
267720|NCT02532764|cystic fibrosis|cystic fibrosis
267721|NCT02532764|ΔF508|δf508
267722|NCT02532764|RNA therapies|rna therapies
267723|NCT02532764|antisense oligonucleotide|antisense oligonucleotide
267724|NCT02532764|CFTR|cftr
267725|NCT02532764|F508del|f508del
267726|NCT02532764|CF|cf
267727|NCT02532764|RNA therapy|rna therapy
267728|NCT02532738|efficacy of MSC|efficacy of msc
267729|NCT02532738|refractory|refractory
267730|NCT02532725|heat stress response|heat stress response
267731|NCT02532725|cardiopulmonary exercise test|cardiopulmonary exercise test
267732|NCT02532725|men|men
267733|NCT02532725|middle aged|middle aged
267734|NCT02532725|heat-shock response|heat-shock response
267735|NCT02532712|EC-18|ec-18
267736|NCT02532712|Hematology|hematology
267737|NCT02532712|Cancer|cancer
267738|NCT02532712|Neutropenia|neutropenia
267739|NCT02532699|Antrodia cinnamomea mycelia|antrodia cinnamomea mycelia
267740|NCT02532699|blood pressure|blood pressure
267741|NCT02532699|adenosine|adenosine
267742|NCT02532699|antrosterol|antrosterol
267743|NCT02532699|clinical trial|clinical trial
739555|NCT00476151|Diabetic|diabetic
267744|NCT02532699|gamma-aminobutyric acid|gamma-aminobutyric acid
267745|NCT02532686|Treatment resistant|treatment resistant
267746|NCT02532686|DAAOI|daaoi
267747|NCT02532686|NMDA|nmda
267748|NCT02532634|ramosetron|ramosetron
267749|NCT02532634|palonosetron|palonosetron
267750|NCT02532634|chemotherapy induced nausea and vomiting|chemotherapy induced nausea and vomiting
267751|NCT02532582|nerve compression|nerve compression
267752|NCT02532530|Aortic valve replacement with or without CABG|aortic valve replacement with or without cabg
267753|NCT02532517|CODMAN ENTERPRISE® Vascular Reconstruction Device|codman enterprise® vascular reconstruction device
267754|NCT02532517|Wide Neck, Intracranial, Saccular Aneurysms|wide neck, intracranial, saccular aneurysms
267755|NCT02532517|Cerebral Aneurysms|cerebral aneurysms
267756|NCT02532504|postnatal depression|postnatal depression
267757|NCT02532504|Cognitive behaviour Therapy|cognitive behaviour therapy
267758|NCT02532504|Traditional Birth Attendants|traditional birth attendants
267759|NCT02532504|low income country|low income country
267760|NCT02532491|Psychosis|psychosis
267761|NCT02532491|Antipsychotic Agents|antipsychotic agents
267762|NCT02532491|Treatment|treatment
267763|NCT02532491|Effectiveness|effectiveness
267764|NCT02532491|Aripiprazole|aripiprazole
267765|NCT02532491|Risperidone|risperidone
267766|NCT02532452|Epstein-Barr Virus (EBV)|epstein-barr virus (ebv)
267767|NCT02532452|Adenovirus (ADV)|adenovirus (adv)
267768|NCT02532452|Cytomegalovirus (CMV)|cytomegalovirus (cmv)
267769|NCT02532452|T-Cells|t-cells
267770|NCT02532452|Donor|donor
267771|NCT02532452|BK virus (BKV)|bk virus (bkv)
267772|NCT02532439|fracture osteoporosis|fracture osteoporosis
267773|NCT02532439|bone microarchitecture|bone microarchitecture
267774|NCT02532439|Inflammatory joint diseases|inflammatory joint diseases
267775|NCT02532439|Bone fragility|bone fragility
267776|NCT02532439|Rheumatoid Arthritis|rheumatoid arthritis
267777|NCT02532439|Spondyloarthritis|spondyloarthritis
267778|NCT02532439|Primary Hyperparathyroidism|primary hyperparathyroidism
267779|NCT02532439|constitutional thinness|constitutional thinness
267780|NCT02532439|anorexia nervosa|anorexia nervosa
267781|NCT02532426|Chronic Obstructive Pulmonary Disease|chronic obstructive pulmonary disease
267782|NCT02532426|Muscle biopsy|muscle biopsy
267783|NCT02532426|Chronic hypoxia|chronic hypoxia
267784|NCT02532426|OXYPHEN|oxyphen
267785|NCT02532426|Oxydative phenotype|oxydative phenotype
267786|NCT02532426|Exercise|exercise
267787|NCT02532400|Breast Neoplasms|breast neoplasms
267788|NCT02532400|Neoadjuvant Endocrine Therapy|neoadjuvant endocrine therapy
267789|NCT02532400|Ovarian Function Suppression|ovarian function suppression
267790|NCT02532400|Neoadjuvant chemotherapy|neoadjuvant chemotherapy
267791|NCT02532374|nicotine absorption|nicotine absorption
267792|NCT02532374|nicotine containing product|nicotine containing product
267793|NCT02532374|adult smoker|adult smoker
267794|NCT02532374|Nicorette|nicorette
267795|NCT02532374|nicotine delivery system|nicotine delivery system
267796|NCT02532361|Sterilization|sterilization
267797|NCT02532361|Hysteroscopic Device Placement|hysteroscopic device placement
267798|NCT02532361|Tubal Ligation|tubal ligation
267799|NCT02532348|Human Immunodeficiency Virus|human immunodeficiency virus
267800|NCT02532348|HIV|hiv
267801|NCT02532348|antiretroviral therapy|antiretroviral therapy
267802|NCT02532348|platelets|platelets
267803|NCT02532348|Immune activation|immune activation
267804|NCT02532348|Inflammatory state|inflammatory state
267805|NCT02532335|FXR|fxr
267806|NCT02532335|bile acids|bile acids
267807|NCT02532335|FGF19|fgf19
267808|NCT02532335|C4|c4
267809|NCT02532335|gut microbiota|gut microbiota
267810|NCT02532335|Pharmacodynamics of FXR activation in the small bowel|pharmacodynamics of fxr activation in the small bowel
267811|NCT02532309|Rosuvastatin|rosuvastatin
267812|NCT02532309|Carotid Atherosclerosis plaque|carotid atherosclerosis plaque
267813|NCT02532309|Crestor|crestor
267814|NCT02532309|Rosuvastatin calcium|rosuvastatin calcium
267815|NCT02532283|Influenza A virus|influenza a virus
267816|NCT02532283|JNJ-63623872|jnj-63623872
267817|NCT02532283|Oseltamivir|oseltamivir
267818|NCT02532270|obstetric|obstetric
267819|NCT02532270|anesthesia|anesthesia
267820|NCT02532270|hypotension|hypotension
267821|NCT02532270|arterial pressure|arterial pressure
267822|NCT02532270|measurement techniques|measurement techniques
267823|NCT02532244|distal hereditary motor neuronopathy|distal hereditary motor neuronopathy
267824|NCT02532192|Lymphoma|lymphoma
267825|NCT02532192|Diffuse large B-cell lymphoma|diffuse large b-cell lymphoma
267826|NCT02532192|DLBCL|dlbcl
267827|NCT02532192|Relapsed|relapsed
267828|NCT02532192|Refractory|refractory
267829|NCT02532192|Belinostat|belinostat
267830|NCT02532192|Rituximab|rituximab
267831|NCT02532192|Rituxan|rituxan
267832|NCT02532192|Cisplatin|cisplatin
267833|NCT02532192|Platinol-AQ|platinol-aq
267834|NCT02532192|Platinol|platinol
267835|NCT02532192|CDDP|cddp
267836|NCT02532192|Cytarabine|cytarabine
267837|NCT02532192|Ara-C|ara-c
267838|NCT02532192|Cytosar|cytosar
267839|NCT02532192|DepoCyt|depocyt
712538|NCT00579787|quality of life assessment|quality of life assessment
267840|NCT02532192|Cytosine arabinosine hydrochloride|cytosine arabinosine hydrochloride
267841|NCT02532192|Dexamethasone|dexamethasone
267842|NCT02532192|Decadron|decadron
267843|NCT02532192|Ciprofloxacin|ciprofloxacin
267844|NCT02532192|Ciprofloxacin hydrochloride|ciprofloxacin hydrochloride
267845|NCT02532192|Cipro|cipro
267846|NCT02532192|Fluconazole|fluconazole
267847|NCT02532192|Diflucan|diflucan
267848|NCT02532179|subcutaneous immunotherapy (SCIT)|subcutaneous immunotherapy (scit)
267849|NCT02532179|glycerinated mouse allergenic extract|glycerinated mouse allergenic extract
267850|NCT02532179|mouse specific IgE|mouse specific ige
267851|NCT02532179|mouse specific IgG and IgG4|mouse specific igg and igg4
267852|NCT02532179|mouse prick skin test wheal|mouse prick skin test wheal
267853|NCT02532166|narrow band imaging|narrow band imaging
267854|NCT02532166|Chromoendoscopy|chromoendoscopy
267855|NCT02532166|Lugol|lugol
267856|NCT02532153|Suicidal Ideation|suicidal ideation
267857|NCT02532153|Suicide|suicide
267858|NCT02532153|Suicidal Thoughts|suicidal thoughts
267859|NCT02532153|Depression|depression
267860|NCT02532153|Ketamine|ketamine
267861|NCT02532127|Low-dose risk|low-dose risk
267862|NCT02532075|COPD|copd
267863|NCT02532075|Respiratory Muscle Warm Up|respiratory muscle warm up
267864|NCT02532062|lung cancer risk|lung cancer risk
267865|NCT02532062|cigarette smokers|cigarette smokers
267866|NCT02532049|Malaria|malaria
267867|NCT02532049|Vaccine|vaccine
267868|NCT02532049|Immune Response|immune response
267869|NCT02532036|MVA85A|mva85a
267870|NCT02532036|Tuberculosis|tuberculosis
267871|NCT02532036|Vaccine|vaccine
267872|NCT02532036|Aerosol|aerosol
267873|NCT02532023|omega 3 fatty acid|omega 3 fatty acid
267874|NCT02532023|curcumin|curcumin
267875|NCT02532023|COX-2|cox-2
267876|NCT02532023|iNOs|inos
267877|NCT02532023|VCAM-1|vcam-1
267878|NCT02532023|ICAM-1|icam-1
267879|NCT02532023|IL-1β|il-1β
267881|NCT02532023|TNF-α|tnf-α
267882|NCT02532023|hsCRP|hscrp
267883|NCT02532023|migraine|migraine
267884|NCT02531997|self-image|self-image
267885|NCT02531997|sexual health|sexual health
267886|NCT02531997|breast cancer|breast cancer
267887|NCT02531997|gynecologic cancer|gynecologic cancer
267888|NCT02531997|ovarian cancer|ovarian cancer
267889|NCT02531997|cervical cancer|cervical cancer
267890|NCT02531997|uterine cancer|uterine cancer
267891|NCT02531997|mind body|mind body
267892|NCT02531997|hypnotic relaxation therapy|hypnotic relaxation therapy
267893|NCT02531997|hypnosis|hypnosis
267894|NCT02531997|progressive muscle relaxation|progressive muscle relaxation
267895|NCT02531971|Bioequivalence|bioequivalence
267896|NCT02531971|Therapeutic Equivalency|therapeutic equivalency
267897|NCT02531945|topography|topography
267898|NCT02531945|cobb angle|cobb angle
267899|NCT02531932|advanced triple negative breast cancer|advanced triple negative breast cancer
267900|NCT02531919|tumor acidity|tumor acidity
267901|NCT02531893|Irritability|irritability
267902|NCT02531893|Disruptive Mood|disruptive mood
267903|NCT02531893|Tantrums|tantrums
267904|NCT02531893|Frustration|frustration
267905|NCT02531893|Interpretation Bias|interpretation bias
267906|NCT02531893|Emotional Judgment|emotional judgment
267907|NCT02531893|Cognitive-Behavioral|cognitive-behavioral
267908|NCT02531893|Exposure|exposure
267909|NCT02531893|Research Psychotherapy|research psychotherapy
267910|NCT02531880|MRI|mri
267911|NCT02531880|Manganese Enhanced MRI|manganese enhanced mri
267912|NCT02531880|Seizure Disorder|seizure disorder
267913|NCT02531880|Seizures|seizures
267914|NCT02531880|Epileptic Focus|epileptic focus
267916|NCT02531867|Bone Disease|bone disease
267917|NCT02531867|Soft Bones|soft bones
267918|NCT02531867|Low Alkaline Phosphatase|low alkaline phosphatase
267919|NCT02531867|Genetic Metabolic Disorder|genetic metabolic disorder
267920|NCT02531867|Alkaline Phosphatase|alkaline phosphatase
267921|NCT02531867|Rickets|rickets
267922|NCT02531867|Osteomalacia|osteomalacia
267923|NCT02531815|safety|safety
267924|NCT02531815|tolerability|tolerability
267925|NCT02531815|pharmacokinetics|pharmacokinetics
267926|NCT02531815|pharmacodynamics|pharmacodynamics
267927|NCT02531815|Phase 1|phase 1
267928|NCT02531815|first in human|first in human
267929|NCT02531815|monoclonal antibody|monoclonal antibody
267930|NCT02531815|tissue factor pathway inhibitor|tissue factor pathway inhibitor
267931|NCT02531815|japanese|japanese
267932|NCT02531802|ETEC diarrhea|etec diarrhea
267933|NCT02531802|Escherichia Coli (ETEC)|escherichia coli (etec)
267934|NCT02531776|Diabetes|diabetes
267935|NCT02531776|Needle|needle
267936|NCT02531776|Pen needle|pen needle
267937|NCT02531763|mHealth|mhealth
267938|NCT02531763|behavioral economics|behavioral economics
267939|NCT02531763|social incentives|social incentives
267940|NCT02531750|Metabolism|metabolism
267941|NCT02531750|Bone metabolism|bone metabolism
267942|NCT02531750|Glucose Metabolism|glucose metabolism
267943|NCT02531750|Lipid metabolism|lipid metabolism
267944|NCT02531750|Low grade inflamation|low grade inflamation
267945|NCT02531724|acute kidney injury|acute kidney injury
267946|NCT02531724|cardiac surgery|cardiac surgery
267947|NCT02531724|renal blood flow|renal blood flow
267948|NCT02531724|levosimendan|levosimendan
267949|NCT02531711|Lumbosacral|lumbosacral
267950|NCT02531711|radicular|radicular
267951|NCT02531685|dmLT|dmlt
267952|NCT02531685|Enteric|enteric
267953|NCT02531685|Escherichia coli Infections|escherichia coli infections
267954|NCT02531685|Shigella|shigella
267955|NCT02531685|Toxin LTR192G/L211A|toxin ltr192g/l211a
267956|NCT02531672|11C-choline|11c-choline
267957|NCT02531672|Positron Emission Tomography|positron emission tomography
267958|NCT02531672|15-117|15-117
267959|NCT02531646|pulmonary nodule|pulmonary nodule
267960|NCT02531633|Giant Cell Arteritis, Sirukumab, Prednisone|giant cell arteritis, sirukumab, prednisone
267961|NCT02531620|prehabilitation|prehabilitation
267962|NCT02531620|colorectal surgery|colorectal surgery
267963|NCT02531555|chronic periodontitis|chronic periodontitis
267964|NCT02531555|dental scaling|dental scaling
267965|NCT02531555|gingival crevicular fluid|gingival crevicular fluid
267966|NCT02531555|lasers|lasers
267967|NCT02531555|periodontal pocket|periodontal pocket
267968|NCT02531555|root planing|root planing
267969|NCT02531516|Prostatic neoplasms|prostatic neoplasms
267970|NCT02531516|Prostate Cancer|prostate cancer
267971|NCT02531516|High-Risk prostate cancer|high-risk prostate cancer
267972|NCT02531516|JNJ-56021927|jnj-56021927
267973|NCT02531516|Apalutamide|apalutamide
267974|NCT02531516|ATLAS|atlas
267975|NCT02531516|Radiation|radiation
267976|NCT02531516|Long-term hormone therapy|long-term hormone therapy
267977|NCT02531516|Localized or locally advanced prostate cancer|localized or locally advanced prostate cancer
267978|NCT02531516|Janssen|janssen
267979|NCT02531503|Asthma remission|asthma remission
267980|NCT02531503|Predicting factors|predicting factors
267981|NCT02531503|Children|children
267982|NCT02531464|family caregiver|family caregiver
267983|NCT02531464|quality of life|quality of life
267984|NCT02531464|supportive care|supportive care
267985|NCT02531464|distress screening|distress screening
267986|NCT02531464|needs assessment|needs assessment
267987|NCT02531451|Muscle mass|muscle mass
267988|NCT02531451|strength|strength
267989|NCT02531451|NSAID|nsaid
267990|NCT02531451|Ibuprofen|ibuprofen
267991|NCT02531451|resistance exercise|resistance exercise
267992|NCT02531425|TNBC|tnbc
267993|NCT02531425|Triple Negative Breast Cancer|triple negative breast cancer
267994|NCT02531412|Acute kidney injury|acute kidney injury
267995|NCT02531412|Critically ill cancer patients|critically ill cancer patients
267996|NCT02531412|Spironolactone|spironolactone
267997|NCT02531399|flicker induced changes|flicker induced changes
267998|NCT02531399|total volumetric retinal blood flow|total volumetric retinal blood flow
267999|NCT02531308|diffuse large b-cell lymphoma (DLBCL),|diffuse large b-cell lymphoma (dlbcl),
268000|NCT02531308|lymphoma|lymphoma
268001|NCT02531282|Patient education as topic|patient education as topic
268002|NCT02531282|Health promotion|health promotion
268003|NCT02531282|Patient participation|patient participation
268004|NCT02531282|Self efficacy|self efficacy
268005|NCT02531256|Laryngeal Mask Airway|laryngeal mask airway
268006|NCT02531243|prodrome|prodrome
268007|NCT02531243|family therapy|family therapy
268008|NCT02531243|clinical high risk|clinical high risk
268009|NCT02531204|ASP1585|asp1585
268010|NCT02531204|Bioequivalence|bioequivalence
268011|NCT02531204|Pharmacodynamic|pharmacodynamic
268012|NCT02531204|Phosphate binder|phosphate binder
268014|NCT02531204|urinary phosphorus excretion|urinary phosphorus excretion
268015|NCT02531191|ASP015K|asp015k
268016|NCT02531191|bioequivalence study|bioequivalence study
268017|NCT02531191|JAK inhibitor|jak inhibitor
268018|NCT02531178|Rheumatoid Arthritis|rheumatoid arthritis
268019|NCT02531139|Cerebrovascular Circulation|cerebrovascular circulation
268020|NCT02531139|Anesthesia|anesthesia
268021|NCT02531139|Blood pressure|blood pressure
268022|NCT02531139|Peripheral Arterial Diseases|peripheral arterial diseases
268023|NCT02531074|Mobile Applications|mobile applications
268024|NCT02531061|Rheumatoid Arthritis|rheumatoid arthritis
268025|NCT02531061|bDMARDs|bdmards
268026|NCT02531061|biotherapy|biotherapy
268027|NCT02531061|remission|remission
268028|NCT02531061|erosion|erosion
268029|NCT02531048|healthy volunteers|healthy volunteers
268030|NCT02530957|Intubation|intubation
268031|NCT02530957|Preoxygenation|preoxygenation
268032|NCT02530957|Complications|complications
268033|NCT02530957|Non invasive ventilation|non invasive ventilation
268034|NCT02530957|High flow nasal cannula|high flow nasal cannula
268035|NCT02530944|Lupus|lupus
268036|NCT02530944|Systemic Lupus Erythematosus (SLE)|systemic lupus erythematosus (sle)
268037|NCT02530944|genetic|genetic
268038|NCT02530944|online|online
268039|NCT02530944|genome wide association|genome wide association
268040|NCT02530944|systemic lupus erythematosus|systemic lupus erythematosus
268041|NCT02530944|genome wide association study (GWAS)|genome wide association study (gwas)
268042|NCT02530918|DS-7080a Monoclonal Antibody|ds-7080a monoclonal antibody
268043|NCT02530905|Duchenne muscular dystrophy|duchenne muscular dystrophy
268044|NCT02530905|Exon Skipping|exon skipping
268045|NCT02530892|embryo|embryo
268046|NCT02530892|in vitro fertilization|in vitro fertilization
268048|NCT02530840|imbalanced diabetic patients|imbalanced diabetic patients
268049|NCT02530840|HbA1c|hba1c
268050|NCT02530840|peers|peers
268051|NCT02530827|energy expenditure|energy expenditure
268052|NCT02530827|doubly labeled water|doubly labeled water
268053|NCT02530827|accelerometer|accelerometer
268054|NCT02530827|HIV|hiv
268055|NCT02530827|lipodystrophy syndrome.|lipodystrophy syndrome.
268056|NCT02530814|organochlorine compounds|organochlorine compounds
268057|NCT02530814|pesticides|pesticides
268058|NCT02530788|Heart Failure|heart failure
268059|NCT02530788|Cardiac Surgery|cardiac surgery
268060|NCT02530788|Ventricular Assist Device|ventricular assist device
268061|NCT02530788|Selenium|selenium
268062|NCT02530762|Gastrointestinal tolerability|gastrointestinal tolerability
268063|NCT02530762|dietary fiber|dietary fiber
268064|NCT02530762|clinical trial|clinical trial
268065|NCT02530762|healthy subjects|healthy subjects
268066|NCT02530749|Surgery|surgery
268067|NCT02530749|Frailty|frailty
268068|NCT02530736|Gait speed|gait speed
268069|NCT02530736|Pulmonary Rehabilitation|pulmonary rehabilitation
268070|NCT02530723|power training|power training
268071|NCT02530723|high-speed training|high-speed training
268072|NCT02530723|high-velocity training|high-velocity training
268073|NCT02530723|function|function
268074|NCT02530723|older adults|older adults
268075|NCT02530723|older women|older women
268076|NCT02530697|Leishmaniasis|leishmaniasis
268077|NCT02530697|Mucocutaneous|mucocutaneous
268078|NCT02530697|Miltefosine|miltefosine
268079|NCT02530697|Pentoxifylline|pentoxifylline
268080|NCT02530671|multi-directional power toothbrush|multi-directional power toothbrush
268081|NCT02530671|manual toothbrush|manual toothbrush
268082|NCT02530658|Genetic Predisposition|genetic predisposition
268083|NCT02530658|Pediatric|pediatric
268084|NCT02530658|Genomic Analysis|genomic analysis
268085|NCT02530658|Heritable Disease|heritable disease
268086|NCT02530658|Cancer Risk|cancer risk
268087|NCT02530658|Genetic Counseling|genetic counseling
268088|NCT02530658|DNA|dna
268089|NCT02530658|Clinical Genomics|clinical genomics
268090|NCT02530658|Clinical Decision-Making|clinical decision-making
268091|NCT02530658|Treatment Planning|treatment planning
268092|NCT02530658|Germline|germline
268093|NCT02530632|microperfusion|microperfusion
268094|NCT02530632|temperature|temperature
268095|NCT02530632|near-infrared spectroscopy|near-infrared spectroscopy
268096|NCT02530632|anesthesia|anesthesia
268097|NCT02530632|total intravenous anaesthesia|total intravenous anaesthesia
268098|NCT02530580|GABA modulator|gaba modulator
268099|NCT02530580|AZD7325|azd7325
268100|NCT02530580|Object manipulation|object manipulation
268101|NCT02530580|Cutaneous sensation|cutaneous sensation
268102|NCT02530580|Manual dexterity|manual dexterity
268103|NCT02530567|portal pressure|portal pressure
268104|NCT02530567|portosystemic pressure gradient|portosystemic pressure gradient
268105|NCT02530567|azygos blood flow|azygos blood flow
268106|NCT02530554|Pilot Projects|pilot projects
268107|NCT02530476|Leukemia|leukemia
268108|NCT02530476|Acute myeloid leukemia|acute myeloid leukemia
268109|NCT02530476|AML|aml
268110|NCT02530476|Relapsed/Refractory|relapsed/refractory
268111|NCT02530476|FLT3-ITD mutation|flt3-itd mutation
268112|NCT02530476|FLT3-mutated high-risk myelodysplastic syndrome|flt3-mutated high-risk myelodysplastic syndrome
268113|NCT02530476|MDS|mds
268114|NCT02530476|Chronic Myelomonocytic Leukemia|chronic myelomonocytic leukemia
268115|NCT02530476|CMML|cmml
268116|NCT02530476|Selinexor|selinexor
268117|NCT02530476|KPT-330|kpt-330
268118|NCT02530476|Sorafenib|sorafenib
268119|NCT02530476|Nexavar|nexavar
268120|NCT02530476|BAY 43-9006|bay 43-9006
268121|NCT02530476|FLT3-inhibitor therapy|flt3-inhibitor therapy
268122|NCT02530463|Leukemia|leukemia
268123|NCT02530463|Myelodysplastic syndrome|myelodysplastic syndrome
268124|NCT02530463|MDS|mds
268125|NCT02530463|Nivolumab|nivolumab
268126|NCT02530463|BMS-936558|bms-936558
268127|NCT02530463|Opdivo|opdivo
268128|NCT02530463|Ipilimumab|ipilimumab
268129|NCT02530463|Yervoy|yervoy
268130|NCT02530463|BMS-734016|bms-734016
268131|NCT02530463|MDX010|mdx010
268132|NCT02530463|5-azacitidine|5-azacitidine
268133|NCT02530463|Azacitidine|azacitidine
268134|NCT02530463|5-AZA|5-aza
268135|NCT02530463|Vidaza|vidaza
268136|NCT02530463|5-AZC|5-azc
268137|NCT02530463|AZA-CR|aza-cr
268138|NCT02530463|Ladakamycin|ladakamycin
268139|NCT02530463|NSC-102816|nsc-102816
268140|NCT02530463|Azacytidine|azacytidine
268141|NCT02530450|children|children
268142|NCT02530450|poor adherence|poor adherence
268143|NCT02530450|continuous glucose monitoring|continuous glucose monitoring
268144|NCT02530424|HER2-positive|her2-positive
268145|NCT02530424|ER-positive|er-positive
268146|NCT02530424|invasive|invasive
268147|NCT02530424|CDK4,6|cdk4,6
268148|NCT02530424|Palbociclib|palbociclib
268149|NCT02530424|neoadjuvant treatment|neoadjuvant treatment
268150|NCT02530411|Hormone resistance|hormone resistance
268151|NCT02530411|vandetanib|vandetanib
268152|NCT02530411|fulvestrant|fulvestrant
268153|NCT02530359|septic acute kidney injury|septic acute kidney injury
268154|NCT02530359|pirfenidone|pirfenidone
268155|NCT02530320|Palbociclib|palbociclib
268156|NCT02530320|oligodendroglioma|oligodendroglioma
268157|NCT02530320|oligoastrocytoma anaplastic|oligoastrocytoma anaplastic
268158|NCT02530307|Stroke,|stroke,
268159|NCT02530307|Rehabilitation|rehabilitation
268160|NCT02530307|Ischemic|ischemic
268161|NCT02530307|fMRI|fmri
268162|NCT02530268|psoriatic arthritis|psoriatic arthritis
268163|NCT02530268|spondyloarthritis|spondyloarthritis
268164|NCT02530268|disease registry|disease registry
268165|NCT02530255|retinal amyloid|retinal amyloid
268166|NCT02530255|Retinal amyloid index|retinal amyloid index
268167|NCT02530255|Alzheimer disease|alzheimer disease
268168|NCT02530255|telomere attrition|telomere attrition
268169|NCT02530255|telomere activation|telomere activation
268170|NCT02530242|Sickle Cell Anemia|sickle cell anemia
268171|NCT02530229|periprosthetic joint infection|periprosthetic joint infection
268172|NCT02530229|septic arthritis|septic arthritis
268173|NCT02530203|post-operative atrial fibrillation|post-operative atrial fibrillation
268174|NCT02530203|spinal cord stimulation|spinal cord stimulation
268175|NCT02530203|CABG|cabg
268176|NCT02530177|Alopecia|alopecia
268177|NCT02530177|Skin Aging|skin aging
268178|NCT02530177|Nail Changes|nail changes
268179|NCT02530177|Hair Changes|hair changes
268180|NCT02530177|15-198|15-198
268181|NCT02530164|tDCS|tdcs
268182|NCT02530164|SSRI|ssri
268183|NCT02530151|Hip arthroscopy|hip arthroscopy
268184|NCT02530151|Intra-articular injection|intra-articular injection
268185|NCT02530151|Morphine|morphine
268186|NCT02530151|Clonidine|clonidine
268187|NCT02530073|congenital diaphragmatic hernia|congenital diaphragmatic hernia
268188|NCT02530073|FETO|feto
268189|NCT02530073|tracheal occlusion|tracheal occlusion
268190|NCT02530060|Healthy|healthy
268191|NCT02530060|Rilpivirine|rilpivirine
268192|NCT02530060|Tenofovir|tenofovir
268193|NCT02530060|Emtricitabine|emtricitabine
268194|NCT02530060|Tenofovir Disoproxil Fumarate|tenofovir disoproxil fumarate
268195|NCT02530047|Ovarian cancer|ovarian cancer
268196|NCT02530047|Epithelial ovarian cancer|epithelial ovarian cancer
268197|NCT02530047|Mesenchymal Stem Cells Secreting Interferon Beta|mesenchymal stem cells secreting interferon beta
268198|NCT02530047|MSC-INFb|msc-infb
268199|NCT02530047|Questionnaires|questionnaires
268200|NCT02530047|Surveys|surveys
268201|NCT02530021|Ischemic heart disease|ischemic heart disease
268202|NCT02530021|Heart rate variability|heart rate variability
268203|NCT02530021|Exercise Strss Test|exercise strss test
268204|NCT02529956|Psoriasis|psoriasis
268205|NCT02529956|UCB4940|ucb4940
268206|NCT02529943|Spinal Stenosis|spinal stenosis
268207|NCT02529943|Motor Evoked Potential|motor evoked potential
268208|NCT02529930|HSIL|hsil
268209|NCT02529930|CIN 2/3|cin 2/3
268210|NCT02529930|Therapeutic DNA vaccine|therapeutic dna vaccine
268211|NCT02529930|Human Papillomavirus|human papillomavirus
268212|NCT02529930|Immunotherapy|immunotherapy
268213|NCT02529891|Chronic Obstructive Pulmonary Disease|chronic obstructive pulmonary disease
268214|NCT02529891|COPD|copd
268215|NCT02529891|Volatile Organic Compounds|volatile organic compounds
268216|NCT02529891|Exacerbation|exacerbation
268217|NCT02529878|gastric caner|gastric caner
268218|NCT02529878|Apatinib|apatinib
268219|NCT02529878|S1|s1
269513|NCT02521779|Diet|diet
268220|NCT02529878|conversion therapy|conversion therapy
268221|NCT02529878|metastatic gastric cancer|metastatic gastric cancer
268222|NCT02529865|Cell Transplantation|cell transplantation
268223|NCT02529852|Lymphoma|lymphoma
268224|NCT02529852|Diffuse Large B Cell Lymphoma|diffuse large b cell lymphoma
268225|NCT02529852|DLBCL|dlbcl
268226|NCT02529852|Lenalidomide|lenalidomide
268227|NCT02529852|CC-5013|cc-5013
268228|NCT02529852|Revlimid|revlimid
268229|NCT02529852|Obinutuzumab|obinutuzumab
268230|NCT02529852|GA101|ga101
268231|NCT02529852|Gazyva|gazyva
268232|NCT02529852|Cyclophosphamide|cyclophosphamide
268233|NCT02529852|Cytoxan|cytoxan
268234|NCT02529852|Neosar|neosar
268235|NCT02529852|Doxorubicin|doxorubicin
268236|NCT02529852|Doxorubicin Hydrochloride|doxorubicin hydrochloride
268237|NCT02529852|Adriamycin PFS|adriamycin pfs
268238|NCT02529852|Adriamycin RDF|adriamycin rdf
268239|NCT02529852|Adriamycin|adriamycin
268240|NCT02529852|Rubex|rubex
268241|NCT02529852|Vincristine|vincristine
268242|NCT02529852|Prednisone|prednisone
268243|NCT02529839|MS|ms
268244|NCT02529839|BMT|bmt
268245|NCT02529826|Cancer-affected prepubertal boys|cancer-affected prepubertal boys
268246|NCT02529761|HCC|hcc
268247|NCT02529761|sorafenib|sorafenib
268248|NCT02529761|TACE|tace
268249|NCT02529761|overall survival|overall survival
268250|NCT02529735|blood pressure|blood pressure
268251|NCT02529735|alternative measure|alternative measure
268252|NCT02529696|accelerometer|accelerometer
268253|NCT02529696|RASS|rass
268254|NCT02529683|Nuvaring|nuvaring
268255|NCT02529683|contraceptive vaginal ring|contraceptive vaginal ring
268256|NCT02529683|Kenya|kenya
268257|NCT02529683|adherence|adherence
268258|NCT02529683|acceptability|acceptability
268259|NCT02529683|immunological effects|immunological effects
268260|NCT02529670|Low Level Laser Therapy|low level laser therapy
268261|NCT02529670|Low Back Pain|low back pain
268262|NCT02529670|Diagnosis|diagnosis
268263|NCT02529670|Genetic|genetic
268264|NCT02529670|Clinical trial|clinical trial
268265|NCT02529657|Lower Level Laser Therapy (LLLT)|lower level laser therapy (lllt)
268266|NCT02529657|inflammation|inflammation
268267|NCT02529657|cytokines|cytokines
268268|NCT02529657|wound healing|wound healing
268269|NCT02529657|laminectomy|laminectomy
268270|NCT02529657|clinical study|clinical study
268271|NCT02529644|HIV Screening|hiv screening
268272|NCT02529644|African American|african american
268273|NCT02529644|Church|church
268274|NCT02529631|Polyglucosamine|polyglucosamine
268275|NCT02529631|L 112|l 112
268276|NCT02529631|overweight,|overweight,
268277|NCT02529631|obesity|obesity
268278|NCT02529631|orlistat|orlistat
268279|NCT02529631|weight reduction|weight reduction
268280|NCT02529605|dietary supplement|dietary supplement
268281|NCT02529605|pharmacokinetics|pharmacokinetics
268282|NCT02529605|Healthy Volunteers|healthy volunteers
268283|NCT02529592|Sickness behavior|sickness behavior
268284|NCT02529592|Cytokines|cytokines
268285|NCT02529592|Psychoneuroimmunology|psychoneuroimmunology
268286|NCT02529579|adoptive Cellular Immunotherapy|adoptive cellular immunotherapy
268287|NCT02529579|patient safety|patient safety
268288|NCT02529579|therapeutic effect|therapeutic effect
268289|NCT02529566|Lumbar Degenerative Disc Disease|lumbar degenerative disc disease
268290|NCT02529566|Degenerative Spinal Conditions|degenerative spinal conditions
268291|NCT02529566|Adjacent Segment Disease|adjacent segment disease
268292|NCT02529566|Autologous Bone Marrow|autologous bone marrow
268293|NCT02529566|Lower Back Pain|lower back pain
268294|NCT02529566|Chronic Lower Back Pain|chronic lower back pain
268295|NCT02529566|Stem Cells|stem cells
268296|NCT02529566|Lumbar disk|lumbar disk
268297|NCT02529566|Mesenchymal Stem Cells|mesenchymal stem cells
268298|NCT02529566|Stabilization|stabilization
268299|NCT02529566|CLBP|clbp
268300|NCT02529566|Autograft|autograft
268301|NCT02529566|Allograft|allograft
268302|NCT02529566|Autograft versus Allograft|autograft versus allograft
268303|NCT02529566|Facet Joint|facet joint
268304|NCT02529566|Radicular Pain|radicular pain
268305|NCT02529566|Adipose|adipose
268306|NCT02529566|Disc Replacement|disc replacement
268307|NCT02529566|Facet Joint Replacement|facet joint replacement
268308|NCT02529553|bladder cancer|bladder cancer
268309|NCT02529540|Myopia|myopia
268310|NCT02529540|self-refraction|self-refraction
268311|NCT02529540|glasses|glasses
268312|NCT02529540|spectacles|spectacles
268313|NCT02529514|Baclofen|baclofen
268314|NCT02529514|Cardiac Surgery|cardiac surgery
268315|NCT02529514|Polysomnography|polysomnography
268316|NCT02529514|Intensive Care Units|intensive care units
268317|NCT02529514|Sleep|sleep
268318|NCT02529449|ASP1941|asp1941
268319|NCT02529449|type 1 diabetes mellitus|type 1 diabetes mellitus
268320|NCT02529449|SGLT2 inhibitor|sglt2 inhibitor
268321|NCT02529436|overuse antidepressant|overuse antidepressant
268322|NCT02529436|dementia|dementia
268323|NCT02529423|food intake|food intake
268324|NCT02529423|food-related behaviour|food-related behaviour
268325|NCT02529423|obesity|obesity
269514|NCT02521779|Fat|fat
268326|NCT02529423|socioeconomic environment|socioeconomic environment
268327|NCT02529423|depression|depression
268328|NCT02529423|nutritional strategies|nutritional strategies
268329|NCT02529397|Working Memory Training, Weight Loss,|working memory training, weight loss,
268330|NCT02529384|Breast magnetic resonance imaging|breast magnetic resonance imaging
268331|NCT02529384|Diffusion-weighted imaging|diffusion-weighted imaging
268332|NCT02529384|Multiple b-value diffusion weighted imaging|multiple b-value diffusion weighted imaging
268333|NCT02529358|Maintenance intervention|maintenance intervention
268334|NCT02529358|Text messages|text messages
268335|NCT02529358|Emotion Regulation|emotion regulation
268336|NCT02529332|Endoscopic Sellar/Parasellar Tumor Resection|endoscopic sellar/parasellar tumor resection
268337|NCT02529319|atrial fibrillation|atrial fibrillation
268338|NCT02529319|ablation|ablation
268339|NCT02529306|men|men
268340|NCT02529280|Latinas|latinas
268341|NCT02529280|Breast Cancer|breast cancer
268342|NCT02529280|Clinical Trials|clinical trials
268343|NCT02529280|Participation|participation
268344|NCT02529267|Cohort Studies|cohort studies
268345|NCT02529267|intimate partner violence|intimate partner violence
268346|NCT02529267|orthopaedic surgery|orthopaedic surgery
268347|NCT02529267|epidemiology|epidemiology
268348|NCT02529267|outcomes in fracture care|outcomes in fracture care
268349|NCT02529254|post graduate surgical education|post graduate surgical education
268350|NCT02529254|video coaching|video coaching
268351|NCT02529254|Surgical education|surgical education
268352|NCT02529254|coaching|coaching
268353|NCT02529202|Dexmedetomidine|dexmedetomidine
268354|NCT02529202|Neonate|neonate
268355|NCT02529202|Pharmacokinetics|pharmacokinetics
268356|NCT02529202|Therapeutic Hypothermia|therapeutic hypothermia
268357|NCT02529202|Hypoxic-ischemic Encephalopathy|hypoxic-ischemic encephalopathy
268358|NCT02529202|Adrenergic Agents|adrenergic agents
268359|NCT02529202|Adrenergic Agonists|adrenergic agonists
268360|NCT02529202|Analgesics|analgesics
268361|NCT02529202|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists
268362|NCT02529202|Central Nervous System Agents|central nervous system agents
268363|NCT02529202|Central Nervous System Depressants|central nervous system depressants
268364|NCT02529189|Stable Angina|stable angina
268365|NCT02529189|Angioplasty|angioplasty
268366|NCT02529189|Optical Coherence Tomography|optical coherence tomography
268367|NCT02529189|Nitrate|nitrate
268368|NCT02529176|telemetry|telemetry
268369|NCT02529176|cardiac monitoring|cardiac monitoring
268370|NCT02529163|Integrated Care Pathway|integrated care pathway
268371|NCT02529163|Acute Psychotic Episode|acute psychotic episode
268372|NCT02529163|Randomised Control Trial|randomised control trial
268373|NCT02529124|Ageing|ageing
268374|NCT02529124|Body Composition|body composition
268375|NCT02529124|Nutrition|nutrition
268376|NCT02529124|Physical Activity|physical activity
268377|NCT02529111|Atrial Septal Defects (ASD)|atrial septal defects (asd)
268378|NCT02529111|Percutaneous closure|percutaneous closure
268379|NCT02529098|functional magnetic resonance imaging|functional magnetic resonance imaging
268380|NCT02529098|Lens implantation|lens implantation
268381|NCT02529098|pseudophakia|pseudophakia
268382|NCT02529020|mouthguard|mouthguard
268383|NCT02529020|ventilation|ventilation
268384|NCT02529020|anaerobic power|anaerobic power
268385|NCT02529020|ergogenic effects|ergogenic effects
268386|NCT02529007|Colonoscopy|colonoscopy
268387|NCT02529007|early cancer detection|early cancer detection
268388|NCT02529007|cancer screening|cancer screening
268389|NCT02528994|Dietary supplements|dietary supplements
268390|NCT02528994|Metabolism|metabolism
268391|NCT02528981|GBS|gbs
268392|NCT02528981|Probiotics|probiotics
268393|NCT02528981|Group B Streptococcal|group b streptococcal
268394|NCT02528981|Pregnancy|pregnancy
268395|NCT02528968|Pharmacokinetic dosing|pharmacokinetic dosing
268396|NCT02528968|Haemophilia|haemophilia
268397|NCT02528955|Head and neck cancer|head and neck cancer
268398|NCT02528955|postoperative|postoperative
268399|NCT02528955|radiotherapy|radiotherapy
268400|NCT02528955|de-intensification|de-intensification
268401|NCT02528942|Lung cancer|lung cancer
268402|NCT02528942|Radiation therapy|radiation therapy
268403|NCT02528942|4DCT-ventilation imaging|4dct-ventilation imaging
268404|NCT02528890|group B streptococcus|group b streptococcus
268405|NCT02528890|GBS|gbs
268406|NCT02528864|biomarker|biomarker
268407|NCT02528864|cancer metabolism|cancer metabolism
268408|NCT02528864|chemical exchange saturation transfer|chemical exchange saturation transfer
268409|NCT02528864|endometrial cancer|endometrial cancer
268410|NCT02528864|diffusion-weighted imaging|diffusion-weighted imaging
268411|NCT02528864|magnetic resonance spectroscopy|magnetic resonance spectroscopy
268412|NCT02528864|uterine malignancy|uterine malignancy
268413|NCT02528851|CPAP|cpap
268414|NCT02528851|preterm|preterm
268415|NCT02528851|cardiac output|cardiac output
268416|NCT02528838|Myeloma|myeloma
268417|NCT02528838|Non-interventional|non-interventional
268418|NCT02528838|Observational|observational
268419|NCT02528838|Lenalidomide|lenalidomide
268420|NCT02528838|REVIEW|review
268421|NCT02528838|Post-authorization|post-authorization
268422|NCT02528838|Netherlands|netherlands
268423|NCT02528786|Drug therapy|drug therapy
268424|NCT02528734|pneumothorax|pneumothorax
268425|NCT02528708|fibrinogen concentrate|fibrinogen concentrate
268426|NCT02528708|coagulation|coagulation
268427|NCT02528695|18F-FDG PET/CT|18f-fdg pet/ct
268428|NCT02528695|Adipose tissue|adipose tissue
268429|NCT02528695|type 2 diabetes|type 2 diabetes
268430|NCT02528682|dendritic cells|dendritic cells
268431|NCT02528682|PD-L1/L2 silencing|pd-l1/l2 silencing
268432|NCT02528682|vaccination|vaccination
268433|NCT02528682|stem cell transplantation|stem cell transplantation
268434|NCT02528682|minor histocompatibility antigens|minor histocompatibility antigens
268435|NCT02528669|accelerometer|accelerometer
268436|NCT02528669|patient ambulation|patient ambulation
268437|NCT02528656|Pectus Excavatum|pectus excavatum
268438|NCT02528656|Pectus Carinatum|pectus carinatum
268439|NCT02528656|Vacuum Bell|vacuum bell
268440|NCT02528656|Dynamic compression system|dynamic compression system
268441|NCT02528656|Hearth variability|hearth variability
268442|NCT02528656|Autonomic Nervous System|autonomic nervous system
268443|NCT02528643|MDV3100|mdv3100
268444|NCT02528643|advanced hepatocellular carcinoma|advanced hepatocellular carcinoma
268445|NCT02528643|enzalutamide|enzalutamide
268446|NCT02528643|Xtandi|xtandi
268447|NCT02528643|ASP9785|asp9785
268448|NCT02528604|Catheter Ablation|catheter ablation
268449|NCT02528604|Permanent pacemaker|permanent pacemaker
268450|NCT02528604|AV node ablation|av node ablation
268451|NCT02528604|Electrical Cardioversion|electrical cardioversion
268452|NCT02528604|Implantable loop recorder|implantable loop recorder
268453|NCT02528591|patient|patient
268454|NCT02528591|renal transplant|renal transplant
268455|NCT02528578|healthy volunteers|healthy volunteers
268456|NCT02528539|Prevention|prevention
268457|NCT02528539|lymphedema|lymphedema
268458|NCT02528539|acupuncture|acupuncture
268459|NCT02528539|self-management|self-management
268460|NCT02528526|Hypoxia|hypoxia
268461|NCT02528526|Pancreatic Neoplasms|pancreatic neoplasms
268462|NCT02528526|Hepatocellular Cancer|hepatocellular cancer
268463|NCT02528526|Cholangiocarcinoma|cholangiocarcinoma
268464|NCT02528526|Colorectal Neoplasms|colorectal neoplasms
268465|NCT02528526|Treatment|treatment
268466|NCT02528513|sedation|sedation
268467|NCT02528513|Midazolam|midazolam
268468|NCT02528513|Propofol|propofol
268469|NCT02528513|Dexmedetomidine|dexmedetomidine
268470|NCT02528487|Pulmonary Rehabilitation|pulmonary rehabilitation
268471|NCT02528487|Chronic Obstructive Pulmonary Disease|chronic obstructive pulmonary disease
268472|NCT02528487|Psychiatric Disorders|psychiatric disorders
268473|NCT02528461|Sofosbuvir|sofosbuvir
268474|NCT02528461|Direct acting anti-viral treatment|direct acting anti-viral treatment
268475|NCT02528461|liver cirrhosis|liver cirrhosis
268476|NCT02528448|Vasoactive hormones|vasoactive hormones
268477|NCT02528448|bio markers|bio markers
268478|NCT02528448|salt regulation|salt regulation
268479|NCT02528448|Renal variables|renal variables
268480|NCT02528435|Methotrexate|methotrexate
268481|NCT02528383|Postmenopausal Women on Aromatase Inhibitors|postmenopausal women on aromatase inhibitors
268482|NCT02528383|Vagifem|vagifem
268483|NCT02528370|COPD exacerbation|copd exacerbation
268484|NCT02528370|Telemedicine|telemedicine
268485|NCT02528370|Intervention Studies|intervention studies
268486|NCT02528370|Patient Readmission|patient readmission
268487|NCT02528357|mAb|mab
268488|NCT02528357|GSK3174998|gsk3174998
268489|NCT02528357|anticancer agent|anticancer agent
268490|NCT02528357|checkpoint|checkpoint
268491|NCT02528357|OX40|ox40
268492|NCT02528357|Pembrolizumab|pembrolizumab
268493|NCT02528357|MK-3475-167|mk-3475-167
268494|NCT02528357|solid tumor|solid tumor
268495|NCT02528357|immunotherapy|immunotherapy
268496|NCT02528357|KEYNOTE-167|keynote-167
268497|NCT02528357|monoclonal antibody|monoclonal antibody
268498|NCT02528357|antitumor|antitumor
268499|NCT02528344|High Intensity Interval Training|high intensity interval training
268500|NCT02528331|Transcranial magnetic stimulation (TMS)|transcranial magnetic stimulation (tms)
268501|NCT02528331|Cognitive behavioral therapy (CBT)|cognitive behavioral therapy (cbt)
268502|NCT02528305|High-intensity Interval Training|high-intensity interval training
268503|NCT02528292|Rheumatoid Arthritis|rheumatoid arthritis
268504|NCT02528292|Anti-TNF|anti-tnf
268505|NCT02528292|Ultrasound|ultrasound
268506|NCT02528292|Synovial histomorphology|synovial histomorphology
268507|NCT02528292|Ectopic Lymphoneogenesis|ectopic lymphoneogenesis
268508|NCT02528279|Plasmodium ovale|plasmodium ovale
268509|NCT02528279|relapse|relapse
268510|NCT02528279|artemether-lumefantrine|artemether-lumefantrine
268511|NCT02528279|mixed species malaria|mixed species malaria
268512|NCT02528279|non-falciparum malaria|non-falciparum malaria
268513|NCT02528253|Chronic low back pain|chronic low back pain
268514|NCT02528253|Chronic pain|chronic pain
268515|NCT02528240|platelets|platelets
268516|NCT02528201|Ankylosing Spondylitis|ankylosing spondylitis
268517|NCT02528201|Celecoxib|celecoxib
268518|NCT02528201|Diclofenac|diclofenac
268519|NCT02528162|gestational diabetes|gestational diabetes
268520|NCT02528162|education|education
268521|NCT02528149|Fibromuscular Dysplasia|fibromuscular dysplasia
268522|NCT02528149|dysplastic renal artery aneurysm|dysplastic renal artery aneurysm
268523|NCT02528149|renal artery aneurysms|renal artery aneurysms
268524|NCT02528149|non atheromatous|non atheromatous
268525|NCT02528149|dysplastic|dysplastic
268526|NCT02528149|anatomopathologic|anatomopathologic
268527|NCT02528149|genetic|genetic
268528|NCT02528123|Small incision lenticule extraction (SMILE)|small incision lenticule extraction (smile)
268529|NCT02528123|Femtosecond laser|femtosecond laser
268530|NCT02528084|rotator cuff, shoulder, rehabilitation, yoga|rotator cuff, shoulder, rehabilitation, yoga
268531|NCT02528071|Amyotrophic Lateral Sclerosis|amyotrophic lateral sclerosis
268533|NCT02528071|Diaphragmatic Endurance Test|diaphragmatic endurance test
268534|NCT02528058|Myopic traction maculopathy|myopic traction maculopathy
268535|NCT02528045|Myopic traction maculopathy|myopic traction maculopathy
268536|NCT02528032|Left ventricular dysfunction|left ventricular dysfunction
268537|NCT02528032|Other cardiac dysrhythmias|other cardiac dysrhythmias
268538|NCT02528006|Spasmodic Dysphonia|spasmodic dysphonia
268539|NCT02528006|Type 2 Thyroplasty|type 2 thyroplasty
268540|NCT02528006|Titanium Bridges|titanium bridges
268541|NCT02528006|Operation|operation
268542|NCT02527980|electronic cigarettes|electronic cigarettes
268543|NCT02527980|nicotine dependence|nicotine dependence
268544|NCT02527980|smoking|smoking
268545|NCT02527980|tobacco use|tobacco use
268546|NCT02527967|colorectal cancer|colorectal cancer
268547|NCT02527967|enhanced recovery after surgery|enhanced recovery after surgery
268548|NCT02527967|perioperative care|perioperative care
268549|NCT02527967|fast-track surgery|fast-track surgery
268550|NCT02527967|laparoscopy|laparoscopy
268551|NCT02527967|minimally invasive surgery|minimally invasive surgery
268552|NCT02527967|complications|complications
268553|NCT02527954|Y-chromosome microdeletions|y-chromosome microdeletions
268554|NCT02527954|aneuploidy|aneuploidy
268555|NCT02527954|embryos|embryos
268556|NCT02527954|spermatozoa|spermatozoa
268557|NCT02527941|Genital immunology|genital immunology
268558|NCT02527941|HIV susceptibility|hiv susceptibility
268559|NCT02527941|Microbiome|microbiome
268560|NCT02527941|Bacterial vaginosis|bacterial vaginosis
268561|NCT02527941|Virus entry assay|virus entry assay
268562|NCT02527928|pharmacoeconomics|pharmacoeconomics
268563|NCT02527902|IGA Glomerulonephritis|iga glomerulonephritis
268564|NCT02527902|Autonomic nervous system|autonomic nervous system
268565|NCT02527902|ANS|ans
268566|NCT02527889|Exercise|exercise
268567|NCT02527889|blood flow velocity|blood flow velocity
268568|NCT02527889|tissue oxygenation|tissue oxygenation
268569|NCT02527889|BCRL|bcrl
268570|NCT02527876|Exercise|exercise
268571|NCT02527876|Smoking|smoking
268572|NCT02527863|Tolvaptan|tolvaptan
268573|NCT02527863|L-NMMA|l-nmma
268574|NCT02527863|ADPKD|adpkd
268575|NCT02527824|biliary tract neoplasm|biliary tract neoplasm
268576|NCT02527824|oxaliplatin|oxaliplatin
268577|NCT02527824|irinotecan|irinotecan
268578|NCT02527824|S-1|s-1
268579|NCT02527811|ulinastatin|ulinastatin
268580|NCT02527811|CPB|cpb
268581|NCT02527811|pediatric|pediatric
268582|NCT02527785|stomach neoplasm|stomach neoplasm
268583|NCT02527785|oxaliplatin|oxaliplatin
268584|NCT02527785|irinotecan|irinotecan
268585|NCT02527785|S-1|s-1
268586|NCT02527720|Mindfulness|mindfulness
268587|NCT02527720|Therapy|therapy
268588|NCT02527720|Problem Drinking|problem drinking
268589|NCT02527720|Breathing-based mindfulness training|breathing-based mindfulness training
268590|NCT02527694|Emergency medical services|emergency medical services
268591|NCT02527694|Resuscitation|resuscitation
268592|NCT02527512|Scoliosis|scoliosis
268593|NCT02527512|Spine fusion|spine fusion
268594|NCT02527512|0.35% povidone-iodine|0.35% povidone-iodine
268595|NCT02527486|COPD|copd
268596|NCT02527486|Asthma|asthma
268597|NCT02527486|ACOS|acos
268598|NCT02527486|Bronchiectasis|bronchiectasis
268599|NCT02527460|Inflammation|inflammation
268600|NCT02527460|Cognitive Function|cognitive function
268601|NCT02527460|HIV|hiv
268602|NCT02527447|Measurable Residual Disease|measurable residual disease
268603|NCT02527447|Relapsed/Refractory AML|relapsed/refractory aml
268604|NCT02527447|Salvage Chemotherapy|salvage chemotherapy
268605|NCT02527434|Urothelial bladder cancer, Triple-negative breast cancer, Pancreatic ductal adenocarcinoma, Advanced Solid Tumors, Tremelimumab, MEDI4736, ORR|urothelial bladder cancer, triple-negative breast cancer, pancreatic ductal adenocarcinoma, advanced solid tumors, tremelimumab, medi4736, orr
268606|NCT02527395|Experimental pain|experimental pain
268607|NCT02527395|Men|men
268608|NCT02527369|Fat Reduction|fat reduction
268609|NCT02527369|Lipolysis|lipolysis
268610|NCT02527330|Myocardial iron deposition|myocardial iron deposition
268611|NCT02527330|T2* imaging|t2* imaging
268612|NCT02527330|heart failure|heart failure
268613|NCT02527317|Early|early
268614|NCT02527291|Cytomegalovirus|cytomegalovirus
268615|NCT02527291|Interleukin|interleukin
268616|NCT02527291|Polymerase Chain Reaction|polymerase chain reaction
268617|NCT02527291|CMV antibodies|cmv antibodies
268618|NCT02527252|Massage|massage
268619|NCT02527252|Craniosacral|craniosacral
268620|NCT02527252|Disability Evaluation|disability evaluation
268621|NCT02527252|Randomized Controlled Trial|randomized controlled trial
268622|NCT02527187|Immune System Diseases|immune system diseases
268623|NCT02527187|Prick Test|prick test
268624|NCT02527187|Betula verrucosa|betula verrucosa
268625|NCT02527135|SMS|sms
268626|NCT02527135|Text messages|text messages
268627|NCT02527135|Young women|young women
268628|NCT02527135|HIV|hiv
268629|NCT02527122|Immune System Diseases|immune system diseases
268630|NCT02527122|Prick Test|prick test
268631|NCT02527122|Dermatophagoides pteronyssinus|dermatophagoides pteronyssinus
268632|NCT02527122|Dermatophagoides farinae|dermatophagoides farinae
268633|NCT02527096|dolutegravir(Tivicay®)|dolutegravir(tivicay®)
268634|NCT02527096|lamivudine(Epivir®)|lamivudine(epivir®)
268635|NCT02527096|HIV-1|hiv-1
268636|NCT02527096|efficacy|efficacy
268637|NCT02527096|safety|safety
268638|NCT02527057|Diffusion-weighted magnetic resonance imaging|diffusion-weighted magnetic resonance imaging
268639|NCT02527057|Preoperative concurrent chemoradiation|preoperative concurrent chemoradiation
268640|NCT02527057|Response|response
268641|NCT02527044|Coronary Artery Bypass|coronary artery bypass
268642|NCT02527044|Flow Reserve|flow reserve
268643|NCT02527031|Emergency Medical Services|emergency medical services
268644|NCT02527031|Extracorporeal Membrane Oxygenation|extracorporeal membrane oxygenation
268645|NCT02527018|OBGYN|obgyn
268646|NCT02527018|Nexfin|nexfin
268647|NCT02527018|Hypertensive|hypertensive
268648|NCT02527018|Hemodynamic|hemodynamic
268649|NCT02527005|IPT|ipt
268650|NCT02527005|malaria|malaria
268651|NCT02527005|pregnant|pregnant
268652|NCT02527005|HIV positive|hiv positive
268653|NCT02526979|OAB|oab
268654|NCT02526979|overactive bladder|overactive bladder
268655|NCT02526979|Myrbetric|myrbetric
268656|NCT02526979|neurogenic detrusor overactivity|neurogenic detrusor overactivity
268657|NCT02526979|Betanis|betanis
268658|NCT02526979|Myrbetriq|myrbetriq
268659|NCT02526979|NDO|ndo
268660|NCT02526979|YM178|ym178
268661|NCT02526979|mirabegron|mirabegron
268662|NCT02526979|Betmiga|betmiga
268663|NCT02526953|anal cancer|anal cancer
268664|NCT02526953|chemoradiation|chemoradiation
268665|NCT02526953|intensity-modulated radiotherapy|intensity-modulated radiotherapy
268666|NCT02526953|paclitaxel|paclitaxel
268667|NCT02526940|Human Immunodeficiency Virus|human immunodeficiency virus
268668|NCT02526940|HIV|hiv
268669|NCT02526940|HAART|haart
268670|NCT02526940|Highly Active antiretroviral therapy|highly active antiretroviral therapy
268671|NCT02526940|GALT|galt
268672|NCT02526940|Gut Associated Lymphoid Tissue|gut associated lymphoid tissue
268673|NCT02526940|reservoir|reservoir
268674|NCT02526940|rectum|rectum
268675|NCT02526927|Anorexia Nervosa|anorexia nervosa
268676|NCT02526927|microarchitecture|microarchitecture
268677|NCT02526927|prepubertal|prepubertal
268678|NCT02526914|social cognition|social cognition
268679|NCT02526914|oxytocin|oxytocin
268680|NCT02526914|vasopressin|vasopressin
268681|NCT02526914|decision making|decision making
268682|NCT02526914|social decision making|social decision making
268683|NCT02526914|economic games|economic games
268684|NCT02526888|pharmacokinetic|pharmacokinetic
268685|NCT02526888|interaction|interaction
268686|NCT02526875|hypertension, Telmisartan/S-Amlodipine|hypertension, telmisartan/s-amlodipine
268687|NCT02526862|noninvasive mechanical ventilation (NIVM)|noninvasive mechanical ventilation (nivm)
268688|NCT02526862|continuous positive airway pressure (CPAP) ventilation|continuous positive airway pressure (cpap) ventilation
268689|NCT02526862|bilevel positive airway pressure (BIPAP) ventilation|bilevel positive airway pressure (bipap) ventilation
268690|NCT02526862|pressure ulcer (PU)|pressure ulcer (pu)
268691|NCT02526862|nursing assessment|nursing assessment
268692|NCT02526849|Fecal Microbiota Transplantation|fecal microbiota transplantation
268693|NCT02526849|Slow Transit Constipation|slow transit constipation
268694|NCT02526849|Randomized Controlled Trial|randomized controlled trial
268695|NCT02526836|colon cancer mesocolic excision central ligation|colon cancer mesocolic excision central ligation
268696|NCT02526810|glargine|glargine
268697|NCT02526810|continuous subcutaneous insulin injection|continuous subcutaneous insulin injection
268698|NCT02526810|blood glucose control|blood glucose control
268699|NCT02526810|blood glucose fluctuation|blood glucose fluctuation
268700|NCT02526810|Oxidative Stress|oxidative stress
268701|NCT02526797|prostate biopsy|prostate biopsy
268702|NCT02526797|prostate cancer|prostate cancer
268703|NCT02526797|Magnetic resonance imaging|magnetic resonance imaging
268704|NCT02526797|Neoplasm staging|neoplasm staging
268705|NCT02526771|lymph node dissection|lymph node dissection
268706|NCT02526758|Pulmonary disease|pulmonary disease
268707|NCT02526758|chronic obstructive|chronic obstructive
268708|NCT02526758|small airway|small airway
268709|NCT02526745|vaccine|vaccine
268710|NCT02526745|safety|safety
268711|NCT02526745|immunogenicity|immunogenicity
268712|NCT02526732|NASH|nash
268713|NCT02526732|fatty Liver|fatty liver
268714|NCT02526732|VO2 max|vo2 max
268715|NCT02526732|M30 antigen|m30 antigen
268716|NCT02526719|bilateral prophylactic mastectomies|bilateral prophylactic mastectomies
268717|NCT02526719|immediate breast reconstruction|immediate breast reconstruction
268718|NCT02526719|nipple sparing|nipple sparing
268719|NCT02526719|BRCA1 Protein|brca1 protein
268720|NCT02526706|Bleb filtration|bleb filtration
268721|NCT02526706|VisionBlue|visionblue
268722|NCT02526693|glaucoma|glaucoma
268723|NCT02526693|relative afferent pupillary defect|relative afferent pupillary defect
268724|NCT02526693|pupillography|pupillography
268725|NCT02526680|OrCam|orcam
268726|NCT02526680|Low-vision device|low-vision device
268727|NCT02526680|End-stage glaucoma|end-stage glaucoma
268728|NCT02526641|Direct acting antiviral treatment|direct acting antiviral treatment
268729|NCT02526641|sCD163|scd163
268730|NCT02526641|Portal hypertension|portal hypertension
268731|NCT02526641|Metabolic liver function|metabolic liver function
268732|NCT02526641|Cirrhosis|cirrhosis
268733|NCT02526628|Testosterone|testosterone
268734|NCT02526628|Neurocognition|neurocognition
268735|NCT02526615|rosiglitazone|rosiglitazone
268736|NCT02526615|metformin|metformin
268737|NCT02526615|muscle|muscle
268738|NCT02526576|Facial Atrophy|facial atrophy
268739|NCT02526576|Autologous|autologous
268740|NCT02526576|Adult|adult
268741|NCT02526576|Adipose Derived Stem Cells|adipose derived stem cells
268742|NCT02526576|Stromal Vascular Fraction|stromal vascular fraction
268743|NCT02526576|Collagenase|collagenase
268744|NCT02526550|Live attenuated Japanese Encephalitis vaccine|live attenuated japanese encephalitis vaccine
268745|NCT02526550|IMOJEV|imojev
268746|NCT02526550|CD.JEVAX|cd.jevax
268747|NCT02526550|Booster|booster
268748|NCT02526550|Thai children|thai children
268749|NCT02526550|Immunogenicity|immunogenicity
268750|NCT02526550|Safety|safety
268751|NCT02526550|Interchangeability|interchangeability
268752|NCT02526550|Hepatitis A vaccine|hepatitis a vaccine
268753|NCT02526550|Vaccination or Other Immunization Procedure|vaccination or other immunization procedure
268754|NCT02526537|Gefitinib|gefitinib
268755|NCT02526537|NSCLC|nsclc
268756|NCT02526537|postoperative|postoperative
268757|NCT02526537|stage Ib|stage ib
268758|NCT02526537|Relapse Free Survival in 2 years|relapse free survival in 2 years
268759|NCT02526485|heparin|heparin
268760|NCT02526485|thrombocytopenia|thrombocytopenia
268761|NCT02526485|genomics|genomics
268762|NCT02526472|embryo transfer, in vitro fertilization|embryo transfer, in vitro fertilization
268763|NCT02526446|Chinese|chinese
268764|NCT02526446|caregiver stress|caregiver stress
268765|NCT02526446|self-administered acupressure|self-administered acupressure
268766|NCT02526433|depression|depression
268767|NCT02526433|mental wellbeing|mental wellbeing
268768|NCT02526433|motherhood|motherhood
268770|NCT02526433|alternative therapies|alternative therapies
268771|NCT02526420|VRS-317|vrs-317
268772|NCT02526420|Long Acting Growth Hormone|long acting growth hormone
268773|NCT02526420|Versartis|versartis
268774|NCT02526420|somavaratan|somavaratan
268775|NCT02526420|Growth Hormone Deficiency|growth hormone deficiency
268776|NCT02526420|Adult Growth Hormone Deficiency|adult growth hormone deficiency
268777|NCT02526420|AGHD|aghd
268778|NCT02526420|Growth Hormone Replacement|growth hormone replacement
268779|NCT02526420|Growth Hormone Replacement Therapy|growth hormone replacement therapy
268780|NCT02526420|XTEN|xten
268781|NCT02526407|postnatal depression|postnatal depression
268782|NCT02526407|mental wellbeing|mental wellbeing
268783|NCT02526407|baby blues|baby blues
268784|NCT02526407|mothers|mothers
268785|NCT02526407|music|music
268786|NCT02526407|alternative therapies|alternative therapies
268787|NCT02526355|Maternal depression|maternal depression
268788|NCT02526355|Mobile phone based intervention|mobile phone based intervention
268789|NCT02526355|Learning Through Play|learning through play
268790|NCT02526355|CBT|cbt
268791|NCT02526355|Intelligent Real Time Therapy|intelligent real time therapy
268792|NCT02526316|cervical cancer|cervical cancer
268793|NCT02526316|vulvar cancer|vulvar cancer
268794|NCT02526316|vaginal cancer|vaginal cancer
268795|NCT02526316|penile cancer|penile cancer
268796|NCT02526316|anal cancer|anal cancer
268797|NCT02526316|head and neck cancer|head and neck cancer
268798|NCT02526277|RLS|rls
268799|NCT02526264|stoma|stoma
268800|NCT02526264|quality of life|quality of life
268801|NCT02526251|IBD|ibd
268802|NCT02526251|Fecal calprotectin|fecal calprotectin
268803|NCT02526251|Microbiome|microbiome
268804|NCT02526251|Dysbiosis|dysbiosis
268805|NCT02526251|Disease activity|disease activity
268806|NCT02526251|telemedicine|telemedicine
268807|NCT02526238|transcranial magnetic stimulation|transcranial magnetic stimulation
268808|NCT02526238|trunk rotation|trunk rotation
268809|NCT02526225|acute ischemic stroke|acute ischemic stroke
268810|NCT02526225|safety and effectiveness|safety and effectiveness
268811|NCT02526225|Ginkgo diterpene lactone meglumine injection|ginkgo diterpene lactone meglumine injection
268812|NCT02526212|opioid use disorder|opioid use disorder
268813|NCT02526212|group counseling|group counseling
268814|NCT02526212|office-based buprenorphine treatment|office-based buprenorphine treatment
268815|NCT02526199|Local anesthetics|local anesthetics
268816|NCT02526199|Perineural nerve blocks|perineural nerve blocks
268817|NCT02526199|Perineurial Dexamethasone|perineurial dexamethasone
268818|NCT02526160|KRN23|krn23
268819|NCT02526160|Fibroblast growth factor 23 (FGF23)|fibroblast growth factor 23 (fgf23)
268820|NCT02526160|XLH|xlh
268821|NCT02526160|X-linked hypophosphatemia|x-linked hypophosphatemia
268822|NCT02526160|burosumab|burosumab
268823|NCT02526160|Crysvita|crysvita
268824|NCT02526134|Laying of medical devices (radio opaque markers)|laying of medical devices (radio opaque markers)
268825|NCT02526095|Esophagus|esophagus
268826|NCT02526095|Surgery|surgery
268827|NCT02526082|cardiovascular disease|cardiovascular disease
268828|NCT02526082|frailty|frailty
268829|NCT02526082|quality of life|quality of life
268830|NCT02526082|mortality|mortality
268831|NCT02526082|prevention|prevention
268832|NCT02526030|psychosis|psychosis
268833|NCT02526030|antipsychotic agents|antipsychotic agents
268834|NCT02526030|treatment|treatment
268835|NCT02526030|effectiveness|effectiveness
268836|NCT02526004|Cystic Fibrosis|cystic fibrosis
268837|NCT02526004|Microbiome|microbiome
268838|NCT02526004|Stratified Antibacterial therapy|stratified antibacterial therapy
268839|NCT02526004|Resistance|resistance
268840|NCT02526004|Pathogen Host Interaction|pathogen host interaction
268841|NCT02525991|schizophrenia|schizophrenia
268842|NCT02525991|bipolar disorder|bipolar disorder
343633|NCT02124785|Havrix|havrix
268843|NCT02525978|Heart Rate|heart rate
268844|NCT02525965|Wide resection margin|wide resection margin
268845|NCT02525965|Recurrence|recurrence
268846|NCT02525965|Early-stage hepatocellular carcinoma|early-stage hepatocellular carcinoma
268847|NCT02525952|Carcinoma, Hepatocellular|carcinoma, hepatocellular
268848|NCT02525952|Hepatectomy|hepatectomy
268849|NCT02525952|Transarterial Chemoembolization|transarterial chemoembolization
268850|NCT02525952|Scoring System|scoring system
268851|NCT02525913|Breast|breast
268852|NCT02525913|Mastectomy|mastectomy
268853|NCT02525874|Tecfidera|tecfidera
268854|NCT02525874|DMF|dmf
268855|NCT02525874|dimethyl fumarate|dimethyl fumarate
268856|NCT02525757|Lung Cancer|lung cancer
268857|NCT02525757|Non-small cell lung cancer|non-small cell lung cancer
268858|NCT02525757|NSCLC|nsclc
268859|NCT02525757|Unresectable|unresectable
268860|NCT02525757|MPDL3280A|mpdl3280a
268861|NCT02525757|Carboplatin|carboplatin
268862|NCT02525757|Paraplatin|paraplatin
268863|NCT02525757|Paclitaxel|paclitaxel
268864|NCT02525757|Taxol|taxol
268865|NCT02525757|Radiation therapy|radiation therapy
268866|NCT02525757|XRT|xrt
268867|NCT02525731|HIV Infection|hiv infection
268868|NCT02525731|Pain|pain
268869|NCT02525731|Chronic Opioid Therapy|chronic opioid therapy
268870|NCT02525731|Addiction|addiction
268871|NCT02525731|Analgesics, Opioid|analgesics, opioid
268872|NCT02525718|Breast Reconstruction|breast reconstruction
268873|NCT02525718|Mastectomy|mastectomy
268874|NCT02525705|infants|infants
268875|NCT02525705|oesophageal atresia|oesophageal atresia
268876|NCT02525705|dumping syndrome|dumping syndrome
268877|NCT02525705|prevalence|prevalence
268878|NCT02525705|Type III and IV|type iii and iv
268879|NCT02525705|Oral glucose tolerance test|oral glucose tolerance test
268880|NCT02525705|early hyperglycemia|early hyperglycemia
268881|NCT02525705|late hypoglycemia|late hypoglycemia
268882|NCT02525653|Albumin-Bound|albumin-bound
268883|NCT02525653|Paclitaxel|paclitaxel
268884|NCT02525653|Gemcitabine|gemcitabine
268885|NCT02525653|15-054|15-054
268886|NCT02525640|Single sided hearing loss|single sided hearing loss
268887|NCT02525640|Single sided deafness|single sided deafness
268888|NCT02525640|Hearing loss music appreciation|hearing loss music appreciation
268889|NCT02525536|Drug Therapy|drug therapy
268890|NCT02525510|Mild Hypothermia|mild hypothermia
268891|NCT02525510|Machine Perfusion|machine perfusion
268892|NCT02525510|Kidney Transplantation|kidney transplantation
268893|NCT02525497|Automated PD|automated pd
268894|NCT02525497|Effectiveness|effectiveness
268895|NCT02525497|Safety|safety
268896|NCT02525497|Manipulability|manipulability
268897|NCT02525458|antimicrobial|antimicrobial
268898|NCT02525458|biofilms|biofilms
268899|NCT02525458|acrylic resin|acrylic resin
268900|NCT02525458|polymethyl methacrylate|polymethyl methacrylate
268901|NCT02525458|confocal laser scanning microscopy|confocal laser scanning microscopy
268902|NCT02525458|split-mouth design|split-mouth design
268903|NCT02525458|quaternary ammonium methacryloxy silicate|quaternary ammonium methacryloxy silicate
268904|NCT02525445|placebo effects|placebo effects
268905|NCT02525445|communication|communication
268906|NCT02525445|acupuncture therapy|acupuncture therapy
268907|NCT02525445|relaxation|relaxation
268908|NCT02525432|Mesenchymal Stromal Cells, Multipotent|mesenchymal stromal cells, multipotent
268909|NCT02525432|Multipotent Mesenchymal Stromal Cells|multipotent mesenchymal stromal cells
268910|NCT02525432|Stem Cells, Mesenchymal|stem cells, mesenchymal
268911|NCT02525393|Rehabilitation|rehabilitation
268912|NCT02525393|Non Invasive Brain Stimulation|non invasive brain stimulation
268913|NCT02525380|Transarterial chemoembolization|transarterial chemoembolization
268914|NCT02525380|Doxorubicin-Eluting-Bead Embolization|doxorubicin-eluting-bead embolization
268915|NCT02525380|DC Bead TACE|dc bead tace
268916|NCT02525380|Hepatocellular carcinoma|hepatocellular carcinoma
268917|NCT02525367|Parkinson's disease|parkinson's disease
268918|NCT02525367|Multiple Sclerosis|multiple sclerosis
268919|NCT02525367|Depressed Elderly|depressed elderly
269813|NCT02519634|RCT|rct
268920|NCT02525367|Cognitive Dysfunction|cognitive dysfunction
268921|NCT02525367|Online Cognitive Training|online cognitive training
268922|NCT02525354|arachidonic aci|arachidonic aci
268923|NCT02525354|adiposity|adiposity
268924|NCT02525354|atopy|atopy
268925|NCT02525341|Yoga|yoga
268926|NCT02525341|exercises|exercises
268927|NCT02525341|knee osteoarthritis|knee osteoarthritis
268928|NCT02525341|older adults|older adults
268929|NCT02525328|Constitutional Thinness|constitutional thinness
268930|NCT02525328|linkage study|linkage study
268931|NCT02525328|genome wide scan (GWAS)|genome wide scan (gwas)
268932|NCT02525315|Schizophrenia|schizophrenia
268933|NCT02525315|auditory hallucinations|auditory hallucinations
268934|NCT02525315|TMS|tms
268935|NCT02525302|DMD|dmd
268936|NCT02525302|neuromuscular|neuromuscular
268937|NCT02525302|Duchenne|duchenne
268938|NCT02525289|mobility|mobility
268939|NCT02525289|coronary artery bypass|coronary artery bypass
268940|NCT02525289|positioning|positioning
268941|NCT02525289|body|body
268942|NCT02525263|Neo-Kidney Augment|neo-kidney augment
268943|NCT02525263|Type 2 Diabetes|type 2 diabetes
268944|NCT02525263|Chronic Kidney Disease|chronic kidney disease
268945|NCT02525263|Cell Therapy|cell therapy
268946|NCT02525250|Acute myeloid leukemia or myelodysplasic syndrome|acute myeloid leukemia or myelodysplasic syndrome
268947|NCT02525198|Mild cognitive impairment|mild cognitive impairment
268948|NCT02525198|Subjective memory impairment|subjective memory impairment
268949|NCT02525198|Dementia|dementia
268950|NCT02525198|Flavonoids|flavonoids
268951|NCT02525198|Fatty acids|fatty acids
268952|NCT02525198|Cognition|cognition
268953|NCT02525198|Gut microflora|gut microflora
268954|NCT02525172|immune modulation therapy|immune modulation therapy
268955|NCT02525172|acid α-glucosidase|acid α-glucosidase
268956|NCT02525172|antibody|antibody
268957|NCT02525159|3,3'-diindolylmethane|3,3'-diindolylmethane
268958|NCT02525159|premenopause|premenopause
268959|NCT02525159|2-hydroxyestrone|2-hydroxyestrone
268960|NCT02525146|HIV|hiv
268961|NCT02525146|Reengagement in HIV Care|reengagement in hiv care
268962|NCT02525146|ARTAS|artas
268963|NCT02525133|post operative pain|post operative pain
268964|NCT02525133|hernioplasty|hernioplasty
268965|NCT02525133|bupivacaine|bupivacaine
268966|NCT02525120|Disc herniation|disc herniation
268967|NCT02525120|Herniated disc|herniated disc
268968|NCT02525120|Triojection|triojection
268969|NCT02525120|Ozone|ozone
268970|NCT02525120|Lumbar spine|lumbar spine
268971|NCT02525120|Leg pain|leg pain
268972|NCT02525107|Prevention of Vaso Occlusive Painful Crisis|prevention of vaso occlusive painful crisis
268973|NCT02525094|Eczema|eczema
268974|NCT02525081|Microvascular Angina|microvascular angina
268975|NCT02525081|therapy|therapy
268976|NCT02525068|enzalutamide|enzalutamide
268977|NCT02525068|AZD5363|azd5363
268978|NCT02525068|Prostate|prostate
268979|NCT02525055|Flu|flu
268980|NCT02525055|Influenza|influenza
268981|NCT02525055|Human Viral Challenge Model|human viral challenge model
268982|NCT02525055|Wild-Type|wild-type
268983|NCT02525055|H3N2|h3n2
268984|NCT02525055|H1N1|h1n1
268985|NCT02525055|Universal Influenza Vaccine|universal influenza vaccine
268986|NCT02525055|intra-seasonal vaccines|intra-seasonal vaccines
268987|NCT02525055|antiviral|antiviral
268988|NCT02525042|Ankylosing Spondylitis|ankylosing spondylitis
268989|NCT02525042|Dendritic cells (DC)|dendritic cells (dc)
268990|NCT02525042|RNA|rna
268991|NCT02525042|Axial spondyloarthritis|axial spondyloarthritis
268992|NCT02525042|Lod score|lod score
268993|NCT02525042|Human leucocyte antigen (HLA-B27)|human leucocyte antigen (hla-b27)
268994|NCT02525029|GVHD|gvhd
268995|NCT02525016|Bariatric surgery, lidocaine, plasmatic concentration, MonoEthylGlycineXylidide (MEGx), safety|bariatric surgery, lidocaine, plasmatic concentration, monoethylglycinexylidide (megx), safety
268996|NCT02525003|vitamin D|vitamin d
268997|NCT02525003|Serum 25-hydroxyvitamin D|serum 25-hydroxyvitamin d
268998|NCT02525003|vitamin D2|vitamin d2
268999|NCT02525003|UV-irradiated yeast|uv-irradiated yeast
269000|NCT02525003|serum 25-hydroxyvitamin D3|serum 25-hydroxyvitamin d3
269001|NCT02525003|serum 25-hydroxyvitamin D2|serum 25-hydroxyvitamin d2
269002|NCT02525003|randomized controlled trial|randomized controlled trial
269003|NCT02525003|vitamin D3|vitamin d3
269004|NCT02525003|bioavailability|bioavailability
269005|NCT02524990|Medical abortion|medical abortion
269006|NCT02524990|pregnancy tests|pregnancy tests
269007|NCT02524964|left ventricular remodeling|left ventricular remodeling
269008|NCT02524964|cardiac magnetic resonance imaging|cardiac magnetic resonance imaging
269009|NCT02524964|acute myocardial infarction|acute myocardial infarction
269010|NCT02524938|Dietary polyphenols|dietary polyphenols
269011|NCT02524938|Protein glycation|protein glycation
269012|NCT02524925|fast track surgery|fast track surgery
269013|NCT02524925|eras program|eras program
269014|NCT02524925|hepatectomy|hepatectomy
269015|NCT02524925|pancreatectomy|pancreatectomy
269016|NCT02524925|NPY|npy
269017|NCT02524925|ACTH/Cortsiosol|acth/cortsiosol
269018|NCT02524925|postoperative stress|postoperative stress
269019|NCT02524899|Schizotypal Personality Disorder|schizotypal personality disorder
269021|NCT02524899|cognitive remediation therapy|cognitive remediation therapy
269022|NCT02524899|CRT|crt
269023|NCT02524899|guanfacine|guanfacine
269024|NCT02524899|cognitive impairment|cognitive impairment
269025|NCT02524899|working memory|working memory
269026|NCT02524899|pharmacological cognitive enhancing agent|pharmacological cognitive enhancing agent
269027|NCT02524899|neuropsychological testing|neuropsychological testing
269028|NCT02524899|schizophrenia spectrum disorders|schizophrenia spectrum disorders
269029|NCT02524899|Personality Disorders|personality disorders
269030|NCT02524886|Deep Brain Simulation|deep brain simulation
269031|NCT02524886|Psychiatric|psychiatric
269032|NCT02524886|Side-effects|side-effects
269033|NCT02524860|Prostate Cancer|prostate cancer
269034|NCT02524860|Biopsy|biopsy
269035|NCT02524860|Focal Healthcare|focal healthcare
269036|NCT02524860|Fusion Targeted Biopsy|fusion targeted biopsy
269037|NCT02524860|High Risk Cancer|high risk cancer
269038|NCT02524860|Imaging|imaging
343870|NCT02123732|Herbal|herbal
269039|NCT02524860|Diagnostic|diagnostic
269040|NCT02524860|Ultrasound|ultrasound
269041|NCT02524860|Multiparametric Magnetic Resonance Imaging (MP-MRI)|multiparametric magnetic resonance imaging (mp-mri)
269042|NCT02524860|MRI-Ultrasound Fusion|mri-ultrasound fusion
269043|NCT02524860|Focal-Fusion Bx|focal-fusion bx
269044|NCT02524834|Thoracoabdominal lesions|thoracoabdominal lesions
269045|NCT02524795|Omega 3, Cytokines, Adipokines, Systemic lupus erythematosus|omega 3, cytokines, adipokines, systemic lupus erythematosus
269046|NCT02524782|MEDI-4166, diabetes|medi-4166, diabetes
269047|NCT02524769|Urge Urinary Incontinence|urge urinary incontinence
269048|NCT02524769|Urinary Incontinence|urinary incontinence
269049|NCT02524756|nerve sparing radical hysterectomy|nerve sparing radical hysterectomy
269050|NCT02524743|Rocuronium|rocuronium
269051|NCT02524743|lidocaine|lidocaine
269052|NCT02524743|acetaminophen,|acetaminophen,
269053|NCT02524743|pain|pain
269054|NCT02524743|injection|injection
269055|NCT02524717|Hepatic Impairment|hepatic impairment
269056|NCT02524717|JNJ-56021927|jnj-56021927
269057|NCT02524704|Cystic fibrosis|cystic fibrosis
269058|NCT02524704|Electrical Impedance Tomography|electrical impedance tomography
269059|NCT02524626|Vagus nerve stimulation|vagus nerve stimulation
269060|NCT02524626|Postoperative ileus|postoperative ileus
269061|NCT02524561|mammographic density|mammographic density
269062|NCT02524561|abnormal mammogram|abnormal mammogram
269063|NCT02524561|biopsy|biopsy
269064|NCT02524548|Aromatase inhibitors|aromatase inhibitors
269065|NCT02524548|Reminder Systems|reminder systems
269066|NCT02524522|Integrated Pulmonary Index|integrated pulmonary index
269067|NCT02524522|automated protocol-driven weaning|automated protocol-driven weaning
269068|NCT02524522|pulmonary recruitment maneuver|pulmonary recruitment maneuver
269069|NCT02524509|Chonodron|chonodron
269070|NCT02524509|Microfracture|microfracture
269071|NCT02524509|autologous cultured chondrocyte|autologous cultured chondrocyte
269072|NCT02524509|cartilage defect of knee|cartilage defect of knee
269073|NCT02524444|Intermittent preventive therapy|intermittent preventive therapy
269074|NCT02524444|malaria|malaria
269075|NCT02524444|pregnant|pregnant
269076|NCT02524444|HIV positive|hiv positive
269077|NCT02524444|Prevention|prevention
269078|NCT02524431|Mitochondria|mitochondria
269079|NCT02524431|trabeculectomy|trabeculectomy
269080|NCT02524431|trabecular meshwork|trabecular meshwork
269081|NCT02524431|Glaucoma surgery|glaucoma surgery
269082|NCT02524418|Main Pancreatic Duct|main pancreatic duct
269083|NCT02524392|independent medical evaluation|independent medical evaluation
269084|NCT02524392|sick leave|sick leave
269085|NCT02524392|sickness absence|sickness absence
269086|NCT02524392|physician primary care|physician primary care
269087|NCT02524392|general practitioner|general practitioner
269088|NCT02524392|family physician|family physician
269089|NCT02524366|Stress Urinary Incontinence|stress urinary incontinence
269090|NCT02524366|Artificial Urinary Sphincter|artificial urinary sphincter
269091|NCT02524353|cardiac surgery|cardiac surgery
269092|NCT02524340|JIA|jia
269093|NCT02524340|Arthritis|arthritis
269094|NCT02524340|pcJIA|pcjia
269095|NCT02524340|PCATS|pcats
269096|NCT02524301|anorexia nervosa|anorexia nervosa
269097|NCT02524301|opioid receptors|opioid receptors
269098|NCT02524301|Positron emission tomography (PET)|positron emission tomography (pet)
269099|NCT02524301|diprenorphine|diprenorphine
269100|NCT02524262|atrohpic gastritis|atrohpic gastritis
269101|NCT02524262|acetaldehyde|acetaldehyde
269102|NCT02524262|ethanol|ethanol
269103|NCT02524262|L-cysteine|l-cysteine
269104|NCT02524236|BPH, OAB, Botox, dose response|bph, oab, botox, dose response
269105|NCT02524223|medically assisted procreation|medically assisted procreation
269106|NCT02524210|volunteers|volunteers
269107|NCT02524197|Hip|hip
269108|NCT02524197|Knee|knee
269109|NCT02524197|Arthritis|arthritis
269110|NCT02524197|pain|pain
269111|NCT02524197|CR845|cr845
269112|NCT02524197|kappa opioid|kappa opioid
269113|NCT02524171|crime|crime
269114|NCT02524171|mental health|mental health
269115|NCT02524171|substance abuse|substance abuse
269116|NCT02524171|homelessness|homelessness
269117|NCT02524171|Veterans|veterans
269118|NCT02524158|Yoga|yoga
269119|NCT02524158|Mind-Body Therapies|mind-body therapies
269120|NCT02524158|Chronic Low Back Pain|chronic low back pain
269121|NCT02524158|Military Veterans|military veterans
269122|NCT02524158|VA patients|va patients
269123|NCT02524080|Ambulance|ambulance
269124|NCT02524080|Trust|trust
269125|NCT02524080|Patients|patients
269126|NCT02524080|Healthcare chain|healthcare chain
269127|NCT02524054|Dyspnea|dyspnea
269128|NCT02524054|Hospitalized patients|hospitalized patients
269129|NCT02524054|Ambulatory outpatients|ambulatory outpatients
269130|NCT02524054|Shortness of breath|shortness of breath
269131|NCT02524054|Chronic obstructive pulmonary disease|chronic obstructive pulmonary disease
269132|NCT02524054|Pulmonary disease|pulmonary disease
269133|NCT02524041|Hyperparathyroidism|hyperparathyroidism
712539|NCT00579787|behavioral|behavioral
269134|NCT02524041|microarchitecture|microarchitecture
269135|NCT02524041|periostin|periostin
269136|NCT02524028|Atrial Fibrillation|atrial fibrillation
269137|NCT02524028|fMRI|fmri
269138|NCT02524015|stroke|stroke
269139|NCT02524015|pusher syndrome|pusher syndrome
269140|NCT02524015|contraversive pushing|contraversive pushing
269141|NCT02524015|lateropulsion|lateropulsion
269142|NCT02524015|rehabilitation|rehabilitation
269143|NCT02524015|physical therapy|physical therapy
269144|NCT02524002|Abnormal Labor|abnormal labor
269145|NCT02524002|Prolonged Induction|prolonged induction
269146|NCT02524002|Ketosis|ketosis
269147|NCT02524002|Diet|diet
269148|NCT02523989|arsenic|arsenic
269149|NCT02523989|heavy metal|heavy metal
269150|NCT02523976|Acute|acute
269151|NCT02523976|Leukemia|leukemia
269152|NCT02523976|Lymphoid|lymphoid
269153|NCT02523976|Philadelphia chromosome|philadelphia chromosome
269154|NCT02523976|dasatinib|dasatinib
269155|NCT02523963|family work shop|family work shop
269156|NCT02523937|Pulmonary Embolism|pulmonary embolism
269157|NCT02523937|Deep Venous Thrombosis|deep venous thrombosis
269158|NCT02523937|Soluble Fibrin|soluble fibrin
269159|NCT02523937|D-Dimers|d-dimers
269160|NCT02523937|Low and intermediate clinical probability|low and intermediate clinical probability
269161|NCT02523911|Suprep|suprep
269162|NCT02523911|Simethicone|simethicone
269163|NCT02523911|Colorectal cancer screening|colorectal cancer screening
269164|NCT02523911|Routine colonoscopy|routine colonoscopy
269165|NCT02523911|sodium sulfate/potassium sulfate/magnesium sulfate|sodium sulfate/potassium sulfate/magnesium sulfate
269166|NCT02523911|Bowel cleansing|bowel cleansing
269167|NCT02523911|Mass screening|mass screening
269168|NCT02523898|Clomiphene|clomiphene
269169|NCT02523898|infertility|infertility
269170|NCT02523898|insuline resistant|insuline resistant
269171|NCT02523898|metformine|metformine
269172|NCT02523898|PCOS|pcos
269173|NCT02523885|Pneumonia, Bacterial [C01.252.620]|pneumonia, bacterial [c01.252.620]
269174|NCT02523885|Bronchopneumonia [C08.381.677.127]|bronchopneumonia [c08.381.677.127]
269175|NCT02523885|Pleuropneumonia [C08.730.610.473]|pleuropneumonia [c08.730.610.473]
269176|NCT02523885|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal
269177|NCT02523872|Fluid overload|fluid overload
269178|NCT02523872|Acute respiratory failure|acute respiratory failure
269179|NCT02523872|Acute respiratory distress syndrome|acute respiratory distress syndrome
269180|NCT02523872|Medication administration|medication administration
269181|NCT02523846|IV-Patient Controlled Analgesia (IV-PCA)|iv-patient controlled analgesia (iv-pca)
269182|NCT02523846|background morphine infusion|background morphine infusion
269183|NCT02523846|patient re-education|patient re-education
269184|NCT02523781|preeclampsia|preeclampsia
269185|NCT02523781|information pamphlet|information pamphlet
269186|NCT02523781|patient education|patient education
269187|NCT02523755|epidural analgesia for labor|epidural analgesia for labor
269188|NCT02523755|respiratory function|respiratory function
269189|NCT02523755|electrical impedance tomography|electrical impedance tomography
269190|NCT02523729|lactation|lactation
269191|NCT02523729|human milk|human milk
269192|NCT02523729|maltz|maltz
269193|NCT02523729|antioxidant|antioxidant
269194|NCT02523716|Hypoxic conditioning|hypoxic conditioning
269195|NCT02523716|Cardio pulmonary exercise testing|cardio pulmonary exercise testing
269196|NCT02523651|Periodontal Diseases|periodontal diseases
269197|NCT02523651|Bone Regeneration|bone regeneration
269198|NCT02523651|Dental Pulp Stem Cell|dental pulp stem cell
269199|NCT02523638|Pegylated-Proline-interferon alpha-2b (AOP2014)|pegylated-proline-interferon alpha-2b (aop2014)
269200|NCT02523638|Polycythemia Vera|polycythemia vera
269201|NCT02523638|PEN-PV|pen-pv
269202|NCT02523638|PROUD-PV|proud-pv
269203|NCT02523638|CONTINUATION-PV|continuation-pv
269204|NCT02523638|AOP Orphan|aop orphan
269205|NCT02523638|Polycythemia|polycythemia
269206|NCT02523638|Hematologic Diseases|hematologic diseases
269207|NCT02523638|Myeloproliferative Disorders|myeloproliferative disorders
269208|NCT02523638|Bone Marrow Diseases|bone marrow diseases
269209|NCT02523638|Interferon-alpha|interferon-alpha
269210|NCT02523638|Peginterferon alfa-2b|peginterferon alfa-2b
269211|NCT02523625|Ultrasound|ultrasound
269212|NCT02523599|post operative pain|post operative pain
269213|NCT02523599|hernioplasty|hernioplasty
269214|NCT02523599|bupivacaine|bupivacaine
269918|NCT02519062|FDG PET|fdg pet
269215|NCT02523586|oxygen concentration|oxygen concentration
269216|NCT02523586|oxygen therapy|oxygen therapy
269217|NCT02523586|oxygen delivery|oxygen delivery
269218|NCT02523586|oxygen masks|oxygen masks
269219|NCT02523560|Telerehabilitation|telerehabilitation
269220|NCT02523560|Home Monitoring|home monitoring
269221|NCT02523560|Heart Failure|heart failure
269222|NCT02523547|entecavir|entecavir
269223|NCT02523495|Molecular Targeted Therapy|molecular targeted therapy
269224|NCT02523495|metastasis colorectal cancer|metastasis colorectal cancer
269225|NCT02523495|biomarker|biomarker
269226|NCT02523482|Prescriptions|prescriptions
269227|NCT02523482|Epidemiology|epidemiology
269228|NCT02523482|STOPP/START Criteria|stopp/start criteria
269229|NCT02523482|Beers Criteria|beers criteria
269230|NCT02523456|Early warning score|early warning score
269231|NCT02523456|Cardiac arrest|cardiac arrest
269232|NCT02523443|Epidural Analgesia|epidural analgesia
269233|NCT02523443|Intravenous Patient Controlled|intravenous patient controlled
269234|NCT02523443|15-148|15-148
269235|NCT02523430|Nasopharyngeal Carcinoma|nasopharyngeal carcinoma
269236|NCT02523430|HepaSphere|hepasphere
269237|NCT02523417|Breast Cancer|breast cancer
269238|NCT02523417|HepaSphere|hepasphere
269239|NCT02523404|Lung Cancer|lung cancer
269240|NCT02523404|HepaSphere|hepasphere
269241|NCT02523378|Advanced Cancers|advanced cancers
269242|NCT02523378|Recurrent|recurrent
269243|NCT02523378|Locally advanced|locally advanced
269244|NCT02523378|Metastatic|metastatic
269245|NCT02523378|Edmonton Symptom Assessment Scale|edmonton symptom assessment scale
269246|NCT02523378|ESAS|esas
269247|NCT02523378|Survey|survey
269248|NCT02523378|Interview|interview
269249|NCT02523378|Symptom questionnaire|symptom questionnaire
269250|NCT02523365|Cervical Carcinoma|cervical carcinoma
269251|NCT02523365|HepaSphere|hepasphere
269252|NCT02523326|Genomic DNA|genomic dna
269253|NCT02523326|chronic periodontitis|chronic periodontitis
269254|NCT02523326|saliva|saliva
269255|NCT02523326|mouthwash|mouthwash
269256|NCT02523326|PCR|pcr
269257|NCT02523326|genotyping|genotyping
269258|NCT02523326|sequencing|sequencing
269259|NCT02523235|moderate pain|moderate pain
269260|NCT02523235|severe pain|severe pain
269261|NCT02523235|surgery|surgery
269262|NCT02523235|postop analgesia|postop analgesia
269263|NCT02523235|TKA|tka
269264|NCT02523235|adductor catheter|adductor catheter
269265|NCT02523235|poplital catheter|poplital catheter
269266|NCT02523235|foot/ankle surgery|foot/ankle surgery
269267|NCT02523222|dextrose gel|dextrose gel
269268|NCT02523222|newborn hypoglycemia|newborn hypoglycemia
269269|NCT02523222|late preterm infant|late preterm infant
269270|NCT02523222|large for gestational age|large for gestational age
269271|NCT02523222|small for gestational age|small for gestational age
269272|NCT02523222|prophylactic|prophylactic
269273|NCT02523222|neonatal hypoglycemia|neonatal hypoglycemia
269274|NCT02523209|Osteoporosis|osteoporosis
269275|NCT02523209|chronic kidney disease|chronic kidney disease
269276|NCT02523209|kidney transplantation|kidney transplantation
269277|NCT02523209|fracture risk|fracture risk
269278|NCT02523196|Hepatic Venous Pressure Gradient (HVPG) testing|hepatic venous pressure gradient (hvpg) testing
269279|NCT02523196|HepQuant-SHUNT|hepquant-shunt
269280|NCT02523196|Liver Function|liver function
269281|NCT02523183|Epilepsy|epilepsy
269282|NCT02523183|Marijuana|marijuana
269283|NCT02523144|Transthoracic echocardiography|transthoracic echocardiography
269284|NCT02523144|echo|echo
269285|NCT02523144|TTE|tte
269286|NCT02523131|Type 1 diabetes|type 1 diabetes
269287|NCT02523131|Closed-loop glucose control|closed-loop glucose control
269288|NCT02523131|Artificial Pancreas|artificial pancreas
269289|NCT02523131|Continuous subcutaneous insulin infusion|continuous subcutaneous insulin infusion
269290|NCT02523131|Continuous glucose monitoring|continuous glucose monitoring
269291|NCT02523131|threshold suspend|threshold suspend
269292|NCT02523131|predictive low glucose suspend|predictive low glucose suspend
269293|NCT02523092|sarcoidosis|sarcoidosis
269294|NCT02523092|Acthar|acthar
269295|NCT02523092|CXCL9|cxcl9
269296|NCT02523092|chemokine ligand 9|chemokine ligand 9
269297|NCT02523053|Hepatocellular Carcinoma|hepatocellular carcinoma
269298|NCT02523053|Recurrence|recurrence
269299|NCT02523053|Microvascular Invasion|microvascular invasion
269300|NCT02523053|5-Fluorouracil|5-fluorouracil
269301|NCT02523040|Langerhans cell histiocytosis (LCH)|langerhans cell histiocytosis (lch)
269302|NCT02523040|Erdheim-Chester disease (ECD)|erdheim-chester disease (ecd)
269303|NCT02523040|Histiocytic Sarcoma (HS)|histiocytic sarcoma (hs)
269304|NCT02522988|cancer-related fatigue|cancer-related fatigue
269305|NCT02522975|biosimilar epoetin|biosimilar epoetin
269306|NCT02522975|efficacy|efficacy
269307|NCT02522975|safety|safety
269308|NCT02522975|immunogenicity|immunogenicity
269309|NCT02522975|renal anaemia|renal anaemia
269310|NCT02522962|physical therapy|physical therapy
269311|NCT02522962|group-based|group-based
269312|NCT02522962|core stability|core stability
269313|NCT02522962|balance|balance
269314|NCT02522962|movement quality|movement quality
269315|NCT02522962|somatosensory stimulation|somatosensory stimulation
269316|NCT02522962|coordination|coordination
269317|NCT02522923|Physical Therapy Modalities|physical therapy modalities
269318|NCT02522923|Primary Care|primary care
269319|NCT02522923|Health Services Research|health services research
269320|NCT02522884|Angioplasty|angioplasty
269321|NCT02522884|Peripheral Artery Disease|peripheral artery disease
269322|NCT02522884|PAD|pad
269323|NCT02522884|Lesion|lesion
269324|NCT02522884|Claudication|claudication
269325|NCT02522858|premedication|premedication
269326|NCT02522858|dexmedetomidine|dexmedetomidine
269327|NCT02522858|anesthesia, spinal|anesthesia, spinal
269328|NCT02522845|Varicose Veins|varicose veins
269329|NCT02522845|Compression Stockings|compression stockings
269330|NCT02522845|Laser Ablation|laser ablation
269331|NCT02522845|Catheter Ablation, Radiofrequency|catheter ablation, radiofrequency
269332|NCT02522819|Obstructive Sleep Apnea Syndrome|obstructive sleep apnea syndrome
269333|NCT02522819|acute stroke|acute stroke
269334|NCT02522819|apnea-hypopnea index (AHI)|apnea-hypopnea index (ahi)
269335|NCT02522806|Endometrial biopsy|endometrial biopsy
269336|NCT02522806|previous ovarian hyperstimulation cycle|previous ovarian hyperstimulation cycle
269337|NCT02522806|first IVF|first ivf
269338|NCT02522806|antagonist protocol|antagonist protocol
269339|NCT02522806|clinical pregnancy rate|clinical pregnancy rate
269340|NCT02522793|skin lesion|skin lesion
269341|NCT02522728|Knee|knee
269342|NCT02522728|Arthroplasty|arthroplasty
269343|NCT02522728|Implant|implant
269344|NCT02522689|kidney stone|kidney stone
269345|NCT02522689|percutaneous nephrolithotripsy|percutaneous nephrolithotripsy
269346|NCT02522689|ultra-mini PCNL|ultra-mini pcnl
269347|NCT02522689|micro PCNL|micro pcnl
269348|NCT02522676|kidney stone|kidney stone
269349|NCT02522676|percutaneous nephrolithotripsy|percutaneous nephrolithotripsy
269350|NCT02522676|retrograde intrarenal surgery|retrograde intrarenal surgery
269351|NCT02522676|extracorporeal shock wave lithotripsy|extracorporeal shock wave lithotripsy
269352|NCT02522676|mini PCNL|mini pcnl
269353|NCT02522676|ultra-mini PCNL|ultra-mini pcnl
269354|NCT02522676|micro PCNL|micro pcnl
269355|NCT02522663|telephone support|telephone support
269356|NCT02522663|discharge management|discharge management
269357|NCT02522663|readmission|readmission
269358|NCT02522663|aortic valve replacement|aortic valve replacement
269359|NCT02522650|amiloride|amiloride
269360|NCT02522650|proteinuric kidney disease|proteinuric kidney disease
269361|NCT02522650|urokinase plasminogen activator receptor|urokinase plasminogen activator receptor
269362|NCT02522650|proteinuria|proteinuria
269363|NCT02522637|exercise|exercise
269364|NCT02522637|training|training
269365|NCT02522637|endurance|endurance
269366|NCT02522624|Health insurance|health insurance
269367|NCT02522624|Health services accessibility|health services accessibility
269368|NCT02522624|Decision making|decision making
269369|NCT02522624|Health literacy|health literacy
269370|NCT02522611|Palliative Care|palliative care
269371|NCT02522611|Adults|adults
269372|NCT02522611|Cancer Pain|cancer pain
269373|NCT02522611|Nerve Block|nerve block
269374|NCT02522611|Quality of Life|quality of life
269375|NCT02522585|expectant management|expectant management
269376|NCT02522585|p16|p16
269377|NCT02522585|immunohistochemistry|immunohistochemistry
269378|NCT02522585|regression|regression
269379|NCT02522585|progression|progression
269380|NCT02522585|cervical intraepithelial neoplasia|cervical intraepithelial neoplasia
269381|NCT02522572|Renal Transplantation|renal transplantation
269382|NCT02522572|Desensitization|desensitization
269383|NCT02522572|plerixafor|plerixafor
269384|NCT02522572|bortezomib|bortezomib
269385|NCT02522520|Undergoing chemotherapy|undergoing chemotherapy
269386|NCT02522520|Exercise intervention|exercise intervention
269387|NCT02522520|Health counselling|health counselling
269388|NCT02522520|Symptom management|symptom management
269389|NCT02522481|Lumason|lumason
269390|NCT02522481|Dobutamine stress echo|dobutamine stress echo
269391|NCT02522481|stress echo|stress echo
269392|NCT02522481|coronary artery disease|coronary artery disease
269393|NCT02522455|Flow-cycled pressure-support ventilation|flow-cycled pressure-support ventilation
269394|NCT02522403|distal radius fracture|distal radius fracture
269395|NCT02522403|laser acupuncture|laser acupuncture
269396|NCT02522403|rehabilitation|rehabilitation
269397|NCT02522390|data collection|data collection
269398|NCT02522390|personal health services|personal health services
269399|NCT02522390|personal health records|personal health records
269400|NCT02522390|do-it-yourself|do-it-yourself
269401|NCT02522390|nutrition researchers|nutrition researchers
269402|NCT02522390|cohort studies|cohort studies
269403|NCT02522390|databases, factual|databases, factual
269404|NCT02522390|self-quantification methods|self-quantification methods
269405|NCT02522377|Ketamine|ketamine
269406|NCT02522377|Electroconvulsive Therapy|electroconvulsive therapy
269407|NCT02522377|Major Depressive Disorder|major depressive disorder
269408|NCT02522377|Treatment Resistant Depression|treatment resistant depression
269409|NCT02522377|electroconvulsive treatment|electroconvulsive treatment
269410|NCT02522377|Severe depression|severe depression
269411|NCT02522364|Postoperative atrial fibrillation|postoperative atrial fibrillation
270212|NCT02517151|fatigue|fatigue
269412|NCT02522364|Dysfunction Following Cardiac Surgery|dysfunction following cardiac surgery
269413|NCT02522312|Dry Eye|dry eye
269414|NCT02522299|double-blind|double-blind
269415|NCT02522299|PI3Kdelta|pi3kdelta
269416|NCT02522299|GSK2269557|gsk2269557
269417|NCT02522299|exacerbation|exacerbation
269418|NCT02522299|Chronic Obstructive Pulmonary Disease|chronic obstructive pulmonary disease
269419|NCT02522299|randomised|randomised
269420|NCT02522299|placebo-controlled|placebo-controlled
269421|NCT02522286|patient engagement|patient engagement
712540|NCT00579774|Aging|aging
269422|NCT02522286|physician's role|physician's role
269423|NCT02522286|patient- centered care|patient- centered care
269424|NCT02522286|communication|communication
269425|NCT02522273|Obstetric|obstetric
269426|NCT02522273|Midwifery|midwifery
269427|NCT02522273|Fetal blood sample|fetal blood sample
269428|NCT02522273|Lactate|lactate
269429|NCT02522273|Handheld meter|handheld meter
269430|NCT02522260|Breast cancer, chemotherapy, symptoms, optimal training|breast cancer, chemotherapy, symptoms, optimal training
269431|NCT02522234|Neutropenia|neutropenia
269432|NCT02522234|Chemotherapy|chemotherapy
269433|NCT02522221|chronic anticoagulation|chronic anticoagulation
269434|NCT02522221|vitamin K antagonist|vitamin k antagonist
269435|NCT02522221|mechanical heart valve|mechanical heart valve
269436|NCT02522221|CYP2C9|cyp2c9
269437|NCT02522221|warfarin|warfarin
269438|NCT02522221|tecarfarin|tecarfarin
269439|NCT02522221|chronic kidney disease|chronic kidney disease
269440|NCT02522195|shift work|shift work
269441|NCT02522195|nutritional status|nutritional status
269442|NCT02522195|nursing professionals|nursing professionals
269443|NCT02522195|meal distribution|meal distribution
269444|NCT02522195|food intake|food intake
269445|NCT02522182|Cardiovascular Secondary Prevention|cardiovascular secondary prevention
269446|NCT02522182|Nurse's Role|nurse's role
269447|NCT02522143|self-harm|self-harm
269448|NCT02522143|self-mutilation|self-mutilation
269449|NCT02522143|cutting|cutting
269450|NCT02522117|Kidney Transplantation|kidney transplantation
269451|NCT02522117|Atorvastatin|atorvastatin
269452|NCT02522117|Human Leukocyte Antigens|human leukocyte antigens
269453|NCT02522117|Interleukin|interleukin
269454|NCT02522104|Pharmacokinetics of Hydroxyurea|pharmacokinetics of hydroxyurea
269455|NCT02522078|misoprostol|misoprostol
269456|NCT02522078|abortion|abortion
269457|NCT02522065|Hypokinesia|hypokinesia
269458|NCT02522065|Patient Outcome Assessment|patient outcome assessment
269459|NCT02522013|post-dural puncture headache|post-dural puncture headache
269460|NCT02522013|Aminophylline|aminophylline
269461|NCT02521948|MANTA|manta
269462|NCT02521948|Arterial Closure Device|arterial closure device
269463|NCT02521948|Large Bore Closure Device|large bore closure device
269464|NCT02521909|Root Canal length|root canal length
269465|NCT02521909|Electronic apex locator|electronic apex locator
269466|NCT02521909|Endodontics|endodontics
269467|NCT02521870|Skin Cancer|skin cancer
269468|NCT02521870|Skin Tumors|skin tumors
269469|NCT02521870|Head and Neck Squamous Cell Carcinoma|head and neck squamous cell carcinoma
269470|NCT02521870|Cancer Immunotherapy|cancer immunotherapy
269471|NCT02521857|Alkermes|alkermes
269472|NCT02521857|Samidorphan|samidorphan
269473|NCT02521857|ALKS 5461|alks 5461
269474|NCT02521857|Healthy Volunteer|healthy volunteer
269475|NCT02521857|Pharmacokinetics|pharmacokinetics
269476|NCT02521844|solid tumors|solid tumors
269477|NCT02521844|responsive to Wnt signalling regulation|responsive to wnt signalling regulation
269478|NCT02521844|RSPO fusions|rspo fusions
269479|NCT02521844|Porcupine|porcupine
269480|NCT02521844|PD-1|pd-1
269481|NCT02521844|MSS|mss
269482|NCT02521844|CRC|crc
269483|NCT02521844|endometrial cancer|endometrial cancer
269484|NCT02521844|ovarian cancer|ovarian cancer
269485|NCT02521831|Circumcision|circumcision
269486|NCT02521818|cognition|cognition
269487|NCT02521818|dementia|dementia
269488|NCT02521818|neuropsychological|neuropsychological
269489|NCT02521818|elderly|elderly
269490|NCT02521818|nutrition|nutrition
269491|NCT02521818|diet|diet
269492|NCT02521805|Appetite|appetite
269493|NCT02521805|Protein|protein
269494|NCT02521805|Protein quality|protein quality
269495|NCT02521805|Dietary fibre|dietary fibre
269496|NCT02521805|Satiety|satiety
269497|NCT02521792|Open-label study|open-label study
269498|NCT02521792|Clinical trial Phase 2|clinical trial phase 2
269499|NCT02521792|Efficacy and safety|efficacy and safety
269500|NCT02521792|Heterotopic ossification|heterotopic ossification
269501|NCT02521792|Fibrodysplasia Ossificans Progressiva|fibrodysplasia ossificans progressiva
269502|NCT02521792|Flare-up|flare-up
269503|NCT02521792|Palovarotene|palovarotene
269504|NCT02521792|Retinoic acid receptor agonist|retinoic acid receptor agonist
269505|NCT02521792|Retinoic acid receptor gamma agonist|retinoic acid receptor gamma agonist
269506|NCT02521792|Clementia|clementia
269507|NCT02521792|Myositis Ossificans Progressiva|myositis ossificans progressiva
269508|NCT02521792|Munchmeyer's Disease|munchmeyer's disease
269509|NCT02521792|FOP|fop
269510|NCT02521779|Inflammation|inflammation
269511|NCT02521779|Endotoxemia|endotoxemia
269512|NCT02521779|Lipopolysaccharide|lipopolysaccharide
269515|NCT02521779|Postprandial|postprandial
269516|NCT02521753|Polycystic ovary syndrome|polycystic ovary syndrome
269517|NCT02521753|Obesity|obesity
269518|NCT02521753|Metformin|metformin
269519|NCT02521753|Magnesium|magnesium
269520|NCT02521753|Polyunsaturated fatty acids|polyunsaturated fatty acids
269521|NCT02521740|biological marker|biological marker
269522|NCT02521740|frailty|frailty
269523|NCT02521740|burden|burden
269524|NCT02521740|nutrition|nutrition
269525|NCT02521740|elderly|elderly
269526|NCT02521714|Revlimid|revlimid
269527|NCT02521714|lenalidomide|lenalidomide
269528|NCT02521714|bioavailability|bioavailability
269529|NCT02521714|healthy volunteers|healthy volunteers
269530|NCT02521714|food effect|food effect
269531|NCT02521714|pharmacokinetics|pharmacokinetics
269532|NCT02521662|Electronic Cigarettes|electronic cigarettes
269533|NCT02521662|Nicotine Patch|nicotine patch
269534|NCT02521662|Smoking Cessation|smoking cessation
269535|NCT02521649|Gastric Cancer|gastric cancer
269536|NCT02521649|G17DT|g17dt
269537|NCT02521649|PAS|pas
269538|NCT02521649|Insegia|insegia
269539|NCT02521649|Gastrimmune|gastrimmune
269540|NCT02521623|Acelullar Dermal Matrix|acelullar dermal matrix
269541|NCT02521623|Immediate Breast Reconstruction|immediate breast reconstruction
269542|NCT02521623|Breast Implant|breast implant
269543|NCT02521584|Liver transplant recipient|liver transplant recipient
269544|NCT02521558|Cognitive rehabilitation|cognitive rehabilitation
269545|NCT02521558|Mobile electronic application|mobile electronic application
269546|NCT02521558|Memory tasks|memory tasks
269547|NCT02521545|Oral Remyelination|oral remyelination
269548|NCT02521519|Facet induced pain|facet induced pain
269549|NCT02521519|Myofascial pain|myofascial pain
269550|NCT02521519|Trigger points|trigger points
269551|NCT02521519|Low back pain|low back pain
269552|NCT02521454|policing|policing
269553|NCT02521454|resilience|resilience
269554|NCT02521454|implicit bias|implicit bias
269555|NCT02521454|violence|violence
269556|NCT02521441|Neutropenia|neutropenia
269557|NCT02521441|Myelotoxic Chemotherapy|myelotoxic chemotherapy
269558|NCT02521441|G-CSF|g-csf
269559|NCT02521363|Implantable Microdevice|implantable microdevice
269560|NCT02521363|In Vivo Drug Sensitivity Testing|in vivo drug sensitivity testing
269561|NCT02521363|HER2-Positive|her2-positive
269562|NCT02521363|Triple Negative|triple negative
269563|NCT02521363|15-127|15-127
269564|NCT02521350|Acute Kidney Injury|acute kidney injury
269565|NCT02521350|Surgery|surgery
269566|NCT02521350|Perioperative care|perioperative care
269567|NCT02521311|multiple sclerosis|multiple sclerosis
269568|NCT02521311|eye pain|eye pain
269569|NCT02521311|vision loss|vision loss
269570|NCT02521259|anesthetic depth|anesthetic depth
269571|NCT02521259|emergence agitation|emergence agitation
269572|NCT02521220|L-citrulline|l-citrulline
269573|NCT02521220|Endothelial dysfunction|endothelial dysfunction
269574|NCT02521194|Advanced Cancers|advanced cancers
269575|NCT02521194|Inpatient occupational therapy|inpatient occupational therapy
269576|NCT02521194|Questionnaire|questionnaire
269577|NCT02521194|Survey|survey
269578|NCT02521168|euthyroid sick syndrome|euthyroid sick syndrome
269579|NCT02521168|cardiopulmonary bypass|cardiopulmonary bypass
269580|NCT02521168|congenital heart disease|congenital heart disease
269581|NCT02521168|time to extubation|time to extubation
269582|NCT02521155|Oral health literacy intervention|oral health literacy intervention
269583|NCT02521155|oral hygiene behavior|oral hygiene behavior
269584|NCT02521142|OCT Angiography|oct angiography
269585|NCT02521116|retinal oxygenation|retinal oxygenation
269586|NCT02521116|retinal vessel diameters|retinal vessel diameters
269587|NCT02521116|Dynamic vessel analyzer (DVA)|dynamic vessel analyzer (dva)
269588|NCT02521116|Oxymap T1|oxymap t1
269589|NCT02521077|Ascorbic Acid|ascorbic acid
269590|NCT02521077|Breast Neoplasms|breast neoplasms
269591|NCT02521077|Fatigue|fatigue
269592|NCT02521064|IBD|ibd
269593|NCT02521064|enteral nutrition|enteral nutrition
269594|NCT02521064|corticosteroids|corticosteroids
269595|NCT02521051|Non-Small Cell Lung Cancer (NSCLC)|non-small cell lung cancer (nsclc)
269596|NCT02521051|Anaplastic lymphoma kinase|anaplastic lymphoma kinase
269597|NCT02521051|ALK|alk
269598|NCT02521051|Brain metastases|brain metastases
269599|NCT02521012|Depression|depression
269600|NCT02521012|Depressive symptoms|depressive symptoms
269601|NCT02521012|Vitamin D|vitamin d
269602|NCT02521012|Intervention|intervention
269603|NCT02520986|Sexually transmitted disease|sexually transmitted disease
269604|NCT02520986|Genital Warts|genital warts
269605|NCT02520986|Venereal Warts|venereal warts
269606|NCT02520960|Catheter Ablation|catheter ablation
269607|NCT02520960|Pulmonary Vein Isolation|pulmonary vein isolation
269608|NCT02520960|Radiofrequency|radiofrequency
269609|NCT02520947|desflurane|desflurane
269610|NCT02520947|BIS|bis
269611|NCT02520947|coronary artery bypass grafting surgery|coronary artery bypass grafting surgery
269612|NCT02520934|Enzyme Replacement Therapy|enzyme replacement therapy
269613|NCT02520934|Miglustat|miglustat
269614|NCT02520934|Gaucher Disease|gaucher disease
269615|NCT02520921|Diabetes mellitus|diabetes mellitus
270715|NCT02513862|transfusion|transfusion
269616|NCT02520921|Acute coronary syndrome|acute coronary syndrome
269617|NCT02520921|Coronary artery disease|coronary artery disease
269618|NCT02520921|Aspirin|aspirin
269619|NCT02520921|Secondary prevention|secondary prevention
269620|NCT02520895|Chronic Lymphocytic Leukemia|chronic lymphocytic leukemia
269621|NCT02520895|Non-Hodgkin lymphoma|non-hodgkin lymphoma
269622|NCT02520895|Follicular Lymphoma|follicular lymphoma
269623|NCT02520895|Diffuse Large B Cell Lymphoma|diffuse large b cell lymphoma
269624|NCT02520895|MALT Lymphoma|malt lymphoma
269625|NCT02520895|T Cell Lymphoma|t cell lymphoma
269626|NCT02520895|Immune Repertoire|immune repertoire
269627|NCT02520895|Infection|infection
269628|NCT02520895|relapse|relapse
269629|NCT02520895|survival|survival
269630|NCT02520895|treatment response|treatment response
269631|NCT02520895|VJ rearrangement|vj rearrangement
269632|NCT02520882|PET/CT|pet/ct
269633|NCT02520882|Bombesin|bombesin
269634|NCT02520882|gastrin-releasing peptide receptor|gastrin-releasing peptide receptor
269635|NCT02520882|68Gallium labeling|68gallium labeling
269636|NCT02520830|blueberry polyphenols|blueberry polyphenols
269637|NCT02520830|Polyphenol metabolites|polyphenol metabolites
269638|NCT02520830|endothelial function|endothelial function
269639|NCT02520830|Molecular mechanisms of action|molecular mechanisms of action
269640|NCT02520830|Vascular function|vascular function
269641|NCT02520830|Healthy men|healthy men
269642|NCT02520817|Antioxidants|antioxidants
269643|NCT02520817|Zinc|zinc
269644|NCT02520817|Truck drivers|truck drivers
269645|NCT02520804|balanced salt solution|balanced salt solution
269646|NCT02520765|Obesity Index, ICSI|obesity index, icsi
269647|NCT02520752|cMET, INC280, caffeine, midazolam|cmet, inc280, caffeine, midazolam
269648|NCT02520739|olive oil|olive oil
269649|NCT02520739|phenolic compounds|phenolic compounds
269650|NCT02520739|triterpenes|triterpenes
269651|NCT02520739|oxidation and inflammation|oxidation and inflammation
269652|NCT02520726|Posttraumatic stress disorder|posttraumatic stress disorder
269653|NCT02520726|PTSD|ptsd
269654|NCT02520726|Sertraline|sertraline
269655|NCT02520726|Burns|burns
269656|NCT02520713|Pediatric Solid Tumor|pediatric solid tumor
269657|NCT02520648|Back pain|back pain
269658|NCT02520648|Manual therapy|manual therapy
269659|NCT02520635|prognosis|prognosis
269660|NCT02520635|supra-early chemotherapy|supra-early chemotherapy
269661|NCT02520609|Metabolomics|metabolomics
269662|NCT02520609|Non-Alcoholic Steatohepatitis|non-alcoholic steatohepatitis
269663|NCT02520609|Non-Alcoholic Fatty Liver Disease|non-alcoholic fatty liver disease
269664|NCT02520609|Energy Expenditure|energy expenditure
269665|NCT02520596|Raspberries|raspberries
269666|NCT02520596|Anthocyanins|anthocyanins
269667|NCT02520596|Ellagitannins|ellagitannins
269668|NCT02520596|Metabolites|metabolites
269669|NCT02520557|Epilepsy|epilepsy
269670|NCT02520557|Genetic associations with severe Cutaneous Adverse Reactions|genetic associations with severe cutaneous adverse reactions
269671|NCT02520492|intracranial pressure|intracranial pressure
269672|NCT02520479|extranodal natural killer/T-cell lymphoma|extranodal natural killer/t-cell lymphoma
269673|NCT02520479|nasal type|nasal type
269674|NCT02520479|radiotherapy|radiotherapy
269675|NCT02520479|chemotherapy|chemotherapy
269676|NCT02520440|Citrulline|citrulline
269678|NCT02520440|MOF|mof
269679|NCT02520440|Calprotectina|calprotectina
269680|NCT02520440|intraabdominal pressure|intraabdominal pressure
269681|NCT02520427|Amgen|amgen
269682|NCT02520427|Phase 1|phase 1
269683|NCT02520427|Clinical Trial|clinical trial
269684|NCT02520427|Oncology/Hematology|oncology/hematology
269685|NCT02520427|Relapsed/Refractory AML|relapsed/refractory aml
269686|NCT02520427|Immunotherapy|immunotherapy
269687|NCT02520310|Mitral Regurgitation|mitral regurgitation
269688|NCT02520310|mitral valve surgery|mitral valve surgery
269689|NCT02520310|AVJ-514 Delivery System|avj-514 delivery system
269690|NCT02520310|Symptomatic Heart Failure|symptomatic heart failure
269691|NCT02520310|Heart Valve Disease|heart valve disease
269692|NCT02520297|Pain|pain
269693|NCT02520297|Long bone|long bone
269694|NCT02520297|Fracture|fracture
269695|NCT02520271|Mood Disorders|mood disorders
269696|NCT02520271|Motivational Interview|motivational interview
269697|NCT02520271|Behavioral Activation|behavioral activation
269698|NCT02520258|artificial sweeteners|artificial sweeteners
269699|NCT02520258|obesity|obesity
269700|NCT02520258|diabetes|diabetes
269701|NCT02520258|metabolic syndrome|metabolic syndrome
269702|NCT02520258|aspartame|aspartame
269703|NCT02520232|chronic exercise|chronic exercise
269704|NCT02520232|genetic polymorphisms|genetic polymorphisms
269705|NCT02520232|brain imagery|brain imagery
269706|NCT02520232|executive functions|executive functions
269707|NCT02520232|alzheimer's disease|alzheimer's disease
269708|NCT02520219|Peripheral T-cell lymphomas,Endostar|peripheral t-cell lymphomas,endostar
269709|NCT02520193|Early mobilisation|early mobilisation
269710|NCT02520193|Invasive ventilation|invasive ventilation
269711|NCT02520193|Ventilator free days|ventilator free days
269712|NCT02520193|Intensive Care Unit|intensive care unit
269713|NCT02520167|Gestational weight gain|gestational weight gain
270716|NCT02513849|esophagus|esophagus
269714|NCT02520128|Intensity Modulated Radiotherapy|intensity modulated radiotherapy
269715|NCT02520128|Radiotherapy|radiotherapy
269716|NCT02520089|platelet-rich plasma|platelet-rich plasma
269717|NCT02520089|bone grafting|bone grafting
269718|NCT02520089|pseudoarthrosis|pseudoarthrosis
269719|NCT02520076|Islet Transplantation|islet transplantation
269720|NCT02520063|hormone-receptor positive breast cancer|hormone-receptor positive breast cancer
269721|NCT02520063|Her2 negative breast cancer|her2 negative breast cancer
269722|NCT02520063|neoadjuvant|neoadjuvant
269723|NCT02520063|everolimus|everolimus
269724|NCT02520063|TRC105|trc105
269725|NCT02520063|letrozole|letrozole
269726|NCT02520050|Type 2 diabetes|type 2 diabetes
269727|NCT02520050|Obesity|obesity
269728|NCT02520050|Nutrition|nutrition
269729|NCT02520050|Medical Nutrition Therapy|medical nutrition therapy
269730|NCT02520037|Fluid responsiveness|fluid responsiveness
269731|NCT02520037|Volume responsiveness|volume responsiveness
269732|NCT02520037|Hemodynamics|hemodynamics
269733|NCT02520024|self-directed care|self-directed care
269734|NCT02520024|serious mental illness|serious mental illness
269735|NCT02520011|Refractory AML|refractory aml
269736|NCT02520011|Relapsed AML|relapsed aml
269737|NCT02520011|AML|aml
269738|NCT02519998|Biomarkers|biomarkers
269739|NCT02519998|Electrocardiography|electrocardiography
269740|NCT02519998|Balance|balance
269741|NCT02519998|Neuropsychiatric assessment|neuropsychiatric assessment
269742|NCT02519998|Cortisol|cortisol
269743|NCT02519998|Calcitonin-gene-related peptide|calcitonin-gene-related peptide
269744|NCT02519998|Electroencephalography|electroencephalography
269745|NCT02519998|Optical coherence tomography|optical coherence tomography
269746|NCT02519998|Von Frey Testing|von frey testing
269747|NCT02519985|VHF digital ultrasound|vhf digital ultrasound
269748|NCT02519985|Corneal thickness|corneal thickness
269749|NCT02519985|Epithelial thickness|epithelial thickness
269750|NCT02519985|Angle diameter|angle diameter
269751|NCT02519985|Sulcus diameter|sulcus diameter
269752|NCT02519985|Anterior chamber depth|anterior chamber depth
269753|NCT02519985|Repeatability|repeatability
269754|NCT02519985|Reproducibility|reproducibility
269755|NCT02519972|Low dose CT screening|low dose ct screening
269756|NCT02519972|Family history of lung cancer|family history of lung cancer
269757|NCT02519946|Heart Transplantation|heart transplantation
269758|NCT02519946|Tonometry|tonometry
269759|NCT02519946|Exercise Test|exercise test
269760|NCT02519946|Diet|diet
269761|NCT02519946|Cardiovascular Physiology|cardiovascular physiology
269762|NCT02519946|Telemedicine|telemedicine
269763|NCT02519946|Pediatrics|pediatrics
269764|NCT02519946|Health Behavior|health behavior
269765|NCT02519946|Physical Fitness|physical fitness
269766|NCT02519946|Exercise Movement Techniques|exercise movement techniques
269767|NCT02519946|Adolescent Behavior|adolescent behavior
269768|NCT02519946|Child Behavior|child behavior
269769|NCT02519933|hemodialysis|hemodialysis
269770|NCT02519933|vascular access|vascular access
269771|NCT02519881|cartilage defect in ankle|cartilage defect in ankle
269772|NCT02519881|microfracture|microfracture
269773|NCT02519881|modified microfracture using collagen|modified microfracture using collagen
269774|NCT02519881|collagen|collagen
269775|NCT02519868|Neuromodulation|neuromodulation
269776|NCT02519868|Local anaesthetics|local anaesthetics
269778|NCT02519829|Skin staples|skin staples
269779|NCT02519829|Vicryl|vicryl
269780|NCT02519829|Monocryl|monocryl
269781|NCT02519816|post stem cell transplantation|post stem cell transplantation
269782|NCT02519816|Steroid refractory|steroid refractory
269783|NCT02519816|dependent chronic|dependent chronic
269784|NCT02519790|Pregnancy|pregnancy
269785|NCT02519790|Depression|depression
269786|NCT02519790|Anxiety|anxiety
269787|NCT02519790|Mental Health|mental health
269788|NCT02519790|Women|women
269789|NCT02519777|HIV-Associated Neurocognitive Disorder|hiv-associated neurocognitive disorder
269790|NCT02519764|volunteer runners who are participating in the 2015 Mont Blanc Ultra Trail|volunteer runners who are participating in the 2015 mont blanc ultra trail
269791|NCT02519764|hydration protocol|hydration protocol
269792|NCT02519764|natremia|natremia
269793|NCT02519764|Volunteers|volunteers
269794|NCT02519725|Family|family
269795|NCT02519725|PTSD|ptsd
269796|NCT02519725|Anxiety disorders|anxiety disorders
269797|NCT02519725|Depression disorders|depression disorders
269798|NCT02519725|Qualitative research|qualitative research
269799|NCT02519712|Induction Chemotherapy|induction chemotherapy
269800|NCT02519712|G-CSF-Mobilized Stem Cells|g-csf-mobilized stem cells
269801|NCT02519712|Haploidentical Related Donors|haploidentical related donors
269802|NCT02519712|15-141|15-141
269803|NCT02519660|Ralydan|ralydan
269804|NCT02519660|EMLA cream|emla cream
269805|NCT02519660|Procedural pain|procedural pain
269806|NCT02519660|Phlebotomy|phlebotomy
269807|NCT02519660|Child|child
269808|NCT02519634|Super-Mini Percutaneous Nephrolithotomy|super-mini percutaneous nephrolithotomy
269809|NCT02519634|SMP|smp
269810|NCT02519634|Retrograde Intrarenal Surgery|retrograde intrarenal surgery
269811|NCT02519634|RIRS|rirs
269812|NCT02519634|Randomized Controlled Trial|randomized controlled trial
269814|NCT02519621|diabetic ulcer|diabetic ulcer
269815|NCT02519621|pressure ulcer|pressure ulcer
269816|NCT02519621|chronic or traumatic wound|chronic or traumatic wound
269817|NCT02519621|sub-acute or dehisced wound|sub-acute or dehisced wound
269818|NCT02519608|chronic obstructive pulmonary disease|chronic obstructive pulmonary disease
269819|NCT02519608|stable coronary artery disease|stable coronary artery disease
269820|NCT02519608|ticagrelor|ticagrelor
269821|NCT02519608|clopidogrel|clopidogrel
269822|NCT02519608|endothelial function|endothelial function
269823|NCT02519608|inflammation|inflammation
269824|NCT02519608|platelet reactivity|platelet reactivity
269825|NCT02519595|Procedural sedation|procedural sedation
269826|NCT02519595|ketamine|ketamine
269827|NCT02519595|children|children
269828|NCT02519582|Colorectal Cancer|colorectal cancer
269829|NCT02519582|S100A4|s100a4
269830|NCT02519556|Probiotics|probiotics
269831|NCT02519556|Inflammation|inflammation
269832|NCT02519556|Awareness|awareness
269833|NCT02519556|Immune tolerance|immune tolerance
269834|NCT02519543|insulin resistance|insulin resistance
269835|NCT02519530|Positive Youth Development|positive youth development
269836|NCT02519530|Teen Outreach|teen outreach
269837|NCT02519530|Teen Pregnancy Prevention|teen pregnancy prevention
269838|NCT02519504|Galactose-1-phosphate uridylyltransferase deficiency|galactose-1-phosphate uridylyltransferase deficiency
269839|NCT02519504|Cognitive disorders|cognitive disorders
269840|NCT02519478|football|football
269841|NCT02519478|Training Techniques|training techniques
269842|NCT02519478|education|education
269843|NCT02519478|Athletic Injuries|athletic injuries
269844|NCT02519478|Brain Concussion|brain concussion
269845|NCT02519465|nasal cannula|nasal cannula
269846|NCT02519465|Inhalation Devices|inhalation devices
269847|NCT02519452|Multiple Myeloma|multiple myeloma
269848|NCT02519452|Daratumumab (JNJ-54767414)|daratumumab (jnj-54767414)
269849|NCT02519452|Recombinant Human Hyaluronidase|recombinant human hyaluronidase
269850|NCT02519439|Partial Onset Seizures|partial onset seizures
269851|NCT02519439|complex partial seizures|complex partial seizures
269852|NCT02519439|simple partial seizures|simple partial seizures
269853|NCT02519439|anticonvulsant|anticonvulsant
269854|NCT02519439|ganaxolone|ganaxolone
269855|NCT02519439|neurosteroid|neurosteroid
269856|NCT02519439|Marinus|marinus
269857|NCT02519439|epilepsy|epilepsy
269858|NCT02519426|Third molar|third molar
269859|NCT02519426|Classification|classification
269860|NCT02519426|Inferior alveolar nerve|inferior alveolar nerve
269861|NCT02519426|Lingual nerve injuries|lingual nerve injuries
269862|NCT02519426|Mandibular canal|mandibular canal
269863|NCT02519413|lymphocyte|lymphocyte
269864|NCT02519413|serious infections|serious infections
269865|NCT02519413|opportunistic infections|opportunistic infections
269866|NCT02519413|Relapsing Forms|relapsing forms
269867|NCT02519400|amitriptyline|amitriptyline
269868|NCT02519400|cyp2d6|cyp2d6
269869|NCT02519400|cyp2c19|cyp2c19
269870|NCT02519374|Fiber tolerability|fiber tolerability
269871|NCT02519374|Children|children
269872|NCT02519361|elderly|elderly
269873|NCT02519361|immune response|immune response
269874|NCT02519361|acute infection|acute infection
269875|NCT02519348|Hepatocellular Carcinoma|hepatocellular carcinoma
269876|NCT02519348|Immunotherapy|immunotherapy
269877|NCT02519348|Antibodies, Monoclonal|antibodies, monoclonal
269878|NCT02519348|Tremelimumab|tremelimumab
269879|NCT02519348|MEDI4736|medi4736
269880|NCT02519348|Durvalumab|durvalumab
269881|NCT02519335|cardiopulmonary bypass|cardiopulmonary bypass
269882|NCT02519335|ischemia reperfusion injury|ischemia reperfusion injury
269883|NCT02519283|AHF|ahf
269884|NCT02519283|HF|hf
269885|NCT02519283|ED|ed
269886|NCT02519283|ER|er
269887|NCT02519283|Emergency Department|emergency department
269888|NCT02519283|Emergency Room|emergency room
269889|NCT02519257|CAD|cad
269890|NCT02519257|VHD|vhd
269891|NCT02519257|Thy-1|thy-1
269892|NCT02519244|Multiple Sclerosis|multiple sclerosis
269893|NCT02519244|Ambulation|ambulation
269894|NCT02519244|Rehabilitation|rehabilitation
269895|NCT02519244|Wearable Robotic Devices|wearable robotic devices
269897|NCT02519231|naproxen|naproxen
269898|NCT02519231|bleeding|bleeding
269899|NCT02519153|Phosphodiesterase 5 Inhibitors|phosphodiesterase 5 inhibitors
269900|NCT02519153|PDE5i|pde5i
269901|NCT02519153|Sildinafil|sildinafil
269902|NCT02519140|Gastric cancer|gastric cancer
269903|NCT02519140|colon cancer|colon cancer
269904|NCT02519140|EMR|emr
269905|NCT02519140|biopsy|biopsy
269906|NCT02519140|bariatric surgery|bariatric surgery
269907|NCT02519114|M Myeloma|m myeloma
269908|NCT02519114|KIR ligand mismatch|kir ligand mismatch
269909|NCT02519114|Haploidentical|haploidentical
269910|NCT02519088|Homologous Blood Transfusion|homologous blood transfusion
269911|NCT02519088|Total Hip Replacement|total hip replacement
269912|NCT02519088|Patient Blood Management|patient blood management
269913|NCT02519075|Hepatocarcinoma|hepatocarcinoma
269914|NCT02519075|TARE|tare
269915|NCT02519075|response assessment|response assessment
269916|NCT02519062|Carcinoma|carcinoma
269917|NCT02519062|Non-Small-Cell Lung|non-small-cell lung
269919|NCT02519062|hypoxia markers|hypoxia markers
269920|NCT02519062|immune markers|immune markers
269921|NCT02519049|Mesothelioma|mesothelioma
345000|NCT02118870|PCI|pci
269922|NCT02519049|11C-methionine PET|11c-methionine pet
269923|NCT02519049|talc pleurodesis|talc pleurodesis
269924|NCT02519036|Huntington's Disease|huntington's disease
269926|NCT02519036|Early Manifest Huntington's Disease|early manifest huntington's disease
269927|NCT02518997|Preterm Infants|preterm infants
269928|NCT02518997|Bedside Reading aloud|bedside reading aloud
269929|NCT02518997|Parental wellbeing|parental wellbeing
269930|NCT02518997|Parental Bonding|parental bonding
269931|NCT02518997|cardio-respiratory stability|cardio-respiratory stability
269932|NCT02518945|Type 1 Diabetes|type 1 diabetes
269933|NCT02518945|Liraglutide|liraglutide
269934|NCT02518945|Dapagliflozin|dapagliflozin
269935|NCT02518945|Triple Therapy|triple therapy
269936|NCT02518919|Children|children
269937|NCT02518919|Emergency Department|emergency department
269938|NCT02518919|Sedation|sedation
269939|NCT02518906|Psychotherapy|psychotherapy
269940|NCT02518906|psychotherapy process|psychotherapy process
269941|NCT02518906|therapeutic alliance|therapeutic alliance
269942|NCT02518906|psychotherapeutic change|psychotherapeutic change
269943|NCT02518906|psychophysiology|psychophysiology
269944|NCT02518893|Military Personnel|military personnel
269945|NCT02518893|Air Force Personnel|air force personnel
269946|NCT02518893|Army Personnel|army personnel
269947|NCT02518893|Navy Personnel|navy personnel
269948|NCT02518893|Armed Forces Personnel|armed forces personnel
269949|NCT02518893|Marines|marines
269950|NCT02518893|Soldiers|soldiers
269951|NCT02518893|Sailors|sailors
269952|NCT02518893|Airmen|airmen
269953|NCT02518893|Decision Making|decision making
269954|NCT02518893|Research Subjects|research subjects
269955|NCT02518893|Life Experiences|life experiences
269956|NCT02518893|Patient Participation|patient participation
269957|NCT02518893|Refusal to Participate|refusal to participate
269958|NCT02518893|Healthcare Research|healthcare research
269959|NCT02518893|Qualitative Research|qualitative research
269960|NCT02518893|Interview|interview
269961|NCT02518893|Interviews, Telephone|interviews, telephone
269962|NCT02518893|Ethics, Research|ethics, research
269963|NCT02518867|Cerebral palsy|cerebral palsy
269964|NCT02518867|Transcranial magnetic stimulation|transcranial magnetic stimulation
269965|NCT02518841|ThermaWedge TM|thermawedge tm
269966|NCT02518841|stretches|stretches
269967|NCT02518828|Acute Heart Failure|acute heart failure
269968|NCT02518802|Gefitinib|gefitinib
269969|NCT02518802|Pemetrexed|pemetrexed
269970|NCT02518802|Synchronous therapy|synchronous therapy
269971|NCT02518802|Adjuvent therapy|adjuvent therapy
269972|NCT02518789|myoclonus|myoclonus
269973|NCT02518789|Etomidate|etomidate
269974|NCT02518789|Dexmedetomidine|dexmedetomidine
269975|NCT02518750|Hematopoietic Stem Cell Transplantation|hematopoietic stem cell transplantation
269976|NCT02518750|Salvage Regimen|salvage regimen
269977|NCT02518750|Re-Induction Therapy|re-induction therapy
269978|NCT02518750|Multi-agent chemotherapy|multi-agent chemotherapy
269979|NCT02518737|Glucose-dependent Insulinotropic Polypeptide|glucose-dependent insulinotropic polypeptide
269980|NCT02518737|Receptor Deficiency|receptor deficiency
269981|NCT02518711|symptoms of ADHD|symptoms of adhd
269982|NCT02518698|Castrated resistant prostate cancer|castrated resistant prostate cancer
269983|NCT02518698|Patients with bone metastases|patients with bone metastases
269984|NCT02518685|Obesity|obesity
269985|NCT02518685|Weight loss|weight loss
269986|NCT02518685|Device|device
269987|NCT02518685|Non-surgical|non-surgical
269988|NCT02518685|Endoscopic|endoscopic
269989|NCT02518685|TransPyloric Shuttle|transpyloric shuttle
269990|NCT02518685|TPS|tps
269991|NCT02518659|hypomagnesemia|hypomagnesemia
269992|NCT02518659|hypocalcemia|hypocalcemia
269993|NCT02518659|inulin|inulin
269994|NCT02518659|FOS|fos
269995|NCT02518659|PPI|ppi
269996|NCT02518659|proton-pump inhibitors|proton-pump inhibitors
269997|NCT02518646|Delirium|delirium
269998|NCT02518646|Intensive care unit|intensive care unit
269999|NCT02518646|Adult|adult
270000|NCT02518646|Clinical prediction|clinical prediction
270001|NCT02518633|obesity|obesity
270002|NCT02518633|hypoxia|hypoxia
270003|NCT02518633|adipose tissue|adipose tissue
270004|NCT02518607|Safety and Tolerability|safety and tolerability
270005|NCT02518607|Male Volunteers|male volunteers
270006|NCT02518594|women|women
270007|NCT02518594|cervical length of less than 30 millimeters|cervical length of less than 30 millimeters
270008|NCT02518594|carrying twins|carrying twins
270009|NCT02518594|short cervix|short cervix
270010|NCT02518516|Statins, HMG-CoA|statins, hmg-coa
270011|NCT02518516|Acute kidney injury|acute kidney injury
270012|NCT02518516|Kidney diseases|kidney diseases
270013|NCT02518516|Renal failure|renal failure
270014|NCT02518503|Diabetes Mellitus|diabetes mellitus
270015|NCT02518503|Statins|statins
270016|NCT02518503|HMG-CoA reductase inhibitors|hmg-coa reductase inhibitors
270017|NCT02518477|breast cancer surgery|breast cancer surgery
270018|NCT02518477|axillary lymph node dissection|axillary lymph node dissection
270019|NCT02518477|resistance training|resistance training
270020|NCT02518477|breast cancer related lymphedema|breast cancer related lymphedema
270021|NCT02518464|headache|headache
270022|NCT02518464|chronic|chronic
270023|NCT02518464|migraine|migraine
270024|NCT02518464|right to left shunt|right to left shunt
270025|NCT02518451|antihypertensive|antihypertensive
270026|NCT02518451|bioequivalence|bioequivalence
270027|NCT02518451|formulation|formulation
270028|NCT02518451|pharmakokinetic|pharmakokinetic
270029|NCT02518451|valsartan|valsartan
270030|NCT02518451|subjects|subjects
270031|NCT02518451|Fasting conditions|fasting conditions
270032|NCT02518438|Tramadol|tramadol
270033|NCT02518438|Postoperative analgesia|postoperative analgesia
270034|NCT02518438|Infiltration|infiltration
270035|NCT02518438|Cesarean section|cesarean section
270036|NCT02518412|Alzheimers disease|alzheimers disease
270037|NCT02518412|Transcranial direct current stimulation (tDCS)|transcranial direct current stimulation (tdcs)
270038|NCT02518412|Neuromodulation|neuromodulation
270039|NCT02518412|Neuropsychology|neuropsychology
270040|NCT02518399|Blood vessels|blood vessels
270041|NCT02518399|Heat|heat
270042|NCT02518399|Cardiovascular diseases|cardiovascular diseases
270043|NCT02518386|emergency department|emergency department
270044|NCT02518386|epidemiology|epidemiology
270045|NCT02518386|prehospital care|prehospital care
270046|NCT02518386|dispatch|dispatch
270047|NCT02518386|acute self poisoning|acute self poisoning
270048|NCT02518360|NON SPECIFIC LOW BACK PAIN|non specific low back pain
270049|NCT02518360|OSTEOPATHY|osteopathy
270050|NCT02518360|FOOT PRESSURE PLATFORM|foot pressure platform
270051|NCT02518360|POSTURAL BALANCE|postural balance
270052|NCT02518334|type two diabetes|type two diabetes
270053|NCT02518334|glycemic control|glycemic control
270054|NCT02518321|Toileting|toileting
270055|NCT02518321|Technology-Assisted Toilets|technology-assisted toilets
270056|NCT02518321|Rehabilitation|rehabilitation
270057|NCT02518321|Assistive Devices|assistive devices
270058|NCT02518321|Activities of Daily Living|activities of daily living
270059|NCT02518282|high-sensitivity troponin T|high-sensitivity troponin t
270060|NCT02518282|Acute myocardial infarction|acute myocardial infarction
270061|NCT02518282|Heart valvular surgery|heart valvular surgery
270062|NCT02518282|Cardiac surgery|cardiac surgery
270063|NCT02518269|hip|hip
270064|NCT02518269|arthroplasty|arthroplasty
270065|NCT02518269|G7|g7
270066|NCT02518269|EchoBimetric|echobimetric
270067|NCT02518269|E1|e1
270068|NCT02518269|ceramic|ceramic
270069|NCT02518269|Arcom XL|arcom xl
270070|NCT02518256|Neoplasms|neoplasms
270071|NCT02518256|Glandular and Epithelial|glandular and epithelial
270072|NCT02518256|Ovarian Neoplasms|ovarian neoplasms
270073|NCT02518256|Ovarian cancer|ovarian cancer
270074|NCT02518204|cognitive assessment|cognitive assessment
270075|NCT02518204|neuropsychological assessment|neuropsychological assessment
270076|NCT02518204|Brain Performance Test|brain performance test
270077|NCT02518204|computerized assessment|computerized assessment
270078|NCT02518191|GnRHa|gnrha
270079|NCT02518191|ovarian function|ovarian function
270080|NCT02518191|anti-mullerian hormone|anti-mullerian hormone
270081|NCT02518178|NFC|nfc
270082|NCT02518178|randomization|randomization
270083|NCT02518178|RCT|rct
270084|NCT02518178|mHealth|mhealth
270085|NCT02518178|maternal and child health|maternal and child health
270086|NCT02518165|Cognitive Domain: Speed|cognitive domain: speed
270087|NCT02518165|Cognitive Domain: Reaction Time|cognitive domain: reaction time
270088|NCT02518165|Cognitive Domain: Attention|cognitive domain: attention
270089|NCT02518165|Cognitive Domain: Executive Function|cognitive domain: executive function
270090|NCT02518165|Cognitive Domain Memory|cognitive domain memory
270091|NCT02518165|Sleep Quality|sleep quality
270092|NCT02518165|Sleep Efficiency|sleep efficiency
270093|NCT02518139|Chronic Obstructive Pulmonary Disease, COPD|chronic obstructive pulmonary disease, copd
270094|NCT02518126|LIF IUGR|lif iugr
270095|NCT02518087|CPB|cpb
270096|NCT02518087|oXiris®|oxiris®
270097|NCT02518087|CS-AKI|cs-aki
270098|NCT02518087|SIRS|sirs
270099|NCT02518087|Cytokines|cytokines
270100|NCT02518087|LPS|lps
270101|NCT02518087|AKI|aki
270102|NCT02518074|volunteers|volunteers
270103|NCT02518061|Glioma; 11C-Methionine PET|glioma; 11c-methionine pet
270104|NCT02518048|Psoriasis|psoriasis
270105|NCT02518022|Type 1 Diabetes mellitus|type 1 diabetes mellitus
270106|NCT02518022|Hypoglycemia|hypoglycemia
270107|NCT02518022|continuous subcutaneous insulin infusion|continuous subcutaneous insulin infusion
270108|NCT02518022|Alcohol|alcohol
270109|NCT02518022|continuous glucose monitoring system|continuous glucose monitoring system
270110|NCT02518022|Nutrition|nutrition
270111|NCT02517983|chronic respiratory diseases phenotyping|chronic respiratory diseases phenotyping
270112|NCT02517970|infant feeding|infant feeding
270113|NCT02517970|breast-feeding|breast-feeding
270114|NCT02517970|bottle-feeding|bottle-feeding
270115|NCT02517970|feeding interactions|feeding interactions
270116|NCT02517970|maternal feeding practices|maternal feeding practices
270117|NCT02517957|Xiashi surgical|xiashi surgical
270717|NCT02513849|gastroscopy|gastroscopy
270118|NCT02517944|Familial hypercholesterolemia|familial hypercholesterolemia
270119|NCT02517918|Advanced solid tumor|advanced solid tumor
270120|NCT02517918|Bone metastasis and advanced pretreated osteosarcoma|bone metastasis and advanced pretreated osteosarcoma
270121|NCT02517918|Phase I trial|phase i trial
270122|NCT02517918|Dose escalation and expansion cohort|dose escalation and expansion cohort
270123|NCT02517918|Biomarkers study|biomarkers study
270124|NCT02517879|ITNs|itns
270125|NCT02517879|malaria prevention|malaria prevention
270126|NCT02517866|Drug therapy|drug therapy
270127|NCT02517827|common femoral artery|common femoral artery
270128|NCT02517827|drug-coated balloon|drug-coated balloon
270129|NCT02517827|surgical endarterectomy|surgical endarterectomy
270130|NCT02517801|anthocyanins|anthocyanins
270131|NCT02517801|Post-menopausal women|post-menopausal women
270132|NCT02517801|endothelial function|endothelial function
270133|NCT02517801|vascular function|vascular function
270134|NCT02517775|polyphenols|polyphenols
270135|NCT02517775|vascular function|vascular function
270136|NCT02517775|endothelial function|endothelial function
270137|NCT02517775|cranberry|cranberry
270138|NCT02517775|healthy|healthy
270139|NCT02517723|Borderline Personality Disorder|borderline personality disorder
270140|NCT02517723|comorbid Posttraumatic Stress Disorder|comorbid posttraumatic stress disorder
270141|NCT02517723|Narrative Exposure Therapy|narrative exposure therapy
270142|NCT02517723|Dialectical-Behavioral Therapy|dialectical-behavioral therapy
270143|NCT02517684|Crohn's disease|crohn's disease
270144|NCT02517684|pediatric|pediatric
270145|NCT02517684|infliximab|infliximab
270146|NCT02517684|top-down|top-down
270147|NCT02517684|TISKids|tiskids
270148|NCT02517671|Fitness|fitness
270149|NCT02517671|Run time|run time
270150|NCT02517671|VO2max|vo2max
270151|NCT02517671|VEGF|vegf
270152|NCT02517671|Central blood pressure|central blood pressure
270153|NCT02517671|Augmentation Index|augmentation index
270154|NCT02517671|Pulse wave analysis|pulse wave analysis
270155|NCT02517632|Physical activity|physical activity
270156|NCT02517632|Cardiac rehabilitation|cardiac rehabilitation
270157|NCT02517619|Iontophoresis|iontophoresis
270158|NCT02517619|Ophthalmology|ophthalmology
270159|NCT02517619|Non-Infectious Anterior Segment Uveitis|non-infectious anterior segment uveitis
270160|NCT02517593|BCRAT|bcrat
270161|NCT02517593|IBIS|ibis
270162|NCT02517593|PRS|prs
270163|NCT02517593|breast cancer|breast cancer
270164|NCT02517593|Tyrer-Cuzick|tyrer-cuzick
270165|NCT02517554|meet National Comprehensive Cancer Network® criteria for cancer genetic testing for breast, ovarian and colorectal cancers|meet national comprehensive cancer network® criteria for cancer genetic testing for breast, ovarian and colorectal cancers
270166|NCT02517528|HCV Infection|hcv infection
270167|NCT02517528|Compensated Cirrhosis|compensated cirrhosis
270168|NCT02517515|HCV Infection|hcv infection
270169|NCT02517515|Chronic Hepatitis C Virus|chronic hepatitis c virus
270170|NCT02517515|Hepatitis C Virus (HCV) Genotype 1b|hepatitis c virus (hcv) genotype 1b
270171|NCT02517502|DHA|dha
270172|NCT02517502|Omega-3|omega-3
270173|NCT02517502|neoadjuvant chemotherapy|neoadjuvant chemotherapy
270174|NCT02517502|chemotherapy|chemotherapy
270175|NCT02517502|breast cancer|breast cancer
270176|NCT02517489|Community-Acquired Pneumonia (CAP)|community-acquired pneumonia (cap)
270177|NCT02517489|Hydrocortisone|hydrocortisone
270178|NCT02517489|Corticosteroids|corticosteroids
270179|NCT02517463|Emergency contraception|emergency contraception
270180|NCT02517463|ulipristal acetate|ulipristal acetate
270181|NCT02517463|efficacy|efficacy
270182|NCT02517450|Subjects|subjects
270183|NCT02517424|PTSD|ptsd
270184|NCT02517411|COPD|copd
270185|NCT02517411|physiotherapy|physiotherapy
270186|NCT02517411|Stable disease|stable disease
270187|NCT02517398|Solid tumor|solid tumor
270188|NCT02517398|MSB0011359C (M7824)|msb0011359c (m7824)
270189|NCT02517398|Metastatic or Locally Advanced Solid Tumors|metastatic or locally advanced solid tumors
270190|NCT02517346|CPAP compliance|cpap compliance
270191|NCT02517346|Telemonitoring|telemonitoring
270192|NCT02517346|Standard management|standard management
270193|NCT02517346|Cost effectiveness|cost effectiveness
270194|NCT02517333|Motor skill proficiency|motor skill proficiency
270195|NCT02517333|movement difficulties|movement difficulties
270196|NCT02517333|Developmental Coordination Disorder (DCD)|developmental coordination disorder (dcd)
270197|NCT02517333|Low physical fitness|low physical fitness
270198|NCT02517320|Diabetic Nephropathy|diabetic nephropathy
270199|NCT02517294|Nasotracheal intubation|nasotracheal intubation
270200|NCT02517294|adenoid size|adenoid size
270201|NCT02517294|epistaxis|epistaxis
270202|NCT02517294|nasopharyngeal mucosal injury|nasopharyngeal mucosal injury
270203|NCT02517255|ST segment elevation myocardial infarction|st segment elevation myocardial infarction
270204|NCT02517255|Failed Thrombolysis|failed thrombolysis
270205|NCT02517255|Rescue Percutaneous Coronary Intervention|rescue percutaneous coronary intervention
270206|NCT02517255|Cardiac Magnetic Resonance Imaging|cardiac magnetic resonance imaging
270207|NCT02517229|volunteers|volunteers
270208|NCT02517216|volunteers|volunteers
270209|NCT02517190|volunteers|volunteers
270210|NCT02517177|volunteers|volunteers
270211|NCT02517151|iron|iron
270213|NCT02517151|crohn's disease|crohn's disease
270214|NCT02517151|ulcerative colitis|ulcerative colitis
270215|NCT02517151|IBD|ibd
270216|NCT02517138|volunteers|volunteers
270217|NCT02517112|volunteers|volunteers
270218|NCT02517099|Preschool|preschool
270219|NCT02517099|Wheeze|wheeze
270220|NCT02517099|Moderate|moderate
270221|NCT02517099|Severe|severe
270222|NCT02517086|blood circulation|blood circulation
270223|NCT02517073|mechanical ventilation|mechanical ventilation
270224|NCT02517073|epidemiology|epidemiology
270225|NCT02517073|intensive care unit|intensive care unit
270226|NCT02517073|national survey|national survey
270227|NCT02517060|Social perceptions|social perceptions
270228|NCT02517008|non-monetary incentive|non-monetary incentive
270229|NCT02517008|institutional delivery|institutional delivery
270230|NCT02516982|mHealth|mhealth
270231|NCT02516982|Telemedicine|telemedicine
270232|NCT02516982|Perinatal depression|perinatal depression
270233|NCT02516982|Screening|screening
270234|NCT02516982|Edinburgh Postnatal Depression Scale|edinburgh postnatal depression scale
270235|NCT02516982|Whooley Questions|whooley questions
270236|NCT02516982|Data collection|data collection
270237|NCT02516982|Mood disorders|mood disorders
270238|NCT02516982|Mental health|mental health
270239|NCT02516982|Antenatal care|antenatal care
270240|NCT02516982|Prenatal Care|prenatal care
270241|NCT02516956|Breakfast|breakfast
270242|NCT02516956|Food choices|food choices
270243|NCT02516956|Lunch|lunch
270244|NCT02516956|Eating habits|eating habits
270245|NCT02516956|Appetite|appetite
270246|NCT02516956|Neural activation|neural activation
270247|NCT02516956|Attention|attention
270248|NCT02516956|Glucose|glucose
270249|NCT02516956|Insulin|insulin
270250|NCT02516956|fMRI|fmri
270251|NCT02516943|Arterial blood gas analysis|arterial blood gas analysis
270252|NCT02516930|health promotion|health promotion
270253|NCT02516930|crowdsourcing|crowdsourcing
270254|NCT02516904|Subjects|subjects
270255|NCT02516891|treatment|treatment
270256|NCT02516891|stent|stent
270257|NCT02516891|coronary bifurcations lesions|coronary bifurcations lesions
270258|NCT02516878|acupuncture|acupuncture
270259|NCT02516878|Chinese Medicine|chinese medicine
270260|NCT02516878|obesity|obesity
270261|NCT02516865|postpartum|postpartum
270262|NCT02516865|physical activity|physical activity
270263|NCT02516852|community development; poultry; animal-source food; stunting|community development; poultry; animal-source food; stunting
270264|NCT02516839|Overweight|overweight
270265|NCT02516839|Obesity|obesity
270266|NCT02516839|Overeating|overeating
270267|NCT02516839|Body Mass Index|body mass index
270268|NCT02516839|Weight|weight
270269|NCT02516839|Treatment|treatment
270270|NCT02516839|Cravings|cravings
270271|NCT02516839|Intervention|intervention
270272|NCT02516839|Behavioral Treatment|behavioral treatment
270273|NCT02516813|M3814|m3814
270274|NCT02516813|Advanced solid tumors|advanced solid tumors
270275|NCT02516813|DNA-PK Inhibitor|dna-pk inhibitor
270276|NCT02516813|Radiotherapy|radiotherapy
270277|NCT02516813|Chemotherapy|chemotherapy
270278|NCT02516787|volunteers|volunteers
270279|NCT02516761|Fibromyalgia|fibromyalgia
270280|NCT02516748|optical diagnosis|optical diagnosis
270281|NCT02516748|narrow band image|narrow band image
270282|NCT02516644|Parkinson Disease|parkinson disease
270283|NCT02516644|Mobility|mobility
270284|NCT02516644|Balance|balance
270285|NCT02516644|Virtual Reality|virtual reality
270286|NCT02516644|treadmill training|treadmill training
270287|NCT02516631|Labour, induced|labour, induced
270288|NCT02516631|Misoprostol|misoprostol
270289|NCT02516631|Pharmacokinetics|pharmacokinetics
270290|NCT02516631|Cardiotocography|cardiotocography
270291|NCT02516631|Safety|safety
270292|NCT02516605|Primary Biliary Cirrhosis, PBC|primary biliary cirrhosis, pbc
270293|NCT02516605|Primary Biliary Cholangitis|primary biliary cholangitis
270294|NCT02516566|Positive end-expiratory pressure ventilation|positive end-expiratory pressure ventilation
270295|NCT02516566|Optic nerve sheath diameter|optic nerve sheath diameter
270296|NCT02516553|NUT midline carcinoma|nut midline carcinoma
270297|NCT02516540|hereditary breast and ovarian cancer (HBOC)|hereditary breast and ovarian cancer (hboc)
270298|NCT02516540|BRCA1/2 mutation carriers|brca1/2 mutation carriers
270299|NCT02516540|Mediterranean diet|mediterranean diet
270300|NCT02516540|Structured exercise training|structured exercise training
270301|NCT02516540|prevention|prevention
270302|NCT02516514|Blood culture|blood culture
270303|NCT02516514|Bacteremia|bacteremia
270304|NCT02516514|Single sampling|single sampling
270305|NCT02516501|Ketogenic Diet|ketogenic diet
270306|NCT02516501|Body composition|body composition
270307|NCT02516501|Radiation therapy|radiation therapy
270308|NCT02516436|Bunavail|bunavail
270309|NCT02516436|Suboxone|suboxone
270310|NCT02516436|Heroin|heroin
270311|NCT02516436|Zubsolv|zubsolv
270312|NCT02516436|Buprenorphine|buprenorphine
270313|NCT02516436|Naloxone|naloxone
270314|NCT02516436|Opioids|opioids
270315|NCT02516436|Addiction|addiction
270316|NCT02516436|Induction|induction
270317|NCT02516397|body fat mass reduction|body fat mass reduction
270318|NCT02516384|Fecal Microbiota Transplantation|fecal microbiota transplantation
270319|NCT02516384|Ulcerative Colitis|ulcerative colitis
270320|NCT02516345|Physical activity|physical activity
270321|NCT02516345|Financial incentives|financial incentives
270322|NCT02516345|Children|children
270323|NCT02516345|Parents|parents
270324|NCT02516345|RCT|rct
270325|NCT02516345|Wireless pedometer|wireless pedometer
270326|NCT02516306|Presbyopia|presbyopia
270327|NCT02516306|Vision|vision
270328|NCT02516306|UNR844|unr844
270329|NCT02516280|Total knee replacement|total knee replacement
270330|NCT02516280|Cold|cold
270331|NCT02516280|Neurocryostimulation|neurocryostimulation
270332|NCT02516280|CO2 cryotherapy|co2 cryotherapy
270333|NCT02516280|mobility|mobility
270334|NCT02516267|platelet aggregability|platelet aggregability
270335|NCT02516267|acute coronary syndrome|acute coronary syndrome
270336|NCT02516267|coronary artery bypass graft|coronary artery bypass graft
270337|NCT02516254|vitamin D|vitamin d
270338|NCT02516254|fortified bread|fortified bread
270339|NCT02516254|efficacy|efficacy
270340|NCT02516254|Vitamin D Deficiency|vitamin d deficiency
270341|NCT02516241|Urothelial Cancer|urothelial cancer
270342|NCT02516241|Phase III|phase iii
270343|NCT02516189|Microcirculation|microcirculation
270344|NCT02516189|Electromyography|electromyography
270345|NCT02516189|Motor Activity|motor activity
270346|NCT02516176|stroke|stroke
270347|NCT02516176|cerebral vascular accident|cerebral vascular accident
270348|NCT02516176|balance|balance
270349|NCT02516176|treadmill|treadmill
270350|NCT02516176|falls|falls
270351|NCT02516176|hemiparesis|hemiparesis
270352|NCT02516150|Type 1 Diabetes|type 1 diabetes
270353|NCT02516150|Bionic Pancreas|bionic pancreas
270354|NCT02516150|Artificial Pancreas|artificial pancreas
270355|NCT02516150|Insulin|insulin
270356|NCT02516150|Glucagon|glucagon
270357|NCT02516150|Alcohol|alcohol
270358|NCT02516150|Alcohol Clamp|alcohol clamp
270359|NCT02516137|Dry needling|dry needling
270360|NCT02516124|Autoimmune diseases|autoimmune diseases
270361|NCT02516124|Systemic sclerosis|systemic sclerosis
270362|NCT02516124|Autologous Hematopoietic stem cell transplant|autologous hematopoietic stem cell transplant
270363|NCT02516072|remote ischemic preconditioning|remote ischemic preconditioning
270364|NCT02516059|thoracic epidural analgesia|thoracic epidural analgesia
270365|NCT02516059|oxycodone|oxycodone
270366|NCT02516059|oral naloxone|oral naloxone
270367|NCT02516059|radical cystectomy|radical cystectomy
270368|NCT02516059|bowel function|bowel function
270369|NCT02516059|pain|pain
270370|NCT02516033|Atrial Fibrillation|atrial fibrillation
270371|NCT02516033|Hybrid Ablation|hybrid ablation
270372|NCT02516033|Efficacy|efficacy
270373|NCT02516033|Risk Profile|risk profile
270374|NCT02516033|Biomarkers|biomarkers
270375|NCT02516020|IVF|ivf
270376|NCT02516020|ICSI|icsi
270377|NCT02516020|culture media|culture media
270378|NCT02516020|sequential|sequential
270379|NCT02515981|tobacco dependence|tobacco dependence
270380|NCT02515981|smoking cessation|smoking cessation
270381|NCT02515981|mental health|mental health
270382|NCT02515981|cardiovascular disease|cardiovascular disease
270383|NCT02515981|obesity|obesity
270384|NCT02515955|Healthy|healthy
270385|NCT02515955|JNJ-54175446|jnj-54175446
270386|NCT02515942|Geographic atrophy (GA)|geographic atrophy (ga)
270387|NCT02515942|Macular degeneration|macular degeneration
270388|NCT02515942|Dry age-related macular degeneration (AMD)|dry age-related macular degeneration (amd)
270389|NCT02515942|Intravitreal (IVT)|intravitreal (ivt)
270390|NCT02515942|Retinal diseases|retinal diseases
270391|NCT02515942|Fundus auto fluorescence (FAF)|fundus auto fluorescence (faf)
270392|NCT02515929|Oligomeric Proanthocyanidins|oligomeric proanthocyanidins
270393|NCT02515929|Periodontal Disease|periodontal disease
270394|NCT02515903|Endoscopy|endoscopy
270395|NCT02515903|Intracerebral hemorrhage|intracerebral hemorrhage
270396|NCT02515903|surgery|surgery
270397|NCT02515903|stereotactic aspiration|stereotactic aspiration
270398|NCT02515903|Key-hole approach|key-hole approach
270399|NCT02515903|Intracerebral hemorrhage surgical treatment|intracerebral hemorrhage surgical treatment
270400|NCT02515903|Transparent endoscopic sheath|transparent endoscopic sheath
270401|NCT02515903|Agitation-aspiration device|agitation-aspiration device
270402|NCT02515890|midazolam|midazolam
270403|NCT02515890|dexmedetomidine|dexmedetomidine
270404|NCT02515890|memory|memory
270405|NCT02515890|ketamine|ketamine
270406|NCT02515864|Male and Female Volunteers|male and female volunteers
270407|NCT02515786|Chronic respiratory failure|chronic respiratory failure
270408|NCT02515786|Oxygen therapy|oxygen therapy
270409|NCT02515786|Nasal catheter|nasal catheter
270410|NCT02515786|Mucociliary clearance|mucociliary clearance
270411|NCT02515747|Lipoprotein(a)|lipoprotein(a)
270412|NCT02515747|coronary artery bypass grafting (CABG)|coronary artery bypass grafting (cabg)
270413|NCT02515747|apo(a)|apo(a)
270414|NCT02515747|prognosis|prognosis
270415|NCT02515747|myocardial infarction|myocardial infarction
270416|NCT02515747|cardiovascular death|cardiovascular death
270718|NCT02513849|tamoxifen|tamoxifen
270417|NCT02515747|percutaneous coronary intervention (PCI)|percutaneous coronary intervention (pci)
270418|NCT02515734|FOLFOXIRI|folfoxiri
270419|NCT02515734|Bmab|bmab
270420|NCT02515734|Cmab|cmab
270421|NCT02515617|Ventilator-associated pneumonia|ventilator-associated pneumonia
270422|NCT02515617|Subglottic-secretions drainage|subglottic-secretions drainage
270423|NCT02515617|Critically ill patients|critically ill patients
270424|NCT02515617|Cost-utility analysis|cost-utility analysis
270425|NCT02515617|Prevention|prevention
270426|NCT02515591|Healthy volunteer|healthy volunteer
270427|NCT02515591|Respiratory|respiratory
270428|NCT02515591|Bronchoalveolar lavage|bronchoalveolar lavage
270429|NCT02515578|Primary Health Care|primary health care
270430|NCT02515578|Cardiovascular Diseases|cardiovascular diseases
270431|NCT02515578|Quality Improvement|quality improvement
270432|NCT02515565|pneumonia|pneumonia
270433|NCT02515565|Exacerbation|exacerbation
270434|NCT02515565|physiotherapy|physiotherapy
270435|NCT02515565|hospitalization|hospitalization
270436|NCT02515539|Transcatheter Mitral Valve Replacement|transcatheter mitral valve replacement
270437|NCT02515539|Mitral Regurgitation|mitral regurgitation
270438|NCT02515539|Mitral Insufficiency|mitral insufficiency
270439|NCT02515539|Transapical|transapical
270440|NCT02515539|Transfemoral|transfemoral
270441|NCT02515513|Pancreas|pancreas
270442|NCT02515513|Pancreas Cancer|pancreas cancer
270443|NCT02515513|Muscle Biopsy|muscle biopsy
270444|NCT02515513|Cachexia|cachexia
270445|NCT02515513|Muscle Cachexia|muscle cachexia
270446|NCT02515500|cigarette reduction|cigarette reduction
270447|NCT02515500|digital health|digital health
270448|NCT02515500|mobile health|mobile health
270449|NCT02515500|technology|technology
270450|NCT02515500|Quitbit|quitbit
270451|NCT02515500|mHealth|mhealth
270452|NCT02515500|smoking cessation|smoking cessation
270453|NCT02515500|quit smoking|quit smoking
270454|NCT02515500|self-regulation|self-regulation
270455|NCT02515487|Post-chemotherapy|post-chemotherapy
270456|NCT02515487|cognitive impairment|cognitive impairment
270457|NCT02515474|Cholangiopancreatography|cholangiopancreatography
270458|NCT02515474|Endoscopic|endoscopic
270459|NCT02515474|Common bile duct|common bile duct
270460|NCT02515474|Complication|complication
270461|NCT02515474|Recurrence|recurrence
270462|NCT02515474|Laparoscopic|laparoscopic
270463|NCT02515461|Diabetes mellitus|diabetes mellitus
270464|NCT02515461|Low energy shockwave therapy|low energy shockwave therapy
270465|NCT02515461|Chronic Renal Insufficiency|chronic renal insufficiency
270466|NCT02515448|VAP|vap
270467|NCT02515448|Critical care|critical care
270468|NCT02515448|Pharmacokinetics|pharmacokinetics
270469|NCT02515448|Gentamicin|gentamicin
270470|NCT02515435|apatinib|apatinib
270471|NCT02515435|NSCLC|nsclc
270472|NCT02515435|safety|safety
270473|NCT02515435|efficacy|efficacy
270474|NCT02515422|Caesarean Section|caesarean section
270475|NCT02515409|Obstructive Sleep Apnea Syndrome (OSAS)|obstructive sleep apnea syndrome (osas)
270476|NCT02515409|Heated Humidified High Flow Nasal Cannula (HHHNC)|heated humidified high flow nasal cannula (hhhnc)
270477|NCT02515409|Continues positive airway pressure (CPAP)|continues positive airway pressure (cpap)
270478|NCT02515409|Children|children
270479|NCT02515409|Non invasive ventilation|non invasive ventilation
270480|NCT02515409|Treatment|treatment
270481|NCT02515383|Adolescent Cancer|adolescent cancer
270482|NCT02515383|MD Anderson Symptom Inventory (modified for adolescent use)|md anderson symptom inventory (modified for adolescent use)
270483|NCT02515383|MDASI|mdasi
270484|NCT02515383|Surveys|surveys
270485|NCT02515383|Questionnaires|questionnaires
270486|NCT02515383|Interviews|interviews
270487|NCT02515383|Symptoms|symptoms
270488|NCT02515370|Option B plus|option b plus
270489|NCT02515370|HIV infected women|hiv infected women
270490|NCT02515357|Sleep Disorders|sleep disorders
270491|NCT02515357|Metabolic Syndrome|metabolic syndrome
270492|NCT02515357|Mediterranean Diet|mediterranean diet
270493|NCT02515357|Mediterranean Lifestyle|mediterranean lifestyle
270494|NCT02515344|Patients|patients
270495|NCT02515344|early detection of cancer|early detection of cancer
270496|NCT02515344|patient compliance|patient compliance
270497|NCT02515331|resistant hypertension|resistant hypertension
270498|NCT02515318|COPD|copd
270499|NCT02515318|Exacerbation|exacerbation
270500|NCT02515318|Hospitalisation|hospitalisation
270501|NCT02515318|Physiotherapy|physiotherapy
270502|NCT02515292|IUGR (intrauterine growth restriction)|iugr (intrauterine growth restriction)
270503|NCT02515292|IGF2 (insulin-like growth factor 2)|igf2 (insulin-like growth factor 2)
270504|NCT02515292|morbidity|morbidity
270505|NCT02515266|protein|protein
270506|NCT02515266|growth|growth
270507|NCT02515266|head circumference|head circumference
270508|NCT02515253|Breast Pain|breast pain
270509|NCT02515253|Mastalgia|mastalgia
270510|NCT02515253|Bras|bras
270511|NCT02515253|Breast Support|breast support
270512|NCT02515227|peptide|peptide
270513|NCT02515227|vaccine|vaccine
270514|NCT02515227|Montanide ISA-51|montanide isa-51
270515|NCT02515227|pembrolizumab|pembrolizumab
270516|NCT02515227|PD-1|pd-1
270517|NCT02515227|KEYTRUDA|keytruda
270518|NCT02515214|bariatric surgery|bariatric surgery
270519|NCT02515214|reproduction|reproduction
270520|NCT02515175|HSV|hsv
270521|NCT02515175|Herpes|herpes
270522|NCT02515175|Genital Herpes|genital herpes
270523|NCT02515175|Vaccine|vaccine
270524|NCT02515162|conization|conization
270525|NCT02515162|LLETZ|lletz
270526|NCT02515162|cervical dysplasia|cervical dysplasia
270527|NCT02515162|cervical intraepithelial neoplasia|cervical intraepithelial neoplasia
270528|NCT02515162|Fischer cone biopsy excisor|fischer cone biopsy excisor
270529|NCT02515162|loop electrosurgical excision procedure|loop electrosurgical excision procedure
270530|NCT02515149|linkage to care|linkage to care
270531|NCT02515149|point of care diagnostics|point of care diagnostics
270532|NCT02515149|point of care CD4|point of care cd4
270533|NCT02515149|HIV care cascade|hiv care cascade
270534|NCT02515149|Kenya|kenya
270535|NCT02515123|intensive care unit|intensive care unit
270536|NCT02515123|malnutrition|malnutrition
270537|NCT02515123|GI motility|gi motility
270538|NCT02515123|nutritional intake|nutritional intake
270539|NCT02515110|lumpectomy|lumpectomy
270540|NCT02515110|mastectomy without reconstruction|mastectomy without reconstruction
270541|NCT02515110|mastectomy with reconstruction|mastectomy with reconstruction
270542|NCT02515110|Estrogen Receptor Negative|estrogen receptor negative
270543|NCT02515110|Estrogen Receptor Positive|estrogen receptor positive
270544|NCT02515110|HER2/Neu Negative|her2/neu negative
270545|NCT02515110|HER2/Neu Positive|her2/neu positive
270546|NCT02515110|Progesterone Receptor Negative|progesterone receptor negative
270547|NCT02515110|Progesterone Receptor Positive|progesterone receptor positive
270548|NCT02515110|Stage IA Breast Cancer|stage ia breast cancer
270549|NCT02515110|Stage IB Breast Cancer|stage ib breast cancer
270550|NCT02515110|Stage IIA Breast Cancer|stage iia breast cancer
270551|NCT02515110|Stage IIB Breast Cancer|stage iib breast cancer
270552|NCT02515110|Stage IIIA Breast Cancer|stage iiia breast cancer
270553|NCT02515084|recurrence Thyroid cancer|recurrence thyroid cancer
270554|NCT02515084|18F-FDG PET-CT|18f-fdg pet-ct
270555|NCT02515084|diffusion-weighted Magnetic Resonance Imaging|diffusion-weighted magnetic resonance imaging
270556|NCT02515045|Cataract|cataract
270557|NCT02515045|Surgery|surgery
270558|NCT02515045|Prophylaxis|prophylaxis
270559|NCT02515019|Anaesthetics inhalation|anaesthetics inhalation
270560|NCT02515019|Bispectral index|bispectral index
270561|NCT02515019|Cardiopulmonary bypass|cardiopulmonary bypass
270562|NCT02514993|Sternal fracture|sternal fracture
270563|NCT02514993|Thoracic spine fracture|thoracic spine fracture
270564|NCT02514993|Thoracic cage injury|thoracic cage injury
270565|NCT02514967|SLE|sle
270566|NCT02514967|Lupus|lupus
270567|NCT02514967|Lupus Erythematosus, Systemic|lupus erythematosus, systemic
270568|NCT02514967|Autoimmune Diseases|autoimmune diseases
270569|NCT02514967|A-623|a-623
270570|NCT02514967|Blisibimod|blisibimod
270571|NCT02514967|Nephritis|nephritis
270572|NCT02514902|Lateral Flow Device (LFD)|lateral flow device (lfd)
270573|NCT02514902|Acute Stroke|acute stroke
270574|NCT02514902|Traumatic Brain Injury (TBI)|traumatic brain injury (tbi)
270575|NCT02514902|Point of Care (POC)|point of care (poc)
270576|NCT02514902|Biomarker|biomarker
270577|NCT02514824|recurrent merkel cell carcinoma|recurrent merkel cell carcinoma
270578|NCT02514824|metastatic merkel cell carcinoma|metastatic merkel cell carcinoma
270579|NCT02514798|COPD|copd
270580|NCT02514798|HFNC|hfnc
270581|NCT02514798|work of breathing|work of breathing
270582|NCT02514746|Japanese Encephalitis Vaccines|japanese encephalitis vaccines
270583|NCT02514746|Flavivirus Infections|flavivirus infections
270584|NCT02514733|kidney|kidney
270585|NCT02514733|transplant|transplant
270586|NCT02514655|Tracheal intubation|tracheal intubation
270587|NCT02514655|Cuff pressure|cuff pressure
270588|NCT02514655|Ventilator-acquired pneumonia|ventilator-acquired pneumonia
270589|NCT02514655|Intensive care unit|intensive care unit
270590|NCT02514655|Tracheal injuries|tracheal injuries
270591|NCT02514629|Hypogonadism|hypogonadism
270592|NCT02514629|Obesity|obesity
270593|NCT02514629|Erectile Dysfunction|erectile dysfunction
270594|NCT02514629|Testosterone|testosterone
270595|NCT02514629|Metformin|metformin
270596|NCT02514629|Weight Loss|weight loss
270597|NCT02514629|Insulin Resistance|insulin resistance
270598|NCT02514616|Reflux|reflux
270599|NCT02514616|Reflux disease|reflux disease
270600|NCT02514616|Gastroesophageal reflux disease|gastroesophageal reflux disease
270601|NCT02514616|Lower esophageal sphincter stimulation|lower esophageal sphincter stimulation
270602|NCT02514603|Neoplasm metastasis|neoplasm metastasis
270603|NCT02514603|Checkpoint Kinase 1|checkpoint kinase 1
270604|NCT02514603|CHK1|chk1
270605|NCT02514603|CHK1 inhibitor|chk1 inhibitor
270606|NCT02514551|stomach cancer|stomach cancer
270607|NCT02514512|Lung Cancer|lung cancer
270608|NCT02514512|Stereotactic Ablative Radiotherapy (SABR)|stereotactic ablative radiotherapy (sabr)
270609|NCT02514512|MLC Tracking|mlc tracking
270610|NCT02514512|Radiotherapy|radiotherapy
270611|NCT02514499|patients|patients
270612|NCT02514460|stents|stents
270613|NCT02514460|atherectomy|atherectomy
270614|NCT02514460|femoral artery|femoral artery
270719|NCT02513836|opioids|opioids
270615|NCT02514460|popliteal artery|popliteal artery
270617|NCT02514421|pancreatic adenocarcinoma|pancreatic adenocarcinoma
270618|NCT02514421|electrochemotherapy|electrochemotherapy
270619|NCT02514421|electroporation|electroporation
270620|NCT02514421|radiogenomics|radiogenomics
270621|NCT02514421|imaging|imaging
270622|NCT02514421|magnetic resonance spectroscopy|magnetic resonance spectroscopy
270623|NCT02514395|linguistic validation|linguistic validation
270624|NCT02514395|KOOS|koos
270625|NCT02514395|Marathi translation|marathi translation
270626|NCT02514356|behavioral economics|behavioral economics
270627|NCT02514356|antiretroviral adherence|antiretroviral adherence
270628|NCT02514356|SMS|sms
270629|NCT02514356|mobile health (mHealth)|mobile health (mhealth)
270630|NCT02514356|Adolescents|adolescents
270631|NCT02514356|Uganda|uganda
270632|NCT02514356|HIV|hiv
270633|NCT02514343|radius fracture|radius fracture
270634|NCT02514343|magnesium sulfate|magnesium sulfate
270635|NCT02514343|rehabilitation|rehabilitation
270636|NCT02514343|bupivacaine|bupivacaine
270637|NCT02514330|Drop Jump|drop jump
270638|NCT02514330|High Intensity Interval Training|high intensity interval training
270639|NCT02514330|Muscle Fatigue|muscle fatigue
270640|NCT02514330|Aerobic Performance|aerobic performance
270641|NCT02514278|Organ preservation|organ preservation
270642|NCT02514278|Local excision|local excision
270643|NCT02514278|Radiochemotherapy|radiochemotherapy
270644|NCT02514278|Neoadjuvant chemotherapy|neoadjuvant chemotherapy
270645|NCT02514278|Folfirinox|folfirinox
270646|NCT02514278|Tumour response|tumour response
270647|NCT02514265|pelvic pain, bladder pain|pelvic pain, bladder pain
270648|NCT02514252|Advanced Cancers|advanced cancers
270649|NCT02514252|Metastatic|metastatic
270650|NCT02514252|Recurrent cancer|recurrent cancer
270651|NCT02514252|Incurable cancer|incurable cancer
270652|NCT02514252|Fentanyl sublingual spray|fentanyl sublingual spray
270653|NCT02514252|FSS|fss
270654|NCT02514252|Questionnaires|questionnaires
270655|NCT02514252|Surveys|surveys
270656|NCT02514252|Mental ability tests|mental ability tests
270657|NCT02514252|Phone calls|phone calls
270658|NCT02514252|Study diary|study diary
270659|NCT02514252|Pain control|pain control
270660|NCT02514226|microbiology|microbiology
270661|NCT02514226|halitosis|halitosis
270662|NCT02514213|PSA|psa
270663|NCT02514187|Osteogenesis|osteogenesis
270664|NCT02514161|Smokers|smokers
270665|NCT02514161|Maximum Inspiratory Pressure|maximum inspiratory pressure
270666|NCT02514148|patient education|patient education
270667|NCT02514148|therapeutic exercise|therapeutic exercise
270668|NCT02514148|manual therapy|manual therapy
270669|NCT02514109|neuronopathy|neuronopathy
270670|NCT02514109|antibodies|antibodies
270671|NCT02514109|Clinical and biological diagnostic criteria|clinical and biological diagnostic criteria
270672|NCT02514083|Bruton's Tyrosine Kinase|bruton's tyrosine kinase
270673|NCT02514083|Hematopoietic Neoplasms|hematopoietic neoplasms
270674|NCT02514083|Tumors of B cells|tumors of b cells
270675|NCT02514070|LDL-C|ldl-c
270676|NCT02514070|Omega-3 Fatty Acid|omega-3 fatty acid
270677|NCT02514070|PCSK9|pcsk9
270678|NCT02514070|HDL-C|hdl-c
270679|NCT02514018|Varicella-Zoster Virus|varicella-zoster virus
270680|NCT02514018|Immune Activation|immune activation
270681|NCT02514018|HIV Vaccine|hiv vaccine
270682|NCT02514018|Mucosal Immunity|mucosal immunity
270683|NCT02514005|Trigger points|trigger points
270684|NCT02514005|Manual therapy|manual therapy
270685|NCT02514005|Patellofemoral syndrome|patellofemoral syndrome
270686|NCT02514005|Dry needling|dry needling
270687|NCT02513992|ictal SPECT|ictal spect
270688|NCT02513979|Angiotensin type II receptor (AT2R) antagonists|angiotensin type ii receptor (at2r) antagonists
270689|NCT02513979|Acute postoperative pain|acute postoperative pain
270690|NCT02513979|Chronic postoperative pain|chronic postoperative pain
270691|NCT02513979|Abdominal surgery|abdominal surgery
270692|NCT02513953|Endometriosis|endometriosis
270693|NCT02513953|Mesosalpinx|mesosalpinx
270694|NCT02513953|Broad Ligament|broad ligament
270695|NCT02513953|Laparoscopy|laparoscopy
270696|NCT02513940|Torsades de pointes|torsades de pointes
270697|NCT02513940|Testosterone|testosterone
270698|NCT02513940|Progesterone|progesterone
270699|NCT02513940|Clinical trial|clinical trial
270700|NCT02513940|Risk reduction|risk reduction
270701|NCT02513940|Electrocardiography|electrocardiography
270702|NCT02513927|Blood pressure variability|blood pressure variability
270703|NCT02513927|CCB|ccb
270704|NCT02513927|beta-receptor blockers|beta-receptor blockers
270705|NCT02513927|heart rate|heart rate
270706|NCT02513914|endovascular neurosurgery|endovascular neurosurgery
270707|NCT02513901|Chidamide|chidamide
739556|NCT00476151|Nerve Pain|nerve pain
270708|NCT02513901|Histone Deacetylase Inhibitor|histone deacetylase inhibitor
270709|NCT02513901|HIV-1 Reservoir|hiv-1 reservoir
270710|NCT02513901|Chronic HIV infections|chronic hiv infections
270711|NCT02513901|Antiretroviral Therapy|antiretroviral therapy
270712|NCT02513901|HIV Eradication|hiv eradication
270713|NCT02513862|autologous platelet rich plasma|autologous platelet rich plasma
270714|NCT02513862|deep hypothermic circulatory arrest|deep hypothermic circulatory arrest
270720|NCT02513823|blood pressure|blood pressure
270721|NCT02513823|vitamin D|vitamin d
270722|NCT02513784|Microbiome|microbiome
270723|NCT02513784|Esophagus|esophagus
270724|NCT02513784|Endoscopy|endoscopy
270725|NCT02513784|Mouthwash|mouthwash
270726|NCT02513771|Sitagliptin|sitagliptin
270727|NCT02513771|Inflammation|inflammation
270728|NCT02513771|Immune activation|immune activation
270729|NCT02513771|Viral suppression|viral suppression
270730|NCT02513771|HIV-1|hiv-1
270731|NCT02513771|Immunology biomarkers|immunology biomarkers
270732|NCT02513771|sCD14|scd14
270733|NCT02513758|HIV patients|hiv patients
270734|NCT02513758|Genital HIV penetration|genital hiv penetration
270735|NCT02513745|cataract|cataract
270736|NCT02513745|toric|toric
270737|NCT02513745|phacoemulsification|phacoemulsification
270738|NCT02513732|Drug Eluting Stent|drug eluting stent
270739|NCT02513732|Coronary Stent|coronary stent
270740|NCT02513732|Everolimus|everolimus
270741|NCT02513732|Stent Thrombosis|stent thrombosis
270742|NCT02513719|drug eluting stent|drug eluting stent
270743|NCT02513719|stent|stent
270744|NCT02513719|real world|real world
270745|NCT02513693|Anesthesia|anesthesia
270746|NCT02513693|Rocuronium|rocuronium
270747|NCT02513693|Sugammadex|sugammadex
270748|NCT02513693|Neostigmine|neostigmine
270749|NCT02513693|TOF|tof
270750|NCT02513693|Radical Prostatectomy|radical prostatectomy
270751|NCT02513693|Robotic Surgery|robotic surgery
270752|NCT02513693|Accelerometry|accelerometry
270753|NCT02513680|Skin Aging|skin aging
270754|NCT02513680|laser phototherapy|laser phototherapy
270755|NCT02513680|Rejuvenation|rejuvenation
270756|NCT02513680|Infrared Rays/therapeutic use|infrared rays/therapeutic use
270757|NCT02513680|Female|female
270758|NCT02513680|Humans|humans
270759|NCT02513680|Esthetics|esthetics
270760|NCT02513680|Phototherapy|phototherapy
270761|NCT02513680|facial rejuvenation|facial rejuvenation
270762|NCT02513654|tolerability|tolerability
270763|NCT02513654|repeat dosing|repeat dosing
270764|NCT02513654|safety|safety
270765|NCT02513654|healthy Chinese subjects|healthy chinese subjects
270766|NCT02513654|Pharmacokinetics|pharmacokinetics
270767|NCT02513654|lamotrigine|lamotrigine
270768|NCT02513628|Cardiac arrest|cardiac arrest
270769|NCT02513628|neuroprognostication|neuroprognostication
270770|NCT02513628|optic nerve sheath diameter|optic nerve sheath diameter
270771|NCT02513628|outcome|outcome
270772|NCT02513628|ultrasonography|ultrasonography
270773|NCT02513615|Fibrosis|fibrosis
270774|NCT02513615|Peritoneal Dialysis|peritoneal dialysis
270775|NCT02513615|Epigenetics|epigenetics
270776|NCT02513615|Peritoneal membrane injury|peritoneal membrane injury
270777|NCT02513615|Glucose exposure|glucose exposure
270778|NCT02513602|implantology|implantology
270779|NCT02513602|kidney|kidney
270780|NCT02513602|renal disease|renal disease
270781|NCT02513602|edentulism|edentulism
270782|NCT02513602|tooth loss|tooth loss
270783|NCT02513589|Positron emission tomography|positron emission tomography
270784|NCT02513589|Carotid plaque|carotid plaque
270785|NCT02513589|Inflammation|inflammation
270786|NCT02513589|Stroke|stroke
270787|NCT02513576|Sternal instability|sternal instability
270788|NCT02513576|physical therapy|physical therapy
270789|NCT02513576|Respiratory muscle strength|respiratory muscle strength
270790|NCT02513563|Squamous cell lung cancer|squamous cell lung cancer
270791|NCT02513524|hypertension|hypertension
270792|NCT02513524|adherence|adherence
270793|NCT02513524|resistant hypertension|resistant hypertension
270794|NCT02513524|blood pressure|blood pressure
270795|NCT02513524|non-adherence|non-adherence
270796|NCT02513511|difficult airway|difficult airway
270797|NCT02513511|awake intubation|awake intubation
270798|NCT02513485|Inflammation|inflammation
270799|NCT02513485|Anhedonia|anhedonia
270800|NCT02513485|Psychomotor retardation|psychomotor retardation
270801|NCT02513472|Eribulin Mesylate|eribulin mesylate
270802|NCT02513472|Pembrolizumab|pembrolizumab
270803|NCT02513472|Metastatic Triple-Negative Breast Cancer|metastatic triple-negative breast cancer
270804|NCT02513472|mTNBC|mtnbc
270805|NCT02513459|ABBV-066|abbv-066
270806|NCT02513459|BI 655066|bi 655066
270807|NCT02513459|risankizumab|risankizumab
270808|NCT02513433|Lumbar epidural anaesthesia|lumbar epidural anaesthesia
270809|NCT02513420|levator ani avulsion|levator ani avulsion
270810|NCT02513420|perineal muscle training|perineal muscle training
270811|NCT02513420|pelvic floor ultrasound|pelvic floor ultrasound
270812|NCT02513394|HR+/HER2- breast cancer|hr+/her2- breast cancer
270813|NCT02513394|Palbociclib|palbociclib
270814|NCT02513368|aesthetic|aesthetic
270815|NCT02513368|connective tissue graft|connective tissue graft
270816|NCT02513368|mucosa thickness|mucosa thickness
270817|NCT02513355|Non-small cell lung cancer,Endostar|non-small cell lung cancer,endostar
270818|NCT02513342|Endostar,Advanced lung squamous carcinoma|endostar,advanced lung squamous carcinoma
270819|NCT02513329|Breast Cancer|breast cancer
270820|NCT02513329|Anti-estrogens|anti-estrogens
270821|NCT02513329|Hot Flushes|hot flushes
270822|NCT02513329|Tamoxifen|tamoxifen
271019|NCT02512328|Colonoscopy|colonoscopy
270823|NCT02513329|Aromatase inhibitors|aromatase inhibitors
270824|NCT02513329|Hot Flashes|hot flashes
270825|NCT02513316|Microbleeds|microbleeds
270826|NCT02513303|Dialysis|dialysis
270827|NCT02513303|End Stage Renal Disease|end stage renal disease
270828|NCT02513303|End Stage Kidney Disease|end stage kidney disease
270829|NCT02513303|ESRD|esrd
270830|NCT02513303|Chronic Kidney Failure|chronic kidney failure
270831|NCT02513303|Chronic Renal Failure|chronic renal failure
270832|NCT02513303|Chronic Kidney Disease|chronic kidney disease
270833|NCT02513303|Hemodialysis|hemodialysis
270834|NCT02513303|Vascular Access|vascular access
270835|NCT02513303|Arteriovenous Fistula|arteriovenous fistula
270836|NCT02513303|AV Fistula|av fistula
270837|NCT02513303|AVF|avf
270838|NCT02513303|Nephrology|nephrology
270839|NCT02513303|Vascular Surgery|vascular surgery
270840|NCT02513303|Dialysis Access|dialysis access
270841|NCT02513290|quality of life|quality of life
270842|NCT02513290|allergic rhinitis|allergic rhinitis
270843|NCT02513290|bilastine|bilastine
270844|NCT02513290|loratadine|loratadine
270845|NCT02513290|clinical trial|clinical trial
270846|NCT02513277|type 2 diabetes|type 2 diabetes
270847|NCT02513277|impaired glucose regulation|impaired glucose regulation
270848|NCT02513277|intellectual disability|intellectual disability
270849|NCT02513277|learning disability|learning disability
270850|NCT02513277|screening|screening
270851|NCT02513277|prevention|prevention
270852|NCT02513277|lifestyle education|lifestyle education
270853|NCT02513264|Registry|registry
270854|NCT02513264|Asthma|asthma
270855|NCT02513264|Inner City Asthma Consortium (ICAC) study eligibility|inner city asthma consortium (icac) study eligibility
270856|NCT02513212|Sensitivity|sensitivity
270857|NCT02513199|Hepatocellular Carcinoma|hepatocellular carcinoma
270858|NCT02513199|Trans-Arterial Chemoembolization|trans-arterial chemoembolization
270859|NCT02513199|Stereotactic Body Radiation Therapy|stereotactic body radiation therapy
270860|NCT02513199|HCC|hcc
270861|NCT02513199|TACE|tace
270862|NCT02513199|SBRT|sbrt
270863|NCT02513173|low back pain|low back pain
270864|NCT02513173|verbal instruction|verbal instruction
270865|NCT02513173|lumbar multifidus|lumbar multifidus
270866|NCT02513173|ultrasound imaging|ultrasound imaging
270867|NCT02513173|Muscle thickness|muscle thickness
270868|NCT02513134|IOL power calculations|iol power calculations
270869|NCT02513134|Intraoperative|intraoperative
270870|NCT02513134|OCT|oct
270871|NCT02513134|Refractive outcome|refractive outcome
270872|NCT02513134|Biometry|biometry
270873|NCT02513121|NAFLD|nafld
270874|NCT02513121|Steatohepatitis|steatohepatitis
270875|NCT02513121|NASH|nash
270876|NCT02513121|Liver|liver
270877|NCT02513121|Diet|diet
270878|NCT02513121|Pediatric|pediatric
270879|NCT02513121|Adolescent|adolescent
270880|NCT02513056|non-conditional pacemakers|non-conditional pacemakers
270881|NCT02513056|implantable cardioverter defibrillator|implantable cardioverter defibrillator
270882|NCT02513017|partially randomized clinical trial|partially randomized clinical trial
270883|NCT02513017|cardiovascular disease|cardiovascular disease
270884|NCT02513017|insomnia|insomnia
270885|NCT02513017|preference|preference
270886|NCT02513017|acceptability|acceptability
270887|NCT02512978|myocardial infarction|myocardial infarction
270888|NCT02512978|hypothyroidism|hypothyroidism
270889|NCT02512978|levothyroxine|levothyroxine
270890|NCT02512978|cardiac magnetic resonance imaging|cardiac magnetic resonance imaging
270891|NCT02512978|myocardial perfusion/metabolism radionuclide imaging|myocardial perfusion/metabolism radionuclide imaging
270892|NCT02512978|myocardial fibrosis|myocardial fibrosis
270893|NCT02512978|myocardial perfusion/metabolism|myocardial perfusion/metabolism
270894|NCT02512978|cardiac function|cardiac function
270895|NCT02512952|Periodontal regeneration|periodontal regeneration
270896|NCT02512952|Growth factors|growth factors
270897|NCT02512939|tuberculosis|tuberculosis
270898|NCT02512939|diagnostic test|diagnostic test
270899|NCT02512926|Solid Tumors|solid tumors
270900|NCT02512926|Leukemia|leukemia
270901|NCT02512926|Relapsed|relapsed
270902|NCT02512926|Refractory|refractory
270903|NCT02512913|Smoking Cessation|smoking cessation
270904|NCT02512913|Intervention|intervention
270905|NCT02512913|Pregnancy|pregnancy
270906|NCT02512913|Postnatal|postnatal
270907|NCT02512900|Asthma|asthma
270908|NCT02512887|Hypospadias|hypospadias
270909|NCT02512887|Caudal Block|caudal block
270910|NCT02512887|Dorsal Penile Block|dorsal penile block
270911|NCT02512887|Anesthesia|anesthesia
270912|NCT02512887|Complications|complications
740740|NCT00471588|OCD|ocd
270913|NCT02512887|Post-operative|post-operative
270914|NCT02512887|Urethrocutaneous Fistula|urethrocutaneous fistula
270915|NCT02512887|Glans dehiscence|glans dehiscence
270916|NCT02512861|Bupivacaine|bupivacaine
270917|NCT02512861|Cardiac Surgery|cardiac surgery
270918|NCT02512861|Pediatrics|pediatrics
270919|NCT02512861|Nerve Block|nerve block
270920|NCT02512848|postmenopause|postmenopause
270921|NCT02512848|endometrial sampling|endometrial sampling
270922|NCT02512848|vaginal bleeding|vaginal bleeding
270923|NCT02512835|Primary health care|primary health care
271020|NCT02512328|new media|new media
270924|NCT02512835|Public health|public health
270925|NCT02512835|Medical Informatics|medical informatics
270926|NCT02512835|Social Determinants of Health|social determinants of health
270927|NCT02512822|radiofrequency|radiofrequency
270928|NCT02512822|submental fat|submental fat
270929|NCT02512822|fat reduction|fat reduction
270930|NCT02512822|body contouring|body contouring
270931|NCT02512796|Liver transplantation|liver transplantation
270932|NCT02512796|Renal transplantation|renal transplantation
270933|NCT02512796|Pancreas transplantation|pancreas transplantation
270934|NCT02512783|Propofol|propofol
270935|NCT02512783|Lidocaine|lidocaine
270936|NCT02512783|Intravenous propofol|intravenous propofol
270937|NCT02512757|Neoplasms, Lung|neoplasms, lung
270938|NCT02512757|Pulmonary Neoplasms|pulmonary neoplasms
270939|NCT02512757|Pulmonary Cancer|pulmonary cancer
270940|NCT02512744|Tracheostomy|tracheostomy
270941|NCT02512744|Decannulation|decannulation
270942|NCT02512744|Adult airway management|adult airway management
270943|NCT02512718|intravenous fat emulsions|intravenous fat emulsions
270944|NCT02512718|fish oil lipid emulsion|fish oil lipid emulsion
270945|NCT02512692|intrahepatic cholangiocarcinoma|intrahepatic cholangiocarcinoma
270946|NCT02512692|cholangiocarcinoma|cholangiocarcinoma
270947|NCT02512692|90Y TARE|90y tare
270948|NCT02512692|radioembolization|radioembolization
270949|NCT02512692|gemcitabine and cisplatin|gemcitabine and cisplatin
270950|NCT02512679|Hematopoietic Stem Cell Transplantation Pediatrics,|hematopoietic stem cell transplantation pediatrics,
270951|NCT02512679|stem cell transplantation|stem cell transplantation
270952|NCT02512679|bone marrow transplantation|bone marrow transplantation
270953|NCT02512679|Peripheral Blood Stem Cell Transplantation|peripheral blood stem cell transplantation
270954|NCT02512679|Allogeneic Transplantation|allogeneic transplantation
270955|NCT02512679|pediatrics|pediatrics
270956|NCT02512679|Combined Immune Deficiency|combined immune deficiency
270957|NCT02512679|Chronic Granulomatous disease|chronic granulomatous disease
270958|NCT02512666|Hematologic malignancy|hematologic malignancy
270959|NCT02512653|Allergy to Cupressus pollen|allergy to cupressus pollen
270960|NCT02512640|Pressure-controlled ventilation|pressure-controlled ventilation
270961|NCT02512640|Volume-controlled ventilation|volume-controlled ventilation
270962|NCT02512640|Laparoscopy|laparoscopy
270963|NCT02512640|Oxidative stress|oxidative stress
270964|NCT02512627|mild cognitive impairment|mild cognitive impairment
270965|NCT02512627|exercise|exercise
270966|NCT02512627|cognitive training|cognitive training
270967|NCT02512575|AZD9567|azd9567
270968|NCT02512575|Healthy subjects|healthy subjects
270969|NCT02512575|Phase 1|phase 1
270970|NCT02512575|placebo controlled|placebo controlled
270971|NCT02512575|single ascending dose|single ascending dose
270972|NCT02512575|Pharmacokinetics|pharmacokinetics
270973|NCT02512575|Pharmacodynamics|pharmacodynamics
270974|NCT02512575|Rheumatoid Arthritis|rheumatoid arthritis
270975|NCT02512549|Chronic Obstructive Pulmonary Disease|chronic obstructive pulmonary disease
270976|NCT02512549|rehabiltation|rehabiltation
270977|NCT02512523|Type 2 diabetes mellitus|type 2 diabetes mellitus
270978|NCT02512523|CGMS|cgms
270979|NCT02512523|Teneligliptin|teneligliptin
270980|NCT02512523|Sitagliptin|sitagliptin
270981|NCT02512510|Chronic Obstructive Pulmonary Disease, COPD|chronic obstructive pulmonary disease, copd
270982|NCT02512497|Cutaneous T-cell Lymphoma|cutaneous t-cell lymphoma
270983|NCT02512497|CTCL|ctcl
270984|NCT02512497|T-Prolymphocytic Leukemia|t-prolymphocytic leukemia
270985|NCT02512497|T-PLL|t-pll
270986|NCT02512497|T-Large Granulocytic Leukemia|t-large granulocytic leukemia
270987|NCT02512497|T-LGL|t-lgl
270988|NCT02512497|T-Lymphoblastic Leukemia/Lymphoma|t-lymphoblastic leukemia/lymphoma
270989|NCT02512497|T-ALL|t-all
270990|NCT02512497|Peripheral T-Cell Lymphoma|peripheral t-cell lymphoma
270991|NCT02512497|PTCL|ptcl
270992|NCT02512497|Allogeneic stem cell transplantation|allogeneic stem cell transplantation
270993|NCT02512497|Romidepsin|romidepsin
270994|NCT02512497|Istodax|istodax
270995|NCT02512497|Depsipeptide|depsipeptide
270996|NCT02512497|FK228|fk228
270997|NCT02512497|Busulfan|busulfan
270998|NCT02512497|Busulfex|busulfex
270999|NCT02512497|Myleran|myleran
271000|NCT02512497|Fludarabine|fludarabine
271001|NCT02512497|Fludarabine phosphate|fludarabine phosphate
271002|NCT02512497|Fludara|fludara
271003|NCT02512484|tuberculosis|tuberculosis
271004|NCT02512484|accident and emergency|accident and emergency
271005|NCT02512471|minimum effective volume|minimum effective volume
271006|NCT02512471|ropivacaine|ropivacaine
271007|NCT02512471|ultrasound-guided supraclavicular block|ultrasound-guided supraclavicular block
271008|NCT02512419|Physical Activity|physical activity
271009|NCT02512419|Latinos|latinos
271010|NCT02512419|Mexican American Men|mexican american men
271011|NCT02512419|Spanish-Language|spanish-language
271012|NCT02512419|Text-Message|text-message
271013|NCT02512406|Tourette Syndrome|tourette syndrome
271014|NCT02512406|Tics|tics
271015|NCT02512341|Computer Aided Auscultation (CAA)|computer aided auscultation (caa)
271016|NCT02512341|Electronic Stethoscope|electronic stethoscope
271017|NCT02512341|Phonocardiography|phonocardiography
271018|NCT02512341|Heart Auscultation|heart auscultation
271021|NCT02512328|APP|app
271022|NCT02512328|colonoscopy preparation|colonoscopy preparation
271023|NCT02512328|SPA|spa
271024|NCT02512328|smartphone application|smartphone application
271025|NCT02512315|Nasopharyngeal carcinoma|nasopharyngeal carcinoma
271026|NCT02512315|Neoadjuvant chemotherapy|neoadjuvant chemotherapy
271027|NCT02512315|Concurrent chemoradiation|concurrent chemoradiation
271028|NCT02512315|Distant metastasis|distant metastasis
271029|NCT02512315|Survival|survival
271030|NCT02512302|COPD|copd
271031|NCT02512276|Medication Non-adherence|medication non-adherence
271032|NCT02512276|Hyperlipidemia|hyperlipidemia
271033|NCT02512276|Diabetes|diabetes
271034|NCT02512276|Hypertension|hypertension
271035|NCT02512237|HER2|her2
271036|NCT02512237|breast cancer|breast cancer
271038|NCT02512237|antibody drug conjugate|antibody drug conjugate
271039|NCT02512237|elevated HER2 expression|elevated her2 expression
271040|NCT02512224|parenteral nutrition|parenteral nutrition
271041|NCT02512224|enteral nutrition|enteral nutrition
271042|NCT02512211|Hemophilia|hemophilia
271043|NCT02512211|Validation|validation
271044|NCT02512211|Questionnaires|questionnaires
271045|NCT02512211|Activities|activities
271046|NCT02512211|Sport|sport
271047|NCT02512211|Patients|patients
271048|NCT02512198|Professional Practice|professional practice
271049|NCT02512198|General Practitioners|general practitioners
271050|NCT02512198|Inappropriate Prescribing|inappropriate prescribing
271051|NCT02512198|Persuasive Communication|persuasive communication
271052|NCT02512198|Information Theory|information theory
271053|NCT02512198|Feedback|feedback
271054|NCT02512185|Prostate cancer|prostate cancer
271055|NCT02512185|Chemotherapy|chemotherapy
271056|NCT02512185|mCRPC|mcrpc
271057|NCT02512159|Diabetic foot ulcer|diabetic foot ulcer
271058|NCT02512159|Foot care|foot care
271059|NCT02512159|Wound management|wound management
271060|NCT02512146|IBS|ibs
271061|NCT02512146|Ionotropic glutamate receptors|ionotropic glutamate receptors
271062|NCT02512133|MIGS|migs
271063|NCT02512133|SLT|slt
271064|NCT02512094|Barthel index|barthel index
271065|NCT02512094|Hip fracture|hip fracture
271066|NCT02512094|Validity|validity
271067|NCT02512094|Reliability|reliability
271068|NCT02512081|Sciatica|sciatica
271069|NCT02512081|Patient Experience|patient experience
271070|NCT02512081|Investigations|investigations
271071|NCT02512081|Qualitative Research|qualitative research
271072|NCT02512016|Pelvic floor|pelvic floor
271073|NCT02511990|HIV|hiv
271074|NCT02511990|10-1074|10-1074
271075|NCT02511990|Monoclonal Antibody|monoclonal antibody
271076|NCT02511977|Dental Prosthesis|dental prosthesis
271077|NCT02511977|Implant-Supported|implant-supported
271078|NCT02511964|Aerobic Exercise|aerobic exercise
271079|NCT02511964|HIT,|hit,
271080|NCT02511964|VO2Max|vo2max
271081|NCT02511964|Performance|performance
271082|NCT02511951|postoperative pancreatic fistula|postoperative pancreatic fistula
271083|NCT02511951|postoperative hospital stay time|postoperative hospital stay time
271084|NCT02511951|anastomosis time|anastomosis time
271085|NCT02511951|reoperation rate|reoperation rate
271086|NCT02511951|morbidity|morbidity
271087|NCT02511951|pancreaticojejunostomy|pancreaticojejunostomy
271088|NCT02511951|pancreaticoduodenectomy|pancreaticoduodenectomy
271089|NCT02511938|childhood obesity|childhood obesity
271090|NCT02511938|restaurant|restaurant
271091|NCT02511938|away from home foods|away from home foods
271092|NCT02511925|Critical care|critical care
271093|NCT02511925|Feedback|feedback
271094|NCT02511899|Microcirculation|microcirculation
271095|NCT02511899|Endothelial function|endothelial function
271096|NCT02511899|Metabolism|metabolism
271097|NCT02511899|Cardiovascular Disease|cardiovascular disease
271098|NCT02511899|human study|human study
271099|NCT02511899|healthy subjects|healthy subjects
271100|NCT02511899|Mangifera indica|mangifera indica
271101|NCT02511899|Careless|careless
271102|NCT02511886|Alcoholism|alcoholism
271103|NCT02511886|Alcohol Abuse|alcohol abuse
271104|NCT02511886|Alcohol Addiction|alcohol addiction
271105|NCT02511886|Alcohol Dependence|alcohol dependence
271106|NCT02511886|Alcohol Induced Disorders|alcohol induced disorders
271107|NCT02511886|Alcoholic Intoxication|alcoholic intoxication
271108|NCT02511873|Fycompa|fycompa
271109|NCT02511873|Small Fiber Neuropathy|small fiber neuropathy
271110|NCT02511873|SFN|sfn
271111|NCT02511873|Neuropathy|neuropathy
271112|NCT02511873|Pain|pain
271113|NCT02511847|Breast Cancer|breast cancer
271114|NCT02511847|EGFR|egfr
271115|NCT02511847|Afatinib|afatinib
271116|NCT02511847|Paclitaxel|paclitaxel
271117|NCT02511847|Pathologic complete remission|pathologic complete remission
271118|NCT02511808|Drinking|drinking
271119|NCT02511808|Alcohol Problems|alcohol problems
271120|NCT02511808|Alcoholism|alcoholism
271121|NCT02511808|Reduced Drinking|reduced drinking
271122|NCT02511808|Problematic Drinking|problematic drinking
271123|NCT02511808|Non-Abstinence-based Drinking|non-abstinence-based drinking
271124|NCT02511808|Controlled Drinking|controlled drinking
271125|NCT02511808|Heavy Drinking|heavy drinking
271126|NCT02511795|AZD1775|azd1775
271127|NCT02511795|Olaparib|olaparib
271128|NCT02511795|AZD1775 plus Olaparib|azd1775 plus olaparib
271129|NCT02511795|Refractory Solid Tumours|refractory solid tumours
271130|NCT02511795|Small Cell Lung Cancer (SCLC)|small cell lung cancer (sclc)
271131|NCT02511795|Relapsed Small Cell Lung Cancer|relapsed small cell lung cancer
271132|NCT02511782|children|children
271133|NCT02511782|bone marrow transplant|bone marrow transplant
271134|NCT02511782|GVHD|gvhd
271135|NCT02511756|Perfusion-computed tomography|perfusion-computed tomography
271136|NCT02511730|Mammography|mammography
271137|NCT02511704|Nicotine|nicotine
271138|NCT02511704|Electronic cigarette|electronic cigarette
271139|NCT02511704|Cigarette|cigarette
271140|NCT02511639|Hormone receptor positive|hormone receptor positive
271141|NCT02511639|HER2 negative|her2 negative
271142|NCT02511626|endometriosis|endometriosis
271143|NCT02511626|quality of life|quality of life
271144|NCT02511626|professional activity|professional activity
271145|NCT02511626|pain|pain
271146|NCT02511626|infertility|infertility
271147|NCT02511626|sexuality|sexuality
271148|NCT02511626|partnership|partnership
271149|NCT02511626|anxiety|anxiety
271150|NCT02511626|depression|depression
271151|NCT02511626|stress|stress
271152|NCT02511626|childhood trauma|childhood trauma
271153|NCT02511626|medical support|medical support
271154|NCT02511626|dyspareunia|dyspareunia
271155|NCT02511600|Lung Diseases|lung diseases
271156|NCT02511600|Mesothelioma|mesothelioma
271157|NCT02511600|Pleurectomy decortication|pleurectomy decortication
271158|NCT02511600|Progel|progel
271159|NCT02511600|Talcum powder|talcum powder
271160|NCT02511600|Pain questionnaires|pain questionnaires
271161|NCT02511600|Surveys|surveys
271162|NCT02511600|Intraoperative air leaks|intraoperative air leaks
271163|NCT02511600|IAL|ial
271164|NCT02511574|progesterone|progesterone
271165|NCT02511574|uterine cervix|uterine cervix
271166|NCT02511574|cervical pessary|cervical pessary
271167|NCT02511561|Otitis externa|otitis externa
271168|NCT02511561|Swimmer's ear|swimmer's ear
271169|NCT02511561|Ear infection|ear infection
271170|NCT02511509|Schizophrenia|schizophrenia
271171|NCT02511509|Electroconvulsive Therapy|electroconvulsive therapy
271172|NCT02511509|Bifrontal ECT|bifrontal ect
271173|NCT02511509|Bitemporal ECT|bitemporal ect
271174|NCT02511509|Cognitive functions|cognitive functions
271175|NCT02511509|Postictal delirium|postictal delirium
271176|NCT02511483|COMT|comt
271177|NCT02511483|Beta-blocker|beta-blocker
271178|NCT02511483|Hemicolectomy|hemicolectomy
271179|NCT02511470|Cardiopulmonary Resuscitation|cardiopulmonary resuscitation
271180|NCT02511470|Pediatric simulation study|pediatric simulation study
271181|NCT02511470|Metronome|metronome
271182|NCT02511444|GBS|gbs
271183|NCT02511444|GBS culture|gbs culture
271184|NCT02511444|GBS PCR|gbs pcr
271185|NCT02511444|GBS colonization|gbs colonization
271186|NCT02511431|Delta Hepatitis|delta hepatitis
271187|NCT02511431|Hepatitis D|hepatitis d
271188|NCT02511431|Liver Disease|liver disease
271189|NCT02511431|Hepatitis D Virus|hepatitis d virus
271190|NCT02511431|Chronic Hepatitis|chronic hepatitis
271191|NCT02511405|rGBM|rgbm
271192|NCT02511405|Recurrent Glioblastoma|recurrent glioblastoma
271193|NCT02511405|Recurrent GBM|recurrent gbm
271194|NCT02511366|ileal brake|ileal brake
271195|NCT02511353|malaria|malaria
271196|NCT02511353|plasmodium|plasmodium
271197|NCT02511353|dihydroartemisinin-piperaquine|dihydroartemisinin-piperaquine
271198|NCT02511353|ivermectin|ivermectin
271199|NCT02511327|Pertussis|pertussis
271200|NCT02511327|Pregnancy|pregnancy
271201|NCT02511327|Vaccination|vaccination
271202|NCT02511327|Preterm|preterm
271203|NCT02511327|Breast milk|breast milk
271204|NCT02511327|Humoral immune response|humoral immune response
271205|NCT02511327|Cellular immune response|cellular immune response
271206|NCT02511327|Maternal antibodies|maternal antibodies
271207|NCT02511314|Nursing homes|nursing homes
271208|NCT02511314|quasi-experimental|quasi-experimental
271209|NCT02511314|mixed methods|mixed methods
271210|NCT02511314|parallel study|parallel study
271211|NCT02511314|urinary incontinence|urinary incontinence
271212|NCT02511288|Hematologic test|hematologic test
271213|NCT02511288|Liquid biopsy|liquid biopsy
271214|NCT02511275|parenchymal clamping|parenchymal clamping
271215|NCT02511275|microdialysis technique|microdialysis technique
271216|NCT02511275|partial nephrectomy|partial nephrectomy
271217|NCT02511249|neonatal arterial ischemic stroke|neonatal arterial ischemic stroke
271218|NCT02511249|language development|language development
271219|NCT02511249|global intellectual functioning|global intellectual functioning
271220|NCT02511249|motor abilities|motor abilities
271221|NCT02511197|PET|pet
271222|NCT02511197|lung injury|lung injury
271223|NCT02511197|integrin receptor|integrin receptor
271224|NCT02511184|crizotinib|crizotinib
271225|NCT02511184|pembrolizumab|pembrolizumab
271226|NCT02511184|ALK-positive NSCLC|alk-positive nsclc
271227|NCT02511184|Lung Cancer|lung cancer
271228|NCT02511184|ALK-translocated NSCLC|alk-translocated nsclc
271229|NCT02511184|Non Small Cell Lung Cancer|non small cell lung cancer
271230|NCT02511158|Anterior Cruciate Ligament, Posterior Cruciate Ligament, Medial Collateral Ligament, Lateral Collateral Ligament|anterior cruciate ligament, posterior cruciate ligament, medial collateral ligament, lateral collateral ligament
271231|NCT02511145|volunteers|volunteers
271232|NCT02511132|Ewing's Sarcoma Family of Tumors, ESFT, Sarcoma|ewing's sarcoma family of tumors, esft, sarcoma
271233|NCT02511132|Soft Tissue Sarcoma|soft tissue sarcoma
271234|NCT02511106|Stage IB-IIA-IIIA Non-Small Cell Lung Cancer; EGFRm+; Ex19Del; L858R; AZD9291; Phase III, adjuvant chemotherapy; complete tumour resection; EGFR-TKI|stage ib-iia-iiia non-small cell lung cancer; egfrm+; ex19del; l858r; azd9291; phase iii, adjuvant chemotherapy; complete tumour resection; egfr-tki
271235|NCT02511093|Hypertension|hypertension
271236|NCT02511093|Team-based care|team-based care
271237|NCT02511093|Collaboration|collaboration
271238|NCT02511093|Healthcare professionals|healthcare professionals
271239|NCT02511093|Healthcare services|healthcare services
271240|NCT02511080|Spot-on; perioperative hypothermia.|spot-on; perioperative hypothermia.
271241|NCT02511054|Immunogenicity|immunogenicity
271242|NCT02511054|Liver Stage|liver stage
271243|NCT02511054|Parasites|parasites
271244|NCT02511054|Blood|blood
271245|NCT02511054|Infection|infection
271246|NCT02511041|CDG|cdg
271247|NCT02511041|PGM3|pgm3
271248|NCT02511041|Immune|immune
271249|NCT02511028|MRI|mri
271250|NCT02511028|Multiple Sclerosis|multiple sclerosis
271251|NCT02511028|Healthy Volunteer|healthy volunteer
271252|NCT02511015|Early Onset Parkinson's Disease|early onset parkinson's disease
271253|NCT02511015|Cellular Quality Control Programs|cellular quality control programs
271254|NCT02511015|Mitochondria|mitochondria
271255|NCT02511015|Neuroinflammation|neuroinflammation
271256|NCT02511015|Immunology|immunology
271257|NCT02511002|Influenza Like Infection (ILI)|influenza like infection (ili)
271258|NCT02511002|Longitudinal Observation|longitudinal observation
271259|NCT02511002|Flu|flu
271260|NCT02511002|Immunity|immunity
271261|NCT02511002|Natural History|natural history
271262|NCT02510989|Syndromic obesity|syndromic obesity
271263|NCT02510989|Genes|genes
271264|NCT02510989|Exome|exome
271265|NCT02510963|Vertical infection transmission|vertical infection transmission
271266|NCT02510963|Tenofovir|tenofovir
271267|NCT02510937|pulmonary fibrosis|pulmonary fibrosis
271268|NCT02510937|pharmacokinetic|pharmacokinetic
271269|NCT02510937|pharmacodynamics|pharmacodynamics
271270|NCT02510937|CC-90001|cc-90001
271271|NCT02510937|Safety|safety
271272|NCT02510924|Intubation|intubation
271273|NCT02510924|Airtraq|airtraq
271274|NCT02510924|General anesthesia|general anesthesia
271275|NCT02510924|Difficult airway|difficult airway
271276|NCT02510911|colectomy|colectomy
271277|NCT02510911|laparoscopy|laparoscopy
271278|NCT02510911|caffeine|caffeine
271279|NCT02510885|neovascular age-related macular degeneration|neovascular age-related macular degeneration
271280|NCT02510885|age-related macular degeneration|age-related macular degeneration
271281|NCT02510885|diabetic retinopathy|diabetic retinopathy
271282|NCT02510885|SD-OCT|sd-oct
271283|NCT02510885|Angiography|angiography
271284|NCT02510885|diabetic macular edema|diabetic macular edema
271285|NCT02510846|Polyhandicap|polyhandicap
271286|NCT02510846|Behavior disorders|behavior disorders
271287|NCT02510846|Educative program|educative program
271288|NCT02510846|Caregivers|caregivers
271289|NCT02510846|Quality of life.|quality of life.
271290|NCT02510833|Parkinson Disease|parkinson disease
271291|NCT02510833|Physical Therapy Modalities|physical therapy modalities
271292|NCT02510833|Quality of Life|quality of life
271293|NCT02510833|Self Care|self care
271294|NCT02510768|alba|alba
271295|NCT02510664|Adolescence|adolescence
271296|NCT02510664|Adherence|adherence
271297|NCT02510651|: non-segmental vitiligo|: non-segmental vitiligo
271298|NCT02510651|melanocyte-keratinocyte suspension|melanocyte-keratinocyte suspension
271299|NCT02510651|cryoblebbing|cryoblebbing
271300|NCT02510651|CO2 laser|co2 laser
271301|NCT02510612|Dexmedetomidine|dexmedetomidine
271302|NCT02510612|Diabetic|diabetic
271303|NCT02510612|glycometabolism|glycometabolism
271304|NCT02510612|sedation|sedation
271305|NCT02510599|NASH|nash
271306|NCT02510599|Liver disease|liver disease
271307|NCT02510508|addiction|addiction
740741|NCT00471588|MRI|mri
271308|NCT02510508|substance abuse|substance abuse
271309|NCT02510508|alcohol|alcohol
271310|NCT02510508|drugs|drugs
271311|NCT02510508|community reinforcement|community reinforcement
271312|NCT02510508|family treatment|family treatment
271313|NCT02510508|randomized control trial|randomized control trial
271314|NCT02510495|Sphincterotomy|sphincterotomy
271315|NCT02510495|Dilatation|dilatation
271316|NCT02510495|Common bile duct|common bile duct
271317|NCT02510495|Pancreatitis|pancreatitis
271318|NCT02510482|cardiac biomarkers|cardiac biomarkers
271319|NCT02510443|Permanent contraception method|permanent contraception method
271320|NCT02510443|Contraceptive device|contraceptive device
271321|NCT02510391|modular|modular
271322|NCT02510391|anxiety|anxiety
271323|NCT02510391|preschool|preschool
271324|NCT02510391|exposure and response prevention|exposure and response prevention
271325|NCT02510391|Cognitive behavioral therapy|cognitive behavioral therapy
271427|NCT02509728|choline|choline
271326|NCT02510352|Rotator cuff tear|rotator cuff tear
271327|NCT02510352|MRI|mri
271328|NCT02510287|analgesia, epidural|analgesia, epidural
271329|NCT02510287|labor pain|labor pain
271330|NCT02510287|patient satisfaction|patient satisfaction
271331|NCT02510274|Hyperphosphatemia|hyperphosphatemia
271332|NCT02510274|ASP3325|asp3325
271333|NCT02510274|Chronic Kidney Disease|chronic kidney disease
271334|NCT02510274|pharmacodynamics|pharmacodynamics
271335|NCT02510274|pharmacokinetics|pharmacokinetics
271336|NCT02510261|RNAi therapeutic|rnai therapeutic
271337|NCT02510261|FAP|fap
271338|NCT02510261|Familial Amyloid Polyneuropathy|familial amyloid polyneuropathy
271339|NCT02510261|TTR|ttr
271340|NCT02510261|Transthyretin|transthyretin
271341|NCT02510261|Amyloidosis|amyloidosis
271342|NCT02510235|Dry Eye|dry eye
271343|NCT02510222|child|child
271344|NCT02510209|Teen pregnancy|teen pregnancy
271345|NCT02510183|Acupressure|acupressure
271346|NCT02510183|Perioperative Care|perioperative care
271347|NCT02510183|Postoperative Nausea and Vomiting|postoperative nausea and vomiting
271348|NCT02510183|Nursing Care Management|nursing care management
271349|NCT02510170|Fetus|fetus
271350|NCT02510170|Skull|skull
271351|NCT02510170|ultrasonography|ultrasonography
271352|NCT02510157|sugammadex|sugammadex
271353|NCT02510157|dexamethasone|dexamethasone
271354|NCT02510157|neuromuscular blockade|neuromuscular blockade
271355|NCT02510118|ChangTai Keli|changtai keli
271356|NCT02510118|Colon cancer|colon cancer
271357|NCT02510105|Critical Care|critical care
271358|NCT02510105|ARDS|ards
271359|NCT02510105|Intrapulmonary Percussive Ventilation|intrapulmonary percussive ventilation
271360|NCT02510105|VDR4|vdr4
271361|NCT02510105|Lung aeration|lung aeration
271362|NCT02510105|CT scan|ct scan
271363|NCT02510066|Pancreatic Cancer|pancreatic cancer
271364|NCT02510066|Pain|pain
271365|NCT02510066|Acupuncture|acupuncture
271366|NCT02510040|Convergence Insufficiency|convergence insufficiency
271367|NCT02510040|Divergence Insufficiency|divergence insufficiency
271368|NCT02510040|Small-angle Hypertropia|small-angle hypertropia
271369|NCT02510040|Strabismus|strabismus
271370|NCT02510027|HPV testing|hpv testing
271371|NCT02510027|Triage|triage
271372|NCT02510027|Mexico|mexico
271373|NCT02510027|Cervical cancer screening|cervical cancer screening
271374|NCT02510001|RASMT CRC|rasmt crc
271375|NCT02510001|RASWT/c-MET CRC|raswt/c-met crc
271376|NCT02510001|Dose Escalation|dose escalation
271377|NCT02510001|Histologically or cytologically confirmed|histologically or cytologically confirmed
271378|NCT02510001|Dose Expansion|dose expansion
271379|NCT02509988|Nutrition|nutrition
271380|NCT02509988|Glucose metabolism|glucose metabolism
271381|NCT02509988|Body composition|body composition
271382|NCT02509975|embolization|embolization
271383|NCT02509975|prostate|prostate
271384|NCT02509962|Energy metabolism|energy metabolism
271385|NCT02509962|Glucose tolerance|glucose tolerance
271386|NCT02509962|Blood pressure|blood pressure
271387|NCT02509962|Immunoregulation|immunoregulation
271388|NCT02509923|Male Subjects|male subjects
271389|NCT02509910|Major abdominal surgery|major abdominal surgery
271390|NCT02509910|Goal directed therapy|goal directed therapy
271391|NCT02509897|Hypoxia training|hypoxia training
271392|NCT02509897|Activity energy expenditure|activity energy expenditure
271393|NCT02509897|Immunoregulation|immunoregulation
271394|NCT02509897|Energy Metabolism|energy metabolism
271395|NCT02509897|Exercise|exercise
271396|NCT02509884|Alveolar Echinococcosis (AE)|alveolar echinococcosis (ae)
271397|NCT02509884|Echinococcus multilocularis|echinococcus multilocularis
271398|NCT02509884|antiparasitic treatment|antiparasitic treatment
271399|NCT02509884|surgery|surgery
271400|NCT02509884|classification|classification
271401|NCT02509884|staging|staging
271402|NCT02509884|prospective cohort study|prospective cohort study
271403|NCT02509871|Body composition|body composition
271404|NCT02509858|Diabetes mellitus, thyroxine|diabetes mellitus, thyroxine
271405|NCT02509832|Therapeutic Hypothermia (TH)|therapeutic hypothermia (th)
271406|NCT02509832|Acute Myocardial Infarction (AMI)|acute myocardial infarction (ami)
271407|NCT02509832|Percutaneous Coronary Intervention (PCI)|percutaneous coronary intervention (pci)
271408|NCT02509819|rehabilitation|rehabilitation
271409|NCT02509819|IDEO|ideo
271410|NCT02509780|Vichy|vichy
271411|NCT02509780|urine alkalization|urine alkalization
271412|NCT02509767|Contraceptive Methods|contraceptive methods
271413|NCT02509767|Female Contraception|female contraception
271414|NCT02509767|Contraceptive satisfaction|contraceptive satisfaction
271415|NCT02509767|Injectable contraception|injectable contraception
271416|NCT02509767|Birth control|birth control
271417|NCT02509754|atrial fibrillation|atrial fibrillation
271418|NCT02509754|congestive heart failure|congestive heart failure
271419|NCT02509754|catheter ablation|catheter ablation
271420|NCT02509754|rate control|rate control
271421|NCT02509754|left ventricular function|left ventricular function
271422|NCT02509741|obesity|obesity
271423|NCT02509741|nutrition|nutrition
271424|NCT02509741|intervention|intervention
271425|NCT02509741|food replacement|food replacement
271426|NCT02509741|IOT|iot
271428|NCT02509728|docosahexaenoic acid|docosahexaenoic acid
271429|NCT02509715|thyroidectomy|thyroidectomy
271430|NCT02509715|nerve monitoring|nerve monitoring
271431|NCT02509702|Mobile health|mobile health
271432|NCT02509702|Screening|screening
271433|NCT02509702|Early detection of cancer|early detection of cancer
271434|NCT02509702|HPV|hpv
271435|NCT02509702|SMS intervention|sms intervention
271436|NCT02509702|RCT|rct
271437|NCT02509702|Tanzania|tanzania
271438|NCT02509689|mTBI|mtbi
271439|NCT02509689|cognition disorders|cognition disorders
271440|NCT02509689|post-concussive syndrome|post-concussive syndrome
271441|NCT02509689|neuroplasticity|neuroplasticity
271442|NCT02509689|EEG|eeg
271443|NCT02509689|biofeedback|biofeedback
271444|NCT02509689|stress disorder/post-traumatic|stress disorder/post-traumatic
271445|NCT02509689|depression|depression
271446|NCT02509676|dynamic stretching training|dynamic stretching training
271447|NCT02509676|muscle tendon unit|muscle tendon unit
271448|NCT02509676|ultrasound|ultrasound
271449|NCT02509650|Exome sequencing|exome sequencing
271450|NCT02509650|Skin disease|skin disease
271451|NCT02509650|Familial lipomatosis|familial lipomatosis
271452|NCT02509637|Respiratory System|respiratory system
271453|NCT02509637|Physical Therapy Modalities|physical therapy modalities
271454|NCT02509611|Yoga|yoga
271455|NCT02509611|Parkinson's disease|parkinson's disease
271456|NCT02509611|redox status|redox status
271457|NCT02509611|motor function|motor function
271458|NCT02509559|Receptors, Adrenergic|receptors, adrenergic
271459|NCT02509559|Propranolol|propranolol
271460|NCT02509533|Vacuum Assisted Closure|vacuum assisted closure
271461|NCT02509520|Nutritional supplementation|nutritional supplementation
271462|NCT02509520|Neuromuscular Electric Stimulation|neuromuscular electric stimulation
271463|NCT02509520|ICU acquired weakness|icu acquired weakness
271464|NCT02509520|Post ICU Syndrome|post icu syndrome
271465|NCT02509520|sarcopenia|sarcopenia
271466|NCT02509507|Liver tumours|liver tumours
271467|NCT02509494|Vaccine|vaccine
271468|NCT02509494|Ebola|ebola
271469|NCT02509494|Ebola virus disease|ebola virus disease
271470|NCT02509494|EVD|evd
271471|NCT02509494|Hemorrhagic fever|hemorrhagic fever
271472|NCT02509494|Sierra Leone|sierra leone
271473|NCT02509494|Human adenovirus serotype 26 (Ad26) encoding the Ebola virus Mayinga variant glycoprotein (Ad26.ZEBOV)|human adenovirus serotype 26 (ad26) encoding the ebola virus mayinga variant glycoprotein (ad26.zebov)
271474|NCT02509494|Safety|safety
271475|NCT02509494|Immunogenicity|immunogenicity
271476|NCT02509494|Modified Vaccinia Virus Ankara ‐ Bavarian Nordic Filo‐vector|modified vaccinia virus ankara ‐ bavarian nordic filo‐vector
271477|NCT02509494|(MVA‐BN Filo)|(mva‐bn filo)
271478|NCT02509481|malaria|malaria
271479|NCT02509481|lymphatic filariasis|lymphatic filariasis
271480|NCT02509481|mosquito|mosquito
271481|NCT02509481|ivermectin|ivermectin
271482|NCT02509481|mass drug administration|mass drug administration
271483|NCT02509455|Balance control|balance control
271484|NCT02509455|Body-mounted sensors|body-mounted sensors
271485|NCT02509455|Balance Measures|balance measures
271486|NCT02509442|mapping brain functions|mapping brain functions
271487|NCT02509442|Direct electric stimulation (DES)|direct electric stimulation (des)
271488|NCT02509442|potential evoked|potential evoked
271489|NCT02509429|T1DM|t1dm
271490|NCT02509429|Type 1 Diabetes|type 1 diabetes
271491|NCT02509429|Artificial Pancreas|artificial pancreas
271492|NCT02509429|DiAs platform|dias platform
271493|NCT02509416|endoscopic ultrasound|endoscopic ultrasound
271494|NCT02509416|endoscopic retrograde cholangiopancreatography|endoscopic retrograde cholangiopancreatography
271495|NCT02509416|competency|competency
271496|NCT02509403|Perineal hygiene|perineal hygiene
271497|NCT02509403|Hygiene wipes|hygiene wipes
271498|NCT02509403|Hygiene Towels|hygiene towels
271499|NCT02509403|Safety|safety
271500|NCT02509403|Essential oils|essential oils
271501|NCT02509403|Natural Health Product|natural health product
271502|NCT02509390|Fibrinogen level|fibrinogen level
271503|NCT02509390|Hyperfibrinogenemia|hyperfibrinogenemia
271504|NCT02509390|Trauma|trauma
271505|NCT02509390|Thrombosis risk|thrombosis risk
271506|NCT02509377|Fetal Surgery|fetal surgery
271507|NCT02509377|Open Fetal Surgery|open fetal surgery
271508|NCT02509377|Elevated BMI|elevated bmi
271509|NCT02509377|Body Mass Index|body mass index
271510|NCT02509377|Spina Bifida|spina bifida
271511|NCT02509364|AE-IPF|ae-ipf
271512|NCT02509312|Analgesia, Obstetrical|analgesia, obstetrical
271513|NCT02509312|Blood Loss, Surgical|blood loss, surgical
271514|NCT02509312|Analgesics, Opioid/administration & dosage|analgesics, opioid/administration & dosage
271515|NCT02509312|Cyclooxygenase Inhibitors/administration & dosage|cyclooxygenase inhibitors/administration & dosage
271516|NCT02509312|Cesarean Section|cesarean section
271517|NCT02509312|Female|female
271518|NCT02509312|Humans|humans
271519|NCT02509312|Ketorolac/administration & dosage|ketorolac/administration & dosage
271520|NCT02509312|Hydromorphone/administration & dosage|hydromorphone/administration & dosage
271521|NCT02509312|Pain, Postoperative/drug therapy|pain, postoperative/drug therapy
271522|NCT02509312|Pregnancy|pregnancy
271523|NCT02509312|Morphine/administration & dosage|morphine/administration & dosage
271524|NCT02509299|COPD|copd
271525|NCT02509299|Quality of life|quality of life
271526|NCT02509299|Perceived health status|perceived health status
271527|NCT02509286|Esophageal neoplasms|esophageal neoplasms
271528|NCT02509286|gastro-esophageal junction neoplasms|gastro-esophageal junction neoplasms
271529|NCT02509286|adenocarcinoma|adenocarcinoma
271530|NCT02509286|esophagectomy|esophagectomy
271531|NCT02509286|surgery|surgery
271532|NCT02509286|radiotherapy|radiotherapy
271533|NCT02509286|chemotherapy|chemotherapy
271534|NCT02509260|colorectal surgery|colorectal surgery
271535|NCT02509247|sleep apnea|sleep apnea
271536|NCT02509247|CPAP|cpap
271537|NCT02509247|telemonitoring|telemonitoring
271538|NCT02509247|telecare|telecare
271539|NCT02509234|pediatric sarcomas|pediatric sarcomas
271540|NCT02509234|Ewing sarcoma|ewing sarcoma
271541|NCT02509234|rhabdomyosarcoma|rhabdomyosarcoma
271542|NCT02509234|soft tissue sarcoma|soft tissue sarcoma
271543|NCT02509208|iliac crest bone graft|iliac crest bone graft
271544|NCT02509208|ICBG|icbg
271545|NCT02509208|pelvic osteotomy|pelvic osteotomy
271546|NCT02509208|spinal fusion|spinal fusion
271547|NCT02509208|hemostasis|hemostasis
271548|NCT02509208|haemostasis|haemostasis
271549|NCT02509208|hemostatic|hemostatic
271550|NCT02509208|haemostatic|haemostatic
271551|NCT02509208|dextran|dextran
271552|NCT02509208|SurgiClot|surgiclot
271553|NCT02509208|cancellous bone bleeding|cancellous bone bleeding
271554|NCT02509182|Hyperoxia|hyperoxia
271555|NCT02509182|One-Lung Ventilation|one-lung ventilation
271556|NCT02509182|Thoracic Surgery|thoracic surgery
271557|NCT02509182|Anesthesiology|anesthesiology
271558|NCT02509156|Cardiomyopathy|cardiomyopathy
271560|NCT02509156|Anthracyclines|anthracyclines
271561|NCT02509156|Chemotherapy|chemotherapy
271562|NCT02509156|Allogeneic|allogeneic
271563|NCT02509156|Mesenchymal stem cells|mesenchymal stem cells
271564|NCT02509156|MSCs|mscs
271565|NCT02509156|Cancer survivors|cancer survivors
271566|NCT02509156|Breast Cancer|breast cancer
271567|NCT02509156|Leukemia|leukemia
271568|NCT02509156|Lymphoma|lymphoma
271569|NCT02509156|Sarcoma|sarcoma
271570|NCT02509143|Postoperative Nausea and Vomiting|postoperative nausea and vomiting
271571|NCT02509143|Colorectal Neoplasms|colorectal neoplasms
271572|NCT02509130|Severe Asthma|severe asthma
271573|NCT02509130|Asthma|asthma
271574|NCT02509130|Specialised Asthma Care|specialised asthma care
271575|NCT02509130|Asthma Care|asthma care
271576|NCT02509117|Alzheimer's disease|alzheimer's disease
271577|NCT02509104|Bioavailability|bioavailability
271578|NCT02509104|Dutasteride|dutasteride
271579|NCT02509104|Healthy Male Subjects|healthy male subjects
271580|NCT02509104|Fixed Dose Combination|fixed dose combination
271581|NCT02509078|ARDS|ards
271582|NCT02509078|neuromuscular blocker|neuromuscular blocker
271583|NCT02509078|cisatracurium|cisatracurium
271584|NCT02509065|bionic pancreas|bionic pancreas
271585|NCT02509065|artificial pancreas|artificial pancreas
271586|NCT02509065|insulin|insulin
271587|NCT02509065|glucagon|glucagon
271588|NCT02509065|continuous glucose monitor (CGM)|continuous glucose monitor (cgm)
271589|NCT02509065|insulin pump|insulin pump
271590|NCT02509065|outpatient|outpatient
271591|NCT02509039|CC-122|cc-122
271592|NCT02509039|Phase1|phase1
271593|NCT02509039|solid tumor|solid tumor
271594|NCT02509039|non-Hodgkin's lymphom|non-hodgkin's lymphom
271595|NCT02509026|non-radiographic axial spondyloarthritis|non-radiographic axial spondyloarthritis
271596|NCT02509013|chronic kidney disease|chronic kidney disease
271597|NCT02509013|stable coronary heart disease|stable coronary heart disease
271598|NCT02509013|prevalence|prevalence
271599|NCT02508987|Obesity|obesity
271600|NCT02508987|oxidative stress|oxidative stress
271601|NCT02508987|antioxidants|antioxidants
271602|NCT02508987|periodontal disease|periodontal disease
271603|NCT02508961|Physical Activity|physical activity
271604|NCT02508961|Exercise|exercise
271605|NCT02508961|Physiotherapy|physiotherapy
271606|NCT02508948|airway management|airway management
271607|NCT02508948|critically ill|critically ill
271608|NCT02508948|hemodynamic management|hemodynamic management
271609|NCT02508948|intubation|intubation
271610|NCT02508948|prospective study|prospective study
271611|NCT02508948|risk factors|risk factors
271612|NCT02508909|Videoassisted surgery|videoassisted surgery
271613|NCT02508883|Cancer|cancer
271614|NCT02508883|hemorrhage|hemorrhage
271615|NCT02508883|endoscopy|endoscopy
271616|NCT02508883|gastrointestinal hemorrhage|gastrointestinal hemorrhage
271617|NCT02508857|pain, postoperative|pain, postoperative
271618|NCT02508857|anesthesia adjuvants|anesthesia adjuvants
271619|NCT02508857|magnesium sulfate|magnesium sulfate
271620|NCT02508844|Probiotics|probiotics
271621|NCT02508844|Vivomixx®|vivomixx®
271622|NCT02508844|Microbiota|microbiota
271623|NCT02508831|Bilateral amputation|bilateral amputation
271624|NCT02508831|upper limb|upper limb
271625|NCT02508831|allograft|allograft
271626|NCT02508779|Diabetes|diabetes
271627|NCT02508779|Blood Glucose Management|blood glucose management
271628|NCT02508779|Preconception|preconception
271629|NCT02508779|Hypoglycemia|hypoglycemia
271630|NCT02508779|Women with diabetes|women with diabetes
271631|NCT02508766|Postural Control|postural control
271632|NCT02508766|Plantar Stimulation|plantar stimulation
271633|NCT02508766|Volunteers|volunteers
271634|NCT02508753|QT/QTc Intervals|qt/qtc intervals
271635|NCT02508701|HPV|hpv
271636|NCT02508701|Message Design|message design
271637|NCT02508701|Adolescent Males|adolescent males
271638|NCT02508688|hepatic hydrothorax|hepatic hydrothorax
271639|NCT02508688|thoracoscopic surgery|thoracoscopic surgery
271640|NCT02508688|diaphragmatic defect|diaphragmatic defect
271641|NCT02508675|injury|injury
271642|NCT02508675|risk factors|risk factors
271643|NCT02508675|outcome|outcome
271644|NCT02508675|costs|costs
271645|NCT02508662|Advanced Cancers|advanced cancers
271646|NCT02508662|Solid Tumors|solid tumors
271647|NCT02508662|Genomic Mutations|genomic mutations
271648|NCT02508662|FDA Approved Off-Label Chemotherapy|fda approved off-label chemotherapy
271649|NCT02508662|Refractory|refractory
271650|NCT02508623|Portal hypertension|portal hypertension
271651|NCT02508623|liver cirrhosis|liver cirrhosis
271652|NCT02508623|Rifaximin|rifaximin
271653|NCT02508597|Smoking cessation intervention|smoking cessation intervention
271654|NCT02508571|Infant, Premature|infant, premature
271655|NCT02508571|Intervention Studies|intervention studies
271656|NCT02508571|Bottle feeding|bottle feeding
271657|NCT02508532|2L GIST|2l gist
271658|NCT02508532|GIST second line|gist second line
271659|NCT02508532|GIST gleevec|gist gleevec
271660|NCT02508532|GIST imatinib|gist imatinib
271661|NCT02508532|Second-line GIST clinical trial|second-line gist clinical trial
271662|NCT02508532|BLU-285|blu-285
271663|NCT02508532|BLU 285|blu 285
271664|NCT02508532|BLUE-285|blue-285
271665|NCT02508532|BLUE 285|blue 285
271666|NCT02508532|Avapritinib|avapritinib
271667|NCT02508532|GIST imatinib relapse|gist imatinib relapse
271668|NCT02508532|GIST gleevec relapse|gist gleevec relapse
271669|NCT02508532|GIST KIT|gist kit
271670|NCT02508532|GIST relapse|gist relapse
271671|NCT02508532|GIST refractory|gist refractory
271672|NCT02508532|GIST imatinib intolerance|gist imatinib intolerance
271673|NCT02508532|GIST TKI treatment|gist tki treatment
271674|NCT02508532|GIST tyrosine kinase inhibitor treatment|gist tyrosine kinase inhibitor treatment
271675|NCT02508532|GIST TKI|gist tki
271676|NCT02508532|GIST tyrosine kinase inhibitor|gist tyrosine kinase inhibitor
271677|NCT02508532|Advanced GIST|advanced gist
271678|NCT02508532|GIST mutations|gist mutations
271679|NCT02508532|GIST treatments|gist treatments
271680|NCT02508532|Blueprint GIST|blueprint gist
271681|NCT02508532|Relapsed GIST clinical trial|relapsed gist clinical trial
271682|NCT02508532|Refractory GIST clinical trial|refractory gist clinical trial
271683|NCT02508532|KIT-mutant GIST|kit-mutant gist
271684|NCT02508532|cancer gist|cancer gist
271685|NCT02508532|gastrointestinal stromal tumor|gastrointestinal stromal tumor
271686|NCT02508532|gist cancer|gist cancer
271687|NCT02508532|PDGFRA|pdgfra
271688|NCT02508506|ALKS 5461|alks 5461
271689|NCT02508506|Alkermes|alkermes
271690|NCT02508506|Samidorphan|samidorphan
271691|NCT02508506|Renal Impairment|renal impairment
271692|NCT02508506|Pharmacokinetics|pharmacokinetics
271693|NCT02508506|Buprenorphine|buprenorphine
271694|NCT02508480|Stigma|stigma
271695|NCT02508480|Community Integration|community integration
271696|NCT02508467|Liver cancer|liver cancer
271697|NCT02508467|FGF19 gene amplification|fgf19 gene amplification
271698|NCT02508467|FGF19 overexpression|fgf19 overexpression
271699|NCT02508467|FGF19 upregulation|fgf19 upregulation
271700|NCT02508467|Cyclin D1 (CCND1) gene amplification|cyclin d1 (ccnd1) gene amplification
271701|NCT02508467|Cyclin D1 (CCND1) copy number gain|cyclin d1 (ccnd1) copy number gain
271702|NCT02508467|BLU-554|blu-554
271703|NCT02508467|FGFR4|fgfr4
271704|NCT02508467|Hepatocellular carcinoma|hepatocellular carcinoma
347262|NCT02109367|HE4|he4
271705|NCT02508467|Liver Disease|liver disease
271706|NCT02508467|Liver Neoplasms|liver neoplasms
271707|NCT02508454|Prevention|prevention
271708|NCT02508454|Screening|screening
271709|NCT02508454|Biobanking|biobanking
271710|NCT02508441|Neoplasms|neoplasms
271711|NCT02508441|Solid Tumors|solid tumors
271712|NCT02508441|Advanced Malignancy|advanced malignancy
271713|NCT02508441|Cancer|cancer
271714|NCT02508428|Osteolysis|osteolysis
271715|NCT02508428|Polyethylene|polyethylene
271716|NCT02508428|Crosslinked Polyethylene|crosslinked polyethylene
271717|NCT02508428|Total Hip Replacement|total hip replacement
271718|NCT02508428|Marathon|marathon
271719|NCT02508415|obesity|obesity
271720|NCT02508415|periodontal disease|periodontal disease
271721|NCT02508415|intervention|intervention
271722|NCT02508389|squamous cell carcinoma of the head and neck|squamous cell carcinoma of the head and neck
271723|NCT02508389|oral cavity|oral cavity
271724|NCT02508389|oropharynx|oropharynx
271725|NCT02508389|intensity-modulated radiation therapy|intensity-modulated radiation therapy
271726|NCT02508389|chemotherapy|chemotherapy
271727|NCT02508389|oral mucositis|oral mucositis
271728|NCT02508389|superoxide dismutase|superoxide dismutase
271729|NCT02508389|radioprotection|radioprotection
271730|NCT02508376|adjuvants|adjuvants
271731|NCT02508376|AP10-602|ap10-602
271732|NCT02508376|GLA-SE|gla-se
271733|NCT02508376|ID93|id93
271734|NCT02508376|Tuberculosis|tuberculosis
271735|NCT02508376|vaccine|vaccine
271736|NCT02508363|Taxi drivers|taxi drivers
271737|NCT02508363|Health care access|health care access
271738|NCT02508363|15-163|15-163
271739|NCT02508311|Tetraplegia|tetraplegia
271740|NCT02508311|High Paraplegia|high paraplegia
271741|NCT02508298|ICG|icg
271742|NCT02508298|ARFI|arfi
271743|NCT02508298|portal hypertension|portal hypertension
271744|NCT02508298|cirrhosis|cirrhosis
271745|NCT02508298|diagnostic study|diagnostic study
271746|NCT02508272|Transcriptome profiling|transcriptome profiling
271747|NCT02508259|mitochondria|mitochondria
271748|NCT02508259|purinergic signaling|purinergic signaling
271749|NCT02508259|cell danger response|cell danger response
271750|NCT02508194|RSV|rsv
271751|NCT02508194|Older adults|older adults
271752|NCT02508194|MEDI7510|medi7510
271753|NCT02508194|Vaccine|vaccine
271754|NCT02508194|Efficacy|efficacy
271755|NCT02508181|intra ocular pressure|intra ocular pressure
271756|NCT02508181|I-gel|i-gel
271757|NCT02508181|LMA Supreme|lma supreme
271758|NCT02508181|strabismus surgery|strabismus surgery
271759|NCT02508168|Drug therapy|drug therapy
271760|NCT02508129|Insomnia|insomnia
271761|NCT02508129|hypertension|hypertension
271762|NCT02508129|blood pressure|blood pressure
271763|NCT02508129|sleep|sleep
271764|NCT02508129|behavioral treatment|behavioral treatment
271765|NCT02508129|Cognitive Behavioral Treatment of Insomnia (CBTI)|cognitive behavioral treatment of insomnia (cbti)
271766|NCT02508129|Brief Behavioral Treatment of Insomnia (BBTI)|brief behavioral treatment of insomnia (bbti)
271767|NCT02508129|pragmatic trial|pragmatic trial
271768|NCT02508129|internet|internet
271769|NCT02508116|pharmacogenetics|pharmacogenetics
271770|NCT02508116|clopidogrel|clopidogrel
271771|NCT02508116|genotype|genotype
271772|NCT02508103|Premenstrual Dysphoric Disorder|premenstrual dysphoric disorder
271773|NCT02508103|Premenstrual Syndrome|premenstrual syndrome
271774|NCT02508103|PMS|pms
271775|NCT02508103|PMDD|pmdd
271776|NCT02508038|alpha beta depleted|alpha beta depleted
271777|NCT02508038|alphabeta|alphabeta
271778|NCT02508038|TCR alpha beta depleted|tcr alpha beta depleted
271779|NCT02508038|alpha beta|alpha beta
271780|NCT02508038|haploidentical|haploidentical
271781|NCT02508038|Zoledronate|zoledronate
271782|NCT02508038|Zoledronic acid|zoledronic acid
271783|NCT02508038|Pediatric cancers|pediatric cancers
271784|NCT02508038|alfa beta|alfa beta
271785|NCT02508038|αβ T cell depleted HSCT|αβ t cell depleted hsct
271786|NCT02508038|alpha beta T cell and B cell depleted HSCT|alpha beta t cell and b cell depleted hsct
271787|NCT02508038|haploidentical HSCT|haploidentical hsct
271788|NCT02508025|disability evaluation|disability evaluation
271789|NCT02508025|psychosocial factors|psychosocial factors
271790|NCT02508012|anti-TNF|anti-tnf
271791|NCT02508012|Immuno-monitoring|immuno-monitoring
271792|NCT02508012|Anti-drug antibody (ADAb)|anti-drug antibody (adab)
271793|NCT02508012|Inflammatory bowel disease (IBD)|inflammatory bowel disease (ibd)
271794|NCT02508012|Crohn's disease|crohn's disease
271795|NCT02508012|Ulcerative colitis|ulcerative colitis
271796|NCT02507973|Mechanical Ventilation|mechanical ventilation
271797|NCT02507973|Intracranial Pressure|intracranial pressure
271798|NCT02507973|Airway Pressure Release Ventilation|airway pressure release ventilation
271799|NCT02507934|Dry Eye|dry eye
271800|NCT02507908|neuroendocrine tumors|neuroendocrine tumors
271801|NCT02507908|5-hydroxyindolacetic acid|5-hydroxyindolacetic acid
271802|NCT02507908|serotonin|serotonin
271803|NCT02507908|isotope-dilution massa-spectrometer|isotope-dilution massa-spectrometer
271804|NCT02507895|Stroke|stroke
271805|NCT02507895|lower extremeties|lower extremeties
271806|NCT02507895|Brain-computer interface|brain-computer interface
271807|NCT02507895|Motor imagery|motor imagery
271808|NCT02507895|Rehabilitation|rehabilitation
271809|NCT02507895|TMS|tms
271810|NCT02507843|Vitamin D|vitamin d
271811|NCT02507817|LIF,Magnesium Sulphate|lif,magnesium sulphate
271812|NCT02507791|Fitbit|fitbit
271813|NCT02507791|Obesity|obesity
271814|NCT02507791|Pediatrics|pediatrics
271815|NCT02507778|Lung|lung
271816|NCT02507778|Cancer|cancer
271817|NCT02507778|Biomarkers|biomarkers
271818|NCT02507778|Early detection|early detection
271819|NCT02507778|Circulating tumor cell|circulating tumor cell
271820|NCT02507765|SBRT|sbrt
271821|NCT02507713|Amyotrophic lateral sclerosis|amyotrophic lateral sclerosis
271822|NCT02507713|Ultrasonography|ultrasonography
271823|NCT02507713|Motor neurons|motor neurons
271824|NCT02507713|Neuromuscular diseases|neuromuscular diseases
271825|NCT02507713|Fasciculation|fasciculation
271826|NCT02507700|nerve block|nerve block
271827|NCT02507674|appendicitis|appendicitis
271828|NCT02507674|pediatric|pediatric
271829|NCT02507674|ultrasound|ultrasound
271830|NCT02507635|cytokines|cytokines
271831|NCT02507635|persistent allergic rhinitis|persistent allergic rhinitis
271832|NCT02507635|H1 antihistamines|h1 antihistamines
271833|NCT02507583|Brain Tumor|brain tumor
271834|NCT02507583|Glioma|glioma
271835|NCT02507583|Newly Diagnosed|newly diagnosed
271836|NCT02507557|Therapy, Fluid|therapy, fluid
271837|NCT02507557|Digestive System Surgical Procedures|digestive system surgical procedures
271838|NCT02507557|Postoperative Complications|postoperative complications
271839|NCT02507544|Advanced Solid Malignancy|advanced solid malignancy
271840|NCT02507544|Safety and Tolerability|safety and tolerability
271841|NCT02507544|Tumor Response|tumor response
271842|NCT02507544|Hematology|hematology
271843|NCT02507544|Oncology|oncology
271844|NCT02507518|lung cancer, PET, progression free survival|lung cancer, pet, progression free survival
271845|NCT02507492|POMC, LEPR, PCSK1|pomc, lepr, pcsk1
271846|NCT02507466|locomotion|locomotion
271847|NCT02507453|volunteers|volunteers
271848|NCT02507427|Prostate cancer, robot, nerve mapping and monitoring|prostate cancer, robot, nerve mapping and monitoring
271849|NCT02507414|Mesenteric Traction Syndrome|mesenteric traction syndrome
271850|NCT02507414|Upper gastrointestinal cancer surgery|upper gastrointestinal cancer surgery
271851|NCT02507388|AMD|amd
271852|NCT02507388|nAMD|namd
271853|NCT02507388|wetAMD|wetamd
271854|NCT02507388|Age-Related Macular Degeneration|age-related macular degeneration
271855|NCT02507375|Non-Squamous|non-squamous
271856|NCT02507362|keratoconus , corneal collagen cross-linking|keratoconus , corneal collagen cross-linking
271857|NCT02507349|serious mental illness|serious mental illness
271858|NCT02507349|mental health services research|mental health services research
271859|NCT02507349|measurement-based care|measurement-based care
271860|NCT02507349|shared decision making|shared decision making
271861|NCT02507349|psychiatric medication management|psychiatric medication management
271862|NCT02507349|community psychiatry|community psychiatry
271863|NCT02507349|comparative effectiveness research|comparative effectiveness research
271864|NCT02507349|mixed methods research|mixed methods research
271865|NCT02507336|Mantle Cell Lymphoma (MCL)|mantle cell lymphoma (mcl)
271866|NCT02507336|Non-Hodgkin's Lymphoma (NHL)|non-hodgkin's lymphoma (nhl)
271867|NCT02507258|osteoarthritis|osteoarthritis
271868|NCT02507258|avascular necrosis|avascular necrosis
271869|NCT02507258|correction of functional deformity|correction of functional deformity
271870|NCT02507258|painful hip dysplasia|painful hip dysplasia
271871|NCT02507258|protrusio acetabuli|protrusio acetabuli
271872|NCT02507258|rheumatoid arthritis|rheumatoid arthritis
271873|NCT02507258|ankylosis|ankylosis
271874|NCT02507245|GHD|ghd
271875|NCT02507232|glioma|glioma
271876|NCT02507232|temozolomide|temozolomide
271877|NCT02507232|brain|brain
271878|NCT02507232|NovoTTF-200A|novottf-200a
271879|NCT02507232|cancer|cancer
271880|NCT02507232|low-grade glioma|low-grade glioma
271881|NCT02507206|schizotypal personality disorder|schizotypal personality disorder
271882|NCT02507206|cognitive impairment|cognitive impairment
271883|NCT02507206|working memory|working memory
271884|NCT02507206|Dopamine Agonists|dopamine agonists
271885|NCT02507206|Cognition Disorders|cognition disorders
271886|NCT02507206|Personality Disorders|personality disorders
271887|NCT02507206|Delirium|delirium
271888|NCT02507206|Dementia|dementia
271889|NCT02507206|Amnestic|amnestic
271890|NCT02507206|Cognitive Disorders|cognitive disorders
271891|NCT02507206|Mental Disorders|mental disorders
271892|NCT02507206|Dihydrexidine|dihydrexidine
271893|NCT02507206|Dopamine A|dopamine a
271894|NCT02507180|Clinical Decision Rule|clinical decision rule
271895|NCT02507180|Ultrasound|ultrasound
271896|NCT02507180|Suspected Deep Vein Thrombosis|suspected deep vein thrombosis
271897|NCT02507180|D-Dimer|d-dimer
271898|NCT02507180|LEFt|left
271899|NCT02507154|cetuximab|cetuximab
271900|NCT02507154|NK cells|nk cells
271901|NCT02507154|nasopharyngeal cancer|nasopharyngeal cancer
271902|NCT02507154|head and neck squamous cell cancer|head and neck squamous cell cancer
271903|NCT02507141|Reflectance Confocal Microscopy|reflectance confocal microscopy
271904|NCT02507141|15-128|15-128
271905|NCT02507050|Ivabradine|ivabradine
271906|NCT02507050|Microvascular dysfunction|microvascular dysfunction
271907|NCT02507050|PCI|pci
271908|NCT02507050|Procedural related myocardial injury|procedural related myocardial injury
271909|NCT02507050|IMR|imr
271910|NCT02507050|Index of Microvascular Resistance|index of microvascular resistance
271911|NCT02506998|Allergic rhinoconjunctivitis|allergic rhinoconjunctivitis
271912|NCT02506998|Dialyzable Leukocyte Extracts|dialyzable leukocyte extracts
271913|NCT02506985|Rivaroxaban|rivaroxaban
271914|NCT02506985|CDT (Catheter directed thrombolysis)|cdt (catheter directed thrombolysis)
271915|NCT02506985|PE (pulmonary embolism)|pe (pulmonary embolism)
271916|NCT02506985|NETs|nets
271917|NCT02506985|factor Xa|factor xa
271918|NCT02506972|Blood glucose|blood glucose
271919|NCT02506972|Humans|humans
271920|NCT02506972|Postprandial|postprandial
271921|NCT02506972|Sugar|sugar
271922|NCT02506972|Carbohydrate|carbohydrate
271923|NCT02506972|Oat beta-glucan|oat beta-glucan
271924|NCT02506946|Polycystic Ovary Syndrome|polycystic ovary syndrome
271925|NCT02506946|Non-Alcoholic Fatty Liver Disease|non-alcoholic fatty liver disease
271926|NCT02506946|Adolescents|adolescents
271927|NCT02506946|Young Women|young women
271928|NCT02506946|MRI|mri
271929|NCT02506946|MRS|mrs
271930|NCT02506946|DXA|dxa
271931|NCT02506946|Hirsutism|hirsutism
271932|NCT02506946|Amenorrhea|amenorrhea
271933|NCT02506946|Metabolic syndrome|metabolic syndrome
271934|NCT02506946|Dyslipidemia|dyslipidemia
271935|NCT02506946|Percentage liver fat|percentage liver fat
271936|NCT02506920|Postprandial lipemia|postprandial lipemia
271937|NCT02506920|glycemic response|glycemic response
271938|NCT02506881|darbepoetin alfa|darbepoetin alfa
271939|NCT02506881|pharmacokinetics|pharmacokinetics
271940|NCT02506881|pharmacodynamics|pharmacodynamics
271941|NCT02506881|healthy volunteers|healthy volunteers
271942|NCT02506868|darbepoetin alfa|darbepoetin alfa
271943|NCT02506842|Pancreatic Cancer|pancreatic cancer
271944|NCT02506842|Pancreatic Adenocarcinoma|pancreatic adenocarcinoma
271945|NCT02506842|AG|ag
271946|NCT02506842|OFF|off
271947|NCT02506842|Second-Line Adjuvant Therapy|second-line adjuvant therapy
271948|NCT02506829|Inpatients|inpatients
271949|NCT02506790|Melatonin, metformin, toremifene|melatonin, metformin, toremifene
271950|NCT02506777|Melatonin, metformin, chemotherapy|melatonin, metformin, chemotherapy
271951|NCT02506738|telemonitoring|telemonitoring
271952|NCT02506738|mHealth|mhealth
271953|NCT02506738|functional status|functional status
271954|NCT02506738|older people|older people
271955|NCT02506725|prenatal care|prenatal care
271956|NCT02506725|pregnancy|pregnancy
271957|NCT02506725|prematurity|prematurity
271958|NCT02506673|Audiovisual Aids|audiovisual aids
271959|NCT02506673|Perioperative Period|perioperative period
271960|NCT02506673|Anxiety|anxiety
271961|NCT02506634|symptom|symptom
271962|NCT02506608|Neuroplasticty, Sensory Feedback|neuroplasticty, sensory feedback
271963|NCT02506556|Pi3K pathway|pi3k pathway
271964|NCT02506543|Adolescent Health|adolescent health
271965|NCT02506543|Ethiopia|ethiopia
271966|NCT02506543|Sexual Violence|sexual violence
271967|NCT02506530|lymphedema|lymphedema
271968|NCT02506530|breast cancer|breast cancer
271969|NCT02506517|HER pathway aberrations|her pathway aberrations
271970|NCT02506439|Vitamin D|vitamin d
271971|NCT02506439|Cholecalciferol|cholecalciferol
271972|NCT02506439|Dose-response|dose-response
271973|NCT02506439|Randomized Controlled Trial|randomized controlled trial
271974|NCT02506439|Pregnancy|pregnancy
271975|NCT02506439|Cord blood|cord blood
271976|NCT02506439|Serum 25-hydroxyvitamin D|serum 25-hydroxyvitamin d
271977|NCT02506439|Vitamin D Deficiency|vitamin d deficiency
271978|NCT02506439|Nutrition|nutrition
271979|NCT02506439|Dietary intervention study|dietary intervention study
271980|NCT02506426|Chronic Sinusitis|chronic sinusitis
271981|NCT02506426|Chronic Rhinosinusitis|chronic rhinosinusitis
271982|NCT02506426|Endoscopic sinus surgery|endoscopic sinus surgery
271983|NCT02506426|Septoplasty|septoplasty
271984|NCT02506413|Maternal and Newborn Health|maternal and newborn health
271985|NCT02506361|TOP2α|top2α
271986|NCT02506361|anthracyclines|anthracyclines
271987|NCT02506361|taxanes|taxanes
271988|NCT02506361|non dose-dense chemotherapy|non dose-dense chemotherapy
271989|NCT02506335|Liver disease|liver disease
271990|NCT02506335|cardiomyopathy|cardiomyopathy
271991|NCT02506335|congenital heart disease|congenital heart disease
271992|NCT02506322|Bipolar I Disorder|bipolar i disorder
271993|NCT02506322|Bipolar II Disorder|bipolar ii disorder
271994|NCT02506322|Relapse Prevention|relapse prevention
271995|NCT02506296|type 2 diabetes|type 2 diabetes
271996|NCT02506296|endogenous insulin secretion|endogenous insulin secretion
271997|NCT02506283|cryotherapy|cryotherapy
271998|NCT02506283|recovery|recovery
742606|NCT00464711|depression|depression
271999|NCT02506283|athletic performance|athletic performance
272000|NCT02506283|maximum voluntary contraction|maximum voluntary contraction
272001|NCT02506283|rated perceived exertion|rated perceived exertion
272002|NCT02506283|delayed onset muscle soreness|delayed onset muscle soreness
272003|NCT02506283|jump performance|jump performance
272004|NCT02506244|Atrial Fibrillation|atrial fibrillation
272005|NCT02506244|Wearable device|wearable device
272006|NCT02506244|Wristband|wristband
272007|NCT02506244|ECG Patch|ecg patch
272008|NCT02506244|Strokes|strokes
272009|NCT02506244|Asymptomatic|asymptomatic
272010|NCT02506244|Heart Rhythm|heart rhythm
272011|NCT02506244|Home Monitoring|home monitoring
272012|NCT02506231|Allogeneic hematopoietic cell transplantation|allogeneic hematopoietic cell transplantation
272013|NCT02506231|GVHD prophylaxis|gvhd prophylaxis
272014|NCT02506231|Methotrexate|methotrexate
272015|NCT02506231|Folinic acid|folinic acid
272016|NCT02506231|Leucovorin|leucovorin
272017|NCT02506231|Mucositis|mucositis
272018|NCT02506192|Gulf War Illness|gulf war illness
272019|NCT02506192|Chronic Inflammation|chronic inflammation
272020|NCT02506192|Delayed-Release Prednisone|delayed-release prednisone
272021|NCT02506192|Health-Related Quality of Life|health-related quality of life
272022|NCT02506179|Real-life effect|real-life effect
272023|NCT02506179|Adalimumab|adalimumab
272024|NCT02506179|Patient reported outcomes (PRO)|patient reported outcomes (pro)
272025|NCT02506179|Moderate to severe ulcerative colitis (UC)|moderate to severe ulcerative colitis (uc)
272026|NCT02506179|Ulcerative colitis (UC)|ulcerative colitis (uc)
272027|NCT02506166|sleep apnea|sleep apnea
272028|NCT02506166|sleep disordered breathing|sleep disordered breathing
272029|NCT02506166|sudden cardiac death|sudden cardiac death
272030|NCT02506166|heart failure|heart failure
272031|NCT02506166|ischemic cardiomyopathy|ischemic cardiomyopathy
272032|NCT02506166|implantable cardioverter-defibrillator (ICD) therapy|implantable cardioverter-defibrillator (icd) therapy
272033|NCT02506166|cardiac resynchronization therapy (CRT)|cardiac resynchronization therapy (crt)
272034|NCT02506166|risk stratification|risk stratification
272035|NCT02506166|positive airway pressure therapy|positive airway pressure therapy
272036|NCT02506166|SERVE-HF|serve-hf
272037|NCT02506140|minor stroke|minor stroke
272038|NCT02506140|transient ischemic attack|transient ischemic attack
272039|NCT02506140|ticagrelor|ticagrelor
272040|NCT02506140|clopidogrel|clopidogrel
272041|NCT02506140|dual anti-platelet therapy|dual anti-platelet therapy
272042|NCT02506140|platelet reactivity|platelet reactivity
272043|NCT02506127|TBS, MDD, Sham-controlled, neuromodulation, TMS|tbs, mdd, sham-controlled, neuromodulation, tms
272044|NCT02506114|prostate|prostate
272045|NCT02506062|ischemic preconditioning|ischemic preconditioning
272046|NCT02506062|Raynaud's Phenomenon|raynaud's phenomenon
272047|NCT02506062|(RP)|(rp)
272048|NCT02506036|Treatment|treatment
272049|NCT02506036|Social-Cognitive Training|social-cognitive training
272050|NCT02506036|Web-based|web-based
272051|NCT02506036|Right Hemisphere Stroke|right hemisphere stroke
272052|NCT02506036|Frontotemporal Dementia|frontotemporal dementia
272053|NCT02506036|Right Sided Cerebral Hemisphere Cerebrovascular Accident|right sided cerebral hemisphere cerebrovascular accident
272054|NCT02506023|Factor VIII antigen|factor viii antigen
272055|NCT02506023|von Willebrand factor (vWF) antigen|von willebrand factor (vwf) antigen
272056|NCT02506023|Mutation type|mutation type
272057|NCT02506010|Hypoxia|hypoxia
272058|NCT02505984|oxytocin, bonding|oxytocin, bonding
272059|NCT02505984|child development|child development
272060|NCT02505971|hemangioma, propranolol, nadolol|hemangioma, propranolol, nadolol
272061|NCT02505958|insulin resistance, obesity, caloric intake|insulin resistance, obesity, caloric intake
272062|NCT02505945|Esophageal Reflux|esophageal reflux
272063|NCT02505945|Gastric Acid Reflux Disease|gastric acid reflux disease
272064|NCT02505945|Heartburn|heartburn
272065|NCT02505932|Shoulder instability|shoulder instability
272066|NCT02505919|Lower Urinary Tract Symptoms (LUTS)|lower urinary tract symptoms (luts)
272067|NCT02505906|Late toxicity|late toxicity
272068|NCT02505906|Simultaneous integrated boost (SIB)|simultaneous integrated boost (sib)
272069|NCT02505906|Radiotherapy|radiotherapy
272070|NCT02505880|Hypnosis|hypnosis
272071|NCT02505880|Pediatric surgery|pediatric surgery
272072|NCT02505880|Anesthesia|anesthesia
272073|NCT02505854|Obesity|obesity
272074|NCT02505854|Probiotic|probiotic
272075|NCT02505854|Symbiotic|symbiotic
272076|NCT02505854|Weight loss|weight loss
272077|NCT02505854|Gut microbiota|gut microbiota
272078|NCT02505854|Bifidobacterium lactis|bifidobacterium lactis
272079|NCT02505854|Fructooligosaccharide|fructooligosaccharide
272080|NCT02505854|Blood sugar|blood sugar
272081|NCT02505854|Lipemia|lipemia
272082|NCT02505841|Appendectomy|appendectomy
272083|NCT02505841|Laparoscopy|laparoscopy
272084|NCT02505841|pediatric surgery|pediatric surgery
272085|NCT02505828|Arthritis|arthritis
272086|NCT02505828|septic|septic
272087|NCT02505828|Juvenile idiopathic arthritis|juvenile idiopathic arthritis
272088|NCT02505828|diagnosis|diagnosis
272089|NCT02505828|proteomic|proteomic
272090|NCT02505828|cytokine|cytokine
272091|NCT02505828|monocytes|monocytes
272092|NCT02505802|Stroke|stroke
272093|NCT02505802|Botulinum Toxins|botulinum toxins
272094|NCT02505802|Muscle Spasticity|muscle spasticity
272095|NCT02505802|Gait|gait
272096|NCT02505789|Epstein-Barr Virus|epstein-barr virus
272097|NCT02505789|Post-transplant lymphoproliferative disease (PTLD)|post-transplant lymphoproliferative disease (ptld)
272098|NCT02505789|Infection|infection
272099|NCT02505789|Cell Transplants|cell transplants
272100|NCT02505789|Herpesvirus 4, Human|herpesvirus 4, human
272101|NCT02505711|Agriculture|agriculture
272102|NCT02505711|Food|food
272103|NCT02505711|Micronutrients|micronutrients
272104|NCT02505711|Pregnancy|pregnancy
272105|NCT02505711|Infants|infants
272106|NCT02505711|Women's groups|women's groups
272107|NCT02505711|Bangladesh|bangladesh
272108|NCT02505698|Breast Imaging|breast imaging
272109|NCT02505698|Mammography|mammography
272110|NCT02505698|Anatomical Imaging|anatomical imaging
272111|NCT02505685|Lung|lung
272112|NCT02505685|Cancer|cancer
272113|NCT02505685|Biomarkers|biomarkers
272114|NCT02505685|PET-CT|pet-ct
272115|NCT02505685|Early detection|early detection
272116|NCT02505672|Vestibular function|vestibular function
272117|NCT02505672|chemoradiotherapy|chemoradiotherapy
272118|NCT02505659|Anterior cruciate ligament rupture|anterior cruciate ligament rupture
272119|NCT02505659|Preoperative re-education|preoperative re-education
272120|NCT02505659|Knee functional performance|knee functional performance
272121|NCT02505659|Anterior cruciate ligament surgery|anterior cruciate ligament surgery
272122|NCT02505659|Single-leg hop for distance test performance|single-leg hop for distance test performance
272123|NCT02505646|circulatory failure|circulatory failure
272124|NCT02505646|fluid responsiveness|fluid responsiveness
272125|NCT02505646|abdominal compression|abdominal compression
272126|NCT02505633|brachial plexus block|brachial plexus block
272127|NCT02505633|nerve stimulator|nerve stimulator
272128|NCT02505633|ultrasound|ultrasound
272129|NCT02505620|Neurocognitive function|neurocognitive function
272130|NCT02505620|OSAS|osas
272131|NCT02505594|Obstructive Sleep Apnea|obstructive sleep apnea
272132|NCT02505594|Vasoreactivity|vasoreactivity
272133|NCT02505594|Endothelial function|endothelial function
272134|NCT02505594|Exercise|exercise
272135|NCT02505581|Postoperative Wound Infection|postoperative wound infection
272136|NCT02505581|Surgical Wound Infection|surgical wound infection
272137|NCT02505581|Colorectal Surgery Infection Prophylaxis|colorectal surgery infection prophylaxis
272138|NCT02505568|Behcet Disease|behcet disease
272139|NCT02505568|Infliximab|infliximab
272140|NCT02505568|Adult participants|adult participants
272141|NCT02505555|feasibility|feasibility
272142|NCT02505555|accuracy|accuracy
272143|NCT02505555|tolerability|tolerability
272144|NCT02505555|four dimensional hysterosalpingo-contrast sonography|four dimensional hysterosalpingo-contrast sonography
272145|NCT02505542|Axial Spondyloarthritis|axial spondyloarthritis
272146|NCT02505542|axSpA|axspa
272147|NCT02505542|Ankylosing Spondylitis|ankylosing spondylitis
272148|NCT02505542|Anti TNF-alpha|anti tnf-alpha
272149|NCT02505542|Certolizumab Pegol|certolizumab pegol
272150|NCT02505542|Remission|remission
272151|NCT02505542|Spondylarthropathies|spondylarthropathies
272152|NCT02505542|Arthritis|arthritis
272153|NCT02505542|Spinal Diseases|spinal diseases
272154|NCT02505542|Immunosuppressive Agents|immunosuppressive agents
272155|NCT02505529|Aging|aging
272156|NCT02505529|Muscle|muscle
272157|NCT02505529|Weakness|weakness
272158|NCT02505529|Sarcopenia|sarcopenia
272159|NCT02505529|Dynapenia|dynapenia
272160|NCT02505516|pathology|pathology
272161|NCT02505503|Claudication|claudication
272162|NCT02505503|Footwear|footwear
272163|NCT02505503|Shoes|shoes
272164|NCT02505503|Walking capacity|walking capacity
272165|NCT02505503|Walking distance|walking distance
272166|NCT02505490|Lunch|lunch
272167|NCT02505490|Television|television
272168|NCT02505490|Macaroni and Cheese|macaroni and cheese
272169|NCT02505490|Salad tossed in dressing|salad tossed in dressing
272170|NCT02505477|schiozphrenia|schiozphrenia
272171|NCT02505477|cognition|cognition
272172|NCT02505477|negative symptoms|negative symptoms
272173|NCT02505477|glutamate|glutamate
272174|NCT02505477|glutathione|glutathione
272175|NCT02505477|N-acetylcysteine|n-acetylcysteine
272176|NCT02505451|Metabolic syndrome|metabolic syndrome
272177|NCT02505451|diabetes|diabetes
272178|NCT02505451|myocardial function|myocardial function
272179|NCT02505451|dobutamine|dobutamine
272180|NCT02505399|Rotational Atherectomy|rotational atherectomy
272181|NCT02505399|clopidogrel|clopidogrel
272182|NCT02505399|thrombosis|thrombosis
272183|NCT02505399|ticagrelor|ticagrelor
272184|NCT02505386|Ertapenem|ertapenem
272185|NCT02505386|Subcutaneously|subcutaneously
272186|NCT02505386|Aged|aged
272187|NCT02505386|Elderly|elderly
272188|NCT02505386|Pharmacokinetics|pharmacokinetics
272189|NCT02505373|Brief Therapy|brief therapy
272190|NCT02505373|Attempted Suicide|attempted suicide
742607|NCT00464711|biology|biology
272191|NCT02505373|Therapeutic Alliance|therapeutic alliance
272192|NCT02505373|Suicidal Ideation|suicidal ideation
272193|NCT02505373|Suicide|suicide
272194|NCT02505373|ASSIP|assip
272195|NCT02505321|insulin resistance|insulin resistance
272196|NCT02505321|physiology|physiology
272197|NCT02505321|genetics|genetics
272198|NCT02505321|gene variants|gene variants
272199|NCT02505321|pathogenesis|pathogenesis
272200|NCT02505321|type 2 diabetes|type 2 diabetes
272201|NCT02505321|fat|fat
272202|NCT02505321|polygenic lipodystrophy|polygenic lipodystrophy
272203|NCT02505308|insulin|insulin
272204|NCT02505308|proinsulin|proinsulin
272205|NCT02505308|genotype|genotype
272206|NCT02505308|beta cells|beta cells
272207|NCT02505308|physiology|physiology
272208|NCT02505308|genetics|genetics
272209|NCT02505308|pathogenesis|pathogenesis
272210|NCT02505308|rare variants|rare variants
272211|NCT02505308|type 2 diabetes|type 2 diabetes
272212|NCT02505282|Orthostatic hypotension|orthostatic hypotension
272213|NCT02505282|Vitamin K|vitamin k
272214|NCT02505269|limited stage|limited stage
272215|NCT02505269|Hodgkin's disease|hodgkin's disease
272216|NCT02505269|non-bulky|non-bulky
272217|NCT02505243|ribavirin|ribavirin
272218|NCT02505243|direct-acting antivirals|direct-acting antivirals
272219|NCT02505243|pharmacokinetics|pharmacokinetics
272220|NCT02505243|therapeutic drug monitoring|therapeutic drug monitoring
272221|NCT02505217|platelet reactivity, thrombin generation|platelet reactivity, thrombin generation
272222|NCT02505204|clonidine|clonidine
272223|NCT02505204|paravertebral block|paravertebral block
272224|NCT02505204|hemodynamic stability|hemodynamic stability
272225|NCT02505191|Pharmacokinetics|pharmacokinetics
272226|NCT02505178|Depression|depression
272227|NCT02505178|Depressive Disorder|depressive disorder
272228|NCT02505178|Depressive Disorder, Major|depressive disorder, major
272229|NCT02505178|Mental Disorders|mental disorders
272230|NCT02505178|Mood Disorders|mood disorders
272231|NCT02505178|Behavioural Symptoms|behavioural symptoms
272232|NCT02505178|Problem Solving Therapy|problem solving therapy
272233|NCT02505165|Intervention|intervention
272234|NCT02505165|Illness Uncertainty|illness uncertainty
272235|NCT02505165|Childhood Cancer|childhood cancer
272236|NCT02505165|Solid Tumor|solid tumor
272237|NCT02505165|Leukemia|leukemia
272238|NCT02505165|Lymphoma|lymphoma
272239|NCT02505165|Brain Tumor|brain tumor
272240|NCT02505165|Randomized clinical trial|randomized clinical trial
272241|NCT02505165|Parental uncertainty management intervention|parental uncertainty management intervention
272243|NCT02505165|Oncology|oncology
272244|NCT02505165|Pediatric|pediatric
272245|NCT02505152|Hypertension, Portal|hypertension, portal
272246|NCT02505152|Portal Vein, Cavernous Transformation Of|portal vein, cavernous transformation of
272247|NCT02505152|Portosystemic shunt|portosystemic shunt
272248|NCT02505152|Radiology, Interventional|radiology, interventional
272249|NCT02505139|nasopharyngeal carcinoma|nasopharyngeal carcinoma
272250|NCT02505139|distant metastasis|distant metastasis
272251|NCT02505139|circulating tumor cells|circulating tumor cells
272252|NCT02505139|outcome prediction|outcome prediction
272253|NCT02505113|Portal Vein, Cavernous Transformation Of|portal vein, cavernous transformation of
272254|NCT02505113|Hypertension, Portal|hypertension, portal
272255|NCT02505100|threat of premature birth|threat of premature birth
272256|NCT02505087|Selenoprotein N-related myopathy|selenoprotein n-related myopathy
272257|NCT02505087|biomarkers|biomarkers
272258|NCT02505087|washout|washout
272259|NCT02505087|N-ACETYLCYSTEINE|n-acetylcysteine
272260|NCT02505074|mitral valve|mitral valve
272261|NCT02505074|tricuspid valve|tricuspid valve
272262|NCT02505074|Melody valve|melody valve
272263|NCT02505035|Palliative care|palliative care
272264|NCT02505035|Pragmatic trial|pragmatic trial
272265|NCT02505022|Cognition|cognition
272266|NCT02505022|Early mental illness|early mental illness
272267|NCT02505022|Role functioning|role functioning
272268|NCT02505009|Therapeutic Uses|therapeutic uses
272269|NCT02505009|Entecavir|entecavir
272270|NCT02505009|Tenofovir|tenofovir
272271|NCT02505009|Engerix-B|engerix-b
272272|NCT02505009|DNA Virus Infections|dna virus infections
272273|NCT02505009|Antiviral Agents|antiviral agents
272274|NCT02505009|Vaccination|vaccination
272275|NCT02504996|sciatalgia|sciatalgia
272276|NCT02504996|emergency department|emergency department
272277|NCT02504996|paracetamol|paracetamol
272278|NCT02504996|morphine|morphine
272279|NCT02504983|SNPs|snps
272280|NCT02504970|Anesthesia|anesthesia
272281|NCT02504970|Quality Improvement|quality improvement
272282|NCT02504957|Photodynamic therapy|photodynamic therapy
272283|NCT02504944|Retinopathy of prematurity|retinopathy of prematurity
272284|NCT02504944|Propranolol|propranolol
272285|NCT02504944|Newborn|newborn
272286|NCT02504944|Eye Drops|eye drops
272287|NCT02504944|Retinal angiogenesis|retinal angiogenesis
272288|NCT02504944|Retinal neovascularization|retinal neovascularization
272289|NCT02504931|PTSD|ptsd
272290|NCT02504931|Alcohol|alcohol
272291|NCT02504931|Dual Diagnosis|dual diagnosis
272292|NCT02504931|Sertraline|sertraline
272293|NCT02504931|SSRI|ssri
272294|NCT02504918|Plasmodium Falciparum|plasmodium falciparum
272295|NCT02504918|Regulatory|regulatory
272296|NCT02504918|Chemoprevention|chemoprevention
272297|NCT02504918|Coartem|coartem
272298|NCT02504918|Parasitemia|parasitemia
272299|NCT02504905|Parietal Lobe|parietal lobe
272300|NCT02504905|Plasticity|plasticity
272301|NCT02504905|Cerebellum|cerebellum
272302|NCT02504905|Dystonia|dystonia
272303|NCT02504905|Transcranial Magnetic Stimulation (TMS)|transcranial magnetic stimulation (tms)
272304|NCT02504892|Overall Response Rate|overall response rate
272305|NCT02504892|Hereditary Cancer Syndrome|hereditary cancer syndrome
272306|NCT02504892|mTOR Therapy Naive|mtor therapy naive
272307|NCT02504879|Osteosclerosis|osteosclerosis
272308|NCT02504879|Hyperostosis|hyperostosis
272309|NCT02504866|Aerobic Exercise Training|aerobic exercise training
272310|NCT02504866|Balance|balance
272311|NCT02504866|TBI|tbi
272312|NCT02504853|Eosinophilic Esophagitis|eosinophilic esophagitis
272313|NCT02504853|Loeys-Dietz Syndrome|loeys-dietz syndrome
272314|NCT02504853|TGFbeta|tgfbeta
272315|NCT02504840|Multiple Sclerosis|multiple sclerosis
272316|NCT02504840|Clinically Isolated Syndrome|clinically isolated syndrome
272317|NCT02504840|CNS Inflammatory Demyellnation|cns inflammatory demyellnation
272318|NCT02504840|Radiologically Isolated Syndrome|radiologically isolated syndrome
272319|NCT02504827|pharmacokinetics|pharmacokinetics
272320|NCT02504827|ceftazidime/avibactam|ceftazidime/avibactam
272321|NCT02504814|nasal high flow|nasal high flow
272322|NCT02504801|primary lung cancer patients|primary lung cancer patients
272323|NCT02504788|Whole Brain Radiotherapy (WBRT)|whole brain radiotherapy (wbrt)
272324|NCT02504788|Neurocognitive Functions (NCFs)|neurocognitive functions (ncfs)
272325|NCT02504788|Hippocampus|hippocampus
272326|NCT02504788|Hippocampus Sparing during Whole Brain Radiotherapy (HS-WBRT)|hippocampus sparing during whole brain radiotherapy (hs-wbrt)
272327|NCT02504749|GIT motility|git motility
272328|NCT02504749|General anaesthesia|general anaesthesia
272329|NCT02504749|spinal anaesthesia|spinal anaesthesia
272330|NCT02504736|LDL cholesterol|ldl cholesterol
272332|NCT02504736|High risk South Asians|high risk south asians
272333|NCT02504736|Colesevelam|colesevelam
272334|NCT02504723|Gastric varices|gastric varices
272335|NCT02504723|cyanoacrylate|cyanoacrylate
272336|NCT02504723|carvedilol|carvedilol
272337|NCT02504710|Musculoskeletal Manipulations|musculoskeletal manipulations
272338|NCT02504710|Learning|learning
272339|NCT02504710|Feedback|feedback
272340|NCT02504710|Kinematics|kinematics
272341|NCT02504710|Inertial Sensor|inertial sensor
272342|NCT02504684|varicose veins|varicose veins
272343|NCT02504684|endovenous laser treatment|endovenous laser treatment
272344|NCT02504684|endovenous thermal ablation|endovenous thermal ablation
272345|NCT02504684|saphenous vein|saphenous vein
272346|NCT02504671|DMARD-IR|dmard-ir
272347|NCT02504671|GSK3196165|gsk3196165
272348|NCT02504671|Rheumatoid Arthritis|rheumatoid arthritis
272349|NCT02504658|adolescents text messages eating exercise self-efficacy diabetes|adolescents text messages eating exercise self-efficacy diabetes
272350|NCT02504632|platelet activation|platelet activation
272351|NCT02504632|transcatheter aortic valve implantation|transcatheter aortic valve implantation
272352|NCT02504593|Quality Assurance|quality assurance
272353|NCT02504593|Monitoring & Evaluation|monitoring & evaluation
272354|NCT02504593|Malaria rapid diagnostic test (RDT)|malaria rapid diagnostic test (rdt)
272355|NCT02504593|Community-based malaria diagnosis|community-based malaria diagnosis
272356|NCT02504593|Community health workers|community health workers
272357|NCT02504567|Catheter Ablation|catheter ablation
272358|NCT02504567|Radiofrequency|radiofrequency
272359|NCT02504567|Laser|laser
272360|NCT02504567|Atrial Fibrillation|atrial fibrillation
272361|NCT02504554|children|children
272362|NCT02504541|Hypogonadism|hypogonadism
272363|NCT02504541|Testosterone enanthate|testosterone enanthate
272364|NCT02504528|asthma|asthma
272365|NCT02504528|allergy|allergy
272366|NCT02504528|bronchial hyperresponsiveness|bronchial hyperresponsiveness
272367|NCT02504528|provocation|provocation
272368|NCT02504502|Whole Genome Sequencing|whole genome sequencing
272369|NCT02504502|Laboratory Report|laboratory report
272370|NCT02504502|Patient Centered|patient centered
272371|NCT02504502|Communication of Results|communication of results
272372|NCT02504502|Patient Provider Communication|patient provider communication
272373|NCT02504476|Schizophrenia or Schizoaffective Disorder|schizophrenia or schizoaffective disorder
272374|NCT02504463|Alkermes|alkermes
272375|NCT02504463|Samidorphan|samidorphan
272376|NCT02504463|ALKS 33|alks 33
272377|NCT02504463|Healthy Volunteer|healthy volunteer
272378|NCT02504463|Pharmacokinetics|pharmacokinetics
272379|NCT02504450|Bipolar 1 disorder|bipolar 1 disorder
272380|NCT02504450|schizophrenia|schizophrenia
272381|NCT02504424|Tissue Expansion|tissue expansion
272382|NCT02504424|Tissue Expander|tissue expander
272383|NCT02504424|Breast Tissue Expansion|breast tissue expansion
272384|NCT02504424|Breast Tissue Expander|breast tissue expander
272385|NCT02504424|Breast Reconstruction|breast reconstruction
742608|NCT00464698|OCD|ocd
272386|NCT02504424|2 Stage Breast Reconstruction|2 stage breast reconstruction
272387|NCT02504372|NSCLC|nsclc
272388|NCT02504372|PDL1|pdl1
272389|NCT02504372|PD-L1|pd-l1
272390|NCT02504372|PDL|pdl
272391|NCT02504359|BEAM|beam
272392|NCT02504359|allogeneic|allogeneic
272393|NCT02504359|myeloma|myeloma
272394|NCT02504359|ixazomib|ixazomib
272395|NCT02504359|transplant|transplant
272396|NCT02504359|plasma cell leukemia|plasma cell leukemia
272397|NCT02504333|metastatic pancreatic adenocarcinoma|metastatic pancreatic adenocarcinoma
272398|NCT02504333|Nab-paclitaxel|nab-paclitaxel
272399|NCT02504333|Gemcitabine|gemcitabine
272400|NCT02504333|modified FOLFOX|modified folfox
272401|NCT02504320|Drug therapy|drug therapy
272402|NCT02504255|Crohn disease|crohn disease
272403|NCT02504255|inflammatory biomarkers|inflammatory biomarkers
272404|NCT02504255|immunologic markers|immunologic markers
272405|NCT02504255|calprotectin|calprotectin
272406|NCT02504216|Rivaroxaban|rivaroxaban
272407|NCT02504216|Xarelto|xarelto
272408|NCT02504216|Aspirin|aspirin
272409|NCT02504216|Acetylic salicylic acid|acetylic salicylic acid
272410|NCT02504216|Anticoagulant|anticoagulant
272411|NCT02504216|Peripheral artery disease|peripheral artery disease
272412|NCT02504216|Peripheral arterial disease|peripheral arterial disease
272413|NCT02504216|Revascularization|revascularization
272414|NCT02504216|Acute limb ischemia|acute limb ischemia
272415|NCT02504216|Amputation|amputation
272416|NCT02504216|Cardiovascular events|cardiovascular events
272417|NCT02504190|Lymphoma|lymphoma
272418|NCT02504190|TEAM conditioning|team conditioning
272419|NCT02504190|autologous stem cells transplantation|autologous stem cells transplantation
272420|NCT02504164|midazolam|midazolam
272421|NCT02504164|satisfaction|satisfaction
272422|NCT02504164|endoscopic submucosal dissection|endoscopic submucosal dissection
272423|NCT02504099|Chronic Hepatitis C Infection|chronic hepatitis c infection
272424|NCT02504099|Early Stage Hepatocellular Carcinoma|early stage hepatocellular carcinoma
272425|NCT02504073|Clinical Reasoning|clinical reasoning
272426|NCT02504073|Physiotherapists|physiotherapists
272427|NCT02504060|diarrhea|diarrhea
272428|NCT02504060|abdominal pain|abdominal pain
272429|NCT02504047|Hematopoietic Stem Cell Transplantation|hematopoietic stem cell transplantation
272430|NCT02504034|Portal Vein, Cavernous Transformation Of|portal vein, cavernous transformation of
272431|NCT02504034|Hypertension, Portal|hypertension, portal
272432|NCT02504034|Radiology, Interventional|radiology, interventional
272433|NCT02504034|Portalsystemic shunt|portalsystemic shunt
272434|NCT02504008|bisphosphonate|bisphosphonate
272435|NCT02504008|CRPS|crps
272436|NCT02504008|RSD|rsd
272437|NCT02504008|non-opioid|non-opioid
272438|NCT02504008|CRPS-1|crps-1
272439|NCT02504008|acute on chronic pain|acute on chronic pain
272440|NCT02504008|chronic pain|chronic pain
272441|NCT02504008|zoledronic acid|zoledronic acid
272442|NCT02503969|Colorectal Cancer|colorectal cancer
272443|NCT02503969|Mass Screening|mass screening
272444|NCT02503969|Uptake|uptake
272445|NCT02503969|Morbidity|morbidity
272446|NCT02503969|Mental Health|mental health
272447|NCT02503943|GLP-1|glp-1
272448|NCT02503943|Masked hypertension|masked hypertension
272449|NCT02503943|Lipid metabolism|lipid metabolism
272450|NCT02503917|Imaging, Ultrasound|imaging, ultrasound
272451|NCT02503917|Image-guided radiotherapy|image-guided radiotherapy
272452|NCT02503917|Cancer|cancer
272453|NCT02503904|Pharmacology|pharmacology
272454|NCT02503904|Lidocaine|lidocaine
272455|NCT02503904|Epinephrine|epinephrine
272456|NCT02503904|Cefazolin|cefazolin
272457|NCT02503904|Metronidazole|metronidazole
272458|NCT02503904|Infection|infection
272459|NCT02503904|prevention|prevention
272460|NCT02503904|prophylaxis|prophylaxis
272461|NCT02503904|SSI|ssi
272462|NCT02503904|Surgery|surgery
272463|NCT02503904|Complications|complications
272464|NCT02503865|Metabolic syndrome|metabolic syndrome
272465|NCT02503865|Diabetes mellitus,|diabetes mellitus,
272466|NCT02503865|Hypertension|hypertension
272467|NCT02503865|Overweight|overweight
272468|NCT02503865|analimentary detoxication|analimentary detoxication
272469|NCT02503852|Female Pattern Baldness|female pattern baldness
272470|NCT02503852|Male Pattern Baldness|male pattern baldness
272471|NCT02503852|Genetic Alopecia|genetic alopecia
272472|NCT02503852|Androgenic Alopecia|androgenic alopecia
272473|NCT02503852|Hair Loss|hair loss
272474|NCT02503839|Host-modulating therapy|host-modulating therapy
272475|NCT02503839|Vaccine|vaccine
272476|NCT02503839|Cyclooxygenase inhibitors|cyclooxygenase inhibitors
272477|NCT02503813|brain death|brain death
272478|NCT02503813|apnea challenge test|apnea challenge test
272479|NCT02503787|chronic pain|chronic pain
272480|NCT02503787|intractable pain|intractable pain
272481|NCT02503787|failed back surgery syndrome|failed back surgery syndrome
272482|NCT02503774|Solid Tumors, MEDI9447, oleclumab, MEDI4736, durvalumab, CD73, PD-L1, EGFRm NSCLC, immunotherapy, pancreatic, colorectal|solid tumors, medi9447, oleclumab, medi4736, durvalumab, cd73, pd-l1, egfrm nsclc, immunotherapy, pancreatic, colorectal
272483|NCT02503761|meropenem|meropenem
272484|NCT02503761|infusion|infusion
272485|NCT02503761|late-onset sepsis|late-onset sepsis
272486|NCT02503761|newborn|newborn
272487|NCT02503761|management|management
272488|NCT02503735|CKD|ckd
272489|NCT02503735|HCV|hcv
272490|NCT02503696|Inflammatory Bowel Disease|inflammatory bowel disease
272491|NCT02503696|Cancer|cancer
272492|NCT02503696|Colorectal Cancer|colorectal cancer
272493|NCT02503696|Neoplasm|neoplasm
272494|NCT02503696|Colorectal Neoplasm|colorectal neoplasm
272495|NCT02503696|Intestinal Neoplasms|intestinal neoplasms
272496|NCT02503696|Gastrointestinal Neoplasms|gastrointestinal neoplasms
272497|NCT02503696|Digestive System Neoplasms|digestive system neoplasms
272498|NCT02503696|Neoplasms by Site|neoplasms by site
272499|NCT02503696|Neoplasms|neoplasms
272500|NCT02503696|Digestive System Diseases|digestive system diseases
272501|NCT02503696|Gastrointestinal Diseases|gastrointestinal diseases
272502|NCT02503696|Colonic Diseases|colonic diseases
272503|NCT02503696|Intestinal Diseases|intestinal diseases
272504|NCT02503696|Rectal Diseases|rectal diseases
272505|NCT02503683|RNAi therapeutic|rnai therapeutic
272506|NCT02503683|AAT|aat
272507|NCT02503683|Alpha-1 Antitrypsin Deficiency|alpha-1 antitrypsin deficiency
272508|NCT02503657|tipelukast|tipelukast
272509|NCT02503657|IPF|ipf
272510|NCT02503657|fibrosis|fibrosis
272511|NCT02503657|Idiopathic Pulmonary Fibrosis|idiopathic pulmonary fibrosis
272512|NCT02503644|diffuse cutaneous systemic sclerosis|diffuse cutaneous systemic sclerosis
272513|NCT02503644|scleroderma|scleroderma
272514|NCT02503644|IVA337|iva337
272515|NCT02503644|dcSSc|dcssc
272516|NCT02503644|lanifibranor|lanifibranor
272517|NCT02503631|Cancer|cancer
272518|NCT02503631|Colorectal Cancer|colorectal cancer
272519|NCT02503631|Neoplasm|neoplasm
272520|NCT02503631|Colorectal Neoplasm|colorectal neoplasm
272521|NCT02503631|Intestinal Neoplasms|intestinal neoplasms
272717|NCT02502617|Depression|depression
272522|NCT02503631|Gastrointestinal Neoplasms|gastrointestinal neoplasms
272523|NCT02503631|Digestive System Neoplasms|digestive system neoplasms
272524|NCT02503631|Neoplasms by Site|neoplasms by site
272525|NCT02503631|Neoplasms|neoplasms
272526|NCT02503631|Digestive System Diseases|digestive system diseases
272527|NCT02503631|Gastrointestinal Diseases|gastrointestinal diseases
272528|NCT02503631|Colonic Diseases|colonic diseases
272529|NCT02503631|Intestinal Diseases|intestinal diseases
272530|NCT02503631|Rectal Diseases|rectal diseases
272531|NCT02503605|Biosimilar|biosimilar
272532|NCT02503605|ovarian stimulation|ovarian stimulation
272533|NCT02503605|oocyte donor|oocyte donor
272534|NCT02503579|Brain-derived neurotropic factor|brain-derived neurotropic factor
272535|NCT02503579|Executive function|executive function
272537|NCT02503566|OCT|oct
272538|NCT02503566|heart rate|heart rate
272539|NCT02503566|antibodies|antibodies
272540|NCT02503553|option grid|option grid
272541|NCT02503553|neurosurgery|neurosurgery
272542|NCT02503553|cerebral aneurysm|cerebral aneurysm
272543|NCT02503540|macular edema|macular edema
272544|NCT02503540|rvo|rvo
272545|NCT02503540|diabetic macular edema|diabetic macular edema
272546|NCT02503527|Enteral nutrition|enteral nutrition
272547|NCT02503527|Tube feeding|tube feeding
272548|NCT02503527|Diet, carbohydrate-restricted|diet, carbohydrate-restricted
272549|NCT02503527|Diabetes|diabetes
272550|NCT02503527|Aneurysmal Subarachnoid Hemorrhage|aneurysmal subarachnoid hemorrhage
272551|NCT02503527|Blood glucose|blood glucose
272552|NCT02503527|Insulin|insulin
272553|NCT02503501|Memory|memory
272554|NCT02503501|Insulin glulisine|insulin glulisine
272555|NCT02503501|Alzheimer's disease|alzheimer's disease
272556|NCT02503501|Mild Cognitive Impairment|mild cognitive impairment
272557|NCT02503501|Intranasal insulin|intranasal insulin
272558|NCT02503501|Cognition Disorders|cognition disorders
272559|NCT02503488|Appetitive Aggression|appetitive aggression
272560|NCT02503462|HIV|hiv
272561|NCT02503462|darunavir|darunavir
272562|NCT02503462|ritonavir|ritonavir
272563|NCT02503462|cobicistat|cobicistat
272564|NCT02503462|CSF|csf
272565|NCT02503462|pharmacokinetics|pharmacokinetics
272566|NCT02503449|Pulmonary Cryptococcosis|pulmonary cryptococcosis
272567|NCT02503436|Ovarian Cancer, Fallopian Tube Cancer, primary peritoneal cancer, BRCA1 Gene, BRCA2 Gene|ovarian cancer, fallopian tube cancer, primary peritoneal cancer, brca1 gene, brca2 gene
272568|NCT02503423|cervical cancer|cervical cancer
272569|NCT02503423|HNSCC|hnscc
272570|NCT02503423|CTCL|ctcl
272571|NCT02503423|PTCL|ptcl
272572|NCT02503423|DLBCL|dlbcl
272573|NCT02503410|lower back|lower back
272574|NCT02503410|pain|pain
272575|NCT02503345|Kidney Stones|kidney stones
272576|NCT02503345|Nephrolithiasis|nephrolithiasis
272577|NCT02503345|Urine Oxalate|urine oxalate
272578|NCT02503345|Hyperoxaluria|hyperoxaluria
272579|NCT02503345|Enteric Hyperoxaluria|enteric hyperoxaluria
272580|NCT02503345|Idiopathic Hyperoxaluria|idiopathic hyperoxaluria
272581|NCT02503345|Urological Diseases|urological diseases
272582|NCT02503345|Kidney Diseases|kidney diseases
272583|NCT02503345|Dietary Oxalate|dietary oxalate
272584|NCT02503280|Cardiovascular|cardiovascular
348383|NCT02104882|IORT|iort
272585|NCT02503280|Secondary|secondary
272586|NCT02503267|antithrombin III deficiency|antithrombin iii deficiency
272587|NCT02503267|congenital heart diseases|congenital heart diseases
272588|NCT02503254|Smoking|smoking
272589|NCT02503254|Modified risk tobacco product|modified risk tobacco product
272590|NCT02503254|Conventional cigarette|conventional cigarette
272591|NCT02503254|Reduced exposure|reduced exposure
272592|NCT02503254|Confinement|confinement
272593|NCT02503254|Carbon Heated Tobacco Product|carbon heated tobacco product
272594|NCT02503215|Hemodialysis|hemodialysis
272595|NCT02503215|Obstructive sleep apnea|obstructive sleep apnea
272596|NCT02503215|Compression stockings|compression stockings
272597|NCT02503189|Dry eye syndromes|dry eye syndromes
272598|NCT02503189|Corneal diseases|corneal diseases
272599|NCT02503189|Conjunctival diseases|conjunctival diseases
272600|NCT02503176|Dry eye syndromes|dry eye syndromes
272601|NCT02503176|Corneal diseases|corneal diseases
272602|NCT02503176|Conjunctival diseases|conjunctival diseases
272603|NCT02503163|Dry eye syndromes|dry eye syndromes
272604|NCT02503163|Corneal diseases|corneal diseases
272605|NCT02503163|Conjunctival diseases|conjunctival diseases
272606|NCT02503150|Colorectal Cancer|colorectal cancer
272607|NCT02503150|Tumor Therapeutic Vaccine|tumor therapeutic vaccine
272608|NCT02503150|Dendritic Cell|dendritic cell
272609|NCT02503137|male pattern baldness|male pattern baldness
272610|NCT02503137|SM04554|sm04554
272611|NCT02503137|AGA|aga
272612|NCT02503111|Men who have sex with men|men who have sex with men
272613|NCT02503111|Human immunodeficiency virus|human immunodeficiency virus
272614|NCT02503111|Human papillomavirus|human papillomavirus
272615|NCT02503111|Anal intraepithelial neoplasia|anal intraepithelial neoplasia
272616|NCT02503111|Squamous cell carcinoma|squamous cell carcinoma
272617|NCT02503111|High-resolution anoscopy|high-resolution anoscopy
272618|NCT02503111|Anal cancer|anal cancer
272619|NCT02503111|High-risk oncogenic|high-risk oncogenic
272620|NCT02503111|Intraepithelial lesion|intraepithelial lesion
272621|NCT02503111|Low-risk non-oncogenic|low-risk non-oncogenic
272622|NCT02503111|Dysplasia|dysplasia
272623|NCT02503111|High-grade squamous intraepithelial lesion|high-grade squamous intraepithelial lesion
272624|NCT02503111|Low-grade squamous intraepithelial lesion|low-grade squamous intraepithelial lesion
272625|NCT02503111|Ablative therapy|ablative therapy
272626|NCT02503111|Electrocautery|electrocautery
272627|NCT02503111|Infrared coagulation|infrared coagulation
272628|NCT02503111|Active surveillance|active surveillance
272629|NCT02503098|Eating Disorders|eating disorders
272630|NCT02503098|Cognitive Behavioral Therapy|cognitive behavioral therapy
272631|NCT02503098|Mobile Phone|mobile phone
272632|NCT02503098|Smartphone|smartphone
272634|NCT02503098|Binge Eating Disorder|binge eating disorder
272635|NCT02503098|Bulimia Nervosa|bulimia nervosa
272636|NCT02503098|Signal Detection Analysis|signal detection analysis
272637|NCT02503085|Ibuprofen|ibuprofen
272638|NCT02503072|ARV adherence|arv adherence
272639|NCT02503020|Arachidonic acid|arachidonic acid
272640|NCT02503020|Omega-6/omega-3 ratio|omega-6/omega-3 ratio
272641|NCT02503020|Preterm infants nutrition|preterm infants nutrition
272642|NCT02502981|CKD|ckd
272643|NCT02502981|left ventricle|left ventricle
272644|NCT02502981|aldosterone|aldosterone
272645|NCT02502981|spironolactone|spironolactone
272646|NCT02502955|Quality Control|quality control
272647|NCT02502955|Cardiosurgery|cardiosurgery
272648|NCT02502955|Cardiology|cardiology
272649|NCT02502955|Vascular Surgery|vascular surgery
272650|NCT02502955|ICU|icu
272651|NCT02502942|Obstructive Sleep Apnea|obstructive sleep apnea
272652|NCT02502942|Exercise|exercise
272653|NCT02502942|Upper airway muscle|upper airway muscle
272654|NCT02502929|Diabetes|diabetes
272655|NCT02502929|Depression|depression
272656|NCT02502929|Medication therapy management|medication therapy management
272657|NCT02502929|Community health workers|community health workers
272658|NCT02502929|Cambodian|cambodian
272659|NCT02502929|Refugee|refugee
272660|NCT02502929|Prevention|prevention
272661|NCT02502890|asthma|asthma
272662|NCT02502890|nested case-control study|nested case-control study
272663|NCT02502890|difficult-to-control asthma|difficult-to-control asthma
272664|NCT02502890|asthma exacerbations|asthma exacerbations
272665|NCT02502890|cold symptoms|cold symptoms
272666|NCT02502890|gene expression|gene expression
272667|NCT02502864|senior adult|senior adult
272668|NCT02502864|postmenopausal|postmenopausal
272669|NCT02502838|overactive bladder|overactive bladder
272670|NCT02502838|pelvic organ prolapse|pelvic organ prolapse
272671|NCT02502838|TVT|tvt
272672|NCT02502812|bioequivalence|bioequivalence
272673|NCT02502812|SB224326|sb224326
272674|NCT02502812|clopidogrel|clopidogrel
272675|NCT02502812|Relative bioavailability|relative bioavailability
272676|NCT02502786|Humanized Monoclonal Antibody 3F8 (Hu3F8)|humanized monoclonal antibody 3f8 (hu3f8)
272677|NCT02502786|Granulocyte-Macrophage Colony Stimulating Factor (GM-CSF)|granulocyte-macrophage colony stimulating factor (gm-csf)
272678|NCT02502786|15-096|15-096
272679|NCT02502773|Goal-directed therapy|goal-directed therapy
272680|NCT02502773|Fluid loading|fluid loading
272681|NCT02502773|Abdominal surgery|abdominal surgery
272682|NCT02502773|Postoperative morbidity|postoperative morbidity
272683|NCT02502773|Postoperative mortality|postoperative mortality
272684|NCT02502773|Individualized goal-directed fluid therapy|individualized goal-directed fluid therapy
272685|NCT02502773|Elective or emergency abdominal surgery|elective or emergency abdominal surgery
272686|NCT02502773|General Anesthesia|general anesthesia
272687|NCT02502773|Moderate-to-high risk surgical patients|moderate-to-high risk surgical patients
272688|NCT02502760|Postoperative Complications|postoperative complications
272689|NCT02502760|Perioperative Care|perioperative care
272690|NCT02502760|Colorectal Surgery|colorectal surgery
272691|NCT02502760|Frail Elderly|frail elderly
272692|NCT02502734|inhaled corticosteroids|inhaled corticosteroids
272693|NCT02502734|pediatric subjects|pediatric subjects
272694|NCT02502734|asthma|asthma
272695|NCT02502734|fluticasone furoate|fluticasone furoate
272696|NCT02502721|Male|male
272697|NCT02502708|glioblastoma multiforme|glioblastoma multiforme
272698|NCT02502708|glioma|glioma
272699|NCT02502708|gliosarcoma|gliosarcoma
272700|NCT02502708|malignant brain tumor|malignant brain tumor
272701|NCT02502708|ependymoma|ependymoma
272702|NCT02502708|medulloblastoma|medulloblastoma
272703|NCT02502695|VATS Lobectomy and Segmentectomy for Lung Cancer|vats lobectomy and segmentectomy for lung cancer
272704|NCT02502695|Lung Cancer|lung cancer
272705|NCT02502682|Chlorhexidine bathing|chlorhexidine bathing
272706|NCT02502669|acne|acne
272707|NCT02502669|nodulocystic|nodulocystic
272708|NCT02502669|finasteride|finasteride
272709|NCT02502669|5 alpha reductase inhibitor|5 alpha reductase inhibitor
272710|NCT02502656|RAS mutation|ras mutation
272711|NCT02502656|DNA|dna
272712|NCT02502656|Colorectal Cancer|colorectal cancer
272713|NCT02502643|Safety and Efficacy|safety and efficacy
272714|NCT02502643|Thoracic Surgery|thoracic surgery
272715|NCT02502617|Psychopathology|psychopathology
272716|NCT02502617|Cognition|cognition
272718|NCT02502617|Nutrition|nutrition
272719|NCT02502617|Cortisol|cortisol
272720|NCT02502617|Anorexia nervosa|anorexia nervosa
272721|NCT02502604|Cognitive Remediation|cognitive remediation
272722|NCT02502604|Goal Management Training|goal management training
272723|NCT02502604|Major Depressive Disorder|major depressive disorder
272724|NCT02502604|Post-traumatic Stress Disorder|post-traumatic stress disorder
272725|NCT02502604|Neuropsychological Functioning|neuropsychological functioning
272726|NCT02502578|Triglyceride Deposit Cardiomyovasculopathy|triglyceride deposit cardiomyovasculopathy
272727|NCT02502552|Crohn's Disease|crohn's disease
272728|NCT02502552|Ulcerative Colitis|ulcerative colitis
272729|NCT02502552|Inflammatory Bowel Disease|inflammatory bowel disease
272730|NCT02502552|anti-glycan antibodies|anti-glycan antibodies
272731|NCT02502552|antibodies stability|antibodies stability
272732|NCT02502552|mucosal healing|mucosal healing
272733|NCT02502552|predictive markers|predictive markers
272734|NCT02502539|Juvenile idiopathic arthritis|juvenile idiopathic arthritis
272735|NCT02502539|Physical exercise|physical exercise
272736|NCT02502539|Pro-anti-inflammatory balance|pro-anti-inflammatory balance
272737|NCT02502539|Interleukins|interleukins
272738|NCT02502539|miRNA|mirna
272739|NCT02502539|Calgranulins|calgranulins
272740|NCT02502487|Analgesia|analgesia
272741|NCT02502487|Cystoscopy|cystoscopy
272742|NCT02502487|Dorsal nerve of penis|dorsal nerve of penis
272743|NCT02502487|Nerve block|nerve block
272744|NCT02502487|Ropivacaine|ropivacaine
272745|NCT02502474|staphylococcus aureus|staphylococcus aureus
272746|NCT02502474|digestive carriage|digestive carriage
272747|NCT02502474|mucosal colonization|mucosal colonization
272748|NCT02502448|rotational thromboelastometry|rotational thromboelastometry
272749|NCT02502448|cardiac surgery|cardiac surgery
272750|NCT02502448|acute normovolemic hemodilution|acute normovolemic hemodilution
272751|NCT02502422|Laryngeal mask airway|laryngeal mask airway
272752|NCT02502409|Hemophilia B|hemophilia b
272753|NCT02502409|Hemophilia B with Inhibitors|hemophilia b with inhibitors
272754|NCT02502396|Cancer|cancer
272755|NCT02502396|Deep-vein thrombosis of the lower and upper extremities|deep-vein thrombosis of the lower and upper extremities
272756|NCT02502396|Pulmonary embolism|pulmonary embolism
272757|NCT02502396|Non-valvular atrial fibrillation|non-valvular atrial fibrillation
272758|NCT02502396|Chart review|chart review
272759|NCT02502396|VTE|vte
272760|NCT02502396|NVAF|nvaf
272761|NCT02502396|Rivaroxaban|rivaroxaban
272762|NCT02502383|Adolescent|adolescent
272763|NCT02502383|Overweight|overweight
272764|NCT02502383|Obesity|obesity
272765|NCT02502383|Weight loss|weight loss
272766|NCT02502383|Nutrition|nutrition
272767|NCT02502383|Physical Activity|physical activity
272768|NCT02502383|School-based|school-based
272769|NCT02502383|Primary care|primary care
272770|NCT02502383|Motivational Interviewing|motivational interviewing
272771|NCT02502357|pain control|pain control
272772|NCT02502357|healing statements|healing statements
272773|NCT02502357|pelvic prolapse|pelvic prolapse
742704|NCT00464373|Prostatitis|prostatitis
272774|NCT02502344|insulin resistance|insulin resistance
272775|NCT02502344|abnormal glucose tolerance|abnormal glucose tolerance
272776|NCT02502344|DM prevention|dm prevention
272777|NCT02502331|Oral Cholera Vaccine|oral cholera vaccine
272778|NCT02502331|immunogenicity|immunogenicity
272779|NCT02502331|safety|safety
272780|NCT02502318|Proven or suspected lung cancer treated by lobectomy|proven or suspected lung cancer treated by lobectomy
272781|NCT02502305|health literacy|health literacy
272782|NCT02502305|attitude|attitude
272783|NCT02502305|motivation|motivation
272784|NCT02502292|Health Literacy|health literacy
272785|NCT02502292|Health Ageing|health ageing
272786|NCT02502292|Health Literacy Interventions|health literacy interventions
272787|NCT02502292|IROHLA|irohla
272788|NCT02502292|Photo Novel Study|photo novel study
272789|NCT02502240|ALK|alk
272790|NCT02502240|Latin American|latin american
272791|NCT02502227|mindfulness|mindfulness
272792|NCT02502227|psychological stress|psychological stress
272793|NCT02502227|wellness programs|wellness programs
272794|NCT02502227|cortisol|cortisol
272795|NCT02502214|Preimplantation Genetic Diagnosis|preimplantation genetic diagnosis
272796|NCT02502214|PGD|pgd
272797|NCT02502214|Next-Generation Sequencing|next-generation sequencing
272798|NCT02502214|NGS|ngs
272799|NCT02502214|Single-Gene disorders|single-gene disorders
272800|NCT02502214|Cystic Fibrosis|cystic fibrosis
272801|NCT02502214|CFTR|cftr
272802|NCT02502214|Single-cell analysis|single-cell analysis
272803|NCT02502214|PCR|pcr
272804|NCT02502214|SNP|snp
272805|NCT02502214|Whole Genome Amplification|whole genome amplification
272806|NCT02502201|six-minute walk|six-minute walk
272807|NCT02502188|Healthy Subjects|healthy subjects
272808|NCT02502188|Severe Plaque Psoriasis|severe plaque psoriasis
272809|NCT02502188|Moderate|moderate
272810|NCT02502188|Phase 1|phase 1
272811|NCT02502188|Safety|safety
272812|NCT02502188|Tolerability|tolerability
272813|NCT02502188|CC-90005|cc-90005
272814|NCT02502175|Opium tincture|opium tincture
272815|NCT02502175|opium|opium
272816|NCT02502175|methadone|methadone
272817|NCT02502175|opioid dependence|opioid dependence
272818|NCT02502175|opiate dependence|opiate dependence
272819|NCT02502175|clinical trial|clinical trial
272820|NCT02502175|Iran|iran
272821|NCT02502149|rFVIIIFc|rfviiifc
272822|NCT02502149|Eloctate|eloctate
272823|NCT02502149|Hemophilia|hemophilia
272824|NCT02502136|CO2 insufflation|co2 insufflation
272825|NCT02502110|Atrial Fibrillation|atrial fibrillation
272826|NCT02502110|statin|statin
272827|NCT02502110|radiofrequency ablation|radiofrequency ablation
272828|NCT02502006|Non-steroidal Anti-inflammatory Drugs|non-steroidal anti-inflammatory drugs
272829|NCT02502006|Healthy volunteers|healthy volunteers
272830|NCT02502006|Celecoxib|celecoxib
272831|NCT02502006|Naproxen|naproxen
272832|NCT02502006|Prostaglandin|prostaglandin
272833|NCT02502006|Cyclooxygenase|cyclooxygenase
272834|NCT02501980|Screening|screening
272835|NCT02501980|Hepatocellular Cancer|hepatocellular cancer
272836|NCT02501980|Biomarker|biomarker
272837|NCT02501980|Mortality rate|mortality rate
272838|NCT02501967|multiple chronic conditions|multiple chronic conditions
272839|NCT02501941|Ketamine|ketamine
272840|NCT02501941|Cortical Spreading Depolarization|cortical spreading depolarization
272841|NCT02501941|Cortical Spreading Depression|cortical spreading depression
272842|NCT02501928|neurogenic detrusor overactivity|neurogenic detrusor overactivity
272843|NCT02501928|fesoterodine|fesoterodine
272844|NCT02501928|Japan|japan
272845|NCT02501915|Muscle|muscle
272846|NCT02501902|Ibrance, palbociclib, Abraxane, nab-paclitaxel, pancreas,|ibrance, palbociclib, abraxane, nab-paclitaxel, pancreas,
272847|NCT02501889|obesity|obesity
272848|NCT02501889|overweight|overweight
272849|NCT02501889|weight loss|weight loss
272850|NCT02501889|satiety|satiety
272851|NCT02501889|walnuts|walnuts
272852|NCT02501889|gastrointestinal peptides|gastrointestinal peptides
272853|NCT02501876|The risk of progession|the risk of progession
272854|NCT02501876|patients|patients
272855|NCT02501850|Lipoprotein (a)|lipoprotein (a)
272856|NCT02501837|Healthy women|healthy women
272857|NCT02501811|Heart Failure|heart failure
272858|NCT02501811|Ischemia|ischemia
272859|NCT02501811|Autologous Stem Cells|autologous stem cells
272860|NCT02501811|LV dysfunction|lv dysfunction
272861|NCT02501811|Mesenchymal Stem Cells|mesenchymal stem cells
272862|NCT02501811|c-kit+ Cells|c-kit+ cells
272863|NCT02501811|Combination Cell Therapy|combination cell therapy
272864|NCT02501811|LV function|lv function
272865|NCT02501811|Functional status|functional status
272866|NCT02501798|ADHD|adhd
272867|NCT02501798|Methylphenidate|methylphenidate
272868|NCT02501798|Academic|academic
272869|NCT02501798|Motivation|motivation
272870|NCT02501785|Quality of Life|quality of life
272871|NCT02501785|Patient care givers|patient care givers
272872|NCT02501785|15-145|15-145
272873|NCT02501785|Ambulatory Extended Recovery|ambulatory extended recovery
272874|NCT02501746|Group medical care|group medical care
272875|NCT02501746|Microfinance|microfinance
272876|NCT02501746|Hypertension|hypertension
272877|NCT02501746|Community-based intervention|community-based intervention
272878|NCT02501746|Global health|global health
272879|NCT02501733|Total Knee Replacement|total knee replacement
272880|NCT02501733|Total Knee Arthroplasty|total knee arthroplasty
272881|NCT02501720|burn|burn
272882|NCT02501720|hand|hand
272883|NCT02501720|flexion contracture|flexion contracture
272884|NCT02501720|tourniquet|tourniquet
272885|NCT02501720|tumescent technique|tumescent technique
272886|NCT02501720|children|children
272887|NCT02501707|echocardiography|echocardiography
272888|NCT02501707|radiation-induced lung injury|radiation-induced lung injury
272889|NCT02501707|prognostic|prognostic
272890|NCT02501707|chemo radiotherapy|chemo radiotherapy
272891|NCT02501707|non-small cell lung cancer|non-small cell lung cancer
272892|NCT02501707|NSCLC|nsclc
272893|NCT02501681|sublingual microcirculation|sublingual microcirculation
272894|NCT02501681|cardiovascular surgery|cardiovascular surgery
272895|NCT02501629|Asthma|asthma
272896|NCT02501629|Elevated Blood Eosinophils|elevated blood eosinophils
272897|NCT02501629|Oral corticosteroid dependence|oral corticosteroid dependence
272898|NCT02501629|Reslizumab|reslizumab
272899|NCT02501616|SGLT2 inhibitor|sglt2 inhibitor
272900|NCT02501564|Osteoarthritis|osteoarthritis
272901|NCT02501564|NAPROXEN SODIUM|naproxen sodium
272902|NCT02501551|Malignant melanoma|malignant melanoma
272903|NCT02501551|C-KIT mutation|c-kit mutation
272904|NCT02501525|renal stone|renal stone
272905|NCT02501525|retrograde intrarenal surgery|retrograde intrarenal surgery
272906|NCT02501525|ureteral access sheath|ureteral access sheath
272907|NCT02501525|pain|pain
272908|NCT02501512|transesophageal signal|transesophageal signal
272909|NCT02501512|swallowing|swallowing
272910|NCT02501512|newborn|newborn
272911|NCT02501486|adrenal insufficiency|adrenal insufficiency
272912|NCT02501486|adverse drug reaction|adverse drug reaction
272913|NCT02501486|corticosteroid|corticosteroid
272914|NCT02501473|follicular lymphoma|follicular lymphoma
272916|NCT02501473|low-grade lymphoma|low-grade lymphoma
272917|NCT02501473|Non-Hodgkin's Lymphoma|non-hodgkin's lymphoma
272918|NCT02501473|follicular NHL|follicular nhl
272919|NCT02501473|Marginal Zone|marginal zone
272920|NCT02501460|Adult cancer survivors|adult cancer survivors
272921|NCT02501460|Exercise|exercise
272922|NCT02501460|Dietary supplementation|dietary supplementation
272923|NCT02501434|aneurysmal subarachnoid hemorrhage|aneurysmal subarachnoid hemorrhage
272924|NCT02501434|unfractionated heparin|unfractionated heparin
272925|NCT02501434|neurobehavioral manifestations|neurobehavioral manifestations
272926|NCT02501434|delayed ischemic neurological deficits|delayed ischemic neurological deficits
272927|NCT02501434|cerebral aneurysm|cerebral aneurysm
272928|NCT02501434|coil embolization|coil embolization
272929|NCT02501434|Montreal Cognitive Assessment|montreal cognitive assessment
272930|NCT02501421|vaccine|vaccine
272931|NCT02501421|influenza vector|influenza vector
272932|NCT02501421|tuberculosis|tuberculosis
272933|NCT02501382|Fasciitis|fasciitis
272934|NCT02501382|Fasciitis, Necrotizing|fasciitis, necrotizing
272935|NCT02501382|Soft tissue infections|soft tissue infections
272936|NCT02501382|Fournier's gangrene|fournier's gangrene
272937|NCT02501382|Immunopathogenesis|immunopathogenesis
272938|NCT02501356|prebiotic|prebiotic
272939|NCT02501356|dietary supplement|dietary supplement
272940|NCT02501343|Glucose metabolism|glucose metabolism
272941|NCT02501343|Potential renal acid load|potential renal acid load
272942|NCT02501343|Postprandial glycemia|postprandial glycemia
272943|NCT02501343|Body acid-base homeostasis|body acid-base homeostasis
272944|NCT02501343|Sodium bicarbonate|sodium bicarbonate
272945|NCT02501330|Drug use investigation in Japan|drug use investigation in japan
272946|NCT02501317|urinary incontinence|urinary incontinence
272947|NCT02501317|physical therapy|physical therapy
272948|NCT02501317|rehabilitation|rehabilitation
272949|NCT02501317|pelvic floor|pelvic floor
272950|NCT02501317|perineum|perineum
272951|NCT02501317|conservative treatment|conservative treatment
272952|NCT02501265|Nicotine addiction|nicotine addiction
272953|NCT02501265|Cigarette smoking|cigarette smoking
272954|NCT02501265|Bupropion|bupropion
272955|NCT02501265|Varenicline|varenicline
272956|NCT02501265|Adaptive Approach|adaptive approach
272957|NCT02501265|Nicotine Patch|nicotine patch
272958|NCT02501265|Chantix|chantix
272959|NCT02501252|Community|community
272960|NCT02501252|Skilled birth attendance|skilled birth attendance
272961|NCT02501252|Rural|rural
272962|NCT02501252|Ethiopia|ethiopia
272963|NCT02501226|Psychiatry|psychiatry
272964|NCT02501226|Depression|depression
272965|NCT02501226|Psychoeducation|psychoeducation
272966|NCT02501226|Randomized controlled trial|randomized controlled trial
272967|NCT02501226|Treatment adherence|treatment adherence
272968|NCT02501226|Remission|remission
272969|NCT02501213|Diuretic|diuretic
272970|NCT02501213|Malignant ascites|malignant ascites
272971|NCT02501200|Dyslipidemia|dyslipidemia
272972|NCT02501200|CKD-391|ckd-391
272973|NCT02501200|Atorvastatin|atorvastatin
272974|NCT02501200|Ezetimibe|ezetimibe
272975|NCT02501174|Geriatric oncology|geriatric oncology
272976|NCT02501148|Embolic protection|embolic protection
272977|NCT02501148|Carotid artery stenting|carotid artery stenting
272978|NCT02501135|Femoral nerve blocks|femoral nerve blocks
272979|NCT02501135|children|children
272980|NCT02501135|knee and thigh surgery|knee and thigh surgery
272981|NCT02501122|Quality|quality
272982|NCT02501122|hospital care|hospital care
272983|NCT02501122|adenotonsillectomy|adenotonsillectomy
272984|NCT02501109|Aripiprazole|aripiprazole
272985|NCT02501109|Oral Soluble Film|oral soluble film
272986|NCT02501109|Schizophrenia|schizophrenia
272987|NCT02501096|Lenvatinib|lenvatinib
272988|NCT02501096|Lenvima|lenvima
272989|NCT02501096|E7080|e7080
272990|NCT02501096|Phase 1b/2|phase 1b/2
272991|NCT02501096|Pembrolizumab|pembrolizumab
272992|NCT02501096|Keytruda|keytruda
272993|NCT02501096|Solid tumors|solid tumors
272994|NCT02501083|cardiomyopathy|cardiomyopathy
272995|NCT02501083|echocardiography|echocardiography
272996|NCT02501083|prognosis|prognosis
272997|NCT02501083|respiratory|respiratory
272998|NCT02501083|home mechanical ventilation|home mechanical ventilation
272999|NCT02501083|vital capacity|vital capacity
273000|NCT02501083|maximal inspiratory pressure|maximal inspiratory pressure
273001|NCT02501083|maximal expiratory pressure|maximal expiratory pressure
273002|NCT02501070|Percutaneous Coronary Intervention|percutaneous coronary intervention
273003|NCT02501070|Angioplasty|angioplasty
273004|NCT02501070|Stent|stent
273005|NCT02501070|Community Networks|community networks
273006|NCT02501057|Human Immunodeficiency Virus|human immunodeficiency virus
273007|NCT02501057|Unsafe Drinking|unsafe drinking
273008|NCT02501057|Antiretroviral Therapy (ART)|antiretroviral therapy (art)
273009|NCT02501031|Flaxseed|flaxseed
273010|NCT02501031|Postmenopause|postmenopause
273011|NCT02501031|Hormones|hormones
273012|NCT02501031|Lignans|lignans
273013|NCT02501031|No Evidence of Disease|no evidence of disease
273014|NCT02501018|CLI, ASO, TAO|cli, aso, tao
273015|NCT02500979|Type 1 Diabetes Mellitus; Pramlintide|type 1 diabetes mellitus; pramlintide
273016|NCT02500966|Cervical Intraepithelial Neoplasia|cervical intraepithelial neoplasia
273017|NCT02500966|stenosis|stenosis
273018|NCT02500966|cervix|cervix
273019|NCT02500966|medical device|medical device
273020|NCT02500966|inventories|inventories
273021|NCT02500966|Uterine Cervix|uterine cervix
273022|NCT02500966|Intrauterine Devices|intrauterine devices
273023|NCT02500966|intrauterine|intrauterine
273024|NCT02500966|conization|conization
273025|NCT02500966|loop electrosurgical excision|loop electrosurgical excision
273026|NCT02500953|ASP3325|asp3325
273027|NCT02500953|pharmacokinetics|pharmacokinetics
273028|NCT02500953|pharmacodynamics|pharmacodynamics
273029|NCT02500927|ASP8273|asp8273
273030|NCT02500927|Non-Small Cell Lung Cancer|non-small cell lung cancer
273031|NCT02500927|EGFR Tyrosine Kinase Inhibitor|egfr tyrosine kinase inhibitor
273032|NCT02500927|EGFR Mutation|egfr mutation
273033|NCT02500914|small cell lung cancer|small cell lung cancer
273034|NCT02500901|Enzalutamide|enzalutamide
273035|NCT02500901|Niraparib|niraparib
273036|NCT02500901|PARP-1 inhibitor|parp-1 inhibitor
273037|NCT02500901|PARP-2 inhibitor|parp-2 inhibitor
273038|NCT02500901|Castrate-Resistant Prostate Cancer|castrate-resistant prostate cancer
273039|NCT02500888|OCD|ocd
273040|NCT02500888|Neurosurgery|neurosurgery
273041|NCT02500888|Radiosurgery|radiosurgery
273042|NCT02500875|Negative-Pressure Wound Therapy|negative-pressure wound therapy
273043|NCT02500875|Topical Negative Pressure Therapy|topical negative pressure therapy
273044|NCT02500875|Sodium Hypochlorite|sodium hypochlorite
273045|NCT02500862|Eye|eye
273046|NCT02500862|Imaging|imaging
273047|NCT02500849|Gene therapy|gene therapy
273048|NCT02500849|Acquired Immunodeficiency Syndrome|acquired immunodeficiency syndrome
273049|NCT02500849|HIV Infections|hiv infections
273050|NCT02500849|Retroviridae Infections|retroviridae infections
273051|NCT02500849|RNA Virus Infections|rna virus infections
273052|NCT02500849|Virus Diseases|virus diseases
273053|NCT02500849|Sexually Transmitted Diseases, Viral|sexually transmitted diseases, viral
273054|NCT02500849|Sexually Transmitted Diseases|sexually transmitted diseases
273055|NCT02500849|Immunologic Deficiency Syndromes|immunologic deficiency syndromes
273056|NCT02500849|Immune System Diseases|immune system diseases
273057|NCT02500849|Busulfan|busulfan
273058|NCT02500849|Pharmacologic Actions|pharmacologic actions
273059|NCT02500836|Ear|ear
273060|NCT02500836|Nose|nose
273061|NCT02500836|Throat|throat
273062|NCT02500823|Mitochondrial DNA copy number|mitochondrial dna copy number
273063|NCT02500823|Peripheral blood cells|peripheral blood cells
273064|NCT02500810|neurotoxicity|neurotoxicity
273065|NCT02500810|chemotherapy|chemotherapy
273066|NCT02500810|monosialoganglioside|monosialoganglioside
273067|NCT02500810|prevention|prevention
273068|NCT02500758|Surgical scrubbing|surgical scrubbing
273069|NCT02500758|Chlorhexidine digluconate|chlorhexidine digluconate
273070|NCT02500758|Parachlorometaxylenol|parachlorometaxylenol
273071|NCT02500719|Posttraumatic Stress Disorder|posttraumatic stress disorder
273072|NCT02500719|Neurofeedback|neurofeedback
273073|NCT02500719|fMRI|fmri
273074|NCT02500719|Skin Conductance Response|skin conductance response
273075|NCT02500693|Lung Cancer, Screening, COPD|lung cancer, screening, copd
273076|NCT02500680|Influenza|influenza
273077|NCT02500680|Adjuvant|adjuvant
273078|NCT02500667|N91115|n91115
273079|NCT02500667|Rifampin|rifampin
273080|NCT02500667|drug interaction|drug interaction
273081|NCT02500667|Cavosonstat|cavosonstat
273082|NCT02500654|Peri-implantitis|peri-implantitis
273083|NCT02500654|Regenerative therapy|regenerative therapy
273084|NCT02500654|Surgical therapy|surgical therapy
273085|NCT02500654|Enamel matrix derivative|enamel matrix derivative
273086|NCT02500654|Peri-implant microflora|peri-implant microflora
273087|NCT02500654|Peri-implant fluid|peri-implant fluid
273088|NCT02500641|Biological Markers|biological markers
273089|NCT02500641|Cardiovascular disease|cardiovascular disease
273090|NCT02500641|Humans|humans
273091|NCT02500641|Pulse Wave Velocity|pulse wave velocity
273092|NCT02500641|Cardiovascular risk factors|cardiovascular risk factors
273093|NCT02500641|Allopurinol|allopurinol
273094|NCT02500641|Pulse Wave Analysis|pulse wave analysis
273095|NCT02500641|Thiazoles|thiazoles
273096|NCT02500641|Inflammation|inflammation
273097|NCT02500641|Uric acid|uric acid
273098|NCT02500641|Febuxostat|febuxostat
273099|NCT02500641|Oxidative stress|oxidative stress
273100|NCT02500641|Tumor Necrosis Factor|tumor necrosis factor
273101|NCT02500641|Arthritis|arthritis
273102|NCT02500641|Hyperuricemia|hyperuricemia
273103|NCT02500628|metformin|metformin
273104|NCT02500628|mitochondria|mitochondria
273105|NCT02500628|complex 1|complex 1
273106|NCT02500628|fibromyalgia|fibromyalgia
273107|NCT02500628|neurogenic pain|neurogenic pain
273108|NCT02500628|diabetes|diabetes
273109|NCT02500628|tardive dyskinesia|tardive dyskinesia
273110|NCT02500628|heart rate variability|heart rate variability
273111|NCT02500602|PTSD|ptsd
273112|NCT02500602|alcohol use disorders|alcohol use disorders
273113|NCT02500602|posttraumatic stress disorder|posttraumatic stress disorder
273114|NCT02500602|AUD|aud
273115|NCT02500602|Veteran|veteran
273116|NCT02500602|substance use disorders|substance use disorders
273117|NCT02500602|SUD|sud
273118|NCT02500589|smoking|smoking
273119|NCT02500589|tobacco|tobacco
273120|NCT02500550|Haploidentical stem cell transplantation|haploidentical stem cell transplantation
273121|NCT02500550|Graft versus host disease|graft versus host disease
273122|NCT02500550|Immune reconstitution|immune reconstitution
273123|NCT02500550|Alloreactive T-cells|alloreactive t-cells
273124|NCT02500550|Photodynamic treatment|photodynamic treatment
273125|NCT02500550|Hematologic malignancy|hematologic malignancy
273126|NCT02500550|Transplant-related mortality|transplant-related mortality
273127|NCT02500485|SHR3824 SP2086 drug-drug interaction|shr3824 sp2086 drug-drug interaction
273128|NCT02500472|Tobacco|tobacco
273129|NCT02500472|Smoking|smoking
273130|NCT02500459|Topotecan|topotecan
273131|NCT02500459|Cleveland Multiport Catheter|cleveland multiport catheter
273132|NCT02500459|Cancer|cancer
273133|NCT02500433|Cerebral palsy|cerebral palsy
273134|NCT02500433|child|child
273135|NCT02500433|rehabilitation|rehabilitation
273136|NCT02500433|video games|video games
273137|NCT02500433|virtual reality.|virtual reality.
273138|NCT02500420|Hypertrophic cardiomyopathy|hypertrophic cardiomyopathy
273139|NCT02500420|Stress MRI|stress mri
273140|NCT02500420|Cardiac MRI|cardiac mri
273141|NCT02500420|Stress echocardiography|stress echocardiography
273142|NCT02500420|T1 mapping|t1 mapping
273143|NCT02500420|2D strain|2d strain
273144|NCT02500394|renal replacement therapy|renal replacement therapy
273145|NCT02500381|Duchenne muscular dystrophy|duchenne muscular dystrophy
273146|NCT02500381|Exon Skipping|exon skipping
273147|NCT02500381|DMD|dmd
273148|NCT02500381|Exon 53|exon 53
273149|NCT02500381|Exon 45|exon 45
273150|NCT02500381|Ambulatory|ambulatory
273151|NCT02500381|Pediatric|pediatric
273152|NCT02500381|Duchenne|duchenne
273153|NCT02500342|Thyroid Dysfunction|thyroid dysfunction
273154|NCT02500342|Fatigue|fatigue
273155|NCT02500342|Randomized Controlled Trial|randomized controlled trial
273156|NCT02500342|Thyroxine|thyroxine
273157|NCT02500342|Hypothyroidism|hypothyroidism
273158|NCT02500316|Growth hormone deficiency (GHD)|growth hormone deficiency (ghd)
273159|NCT02500316|r-hGH|r-hgh
273160|NCT02500316|Long-acting|long-acting
273161|NCT02500303|Amputation|amputation
273162|NCT02500290|ACS|acs
273163|NCT02500277|thoracoscopy|thoracoscopy
273164|NCT02500277|pleuroscopy|pleuroscopy
273165|NCT02500277|semirigid thoracoscopy|semirigid thoracoscopy
273166|NCT02500277|flexible cryoprobe|flexible cryoprobe
273167|NCT02500277|cryobiopsy|cryobiopsy
273168|NCT02500277|pleural biopsy|pleural biopsy
273169|NCT02500251|Transplantation|transplantation
273170|NCT02500251|belimumab|belimumab
273171|NCT02500251|Velcade|velcade
273172|NCT02500225|Etomidate|etomidate
273173|NCT02500225|Sevoflurane|sevoflurane
273174|NCT02500199|HER2 positive|her2 positive
273175|NCT02500173|radiotherapy|radiotherapy
273176|NCT02500173|side effects|side effects
273177|NCT02500147|Polycystic Ovary Syndrome|polycystic ovary syndrome
273178|NCT02500147|Non-Alcoholic Fatty Liver Disease|non-alcoholic fatty liver disease
273179|NCT02500147|Adolescents|adolescents
273180|NCT02500147|Young Women|young women
273181|NCT02500147|MRI|mri
273182|NCT02500147|MRS|mrs
273183|NCT02500147|DXA|dxa
273184|NCT02500147|PNPLA3|pnpla3
273185|NCT02500147|Metformin|metformin
273186|NCT02500147|Randomized Clinical Trial|randomized clinical trial
273187|NCT02500147|Placebo|placebo
273188|NCT02500147|Hirsutism|hirsutism
273189|NCT02500147|Acne|acne
273190|NCT02500147|Amenorrhea|amenorrhea
273191|NCT02500147|Metabolic Syndrome|metabolic syndrome
273192|NCT02500147|Dyslipidemia|dyslipidemia
273193|NCT02500147|Percentage liver fat|percentage liver fat
273194|NCT02500121|Pembrolizumab|pembrolizumab
273195|NCT02500121|PD-1 Inhibitor|pd-1 inhibitor
273196|NCT02500108|Domperidone|domperidone
273197|NCT02500108|Ventricular Tachyarrhythmia|ventricular tachyarrhythmia
273198|NCT02500108|Sudden cardiac death|sudden cardiac death
273199|NCT02500108|Pharmacotherapy|pharmacotherapy
273200|NCT02500108|Adverse events|adverse events
273201|NCT02500082|citrate transporter deficiency|citrate transporter deficiency
273202|NCT02500082|SLC13A5 gene|slc13a5 gene
273203|NCT02500082|citric acid cycle|citric acid cycle
273204|NCT02500082|energy metabolism|energy metabolism
273205|NCT02500056|Inguinal hernia|inguinal hernia
273206|NCT02500056|Chronic pain|chronic pain
273207|NCT02500056|Mesh|mesh
273208|NCT02500056|Lichtenstein hernioplasty|lichtenstein hernioplasty
273209|NCT02500043|Gastric Cancer|gastric cancer
273210|NCT02500043|Metastatic Gastric Cancer|metastatic gastric cancer
273211|NCT02499965|Topical Anesthetic|topical anesthetic
273212|NCT02499965|Ethyl Chloride|ethyl chloride
273213|NCT02499965|Pain Reduction|pain reduction
273214|NCT02499965|IV cannulation|iv cannulation
273215|NCT02499952|Pembrolizumab|pembrolizumab
273216|NCT02499952|MK-3475|mk-3475
273217|NCT02499952|PMNSGCT|pmnsgct
273218|NCT02499952|PD-L1|pd-l1
273219|NCT02499952|Non Seminomatous Germ Cell Tumors|non seminomatous germ cell tumors
273220|NCT02499848|MRI Lesion|mri lesion
273221|NCT02499848|transperineal injection|transperineal injection
273222|NCT02499848|prostate biopsies|prostate biopsies
273223|NCT02499822|Hypertension|hypertension
273224|NCT02499822|Blood pressure variability|blood pressure variability
273225|NCT02499822|Home systolic blood pressure|home systolic blood pressure
273226|NCT02499822|Organ damage|organ damage
273227|NCT02499822|Nifedipine GITS|nifedipine gits
273228|NCT02499822|Ramipril|ramipril
273229|NCT02499809|Vibration therapy|vibration therapy
273230|NCT02499809|Recovery from exercise|recovery from exercise
273231|NCT02499796|Invasive mechanical ventilation|invasive mechanical ventilation
273232|NCT02499796|Humidifying devices|humidifying devices
273233|NCT02499796|Respiratory mechanics|respiratory mechanics
273234|NCT02499783|China|china
273235|NCT02499783|Tumor necrosis factor (TNF)-alpha|tumor necrosis factor (tnf)-alpha
273236|NCT02499783|Biologic|biologic
273237|NCT02499770|Small Cell Lung Cancer|small cell lung cancer
273238|NCT02499770|CDK 4/6 Inhibitor|cdk 4/6 inhibitor
273239|NCT02499757|Perception|perception
273240|NCT02499757|brain response|brain response
273241|NCT02499757|nicotine|nicotine
273242|NCT02499757|taste|taste
273243|NCT02499744|NIPPV|nippv
273244|NCT02499744|HHFNC|hhfnc
273245|NCT02499744|RDS|rds
273246|NCT02499744|neonate|neonate
273247|NCT02499731|physical activity|physical activity
273248|NCT02499731|nutrition|nutrition
273249|NCT02499731|social network|social network
273250|NCT02499718|Chronic Obstructive Pulmonary Disease|chronic obstructive pulmonary disease
273251|NCT02499718|Non-invasive positive pressure ventilation|non-invasive positive pressure ventilation
273252|NCT02499718|quality of life|quality of life
273253|NCT02499718|long-term oxygen therapy|long-term oxygen therapy
273254|NCT02499666|Exercise Capacity|exercise capacity
273255|NCT02499666|Chronic Total Occlusion|chronic total occlusion
273256|NCT02499653|Chronic Obstructive Pulmonary Disease (COPD)|chronic obstructive pulmonary disease (copd)
273257|NCT02499653|Non Invasive Ventilation (NIV)|non invasive ventilation (niv)
273258|NCT02499653|Acceptance|acceptance
273259|NCT02499653|Adherence|adherence
273260|NCT02499653|Clinical Psychology|clinical psychology
273261|NCT02499640|Recovery of function|recovery of function
273262|NCT02499640|Autonomic nervous system|autonomic nervous system
273263|NCT02499640|Heart rate variability|heart rate variability
273264|NCT02499640|Cryotherapy|cryotherapy
273265|NCT02499640|Immersion|immersion
273266|NCT02499627|Lymphoma|lymphoma
273267|NCT02499627|Hodgkin|hodgkin
273268|NCT02499627|PTCL|ptcl
273269|NCT02499627|CD30+|cd30+
273270|NCT02499614|MET amplification|met amplification
273271|NCT02499614|ROS1 translocation|ros1 translocation
273272|NCT02499614|Crizotinib|crizotinib
273273|NCT02499601|Heart Failure with Preserved Ejection Fraction (HFpEF)|heart failure with preserved ejection fraction (hfpef)
273274|NCT02499601|Heart Failure (HF)|heart failure (hf)
273275|NCT02499601|New York Heart Association functional Class (NYHA f. Cl)|new york heart association functional class (nyha f. cl)
273276|NCT02499575|Exparel|exparel
273277|NCT02499575|bupivacaine|bupivacaine
273278|NCT02499575|Hallux valgus deformity|hallux valgus deformity
273279|NCT02499575|bunionectomy|bunionectomy
273280|NCT02499536|Atelectasis|atelectasis
273281|NCT02499536|Postoperative|postoperative
273282|NCT02499536|Lung ultrasound|lung ultrasound
273283|NCT02499510|femoropopliteal disease|femoropopliteal disease
273284|NCT02499510|restenosis|restenosis
273285|NCT02499497|Prostate Cancer|prostate cancer
273286|NCT02499432|Evidence Based Psychotherapy|evidence based psychotherapy
273287|NCT02499432|Implementation|implementation
273288|NCT02499432|PTSD|ptsd
273289|NCT02499393|newborn|newborn
273290|NCT02499393|therapeutic hypothermia|therapeutic hypothermia
273291|NCT02499393|magnesium sulphate|magnesium sulphate
273292|NCT02499380|RePneu|repneu
273293|NCT02499380|Coil|coil
273294|NCT02499380|LVRC|lvrc
273295|NCT02499380|PneumRx|pneumrx
273296|NCT02499367|triple negative|triple negative
273297|NCT02499367|metastatic|metastatic
273298|NCT02499341|Tramadol|tramadol
273299|NCT02499341|Ketamine|ketamine
273300|NCT02499341|Morphine|morphine
273301|NCT02499328|Carcinoma of the Head and Neck|carcinoma of the head and neck
273302|NCT02499276|mechanical ventilation|mechanical ventilation
273303|NCT02499276|pressure support ventilation|pressure support ventilation
273304|NCT02499276|NAVA|nava
273305|NCT02499276|PAV|pav
273306|NCT02499276|variable ventilation|variable ventilation
273307|NCT02499276|patient ventilator asynchrony|patient ventilator asynchrony
273308|NCT02499263|Adalimumab trough level|adalimumab trough level
273309|NCT02499263|Fecal Calprotectin|fecal calprotectin
273310|NCT02499263|Fecal microbiota|fecal microbiota
273311|NCT02499250|refractory angina pectoris|refractory angina pectoris
273312|NCT02499250|remote ischemic conditioning|remote ischemic conditioning
273313|NCT02499250|life quality|life quality
273314|NCT02499250|anxiety|anxiety
273315|NCT02499250|depression|depression
273316|NCT02499250|inflammation|inflammation
273317|NCT02499237|osteoporosis|osteoporosis
273318|NCT02499237|denosumab|denosumab
273319|NCT02499237|zoledronic acid|zoledronic acid
273320|NCT02499237|bone mineral density|bone mineral density
273321|NCT02499237|bone markers|bone markers
273322|NCT02499211|obesity|obesity
273323|NCT02499211|health disparities|health disparities
273324|NCT02499211|healthy food marketing|healthy food marketing
273325|NCT02499211|food environments|food environments
273326|NCT02499211|marketing environments|marketing environments
273327|NCT02499211|food access|food access
273328|NCT02499211|food purchase decision making|food purchase decision making
273329|NCT02499198|Nornicotine|nornicotine
273330|NCT02499198|Tobacco|tobacco
273331|NCT02499198|N'-nitrosonornicotine|n'-nitrosonornicotine
273332|NCT02499198|NNN|nnn
273333|NCT02499185|Biomarker|biomarker
273334|NCT02499185|Intra Abdominal Surgery|intra abdominal surgery
273335|NCT02499185|AKI|aki
273336|NCT02499172|Adverse pregnancy outcome|adverse pregnancy outcome
273337|NCT02499159|Exparel|exparel
273338|NCT02499159|Thoracoscopy|thoracoscopy
273339|NCT02499159|Bupivicaine|bupivicaine
273340|NCT02499159|Liposomal|liposomal
273341|NCT02499146|Palbociclib|palbociclib
273342|NCT02499146|PD-0332991|pd-0332991
273343|NCT02499146|pharmacokinetics|pharmacokinetics
273344|NCT02499146|breast cancer patients|breast cancer patients
273345|NCT02499146|Chinese|chinese
273346|NCT02499120|palbociclib, cetuximab, human papillomavirus, squamous cell carcinoma, head and neck cancer|palbociclib, cetuximab, human papillomavirus, squamous cell carcinoma, head and neck cancer
273347|NCT02499107|food intake|food intake
273348|NCT02499107|satiety|satiety
273349|NCT02499107|blood glucose|blood glucose
273350|NCT02499107|potato|potato
273351|NCT02499107|insulin|insulin
273352|NCT02499081|Relapsed|relapsed
273353|NCT02499081|Refractory|refractory
273354|NCT02499081|Proteasome Inhibitor|proteasome inhibitor
273355|NCT02499055|anxiety|anxiety
273356|NCT02499055|behaviour therapy|behaviour therapy
273357|NCT02499055|computer assisted therapy|computer assisted therapy
273358|NCT02499055|psychotherapy|psychotherapy
273359|NCT02499042|post-resuscitation|post-resuscitation
273360|NCT02499042|oxygen therapy|oxygen therapy
273361|NCT02499042|out-of-hospital cardiac arrest|out-of-hospital cardiac arrest
273362|NCT02499016|Appendicitis|appendicitis
273363|NCT02499016|Appendectomy|appendectomy
273364|NCT02499016|Single-incision|single-incision
273365|NCT02499003|Diffuse large B-cell lymphoma|diffuse large b-cell lymphoma
273366|NCT02499003|Follicular lymphoma|follicular lymphoma
273367|NCT02499003|Transformed indolent lymphoma|transformed indolent lymphoma
273368|NCT02498977|Liver|liver
273369|NCT02498977|Transplant|transplant
273370|NCT02498977|Immunosuppression|immunosuppression
273371|NCT02498964|cardiac anesthesia simulation,NASA task load index|cardiac anesthesia simulation,nasa task load index
273372|NCT02498938|Pulmonary disease,chronic obstructive,|pulmonary disease,chronic obstructive,
273373|NCT02498938|generalized chronic periodontitis|generalized chronic periodontitis
273374|NCT02498938|SERPINA1 gene polymorphism|serpina1 gene polymorphism
273375|NCT02498912|T Cells|t cells
273376|NCT02498912|Cyclophosphamide|cyclophosphamide
273377|NCT02498912|MUC16ecto antigen|muc16ecto antigen
273378|NCT02498912|Intraperitoneal Infusion|intraperitoneal infusion
273379|NCT02498912|Maximum Tolerated Dose (MTD)|maximum tolerated dose (mtd)
273380|NCT02498912|15-014|15-014
273381|NCT02498899|Advanced Cancers|advanced cancers
273382|NCT02498899|Video|video
273383|NCT02498899|Questionnaires|questionnaires
273384|NCT02498899|Surveys|surveys
273385|NCT02498873|VO2Max|vo2max
273386|NCT02498873|Physical Conditioning|physical conditioning
273387|NCT02498873|Aerobic Exercise|aerobic exercise
273388|NCT02498873|Performance|performance
273389|NCT02498860|adenocarcinoma|adenocarcinoma
273390|NCT02498860|lung|lung
273391|NCT02498860|adjuvant chemotherapy|adjuvant chemotherapy
273392|NCT02498860|pemetrexed|pemetrexed
273393|NCT02498860|cisplatin|cisplatin
273394|NCT02498860|surgery|surgery
273395|NCT02498834|Communication|communication
273396|NCT02498834|provider|provider
273397|NCT02498834|caregiver|caregiver
273398|NCT02498834|adolescent|adolescent
273399|NCT02498821|PICC|picc
273400|NCT02498821|central catheter|central catheter
273401|NCT02498821|vascular access|vascular access
273402|NCT02498808|Interferon lambda|interferon lambda
273403|NCT02498808|Interleukin-29|interleukin-29
273404|NCT02498808|Neutrophil|neutrophil
273405|NCT02498795|Intratissue Percutaneous Electrolysis|intratissue percutaneous electrolysis
273406|NCT02498795|Dry needling|dry needling
273407|NCT02498795|Eccentric exercise|eccentric exercise
273408|NCT02498795|Patella|patella
273409|NCT02498782|Chagas Disease|chagas disease
273410|NCT02498782|Dosage forms|dosage forms
273411|NCT02498782|Regimens|regimens
273412|NCT02498769|Cardiac Surgery|cardiac surgery
273413|NCT02498769|Postoperative Complications|postoperative complications
273414|NCT02498769|Autonomic Nerve Block|autonomic nerve block
273415|NCT02498730|bipolar disorder|bipolar disorder
273416|NCT02498730|VO2max|vo2max
273417|NCT02498730|aerobic exercise|aerobic exercise
273418|NCT02498691|endometriosis|endometriosis
273419|NCT02498691|preterm delivery|preterm delivery
273420|NCT02498691|caesarean|caesarean
273421|NCT02498691|Pregnancy outcomes of women with or without endometriosis|pregnancy outcomes of women with or without endometriosis
273422|NCT02498665|Wilms' Tumor 1|wilms' tumor 1
273423|NCT02498665|Vaccine|vaccine
273424|NCT02498665|Neoplasms|neoplasms
273425|NCT02498639|balloon aortic valvuloplasty|balloon aortic valvuloplasty
273426|NCT02498639|rapid ventricular pacing|rapid ventricular pacing
273428|NCT02498626|mixed venous saturation|mixed venous saturation
273429|NCT02498626|open heart surgery|open heart surgery
273430|NCT02498626|children|children
273431|NCT02498600|Phase II Randomized Trial of Nivolumab with or without Ipilimumab in Patients with Persistent or Recurrent Epithelial Ovarian|phase ii randomized trial of nivolumab with or without ipilimumab in patients with persistent or recurrent epithelial ovarian
273432|NCT02498600|Primary Peritoneal or Fallopian|primary peritoneal or fallopian
273433|NCT02498600|Tube Cancer|tube cancer
273434|NCT02498587|Severe Acute Respiratory Infection|severe acute respiratory infection
273435|NCT02498496|COPD|copd
273436|NCT02498496|AECOPD|aecopd
273437|NCT02498496|Magnesium Sulfate|magnesium sulfate
273438|NCT02498496|Acute exacerbation of COPD|acute exacerbation of copd
273439|NCT02498496|Chronic Obstructive Pulmonary Disease|chronic obstructive pulmonary disease
273440|NCT02498496|ED|ed
273441|NCT02498496|ER|er
273442|NCT02498496|Emergency Department|emergency department
273443|NCT02498483|Infant pain|infant pain
273444|NCT02498483|Acetaminophen|acetaminophen
273445|NCT02498483|Circumcision|circumcision
273446|NCT02498457|maintenance hemodialysis patients|maintenance hemodialysis patients
273447|NCT02498457|coronary artery calcification|coronary artery calcification
273448|NCT02498457|low calcium dialysate|low calcium dialysate
273449|NCT02498457|effects|effects
273450|NCT02498457|safety|safety
273451|NCT02498444|Fontan|fontan
273452|NCT02498444|Treprostinil|treprostinil
273453|NCT02498444|Remodulin|remodulin
273454|NCT02498444|Single ventricle|single ventricle
273455|NCT02498431|irisin|irisin
273456|NCT02498431|myocardial infarction|myocardial infarction
273457|NCT02498431|coronary|coronary
273458|NCT02498392|Major Depressive Disorder|major depressive disorder
273459|NCT02498392|Depression|depression
273460|NCT02498392|Anxiety symptoms|anxiety symptoms
273461|NCT02498392|JNJ-42165279|jnj-42165279
273462|NCT02498379|novel radiotracer|novel radiotracer
273463|NCT02498379|biodistribution|biodistribution
273464|NCT02498379|safety|safety
273465|NCT02498340|G6PD|g6pd
273466|NCT02498340|genotype|genotype
273467|NCT02498340|phenotype|phenotype
273468|NCT02498340|diet restriction|diet restriction
273469|NCT02498327|Chronic|chronic
273470|NCT02498314|Manual therapy|manual therapy
273471|NCT02498314|Hip osteoarthritis|hip osteoarthritis
273472|NCT02498314|Mobilization|mobilization
273473|NCT02498301|travelers' diarrhea|travelers' diarrhea
273474|NCT02498301|military|military
273475|NCT02498301|enteric illness|enteric illness
273476|NCT02498301|gastrointestinal|gastrointestinal
273477|NCT02498288|capsule|capsule
273478|NCT02498288|Isotretinoin|isotretinoin
273479|NCT02498288|Bioequivalence|bioequivalence
273480|NCT02498262|Severe Mobility and Manipulation Impairments|severe mobility and manipulation impairments
273481|NCT02498249|Low-Level Laser Therapy|low-level laser therapy
273482|NCT02498249|trapezius muscle|trapezius muscle
273483|NCT02498249|neck pain|neck pain
273484|NCT02498236|Psychosis|psychosis
273485|NCT02498236|Schizophrenia|schizophrenia
273486|NCT02498236|Oxytocin|oxytocin
273487|NCT02498210|IVM|ivm
273488|NCT02498210|HIPPO signaling|hippo signaling
273489|NCT02498171|Labour analgesia|labour analgesia
273490|NCT02498171|Intrathecal morphine|intrathecal morphine
273491|NCT02498171|Bupivacaine|bupivacaine
273492|NCT02498171|Fentanyl|fentanyl
273493|NCT02498132|Mobile Technologies|mobile technologies
273494|NCT02498119|Type 2 DM|type 2 dm
273495|NCT02498119|lipid bodies|lipid bodies
273496|NCT02498106|nutrition|nutrition
273497|NCT02498106|aggression|aggression
273498|NCT02498106|n-3 fatty acids|n-3 fatty acids
273499|NCT02498106|psychiatry|psychiatry
273500|NCT02498106|inpatients admitted >2 years|inpatients admitted >2 years
273501|NCT02498093|Resistance training|resistance training
273502|NCT02498093|Arthroplasty, Replacement, Hip|arthroplasty, replacement, hip
273503|NCT02498093|Professional-Patient Relations|professional-patient relations
273504|NCT02498093|Evidence-based practice|evidence-based practice
273505|NCT02498080|Drug eluting balloons|drug eluting balloons
273506|NCT02498080|Critical limb ischemia|critical limb ischemia
273507|NCT02498080|Infra-popliteal arteries|infra-popliteal arteries
273508|NCT02498080|Percutaneous transluminal angioplasty|percutaneous transluminal angioplasty
273509|NCT02498041|Ultrathin Nasal Endoscopy|ultrathin nasal endoscopy
273510|NCT02498041|Barrett's Esophagus|barrett's esophagus
273511|NCT02498041|Transnasal Endoscopy|transnasal endoscopy
273512|NCT02498028|cervical fusion|cervical fusion
273513|NCT02498028|cervical arthroplasty|cervical arthroplasty
273514|NCT02498028|cervicobrachial pain|cervicobrachial pain
273515|NCT02498002|Diet|diet
273516|NCT02498002|Fasting|fasting
273517|NCT02498002|Intermittent Fasting|intermittent fasting
273518|NCT02498002|Alternate-day Fasting|alternate-day fasting
273519|NCT02498002|Physical Activity|physical activity
273520|NCT02498002|Glucose|glucose
273521|NCT02498002|Insulin|insulin
273522|NCT02498002|Appetite|appetite
273523|NCT02497989|Male circumcision|male circumcision
273524|NCT02497989|Demand creation|demand creation
273525|NCT02497976|Interstitial|interstitial
273526|NCT02497976|Cystitis|cystitis
273527|NCT02497976|Bladder|bladder
273528|NCT02497976|Pain|pain
273529|NCT02497950|HeartMate 3|heartmate 3
273530|NCT02497950|LVAS|lvas
273531|NCT02497950|LVAD|lvad
273532|NCT02497950|Heart-assist devices|heart-assist devices
273533|NCT02497950|Thoratec Corporation|thoratec corporation
273534|NCT02497937|GSK2798745|gsk2798745
273535|NCT02497937|TRPV4 Channel Blocker|trpv4 channel blocker
273536|NCT02497937|Pharmacodynamics|pharmacodynamics
273537|NCT02497937|Adults|adults
273538|NCT02497937|Congestive Heart Failure|congestive heart failure
273539|NCT02497911|Adductor Canal Catheter|adductor canal catheter
273540|NCT02497911|Intraarticular Catheter|intraarticular catheter
273541|NCT02497911|Arthroplasty, Replacement, Knee|arthroplasty, replacement, knee
273542|NCT02497885|MERS|mers
273543|NCT02497885|healthcare personnel|healthcare personnel
273544|NCT02497859|Weight Reduction|weight reduction
273545|NCT02497859|Weight Loss Diet|weight loss diet
273546|NCT02497859|Satiety Response|satiety response
273547|NCT02497859|Insulin|insulin
273548|NCT02497859|Glucagon-Like Peptide 1|glucagon-like peptide 1
273549|NCT02497859|PYY (3-36) peptide|pyy (3-36) peptide
273550|NCT02497859|Ghrelin|ghrelin
273551|NCT02497859|Glucose|glucose
273552|NCT02497859|Eggs|eggs
273553|NCT02497859|Protein|protein
273554|NCT02497859|Energy Intake|energy intake
273555|NCT02497859|Breakfast|breakfast
273556|NCT02497846|Hyaluronic acid|hyaluronic acid
273557|NCT02497846|MiconJet needle|miconjet needle
273558|NCT02497807|Tourette syndrome|tourette syndrome
273559|NCT02497807|Iron deficiency|iron deficiency
273560|NCT02497794|chew gum|chew gum
273561|NCT02497794|bowel movements|bowel movements
273562|NCT02497794|cesarean section|cesarean section
273563|NCT02497781|Complicated urinary tract infections (cUTIs)|complicated urinary tract infections (cutis)
273564|NCT02497768|mastication|mastication
273565|NCT02497768|pistachios|pistachios
273566|NCT02497768|brazils|brazils
273567|NCT02497768|participants|participants
273568|NCT02497729|Endotracheal Intubation|endotracheal intubation
273569|NCT02497729|Checklist|checklist
273570|NCT02497729|Positioning|positioning
273571|NCT02497690|Cochlear Implant|cochlear implant
273572|NCT02497690|Hearing Aid|hearing aid
273573|NCT02497690|Telemedicine|telemedicine
273574|NCT02497677|parental sensitivity|parental sensitivity
273575|NCT02497677|child attachment|child attachment
273576|NCT02497664|Radiotherapy|radiotherapy
273577|NCT02497664|Active Breathing Control Technique|active breathing control technique
273578|NCT02497651|Smoking|smoking
273579|NCT02497651|Diabetes|diabetes
273580|NCT02497651|Incretin hormones|incretin hormones
273581|NCT02497651|Glucose tolerance|glucose tolerance
273582|NCT02497638|metformin|metformin
273583|NCT02497638|atorvastatin|atorvastatin
273584|NCT02497638|prostate-specific antigen|prostate-specific antigen
273585|NCT02497638|biochemical recurrence|biochemical recurrence
273586|NCT02497625|Low back pain|low back pain
273587|NCT02497625|Empathy|empathy
273588|NCT02497625|Subgroups|subgroups
273589|NCT02497625|Minimal intervention|minimal intervention
273590|NCT02497547|Atrophy|atrophy
273591|NCT02497547|Pathological Conditions, Anatomical|pathological conditions, anatomical
273592|NCT02497547|Oxytocin|oxytocin
273593|NCT02497547|Oxytocics|oxytocics
273594|NCT02497534|ataxia|ataxia
273595|NCT02497534|neuromuscular|neuromuscular
273596|NCT02497521|polycystic kidney disease|polycystic kidney disease
273597|NCT02497521|autosomal dominant polycystic kidney disease|autosomal dominant polycystic kidney disease
273598|NCT02497521|ADPKD|adpkd
273599|NCT02497521|Tolvaptan|tolvaptan
273600|NCT02497521|Jinarc|jinarc
273601|NCT02497508|progressive disease after at least 1 course of chemotherapy|progressive disease after at least 1 course of chemotherapy
273602|NCT02497495|Immersion|immersion
273603|NCT02497495|Recovery of Function|recovery of function
273604|NCT02497495|Lactate|lactate
273605|NCT02497495|Creatine Kinase|creatine kinase
273606|NCT02497495|Musculoskeletal Pain|musculoskeletal pain
273607|NCT02497469|Drug Therapy|drug therapy
273608|NCT02497456|HIV|hiv
273609|NCT02497456|Counselling|counselling
273610|NCT02497456|Care|care
273611|NCT02497456|antiretroviral therapy|antiretroviral therapy
273612|NCT02497456|linkage|linkage
273613|NCT02497456|Uganda|uganda
273614|NCT02497456|Africa|africa
273615|NCT02497443|drug-resistant symptomatic epilepsy|drug-resistant symptomatic epilepsy
273616|NCT02497443|seizure|seizure
273617|NCT02497443|autologous mesenchymal stem cells|autologous mesenchymal stem cells
273618|NCT02497443|safety|safety
273619|NCT02497443|remission|remission
273620|NCT02497443|electroencephalography|electroencephalography
273621|NCT02497443|refractory symptomatic epilepsy|refractory symptomatic epilepsy
273622|NCT02497443|autologous MSC|autologous msc
273623|NCT02497443|efficacy|efficacy
273624|NCT02497417|ARIES Clostridium difficile|aries clostridium difficile
273625|NCT02497378|Multiple Myeloma|multiple myeloma
273626|NCT02497378|Daratumumab|daratumumab
273627|NCT02497378|JNJ-54767414|jnj-54767414
273628|NCT02497378|Bortezomib|bortezomib
273629|NCT02497378|Dexamethasone|dexamethasone
273630|NCT02497365|keratits|keratits
273631|NCT02497365|besifloxacin|besifloxacin
273632|NCT02497339|Smoking cessation interventions|smoking cessation interventions
273633|NCT02497339|mindfulness training|mindfulness training
273634|NCT02497326|second degree burns|second degree burns
273635|NCT02497326|heparin|heparin
273636|NCT02497326|topical|topical
273637|NCT02497300|Mineralocorticoid Receptor Antagonists|mineralocorticoid receptor antagonists
273638|NCT02497300|Mineralocorticoid Effects|mineralocorticoid effects
273639|NCT02497287|Treatment-resistant Depression|treatment-resistant depression
273640|NCT02497287|Esketamine|esketamine
273641|NCT02497287|Oral Antidepressant|oral antidepressant
273642|NCT02497274|bariatric surgery|bariatric surgery
273643|NCT02497274|taste perception|taste perception
273644|NCT02497274|lipid receptors|lipid receptors
273645|NCT02497261|Food Allergy|food allergy
273646|NCT02497261|Peanut|peanut
273647|NCT02497261|Sensitization|sensitization
273648|NCT02497261|Child|child
273649|NCT02497261|Double-blind placebo-controlled challenge|double-blind placebo-controlled challenge
273650|NCT02497261|Prospective cohort|prospective cohort
273651|NCT02497248|Atrial Fibrillation|atrial fibrillation
273652|NCT02497248|Pulmonary Vein Ablation|pulmonary vein ablation
273653|NCT02497248|Mitral stenosis|mitral stenosis
273654|NCT02497248|Body surface mapping|body surface mapping
273655|NCT02497235|Drug therapy, Positron Emission Tomography, Brain enzyme occupancy, Cholesterol 24S-hydroxylase, CH24H|drug therapy, positron emission tomography, brain enzyme occupancy, cholesterol 24s-hydroxylase, ch24h
273656|NCT02497196|TPCS|tpcs
273657|NCT02497196|tDCS|tdcs
273658|NCT02497196|visceral pain|visceral pain
273659|NCT02497196|pancreatitis|pancreatitis
273660|NCT02497196|healthy subjects|healthy subjects
273661|NCT02497196|pelvic pain|pelvic pain
273662|NCT02497196|neuromodulation|neuromodulation
273663|NCT02497196|non-invasive brain stimulation|non-invasive brain stimulation
273664|NCT02497157|bevacizumab|bevacizumab
273665|NCT02497157|oxaliplatin|oxaliplatin
273666|NCT02497157|irinotecan|irinotecan
273667|NCT02497157|hydrochloride hydrate|hydrochloride hydrate
273668|NCT02497157|fluorouracil|fluorouracil
273669|NCT02497157|levofolinate calcium|levofolinate calcium
273670|NCT02497144|interstitial lung disease|interstitial lung disease
273671|NCT02497144|neuromuscular electrical stimulation|neuromuscular electrical stimulation
273672|NCT02497144|exercise capacity|exercise capacity
273673|NCT02497144|quality of life|quality of life
273674|NCT02497131|PTCL|ptcl
273675|NCT02497131|CD30+|cd30+
273676|NCT02497118|lung cancer Anti angiogenesis therapy survival|lung cancer anti angiogenesis therapy survival
273677|NCT02497105|Epilepsy|epilepsy
273678|NCT02497105|Intractable Seizures|intractable seizures
273679|NCT02497105|Ketogenic Diet|ketogenic diet
273680|NCT02497105|Biochemical Profiles|biochemical profiles
273681|NCT02497079|Bronchoscopy|bronchoscopy
273682|NCT02497079|Ultrasonography|ultrasonography
273683|NCT02497079|Tuberculous lymphadenitis|tuberculous lymphadenitis
273684|NCT02497079|Polymerase chain reaction|polymerase chain reaction
273685|NCT02497079|Sensitivity and specificity|sensitivity and specificity
273686|NCT02497066|topical|topical
273687|NCT02497066|compound|compound
273688|NCT02497066|pain|pain
273689|NCT02497053|MPM|mpm
273690|NCT02497040|anaesthesia|anaesthesia
273691|NCT02497040|local anaesthesia|local anaesthesia
273692|NCT02497040|hemodynamics|hemodynamics
273693|NCT02497040|bupivacaine|bupivacaine
273694|NCT02497040|levobupivacaine|levobupivacaine
273695|NCT02497027|pharmacogenetic, pharmacogenomic, depressive, mental health|pharmacogenetic, pharmacogenomic, depressive, mental health
273696|NCT02496988|Cytokine-Induced Killer Cells|cytokine-induced killer cells
273697|NCT02496988|Milignant Gliomas|milignant gliomas
273698|NCT02496988|Temozolomide|temozolomide
273699|NCT02496962|sleep deprivation|sleep deprivation
273700|NCT02496936|Energy Expenditure|energy expenditure
273701|NCT02496936|Appetite|appetite
273702|NCT02496936|Satiety|satiety
273703|NCT02496923|prophylactic NHFO|prophylactic nhfo
273704|NCT02496923|risk of developing postoperative pulmonary complications|risk of developing postoperative pulmonary complications
273705|NCT02496923|reduces hospital length of stay|reduces hospital length of stay
273706|NCT02496884|chronic kidney disease|chronic kidney disease
273707|NCT02496884|. α2δ ligands|. α2δ ligands
273708|NCT02496884|mirogabalin|mirogabalin
273709|NCT02496884|pain relief|pain relief
273710|NCT02496884|kidney metabolism|kidney metabolism
273711|NCT02496858|Young Patient|young patient
273712|NCT02496858|Genetic Characteristics|genetic characteristics
273713|NCT02496832|Hypoxia|hypoxia
273714|NCT02496832|18F-FAZA|18f-faza
273715|NCT02496832|18F-Fluoroazomycin arabinoside|18f-fluoroazomycin arabinoside
273716|NCT02496832|Positron emission tomography|positron emission tomography
273717|NCT02496832|PET|pet
273718|NCT02496832|Participating in study EMR200592-001|participating in study emr200592-001
273719|NCT02496819|Children|children
273720|NCT02496806|Polyphenols|polyphenols
273721|NCT02496806|Absorption|absorption
273722|NCT02496806|Metabolism|metabolism
273723|NCT02496806|Phlorotannins|phlorotannins
273724|NCT02496806|Seaweeds|seaweeds
273725|NCT02496767|fast skeletal troponin activator|fast skeletal troponin activator
273726|NCT02496767|tirasemtiv|tirasemtiv
273727|NCT02496767|CK-2017357|ck-2017357
273728|NCT02496767|double-blind|double-blind
273729|NCT02496767|randomized|randomized
273730|NCT02496767|placebo-controlled|placebo-controlled
273731|NCT02496741|isocitrate dehydrogenase 1/2 mutation|isocitrate dehydrogenase 1/2 mutation
273732|NCT02496741|metformin|metformin
273733|NCT02496741|chloroquine|chloroquine
273734|NCT02496728|Mobile Health|mobile health
273735|NCT02496728|Smartphone|smartphone
273736|NCT02496728|Cardiovascular health|cardiovascular health
273737|NCT02496728|College students|college students
273738|NCT02496728|Smoking|smoking
273739|NCT02496728|Physical activity|physical activity
273740|NCT02496728|Diet|diet
273741|NCT02496728|BMI|bmi
273742|NCT02496728|Blood pressure|blood pressure
273743|NCT02496728|Cholesterol|cholesterol
273744|NCT02496728|Glucose|glucose
273745|NCT02496728|Text|text
273746|NCT02496728|Facebook|facebook
273747|NCT02496728|Instagram|instagram
273748|NCT02496728|Push Notifications|push notifications
273749|NCT02496728|Ecological Momentary Assessment|ecological momentary assessment
273750|NCT02496702|exergaming|exergaming
273751|NCT02496702|Senior Fitness Test|senior fitness test
273752|NCT02496689|HPP|hpp
273753|NCT02496689|Bone Disease|bone disease
273754|NCT02496689|Soft Bones|soft bones
273755|NCT02496689|Low Alkaline Phosphatase|low alkaline phosphatase
273756|NCT02496689|genetic metabolic disorder|genetic metabolic disorder
273757|NCT02496689|alkaline phosphatase|alkaline phosphatase
273758|NCT02496689|rickets|rickets
273759|NCT02496689|osteomalacia|osteomalacia
273760|NCT02496676|Lymphoma|lymphoma
273761|NCT02496676|MAGT1 Gene|magt1 gene
273762|NCT02496676|Intracellular Magnesium|intracellular magnesium
273763|NCT02496650|alcohol withdrawal state|alcohol withdrawal state
273764|NCT02496650|dexmedetomidine|dexmedetomidine
273765|NCT02496650|benzodiasepines|benzodiasepines
273766|NCT02496650|intensive care|intensive care
273767|NCT02496637|Obesity|obesity
273768|NCT02496637|Eating Disorders|eating disorders
273769|NCT02496637|Appetite regulation|appetite regulation
743092|NCT00463086|TB|tb
273770|NCT02496637|Eating Regulation|eating regulation
273771|NCT02496611|Obesity|obesity
273772|NCT02496611|Pharmacotherapy|pharmacotherapy
273773|NCT02496611|GLP-1|glp-1
273774|NCT02496611|Children|children
273775|NCT02496611|Exenatide|exenatide
273776|NCT02496611|BYDUREON|bydureon
273777|NCT02496611|Weight Loss|weight loss
273778|NCT02496611|Maintenance|maintenance
273779|NCT02496598|Reproductive Techniques, Assisted|reproductive techniques, assisted
273780|NCT02496598|Ovarian Follicle|ovarian follicle
273781|NCT02496585|Nintedanib (BIBF 1120)|nintedanib (bibf 1120)
273782|NCT02496585|Prednisone|prednisone
273783|NCT02496585|Radiation Pneumonitis|radiation pneumonitis
273784|NCT02496572|Tuberculosis, multidrug resistant|tuberculosis, multidrug resistant
273785|NCT02496572|Short-course regimen|short-course regimen
273786|NCT02496572|Medecins sans Frontieres, MSF|medecins sans frontieres, msf
273787|NCT02496572|Uzbekistan, Ministry of Health|uzbekistan, ministry of health
273788|NCT02496559|C-reactive Protein|c-reactive protein
273789|NCT02496559|Primary Health Care|primary health care
273790|NCT02496559|Child Welfare|child welfare
273791|NCT02496559|After-Hours Care|after-hours care
273792|NCT02496559|Anti-Bacterial Agents|anti-bacterial agents
273793|NCT02496559|Drug Prescriptions|drug prescriptions
273794|NCT02496520|dendritic cell vaccination|dendritic cell vaccination
273795|NCT02496520|sarcoma|sarcoma
273796|NCT02496520|central nervous system tumor|central nervous system tumor
273797|NCT02496520|childhood|childhood
273798|NCT02496520|adolescent|adolescent
273799|NCT02496520|immunotherapy|immunotherapy
273800|NCT02496507|sitting|sitting
273801|NCT02496507|intervention|intervention
273802|NCT02496507|desks|desks
273803|NCT02496507|workplace|workplace
273804|NCT02496507|cardiovascular|cardiovascular
273805|NCT02496507|metabolic|metabolic
273806|NCT02496507|qualitative|qualitative
273807|NCT02496507|randomised controlled trial|randomised controlled trial
273808|NCT02496468|childhood asthma|childhood asthma
273809|NCT02496468|preschool wheeze|preschool wheeze
273810|NCT02496468|adult asthma|adult asthma
273811|NCT02496468|transition|transition
273812|NCT02496468|phenotype|phenotype
273813|NCT02496468|endotype|endotype
273814|NCT02496468|trajectory|trajectory
273815|NCT02496455|NAV1.7 Voltage-Gated Sodium Channel|nav1.7 voltage-gated sodium channel
273816|NCT02496455|pain, postoperative|pain, postoperative
273817|NCT02496455|cesarean section|cesarean section
273818|NCT02496442|Transurethral Resection of Prostate|transurethral resection of prostate
273819|NCT02496442|Cystoscopy|cystoscopy
273820|NCT02496442|PCNL|pcnl
273821|NCT02496442|RERAS|reras
273822|NCT02496442|Urethroscopy|urethroscopy
273823|NCT02496403|buprenorphine-naloxone combination|buprenorphine-naloxone combination
273824|NCT02496403|Suboxone|suboxone
274431|NCT02493140|overweight|overweight
273825|NCT02496403|Buprenorphine|buprenorphine
273826|NCT02496403|Substance Use|substance use
273827|NCT02496403|Behavioral intervention|behavioral intervention
273828|NCT02496403|Opioid partial agonist|opioid partial agonist
273829|NCT02496403|medication assisted therapy|medication assisted therapy
273830|NCT02496403|opioid addiction|opioid addiction
273831|NCT02496390|Fecal Microbial Transplantation|fecal microbial transplantation
273832|NCT02496390|Gut microbiome|gut microbiome
273833|NCT02496390|Metabolic disorders|metabolic disorders
273835|NCT02496377|Anaemia|anaemia
273836|NCT02496377|Iron deficiency|iron deficiency
273837|NCT02496377|Ferric carboxymaltose|ferric carboxymaltose
273838|NCT02496377|Patient blood management|patient blood management
273839|NCT02496377|Hip arthroplasty|hip arthroplasty
273840|NCT02496377|Knee arthroplasty|knee arthroplasty
273841|NCT02496364|Tranexamic Acid|tranexamic acid
273842|NCT02496364|Scoliosis|scoliosis
273843|NCT02496364|bleeding control|bleeding control
273844|NCT02496351|transcutaneous electrical nerve stimulation|transcutaneous electrical nerve stimulation
273845|NCT02496338|Menopause|menopause
273846|NCT02496338|Quality of Life|quality of life
273847|NCT02496338|Marital Satisfaction|marital satisfaction
273848|NCT02496338|training|training
273849|NCT02496325|Pudendal nerve block|pudendal nerve block
273850|NCT02496325|Ultrasound guided|ultrasound guided
273851|NCT02496325|Transperineal puncture|transperineal puncture
273852|NCT02496325|Perineal surgery|perineal surgery
273853|NCT02496325|children|children
273854|NCT02496312|Apathy|apathy
273855|NCT02496312|Goal-directed behavior|goal-directed behavior
273856|NCT02496312|Quantitative evaluation|quantitative evaluation
273857|NCT02496312|Sensor|sensor
273858|NCT02496312|Ethogram|ethogram
273859|NCT02496299|COMPARISSON|comparisson
273860|NCT02496299|CAUDAL BLOCK|caudal block
273861|NCT02496299|BUPIVACAINE|bupivacaine
273862|NCT02496299|DEXAMETHASONE|dexamethasone
273863|NCT02496286|Necessary paracentesis for symptom control|necessary paracentesis for symptom control
273864|NCT02496273|Dendritic Cells|dendritic cells
273865|NCT02496273|Cytotoxic T-Lymphocytes|cytotoxic t-lymphocytes
273866|NCT02496273|Adeno-Associated Virus|adeno-associated virus
273867|NCT02496260|Magnetic resonance imaging|magnetic resonance imaging
273868|NCT02496260|Cardiac function|cardiac function
273869|NCT02496260|Breast Cancer|breast cancer
273870|NCT02496247|malnutrition|malnutrition
273871|NCT02496247|undernutrition|undernutrition
273872|NCT02496247|Z-score|z-score
273873|NCT02496247|Guinea-Bissau|guinea-bissau
273874|NCT02496247|food aid|food aid
273875|NCT02496234|Coronary Artery Bypass Graft Surgery|coronary artery bypass graft surgery
273876|NCT02496234|Acute kidney injury|acute kidney injury
273877|NCT02496234|Renal failure|renal failure
273878|NCT02496234|Biomarker|biomarker
273879|NCT02496221|Cholecystokinin|cholecystokinin
273880|NCT02496221|ultrasonography|ultrasonography
273881|NCT02496221|Albiglutide|albiglutide
273882|NCT02496221|Gallbladder ejection fraction|gallbladder ejection fraction
273883|NCT02496169|PTCA|ptca
273884|NCT02496169|stenosis|stenosis
273885|NCT02496169|sirolimus|sirolimus
273886|NCT02496169|stent|stent
273887|NCT02496156|type 1 diabetes mellitus|type 1 diabetes mellitus
273888|NCT02496156|adolescence|adolescence
273889|NCT02496156|adherence|adherence
273890|NCT02496156|insulin pump|insulin pump
273891|NCT02496156|continuous subcutaneous insulin infusion|continuous subcutaneous insulin infusion
273892|NCT02496156|continuous glucose monitor|continuous glucose monitor
273893|NCT02496156|shared medical decision making|shared medical decision making
273894|NCT02496143|Healthy Volunteers|healthy volunteers
273895|NCT02496143|Phase I|phase i
273896|NCT02496143|Placebo controlled|placebo controlled
273897|NCT02496143|Single Ascending Dose|single ascending dose
273898|NCT02496143|PK|pk
273899|NCT02496143|Oral administration|oral administration
273900|NCT02496143|Softgel|softgel
273901|NCT02496130|minilaparotomy|minilaparotomy
273902|NCT02496130|morcellation|morcellation
273903|NCT02496130|laparoscopy|laparoscopy
273904|NCT02496104|Preterm|preterm
273905|NCT02496104|Infant|infant
273906|NCT02496104|Habituation|habituation
273907|NCT02496104|APIB|apib
273908|NCT02496065|breast cancer|breast cancer
273909|NCT02496065|BLZ-100|blz-100
273910|NCT02496065|Tumor Paint|tumor paint
273911|NCT02496065|breast tumors|breast tumors
273912|NCT02496052|amnion graft|amnion graft
273913|NCT02496052|New biological barrier system|new biological barrier system
273914|NCT02496039|PBA|pba
273915|NCT02496039|involuntary crying|involuntary crying
273916|NCT02496039|involuntary laughing|involuntary laughing
273917|NCT02496000|Diabetes Mellitus type 2|diabetes mellitus type 2
273918|NCT02496000|Metformin|metformin
273919|NCT02496000|oral insulin|oral insulin
273920|NCT02495974|Xtandi|xtandi
273921|NCT02495974|Enzalutamide|enzalutamide
273922|NCT02495974|Prostate cancer|prostate cancer
273923|NCT02495974|Metastatic castration resistant prostate cancer|metastatic castration resistant prostate cancer
273924|NCT02495961|hyperlipidemias|hyperlipidemias
273925|NCT02495961|hyperglycemia|hyperglycemia
273926|NCT02495961|hypertension|hypertension
273927|NCT02495961|leptin|leptin
273928|NCT02495961|hyperhomocysteinemia|hyperhomocysteinemia
273929|NCT02495935|TES|tes
273930|NCT02495935|Transcorneal Electrical Stimulation|transcorneal electrical stimulation
273931|NCT02495935|Amblyopia|amblyopia
273932|NCT02495909|paediatric schistosomiasis|paediatric schistosomiasis
273933|NCT02495909|morbidity|morbidity
273934|NCT02495909|immunology|immunology
273935|NCT02495883|Essential Tremor|essential tremor
273936|NCT02495883|Magnetic Resonance Imaging|magnetic resonance imaging
273937|NCT02495883|Therapy|therapy
273938|NCT02495883|Alcohol|alcohol
273939|NCT02495883|Propranolol|propranolol
273940|NCT02495844|UCB0942|ucb0942
273941|NCT02495844|Treatment-resistant focal epilepsy|treatment-resistant focal epilepsy
273942|NCT02495844|Partial seizures|partial seizures
273943|NCT02495844|Seizure therapy|seizure therapy
273944|NCT02495831|PK study|pk study
273945|NCT02495818|Rotator cuff syndrome|rotator cuff syndrome
273946|NCT02495818|supraspinatus tendonitis|supraspinatus tendonitis
273947|NCT02495818|suprascapular nerve block|suprascapular nerve block
273948|NCT02495818|ultrasound guided|ultrasound guided
273949|NCT02495818|supraspinatus|supraspinatus
273950|NCT02495805|a continuous proximal adductor canal block (ACB)|a continuous proximal adductor canal block (acb)
273951|NCT02495805|continuous femoral nerve block (FNB)|continuous femoral nerve block (fnb)
273952|NCT02495779|PrEP|prep
273953|NCT02495779|HIV|hiv
273954|NCT02495779|MSM|msm
273955|NCT02495779|Men Having Sex With Men|men having sex with men
273956|NCT02495779|Episodic PrEP|episodic prep
273957|NCT02495779|Adherence|adherence
273958|NCT02495779|Episodic HIV Risk|episodic hiv risk
273959|NCT02495766|Multiple sclerosis|multiple sclerosis
273960|NCT02495766|Bone marrow mesenchymal stromal cells|bone marrow mesenchymal stromal cells
273961|NCT02495766|Stem cells|stem cells
273962|NCT02495766|Nervous System Diseases|nervous system diseases
273963|NCT02495766|Demyelinating Diseases|demyelinating diseases
273964|NCT02495766|Autoimmune Diseases|autoimmune diseases
273965|NCT02495753|cesarean section|cesarean section
273966|NCT02495753|wound infection|wound infection
273967|NCT02495753|vaginal cleansing|vaginal cleansing
743775|NCT00460590|TB|tb
273968|NCT02495753|endometritis|endometritis
273969|NCT02495727|Step-reduction model|step-reduction model
273970|NCT02495727|Reduced activity|reduced activity
273971|NCT02495727|Atrophy|atrophy
273972|NCT02495727|Skeletal Muscle|skeletal muscle
273973|NCT02495727|Sarcopenia|sarcopenia
273974|NCT02495727|Dynapenia|dynapenia
273975|NCT02495714|Exercise|exercise
273976|NCT02495714|Diet|diet
273977|NCT02495714|Learning|learning
273978|NCT02495688|General Anesthesia|general anesthesia
273979|NCT02495688|Regional Anesthesia|regional anesthesia
273980|NCT02495662|Vascular access|vascular access
273981|NCT02495662|Hemodialysis|hemodialysis
273982|NCT02495662|Arteriovenous shunt|arteriovenous shunt
273983|NCT02495662|Arteriovenous fistula|arteriovenous fistula
273984|NCT02495662|Maturation|maturation
273985|NCT02495662|Liposomal prednisolone|liposomal prednisolone
273986|NCT02495662|PEG-liposomal prednisolone sodium phosphate|peg-liposomal prednisolone sodium phosphate
273987|NCT02495662|Radio-cephalic|radio-cephalic
273988|NCT02495662|Shunt|shunt
273989|NCT02495610|NPH|nph
273990|NCT02495610|Gait analysis|gait analysis
273991|NCT02495610|neuropsychology|neuropsychology
273992|NCT02495610|micturition diary|micturition diary
273993|NCT02495610|MRI|mri
273994|NCT02495597|bronchial inflammation|bronchial inflammation
273995|NCT02495597|Bronchiolitis obliterans|bronchiolitis obliterans
273996|NCT02495597|Sputum|sputum
273997|NCT02495597|Blood|blood
273998|NCT02495597|Inflammation|inflammation
273999|NCT02495597|adaptive immune system|adaptive immune system
274000|NCT02495597|innate immune system|innate immune system
274001|NCT02495584|Vitamin D|vitamin d
274002|NCT02495584|Fortified milk|fortified milk
274003|NCT02495584|Supplementation|supplementation
274004|NCT02495584|UV exposure|uv exposure
274005|NCT02495584|Winter|winter
274006|NCT02495584|Healthy adults|healthy adults
274007|NCT02495584|Body Composition|body composition
274008|NCT02495584|Muscle function|muscle function
274009|NCT02495584|Blood pressure|blood pressure
274010|NCT02495571|ALS and Dysphagia|als and dysphagia
274011|NCT02495571|ALS and cough|als and cough
274012|NCT02495571|cough reflex test|cough reflex test
274013|NCT02495558|Cough Reflex test|cough reflex test
274014|NCT02495558|Decannulation|decannulation
274015|NCT02495545|spinal cord injury (SCI)|spinal cord injury (sci)
274016|NCT02495532|Neoplasm Metastasis|neoplasm metastasis
274017|NCT02495532|Colorectal Neoplasms|colorectal neoplasms
274018|NCT02495532|Lymph Nodes|lymph nodes
274019|NCT02495532|Lymph Node Revealing Solution|lymph node revealing solution
274020|NCT02495506|Cardiac surgery|cardiac surgery
274021|NCT02495506|bleeding|bleeding
274022|NCT02495506|platelet transfusion|platelet transfusion
274023|NCT02495480|disposable sheath|disposable sheath
274024|NCT02495480|intubation|intubation
274025|NCT02495480|colonoscopy|colonoscopy
274026|NCT02495428|Bandage|bandage
274027|NCT02495428|Treadmill|treadmill
274028|NCT02495428|Lactate Acid|lactate acid
274029|NCT02495389|urinary urgency incontinence|urinary urgency incontinence
274031|NCT02495376|cancer|cancer
274032|NCT02495376|MBSR|mbsr
274033|NCT02495311|adenomyosis|adenomyosis
274034|NCT02495311|uterine myoma|uterine myoma
274035|NCT02495311|lower urinary tract symptoms|lower urinary tract symptoms
274036|NCT02495311|sexual dysfunction|sexual dysfunction
274037|NCT02495311|gastrointestinal symptom|gastrointestinal symptom
274038|NCT02495298|Fascial manipulation|fascial manipulation
274039|NCT02495298|Carpal Tunnel Syndrome|carpal tunnel syndrome
274040|NCT02495285|pediatric patients gelatine|pediatric patients gelatine
274041|NCT02495272|Postpartum hemorrhage|postpartum hemorrhage
274042|NCT02495272|Third stage of labour|third stage of labour
274043|NCT02495272|Oxytocin|oxytocin
274044|NCT02495272|Uterotonics|uterotonics
274045|NCT02495272|Active management of third stage of labour|active management of third stage of labour
274046|NCT02495259|Double-lumen endobronchial tube|double-lumen endobronchial tube
274047|NCT02495259|Laryngoscopy|laryngoscopy
274048|NCT02495259|intubating stylet|intubating stylet
274049|NCT02495233|Erlotinib|erlotinib
274050|NCT02495233|ASP2215|asp2215
274051|NCT02495233|NSCLC|nsclc
274052|NCT02495233|Gilteritinib|gilteritinib
274053|NCT02495233|Non-Small-Cell Lung Cancer|non-small-cell lung cancer
274054|NCT02495220|dexmedetomidine|dexmedetomidine
274055|NCT02495220|subtenon anesthesia|subtenon anesthesia
274056|NCT02495220|postoperative pain|postoperative pain
274057|NCT02495220|pov|pov
274058|NCT02495194|Promotion of psychological well-being|promotion of psychological well-being
274059|NCT02495194|Horticultural therapy|horticultural therapy
274060|NCT02495194|Randomized Controlled Trial|randomized controlled trial
274061|NCT02495194|Gardening|gardening
274062|NCT02495194|Elderly|elderly
274063|NCT02495129|Primary Sjögren's syndrome|primary sjögren's syndrome
274064|NCT02495129|Sicca syndrome|sicca syndrome
274065|NCT02495129|Salivary glands|salivary glands
274066|NCT02495129|Positron Emission Tomography|positron emission tomography
274067|NCT02495129|B cell depletion|b cell depletion
274068|NCT02495103|Dose-Escalation|dose-escalation
350291|NCT02096042|AML|aml
274069|NCT02495103|Maximum Tolerated Dose|maximum tolerated dose
274070|NCT02495103|Safety|safety
274071|NCT02495103|Overall Response|overall response
274072|NCT02495090|Hypospadias|hypospadias
274073|NCT02495090|exome sequencing|exome sequencing
274074|NCT02495090|genital malformation|genital malformation
274075|NCT02495077|Kidney Transplantation|kidney transplantation
274076|NCT02495077|infliximab|infliximab
274077|NCT02495077|Tissue Donors|tissue donors
274078|NCT02495077|Remicade|remicade
274079|NCT02495077|Induction Therapy|induction therapy
274080|NCT02495077|Deceased Donor Kidney Transplant Recipients|deceased donor kidney transplant recipients
274081|NCT02495051|gastroesophageal reflux|gastroesophageal reflux
274082|NCT02495051|barrett esophagus|barrett esophagus
274083|NCT02495038|combination|combination
274084|NCT02495038|rocuronium|rocuronium
274085|NCT02495038|cisatracurium|cisatracurium
274086|NCT02495038|neuromuscular blockade monitoring|neuromuscular blockade monitoring
274087|NCT02495038|drug synergism|drug synergism
274088|NCT02495012|efficacy|efficacy
274089|NCT02495012|safety|safety
274090|NCT02495012|STEMI|stemi
274091|NCT02494999|pneumococcal conjugate vaccine|pneumococcal conjugate vaccine
274092|NCT02494999|immunogenicity|immunogenicity
274093|NCT02494999|safety|safety
274094|NCT02494986|Human immunodeficiency virus type 1|human immunodeficiency virus type 1
274095|NCT02494986|Rilpivirine|rilpivirine
274096|NCT02494986|Roll-over study|roll-over study
274097|NCT02494986|Pediatrics|pediatrics
274098|NCT02494960|smoking cessation intervention|smoking cessation intervention
274099|NCT02494947|Coronary Angiography|coronary angiography
274100|NCT02494947|Exercise|exercise
274101|NCT02494921|Metastatic|metastatic
274102|NCT02494921|Castration-Resistant|castration-resistant
274103|NCT02494908|Parkinson Disease|parkinson disease
274104|NCT02494908|MRI|mri
274105|NCT02494882|Ruxolitinib|ruxolitinib
274106|NCT02494882|Dasatinib|dasatinib
274107|NCT02494882|Dexamethasone|dexamethasone
274108|NCT02494882|14-272|14-272
274109|NCT02494869|Aerobic Training|aerobic training
274110|NCT02494869|Exercise|exercise
274111|NCT02494869|Gene Expression|gene expression
274112|NCT02494869|15-093|15-093
274113|NCT02494856|Naproxen|naproxen
274114|NCT02494856|Lower third molar|lower third molar
274115|NCT02494856|Oral Surgery|oral surgery
274116|NCT02494856|Esomeprazole|esomeprazole
274117|NCT02494830|Anesthetic Drugs|anesthetic drugs
274118|NCT02494817|HIV prevention|hiv prevention
274119|NCT02494817|Toolkit|toolkit
274120|NCT02494817|Male couples|male couples
274121|NCT02494817|Sexual agreements|sexual agreements
274122|NCT02494804|Cytokine-Induced Killer Cells|cytokine-induced killer cells
274123|NCT02494804|Milignant Gliomas|milignant gliomas
274124|NCT02494804|Temozolomide|temozolomide
274125|NCT02494778|Huntington's disease, pridopidine|huntington's disease, pridopidine
274126|NCT02494765|I-gelTM|i-geltm
274127|NCT02494765|Ambu® AuraOnceTM|ambu® auraoncetm
274128|NCT02494765|supraglottic devices|supraglottic devices
274129|NCT02494765|laryngeal mask effects on airway|laryngeal mask effects on airway
274130|NCT02494765|3D magnetic resonance imaging|3d magnetic resonance imaging
274131|NCT02494752|Contour deformities of face|contour deformities of face
274132|NCT02494752|autologous fat grafting|autologous fat grafting
274133|NCT02494752|Post traumatic facial contour defects|post traumatic facial contour defects
274134|NCT02494739|antioxidant|antioxidant
274135|NCT02494739|oxidative stress|oxidative stress
274136|NCT02494739|inflammation|inflammation
274137|NCT02494739|polyphenols|polyphenols
274138|NCT02494739|yogurt|yogurt
274139|NCT02494726|Ischemic stroke|ischemic stroke
274140|NCT02494726|ICH stroke|ich stroke
274141|NCT02494726|TEG|teg
274142|NCT02494726|Thromboelastography|thromboelastography
274143|NCT02494726|Stroke|stroke
274144|NCT02494713|Advanced Prostate Cancer|advanced prostate cancer
274145|NCT02494713|Neoadjuvant|neoadjuvant
274146|NCT02494713|Hormone therapy|hormone therapy
274147|NCT02494713|ADT|adt
274148|NCT02494713|Androgen Deprivation Therapy|androgen deprivation therapy
274149|NCT02494713|Chemotherapy|chemotherapy
274150|NCT02494713|Radical Prostatectomy|radical prostatectomy
274151|NCT02494661|Public Health|public health
274152|NCT02494661|Community|community
274153|NCT02494661|Obesity|obesity
274154|NCT02494661|Hispanic|hispanic
274155|NCT02494661|Women|women
274156|NCT02494661|Nutrition|nutrition
274157|NCT02494661|Mindfulness and stress|mindfulness and stress
274158|NCT02494661|Food shopping|food shopping
274159|NCT02494648|Obstructive sleep apnea|obstructive sleep apnea
274160|NCT02494648|Resistive inspiratory muscle training|resistive inspiratory muscle training
274161|NCT02494648|Coronary artery disease|coronary artery disease
274162|NCT02494648|Cardiac rehabilitation|cardiac rehabilitation
274163|NCT02494583|Gastric carcinoma|gastric carcinoma
274164|NCT02494583|Gastric cancer|gastric cancer
274165|NCT02494583|Gastroesophageal junction cancer|gastroesophageal junction cancer
274166|NCT02494583|Gastroesophageal junction carcinoma|gastroesophageal junction carcinoma
274167|NCT02494583|PD1|pd1
274168|NCT02494583|PD-1|pd-1
274169|NCT02494583|PDL1|pdl1
274170|NCT02494583|PD-L1|pd-l1
274171|NCT02494544|knee implant|knee implant
274172|NCT02494544|knee replacement|knee replacement
274173|NCT02494544|total knee replacement|total knee replacement
274174|NCT02494531|Alzheimer Disease|alzheimer disease
274175|NCT02494531|PET|pet
274176|NCT02494531|diagnosis|diagnosis
274177|NCT02494531|MCI|mci
274178|NCT02494531|illiterate|illiterate
274179|NCT02494518|stroke|stroke
274180|NCT02494518|aerobic exercise|aerobic exercise
274181|NCT02494518|forced exercise|forced exercise
274182|NCT02494518|repetitive task practice|repetitive task practice
274183|NCT02494518|arm function|arm function
274184|NCT02494518|upper extremity|upper extremity
274185|NCT02494505|chronic inflammatory demyelinating polyradiculopathy|chronic inflammatory demyelinating polyradiculopathy
274186|NCT02494505|intravenous immunoglobulin (IVIG)|intravenous immunoglobulin (ivig)
274187|NCT02494505|withdrawal|withdrawal
274188|NCT02494505|quality of life|quality of life
274189|NCT02494505|Clinical trial|clinical trial
274190|NCT02494505|cost|cost
274191|NCT02494492|Uveitis|uveitis
274192|NCT02494492|Lymphocyte cells|lymphocyte cells
274193|NCT02494492|lymphocyte T regulator|lymphocyte t regulator
274194|NCT02494492|vitreous haze|vitreous haze
274195|NCT02494492|intravitreal injection|intravitreal injection
274196|NCT02494479|Psoriasis|psoriasis
274197|NCT02494479|Topical Psoriasis|topical psoriasis
274198|NCT02494479|Mild Psoriasis|mild psoriasis
274199|NCT02494479|Moderate Psoriasis|moderate psoriasis
274200|NCT02494479|Active Psoriasis|active psoriasis
274201|NCT02494479|Plaque Psoriasis|plaque psoriasis
274202|NCT02494479|Skin Diseases|skin diseases
274203|NCT02494466|Airway Resistance|airway resistance
274204|NCT02494466|montelukast sodium|montelukast sodium
274205|NCT02494466|laryngeal mask airway|laryngeal mask airway
274206|NCT02494427|Crowns|crowns
274207|NCT02494427|Inlays|inlays
274208|NCT02494427|Onlays|onlays
274209|NCT02494414|Cardiac arrest|cardiac arrest
274210|NCT02494414|outcome|outcome
274211|NCT02494414|neurological status|neurological status
274212|NCT02494401|systemic sclerosis|systemic sclerosis
274213|NCT02494401|ssc|ssc
274214|NCT02494375|Sleep|sleep
274215|NCT02494375|glycemic control|glycemic control
274216|NCT02494375|type 1 diabetes|type 1 diabetes
274217|NCT02494375|amylase|amylase
274218|NCT02494375|body composition|body composition
274219|NCT02494375|lean|lean
274220|NCT02494375|overweight|overweight
274221|NCT02494375|obese|obese
274222|NCT02494362|Hand exercises|hand exercises
274223|NCT02494362|Hand function|hand function
274224|NCT02494362|Computer based exercises|computer based exercises
274225|NCT02494362|Therapeutic gaming|therapeutic gaming
274226|NCT02494349|α1-blockers|α1-blockers
274227|NCT02494349|antimuscarinic agent|antimuscarinic agent
274228|NCT02494323|Dual Channel Functional Electrical Stimulation|dual channel functional electrical stimulation
274229|NCT02494323|dropfoot, balanced dorsiflexion|dropfoot, balanced dorsiflexion
274230|NCT02494284|Coronary artery disease|coronary artery disease
274231|NCT02494284|Dual antiplatelet platelet therapy|dual antiplatelet platelet therapy
274232|NCT02494284|Drug eluting stent|drug eluting stent
274233|NCT02494258|CC-486|cc-486
274234|NCT02494258|Oral Azacitidine|oral azacitidine
274235|NCT02494258|Solid tumors|solid tumors
274236|NCT02494258|hematological disorders|hematological disorders
274237|NCT02494258|rollover study|rollover study
274238|NCT02494245|Rehabilitation|rehabilitation
274239|NCT02494245|Intervention|intervention
274240|NCT02494245|Walking|walking
274241|NCT02494232|minor blunt thoracic trauma|minor blunt thoracic trauma
274242|NCT02494232|physical examination|physical examination
274243|NCT02494219|Group A streptococcal pharyngitis|group a streptococcal pharyngitis
274244|NCT02494219|Rapid streptococcal test|rapid streptococcal test
274245|NCT02494219|Throat swab culture|throat swab culture
274246|NCT02494206|QBX258|qbx258
274247|NCT02494206|human monoclonal antibodies|human monoclonal antibodies
274248|NCT02494206|VAK694|vak694
274249|NCT02494206|QAX576|qax576
274250|NCT02494206|15-085|15-085
274251|NCT02494180|fentanyl|fentanyl
274252|NCT02494180|midazolam|midazolam
274253|NCT02494180|pethidine|pethidine
274254|NCT02494180|diazepam|diazepam
274255|NCT02494167|Acute Myeloid Leukemia|acute myeloid leukemia
274256|NCT02494167|Myelodysplastic Syndrome|myelodysplastic syndrome
274257|NCT02494167|MultiTAA Specific T cells|multitaa specific t cells
274258|NCT02494128|Child health service|child health service
274259|NCT02494128|Family health|family health
274260|NCT02494128|Nurse|nurse
274261|NCT02494128|Education|education
274262|NCT02494128|Parental group|parental group
274263|NCT02494128|Group leadership|group leadership
274264|NCT02494128|Health promotion|health promotion
274265|NCT02494102|Obstructive Sleep Apnea|obstructive sleep apnea
274266|NCT02494102|General Anesthesia|general anesthesia
274267|NCT02494102|Modafinil|modafinil
274268|NCT02494089|in situ simulation|in situ simulation
274269|NCT02494089|in hospital cardiac arrest|in hospital cardiac arrest
274270|NCT02494089|clinical audit|clinical audit
274271|NCT02494089|education|education
274272|NCT02494089|patient simulation|patient simulation
274273|NCT02494063|cervical cancer|cervical cancer
274274|NCT02494063|sentinel lymph node|sentinel lymph node
274275|NCT02494063|lymphadenectomy|lymphadenectomy
274276|NCT02494050|Depression|depression
274277|NCT02494050|Bipolar Disorder|bipolar disorder
274278|NCT02494050|Anhedonia|anhedonia
274279|NCT02494050|Women|women
274280|NCT02494024|PSP|psp
274281|NCT02494024|C2N-8E12|c2n-8e12
274282|NCT02494024|tauopathy|tauopathy
274283|NCT02494024|Progressive Supranuclear Palsy|progressive supranuclear palsy
274284|NCT02494024|Steele Richardson Olszewski Syndrome|steele richardson olszewski syndrome
274285|NCT02494024|Humanized anti-tau antibody|humanized anti-tau antibody
274286|NCT02494011|Colles' Fracture; CKCE; Russian current|colles' fracture; ckce; russian current
274287|NCT02493998|Sanfilippo Syndrome Type B|sanfilippo syndrome type b
274288|NCT02493985|Brain physiology|brain physiology
274289|NCT02493985|Intracranial pressure|intracranial pressure
274290|NCT02493985|Cognition|cognition
274291|NCT02493985|Cerebrovascular|cerebrovascular
274292|NCT02493985|Head down tilt|head down tilt
274293|NCT02493985|Space flight|space flight
274294|NCT02493972|ovarian cancer|ovarian cancer
274295|NCT02493972|peritoneal carcinosis|peritoneal carcinosis
274296|NCT02493972|manual exploration|manual exploration
274297|NCT02493972|surgery|surgery
274298|NCT02493972|GelPort|gelport
274299|NCT02493959|PYY|pyy
274300|NCT02493959|Degradation|degradation
274301|NCT02493959|kinetics|kinetics
274302|NCT02493959|men|men
274303|NCT02493920|Respiratory Distress Syndrome, Newborn|respiratory distress syndrome, newborn
274304|NCT02493920|Delivery Room|delivery room
274305|NCT02493920|Resuscitation|resuscitation
274306|NCT02493920|Premature birth|premature birth
274307|NCT02493920|Infant, Newborn|infant, newborn
274308|NCT02493920|Respiration Artificial|respiration artificial
274309|NCT02493894|Bowel preparation|bowel preparation
274310|NCT02493894|perioperative bleeding|perioperative bleeding
274311|NCT02493894|lumbar fusion|lumbar fusion
274312|NCT02493881|Motor function of the extralaryngeal branches|motor function of the extralaryngeal branches
274313|NCT02493881|intraoperative neuromonitoring|intraoperative neuromonitoring
274314|NCT02493881|recurrent laryngeal nerve|recurrent laryngeal nerve
274315|NCT02493868|Treatment-resistant Depression|treatment-resistant depression
274316|NCT02493868|Esketamine|esketamine
274318|NCT02493868|Oral Antidepressant|oral antidepressant
274319|NCT02493868|Relapse prevention|relapse prevention
274320|NCT02493855|Treatment naive|treatment naive
274321|NCT02493855|HCV|hcv
274322|NCT02493855|Interferon free|interferon free
274323|NCT02493855|Hepatitis C Genotype 1a|hepatitis c genotype 1a
274324|NCT02493855|Chronic Hepatitis C|chronic hepatitis c
274325|NCT02493855|Hepatitis C|hepatitis c
274326|NCT02493842|Nerve Stimulation|nerve stimulation
274327|NCT02493842|Neuroplasticity|neuroplasticity
274328|NCT02493842|Sensory Feedback|sensory feedback
274329|NCT02493790|cognitive dysfunction|cognitive dysfunction
274828|NCT02490540|opioids|opioids
274330|NCT02493790|Activity of Daily Living|activity of daily living
274331|NCT02493790|interference|interference
274332|NCT02493790|rehabilitation|rehabilitation
274333|NCT02493790|cognitive-motor dual task|cognitive-motor dual task
274334|NCT02493751|Cancer, renal cell cancer, kidney disease, kidney neoplasms, axitinib|cancer, renal cell cancer, kidney disease, kidney neoplasms, axitinib
274335|NCT02493673|Continuous Positive Airway Pressure|continuous positive airway pressure
274336|NCT02493673|Stroke|stroke
274337|NCT02493673|Cerebrovascular reactivity|cerebrovascular reactivity
274338|NCT02493673|Brain oxygenation|brain oxygenation
274339|NCT02493660|Massive Rotator Cuff Tear|massive rotator cuff tear
274340|NCT02493660|Arthroscopy|arthroscopy
274341|NCT02493660|Shoulder Joint|shoulder joint
274342|NCT02493660|Rotator cuff partial repair|rotator cuff partial repair
274343|NCT02493634|Magnetic Resonance spectroscopy|magnetic resonance spectroscopy
274344|NCT02493634|Aortic Arch|aortic arch
274345|NCT02493621|Pain, Postoperative|pain, postoperative
274346|NCT02493621|Nerve Block|nerve block
274347|NCT02493621|Anesthesia, Epidural|anesthesia, epidural
274349|NCT02493582|Apatinib|apatinib
274350|NCT02493582|Lung Adenocarcinoma|lung adenocarcinoma
274351|NCT02493569|Breast cancer, hospital, epidemiology, diagnosis, treatment|breast cancer, hospital, epidemiology, diagnosis, treatment
274352|NCT02493556|Phototherapy|phototherapy
274353|NCT02493556|Plyometric exercise|plyometric exercise
274354|NCT02493556|Muscle recovery|muscle recovery
274355|NCT02493543|autoantibodies|autoantibodies
274356|NCT02493530|MDS/MPN|mds/mpn
274357|NCT02493504|Heparin|heparin
274358|NCT02493491|dysphonia|dysphonia
274359|NCT02493491|dysphagia|dysphagia
274360|NCT02493491|neurogenic|neurogenic
274361|NCT02493491|vocal fold augmentation|vocal fold augmentation
274362|NCT02493491|VFA|vfa
274363|NCT02493491|vocal fold insufficiency|vocal fold insufficiency
274364|NCT02493491|Prolaryn|prolaryn
274365|NCT02493491|Radiesse|radiesse
274366|NCT02493491|Coaptite|coaptite
274367|NCT02493491|voice|voice
274368|NCT02493491|Parkinson's Disease|parkinson's disease
274369|NCT02493491|Multiple Sclerosis|multiple sclerosis
274370|NCT02493491|Amyotrophic Lateral Sclerosis|amyotrophic lateral sclerosis
274371|NCT02493491|ALS|als
274372|NCT02493491|MS|ms
274373|NCT02493491|calcium hydroxylapatite|calcium hydroxylapatite
274374|NCT02493491|hyaluronic acid|hyaluronic acid
274375|NCT02493478|Intubation|intubation
274376|NCT02493478|Advanced airway intervention|advanced airway intervention
274377|NCT02493478|Intensive care unit|intensive care unit
274378|NCT02493465|everolimus|everolimus
274379|NCT02493465|left ventricular hypertrophy|left ventricular hypertrophy
274380|NCT02493439|Best Possible Self|best possible self
274381|NCT02493439|Positive Psychology|positive psychology
274382|NCT02493439|Romanian Immigrants|romanian immigrants
274383|NCT02493439|Optimism|optimism
274384|NCT02493439|Future Thinking|future thinking
274385|NCT02493413|psychoneuroimmunology|psychoneuroimmunology
274386|NCT02493413|stress|stress
274387|NCT02493413|lymphocyte population|lymphocyte population
274388|NCT02493413|personality type|personality type
274389|NCT02493413|obesity|obesity
274390|NCT02493413|heart rate variability|heart rate variability
274391|NCT02493413|awareness|awareness
274392|NCT02493400|Follow up|follow up
274393|NCT02493400|Exercise|exercise
274394|NCT02493400|Rehabilitation|rehabilitation
274395|NCT02493387|Physiotherapist led group-based exercise|physiotherapist led group-based exercise
274396|NCT02493387|Physical activity|physical activity
274397|NCT02493387|Atrial fibrillation|atrial fibrillation
274398|NCT02493348|Fibromyalgia|fibromyalgia
274399|NCT02493348|Rhythmic Sensory Stimulation|rhythmic sensory stimulation
274400|NCT02493348|Gamma Stimulation|gamma stimulation
274401|NCT02493283|dapsone|dapsone
274402|NCT02493283|blood leucocytes|blood leucocytes
274403|NCT02493283|pharmacokinetics|pharmacokinetics
274404|NCT02493283|metabolism|metabolism
274405|NCT02493270|smoking cessation|smoking cessation
274406|NCT02493270|tobacco|tobacco
274407|NCT02493270|dental|dental
274408|NCT02493270|periodontal|periodontal
274409|NCT02493257|nonallergic irritant rhinitis|nonallergic irritant rhinitis
274410|NCT02493257|nasal congestion|nasal congestion
274411|NCT02493257|rhinorrhea|rhinorrhea
274412|NCT02493218|mindfulness|mindfulness
274413|NCT02493218|intervention|intervention
274414|NCT02493218|african american|african american
274415|NCT02493218|youth|youth
274416|NCT02493218|stress|stress
274417|NCT02493218|poverty|poverty
274418|NCT02493205|Implantable Cardiac Monitor|implantable cardiac monitor
274419|NCT02493205|Stent|stent
274420|NCT02493192|Parturition|parturition
274421|NCT02493192|Humanizing Deliver|humanizing deliver
274422|NCT02493192|Labor Pain|labor pain
274423|NCT02493192|Natural Childbirth|natural childbirth
274424|NCT02493192|Labor Onset|labor onset
274425|NCT02493192|First Labor Stage|first labor stage
274426|NCT02493192|Birth ball|birth ball
274427|NCT02493192|meperidine|meperidine
274428|NCT02493192|pethidine|pethidine
274429|NCT02493140|Weight management|weight management
274430|NCT02493140|cashew apple extract|cashew apple extract
274432|NCT02493101|Periostin staining|periostin staining
274433|NCT02493101|Urine periostin level|urine periostin level
274434|NCT02493101|Lupus nephritis|lupus nephritis
274435|NCT02493101|IgA nephropathy|iga nephropathy
274436|NCT02493075|atrial fibrillation|atrial fibrillation
274437|NCT02493075|Catheter Ablation|catheter ablation
274438|NCT02493075|contact force|contact force
274439|NCT02493075|Chinese-specific|chinese-specific
274440|NCT02493062|Hysterotomy|hysterotomy
274441|NCT02493062|Myelomeningocele|myelomeningocele
274442|NCT02493062|Open fetal surgery|open fetal surgery
274443|NCT02493062|Sonohysterogram|sonohysterogram
274444|NCT02493049|Multiple Sclerosis|multiple sclerosis
274445|NCT02493049|Domperidone|domperidone
274446|NCT02493049|Relapsing-Remitting MS|relapsing-remitting ms
274447|NCT02493049|Demyelinating disease|demyelinating disease
274448|NCT02493049|Remyelination|remyelination
274449|NCT02493023|Bronchoscopy|bronchoscopy
274450|NCT02493023|Bronchoscopes|bronchoscopes
274451|NCT02493010|Virtual Reality Exposure Therapy|virtual reality exposure therapy
274452|NCT02493010|Computerized Cognitive Behavioral Therapy|computerized cognitive behavioral therapy
274453|NCT02493010|Public Speaking|public speaking
274454|NCT02493010|Social Phobia|social phobia
274455|NCT02493010|Biofeedback|biofeedback
274456|NCT02492997|body fat|body fat
274457|NCT02492984|FVIII inhibitor|fviii inhibitor
274458|NCT02492971|Assistive technology|assistive technology
274459|NCT02492971|functional needs|functional needs
274460|NCT02492971|system usability|system usability
274461|NCT02492945|Tennis elbow|tennis elbow
274462|NCT02492945|Polydeoxyribonucleotides|polydeoxyribonucleotides
274463|NCT02492945|Prolotherapy|prolotherapy
274464|NCT02492945|Randomized controlled trial|randomized controlled trial
274465|NCT02492945|Visual analogue scale|visual analogue scale
274466|NCT02492945|disability|disability
274467|NCT02492945|ultrasonography|ultrasonography
274468|NCT02492919|cardiac surgery|cardiac surgery
274469|NCT02492919|risk factors|risk factors
274470|NCT02492919|infection|infection
274471|NCT02492880|stimulation|stimulation
274472|NCT02492880|implantable|implantable
274473|NCT02492880|pulse generator|pulse generator
274474|NCT02492880|back pain|back pain
274475|NCT02492880|chronic pain|chronic pain
274476|NCT02492880|leg pain|leg pain
274477|NCT02492854|Lower Extremity Bypass|lower extremity bypass
274478|NCT02492854|Surgical Site Infection|surgical site infection
274479|NCT02492854|Wound Dressing|wound dressing
274480|NCT02492854|Negative Pressure Wound Dressing|negative pressure wound dressing
274481|NCT02492841|dentin substitute|dentin substitute
274482|NCT02492841|vital pulp therapy|vital pulp therapy
274483|NCT02492841|Biodentine|biodentine
274484|NCT02492841|caries|caries
274485|NCT02492789|immunotherapy|immunotherapy
274486|NCT02492789|solid tumor|solid tumor
274487|NCT02492789|PD-1 blockade|pd-1 blockade
274488|NCT02492776|Volunteers|volunteers
274489|NCT02492737|acute myeloid leukemia|acute myeloid leukemia
274491|NCT02492737|myelodysplastic syndrome|myelodysplastic syndrome
274492|NCT02492737|MDS|mds
274493|NCT02492737|dual mutation|dual mutation
274494|NCT02492737|MPN|mpn
274495|NCT02492737|AITL|aitl
274496|NCT02492737|hematologic malignancies|hematologic malignancies
274497|NCT02492737|IDH1|idh1
274498|NCT02492737|IDH2|idh2
274499|NCT02492737|AG-881|ag-881
274500|NCT02492724|cervical spine|cervical spine
274501|NCT02492724|total disc replacement (cTDR)|total disc replacement (ctdr)
274502|NCT02492724|degenerative disc disease|degenerative disc disease
274503|NCT02492724|activ® C|activ® c
274504|NCT02492724|clinical outcome|clinical outcome
274505|NCT02492724|long-term results|long-term results
274506|NCT02492724|NDI|ndi
274507|NCT02492724|VAS|vas
274508|NCT02492724|heterotopic ossification (HO)|heterotopic ossification (ho)
274509|NCT02492724|range of motion (ROM)|range of motion (rom)
274510|NCT02492724|adjacent segment degeneration|adjacent segment degeneration
274511|NCT02492698|Probiotic|probiotic
274512|NCT02492698|Weight loss|weight loss
274513|NCT02492698|Lp-PLA2|lp-pla2
274514|NCT02492685|Quantitative analysis|quantitative analysis
274515|NCT02492685|contrast enhanced endoscopic ultrasonography|contrast enhanced endoscopic ultrasonography
274516|NCT02492659|femtosecond laser|femtosecond laser
274517|NCT02492633|Smoking cessation|smoking cessation
274518|NCT02492633|Smoke-free housing|smoke-free housing
274519|NCT02492633|Affordable housing|affordable housing
274520|NCT02492633|Second-hand smoke|second-hand smoke
274521|NCT02492633|Tobacco control|tobacco control
274522|NCT02492620|ferric citrate|ferric citrate
274523|NCT02492620|phosphate|phosphate
274524|NCT02492620|kidney|kidney
274525|NCT02492607|Women|women
274526|NCT02492607|DCIS grade I and II|dcis grade i and ii
274527|NCT02492607|Active surveillance|active surveillance
274528|NCT02492607|Standard treatment|standard treatment
274529|NCT02492581|Selincro|selincro
274530|NCT02492581|cohort|cohort
274531|NCT02492581|real-life|real-life
274532|NCT02492581|total alcohol consumption|total alcohol consumption
274533|NCT02492581|heavy drinking days|heavy drinking days
274534|NCT02492581|clinical global impression-severity|clinical global impression-severity
274535|NCT02492581|EQ5D|eq5d
274536|NCT02492581|AQoLS|aqols
274537|NCT02492581|Sheehan disability scale|sheehan disability scale
274538|NCT02492568|recurrent|recurrent
274539|NCT02492568|NSCLC|nsclc
274540|NCT02492568|pembrolizumab|pembrolizumab
274541|NCT02492568|SBRT|sbrt
274542|NCT02492555|IBD|ibd
274543|NCT02492555|Telemedicine|telemedicine
274544|NCT02492555|At-home monitoring|at-home monitoring
274545|NCT02492555|Disease activity|disease activity
274546|NCT02492555|fecal calprotectin|fecal calprotectin
274547|NCT02492542|electrical stimulation|electrical stimulation
274548|NCT02492542|urinary incontinence|urinary incontinence
274549|NCT02492529|Alzheimer, Recognition Memory, Mild Cognitive Impairment, fMRI|alzheimer, recognition memory, mild cognitive impairment, fmri
274550|NCT02492516|adipose tissue mesenchymal stem cell intravenous injection ALS|adipose tissue mesenchymal stem cell intravenous injection als
274551|NCT02492503|recurrent or metastatic carcinoma cervix chemotherapy|recurrent or metastatic carcinoma cervix chemotherapy
274552|NCT02492490|Kidney transplantation|kidney transplantation
274553|NCT02492490|DCD|dcd
274554|NCT02492490|Stromal Vascular Fraction|stromal vascular fraction
274555|NCT02492490|MSC|msc
274556|NCT02492451|intrauterine insemination|intrauterine insemination
274557|NCT02492451|pregnancy rate|pregnancy rate
274558|NCT02492451|endometrial injury|endometrial injury
274559|NCT02492438|pneumococcal vaccination|pneumococcal vaccination
274560|NCT02492438|dialysis|dialysis
274561|NCT02492438|immune response|immune response
274562|NCT02492425|Community Acquired Pneumonia|community acquired pneumonia
274563|NCT02492425|Healthcare Associated Pneumonia|healthcare associated pneumonia
274564|NCT02492399|hypertrophic cardiomyopathy|hypertrophic cardiomyopathy
274565|NCT02492399|mitral valve|mitral valve
274566|NCT02492399|SAM syndrome|sam syndrome
274567|NCT02492386|bioabsorbable vascular scaffold|bioabsorbable vascular scaffold
274568|NCT02492386|erectile dysfunction|erectile dysfunction
274569|NCT02492373|Post inflammatory hyperpigmentation|post inflammatory hyperpigmentation
274570|NCT02492373|topical high potency steroid|topical high potency steroid
274571|NCT02492373|Qs NdYAG laser|qs ndyag laser
274572|NCT02492360|Peripheral Neuropathies|peripheral neuropathies
274573|NCT02492360|Testicular Cancer|testicular cancer
274574|NCT02492360|Cisplatin|cisplatin
274575|NCT02492360|Pharmacogenomics|pharmacogenomics
274576|NCT02492308|kidney|kidney
274577|NCT02492308|transplantation|transplantation
274578|NCT02492308|MSC|msc
274579|NCT02492217|Ankylosing Spondylitis|ankylosing spondylitis
274580|NCT02492217|adalimumab|adalimumab
274581|NCT02492217|TNF-alpha agents|tnf-alpha agents
274582|NCT02492217|spondyloarthritis|spondyloarthritis
274583|NCT02492217|biologic therapies|biologic therapies
274584|NCT02492217|AS|as
274585|NCT02492217|biomarkers|biomarkers
274586|NCT02492217|efficacy prediction|efficacy prediction
274587|NCT02492191|Smart Phones|smart phones
274588|NCT02492191|Ambulatory Care|ambulatory care
274589|NCT02492191|Outcome and Process Assessment|outcome and process assessment
274590|NCT02492165|Japanese Encephalitis|japanese encephalitis
274591|NCT02492165|Japanese encephalitis chimeric virus vaccine|japanese encephalitis chimeric virus vaccine
274592|NCT02492165|IMOJEV®|imojev®
274593|NCT02492165|Live attenuated vaccine|live attenuated vaccine
274594|NCT02492152|women|women
274595|NCT02492152|active labor|active labor
274596|NCT02492126|Chronic Cough|chronic cough
274597|NCT02492126|Gastroesophageal Reflux|gastroesophageal reflux
274598|NCT02492126|Esophageal Motility|esophageal motility
274599|NCT02492126|Cough Sensitivity|cough sensitivity
274600|NCT02492113|Mechanical ventilation|mechanical ventilation
274601|NCT02492113|Positive end-expiratory pressure|positive end-expiratory pressure
274602|NCT02492113|Work of breathing|work of breathing
274603|NCT02492113|Morbidly obese|morbidly obese
274604|NCT02492100|Sexual Dysfunction Post-Bone Marrow Transplant|sexual dysfunction post-bone marrow transplant
274605|NCT02492087|topical|topical
274606|NCT02492087|tranexamic acid|tranexamic acid
274607|NCT02492087|haemostasis|haemostasis
274608|NCT02492087|caesarean section|caesarean section
274609|NCT02492087|bleeding|bleeding
274610|NCT02492087|postpartum hemorrhage|postpartum hemorrhage
274611|NCT02492087|prophylactic|prophylactic
274612|NCT02492074|delta-9-tetrahydrocannabinol|delta-9-tetrahydrocannabinol
274613|NCT02492074|cannabidiol|cannabidiol
274614|NCT02492074|COMT|comt
274615|NCT02492061|couples' HCT married couples|couples' hct married couples
274616|NCT02492061|Rakai|rakai
274617|NCT02492061|Uganda|uganda
274618|NCT02492035|Hypertension|hypertension
274619|NCT02492035|lifestyle|lifestyle
274620|NCT02492035|clinical trials|clinical trials
274621|NCT02492035|primary care setting|primary care setting
274622|NCT02491996|desire model|desire model
274623|NCT02491983|metastatic breast cancer|metastatic breast cancer
274624|NCT02491983|Endocrine receptors positive|endocrine receptors positive
274625|NCT02491983|HER-2 negative|her-2 negative
274626|NCT02491957|Energy Expenditure|energy expenditure
274627|NCT02491957|Physical Endurance|physical endurance
274628|NCT02491957|Muscle Stength|muscle stength
274629|NCT02491957|Metabolism|metabolism
274630|NCT02491931|Cardiac Surgical Procedures|cardiac surgical procedures
274631|NCT02491931|Cardiovascular Surgical Procedures|cardiovascular surgical procedures
274632|NCT02491931|Dietary Supplements|dietary supplements
274633|NCT02491931|Glutamine|glutamine
274634|NCT02491931|TROPONIN I|troponin i
274635|NCT02491931|cardiopulmonary bypass|cardiopulmonary bypass
274636|NCT02491879|mechanical low back pain|mechanical low back pain
274637|NCT02491879|emergency department|emergency department
274638|NCT02491879|ketoprofen|ketoprofen
274639|NCT02491879|gel|gel
274640|NCT02491840|gastric cancer|gastric cancer
274641|NCT02491840|cardia cancer|cardia cancer
274642|NCT02491827|optical biopsy|optical biopsy
274643|NCT02491814|Dairy|dairy
274644|NCT02491814|Breakfast cereal|breakfast cereal
274645|NCT02491814|Postprandial Glycemia|postprandial glycemia
274646|NCT02491814|Satiety|satiety
274647|NCT02491814|Food Intake|food intake
274648|NCT02491814|Milk|milk
274649|NCT02491814|Yogurt|yogurt
274650|NCT02491814|Soy|soy
274651|NCT02491814|Almond|almond
274652|NCT02491801|Dairy|dairy
274653|NCT02491801|Milk|milk
274654|NCT02491801|Yogurt|yogurt
274655|NCT02491801|Cheese|cheese
274656|NCT02491801|Postprandial glycaemia|postprandial glycaemia
274657|NCT02491801|Satiety|satiety
274658|NCT02491801|Food Intake|food intake
274659|NCT02491801|Elderly|elderly
274660|NCT02491801|Prevention and Treatment|prevention and treatment
274661|NCT02491762|Serratus Anterior|serratus anterior
274662|NCT02491762|Accessory Respiratory|accessory respiratory
274663|NCT02491762|Tissue Expander|tissue expander
274664|NCT02491762|Respiratory Function Tests|respiratory function tests
274665|NCT02491749|Cardiac anesthesia|cardiac anesthesia
274666|NCT02491749|ultra fast track|ultra fast track
274667|NCT02491749|ICU stay|icu stay
743776|NCT00460590|MVA 85A|mva 85a
274668|NCT02491710|Surgical education|surgical education
274669|NCT02491710|Laparoscopy|laparoscopy
274670|NCT02491710|Laparoscopic suturing|laparoscopic suturing
274671|NCT02491697|DC-CIK|dc-cik
274672|NCT02491697|Breast cancer|breast cancer
274673|NCT02491697|Capecitabine|capecitabine
274674|NCT02491684|asthma|asthma
274675|NCT02491684|Upper Respiratory Tract Infection|upper respiratory tract infection
274676|NCT02491684|exacerbation|exacerbation
274677|NCT02491684|Interferon|interferon
274678|NCT02491684|efficacy|efficacy
274679|NCT02491684|safety|safety
274680|NCT02491684|prevention|prevention
274681|NCT02491671|Prevention PAL Prolonged Air Leak (PAL)|prevention pal prolonged air leak (pal)
274682|NCT02491671|Lung Resection|lung resection
274683|NCT02491671|Thoracic Surgery|thoracic surgery
274684|NCT02491671|Post-operative Thoracic Air Leak|post-operative thoracic air leak
274685|NCT02491645|Autistic spectrum disorder|autistic spectrum disorder
274686|NCT02491645|Sensory processing abnormalities|sensory processing abnormalities
274687|NCT02491645|Sensory interventions|sensory interventions
274688|NCT02491645|occupational therapy|occupational therapy
274689|NCT02491619|Angle class III|angle class iii
274690|NCT02491619|tomography|tomography
274691|NCT02491619|tooth inclination|tooth inclination
274692|NCT02491619|bone thickness|bone thickness
274693|NCT02491593|fecal occult blood|fecal occult blood
274694|NCT02491554|Deep Brain Stimulation|deep brain stimulation
274695|NCT02491554|Essential tremor|essential tremor
274696|NCT02491554|DISTINCT|distinct
274697|NCT02491554|MR-tractography guided DBS implantation|mr-tractography guided dbs implantation
274698|NCT02491554|Conventional AC-PC based DBS implantation|conventional ac-pc based dbs implantation
274699|NCT02491515|Osteoporosis|osteoporosis
274700|NCT02491515|BMD|bmd
274701|NCT02491515|denosumab|denosumab
274702|NCT02491515|previous therapy|previous therapy
274703|NCT02491489|Manual therapy|manual therapy
274704|NCT02491476|Safety|safety
274705|NCT02491476|Electrodes|electrodes
274706|NCT02491476|Device|device
274707|NCT02491476|StereoElectroencephalograph|stereoelectroencephalograph
274708|NCT02491476|Epileptogenic zone|epileptogenic zone
274709|NCT02491476|Fast ripples|fast ripples
274710|NCT02491463|Reactogenicity|reactogenicity
274711|NCT02491463|Safety|safety
274712|NCT02491463|Respiratory syncytial virus (RSV)|respiratory syncytial virus (rsv)
274713|NCT02491463|Vaccine|vaccine
274714|NCT02491463|Immunogenicity|immunogenicity
274715|NCT02491424|Osseointegration|osseointegration
274716|NCT02491424|Direct skeletal attachment|direct skeletal attachment
274717|NCT02491385|Thoracic epidural analgesia|thoracic epidural analgesia
274718|NCT02491385|bowel function recovery|bowel function recovery
274719|NCT02491333|polycystic ovary syndrome|polycystic ovary syndrome
274720|NCT02491333|acupuncture|acupuncture
274721|NCT02491333|insulin resistance|insulin resistance
274722|NCT02491333|HOMA-IR|homa-ir
274723|NCT02491333|metformin|metformin
274724|NCT02491320|polycystic ovary syndrome|polycystic ovary syndrome
274725|NCT02491320|acupuncture|acupuncture
274726|NCT02491320|pre-treatment|pre-treatment
274727|NCT02491320|Letrozole|letrozole
274728|NCT02491320|Live Birth|live birth
274729|NCT02491294|School|school
274730|NCT02491294|Family|family
274731|NCT02491294|Fruit and Vegetables|fruit and vegetables
274732|NCT02491294|Cooking|cooking
274733|NCT02491294|Physical Activity|physical activity
274734|NCT02491281|Primary Osteoarthritis, Total Knee Replacement, cartilage|primary osteoarthritis, total knee replacement, cartilage
274735|NCT02491242|HIV|hiv
274736|NCT02491242|dolutegravir|dolutegravir
274737|NCT02491242|intolerance|intolerance
274738|NCT02491242|dual therapies|dual therapies
274739|NCT02491229|non-alcoholic fatty liver disease (NAFLD)|non-alcoholic fatty liver disease (nafld)
274740|NCT02491229|Obesity|obesity
274741|NCT02491229|Hepafast|hepafast
274742|NCT02491216|Frailty|frailty
274743|NCT02491216|Frail elderly|frail elderly
274744|NCT02491216|Acupressure|acupressure
274745|NCT02491216|Pragmatic Randomised Controlled Trial|pragmatic randomised controlled trial
274746|NCT02491203|Virtual reality|virtual reality
274747|NCT02491203|telerehabilitation|telerehabilitation
274748|NCT02491203|Stroke rehabilitation|stroke rehabilitation
274749|NCT02491177|HIV Transmission|hiv transmission
274750|NCT02491177|Prevention of Mother to Child Transmission|prevention of mother to child transmission
274751|NCT02491177|Linkage to care|linkage to care
274752|NCT02491177|Retention in care|retention in care
274753|NCT02491177|Community Mentor Mothers|community mentor mothers
274754|NCT02491177|Mobile phone text messaging|mobile phone text messaging
274755|NCT02491177|Antiretroviral therapy adherence|antiretroviral therapy adherence
274756|NCT02491177|Infant Health|infant health
274757|NCT02491177|Maternal CD4/viral loads|maternal cd4/viral loads
274758|NCT02491177|Early infant diagnosis|early infant diagnosis
274759|NCT02491177|Acceptability of interventions|acceptability of interventions
274760|NCT02491177|Vertical transmission|vertical transmission
274761|NCT02491138|participants|participants
400508|NCT01866553|suboptimal molecular response|suboptimal molecular response
400509|NCT01866553|nilotinib|nilotinib
274762|NCT02491086|intervention, nicotine replacement sampling, smoking cessation, smoking hotspots|intervention, nicotine replacement sampling, smoking cessation, smoking hotspots
274763|NCT02491034|Depression|depression
274764|NCT02491034|Hispanics|hispanics
274765|NCT02491034|Stigma|stigma
274766|NCT02491034|Barriers to Treatment|barriers to treatment
274767|NCT02491008|Thyroid Dysfunction|thyroid dysfunction
274768|NCT02491008|Bone mineral density|bone mineral density
274769|NCT02491008|Osteoporosis|osteoporosis
274770|NCT02491008|Fractures, Bone|fractures, bone
274771|NCT02491008|Randomized Controlled Trial|randomized controlled trial
274772|NCT02490995|children|children
274773|NCT02490969|copeptin|copeptin
274774|NCT02490969|rule out marker, emergency department, cheast pain unit|rule out marker, emergency department, cheast pain unit
274775|NCT02490969|emergency department|emergency department
274776|NCT02490969|chest pain unit|chest pain unit
274777|NCT02490956|Diagnostic immunization with rabies vaccine|diagnostic immunization with rabies vaccine
274778|NCT02490956|Primary immunodeficiency|primary immunodeficiency
274779|NCT02490943|peginterferon beta-1a|peginterferon beta-1a
274780|NCT02490943|MS (Multiple Sclerosis)|ms (multiple sclerosis)
274781|NCT02490943|Injection Site Reaction Erythema|injection site reaction erythema
274782|NCT02490930|lymphopenia|lymphopenia
274783|NCT02490917|Female urinary incontinence|female urinary incontinence
274784|NCT02490917|Sphincter deficiency|sphincter deficiency
274785|NCT02490904|Kidney transplantation|kidney transplantation
274786|NCT02490904|Eplerenone|eplerenone
274787|NCT02490891|Lymphoma, angiogenesis, PET scan|lymphoma, angiogenesis, pet scan
274788|NCT02490839|Helicobacter pylori|helicobacter pylori
274789|NCT02490839|high dose dual therapy|high dose dual therapy
274790|NCT02490839|bismuth-containing quadruple therapy|bismuth-containing quadruple therapy
274791|NCT02490839|antibiotic resistance|antibiotic resistance
274792|NCT02490826|Speech Sound Disorders|speech sound disorders
274793|NCT02490826|Tabletop|tabletop
274794|NCT02490826|Digital|digital
274795|NCT02490813|Fish allergy|fish allergy
274796|NCT02490813|shrimp allergy|shrimp allergy
274797|NCT02490813|crab allergy|crab allergy
274798|NCT02490813|traditional Chinese medicine|traditional chinese medicine
274799|NCT02490761|Geriatrics|geriatrics
274800|NCT02490761|Nutritional Status|nutritional status
274801|NCT02490761|Hospitalisation|hospitalisation
274802|NCT02490722|Patient education|patient education
274803|NCT02490722|Empowerment|empowerment
274804|NCT02490709|Rectal neoplasms|rectal neoplasms
274805|NCT02490709|Colorectal neoplasms|colorectal neoplasms
274806|NCT02490709|Local excision|local excision
274807|NCT02490696|PET scan|pet scan
274808|NCT02490696|FAZA|faza
274809|NCT02490696|F-Miso|f-miso
274810|NCT02490696|hypoxia|hypoxia
274811|NCT02490696|lung cancer|lung cancer
274812|NCT02490631|skin flora|skin flora
274813|NCT02490605|Postural balance|postural balance
274814|NCT02490605|Temporomandibular disorders|temporomandibular disorders
274815|NCT02490605|Splints|splints
274816|NCT02490579|video messaging|video messaging
274817|NCT02490579|exercise|exercise
274818|NCT02490579|diet|diet
274819|NCT02490579|weight gain|weight gain
274820|NCT02490579|pregnancy|pregnancy
274821|NCT02490566|chronic condition|chronic condition
274822|NCT02490566|telehealth|telehealth
274823|NCT02490566|nutrition|nutrition
274824|NCT02490566|exercise|exercise
274825|NCT02490553|air pollution|air pollution
274826|NCT02490553|epidemiological survey|epidemiological survey
274827|NCT02490553|representative sample|representative sample
274829|NCT02490540|analgesia|analgesia
274830|NCT02490540|pain|pain
274831|NCT02490540|anesthesia|anesthesia
274832|NCT02490527|myopathy|myopathy
274833|NCT02490527|muscular weakness|muscular weakness
274834|NCT02490527|cramping|cramping
274835|NCT02490527|fatigue|fatigue
274836|NCT02490488|ovarian cancer|ovarian cancer
274837|NCT02490488|tyrosine kinase inhibitor|tyrosine kinase inhibitor
274838|NCT02490462|Cerebral Palsy|cerebral palsy
274839|NCT02490462|Physical Therapy|physical therapy
274840|NCT02490462|Family-centered Care|family-centered care
274841|NCT02490384|Cervical cerclage|cervical cerclage
274842|NCT02490345|gabapentin|gabapentin
274843|NCT02490319|radiation pneumonitis|radiation pneumonitis
274844|NCT02490319|lung cancer|lung cancer
274845|NCT02490319|prediction models|prediction models
274846|NCT02490319|genetic variants|genetic variants
274847|NCT02490241|pregnant|pregnant
274848|NCT02490241|female|female
274849|NCT02490241|women|women
274850|NCT02490241|lithium|lithium
274851|NCT02490241|bipolar|bipolar
274852|NCT02490228|female|female
274853|NCT02490228|minimally invasive surgery|minimally invasive surgery
274854|NCT02490150|Corifollitropin alfa|corifollitropin alfa
274855|NCT02490150|Stimulation protocol|stimulation protocol
274856|NCT02490124|Diabetes Type 1|diabetes type 1
274857|NCT02490124|Vascular Function|vascular function
274858|NCT02490098|Type 1 diabetes|type 1 diabetes
274859|NCT02490098|Closed-loop system|closed-loop system
274860|NCT02490098|Artificial pancreas|artificial pancreas
274861|NCT02490098|Insulin|insulin
274862|NCT02490098|Glucagon|glucagon
274863|NCT02490098|Hypoglycemia|hypoglycemia
274864|NCT02490098|Postprandial glucose|postprandial glucose
274865|NCT02490085|Type 2 diabetes|type 2 diabetes
274866|NCT02490085|Closed-loop strategy|closed-loop strategy
274867|NCT02490085|Artificial pancreas|artificial pancreas
274868|NCT02490085|Insulin|insulin
274869|NCT02490085|Elderly|elderly
274870|NCT02490085|Multiple daily injections|multiple daily injections
274871|NCT02490085|Hypoglycemia|hypoglycemia
274872|NCT02490046|D mannose|d mannose
274873|NCT02490046|multiple sclerosis|multiple sclerosis
274874|NCT02490046|recurrent urinary infections|recurrent urinary infections
274875|NCT02490020|Renal transplantation|renal transplantation
274876|NCT02490020|mesenchymal stem cell|mesenchymal stem cell
274877|NCT02490020|Transplantation Rejection|transplantation rejection
274878|NCT02490020|donation after cardiac death|donation after cardiac death
274879|NCT02490007|Acellular pertussis vaccine|acellular pertussis vaccine
274880|NCT02490007|whole cell pertussis vaccine|whole cell pertussis vaccine
274881|NCT02490007|IgE-mediated food allergy|ige-mediated food allergy
274882|NCT02489916|Metastatic Colorectal Cancer|metastatic colorectal cancer
274883|NCT02489916|CM4307|cm4307
274884|NCT02489916|Previously treated metastatic colorectal cancer|previously treated metastatic colorectal cancer
274885|NCT02489903|Epigenetics|epigenetics
274886|NCT02489903|resensitization|resensitization
274887|NCT02489903|Platinum doublets|platinum doublets
274888|NCT02489903|lung cancer|lung cancer
274889|NCT02489903|Ovarian epithelial cancer|ovarian epithelial cancer
274890|NCT02489877|multiple sclerosis|multiple sclerosis
274891|NCT02489877|HERV-W virus|herv-w virus
274892|NCT02489877|Herpesviridae family|herpesviridae family
274893|NCT02489864|Terlipressin|terlipressin
274894|NCT02489864|mean arterial pressure|mean arterial pressure
274895|NCT02489864|type 2 HRS|type 2 hrs
274896|NCT02489838|Liver Neoplasma|liver neoplasma
274897|NCT02489838|Lung Radiation dose|lung radiation dose
274898|NCT02489825|randomized controlled trial|randomized controlled trial
274899|NCT02489825|vertebral fracture|vertebral fracture
274900|NCT02489825|osteoporosis|osteoporosis
274901|NCT02489825|vertebroplasty|vertebroplasty
274902|NCT02489825|augmentation|augmentation
274903|NCT02489812|children|children
274904|NCT02489812|behavior|behavior
274905|NCT02489812|anxiety|anxiety
274906|NCT02489812|dentistry|dentistry
274907|NCT02489799|advance care planning|advance care planning
274908|NCT02489773|Lucica|lucica
274909|NCT02489773|glycated albumin|glycated albumin
274910|NCT02489773|GA|ga
274911|NCT02489773|fructosamine|fructosamine
274912|NCT02489760|Etanercept|etanercept
274913|NCT02489760|Adalimumab|adalimumab
274914|NCT02489760|Ankylosing Spondylitis|ankylosing spondylitis
274915|NCT02489760|Switch Study|switch study
274916|NCT02489747|cognitive function|cognitive function
274917|NCT02489747|CNT|cnt
274918|NCT02489747|memory function|memory function
274919|NCT02489747|Triticum aestivum L|triticum aestivum l
274920|NCT02489747|wheat bran|wheat bran
274921|NCT02489734|sevoflurane|sevoflurane
274922|NCT02489734|emergence delirium|emergence delirium
274923|NCT02489734|preschool|preschool
274924|NCT02489721|peripherally inserted central venous catheter|peripherally inserted central venous catheter
274925|NCT02489721|depp vein thrombosis|depp vein thrombosis
274926|NCT02489721|related blood stream infections|related blood stream infections
274927|NCT02489721|midline|midline
274928|NCT02489708|Bronchiolitis|bronchiolitis
274929|NCT02489708|Cough|cough
274930|NCT02489708|Ear Infection|ear infection
274931|NCT02489708|Respiratory Infection|respiratory infection
274932|NCT02489708|Wheezing|wheezing
274933|NCT02489708|Clinical Decision Support Systems|clinical decision support systems
274934|NCT02489695|locally advanced or metastatic|locally advanced or metastatic
274935|NCT02489656|Double loop ureteral stent|double loop ureteral stent
274936|NCT02489656|USSQ|ussq
274937|NCT02489656|Quality of life|quality of life
274938|NCT02489656|Pain|pain
274939|NCT02489604|neuroendocrine tumors|neuroendocrine tumors
274940|NCT02489578|Community Acquired Pneumonia|community acquired pneumonia
274941|NCT02489578|health care associated pneumonia|health care associated pneumonia
274942|NCT02489565|Coronary Artery Disease|coronary artery disease
274943|NCT02489565|stable|stable
274944|NCT02489565|Telemedicine|telemedicine
274945|NCT02489565|Patient Discharge|patient discharge
274946|NCT02489539|Aortic aneurysm|aortic aneurysm
274947|NCT02489539|Abdominal aorta|abdominal aorta
274948|NCT02489539|Stent graft|stent graft
274949|NCT02489539|Aneurysm|aneurysm
274950|NCT02489539|Vascular Diseases|vascular diseases
274951|NCT02489539|Cardiovascular Diseases|cardiovascular diseases
274952|NCT02489500|AL Amyloidosis|al amyloidosis
274953|NCT02489500|Stem Cell Transplantation|stem cell transplantation
274955|NCT02489448|Breast Cancer|breast cancer
274956|NCT02489383|Asthma|asthma
274957|NCT02489383|Continuous Exercise Training|continuous exercise training
274958|NCT02489383|interval Exercise Training|interval exercise training
274959|NCT02489383|Clinical Control|clinical control
743881|NCT00460252|adults|adults
274960|NCT02489383|Inflammation|inflammation
274961|NCT02489370|home care|home care
274962|NCT02489370|telecare|telecare
274963|NCT02489370|telehealth|telehealth
274964|NCT02489370|telemonitoring|telemonitoring
274965|NCT02489370|chronic heart failure|chronic heart failure
274966|NCT02489370|randomized controlled trial|randomized controlled trial
274967|NCT02489370|Congestive Heart Failure|congestive heart failure
274968|NCT02489370|telemedicine|telemedicine
274969|NCT02489331|Dyslipidemias|dyslipidemias
274970|NCT02489318|Prostate Cancer|prostate cancer
274971|NCT02489318|JNJ-56021927|jnj-56021927
274972|NCT02489318|Androgen Deprivation Therapy|androgen deprivation therapy
274973|NCT02489318|ARN-509|arn-509
274974|NCT02489318|Apalutamide|apalutamide
274975|NCT02489318|TITAN|titan
274976|NCT02489318|Metastatic Hormone-sensitive Prostate Cancer|metastatic hormone-sensitive prostate cancer
274977|NCT02489305|Depressive Disorder, Major|depressive disorder, major
274978|NCT02489305|Depression|depression
274979|NCT02489305|Anti-Depressant|anti-depressant
274980|NCT02489305|Observational|observational
274981|NCT02489292|Urea Cycle Disorder|urea cycle disorder
274982|NCT02489292|UCD|ucd
274983|NCT02489292|cell therapy|cell therapy
274984|NCT02489292|stem cell|stem cell
274985|NCT02489279|Attention deficit hyperactivity disorder.|attention deficit hyperactivity disorder.
274986|NCT02489279|Attention training|attention training
274987|NCT02489279|Mobile devices|mobile devices
274988|NCT02489279|Brain training|brain training
274989|NCT02489266|Melanoma|melanoma
274990|NCT02489266|Immunotherapy|immunotherapy
274991|NCT02489227|PsO|pso
274992|NCT02489214|donafenib|donafenib
274993|NCT02489201|donafenib|donafenib
274994|NCT02489188|gait asymmetry|gait asymmetry
274995|NCT02489188|joint angles|joint angles
274996|NCT02489175|Parastomal hernia|parastomal hernia
274997|NCT02489175|prevention|prevention
274998|NCT02489175|stomaplasty|stomaplasty
274999|NCT02489175|ring|ring
275000|NCT02489149|food insecurity|food insecurity
275001|NCT02489136|spiritist passe|spiritist passe
275002|NCT02489136|laying of hands|laying of hands
275003|NCT02489136|newborn|newborn
275004|NCT02489136|adult|adult
275005|NCT02489136|conditions|conditions
275006|NCT02489110|Alzheimer's Disease|alzheimer's disease
275007|NCT02489110|Dementia|dementia
275008|NCT02489110|caregiving|caregiving
275009|NCT02489110|caregiver|caregiver
275010|NCT02489110|coping|coping
275011|NCT02489110|coping with caregiving|coping with caregiving
275012|NCT02489110|stress|stress
275013|NCT02489110|Hispanic caregiver|hispanic caregiver
275014|NCT02489110|Latino caregiver|latino caregiver
275015|NCT02489084|Head and Neck neoplasms|head and neck neoplasms
275016|NCT02489084|Genome-wide association study|genome-wide association study
275017|NCT02489084|Polymorphism, single nucleotide|polymorphism, single nucleotide
275018|NCT02489084|Toxicity|toxicity
275019|NCT02489019|Anesthesia|anesthesia
275020|NCT02489019|Fentanyl|fentanyl
275021|NCT02489019|Elderly|elderly
275022|NCT02488980|Falciparum Parasitaemia, Malaria|falciparum parasitaemia, malaria
275023|NCT02488954|Ulcerative colitis|ulcerative colitis
275024|NCT02488954|Probiotics|probiotics
275025|NCT02488954|treatments|treatments
275026|NCT02488954|Propionibacterium freudenreichii|propionibacterium freudenreichii
275027|NCT02488941|Liver Function Tests|liver function tests
275028|NCT02488941|Blood Coagulation|blood coagulation
275029|NCT02488928|NSCLC|nsclc
275030|NCT02488928|EBUS|ebus
275031|NCT02488928|elastography|elastography
275032|NCT02488928|predictive value|predictive value
275033|NCT02488928|strain|strain
275034|NCT02488915|Brain|brain
275035|NCT02488915|Brain Clot|brain clot
275036|NCT02488915|Brain Diseases|brain diseases
275037|NCT02488915|Brain Infarction|brain infarction
275038|NCT02488915|Cerebral Ischemia|cerebral ischemia
275039|NCT02488915|Cerebrovascular Disorders|cerebrovascular disorders
275040|NCT02488915|EmboTrap® Revascularization Device|embotrap® revascularization device
275041|NCT02488915|EmboTrap|embotrap
275042|NCT02488915|Ischemia|ischemia
275043|NCT02488915|Ischemic|ischemic
275044|NCT02488915|Ischemic Stroke|ischemic stroke
275045|NCT02488915|Mechanical Thrombectomy|mechanical thrombectomy
275046|NCT02488915|Neurovascular Intervention|neurovascular intervention
275047|NCT02488915|Revascularization|revascularization
275048|NCT02488915|Stent Retriever|stent retriever
275049|NCT02488915|Stroke|stroke
275050|NCT02488915|Vascular Diseases|vascular diseases
275051|NCT02488915|Neuravi|neuravi
275052|NCT02488889|Chantix|chantix
275053|NCT02488876|Cardiac surgery|cardiac surgery
275054|NCT02488876|Tissue sample database|tissue sample database
275055|NCT02488876|Inflammatory responds|inflammatory responds
275056|NCT02488863|Older adults|older adults
275057|NCT02488863|Chronic Pain|chronic pain
275058|NCT02488863|Musculoskeletal|musculoskeletal
275059|NCT02488850|immune monitoring|immune monitoring
275060|NCT02488850|T cell activation|t cell activation
275061|NCT02488850|early stage|early stage
275062|NCT02488837|Deep Brain Stimulation|deep brain stimulation
275063|NCT02488824|Quadriplegia|quadriplegia
275064|NCT02488824|Paraplegia|paraplegia
275065|NCT02488824|Spinal Cord Injury|spinal cord injury
275066|NCT02488824|Body Temperature Regulation|body temperature regulation
275067|NCT02488824|Mild Cognitive Impairment|mild cognitive impairment
275068|NCT02488785|Type 2 Diabetes Mellitus|type 2 diabetes mellitus
275069|NCT02488785|Telehealth|telehealth
275070|NCT02488785|Hispanics|hispanics
275071|NCT02488785|Latinos|latinos
275072|NCT02488785|Self-Care|self-care
275073|NCT02488785|Mobile Health|mobile health
275074|NCT02488785|mHealth|mhealth
275075|NCT02488772|sleep quality|sleep quality
275076|NCT02488772|emergency department|emergency department
275077|NCT02488733|type 2 diabetes mellitus|type 2 diabetes mellitus
275078|NCT02488733|obesity|obesity
275079|NCT02488733|laparoscopic sleeve gastrectomy|laparoscopic sleeve gastrectomy
275080|NCT02488733|bariatric surgery|bariatric surgery
275081|NCT02488733|metabolic surgery|metabolic surgery
275082|NCT02488720|amyloid imaging|amyloid imaging
275083|NCT02488720|biomarkers|biomarkers
275084|NCT02488720|cognition|cognition
275085|NCT02488720|longitudinal|longitudinal
275086|NCT02488720|cognitive decline|cognitive decline
275087|NCT02488720|observational|observational
275088|NCT02488707|low rectal cancer|low rectal cancer
275089|NCT02488707|minimally invasive colorectal surgery|minimally invasive colorectal surgery
275090|NCT02488707|trans-anal endoscopic microsurgery|trans-anal endoscopic microsurgery
275092|NCT02488707|intersphincteric resection|intersphincteric resection
275093|NCT02488707|ISR|isr
275094|NCT02488707|subtotal intersphincteric resection|subtotal intersphincteric resection
275095|NCT02488707|total intersphincteric resection|total intersphincteric resection
275096|NCT02488707|trans-anal trans-abdominal resection|trans-anal trans-abdominal resection
275097|NCT02488707|laparoscopic intersphincteric resection|laparoscopic intersphincteric resection
275098|NCT02488707|anal sphincter preservation|anal sphincter preservation
275099|NCT02488707|total mesorectal excision|total mesorectal excision
275100|NCT02488707|TME|tme
275101|NCT02488707|TATA|tata
275102|NCT02488707|laparoscopic total mesorectal excision|laparoscopic total mesorectal excision
275103|NCT02488707|external sphincter preservation|external sphincter preservation
275104|NCT02488707|Neoadjuvant chemo-radiotherapy for rectal cancer|neoadjuvant chemo-radiotherapy for rectal cancer
275105|NCT02488707|fit patients for minimally invasive surgery|fit patients for minimally invasive surgery
275106|NCT02488668|Transcutaneous Electrical Stimulation|transcutaneous electrical stimulation
275107|NCT02488668|Neuroplasticity|neuroplasticity
275108|NCT02488668|Sensory Feedback|sensory feedback
275109|NCT02488642|Isosorbide dinitrate gel solution|isosorbide dinitrate gel solution
275110|NCT02488642|late intrauterine death|late intrauterine death
275111|NCT02488642|nitric oxide donors|nitric oxide donors
275112|NCT02488629|Head and neck squamous cell carcinoma|head and neck squamous cell carcinoma
275113|NCT02488616|Closed-loop system|closed-loop system
275114|NCT02488616|Artificial pancreas|artificial pancreas
275115|NCT02488616|Type 1 diabetes|type 1 diabetes
275116|NCT02488616|Hypoglycemia|hypoglycemia
275117|NCT02488616|Insulin|insulin
275118|NCT02488603|Breast Neoplasms|breast neoplasms
275119|NCT02488603|Tamoxifen|tamoxifen
275120|NCT02488603|Decision Aids|decision aids
275121|NCT02488564|HER-2 Positive Breast Cancer|her-2 positive breast cancer
275122|NCT02488564|operable breast cancer|operable breast cancer
275123|NCT02488564|locally advanced breast cancer|locally advanced breast cancer
275124|NCT02488564|no prior therapy|no prior therapy
275125|NCT02488564|pCR|pcr
275126|NCT02488525|Acquired Von Willebrand|acquired von willebrand
275127|NCT02488525|Gastro-intestinal bleeding|gastro-intestinal bleeding
275129|NCT02488512|Relapsed/refractory diffuse large b cell|relapsed/refractory diffuse large b cell
275130|NCT02488512|Relapsed/refractory mantle cell lymphomas|relapsed/refractory mantle cell lymphomas
275131|NCT02488512|DLBCL|dlbcl
275132|NCT02488512|MCL|mcl
275133|NCT02488512|90Y-DOTATOC|90y-dotatoc
275134|NCT02488512|SSR-positive tumour|ssr-positive tumour
275135|NCT02488499|Disruptive Behaviour Disorder|disruptive behaviour disorder
275136|NCT02488499|Psychosocial|psychosocial
275137|NCT02488499|Group Treatment|group treatment
275138|NCT02488473|Volunteers|volunteers
275139|NCT02488460|Motor Activity|motor activity
275140|NCT02488460|Cognition|cognition
275141|NCT02488460|Academic Acheivement|academic acheivement
275142|NCT02488460|Preadolescent Children|preadolescent children
275143|NCT02488447|Allergy|allergy
275144|NCT02488447|Allergic rhinoconjunctivitis|allergic rhinoconjunctivitis
275145|NCT02488447|Immunotherapy|immunotherapy
275146|NCT02488447|Life Quality|life quality
275147|NCT02488447|Adherence|adherence
275148|NCT02488434|ICSI|icsi
275149|NCT02488434|sperm selection|sperm selection
275150|NCT02488434|fertile chip|fertile chip
275151|NCT02488434|ıcsı outcomes|ıcsı outcomes
275152|NCT02488395|Parkinson's disease|parkinson's disease
275153|NCT02488395|Non-motor symptoms|non-motor symptoms
275154|NCT02488395|Visual deficits|visual deficits
275155|NCT02488395|Superior colliculus|superior colliculus
275156|NCT02488395|fMRI|fmri
275157|NCT02488382|lymphoma|lymphoma
275158|NCT02488382|multiple myeloma|multiple myeloma
275159|NCT02488382|stem cell mobilization|stem cell mobilization
275160|NCT02488382|autologous stem cell transplantation|autologous stem cell transplantation
275161|NCT02488369|Children and adolescents|children and adolescents
275162|NCT02488343|Multiple Sclerosis|multiple sclerosis
275163|NCT02488343|Adherence|adherence
275164|NCT02488343|Therapies|therapies
275165|NCT02488343|Psychological Intervention|psychological intervention
275166|NCT02488317|Chronic Kidney Disease|chronic kidney disease
275167|NCT02488317|Hemodialysis|hemodialysis
275168|NCT02488317|Peritoneal Dialysis|peritoneal dialysis
275169|NCT02488304|HRCT|hrct
275170|NCT02488304|High Resolution Computed Tomography scans|high resolution computed tomography scans
275171|NCT02488304|Functional Respiratory Imaging|functional respiratory imaging
275172|NCT02488304|FRI|fri
275173|NCT02488304|Computed Tomography|computed tomography
275174|NCT02488304|CT|ct
275175|NCT02488304|Bronchiolitis Obliterans Syndrome|bronchiolitis obliterans syndrome
275176|NCT02488304|BOS|bos
275177|NCT02488304|Lung Transplant|lung transplant
275178|NCT02488291|Epidural|epidural
275179|NCT02488291|Analgesia labor|analgesia labor
275180|NCT02488291|Perinatal|perinatal
275181|NCT02488291|anesthesia|anesthesia
275182|NCT02488278|Glucose blood measurements, glucometers ,audio communication|glucose blood measurements, glucometers ,audio communication
275183|NCT02488265|Parkinson´s disease|parkinson´s disease
275184|NCT02488265|Physicaltherapy|physicaltherapy
275185|NCT02488265|Postural Balance|postural balance
275186|NCT02488265|Gait|gait
275187|NCT02488265|Rehabilitation|rehabilitation
275188|NCT02488252|Chinese Medicine|chinese medicine
275189|NCT02488252|ACEI|acei
275190|NCT02488252|ARB|arb
275191|NCT02488252|Pragmatic trial|pragmatic trial
275192|NCT02488213|Nutritional Counseling|nutritional counseling
275193|NCT02488213|Diet|diet
275194|NCT02488187|Breast Cancer|breast cancer
275195|NCT02488187|MRI|mri
275196|NCT02488187|Mammogram|mammogram
275197|NCT02488187|Whole Breast Sonogram|whole breast sonogram
275198|NCT02488187|ABUS|abus
275199|NCT02488161|Colorectal cancer|colorectal cancer
275200|NCT02488161|Risk factors|risk factors
275201|NCT02488161|Adverse events|adverse events
275202|NCT02488161|Predictive models|predictive models
275203|NCT02488122|Bone Mineral Density|bone mineral density
275204|NCT02488122|Isometric Exercise|isometric exercise
275205|NCT02488122|Bone Growth|bone growth
275206|NCT02488109|anorexia nervosa|anorexia nervosa
275207|NCT02488109|eating disorders|eating disorders
275208|NCT02488109|refeeding|refeeding
275209|NCT02488109|adolescent medicine|adolescent medicine
275210|NCT02488109|nutritional rehabilitation|nutritional rehabilitation
275211|NCT02488083|non-invasive|non-invasive
275212|NCT02488031|SCA, dysmetria|sca, dysmetria
275213|NCT02488018|Glycemic index|glycemic index
275214|NCT02488018|honey|honey
275215|NCT02488018|reference glucose|reference glucose
275216|NCT02488005|Inflammatory Bowel Disease|inflammatory bowel disease
275217|NCT02488005|Small Bowel|small bowel
275218|NCT02488005|Crohn's Disease|crohn's disease
275219|NCT02488005|Small Bowel Ultrasound|small bowel ultrasound
275220|NCT02487966|tDCS|tdcs
275221|NCT02487966|Mirror Therapy|mirror therapy
275222|NCT02487966|Phantom Limb Pain|phantom limb pain
275223|NCT02487966|Traumatic amputation|traumatic amputation
275224|NCT02487953|Nicotine addiction|nicotine addiction
275225|NCT02487953|Cigarette smoking|cigarette smoking
275226|NCT02487953|Smoking cessation|smoking cessation
275227|NCT02487953|Nicotine patches|nicotine patches
275228|NCT02487953|E-cigarettes|e-cigarettes
275229|NCT02487940|Recurrent implantation failure|recurrent implantation failure
275230|NCT02487940|IVF|ivf
275231|NCT02487940|ICSI|icsi
275232|NCT02487940|Intralipid|intralipid
275233|NCT02487914|Drug Delivery|drug delivery
275234|NCT02487914|Iontophoresis|iontophoresis
275235|NCT02487914|Lidocaine|lidocaine
275236|NCT02487914|Pressure|pressure
275237|NCT02487914|Tactile perception|tactile perception
275238|NCT02487901|arthrodesiss|arthrodesiss
275239|NCT02487901|cervical vertebra|cervical vertebra
275240|NCT02487901|laminoplasty|laminoplasty
275241|NCT02487888|Genetic Variation|genetic variation
275242|NCT02487888|Genetic Polymorphism|genetic polymorphism
275243|NCT02487888|Polymorphism, Single Nucleotide|polymorphism, single nucleotide
275244|NCT02487888|Genetic Association Studies|genetic association studies
275245|NCT02487888|Healthcare Utilization|healthcare utilization
275246|NCT02487875|Sit-to-stand test|sit-to-stand test
275247|NCT02487875|Muscle strength|muscle strength
275248|NCT02487875|Pulmonary rehabilitation|pulmonary rehabilitation
275249|NCT02487836|Laying of the biliary stent|laying of the biliary stent
275250|NCT02487771|DHA|dha
275251|NCT02487771|childhood development|childhood development
275252|NCT02487745|Cocaine|cocaine
275253|NCT02487745|Methadone|methadone
275254|NCT02487745|Employment|employment
275255|NCT02487745|Opioids|opioids
275256|NCT02487732|Diabetic Patients With Non-ST Elevation|diabetic patients with non-st elevation
743979|NCT00459888|Cryoplasty|cryoplasty
275257|NCT02487719|Iron deficiecy|iron deficiecy
275258|NCT02487719|pregnancy|pregnancy
275259|NCT02487719|prenatal care|prenatal care
275260|NCT02487706|Hemodialysis|hemodialysis
275261|NCT02487706|HIV-infection|hiv-infection
275262|NCT02487654|Paroxysmal atrial fibrillation|paroxysmal atrial fibrillation
275263|NCT02487654|Pulmonary vein isolation|pulmonary vein isolation
275264|NCT02487654|Ganglionic plexi|ganglionic plexi
275265|NCT02487654|Radiofrequency|radiofrequency
275266|NCT02487654|late gadolinium enhancement cardiac MR imaging|late gadolinium enhancement cardiac mr imaging
275267|NCT02487654|High Frequency Stimulation|high frequency stimulation
275268|NCT02487641|Ultrasound|ultrasound
275269|NCT02487641|mid-trimester|mid-trimester
275270|NCT02487641|Obesity|obesity
275271|NCT02487641|pregnancy|pregnancy
275272|NCT02487615|Glycaemia|glycaemia
275273|NCT02487615|Subclinical Atherosclerosis|subclinical atherosclerosis
275274|NCT02487615|Carotid Doppler Ultrasound|carotid doppler ultrasound
275275|NCT02487615|Carotid Plaque|carotid plaque
275276|NCT02487615|Intima Media Thickness|intima media thickness
275277|NCT02487615|Ankle Brachial Index|ankle brachial index
275278|NCT02487615|Exercise Stress Test|exercise stress test
275279|NCT02487615|Coronary Calcium Score|coronary calcium score
275280|NCT02487615|Insulinemia|insulinemia
275281|NCT02487615|Leptin|leptin
275282|NCT02487615|Inflammation|inflammation
275283|NCT02487615|Resistin|resistin
275284|NCT02487615|Tumor Necrosis Factor alpha|tumor necrosis factor alpha
275285|NCT02487615|Phospholipase A2, Group VII|phospholipase a2, group vii
275286|NCT02487615|Body Mass Index|body mass index
275287|NCT02487615|Adipose Tissue Function|adipose tissue function
275288|NCT02487615|Single Gene Polymorphism|single gene polymorphism
275289|NCT02487589|Falls|falls
275290|NCT02487589|Elderly|elderly
275291|NCT02487589|e-Health|e-health
275292|NCT02487589|Telemedicine|telemedicine
275293|NCT02487563|Isolated thrombocytopenia|isolated thrombocytopenia
275294|NCT02487563|decitabine|decitabine
275295|NCT02487563|rhTPO|rhtpo
275296|NCT02487550|Renal neoplasma|renal neoplasma
275297|NCT02487550|CIK cells|cik cells
275298|NCT02487537|incretin release|incretin release
275299|NCT02487524|Neuropathic Pain|neuropathic pain
275300|NCT02487524|Breast Cancer|breast cancer
275301|NCT02487524|Post surgical|post surgical
275302|NCT02487498|Chronic Obstructive Pulmonary Disease (COPD)|chronic obstructive pulmonary disease (copd)
275303|NCT02487472|France|france
275304|NCT02487472|Post-herpetic neuralgia|post-herpetic neuralgia
275305|NCT02487472|Herpes zoster|herpes zoster
275306|NCT02487472|Economic burden of disease|economic burden of disease
275307|NCT02487459|acute lymphoblastic leukemia|acute lymphoblastic leukemia
275308|NCT02487459|acute myeloid leukemia|acute myeloid leukemia
275309|NCT02487459|chronic myeloid leukemia|chronic myeloid leukemia
275310|NCT02487459|myelodysplastic syndrome|myelodysplastic syndrome
275311|NCT02487459|non-hodgkin lymphoma|non-hodgkin lymphoma
275312|NCT02487459|hodgkin lymphoma|hodgkin lymphoma
275313|NCT02487446|Chronic Obstructive Pulmonary Disease (COPD)|chronic obstructive pulmonary disease (copd)
275314|NCT02487433|food effect|food effect
275315|NCT02487433|pharmacokinetics|pharmacokinetics
275316|NCT02487433|healthy volunteers|healthy volunteers
275317|NCT02487381|delta-9-tetrahydrocannabinol|delta-9-tetrahydrocannabinol
275318|NCT02487381|cannabidiol|cannabidiol
275319|NCT02487381|COMT|comt
275320|NCT02487381|Volunteers|volunteers
275321|NCT02487355|dexmedetomidine|dexmedetomidine
275322|NCT02487355|magnesium sulphate|magnesium sulphate
275323|NCT02487342|Dairy|dairy
275324|NCT02487342|appetite|appetite
275325|NCT02487342|feeding behaviour|feeding behaviour
275326|NCT02487329|Direct pulp capping|direct pulp capping
275627|NCT02485743|satiety|satiety
275327|NCT02487329|Er,Cr:YSGG laser|er,cr:ysgg laser
275328|NCT02487329|Tricalcium silicate|tricalcium silicate
275329|NCT02487316|Anaplastic Large Cell Lymphoma|anaplastic large cell lymphoma
275330|NCT02487316|anaplastic lymphoma kinase rearrangement|anaplastic lymphoma kinase rearrangement
275331|NCT02487316|crizotinib|crizotinib
275332|NCT02487316|CHOP chemotherapy|chop chemotherapy
275333|NCT02487303|Acetaminophen|acetaminophen
275334|NCT02487303|Pain, Postoperative|pain, postoperative
275335|NCT02487303|Analgesia, Obstetrical|analgesia, obstetrical
275336|NCT02487303|Cesarean Section|cesarean section
275337|NCT02487290|AAA|aaa
275338|NCT02487290|Endoleak|endoleak
275339|NCT02487277|Pancreatic|pancreatic
275340|NCT02487251|Obesity|obesity
275341|NCT02487251|Family Mealtimes|family mealtimes
275342|NCT02487251|Prevention|prevention
275343|NCT02487238|Microbiome|microbiome
275344|NCT02487238|Microbiota|microbiota
275345|NCT02487238|Fecal Microbial Transplant|fecal microbial transplant
275346|NCT02487238|Fecal Microbiota Transplant|fecal microbiota transplant
275347|NCT02487238|FMT|fmt
275348|NCT02487238|Gastroenterology|gastroenterology
275349|NCT02487238|IBD|ibd
275350|NCT02487238|Inflammatory Bowel Disease|inflammatory bowel disease
275351|NCT02487238|Ulcerative Colitis|ulcerative colitis
275352|NCT02487238|UC|uc
400510|NCT01866553|pegylated interferon α2b|pegylated interferon α2b
275353|NCT02487238|Inflammatory Bowel Disease Unclassified|inflammatory bowel disease unclassified
275354|NCT02487238|IBD-U|ibd-u
275355|NCT02487238|Rebiotix|rebiotix
275356|NCT02487238|RBX2660|rbx2660
275357|NCT02487238|Pediatrics|pediatrics
275358|NCT02487238|McMaster Children's Hospital|mcmaster children's hospital
275359|NCT02487238|Centre Hospitalier Universitaire Sainte-Justine|centre hospitalier universitaire sainte-justine
275360|NCT02487238|Children's Hospital at London Health Sciences Centre|children's hospital at london health sciences centre
275361|NCT02487225|Post-Endoscopic Retrograde Cholangiopancreatography (ERCP) pancreatitis|post-endoscopic retrograde cholangiopancreatography (ercp) pancreatitis
275362|NCT02487212|fractional laser|fractional laser
275363|NCT02487212|hypertrophic scar|hypertrophic scar
275364|NCT02487212|topical corticosteroid|topical corticosteroid
275365|NCT02487212|laser assisted delivery systems|laser assisted delivery systems
275366|NCT02487199|hepatitis C infection|hepatitis c infection
275367|NCT02487199|hepatitis C|hepatitis c
275368|NCT02487199|severe kidney disease|severe kidney disease
275369|NCT02487199|chronic kidney disease|chronic kidney disease
275370|NCT02487199|Genotype 1a|genotype 1a
275371|NCT02487199|Genotype 4|genotype 4
275372|NCT02487199|treatment experienced|treatment experienced
275373|NCT02487199|interferon|interferon
275374|NCT02487199|IFN|ifn
275375|NCT02487199|pegIFN|pegifn
275376|NCT02487186|Chronic periodontitis|chronic periodontitis
275377|NCT02487186|Local doxycycline|local doxycycline
275378|NCT02487186|Ultrasonic debridement|ultrasonic debridement
275379|NCT02487186|PLGA microspheres|plga microspheres
275380|NCT02487186|Microbiologic assessment|microbiologic assessment
275381|NCT02487147|Live Attenuated Influenza Vaccine (FluMist)|live attenuated influenza vaccine (flumist)
275382|NCT02487147|Free Air Portable Air Powered Respirator|free air portable air powered respirator
275383|NCT02487147|N95 Respirator|n95 respirator
275384|NCT02487147|Personal Protective Equipment|personal protective equipment
275385|NCT02487147|Viral Transmission|viral transmission
275386|NCT02487121|weight loss|weight loss
275387|NCT02487095|RB1 Inactivation|rb1 inactivation
275388|NCT02487095|Kinase Inhibitor|kinase inhibitor
275389|NCT02487095|DNA Damage Response Network|dna damage response network
275390|NCT02487095|MYC And CCNE1 Activation|myc and ccne1 activation
275391|NCT02487095|Defective ATM-p53 Signaling Pathway|defective atm-p53 signaling pathway
275392|NCT02487082|Autism Spectrum Disorder|autism spectrum disorder
275393|NCT02487082|Children|children
275394|NCT02487082|Melatonin|melatonin
275395|NCT02487082|Donepezil|donepezil
275396|NCT02487082|Sleep disorder|sleep disorder
275397|NCT02487056|Heart Failure|heart failure
275398|NCT02487056|Diagnosis|diagnosis
275399|NCT02487056|Management|management
275400|NCT02487043|Caries prevention|caries prevention
275401|NCT02487043|Early Childhood Caries|early childhood caries
275402|NCT02487030|HCV genotype 4 (GT-4)|hcv genotype 4 (gt-4)
275403|NCT02487030|HCV|hcv
275404|NCT02487030|Sustained Virologic Response|sustained virologic response
275405|NCT02487030|Direct Acting Antiviral|direct acting antiviral
275406|NCT02487030|Combination Therapy|combination therapy
275407|NCT02487030|GS-7977|gs-7977
275408|NCT02487030|GS-5885|gs-5885
275409|NCT02487030|Ribavirin|ribavirin
275410|NCT02487030|Sofosbuvir|sofosbuvir
275411|NCT02487030|ledipasvir|ledipasvir
275412|NCT02487030|Hepatitis C|hepatitis c
275413|NCT02487030|Hepatitis C, Chronic|hepatitis c, chronic
275414|NCT02487030|Liver Diseases|liver diseases
275415|NCT02487030|Virus Diseases|virus diseases
275416|NCT02487030|Antiviral Agents|antiviral agents
275417|NCT02486965|VAS|vas
275418|NCT02486965|thermode test|thermode test
275419|NCT02486965|training program|training program
275420|NCT02486965|6MWT|6mwt
275421|NCT02486913|Primary prevention|primary prevention
275422|NCT02486913|National Health Service Health Check|national health service health check
275423|NCT02486900|Craving|craving
275424|NCT02486900|Cue Reactivity|cue reactivity
275425|NCT02486900|Neurofeedback|neurofeedback
275426|NCT02486887|telemonitoring|telemonitoring
275427|NCT02486874|Human acellular dermal matrix, burns, wound healing|human acellular dermal matrix, burns, wound healing
275428|NCT02486861|Tomography, Optical Coherence|tomography, optical coherence
275429|NCT02486848|Hairloss|hairloss
275430|NCT02486848|Female Pattern Hair Loss|female pattern hair loss
275431|NCT02486848|Androgenetic Alopecia|androgenetic alopecia
275432|NCT02486848|Minoxidil|minoxidil
275433|NCT02486822|Labor scale|labor scale
275434|NCT02486822|Partograph|partograph
275435|NCT02486822|Spontaneous labor|spontaneous labor
275436|NCT02486822|Primigravida|primigravida
275437|NCT02486744|Acthar|acthar
275438|NCT02486744|Dialysis|dialysis
275439|NCT02486744|Kidney|kidney
275440|NCT02486744|Non-Diabetic|non-diabetic
275441|NCT02486731|Hormonal sensitivity|hormonal sensitivity
275442|NCT02486731|bone growth|bone growth
275443|NCT02486705|ptsd|ptsd
275444|NCT02486705|family|family
275445|NCT02486705|caregiver|caregiver
275446|NCT02486705|burden|burden
275447|NCT02486692|Mental Health|mental health
275448|NCT02486692|PTSD|ptsd
275449|NCT02486692|Stigma|stigma
275450|NCT02486692|Peer Education|peer education
275451|NCT02486692|Web Education|web education
275452|NCT02486692|Self Help|self help
275453|NCT02486666|Enoxaparin|enoxaparin
275454|NCT02486666|thrombosis|thrombosis
275455|NCT02486666|neonate|neonate
275456|NCT02486666|RCT|rct
275457|NCT02486653|tamsulosin|tamsulosin
275458|NCT02486653|randomized controlled trials as topic|randomized controlled trials as topic
275459|NCT02486653|double-blind method|double-blind method
275460|NCT02486653|random allocation|random allocation
275461|NCT02486653|placebos|placebos
275462|NCT02486653|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists
275463|NCT02486653|urinary retention|urinary retention
275464|NCT02486653|urinary tract infections|urinary tract infections
275465|NCT02486653|urinary catheters|urinary catheters
275466|NCT02486653|catheter-related infections|catheter-related infections
275467|NCT02486653|postoperative complications|postoperative complications
275468|NCT02486640|RRMS, CIS|rrms, cis
275469|NCT02486627|cUTI|cuti
275470|NCT02486627|AP|ap
275471|NCT02486627|ACHN-490|achn-490
275472|NCT02486627|anti-infective|anti-infective
275473|NCT02486627|anti-bacterial|anti-bacterial
275474|NCT02486627|antibiotic|antibiotic
275475|NCT02486627|anti-microbial|anti-microbial
275476|NCT02486627|UTI|uti
275477|NCT02486627|bacterial infection|bacterial infection
275478|NCT02486627|Gram-negative|gram-negative
275479|NCT02486588|Financial incentives|financial incentives
275480|NCT02486588|Messaging|messaging
275481|NCT02486575|Residents|residents
275482|NCT02486575|Training|training
275483|NCT02486575|simulation|simulation
275484|NCT02486575|mentoring|mentoring
275485|NCT02486575|proctor|proctor
275486|NCT02486562|Multiple Sclerosis|multiple sclerosis
275487|NCT02486562|MS|ms
275488|NCT02486549|Pain|pain
275489|NCT02486549|Anesthesia Recovery Period|anesthesia recovery period
275490|NCT02486549|Brachial Plexus|brachial plexus
275491|NCT02486536|capsule endoscopy|capsule endoscopy
275492|NCT02486536|polyethylene glycol|polyethylene glycol
275493|NCT02486536|bowel preparation solutions|bowel preparation solutions
275494|NCT02486523|SAM, severe acute malnutrition|sam, severe acute malnutrition
275495|NCT02486510|HIV-1|hiv-1
275496|NCT02486510|CCR5 coreceptors|ccr5 coreceptors
275497|NCT02486510|Maraviroc|maraviroc
275498|NCT02486497|Pancreatic cancer|pancreatic cancer
275499|NCT02486497|Adjuvant chemotherapy|adjuvant chemotherapy
275500|NCT02486497|hENT1|hent1
275501|NCT02486497|Gemcitabine|gemcitabine
275502|NCT02486484|macular degeneration|macular degeneration
275503|NCT02486484|diabetic retinopathy|diabetic retinopathy
275504|NCT02486484|macular edema|macular edema
275505|NCT02486484|retinal vein occlusion|retinal vein occlusion
275506|NCT02486484|choroidal neovascularization|choroidal neovascularization
275507|NCT02486471|cervical dysplasia|cervical dysplasia
275508|NCT02486471|colposcopy|colposcopy
275509|NCT02486471|haemostatic procedure|haemostatic procedure
275510|NCT02486471|biopsy of the cervix uteri|biopsy of the cervix uteri
275511|NCT02486458|Fluoride|fluoride
275512|NCT02486458|Biofilm fluid|biofilm fluid
275513|NCT02486458|Calcium fluoride|calcium fluoride
275514|NCT02486458|Topical|topical
275515|NCT02486445|Deep venous thrombosis|deep venous thrombosis
275516|NCT02486445|Rivaroxaban|rivaroxaban
275517|NCT02486406|Hepatitis C Virus|hepatitis c virus
275518|NCT02486406|Hepatitis C Genotype 1|hepatitis c genotype 1
275519|NCT02486406|Hepatitis C Genotype 4|hepatitis c genotype 4
275520|NCT02486406|Pediatric|pediatric
275521|NCT02486341|continuous glucose monitoring system|continuous glucose monitoring system
275522|NCT02486341|basal insulin|basal insulin
275523|NCT02486341|diabetes mellitus|diabetes mellitus
275524|NCT02486341|elderly|elderly
275525|NCT02486328|Cognitive dysfunction|cognitive dysfunction
275526|NCT02486328|Colonoscopy|colonoscopy
275527|NCT02486328|Sedation|sedation
275528|NCT02486315|coronary bifurcation|coronary bifurcation
275529|NCT02486315|coronary stent|coronary stent
275530|NCT02486289|Mercury toxicity poisoning|mercury toxicity poisoning
275531|NCT02486263|infant|infant
275532|NCT02486263|esophagitis|esophagitis
275533|NCT02486263|neonate|neonate
275534|NCT02486263|GERD|gerd
275535|NCT02486237|diabetes mellitus|diabetes mellitus
275536|NCT02486237|complications|complications
275537|NCT02486237|prevalence|prevalence
275538|NCT02486224|deep sea mineral water|deep sea mineral water
275539|NCT02486224|exercise recovery|exercise recovery
275540|NCT02486224|hydration|hydration
275541|NCT02486224|salivary osmolar concentration|salivary osmolar concentration
275542|NCT02486224|urinary osmolar concentration|urinary osmolar concentration
275543|NCT02486211|heart arrest|heart arrest
275544|NCT02486211|resuscitation|resuscitation
275545|NCT02486211|seizures|seizures
275546|NCT02486211|hypothermia, induced|hypothermia, induced
275547|NCT02486211|Amantadine|amantadine
275548|NCT02486198|Gastrointestinal cancer|gastrointestinal cancer
275549|NCT02486198|oxaliplatin|oxaliplatin
275550|NCT02486198|neurotoxicity|neurotoxicity
275551|NCT02486120|Genetic Counseling|genetic counseling
275552|NCT02486120|Clinical Decision-Making|clinical decision-making
275553|NCT02486107|cervical vertebra|cervical vertebra
275554|NCT02486107|surgery|surgery
275555|NCT02486107|tubular retractor|tubular retractor
275556|NCT02486107|endoscope|endoscope
275557|NCT02486094|Imaging, Magnetic Resonance|imaging, magnetic resonance
275558|NCT02486094|Rectal Cancer|rectal cancer
275559|NCT02486094|Apoptosis|apoptosis
275560|NCT02486094|Proliferation|proliferation
275561|NCT02486094|Cancer|cancer
275562|NCT02486094|Tissue Study|tissue study
275563|NCT02486081|Assistive device|assistive device
275564|NCT02486081|the disabled|the disabled
275565|NCT02486081|special education|special education
275566|NCT02486081|movement analysis|movement analysis
275567|NCT02486081|system development|system development
275568|NCT02486055|Study safety of BPM31510 in healthy subjects|study safety of bpm31510 in healthy subjects
275569|NCT02486042|ROP|rop
275570|NCT02486042|Premature infant|premature infant
275571|NCT02486016|Bioequivalence|bioequivalence
275572|NCT02486016|Therapeutic Equivalency|therapeutic equivalency
275573|NCT02485990|Fallopian Tube|fallopian tube
275574|NCT02485990|Epithelial Ovarian|epithelial ovarian
275575|NCT02485990|EOC|eoc
275576|NCT02485977|Pulmonary hypertension|pulmonary hypertension
275577|NCT02485977|Magnetic Resonance Imaging|magnetic resonance imaging
275578|NCT02485964|Vaccine|vaccine
275579|NCT02485951|deep anterior lamellar keratoplasty|deep anterior lamellar keratoplasty
275580|NCT02485951|big-bubble technique|big-bubble technique
275581|NCT02485951|peripheral air injection|peripheral air injection
275582|NCT02485951|keratoconus|keratoconus
275583|NCT02485938|Duchenne Muscular Dystrophy|duchenne muscular dystrophy
275584|NCT02485938|Cardiomyopathy|cardiomyopathy
275585|NCT02485925|Interventional|interventional
275586|NCT02485925|Radiofrequency ablation|radiofrequency ablation
275587|NCT02485925|Paroxysmal Atrial Fibrillation|paroxysmal atrial fibrillation
275588|NCT02485925|Catheter ablation|catheter ablation
275589|NCT02485912|Ebola|ebola
275590|NCT02485912|vaccine|vaccine
275591|NCT02485912|safety|safety
275592|NCT02485912|immunogenicity|immunogenicity
275593|NCT02485899|Late infantile Neuronal Ceroid Lipofuscinosis Type 2|late infantile neuronal ceroid lipofuscinosis type 2
275594|NCT02485899|LINCL|lincl
275595|NCT02485899|NCL2|ncl2
275596|NCT02485899|CLN2|cln2
275597|NCT02485899|Jansky-Bielschowsky disease|jansky-bielschowsky disease
275598|NCT02485886|PET|pet
275599|NCT02485886|interstitial pulmonary fibrosis (IPF)|interstitial pulmonary fibrosis (ipf)
275600|NCT02485886|cysteine cathepsins|cysteine cathepsins
275601|NCT02485886|macrophage|macrophage
275602|NCT02485873|Non-valvular atrial fibrillation (NVAF)|non-valvular atrial fibrillation (nvaf)
275603|NCT02485873|Pevention|pevention
275604|NCT02485873|Stroke|stroke
275605|NCT02485860|pilonidal cysts|pilonidal cysts
275606|NCT02485860|Cavity wound|cavity wound
275607|NCT02485860|long healing|long healing
275608|NCT02485860|honey|honey
275609|NCT02485847|Eye Diseases|eye diseases
275610|NCT02485821|Estradiol|estradiol
275611|NCT02485821|Misoprostol|misoprostol
275612|NCT02485821|Induction of labor|induction of labor
275613|NCT02485821|Cervical ripening|cervical ripening
275614|NCT02485821|Bishop score|bishop score
275615|NCT02485808|Lower Urinary Tract Symptoms|lower urinary tract symptoms
275616|NCT02485808|Bladder Symptoms|bladder symptoms
275617|NCT02485808|Overactive Bladder|overactive bladder
275618|NCT02485808|Urinary Urgency|urinary urgency
275619|NCT02485808|Lower Urinary Tract Dysfunction|lower urinary tract dysfunction
275620|NCT02485795|Pain Management|pain management
275621|NCT02485795|Genetic Variation|genetic variation
275622|NCT02485795|Genetic Polymorphism|genetic polymorphism
275623|NCT02485795|Polymorphism, Single Nucleotide Genetic Association Studies|polymorphism, single nucleotide genetic association studies
275624|NCT02485795|Healthcare Utilization|healthcare utilization
275625|NCT02485756|Drug interactions|drug interactions
275626|NCT02485743|satiation|satiation
275628|NCT02485743|weight loss|weight loss
275629|NCT02485743|maintained weight loss|maintained weight loss
275630|NCT02485730|Prevention|prevention
275631|NCT02485730|Cohort Analysis|cohort analysis
275632|NCT02485730|Healthy Participants|healthy participants
275633|NCT02485678|ambulatory toxicity management|ambulatory toxicity management
275634|NCT02485678|adjuvant or neoadjuvant chemotherapy|adjuvant or neoadjuvant chemotherapy
275635|NCT02485665|Prostate cancer|prostate cancer
275636|NCT02485665|Robot-assisted laparoscopic surgery|robot-assisted laparoscopic surgery
275637|NCT02485665|Radical prostatectomy|radical prostatectomy
275638|NCT02485665|Post-prostatectomy incontinence|post-prostatectomy incontinence
275639|NCT02485665|Pelvic floor muscle exercise|pelvic floor muscle exercise
275640|NCT02485665|Extracorporeal biofeedback device|extracorporeal biofeedback device
275642|NCT02485652|EGFR-TKI|egfr-tki
275643|NCT02485652|non small cell lung cancer|non small cell lung cancer
275644|NCT02485652|HM61713|hm61713
275645|NCT02485652|T790M-positive|t790m-positive
275646|NCT02485652|lung cancer|lung cancer
275647|NCT02485652|Phase II|phase ii
275648|NCT02485652|Olmutinib|olmutinib
744084|NCT00459511|Insulin|insulin
352331|NCT02086084|NIV|niv
275649|NCT02485639|HA-specific plasmablasts|ha-specific plasmablasts
275650|NCT02485639|humoral immunity|humoral immunity
275651|NCT02485639|influenza|influenza
275652|NCT02485639|memory B cells|memory b cells
275653|NCT02485626|Anthracyclines|anthracyclines
275654|NCT02485600|Cadence|cadence
275655|NCT02485600|Duodopa|duodopa
275656|NCT02485600|Advanced Parkinson's disease|advanced parkinson's disease
275657|NCT02485600|LCIG|lcig
275658|NCT02485600|Levodopa-carbidopa intestinal gel|levodopa-carbidopa intestinal gel
275659|NCT02485600|Observational|observational
275660|NCT02485587|Arousal Biofeedback|arousal biofeedback
275661|NCT02485587|Electrodermal activity|electrodermal activity
275662|NCT02485574|Bone bridging|bone bridging
275663|NCT02485574|Arthrodesis|arthrodesis
275664|NCT02485574|Lumbar|lumbar
275665|NCT02485574|Cage|cage
275666|NCT02485561|Colon cancer screening|colon cancer screening
275667|NCT02485561|Colorectal cancer screening|colorectal cancer screening
275668|NCT02485561|Colonoscopy|colonoscopy
275669|NCT02485561|Sigmoidoscopy|sigmoidoscopy
275670|NCT02485561|Stool blood test|stool blood test
275671|NCT02485561|Narrative|narrative
275672|NCT02485522|fecal incontinence|fecal incontinence
275673|NCT02485522|diet|diet
275674|NCT02485522|nutrition|nutrition
275675|NCT02485522|metabolites|metabolites
275676|NCT02485522|stool|stool
275677|NCT02485522|FI|fi
275678|NCT02485379|Prostate cancer|prostate cancer
275679|NCT02485379|Multiparametric MRI|multiparametric mri
275680|NCT02485379|Prostate biopsy|prostate biopsy
275681|NCT02485379|Targeted biopsy|targeted biopsy
275682|NCT02485379|Comparative study|comparative study
275683|NCT02485366|Rejuvenated packed red blood cells|rejuvenated packed red blood cells
275684|NCT02485353|Vosaroxin|vosaroxin
275685|NCT02485353|Cytarabine|cytarabine
275686|NCT02485353|Remission Induction|remission induction
275687|NCT02485353|Safety|safety
275688|NCT02485353|Progression-Free Survival|progression-free survival
275689|NCT02485353|Mortality Rate|mortality rate
275690|NCT02485353|Length of Stay|length of stay
275691|NCT02485314|children|children
275692|NCT02485314|disability|disability
275693|NCT02485314|family|family
275694|NCT02485314|participation|participation
275695|NCT02485301|Protection against Ebola Zaire virus|protection against ebola zaire virus
275696|NCT02485275|AIS|ais
275697|NCT02485275|ICAS|icas
275698|NCT02485275|CSVD|csvd
275699|NCT02485262|Protease inhibitor treatment|protease inhibitor treatment
275700|NCT02485249|Iontophoresis|iontophoresis
275701|NCT02485249|Macular Edema|macular edema
275702|NCT02485249|Ophthalmology|ophthalmology
275703|NCT02485223|Multiple Sclerosis|multiple sclerosis
275704|NCT02485223|MS|ms
275705|NCT02485223|Diagnostic test|diagnostic test
275706|NCT02485223|Central veins|central veins
275707|NCT02485223|MRI|mri
275708|NCT02485210|photodynamic therapy , Endodontic treatment|photodynamic therapy , endodontic treatment
275709|NCT02485197|Muscle Metabolic Function|muscle metabolic function
275710|NCT02485197|Vitamin D Status|vitamin d status
275711|NCT02485197|25(OH)D|25(oh)d
275712|NCT02485197|Older Adults|older adults
275713|NCT02485158|Subjective Effects|subjective effects
275714|NCT02485158|Alcohol|alcohol
275715|NCT02485158|Amphetamine|amphetamine
275716|NCT02485158|THC|thc
275717|NCT02485158|Personality|personality
275718|NCT02485145|Topical|topical
275719|NCT02485145|Hand osteoarthritis|hand osteoarthritis
275720|NCT02485132|Type 2 diabetes|type 2 diabetes
275721|NCT02485132|Sulfonylurea|sulfonylurea
275722|NCT02485132|Hypoglycemia|hypoglycemia
275723|NCT02485132|Quality of life|quality of life
275724|NCT02485119|BAY 94-9343|bay 94-9343
275725|NCT02485119|Anetumab ravtansine|anetumab ravtansine
275726|NCT02485119|ADC (Antibody Drug Conjugate)|adc (antibody drug conjugate)
275727|NCT02485119|Phase I|phase i
275728|NCT02485119|Japan|japan
275729|NCT02485119|solid cancers|solid cancers
275730|NCT02485119|Advanced, refractory solid tumors|advanced, refractory solid tumors
275731|NCT02485119|mesothelin|mesothelin
275732|NCT02485119|endometrial|endometrial
275733|NCT02485119|adenocarcinoma of lung|adenocarcinoma of lung
275734|NCT02485119|gastrointestinal, ovarian, pancreatic, cholangio, mesothelioma and triple negative breast cancers|gastrointestinal, ovarian, pancreatic, cholangio, mesothelioma and triple negative breast cancers
275735|NCT02485080|hepatitis C|hepatitis c
275736|NCT02485080|liver transplantation|liver transplantation
275737|NCT02485080|genotype 1|genotype 1
275738|NCT02485067|Overactive Bladder|overactive bladder
275739|NCT02485067|Tolterodine (Detrusitol)|tolterodine (detrusitol)
275740|NCT02485067|Pilocarpine|pilocarpine
275741|NCT02485041|Dapoxetine|dapoxetine
275742|NCT02485041|Mirodenafil|mirodenafil
275743|NCT02485041|DDI study|ddi study
275744|NCT02485028|Dapoxetine|dapoxetine
275745|NCT02485028|Mirodenafil|mirodenafil
275746|NCT02485028|DDI study|ddi study
275747|NCT02485015|CIK|cik
275748|NCT02485015|gastric cancer|gastric cancer
275749|NCT02485015|Apatinib|apatinib
275750|NCT02485002|kidney|kidney
275751|NCT02485002|kidney stone|kidney stone
275752|NCT02485002|NGAL|ngal
275753|NCT02485002|ureterorenoscopy|ureterorenoscopy
275754|NCT02485002|intrarenal surgery|intrarenal surgery
275755|NCT02485002|kidney function|kidney function
275756|NCT02484976|Family Based Behavioral Treatment|family based behavioral treatment
275757|NCT02484976|functional magnetic resonance imaging (fMRI)|functional magnetic resonance imaging (fmri)
275758|NCT02484976|Childhood Obesity|childhood obesity
275759|NCT02484976|Satiety|satiety
275760|NCT02484976|BMI z-score|bmi z-score
275761|NCT02484976|Impulsive|impulsive
275762|NCT02484976|Non-obese controls|non-obese controls
275763|NCT02484976|Visual food cues|visual food cues
275764|NCT02484976|Leptin|leptin
275765|NCT02484976|Hormones|hormones
275766|NCT02484950|Mesenchymal stem cells|mesenchymal stem cells
275767|NCT02484937|Pain management|pain management
275768|NCT02484911|chemotherapy nausea vomiting|chemotherapy nausea vomiting
275769|NCT02484885|Magnetic Resonance Imaging|magnetic resonance imaging
275770|NCT02484885|Pulmonary Function|pulmonary function
275771|NCT02484872|Inflammation|inflammation
275772|NCT02484872|Glasgow score|glasgow score
275773|NCT02484872|Intensive Care Unit|intensive care unit
275774|NCT02484872|Emergency|emergency
275775|NCT02484859|Drug: remifentanil|drug: remifentanil
275776|NCT02484859|Drug: tramadol|drug: tramadol
275777|NCT02484859|Drug: metoprolol|drug: metoprolol
275778|NCT02484859|Functional endoscopic sinus surgery|functional endoscopic sinus surgery
275779|NCT02484859|Controlled hypotension|controlled hypotension
275780|NCT02484833|First line|first line
275781|NCT02484833|metastatic colorectal cancer|metastatic colorectal cancer
275782|NCT02484833|Cetuximab|cetuximab
275783|NCT02484833|strategy study|strategy study
275784|NCT02484820|Preterm Birth|preterm birth
275785|NCT02484820|pessary|pessary
275786|NCT02484820|threatened preterm labor|threatened preterm labor
275787|NCT02484794|Eating Disorders|eating disorders
275788|NCT02484794|Smartphone|smartphone
275789|NCT02484794|App|app
275790|NCT02484794|Mobile Health|mobile health
275791|NCT02484794|Recovery Record|recovery record
275792|NCT02484794|Cognitive Behavioural Therapy|cognitive behavioural therapy
275793|NCT02484794|Outpatient Program|outpatient program
275794|NCT02484794|Self Monitoring|self monitoring
275795|NCT02484781|Gait disorder|gait disorder
275796|NCT02484781|Resurfacing Hip Arthroplasty|resurfacing hip arthroplasty
275797|NCT02484781|Total Hip Arthroplasty|total hip arthroplasty
275798|NCT02484729|AZD9977|azd9977
275799|NCT02484729|Safety|safety
275800|NCT02484729|Tolerability|tolerability
275801|NCT02484729|Pharmacokinetics|pharmacokinetics
275802|NCT02484729|First-in-human|first-in-human
275803|NCT02484729|Single Ascending Dose|single ascending dose
275804|NCT02484729|Regional absorption|regional absorption
275805|NCT02484729|Healthy male subjects|healthy male subjects
275806|NCT02484716|Hemorrhagic Hereditary Telangiectasia (HHT)|hemorrhagic hereditary telangiectasia (hht)
275807|NCT02484716|Antiangiogenic therapy|antiangiogenic therapy
275808|NCT02484716|Timolol|timolol
275809|NCT02484651|deep neuromuscular block|deep neuromuscular block
275810|NCT02484651|sugammadex|sugammadex
275811|NCT02484651|stability of anesthesia|stability of anesthesia
275812|NCT02484651|suppression of EMG activity|suppression of emg activity
275813|NCT02484651|PQRS|pqrs
275814|NCT02484651|General Anesthesia|general anesthesia
275815|NCT02484651|Quality of Recovery|quality of recovery
275816|NCT02484625|snacking|snacking
275817|NCT02484625|food intake|food intake
275818|NCT02484625|satiety|satiety
275819|NCT02484625|obesity|obesity
275820|NCT02484625|type-2 diabetes|type-2 diabetes
275821|NCT02484599|Eating Disorders|eating disorders
275822|NCT02484599|Anorexia Nervosa|anorexia nervosa
275823|NCT02484599|Attention bias|attention bias
275824|NCT02484599|Attention bias modification|attention bias modification
275825|NCT02484586|Presbyopia|presbyopia
275826|NCT02484586|Refractive error|refractive error
275827|NCT02484586|Contact lens|contact lens
275828|NCT02484573|Cirrhosis|cirrhosis
275829|NCT02484573|Variceal Bleeding|variceal bleeding
275830|NCT02484573|Non-selective beta blocker|non-selective beta blocker
275831|NCT02484573|Intestinal Permeability|intestinal permeability
275832|NCT02484573|Gene expression|gene expression
275833|NCT02484573|Bacterial translocation|bacterial translocation
275834|NCT02484560|Duchenne Muscular Dystrophy|duchenne muscular dystrophy
275835|NCT02484560|Neuromuscular Diseases|neuromuscular diseases
275836|NCT02484560|Muscular Dystrophy|muscular dystrophy
275837|NCT02484560|Genetic Diseases, X-linked|genetic diseases, x-linked
275838|NCT02484560|Musculoskeletal Diseases|musculoskeletal diseases
275839|NCT02484560|Nervous System Diseases|nervous system diseases
275840|NCT02484547|Aducanumab|aducanumab
275842|NCT02484534|Coagulation Factor|coagulation factor
275843|NCT02484534|cirrhosis|cirrhosis
275844|NCT02484508|Guli capsule|guli capsule
275845|NCT02484508|knee osteoarthritis|knee osteoarthritis
275846|NCT02484508|Changing of WOMAC and VAS score|changing of womac and vas score
275847|NCT02484495|Complementary feeding recommendation|complementary feeding recommendation
275848|NCT02484495|Program evaluation|program evaluation
275849|NCT02484495|Process and impact evaluation|process and impact evaluation
275850|NCT02484456|Major Depression|major depression
275851|NCT02484456|Glycine Receptor Antagonist|glycine receptor antagonist
275852|NCT02484456|4-Chlorokyneurenine|4-chlorokyneurenine
275853|NCT02484456|Treatment Resistant|treatment resistant
275854|NCT02484456|Glutamatergic System|glutamatergic system
275855|NCT02484417|Neutralizing Antibody|neutralizing antibody
275856|NCT02484417|Viral Shedding|viral shedding
275857|NCT02484417|Mucosal Immune Reponse|mucosal immune reponse
275858|NCT02484417|RSV|rsv
275859|NCT02484417|Healthy Volunteer|healthy volunteer
275860|NCT02484404|Immune Checkpoint Inhibitor|immune checkpoint inhibitor
275861|NCT02484404|PARP Inhibitor|parp inhibitor
275862|NCT02484404|VEGFR Inhibitor|vegfr inhibitor
275863|NCT02484378|ACS|acs
275864|NCT02484378|IVUS|ivus
275865|NCT02484378|HDL|hdl
275866|NCT02484365|Hemoglobins|hemoglobins
275867|NCT02484365|Monitoring, Outpatient|monitoring, outpatient
275868|NCT02484365|Preoperative Period|preoperative period
275869|NCT02484365|Pediatrics|pediatrics
275870|NCT02484352|dosage of oxycodone during intubation|dosage of oxycodone during intubation
275871|NCT02484326|ST-elevation myocardial infarction|st-elevation myocardial infarction
275872|NCT02484326|Cardiac rupture|cardiac rupture
275873|NCT02484326|Risk assessment|risk assessment
275874|NCT02484300|loop gain|loop gain
275875|NCT02484300|chemoreflex control|chemoreflex control
275876|NCT02484300|melatonin|melatonin
275877|NCT02484300|antioxidant|antioxidant
275878|NCT02484300|obstructive sleep apnea|obstructive sleep apnea
275879|NCT02484300|ventilatory control|ventilatory control
275880|NCT02484274|iron-deficiency|iron-deficiency
275881|NCT02484274|iron-deficiency anemia|iron-deficiency anemia
275882|NCT02484274|infants and toddlers|infants and toddlers
275883|NCT02484274|industrialised countries|industrialised countries
275884|NCT02484274|population-based study|population-based study
275885|NCT02484274|prevalence and risk factors|prevalence and risk factors
275886|NCT02484274|screening strategies|screening strategies
275887|NCT02484274|diagnosis markers|diagnosis markers
275888|NCT02484274|primary prevention|primary prevention
275889|NCT02484261|childhood leukemia|childhood leukemia
275890|NCT02484261|relapsed leukemia|relapsed leukemia
275891|NCT02484261|Hematopoietic Stem Cell Transplantation|hematopoietic stem cell transplantation
275892|NCT02484248|pediatric|pediatric
275893|NCT02484248|eosinophilia|eosinophilia
275894|NCT02484248|duodenal|duodenal
275895|NCT02484248|ketotifen|ketotifen
275896|NCT02484248|functional dyspepsia|functional dyspepsia
275897|NCT02484235|obesity|obesity
275898|NCT02484235|exercise|exercise
275899|NCT02484235|HIIT|hiit
275900|NCT02484235|Vo2|vo2
275901|NCT02484235|kinetics|kinetics
275902|NCT02484222|adenotonsillectomy|adenotonsillectomy
275903|NCT02484222|fentanyl|fentanyl
275904|NCT02484209|diabetes|diabetes
275905|NCT02484209|frailty|frailty
275906|NCT02484209|aged|aged
275907|NCT02484209|metformin|metformin
275908|NCT02484209|sulphonylurea|sulphonylurea
275909|NCT02484209|hypoglycaemia|hypoglycaemia
275910|NCT02484183|bubble continuous positive airway pressure (CPAP)|bubble continuous positive airway pressure (cpap)
275911|NCT02484183|pneumonia|pneumonia
275912|NCT02484183|Human Immunodeficiency Virus (HIV)|human immunodeficiency virus (hiv)
275913|NCT02484183|malnutrition|malnutrition
275914|NCT02484183|Malawi|malawi
275915|NCT02484183|Africa|africa
275916|NCT02484183|Noninvasive Ventilation|noninvasive ventilation
275917|NCT02484183|child|child
275918|NCT02484183|pediatric|pediatric
275919|NCT02484183|hypoxemia|hypoxemia
275920|NCT02484170|Mannitol|mannitol
275921|NCT02484170|cream|cream
275922|NCT02484170|neuropathic pain|neuropathic pain
275923|NCT02484157|Whole Blood Coagulation Time|whole blood coagulation time
275924|NCT02484157|cardiac surgery|cardiac surgery
275925|NCT02484144|information|information
275926|NCT02484144|coronarography|coronarography
275927|NCT02484144|understanding|understanding
275928|NCT02484131|Osteoporosis|osteoporosis
275929|NCT02484131|DXA Screening|dxa screening
275930|NCT02484131|Women|women
275931|NCT02484131|Breast Cancer|breast cancer
275932|NCT02484131|Survivors|survivors
275933|NCT02484131|Educational materials|educational materials
275934|NCT02484131|Personal choices on delivery methods|personal choices on delivery methods
275935|NCT02484092|Hemophilia B|hemophilia b
275936|NCT02484092|Blood Coagulation Disorders|blood coagulation disorders
275937|NCT02484092|Gene Therapy|gene therapy
275938|NCT02484092|Gene Transfer|gene transfer
275939|NCT02484092|Factor IX Deficiency|factor ix deficiency
275940|NCT02484092|Factor IX Gene|factor ix gene
275941|NCT02484092|Factor IX Protein|factor ix protein
275942|NCT02484092|Vector|vector
275943|NCT02484092|AAV|aav
275944|NCT02484066|Virtual bronchoscopic navigation|virtual bronchoscopic navigation
275945|NCT02484066|Endobronchial ultrasound|endobronchial ultrasound
275946|NCT02484066|Guide Sheath|guide sheath
275947|NCT02484066|Transbronchial biopsy|transbronchial biopsy
712541|NCT00579774|oxidative stress|oxidative stress
275948|NCT02484066|Peripheral pulmonary lesions|peripheral pulmonary lesions
275949|NCT02484053|adult and pediatric cancers|adult and pediatric cancers
275950|NCT02484053|blood disorders|blood disorders
275951|NCT02484053|lymphoma|lymphoma
275952|NCT02484053|graft-versus-host-disease|graft-versus-host-disease
275953|NCT02484053|diseases of the immune system|diseases of the immune system
275954|NCT02484040|tumor response|tumor response
275955|NCT02484040|toxicity|toxicity
275956|NCT02484040|recurrence|recurrence
275957|NCT02484040|chemoradiotherpy|chemoradiotherpy
275958|NCT02484040|rectum|rectum
275959|NCT02484027|acute ischemic stroke|acute ischemic stroke
275960|NCT02484027|mRS|mrs
275961|NCT02484027|rosuvastatin|rosuvastatin
275962|NCT02484001|Eslicarbazepine acetate|eslicarbazepine acetate
275963|NCT02484001|BIA 2-093|bia 2-093
275964|NCT02484001|Epilepsy|epilepsy
275965|NCT02483988|NUsurface|nusurface
275966|NCT02483988|Meniscus|meniscus
275967|NCT02483988|prosthesis|prosthesis
275968|NCT02483988|KOOS|koos
275969|NCT02483975|Fluticasone Furoate|fluticasone furoate
275970|NCT02483975|Asthma|asthma
275971|NCT02483975|HPA axis|hpa axis
275972|NCT02483975|Children|children
275973|NCT02483975|Inhaled corticosteroid|inhaled corticosteroid
275974|NCT02483962|Chronic|chronic
275975|NCT02483923|serratus anterior block|serratus anterior block
275976|NCT02483923|ultrasound|ultrasound
275977|NCT02483923|breast cancer|breast cancer
275978|NCT02483923|postoperative pain|postoperative pain
275979|NCT02483910|School-age children|school-age children
275980|NCT02483910|Pediatrics|pediatrics
275981|NCT02483910|Direct Instruction-Language for Learning|direct instruction-language for learning
275982|NCT02483884|Bombesin|bombesin
275983|NCT02483884|Gastrin-Releasing Peptide|gastrin-releasing peptide
275984|NCT02483884|Prostatic Neoplasms|prostatic neoplasms
275985|NCT02483884|Genital Diseases, Male|genital diseases, male
275986|NCT02483884|Genital Neoplasms, Male|genital neoplasms, male
275987|NCT02483884|Neoplasms|neoplasms
275988|NCT02483884|Neoplasms by Site|neoplasms by site
275989|NCT02483884|Urogenital Neoplasms|urogenital neoplasms
275990|NCT02483884|Gastrointestinal Agents|gastrointestinal agents
275991|NCT02483884|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action
275992|NCT02483884|Neurotransmitter Agents|neurotransmitter agents
275993|NCT02483884|Pharmacologic Actions|pharmacologic actions
275994|NCT02483884|Physiological Effects of Drugs|physiological effects of drugs
275995|NCT02483884|Therapeutic Uses|therapeutic uses
275996|NCT02483871|Estrogen Receptor Positive|estrogen receptor positive
275997|NCT02483858|oncology, solid tumors|oncology, solid tumors
275998|NCT02483819|Elderly patient|elderly patient
275999|NCT02483819|NICOM|nicom
276000|NCT02483819|TURP|turp
276001|NCT02483767|Premenopausal Breast Cancer|premenopausal breast cancer
276002|NCT02483767|Preservation of Ovarian Function|preservation of ovarian function
276003|NCT02483767|Gonadotropin-Releasing Hormone Agonist|gonadotropin-releasing hormone agonist
276004|NCT02483728|Metal Allergy|metal allergy
276005|NCT02483715|Helicobacter pylori|helicobacter pylori
276006|NCT02483715|high dose dual therapy|high dose dual therapy
276007|NCT02483715|bismuth-containing quadruple therapy|bismuth-containing quadruple therapy
276008|NCT02483715|antibiotic resistance|antibiotic resistance
276009|NCT02483702|Irradiated Blood|irradiated blood
276010|NCT02483702|Non-Irradiated Blood|non-irradiated blood
276011|NCT02483702|graft versus host disease|graft versus host disease
276012|NCT02483702|TA-GVHD|ta-gvhd
276013|NCT02483702|potassium|potassium
276014|NCT02483702|Blood transfusion|blood transfusion
276015|NCT02483689|Post Operative Pain|post operative pain
276016|NCT02483689|Appendicitis|appendicitis
276017|NCT02483689|Appendectomy|appendectomy
276018|NCT02483689|Local Anesthetic|local anesthetic
276019|NCT02483689|Saline|saline
276020|NCT02483689|Pain Management|pain management
276021|NCT02483689|Surgery|surgery
276022|NCT02483689|Recovery|recovery
276023|NCT02483676|Rehabilitation|rehabilitation
276024|NCT02483676|Robotics|robotics
276025|NCT02483676|Gait|gait
276026|NCT02483663|Twins|twins
276027|NCT02483663|Obesity|obesity
276028|NCT02483663|Appetite|appetite
276029|NCT02483637|spray cryotherapy|spray cryotherapy
276030|NCT02483637|cryotherapy|cryotherapy
276031|NCT02483637|chronic bronchitis|chronic bronchitis
276032|NCT02483637|airflow restrictions|airflow restrictions
276033|NCT02483611|Onset|onset
276034|NCT02483611|Recovery|recovery
276035|NCT02483611|Lidocaine|lidocaine
276036|NCT02483611|Cisatracurium|cisatracurium
276037|NCT02483611|Magnesium sulfate|magnesium sulfate
276038|NCT02483611|Isotonic solution|isotonic solution
276039|NCT02483598|buspirone|buspirone
276040|NCT02483598|pharmacokinetics|pharmacokinetics
276041|NCT02483598|Cytochrome P450 3A4|cytochrome p450 3a4
276042|NCT02483585|Migraine|migraine
276043|NCT02483585|Headache|headache
276044|NCT02483585|Episodic|episodic
276045|NCT02483585|Prevention|prevention
276046|NCT02483585|Prophylaxis|prophylaxis
276047|NCT02483559|Sleep|sleep
276048|NCT02483559|Photoreceptor Cells, Vertebrate|photoreceptor cells, vertebrate
276049|NCT02483559|Melatonin|melatonin
276050|NCT02483546|Medical education|medical education
276051|NCT02483546|simulation|simulation
276052|NCT02483546|ACLS|acls
276053|NCT02483520|Family caregiver|family caregiver
276054|NCT02483507|Ultrasound guidance|ultrasound guidance
276055|NCT02483507|Vascular access|vascular access
276056|NCT02483507|Pediatric anesthesia|pediatric anesthesia
276057|NCT02483494|Telemedicine|telemedicine
276058|NCT02483494|Advanced Practice Nurse|advanced practice nurse
276059|NCT02483481|sinusoidal obstruction syndrome|sinusoidal obstruction syndrome
276060|NCT02483481|ultrasound elastography|ultrasound elastography
276061|NCT02483481|bone marrow transplant|bone marrow transplant
276062|NCT02483429|Vertigo|vertigo
276063|NCT02483429|Dizziness|dizziness
276064|NCT02483429|Unsteadiness|unsteadiness
276065|NCT02483429|Stroke|stroke
276066|NCT02483429|Vestibular neuritis|vestibular neuritis
276194|NCT02482675|Prediabetes|prediabetes
276067|NCT02483429|Benign paroxysmal positional vertigo|benign paroxysmal positional vertigo
276068|NCT02483429|Vestibulo-ocular reflex|vestibulo-ocular reflex
276069|NCT02483429|Video-oculography|video-oculography
276070|NCT02483429|Emergency department|emergency department
276071|NCT02483403|Magnetic Resonance Imaging|magnetic resonance imaging
276072|NCT02483403|Pulmonary Function|pulmonary function
276073|NCT02483403|Volunteers|volunteers
276074|NCT02483390|palliative care|palliative care
276075|NCT02483390|e-health|e-health
276076|NCT02483390|e-therapy|e-therapy
276077|NCT02483390|psychosocial services|psychosocial services
276078|NCT02483377|Sign or Symptom|sign or symptom
276079|NCT02483351|Blood Transfusion|blood transfusion
276080|NCT02483338|Psychometric validity|psychometric validity
276081|NCT02483338|Pain scale|pain scale
276082|NCT02483338|Postoperative|postoperative
276083|NCT02483338|Children|children
276084|NCT02483312|Recurrent|recurrent
276085|NCT02483299|response to therapy|response to therapy
276086|NCT02483286|Osteoporosis|osteoporosis
276087|NCT02483286|Fall|fall
276088|NCT02483286|Fracture|fracture
276089|NCT02483286|sarcopenia|sarcopenia
276090|NCT02483286|Exercise|exercise
276091|NCT02483273|Conjunctival microcirculation|conjunctival microcirculation
276092|NCT02483273|Sublingual microcirculation|sublingual microcirculation
276093|NCT02483273|Sidestream Dark Field (SDF) microscopy|sidestream dark field (sdf) microscopy
276094|NCT02483247|Neoplasms|neoplasms
276095|NCT02483195|Hair loss|hair loss
276096|NCT02483195|Post Menopausal|post menopausal
276097|NCT02483182|Herpes labialis, Cold sores, ZEP-3 ointment|herpes labialis, cold sores, zep-3 ointment
276098|NCT02483169|ischemic stroke|ischemic stroke
276099|NCT02483169|intracranial hemorrhage|intracranial hemorrhage
276100|NCT02483169|cilostazol|cilostazol
276101|NCT02483169|probucol|probucol
276102|NCT02483169|intima media thickness|intima media thickness
276103|NCT02483156|HCV|hcv
276104|NCT02483156|Sofosbuvir|sofosbuvir
276105|NCT02483156|Ribavirin|ribavirin
276106|NCT02483143|contrast media|contrast media
276107|NCT02483143|pulmonary embolism|pulmonary embolism
276108|NCT02483143|N-acetylcysteine|n-acetylcysteine
276109|NCT02483104|ABT-888|abt-888
276110|NCT02483104|BRCA|brca
276111|NCT02483104|Primary peritoneal cancer|primary peritoneal cancer
276112|NCT02483104|carboplatin|carboplatin
276113|NCT02483104|Fallopian tube|fallopian tube
276114|NCT02483104|Poly (ADP-ribose) polymerase (PARP)|poly (adp-ribose) polymerase (parp)
276115|NCT02483104|paclitaxel|paclitaxel
276116|NCT02483104|Ovarian cancer|ovarian cancer
276117|NCT02483104|veliparib|veliparib
276118|NCT02483091|Knowledge translation|knowledge translation
276119|NCT02483091|Clinical practice guidelines|clinical practice guidelines
276120|NCT02483091|Multimodal care|multimodal care
276121|NCT02483091|Brief Action Planning|brief action planning
276122|NCT02483091|Feasibility outcomes|feasibility outcomes
276123|NCT02483065|dementia|dementia
276124|NCT02483065|hospital admission|hospital admission
276125|NCT02483065|mortality|mortality
276126|NCT02483065|health-related quality of life|health-related quality of life
276127|NCT02483065|activities of daily living|activities of daily living
276128|NCT02483052|lobectomy|lobectomy
276129|NCT02483052|spray cryotherapy|spray cryotherapy
276130|NCT02483052|lung cancer|lung cancer
276131|NCT02483039|Acute kidney injury|acute kidney injury
276132|NCT02483039|Chronic kidney disease|chronic kidney disease
276133|NCT02483039|Quality improvement|quality improvement
276134|NCT02483013|whitening dentifrices|whitening dentifrices
276135|NCT02483013|color alteration|color alteration
276136|NCT02483013|tooth sensitivity|tooth sensitivity
276137|NCT02482987|dental|dental
276138|NCT02482987|extraction|extraction
276139|NCT02482987|socket preservation|socket preservation
276140|NCT02482987|ridge preservation|ridge preservation
276141|NCT02482987|implant site preparation|implant site preparation
276142|NCT02482974|Liver transplantation|liver transplantation
276143|NCT02482974|Everolimus|everolimus
276144|NCT02482974|Sirolimus|sirolimus
276145|NCT02482974|Treatment outcome|treatment outcome
352880|NCT02083588|dTMS|dtms
276146|NCT02482974|Safety|safety
276147|NCT02482948|Debridement|debridement
276148|NCT02482948|collagenase|collagenase
276149|NCT02482948|leptospermum honey|leptospermum honey
276150|NCT02482922|feasibility studies|feasibility studies
276151|NCT02482922|intervention|intervention
276152|NCT02482922|Pre-Hypertensive|pre-hypertensive
276153|NCT02482922|Pre-Hyperlipidemia|pre-hyperlipidemia
276154|NCT02482844|TAVI|tavi
276155|NCT02482844|de novo and persistent LBBB|de novo and persistent lbbb
276156|NCT02482844|electrophysiology|electrophysiology
276157|NCT02482844|Holter|holter
276158|NCT02482844|pacemaker|pacemaker
276159|NCT02482831|Sciatic nerve block|sciatic nerve block
276160|NCT02482831|block duration|block duration
276161|NCT02482831|Semmes Weinstein monofilaments|semmes weinstein monofilaments
276162|NCT02482831|fasting blood glucose|fasting blood glucose
276163|NCT02482831|nerve block|nerve block
276164|NCT02482831|sensory block duration|sensory block duration
276165|NCT02482831|motor block duration|motor block duration
276166|NCT02482818|chronic cough|chronic cough
276167|NCT02482818|cough hypersensitivity|cough hypersensitivity
276168|NCT02482818|Lyrica|lyrica
276169|NCT02482818|Pregabalin|pregabalin
276170|NCT02482818|cough reflex sensitivity|cough reflex sensitivity
276171|NCT02482792|Musculoskeletal disorders|musculoskeletal disorders
276172|NCT02482792|Psychosomatic|psychosomatic
276173|NCT02482792|Pain|pain
276174|NCT02482753|Chidamide|chidamide
276175|NCT02482753|breast cancer|breast cancer
276176|NCT02482753|exemestane|exemestane
276177|NCT02482753|Estrogen Receptor|estrogen receptor
276178|NCT02482740|Uterine Cervical Neoplasms|uterine cervical neoplasms
276179|NCT02482740|antiestrogens|antiestrogens
276180|NCT02482727|Blood Flow Restriction|blood flow restriction
276181|NCT02482727|Occlusion training|occlusion training
276182|NCT02482727|Distal radius fracture|distal radius fracture
276183|NCT02482714|Quality of Life|quality of life
276184|NCT02482714|Physical Activity|physical activity
276185|NCT02482701|EMR|emr
276186|NCT02482701|EAC|eac
276187|NCT02482701|Barrett's Neoplasia|barrett's neoplasia
276188|NCT02482701|Multiband Mucosectomy|multiband mucosectomy
276189|NCT02482675|Dairy|dairy
276190|NCT02482675|Milk|milk
276191|NCT02482675|Glucose|glucose
276192|NCT02482675|Postprandial|postprandial
276193|NCT02482675|Hyperglycemia|hyperglycemia
276195|NCT02482675|Blood glucose|blood glucose
276196|NCT02482675|Oxidative stress|oxidative stress
276197|NCT02482675|Vascular health|vascular health
276198|NCT02482675|Vascular function|vascular function
276199|NCT02482662|Diagnosis|diagnosis
276200|NCT02482636|infant immunisations|infant immunisations
276201|NCT02482636|vaccines|vaccines
276202|NCT02482636|paediatric|paediatric
276203|NCT02482636|pneumococcal|pneumococcal
276204|NCT02482636|meningococcal|meningococcal
276205|NCT02482623|Dementia|dementia
276206|NCT02482623|neuropsychiatric symptoms|neuropsychiatric symptoms
276207|NCT02482623|implementation science|implementation science
276208|NCT02482623|depression|depression
276209|NCT02482623|pain|pain
276210|NCT02482610|Dairy|dairy
276211|NCT02482610|Milk|milk
276212|NCT02482610|Glucose|glucose
276213|NCT02482610|Postprandial|postprandial
276214|NCT02482610|Hyperglycemia|hyperglycemia
276215|NCT02482610|Prediabetes|prediabetes
276216|NCT02482610|Blood glucose|blood glucose
276217|NCT02482610|Oxidative stress|oxidative stress
276218|NCT02482610|Vascular health|vascular health
276219|NCT02482610|Vascular function|vascular function
276220|NCT02482571|Functional MRS|functional mrs
276221|NCT02482571|Glutamate|glutamate
276222|NCT02482558|Glycaemic Index|glycaemic index
276223|NCT02482558|NAFLD|nafld
276224|NCT02482558|Glycogen|glycogen
276225|NCT02482558|Liver|liver
276226|NCT02482558|Diet|diet
276227|NCT02482532|Melanoma|melanoma
276228|NCT02482532|metastatic|metastatic
276229|NCT02482532|relapsed|relapsed
276230|NCT02482532|refractory|refractory
276231|NCT02482506|African American|african american
276232|NCT02482506|Overweight|overweight
276233|NCT02482506|Adults|adults
276234|NCT02482480|SLEEP|sleep
276235|NCT02482480|APNEA|apnea
276236|NCT02482480|EXERCISE|exercise
276237|NCT02482467|ovarian cyst|ovarian cyst
276238|NCT02482467|prenatal diagnosis|prenatal diagnosis
276239|NCT02482467|puberty|puberty
276240|NCT02482454|radiofrequency ablation|radiofrequency ablation
276241|NCT02482454|cytokine-induced killer cells|cytokine-induced killer cells
276242|NCT02482454|cholangiocarcinoma|cholangiocarcinoma
276243|NCT02482441|Advanced Solid Tumors and in Combination|advanced solid tumors and in combination
276244|NCT02482441|FOLFIRI for Patients with Previously Treated Metastatic|folfiri for patients with previously treated metastatic
276245|NCT02482441|Colorectal Cancer|colorectal cancer
276246|NCT02482428|human papilloma virus (HPV), Genital Warts, Sexually transmitted disease (STD), viral disease|human papilloma virus (hpv), genital warts, sexually transmitted disease (std), viral disease
276247|NCT02482415|Palliative Care|palliative care
276248|NCT02482415|Randomized controlled trial|randomized controlled trial
276249|NCT02482415|Family caregivers|family caregivers
276250|NCT02482415|Intervention|intervention
276251|NCT02482415|Family|family
276252|NCT02482415|Intervention studies|intervention studies
276253|NCT02482415|Home Care|home care
276254|NCT02482311|AZD1775|azd1775
276255|NCT02482311|Ovarian cancer (BRCA1/2 mutation)|ovarian cancer (brca1/2 mutation)
276256|NCT02482311|Ovarian cancer (PARP-failure)|ovarian cancer (parp-failure)
276257|NCT02482311|Triple negative breast cancer (TNBC)|triple negative breast cancer (tnbc)
276258|NCT02482311|Small-cell lung cancer (SCLC)|small-cell lung cancer (sclc)
276259|NCT02482311|Solid tumours|solid tumours
276260|NCT02482298|Sickle cell disease|sickle cell disease
276261|NCT02482298|Young adults|young adults
276262|NCT02482298|Hestia2|hestia2
276263|NCT02482298|Ticagrelor|ticagrelor
276264|NCT02482233|electronic cigarette|electronic cigarette
276265|NCT02482233|nicotine replacement therapy|nicotine replacement therapy
276266|NCT02482233|smoking cessation|smoking cessation
276267|NCT02482233|perioperative|perioperative
276268|NCT02482194|Spinal cord injury|spinal cord injury
276269|NCT02482194|mesenchymal stem cells|mesenchymal stem cells
276270|NCT02482194|transplantation|transplantation
276271|NCT02482181|diffusion weighted magnetic resonance imaging|diffusion weighted magnetic resonance imaging
276272|NCT02482168|immunotherapy|immunotherapy
276273|NCT02482168|CD40|cd40
276274|NCT02482155|pharmacokinetics|pharmacokinetics
276275|NCT02482155|MOMENTACT|momentact
276276|NCT02482155|ibuprofen 400 mg|ibuprofen 400 mg
276277|NCT02482155|oral|oral
276278|NCT02482155|granules|granules
276279|NCT02482142|phosphorus|phosphorus
276280|NCT02482142|lean|lean
276281|NCT02482142|obese|obese
276282|NCT02482142|energy expenditure|energy expenditure
276283|NCT02482129|Acute anterior uveitis|acute anterior uveitis
276284|NCT02482129|LME636|lme636
276285|NCT02482116|malaria|malaria
276286|NCT02482116|pneumonia|pneumonia
276287|NCT02482116|Nigeria|nigeria
276288|NCT02482116|IMCI|imci
276289|NCT02482116|diagnosis|diagnosis
276290|NCT02482103|Therapy resistant hypertension|therapy resistant hypertension
276291|NCT02482051|Carbapenem-resistant Enterobacteriaceae|carbapenem-resistant enterobacteriaceae
276292|NCT02482051|Accelerate ID/AST|accelerate id/ast
276293|NCT02482025|Medications|medications
276294|NCT02482025|Hospitalization|hospitalization
276295|NCT02482025|Electronic medical records|electronic medical records
276296|NCT02482012|research|research
276297|NCT02482012|vulnerable population|vulnerable population
276298|NCT02482012|45 CFR 46.406|45 cfr 46.406
276299|NCT02481999|Depth of anesthesia|depth of anesthesia
276300|NCT02481973|PMS|pms
276301|NCT02481973|Homoeopathy|homoeopathy
276302|NCT02481973|Grant Bentley Method|grant bentley method
276303|NCT02481934|Recurrent multiple myeloma|recurrent multiple myeloma
276304|NCT02481934|NK cells|nk cells
276305|NCT02481934|cell therapy|cell therapy
276306|NCT02481934|NKAE|nkae
276307|NCT02481934|Relapsed multiple myeloma|relapsed multiple myeloma
276308|NCT02481921|heart failure|heart failure
276309|NCT02481921|self-management|self-management
276310|NCT02481921|group intervention|group intervention
276311|NCT02481908|AECOPD|aecopd
276312|NCT02481908|left ventricular dysfunction|left ventricular dysfunction
276313|NCT02481908|valsalva maneuver|valsalva maneuver
276314|NCT02481908|systolic time intervals|systolic time intervals
276315|NCT02481895|cognition|cognition
276316|NCT02481895|psychosocial functioning|psychosocial functioning
276317|NCT02481869|Closed|closed
276318|NCT02481869|unilateral|unilateral
276319|NCT02481869|pilon|pilon
276320|NCT02481843|Hyperoxia|hyperoxia
276321|NCT02481843|Microcirculation|microcirculation
276322|NCT02481843|Erythropoietin|erythropoietin
276323|NCT02481843|Normobaric Oxygen Paradox|normobaric oxygen paradox
276324|NCT02481804|diet|diet
276325|NCT02481804|vitamin|vitamin
276326|NCT02481778|Radiotherapy|radiotherapy
276327|NCT02481778|Cardiac|cardiac
276328|NCT02481778|Toxicity|toxicity
276329|NCT02481752|Tobacco Use|tobacco use
276330|NCT02481752|Nicotine Dependence|nicotine dependence
276331|NCT02481739|endometriosis|endometriosis
276332|NCT02481739|fertility|fertility
276333|NCT02481739|endometriosis surgery|endometriosis surgery
276334|NCT02481726|68Ga|68ga
276335|NCT02481726|Alfatide II|alfatide ii
276336|NCT02481726|RGD|rgd
276337|NCT02481726|αvβ3|αvβ3
276338|NCT02481726|PET/CT|pet/ct
276339|NCT02481713|psychosis|psychosis
276340|NCT02481713|adherence|adherence
276341|NCT02481713|motivation|motivation
276342|NCT02481674|Prodromal Stage|prodromal stage
276343|NCT02481674|Early Manifest Stage|early manifest stage
276344|NCT02481635|Blood Vessels|blood vessels
276345|NCT02481635|Reconstructive Surgery|reconstructive surgery
276346|NCT02481622|HIV infection|hiv infection
276347|NCT02481622|vaginal tissues|vaginal tissues
276348|NCT02481622|uterine tissues|uterine tissues
276349|NCT02481609|Loss of Smell|loss of smell
276350|NCT02481609|Olfaction|olfaction
276351|NCT02481609|Hyposmia|hyposmia
276352|NCT02481596|family|family
276353|NCT02481596|support|support
276354|NCT02481596|diet|diet
276355|NCT02481596|exercise|exercise
276356|NCT02481596|social|social
276357|NCT02481583|levosulpiride|levosulpiride
276358|NCT02481583|pharmacokinetics|pharmacokinetics
276359|NCT02481583|adverse effects|adverse effects
276360|NCT02481583|bioavailability|bioavailability
276361|NCT02481570|Adolescent Idiopathic Scoliosis|adolescent idiopathic scoliosis
276362|NCT02481570|Scoliosis surgery|scoliosis surgery
276363|NCT02481570|Pharmacokinetic simulation|pharmacokinetic simulation
276364|NCT02481518|Cisplatin nephrotoxicity|cisplatin nephrotoxicity
276365|NCT02481518|Acute kidney injury|acute kidney injury
276366|NCT02481492|Circumcision, Male|circumcision, male
276367|NCT02481492|Shang Ring|shang ring
276368|NCT02481492|Children|children
276369|NCT02481492|Foreskin|foreskin
276370|NCT02481466|Arterial plaque|arterial plaque
276371|NCT02481466|Magnetic resonance imaging (MRI)|magnetic resonance imaging (mri)
276372|NCT02481466|Portfolio diet|portfolio diet
276373|NCT02481466|Dietary modification|dietary modification
276374|NCT02481466|Dietary trials|dietary trials
276375|NCT02481466|hypercholesterolemia|hypercholesterolemia
276376|NCT02481466|diabetes|diabetes
276377|NCT02481466|exercise|exercise
276378|NCT02481466|cardiovascular disease risk|cardiovascular disease risk
276379|NCT02481466|glycemic index (GI)|glycemic index (gi)
276380|NCT02481466|Carotid Ultrasound|carotid ultrasound
276381|NCT02481466|Dietary Approaches to Stop Hypertension (DASH) diet|dietary approaches to stop hypertension (dash) diet
276382|NCT02481440|umbilical cord mesenchymal stem cells|umbilical cord mesenchymal stem cells
276383|NCT02481440|spinal cord injury|spinal cord injury
276384|NCT02481427|Total|total
276385|NCT02481427|Unicondylar|unicondylar
276386|NCT02481427|Osteoarthritis|osteoarthritis
276387|NCT02481427|Arthroplasty|arthroplasty
276388|NCT02481427|Replacement|replacement
276389|NCT02481427|Knee|knee
276390|NCT02481414|HSIL, CIN II/III|hsil, cin ii/iii
276391|NCT02481401|cardiovascular health|cardiovascular health
276392|NCT02481401|behavior change|behavior change
276393|NCT02481401|community-based|community-based
276394|NCT02481401|family-based|family-based
276395|NCT02481401|prevention|prevention
276396|NCT02481375|iron|iron
276397|NCT02481375|ferritin|ferritin
276398|NCT02481375|soluble transferrin receptor|soluble transferrin receptor
276399|NCT02481375|hepcidin|hepcidin
276400|NCT02481375|reticulocyte count|reticulocyte count
276401|NCT02481375|hemoglobin|hemoglobin
276402|NCT02481375|supplementation|supplementation
276403|NCT02481336|Chemotherapy|chemotherapy
276404|NCT02481336|Peripheral Neuropathy|peripheral neuropathy
276405|NCT02481323|cerebral small vessel disease|cerebral small vessel disease
276406|NCT02481323|cerebrovascular reactivity|cerebrovascular reactivity
276407|NCT02481323|cilostazol|cilostazol
276408|NCT02481323|isosorbide mononitrate|isosorbide mononitrate
276409|NCT02481297|Leukemia|leukemia
276410|NCT02481297|Chronic Lymphocytic Leukemia|chronic lymphocytic leukemia
276412|NCT02481297|Refractory/Relapsed|refractory/relapsed
276413|NCT02481297|Untreated with high-risk molecular features|untreated with high-risk molecular features
276414|NCT02481297|Small lymphocytic leukemia|small lymphocytic leukemia
276415|NCT02481297|SLL|sll
276416|NCT02481297|Lirilumab|lirilumab
276417|NCT02481297|Rituximab|rituximab
276418|NCT02481297|Rituxan|rituxan
276419|NCT02481284|Breast reconstruction|breast reconstruction
276420|NCT02481284|Deep inferior epigastric artery perforator flap|deep inferior epigastric artery perforator flap
276421|NCT02481284|Skin perfusion|skin perfusion
276422|NCT02481284|Plastic and reconstructive surgery|plastic and reconstructive surgery
276423|NCT02481271|cholecystectomy|cholecystectomy
276424|NCT02481258|Stenosis|stenosis
276425|NCT02481258|Aortic Valve|aortic valve
276426|NCT02481258|Aorta|aorta
276427|NCT02481258|Calcified|calcified
276428|NCT02481258|Calcific|calcific
276429|NCT02481258|Calcification|calcification
276430|NCT02481245|Bipolar Disorder|bipolar disorder
276431|NCT02481245|Bezafibrate|bezafibrate
276432|NCT02481245|Depressive Episode|depressive episode
276433|NCT02481219|Polyps|polyps
276434|NCT02481219|Capsule endoscopy|capsule endoscopy
276435|NCT02481219|Bowel preparation regimen|bowel preparation regimen
276436|NCT02481219|Average risk patients for colorectal cancer screening|average risk patients for colorectal cancer screening
276437|NCT02481206|Ventricular Tachycardia|ventricular tachycardia
276438|NCT02481193|Cisatracurium|cisatracurium
276440|NCT02481193|Fasciculation|fasciculation
276441|NCT02481193|Succinylcholine|succinylcholine
276442|NCT02481167|Aged|aged
276443|NCT02481167|Meibomian Glands|meibomian glands
276444|NCT02481167|dry eye|dry eye
276445|NCT02481167|Elderly|elderly
276446|NCT02481154|Glioma|glioma
276447|NCT02481154|IDH1|idh1
276448|NCT02481154|IDH2|idh2
276449|NCT02481154|Dual Mutation|dual mutation
276450|NCT02481154|AG-881|ag-881
276451|NCT02481128|lymphoscintigraphy|lymphoscintigraphy
744853|NCT00456443|Thalassemia|thalassemia
276452|NCT02481128|sentinel lymph node biopsy|sentinel lymph node biopsy
276453|NCT02481076|malleolar fractures|malleolar fractures
276454|NCT02481076|ORIF|orif
276455|NCT02481076|compression|compression
276456|NCT02481076|infection|infection
276457|NCT02481076|wound dehisence|wound dehisence
276458|NCT02481063|Eccentric|eccentric
276459|NCT02481063|Running|running
276460|NCT02481063|Muscle|muscle
276461|NCT02481063|Tendon|tendon
276462|NCT02481063|Ultrasound|ultrasound
276463|NCT02481063|Thermography|thermography
276464|NCT02481050|Eribulin Mesylate|eribulin mesylate
276465|NCT02481050|Human Epidermal Growth Factor Receptor 2|human epidermal growth factor receptor 2
276466|NCT02481050|Metastatic Breast Cancer|metastatic breast cancer
276467|NCT02481050|HER2-Negative|her2-negative
276468|NCT02481024|Qualitative|qualitative
276469|NCT02481024|Care transition|care transition
276470|NCT02481024|Medication|medication
276471|NCT02481011|Fibrinolytic agents|fibrinolytic agents
276472|NCT02481011|Adverse effects|adverse effects
276473|NCT02481011|Registries|registries
276474|NCT02481011|Incidence|incidence
276475|NCT02481011|Risk assessment|risk assessment
276476|NCT02480985|Pituitary Disorders|pituitary disorders
276477|NCT02480985|Traumatic Brain Injury|traumatic brain injury
276478|NCT02480985|Critical Care|critical care
276479|NCT02480985|Outcome Research|outcome research
276480|NCT02480985|Risk Factors|risk factors
276481|NCT02480985|Patient Oriented Research|patient oriented research
276482|NCT02480972|fibrosis|fibrosis
276483|NCT02480972|cirrhosis|cirrhosis
276484|NCT02480972|MRI|mri
276485|NCT02480946|Rheumatoid Arthritis|rheumatoid arthritis
276486|NCT02480946|Osteoclastogenesis inhibitor|osteoclastogenesis inhibitor
276487|NCT02480946|Anti-Inflammatory Agent|anti-inflammatory agent
276488|NCT02480946|Musculoskeletal Diseases|musculoskeletal diseases
276489|NCT02480946|Joint Diseases|joint diseases
276490|NCT02480920|Atrial fibrillation Drug Adherence|atrial fibrillation drug adherence
276491|NCT02480920|New Oral Anticoagulants|new oral anticoagulants
276492|NCT02480920|Drug Adherence|drug adherence
276493|NCT02480907|eating disorders|eating disorders
276494|NCT02480907|caregivers|caregivers
276495|NCT02480907|parents|parents
276496|NCT02480907|skills training|skills training
276497|NCT02480907|workshops|workshops
276498|NCT02480907|support|support
276499|NCT02480907|internet|internet
276500|NCT02480907|online|online
276501|NCT02480907|family|family
276502|NCT02480868|Primary or secondary osteoarthritis|primary or secondary osteoarthritis
276503|NCT02480868|fusion of the ankle|fusion of the ankle
276504|NCT02480855|work related stress|work related stress
276505|NCT02480855|questionnaire|questionnaire
276506|NCT02480855|early identification|early identification
276507|NCT02480842|Breast Neoplasms|breast neoplasms
276508|NCT02480842|Mammaplasty|mammaplasty
276509|NCT02480842|Breast Implantation|breast implantation
276510|NCT02480842|Range of Motion, Articular|range of motion, articular
276511|NCT02480842|Shoulder Joint|shoulder joint
276512|NCT02480842|Physical Therapy Modalities|physical therapy modalities
276513|NCT02480803|Parkinson|parkinson
276514|NCT02480803|Parkinson's Disease|parkinson's disease
276515|NCT02480803|Deep Brain Stimulation|deep brain stimulation
276516|NCT02480803|levodopa-carbidopa|levodopa-carbidopa
276517|NCT02480803|Duodopa|duodopa
276518|NCT02480803|continuous intrajejunal infusion|continuous intrajejunal infusion
276519|NCT02480764|Drug therapy|drug therapy
276520|NCT02480751|Chronic Renal Failure|chronic renal failure
276521|NCT02480751|Prostaglandin|prostaglandin
276522|NCT02480751|Prostacyclin|prostacyclin
276523|NCT02480751|Glomerular Disease; Nephrosclerosis|glomerular disease; nephrosclerosis
276524|NCT02480738|subjective cognitive impairment|subjective cognitive impairment
276525|NCT02480725|CJD|cjd
276526|NCT02480725|CSF|csf
276527|NCT02480725|prion|prion
276528|NCT02480725|thrombin|thrombin
276529|NCT02480673|Metabolic Syndrome X|metabolic syndrome x
276530|NCT02480673|Chia|chia
276531|NCT02480673|Dyslipidemia|dyslipidemia
276532|NCT02480660|Hospitalized|hospitalized
276533|NCT02480660|adolescents|adolescents
276534|NCT02480660|knowledge|knowledge
276535|NCT02480660|transition|transition
276536|NCT02480660|educational intervention|educational intervention
276537|NCT02480634|zoledronic acid|zoledronic acid
276538|NCT02480634|radiotherapy|radiotherapy
276539|NCT02480595|Abdominal Aortic Aneurysm|abdominal aortic aneurysm
276540|NCT02480595|AAA|aaa
276541|NCT02480595|Endovascular|endovascular
276542|NCT02480595|EVAR|evar
276543|NCT02480595|Stent|stent
276544|NCT02480595|Stent Graft|stent graft
276545|NCT02480595|High Angle|high angle
276546|NCT02480595|Tortuous|tortuous
276547|NCT02480556|blood loss; caesarean section ; manual placental separation|blood loss; caesarean section ; manual placental separation
276548|NCT02480530|Medication Adherence|medication adherence
276549|NCT02480530|Reciprocal Peer|reciprocal peer
276550|NCT02480530|Telemonitoring|telemonitoring
276551|NCT02480517|Hypertension|hypertension
276552|NCT02480517|Renal Denervation|renal denervation
744956|NCT00456092|DAS|das
276553|NCT02480478|Intrahepatic Cholestasis of Pregnancy|intrahepatic cholestasis of pregnancy
276554|NCT02480439|Drug Therapy|drug therapy
276555|NCT02480413|Broselow Tape|broselow tape
276556|NCT02480413|Weight estimation|weight estimation
276557|NCT02480413|Patient safety|patient safety
276558|NCT02480400|MDD|mdd
276559|NCT02480400|Escitalopram|escitalopram
276560|NCT02480400|Placebo|placebo
276561|NCT02480361|Acupuncture|acupuncture
276562|NCT02480361|Gastric cancer|gastric cancer
276563|NCT02480322|metabolic alterations|metabolic alterations
276564|NCT02480257|intervention|intervention
276565|NCT02480257|emotion regulation|emotion regulation
276566|NCT02480257|fMRI|fmri
276567|NCT02480257|mindfulness|mindfulness
276568|NCT02480257|yoga-based movement|yoga-based movement
276569|NCT02480231|Tension-Free Vaginal Tape|tension-free vaginal tape
276570|NCT02480231|Suburethral Slings|suburethral slings
276571|NCT02480231|Midurethral Slings|midurethral slings
276572|NCT02480231|Mid-urethral sling|mid-urethral sling
276573|NCT02480231|urinary retention|urinary retention
276574|NCT02480218|cognition|cognition
276575|NCT02480218|tamoxifen|tamoxifen
276576|NCT02480218|aromatase inhibitors|aromatase inhibitors
276577|NCT02480205|CPAP|cpap
276578|NCT02480205|NIV|niv
276579|NCT02480205|NIPPV|nippv
276580|NCT02480205|Edi|edi
276581|NCT02480192|Vasomotor|vasomotor
276582|NCT02480192|Symptoms|symptoms
276583|NCT02480179|functional MRI|functional mri
276584|NCT02480179|appetite|appetite
276585|NCT02480179|neurofeedback|neurofeedback
276586|NCT02480166|hepatitis C, genotype 6|hepatitis c, genotype 6
276587|NCT02480153|Phase 3|phase 3
276588|NCT02480153|adalimumab|adalimumab
276589|NCT02480153|rheumatoid arthritis|rheumatoid arthritis
276590|NCT02480140|Self-regulation|self-regulation
276591|NCT02480140|Constraint-induced movement therapy|constraint-induced movement therapy
276592|NCT02480140|Stroke|stroke
276593|NCT02480140|Functional recovery|functional recovery
276594|NCT02480140|Randomized controlled trial|randomized controlled trial
276595|NCT02480101|influenza vaccine pandemic|influenza vaccine pandemic
276596|NCT02480075|Genetic Variation|genetic variation
276597|NCT02480075|Genetic Polymorphism|genetic polymorphism
276598|NCT02480075|Polymorphism, Single Nucleotide|polymorphism, single nucleotide
276599|NCT02480075|Genetic Association Studies|genetic association studies
276600|NCT02480062|Decision Support System|decision support system
276601|NCT02480062|mHealth|mhealth
276602|NCT02480062|Primary Health Care|primary health care
276603|NCT02480062|Non-communicable diseases|non-communicable diseases
276604|NCT02480036|IORT|iort
276605|NCT02480036|Kyphoplasty|kyphoplasty
276606|NCT02480036|Spine|spine
276607|NCT02480036|Cancer|cancer
276608|NCT02479997|Neoadjuvant chemotherapy|neoadjuvant chemotherapy
276609|NCT02479997|Indocyanine green (ICG)|indocyanine green (icg)
276610|NCT02479997|Radioisotope (RI)|radioisotope (ri)
276611|NCT02479997|Near infrared fluorescence camera|near infrared fluorescence camera
276612|NCT02479984|staging laparoscopy|staging laparoscopy
276613|NCT02479984|pancreatic cancer|pancreatic cancer
276614|NCT02479984|biliary cancer|biliary cancer
276615|NCT02479958|Photochemotherapy|photochemotherapy
276616|NCT02479958|Bacteria|bacteria
276617|NCT02479932|Extra-peritoneal cesarean|extra-peritoneal cesarean
276618|NCT02479932|Intra-peritoneal cesarean|intra-peritoneal cesarean
276619|NCT02479919|theta burst stimulation|theta burst stimulation
276620|NCT02479919|Social Cognition|social cognition
276621|NCT02479919|Schizophrenia|schizophrenia
276622|NCT02479919|transcranial magnetic stimulation|transcranial magnetic stimulation
276623|NCT02479906|Post-Traumatic Stress Disorder|post-traumatic stress disorder
276624|NCT02479906|PTSD|ptsd
276625|NCT02479906|dTMS|dtms
276626|NCT02479893|cold snare polypectomy|cold snare polypectomy
276627|NCT02479893|APC|apc
276628|NCT02479893|hot snare polypectomy|hot snare polypectomy
276629|NCT02479815|Complementary feeding recommendation|complementary feeding recommendation
276630|NCT02479815|Program evaluation|program evaluation
276631|NCT02479815|Process and impact evaluation|process and impact evaluation
276632|NCT02479815|Micronutrient powder (MNP) safety|micronutrient powder (mnp) safety
276633|NCT02479802|plasma exchange|plasma exchange
276634|NCT02479802|albumin|albumin
276635|NCT02479789|Intravenous Lidocaine|intravenous lidocaine
276636|NCT02479789|Recurrent laryngeal nerve|recurrent laryngeal nerve
276637|NCT02479789|Intra operative nerve monitoring|intra operative nerve monitoring
276638|NCT02479789|Thyroidectomy|thyroidectomy
276639|NCT02479763|Epidural waveform analysis|epidural waveform analysis
276640|NCT02479763|Loss of resistance|loss of resistance
276641|NCT02479737|Chest tube|chest tube
276642|NCT02479737|chest drainage|chest drainage
276643|NCT02479737|retained blood complications|retained blood complications
276644|NCT02479737|chest tube clogging|chest tube clogging
276645|NCT02479737|hemothorax|hemothorax
276646|NCT02479737|tamponade|tamponade
276647|NCT02479737|heart surgery|heart surgery
276648|NCT02479737|pleural effusion|pleural effusion
276649|NCT02479737|intensive care|intensive care
276650|NCT02479724|continuous, non-invasive|continuous, non-invasive
276651|NCT02479711|glass ionomer|glass ionomer
276652|NCT02479711|bulk fill composite|bulk fill composite
276653|NCT02479672|breathing tube placement|breathing tube placement
276654|NCT02479672|VideoTrac® laryngoscope|videotrac® laryngoscope
276655|NCT02479672|direct laryngoscopy|direct laryngoscopy
276656|NCT02479659|Immunizations|immunizations
276657|NCT02479646|Pegfilgrastim|pegfilgrastim
276658|NCT02479646|G-CSF|g-csf
276659|NCT02479646|Pharmacokinetics|pharmacokinetics
276660|NCT02479646|Pharmacodynamics|pharmacodynamics
276661|NCT02479633|prognostic factors|prognostic factors
276662|NCT02479607|Breast Cancer|breast cancer
276663|NCT02479607|Cytostatic Agents|cytostatic agents
276664|NCT02479607|Nursing|nursing
276665|NCT02479607|Health Literacy|health literacy
276666|NCT02479607|Quality of Life|quality of life
276667|NCT02479607|Oncology Nursing|oncology nursing
276668|NCT02479607|Self Care|self care
276669|NCT02479607|Symptom Management|symptom management
276670|NCT02479607|Participatory Care|participatory care
276671|NCT02479607|Person-centered Care|person-centered care
276672|NCT02479607|Information and Communication Technology|information and communication technology
276673|NCT02479607|Patient-reported symptoms|patient-reported symptoms
276674|NCT02479607|Mobile device|mobile device
276675|NCT02479594|competence-feedback|competence-feedback
276676|NCT02479581|Enhanced Recovery after Surgery|enhanced recovery after surgery
276677|NCT02479568|Cardiovascular disease|cardiovascular disease
276678|NCT02479568|biomarkers|biomarkers
276679|NCT02479568|transcriptomics|transcriptomics
276680|NCT02479568|orange juice|orange juice
276681|NCT02479568|hesperidin|hesperidin
276682|NCT02479568|systolic blood pressure|systolic blood pressure
276683|NCT02479568|metabolomics|metabolomics
276684|NCT02479568|cardiovascular risk factor|cardiovascular risk factor
276685|NCT02479542|Negative-Pressure Wound Therapy|negative-pressure wound therapy
276686|NCT02479542|Wound Healing|wound healing
276687|NCT02479542|Global Health|global health
276688|NCT02479542|Cameroon|cameroon
276689|NCT02479516|Diabetes screening|diabetes screening
276690|NCT02479516|Health Promotion|health promotion
276691|NCT02479516|Low and Middle Income Countries|low and middle income countries
276692|NCT02479516|CHAP|chap
276693|NCT02479503|antibiotic prophylaxis heart transplantation|antibiotic prophylaxis heart transplantation
276694|NCT02479490|metastatic renal cancer|metastatic renal cancer
276695|NCT02479490|failure of VEGFR_TKI|failure of vegfr_tki
276696|NCT02479490|prednisone|prednisone
276697|NCT02479490|everolimus|everolimus
276698|NCT02479477|Public Health|public health
276699|NCT02479477|Nursing Staff, Hospital|nursing staff, hospital
276700|NCT02479464|AssureRx|assurerx
276701|NCT02479464|Algorithm|algorithm
276702|NCT02479464|Major depressive disorder|major depressive disorder
276703|NCT02479451|End stage renal disease|end stage renal disease
276704|NCT02479451|Olfaction|olfaction
276705|NCT02479451|Dialysis|dialysis
276706|NCT02479451|Hemodialysis|hemodialysis
276707|NCT02479451|Malnutrition|malnutrition
276708|NCT02479425|pressure ulcer|pressure ulcer
276709|NCT02479425|Positioning|positioning
276710|NCT02479412|Mild to moderate asthma|mild to moderate asthma
276711|NCT02479412|FEV1|fev1
276712|NCT02479412|efficacy|efficacy
276713|NCT02479412|safety|safety
276714|NCT02479399|Suglat|suglat
276715|NCT02479399|SGLT-2 inhibitor|sglt-2 inhibitor
276716|NCT02479399|Ipragliflozin L-Proline|ipragliflozin l-proline
276717|NCT02479399|ASP1941 long-term use|asp1941 long-term use
276718|NCT02479347|General surgery|general surgery
276719|NCT02479347|Postoperative|postoperative
276720|NCT02479334|Spices|spices
276721|NCT02479334|Functional food|functional food
276722|NCT02479334|Cardiometabolic risk|cardiometabolic risk
276723|NCT02479334|Metabolic syndrome|metabolic syndrome
276724|NCT02479334|Inflammation|inflammation
276725|NCT02479334|Peripheral blood mononuclear cell|peripheral blood mononuclear cell
276726|NCT02479334|Acute|acute
276727|NCT02479321|Perioperative Goal-Directed Hemodynamic Therapy|perioperative goal-directed hemodynamic therapy
276728|NCT02479321|Fluid therapy|fluid therapy
276729|NCT02479321|Aged|aged
276730|NCT02479321|Perioperative complications|perioperative complications
276731|NCT02479321|Survival|survival
276732|NCT02479308|Alkermes|alkermes
276733|NCT02479308|Samidorphan|samidorphan
276734|NCT02479308|ALKS 5461|alks 5461
276735|NCT02479308|QT/QTc|qt/qtc
276736|NCT02479308|Buprenorphine|buprenorphine
276737|NCT02479308|Pharmacodynamics|pharmacodynamics
276738|NCT02479269|Brain Natriuretic Peptide|brain natriuretic peptide
276739|NCT02479269|aerobic execise|aerobic execise
276740|NCT02479269|C- Reactive Protein|c- reactive protein
276741|NCT02479256|PCOS|pcos
276742|NCT02479256|Induction of ovulation|induction of ovulation
276743|NCT02479256|Clomiphene citrate|clomiphene citrate
276744|NCT02479256|Tamoxifen|tamoxifen
276745|NCT02479243|Arterial Spin Labeling|arterial spin labeling
276746|NCT02479243|MRI|mri
276747|NCT02479243|Atherosclerotic Stenosis|atherosclerotic stenosis
276748|NCT02479243|Collateral Circulation|collateral circulation
353694|NCT02079935|BN|bn
276749|NCT02479243|Ischemic stroke|ischemic stroke
276750|NCT02479230|vaccine|vaccine
276751|NCT02479230|breast cancer|breast cancer
276752|NCT02479230|metastatic|metastatic
276753|NCT02479204|safety|safety
276754|NCT02479204|heart rate|heart rate
276755|NCT02479204|pharmacokinetics|pharmacokinetics
276756|NCT02479191|Abdominal|abdominal
276757|NCT02479191|Aortic|aortic
276758|NCT02479191|Aneurysm|aneurysm
276759|NCT02479152|Mechanical CPR|mechanical cpr
276760|NCT02479152|Hemodynamics|hemodynamics
276761|NCT02479126|Interstitial Lung Disease|interstitial lung disease
276762|NCT02479126|Idiopathic Pulmonary Fibrosis|idiopathic pulmonary fibrosis
276763|NCT02479126|Electronic Health Records|electronic health records
276764|NCT02479126|Computed Tomography|computed tomography
276765|NCT02479126|Mortality|mortality
276766|NCT02479126|Hospitalization|hospitalization
276767|NCT02479126|Acute care visits|acute care visits
276768|NCT02479126|Anti-inflammatory drug therapies|anti-inflammatory drug therapies
276769|NCT02479113|GDM|gdm
276770|NCT02479113|Maternal Hypertriglyceridaemia|maternal hypertriglyceridaemia
276771|NCT02479100|Contrast Enhanced Spectral Mammography|contrast enhanced spectral mammography
276772|NCT02479100|Breast|breast
276773|NCT02479100|Cancer|cancer
276774|NCT02479100|Diagnosis|diagnosis
276775|NCT02479100|Patient management|patient management
276776|NCT02479087|von Willebrand Factor|von willebrand factor
276777|NCT02479087|Factor VIII|factor viii
276778|NCT02479087|Hemorrhage|hemorrhage
276779|NCT02479087|Immune Tolerance|immune tolerance
276780|NCT02479087|Hemophilia A|hemophilia a
276781|NCT02479074|Chronic|chronic
276782|NCT02479061|Observationnal study|observationnal study
276783|NCT02479061|Prevalence|prevalence
276784|NCT02479061|Palliative care|palliative care
276785|NCT02479061|Anti cancer center|anti cancer center
276786|NCT02479048|satiety/appetite|satiety/appetite
276787|NCT02479048|glycemic response|glycemic response
276788|NCT02479048|cardiometabolic risk|cardiometabolic risk
276789|NCT02479035|insulin sensitive|insulin sensitive
276790|NCT02479035|insulin resistant|insulin resistant
276791|NCT02479035|red raspberry|red raspberry
276792|NCT02479035|polyphenols|polyphenols
276793|NCT02479035|bioavailability|bioavailability
276794|NCT02478996|perioperative|perioperative
276795|NCT02478996|internet-based|internet-based
276796|NCT02478996|exercise program|exercise program
276797|NCT02478957|mastocytosis|mastocytosis
276798|NCT02478957|cromolyn sodium|cromolyn sodium
276799|NCT02478944|Inflammatory bowel disease|inflammatory bowel disease
276800|NCT02478944|Manometry|manometry
276801|NCT02478892|high risk|high risk
276802|NCT02478892|specifically those with BRCA1/2 mutations|specifically those with brca1/2 mutations
276803|NCT02478827|Cognitive Training|cognitive training
276804|NCT02478827|Working Memory|working memory
276805|NCT02478827|Processing Speed|processing speed
276806|NCT02478788|ADHD|adhd
276807|NCT02478775|obesity|obesity
276808|NCT02478775|fertility|fertility
276809|NCT02478775|infertility|infertility
276810|NCT02478775|reproductive hormones|reproductive hormones
276811|NCT02478762|Foetal glycated hemoglobin|foetal glycated hemoglobin
276812|NCT02478762|Glycemic objectives treatment|glycemic objectives treatment
276813|NCT02478736|postoperative delirium|postoperative delirium
276814|NCT02478736|on-pump cardiac surgery|on-pump cardiac surgery
276815|NCT02478736|cerebral oximetry|cerebral oximetry
276816|NCT02478736|cerebral blood flow velosity|cerebral blood flow velosity
276817|NCT02478723|requiring therapy|requiring therapy
276818|NCT02478723|Teeth|teeth
276819|NCT02478697|tobacco smoking behavior|tobacco smoking behavior
276820|NCT02478697|employment|employment
276821|NCT02478697|job-seeking|job-seeking
276822|NCT02478697|tobacco cessation|tobacco cessation
276823|NCT02478697|transtheoretical model|transtheoretical model
276824|NCT02478697|behavior change|behavior change
276825|NCT02478684|delayed cord clamping|delayed cord clamping
276826|NCT02478684|premature infants|premature infants
276827|NCT02478684|randomized study|randomized study
276828|NCT02478684|hematocrit|hematocrit
276829|NCT02478658|irisin|irisin
276830|NCT02478658|resistance training|resistance training
276831|NCT02478658|physical fitness|physical fitness
276832|NCT02478658|Volunteers|volunteers
276833|NCT02478632|tenofovir disoproxil fumarate|tenofovir disoproxil fumarate
276834|NCT02478632|dolutegravir plus rilpivirine|dolutegravir plus rilpivirine
276835|NCT02478632|two-drug regimen|two-drug regimen
276836|NCT02478632|bone mineral density|bone mineral density
276837|NCT02478632|dual energy X-ray absorptiometry (DEXA)|dual energy x-ray absorptiometry (dexa)
276838|NCT02478632|Human Immunodeficiency Virus-1|human immunodeficiency virus-1
276839|NCT02478632|nucleoside reverse transcriptase inhibitor -sparing regimen|nucleoside reverse transcriptase inhibitor -sparing regimen
276840|NCT02478632|integrase inhibitor|integrase inhibitor
276841|NCT02478619|Obesity|obesity
276842|NCT02478619|Respiratory Muscle Training|respiratory muscle training
276843|NCT02478619|Bariatric Surgery|bariatric surgery
276844|NCT02478619|Breathing exercises|breathing exercises
276845|NCT02478619|Gastroplasty|gastroplasty
276846|NCT02478606|Lower Extremity|lower extremity
276847|NCT02478606|Muscle Stretching Exercises|muscle stretching exercises
276848|NCT02478606|Muscle Strength|muscle strength
276849|NCT02478606|Static Stretching|static stretching
276850|NCT02478606|Proprioceptive Neuromuscular Facilitation (PNF) Stretching|proprioceptive neuromuscular facilitation (pnf) stretching
276851|NCT02478606|Muscle Strength Dynamometer|muscle strength dynamometer
276852|NCT02478593|Education|education
276853|NCT02478593|Geriatric|geriatric
276854|NCT02478593|Benzodiazepine|benzodiazepine
276855|NCT02478593|Prevalence|prevalence
276856|NCT02478580|Obstructive Sleep Apnea|obstructive sleep apnea
276857|NCT02478580|Anesthesia Recovery Period|anesthesia recovery period
276858|NCT02478554|Fetal growth restriction|fetal growth restriction
276859|NCT02478554|macrosomia|macrosomia
276860|NCT02478541|triglycerides|triglycerides
276861|NCT02478541|glucose|glucose
276862|NCT02478541|fructose|fructose
276863|NCT02478541|fatty acids|fatty acids
276864|NCT02478515|ranibizumab|ranibizumab
276865|NCT02478515|PRN regimen|prn regimen
276866|NCT02478515|macular edema|macular edema
276867|NCT02478515|branch retinal vein occlusion|branch retinal vein occlusion
276868|NCT02478502|testicular cancer|testicular cancer
276869|NCT02478502|cisplatin resistancy|cisplatin resistancy
276870|NCT02478489|alcohol|alcohol
276871|NCT02478489|heavy drinking|heavy drinking
276872|NCT02478489|naltrexone|naltrexone
276873|NCT02478489|hospital|hospital
276874|NCT02478489|alcohol use disorder|alcohol use disorder
276875|NCT02478489|alcohol dependence|alcohol dependence
276876|NCT02478489|comparative effectiveness|comparative effectiveness
276877|NCT02478463|Cabotegravir|cabotegravir
276878|NCT02478463|Pharmacokinetic|pharmacokinetic
276879|NCT02478463|Healthy Adult Volunteers|healthy adult volunteers
276880|NCT02478463|GSK1265744|gsk1265744
276881|NCT02478437|Lumbar Facet Syndrome|lumbar facet syndrome
276882|NCT02478411|muscle weakness|muscle weakness
276883|NCT02478411|rehabilitation|rehabilitation
276884|NCT02478411|intensive care|intensive care
276885|NCT02478411|mechanical ventilation|mechanical ventilation
276886|NCT02478411|cyclo ergometer|cyclo ergometer
276887|NCT02478411|physiotherapy|physiotherapy
276888|NCT02478385|Birth environment|birth environment
276889|NCT02478385|oxytocin|oxytocin
276890|NCT02478385|epidural|epidural
276891|NCT02478385|analgesia|analgesia
276892|NCT02478385|home-like|home-like
276893|NCT02478372|local infiltration analgesia|local infiltration analgesia
276894|NCT02478372|Epidural|epidural
276895|NCT02478372|Enhanced Recovery|enhanced recovery
276896|NCT02478372|Total Knee Arthroplasty|total knee arthroplasty
276897|NCT02478333|Healthy|healthy
276898|NCT02478333|ALS-008176|als-008176
276899|NCT02478333|Japanese adult participants|japanese adult participants
276900|NCT02478320|Advanced Cancers|advanced cancers
276901|NCT02478320|CDKN2A-Deficient Advanced Solid Cancers|cdkn2a-deficient advanced solid cancers
276902|NCT02478320|Advanced or metastatic cancer.|advanced or metastatic cancer.
276903|NCT02478320|Ilorasertib|ilorasertib
276904|NCT02478320|ABT-348|abt-348
276905|NCT02478307|chronic low back pain|chronic low back pain
276906|NCT02478307|mindfulness meditation|mindfulness meditation
276907|NCT02478307|cognitive therapy|cognitive therapy
276908|NCT02478307|mindfulness-based cognitive therapy|mindfulness-based cognitive therapy
276909|NCT02478307|efficacy|efficacy
276910|NCT02478307|mechanisms|mechanisms
276911|NCT02478307|coping|coping
276912|NCT02478294|Atrial Fibrillation|atrial fibrillation
276913|NCT02478294|Stroke|stroke
276914|NCT02478294|Systemic embolism|systemic embolism
276915|NCT02478294|Left atrial appendage excision|left atrial appendage excision
276916|NCT02478294|Warfarin|warfarin
276917|NCT02478268|idiopathic pulmonary fibrosis|idiopathic pulmonary fibrosis
276918|NCT02478268|xenon gas|xenon gas
276919|NCT02478255|Radiation induced lung injury|radiation induced lung injury
276920|NCT02478255|Xenon gas|xenon gas
276921|NCT02478255|hyperpolarized|hyperpolarized
276922|NCT02478229|Liver transplant|liver transplant
276923|NCT02478229|Genotype 1 HCV infection|genotype 1 hcv infection
276924|NCT02478229|Sofosbuvir (SOF)/ Ledipasvir (LDV)|sofosbuvir (sof)/ ledipasvir (ldv)
276925|NCT02478229|Sustained virological response (SVR12 )|sustained virological response (svr12 )
276926|NCT02478203|Airtraq|airtraq
276927|NCT02478203|Glidescope|glidescope
276928|NCT02478203|pediatric|pediatric
276929|NCT02478203|face-to-face|face-to-face
276930|NCT02478177|Anticoagulant|anticoagulant
276931|NCT02478177|Stroke|stroke
276932|NCT02478177|Ischemic Stroke|ischemic stroke
276933|NCT02478177|Intracerebral hemorrhage|intracerebral hemorrhage
276934|NCT02478151|Deceased donor liver transplant|deceased donor liver transplant
276935|NCT02478151|Normothermic machine perfusion|normothermic machine perfusion
276936|NCT02478125|metastatic castrate resistant prostate cancer|metastatic castrate resistant prostate cancer
276937|NCT02478112|Intensity Modulated Radiotherapy|intensity modulated radiotherapy
276938|NCT02478112|Balloon implant|balloon implant
276939|NCT02478099|MPDL3280A|mpdl3280a
276940|NCT02478099|solid tumors|solid tumors
276941|NCT02478086|amino acids|amino acids
276942|NCT02478086|renal function|renal function
276943|NCT02478086|extreme premature|extreme premature
276944|NCT02478060|Allergy|allergy
276945|NCT02478060|Birch|birch
276946|NCT02478060|Rhinitis|rhinitis
276947|NCT02478060|Rhinoconjuntivitis|rhinoconjuntivitis
276948|NCT02478060|SPIRE|spire
276949|NCT02478060|Toleromune|toleromune
276950|NCT02478047|to Evaluate the Effectiveness of Acupucnture in the Management of Chemotherapy-induced Nausea and Vomiting|to evaluate the effectiveness of acupucnture in the management of chemotherapy-induced nausea and vomiting
276951|NCT02478021|effects of cortisol on cognition|effects of cortisol on cognition
277077|NCT02477137|Prostate Cancer|prostate cancer
276952|NCT02478008|Transcatheter Mitral Valve Replacement|transcatheter mitral valve replacement
276953|NCT02478008|Mitral Regurgitation|mitral regurgitation
276954|NCT02478008|Mitral Insufficiency|mitral insufficiency
276955|NCT02478008|Transapical|transapical
276956|NCT02477995|Immunogenicity|immunogenicity
276957|NCT02477995|Safety|safety
276958|NCT02477995|DTaP Vaccine|dtap vaccine
276959|NCT02477982|Propofol|propofol
276960|NCT02477982|Cardiopulmonary Bypass|cardiopulmonary bypass
276961|NCT02477982|Pharmacokinetics|pharmacokinetics
276962|NCT02477982|Obesity|obesity
276963|NCT02477956|vitamin D|vitamin d
276964|NCT02477956|obesity|obesity
276965|NCT02477956|bariatric surgery|bariatric surgery
276966|NCT02477943|Concussion|concussion
276967|NCT02477943|Mild Traumatic Brain Injury|mild traumatic brain injury
276968|NCT02477943|Sport Related Concussion|sport related concussion
276969|NCT02477917|allergy|allergy
276970|NCT02477917|SCIT|scit
276971|NCT02477904|Autism|autism
276972|NCT02477904|Autism Spectrum Disorder|autism spectrum disorder
276973|NCT02477904|Ketogenic Diet|ketogenic diet
276974|NCT02477904|Biochemical Profiles|biochemical profiles
276975|NCT02477891|Multiple myeloma|multiple myeloma
276976|NCT02477891|Daratumumab|daratumumab
276977|NCT02477891|Early access|early access
276978|NCT02477878|Adult leukemias and myelodysplasia|adult leukemias and myelodysplasia
276979|NCT02477878|Adult lymphomas|adult lymphomas
276980|NCT02477878|Adult multiple myeloma|adult multiple myeloma
276981|NCT02477878|allogeneic stem cell transplant|allogeneic stem cell transplant
276982|NCT02477878|donor lymphocyte infusion|donor lymphocyte infusion
276983|NCT02477852|tuberculosis|tuberculosis
276984|NCT02477852|spinal|spinal
276985|NCT02477852|general|general
276986|NCT02477852|operation|operation
276987|NCT02477852|drug|drug
276988|NCT02477852|therapy|therapy
276989|NCT02477839|Epilepsy, children, partial-onset seizures, lacosamide, LCM, pediatric|epilepsy, children, partial-onset seizures, lacosamide, lcm, pediatric
276990|NCT02477800|BIIB037|biib037
276991|NCT02477800|Aducanumab|aducanumab
276992|NCT02477787|HLA-haploidentical hematopoietic cell transplantation|hla-haploidentical hematopoietic cell transplantation
276993|NCT02477787|natural killer cells|natural killer cells
276994|NCT02477774|Anterolateral Thigh|anterolateral thigh
276995|NCT02477670|Negative Symptoms|negative symptoms
276996|NCT02477670|Schizophrenia|schizophrenia
276997|NCT02477670|AVP-786|avp-786
276998|NCT02477657|Adult patients with refractory malignant ascites secondary to GU or GI malignancy.|adult patients with refractory malignant ascites secondary to gu or gi malignancy.
276999|NCT02477644|Advanced FIGO IIIB|advanced figo iiib
277000|NCT02477644|IV high grade serious ovarian cancer|iv high grade serious ovarian cancer
277001|NCT02477644|endometrioid ovarian cancer|endometrioid ovarian cancer
277002|NCT02477644|standard first-line treatment|standard first-line treatment
277003|NCT02477644|platinum-taxane chemotherapy|platinum-taxane chemotherapy
277004|NCT02477644|bevacizumab|bevacizumab
277005|NCT02477644|olaparib|olaparib
277006|NCT02477644|placebo|placebo
277007|NCT02477631|Myelodysplastic syndrome|myelodysplastic syndrome
277008|NCT02477631|oxidative stress|oxidative stress
277009|NCT02477631|labile plasma iron|labile plasma iron
277010|NCT02477592|long standing persistent atrial fibrillation|long standing persistent atrial fibrillation
277011|NCT02477592|novel approach|novel approach
277012|NCT02477592|ablation|ablation
277013|NCT02477566|pcos|pcos
277014|NCT02477566|Long acting Triptorelin|long acting triptorelin
277015|NCT02477566|Short acting Triptorelin|short acting triptorelin
277016|NCT02477566|In Vitro Fertilization|in vitro fertilization
277017|NCT02477553|decision aid|decision aid
277018|NCT02477553|cancer screening|cancer screening
277019|NCT02477553|colorectal neoplasm|colorectal neoplasm
277020|NCT02477553|decision making|decision making
277021|NCT02477553|risk communication|risk communication
277022|NCT02477553|numeracy|numeracy
277023|NCT02477553|health literacy|health literacy
277024|NCT02477527|atripla|atripla
277025|NCT02477527|stribild|stribild
277026|NCT02477527|dreams|dreams
277027|NCT02477501|Spinal anesthesia|spinal anesthesia
277028|NCT02477501|cesarean|cesarean
277029|NCT02477501|blood pressure|blood pressure
277030|NCT02477501|Norepinephrine|norepinephrine
277031|NCT02477501|Ephedrine|ephedrine
277032|NCT02477488|Allopurinol|allopurinol
277033|NCT02477488|Renal Dialysis|renal dialysis
277135|NCT02476955|Biomarkers|biomarkers
277034|NCT02477475|reflux esophagitis|reflux esophagitis
277035|NCT02477475|Nexium|nexium
277036|NCT02477449|safety|safety
277037|NCT02477449|istaroxime|istaroxime
277038|NCT02477423|Microbiome|microbiome
277039|NCT02477423|Antibiotics|antibiotics
277040|NCT02477410|porcine protein|porcine protein
277041|NCT02477410|appetite|appetite
277042|NCT02477410|muscle protein synthesis|muscle protein synthesis
277043|NCT02477410|gastrointestinal hormones|gastrointestinal hormones
277044|NCT02477397|Spiromax|spiromax
277045|NCT02477397|Budesonide/formoterol|budesonide/formoterol
277046|NCT02477397|COPD|copd
277047|NCT02477397|exacerbations|exacerbations
277048|NCT02477397|SMART|smart
277049|NCT02477345|Cholestasis|cholestasis
277050|NCT02477345|Parenteral Nutrition|parenteral nutrition
277051|NCT02477345|Liver disease|liver disease
277052|NCT02477332|QGE031|qge031
277053|NCT02477332|ligelizumab|ligelizumab
277054|NCT02477332|omalizumab|omalizumab
277055|NCT02477332|chronic|chronic
277056|NCT02477332|spontaneous|spontaneous
277057|NCT02477332|urticaria|urticaria
277058|NCT02477332|adults|adults
277059|NCT02477332|CSU|csu
277060|NCT02477293|Hyeonggaeyeongyo-tang|hyeonggaeyeongyo-tang
277061|NCT02477293|Chronic rhinitis|chronic rhinitis
277062|NCT02477293|Pattern identification|pattern identification
277063|NCT02477293|Korean medicine|korean medicine
277064|NCT02477254|lupus|lupus
277065|NCT02477241|overactive bladder syndrome|overactive bladder syndrome
277066|NCT02477241|urgency urinary incontinence|urgency urinary incontinence
277067|NCT02477241|fMRI|fmri
277068|NCT02477241|urodynamics|urodynamics
277069|NCT02477215|Multiple Myeloma|multiple myeloma
277070|NCT02477202|Mirena® IUD's|mirena® iud's
277071|NCT02477202|Women|women
277072|NCT02477202|risk-reducing salpingo-oophorectomy|risk-reducing salpingo-oophorectomy
277073|NCT02477202|risk-reducing salpingectomy|risk-reducing salpingectomy
277074|NCT02477163|Nephropathy induced by drugs medicaments and biological substances|nephropathy induced by drugs medicaments and biological substances
277075|NCT02477163|Other nephritis and nephropathy not specified as acute or chronic|other nephritis and nephropathy not specified as acute or chronic
277076|NCT02477150|lupus|lupus
277079|NCT02477137|Health Literacy|health literacy
277080|NCT02477137|Quality of Life|quality of life
277081|NCT02477137|Radiotherapy|radiotherapy
277082|NCT02477137|Oncology Nursing|oncology nursing
277083|NCT02477137|Self Care|self care
277084|NCT02477137|Symptom Management|symptom management
277085|NCT02477137|Participatory Care|participatory care
277086|NCT02477137|Person-centered Care|person-centered care
277087|NCT02477137|Information and Communication Technology|information and communication technology
277088|NCT02477137|Patient-reported symptoms|patient-reported symptoms
277089|NCT02477137|Mobile device|mobile device
277090|NCT02477111|Endovascular repair|endovascular repair
277091|NCT02477098|rectus sheath block|rectus sheath block
277092|NCT02477098|cytokines|cytokines
277093|NCT02477098|sleep|sleep
277094|NCT02477085|Labor|labor
277095|NCT02477085|induction|induction
277096|NCT02477085|delivery|delivery
277097|NCT02477085|prostaglandins|prostaglandins
277098|NCT02477085|oxytocin|oxytocin
277099|NCT02477085|amniotomy|amniotomy
277100|NCT02477085|balloon catheter|balloon catheter
277101|NCT02477059|Hand OA|hand oa
277102|NCT02477059|Tocilizumab|tocilizumab
277103|NCT02477059|Osteoarthritis|osteoarthritis
277104|NCT02477059|Interleukin-6|interleukin-6
277105|NCT02477020|Drug Therapy|drug therapy
277106|NCT02477007|Paediatric emergency|paediatric emergency
277107|NCT02477007|pain|pain
277108|NCT02477007|long-bones fractures|long-bones fractures
277109|NCT02477007|morphine|morphine
277110|NCT02477007|ibuprofen|ibuprofen
277111|NCT02477007|paracetamol|paracetamol
277112|NCT02477007|children|children
277113|NCT02476994|Essential Fatty Acids (EFA)|essential fatty acids (efa)
277114|NCT02476994|Parenteral Nutrition|parenteral nutrition
277115|NCT02476994|Clinolipid/Clinoleic|clinolipid/clinoleic
277116|NCT02476994|Parenteral Nutrition Associated Cholestasis (PNAC)|parenteral nutrition associated cholestasis (pnac)
277117|NCT02476994|Parenteral Nutrition Associated Liver Disease (PNALD)|parenteral nutrition associated liver disease (pnald)
277118|NCT02476994|Intestinal Failure Associated Liver Disease (IFALD)|intestinal failure associated liver disease (ifald)
277119|NCT02476994|Phytosterols|phytosterols
277120|NCT02476994|Intralipid|intralipid
277121|NCT02476994|Infants/Preterm Infants|infants/preterm infants
277122|NCT02476994|FADS1 and FADS2|fads1 and fads2
277123|NCT02476994|Short Bowel Syndrome|short bowel syndrome
277124|NCT02476994|Cancer Nutrition|cancer nutrition
277125|NCT02476994|Olive Oil Emulsion|olive oil emulsion
277126|NCT02476994|Soybean Oil Emulsion|soybean oil emulsion
277127|NCT02476955|ARQ 092|arq 092
277128|NCT02476955|Carboplatin|carboplatin
277129|NCT02476955|Paclitaxel|paclitaxel
277130|NCT02476955|AKT inhibitor in combination therapy|akt inhibitor in combination therapy
277131|NCT02476955|Targeted therapy|targeted therapy
277132|NCT02476955|Molecular therapy|molecular therapy
277133|NCT02476955|Tyrosine kinase inhibitor (TKI)|tyrosine kinase inhibitor (tki)
354142|NCT02077738|elderly|elderly
277134|NCT02476955|Receptor tyrosine kinase (RTK)|receptor tyrosine kinase (rtk)
277136|NCT02476955|Phase 1 - Phase I|phase 1 - phase i
277137|NCT02476955|Solid tumors|solid tumors
277138|NCT02476955|Metastatic solid tumors|metastatic solid tumors
277139|NCT02476955|Recurrent solid tumors|recurrent solid tumors
277140|NCT02476955|Ovarian cancer|ovarian cancer
277141|NCT02476955|Endometrial cancer|endometrial cancer
277142|NCT02476955|Cervical cancer|cervical cancer
277143|NCT02476955|Triple-negative breast cancer|triple-negative breast cancer
277144|NCT02476955|AKT kinases|akt kinases
277145|NCT02476955|AKT pathway|akt pathway
277146|NCT02476955|AKT signaling|akt signaling
277147|NCT02476955|AKT inhibitor|akt inhibitor
277148|NCT02476955|AKT pan inhibitor|akt pan inhibitor
277149|NCT02476955|Chemotherapy|chemotherapy
277150|NCT02476955|PI3K/AKT/mTOR signaling pathway|pi3k/akt/mtor signaling pathway
277152|NCT02476955|AKT2|akt2
277153|NCT02476955|AKT3|akt3
277154|NCT02476955|Phase I Clinical Trial|phase i clinical trial
277155|NCT02476955|Clinical oncology|clinical oncology
277156|NCT02476955|Tumor|tumor
277157|NCT02476955|AKT1 inhibitor|akt1 inhibitor
277158|NCT02476955|AKT2 inhibitor|akt2 inhibitor
277159|NCT02476955|AKT3 inhibitor|akt3 inhibitor
277160|NCT02476955|AKT1 mutation|akt1 mutation
277161|NCT02476955|AKT2 mutation|akt2 mutation
277162|NCT02476955|AKT3 mutation|akt3 mutation
277163|NCT02476955|AKT1 amplification|akt1 amplification
277164|NCT02476955|AKT2 amplification|akt2 amplification
277165|NCT02476955|AKT3 amplification|akt3 amplification
277166|NCT02476955|Anastrozole|anastrozole
277167|NCT02476955|Estrogen receptor positive|estrogen receptor positive
277168|NCT02476955|PIK3CA mutation|pik3ca mutation
277169|NCT02476929|Electronic nose|electronic nose
277170|NCT02476929|Nasal nitrous oxide|nasal nitrous oxide
277171|NCT02476929|Allergic Rhinitis|allergic rhinitis
277172|NCT02476929|Non-Allergic Rhinitis|non-allergic rhinitis
277173|NCT02476929|Nasal polyps|nasal polyps
277174|NCT02476916|Pyruvate Kinase Deficiency|pyruvate kinase deficiency
277175|NCT02476916|Hemolytic anemia|hemolytic anemia
277176|NCT02476916|Protein Kinase R (PKR)|protein kinase r (pkr)
277177|NCT02476916|Drive PK|drive pk
277178|NCT02476877|comorbidity|comorbidity
277179|NCT02476877|epidemiology|epidemiology
277180|NCT02476877|mental illness|mental illness
277181|NCT02476877|drug abuse|drug abuse
277182|NCT02476864|macitentan|macitentan
277183|NCT02476864|biocomparison|biocomparison
277184|NCT02476864|safety|safety
277185|NCT02476851|Blood Donation|blood donation
277186|NCT02476851|Whole Blood|whole blood
277187|NCT02476838|hand injury|hand injury
277188|NCT02476838|hand amputation|hand amputation
277189|NCT02476838|hand amputee|hand amputee
277190|NCT02476838|hand surgery|hand surgery
277191|NCT02476825|volunteers|volunteers
277192|NCT02476773|Hookworm Vaccine|hookworm vaccine
277193|NCT02476773|Na-APR-1 (M74)/Alhydrogel® Hookworm Vaccine|na-apr-1 (m74)/alhydrogel® hookworm vaccine
277194|NCT02476773|Na-GST-1/Alhydrogel® Hookworm Vaccine|na-gst-1/alhydrogel® hookworm vaccine
277195|NCT02476760|Incretins|incretins
277196|NCT02476760|Antidiabetic agents|antidiabetic agents
277197|NCT02476760|Pancreatitis|pancreatitis
277198|NCT02476747|Colonic polyp|colonic polyp
277199|NCT02476734|REDIRECTED AUTOLOGOUS CART- 19 T-CELL IMMUNOTHERAPY|redirected autologous cart- 19 t-cell immunotherapy
277200|NCT02476721|pulmonary embolism|pulmonary embolism
277201|NCT02476721|emergency department|emergency department
277202|NCT02476708|schizophrenia|schizophrenia
277203|NCT02476708|schizoaffective disorder|schizoaffective disorder
277204|NCT02476708|cognition|cognition
277205|NCT02476708|curcumin|curcumin
277206|NCT02476695|CHB|chb
277207|NCT02476682|Sessile serrated polyps|sessile serrated polyps
277208|NCT02476682|Advanced mucosal neoplasia|advanced mucosal neoplasia
277209|NCT02476669|plasma EBV DNA|plasma ebv dna
277210|NCT02476669|biomarker|biomarker
277211|NCT02476669|intensity-modulated radiation therapy|intensity-modulated radiation therapy
277212|NCT02476617|Treatment naive|treatment naive
277213|NCT02476617|Interferon free|interferon free
277214|NCT02476617|HCV|hcv
277215|NCT02476617|Chronic Hepatitis C|chronic hepatitis c
277216|NCT02476617|Hepatitis C Genotype 1a|hepatitis c genotype 1a
277217|NCT02476617|Hepatitis C|hepatitis c
277218|NCT02476617|pegylated-interferon (pegIFN)/ribavirin (RBV) experienced|pegylated-interferon (pegifn)/ribavirin (rbv) experienced
277219|NCT02476604|prevention|prevention
277220|NCT02476604|adult|adult
277221|NCT02476604|student|student
277222|NCT02476591|Resource utilization|resource utilization
277223|NCT02476591|intensive care unit|intensive care unit
277224|NCT02476578|Hypocholesterolemia|hypocholesterolemia
277225|NCT02476578|Frail Elderly|frail elderly
277226|NCT02476578|Aged|aged
277227|NCT02476578|Aged, 80 and over|aged, 80 and over
277228|NCT02476578|Cholesterol|cholesterol
277229|NCT02476578|Clinical Laboratory Information Systems|clinical laboratory information systems
277230|NCT02476578|Hemoglobin A, Glycosylated|hemoglobin a, glycosylated
277231|NCT02476578|diet therapy|diet therapy
277232|NCT02476578|Anticholesteremic Agents|anticholesteremic agents
277233|NCT02476578|Health Services for the Aged|health services for the aged
277234|NCT02476578|Hypoglycemic Agents|hypoglycemic agents
277235|NCT02476578|Hypoglycemia|hypoglycemia
277236|NCT02476565|Intubation|intubation
277237|NCT02476461|percutanepus needle fasciotomy|percutanepus needle fasciotomy
277238|NCT02476461|xiapex|xiapex
277239|NCT02476461|clostridium histolyticum|clostridium histolyticum
277240|NCT02476448|ureteral jet|ureteral jet
277241|NCT02476448|pelvic surgery|pelvic surgery
277242|NCT02476448|cystoscopy|cystoscopy
277243|NCT02476435|Depersonalization|depersonalization
277244|NCT02476435|Derealization|derealization
277245|NCT02476435|Embodiment|embodiment
277246|NCT02476435|Emotional numbing|emotional numbing
277247|NCT02476435|Transcranial magnetic stimulation|transcranial magnetic stimulation
277248|NCT02476435|Angular gyrus|angular gyrus
277249|NCT02476435|Temporo-parietal junction|temporo-parietal junction
277250|NCT02476422|Diclofenac potassium|diclofenac potassium
277251|NCT02476422|Post-operative dental pain|post-operative dental pain
277252|NCT02476422|Moderate to severe pain|moderate to severe pain
277253|NCT02476409|congestive heart failure|congestive heart failure
277254|NCT02476409|tolvaptan|tolvaptan
277255|NCT02476409|copeptin|copeptin
277256|NCT02476331|Cognitive training|cognitive training
277257|NCT02476331|Working memory|working memory
277258|NCT02476331|Emotion regulation|emotion regulation
277259|NCT02476266|resistance training|resistance training
277260|NCT02476266|strength training|strength training
277261|NCT02476266|balance|balance
277262|NCT02476266|muscle strength|muscle strength
277263|NCT02476253|acidosis|acidosis
277264|NCT02476253|shock|shock
277265|NCT02476253|sodium bicarbonate|sodium bicarbonate
277266|NCT02476253|renal replacement therapy|renal replacement therapy
277267|NCT02476240|Exercise|exercise
277268|NCT02476240|Attention|attention
277269|NCT02476227|atrial fibrillation|atrial fibrillation
277270|NCT02476227|pulmonary vein isolation|pulmonary vein isolation
277271|NCT02476227|RF ablation|rf ablation
277272|NCT02476214|group prenatal care, group guidance|group prenatal care, group guidance
277273|NCT02476201|Heart Failure|heart failure
277274|NCT02476201|Cardiac Resynchronization Therapy|cardiac resynchronization therapy
277275|NCT02476201|Quadripolar Left Ventricular Lead|quadripolar left ventricular lead
277276|NCT02476201|Multipoint Pacing|multipoint pacing
277277|NCT02476201|Hemodynamic Response|hemodynamic response
277278|NCT02476188|Neutrophil extracellular traps, stroke|neutrophil extracellular traps, stroke
277279|NCT02476175|mirabegron|mirabegron
277280|NCT02476175|antimuscarinics|antimuscarinics
277281|NCT02476175|beta 3 agonist|beta 3 agonist
277282|NCT02476175|overactive bladder|overactive bladder
277283|NCT02476175|children|children
277284|NCT02476162|Childhood Cancer Survivor|childhood cancer survivor
277285|NCT02476162|Cancer Prevention and Control|cancer prevention and control
277286|NCT02476162|Blood Pressure Monitoring|blood pressure monitoring
277287|NCT02476162|Pre-Hypertension|pre-hypertension
277288|NCT02476136|individual patient data meta-analysis|individual patient data meta-analysis
277289|NCT02476136|anxiety disorder|anxiety disorder
277290|NCT02476136|antidepressants|antidepressants
277291|NCT02476136|selective serotonin reuptake inhibitors|selective serotonin reuptake inhibitors
277292|NCT02476136|serotonin-norepinephrine reuptake inhibitors|serotonin-norepinephrine reuptake inhibitors
277293|NCT02476110|Oral nutritive supplements|oral nutritive supplements
277294|NCT02476110|Nutritional risk screening|nutritional risk screening
277295|NCT02476110|Homecare|homecare
277296|NCT02476097|esomeprazole randomized study|esomeprazole randomized study
277297|NCT02476097|proton pump inhibitor|proton pump inhibitor
277298|NCT02476097|gastric acid rebound|gastric acid rebound
277299|NCT02476097|randomized study|randomized study
277300|NCT02476097|esomeprazole|esomeprazole
277301|NCT02476071|HIV prevention|hiv prevention
277302|NCT02476071|Demand for voluntary male circumcision|demand for voluntary male circumcision
277303|NCT02476058|Major Depressive Disorder|major depressive disorder
277304|NCT02476058|JNJ-42847922|jnj-42847922
277305|NCT02476058|Diphenhydramine|diphenhydramine
277306|NCT02476058|Placebo|placebo
277307|NCT02476045|metastatic colorectal cancer|metastatic colorectal cancer
277308|NCT02476045|RAS wild-type|ras wild-type
277309|NCT02476045|maintenance therapy|maintenance therapy
277310|NCT02476045|panitumumab|panitumumab
277311|NCT02476019|Obesity|obesity
277312|NCT02476019|Energy Expenditure|energy expenditure
277313|NCT02475993|Sickle Cell Disease|sickle cell disease
277314|NCT02475980|Adolescent|adolescent
277315|NCT02475980|Contraception|contraception
277316|NCT02475980|Counseling|counseling
277317|NCT02475967|E-Learning|e-learning
277318|NCT02475967|coronary artery disease|coronary artery disease
277319|NCT02475967|telerehabilitation|telerehabilitation
277320|NCT02475967|e-health|e-health
277321|NCT02475954|Depression|depression
277322|NCT02475954|Telehealth|telehealth
277323|NCT02475954|Parkinson's Disease|parkinson's disease
277324|NCT02475954|Veterans|veterans
277325|NCT02475954|Care-partners|care-partners
277326|NCT02475954|Cognitive-Behavioral Therapy|cognitive-behavioral therapy
277327|NCT02475954|Caregiver|caregiver
277328|NCT02475941|geriatric fractures|geriatric fractures
277329|NCT02475915|Treatment interruption|treatment interruption
277330|NCT02475915|Controlling HIV|controlling hiv
277331|NCT02475902|prevention and control|prevention and control
277332|NCT02475824|ERCP|ercp
277333|NCT02475824|Sedation|sedation
277334|NCT02475824|safety|safety
277335|NCT02475811|3D ultrasonography|3d ultrasonography
277336|NCT02475811|fetal Lung Volume|fetal lung volume
277337|NCT02475811|neonatal respiratory function|neonatal respiratory function
277338|NCT02475798|Zenith aortoiliac aneurysm|zenith aortoiliac aneurysm
277339|NCT02475798|Iliac aneurysm|iliac aneurysm
277340|NCT02475798|Branch|branch
277341|NCT02475798|Connections|connections
277342|NCT02475798|Endovascular graft|endovascular graft
277343|NCT02475798|Graft-iliac bifurcation|graft-iliac bifurcation
277344|NCT02475798|Aneurysm|aneurysm
277345|NCT02475798|Vascular Diseases|vascular diseases
277346|NCT02475798|Cardiovascular Diseases|cardiovascular diseases
277347|NCT02475785|Forsus Fatigue Resistant Device|forsus fatigue resistant device
277348|NCT02475785|Class II|class ii
277349|NCT02475785|anchorage|anchorage
277350|NCT02475785|FFRD|ffrd
277351|NCT02475785|mini plates|mini plates
277352|NCT02475785|fixed functional appliance|fixed functional appliance
277353|NCT02475772|ovarian cancer|ovarian cancer
277354|NCT02475772|recurrent|recurrent
277355|NCT02475772|chemotherapy|chemotherapy
277356|NCT02475772|intraperitoneal|intraperitoneal
277357|NCT02475772|cisplatin|cisplatin
277358|NCT02475772|doxorubicin|doxorubicin
277359|NCT02475746|drug interaction, PF-06372865, itraconazole|drug interaction, pf-06372865, itraconazole
277360|NCT02475707|leukemia|leukemia
277361|NCT02475707|lymphoblastic|lymphoblastic
277362|NCT02475707|ALL|all
277363|NCT02475707|multiTAA-specific T cells|multitaa-specific t cells
277364|NCT02475707|HSCT|hsct
277365|NCT02475590|Sleeve gastrectomy|sleeve gastrectomy
277366|NCT02475590|Roux-en-Y gastric bypass|roux-en-y gastric bypass
277367|NCT02475590|Excess weight loss|excess weight loss
277368|NCT02475590|Quality of life|quality of life
277369|NCT02475577|telemedicine|telemedicine
277370|NCT02475577|heart failure|heart failure
277371|NCT02475577|home blood pressure monitoring|home blood pressure monitoring
277372|NCT02475564|resveratrol|resveratrol
277373|NCT02475512|elderly|elderly
277374|NCT02475512|long-term care|long-term care
277375|NCT02475499|Incretins|incretins
277376|NCT02475499|Antidiabetic agents|antidiabetic agents
277377|NCT02475499|Pancreatic Cancer|pancreatic cancer
277378|NCT02475486|Rheumatoid Arthritis|rheumatoid arthritis
277379|NCT02475486|sympathetic nervous system|sympathetic nervous system
277380|NCT02475486|SNA|sna
277381|NCT02475486|fatigue|fatigue
277382|NCT02475473|Volunteers|volunteers
277383|NCT02475460|HeartMate 3|heartmate 3
277384|NCT02475460|LVAS|lvas
277385|NCT02475460|LVAD|lvad
277386|NCT02475460|Heart-assist Devices|heart-assist devices
277387|NCT02475460|Advanced|advanced
277388|NCT02475460|Ventricular Dysfunction|ventricular dysfunction
277389|NCT02475460|refractory left ventricular|refractory left ventricular
277390|NCT02475460|Thoratec Corporation|thoratec corporation
277391|NCT02475434|Human Milk|human milk
277392|NCT02475434|Prematurity|prematurity
277393|NCT02475434|Nutrition|nutrition
277394|NCT02475421|Diabetes|diabetes
277395|NCT02475421|Glucagon|glucagon
277396|NCT02475421|Metabolic clearance rate of glucagon|metabolic clearance rate of glucagon
277397|NCT02475408|Circulation, Collateral|circulation, collateral
277398|NCT02475408|Coronary Artery Disease|coronary artery disease
277399|NCT02475408|Internal Mammary-Coronary Artery Anastomosis|internal mammary-coronary artery anastomosis
277400|NCT02475408|Ischemia|ischemia
277401|NCT02475395|Male Fertility|male fertility
277402|NCT02475395|Male Infertility|male infertility
277403|NCT02475395|Fertility|fertility
277404|NCT02475395|Sperm|sperm
277405|NCT02475395|Sperm Concentration|sperm concentration
277406|NCT02475369|pancreatic enzyme supplementation|pancreatic enzyme supplementation
277407|NCT02475356|Mirena|mirena
277408|NCT02475356|Heavy Menstrual Bleeding|heavy menstrual bleeding
277409|NCT02475356|Dysmenorrhea|dysmenorrhea
277410|NCT02475356|Japan|japan
277411|NCT02475356|Post-marketing surveillance|post-marketing surveillance
277412|NCT02475317|Volunteer|volunteer
277413|NCT02475278|Drug therapy|drug therapy
277414|NCT02475265|Anorexia Nervosa|anorexia nervosa
277415|NCT02475265|Osteoporosis|osteoporosis
277416|NCT02475265|Eating Disorder|eating disorder
277417|NCT02475265|Disordered Eating|disordered eating
277418|NCT02475265|Estrogen|estrogen
277419|NCT02475265|Bone|bone
277420|NCT02475239|Benign Paroxysmal Positional Vertigo, Postural Restriction|benign paroxysmal positional vertigo, postural restriction
277421|NCT02475226|Traumatic Brain Injury|traumatic brain injury
277422|NCT02475226|Brain Damage|brain damage
277423|NCT02475226|Mortality|mortality
277424|NCT02475226|C10.228.140.199|c10.228.140.199
277425|NCT02475213|Melanoma, Non small cell lung cancer, SCCHN|melanoma, non small cell lung cancer, scchn
746287|NCT00451659|Deployed|deployed
277426|NCT02475213|Other B7-H3 expressing cancers|other b7-h3 expressing cancers
277427|NCT02475187|TEG|teg
277428|NCT02475187|MEA|mea
277429|NCT02475187|Thrombotic events|thrombotic events
277430|NCT02475187|VTE|vte
277431|NCT02475187|LMWH|lmwh
277432|NCT02475187|Hip fractures|hip fractures
277433|NCT02475161|Healthy|healthy
277434|NCT02475161|Rabeprazole|rabeprazole
277435|NCT02475161|JNJ-42847922|jnj-42847922
277436|NCT02475148|JNJ-54175446|jnj-54175446
277437|NCT02475148|Healthy|healthy
277438|NCT02475135|Immunodeficiency Virus Type 1, Human|immunodeficiency virus type 1, human
277439|NCT02475135|Immunodeficiency Virus Type 2, Human|immunodeficiency virus type 2, human
277440|NCT02475135|Darunavir|darunavir
277441|NCT02475135|Cobicistat|cobicistat
277442|NCT02475135|Tenofovir Alafenamide|tenofovir alafenamide
277443|NCT02475135|Emtricitabine|emtricitabine
277444|NCT02475135|Elvitegravir|elvitegravir
277445|NCT02475122|Measurement of azygos blood flow|measurement of azygos blood flow
277446|NCT02475109|Proliferative Diabetic Retinopathy|proliferative diabetic retinopathy
277447|NCT02475083|Stroke|stroke
277448|NCT02475083|Virtual reality|virtual reality
277449|NCT02475083|Balance|balance
277450|NCT02475083|Falls|falls
277451|NCT02475057|Prostate Cancer|prostate cancer
277452|NCT02475057|Cardiovascular disease|cardiovascular disease
277453|NCT02475057|Degarelix|degarelix
277454|NCT02475044|post-concussion|post-concussion
277455|NCT02475044|Cognitive-Behavioral Theray|cognitive-behavioral theray
277456|NCT02475044|parenting|parenting
277457|NCT02475031|transversus abdominis plane block|transversus abdominis plane block
277458|NCT02475018|Shuhua Milk|shuhua milk
277459|NCT02475018|plant sterol esters|plant sterol esters
277460|NCT02475018|serum cholesterol|serum cholesterol
277461|NCT02475018|human|human
277462|NCT02475005|self management app|self management app
277463|NCT02475005|headache|headache
277464|NCT02475005|adolescent|adolescent
277466|NCT02474992|Social network|social network
277467|NCT02474992|Social support|social support
277468|NCT02474992|Disclosure|disclosure
277469|NCT02474992|Stigma|stigma
277470|NCT02474992|Kenya|kenya
277471|NCT02474979|Pressure ulcer|pressure ulcer
277472|NCT02474979|Prevention|prevention
277473|NCT02474979|Pressure mapping|pressure mapping
277474|NCT02474953|Curcumin|curcumin
277475|NCT02474953|Pharmacokinetic|pharmacokinetic
277476|NCT02474940|Multiple Sclerosis|multiple sclerosis
277477|NCT02474940|Chronic Pain|chronic pain
277478|NCT02474940|Chronic Fatigue|chronic fatigue
277479|NCT02474940|Autoimmune Diseases|autoimmune diseases
277480|NCT02474940|Autoimmune Diseases of the Nervous System|autoimmune diseases of the nervous system
277481|NCT02474940|Central Nervous System Diseases|central nervous system diseases
277482|NCT02474940|Demyelinating Autoimmune Diseases, CNS|demyelinating autoimmune diseases, cns
277483|NCT02474940|Demyelinating Diseases|demyelinating diseases
277484|NCT02474927|antibody-mediated rejection|antibody-mediated rejection
277485|NCT02474927|lung transplant|lung transplant
277486|NCT02474927|Carfilzomib|carfilzomib
277487|NCT02474901|Shedding|shedding
277488|NCT02474901|Immunogenicity|immunogenicity
277489|NCT02474901|Safety|safety
277490|NCT02474901|HIV infected|hiv infected
277491|NCT02474901|Children|children
277492|NCT02474901|Young adults|young adults
277493|NCT02474875|Fibromyalgia|fibromyalgia
277494|NCT02474875|Patient education|patient education
277495|NCT02474875|Central sensitization|central sensitization
277496|NCT02474836|Allergy|allergy
277497|NCT02474810|central venous catheters|central venous catheters
277498|NCT02474810|hemodialysis|hemodialysis
277499|NCT02474810|thrombosis|thrombosis
277500|NCT02474810|tissue plasminogen activator|tissue plasminogen activator
277501|NCT02474797|Ultrasonography|ultrasonography
277502|NCT02474797|Diaphragm|diaphragm
277503|NCT02474797|Lung ultrasound|lung ultrasound
277504|NCT02474797|Sepsis|sepsis
277505|NCT02474797|Critical care|critical care
277506|NCT02474797|Chest physiotherapy|chest physiotherapy
277507|NCT02474745|second stage of labor|second stage of labor
277508|NCT02474745|pushing techniques|pushing techniques
277509|NCT02474719|nephrology|nephrology
277510|NCT02474719|extra-renal purification|extra-renal purification
277511|NCT02474719|peritoneal dialysis|peritoneal dialysis
277512|NCT02474706|cefoxitin Patient safety|cefoxitin patient safety
277513|NCT02474706|Infectious diseases|infectious diseases
277514|NCT02474706|Extended-Spectrum β-lactamases E.coli|extended-spectrum β-lactamases e.coli
277515|NCT02474706|Antibiotics|antibiotics
277516|NCT02474680|depression|depression
277517|NCT02474680|Major Depressive Disorder|major depressive disorder
277518|NCT02474680|MDD|mdd
277519|NCT02474680|mental health|mental health
277520|NCT02474680|pharmacogenomics|pharmacogenomics
277521|NCT02474680|personalized medicine|personalized medicine
277522|NCT02474680|precision medicine|precision medicine
277523|NCT02474680|anti-depressants|anti-depressants
277524|NCT02474667|DGF|dgf
277525|NCT02474667|Delayed Graft Function|delayed graft function
277526|NCT02474667|Renal Transplantation|renal transplantation
746388|NCT00451165|Surgery|surgery
277527|NCT02474667|Deseased Donor Kidney|deseased donor kidney
277528|NCT02474667|BB3|bb3
277529|NCT02474667|Kidney Transplantation|kidney transplantation
277530|NCT02474667|Acute Kidney Injury|acute kidney injury
277531|NCT02474641|Breast cancer|breast cancer
277532|NCT02474641|Hypofractionation with SIB|hypofractionation with sib
277533|NCT02474641|Non-inferiority|non-inferiority
277933|NCT02472613|Fluoxetine|fluoxetine
277534|NCT02474641|adjuvant radiotherapy with simultaneous integrated boost|adjuvant radiotherapy with simultaneous integrated boost
277535|NCT02474628|Physiological Phenomena|physiological phenomena
277536|NCT02474615|Apicoectomy|apicoectomy
277537|NCT02474615|Oral surgery|oral surgery
277538|NCT02474615|Biocompatible materials|biocompatible materials
277539|NCT02474615|Dental Cements|dental cements
277540|NCT02474615|Translational Medical Research|translational medical research
277541|NCT02474602|phototherapy|phototherapy
277542|NCT02474602|strength training|strength training
277543|NCT02474602|photobiostimulation|photobiostimulation
277544|NCT02474602|muscle development|muscle development
277545|NCT02474589|Treatment|treatment
277546|NCT02474589|orthopoxvirus|orthopoxvirus
277547|NCT02474589|smallpox|smallpox
277548|NCT02474563|Multiple Myeloma|multiple myeloma
277549|NCT02474563|Bortezomib|bortezomib
277550|NCT02474563|Melphalan|melphalan
277551|NCT02474563|Prednisone|prednisone
277552|NCT02474550|diffuse large b cell lymphoma|diffuse large b cell lymphoma
277553|NCT02474550|peg-filgrastim|peg-filgrastim
277554|NCT02474550|febrile neutropenia|febrile neutropenia
277555|NCT02474537|hepatic impairment,|hepatic impairment,
277557|NCT02474537|Oral cMET Inhibitor,|oral cmet inhibitor,
277558|NCT02474537|Non-Cancer|non-cancer
277559|NCT02474524|Psychosis|psychosis
277560|NCT02474524|Schizophrenia|schizophrenia
277561|NCT02474524|Self-management|self-management
277562|NCT02474524|Recovery|recovery
277563|NCT02474524|Tablet computer|tablet computer
277564|NCT02474524|Digital health|digital health
277565|NCT02474524|Internet|internet
277566|NCT02474524|Online|online
277567|NCT02474524|Peer support|peer support
277568|NCT02474498|Regenerative therapy|regenerative therapy
277569|NCT02474498|Randomized clinical trial (RCT)|randomized clinical trial (rct)
277570|NCT02474498|Enamel matrix derivative|enamel matrix derivative
277571|NCT02474498|Hydroxyapatite-beta tricalcium phosphate|hydroxyapatite-beta tricalcium phosphate
277572|NCT02474498|Buccal furcation|buccal furcation
277573|NCT02474485|bioresorbable vascular scaffold|bioresorbable vascular scaffold
277574|NCT02474485|Absorb|absorb
277575|NCT02474485|drug eluting balloon|drug eluting balloon
277576|NCT02474485|percutaneous coronary intervention|percutaneous coronary intervention
277577|NCT02474459|Deep Brain Stimulation|deep brain stimulation
277578|NCT02474459|DBS|dbs
277579|NCT02474459|STN|stn
277580|NCT02474459|GPi|gpi
277581|NCT02474459|Globus pallidus|globus pallidus
277582|NCT02474459|Subthalamic nucleus|subthalamic nucleus
277583|NCT02474459|Neuromodulation|neuromodulation
277584|NCT02474407|Seizures|seizures
277585|NCT02474407|Epilepsy|epilepsy
277586|NCT02474355|NSCLC|nsclc
277587|NCT02474355|EGFRm|egfrm
277588|NCT02474355|T790M|t790m
277589|NCT02474329|Parkinson's disease|parkinson's disease
277590|NCT02474329|Ambulatory monitoring|ambulatory monitoring
277591|NCT02474329|Disease progression|disease progression
277592|NCT02474303|Truvada|truvada
277593|NCT02474303|EMTRICITABINE/TENOFOVIR DISPROXIL FUMARATE|emtricitabine/tenofovir disproxil fumarate
277594|NCT02474303|HIV PREEXPOSURE PROPHYLAXIS (PrEP)|hiv preexposure prophylaxis (prep)
277595|NCT02474303|Female Sex Workers|female sex workers
277596|NCT02474290|Acute Myeloid Leukemia|acute myeloid leukemia
277597|NCT02474290|FLT3-ITD|flt3-itd
277598|NCT02474290|Hematopoietic Stem Cell Transplantation|hematopoietic stem cell transplantation
277599|NCT02474238|Iridotomy|iridotomy
277600|NCT02474225|intraocular pressure|intraocular pressure
277601|NCT02474225|intravitreal|intravitreal
277602|NCT02474212|Venous thromboembolism|venous thromboembolism
277603|NCT02474212|pulmonary embolism|pulmonary embolism
277604|NCT02474212|thromboprophylaxis|thromboprophylaxis
277605|NCT02474212|anticoagulant|anticoagulant
277606|NCT02474212|anti-FXa|anti-fxa
277607|NCT02474212|low-molecular weight heparin|low-molecular weight heparin
277608|NCT02474212|enoxaparin|enoxaparin
277609|NCT02474199|Regulatory T Cells ( Treg)|regulatory t cells ( treg)
277610|NCT02474199|Donor Alloantigen Reactive Tregs (darTregs)|donor alloantigen reactive tregs (dartregs)
277611|NCT02474199|Liver Transplant|liver transplant
277612|NCT02474199|Alloantigen Reactive Tregs|alloantigen reactive tregs
277613|NCT02474199|Calcineurin Inhibitors (CNI)|calcineurin inhibitors (cni)
277614|NCT02474199|immunosuppressants (IS)|immunosuppressants (is)
277615|NCT02474186|breast|breast
277616|NCT02474186|cancer|cancer
277617|NCT02474186|metastatic|metastatic
277618|NCT02474186|breast cancer|breast cancer
277619|NCT02474186|metastatic breast cancer|metastatic breast cancer
277620|NCT02474186|radiation|radiation
277621|NCT02474186|radiotherapy|radiotherapy
277622|NCT02474186|radiation therapy|radiation therapy
277623|NCT02474186|abscopal|abscopal
354757|NCT02075242|HBV|hbv
277624|NCT02474186|abscopal effect|abscopal effect
277625|NCT02474186|T-cell|t-cell
277626|NCT02474186|GM-CSF|gm-csf
277627|NCT02474186|anti-tumor|anti-tumor
277628|NCT02474186|immune|immune
277629|NCT02474186|immune response|immune response
277630|NCT02474186|capecitabine|capecitabine
277631|NCT02474186|xeloda|xeloda
277632|NCT02474186|taxol|taxol
277633|NCT02474186|paclitaxel|paclitaxel
277634|NCT02474186|other solid metastatic tumor|other solid metastatic tumor
277635|NCT02474108|atrial fibrillation|atrial fibrillation
277636|NCT02474108|radiofrequency ablation|radiofrequency ablation
277637|NCT02474108|prevention of AF|prevention of af
277638|NCT02474108|mitral valve|mitral valve
277639|NCT02474108|left atrium enlargement|left atrium enlargement
277640|NCT02474108|cryoablation|cryoablation
277641|NCT02474069|skin condition|skin condition
277642|NCT02474069|skin disease|skin disease
277643|NCT02474069|itching condition|itching condition
277644|NCT02474069|psoriasis vulgaris|psoriasis vulgaris
277645|NCT02474069|relapsing psoriasis|relapsing psoriasis
277646|NCT02474069|remitting psoriasis|remitting psoriasis
277647|NCT02474069|immune-mediated systemic disease|immune-mediated systemic disease
277648|NCT02474069|skin lesions, red skin lesions|skin lesions, red skin lesions
277649|NCT02474069|scaly patches|scaly patches
277650|NCT02474069|papules, plaques|papules, plaques
277651|NCT02474069|itching|itching
277652|NCT02474069|auto-immune|auto-immune
277653|NCT02474069|plaque-type psoriasis|plaque-type psoriasis
277654|NCT02474069|plaque|plaque
277655|NCT02474056|decreased blood volume vein volume flow ultrasound exam|decreased blood volume vein volume flow ultrasound exam
277656|NCT02474043|Injection drug use|injection drug use
277657|NCT02474017|Inhaler|inhaler
277658|NCT02474017|Adolescent|adolescent
277659|NCT02473978|During Labor|during labor
277660|NCT02473978|Complicating Anesthesia or Other Sedation|complicating anesthesia or other sedation
277661|NCT02473978|Cerebral|cerebral
277662|NCT02473926|Physical Activity|physical activity
277663|NCT02473926|Physical Function|physical function
277664|NCT02473926|Physical Impairment|physical impairment
277665|NCT02473926|Sedentary Lifestyle|sedentary lifestyle
277666|NCT02473887|ondansetron|ondansetron
277667|NCT02473887|palatability|palatability
277668|NCT02473887|vomiting|vomiting
277669|NCT02473861|exercise training|exercise training
277670|NCT02473861|breast cancer|breast cancer
277671|NCT02473861|taxane chemotherapy|taxane chemotherapy
277672|NCT02473861|peripheral neuropathy|peripheral neuropathy
277673|NCT02473861|fatigue|fatigue
277674|NCT02473861|autonomic function|autonomic function
277675|NCT02473835|T-lymphocyte|t-lymphocyte
277676|NCT02473835|Adipose tissue|adipose tissue
277677|NCT02473835|Inflammation|inflammation
277678|NCT02473835|Calorie restriction|calorie restriction
277679|NCT02473822|anterior cruciate ligament|anterior cruciate ligament
277680|NCT02473822|Tape Locking Screw|tape locking screw
277681|NCT02473822|LCA|lca
277682|NCT02473822|joint trauma|joint trauma
277683|NCT02473796|home based child care|home based child care
277684|NCT02473770|Registry|registry
277685|NCT02473770|Exposures|exposures
277686|NCT02473770|Biological Specimens|biological specimens
277687|NCT02473770|Occupational Health|occupational health
277688|NCT02473770|Exposure|exposure
277689|NCT02473757|Recombinant DNA Product|recombinant dna product
277690|NCT02473757|Laboratory Evaluation|laboratory evaluation
277691|NCT02473757|NIH Office of Biotechnology Activities|nih office of biotechnology activities
277692|NCT02473757|Gamma-Retroviral Vectors|gamma-retroviral vectors
277693|NCT02473744|lower limb edema|lower limb edema
277694|NCT02473744|subcutaneous drainage|subcutaneous drainage
277695|NCT02473744|bioelectrical impedance|bioelectrical impedance
277696|NCT02473744|quality of life|quality of life
277697|NCT02473731|CDX3379|cdx3379
277698|NCT02473705|Geriatric|geriatric
277699|NCT02473705|bicarbonate|bicarbonate
277700|NCT02473705|omega polyunsaturated fatty acids|omega polyunsaturated fatty acids
277701|NCT02473705|exercise capacity|exercise capacity
277702|NCT02473679|First Responder|first responder
277703|NCT02473679|BLS|bls
277704|NCT02473679|AED|aed
277705|NCT02473679|Resuscitation|resuscitation
277706|NCT02473666|Patient Blood Management|patient blood management
277707|NCT02473666|Red Blood Cells|red blood cells
277708|NCT02473666|Platelet|platelet
277709|NCT02473627|Pharmacokinetics|pharmacokinetics
277710|NCT02473601|mivacurium chloramine|mivacurium chloramine
277711|NCT02473601|patients with liver cirrhosis|patients with liver cirrhosis
277712|NCT02473601|muscle relaxation effect|muscle relaxation effect
277713|NCT02473575|Caffeine, running, performance|caffeine, running, performance
277714|NCT02473562|Parkinson's disease|parkinson's disease
277715|NCT02473562|Varenicline|varenicline
277716|NCT02473562|Excessive daytime sleepiness|excessive daytime sleepiness
277717|NCT02473549|motor|motor
277718|NCT02473549|rehabilitation|rehabilitation
277719|NCT02473549|transcranial direct current stimulation|transcranial direct current stimulation
277720|NCT02473523|Fatigue|fatigue
277721|NCT02473523|Pain Alleviation|pain alleviation
277722|NCT02473523|Emotional Wellbeing|emotional wellbeing
277723|NCT02473523|Physical Wellbeing|physical wellbeing
277724|NCT02473523|Yoga|yoga
277725|NCT02473510|Trivalent|trivalent
277726|NCT02473510|Influenza|influenza
277727|NCT02473510|FluMist Quadrivalent|flumist quadrivalent
277728|NCT02473510|Vaccine|vaccine
277729|NCT02473510|Prevention|prevention
277730|NCT02473510|Healthy|healthy
277731|NCT02473497|chromosomal rearrangement|chromosomal rearrangement
277732|NCT02473497|activating mutation|activating mutation
277733|NCT02473497|activating genetic alteration|activating genetic alteration
277734|NCT02473497|genetic aberration|genetic aberration
277736|NCT02473497|ROS1|ros1
277737|NCT02473497|cMET|cmet
277738|NCT02473497|crizotinib|crizotinib
277739|NCT02473497|oral formulation|oral formulation
277740|NCT02473484|High Grade Glioma|high grade glioma
277741|NCT02473484|Proteomics|proteomics
277742|NCT02473484|MALDI-MSI|maldi-msi
277743|NCT02473471|Micro-Osteoperforation (MOPs)|micro-osteoperforation (mops)
277744|NCT02473471|regional acceleratory phenomenon (RAP)|regional acceleratory phenomenon (rap)
277745|NCT02473471|Malocculsion|malocculsion
277746|NCT02473458|Licorice|licorice
277747|NCT02473458|Glycyrrhizic acid|glycyrrhizic acid
277748|NCT02473458|Ischemic Stroke|ischemic stroke
277749|NCT02473458|Acute|acute
277750|NCT02473445|Inherited mitochondrial disease|inherited mitochondrial disease
277751|NCT02473445|Leigh Syndrome|leigh syndrome
277752|NCT02473445|Leber's Hereditary Optic Neuropathy (LHON)|leber's hereditary optic neuropathy (lhon)
277753|NCT02473445|Myoclonic epilepsy and ragged-red fibers (MERFF)|myoclonic epilepsy and ragged-red fibers (merff)
277754|NCT02473445|Mitochondrial encephalomyopathy, lactic acidosis, and stroke-like syndrome (MELAS)|mitochondrial encephalomyopathy, lactic acidosis, and stroke-like syndrome (melas)
277755|NCT02473445|Kearn-Sayre syndrome|kearn-sayre syndrome
277756|NCT02473445|Polymerase gamma (POLG) -related disorders|polymerase gamma (polg) -related disorders
277757|NCT02473445|Mitochondrial neurogastrointestinal encephalopathy syndrome (MNGIE)|mitochondrial neurogastrointestinal encephalopathy syndrome (mngie)
277758|NCT02473432|respiratory muscle training|respiratory muscle training
277759|NCT02473432|neuromuscular electrical stimulation|neuromuscular electrical stimulation
277760|NCT02473432|oropharyngeal dysphagia|oropharyngeal dysphagia
277761|NCT02473432|stroke|stroke
277762|NCT02473432|rehabilitation|rehabilitation
277763|NCT02473419|Medical food|medical food
277764|NCT02473419|ADHD|adhd
277765|NCT02473419|Vayarin|vayarin
277766|NCT02473419|Fish Oil|fish oil
277767|NCT02473406|Acute Pancreatitis, prevent,Necrotizing|acute pancreatitis, prevent,necrotizing
277768|NCT02473380|glioma|glioma
277769|NCT02473380|fluorescence spectroscopy|fluorescence spectroscopy
277770|NCT02473341|Bovine Colostrum|bovine colostrum
277771|NCT02473341|Corticosteriods|corticosteriods
277772|NCT02473341|Endotoxin|endotoxin
277773|NCT02473341|MELD|meld
277774|NCT02473341|mDF|mdf
277775|NCT02473328|dose reduction study|dose reduction study
277776|NCT02473289|Depressive disorder, major|depressive disorder, major
277777|NCT02473289|Sirukumab|sirukumab
277778|NCT02473263|Severe septic syndrome|severe septic syndrome
277779|NCT02473263|mobile intensive care unit|mobile intensive care unit
277780|NCT02473263|strategy|strategy
277781|NCT02473263|antibiotics|antibiotics
277782|NCT02473263|hemodynamic optimization|hemodynamic optimization
277783|NCT02473237|COPD|copd
277784|NCT02473237|biomass|biomass
277785|NCT02473224|challenge|challenge
277786|NCT02473224|GII.2|gii.2
277787|NCT02473224|HID50|hid50
277788|NCT02473224|Norovirus|norovirus
277789|NCT02473224|Snow Mountain filtrate|snow mountain filtrate
277790|NCT02473198|Total Knee Arthroplasty|total knee arthroplasty
277791|NCT02473198|Amide Local Anesthetic|amide local anesthetic
277792|NCT02473172|Weaning from mechanical ventilation|weaning from mechanical ventilation
277793|NCT02473159|Near-infrared fluorescence|near-infrared fluorescence
277794|NCT02473159|Indocyanine green, ICG|indocyanine green, icg
277795|NCT02473159|breast cancer|breast cancer
277796|NCT02473146|AML|aml
277797|NCT02473146|untreated|untreated
277798|NCT02473146|60-80 years old|60-80 years old
277799|NCT02473146|favorable and intermediate karyotype|favorable and intermediate karyotype
277800|NCT02473133|radiotherapy|radiotherapy
277801|NCT02473133|dose redistribution|dose redistribution
277802|NCT02473133|boost|boost
277803|NCT02473120|metastatic|metastatic
277804|NCT02473120|ESR1|esr1
277805|NCT02473120|aromatase inhibitor|aromatase inhibitor
277806|NCT02473120|breast cancer|breast cancer
277807|NCT02473107|Dental caries|dental caries
277808|NCT02473107|Primary tooth|primary tooth
277809|NCT02473107|Caries Detection|caries detection
277810|NCT02473094|Metformin|metformin
277811|NCT02473094|Rectal Cancer|rectal cancer
277812|NCT02473094|Rectum|rectum
277813|NCT02473094|Radiotherapy|radiotherapy
277814|NCT02473094|Capecitabine|capecitabine
277815|NCT02473094|Neoadjuvant|neoadjuvant
277816|NCT02473094|Adenocarcinoma|adenocarcinoma
277817|NCT02473094|Carcinoma|carcinoma
277818|NCT02473081|Type 2 diabetes|type 2 diabetes
277819|NCT02473081|Minimal psychological intervention|minimal psychological intervention
277820|NCT02473081|Glycemic control|glycemic control
277821|NCT02473081|Depressive symptoms|depressive symptoms
277822|NCT02473081|Problem Area in Diabetes|problem area in diabetes
277823|NCT02473081|Middle-aged and older adults|middle-aged and older adults
277824|NCT02473081|HbA1c protein, human|hba1c protein, human
277825|NCT02473068|CPAP|cpap
277826|NCT02473055|kangaroo care|kangaroo care
277827|NCT02473055|sleep|sleep
277828|NCT02473055|heart rate|heart rate
277829|NCT02473055|respiratory rate|respiratory rate
277830|NCT02473055|preterm infant|preterm infant
277831|NCT02473042|Post-operative nausea and vomiting|post-operative nausea and vomiting
277833|NCT02473042|Breast cancer|breast cancer
277834|NCT02473042|Neuromuscular blockade monitor|neuromuscular blockade monitor
277835|NCT02473042|NMBM|nmbm
277836|NCT02473042|Breast cancer surgery|breast cancer surgery
277837|NCT02473042|Prophylactic anti-emetics|prophylactic anti-emetics
277838|NCT02473042|Electrical stimulation|electrical stimulation
277839|NCT02473042|Zofran|zofran
277840|NCT02473042|Ondansetron|ondansetron
277841|NCT02473042|Dexamethasone|dexamethasone
277842|NCT02473042|Decadron|decadron
277843|NCT02473042|Phenergan|phenergan
277844|NCT02473042|Promethazine|promethazine
277845|NCT02473042|Phenazine|phenazine
277846|NCT02473042|Phencen|phencen
277847|NCT02473042|Prometh|prometh
277848|NCT02473042|Prorex|prorex
277849|NCT02473042|V-Gan|v-gan
277850|NCT02473042|Pepcid|pepcid
277851|NCT02473042|Famotidine|famotidine
277852|NCT02473042|Questionnaire|questionnaire
277853|NCT02473042|Survey|survey
277854|NCT02473016|Classical Trigeminal Neuralgia|classical trigeminal neuralgia
277855|NCT02473003|Breast cancer|breast cancer
277856|NCT02473003|prostate cancer|prostate cancer
277857|NCT02473003|colorectal cancer|colorectal cancer
277858|NCT02473003|fatigue|fatigue
277859|NCT02473003|physical exercise|physical exercise
277860|NCT02473003|randomised trial|randomised trial
277861|NCT02473003|intervention|intervention
277862|NCT02472990|DMD|dmd
277863|NCT02472990|morphological predictive factors|morphological predictive factors
277864|NCT02472990|Mechanical|mechanical
277865|NCT02472938|Relapsing remitting Multiple Sclerosis|relapsing remitting multiple sclerosis
277866|NCT02472912|Pharmacokinetics|pharmacokinetics
277867|NCT02472912|Adalimumab|adalimumab
277868|NCT02472912|Biosimilar Pharmaceuticals|biosimilar pharmaceuticals
277869|NCT02472899|Geriatrics|geriatrics
277870|NCT02472899|Neurocognitive Disorder|neurocognitive disorder
277871|NCT02472899|Biomarkers|biomarkers
277872|NCT02472899|Immunology|immunology
277873|NCT02472886|HCV genotype 1|hcv genotype 1
277874|NCT02472886|HCV|hcv
277875|NCT02472886|Sustained Virologic Response|sustained virologic response
277876|NCT02472886|Direct Acting Antiviral|direct acting antiviral
277877|NCT02472886|Combination Therapy|combination therapy
277878|NCT02472886|GS-7977|gs-7977
277879|NCT02472886|GS-5885|gs-5885
277880|NCT02472886|Ribavirin|ribavirin
277881|NCT02472886|Sofosbuvir|sofosbuvir
277882|NCT02472886|ledipasvir|ledipasvir
277883|NCT02472886|Hepatitis C|hepatitis c
277884|NCT02472886|Hepatitis C, Chronic|hepatitis c, chronic
277885|NCT02472886|Liver Diseases|liver diseases
277886|NCT02472886|Virus Diseases|virus diseases
277887|NCT02472886|Antiviral Agents|antiviral agents
277888|NCT02472886|HCV/HIV co-infection|hcv/hiv co-infection
277889|NCT02472873|endometrioma|endometrioma
277890|NCT02472873|endometriosis|endometriosis
277891|NCT02472873|sclerotherapy|sclerotherapy
277892|NCT02472873|ethanol|ethanol
277893|NCT02472873|aspiration|aspiration
277894|NCT02472873|laparoscopy|laparoscopy
277895|NCT02472860|Autism Spectrum Disorder|autism spectrum disorder
277896|NCT02472860|Neuroplasticity-based Cognitive Training|neuroplasticity-based cognitive training
277897|NCT02472847|Marinol|marinol
277898|NCT02472847|Dronabinol|dronabinol
277899|NCT02472847|Fear extinction|fear extinction
277900|NCT02472847|Healthy volunteers|healthy volunteers
277901|NCT02472834|Carbamylation|carbamylation
277902|NCT02472834|Albumin|albumin
277903|NCT02472834|Protein structure|protein structure
277904|NCT02472834|Kidney disease|kidney disease
277905|NCT02472795|Systemic lupus erythematosus|systemic lupus erythematosus
277906|NCT02472782|osteoporosis|osteoporosis
277907|NCT02472782|quality of life|quality of life
277908|NCT02472782|adherence|adherence
277909|NCT02472782|treatment|treatment
277910|NCT02472743|Phototherapy|phototherapy
277911|NCT02472730|Colonoscopy|colonoscopy
277912|NCT02472730|Training Techniques|training techniques
277913|NCT02472730|Endoscopy, Gastrointestinal|endoscopy, gastrointestinal
277914|NCT02472717|liraglutide, GLP-1 receptor agonists|liraglutide, glp-1 receptor agonists
277915|NCT02472704|celiac disease|celiac disease
277916|NCT02472704|lymphocytic enteritis|lymphocytic enteritis
277917|NCT02472704|non-celiac gluten sensitivity|non-celiac gluten sensitivity
277918|NCT02472704|double-blind gluten rechallenge|double-blind gluten rechallenge
277919|NCT02472691|relapse after allogeneic transplantation|relapse after allogeneic transplantation
277920|NCT02472691|MDS|mds
355128|NCT02073591|PEST|pest
277921|NCT02472691|AML|aml
277922|NCT02472691|CMML|cmml
277923|NCT02472691|DLI|dli
277924|NCT02472691|Azacitidine|azacitidine
277925|NCT02472691|Lenalidomide|lenalidomide
277926|NCT02472691|C04.557.337.539.275|c04.557.337.539.275
277927|NCT02472691|C15.378.190.625|c15.378.190.625
277928|NCT02472691|C04.557.337.539.522|c04.557.337.539.522
277929|NCT02472665|pediatric|pediatric
277930|NCT02472665|plasma-derived FVIII concentrate|plasma-derived fviii concentrate
277931|NCT02472613|Post－Stroke Depression|post－stroke depression
277932|NCT02472613|Acupunture|acupunture
277934|NCT02472613|RCT|rct
277935|NCT02472600|extended spectrum beta-lactamase producing enterobacteriaceae|extended spectrum beta-lactamase producing enterobacteriaceae
277936|NCT02472600|carbapenemase producing enterobacteriaceae|carbapenemase producing enterobacteriaceae
277937|NCT02472600|multidrug resistant bacteria|multidrug resistant bacteria
277938|NCT02472574|Intracerebral Hemorrhage|intracerebral hemorrhage
277939|NCT02472574|minimally invasive surgery|minimally invasive surgery
277940|NCT02472574|recombinant tissue plasminogen activator|recombinant tissue plasminogen activator
277941|NCT02472574|Dose-effect Relationship|dose-effect relationship
277942|NCT02472561|Cardiology|cardiology
277943|NCT02472561|Vascular|vascular
277944|NCT02472561|Peripheral Artery Disease|peripheral artery disease
277945|NCT02472561|Artery|artery
277946|NCT02472561|Mobile Health|mobile health
277947|NCT02472561|Exercise|exercise
277948|NCT02472561|PAD|pad
277949|NCT02472535|HoFH|hofh
277950|NCT02472509|Ursodeoxycholic acid (UDCA)|ursodeoxycholic acid (udca)
277951|NCT02472509|White blood cells (WBC)|white blood cells (wbc)
277952|NCT02472509|Alanine Transaminase (ALT)|alanine transaminase (alt)
278203|NCT02471131|Stroke Prevention|stroke prevention
277953|NCT02472509|Alkaline Phosphatase (ALP)|alkaline phosphatase (alp)
277954|NCT02472509|Aspartate Aminotransferase (AST)|aspartate aminotransferase (ast)
277955|NCT02472509|Gamma-Glutamyl Transpeptidase (GGT)|gamma-glutamyl transpeptidase (ggt)
277956|NCT02472509|Lactate dehydrogenase (LDH)|lactate dehydrogenase (ldh)
277957|NCT02472509|Low-Density Lipoprotein (LDL)|low-density lipoprotein (ldl)
277958|NCT02472509|High-Density Lipoprotein (HDL)|high-density lipoprotein (hdl)
277959|NCT02472509|Glucose-6-phosphate dehydrogenase (G6PD)|glucose-6-phosphate dehydrogenase (g6pd)
277960|NCT02472509|Ultrasound (US)|ultrasound (us)
277961|NCT02472470|rTMS|rtms
277962|NCT02472470|Depression|depression
277963|NCT02472470|Youth|youth
277964|NCT02472470|TBS|tbs
277965|NCT02472470|Brain Stimulation|brain stimulation
277966|NCT02472470|Electrophysiology|electrophysiology
277967|NCT02472470|Imaging|imaging
277968|NCT02472431|ADRC|adrc
277969|NCT02472431|Adipose-Derived Regenerative Cells|adipose-derived regenerative cells
277970|NCT02472431|Fat Tissue|fat tissue
277971|NCT02472431|Stem Cells|stem cells
277972|NCT02472431|Erectile Dysfunction|erectile dysfunction
277973|NCT02472431|Arteriogenic Impotence|arteriogenic impotence
277974|NCT02472431|Venogenic Impotence|venogenic impotence
277975|NCT02472431|Vasculogenic Impotence|vasculogenic impotence
277976|NCT02472431|Male Impotence|male impotence
277977|NCT02472431|Male Sexual Impotence|male sexual impotence
277978|NCT02472392|EWINGS, SARCOMA|ewings, sarcoma
277979|NCT02472379|Immune System|immune system
277980|NCT02472379|Behavioral Sciences|behavioral sciences
277981|NCT02472379|Women's Health|women's health
277982|NCT02472379|Health Psychology|health psychology
277983|NCT02472379|Writing|writing
277984|NCT02472353|breast|breast
277985|NCT02472353|cancer|cancer
277986|NCT02472353|doxorubicin|doxorubicin
277987|NCT02472353|metformin|metformin
277988|NCT02472353|cardiotoxicity|cardiotoxicity
277989|NCT02472353|ejection fraction|ejection fraction
277990|NCT02472353|LVEF|lvef
277991|NCT02472288|urinary retention|urinary retention
277992|NCT02472288|poststroke|poststroke
277993|NCT02472288|electroacupuncture|electroacupuncture
277994|NCT02472288|randomized controlled trial|randomized controlled trial
277995|NCT02472288|effectiveness|effectiveness
277996|NCT02472288|safety|safety
277997|NCT02472262|Environmental|environmental
277998|NCT02472262|Enteric|enteric
277999|NCT02472249|TACE|tace
278000|NCT02472249|CT perfusion|ct perfusion
278001|NCT02472249|Liver blood flow|liver blood flow
278002|NCT02472236|Type 2 Diabetes Mellitus|type 2 diabetes mellitus
278003|NCT02472223|"Pink Eye"|"pink eye"
278004|NCT02472197|Endometrial polyp|endometrial polyp
278005|NCT02472197|Hysteroscopic resection|hysteroscopic resection
278006|NCT02472197|Morcellation|morcellation
278007|NCT02472184|Office hysteroscopy|office hysteroscopy
278008|NCT02472184|Endometrial biopsy|endometrial biopsy
278009|NCT02472184|Abnormal uterine bleeding|abnormal uterine bleeding
278010|NCT02472184|Uterine fibroids|uterine fibroids
278011|NCT02472171|n-3 polyunsaturated fatty acids|n-3 polyunsaturated fatty acids
278012|NCT02472171|blueberries|blueberries
278013|NCT02472158|Bandages|bandages
278014|NCT02472158|Central Venous Catheters|central venous catheters
278015|NCT02472158|Catheter-Related Infections|catheter-related infections
746468|NCT00450840|simvastatin|simvastatin
278016|NCT02472145|Leukemia, myeloid, acute|leukemia, myeloid, acute
278017|NCT02472145|DACOGEN|dacogen
278018|NCT02472145|Decitabine|decitabine
278019|NCT02472145|JNJ-56022473|jnj-56022473
278020|NCT02472145|CLS362|cls362
278021|NCT02472132|Central Venous Catheter|central venous catheter
278022|NCT02472132|Point Of Care Ultra Sound|point of care ultra sound
278023|NCT02472132|Sub Clavian Vein|sub clavian vein
278024|NCT02472132|Internal Jugular Vein|internal jugular vein
278025|NCT02472132|Trans Thoracic Echocardiography|trans thoracic echocardiography
278026|NCT02472119|Celiac disease|celiac disease
278027|NCT02472119|Gluten-free diet|gluten-free diet
278028|NCT02472119|Wheat flour treatment|wheat flour treatment
278029|NCT02472119|Microbial transglutaminase|microbial transglutaminase
278030|NCT02472119|Lysine Ethyl Ester|lysine ethyl ester
278031|NCT02472119|Celiac Disease Treatment|celiac disease treatment
278032|NCT02472106|Aortic Valve|aortic valve
278033|NCT02472106|TAVI|tavi
278034|NCT02472106|Stenosis|stenosis
278035|NCT02472093|Postural exercise|postural exercise
278036|NCT02472093|Back pain|back pain
278037|NCT02472093|Tender points|tender points
278038|NCT02472093|Fibromyalgia|fibromyalgia
278039|NCT02472093|Perceptive rehabilitation|perceptive rehabilitation
278040|NCT02472067|Musculoskeletal Injury|musculoskeletal injury
278041|NCT02472067|physical therapy|physical therapy
278042|NCT02472067|psychological intervention|psychological intervention
278043|NCT02472067|risk factors|risk factors
278044|NCT02472054|hemophagocytic lymphohistiocytosis (HLH)|hemophagocytic lymphohistiocytosis (hlh)
278045|NCT02472054|Alemtuzumab (CAMPATH®)|alemtuzumab (campath®)
278046|NCT02472041|chest drain|chest drain
278047|NCT02472028|Cerebrovascular Disorders|cerebrovascular disorders
278048|NCT02472028|Stroke|stroke
278049|NCT02472028|Antihypertensive Agents|antihypertensive agents
278050|NCT02472028|Arterial Pressure|arterial pressure
278051|NCT02472028|Memory Disorders|memory disorders
278052|NCT02472015|neuropsychiatric symptoms|neuropsychiatric symptoms
278053|NCT02472015|dementia|dementia
278054|NCT02472015|telemedicine|telemedicine
278055|NCT02472015|long-term care facilities|long-term care facilities
278056|NCT02472002|Transplant coronary diseases|transplant coronary diseases
278057|NCT02472002|Mesenchymal cell therapy|mesenchymal cell therapy
278058|NCT02472002|Administration of CSM by NOGA system|administration of csm by noga system
278059|NCT02472002|Coronary disease in heart transplant patients|coronary disease in heart transplant patients
278060|NCT02471989|FODMAP|fodmap
278061|NCT02471989|Diet|diet
278062|NCT02471989|pH-impedance monitoring|ph-impedance monitoring
278063|NCT02471976|Leonetti law|leonetti law
278064|NCT02471976|palliative care|palliative care
278065|NCT02471963|Empagliflozin|empagliflozin
278066|NCT02471963|Diabetes mellitus|diabetes mellitus
278067|NCT02471963|Macro- and Microcirculation|macro- and microcirculation
278068|NCT02471963|Vascular Improvement|vascular improvement
278069|NCT02471963|Endothelium function|endothelium function
278070|NCT02471937|Streptococcus agalactiae|streptococcus agalactiae
278071|NCT02471937|Group B Streptococcus|group b streptococcus
278072|NCT02471937|Neonates|neonates
278073|NCT02471937|colonization|colonization
278074|NCT02471937|meningitis|meningitis
278075|NCT02471937|Clonal Complex CC17|clonal complex cc17
278076|NCT02471937|microbiota|microbiota
278077|NCT02471937|next generation sequencing (NGS)|next generation sequencing (ngs)
278078|NCT02471924|Pregnant women|pregnant women
278079|NCT02471911|DLBCL|dlbcl
278080|NCT02471911|Aggressive|aggressive
278081|NCT02471911|Diffuse|diffuse
278082|NCT02471911|Large|large
278083|NCT02471885|remote ischaemic conditioning|remote ischaemic conditioning
278084|NCT02471885|remote ischemic conditioning|remote ischemic conditioning
278085|NCT02471885|cardio-oncology|cardio-oncology
278086|NCT02471885|anthracycline|anthracycline
278087|NCT02471885|troponin|troponin
278088|NCT02471885|chemotherapy|chemotherapy
278089|NCT02471885|myocardial reperfusion injury|myocardial reperfusion injury
278090|NCT02471833|Hypertension|hypertension
278091|NCT02471833|Prevention|prevention
278092|NCT02471833|Family History|family history
278093|NCT02471833|inflammation|inflammation
278094|NCT02471833|blood brain barrier|blood brain barrier
278095|NCT02471833|amyloid|amyloid
278096|NCT02471820|Multiple Myeloma|multiple myeloma
278097|NCT02471794|Type II Diabetes|type ii diabetes
278098|NCT02471794|Personalized Health Planning|personalized health planning
278099|NCT02471794|Shared Medical Appointments|shared medical appointments
278100|NCT02471781|Aortic Aneurysm|aortic aneurysm
278101|NCT02471781|Aneurysm|aneurysm
278102|NCT02471781|Vascular Prosthesis|vascular prosthesis
278103|NCT02471781|Vascular Disease|vascular disease
278104|NCT02471781|Blood Vessel Prosthesis Implantation|blood vessel prosthesis implantation
278105|NCT02471768|central pressure|central pressure
278106|NCT02471768|Gensini score|gensini score
278107|NCT02471768|pulsatility|pulsatility
278108|NCT02471768|coronary artery disease|coronary artery disease
278109|NCT02471755|electro-acupuncture|electro-acupuncture
278110|NCT02471755|menopause|menopause
355380|NCT02072356|HUD|hud
278111|NCT02471755|menopausal transition symptoms|menopausal transition symptoms
278112|NCT02471755|efficacy|efficacy
278113|NCT02471755|RCT|rct
278114|NCT02471755|placebo control|placebo control
278115|NCT02471729|Cardio-Renal Syndrome|cardio-renal syndrome
278116|NCT02471729|Chronic Heart Failure|chronic heart failure
278117|NCT02471729|Renal Denervation|renal denervation
278118|NCT02471729|Sympathetic activation|sympathetic activation
278119|NCT02471729|Heart Failure|heart failure
278120|NCT02471729|Cardiovascular Diseases|cardiovascular diseases
278121|NCT02471729|Heart Diseases|heart diseases
278122|NCT02471716|Diffuse Type Tenosynovial Giant Cell Tumor (dt-TGCT)|diffuse type tenosynovial giant cell tumor (dt-tgct)
278123|NCT02471703|Total Hip Arthroplasty|total hip arthroplasty
278124|NCT02471703|Total Hip Replacement|total hip replacement
278125|NCT02471703|Inflammatory Joint Disease|inflammatory joint disease
278126|NCT02471703|Non-Inflammatory Joint Disease|non-inflammatory joint disease
278127|NCT02471690|Volunteers|volunteers
278128|NCT02471677|Ovarian stimulation|ovarian stimulation
278129|NCT02471677|corifollitropin alfa|corifollitropin alfa
278130|NCT02471677|GnRH antagonist protocol|gnrh antagonist protocol
278131|NCT02471677|high responders|high responders
278132|NCT02471677|follitropin beta|follitropin beta
278133|NCT02471664|Percutaneous mitral valve repair|percutaneous mitral valve repair
278134|NCT02471664|Coronary sinus annuloplasty|coronary sinus annuloplasty
278135|NCT02471664|Mitral loop cerclage|mitral loop cerclage
278136|NCT02471625|Controls|controls
278137|NCT02471599|IgA nephropathy|iga nephropathy
278138|NCT02471599|tonsillitis|tonsillitis
278139|NCT02471599|tonsil provocation test|tonsil provocation test
278140|NCT02471599|Tonsillectomy|tonsillectomy
278141|NCT02471573|IVF|ivf
278142|NCT02471573|Freeze-all|freeze-all
278143|NCT02471573|frozen embryo transfer|frozen embryo transfer
278144|NCT02471573|fresh transfer|fresh transfer
278145|NCT02471560|Microbiota|microbiota
278146|NCT02471560|DMF|dmf
278147|NCT02471560|Gastro intestinal|gastro intestinal
278148|NCT02471560|MS|ms
278149|NCT02471547|Recurrence|recurrence
278150|NCT02471495|NMIBC|nmibc
278151|NCT02471495|Non-Muscle-Invasive Bladder Cancer|non-muscle-invasive bladder cancer
278152|NCT02471495|Nonmuscle Invasive Bladder Cancer|nonmuscle invasive bladder cancer
278153|NCT02471495|BCG refractory|bcg refractory
278154|NCT02471495|BCG failure|bcg failure
278155|NCT02471495|Carcinoma in situ|carcinoma in situ
278156|NCT02471495|CIS|cis
278157|NCT02471482|Near Infra Red Spectrometry|near infra red spectrometry
278158|NCT02471482|Cerebral oxygenation|cerebral oxygenation
278159|NCT02471482|Mozart music|mozart music
278160|NCT02471404|Diabetes Mellitus Type 2,|diabetes mellitus type 2,
278161|NCT02471404|metformin,|metformin,
278162|NCT02471404|saxagliptin,|saxagliptin,
278163|NCT02471404|dapagliflozin,|dapagliflozin,
278164|NCT02471404|glimepiride,|glimepiride,
278165|NCT02471404|inadequate glycaemic control|inadequate glycaemic control
278166|NCT02471378|Assay|assay
278167|NCT02471378|Women|women
278168|NCT02471378|Infected|infected
278169|NCT02471378|Antibodies|antibodies
278170|NCT02471378|Plasmodium Falciparum|plasmodium falciparum
278171|NCT02471365|Exposure Assessment|exposure assessment
278172|NCT02471365|Questionnaire|questionnaire
278173|NCT02471365|Product Use|product use
278174|NCT02471365|Biomonitoring|biomonitoring
278175|NCT02471352|Dermatologic Condition|dermatologic condition
278176|NCT02471352|Skin Disease|skin disease
278177|NCT02471352|Biospecimen|biospecimen
278178|NCT02471352|Healthy Volunteers|healthy volunteers
278179|NCT02471352|Merkel Cell Carcinoma|merkel cell carcinoma
278180|NCT02471339|Psychological Intervention|psychological intervention
278181|NCT02471339|Coping|coping
278182|NCT02471339|Mindfulness|mindfulness
278183|NCT02471339|Randomized|randomized
278184|NCT02471326|HIV Neutralizing Antibodies|hiv neutralizing antibodies
278185|NCT02471326|HIV Therapy|hiv therapy
278186|NCT02471313|Cross-Sectional Imaging|cross-sectional imaging
278187|NCT02471313|Chemoembolization|chemoembolization
278188|NCT02471313|Radiation Therapy|radiation therapy
278189|NCT02471313|Tumor Hypoxia|tumor hypoxia
278190|NCT02471313|PET Imaging|pet imaging
278191|NCT02471300|Asthma|asthma
278192|NCT02471300|Inflammasome|inflammasome
278193|NCT02471300|Fasting|fasting
278194|NCT02471300|Airflow Obstruction|airflow obstruction
278195|NCT02471287|Ocular Genetic Diseases|ocular genetic diseases
278196|NCT02471287|GENETIC DISEASE|genetic disease
278197|NCT02471144|pediatric, chronic severe plaque psoriasis, secukinumab, etanercept|pediatric, chronic severe plaque psoriasis, secukinumab, etanercept
278198|NCT02471131|WATCHMAN|watchman
278199|NCT02471131|Atrial Fibrillation|atrial fibrillation
278200|NCT02471131|Hybrid Ablation|hybrid ablation
278201|NCT02471131|Safety|safety
278202|NCT02471131|Feasibility|feasibility
278204|NCT02471118|Inflammatory Type|inflammatory type
278205|NCT02471092|satiety|satiety
278206|NCT02471092|glycemia|glycemia
278207|NCT02471092|milk protein|milk protein
278208|NCT02471079|Radiation-induced health problems|radiation-induced health problems
278209|NCT02471079|Cardiovascular events|cardiovascular events
278210|NCT02471079|Lung toxicity|lung toxicity
278211|NCT02471053|Exercise|exercise
278212|NCT02471053|Quality of Life|quality of life
278213|NCT02471053|Complementary Therapies|complementary therapies
278214|NCT02471053|Neoadjuvant Therapy|neoadjuvant therapy
278215|NCT02471053|Feasibility Studies|feasibility studies
278216|NCT02471040|brain metabolism|brain metabolism
278217|NCT02471040|cognitive function|cognitive function
278218|NCT02471027|Locally advanced cervical cancer|locally advanced cervical cancer
278219|NCT02471027|Neoadjuvant chemotherapy|neoadjuvant chemotherapy
278220|NCT02471027|Disease-free survival|disease-free survival
278221|NCT02471027|Overall survival|overall survival
278222|NCT02471014|Pneumovax23|pneumovax23
278223|NCT02471014|Obesity|obesity
278224|NCT02471001|concentration|concentration
278225|NCT02471001|Isoflurane|isoflurane
278226|NCT02471001|cardioprotective|cardioprotective
278227|NCT02471001|cardioplegia|cardioplegia
278228|NCT02471001|heart surgery|heart surgery
278229|NCT02471001|Disorder|disorder
278231|NCT02471001|Functional|functional
278232|NCT02471001|Postoperative|postoperative
278233|NCT02470949|body weight|body weight
278234|NCT02470949|Hispanics|hispanics
278235|NCT02470949|Energy Intake|energy intake
278236|NCT02470949|Social Status|social status
278237|NCT02470923|Smoking cessation|smoking cessation
278238|NCT02470923|Nicotine|nicotine
278239|NCT02470923|Spirometry|spirometry
278240|NCT02470923|Internal medicine|internal medicine
278241|NCT02470910|Prostate Cancer|prostate cancer
278242|NCT02470910|Stage I-III prostate adenocarcinoma|stage i-iii prostate adenocarcinoma
278243|NCT02470806|Venous leg ulcer|venous leg ulcer
278244|NCT02470806|ulcer|ulcer
278245|NCT02470806|venous stasis|venous stasis
278246|NCT02470806|compression|compression
278247|NCT02470806|diabetic foot ulcers|diabetic foot ulcers
278248|NCT02470806|dfu|dfu
278249|NCT02470806|vlu|vlu
278250|NCT02470793|Corneal Endothelial Cell Loss|corneal endothelial cell loss
278251|NCT02470793|Fuchs' Endothelial Dystrophy|fuchs' endothelial dystrophy
278252|NCT02470793|Lamellar Keratoplasty|lamellar keratoplasty
278253|NCT02470793|Descemet Stripping Endothelial Keratoplasty|descemet stripping endothelial keratoplasty
278254|NCT02470793|Descemet Membrane Endothelial Keratoplasty|descemet membrane endothelial keratoplasty
278255|NCT02470793|Minimal Surgical Procedure|minimal surgical procedure
278256|NCT02470728|patient readmission|patient readmission
278257|NCT02470728|pain relief units|pain relief units
278258|NCT02470728|pain centers|pain centers
278259|NCT02470728|multidisciplinary pain clinics|multidisciplinary pain clinics
278260|NCT02470728|multidisciplinary pain centers|multidisciplinary pain centers
278261|NCT02470728|pain clinics|pain clinics
278262|NCT02470728|hospital readmission|hospital readmission
278263|NCT02470728|emergencies|emergencies
278264|NCT02470728|emergency medicine|emergency medicine
278265|NCT02470728|critical care|critical care
278266|NCT02470728|emergency treatment|emergency treatment
278267|NCT02470728|opioid|opioid
278268|NCT02470728|acute pain service|acute pain service
278269|NCT02470715|genetic sequencing|genetic sequencing
278270|NCT02470715|genome|genome
278271|NCT02470715|cancer|cancer
278272|NCT02470715|DNA|dna
278273|NCT02470715|RNA|rna
278274|NCT02470715|protein|protein
278275|NCT02470715|metabolite|metabolite
278276|NCT02470702|Volunteers|volunteers
278277|NCT02470650|comparative effectiveness|comparative effectiveness
278278|NCT02470598|Automated Peritoneal Dialysis|automated peritoneal dialysis
278279|NCT02470598|Adapted APD (aAPD)|adapted apd (aapd)
278280|NCT02470598|Hydration status|hydration status
278281|NCT02470598|Residual Renal Function|residual renal function
278282|NCT02470598|Ultrafiltration|ultrafiltration
278283|NCT02470585|Veliparib|veliparib
278284|NCT02470585|Carboplatin|carboplatin
278285|NCT02470585|Paclitaxel|paclitaxel
278286|NCT02470585|Overall Survival|overall survival
278287|NCT02470585|ABT-888|abt-888
278288|NCT02470585|Randomized|randomized
278289|NCT02470585|Poly Adenosine Diphosphate (ADP) - Ribose Polymerase (PARP)|poly adenosine diphosphate (adp) - ribose polymerase (parp)
278290|NCT02470585|Ovarian|ovarian
278291|NCT02470585|BRCA|brca
278292|NCT02470585|VELIA|velia
278293|NCT02470546|Hepatic encephalopathy|hepatic encephalopathy
278294|NCT02470546|Metformin|metformin
278295|NCT02470546|Liver cirrhosis|liver cirrhosis
278296|NCT02470481|Psoriatic arthritis|psoriatic arthritis
278297|NCT02470468|Immunotherapy|immunotherapy
278298|NCT02470468|Metastatic|metastatic
278299|NCT02470468|NSCLC|nsclc
278300|NCT02470468|Biological|biological
278301|NCT02470468|Lung Cancer|lung cancer
278302|NCT02470468|Vaccine|vaccine
278303|NCT02470455|Atorvastatin|atorvastatin
278304|NCT02470455|Prediabetics|prediabetics
278305|NCT02470455|HbA1c|hba1c
278306|NCT02470416|duodenal|duodenal
278307|NCT02470416|ampulla|ampulla
278308|NCT02470403|dysglycemic, normoglycemic, prediabetes, type 2 diabetes mellitus|dysglycemic, normoglycemic, prediabetes, type 2 diabetes mellitus
278309|NCT02470390|Volunteer|volunteer
278310|NCT02470390|Pharmacokenetics (PK) (plasma and Cerebrospinal Fluid [CSF])|pharmacokenetics (pk) (plasma and cerebrospinal fluid [csf])
278311|NCT02470377|MdDS|mdds
278312|NCT02470377|TMS|tms
278313|NCT02470377|fMRI|fmri
278314|NCT02470377|EEG|eeg
278315|NCT02470364|Myasthenia gravis|myasthenia gravis
278316|NCT02470364|Quality of life|quality of life
278317|NCT02470325|Cerebral palsy|cerebral palsy
278318|NCT02470325|Genetic neurodegenerative diseases|genetic neurodegenerative diseases
278319|NCT02470312|utility of MediGuide system|utility of mediguide system
278320|NCT02470312|CRT|crt
278321|NCT02470312|EP|ep
278322|NCT02470299|ketorolac|ketorolac
278323|NCT02470299|GTPase|gtpase
278324|NCT02470299|cancer|cancer
278325|NCT02470299|peritoneal|peritoneal
278326|NCT02470299|fallopian|fallopian
278327|NCT02470299|ovarian|ovarian
278328|NCT02470273|Melanoma|melanoma
278329|NCT02470260|Diabetes|diabetes
278330|NCT02470260|Pre-diabetes|pre-diabetes
278331|NCT02470260|Cognition|cognition
278332|NCT02470260|Depressive symptoms|depressive symptoms
278333|NCT02470247|Transcatheter Aortic Valve Implantation|transcatheter aortic valve implantation
278334|NCT02470234|ADHD|adhd
278335|NCT02470234|Children|children
278336|NCT02470234|Pharmacokinetics|pharmacokinetics
278337|NCT02470221|goal-directed fluid therapy|goal-directed fluid therapy
278338|NCT02470221|intraoperative hemodynamics|intraoperative hemodynamics
278339|NCT02470221|postoperative complications|postoperative complications
278340|NCT02470208|Cytomegalovirus reactivation in stem cell transplant|cytomegalovirus reactivation in stem cell transplant
278341|NCT02470182|sleep apnea|sleep apnea
278342|NCT02470182|snoring|snoring
278343|NCT02470156|community based participatory research|community based participatory research
278344|NCT02470156|healthy eating|healthy eating
278345|NCT02470156|physical activity|physical activity
278346|NCT02470156|obesity|obesity
278347|NCT02470143|Human-computer interaction|human-computer interaction
278348|NCT02470143|Fear|fear
278349|NCT02470143|Motivation|motivation
278350|NCT02470143|Usability|usability
278351|NCT02470130|simulation|simulation
278352|NCT02470130|anxiety|anxiety
278353|NCT02470130|debriefing|debriefing
278354|NCT02470130|memorization|memorization
278355|NCT02470104|children|children
278356|NCT02470104|bone marrow transplant|bone marrow transplant
278357|NCT02470104|autologous|autologous
278358|NCT02470104|allogeneic|allogeneic
278359|NCT02470104|breastmilk|breastmilk
278360|NCT02470104|hematopoietic stem cell transplantation (HSCT)|hematopoietic stem cell transplantation (hsct)
278361|NCT02470078|extubation|extubation
278362|NCT02470065|NSCLC|nsclc
278363|NCT02470065|Early stage|early stage
278364|NCT02470065|Phase II|phase ii
278365|NCT02470065|Randomized|randomized
278366|NCT02470065|EGFR mutated|egfr mutated
278367|NCT02470052|Endobronchial Valves|endobronchial valves
278368|NCT02470052|Intrabronchial Valves|intrabronchial valves
278369|NCT02470052|Bronchial Valve|bronchial valve
278370|NCT02470052|Chronic Obstructive Pulmonary Disease|chronic obstructive pulmonary disease
278371|NCT02470052|Pulmonary Disease, Chronic Obstructive|pulmonary disease, chronic obstructive
278372|NCT02470052|Bronchoscopic Lung Volume Reduction|bronchoscopic lung volume reduction
278373|NCT02470052|Emphysema|emphysema
278374|NCT02470052|Pulmonary Emphysema|pulmonary emphysema
278375|NCT02470052|Lung Diseases|lung diseases
278376|NCT02470052|Respiratory Tract Disease|respiratory tract disease
278377|NCT02470013|Malnutrition|malnutrition
278378|NCT02470013|Geriatrics|geriatrics
278379|NCT02470013|Enteral Nutrition|enteral nutrition
278380|NCT02470000|myofascial pain|myofascial pain
278381|NCT02470000|neck|neck
278382|NCT02470000|laser|laser
278383|NCT02470000|elastography|elastography
278384|NCT02470000|shear wave velocity|shear wave velocity
278385|NCT02470000|randomized control trial|randomized control trial
278386|NCT02470000|Intravascular Laser Irradiation of Blood|intravascular laser irradiation of blood
278387|NCT02469987|safety|safety
278388|NCT02469987|tolerability|tolerability
278389|NCT02469987|immunogenicity|immunogenicity
278390|NCT02469987|MYL-1402O|myl-1402o
278391|NCT02469987|PK|pk
278392|NCT02469987|Avastin®|avastin®
278393|NCT02469987|biosimilarity|biosimilarity
278394|NCT02469987|male|male
278395|NCT02469974|Myelofibrosis|myelofibrosis
278396|NCT02469974|RUXOLITINIB|ruxolitinib
278397|NCT02469974|Autologous stem cell transplant|autologous stem cell transplant
278398|NCT02469948|spasticity|spasticity
278399|NCT02469948|botulinum toxin|botulinum toxin
278400|NCT02469948|ultrasonography guidance|ultrasonography guidance
278401|NCT02469948|electric stimulation guidance|electric stimulation guidance
278402|NCT02469948|stroke|stroke
278403|NCT02469935|Validation|validation
278404|NCT02469935|Surgeon-performed ultrasound|surgeon-performed ultrasound
278405|NCT02469935|Gallstones|gallstones
278406|NCT02469909|Decannulation|decannulation
278407|NCT02469909|tracheostomy|tracheostomy
278408|NCT02469896|ALS|als
278409|NCT02469896|tocilizumab|tocilizumab
278410|NCT02469896|biomarker|biomarker
750807|NCT00438152|Lipids|lipids
355754|NCT02070484|NuCel|nucel
278411|NCT02469870|Parents of children who have autism|parents of children who have autism
278412|NCT02469870|video-conferencing|video-conferencing
278413|NCT02469870|Applied Behavior Analysis|applied behavior analysis
278414|NCT02469870|Acceptance Commitment Training|acceptance commitment training
278415|NCT02469870|optimism training|optimism training
278416|NCT02469870|Positive Behavior Support|positive behavior support
278417|NCT02469857|AB103|ab103
278418|NCT02469857|Necrotizing fasciitis|necrotizing fasciitis
278419|NCT02469818|pocus|pocus
278420|NCT02469818|ultrasonography|ultrasonography
278421|NCT02469818|glenohumeral dislocation|glenohumeral dislocation
278422|NCT02469792|Anterior cruciate ligament|anterior cruciate ligament
278423|NCT02469792|Ligament rupture|ligament rupture
278424|NCT02469792|Intraarticular injection|intraarticular injection
278425|NCT02469792|ADRC|adrc
278426|NCT02469792|Adipose-derived regenerative cells|adipose-derived regenerative cells
278427|NCT02469792|Adipose tissue|adipose tissue
278428|NCT02469792|Stem cells|stem cells
278429|NCT02469779|Tobacco Prevention|tobacco prevention
278430|NCT02469779|ASPIRE Website|aspire website
278431|NCT02469779|Surveys|surveys
278432|NCT02469779|Questionnaires|questionnaires
278433|NCT02469779|Focus Groups|focus groups
278434|NCT02469779|Health Interactive Website|health interactive website
278435|NCT02469766|ureteral stones|ureteral stones
278436|NCT02469766|ureter|ureter
278437|NCT02469766|ureteroscopy|ureteroscopy
278438|NCT02469766|flexible|flexible
278439|NCT02469766|SWL|swl
278440|NCT02469753|NSAIDs|nsaids
278441|NCT02469753|Anti-TNF|anti-tnf
278442|NCT02469753|syndesmophytes|syndesmophytes
278443|NCT02469753|mSASSS|msasss
278444|NCT02469740|Ticagrelor|ticagrelor
278445|NCT02469740|Clopidogrel|clopidogrel
278446|NCT02469740|Coronary Artery Disease|coronary artery disease
278447|NCT02469740|Percutaneous Coronary Intervention|percutaneous coronary intervention
278448|NCT02469740|Acute Coronary Syndrome|acute coronary syndrome
278449|NCT02469714|Patient Navigator|patient navigator
278450|NCT02469714|Integrated Care|integrated care
278451|NCT02469714|Latino|latino
278452|NCT02469714|Mental health and wellness|mental health and wellness
278453|NCT02469714|Physical health and wellness|physical health and wellness
278454|NCT02469688|cedar pollinosis|cedar pollinosis
278455|NCT02469688|immunological response,|immunological response,
278456|NCT02469688|ASP4070|asp4070
278457|NCT02469688|vaccine|vaccine
278458|NCT02469675|Spinal Cord Injuries|spinal cord injuries
278459|NCT02469675|Amyotrophic Lateral Sclerosis|amyotrophic lateral sclerosis
278460|NCT02469675|Transcranial magnetic stimulation, single pulse|transcranial magnetic stimulation, single pulse
278461|NCT02469675|non-invasive brain stimulation|non-invasive brain stimulation
278462|NCT02469662|Total Elbow Arthroplasty|total elbow arthroplasty
278463|NCT02469662|TEA|tea
278464|NCT02469662|Elbow Arthroplasty|elbow arthroplasty
278465|NCT02469662|Elbow Replacement|elbow replacement
278466|NCT02469662|Advanced Rheumatoid Arthritis|advanced rheumatoid arthritis
278467|NCT02469662|Post-Traumatic Arthritis|post-traumatic arthritis
278468|NCT02469662|Degenerative Arthritis|degenerative arthritis
278469|NCT02469662|Elbow Joint Destruction|elbow joint destruction
278470|NCT02469662|Post-Traumatic Lesions or Bone Loss|post-traumatic lesions or bone loss
278471|NCT02469662|Ankylosed Joints|ankylosed joints
278472|NCT02469662|Acute Comminuted Articular Fracture|acute comminuted articular fracture
278473|NCT02469662|significantly compromises daily living activities|significantly compromises daily living activities
278474|NCT02469662|degree of joint or soft tissue damage precludes reliable osteosynthesis|degree of joint or soft tissue damage precludes reliable osteosynthesis
278475|NCT02469662|precludes less radical procedures, including 13-C3 fractures of the distal humerus|precludes less radical procedures, including 13-c3 fractures of the distal humerus
278476|NCT02469610|Post surgical pain|post surgical pain
278477|NCT02469584|prolapse|prolapse
278478|NCT02469584|anterior colporrhaphy|anterior colporrhaphy
278479|NCT02469545|depression|depression
278480|NCT02469545|microbiota-gut-brain axis|microbiota-gut-brain axis
278481|NCT02469545|Lactobacillus Plantarum 299v|lactobacillus plantarum 299v
278482|NCT02469545|probiotic|probiotic
278483|NCT02469480|MCRC|mcrc
278484|NCT02469480|iron substitution|iron substitution
278485|NCT02469480|iron deficiency anemia|iron deficiency anemia
278486|NCT02469467|phosphate binder|phosphate binder
278487|NCT02469467|dialysis|dialysis
278488|NCT02469454|etonogestrel-implant|etonogestrel-implant
278489|NCT02469454|newborn|newborn
278490|NCT02469454|growth|growth
278491|NCT02469454|Child Development|child development
278492|NCT02469441|coffee|coffee
278493|NCT02469441|postoperative ileus|postoperative ileus
278494|NCT02469441|colorectal surgery|colorectal surgery
278495|NCT02469428|Controlled human exposure study|controlled human exposure study
278496|NCT02469428|Ozone|ozone
278497|NCT02469428|Inflammation|inflammation
278498|NCT02469415|Leukemia|leukemia
278499|NCT02469415|Myelodysplastic syndromes|myelodysplastic syndromes
278500|NCT02469415|MDS|mds
278501|NCT02469415|Lower-risk|lower-risk
278502|NCT02469415|Pacritinib|pacritinib
278503|NCT02469415|5-azacitidine|5-azacitidine
278504|NCT02469415|Azacitidine|azacitidine
278505|NCT02469415|5-azacytidine|5-azacytidine
278506|NCT02469415|Vidaza|vidaza
278507|NCT02469415|5-AZC|5-azc
278508|NCT02469415|AZA-CR|aza-cr
278509|NCT02469415|Ladakamycin|ladakamycin
278510|NCT02469415|NSC-102816|nsc-102816
278511|NCT02469415|Azacytidine|azacytidine
278512|NCT02469415|Decitabine|decitabine
278513|NCT02469415|Dacogen|dacogen
278514|NCT02469402|reduced|reduced
278515|NCT02469402|protein|protein
278516|NCT02469402|formula|formula
278517|NCT02469402|Alpha-lactalbumin|alpha-lactalbumin
278518|NCT02469402|infant|infant
278519|NCT02469389|Schizophrenia|schizophrenia
278520|NCT02469389|Negative Symptoms|negative symptoms
278521|NCT02469363|Macintosh laryngoscope|macintosh laryngoscope
278522|NCT02469363|McCoy laryngoscope|mccoy laryngoscope
278523|NCT02469363|C-Mac videolaryngoscope|c-mac videolaryngoscope
278524|NCT02469363|McGrath videolaryngoscope|mcgrath videolaryngoscope
278525|NCT02469363|Hemodynamic parameters|hemodynamic parameters
278526|NCT02469350|Gait and balance disorders|gait and balance disorders
278527|NCT02469350|serious game|serious game
278630|NCT02468778|HeartMate PHP|heartmate php
278528|NCT02469311|infection; arthroplasty; chlorhexidine; hip; knee|infection; arthroplasty; chlorhexidine; hip; knee
278529|NCT02469298|acute, uncomplicated influenza|acute, uncomplicated influenza
278530|NCT02469298|Danirixin|danirixin
278531|NCT02469298|oseltamivir|oseltamivir
278532|NCT02469285|Fatty acids|fatty acids
278533|NCT02469285|Lipids|lipids
278534|NCT02469285|Nitroso compounds|nitroso compounds
278535|NCT02469285|Lipid metabolism|lipid metabolism
278536|NCT02469285|Gut metabolism|gut metabolism
278537|NCT02469259|oxytocin|oxytocin
278538|NCT02469259|PTSD|ptsd
278539|NCT02469259|Alcohol Use Disorder|alcohol use disorder
278540|NCT02469259|social cognition|social cognition
278541|NCT02469259|craving|craving
278542|NCT02469259|fear-potentiated startle|fear-potentiated startle
278543|NCT02469246|HIV|hiv
278544|NCT02469246|HIV-1 Positive|hiv-1 positive
278545|NCT02469246|Virologically-Suppressed|virologically-suppressed
278546|NCT02469220|Diet|diet
278547|NCT02469220|low FODMAP|low fodmap
278548|NCT02469220|UC|uc
278549|NCT02469220|IBS|ibs
278550|NCT02469207|regenerative medicine|regenerative medicine
278551|NCT02469207|stem cells|stem cells
278552|NCT02469207|immunomodulatory|immunomodulatory
278553|NCT02469207|induced pluripotent stem cells|induced pluripotent stem cells
278554|NCT02469207|gut physiology|gut physiology
278555|NCT02469129|positron emission tomography (PET) imaging|positron emission tomography (pet) imaging
278556|NCT02469129|poly(ADP-ribose) polymerase 1 (PARP1)|poly(adp-ribose) polymerase 1 (parp1)
278557|NCT02469129|[18F]FluorThanatrace ([18F]FTT)|[18f]fluorthanatrace ([18f]ftt)
278558|NCT02469129|PARP1 inhibitors|parp1 inhibitors
278559|NCT02469129|cancer treatments|cancer treatments
278560|NCT02469103|capsule colonoscopy|capsule colonoscopy
278561|NCT02469103|ulcerative colitis|ulcerative colitis
278562|NCT02469090|Parkinson Disease, off episodes|parkinson disease, off episodes
278563|NCT02469077|Chronic Low Back Pain|chronic low back pain
278564|NCT02469064|mechanical ventilation|mechanical ventilation
278565|NCT02469064|respiratory muscle|respiratory muscle
278566|NCT02469064|weaning|weaning
278567|NCT02469064|training|training
278568|NCT02469064|Intensive care|intensive care
278569|NCT02469012|chronic hepatitis C|chronic hepatitis c
278570|NCT02469012|antiviral treatment|antiviral treatment
278571|NCT02469012|interferon-free|interferon-free
278572|NCT02469012|neurocognitive performance|neurocognitive performance
278573|NCT02469012|emotional state|emotional state
278574|NCT02469012|quality of life|quality of life
278575|NCT02468999|Intranasal insulin|intranasal insulin
278576|NCT02468986|Rheumatoid Arthritis|rheumatoid arthritis
278577|NCT02468973|health behavior|health behavior
278578|NCT02468973|consultation|consultation
278579|NCT02468973|undergraduate|undergraduate
278580|NCT02468960|Coronary Artery Disease|coronary artery disease
278581|NCT02468960|OPN NC|opn nc
278582|NCT02468960|Angina|angina
278583|NCT02468960|Stable|stable
278584|NCT02468960|Unstable|unstable
278585|NCT02468947|Neonatal sepsis|neonatal sepsis
278586|NCT02468934|electrical stimulation|electrical stimulation
278587|NCT02468934|neurostimulation|neurostimulation
278588|NCT02468934|neuromodulation|neuromodulation
278589|NCT02468934|TKA pain|tka pain
278590|NCT02468934|pain following total knee replacement|pain following total knee replacement
278591|NCT02468934|total knee arthroplasty|total knee arthroplasty
278592|NCT02468921|Goitre|goitre
278593|NCT02468921|thyroid disease|thyroid disease
278594|NCT02468921|struma|struma
278595|NCT02468895|Myositis|myositis
278596|NCT02468895|Idiopathic inflammatory myopathy|idiopathic inflammatory myopathy
278597|NCT02468895|Antibodies|antibodies
278598|NCT02468895|Genetics|genetics
278599|NCT02468895|Biomarkers|biomarkers
278600|NCT02468882|Breast cancer|breast cancer
278601|NCT02468882|Radiotherapy|radiotherapy
278602|NCT02468882|Toxicity|toxicity
278603|NCT02468882|Outcomes|outcomes
278604|NCT02468882|Watercress|watercress
278605|NCT02468869|Recall|recall
278606|NCT02468869|Discharge communication|discharge communication
278607|NCT02468869|Satisfaction|satisfaction
278608|NCT02468869|Adherence|adherence
278609|NCT02468869|Information structuring|information structuring
278610|NCT02468869|Empathy skills|empathy skills
278611|NCT02468843|Deep brain stimulation|deep brain stimulation
278612|NCT02468843|DBS|dbs
278613|NCT02468843|Dystonia|dystonia
278614|NCT02468843|DYT1|dyt1
278615|NCT02468830|mirabegron|mirabegron
278616|NCT02468830|antimuscarinics|antimuscarinics
278617|NCT02468830|beta 3 agonist|beta 3 agonist
278618|NCT02468830|overactive bladder|overactive bladder
278619|NCT02468830|children|children
278620|NCT02468817|parathyroid hormone (PTH)|parathyroid hormone (pth)
278621|NCT02468817|bone mineral density (BMD)|bone mineral density (bmd)
278622|NCT02468804|Parkinson's|parkinson's
278623|NCT02468804|Non-parkinsons|non-parkinsons
278624|NCT02468791|Rheumatoid Arthritis|rheumatoid arthritis
278625|NCT02468791|Autoimmune Diseases|autoimmune diseases
278626|NCT02468791|Rituximab|rituximab
278627|NCT02468791|Immune System Diseases|immune system diseases
278628|NCT02468791|Joint Diseases|joint diseases
278629|NCT02468791|Rheumatic Diseases|rheumatic diseases
278631|NCT02468778|High Risk PCI|high risk pci
278632|NCT02468778|Mechanical circulatory support device|mechanical circulatory support device
278633|NCT02468778|MCS|mcs
278634|NCT02468778|Abbott|abbott
278635|NCT02468713|Omega-3|omega-3
278636|NCT02468713|Blood lipid profiles|blood lipid profiles
278637|NCT02468713|DHA|dha
278638|NCT02468713|EPA|epa
278639|NCT02468713|Triglyceride|triglyceride
278640|NCT02468713|Glucose|glucose
278641|NCT02468713|Insulin|insulin
278642|NCT02468713|LDL|ldl
278643|NCT02468713|TPN|tpn
278644|NCT02468687|Relapsed/Refractory|relapsed/refractory
278645|NCT02468674|Sarcopenia, muscle wasting, elderly, strength, physical|sarcopenia, muscle wasting, elderly, strength, physical
278646|NCT02468674|function, lean body mass, gait speed|function, lean body mass, gait speed
278647|NCT02468661|Non-Small Cell Lung Cancer|non-small cell lung cancer
278648|NCT02468661|NSCLC|nsclc
278649|NCT02468661|INC280|inc280
278650|NCT02468661|erlotinib|erlotinib
278651|NCT02468661|advanced/metastatic non-small cell lung cancer|advanced/metastatic non-small cell lung cancer
278652|NCT02468661|EGFR mutation|egfr mutation
278653|NCT02468661|cMET amplification|cmet amplification
278654|NCT02468661|EGFR tyrosine kinase inhibitor (EGFR TKI)|egfr tyrosine kinase inhibitor (egfr tki)
278655|NCT02468648|Oral Therapy|oral therapy
278656|NCT02468648|Liver Biopsy|liver biopsy
278657|NCT02468648|Chronic Hepatitis C|chronic hepatitis c
278658|NCT02468635|Pulmonary rehabilitation|pulmonary rehabilitation
278659|NCT02468635|chronic obstructive pulmonary disease|chronic obstructive pulmonary disease
278660|NCT02468635|physical ability|physical ability
278661|NCT02468635|pulmonary function|pulmonary function
278662|NCT02468635|quality of daily life|quality of daily life
278663|NCT02468596|Axonal excitability|axonal excitability
278664|NCT02468596|Neuropathy|neuropathy
278665|NCT02468596|QTRAC|qtrac
278666|NCT02468596|anti-MAG|anti-mag
278667|NCT02468596|Electrophysiology|electrophysiology
278668|NCT02468583|Osteoarthritis|osteoarthritis
278669|NCT02468583|Post-traumatic|post-traumatic
278670|NCT02468583|Knee|knee
278671|NCT02468583|Pain|pain
278672|NCT02468583|Corticosteroid|corticosteroid
278673|NCT02468583|Intra-articular|intra-articular
278674|NCT02468583|Injection|injection
278675|NCT02468570|PKU|pku
278676|NCT02468570|PEG-PAL|peg-pal
278677|NCT02468570|Pegvaliase|pegvaliase
278678|NCT02468570|BMN 165|bmn 165
278679|NCT02468570|rAv-PAL PEG|rav-pal peg
278680|NCT02468570|PRISM 302|prism 302
278681|NCT02468570|PRISM 303|prism 303
278682|NCT02468570|BioMarin|biomarin
278683|NCT02468570|165-302|165-302
278684|NCT02468557|Relapsed/refractory pancreatic ductal adenocarcinoma|relapsed/refractory pancreatic ductal adenocarcinoma
278685|NCT02468557|Previously untreated pancreatic ductal adenocarcinoma|previously untreated pancreatic ductal adenocarcinoma
278686|NCT02468544|Engagement in care|engagement in care
278687|NCT02468544|mHealth|mhealth
278688|NCT02468531|Xenon|xenon
278689|NCT02468531|Standford A acute aortic dissection|standford a acute aortic dissection
278690|NCT02468505|Structured transition support program|structured transition support program
278691|NCT02468505|Transition 'as usual'|transition 'as usual'
278692|NCT02468492|Knee Osteoarthritis|knee osteoarthritis
278693|NCT02468492|Platelet Rich Plasma|platelet rich plasma
278694|NCT02468492|Mechanism of Action|mechanism of action
278695|NCT02468492|Stem Cells|stem cells
278696|NCT02468492|Synovial Fluid|synovial fluid
278697|NCT02468479|Liver cirrhosis|liver cirrhosis
278698|NCT02468466|suicide|suicide
278699|NCT02468466|prevention|prevention
278700|NCT02468453|velos|velos
278701|NCT02468453|Vascular|vascular
278702|NCT02468453|Rejuvenation|rejuvenation
278703|NCT02468440|renal insufficiency|renal insufficiency
278704|NCT02468440|kidney transplant|kidney transplant
278705|NCT02468440|educational therapy|educational therapy
278706|NCT02468414|Peritoneal Dialysis|peritoneal dialysis
278707|NCT02468414|End Stage Renal Disease|end stage renal disease
278708|NCT02468414|Anemia|anemia
278709|NCT02468388|maltitol|maltitol
278710|NCT02468388|xylitol|xylitol
278711|NCT02468388|quantitative light-induced fluorescence|quantitative light-induced fluorescence
278712|NCT02468388|saliva pH|saliva ph
278713|NCT02468388|re-mineralization|re-mineralization
278714|NCT02468388|dental caries|dental caries
278715|NCT02468362|Intersphincteric resection|intersphincteric resection
278716|NCT02468362|laparoscopic rectal rescetion|laparoscopic rectal rescetion
278717|NCT02468362|total mesorectal excsison|total mesorectal excsison
278718|NCT02468349|Acute Myocardial Infarction|acute myocardial infarction
278719|NCT02468349|Telemedicine|telemedicine
278720|NCT02468349|Readmissions|readmissions
278721|NCT02468336|Physiology|physiology
278722|NCT02468323|PONV|ponv
278723|NCT02468323|Palonosetron|palonosetron
278724|NCT02468323|Ondansetron|ondansetron
278725|NCT02468323|Cesarean section|cesarean section
278726|NCT02468310|Maternal mortality|maternal mortality
278727|NCT02468310|Neonatal mortality|neonatal mortality
278728|NCT02468310|Neonatal morbidity|neonatal morbidity
278729|NCT02468310|Text messaging|text messaging
278730|NCT02468310|Clinical decision making|clinical decision making
278731|NCT02468310|Maternal Morbidity|maternal morbidity
278732|NCT02468271|Clinimetrics|clinimetrics
278733|NCT02468271|Lung function|lung function
278734|NCT02468271|Lung clearance index|lung clearance index
278735|NCT02468258|Assisted Reproduction|assisted reproduction
278736|NCT02468245|Nursing intervention|nursing intervention
278737|NCT02468245|compliance|compliance
278738|NCT02468232|chronic heart failure|chronic heart failure
278739|NCT02468232|cardiovascular death|cardiovascular death
278740|NCT02468232|hospitalization|hospitalization
278741|NCT02468232|outcome study|outcome study
278742|NCT02468232|worsening heart failure|worsening heart failure
278743|NCT02468232|NT-proBNP|nt-probnp
278744|NCT02468232|NYHA|nyha
278745|NCT02468232|KCCQ|kccq
278746|NCT02468232|HF-rEF|hf-ref
278747|NCT02468219|aortic stenosis|aortic stenosis
278748|NCT02468219|aortic valve replacement|aortic valve replacement
278749|NCT02468219|transcatheter aortic valve implantation|transcatheter aortic valve implantation
278750|NCT02468219|frailty|frailty
278751|NCT02468219|cardiac rehabilitation|cardiac rehabilitation
278752|NCT02468193|Cushing's syndrome|cushing's syndrome
278753|NCT02468193|osilodrostat|osilodrostat
278754|NCT02468193|LCI699|lci699
278755|NCT02468193|ectopic corticotropin syndrome|ectopic corticotropin syndrome
278756|NCT02468193|adrenal adenoma|adrenal adenoma
278757|NCT02468193|adrenal carcinoma|adrenal carcinoma
278758|NCT02468193|ACTH-Independent Macronodular Adrenal Hyperplasia|acth-independent macronodular adrenal hyperplasia
278759|NCT02468193|AIMAH|aimah
278760|NCT02468193|Primary Pigmented Nodular Adrenal Dysplasia|primary pigmented nodular adrenal dysplasia
278761|NCT02468193|PPNAD|ppnad
278762|NCT02468128|Analgesic|analgesic
278763|NCT02468128|Opioids|opioids
278764|NCT02468128|Pain relief after surgery|pain relief after surgery
278765|NCT02468128|Dinalbuphine|dinalbuphine
278766|NCT02468128|Sebacoyl Dinalbuphine Ester|sebacoyl dinalbuphine ester
278767|NCT02468128|SDE|sde
278768|NCT02468128|SDN|sdn
278769|NCT02468128|LT1001|lt1001
278770|NCT02468102|Rivaroxaban|rivaroxaban
278771|NCT02468102|Venous Thrombosis/Pulmonary Embolism|venous thrombosis/pulmonary embolism
278772|NCT02468102|Stroke Prevention in Atrial Fibrillation|stroke prevention in atrial fibrillation
278773|NCT02468102|Anticoagulants|anticoagulants
278774|NCT02468102|Hematologic Agents|hematologic agents
278775|NCT02468102|Therapeutic Uses|therapeutic uses
278776|NCT02468102|Observational|observational
278777|NCT02468102|Pulmonary Embolism|pulmonary embolism
278778|NCT02468102|Venous Thrombosis|venous thrombosis
278779|NCT02468102|Venous Thromboembolism|venous thromboembolism
278780|NCT02468102|Intracranial Hemorrhages|intracranial hemorrhages
278781|NCT02468102|Gastrointestinal Hemorrhage|gastrointestinal hemorrhage
278782|NCT02468076|ERCP|ercp
278783|NCT02468076|radiofrequency ablation|radiofrequency ablation
278784|NCT02468076|obstructive jaundice|obstructive jaundice
278785|NCT02468050|Anxiety|anxiety
278786|NCT02468050|Depression|depression
278787|NCT02468050|Exercise|exercise
278788|NCT02468050|Breast Cancer|breast cancer
278789|NCT02468050|Biopsy|biopsy
278790|NCT02468050|Screening|screening
278791|NCT02468050|Diagnosis|diagnosis
278792|NCT02468037|iron|iron
278793|NCT02468037|diabetes|diabetes
278794|NCT02468037|phlebotomy|phlebotomy
278795|NCT02467998|meaningful use|meaningful use
278796|NCT02467998|electronic health records|electronic health records
278797|NCT02467998|structured language|structured language
278798|NCT02467998|NPWT|npwt
278799|NCT02467998|PQRS|pqrs
278800|NCT02467985|gynecological laparoscopic surgery|gynecological laparoscopic surgery
278801|NCT02467972|Hunger and satiety|hunger and satiety
278802|NCT02467972|Hormones gastrointestinal|hormones gastrointestinal
278803|NCT02467972|Bowel movements|bowel movements
278804|NCT02467959|emergency ultrasound|emergency ultrasound
278805|NCT02467959|acute appendicitis|acute appendicitis
278806|NCT02467959|bedside ultrasound|bedside ultrasound
278807|NCT02467920|exenatide|exenatide
278808|NCT02467920|glargine|glargine
278809|NCT02467920|aspart 30|aspart 30
278810|NCT02467894|Adherence|adherence
278811|NCT02467894|Exercise|exercise
278812|NCT02467881|Physical Activity|physical activity
278813|NCT02467881|Sedentary|sedentary
278814|NCT02467881|Lifestyle Intervention|lifestyle intervention
278815|NCT02467868|Pegfilgrastim|pegfilgrastim
278816|NCT02467868|Granulocyte Colony Stimulating Factor (G-CSF)|granulocyte colony stimulating factor (g-csf)
278817|NCT02467868|Breast Cancer|breast cancer
278818|NCT02467868|Neutropenia|neutropenia
278819|NCT02467855|Drug therapy|drug therapy
278820|NCT02467842|Influenza vaccine|influenza vaccine
278821|NCT02467842|Quadrivalent|quadrivalent
278822|NCT02467842|Inactivated cell culture-derived|inactivated cell culture-derived
278823|NCT02467829|Cerebral Palsy|cerebral palsy
278824|NCT02467829|Walking Aids|walking aids
278825|NCT02467816|Secondary schools|secondary schools
278826|NCT02467816|School lunch|school lunch
278827|NCT02467816|Plate waste|plate waste
278828|NCT02467803|humeral fracture|humeral fracture
278829|NCT02467803|exercise|exercise
278830|NCT02467803|musculoskeletal manipulations|musculoskeletal manipulations
278831|NCT02467777|orthopaedics|orthopaedics
278832|NCT02467777|post-operative warming|post-operative warming
278833|NCT02467764|Knee|knee
278834|NCT02467764|Knee osteoarthritis|knee osteoarthritis
278835|NCT02467764|Knee replacement|knee replacement
278836|NCT02467764|Hip|hip
278837|NCT02467764|Hip osteoarthritis|hip osteoarthritis
278838|NCT02467764|Hip replacement|hip replacement
278839|NCT02467725|Preimplantation Embryo Development|preimplantation embryo development
278840|NCT02467712|Fongal infection|fongal infection
278841|NCT02467712|joint prosthesis|joint prosthesis
278842|NCT02467712|prosthetic reconstruction|prosthetic reconstruction
278843|NCT02467699|Knee|knee
278844|NCT02467699|Knee osteoarthritis|knee osteoarthritis
278845|NCT02467699|Knee replacement|knee replacement
278846|NCT02467621|Stress ulcer prophylaxis|stress ulcer prophylaxis
278847|NCT02467621|Proton pump inhibitor|proton pump inhibitor
278848|NCT02467621|Pneumonia|pneumonia
278849|NCT02467621|Clostridium difficile infection|clostridium difficile infection
278850|NCT02467608|HUEXC030|huexc030
278851|NCT02467608|Pulmonary Tuberculosis|pulmonary tuberculosis
278852|NCT02467595|no muscle relaxant|no muscle relaxant
278853|NCT02467595|rocuronium|rocuronium
278854|NCT02467595|intubation condition|intubation condition
278855|NCT02467595|tracheal intubation|tracheal intubation
278856|NCT02467595|operating room time|operating room time
278857|NCT02467595|low-dose rocuronium|low-dose rocuronium
278858|NCT02467582|Aspirin|aspirin
278859|NCT02467582|colon cancer|colon cancer
278860|NCT02467582|stage II|stage ii
278861|NCT02467582|stage III|stage iii
278862|NCT02467582|PIK3CA|pik3ca
278863|NCT02467582|double-blind|double-blind
278864|NCT02467582|placebo|placebo
278865|NCT02467582|Adjuvant Treatment|adjuvant treatment
278866|NCT02467556|CRPS|crps
278867|NCT02467556|intervention|intervention
278868|NCT02467556|multimodal|multimodal
278869|NCT02467543|Primary dysmenorrhea|primary dysmenorrhea
278870|NCT02467543|Viburnum opulus 3X|viburnum opulus 3x
278871|NCT02467543|Homoeopathic|homoeopathic
278872|NCT02467530|end stage renal disease|end stage renal disease
278873|NCT02467530|peritoneal dialysis (PD)|peritoneal dialysis (pd)
278874|NCT02467530|advanced glycation end products|advanced glycation end products
278875|NCT02467530|Gut Microbiota Inflammation|gut microbiota inflammation
278876|NCT02467517|Neuropathic pain|neuropathic pain
278877|NCT02467517|Ketamine|ketamine
278878|NCT02467517|Magnesium sulfate|magnesium sulfate
278879|NCT02467517|Quality of life|quality of life
278880|NCT02467517|Anxiety and depression|anxiety and depression
278881|NCT02467517|Mood and sleep|mood and sleep
278882|NCT02467491|Exercise|exercise
278883|NCT02467491|Technology|technology
278884|NCT02467491|Aging|aging
278885|NCT02467478|Diabetes Mellitus, Type 2|diabetes mellitus, type 2
278886|NCT02467478|Endothelial cells|endothelial cells
278887|NCT02467478|Cellular biomarker|cellular biomarker
278888|NCT02467478|endothelial dysfunction|endothelial dysfunction
278889|NCT02467478|CD34+|cd34+
278890|NCT02467478|Impaired renal function|impaired renal function
278891|NCT02467465|Fasciosis plantar|fasciosis plantar
278892|NCT02467465|physiotherapy|physiotherapy
278893|NCT02467465|fascitis plantar|fascitis plantar
278894|NCT02467465|dry needling|dry needling
278895|NCT02467439|unaware intervention;|unaware intervention;
278896|NCT02467439|contract sexual partner referral|contract sexual partner referral
278897|NCT02467439|peer referral|peer referral
278898|NCT02467426|Mesothelioma, malignant|mesothelioma, malignant
278899|NCT02467426|Chemotherapy|chemotherapy
278900|NCT02467413|Alzheimer's Disease|alzheimer's disease
278901|NCT02467413|Vascular Dementia|vascular dementia
278902|NCT02467400|bone formation|bone formation
278903|NCT02467387|Non-ischemic Heart Failure|non-ischemic heart failure
278904|NCT02467387|Stem Cells|stem cells
278905|NCT02467374|OCD|ocd
278906|NCT02467374|Neuroimaging|neuroimaging
278907|NCT02467374|Fear Extinction|fear extinction
278908|NCT02467374|Behavior Therapy|behavior therapy
278909|NCT02467361|Neoplasms|neoplasms
278910|NCT02467296|Sodium|sodium
278911|NCT02467296|outcomes|outcomes
278912|NCT02467283|chronic periodontitis|chronic periodontitis
278913|NCT02467283|genetics|genetics
278914|NCT02467283|microarray analysis|microarray analysis
278915|NCT02467283|gingiva|gingiva
278916|NCT02467283|genes|genes
278917|NCT02467283|inflammation|inflammation
278918|NCT02467270|Chronic Phase Chronic Myeloid Leukemia|chronic phase chronic myeloid leukemia
278919|NCT02467270|Molecular Response|molecular response
278920|NCT02467270|CML|cml
278921|NCT02467270|Leukemia|leukemia
278922|NCT02467270|Leukemia, Myeloid|leukemia, myeloid
278923|NCT02467270|Leukemia, Myelogenous, Chronic, BCR-ABL Positive|leukemia, myelogenous, chronic, bcr-abl positive
278924|NCT02467270|Neoplasms by Histologic Type|neoplasms by histologic type
278925|NCT02467270|Neoplasms|neoplasms
278926|NCT02467270|Myeloproliferative Disorders|myeloproliferative disorders
278927|NCT02467270|Bone Marrow Diseases|bone marrow diseases
278928|NCT02467270|Hematologic Diseases|hematologic diseases
278929|NCT02467270|CP-CML|cp-cml
278930|NCT02467244|Hypothyroidism|hypothyroidism
278931|NCT02467244|Serum adiponectin|serum adiponectin
278932|NCT02467244|hsCRP|hscrp
278933|NCT02467244|Homeostatic Model Assessment (HOMA-IR)|homeostatic model assessment (homa-ir)
278934|NCT02467244|Quantitative Insulin Sensitivity Check Index (QUICKI)|quantitative insulin sensitivity check index (quicki)
278935|NCT02467244|Cardiovascular risk assessment scoring (Framingham scoring)|cardiovascular risk assessment scoring (framingham scoring)
278936|NCT02467244|Levothyroxin|levothyroxin
278937|NCT02467231|new diagnosis of cancer|new diagnosis of cancer
278938|NCT02467231|chemotherapy|chemotherapy
278939|NCT02467231|oncofertility|oncofertility
278940|NCT02467231|alkylating agent|alkylating agent
278941|NCT02467231|fertility preservation|fertility preservation
278942|NCT02467231|fertility after cancer|fertility after cancer
278943|NCT02467231|late effects|late effects
278944|NCT02467218|Hyperbaric Oxygen Treatment|hyperbaric oxygen treatment
278945|NCT02467218|Fibromyalgia|fibromyalgia
278946|NCT02467218|Global Function|global function
278947|NCT02467218|Sleep|sleep
278948|NCT02467218|Chronic Pain|chronic pain
278949|NCT02467218|Depression|depression
278950|NCT02467218|Anxiety|anxiety
278951|NCT02467205|Physical Activity|physical activity
278952|NCT02467179|Arrhythmia|arrhythmia
278953|NCT02467179|cavo-tricuspid isthmus|cavo-tricuspid isthmus
278954|NCT02467179|atrial fibrillation|atrial fibrillation
278955|NCT02467179|atrial fibrillation ablation|atrial fibrillation ablation
278956|NCT02467166|esophagoscopy|esophagoscopy
278957|NCT02467166|atrial fibrillation ablation|atrial fibrillation ablation
278958|NCT02467166|radio frequency catheter ablation|radio frequency catheter ablation
278959|NCT02467166|esophageal lesion|esophageal lesion
278960|NCT02467166|arrhythmia|arrhythmia
278961|NCT02467166|atrial fibrillation|atrial fibrillation
278962|NCT02467166|AF|af
278963|NCT02467166|esophageal damage|esophageal damage
278964|NCT02467153|Sarcopenia|sarcopenia
278965|NCT02467153|Older adult|older adult
278966|NCT02467153|Vitamin D|vitamin d
278967|NCT02467153|Physical activity|physical activity
278968|NCT02467153|Muscle atrophy|muscle atrophy
278969|NCT02467153|Muscle strength|muscle strength
278970|NCT02467153|Physical function|physical function
278971|NCT02467153|Frailty|frailty
278972|NCT02467153|Osteoporosis|osteoporosis
278973|NCT02467140|Inguinal hernia repair|inguinal hernia repair
278974|NCT02467140|Hernia|hernia
278975|NCT02467140|ProGrib self-fixating mesh|progrib self-fixating mesh
278976|NCT02467140|Biological mesh|biological mesh
278977|NCT02467140|Tack fixation|tack fixation
278978|NCT02467101|cicatricial alopecia|cicatricial alopecia
278979|NCT02467101|treatment|treatment
278980|NCT02467101|placebo|placebo
278981|NCT02467101|double-blind|double-blind
278982|NCT02467088|PMS|pms
278983|NCT02467088|Individualised homoeopathic treatment|individualised homoeopathic treatment
278984|NCT02467088|Indian females|indian females
278985|NCT02467075|CT, iodinated contrast, contrast-induced AKI, kidney injury|ct, iodinated contrast, contrast-induced aki, kidney injury
278986|NCT02467062|4D flow|4d flow
278987|NCT02467049|ECG|ecg
278988|NCT02467049|Ultrasound|ultrasound
278989|NCT02467049|Peripherally Inserted Central Catheters|peripherally inserted central catheters
278990|NCT02467049|PICC|picc
278991|NCT02467036|overweight children|overweight children
278992|NCT02467036|overweight parents|overweight parents
278993|NCT02467036|eating in the absence of hunger|eating in the absence of hunger
278994|NCT02467036|families with overweight child|families with overweight child
278995|NCT02467036|bmi|bmi
278996|NCT02467036|body mass index|body mass index
278997|NCT02467036|treatment|treatment
278998|NCT02467036|behavioral treatment|behavioral treatment
278999|NCT02467036|family based treatment|family based treatment
279000|NCT02467036|experiments|experiments
279001|NCT02467036|intervention|intervention
279002|NCT02467036|psychophysiological response to food cues|psychophysiological response to food cues
279003|NCT02467023|chronic critical illness|chronic critical illness
279004|NCT02467023|strength training|strength training
279005|NCT02467023|exercise|exercise
279006|NCT02467023|sepsis|sepsis
279007|NCT02467023|mechanical ventilation|mechanical ventilation
279008|NCT02467010|Bortezomib|bortezomib
279009|NCT02467010|cyclophosphamide|cyclophosphamide
279010|NCT02467010|dexamethason|dexamethason
279011|NCT02467010|multiple myeloma|multiple myeloma
279012|NCT02466997|Vitiligo|vitiligo
279013|NCT02466997|Tacrolimus|tacrolimus
279014|NCT02466997|Face|face
279015|NCT02466984|metoclopramide|metoclopramide
279016|NCT02466984|subcutaneous route|subcutaneous route
279017|NCT02466984|palliative care|palliative care
279018|NCT02466984|pharmacology|pharmacology
279019|NCT02466984|bioavailability|bioavailability
279020|NCT02466984|nausea|nausea
279021|NCT02466984|vomiting|vomiting
279022|NCT02466958|depressed|depressed
279023|NCT02466958|older adults|older adults
279024|NCT02466958|antidepressants|antidepressants
279025|NCT02466958|depression|depression
279026|NCT02466958|MDD|mdd
279027|NCT02466919|Helicobacter pylori|helicobacter pylori
279028|NCT02466906|Stage III colon cancer|stage iii colon cancer
279029|NCT02466906|rhGM-CSF|rhgm-csf
279030|NCT02466906|Immunotherapy|immunotherapy
279031|NCT02466906|Surgery|surgery
279032|NCT02466906|Adjuvant chemotherapy|adjuvant chemotherapy
279033|NCT02466880|Type 2|type 2
279034|NCT02466880|NIDDM|niddm
279035|NCT02466867|Ringworm|ringworm
279036|NCT02466854|Bleeding|bleeding
279037|NCT02466854|Acute Coronary Syndrome|acute coronary syndrome
279038|NCT02466854|percutaneous coronary intervention|percutaneous coronary intervention
279039|NCT02466854|1 year follow up|1 year follow up
279040|NCT02466815|Healthy|healthy
279041|NCT02466815|JNJ-42756493|jnj-42756493
279042|NCT02466802|Advanced|advanced
279043|NCT02466789|Bleeding Disorder, inherited|bleeding disorder, inherited
279044|NCT02466789|Von Willebrands Disease|von willebrands disease
279045|NCT02466789|Hematologic Test|hematologic test
279046|NCT02466789|VWF|vwf
279047|NCT02466789|VWD|vwd
279048|NCT02466763|round window|round window
279049|NCT02466763|cochlear implants|cochlear implants
279050|NCT02466763|cochleostomy|cochleostomy
279051|NCT02466737|axillary surgery|axillary surgery
279052|NCT02466737|sentinel lymph node biopsy|sentinel lymph node biopsy
279053|NCT02466711|gastric motility|gastric motility
279054|NCT02466698|Colectomy|colectomy
279055|NCT02466698|Surgical Procedures, Operative|surgical procedures, operative
279056|NCT02466685|Bipolar|bipolar
279057|NCT02466685|Depression|depression
279058|NCT02466685|Cognition|cognition
279059|NCT02466685|Cognitive|cognitive
279060|NCT02466659|IXT|ixt
279061|NCT02466646|Periodontal Debridement|periodontal debridement
279062|NCT02466646|Gingival Crevicular Fluid|gingival crevicular fluid
279063|NCT02466646|Aggressive Periodontitis|aggressive periodontitis
279064|NCT02466646|Interleukin-1beta|interleukin-1beta
279065|NCT02466646|Interleukin-17|interleukin-17
279066|NCT02466620|Body Weight|body weight
279067|NCT02466620|Resuscitation|resuscitation
279068|NCT02466620|Pediatric weight estimation|pediatric weight estimation
279069|NCT02466607|Retinal function|retinal function
279070|NCT02466568|advanced|advanced
279071|NCT02466568|metastatic|metastatic
279072|NCT02466568|lung disease|lung disease
279073|NCT02466568|adenocarcinoma|adenocarcinoma
279074|NCT02466568|non-small cell lung cancer (NSCLC)|non-small cell lung cancer (nsclc)
279075|NCT02466542|Esmolol|esmolol
279076|NCT02466542|Pain|pain
279077|NCT02466542|Anesthesia|anesthesia
279078|NCT02466542|Analgesia|analgesia
279079|NCT02466529|type 1 spinal muscular atrophy (SMA)|type 1 spinal muscular atrophy (sma)
279080|NCT02466516|GS-4997|gs-4997
279081|NCT02466516|Non-alcoholic fatty liver disease (NAFLD)|non-alcoholic fatty liver disease (nafld)
279082|NCT02466516|Fibrosis|fibrosis
279083|NCT02466516|Simtuzumab (SIM)|simtuzumab (sim)
279084|NCT02466516|Apoptosis signal-regulating kinase 1|apoptosis signal-regulating kinase 1
279085|NCT02466516|ASK1 inhibitor|ask1 inhibitor
279086|NCT02466477|Pharmacogenomic|pharmacogenomic
279087|NCT02466477|Pharmacogenomic Testing|pharmacogenomic testing
279088|NCT02466477|Pharmacogenomics|pharmacogenomics
279089|NCT02466477|Genetic Testing|genetic testing
279090|NCT02466477|Genetics|genetics
279091|NCT02466477|Major Depressive Disorder|major depressive disorder
279092|NCT02466477|GeneSight|genesight
279093|NCT02466477|Enhanced GeneSight|enhanced genesight
279094|NCT02466477|Psychotropic|psychotropic
279095|NCT02466438|Antibiotics|antibiotics
279096|NCT02466438|Piperacillin-tazobactam|piperacillin-tazobactam
279097|NCT02466438|Resistant bacteria|resistant bacteria
279098|NCT02466412|smoking|smoking
279099|NCT02466412|nicotine absorption|nicotine absorption
712542|NCT00579774|glycoxidative stress|glycoxidative stress
279100|NCT02466412|potential modified risk tobacco product|potential modified risk tobacco product
279101|NCT02466412|cigarette|cigarette
279102|NCT02466412|Carbon Heated Tobacco Product|carbon heated tobacco product
279103|NCT02466373|clonidine|clonidine
279104|NCT02466373|pharmacodynamics|pharmacodynamics
279105|NCT02466373|pharmacokinetics|pharmacokinetics
279106|NCT02466373|intensive care|intensive care
279107|NCT02466373|delirium|delirium
279108|NCT02466360|Non-specific chronic lower back pain|non-specific chronic lower back pain
279109|NCT02466360|Physical activity|physical activity
279110|NCT02466360|Self-exercises|self-exercises
279111|NCT02466360|Brakes|brakes
279112|NCT02466360|Levers|levers
279113|NCT02466360|Adhesion|adhesion
279114|NCT02466360|Self-care|self-care
279115|NCT02466321|Inverse Reverse Shoulder|inverse reverse shoulder
279116|NCT02466308|sustained acoustic medicine|sustained acoustic medicine
279117|NCT02466308|therapeutic ultrasound|therapeutic ultrasound
279118|NCT02466308|SAM|sam
279119|NCT02466308|LITUS|litus
279120|NCT02466269|Facial Nerve Injuries|facial nerve injuries
279121|NCT02466256|Intraocular lens implantation|intraocular lens implantation
279122|NCT02466243|JBT-101, lenabasum, dermatomyositis|jbt-101, lenabasum, dermatomyositis
279123|NCT02466230|Magnetic stimulation of the brain|magnetic stimulation of the brain
279124|NCT02466230|Antidepressant mechanisms|antidepressant mechanisms
279125|NCT02466217|Auto-immune disease|auto-immune disease
279126|NCT02466217|Auto-inflammatory disease|auto-inflammatory disease
279127|NCT02466217|Omics|omics
279128|NCT02466217|System biology|system biology
279129|NCT02466191|nystagmus|nystagmus
279130|NCT02466191|pharmacological trial|pharmacological trial
279131|NCT02466191|multiple sclerosis|multiple sclerosis
279132|NCT02466191|oscillopsia|oscillopsia
279133|NCT02466165|cardiometabolic risk|cardiometabolic risk
279134|NCT02466165|physical exercise|physical exercise
279135|NCT02466152|PK|pk
279136|NCT02466152|GSK2894512|gsk2894512
279137|NCT02466152|Atopic Dermatitis|atopic dermatitis
279138|NCT02466139|microbiology|microbiology
279139|NCT02466139|c reactive protein|c reactive protein
279140|NCT02466139|urgent cardiac surgery|urgent cardiac surgery
279141|NCT02466126|Depression|depression
279142|NCT02466126|brief Cognitive Behavioral Therapy (bCBT)|brief cognitive behavioral therapy (bcbt)
279143|NCT02466126|Randomized Controlled Trial|randomized controlled trial
279144|NCT02466074|Acetazolamide|acetazolamide
279145|NCT02466074|Lesions|lesions
279146|NCT02466074|Neurodegeneration|neurodegeneration
279147|NCT02466074|Repair|repair
279148|NCT02466061|BMI >= 30 kg/m2|bmi >= 30 kg/m2
279149|NCT02466048|spinal fusion|spinal fusion
279150|NCT02466048|bone graft|bone graft
279151|NCT02466048|collagen|collagen
279152|NCT02466009|Colorectal cancer|colorectal cancer
279153|NCT02466009|metastatic colorectal cancer|metastatic colorectal cancer
279154|NCT02466009|colorectal adenocarcinoma|colorectal adenocarcinoma
279155|NCT02465996|barrier dysfunction|barrier dysfunction
279156|NCT02465996|functional dyspepsia|functional dyspepsia
279157|NCT02465996|Confocal Laser Endomicroscopic|confocal laser endomicroscopic
279158|NCT02465996|therapeutic response|therapeutic response
279159|NCT02465983|Pancreatic Cancer|pancreatic cancer
279160|NCT02465983|CAR / CART|car / cart
279161|NCT02465983|T cells|t cells
279162|NCT02465983|Immunotherapy|immunotherapy
279163|NCT02465983|Gene therapy|gene therapy
279164|NCT02465983|Redirected T cells|redirected t cells
279165|NCT02465983|Autologous T cells|autologous t cells
279166|NCT02465970|Transcranial Direct Current Stimulation|transcranial direct current stimulation
279167|NCT02465957|Merkel Cell Carcinoma|merkel cell carcinoma
279168|NCT02465957|Neukoplast|neukoplast
279169|NCT02465957|NK-92|nk-92
279170|NCT02465957|Natural Killer Cell|natural killer cell
279171|NCT02465957|MCC|mcc
279172|NCT02465957|aNK|ank
279173|NCT02465944|inflammation|inflammation
279174|NCT02465931|Informed Consent|informed consent
279175|NCT02465931|Fragile X Syndrome|fragile x syndrome
279176|NCT02465931|Tablets|tablets
279177|NCT02465931|Decisional Capacity|decisional capacity
279178|NCT02465892|cancer|cancer
279179|NCT02465892|stress|stress
279180|NCT02465892|chronic pain|chronic pain
279181|NCT02465892|anxiety|anxiety
279182|NCT02465892|coping|coping
279183|NCT02465892|balance|balance
279184|NCT02465892|online course|online course
279185|NCT02465892|psychosocial|psychosocial
279186|NCT02465892|support|support
279187|NCT02465892|tools|tools
279188|NCT02465879|Psoriatic arthritis|psoriatic arthritis
279189|NCT02465879|Ankylosing spondylitis|ankylosing spondylitis
279190|NCT02465879|Rheumatoid arthritis|rheumatoid arthritis
279191|NCT02465879|Seronegative|seronegative
279192|NCT02465866|Plasma concentration|plasma concentration
279193|NCT02465866|Time to plasma concentration|time to plasma concentration
279194|NCT02465866|Elimination rate constant|elimination rate constant
279195|NCT02465866|Elimination half life|elimination half life
279196|NCT02465866|Area under the curve|area under the curve
279197|NCT02465853|hemiplegic shoulder pain|hemiplegic shoulder pain
712543|NCT00579774|glycation|glycation
356770|NCT02065674|FBS|fbs
279198|NCT02465853|quality of Life|quality of life
279199|NCT02465853|stroke|stroke
279200|NCT02465840|rehabilitation|rehabilitation
279201|NCT02465840|functional MRI|functional mri
279202|NCT02465814|Uterine fibroids|uterine fibroids
279203|NCT02465814|Heavy Menstrual Bleeding|heavy menstrual bleeding
279204|NCT02465788|Helos|helos
279205|NCT02465788|Hair Removal|hair removal
279206|NCT02465788|Hair Reduction|hair reduction
279207|NCT02465775|non-invasive|non-invasive
279208|NCT02465762|non-invasive|non-invasive
279209|NCT02465749|Retinitis Pigmentosa|retinitis pigmentosa
279210|NCT02465749|oxygen|oxygen
279211|NCT02465749|blue light|blue light
279212|NCT02465723|Intravoxel Incoherent Motion (IVIM)|intravoxel incoherent motion (ivim)
279213|NCT02465723|Diffusion-weighted Magnetic Resonance|diffusion-weighted magnetic resonance
279214|NCT02465723|Acid Sphingomyelinase/Ceramide Pathway Activation|acid sphingomyelinase/ceramide pathway activation
279215|NCT02465723|15-104|15-104
279216|NCT02465710|pelvic organ prolapse|pelvic organ prolapse
279217|NCT02465710|pelvic floor reconstruction surgery|pelvic floor reconstruction surgery
279218|NCT02465710|transvaginal mesh surgery|transvaginal mesh surgery
279219|NCT02465710|Women|women
279220|NCT02465710|Surgical treatment|surgical treatment
279221|NCT02465697|Borderline Personality Disorder|borderline personality disorder
279222|NCT02465697|Avoidant Personality Disorder|avoidant personality disorder
279223|NCT02465697|Brain Imaging|brain imaging
279224|NCT02465658|uterine prolapse|uterine prolapse
279225|NCT02465658|cervical elongation|cervical elongation
279226|NCT02465658|pelvic floor reconstruction surgery|pelvic floor reconstruction surgery
279227|NCT02465541|Cancer Survivors|cancer survivors
279228|NCT02465541|Yoga|yoga
279229|NCT02465541|Endometrial Cancer|endometrial cancer
279230|NCT02465528|ALK|alk
279231|NCT02465528|GBM|gbm
279232|NCT02465528|hematological malignancy|hematological malignancy
279233|NCT02465528|anaplastic lymphoma kinase|anaplastic lymphoma kinase
279234|NCT02465528|glioblastoma|glioblastoma
279235|NCT02465528|anaplastic large cell lymphoma|anaplastic large cell lymphoma
279237|NCT02465528|inflammatory myofibroblastic tumor|inflammatory myofibroblastic tumor
279238|NCT02465515|cardiovascular events /outcomes|cardiovascular events /outcomes
279239|NCT02465515|Type 2 diabetes mellitus|type 2 diabetes mellitus
279240|NCT02465515|albiglutide|albiglutide
279241|NCT02465515|glucagon-like peptide-1 receptor agonist|glucagon-like peptide-1 receptor agonist
279242|NCT02465502|Colorectal cancer|colorectal cancer
279243|NCT02465502|Regorafenib|regorafenib
279244|NCT02465489|deferiprone|deferiprone
279245|NCT02465489|deferiprone extended release formulation|deferiprone extended release formulation
279246|NCT02465489|pharmacokinetics|pharmacokinetics
279247|NCT02465476|skin disease|skin disease
279248|NCT02465476|telemedicine|telemedicine
279249|NCT02465463|fecal microbiota transplant|fecal microbiota transplant
279250|NCT02465463|probiotic|probiotic
279251|NCT02465450|JBT-101, Lenabasum, Cystic Fibrosis|jbt-101, lenabasum, cystic fibrosis
279252|NCT02465437|JBT-101, Lenabasum, Systemic Sclerosis|jbt-101, lenabasum, systemic sclerosis
279253|NCT02465424|quality of life questionnaires|quality of life questionnaires
279254|NCT02465398|Fracture shoulder arthroplasty|fracture shoulder arthroplasty
279255|NCT02465398|Three or four part fracture|three or four part fracture
279256|NCT02465398|Hemiarthroplasty|hemiarthroplasty
279257|NCT02465398|Multi-center|multi-center
279258|NCT02465398|Europe|europe
279259|NCT02465398|Non-controlled|non-controlled
279260|NCT02465398|Anatomical reconstruction|anatomical reconstruction
279261|NCT02465398|Proximal|proximal
279262|NCT02465372|Physical Activity|physical activity
279263|NCT02465372|Youth|youth
279264|NCT02465372|School Health|school health
279265|NCT02465346|acute stroke|acute stroke
279266|NCT02465346|prehospital|prehospital
279267|NCT02465346|treatment|treatment
279268|NCT02465333|heel|heel
279269|NCT02465333|atrophy|atrophy
279270|NCT02465333|fat|fat
279271|NCT02465333|adipose tissue|adipose tissue
279272|NCT02465333|fat pad|fat pad
279273|NCT02465307|Consciousness|consciousness
279274|NCT02465307|Alertness|alertness
279275|NCT02465307|Cognition|cognition
279276|NCT02465307|Activity level|activity level
279277|NCT02465307|Delirium|delirium
279278|NCT02465307|Hyperactive delirium|hyperactive delirium
279279|NCT02465307|Hypoactive delirium|hypoactive delirium
279280|NCT02465307|Facial expression|facial expression
279281|NCT02465307|Posture|posture
279282|NCT02465307|Intensive care unit|intensive care unit
279283|NCT02465294|Probiotics|probiotics
279284|NCT02465294|Weight loss|weight loss
279285|NCT02465294|Body composition|body composition
279286|NCT02465255|Acute Abdominal Pain|acute abdominal pain
279287|NCT02465255|Sublingual Analgesia|sublingual analgesia
279288|NCT02465255|Children|children
279289|NCT02465255|Ketorolac|ketorolac
279290|NCT02465255|Tramadol|tramadol
279291|NCT02465255|Paracetamol|paracetamol
279292|NCT02465255|Analgesia|analgesia
279293|NCT02465216|Tuberculosis|tuberculosis
279294|NCT02465216|TB|tb
279295|NCT02465216|Pulmonary|pulmonary
279296|NCT02465216|Vaccine|vaccine
279297|NCT02465216|Adjuvant|adjuvant
279298|NCT02465203|Hepatitis C, chronic|hepatitis c, chronic
279299|NCT02465190|Vaccine|vaccine
279300|NCT02465190|Effectiveness|effectiveness
279301|NCT02465190|Influenza|influenza
279302|NCT02465177|Unhealthy alcohol use|unhealthy alcohol use
279303|NCT02465177|ICU survivors|icu survivors
279304|NCT02465177|Alcohol use disorder|alcohol use disorder
279305|NCT02465177|SBIRT|sbirt
279306|NCT02465177|Screening, brief intervention, and referral to treatment|screening, brief intervention, and referral to treatment
279307|NCT02465034|Neural plasticity|neural plasticity
279308|NCT02465034|Noninvasive brain stimulation|noninvasive brain stimulation
279309|NCT02465034|Motor cortex|motor cortex
279310|NCT02465021|Satiety|satiety
279311|NCT02465021|Food intake|food intake
279312|NCT02465021|Breakfast cereals/snacks|breakfast cereals/snacks
279313|NCT02465021|Postprandial glycemia|postprandial glycemia
279314|NCT02465008|postoperative|postoperative
279315|NCT02465008|Patient-reported|patient-reported
279316|NCT02464995|Asthma,|asthma,
279317|NCT02464995|Asthma exacerbation|asthma exacerbation
279318|NCT02464995|Bronchial thermoplasty|bronchial thermoplasty
279319|NCT02464969|VTE, thromboembolism, thrombosis, embolism, apixaban, Eliquis|vte, thromboembolism, thrombosis, embolism, apixaban, eliquis
279320|NCT02464943|Aorta|aorta
279321|NCT02464943|Thoracic|thoracic
279322|NCT02464943|Aortic dissection|aortic dissection
279323|NCT02464943|Type B|type b
279324|NCT02464943|DeBakey type III|debakey type iii
279325|NCT02464943|Endovascular|endovascular
279326|NCT02464930|Blood|blood
279327|NCT02464930|Cytology|cytology
279328|NCT02464930|Esophagus|esophagus
279329|NCT02464930|microRNA|microrna
279330|NCT02464891|Atypical Hemolytic Uremic Syndrome|atypical hemolytic uremic syndrome
279331|NCT02464891|CCX168|ccx168
279332|NCT02464891|dialysis|dialysis
279333|NCT02464891|C5aR antagonist|c5ar antagonist
279334|NCT02464865|thiamine deficiency|thiamine deficiency
279335|NCT02464865|obese children|obese children
279336|NCT02464865|Thai|thai
279337|NCT02464839|Fungal nails and feet infection|fungal nails and feet infection
279338|NCT02464839|Onychomycosis|onychomycosis
279339|NCT02464839|Hallux valgus|hallux valgus
279340|NCT02464826|Onychomycosis|onychomycosis
279341|NCT02464826|Chronic paronychia|chronic paronychia
279342|NCT02464826|Treatment|treatment
279343|NCT02464813|pregabalin|pregabalin
279344|NCT02464813|idiopathic scoliosis|idiopathic scoliosis
279345|NCT02464800|diabetic retinopathy|diabetic retinopathy
279346|NCT02464787|antioxidants|antioxidants
279347|NCT02464787|carotenoids|carotenoids
279348|NCT02464787|diet|diet
279349|NCT02464774|Breast Cancer|breast cancer
279350|NCT02464774|Triple-Negative Breast Cancer|triple-negative breast cancer
279351|NCT02464774|Breast-Conserving Therapy|breast-conserving therapy
279352|NCT02464774|Mastectomy|mastectomy
279353|NCT02464774|Recurrence|recurrence
279354|NCT02464735|Sleep disruption|sleep disruption
279355|NCT02464735|Spontaneous breathing trial|spontaneous breathing trial
279356|NCT02464735|Weaning|weaning
279357|NCT02464722|Remifentanil|remifentanil
279358|NCT02464722|Dexmedetomidine|dexmedetomidine
279359|NCT02464722|Endoscopic sinus surgery|endoscopic sinus surgery
279360|NCT02464709|Actinic Keratosis|actinic keratosis
279361|NCT02464709|Photodynamic Therapy|photodynamic therapy
279362|NCT02464709|Natural Daylight|natural daylight
279363|NCT02464696|Hematological Malignancies|hematological malignancies
279364|NCT02464696|Hypoxemic Respiratory Failure|hypoxemic respiratory failure
279365|NCT02464696|Blood cancer|blood cancer
279366|NCT02464696|Non-invasive positive pressure ventilation|non-invasive positive pressure ventilation
279367|NCT02464696|NIPPV|nippv
279368|NCT02464696|High flow nasal cannula oxygen therapy|high flow nasal cannula oxygen therapy
279369|NCT02464670|Ebola|ebola
279370|NCT02464670|Vaccine|vaccine
279371|NCT02464657|Leukemia|leukemia
279372|NCT02464657|Acute myeloid leukemia|acute myeloid leukemia
279373|NCT02464657|AML|aml
279374|NCT02464657|Myelodysplastic Syndrome|myelodysplastic syndrome
279375|NCT02464657|MDS|mds
279376|NCT02464657|High-risk|high-risk
279377|NCT02464657|Nivolumab|nivolumab
279378|NCT02464657|BMS-936558|bms-936558
279379|NCT02464657|Opdivo|opdivo
279380|NCT02464657|Idarubicin|idarubicin
279381|NCT02464657|Idamycin|idamycin
279382|NCT02464657|Cytarabine|cytarabine
279383|NCT02464657|Ara-C|ara-c
279384|NCT02464657|Cytosar|cytosar
279385|NCT02464657|DepoCyt|depocyt
279386|NCT02464657|Cytosine Arabinosine Hydrochloride|cytosine arabinosine hydrochloride
279387|NCT02464657|Solu-Medrol|solu-medrol
279388|NCT02464657|Methylprednisolone|methylprednisolone
279389|NCT02464657|Depo-Medrol|depo-medrol
279390|NCT02464657|Medrol|medrol
279391|NCT02464657|Dexamethasone|dexamethasone
279392|NCT02464657|Decadron|decadron
279393|NCT02464644|On-line Questionnaire|on-line questionnaire
279394|NCT02464644|No travel|no travel
279395|NCT02464644|Health|health
279396|NCT02464644|Medicines|medicines
279397|NCT02464644|Drugs|drugs
279398|NCT02464644|Lifestyle|lifestyle
279399|NCT02464644|Family|family
279400|NCT02464644|Help for others|help for others
279401|NCT02464644|Rare condition|rare condition
279402|NCT02464644|General population|general population
279403|NCT02464618|Colonoscopy|colonoscopy
279404|NCT02464618|Upper endoscopy|upper endoscopy
279405|NCT02464618|Adherence|adherence
279406|NCT02464618|Disparities|disparities
279407|NCT02464592|Cryoprobes|cryoprobes
279408|NCT02464592|Transbronchial lung biopsy|transbronchial lung biopsy
279409|NCT02464592|Cryobiopsy|cryobiopsy
279410|NCT02464579|breastfeeding rate|breastfeeding rate
279411|NCT02464579|preterm infant|preterm infant
279412|NCT02464579|neonatal intensive care unit|neonatal intensive care unit
279413|NCT02464553|Low Back Pain Pain|low back pain pain
279414|NCT02464553|Periradicular therapy|periradicular therapy
279415|NCT02464553|Spinal Stenosis with neurologic changes|spinal stenosis with neurologic changes
279416|NCT02464540|laminate veneers|laminate veneers
279417|NCT02464540|luting agent|luting agent
279418|NCT02464527|Stimulus-stimulus pairing|stimulus-stimulus pairing
279419|NCT02464514|Obesity|obesity
279420|NCT02464514|Orexigen|orexigen
279421|NCT02464514|Insulin|insulin
279422|NCT02464514|Leptin|leptin
279423|NCT02464514|Adiponectin|adiponectin
279424|NCT02464514|Growth hormone replacement|growth hormone replacement
279425|NCT02464501|PAD|pad
279426|NCT02464501|COPPER-A|copper-a
279427|NCT02464501|Peripheral Arterial Disease|peripheral arterial disease
279428|NCT02464501|OPC|opc
279429|NCT02464501|Occlusion Perfusion Catheter|occlusion perfusion catheter
279430|NCT02464501|Paclitaxel|paclitaxel
279431|NCT02464501|Pressana|pressana
279432|NCT02464501|Precision Delivery System|precision delivery system
279433|NCT02464488|Anticoagulants|anticoagulants
279434|NCT02464488|Factor Xa Inhibitors|factor xa inhibitors
279435|NCT02464488|Antithrombins|antithrombins
279536|NCT02464033|GAD65|gad65
279436|NCT02464488|Pharmacokinetics|pharmacokinetics
279437|NCT02464488|Aged, 80 years and older|aged, 80 years and older
279438|NCT02464475|osteopathic manipulative treatment|osteopathic manipulative treatment
279439|NCT02464475|interoception|interoception
279440|NCT02464462|serum calcidiol|serum calcidiol
279441|NCT02464462|T2DM|t2dm
279442|NCT02464462|vitamin D3 supplementation|vitamin d3 supplementation
279443|NCT02464462|post-menopausal women|post-menopausal women
279444|NCT02464462|ethnic diverse|ethnic diverse
279445|NCT02464462|calcium supplementation|calcium supplementation
279446|NCT02464449|Cognitive Behavioral Therapy|cognitive behavioral therapy
279447|NCT02464449|Mobile Health Technology|mobile health technology
279448|NCT02464449|Patient Care Management|patient care management
279449|NCT02464436|RP|rp
279450|NCT02464410|Opioid analgesics|opioid analgesics
279451|NCT02464410|Primary care|primary care
279452|NCT02464410|Veterans|veterans
279453|NCT02464410|Motivational interviewing|motivational interviewing
279454|NCT02464410|Cognitive behavioral therapy|cognitive behavioral therapy
279455|NCT02464410|Self-efficacy|self-efficacy
279456|NCT02464410|Behavioral symptoms|behavioral symptoms
279457|NCT02464410|Injuries|injuries
279458|NCT02464410|Opioid Safety|opioid safety
279459|NCT02464397|Vascular healing of coronary stents in patients with acute coronary syndrome|vascular healing of coronary stents in patients with acute coronary syndrome
279460|NCT02464384|ultrasound and cartilage biodegradation markers|ultrasound and cartilage biodegradation markers
279461|NCT02464371|muscle weakness|muscle weakness
279462|NCT02464371|microRNAs|micrornas
279463|NCT02464371|septic shock|septic shock
279464|NCT02464358|HPV|hpv
279465|NCT02464345|BED|bed
279466|NCT02464345|Binge Eating Disorer|binge eating disorer
279467|NCT02464345|BN|bn
279468|NCT02464345|Bulimia Nervosa|bulimia nervosa
279469|NCT02464345|Obesity|obesity
279470|NCT02464332|soft tissue sarcoma|soft tissue sarcoma
279471|NCT02464332|BLZ-100|blz-100
279472|NCT02464332|Tumor Paint|tumor paint
279473|NCT02464306|recipients|recipients
279474|NCT02464293|depression|depression
279475|NCT02464293|anxiety|anxiety
279476|NCT02464293|stress|stress
279477|NCT02464280|Tomosynthesis|tomosynthesis
279478|NCT02464280|osteosynthetic implant|osteosynthetic implant
279479|NCT02464280|CT|ct
279480|NCT02464280|monitoring|monitoring
279481|NCT02464267|patient reported outcome instrument|patient reported outcome instrument
279482|NCT02464254|Physical activity, positive affect, older adults, aging|physical activity, positive affect, older adults, aging
279483|NCT02464228|PTCL|ptcl
279484|NCT02464228|Lymphoma|lymphoma
279485|NCT02464228|AITL|aitl
279486|NCT02464215|gastric cancer|gastric cancer
279487|NCT02464215|D2|d2
279488|NCT02464215|laparoscopic|laparoscopic
279489|NCT02464215|open|open
279490|NCT02464215|surgery|surgery
279491|NCT02464202|Tooth autotransplantation|tooth autotransplantation
279492|NCT02464202|stereolithography tooth replica|stereolithography tooth replica
279493|NCT02464202|CBCT|cbct
279494|NCT02464202|Outcome|outcome
279495|NCT02464176|Arthroplasty, Hip, Replacement|arthroplasty, hip, replacement
279496|NCT02464176|Anesthesia, Local|anesthesia, local
279497|NCT02464176|Anesthesia Conduction|anesthesia conduction
279498|NCT02464176|Bupivacaine|bupivacaine
279499|NCT02464176|Dexamethasone|dexamethasone
279500|NCT02464176|Preanesthetic Medications|preanesthetic medications
279501|NCT02464176|Nerve Block|nerve block
279502|NCT02464176|Lumbar Plexus Block|lumbar plexus block
279503|NCT02464176|Analgesia|analgesia
279504|NCT02464176|Glucocorticoids|glucocorticoids
279505|NCT02464176|Local Anesthetics|local anesthetics
279506|NCT02464163|Influenza|influenza
279507|NCT02464150|gluten|gluten
279508|NCT02464150|antigen-specific T cells|antigen-specific t cells
279509|NCT02464150|transcriptome|transcriptome
279510|NCT02464098|Hematological Malignancies|hematological malignancies
279511|NCT02464098|Solid Tumors|solid tumors
279512|NCT02464098|Hematopoietic Stem Cell Transplantation (HSCT)|hematopoietic stem cell transplantation (hsct)
279513|NCT02464098|Childhood Cancer|childhood cancer
279514|NCT02464098|Polymerase Chain Reaction (PCR)|polymerase chain reaction (pcr)
279515|NCT02464085|Stroke|stroke
279516|NCT02464085|Upper limb|upper limb
279517|NCT02464085|Neuroplastic change|neuroplastic change
279518|NCT02464085|Longitudinal|longitudinal
279519|NCT02464085|Function|function
279520|NCT02464072|Parathyroidectomy|parathyroidectomy
279521|NCT02464072|Renal Insufficiency, Chronic|renal insufficiency, chronic
279522|NCT02464059|cathelicidin|cathelicidin
279523|NCT02464059|vitamin D|vitamin d
279524|NCT02464046|Insomnia|insomnia
279525|NCT02464046|JNJ-42847922|jnj-42847922
279526|NCT02464046|Placebo|placebo
279527|NCT02464033|Diamyd|diamyd
279528|NCT02464033|Diabetes|diabetes
279529|NCT02464033|Juvenile Diabetes|juvenile diabetes
279530|NCT02464033|Diabetes Type 1|diabetes type 1
279531|NCT02464033|Type 1 Diabetes|type 1 diabetes
279532|NCT02464033|Autoimmune Diabetes|autoimmune diabetes
279533|NCT02464033|Insulin Dependent Diabetes|insulin dependent diabetes
279534|NCT02464033|Type 1 Diabetes MellitusType 1 Diabetes Mellitus|type 1 diabetes mellitustype 1 diabetes mellitus
279535|NCT02464033|rhGAD65|rhgad65
279537|NCT02464033|GAD-Alum|gad-alum
279538|NCT02464033|Diabetes Mellitus|diabetes mellitus
279539|NCT02464033|Diabetes mellitus Type 1|diabetes mellitus type 1
279540|NCT02464033|Glucose Metabolism Disorders|glucose metabolism disorders
279541|NCT02464033|Metabolic Diseases|metabolic diseases
279542|NCT02464033|Vitamin D|vitamin d
279543|NCT02464033|Etanercept|etanercept
279544|NCT02463955|flexible endoscopy|flexible endoscopy
279545|NCT02463929|Diphenhydramine|diphenhydramine
279546|NCT02463929|emergence agitation|emergence agitation
279547|NCT02463929|pediatric anesthesia|pediatric anesthesia
279548|NCT02463929|PAEDS|paeds
279549|NCT02463929|Withdrawal|withdrawal
279550|NCT02463903|Adaptation, Psychological|adaptation, psychological
279551|NCT02463903|Heart Failure|heart failure
279552|NCT02463903|Intervention Studies|intervention studies
279553|NCT02463903|Quality of Life|quality of life
279554|NCT02463903|Hospital Readmission|hospital readmission
279555|NCT02463903|Depression|depression
279556|NCT02463903|Anxiety|anxiety
279557|NCT02463890|Sleep Apnea Syndromes|sleep apnea syndromes
279558|NCT02463890|Sleep Apnea, Obstructives|sleep apnea, obstructives
279559|NCT02463890|Training|training
279560|NCT02463864|frailty|frailty
279561|NCT02463864|older adult|older adult
279562|NCT02463864|hospital|hospital
279563|NCT02463864|exercise|exercise
279564|NCT02463864|randomised control trial|randomised control trial
279565|NCT02463864|functional decline|functional decline
279566|NCT02463851|Ablation|ablation
279567|NCT02463851|Multi-electrode catheter PVAC|multi-electrode catheter pvac
279568|NCT02463851|Single-tip catheter Contact Force|single-tip catheter contact force
279569|NCT02463851|Holter|holter
279570|NCT02463838|Medi-Cal|medi-cal
279571|NCT02463838|Health Plan|health plan
279572|NCT02463838|Frequent Users|frequent users
279573|NCT02463838|Heavy users|heavy users
279574|NCT02463838|Care Coordination|care coordination
279575|NCT02463838|Managed Care|managed care
279576|NCT02463838|Case Management|case management
279577|NCT02463838|Mental Health|mental health
279578|NCT02463838|Substance Use|substance use
279579|NCT02463838|Emergency Department|emergency department
279580|NCT02463799|prostatic neoplasms|prostatic neoplasms
279581|NCT02463799|castration-resistant|castration-resistant
279582|NCT02463799|bone metastasis|bone metastasis
279583|NCT02463799|radium-223|radium-223
279584|NCT02463799|sipuleucel-T|sipuleucel-t
279585|NCT02463773|ARDS, PEEP, Critical Care Ultrasound|ards, peep, critical care ultrasound
279586|NCT02463747|Neutropenic fever|neutropenic fever
279587|NCT02463747|extended infusion|extended infusion
279588|NCT02463747|beta-lactam|beta-lactam
279589|NCT02463747|empiric antibiotic treatment|empiric antibiotic treatment
279590|NCT02463721|sbp|sbp
279591|NCT02463721|culture|culture
279592|NCT02463708|Care Giver|care giver
279593|NCT02463708|Dementia|dementia
279594|NCT02463695|partial vestibular deficit|partial vestibular deficit
279595|NCT02463695|cortical vestibular evoked potential|cortical vestibular evoked potential
279596|NCT02463682|Artificial Pancreas|artificial pancreas
279597|NCT02463682|Diabetes Mellitus, Type 1|diabetes mellitus, type 1
279598|NCT02463682|Autoimmune Diseases|autoimmune diseases
279599|NCT02463682|Diabetes Mellitus|diabetes mellitus
279600|NCT02463682|Endocrine System Diseases|endocrine system diseases
279601|NCT02463682|Glucose Metabolism Disorders|glucose metabolism disorders
279602|NCT02463682|Immune System Diseases|immune system diseases
279603|NCT02463682|Metabolic Diseases|metabolic diseases
279604|NCT02463669|Point-of-care ultrasound|point-of-care ultrasound
279605|NCT02463630|basilar invagination|basilar invagination
279606|NCT02463630|atlantoaxial dislocation|atlantoaxial dislocation
279607|NCT02463630|surgery|surgery
279608|NCT02463630|restoration technique|restoration technique
279609|NCT02463591|Direct Thrombin Inhibitor|direct thrombin inhibitor
279610|NCT02463591|Prothrombin Complex Concentrate|prothrombin complex concentrate
279611|NCT02463591|Dabigatran Etexilate|dabigatran etexilate
279612|NCT02463591|Beriplex|beriplex
279613|NCT02463591|Shed Blood|shed blood
279614|NCT02463591|Washed Blood|washed blood
279615|NCT02463591|Fibrinopeptide A|fibrinopeptide a
279616|NCT02463578|Pneumococcal infection|pneumococcal infection
279617|NCT02463578|Invasive pneumococcal disease (IPD)|invasive pneumococcal disease (ipd)
279618|NCT02463578|Pneumococcal vaccine|pneumococcal vaccine
279619|NCT02463578|Vaccinology|vaccinology
279620|NCT02463578|Immunocompromised|immunocompromised
279621|NCT02463578|Auto-immune diseases|auto-immune diseases
279622|NCT02463578|Systemic vasculitis|systemic vasculitis
279623|NCT02463578|ANCA-associated vasculitis|anca-associated vasculitis
279624|NCT02463565|nutritional assessment|nutritional assessment
279625|NCT02463565|food survey|food survey
279626|NCT02463565|hospitalized patients|hospitalized patients
279627|NCT02463565|hospital food|hospital food
279628|NCT02463539|Pneumococcal infection|pneumococcal infection
279629|NCT02463539|Invasive pneumococcal disease (IPD)|invasive pneumococcal disease (ipd)
279630|NCT02463539|Pneumococcal vaccine|pneumococcal vaccine
279631|NCT02463539|Systemic vasculitis|systemic vasculitis
279632|NCT02463539|ANCA-associated vasculitis|anca-associated vasculitis
279633|NCT02463539|Vaccinology|vaccinology
279634|NCT02463539|Immunocompromised|immunocompromised
279635|NCT02463539|Auto-immune disease|auto-immune disease
279636|NCT02463526|Shoulder Impingement Syndrome|shoulder impingement syndrome
279637|NCT02463526|Mulligan's Mobilization with Movement|mulligan's mobilization with movement
279638|NCT02463526|Physical Therapy|physical therapy
279639|NCT02463513|Riboflavin|riboflavin
279640|NCT02463513|Blood pressure|blood pressure
279641|NCT02463513|MTHFR|mthfr
279642|NCT02463513|Methylenetetrahydrofolate reductase|methylenetetrahydrofolate reductase
279643|NCT02463448|Underactive Bladder|underactive bladder
279644|NCT02463435|nutritional management|nutritional management
279645|NCT02463435|olive oil|olive oil
279646|NCT02463435|weight loss|weight loss
279647|NCT02463435|body composition|body composition
279648|NCT02463435|nutrigenomics|nutrigenomics
279649|NCT02463435|polymorphisms|polymorphisms
279650|NCT02463435|cardiovascular risk|cardiovascular risk
279651|NCT02463435|sarcopenia|sarcopenia
279652|NCT02463435|inflammation|inflammation
279653|NCT02463435|food intake|food intake
279654|NCT02463435|sedentary lifestyle|sedentary lifestyle
279655|NCT02463435|patient adherence|patient adherence
279656|NCT02463435|bone density|bone density
279657|NCT02463396|MBCT|mbct
279658|NCT02463396|Mindfulness|mindfulness
279659|NCT02463396|ADHD|adhd
279660|NCT02463383|PPAR-gamma|ppar-gamma
279661|NCT02463383|estrogens|estrogens
279662|NCT02463383|NSAIDS|nsaids
279663|NCT02463383|polymorphism|polymorphism
279664|NCT02463383|metabolomics|metabolomics
279665|NCT02463357|Exercise, Aerobic|exercise, aerobic
279666|NCT02463357|Cognitive Function|cognitive function
279667|NCT02463344|Dry AMD|dry amd
279668|NCT02463344|Geographic atrophy|geographic atrophy
279669|NCT02463344|ASP7316|asp7316
279670|NCT02463331|autoimmune hepatitis|autoimmune hepatitis
279671|NCT02463331|chloroquine|chloroquine
279672|NCT02463331|treatment|treatment
279673|NCT02463318|Multiple sclerosis|multiple sclerosis
279674|NCT02463318|SIRT1|sirt1
279675|NCT02463318|MnSOD|mnsod
279676|NCT02463318|Catalase|catalase
279677|NCT02463318|Oxidative stress|oxidative stress
279678|NCT02463318|Antioxidant enzyme|antioxidant enzyme
279679|NCT02463305|Colitis, ulcerative|colitis, ulcerative
279680|NCT02463305|Inflammatory bowel diseases|inflammatory bowel diseases
279681|NCT02463292|quality of life|quality of life
279682|NCT02463292|young adults|young adults
279683|NCT02463292|congenital heart disease|congenital heart disease
279684|NCT02463266|Primary Care|primary care
279685|NCT02463266|Elderly|elderly
279686|NCT02463266|Depression|depression
279687|NCT02463253|Renal Biopsy|renal biopsy
279688|NCT02463253|elevated serum creatinine|elevated serum creatinine
279689|NCT02463253|proteinuria|proteinuria
279690|NCT02463201|Sleep Apnea, Obstructive|sleep apnea, obstructive
279691|NCT02463201|Pediatric Obesity|pediatric obesity
279692|NCT02463188|Sleep|sleep
279693|NCT02463188|Substance Use|substance use
279694|NCT02463188|Adolescents|adolescents
357400|NCT02062840|EEG|eeg
279695|NCT02463175|Fluid Therapy;|fluid therapy;
279696|NCT02463175|Transesophageal Doppler|transesophageal doppler
279697|NCT02463149|School health|school health
279698|NCT02463136|Adolescence|adolescence
279699|NCT02463136|Brain Development|brain development
279700|NCT02463136|Neuroimaging|neuroimaging
279701|NCT02463136|Neurofeedback|neurofeedback
279702|NCT02463136|Anxiety|anxiety
279703|NCT02463110|Acute Coronary Syndrome|acute coronary syndrome
279704|NCT02463110|Depression|depression
279705|NCT02463110|Coronary Artery Disease|coronary artery disease
279706|NCT02463110|Myocardial Infarction|myocardial infarction
279707|NCT02463110|Percutaneous Coronary Intervention|percutaneous coronary intervention
279708|NCT02463019|hepatitis B virus|hepatitis b virus
279709|NCT02463019|tenofovir|tenofovir
279710|NCT02462967|Liver Cirrhosis|liver cirrhosis
279711|NCT02462954|Contraception|contraception
279712|NCT02462954|Vaginal Gel|vaginal gel
279713|NCT02462954|Diaphragm|diaphragm
279714|NCT02462941|Heart transplant|heart transplant
279715|NCT02462941|Adenosine|adenosine
279716|NCT02462941|Pediatrics|pediatrics
279717|NCT02462863|Diabetes|diabetes
279718|NCT02462863|fish oil|fish oil
279719|NCT02462863|arginine|arginine
279720|NCT02462863|hyperglycemia|hyperglycemia
279721|NCT02462850|Pain|pain
279722|NCT02462850|Nausea|nausea
279723|NCT02462850|Vomiting|vomiting
279724|NCT02462837|Ureteral Stents|ureteral stents
279725|NCT02462837|Pain and Discomfort|pain and discomfort
279726|NCT02462837|Bladder Storage Symptoms|bladder storage symptoms
279727|NCT02462824|Peripheral Artery Disease|peripheral artery disease
279728|NCT02462824|Peripheral Arterial Disease|peripheral arterial disease
279730|NCT02462811|Pain|pain
279731|NCT02462811|Nausea|nausea
279732|NCT02462811|Vomiting|vomiting
279733|NCT02462785|Type 1 Diabetes Mellitus|type 1 diabetes mellitus
279734|NCT02462785|Adolescents|adolescents
279735|NCT02462785|Carbohydrate Counting|carbohydrate counting
279736|NCT02462785|Glycemic Control|glycemic control
279737|NCT02462785|Self-Management|self-management
279738|NCT02462785|T1DM|t1dm
279739|NCT02462772|Cabotegravir|cabotegravir
279740|NCT02462772|safety|safety
279741|NCT02462772|long-acting injectable|long-acting injectable
279742|NCT02462772|HIV prevention|hiv prevention
279743|NCT02462772|acceptability|acceptability
279744|NCT02462759|EMBRACE|embrace
279745|NCT02462759|SMA|sma
279746|NCT02462746|Postpartum|postpartum
279747|NCT02462746|Dietary Supplements|dietary supplements
279748|NCT02462746|Breastfeeding Women|breastfeeding women
279749|NCT02462733|Self-control|self-control
279750|NCT02462733|Preschoolers|preschoolers
279751|NCT02462733|Tools of the Mind|tools of the mind
279752|NCT02462733|Playing to Learn|playing to learn
279753|NCT02462681|ketamine|ketamine
279754|NCT02462681|adjuvant|adjuvant
279755|NCT02462681|paravertebral block|paravertebral block
279756|NCT02462668|Bronchoscopy|bronchoscopy
279757|NCT02462668|Intubation|intubation
279758|NCT02462668|Noninvasive positive pressure ventilation|noninvasive positive pressure ventilation
279759|NCT02462642|Brahmi, Cognition, Anxiety, Pharmacokinetics|brahmi, cognition, anxiety, pharmacokinetics
279760|NCT02462629|central nervous system tumor|central nervous system tumor
279761|NCT02462629|BLZ-100|blz-100
279762|NCT02462629|pediatrics|pediatrics
279763|NCT02462629|Tumor Paint|tumor paint
279764|NCT02462629|brain cancer|brain cancer
279765|NCT02462629|tozuleristide|tozuleristide
279766|NCT02462616|risk analysis|risk analysis
279767|NCT02462616|general Chinese population|general chinese population
279768|NCT02462616|cardiovascular autonomic neuropathy|cardiovascular autonomic neuropathy
279769|NCT02462603|Parkinson's Disease|parkinson's disease
279770|NCT02462603|PD|pd
279771|NCT02462603|EPI-589|epi-589
279772|NCT02462603|EPI589|epi589
279773|NCT02462590|Probiotics|probiotics
279774|NCT02462590|Ventilator Associated Pneumonia|ventilator associated pneumonia
279775|NCT02462590|Infections|infections
279776|NCT02462590|C-Difficile|c-difficile
279777|NCT02462590|Antibiotic-associated Diarrhea|antibiotic-associated diarrhea
279778|NCT02462590|Diarrhea|diarrhea
279779|NCT02462577|Local morphine|local morphine
279780|NCT02462577|Postmastectomy pain|postmastectomy pain
279781|NCT02462564|peritoneal surface malignancies|peritoneal surface malignancies
279782|NCT02462564|Post operative cognitive dysfunction|post operative cognitive dysfunction
279783|NCT02462551|Depression|depression
279784|NCT02462551|Treatment Resistant Depression|treatment resistant depression
279785|NCT02462525|relapsed multiple myeloma|relapsed multiple myeloma
279786|NCT02462525|antibody drug conjugate|antibody drug conjugate
279787|NCT02462525|refractory multiple myeloma|refractory multiple myeloma
279788|NCT02462512|Elastography|elastography
279789|NCT02462512|Thyroid nodule|thyroid nodule
279790|NCT02462473|Schizophrenia|schizophrenia
279791|NCT02462473|Schizoaffective Disorder|schizoaffective disorder
279792|NCT02462473|Aripiprazole|aripiprazole
279793|NCT02462473|Olanzapine|olanzapine
279794|NCT02462473|Paliperidone|paliperidone
279795|NCT02462473|Quetiapine|quetiapine
279796|NCT02462473|Risperidone|risperidone
279797|NCT02462473|Liquid Chromatography-Tandem Mass Spectrometry|liquid chromatography-tandem mass spectrometry
279798|NCT02462460|Breast MRI|breast mri
279799|NCT02462460|T1 weighted and diffusion weighted MR|t1 weighted and diffusion weighted mr
279800|NCT02462460|screening pancreatic|screening pancreatic
279801|NCT02462460|screening ovarian|screening ovarian
279802|NCT02462460|15-120|15-120
279803|NCT02462447|prostate|prostate
279804|NCT02462447|cancer|cancer
279805|NCT02462447|biopsy|biopsy
279806|NCT02462447|PET|pet
279807|NCT02462434|Pediatric palliative care|pediatric palliative care
279808|NCT02462421|SGLT2|sglt2
279809|NCT02462421|SLC5A2|slc5a2
279810|NCT02462421|SLC5A4|slc5a4
279811|NCT02462421|SLC5A9|slc5a9
279812|NCT02462421|SLC2A9|slc2a9
279813|NCT02462421|GLUT9|glut9
279814|NCT02462421|SGLT3|sglt3
279815|NCT02462421|SGLT4|sglt4
279816|NCT02462421|pharmacogenomics|pharmacogenomics
279817|NCT02462356|CVATS|cvats
279818|NCT02462356|UVATS|uvats
279819|NCT02462356|perioperative effect|perioperative effect
279820|NCT02462356|ergonomic influence|ergonomic influence
279821|NCT02462330|Mesenchymal stem cells|mesenchymal stem cells
279822|NCT02462330|ischemic cardiomyopathy|ischemic cardiomyopathy
279823|NCT02462330|NogaStar XP system catheter|nogastar xp system catheter
279824|NCT02462317|Spasticity|spasticity
279825|NCT02462317|Post stroke motor recovery|post stroke motor recovery
279826|NCT02462317|Botulinum toxin|botulinum toxin
279827|NCT02462317|Baclofen|baclofen
279828|NCT02462317|Pharmacological modulation|pharmacological modulation
279829|NCT02462304|Diabetic Macula Edema|diabetic macula edema
279830|NCT02462304|End-Point-Management|end-point-management
279831|NCT02462304|ranibizumab|ranibizumab
279832|NCT02462304|bevacizumab|bevacizumab
279833|NCT02462291|Neurological Disorders|neurological disorders
279834|NCT02462291|Non Pharmacological Treatment|non pharmacological treatment
279835|NCT02462291|Ecological Therapy|ecological therapy
279836|NCT02462278|Fertility|fertility
279837|NCT02462278|Continuous temperature monitor|continuous temperature monitor
279838|NCT02462278|Basal Body Temperature|basal body temperature
279839|NCT02462278|Natural family planning|natural family planning
279840|NCT02462239|Muscle-invasive bladder cancer|muscle-invasive bladder cancer
279841|NCT02462239|Bladder cancer|bladder cancer
279842|NCT02462239|PET imaging|pet imaging
279843|NCT02462239|FDG|fdg
279844|NCT02462213|Cardiac amyloidosis|cardiac amyloidosis
279845|NCT02462213|Cardiac MRI|cardiac mri
279846|NCT02462213|Infiltrative cardiomyopathies|infiltrative cardiomyopathies
279847|NCT02462187|genital warts|genital warts
279848|NCT02462187|perianal warts|perianal warts
279849|NCT02462174|anesthesia|anesthesia
279850|NCT02462174|analgesia|analgesia
279851|NCT02462174|caudal|caudal
279852|NCT02462174|ketamine|ketamine
279853|NCT02462174|bupivacaine|bupivacaine
279854|NCT02462148|Anesthesia|anesthesia
279855|NCT02462148|Anesthesia, Conduction|anesthesia, conduction
279856|NCT02462148|Anesthesia, Local|anesthesia, local
279857|NCT02462148|Bupivacaine|bupivacaine
279858|NCT02462148|Dexamethasone|dexamethasone
279859|NCT02462148|Saphenous|saphenous
279860|NCT02462148|Adductor Canal|adductor canal
279861|NCT02462148|Nerve Block|nerve block
279862|NCT02462148|Analgesia|analgesia
279863|NCT02462148|Preanesthetic Medication|preanesthetic medication
279864|NCT02462148|Perioperative Period|perioperative period
279865|NCT02462148|Peripheral Nerve Block|peripheral nerve block
279866|NCT02462135|Mild cognitive impairment|mild cognitive impairment
279867|NCT02462135|Memory training|memory training
279868|NCT02462135|Randomized controlled study|randomized controlled study
279869|NCT02462044|Computed tomography|computed tomography
279870|NCT02462044|Coronary CTA|coronary cta
279871|NCT02462044|Contrast media|contrast media
279872|NCT02462018|Cerebral Palsy|cerebral palsy
279873|NCT02462018|Muscle Spasticity|muscle spasticity
279874|NCT02462018|Orthoses|orthoses
279875|NCT02462018|Functional Electrical Stimulation|functional electrical stimulation
279876|NCT02462018|Prospective|prospective
279877|NCT02461992|FVIII activity|fviii activity
279878|NCT02461953|hemodialysis|hemodialysis
279879|NCT02461953|hemoperfusion|hemoperfusion
279880|NCT02461953|quality of life|quality of life
279881|NCT02461940|Sexual behavior|sexual behavior
279882|NCT02461940|condom use|condom use
279883|NCT02461940|secondary abstinence|secondary abstinence
279884|NCT02461914|Type 2 diabetes mellitus|type 2 diabetes mellitus
279885|NCT02461901|clostridium difficile|clostridium difficile
279886|NCT02461901|environment|environment
279887|NCT02461901|contamination|contamination
279888|NCT02461901|fidaxomicin|fidaxomicin
279889|NCT02461888|Relapsed|relapsed
279890|NCT02461888|Refractory|refractory
279891|NCT02461888|Cyclophosphamide|cyclophosphamide
279892|NCT02461888|Dexamethasone|dexamethasone
279893|NCT02461875|OHSS|ohss
279894|NCT02461875|Infertility|infertility
279895|NCT02461875|Cabergoline|cabergoline
279896|NCT02461875|GnRH antagonist|gnrh antagonist
279897|NCT02461875|IVF-ET|ivf-et
279898|NCT02461862|Contraception|contraception
279899|NCT02461862|Contraception Behavior|contraception behavior
279900|NCT02461862|Intra uterine device|intra uterine device
279901|NCT02461862|Intra uterine System|intra uterine system
279902|NCT02461862|IUD|iud
279903|NCT02461862|IUS|ius
279904|NCT02461862|Acute Pain|acute pain
279905|NCT02461771|AMD|amd
279906|NCT02461771|Wet AMD|wet amd
279907|NCT02461771|Neovascular AMD|neovascular amd
279908|NCT02461745|VIEKIRA PAK|viekira pak
279909|NCT02461732|posttraumatic stress disorder|posttraumatic stress disorder
279910|NCT02461732|PTSD|ptsd
279911|NCT02461732|substance dependence|substance dependence
279912|NCT02461732|substance use|substance use
279913|NCT02461706|Drug resistant epilepsy|drug resistant epilepsy
279914|NCT02461693|Vigilance|vigilance
279915|NCT02461693|Mood|mood
279916|NCT02461693|Randomized Controlled Trial|randomized controlled trial
279917|NCT02461693|Probability|probability
279918|NCT02461680|partial section of the flexor tendons|partial section of the flexor tendons
279919|NCT02461667|alendronate, metformin|alendronate, metformin
279920|NCT02461641|amniotic tissue|amniotic tissue
279921|NCT02461641|diabetic foot ulcer|diabetic foot ulcer
279922|NCT02461641|Affinity|affinity
279923|NCT02461641|NuShield|nushield
279924|NCT02461628|Malaria|malaria
279925|NCT02461628|Antimalarial subsidy|antimalarial subsidy
279926|NCT02461628|Malaria rapid diagnostic test (RDT)|malaria rapid diagnostic test (rdt)
279927|NCT02461628|Public-private partnership|public-private partnership
279928|NCT02461628|Community health workers|community health workers
279929|NCT02461615|Pulmonary Surfactant|pulmonary surfactant
279930|NCT02461615|Rare Lung Disease|rare lung disease
279931|NCT02461615|Registry|registry
279932|NCT02461602|Warfarin|warfarin
279933|NCT02461576|HIV-1|hiv-1
279934|NCT02461550|Irreversible Electroporation Ablation|irreversible electroporation ablation
279935|NCT02461550|15-001|15-001
279936|NCT02461498|Warfarin|warfarin
279937|NCT02461485|adults|adults
279938|NCT02461485|moderate constipation|moderate constipation
279939|NCT02461472|risk factors|risk factors
279940|NCT02461472|risk analysis|risk analysis
279941|NCT02461472|diabetic cardiovascular autonomic neuropathy|diabetic cardiovascular autonomic neuropathy
279942|NCT02461472|general Chinese population|general chinese population
279943|NCT02461459|Tuberous Sclerosis Complex|tuberous sclerosis complex
279944|NCT02461459|TSC|tsc
279945|NCT02461459|Autism|autism
279946|NCT02461459|ASD|asd
279947|NCT02461459|Intellectual Disability|intellectual disability
279948|NCT02461459|ID|id
279949|NCT02461459|MRI|mri
279950|NCT02461446|germline heterozygous PTEN mutations|germline heterozygous pten mutations
279951|NCT02461446|MRI|mri
279952|NCT02461446|10q23.3|10q23.3
279953|NCT02461446|ASD|asd
279954|NCT02461446|Autism|autism
279955|NCT02461446|Macrocephaly|macrocephaly
279956|NCT02461446|PTEN Hamartoma Tumor Syndrome|pten hamartoma tumor syndrome
279957|NCT02461446|PTEN|pten
279958|NCT02461433|Obesity|obesity
279959|NCT02461433|Obese|obese
279960|NCT02461433|surgical site infection|surgical site infection
279961|NCT02461433|closed incisions|closed incisions
279962|NCT02461433|negative pressure therapy|negative pressure therapy
279963|NCT02461420|Phelan-McDermid Syndrome|phelan-mcdermid syndrome
279964|NCT02461420|PMS|pms
279965|NCT02461420|Genotype|genotype
279966|NCT02461420|Phenotype|phenotype
279967|NCT02461420|Natural History|natural history
279968|NCT02461420|Mapping|mapping
279969|NCT02461420|22q13 Deletion Syndrome|22q13 deletion syndrome
279970|NCT02461420|SHANK3|shank3
279971|NCT02461420|Autism Spectrum Disorder|autism spectrum disorder
279972|NCT02461420|ASD|asd
279973|NCT02461420|Intellectual Disability|intellectual disability
279974|NCT02461420|ID|id
280097|NCT02460744|radiotherapy|radiotherapy
280098|NCT02460731|PSP|psp
279975|NCT02461381|Bayesian estimation, short-term heart rate variability, diabetic cardiovascular autonomic neuropathy, diagnostic performance|bayesian estimation, short-term heart rate variability, diabetic cardiovascular autonomic neuropathy, diagnostic performance
279976|NCT02461381|Diagnostic performance|diagnostic performance
279977|NCT02461381|short-term heart rate variability|short-term heart rate variability
279978|NCT02461381|diabetic cardiovascular autonomic neuropathy|diabetic cardiovascular autonomic neuropathy
279979|NCT02461381|DCAN|dcan
279980|NCT02461342|Genetic|genetic
279981|NCT02461342|environment|environment
279982|NCT02461342|interaction analysis|interaction analysis
279983|NCT02461342|cardiovascular autonomic neuropathy|cardiovascular autonomic neuropathy
279984|NCT02461342|CAN|can
279985|NCT02461329|Hip Replacement, Total|hip replacement, total
279986|NCT02461329|Gelatine solution|gelatine solution
279987|NCT02461329|Balanced Crystaloid Solution|balanced crystaloid solution
279988|NCT02461329|Volume therapy|volume therapy
279989|NCT02461329|Platelet aggregation|platelet aggregation
279990|NCT02461303|Klinefelter|klinefelter
279991|NCT02461303|Spermatogenesis|spermatogenesis
279992|NCT02461303|Puberty|puberty
279993|NCT02461303|Fertility|fertility
279994|NCT02461277|postoperative care|postoperative care
750808|NCT00438152|HIV-1|hiv-1
279995|NCT02461277|exercise test|exercise test
279996|NCT02461277|early ambulation|early ambulation
279997|NCT02461277|Fast-track|fast-track
279998|NCT02461251|Thromboelastometry|thromboelastometry
279999|NCT02461251|Obstetric Hemorrhage|obstetric hemorrhage
280000|NCT02461251|Blood Component Transfusion|blood component transfusion
280001|NCT02461212|HepaFat-Scan|hepafat-scan
280002|NCT02461212|Liver Disease|liver disease
280003|NCT02461212|Pediatrics|pediatrics
280004|NCT02461199|Fecal microbiota transplantation|fecal microbiota transplantation
280005|NCT02461199|Gut colonization|gut colonization
280006|NCT02461199|Multidrug-resistant bacteria|multidrug-resistant bacteria
280007|NCT02461199|Blood disorders|blood disorders
280008|NCT02461199|Drug Resistance, Multiple|drug resistance, multiple
280009|NCT02461199|Disease Eradication|disease eradication
280010|NCT02461186|Arterolane-piperaquine|arterolane-piperaquine
280011|NCT02461186|Dehydroartemisinin-piperaquine|dehydroartemisinin-piperaquine
280012|NCT02461186|therapeutic efficacy|therapeutic efficacy
280013|NCT02461186|Uncomplicated falciparum malaria|uncomplicated falciparum malaria
280014|NCT02461186|Artemisinin-resistant|artemisinin-resistant
280015|NCT02461160|Drug therapy|drug therapy
280016|NCT02461134|GVHD|gvhd
280017|NCT02461134|ponesimod|ponesimod
280018|NCT02461121|Acute Myeloid Leukemia|acute myeloid leukemia
280019|NCT02461121|microtransplantationHLA-mismatched microtransplantation|microtransplantationhla-mismatched microtransplantation
280020|NCT02461121|nonmyeloablative stem cell transplantation|nonmyeloablative stem cell transplantation
280021|NCT02461121|graft-versus-host disease|graft-versus-host disease
280022|NCT02461108|Public policy|public policy
280023|NCT02461108|Food choice|food choice
280024|NCT02461108|Nutrition labeling|nutrition labeling
280025|NCT02461108|Fat tax|fat tax
280026|NCT02461108|Vegetable subsidy|vegetable subsidy
280027|NCT02461108|Behavioral economics|behavioral economics
280028|NCT02461108|Health behavior|health behavior
280029|NCT02461069|dimethyl fumarate|dimethyl fumarate
280030|NCT02461056|ibuprofen|ibuprofen
280031|NCT02461056|hydromorphone|hydromorphone
280032|NCT02461056|drug interactions|drug interactions
280033|NCT02461043|esophageal cancer|esophageal cancer
280034|NCT02461043|adjuvant chemotherapy|adjuvant chemotherapy
280035|NCT02461043|esophageal surgery|esophageal surgery
280036|NCT02461043|paclitaxel|paclitaxel
280037|NCT02461030|Dentin hypersensitivity|dentin hypersensitivity
280241|NCT02459860|aged|aged
280038|NCT02461030|Periodontal disease|periodontal disease
280039|NCT02461030|Arginine|arginine
280040|NCT02461017|intubation|intubation
280041|NCT02461017|ventilation|ventilation
280042|NCT02461017|airway|airway
280043|NCT02461017|airleak|airleak
280044|NCT02461004|Dyslipidemia|dyslipidemia
280045|NCT02461004|CKD-391|ckd-391
280046|NCT02461004|Atorvastatin|atorvastatin
280047|NCT02461004|Ezetimibe|ezetimibe
280048|NCT02460978|Dapagliflozin|dapagliflozin
280049|NCT02460978|Efficacy|efficacy
280050|NCT02460978|Safety|safety
280051|NCT02460978|Add on to insulin|add on to insulin
280052|NCT02460978|Oral Antidiabetic|oral antidiabetic
280053|NCT02460978|Type 1 diabetes|type 1 diabetes
280054|NCT02460952|Pulmonary Embolism;|pulmonary embolism;
280055|NCT02460952|perioperative period;|perioperative period;
280056|NCT02460952|general anesthesia|general anesthesia
280057|NCT02460939|Pulmonary Vessel Disease|pulmonary vessel disease
280058|NCT02460939|metabolism of small molecules|metabolism of small molecules
280059|NCT02460926|Scaling and root planning|scaling and root planning
280060|NCT02460926|C-reactive protein|c-reactive protein
280061|NCT02460913|acupuncture|acupuncture
280062|NCT02460913|morphine|morphine
280063|NCT02460913|acute pain|acute pain
280064|NCT02460887|nasopharyngeal carcinoma|nasopharyngeal carcinoma
280065|NCT02460887|induction chemotherapy|induction chemotherapy
280066|NCT02460874|Brain Metastases|brain metastases
280067|NCT02460874|Stereotactic Radiosurgery|stereotactic radiosurgery
280068|NCT02460874|Glyburide|glyburide
280069|NCT02460861|Prostate Cancer|prostate cancer
280070|NCT02460861|Molecular staging|molecular staging
280071|NCT02460861|GSTP1|gstp1
280072|NCT02460861|Surgical margins|surgical margins
280073|NCT02460861|prostatovesiculectomy|prostatovesiculectomy
280074|NCT02460848|Malnutrition|malnutrition
280075|NCT02460848|Severe Acute Malnutrition|severe acute malnutrition
280076|NCT02460848|Cash Transfer|cash transfer
280077|NCT02460848|Democratic Republic of Congo|democratic republic of congo
280078|NCT02460848|Cluster randomize trial|cluster randomize trial
280079|NCT02460796|Parkinson's disease|parkinson's disease
280080|NCT02460796|Quality of life|quality of life
280081|NCT02460796|Gait velocity|gait velocity
280082|NCT02460796|Capacity|capacity
280083|NCT02460783|Biomarkers|biomarkers
280084|NCT02460783|Diabetes|diabetes
280085|NCT02460783|Obesity|obesity
280086|NCT02460783|Dementia of the Alzheimer Type|dementia of the alzheimer type
280087|NCT02460783|Functional Magnetic Resonance Imaging (fMRI)|functional magnetic resonance imaging (fmri)
280088|NCT02460770|Left Ventricular Assist Device|left ventricular assist device
280089|NCT02460770|stem cell therapy|stem cell therapy
280090|NCT02460770|ischemic heart failure|ischemic heart failure
280091|NCT02460757|glottic movement|glottic movement
280092|NCT02460757|emphysema|emphysema
280093|NCT02460757|copd|copd
280094|NCT02460757|vocal cord|vocal cord
280095|NCT02460744|Breast cancer|breast cancer
280096|NCT02460744|hypofractionation|hypofractionation
280099|NCT02460731|Young Plasma|young plasma
280100|NCT02460718|diabetes mellitus|diabetes mellitus
280101|NCT02460718|peer support|peer support
280102|NCT02460718|pragmatic clinical trial|pragmatic clinical trial
280103|NCT02460666|depressed|depressed
280104|NCT02460666|older adults|older adults
280105|NCT02460666|Major Depressive Disorder|major depressive disorder
280106|NCT02460666|Tai-Chi|tai-chi
280107|NCT02460666|geriatric|geriatric
280108|NCT02460653|High flow nasal cannula|high flow nasal cannula
280109|NCT02460653|Oxygen therapy|oxygen therapy
280110|NCT02460653|Ventilation|ventilation
280111|NCT02460640|Minimally invasive surgery|minimally invasive surgery
280112|NCT02460640|Partial nephrectomy|partial nephrectomy
280113|NCT02460627|Arthroscopy|arthroscopy
280114|NCT02460627|Meniscus|meniscus
280115|NCT02460627|Lidocaine|lidocaine
280116|NCT02460614|bronchiolitis|bronchiolitis
280117|NCT02460614|respiratory physiotherapy|respiratory physiotherapy
280118|NCT02460614|pediatrics|pediatrics
280119|NCT02460614|rhinopharyngeal clearance|rhinopharyngeal clearance
280120|NCT02460575|Safety|safety
280121|NCT02460562|resin denture base|resin denture base
280122|NCT02460549|therapeutic patient education|therapeutic patient education
280123|NCT02460549|insulinoresistance|insulinoresistance
280124|NCT02460549|empowerment|empowerment
280125|NCT02460549|prostate cancer|prostate cancer
280126|NCT02460549|oral endocrine therapy|oral endocrine therapy
280127|NCT02460549|side effects|side effects
280128|NCT02460536|attention bias modification treatment|attention bias modification treatment
280129|NCT02460536|attention training|attention training
280130|NCT02460536|anxiety disorders|anxiety disorders
280131|NCT02460536|clinical trials|clinical trials
280132|NCT02460471|Radiotherapy|radiotherapy
280133|NCT02460471|Palliative Care|palliative care
280134|NCT02460471|IMRT|imrt
280135|NCT02460458|Factor VIII|factor viii
280136|NCT02460458|Hemorrhage|hemorrhage
280137|NCT02460458|von Willebrand Diseases|von willebrand diseases
280138|NCT02460458|von Willebrand Factor|von willebrand factor
280139|NCT02460445|Functional hyperandrogenism|functional hyperandrogenism
280242|NCT02459860|Latinos|latinos
280140|NCT02460445|Polycystic ovary syndrome|polycystic ovary syndrome
280141|NCT02460445|Idiopathic hyperandrogenism|idiopathic hyperandrogenism
280142|NCT02460445|Iron tissue depots|iron tissue depots
280143|NCT02460445|Phlebotomy|phlebotomy
280144|NCT02460445|Insulin resistance|insulin resistance
280145|NCT02460445|Carbohydrate metabolism|carbohydrate metabolism
280146|NCT02460445|Blood pressure|blood pressure
280147|NCT02460445|Autonomic dysfunction|autonomic dysfunction
280148|NCT02460445|Oxidative stress|oxidative stress
280149|NCT02460445|Blood clotting tests|blood clotting tests
280150|NCT02460445|Efficacy|efficacy
280151|NCT02460445|Side effects|side effects
280152|NCT02460445|Randomized clinical trial|randomized clinical trial
280153|NCT02460432|Drug-eluting Biliary stent|drug-eluting biliary stent
280154|NCT02460432|Covered metalic stent|covered metalic stent
280155|NCT02460419|Nasopharyngeal carcinoma|nasopharyngeal carcinoma
280156|NCT02460419|metastasis|metastasis
280157|NCT02460419|capecitabine|capecitabine
280158|NCT02460406|strength training|strength training
280159|NCT02460406|virtual reality|virtual reality
280160|NCT02460406|plyometric exercises|plyometric exercises
280161|NCT02460406|cerebral palsy|cerebral palsy
280162|NCT02460406|hemiplegic|hemiplegic
280163|NCT02460393|tolerance|tolerance
280164|NCT02460393|safety and pharmacokinetic characteristics|safety and pharmacokinetic characteristics
280165|NCT02460367|Non-small Cell Lung Cancer|non-small cell lung cancer
280166|NCT02460367|Vaccine Therapy|vaccine therapy
280167|NCT02460367|Immunotherapy|immunotherapy
280168|NCT02460367|Second line therapy|second line therapy
280169|NCT02460367|Progressive|progressive
280170|NCT02460367|Relapsed|relapsed
280171|NCT02460367|IDO|ido
280172|NCT02460367|IDO Inhibitor|ido inhibitor
280173|NCT02460354|Congenital nephrogenic diabetes insipidus|congenital nephrogenic diabetes insipidus
280174|NCT02460341|fMRI|fmri
280175|NCT02460341|Brain function|brain function
280176|NCT02460341|Sensory processing|sensory processing
280177|NCT02460315|time of cholecystectomy after ERCP|time of cholecystectomy after ercp
280178|NCT02460276|Mantle cell lymphoma|mantle cell lymphoma
280179|NCT02460276|Relapsed mantle cell lymphoma|relapsed mantle cell lymphoma
280180|NCT02460276|Lenalidomide|lenalidomide
280181|NCT02460276|Rituximab|rituximab
280182|NCT02460276|Ibrutinib|ibrutinib
280183|NCT02460276|Response duration|response duration
280184|NCT02460276|Complete remission rate|complete remission rate
280185|NCT02460276|Quality of life|quality of life
280186|NCT02460276|Overall survival|overall survival
280187|NCT02460276|Safety|safety
280188|NCT02460250|Tissue and Organ Harvesting|tissue and organ harvesting
280189|NCT02460250|Liver graft|liver graft
280190|NCT02460250|Brain Death|brain death
280191|NCT02460250|FibroScan®|fibroscan®
280192|NCT02460237|HPV|hpv
280193|NCT02460224|Non-small cell lung cancer|non-small cell lung cancer
280194|NCT02460224|Melanoma|melanoma
280195|NCT02460224|Renal cancer|renal cancer
280196|NCT02460224|Mesothelioma|mesothelioma
280197|NCT02460224|Triple Negative Breast|triple negative breast
280198|NCT02460224|TNBC|tnbc
280199|NCT02460224|Renal|renal
280200|NCT02460211|Cardiovascular Disease|cardiovascular disease
280201|NCT02460211|Vitamin D|vitamin d
280202|NCT02460211|Open Heart Surgery|open heart surgery
280203|NCT02460198|Programmed Cell Death-1 (PD1, PD-1)|programmed cell death-1 (pd1, pd-1)
280204|NCT02460198|Programmed Death-Ligand 1 (PDL1, PD-L1)|programmed death-ligand 1 (pdl1, pd-l1)
280205|NCT02460198|MSI-H|msi-h
280206|NCT02460198|MSI|msi
280207|NCT02460172|bi lateral|bi lateral
280208|NCT02460172|knee surgery|knee surgery
280209|NCT02460172|arthroplasty|arthroplasty
280210|NCT02460172|orthopedics|orthopedics
280211|NCT02460081|PDA-002|pda-002
280212|NCT02460081|Diabetic Foot Ulcer|diabetic foot ulcer
280213|NCT02460081|Peripheral arterial disease|peripheral arterial disease
280214|NCT02460081|Phase 2|phase 2
280215|NCT02460081|Randomized|randomized
280216|NCT02460068|melanoma brain metastases|melanoma brain metastases
280217|NCT02460068|nivolumab|nivolumab
280218|NCT02460068|ipilimumab|ipilimumab
280219|NCT02460055|EGD Dysphagia|egd dysphagia
280220|NCT02460055|ETT Intubation dysphagia|ett intubation dysphagia
280221|NCT02459990|Hypertension malformation fetal mortality|hypertension malformation fetal mortality
280222|NCT02459964|Advanced Cancers|advanced cancers
280223|NCT02459964|Pain|pain
280224|NCT02459964|Fentanyl nasal spray|fentanyl nasal spray
280225|NCT02459964|Hydromorphone hydrochloride|hydromorphone hydrochloride
280226|NCT02459964|Phone call|phone call
280227|NCT02459964|Numeric Rating Scale|numeric rating scale
280228|NCT02459964|NRS|nrs
280229|NCT02459951|Muscle Spasticity|muscle spasticity
280230|NCT02459951|Botox A|botox a
280231|NCT02459951|Upper limb hemiplegia|upper limb hemiplegia
280232|NCT02459912|Prostate|prostate
280233|NCT02459912|Minimally|minimally
280234|NCT02459912|Low-Risk|low-risk
280235|NCT02459912|Invasive|invasive
280236|NCT02459912|Cancer|cancer
280237|NCT02459886|alpha synuclein|alpha synuclein
280238|NCT02459886|PD|pd
280239|NCT02459860|depression|depression
280240|NCT02459860|randomized behavioral trial|randomized behavioral trial
280243|NCT02459860|Spanish-speaking|spanish-speaking
280244|NCT02459860|chronic medical conditions|chronic medical conditions
280245|NCT02459834|Allulose|allulose
280246|NCT02459834|Fructose|fructose
280247|NCT02459834|Dose Response|dose response
280248|NCT02459834|Catalytic Dose|catalytic dose
280249|NCT02459834|Carbohydrate metabolism|carbohydrate metabolism
280250|NCT02459834|Randomized clinical trials|randomized clinical trials
280251|NCT02459821|Multiple sclerosis|multiple sclerosis
280252|NCT02459821|Gait rehabilitation|gait rehabilitation
280253|NCT02459821|Quality of life|quality of life
280254|NCT02459821|Stair climbing|stair climbing
280255|NCT02459821|Robotic|robotic
280256|NCT02459782|Ultrasound guided peribulbar anesthesia|ultrasound guided peribulbar anesthesia
280257|NCT02459756|anthocyanins|anthocyanins
280258|NCT02459756|bioavailability|bioavailability
280259|NCT02459743|Hematological malignancies|hematological malignancies
280260|NCT02459743|Next Generation Sequencing|next generation sequencing
280261|NCT02459743|Genotype-phenotype correlations|genotype-phenotype correlations
280262|NCT02459743|Prognosis|prognosis
280263|NCT02459743|Diagnosis|diagnosis
280264|NCT02459730|Dental caries|dental caries
280265|NCT02459730|glass ionomer cement|glass ionomer cement
280266|NCT02459730|ART|art
280267|NCT02459704|Gingival Recession|gingival recession
280268|NCT02459704|Semilunar flap|semilunar flap
280269|NCT02459704|Enamel matrix derivative|enamel matrix derivative
280270|NCT02459704|Periodontal regeneration|periodontal regeneration
280271|NCT02459691|prediabetes|prediabetes
280272|NCT02459691|metabolic syndrome|metabolic syndrome
280273|NCT02459691|lifestyle|lifestyle
280274|NCT02459691|behavior change|behavior change
280275|NCT02459691|primary care|primary care
280276|NCT02459691|latinos|latinos
280277|NCT02459691|diet|diet
280278|NCT02459691|physical activity|physical activity
280279|NCT02459652|Borderline Resectable Pancreatic Cancer|borderline resectable pancreatic cancer
280280|NCT02459639|Chronic Widespread Pain|chronic widespread pain
280281|NCT02459639|Telomere length|telomere length
280282|NCT02459639|Multimodal rehabilitation|multimodal rehabilitation
280283|NCT02459639|Integrative care|integrative care
280284|NCT02459639|Existential aspects|existential aspects
280285|NCT02459613|Radionuclide imaging|radionuclide imaging
280286|NCT02459613|Annexin|annexin
280287|NCT02459600|Eye surgery|eye surgery
280288|NCT02459600|Children|children
280289|NCT02459587|Self-Injurious Behavior|self-injurious behavior
280290|NCT02459587|suicide prevention|suicide prevention
280291|NCT02459574|Heart Failure|heart failure
280292|NCT02459561|Obesity|obesity
280293|NCT02459561|Diabetes|diabetes
280294|NCT02459561|Overweight|overweight
280295|NCT02459561|Medical device|medical device
280296|NCT02459561|Endobarrier|endobarrier
280297|NCT02459561|Clinical trial|clinical trial
280298|NCT02459561|Diet|diet
280299|NCT02459561|Exercise|exercise
280300|NCT02459561|Body weight|body weight
280301|NCT02459561|Medical therapy|medical therapy
280302|NCT02459561|Medicine|medicine
280303|NCT02459561|Device|device
280304|NCT02459561|Randomised|randomised
280305|NCT02459561|Control|control
280306|NCT02459561|Intervention|intervention
280307|NCT02459561|EndoBarrier Medical device|endobarrier medical device
280308|NCT02459548|OSA|osa
280309|NCT02459548|CPAP treatment|cpap treatment
280310|NCT02459548|Primary care|primary care
280311|NCT02459548|Efficacy|efficacy
280312|NCT02459535|incretin release|incretin release
280313|NCT02459522|Bayesian estimation|bayesian estimation
280314|NCT02459522|short-term heart rate variability|short-term heart rate variability
280315|NCT02459522|cardiovascular autonomic neuropathy|cardiovascular autonomic neuropathy
280316|NCT02459522|diagnostic performance|diagnostic performance
280317|NCT02459509|Sedation|sedation
280318|NCT02459509|dexmedetomidine|dexmedetomidine
280319|NCT02459509|pediatric|pediatric
280320|NCT02459509|preoperative period|preoperative period
280321|NCT02459470|Fluid Responsiveness|fluid responsiveness
280322|NCT02459470|Pulse Pressure Variation|pulse pressure variation
280323|NCT02459470|Stroke Volume Variation|stroke volume variation
280324|NCT02459457|esophageal squamous cell carcinoma|esophageal squamous cell carcinoma
280325|NCT02459457|concurrent chemoradiotherapy|concurrent chemoradiotherapy
280326|NCT02459457|paclitaxel|paclitaxel
280327|NCT02459457|cisplatin|cisplatin
280328|NCT02459457|carboplatin|carboplatin
280329|NCT02459457|fluorouracil|fluorouracil
280330|NCT02459444|Respiratory Muscles|respiratory muscles
280331|NCT02459444|Muscle Weakness|muscle weakness
280332|NCT02459444|Hospitalization|hospitalization
280333|NCT02459444|Length of Stay|length of stay
280334|NCT02459444|Mortality|mortality
280335|NCT02459418|Afolia|afolia
280336|NCT02459418|Follitropin|follitropin
280337|NCT02459405|Colorectal surgery|colorectal surgery
280338|NCT02459405|Near infrared|near infrared
280339|NCT02459405|Indocyanine green|indocyanine green
280340|NCT02459405|anastomotic leak|anastomotic leak
280341|NCT02459405|Prevention of leak|prevention of leak
280342|NCT02459392|Epiduroscopy,|epiduroscopy,
280343|NCT02459392|Failed back surgery syndrome|failed back surgery syndrome
280946|NCT02455388|Obesity|obesity
280344|NCT02459392|Spinal Stenosis with neurologic changes|spinal stenosis with neurologic changes
280345|NCT02459366|Thoracolumbar fascia|thoracolumbar fascia
280346|NCT02459366|Mechanical properties|mechanical properties
280347|NCT02459366|Low back pain|low back pain
280348|NCT02459353|dapagliflozin|dapagliflozin
280349|NCT02459353|glucose variability|glucose variability
280350|NCT02459327|Infant behavior|infant behavior
280351|NCT02459327|Child behavior|child behavior
280352|NCT02459327|Parenting|parenting
280353|NCT02459327|Child rearing|child rearing
280354|NCT02459327|Depression|depression
280355|NCT02459327|Personal satisfaction|personal satisfaction
280356|NCT02459327|Randomized controlled trials|randomized controlled trials
280357|NCT02459327|Intervention studies|intervention studies
280358|NCT02459327|Behavioral symptoms|behavioral symptoms
280359|NCT02459327|Social behavior|social behavior
280360|NCT02459288|Acute coronary syndrome|acute coronary syndrome
280361|NCT02459288|Chronic kidney disease|chronic kidney disease
280362|NCT02459288|End-Stage Renal Disease|end-stage renal disease
280363|NCT02459288|eGFR|egfr
280364|NCT02459288|Ticagrelor|ticagrelor
280365|NCT02459288|Clopidogrel|clopidogrel
280366|NCT02459275|feeding protocol|feeding protocol
280367|NCT02459275|enteral nutrition protocol|enteral nutrition protocol
280368|NCT02459275|critically ill|critically ill
280369|NCT02459275|surgical ICU|surgical icu
280370|NCT02459275|enteral nutrition|enteral nutrition
280371|NCT02459275|nutrition therapy|nutrition therapy
280372|NCT02459223|Nutritional intervention|nutritional intervention
280373|NCT02459223|iron deficiency anemia|iron deficiency anemia
280374|NCT02459210|clinical high risk for psychosis|clinical high risk for psychosis
280375|NCT02459210|psychosis prodrome|psychosis prodrome
280376|NCT02459210|cognitive remediation|cognitive remediation
280377|NCT02459210|psychosis prevention|psychosis prevention
280378|NCT02459197|Pain|pain
280379|NCT02459184|preventive medicine|preventive medicine
280380|NCT02459184|social determinants of health|social determinants of health
280381|NCT02459184|primary health care|primary health care
280382|NCT02459184|poverty|poverty
280383|NCT02459184|income|income
280384|NCT02459184|health promotion|health promotion
280385|NCT02459132|High-intensity interval training|high-intensity interval training
280386|NCT02459132|VO2peak|vo2peak
280387|NCT02459132|Brachial flow-mediated dilation|brachial flow-mediated dilation
280388|NCT02459132|Carotid-femoral pulse wave velocity|carotid-femoral pulse wave velocity
280389|NCT02459132|Carotid intima-media thickness|carotid intima-media thickness
280390|NCT02459132|Carotid distensibility|carotid distensibility
280391|NCT02459132|Respiratory sinus arrhythmia|respiratory sinus arrhythmia
280392|NCT02459119|urothelial cancer|urothelial cancer
280393|NCT02459119|Regorafenib|regorafenib
280394|NCT02459106|micro-RNA|micro-rna
280395|NCT02459106|insulin resistance|insulin resistance
280396|NCT02459093|wound complications|wound complications
280397|NCT02459080|Chronic Obstructive Pulmonary Disease, COPD|chronic obstructive pulmonary disease, copd
280398|NCT02459054|Artificial Heart|artificial heart
280399|NCT02459054|Biventricular Heart Failure|biventricular heart failure
280400|NCT02459054|SynCardia|syncardia
280401|NCT02459002|Advanced lung cancer|advanced lung cancer
280402|NCT02459002|NSCLC|nsclc
280403|NCT02459002|palliative care|palliative care
280404|NCT02458989|Thyroidectomy|thyroidectomy
280405|NCT02458989|Thyroid surgery|thyroid surgery
280406|NCT02458989|Scalpel|scalpel
280407|NCT02458989|Electrocautery|electrocautery
280408|NCT02458976|Scar|scar
280409|NCT02458976|Pulsed-dye laser|pulsed-dye laser
280410|NCT02458976|PDL|pdl
280411|NCT02458963|PCOS|pcos
280412|NCT02458963|Clomiphene citrate resistant|clomiphene citrate resistant
280413|NCT02458963|Gonadotropin|gonadotropin
280414|NCT02458963|IVF|ivf
280415|NCT02458950|Anorexia nervosa|anorexia nervosa
280416|NCT02458950|Siriraj Hospital|siriraj hospital
280417|NCT02458950|Thai|thai
280418|NCT02458937|Leukemia|leukemia
280419|NCT02458937|Hodgkin Disease|hodgkin disease
280420|NCT02458937|Non-Hodgkin's Lymphoma|non-hodgkin's lymphoma
280421|NCT02458937|Sickle Cell Disease|sickle cell disease
280422|NCT02458937|Hip Core Decompression|hip core decompression
280423|NCT02458937|Function Outcomes|function outcomes
280424|NCT02458885|myocardial infarction|myocardial infarction
280425|NCT02458885|observational registry|observational registry
280426|NCT02458885|mortality|mortality
280427|NCT02458872|Clinical Alarms|clinical alarms
280428|NCT02458872|Patient Safety|patient safety
280429|NCT02458859|Chronic|chronic
280430|NCT02458859|Subacute|subacute
280431|NCT02458833|Obesity|obesity
280432|NCT02458833|Nutrition|nutrition
280433|NCT02458833|Home Food Preparation|home food preparation
280434|NCT02458833|Home Food Environment|home food environment
280435|NCT02458833|Peer Mentoring|peer mentoring
280436|NCT02458833|Early Head Start|early head start
280437|NCT02458833|Cooking|cooking
280438|NCT02458833|Diet|diet
280439|NCT02458820|Cardiopulmonary Resuscitation|cardiopulmonary resuscitation
280440|NCT02458820|Return of Spontaneous Circulation|return of spontaneous circulation
280441|NCT02458820|ROSC|rosc
280442|NCT02458820|Electroencephalogram|electroencephalogram
280443|NCT02458742|spinal anesthesia|spinal anesthesia
280444|NCT02458742|intrathecal morphine|intrathecal morphine
280445|NCT02458742|transurethral resection of prostate|transurethral resection of prostate
280446|NCT02458742|postoperative pain|postoperative pain
280447|NCT02458729|Tranexamic Acid|tranexamic acid
280448|NCT02458729|Total Knee Arthroplasty|total knee arthroplasty
280449|NCT02458729|Rivaroxaban|rivaroxaban
280450|NCT02458703|workload|workload
280451|NCT02458703|oxygen level|oxygen level
280452|NCT02458703|oxygen consumption|oxygen consumption
280453|NCT02458703|breathing reserve|breathing reserve
280454|NCT02458703|ventilatory efficiency|ventilatory efficiency
280455|NCT02458690|Primary Care|primary care
280456|NCT02458690|Older Adults|older adults
280457|NCT02458690|Antidepressant Medications|antidepressant medications
280458|NCT02458690|Cognitive-Behavioral Therapy|cognitive-behavioral therapy
280459|NCT02458690|Computer-Based Psychotherapy|computer-based psychotherapy
280460|NCT02458612|cerebral palsy|cerebral palsy
280461|NCT02458612|mirror therapy|mirror therapy
280462|NCT02458612|strength training|strength training
280463|NCT02458560|Transcatheter Aortic Valve Replacement|transcatheter aortic valve replacement
280464|NCT02458560|Aortic Stenosis|aortic stenosis
280465|NCT02458534|Simulated manikin|simulated manikin
280466|NCT02458508|MC4R|mc4r
280467|NCT02458508|chemotherapy|chemotherapy
280468|NCT02458508|radiotherapy|radiotherapy
280469|NCT02458495|Internet|internet
280470|NCT02458495|Mobile Health|mobile health
280471|NCT02458495|Hemoglobin A, Glycosylated|hemoglobin a, glycosylated
280472|NCT02458495|Medication Adherence|medication adherence
280473|NCT02458495|Psychological Theory|psychological theory
280474|NCT02458482|Children|children
280475|NCT02458482|Positive Airway Pressure|positive airway pressure
280476|NCT02458482|Nebulizer|nebulizer
280477|NCT02458482|Moderate|moderate
280478|NCT02458482|Acute|acute
280479|NCT02458482|AccuPAP|accupap
280480|NCT02458417|Ablative laser|ablative laser
280481|NCT02458417|Fractional laser|fractional laser
280482|NCT02458417|Vitiligo|vitiligo
280483|NCT02458417|Piebaldism|piebaldism
280484|NCT02458417|Cell suspension grafting|cell suspension grafting
280485|NCT02458391|Breast Cancer|breast cancer
280486|NCT02458391|Lymphedema|lymphedema
280487|NCT02458365|Violence|violence
280488|NCT02458365|Bullying|bullying
280489|NCT02458365|Social skills|social skills
358458|NCT02058212|ROS|ros
280490|NCT02458365|Prevention & control|prevention & control
280491|NCT02458365|Adolescent|adolescent
280492|NCT02458339|Brain tumor|brain tumor
280493|NCT02458339|Malignant Fourth Ventricular Brain Tumors|malignant fourth ventricular brain tumors
280494|NCT02458326|Migraine|migraine
280495|NCT02458326|Fibromyalgia|fibromyalgia
280496|NCT02458326|Aerobic exercise|aerobic exercise
280497|NCT02458300|Bronchiolitis|bronchiolitis
280498|NCT02458300|Chest|chest
280499|NCT02458300|Physical therapy|physical therapy
280500|NCT02458287|mixed dyslipidemia|mixed dyslipidemia
280501|NCT02458248|Chronic Kidney Disease|chronic kidney disease
280502|NCT02458248|Sodium Reduction|sodium reduction
280503|NCT02458248|eGFR 30-60ml/min/1.73m2|egfr 30-60ml/min/1.73m2
280504|NCT02458235|pediatric leukemia myelodysplastic syndrome azacitidine|pediatric leukemia myelodysplastic syndrome azacitidine
280505|NCT02458209|PK, bococizumab, comparability, LDL-C|pk, bococizumab, comparability, ldl-c
280506|NCT02458196|IgG4 related disease|igg4 related disease
280507|NCT02458196|IgG4-RD|igg4-rd
280508|NCT02458196|Response rate|response rate
280509|NCT02458196|Relapse|relapse
280510|NCT02458170|Rheumatoid arthritis|rheumatoid arthritis
280511|NCT02458170|Synovial tissue|synovial tissue
280512|NCT02458170|Joint destruction|joint destruction
280513|NCT02458170|Inflammation|inflammation
280514|NCT02458157|ICU|icu
280515|NCT02458157|Intensive|intensive
280516|NCT02458157|CRRT|crrt
280517|NCT02458157|Fluid Removal|fluid removal
280518|NCT02458157|AKI|aki
280519|NCT02458157|Critical Care|critical care
280520|NCT02458131|community-based participatory research|community-based participatory research
280521|NCT02458131|adolescents|adolescents
280522|NCT02458118|chronic|chronic
280523|NCT02458118|pancreatitis|pancreatitis
280524|NCT02458118|secretin|secretin
280525|NCT02458118|Blood flow|blood flow
280526|NCT02458105|Acceptance and commitment therapy|acceptance and commitment therapy
280527|NCT02458105|Cognitive behavior therapy|cognitive behavior therapy
280528|NCT02458053|African American|african american
280529|NCT02458053|male|male
280530|NCT02458053|couples|couples
280531|NCT02458053|randomized control trial|randomized control trial
280532|NCT02457975|Diabetic Macular Edema|diabetic macular edema
280533|NCT02457975|Photobiomodulation|photobiomodulation
280534|NCT02457975|Phototherapy|phototherapy
280535|NCT02457949|Social Assistance|social assistance
280536|NCT02457949|Drug Use|drug use
280537|NCT02457949|Drug-Related harm|drug-related harm
280538|NCT02457923|mobile phone counselling|mobile phone counselling
280539|NCT02457923|infant feeding|infant feeding
280540|NCT02457923|nutrition|nutrition
280541|NCT02457897|Brown Adipose Tissue|brown adipose tissue
280542|NCT02457897|Liothyronine|liothyronine
280543|NCT02457897|Insulin Receptors|insulin receptors
280544|NCT02457884|Diabetic macular oedema|diabetic macular oedema
280545|NCT02457884|Perceptual learning|perceptual learning
280546|NCT02457884|Chinese|chinese
280547|NCT02457884|Hong Kong|hong kong
280548|NCT02457858|Type 1 Diabetes|type 1 diabetes
280549|NCT02457858|Islet Transplant|islet transplant
280550|NCT02457845|Brain Tumor, Recurrent|brain tumor, recurrent
280551|NCT02457845|Glioma|glioma
280552|NCT02457845|Glioblastoma|glioblastoma
280553|NCT02457845|Gliosarcoma|gliosarcoma
280554|NCT02457845|Anaplastic Astrocytoma|anaplastic astrocytoma
280555|NCT02457845|Oligodendroglioma|oligodendroglioma
280556|NCT02457845|Rhabdoid Tumor|rhabdoid tumor
280557|NCT02457845|Cerebral Primitive Neuroectodermal Tumor|cerebral primitive neuroectodermal tumor
280558|NCT02457845|PNET|pnet
280559|NCT02457845|Ependymoma|ependymoma
280560|NCT02457845|Germ Cell Tumor|germ cell tumor
280561|NCT02457845|Choroid Plexus Carcinoma|choroid plexus carcinoma
280562|NCT02457845|Oncolytic Virus Therapy|oncolytic virus therapy
280563|NCT02457845|Virotherapy, Oncolytic|virotherapy, oncolytic
280564|NCT02457845|Immunotherapy|immunotherapy
280565|NCT02457845|Central Nervous System Agents|central nervous system agents
280566|NCT02457845|Antineoplastic Agents|antineoplastic agents
280567|NCT02457845|Neoplasms|neoplasms
280568|NCT02457845|Pediatric|pediatric
280569|NCT02457845|Pediatrics|pediatrics
280570|NCT02457845|Embryonal Tumor|embryonal tumor
280571|NCT02457845|Oncolytic|oncolytic
280572|NCT02457845|Virus|virus
280573|NCT02457845|HSV|hsv
280574|NCT02457845|Herpes Virus|herpes virus
280575|NCT02457832|Magnetic Resonance Imaging|magnetic resonance imaging
280576|NCT02457832|Neurology|neurology
280577|NCT02457832|Neurosciences|neurosciences
280578|NCT02457832|Physical Medicine|physical medicine
280579|NCT02457832|Parkinson Disease|parkinson disease
280580|NCT02457832|Rehabilitation|rehabilitation
280581|NCT02457806|Dental Anesthesia|dental anesthesia
280582|NCT02457780|PTSD|ptsd
280583|NCT02457780|Trauma|trauma
280584|NCT02457780|World Trade Center|world trade center
280585|NCT02457780|Respiratory|respiratory
280586|NCT02457780|Mind-Body|mind-body
280587|NCT02457741|Mechanical ventilation|mechanical ventilation
280588|NCT02457741|PEEP|peep
751108|NCT00436670|IL-4|il-4
280589|NCT02457741|Respiratory mechanics|respiratory mechanics
280590|NCT02457741|End-expiratory lung volume|end-expiratory lung volume
280591|NCT02457689|Human Immunodeficiency Virus|human immunodeficiency virus
280592|NCT02457689|Immunodeficiency Virus, Human|immunodeficiency virus, human
280593|NCT02457676|Self-Regulation Training|self-regulation training
280594|NCT02457676|Neuroimaging|neuroimaging
280595|NCT02457676|Response Inhibition|response inhibition
280596|NCT02457676|Behavioral Regulation|behavioral regulation
280597|NCT02457676|Emotional Regulation|emotional regulation
280598|NCT02457663|Burns|burns
280599|NCT02457637|chronic liver disease|chronic liver disease
280600|NCT02457637|acute liver injury|acute liver injury
280601|NCT02457637|acute decompensation|acute decompensation
280602|NCT02457637|multiple organ failures|multiple organ failures
280603|NCT02457637|acute on chronic liver failure|acute on chronic liver failure
280604|NCT02457624|gastric cancer|gastric cancer
280605|NCT02457624|chronic atrophic gastritis|chronic atrophic gastritis
280606|NCT02457624|intestinal metaplasia|intestinal metaplasia
280607|NCT02457546|Fibrin sealant|fibrin sealant
280608|NCT02457546|CSF leak|csf leak
280609|NCT02457494|CALVIH|calvih
280610|NCT02457494|Renal stone|renal stone
280611|NCT02457494|HIV1|hiv1
280612|NCT02457494|Renal colic|renal colic
280613|NCT02457494|Atazanavir|atazanavir
280614|NCT02457494|Crystalluria|crystalluria
280615|NCT02457494|Chronic Kidney Disease|chronic kidney disease
280616|NCT02457494|Calcium Oxalate|calcium oxalate
280617|NCT02457481|Embryo Culture Techniques|embryo culture techniques
280618|NCT02457481|Embryonic Development|embryonic development
280619|NCT02457468|coflex|coflex
280620|NCT02457468|interlaminar stabilization|interlaminar stabilization
280621|NCT02457468|lumbar spinal stenosis|lumbar spinal stenosis
280622|NCT02457468|neurogenic claudication|neurogenic claudication
280623|NCT02457468|decompression|decompression
280624|NCT02457455|inflight emergencies|inflight emergencies
280625|NCT02457442|Anesthetics, Inhalation|anesthetics, inhalation
280626|NCT02457442|Anesthetics, Intravenous|anesthetics, intravenous
280627|NCT02457442|Analgesics, Opioid|analgesics, opioid
280628|NCT02457429|Gastro-oesophageal reflux|gastro-oesophageal reflux
280629|NCT02457429|Children|children
280630|NCT02457429|Dx-pH Pharyngeal probe|dx-ph pharyngeal probe
280631|NCT02457429|GORD|gord
280632|NCT02457429|Trans-nasal catheter|trans-nasal catheter
280633|NCT02457416|Peanut allergy|peanut allergy
280634|NCT02457416|Oral immunotherapy|oral immunotherapy
280635|NCT02457390|contrast enhanced laparoscopic ultrasound|contrast enhanced laparoscopic ultrasound
280636|NCT02457390|CE-LUS|ce-lus
280637|NCT02457390|LUS|lus
280638|NCT02457390|robot assisted CRC resection|robot assisted crc resection
280639|NCT02457377|recurrent abortion|recurrent abortion
280640|NCT02457377|cerclage|cerclage
280641|NCT02457377|laparoscopy|laparoscopy
280642|NCT02457377|cervical imcompetence|cervical imcompetence
280643|NCT02457364|non-operative management|non-operative management
280644|NCT02457351|Phase 1|phase 1
280645|NCT02457351|Advanced solid tumor|advanced solid tumor
280646|NCT02457351|pan-CDK inhibitor|pan-cdk inhibitor
280647|NCT02457351|Drug-drug Interaction|drug-drug interaction
280648|NCT02457338|C-section|c-section
280649|NCT02457338|Infants|infants
280650|NCT02457338|Probiotic|probiotic
280651|NCT02457338|B. infantis|b. infantis
280652|NCT02457338|Microbiota|microbiota
280653|NCT02457338|Gut|gut
280654|NCT02457338|Breast milk|breast milk
280655|NCT02457338|Vaginal|vaginal
280656|NCT02457325|Articaine|articaine
280657|NCT02457325|Lower third molar|lower third molar
280658|NCT02457325|Oral Surgery|oral surgery
280659|NCT02457299|Esophagectomy|esophagectomy
280660|NCT02457299|Gastric Conduit|gastric conduit
280661|NCT02457299|Esophageal Cancer|esophageal cancer
280662|NCT02457273|PDNC(Poorly Differentiated Neuroendocrine Carcinomas)|pdnc(poorly differentiated neuroendocrine carcinomas)
280663|NCT02457273|TLC-388 (Lipotecan®)|tlc-388 (lipotecan®)
280664|NCT02457247|Drug therapy|drug therapy
280665|NCT02457234|fruits and vegetables|fruits and vegetables
280666|NCT02457234|cultural immersion|cultural immersion
280667|NCT02457221|Tacrolimus|tacrolimus
280668|NCT02457221|Cyclophosphamide|cyclophosphamide
280669|NCT02457221|Prograf|prograf
280670|NCT02457221|lupus nephritis|lupus nephritis
280671|NCT02457208|pharmacokinetics|pharmacokinetics
280672|NCT02457195|PONV|ponv
280673|NCT02457195|anesthesia|anesthesia
280674|NCT02457195|granisetron|granisetron
280675|NCT02457156|Pancreatico-jejunostomy|pancreatico-jejunostomy
280676|NCT02457156|Pancreato-duodenectomy|pancreato-duodenectomy
280677|NCT02457156|Cattell-Warren anastomosis|cattell-warren anastomosis
280678|NCT02457156|Blumgart anastomosis|blumgart anastomosis
280679|NCT02457143|recall|recall
280680|NCT02457143|income-related disparities|income-related disparities
280681|NCT02457143|cancer screening|cancer screening
280682|NCT02457117|CyberKnife|cyberknife
280683|NCT02457117|Partial breast irradiation|partial breast irradiation
280684|NCT02457117|accelerated partial breast irradiation|accelerated partial breast irradiation
280685|NCT02457117|breast sbrt|breast sbrt
280686|NCT02457091|multiple sclerosis|multiple sclerosis
280687|NCT02457091|exercise|exercise
280688|NCT02457091|home-based|home-based
280689|NCT02457091|training|training
280690|NCT02457091|fitness|fitness
280691|NCT02457078|nutritional supplements|nutritional supplements
280692|NCT02457078|lutein|lutein
280693|NCT02457078|DHA|dha
280694|NCT02457078|vitamin E|vitamin e
280695|NCT02457078|infant brain development|infant brain development
280696|NCT02457065|survivors|survivors
280697|NCT02457065|family|family
280698|NCT02457052|Medical device|medical device
280699|NCT02457039|Chemo-brain|chemo-brain
280700|NCT02457039|Drug-Related Side Effects and Adverse Reactions|drug-related side effects and adverse reactions
280701|NCT02457039|Mild Cognitive Impairment|mild cognitive impairment
280702|NCT02457039|Breast cancer|breast cancer
280703|NCT02457026|neovascular age-related macular degeneration|neovascular age-related macular degeneration
280704|NCT02457026|age-related macular degeneration|age-related macular degeneration
280705|NCT02457026|verteporfin|verteporfin
280706|NCT02457026|persistent disease activity|persistent disease activity
280707|NCT02457026|photodynamic therapy|photodynamic therapy
280708|NCT02457026|Aflibercept|aflibercept
280709|NCT02457000|Sleep|sleep
280710|NCT02457000|Skin|skin
280711|NCT02457000|Circadian Rhythm|circadian rhythm
280712|NCT02456961|Collagen crosslinking (CXL)|collagen crosslinking (cxl)
280713|NCT02456961|Standard corneal crosslinking (CXL)|standard corneal crosslinking (cxl)
280714|NCT02456961|Transepithelial CXL|transepithelial cxl
280715|NCT02456961|Iontophoresis|iontophoresis
280716|NCT02456961|Riboflavin|riboflavin
280717|NCT02456948|treatment resistant depression|treatment resistant depression
280718|NCT02456948|inflammation|inflammation
280719|NCT02456948|microglia|microglia
280720|NCT02456948|minocycline|minocycline
280721|NCT02456922|Type 1 Diabetes|type 1 diabetes
280722|NCT02456922|Type 2 Diabetes|type 2 diabetes
280723|NCT02456922|Harmony 1|harmony 1
280724|NCT02456896|Oxcarbazepine|oxcarbazepine
280725|NCT02456896|Brain Derived Neurotrophic Factor|brain derived neurotrophic factor
280726|NCT02456896|Bipolar disorder|bipolar disorder
280727|NCT02456896|Neuroprotection|neuroprotection
280728|NCT02456883|ASP2215|asp2215
280729|NCT02456883|14C-labeled gilteritinib|14c-labeled gilteritinib
280730|NCT02456883|Advanced Solid Tumors|advanced solid tumors
280731|NCT02456883|Pharmacokinetics|pharmacokinetics
280732|NCT02456883|gilteritinib|gilteritinib
280733|NCT02456870|Adipose tissue|adipose tissue
280734|NCT02456870|Overfeeding|overfeeding
280735|NCT02456818|Colonization|colonization
280736|NCT02456818|Multi-resistant gram negative bacteria|multi-resistant gram negative bacteria
280737|NCT02456818|Infection control measures|infection control measures
280738|NCT02456818|Hand hygiene program|hand hygiene program
280739|NCT02456818|Contact precautions|contact precautions
280740|NCT02456818|Immunocompromised host|immunocompromised host
280741|NCT02456792|PCOS|pcos
280844|NCT02456220|Herbst appliance|herbst appliance
280742|NCT02456792|Clomiphene citrate resistant|clomiphene citrate resistant
280743|NCT02456792|LOD|lod
280744|NCT02456792|IVF|ivf
280745|NCT02456779|pepsin|pepsin
280746|NCT02456779|peptest|peptest
280747|NCT02456779|GERD|gerd
280748|NCT02456779|NERD|nerd
280749|NCT02456779|diagnostic|diagnostic
280750|NCT02456766|FibroTouch|fibrotouch
280751|NCT02456766|acoustic attenuation parameter|acoustic attenuation parameter
280752|NCT02456766|liver biopsy|liver biopsy
280753|NCT02456766|hepatic steatosis|hepatic steatosis
280754|NCT02456753|in labor|in labor
280755|NCT02456753|Ultrasonography|ultrasonography
280756|NCT02456753|clinical examination|clinical examination
280757|NCT02456753|Prenatal|prenatal
280758|NCT02456740|Migraine|migraine
280759|NCT02456740|Headache|headache
280760|NCT02456740|Prevention|prevention
280761|NCT02456740|Prophylaxis|prophylaxis
280762|NCT02456727|Acupuncture|acupuncture
280763|NCT02456727|Group/Community Acupuncture|group/community acupuncture
280764|NCT02456727|Individual Acupuncture|individual acupuncture
280765|NCT02456727|Chronic Pain|chronic pain
280766|NCT02456727|Underserved|underserved
280767|NCT02456727|Urban Primary Care|urban primary care
280768|NCT02456727|Osteoarthritis|osteoarthritis
280769|NCT02456727|Back Pain|back pain
280770|NCT02456727|Neck Pain|neck pain
280771|NCT02456714|Cholangiocarcinoma|cholangiocarcinoma
280772|NCT02456714|FOLFIRINOX|folfirinox
280773|NCT02456714|Phase II study|phase ii study
280774|NCT02456701|CDX3379|cdx3379
280775|NCT02456675|Refractory Hodgkin lymphoma|refractory hodgkin lymphoma
280776|NCT02456675|Relapsed Hodgkin Lymphoma|relapsed hodgkin lymphoma
280777|NCT02456649|lumpectomy margins|lumpectomy margins
280778|NCT02456636|Weight loss|weight loss
280779|NCT02456636|Weight management|weight management
280780|NCT02456636|Diabetes|diabetes
280781|NCT02456636|Heart disease|heart disease
280782|NCT02456597|Peripheral Nerve Blocks|peripheral nerve blocks
280783|NCT02456584|depot medroxyprogesterone acetate (DMPA)|depot medroxyprogesterone acetate (dmpa)
280784|NCT02456584|confidence interval (CI)|confidence interval (ci)
280785|NCT02456584|Subcutaneous (sub-Q)|subcutaneous (sub-q)
280786|NCT02456584|Intrauterine device (IUD)|intrauterine device (iud)
280787|NCT02456584|Levonorgestrel (LNG)|levonorgestrel (lng)
280788|NCT02456584|intrauterine system (IUS)|intrauterine system (ius)
280789|NCT02456558|HIV infection|hiv infection
280790|NCT02456558|antiretroviral drugs|antiretroviral drugs
280791|NCT02456558|deferiprone|deferiprone
280792|NCT02456558|pharmacokinetics|pharmacokinetics
280793|NCT02456519|children|children
280794|NCT02456519|surgery|surgery
280795|NCT02456428|Incretins|incretins
280796|NCT02456428|Antidiabetic Agents|antidiabetic agents
280797|NCT02456428|Heart Failure|heart failure
280798|NCT02456389|Probable cancer|probable cancer
280799|NCT02456389|Proven cancer|proven cancer
280800|NCT02456389|Elective cancer surgery|elective cancer surgery
280801|NCT02456389|Postoperative death|postoperative death
280802|NCT02456389|Postoperative complications|postoperative complications
280803|NCT02456389|Healthcare utilization|healthcare utilization
280804|NCT02456389|Quality of life|quality of life
280805|NCT02456389|Adjuvant therapy|adjuvant therapy
280806|NCT02456389|Disease-free survival|disease-free survival
280807|NCT02456389|Overall survival|overall survival
280808|NCT02456376|Sensor Fusion|sensor fusion
280809|NCT02456376|Stochastic Resonance Stimulation|stochastic resonance stimulation
280810|NCT02456376|Sensory deficits|sensory deficits
280811|NCT02456376|Postural Control|postural control
280812|NCT02456363|Adalimumab|adalimumab
280813|NCT02456363|NSAIDs|nsaids
280814|NCT02456363|safety|safety
280815|NCT02456363|efficacy|efficacy
280816|NCT02456337|Gingival Recession|gingival recession
280817|NCT02456337|Coronally advanced flap|coronally advanced flap
280818|NCT02456337|Periodontal regeneration|periodontal regeneration
280819|NCT02456324|Fistula, Anorectal|fistula, anorectal
280820|NCT02456311|VATS|vats
280821|NCT02456311|Energy sealing|energy sealing
280822|NCT02456298|Telehealth|telehealth
280823|NCT02456298|Applied behavior analysis|applied behavior analysis
280824|NCT02456272|Otosclerosis|otosclerosis
280825|NCT02456272|Surgical treatment|surgical treatment
280826|NCT02456272|Hearing aids|hearing aids
280827|NCT02456259|internal jugular vein patency|internal jugular vein patency
280828|NCT02456259|MICS|mics
280829|NCT02456259|neck cannula|neck cannula
280830|NCT02456259|Jugular veins|jugular veins
280831|NCT02456246|Stereotactive Body Radiation Therapy (SBRT)|stereotactive body radiation therapy (sbrt)
280832|NCT02456246|Lung Fibrosis|lung fibrosis
280833|NCT02456246|FLT-PET|flt-pet
280834|NCT02456246|NSCLC|nsclc
280835|NCT02456233|rotor|rotor
280836|NCT02456233|FIRM|firm
280837|NCT02456233|paroxysmal atrial fibrillation|paroxysmal atrial fibrillation
280838|NCT02456233|persistent atrial fibrillation|persistent atrial fibrillation
280839|NCT02456233|atrial tachyarrhythmia|atrial tachyarrhythmia
280840|NCT02456233|ablation|ablation
280841|NCT02456233|contact mapping|contact mapping
280842|NCT02456233|clinical trial|clinical trial
280843|NCT02456233|signal processing|signal processing
280845|NCT02456220|Computed tomography|computed tomography
280846|NCT02456220|3D imaging|3d imaging
280847|NCT02456220|Growth and development|growth and development
280848|NCT02456220|Orthodontic Appliances, Functional|orthodontic appliances, functional
280849|NCT02456168|Lupus|lupus
280850|NCT02456168|SLE|sle
280851|NCT02456155|bedside placement|bedside placement
280852|NCT02456155|nasal jejunal tube|nasal jejunal tube
280853|NCT02456155|ultrasound|ultrasound
280854|NCT02456155|severe acute pancreatitis|severe acute pancreatitis
280855|NCT02456155|endoscope|endoscope
280856|NCT02456155|efficacy|efficacy
280857|NCT02456155|safety|safety
280858|NCT02456129|Clinical Trial, Phase I|clinical trial, phase i
280859|NCT02456077|MCV4: Meningococcal Conjugate Vaccine|mcv4: meningococcal conjugate vaccine
280860|NCT02456077|HPV: Human Papillomavirus|hpv: human papillomavirus
280861|NCT02456051|Pancreatic Carcinoma|pancreatic carcinoma
280862|NCT02456051|New-Onset Diabetes|new-onset diabetes
280863|NCT02456051|Adrenomedullin|adrenomedullin
280864|NCT02456051|Early Diagnosis|early diagnosis
280865|NCT02456051|Biological Markers|biological markers
280866|NCT02456012|peptic ulcer hemorrhage|peptic ulcer hemorrhage
280867|NCT02456012|comorbidity|comorbidity
280868|NCT02456012|clinical trial|clinical trial
280869|NCT02455973|obesity|obesity
280870|NCT02455973|overweight|overweight
280871|NCT02455947|Burnout|burnout
280872|NCT02455947|Teachers|teachers
280873|NCT02455947|Meditation|meditation
280874|NCT02455947|IBSR|ibsr
280875|NCT02455947|"The Work"|"the work"
280876|NCT02455947|Byron Katie|byron katie
280877|NCT02455895|Blepharitis|blepharitis
280878|NCT02455856|Healthy|healthy
280879|NCT02455856|Itraconazole|itraconazole
280880|NCT02455856|JNJ-42847922|jnj-42847922
280881|NCT02455843|microwave ablation|microwave ablation
280882|NCT02455843|chemotherapy|chemotherapy
280883|NCT02455830|Neonatal encephalopathy|neonatal encephalopathy
280884|NCT02455830|Hypoxic-ischemic encephalopathy|hypoxic-ischemic encephalopathy
280885|NCT02455830|Newborn infants|newborn infants
280886|NCT02455830|Cytokines|cytokines
280887|NCT02455830|Trophic factors|trophic factors
280888|NCT02455791|Breast Cancer|breast cancer
280889|NCT02455791|Triple negative breast cancer|triple negative breast cancer
280890|NCT02455791|HER2 amplified breast cancer|her2 amplified breast cancer
280891|NCT02455791|Ultrasound-guided biopsy|ultrasound-guided biopsy
280892|NCT02455791|Fine needle aspirate|fine needle aspirate
280893|NCT02455791|FNA|fna
280894|NCT02455791|Core biopsy|core biopsy
280895|NCT02455752|LE-TME|le-tme
280896|NCT02455752|Laparoscopic rectal resection|laparoscopic rectal resection
280897|NCT02455752|Retroperitoneal resection|retroperitoneal resection
280898|NCT02455739|intestinal function|intestinal function
280899|NCT02455739|chewing gum|chewing gum
280900|NCT02455726|Peripheral Arterial Disease|peripheral arterial disease
280901|NCT02455726|Magnesium Oxide|magnesium oxide
280902|NCT02455726|Pain|pain
280903|NCT02455687|Bronchial asthma|bronchial asthma
280904|NCT02455687|Magnesium Sulfate|magnesium sulfate
280905|NCT02455687|Inhaled budesonide|inhaled budesonide
280906|NCT02455674|weight estimation|weight estimation
280907|NCT02455674|emergency|emergency
280908|NCT02455674|child|child
280909|NCT02455635|Office Hysteroscopy|office hysteroscopy
280910|NCT02455635|tubal patency|tubal patency
280911|NCT02455635|infertility|infertility
280912|NCT02455635|Lower Abdominal Pain|lower abdominal pain
280913|NCT02455609|dexmedetomidine|dexmedetomidine
280914|NCT02455609|ketamine|ketamine
280915|NCT02455609|postoperative pain|postoperative pain
280916|NCT02455596|Novaferon|novaferon
280917|NCT02455596|Recombinant anti-tumor and anti-virus protein for injection|recombinant anti-tumor and anti-virus protein for injection
280918|NCT02455596|Carcinoid Tumor|carcinoid tumor
280919|NCT02455596|Pancreatic Neuroendocrine Tumor|pancreatic neuroendocrine tumor
280920|NCT02455583|HIV prevention|hiv prevention
280921|NCT02455583|Sexual activity biomarker|sexual activity biomarker
280922|NCT02455583|Youth|youth
280923|NCT02455583|Adolescents|adolescents
280924|NCT02455570|Endoscopic Ultrasound|endoscopic ultrasound
280925|NCT02455570|Quality Management|quality management
280926|NCT02455570|Education and training|education and training
280927|NCT02455570|Safety|safety
280928|NCT02455570|Learning curve|learning curve
280929|NCT02455544|Urine congophilia|urine congophilia
280930|NCT02455518|pain|pain
280931|NCT02455505|Cancer Care and Bereavement|cancer care and bereavement
280932|NCT02455505|Supportive Care|supportive care
280933|NCT02455505|15-095|15-095
280934|NCT02455492|Mortality|mortality
280935|NCT02455492|Perioperative period|perioperative period
280936|NCT02455492|Elective surgical procedures|elective surgical procedures
280937|NCT02455479|cocaine vaccine|cocaine vaccine
280938|NCT02455479|cocaine dependence|cocaine dependence
280939|NCT02455479|Cocaine|cocaine
280940|NCT02455440|esmolol|esmolol
280941|NCT02455440|anesthetics|anesthetics
280942|NCT02455427|transcranial direct current stimulation|transcranial direct current stimulation
280943|NCT02455427|conventional physical therapy|conventional physical therapy
280944|NCT02455401|Postoperative Vomiting|postoperative vomiting
280945|NCT02455388|Nutrition|nutrition
280947|NCT02455388|Pediatric|pediatric
280948|NCT02455375|Puumala virus|puumala virus
280949|NCT02455375|diagnostic|diagnostic
280950|NCT02455375|France|france
280951|NCT02455336|tetraplegia|tetraplegia
280952|NCT02455336|paraplegia|paraplegia
280953|NCT02455336|hypertriglyceridemia|hypertriglyceridemia
280954|NCT02455336|hyperlipidemia|hyperlipidemia
280955|NCT02455336|peroxisome proliferator-activated receptor alpha|peroxisome proliferator-activated receptor alpha
280956|NCT02455323|Efficacy|efficacy
280957|NCT02455323|Tension-type headache|tension-type headache
280958|NCT02455323|Manual therapy|manual therapy
280959|NCT02455284|MRI|mri
280960|NCT02455284|Tractography|tractography
280961|NCT02455284|white|white
280962|NCT02455284|physiology|physiology
280963|NCT02455284|analysis|analysis
280964|NCT02455284|matter|matter
280965|NCT02455284|tracts|tracts
280966|NCT02455271|Insomnia|insomnia
280967|NCT02455258|Inactivity|inactivity
280968|NCT02455180|Critical Care|critical care
280969|NCT02455167|HCV|hcv
280970|NCT02455167|Hepatitis C|hepatitis c
280971|NCT02455154|Chinese Traditional Medicine|chinese traditional medicine
280972|NCT02455154|Osteoporosis|osteoporosis
280973|NCT02455154|adjuvant endocrine therapy|adjuvant endocrine therapy
280974|NCT02455154|early breast cancer|early breast cancer
280975|NCT02455141|chemptherapy|chemptherapy
280976|NCT02455141|triple negative|triple negative
280977|NCT02455141|taxanes|taxanes
280978|NCT02455141|carboplatin|carboplatin
280979|NCT02455128|Anxiety|anxiety
280980|NCT02455128|Fear|fear
280981|NCT02455128|Colorectal Surgery|colorectal surgery
280982|NCT02455128|Colorectal Neoplasms|colorectal neoplasms
280983|NCT02455115|Acute kidney injury|acute kidney injury
280984|NCT02455115|Liver transplantation|liver transplantation
280985|NCT02455115|Postoperative care|postoperative care
280986|NCT02455115|Glomerular filtration rate|glomerular filtration rate
280987|NCT02455115|Renal blood flow|renal blood flow
280988|NCT02455115|Vasopressor|vasopressor
280989|NCT02455115|Norepinephrine|norepinephrine
280990|NCT02455102|Prevention|prevention
280991|NCT02455102|Anticoagulation|anticoagulation
280992|NCT02455102|Electronic warning system|electronic warning system
280993|NCT02455089|Flare|flare
280994|NCT02455089|Therapeutic adjustments|therapeutic adjustments
280995|NCT02455089|Biological Marker|biological marker
280996|NCT02455089|Immunologic Marker|immunologic marker
280997|NCT02455089|Prognosis|prognosis
280998|NCT02455076|Hypoglycemia|hypoglycemia
280999|NCT02455037|Concussion|concussion
281000|NCT02455037|Contact sport|contact sport
281001|NCT02455037|Collision sport|collision sport
281002|NCT02455037|Neck strengthening|neck strengthening
281003|NCT02455024|Leukemia|leukemia
281004|NCT02455024|Leukemia, Myeloid|leukemia, myeloid
281005|NCT02455024|Leukemia, Myelogenous, Chronic, BCR-ABL Positive|leukemia, myelogenous, chronic, bcr-abl positive
281006|NCT02455024|ponatinib|ponatinib
281007|NCT02455024|Pharmacologic Actions|pharmacologic actions
281008|NCT02455024|Protein Kinase Inhibitors|protein kinase inhibitors
281009|NCT02455024|Risk factor|risk factor
281010|NCT02455024|Leukemia, Myelogenous, Chronic|leukemia, myelogenous, chronic
281011|NCT02455024|CML|cml
281012|NCT02455024|CP-CML|cp-cml
281013|NCT02455024|Iclusig|iclusig
281014|NCT02455024|AP24534|ap24534
281015|NCT02455024|AP-CML|ap-cml
281016|NCT02455024|BP-CML|bp-cml
281017|NCT02455024|Ph+ALL|ph+all
281018|NCT02454998|Unilateral complete cleft lip|unilateral complete cleft lip
281019|NCT02454998|Alveolar bone graft|alveolar bone graft
281020|NCT02454946|Blood Group Antigens|blood group antigens
281021|NCT02454946|erectile dysfunction|erectile dysfunction
281022|NCT02454933|Phase III Open Label Study; AZD9291 plus MEDI4736 versus AZD9291 Monotherapy; NSCLC After Previous EGFR TKI Therapy; T790M Mutation Positive Tumours.|phase iii open label study; azd9291 plus medi4736 versus azd9291 monotherapy; nsclc after previous egfr tki therapy; t790m mutation positive tumours.
281023|NCT02454920|Strabismus|strabismus
281024|NCT02454920|Optical Coherence Tomography|optical coherence tomography
281025|NCT02454920|Extraocular muscles|extraocular muscles
281026|NCT02454868|Remifentanil|remifentanil
281027|NCT02454868|Intubation|intubation
281028|NCT02454868|Children|children
281029|NCT02454855|quality of life|quality of life
281030|NCT02454855|melatonin|melatonin
281031|NCT02454855|Elderly patient|elderly patient
281032|NCT02454842|TH-4000|th-4000
281033|NCT02454842|low-oxygen conditions|low-oxygen conditions
281034|NCT02454842|hypoxia|hypoxia
281035|NCT02454842|non-small cell lung cancer|non-small cell lung cancer
281036|NCT02454842|NSCLC|nsclc
281037|NCT02454842|squamous cell carcinoma|squamous cell carcinoma
281038|NCT02454842|Tarloxotinib|tarloxotinib
281039|NCT02454829|Ovarian cortex cryopreservation|ovarian cortex cryopreservation
281040|NCT02454829|ovarian function|ovarian function
281041|NCT02454790|Acute toxicity|acute toxicity
281042|NCT02454790|Late toxicity|late toxicity
281043|NCT02454790|Prediction models|prediction models
281044|NCT02454738|pulmonary tuberculosis|pulmonary tuberculosis
281045|NCT02454738|chest|chest
281046|NCT02454738|ultralow dose computed tomography|ultralow dose computed tomography
281047|NCT02454725|HIV Testing|hiv testing
281048|NCT02454725|Latino|latino
281049|NCT02454712|Prodrug|prodrug
281050|NCT02454712|PF614|pf614
281051|NCT02454712|oxycodone extended-release|oxycodone extended-release
281052|NCT02454712|oral|oral
281053|NCT02454699|antiviral|antiviral
281054|NCT02454699|ascending dose|ascending dose
281055|NCT02454699|Cytomegalovirus|cytomegalovirus
281056|NCT02454699|food effect|food effect
281057|NCT02454699|Herpesviridae|herpesviridae
281058|NCT02454699|MBX-400|mbx-400
281059|NCT02454686|Complications after hepatectomy|complications after hepatectomy
281060|NCT02454673|Radiotherapy|radiotherapy
281061|NCT02454673|Neoadjuvant therapy|neoadjuvant therapy
281062|NCT02454673|Pharmacodynamics|pharmacodynamics
281063|NCT02454673|Pharmacokinetics|pharmacokinetics
281064|NCT02454673|Nonlinear Dynamics|nonlinear dynamics
281065|NCT02454660|adherence|adherence
281066|NCT02454660|hypertension|hypertension
281067|NCT02454660|mobile technology|mobile technology
281068|NCT02454660|intervention|intervention
281069|NCT02454647|Radiotherapy|radiotherapy
281070|NCT02454647|Neoadjuvant therapy|neoadjuvant therapy
281071|NCT02454647|Induction chemotherapy|induction chemotherapy
281072|NCT02454647|Concurrent chemoradiotherapy|concurrent chemoradiotherapy
281073|NCT02454647|Preoperative factors|preoperative factors
281074|NCT02454647|Dynamic factors|dynamic factors
281075|NCT02454647|Prognostic Factor|prognostic factor
281076|NCT02454634|IDH1R132H|idh1r132h
281077|NCT02454634|peptide vaccine|peptide vaccine
281078|NCT02454634|immunotherapy|immunotherapy
281079|NCT02454634|IDH1R132H-mutated glioma|idh1r132h-mutated glioma
281080|NCT02454556|Assisted reproduction technologies|assisted reproduction technologies
281081|NCT02454556|Follicle stimulating hormone (FSH).|follicle stimulating hormone (fsh).
281082|NCT02454543|metastatic|metastatic
281083|NCT02454543|prostatectomy|prostatectomy
281084|NCT02454543|androgen deprivation|androgen deprivation
359193|NCT02055079|PKD|pkd
281085|NCT02454543|best systemic therapy|best systemic therapy
281086|NCT02454504|Sugammadex|sugammadex
281087|NCT02454504|Delayed Emergence from Anesthesia|delayed emergence from anesthesia
281088|NCT02454504|Curare|curare
281089|NCT02454504|Robotic Surgical Procedures|robotic surgical procedures
281090|NCT02454491|percutaneous coronary interventions|percutaneous coronary interventions
281091|NCT02454491|radial artery access|radial artery access
281092|NCT02454491|access site complications|access site complications
281093|NCT02454491|verapamil|verapamil
281094|NCT02454491|heparin|heparin
281095|NCT02454478|lenvatinib|lenvatinib
281096|NCT02454478|Everolimus|everolimus
281097|NCT02454478|Carcinoma|carcinoma
281098|NCT02454478|Unresectable advanced renal cell carcinoma|unresectable advanced renal cell carcinoma
281099|NCT02454478|Metastatic renal cell carcinoma|metastatic renal cell carcinoma
281100|NCT02454452|Varicose Veins|varicose veins
281101|NCT02454439|Heart Failure with reduced ejection fraction (<35%)|heart failure with reduced ejection fraction (<35%)
281102|NCT02454439|Cardiac Resynchronisation Therapy|cardiac resynchronisation therapy
281103|NCT02454439|Non specific intraventricular conduction|non specific intraventricular conduction
281104|NCT02454439|Efficacy|efficacy
281105|NCT02454439|Life expectancy expected to exceed one year with a good functional status|life expectancy expected to exceed one year with a good functional status
281106|NCT02454439|QRS morphology : NICD according to the AHA/ACCF/HRS Recommendations (non-LBBB and non-RBBB):|qrs morphology : nicd according to the aha/accf/hrs recommendations (non-lbbb and non-rbbb):
281107|NCT02454439|QRS duration > 130 ms|qrs duration > 130 ms
281108|NCT02454426|Depression|depression
281109|NCT02454426|Heart disease|heart disease
281110|NCT02454413|dentures hygiene|dentures hygiene
281111|NCT02454413|biofilm formation|biofilm formation
281112|NCT02454413|oral health|oral health
281113|NCT02454400|physical therapy|physical therapy
281114|NCT02454400|lumbar spine surgery|lumbar spine surgery
281115|NCT02454400|pre-surgical intervention|pre-surgical intervention
281116|NCT02454400|RCT|rct
281117|NCT02454374|Physiotherapy|physiotherapy
281118|NCT02454374|Knee Loading|knee loading
281119|NCT02454374|Randomised Controlled Trial|randomised controlled trial
281120|NCT02454374|Pain|pain
281121|NCT02454361|Safety|safety
281122|NCT02454361|tolerability|tolerability
281123|NCT02454361|pharmacokinetics|pharmacokinetics
281124|NCT02454361|KBP-7072|kbp-7072
281125|NCT02454348|septic shock|septic shock
281126|NCT02454348|vasopressin|vasopressin
281127|NCT02454348|norepinephrine|norepinephrine
281128|NCT02454296|Laminaria|laminaria
281129|NCT02454270|First-in-Human|first-in-human
281130|NCT02454270|B-Cell Chronic Lymphocytic Leukemia|b-cell chronic lymphocytic leukemia
281131|NCT02454270|Diffuse Large-Cell Lymphoma|diffuse large-cell lymphoma
281132|NCT02454270|Follicular Lymphoma|follicular lymphoma
281133|NCT02454270|Mantle-Cell Lymphoma|mantle-cell lymphoma
281134|NCT02454270|Acute Lymphoid Leukemia|acute lymphoid leukemia
281135|NCT02454270|Dose Escalation Study|dose escalation study
281136|NCT02454270|Duvortuxizumab|duvortuxizumab
281137|NCT02454231|EPC|epc
281138|NCT02454231|CD34+|cd34+
281139|NCT02454231|CD14+CD34low|cd14+cd34low
281140|NCT02454218|Fibromyalgia|fibromyalgia
281141|NCT02454218|Transcranial direct current stimulation|transcranial direct current stimulation
281645|NCT02450968|lung|lung
281142|NCT02454192|Evidence-based intervention|evidence-based intervention
281143|NCT02454192|Implementation|implementation
281144|NCT02454192|Underserved communities|underserved communities
281145|NCT02454127|nutrition|nutrition
281146|NCT02454127|popular diets|popular diets
281147|NCT02454127|weight loss|weight loss
281148|NCT02454127|lifestyle|lifestyle
281149|NCT02454127|counseling|counseling
281150|NCT02454114|Pneumonia|pneumonia
281151|NCT02454114|Community|community
281152|NCT02454114|Hospital|hospital
281153|NCT02454114|Respiratory|respiratory
281154|NCT02454114|Infection|infection
281155|NCT02454088|Volume|volume
281156|NCT02454088|Hands|hands
281157|NCT02454088|Filler|filler
281158|NCT02454088|Radiesse|radiesse
281159|NCT02454088|Calcium hydroxylapatite|calcium hydroxylapatite
281160|NCT02454075|YF476|yf476
281161|NCT02454075|netazepide|netazepide
281162|NCT02454075|gastric carcinoids|gastric carcinoids
281163|NCT02454075|Zollinger-Ellison syndrome|zollinger-ellison syndrome
281164|NCT02454062|Phase I|phase i
281165|NCT02454062|Solid Tumors|solid tumors
281166|NCT02454062|Pharmacokinetics|pharmacokinetics
281167|NCT02454062|Pharmacodynamics|pharmacodynamics
281168|NCT02454062|MTD|mtd
281169|NCT02454023|Stroke|stroke
281170|NCT02454023|Transient ischemic attack|transient ischemic attack
281171|NCT02454023|Obstructive sleep apnea|obstructive sleep apnea
281172|NCT02454023|Portable sleep monitor|portable sleep monitor
281173|NCT02454023|Screening|screening
281174|NCT02453997|lupus nephritis|lupus nephritis
281175|NCT02453997|mycophenolic acid|mycophenolic acid
281176|NCT02453997|pharmacokinetics|pharmacokinetics
281177|NCT02453997|pharmacogenomics|pharmacogenomics
281178|NCT02453984|89Zr-MPLD3280A-PET|89zr-mpld3280a-pet
359285|NCT02054650|OMT|omt
281179|NCT02453971|alcohol consumption|alcohol consumption
281180|NCT02453971|binge drinking|binge drinking
281181|NCT02453971|web-based personalized feedback program|web-based personalized feedback program
281182|NCT02453971|students|students
281183|NCT02453958|Injury|injury
281184|NCT02453958|Brain|brain
281185|NCT02453958|Traumatic Mild|traumatic mild
281186|NCT02453958|Mild Traumatic Brain Injury|mild traumatic brain injury
281187|NCT02453945|pain|pain
281188|NCT02453945|comfort|comfort
281189|NCT02453945|healing|healing
281190|NCT02453945|quality of life|quality of life
281191|NCT02453932|Vascular dementia|vascular dementia
281192|NCT02453932|Tianzhi granule|tianzhi granule
281193|NCT02453932|Herbal medicine|herbal medicine
281194|NCT02453932|Randomized controlled trial|randomized controlled trial
281195|NCT02453932|Three arms|three arms
281196|NCT02453919|functional cardiac abnormality|functional cardiac abnormality
281197|NCT02453919|morphologic cardiac abnormality|morphologic cardiac abnormality
281198|NCT02453919|blood pressure abnormality|blood pressure abnormality
281199|NCT02453893|Iloperidone|iloperidone
281200|NCT02453893|Risperidone|risperidone
281201|NCT02453893|PANSS|panss
281202|NCT02453880|anxiety|anxiety
281203|NCT02453880|depression|depression
281204|NCT02453880|chronic illness|chronic illness
281205|NCT02453880|teen|teen
281206|NCT02453880|young adult|young adult
281207|NCT02453867|kidney transplantation|kidney transplantation
281208|NCT02453867|senior kidney transplant recipients|senior kidney transplant recipients
281209|NCT02453867|tacrolimus once daily|tacrolimus once daily
281210|NCT02453867|reduced immunosuppression|reduced immunosuppression
281211|NCT02453867|recipients >65 years|recipients >65 years
281212|NCT02453867|Senior|senior
281213|NCT02453802|Tranexamic Acid|tranexamic acid
281214|NCT02453802|Total Knee Arthroplasty|total knee arthroplasty
281215|NCT02453802|Rivaroxaban|rivaroxaban
281216|NCT02453789|alginate oligosaccharide|alginate oligosaccharide
281217|NCT02453789|cystic fibrosis|cystic fibrosis
281218|NCT02453789|Burkholderia|burkholderia
281219|NCT02453789|aztreonam|aztreonam
281220|NCT02453776|Crohns Disease|crohns disease
281221|NCT02453776|Ulcerative Colitis|ulcerative colitis
281222|NCT02453776|Infliximab|infliximab
281223|NCT02453776|Sustained|sustained
281224|NCT02453776|Remission|remission
281225|NCT02453776|Inflammatory bowel disease|inflammatory bowel disease
281226|NCT02453776|IBD|ibd
281227|NCT02453763|Transcranial direct current stimulation|transcranial direct current stimulation
281228|NCT02453763|Noninvasive brain stimulation|noninvasive brain stimulation
281229|NCT02453763|Brain|brain
281230|NCT02453763|Central Nervous System Diseases|central nervous system diseases
281231|NCT02453763|Nervous System Diseases|nervous system diseases
281232|NCT02453763|Parkinson disease|parkinson disease
281233|NCT02453763|Stroke|stroke
281234|NCT02453763|Epilepsy|epilepsy
281235|NCT02453763|Depression|depression
281236|NCT02453763|Schizophrenia|schizophrenia
281237|NCT02453763|Brain imaging|brain imaging
281238|NCT02453763|Electrical impedance tomography|electrical impedance tomography
281239|NCT02453763|Magnetic resonance electrical impedance tomography|magnetic resonance electrical impedance tomography
281240|NCT02453763|Diffusion tensor imaging|diffusion tensor imaging
281241|NCT02453763|Functional magnetic imaging|functional magnetic imaging
281242|NCT02453763|Rehabilitation|rehabilitation
281243|NCT02453750|Congenital Diaphragmatic Hernia|congenital diaphragmatic hernia
281244|NCT02453750|Airway Inflammation|airway inflammation
281245|NCT02453750|Asthma|asthma
281246|NCT02453750|Hypersaline|hypersaline
281247|NCT02453750|Pediatrics|pediatrics
281248|NCT02453737|Proton|proton
281249|NCT02453737|Brachytherapy|brachytherapy
281250|NCT02453737|Partial Breast Irradiation|partial breast irradiation
281251|NCT02453737|3D Conformal Photon|3d conformal photon
281252|NCT02453724|Ultrasonography|ultrasonography
281253|NCT02453724|Lung|lung
281254|NCT02453724|Hemorrhage|hemorrhage
281255|NCT02453724|Point of care ultrasound|point of care ultrasound
281256|NCT02453698|Stop task|stop task
281257|NCT02453698|modulatory effect of MPH|modulatory effect of mph
281258|NCT02453698|bottom-up and top-down|bottom-up and top-down
281259|NCT02453698|cognitive processes|cognitive processes
281260|NCT02453633|Appointment reminder|appointment reminder
281261|NCT02453633|Attendance|attendance
281262|NCT02453633|No-show|no-show
281263|NCT02453594|PD1|pd1
281264|NCT02453594|PD-1|pd-1
281265|NCT02453594|PDL1|pdl1
281266|NCT02453594|PD-L1|pd-l1
281267|NCT02453542|hemophilia|hemophilia
281268|NCT02453542|inhibitors|inhibitors
281269|NCT02453542|thrombin|thrombin
281270|NCT02453529|plasma concentration|plasma concentration
281271|NCT02453529|pulmonary concentration|pulmonary concentration
281272|NCT02453516|Serratus Block|serratus block
281273|NCT02453516|Breast Surgery|breast surgery
281274|NCT02453503|Lichen planus|lichen planus
281275|NCT02453503|Mucoadhesive film|mucoadhesive film
281276|NCT02453503|licorice|licorice
281277|NCT02453490|Colorectal Cancer|colorectal cancer
281278|NCT02453490|liver metastasis|liver metastasis
281279|NCT02453490|neoadjuvant chemotherapy|neoadjuvant chemotherapy
281280|NCT02453477|Beta thalassemia|beta thalassemia
281281|NCT02453477|Gene therapy|gene therapy
281282|NCT02453477|Lentiviral vector|lentiviral vector
281283|NCT02453451|MitraClip|mitraclip
281284|NCT02453451|atrial septal defect|atrial septal defect
281285|NCT02453451|iatrogenic|iatrogenic
281286|NCT02453425|renal blood flow|renal blood flow
281287|NCT02453425|renal oxygenation|renal oxygenation
281288|NCT02453425|glomerular filtration rate|glomerular filtration rate
281289|NCT02453425|filtration fraction|filtration fraction
281290|NCT02453425|blood pressure|blood pressure
281291|NCT02453412|Arteriovenous fistulae (AVFs)|arteriovenous fistulae (avfs)
281292|NCT02453412|Non-maturation|non-maturation
281293|NCT02453412|Computational simulation|computational simulation
281294|NCT02453386|Motor fluctuations|motor fluctuations
281295|NCT02453386|Off time|off time
281296|NCT02453386|On time|on time
281297|NCT02453386|Dyskinesia|dyskinesia
281298|NCT02453360|Anesthesia|anesthesia
281299|NCT02453360|Analgesia|analgesia
281300|NCT02453347|Stable chronic medical conditions|stable chronic medical conditions
281301|NCT02453347|No current alcohol or substance abuse|no current alcohol or substance abuse
281302|NCT02453347|Alpha Stim|alpha stim
281303|NCT02453321|Continuous Femoral Nerve Block|continuous femoral nerve block
281304|NCT02453321|Continuous Adductor Canal Block|continuous adductor canal block
281305|NCT02453308|Artemisinin combination Therapies|artemisinin combination therapies
281306|NCT02453295|Lymphedema|lymphedema
281307|NCT02453295|Arm Disability|arm disability
281308|NCT02453295|Cancer Survivorship|cancer survivorship
281309|NCT02453295|Intervention|intervention
281310|NCT02453282|NSCLC, PD-L1, MEDI4736, Tremelimumab, PFS, OS|nsclc, pd-l1, medi4736, tremelimumab, pfs, os
281311|NCT02453269|Obesity|obesity
281312|NCT02453269|Children|children
281313|NCT02453269|Health Colective|health colective
281314|NCT02453243|Suicide screening in the ED|suicide screening in the ed
281315|NCT02453243|Safety Planning|safety planning
281316|NCT02453217|severe mental illness|severe mental illness
281317|NCT02453217|physical health screening|physical health screening
281318|NCT02453217|randomised controlled trial|randomised controlled trial
281319|NCT02453217|health behaviour change|health behaviour change
281320|NCT02453178|physical activity|physical activity
281321|NCT02453178|aging|aging
281322|NCT02453178|cognition|cognition
281323|NCT02453178|brain|brain
281324|NCT02453178|exercise|exercise
281325|NCT02453165|vaginal dehiscence|vaginal dehiscence
281326|NCT02453152|myotubular myopathy|myotubular myopathy
281327|NCT02453152|respiratory muscles|respiratory muscles
281328|NCT02453152|natural history|natural history
281329|NCT02453126|Eosinophilic Esophagitis|eosinophilic esophagitis
281330|NCT02453126|Esophageal Stricture|esophageal stricture
281331|NCT02453048|Pertussis|pertussis
281332|NCT02453048|Colonization|colonization
281333|NCT02453048|Vaccine|vaccine
281334|NCT02453048|Immune response|immune response
281335|NCT02453048|BPZE1|bpze1
281336|NCT02453048|Infection|infection
281337|NCT02453048|Bordetella pertussis|bordetella pertussis
281338|NCT02453048|B. pertussis|b. pertussis
281339|NCT02453048|respiratory Tract Infection|respiratory tract infection
281340|NCT02453035|bioresorbable scaffold|bioresorbable scaffold
281341|NCT02453035|CAD|cad
281342|NCT02453022|Bioavailability|bioavailability
281343|NCT02453022|Omeprazole|omeprazole
281344|NCT02453022|Danirixin|danirixin
281345|NCT02453022|Food Effect|food effect
281346|NCT02453022|Pharmacokinetics|pharmacokinetics
281347|NCT02452996|GNbAC1|gnbac1
281348|NCT02452996|Multiple Sclerosis|multiple sclerosis
281349|NCT02452996|Multiple Sclerosis Associated Retrovirus (MSRV)|multiple sclerosis associated retrovirus (msrv)
281350|NCT02452996|MSRV-Envelope protein|msrv-envelope protein
281351|NCT02452996|Monoclonal antibody|monoclonal antibody
281352|NCT02452983|Anemia|anemia
281353|NCT02452983|Leukemia|leukemia
281354|NCT02452983|Hematologic diseases|hematologic diseases
281355|NCT02452983|Cytopenias|cytopenias
281356|NCT02452983|Bone marrow diseases|bone marrow diseases
281357|NCT02452983|Preleukemia|preleukemia
281358|NCT02452944|nerve stimulator, obturator nerve, ultrasound|nerve stimulator, obturator nerve, ultrasound
281359|NCT02452918|skin infection|skin infection
281360|NCT02452892|Depression|depression
281361|NCT02452892|Major depression|major depression
281362|NCT02452892|Low-field magnetic stimulation|low-field magnetic stimulation
281363|NCT02452892|LFMS|lfms
281364|NCT02452840|neovascular age-related macular degeneration|neovascular age-related macular degeneration
281365|NCT02452840|anti-vascular endothelial growth factor|anti-vascular endothelial growth factor
281366|NCT02452840|verteporfin|verteporfin
281367|NCT02452840|photodynamic therapy|photodynamic therapy
281368|NCT02452840|persistent disease activity|persistent disease activity
281369|NCT02452710|Fatigue in Cancer Survivors|fatigue in cancer survivors
281370|NCT02452697|Nonmyeloablative|nonmyeloablative
281371|NCT02452697|Stem Cell|stem cell
281372|NCT02452697|Transplant|transplant
281373|NCT02452684|Insomnia|insomnia
281374|NCT02452658|Fast food literacy|fast food literacy
281375|NCT02452645|Food|food
281376|NCT02452645|Nutrition|nutrition
281377|NCT02452645|Physical Activity|physical activity
281378|NCT02452645|Family|family
281379|NCT02452645|Child Care|child care
281380|NCT02452645|Home|home
281381|NCT02452645|Environment|environment
281382|NCT02452632|ASP1941|asp1941
281383|NCT02452632|Type 2 diabetes mellitus|type 2 diabetes mellitus
281384|NCT02452619|Hyperbaric oxygen therapy|hyperbaric oxygen therapy
281385|NCT02452619|brain trauma|brain trauma
281386|NCT02452619|cognitive impairment|cognitive impairment
281387|NCT02452606|Stalevo|stalevo
281388|NCT02452606|sleep disturbance|sleep disturbance
281389|NCT02452606|central circadian clock|central circadian clock
281390|NCT02452606|narcolepsy|narcolepsy
281391|NCT02452593|incontinence; pelvic floor exercises; neuromodulation|incontinence; pelvic floor exercises; neuromodulation
281392|NCT02452580|Kangaroo Mother Care|kangaroo mother care
281393|NCT02452580|Neonatal Intensive Care Units|neonatal intensive care units
281394|NCT02452580|Postnatal growth|postnatal growth
281395|NCT02452541|Traumatic Brain Injury|traumatic brain injury
281396|NCT02452541|Critically ill Patients|critically ill patients
281397|NCT02452541|Death|death
281398|NCT02452541|Head Injury|head injury
281399|NCT02452541|TBI-Prognosis|tbi-prognosis
281400|NCT02452541|Critical Care Medicine|critical care medicine
281401|NCT02452541|Withdrawal of Life Sustaining Therapy|withdrawal of life sustaining therapy
281402|NCT02452541|Prognosis|prognosis
281403|NCT02452541|Prognostic Evaluation|prognostic evaluation
281404|NCT02452541|Outcome Research|outcome research
281405|NCT02452541|Mortality|mortality
281406|NCT02452541|Decision-making|decision-making
281407|NCT02452528|Hepatitis B Virus|hepatitis b virus
281408|NCT02452528|Chronic Hepatitis B|chronic hepatitis b
281409|NCT02452528|HBV|hbv
281410|NCT02452502|stroke|stroke
281411|NCT02452502|thrombolytic therapy|thrombolytic therapy
281412|NCT02452502|atorvastatin|atorvastatin
281413|NCT02452489|Different acupoints compatibility|different acupoints compatibility
281414|NCT02452437|oxycodone|oxycodone
281415|NCT02452437|hemodialysis|hemodialysis
281416|NCT02452411|Internet|internet
281417|NCT02452411|Adjustment disorders|adjustment disorders
281418|NCT02452411|Homework assignments|homework assignments
281419|NCT02452411|Cognitive-Behavioral treatment|cognitive-behavioral treatment
281420|NCT02452411|Online therapy|online therapy
281421|NCT02452411|Emotional Regulation|emotional regulation
281422|NCT02452411|ICT's|ict's
281423|NCT02452398|Hair removal|hair removal
281424|NCT02452398|depilation|depilation
281425|NCT02452398|epilation|epilation
281426|NCT02452372|RNAi therapeutic|rnai therapeutic
281427|NCT02452372|Porphyria|porphyria
281428|NCT02452372|AIP|aip
281429|NCT02452359|stretch marks|stretch marks
281430|NCT02452346|MDS|mds
281431|NCT02452333|Excisional breast biopsy|excisional breast biopsy
281432|NCT02452333|Oncoplastic surgery|oncoplastic surgery
281433|NCT02452333|Oncoplastic reconstruction|oncoplastic reconstruction
281434|NCT02452333|Breast conserving surgery|breast conserving surgery
281435|NCT02452333|Tezel method of breast volume measurement|tezel method of breast volume measurement
281436|NCT02452320|bariatric|bariatric
281437|NCT02452320|Post-operative nausea and vomiting|post-operative nausea and vomiting
281438|NCT02452320|laparoscopic Sleeve gastrectomy|laparoscopic sleeve gastrectomy
281439|NCT02452320|intravenous acetaminophen|intravenous acetaminophen
281440|NCT02452294|Brain|brain
281441|NCT02452281|Therapeutically Unresectable|therapeutically unresectable
281442|NCT02452281|Stage III or Stage IV|stage iii or stage iv
281443|NCT02452281|Malignant Melanoma|malignant melanoma
281444|NCT02452281|Advanced Melanoma|advanced melanoma
281445|NCT02452203|floating|floating
281446|NCT02452203|interoception|interoception
281447|NCT02452177|parenteral nutrition associated liver disease|parenteral nutrition associated liver disease
281448|NCT02452177|vitamin D|vitamin d
281449|NCT02452177|short bowel syndrome|short bowel syndrome
281450|NCT02452177|farnesoid X receptor|farnesoid x receptor
281451|NCT02452177|cholestasis|cholestasis
281452|NCT02452164|otoscopy|otoscopy
281453|NCT02452164|otitis media|otitis media
281454|NCT02452164|cellphone|cellphone
281455|NCT02452164|family|family
281456|NCT02452151|Inflectra|inflectra
281457|NCT02452151|Infliximab|infliximab
281458|NCT02452151|Biosimilar|biosimilar
281459|NCT02452099|DMSO|dmso
281460|NCT02452099|cryopreservation|cryopreservation
281461|NCT02452099|autologous transplantation|autologous transplantation
281462|NCT02452099|hematopoietic stem cells|hematopoietic stem cells
281463|NCT02452099|hematological malignancies|hematological malignancies
281464|NCT02452073|low triiodothyronine syndrome|low triiodothyronine syndrome
281465|NCT02452073|chronic radiation enteritis|chronic radiation enteritis
281466|NCT02452073|triiodothyronine|triiodothyronine
281467|NCT02452073|thyroxine|thyroxine
281468|NCT02452073|thyroid stimulating hormone|thyroid stimulating hormone
281469|NCT02452060|perioperative period|perioperative period
281470|NCT02452060|pain|pain
281471|NCT02452060|gastric bypass|gastric bypass
281472|NCT02452008|metastatic castration-resistant prostate cancer|metastatic castration-resistant prostate cancer
281473|NCT02452008|enzalutamide|enzalutamide
281474|NCT02452008|LY2157299|ly2157299
281475|NCT02452008|TGF-β receptor inhibitor|tgf-β receptor inhibitor
281476|NCT02451943|leiomyosarcoma|leiomyosarcoma
281477|NCT02451943|soft tissue sarcoma (STS)|soft tissue sarcoma (sts)
281478|NCT02451943|advanced soft tissue sarcoma|advanced soft tissue sarcoma
281479|NCT02451943|metastatic soft tissue sarcoma|metastatic soft tissue sarcoma
281480|NCT02451943|liposarcoma|liposarcoma
281481|NCT02451943|undifferentiated pleomorphic sarcoma|undifferentiated pleomorphic sarcoma
281482|NCT02451943|doxorubicin|doxorubicin
281483|NCT02451917|Glargine insulin|glargine insulin
281484|NCT02451917|Chronic Kidney Disease|chronic kidney disease
281485|NCT02451917|CGMS|cgms
281486|NCT02451904|Pathogenesis|pathogenesis
281487|NCT02451904|Microvascular function|microvascular function
281488|NCT02451904|Metabolic dysregulation|metabolic dysregulation
281489|NCT02451904|Metabolomics|metabolomics
281490|NCT02451878|shyness|shyness
281491|NCT02451878|internet|internet
281492|NCT02451878|self-help|self-help
281493|NCT02451878|psychology|psychology
281494|NCT02451878|wellbeing|wellbeing
281495|NCT02451839|Crohn Disease|crohn disease
281496|NCT02451839|Arthritis, Rheumatoid|arthritis, rheumatoid
281497|NCT02451839|Psoriasis|psoriasis
281498|NCT02451839|Patient Outcome Assessment|patient outcome assessment
281499|NCT02451839|Adalimumab|adalimumab
281500|NCT02451839|Global Health|global health
281501|NCT02451839|Quality of Life|quality of life
281502|NCT02451826|ovulation inhibition|ovulation inhibition
281503|NCT02451826|endometrial changes|endometrial changes
281504|NCT02451826|bleeding patterns|bleeding patterns
281505|NCT02451813|opening injection pressure|opening injection pressure
281506|NCT02451813|femoral nerve block|femoral nerve block
281507|NCT02451813|fascia iliaca|fascia iliaca
281508|NCT02451813|ultrasound guided nerve block|ultrasound guided nerve block
281509|NCT02451774|pediatric|pediatric
281510|NCT02451774|apoptosis|apoptosis
281511|NCT02451761|chromosomal rearrangement|chromosomal rearrangement
281512|NCT02451761|next generation sequencing|next generation sequencing
281513|NCT02451761|intellectual disability|intellectual disability
281514|NCT02451761|multiple congenital anomalies|multiple congenital anomalies
281515|NCT02451761|gene disruption|gene disruption
281516|NCT02451735|female breast cancer|female breast cancer
281517|NCT02451735|bilateral breast cancer|bilateral breast cancer
281518|NCT02451735|triple negative breast cancer|triple negative breast cancer
281519|NCT02451735|breast cancer diagnosis|breast cancer diagnosis
281520|NCT02451735|BRCA 1|brca 1
281521|NCT02451735|BRCA 2|brca 2
281522|NCT02451735|psychoeducational intervention (PEI)|psychoeducational intervention (pei)
281523|NCT02451735|genetic counseling|genetic counseling
281524|NCT02451735|hereditary breast and ovarian cancer (HBOC)|hereditary breast and ovarian cancer (hboc)
281525|NCT02451735|cancer education materials|cancer education materials
281526|NCT02451683|SCI|sci
281527|NCT02451631|Mobile Application|mobile application
281528|NCT02451631|Diabetes management|diabetes management
281529|NCT02451618|Perinatal Depression|perinatal depression
281530|NCT02451605|surgery|surgery
281531|NCT02451592|Fungemia|fungemia
281532|NCT02451592|Hematologic malignancies|hematologic malignancies
281533|NCT02451579|Actinic Keratoses|actinic keratoses
281534|NCT02451579|Photodynamic Therapy|photodynamic therapy
281535|NCT02451579|PDT|pdt
281536|NCT02451579|Blue Light|blue light
281537|NCT02451566|Abdominal|abdominal
281538|NCT02451566|Aortic|aortic
281539|NCT02451566|Aneurysm|aneurysm
281646|NCT02450968|treatment|treatment
281540|NCT02451540|Pulmonary Disease, Chronic Obstructive|pulmonary disease, chronic obstructive
281541|NCT02451540|dynamics hyperinflation|dynamics hyperinflation
281542|NCT02451540|Computed Tomography scan|computed tomography scan
281543|NCT02451540|CT scan|ct scan
281544|NCT02451540|Functional Respiratory Imaging|functional respiratory imaging
281545|NCT02451540|FRI|fri
281546|NCT02451540|Roflumilast|roflumilast
281547|NCT02451540|PRO|pro
281548|NCT02451514|Antibody persistence|antibody persistence
281549|NCT02451514|Young Adults|young adults
281550|NCT02451514|Healthy Adolescents|healthy adolescents
281551|NCT02451514|MenABCWY vaccine|menabcwy vaccine
281552|NCT02451514|Booster response|booster response
281553|NCT02451514|MenABCWY+OMV|menabcwy+omv
281554|NCT02451475|Pregabalin|pregabalin
281555|NCT02451475|Fibromyalgia|fibromyalgia
281556|NCT02451462|hematopoietic stem cell transplant|hematopoietic stem cell transplant
281557|NCT02451462|bone marrow transplant|bone marrow transplant
281558|NCT02451449|Celiac disease|celiac disease
281559|NCT02451449|Infertility|infertility
281560|NCT02451449|Prevalence study|prevalence study
281561|NCT02451436|Adolescents, sleep, media use, obesity, type 2 diabetes|adolescents, sleep, media use, obesity, type 2 diabetes
281562|NCT02451423|Non-metastatic|non-metastatic
281563|NCT02451423|Bladder|bladder
281564|NCT02451410|Nutrition|nutrition
281565|NCT02451410|Physical activity|physical activity
281566|NCT02451410|Overweight|overweight
281567|NCT02451410|Obesity|obesity
281568|NCT02451410|Malnutrition|malnutrition
281569|NCT02451371|Schizophrenia|schizophrenia
281570|NCT02451371|Refractory auditory hallucination|refractory auditory hallucination
281571|NCT02451371|tDCS|tdcs
281572|NCT02451358|Influenza|influenza
281573|NCT02451358|Quadrivalent Inactivated Influenza Vaccine (QIV)|quadrivalent inactivated influenza vaccine (qiv)
281574|NCT02451345|Prostate cancer|prostate cancer
281575|NCT02451345|Tranformative Impact Award|tranformative impact award
281576|NCT02451345|Early stage|early stage
281577|NCT02451345|Active Surveillance|active surveillance
281578|NCT02451345|Decision aid|decision aid
281579|NCT02451345|Coaching session|coaching session
281580|NCT02451345|Personalized|personalized
281581|NCT02451345|UCSF|ucsf
281582|NCT02451345|validation|validation
281583|NCT02451319|RIRS, holmium, 1-2 cm,stones,kidney|rirs, holmium, 1-2 cm,stones,kidney
281584|NCT02451293|Depression|depression
281585|NCT02451293|Acute Coronary Syndrome|acute coronary syndrome
281586|NCT02451293|Anxiety|anxiety
281587|NCT02451293|Sleep|sleep
281588|NCT02451293|Circadian|circadian
281589|NCT02451280|stroke rehabilitation|stroke rehabilitation
281590|NCT02451280|robot-assisted therapy|robot-assisted therapy
281591|NCT02451280|hybrid therapy|hybrid therapy
281592|NCT02451267|neck pain|neck pain
281593|NCT02451267|aerobic exercise|aerobic exercise
281594|NCT02451267|cervical pain|cervical pain
281595|NCT02451241|Acupuncture|acupuncture
281596|NCT02451228|Pharmacokinetics|pharmacokinetics
281597|NCT02451228|Pharmacodynamics|pharmacodynamics
281598|NCT02451228|Preterm labor|preterm labor
281599|NCT02451228|Preterm birth|preterm birth
281600|NCT02451228|Estradiol|estradiol
281601|NCT02451228|Indomethacin|indomethacin
281602|NCT02451228|Pregnancy|pregnancy
281603|NCT02451228|Short Cervix|short cervix
281604|NCT02451228|CYP2C9 Genotype|cyp2c9 genotype
281605|NCT02451202|"surgical conditions"|"surgical conditions"
281606|NCT02451202|"deep neuromuscular blockade"|"deep neuromuscular blockade"
281607|NCT02451202|"deep neuromuscular paralysis"|"deep neuromuscular paralysis"
281608|NCT02451189|Obesity|obesity
281609|NCT02451189|Weight maintenance|weight maintenance
281610|NCT02451189|Appetite|appetite
281611|NCT02451189|Energy intake|energy intake
281612|NCT02451189|Dietary fibre|dietary fibre
281613|NCT02451189|Short-chain fatty acids|short-chain fatty acids
281614|NCT02451189|Fermentation|fermentation
281615|NCT02451189|Overweight|overweight
281616|NCT02451150|Drug therapy|drug therapy
281617|NCT02451124|Barrett|barrett
281618|NCT02451124|Cancer|cancer
281619|NCT02451124|Screening|screening
281620|NCT02451111|Rituximab|rituximab
281621|NCT02451111|Ibrutinib|ibrutinib
281622|NCT02451111|Follicular Lymphoma|follicular lymphoma
281624|NCT02451085|surgery|surgery
281625|NCT02451085|Replacement|replacement
281626|NCT02451059|community resource|community resource
281627|NCT02451059|well-child care visit|well-child care visit
281628|NCT02451059|low-income|low-income
281629|NCT02451046|Liver transplantation|liver transplantation
281630|NCT02451046|Primary dysfunction|primary dysfunction
281631|NCT02451033|Regenerative medicine|regenerative medicine
281632|NCT02451020|healthy volunteers|healthy volunteers
281633|NCT02451020|acclimatization|acclimatization
281634|NCT02451020|sleep|sleep
281635|NCT02451020|hypoxia|hypoxia
281636|NCT02450994|airway disease|airway disease
281637|NCT02450994|bronchitis|bronchitis
281638|NCT02450994|emphysema|emphysema
281639|NCT02450994|lung|lung
281640|NCT02450994|treatment|treatment
281641|NCT02450994|sleep|sleep
281642|NCT02450968|airway disease|airway disease
281643|NCT02450968|bronchitis|bronchitis
281644|NCT02450968|emphysema|emphysema
281647|NCT02450955|Tension-type headache|tension-type headache
281648|NCT02450955|manual therapy|manual therapy
281649|NCT02450955|disability|disability
281650|NCT02450955|spinal manipulation|spinal manipulation
281651|NCT02450929|post operative|post operative
281652|NCT02450929|pneumonia|pneumonia
281653|NCT02450929|vascular|vascular
281654|NCT02450929|orthopedic|orthopedic
281655|NCT02450929|urologic|urologic
281656|NCT02450929|neurologic|neurologic
281657|NCT02450916|work-related injury|work-related injury
281658|NCT02450916|occupational disease|occupational disease
281659|NCT02450916|workers' compensation|workers' compensation
281660|NCT02450916|psychological|psychological
281661|NCT02450916|policy|policy
281662|NCT02450903|Non-Small-Cell Lung Cancer, ALK, LDK378|non-small-cell lung cancer, alk, ldk378
281663|NCT02450890|ORADUR®-Methylphenidate|oradur®-methylphenidate
281664|NCT02450877|Children|children
281665|NCT02450877|Young Adults|young adults
281666|NCT02450877|Azacitidine|azacitidine
281667|NCT02450877|Acute Myeloid Leukemia|acute myeloid leukemia
281668|NCT02450877|Molecular Relapse|molecular relapse
281669|NCT02450877|Vidaza|vidaza
281670|NCT02450877|AZA-AML-004|aza-aml-004
281671|NCT02450864|Stiffness of Shoulder, Not Elsewhere Classified|stiffness of shoulder, not elsewhere classified
281672|NCT02450851|Rare Diseases|rare diseases
281673|NCT02450851|Undiagnosed Disease|undiagnosed disease
281674|NCT02450838|Dengue Vaccine|dengue vaccine
281675|NCT02450812|mCRPC|mcrpc
281676|NCT02450773|postpartum|postpartum
281677|NCT02450773|preeclampsia|preeclampsia
281678|NCT02450773|gestational hypertension|gestational hypertension
281679|NCT02450747|Visual Acuity|visual acuity
281680|NCT02450734|ultrasound-guided intermediate cervical plexus block|ultrasound-guided intermediate cervical plexus block
281681|NCT02450721|atherosclerosis|atherosclerosis
281682|NCT02450721|biomarkers|biomarkers
281683|NCT02450721|carotid artery stenosis|carotid artery stenosis
281684|NCT02450721|ischemic stroke.|ischemic stroke.
281685|NCT02450708|Allogeneic Hematopoietic Cell Donors|allogeneic hematopoietic cell donors
281686|NCT02450708|KIR and HLA Genotypes|kir and hla genotypes
281687|NCT02450708|15-059|15-059
281688|NCT02450695|rTMS|rtms
281689|NCT02450695|treatment refractory|treatment refractory
281690|NCT02450695|treatment resistant|treatment resistant
281691|NCT02450695|SSRI|ssri
281692|NCT02450695|clomipramine|clomipramine
281693|NCT02450669|Intubation|intubation
281694|NCT02450669|Extubation|extubation
281695|NCT02450669|Weaning|weaning
281696|NCT02450669|Mechanical ventilation|mechanical ventilation
281697|NCT02450617|Complex PTSD|complex ptsd
281698|NCT02450604|Prevalence Study|prevalence study
281699|NCT02450604|Fabry's disease|fabry's disease
281700|NCT02450604|Chronic pain|chronic pain
281701|NCT02450591|Sensitizing EGFR Mutations|sensitizing egfr mutations
281702|NCT02450591|Erlotinib|erlotinib
281703|NCT02450591|Surgery|surgery
281704|NCT02450591|Radiation Therapy|radiation therapy
281705|NCT02450591|15-067|15-067
281706|NCT02450552|Amyotrophic Lateral Sclerosis|amyotrophic lateral sclerosis
281708|NCT02450552|Lou Gehrig|lou gehrig
281709|NCT02450539|patient reported outcomes (PRO)|patient reported outcomes (pro)
281710|NCT02450539|patient focused outcomes (PFO)|patient focused outcomes (pfo)
281711|NCT02450539|biomarkers|biomarkers
281712|NCT02450539|CDK 4 and 6|cdk 4 and 6
281713|NCT02450513|adalimumab|adalimumab
281714|NCT02450513|anti-TNF|anti-tnf
281715|NCT02450513|pharmacokinetics|pharmacokinetics
281716|NCT02450513|trough level|trough level
281717|NCT02450513|immunogenicity|immunogenicity
281718|NCT02450487|Piroxicam|piroxicam
281719|NCT02450487|Pharmacogenetic|pharmacogenetic
281720|NCT02450487|Lower Third molar|lower third molar
281721|NCT02450448|Renal Neoplasms|renal neoplasms
281722|NCT02450448|Circulating Tumor Cells|circulating tumor cells
281723|NCT02450435|Prostatic Neoplasms|prostatic neoplasms
281724|NCT02450435|Circulating TUmor Cells|circulating tumor cells
281725|NCT02450422|Colorectal Neoplasms|colorectal neoplasms
281726|NCT02450422|Circulating Tumor Cells|circulating tumor cells
281727|NCT02450409|Total knee arthroplasty|total knee arthroplasty
281728|NCT02450409|Midflexion instability|midflexion instability
281729|NCT02450409|Gap technique|gap technique
281730|NCT02450409|Anatomical alignment|anatomical alignment
281731|NCT02450396|Rare diseases|rare diseases
281732|NCT02450396|pregnancy|pregnancy
281733|NCT02450396|pregnancy,|pregnancy,
281734|NCT02450357|Breast Neoplasms|breast neoplasms
281735|NCT02450357|Circulating Tumor Cells|circulating tumor cells
281736|NCT02450279|Aerosol delivery|aerosol delivery
281737|NCT02450279|Invasive mechanical ventilation|invasive mechanical ventilation
281738|NCT02450279|Jet Nebulizer|jet nebulizer
281739|NCT02450279|Vibrating-Mesh nebulizer|vibrating-mesh nebulizer
281740|NCT02450266|Primary disease|primary disease
281741|NCT02450266|multiparametric MRI|multiparametric mri
281742|NCT02450266|targeted prostate biopsy|targeted prostate biopsy
281743|NCT02450266|MRI/ultrasound fusion-guided prostate biopsy|mri/ultrasound fusion-guided prostate biopsy
281744|NCT02450266|systematic transrectal ultrasound-guided prostate biopsy|systematic transrectal ultrasound-guided prostate biopsy
281745|NCT02450253|Vascular cognitive impairment|vascular cognitive impairment
281746|NCT02450240|Depression|depression
281748|NCT02450240|Eating Disorders|eating disorders
281749|NCT02450240|Substance Use|substance use
281750|NCT02450240|Functional Magnetic Resonance Imaging|functional magnetic resonance imaging
281751|NCT02450240|Genetics|genetics
281752|NCT02450240|Behavior|behavior
281753|NCT02450240|Mental Health|mental health
281754|NCT02450214|Ketamine|ketamine
281755|NCT02450214|Magnesium|magnesium
281756|NCT02450214|Analgesia|analgesia
281757|NCT02450214|Liposuction|liposuction
281758|NCT02450214|Lipoabdominoplasty|lipoabdominoplasty
281759|NCT02450214|Preemptive analgesia|preemptive analgesia
281760|NCT02450188|Erectile Dysfunction|erectile dysfunction
281761|NCT02450188|PDE5 inhibitors|pde5 inhibitors
281762|NCT02450188|Cognitive-behavioral Sex Therapy|cognitive-behavioral sex therapy
281763|NCT02450175|Platelet Activation|platelet activation
281764|NCT02450175|metastasis|metastasis
281765|NCT02450110|spinal cord stimulation|spinal cord stimulation
281766|NCT02450110|heart failure|heart failure
281767|NCT02450110|autonomic regulation|autonomic regulation
281768|NCT02450110|BNP|bnp
281769|NCT02450110|left ventricle systolic dysfunction|left ventricle systolic dysfunction
281770|NCT02450071|Pre-hospital|pre-hospital
281771|NCT02450071|Out-of-hospital|out-of-hospital
281772|NCT02450071|Prehospital emergency care (MeSH)|prehospital emergency care (mesh)
281773|NCT02450071|Emergency medical services (MeSH)|emergency medical services (mesh)
281774|NCT02450071|Helicopter emergency medical service|helicopter emergency medical service
281775|NCT02450071|Critical care (MeSH)|critical care (mesh)
281776|NCT02450071|Airway management (MeSH)|airway management (mesh)
281777|NCT02450071|Endotracheal intubation (MeSH)|endotracheal intubation (mesh)
281778|NCT02450071|Difficult endotracheal intubation|difficult endotracheal intubation
281779|NCT02450071|Complications (MeSH)|complications (mesh)
281780|NCT02450071|Patient safety|patient safety
281781|NCT02450058|early breast cancer|early breast cancer
281782|NCT02450058|adjuvant chemotherapy|adjuvant chemotherapy
281783|NCT02450058|FEC|fec
281784|NCT02450058|paclitaxel|paclitaxel
281785|NCT02449993|diagnostic study|diagnostic study
281786|NCT02449993|analysis of estrogen receptor|analysis of estrogen receptor
281787|NCT02449993|progesterone receptor|progesterone receptor
281788|NCT02449993|Human epidermal growth factor receptor 2|human epidermal growth factor receptor 2
281789|NCT02449993|Ki-67|ki-67
281790|NCT02449980|Spontaneous Pneumothorax|spontaneous pneumothorax
281791|NCT02449980|Video Assisted Thoracoscopic Surgery|video assisted thoracoscopic surgery
281792|NCT02449980|Tube Thoracostomy|tube thoracostomy
281793|NCT02449980|Pediatric Surgery|pediatric surgery
281794|NCT02449967|Pancreatic Cancer|pancreatic cancer
281795|NCT02449967|HepaSphere|hepasphere
281796|NCT02449954|Stress and Immune Responses|stress and immune responses
281797|NCT02449954|morphine|morphine
281798|NCT02449954|tramadol|tramadol
281799|NCT02449954|ketorolac|ketorolac
281800|NCT02449941|Stomach Neoplasms|stomach neoplasms
281801|NCT02449941|proton pump inhibitor|proton pump inhibitor
281802|NCT02449941|endoscopic submucosal dissection|endoscopic submucosal dissection
281803|NCT02449941|Helicobacter pylori|helicobacter pylori
281804|NCT02449941|Gastritis, Atrophic|gastritis, atrophic
281805|NCT02449928|Severe Sepsis with Septic Shock, Lactate|severe sepsis with septic shock, lactate
281806|NCT02449915|sacrocolpopexy|sacrocolpopexy
281807|NCT02449915|rectocele repair|rectocele repair
281808|NCT02449902|VVA|vva
281809|NCT02449902|Postmenopausal|postmenopausal
281810|NCT02449902|Painful Sex|painful sex
281811|NCT02449863|Lung ultrasound|lung ultrasound
281812|NCT02449863|Mechanical ventilation|mechanical ventilation
281813|NCT02449863|Respiratory distress syndrome|respiratory distress syndrome
281814|NCT02449863|Transient tachypnea of the newborn|transient tachypnea of the newborn
281815|NCT02449850|In-utero environment|in-utero environment
281816|NCT02449850|Asthma|asthma
281817|NCT02449850|Allergic diseases|allergic diseases
281818|NCT02449850|Food allergy|food allergy
281819|NCT02449850|Birth cohort study|birth cohort study
281820|NCT02449850|Primary prevention|primary prevention
281821|NCT02449850|Intervention study|intervention study
281822|NCT02449850|Atopic dermatitis|atopic dermatitis
281823|NCT02449850|Rhinitis|rhinitis
281824|NCT02449850|Allergy|allergy
281825|NCT02449850|Lung function|lung function
281826|NCT02449850|Non-communicable diseases|non-communicable diseases
281827|NCT02449850|Foetal growth|foetal growth
281828|NCT02449850|Obesity|obesity
281829|NCT02449850|Cardiovascular disease|cardiovascular disease
281830|NCT02449850|Diabetes|diabetes
281831|NCT02449850|Blood pressure|blood pressure
281832|NCT02449850|Anthropometric|anthropometric
281833|NCT02449850|Trans epidermic water loss|trans epidermic water loss
281834|NCT02449824|neoadjuvant chemotherapy|neoadjuvant chemotherapy
281835|NCT02449824|magnetic resonance imaging|magnetic resonance imaging
281836|NCT02449798|Difficult IV access|difficult iv access
281837|NCT02449798|AccuCath|accucath
281838|NCT02449798|IV outcomes|iv outcomes
281839|NCT02449798|patient satisfaction|patient satisfaction
281840|NCT02449785|Cystic fibrosis|cystic fibrosis
281841|NCT02449785|MRI|mri
281842|NCT02449785|UTE|ute
281843|NCT02449785|CT|ct
281844|NCT02449785|Exacerbation|exacerbation
281845|NCT02449785|Quality of life|quality of life
281846|NCT02449785|Pulmonary function|pulmonary function
281847|NCT02449772|N04.452.442.422.336|n04.452.442.422.336
281848|NCT02449746|Schizophrenia|schizophrenia
281849|NCT02449746|Psychosis|psychosis
281850|NCT02449746|Mental Health|mental health
281851|NCT02449746|Autoimmunity|autoimmunity
281852|NCT02449746|Psychoneuroimmunology|psychoneuroimmunology
281853|NCT02449733|voluntary counseling and testing (VCT)|voluntary counseling and testing (vct)
281854|NCT02449733|couples voluntary counseling and testing (CVCT)|couples voluntary counseling and testing (cvct)
281855|NCT02449733|pre-exposure prophylaxis (PrEP)|pre-exposure prophylaxis (prep)
281856|NCT02449733|homosexuality|homosexuality
281857|NCT02449733|male|male
281858|NCT02449733|South Africa|south africa
281859|NCT02449720|intraperitoneal|intraperitoneal
281860|NCT02449720|ropivacaine|ropivacaine
281861|NCT02449720|bowel resection|bowel resection
281862|NCT02449720|local anaesthetic|local anaesthetic
281863|NCT02449720|recovery|recovery
281864|NCT02449681|squamous cell carcinoma|squamous cell carcinoma
751109|NCT00436670|IL-4R|il-4r
281865|NCT02449681|the head and neck|the head and neck
281866|NCT02449681|skin|skin
281867|NCT02449681|TH-4000|th-4000
281868|NCT02449681|Hypoxia|hypoxia
281869|NCT02449681|Tarloxotinib|tarloxotinib
281870|NCT02449668|Acupuncture|acupuncture
281871|NCT02449668|Shoulder pain|shoulder pain
281872|NCT02449668|Impingement syndrome|impingement syndrome
281873|NCT02449668|Rotator cuff tendinitis|rotator cuff tendinitis
281874|NCT02449668|Traditional Chinese medicine (TCM)|traditional chinese medicine (tcm)
281875|NCT02449642|luteinizing hormone pulsatility|luteinizing hormone pulsatility
281876|NCT02449642|estradiol level|estradiol level
281877|NCT02449642|progesterone level|progesterone level
281879|NCT02449629|Transgender|transgender
281880|NCT02449629|HIV Continuum of Care|hiv continuum of care
281881|NCT02449616|Sickle cell|sickle cell
281882|NCT02449616|vaso-occlusive crisis|vaso-occlusive crisis
281883|NCT02449603|Chinese population|chinese population
281884|NCT02449590|Onion|onion
281885|NCT02449590|Cardiovascular disease|cardiovascular disease
281886|NCT02449590|metabolomics|metabolomics
281887|NCT02449590|Gene expression|gene expression
281888|NCT02449590|Biomarker|biomarker
281889|NCT02449577|Metabolomics|metabolomics
281890|NCT02449577|Beer|beer
281891|NCT02449577|Biomarker|biomarker
281892|NCT02449577|Glucose response|glucose response
281893|NCT02449577|Insulin response|insulin response
281894|NCT02449486|Requirement of postoperative pain medication|requirement of postoperative pain medication
281895|NCT02449473|Asthma|asthma
281896|NCT02449473|Reactive Airways|reactive airways
281897|NCT02449473|Respiratory Tract Disease|respiratory tract disease
281898|NCT02449473|Obstructive Tract Disease|obstructive tract disease
281899|NCT02449473|Lung Diseases|lung diseases
281900|NCT02449460|hypertension|hypertension
281901|NCT02449460|epidemiology|epidemiology
281902|NCT02449460|glucose|glucose
281903|NCT02449460|body mass index|body mass index
281904|NCT02449460|lipids|lipids
281905|NCT02449460|smoking|smoking
281906|NCT02449460|coronary artery disease|coronary artery disease
281907|NCT02449460|arterial stiffness|arterial stiffness
281908|NCT02449460|carotid ultrasound|carotid ultrasound
281909|NCT02449447|Major Depressive Disorder (MDD)|major depressive disorder (mdd)
281910|NCT02449447|Blended treatment|blended treatment
281911|NCT02449447|Cognitive behavior Therapy (CBT)|cognitive behavior therapy (cbt)
281912|NCT02449447|Face-to-face|face-to-face
281913|NCT02449447|internet-based treatment|internet-based treatment
281914|NCT02449421|trauma|trauma
281915|NCT02449382|continuous venovenous hemofiltration|continuous venovenous hemofiltration
281916|NCT02449382|conventional treatment|conventional treatment
281917|NCT02449382|mortality|mortality
281918|NCT02449382|acute severe hypernatremia|acute severe hypernatremia
281919|NCT02449356|Prone position ventilation|prone position ventilation
281920|NCT02449356|Endotracheal intubation|endotracheal intubation
281921|NCT02449356|Displacement|displacement
281922|NCT02449317|contrast induced acute kidney injury|contrast induced acute kidney injury
281923|NCT02449317|bioimpedance|bioimpedance
281924|NCT02449304|endometrial ablation, heavy menstrual bleeding, novosure|endometrial ablation, heavy menstrual bleeding, novosure
281925|NCT02449278|advanced-stage DLBCL|advanced-stage dlbcl
281926|NCT02449278|ISRT|isrt
281927|NCT02449278|chemotherapy|chemotherapy
281928|NCT02449265|limited-stage DLBCL|limited-stage dlbcl
281929|NCT02449265|consolidation involved-site radiotherapy|consolidation involved-site radiotherapy
281930|NCT02449265|Chemotherapy|chemotherapy
281931|NCT02449252|limited stage FL|limited stage fl
281932|NCT02449252|Involved-site Radiotherapy|involved-site radiotherapy
281933|NCT02449252|Chemotherapy|chemotherapy
281934|NCT02449239|Urinary Bladder Cancer|urinary bladder cancer
281935|NCT02449239|Non-muscle invasive bladder cancer|non-muscle invasive bladder cancer
281936|NCT02449239|Bladder Neoplasm|bladder neoplasm
281937|NCT02449239|Bladder Tumor|bladder tumor
281939|NCT02449239|Papillary bladder cancer|papillary bladder cancer
281940|NCT02449239|High grade bladder cancer|high grade bladder cancer
281941|NCT02449200|cervical radiculopathy|cervical radiculopathy
281942|NCT02449200|exercise|exercise
281943|NCT02449200|manual therapy|manual therapy
281944|NCT02449200|tape|tape
281945|NCT02449174|C. difficile|c. difficile
281946|NCT02449174|Fecal Microbiota transplantation|fecal microbiota transplantation
281947|NCT02449161|endometrial ablation|endometrial ablation
281948|NCT02449148|energy restriction|energy restriction
281949|NCT02449148|fasting|fasting
281950|NCT02449148|intermittent fast|intermittent fast
281951|NCT02449148|cancer prevention|cancer prevention
281952|NCT02449148|subcutaneous fat tissue gene expression|subcutaneous fat tissue gene expression
281953|NCT02449135|Pancreatic Cancer|pancreatic cancer
281954|NCT02449135|Nano drug|nano drug
281955|NCT02449122|Lung Cancer|lung cancer
281956|NCT02449122|Nano drug|nano drug
281957|NCT02449109|Liver Cancer|liver cancer
281958|NCT02449109|Nano drug|nano drug
281959|NCT02449083|MRI|mri
281960|NCT02449083|Shunt|shunt
281961|NCT02449083|COPD|copd
751110|NCT00436657|Children|children
281962|NCT02449083|Dynamic T2 Preparation Puls|dynamic t2 preparation puls
281963|NCT02449083|new sequences|new sequences
281964|NCT02449083|magnet resonance imaging|magnet resonance imaging
281965|NCT02449083|ventricular septal defect|ventricular septal defect
281966|NCT02449083|Atrial septal defect|atrial septal defect
281967|NCT02449070|Nicorandil|nicorandil
281968|NCT02449070|Cardiac MRI|cardiac mri
281969|NCT02449044|Hyponatremia|hyponatremia
281970|NCT02449018|COPD,|copd,
281971|NCT02449018|chronic bronchitis,|chronic bronchitis,
281972|NCT02449018|inflammation,|inflammation,
281973|NCT02449018|airway,|airway,
281974|NCT02449018|LCI,|lci,
281975|NCT02449018|pulmonary function test,|pulmonary function test,
281976|NCT02449018|lung function,|lung function,
281977|NCT02449018|controlled clinical trial,|controlled clinical trial,
281978|NCT02449018|randomized,|randomized,
281979|NCT02449018|airflow,|airflow,
281980|NCT02449018|smoker|smoker
281981|NCT02449005|regeneration|regeneration
281982|NCT02449005|stem cells|stem cells
281983|NCT02449005|infrabony periodontal defect|infrabony periodontal defect
281984|NCT02449005|fibrin glue|fibrin glue
281985|NCT02449005|collagen fleece|collagen fleece
281986|NCT02448992|Neurobehavioral Assessments|neurobehavioral assessments
281987|NCT02448992|Neurocognitive Functions (NCF)|neurocognitive functions (ncf)
281988|NCT02448992|Prophylactic Cranial Irradiation (PCI)|prophylactic cranial irradiation (pci)
281989|NCT02448992|Hippocampus|hippocampus
281990|NCT02448992|Hippocampal-Sparing PCI|hippocampal-sparing pci
281991|NCT02448953|Without cervical lymph node involvement|without cervical lymph node involvement
281992|NCT02448940|probiotics|probiotics
281993|NCT02448940|Lactobacillus|lactobacillus
281994|NCT02448940|obesity|obesity
281995|NCT02448940|body composition|body composition
281996|NCT02448927|transcatheter aortic valve implantation|transcatheter aortic valve implantation
281997|NCT02448927|Balloon aortic valvuloplasty|balloon aortic valvuloplasty
281998|NCT02448927|Aortic stenosis|aortic stenosis
281999|NCT02448927|TAVI|tavi
282000|NCT02448927|TAVR (transcatheter aortic valve replacement)|tavr (transcatheter aortic valve replacement)
282001|NCT02448927|CoreValve|corevalve
282002|NCT02448927|BAV|bav
282003|NCT02448927|Evolut R|evolut r
282004|NCT02448862|IV-PCA|iv-pca
282005|NCT02448862|Elderly patients|elderly patients
282006|NCT02448862|Yound adults|yound adults
282007|NCT02448862|Side effect|side effect
282008|NCT02448862|Postoperative pain|postoperative pain
282009|NCT02448862|Postoperative nausea and vomiting|postoperative nausea and vomiting
282010|NCT02448849|Autologous|autologous
282011|NCT02448849|nonunion fracture|nonunion fracture
282012|NCT02448849|bone marrow|bone marrow
282013|NCT02448849|mesenchymal|mesenchymal
282014|NCT02448849|stromal cell|stromal cell
282015|NCT02448849|platelet lysate product|platelet lysate product
282016|NCT02448823|HIV|hiv
282017|NCT02448823|combined prevention|combined prevention
282018|NCT02448823|demand generation|demand generation
282019|NCT02448784|Donepezil Hydrochloride|donepezil hydrochloride
282020|NCT02448784|ARICEPT|aricept
282021|NCT02448784|Dementia|dementia
282022|NCT02448784|Lewy bodies|lewy bodies
282023|NCT02448784|Dementia with Lewy bodies|dementia with lewy bodies
282024|NCT02448784|Post-marketing surveillance|post-marketing surveillance
282025|NCT02448771|Unresectable locally advanced invasive breast cancer|unresectable locally advanced invasive breast cancer
282026|NCT02448771|Metastatic invasive breast cancer|metastatic invasive breast cancer
282027|NCT02448758|mutation|mutation
282028|NCT02448732|ACM-1|acm-1
282029|NCT02448732|intravitreal injection|intravitreal injection
282030|NCT02448732|neovascularization|neovascularization
282031|NCT02448706|hearing aid|hearing aid
282032|NCT02448693|endoscopic mucosal resection|endoscopic mucosal resection
282033|NCT02448693|piecemeal polypectomy scar|piecemeal polypectomy scar
282034|NCT02448693|colorectal neoplasms|colorectal neoplasms
282035|NCT02448693|Narrow Band Imaging|narrow band imaging
282036|NCT02448693|chromoendoscopy|chromoendoscopy
282037|NCT02448641|ischemic stroke|ischemic stroke
282038|NCT02448641|chronic stroke|chronic stroke
282039|NCT02448641|fixed motor deficits|fixed motor deficits
282040|NCT02448628|Hypertension|hypertension
282041|NCT02448628|moderate renal impairment|moderate renal impairment
282042|NCT02448628|mineralocorticoid receptor antagonist|mineralocorticoid receptor antagonist
282043|NCT02448628|CS-3150|cs-3150
282044|NCT02448628|Japanese|japanese
282045|NCT02448615|Kenya|kenya
282046|NCT02448615|Cohort|cohort
282047|NCT02448602|Different acupoints compatibility|different acupoints compatibility
282048|NCT02448589|Advanced Solid Tumors|advanced solid tumors
282049|NCT02448589|Dose Escalation|dose escalation
282050|NCT02448589|Dose Expansion|dose expansion
282051|NCT02448589|MTD|mtd
282052|NCT02448589|TAS-119|tas-119
282053|NCT02448589|Aurora A Kinase Inhibitor|aurora a kinase inhibitor
282054|NCT02448576|phase 3 randomized controlled trial|phase 3 randomized controlled trial
282055|NCT02448576|prophylactic cranial irradiation|prophylactic cranial irradiation
282056|NCT02448576|triple negative breast cancer|triple negative breast cancer
282057|NCT02448576|brain metastasis|brain metastasis
360431|NCT02049437|HIV|hiv
282058|NCT02448576|advanced breast cancer|advanced breast cancer
282059|NCT02448563|Pregnancy|pregnancy
282060|NCT02448563|African American|african american
282061|NCT02448563|Weight Management Program|weight management program
282062|NCT02448563|Behavioral Modifications|behavioral modifications
282063|NCT02448537|Metastatic Sarcoma|metastatic sarcoma
282064|NCT02448537|Unresectable Sarcoma|unresectable sarcoma
282065|NCT02448537|PM01183|pm01183
282066|NCT02448524|Treatment|treatment
282067|NCT02448524|patients|patients
282068|NCT02448524|primary in situ CHD (de novo) lesions|primary in situ chd (de novo) lesions
282069|NCT02448511|ozone gas|ozone gas
282070|NCT02448511|ulcer|ulcer
282071|NCT02448511|infected ulcer|infected ulcer
282072|NCT02448433|Phototherapy|phototherapy
282073|NCT02448433|Light|light
282074|NCT02448433|Depression|depression
282075|NCT02448433|Sleep and circadian disturbances|sleep and circadian disturbances
282076|NCT02448433|Youth|youth
282077|NCT02448407|Knee osteoarthritis|knee osteoarthritis
282078|NCT02448407|Platelet-rich plasma|platelet-rich plasma
282079|NCT02448407|Pain's treatment|pain's treatment
282080|NCT02448394|community support workers|community support workers
282081|NCT02448394|retention in care|retention in care
282082|NCT02448381|CTCL|ctcl
282083|NCT02448381|Mycosis fungoides|mycosis fungoides
282084|NCT02448381|Hypericin|hypericin
282085|NCT02448381|SGX301|sgx301
282086|NCT02448381|MF|mf
282087|NCT02448355|OCT|oct
282088|NCT02448342|Heart Failure|heart failure
282089|NCT02448342|Remote Patient Monitoring|remote patient monitoring
282090|NCT02448342|Non Invasive Lung Fluid Status Monitor|non invasive lung fluid status monitor
282091|NCT02448290|gastric adenocarcinoma patients with low/high MEK signature,|gastric adenocarcinoma patients with low/high mek signature,
282092|NCT02448277|Macintosh laryngoscope, Pentax, Glidescope|macintosh laryngoscope, pentax, glidescope
282093|NCT02448264|kallikrein inhibitor|kallikrein inhibitor
282094|NCT02448264|oral prophylaxis|oral prophylaxis
282095|NCT02448264|BioCryst|biocryst
282096|NCT02448264|first-in-human|first-in-human
282097|NCT02448264|hereditary angioedema|hereditary angioedema
282098|NCT02448238|Human Immunodeficiency Virus|human immunodeficiency virus
282099|NCT02448238|probiotic|probiotic
282100|NCT02448238|microbial translocation|microbial translocation
282101|NCT02448238|immune activation|immune activation
282102|NCT02448238|inflammation|inflammation
282103|NCT02448238|VSL#3|vsl#3
282104|NCT02448238|Mali|mali
282105|NCT02448238|Africa|africa
282106|NCT02448212|PET|pet
282107|NCT02448212|Receptor Occupancy|receptor occupancy
282108|NCT02448199|pain|pain
282109|NCT02448199|Knee|knee
282110|NCT02448147|Heart failure|heart failure
282111|NCT02448147|Exercise|exercise
282112|NCT02448147|Biomarkers|biomarkers
282113|NCT02448147|Sympathetic Nervous System|sympathetic nervous system
282114|NCT02448147|MicroRNA|microrna
282115|NCT02448121|Cell therapy|cell therapy
282116|NCT02448121|Sickle cell disease|sickle cell disease
282117|NCT02448121|Hip Osteonecrosis|hip osteonecrosis
282118|NCT02448121|Autologous implantation|autologous implantation
282119|NCT02448121|Mesenchymal stromal cell|mesenchymal stromal cell
282120|NCT02448121|Humeral Osteonecrosis|humeral osteonecrosis
282121|NCT02448121|Knee Osteonecrosis|knee osteonecrosis
282122|NCT02448121|Ankle Osteonecrosis|ankle osteonecrosis
282123|NCT02448095|Chronic myeloid leukemia|chronic myeloid leukemia
282124|NCT02448095|Philadelphia positive|philadelphia positive
282125|NCT02448095|Compassionate use|compassionate use
282126|NCT02448082|Dandruff|dandruff
282127|NCT02448082|Pityriasis capitis|pityriasis capitis
282128|NCT02448082|Ichthyol® Pale|ichthyol® pale
282129|NCT02448082|Sodium shale oil sulponate 1%|sodium shale oil sulponate 1%
282130|NCT02448043|brittleness|brittleness
282131|NCT02448030|Metaboreflex|metaboreflex
282132|NCT02448030|Variation of blood flow|variation of blood flow
282133|NCT02448030|Functional electrical stimulation|functional electrical stimulation
282134|NCT02448030|Isometric exercise.|isometric exercise.
282135|NCT02448004|Healthy|healthy
282136|NCT02448004|JNJ-63623872|jnj-63623872
282137|NCT02448004|14C-JNJ-63623872|14c-jnj-63623872
282138|NCT02447965|Rectus Sheath Blocks|rectus sheath blocks
282139|NCT02447965|Abdominal Surgery|abdominal surgery
282140|NCT02447952|Amyotrophic Lateral Sclerosis|amyotrophic lateral sclerosis
282141|NCT02447952|Biotelemetry|biotelemetry
282142|NCT02447939|pharmacokinetics|pharmacokinetics
282143|NCT02447939|trametinib|trametinib
282144|NCT02447939|cutaneous melanoma|cutaneous melanoma
282145|NCT02447939|dabrafenib|dabrafenib
282146|NCT02447939|safety|safety
282147|NCT02447926|leukapheresis|leukapheresis
282148|NCT02447926|regulatory T cells|regulatory t cells
282149|NCT02447926|liver transplantation|liver transplantation
282150|NCT02447913|Family planning|family planning
282151|NCT02447913|Voucher|voucher
282152|NCT02447913|Immunisations|immunisations
282153|NCT02447835|Metabolic Disorders|metabolic disorders
282154|NCT02447809|microRNA|microrna
282155|NCT02447809|Platelet|platelet
282156|NCT02447809|Clopidogrel low response|clopidogrel low response
282157|NCT02447796|(AVF)|(avf)
282158|NCT02447796|surgery|surgery
282159|NCT02447783|Flavanols|flavanols
282160|NCT02447783|Cocoa flavanols|cocoa flavanols
282161|NCT02447783|Blood pressure|blood pressure
282162|NCT02447783|Platelet Function|platelet function
282163|NCT02447770|Flavanols|flavanols
282164|NCT02447770|Cocoa flavanols|cocoa flavanols
282165|NCT02447770|Blood pressure|blood pressure
282166|NCT02447770|Platelet Function|platelet function
282167|NCT02447757|Remifentanil, delivery, childbirth, analgesia, parturition, confinement|remifentanil, delivery, childbirth, analgesia, parturition, confinement
282168|NCT02447744|depression|depression
282169|NCT02447744|anxiety|anxiety
282170|NCT02447744|early life stress|early life stress
282171|NCT02447731|respiratory insufficiency|respiratory insufficiency
282172|NCT02447692|Proportional Assist Ventilation|proportional assist ventilation
282173|NCT02447692|Pressure Support Ventilation|pressure support ventilation
282174|NCT02447692|Weaning|weaning
282175|NCT02447666|Azacitidine|azacitidine
282176|NCT02447666|Myelodysplastic syndrome|myelodysplastic syndrome
282177|NCT02447666|Juvenile myelomonocytic leukemia|juvenile myelomonocytic leukemia
282178|NCT02447666|Hematopoietic stem cell transplantation|hematopoietic stem cell transplantation
282179|NCT02447666|Vidaza|vidaza
282180|NCT02447666|Hypomethylating agent|hypomethylating agent
282181|NCT02447640|Volunteers|volunteers
282182|NCT02447614|follow up|follow up
282183|NCT02447614|Primary Snoring|primary snoring
282184|NCT02447614|Obstructive Sleep Apnea Syndrome|obstructive sleep apnea syndrome
282185|NCT02447588|intrauterine insemination|intrauterine insemination
282186|NCT02447588|progesterone|progesterone
282187|NCT02447549|IMRT|imrt
282188|NCT02447549|IGRT|igrt
282189|NCT02447549|Muscle invasive|muscle invasive
282190|NCT02447549|Adaptive Radiotherapy|adaptive radiotherapy
282191|NCT02447536|Immunization|immunization
282192|NCT02447536|Morbidity|morbidity
282193|NCT02447536|Mortality|mortality
282194|NCT02447536|BCG|bcg
282195|NCT02447484|female sex workers|female sex workers
282196|NCT02447484|HIV sexual risk reduction|hiv sexual risk reduction
282197|NCT02447484|behavior maintenance|behavior maintenance
282198|NCT02447484|text messaging|text messaging
282199|NCT02447458|Drug therapy|drug therapy
282200|NCT02447432|Invasive disease by Streptococcus pneumoniae (S. pneumoniae) (including sepsis, meningitis, pneumonia, bacteraemia and acute otitis media)|invasive disease by streptococcus pneumoniae (s. pneumoniae) (including sepsis, meningitis, pneumonia, bacteraemia and acute otitis media)
282201|NCT02447432|Infants|infants
282202|NCT02447432|Multidose|multidose
282203|NCT02447432|Haemophilus influenzae|haemophilus influenzae
282204|NCT02447432|Streptococcus pneumoniae|streptococcus pneumoniae
282205|NCT02447432|Preservative|preservative
282206|NCT02447432|Safety|safety
282207|NCT02447432|Pneumonia|pneumonia
282208|NCT02447432|Immunogenicity|immunogenicity
282209|NCT02447432|Pneumococcal conjugate vaccine|pneumococcal conjugate vaccine
282210|NCT02447432|Acute otitis media caused by non-typeable Haemophilus influenzae (NTHi).|acute otitis media caused by non-typeable haemophilus influenzae (nthi).
282211|NCT02447432|Respiratory tract infections|respiratory tract infections
282212|NCT02447367|α1-blockers|α1-blockers
282213|NCT02447367|antimuscarinic agent|antimuscarinic agent
282214|NCT02447315|Pilocarpine|pilocarpine
282215|NCT02447289|Dental caries|dental caries
282216|NCT02447289|Moderate sedation|moderate sedation
282217|NCT02447263|Liver Cancer|liver cancer
282218|NCT02447263|HepaSphere|hepasphere
282219|NCT02447250|Bronchopulmonary dysplasia|bronchopulmonary dysplasia
282220|NCT02447250|very low birth weight|very low birth weight
282221|NCT02447250|albuterol|albuterol
282222|NCT02447250|pulmonary function test|pulmonary function test
282223|NCT02447237|liquid diet|liquid diet
282224|NCT02447237|solid diet|solid diet
282225|NCT02447224|appendicitis|appendicitis
282226|NCT02447224|non operative management|non operative management
282227|NCT02447224|appendectomy|appendectomy
282228|NCT02447185|Lucentis|lucentis
282229|NCT02447185|Ranibizumab|ranibizumab
282230|NCT02447185|Triamcinolone Acetonide|triamcinolone acetonide
282231|NCT02447185|Vitrectomy|vitrectomy
282232|NCT02447185|PDR|pdr
282233|NCT02447185|25-Gauge Vitrectomy|25-gauge vitrectomy
282234|NCT02447159|Nigeria|nigeria
282235|NCT02447159|Developing Countries|developing countries
282236|NCT02447159|Hospitals, Maternity/Utilization|hospitals, maternity/utilization
282237|NCT02447159|Hospitals/Economics|hospitals/economics
282238|NCT02447159|HIV|hiv
282239|NCT02447133|no known ocular pathology|no known ocular pathology
282240|NCT02447120|Volunteers with Healthy Eyes|volunteers with healthy eyes
282241|NCT02447107|Chronic Pain|chronic pain
282242|NCT02447107|Technology|technology
282243|NCT02447107|Mobile Phone Applications|mobile phone applications
282244|NCT02447094|ischemic|ischemic
282245|NCT02447094|tPA|tpa
282246|NCT02447094|tele-medicine|tele-medicine
282247|NCT02447094|robot|robot
282248|NCT02447094|tele-stroke|tele-stroke
282249|NCT02447042|sepsis|sepsis
282250|NCT02447042|Fluids|fluids
282251|NCT02447042|Mean systemic filling pressure|mean systemic filling pressure
282252|NCT02447029|abortion|abortion
282253|NCT02447029|pain management|pain management
282254|NCT02447003|PD1|pd1
282255|NCT02447003|PD-1|pd-1
282256|NCT02447003|PDL1|pdl1
282257|NCT02447003|PD-L1|pd-l1
282258|NCT02446977|ischemic|ischemic
282259|NCT02446977|stroke|stroke
282260|NCT02446977|vitamin B2|vitamin b2
282261|NCT02446938|mechanical ventilation|mechanical ventilation
282262|NCT02446938|esophageal pressure|esophageal pressure
282263|NCT02446938|catheter position|catheter position
282264|NCT02446938|validation|validation
282265|NCT02446912|Active Systemic Lupus Erythematosus|active systemic lupus erythematosus
282266|NCT02446899|Active Systemic Lupus Erythematosus|active systemic lupus erythematosus
282267|NCT02446886|Multiple Sclerosis|multiple sclerosis
282268|NCT02446886|MS|ms
282269|NCT02446886|RRMS|rrms
282270|NCT02446886|SPMS|spms
282271|NCT02446886|ACTH|acth
282272|NCT02446873|children|children
282273|NCT02446873|Ecuador|ecuador
282274|NCT02446873|rural|rural
282275|NCT02446873|poor|poor
282276|NCT02446847|HIV|hiv
282277|NCT02446847|3BNC117|3bnc117
282278|NCT02446847|Broadly neutralizing antibody|broadly neutralizing antibody
282279|NCT02446834|PCOS|pcos
282280|NCT02446834|intensive lifestyle intervention|intensive lifestyle intervention
282281|NCT02446834|IGT|igt
282282|NCT02446834|drugs treatment|drugs treatment
282283|NCT02446795|Renal cell carcinoma|renal cell carcinoma
282284|NCT02446795|Isoquercetin|isoquercetin
282285|NCT02446795|kidney cancer|kidney cancer
282286|NCT02446795|sunitinib|sunitinib
282287|NCT02446795|fatigue|fatigue
282288|NCT02446782|thoracoscopy|thoracoscopy
282289|NCT02446782|pleuroscopy|pleuroscopy
282290|NCT02446782|antibiotic prophylaxis|antibiotic prophylaxis
282291|NCT02446782|pleural effusion|pleural effusion
282292|NCT02446756|Osteoarthritis|osteoarthritis
282293|NCT02446756|MRI|mri
282294|NCT02446756|Cartilage|cartilage
282295|NCT02446756|Acupuncture|acupuncture
282296|NCT02446743|Nervous System Diseases|nervous system diseases
282297|NCT02446743|Meningitis|meningitis
282298|NCT02446743|Central Nervous System Diseases|central nervous system diseases
282299|NCT02446717|Hepatitis C|hepatitis c
282300|NCT02446717|HCV Genotype 6|hcv genotype 6
282301|NCT02446717|HCV GT1|hcv gt1
282302|NCT02446717|Interferon (IFN) free|interferon (ifn) free
282303|NCT02446717|HCV Genotype 5|hcv genotype 5
282304|NCT02446717|HCV|hcv
282305|NCT02446717|HCV GT4|hcv gt4
282306|NCT02446717|HCV Genotype 4|hcv genotype 4
282307|NCT02446717|Chronic Hepatitis C|chronic hepatitis c
282308|NCT02446717|Chronic HCV|chronic hcv
282309|NCT02446717|Hepatitis C Genotype 1|hepatitis c genotype 1
282310|NCT02446717|HCV GT5|hcv gt5
282311|NCT02446717|HCV Genotype 1|hcv genotype 1
282312|NCT02446704|Small Cell Lung Cancer|small cell lung cancer
282313|NCT02446704|SCLC|sclc
282314|NCT02446678|Gastrointestinal bleeding|gastrointestinal bleeding
282315|NCT02446678|emergency department|emergency department
282316|NCT02446678|PillCam ESO2|pillcam eso2
282317|NCT02446652|Advanced cervical cancer|advanced cervical cancer
282318|NCT02446652|Epigenetic therapy|epigenetic therapy
282319|NCT02446652|Randomized phase III|randomized phase iii
282320|NCT02446626|Lyme Disease|lyme disease
282321|NCT02446626|Ixodes scapularis|ixodes scapularis
282322|NCT02446626|Borrelia Burgdorferi|borrelia burgdorferi
282323|NCT02446626|Post treatment|post treatment
282324|NCT02446626|Infection|infection
282325|NCT02446613|Allergic Rhinitis|allergic rhinitis
282326|NCT02446613|Nasal allergen challenge|nasal allergen challenge
282327|NCT02446613|Allergic Asthma|allergic asthma
282328|NCT02446613|Effect on Allergen Reactivity|effect on allergen reactivity
282329|NCT02446587|endovascular therapy|endovascular therapy
282330|NCT02446587|thrombectomy|thrombectomy
282331|NCT02446587|selection|selection
282332|NCT02446587|imaging|imaging
282333|NCT02446587|perfusion|perfusion
282334|NCT02446587|collaterals|collaterals
282335|NCT02446587|ASPECTS|aspects
282336|NCT02446574|chemoradiation|chemoradiation
282337|NCT02446574|dose escalation|dose escalation
282537|NCT02445339|Alcoholism|alcoholism
282338|NCT02446561|Healthy Volunteer|healthy volunteer
282339|NCT02446561|Pharmacokinetics|pharmacokinetics
282340|NCT02446548|direct renin inhibitor|direct renin inhibitor
282341|NCT02446548|kidney transplantation|kidney transplantation
282342|NCT02446548|albuminuria|albuminuria
282343|NCT02446496|Bioequivalence|bioequivalence
282344|NCT02446496|film coated tablets|film coated tablets
282345|NCT02446496|cefadroxil|cefadroxil
282346|NCT02446483|Idiazole 20mg|idiazole 20mg
282347|NCT02446483|PARIET 20 mg|pariet 20 mg
282348|NCT02446483|Rabeprazole|rabeprazole
282349|NCT02446483|bioequivalence|bioequivalence
282350|NCT02446470|calcaneus|calcaneus
282351|NCT02446470|fracture fixation, internal|fracture fixation, internal
282352|NCT02446444|High risk|high risk
282353|NCT02446444|clinically localised prostate cancer|clinically localised prostate cancer
751111|NCT00436657|Pediatric|pediatric
282354|NCT02446431|Metronomic Drug Therapy|metronomic drug therapy
282355|NCT02446418|dry powder inahler|dry powder inahler
282356|NCT02446418|vilanerol|vilanerol
282357|NCT02446418|efficacy|efficacy
282358|NCT02446418|safety|safety
282359|NCT02446418|fluticasone furoate|fluticasone furoate
282360|NCT02446418|quality of life|quality of life
282361|NCT02446405|metastatic prostate cancer|metastatic prostate cancer
282362|NCT02446405|prostate cancer|prostate cancer
282488|NCT02445651|Movement Disorders|movement disorders
282363|NCT02446405|prostate cancer treatment|prostate cancer treatment
282364|NCT02446405|enzalutamide|enzalutamide
282365|NCT02446353|Male Volunteers|male volunteers
282366|NCT02446340|ShK-186|shk-186
282367|NCT02446340|dalazatide|dalazatide
282368|NCT02446340|Kv1.3|kv1.3
282369|NCT02446340|SHK|shk
282370|NCT02446301|Nalbuphine|nalbuphine
282371|NCT02446301|SDE|sde
282372|NCT02446301|dinalbuphine|dinalbuphine
282373|NCT02446301|SDN|sdn
282374|NCT02446301|pain|pain
282375|NCT02446301|LT1001|lt1001
282376|NCT02446275|efficacy, manual therapy, migraine, quality of life|efficacy, manual therapy, migraine, quality of life
282377|NCT02446262|Pain|pain
282378|NCT02446262|Visual Analogue Pain Scale|visual analogue pain scale
282379|NCT02446262|Placebo|placebo
282380|NCT02446262|Affective Neuroscience|affective neuroscience
282381|NCT02446262|Functional Magnetic Resonance Imaging (fMRI)|functional magnetic resonance imaging (fmri)
282382|NCT02446249|Gene Therapy|gene therapy
282383|NCT02446249|Xerostomia|xerostomia
282384|NCT02446223|Actinic Keratosis AKs Chest Pre-Cancer|actinic keratosis aks chest pre-cancer
282385|NCT02446210|SCI|sci
282386|NCT02446210|Neural Control|neural control
282387|NCT02446210|Bilateral Movement|bilateral movement
282388|NCT02446210|TMS|tms
282389|NCT02446184|urethral obstruction|urethral obstruction
282390|NCT02446184|posterior urethral valves|posterior urethral valves
282391|NCT02446184|lower urinary tract obstruction|lower urinary tract obstruction
282392|NCT02446171|naloxegol tablet crushed|naloxegol tablet crushed
282393|NCT02446171|naloxegol oral solution|naloxegol oral solution
282394|NCT02446171|naloxegol whole tablet|naloxegol whole tablet
282395|NCT02446171|relative bioavailability|relative bioavailability
282396|NCT02446171|Phase I|phase i
282397|NCT02446171|healthy subjects|healthy subjects
282398|NCT02446106|Monosodium L-Glutamate (MSG)|monosodium l-glutamate (msg)
282399|NCT02446106|Satiety|satiety
282400|NCT02446106|Soups|soups
282401|NCT02446106|Energy Intake|energy intake
282402|NCT02446106|Snack Intake|snack intake
282403|NCT02446093|pancreas cancer|pancreas cancer
282404|NCT02446093|immunotherapy|immunotherapy
282405|NCT02446093|GMCI|gmci
282406|NCT02446093|AdV-tk|adv-tk
282407|NCT02446093|aglatimagene besadenovec|aglatimagene besadenovec
282408|NCT02446080|Constipation|constipation
282409|NCT02446080|Probiotics|probiotics
282410|NCT02446080|Women|women
282411|NCT02446067|Transcranial Doppler (TCD) sonography|transcranial doppler (tcd) sonography
282412|NCT02446067|rTMS|rtms
282413|NCT02446067|Cerebral hemodynamics|cerebral hemodynamics
282414|NCT02446054|T2DM, type II diabetes Mellitus, HbA1c|t2dm, type ii diabetes mellitus, hba1c
282415|NCT02446041|COPD|copd
282416|NCT02446041|Chronic Bronchitis|chronic bronchitis
282417|NCT02446041|Pulmonary Emphysema|pulmonary emphysema
282418|NCT02446002|Volunteer|volunteer
282419|NCT02445989|HIV|hiv
282420|NCT02445989|Contraceptive Vaginal Ring|contraceptive vaginal ring
282421|NCT02445989|Bacterial Vaginosis|bacterial vaginosis
282422|NCT02445976|mCRPC|mcrpc
282423|NCT02445976|metastatic|metastatic
282424|NCT02445976|castration-resistant prostate cancer|castration-resistant prostate cancer
282425|NCT02445950|Coaching|coaching
282426|NCT02445950|Well-being|well-being
282427|NCT02445950|Digital Health|digital health
282428|NCT02445950|Profiling|profiling
282429|NCT02445950|Customer Satisfaction|customer satisfaction
282430|NCT02445950|User Experience|user experience
282431|NCT02445950|Occupational Health|occupational health
282432|NCT02445950|Lifestyle|lifestyle
282433|NCT02445950|Psychological Stress|psychological stress
282434|NCT02445950|Cost-Effectiveness|cost-effectiveness
282435|NCT02445950|Guideline Adherence|guideline adherence
282436|NCT02445937|decision making for incapacitated patients|decision making for incapacitated patients
282437|NCT02445937|intensive care|intensive care
282438|NCT02445937|surrogate decision making|surrogate decision making
282439|NCT02445937|patient centered care|patient centered care
282440|NCT02445937|palliative care|palliative care
282441|NCT02445924|genetic signature|genetic signature
282442|NCT02445924|non-small cell lung cancer|non-small cell lung cancer
282443|NCT02445924|micro RNA|micro rna
282444|NCT02445898|Glucocorticoid|glucocorticoid
282445|NCT02445898|Orthostatic Intolerance|orthostatic intolerance
282446|NCT02445898|Heart Rate Variability|heart rate variability
282447|NCT02445898|Hip arthroplasty, total|hip arthroplasty, total
282448|NCT02445885|Myocardial infarction|myocardial infarction
282449|NCT02445885|Late presenters|late presenters
282450|NCT02445885|Primary percutaneous coronary intervention|primary percutaneous coronary intervention
360885|NCT02047552|trauma|trauma
282451|NCT02445885|Reperfusion|reperfusion
282452|NCT02445885|Angioplasty|angioplasty
282453|NCT02445885|Duration of ischemia|duration of ischemia
282454|NCT02445885|Cardiovascular magnetic resonance imaging|cardiovascular magnetic resonance imaging
282455|NCT02445872|Nausea|nausea
282456|NCT02445872|Vomiting|vomiting
282457|NCT02445872|Chemotherapy-induced Nausea and Vomiting|chemotherapy-induced nausea and vomiting
282458|NCT02445872|CINV|cinv
282459|NCT02445872|Aprepitant|aprepitant
282460|NCT02445872|Lung cancer|lung cancer
282461|NCT02445859|Antibiotic|antibiotic
282462|NCT02445859|prophylaxis|prophylaxis
282463|NCT02445859|surgical site infection|surgical site infection
282464|NCT02445833|Obesity|obesity
282465|NCT02445833|Internet intervention|internet intervention
282466|NCT02445833|Cardiovascular disease|cardiovascular disease
282467|NCT02445833|Hypertension|hypertension
282468|NCT02445833|Lifestyle intervention|lifestyle intervention
282469|NCT02445833|Weight loss treatment|weight loss treatment
282470|NCT02445755|Neonates|neonates
282471|NCT02445755|Bilicare System|bilicare system
282472|NCT02445742|Chronic Myeloblastic Leukaemia|chronic myeloblastic leukaemia
282473|NCT02445729|Cesarean Section|cesarean section
282474|NCT02445729|Wound Healing|wound healing
282475|NCT02445677|TENS|tens
282476|NCT02445677|chronic pain|chronic pain
282477|NCT02445677|rehabilitation|rehabilitation
282478|NCT02445664|Patient education|patient education
282479|NCT02445664|Video intervention|video intervention
282480|NCT02445651|Integrative Medicine|integrative medicine
282481|NCT02445651|Alternative Medicine|alternative medicine
282482|NCT02445651|Complementary Medicine|complementary medicine
282483|NCT02445651|Parkinson's disease|parkinson's disease
282484|NCT02445651|Neurodegenerative Diseases|neurodegenerative diseases
282485|NCT02445651|Idiopathic Parkinson's disease|idiopathic parkinson's disease
282486|NCT02445651|Single Photon Emission Computed Tomography (SPECT)|single photon emission computed tomography (spect)
282487|NCT02445651|Central Nervous System Diseases|central nervous system diseases
282489|NCT02445651|Nervous System Diseases|nervous system diseases
282490|NCT02445651|Brain Diseases|brain diseases
282491|NCT02445651|Oral supplements|oral supplements
282492|NCT02445651|N-acetyl cysteine|n-acetyl cysteine
282493|NCT02445612|fundus flavimaculatus|fundus flavimaculatus
282494|NCT02445612|ASP7316|asp7316
282495|NCT02445612|SMD|smd
282496|NCT02445612|long term follow-up|long term follow-up
282497|NCT02445612|juvenile macular dystrophy|juvenile macular dystrophy
282498|NCT02445599|thoracotomy|thoracotomy
282499|NCT02445599|pain management|pain management
282500|NCT02445599|analgesia|analgesia
282501|NCT02445599|postoperative care|postoperative care
282502|NCT02445599|premedication|premedication
282503|NCT02445599|preventive|preventive
282504|NCT02445573|stress urinary incontinence|stress urinary incontinence
282505|NCT02445573|electroacupuncture|electroacupuncture
282506|NCT02445573|efficacy|efficacy
282507|NCT02445560|probiotics|probiotics
282508|NCT02445560|prebiotics|prebiotics
282509|NCT02445560|high protein diet|high protein diet
282510|NCT02445560|microbiota|microbiota
282511|NCT02445534|Cell Therapy|cell therapy
282512|NCT02445456|Rectal cancer|rectal cancer
282513|NCT02445456|Sentinel Lymph Node Biopsy|sentinel lymph node biopsy
282514|NCT02445417|Perinatal depression|perinatal depression
282515|NCT02445378|Aromatherapy|aromatherapy
282516|NCT02445378|essential oils|essential oils
282517|NCT02445378|Acute Leukemia|acute leukemia
282518|NCT02445365|Ulcerative colitis|ulcerative colitis
282519|NCT02445365|Remote ischemic conditioning|remote ischemic conditioning
282520|NCT02445339|Alcohol Dependence|alcohol dependence
282521|NCT02445339|Alcohol Use Disorder|alcohol use disorder
282522|NCT02445339|Care Management|care management
282523|NCT02445339|Case Management|case management
282524|NCT02445339|Emergency Care Services|emergency care services
282525|NCT02445339|Emergency Department|emergency department
282526|NCT02445339|Emergency Room|emergency room
282527|NCT02445339|Extended-release naltrexone|extended-release naltrexone
282528|NCT02445339|Frequent Users|frequent users
282529|NCT02445339|Health Care Utilization|health care utilization
282530|NCT02445339|Medical Management|medical management
282531|NCT02445339|Naltrexone|naltrexone
282532|NCT02445339|Population Health|population health
282533|NCT02445339|Public Health|public health
282534|NCT02445339|Vivitrol|vivitrol
282535|NCT02445339|XR-NTX|xr-ntx
282536|NCT02445339|XR-NTX+CM|xr-ntx+cm
282538|NCT02445339|Alcohol-Related Disorders|alcohol-related disorders
282539|NCT02445339|Central Nervous System Agents|central nervous system agents
282540|NCT02445339|Chemically-Induced Disorders|chemically-induced disorders
282541|NCT02445339|Clinical Trial|clinical trial
282542|NCT02445339|Emergency Medicine|emergency medicine
282543|NCT02445339|Mental Disorders|mental disorders
282544|NCT02445339|Narcotic Antagonists|narcotic antagonists
282545|NCT02445339|Peripheral Nervous System Agents|peripheral nervous system agents
282546|NCT02445339|Pharmacologic Actions|pharmacologic actions
751197|NCT00436501|docetaxel|docetaxel
282547|NCT02445339|Physiological Effects of Drugs|physiological effects of drugs
282548|NCT02445339|Sensory System Agents|sensory system agents
282549|NCT02445339|Substance-Related Disorders|substance-related disorders
282550|NCT02445300|dressing|dressing
282551|NCT02445300|TKA|tka
282552|NCT02445261|MOBILE PHONE ON AND IN AND|mobile phone on and in and
282553|NCT02445261|UMBILICAL ARTERY DOPPLER|umbilical artery doppler
282554|NCT02445261|FETAL CARDIOTOCOGRAPHY|fetal cardiotocography
282555|NCT02445261|GROWTH RESTRICTED FETUS|growth restricted fetus
282556|NCT02445261|NORMAL GROWTH FETUS|normal growth fetus
282557|NCT02445248|Diffuse large B-cell lymphoma,|diffuse large b-cell lymphoma,
282558|NCT02445248|DLBCL,|dlbcl,
282559|NCT02445248|Relapsed/refractory,|relapsed/refractory,
282560|NCT02445248|CTL019|ctl019
282561|NCT02445248|CART19|cart19
282562|NCT02445248|CART|cart
282563|NCT02445248|CAR T cells|car t cells
282564|NCT02445248|Chimeric antigen receptor|chimeric antigen receptor
282565|NCT02445235|pain|pain
282566|NCT02445235|wound care|wound care
282567|NCT02445235|fungal infections|fungal infections
282568|NCT02445235|scars|scars
282569|NCT02445235|chronic pain|chronic pain
282570|NCT02445235|outcomes|outcomes
282571|NCT02445235|PRO|pro
282572|NCT02445209|HER2-negative gastric and GEJ adenocarcinoma|her2-negative gastric and gej adenocarcinoma
282573|NCT02445209|first-line palliative chemotherapy|first-line palliative chemotherapy
282574|NCT02445209|EOX|eox
282575|NCT02445209|mDCF|mdcf
282576|NCT02445209|efficacy|efficacy
282577|NCT02445209|safety|safety
282578|NCT02445170|Diabetes|diabetes
282579|NCT02445170|amputation|amputation
282580|NCT02445170|below-knee|below-knee
282581|NCT02445170|transmetatarsal|transmetatarsal
282582|NCT02445170|[M01.150.100]|[m01.150.100]
282583|NCT02445170|[C19.246.099]|[c19.246.099]
282584|NCT02445157|Gait speed|gait speed
282585|NCT02445157|Functional outcome measure|functional outcome measure
282586|NCT02445144|Inflammation|inflammation
282587|NCT02445144|Blood Flow|blood flow
282588|NCT02445144|Cognition|cognition
282589|NCT02445131|CLL|cll
282590|NCT02445118|adipose, allograft|adipose, allograft
282591|NCT02445092|Intrauterine insemination|intrauterine insemination
282592|NCT02445092|Insemination catheter prewashing|insemination catheter prewashing
282593|NCT02445092|Pregnancy outcome|pregnancy outcome
282594|NCT02445066|Vitamin D|vitamin d
282595|NCT02445053|Cystic Fibrosis|cystic fibrosis
282596|NCT02445040|High Frequency Oscillatory Ventilation|high frequency oscillatory ventilation
282597|NCT02445040|Infant, Very Low Birth Weight|infant, very low birth weight
282598|NCT02445040|Periventricular Leukomalacia|periventricular leukomalacia
282599|NCT02445040|Intraventricular Hemorrhage|intraventricular hemorrhage
282600|NCT02445040|multi-center study|multi-center study
282601|NCT02445027|Primary Care|primary care
282602|NCT02445027|Healthy|healthy
282603|NCT02445014|Barrett's|barrett's
282604|NCT02445014|GERD|gerd
282605|NCT02445014|Capsule|capsule
282606|NCT02445014|SECM|secm
282607|NCT02444988|crystalloid|crystalloid
282608|NCT02444988|acute kidney injury|acute kidney injury
282609|NCT02444975|Urinary Tract Infections|urinary tract infections
282610|NCT02444975|Water intake|water intake
282611|NCT02444936|solid tumor|solid tumor
282612|NCT02444936|chemotherapy|chemotherapy
282613|NCT02444936|vaccine|vaccine
282614|NCT02444923|Corneal rigid gas permeable contact lenses|corneal rigid gas permeable contact lenses
282615|NCT02444923|Scleral rigid gas permeable contact lenses|scleral rigid gas permeable contact lenses
282616|NCT02444923|Custom Scleral contact lenses|custom scleral contact lenses
282617|NCT02444923|Keratoconus|keratoconus
282618|NCT02444923|Irregular cornea|irregular cornea
282619|NCT02444923|Pellucid marginal degeneration|pellucid marginal degeneration
282620|NCT02444923|Post keratoplasty irregular cornea|post keratoplasty irregular cornea
282621|NCT02444923|Post refractive surgery irregular cornea|post refractive surgery irregular cornea
282622|NCT02444923|Traumatic irregular cornea|traumatic irregular cornea
282624|NCT02444910|Diabetes|diabetes
282625|NCT02444910|Diabetes Mellitus|diabetes mellitus
282626|NCT02444910|Type 2|type 2
282627|NCT02444910|KinDex|kindex
282628|NCT02444897|Gastric cancer|gastric cancer
282629|NCT02444897|epidural|epidural
282630|NCT02444897|PCA|pca
282631|NCT02444897|laparoscopy|laparoscopy
282632|NCT02444871|IgM-enriched immunoglobulins|igm-enriched immunoglobulins
282633|NCT02444871|endotoxin activity assay|endotoxin activity assay
282634|NCT02444871|thrombelastometry|thrombelastometry
282635|NCT02444871|aggregometry|aggregometry
282636|NCT02444858|paraquat poisoning|paraquat poisoning
282637|NCT02444858|lung injury|lung injury
282638|NCT02444858|stem cell therapy|stem cell therapy
282639|NCT02444858|human umbilical cord mesenchymal stem cell|human umbilical cord mesenchymal stem cell
282640|NCT02444858|phase 1/2 clinical study|phase 1/2 clinical study
282641|NCT02444858|allogeneic stem cell transplantation|allogeneic stem cell transplantation
282642|NCT02444819|HM61713|hm61713
282643|NCT02444819|Epidermal Growth Factor Receptor mutation positive NSCLC|epidermal growth factor receptor mutation positive nsclc
282644|NCT02444819|olmutinib|olmutinib
282645|NCT02444806|Sleep disordered breathing|sleep disordered breathing
282646|NCT02444806|Domiciliary NIV|domiciliary niv
282647|NCT02444728|thrombocytopenia|thrombocytopenia
282648|NCT02444728|systemic lupus erythematosus|systemic lupus erythematosus
282649|NCT02444728|hydroxychloroquine|hydroxychloroquine
282650|NCT02444728|cyclophosphamide|cyclophosphamide
282651|NCT02444728|remission|remission
282652|NCT02444715|Lifestyle coaching|lifestyle coaching
282653|NCT02444715|Phone-based system|phone-based system
282654|NCT02444715|CVD prevention|cvd prevention
282655|NCT02444715|Patient-centered decision support|patient-centered decision support
282656|NCT02444702|spinal stenosis, clinical predictors rules, MRI, fusion, low back pain|spinal stenosis, clinical predictors rules, mri, fusion, low back pain
282657|NCT02444689|Blood pressure|blood pressure
282658|NCT02444689|Cardiovascular disease|cardiovascular disease
282659|NCT02444689|Children|children
282660|NCT02444689|Adolescent|adolescent
282661|NCT02444689|Pediatrics|pediatrics
282662|NCT02444689|End-organ damage|end-organ damage
282663|NCT02444650|Correlation|correlation
282664|NCT02444650|pulse wave velocity measurement|pulse wave velocity measurement
282665|NCT02444650|tonometry|tonometry
282666|NCT02444624|necrotizing enterocolitis|necrotizing enterocolitis
282667|NCT02444624|Clostridium|clostridium
282668|NCT02444624|premature birth|premature birth
282669|NCT02444611|neonates|neonates
282670|NCT02444611|BCG|bcg
282671|NCT02444611|Hepatitis B vaccine|hepatitis b vaccine
282672|NCT02444611|vaccines|vaccines
282673|NCT02444611|immunity|immunity
282674|NCT02444611|immune response|immune response
282675|NCT02444611|Bacille- Calmette-Guerin|bacille- calmette-guerin
282676|NCT02444598|wounds|wounds
282677|NCT02444598|negative-pressure wound therapy|negative-pressure wound therapy
282678|NCT02444598|conflict|conflict
282679|NCT02444598|gunshot wound|gunshot wound
282680|NCT02444598|blast injuries|blast injuries
282681|NCT02444598|civilian|civilian
282682|NCT02444598|war|war
282683|NCT02444572|Enoxaparin|enoxaparin
282684|NCT02444572|Immunogenicity|immunogenicity
282685|NCT02444559|Volunteers|volunteers
282686|NCT02444533|Liposomal Bupivacaine|liposomal bupivacaine
282687|NCT02444520|Medically unexplained symptoms|medically unexplained symptoms
282688|NCT02444520|Primary care|primary care
282689|NCT02444520|Cognitive behaviour therapy skills|cognitive behaviour therapy skills
282690|NCT02444520|Cluster randomised controlled trial|cluster randomised controlled trial
282691|NCT02444520|Feasibility|feasibility
282692|NCT02444481|Mycotic Vaginitis|mycotic vaginitis
282693|NCT02444455|cellular therapy|cellular therapy
282694|NCT02444455|acute lung injury|acute lung injury
282695|NCT02444455|acute respiratory distress snydrome|acute respiratory distress snydrome
282696|NCT02444455|human umbilical cord mesenchymal stem cell|human umbilical cord mesenchymal stem cell
282697|NCT02444455|phase 1/2 clinical study|phase 1/2 clinical study
282698|NCT02444455|allogeneic stem cell transplantation|allogeneic stem cell transplantation
282699|NCT02444455|ALI|ali
282700|NCT02444455|ARDS|ards
282701|NCT02444442|Renal denervation|renal denervation
282702|NCT02444442|Blood pressure|blood pressure
282703|NCT02444442|Cardiovascular risk|cardiovascular risk
282704|NCT02444442|Target organ damage|target organ damage
282705|NCT02444442|Sympathetic activity|sympathetic activity
282706|NCT02444442|Non-compliance|non-compliance
282707|NCT02444429|Screening renal biopsy|screening renal biopsy
282708|NCT02444429|Immunosuppression|immunosuppression
282709|NCT02444403|HIV|hiv
282710|NCT02444403|Viral hepatitis|viral hepatitis
282711|NCT02444403|HCV|hcv
282712|NCT02444403|Needle-stick injury|needle-stick injury
282713|NCT02444403|Needle/syringes|needle/syringes
282714|NCT02444403|Structural intervention|structural intervention
282715|NCT02444403|Stepped wedge|stepped wedge
282716|NCT02444403|Police|police
282717|NCT02444403|Occupational safety|occupational safety
282718|NCT02444403|Police Training|police training
282719|NCT02444390|Failed non steroidal aromatases inhibitors|failed non steroidal aromatases inhibitors
282720|NCT02444390|Eligible for everolimus+exemestane|eligible for everolimus+exemestane
282721|NCT02444364|diabetes|diabetes
282722|NCT02444364|bone loss|bone loss
282723|NCT02444364|Bone Density|bone density
282724|NCT02444325|group prenatal care|group prenatal care
282725|NCT02444325|CenteringPregnancy|centeringpregnancy
282726|NCT02444325|diabetes|diabetes
282727|NCT02444312|Caregiving|caregiving
282728|NCT02444312|Benefit Finding|benefit finding
282729|NCT02444312|Writing Intervention|writing intervention
282730|NCT02444273|liver diseases|liver diseases
282731|NCT02444273|liver transplantation|liver transplantation
282732|NCT02444273|preoperative care|preoperative care
282733|NCT02444273|physical therapy|physical therapy
282734|NCT02444260|Inguinal Hernia,|inguinal hernia,
282735|NCT02444260|Local Anesthesia|local anesthesia
282736|NCT02444260|Randomized Clinical trial|randomized clinical trial
282737|NCT02444260|HERNIOPLASTY|hernioplasty
282738|NCT02444221|Atrial Fibrillation|atrial fibrillation
282739|NCT02444221|Rivaroxaban|rivaroxaban
282740|NCT02444221|Stroke|stroke
282741|NCT02444195|gynecologic cancer|gynecologic cancer
282742|NCT02444195|guided imagery|guided imagery
282743|NCT02444195|postoperative distress|postoperative distress
282744|NCT02444195|perioperative distress|perioperative distress
282745|NCT02444143|Kidney|kidney
282746|NCT02444143|Immunosuppression|immunosuppression
282747|NCT02444143|Transplant|transplant
282748|NCT02444130|multifocality|multifocality
282749|NCT02444130|monovision|monovision
282750|NCT02444117|neurophysiology|neurophysiology
282751|NCT02444104|Left Ventricular Assist Device|left ventricular assist device
282752|NCT02444091|Chronic Fatigue Syndrome|chronic fatigue syndrome
282753|NCT02444091|Myalgic Encephalomyelitis (ME)|myalgic encephalomyelitis (me)
282754|NCT02444091|Cyclophosphamide|cyclophosphamide
282755|NCT02444091|Immunomodulatory treatment|immunomodulatory treatment
282757|NCT02444078|Alzheimer Disease|alzheimer disease
282758|NCT02444078|Dementia|dementia
282759|NCT02444078|Physical activity|physical activity
282760|NCT02444078|Functional ability|functional ability
282761|NCT02444078|Disability|disability
282762|NCT02444078|Functional limitation|functional limitation
282763|NCT02444065|Cognitive behavior therapy|cognitive behavior therapy
282764|NCT02444065|Motivational interviewing|motivational interviewing
282765|NCT02444065|Bulimia nervosa|bulimia nervosa
282766|NCT02444065|Rapid response|rapid response
282767|NCT02444013|Contrast induced nephropathy|contrast induced nephropathy
282768|NCT02444000|chemotherapy|chemotherapy
282769|NCT02444000|PCV|pcv
282770|NCT02444000|radiotherapy|radiotherapy
282771|NCT02444000|post operative treatment|post operative treatment
282772|NCT02444000|anaplastic gliomas|anaplastic gliomas
282773|NCT02444000|1p/19q codeletion|1p/19q codeletion
282774|NCT02444000|cognition|cognition
282775|NCT02443987|Tension-Free Vaginal Tape|tension-free vaginal tape
282776|NCT02443961|Bronchopulmonary dysplasia|bronchopulmonary dysplasia
282777|NCT02443961|pulmonary hypertension|pulmonary hypertension
282778|NCT02443961|stem cell therapy|stem cell therapy
282779|NCT02443961|mesenchymal stem cells|mesenchymal stem cells
282780|NCT02443961|very low weight preterm babies|very low weight preterm babies
282781|NCT02443922|type 2 diabetes|type 2 diabetes
282782|NCT02443922|beta cell function|beta cell function
282783|NCT02443922|meal tolerance test (MTT)|meal tolerance test (mtt)
282784|NCT02443922|maximal stimulation test (MaxStim)|maximal stimulation test (maxstim)
282785|NCT02443922|method standardization|method standardization
282786|NCT02443922|insulin secretion|insulin secretion
282787|NCT02443922|prediabetes|prediabetes
282788|NCT02443922|insulin sensitivity|insulin sensitivity
282789|NCT02443922|glimepiride|glimepiride
282790|NCT02443922|sitagliptin|sitagliptin
282791|NCT02443922|metformin|metformin
282792|NCT02443909|Holmium Laser|holmium laser
282793|NCT02443909|Kidney Stones|kidney stones
282794|NCT02443909|RIRS|rirs
282795|NCT02443883|stomach cancer|stomach cancer
282796|NCT02443844|BPH|bph
282797|NCT02443844|bladder cancer|bladder cancer
282798|NCT02443844|treatment|treatment
282799|NCT02443844|recurrence|recurrence
282800|NCT02443844|progression|progression
282801|NCT02443831|high risk relapsed CD19+ hematological malignancies|high risk relapsed cd19+ hematological malignancies
282802|NCT02443766|Integrative Medicine|integrative medicine
282803|NCT02443766|Alternative Medicine|alternative medicine
282804|NCT02443766|Complementary Medicine|complementary medicine
282805|NCT02443766|Meditation Retreat|meditation retreat
282806|NCT02443766|Ignatian Retreat|ignatian retreat
282807|NCT02443766|Single Photon Emission Computed Tomography (SPECT)|single photon emission computed tomography (spect)
282808|NCT02443766|Functional Magnetic Resonance Imaging (fMRI)|functional magnetic resonance imaging (fmri)
282809|NCT02443766|Wellbeing|wellbeing
282810|NCT02443766|General Health|general health
282811|NCT02443740|First in human|first in human
282812|NCT02443740|Single Ascending Dose Study|single ascending dose study
282813|NCT02443740|Safety and Tolerability|safety and tolerability
282814|NCT02443740|Pharmacokinetics|pharmacokinetics
282815|NCT02443740|Plasma|plasma
282816|NCT02443740|Cerebrospinal Fluid|cerebrospinal fluid
282817|NCT02443714|Needle-Free Jet Injection|needle-free jet injection
282818|NCT02443714|Insulin Lispro|insulin lispro
282819|NCT02443714|pharmacokinetics|pharmacokinetics
282820|NCT02443714|pharmacodynamics|pharmacodynamics
282821|NCT02443636|Depression|depression
282822|NCT02443636|Mental Health|mental health
282823|NCT02443636|Registry|registry
282824|NCT02443636|Reliability|reliability
282825|NCT02443636|Post Traumatic Stress Disorder|post traumatic stress disorder
282826|NCT02443636|Bipolar Disorder|bipolar disorder
282827|NCT02443636|Mood disorder|mood disorder
282828|NCT02443636|Suicide|suicide
282829|NCT02443610|Postpartum Hemorrhage|postpartum hemorrhage
282830|NCT02443610|Venous Thromboembolism|venous thromboembolism
282831|NCT02443610|Pregnancy|pregnancy
282832|NCT02443597|ultrasound|ultrasound
282833|NCT02443597|trisomy screening|trisomy screening
282834|NCT02443597|obesity|obesity
282835|NCT02443584|depression|depression
282836|NCT02443584|pharmacogenetics|pharmacogenetics
282837|NCT02443584|pharmacogenomics|pharmacogenomics
282838|NCT02443584|major depressive disorder|major depressive disorder
282839|NCT02443584|genetics|genetics
282840|NCT02443584|anti-depressants|anti-depressants
282841|NCT02443571|observational study|observational study
282842|NCT02443558|Robotics|robotics
282843|NCT02443558|Cerebral cortex|cerebral cortex
282844|NCT02443558|Brain waves|brain waves
282845|NCT02443558|Electroencephalography|electroencephalography
282846|NCT02443558|Rehabilitation|rehabilitation
282847|NCT02443558|Brain-Computer Interfaces|brain-computer interfaces
282848|NCT02443545|Iron overload|iron overload
282849|NCT02443545|Sickle cell disease|sickle cell disease
282850|NCT02443545|Deferiprone|deferiprone
282851|NCT02443545|Ferriprox|ferriprox
282852|NCT02443545|Iron chelation|iron chelation
282853|NCT02443519|Mindfulness|mindfulness
282854|NCT02443519|MBCT|mbct
282855|NCT02443519|Cognitive Therapy|cognitive therapy
282856|NCT02443519|Disability|disability
282857|NCT02443428|Breast Cancer|breast cancer
282858|NCT02443402|Non diabetic hyperglycemia|non diabetic hyperglycemia
282859|NCT02443389|nephrotoxic|nephrotoxic
282860|NCT02443389|Fluid overload|fluid overload
282861|NCT02443389|Acute renal failure|acute renal failure
282862|NCT02443389|Prematurity|prematurity
282863|NCT02443389|Risk factors|risk factors
282864|NCT02443389|Epidemiology|epidemiology
282865|NCT02443324|immuno-oncology|immuno-oncology
282866|NCT02443324|Vascular Endothelial Growth Factor (VEGF)|vascular endothelial growth factor (vegf)
282867|NCT02443324|angiogenesis|angiogenesis
282868|NCT02443324|PD-1|pd-1
282869|NCT02443324|carcinoma of the bladder|carcinoma of the bladder
282870|NCT02443324|carcinoma of the urethra|carcinoma of the urethra
282871|NCT02443324|carcinoma of the ureter|carcinoma of the ureter
282872|NCT02443324|carcinoma of the renal pelvis|carcinoma of the renal pelvis
282873|NCT02443324|carcinoma of the biliary tract|carcinoma of the biliary tract
282874|NCT02443259|NAPI|napi
282875|NCT02443259|late preterm|late preterm
282876|NCT02443207|Toothache|toothache
282877|NCT02443207|Quality of life|quality of life
282878|NCT02443207|Oral Health|oral health
282879|NCT02443207|Children|children
282880|NCT02443194|depression|depression
282881|NCT02443194|glioblastoma|glioblastoma
282882|NCT02443181|Essential tremor; closed-loop DBS|essential tremor; closed-loop dbs
282883|NCT02443168|Pharmacokinetic|pharmacokinetic
282884|NCT02443168|Healthy|healthy
282885|NCT02443168|Male|male
282886|NCT02443168|AG-221|ag-221
282887|NCT02443168|[14C]|[14c]
282888|NCT02443168|Single dose|single dose
282889|NCT02443168|Oral|oral
282890|NCT02443168|Intravenous|intravenous
282891|NCT02443142|mild TBI|mild tbi
282892|NCT02443142|concussion|concussion
282893|NCT02443142|post-concussion syndrome|post-concussion syndrome
282894|NCT02443103|pilot study|pilot study
282895|NCT02443103|guanabenz acetate|guanabenz acetate
282896|NCT02443090|secondary hypogonadism|secondary hypogonadism
282897|NCT02443090|sexual dysfunction|sexual dysfunction
282898|NCT02443090|erectile dysfunction|erectile dysfunction
282899|NCT02443064|Pharmacokinetics/pharmacodynamics|pharmacokinetics/pharmacodynamics
282900|NCT02443064|vancomycin|vancomycin
282901|NCT02443064|blood stream infections|blood stream infections
282902|NCT02443064|Chinese patients|chinese patients
282903|NCT02443064|MRSA|mrsa
282904|NCT02443038|patient fall|patient fall
282905|NCT02443038|yoga|yoga
282906|NCT02443038|balance|balance
282907|NCT02443012|Diabetic Macular Edema|diabetic macular edema
282908|NCT02443012|Nepafenac|nepafenac
282909|NCT02443012|Laser therapy|laser therapy
282910|NCT02443012|Clinically significant macular edema|clinically significant macular edema
282911|NCT02443012|Adjunct Treatment|adjunct treatment
282912|NCT02443012|Topical Nepafenac|topical nepafenac
282913|NCT02442986|weaning failure|weaning failure
282914|NCT02442986|polyneuropathy|polyneuropathy
282915|NCT02442986|encephalopathy|encephalopathy
282916|NCT02442986|sepsis|sepsis
282917|NCT02442947|stress when dressed|stress when dressed
282918|NCT02442947|protective garment|protective garment
282919|NCT02442947|work clothes|work clothes
282920|NCT02442934|Critical Care|critical care
282921|NCT02442934|Critical Care Nursing|critical care nursing
282922|NCT02442934|Discomfort|discomfort
282923|NCT02442934|Sleep deprivation|sleep deprivation
282924|NCT02442934|Noise|noise
282925|NCT02442934|Thirst|thirst
282926|NCT02442934|Pain|pain
282927|NCT02442895|mature oocytes|mature oocytes
282928|NCT02442895|antral follicles count|antral follicles count
282929|NCT02442895|follicle stimulating hormone|follicle stimulating hormone
282930|NCT02442895|antimullerian hormone|antimullerian hormone
282931|NCT02442882|Brain Concussion|brain concussion
282932|NCT02442882|Balance|balance
282933|NCT02442882|Locomotion|locomotion
282934|NCT02442882|Mild Traumatic Brain Injury|mild traumatic brain injury
282935|NCT02442869|Suicide|suicide
282936|NCT02442817|DPP-4 Inhibitor|dpp-4 inhibitor
282937|NCT02442817|Linagliptin|linagliptin
282938|NCT02442817|SDF1-α|sdf1-α
282939|NCT02442804|Pomegranate|pomegranate
282940|NCT02442804|Stroke|stroke
282941|NCT02442804|Neuropsychology|neuropsychology
282942|NCT02442791|Cardiac arrest|cardiac arrest
282943|NCT02442791|GLP-1|glp-1
282944|NCT02442791|Neuroprotection|neuroprotection
282945|NCT02442752|Drug therapy|drug therapy
282946|NCT02442739|Ketamine|ketamine
282947|NCT02442739|Prevention of depression|prevention of depression
282948|NCT02442726|Heat Injury|heat injury
282949|NCT02442726|Humans|humans
282950|NCT02442726|Laser Stimulation|laser stimulation
282951|NCT02442726|Quantitative Sensory Testing|quantitative sensory testing
282952|NCT02442726|Reaction Time|reaction time
282953|NCT02442726|Secondary Hyperalgesia|secondary hyperalgesia
282954|NCT02442726|Thermal Thresholds|thermal thresholds
282955|NCT02442713|Polysomnograph|polysomnograph
282956|NCT02442713|fluvoxamine|fluvoxamine
282957|NCT02442700|HIV-infected patients with dyslipidemia and receiving atazanavir/ritonavir|hiv-infected patients with dyslipidemia and receiving atazanavir/ritonavir
282958|NCT02442674|Hyponatremia|hyponatremia
282959|NCT02442674|Euvolemic|euvolemic
282960|NCT02442674|Hypervolemic|hypervolemic
282961|NCT02442674|Serum sodium|serum sodium
282962|NCT02442674|Dilutional hyponatremia|dilutional hyponatremia
282963|NCT02442674|Electrolyte abnormality|electrolyte abnormality
282964|NCT02442674|Electrolyte imbalance|electrolyte imbalance
282965|NCT02442674|Metabolic disease|metabolic disease
282966|NCT02442674|Water-Electrolyte Imbalance|water-electrolyte imbalance
282967|NCT02442648|Renal Transplantation|renal transplantation
282968|NCT02442648|Carfilzomib|carfilzomib
282969|NCT02442648|Kyprolis|kyprolis
282970|NCT02442648|Desensitization|desensitization
282971|NCT02442622|de Quervain's disease|de quervain's disease
282972|NCT02442622|de Quervain's tenosynovitis.|de quervain's tenosynovitis.
282973|NCT02442622|ASTYM|astym
282974|NCT02442622|de Quervain's treatment|de quervain's treatment
282975|NCT02442609|internet|internet
282976|NCT02442609|anesthesia|anesthesia
282977|NCT02442609|information|information
282978|NCT02442609|surgery|surgery
282979|NCT02442609|question|question
282980|NCT02442596|Abdominal sepsis|abdominal sepsis
282981|NCT02442596|Sepsis|sepsis
282982|NCT02442596|Septic shock|septic shock
282983|NCT02442596|Epidemiology|epidemiology
282984|NCT02442596|Etiology|etiology
282985|NCT02442596|Microbiology|microbiology
282986|NCT02442596|Abdomen|abdomen
282987|NCT02442596|Intra-abdominal|intra-abdominal
282988|NCT02442596|Infection|infection
282989|NCT02442596|Gastrointestinal tract|gastrointestinal tract
282990|NCT02442596|Perforation|perforation
282991|NCT02442596|Peritonitis|peritonitis
282992|NCT02442596|Pancreas|pancreas
282993|NCT02442596|Biliary tract|biliary tract
282994|NCT02442596|Megacolon|megacolon
282995|NCT02442583|colorectal cancer|colorectal cancer
282996|NCT02442583|survivor|survivor
282997|NCT02442583|exercise|exercise
282998|NCT02442583|physical activity|physical activity
282999|NCT02442583|sedentary|sedentary
283000|NCT02442570|alpha B-crystallin|alpha b-crystallin
283001|NCT02442570|immune tolerance|immune tolerance
283002|NCT02442557|alpha B-crystallin|alpha b-crystallin
283003|NCT02442557|immune tolerance|immune tolerance
283004|NCT02442518|placenta accreta|placenta accreta
283005|NCT02442518|placenta previa|placenta previa
283006|NCT02442518|ultrasound|ultrasound
283007|NCT02442505|Atrial Fibrillation; Pacemaker; Device-detected; Sensitivity; Specificity|atrial fibrillation; pacemaker; device-detected; sensitivity; specificity
283008|NCT02442492|sildenafil|sildenafil
283009|NCT02442492|IUGR|iugr
283011|NCT02442492|STRIDER|strider
283012|NCT02442479|exercise|exercise
283013|NCT02442479|resistance training|resistance training
283014|NCT02442479|muscle strength|muscle strength
283015|NCT02442479|muscle hypertrophy|muscle hypertrophy
283016|NCT02442440|anisodamine|anisodamine
283017|NCT02442440|septic shock|septic shock
283018|NCT02442427|Respiratory syncytial virus|respiratory syncytial virus
283019|NCT02442427|Palivizumab|palivizumab
283020|NCT02442427|Bronchiolitis|bronchiolitis
283021|NCT02442427|Treatment|treatment
283022|NCT02442414|Cancer|cancer
283023|NCT02442414|Advanced Solid Tumors|advanced solid tumors
283024|NCT02442414|EGFR|egfr
283025|NCT02442414|HER2|her2
283026|NCT02442414|HER3|her3
283027|NCT02442414|HER4|her4
283028|NCT02442414|ALK mutations|alk mutations
283029|NCT02442414|irreversible tyrosine kinase inhibitor|irreversible tyrosine kinase inhibitor
283030|NCT02442414|Metastatic Non Small Cell Lung Cancer|metastatic non small cell lung cancer
283031|NCT02442414|Gastric Cancer|gastric cancer
283032|NCT02442414|Colorectal Cancer|colorectal cancer
283033|NCT02442388|pain|pain
283034|NCT02442388|root canal therapy|root canal therapy
283035|NCT02442388|endodontics|endodontics
283036|NCT02442388|file|file
283037|NCT02442375|head and neck cancer|head and neck cancer
283235|NCT02441673|Tramadol|tramadol
283038|NCT02442375|accelerated radiotherapy|accelerated radiotherapy
283039|NCT02442375|dose reduction|dose reduction
283040|NCT02442375|dose de-escalation|dose de-escalation
283041|NCT02442375|elective lymph nodes|elective lymph nodes
283042|NCT02442375|FDG-PET|fdg-pet
283043|NCT02442349|Phase II, Open Label, Single-arm study, Safety and Efficacy of AZD9291, Asia Pacific, NSCLC with T790M mutation within the Epidermal Growth Factor Receptor Gene|phase ii, open label, single-arm study, safety and efficacy of azd9291, asia pacific, nsclc with t790m mutation within the epidermal growth factor receptor gene
283044|NCT02442310|deferiprone|deferiprone
283045|NCT02442310|deferiprone delayed release formulation|deferiprone delayed release formulation
283046|NCT02442310|pharmacokinetics|pharmacokinetics
283047|NCT02442297|CNS Tumors|cns tumors
283048|NCT02442297|T cells Expressing HER2-specific Chimeric Antigen Receptors|t cells expressing her2-specific chimeric antigen receptors
283049|NCT02442297|HER2-specific T cells|her2-specific t cells
283050|NCT02442297|intracranial injection|intracranial injection
283051|NCT02442284|Chronic Hepatitis C|chronic hepatitis c
283052|NCT02442284|Interferon-Free|interferon-free
283053|NCT02442284|Hepatitis C Genotype 1|hepatitis c genotype 1
283054|NCT02442284|Hepatitis C Virus|hepatitis c virus
283055|NCT02442284|Hepatitis C|hepatitis c
283056|NCT02442284|Cirrhosis|cirrhosis
283057|NCT02442271|Chronic Hepatitis C|chronic hepatitis c
283058|NCT02442271|Hepatitis C Treatment Naive|hepatitis c treatment naive
283059|NCT02442271|Hepatitis C Genotype 1|hepatitis c genotype 1
283060|NCT02442271|Hepatitis C Treatment Experienced|hepatitis c treatment experienced
283061|NCT02442271|Hepatitis C Virus|hepatitis c virus
283062|NCT02442258|Renal Impairment|renal impairment
283063|NCT02442219|gluten|gluten
283064|NCT02442219|Tetramer|tetramer
283065|NCT02442206|QVA149, cardiac function, ventricular enddiastolic volume, hyperinflated COPD patients|qva149, cardiac function, ventricular enddiastolic volume, hyperinflated copd patients
283066|NCT02442154|early tracheostomy|early tracheostomy
283067|NCT02442154|severe head injury|severe head injury
283068|NCT02442154|endotracheal intubation|endotracheal intubation
283069|NCT02442141|Near-Infrared Spectroscopy|near-infrared spectroscopy
283070|NCT02442141|Cerebral|cerebral
283071|NCT02442141|Infants|infants
283072|NCT02442141|Anesthesia|anesthesia
283073|NCT02442141|Neurodevelopmental|neurodevelopmental
283074|NCT02442128|Fentany|fentany
283075|NCT02442128|intubation|intubation
283076|NCT02442128|sevoflurane|sevoflurane
283077|NCT02442128|children|children
283078|NCT02442128|Propofol|propofol
283079|NCT02442115|Autism|autism
283080|NCT02442115|Autism Spectrum Disorder (ASD)|autism spectrum disorder (asd)
283081|NCT02442115|Tummy Troubles|tummy troubles
283082|NCT02442115|Constipation|constipation
283083|NCT02442115|GI Disorders|gi disorders
283084|NCT02442115|Gastrointestinal Disorders|gastrointestinal disorders
283085|NCT02442115|Gastrointestinal|gastrointestinal
283086|NCT02442115|Oxidative Stress|oxidative stress
283087|NCT02442115|Stomach problems|stomach problems
283088|NCT02442115|Behaviors|behaviors
283089|NCT02442115|Autistic|autistic
283091|NCT02442115|MET gene|met gene
283092|NCT02442115|GID|gid
283093|NCT02442115|Pediatric|pediatric
283094|NCT02442115|Pediatric GI disorders|pediatric gi disorders
283095|NCT02442115|Children with Autism|children with autism
283096|NCT02442115|functional constipation|functional constipation
283097|NCT02442102|deglutition disorders|deglutition disorders
283098|NCT02442102|therapeutics|therapeutics
283099|NCT02442102|rehabilitation|rehabilitation
283100|NCT02442102|outcome assessment|outcome assessment
283101|NCT02442102|intubation|intubation
283102|NCT02442102|critical care|critical care
283103|NCT02442102|larynx|larynx
283104|NCT02442102|voice|voice
283105|NCT02442089|mHealth|mhealth
283106|NCT02442089|eHealth|ehealth
283107|NCT02442089|Health Systems|health systems
283108|NCT02442089|Health Technology|health technology
283109|NCT02442089|No Show|no show
283110|NCT02442089|Non-attendance|non-attendance
283111|NCT02442089|Chile|chile
283112|NCT02442089|Randomized controlled trial|randomized controlled trial
283113|NCT02442089|Efficiency, Organizational|efficiency, organizational
283114|NCT02442089|Pediatric Hospitals|pediatric hospitals
283115|NCT02442089|Global Health|global health
283116|NCT02442089|Referral and Consultation|referral and consultation
283117|NCT02442089|Health Care Systems|health care systems
283118|NCT02442089|Community Health Systems|community health systems
283119|NCT02442089|Health Information Systems|health information systems
283120|NCT02442089|Integrated Health Care Systems|integrated health care systems
283121|NCT02442089|Community Medicine|community medicine
283122|NCT02442076|Skin vibration|skin vibration
283123|NCT02442076|Acupuncture needle vibration|acupuncture needle vibration
283124|NCT02442050|CABG|cabg
283125|NCT02442050|valve surgery|valve surgery
283126|NCT02442050|cardioplegia|cardioplegia
283127|NCT02442050|heart surgery|heart surgery
283128|NCT02442050|cardiac surgery|cardiac surgery
283129|NCT02442050|Cardio-Pulmonary Bypass|cardio-pulmonary bypass
283130|NCT02442050|myocardial arrest|myocardial arrest
283131|NCT02442050|coronary artery bypass graft|coronary artery bypass graft
283132|NCT02442050|CPB|cpb
283133|NCT02442037|cellular therapy|cellular therapy
283134|NCT02442037|active ulcerative colitis|active ulcerative colitis
283135|NCT02442037|phase 1/2 clinical study|phase 1/2 clinical study
361772|NCT02043691|Stent|stent
283136|NCT02442037|human umbilical cord mesenchymal stem cell|human umbilical cord mesenchymal stem cell
283137|NCT02442037|allogeneic stem cell transplantation|allogeneic stem cell transplantation
283139|NCT02442024|diabetes mellitus|diabetes mellitus
283140|NCT02442024|diet|diet
283141|NCT02442024|nutrient sensing|nutrient sensing
283142|NCT02442011|Hematology Biobank|hematology biobank
283143|NCT02441998|Colorectal Cancer|colorectal cancer
283144|NCT02441998|Diminutive Polyps|diminutive polyps
283145|NCT02441998|Narrow Band Imaging|narrow band imaging
283146|NCT02441998|Colonic Polyps|colonic polyps
283147|NCT02441998|colonoscopy|colonoscopy
283148|NCT02441998|diagnostic imaging|diagnostic imaging
283149|NCT02441998|optical diagnosis|optical diagnosis
283150|NCT02441985|Primary orthostatic tremor|primary orthostatic tremor
283151|NCT02441946|cyclin-dependent kinase (CDK) 4/6 inhibitor|cyclin-dependent kinase (cdk) 4/6 inhibitor
283152|NCT02441946|CDK 4 and 6 inhibitor|cdk 4 and 6 inhibitor
283153|NCT02441907|Diabetic Macular Edema|diabetic macular edema
283154|NCT02441907|Ocular Cytokines|ocular cytokines
283155|NCT02441907|Triamcinolone Acetonide|triamcinolone acetonide
283156|NCT02441881|Radiofrequency ablation|radiofrequency ablation
283157|NCT02441881|varicose veins|varicose veins
283158|NCT02441881|endothermal ablation|endothermal ablation
283159|NCT02441881|RFITT|rfitt
283160|NCT02441881|Venefit|venefit
283161|NCT02441842|β-blocker|β-blocker
283162|NCT02441842|ACE inhibitor|ace inhibitor
283163|NCT02441842|Stress|stress
283164|NCT02441842|Craniotomy|craniotomy
283165|NCT02441842|Postop hypertension|postop hypertension
283166|NCT02441842|neurosurgical patients|neurosurgical patients
283167|NCT02441829|Renal Impairment|renal impairment
283168|NCT02441816|wet AMD|wet amd
283169|NCT02441816|neovascular AMD|neovascular amd
283170|NCT02441803|Leukemia|leukemia
283171|NCT02441803|Acute myeloid leukemia|acute myeloid leukemia
283172|NCT02441803|AML|aml
283173|NCT02441803|Refractory|refractory
283174|NCT02441803|Allogeneic hematopoietic stem cell transplantation|allogeneic hematopoietic stem cell transplantation
283175|NCT02441803|AHSCT|ahsct
283176|NCT02441803|Busulfan|busulfan
283177|NCT02441803|Busulfex|busulfex
283178|NCT02441803|Myleran|myleran
283179|NCT02441803|Fludarabine|fludarabine
283180|NCT02441803|Fludarabine Phosphate|fludarabine phosphate
283181|NCT02441803|Fludara|fludara
283182|NCT02441803|Clofarabine|clofarabine
283183|NCT02441803|Clofarex|clofarex
283184|NCT02441803|Clolar|clolar
283185|NCT02441803|Total body irradiation|total body irradiation
283186|NCT02441803|TBI|tbi
283187|NCT02441803|XRT|xrt
283188|NCT02441803|Thymoglobulin|thymoglobulin
283189|NCT02441803|ATG (Rabbit)|atg (rabbit)
283190|NCT02441803|Rabbit antithymocyte Globulin|rabbit antithymocyte globulin
283191|NCT02441803|Rabbit Antilymphocyte Globulin|rabbit antilymphocyte globulin
283192|NCT02441803|Rabbit ATG|rabbit atg
283193|NCT02441803|rATG|ratg
283194|NCT02441803|Stem cell infusion|stem cell infusion
283195|NCT02441803|Cyclophosphamide|cyclophosphamide
283196|NCT02441803|Cytoxan|cytoxan
283197|NCT02441803|Neosar|neosar
283198|NCT02441803|Tacrolimus|tacrolimus
283199|NCT02441803|Prograf|prograf
283200|NCT02441803|Mycophenolate mofetil|mycophenolate mofetil
283201|NCT02441803|MMF|mmf
283202|NCT02441803|CellCept|cellcept
283203|NCT02441803|Decitabine|decitabine
283204|NCT02441803|Dacogen|dacogen
283205|NCT02441803|Cytarabine|cytarabine
283206|NCT02441803|Ara-C|ara-c
283207|NCT02441803|Cytosar|cytosar
283208|NCT02441803|DepoCyt|depocyt
283209|NCT02441803|Cytosine Arabinosine Hydrochloride|cytosine arabinosine hydrochloride
283210|NCT02441803|Idarubicin|idarubicin
283211|NCT02441803|Idamycin|idamycin
283212|NCT02441790|5th metacarpal|5th metacarpal
283213|NCT02441790|EAROM|earom
283214|NCT02441790|standard immobilization|standard immobilization
283215|NCT02441790|Boxer's Fracture|boxer's fracture
283216|NCT02441790|hand function|hand function
283217|NCT02441790|DASH|dash
283218|NCT02441790|trauma|trauma
283219|NCT02441777|retinal imaging|retinal imaging
283220|NCT02441777|optical imaging|optical imaging
283221|NCT02441777|optical coherence tomography|optical coherence tomography
283222|NCT02441777|polarization sensitive coherence tomography|polarization sensitive coherence tomography
283223|NCT02441764|Halaven|halaven
283224|NCT02441764|Eribulin Mesylate|eribulin mesylate
283225|NCT02441764|locally advanced or metastatic breast cancer|locally advanced or metastatic breast cancer
283226|NCT02441751|Electrocardiography|electrocardiography
283227|NCT02441751|Hemorrhage|hemorrhage
283228|NCT02441751|Monitoring, Intraoperative|monitoring, intraoperative
283229|NCT02441738|Atrial Fibrillation|atrial fibrillation
283230|NCT02441738|Hybrid Ablation|hybrid ablation
283231|NCT02441738|Catheter Ablation|catheter ablation
283232|NCT02441686|Multiple Myeloma|multiple myeloma
283233|NCT02441673|Postanaesthetic shivering|postanaesthetic shivering
283234|NCT02441673|Subarachnoid block|subarachnoid block
283236|NCT02441673|Nefopam|nefopam
283237|NCT02441621|fluid responsiveness|fluid responsiveness
283238|NCT02441621|diastolic dysfunction|diastolic dysfunction
283239|NCT02441621|left ventricular|left ventricular
283240|NCT02441556|thrombectomy|thrombectomy
283241|NCT02441556|rt-PA|rt-pa
283242|NCT02441556|stroke|stroke
283243|NCT02441556|endovascular treatment|endovascular treatment
283244|NCT02441556|randomized|randomized
283245|NCT02441530|vitamin D|vitamin d
283246|NCT02441517|Xtandi|xtandi
283247|NCT02441517|Metastatic Castration Resistant Prostate Cancer|metastatic castration resistant prostate cancer
283248|NCT02441517|Metastatic|metastatic
283249|NCT02441517|Prostate Cancer|prostate cancer
283250|NCT02441517|Chemotherapy|chemotherapy
283251|NCT02441517|Castration-resistant|castration-resistant
283252|NCT02441517|Enzalutamide|enzalutamide
283253|NCT02441504|Exercise training|exercise training
283254|NCT02441504|microvascular rarefaction|microvascular rarefaction
283255|NCT02441478|cooperative behavior, therapy adherence, fMRI|cooperative behavior, therapy adherence, fmri
283256|NCT02441452|Nuss procedure|nuss procedure
283257|NCT02441452|postoperative care|postoperative care
283258|NCT02441452|early ambulation|early ambulation
283259|NCT02441426|Cognitive development|cognitive development
283260|NCT02441426|Diarrheal disease|diarrheal disease
283261|NCT02441426|Enteric infections|enteric infections
283262|NCT02441426|Malnutrition|malnutrition
283263|NCT02441426|Vaccine Response|vaccine response
283264|NCT02441426|Enteropathy|enteropathy
283265|NCT02441426|Antibiotic use|antibiotic use
283266|NCT02441426|Micronutrients|micronutrients
283267|NCT02441426|Breast feeding|breast feeding
283268|NCT02441426|Gut inflammation|gut inflammation
283269|NCT02441413|HRCT|hrct
283270|NCT02441413|High Resolution Computed Tomography scans|high resolution computed tomography scans
283271|NCT02441413|Functional Respiratory Imaging|functional respiratory imaging
283272|NCT02441413|FRI|fri
283273|NCT02441413|Computed Tomography|computed tomography
283274|NCT02441413|CT|ct
283275|NCT02441413|Bronchiolitis Obliterans Syndrome|bronchiolitis obliterans syndrome
283276|NCT02441413|BOS|bos
283277|NCT02441413|Lung Transplant|lung transplant
283278|NCT02441400|GERD|gerd
283279|NCT02441400|LES Pressure|les pressure
283280|NCT02441400|Electrical Stimulation|electrical stimulation
283281|NCT02441387|depression|depression
283282|NCT02441387|elderly|elderly
283283|NCT02441387|remission|remission
283284|NCT02441387|treatment response|treatment response
283285|NCT02441387|predictors of response|predictors of response
283286|NCT02441387|cognitive decline|cognitive decline
283287|NCT02441387|structural neuroimage|structural neuroimage
283288|NCT02441387|genetic polymorphism|genetic polymorphism
283289|NCT02441387|psychoeducation|psychoeducation
283290|NCT02441374|Stroke|stroke
283291|NCT02441374|Hemiparesis|hemiparesis
283292|NCT02441374|Upper limb|upper limb
283293|NCT02441348|Voice Therapy|voice therapy
283294|NCT02441348|Muscle Tension Dysphonia|muscle tension dysphonia
283295|NCT02441348|Lesions|lesions
283296|NCT02441309|Metastatic and/or Recurrent Osteosarcoma|metastatic and/or recurrent osteosarcoma
283297|NCT02441283|Chronic hepatitis C|chronic hepatitis c
283298|NCT02441283|Hepatitis C virus|hepatitis c virus
283299|NCT02441283|Sustained virologic response|sustained virologic response
283300|NCT02441283|Hepatitis C|hepatitis c
283301|NCT02441283|Direct Acting Antiviral|direct acting antiviral
283302|NCT02441257|Gastroesophageal Reflux|gastroesophageal reflux
283303|NCT02441257|Laryngeal Mask Airway|laryngeal mask airway
283304|NCT02441257|Control Ventilation|control ventilation
283305|NCT02441257|Spontaneous Ventilation|spontaneous ventilation
283306|NCT02441205|High Intensity Interval Training|high intensity interval training
283307|NCT02441192|physical training|physical training
283308|NCT02441192|aerobic training|aerobic training
283309|NCT02441192|resistance training|resistance training
283310|NCT02441179|acute intermittent hypoxia|acute intermittent hypoxia
283311|NCT02441179|rehabilitation|rehabilitation
283312|NCT02441179|spinal cord injury|spinal cord injury
283313|NCT02441166|Bone marrow tryptase|bone marrow tryptase
283314|NCT02441166|cutaneous mastocytosis|cutaneous mastocytosis
283315|NCT02441140|Stage III Ovarian Cancer|stage iii ovarian cancer
283316|NCT02441140|Stage IV Ovarian Cancer|stage iv ovarian cancer
283317|NCT02441127|free gingival graft|free gingival graft
283318|NCT02441127|diode laser|diode laser
283319|NCT02441127|donor site|donor site
283320|NCT02441127|mucogingival surgery|mucogingival surgery
283321|NCT02441101|Cardiac Resynchronization therapy|cardiac resynchronization therapy
283322|NCT02441075|patients|patients
283323|NCT02441075|BMT|bmt
283324|NCT02441075|cyclosporine|cyclosporine
283325|NCT02441075|tacrolimus|tacrolimus
283326|NCT02441075|HSCT|hsct
283327|NCT02441049|Latino|latino
283328|NCT02441049|Hispanic|hispanic
283329|NCT02441049|Diet|diet
283330|NCT02441049|Family health|family health
283331|NCT02441049|Promotora|promotora
283332|NCT02441049|Intervention|intervention
283333|NCT02441036|Gene expression and protein production|gene expression and protein production
283334|NCT02441023|type 2 diabetes mellitus|type 2 diabetes mellitus
283335|NCT02441023|nutritional therapy|nutritional therapy
283336|NCT02441023|health education|health education
283337|NCT02441023|self-management|self-management
283338|NCT02441023|multimedia|multimedia
283339|NCT02440997|aromatherapy, peppermint|aromatherapy, peppermint
283340|NCT02440984|enteric nervous system|enteric nervous system
283341|NCT02440984|anorectal disorder|anorectal disorder
283342|NCT02440984|barostat anorectal|barostat anorectal
283343|NCT02440984|physiology|physiology
283344|NCT02440984|spina bifida|spina bifida
283345|NCT02440971|Adaptive Servo Ventilation|adaptive servo ventilation
283346|NCT02440971|Acute decompensated heart failure|acute decompensated heart failure
283347|NCT02440971|SleepMinder|sleepminder
283348|NCT02440971|ApneaLink Plus|apnealink plus
283349|NCT02440971|Sleep disordered breathing|sleep disordered breathing
283350|NCT02440971|Natriuretic peptide|natriuretic peptide
283351|NCT02440932|low Phenylalanine diet|low phenylalanine diet
283352|NCT02440932|PKU supplements|pku supplements
283353|NCT02440932|diet induced thermogenesis|diet induced thermogenesis
283354|NCT02440932|appetite|appetite
283355|NCT02440932|body weight|body weight
283356|NCT02440919|Respiratory mechanics|respiratory mechanics
283357|NCT02440919|Oxygenation|oxygenation
283358|NCT02440919|Suction|suction
283359|NCT02440919|Mechanical ventilation|mechanical ventilation
283360|NCT02440919|Respiratory therapy|respiratory therapy
283361|NCT02440919|Capnography|capnography
283362|NCT02440919|Pulmonary Ventilation|pulmonary ventilation
283363|NCT02440906|Asthma|asthma
283364|NCT02440906|Cerebrovascular Disease|cerebrovascular disease
283365|NCT02440906|Intracranial Injury|intracranial injury
283366|NCT02440906|Neoplasms|neoplasms
283367|NCT02440906|Heart Failure|heart failure
283368|NCT02440906|HIV/AIDs|hiv/aids
283369|NCT02440906|Hereditary and Degenerative Diseases of the Central Nervous System|hereditary and degenerative diseases of the central nervous system
283370|NCT02440906|Disorders of the Peripheral Nervous System|disorders of the peripheral nervous system
283371|NCT02440906|Rheumatoid Arthritis and Other Inflammatory Polyarthropathies|rheumatoid arthritis and other inflammatory polyarthropathies
283372|NCT02440906|History of hepatitis C|history of hepatitis c
283373|NCT02440906|Schizophrenia|schizophrenia
283374|NCT02440906|Episodic Mood Disorders|episodic mood disorders
283375|NCT02440906|Delusional Disorders|delusional disorders
283376|NCT02440906|Other Non-Organic Psychoses|other non-organic psychoses
283377|NCT02440906|Organic Psychotic Conditions|organic psychotic conditions
283378|NCT02440906|Neurotic Disorders|neurotic disorders
283379|NCT02440906|Other Non-Psychotic Mental Disorders|other non-psychotic mental disorders
283380|NCT02440893|Corus CAD|corus cad
283381|NCT02440893|ASGES|asges
283382|NCT02440893|Age/Sex/Gene Expression Score|age/sex/gene expression score
283383|NCT02440893|Gene Expression|gene expression
283384|NCT02440893|GES|ges
283385|NCT02440893|CAD|cad
283386|NCT02440893|CVD|cvd
283387|NCT02440893|CHD|chd
283388|NCT02440893|Precision Medicine|precision medicine
283389|NCT02440893|Coronary Artery Disease|coronary artery disease
283390|NCT02440893|Angina Pectoris|angina pectoris
283391|NCT02440893|Chest Pain|chest pain
283392|NCT02440893|Cardiovascular Disease|cardiovascular disease
283393|NCT02440893|Coronary Heart Disease|coronary heart disease
283394|NCT02440893|Metformin|metformin
283395|NCT02440867|theta burst stimulation|theta burst stimulation
283396|NCT02440867|Social Cognition|social cognition
283397|NCT02440867|MRSI|mrsi
283398|NCT02440867|Schizophrenia|schizophrenia
283399|NCT02440867|transcranial magnetic stimulation|transcranial magnetic stimulation
283400|NCT02440841|VA106483|va106483
283401|NCT02440841|fedovapagon|fedovapagon
283402|NCT02440841|drug-drug interaction|drug-drug interaction
283403|NCT02440841|DDI|ddi
283404|NCT02440841|males|males
283405|NCT02440841|rifampicin|rifampicin
283406|NCT02440841|rifampin|rifampin
283407|NCT02440841|itraconazole|itraconazole
283408|NCT02440841|CYP3A4|cyp3a4
283409|NCT02440841|pharmacokinetics|pharmacokinetics
283410|NCT02440841|PK|pk
283411|NCT02440815|Psychotherapy|psychotherapy
283412|NCT02440815|Problem Solving Therapy (PST)|problem solving therapy (pst)
283413|NCT02440815|Depression|depression
283414|NCT02440815|Major Depression|major depression
283415|NCT02440815|Major Depressive Disorder|major depressive disorder
283416|NCT02440815|Late Life Depression|late life depression
283417|NCT02440815|Multimodal imaging|multimodal imaging
283418|NCT02440815|Magnetic Resonance Imaging (MRI)|magnetic resonance imaging (mri)
283419|NCT02440815|Cerebral blood flow|cerebral blood flow
283420|NCT02440815|Cortical atrophy|cortical atrophy
283421|NCT02440815|White matter lesion|white matter lesion
283422|NCT02440763|Natural History|natural history
283423|NCT02440737|Newly diagnosed|newly diagnosed
283424|NCT02440737|Cancer patient|cancer patient
283425|NCT02440737|Caregiver|caregiver
283426|NCT02440737|Support person|support person
283427|NCT02440724|winged stents|winged stents
283428|NCT02440724|Self-expandable Metal Stents(SEMS)|self-expandable metal stents(sems)
283429|NCT02440724|partial covered|partial covered
283430|NCT02440724|uncovered|uncovered
283431|NCT02440724|endoscopic insertion|endoscopic insertion
283432|NCT02440685|DLBCL|dlbcl
283434|NCT02440685|MCL|mcl
283435|NCT02440685|PTCL|ptcl
283436|NCT02440685|MF|mf
283437|NCT02440685|CLL|cll
283438|NCT02440672|Osteoarthritis|osteoarthritis
283439|NCT02440672|TKA|tka
283440|NCT02440672|Degenerative Knee Disease|degenerative knee disease
283441|NCT02440659|Chronic Kidney Disease|chronic kidney disease
283442|NCT02440659|Hemodialysis|hemodialysis
283443|NCT02440659|Peritoneal Dialysis|peritoneal dialysis
283444|NCT02440646|Computed tomography angiography|computed tomography angiography
283445|NCT02440646|Quantitative coronary angiography|quantitative coronary angiography
283446|NCT02440646|Coronary artery disease|coronary artery disease
283447|NCT02440646|Natural history of atherosclerosis|natural history of atherosclerosis
283448|NCT02440646|Radiocontrast-induced thyroid dysfunction|radiocontrast-induced thyroid dysfunction
283449|NCT02440646|Contrast-induced nephropathy|contrast-induced nephropathy
283450|NCT02440646|Plaque burden|plaque burden
283451|NCT02440646|Glagovian artery remodeling|glagovian artery remodeling
283452|NCT02440646|Radiation dose|radiation dose
283453|NCT02440646|SYNTAX score|syntax score
283454|NCT02440646|Fractional flow reserve|fractional flow reserve
283455|NCT02440620|Heart failure related to medical treatment of breast cancer|heart failure related to medical treatment of breast cancer
283456|NCT02440607|Randomization|randomization
283457|NCT02440607|cognitive aids types|cognitive aids types
283458|NCT02440607|aids|aids
283459|NCT02440594|Primary Care|primary care
283460|NCT02440594|Depression|depression
283461|NCT02440594|Elderly|elderly
283462|NCT02440555|diabetes, capillary blood glucose, self-administered questionnaire|diabetes, capillary blood glucose, self-administered questionnaire
283463|NCT02440542|Nerve block|nerve block
283464|NCT02440542|Ankle|ankle
283465|NCT02440542|Talus|talus
283466|NCT02440542|Pain, Postoperative|pain, postoperative
283467|NCT02440516|Standardized|standardized
283468|NCT02440516|Physical therapy|physical therapy
283469|NCT02440516|occupational therapy|occupational therapy
283470|NCT02440516|quality of life|quality of life
283471|NCT02440516|disability|disability
283472|NCT02440516|activities of daily living|activities of daily living
283473|NCT02440516|ambulatory therapy|ambulatory therapy
283474|NCT02440516|multiple sclerosis|multiple sclerosis
283475|NCT02440464|Multiple Myeloma|multiple myeloma
283476|NCT02440464|Allogeneic Transplant|allogeneic transplant
283477|NCT02440464|Maintenance Therapy|maintenance therapy
283478|NCT02440464|Anti-Myeloma Agents|anti-myeloma agents
283479|NCT02440464|Hematologic Disorders|hematologic disorders
283480|NCT02440438|Clostridium difficile, recurrence, relapse, antibodies, immune response, prognosis|clostridium difficile, recurrence, relapse, antibodies, immune response, prognosis
283481|NCT02440425|platinum resistant|platinum resistant
283482|NCT02440425|recurrent|recurrent
283483|NCT02440425|persistent|persistent
283484|NCT02440425|epithelial|epithelial
283485|NCT02440425|ovarian|ovarian
283486|NCT02440425|fallopian tube|fallopian tube
283487|NCT02440425|primary peritoneal|primary peritoneal
283488|NCT02440425|carcinoma|carcinoma
283489|NCT02440412|Massage|massage
283490|NCT02440412|Stress|stress
283491|NCT02440412|salivary cortisol|salivary cortisol
283492|NCT02440360|chronic homelessness|chronic homelessness
283493|NCT02440347|local anesthesia|local anesthesia
283494|NCT02440347|articaine|articaine
283495|NCT02440347|AMSA|amsa
283496|NCT02440334|cryosurgery|cryosurgery
283497|NCT02440334|ultrasonography|ultrasonography
283498|NCT02440282|patients|patients
283499|NCT02440256|Cost-effectiveness|cost-effectiveness
283500|NCT02440256|Opioid substitution treatment|opioid substitution treatment
283501|NCT02440256|Integrated care|integrated care
283502|NCT02440256|HIV|hiv
283503|NCT02440256|HAART|haart
283504|NCT02440256|Testing|testing
283505|NCT02440256|Linkage to care|linkage to care
283506|NCT02440256|Treatment adherence|treatment adherence
283507|NCT02440230|adjuvant endocrine therapy|adjuvant endocrine therapy
283508|NCT02440230|safety|safety
283509|NCT02440230|Exemestane|exemestane
283510|NCT02440230|ovarian function suppression|ovarian function suppression
283511|NCT02440230|anastrozole|anastrozole
283512|NCT02440204|sevoflurane|sevoflurane
283513|NCT02440204|remifentanil|remifentanil
283514|NCT02440204|intubation without using muscle relaxants|intubation without using muscle relaxants
283515|NCT02440178|leukemia|leukemia
283516|NCT02440178|induction|induction
283517|NCT02440178|prophylaxis|prophylaxis
283518|NCT02440178|antifungal|antifungal
283519|NCT02440178|micafungin|micafungin
283520|NCT02440178|phase II|phase ii
283521|NCT02440165|nutrition|nutrition
283522|NCT02440165|nurse|nurse
283523|NCT02440165|intervention|intervention
283524|NCT02440165|malnutrition|malnutrition
283525|NCT02440126|Multiple Sclerosis|multiple sclerosis
283526|NCT02440126|immunological|immunological
283527|NCT02440126|biomarkers|biomarkers
283528|NCT02440126|observational|observational
283529|NCT02440126|Relapsing|relapsing
283530|NCT02440126|Remitting Multiple Sclerosis|remitting multiple sclerosis
283531|NCT02440100|Phase 1|phase 1
283532|NCT02440100|Multiple doses of PF-06648671|multiple doses of pf-06648671
283533|NCT02440100|safety, tolerability, PK|safety, tolerability, pk
283534|NCT02440100|plasma and CSF abeta|plasma and csf abeta
283535|NCT02440100|drug interaction|drug interaction
283536|NCT02440074|Lumbar pain|lumbar pain
283537|NCT02440074|Mesenchymal Stem Cells|mesenchymal stem cells
283538|NCT02440061|Ghrelin|ghrelin
283539|NCT02440061|age, BMI, and gender matched controls|age, bmi, and gender matched controls
283540|NCT02440048|extraction|extraction
283541|NCT02440048|Bond Apatite|bond apatite
283542|NCT02440035|Healthy Participants|healthy participants
283543|NCT02440035|Ad35.RSV.FA2|ad35.rsv.fa2
283544|NCT02440035|JNJ-61187191|jnj-61187191
283545|NCT02439996|Kawasaki disease IVIG|kawasaki disease ivig
283546|NCT02439970|kidney transplant allograft|kidney transplant allograft
283547|NCT02439970|recipients|recipients
283548|NCT02439944|Nicotine Patch|nicotine patch
283549|NCT02439944|Nicotine Mouth Spray|nicotine mouth spray
283550|NCT02439944|Smoking Cessation|smoking cessation
283551|NCT02439944|Quit Smoking|quit smoking
283552|NCT02439944|Abstinence|abstinence
283553|NCT02439944|Dependence|dependence
283554|NCT02439944|Nicotine|nicotine
283555|NCT02439944|Tobacco|tobacco
283556|NCT02439944|Transdermal Nicotine Replacement Therapy|transdermal nicotine replacement therapy
283557|NCT02439944|Functional Magnetic Resonance Imaging|functional magnetic resonance imaging
283558|NCT02439944|Neuroimaging|neuroimaging
283559|NCT02439944|Cue Reactivity|cue reactivity
283560|NCT02439944|Resting State|resting state
283561|NCT02439944|BOLD fMRI|bold fmri
283562|NCT02439905|inflammatory cytokine|inflammatory cytokine
283563|NCT02439905|protective effect|protective effect
283564|NCT02439905|Dexmedetomidine|dexmedetomidine
283565|NCT02439905|Precedex|precedex
283566|NCT02439905|one lung ventilation|one lung ventilation
283567|NCT02439905|ischemia-reperfusion|ischemia-reperfusion
283568|NCT02439892|Radiotherapy|radiotherapy
283569|NCT02439892|Exercise|exercise
283570|NCT02439892|Diet therapy|diet therapy
283571|NCT02439892|Rehabilitation|rehabilitation
283572|NCT02439892|Patient Compliance|patient compliance
283573|NCT02439892|Feasibility Studies|feasibility studies
283574|NCT02439892|Sample Size|sample size
283575|NCT02439892|Patient satisfaction|patient satisfaction
283576|NCT02439853|primary progressive aphasia|primary progressive aphasia
283577|NCT02439853|progressive nonfluent aphasia|progressive nonfluent aphasia
283578|NCT02439853|progressive aphasia|progressive aphasia
283579|NCT02439853|frontotemporal dementia|frontotemporal dementia
283580|NCT02439853|frontotemporal lobar degeneration|frontotemporal lobar degeneration
283581|NCT02439827|Lifestyle|lifestyle
283582|NCT02439827|Intervention|intervention
283583|NCT02439827|Motor Activity|motor activity
283584|NCT02439827|Mediating Variables|mediating variables
283585|NCT02439827|Mental Health|mental health
283586|NCT02439827|Obesity|obesity
283587|NCT02439827|Adolescent Health|adolescent health
283588|NCT02439827|School|school
283589|NCT02439827|Health Promotion|health promotion
283590|NCT02439827|Brazil|brazil
283591|NCT02439801|PEEP|peep
283592|NCT02439801|compliance|compliance
283593|NCT02439801|peak airway pressures|peak airway pressures
283594|NCT02439788|Neuroblastoma|neuroblastoma
283595|NCT02439788|Natural Killer T Cells|natural killer t cells
283596|NCT02439788|Gene Therapy|gene therapy
283597|NCT02439788|Chimeric Antigen Receptor|chimeric antigen receptor
283598|NCT02439775|Uncontrolled hypertension|uncontrolled hypertension
283599|NCT02439775|Renal denervation|renal denervation
283600|NCT02439762|Veterans|veterans
283601|NCT02439762|Cognitive Behavioral Therapy|cognitive behavioral therapy
283602|NCT02439749|Uncontrolled hypertension|uncontrolled hypertension
283603|NCT02439749|Renal denervation|renal denervation
283604|NCT02439736|Traumatic Brain Injury|traumatic brain injury
283605|NCT02439736|Head Injury|head injury
283606|NCT02439723|Regorafenib|regorafenib
283607|NCT02439723|Lean body mass|lean body mass
283608|NCT02439723|Proton pump inhibitors pharmacokinetics|proton pump inhibitors pharmacokinetics
283609|NCT02439684|HbA1c|hba1c
283610|NCT02439684|Diagnostic accuracy|diagnostic accuracy
283611|NCT02439684|Diabetes Mellitus|diabetes mellitus
283612|NCT02439684|Chinese|chinese
283613|NCT02439684|Impaired fasting glucose|impaired fasting glucose
283614|NCT02439671|Transition Support Program for young adults|transition support program for young adults
283615|NCT02439658|genetic research|genetic research
283616|NCT02439645|genetic research|genetic research
283617|NCT02439606|GlideRite|gliderite
283618|NCT02439606|Stylet|stylet
283619|NCT02439606|Parker|parker
283620|NCT02439606|orotracheal|orotracheal
283621|NCT02439606|intubation|intubation
283622|NCT02439606|GlideScope|glidescope
283623|NCT02439593|Pancreas|pancreas
283624|NCT02439593|chemoradiotherapy|chemoradiotherapy
283625|NCT02439593|hyperthermia|hyperthermia
283626|NCT02439580|Patients|patients
283627|NCT02439580|After Surgery|after surgery
283628|NCT02439567|Cirrhosis|cirrhosis
283629|NCT02439567|Chronic hepatitis C|chronic hepatitis c
283630|NCT02439567|Clinically significant portal hypertension|clinically significant portal hypertension
283631|NCT02439567|Portal hypertension|portal hypertension
283632|NCT02439567|Elastography|elastography
283633|NCT02439567|Antiviral therapy|antiviral therapy
283634|NCT02439541|cellular therapy|cellular therapy
283635|NCT02439541|Chronic ischemic heart disease|chronic ischemic heart disease
283636|NCT02439541|phase 1/2 clinical study|phase 1/2 clinical study
283637|NCT02439541|human umbilical cord mesenchymal stem cell|human umbilical cord mesenchymal stem cell
283638|NCT02439541|ischemic heart disease|ischemic heart disease
283639|NCT02439541|allogeneic stem cell transplantation|allogeneic stem cell transplantation
283640|NCT02439528|pulmonary fibrosis|pulmonary fibrosis
283641|NCT02439528|syndrome|syndrome
283642|NCT02439528|genetic|genetic
283643|NCT02439528|emphysema|emphysema
283644|NCT02439515|post-acute stroke|post-acute stroke
283645|NCT02439515|functional electrical stimulation|functional electrical stimulation
283646|NCT02439515|biofeedback|biofeedback
283647|NCT02439515|balance|balance
283648|NCT02439515|cycling|cycling
283649|NCT02439515|rehabilitation|rehabilitation
283650|NCT02439515|gait|gait
283651|NCT02439476|Multiple myeloma|multiple myeloma
283652|NCT02439476|ASCT|asct
283653|NCT02439476|plerixafor|plerixafor
283654|NCT02439476|stem cell mobilization|stem cell mobilization
283655|NCT02439476|Salvage ASCT using plerixafor-based stem cell mobilization in relapsed multiple myeloma|salvage asct using plerixafor-based stem cell mobilization in relapsed multiple myeloma
283656|NCT02439450|lung|lung
283657|NCT02439450|cancer|cancer
283658|NCT02439450|gp96|gp96
283659|NCT02439450|vaccine|vaccine
283660|NCT02439450|immunotherapy|immunotherapy
283661|NCT02439450|Heat Biologics|heat biologics
283662|NCT02439450|Nivolumab|nivolumab
283663|NCT02439450|checkpoint inhibitor|checkpoint inhibitor
283664|NCT02439385|Curcumin|curcumin
283665|NCT02439385|Avastin|avastin
283666|NCT02439385|FOLFIRI|folfiri
283667|NCT02439385|Colorectal cancer|colorectal cancer
283668|NCT02439385|Unresectable metastasis|unresectable metastasis
283669|NCT02439346|Advanced solid tumors|advanced solid tumors
283670|NCT02439346|Docetaxel|docetaxel
283671|NCT02439346|mitogen-activated protein (MAP) kinase-interacting serine / threonine-protein kinase 1, also known as Mnk1 (MKNK1 inhibitor)|mitogen-activated protein (map) kinase-interacting serine / threonine-protein kinase 1, also known as mnk1 (mknk1 inhibitor)
283672|NCT02439346|Taxanes|taxanes
283673|NCT02439346|Non-small cell lung cancer|non-small cell lung cancer
283674|NCT02439333|Acute exacerbation of chronic obstructive pulmonary disease|acute exacerbation of chronic obstructive pulmonary disease
283675|NCT02439333|Nasal high flow therapy|nasal high flow therapy
283676|NCT02439333|Oxygen therapy|oxygen therapy
283677|NCT02439307|Rifaximin|rifaximin
283678|NCT02439307|Minimal hepatic encephalopathy|minimal hepatic encephalopathy
283679|NCT02439294|Recent acute myocardial infarction|recent acute myocardial infarction
283680|NCT02439294|Obstructive sleep apnée (syndrome)|obstructive sleep apnée (syndrome)
283681|NCT02439294|Ventricular remodeling|ventricular remodeling
283682|NCT02439294|Continuous Positive Airway Pressure|continuous positive airway pressure
283683|NCT02439281|Ropivacaine|ropivacaine
283684|NCT02439281|Anesthesia adjuncts|anesthesia adjuncts
283685|NCT02439281|clonidine|clonidine
283686|NCT02439281|laparoscopic appendectomy|laparoscopic appendectomy
283687|NCT02439281|rectus sheath block|rectus sheath block
283688|NCT02439242|stroke volume, haemodynamic, fluid resucitation|stroke volume, haemodynamic, fluid resucitation
283689|NCT02439216|Muscular Dystrophies|muscular dystrophies
283690|NCT02439216|Musculoskeletal Diseases|musculoskeletal diseases
283691|NCT02439216|Nervous System Diseases|nervous system diseases
283692|NCT02439216|Neuromuscular Diseases|neuromuscular diseases
283693|NCT02439216|Duchenne muscular dystrophy|duchenne muscular dystrophy
283694|NCT02439216|DMD|dmd
283695|NCT02439216|dystrophin|dystrophin
283696|NCT02439216|dystrophy|dystrophy
283697|NCT02439216|Duchenne|duchenne
283698|NCT02439203|Parkinson Disease|parkinson disease
283699|NCT02439203|Levodopa Induced Dyskinesia (LID)|levodopa induced dyskinesia (lid)
283700|NCT02439203|Dyskinesia|dyskinesia
283701|NCT02439177|Blood glucose monitoring system|blood glucose monitoring system
283702|NCT02439177|System Accuracy|system accuracy
283703|NCT02439164|sedation|sedation
283704|NCT02439164|eloquent area glioma|eloquent area glioma
283705|NCT02439164|neurologic function|neurologic function
283706|NCT02439151|Extracorporeal Membrane Oxygenation|extracorporeal membrane oxygenation
283707|NCT02439138|Waldenstrom's Macroglobulinemia|waldenstrom's macroglobulinemia
283708|NCT02439125|levodopa|levodopa
283709|NCT02439125|dyskinesia|dyskinesia
283710|NCT02439125|parkinsons disease|parkinsons disease
283711|NCT02439125|PD|pd
283712|NCT02439112|Exercise|exercise
283713|NCT02439112|Physical Function|physical function
283714|NCT02439112|Physical Activity|physical activity
283715|NCT02439112|Quality of Life|quality of life
283716|NCT02439112|Pain|pain
283717|NCT02439112|Bone Disease|bone disease
283718|NCT02439086|rectal cancer|rectal cancer
283719|NCT02439086|neoadjuvant chemoradiotherapy|neoadjuvant chemoradiotherapy
751198|NCT00436501|RP 56976|rp 56976
283720|NCT02439086|long course radiotherapy|long course radiotherapy
283721|NCT02439086|response|response
283722|NCT02439047|reconstructive surgery|reconstructive surgery
283723|NCT02439047|abdominal surgery|abdominal surgery
283724|NCT02439034|pain management|pain management
283725|NCT02439034|brachytherapy|brachytherapy
283726|NCT02439008|liver metastases of colorectal cancer|liver metastases of colorectal cancer
283727|NCT02439008|metastases of melanoma or renal cancer|metastases of melanoma or renal cancer
283728|NCT02438969|Alcohol|alcohol
283729|NCT02438969|Alcohol Dependence|alcohol dependence
283730|NCT02438969|Stress|stress
283731|NCT02438969|Fear Conditioning|fear conditioning
283732|NCT02438917|Hepatitis C|hepatitis c
283733|NCT02438917|Cirrhosis|cirrhosis
283734|NCT02438917|Biomarkers|biomarkers
283735|NCT02438917|Fibrosis|fibrosis
283864|NCT02438072|Phenotypic study|phenotypic study
283736|NCT02438904|Blood And Marrow Transplantation|blood and marrow transplantation
283737|NCT02438904|Stem cell transplantation|stem cell transplantation
283738|NCT02438904|SCT|sct
283739|NCT02438904|Poor graft function|poor graft function
283740|NCT02438904|CD34+ cell infusion|cd34+ cell infusion
283741|NCT02438865|Upper Tract Urothelial Carcinoma|upper tract urothelial carcinoma
283742|NCT02438865|Intravesical Chemotherapy|intravesical chemotherapy
283743|NCT02438865|Epirubicin|epirubicin
283744|NCT02438865|Urothelial Carcinoma|urothelial carcinoma
283745|NCT02438800|Postpartum Period|postpartum period
283746|NCT02438787|Ankylosing Spondylitis|ankylosing spondylitis
283747|NCT02438787|Ustekinumab|ustekinumab
283748|NCT02438787|Golimumab|golimumab
283749|NCT02438787|STELARA|stelara
283750|NCT02438774|Post-harvest practices , complementary foods|post-harvest practices , complementary foods
283751|NCT02438774|aflatoxins and fumonisins exposure,|aflatoxins and fumonisins exposure,
283752|NCT02438774|Maize, breast milk|maize, breast milk
283753|NCT02438774|child growth, Tanzania|child growth, tanzania
283754|NCT02438761|Acute Myeloid Leukemia|acute myeloid leukemia
283755|NCT02438761|Myelodysplastic Syndrome|myelodysplastic syndrome
283756|NCT02438761|PIK/Akt/mTor|pik/akt/mtor
283757|NCT02438748|Oxidized Phosphatidylcholines|oxidized phosphatidylcholines
283758|NCT02438748|Oxylipins|oxylipins
283759|NCT02438735|ovarian endometriomas|ovarian endometriomas
283760|NCT02438735|AMH|amh
283761|NCT02438735|ovarian reserve|ovarian reserve
283762|NCT02438670|Artificial Pancreas|artificial pancreas
283763|NCT02438670|Type 1 Diabetes|type 1 diabetes
283764|NCT02438670|MPC|mpc
283765|NCT02438670|PID|pid
283766|NCT02438631|placenta|placenta
283767|NCT02438631|placental passage|placental passage
283768|NCT02438605|Nellix|nellix
283769|NCT02438605|EVAS|evas
283770|NCT02438605|EVAR|evar
283771|NCT02438605|Dynamic CT|dynamic ct
283772|NCT02438605|Dyna CT|dyna ct
283773|NCT02438592|Continuum of care|continuum of care
283774|NCT02438579|Hypertonic saline|hypertonic saline
283775|NCT02438579|nasal irrigation|nasal irrigation
283776|NCT02438579|gargling|gargling
283777|NCT02438579|URTI|urti
283778|NCT02438566|Tranexamic Acid|tranexamic acid
283779|NCT02438566|Blood Loss|blood loss
283780|NCT02438566|Total Hip Replacement|total hip replacement
283781|NCT02438566|Bilateral Knee Replacement|bilateral knee replacement
283782|NCT02438540|acupuncture|acupuncture
283783|NCT02438540|obesity|obesity
283784|NCT02438540|type 2 diabetic mellitus|type 2 diabetic mellitus
283785|NCT02438540|insulin sensitivity|insulin sensitivity
283786|NCT02438540|metformin|metformin
283787|NCT02438540|inflammatory factor|inflammatory factor
283788|NCT02438540|adipokines|adipokines
283789|NCT02438540|lipid profile|lipid profile
283790|NCT02438501|low-dose involved field radiotherapy|low-dose involved field radiotherapy
283791|NCT02438501|recurrent|recurrent
283792|NCT02438501|advanced|advanced
283793|NCT02438501|follicular lymphoma|follicular lymphoma
283794|NCT02438462|Pulmonary Embolism|pulmonary embolism
283795|NCT02438462|Soluble Fibrin|soluble fibrin
283796|NCT02438462|D-Dimers|d-dimers
283797|NCT02438462|Clinical Probability Score|clinical probability score
283798|NCT02438462|Imaging|imaging
283799|NCT02438449|breast reconstruction|breast reconstruction
283800|NCT02438449|mastectomy|mastectomy
283801|NCT02438449|health-related quality of life|health-related quality of life
283802|NCT02438449|Health Utilities Index|health utilities index
283803|NCT02438449|HUI|hui
283804|NCT02438449|prospective|prospective
283805|NCT02438449|quality-adjusted life years|quality-adjusted life years
283806|NCT02438449|QALY|qaly
283807|NCT02438410|infliximab|infliximab
283808|NCT02438410|remicade|remicade
283809|NCT02438410|IBD|ibd
283810|NCT02438410|Colitis, Ulcerative|colitis, ulcerative
283811|NCT02438371|pregnancy|pregnancy
283812|NCT02438371|preterm labor|preterm labor
283813|NCT02438371|tocolysis|tocolysis
283814|NCT02438293|rhinovirus|rhinovirus
283815|NCT02438293|cardiac surgery|cardiac surgery
283816|NCT02438293|paediatric|paediatric
283817|NCT02438293|respiratory infection|respiratory infection
283818|NCT02438293|children|children
283819|NCT02438280|Orthodontic|orthodontic
283820|NCT02438280|Orthodontic treatment|orthodontic treatment
283821|NCT02438280|Accelerated orthodontics|accelerated orthodontics
283822|NCT02438280|Vibration|vibration
283823|NCT02438241|Pain Measurement|pain measurement
283824|NCT02438241|Electric Stimulation|electric stimulation
283825|NCT02438241|Spirometry|spirometry
283826|NCT02438241|Manometry|manometry
283827|NCT02438228|cardiac output|cardiac output
283828|NCT02438228|transpulmonary thermodilution|transpulmonary thermodilution
283829|NCT02438228|pulse contour analysis|pulse contour analysis
283830|NCT02438228|G09.330.380.124|g09.330.380.124
283831|NCT02438215|PD|pd
283832|NCT02438215|Parkinson's Disease|parkinson's disease
283833|NCT02438189|Type 1 Diabetes|type 1 diabetes
283834|NCT02438189|Hypoglycemia|hypoglycemia
283835|NCT02438189|Hyperglycemia|hyperglycemia
283836|NCT02438189|Artificial Pancreas|artificial pancreas
283837|NCT02438163|Theta Burst Stimulation|theta burst stimulation
283838|NCT02438150|Disaster|disaster
283839|NCT02438150|Training|training
283840|NCT02438137|Obstructive Sleep Apnea|obstructive sleep apnea
283841|NCT02438137|OSA|osa
283842|NCT02438137|sleep apnea|sleep apnea
283843|NCT02438137|snoring|snoring
283844|NCT02438137|dimethyl fumarate|dimethyl fumarate
283845|NCT02438137|CPAP|cpap
283846|NCT02438137|continuous positive airway pressure|continuous positive airway pressure
283847|NCT02438124|Parkinson's disease|parkinson's disease
283848|NCT02438124|Rhythmic auditory stimulation|rhythmic auditory stimulation
283849|NCT02438124|Gait|gait
283850|NCT02438098|Rivaroxaban|rivaroxaban
283851|NCT02438098|Obesity|obesity
283852|NCT02438098|Bariatric surgery|bariatric surgery
283853|NCT02438098|Pharmacokinetics|pharmacokinetics
283854|NCT02438098|Pharmacodynamics|pharmacodynamics
283855|NCT02438085|acute coronary syndromes|acute coronary syndromes
283856|NCT02438085|outcome|outcome
283857|NCT02438085|medical management|medical management
283858|NCT02438085|comorbidities|comorbidities
283859|NCT02438085|registry|registry
283860|NCT02438072|antidepressive agent|antidepressive agent
283861|NCT02438072|drug metabolism|drug metabolism
283862|NCT02438072|CYP450|cyp450
283863|NCT02438072|P-glycoprotein|p-glycoprotein
283865|NCT02438059|Inequality in health|inequality in health
283866|NCT02438059|workplace health promotion|workplace health promotion
283867|NCT02438059|internet|internet
283868|NCT02438059|mobile app|mobile app
283869|NCT02438059|weight loss|weight loss
283870|NCT02438059|intervention|intervention
283871|NCT02438059|randomized controlled trial|randomized controlled trial
283872|NCT02438046|Connective Tissue Grafts|connective tissue grafts
283873|NCT02438046|Wound healing|wound healing
283874|NCT02438046|Biomaterials|biomaterials
283875|NCT02438046|Pain|pain
283876|NCT02438046|Clinical Trials|clinical trials
283877|NCT02438046|Mucogingival Surgery|mucogingival surgery
283878|NCT02438033|Deep Brain Stimulation|deep brain stimulation
283879|NCT02438033|Globus Pallidus|globus pallidus
283880|NCT02438033|GPi|gpi
283881|NCT02438033|PC+S|pc+s
283882|NCT02438020|Acanthosis nigricans|acanthosis nigricans
283883|NCT02438020|obesity|obesity
283884|NCT02438020|children|children
283885|NCT02438020|metformin|metformin
283886|NCT02437942|Athletic injuries|athletic injuries
283887|NCT02437942|chronic|chronic
283888|NCT02437942|rehabilitation|rehabilitation
283889|NCT02437942|diagnosis|diagnosis
283890|NCT02437942|biomechanics|biomechanics
283891|NCT02437916|Melanoma|melanoma
283892|NCT02437916|Non-small Cell Lung Cancer (NSCLC)|non-small cell lung cancer (nsclc)
283893|NCT02437916|Squamous Cell Carcinoma|squamous cell carcinoma
283894|NCT02437916|Carcinoma|carcinoma
283895|NCT02437916|Head and Neck|head and neck
283896|NCT02437916|Transitional Cell Carinoma (TCC)|transitional cell carinoma (tcc)
283897|NCT02437916|Bladder|bladder
283898|NCT02437916|Colorectal|colorectal
283899|NCT02437916|Colorectal Cancer (CRC)|colorectal cancer (crc)
283900|NCT02437903|voluma temporal, facial, volume loss|voluma temporal, facial, volume loss
283901|NCT02437877|Respiration|respiration
283902|NCT02437877|Learning|learning
283903|NCT02437877|Speech|speech
283904|NCT02437877|Language and Hearing Sciences|language and hearing sciences
283905|NCT02437799|Pulse oximeter|pulse oximeter
283906|NCT02437799|Caesarean section|caesarean section
283907|NCT02437799|hypotension|hypotension
283908|NCT02437799|Spinal anaesthesia|spinal anaesthesia
283909|NCT02437773|OCD|ocd
283910|NCT02437747|clinical trial|clinical trial
283911|NCT02437708|regenerative endodontics|regenerative endodontics
283912|NCT02437708|platelet rich fibrin|platelet rich fibrin
283913|NCT02437695|Robotic Surgical Procedures|robotic surgical procedures
283914|NCT02437695|Trendelenburg Position|trendelenburg position
283915|NCT02437682|Gastro-esophageal Reflux Disease|gastro-esophageal reflux disease
283916|NCT02437682|Proton pump inhibitor|proton pump inhibitor
283917|NCT02437669|Intranasal|intranasal
283918|NCT02437669|Hydromorphone|hydromorphone
283919|NCT02437669|Pediatric|pediatric
283920|NCT02437669|Emergency department|emergency department
283921|NCT02437656|Radiochemotherapy|radiochemotherapy
362787|NCT02039401|ALS|als
283922|NCT02437656|Metformin|metformin
283923|NCT02437656|Rectal cancer|rectal cancer
283924|NCT02437617|Advanced cancers|advanced cancers
283925|NCT02437617|Tumor tissue|tumor tissue
283926|NCT02437617|Genomic profile test|genomic profile test
283927|NCT02437617|Analysis of treatment outcomes|analysis of treatment outcomes
283928|NCT02437617|Molecular profiling|molecular profiling
283929|NCT02437617|Molecular alteration|molecular alteration
283930|NCT02437591|ASP2819|asp2819
283931|NCT02437591|PAR-101|par-101
283932|NCT02437591|OPT-80|opt-80
283933|NCT02437591|Inflammatory Bowel Disease (IBD)|inflammatory bowel disease (ibd)
283934|NCT02437591|Clostridium difficile Infection (CDI)|clostridium difficile infection (cdi)
283935|NCT02437591|fidaxomicin|fidaxomicin
283936|NCT02437591|Dificlir|dificlir
283937|NCT02437578|vitamin d|vitamin d
283938|NCT02437578|fertility|fertility
283939|NCT02437578|markers|markers
283940|NCT02437578|endocrine disruption|endocrine disruption
283941|NCT02437578|reproduction|reproduction
283942|NCT02437552|Cardiac Surgery, Coronary Artery Bypass, Exercise Movement Techniques|cardiac surgery, coronary artery bypass, exercise movement techniques
283943|NCT02437526|Cure|cure
283944|NCT02437526|Analytic treatment interruption|analytic treatment interruption
283945|NCT02437513|Dysphagia|dysphagia
283946|NCT02437513|Aspiration|aspiration
283947|NCT02437513|Laryngeal cancer|laryngeal cancer
283948|NCT02437474|vegan diet|vegan diet
283949|NCT02437474|lacto-ovo-vegetarian diet|lacto-ovo-vegetarian diet
283950|NCT02437474|cancer|cancer
283951|NCT02437474|tumor remission|tumor remission
283952|NCT02437461|knee synovitis|knee synovitis
283953|NCT02437461|triamcinolone hexacetonide|triamcinolone hexacetonide
283954|NCT02437461|treatment response|treatment response
283955|NCT02437448|Mass spectrometry|mass spectrometry
283956|NCT02437448|Exhaled breath analysis|exhaled breath analysis
283957|NCT02437435|assisted reproduction|assisted reproduction
283958|NCT02437435|physical therapy|physical therapy
283959|NCT02437435|manual therapy|manual therapy
283960|NCT02437435|uterine artery|uterine artery
283961|NCT02437435|Vascularization Index (VI)|vascularization index (vi)
283962|NCT02437435|Doppler ultrasonography|doppler ultrasonography
283963|NCT02437435|vocal|vocal
283964|NCT02437409|Ischemic, Acute|ischemic, acute
283965|NCT02437357|Psychotherapy, Group|psychotherapy, group
283966|NCT02437357|Metacognition|metacognition
283967|NCT02437357|Cognitive Bias|cognitive bias
283968|NCT02437331|Advanced heart failure|advanced heart failure
283969|NCT02437331|diseased experience|diseased experience
283970|NCT02437318|BYL719|byl719
283971|NCT02437318|HR+|hr+
283972|NCT02437318|HER2-negative|her2-negative
283973|NCT02437318|advanced breast cancer|advanced breast cancer
283974|NCT02437318|alpelisib|alpelisib
283975|NCT02437318|fulvestrant|fulvestrant
283976|NCT02437318|PI3K|pi3k
283977|NCT02437318|Phase III|phase iii
283978|NCT02437318|ER+|er+
283979|NCT02437318|PgR+|pgr+
283980|NCT02437318|men|men
283981|NCT02437318|postmenopausal|postmenopausal
283982|NCT02437318|aromatase inhibitor|aromatase inhibitor
283983|NCT02437318|neoplasms|neoplasms
283984|NCT02437305|Melanoma|melanoma
283985|NCT02437305|People of Color|people of color
283986|NCT02437279|Palpable|palpable
283987|NCT02437279|Stage III|stage iii
283988|NCT02437279|Skin melanoma|skin melanoma
283989|NCT02437279|Ipilimumab|ipilimumab
283990|NCT02437279|Nivolumab|nivolumab
283991|NCT02437279|Surgery|surgery
283992|NCT02437253|Mucopolysaccharidosis|mucopolysaccharidosis
283993|NCT02437253|Inflammation|inflammation
283994|NCT02437253|Tumor necrosis factor - alpha inhibitor|tumor necrosis factor - alpha inhibitor
283995|NCT02437240|Pilates-based exercise|pilates-based exercise
283996|NCT02437240|respiratory mechanics|respiratory mechanics
283997|NCT02437240|cardiopulmonary physical therapy|cardiopulmonary physical therapy
283998|NCT02437240|sternotomy|sternotomy
283999|NCT02437175|pelvic pain|pelvic pain
284000|NCT02437175|quality of life|quality of life
284001|NCT02437175|adenomyosis|adenomyosis
284002|NCT02437162|Axial Spondyloarthritis|axial spondyloarthritis
284003|NCT02437162|Ustekinumab|ustekinumab
284004|NCT02437162|Golimumab|golimumab
284005|NCT02437162|Stelara|stelara
284006|NCT02437149|Texting and driving|texting and driving
284007|NCT02437149|Teenager and driving|teenager and driving
284008|NCT02437149|Distracted Driving Campaign|distracted driving campaign
284009|NCT02437123|mHealth|mhealth
284010|NCT02437123|Indigenous|indigenous
284011|NCT02437123|HIV prevention|hiv prevention
284012|NCT02437123|substance use|substance use
284013|NCT02437110|Amyotrophic Lateral Sclerosis|amyotrophic lateral sclerosis
284014|NCT02437110|Antiretroviral Therapy|antiretroviral therapy
284015|NCT02437110|Virus|virus
284016|NCT02437071|Radiotherapy|radiotherapy
284017|NCT02437071|Ablation|ablation
284018|NCT02437071|Pembrolizumab|pembrolizumab
284019|NCT02437071|15-069|15-069
284020|NCT02437071|Metastatic Colorectal Cancer Patients|metastatic colorectal cancer patients
284021|NCT02437032|GDF-9|gdf-9
284022|NCT02437032|BMP-15|bmp-15
284023|NCT02437032|Steroids|steroids
284024|NCT02437032|Apoptosis rate|apoptosis rate
284025|NCT02437032|Endocrinology|endocrinology
284026|NCT02437019|PCI-32765|pci-32765
284027|NCT02437019|Ibrutinib|ibrutinib
284028|NCT02437019|Early access program|early access program
284029|NCT02437019|Chronic lymphocytic leukemia|chronic lymphocytic leukemia
284030|NCT02437019|Relapsed or refractory chronic lymphocytic leukemia|relapsed or refractory chronic lymphocytic leukemia
284031|NCT02437006|stroke|stroke
284032|NCT02437006|exercise capacity|exercise capacity
284033|NCT02436993|Neoadjuvant Treatment|neoadjuvant treatment
284034|NCT02436993|Carboplatin|carboplatin
284035|NCT02436993|Paclitaxel|paclitaxel
284036|NCT02436993|Pertuzumab|pertuzumab
284037|NCT02436993|Trastuzumab|trastuzumab
284038|NCT02436993|Bevacizumab|bevacizumab
284039|NCT02436980|premedication|premedication
284040|NCT02436980|ERCP|ercp
284041|NCT02436980|midazolam|midazolam
284042|NCT02436980|tramadol|tramadol
284043|NCT02436980|cognitive|cognitive
284044|NCT02436928|H7N9 Influenza|h7n9 influenza
284045|NCT02436928|Avian influenza A|avian influenza a
284046|NCT02436928|cell culture derived|cell culture derived
284047|NCT02436915|Slow gait|slow gait
284048|NCT02436915|Executive function|executive function
284049|NCT02436915|Transcranial direct current stimulation|transcranial direct current stimulation
284050|NCT02436876|Osteosynthesis|osteosynthesis
284051|NCT02436876|Complications|complications
284052|NCT02436876|Infection or Inflammation|infection or inflammation
284053|NCT02436876|Orthopedic|orthopedic
284054|NCT02436876|Device|device
284055|NCT02436876|Fracture|fracture
284056|NCT02436876|Osteomyelitis|osteomyelitis
284057|NCT02436863|Laminectomy|laminectomy
284058|NCT02436863|Laminoplasty|laminoplasty
284059|NCT02436863|Internal fixation|internal fixation
284060|NCT02436863|deformity|deformity
284061|NCT02436850|Thoracentesis|thoracentesis
284062|NCT02436850|Pocket Ultrasound Device|pocket ultrasound device
284063|NCT02436850|Ultrasound|ultrasound
284064|NCT02436850|Soroka University Medical Center|soroka university medical center
284065|NCT02436850|Physical Examination|physical examination
284066|NCT02436850|Ethical Committee|ethical committee
284067|NCT02436824|topical patch|topical patch
284068|NCT02436824|chronic low back pain|chronic low back pain
284069|NCT02436811|Health literacy|health literacy
284070|NCT02436811|Pregnant women|pregnant women
284071|NCT02436811|Feeding behaviour|feeding behaviour
284072|NCT02436811|Oral health|oral health
284073|NCT02436811|Child|child
284074|NCT02436798|QT prolongation|qt prolongation
284075|NCT02436798|Genomic biomarkers|genomic biomarkers
284076|NCT02436785|music therapy|music therapy
284077|NCT02436785|pain management|pain management
284078|NCT02436785|self efficacy|self efficacy
284079|NCT02436785|patient education|patient education
284080|NCT02436785|relaxation|relaxation
284081|NCT02436746|Von Recklinghausen's disease|von recklinghausen's disease
284082|NCT02436746|Bourneville's disease|bourneville's disease
284083|NCT02436746|Cognitive variability|cognitive variability
284084|NCT02436746|Loss of heterozygosity|loss of heterozygosity
284085|NCT02436733|pleural mesothelioma|pleural mesothelioma
284086|NCT02436733|phase II|phase ii
284087|NCT02436733|randomized|randomized
284088|NCT02436733|surgery|surgery
284089|NCT02436733|chemotherapy|chemotherapy
284090|NCT02436733|feasibility|feasibility
284091|NCT02436694|Dexamethasone|dexamethasone
284092|NCT02436694|Perineural|perineural
284093|NCT02436655|aortic stenosis|aortic stenosis
284094|NCT02436655|normal ejection fraction|normal ejection fraction
284095|NCT02436655|asymptomatic|asymptomatic
284096|NCT02436629|Red beetroot juice|red beetroot juice
284097|NCT02436629|High intensity intermittent exercise|high intensity intermittent exercise
284098|NCT02436629|Nitrite|nitrite
284099|NCT02436629|Soccer|soccer
284101|NCT02436616|Preterm Infants|preterm infants
284102|NCT02436616|Neonate|neonate
284103|NCT02436616|wireless|wireless
284104|NCT02436603|Irritable Bowel Syndrome|irritable bowel syndrome
284106|NCT02436603|Mind-Body Training|mind-body training
284107|NCT02436603|Integrative Medicine|integrative medicine
284108|NCT02436603|FODMAP|fodmap
284109|NCT02436590|osteoarthritis|osteoarthritis
284110|NCT02436590|knee|knee
284111|NCT02436590|pulsed electromagnetic fields|pulsed electromagnetic fields
284112|NCT02436590|PEMF|pemf
284113|NCT02436577|ticagrelor orodispersible tablet|ticagrelor orodispersible tablet
284114|NCT02436577|ticagrelor immediate-release tablet|ticagrelor immediate-release tablet
284115|NCT02436577|bioequivalence|bioequivalence
284116|NCT02436577|Phase I|phase i
284117|NCT02436577|healthy Japanese subjects|healthy japanese subjects
284118|NCT02436564|pancreas|pancreas
284119|NCT02436564|stem cells|stem cells
284120|NCT02436564|tumours|tumours
284121|NCT02436564|in vitro models|in vitro models
284122|NCT02436564|organoids|organoids
284123|NCT02436564|cancer,|cancer,
284124|NCT02436564|bile duct|bile duct
284125|NCT02436564|liver|liver
284126|NCT02436538|anti-Müllerian hormone (AMH)|anti-müllerian hormone (amh)
284127|NCT02436538|Mullerian anomalies|mullerian anomalies
284128|NCT02436538|ICSI|icsi
284129|NCT02436447|Renal Impairment, Renal function, MTP-131, Bendavia™|renal impairment, renal function, mtp-131, bendavia™
284130|NCT02436434|Pulsed radiofrequency, osteoarthritis|pulsed radiofrequency, osteoarthritis
284131|NCT02436395|gastric cancer|gastric cancer
284132|NCT02436395|gastrectomy|gastrectomy
284133|NCT02436395|laparotomy|laparotomy
284134|NCT02436395|SSIs|ssis
284135|NCT02436395|povidone-iodine|povidone-iodine
284136|NCT02436395|normal saline|normal saline
284137|NCT02436369|diabetic patients|diabetic patients
284138|NCT02436369|flaxseed|flaxseed
284139|NCT02436369|lipid profile|lipid profile
284140|NCT02436369|cardiovascular risc factors|cardiovascular risc factors
284141|NCT02436343|left ventricular functions|left ventricular functions
284142|NCT02436343|pregnancy|pregnancy
284143|NCT02436343|obesity|obesity
284144|NCT02436330|Exergaming, Weight management|exergaming, weight management
284145|NCT02436317|Point Of Care Ultrasonography|point of care ultrasonography
284146|NCT02436317|Soroka University Medical Center|soroka university medical center
284147|NCT02436317|Heart Failure|heart failure
284148|NCT02436317|cardiovascular|cardiovascular
284149|NCT02436278|Gait speed|gait speed
284150|NCT02436278|Mortality|mortality
284151|NCT02436278|Morbidity|morbidity
284152|NCT02436265|Neuraxial|neuraxial
284153|NCT02436265|Caudal|caudal
284154|NCT02436265|Block|block
284155|NCT02436265|Anesthesia|anesthesia
284156|NCT02436265|Dexamethasone|dexamethasone
284157|NCT02436252|Myelodysplastic Syndrome|myelodysplastic syndrome
284158|NCT02436252|MDS|mds
284159|NCT02436226|PCOS|pcos
284160|NCT02436226|Clomiphene citrate resistant|clomiphene citrate resistant
284161|NCT02436226|HCG|hcg
284162|NCT02436213|workload|workload
284163|NCT02436213|oxygen level|oxygen level
284164|NCT02436213|oxygen consumption|oxygen consumption
284165|NCT02436213|breathing reserve|breathing reserve
284166|NCT02436213|ventilatory efficiency|ventilatory efficiency
284167|NCT02436200|Intermittent Claudication|intermittent claudication
284168|NCT02436200|IC|ic
284169|NCT02436200|Peripheral Arterial Disease|peripheral arterial disease
284170|NCT02436200|Peripheral Vascular Disease|peripheral vascular disease
284171|NCT02436200|Peripheral Arterial Occlusive Disease|peripheral arterial occlusive disease
284172|NCT02436187|NSTEMI|nstemi
284173|NCT02436187|excess mortality|excess mortality
284174|NCT02436187|evidence-based care|evidence-based care
284175|NCT02436187|MINAP|minap
284176|NCT02436161|Heart Failure|heart failure
284177|NCT02436161|Comorbidity|comorbidity
284178|NCT02436161|Patient Care Management|patient care management
284179|NCT02436161|Primary Health Care|primary health care
284180|NCT02436161|Delivery of Health Care, Integrated|delivery of health care, integrated
284181|NCT02436148|PEQ validation study, Finland|peq validation study, finland
284182|NCT02436122|Prostate cancer|prostate cancer
284183|NCT02436122|Preoperative|preoperative
284184|NCT02436122|Glycemic control|glycemic control
284185|NCT02436122|Hemoglobin A1c|hemoglobin a1c
284186|NCT02436122|Pathologic outcomes|pathologic outcomes
284187|NCT02436122|Oncological outcomes|oncological outcomes
284188|NCT02436122|Treatment Outcome|treatment outcome
284189|NCT02436122|Hemoglobin A1c Protein, Human|hemoglobin a1c protein, human
284190|NCT02436096|Pain|pain
284191|NCT02436096|Sleep|sleep
284192|NCT02436070|Pediatrics|pediatrics
284193|NCT02436070|Emergency Medicine|emergency medicine
284194|NCT02436070|Text messaging|text messaging
284195|NCT02436044|Hepatocellular Carcinoma|hepatocellular carcinoma
284196|NCT02436044|Locally advanced stge|locally advanced stge
284197|NCT02436044|HAIC|haic
284198|NCT02436044|FOLFOX4|folfox4
284199|NCT02436044|Locally advanced|locally advanced
284200|NCT02436018|Sedation|sedation
284201|NCT02436018|Low pulse oximetry|low pulse oximetry
284202|NCT02436018|Upper gastrointestinal endoscopy|upper gastrointestinal endoscopy
284203|NCT02436018|WEI NASAL JET|wei nasal jet
284204|NCT02435979|wrist|wrist
284205|NCT02435979|proximal strengthening|proximal strengthening
284206|NCT02435979|hand therapy|hand therapy
284207|NCT02435953|Hepatocellular Carcinoma,TACE,Chemoembolization, RFA,Intermediate-stage|hepatocellular carcinoma,tace,chemoembolization, rfa,intermediate-stage
284208|NCT02435940|inherited retinal degenerative disease|inherited retinal degenerative disease
284209|NCT02435940|retinitis pigmentosa|retinitis pigmentosa
284210|NCT02435940|Usher|usher
284211|NCT02435940|Leber|leber
284212|NCT02435940|Bardet-Biedl|bardet-biedl
284213|NCT02435940|Batten|batten
284214|NCT02435940|Best|best
284215|NCT02435940|cone dystrophy|cone dystrophy
284216|NCT02435940|cone-rod dystrophy|cone-rod dystrophy
284217|NCT02435940|choroideremia|choroideremia
284218|NCT02435940|congenital night blindness|congenital night blindness
284219|NCT02435940|enhanced s-cone|enhanced s-cone
284220|NCT02435940|cone monochromacy|cone monochromacy
284221|NCT02435940|Goldmann-Favre|goldmann-favre
284222|NCT02435940|Kearns-Sayre|kearns-sayre
284223|NCT02435940|Refsum|refsum
284224|NCT02435940|retinoschisis|retinoschisis
284225|NCT02435940|rod-cone dystrophy|rod-cone dystrophy
284226|NCT02435940|rod dystrophy|rod dystrophy
284227|NCT02435940|rod monochromacy|rod monochromacy
284228|NCT02435940|Sorsby pseudoinflammatory dystrophy|sorsby pseudoinflammatory dystrophy
284229|NCT02435940|stargardt|stargardt
284230|NCT02435940|achromatopsia|achromatopsia
284231|NCT02435940|juvenile inherited macular degeneration|juvenile inherited macular degeneration
284232|NCT02435940|cone dichromacy|cone dichromacy
284233|NCT02435940|cone trichromacy|cone trichromacy
284234|NCT02435940|Charcot-Marie-Tooth|charcot-marie-tooth
284235|NCT02435940|albipunctate dystrophy|albipunctate dystrophy
284236|NCT02435901|Reduced Intensity Conditioning Regimen|reduced intensity conditioning regimen
284237|NCT02435888|Resting energy expenditure|resting energy expenditure
284238|NCT02435888|Predictive equations|predictive equations
284239|NCT02435888|Overweight|overweight
284240|NCT02435875|hypertension|hypertension
284241|NCT02435875|perioperative|perioperative
284242|NCT02435875|baroreflex sensitivity|baroreflex sensitivity
284243|NCT02435862|Vitreolysis of the Vitreous|vitreolysis of the vitreous
284244|NCT02435849|Pediatric|pediatric
284245|NCT02435849|ALL|all
284246|NCT02435849|Cell therapy|cell therapy
284247|NCT02435810|Neuroinflammation|neuroinflammation
284248|NCT02435810|Infections|infections
284249|NCT02435797|nicorandil|nicorandil
284250|NCT02435797|primary percutaneous coronary intervention|primary percutaneous coronary intervention
284251|NCT02435797|acute ST segment elevation myocardial infarction|acute st segment elevation myocardial infarction
284252|NCT02435797|thrombus aspiration|thrombus aspiration
284253|NCT02435784|2-COM|2-com
284254|NCT02435745|Ehlers-Danlos Syndrome|ehlers-danlos syndrome
284255|NCT02435745|Obstructive Sleep Apnea|obstructive sleep apnea
284256|NCT02435745|Prevalence|prevalence
284257|NCT02435745|Aortic Aneurysm|aortic aneurysm
284258|NCT02435719|HCAIs|hcais
284259|NCT02435719|Handgel|handgel
284260|NCT02435719|Hospital|hospital
284261|NCT02435719|Effectiveness|effectiveness
284262|NCT02435706|Dental implants|dental implants
284263|NCT02435706|surgical flap|surgical flap
284264|NCT02435706|esthetics|esthetics
284265|NCT02435706|alveolar process|alveolar process
284266|NCT02435693|pharmaceutical care|pharmaceutical care
284267|NCT02435680|MCS110; carboplatin; gemcitabine; TNBC; TAMs|mcs110; carboplatin; gemcitabine; tnbc; tams
284268|NCT02435667|Resistance Training|resistance training
284269|NCT02435667|Exercise|exercise
284270|NCT02435667|Heart Failure preserved Ejection Fraction|heart failure preserved ejection fraction
284271|NCT02435654|Genes Polymorphisms|genes polymorphisms
284272|NCT02435654|Plasma Concentration|plasma concentration
284273|NCT02435602|endoscopy, gastrointestinal|endoscopy, gastrointestinal
284274|NCT02435602|cancer screening|cancer screening
284275|NCT02435576|Acute toxicity|acute toxicity
284276|NCT02435576|Late toxicity|late toxicity
284277|NCT02435576|NTCP models|ntcp models
284278|NCT02435563|Anti-HIV Agents|anti-hiv agents
284279|NCT02435563|cardiovascular agents|cardiovascular agents
284280|NCT02435563|drug interactions|drug interactions
284281|NCT02435537|analgesia|analgesia
284282|NCT02435537|intrathecal|intrathecal
284283|NCT02435537|opioids|opioids
284284|NCT02435537|morphine|morphine
284285|NCT02435537|dexmedetomidine|dexmedetomidine
284286|NCT02435524|Breast Feeding, Exclusive|breast feeding, exclusive
284287|NCT02435524|Infant Nutrition|infant nutrition
284288|NCT02435524|Burkina Faso|burkina faso
284289|NCT02435511|agent-based modeling|agent-based modeling
284290|NCT02435511|community resources|community resources
284291|NCT02435511|simulation modeling|simulation modeling
284292|NCT02435511|information intervention|information intervention
284293|NCT02435511|clinic-to-community linkages|clinic-to-community linkages
284294|NCT02435485|degerative lumbar spondylolisthesis|degerative lumbar spondylolisthesis
284295|NCT02435485|rehabilitation|rehabilitation
284296|NCT02435485|balance|balance
284297|NCT02435472|Active Surveillance|active surveillance
284298|NCT02435472|Exercise|exercise
284299|NCT02435472|Prostate cancer|prostate cancer
284300|NCT02435472|Life style|life style
284301|NCT02435472|Survey|survey
284302|NCT02435472|Personalized exercise|personalized exercise
284303|NCT02435472|Exercise trainer|exercise trainer
284304|NCT02435433|liver cancer|liver cancer
284305|NCT02435420|Total Hip Arthroplasty|total hip arthroplasty
284306|NCT02435420|EMPERION Modular Stem|emperion modular stem
284307|NCT02435420|Survivorship|survivorship
284308|NCT02435355|Sleep apnea|sleep apnea
284309|NCT02435355|education|education
284310|NCT02435355|compliance|compliance
284311|NCT02435355|CPAP|cpap
284312|NCT02435342|ShK-186|shk-186
284313|NCT02435342|dalazatide|dalazatide
284314|NCT02435342|psoriasis|psoriasis
284315|NCT02435342|Kv1.3,|kv1.3,
284316|NCT02435342|autoimmune|autoimmune
284317|NCT02435316|Education|education
284318|NCT02435290|prediction|prediction
284319|NCT02435290|prescribing error|prescribing error
284320|NCT02435290|risk factors|risk factors
284321|NCT02435277|Diabetes|diabetes
363297|NCT02037113|PAD|pad
284322|NCT02435212|New formulation|new formulation
284323|NCT02435212|deferasirox|deferasirox
284324|NCT02435212|chelation|chelation
284325|NCT02435212|iron overload|iron overload
284326|NCT02435212|compliance|compliance
284327|NCT02435212|satisfaction|satisfaction
284328|NCT02435212|palatability|palatability
284329|NCT02435212|PRO|pro
284330|NCT02435212|PK|pk
284331|NCT02435212|safety|safety
284332|NCT02435212|PK/PD|pk/pd
284333|NCT02435212|ICL670|icl670
284334|NCT02435186|p53 gene|p53 gene
284335|NCT02435186|chemotherapy|chemotherapy
284336|NCT02435186|recurrent|recurrent
284337|NCT02435186|epithelial|epithelial
284338|NCT02435186|ovarian cancer|ovarian cancer
284435|NCT02434601|Adhesion|adhesion
284339|NCT02435186|fallopian tube cancer|fallopian tube cancer
284340|NCT02435186|primary peritoneal cancer|primary peritoneal cancer
284341|NCT02435173|APDS PASLI PI3Kdelta|apds pasli pi3kdelta
284342|NCT02435108|MET poisitivity is defined as at least half of tumor cells show weak, moderate or high staining|met poisitivity is defined as at least half of tumor cells show weak, moderate or high staining
284343|NCT02435095|Schizophrenia|schizophrenia
284344|NCT02435095|Maintenance treatment, Intermittent treatment|maintenance treatment, intermittent treatment
284345|NCT02435095|Brain volume|brain volume
284346|NCT02435095|Antipsychotics|antipsychotics
284347|NCT02435082|Concussion|concussion
284348|NCT02435082|Vascular Assessment|vascular assessment
284349|NCT02435082|Vascular Regulation|vascular regulation
284350|NCT02435082|mild Traumatic Brain Injury, mTBI|mild traumatic brain injury, mtbi
284351|NCT02435082|Traumatic Brain Injury, TBI|traumatic brain injury, tbi
284352|NCT02435082|Cerebrovascular Regulation|cerebrovascular regulation
284353|NCT02435082|Cerebral Blood Flow|cerebral blood flow
284354|NCT02435082|Cerebral Blood Flow Velocity, CBFV|cerebral blood flow velocity, cbfv
284355|NCT02435082|Cerebral Blood Flow Velocity Variability|cerebral blood flow velocity variability
284356|NCT02435082|Cerebrovascular Assessment|cerebrovascular assessment
284357|NCT02435069|cecostomy|cecostomy
284358|NCT02435069|appendicostomy|appendicostomy
284359|NCT02435056|medication overuse headache|medication overuse headache
284360|NCT02435056|health care system|health care system
284361|NCT02435030|NP-C|np-c
284362|NCT02435030|LSD|lsd
284363|NCT02435030|lysosomal storage disorder|lysosomal storage disorder
284364|NCT02435030|lysosomal storage disease|lysosomal storage disease
284365|NCT02435030|NPC2|npc2
284366|NCT02435030|NPC1|npc1
284367|NCT02435030|Niemann-Pick Type C|niemann-pick type c
284368|NCT02435030|Niemann-Pick,|niemann-pick,
284369|NCT02435030|Arimoclomol|arimoclomol
284370|NCT02435017|kidney disease|kidney disease
284371|NCT02435017|recommended dietary allowances|recommended dietary allowances
284372|NCT02435017|nutrition assessment|nutrition assessment
284373|NCT02435017|food|food
284374|NCT02435017|dietary proteins|dietary proteins
284375|NCT02435017|Vitamin D|vitamin d
284376|NCT02435017|dietary fats|dietary fats
284377|NCT02435017|ethnology|ethnology
284378|NCT02435017|Continental Population Groups|continental population groups
284379|NCT02435017|Phosphorus, dietary|phosphorus, dietary
284380|NCT02435017|Phosphorus/analysis|phosphorus/analysis
284381|NCT02434991|trouble swallowing|trouble swallowing
284382|NCT02434991|food sticking|food sticking
284383|NCT02434991|Achalasia|achalasia
284384|NCT02434965|Neonates|neonates
284385|NCT02434965|hypoxic-ischemic encephalopathy|hypoxic-ischemic encephalopathy
284386|NCT02434965|human placental-derived stem cells|human placental-derived stem cells
284387|NCT02434965|autologous|autologous
284388|NCT02434952|Malaria, Falciparum|malaria, falciparum
284389|NCT02434952|G6PD deficiency|g6pd deficiency
284390|NCT02434952|Primaquine|primaquine
284391|NCT02434952|Asia|asia
284392|NCT02434926|fetoscopy|fetoscopy
284393|NCT02434926|fetal surgery|fetal surgery
284394|NCT02434926|anesthetic complications|anesthetic complications
284395|NCT02434913|Proximal interphalangeal joint deformity|proximal interphalangeal joint deformity
284396|NCT02434913|Arthroplasty|arthroplasty
284397|NCT02434822|Cholera|cholera
284398|NCT02434822|Shanchol™|shanchol™
284399|NCT02434822|Cholera Vaccine|cholera vaccine
284400|NCT02434809|Respiratory Motion-Corrected Cone-Beam CT|respiratory motion-corrected cone-beam ct
284401|NCT02434809|Radiation|radiation
284402|NCT02434809|14-225|14-225
284403|NCT02434796|Intimate Partner Violence|intimate partner violence
284404|NCT02434796|Gender-Based Violence|gender-based violence
284405|NCT02434796|Gender|gender
284406|NCT02434796|HIV|hiv
284407|NCT02434783|Blood circulation|blood circulation
284408|NCT02434783|Blood vessels|blood vessels
284409|NCT02434783|Mitochondria|mitochondria
284410|NCT02434783|Muscle, skeletal|muscle, skeletal
284411|NCT02434783|Legs|legs
284412|NCT02434783|Energy metabolism|energy metabolism
284413|NCT02434731|Procedural pain|procedural pain
284414|NCT02434731|Phlebotomy|phlebotomy
284415|NCT02434731|Intellectual Disability|intellectual disability
284416|NCT02434731|Child|child
284417|NCT02434731|Buzzy|buzzy
751199|NCT00436501|Taxotere|taxotere
284418|NCT02434705|Eosinophilic|eosinophilic
284419|NCT02434692|Primary Open Angle Glaucoma|primary open angle glaucoma
284420|NCT02434692|POAG|poag
284421|NCT02434692|Glaucoma|glaucoma
284422|NCT02434692|Cataract|cataract
284423|NCT02434692|Surgery|surgery
284424|NCT02434692|Ocular Pressure|ocular pressure
284425|NCT02434679|antibiotics resistance integrons|antibiotics resistance integrons
284426|NCT02434679|neonatology newborns|neonatology newborns
284427|NCT02434679|digestive acquisition|digestive acquisition
284428|NCT02434679|dynamic of the acquisition of integrons|dynamic of the acquisition of integrons
284429|NCT02434627|Becker|becker
284430|NCT02434627|Dystrophy|dystrophy
284431|NCT02434601|Non-carious cervical lesions|non-carious cervical lesions
284432|NCT02434601|Randomized clinical trial|randomized clinical trial
284433|NCT02434601|Permanent dental restoration|permanent dental restoration
284434|NCT02434601|Dentin|dentin
284436|NCT02434601|Restoration|restoration
284437|NCT02434601|Sensitivity|sensitivity
284438|NCT02434601|Prophylaxis|prophylaxis
284439|NCT02434601|Randomized|randomized
284440|NCT02434575|Lower Urinary Tract Symptoms|lower urinary tract symptoms
284441|NCT02434575|Prostatic artery embolisation|prostatic artery embolisation
284442|NCT02434575|Transurethral resection of the prostate|transurethral resection of the prostate
284443|NCT02434575|Benign prostatic hyperplasia|benign prostatic hyperplasia
284444|NCT02434575|Benign prostatic enlargement|benign prostatic enlargement
284445|NCT02434549|Randomized Controlled Trial|randomized controlled trial
284446|NCT02434549|Placebo Controlled|placebo controlled
284447|NCT02434549|Double Blinded|double blinded
284448|NCT02434549|Botulinum Toxin Type A|botulinum toxin type a
284450|NCT02434549|Pain|pain
284451|NCT02434549|Spasticity|spasticity
284452|NCT02434549|Cerebral Palsy, Spastic|cerebral palsy, spastic
284453|NCT02434549|Dysport|dysport
284454|NCT02434536|Chronic Obstructive Pulmonary Disease|chronic obstructive pulmonary disease
284455|NCT02434536|Disease Exacerbation Clinical Prediction Rule|disease exacerbation clinical prediction rule
284456|NCT02434536|Decision Analysis|decision analysis
284457|NCT02434523|laryngeal sensory neuropathy|laryngeal sensory neuropathy
284458|NCT02434510|Infection|infection
284459|NCT02434510|Total Knee Arthroplasty|total knee arthroplasty
284460|NCT02434510|Total Hip Arthroplasty|total hip arthroplasty
284461|NCT02434510|Splash Basins|splash basins
284462|NCT02434497|LDL-C|ldl-c
284463|NCT02434497|HoFH|hofh
284464|NCT02434497|Hyperlipidemia|hyperlipidemia
284465|NCT02434484|Symbenda|symbenda
284466|NCT02434484|Non-Hodgkin's lymphomas|non-hodgkin's lymphomas
284467|NCT02434484|Chronic lymphocytic leukemia|chronic lymphocytic leukemia
284468|NCT02434484|Multiple myeloma|multiple myeloma
284469|NCT02434484|Bendamustine Hydrochloride|bendamustine hydrochloride
284470|NCT02434458|fibromyalgia,|fibromyalgia,
284471|NCT02434458|polyneuropathy|polyneuropathy
284472|NCT02434458|small fiber neuropathy|small fiber neuropathy
284473|NCT02434458|rheumatoid arthritis|rheumatoid arthritis
284474|NCT02434458|sudomotor|sudomotor
284475|NCT02434406|Anxiety|anxiety
284476|NCT02434406|Anxiety disorders|anxiety disorders
284477|NCT02434406|Mental health|mental health
284478|NCT02434406|Postpartum period|postpartum period
284479|NCT02434406|maternal welfare|maternal welfare
284480|NCT02434406|internet|internet
284481|NCT02434406|intervention studies|intervention studies
284482|NCT02434406|feasibility studies|feasibility studies
284483|NCT02434406|randomized controlled trial|randomized controlled trial
284484|NCT02434406|patient acceptance of health care|patient acceptance of health care
284485|NCT02434393|Depression|depression
284486|NCT02434393|Late Life Depression|late life depression
284487|NCT02434393|LLD|lld
284488|NCT02434393|amyloid imaging|amyloid imaging
284489|NCT02434393|biomarkers|biomarkers
284490|NCT02434380|Vitamin D|vitamin d
284491|NCT02434380|Bone mineral content|bone mineral content
284492|NCT02434380|Knee-heel length|knee-heel length
284493|NCT02434380|Middle East|middle east
284494|NCT02434367|Cancer|cancer
284495|NCT02434354|Clinical stage III (nodal and/or intransit disease) or resectable stage IV melanoma (MEL), with or without prior treatment|clinical stage iii (nodal and/or intransit disease) or resectable stage iv melanoma (mel), with or without prior treatment
284496|NCT02434328|AMD|amd
284497|NCT02434328|CNV|cnv
284498|NCT02434328|IVT|ivt
284499|NCT02434315|Diabetes Mellitus|diabetes mellitus
284500|NCT02434315|Sensing Technology|sensing technology
284501|NCT02434289|Older adults|older adults
284502|NCT02434289|Dietary protein|dietary protein
284503|NCT02434289|Resistance exercise|resistance exercise
284504|NCT02434289|Feasibility study|feasibility study
284505|NCT02434289|Physical functioning|physical functioning
284506|NCT02434289|Real-life setting|real-life setting
284507|NCT02434250|Open angle glaucoma|open angle glaucoma
284508|NCT02434250|Ocular hypertension|ocular hypertension
284509|NCT02434250|Cataract|cataract
284510|NCT02434250|Selective Laser Trabeculoplasty|selective laser trabeculoplasty
284511|NCT02434250|Eximer Laser Trabeculectomy|eximer laser trabeculectomy
284512|NCT02434250|Phacoemulsification Cataract Extraction|phacoemulsification cataract extraction
284513|NCT02434224|Music therapy|music therapy
284514|NCT02434224|premature infant|premature infant
284515|NCT02434224|brain development|brain development
284516|NCT02434198|pulmonary rehabilitation|pulmonary rehabilitation
284517|NCT02434198|balance assessment|balance assessment
284518|NCT02434198|Chronic Obstructive Pulmonary Disease|chronic obstructive pulmonary disease
284519|NCT02434185|Musculoskeletal Physiological Phenomena|musculoskeletal physiological phenomena
284520|NCT02434185|Postmenopause|postmenopause
284521|NCT02434185|Muscle Strength|muscle strength
284522|NCT02434185|Absorptiometry, Photon|absorptiometry, photon
284523|NCT02434172|HIV|hiv
284524|NCT02434172|Cryptococcus|cryptococcus
284525|NCT02434172|Lateral Flow Assay|lateral flow assay
284526|NCT02434172|sub-Saharan Africa|sub-saharan africa
284527|NCT02434172|Screening|screening
284528|NCT02434172|treatment|treatment
284529|NCT02434172|cryptococcal meningitis|cryptococcal meningitis
284530|NCT02434120|MRI|mri
284531|NCT02434120|Orbital neoplasm|orbital neoplasm
284532|NCT02434107|Sentinel Lymph Node Biopsy|sentinel lymph node biopsy
284533|NCT02434107|Lymph Node Excision|lymph node excision
284534|NCT02434094|Diabetes Assistant (DiAs)|diabetes assistant (dias)
284535|NCT02434094|Continuous Glucose Monitor (CGM)|continuous glucose monitor (cgm)
284536|NCT02434094|Insulin Pump|insulin pump
284537|NCT02434094|Human Factors|human factors
284538|NCT02434094|Focus Group|focus group
284539|NCT02434094|Artificial Pancreas (AP)|artificial pancreas (ap)
284540|NCT02434094|eDAPT (electronic Diabetes Artificial Pancreas Training)|edapt (electronic diabetes artificial pancreas training)
284541|NCT02434081|NSCLC|nsclc
284542|NCT02434081|IIIA/B|iiia/b
284543|NCT02434068|kidney calculi|kidney calculi
284544|NCT02434068|followup studies|followup studies
284545|NCT02434042|probiotic|probiotic
284546|NCT02434042|children|children
284547|NCT02434042|gastrointestinal|gastrointestinal
284548|NCT02434042|upper respiratory|upper respiratory
284549|NCT02434016|Diaphragm|diaphragm
284550|NCT02434016|Mechanical ventilation|mechanical ventilation
284551|NCT02434003|3D reconstruction|3d reconstruction
284552|NCT02434003|AIS|ais
284553|NCT02434003|Computer models|computer models
284554|NCT02434003|Spinal Deformity|spinal deformity
284555|NCT02433990|Congenital Heart Disease|congenital heart disease
284556|NCT02433990|Acquired Cardiovascular Disease|acquired cardiovascular disease
284557|NCT02433977|Asthma|asthma
284558|NCT02433977|Obesity|obesity
284559|NCT02433977|conjugated linolenic acid|conjugated linolenic acid
284560|NCT02433977|nitrate|nitrate
284561|NCT02433977|nitrite|nitrite
284562|NCT02433977|nutritional supplements|nutritional supplements
284563|NCT02433964|laser|laser
284564|NCT02433964|LED|led
284565|NCT02433964|PRICE|price
284566|NCT02433964|pain|pain
284567|NCT02433964|edema|edema
284568|NCT02433951|exercise tolerance|exercise tolerance
284569|NCT02433925|resveratrol|resveratrol
284570|NCT02433925|oxidative stress|oxidative stress
284571|NCT02433925|inflammation|inflammation
284572|NCT02433873|Microbiota|microbiota
284573|NCT02433873|Body weight|body weight
284574|NCT02433873|Digestive system|digestive system
284575|NCT02433847|mosapride|mosapride
284576|NCT02433821|Mechanical Neck Pain|mechanical neck pain
284577|NCT02433821|Pain|pain
284578|NCT02433821|Function|function
284579|NCT02433821|Quality of life|quality of life
284580|NCT02433821|Pilates|pilates
284581|NCT02433795|Marginal zone B-cell lymphoma|marginal zone b-cell lymphoma
284582|NCT02433795|bendamustine plus rituximab|bendamustine plus rituximab
284583|NCT02433782|Haemophilia|haemophilia
284584|NCT02433782|Arthropathy|arthropathy
284585|NCT02433782|Pain|pain
284586|NCT02433782|Range of motion|range of motion
284587|NCT02433782|Miofascial techniques|miofascial techniques
284588|NCT02433743|HIV/AIDS|hiv/aids
284589|NCT02433743|RUTF|rutf
284590|NCT02433743|fat free mass|fat free mass
284591|NCT02433743|anemia|anemia
284592|NCT02433743|zinc|zinc
284593|NCT02433743|Senegal|senegal
284594|NCT02433717|schizophrenia|schizophrenia
284595|NCT02433717|schizoaffective disorder|schizoaffective disorder
284596|NCT02433717|pharmacogenetics|pharmacogenetics
284597|NCT02433717|pharmacokinetics|pharmacokinetics
284598|NCT02433717|event-related potentials|event-related potentials
284599|NCT02433717|paliperidone|paliperidone
284600|NCT02433691|(An)aerobic exercise|(an)aerobic exercise
284601|NCT02433691|memory training|memory training
284602|NCT02433691|cognitive benefits|cognitive benefits
284603|NCT02433652|Dengue Vaccine|dengue vaccine
284604|NCT02433639|advanced biliary tract cancer, TH-302|advanced biliary tract cancer, th-302
284605|NCT02433613|Pulmonary Vein Isolation|pulmonary vein isolation
284606|NCT02433613|Phased Radiofrequency Ablation|phased radiofrequency ablation
284607|NCT02433574|radiosurgery|radiosurgery
284608|NCT02433574|Neoadjuvant Therapy|neoadjuvant therapy
284609|NCT02433548|Analgesia|analgesia
284610|NCT02433548|Emergency medicine|emergency medicine
284611|NCT02433548|Anesthesia, Regional|anesthesia, regional
284612|NCT02433535|severe asthma|severe asthma
284613|NCT02433535|simvastatin|simvastatin
284614|NCT02433535|allergic airway inflammation|allergic airway inflammation
284615|NCT02433522|ANCA-associated vasculitides|anca-associated vasculitides
284616|NCT02433522|Maintenance treatment|maintenance treatment
284617|NCT02433522|Rituximab|rituximab
284618|NCT02433522|Granulomatosis with polyangiitis|granulomatosis with polyangiitis
284619|NCT02433522|Microscopic polyangiitis|microscopic polyangiitis
284620|NCT02433509|acute ischemic stroke|acute ischemic stroke
284621|NCT02433509|umbilical cord blood|umbilical cord blood
284622|NCT02433496|Opioid|opioid
284623|NCT02433483|Adolescent|adolescent
284624|NCT02433483|Children|children
284625|NCT02433483|Microtransplant|microtransplant
284626|NCT02433483|Leukemia|leukemia
284627|NCT02433457|Healthy Volunteers|healthy volunteers
284628|NCT02433457|CC-292|cc-292
284629|NCT02433457|Open-Label|open-label
284630|NCT02433457|Bioavailability Pharmacokinetics|bioavailability pharmacokinetics
284631|NCT02433457|Phase I|phase i
285040|NCT02431351|Selinexor|selinexor
284632|NCT02433444|Biosensing Techniques|biosensing techniques
284633|NCT02433431|mindfulness|mindfulness
284634|NCT02433431|psychological stress|psychological stress
284635|NCT02433431|immune marker|immune marker
284636|NCT02433431|wellness programs|wellness programs
284637|NCT02433431|mobile applications|mobile applications
284638|NCT02433431|cortisol|cortisol
284639|NCT02433405|Serum Amyloid A|serum amyloid a
284640|NCT02433405|Fetuin-A|fetuin-a
284641|NCT02433405|gingival crevicular fluid|gingival crevicular fluid
284642|NCT02433405|serum|serum
284643|NCT02433405|periodontal diseases|periodontal diseases
284644|NCT02433392|drug-eluting beads|drug-eluting beads
284645|NCT02433392|irinotecan hydrochloride|irinotecan hydrochloride
284646|NCT02433353|PTSD|ptsd
284647|NCT02433353|posttraumatic stress disorder|posttraumatic stress disorder
284648|NCT02433353|venlafaxine|venlafaxine
284649|NCT02433353|EMDR|emdr
284650|NCT02433353|eye movement desensitization reprocessing|eye movement desensitization reprocessing
284651|NCT02433353|antidepressant|antidepressant
284652|NCT02433353|psychotherapy|psychotherapy
284653|NCT02433340|Tolerability|tolerability
284654|NCT02433340|Methotrexate|methotrexate
284655|NCT02433340|Safety|safety
284656|NCT02433327|Paediatric Early Warning System|paediatric early warning system
284657|NCT02433327|trigger tool|trigger tool
284658|NCT02433327|screening tool|screening tool
284659|NCT02433327|risk assessment|risk assessment
284660|NCT02433327|early recognition|early recognition
284661|NCT02433301|chemotherapy|chemotherapy
284662|NCT02433301|GEJ cancer|gej cancer
284663|NCT02433301|PET/MR-imaging|pet/mr-imaging
284664|NCT02433288|smart phone-based|smart phone-based
284665|NCT02433288|rosuvastatin|rosuvastatin
284666|NCT02433288|duration of treatment|duration of treatment
284667|NCT02433288|Treatment adherence|treatment adherence
284668|NCT02433223|outreach nursing|outreach nursing
284669|NCT02433223|respiratory nursing guidelines|respiratory nursing guidelines
284670|NCT02433197|Testicular cancer|testicular cancer
284671|NCT02433197|Germ cell cancer|germ cell cancer
284672|NCT02433197|Physical exercise|physical exercise
284673|NCT02433197|Cancer-related fatigue|cancer-related fatigue
284674|NCT02433197|Chemotherapy|chemotherapy
284675|NCT02433197|Clinical rules|clinical rules
284676|NCT02433197|Metabolomics|metabolomics
284677|NCT02433184|Etanercept|etanercept
284678|NCT02433184|treat to target|treat to target
284679|NCT02433184|Disease Modifying Antirheumatic Drugs (DMARDs)|disease modifying antirheumatic drugs (dmards)
284680|NCT02433171|regrowth|regrowth
284681|NCT02433171|radiosurgery|radiosurgery
284682|NCT02433171|radiation necrosis|radiation necrosis
284683|NCT02433158|Rivipansel|rivipansel
284684|NCT02433158|GMI-1070|gmi-1070
284685|NCT02433158|Selectin Inhibitor|selectin inhibitor
284687|NCT02433158|VOC|voc
284688|NCT02433145|ADHD in preschoolers|adhd in preschoolers
284689|NCT02433145|neuropsychological functions|neuropsychological functions
284690|NCT02433145|behavior inhibition|behavior inhibition
284691|NCT02433145|family function and parenting|family function and parenting
284692|NCT02433132|Cystic fibrosis|cystic fibrosis
284693|NCT02433132|Adults|adults
284694|NCT02433132|Atypical form|atypical form
284695|NCT02433132|Nasal brushing|nasal brushing
284696|NCT02433132|Epithelial cells|epithelial cells
284697|NCT02433132|Ion transport|ion transport
284698|NCT02433106|Balance|balance
284699|NCT02433106|Exercise|exercise
284700|NCT02433054|deep vein thrombosis|deep vein thrombosis
284701|NCT02433054|chronic venous disease|chronic venous disease
284702|NCT02433054|May-Thurner syndrome|may-thurner syndrome
284703|NCT02433054|venous stent|venous stent
284704|NCT02433041|Postoperative delirium|postoperative delirium
284705|NCT02433041|Cortisol|cortisol
284706|NCT02433041|NSE|nse
284707|NCT02433041|S-100beta|s-100beta
284708|NCT02433041|MMSE|mmse
284709|NCT02433041|Nu-DESC|nu-desc
284710|NCT02433041|ICDSC|icdsc
284711|NCT02433041|DOS|dos
284712|NCT02433041|Haloperidol|haloperidol
284713|NCT02433041|Ketamine|ketamine
751200|NCT00436501|TXT|txt
284714|NCT02433041|Combination of Haloperidol and Ketamine|combination of haloperidol and ketamine
284715|NCT02433041|Placebo|placebo
284716|NCT02433041|Prevention of|prevention of
284717|NCT02433028|MS key phases of disease evolution|ms key phases of disease evolution
284718|NCT02433028|MS New Treatment Options|ms new treatment options
284719|NCT02433015|Electronic Cigarette|electronic cigarette
284720|NCT02433002|eGFR|egfr
284721|NCT02433002|CKD|ckd
284722|NCT02433002|Cystatin|cystatin
284723|NCT02433002|Creatinine|creatinine
284724|NCT02433002|Albuminuria|albuminuria
284725|NCT02432989|Exercise Therapy|exercise therapy
284726|NCT02432989|Concussion Management|concussion management
284727|NCT02432989|Concussion Recovery|concussion recovery
284728|NCT02432976|Quality of Life|quality of life
284729|NCT02432976|Cardiac Surgery|cardiac surgery
284730|NCT02432976|Coronary Artery Bypass Graft Surgery|coronary artery bypass graft surgery
284731|NCT02432976|Incretin mimetic|incretin mimetic
284732|NCT02432976|Exenatide|exenatide
284733|NCT02432937|Corever|corever
284734|NCT02432937|hypertension|hypertension
284735|NCT02432885|cardiac magnetic resonance|cardiac magnetic resonance
284736|NCT02432885|myocardial fibrosis|myocardial fibrosis
284737|NCT02432885|muscular dystrophies|muscular dystrophies
284738|NCT02432820|Prostate Cancer|prostate cancer
284739|NCT02432768|Anaplerotic diet|anaplerotic diet
284740|NCT02432768|McArdle Disease|mcardle disease
284741|NCT02432768|Glycogen Storage Disease|glycogen storage disease
284742|NCT02432768|Triheptanoin|triheptanoin
284743|NCT02432755|home-based rehabilitation|home-based rehabilitation
284745|NCT02432755|combination therapy|combination therapy
284746|NCT02432755|client-centered approach|client-centered approach
284747|NCT02432755|post-acute|post-acute
284748|NCT02432742|hyaluronic acid, comparative study, NLF|hyaluronic acid, comparative study, nlf
284749|NCT02432729|smoking cessation|smoking cessation
284750|NCT02432729|smoking abstinence|smoking abstinence
284751|NCT02432729|clinical, biological and functional changes|clinical, biological and functional changes
284752|NCT02432729|one year|one year
284753|NCT02432729|healthy smokers|healthy smokers
284754|NCT02432729|quit smoking|quit smoking
284755|NCT02432703|Social Anxiety Disorder|social anxiety disorder
284756|NCT02432703|JNJ-42165279|jnj-42165279
284757|NCT02432690|Neoplasms|neoplasms
284758|NCT02432677|tDCS|tdcs
284759|NCT02432677|Opioid|opioid
284760|NCT02432677|Pain|pain
284761|NCT02432677|Pain threshold|pain threshold
284762|NCT02432651|oxidative stress|oxidative stress
284763|NCT02432651|hops|hops
284764|NCT02432651|xanthohumol|xanthohumol
284765|NCT02432651|DNA damage|dna damage
284766|NCT02432651|cancer|cancer
284767|NCT02432625|Osteogenesis Imperfecta|osteogenesis imperfecta
284768|NCT02432625|Collagen|collagen
284769|NCT02432625|Brittle Bone Disorder|brittle bone disorder
284770|NCT02432625|Rare Disease Clinical Research Network|rare disease clinical research network
284771|NCT02432625|COL1A2|col1a2
284772|NCT02432599|F18-choline|f18-choline
284773|NCT02432586|T1DM|t1dm
284774|NCT02432586|Diabetes|diabetes
284775|NCT02432586|Child|child
284776|NCT02432586|Toddler|toddler
284777|NCT02432573|timing|timing
284778|NCT02432560|Lymphangioleiomyomatosis|lymphangioleiomyomatosis
284779|NCT02432560|LAM|lam
284780|NCT02432560|rare lung|rare lung
284781|NCT02432560|Rare Lung Disease|rare lung disease
284782|NCT02432547|Diabetic|diabetic
284783|NCT02432547|Macular Oedema|macular oedema
284784|NCT02432547|Retinopathy|retinopathy
284785|NCT02432521|stroke|stroke
284786|NCT02432521|transcranial magnetic stimulation (TMS)|transcranial magnetic stimulation (tms)
284787|NCT02432521|Electroencephalography (EEG)|electroencephalography (eeg)
284788|NCT02432521|Cerebrovascular Accident|cerebrovascular accident
284789|NCT02432521|Brain Vascular Accident|brain vascular accident
284790|NCT02432508|acupuncture|acupuncture
284791|NCT02432508|laser|laser
284792|NCT02432508|uremic pruritus|uremic pruritus
284793|NCT02432508|randomized clinical trial|randomized clinical trial
284794|NCT02432482|Tobacco|tobacco
284795|NCT02432482|Cigarette|cigarette
284796|NCT02432482|HIV|hiv
284797|NCT02432482|Treatment|treatment
284798|NCT02432482|Mobile|mobile
284799|NCT02432482|Smartphone|smartphone
284800|NCT02432469|coronary artery bypass|coronary artery bypass
284801|NCT02432469|medication adherence|medication adherence
284802|NCT02432469|secondary prevention|secondary prevention
284803|NCT02432469|mobile applications|mobile applications
284804|NCT02432443|Motor Skills|motor skills
284805|NCT02432443|Pre-literacy Skills|pre-literacy skills
284806|NCT02432443|Early Intervention|early intervention
284807|NCT02432430|N05.300.150.410|n05.300.150.410
284808|NCT02432430|practice guideline|practice guideline
284809|NCT02432430|D20.215.894.899.290.130|d20.215.894.899.290.130
284810|NCT02432430|Health Knowledge, Attitudes, Practice|health knowledge, attitudes, practice
284811|NCT02432417|Glioblastoma|glioblastoma
284812|NCT02432417|Autophagy|autophagy
284813|NCT02432417|EGFR|egfr
284814|NCT02432417|EGFRvIII|egfrviii
284815|NCT02432417|Chloroquine|chloroquine
284816|NCT02432417|Radiotherapy|radiotherapy
284817|NCT02432417|Temozolomide|temozolomide
284818|NCT02432404|HSV-2|hsv-2
284819|NCT02432404|Contraceptive Vaginal Ring|contraceptive vaginal ring
284820|NCT02432365|Paclitaxel|paclitaxel
284821|NCT02432365|Cisplatin|cisplatin
284822|NCT02432365|Cervical cancer|cervical cancer
284823|NCT02432365|Radical hysterectomy|radical hysterectomy
284824|NCT02432365|Neoadjuvant|neoadjuvant
284825|NCT02432339|immune system|immune system
284826|NCT02432339|RENIN-ANGIOTENSIN SYSTEM|renin-angiotensin system
284827|NCT02432326|Neoplasms|neoplasms
284828|NCT02432300|Traumatic Brain Injury|traumatic brain injury
284829|NCT02432300|Alexithymia|alexithymia
284830|NCT02432300|Emotions|emotions
284831|NCT02432287|aging|aging
284832|NCT02432287|metformin|metformin
284833|NCT02432287|prediabetes|prediabetes
284834|NCT02432274|E7080|e7080
284835|NCT02432274|Lenvatinib|lenvatinib
284836|NCT02432274|Solid malignancies|solid malignancies
284837|NCT02432274|Osteosarcoma|osteosarcoma
284838|NCT02432274|Differentiated Thyroid Cancer|differentiated thyroid cancer
284839|NCT02432261|spermatogenesis|spermatogenesis
284840|NCT02432261|androgen|androgen
284841|NCT02432261|male contraception|male contraception
284842|NCT02432248|DHEA|dhea
284843|NCT02432248|live birth rate|live birth rate
284844|NCT02432248|poor ovarian responder|poor ovarian responder
284845|NCT02432235|Camidanlumab tesirine|camidanlumab tesirine
284846|NCT02432196|Mitral Valve Repair|mitral valve repair
284847|NCT02432196|Transapical|transapical
284848|NCT02432196|artificial chordae|artificial chordae
284849|NCT02432183|individual|individual
284850|NCT02432144|MPS 7|mps 7
284851|NCT02432144|Sly Syndrome|sly syndrome
284852|NCT02432144|MPS VII|mps vii
284853|NCT02432144|Enzyme Replacement Therapy|enzyme replacement therapy
284854|NCT02432144|Rare Disease|rare disease
284855|NCT02432144|Mucopolysaccharidosis Type 7|mucopolysaccharidosis type 7
284856|NCT02432144|Lysosomal Storage Disease|lysosomal storage disease
284857|NCT02432144|Metabolic Disorder|metabolic disorder
284858|NCT02432092|Cardiomegaly|cardiomegaly
284859|NCT02432092|Cardiovascular Diseases|cardiovascular diseases
284860|NCT02432092|Heart Diseases|heart diseases
284861|NCT02432092|Systolic dysfunction|systolic dysfunction
284862|NCT02432092|Diastolic dysfunction|diastolic dysfunction
284863|NCT02432092|Ventricular hypertrophy|ventricular hypertrophy
284864|NCT02432092|Heart failure|heart failure
284865|NCT02432079|Abnormalities, Multiple|abnormalities, multiple
284866|NCT02432079|Asplenia|asplenia
284867|NCT02432079|Bilary Atresia|bilary atresia
284868|NCT02432079|Birth Defect|birth defect
284869|NCT02432079|Cardiovascular Abnormalities|cardiovascular abnormalities
284870|NCT02432079|Cardiovascular Diseases|cardiovascular diseases
284871|NCT02432079|Congenital Abnormalities|congenital abnormalities
284872|NCT02432079|Congenital Heart Disease|congenital heart disease
284873|NCT02432079|Dextrocardia Syndrome|dextrocardia syndrome
284874|NCT02432079|Disturbed Internal Organ Positioning|disturbed internal organ positioning
284875|NCT02432079|Genetics|genetics
284876|NCT02432079|Genetic Testing|genetic testing
284877|NCT02432079|Heart Defects, Congenital|heart defects, congenital
284878|NCT02432079|Heart Diseases|heart diseases
284879|NCT02432079|Heterotaxy syndrome|heterotaxy syndrome
284880|NCT02432079|Intestinal malrotation|intestinal malrotation
284881|NCT02432079|Laterality|laterality
284882|NCT02432079|Left Atrial Isomerism|left atrial isomerism
284883|NCT02432079|Pediatrics|pediatrics
284884|NCT02432079|Polysplenia|polysplenia
284885|NCT02432079|Right Atrial Isomerism|right atrial isomerism
284886|NCT02432079|Splenic Diseases|splenic diseases
284887|NCT02432079|Cilia|cilia
284888|NCT02432079|Situs inversus|situs inversus
284889|NCT02432079|Dextrocardia|dextrocardia
284890|NCT02432066|Smoking|smoking
284891|NCT02432066|Smoking Cessation|smoking cessation
284892|NCT02432053|FK506|fk506
284893|NCT02432053|Advagraf|advagraf
284894|NCT02432053|Tacrolimus|tacrolimus
284895|NCT02432053|Transplantation|transplantation
284896|NCT02432040|chronic plaque psoriasis|chronic plaque psoriasis
284897|NCT02432040|psoriasis|psoriasis
284898|NCT02432040|atorvastatin|atorvastatin
284899|NCT02432040|psoriasis area and severity index|psoriasis area and severity index
284900|NCT02432040|betamethasone valerate|betamethasone valerate
284901|NCT02431988|Relapsed|relapsed
284902|NCT02431988|refractory|refractory
284903|NCT02431988|DLBCL|dlbcl
284905|NCT02431975|infant|infant
284906|NCT02431975|antiretroviral therapy, highly active|antiretroviral therapy, highly active
284907|NCT02431975|antiretroviral agents|antiretroviral agents
284908|NCT02431962|Lung Cancer|lung cancer
284909|NCT02431962|Screening|screening
284910|NCT02431962|Computed Tomography|computed tomography
284911|NCT02431949|Music|music
284912|NCT02431949|Amusia|amusia
284913|NCT02431936|Stress|stress
284914|NCT02431936|Blood Pressure|blood pressure
284915|NCT02431936|Salt Sensitivity|salt sensitivity
284916|NCT02431936|Renin-Angiotensin-Aldosterone System|renin-angiotensin-aldosterone system
751201|NCT00436488|ICAM-1|icam-1
284917|NCT02431936|Sympathetic Nervous System|sympathetic nervous system
284918|NCT02431923|Sequelae|sequelae
284919|NCT02431923|Seroprevalence|seroprevalence
284920|NCT02431923|Household Contacts|household contacts
284921|NCT02431910|Electromyography|electromyography
284922|NCT02431910|Baropodometry|baropodometry
284923|NCT02431910|Torque|torque
284924|NCT02431897|Pelvic Organ Prolapse|pelvic organ prolapse
284925|NCT02431897|Pelvic Floor Disorders|pelvic floor disorders
284926|NCT02431897|Therapy, Estrogen Replacement|therapy, estrogen replacement
284927|NCT02431897|Estrogens, Conjugated|estrogens, conjugated
284928|NCT02431871|Developmental dysplasia of the hip|developmental dysplasia of the hip
284929|NCT02431871|Hip dysplasia|hip dysplasia
284930|NCT02431871|Occlusal defect|occlusal defect
284931|NCT02431858|Nerve block|nerve block
284932|NCT02431858|Catheter|catheter
284933|NCT02431858|Catheter over needle|catheter over needle
284934|NCT02431858|Femoral Nerve|femoral nerve
284935|NCT02431858|Anaesthesia|anaesthesia
284936|NCT02431858|[E04.525.210.550]|[e04.525.210.550]
284937|NCT02431858|[E02.148]|[e02.148]
285041|NCT02431351|SIER|sier
284938|NCT02431845|Obsessive-Compulsive Disorder|obsessive-compulsive disorder
284939|NCT02431845|Pharmaco(epi)genetics|pharmaco(epi)genetics
284940|NCT02431832|Elderly|elderly
284941|NCT02431819|Peripheral Arterial Disease|peripheral arterial disease
284942|NCT02431819|Progressive compressive stockings|progressive compressive stockings
284943|NCT02431793|Opioids|opioids
284944|NCT02431780|Neonatal Seizures|neonatal seizures
284945|NCT02431780|Decision Support Algorithm|decision support algorithm
284946|NCT02431780|EEG|eeg
284947|NCT02431741|Presence of at least one exuding malignant (fungating) wound in need for antimicrobial treatment|presence of at least one exuding malignant (fungating) wound in need for antimicrobial treatment
284948|NCT02431728|Melatonin|melatonin
284949|NCT02431728|Post-acute withdrawal symptoms|post-acute withdrawal symptoms
284950|NCT02431728|Anxiety|anxiety
284951|NCT02431728|Depression|depression
284952|NCT02431728|Insomnia|insomnia
284953|NCT02431728|Stress|stress
284954|NCT02431728|Substance withdrawal syndrome|substance withdrawal syndrome
284955|NCT02431702|Paliperidone Palmitate|paliperidone palmitate
284956|NCT02431702|Oral Antipsychotics|oral antipsychotics
284957|NCT02431702|Schizophrenia|schizophrenia
284958|NCT02431702|Psychotic Disorders|psychotic disorders
284959|NCT02431702|Cognition in Schizophrenia|cognition in schizophrenia
284960|NCT02431702|Brain intracortical myelin volume|brain intracortical myelin volume
284961|NCT02431702|Personal and Social Performance|personal and social performance
284962|NCT02431702|Disease Modification|disease modification
284963|NCT02431663|refractory convulsive status epilepticus|refractory convulsive status epilepticus
284964|NCT02431663|ketamine|ketamine
284965|NCT02431663|conventional anesthetics|conventional anesthetics
284966|NCT02431663|children|children
284967|NCT02431650|Induced blood stage malaria|induced blood stage malaria
284968|NCT02431650|Transmission|transmission
284969|NCT02431650|Mosquito feeding|mosquito feeding
284970|NCT02431650|OZ439|oz439
284971|NCT02431650|Primaquine|primaquine
284972|NCT02431650|Piperaquine|piperaquine
284973|NCT02431650|Artefonomel|artefonomel
284974|NCT02431637|Induced blood stage malaria|induced blood stage malaria
284975|NCT02431637|Transmission|transmission
284976|NCT02431637|Standard membrane feeding assay|standard membrane feeding assay
284977|NCT02431624|Healthy Volunteer|healthy volunteer
284978|NCT02431585|abdominal pain|abdominal pain
284979|NCT02431585|gluten free diet|gluten free diet
284980|NCT02431585|functional gastrointestinal disorders|functional gastrointestinal disorders
284981|NCT02431572|Intracranial Tumors|intracranial tumors
284982|NCT02431572|Glioblastoma|glioblastoma
284983|NCT02431572|Melanoma|melanoma
284984|NCT02431559|Ovarian Cancer|ovarian cancer
284985|NCT02431559|Motolimod|motolimod
284986|NCT02431559|Immunotherapy|immunotherapy
284987|NCT02431559|PD-L1|pd-l1
284988|NCT02431559|MEDI4736|medi4736
284989|NCT02431559|Pegylated|pegylated
284990|NCT02431559|Liposomal|liposomal
284991|NCT02431559|Doxorubicin|doxorubicin
284992|NCT02431559|PLD|pld
284993|NCT02431559|TLR-8|tlr-8
284994|NCT02431559|Durvalumab|durvalumab
284995|NCT02431546|Cardiology|cardiology
284996|NCT02431546|Vascular|vascular
284997|NCT02431546|CAD|cad
284998|NCT02431546|Duke|duke
284999|NCT02431546|Cardiac Rehabilitation|cardiac rehabilitation
285000|NCT02431546|Prevention|prevention
285001|NCT02431546|CVD|cvd
285002|NCT02431546|Mobile Health|mobile health
285003|NCT02431546|Exercise|exercise
285004|NCT02431533|IBS-D|ibs-d
285005|NCT02431533|diarrhea predominant|diarrhea predominant
285006|NCT02431520|Patient Compliance|patient compliance
285007|NCT02431520|HPV-DNA probes|hpv-dna probes
285008|NCT02431520|Papanicolaou test|papanicolaou test
285009|NCT02431520|Cervical cancer|cervical cancer
285010|NCT02431507|apnea|apnea
285011|NCT02431507|sleep apnea|sleep apnea
285012|NCT02431507|magnetic sleep apnea device|magnetic sleep apnea device
285013|NCT02431507|hyoid bone|hyoid bone
285014|NCT02431455|Bariatric Surgery|bariatric surgery
285015|NCT02431455|obesity, morbid|obesity, morbid
285016|NCT02431455|incentive spirometry|incentive spirometry
285017|NCT02431442|Heterozygous|heterozygous
285018|NCT02431442|MC4R deficiency|mc4r deficiency
285019|NCT02431442|associated|associated
285020|NCT02431429|leishmaniasis|leishmaniasis
285021|NCT02431429|miltefosine|miltefosine
285022|NCT02431429|spermiogram|spermiogram
285023|NCT02431416|females|females
285024|NCT02431416|ghrelin|ghrelin
285025|NCT02431416|GnRH|gnrh
285026|NCT02431416|randomized, controlled study|randomized, controlled study
285027|NCT02431416|children|children
285028|NCT02431390|RAPAELⓇ Smart Glove digital treatment system|rapaelⓡ smart glove digital treatment system
285029|NCT02431390|Rehabilitation|rehabilitation
285030|NCT02431390|Stroke|stroke
285031|NCT02431390|Upper limbs|upper limbs
285032|NCT02431377|infant formula|infant formula
285033|NCT02431364|KPT-335|kpt-335
285034|NCT02431364|Verdinexor|verdinexor
285035|NCT02431364|Karyopharm|karyopharm
285036|NCT02431364|First-in-Human|first-in-human
285037|NCT02431364|Adult Subjects|adult subjects
285038|NCT02431351|KPT-330|kpt-330
285039|NCT02431351|Karyopharm|karyopharm
285042|NCT02431351|Myelodysplastic Syndrome (MDS)|myelodysplastic syndrome (mds)
285043|NCT02431351|Erythropoietin (EPO)|erythropoietin (epo)
285044|NCT02431351|Refractory|refractory
285045|NCT02431338|Remote ischemic conditioning|remote ischemic conditioning
285046|NCT02431338|Cost-effectiveness analysis|cost-effectiveness analysis
285047|NCT02431325|HIV|hiv
285048|NCT02431325|Atherosclerosis|atherosclerosis
285049|NCT02431325|Microbial Translocation|microbial translocation
285050|NCT02431325|Teduglutide|teduglutide
285051|NCT02431325|Gastrointestinal Permeability|gastrointestinal permeability
285052|NCT02431325|Inflammation|inflammation
285053|NCT02431312|Chronic HBV|chronic hbv
285054|NCT02431312|immunotherapy|immunotherapy
285055|NCT02431312|DNA vaccine|dna vaccine
285056|NCT02431312|electroporation|electroporation
285057|NCT02431286|nausea and vomiting, postoperative|nausea and vomiting, postoperative
285058|NCT02431286|emesis, postoperative|emesis, postoperative
285059|NCT02431273|TDF|tdf
285060|NCT02431273|FTC|ftc
285061|NCT02431273|MVC|mvc
285062|NCT02431273|TDF-FTC|tdf-ftc
285063|NCT02431273|TDF-FTC-MVC|tdf-ftc-mvc
285064|NCT02431273|IVR|ivr
285065|NCT02431273|ARV|arv
285066|NCT02431260|solid tumor|solid tumor
285067|NCT02431260|lymphoma|lymphoma
285068|NCT02431260|BET bromodomain inhibitor|bet bromodomain inhibitor
285069|NCT02431260|BRD|brd
285070|NCT02431260|Diffuse large B-cell lymphoma (DLBCL)|diffuse large b-cell lymphoma (dlbcl)
285071|NCT02431260|Burkitt's lymphoma|burkitt's lymphoma
285072|NCT02431260|c-MYC|c-myc
285073|NCT02431260|colorectal cancer|colorectal cancer
285074|NCT02431260|Non-small cell lung cancer|non-small cell lung cancer
285075|NCT02431260|Pancreatic adenocarcinoma|pancreatic adenocarcinoma
285076|NCT02431260|castration-resistant prostate cancer|castration-resistant prostate cancer
285077|NCT02431260|breast cancer|breast cancer
285078|NCT02431260|NUT midline carcinoma|nut midline carcinoma
285079|NCT02431260|leukemia|leukemia
285080|NCT02431260|acute myeloid leukemia (AML)|acute myeloid leukemia (aml)
285081|NCT02431260|myelodysplastic syndrome (MDS)|myelodysplastic syndrome (mds)
285082|NCT02431260|myeloproliferative neoplasms|myeloproliferative neoplasms
285083|NCT02431260|myelofibrosis (MF)|myelofibrosis (mf)
285084|NCT02431260|multiple myeloma (MM)|multiple myeloma (mm)
285085|NCT02431260|MDS/MPN|mds/mpn
285086|NCT02431247|Immunodeficiency Virus Type 1, Human|immunodeficiency virus type 1, human
285087|NCT02431247|Darunavir|darunavir
285088|NCT02431247|Cobicistat|cobicistat
285089|NCT02431247|Tenofovir Alafenamide|tenofovir alafenamide
285090|NCT02431247|Emtricitabine|emtricitabine
285091|NCT02431247|Tenofovir Disoproxil Fumarate|tenofovir disoproxil fumarate
285092|NCT02431234|Type 2 diabetes|type 2 diabetes
285093|NCT02431234|Arterial calcification|arterial calcification
285094|NCT02431234|Mediacalcosis|mediacalcosis
285095|NCT02431234|Calcium score|calcium score
285096|NCT02431221|perhexiline|perhexiline
285097|NCT02431221|HCM|hcm
285098|NCT02431221|Hypertrophic Cardiomyopathy|hypertrophic cardiomyopathy
285099|NCT02431221|CPEX|cpex
285100|NCT02431195|obesity|obesity
285101|NCT02431195|bariatric surgery|bariatric surgery
285102|NCT02431195|physical activity|physical activity
285103|NCT02431195|eating habits|eating habits
285104|NCT02431156|presbyopia|presbyopia
285105|NCT02431156|monovision|monovision
285106|NCT02431156|activities of daily living,|activities of daily living,
285107|NCT02431156|pseudophakic|pseudophakic
285108|NCT02431130|Training Program|training program
285109|NCT02431091|Optical Coherence Tomography|optical coherence tomography
285110|NCT02431078|CTCs|ctcs
285111|NCT02431078|ZEB1|zeb1
285112|NCT02431078|gastric cancer|gastric cancer
285113|NCT02431065|Rectus sheath block|rectus sheath block
285114|NCT02431065|Single port laparoscopy|single port laparoscopy
285115|NCT02431026|induced mild hypothermia|induced mild hypothermia
285116|NCT02431026|cervical cooling collar|cervical cooling collar
285117|NCT02431026|mri brain thermometry|mri brain thermometry
285118|NCT02431026|MRI thermometry|mri thermometry
285119|NCT02431026|rate-of-cooling|rate-of-cooling
285120|NCT02431026|Excel Cryo Cooling Collar|excel cryo cooling collar
285121|NCT02431013|Drug-drug interaction|drug-drug interaction
285122|NCT02431013|Pharmacokinetics|pharmacokinetics
285123|NCT02430961|Critical Care|critical care
285124|NCT02430961|Palliative Care|palliative care
285125|NCT02430948|Screening|screening
285126|NCT02430948|Shared Decision Making|shared decision making
285127|NCT02430935|Psychosis|psychosis
285128|NCT02430935|Psychosis NOS|psychosis nos
285129|NCT02430935|Schizophrenia|schizophrenia
285130|NCT02430935|Schizoaffective Disorder|schizoaffective disorder
285131|NCT02430935|Early Intervention|early intervention
285132|NCT02430896|Neuropsychological|neuropsychological
285133|NCT02430896|neuroimaging|neuroimaging
285134|NCT02430896|genetic markers|genetic markers
285135|NCT02430896|treatment response predictor|treatment response predictor
285136|NCT02430883|pain, RIRS, kidney|pain, rirs, kidney
285137|NCT02430870|Drug therapy|drug therapy
285138|NCT02430844|acute kidney injury|acute kidney injury
285139|NCT02430844|radiographic contrast|radiographic contrast
285140|NCT02430844|critically ill|critically ill
285141|NCT02430844|biomarker|biomarker
285142|NCT02430818|ketamine|ketamine
285143|NCT02430818|emergency medicine|emergency medicine
285144|NCT02430818|orthopedics|orthopedics
285145|NCT02430805|hypertension|hypertension
285146|NCT02430805|microinflammation and oxidative stress|microinflammation and oxidative stress
285147|NCT02430805|renal disease|renal disease
285148|NCT02430805|heart failure|heart failure
285149|NCT02430805|genetics markers|genetics markers
285150|NCT02430805|genomics markers|genomics markers
285151|NCT02430805|proteomics markers|proteomics markers
285152|NCT02430792|Prostatic Neoplasms|prostatic neoplasms
285153|NCT02430792|Exercise|exercise
285154|NCT02430792|Football|football
285155|NCT02430792|Quality of Life|quality of life
285156|NCT02430779|irreversible electroporation|irreversible electroporation
285157|NCT02430779|Unresectable Renal Pelvic and Ureteral Neoplasms|unresectable renal pelvic and ureteral neoplasms
285158|NCT02430766|irreversible electroporation|irreversible electroporation
285159|NCT02430766|Unresectable Lymph Node Metastases|unresectable lymph node metastases
285160|NCT02430753|irreversible electroporation|irreversible electroporation
285161|NCT02430753|Lung Neoplasms|lung neoplasms
285162|NCT02430753|Respiratory Function Insufficiency|respiratory function insufficiency
285163|NCT02430740|Fertilization in Vitro|fertilization in vitro
285164|NCT02430740|antagonist protocol|antagonist protocol
285165|NCT02430740|antral follicle count|antral follicle count
285166|NCT02430740|Anti-Mullerian Hormone|anti-mullerian hormone
285167|NCT02430740|Reproductive Techniques, Assisted|reproductive techniques, assisted
285168|NCT02430714|Thyroid Cancer|thyroid cancer
285169|NCT02430714|Lenvima|lenvima
285170|NCT02430714|Post-marketing surveillance|post-marketing surveillance
285171|NCT02430714|LEN01T|len01t
285172|NCT02430714|All-Patient Investigation|all-patient investigation
285173|NCT02430714|Lenvatinib Mesylate|lenvatinib mesylate
285174|NCT02430701|irreversible electroporation|irreversible electroporation
285175|NCT02430701|Unresectable Esophageal Neoplasms|unresectable esophageal neoplasms
285176|NCT02430688|irreversible electroporation|irreversible electroporation
285177|NCT02430688|Unresectable Extremities|unresectable extremities
285178|NCT02430675|irreversible electroporation|irreversible electroporation
285179|NCT02430675|Unresectable Laryngeal Neoplasms|unresectable laryngeal neoplasms
285180|NCT02430662|irreversible electroporation|irreversible electroporation
285181|NCT02430662|Unresectable Gallbladder Neoplasms|unresectable gallbladder neoplasms
285182|NCT02430649|irreversible electroporation|irreversible electroporation
285183|NCT02430649|Unresectable Prostatic Neoplasms|unresectable prostatic neoplasms
285184|NCT02430636|irreversible electroporation|irreversible electroporation
285185|NCT02430636|Unresectable Stomach Neoplasms|unresectable stomach neoplasms
285186|NCT02430623|irreversible electroporation|irreversible electroporation
285187|NCT02430623|Unresectable Urinary Neoplasms|unresectable urinary neoplasms
285188|NCT02430610|irreversible electroporation|irreversible electroporation
285189|NCT02430610|Unresectable Uterine Cervical Neoplasms|unresectable uterine cervical neoplasms
285190|NCT02430597|irreversible electroporation|irreversible electroporation
285191|NCT02430597|Hilus Pulmonary Neoplasms|hilus pulmonary neoplasms
285192|NCT02430545|Glasdegib|glasdegib
285193|NCT02430545|PF-04449913|pf-04449913
285194|NCT02430545|Drug-drug interaction|drug-drug interaction
285195|NCT02430545|CYP3A4 inducer|cyp3a4 inducer
285196|NCT02430545|Pharmacokinetics|pharmacokinetics
285197|NCT02430532|INSPIRE|inspire
285198|NCT02430532|SPMS|spms
285199|NCT02430532|Tecfidera|tecfidera
285200|NCT02430532|BG00012|bg00012
285201|NCT02430519|Chronic Periodontitis|chronic periodontitis
285202|NCT02430519|Clinical Parameters|clinical parameters
285203|NCT02430519|Furcation defects|furcation defects
285204|NCT02430519|Radiographic bone fill|radiographic bone fill
285205|NCT02430493|ACS|acs
285206|NCT02430480|Multiparametric MRI|multiparametric mri
285207|NCT02430480|Prostatectomy|prostatectomy
364393|NCT02031991|PK|pk
285208|NCT02430480|Focal Prostate Cancer|focal prostate cancer
285209|NCT02430480|Normal Testosterone|normal testosterone
285210|NCT02430480|Non Metastatic|non metastatic
285211|NCT02430454|ICU|icu
285212|NCT02430454|decision making|decision making
285213|NCT02430402|Climatotherapy|climatotherapy
285214|NCT02430389|hemodynamic stability|hemodynamic stability
285215|NCT02430389|remifentanil|remifentanil
285216|NCT02430376|Non-Muscle Myosin|non-muscle myosin
285217|NCT02430363|pembrolizumab|pembrolizumab
285218|NCT02430363|MK-3475|mk-3475
285219|NCT02430363|Glioblastoma|glioblastoma
285220|NCT02430363|Gliosarcoma|gliosarcoma
285221|NCT02430363|Suppressor of the PI3K/Akt pathways|suppressor of the pi3k/akt pathways
285222|NCT02430363|Pictilisib|pictilisib
285223|NCT02430363|GDC-0941|gdc-0941
285224|NCT02430363|BEZ235|bez235
285225|NCT02430363|NVP-BEZ235|nvp-bez235
285226|NCT02430363|Ipatasertib|ipatasertib
285227|NCT02430363|GDC-0068|gdc-0068
285228|NCT02430311|Chinese Patients|chinese patients
285229|NCT02430285|biliary stone|biliary stone
285230|NCT02430285|cholelithiasis|cholelithiasis
285231|NCT02430285|pancreatitis|pancreatitis
285232|NCT02430285|EUS|eus
285233|NCT02430285|ERCP|ercp
285234|NCT02430285|early|early
285235|NCT02430285|choledocholithiasis|choledocholithiasis
285236|NCT02430272|Child|child
285237|NCT02430272|outpatient|outpatient
285238|NCT02430272|premedication|premedication
285239|NCT02430259|rifapentine|rifapentine
285240|NCT02430259|isoniazid|isoniazid
285241|NCT02430259|QuantiFERON Gold In-Tube|quantiferon gold in-tube
285242|NCT02430259|tuberculin skin test|tuberculin skin test
285243|NCT02430207|Pulmonary Embolism|pulmonary embolism
285244|NCT02430207|Temporary Pacing|temporary pacing
285245|NCT02430207|Femoral Vein|femoral vein
285246|NCT02430207|Subclavian Vein|subclavian vein
285247|NCT02430168|Stone|stone
285248|NCT02430168|RIRs|rirs
285249|NCT02430168|PCNL|pcnl
285250|NCT02430168|Pain|pain
285251|NCT02430155|condom-loaded Foley's catheter|condom-loaded foley's catheter
285252|NCT02430155|Bakri balloon|bakri balloon
285253|NCT02430155|primary atonic postpartum hemorrhage|primary atonic postpartum hemorrhage
285254|NCT02430142|microcirculation|microcirculation
285255|NCT02430142|oxygen uptake|oxygen uptake
285257|NCT02430142|adenosine|adenosine
285258|NCT02430142|central venous saturation|central venous saturation
285259|NCT02430142|hypoxanthine|hypoxanthine
285260|NCT02430142|laserdoppler|laserdoppler
285261|NCT02430103|Breast Cancer|breast cancer
285262|NCT02430103|Preservation of Ovarian Reserve Function|preservation of ovarian reserve function
285263|NCT02430090|regionel anesthesia|regionel anesthesia
285264|NCT02430090|levobupivacaine|levobupivacaine
285265|NCT02430090|ceserean section|ceserean section
285266|NCT02430077|Hepatic Steatosis|hepatic steatosis
285267|NCT02430051|sensory processing|sensory processing
285268|NCT02430051|oral care|oral care
285269|NCT02430051|electrodermal activity|electrodermal activity
285270|NCT02430051|cooperation|cooperation
285271|NCT02430051|anxiety|anxiety
285272|NCT02430051|distress|distress
285273|NCT02430051|stress|stress
285274|NCT02430051|behavior|behavior
285275|NCT02430051|occupational therapy|occupational therapy
285276|NCT02430038|transperineal ultrasound|transperineal ultrasound
285277|NCT02430038|labour|labour
285278|NCT02430038|sonopartogram|sonopartogram
285279|NCT02430038|prediction model|prediction model
285280|NCT02430025|Cardiovascular Diseases|cardiovascular diseases
285281|NCT02430025|Vascular Diseases|vascular diseases
285282|NCT02430025|Acute Coronary Syndrome|acute coronary syndrome
285283|NCT02430025|Chest Pain|chest pain
285284|NCT02430025|Heart Diseases|heart diseases
285285|NCT02430025|Myocardial Ischemia|myocardial ischemia
285286|NCT02430025|Pathologic Processes|pathologic processes
285287|NCT02430012|coronary artery bypass grafting|coronary artery bypass grafting
285288|NCT02430012|quality improvement|quality improvement
285289|NCT02430012|secondary preventions|secondary preventions
285290|NCT02429986|Adaptive Servo-Ventilation|adaptive servo-ventilation
285291|NCT02429986|Chronic Heart Failure|chronic heart failure
285292|NCT02429986|Central Sleep Apnea Syndrome|central sleep apnea syndrome
285293|NCT02429986|Central and Obstructive Sleep Apnea Syndrome|central and obstructive sleep apnea syndrome
285294|NCT02429986|Complex Sleep Apnea Syndrome|complex sleep apnea syndrome
285295|NCT02429986|Hunter-Cheyne-Stokes Breathing|hunter-cheyne-stokes breathing
285296|NCT02429986|Periodic Breathing|periodic breathing
285297|NCT02429973|Osteosarcoma|osteosarcoma
285298|NCT02429960|Nociception|nociception
285299|NCT02429960|Analgesia|analgesia
285300|NCT02429960|Intraoperative|intraoperative
285301|NCT02429960|Monitoring|monitoring
285302|NCT02429947|Charcot Marie Tooth disease|charcot marie tooth disease
285303|NCT02429947|CMT|cmt
285304|NCT02429947|HMSN|hmsn
285305|NCT02429947|HMN|hmn
285306|NCT02429947|HSN|hsn
285307|NCT02429934|Systemic Lupus Erythematosus (SLE)|systemic lupus erythematosus (sle)
751202|NCT00436488|Obesity|obesity
285308|NCT02429934|Abatacept (Orencia)|abatacept (orencia)
285309|NCT02429934|Arthritis|arthritis
285310|NCT02429921|dietary intervention|dietary intervention
285311|NCT02429921|arsenic poisoning|arsenic poisoning
285312|NCT02429921|high-Se lentils|high-se lentils
285313|NCT02429895|Methotrexate|methotrexate
285314|NCT02429895|Efficacy|efficacy
285315|NCT02429895|Safety|safety
285316|NCT02429882|Ankylosing Spondyloarthritis; non-radiographic axial spondyloarthritis|ankylosing spondyloarthritis; non-radiographic axial spondyloarthritis
285317|NCT02429843|Non-squamous cell lung cancer|non-squamous cell lung cancer
285318|NCT02429843|Non-squamous non-small cell lung cancer|non-squamous non-small cell lung cancer
285319|NCT02429843|vascular endothelial growth factor (VEGF)|vascular endothelial growth factor (vegf)
285320|NCT02429843|TRC105|trc105
285321|NCT02429830|gastroesophageal reflux disease|gastroesophageal reflux disease
285322|NCT02429830|GERD|gerd
285323|NCT02429830|obesity|obesity
285324|NCT02429830|LSG|lsg
285325|NCT02429830|Laparoscopic Sleeve Gastrectomy|laparoscopic sleeve gastrectomy
285326|NCT02429817|Pulmonary aerosol distribution|pulmonary aerosol distribution
285327|NCT02429817|SPECT-CT analysis|spect-ct analysis
285328|NCT02429817|High flow nasal cannula|high flow nasal cannula
285329|NCT02429817|Vibrating-mesh nebulizer|vibrating-mesh nebulizer
285330|NCT02429817|Jet nebulizer|jet nebulizer
285331|NCT02429791|two-drug regimen|two-drug regimen
285332|NCT02429791|virologically-suppressed|virologically-suppressed
285333|NCT02429791|dolutegravir plus rilpivirine|dolutegravir plus rilpivirine
285631|NCT02428374|MRI|mri
285334|NCT02429791|integrase inhibitor|integrase inhibitor
285335|NCT02429791|protease inhibitor|protease inhibitor
285336|NCT02429791|NNRTI-sparing|nnrti-sparing
285337|NCT02429791|non-nucleoside reverse transcriptase inhibitor|non-nucleoside reverse transcriptase inhibitor
285338|NCT02429791|HIV|hiv
285339|NCT02429791|nucleoside reverse transcriptase inhibitors|nucleoside reverse transcriptase inhibitors
285340|NCT02429752|inspiratory muscle training|inspiratory muscle training
285341|NCT02429752|low back pain|low back pain
285342|NCT02429752|respiration|respiration
285343|NCT02429752|breathing|breathing
285344|NCT02429739|Working Memory Training, computerized|working memory training, computerized
285345|NCT02429739|Dyslexia|dyslexia
285346|NCT02429739|Reading fluency|reading fluency
285347|NCT02429739|Reading comprehension|reading comprehension
285348|NCT02429726|malignant pleural effusion, p53 gene therapy, cisplatin|malignant pleural effusion, p53 gene therapy, cisplatin
285349|NCT02429713|tourniquet|tourniquet
285350|NCT02429713|total knee arthroplasty|total knee arthroplasty
285351|NCT02429713|blood loss|blood loss
285352|NCT02429674|Depression|depression
285353|NCT02429674|Adolescence|adolescence
285354|NCT02429648|AF|af
285355|NCT02429635|Exercise|exercise
285356|NCT02429635|lifestyle diseases|lifestyle diseases
285357|NCT02429635|well-being|well-being
285358|NCT02429596|antiepileptic drugs|antiepileptic drugs
285359|NCT02429596|generic substitution|generic substitution
285360|NCT02429570|meclofenamate|meclofenamate
285361|NCT02429570|15-068|15-068
285362|NCT02429557|autonomic failure|autonomic failure
285363|NCT02429557|orthostatic hypotension|orthostatic hypotension
285364|NCT02429557|compression garments|compression garments
285365|NCT02429557|treatment|treatment
285366|NCT02429544|Breast cancer|breast cancer
285367|NCT02429544|Stage IV breast cancer|stage iv breast cancer
285368|NCT02429544|Metastatic|metastatic
285369|NCT02429544|Residential group programs|residential group programs
285370|NCT02429544|Questionnaires|questionnaires
285371|NCT02429544|Surveys|surveys
285372|NCT02429544|EEG|eeg
285373|NCT02429544|Computer testing|computer testing
285374|NCT02429544|Saliva test|saliva test
285375|NCT02429544|Study diary|study diary
285376|NCT02429544|Actigraph|actigraph
285377|NCT02429531|Pneumovax 23|pneumovax 23
285378|NCT02429531|Typhim Vi|typhim vi
285379|NCT02429531|allohemagglutinins|allohemagglutinins
285380|NCT02429518|leishmaniasis|leishmaniasis
285381|NCT02429518|miltefosine|miltefosine
285382|NCT02429518|EKG|ekg
285383|NCT02429492|Pathophysiology|pathophysiology
285384|NCT02429492|Spinal interneurons|spinal interneurons
285385|NCT02429492|Electrophysiology|electrophysiology
285386|NCT02429492|EMG|emg
285387|NCT02429492|transcranial magnetic stimulation (TMS)|transcranial magnetic stimulation (tms)
285388|NCT02429479|Advance Care Planning|advance care planning
285389|NCT02429479|Living Will|living will
285390|NCT02429479|Family Caregiver|family caregiver
285391|NCT02429479|Advance Directive|advance directive
285392|NCT02429479|Surrogate Decision Maker|surrogate decision maker
285393|NCT02429479|Proxy|proxy
285394|NCT02429479|Self-Efficacy|self-efficacy
285395|NCT02429466|testicular germ cell tumor|testicular germ cell tumor
285396|NCT02429466|ovarian germ cell tumor|ovarian germ cell tumor
285397|NCT02429466|platinum refractory|platinum refractory
285398|NCT02429466|cisplatin|cisplatin
285399|NCT02429466|SGI110|sgi110
285400|NCT02429466|Guadecitabine|guadecitabine
285401|NCT02429453|Warfarin|warfarin
285402|NCT02429453|Traumatic intracranial hemorrhage|traumatic intracranial hemorrhage
751486|NCT00435357|patella|patella
285403|NCT02429453|prothrombin complex concentrate|prothrombin complex concentrate
285404|NCT02429453|fresh frozen plasma|fresh frozen plasma
285405|NCT02429453|Spontaneous intracranial hemorrhage|spontaneous intracranial hemorrhage
285406|NCT02429427|Primary Breast Cancer|primary breast cancer
285407|NCT02429427|Celecoxib|celecoxib
285408|NCT02429414|Surgical Procedure|surgical procedure
285409|NCT02429414|Fiberoptic bronchoscopy|fiberoptic bronchoscopy
285410|NCT02429414|FOB|fob
285411|NCT02429414|Non-Video Double Lumen Tube|non-video double lumen tube
285412|NCT02429414|DLT|dlt
285413|NCT02429414|Video Double Lumen Tube|video double lumen tube
285414|NCT02429414|VDLT|vdlt
285415|NCT02429401|binge drinking|binge drinking
285416|NCT02429401|heavy drinking|heavy drinking
285417|NCT02429388|Heart failure|heart failure
285418|NCT02429388|Spironolactone|spironolactone
285419|NCT02429388|Diuretics|diuretics
285420|NCT02429375|Mocetinostat (MGCD0103)|mocetinostat (mgcd0103)
285421|NCT02429375|Brentuximab Vedotin (SGN-35)|brentuximab vedotin (sgn-35)
285422|NCT02429375|Relapsed|relapsed
285423|NCT02429375|Refractory|refractory
285424|NCT02429323|induction|induction
285425|NCT02429323|pediatrics|pediatrics
285426|NCT02429323|sevoflurane|sevoflurane
285427|NCT02429323|intubation time|intubation time
285428|NCT02429310|Intermittent Claudication|intermittent claudication
285429|NCT02429310|IC|ic
285430|NCT02429310|Peripheral Arterial Disease|peripheral arterial disease
285431|NCT02429310|Peripheral Vascular Disease|peripheral vascular disease
285432|NCT02429310|Peripheral Arterial Occlusive Disease|peripheral arterial occlusive disease
285433|NCT02429310|Lower Limb Arterial Disease|lower limb arterial disease
285434|NCT02429310|Supervised Exercise Therapy|supervised exercise therapy
285435|NCT02429310|Supervised Exercise Programme|supervised exercise programme
285436|NCT02429310|Exercise Therapy|exercise therapy
285437|NCT02429297|Hypertension|hypertension
285438|NCT02429297|Diabetes|diabetes
285439|NCT02429297|mHealth|mhealth
285440|NCT02429297|Interactive Voice Response|interactive voice response
285441|NCT02429297|Bolivia|bolivia
285442|NCT02429297|Chronic disease|chronic disease
285443|NCT02429284|Chronic Thromboembolic Pulmonary Hypertension (CTEPH)|chronic thromboembolic pulmonary hypertension (cteph)
285444|NCT02429284|Pulmonary Endarterectomy (PEA)|pulmonary endarterectomy (pea)
285445|NCT02429284|Pulmonary Thromboendarterectomy (PTE)|pulmonary thromboendarterectomy (pte)
285446|NCT02429284|Pulmonary Hypertension|pulmonary hypertension
285447|NCT02429284|Balloon Pulmonary Angioplasty (BPA)|balloon pulmonary angioplasty (bpa)
285448|NCT02429271|undergoing thrombolysis|undergoing thrombolysis
285449|NCT02429245|Knee|knee
285450|NCT02429245|Knee osteoarthritis|knee osteoarthritis
285451|NCT02429245|Knee replacement|knee replacement
285452|NCT02429232|Pioglitazone|pioglitazone
285453|NCT02429232|Linagliptin|linagliptin
285454|NCT02429232|Diabetes mellitus|diabetes mellitus
285455|NCT02429232|Diabetic macular edema|diabetic macular edema
285456|NCT02429232|Kidney|kidney
285457|NCT02429154|spectroscopy, near-infrared|spectroscopy, near-infrared
285458|NCT02429154|Infant|infant
285459|NCT02429154|Anesthesia, general|anesthesia, general
285460|NCT02429128|Polycystic Ovary Syndrome (PCOS)|polycystic ovary syndrome (pcos)
285461|NCT02429115|peer mentoring|peer mentoring
285462|NCT02429115|chronic kidney disease|chronic kidney disease
285463|NCT02429115|quality of life|quality of life
285464|NCT02429115|pcori|pcori
285465|NCT02429115|caregiver burden|caregiver burden
285466|NCT02429102|Phase 1|phase 1
285467|NCT02429102|Healthy subjects|healthy subjects
285468|NCT02429102|Pharmacokinetics of MT-8554|pharmacokinetics of mt-8554
285469|NCT02429089|recurrent|recurrent
285470|NCT02429089|metastatic|metastatic
285471|NCT02429063|Solid Tumors|solid tumors
285472|NCT02429050|Chronic Obstructive Pulmonary Disease|chronic obstructive pulmonary disease
285473|NCT02429050|Dyspnea|dyspnea
285474|NCT02429050|Breathlessness|breathlessness
285475|NCT02429050|Morphine|morphine
285476|NCT02429050|Opioid|opioid
285477|NCT02429050|Symptom Management|symptom management
285478|NCT02429037|p53|p53
285479|NCT02429037|gene therapy|gene therapy
285480|NCT02429037|head and neck cancer|head and neck cancer
285481|NCT02429024|Diabetes Mellitus|diabetes mellitus
285482|NCT02429024|A1c|a1c
285483|NCT02429011|depression|depression
285484|NCT02429011|MRI|mri
285485|NCT02429011|treatment-resistant|treatment-resistant
285486|NCT02429011|imaging|imaging
285487|NCT02429011|ketamine|ketamine
285488|NCT02428985|Riociguat|riociguat
285489|NCT02428985|Adempas|adempas
285490|NCT02428985|soluble guanylate cyclase (sGC) stimulator|soluble guanylate cyclase (sgc) stimulator
285491|NCT02428985|Pulmonary arterial hypertension|pulmonary arterial hypertension
285492|NCT02428985|Japan|japan
285493|NCT02428985|Post-marketing surveillance|post-marketing surveillance
285494|NCT02428972|brain tumor|brain tumor
285495|NCT02428972|quality of life|quality of life
285496|NCT02428972|cognition|cognition
285497|NCT02428972|anesthetic technique|anesthetic technique
285498|NCT02428959|Amyl Nitrite|amyl nitrite
285499|NCT02428959|High Resolution Manometry|high resolution manometry
285500|NCT02428946|Insulin Sensitivity|insulin sensitivity
285501|NCT02428946|obesity|obesity
285502|NCT02428946|dopamine|dopamine
285503|NCT02428933|Brown Adipose Tissue|brown adipose tissue
285504|NCT02428933|Obesity|obesity
285505|NCT02428933|Insulin Sensitivity|insulin sensitivity
285506|NCT02428933|Dopamine|dopamine
285507|NCT02428920|cardiovascular health|cardiovascular health
285508|NCT02428920|behavior change|behavior change
285509|NCT02428920|community-based|community-based
285510|NCT02428920|prevention|prevention
285511|NCT02428907|simulation training|simulation training
285512|NCT02428907|minimal sedation|minimal sedation
285513|NCT02428907|colonoscopy|colonoscopy
285514|NCT02428907|patient satisfaction|patient satisfaction
285515|NCT02428907|teamwork|teamwork
285516|NCT02428907|team training|team training
285517|NCT02428907|patient safety|patient safety
285518|NCT02428881|onabotulinumtoxin A|onabotulinumtoxin a
285519|NCT02428868|hip fracture|hip fracture
285520|NCT02428868|anemia|anemia
285521|NCT02428868|blood transfusion|blood transfusion
285522|NCT02428868|tranexamic acid|tranexamic acid
285523|NCT02428868|intravenous iron|intravenous iron
285524|NCT02428855|Cholangiocarcinoma|cholangiocarcinoma
285525|NCT02428842|Cervical cancer|cervical cancer
285526|NCT02428842|Tumor biopsies|tumor biopsies
285527|NCT02428842|Standard treatment|standard treatment
285528|NCT02428842|Molecular profile|molecular profile
285529|NCT02428842|Next Generation Sequencing|next generation sequencing
285530|NCT02428829|hip|hip
285531|NCT02428829|replacement|replacement
285532|NCT02428829|arthroplasty|arthroplasty
285533|NCT02428829|total|total
285534|NCT02428829|orthopaedic|orthopaedic
285535|NCT02428829|rehabiliation|rehabiliation
285536|NCT02428829|physiotherapy|physiotherapy
285537|NCT02428829|therapy|therapy
285538|NCT02428816|differential diagnosis|differential diagnosis
285539|NCT02428816|multimodal MRI|multimodal mri
285540|NCT02428816|Parkinson's Disease|parkinson's disease
285541|NCT02428816|Multiple System Atrophy|multiple system atrophy
285542|NCT02428803|Peritoneal Dialysis|peritoneal dialysis
285543|NCT02428777|Hysteroscopy|hysteroscopy
285544|NCT02428751|Lymphoma, Large B-Cell, Diffuse|lymphoma, large b-cell, diffuse
285545|NCT02428751|liposomal doxorubicin|liposomal doxorubicin
285546|NCT02428751|doxorubicin|doxorubicin
285547|NCT02428751|event-free survival|event-free survival
285548|NCT02428738|Influenza Vaccine|influenza vaccine
285549|NCT02428738|Text Message|text message
285550|NCT02428673|Osteopenia|osteopenia
285551|NCT02428673|spinal muscular atrophy|spinal muscular atrophy
285552|NCT02428673|cerebral palsy|cerebral palsy
285553|NCT02428673|muscular dystrophy|muscular dystrophy
285554|NCT02428673|spina bifida|spina bifida
285555|NCT02428673|Rett Syndrome|rett syndrome
285556|NCT02428660|Polypharmacy|polypharmacy
285557|NCT02428660|Chronic conditions|chronic conditions
285558|NCT02428660|Drug Therapy Problems|drug therapy problems
285559|NCT02428660|Medication Therapy Management|medication therapy management
285560|NCT02428660|Medication-Related Problems|medication-related problems
285561|NCT02428660|CYP3A4|cyp3a4
285562|NCT02428660|CYP3A5|cyp3a5
285563|NCT02428660|Drug-drug interactions|drug-drug interactions
285564|NCT02428660|Drug-gene interactions|drug-gene interactions
285565|NCT02428660|Drug-drug-gene interactions|drug-drug-gene interactions
285566|NCT02428660|Adverse Drug Reactions|adverse drug reactions
285567|NCT02428660|Activities of Daily Living|activities of daily living
285568|NCT02428647|growth|growth
285569|NCT02428647|plasma zinc concentration|plasma zinc concentration
285570|NCT02428634|Cardiovascular health promotion|cardiovascular health promotion
285571|NCT02428634|Children|children
285572|NCT02428634|School intervention|school intervention
285573|NCT02428621|early orthodontic treatment|early orthodontic treatment
285574|NCT02428621|activator|activator
285575|NCT02428621|removable appliance|removable appliance
285576|NCT02428621|Twicare®|twicare®
285577|NCT02428621|Herbst appliance|herbst appliance
285578|NCT02428608|Glabellar Lines|glabellar lines
285579|NCT02428608|Botulinum toxin, Type A|botulinum toxin, type a
285580|NCT02428582|endovascular treatment|endovascular treatment
285581|NCT02428582|arterial occlusive disease|arterial occlusive disease
285582|NCT02428582|bare metal stent|bare metal stent
285583|NCT02428582|polytetrafluoroethylene covered stent|polytetrafluoroethylene covered stent
285584|NCT02428569|shared decision making|shared decision making
285585|NCT02428569|patient education|patient education
285586|NCT02428569|decision aids|decision aids
285587|NCT02428556|Decision making|decision making
285588|NCT02428543|FLT3-ITD patients in first complete remission|flt3-itd patients in first complete remission
285589|NCT02428517|acute lymphoblastic leukemia|acute lymphoblastic leukemia
285590|NCT02428517|allogeneic hematopoietic stem cell transplantation|allogeneic hematopoietic stem cell transplantation
285591|NCT02428517|alternative hematopoietic stem cell donor|alternative hematopoietic stem cell donor
285592|NCT02428517|busulfan|busulfan
285593|NCT02428517|antithymocyte globulin|antithymocyte globulin
285594|NCT02428504|Questionnaire|questionnaire
285595|NCT02428491|Diphtheria|diphtheria
285596|NCT02428491|Tetanus|tetanus
285597|NCT02428491|Pertussis|pertussis
285598|NCT02428491|Poliomyelitis|poliomyelitis
285599|NCT02428491|Hepatitis B|hepatitis b
285600|NCT02428491|Haemophilus Influenzae Type b|haemophilus influenzae type b
285601|NCT02428491|DTaP-IPV-Hep B-PRP-T Combined Vaccine (Hexaxim®)|dtap-ipv-hep b-prp-t combined vaccine (hexaxim®)
285602|NCT02428465|Purposeful Parenting|purposeful parenting
285603|NCT02428465|Parenting stress|parenting stress
285604|NCT02428465|Social-emotional and linguistic (SEL) skills|social-emotional and linguistic (sel) skills
285605|NCT02428452|autism|autism
285606|NCT02428452|Autism SPectrum Disorder|autism spectrum disorder
285607|NCT02428452|early intervention|early intervention
285608|NCT02428452|infant|infant
285609|NCT02428452|toddler|toddler
285610|NCT02428452|early identification|early identification
285611|NCT02428452|pivotal response training (PRT)|pivotal response training (prt)
285612|NCT02428452|control group|control group
285613|NCT02428452|treatment group|treatment group
285614|NCT02428452|at risk|at risk
285615|NCT02428452|social communication|social communication
285616|NCT02428452|positive affect|positive affect
285617|NCT02428452|smiling|smiling
285618|NCT02428439|genetic markers|genetic markers
285619|NCT02428439|predictors|predictors
285620|NCT02428439|Antidepressive Agents|antidepressive agents
285621|NCT02428439|Suicidal Ideation|suicidal ideation
285622|NCT02428439|Adolescent|adolescent
285623|NCT02428426|Mucosal Microbiome|mucosal microbiome
285624|NCT02428426|gastric intestinal metaplasia|gastric intestinal metaplasia
285625|NCT02428426|duodenum|duodenum
285626|NCT02428413|Waste Anesthetic Gas (WAG)|waste anesthetic gas (wag)
285627|NCT02428387|caregivers|caregivers
285628|NCT02428387|intervention|intervention
285629|NCT02428387|health related quality of life|health related quality of life
285630|NCT02428387|dementia|dementia
285632|NCT02428374|Ventricular function, left|ventricular function, left
285633|NCT02428309|active cutaneous lupus|active cutaneous lupus
285634|NCT02428309|systemic lupus erythematosus (SLE)|systemic lupus erythematosus (sle)
285635|NCT02428309|autologous polyclonal regulatory T cell Therapy|autologous polyclonal regulatory t cell therapy
285636|NCT02428309|polyclonal Tregs for treatment of lupus|polyclonal tregs for treatment of lupus
285637|NCT02428296|Clinical Trial|clinical trial
285638|NCT02428296|Congenital Malformations|congenital malformations
285639|NCT02428296|Overgrowth|overgrowth
285640|NCT02428296|Pilot Drug Treatment Trial|pilot drug treatment trial
285641|NCT02428257|hip fracture|hip fracture
285642|NCT02428257|elderly|elderly
285643|NCT02428257|continous spinal anesthesia|continous spinal anesthesia
285644|NCT02428257|hypobaric bupivacaine|hypobaric bupivacaine
285645|NCT02428257|isobaric bupivacaine|isobaric bupivacaine
285646|NCT02428257|hypotension|hypotension
285647|NCT02428244|Smoking|smoking
285648|NCT02428244|Cessation|cessation
285649|NCT02428244|Trauma|trauma
285650|NCT02428244|Fracture|fracture
285651|NCT02428244|Complications|complications
285652|NCT02428218|Randomized|randomized
285653|NCT02428218|Ages 10-17|ages 10-17
285654|NCT02428218|Pediatrics|pediatrics
285655|NCT02428218|Placebo controlled|placebo controlled
285656|NCT02428218|Relapse-Remitting|relapse-remitting
285657|NCT02428218|Multiple Sclerosis|multiple sclerosis
285658|NCT02428218|Safety|safety
285659|NCT02428218|Efficacy|efficacy
285660|NCT02428218|BG00012|bg00012
285661|NCT02428179|Surgical site infection|surgical site infection
285662|NCT02428179|Intraoperative briefings|intraoperative briefings
285663|NCT02428179|Mortality|mortality
285664|NCT02428179|Wound closure|wound closure
285665|NCT02428179|Surgical procedure|surgical procedure
285666|NCT02428166|crosslinking|crosslinking
285667|NCT02428166|keratoconus|keratoconus
285668|NCT02428166|keratometry|keratometry
285669|NCT02428166|pachymetry|pachymetry
285670|NCT02428166|pentacam|pentacam
285671|NCT02428153|static stretching|static stretching
285672|NCT02428153|dynamic stretching|dynamic stretching
285673|NCT02428153|muscle-tendon unit|muscle-tendon unit
285674|NCT02428153|ultrasound|ultrasound
285675|NCT02428153|Subjects|subjects
285676|NCT02428140|ischemic stroke|ischemic stroke
285677|NCT02428140|atrial fibrillation|atrial fibrillation
285678|NCT02428140|etiologic investigations|etiologic investigations
285679|NCT02428140|secondary prevention|secondary prevention
285680|NCT02428140|anticoagulation|anticoagulation
285681|NCT02428140|arrhythmias|arrhythmias
285682|NCT02428140|embolic stroke, undetermined etiology|embolic stroke, undetermined etiology
285683|NCT02428140|implantable loop recorder|implantable loop recorder
285684|NCT02428140|external loop recorder|external loop recorder
285685|NCT02428062|Post-operative complications|post-operative complications
285686|NCT02428062|Mild cognitive impairment|mild cognitive impairment
285687|NCT02428062|Delirium|delirium
285688|NCT02428036|TBI-1401(HF10)|tbi-1401(hf10)
285689|NCT02428036|HF10|hf10
285690|NCT02428036|HSV-1|hsv-1
285691|NCT02428036|Oncolytic virus|oncolytic virus
285692|NCT02428036|Oncolytic virotherapy|oncolytic virotherapy
285693|NCT02428036|Phase I|phase i
285694|NCT02428036|Melanoma|melanoma
285695|NCT02428036|Intratumoral administration|intratumoral administration
285696|NCT02428023|Thalassemia|thalassemia
285697|NCT02428023|trait|trait
285698|NCT02428023|coronary|coronary
285699|NCT02428023|stroke|stroke
285700|NCT02427997|Virtual Reality|virtual reality
285701|NCT02427997|Treadmill|treadmill
285702|NCT02427997|Multiple Sclerosis|multiple sclerosis
285703|NCT02427984|Internal Left Hip Prosthesis|internal left hip prosthesis
285704|NCT02427984|Internal Right Hip Prosthesis|internal right hip prosthesis
285705|NCT02427958|Drug Therapy|drug therapy
285706|NCT02427945|Information provision|information provision
285707|NCT02427932|Pharmacokinetics (PK)|pharmacokinetics (pk)
285708|NCT02427932|Pharmacodynamics (PD)|pharmacodynamics (pd)
285709|NCT02427919|G-CSF|g-csf
285710|NCT02427919|G-CSF receptor|g-csf receptor
285711|NCT02427919|AML|aml
285712|NCT02427919|refractory AML|refractory aml
285713|NCT02427919|Neutropenic fever|neutropenic fever
285714|NCT02427919|salvage chemotherapy|salvage chemotherapy
285715|NCT02427906|cirrhosis|cirrhosis
285716|NCT02427906|gut microbiota|gut microbiota
285717|NCT02427906|transjugular portosystemic shunt|transjugular portosystemic shunt
285718|NCT02427906|hepatic encephalopathy|hepatic encephalopathy
285719|NCT02427893|immunotherapy|immunotherapy
285720|NCT02427893|Vemurafenib|vemurafenib
285721|NCT02427893|Cobimetinib|cobimetinib
285722|NCT02427880|Edema|edema
285723|NCT02427880|Nephrotic syndrome|nephrotic syndrome
285724|NCT02427880|Acetazolamide|acetazolamide
285725|NCT02427880|Furosemide|furosemide
285726|NCT02427867|remote ischemic preconditioning|remote ischemic preconditioning
285727|NCT02427867|non cardiac surgery|non cardiac surgery
285728|NCT02427867|myocardial ischemia|myocardial ischemia
285729|NCT02427854|Major delivery complications|major delivery complications
285730|NCT02427854|Perineal injuries|perineal injuries
285731|NCT02427854|episiotomy|episiotomy
285829|NCT02427191|Heel pain|heel pain
285732|NCT02427789|Physical exercise|physical exercise
285733|NCT02427789|Biomarkers|biomarkers
285734|NCT02427789|Neuroprotection|neuroprotection
285735|NCT02427789|ergospirometry|ergospirometry
285736|NCT02427789|Major Depressive Disorder|major depressive disorder
285737|NCT02427763|Removable Orthodontic Appliance;|removable orthodontic appliance;
285738|NCT02427763|malocclusion|malocclusion
285739|NCT02427763|Streptococcus mutans|streptococcus mutans
285740|NCT02427763|Lactobacillus|lactobacillus
285741|NCT02427763|Epithelium|epithelium
285742|NCT02427737|Magnetic Resonance Imaging|magnetic resonance imaging
285743|NCT02427737|Patient satisfaction|patient satisfaction
285744|NCT02427737|Diagnostic Imaging|diagnostic imaging
285745|NCT02427711|Reduction of blood loss for revisions of knee arthroplasty|reduction of blood loss for revisions of knee arthroplasty
285746|NCT02427711|blood transfusions|blood transfusions
285747|NCT02427711|Readmission|readmission
285748|NCT02427711|Bipolar sealer|bipolar sealer
285749|NCT02427672|antisocial behavior|antisocial behavior
285750|NCT02427672|aggression|aggression
285751|NCT02427672|transcranial direct current stimulation|transcranial direct current stimulation
285752|NCT02427672|dorsolateral prefrontal cortex|dorsolateral prefrontal cortex
285753|NCT02427672|associated risk factors|associated risk factors
285755|NCT02427659|Virtual Reality as Distraction during Procedure|virtual reality as distraction during procedure
285756|NCT02427659|Burn Wound Care|burn wound care
285757|NCT02427646|Kinematics|kinematics
285758|NCT02427646|Botulinum toxin type A|botulinum toxin type a
285759|NCT02427633|recovery position|recovery position
285760|NCT02427633|comatose|comatose
285761|NCT02427633|resource limited|resource limited
285762|NCT02427607|Epilepsy|epilepsy
285763|NCT02427607|Perampanel|perampanel
285764|NCT02427594|Kidney Diseases|kidney diseases
285765|NCT02427594|Renal Insufficiency, Chronic|renal insufficiency, chronic
285766|NCT02427594|Dietary nonvolatile acid load|dietary nonvolatile acid load
285767|NCT02427594|Blood pressure|blood pressure
285768|NCT02427594|Urine net acid excretion|urine net acid excretion
285769|NCT02427568|Anxiety|anxiety
285770|NCT02427568|MDMA|mdma
285771|NCT02427568|Life-threatening illness|life-threatening illness
285772|NCT02427568|psychotherapy|psychotherapy
285773|NCT02427542|Randomized Controlled Trial|randomized controlled trial
285774|NCT02427529|hcg|hcg
285775|NCT02427503|asthma|asthma
285776|NCT02427503|sinonasal polyposis|sinonasal polyposis
285777|NCT02427503|eosinophilic bronchial inflammation|eosinophilic bronchial inflammation
285778|NCT02427503|endoscopic sinus surgery|endoscopic sinus surgery
285779|NCT02427490|Palliative Care|palliative care
285780|NCT02427490|Caregivers|caregivers
285781|NCT02427490|Medical Oncology|medical oncology
285782|NCT02427464|diabetic|diabetic
285783|NCT02427464|neuropathy|neuropathy
285784|NCT02427464|shooting pain|shooting pain
285785|NCT02427464|burning pain|burning pain
285786|NCT02427464|pins and needles pain|pins and needles pain
285787|NCT02427464|foot pain|foot pain
285788|NCT02427464|ViroMed|viromed
285789|NCT02427438|video|video
285790|NCT02427438|handout|handout
285791|NCT02427438|home program|home program
285792|NCT02427438|stabilization|stabilization
285793|NCT02427438|strengthening|strengthening
285794|NCT02427438|core|core
285795|NCT02427425|Transcutaneous Electric Nerve Stimulation|transcutaneous electric nerve stimulation
285796|NCT02427425|Pain|pain
285797|NCT02427412|Tranexamic Acid|tranexamic acid
285798|NCT02427412|Knee Arthroplasty|knee arthroplasty
285799|NCT02427412|Blood loss|blood loss
285800|NCT02427412|Blood transfusion|blood transfusion
285801|NCT02427412|Thrombolic complication|thrombolic complication
285802|NCT02427412|Total blood loss 24 h after ended surgery.|total blood loss 24 h after ended surgery.
285803|NCT02427412|Total blood loss 2 days after ended surgery.|total blood loss 2 days after ended surgery.
285804|NCT02427386|Endometriosis|endometriosis
285805|NCT02427386|Pelvic pain|pelvic pain
285806|NCT02427386|Homeopathy|homeopathy
285807|NCT02427386|RCT|rct
285808|NCT02427373|bioavailability|bioavailability
285809|NCT02427373|fish oil|fish oil
285810|NCT02427373|krill oil|krill oil
285811|NCT02427360|Retrospective Studies|retrospective studies
285812|NCT02427360|Clinical Efficacy|clinical efficacy
285813|NCT02427321|Cystoscopy|cystoscopy
285814|NCT02427321|Bladder cancer|bladder cancer
285815|NCT02427321|Bladder imaging|bladder imaging
285816|NCT02427308|leishmaniasis|leishmaniasis
285817|NCT02427308|miltefosine|miltefosine
285818|NCT02427308|pregnancy|pregnancy
285819|NCT02427269|Barrett's Esophagus|barrett's esophagus
285820|NCT02427269|Esophageal Cancer|esophageal cancer
285821|NCT02427269|Intramucosal Adenocarcinoma|intramucosal adenocarcinoma
285822|NCT02427230|Pelvic Floor Muscle Training|pelvic floor muscle training
285823|NCT02427230|Neuromuscular Electrical Stimulation|neuromuscular electrical stimulation
285824|NCT02427230|Urinary Incontinence|urinary incontinence
285825|NCT02427230|Spinal Cord Injury|spinal cord injury
285826|NCT02427204|Hepatitis C infection|hepatitis c infection
285827|NCT02427204|Hepatitis C treatment|hepatitis c treatment
285828|NCT02427191|Chronic plantar fasciitis|chronic plantar fasciitis
285830|NCT02427178|Allogeneic Hematopoietic Stem Cell Transplantation|allogeneic hematopoietic stem cell transplantation
285831|NCT02427178|MNGIE|mngie
285832|NCT02427178|Stem Cell transplant|stem cell transplant
285833|NCT02427126|ESUS|esus
285834|NCT02427126|anticoagulation|anticoagulation
285835|NCT02427113|TMD|tmd
285836|NCT02427113|Music Medicine|music medicine
285837|NCT02427113|Vibroacousitc Therapy|vibroacousitc therapy
285838|NCT02427100|Homeless|homeless
285839|NCT02427100|Randomized Controlled Trial|randomized controlled trial
285840|NCT02427100|Diet|diet
285841|NCT02427100|Physical Activity|physical activity
285842|NCT02427087|Nonalcoholic fatty liver|nonalcoholic fatty liver
285843|NCT02427087|Physical activity|physical activity
285844|NCT02427087|NAFLD|nafld
285845|NCT02427087|Anthropometry|anthropometry
285846|NCT02427087|Body Composition|body composition
285847|NCT02427048|Clinical Practice Guidelines|clinical practice guidelines
285848|NCT02427022|evidence based practices, critical time intervention|evidence based practices, critical time intervention
285849|NCT02426944|atrial fibrillation|atrial fibrillation
285850|NCT02426944|cardioembolic event|cardioembolic event
285851|NCT02426944|stroke|stroke
285852|NCT02426944|left atrial appendage closure|left atrial appendage closure
285853|NCT02426944|novel anticoagulants|novel anticoagulants
285854|NCT02426931|retrograde intrarenal surgery|retrograde intrarenal surgery
285855|NCT02426931|flexible ureteroscopy|flexible ureteroscopy
285856|NCT02426931|renal calculi|renal calculi
285857|NCT02426892|Solid Tumors|solid tumors
285858|NCT02426892|HPV-16 Positive Incurable Solid Tumors|hpv-16 positive incurable solid tumors
285859|NCT02426892|ISA101|isa101
285860|NCT02426892|HPV-16 vaccination|hpv-16 vaccination
285861|NCT02426892|Nivolumab|nivolumab
285862|NCT02426892|BMS-936558|bms-936558
285863|NCT02426892|Opdivo|opdivo
285864|NCT02426879|three-field lymphadenectomy|three-field lymphadenectomy
285865|NCT02426879|cervical metastases|cervical metastases
285866|NCT02426879|esophagectomy|esophagectomy
285867|NCT02426853|Cancer Prevention|cancer prevention
285868|NCT02426853|Sun protection|sun protection
285869|NCT02426853|Photograph|photograph
285870|NCT02426853|UV photograph|uv photograph
285871|NCT02426853|Ultraviolet|ultraviolet
285872|NCT02426853|Pamphlets|pamphlets
285873|NCT02426853|Handouts|handouts
285874|NCT02426853|Questionnaires|questionnaires
285875|NCT02426853|Surveys|surveys
285876|NCT02426853|Skin cancer risk behaviors|skin cancer risk behaviors
285877|NCT02426840|Adverse bone health|adverse bone health
285878|NCT02426840|Bone demineralization|bone demineralization
285879|NCT02426840|HIV-infection|hiv-infection
285880|NCT02426840|Children|children
285881|NCT02426840|Adolescents|adolescents
285882|NCT02426840|Calcium|calcium
285883|NCT02426840|Vitamin D|vitamin d
285884|NCT02426840|Supplementation|supplementation
285885|NCT02426814|Patient Compliance|patient compliance
285886|NCT02426814|Mobile Applications|mobile applications
285887|NCT02426801|Patient Compliance|patient compliance
285888|NCT02426801|Mobile Applications|mobile applications
285889|NCT02426801|Medication Adherence|medication adherence
285890|NCT02426788|medically unexplained|medically unexplained
285891|NCT02426788|fibromyalgia|fibromyalgia
285892|NCT02426788|postural orthostatic tachycardia syndrome (PoTs)|postural orthostatic tachycardia syndrome (pots)
285893|NCT02426788|non-cardiac chest pain|non-cardiac chest pain
285894|NCT02426788|CFS|cfs
285895|NCT02426788|irritable bowel syndrome (IBS)|irritable bowel syndrome (ibs)
285896|NCT02426788|functional neurological|functional neurological
285897|NCT02426788|chronic pain|chronic pain
285898|NCT02426788|hyperventilation|hyperventilation
285899|NCT02426788|unexplained cough|unexplained cough
285900|NCT02426762|skin sealant|skin sealant
285901|NCT02426762|laparoscopic surgery|laparoscopic surgery
285902|NCT02426762|surgical site infection|surgical site infection
285903|NCT02426762|wound healing|wound healing
285904|NCT02426736|Shoulder Joint|shoulder joint
285905|NCT02426736|Arthroscopy|arthroscopy
285906|NCT02426736|Ambulatory surgical procedures|ambulatory surgical procedures
285907|NCT02426736|Pain, Postoperative|pain, postoperative
285908|NCT02426736|Brachial Plexus Block|brachial plexus block
285909|NCT02426736|Corticosteroid|corticosteroid
285910|NCT02426736|Dexamethasone|dexamethasone
285911|NCT02426736|Bupivacaine|bupivacaine
285912|NCT02426736|Perineural|perineural
285913|NCT02426710|ablation, atrial flutter, intracardiac echocardiography|ablation, atrial flutter, intracardiac echocardiography
285914|NCT02426697|bone metastasis, radiotherapy, pain, prevention|bone metastasis, radiotherapy, pain, prevention
285915|NCT02426684|End Stage Renal Disease|end stage renal disease
285916|NCT02426684|Kidney Transplant|kidney transplant
285917|NCT02426684|Desensitization|desensitization
285918|NCT02426684|Highly Sensitized|highly sensitized
285919|NCT02426684|Antibodies|antibodies
285920|NCT02426671|neuromodulation|neuromodulation
285921|NCT02426671|Minimum Masking Level|minimum masking level
285922|NCT02426645|Biomarkers|biomarkers
285923|NCT02426645|Sepsis|sepsis
285924|NCT02426645|Multi organ dysfunction|multi organ dysfunction
285925|NCT02426645|Immunomonitoring|immunomonitoring
285926|NCT02426645|CEUS|ceus
285927|NCT02426632|Healthy|healthy
285928|NCT02426632|JNJ-53718678|jnj-53718678
285929|NCT02426606|Lentils|lentils
285930|NCT02426606|Post-prandial|post-prandial
285931|NCT02426606|Glycemic response|glycemic response
285932|NCT02426606|Insulin response|insulin response
285933|NCT02426606|Diabetes|diabetes
285934|NCT02426606|Mixed meal|mixed meal
285935|NCT02426606|Glycemia|glycemia
285936|NCT02426606|Slowly digestible starch|slowly digestible starch
285937|NCT02426606|Post-prandial glycemia|post-prandial glycemia
285938|NCT02426593|CHF|chf
285939|NCT02426593|Heart Failure|heart failure
285940|NCT02426567|Crohn's Disease|crohn's disease
285941|NCT02426567|Exclusive Enteral Nutrition|exclusive enteral nutrition
285942|NCT02426567|Dietary Treatment|dietary treatment
285943|NCT02426567|Gut microbiota|gut microbiota
285944|NCT02426541|Diabetes Mellitus|diabetes mellitus
285945|NCT02426541|Dapagliflozin|dapagliflozin
285946|NCT02426541|Placebo|placebo
285947|NCT02426541|Insulin resistance|insulin resistance
285948|NCT02426541|Insulin sensitivity|insulin sensitivity
285949|NCT02426476|heart rate variability|heart rate variability
285950|NCT02426476|biofeedback|biofeedback
285951|NCT02426476|chronic pain|chronic pain
285952|NCT02426476|Veterans|veterans
285953|NCT02426463|Neonatal intensive care|neonatal intensive care
285954|NCT02426463|need for intratracheal intubation|need for intratracheal intubation
285955|NCT02426437|Acute Exacerbation of COPD (AECOPD)|acute exacerbation of copd (aecopd)
285956|NCT02426437|COPD|copd
285957|NCT02426437|Emphysema|emphysema
285958|NCT02426437|Chronic Bronchitis|chronic bronchitis
285959|NCT02426424|c-PAP|c-pap
285960|NCT02426398|EEG|eeg
285961|NCT02426372|Ulcerative Colitis|ulcerative colitis
285962|NCT02426372|Inflammatory Bowel Disease|inflammatory bowel disease
285963|NCT02426346|Adolescent; Adolescent obesity; Community-based; Overweight|adolescent; adolescent obesity; community-based; overweight
285964|NCT02426307|Thrombosis|thrombosis
285965|NCT02426307|Cardiovascular disease|cardiovascular disease
285966|NCT02426307|Oral anticoagulation|oral anticoagulation
285967|NCT02426307|bioprosthesis|bioprosthesis
285968|NCT02426307|Multidetector Computed Tomography|multidetector computed tomography
285969|NCT02426268|cardiac surgery|cardiac surgery
285970|NCT02426268|cerebral oximetry|cerebral oximetry
285971|NCT02426268|lower extremity oximetry|lower extremity oximetry
285972|NCT02426255|Severe trauma|severe trauma
285973|NCT02426255|traumatic Brain injury|traumatic brain injury
285974|NCT02426255|Hemorrhage|hemorrhage
285975|NCT02426242|brain-injury|brain-injury
285976|NCT02426242|extubation|extubation
285977|NCT02426229|SSc|ssc
285978|NCT02426229|systemic sclerosis|systemic sclerosis
285979|NCT02426229|cutaneous systemic sclerosis|cutaneous systemic sclerosis
285980|NCT02426216|prostate cancer|prostate cancer
285981|NCT02426216|chemoprevention|chemoprevention
285982|NCT02426216|biomarker|biomarker
285983|NCT02426203|Echocardiography|echocardiography
285984|NCT02426177|postpartum hypertension|postpartum hypertension
285985|NCT02426177|labetalol in postpartum hypertension|labetalol in postpartum hypertension
285986|NCT02426177|nifedipine in postpartum hypertension|nifedipine in postpartum hypertension
285987|NCT02426125|carcinoma of the bladder|carcinoma of the bladder
285988|NCT02426125|carcinoma of the urethra|carcinoma of the urethra
285989|NCT02426125|carcinoma the of ureter|carcinoma the of ureter
285990|NCT02426125|carcinoma of the renal pelvis|carcinoma of the renal pelvis
285991|NCT02426125|transitional cell carcinoma|transitional cell carcinoma
285992|NCT02426125|transitional cell tumor|transitional cell tumor
285993|NCT02426125|RANGE|range
285994|NCT02426125|bladder cancer|bladder cancer
285995|NCT02426099|Resistant hypertension|resistant hypertension
285996|NCT02426099|diabetes mellitus|diabetes mellitus
285997|NCT02426099|Spironolactone|spironolactone
285998|NCT02426099|African|african
285999|NCT02426086|Myelofibrosis|myelofibrosis
286000|NCT02426086|Imetelstat|imetelstat
286001|NCT02426086|GRN163L|grn163l
286002|NCT02426086|Relapsed/refractory to JAKi|relapsed/refractory to jaki
286003|NCT02426073|Inflammaging|inflammaging
286004|NCT02426047|seizures|seizures
286005|NCT02426047|epilepsy|epilepsy
286006|NCT02426047|catamenial|catamenial
286007|NCT02426047|ketogenic diet|ketogenic diet
286008|NCT02426047|modified Atkins diet|modified atkins diet
286009|NCT02426047|intractable epilepsy|intractable epilepsy
286010|NCT02426047|medically refractory epilepsy|medically refractory epilepsy
286011|NCT02426047|adult|adult
286012|NCT02426047|medium chain triglyceride|medium chain triglyceride
286013|NCT02426034|Advanced|advanced
286014|NCT02426034|Metastatic|metastatic
286015|NCT02425995|ACL|acl
286016|NCT02425995|Hidden lesions of the medial meniscus|hidden lesions of the medial meniscus
286017|NCT02425995|Chronic knee instability|chronic knee instability
286018|NCT02425995|Intercondylar and posteromedial arthroscopy|intercondylar and posteromedial arthroscopy
286019|NCT02425995|Arthroscopic Posteromedial and Intercondylar portal|arthroscopic posteromedial and intercondylar portal
286020|NCT02425995|Diagnosis capacity of hidden lesions of the medial meniscus|diagnosis capacity of hidden lesions of the medial meniscus
286021|NCT02425982|Tennis Elbow|tennis elbow
286022|NCT02425982|Lateral elbow pain|lateral elbow pain
286023|NCT02425982|Latera epicondylitis|latera epicondylitis
286024|NCT02425930|gastric cancer|gastric cancer
286025|NCT02425930|complement system|complement system
286026|NCT02425930|overal survival|overal survival
286027|NCT02425904|Langerhans Cell Histiocytosis|langerhans cell histiocytosis
286028|NCT02425865|UC, IBD|uc, ibd
286029|NCT02425839|shear wave elastography|shear wave elastography
286030|NCT02425839|surface electromyogram|surface electromyogram
286031|NCT02425839|masseter|masseter
286032|NCT02425826|Parapsoriasis|parapsoriasis
286033|NCT02425826|Plaque Psoriasis|plaque psoriasis
286034|NCT02425826|CC-10004|cc-10004
286035|NCT02425826|Apremilast|apremilast
286036|NCT02425826|Moderate Plaque Psoriasis|moderate plaque psoriasis
286037|NCT02425826|Safety|safety
286038|NCT02425787|Loss of a child|loss of a child
286039|NCT02425787|Grief|grief
286040|NCT02425774|Prucalopride|prucalopride
286041|NCT02425774|Vagus Nerve Stimulation|vagus nerve stimulation
286042|NCT02425774|Postoperative Ileus|postoperative ileus
286043|NCT02425761|Cerebrospinal Fluid Shunts|cerebrospinal fluid shunts
286044|NCT02425761|Randomized Controlled Trial|randomized controlled trial
286045|NCT02425748|γδ T Cell, non small lung cancer, Without EGFR Mutation|γδ t cell, non small lung cancer, without egfr mutation
286046|NCT02425735|Immunotherapy, γδ T Cell, heptocellular liver cancer|immunotherapy, γδ t cell, heptocellular liver cancer
286047|NCT02425722|linaclotide|linaclotide
286048|NCT02425722|ASP0456|asp0456
286049|NCT02425722|chronic constipation|chronic constipation
286050|NCT02425696|right-to-left shunt|right-to-left shunt
286051|NCT02425696|contrast-enhanced transcranial Doppler|contrast-enhanced transcranial doppler
286052|NCT02425696|migraine|migraine
286053|NCT02425696|silent cerebral infarction|silent cerebral infarction
286054|NCT02425683|Colon Cancer|colon cancer
286055|NCT02425683|Rectal Cancer|rectal cancer
286056|NCT02425683|Colorectal Cancer|colorectal cancer
286057|NCT02425683|Stage IIIC Colorectal Cancer|stage iiic colorectal cancer
286058|NCT02425670|Brain attack|brain attack
286059|NCT02425670|stroke|stroke
286060|NCT02425670|Ischemic stroke|ischemic stroke
286061|NCT02425670|stem cell therapy|stem cell therapy
286062|NCT02425657|Education|education
286063|NCT02425657|Training|training
286064|NCT02425657|Fast track|fast track
286065|NCT02425657|Colonoscopy|colonoscopy
286066|NCT02425644|relapsing multiple sclerosis|relapsing multiple sclerosis
286067|NCT02425631|SI joint fusion|si joint fusion
286068|NCT02425631|SI joint pain|si joint pain
286069|NCT02425631|SI joint|si joint
286070|NCT02425631|SI joint treatment|si joint treatment
286071|NCT02425631|SI joint disease|si joint disease
286072|NCT02425631|Sacroiliac joint|sacroiliac joint
286073|NCT02425631|Simmetry|simmetry
286074|NCT02425566|autonomic nervous system|autonomic nervous system
286075|NCT02425566|hypertension|hypertension
286076|NCT02425566|ganglionic blocker|ganglionic blocker
286077|NCT02425566|trimethaphan|trimethaphan
286078|NCT02425566|splanchnic circulation|splanchnic circulation
286079|NCT02425566|capacitance|capacitance
286080|NCT02425553|Diet|diet
286081|NCT02425553|Reflux|reflux
286082|NCT02425553|Dyspepsia|dyspepsia
286083|NCT02425553|Symptoms|symptoms
286084|NCT02425553|Alcohol|alcohol
286085|NCT02425540|Pelvic MRI|pelvic mri
286086|NCT02425527|Brain Injuries|brain injuries
286087|NCT02425527|Traumatic Brain Injury|traumatic brain injury
286088|NCT02425527|Video Games|video games
286089|NCT02425514|Anterior cervical discectomy and fusion|anterior cervical discectomy and fusion
286090|NCT02425514|NovoMax|novomax
286091|NCT02425514|Bioactive Glass-ceramic Intervertebral Spacer|bioactive glass-ceramic intervertebral spacer
286092|NCT02425501|Aflibercept|aflibercept
286093|NCT02425501|anti-VEGF|anti-vegf
286094|NCT02425488|Nursing|nursing
286095|NCT02425488|Outcome and Process Assessment|outcome and process assessment
286096|NCT02425488|Cardiac Resynchronization Therapy Devices|cardiac resynchronization therapy devices
286097|NCT02425488|Heart Failure|heart failure
286098|NCT02425488|Education|education
286099|NCT02425475|Dermoscopy|dermoscopy
286100|NCT02425449|succinylcholine|succinylcholine
286101|NCT02425449|depolarizing muscle relaxants|depolarizing muscle relaxants
286102|NCT02425449|pharmacologic effects|pharmacologic effects
286103|NCT02425410|Diabetes Mellitus|diabetes mellitus
286104|NCT02425410|Insulin-Dependent|insulin-dependent
286105|NCT02425410|Virus Diseases|virus diseases
286106|NCT02425410|Questionnaires|questionnaires
286107|NCT02425410|Risk assessment|risk assessment
286108|NCT02425410|Genome-Wide Association Study|genome-wide association study
286109|NCT02425397|Ototoxicity|ototoxicity
286110|NCT02425397|platinum derivatives|platinum derivatives
286111|NCT02425397|paediatrics|paediatrics
286112|NCT02425397|oncology|oncology
286113|NCT02425397|clinical research|clinical research
286114|NCT02425384|adolescent|adolescent
286115|NCT02425384|physical activity|physical activity
286116|NCT02425384|accelerometer|accelerometer
286117|NCT02425358|cell therapy|cell therapy
286118|NCT02425358|BMC|bmc
286119|NCT02425358|timing|timing
286120|NCT02425345|Physical Activity|physical activity
286121|NCT02425345|National Institute of Aging Go4Life|national institute of aging go4life
286122|NCT02425345|Postmenopausal Women|postmenopausal women
286123|NCT02425345|Balance|balance
286124|NCT02425345|Strength|strength
286125|NCT02425345|Exercise|exercise
286126|NCT02425345|Cardiovascular Disease|cardiovascular disease
286127|NCT02425345|Stroke|stroke
286128|NCT02425345|Mortality|mortality
286129|NCT02425345|Myocardial Infarction|myocardial infarction
286130|NCT02425345|Falls|falls
286131|NCT02425345|Venous Thromboembolic Event|venous thromboembolic event
286132|NCT02425345|Peripheral Artery Disease|peripheral artery disease
286133|NCT02425345|Physical Function|physical function
286134|NCT02425345|Mobility and Independence|mobility and independence
286135|NCT02425345|Coronary Artery Bypass Graft (CABG)|coronary artery bypass graft (cabg)
286136|NCT02425345|Percutaneous Coronary Intervention (PCI)|percutaneous coronary intervention (pci)
286137|NCT02425345|Hip Fractures|hip fractures
286138|NCT02425345|Cardiovascular Mortality|cardiovascular mortality
286139|NCT02425345|Clinical (non-hip) Fractures|clinical (non-hip) fractures
286140|NCT02425332|Spinal Cord Injury|spinal cord injury
286141|NCT02425332|adaptive control|adaptive control
286142|NCT02425332|assessment|assessment
286143|NCT02425332|assist-as-needed|assist-as-needed
286144|NCT02425332|walking ability|walking ability
286145|NCT02425332|Lokomat|lokomat
286146|NCT02425306|peptide|peptide
286147|NCT02425306|vaccine|vaccine
286148|NCT02425306|adjuvant|adjuvant
286149|NCT02425306|polyICLC|polyiclc
286150|NCT02425306|cyclophosphamide|cyclophosphamide
286151|NCT02425306|Montanide ISA-51|montanide isa-51
286152|NCT02425267|Telerehabilitation|telerehabilitation
286153|NCT02425241|Vaccine|vaccine
286154|NCT02425241|DNA|dna
286155|NCT02425241|HIV-1|hiv-1
286156|NCT02425241|Serum amyloid P component (SAP)|serum amyloid p component (sap)
286157|NCT02425241|Clinical trial|clinical trial
286158|NCT02425241|Vaccination|vaccination
286159|NCT02425241|Prophylaxis|prophylaxis
286160|NCT02425241|Adult male|adult male
286161|NCT02425228|targeted biopsy|targeted biopsy
286162|NCT02425228|conventional biopsy|conventional biopsy
286163|NCT02425228|cognitive biopsy|cognitive biopsy
286164|NCT02425215|Hyperbaric Oxygen Treatment|hyperbaric oxygen treatment
286165|NCT02425215|Late radiation injury|late radiation injury
286166|NCT02425215|Adult|adult
286167|NCT02425215|Malignancy|malignancy
286168|NCT02425215|Quality of Life|quality of life
286169|NCT02425215|Chronic Pain|chronic pain
286170|NCT02425202|pediatric|pediatric
286171|NCT02425202|obstructive sleep apnea|obstructive sleep apnea
286172|NCT02425202|tonsillectomy|tonsillectomy
286173|NCT02425202|analgesia|analgesia
286174|NCT02425176|botulinum toxin|botulinum toxin
286175|NCT02425176|sialorrhoea|sialorrhoea
286176|NCT02425176|drooling|drooling
286177|NCT02425163|Prostate Cancer|prostate cancer
286178|NCT02425163|Shear Wave Elastography|shear wave elastography
286179|NCT02425163|Prostate|prostate
286180|NCT02425163|Prostate Biopsy|prostate biopsy
286181|NCT02425150|Keratoconus|keratoconus
286182|NCT02425150|Corneal crosslinking|corneal crosslinking
286183|NCT02425150|Corneal biomechanics|corneal biomechanics
286184|NCT02425150|Corneal densitometry|corneal densitometry
286185|NCT02425150|Scheimpflug photography|scheimpflug photography
286186|NCT02425111|Drug therapy|drug therapy
286187|NCT02425098|Vaccine|vaccine
286188|NCT02425085|retinectomy|retinectomy
286189|NCT02425085|endodiathermy|endodiathermy
286190|NCT02425085|inferior|inferior
286191|NCT02425085|retinal redetachment|retinal redetachment
286192|NCT02425072|Cancer|cancer
286193|NCT02425072|Brain|brain
286194|NCT02425072|Lung|lung
286195|NCT02425072|Small-cell|small-cell
286196|NCT02425059|irreversible electroporation|irreversible electroporation
286197|NCT02425059|Unresectable Rectal Neoplasms|unresectable rectal neoplasms
286198|NCT02425046|family|family
286199|NCT02425033|POEM|poem
286200|NCT02425033|Minimally invasive surgery|minimally invasive surgery
286201|NCT02425033|Achalasia|achalasia
286202|NCT02425033|Spastic esophageal disorders|spastic esophageal disorders
286203|NCT02425020|Supplement|supplement
286204|NCT02425020|performance|performance
286205|NCT02425020|whey|whey
286206|NCT02425020|meat|meat
286207|NCT02425020|protein|protein
286208|NCT02424994|Morbidity|morbidity
286209|NCT02424994|Mortality|mortality
286210|NCT02424994|Health care utilization|health care utilization
286211|NCT02424994|Cohort|cohort
286212|NCT02424994|Epidemiology|epidemiology
286213|NCT02424994|Cardiovascular diseases|cardiovascular diseases
286214|NCT02424968|Healthy Stem Cell Donor|healthy stem cell donor
286215|NCT02424955|Liver cancer|liver cancer
286216|NCT02424955|Hepatocellular Carcinoma|hepatocellular carcinoma
286217|NCT02424955|Liver imaging|liver imaging
286218|NCT02424955|Stereotactic Ablative Radiotherapy|stereotactic ablative radiotherapy
286219|NCT02424955|SABR|sabr
286220|NCT02424929|Deep Brain Stimulation|deep brain stimulation
286221|NCT02424916|Onco-dermatology|onco-dermatology
286222|NCT02424916|Adoptive transfer|adoptive transfer
286223|NCT02424916|Immunotherapy|immunotherapy
286224|NCT02424903|infection|infection
286225|NCT02424903|prosthesis|prosthesis
286226|NCT02424903|hip|hip
286227|NCT02424903|knee|knee
286228|NCT02424903|shoulder|shoulder
286229|NCT02424877|rheumatoid arthritis|rheumatoid arthritis
286230|NCT02424877|drug treatment|drug treatment
286231|NCT02424877|compliance|compliance
286232|NCT02424877|outcome|outcome
286233|NCT02424864|4D PET-CT|4d pet-ct
286234|NCT02424851|myeloma|myeloma
286235|NCT02424851|multiple myeloma|multiple myeloma
286236|NCT02424851|chronic kidney disease|chronic kidney disease
286237|NCT02424851|renal failure|renal failure
286238|NCT02424851|bortezomib|bortezomib
286239|NCT02424851|Velcade|velcade
286240|NCT02424851|thalidomide|thalidomide
286241|NCT02424851|bendamustine|bendamustine
286242|NCT02424851|dexamethasone|dexamethasone
286243|NCT02424851|serum free light chains|serum free light chains
286244|NCT02424851|proteosomal inhibition|proteosomal inhibition
286245|NCT02424851|immunomodulatory|immunomodulatory
286246|NCT02424825|diet|diet
286247|NCT02424825|cooking|cooking
286248|NCT02424825|multiple sclerosis|multiple sclerosis
286249|NCT02424825|fatigue|fatigue
286250|NCT02424812|handwashing|handwashing
286251|NCT02424812|behavior|behavior
286252|NCT02424799|Urticaria|urticaria
286253|NCT02424799|SYK Inhibitor|syk inhibitor
286254|NCT02424786|Adherence|adherence
286255|NCT02424786|Polypharmacy|polypharmacy
286256|NCT02424786|Elderly|elderly
286257|NCT02424786|Chronic kidney disease|chronic kidney disease
286258|NCT02424734|Late-onset Sepsis|late-onset sepsis
286259|NCT02424708|Reduced Glutathione|reduced glutathione
286260|NCT02424708|Intranasal|intranasal
286261|NCT02424708|(in)GSH|(in)gsh
286262|NCT02424708|Parkinson's Disease|parkinson's disease
286263|NCT02424708|Glutathione|glutathione
286264|NCT02424708|Uptake|uptake
286265|NCT02424708|central nervous system|central nervous system
286266|NCT02424695|Cortical arousal intensity|cortical arousal intensity
286267|NCT02424695|RLS|rls
286268|NCT02424695|Heart rate|heart rate
286269|NCT02424695|Blood pressure|blood pressure
286270|NCT02424695|PLMs|plms
286271|NCT02424630|sono-guided interscalene brachial plexus block|sono-guided interscalene brachial plexus block
286272|NCT02424630|arthroscopy-guided suprascapular nerve block|arthroscopy-guided suprascapular nerve block
286273|NCT02424630|arthroscopic rotator cuff repair|arthroscopic rotator cuff repair
286274|NCT02424630|postoperative pain|postoperative pain
286275|NCT02424591|Anesthesia Recovery Period|anesthesia recovery period
286276|NCT02424591|Spinal Fusion|spinal fusion
286277|NCT02424552|severe asthma|severe asthma
286278|NCT02424552|vitamin D|vitamin d
286279|NCT02424552|treatment|treatment
286280|NCT02424539|Seasonal|seasonal
286281|NCT02424539|Fluticasone Furoate|fluticasone furoate
286282|NCT02424539|Perennial|perennial
286283|NCT02424539|Allergic Rhinitis|allergic rhinitis
286284|NCT02424539|Nasal Spray|nasal spray
286285|NCT02424526|cerebral palsy|cerebral palsy
286286|NCT02424526|treadmill training|treadmill training
286287|NCT02424526|walking|walking
286288|NCT02424487|Initial pressure|initial pressure
286289|NCT02424487|changes of intracuff pressure|changes of intracuff pressure
286290|NCT02424487|infants and children|infants and children
286291|NCT02424474|cell free fetal DNA|cell free fetal dna
286292|NCT02424474|general population|general population
286293|NCT02424474|screening|screening
286294|NCT02424474|trisomy 21|trisomy 21
286295|NCT02424474|IVF|ivf
286296|NCT02424435|Friedreich Ataxia|friedreich ataxia
286297|NCT02424435|FRDA|frda
286298|NCT02424422|Corrective Orthodontics|corrective orthodontics
286299|NCT02424422|CBCT|cbct
286300|NCT02424422|Rapid Maxillary Expansion|rapid maxillary expansion
286301|NCT02424422|Cone Beam Computed Tomography|cone beam computed tomography
286302|NCT02424422|Hyrax Expansion|hyrax expansion
286303|NCT02424422|Craniofacial Sutures|craniofacial sutures
286304|NCT02424409|Asthma|asthma
286305|NCT02424409|Relapse|relapse
286306|NCT02424409|Therapeutic counselling|therapeutic counselling
286307|NCT02424409|Protocol of care|protocol of care
286308|NCT02424396|Interleukin 2, IL2|interleukin 2, il2
286309|NCT02424396|Relapsing Remitting Multiple Sclerosis|relapsing remitting multiple sclerosis
286310|NCT02424396|Autoimmune diseases|autoimmune diseases
286311|NCT02424396|Regulatory T cells, Tregs|regulatory t cells, tregs
286312|NCT02424370|Aortic stenosis|aortic stenosis
286313|NCT02424370|TAVR|tavr
286314|NCT02424370|Frailty|frailty
286315|NCT02424370|Elderly|elderly
286316|NCT02424357|Adjustable strabismus surgery|adjustable strabismus surgery
286317|NCT02424357|suture contamination|suture contamination
286318|NCT02424357|5%povidone iodine|5%povidone iodine
286319|NCT02424344|COPD|copd
286320|NCT02424331|Chronic Obstructive Pulmonary Disease|chronic obstructive pulmonary disease
286321|NCT02424331|Respiratory mechanics|respiratory mechanics
286322|NCT02424331|Plethysmography|plethysmography
286323|NCT02424331|Diaphragm|diaphragm
286324|NCT02424331|Respiratory muscles|respiratory muscles
286325|NCT02424331|Breathing exercises|breathing exercises
286326|NCT02424292|Breast cancer|breast cancer
286327|NCT02424292|Physcial activity/exercise|physcial activity/exercise
286328|NCT02424292|anti-hormonal treatment|anti-hormonal treatment
286329|NCT02424279|pancreatic cancer|pancreatic cancer
286330|NCT02424279|pain|pain
286331|NCT02424279|splanchnicectomy|splanchnicectomy
286332|NCT02424266|Tear film|tear film
286334|NCT02424266|Tomogrophy|tomogrophy
286335|NCT02424266|dry eye|dry eye
286336|NCT02424201|uterine atony|uterine atony
286337|NCT02424175|Fecal Transplant|fecal transplant
286338|NCT02424175|Primary Sclerosing Cholangitis|primary sclerosing cholangitis
286339|NCT02424175|Fecal Microbiota Transplantation|fecal microbiota transplantation
286340|NCT02424110|bipolar radiofrequency ablation|bipolar radiofrequency ablation
286341|NCT02424110|argon beam coagulator|argon beam coagulator
286342|NCT02424097|Prevention|prevention
286343|NCT02424071|melatonin's|melatonin's
286344|NCT02424071|quality of recovery|quality of recovery
286345|NCT02424032|Neck pain|neck pain
286346|NCT02424032|stabilization exercise|stabilization exercise
286347|NCT02424032|connective tissue massage|connective tissue massage
286348|NCT02424006|keratoplasty|keratoplasty
286349|NCT02424006|bioengineered cornea|bioengineered cornea
286350|NCT02424006|donor cornea|donor cornea
286351|NCT02423993|Type 1 diabetes mellitus|type 1 diabetes mellitus
286352|NCT02423993|Continuous subcutaneous insulin infusion|continuous subcutaneous insulin infusion
286353|NCT02423993|Quality of life|quality of life
286354|NCT02423993|Therapeutic education|therapeutic education
286355|NCT02423993|Insulin pump|insulin pump
286356|NCT02423941|Liver Transplantation|liver transplantation
286357|NCT02423941|Retrograde Reperfusion|retrograde reperfusion
286358|NCT02423941|Graft dysfunction|graft dysfunction
286359|NCT02423941|Randomized study|randomized study
286360|NCT02423928|immunotherapy|immunotherapy
286361|NCT02423928|cryoablation|cryoablation
286362|NCT02423928|prostate cancer|prostate cancer
286363|NCT02423928|dendritic cell|dendritic cell
286364|NCT02423915|Leukemia|leukemia
286365|NCT02423915|Lymphoma|lymphoma
286366|NCT02423915|Advanced hematologic malignancies|advanced hematologic malignancies
286367|NCT02423915|Graft versus host disease|graft versus host disease
286368|NCT02423915|GVHD|gvhd
286369|NCT02423915|Fucosylated umbilical cord blood Regulatory T cells|fucosylated umbilical cord blood regulatory t cells
286370|NCT02423915|CB|cb
286371|NCT02423915|Tregs|tregs
286372|NCT02423915|T cells|t cells
286373|NCT02423915|Cord blood transplant|cord blood transplant
286374|NCT02423915|Total body radiation|total body radiation
286375|NCT02423915|TBI|tbi
286376|NCT02423915|Radiation therapy|radiation therapy
286377|NCT02423915|XRT|xrt
286378|NCT02423915|Rituximab|rituximab
286379|NCT02423915|Rituxan|rituxan
286380|NCT02423915|Fludarabine|fludarabine
286381|NCT02423915|Fludarabine phosphate|fludarabine phosphate
286382|NCT02423915|Fludara|fludara
286383|NCT02423915|Cyclophosphamide|cyclophosphamide
286384|NCT02423915|Cytoxan|cytoxan
286385|NCT02423915|Neosar|neosar
286386|NCT02423915|Mycophenolate|mycophenolate
286387|NCT02423915|Mycophenolate mofetil|mycophenolate mofetil
286389|NCT02423915|CellCept|cellcept
286390|NCT02423915|Sirolimus|sirolimus
286391|NCT02423915|Rapamune|rapamune
286392|NCT02423915|G-CSF|g-csf
286393|NCT02423915|Filgrastim|filgrastim
286394|NCT02423915|Neupogen|neupogen
286395|NCT02423889|Hypofractionated radiotherapy|hypofractionated radiotherapy
286396|NCT02423889|SBRT|sbrt
286397|NCT02423863|Cancer|cancer
286398|NCT02423863|Immunotherapy|immunotherapy
286399|NCT02423863|Intratumoral Injection|intratumoral injection
286400|NCT02423863|Multicenter Study|multicenter study
286401|NCT02423863|Autovaccination|autovaccination
286402|NCT02423863|Solid Tumors|solid tumors
286403|NCT02423863|anti-PD1|anti-pd1
286404|NCT02423863|anti-PDL1|anti-pdl1
286405|NCT02423850|Diabetic foot ulcers|diabetic foot ulcers
286406|NCT02423850|Ulcer healing|ulcer healing
286407|NCT02423850|Ulcer measurement|ulcer measurement
286408|NCT02423850|Ulcer area|ulcer area
286409|NCT02423850|Ulcer volume|ulcer volume
286410|NCT02423850|3D measurement|3d measurement
286411|NCT02423837|follicular lymphoma|follicular lymphoma
286412|NCT02423837|bendamustine|bendamustine
286413|NCT02423837|rituximab|rituximab
286414|NCT02423798|Diabetes|diabetes
286415|NCT02423798|Glucose sensor|glucose sensor
286416|NCT02423798|Sensor accuracy and performance|sensor accuracy and performance
286417|NCT02423798|CGM|cgm
286418|NCT02423759|Chemoprevention|chemoprevention
286419|NCT02423733|depression|depression
286420|NCT02423733|dysthymia|dysthymia
286421|NCT02423733|cognitive behavioural therapy|cognitive behavioural therapy
286422|NCT02423733|CBT|cbt
286423|NCT02423733|problem-solving therapy|problem-solving therapy
286424|NCT02423733|PST|pst
286425|NCT02423733|waitlist|waitlist
286426|NCT02423733|secondary mental health care|secondary mental health care
286427|NCT02423733|mental health|mental health
286428|NCT02423733|e-therapy|e-therapy
286429|NCT02423733|computerized therapy|computerized therapy
286430|NCT02423668|cataract surgery|cataract surgery
286431|NCT02423668|biometry|biometry
286432|NCT02423668|second eye refinement|second eye refinement
286433|NCT02423668|effective lens position|effective lens position
286536|NCT02423096|biomarker|biomarker
286434|NCT02423642|Acute Kidney Injury Requiring Continuous Renal Replacement Therapy|acute kidney injury requiring continuous renal replacement therapy
286435|NCT02423616|MIP|mip
286436|NCT02423616|Hand Grip|hand grip
286437|NCT02423616|Correlation|correlation
286438|NCT02423616|Inspiratory Pressure|inspiratory pressure
286439|NCT02423616|Hand Grip Force|hand grip force
286440|NCT02423603|Triple Negative Breast Cancer|triple negative breast cancer
286441|NCT02423603|Metastatic|metastatic
286442|NCT02423603|AKT Inhibitor|akt inhibitor
286443|NCT02423603|Advanced|advanced
286444|NCT02423603|AZD5363|azd5363
286445|NCT02423603|Paclitaxel|paclitaxel
286446|NCT02423603|PAKT|pakt
286447|NCT02423590|Squamous|squamous
286448|NCT02423590|Lung|lung
286449|NCT02423590|Apatorsen|apatorsen
286450|NCT02423577|antiviral|antiviral
286451|NCT02423577|influenza|influenza
286452|NCT02423577|challenge|challenge
286453|NCT02423564|Probiotic|probiotic
286454|NCT02423564|Digesta-Lac|digesta-lac
286455|NCT02423564|Occasional Constipation|occasional constipation
286456|NCT02423564|Constipation|constipation
286457|NCT02423551|Gut microbiota|gut microbiota
286458|NCT02423551|Intestinal permeability|intestinal permeability
286459|NCT02423551|Gut barrier integrity|gut barrier integrity
286460|NCT02423525|glioblastoma|glioblastoma
286461|NCT02423525|astrocytoma|astrocytoma
286462|NCT02423525|oligodendroglioma|oligodendroglioma
286463|NCT02423525|mixed oligoastrocytoma|mixed oligoastrocytoma
286464|NCT02423525|low grade gliomas|low grade gliomas
286465|NCT02423525|brain metastases|brain metastases
286466|NCT02423525|meningiomas|meningiomas
286467|NCT02423525|leptomeningeal metastases|leptomeningeal metastases
286468|NCT02423512|Inflammatory Bowel Diseases|inflammatory bowel diseases
286469|NCT02423512|Vedolizumab|vedolizumab
286470|NCT02423512|Ulcerative Colitis|ulcerative colitis
286471|NCT02423512|Crohn's Disease|crohn's disease
286472|NCT02423512|MADCAM1|madcam1
286473|NCT02423512|integrin alpha4beta7|integrin alpha4beta7
286474|NCT02423499|Autism Spectrum Disorder|autism spectrum disorder
286475|NCT02423499|Bipolar Disorder|bipolar disorder
286476|NCT02423499|Emotions|emotions
286477|NCT02423460|Ulcerative Colitis|ulcerative colitis
286478|NCT02423460|Healthy Controls|healthy controls
286479|NCT02423460|Crohn's Disease|crohn's disease
286480|NCT02423434|Corneal Confocal Microscopy|corneal confocal microscopy
286481|NCT02423434|Diabetes Mellitus|diabetes mellitus
286482|NCT02423434|Type 1 Diabetes Mellitus|type 1 diabetes mellitus
286483|NCT02423434|Type 2 Diabetes Mellitus|type 2 diabetes mellitus
286484|NCT02423434|Diabetic Neuropathy|diabetic neuropathy
286485|NCT02423434|Diabetes Complications|diabetes complications
286486|NCT02423382|silicone oil|silicone oil
286487|NCT02423382|retinal saturation|retinal saturation
286488|NCT02423382|retinal blood flow|retinal blood flow
286489|NCT02423382|retinal detachment|retinal detachment
286490|NCT02423369|S-100B protein|s-100b protein
286491|NCT02423369|Neuron-specific Enolase|neuron-specific enolase
286492|NCT02423356|breast cancer|breast cancer
286493|NCT02423356|sarcoma|sarcoma
286494|NCT02423356|lymphoma|lymphoma
286495|NCT02423356|echocardiography|echocardiography
286496|NCT02423356|cardiotoxicity|cardiotoxicity
286497|NCT02423356|pharmacogenetics|pharmacogenetics
286498|NCT02423356|doxorubicin|doxorubicin
286499|NCT02423356|chemotherapy|chemotherapy
286500|NCT02423291|PMLBCL|pmlbcl
286501|NCT02423291|Brentuximab Vedotin|brentuximab vedotin
286502|NCT02423291|CD30-positive|cd30-positive
286503|NCT02423291|Mediastinal Lymphoma|mediastinal lymphoma
286504|NCT02423278|gastrectomy|gastrectomy
286505|NCT02423278|lymphadenectomy|lymphadenectomy
286506|NCT02423278|gastric cancer|gastric cancer
286507|NCT02423278|adjuvant chemotherapy|adjuvant chemotherapy
286508|NCT02423278|overall survival|overall survival
286509|NCT02423265|Chronic total coronary occlusions|chronic total coronary occlusions
286510|NCT02423265|Ranolazine|ranolazine
286511|NCT02423252|Critical illness|critical illness
286512|NCT02423252|Intervention|intervention
286513|NCT02423252|RCT|rct
286514|NCT02423252|Relaxation|relaxation
286515|NCT02423252|Guided imagery|guided imagery
286516|NCT02423252|Touch/Massage|touch/massage
286517|NCT02423252|Music listening|music listening
286518|NCT02423252|Neuropeptides|neuropeptides
286519|NCT02423252|Inflammatory molecules|inflammatory molecules
286520|NCT02423252|Post-traumatic stress|post-traumatic stress
286521|NCT02423252|Critical care nurse|critical care nurse
286522|NCT02423252|Psychocognitive nursing intervention|psychocognitive nursing intervention
286523|NCT02423252|Interpersonal support|interpersonal support
286524|NCT02423213|OCT|oct
286525|NCT02423213|image-guided surgery|image-guided surgery
286526|NCT02423213|ophthalmic surgery|ophthalmic surgery
286527|NCT02423187|Stomach ulcer|stomach ulcer
286528|NCT02423187|Duodenal ulcer|duodenal ulcer
286529|NCT02423187|Rabeprazole|rabeprazole
286530|NCT02423187|Recurrence|recurrence
286531|NCT02423161|OCT|oct
286532|NCT02423161|image-guided surgery|image-guided surgery
286533|NCT02423161|vitreoretinal surgery|vitreoretinal surgery
286534|NCT02423161|corneal surgery|corneal surgery
286535|NCT02423148|Lung Cancer|lung cancer
286537|NCT02423096|neuroendocrine|neuroendocrine
286538|NCT02423096|metabolite|metabolite
286539|NCT02423096|cognitive functioning|cognitive functioning
286540|NCT02423096|clinical symptoms|clinical symptoms
286541|NCT02423096|schizophrenia|schizophrenia
286542|NCT02423083|Neuroprotection|neuroprotection
286543|NCT02423083|Multiple Sclerosis|multiple sclerosis
286544|NCT02423083|Clinical Trial|clinical trial
286545|NCT02423083|Safety and Tolerability|safety and tolerability
286546|NCT02423070|Cell-free DNA|cell-free dna
286547|NCT02423070|Acute Rejection|acute rejection
286548|NCT02423070|Thoracic Organ Transplantation|thoracic organ transplantation
286549|NCT02423070|Non-Invasive Testing|non-invasive testing
286550|NCT02423070|Chronic Rejection|chronic rejection
286551|NCT02423057|Pharmacodynamics|pharmacodynamics
286552|NCT02423057|DNA Methylation|dna methylation
286553|NCT02423057|Pharmacokinetics|pharmacokinetics
286554|NCT02423057|Nucleoside Analogue|nucleoside analogue
286555|NCT02423057|Epigenetics|epigenetics
286557|NCT02423044|fMRI|fmri
286558|NCT02423044|Virtual Reality|virtual reality
286559|NCT02423044|Shock Threat|shock threat
286560|NCT02423044|Healthy Volunteer|healthy volunteer
286561|NCT02423031|Physiological Measures|physiological measures
286562|NCT02423031|Emotional Context|emotional context
286563|NCT02423031|Pediatric|pediatric
286564|NCT02423031|Distresss Screening|distresss screening
286565|NCT02423005|Stress urinary incontinence|stress urinary incontinence
286566|NCT02423005|Neurotech Vital Compact|neurotech vital compact
286567|NCT02423005|1h Provacative Pad Test|1h provacative pad test
286568|NCT02423005|Neuroelectrical Muscle Stimulation (NEMS)|neuroelectrical muscle stimulation (nems)
286569|NCT02422992|Iron metabolism|iron metabolism
286570|NCT02422992|MRI|mri
286571|NCT02422992|risk factors|risk factors
286572|NCT02422992|haptoglobin phenotype|haptoglobin phenotype
286573|NCT02422953|Stunting|stunting
286574|NCT02422953|Wasting|wasting
286575|NCT02422953|Underweight|underweight
286576|NCT02422927|C-Reactive Protein|c-reactive protein
286577|NCT02422927|Endothelial Microparticles|endothelial microparticles
286578|NCT02422927|Endothelium|endothelium
286579|NCT02422927|Nutraceutical|nutraceutical
286580|NCT02422927|Cholesterol|cholesterol
286581|NCT02422888|ST elevation myocardial infarction|st elevation myocardial infarction
286582|NCT02422888|Percutaneous coronary intervention|percutaneous coronary intervention
286583|NCT02422888|Endothelial function|endothelial function
286584|NCT02422888|Ticagrelor|ticagrelor
286585|NCT02422888|Prasugrel|prasugrel
286586|NCT02422875|Sjögren's Syndrome|sjögren's syndrome
286587|NCT02422875|Scleroderma|scleroderma
286588|NCT02422875|Myositis|myositis
286589|NCT02422875|Juvenile Idiopathic Arthritis|juvenile idiopathic arthritis
366232|NCT02023658|HIV|hiv
286590|NCT02422875|Rheumatoid Arthritis|rheumatoid arthritis
286591|NCT02422875|Inflammatory Arthritis|inflammatory arthritis
286592|NCT02422875|Undifferentiated Connective Tissue Disease|undifferentiated connective tissue disease
286593|NCT02422875|Idiopathic thrombocytopenic purpura|idiopathic thrombocytopenic purpura
286594|NCT02422875|Graft vs Host Disease|graft vs host disease
286595|NCT02422875|Autoimmune Lymphoproliferative Syndrome|autoimmune lymphoproliferative syndrome
286596|NCT02422875|Immunoglobulin G4 (IgG4)-related disease|immunoglobulin g4 (igg4)-related disease
286597|NCT02422875|Hepatitis C|hepatitis c
286598|NCT02422875|Epstein Barr Virus (infectious mononucleosis - EBV)|epstein barr virus (infectious mononucleosis - ebv)
286599|NCT02422875|Sepsis|sepsis
286600|NCT02422875|Guillain-Barre syndrome|guillain-barre syndrome
286601|NCT02422875|Mycoplasma pneumoniae|mycoplasma pneumoniae
286602|NCT02422875|Human Immunodeficiency Virus|human immunodeficiency virus
286603|NCT02422862|Physiotherapy|physiotherapy
286604|NCT02422862|Manual Therapy|manual therapy
286605|NCT02422849|Patient admission|patient admission
286606|NCT02422836|photodamage|photodamage
286607|NCT02422836|fine lines|fine lines
286608|NCT02422836|wrinkles|wrinkles
286609|NCT02422836|dyschromia|dyschromia
286610|NCT02422823|anesthesia|anesthesia
286611|NCT02422823|volumes|volumes
286612|NCT02422823|articaine|articaine
286613|NCT02422823|Inferior alveolar nerve block|inferior alveolar nerve block
286614|NCT02422797|HIV|hiv
286615|NCT02422797|NNRTI-sparing|nnrti-sparing
286616|NCT02422797|two-drug regimen|two-drug regimen
286617|NCT02422797|nucleoside reverse transcriptase inhibitors|nucleoside reverse transcriptase inhibitors
286618|NCT02422797|protease inhibitor|protease inhibitor
286619|NCT02422797|integrase inhibitor|integrase inhibitor
286620|NCT02422797|non-nucleoside reverse transcriptase inhibitor|non-nucleoside reverse transcriptase inhibitor
286621|NCT02422797|dolutegravir plus rilpivirine|dolutegravir plus rilpivirine
286622|NCT02422797|virologically-suppressed|virologically-suppressed
286623|NCT02422784|Vitamin D insufficient|vitamin d insufficient
286624|NCT02422784|rooibos tea|rooibos tea
286625|NCT02422784|calcium|calcium
286626|NCT02422758|hypothermia|hypothermia
286627|NCT02422758|perioperative nursing|perioperative nursing
286628|NCT02422758|prewarming|prewarming
286629|NCT02422758|prevention and control|prevention and control
286630|NCT02422745|Cocoa extract multivitamins cardiovascular disease cancer|cocoa extract multivitamins cardiovascular disease cancer
286631|NCT02422732|NF1|nf1
286632|NCT02422732|Children|children
286633|NCT02422732|Reading disability|reading disability
286634|NCT02422732|Morphological and functional MRI|morphological and functional mri
286635|NCT02422732|Genetic analysis|genetic analysis
286636|NCT02422719|Chronic myeloid leukemia|chronic myeloid leukemia
286637|NCT02422719|Intolerance|intolerance
286638|NCT02422719|Resitance|resitance
286639|NCT02422719|Radotinib|radotinib
286640|NCT02422693|hydrotherapy|hydrotherapy
286641|NCT02422693|aquatic|aquatic
286642|NCT02422680|Quality assurance|quality assurance
286643|NCT02422680|Caecum intubation rate|caecum intubation rate
286644|NCT02422680|Patient satisfaction|patient satisfaction
286645|NCT02422667|Orthopedics|orthopedics
286646|NCT02422667|Outcome Assessment|outcome assessment
286647|NCT02422628|EGFR inhibitor|egfr inhibitor
286648|NCT02422628|EGFR mutation|egfr mutation
286649|NCT02422628|EGFR|egfr
286650|NCT02422628|adenocarcinoma|adenocarcinoma
286651|NCT02422628|EGFR TKI|egfr tki
286652|NCT02422628|treatment|treatment
286653|NCT02422628|Non small cell|non small cell
286654|NCT02422615|HR-positive|hr-positive
286655|NCT02422615|HER2-negative|her2-negative
286656|NCT02422615|Advanced breast cancer|advanced breast cancer
286657|NCT02422615|LEE011|lee011
286658|NCT02422615|ribociclib|ribociclib
286659|NCT02422615|fulvestrant|fulvestrant
286660|NCT02422615|faslodex|faslodex
286662|NCT02422615|CDK4|cdk4
286663|NCT02422615|CDK6|cdk6
286664|NCT02422615|CDK4/6|cdk4/6
286665|NCT02422615|CDK4/6 inhibitor|cdk4/6 inhibitor
286666|NCT02422615|Phase III|phase iii
286667|NCT02422615|ER-positive|er-positive
286668|NCT02422615|PR-positive|pr-positive
286669|NCT02422615|Postmenopausal|postmenopausal
286670|NCT02422615|Men|men
286671|NCT02422615|Breast Neoplasms|breast neoplasms
286672|NCT02422615|Breast Diseases|breast diseases
286673|NCT02422615|Neoplasms|neoplasms
286674|NCT02422615|Neoplasms by Site|neoplasms by site
286675|NCT02422615|Antineoplastic Agents|antineoplastic agents
286676|NCT02422615|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal
286677|NCT02422615|Estrogen Receptor Antagonists|estrogen receptor antagonists
286678|NCT02422615|Hormone Antagonists|hormone antagonists
286679|NCT02422615|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists
286680|NCT02422615|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action
286681|NCT02422615|Pharmacologic Actions|pharmacologic actions
286682|NCT02422615|Therapeutic Use|therapeutic use
286683|NCT02422602|Patients|patients
286684|NCT02422602|treated by Rivaroxaban|treated by rivaroxaban
286685|NCT02422589|ALK-positive advanced tumors|alk-positive advanced tumors
286686|NCT02422589|midazolam|midazolam
286687|NCT02422589|warfarin|warfarin
286688|NCT02422589|ceritinib|ceritinib
286689|NCT02422589|ALK|alk
286690|NCT02422589|CYP3A-4|cyp3a-4
286691|NCT02422589|Drug drug intereaction|drug drug intereaction
286692|NCT02422563|neoadjuvant chemotherapy|neoadjuvant chemotherapy
286693|NCT02422563|FIGO IB2, FIGO IIB|figo ib2, figo iib
286694|NCT02422563|chemo-radiation|chemo-radiation
286695|NCT02422563|dose dense chemotherapy|dose dense chemotherapy
286696|NCT02422563|cisplatin|cisplatin
286697|NCT02422563|paclitaxel|paclitaxel
286698|NCT02422563|carboplatin|carboplatin
286699|NCT02422563|ifosfamide|ifosfamide
286700|NCT02422550|MRI|mri
286701|NCT02422550|15-073|15-073
286702|NCT02422550|participants undergoing radiation therapy|participants undergoing radiation therapy
286703|NCT02422524|Hepatic|hepatic
286704|NCT02422524|impairment|impairment
286705|NCT02422524|PA-824|pa-824
286706|NCT02422524|Pharmacokinetics|pharmacokinetics
286707|NCT02422524|Safety|safety
286708|NCT02422524|Tuberculosis|tuberculosis
286709|NCT02422511|Genome Sequencing|genome sequencing
286710|NCT02422511|Exome Sequencing|exome sequencing
286711|NCT02422511|Newborn Screening|newborn screening
286712|NCT02422511|Childhood Onset Genetic Conditions|childhood onset genetic conditions
286713|NCT02422498|Treated with Concurrent Cisplatin|treated with concurrent cisplatin
286714|NCT02422498|Treated with Radiation Therapy|treated with radiation therapy
286715|NCT02422498|Homologous Recombination Repair Status|homologous recombination repair status
286716|NCT02422498|Biomarker of Response|biomarker of response
286717|NCT02422498|15-032|15-032
286718|NCT02422498|Patients|patients
286719|NCT02422485|Salsalate|salsalate
286720|NCT02422446|Endothelial function|endothelial function
286721|NCT02422446|Eicosapentaenoic acid|eicosapentaenoic acid
286722|NCT02422446|Triglycerides|triglycerides
286723|NCT02422433|EGD|egd
286724|NCT02422433|OFDI|ofdi
286725|NCT02422433|Barrett's Esophagus|barrett's esophagus
286726|NCT02422433|Imaging|imaging
286727|NCT02422433|Biopsy|biopsy
286728|NCT02422433|OCT|oct
286729|NCT02422420|Diabetes Prevention|diabetes prevention
286730|NCT02422420|Financial Incentives|financial incentives
286731|NCT02422420|Medicaid|medicaid
286732|NCT02422420|Motivation|motivation
286733|NCT02422381|NSCLC|nsclc
286734|NCT02422381|lung cancer|lung cancer
286735|NCT02422381|Gemzar|gemzar
286736|NCT02422381|Pembrolizumab|pembrolizumab
286737|NCT02422381|Anti-PD-1|anti-pd-1
286738|NCT02422381|Immunotherapy|immunotherapy
286739|NCT02422368|Graves' ophthalmopathy|graves' ophthalmopathy
286740|NCT02422368|Antioxidant|antioxidant
286741|NCT02422368|Activity|activity
286742|NCT02422368|Severity|severity
286743|NCT02422355|hip|hip
286744|NCT02422355|femoral neck|femoral neck
286745|NCT02422355|Garden classification|garden classification
286746|NCT02422355|healing|healing
286747|NCT02422355|cut-out|cut-out
286748|NCT02422355|iatrogenic fracture|iatrogenic fracture
286749|NCT02422355|implant|implant
286750|NCT02422355|rotational stability|rotational stability
286751|NCT02422355|minimal invasive|minimal invasive
286752|NCT02422329|Advanced Cancers|advanced cancers
286753|NCT02422329|Constipation|constipation
286754|NCT02422329|Recurrent cancer|recurrent cancer
286755|NCT02422329|Locally advanced cancer|locally advanced cancer
286756|NCT02422329|Metastatic cancer|metastatic cancer
286757|NCT02422329|Video|video
286758|NCT02422329|Fact sheet|fact sheet
286759|NCT02422329|Questionnaires|questionnaires
286760|NCT02422329|Surveys|surveys
286761|NCT02422303|Depression|depression
286762|NCT02422303|Gynecoligical surgery|gynecoligical surgery
286763|NCT02422303|Ketamine|ketamine
286764|NCT02422290|Obsessive Compulsive Disorder|obsessive compulsive disorder
286765|NCT02422290|Ketamine|ketamine
286766|NCT02422290|Glutamate|glutamate
286767|NCT02422290|OCD treatment|ocd treatment
286768|NCT02422290|OCD medication|ocd medication
286769|NCT02422277|Cystoprostatectomy|cystoprostatectomy
286770|NCT02422277|Sexual function|sexual function
286771|NCT02422277|Phosphodiestrase 5 inhibitors|phosphodiestrase 5 inhibitors
286772|NCT02422277|Low intensity extracorporeal shock wave therapy|low intensity extracorporeal shock wave therapy
286773|NCT02422277|Erectile dysfunction|erectile dysfunction
286774|NCT02422277|Penile rehabilitation|penile rehabilitation
286775|NCT02422212|metabolism|metabolism
286776|NCT02422212|Diet Induced Thermogenesis|diet induced thermogenesis
286777|NCT02422212|weight regain|weight regain
286778|NCT02422212|energy expenditure|energy expenditure
286779|NCT02422212|bariatric|bariatric
286780|NCT02422186|Depressive Disorder, Treatment-Resistant|depressive disorder, treatment-resistant
286781|NCT02422186|Esketamine|esketamine
286782|NCT02422186|Oral Antidepressant|oral antidepressant
286783|NCT02422186|Elderly Participants|elderly participants
286784|NCT02422134|Pregnancy|pregnancy
286785|NCT02422134|implantation|implantation
286786|NCT02422134|Cytokine|cytokine
286787|NCT02422108|RANKL|rankl
286788|NCT02422082|Osteopenia|osteopenia
286789|NCT02422082|Lactobacillus reuteri|lactobacillus reuteri
286790|NCT02422082|Volumetric bone mineral density|volumetric bone mineral density
286791|NCT02422056|Cleft Palate|cleft palate
286792|NCT02422056|Hemorrhage|hemorrhage
286793|NCT02422056|Palatoplasty|palatoplasty
286794|NCT02422043|adolescence|adolescence
286795|NCT02422030|Male Volunteers|male volunteers
286796|NCT02422017|Leg ulcer|leg ulcer
286797|NCT02422017|wound|wound
286798|NCT02422017|topical timolol|topical timolol
286799|NCT02422004|Rehabilitation|rehabilitation
286800|NCT02422004|Weight-bearing|weight-bearing
286801|NCT02422004|Range of motion|range of motion
286802|NCT02421978|Cognitive dysfunction|cognitive dysfunction
286803|NCT02421978|Inflammation|inflammation
286804|NCT02421978|Fatigue|fatigue
286805|NCT02421978|Decreased motivation|decreased motivation
286806|NCT02421965|Schizophrenia|schizophrenia
286807|NCT02421965|Schizoaffective Disorder|schizoaffective disorder
286808|NCT02421965|Bipolar Disorder|bipolar disorder
286809|NCT02421965|Major Depressive Disorder|major depressive disorder
286810|NCT02421965|Mobile Application|mobile application
286811|NCT02421965|Smartphone|smartphone
286812|NCT02421965|SMI|smi
286813|NCT02421965|Illness Self-Management|illness self-management
286814|NCT02421965|EHealth|ehealth
286815|NCT02421965|E-Health|e-health
286816|NCT02421965|Health Technology|health technology
286817|NCT02421965|mHealth|mhealth
286818|NCT02421965|m-Health|m-health
286819|NCT02421939|ASP2215|asp2215
286820|NCT02421939|Relapsed Acute Myeloid Leukemia|relapsed acute myeloid leukemia
286821|NCT02421939|FLT3 Mutation|flt3 mutation
286822|NCT02421939|gilteritinib|gilteritinib
286823|NCT02421939|Refractory Acute Myeloid Leukemia|refractory acute myeloid leukemia
286824|NCT02421939|Acute Myeloid Leukemia (AML)|acute myeloid leukemia (aml)
286825|NCT02421939|XOSPATA®|xospata®
286826|NCT02421874|Patient care team|patient care team
286827|NCT02421874|Care management|care management
286828|NCT02421874|Electronic health records|electronic health records
286829|NCT02421861|anxiety|anxiety
286830|NCT02421861|intensive care unit|intensive care unit
286831|NCT02421861|critical care|critical care
286832|NCT02421848|Body composition|body composition
286833|NCT02421848|Sarcopenia|sarcopenia
286834|NCT02421848|Cirrhotic with Ascites|cirrhotic with ascites
286835|NCT02421796|n Non-Celiac Wheat Sensitivity|n non-celiac wheat sensitivity
286836|NCT02421796|Malnutrition|malnutrition
286837|NCT02421796|Celiac disease|celiac disease
287951|NCT02416258|Psoriasis|psoriasis
286838|NCT02421796|Irritable Bowel Syndrome|irritable bowel syndrome
286839|NCT02421783|Non-celiac wheat sensitivity|non-celiac wheat sensitivity
286840|NCT02421783|Multiple food allergy|multiple food allergy
286841|NCT02421783|Body mass index|body mass index
286842|NCT02421783|Osteoporosis|osteoporosis
286843|NCT02421757|Transcutaneous Magnetic Stimulation|transcutaneous magnetic stimulation
286844|NCT02421757|placebo|placebo
286845|NCT02421744|rehabilitation|rehabilitation
286846|NCT02421744|Multiple Sclerosis|multiple sclerosis
286847|NCT02421744|mobility|mobility
286848|NCT02421744|gait|gait
286849|NCT02421744|task-oriented training|task-oriented training
286850|NCT02421731|Rehabilitation|rehabilitation
286851|NCT02421731|Gait|gait
286852|NCT02421718|Acute toxicity|acute toxicity
286853|NCT02421718|Late toxicity|late toxicity
286854|NCT02421718|Prediction models|prediction models
286855|NCT02421679|PTSD|ptsd
286856|NCT02421679|Military-related PTSD and other related conditions|military-related ptsd and other related conditions
286857|NCT02421679|open-label extension|open-label extension
286858|NCT02421653|Micronutrient powders|micronutrient powders
286859|NCT02421653|MNP|mnp
286860|NCT02421653|Weaning|weaning
286861|NCT02421653|Home fortification|home fortification
286862|NCT02421653|Iodine|iodine
286863|NCT02421653|Iodine deficiency|iodine deficiency
286864|NCT02421653|Iodine Deficiency Disorder|iodine deficiency disorder
286865|NCT02421653|IDD|idd
286866|NCT02421653|Infant|infant
286867|NCT02421653|Growth|growth
286868|NCT02421653|Iodised oil|iodised oil
286869|NCT02421627|moxibustion|moxibustion
286870|NCT02421627|irritable bowel syndrome|irritable bowel syndrome
286871|NCT02421627|Magnetic Resonance Imaging|magnetic resonance imaging
286872|NCT02421614|acute respiratory failure|acute respiratory failure
286873|NCT02421614|lung|lung
286874|NCT02421614|enteral feeding|enteral feeding
286875|NCT02421614|feeding composition|feeding composition
286876|NCT02421614|olive|olive
286877|NCT02421614|high fat|high fat
286878|NCT02421549|Remote Monitoring|remote monitoring
286879|NCT02421549|Remote Care|remote care
286880|NCT02421549|Cardiac Resynchronization Therapy|cardiac resynchronization therapy
286881|NCT02421549|Pacemaker|pacemaker
286882|NCT02421549|Implantable Cardioverter Defibrillator|implantable cardioverter defibrillator
286883|NCT02421523|Exercise|exercise
286884|NCT02421523|Strength training|strength training
286885|NCT02421510|High level of sugar (glucose) in the blood|high level of sugar (glucose) in the blood
286886|NCT02421484|Phase I clinical trial|phase i clinical trial
286887|NCT02421484|stem cell|stem cell
286888|NCT02421484|mesenchymal stromal cell|mesenchymal stromal cell
286889|NCT02421484|mesenchymal stem cell|mesenchymal stem cell
286890|NCT02421471|Actinic Keratosis|actinic keratosis
286891|NCT02421471|topical treatment|topical treatment
286892|NCT02421471|ingenol mebutate|ingenol mebutate
286893|NCT02421432|trananal TME|trananal tme
286894|NCT02421432|safety|safety
286895|NCT02421432|efficacy|efficacy
286896|NCT02421432|difficult cases|difficult cases
286897|NCT02421419|flexor tendon entrapment|flexor tendon entrapment
286898|NCT02421419|snapping finger|snapping finger
286899|NCT02421419|trigger digits|trigger digits
286900|NCT02421419|trigger thumb|trigger thumb
286901|NCT02421393|Bone quality|bone quality
286902|NCT02421393|Bone strength|bone strength
286903|NCT02421393|Fractures|fractures
286904|NCT02421393|Muscle strength|muscle strength
286905|NCT02421393|Gait and balance|gait and balance
286906|NCT02421393|Musculo-skeletal symptoms|musculo-skeletal symptoms
286907|NCT02421393|Falls|falls
286908|NCT02421380|Hyperpolarized Pyruvate|hyperpolarized pyruvate
286909|NCT02421380|MRI|mri
286910|NCT02421380|14-205|14-205
286911|NCT02421341|Heart, Cardiovascular|heart, cardiovascular
286912|NCT02421341|Pulmonary|pulmonary
286913|NCT02421341|Skeletal Muscle|skeletal muscle
286914|NCT02421341|Exercise|exercise
286915|NCT02421315|OCD|ocd
286916|NCT02421315|Functional Magnetic Resonance Imaging (fMRI)|functional magnetic resonance imaging (fmri)
286917|NCT02421315|Magnetic Resonance Imaging (MRI)|magnetic resonance imaging (mri)
286918|NCT02421289|CYP2B6 polymorphism|cyp2b6 polymorphism
286919|NCT02421289|efavirenz|efavirenz
286920|NCT02421289|Thai|thai
286921|NCT02421289|HIV-infected patient|hiv-infected patient
286922|NCT02421289|pharmacogenomic|pharmacogenomic
286923|NCT02421263|Psilocybin|psilocybin
286924|NCT02421263|Pharmacologic Actions|pharmacologic actions
286925|NCT02421263|Psychotropic Drugs|psychotropic drugs
286926|NCT02421224|Smoking Cessation|smoking cessation
286927|NCT02421224|Incentives|incentives
286928|NCT02421224|Health Behavior|health behavior
286929|NCT02421224|Smoking|smoking
286930|NCT02421224|Work-site|work-site
286931|NCT02421211|Hepatitis C, Chronic|hepatitis c, chronic
286932|NCT02421211|Simeprevir|simeprevir
286933|NCT02421211|Ledipasvir|ledipasvir
286934|NCT02421211|Sofosbuvir|sofosbuvir
286935|NCT02421198|Intervention Studies|intervention studies
286936|NCT02421185|Carcinoma, Hepatocellular|carcinoma, hepatocellular
286937|NCT02421185|JNJ 42756493|jnj 42756493
287038|NCT02420847|Adriamycin PFS|adriamycin pfs
287952|NCT02416232|melanoma|melanoma
286938|NCT02421185|a pan-Fibroblast Growth Factor Receptor Tyrosine Kinase Inhibitor|a pan-fibroblast growth factor receptor tyrosine kinase inhibitor
286939|NCT02421172|Hidradenitis Suppurativa|hidradenitis suppurativa
286940|NCT02421159|HIV/AIDS|hiv/aids
286941|NCT02421159|vulnerable populations|vulnerable populations
286942|NCT02421159|heterosexuals at high risk|heterosexuals at high risk
286943|NCT02421159|peer-driven intervention|peer-driven intervention
286944|NCT02421159|tailored intervention|tailored intervention
286945|NCT02421159|African-American|african-american
286946|NCT02421159|Latino/Hispanic|latino/hispanic
286947|NCT02421159|Seek, test, treat, and retain (STTR)|seek, test, treat, and retain (sttr)
286948|NCT02421159|Brooklyn|brooklyn
286949|NCT02421133|Care transition program|care transition program
286950|NCT02421133|Patient readmission|patient readmission
286951|NCT02421133|Transition Nurse|transition nurse
286952|NCT02421133|Stepped wedge|stepped wedge
286953|NCT02421133|elderly|elderly
286954|NCT02421081|CD34|cd34
286955|NCT02421081|CD133|cd133
286956|NCT02421081|CD309|cd309
286957|NCT02421081|Radial Artery|radial artery
286958|NCT02421081|Ulnar Artery|ulnar artery
286959|NCT02421081|Lymphoid Cell|lymphoid cell
286960|NCT02421081|blood levels|blood levels
286961|NCT02421081|endothelial progenitor cells|endothelial progenitor cells
286962|NCT02421081|stem cells|stem cells
286963|NCT02421068|Paracetamol|paracetamol
286964|NCT02421068|Fentanyl|fentanyl
286965|NCT02421068|Phenobarbital|phenobarbital
286966|NCT02421068|Doxapram|doxapram
286967|NCT02421068|Midazolam|midazolam
286968|NCT02421068|Sildenafil|sildenafil
286969|NCT02421068|Levetiracetam|levetiracetam
286970|NCT02421068|Pharmacokinetics|pharmacokinetics
286971|NCT02421068|Pharmacology|pharmacology
286972|NCT02421068|Fluconazole|fluconazole
286973|NCT02421068|Ibuprofen|ibuprofen
286974|NCT02421055|Bariatric Surgery|bariatric surgery
286975|NCT02421055|Gastric Bypass|gastric bypass
286976|NCT02421055|Sleeve Gastrectomy|sleeve gastrectomy
286977|NCT02421055|Gastroplasty|gastroplasty
286978|NCT02421042|Hepatic Impairment|hepatic impairment
286979|NCT02421042|Hepatic Function|hepatic function
286980|NCT02421029|gadolinium|gadolinium
286981|NCT02421029|calcium disodium ethylenediaminetetraacetic acid (EDTA)|calcium disodium ethylenediaminetetraacetic acid (edta)
286982|NCT02421029|heavy metal toxicity|heavy metal toxicity
286983|NCT02421016|De novo stenosis|de novo stenosis
751798|NCT00434291|Nemonoxacin|nemonoxacin
366672|NCT02021526|G1D|g1d
286984|NCT02421016|bioresorbable polymer coating|bioresorbable polymer coating
286985|NCT02421016|bioresorbable polymer backbone|bioresorbable polymer backbone
286986|NCT02421003|heart surgery blood|heart surgery blood
286987|NCT02420990|ADHD|adhd
286988|NCT02420990|Adolescents|adolescents
286989|NCT02420990|Substance Use Disorders|substance use disorders
286990|NCT02420977|radiotracer|radiotracer
286991|NCT02420964|injectable|injectable
286992|NCT02420964|teaching methods|teaching methods
286993|NCT02420951|Knee|knee
286994|NCT02420951|Arthroplasty|arthroplasty
286995|NCT02420951|Bupivacaine|bupivacaine
286996|NCT02420951|Anesthetics, Local|anesthetics, local
286997|NCT02420938|Leukemia|leukemia
286998|NCT02420938|Chronic Lymphocytic Leukemia|chronic lymphocytic leukemia
286999|NCT02420938|CLL|cll
287000|NCT02420938|Small Lymphocytic Lymphoma|small lymphocytic lymphoma
287001|NCT02420938|SLL|sll
287002|NCT02420938|Refractory/relapsed|refractory/relapsed
287003|NCT02420938|High-risk molecular features|high-risk molecular features
287004|NCT02420938|Rituximab|rituximab
287005|NCT02420938|Rituxan|rituxan
287006|NCT02420938|Urelumab|urelumab
287007|NCT02420925|Gastroparesis|gastroparesis
287008|NCT02420925|Celiac Plexus Block|celiac plexus block
287009|NCT02420899|IVUS|ivus
287010|NCT02420899|ACS|acs
287011|NCT02420886|In Vitro culture of human embryos|in vitro culture of human embryos
287012|NCT02420873|Leukemia|leukemia
287013|NCT02420873|Hematological malignancy|hematological malignancy
287014|NCT02420873|Myelofibrosis|myelofibrosis
287015|NCT02420873|MF|mf
287016|NCT02420873|Blastic plasmacytoid dendritic cell neoplasm|blastic plasmacytoid dendritic cell neoplasm
287017|NCT02420873|BPDCN|bpdcn
287018|NCT02420873|CD56 tumor marker|cd56 tumor marker
287019|NCT02420873|Acute myeloid leukemia|acute myeloid leukemia
287021|NCT02420873|Natural-killer leukemia|natural-killer leukemia
287022|NCT02420873|Acute lymphoblastic leukemia|acute lymphoblastic leukemia
287023|NCT02420873|ALL|all
287024|NCT02420873|CD56 expressing hematological malignancy|cd56 expressing hematological malignancy
287025|NCT02420873|IMGN901|imgn901
287026|NCT02420873|Lorvotuzumab mertansine|lorvotuzumab mertansine
287027|NCT02420847|Bladder cancer|bladder cancer
287028|NCT02420847|Urothelial cancer|urothelial cancer
287029|NCT02420847|Transitional cell carcinoma of the urothelium|transitional cell carcinoma of the urothelium
287030|NCT02420847|Metastatic|metastatic
287031|NCT02420847|Locally unresectable|locally unresectable
287032|NCT02420847|Ixazomib|ixazomib
287033|NCT02420847|Gemcitabine|gemcitabine
287034|NCT02420847|Gemcitabine hydrochloride|gemcitabine hydrochloride
287035|NCT02420847|Gemzar|gemzar
287036|NCT02420847|Doxorubicin|doxorubicin
287037|NCT02420847|Doxorubicin hydrochloride|doxorubicin hydrochloride
287039|NCT02420847|Adriamycin RDF|adriamycin rdf
287040|NCT02420847|Adriamycin|adriamycin
287041|NCT02420847|Rubex|rubex
287042|NCT02420808|CAD|cad
287043|NCT02420808|STEMI|stemi
287044|NCT02420808|non STEMI|non stemi
287045|NCT02420808|Unstable angina|unstable angina
287046|NCT02420808|Greece|greece
287047|NCT02420782|Pharmacokinetics|pharmacokinetics
287048|NCT02420782|ASP6282|asp6282
287049|NCT02420782|Pharmacodynamics|pharmacodynamics
287050|NCT02420782|Drug-drug interaction|drug-drug interaction
287051|NCT02420782|Midazolam|midazolam
287052|NCT02420782|Safety and tolerability|safety and tolerability
287053|NCT02420782|Healthy volunteers|healthy volunteers
287054|NCT02420782|Itraconazole|itraconazole
287055|NCT02420769|CA 125|ca 125
287056|NCT02420769|Progesterone|progesterone
287057|NCT02420769|Doppler|doppler
287058|NCT02420769|Corpus Luteum|corpus luteum
287059|NCT02420743|PTD|ptd
287060|NCT02420704|IVF|ivf
287061|NCT02420704|endometrial thickness|endometrial thickness
287062|NCT02420704|cleavage stage embryo|cleavage stage embryo
287063|NCT02420704|blastocyst stage embryo|blastocyst stage embryo
287064|NCT02420704|Ongoing pregnancy rate|ongoing pregnancy rate
287065|NCT02420691|Gastrointestinal cancer|gastrointestinal cancer
287066|NCT02420691|Foregut neuroendocrine tumors|foregut neuroendocrine tumors
287067|NCT02420691|NET|net
287068|NCT02420691|Thymic|thymic
287069|NCT02420691|Bronchopulmonary|bronchopulmonary
287070|NCT02420691|Gastric|gastric
287071|NCT02420691|Duodenal|duodenal
287072|NCT02420691|Pancreatic|pancreatic
287073|NCT02420691|LEE011|lee011
287074|NCT02420665|Cervical Cancer|cervical cancer
287075|NCT02420665|Cervical Dysplasia|cervical dysplasia
287076|NCT02420665|Abnormal Pap test|abnormal pap test
287077|NCT02420665|Positive human papillomavirus test|positive human papillomavirus test
287078|NCT02420665|HPV|hpv
287079|NCT02420665|Visual inspection with acetic acid|visual inspection with acetic acid
287080|NCT02420665|VIA|via
287081|NCT02420665|Colposcopy|colposcopy
287082|NCT02420665|Proflavine|proflavine
287083|NCT02420665|Acetic acid|acetic acid
287084|NCT02420665|High-Resolution Microendoscopy|high-resolution microendoscopy
287085|NCT02420665|HRME|hrme
287086|NCT02420665|Phone call|phone call
751905|NCT00433966|Angioplasty|angioplasty
366869|NCT02020382|IBD|ibd
287087|NCT02420600|Circulating tumor cells|circulating tumor cells
287088|NCT02420600|Head and neck cancer|head and neck cancer
287089|NCT02420600|PD-1|pd-1
287090|NCT02420600|natural killer cells|natural killer cells
287091|NCT02420600|cytotoxic T lymphocytes|cytotoxic t lymphocytes
287092|NCT02420587|Prostate Cancer|prostate cancer
287093|NCT02420587|Adenocarcinoma of the prostate|adenocarcinoma of the prostate
287094|NCT02420587|Castration resistant prostate cancer metastatic to bone|castration resistant prostate cancer metastatic to bone
287095|NCT02420587|mCRPC|mcrpc
287096|NCT02420587|AMG 208|amg 208
287097|NCT02420587|Questionnaire|questionnaire
287098|NCT02420587|Survey|survey
287099|NCT02420561|Depression|depression
287100|NCT02420561|Substance-Related Disorders|substance-related disorders
287101|NCT02420561|Mental Health|mental health
287102|NCT02420535|Dementia|dementia
287103|NCT02420535|Alzheimer's Disease|alzheimer's disease
287104|NCT02420535|Caregivers|caregivers
287105|NCT02420535|Behavioral|behavioral
287106|NCT02420535|Caregiver burden|caregiver burden
287107|NCT02420496|Parental nutrition|parental nutrition
287108|NCT02420496|associated|associated
287109|NCT02420470|diabetes|diabetes
287110|NCT02420470|neural and vessel alteration|neural and vessel alteration
287111|NCT02420470|prodromal stage|prodromal stage
287112|NCT02420457|Fitness devices|fitness devices
287113|NCT02420418|Tobacco use disorder and bipolar disorders|tobacco use disorder and bipolar disorders
287114|NCT02420418|N-acetylcysteine|n-acetylcysteine
287115|NCT02420418|Oxidative stress|oxidative stress
287116|NCT02420418|inflammation|inflammation
287117|NCT02420405|Gene testing|gene testing
287118|NCT02420405|Endobronchial ultrasound (EBUS)|endobronchial ultrasound (ebus)
287119|NCT02420405|Next-generation sequencing (NGS)|next-generation sequencing (ngs)
287120|NCT02420405|Small biopsies|small biopsies
287121|NCT02420379|DMD|dmd
287122|NCT02420379|Duchenne muscular dystrophy|duchenne muscular dystrophy
287123|NCT02420379|eteplirsen|eteplirsen
287124|NCT02420379|Dystrophin|dystrophin
287125|NCT02420379|exon 51|exon 51
287126|NCT02420353|muscle atrophy|muscle atrophy
287127|NCT02420353|growth hormone|growth hormone
287128|NCT02420353|ACL tear|acl tear
287129|NCT02420340|Serious Mental Illness|serious mental illness
287130|NCT02420340|Psychosocial Rehabilitation|psychosocial rehabilitation
287131|NCT02420327|nicotine|nicotine
287132|NCT02420327|galantamine|galantamine
287133|NCT02420327|attention|attention
287134|NCT02420327|cognition|cognition
287135|NCT02420327|non-smoker|non-smoker
287136|NCT02420314|Ascorbate|ascorbate
287137|NCT02420314|Ascorbic acid|ascorbic acid
287138|NCT02420314|Vitamin C|vitamin c
287139|NCT02420314|NSCLC|nsclc
287140|NCT02420314|Non Small Cell Lung Cancer|non small cell lung cancer
287141|NCT02420314|carboplatin|carboplatin
287142|NCT02420314|paclitaxel|paclitaxel
287143|NCT02420288|Pregnancy|pregnancy
287144|NCT02420288|Fetoplacental growth|fetoplacental growth
287145|NCT02420288|Physical exercise|physical exercise
287146|NCT02420288|Pregnant|pregnant
287147|NCT02420288|Placental development|placental development
287148|NCT02420288|Active pregnancy|active pregnancy
287149|NCT02420275|brain injury|brain injury
287150|NCT02420275|blue enriched withe bright light therapy|blue enriched withe bright light therapy
287151|NCT02420275|sequel fatigue|sequel fatigue
287152|NCT02420236|Exercise therapy|exercise therapy
287153|NCT02420236|Resistance training|resistance training
287154|NCT02420236|Multidisciplinary treatment|multidisciplinary treatment
287155|NCT02420223|Recipients|recipients
287156|NCT02420197|Exercise therapy|exercise therapy
287157|NCT02420197|Resistance training|resistance training
287158|NCT02420197|Multidisciplinary treatment|multidisciplinary treatment
287159|NCT02420171|In Vitro|in vitro
287160|NCT02420171|embryo quality|embryo quality
287161|NCT02420171|Intracytoplasmic sperm injection|intracytoplasmic sperm injection
287162|NCT02420158|Irritable Bowel Syndrome|irritable bowel syndrome
287163|NCT02420158|Vagal nerve stimulation|vagal nerve stimulation
287164|NCT02420158|Quality of life|quality of life
287165|NCT02420119|Iron Therapy|iron therapy
287166|NCT02420119|serum phosphates|serum phosphates
287167|NCT02420119|vitamin D|vitamin d
287168|NCT02420106|cervical dystonia|cervical dystonia
287169|NCT02420106|neck pain|neck pain
287170|NCT02420106|OMM|omm
287171|NCT02420106|spasmodic torticollis|spasmodic torticollis
287172|NCT02420067|von Hippel-Lindau disease|von hippel-lindau disease
287173|NCT02420067|Endolymphatic sac tumors|endolymphatic sac tumors
287174|NCT02420067|Audiological examination|audiological examination
287175|NCT02420067|MRI|mri
287176|NCT02420067|Surveillance|surveillance
287177|NCT02420054|intermittent fasting|intermittent fasting
287178|NCT02420054|alternate day fasting|alternate day fasting
287179|NCT02420054|diabetes mellitus|diabetes mellitus
287180|NCT02420054|non-alcoholic fatty liver disease|non-alcoholic fatty liver disease
287181|NCT02420054|insulin sensitivity|insulin sensitivity
287182|NCT02420041|Sacroiliac Joint Injection|sacroiliac joint injection
287183|NCT02420041|Fluoroscopy|fluoroscopy
287184|NCT02420041|Ultrasound|ultrasound
287185|NCT02419989|Nontuberculous Mycobacteria|nontuberculous mycobacteria
287186|NCT02419963|microbiome|microbiome
287187|NCT02419963|biomarkers|biomarkers
287188|NCT02419963|Vitamin D|vitamin d
287189|NCT02419963|Serotonin|serotonin
287190|NCT02419950|inguinal hernia|inguinal hernia
287191|NCT02419950|TEP|tep
287192|NCT02419950|chronic pain|chronic pain
287193|NCT02419950|male sex|male sex
287194|NCT02419950|mesh fixation|mesh fixation
287195|NCT02419950|quality of life|quality of life
287196|NCT02419950|national register|national register
287197|NCT02419911|gastrointestinal|gastrointestinal
287198|NCT02419911|gynecologic|gynecologic
287199|NCT02419911|urologic|urologic
287200|NCT02419911|bariatric|bariatric
287201|NCT02419911|laparoscopic surgery|laparoscopic surgery
287202|NCT02419898|Feasibility|feasibility
287203|NCT02419885|finger amputation|finger amputation
287204|NCT02419885|composite graft|composite graft
287205|NCT02419885|adipo-fascia flap|adipo-fascia flap
287206|NCT02419859|Diabetes Mellitus|diabetes mellitus
287207|NCT02419859|Diabetes Mellitus, Type 2|diabetes mellitus, type 2
287208|NCT02419859|Glucose Metabolism Disorders|glucose metabolism disorders
287209|NCT02419859|Metabolic Diseases|metabolic diseases
287210|NCT02419859|Endocrine System Diseases|endocrine system diseases
287211|NCT02419859|Insulin|insulin
287212|NCT02419859|Continuous subcutaneous insulin infusion (CSII)|continuous subcutaneous insulin infusion (csii)
287213|NCT02419859|Insulin pumps|insulin pumps
287214|NCT02419846|Informed Decision Making|informed decision making
287215|NCT02419846|Prostate|prostate
287216|NCT02419846|Cancer|cancer
287217|NCT02419833|non-STEMI|non-stemi
287218|NCT02419833|immediate|immediate
287219|NCT02419833|delayed|delayed
287220|NCT02419833|PCI|pci
287221|NCT02419807|Near Infrared Fluorescence Imaging|near infrared fluorescence imaging
287222|NCT02419807|Indocyanine Green|indocyanine green
287223|NCT02419807|axillary lymph node mapping|axillary lymph node mapping
287224|NCT02419807|Mastectomy, Segmental|mastectomy, segmental
287225|NCT02419807|Sentinel Lymph Node Biopsy|sentinel lymph node biopsy
287226|NCT02419807|Lumpectomy|lumpectomy
287227|NCT02419768|Long-range autocorrelations|long-range autocorrelations
287228|NCT02419768|Variability|variability
287229|NCT02419768|Physical Exercise|physical exercise
287230|NCT02419768|Parkinson's Disease|parkinson's disease
287231|NCT02419768|ICF|icf
287232|NCT02419755|Infant leukemia|infant leukemia
287233|NCT02419755|ALL|all
287234|NCT02419755|AML|aml
287235|NCT02419755|Biphenotypic leukemia|biphenotypic leukemia
287236|NCT02419755|Pediatric|pediatric
287237|NCT02419729|Vulvovaginal atrophy|vulvovaginal atrophy
287238|NCT02419729|Menopause|menopause
287239|NCT02419729|Fractional CO2 laser|fractional co2 laser
287240|NCT02419729|Estrogen cream|estrogen cream
287241|NCT02419716|colorectal cancer|colorectal cancer
287242|NCT02419716|Colorectal cancer screening|colorectal cancer screening
287346|NCT02419235|Homoeopathy|homoeopathy
287243|NCT02419677|radiofrequency ablation|radiofrequency ablation
287244|NCT02419677|cytokine-induced killer cells|cytokine-induced killer cells
287245|NCT02419677|colorectal cancer iver metastases|colorectal cancer iver metastases
287246|NCT02419664|pituitary|pituitary
287247|NCT02419664|pituitary adenomas|pituitary adenomas
287248|NCT02419664|Ga-PET|ga-pet
287249|NCT02419664|Acromegaly|acromegaly
287250|NCT02419664|TSHomas|tshomas
287251|NCT02419664|Cushing|cushing
287252|NCT02419651|out patient hysteroscopy|out patient hysteroscopy
287253|NCT02419638|relapsing-remitting MS|relapsing-remitting ms
287254|NCT02419638|lesions|lesions
287255|NCT02419638|treatment|treatment
287256|NCT02419573|cardiac arrest|cardiac arrest
287257|NCT02419573|cardiopulmonary resuscitation|cardiopulmonary resuscitation
287258|NCT02419573|laryngeal tube|laryngeal tube
287259|NCT02419573|endotracheal intubation|endotracheal intubation
287260|NCT02419573|non-traumatic Out of Hospital Cardiac Arrest (OOHCA)|non-traumatic out of hospital cardiac arrest (oohca)
287261|NCT02419560|Relapsed|relapsed
287262|NCT02419560|Laboratory biomarker research|laboratory biomarker research
287263|NCT02419560|Pharmacologic study|pharmacologic study
287264|NCT02419560|Bruton's tyrosine kinase inhibitor|bruton's tyrosine kinase inhibitor
287265|NCT02419560|BCL-2 inhibitor|bcl-2 inhibitor
287266|NCT02419547|Ventricular tachycardia|ventricular tachycardia
287267|NCT02419547|ventricular tachycardia ablation|ventricular tachycardia ablation
287268|NCT02419547|effects of anesthesia on VT induction|effects of anesthesia on vt induction
287269|NCT02419547|programed stimulation|programed stimulation
287270|NCT02419534|Pediatric, fissure in ano|pediatric, fissure in ano
287271|NCT02419482|Exercise therapy|exercise therapy
287272|NCT02419482|Reproductive Physiological Processes|reproductive physiological processes
287273|NCT02419482|Fertility|fertility
287274|NCT02419469|Leukemia|leukemia
287275|NCT02419469|Precursor-B acute lymphoblastic leukemia|precursor-b acute lymphoblastic leukemia
287277|NCT02419469|Lymphoblastic lymphoma|lymphoblastic lymphoma
287278|NCT02419469|LL|ll
287279|NCT02419469|Lymphoma|lymphoma
367044|NCT02019615|stroke|stroke
287280|NCT02419469|Cytarabine|cytarabine
287281|NCT02419469|Ara-C|ara-c
287282|NCT02419469|Cytosar|cytosar
287283|NCT02419469|DepoCyt|depocyt
287284|NCT02419469|Cytosine Arabinosine Hydrochloride|cytosine arabinosine hydrochloride
287285|NCT02419469|Daunorubicin|daunorubicin
287286|NCT02419469|Daunorubicin Hydrochloride|daunorubicin hydrochloride
287287|NCT02419469|Cerubidine|cerubidine
287288|NCT02419469|Daunomycin|daunomycin
287289|NCT02419469|DNR|dnr
287290|NCT02419469|Vincristine|vincristine
287291|NCT02419469|Prednisone|prednisone
287292|NCT02419469|PEG asparaginase|peg asparaginase
287293|NCT02419469|Pegaspargase|pegaspargase
287294|NCT02419469|Oncaspar|oncaspar
287295|NCT02419469|Polyethylene glycol conjugated lasparaginase-H|polyethylene glycol conjugated lasparaginase-h
287296|NCT02419469|Ofatumumab|ofatumumab
287297|NCT02419469|Arzerra|arzerra
287298|NCT02419469|Rituximab|rituximab
287299|NCT02419469|Rituxan|rituxan
287300|NCT02419469|Methotrexate|methotrexate
287301|NCT02419469|Cyclophosphamide|cyclophosphamide
287302|NCT02419469|Cytoxan|cytoxan
287303|NCT02419469|Neosar|neosar
287304|NCT02419469|Mercaptopurine|mercaptopurine
287305|NCT02419469|6-mercaptopurine|6-mercaptopurine
287306|NCT02419469|Purinethol|purinethol
287307|NCT02419469|6-MP|6-mp
287308|NCT02419469|Doxorubicin|doxorubicin
287309|NCT02419469|Doxorubicin hydrochloride|doxorubicin hydrochloride
287310|NCT02419469|Adriamycin PFS|adriamycin pfs
287311|NCT02419469|Adriamycin RDF|adriamycin rdf
287312|NCT02419469|Adriamycin|adriamycin
287313|NCT02419469|Rubex|rubex
287314|NCT02419469|Dexamethasone|dexamethasone
287315|NCT02419469|Decadron|decadron
287316|NCT02419469|Thioguanine|thioguanine
287317|NCT02419469|6-thioguanine|6-thioguanine
287318|NCT02419443|inguinal hernia repair, chronic pain|inguinal hernia repair, chronic pain
287319|NCT02419430|well-being|well-being
287320|NCT02419430|stress|stress
287321|NCT02419430|resilience|resilience
287322|NCT02419430|self-compassion|self-compassion
287323|NCT02419391|RSV Vaccines|rsv vaccines
287324|NCT02419391|Respiratory Syncytial Virus Vaccines|respiratory syncytial virus vaccines
287325|NCT02419365|Primary Ciliary Dyskinesia (PCD)|primary ciliary dyskinesia (pcd)
287326|NCT02419352|Cognitive function|cognitive function
287327|NCT02419326|couples|couples
287328|NCT02419326|relationships|relationships
287329|NCT02419326|binge eating|binge eating
287330|NCT02419326|eating disorder|eating disorder
287331|NCT02419326|couple therapy|couple therapy
287332|NCT02419313|Tremor|tremor
287333|NCT02419313|Parkinson|parkinson
287334|NCT02419313|botulinum|botulinum
287335|NCT02419313|Xeomin|xeomin
287336|NCT02419287|ALK|alk
287337|NCT02419287|crizotinib|crizotinib
287338|NCT02419274|asthma|asthma
287339|NCT02419274|phenotype|phenotype
287340|NCT02419274|childhood|childhood
287341|NCT02419274|adulthood|adulthood
287342|NCT02419261|knee surgery|knee surgery
287343|NCT02419261|anterior cruciate ligament surgery|anterior cruciate ligament surgery
287344|NCT02419261|nerve block|nerve block
287345|NCT02419235|Refractory hypertension|refractory hypertension
287347|NCT02419235|Homoeopathic complex|homoeopathic complex
287348|NCT02419235|Amylenum nitrosum 6cH|amylenum nitrosum 6ch
287349|NCT02419235|Crataegus oxyacantha 6cH|crataegus oxyacantha 6ch
287350|NCT02419235|Natrum muriaticum 6cH|natrum muriaticum 6ch
287351|NCT02419235|Scutellaria lateriflora 6cH|scutellaria lateriflora 6ch
287352|NCT02419209|Low sexual desire|low sexual desire
287353|NCT02419209|Perimenopause|perimenopause
287354|NCT02419209|Homeopathy|homeopathy
287355|NCT02419209|Hypoactive Sexual Desire Disorder|hypoactive sexual desire disorder
287356|NCT02419183|Mild Cognitive Impairment|mild cognitive impairment
287357|NCT02419183|Self-Administered Memory Screening Test With Automated Reporting (SAMSTAR)|self-administered memory screening test with automated reporting (samstar)
287358|NCT02419183|Rey Auditory Verbal Learning Test (RAVLT)|rey auditory verbal learning test (ravlt)
287359|NCT02419183|Word List Recall (WLR)|word list recall (wlr)
287360|NCT02419157|Cervical lesions|cervical lesions
287361|NCT02419157|Clinical trial|clinical trial
287362|NCT02419157|Self-etch adhesive|self-etch adhesive
287363|NCT02419144|older adults;|older adults;
287364|NCT02419144|oral hygiene;|oral hygiene;
287365|NCT02419144|adapted motivational interviewing|adapted motivational interviewing
287366|NCT02419118|Myeloma|myeloma
287367|NCT02419118|monoclonal antibody|monoclonal antibody
287368|NCT02419118|Daratumumab|daratumumab
287369|NCT02419105|Falls|falls
287370|NCT02419105|hypogonadal men|hypogonadal men
287371|NCT02419105|Seniors|seniors
287372|NCT02419105|Testosterone|testosterone
287373|NCT02419105|Colecalciferol|colecalciferol
287374|NCT02419092|Inflammation|inflammation
287375|NCT02419092|Insulin resistance|insulin resistance
287376|NCT02419092|Bariatric surgery|bariatric surgery
287377|NCT02419053|Surgical safety checklist|surgical safety checklist
287378|NCT02419053|perioperative complications|perioperative complications
287379|NCT02419053|pediatric|pediatric
287380|NCT02419040|shoulder pain|shoulder pain
287381|NCT02419040|rotator cuff|rotator cuff
287382|NCT02419040|calcific tendonitis|calcific tendonitis
287383|NCT02419040|barbotage|barbotage
287384|NCT02419027|GI Flora|gi flora
287385|NCT02419014|cranial electrotherapy|cranial electrotherapy
287386|NCT02419014|cranial electrical stimulation|cranial electrical stimulation
287387|NCT02419014|restless legs syndrome|restless legs syndrome
287388|NCT02418962|PfSPZ Vaccine|pfspz vaccine
287389|NCT02418949|hand|hand
287390|NCT02418949|rehabilitation|rehabilitation
287391|NCT02418949|active movement training|active movement training
287392|NCT02418949|passive cyclical stretching|passive cyclical stretching
287393|NCT02418936|Waardenburg syndrome|waardenburg syndrome
287394|NCT02418936|Large vestibular aqueduct syndrome|large vestibular aqueduct syndrome
287395|NCT02418936|Diagnosis|diagnosis
287396|NCT02418936|copy number variation|copy number variation
287397|NCT02418936|Multiplex polymerase chain reaction|multiplex polymerase chain reaction
287398|NCT02418910|bipolar|bipolar
287399|NCT02418910|self assessment|self assessment
287400|NCT02418910|prospective randomized trial|prospective randomized trial
287401|NCT02418897|Fatigue|fatigue
287402|NCT02418897|multiple sclerosis|multiple sclerosis
287403|NCT02418897|neuromuscular junction|neuromuscular junction
287404|NCT02418897|SFEMG|sfemg
287405|NCT02418871|cataract|cataract
287406|NCT02418871|presbyopia|presbyopia
287407|NCT02418858|Essential tremor|essential tremor
287408|NCT02418858|DBS|dbs
287409|NCT02418832|Azoospermia|azoospermia
287410|NCT02418832|Rete Testis|rete testis
287411|NCT02418832|TEFNA|tefna
287412|NCT02418806|Family Caregivers|family caregivers
287413|NCT02418806|Psychotherapy Group|psychotherapy group
287414|NCT02418793|Hemophilia|hemophilia
287415|NCT02418793|Factor VII|factor vii
287416|NCT02418793|Factor VIIa|factor viia
287417|NCT02418793|Inhibitors|inhibitors
287418|NCT02418793|Long Acting|long acting
287419|NCT02418728|obesity|obesity
287420|NCT02418728|adipose tissue lipolysis|adipose tissue lipolysis
287421|NCT02418728|lipolysis|lipolysis
287422|NCT02418728|microdialysis|microdialysis
287423|NCT02418728|atrial natriuretic peptide|atrial natriuretic peptide
287424|NCT02418702|depression|depression
287425|NCT02418702|suicide|suicide
287426|NCT02418702|ketamine|ketamine
287427|NCT02418702|rapid intravenous bolus|rapid intravenous bolus
287428|NCT02418702|sub-anesthetic dose|sub-anesthetic dose
287429|NCT02418702|double-blind placebo control|double-blind placebo control
287430|NCT02418676|Human insulin|human insulin
287431|NCT02418676|Hydroxypropyl-beta-cyclodextrin|hydroxypropyl-beta-cyclodextrin
287432|NCT02418676|Pressure Ulcer|pressure ulcer
287433|NCT02418676|Wound Healing|wound healing
287434|NCT02418676|Gel|gel
287435|NCT02418663|fluid responsiveness|fluid responsiveness
287436|NCT02418663|enhanced recovery program|enhanced recovery program
287437|NCT02418650|volunteers|volunteers
287438|NCT02418637|worksite|worksite
287439|NCT02418637|screen|screen
287440|NCT02418637|migrant|migrant
287441|NCT02418637|agricultural|agricultural
287442|NCT02418637|worker|worker
287443|NCT02418637|hypertension|hypertension
287444|NCT02418637|Hyperlipidemia|hyperlipidemia
287445|NCT02418637|diabetes|diabetes
287446|NCT02418637|feasibility|feasibility
287447|NCT02418624|breast cancer 1, early onset (BRCA1)|breast cancer 1, early onset (brca1)
287448|NCT02418624|breast cancer 2, early onset (BRCA2)|breast cancer 2, early onset (brca2)
287449|NCT02418624|homologous recombination deficiency|homologous recombination deficiency
287450|NCT02418624|carboplatin|carboplatin
287451|NCT02418624|olaparib|olaparib
287452|NCT02418598|Adeno-associated virus|adeno-associated virus
287453|NCT02418598|Aromatic L-amino acid decarboxylase|aromatic l-amino acid decarboxylase
287454|NCT02418598|AAV-hAADC-2|aav-haadc-2
287455|NCT02418598|AAV-2|aav-2
287456|NCT02418598|Gene Therapy|gene therapy
287457|NCT02418598|Gene Transfer|gene transfer
287458|NCT02418598|Parkinson Disease|parkinson disease
287459|NCT02418598|Basal Ganglia Disease|basal ganglia disease
287460|NCT02418598|Brain Disease|brain disease
287461|NCT02418585|Treatment-resistant Depression|treatment-resistant depression
287462|NCT02418585|Esketamine|esketamine
287463|NCT02418585|Placebo|placebo
287464|NCT02418585|Oral Antidepressant|oral antidepressant
287465|NCT02418559|Healthy|healthy
287466|NCT02418559|JNJ-63623872|jnj-63623872
287467|NCT02418559|Japanese Adult Participants|japanese adult participants
287468|NCT02418533|infertility|infertility
287469|NCT02418533|in vitro fertilization|in vitro fertilization
287470|NCT02418533|fertility|fertility
287471|NCT02418533|preimplantation genetic screening|preimplantation genetic screening
287472|NCT02418533|embryo|embryo
287473|NCT02418533|PGS|pgs
287474|NCT02418533|Eeva|eeva
287475|NCT02418533|IVF|ivf
287476|NCT02418481|γδ T Cell|γδ t cell
287477|NCT02418481|breast cancer|breast cancer
287478|NCT02418481|her2-|her2-
287479|NCT02418481|er-|er-
287480|NCT02418481|pr-|pr-
287481|NCT02418468|COPD, FEV1, indacaterol|copd, fev1, indacaterol
287482|NCT02418455|MPS 7|mps 7
287483|NCT02418455|Sly Syndrome|sly syndrome
287484|NCT02418455|MPS VII|mps vii
287485|NCT02418455|Enzyme Replacement Therapy|enzyme replacement therapy
287486|NCT02418455|Rare Disease|rare disease
287487|NCT02418455|Mucopolysaccharidosis type 7|mucopolysaccharidosis type 7
287488|NCT02418455|Lysosomal Storage Disease|lysosomal storage disease
287489|NCT02418455|Metabolic Disorder|metabolic disorder
287490|NCT02418442|Systemic Arthritis|systemic arthritis
287491|NCT02418442|Oligoarthritis|oligoarthritis
287492|NCT02418442|Polyarthritis (Rheumatoid Factor Negative)|polyarthritis (rheumatoid factor negative)
287493|NCT02418442|Polyarthritis (Rheumatoid Factor Positive)|polyarthritis (rheumatoid factor positive)
287494|NCT02418442|Psoriatic Arthritis|psoriatic arthritis
287495|NCT02418442|Enthesitis Related Arthritis (ERA)|enthesitis related arthritis (era)
287496|NCT02418442|Undifferianted Arthritis|undifferianted arthritis
287497|NCT02418442|CARRA Consensus Treatment Plans|carra consensus treatment plans
287498|NCT02418442|FROST|frost
287499|NCT02418429|fat oxidation|fat oxidation
287500|NCT02418429|hunger|hunger
287501|NCT02418429|resistant starch|resistant starch
287502|NCT02418429|whey protein|whey protein
287503|NCT02418377|Obesity|obesity
287504|NCT02418377|Genetics|genetics
287505|NCT02418377|Whole exome sequencing|whole exome sequencing
287506|NCT02418377|Children|children
287507|NCT02418325|RRMS|rrms
287508|NCT02418312|histamine-2 receptor antagonist|histamine-2 receptor antagonist
287509|NCT02418312|peptic ulcer|peptic ulcer
287510|NCT02418312|thienopyridine|thienopyridine
287511|NCT02418312|prevention|prevention
287512|NCT02418299|urinary incontinence|urinary incontinence
287513|NCT02418299|Er:YAG laser|er:yag laser
287514|NCT02418286|Low Back Pain|low back pain
287515|NCT02418286|Korean Rehabilitation Clinic|korean rehabilitation clinic
287516|NCT02418286|Patient Registry|patient registry
287517|NCT02418273|denosumab|denosumab
287518|NCT02418273|pediatric|pediatric
287519|NCT02418273|rheumatology|rheumatology
287520|NCT02418273|osteoporosis|osteoporosis
287521|NCT02418273|glucocorticoid|glucocorticoid
287522|NCT02418260|Humerus|humerus
287523|NCT02418260|shaft|shaft
287524|NCT02418260|diaphyseal|diaphyseal
287525|NCT02418260|fractures|fractures
287526|NCT02418247|radioactive iodine therapy|radioactive iodine therapy
287527|NCT02418247|ablation|ablation
287528|NCT02418247|thyroid cancer|thyroid cancer
287529|NCT02418234|Non-small Cell Lung Cancer|non-small cell lung cancer
287530|NCT02418234|circulating tumor DNA|circulating tumor dna
287531|NCT02418234|T790M|t790m
287532|NCT02418234|amplification refractory mutation system|amplification refractory mutation system
287533|NCT02418234|digital droplet PCR|digital droplet pcr
287534|NCT02418221|histamine, biogenic amines, diamine oxidase|histamine, biogenic amines, diamine oxidase
287535|NCT02418195|Depression|depression
287536|NCT02418195|Ketamine|ketamine
287537|NCT02418195|Suicide Attempt|suicide attempt
287538|NCT02418195|Suicidal Ideation|suicidal ideation
287539|NCT02418195|Suicidality|suicidality
287540|NCT02418182|Analgesic|analgesic
287541|NCT02418182|Pain Control|pain control
287543|NCT02418182|Tylenol|tylenol
287544|NCT02418182|Acetaminophen|acetaminophen
287545|NCT02418182|Egg Retrieval|egg retrieval
287546|NCT02418182|iv vitro Fertilization|iv vitro fertilization
287547|NCT02418117|Stereolitographic guide|stereolitographic guide
287649|NCT02417467|E-cigarette|e-cigarette
287548|NCT02418117|flapless surgery|flapless surgery
287549|NCT02418117|dental implants|dental implants
287550|NCT02418091|patients with moderate DKD and uncontrolled HTN|patients with moderate dkd and uncontrolled htn
287551|NCT02418065|Physical exercises|physical exercises
287552|NCT02418065|Oral nutritional supplementation|oral nutritional supplementation
287553|NCT02418065|Multimodal|multimodal
287554|NCT02418065|Hemodialysis|hemodialysis
287555|NCT02418065|Protein-Energy Wasting|protein-energy wasting
287556|NCT02418052|esophageal cancer|esophageal cancer
287557|NCT02418052|minimally invasive esophagectomy|minimally invasive esophagectomy
287558|NCT02418052|anastomotic leak|anastomotic leak
287559|NCT02418052|neck flexion|neck flexion
287560|NCT02418039|Minimal hepatic encephalopathy|minimal hepatic encephalopathy
287561|NCT02418039|Nutrition|nutrition
287562|NCT02418013|Frailty|frailty
287563|NCT02418013|Umbilical cord blood|umbilical cord blood
287564|NCT02418013|Plasma|plasma
287565|NCT02418013|Randomized trial|randomized trial
287566|NCT02418013|Double-blinded trial|double-blinded trial
287567|NCT02418013|Placebo-controlled trial|placebo-controlled trial
287568|NCT02417974|Prevention|prevention
287569|NCT02417974|Recurrence|recurrence
287570|NCT02417974|Fecal Microbiota Therapy|fecal microbiota therapy
287571|NCT02417961|Asthma,|asthma,
287572|NCT02417961|Bronchial Diseases,|bronchial diseases,
287573|NCT02417961|Respiratory Tract Diseases,|respiratory tract diseases,
287574|NCT02417961|Lung Diseases,|lung diseases,
287575|NCT02417961|Obstructive Lung Diseases,|obstructive lung diseases,
287576|NCT02417961|Benralizumab|benralizumab
287577|NCT02417909|Obesity|obesity
287578|NCT02417909|quality of life|quality of life
287579|NCT02417909|teenagers|teenagers
287580|NCT02417909|psychological impact|psychological impact
287581|NCT02417896|Acute kidney injury|acute kidney injury
287582|NCT02417896|Spironolactone|spironolactone
287583|NCT02417883|Furosemide|furosemide
287584|NCT02417883|Interstitial Fibrosis|interstitial fibrosis
287585|NCT02417870|Transplantation|transplantation
287586|NCT02417870|interleukin-2|interleukin-2
287587|NCT02417870|IL-2|il-2
287588|NCT02417870|Kidney|kidney
287589|NCT02417870|Renal|renal
287590|NCT02417857|Single İncision Laparoscopic Surgery|single incision laparoscopic surgery
287591|NCT02417857|Conventional Laparoscopic Surgery|conventional laparoscopic surgery
287592|NCT02417792|psoriasis|psoriasis
287593|NCT02417792|microbiota|microbiota
287594|NCT02417766|Genetic Testing|genetic testing
287595|NCT02417766|Secondary Findings|secondary findings
287596|NCT02417766|Immune-Mediated Disorders|immune-mediated disorders
287597|NCT02417766|Whole Exome Sequencing|whole exome sequencing
287598|NCT02417753|PARACENTESIS|paracentesis
287599|NCT02417753|STAT3 Antisense Oligonucleotide|stat3 antisense oligonucleotide
287600|NCT02417753|Ascites|ascites
287601|NCT02417753|AZD9150|azd9150
287602|NCT02417753|Surgical Resection|surgical resection
287603|NCT02417740|Portal Hypertension|portal hypertension
287604|NCT02417740|Portal Fibrosis|portal fibrosis
287605|NCT02417740|Liver Disease|liver disease
287606|NCT02417740|Varices|varices
287607|NCT02417740|Splenomegaly|splenomegaly
287608|NCT02417727|MEMORY TESTING|memory testing
287609|NCT02417727|Biomarkers|biomarkers
287610|NCT02417727|Learning|learning
287611|NCT02417714|Computed Tomography|computed tomography
287612|NCT02417714|Radiation Reduction|radiation reduction
287613|NCT02417714|Iterative Reconstruction|iterative reconstruction
287614|NCT02417688|carotid atherosclerosis, PET imaging agent|carotid atherosclerosis, pet imaging agent
287615|NCT02417675|Option B+|option b+
287616|NCT02417675|Adherence Club|adherence club
287617|NCT02417675|Postpartum|postpartum
287618|NCT02417675|Breastfeeding|breastfeeding
287619|NCT02417675|Mother-to-child transmission|mother-to-child transmission
287620|NCT02417662|NSCLC|nsclc
287621|NCT02417662|Stereotactic Ablative Radiotherapy|stereotactic ablative radiotherapy
287622|NCT02417662|Radiotherapy|radiotherapy
287623|NCT02417662|Randomised|randomised
287624|NCT02417662|Controlled|controlled
287625|NCT02417662|Oligometastatic|oligometastatic
287626|NCT02417610|Polynucleotide|polynucleotide
287627|NCT02417610|Hyaluronic acid|hyaluronic acid
287628|NCT02417610|Intra articular injection|intra articular injection
287629|NCT02417597|hepatitis E|hepatitis e
287630|NCT02417571|Chronic kidney disease|chronic kidney disease
287631|NCT02417571|Blood pressure|blood pressure
287632|NCT02417571|ambulatory blood pressure|ambulatory blood pressure
287633|NCT02417571|glomerular filtration rate|glomerular filtration rate
287634|NCT02417519|Coffee|coffee
287635|NCT02417519|Chlorogenic acid|chlorogenic acid
287636|NCT02417519|Insulin|insulin
287637|NCT02417519|Appetite|appetite
287638|NCT02417519|Metabolomics|metabolomics
287639|NCT02417506|Acute pain|acute pain
287640|NCT02417506|Herbal|herbal
287641|NCT02417506|VAS|vas
287642|NCT02417506|Stop watch|stop watch
287643|NCT02417493|Food allergy|food allergy
287644|NCT02417493|self-management|self-management
287645|NCT02417493|epinephrine self-injection|epinephrine self-injection
287646|NCT02417493|ntervention|ntervention
287647|NCT02417493|adolescents|adolescents
287648|NCT02417467|Electronic cigarette|electronic cigarette
287650|NCT02417467|Smoking cessation|smoking cessation
287651|NCT02417454|probiotic|probiotic
287652|NCT02417454|stress|stress
287653|NCT02417454|emotion psychophysiology|emotion psychophysiology
287654|NCT02417454|brain-body-gut interactions|brain-body-gut interactions
287655|NCT02417441|TiLE|tile
287656|NCT02417441|Embryo Assessment|embryo assessment
287657|NCT02417441|Pregnancy|pregnancy
287658|NCT02417441|Implantation|implantation
287659|NCT02417428|Muscle function|muscle function
287660|NCT02417428|Functional capacity|functional capacity
287661|NCT02417415|Supine hypertension|supine hypertension
287662|NCT02417415|Autonomic failure|autonomic failure
287663|NCT02417415|Heat intolerance|heat intolerance
287664|NCT02417415|Orthostatic hypotension|orthostatic hypotension
287665|NCT02417415|Heat stress|heat stress
287666|NCT02417402|back pain|back pain
287667|NCT02417402|low back pain|low back pain
287668|NCT02417402|chronic low back pain|chronic low back pain
287669|NCT02417389|primary hyperparathyroidism|primary hyperparathyroidism
287670|NCT02417389|hypercalcemia|hypercalcemia
287671|NCT02417389|osteoporosis|osteoporosis
287672|NCT02417389|bone turnover|bone turnover
287673|NCT02417389|bone mineral density|bone mineral density
287674|NCT02417389|fractures|fractures
287675|NCT02417376|Coronary heart disease|coronary heart disease
287676|NCT02417376|Periodontitis|periodontitis
287677|NCT02417376|C-reactive protein|c-reactive protein
287678|NCT02417376|Blood pressure|blood pressure
287679|NCT02417363|biomarkers|biomarkers
287680|NCT02417363|renal disease|renal disease
287681|NCT02417363|periodontitis|periodontitis
287682|NCT02417324|medulloblastoma|medulloblastoma
287683|NCT02417324|ependymoma|ependymoma
367608|NCT02017067|RFD|rfd
287684|NCT02417324|pineoblastoma|pineoblastoma
287685|NCT02417324|CNS-PNET|cns-pnet
287686|NCT02417311|Engineered Heart Tissue (EHT)|engineered heart tissue (eht)
287687|NCT02417311|human induced pluripotent stem cells (hiPSC)|human induced pluripotent stem cells (hipsc)
287688|NCT02417298|ketamine|ketamine
287689|NCT02417298|pain|pain
287690|NCT02417298|sickle cell disorder|sickle cell disorder
287691|NCT02417285|Non-Hodgkin's Lymphoma|non-hodgkin's lymphoma
287692|NCT02417285|Diffused Large B-Cell Lymphoma|diffused large b-cell lymphoma
287693|NCT02417285|Phase 1B|phase 1b
287694|NCT02417285|Open-Label|open-label
287695|NCT02417285|Safety and Efficacy|safety and efficacy
287696|NCT02417285|CC-122|cc-122
287697|NCT02417285|Obinutuzumab|obinutuzumab
287698|NCT02417285|GA101|ga101
287699|NCT02417285|Relapsed|relapsed
287700|NCT02417285|Refractory|refractory
287701|NCT02417272|Total Disc Replacement|total disc replacement
287702|NCT02417272|Anterior Cervical Decompression and Fusion|anterior cervical decompression and fusion
287703|NCT02417259|Spectroscopy, Near-Infrared|spectroscopy, near-infrared
287704|NCT02417246|pharmacokinetics|pharmacokinetics
287705|NCT02417246|pharmacodynamics|pharmacodynamics
287706|NCT02417246|pharmacogenetics|pharmacogenetics
287707|NCT02417233|HIV-positive|hiv-positive
287708|NCT02417233|adherence|adherence
287709|NCT02417233|engagement to care|engagement to care
287710|NCT02417233|mobile Health (mHealth)|mobile health (mhealth)
287712|NCT02417233|peer navigation|peer navigation
287713|NCT02417233|retention|retention
287714|NCT02417207|hepatitis B immune globulin (HBIG)|hepatitis b immune globulin (hbig)
287715|NCT02417207|liver transplantation|liver transplantation
287716|NCT02417207|hepatitis B|hepatitis b
287717|NCT02417207|entecavir|entecavir
287718|NCT02417194|Renal cell carcinoma|renal cell carcinoma
287719|NCT02417194|hemoglobin A1c protein|hemoglobin a1c protein
287720|NCT02417194|Pathologic outcomes|pathologic outcomes
287721|NCT02417194|Oncological outcomes|oncological outcomes
287722|NCT02417194|Nephrectomy|nephrectomy
287723|NCT02417181|Physician assistants|physician assistants
287724|NCT02417181|Out-of-hours medical care|out-of-hours medical care
287725|NCT02417181|Primary healthcare|primary healthcare
287726|NCT02417181|Emergency Medical Services|emergency medical services
287727|NCT02417155|Autonomic Nerve System|autonomic nerve system
287728|NCT02417155|Epinephrin|epinephrin
287729|NCT02417155|Hyperventilation|hyperventilation
287730|NCT02417155|Hypoventilation|hypoventilation
287731|NCT02417064|Treatment-resistant Depression|treatment-resistant depression
287732|NCT02417064|Esketamine|esketamine
287733|NCT02417064|Placebo|placebo
287734|NCT02417064|Oral Antidepressant|oral antidepressant
287735|NCT02417051|Psychological Resilience|psychological resilience
287736|NCT02417051|Perceived Stress|perceived stress
287737|NCT02417051|Psychological Stress|psychological stress
287738|NCT02417051|Disaster Worker|disaster worker
287739|NCT02417051|Superstorm Sandy|superstorm sandy
287740|NCT02417051|Mental Health|mental health
287741|NCT02417051|Prevention|prevention
287742|NCT02417038|Postoperative Respiratory Monitoring|postoperative respiratory monitoring
287743|NCT02417038|Neuraxial Opioid Administration for Cesarean Delivery|neuraxial opioid administration for cesarean delivery
287744|NCT02417025|Military|military
287745|NCT02417025|Health Service Delivery|health service delivery
287746|NCT02417025|Telepsychology|telepsychology
287747|NCT02417025|Prolonged Exposure|prolonged exposure
287748|NCT02417025|Off-duty Activity of Military Personnel|off-duty activity of military personnel
287749|NCT02417012|lifestyle|lifestyle
287750|NCT02417012|exercise|exercise
287751|NCT02417012|physical activity|physical activity
287753|NCT02417012|glycemic control|glycemic control
287754|NCT02417012|hba1c|hba1c
287755|NCT02417012|glucose lowering drugs|glucose lowering drugs
287756|NCT02416999|glioma|glioma
287757|NCT02416999|high-grade glioma|high-grade glioma
287758|NCT02416960|female infertility|female infertility
287759|NCT02416960|glycemic index|glycemic index
287760|NCT02416960|leptin|leptin
287761|NCT02416960|ghrelin|ghrelin
287762|NCT02416960|overweight|overweight
287763|NCT02416960|obesity|obesity
287764|NCT02416960|in vitro fertilization|in vitro fertilization
287765|NCT02416947|Soluble Corn Fiber|soluble corn fiber
287766|NCT02416947|Osteoporosis|osteoporosis
287767|NCT02416947|Bone Loss|bone loss
287768|NCT02416921|Facebook|facebook
287769|NCT02416921|Weight Gain Prevention|weight gain prevention
287770|NCT02416921|Women's Health|women's health
287771|NCT02416921|Online|online
287772|NCT02416921|Weight Gain|weight gain
287773|NCT02416921|Weight Loss|weight loss
287774|NCT02416921|Female Contraception|female contraception
287775|NCT02416921|Obesity|obesity
287776|NCT02416921|Body Weight|body weight
287777|NCT02416921|Internet|internet
287778|NCT02416882|active|active
287779|NCT02416882|not active|not active
287780|NCT02416882|normal body weight|normal body weight
287781|NCT02416869|Dexamethasone|dexamethasone
287782|NCT02416869|Lower third molar surgery|lower third molar surgery
287783|NCT02416856|Aphasia|aphasia
287784|NCT02416856|Brain|brain
287785|NCT02416856|Stimulation|stimulation
287786|NCT02416856|Communication|communication
287787|NCT02416856|Stroke|stroke
287788|NCT02416856|Speech Disorders|speech disorders
287789|NCT02416856|Communications Disorders|communications disorders
287790|NCT02416856|Neurobehavioral Manifestations|neurobehavioral manifestations
287791|NCT02416856|Neurologic Manifestations|neurologic manifestations
287792|NCT02416856|Nervous System Diseases|nervous system diseases
287793|NCT02416856|Signs and Symptoms|signs and symptoms
287794|NCT02416843|Adipose tissue|adipose tissue
287795|NCT02416843|metabolism|metabolism
287796|NCT02416843|inflammation|inflammation
287797|NCT02416843|post-prandial|post-prandial
287798|NCT02416843|human|human
287799|NCT02416830|embolization|embolization
287800|NCT02416830|visceral Aneurysms|visceral aneurysms
287801|NCT02416830|Prospective Registry|prospective registry
287802|NCT02416817|Thrombelastography|thrombelastography
287803|NCT02416817|Massive Transfusion|massive transfusion
287804|NCT02416817|Major Trauma|major trauma
287805|NCT02416817|Blood products|blood products
287806|NCT02416817|Thromboelastometry|thromboelastometry
287807|NCT02416804|buprenorphine|buprenorphine
287808|NCT02416804|transdermal system|transdermal system
287809|NCT02416804|Pain, postoperative|pain, postoperative
287810|NCT02416804|Quality of life|quality of life
287811|NCT02416804|Spinal stenosis|spinal stenosis
287812|NCT02416804|Posterior lumbar fusion|posterior lumbar fusion
287813|NCT02416791|robotic therapy|robotic therapy
287814|NCT02416791|transcranial direct current stimulation|transcranial direct current stimulation
287815|NCT02416778|COPD|copd
287816|NCT02416778|Chronic Obstructive Pulmonary Disease|chronic obstructive pulmonary disease
287817|NCT02416778|Iron deficiency|iron deficiency
287818|NCT02416778|6 Minute-Walking-Test|6 minute-walking-test
287819|NCT02416765|Closed-loop strategy|closed-loop strategy
287820|NCT02416765|Artificial pancreas|artificial pancreas
287821|NCT02416765|Postprandial glucose|postprandial glucose
287822|NCT02416765|Insulin|insulin
287823|NCT02416765|Glucagon|glucagon
287824|NCT02416765|Hypoglycemia|hypoglycemia
287825|NCT02416765|Type 1 diabetes|type 1 diabetes
287826|NCT02416752|remifentanil|remifentanil
287827|NCT02416752|head and neck surgery|head and neck surgery
287828|NCT02416752|recovery pofile|recovery pofile
287829|NCT02416752|Opioid induced hyperalgesia|opioid induced hyperalgesia
287830|NCT02416752|post operative pain|post operative pain
287831|NCT02416739|EGFR mutated lung cancer|egfr mutated lung cancer
287832|NCT02416726|Gene testing|gene testing
287833|NCT02416726|Next-generation sequecing|next-generation sequecing
287834|NCT02416726|Primary tumor|primary tumor
287835|NCT02416726|Metastatic lymph node|metastatic lymph node
287836|NCT02416726|Peripheral blood|peripheral blood
287837|NCT02416713|Driving|driving
287838|NCT02416713|Teens|teens
287839|NCT02416713|Texting|texting
287840|NCT02416713|Cellphone|cellphone
287841|NCT02416713|DriveID|driveid
287842|NCT02416713|Motor vehicle accident|motor vehicle accident
287843|NCT02416700|Dental prosthesis|dental prosthesis
287844|NCT02416700|Patients|patients
287845|NCT02416700|Osseointegrated implants|osseointegrated implants
287846|NCT02416674|abdominal wall|abdominal wall
287847|NCT02416674|vascularized composite allotransplantation|vascularized composite allotransplantation
287848|NCT02416661|Gaucher Disease type 1|gaucher disease type 1
287849|NCT02416661|Lymphatic Diseases|lymphatic diseases
287850|NCT02416661|Lipid Metabolism, Inborn Errors|lipid metabolism, inborn errors
287851|NCT02416661|Lipid Metabolism Disorders|lipid metabolism disorders
287852|NCT02416661|Lipidoses|lipidoses
287853|NCT02416648|Adult HIV patients|adult hiv patients
287854|NCT02416648|Knowledge|knowledge
287855|NCT02416648|Attitudes|attitudes
287856|NCT02416648|Sexual behaviors|sexual behaviors
287857|NCT02416635|Liver Neoplasms|liver neoplasms
287858|NCT02416635|Circulating Tumor Cells|circulating tumor cells
287859|NCT02416622|XLRS|xlrs
287860|NCT02416622|maculoschisis|maculoschisis
287861|NCT02416622|retinal degeneration|retinal degeneration
287862|NCT02416622|RS1|rs1
287863|NCT02416622|adeno-associated virus|adeno-associated virus
287864|NCT02416622|gene therapy|gene therapy
287865|NCT02416622|AAV|aav
287866|NCT02416609|Locally advanced pancreatic cancer|locally advanced pancreatic cancer
287867|NCT02416609|Stereotactic Body Radiotherapy|stereotactic body radiotherapy
287868|NCT02416609|Chemopotentiator|chemopotentiator
287869|NCT02416609|Low dose radiotherapy|low dose radiotherapy
287870|NCT02416609|Hyper-Radiosensitivity|hyper-radiosensitivity
287871|NCT02416596|ICSI|icsi
287872|NCT02416596|IVF|ivf
287873|NCT02416596|hysteroscopy|hysteroscopy
287874|NCT02416596|Supervision|supervision
287875|NCT02416596|In-vitro Fertilization|in-vitro fertilization
287876|NCT02416583|membrane sweeping|membrane sweeping
287877|NCT02416583|dinoprostone|dinoprostone
287878|NCT02416583|nulliparas|nulliparas
287879|NCT02416583|labor induction|labor induction
287880|NCT02416570|Clarithromycin|clarithromycin
287881|NCT02416544|Overweight|overweight
287882|NCT02416544|Obesity|obesity
287883|NCT02416544|Caloric Restriction|caloric restriction
287884|NCT02416544|Diet, Reducing|diet, reducing
287885|NCT02416544|Diet, Sodium-Restricted|diet, sodium-restricted
287886|NCT02416544|Body Weight Changes|body weight changes
287887|NCT02416544|Energy intake|energy intake
287888|NCT02416544|Feeding Behavior|feeding behavior
287889|NCT02416531|Vulvar lichen sclerosus|vulvar lichen sclerosus
287890|NCT02416531|Photodynamic therapy|photodynamic therapy
287891|NCT02416531|Low-level laser therapy|low-level laser therapy
287892|NCT02416531|Clobetasol propionate|clobetasol propionate
287893|NCT02416518|Cancer|cancer
287894|NCT02416518|Malignancy|malignancy
287895|NCT02416518|Genomic|genomic
287896|NCT02416518|Molecular|molecular
287897|NCT02416479|medication adherence|medication adherence
287898|NCT02416479|outcomes|outcomes
287899|NCT02416479|intervention|intervention
287900|NCT02416479|randomized controlled trial|randomized controlled trial
287901|NCT02416466|Colorectal cancer|colorectal cancer
287902|NCT02416466|Liver metastases|liver metastases
287903|NCT02416466|Breast cancer|breast cancer
287904|NCT02416466|Gastric cancer|gastric cancer
287905|NCT02416466|Pancreas cancer|pancreas cancer
287906|NCT02416466|Carcinoembryonic antigen|carcinoembryonic antigen
287908|NCT02416466|Immunotherapy|immunotherapy
287909|NCT02416453|Healthy|healthy
287910|NCT02416453|Ebola viruses|ebola viruses
287911|NCT02416453|Ebola Viral Disease (EVD)|ebola viral disease (evd)
287912|NCT02416453|Filoviruses|filoviruses
287913|NCT02416453|Monovalent vaccine|monovalent vaccine
287914|NCT02416453|Human adenovirus serotype 26 (Ad26) encoding the Ebola virus Mayinga variant glycoprotein (Ad26.ZEBOV)|human adenovirus serotype 26 (ad26) encoding the ebola virus mayinga variant glycoprotein (ad26.zebov)
287915|NCT02416453|Modified Vaccinia Virus Ankara - Bavarian Nordic Filo-vector (MVA-BN Filo)|modified vaccinia virus ankara - bavarian nordic filo-vector (mva-bn filo)
287916|NCT02416453|Safety|safety
287917|NCT02416453|Immunogenicity|immunogenicity
287918|NCT02416453|Inserm and University of Oxford|inserm and university of oxford
287919|NCT02416440|South African|south african
287920|NCT02416440|urban African|urban african
287921|NCT02416440|diabetes|diabetes
287922|NCT02416440|prevalence|prevalence
287923|NCT02416440|risk factors|risk factors
287924|NCT02416440|genetics|genetics
287925|NCT02416427|Atorvastatin|atorvastatin
287926|NCT02416427|TAZ|taz
287927|NCT02416427|Hippo pathway|hippo pathway
287928|NCT02416427|ki67|ki67
287929|NCT02416401|healthy|healthy
287930|NCT02416401|aging|aging
287931|NCT02416401|cognition|cognition
287932|NCT02416401|age-related cognitive decline|age-related cognitive decline
287933|NCT02416362|Postural Balance|postural balance
287934|NCT02416362|Electromyography|electromyography
287935|NCT02416362|Torque|torque
287936|NCT02416349|Stroke|stroke
287937|NCT02416349|Stretching|stretching
287938|NCT02416349|Respiratory muscle|respiratory muscle
287939|NCT02416349|Ventilatory pattern|ventilatory pattern
287940|NCT02416349|Optoelectronic plethysmography|optoelectronic plethysmography
287941|NCT02416336|sentinel lymph node|sentinel lymph node
287942|NCT02416336|lymphoscintigraphy|lymphoscintigraphy
287943|NCT02416336|intraoperative gamma camera|intraoperative gamma camera
287944|NCT02416310|TEAS|teas
287945|NCT02416310|cesarean section|cesarean section
287946|NCT02416310|gastrointestinal function|gastrointestinal function
287947|NCT02416297|malocclusion|malocclusion
287948|NCT02416297|accelerated tooth movement|accelerated tooth movement
287949|NCT02416297|Tomography|tomography
287950|NCT02416297|Extraction|extraction
287953|NCT02416232|dabrafenib|dabrafenib
287954|NCT02416232|trametinib|trametinib
287955|NCT02416232|BRAF V600E/K mutation|braf v600e/k mutation
287956|NCT02416219|Cricoid cartilage, cricoid pressure, obstetric|cricoid cartilage, cricoid pressure, obstetric
287957|NCT02416206|Multiple myeloma|multiple myeloma
287958|NCT02416206|hematopoietic stem cell transplant|hematopoietic stem cell transplant
287959|NCT02416193|Diabetes|diabetes
287960|NCT02416193|Cognition|cognition
287961|NCT02416193|Functioning|functioning
287962|NCT02416180|EVOHALER|evohaler
287963|NCT02416180|Asthma|asthma
287964|NCT02416180|SERETIDE|seretide
287965|NCT02416180|DISKUS Inhaler|diskus inhaler
287966|NCT02416180|MDI|mdi
287967|NCT02416154|interferon-epsilon|interferon-epsilon
287968|NCT02416154|female reproductive tract|female reproductive tract
287969|NCT02416154|neopterin|neopterin
287970|NCT02416154|menstrual cycle|menstrual cycle
287971|NCT02416115|PONV|ponv
287972|NCT02416115|ramosetron|ramosetron
287973|NCT02416115|naloxone|naloxone
287974|NCT02416089|Tampostat|tampostat
287975|NCT02416089|Tamponade|tamponade
287976|NCT02416089|Postpartum hemorrhage|postpartum hemorrhage
287977|NCT02416076|Ulthera® System|ulthera® system
287978|NCT02416076|Ultherapy®|ultherapy®
287979|NCT02416076|Ulthera, Inc.|ulthera, inc.
287980|NCT02416050|Cocaine|cocaine
287981|NCT02416050|Dependence|dependence
287982|NCT02416050|Abstinence|abstinence
287983|NCT02416050|Prediction|prediction
287984|NCT02416050|Model|model
287985|NCT02416050|Humans|humans
287986|NCT02416050|MRI|mri
287987|NCT02416050|Cognitive|cognitive
287988|NCT02416050|Impulsivity|impulsivity
287989|NCT02416050|Craving|craving
287990|NCT02416037|ARDS|ards
287991|NCT02416037|prone position|prone position
287992|NCT02416037|PEEP|peep
287993|NCT02416037|mechanical ventilation|mechanical ventilation
287994|NCT02416024|angiotensin converting enzyme inhibitor|angiotensin converting enzyme inhibitor
287995|NCT02416024|anesthesia|anesthesia
287996|NCT02416011|e-cigarette|e-cigarette
287997|NCT02416011|nicotine dependence|nicotine dependence
287998|NCT02415998|TEE|tee
287999|NCT02415985|pharmacokinetics of rifabutin|pharmacokinetics of rifabutin
288000|NCT02415985|HIV/TB co-infection|hiv/tb co-infection
288001|NCT02415985|resource limited setting|resource limited setting
288002|NCT02415985|AUC|auc
288003|NCT02415985|Cmax|cmax
288004|NCT02415985|Cmin|cmin
288005|NCT02415985|Ctrough|ctrough
288006|NCT02415972|ultrasound imaging|ultrasound imaging
288007|NCT02415972|acute ischemic stroke|acute ischemic stroke
288008|NCT02415972|cerebral perfusion measurement in acute ischemic stroke|cerebral perfusion measurement in acute ischemic stroke
288009|NCT02415959|Exocrine Pancreatic Insufficiency|exocrine pancreatic insufficiency
288010|NCT02415946|regenerative medicine|regenerative medicine
288011|NCT02415946|bone substitutes|bone substitutes
288012|NCT02415946|sinus floor augmentation|sinus floor augmentation
288013|NCT02415933|Burkina Faso|burkina faso
288014|NCT02415933|West Africa|west africa
288015|NCT02415933|Children|children
288016|NCT02415933|Child Abuse|child abuse
288017|NCT02415933|Child Mental Health|child mental health
288018|NCT02415933|Economic Empowerment|economic empowerment
288019|NCT02415933|Women's Empowerment|women's empowerment
288020|NCT02415933|Domestic Violence|domestic violence
288021|NCT02415933|Child and Family Well-being|child and family well-being
288022|NCT02415933|Child Separation|child separation
288023|NCT02415933|Child Labor|child labor
288024|NCT02415933|Child Maltreatment|child maltreatment
288025|NCT02415920|Investigating oxytocin's effects|investigating oxytocin's effects
288026|NCT02415920|human communication|human communication
288027|NCT02415881|Panitumumab|panitumumab
288028|NCT02415881|Optical Imaging|optical imaging
288029|NCT02415868|Vaginal Microbiota|vaginal microbiota
288030|NCT02415842|Supra-seasonal influenza vaccine|supra-seasonal influenza vaccine
288031|NCT02415842|Pandemic|pandemic
288032|NCT02415842|Exploratory|exploratory
288033|NCT02415842|Protein epitopes|protein epitopes
288034|NCT02415842|Laboratory evaluation|laboratory evaluation
288035|NCT02415842|Retrospective|retrospective
288036|NCT02415829|Neoajuvant chemotherapy|neoajuvant chemotherapy
288037|NCT02415816|Pediatric|pediatric
288038|NCT02415816|Whole body DWI MRI|whole body dwi mri
288039|NCT02415803|low-dose ticagrelor|low-dose ticagrelor
288040|NCT02415803|clopidogrel|clopidogrel
288041|NCT02415803|Chinese patients with NSTE-ACS|chinese patients with nste-acs
288042|NCT02415803|platelet reactivity|platelet reactivity
288043|NCT02415803|inhibition of platelet aggregation|inhibition of platelet aggregation
288044|NCT02415790|E2027|e2027
288045|NCT02415790|Healthy Adult and Elderly Subjects|healthy adult and elderly subjects
288046|NCT02415790|Pharmacokinetics/Pharmacodynamics|pharmacokinetics/pharmacodynamics
288047|NCT02415738|Near infrared spectroscopy|near infrared spectroscopy
288048|NCT02415738|Cerebral oxygenation|cerebral oxygenation
288049|NCT02415738|Acute respiratory distress syndrom|acute respiratory distress syndrom
288050|NCT02415738|Prone positioning|prone positioning
288051|NCT02415712|Pharmacotherapy|pharmacotherapy
288052|NCT02415686|Dravet syndrome|dravet syndrome
288345|NCT02414087|insoles|insoles
288053|NCT02415686|Sudden Unexpected Death in Epilepsy (SUDEP)|sudden unexpected death in epilepsy (sudep)
288054|NCT02415686|Arrhythmias|arrhythmias
288055|NCT02415673|Orthodontics|orthodontics
288056|NCT02415673|Nitinol|nitinol
288057|NCT02415660|trigger point dry needling|trigger point dry needling
288058|NCT02415660|thoracic spine manipulation|thoracic spine manipulation
288059|NCT02415660|deep cervical extensor muscle|deep cervical extensor muscle
288060|NCT02415660|deep cervical flexor muscle|deep cervical flexor muscle
288061|NCT02415660|shear wave elastography|shear wave elastography
288062|NCT02415647|children|children
288063|NCT02415647|mental health|mental health
288064|NCT02415647|family genetic study|family genetic study
288065|NCT02415621|metastatic|metastatic
288066|NCT02415621|castration resistant|castration resistant
288067|NCT02415621|abiraterone therapy|abiraterone therapy
288068|NCT02415582|Hypertension|hypertension
288069|NCT02415582|Bloodpressure|bloodpressure
288070|NCT02415582|Post-exercise hypotension|post-exercise hypotension
288071|NCT02415582|Combined exercise|combined exercise
288072|NCT02415582|Aerobic exercise|aerobic exercise
288073|NCT02415582|Resistance exercise|resistance exercise
288074|NCT02415582|Aging|aging
288075|NCT02415582|Elderly|elderly
288076|NCT02415582|Ambulatory blood pressure monitoring|ambulatory blood pressure monitoring
288077|NCT02415569|bowel cleansing|bowel cleansing
288078|NCT02415569|bisacodyl|bisacodyl
288079|NCT02415569|polyethyleneglycol|polyethyleneglycol
288080|NCT02415569|colonoscopy|colonoscopy
288081|NCT02415569|the bristol stool form scale|the bristol stool form scale
288082|NCT02415556|Type 2 Diabetes Mellitus|type 2 diabetes mellitus
288083|NCT02415556|Intranasal Insulin|intranasal insulin
288084|NCT02415556|Placebo|placebo
288085|NCT02415556|Memory|memory
288086|NCT02415556|Gait|gait
288087|NCT02415556|Non diabetic older controls|non diabetic older controls
288088|NCT02415517|Cognitive training|cognitive training
288089|NCT02415517|Cognitive impairment|cognitive impairment
288090|NCT02415517|Heart failure|heart failure
288091|NCT02415517|Cognition|cognition
288092|NCT02415504|Care transition|care transition
288093|NCT02415504|Behavioural and psychological symptoms of dementia|behavioural and psychological symptoms of dementia
288094|NCT02415504|BPSD|bpsd
288095|NCT02415504|Dementia|dementia
288096|NCT02415504|Persons with dementia|persons with dementia
288097|NCT02415504|Discharge processes|discharge processes
288098|NCT02415491|TGA|tga
288099|NCT02415491|ASO|aso
288100|NCT02415491|magnetic resonance imaging (MRI)|magnetic resonance imaging (mri)
288101|NCT02415491|young adulthood|young adulthood
288102|NCT02415478|Chronic obstructive pulmonary disease (COPD)|chronic obstructive pulmonary disease (copd)
288103|NCT02415478|endoscopic lung volume reduction|endoscopic lung volume reduction
288104|NCT02415478|Endobronchial valve|endobronchial valve
288105|NCT02415478|physical capacity|physical capacity
288106|NCT02415478|quality of life|quality of life
288107|NCT02415465|Knee|knee
288108|NCT02415465|Replacement|replacement
288109|NCT02415452|relationship|relationship
288110|NCT02415452|retinal artery lesions|retinal artery lesions
288111|NCT02415452|long-term outcomes|long-term outcomes
288112|NCT02415439|Safety|safety
288113|NCT02415439|tolerability|tolerability
288114|NCT02415439|pharmacokinetics|pharmacokinetics
288115|NCT02415439|adult|adult
288116|NCT02415439|volunteers|volunteers
288117|NCT02415413|Smoldering multiple myeloma|smoldering multiple myeloma
288118|NCT02415413|Carfilzomib|carfilzomib
288119|NCT02415413|Lenalidomide|lenalidomide
288120|NCT02415413|Melphalan|melphalan
288121|NCT02415413|Dexamethasone|dexamethasone
288122|NCT02415413|Autologous stem cell transplantation|autologous stem cell transplantation
288123|NCT02415361|Parents|parents
288124|NCT02415361|Follow-Up Studies|follow-up studies
288125|NCT02415309|Melatonin|melatonin
288126|NCT02415309|Lumbar medial branch block (LMBB)|lumbar medial branch block (lmbb)
288127|NCT02415309|Anxiety|anxiety
288128|NCT02415309|Interventional Pain|interventional pain
288129|NCT02415309|Pain Procedure|pain procedure
288130|NCT02415296|gambling disorder|gambling disorder
288131|NCT02415296|screening model|screening model
288132|NCT02415296|online gambling|online gambling
288133|NCT02415296|clinical validation|clinical validation
288134|NCT02415257|Vestibular schwannoma|vestibular schwannoma
288135|NCT02415257|acoustic neuroma|acoustic neuroma
288136|NCT02415257|cerebellopontine angle tumour|cerebellopontine angle tumour
288137|NCT02415257|gentamicin|gentamicin
288138|NCT02415257|rehabilitation|rehabilitation
288139|NCT02415257|postural balance|postural balance
288140|NCT02415244|ultrasound|ultrasound
288141|NCT02415231|humor laughter C reactive protein|humor laughter c reactive protein
288142|NCT02415205|Pain and stress assessment in premature infants|pain and stress assessment in premature infants
288143|NCT02415192|safety data|safety data
288144|NCT02415192|hypertension therapy|hypertension therapy
288145|NCT02415179|Newly diagnosed asthma|newly diagnosed asthma
288146|NCT02415179|peripheral airway function|peripheral airway function
288147|NCT02415127|Interferon gamma|interferon gamma
288148|NCT02415114|Coenzyme Q10|coenzyme q10
288149|NCT02415114|Resveratrol|resveratrol
288150|NCT02415114|Statin|statin
288151|NCT02415101|Adenocarcinoma|adenocarcinoma
288152|NCT02415101|Squamous cell carcinoma|squamous cell carcinoma
288153|NCT02415101|Gastroesophageal Junction|gastroesophageal junction
288154|NCT02415088|Nerve block|nerve block
288155|NCT02415075|Return to work, state of subjective health, medical rehabilitation, motivational interviewing|return to work, state of subjective health, medical rehabilitation, motivational interviewing
288156|NCT02415062|Parkinson's disease|parkinson's disease
288157|NCT02415062|dementia|dementia
288159|NCT02415036|ICC|icc
288160|NCT02415036|Percutaneous hepatic perfusion|percutaneous hepatic perfusion
288161|NCT02414997|RIPC (remote ischemic preconditioning)|ripc (remote ischemic preconditioning)
288162|NCT02414997|primary hypertension stage I|primary hypertension stage i
288163|NCT02414997|vascular function|vascular function
288164|NCT02414997|microRNA-126|microrna-126
288165|NCT02414997|microRNA-34a|microrna-34a
288166|NCT02414984|Rheumatoid Arthritis|rheumatoid arthritis
288167|NCT02414984|Golimumab|golimumab
288168|NCT02414984|Observational|observational
288169|NCT02414984|Compliance|compliance
288170|NCT02414971|cancer related fatigue|cancer related fatigue
288171|NCT02414971|prostate cancer|prostate cancer
288172|NCT02414971|mitochondria|mitochondria
288173|NCT02414932|ketamine|ketamine
288174|NCT02414932|electroconvulsive therapy|electroconvulsive therapy
288175|NCT02414932|glutamate|glutamate
368175|NCT02014675|ICD|icd
288176|NCT02414906|Goal Directed Therapy|goal directed therapy
288177|NCT02414906|Acute Kidney Injury|acute kidney injury
288178|NCT02414880|Sugammadex|sugammadex
288179|NCT02414880|Neostigmine|neostigmine
288180|NCT02414880|Rocuronium|rocuronium
288181|NCT02414880|Cirrhosis|cirrhosis
288182|NCT02414880|Liver resection|liver resection
288183|NCT02414880|Neuromuscular|neuromuscular
288184|NCT02414841|radiocephalic|radiocephalic
288185|NCT02414841|arteriovenous fistula|arteriovenous fistula
288186|NCT02414841|AVF|avf
288187|NCT02414841|hemodialysis|hemodialysis
288188|NCT02414841|PRT-201|prt-201
288189|NCT02414841|vonapanitase|vonapanitase
288190|NCT02414841|vascular access|vascular access
288191|NCT02414841|kidney|kidney
288192|NCT02414841|renal|renal
288193|NCT02414841|PATENCY-2|patency-2
288194|NCT02414841|secondary patency|secondary patency
288195|NCT02414841|fistula abandonment|fistula abandonment
288196|NCT02414841|use for hemodialysis|use for hemodialysis
288197|NCT02414789|erythema migrans|erythema migrans
288198|NCT02414789|Lyme|lyme
288199|NCT02414789|early diagnosis|early diagnosis
288200|NCT02414789|skin biomarkers|skin biomarkers
288201|NCT02414789|proteomics diagnostic|proteomics diagnostic
288202|NCT02414789|mass spectrometry|mass spectrometry
288203|NCT02414750|Vemurafenib/cobimetinib (GDC-0973)|vemurafenib/cobimetinib (gdc-0973)
288204|NCT02414750|Melanoma|melanoma
288205|NCT02414750|Positron Emission Tomography|positron emission tomography
288206|NCT02414750|Tumor Characteristics|tumor characteristics
288207|NCT02414750|Response monitoring|response monitoring
288208|NCT02414750|Resistance prediction|resistance prediction
288209|NCT02414750|molecular targeted therapy|molecular targeted therapy
288210|NCT02414711|Depression|depression
288211|NCT02414711|Primary care|primary care
288212|NCT02414711|General Practitioners|general practitioners
288213|NCT02414685|poor-prognosis germ cell cancer, paclitaxel, ifosfamid and cisplatin regimen, tumor marker decline|poor-prognosis germ cell cancer, paclitaxel, ifosfamid and cisplatin regimen, tumor marker decline
288214|NCT02414672|psychosocial intervention|psychosocial intervention
288215|NCT02414672|advanced lung cancer|advanced lung cancer
288216|NCT02414672|caregivers|caregivers
288217|NCT02414672|self-care|self-care
288218|NCT02414633|Psoriatic Arthritis|psoriatic arthritis
288219|NCT02414620|Efficacy|efficacy
288220|NCT02414620|Dental Vibe Unit|dental vibe unit
288221|NCT02414620|Reduction|reduction
288222|NCT02414620|Elimination|elimination
288223|NCT02414620|Dental Anesthetic Injection|dental anesthetic injection
288224|NCT02414607|Elderberry juice|elderberry juice
288225|NCT02414607|Alzheimer's|alzheimer's
288226|NCT02414607|Inflammation|inflammation
288227|NCT02414555|Fluid Management|fluid management
288228|NCT02414516|HDAC|hdac
288229|NCT02414516|Epigenetic|epigenetic
288230|NCT02414516|Histone|histone
288231|NCT02414516|Acetylation|acetylation
288232|NCT02414503|oxytocin|oxytocin
288233|NCT02414503|social cognition|social cognition
288234|NCT02414490|CIDP|cidp
288235|NCT02414477|tobacco toxicants|tobacco toxicants
288236|NCT02414477|smokeless tobacco|smokeless tobacco
288237|NCT02414477|nitrosamines|nitrosamines
288238|NCT02414477|tobacco specific nitrosamines (TSNAs)|tobacco specific nitrosamines (tsnas)
288239|NCT02414464|tooth bleaching|tooth bleaching
288240|NCT02414464|adolescent|adolescent
288241|NCT02414464|clinical trial|clinical trial
288242|NCT02414451|Propranolol|propranolol
288243|NCT02414425|Fecal Incontinence|fecal incontinence
288244|NCT02414425|Botulinum Toxin A|botulinum toxin a
288245|NCT02414425|Rectal injection|rectal injection
288246|NCT02414412|Ulmus macrocarpa water extract|ulmus macrocarpa water extract
288247|NCT02414412|immunity|immunity
288248|NCT02414399|post-discharge mortality|post-discharge mortality
288344|NCT02414087|therapeutic effect|therapeutic effect
288249|NCT02414399|morbidity and mortality prevention|morbidity and mortality prevention
288250|NCT02414399|azithromycin|azithromycin
288251|NCT02414399|linear growth|linear growth
288252|NCT02414386|Vitamin D|vitamin d
288253|NCT02414386|Continuous Renal Replacement Therapy|continuous renal replacement therapy
288254|NCT02414386|Multi Organ Failure|multi organ failure
288255|NCT02414386|Acute Kidney Injury|acute kidney injury
288256|NCT02414386|Critical Care|critical care
288257|NCT02414386|Citrate anticoagulation|citrate anticoagulation
288258|NCT02414373|urination|urination
288259|NCT02414373|analgesia, epidural|analgesia, epidural
288260|NCT02414373|local anesthetics|local anesthetics
288261|NCT02414360|Review Literature as Topic|review literature as topic
288262|NCT02414347|Dementia|dementia
288263|NCT02414347|Tauopathies|tauopathies
288264|NCT02414347|Brain Diseases|brain diseases
288265|NCT02414347|Central Nervous System Diseases|central nervous system diseases
288266|NCT02414347|Mild Cognitive Impairment|mild cognitive impairment
288267|NCT02414347|Nervous System Diseases|nervous system diseases
288268|NCT02414347|Neurodegenerative Disease|neurodegenerative disease
288269|NCT02414334|Oligometastases|oligometastases
712544|NCT00579774|inflammation|inflammation
368303|NCT02014246|DNA|dna
288270|NCT02414334|Stereotactic ablative radiotherapy (SABR)|stereotactic ablative radiotherapy (sabr)
288271|NCT02414334|Metastatic tumours|metastatic tumours
288272|NCT02414308|Erectile dysfunction, Peyronie's disease, stem cell|erectile dysfunction, peyronie's disease, stem cell
288273|NCT02414295|Stem cell|stem cell
288274|NCT02414295|Kleinfelter syndrome|kleinfelter syndrome
288275|NCT02414295|Azoospermia|azoospermia
288276|NCT02414295|Sterility|sterility
288277|NCT02414295|Infertility|infertility
288278|NCT02414282|Dementia|dementia
288279|NCT02414282|Brain Diseases|brain diseases
288280|NCT02414282|mild cognitive impairment|mild cognitive impairment
288281|NCT02414282|Central Nervous System Diseases|central nervous system diseases
288282|NCT02414282|Neurodegenerative Disease|neurodegenerative disease
288283|NCT02414269|modified T cells|modified t cells
288284|NCT02414269|cyclophosphamide|cyclophosphamide
288285|NCT02414269|CAR T cells|car t cells
288286|NCT02414269|15-007|15-007
288288|NCT02414269|immunotherapy|immunotherapy
288289|NCT02414256|breast surgery|breast surgery
288290|NCT02414230|fronto-temporal dementia|fronto-temporal dementia
288291|NCT02414230|Tauopathies|tauopathies
288292|NCT02414230|Nervous System Diseases|nervous system diseases
288293|NCT02414230|Neurodegenerative Diseases|neurodegenerative diseases
288294|NCT02414217|numeracy|numeracy
288295|NCT02414217|health literacy|health literacy
288296|NCT02414204|Arteriovenous Fistulas (AVFS)|arteriovenous fistulas (avfs)
288297|NCT02414204|Hemodialysis Fistula Maturation (HFM)|hemodialysis fistula maturation (hfm)
288298|NCT02414204|Flow-Mediated Dilation (FMD)|flow-mediated dilation (fmd)
288299|NCT02414204|Nitroglycerin-Mediated (NMD)|nitroglycerin-mediated (nmd)
288300|NCT02414204|Venous Plethysmography (VP)|venous plethysmography (vp)
288301|NCT02414191|Feedback|feedback
288302|NCT02414191|Temperature management|temperature management
288303|NCT02414191|Anesthesia|anesthesia
288304|NCT02414178|Dementia|dementia
288305|NCT02414178|Brain Diseases|brain diseases
288306|NCT02414178|Central Nervous System Diseases|central nervous system diseases
288307|NCT02414178|Mild Cognitive Impairment|mild cognitive impairment
288308|NCT02414178|nervous system diseases|nervous system diseases
288309|NCT02414178|Neurodegenerative Disease|neurodegenerative disease
288310|NCT02414165|Recurrence|recurrence
288311|NCT02414139|Non Small Cell Lung|non small cell lung
288312|NCT02414139|Non Small Cell Lung Cancer|non small cell lung cancer
288313|NCT02414139|Non-small cell lung cancer|non-small cell lung cancer
288314|NCT02414139|NSCLC|nsclc
288315|NCT02414139|INC280|inc280
288316|NCT02414139|EGFR wild-type (wt)|egfr wild-type (wt)
288317|NCT02414139|advanced non-small cell lung cancer|advanced non-small cell lung cancer
288318|NCT02414139|advanced/metastatic disease|advanced/metastatic disease
288319|NCT02414139|Non-small cell lung carcinoma (NSCLC)|non-small cell lung carcinoma (nsclc)
288320|NCT02414139|treatment of lung cancer after first metastasis|treatment of lung cancer after first metastasis
288321|NCT02414139|lung cancer|lung cancer
288322|NCT02414139|lung adenocarcinoma|lung adenocarcinoma
288323|NCT02414139|Non small cell lung carcinoma|non small cell lung carcinoma
288324|NCT02414139|MET exon 14 deletion|met exon 14 deletion
288325|NCT02414139|MET exon 14 skipping|met exon 14 skipping
288326|NCT02414139|MET exon 14 mutation|met exon 14 mutation
288327|NCT02414139|MET mutation|met mutation
288328|NCT02414139|MET amplification|met amplification
288329|NCT02414139|MET inhibitor|met inhibitor
288330|NCT02414139|MET dysregulation|met dysregulation
288331|NCT02414139|MET activation|met activation
288332|NCT02414139|MET signaling|met signaling
288333|NCT02414139|MET pathway|met pathway
288334|NCT02414139|met|met
288335|NCT02414139|cMET|cmet
288336|NCT02414126|Heart failure|heart failure
288337|NCT02414126|child|child
288338|NCT02414126|work of breathing|work of breathing
288339|NCT02414126|cardiac function|cardiac function
288340|NCT02414126|sleep|sleep
288341|NCT02414126|polysomnography|polysomnography
288342|NCT02414126|CPAP|cpap
288343|NCT02414087|flat foot|flat foot
288346|NCT02414087|children|children
288347|NCT02414061|Postprandial glycemia|postprandial glycemia
288348|NCT02414061|metabolic health measures|metabolic health measures
288350|NCT02414048|Head and neck cancer|head and neck cancer
288351|NCT02414035|atrial fibrillation|atrial fibrillation
288352|NCT02414035|anticoagulation|anticoagulation
288353|NCT02414035|Dabigatran|dabigatran
288354|NCT02413996|Virtual Reality Therapy|virtual reality therapy
288355|NCT02413996|Rehabilitation|rehabilitation
288356|NCT02413996|Total Knee Replacement|total knee replacement
288357|NCT02413996|Knee Arthroplasty|knee arthroplasty
288358|NCT02413996|Exercise|exercise
288359|NCT02413996|Arthritis|arthritis
288360|NCT02413996|Rheumatic Disease|rheumatic disease
288361|NCT02413970|OSA|osa
288362|NCT02413970|Neurostimulation|neurostimulation
288363|NCT02413970|Hypoglossal nerve|hypoglossal nerve
288364|NCT02413970|Tongue|tongue
288365|NCT02413970|Upper airway stimulation|upper airway stimulation
288366|NCT02413970|Surgery|surgery
288367|NCT02413957|Elderly Patients|elderly patients
288368|NCT02413957|Medication Safety|medication safety
288369|NCT02413957|Pharmaceutical Care|pharmaceutical care
288370|NCT02413957|Medication Reconciliation|medication reconciliation
288371|NCT02413931|tuberculosis|tuberculosis
288372|NCT02413931|MDR-TB|mdr-tb
288373|NCT02413918|mixed episode|mixed episode
288374|NCT02413866|body composition|body composition
288375|NCT02413866|anthropometry|anthropometry
288376|NCT02413840|COPD|copd
288377|NCT02413840|Baduanjin qigong|baduanjin qigong
288378|NCT02413840|depression|depression
288379|NCT02413840|anxiety|anxiety
288380|NCT02413827|Yervoy™, CDX-1401|yervoy™, cdx-1401
288381|NCT02413801|Psoriasis|psoriasis
288382|NCT02413801|PDUS|pdus
288383|NCT02413788|adolescent idiopathic scoliosis|adolescent idiopathic scoliosis
288384|NCT02413788|inflammatory markers|inflammatory markers
288385|NCT02413788|exercise|exercise
288386|NCT02413749|Psoriatic Arthritis|psoriatic arthritis
288387|NCT02413723|intubation|intubation
288388|NCT02413723|critical care|critical care
288389|NCT02413723|laryngoscope|laryngoscope
288390|NCT02413723|videolaryngoscope|videolaryngoscope
288391|NCT02413723|intratracheal|intratracheal
288392|NCT02413658|Phenytoin|phenytoin
288393|NCT02413658|Skin graft donor site|skin graft donor site
288394|NCT02413658|Clean surgical site|clean surgical site
288395|NCT02413658|Wound model|wound model
288396|NCT02413632|HIV-positive MSM (men who have sex with men)|hiv-positive msm (men who have sex with men)
288397|NCT02413632|asymptomatic sexually transmitted infections|asymptomatic sexually transmitted infections
288398|NCT02413632|screening|screening
288399|NCT02413606|follow up care|follow up care
288400|NCT02413606|satisfaction with care|satisfaction with care
288401|NCT02413593|HCV genotype 3 (GT-3)|hcv genotype 3 (gt-3)
288402|NCT02413593|HCV|hcv
288403|NCT02413593|Sustained Virologic Response|sustained virologic response
288404|NCT02413593|Direct Acting Antiviral|direct acting antiviral
288405|NCT02413593|GS-7977|gs-7977
288406|NCT02413593|GS-5885|gs-5885
288407|NCT02413593|Ribavirin|ribavirin
288408|NCT02413593|Sofosbuvir|sofosbuvir
288409|NCT02413593|Ledipasvir|ledipasvir
288410|NCT02413593|Hepatitis C|hepatitis c
288411|NCT02413593|Hepatitis C, Chronic|hepatitis c, chronic
288412|NCT02413554|acetylcholinesterase inhibitors|acetylcholinesterase inhibitors
288413|NCT02413554|rivastigmine patch|rivastigmine patch
288414|NCT02413554|post-operational delirium|post-operational delirium
288415|NCT02413528|Patient Compliance|patient compliance
288416|NCT02413528|Mobile Applications|mobile applications
288417|NCT02413489|Lymphoma, Mantle-Cell|lymphoma, mantle-cell
288418|NCT02413489|Lymphoma, Large B-Cell, Diffuse|lymphoma, large b-cell, diffuse
288419|NCT02413489|Lymphoma, Follicular|lymphoma, follicular
288420|NCT02413489|Daratumumab|daratumumab
288421|NCT02413476|robotic-assisted gastrectomy|robotic-assisted gastrectomy
288422|NCT02413476|laparoscopic-assisted gastrectomy|laparoscopic-assisted gastrectomy
288423|NCT02413476|gastric cancer|gastric cancer
288424|NCT02413450|induced Pluripotent Stem Cells (iPSC)|induced pluripotent stem cells (ipsc)
288425|NCT02413450|Channelopathies|channelopathies
288426|NCT02413450|Catecholaminergic|catecholaminergic
288427|NCT02413450|Arrhythmogenic|arrhythmogenic
288428|NCT02413437|contrast-enhanced ultrasound|contrast-enhanced ultrasound
288429|NCT02413437|biopsy|biopsy
288430|NCT02413424|sucralose|sucralose
288431|NCT02413411|Arthroplasty|arthroplasty
288432|NCT02413411|Osteoarthritis|osteoarthritis
288433|NCT02413411|Replacement|replacement
288434|NCT02413411|Intervention|intervention
288435|NCT02413385|lifestyle intervention|lifestyle intervention
288436|NCT02413385|physical activity|physical activity
288437|NCT02413385|exercise|exercise
288438|NCT02413385|eHealth|ehealth
288439|NCT02413385|technology|technology
288440|NCT02413385|coaching|coaching
288441|NCT02413385|healthy eating|healthy eating
288442|NCT02413372|First Line Therapy|first line therapy
288443|NCT02413372|NASH|nash
288444|NCT02413333|Contact lens solution|contact lens solution
288542|NCT02412735|Chronic Lumbar Back Pain|chronic lumbar back pain
288445|NCT02413320|TNBC, breast cancer, neoadjuvant, carboplatin, docetaxel, paclitaxel, doxorubicin, cyclophosphamide|tnbc, breast cancer, neoadjuvant, carboplatin, docetaxel, paclitaxel, doxorubicin, cyclophosphamide
288446|NCT02413307|Compassion Focused Therapy|compassion focused therapy
288447|NCT02413281|Healthy Volunteer|healthy volunteer
288448|NCT02413281|Abuse Liability|abuse liability
288449|NCT02413281|ALKS 5461|alks 5461
288450|NCT02413281|Alkermes|alkermes
288451|NCT02413255|Drug therapy|drug therapy
288452|NCT02413242|S. aureus|s. aureus
288453|NCT02413242|P. aeruginosa|p. aeruginosa
288454|NCT02413242|Colonization|colonization
288455|NCT02413242|Pneumonia|pneumonia
288456|NCT02413242|ICU|icu
288457|NCT02413216|Tic Disorder|tic disorder
288458|NCT02413216|Tourette|tourette
288459|NCT02413216|Motor tic|motor tic
288460|NCT02413216|Vocal tic|vocal tic
288461|NCT02413216|Habit reversal training|habit reversal training
288462|NCT02413216|CBIT|cbit
288463|NCT02413216|TicHelper|tichelper
288464|NCT02413216|Behavior Therapy|behavior therapy
288465|NCT02413203|lipidomics|lipidomics
288466|NCT02413203|ex vivo human whole blood assay|ex vivo human whole blood assay
288467|NCT02413203|celecoxib|celecoxib
288468|NCT02413203|selective COX-2 inhibitor|selective cox-2 inhibitor
288469|NCT02413164|Schizophrenia|schizophrenia
288470|NCT02413164|Mental Health|mental health
288471|NCT02413164|Physical Therapy|physical therapy
288472|NCT02413164|Quality of life|quality of life
288473|NCT02413164|Stigma|stigma
288474|NCT02413164|Positive and negative symptoms|positive and negative symptoms
288475|NCT02413164|Physical fitness|physical fitness
288476|NCT02413164|Physical activity|physical activity
288477|NCT02413151|Exercise training|exercise training
288478|NCT02413151|Cardiac resynchronization therapy|cardiac resynchronization therapy
288479|NCT02413151|Autonomic nervous system modulation|autonomic nervous system modulation
288480|NCT02413151|Chronic Heart failure|chronic heart failure
288481|NCT02413138|GHD|ghd
288482|NCT02413112|Aging|aging
288483|NCT02413112|Sarcopenia|sarcopenia
288484|NCT02413112|Resistance training|resistance training
288485|NCT02413112|Strength|strength
288486|NCT02413112|Muscle mass|muscle mass
288487|NCT02413086|diabetic foot ulcer|diabetic foot ulcer
288488|NCT02413086|early-stage amputation|early-stage amputation
288489|NCT02413086|external therapy of herbs chitosan|external therapy of herbs chitosan
288490|NCT02413086|wound surface healing|wound surface healing
288491|NCT02413073|whole body vibration|whole body vibration
288492|NCT02413073|kidney disease|kidney disease
288493|NCT02413034|antibiotic|antibiotic
288494|NCT02413021|Acute Myeloid Leukemia|acute myeloid leukemia
288495|NCT02413021|Acute Lymphoid Leukemia|acute lymphoid leukemia
288496|NCT02413021|deferasirox|deferasirox
288497|NCT02413008|vaginal atrophy|vaginal atrophy
288498|NCT02413008|breast cancer|breast cancer
288499|NCT02413008|vaginal dryness|vaginal dryness
288500|NCT02413008|aromatase inhibitor|aromatase inhibitor
288501|NCT02412995|sea buckthorn|sea buckthorn
288502|NCT02412995|strawberry|strawberry
288503|NCT02412995|glucose response|glucose response
288504|NCT02412995|satiety|satiety
288505|NCT02412995|metabolomics|metabolomics
288506|NCT02412995|intake biomarker|intake biomarker
288507|NCT02412956|mHealth|mhealth
288508|NCT02412904|follicular stimulating hormone|follicular stimulating hormone
288509|NCT02412904|human menopausal gonadotrophin|human menopausal gonadotrophin
288510|NCT02412904|Recombinant follicular stimulating hormone (rFSH)|recombinant follicular stimulating hormone (rfsh)
288511|NCT02412904|Gonadotrophin releasing hormone (GnRH) antagonists|gonadotrophin releasing hormone (gnrh) antagonists
288512|NCT02412904|GnRH agonist|gnrh agonist
288513|NCT02412904|in vitro fertilization|in vitro fertilization
288514|NCT02412904|controled ovarian stimulation|controled ovarian stimulation
288515|NCT02412904|number of mature oocytes|number of mature oocytes
288516|NCT02412891|introduction of urinary catheter|introduction of urinary catheter
288517|NCT02412865|mhealth|mhealth
288518|NCT02412852|neuropathy|neuropathy
288519|NCT02412826|pancreatitis|pancreatitis
288520|NCT02412826|acoustic|acoustic
288521|NCT02412826|sensor|sensor
288522|NCT02412813|hypersensitivity|hypersensitivity
288523|NCT02412813|metal sensitivity|metal sensitivity
288524|NCT02412813|arthroplasty|arthroplasty
288525|NCT02412813|implant-related hypersensitivity|implant-related hypersensitivity
288526|NCT02412813|metal-on-metal implants|metal-on-metal implants
288527|NCT02412813|knee revision|knee revision
288528|NCT02412800|Extravascular lung water|extravascular lung water
288529|NCT02412800|Pulmonary vascualr permeability index|pulmonary vascualr permeability index
288530|NCT02412800|Liver transplantation|liver transplantation
288531|NCT02412774|diet beverages|diet beverages
288532|NCT02412774|water|water
288533|NCT02412774|diabetes|diabetes
288534|NCT02412774|weight loss|weight loss
288535|NCT02412774|insulin sensitivity|insulin sensitivity
288536|NCT02412761|Anti-hypertensive medications|anti-hypertensive medications
288537|NCT02412761|Pediatrics|pediatrics
288538|NCT02412761|N-of-1 trial|n-of-1 trial
288539|NCT02412748|Non-Resident|non-resident
288540|NCT02412748|Fathers|fathers
288541|NCT02412748|African American|african american
288543|NCT02412735|Low back pain|low back pain
288544|NCT02412735|Back pain|back pain
288545|NCT02412735|Degenerative Disc Disease|degenerative disc disease
288546|NCT02412735|Injection of Degenerated Lumbar Disc|injection of degenerated lumbar disc
288547|NCT02412735|Intervertebral Disc Degeneration|intervertebral disc degeneration
288548|NCT02412735|Bone Diseases|bone diseases
288549|NCT02412735|Musculoskeletal Diseases|musculoskeletal diseases
288550|NCT02412735|Nervous System Diseases|nervous system diseases
288551|NCT02412735|Neurologic Manifestations|neurologic manifestations
288552|NCT02412735|Pain|pain
288553|NCT02412735|Spinal Diseases|spinal diseases
288554|NCT02412735|Stem Cells|stem cells
288555|NCT02412735|Adult Stem Cells|adult stem cells
288556|NCT02412735|Allogeneic Mesenchymal Precursor cells (MPCs)|allogeneic mesenchymal precursor cells (mpcs)
288557|NCT02412735|Mesoblast|mesoblast
288558|NCT02412735|Hyaluronic Acid|hyaluronic acid
288559|NCT02412735|Pharmaceutical Solutions|pharmaceutical solutions
368671|NCT02012413|PST|pst
288560|NCT02412735|Adjuvants, Immunologic|adjuvants, immunologic
288561|NCT02412735|Immunologic Factors|immunologic factors
288562|NCT02412735|Pharmacologic Actions|pharmacologic actions
288563|NCT02412735|Protective Agents|protective agents
288564|NCT02412735|rexlemestrocel-L|rexlemestrocel-l
288565|NCT02412735|Viscosupplements|viscosupplements
288566|NCT02412722|Drug therapy|drug therapy
288567|NCT02412709|Long QT Syndrome|long qt syndrome
288568|NCT02412709|LQTS|lqts
288569|NCT02412709|genetic testing|genetic testing
288571|NCT02412709|saliva testing|saliva testing
288572|NCT02412696|placental morphology|placental morphology
288573|NCT02412696|CPAP|cpap
288574|NCT02412696|placental secretory function|placental secretory function
288575|NCT02412592|HBeAg positive|hbeag positive
288576|NCT02412592|interferon|interferon
288577|NCT02412592|peginterferon|peginterferon
288578|NCT02412592|HBeAg seroconversion|hbeag seroconversion
288579|NCT02412592|sustained viral response|sustained viral response
288580|NCT02412592|relapse|relapse
288581|NCT02412579|HCC|hcc
288582|NCT02412579|Liver Cancer|liver cancer
288583|NCT02412566|cholestasis|cholestasis
288584|NCT02412566|growth failure|growth failure
288585|NCT02412566|intravenous fat emulsion|intravenous fat emulsion
288586|NCT02412566|SMOF|smof
288587|NCT02412514|polio|polio
288588|NCT02412514|inactivated poliovirus vaccine|inactivated poliovirus vaccine
288589|NCT02412514|oral poliovirus vaccine|oral poliovirus vaccine
288590|NCT02412514|IPV|ipv
288591|NCT02412514|OPV|opv
288592|NCT02412462|Phase I|phase i
288593|NCT02412462|Clusterin|clusterin
288594|NCT02412462|Epithelial-to-Mesenchymal Transition (EMT)|epithelial-to-mesenchymal transition (emt)
288595|NCT02412462|Circulating Tumor Cells (CTC)|circulating tumor cells (ctc)
288596|NCT02412462|EMT and Stem Cell Biomarkers|emt and stem cell biomarkers
288597|NCT02412462|Pharmacokinetics|pharmacokinetics
288598|NCT02412449|Pharmacokinetics|pharmacokinetics
288599|NCT02412449|Anemia|anemia
288600|NCT02412449|Chronic kidney disease|chronic kidney disease
288601|NCT02412449|CKD|ckd
288602|NCT02412449|Renal impairment|renal impairment
288603|NCT02412449|Chronic renal insufficiency|chronic renal insufficiency
288604|NCT02412449|Ferrous sulfate|ferrous sulfate
288605|NCT02412449|Iron|iron
288606|NCT02412449|End stage renal disease|end stage renal disease
288607|NCT02412449|Dialysis|dialysis
288608|NCT02412449|Oral anemia treatment|oral anemia treatment
288609|NCT02412449|Bioavailability|bioavailability
288610|NCT02412449|Erythropoietin|erythropoietin
288611|NCT02412449|Hypoxia-inducible factor|hypoxia-inducible factor
288612|NCT02412449|Volunteers|volunteers
288613|NCT02412410|laborist|laborist
288614|NCT02412410|efficacy|efficacy
288615|NCT02412410|sleep|sleep
288616|NCT02412410|fatigue|fatigue
288617|NCT02412410|SAFTE|safte
288618|NCT02412410|cognition|cognition
288619|NCT02412397|Shoulder|shoulder
288620|NCT02412384|Lung Neoplasms|lung neoplasms
288621|NCT02412384|Circulating Tumor Cells|circulating tumor cells
288622|NCT02412371|veliparib|veliparib
288623|NCT02412371|PARP inhibitor|parp inhibitor
288624|NCT02412371|ABT-888|abt-888
288625|NCT02412371|first line|first line
288626|NCT02412371|previously untreated|previously untreated
288627|NCT02412371|stage III|stage iii
288628|NCT02412371|non-small cell lung cancer|non-small cell lung cancer
288629|NCT02412371|radiotherapy|radiotherapy
288630|NCT02412371|paclitaxel|paclitaxel
288631|NCT02412371|carboplatin|carboplatin
288632|NCT02412358|toothbrushing|toothbrushing
288633|NCT02412358|plaque control|plaque control
288634|NCT02412358|gingivitis|gingivitis
288635|NCT02412345|Erectile Dysfunction|erectile dysfunction
288636|NCT02412345|Shockwave therapy|shockwave therapy
288637|NCT02412345|Renal Transplant|renal transplant
288638|NCT02412345|Male|male
288639|NCT02412345|Renal Transplant Recipients|renal transplant recipients
288640|NCT02412332|advanced COPD (stage III)|advanced copd (stage iii)
288641|NCT02412332|Adult stem cells|adult stem cells
288642|NCT02412332|Cell therapy|cell therapy
288643|NCT02412319|HBeAg positive chronic hepatitis B|hbeag positive chronic hepatitis b
288644|NCT02412319|HBeAg serum conversion rate|hbeag serum conversion rate
288645|NCT02412319|HBeAg serum disappearance rate|hbeag serum disappearance rate
288646|NCT02412319|HBeAg and HBsAg titer|hbeag and hbsag titer
288647|NCT02412306|Amgen|amgen
288648|NCT02412293|Perinatal|perinatal
288649|NCT02412293|neonatal|neonatal
288650|NCT02412293|newborn|newborn
288651|NCT02412293|mortality|mortality
288652|NCT02412189|Anesthesia|anesthesia
288653|NCT02412189|Blood pressure|blood pressure
288654|NCT02412189|Plasma volume|plasma volume
288655|NCT02412189|Vasopressor agents|vasopressor agents
288656|NCT02412189|Continuous noninvasive hemoglobin measurement|continuous noninvasive hemoglobin measurement
288657|NCT02412189|Coronary artery bypass|coronary artery bypass
288658|NCT02412176|pacemaker|pacemaker
288659|NCT02412176|dyssynchrony|dyssynchrony
288660|NCT02412176|apical pacing|apical pacing
288661|NCT02412176|mid-septum|mid-septum
288662|NCT02412098|Hepatic Impairment|hepatic impairment
288663|NCT02412085|golimumab|golimumab
288664|NCT02412085|ulcerative colitis|ulcerative colitis
288665|NCT02412085|steroid-dependent|steroid-dependent
288666|NCT02412072|Endometrial hyperplasia|endometrial hyperplasia
288667|NCT02412072|Progesterone|progesterone
288668|NCT02412072|LNG-IUS|lng-ius
288669|NCT02412072|dilatation & curettage|dilatation & curettage
288670|NCT02412072|endometrial aspiration sampling|endometrial aspiration sampling
288671|NCT02412046|Pressure ulcer|pressure ulcer
288672|NCT02412046|Interface pressure|interface pressure
288673|NCT02412046|Pressure mapping device|pressure mapping device
288674|NCT02412046|Ischemia reperfusion|ischemia reperfusion
288675|NCT02412046|Monitoring|monitoring
288676|NCT02412046|Microvascularization|microvascularization
288677|NCT02412033|vaginal misoprostol|vaginal misoprostol
288678|NCT02412007|spastic diplegia;cerebral palsy;activity based therapy|spastic diplegia;cerebral palsy;activity based therapy
288679|NCT02411981|Lung Clearance Index|lung clearance index
288680|NCT02411981|Non cystic fibrosis Bronchiectasis|non cystic fibrosis bronchiectasis
288681|NCT02411981|Multiple Breath Nitrogen Washout|multiple breath nitrogen washout
288682|NCT02411968|Cryosurgery|cryosurgery
288683|NCT02411968|Carcinoma, renal cell|carcinoma, renal cell
288684|NCT02411968|Diagnostic Imaging|diagnostic imaging
288685|NCT02411968|Diagnostic techniques, urological|diagnostic techniques, urological
288686|NCT02411968|Radionuclide imaging|radionuclide imaging
288687|NCT02411968|Follow up|follow up
288688|NCT02411903|Clopidogrel-drug interactions|clopidogrel-drug interactions
288689|NCT02411890|postoperative pain|postoperative pain
288690|NCT02411890|femoral nerve block|femoral nerve block
288691|NCT02411890|adductor canal block|adductor canal block
288692|NCT02411890|anterior cruciate ligament reconstruction|anterior cruciate ligament reconstruction
288693|NCT02411877|Acute ischemic stroke|acute ischemic stroke
288694|NCT02411877|Mild hypothermia|mild hypothermia
288695|NCT02411877|Stroke|stroke
288696|NCT02411877|Hypothermia|hypothermia
288697|NCT02411877|Cerebral infarction|cerebral infarction
288698|NCT02411877|Ischemia|ischemia
288699|NCT02411877|Cerebrovascular disorder|cerebrovascular disorder
288700|NCT02411877|Brain disease|brain disease
288701|NCT02411877|Central nervous system disease|central nervous system disease
288702|NCT02411877|Nervous system disease|nervous system disease
288703|NCT02411877|Vascular disease|vascular disease
288704|NCT02411877|Cardiovascular disease|cardiovascular disease
288705|NCT02411877|Brain infarction|brain infarction
288706|NCT02411877|Brain ischemia|brain ischemia
288707|NCT02411877|Pathologic process|pathologic process
288708|NCT02411877|Body temperature change|body temperature change
288709|NCT02411877|Signs and symptoms|signs and symptoms
288710|NCT02411864|IVIM|ivim
288711|NCT02411864|brain|brain
288712|NCT02411864|diffusion-weighted imaging|diffusion-weighted imaging
288713|NCT02411851|Actinic Keratoses|actinic keratoses
288714|NCT02411838|Multiple sclerosis|multiple sclerosis
288715|NCT02411838|calorie restriction|calorie restriction
288716|NCT02411838|adipokines|adipokines
288717|NCT02411812|Orthodontic Appliances, Functional|orthodontic appliances, functional
288718|NCT02411812|Herbst Appliance|herbst appliance
288719|NCT02411812|Malocclusion, Angle Class II|malocclusion, angle class ii
288720|NCT02411760|MRI|mri
288721|NCT02411747|Medical|medical
288722|NCT02411747|Urology|urology
288723|NCT02411747|Randomized Controlled Trial|randomized controlled trial
288724|NCT02411747|Endoscopy|endoscopy
288725|NCT02411747|Cystoscopy|cystoscopy
288726|NCT02411721|Anxiety|anxiety
288727|NCT02411721|Dog Intervention|dog intervention
288728|NCT02411721|MRI|mri
288729|NCT02411721|Children|children
288730|NCT02411695|Adolescent|adolescent
288731|NCT02411695|Otsuka,|otsuka,
288732|NCT02411695|Brexpiprazole|brexpiprazole
288733|NCT02411669|Patient centred care|patient centred care
288734|NCT02411630|PrEP|prep
288735|NCT02411630|HIV Prevention|hiv prevention
288736|NCT02411578|T1D|t1d
288737|NCT02411578|Type 1 diabetes|type 1 diabetes
288738|NCT02411578|Mini-dose glucagon|mini-dose glucagon
288739|NCT02411578|adults|adults
288740|NCT02411578|non-severe hypoglycemia|non-severe hypoglycemia
288741|NCT02411565|epithelial|epithelial
288742|NCT02411565|ovarian|ovarian
288743|NCT02411565|fallopian tube|fallopian tube
288744|NCT02411565|primary peritoneal carcinoma|primary peritoneal carcinoma
288745|NCT02411565|peritoneal|peritoneal
288746|NCT02411565|ovary|ovary
288747|NCT02411539|HIV|hiv
288748|NCT02411539|VRC01|vrc01
288749|NCT02411500|Healthy|healthy
288750|NCT02411500|Male|male
288751|NCT02411500|Pharmacokinetics|pharmacokinetics
288752|NCT02411474|stem cell transplantation (SCT)|stem cell transplantation (sct)
288753|NCT02411461|Pediatric obesity|pediatric obesity
288754|NCT02411461|pseudohypoparathyroidism|pseudohypoparathyroidism
288755|NCT02411461|Albright Hereditary Osteodystrophy|albright hereditary osteodystrophy
288756|NCT02411435|rifampin|rifampin
288757|NCT02411435|drug interaction|drug interaction
288758|NCT02411435|pharmacokinetics|pharmacokinetics
288759|NCT02411435|cabotegravir|cabotegravir
288760|NCT02411422|intubation|intubation
288761|NCT02411422|cardiopulmonary resuscitation|cardiopulmonary resuscitation
288762|NCT02411422|manikins|manikins
288763|NCT02411409|Health Information Technology (HIT)|health information technology (hit)
288764|NCT02411409|self-care|self-care
288765|NCT02411383|Diaphragm pacing|diaphragm pacing
288766|NCT02411383|Respiratory assistance|respiratory assistance
288767|NCT02411383|Lung transplant|lung transplant
288768|NCT02411357|Contraception|contraception
288769|NCT02411357|Unintended pregnancy|unintended pregnancy
288770|NCT02411357|HIV risk|hiv risk
288771|NCT02411357|Sexually transmitted infections|sexually transmitted infections
288772|NCT02411357|Women|women
288773|NCT02411357|Pregnancy|pregnancy
288774|NCT02411357|Neonatal health|neonatal health
288775|NCT02411357|Drug use|drug use
288776|NCT02411357|Drug treatment|drug treatment
288777|NCT02411357|Opioids|opioids
288778|NCT02411344|HER2+/HR+|her2+/hr+
288779|NCT02411344|breast cancer|breast cancer
288780|NCT02411331|Lock Solution|lock solution
288781|NCT02411331|Catheter related blood stream infections|catheter related blood stream infections
288782|NCT02411331|Central venous catheter infection|central venous catheter infection
288783|NCT02411331|Intravenous Drug Delivery Systems|intravenous drug delivery systems
288784|NCT02411331|Coagulase-negative staphylococci infection|coagulase-negative staphylococci infection
288785|NCT02411331|Ethanol lock solution|ethanol lock solution
288786|NCT02411331|Vancomycin lock solution|vancomycin lock solution
288787|NCT02411279|Heart failure|heart failure
288788|NCT02411279|telemonitoring|telemonitoring
288789|NCT02411279|intrusive sensors|intrusive sensors
288790|NCT02411279|intrusive devices|intrusive devices
288791|NCT02411279|Heart failure stage II|heart failure stage ii
288792|NCT02411279|Heart failure stage III|heart failure stage iii
288793|NCT02411279|heart disease|heart disease
288794|NCT02411253|IL2|il2
288795|NCT02411253|Interleukin 2|interleukin 2
288796|NCT02411253|IL-2|il-2
288797|NCT02411253|Auto-immune disease|auto-immune disease
288798|NCT02411253|Insulin|insulin
288799|NCT02411253|Diabetes|diabetes
288800|NCT02411253|Regulatory T cells|regulatory t cells
288801|NCT02411253|Treg|treg
288802|NCT02411253|Immunoregulation|immunoregulation
288803|NCT02411253|Immune tolerance|immune tolerance
288804|NCT02411253|Immunotherapy|immunotherapy
288805|NCT02411240|Air filtration|air filtration
288806|NCT02411240|cardiovascular health|cardiovascular health
288807|NCT02411240|cognition|cognition
288808|NCT02411240|particulate matter|particulate matter
288809|NCT02411240|mitochondrial DNA|mitochondrial dna
288810|NCT02411227|Neuropsychologic Testing|neuropsychologic testing
288811|NCT02411227|Neurocognitive|neurocognitive
288812|NCT02411227|Virtual Reality|virtual reality
288813|NCT02411227|Rehabilitation|rehabilitation
288814|NCT02411227|Driving|driving
288815|NCT02411175|Constipation|constipation
288816|NCT02411175|Homeopathy|homeopathy
288817|NCT02411162|atopic dermatitis|atopic dermatitis
288818|NCT02411162|FLIM|flim
288819|NCT02411162|chronic plaque psoriasis|chronic plaque psoriasis
288820|NCT02411162|healthy volunteers|healthy volunteers
288821|NCT02411162|GSK2894512|gsk2894512
288822|NCT02411162|Skin residency|skin residency
288823|NCT02411149|Adductor Canal Block|adductor canal block
288824|NCT02411149|Total Knee Arthroplasty|total knee arthroplasty
288825|NCT02411123|PGx|pgx
288826|NCT02411123|pharmacogenetics|pharmacogenetics
288827|NCT02411123|depression|depression
288828|NCT02411123|anxiety|anxiety
288829|NCT02411123|Neuropsychiatric diseases|neuropsychiatric diseases
288830|NCT02411123|IDgenetix|idgenetix
288831|NCT02411123|AltheaDx|altheadx
288832|NCT02411097|Deep venous thromboembolism|deep venous thromboembolism
288833|NCT02411097|Femoral nerve block|femoral nerve block
288834|NCT02411097|Total knee arthroplasty|total knee arthroplasty
288835|NCT02411084|Graft vs Host Disease|graft vs host disease
288836|NCT02411084|Immune System Diseases|immune system diseases
288837|NCT02411084|Dipeptidyl Peptidase 4|dipeptidyl peptidase 4
288838|NCT02411084|CD4-Positive T-Lymphocytes|cd4-positive t-lymphocytes
288839|NCT02411084|Hematopoietic Stem Cell Transplantation|hematopoietic stem cell transplantation
288840|NCT02411071|HIV-1|hiv-1
288841|NCT02411071|antiretroviral treatment|antiretroviral treatment
288842|NCT02411071|low viral load|low viral load
288843|NCT02411071|low-level viremia|low-level viremia
288844|NCT02411058|information|information
288845|NCT02411058|incentives|incentives
288846|NCT02411045|Indirect incentives|indirect incentives
288847|NCT02411045|Exercise more|exercise more
288848|NCT02411019|Phase 2 follow up|phase 2 follow up
288849|NCT02411019|Cervical Intraepithelial Neoplasia|cervical intraepithelial neoplasia
288850|NCT02411019|Adult|adult
288851|NCT02411019|Safety|safety
288852|NCT02411019|Efficacy|efficacy
288853|NCT02410941|Randomized controlled trial|randomized controlled trial
288854|NCT02410941|Practice management|practice management
288855|NCT02410941|tomography, x-ray computed/adverse effects|tomography, x-ray computed/adverse effects
712545|NCT00579774|nutrition|nutrition
288856|NCT02410941|Clinical decision support|clinical decision support
288857|NCT02410941|Computerized clinical decision support|computerized clinical decision support
288858|NCT02410941|Decision support systems, clinical|decision support systems, clinical
288859|NCT02410941|Health Expenditures|health expenditures
288860|NCT02410941|Physician's practice patterns|physician's practice patterns
288861|NCT02410941|Unnecessary Procedures/economics|unnecessary procedures/economics
288862|NCT02410941|Physician's Practice Patterns/economics|physician's practice patterns/economics
288863|NCT02410941|Diffusion of innovation|diffusion of innovation
288864|NCT02410941|Decision Support Models|decision support models
288865|NCT02410941|Clinical Prediction Rules|clinical prediction rules
288866|NCT02410915|Rehabilitation|rehabilitation
288867|NCT02410915|Robotics|robotics
288868|NCT02410902|Autism|autism
288869|NCT02410876|Bladder|bladder
288870|NCT02410876|neurogenic lower urinary tract dysfunction|neurogenic lower urinary tract dysfunction
288871|NCT02410876|benign prostatic obstruction|benign prostatic obstruction
288872|NCT02410863|Stage III or IV with BRAF V600E/K mutation|stage iii or iv with braf v600e/k mutation
288873|NCT02410850|Oral Appliance|oral appliance
288874|NCT02410850|objective adherence|objective adherence
288875|NCT02410850|cardiovascular events|cardiovascular events
288876|NCT02410850|cardiovascular mortality|cardiovascular mortality
288877|NCT02410850|cerebrovascular mortality|cerebrovascular mortality
288878|NCT02410850|cost effectiveness|cost effectiveness
288879|NCT02410837|lung lesion|lung lesion
288880|NCT02410837|biopsy|biopsy
288881|NCT02410837|bronchoscopy|bronchoscopy
288882|NCT02410811|Sickle Cell Disease (SCD)|sickle cell disease (scd)
288883|NCT02410811|Cardiac Magnetic Resonance Imaging (CMR)|cardiac magnetic resonance imaging (cmr)
288884|NCT02410811|Cardiomyopathy|cardiomyopathy
288885|NCT02410811|Pulmonary Hypertension|pulmonary hypertension
288886|NCT02410785|obesity,|obesity,
288887|NCT02410785|body weight,|body weight,
288888|NCT02410785|overweight,|overweight,
288889|NCT02410785|weight loss,|weight loss,
288890|NCT02410785|polyglucosamine,|polyglucosamine,
288891|NCT02410785|L112|l112
288892|NCT02410785|caloric restriction|caloric restriction
288893|NCT02410785|physical activity|physical activity
288894|NCT02410746|pain|pain
288895|NCT02410746|surgery|surgery
288896|NCT02410733|melanoma|melanoma
288897|NCT02410733|Lipo-MERIT|lipo-merit
288898|NCT02410733|cancer vaccine|cancer vaccine
288899|NCT02410733|RB_0003-01|rb_0003-01
288900|NCT02410733|BioNTech|biontech
288901|NCT02410733|BioNTech RNA Pharmaceuticals|biontech rna pharmaceuticals
288902|NCT02410733|BioNTech RNA|biontech rna
288904|NCT02410720|Colonoscopy Preparation|colonoscopy preparation
288905|NCT02410720|Polyethylene Glycols|polyethylene glycols
288906|NCT02410720|Mobile application|mobile application
288907|NCT02410720|Software|software
288908|NCT02410720|Compliance|compliance
288909|NCT02410720|Patient Compliance|patient compliance
288910|NCT02410720|Adherence|adherence
288911|NCT02410707|procedural sedation|procedural sedation
288912|NCT02410707|procedural pain|procedural pain
288913|NCT02410707|procedural anxiolysis|procedural anxiolysis
288914|NCT02410655|Uterine atony|uterine atony
288915|NCT02410655|Postpartum hemorrhage|postpartum hemorrhage
288916|NCT02410655|Vaginal delivery|vaginal delivery
288917|NCT02410655|Uterotonic|uterotonic
288918|NCT02410655|Oxytocin|oxytocin
288919|NCT02410655|Bolus|bolus
288920|NCT02410655|Evidence-based|evidence-based
288921|NCT02410655|Protocol|protocol
288922|NCT02410642|cardiopulmonary bypass|cardiopulmonary bypass
288923|NCT02410629|Stroke|stroke
288924|NCT02410616|Psychotherapy|psychotherapy
288925|NCT02410616|Comparative Effectiveness Research|comparative effectiveness research
288926|NCT02410616|Randomized Controlled Trial|randomized controlled trial
288927|NCT02410616|Secondary Care|secondary care
288928|NCT02410603|Chemotherapy|chemotherapy
288929|NCT02410577|89Zr-J591|89zr-j591
288930|NCT02410577|15-002|15-002
288931|NCT02410564|insomnia|insomnia
288932|NCT02410564|Sleep|sleep
288933|NCT02410564|CBT-I intervention|cbt-i intervention
288934|NCT02410564|SHUTi|shuti
288935|NCT02410551|Myeloproliferative Diseases|myeloproliferative diseases
288936|NCT02410551|Myeloproliferative Neoplasms|myeloproliferative neoplasms
288937|NCT02410551|MPN|mpn
288938|NCT02410551|Myelofibrosis|myelofibrosis
288939|NCT02410551|Polycythemia vera|polycythemia vera
288940|NCT02410551|PV|pv
288941|NCT02410551|Essential thrombocythemia|essential thrombocythemia
288942|NCT02410551|Allogeneic stem cell transplantation|allogeneic stem cell transplantation
288943|NCT02410551|Allo TP|allo tp
288944|NCT02410551|Pacritinib|pacritinib
288945|NCT02410551|Busulfan|busulfan
288946|NCT02410551|Busulfex|busulfex
288947|NCT02410551|Myleran|myleran
288948|NCT02410551|Questionnaires|questionnaires
288949|NCT02410551|Surveys|surveys
288950|NCT02410551|Phone calls|phone calls
288951|NCT02410525|hyperlipidemia|hyperlipidemia
288952|NCT02410525|positron emission tomography|positron emission tomography
288953|NCT02410499|Drug therapy|drug therapy
288954|NCT02410473|Congenital Heart Disease|congenital heart disease
369163|NCT02010203|BCG|bcg
288955|NCT02410473|Point-of-care coagulation monitoring|point-of-care coagulation monitoring
288956|NCT02410447|Shock waves|shock waves
288957|NCT02410434|Stigma|stigma
288958|NCT02410434|lesbian|lesbian
288959|NCT02410434|gay|gay
288960|NCT02410434|bisexual|bisexual
288961|NCT02410434|transgender|transgender
288962|NCT02410421|Individualized Medicine|individualized medicine
288963|NCT02410421|Functional Neuroimaging|functional neuroimaging
288964|NCT02410421|Robotic Proceedure|robotic proceedure
288965|NCT02410421|Transcranial Magnetic Stimulation, Repetitive|transcranial magnetic stimulation, repetitive
288966|NCT02410421|Transcranial Direct Current Stimulation Monocentric|transcranial direct current stimulation monocentric
288967|NCT02410421|Compariative Cross-Over 3 Arms Study Randomized, Single-Blind Method|compariative cross-over 3 arms study randomized, single-blind method
288968|NCT02410408|Patient Safety|patient safety
288969|NCT02410408|App|app
288970|NCT02410408|Root Cause Analysis|root cause analysis
288971|NCT02410408|Patient Safety Certification|patient safety certification
288972|NCT02410382|cancer|cancer
288973|NCT02410382|radiation therapy|radiation therapy
288974|NCT02410382|chemotherapy|chemotherapy
288975|NCT02410382|dexamethasone|dexamethasone
288976|NCT02410382|corticosteroids|corticosteroids
288977|NCT02410343|long acting growth hormone|long acting growth hormone
288978|NCT02410330|Therapeutic ultrasound|therapeutic ultrasound
288979|NCT02410330|Angiographic recanalization rate|angiographic recanalization rate
288980|NCT02410330|Salvagability index|salvagability index
288981|NCT02410330|Sonothrombolysis|sonothrombolysis
288982|NCT02410317|Postoperative pain|postoperative pain
288983|NCT02410317|Postoperative morphine consumption|postoperative morphine consumption
288984|NCT02410317|Emergency cesarean delivery|emergency cesarean delivery
288985|NCT02410317|Ropivacaine|ropivacaine
288986|NCT02410317|Local anesthetic wound 48-hours infusion|local anesthetic wound 48-hours infusion
288987|NCT02410317|Emergency cesarean section|emergency cesarean section
288988|NCT02410304|Rheumatoid arthritis / ultrasonography / synovitis|rheumatoid arthritis / ultrasonography / synovitis
288989|NCT02410265|guided self-help|guided self-help
288990|NCT02410265|student mental health|student mental health
288991|NCT02410265|task shifting|task shifting
288992|NCT02410265|prevention|prevention
288993|NCT02410252|continuous temperature monitoring|continuous temperature monitoring
288994|NCT02410252|patient self-management|patient self-management
288995|NCT02410252|iThermonitor|ithermonitor
288996|NCT02410252|Home monitoring|home monitoring
288997|NCT02410239|Cerebral Adrenoleukodystrophy|cerebral adrenoleukodystrophy
288998|NCT02410239|cALD|cald
288999|NCT02410200|Pediatrics|pediatrics
289000|NCT02410187|stereotactic body radiotherapy|stereotactic body radiotherapy
289001|NCT02410174|Renal Cell Carcinoma|renal cell carcinoma
289002|NCT02410174|RCC|rcc
289003|NCT02410174|Stereotactic Body Radiotherapy|stereotactic body radiotherapy
289004|NCT02410174|SBRT|sbrt
289005|NCT02410161|ketone|ketone
289006|NCT02410161|α-linolenic acid|α-linolenic acid
289007|NCT02410161|flaxseed|flaxseed
289008|NCT02410161|aging|aging
289009|NCT02410161|β-hydroxybutyrate|β-hydroxybutyrate
289010|NCT02410161|acetoacetate|acetoacetate
289011|NCT02410161|omega-3 fatty acids|omega-3 fatty acids
289012|NCT02410161|ketogenesis|ketogenesis
289013|NCT02410148|open-angle glaucoma|open-angle glaucoma
289014|NCT02410148|papilledema|papilledema
289015|NCT02410148|non-invasive ICP|non-invasive icp
289016|NCT02410148|Intracranial pressure|intracranial pressure
289017|NCT02410135|Lower Urinary Tract Symptoms|lower urinary tract symptoms
289018|NCT02410135|Sleep Disturbance|sleep disturbance
289019|NCT02410096|exercise-induced asthma|exercise-induced asthma
289020|NCT02410096|cold chamber|cold chamber
289021|NCT02410096|exercise challenge|exercise challenge
289022|NCT02410096|cold air challenge|cold air challenge
289023|NCT02410096|oil supplementation|oil supplementation
289024|NCT02410096|middle-chain and Polyunsaturated Fatty Acids|middle-chain and polyunsaturated fatty acids
289025|NCT02410070|Distal radial fracture|distal radial fracture
289026|NCT02410070|pronator quadratus|pronator quadratus
289027|NCT02410070|mini-approach|mini-approach
289028|NCT02410070|volar plating|volar plating
289029|NCT02410070|open reduction and internal fixation|open reduction and internal fixation
289030|NCT02410057|growth|growth
289031|NCT02410057|formula|formula
289032|NCT02410057|protein|protein
289033|NCT02410057|alpha-lactalbumin|alpha-lactalbumin
289034|NCT02410057|amino acids|amino acids
289035|NCT02410044|Patient Reported Outcomes|patient reported outcomes
289138|NCT02409511|Hypertension|hypertension
289036|NCT02409992|Children with ODD and low prosocial emotions|children with odd and low prosocial emotions
289037|NCT02409979|colonoscopy|colonoscopy
289038|NCT02409979|carbon dioxide|carbon dioxide
289039|NCT02409979|water exchange|water exchange
289040|NCT02409979|discomfort|discomfort
289041|NCT02409979|colonoscopy pain|colonoscopy pain
289042|NCT02409966|periodontitis|periodontitis
289043|NCT02409966|therapeutics|therapeutics
289044|NCT02409966|quality of life|quality of life
289045|NCT02409966|fear|fear
289046|NCT02409966|anxiety|anxiety
289047|NCT02409966|pain|pain
289048|NCT02409953|volunteers|volunteers
289049|NCT02409927|Medium-chain triglycerides|medium-chain triglycerides
289050|NCT02409927|Metabolism|metabolism
289051|NCT02409927|Ketones|ketones
289052|NCT02409927|Lipids|lipids
289053|NCT02409927|Emulsification|emulsification
289054|NCT02409914|Insulin Resistance|insulin resistance
289055|NCT02409914|Brain metabolism|brain metabolism
289057|NCT02409914|MRI|mri
289058|NCT02409901|Physical Activity|physical activity
289059|NCT02409901|Exercise Rehabilitation|exercise rehabilitation
289060|NCT02409901|Kidney Function|kidney function
289061|NCT02409901|Employment|employment
289062|NCT02409901|Kidney Transplant|kidney transplant
289063|NCT02409875|early intervention|early intervention
289064|NCT02409875|obesity|obesity
289065|NCT02409875|body weight|body weight
289066|NCT02409875|body mass index|body mass index
289067|NCT02409875|overnutrition|overnutrition
289068|NCT02409875|early promoters, genetic|early promoters, genetic
289069|NCT02409862|oxytocin|oxytocin
289070|NCT02409862|socioemotional functioning|socioemotional functioning
289071|NCT02409862|aging|aging
289072|NCT02409849|Octreotide LAR|octreotide lar
289073|NCT02409849|Neuroendocrine carcinomas|neuroendocrine carcinomas
289074|NCT02409849|unresectable or metastatic|unresectable or metastatic
289075|NCT02409849|Disease-free survival|disease-free survival
289076|NCT02409823|adverse drug reactions|adverse drug reactions
289077|NCT02409823|adherence to treatment|adherence to treatment
289078|NCT02409823|quality of life|quality of life
289079|NCT02409823|clinical status|clinical status
289080|NCT02409784|Brain metabolism|brain metabolism
289081|NCT02409784|Ketones|ketones
289082|NCT02409784|Ketogenic diet|ketogenic diet
289083|NCT02409784|TEP scan|tep scan
289084|NCT02409758|Voice disorders|voice disorders
289085|NCT02409758|Hoarseness|hoarseness
289086|NCT02409758|Therapy|therapy
289087|NCT02409745|endometrial scratch|endometrial scratch
289088|NCT02409745|IVF|ivf
289089|NCT02409745|randomized controlled study|randomized controlled study
289090|NCT02409745|Prospective controlled trial|prospective controlled trial
289091|NCT02409745|Different time to perform endometrial scratch|different time to perform endometrial scratch
289092|NCT02409745|In vitro fertilization|in vitro fertilization
289093|NCT02409745|embryo transfer|embryo transfer
289094|NCT02409732|Actinic cheilitis|actinic cheilitis
289095|NCT02409732|Photodynamic therapy|photodynamic therapy
289096|NCT02409732|Levulan|levulan
289097|NCT02409732|Blue light|blue light
289098|NCT02409719|Arthritis, Degenerative|arthritis, degenerative
289099|NCT02409719|Recovery of function|recovery of function
289100|NCT02409706|Paediatric|paediatric
289101|NCT02409706|Critical care|critical care
289102|NCT02409706|Micronutrients|micronutrients
289103|NCT02409680|Preterm birth|preterm birth
289104|NCT02409680|Low dose aspirin|low dose aspirin
289105|NCT02409667|plaque, psoriasis|plaque, psoriasis
289106|NCT02409641|IOL|iol
289107|NCT02409628|Non-melanoma Skin Cancer|non-melanoma skin cancer
289108|NCT02409628|Basal Cell Carcinoma|basal cell carcinoma
289109|NCT02409628|Squamous Cell Carcinoma|squamous cell carcinoma
289110|NCT02409628|Surgical excision|surgical excision
289111|NCT02409628|EktoTherix|ektotherix
289112|NCT02409628|Secondary intention healing|secondary intention healing
289113|NCT02409628|Acute wound repair|acute wound repair
289114|NCT02409628|Tissue repair scaffold|tissue repair scaffold
289115|NCT02409628|Regenerative medicine scaffold|regenerative medicine scaffold
289116|NCT02409628|Electrospun scaffold|electrospun scaffold
289117|NCT02409615|Complementary therapies|complementary therapies
289118|NCT02409615|Hypnosis|hypnosis
289119|NCT02409615|Healing Touch|healing touch
289120|NCT02409602|Ultrasonography, Doppler, Color|ultrasonography, doppler, color
289121|NCT02409602|Postpartum hemorrhage|postpartum hemorrhage
289122|NCT02409602|Bilateral iliac artery ligation|bilateral iliac artery ligation
289123|NCT02409602|Dorsal clitoral artery|dorsal clitoral artery
289124|NCT02409576|EWS|ews
289125|NCT02409576|RMS|rms
289126|NCT02409550|Allergic Rhinitis|allergic rhinitis
289127|NCT02409550|Asthma|asthma
289128|NCT02409550|Children|children
289129|NCT02409550|Control|control
289130|NCT02409537|Asymptomatic hypercholesterolemia,|asymptomatic hypercholesterolemia,
289131|NCT02409537|cardiovascular risk,|cardiovascular risk,
289132|NCT02409537|total antioxidant capacity|total antioxidant capacity
289133|NCT02409537|red wine polyphenol content|red wine polyphenol content
289134|NCT02409537|vitamin E.|vitamin e.
289135|NCT02409537|resveratrol|resveratrol
289136|NCT02409511|Type 1 Diabetic|type 1 diabetic
289137|NCT02409511|Type 2 Diabetic|type 2 diabetic
289139|NCT02409511|Renal Injury|renal injury
289140|NCT02409511|Diabetic retinopathy|diabetic retinopathy
289141|NCT02409498|pudendal nerve block|pudendal nerve block
289142|NCT02409498|vaginal reconstructive surgery|vaginal reconstructive surgery
289143|NCT02409485|self-management|self-management
289144|NCT02409485|head and neck cancer|head and neck cancer
289145|NCT02409485|psychosocial intervention|psychosocial intervention
289146|NCT02409485|couples|couples
289147|NCT02409472|randomized clinical trial|randomized clinical trial
289148|NCT02409433|lacosamide|lacosamide
289149|NCT02409433|phenytoin|phenytoin
289150|NCT02409394|Subjects|subjects
289151|NCT02409303|Autism Spectrum Disorder|autism spectrum disorder
289152|NCT02409303|Screening|screening
289153|NCT02409303|Preventive intervention|preventive intervention
289154|NCT02409303|Risk|risk
289155|NCT02409277|Self-Management|self-management
289156|NCT02409277|Asthma|asthma
289157|NCT02409264|Insomnia|insomnia
289158|NCT02409264|Females|females
289159|NCT02409264|Homeopathy|homeopathy
289160|NCT02409251|Antinuclear antibody (ANA)|antinuclear antibody (ana)
289161|NCT02409251|Overuse|overuse
289162|NCT02409251|Rheumatologists|rheumatologists
289163|NCT02409251|Quality of care|quality of care
289164|NCT02409238|Mild Cognitive Impairment|mild cognitive impairment
289165|NCT02409238|Insulin Resistance|insulin resistance
289166|NCT02409238|Diabetes Mellitus, Type 2|diabetes mellitus, type 2
289167|NCT02409225|remote monitoring|remote monitoring
289168|NCT02409225|ICD|icd
289169|NCT02409225|CRT-D|crt-d
289170|NCT02409199|Gastric Carcinoma|gastric carcinoma
289171|NCT02409199|apatinib|apatinib
289172|NCT02409173|Metabolic syndrome|metabolic syndrome
289173|NCT02409173|Sleep disorders|sleep disorders
289174|NCT02409173|Bariatric Surgery|bariatric surgery
289175|NCT02409173|Noninvasive ventilation|noninvasive ventilation
289176|NCT02409173|Inflammation|inflammation
289177|NCT02409173|Quality of life|quality of life
289178|NCT02409160|Severe Obesity|severe obesity
289179|NCT02409160|Sleep Disorders|sleep disorders
289180|NCT02409160|Bariatric Surgery|bariatric surgery
289181|NCT02409160|Inflammation|inflammation
289182|NCT02409160|Quality of Life|quality of life
289183|NCT02409134|Bone Marrow Transplantation|bone marrow transplantation
289184|NCT02409134|Hematologic Malignancies|hematologic malignancies
289185|NCT02409134|Adults|adults
289186|NCT02409134|Cognition|cognition
289187|NCT02409121|hematopoietic cell transplantation|hematopoietic cell transplantation
289188|NCT02409121|caregivers|caregivers
289189|NCT02409121|health information technology|health information technology
289190|NCT02409121|patient-centered care|patient-centered care
289191|NCT02409069|Transcutaneous vagus nerve stimulation|transcutaneous vagus nerve stimulation
289192|NCT02409069|P300|p300
289193|NCT02409069|Memory task|memory task
289194|NCT02409056|intervention|intervention
289195|NCT02409056|translation|translation
289196|NCT02409056|workplace|workplace
289197|NCT02409056|CVD|cvd
289198|NCT02409056|CDSMP|cdsmp
289199|NCT02409043|Stroke|stroke
289200|NCT02409043|Ischemic stroke|ischemic stroke
289201|NCT02409043|Hemorrhagic stroke|hemorrhagic stroke
289202|NCT02409043|Biomarkers|biomarkers
289203|NCT02409043|Angiotensins|angiotensins
289204|NCT02409017|insulin drip|insulin drip
289205|NCT02409017|labor|labor
289206|NCT02409004|Drug-drug interaction|drug-drug interaction
289207|NCT02408991|Chronic lower limb ischemia|chronic lower limb ischemia
289208|NCT02408991|Art-Assist Device|art-assist device
289209|NCT02408991|Neupogen|neupogen
289210|NCT02408926|Pertussis|pertussis
289211|NCT02408926|Pregnancy|pregnancy
289212|NCT02408926|Humoral immune response|humoral immune response
289213|NCT02408926|Functionality|functionality
289214|NCT02408926|Vaccination|vaccination
289215|NCT02408913|Immunity|immunity
289216|NCT02408913|Ebola Virus|ebola virus
289217|NCT02408913|Ebola Hemorrhagic Fever|ebola hemorrhagic fever
289218|NCT02408913|Healthy|healthy
289219|NCT02408913|Filovirus|filovirus
289220|NCT02408900|Spasticity|spasticity
289221|NCT02408900|Primary Lateral Sclerosis|primary lateral sclerosis
289222|NCT02408900|Elastography|elastography
289223|NCT02408900|Ultrasound|ultrasound
289224|NCT02408887|Thyroidectomy|thyroidectomy
289225|NCT02408887|Serum Thyroglobulin|serum thyroglobulin
289226|NCT02408887|Quality of Life|quality of life
289227|NCT02408887|Central Neck Lymph Node Metastasis|central neck lymph node metastasis
289228|NCT02408887|Central Neck Lymph Node Dissection|central neck lymph node dissection
289229|NCT02408874|Nanoparticles|nanoparticles
289230|NCT02408874|Inflammatory Response|inflammatory response
289231|NCT02408874|Silver|silver
289232|NCT02408874|Lung Function|lung function
289233|NCT02408874|Lung Microbiome|lung microbiome
289234|NCT02408835|negative pressure wound therapy|negative pressure wound therapy
289235|NCT02408835|lymphadenectomy|lymphadenectomy
289236|NCT02408835|wound healing|wound healing
289237|NCT02408809|Orthopaedic Smoking Cessation Discussion|orthopaedic smoking cessation discussion
289238|NCT02408809|Smoking Cessation|smoking cessation
289239|NCT02408809|Randomized Controlled Trial|randomized controlled trial
289338|NCT02408133|elderly|elderly
289240|NCT02408796|Acute otitis media with tympanostomy tubes|acute otitis media with tympanostomy tubes
289241|NCT02408757|ultrasound|ultrasound
289242|NCT02408757|cerebral perfusion|cerebral perfusion
289243|NCT02408757|cerebrospinal fluid drainage|cerebrospinal fluid drainage
289244|NCT02408744|nephroprotection|nephroprotection
289245|NCT02408744|pirfenidone|pirfenidone
289246|NCT02408744|polymorphisms|polymorphisms
289247|NCT02408718|Mobility|mobility
289248|NCT02408718|walking aids|walking aids
289249|NCT02408718|falls|falls
289250|NCT02408718|gait and balance|gait and balance
289251|NCT02408705|Endogenous Glucose Production|endogenous glucose production
289252|NCT02408705|Hypoglycemic clamp|hypoglycemic clamp
289253|NCT02408705|Tracer to Tracee Technique|tracer to tracee technique
289254|NCT02408705|Type 1 diabetes mellitus|type 1 diabetes mellitus
289255|NCT02408692|Emergency contraception|emergency contraception
289256|NCT02408692|Obese BMI|obese bmi
289257|NCT02408692|Normal BMI|normal bmi
289258|NCT02408679|Vitamin D|vitamin d
289259|NCT02408679|Vitamin D Deficiency|vitamin d deficiency
289260|NCT02408679|Vitamin D Insufficiency|vitamin d insufficiency
289261|NCT02408679|Healthy adults|healthy adults
289262|NCT02408679|Predictive questionnaire|predictive questionnaire
289263|NCT02408640|Internet-Based|internet-based
289264|NCT02408640|Treatment|treatment
289265|NCT02408549|Lacosamide|lacosamide
289266|NCT02408549|Vimpat|vimpat
289267|NCT02408549|Epilepsy|epilepsy
289268|NCT02408549|Children|children
289269|NCT02408549|Primary Generalized Tonic Clonic seizures|primary generalized tonic clonic seizures
289270|NCT02408549|Idiopathic Generalized Epilepsy|idiopathic generalized epilepsy
289271|NCT02408549|Adults|adults
289272|NCT02408536|chemotherapy|chemotherapy
289273|NCT02408536|hormone therapy|hormone therapy
289274|NCT02408536|borderline|borderline
289275|NCT02408536|low-grade|low-grade
289276|NCT02408536|serous ovarian cancer|serous ovarian cancer
289277|NCT02408523|Lacosamide|lacosamide
289278|NCT02408523|Vimpat|vimpat
289279|NCT02408523|Epilepsy|epilepsy
289280|NCT02408523|Children|children
289281|NCT02408523|Primary Generalized Tonic Clonic seizures|primary generalized tonic clonic seizures
289282|NCT02408523|Idiopathic Generalized Epilepsy|idiopathic generalized epilepsy
289283|NCT02408523|Adults|adults
289284|NCT02408510|Volunteers|volunteers
289285|NCT02408471|Arthritis|arthritis
289286|NCT02408471|Rheumatoid Arthritis|rheumatoid arthritis
289287|NCT02408471|Systemic Lupus Erythematosus|systemic lupus erythematosus
289288|NCT02408471|Osteoarthritis|osteoarthritis
289289|NCT02408471|Autoimmune Diseases|autoimmune diseases
289290|NCT02408471|Connective Tissue Diseases|connective tissue diseases
289291|NCT02408471|Immune System Diseases|immune system diseases
289292|NCT02408471|Joint Diseases|joint diseases
289293|NCT02408471|Musculoskeletal Diseases|musculoskeletal diseases
289294|NCT02408471|Rheumatic Diseases|rheumatic diseases
289295|NCT02408445|body composition|body composition
289296|NCT02408445|Klinefelter syndrome|klinefelter syndrome
289297|NCT02408445|XXY|xxy
289298|NCT02408445|sex chromosome variation|sex chromosome variation
289299|NCT02408445|sex chromsome aneuploidy|sex chromsome aneuploidy
289300|NCT02408393|Surgery|surgery
289301|NCT02408393|Paravertebral block|paravertebral block
289302|NCT02408393|Chronic pain|chronic pain
289303|NCT02408380|biomarker|biomarker
289304|NCT02408380|disease progression|disease progression
289305|NCT02408367|Training|training
289306|NCT02408367|Cognition|cognition
289307|NCT02408367|Multiple Sclerosis|multiple sclerosis
289308|NCT02408341|Propofol, Induction anesthesia, Doppler tissue imaging|propofol, induction anesthesia, doppler tissue imaging
289309|NCT02408315|induction of labor|induction of labor
289310|NCT02408315|safety|safety
289311|NCT02408315|pharmacokinetic|pharmacokinetic
289312|NCT02408315|misoprostol|misoprostol
289313|NCT02408250|algorithm|algorithm
289314|NCT02408250|critical illness|critical illness
289315|NCT02408250|early exercise|early exercise
289316|NCT02408250|feasibility|feasibility
289317|NCT02408250|intensive care unit|intensive care unit
289318|NCT02408250|physical therapy|physical therapy
289319|NCT02408237|Transcranial direct current stimulation (tDCS)|transcranial direct current stimulation (tdcs)
289320|NCT02408237|tDCS for domiciliary use|tdcs for domiciliary use
289321|NCT02408237|Healthy Participants|healthy participants
289322|NCT02408224|ACS|acs
289323|NCT02408185|infections|infections
289324|NCT02408185|multidrug resistant Gram negative bacteria (MDR-GNB)|multidrug resistant gram negative bacteria (mdr-gnb)
289325|NCT02408185|Skin infections|skin infections
289326|NCT02408185|Pneumonia|pneumonia
289327|NCT02408185|Bacteriemia|bacteriemia
289328|NCT02408185|Nosocomial infections|nosocomial infections
289329|NCT02408172|hypertension|hypertension
289330|NCT02408172|Sleep apnea syndrome|sleep apnea syndrome
289331|NCT02408172|Amlodipine|amlodipine
289332|NCT02408172|metoprolol|metoprolol
289333|NCT02408159|Live, attenuated virus varicella-zoster vaccine|live, attenuated virus varicella-zoster vaccine
289334|NCT02408159|Zostavax|zostavax
289335|NCT02408159|herpes zoster|herpes zoster
289336|NCT02408159|shingles|shingles
289337|NCT02408133|Breast Cancer|breast cancer
289339|NCT02408133|quality of life|quality of life
289340|NCT02408133|exercise|exercise
289341|NCT02408120|Hyperglycemia|hyperglycemia
289342|NCT02408120|Hypoglycemia|hypoglycemia
289343|NCT02408107|Physical activity|physical activity
289344|NCT02408107|Randomized controlled trial|randomized controlled trial
289345|NCT02408094|Rheumatoid Arthritis|rheumatoid arthritis
289346|NCT02408094|Heat-dampness and blood stasis syndrome|heat-dampness and blood stasis syndrome
289347|NCT02408094|Protein markers|protein markers
289348|NCT02408081|Depression|depression
289349|NCT02408081|Family functioning|family functioning
289350|NCT02408081|Family Focused Nursing|family focused nursing
289351|NCT02408081|Quality of life|quality of life
289352|NCT02408068|subjects|subjects
289353|NCT02408029|Focus|focus
289354|NCT02408029|Testing Performance|testing performance
289355|NCT02408029|CORA Hemostasis System|cora hemostasis system
289356|NCT02408003|Transesophageal|transesophageal
289357|NCT02408003|Echocardiography|echocardiography
289358|NCT02408003|Milrinone|milrinone
289359|NCT02408003|Levosimendan|levosimendan
289360|NCT02408003|Strain|strain
289361|NCT02408003|Deformation|deformation
289362|NCT02408003|Diastole|diastole
289363|NCT02408003|Afterload|afterload
289364|NCT02408003|Preload|preload
289365|NCT02408003|Systole|systole
289366|NCT02407964|Drug-Induced Liver Injury|drug-induced liver injury
289367|NCT02407964|DILI|dili
289368|NCT02407938|dysphagia|dysphagia
289369|NCT02407938|reflux symptoms|reflux symptoms
289370|NCT02407938|retrosternal pain|retrosternal pain
289371|NCT02407925|Optical diagnosis|optical diagnosis
289372|NCT02407899|LADA|lada
289373|NCT02407899|saxagliptin|saxagliptin
289374|NCT02407899|vitamin D3|vitamin d3
289375|NCT02407899|C-Peptide|c-peptide
289376|NCT02407873|aged of 75 years or more|aged of 75 years or more
289377|NCT02407860|breast feeding|breast feeding
289378|NCT02407860|sucking|sucking
289379|NCT02407860|dysfunction|dysfunction
289380|NCT02407860|Latch assessment tool|latch assessment tool
289381|NCT02407860|visual analogic scale|visual analogic scale
289382|NCT02407860|infant physiology|infant physiology
289383|NCT02407847|Nurse practitioners|nurse practitioners
289384|NCT02407847|Primary healthcare|primary healthcare
289385|NCT02407847|Emergency Medical Services|emergency medical services
289386|NCT02407847|Substitution of care|substitution of care
289387|NCT02407834|Biofilms|biofilms
289388|NCT02407834|Dentures|dentures
289389|NCT02407834|Denture Cleansers|denture cleansers
289390|NCT02407834|Castor Oil|castor oil
289391|NCT02407834|Stomatitis|stomatitis
289392|NCT02407821|Controlled Clinical Trials, Randomized|controlled clinical trials, randomized
289393|NCT02407821|Kidney Failure|kidney failure
289394|NCT02407821|Renal Insufficiency, Chronic|renal insufficiency, chronic
289395|NCT02407821|Dialysis, Renal|dialysis, renal
289396|NCT02407821|Peritoneal Dialysis|peritoneal dialysis
289397|NCT02407821|Hemodialysis|hemodialysis
289398|NCT02407821|Depressive Symptoms|depressive symptoms
289399|NCT02407821|Selective Serotonin Reuptake Inhibitors|selective serotonin reuptake inhibitors
289400|NCT02407821|Antidepressants|antidepressants
289401|NCT02407821|Escitalopram|escitalopram
289402|NCT02407795|stereotactic radiotherapy|stereotactic radiotherapy
289403|NCT02407795|pain reduction|pain reduction
289404|NCT02407795|quality of life|quality of life
289406|NCT02407782|children|children
289407|NCT02407782|cluster|cluster
289408|NCT02407782|permethrin|permethrin
289409|NCT02407782|Ivermectin|ivermectin
289410|NCT02407769|Liver transplantation|liver transplantation
289411|NCT02407769|Liver cirrhosis|liver cirrhosis
289412|NCT02407769|Branched chain amino acids|branched chain amino acids
289413|NCT02407769|Late evening supplementation|late evening supplementation
289414|NCT02407769|Nutritional status|nutritional status
289415|NCT02407756|Eczema|eczema
289416|NCT02407743|postoperative pain|postoperative pain
289417|NCT02407743|surgery|surgery
289418|NCT02407743|pain resolution|pain resolution
289419|NCT02407743|pain intensity|pain intensity
289420|NCT02407743|persistent postsurgical pain|persistent postsurgical pain
289421|NCT02407743|pain-related genes|pain-related genes
289422|NCT02407743|analgesic|analgesic
289423|NCT02407704|Exercise|exercise
289424|NCT02407704|Physical activity|physical activity
289425|NCT02407704|GABA|gaba
289426|NCT02407704|Venlafaxine|venlafaxine
289427|NCT02407704|fMRI|fmri
289428|NCT02407704|Spectroscopy|spectroscopy
289429|NCT02407704|Reward system|reward system
289430|NCT02407704|BDNF|bdnf
289431|NCT02407704|Sleep|sleep
289432|NCT02407704|Cognitive function|cognitive function
289433|NCT02407704|Biomarkers|biomarkers
289434|NCT02407704|Aerobic exercise|aerobic exercise
289435|NCT02407665|Tai Chi|tai chi
289436|NCT02407665|fMRI|fmri
289437|NCT02407639|insufflation|insufflation
289438|NCT02407639|abdominal pain|abdominal pain
289439|NCT02407626|ischemia|ischemia
289440|NCT02407626|cardiac surgery|cardiac surgery
289441|NCT02407626|volatile anesthetic|volatile anesthetic
289442|NCT02407626|total intravenous anesthesia|total intravenous anesthesia
289443|NCT02407613|breast cancer|breast cancer
289445|NCT02407613|ablation|ablation
289446|NCT02407613|non-invasive treatment|non-invasive treatment
289447|NCT02407600|EMEND for Injection|emend for injection
289448|NCT02407600|5HT-3|5ht-3
289449|NCT02407600|Fosaprepitant|fosaprepitant
289450|NCT02407561|rectal|rectal
289451|NCT02407561|adenocarcinoma|adenocarcinoma
289452|NCT02407561|DecisionDx|decisiondx
289453|NCT02407548|cholesterol efflux|cholesterol efflux
289454|NCT02407548|dyslipidemia|dyslipidemia
289455|NCT02407522|Metabolic Syndrome|metabolic syndrome
289456|NCT02407522|black rice|black rice
289457|NCT02407483|Laparoscopy|laparoscopy
289458|NCT02407483|Training Programs|training programs
289459|NCT02407470|Severe Aplastic Anemia (SAA), Hematopoietic Stem Cells, HSC Transplantation|severe aplastic anemia (saa), hematopoietic stem cells, hsc transplantation
289460|NCT02407470|ATG, Mesenchymal Stem Cells, Transdifferentiation,|atg, mesenchymal stem cells, transdifferentiation,
289461|NCT02407444|Proximal hip fracture|proximal hip fracture
289462|NCT02407444|Elderly patients|elderly patients
289463|NCT02407444|Physiotherapy|physiotherapy
289464|NCT02407444|Leg cycling ergometer|leg cycling ergometer
289465|NCT02407418|spinal manipulation|spinal manipulation
289466|NCT02407418|muscle strength dynamometer|muscle strength dynamometer
289467|NCT02407418|muscle strength|muscle strength
289468|NCT02407405|Objective Response|objective response
289469|NCT02407405|pERK inhibition|perk inhibition
289470|NCT02407405|MEK Inhibition|mek inhibition
289471|NCT02407405|Biopsy|biopsy
289472|NCT02407405|Volumetric MRI|volumetric mri
289473|NCT02407379|Laser|laser
289474|NCT02407379|periodontitis|periodontitis
289475|NCT02407379|scaling root planing|scaling root planing
289476|NCT02407379|bacteria|bacteria
289477|NCT02407379|PMN|pmn
289478|NCT02407366|Inoperable stage III non-small cell lung cancer|inoperable stage iii non-small cell lung cancer
289479|NCT02407366|EGFR mutation|egfr mutation
289480|NCT02407366|Icotinib|icotinib
289481|NCT02407366|Radiotherapy|radiotherapy
289482|NCT02407366|Chemoradiotherapy|chemoradiotherapy
289483|NCT02407353|Phase 1|phase 1
289484|NCT02407353|Double blind|double blind
289485|NCT02407353|Placebo-Controlled|placebo-controlled
289486|NCT02407353|Parallel Design|parallel design
289487|NCT02407353|CSF Aβ Concentrations|csf aβ concentrations
289488|NCT02407353|PF-06648671|pf-06648671
289489|NCT02407340|Alcohol Withdrawal Delirium|alcohol withdrawal delirium
289490|NCT02407327|Circulating tumour cells in Advanced Non Small Cell Lung Cancer|circulating tumour cells in advanced non small cell lung cancer
289491|NCT02407314|Peripheral Arterial Disease|peripheral arterial disease
289492|NCT02407314|Optical Coherence Tomography|optical coherence tomography
289493|NCT02407314|Ticagrelor|ticagrelor
289494|NCT02407314|Aspirin|aspirin
289495|NCT02407314|Claudication|claudication
289496|NCT02407314|Clopidogrel|clopidogrel
289497|NCT02407288|OCD|ocd
289498|NCT02407262|asthma|asthma
289499|NCT02407262|black seed|black seed
289500|NCT02407262|Nigella sativa|nigella sativa
289501|NCT02407262|supplementation|supplementation
289502|NCT02407236|Ustekinumab|ustekinumab
289503|NCT02407236|Inflammatory Bowel Diseases (IBD)|inflammatory bowel diseases (ibd)
289504|NCT02407236|Colitis, Ulcerative|colitis, ulcerative
289505|NCT02407223|Nonradiographic Axial Spondylitis, Ankylosing|nonradiographic axial spondylitis, ankylosing
289506|NCT02407223|Ustekinumab|ustekinumab
289507|NCT02407210|Azilsartan，Olmesartan Medoxomil|azilsartan，olmesartan medoxomil
289508|NCT02407197|T1 mapping|t1 mapping
289509|NCT02407197|CMR|cmr
289510|NCT02407197|Outcome|outcome
289511|NCT02407197|multicenter|multicenter
289512|NCT02407184|Microbiota|microbiota
289513|NCT02407184|Microbiome|microbiome
289514|NCT02407145|retropubic|retropubic
289515|NCT02407145|midurethral sling|midurethral sling
289516|NCT02407145|polyvinylidene fluoride|polyvinylidene fluoride
289517|NCT02407119|H. pylori eradication|h. pylori eradication
289518|NCT02407119|Atrophy|atrophy
289519|NCT02407119|Intestinal metaplasia|intestinal metaplasia
289520|NCT02407119|Endoscopic resection|endoscopic resection
289521|NCT02407119|Stomach neoplasm|stomach neoplasm
289522|NCT02407106|BLIS K12|blis k12
289523|NCT02407106|streptococcus|streptococcus
289524|NCT02407093|Body Composition|body composition
289525|NCT02407093|Military|military
289526|NCT02407093|High-Intensity Functional Training|high-intensity functional training
289527|NCT02407093|Army Physical Fitness|army physical fitness
289528|NCT02407093|CrossFit|crossfit
289529|NCT02407002|Nitroglycerin|nitroglycerin
289530|NCT02407002|Safety|safety
289531|NCT02406976|Exercise|exercise
289532|NCT02406976|Morbidity Obesity|morbidity obesity
289533|NCT02406963|telemedicine|telemedicine
289534|NCT02406950|Sitagliptin|sitagliptin
289535|NCT02406950|Endothelium|endothelium
289536|NCT02406950|Ischemia-Reperfusion Injury|ischemia-reperfusion injury
289537|NCT02406950|human|human
289538|NCT02406924|pin|pin
289539|NCT02406924|particulated graft|particulated graft
289540|NCT02406924|bone augmentation|bone augmentation
289541|NCT02406924|vertical augmentation|vertical augmentation
289542|NCT02406924|horizontal augmentation|horizontal augmentation
289543|NCT02406911|platelet|platelet
289544|NCT02406911|ticagrelor|ticagrelor
289545|NCT02406911|clopidogrel|clopidogrel
289546|NCT02406911|end stage renal disease|end stage renal disease
289547|NCT02406911|hemodialysis|hemodialysis
289548|NCT02406859|Spinal Cord Injury|spinal cord injury
369913|NCT02007070|PD1|pd1
289549|NCT02406859|Constipation|constipation
289550|NCT02406859|Fecal Incontinence|fecal incontinence
289551|NCT02406859|Neurogenic Bowel|neurogenic bowel
289552|NCT02406859|Bowel Biofeedback|bowel biofeedback
289553|NCT02406859|Manometry|manometry
289554|NCT02406846|Pancreatic Neoplasms|pancreatic neoplasms
289555|NCT02406846|Circulating Tumor Cells|circulating tumor cells
289556|NCT02406833|glaucoma|glaucoma
289557|NCT02406833|trabeculectomy|trabeculectomy
289558|NCT02406807|chronic low back pain|chronic low back pain
289559|NCT02406807|HVLA manipulation|hvla manipulation
289560|NCT02406794|Breast cancer|breast cancer
289561|NCT02406794|Hormonal therapy|hormonal therapy
289562|NCT02406794|Aromatase inhibitors|aromatase inhibitors
289563|NCT02406794|Estrogen deprivation|estrogen deprivation
289564|NCT02406794|Myalgia|myalgia
289565|NCT02406794|Arthralgia|arthralgia
289566|NCT02406794|Carpal tunnel syndrome|carpal tunnel syndrome
289567|NCT02406794|Pressure pain threshold|pressure pain threshold
289568|NCT02406794|Neuromuscular taping|neuromuscular taping
289569|NCT02406794|Kinesio taping|kinesio taping
289570|NCT02406781|Efficacy of MK 3475 with Metronomic Cyclophosphamide|efficacy of mk 3475 with metronomic cyclophosphamide
289571|NCT02406781|Advanced Sarcomas|advanced sarcomas
289572|NCT02406781|Leiomyosarcoma|leiomyosarcoma
289573|NCT02406781|Undifferentiated Sarcoma|undifferentiated sarcoma
289574|NCT02406781|Other Sarcoma|other sarcoma
289575|NCT02406781|GIST|gist
289576|NCT02406781|Osteosarcoma|osteosarcoma
289577|NCT02406768|normal controls|normal controls
289578|NCT02406742|CC-122|cc-122
289579|NCT02406742|Pharmacokinetics|pharmacokinetics
289580|NCT02406742|Safety|safety
289581|NCT02406742|Ibrutinib|ibrutinib
289582|NCT02406742|Obinutuzumab|obinutuzumab
289583|NCT02406742|GA101|ga101
289584|NCT02406742|Chronic Lymphocytic Leukemia|chronic lymphocytic leukemia
289585|NCT02406742|Small Lymphocytic Lymphoma|small lymphocytic lymphoma
289586|NCT02406703|local anesthesia|local anesthesia
289587|NCT02406703|regional anesthetic|regional anesthetic
289588|NCT02406690|Endometrial Insufficiency|endometrial insufficiency
289589|NCT02406690|Endometrial Receptivity|endometrial receptivity
289590|NCT02406677|Acute Coronary Syndromes, ACS, Myocardial Infarction, STEMI, NSTEMI, MI, Co-Payments, Copay, Cost Sharing|acute coronary syndromes, acs, myocardial infarction, stemi, nstemi, mi, co-payments, copay, cost sharing
289591|NCT02406638|3D Pelvic floor USG|3d pelvic floor usg
289592|NCT02406638|Mid-Urethral Sling|mid-urethral sling
289593|NCT02406638|TVT|tvt
289594|NCT02406638|TVT-O|tvt-o
289595|NCT02406638|TVT-S|tvt-s
289596|NCT02406612|Vascular Closure Device|vascular closure device
289597|NCT02406612|Femoral Artery Closure|femoral artery closure
289598|NCT02406573|Sensitivity|sensitivity
289599|NCT02406547|Serrated lesion|serrated lesion
289600|NCT02406547|sessile serrated adenoma|sessile serrated adenoma
289601|NCT02406547|Narrow Band Imaging|narrow band imaging
289602|NCT02406547|Colonoscopy|colonoscopy
289603|NCT02406547|colorectal neoplasms|colorectal neoplasms
289604|NCT02406521|Metastatic renal cell carcinoma|metastatic renal cell carcinoma
289605|NCT02406521|mRCC|mrcc
289606|NCT02406482|sex work, Kazakhstan, microfinance, drug use|sex work, kazakhstan, microfinance, drug use
289607|NCT02406443|Type 2 Diabetes, DPP-4 inhibitors, renal sodium excretion|type 2 diabetes, dpp-4 inhibitors, renal sodium excretion
289608|NCT02406339|Physical Therapy|physical therapy
289609|NCT02406339|Rehabilitation|rehabilitation
289610|NCT02406339|Neuromuscular Electrical Stimulation|neuromuscular electrical stimulation
289611|NCT02406339|Muscle Strength|muscle strength
289612|NCT02406300|Hip Fracture|hip fracture
289613|NCT02406300|Regional Anesthesia|regional anesthesia
289614|NCT02406300|Peripheral Nerve Blocks|peripheral nerve blocks
289615|NCT02406300|Post-operative Mortality|post-operative mortality
289616|NCT02406300|Cognitive Dysfunction|cognitive dysfunction
289617|NCT02406300|Quality of Life|quality of life
289618|NCT02406274|Mammography|mammography
289619|NCT02406274|Contrast Enhanced Spectral Mammography|contrast enhanced spectral mammography
289620|NCT02406274|Palpable Breast Abnormalities|palpable breast abnormalities
289621|NCT02406274|15-053|15-053
289622|NCT02406248|NSTEMI|nstemi
289623|NCT02406222|Relapsed|relapsed
289624|NCT02406222|Refractory|refractory
289625|NCT02406222|Pomalidomide|pomalidomide
289626|NCT02406222|Dexamethasone|dexamethasone
289627|NCT02406222|Cyclophosphamide|cyclophosphamide
289628|NCT02406209|uveitis|uveitis
289629|NCT02406209|acute uveitis|acute uveitis
289630|NCT02406209|anterior uveitis|anterior uveitis
289631|NCT02406209|NS2|ns2
289632|NCT02406209|Aldeyra|aldeyra
289633|NCT02406209|prednisolone acetate|prednisolone acetate
289634|NCT02406157|diabetic macular edema|diabetic macular edema
289635|NCT02406157|micropulse|micropulse
289636|NCT02406157|laser|laser
289637|NCT02406157|subthreshold|subthreshold
289638|NCT02406144|Multiple Myeloma|multiple myeloma
289639|NCT02406131|Peripheral Vascular Diseases|peripheral vascular diseases
289640|NCT02406131|Ischemic Preconditioning|ischemic preconditioning
289641|NCT02406131|Inflammation|inflammation
289642|NCT02406131|Angioplasty|angioplasty
289643|NCT02406131|Restenosis|restenosis
289645|NCT02406118|transanal TME quality|transanal tme quality
289646|NCT02406118|CRM|crm
289647|NCT02406105|tremor|tremor
289648|NCT02406105|Parkinson disease|parkinson disease
289649|NCT02406105|functional radioablation|functional radioablation
289650|NCT02406105|Cyber Knife radiosurgery|cyber knife radiosurgery
289651|NCT02406079|tracheotomy|tracheotomy
289652|NCT02406079|procalcitonin|procalcitonin
289653|NCT02406079|sepsis|sepsis
289654|NCT02406053|lung cancer|lung cancer
289655|NCT02406053|antioxidants|antioxidants
289656|NCT02406053|oxidative damage|oxidative damage
289657|NCT02406040|Protein synthesis|protein synthesis
289658|NCT02406040|Protein breakdown|protein breakdown
289659|NCT02406040|Muscle|muscle
289660|NCT02406040|Energy restriction|energy restriction
289661|NCT02406027|Alzheimer's Disease|alzheimer's disease
289662|NCT02406027|JNJ-54861911|jnj-54861911
289663|NCT02406027|Placebo|placebo
289664|NCT02406001|peri-implantitis|peri-implantitis
289665|NCT02406001|osseous defects|osseous defects
289666|NCT02406001|implant surface decontamination|implant surface decontamination
289667|NCT02406001|bone grafting|bone grafting
289668|NCT02406001|surgical therapy|surgical therapy
289669|NCT02406001|porous titanium granules|porous titanium granules
289670|NCT02406001|reconstruction|reconstruction
289671|NCT02405988|Emergency Treatment|emergency treatment
289672|NCT02405988|Morphine Derivates|morphine derivates
289673|NCT02405988|Heroin|heroin
289674|NCT02405988|Antidotes|antidotes
289675|NCT02405988|Administration, Intravenous|administration, intravenous
289676|NCT02405988|Pharmacology|pharmacology
289677|NCT02405988|Naloxone|naloxone
289678|NCT02405988|Healthy volunteers|healthy volunteers
289679|NCT02405962|Acceptance and Commitment Therapy|acceptance and commitment therapy
289680|NCT02405962|Childhood asthma|childhood asthma
289681|NCT02405962|Randomized controlled trial|randomized controlled trial
289682|NCT02405962|Training parents|training parents
289683|NCT02405910|advanced|advanced
289684|NCT02405910|non-squamous|non-squamous
289685|NCT02405910|first line therapy|first line therapy
289686|NCT02405897|flexible bronchoscopy|flexible bronchoscopy
289687|NCT02405897|transbronchial lung biopsy|transbronchial lung biopsy
289688|NCT02405897|forceps|forceps
289689|NCT02405884|Glaucoma|glaucoma
289690|NCT02405884|Renal Insufficiency, Chronic|renal insufficiency, chronic
289691|NCT02405884|Low Tension Glaucoma|low tension glaucoma
289692|NCT02405884|Ocular Hypertension|ocular hypertension
289693|NCT02405858|Metastatic Castration-Resistant Prostate Cancer|metastatic castration-resistant prostate cancer
289694|NCT02405858|Abiraterone Acetate|abiraterone acetate
289695|NCT02405858|ZYTIGA|zytiga
289696|NCT02405858|Prednisolone|prednisolone
289697|NCT02405845|Atherosclerosis|atherosclerosis
289698|NCT02405845|Internal Carotid Artery|internal carotid artery
289699|NCT02405845|Free-floating thrombus|free-floating thrombus
289700|NCT02405845|Ulcerated plaque|ulcerated plaque
289701|NCT02405845|FFT|fft
289702|NCT02405819|Cancer|cancer
289703|NCT02405819|Oncology|oncology
289704|NCT02405819|Survivorship|survivorship
289705|NCT02405819|Care|care
289706|NCT02405819|Plan|plan
289707|NCT02405780|Rheumatoid|rheumatoid
289708|NCT02405780|Arthritis|arthritis
289709|NCT02405767|Diabetic foot ulcer|diabetic foot ulcer
289710|NCT02405754|Corus CAD|corus cad
289711|NCT02405754|Personalized Medicine|personalized medicine
289712|NCT02405754|CAD|cad
289713|NCT02405754|ASGES|asges
289714|NCT02405754|Age/Sex/Gene Expression Score|age/sex/gene expression score
289715|NCT02405754|GES|ges
289716|NCT02405754|CVD|cvd
289717|NCT02405754|CHD|chd
289718|NCT02405754|Precision Medicine|precision medicine
289719|NCT02405754|Clinical Utility|clinical utility
289720|NCT02405754|Gene Expression|gene expression
289721|NCT02405754|Coronary Heart Disease|coronary heart disease
289722|NCT02405754|Cardiovascular Disease|cardiovascular disease
289723|NCT02405754|Chest Pain|chest pain
289724|NCT02405754|Coronary Artery Disease|coronary artery disease
289725|NCT02405754|Angina Pectoris|angina pectoris
289726|NCT02405754|exercise stress testing|exercise stress testing
289727|NCT02405754|CT angiography|ct angiography
289728|NCT02405754|invasive cardiac angiography|invasive cardiac angiography
289729|NCT02405754|African-American patient|african-american patient
289730|NCT02405754|ICA|ica
289731|NCT02405754|CTA|cta
289732|NCT02405728|PICC|picc
289733|NCT02405728|BLOODSTREAM INFECTIONS|bloodstream infections
289734|NCT02405728|VASCULAR ACCESS|vascular access
289735|NCT02405728|DEEP VEIN THROMBOSIS|deep vein thrombosis
289736|NCT02405728|CICC|cicc
289737|NCT02405702|Infection|infection
289738|NCT02405702|Knee|knee
289739|NCT02405702|knee replacement|knee replacement
289740|NCT02405676|Lymphoma|lymphoma
289741|NCT02405676|non-Hodgkin|non-hodgkin
289742|NCT02405676|B-lymphocytes|b-lymphocytes
289743|NCT02405676|Child|child
289744|NCT02405676|Multicenter study|multicenter study
289745|NCT02405663|blood loss|blood loss
289746|NCT02405663|caesarean section|caesarean section
289747|NCT02405663|placental delivery|placental delivery
289748|NCT02405650|CKD, chronic kidney disease, CRIC|ckd, chronic kidney disease, cric
289749|NCT02405637|Feeding intolerance|feeding intolerance
289750|NCT02405637|Simulated amniotic fluid|simulated amniotic fluid
289751|NCT02405637|Necrotizing enterocolitis|necrotizing enterocolitis
289752|NCT02405585|Pancreatic Cancer|pancreatic cancer
289753|NCT02405585|Immunotherapy|immunotherapy
289754|NCT02405585|Vaccine Therapy|vaccine therapy
289755|NCT02405572|formula-fed|formula-fed
289757|NCT02405546|Nasal intubation|nasal intubation
289758|NCT02405546|Counterclockwise rotation|counterclockwise rotation
289759|NCT02405533|AHCC|ahcc
289760|NCT02405533|nutritional supplement|nutritional supplement
289761|NCT02405533|HPV|hpv
289762|NCT02405520|human papillomavirus vaccine|human papillomavirus vaccine
289763|NCT02405520|condylomata acuminata|condylomata acuminata
289764|NCT02405507|Gastrointestinal Discomfort|gastrointestinal discomfort
289765|NCT02405507|Wheat germ|wheat germ
289766|NCT02405507|Constipation|constipation
289767|NCT02405507|Glycaemic Index|glycaemic index
289768|NCT02405507|Blood Cholesterol Level|blood cholesterol level
289769|NCT02405507|Glycaemic Response|glycaemic response
289770|NCT02405507|Cholesterol|cholesterol
289771|NCT02405507|PAC-SYM|pac-sym
289772|NCT02405507|Gut Microbiota|gut microbiota
289773|NCT02405468|blood microbiota|blood microbiota
289774|NCT02405468|coronary disease|coronary disease
289775|NCT02405468|myocardial infarction|myocardial infarction
289776|NCT02405455|cervical insufficiency|cervical insufficiency
289777|NCT02405455|cervical cerclage|cervical cerclage
289778|NCT02405455|cervical pessary|cervical pessary
290032|NCT02404142|NMBA|nmba
289779|NCT02405416|Hepatocellular Carcinoma|hepatocellular carcinoma
289780|NCT02405416|Blood Loss|blood loss
289781|NCT02405416|Haemorrhage|haemorrhage
289782|NCT02405416|Vascular Control|vascular control
289783|NCT02405403|amyotrophic lateral sclerosis disease|amyotrophic lateral sclerosis disease
289784|NCT02405403|PET|pet
289785|NCT02405403|microglial activation|microglial activation
289786|NCT02405390|Storz C-Mac®|storz c-mac®
289787|NCT02405390|Pediatric Airway|pediatric airway
289788|NCT02405390|Cervical Spine Injury|cervical spine injury
289789|NCT02405390|Trauma Airway Management|trauma airway management
289790|NCT02405377|contrast-induced nephropathy|contrast-induced nephropathy
289791|NCT02405377|hydration|hydration
289792|NCT02405377|Percutaneous coronary intervention|percutaneous coronary intervention
289793|NCT02405364|Multiple Myeloma|multiple myeloma
289794|NCT02405364|Carfilzomib|carfilzomib
289795|NCT02405364|Lenalidomide|lenalidomide
289796|NCT02405364|Dexamethasone|dexamethasone
289797|NCT02405364|Patient up to 65 years|patient up to 65 years
289798|NCT02405364|initial management|initial management
289799|NCT02405351|Telemedicine, Stroke, Working Memory, Cognitive Training|telemedicine, stroke, working memory, cognitive training
289800|NCT02405338|AML|aml
289801|NCT02405325|physical activity|physical activity
289802|NCT02405325|multilevel|multilevel
289803|NCT02405325|cost-effectiveness|cost-effectiveness
289804|NCT02405325|older adults|older adults
289805|NCT02405312|communication|communication
289806|NCT02405312|palliative care|palliative care
289807|NCT02405312|death|death
289808|NCT02405299|child|child
289809|NCT02405299|disorders inhibition|disorders inhibition
289810|NCT02405299|neuropsychology|neuropsychology
289811|NCT02405299|rehabilitation|rehabilitation
289812|NCT02405299|ADHD|adhd
289813|NCT02405299|assessment of neurocognitive rehabilitations in ADHD in children|assessment of neurocognitive rehabilitations in adhd in children
289814|NCT02405273|Lung Cancer|lung cancer
289815|NCT02405273|Surgery|surgery
289816|NCT02405273|COPD|copd
289817|NCT02405273|Rehabilitation|rehabilitation
289818|NCT02405247|NSCLC|nsclc
289819|NCT02405247|T790M|t790m
289820|NCT02405247|EGFR|egfr
289821|NCT02405247|TKI|tki
289822|NCT02405247|Resistance|resistance
289823|NCT02405247|Non Small Cell Lung Cancer|non small cell lung cancer
289824|NCT02405247|AZD9291|azd9291
289825|NCT02405234|Radial Head Arthroplasty|radial head arthroplasty
289826|NCT02405221|HPV|hpv
289827|NCT02405221|HPV16|hpv16
289828|NCT02405221|Cervical Cancer|cervical cancer
289829|NCT02405221|TA-CIN|ta-cin
289830|NCT02405221|Vaccine|vaccine
289831|NCT02405221|Adjuvant|adjuvant
289832|NCT02405221|Nickles FaderPI|nickles faderpi
289833|NCT02405182|Magnetic Resonance Imaging|magnetic resonance imaging
289834|NCT02405182|MRI|mri
289835|NCT02405182|Biomarker|biomarker
289836|NCT02405169|Implantology|implantology
289837|NCT02405169|oral surgery|oral surgery
289838|NCT02405169|bone level changes|bone level changes
289839|NCT02405169|marginal bone level|marginal bone level
289840|NCT02405156|Letrozole|letrozole
289841|NCT02405156|misoprostol|misoprostol
289842|NCT02405156|second trimester miscarriage|second trimester miscarriage
289843|NCT02405143|Controlled clinical trial|controlled clinical trial
289844|NCT02405143|Electric Stimulation Therapy|electric stimulation therapy
289845|NCT02405117|Bipolar Disorder|bipolar disorder
289846|NCT02405117|Behavior Therapy|behavior therapy
289847|NCT02405117|Technology Assisted|technology assisted
289848|NCT02405117|Mobile Phone|mobile phone
289849|NCT02405117|Smartphone|smartphone
289850|NCT02405104|osteoarthritis|osteoarthritis
289851|NCT02405104|hip|hip
289852|NCT02405104|knee|knee
289853|NCT02405104|total hip arthroplasty|total hip arthroplasty
289854|NCT02405104|total knee arthroplasty|total knee arthroplasty
289855|NCT02405104|post operative pain management|post operative pain management
289856|NCT02405039|DED|ded
289857|NCT02405039|Disease|disease
289858|NCT02405013|Africa|africa
289859|NCT02405013|Hepatitis C|hepatitis c
289860|NCT02405013|HIV|hiv
289861|NCT02405013|Antiviral treatment|antiviral treatment
289862|NCT02405013|Adults|adults
289863|NCT02405013|HCV genotype 1|hcv genotype 1
289864|NCT02405013|HCV genotype 2|hcv genotype 2
289865|NCT02405013|HCV genotype 4|hcv genotype 4
289866|NCT02404974|physical activity|physical activity
289867|NCT02404948|coronary artery disease|coronary artery disease
289868|NCT02404948|diagnosis|diagnosis
289869|NCT02404948|non-invasive|non-invasive
289870|NCT02404935|Metastatic colorectal cancer|metastatic colorectal cancer
289871|NCT02404935|cetuximab|cetuximab
289872|NCT02404935|maintenance|maintenance
289873|NCT02404922|Safety/Efficacy Study|safety/efficacy study
289874|NCT02404922|Randomized|randomized
289875|NCT02404922|Double Blind|double blind
289876|NCT02404883|Cancer|cancer
289877|NCT02404883|decisional conflict|decisional conflict
289878|NCT02404883|online|online
289879|NCT02404883|decision-aid tool|decision-aid tool
289880|NCT02404870|Diabetes|diabetes
289881|NCT02404870|Phosphate|phosphate
289882|NCT02404870|Fibroblast Growth Factor 23 (FGF23)|fibroblast growth factor 23 (fgf23)
289883|NCT02404870|Vitamin D|vitamin d
289884|NCT02404870|PTH|pth
289885|NCT02404857|Post stroke|post stroke
289886|NCT02404857|BCI|bci
289887|NCT02404857|Reeducation|reeducation
289888|NCT02404857|Hand movement|hand movement
289889|NCT02404831|Physiotherapy|physiotherapy
289890|NCT02404831|Pulmonary Rehabilitation|pulmonary rehabilitation
289891|NCT02404831|Exercise|exercise
289892|NCT02404831|Telerehab|telerehab
289893|NCT02404818|Radiation|radiation
289894|NCT02404818|Cardiac|cardiac
289895|NCT02404818|Hodgkin's lymphoma|hodgkin's lymphoma
289896|NCT02404805|dolutegravir|dolutegravir
289897|NCT02404805|simeprevir|simeprevir
289898|NCT02404805|HIV|hiv
289899|NCT02404805|HCV|hcv
289900|NCT02404792|Frail Elderly|frail elderly
289901|NCT02404792|IGF-1|igf-1
289902|NCT02404779|ICU|icu
289903|NCT02404779|Deep sedation|deep sedation
289904|NCT02404779|Mechanical ventilation|mechanical ventilation
289905|NCT02404779|Traumatic brain injury|traumatic brain injury
289906|NCT02404779|Intracranial hypertension|intracranial hypertension
289907|NCT02404779|Cisatracurium|cisatracurium
289908|NCT02404779|Neuromuscular Blocking Agent|neuromuscular blocking agent
289909|NCT02404779|Randomization versus placebo|randomization versus placebo
289910|NCT02404766|manual therapy|manual therapy
289911|NCT02404766|cervical|cervical
289912|NCT02404766|range of movement|range of movement
289913|NCT02404753|Locally advanced gastric cancer|locally advanced gastric cancer
289914|NCT02404753|Laparoscopic distal D2 gastrectomy|laparoscopic distal d2 gastrectomy
289915|NCT02404753|Neoadjuvant chemotherapy|neoadjuvant chemotherapy
289916|NCT02404740|VP shunted|vp shunted
289917|NCT02404740|Normal intracranial pathology|normal intracranial pathology
289918|NCT02404740|patients|patients
289919|NCT02404727|Osteoarthritis, Hip|osteoarthritis, hip
289920|NCT02404727|acetabular fixation|acetabular fixation
289921|NCT02404727|dual mobility cup|dual mobility cup
289922|NCT02404727|Radiostereometric Analysis|radiostereometric analysis
289923|NCT02404727|Dual-Energy Radiographic Absorptiometry|dual-energy radiographic absorptiometry
289924|NCT02404727|Accelerometry|accelerometry
289925|NCT02404727|total hip arthroplasty|total hip arthroplasty
289926|NCT02404727|intra-prosthetic dislocation|intra-prosthetic dislocation
289927|NCT02404662|Alcohol use disorder|alcohol use disorder
289928|NCT02404662|Depression|depression
289929|NCT02404662|Mood disorders|mood disorders
289930|NCT02404662|Bipolar disorder|bipolar disorder
289931|NCT02404662|Supportive text messages|supportive text messages
289932|NCT02404623|Vitamin D|vitamin d
289933|NCT02404623|Respiratory Morbidity|respiratory morbidity
289934|NCT02404623|prematurity|prematurity
289935|NCT02404610|propofol|propofol
289936|NCT02404610|moderate procedural sedation|moderate procedural sedation
289937|NCT02404610|deep procedural sedation|deep procedural sedation
289938|NCT02404610|memory|memory
289939|NCT02404610|emergency department|emergency department
289940|NCT02404597|Cardiac output|cardiac output
289941|NCT02404597|Low blood pressure|low blood pressure
289942|NCT02404597|Total Body Surface Area (TBSA)|total body surface area (tbsa)
289943|NCT02404584|Metastatic kidney cancer|metastatic kidney cancer
289944|NCT02404545|Hernia|hernia
289945|NCT02404545|Mesh|mesh
290249|NCT02403154|pubic rami|pubic rami
289946|NCT02404545|Ileal conduit|ileal conduit
289947|NCT02404532|OPC-14597 Digital|opc-14597 digital
289948|NCT02404532|Aripiprazole|aripiprazole
289949|NCT02404532|Medical Information Device #1 System (MIND1)|medical information device #1 system (mind1)
289950|NCT02404532|Ingestible Event Marker|ingestible event marker
289951|NCT02404519|Vitamin K|vitamin k
289952|NCT02404519|Menaquinone-7|menaquinone-7
289953|NCT02404519|Matrix Gla Protein|matrix gla protein
289954|NCT02404519|Vascular stiffness|vascular stiffness
289955|NCT02404506|Eribulin|eribulin
289956|NCT02404506|Breast Cancer|breast cancer
289957|NCT02404506|Elderly Patient|elderly patient
289958|NCT02404506|Phase II Trial|phase ii trial
289959|NCT02404506|HER2-neg|her2-neg
289960|NCT02404506|adenocarcinoma|adenocarcinoma
289961|NCT02404493|Atopic Dermatitis|atopic dermatitis
289962|NCT02404441|Phase I/II, PDR001, Checkpoint inhibitor, PD-1, PD-L1|phase i/ii, pdr001, checkpoint inhibitor, pd-1, pd-l1
289963|NCT02404428|active surveillance|active surveillance
289964|NCT02404428|MRI|mri
289965|NCT02404428|diet|diet
289966|NCT02404415|catheter ablation|catheter ablation
289967|NCT02404415|genomics|genomics
289968|NCT02404402|Traumatic Brain Injury|traumatic brain injury
289969|NCT02404402|Light Emitting Diodes|light emitting diodes
289970|NCT02404402|Cognition|cognition
289971|NCT02404402|Neuromodulation|neuromodulation
289972|NCT02404402|PTSD|ptsd
289973|NCT02404402|Neurorehabilitation|neurorehabilitation
289974|NCT02404402|Veterans|veterans
289975|NCT02404402|Sleep|sleep
289976|NCT02404389|Actinic keratosis, patients, topical, lesion count, clearance rate|actinic keratosis, patients, topical, lesion count, clearance rate
289977|NCT02404376|STEMI|stemi
289978|NCT02404376|Reperfusion Injury|reperfusion injury
289979|NCT02404376|Myocardial Infarction|myocardial infarction
289980|NCT02404376|Myocardial Ischemia|myocardial ischemia
289981|NCT02404376|Remote Ischemic Conditioning|remote ischemic conditioning
289982|NCT02404376|Exenatide|exenatide
289983|NCT02404376|Glucagon-Like Peptide-1 (GLP-1)|glucagon-like peptide-1 (glp-1)
289984|NCT02404376|Acute Coronary Syndrome|acute coronary syndrome
289985|NCT02404376|Cardioprotection|cardioprotection
289986|NCT02404363|Clopidogrel|clopidogrel
289987|NCT02404363|Pancreatic Cancer|pancreatic cancer
289988|NCT02404363|Efficacy|efficacy
289989|NCT02404363|Chemotherapy|chemotherapy
289990|NCT02404363|Microparticles|microparticles
289991|NCT02404363|Disease free survival|disease free survival
289992|NCT02404363|First line chemotherapy|first line chemotherapy
289993|NCT02404350|Psoriatic Arthritis, Arthritis, Psoriatic, Psoriatic Arthropathy|psoriatic arthritis, arthritis, psoriatic, psoriatic arthropathy
289994|NCT02404311|HIV|hiv
289995|NCT02404311|AIDS|aids
289996|NCT02404311|Vaccine|vaccine
289997|NCT02404298|Transcriptome analysis|transcriptome analysis
289998|NCT02404298|peripheral blood|peripheral blood
289999|NCT02404298|chronic inflammatory demyelinating polyradiculoneuropathy|chronic inflammatory demyelinating polyradiculoneuropathy
290000|NCT02404298|auto immune diseases|auto immune diseases
290001|NCT02404298|IVIg|ivig
290002|NCT02404272|Neonate|neonate
290003|NCT02404272|oral feeding disorder|oral feeding disorder
290004|NCT02404272|full oral feeding|full oral feeding
290005|NCT02404272|training|training
290006|NCT02404272|quality of health care|quality of health care
290007|NCT02404259|pharmacokinetics|pharmacokinetics
290008|NCT02404259|TDF|tdf
290009|NCT02404259|HIV-infected children|hiv-infected children
290010|NCT02404259|Thai|thai
290011|NCT02404259|non-nucleoside reverse transcriptase inhibitor (NNRTI)|non-nucleoside reverse transcriptase inhibitor (nnrti)
290012|NCT02404259|ritonavir-boosted protease inhibitor (bPI)|ritonavir-boosted protease inhibitor (bpi)
290013|NCT02404259|less than eighteen years old|less than eighteen years old
290014|NCT02404246|Bipolar|bipolar
290015|NCT02404246|Peers|peers
290016|NCT02404246|DBSA|dbsa
290017|NCT02404220|Syk inhibitor|syk inhibitor
290018|NCT02404220|Blood malignancy|blood malignancy
290019|NCT02404220|Leukemia|leukemia
290020|NCT02404207|Prevention|prevention
290021|NCT02404194|schizophrenia|schizophrenia
290022|NCT02404194|psychosis|psychosis
290023|NCT02404194|at risk|at risk
290024|NCT02404194|prodrome|prodrome
290025|NCT02404194|attenuated psychosis syndrome|attenuated psychosis syndrome
290026|NCT02404181|Validation Studies|validation studies
290027|NCT02404181|EEG|eeg
290028|NCT02404142|Trachel intubation|trachel intubation
290029|NCT02404142|IDS score|ids score
290030|NCT02404142|Videoaryngoscopy|videoaryngoscopy
290031|NCT02404142|Glidescope® Titanium®|glidescope® titanium®
290033|NCT02404142|Curare (Atracurium)|curare (atracurium)
290034|NCT02404129|Fall|fall
290035|NCT02404129|Turn 180 test|turn 180 test
290036|NCT02404129|elderly|elderly
290037|NCT02404129|balance|balance
290038|NCT02404090|Obesity|obesity
290039|NCT02404090|Weight Loss|weight loss
290040|NCT02404090|Knee Osteoarthritis|knee osteoarthritis
290041|NCT02404090|Subchondral Mineralization|subchondral mineralization
290042|NCT02404077|Patients|patients
290043|NCT02404077|undergoing|undergoing
290044|NCT02404077|ICU|icu
290045|NCT02404051|Breast cancer|breast cancer
290046|NCT02404051|HER2Negative|her2negative
290047|NCT02404051|hormone receptor positive (HR+)|hormone receptor positive (hr+)
290048|NCT02404051|Metastatic|metastatic
290049|NCT02404051|Locally Advanced|locally advanced
290050|NCT02404051|fulvestrant|fulvestrant
290051|NCT02404051|everolimus|everolimus
290052|NCT02404051|exemestane|exemestane
290053|NCT02404038|choice|choice
290054|NCT02404038|young women|young women
290055|NCT02404038|adolescent girls|adolescent girls
290056|NCT02404038|preference|preference
290057|NCT02404025|Eltrombopag|eltrombopag
290058|NCT02404025|rabbit anti-thymocyte globulin|rabbit anti-thymocyte globulin
290059|NCT02404025|additive effect|additive effect
290060|NCT02404025|cyclosporine A|cyclosporine a
290061|NCT02404025|bone marrow|bone marrow
290062|NCT02404025|hematopoietic stem cells|hematopoietic stem cells
290063|NCT02404025|pancytopenia|pancytopenia
290064|NCT02404025|leukopenia|leukopenia
290065|NCT02404025|platelets|platelets
290066|NCT02404025|throbocytopenia|throbocytopenia
290067|NCT02404025|mature blood cells|mature blood cells
290068|NCT02404025|bone marrow biopsy|bone marrow biopsy
290069|NCT02404012|iron deficiency|iron deficiency
290070|NCT02404012|sleeve gastrectomy|sleeve gastrectomy
290071|NCT02404012|gastric bypass|gastric bypass
290072|NCT02404012|bariatric surgery|bariatric surgery
290073|NCT02403973|Patient hotel|patient hotel
290074|NCT02403973|Patient Satisfaction|patient satisfaction
290075|NCT02403973|Perioperative care|perioperative care
290076|NCT02403973|IN2005E|in2005e
290077|NCT02403947|Multiple Sclerosis|multiple sclerosis
290078|NCT02403947|Bone-marrow|bone-marrow
290079|NCT02403947|Stem cells|stem cells
290080|NCT02403947|Cell therapy|cell therapy
290081|NCT02403934|Airway Management|airway management
290082|NCT02403934|deep sedation|deep sedation
290083|NCT02403934|Jaw elevation device|jaw elevation device
290084|NCT02403921|biomarker|biomarker
290085|NCT02403908|radiofrequency denervation, pulmonary hypertension|radiofrequency denervation, pulmonary hypertension
290086|NCT02403882|behavioral economics|behavioral economics
290087|NCT02403882|food pantry|food pantry
290088|NCT02403882|food choice|food choice
290089|NCT02403869|Metastatic breast cancer|metastatic breast cancer
290090|NCT02403869|Monotherapy|monotherapy
290091|NCT02403869|chemotherapy|chemotherapy
290092|NCT02403869|second line|second line
290093|NCT02403869|treatment|treatment
290094|NCT02403869|Her 2 negative|her 2 negative
290095|NCT02403856|calcifying tendinitis|calcifying tendinitis
290096|NCT02403856|Needle lavage|needle lavage
290097|NCT02403856|Shoulder|shoulder
290098|NCT02403856|Corticosteroid injection|corticosteroid injection
290099|NCT02403856|Ultrasound-guided|ultrasound-guided
290100|NCT02403817|Video Games|video games
290101|NCT02403804|Dietary supplements|dietary supplements
290102|NCT02403804|serum choline|serum choline
290103|NCT02403804|women|women
290104|NCT02403791|Acute Respiratory Distress Syndrome|acute respiratory distress syndrome
290105|NCT02403778|Melanoma|melanoma
290106|NCT02403778|Malignant Melanoma|malignant melanoma
290107|NCT02403752|dementia|dementia
290108|NCT02403752|Alzheimer's disease|alzheimer's disease
290109|NCT02403752|exercise|exercise
290110|NCT02403739|Growth|growth
290111|NCT02403700|bone remodeling|bone remodeling
290112|NCT02403700|bone resorption|bone resorption
290113|NCT02403700|three-dimensional imaging|three-dimensional imaging
290114|NCT02403700|clinical trial|clinical trial
290115|NCT02403700|dental implant|dental implant
290116|NCT02403700|maxilla|maxilla
290117|NCT02403700|bone healing|bone healing
290118|NCT02403635|HSV|hsv
290119|NCT02403635|Herpes|herpes
290120|NCT02403635|volunteers|volunteers
290121|NCT02403635|drug-drug interaction|drug-drug interaction
290122|NCT02403609|cognitive assessment|cognitive assessment
290123|NCT02403609|Brain Performance Test|brain performance test
290124|NCT02403609|Lumosity|lumosity
290125|NCT02403609|test-retest reliability|test-retest reliability
290126|NCT02403609|computerized assessment|computerized assessment
290127|NCT02403596|Hip replacement|hip replacement
290128|NCT02403596|rivaroxaban|rivaroxaban
290129|NCT02403596|exacyl|exacyl
290130|NCT02403596|blood loss|blood loss
290131|NCT02403583|HIV Transmission|hiv transmission
290132|NCT02403583|Prevention of Mother to Child Transmission|prevention of mother to child transmission
290133|NCT02403583|Serodiscordancy|serodiscordancy
290134|NCT02403583|Home-based testing|home-based testing
290135|NCT02403583|Home-based counseling|home-based counseling
290136|NCT02403583|Linkage to care|linkage to care
290137|NCT02403583|Couples HIV Testing and Counseling|couples hiv testing and counseling
290138|NCT02403583|Acceptance of repeat HIV testing during pregnancy|acceptance of repeat hiv testing during pregnancy
290139|NCT02403583|Retention in care|retention in care
290140|NCT02403570|Multiple Sclerosis, MRI, rotating frame|multiple sclerosis, mri, rotating frame
290141|NCT02403544|Clinical Trial, Phase I|clinical trial, phase i
290142|NCT02403544|Concurrent Chemoradiation|concurrent chemoradiation
290143|NCT02403544|Oxaliplatin|oxaliplatin
290144|NCT02403544|Capecitabine|capecitabine
290145|NCT02403544|Carcinoma, Hepatocellular|carcinoma, hepatocellular
290146|NCT02403531|Esophageal cancer|esophageal cancer
290250|NCT02403128|362.17|362.17
290147|NCT02403531|Chemoradiotherapy|chemoradiotherapy
290148|NCT02403531|induction chemotherapy|induction chemotherapy
290149|NCT02403505|Prostate Cancer|prostate cancer
290150|NCT02403505|SNP|snp
290151|NCT02403505|Single Nucleotide Polymorphism|single nucleotide polymorphism
290152|NCT02403505|Genetics|genetics
290153|NCT02403505|Pharmacogenomic|pharmacogenomic
290154|NCT02403505|Pharmacogenetic|pharmacogenetic
290155|NCT02403505|gene|gene
290156|NCT02403505|genome|genome
290157|NCT02403505|genotype|genotype
290158|NCT02403505|genotyping|genotyping
290159|NCT02403505|Oncology|oncology
290160|NCT02403505|Chemotherapy|chemotherapy
290161|NCT02403505|Personalize|personalize
290162|NCT02403505|Individualize|individualize
290163|NCT02403492|Children|children
290164|NCT02403492|Obesity|obesity
290165|NCT02403492|Cardiovascular|cardiovascular
290166|NCT02403492|Sleep|sleep
290167|NCT02403492|Apnea|apnea
290168|NCT02403492|Obstructive|obstructive
290169|NCT02403466|Medical errors|medical errors
290170|NCT02403466|Communication|communication
290171|NCT02403466|Resident sign-out|resident sign-out
290172|NCT02403453|Radiculopathy|radiculopathy
290173|NCT02403453|Myelopathy|myelopathy
290174|NCT02403453|Spondylosis|spondylosis
290175|NCT02403453|Herniated Nucleus Pulposus|herniated nucleus pulposus
290176|NCT02403453|C3-C7|c3-c7
290177|NCT02403453|Osteophytes|osteophytes
290178|NCT02403453|Neurological deficit|neurological deficit
290179|NCT02403427|Bolus calculator|bolus calculator
290180|NCT02403427|Insulin pump|insulin pump
290181|NCT02403427|basal-bolus insulin therapy|basal-bolus insulin therapy
290182|NCT02403401|Pregnancy prevention|pregnancy prevention
290183|NCT02403388|Patient safety|patient safety
290184|NCT02403388|Primary care|primary care
290185|NCT02403388|Incident reporting|incident reporting
290186|NCT02403388|Pluridisciplinary care offices|pluridisciplinary care offices
290187|NCT02403388|Risk management|risk management
290188|NCT02403388|Assessment|assessment
290189|NCT02403310|adverse-risk AML|adverse-risk aml
290190|NCT02403310|poor-risk karyotype|poor-risk karyotype
290191|NCT02403310|cytogenetic abnormality|cytogenetic abnormality
290192|NCT02403310|poor-risk mutations|poor-risk mutations
290193|NCT02403310|antecedent hematologic disorder|antecedent hematologic disorder
290194|NCT02403310|treatment related AML|treatment related aml
290195|NCT02403297|Bleeding gums|bleeding gums
290196|NCT02403297|Gum inflammation|gum inflammation
290197|NCT02403297|Saliva|saliva
290198|NCT02403284|insulin resistance|insulin resistance
290199|NCT02403284|lipid metabolism|lipid metabolism
290200|NCT02403284|glucose metabolism|glucose metabolism
290201|NCT02403284|high fat diets|high fat diets
290202|NCT02403271|Pharmacyclics|pharmacyclics
290203|NCT02403271|PCYC|pcyc
290204|NCT02403271|Ibrutinib|ibrutinib
290205|NCT02403271|Durvalumab (MEDI4736)|durvalumab (medi4736)
290206|NCT02403271|Relapsed Refractory Solid Tumor|relapsed refractory solid tumor
290207|NCT02403271|Non-Small Cell Lung Cancer|non-small cell lung cancer
290208|NCT02403271|NSCLC|nsclc
290209|NCT02403271|Squamous|squamous
290210|NCT02403271|Squamous NSCLC|squamous nsclc
290211|NCT02403271|Squamous Non-Small Cell Lung Cancer|squamous non-small cell lung cancer
290212|NCT02403271|Immunotherapy|immunotherapy
290213|NCT02403271|IMBRUVICA®|imbruvica®
290214|NCT02403271|Tumor Immunotherapy|tumor immunotherapy
290215|NCT02403271|Anti-PD-L1|anti-pd-l1
290216|NCT02403271|Lung Cancer|lung cancer
290217|NCT02403271|Breast Cancer|breast cancer
290218|NCT02403271|Triple Negative|triple negative
290219|NCT02403271|HER2 Positive|her2 positive
290220|NCT02403271|HER2 + Breast Cancer|her2 + breast cancer
290221|NCT02403271|Pancreatic Cancer|pancreatic cancer
290222|NCT02403258|acupuncture|acupuncture
290223|NCT02403258|plum-blossom needle|plum-blossom needle
290224|NCT02403258|tourette syndrome|tourette syndrome
290225|NCT02403258|randomized controlled trial|randomized controlled trial
290226|NCT02403245|Social interactions|social interactions
290227|NCT02403245|Dementia|dementia
290228|NCT02403245|Social stimulation|social stimulation
290229|NCT02403245|Direct observation|direct observation
290230|NCT02403232|Autologous adipose-derived stem cells|autologous adipose-derived stem cells
290231|NCT02403219|Dry eye|dry eye
290232|NCT02403219|Botulinum toxin A|botulinum toxin a
290233|NCT02403219|Orbicularis muscle of the eye|orbicularis muscle of the eye
290234|NCT02403193|Adenosine A2a receptor antagonist|adenosine a2a receptor antagonist
290235|NCT02403193|NSCLC|nsclc
290236|NCT02403193|PBF-509|pbf-509
290237|NCT02403193|Immunotherapy|immunotherapy
290238|NCT02403193|adenosine|adenosine
290239|NCT02403193|PDR001|pdr001
290240|NCT02403193|immune checkpoint inhibitors|immune checkpoint inhibitors
290241|NCT02403193|Programmed Death-1 (PD-1) receptor|programmed death-1 (pd-1) receptor
290242|NCT02403193|Adenosine A2a receptor (A2AR)|adenosine a2a receptor (a2ar)
290243|NCT02403180|Visual Performance|visual performance
752941|NCT00430365|Revlimid|revlimid
290244|NCT02403154|Anterior pelvic ring|anterior pelvic ring
290245|NCT02403154|Internal fixation|internal fixation
290246|NCT02403154|External fixation|external fixation
290247|NCT02403154|Orthopaedic|orthopaedic
290248|NCT02403154|Orthopedic|orthopedic
290251|NCT02403102|Magnetic Resonance Imaging|magnetic resonance imaging
290252|NCT02403102|Myeloma|myeloma
290253|NCT02403102|Autograft|autograft
290254|NCT02403089|MAIT (Mucosal-Associated Invariant T) cells|mait (mucosal-associated invariant t) cells
290255|NCT02403089|Gut microbiota|gut microbiota
290256|NCT02403089|Preterm birth|preterm birth
290257|NCT02403089|Hematopoietic stem cell transplantation|hematopoietic stem cell transplantation
290258|NCT02403089|Microbial infections|microbial infections
290259|NCT02403050|Neoplasm Staging|neoplasm staging
290260|NCT02403050|Radiotherapy|radiotherapy
290261|NCT02403050|Fiducial Markers|fiducial markers
290262|NCT02403037|Breast Neoplasms|breast neoplasms
290263|NCT02403037|Auricular Therapy|auricular therapy
290264|NCT02403037|Acupressure|acupressure
290265|NCT02403037|Chemotherapy|chemotherapy
290266|NCT02403037|Nausea|nausea
290267|NCT02403037|Vomiting|vomiting
290268|NCT02403024|Colon cancer|colon cancer
290269|NCT02403024|rectal cancer|rectal cancer
290270|NCT02403024|exercise|exercise
290271|NCT02403024|physical activity|physical activity
290272|NCT02403024|metabolic health|metabolic health
290273|NCT02403011|Congenital Muscular Torticollis|congenital muscular torticollis
290274|NCT02403011|Manual Therapy|manual therapy
290275|NCT02403011|Infant|infant
290276|NCT02402998|Primacy immune thrombocytopenia|primacy immune thrombocytopenia
290277|NCT02402998|Adults|adults
290278|NCT02402998|Eltrombopag|eltrombopag
290279|NCT02402998|Long-term remission|long-term remission
290280|NCT02402985|nutritional support|nutritional support
290281|NCT02402985|diet therapy|diet therapy
290282|NCT02402985|protein diet|protein diet
290283|NCT02402985|isocaloric diet|isocaloric diet
290284|NCT02402972|adjuvant chemotherapy|adjuvant chemotherapy
290285|NCT02402972|intraportal chemotherapy|intraportal chemotherapy
290286|NCT02402972|prevention|prevention
290287|NCT02402959|Insomnia|insomnia
290288|NCT02402959|Traditional Chinese Medicine|traditional chinese medicine
290289|NCT02402959|herbal medicine|herbal medicine
290290|NCT02402959|cohort study|cohort study
290291|NCT02402959|individualized treatment|individualized treatment
290292|NCT02402959|TCM pattern differentiation|tcm pattern differentiation
290293|NCT02402907|cesarean section|cesarean section
290294|NCT02402907|chlorhexidine gluconate|chlorhexidine gluconate
290295|NCT02402907|CHG|chg
290296|NCT02402907|surgical site infection|surgical site infection
290297|NCT02402907|obstetrics|obstetrics
290298|NCT02402907|infection prevention|infection prevention
290299|NCT02402907|pregnancy|pregnancy
290300|NCT02402881|venous thromboembolism|venous thromboembolism
290301|NCT02402881|deep venous thrombosis|deep venous thrombosis
290302|NCT02402881|pulmonary embolism|pulmonary embolism
290303|NCT02402881|blood clots|blood clots
290304|NCT02402855|Couverture Maladie Universelle|couverture maladie universelle
290305|NCT02402855|Couverture Maladie Universelle-Complémentaire|couverture maladie universelle-complémentaire
290306|NCT02402855|free health care|free health care
290307|NCT02402842|gastrointestinal oncology|gastrointestinal oncology
290308|NCT02402842|immunology|immunology
290309|NCT02402842|taxane|taxane
290310|NCT02402764|Triple Negative Breast Cancer (TNBC)|triple negative breast cancer (tnbc)
290311|NCT02402764|Breast - Female|breast - female
290312|NCT02402764|Breast - Male|breast - male
290313|NCT02402764|Metastatic Triple Negative Breast Cancer|metastatic triple negative breast cancer
290314|NCT02402764|Receptor Tyrosine-protein Kinase erbB-2 (HER2) Negative|receptor tyrosine-protein kinase erbb-2 (her2) negative
290315|NCT02402764|Erythroblastosis virus oncogene B (erbB)|erythroblastosis virus oncogene b (erbb)
290316|NCT02402751|Volunteers|volunteers
290317|NCT02402725|Relapsed Multiple Myeloma|relapsed multiple myeloma
290318|NCT02402699|HBV|hbv
290319|NCT02402699|HBC|hbc
290320|NCT02402647|Hoarding|hoarding
290321|NCT02402647|Compulsive Hoarding|compulsive hoarding
290322|NCT02402595|Drug-drug interaction|drug-drug interaction
290323|NCT02402595|Healthy Volunteers|healthy volunteers
290324|NCT02402595|Pharmacokinetics|pharmacokinetics
290325|NCT02402595|deuterated dextromethorphan|deuterated dextromethorphan
290326|NCT02402595|dextromethorphan|dextromethorphan
290327|NCT02402595|dextromethorphan with quinidine|dextromethorphan with quinidine
290328|NCT02402595|deuterated dextromethorphan with quinidine|deuterated dextromethorphan with quinidine
290329|NCT02402595|itraconazole|itraconazole
290330|NCT02402582|Family-Centered Empowerment Model|family-centered empowerment model
290331|NCT02402582|Quality of life|quality of life
290332|NCT02402582|Perceived stress|perceived stress
290333|NCT02402582|Anxiety|anxiety
290334|NCT02402582|Myocardial infarction|myocardial infarction
290335|NCT02402582|Clinical trial|clinical trial
290336|NCT02402582|Iran|iran
290337|NCT02402543|preemptive analgesia|preemptive analgesia
290338|NCT02402543|anorectal surgery|anorectal surgery
290339|NCT02402543|gabapentin|gabapentin
290340|NCT02402543|neurontin|neurontin
290341|NCT02402543|ketamine|ketamine
290342|NCT02402543|acetaminophen|acetaminophen
290343|NCT02402543|tylenol|tylenol
290344|NCT02402543|postoperative pain|postoperative pain
290345|NCT02402543|postoperative narcotic usage|postoperative narcotic usage
290346|NCT02402543|dexamethasone|dexamethasone
290347|NCT02402543|decadron|decadron
290348|NCT02402530|Neridronic Acid|neridronic acid
290349|NCT02402530|Neridronate|neridronate
290350|NCT02402530|CRPS|crps
290351|NCT02402530|RSD|rsd
290352|NCT02402517|Diabetes Prevention|diabetes prevention
290353|NCT02402517|Obesity Prevention|obesity prevention
290354|NCT02402491|Dual Antiplatelet Treatment|dual antiplatelet treatment
290355|NCT02402491|In-Stent Restenosis|in-stent restenosis
290356|NCT02402478|Clinical Cohort|clinical cohort
290357|NCT02402478|Electronic Health Records|electronic health records
290358|NCT02402478|Prognosis|prognosis
290359|NCT02402478|Stable Coronary Artery Disease|stable coronary artery disease
290360|NCT02402439|Type 1 diabetes|type 1 diabetes
290361|NCT02402439|diabetes mellitus|diabetes mellitus
290362|NCT02402439|pancreatic islet transplant|pancreatic islet transplant
290363|NCT02402439|beta cell replacement|beta cell replacement
290364|NCT02402426|Brain Health|brain health
290365|NCT02402426|Brain Research|brain research
290366|NCT02402426|Alzheimer's Disease|alzheimer's disease
290367|NCT02402426|Neurodegenerative Disease|neurodegenerative disease
290368|NCT02402426|Parkinson's Disease|parkinson's disease
290369|NCT02402426|Dementia|dementia
290370|NCT02402426|Stroke|stroke
290371|NCT02402426|PTSD|ptsd
290372|NCT02402426|Multiple Sclerosis|multiple sclerosis
290373|NCT02402400|NSTEMI|nstemi
290374|NCT02402361|Neuropathic pain|neuropathic pain
290375|NCT02402361|Diabetic Neuropathy|diabetic neuropathy
290376|NCT02402348|head and neck squamous cell carcinoma|head and neck squamous cell carcinoma
290377|NCT02402309|Sjögren-Larsson Syndrome|sjögren-larsson syndrome
290378|NCT02402309|SLS|sls
290379|NCT02402309|Ichthyosis|ichthyosis
290380|NCT02402309|FALDH Deficiency|faldh deficiency
290381|NCT02402309|Neuro-ichthyosis|neuro-ichthyosis
290382|NCT02402309|Fatty Alcohol:NAD+ Oxidoreductase Deficiency|fatty alcohol:nad+ oxidoreductase deficiency
290383|NCT02402309|Fatty Aldehyde Dehydrogenase Deficiency Disease|fatty aldehyde dehydrogenase deficiency disease
290384|NCT02402309|Congenital Icthyosis Mental Retardation Spasticity Syndrome|congenital icthyosis mental retardation spasticity syndrome
290385|NCT02402309|Spastic Neurologic Disorder|spastic neurologic disorder
290386|NCT02402309|Oligophrenia|oligophrenia
290387|NCT02402283|Bioequivalency|bioequivalency
290388|NCT02402283|two metronidazole-containing products|two metronidazole-containing products
290389|NCT02402270|Colonoscopy|colonoscopy
290390|NCT02402270|Preparation|preparation
290391|NCT02402257|Central Venous Catheter|central venous catheter
290392|NCT02402257|Simulation-based Mastery Learning|simulation-based mastery learning
290393|NCT02402257|Medical Education|medical education
290394|NCT02402257|Patient Outcomes|patient outcomes
290395|NCT02402257|Bloodstream Infection Due to Central Venous Catheter|bloodstream infection due to central venous catheter
290396|NCT02402257|Pneumothorax|pneumothorax
290397|NCT02402257|Inadvertent Arterial Puncture|inadvertent arterial puncture
290398|NCT02402205|Implementation; TF-CBT; adjudicated youth; RTF; trauma|implementation; tf-cbt; adjudicated youth; rtf; trauma
290399|NCT02402192|corifollitropin alfa|corifollitropin alfa
290400|NCT02402192|recombinant FSH|recombinant fsh
290401|NCT02402192|HP-hMG|hp-hmg
290402|NCT02402192|time-lapse|time-lapse
290403|NCT02402192|kinetics of development|kinetics of development
290404|NCT02402179|protein quality|protein quality
290405|NCT02402153|Evaluation of subcutaneous EEG recording|evaluation of subcutaneous eeg recording
290406|NCT02402140|tacrolimus blood concentration|tacrolimus blood concentration
290407|NCT02402140|pharmaceutical intervention|pharmaceutical intervention
290408|NCT02402140|intrasubject variability|intrasubject variability
290409|NCT02402127|Contact lenses|contact lenses
290410|NCT02402127|Lubricity|lubricity
290411|NCT02402101|tDCS|tdcs
290412|NCT02402101|Dopamine|dopamine
290413|NCT02402101|PET|pet
290414|NCT02402088|stress|stress
290415|NCT02402088|food cues|food cues
290416|NCT02402088|obesity|obesity
290417|NCT02402075|muscle motor evoked potentials|muscle motor evoked potentials
290418|NCT02402075|spinal motor evoked potentials|spinal motor evoked potentials
290419|NCT02402075|D-wave|d-wave
290420|NCT02402075|brain tumor surgery|brain tumor surgery
290421|NCT02402075|intraoperative neuromonitoring|intraoperative neuromonitoring
290422|NCT02402062|pNET|pnet
290423|NCT02401997|sperm|sperm
290424|NCT02401997|oxidative stress|oxidative stress
290425|NCT02401997|sexual abstinence|sexual abstinence
290426|NCT02401971|Thalidomide|thalidomide
290427|NCT02401971|Irinotecan|irinotecan
290428|NCT02401971|Second Line|second line
290429|NCT02401945|Macular Degeneration|macular degeneration
290430|NCT02401919|Nursing|nursing
290431|NCT02401919|Hospital|hospital
290432|NCT02401919|Communication|communication
290433|NCT02401919|Patient Participation|patient participation
290434|NCT02401919|Individualised Care|individualised care
290435|NCT02401893|aging|aging
290436|NCT02401893|influenza vaccine|influenza vaccine
290437|NCT02401893|immune responses|immune responses
290438|NCT02401867|transgender|transgender
290439|NCT02401867|female-to-male|female-to-male
290440|NCT02401867|cervical cancer|cervical cancer
290441|NCT02401867|HPV|hpv
290442|NCT02401867|sexual health|sexual health
290443|NCT02401854|atrial fibrillation|atrial fibrillation
290444|NCT02401854|hypertension|hypertension
290445|NCT02401854|risk factors|risk factors
290446|NCT02401854|primary care|primary care
290447|NCT02401854|elderly|elderly
290448|NCT02401815|Gastrointestinal Stromal Tumors|gastrointestinal stromal tumors
290449|NCT02401815|KIT|kit
290450|NCT02401815|Biomarkers|biomarkers
290451|NCT02401815|PLX9486|plx9486
290452|NCT02401815|PLX3397|plx3397
290453|NCT02401815|Sunitinib|sunitinib
290454|NCT02401802|Colonoscopy|colonoscopy
290455|NCT02401802|Diet|diet
290456|NCT02401802|Polyethylene glycols|polyethylene glycols
290457|NCT02401802|Efficacy|efficacy
290458|NCT02401802|Personal satisfaction|personal satisfaction
290459|NCT02401802|Colorectal cancer screening|colorectal cancer screening
290460|NCT02401789|oral surgery|oral surgery
290461|NCT02401789|Implantology|implantology
290462|NCT02401776|heart rate|heart rate
290463|NCT02401776|blood pressure|blood pressure
290464|NCT02401776|caffeine|caffeine
290465|NCT02401776|energy drink|energy drink
290466|NCT02401763|biomarker|biomarker
290467|NCT02401737|Hepatitis B|hepatitis b
290468|NCT02401724|Hemispatial neglect|hemispatial neglect
290469|NCT02401724|Transcranial direct current stimulation|transcranial direct current stimulation
290470|NCT02401724|Rehabilitation|rehabilitation
290471|NCT02401698|Stroke|stroke
290472|NCT02401698|Transcranial Magnetic Stimulation|transcranial magnetic stimulation
290473|NCT02401698|Neuronal Plasticity|neuronal plasticity
290474|NCT02401698|Rehabilitation|rehabilitation
290475|NCT02401685|breast cancer|breast cancer
290476|NCT02401685|sentinel lymph node biopsy|sentinel lymph node biopsy
290477|NCT02401685|axillary lymph node clearance|axillary lymph node clearance
290478|NCT02401685|axillary lymph node dissection|axillary lymph node dissection
290479|NCT02401685|macrometastases|macrometastases
290480|NCT02401685|axillary radiotherapy|axillary radiotherapy
290481|NCT02401685|POSNOC|posnoc
290482|NCT02401672|TMS|tms
290483|NCT02401672|nicotine dependence|nicotine dependence
290484|NCT02401672|smoking cessation|smoking cessation
290485|NCT02401659|remote monitoring|remote monitoring
290486|NCT02401659|satisfaction|satisfaction
290487|NCT02401659|telemonitoring|telemonitoring
290488|NCT02401659|quality of life|quality of life
290489|NCT02401633|Cardio-Pulmonary-Resuscitation|cardio-pulmonary-resuscitation
290490|NCT02401633|Advanced Cardiac Life Support|advanced cardiac life support
290491|NCT02401633|Compression-Only CPR|compression-only cpr
290492|NCT02401633|Chest compression CPR|chest compression cpr
290493|NCT02401620|AR: arthritis rheumatoid|ar: arthritis rheumatoid
290494|NCT02401620|DMARDs: Disease-modifying antirheumatic drugs|dmards: disease-modifying antirheumatic drugs
290495|NCT02401620|ACR. American College of Rheumatology|acr. american college of rheumatology
290496|NCT02401620|EULAR: European League against rheumatology|eular: european league against rheumatology
290497|NCT02401607|stress|stress
290498|NCT02401607|emergency physicians|emergency physicians
290499|NCT02401607|health care workers|health care workers
290500|NCT02401607|biomarkers|biomarkers
290501|NCT02401607|questionnaires|questionnaires
290502|NCT02401607|anxiety|anxiety
290503|NCT02401607|depression|depression
290504|NCT02401607|burn-out|burn-out
290505|NCT02401594|Non-major orthopaedic surgery|non-major orthopaedic surgery
290506|NCT02401594|deep vein thrombosis|deep vein thrombosis
290507|NCT02401542|Urothelial Cell Carcinoma|urothelial cell carcinoma
290508|NCT02401542|UCC|ucc
290509|NCT02401542|bladder cancer|bladder cancer
290510|NCT02401542|vofatamab|vofatamab
290511|NCT02401542|FGFR3|fgfr3
290512|NCT02401542|invasive bladder cancer|invasive bladder cancer
290513|NCT02401542|targeted therapy|targeted therapy
290514|NCT02401542|Transitional Cell Carcinoma|transitional cell carcinoma
290515|NCT02401542|TCC|tcc
290516|NCT02401542|Phase 2|phase 2
290517|NCT02401542|second line therapy|second line therapy
290518|NCT02401542|monoclonal antibody|monoclonal antibody
290519|NCT02401542|docetaxel|docetaxel
290520|NCT02401542|combination therapy|combination therapy
290521|NCT02401542|Phase 1|phase 1
290522|NCT02401542|monotherapy|monotherapy
290523|NCT02401542|B-701|b-701
290524|NCT02401529|Dexamethasone|dexamethasone
290525|NCT02401529|Prednisolone|prednisolone
290526|NCT02401529|Tonsillectomy Nausea|tonsillectomy nausea
290527|NCT02401529|Pain, Postoperative|pain, postoperative
290528|NCT02401529|Postoperative Nausea and Vomiting|postoperative nausea and vomiting
290529|NCT02401529|Randomized controlled trial|randomized controlled trial
290530|NCT02401529|Post-tonsillectomy pain|post-tonsillectomy pain
290531|NCT02401529|delayed feeding|delayed feeding
290532|NCT02401516|Postural Reprogramming Insole|postural reprogramming insole
290533|NCT02401516|Blood Pressure|blood pressure
290534|NCT02401516|Posture|posture
290535|NCT02401516|Quality Of Life|quality of life
290536|NCT02401516|General Functional Capacity|general functional capacity
290537|NCT02401516|Respiratory Muscles Strength|respiratory muscles strength
290538|NCT02401516|Flexibility|flexibility
290539|NCT02401516|Arterial Systemic Hypertension|arterial systemic hypertension
290540|NCT02401503|CLL|cll
290541|NCT02401477|helicobacter pylori|helicobacter pylori
290542|NCT02401477|ilaprazole|ilaprazole
290543|NCT02401477|eradication|eradication
290544|NCT02401477|dual therapy|dual therapy
290545|NCT02401477|high dose therapy|high dose therapy
290546|NCT02401425|Letrozole|letrozole
290547|NCT02401425|Misoprostol|misoprostol
290548|NCT02401425|First-Trimester|first-trimester
290549|NCT02401425|Pretreatment|pretreatment
290550|NCT02401386|Fibromyalgia; Eight Brocades; Baduanjin; Qigong; Pain severity|fibromyalgia; eight brocades; baduanjin; qigong; pain severity
290551|NCT02401373|Vaccines|vaccines
290552|NCT02401373|Ebola Virus Disease|ebola virus disease
290553|NCT02401347|PALB2 mutation|palb2 mutation
290554|NCT02401347|BRIP1 mutation|brip1 mutation
290555|NCT02401347|BARD1 mutation|bard1 mutation
290556|NCT02401347|Rad51c mutation|rad51c mutation
290557|NCT02401347|PTEN mutation|pten mutation
290558|NCT02401347|CHEK2 mutation|chek2 mutation
290559|NCT02401347|ATM mutation|atm mutation
290560|NCT02401347|NBN mutation|nbn mutation
290561|NCT02401347|Rad51d mutation|rad51d mutation
290562|NCT02401347|Rad50 mutation|rad50 mutation
290563|NCT02401347|MRE11 mutation|mre11 mutation
290564|NCT02401347|FANC mutation|fanc mutation
290565|NCT02401347|HRD assay score|hrd assay score
290566|NCT02401347|ATR mutation|atr mutation
290567|NCT02401295|Relapsed multiple myeloma|relapsed multiple myeloma
290568|NCT02401256|Efavirenz|efavirenz
290569|NCT02401256|metabolism|metabolism
290570|NCT02401256|pharmacokinetics changes|pharmacokinetics changes
290571|NCT02401230|Human Immunodeficiency Virus|human immunodeficiency virus
290572|NCT02401230|Acquired Immune Deficiency Syndrome Virus|acquired immune deficiency syndrome virus
290573|NCT02401230|Pre-exposure Prophylaxis|pre-exposure prophylaxis
290574|NCT02401204|Bacterial transmission|bacterial transmission
290575|NCT02401204|Surveillance|surveillance
290576|NCT02401204|Neonatal|neonatal
290577|NCT02401204|Drug Resistance|drug resistance
290578|NCT02401178|FLG-FADS genes variations-LCPUFA-atopic dermatitis|flg-fads genes variations-lcpufa-atopic dermatitis
290579|NCT02401165|GADD34|gadd34
290580|NCT02401165|Unfolded Protein Response|unfolded protein response
290581|NCT02401165|Anti-citrullinated protein antibodies|anti-citrullinated protein antibodies
290582|NCT02401100|Rectal Neoplasms|rectal neoplasms
290584|NCT02401061|Thrombocytopenia|thrombocytopenia
290585|NCT02401035|candidate for acid suppression therapy|candidate for acid suppression therapy
290586|NCT02401035|presumptive diagnosis of GERD|presumptive diagnosis of gerd
290587|NCT02401035|clinical diagnosis of suspected GERD|clinical diagnosis of suspected gerd
290588|NCT02401035|symptomatic GERD|symptomatic gerd
290589|NCT02401035|endoscopically proven GERD|endoscopically proven gerd
290590|NCT02401022|smoking|smoking
290591|NCT02401022|smoking cessation|smoking cessation
290592|NCT02401022|cigarette|cigarette
290593|NCT02400996|Endocrine Pancreas|endocrine pancreas
290594|NCT02400996|Pancreatic Endocrine Neoplasm|pancreatic endocrine neoplasm
290595|NCT02400983|ACAP, Automatic Algorithm|acap, automatic algorithm
290596|NCT02400970|Polymerase Chain Reaction|polymerase chain reaction
290597|NCT02400970|fertility preservation|fertility preservation
290598|NCT02400957|silver nanoparticles|silver nanoparticles
290599|NCT02400957|demineralization|demineralization
290600|NCT02400957|brackets|brackets
290601|NCT02400944|MSK Tobacco Cessation Program|msk tobacco cessation program
290602|NCT02400944|smoking exposure|smoking exposure
290603|NCT02400944|15-047|15-047
290604|NCT02400905|PAD|pad
290605|NCT02400905|PVD|pvd
290606|NCT02400905|SFA stent|sfa stent
290607|NCT02400879|bispectral index|bispectral index
290608|NCT02400879|cardiac surgery|cardiac surgery
290609|NCT02400879|recovery|recovery
290610|NCT02400879|remifentanil|remifentanil
290611|NCT02400866|cancer patients receiving moderately emetogenic chemotherapy|cancer patients receiving moderately emetogenic chemotherapy
290612|NCT02400827|Polymerase Chain Reaction|polymerase chain reaction
290613|NCT02400827|fertility preservation|fertility preservation
290614|NCT02400801|endometriosis|endometriosis
290615|NCT02400801|infertility|infertility
290616|NCT02400801|assisted reproductive technology|assisted reproductive technology
290617|NCT02400775|Pharmacotherapy|pharmacotherapy
290618|NCT02400749|moderate to severe non-pustular palmo-plantar psoriasis|moderate to severe non-pustular palmo-plantar psoriasis
290619|NCT02400736|Individual Placement and Support|individual placement and support
290620|NCT02400736|Supported Employment|supported employment
290621|NCT02400736|Employment|employment
290622|NCT02400736|Vocational Rehabilitation|vocational rehabilitation
290623|NCT02400736|Veterans|veterans
290624|NCT02400736|Patient Aligned Care Team|patient aligned care team
290625|NCT02400723|behavioral intervention|behavioral intervention
290626|NCT02400723|relaxation|relaxation
290627|NCT02400723|Veterans|veterans
290628|NCT02400723|geriatric|geriatric
290629|NCT02400684|AFSr classification|afsr classification
290630|NCT02400684|laparoscopy|laparoscopy
290631|NCT02400658|breast cancer|breast cancer
290632|NCT02400658|early-stage|early-stage
290633|NCT02400658|IORT|iort
290634|NCT02400658|brachytherapy|brachytherapy
290635|NCT02400645|laparoscopic hysterectomy|laparoscopic hysterectomy
290636|NCT02400645|robotic assisted hysterectomy|robotic assisted hysterectomy
290637|NCT02400632|drug-eluting balloon|drug-eluting balloon
290638|NCT02400632|in-stent restenosis|in-stent restenosis
290639|NCT02400619|shockwaves|shockwaves
290640|NCT02400619|Physiotherapy|physiotherapy
290641|NCT02400619|Botulinum toxin|botulinum toxin
290642|NCT02400606|constructing VPs|constructing vps
290643|NCT02400606|knowledge and skills transfer|knowledge and skills transfer
290644|NCT02400580|Laparoscopic Hysterectomy|laparoscopic hysterectomy
290645|NCT02400580|IV acetaminophen|iv acetaminophen
290646|NCT02400580|Postoperative pain control|postoperative pain control
290648|NCT02400567|Luminal|luminal
290649|NCT02400567|Post menopausal|post menopausal
290650|NCT02400567|Breast conservation|breast conservation
290651|NCT02400567|Neoadjuvant|neoadjuvant
290652|NCT02400554|Indian, North American|indian, north american
290653|NCT02400554|Oklahoma|oklahoma
290654|NCT02400554|Female|female
290655|NCT02400554|health promotion|health promotion
290656|NCT02400541|Anorexia nervosa|anorexia nervosa
290657|NCT02400541|Cognitive remediation therapy|cognitive remediation therapy
290658|NCT02400515|Exercise|exercise
290659|NCT02400515|Exercise Therapy|exercise therapy
290660|NCT02400515|Diabetes Mellitus, Type 2|diabetes mellitus, type 2
290661|NCT02400502|Schizophrenia|schizophrenia
290662|NCT02400502|Treatment|treatment
290663|NCT02400502|Meditation|meditation
290664|NCT02400502|Mindfulness|mindfulness
290665|NCT02400502|Stress reactivity|stress reactivity
290666|NCT02400502|First Episode Psychosis|first episode psychosis
290667|NCT02400502|Coping|coping
290668|NCT02400489|Heart Valve Replacement Surgery|heart valve replacement surgery
290669|NCT02400489|Perimount|perimount
290670|NCT02400489|Edwards|edwards
290671|NCT02400476|HER2 +|her2 +
290672|NCT02400476|Breast Cancer|breast cancer
290673|NCT02400476|Neratinib|neratinib
290674|NCT02400476|Nerlynx|nerlynx
290675|NCT02400476|Loperamide|loperamide
290676|NCT02400476|Colestipol|colestipol
290677|NCT02400476|Budesonide|budesonide
290678|NCT02400450|Pre-diabetes|pre-diabetes
290679|NCT02400450|prediabetes|prediabetes
290680|NCT02400450|glycated hemoglobin|glycated hemoglobin
290681|NCT02400450|hemoglobin A1c|hemoglobin a1c
290682|NCT02400450|LDL cholesterol|ldl cholesterol
290683|NCT02400450|Cholesterol|cholesterol
290684|NCT02400450|metabolic function|metabolic function
290685|NCT02400450|vascular function|vascular function
290686|NCT02400450|functional food|functional food
290687|NCT02400437|Waldenstrom's Macroglobulinemia|waldenstrom's macroglobulinemia
290688|NCT02400424|Stereotactic lung radiation therapy|stereotactic lung radiation therapy
290689|NCT02400424|Radiochemotherapy|radiochemotherapy
290690|NCT02400424|Unresectable stage III Non-Small Cell lung Carcinoma|unresectable stage iii non-small cell lung carcinoma
290691|NCT02400424|Peripheral primary tumor|peripheral primary tumor
290692|NCT02400411|Carbohydrate|carbohydrate
290693|NCT02400411|Glycemic response|glycemic response
290694|NCT02400411|insulin|insulin
290695|NCT02400411|whole grain|whole grain
290696|NCT02400411|meal|meal
290697|NCT02400359|fMRI|fmri
290698|NCT02400359|Magnetic Resonance Imaging|magnetic resonance imaging
290699|NCT02400359|endocrinology|endocrinology
290700|NCT02400359|MRI|mri
290701|NCT02400359|obesity|obesity
290702|NCT02400359|weight loss|weight loss
290703|NCT02400359|lorcaserin|lorcaserin
290704|NCT02400333|ticagrelor orodispersible tablet|ticagrelor orodispersible tablet
290705|NCT02400333|ticagrelor immediate-release tablet|ticagrelor immediate-release tablet
290706|NCT02400333|relative bioavailability|relative bioavailability
290707|NCT02400333|Phase I|phase i
290708|NCT02400333|healthy subjects|healthy subjects
290709|NCT02400307|Phase 1|phase 1
290710|NCT02400307|Renally Impaired|renally impaired
290711|NCT02400294|Critical care|critical care
290712|NCT02400294|Mechanical ventilation|mechanical ventilation
290713|NCT02400294|Ventilator associated pneumonia|ventilator associated pneumonia
290714|NCT02400294|Oral care|oral care
290715|NCT02400268|Enterobacteriaceae|enterobacteriaceae
290716|NCT02400268|Bloodstream|bloodstream
290717|NCT02400268|Bacteremia|bacteremia
290718|NCT02400268|Recurrence|recurrence
290719|NCT02400268|Reinfection|reinfection
290720|NCT02400229|coronary artery disease|coronary artery disease
290721|NCT02400229|stable chest pain|stable chest pain
290722|NCT02400229|intermediate pretest probability|intermediate pretest probability
290723|NCT02400229|pragmatic randomised controlled trial|pragmatic randomised controlled trial
290724|NCT02400229|coronary computed tomography|coronary computed tomography
290725|NCT02400229|angiography|angiography
290726|NCT02400229|invasive coronary angiography|invasive coronary angiography
290727|NCT02400216|Chronic Hepatitis C|chronic hepatitis c
371428|NCT02000089|p16|p16
290728|NCT02400216|Cirrhosis|cirrhosis
290729|NCT02400216|Liver Biopsy|liver biopsy
290730|NCT02400216|Microbiome|microbiome
290731|NCT02400203|hemp oil,|hemp oil,
290732|NCT02400203|hemp|hemp
290733|NCT02400203|fatty acids|fatty acids
290734|NCT02400203|omega-6|omega-6
290735|NCT02400203|omega-3|omega-3
290736|NCT02400203|blood pressure|blood pressure
290737|NCT02400203|blood lipids|blood lipids
290738|NCT02400190|radiation|radiation
290739|NCT02400190|lumpectomy|lumpectomy
290740|NCT02400190|favorable biology|favorable biology
290741|NCT02400190|omission|omission
290742|NCT02400125|Patient Registry|patient registry
290743|NCT02400125|Coronary Artery Bypass|coronary artery bypass
290744|NCT02400125|Cardiac Valve Annuloplasty|cardiac valve annuloplasty
290745|NCT02400112|Vancomycin|vancomycin
290746|NCT02400086|neuroligical or neuromuscular diseases|neuroligical or neuromuscular diseases
290747|NCT02400086|bacterial respiratory tract flora|bacterial respiratory tract flora
290748|NCT02400086|long term tracheostomy|long term tracheostomy
290749|NCT02400047|Paediatric surgery|paediatric surgery
290750|NCT02400034|midurethral sling|midurethral sling
290751|NCT02400034|Voiding trial|voiding trial
290752|NCT02400034|stress urinary incontinence|stress urinary incontinence
290753|NCT02399995|Quality of Life|quality of life
290754|NCT02399995|Hepatectomy|hepatectomy
290756|NCT02399982|Smartphone Application|smartphone application
290757|NCT02399982|mobile mental health|mobile mental health
290758|NCT02399982|Binge Eating|binge eating
290759|NCT02399982|Cognitive behavioral therapy|cognitive behavioral therapy
290760|NCT02399982|Eating Disorder treatment|eating disorder treatment
290761|NCT02399982|Cognitive behavioral therapy guided self-help|cognitive behavioral therapy guided self-help
290762|NCT02399982|self-monitoring|self-monitoring
290763|NCT02399982|eating disorders|eating disorders
290764|NCT02399982|ecological momentary intervention|ecological momentary intervention
290765|NCT02399969|Low back pain|low back pain
290766|NCT02399969|Acupuncture therapy|acupuncture therapy
290767|NCT02399969|Acupuncture, ear|acupuncture, ear
290768|NCT02399956|Lactation|lactation
290769|NCT02399956|Pediatric malignancies|pediatric malignancies
290770|NCT02399956|Cancer survivor|cancer survivor
290771|NCT02399891|Remodeling|remodeling
290772|NCT02399891|Prognosis|prognosis
290773|NCT02399891|Incidence|incidence
290774|NCT02399891|Quality Assurance|quality assurance
290775|NCT02399891|Ejection Fraction|ejection fraction
290776|NCT02399891|Sudden Death|sudden death
290777|NCT02399800|pancreatitis, chronic|pancreatitis, chronic
290778|NCT02399800|endosonography|endosonography
290779|NCT02399761|AADC deficiency, newborn screening|aadc deficiency, newborn screening
290780|NCT02399735|NK cells|nk cells
290781|NCT02399735|Liver Transplantation|liver transplantation
290782|NCT02399735|Hepatocellular Carcinoma Recurrence|hepatocellular carcinoma recurrence
290783|NCT02399722|Negative Pressure Wound Therapy, polymeric membrane dressing, wounds|negative pressure wound therapy, polymeric membrane dressing, wounds
290784|NCT02399670|Total hip arthroplasty|total hip arthroplasty
290785|NCT02399670|degenerative joint disease|degenerative joint disease
290786|NCT02399670|Femoral offset|femoral offset
290787|NCT02399670|Patient reported outcome|patient reported outcome
290788|NCT02399657|diabetes mellitus|diabetes mellitus
290789|NCT02399657|macular edema|macular edema
290790|NCT02399657|hard exudate|hard exudate
290791|NCT02399657|intravitreal injections|intravitreal injections
290792|NCT02399657|dexamethasone|dexamethasone
290793|NCT02399657|implant|implant
290794|NCT02399644|pain|pain
290795|NCT02399644|rehabilitation|rehabilitation
290796|NCT02399644|exercise|exercise
290797|NCT02399644|psychological|psychological
290798|NCT02399644|intervention|intervention
290799|NCT02399631|Perioperative treatment|perioperative treatment
290800|NCT02399631|Laparoscopic surgery|laparoscopic surgery
290801|NCT02399618|Clostridium difficile Infection|clostridium difficile infection
290802|NCT02399618|Fecal Microbiota Transplantation|fecal microbiota transplantation
290803|NCT02399618|Freeze-dried|freeze-dried
290804|NCT02399618|Acid-resistant Capsules|acid-resistant capsules
290805|NCT02399592|Platinum resistant|platinum resistant
290806|NCT02399579|cat allergy|cat allergy
290807|NCT02399579|symptom score|symptom score
290808|NCT02399566|erlotinib|erlotinib
290809|NCT02399566|pemetrexed|pemetrexed
290810|NCT02399566|maintenance therapy|maintenance therapy
290811|NCT02399527|Vascular Anomalies|vascular anomalies
290812|NCT02399527|Lymphatic Anomalies|lymphatic anomalies
290813|NCT02399527|Lymphatic Malformation|lymphatic malformation
290814|NCT02399514|Sleep|sleep
290815|NCT02399514|emphysema|emphysema
290816|NCT02399514|coils|coils
290817|NCT02399514|lung volume reduction|lung volume reduction
290818|NCT02399501|2D ultrasound|2d ultrasound
290819|NCT02399501|3D ultrasound|3d ultrasound
290820|NCT02399501|sonohysterography|sonohysterography
290821|NCT02399501|hysteroscopy|hysteroscopy
290822|NCT02399501|Uterine factor of infertility|uterine factor of infertility
290823|NCT02399475|Levothyroxine|levothyroxine
290824|NCT02399475|Liothyronine|liothyronine
290825|NCT02399475|Thyrotropin Releasing Hormone|thyrotropin releasing hormone
290826|NCT02399475|Aging|aging
290827|NCT02399475|Hypothyroidism|hypothyroidism
290828|NCT02399475|Thyroid diseases|thyroid diseases
290829|NCT02399449|iron|iron
290830|NCT02399449|pharmacokinetics|pharmacokinetics
290831|NCT02399436|Community-Based Participatory Research|community-based participatory research
290832|NCT02399436|Community-Institutional Relations|community-institutional relations
290833|NCT02399423|diabetes|diabetes
290834|NCT02399423|metabolism|metabolism
290835|NCT02399423|cardiovascular disease|cardiovascular disease
290836|NCT02399423|weight gain|weight gain
290837|NCT02399423|weight loss|weight loss
290838|NCT02399423|european|european
290839|NCT02399423|south asian|south asian
290840|NCT02399423|obesity|obesity
290841|NCT02399410|cytoreductive surgery|cytoreductive surgery
290842|NCT02399410|hipec|hipec
290843|NCT02399410|perioperative chemotherapy|perioperative chemotherapy
290844|NCT02399410|peritoneal carcinomatosis|peritoneal carcinomatosis
290845|NCT02399410|bevacizumab|bevacizumab
290846|NCT02399410|colorectal surgery|colorectal surgery
290847|NCT02399384|Cardiac Magnetic Resonance (CMR)|cardiac magnetic resonance (cmr)
290848|NCT02399358|Drug induced Hyponatremia|drug induced hyponatremia
290849|NCT02399358|Cyclophosphamide|cyclophosphamide
290850|NCT02399358|Hyponatremia|hyponatremia
290851|NCT02399358|Cyclophosphamide induced Hyponatremia|cyclophosphamide induced hyponatremia
290852|NCT02399345|Treatment naive|treatment naive
290853|NCT02399345|Hepatitis C Genotype 1|hepatitis c genotype 1
290854|NCT02399319|anterior pelvic ring|anterior pelvic ring
290855|NCT02399319|symphysis disruption|symphysis disruption
290856|NCT02399293|Cognitive training|cognitive training
290857|NCT02399293|Cognitive rehabilitation|cognitive rehabilitation
290858|NCT02399293|Acquired brain injury|acquired brain injury
290859|NCT02399293|N-back|n-back
290860|NCT02399293|Visual Search|visual search
290861|NCT02399293|Cognitive transfer|cognitive transfer
290862|NCT02399280|Meal pattern|meal pattern
290863|NCT02399280|weight loss|weight loss
290864|NCT02399280|high caloric intake|high caloric intake
290865|NCT02399280|Dinner|dinner
290866|NCT02399280|Lunch|lunch
290867|NCT02399267|mechanical ventilation|mechanical ventilation
290868|NCT02399267|weaning|weaning
290869|NCT02399267|critically ill|critically ill
290870|NCT02399267|spontaneous breathing trial|spontaneous breathing trial
290871|NCT02399267|screening|screening
290872|NCT02399267|invasive ventilation|invasive ventilation
290873|NCT02399267|SBT technique|sbt technique
290874|NCT02399254|Pulmonary Rehabilitation|pulmonary rehabilitation
290875|NCT02399228|radiation therapy|radiation therapy
290876|NCT02399228|chemotherapy|chemotherapy
290877|NCT02399228|head and neck cancer|head and neck cancer
290878|NCT02399202|Renal impairment, osilodrostat, LCI699|renal impairment, osilodrostat, lci699
290879|NCT02399189|Primary central nervous system lymphoma|primary central nervous system lymphoma
290880|NCT02399189|rituximab|rituximab
290881|NCT02399189|Methotrexate and Temozolomide|methotrexate and temozolomide
290882|NCT02399189|autologous stem cell transplantation|autologous stem cell transplantation
290883|NCT02399189|Carmustine and thiotepa|carmustine and thiotepa
290884|NCT02399176|Osteoporosis|osteoporosis
290885|NCT02399176|Yoga|yoga
290886|NCT02399150|acute abdomen|acute abdomen
290887|NCT02399150|Pain|pain
290888|NCT02399150|stress biomarker|stress biomarker
290889|NCT02399137|Pancreatic Cancer|pancreatic cancer
290890|NCT02399137|Front-line Pancreatic Cancer|front-line pancreatic cancer
290891|NCT02399137|Metastatic Pancreatic Cancer|metastatic pancreatic cancer
290892|NCT02399137|Gemcitabine|gemcitabine
290893|NCT02399137|Nab-paclitaxel|nab-paclitaxel
290894|NCT02399137|Abraxane|abraxane
290895|NCT02399137|Free IGF-1|free igf-1
290896|NCT02399137|Heregulin|heregulin
290897|NCT02399124|RCC|rcc
290898|NCT02399124|Renal Cell Carcinoma|renal cell carcinoma
290899|NCT02399124|Kidney tumors|kidney tumors
290900|NCT02399111|Prevena Incision Management System (PIMS)|prevena incision management system (pims)
290901|NCT02399111|Surgical Site Infection (SSI)|surgical site infection (ssi)
290902|NCT02399085|DLBCL|dlbcl
290903|NCT02399085|CD19|cd19
290904|NCT02399085|monoclonal antibody|monoclonal antibody
290905|NCT02399085|MOR00208|mor00208
290906|NCT02399085|MOR208|mor208
290907|NCT02399085|lenalidomide|lenalidomide
290908|NCT02399059|recurrence|recurrence
290909|NCT02399033|Xihuang Capsules|xihuang capsules
290910|NCT02399033|hepatocellular carcinoma|hepatocellular carcinoma
290911|NCT02399033|Recurrence|recurrence
290912|NCT02399033|hepatectomy|hepatectomy
290913|NCT02398994|Clinical Trials Unit|clinical trials unit
290914|NCT02398994|Pediatric|pediatric
290915|NCT02398968|Iron|iron
290916|NCT02398968|RURTIs|rurtis
290917|NCT02398968|CARIFS|carifs
290918|NCT02398968|children|children
290919|NCT02398955|Drug-Eluting Stents|drug-eluting stents
290920|NCT02398955|Coronary Artery Disease|coronary artery disease
290921|NCT02398955|Sirolimus|sirolimus
290922|NCT02398955|Absorbable Implants|absorbable implants
290923|NCT02398903|Morbid obesity|morbid obesity
290924|NCT02398903|bariatric surgery|bariatric surgery
290925|NCT02398903|sleeve gastrectomy|sleeve gastrectomy
290926|NCT02398903|Roux-en-Y gastric bypass|roux-en-y gastric bypass
290927|NCT02398903|hormonal contraception|hormonal contraception
290928|NCT02398903|combined oral contraceptive|combined oral contraceptive
290929|NCT02398903|progestin contraceptive desogestrel|progestin contraceptive desogestrel
290930|NCT02398903|pharmacokinetics|pharmacokinetics
290931|NCT02398825|Chronic myeloid leukemia|chronic myeloid leukemia
290932|NCT02398825|Chronic phase|chronic phase
290933|NCT02398825|Adults|adults
290934|NCT02398825|Ponatinib|ponatinib
290935|NCT02398825|Imatinib resistant|imatinib resistant
290936|NCT02398760|Low Back Pain|low back pain
290937|NCT02398760|Clinical Instability|clinical instability
290938|NCT02398760|Motor Control Exercises|motor control exercises
290939|NCT02398760|Clinical Tests|clinical tests
290940|NCT02398734|sonolysis|sonolysis
290941|NCT02398734|carotid endarterectomy|carotid endarterectomy
290942|NCT02398734|stroke prevention|stroke prevention
290943|NCT02398734|brain infarction|brain infarction
290944|NCT02398721|FNAC|fnac
290945|NCT02398721|Small Incidental Thyroid Nodules|small incidental thyroid nodules
290946|NCT02398708|Hematopoietic Stem Cell Transplantation|hematopoietic stem cell transplantation
290947|NCT02398708|Graft versus Host Disease|graft versus host disease
290948|NCT02398695|Plaque|plaque
290949|NCT02398695|Saliva|saliva
290950|NCT02398695|Caries|caries
290951|NCT02398682|electronic alerts|electronic alerts
290952|NCT02398682|acute kidney injury|acute kidney injury
290953|NCT02398682|NHS|nhs
290954|NCT02398682|mortality|mortality
290955|NCT02398669|Obesity|obesity
290956|NCT02398669|Lorcaserin hydrochloride|lorcaserin hydrochloride
290957|NCT02398669|APD356|apd356
290958|NCT02398669|Pediatric|pediatric
290959|NCT02398669|Pharmacokinetics|pharmacokinetics
290960|NCT02398656|Minor Ischemic Stroke|minor ischemic stroke
290961|NCT02398643|Acute Exacerbation of COPD|acute exacerbation of copd
290962|NCT02398643|COPD|copd
290963|NCT02398643|Emphysema|emphysema
290964|NCT02398643|Chronic Bronchitis|chronic bronchitis
290965|NCT02398630|Histerosalpingography|histerosalpingography
290966|NCT02398630|MRI|mri
290967|NCT02398630|Magnetic Resonance Imaging|magnetic resonance imaging
290968|NCT02398630|HSG|hsg
290969|NCT02398630|Diagnostico Maipu|diagnostico maipu
290970|NCT02398630|Imaging|imaging
290971|NCT02398630|Carrascosa Patricia|carrascosa patricia
290972|NCT02398617|Heart Failure|heart failure
290973|NCT02398617|End of Life Care|end of life care
290974|NCT02398617|Decision Making|decision making
290975|NCT02398604|Pediatrics|pediatrics
290976|NCT02398604|HLHS|hlhs
290977|NCT02398591|Healthy|healthy
290978|NCT02398591|JNJ 53718678|jnj 53718678
290979|NCT02398552|metastatic renal cell carcinoma|metastatic renal cell carcinoma
290980|NCT02398552|sunitinib|sunitinib
290981|NCT02398552|schedule 2weeks on/1 week off|schedule 2weeks on/1 week off
290982|NCT02398526|Observational study|observational study
290983|NCT02398526|Bone metastases|bone metastases
290984|NCT02398526|Hormone Refractory Prostatic Cancer|hormone refractory prostatic cancer
290985|NCT02398526|Xofigo|xofigo
290986|NCT02398526|Radium-223|radium-223
290987|NCT02398500|First-in-human|first-in-human
290988|NCT02398500|anti-VEGF|anti-vegf
290989|NCT02398500|neovascular AMD (nvAMD)|neovascular amd (nvamd)
290990|NCT02398435|Auto-inflammatory disease|auto-inflammatory disease
290991|NCT02398435|Still's disease|still's disease
290992|NCT02398435|Arthritis Rheumatoid|arthritis rheumatoid
290993|NCT02398435|IL-18|il-18
290994|NCT02398435|interleukin-18|interleukin-18
290995|NCT02398435|IL-18 binding protein|il-18 binding protein
290996|NCT02398422|Autonomic nervous system|autonomic nervous system
290997|NCT02398422|Auditory processing disorder|auditory processing disorder
290998|NCT02398422|Social behavior|social behavior
290999|NCT02398409|stroke|stroke
291000|NCT02398409|Injury, Brain, Traumatic|injury, brain, traumatic
291001|NCT02398409|Family Caregivers|family caregivers
291002|NCT02398409|TBI (Traumatic Brain Injury)|tbi (traumatic brain injury)
291003|NCT02398409|Informal Caregivers|informal caregivers
291004|NCT02398370|ED|ed
291005|NCT02398357|anticoagulation|anticoagulation
291006|NCT02398357|Zelen-designed randomized controlled trial|zelen-designed randomized controlled trial
291007|NCT02398331|Spinal cord injuries|spinal cord injuries
291008|NCT02398331|Sexual function|sexual function
291009|NCT02398331|Sexual response|sexual response
291010|NCT02398331|Sexuality|sexuality
291011|NCT02398331|Women|women
291012|NCT02398318|neurosurgery|neurosurgery
291013|NCT02398318|deep brain stimulation|deep brain stimulation
291014|NCT02398318|exposure response prevention|exposure response prevention
291015|NCT02398305|Cardiac catheterisation|cardiac catheterisation
291016|NCT02398305|Radial access|radial access
291017|NCT02398305|Compression|compression
291018|NCT02398305|Terumo TR Band|terumo tr band
291019|NCT02398305|radial artery|radial artery
291020|NCT02398305|diagnostic|diagnostic
291021|NCT02398279|schizophrenia|schizophrenia
291022|NCT02398279|L-Arginine|l-arginine
291023|NCT02398279|nitric oxide|nitric oxide
291024|NCT02398279|drug augmentation|drug augmentation
291025|NCT02398253|weight maintenance|weight maintenance
291026|NCT02398253|cognitive behavior therapy|cognitive behavior therapy
291027|NCT02398253|successful weight loss|successful weight loss
291028|NCT02398227|Battered Women|battered women
291029|NCT02398227|Trauma|trauma
291030|NCT02398227|Domestic Violence|domestic violence
291031|NCT02398214|Sleep|sleep
291032|NCT02398214|Infants|infants
291033|NCT02398214|Toddlers|toddlers
291034|NCT02398214|Behavioral intervention|behavioral intervention
291035|NCT02398175|Pediatric polytrauma|pediatric polytrauma
291036|NCT02398175|thoracic injuries|thoracic injuries
291037|NCT02398162|Scrub Typhus in Pediatric|scrub typhus in pediatric
291038|NCT02398162|Immunology|immunology
291039|NCT02398136|intervention|intervention
291040|NCT02398136|ketamine|ketamine
291041|NCT02398136|PTSD|ptsd
291042|NCT02398136|treatment|treatment
291043|NCT02398136|posttraumatic stress disorder|posttraumatic stress disorder
291044|NCT02398123|Transversus Abdominis Plane|transversus abdominis plane
291045|NCT02398123|caudal block|caudal block
291046|NCT02398123|postoperative pain|postoperative pain
291047|NCT02398123|children|children
291048|NCT02398084|mastication|mastication
291049|NCT02398084|cashews|cashews
291050|NCT02398084|walnuts|walnuts
291051|NCT02398084|participants|participants
291052|NCT02398071|Positive Expiratory Pressure|positive expiratory pressure
291053|NCT02398071|Exercise Recovery|exercise recovery
291054|NCT02398071|COPD|copd
291055|NCT02398058|trabectedin|trabectedin
291056|NCT02398058|olaparib|olaparib
291057|NCT02398058|sarcoma|sarcoma
291058|NCT02398058|bone tumor|bone tumor
291059|NCT02398045|Obsessive-compulsive disorder|obsessive-compulsive disorder
291060|NCT02398045|cognitive behavioural therapy|cognitive behavioural therapy
291061|NCT02398045|computerised|computerised
291062|NCT02398032|sleep apnea|sleep apnea
291063|NCT02398032|hypertension|hypertension
291064|NCT02398032|mechanosensitivity|mechanosensitivity
291065|NCT02398032|chemosensitivity|chemosensitivity
291066|NCT02398032|adhesion factors|adhesion factors
291067|NCT02398019|CPB|cpb
291068|NCT02398019|oXiris®|oxiris®
291069|NCT02398019|SIRS|sirs
291070|NCT02398019|AKI|aki
291071|NCT02398019|Cytokines|cytokines
291072|NCT02398019|CSA-AKI|csa-aki
291073|NCT02398006|Clavicle [mh]|clavicle [mh]
291074|NCT02398006|Fracture Healing [mh]|fracture healing [mh]
291075|NCT02398006|Fractures, Bone [mh]|fractures, bone [mh]
291076|NCT02398006|Treatment outcome [mh]|treatment outcome [mh]
291077|NCT02398006|Conservative treatment [tw]|conservative treatment [tw]
291078|NCT02397980|Caregivers|caregivers
291079|NCT02397967|NF1|nf1
291080|NCT02397967|children|children
291081|NCT02397967|reading disabilities|reading disabilities
291082|NCT02397954|idiopathic polypoidal choroidal vasculopathy|idiopathic polypoidal choroidal vasculopathy
291083|NCT02397954|IPCV|ipcv
291084|NCT02397954|Zimura™|zimura™
291085|NCT02397954|Avastin®|avastin®
291086|NCT02397954|Eylea®|eylea®
291087|NCT02397954|Lucentis®|lucentis®
291088|NCT02397928|Malignant Pleural Mesothelioma|malignant pleural mesothelioma
291089|NCT02397928|Treatment|treatment
291090|NCT02397928|Minimal toxicity|minimal toxicity
291091|NCT02397928|TTFields|ttfields
291092|NCT02397928|Tumor Treating Fields|tumor treating fields
291093|NCT02397928|Novocure|novocure
291094|NCT02397928|Pemetrexed|pemetrexed
291095|NCT02397928|Carboplatin|carboplatin
291096|NCT02397928|Cisplatin|cisplatin
291097|NCT02397915|Nasal Spray|nasal spray
291098|NCT02397915|Fluticasone Furoate|fluticasone furoate
291099|NCT02397915|Attributes|attributes
291100|NCT02397915|Single Dose|single dose
291101|NCT02397915|Allergic Rhinitis|allergic rhinitis
291102|NCT02397915|Mometasone Furoate|mometasone furoate
291103|NCT02397915|Questionnaire|questionnaire
291104|NCT02397915|Preference|preference
291105|NCT02397889|posttraumatic stress disorder|posttraumatic stress disorder
291106|NCT02397889|PTSD|ptsd
291107|NCT02397889|ketamine|ketamine
291108|NCT02397889|trauma|trauma
291109|NCT02397889|treatment|treatment
291110|NCT02397889|New York|new york
291111|NCT02397889|NYC|nyc
291112|NCT02397876|Food Allergy|food allergy
291113|NCT02397876|Cows Milk Allergy|cows milk allergy
291114|NCT02397850|depression, chronic, psychotherapy, telephone, feasibility|depression, chronic, psychotherapy, telephone, feasibility
291115|NCT02397837|Bipolar Disorder|bipolar disorder
291116|NCT02397837|Cognition|cognition
291117|NCT02397785|chronic pelvic pain|chronic pelvic pain
291118|NCT02397785|electrical stimulation|electrical stimulation
291119|NCT02397785|pelvic floor rehabilitation|pelvic floor rehabilitation
291120|NCT02397785|neuromodulation|neuromodulation
291121|NCT02397772|Soil-transmitted helminths|soil-transmitted helminths
291122|NCT02397772|Intestinal Nematodes|intestinal nematodes
291123|NCT02397772|Hookworm|hookworm
291124|NCT02397772|Ascaris|ascaris
291125|NCT02397772|Mass Treatment|mass treatment
291126|NCT02397772|Kenya|kenya
291127|NCT02397746|osteoarthritis|osteoarthritis
291128|NCT02397746|avascular necrosis|avascular necrosis
291129|NCT02397746|ankylosis|ankylosis
291130|NCT02397746|protrusio acetabuli|protrusio acetabuli
291131|NCT02397746|rheumatoid arthritis|rheumatoid arthritis
291132|NCT02397746|correction of functional deformity|correction of functional deformity
291133|NCT02397746|revision procedures|revision procedures
291134|NCT02397694|Adult|adult
291135|NCT02397694|HIV|hiv
291136|NCT02397694|naive|naive
291137|NCT02397655|stroke|stroke
291138|NCT02397655|ischemia|ischemia
291139|NCT02397655|atherosclerosis|atherosclerosis
291140|NCT02397655|ultrasonography|ultrasonography
291141|NCT02397590|Fimasartan|fimasartan
291142|NCT02397564|scar|scar
291143|NCT02397564|ICD-10 CM:L90.5|icd-10 cm:l90.5
291144|NCT02397538|Fimasartan|fimasartan
291145|NCT02397447|Momordica Charantia|momordica charantia
291146|NCT02397447|Insulin secretion|insulin secretion
291147|NCT02397447|Insulin sensitivity|insulin sensitivity
291148|NCT02397434|assessment of QOL (EORTC QLQ-C30)|assessment of qol (eortc qlq-c30)
291149|NCT02397421|Heart failure|heart failure
291150|NCT02397421|Diabetes|diabetes
291151|NCT02397421|Left ventricular remodelling|left ventricular remodelling
291152|NCT02397421|SGLT-2 inhibitors|sglt-2 inhibitors
291153|NCT02397395|Renal Impairment|renal impairment
291154|NCT02397395|End-stage Renal Disease|end-stage renal disease
291155|NCT02397395|Simeprevir|simeprevir
291156|NCT02397395|Daclatasvir|daclatasvir
291157|NCT02397382|Psoriasis|psoriasis
291158|NCT02397382|Guselkumab|guselkumab
291159|NCT02397382|Cytochromes P450|cytochromes p450
291160|NCT02397369|Education and evaluate post intervention KAP|education and evaluate post intervention kap
291161|NCT02397356|ketamine|ketamine
291162|NCT02397343|Reduction of secondary hyperalgesia and/-or local inflammation|reduction of secondary hyperalgesia and/-or local inflammation
291163|NCT02397304|Intra-muscular triglyceride use|intra-muscular triglyceride use
291164|NCT02397291|Pregnancy|pregnancy
291165|NCT02397291|IUGR|iugr
291166|NCT02397265|Type 1 diabetes|type 1 diabetes
291167|NCT02397265|Hypoglycaemia|hypoglycaemia
291168|NCT02397265|Closed loop insulin pump|closed loop insulin pump
291169|NCT02397265|Artificial pancreas|artificial pancreas
291170|NCT02397265|Exercise|exercise
291171|NCT02397265|Mixed meals|mixed meals
291172|NCT02397265|Bihormonal pump|bihormonal pump
291173|NCT02397252|Human Papillomavirus|human papillomavirus
291174|NCT02397252|Screening|screening
291175|NCT02397252|Self-collection test|self-collection test
291176|NCT02397252|Pap test|pap test
291177|NCT02397226|Radiofrequency ablation|radiofrequency ablation
291178|NCT02397226|Plethysmography|plethysmography
291179|NCT02397226|Duplex ultrasound|duplex ultrasound
291180|NCT02397226|High ligation/stripping|high ligation/stripping
291181|NCT02397213|Ciclosporin|ciclosporin
291182|NCT02397213|Acute Kidney injury|acute kidney injury
291183|NCT02397213|Cardiac surgery|cardiac surgery
291184|NCT02397213|Ischemia|ischemia
291185|NCT02397213|Safety|safety
291186|NCT02397213|Cystatin C|cystatin c
291187|NCT02397200|Growth|growth
291188|NCT02397200|low weight|low weight
291189|NCT02397200|low height|low height
291190|NCT02397200|Nutritional Supplementation|nutritional supplementation
291191|NCT02397174|Polycystic Ovary syndrome|polycystic ovary syndrome
291192|NCT02397174|hypocaloric diet|hypocaloric diet
291193|NCT02397174|Ovarian Cysts|ovarian cysts
291194|NCT02397174|Ovarian Diseases|ovarian diseases
291195|NCT02397174|Obesity|obesity
291196|NCT02397174|Mediterranean Diet|mediterranean diet
291197|NCT02397135|genomic markers|genomic markers
291198|NCT02397070|Jaw exercise|jaw exercise
291199|NCT02397070|Occlusal splint|occlusal splint
291200|NCT02397070|Treatment|treatment
291201|NCT02397070|Muscular pain|muscular pain
291202|NCT02397070|Mandibular movement|mandibular movement
291203|NCT02397044|Implants, stability, loading|implants, stability, loading
291204|NCT02397031|borderline personality disorder|borderline personality disorder
291205|NCT02397031|mindfulness|mindfulness
291206|NCT02397018|stroke|stroke
291207|NCT02397018|cord blood|cord blood
291208|NCT02397018|umbilical cord blood|umbilical cord blood
291209|NCT02397018|hematopoietic stem cells|hematopoietic stem cells
291210|NCT02397018|acute ischemic stroke|acute ischemic stroke
291211|NCT02396992|Oropharyngeal Dysphagia|oropharyngeal dysphagia
291212|NCT02396992|Aspiration pneumonia|aspiration pneumonia
291213|NCT02396992|Malnutrition|malnutrition
291214|NCT02396992|Oral Health|oral health
291215|NCT02396992|Bacterial colonization|bacterial colonization
291216|NCT02396992|Aging|aging
291218|NCT02396940|Three-dimensional|three-dimensional
291219|NCT02396940|Laparoscopy|laparoscopy
291220|NCT02396940|Inguinal hernia repair|inguinal hernia repair
291221|NCT02396927|3D|3d
291222|NCT02396927|Three-dimensional|three-dimensional
291223|NCT02396927|laparoscopy|laparoscopy
291224|NCT02396927|cholecystectomy|cholecystectomy
291225|NCT02396901|early goal direct therapy|early goal direct therapy
754450|NCT00424918|Dance|dance
291226|NCT02396901|preventive strategies|preventive strategies
291227|NCT02396901|cardiac surgery|cardiac surgery
291228|NCT02396888|Blood vessel|blood vessel
291229|NCT02396888|Fibroplasia|fibroplasia
291230|NCT02396888|Wound healing|wound healing
291231|NCT02396888|Insulin|insulin
291232|NCT02396836|Hand hygiene|hand hygiene
291233|NCT02396836|Hand decontamination|hand decontamination
291234|NCT02396836|Microbial load|microbial load
291235|NCT02396836|Hand coverage|hand coverage
291236|NCT02396836|Glove juice technique|glove juice technique
291237|NCT02396836|Ayliffe technique|ayliffe technique
291238|NCT02396836|6 step technique|6 step technique
291239|NCT02396823|Blood pressure regulation|blood pressure regulation
291240|NCT02396823|Respiratory Muscle Training|respiratory muscle training
291241|NCT02396797|Sick leave|sick leave
291242|NCT02396797|Mental Health|mental health
291243|NCT02396797|Coping|coping
291244|NCT02396797|Social Support|social support
291245|NCT02396797|Subjective Health Complaints|subjective health complaints
291246|NCT02396784|child overweight|child overweight
291247|NCT02396784|child obesity|child obesity
291248|NCT02396784|prevention|prevention
291249|NCT02396784|targeted intervention|targeted intervention
291250|NCT02396784|development of overweight|development of overweight
291251|NCT02396771|Uterine|uterine
291252|NCT02396771|Massage|massage
291253|NCT02396771|Compression|compression
291254|NCT02396732|Aspirin|aspirin
291255|NCT02396732|Enoxaparin|enoxaparin
291256|NCT02396732|Thromboprophylaxis|thromboprophylaxis
291257|NCT02396732|Trauma|trauma
291258|NCT02396732|Venous thromboembolism|venous thromboembolism
291259|NCT02396693|Newborn|newborn
291260|NCT02396693|non invasive ventilation|non invasive ventilation
291261|NCT02396680|Ragweed Allergy|ragweed allergy
291262|NCT02396680|Rhinoconjunctivitis|rhinoconjunctivitis
291263|NCT02396680|Immunotherapy|immunotherapy
291264|NCT02396680|Ragweed-SPIRE|ragweed-spire
291265|NCT02396641|Best Supportive Care|best supportive care
291266|NCT02396628|Graft-versus-Host Disease (GvHD)|graft-versus-host disease (gvhd)
291267|NCT02396628|resistance to therapy|resistance to therapy
291268|NCT02396628|allogeneic stem cell transplantation|allogeneic stem cell transplantation
291269|NCT02396628|Ruxolitinib|ruxolitinib
291270|NCT02396615|Ad libitum energy intake|ad libitum energy intake
291271|NCT02396615|Appetite|appetite
291272|NCT02396589|stroke rehabilitation|stroke rehabilitation
291273|NCT02396589|barriers to independence|barriers to independence
291274|NCT02396589|environmental support|environmental support
291275|NCT02396550|Expectations|expectations
291276|NCT02396537|Children|children
291277|NCT02396537|Midazolam|midazolam
291278|NCT02396537|Lidocaine|lidocaine
291279|NCT02396537|Intranasal|intranasal
291280|NCT02396524|Chronic Disease|chronic disease
291281|NCT02396524|Lifestyle Intervention|lifestyle intervention
291282|NCT02396524|Health Promotion|health promotion
291283|NCT02396524|Sport Mentorship|sport mentorship
291284|NCT02396524|Men|men
291285|NCT02396524|Health Technology|health technology
291286|NCT02396524|Prevention|prevention
291287|NCT02396524|Exercise|exercise
291288|NCT02396524|Diet|diet
291289|NCT02396472|social support|social support
291290|NCT02396459|Triac|triac
291291|NCT02396459|MCT8|mct8
291292|NCT02396459|Allan-Herndon-Dudley Syndrome|allan-herndon-dudley syndrome
291293|NCT02396433|Halaven|halaven
291294|NCT02396433|BRCA|brca
291295|NCT02396433|E7449|e7449
291297|NCT02396420|prostatic hyperplasia|prostatic hyperplasia
291298|NCT02396420|enlarged prostate|enlarged prostate
291299|NCT02396420|benign prostatic hypertrophy|benign prostatic hypertrophy
291300|NCT02396407|Chlorine water treatment|chlorine water treatment
291301|NCT02396407|Point-of-use water treatment|point-of-use water treatment
291302|NCT02396407|Household water treatment with safe storage|household water treatment with safe storage
291303|NCT02396407|Handwashing with soap|handwashing with soap
291304|NCT02396407|Hand hygiene|hand hygiene
291305|NCT02396407|Latrines|latrines
291306|NCT02396407|Child potties|child potties
291307|NCT02396407|Intestinal parasitic infection|intestinal parasitic infection
291308|NCT02396407|Soil-transmitted helminths|soil-transmitted helminths
291309|NCT02396407|Water|water
291310|NCT02396407|Sanitation|sanitation
291311|NCT02396407|Handwashing|handwashing
291312|NCT02396407|Diarrhea|diarrhea
291313|NCT02396407|Herd immunity|herd immunity
291314|NCT02396407|Helminths|helminths
291315|NCT02396394|HIV|hiv
291316|NCT02396394|ART Adherence|art adherence
291317|NCT02396394|Retention in Care|retention in care
291318|NCT02396394|Pregnant Women|pregnant women
291319|NCT02396394|Postpartum Women|postpartum women
291320|NCT02396381|Candidate modified risk tobacco product|candidate modified risk tobacco product
291321|NCT02396381|Conventional cigarette|conventional cigarette
291322|NCT02396381|Exposure response|exposure response
291323|NCT02396381|Smoking|smoking
291324|NCT02396381|Tobacco Heating System|tobacco heating system
291325|NCT02396368|Prostate cancer|prostate cancer
712546|NCT00579774|low AGE intake|low age intake
291326|NCT02396368|Bone metastatic Castration-Resistant Prostate Cancer|bone metastatic castration-resistant prostate cancer
291327|NCT02396368|Radium 223|radium 223
291328|NCT02396368|Tasquinimod|tasquinimod
291329|NCT02396355|flow cytometry|flow cytometry
291330|NCT02396342|Hemophilia B, gene therapy|hemophilia b, gene therapy
291331|NCT02396303|General: To compare Carbetocin and Oxytocin for the control of PPH.|general: to compare carbetocin and oxytocin for the control of pph.
291332|NCT02396290|acne scar|acne scar
291333|NCT02396290|fractional carbon dioxide laser|fractional carbon dioxide laser
291334|NCT02396290|platelet rich plasma|platelet rich plasma
291335|NCT02396264|Mediterranean Diet|mediterranean diet
291336|NCT02396264|Ovarian Cysts|ovarian cysts
291337|NCT02396264|Treatment|treatment
291338|NCT02396264|Ovarian Diseases|ovarian diseases
291339|NCT02396264|normocaloric diet|normocaloric diet
291340|NCT02396225|voriconazole|voriconazole
291341|NCT02396225|inhalation|inhalation
291342|NCT02396225|aerosol|aerosol
291343|NCT02396225|epithelial lining fluid|epithelial lining fluid
291344|NCT02396225|concentration|concentration
291345|NCT02396225|pharmacokinetic|pharmacokinetic
291346|NCT02396212|ACZ885|acz885
291347|NCT02396212|canakinumab|canakinumab
291348|NCT02396212|Juvenile Rheumatoid arthritis (JRA) chronic|juvenile rheumatoid arthritis (jra) chronic
291349|NCT02396212|systemic inflammatory disorder|systemic inflammatory disorder
291350|NCT02396212|painful joints|painful joints
291351|NCT02396212|inflammation of the synovial membrane|inflammation of the synovial membrane
291352|NCT02396212|auto-immune rheumatoid disease|auto-immune rheumatoid disease
291353|NCT02396212|reactive rheumatoid arthritis|reactive rheumatoid arthritis
291354|NCT02396212|Systemic Juvenile Rheumatoid arthritis (SJRA)|systemic juvenile rheumatoid arthritis (sjra)
291355|NCT02396212|Japanese patients|japanese patients
291356|NCT02396199|Abdominal aortic aneurysm|abdominal aortic aneurysm
291357|NCT02396199|Endovascular|endovascular
291358|NCT02396199|Juxtarenal|juxtarenal
291359|NCT02396199|Pararenal|pararenal
291360|NCT02396199|Fenestrated|fenestrated
291361|NCT02396173|disability|disability
291362|NCT02396173|vocational|vocational
291363|NCT02396173|rehabilitation|rehabilitation
291364|NCT02396173|prediction|prediction
291365|NCT02396160|overactive bladder|overactive bladder
291366|NCT02396160|urinary incontinence|urinary incontinence
291367|NCT02396160|nocturia|nocturia
291368|NCT02396160|urinary frequency|urinary frequency
291369|NCT02396147|Drug therapy|drug therapy
291370|NCT02396095|female|female
291371|NCT02396095|cancer|cancer
291372|NCT02396082|care coordination|care coordination
291373|NCT02396082|quality of life|quality of life
291374|NCT02396082|community-based|community-based
291375|NCT02396082|care quality|care quality
291376|NCT02396082|Long term care placement|long term care placement
291377|NCT02396082|memory care|memory care
291378|NCT02396082|Neuropsychiatric behaviors|neuropsychiatric behaviors
291379|NCT02396056|Guided Bone Regeneration|guided bone regeneration
291380|NCT02396056|Gingival Mesenchymal Stem Cells|gingival mesenchymal stem cells
291381|NCT02395991|gadoxetic acid|gadoxetic acid
291382|NCT02395991|transient dyspnea|transient dyspnea
291383|NCT02395965|Osteopathic manipulative medicine|osteopathic manipulative medicine
291384|NCT02395965|Osteopathic manipulative treatment|osteopathic manipulative treatment
291385|NCT02395952|cornea|cornea
291386|NCT02395952|epithelial defect|epithelial defect
291387|NCT02395952|amniotic membrane|amniotic membrane
291388|NCT02395939|Cryobiopsy|cryobiopsy
291389|NCT02395939|Radial EBUS|radial ebus
291390|NCT02395939|Guide Sheath|guide sheath
291391|NCT02395939|Peripheral pulmonary lesions|peripheral pulmonary lesions
291392|NCT02395887|Spinal stenosis|spinal stenosis
291393|NCT02395887|Spinal decompression|spinal decompression
291394|NCT02395887|Postural balance|postural balance
291395|NCT02395887|Neurogenic claudication|neurogenic claudication
291396|NCT02395848|recurrent|recurrent
291397|NCT02395848|infection|infection
291398|NCT02395835|body mass index|body mass index
291399|NCT02395835|methylation|methylation
291400|NCT02395835|PPAR gamma|ppar gamma
291401|NCT02395835|pregnancy|pregnancy
291402|NCT02395822|AML|aml
291403|NCT02395822|Relapsed|relapsed
291404|NCT02395822|Refractory|refractory
291405|NCT02395796|epidural|epidural
291406|NCT02395796|labor analgesia|labor analgesia
291407|NCT02395796|pressure monitoring|pressure monitoring
291408|NCT02395783|Preterm infants|preterm infants
291409|NCT02395783|diagnosis of cerebral white matter injury|diagnosis of cerebral white matter injury
291410|NCT02395770|Shoulder|shoulder
291411|NCT02395770|Rotator cuff|rotator cuff
291412|NCT02395770|Rehabilitation|rehabilitation
291413|NCT02395770|Motor control|motor control
291414|NCT02395757|Age Related Macular Degeneration (AMD)|age related macular degeneration (amd)
291415|NCT02395757|Microperimetry|microperimetry
291416|NCT02395757|Diagnostic|diagnostic
291417|NCT02395731|dual eligible|dual eligible
291418|NCT02395731|care coordination|care coordination
291419|NCT02395731|community-based|community-based
291420|NCT02395731|care quality|care quality
291421|NCT02395731|care needs|care needs
291422|NCT02395731|health services|health services
291423|NCT02395731|care management|care management
291424|NCT02395731|low income|low income
291425|NCT02395731|Neuropsychiatric behaviors|neuropsychiatric behaviors
291426|NCT02395718|elderly|elderly
291427|NCT02395718|quick diagnostic unit|quick diagnostic unit
291428|NCT02395718|short stay unit|short stay unit
291429|NCT02395718|randomised controlled trial|randomised controlled trial
291430|NCT02395679|Dendritic cell-based immunotherapy|dendritic cell-based immunotherapy
291431|NCT02395666|Neuroblastoma in remission|neuroblastoma in remission
291432|NCT02395666|Relapsed Neuroblastoma|relapsed neuroblastoma
291433|NCT02395666|Refractory Neuroblastoma|refractory neuroblastoma
291434|NCT02395653|Pediatric|pediatric
291435|NCT02395653|Postoperative|postoperative
291436|NCT02395653|Pain Management|pain management
291437|NCT02395627|Hormone Therapy Resistant|hormone therapy resistant
291438|NCT02395627|Estrogen Receptor-Positive|estrogen receptor-positive
291439|NCT02395627|Estrogen Receptor-Negative|estrogen receptor-negative
291440|NCT02395614|tissue expander|tissue expander
291441|NCT02395614|breast reconstruction|breast reconstruction
291442|NCT02395601|B-Cell Lymphoma|b-cell lymphoma
291443|NCT02395601|EZH2 Inhibitor|ezh2 inhibitor
291444|NCT02395601|Phase 1|phase 1
291445|NCT02395497|Penile Transplant|penile transplant
291446|NCT02395497|Vascularized Composite Allotransplantation (VCA)|vascularized composite allotransplantation (vca)
291447|NCT02395497|Composite Tissue Allotransplantation (CTA)|composite tissue allotransplantation (cta)
291448|NCT02395497|Penis|penis
291449|NCT02395497|Amputation|amputation
291450|NCT02395497|Immunosuppression|immunosuppression
291451|NCT02395497|Composite Tissue|composite tissue
291452|NCT02395497|Male|male
291453|NCT02395497|Humans|humans
291454|NCT02395497|Allotransplantation|allotransplantation
291455|NCT02395458|Sequential therapy|sequential therapy
291456|NCT02395458|Triple therapy|triple therapy
291457|NCT02395458|Eradication|eradication
291458|NCT02395393|Acute rejection|acute rejection
291459|NCT02395393|Chronic rejection|chronic rejection
291460|NCT02395393|Confocal microscopy|confocal microscopy
291462|NCT02395380|Postoperative complication|postoperative complication
291463|NCT02395380|Length of stay|length of stay
291464|NCT02395367|Prognosis|prognosis
291465|NCT02395367|Risk Factors|risk factors
291466|NCT02395354|Endoscopic treatment|endoscopic treatment
291467|NCT02395354|Stenosis|stenosis
291468|NCT02395354|Crohn's Disease|crohn's disease
291469|NCT02395354|balloon dilatation|balloon dilatation
291470|NCT02395354|self-expanding metallic stent|self-expanding metallic stent
291471|NCT02395354|chronic transmural inflammation|chronic transmural inflammation
291472|NCT02395354|steady narrowing of the intestinal lumen|steady narrowing of the intestinal lumen
291473|NCT02395341|reproductive hormones|reproductive hormones
291474|NCT02395341|cancer survivors|cancer survivors
291475|NCT02395341|endocrine function|endocrine function
291476|NCT02395341|antral follicle counts|antral follicle counts
291477|NCT02395341|female infertility due to diminished ovarian reserve|female infertility due to diminished ovarian reserve
291478|NCT02395341|perimenopause|perimenopause
291479|NCT02395341|premature menopause|premature menopause
291480|NCT02395328|Orphans and vulnerable children (OVC)|orphans and vulnerable children (ovc)
291481|NCT02395328|Home visiting intervention|home visiting intervention
291482|NCT02395328|South Africa|south africa
291483|NCT02395328|Program evaluation|program evaluation
291484|NCT02395315|Diabetes Mellitus|diabetes mellitus
291485|NCT02395315|Osseointegration|osseointegration
291486|NCT02395315|Bone vascularity|bone vascularity
291487|NCT02395315|Primary implant stability|primary implant stability
291488|NCT02395289|Cognitive-Based Compassion Training (CBCT)|cognitive-based compassion training (cbct)
291489|NCT02395289|HIV-related clinical outcomes|hiv-related clinical outcomes
291490|NCT02395289|Stress and stress-related psychological adjustment|stress and stress-related psychological adjustment
291491|NCT02395289|Stress-related inflammatory biomarkers|stress-related inflammatory biomarkers
291492|NCT02395276|Congenital Heart Defects|congenital heart defects
291493|NCT02395276|Hypoxic Ischemic Brain Injury|hypoxic ischemic brain injury
291494|NCT02395276|Hypothermia Therapy|hypothermia therapy
291495|NCT02395276|Pediatrics|pediatrics
291496|NCT02395237|Fed Conditions|fed conditions
291497|NCT02395224|Follow-up studies|follow-up studies
291498|NCT02395224|Prognosis|prognosis
291499|NCT02395224|Palliative care|palliative care
291500|NCT02395224|Chemotherapy, adjuvant|chemotherapy, adjuvant
291501|NCT02395224|Cost-benefit analysis|cost-benefit analysis
291502|NCT02395224|Population|population
291503|NCT02395224|Antineoplastic agents/Adverse effects|antineoplastic agents/adverse effects
291504|NCT02395224|Terminal care|terminal care
291505|NCT02395224|Medical futility|medical futility
291506|NCT02395224|Survival rate|survival rate
291507|NCT02395224|Norway|norway
291508|NCT02395198|hepatitis c virus|hepatitis c virus
291509|NCT02395198|opioid substitution treatment|opioid substitution treatment
291510|NCT02395172|Avelumab|avelumab
291511|NCT02395172|MSB0010718C|msb0010718c
291512|NCT02395172|Non-Small Cell Lung Cancer|non-small cell lung cancer
372413|NCT01995942|CRM|crm
291513|NCT02395172|Anti-PD-L1|anti-pd-l1
291514|NCT02395159|vascular surgery patients|vascular surgery patients
291515|NCT02395159|wound management|wound management
291516|NCT02395133|Eczema|eczema
291517|NCT02395120|Dental Care|dental care
291518|NCT02395120|Caregiver Illness Perception|caregiver illness perception
291519|NCT02395120|Common Sense Model of Self-Regulation|common sense model of self-regulation
291520|NCT02395120|Dental Access|dental access
291521|NCT02395120|Referral letter|referral letter
291522|NCT02395120|Dental Caries|dental caries
291523|NCT02395107|Aortic Valve Stenosis|aortic valve stenosis
291524|NCT02395107|Functional Capacity|functional capacity
291525|NCT02395107|Cardiomyopathies|cardiomyopathies
291526|NCT02395107|Endomyocardial Fibrosis|endomyocardial fibrosis
291527|NCT02395107|Cardiovascular Diseases|cardiovascular diseases
291528|NCT02395107|Heart Diseases|heart diseases
291529|NCT02395107|Heart Valve Diseases|heart valve diseases
291530|NCT02395107|Atrial Fibrillation|atrial fibrillation
291531|NCT02395107|Hypertrophy|hypertrophy
291532|NCT02395107|Hypertrophy, Left Ventricular|hypertrophy, left ventricular
291533|NCT02395107|Diastology|diastology
291534|NCT02395081|pregnancy|pregnancy
291535|NCT02395081|Mongolia|mongolia
291536|NCT02395081|Vitamin D|vitamin d
291537|NCT02395081|preeclampsia|preeclampsia
291538|NCT02395068|Pharmacokinetics|pharmacokinetics
291539|NCT02395068|Nimotuzumab|nimotuzumab
291540|NCT02395068|Safety|safety
291541|NCT02395068|Effcacy|effcacy
291542|NCT02395068|Irinotecan|irinotecan
291543|NCT02395029|PD|pd
291544|NCT02395003|Obesity|obesity
291545|NCT02395003|Pediatric|pediatric
291546|NCT02394977|CPR|cpr
291547|NCT02394977|Cardio first angle|cardio first angle
291548|NCT02394977|Clinical trial|clinical trial
291549|NCT02394951|chemotherapy|chemotherapy
291550|NCT02394938|Music therapy|music therapy
291551|NCT02394912|vena cava filter|vena cava filter
291552|NCT02394899|SCD|scd
291553|NCT02394899|early childhood intervention|early childhood intervention
291554|NCT02394899|parental stress|parental stress
291555|NCT02394899|neurocognition|neurocognition
291556|NCT02394873|Deep Second-Degree Burn Wound|deep second-degree burn wound
291557|NCT02394847|propofol|propofol
291558|NCT02394847|electroconvulsive therapy|electroconvulsive therapy
291559|NCT02394847|anesthesia|anesthesia
291560|NCT02394834|Metastatic colorectal cancer, Panitumumab, mFOLFOX6, Bevacizumab|metastatic colorectal cancer, panitumumab, mfolfox6, bevacizumab
291561|NCT02394795|Metastatic colorectal cancer, Panitumumab, mFOLFOX6, Bevacizumab|metastatic colorectal cancer, panitumumab, mfolfox6, bevacizumab
291562|NCT02394782|Multiple sclerosis, relapsing-remitting|multiple sclerosis, relapsing-remitting
291563|NCT02394782|Rebif|rebif
291564|NCT02394782|Interferon beta-1a|interferon beta-1a
291565|NCT02394782|RebiSmart®2.0|rebismart®2.0
291566|NCT02394782|MSdialog™|msdialog™
291567|NCT02394769|Colorectal Cancer|colorectal cancer
291568|NCT02394743|Glomerular Filtration Rate|glomerular filtration rate
291569|NCT02394730|HIV, d-dimer, hs-CRP, activated T-lymphocytes|hiv, d-dimer, hs-crp, activated t-lymphocytes
291570|NCT02394704|Rumination|rumination
291571|NCT02394704|Sensory processing|sensory processing
291572|NCT02394704|Non-pharmacological intervention|non-pharmacological intervention
291573|NCT02394704|Depression|depression
291574|NCT02394704|Anxiety|anxiety
291575|NCT02394704|PTSD|ptsd
291576|NCT02394665|Glioblastoma|glioblastoma
291577|NCT02394665|Gliosarcoma|gliosarcoma
291578|NCT02394665|GBM|gbm
291579|NCT02394626|Recurrent glioblastoma|recurrent glioblastoma
291580|NCT02394626|Surgery|surgery
291581|NCT02394626|Complete resection of enhancing tumor|complete resection of enhancing tumor
291582|NCT02394626|Survival|survival
291583|NCT02394626|Quality of life|quality of life
291584|NCT02394613|Glaucoma|glaucoma
291585|NCT02394613|DARC|darc
291586|NCT02394613|Diagnosis|diagnosis
291587|NCT02394600|rhinitis|rhinitis
291588|NCT02394600|allergy|allergy
291589|NCT02394587|mindfulness|mindfulness
291590|NCT02394587|MBSR|mbsr
291591|NCT02394587|SCD|scd
291592|NCT02394587|experimental|experimental
291593|NCT02394548|Locally advanced, inoperable non-small cell lung carcinoma|locally advanced, inoperable non-small cell lung carcinoma
291594|NCT02394548|Limited stage small cell lung carcinoma|limited stage small cell lung carcinoma
291595|NCT02394548|Acute esophagitis|acute esophagitis
291596|NCT02394548|Intensity-modulated radiation therapy|intensity-modulated radiation therapy
291597|NCT02394522|Malaria|malaria
291598|NCT02394522|Spatial Repellents|spatial repellents
291599|NCT02394522|Plasmodium|plasmodium
291600|NCT02394509|Epilepsy Memory Problems|epilepsy memory problems
291601|NCT02394509|Self-Management|self-management
291602|NCT02394496|Fulvestrant|fulvestrant
291603|NCT02394496|Lapatinib|lapatinib
291604|NCT02394496|Aromatase Inhibitor|aromatase inhibitor
291605|NCT02394496|metastatic breast cancer|metastatic breast cancer
291606|NCT02394483|Single ascending dose|single ascending dose
291607|NCT02394483|double blind|double blind
291608|NCT02394470|congestion|congestion
754451|NCT00424918|Peers|peers
291609|NCT02394470|total body water|total body water
291610|NCT02394470|bioimpedentiometry|bioimpedentiometry
291611|NCT02394470|lung ultrasound|lung ultrasound
291612|NCT02394470|diuretics|diuretics
291613|NCT02394470|dyspnea|dyspnea
291614|NCT02394470|pulmonary B lines|pulmonary b lines
291615|NCT02394470|deuterium|deuterium
291616|NCT02394457|Postdural puncture headache|postdural puncture headache
291617|NCT02394457|Epidural Blood Patch|epidural blood patch
291618|NCT02394457|Cosyntropin|cosyntropin
291619|NCT02394457|PDPH|pdph
291620|NCT02394457|Regional anesthesia|regional anesthesia
291621|NCT02394457|Lumbar puncture|lumbar puncture
291622|NCT02394457|ACTH|acth
291623|NCT02394457|Tetracosactin|tetracosactin
291624|NCT02394444|Intervention program|intervention program
291625|NCT02394444|Parenting stress|parenting stress
291626|NCT02394444|Parental mental health|parental mental health
291627|NCT02394444|Preterm infant's development|preterm infant's development
291628|NCT02394431|Sickle Cell Disease|sickle cell disease
291629|NCT02394431|Echocardiography|echocardiography
291630|NCT02394431|Speckle tracking|speckle tracking
291631|NCT02394392|Medication satisfaction|medication satisfaction
291632|NCT02394392|Quality of life|quality of life
291633|NCT02394392|Drug compliance|drug compliance
291634|NCT02394366|Skin oxygenation|skin oxygenation
291635|NCT02394366|peripheral perfusion|peripheral perfusion
291636|NCT02394353|bariatrics|bariatrics
291637|NCT02394353|transient elastography|transient elastography
291638|NCT02394314|MEDI0382, diabetes|medi0382, diabetes
291639|NCT02394301|Efficacy of Novel Drug Combinations for Relief of Psoriasis|efficacy of novel drug combinations for relief of psoriasis
291640|NCT02394288|Cardiac Troponin|cardiac troponin
291641|NCT02394288|Perioperative Period|perioperative period
291642|NCT02394288|surgery|surgery
291643|NCT02394262|Biological Markers|biological markers
291644|NCT02394262|Multidetector Computed Tomography|multidetector computed tomography
291645|NCT02394249|Insulin Resistance|insulin resistance
291646|NCT02394249|Cognition|cognition
291647|NCT02394249|Affect|affect
291648|NCT02394249|Insulin|insulin
291649|NCT02394249|Lipids|lipids
291650|NCT02394236|exercise training|exercise training
291651|NCT02394223|Cancer|cancer
291652|NCT02394223|Prostate|prostate
291654|NCT02394223|Biopsies|biopsies
291655|NCT02394223|FFOCT procedure|ffoct procedure
291656|NCT02394210|Multiple myeloma asymptomatic relapse symptomatic relapse|multiple myeloma asymptomatic relapse symptomatic relapse
291657|NCT02394210|IMW Consensus Panel|imw consensus panel
291658|NCT02394210|anti-MM therapy|anti-mm therapy
291659|NCT02394197|Plasmodium vivax|plasmodium vivax
291660|NCT02394197|Mexico|mexico
291661|NCT02394197|treatment|treatment
291662|NCT02394197|chloroquine|chloroquine
291663|NCT02394197|primaquine|primaquine
291664|NCT02394197|14-day treatment (T14)|14-day treatment (t14)
291665|NCT02394197|intermittent single doses (ISD)|intermittent single doses (isd)
291666|NCT02394184|transcatheter aortic valve replacement|transcatheter aortic valve replacement
291667|NCT02394171|Physical Activity|physical activity
291668|NCT02394171|Social Cohesion|social cohesion
291669|NCT02394171|Intervention Development|intervention development
291670|NCT02394171|Ethnic Minorities|ethnic minorities
291671|NCT02394171|Nutrition|nutrition
291672|NCT02394158|Recurrent Gestational Diabetes Mellitus|recurrent gestational diabetes mellitus
291673|NCT02394158|Prevention|prevention
291674|NCT02394158|Metformin|metformin
291675|NCT02394145|platelet|platelet
291676|NCT02394145|ticagrelor|ticagrelor
291677|NCT02394145|clopidogrel|clopidogrel
291678|NCT02394145|end stage renal disease|end stage renal disease
291679|NCT02394145|hemodialysis|hemodialysis
291680|NCT02394145|genetics|genetics
291681|NCT02394132|Lentigo maligna|lentigo maligna
291682|NCT02394132|Imiquimod|imiquimod
291683|NCT02394132|Radiotherapy|radiotherapy
291684|NCT02394054|vasopressin|vasopressin
291685|NCT02394054|intranasal administration|intranasal administration
291686|NCT02394054|healthy sample|healthy sample
291687|NCT02394041|acupuncture|acupuncture
291688|NCT02394041|cervical dystocia|cervical dystocia
291689|NCT02394041|caesarean section|caesarean section
291690|NCT02394041|obstetric labor|obstetric labor
291691|NCT02394041|randomized controlled trial|randomized controlled trial
291692|NCT02394015|Platinum-sensitive Recurrent Ovarian Cancer|platinum-sensitive recurrent ovarian cancer
291693|NCT02394002|EEG, burst-suppression, N20, SEP, median nerve, facilitation|eeg, burst-suppression, n20, sep, median nerve, facilitation
291694|NCT02393911|vestibulitis|vestibulitis
291695|NCT02393911|microbiome|microbiome
291696|NCT02393872|Prevention|prevention
291697|NCT02393859|ALL|all
291698|NCT02393859|High-risk first relapse B-precursor ALL|high-risk first relapse b-precursor all
291699|NCT02393859|Precursor Cell Lymphoblastic Leukemia|precursor cell lymphoblastic leukemia
291700|NCT02393859|Neoplasms|neoplasms
291701|NCT02393859|Lymphoproliferative Disorders|lymphoproliferative disorders
291702|NCT02393859|Immunoproliferative Disorders|immunoproliferative disorders
291703|NCT02393859|Antibodies, Bispecific|antibodies, bispecific
291704|NCT02393846|ankle sprain|ankle sprain
291705|NCT02393846|topical ketoprofen|topical ketoprofen
291706|NCT02393846|non-steroidal anti-inflammatory drug|non-steroidal anti-inflammatory drug
291707|NCT02393846|emergency department|emergency department
291708|NCT02393833|Vascular endothelial growth factor (VEGF)|vascular endothelial growth factor (vegf)
291709|NCT02393833|Vascular cell adhesion molecule-1 (VCAM-1)|vascular cell adhesion molecule-1 (vcam-1)
291710|NCT02393833|HER2-ECD|her2-ecd
291711|NCT02393807|Chronic Obstructive Pulmonary Disease|chronic obstructive pulmonary disease
291712|NCT02393794|BRCA1|brca1
291713|NCT02393794|BRCA2|brca2
291714|NCT02393794|TNBC|tnbc
291715|NCT02393781|severe sepsis|severe sepsis
291716|NCT02393781|septic shock|septic shock
291717|NCT02393781|adrenomedullin|adrenomedullin
291718|NCT02393781|organ dysfunction|organ dysfunction
291719|NCT02393703|exosomes|exosomes
291720|NCT02393703|15-015|15-015
291721|NCT02393664|Thoracoscopy|thoracoscopy
291722|NCT02393664|Recovery|recovery
291723|NCT02393664|Tracheal intubation|tracheal intubation
291724|NCT02393638|Endoscopic Sphincterotomy|endoscopic sphincterotomy
291725|NCT02393625|NSCLC, ALK-positive|nsclc, alk-positive
291726|NCT02393586|Tuberculosis|tuberculosis
291727|NCT02393586|Whole blood Bactericidal Activity|whole blood bactericidal activity
291728|NCT02393586|WBA|wba
291729|NCT02393586|Faropenem|faropenem
291730|NCT02393573|Insulin Resistance|insulin resistance
291731|NCT02393573|Protein balance|protein balance
291732|NCT02393573|Surgery|surgery
291733|NCT02393573|Post operative complications|post operative complications
291734|NCT02393573|metformin|metformin
291735|NCT02393573|Pre-diabetes|pre-diabetes
291736|NCT02393573|Fasting blood glucose|fasting blood glucose
291737|NCT02393547|obesity|obesity
291738|NCT02393534|Primary Care|primary care
291739|NCT02393534|Health Services Research|health services research
291740|NCT02393534|Telemedicine|telemedicine
291741|NCT02393521|Vibration|vibration
291742|NCT02393521|Pressure Pain Threshold|pressure pain threshold
291743|NCT02393521|Trigger Points|trigger points
291744|NCT02393521|Neck Pain|neck pain
291745|NCT02393508|transfusion, red blood cell|transfusion, red blood cell
291746|NCT02393508|transfusion reaction|transfusion reaction
291747|NCT02393508|quality of life|quality of life
291748|NCT02393443|oxytocin|oxytocin
291749|NCT02393443|healthy sample|healthy sample
291750|NCT02393443|intranasal administration|intranasal administration
291751|NCT02393443|learning|learning
291752|NCT02393417|Verruca vulgaris|verruca vulgaris
291753|NCT02393417|Common Warts|common warts
291754|NCT02393378|Drug Therapy|drug therapy
291755|NCT02393365|Hepatitis C|hepatitis c
291756|NCT02393365|HCV|hcv
291757|NCT02393365|screening|screening
291758|NCT02393352|Body Composition|body composition
291759|NCT02393352|Autonomic Nervous System|autonomic nervous system
291760|NCT02393352|Oxygen|oxygen
291761|NCT02393352|Randomized Controlled Trial|randomized controlled trial
291762|NCT02393300|tranexamic acid|tranexamic acid
291763|NCT02393300|blood loss|blood loss
291764|NCT02393300|topical administration|topical administration
291765|NCT02393300|intravenous administration|intravenous administration
291766|NCT02393248|alterations in FGF or FGFR|alterations in fgf or fgfr
291767|NCT02393248|squamous non-small cell lung cancer|squamous non-small cell lung cancer
291768|NCT02393248|gastric cancer|gastric cancer
291769|NCT02393248|urothelial cancer|urothelial cancer
291770|NCT02393248|endometrial cancer|endometrial cancer
291771|NCT02393248|multiple myeloma|multiple myeloma
291772|NCT02393248|MPN|mpn
291773|NCT02393235|unexplained infertility|unexplained infertility
291774|NCT02393235|tubal infertility|tubal infertility
291775|NCT02393235|pulsatility index|pulsatility index
291776|NCT02393235|resistance index|resistance index
291777|NCT02393235|fertile women|fertile women
291778|NCT02393222|Dialysis|dialysis
291779|NCT02393222|Cerebrovascular disease|cerebrovascular disease
291780|NCT02393222|ESRD|esrd
291781|NCT02393209|Drug therapy|drug therapy
291782|NCT02393196|colloid preloading|colloid preloading
291783|NCT02393196|colloid coloading|colloid coloading
291784|NCT02393183|Antioxidant|antioxidant
291785|NCT02393183|Graves' ophthalmopathy|graves' ophthalmopathy
291786|NCT02393183|Thyroid eye disease|thyroid eye disease
291787|NCT02393183|Severity score|severity score
291788|NCT02393183|Activity score|activity score
291789|NCT02393183|Quality of life|quality of life
291790|NCT02393144|Labor analysis|labor analysis
291791|NCT02393144|Transperineal ultrasound imaging|transperineal ultrasound imaging
291792|NCT02393144|Labor curve|labor curve
291793|NCT02393131|Brain Metastases|brain metastases
291794|NCT02393131|Whole Brain Radiotherapy|whole brain radiotherapy
291795|NCT02393131|Neurocognitive function|neurocognitive function
291796|NCT02393118|Assistive technology|assistive technology
291797|NCT02393118|Non-surgical visual prosthetic|non-surgical visual prosthetic
291798|NCT02393118|sensory substitution|sensory substitution
291799|NCT02393118|BrainPort|brainport
291800|NCT02393118|Blindness|blindness
291801|NCT02393118|Assistive device|assistive device
291802|NCT02393105|Breast Cancer|breast cancer
291803|NCT02393079|Traumatic Brain Injury|traumatic brain injury
291804|NCT02393079|Cognitive|cognitive
291805|NCT02393053|Gingival Recession|gingival recession
291806|NCT02393053|Case-Control Studies|case-control studies
291807|NCT02393053|Adipose Tissue|adipose tissue
291808|NCT02393040|Alopecia|alopecia
291809|NCT02393040|Androgenetic Alopecia|androgenetic alopecia
291810|NCT02393040|Alopecia, Male Pattern|alopecia, male pattern
291811|NCT02393040|Hair loss|hair loss
291812|NCT02393040|Platelet-Rich Plasma|platelet-rich plasma
291813|NCT02393040|Alopecia, Female Pattern|alopecia, female pattern
291814|NCT02393040|placebo|placebo
291815|NCT02393040|double-blind|double-blind
291816|NCT02393014|65 years old or older|65 years old or older
291817|NCT02393014|hospitalized in|hospitalized in
291818|NCT02393014|geriatrics|geriatrics
291819|NCT02393001|skin cancer|skin cancer
291820|NCT02393001|suspicious lesion|suspicious lesion
291821|NCT02393001|skin biopsy|skin biopsy
291822|NCT02393001|noninvasive|noninvasive
291823|NCT02393001|screening|screening
291824|NCT02392962|proprioception|proprioception
291825|NCT02392962|countermovement jump|countermovement jump
291826|NCT02392962|postural balance|postural balance
291827|NCT02392949|Spine|spine
291828|NCT02392949|mobilization|mobilization
291829|NCT02392936|according to the definition of the Comité Technique des Infections Nosocomiales et Liées aux Soins (2007)|according to the definition of the comité technique des infections nosocomiales et liées aux soins (2007)
291830|NCT02392923|health related quality of life|health related quality of life
291831|NCT02392910|Iron Sucrose|iron sucrose
291832|NCT02392910|Mortality|mortality
291833|NCT02392910|Hospitalization|hospitalization
291834|NCT02392897|meal frequency|meal frequency
291835|NCT02392897|eating frequency|eating frequency
291836|NCT02392897|ingestive frequency|ingestive frequency
291837|NCT02392897|Positive energy balance|positive energy balance
291838|NCT02392897|Satiation|satiation
291839|NCT02392884|Human Immunodeficiency Virus|human immunodeficiency virus
291840|NCT02392884|Acquired Immunodeficiency Syndrome|acquired immunodeficiency syndrome
291841|NCT02392884|Cognitive Rehabilitation|cognitive rehabilitation
291842|NCT02392884|Minority Health|minority health
291843|NCT02392884|Vulnerable Populations|vulnerable populations
291844|NCT02392884|Underserved, Patients|underserved, patients
291845|NCT02392884|Medication Adherence|medication adherence
291846|NCT02392884|Medication Compliance|medication compliance
291847|NCT02392884|Medication Non-compliance|medication non-compliance
291848|NCT02392884|Medication Persistence|medication persistence
291849|NCT02392884|Medication Non-Adherence|medication non-adherence
291850|NCT02392871|Metastatic melanoma|metastatic melanoma
291851|NCT02392871|Palliative radiotherapy|palliative radiotherapy
291852|NCT02392845|Drug combination|drug combination
291853|NCT02392845|Accelerated chemotherapy|accelerated chemotherapy
291854|NCT02392845|Mathematical model|mathematical model
291855|NCT02392845|Hematotoxicity|hematotoxicity
291856|NCT02392845|Individualized dosage|individualized dosage
291857|NCT02392832|long-lasting microbial larvicide|long-lasting microbial larvicide
291858|NCT02392832|intervention|intervention
291859|NCT02392832|cluster randomised controlled trial|cluster randomised controlled trial
291860|NCT02392832|Anopheles mosquito|anopheles mosquito
291861|NCT02392806|Continuous positive airway pressure|continuous positive airway pressure
291862|NCT02392806|CPAP|cpap
291863|NCT02392806|Bubble CPAP|bubble cpap
291864|NCT02392806|Extubation failure|extubation failure
291865|NCT02392806|Preterm infant|preterm infant
291866|NCT02392767|L-Arginine|l-arginine
291867|NCT02392767|Pycnogenol|pycnogenol
291868|NCT02392767|vitamin K2|vitamin k2
291869|NCT02392767|vitamin B|vitamin b
291870|NCT02392767|endothelial function|endothelial function
291871|NCT02392767|hypertension|hypertension
291872|NCT02392767|Homocystein >10|homocystein >10
291873|NCT02392754|Screening|screening
291874|NCT02392754|Atrial Fibrillation|atrial fibrillation
291875|NCT02392754|ECG|ecg
291876|NCT02392754|Primary care|primary care
291877|NCT02392741|Physical Activity|physical activity
291878|NCT02392741|Microcirculation|microcirculation
291879|NCT02392741|Pregnancy Outcome|pregnancy outcome
291880|NCT02392741|Obesity|obesity
291881|NCT02392741|Pregnancy|pregnancy
291882|NCT02392715|Inspiratory muscle training|inspiratory muscle training
291883|NCT02392715|General exercise training|general exercise training
291884|NCT02392715|pulmonary rehabilitation|pulmonary rehabilitation
291885|NCT02392715|chronic obstructive pulmonary disease|chronic obstructive pulmonary disease
291886|NCT02392702|Subjects|subjects
291887|NCT02392702|Safety/Efficacy Study|safety/efficacy study
291888|NCT02392702|Randomized|randomized
291889|NCT02392702|Open Label|open label
291890|NCT02392689|procalcitonin|procalcitonin
291891|NCT02392689|biomarker|biomarker
291892|NCT02392689|antibiotic therapy|antibiotic therapy
291893|NCT02392689|emergency department|emergency department
291894|NCT02392689|cardiology|cardiology
291895|NCT02392689|in vitro diagnostics|in vitro diagnostics
291896|NCT02392676|Ovarian cancer|ovarian cancer
291897|NCT02392676|Platinum|platinum
291898|NCT02392676|Somatic BRCA mutation|somatic brca mutation
291899|NCT02392676|Homologous recombination repair|homologous recombination repair
291900|NCT02392663|Sputum clearance|sputum clearance
291901|NCT02392663|Cough severity|cough severity
291902|NCT02392663|Hypertonic saline|hypertonic saline
291903|NCT02392663|Acid hyaluronic|acid hyaluronic
291904|NCT02392663|Tolerability|tolerability
291905|NCT02392637|Biliary Tract Cancer|biliary tract cancer
291906|NCT02392637|Intrahepatic cholangiocarcinoma|intrahepatic cholangiocarcinoma
291907|NCT02392637|Extrahepatic cholangiocarcinoma,|extrahepatic cholangiocarcinoma,
291908|NCT02392637|Gallbladder cancer|gallbladder cancer
291909|NCT02392637|Metastatic|metastatic
291910|NCT02392637|Unresectable|unresectable
291911|NCT02392637|Abraxane|abraxane
291912|NCT02392637|Nab-Paclitaxel|nab-paclitaxel
291913|NCT02392637|Paclitaxel (Protein-Bound)|paclitaxel (protein-bound)
291914|NCT02392637|ABI-007|abi-007
291915|NCT02392637|Cisplatin|cisplatin
291916|NCT02392637|Platinol-AQ|platinol-aq
291917|NCT02392637|Platinol|platinol
291918|NCT02392637|CDDP|cddp
291919|NCT02392637|Gemcitabine|gemcitabine
291920|NCT02392637|Gemcitabine Hydrochloride|gemcitabine hydrochloride
291921|NCT02392637|Gemzar|gemzar
291922|NCT02392637|Phone calls|phone calls
291923|NCT02392611|Estrogen Receptor Positive Breast Cancer|estrogen receptor positive breast cancer
291924|NCT02392585|Leiomyoma of uterus|leiomyoma of uterus
291925|NCT02392585|Hemostasis, Surgical|hemostasis, surgical
291926|NCT02392585|Prevention of Surgical Blood Loss|prevention of surgical blood loss
291927|NCT02392585|mechanical uterine tourniquet|mechanical uterine tourniquet
291928|NCT02392572|Leukemia|leukemia
291929|NCT02392572|Acute myelogenous leukemia|acute myelogenous leukemia
291930|NCT02392572|AML|aml
291931|NCT02392572|Myelodysplastic syndrome|myelodysplastic syndrome
291932|NCT02392572|MDS|mds
291933|NCT02392572|Acute lymphoblastic leukemia|acute lymphoblastic leukemia
291934|NCT02392572|ALL|all
291935|NCT02392572|Relapsed|relapsed
291936|NCT02392572|Refractory|refractory
291937|NCT02392572|ONC201|onc201
291938|NCT02392572|Cytarabine|cytarabine
291939|NCT02392572|Ara-C|ara-c
291940|NCT02392572|Cytosar|cytosar
291941|NCT02392572|DepoCyt|depocyt
291942|NCT02392572|Cytosine Arabinosine Hydrochloride|cytosine arabinosine hydrochloride
291943|NCT02392559|Hypercholesterolemia|hypercholesterolemia
291944|NCT02392559|Elevated Cholesterol|elevated cholesterol
291945|NCT02392559|High Cholesterol|high cholesterol
291946|NCT02392559|Heterozygous Familial Hypercholesterolemia|heterozygous familial hypercholesterolemia
291947|NCT02392559|PCSK9 mutations|pcsk9 mutations
291948|NCT02392559|Paediatric|paediatric
291949|NCT02392559|pediatric|pediatric
291950|NCT02392559|Childhood Familial Hypercholesterolemia|childhood familial hypercholesterolemia
291951|NCT02392533|ultrasound|ultrasound
291952|NCT02392520|severe OHSS|severe ohss
291953|NCT02392520|antagonist administration|antagonist administration
291954|NCT02392520|conventional treatment|conventional treatment
291955|NCT02392442|immunophenotypes|immunophenotypes
291956|NCT02392442|Bronchoalveolar Lavage|bronchoalveolar lavage
291957|NCT02392442|Bronchoscopy|bronchoscopy
291958|NCT02392442|Endotoxin Instillation|endotoxin instillation
291959|NCT02392442|miRNA|mirna
291960|NCT02392390|Topical Dynamic Phototherapy|topical dynamic phototherapy
291961|NCT02392390|Microbiota|microbiota
291962|NCT02392351|Hypertension|hypertension
291963|NCT02392351|Renal Denervation|renal denervation
291964|NCT02392338|Atrial fibrillation|atrial fibrillation
291965|NCT02392338|Ablation|ablation
291966|NCT02392338|Hybrid|hybrid
291967|NCT02392312|kidney transplant|kidney transplant
291968|NCT02392312|ATG-F|atg-f
291969|NCT02392286|Corticosteroid|corticosteroid
291970|NCT02392273|migraine|migraine
291971|NCT02392273|cluster headache|cluster headache
291972|NCT02392273|primary headache|primary headache
291973|NCT02392273|Ausanil|ausanil
291974|NCT02392273|capsicum annuum|capsicum annuum
291975|NCT02392221|Crohn's disease (CD)|crohn's disease (cd)
291976|NCT02392221|Pediatric|pediatric
291977|NCT02392221|Inflammatory Bowel Disease|inflammatory bowel disease
291978|NCT02392208|telavancin|telavancin
291979|NCT02392208|end-stage renal disease|end-stage renal disease
291980|NCT02392208|ESRD|esrd
291981|NCT02392208|pharmacokinetics|pharmacokinetics
291982|NCT02392208|hemodialysis|hemodialysis
291983|NCT02392208|chronic kidney disease|chronic kidney disease
291984|NCT02392208|CKD|ckd
291985|NCT02392208|dialysis|dialysis
291986|NCT02392208|Vibativ|vibativ
291987|NCT02392195|Plagiocephaly|plagiocephaly
291988|NCT02392182|lung|lung
291989|NCT02392169|neuroendocrine|neuroendocrine
291990|NCT02392169|ADHD|adhd
291991|NCT02392169|heredity|heredity
291992|NCT02392169|cognitive function|cognitive function
291993|NCT02392143|colorectal cancer screening|colorectal cancer screening
291994|NCT02392104|International Normalized Ratio|international normalized ratio
291995|NCT02392104|Warfarin|warfarin
291996|NCT02392078|Procedural Success|procedural success
291997|NCT02392078|Progression|progression
755899|NCT00419536|LBH589|lbh589
291998|NCT02392078|Quality of Life|quality of life
291999|NCT02392052|caregivers|caregivers
292000|NCT02392039|Lymphoma|lymphoma
292001|NCT02392039|Diffuse Large B-cell Lymphoma|diffuse large b-cell lymphoma
292002|NCT02392039|Mantle Cell Lymphoma|mantle cell lymphoma
292003|NCT02392039|Grade 3B Follicular Lymphoma|grade 3b follicular lymphoma
292004|NCT02392039|Burkitt Lymphoma|burkitt lymphoma
292005|NCT02392039|Peripheral T cell Lymphoma NOS|peripheral t cell lymphoma nos
292006|NCT02392039|NK/T cell Lymphoma|nk/t cell lymphoma
292007|NCT02392039|Transformed Lymphoma|transformed lymphoma
292008|NCT02392039|Aggressive lymphoma|aggressive lymphoma
292009|NCT02392039|Bone pain|bone pain
292010|NCT02392039|Pegfilgrastim|pegfilgrastim
292011|NCT02392039|Neulasta|neulasta
292012|NCT02392039|PEG-G-CSF|peg-g-csf
292013|NCT02392039|Loratadine|loratadine
292014|NCT02392039|Placebo|placebo
292015|NCT02392039|Sugar pill|sugar pill
292016|NCT02392039|Questionnaires|questionnaires
292017|NCT02392039|Surveys|surveys
292018|NCT02392013|older adult falls|older adult falls
292019|NCT02392013|home hazards|home hazards
292020|NCT02392013|home barriers|home barriers
292021|NCT02392000|chronic insomnia|chronic insomnia
292022|NCT02392000|Veterans Health|veterans health
292023|NCT02391974|Hyaluronic acid|hyaluronic acid
292024|NCT02391974|Periodontal pockets|periodontal pockets
292025|NCT02391974|Periodontitis|periodontitis
292026|NCT02391948|Cerebral palsy|cerebral palsy
292027|NCT02391948|Gross motor delay|gross motor delay
292028|NCT02391935|Chronic Effect of Ultraviolet Radiation on Normal Skin (Photo-aging)|chronic effect of ultraviolet radiation on normal skin (photo-aging)
292029|NCT02391922|out of hospital cardiac arrest|out of hospital cardiac arrest
292030|NCT02391922|first aid|first aid
292031|NCT02391909|Vaccine|vaccine
292032|NCT02391883|clopidogrel therapy|clopidogrel therapy
292033|NCT02391883|platelet aggregation inhibitor|platelet aggregation inhibitor
292034|NCT02391883|adverse event|adverse event
292035|NCT02391870|depression|depression
292036|NCT02391870|mindfulness|mindfulness
292037|NCT02391870|pregnancy|pregnancy
292038|NCT02391870|prevention|prevention
292039|NCT02391870|cognitive behavioral therapy|cognitive behavioral therapy
292040|NCT02391857|cardiopulmonary resuscitation|cardiopulmonary resuscitation
292041|NCT02391857|Gastric emptying|gastric emptying
292042|NCT02391844|Knee|knee
292043|NCT02391844|Post-Operative Pain|post-operative pain
292044|NCT02391844|Xartemis|xartemis
292045|NCT02391831|SMA|sma
292046|NCT02391831|Spinal Muscular Atrophy|spinal muscular atrophy
292047|NCT02391831|Neuromuscular disease|neuromuscular disease
292048|NCT02391818|balance|balance
292049|NCT02391818|quality of life|quality of life
292050|NCT02391818|chemotherapy|chemotherapy
292051|NCT02391818|neuropathy|neuropathy
292052|NCT02391818|cancer|cancer
292053|NCT02391779|High normal blood pressure|high normal blood pressure
292054|NCT02391779|Stage I|stage i
292055|NCT02391766|Self-management|self-management
292056|NCT02391766|Caregiving|caregiving
292057|NCT02391766|Quality of life|quality of life
292058|NCT02391766|Empowerment|empowerment
292059|NCT02391753|levator avulsion|levator avulsion
292060|NCT02391753|transperineal ultrasound|transperineal ultrasound
292061|NCT02391753|levator hiatus|levator hiatus
292062|NCT02391727|SYN004|syn004
292063|NCT02391727|cetuximab|cetuximab
292064|NCT02391714|pain assessment|pain assessment
292065|NCT02391714|patient satisfaction|patient satisfaction
292066|NCT02391714|Visual Analog Scale|visual analog scale
292067|NCT02391714|contraceptive devices|contraceptive devices
292068|NCT02391714|nulliparity|nulliparity
292069|NCT02391662|Metastatic Pancreatic Adenocarcinoma|metastatic pancreatic adenocarcinoma
292070|NCT02391662|Elderly|elderly
292071|NCT02391662|Nab-paclitaxel|nab-paclitaxel
292072|NCT02391662|Gemcitabine|gemcitabine
292073|NCT02391649|schizophrenia|schizophrenia
292074|NCT02391649|bibliotherapy program|bibliotherapy program
292075|NCT02391649|problem-solving|problem-solving
292076|NCT02391649|family caregivers|family caregivers
292077|NCT02391649|randomized controlled trial|randomized controlled trial
292078|NCT02391636|Postpartum Hemorrhage|postpartum hemorrhage
292079|NCT02391636|carbetocin|carbetocin
292080|NCT02391636|oxytocin|oxytocin
292081|NCT02391623|Multiple Ascending Dose|multiple ascending dose
292082|NCT02391623|Healthy Subjects|healthy subjects
292083|NCT02391623|Hyperlipidemia|hyperlipidemia
292084|NCT02391623|Lipid Metabolism Disorders|lipid metabolism disorders
292085|NCT02391623|Metabolic Diseases|metabolic diseases
292086|NCT02391610|birth cohort study|birth cohort study
292087|NCT02391610|environmental exposures|environmental exposures
292088|NCT02391610|birth defects|birth defects
292089|NCT02391610|pregnant outcomes|pregnant outcomes
292090|NCT02391610|children development|children development
292091|NCT02391545|Follicular Lymphoma|follicular lymphoma
292092|NCT02391545|Previously Untreated|previously untreated
292093|NCT02391519|Pregnancy|pregnancy
292094|NCT02391519|High altitude|high altitude
292095|NCT02391519|vasoreactivity|vasoreactivity
292096|NCT02391519|myometrial arteries|myometrial arteries
292097|NCT02391506|First CMC joint|first cmc joint
292098|NCT02391506|Osteoarthritis|osteoarthritis
292099|NCT02391506|Cartilage Replacement|cartilage replacement
292100|NCT02391506|First CMC Joint Osteoarthritis|first cmc joint osteoarthritis
292101|NCT02391506|Damaged Articular Surface|damaged articular surface
292102|NCT02391493|bilinguals|bilinguals
292103|NCT02391493|language control|language control
292104|NCT02391493|executive functions|executive functions
292105|NCT02391493|functional MRI|functional mri
292106|NCT02391493|stimulation mapping|stimulation mapping
292107|NCT02391493|brain tumors|brain tumors
292108|NCT02391480|Cancer|cancer
292109|NCT02391480|Bromodomain Inhibitor|bromodomain inhibitor
292110|NCT02391454|Neoplasms|neoplasms
292111|NCT02391454|Cell Phones|cell phones
292112|NCT02391454|Motor Activity|motor activity
292113|NCT02391454|Feasibility|feasibility
292114|NCT02391441|Pulmonary|pulmonary
292115|NCT02391441|Arterial|arterial
292116|NCT02391441|Hypertension|hypertension
292117|NCT02391441|Lung|lung
292118|NCT02391441|Transplantation|transplantation
292119|NCT02391441|MRI|mri
292120|NCT02391428|ADHD|adhd
292121|NCT02391428|omega3|omega3
292122|NCT02391402|Brain injury|brain injury
292123|NCT02391402|TBI|tbi
292124|NCT02391402|PTSD|ptsd
292125|NCT02391402|Polytrauma|polytrauma
292126|NCT02391389|preterm infant|preterm infant
292127|NCT02391376|superficial heat|superficial heat
292128|NCT02391376|hot pack|hot pack
292129|NCT02391376|thermotherapy|thermotherapy
292130|NCT02391376|physiotherapy|physiotherapy
292131|NCT02391376|Schober Test|schober test
292132|NCT02391363|anxiety|anxiety
292133|NCT02391363|worry|worry
292134|NCT02391337|Atrial fibrillation|atrial fibrillation
292135|NCT02391337|Quality of life|quality of life
292136|NCT02391337|Left ventricular ejection fraction|left ventricular ejection fraction
292137|NCT02391337|Diastolic function|diastolic function
292138|NCT02391337|Echocardiography|echocardiography
292139|NCT02391337|Beta-blockers|beta-blockers
292140|NCT02391337|Digoxin|digoxin
292141|NCT02391311|tDCS|tdcs
292142|NCT02391311|Cognitive remediation therapy|cognitive remediation therapy
292143|NCT02391298|Multiple Sclerosis|multiple sclerosis
292144|NCT02391298|stress|stress
292145|NCT02391298|meditation|meditation
292146|NCT02391298|attention|attention
292147|NCT02391272|recombinant human thrombopoietin|recombinant human thrombopoietin
292148|NCT02391272|immune thrombocytopenia|immune thrombocytopenia
292149|NCT02391272|pregnancy|pregnancy
292150|NCT02391246|central nervous system tumours|central nervous system tumours
292151|NCT02391246|[18F]-fluorodeoxyglucose|[18f]-fluorodeoxyglucose
292152|NCT02391233|Effectiveness intervention|effectiveness intervention
292153|NCT02391233|Cost-effectiveness intervention|cost-effectiveness intervention
292154|NCT02391233|HIV prevention|hiv prevention
292155|NCT02391233|Sexually transmitted infections prevention|sexually transmitted infections prevention
292156|NCT02391233|Multimedia evidence-based intervention|multimedia evidence-based intervention
292157|NCT02391233|Drug-users|drug-users
292158|NCT02391233|Black/African-American women|black/african-american women
292159|NCT02391233|Probation|probation
292160|NCT02391233|HIV testing|hiv testing
292161|NCT02391194|AVB-620|avb-620
292162|NCT02391194|stage I|stage i
292163|NCT02391194|newly diagnosed|newly diagnosed
292164|NCT02391194|breast cancer|breast cancer
292165|NCT02391194|stage II|stage ii
292166|NCT02391194|stage III|stage iii
292167|NCT02391194|ductal carcinoma in situ|ductal carcinoma in situ
292168|NCT02391181|Bioequivalence|bioequivalence
292169|NCT02391181|Iron Status|iron status
292170|NCT02391155|follicular flushing|follicular flushing
292171|NCT02391155|IVF|ivf
292172|NCT02391155|poor responders|poor responders
292173|NCT02391155|oocyte retrival|oocyte retrival
292174|NCT02391142|heart failure|heart failure
292175|NCT02391142|cardiac sympathetic nerve block|cardiac sympathetic nerve block
292176|NCT02391142|sympathetic nervous system|sympathetic nervous system
292177|NCT02391090|asthma|asthma
292178|NCT02391090|hypoxia|hypoxia
292179|NCT02391090|forced exhaled nitric oxide|forced exhaled nitric oxide
292180|NCT02391090|inflammation|inflammation
292181|NCT02391077|PrePex|prepex
292182|NCT02391077|Male Circumcision|male circumcision
292183|NCT02391077|Bacterial Load|bacterial load
292184|NCT02391064|cognition|cognition
292185|NCT02391064|brief computerized cognitive assessment|brief computerized cognitive assessment
292186|NCT02391064|impairment prediction|impairment prediction
292187|NCT02391051|prostate cancer|prostate cancer
292188|NCT02391051|focal brachytherapy|focal brachytherapy
292189|NCT02391051|PSA|psa
292190|NCT02391051|Biological marker|biological marker
292191|NCT02391038|MLN0264|mln0264
292192|NCT02391038|Advanced gastrointestinal carcinoma|advanced gastrointestinal carcinoma
292193|NCT02391025|Metastatic|metastatic
292194|NCT02391025|Prostate Cancer|prostate cancer
292195|NCT02391025|Castrate Resistant|castrate resistant
292196|NCT02391012|Ulcerative colitis|ulcerative colitis
292197|NCT02391012|Crohns disease|crohns disease
292198|NCT02391012|Microbial transplantation|microbial transplantation
292199|NCT02390986|Cancer|cancer
292200|NCT02390986|Malignant Neoplasm|malignant neoplasm
292201|NCT02390986|Anti-cancer drug|anti-cancer drug
292202|NCT02390947|Colorectal Cancer|colorectal cancer
292203|NCT02390947|Famitinib|famitinib
292204|NCT02390934|Radium 223|radium 223
292205|NCT02390934|bone metastases|bone metastases
292206|NCT02390908|alcohol use|alcohol use
292207|NCT02390908|hazardous drinking|hazardous drinking
292208|NCT02390908|behavioral intervention|behavioral intervention
292209|NCT02390908|ART adherence|art adherence
292210|NCT02390908|viral load|viral load
292211|NCT02390908|CD4|cd4
292212|NCT02390895|Minimally-invasive endoscopic repair|minimally-invasive endoscopic repair
292213|NCT02390895|fetal surgery|fetal surgery
292214|NCT02390895|outcome|outcome
292215|NCT02390895|Foetus|foetus
292216|NCT02390869|relapse|relapse
292217|NCT02390869|progression|progression
292218|NCT02390804|postoperative pain|postoperative pain
292219|NCT02390804|hysterectomy|hysterectomy
292220|NCT02390804|single-port access laparoscopy|single-port access laparoscopy
292221|NCT02390804|multi-port access laparoscopy|multi-port access laparoscopy
292222|NCT02390804|TLH|tlh
292223|NCT02390778|secondary traumatic stress|secondary traumatic stress
292224|NCT02390778|vicarious trauma|vicarious trauma
292225|NCT02390778|secondary distress|secondary distress
292226|NCT02390765|Stress Response|stress response
292227|NCT02390765|Binge Eating|binge eating
292228|NCT02390765|Eating Behavior|eating behavior
292229|NCT02390765|Obesity|obesity
292230|NCT02390765|Disordered Eating|disordered eating
292231|NCT02390752|Maximum Tolerated Dose|maximum tolerated dose
292232|NCT02390752|Dose Escalation|dose escalation
292233|NCT02390752|Acute Lymphocytic Leukemia|acute lymphocytic leukemia
293242|NCT02385071|Simeprevir|simeprevir
292234|NCT02390752|Acute Myelogenous Leukemia|acute myelogenous leukemia
292235|NCT02390739|Immunotherapy|immunotherapy
292236|NCT02390739|Gene Therapy|gene therapy
292237|NCT02390739|Metastatic Cancer|metastatic cancer
292238|NCT02390713|hepatectomy|hepatectomy
292239|NCT02390713|post-operative liver failure|post-operative liver failure
292240|NCT02390713|portal vein|portal vein
292241|NCT02390713|portal flow|portal flow
292242|NCT02390713|portal pressure|portal pressure
292243|NCT02390713|modulation|modulation
292244|NCT02390713|surgical device|surgical device
292245|NCT02390700|Rheumatoid Arthritis|rheumatoid arthritis
292246|NCT02390700|Observational|observational
292247|NCT02390700|Golimumab|golimumab
292248|NCT02390700|SIMPONI|simponi
292249|NCT02390700|Intravenous Infusion|intravenous infusion
292250|NCT02390661|seroma|seroma
292251|NCT02390661|accelerated partial breast irradiation (APBI)|accelerated partial breast irradiation (apbi)
292252|NCT02390661|breast lumpectomy|breast lumpectomy
292253|NCT02390661|breast cancer|breast cancer
292254|NCT02390609|Healthy|healthy
292255|NCT02390609|Ibrutinib|ibrutinib
292256|NCT02390609|Bioavailability|bioavailability
292257|NCT02390596|Kawasaki disease|kawasaki disease
292258|NCT02390596|anti Interleukin 1 treatment|anti interleukin 1 treatment
292259|NCT02390596|anakinra|anakinra
292260|NCT02390596|resistance to IVIg|resistance to ivig
292261|NCT02390596|coronary aneurysms|coronary aneurysms
292262|NCT02390596|phase II trial|phase ii trial
292263|NCT02390583|Internet dependence|internet dependence
292264|NCT02390583|Sleep disorders|sleep disorders
292265|NCT02390583|pathological gambling|pathological gambling
292266|NCT02390570|Patient Capacity|patient capacity
292267|NCT02390544|children|children
292268|NCT02390544|bone marrow transplant|bone marrow transplant
292269|NCT02390544|pharmacokinetics|pharmacokinetics
292270|NCT02390531|Retinopathy of Prematurity|retinopathy of prematurity
292271|NCT02390531|Bevacizumab|bevacizumab
292272|NCT02390531|ROP|rop
292273|NCT02390505|vitamin C|vitamin c
292274|NCT02390505|CRPS|crps
292275|NCT02390505|Upper limb surgery|upper limb surgery
292276|NCT02390479|Sclerostin|sclerostin
292277|NCT02390479|OPG|opg
292278|NCT02390479|RANKL|rankl
292279|NCT02390453|mild cognitive impairment|mild cognitive impairment
292280|NCT02390453|randomized controlled trial|randomized controlled trial
292281|NCT02390453|cognitive training|cognitive training
292282|NCT02390453|exercise training|exercise training
292283|NCT02390453|cognition|cognition
292284|NCT02390453|physical performance|physical performance
292285|NCT02390453|disability|disability
292286|NCT02390453|mood|mood
292287|NCT02390440|Pain management|pain management
292288|NCT02390440|Exparel|exparel
292289|NCT02390440|Rib fracture|rib fracture
292290|NCT02390427|Metastatic Breast Cancer|metastatic breast cancer
292291|NCT02390427|Advanced Breast Cancer|advanced breast cancer
292292|NCT02390427|Recurrent Breast Cancer|recurrent breast cancer
292293|NCT02390414|Myelodysplastic syndromes (MDS)|myelodysplastic syndromes (mds)
292294|NCT02390388|pudendal block|pudendal block
292295|NCT02390388|Hypospadias|hypospadias
292296|NCT02390388|caudal block|caudal block
292297|NCT02390388|child|child
292298|NCT02390388|analgesia|analgesia
292299|NCT02390336|Osteoarthritis of the hip|osteoarthritis of the hip
292300|NCT02390336|Pain|pain
292301|NCT02390336|Range of Motion|range of motion
292302|NCT02390336|Physical Function|physical function
292303|NCT02390336|Manual Therapy|manual therapy
292304|NCT02390310|male circumcision|male circumcision
292305|NCT02390310|Shang Ring|shang ring
292306|NCT02390310|male circumcision device|male circumcision device
292307|NCT02390310|prevention|prevention
292308|NCT02390310|voluntary medical male circumcision (VMMC)|voluntary medical male circumcision (vmmc)
292309|NCT02390284|RGCD|rgcd
292310|NCT02390284|Glaucoma Suspect|glaucoma suspect
292311|NCT02390232|gut microbiota|gut microbiota
292312|NCT02390232|Non Alcoholic Steato Hepatitis|non alcoholic steato hepatitis
292313|NCT02390232|Steatohepatitis|steatohepatitis
292314|NCT02390232|Escherichia coli|escherichia coli
292315|NCT02390232|colibactin|colibactin
292316|NCT02390206|Stroke|stroke
292317|NCT02390206|Spasticity|spasticity
292318|NCT02390206|Botulinum Toxin type A|botulinum toxin type a
292319|NCT02390206|Dysport|dysport
292320|NCT02390193|Chronic kidney disease|chronic kidney disease
292321|NCT02390193|Dialysis|dialysis
292322|NCT02390193|Sleep|sleep
292323|NCT02390193|Pulmonary function|pulmonary function
292324|NCT02390193|Polysomnography|polysomnography
292325|NCT02390193|Upper airway|upper airway
292326|NCT02390128|iodine|iodine
292327|NCT02390128|thyroid|thyroid
292328|NCT02390128|TSH|tsh
292329|NCT02390128|pregnancy|pregnancy
292330|NCT02390128|nutrition|nutrition
292331|NCT02390128|diet|diet
292332|NCT02390102|Anemia|anemia
292333|NCT02390102|Severe aortic stenosis|severe aortic stenosis
292334|NCT02390102|Red blood cell transfusion|red blood cell transfusion
292335|NCT02390102|Erythropoietin|erythropoietin
292336|NCT02390089|Dysphagia|dysphagia
292337|NCT02390089|Cough|cough
293959|NCT02381028|Children|children
292338|NCT02390089|Aspiration pneumonia|aspiration pneumonia
292339|NCT02390024|Mechanical Ventilation|mechanical ventilation
292340|NCT02390024|Asynchronies|asynchronies
292341|NCT02390024|Cognition|cognition
292342|NCT02390011|Advanced Solid Tumor|advanced solid tumor
292343|NCT02389998|Functional Pain|functional pain
292344|NCT02389998|Abdominal Pain|abdominal pain
292345|NCT02389998|Irritable Bowel Syndrome|irritable bowel syndrome
292347|NCT02389998|Functional Dyspepsia|functional dyspepsia
292348|NCT02389998|FGID|fgid
292349|NCT02389998|Functional Gastrointestinal Disorders|functional gastrointestinal disorders
292350|NCT02389959|HHT|hht
292351|NCT02389959|Hereditary Hemorrhagic Telangiectasia|hereditary hemorrhagic telangiectasia
292352|NCT02389959|epistaxis|epistaxis
292353|NCT02389959|nose bleeds|nose bleeds
292354|NCT02389959|nasal bleeding|nasal bleeding
292355|NCT02389959|Avastin|avastin
292356|NCT02389959|bevacizumab|bevacizumab
292357|NCT02389946|Drug eluting coronary stents|drug eluting coronary stents
292358|NCT02389946|Sirolimus|sirolimus
292359|NCT02389946|Bioabsorbable polymer|bioabsorbable polymer
292360|NCT02389946|DES|des
292361|NCT02389933|Multiple Patient Program, LCZ696, heart failure, heart failure with reduced ejection fraction, HF-rEF|multiple patient program, lcz696, heart failure, heart failure with reduced ejection fraction, hf-ref
292362|NCT02389894|Embolic Protection Device|embolic protection device
292363|NCT02389894|Stroke|stroke
292364|NCT02389894|Brain Infarction|brain infarction
292365|NCT02389894|atheroma|atheroma
292366|NCT02389894|Aortic Valve Replacement|aortic valve replacement
292367|NCT02389881|Drug therapy|drug therapy
292368|NCT02389868|Lovastatin|lovastatin
292369|NCT02389868|Proteome|proteome
292370|NCT02389868|Blood platelets|blood platelets
292371|NCT02389855|Progression|progression
292372|NCT02389855|Quality of Life|quality of life
292373|NCT02389816|Drug therapy|drug therapy
292374|NCT02389790|Crohn's Disease|crohn's disease
292375|NCT02389764|Breast cancer|breast cancer
292376|NCT02389764|Metastatic inflammatory breast cancer|metastatic inflammatory breast cancer
292377|NCT02389764|MIBC|mibc
292378|NCT02389764|HER2-negative|her2-negative
292379|NCT02389764|Breast carcinoma|breast carcinoma
292380|NCT02389764|BIBF 1120|bibf 1120
292381|NCT02389764|Nintedanib|nintedanib
292382|NCT02389764|Phone call|phone call
292383|NCT02389725|peripheral intravenous access|peripheral intravenous access
292384|NCT02389725|tourniquet techniques|tourniquet techniques
292385|NCT02389712|Bipolar Disorder|bipolar disorder
292386|NCT02389712|Mayo Clinic|mayo clinic
292387|NCT02389699|Intermediate and high grade ductal carcinoma in situ （DCIS）|intermediate and high grade ductal carcinoma in situ （dcis）
292388|NCT02389686|Ductal carcinoma in situ （DCIS）|ductal carcinoma in situ （dcis）
292389|NCT02389686|Nipple-sparing mastectomy (NSM)|nipple-sparing mastectomy (nsm)
292390|NCT02389686|Intraoperative radiotherapy (IORT)|intraoperative radiotherapy (iort)
292391|NCT02389686|INTRABEAM|intrabeam
292392|NCT02389673|Intermediate and high grade ductal carcinoma in situ （DCIS）|intermediate and high grade ductal carcinoma in situ （dcis）
292393|NCT02389660|Depression, Blended Cognitive Behavioural Therapy, Internet intervention|depression, blended cognitive behavioural therapy, internet intervention
292394|NCT02389621|Elective invasive procedures|elective invasive procedures
755999|NCT00419146|Niacin|niacin
292395|NCT02389608|Transcranial direct current stimulation|transcranial direct current stimulation
292396|NCT02389608|functional electrical stimulation|functional electrical stimulation
292397|NCT02389608|hemiparesis|hemiparesis
292398|NCT02389608|electromyography|electromyography
292399|NCT02389608|balance|balance
292400|NCT02389595|HIV|hiv
292401|NCT02389595|vaccine|vaccine
292402|NCT02389595|T cell|t cell
292403|NCT02389582|platelet function; dabigatran;enoxaparin|platelet function; dabigatran;enoxaparin
292404|NCT02389569|Biomaterial|biomaterial
292405|NCT02389569|Dental caries|dental caries
292406|NCT02389569|Composite|composite
292407|NCT02389543|KPT-330|kpt-330
292408|NCT02389543|Selinexor|selinexor
292409|NCT02389543|Multiple Myeloma|multiple myeloma
292410|NCT02389543|Relapsed/refractory|relapsed/refractory
292411|NCT02389543|Lenalidomide|lenalidomide
292412|NCT02389543|Dexamethasone|dexamethasone
292413|NCT02389543|Karyopharm|karyopharm
292414|NCT02389530|glioma|glioma
292415|NCT02389530|neoplasms|neoplasms
292416|NCT02389504|Exertion|exertion
292417|NCT02389504|Efficacy of Treatment|efficacy of treatment
292418|NCT02389491|high density formula|high density formula
292419|NCT02389491|heart defects|heart defects
292420|NCT02389491|infant|infant
292421|NCT02389478|oropharyngeal|oropharyngeal
292422|NCT02389478|breastmilk|breastmilk
292423|NCT02389478|colostrum|colostrum
292424|NCT02389478|human milk|human milk
292425|NCT02389478|premature infant|premature infant
292426|NCT02389465|Depression|depression
292427|NCT02389465|Geriatric|geriatric
292428|NCT02389465|Inflammation|inflammation
292429|NCT02389426|Multiple Sclerosis|multiple sclerosis
292430|NCT02389426|Cerebral hemodynamics|cerebral hemodynamics
292431|NCT02389426|Cerebral hypoperfusion|cerebral hypoperfusion
292432|NCT02389426|Cerebral circulation|cerebral circulation
292433|NCT02389413|PQ912|pq912
292434|NCT02389413|Glutaminy Cyclase (QC)|glutaminy cyclase (qc)
292435|NCT02389413|QC - Inhibitor|qc - inhibitor
292436|NCT02389400|adult with Langerhans cell histiocytosis|adult with langerhans cell histiocytosis
292437|NCT02389400|newly diagnosed|newly diagnosed
292438|NCT02389400|methotrexate|methotrexate
292439|NCT02389400|cytosine arabinoside|cytosine arabinoside
292440|NCT02389387|Dialysis Facilities|dialysis facilities
292441|NCT02389387|African Americans|african americans
292442|NCT02389387|Racial Disparity|racial disparity
292443|NCT02389387|Kidney Transplantation|kidney transplantation
292444|NCT02389387|Community-based Participatory Research|community-based participatory research
292445|NCT02389387|Coalition|coalition
292446|NCT02389348|Induced blood stage malaria|induced blood stage malaria
292447|NCT02389335|type 1diabetes|type 1diabetes
292448|NCT02389335|IFN γ|ifn γ
292449|NCT02389335|IL-2|il-2
292450|NCT02389335|TNF α|tnf α
292451|NCT02389322|ESAT6|esat6
292452|NCT02389322|CFP10|cfp10
292453|NCT02389322|skin test|skin test
292454|NCT02389322|diagnostic test|diagnostic test
292455|NCT02389283|Rheumatoid arthritis|rheumatoid arthritis
292456|NCT02389283|ultrasound joint count|ultrasound joint count
292457|NCT02389270|Neurotrophins|neurotrophins
292458|NCT02389270|Nerve Growth Factor|nerve growth factor
292459|NCT02389270|Brain-Derived Neurotrophic Factor|brain-derived neurotrophic factor
292460|NCT02389270|Urinary Biomarkers|urinary biomarkers
292461|NCT02389270|Children|children
292462|NCT02389257|volunteers|volunteers
292463|NCT02389231|interleukine 2|interleukine 2
292464|NCT02389231|warm autoimmune hemolytic anemia|warm autoimmune hemolytic anemia
292465|NCT02389231|CD8 regulatory T cells|cd8 regulatory t cells
292466|NCT02389218|atrial fibrillation|atrial fibrillation
292467|NCT02389218|cryoablation|cryoablation
292468|NCT02389218|catheter ablation|catheter ablation
292469|NCT02389192|Ebola|ebola
292470|NCT02389192|Mono-clonal Antibody|mono-clonal antibody
292471|NCT02389179|Vitamin D Deficiency|vitamin d deficiency
292472|NCT02389153|secondary prevention coronary heart disease|secondary prevention coronary heart disease
292473|NCT02389153|myocardial infarction|myocardial infarction
292474|NCT02389153|cardiovascular risk factors|cardiovascular risk factors
292475|NCT02389153|collaborative care|collaborative care
292476|NCT02389153|quality of life|quality of life
292477|NCT02389153|patients´ satisfaction with treatment|patients´ satisfaction with treatment
292478|NCT02389140|Blood flow|blood flow
292479|NCT02389140|Glucose|glucose
292480|NCT02389140|lactic acid|lactic acid
292481|NCT02389127|Cirrhosis|cirrhosis
292482|NCT02389127|Diabetes Mellitus, Type 2|diabetes mellitus, type 2
292483|NCT02389127|Glycosylated hemoglobin A1c|glycosylated hemoglobin a1c
292484|NCT02389127|Glucose|glucose
292485|NCT02389101|Lymphoma|lymphoma
292486|NCT02389101|68Ga-DOTANOC PET/CT|68ga-dotanoc pet/ct
292487|NCT02389101|Somatostatin receptor|somatostatin receptor
292488|NCT02389101|MRI|mri
292489|NCT02389101|Diffusion weighted imaging|diffusion weighted imaging
292490|NCT02389101|Early treatment response|early treatment response
292491|NCT02389088|Granulosa Cell|granulosa cell
292492|NCT02389088|Androgens|androgens
292493|NCT02389088|FSH|fsh
292494|NCT02389088|Ovary|ovary
292495|NCT02389075|intraepithelial lymphocytes (IEL)|intraepithelial lymphocytes (iel)
292496|NCT02389075|microbiome|microbiome
292497|NCT02389075|colon mucosa|colon mucosa
292498|NCT02389049|Primary Ciliary Dyskinesia|primary ciliary dyskinesia
292499|NCT02389049|Kartagener Syndrome|kartagener syndrome
292500|NCT02389023|surgical site infection|surgical site infection
292501|NCT02389023|infrainguinal bypass|infrainguinal bypass
292502|NCT02389023|incisional wound vacuum assisted closure|incisional wound vacuum assisted closure
292503|NCT02389023|Prevena|prevena
292504|NCT02389010|Umbilical Cord Blood|umbilical cord blood
292505|NCT02389010|Diabetic Foot|diabetic foot
292506|NCT02389010|Ulcer|ulcer
292507|NCT02389010|Cost|cost
292508|NCT02389010|Effectiveness|effectiveness
292509|NCT02389010|Safety|safety
292510|NCT02389010|Platelet Gel|platelet gel
292511|NCT02389010|Cord Blood Platelet Gel|cord blood platelet gel
292512|NCT02389010|Adverse Event|adverse event
292513|NCT02388997|mild asthma|mild asthma
292514|NCT02388997|young adults|young adults
292515|NCT02388997|rhinovirus|rhinovirus
292516|NCT02388971|Drug therapy|drug therapy
292517|NCT02388919|anlotinib|anlotinib
292518|NCT02388919|Cancer|cancer
292519|NCT02388919|NSCLC|nsclc
292520|NCT02388919|Non-small Cell Lung Cancer|non-small cell lung cancer
292521|NCT02388880|ITPR|itpr
292522|NCT02388880|CPP|cpp
292523|NCT02388880|TBI|tbi
292524|NCT02388880|traumatic brain injury|traumatic brain injury
292525|NCT02388880|cerebral perfusion pressure|cerebral perfusion pressure
292526|NCT02388880|intrathoracic pressure regulator|intrathoracic pressure regulator
292527|NCT02388841|Pulmonary embolism, Computed tomographic pulmonary|pulmonary embolism, computed tomographic pulmonary
292528|NCT02388815|Diabetes Mellitus|diabetes mellitus
292529|NCT02388815|Sensing Technology|sensing technology
292530|NCT02388802|Infertility|infertility
292531|NCT02388802|Transplant|transplant
292532|NCT02388802|IVF|ivf
292533|NCT02388802|Hysterectomy|hysterectomy
292534|NCT02388802|Absolute uterine infertility|absolute uterine infertility
292535|NCT02388789|sensory receptors|sensory receptors
292536|NCT02388789|balance control|balance control
292537|NCT02388789|gait|gait
292538|NCT02388789|temperature|temperature
292539|NCT02388776|ROTEM|rotem
292540|NCT02388776|Fibrinogen|fibrinogen
292541|NCT02388763|Contact lenses|contact lenses
292542|NCT02388750|nausea|nausea
292543|NCT02388750|vomiting|vomiting
292544|NCT02388750|radiation|radiation
292545|NCT02388750|anti-emetic drug|anti-emetic drug
292546|NCT02388737|Drug therapy|drug therapy
292547|NCT02388724|Drug therapy|drug therapy
292548|NCT02388711|Dementia|dementia
292549|NCT02388711|Transitional Care|transitional care
292550|NCT02388711|Caregiver|caregiver
292551|NCT02388698|HPV DNA|hpv dna
292552|NCT02388698|PET-CT|pet-ct
292553|NCT02388698|Recurrent cervical cancer|recurrent cervical cancer
292554|NCT02388698|chemoradiation|chemoradiation
292555|NCT02388685|peripheral arterial disease|peripheral arterial disease
292556|NCT02388685|exercise|exercise
292557|NCT02388685|perfusion|perfusion
292558|NCT02388685|energetics|energetics
292559|NCT02388685|magnetic resonance imaging|magnetic resonance imaging
292560|NCT02388685|magnetic resonance spectroscopy|magnetic resonance spectroscopy
292561|NCT02388659|MRS Biomarkers|mrs biomarkers
292562|NCT02388581|Helicobactor pylori, Hp|helicobactor pylori, hp
292563|NCT02388581|mucosa-associated lymphoid tissue-type lymphoma, MALToma|mucosa-associated lymphoid tissue-type lymphoma, maltoma
292564|NCT02388542|cardiovascular disease|cardiovascular disease
292565|NCT02388542|education|education
292566|NCT02388542|peer mentor|peer mentor
292567|NCT02388529|Heart Failure|heart failure
292568|NCT02388529|Bendavia™|bendavia™
292569|NCT02388529|MTP-131|mtp-131
292570|NCT02388516|Bangladesh|bangladesh
292571|NCT02388516|Vitamin D|vitamin d
292572|NCT02388516|Acute Respiratory Infections|acute respiratory infections
292573|NCT02388516|Infancy|infancy
292574|NCT02388516|Pregnancy|pregnancy
292575|NCT02388503|Blood glucose|blood glucose
292576|NCT02388490|Brentuximabvedotin|brentuximabvedotin
292577|NCT02388490|EBV|ebv
292578|NCT02388490|Lymphoma|lymphoma
292579|NCT02388477|rotator cuff repair|rotator cuff repair
292580|NCT02388477|Doxycycline|doxycycline
292581|NCT02388464|Congestive Heart Failure|congestive heart failure
292582|NCT02388464|Bendavia™|bendavia™
292583|NCT02388464|MTP-131|mtp-131
292584|NCT02388451|Mild Cognitive Impairment|mild cognitive impairment
292585|NCT02388438|demineralized bone matrix|demineralized bone matrix
292586|NCT02388412|Positron emission tomography|positron emission tomography
292587|NCT02388412|Tissue background ratio|tissue background ratio
292588|NCT02388412|Optical coherence tomography|optical coherence tomography
292589|NCT02388412|Thin cap fibroous atheroma|thin cap fibroous atheroma
292590|NCT02388412|Vulnerability|vulnerability
292591|NCT02388412|Acute coronary syndrome|acute coronary syndrome
292592|NCT02388399|Optical coherence tomography|optical coherence tomography
292593|NCT02388399|Axial Plaque Stress|axial plaque stress
292594|NCT02388399|Wall Shear Stress|wall shear stress
292595|NCT02388399|Vulnerability|vulnerability
292596|NCT02388386|Telemedicine|telemedicine
292597|NCT02388386|Mobile Health|mobile health
292598|NCT02388360|Prostaglandin analogs|prostaglandin analogs
292599|NCT02388360|Corneal biomechanics|corneal biomechanics
292600|NCT02388360|Corneal Hysteresis|corneal hysteresis
292601|NCT02388360|Glaucoma, Open-Angle|glaucoma, open-angle
292602|NCT02388334|Caregivers|caregivers
292603|NCT02388334|Quality of life|quality of life
292604|NCT02388334|Quality of care|quality of care
292605|NCT02388321|Analgesia|analgesia
292606|NCT02388321|pediatrics|pediatrics
292607|NCT02388321|pain management|pain management
292608|NCT02388308|Prostate cancer|prostate cancer
292609|NCT02388308|Image-guided radiotherapy|image-guided radiotherapy
292610|NCT02388308|Ultrasound guidance|ultrasound guidance
292611|NCT02388295|Multiple System Atrophy (MSA), PET imaging, myeloperoxidase (MPO) inhibitor|multiple system atrophy (msa), pet imaging, myeloperoxidase (mpo) inhibitor
292612|NCT02388282|dynamic intrinsic PEEP|dynamic intrinsic peep
292613|NCT02388282|diaphragm echography|diaphragm echography
292614|NCT02388282|respiratory mechanics|respiratory mechanics
292615|NCT02388256|colon|colon
292616|NCT02388256|colorectal|colorectal
292617|NCT02388256|cancer|cancer
292618|NCT02388256|neoplasm|neoplasm
292619|NCT02388243|Brief intervention|brief intervention
292620|NCT02388243|Low and middle income countries (LMIC)|low and middle income countries (lmic)
292621|NCT02388243|eLearning|elearning
292622|NCT02388243|Screening|screening
292623|NCT02388243|Capacity Building|capacity building
292624|NCT02388243|Primary Health Care|primary health care
292625|NCT02388243|Education, Medical|education, medical
292626|NCT02388243|Education, Nursing|education, nursing
292627|NCT02388243|Education, Professional|education, professional
292628|NCT02388243|Community Health Workers|community health workers
292629|NCT02388230|Breast cancer|breast cancer
292630|NCT02388230|Elastography|elastography
292631|NCT02388230|Ultrasound imaging|ultrasound imaging
292632|NCT02388230|Quantification of toxicity|quantification of toxicity
292633|NCT02388230|Side-effects|side-effects
292634|NCT02388217|chronic pain|chronic pain
292635|NCT02388217|cannabis|cannabis
292636|NCT02388217|Approved for cannabis treatment by Israeli ministry of health|approved for cannabis treatment by israeli ministry of health
292637|NCT02388217|Unrelieved chronic pain|unrelieved chronic pain
292638|NCT02388204|Gait|gait
292639|NCT02388204|Locomotion|locomotion
292640|NCT02388204|Freezing|freezing
292641|NCT02388191|Contraception|contraception
292642|NCT02388191|Naproxen|naproxen
292643|NCT02388191|Intrauterine devices|intrauterine devices
292644|NCT02388191|Pain Control|pain control
292645|NCT02388165|Staphylococcal Vaccine|staphylococcal vaccine
292646|NCT02388165|Post-operative Surgical Site Infection|post-operative surgical site infection
292647|NCT02388165|Spinal Surgery|spinal surgery
292648|NCT02388165|MRSA|mrsa
292649|NCT02388165|Staphylococcus aureus|staphylococcus aureus
292650|NCT02388139|acute myocardial infarction|acute myocardial infarction
292651|NCT02388139|renal artery stenosis|renal artery stenosis
292652|NCT02388113|Exercise therapy|exercise therapy
292653|NCT02388113|Time factors|time factors
292654|NCT02388074|Lung Cancer|lung cancer
292655|NCT02388074|Porphyrin|porphyrin
292656|NCT02388074|Fluorescence|fluorescence
292657|NCT02388074|Diagnostic|diagnostic
292658|NCT02388074|Sputum Cytology|sputum cytology
292659|NCT02388074|Early Detection|early detection
292660|NCT02388048|Leukemia|leukemia
292661|NCT02388048|Chronic|chronic
292662|NCT02388048|High-risk|high-risk
292663|NCT02388048|ofatumumab|ofatumumab
292664|NCT02388048|ibrutinib|ibrutinib
292665|NCT02388048|Lymphoblastic|lymphoblastic
292666|NCT02388035|profiles changes|profiles changes
292667|NCT02388035|microorganisms|microorganisms
292668|NCT02388035|cefotaxime|cefotaxime
292669|NCT02388035|SBP|sbp
292670|NCT02388035|Egyptian|egyptian
292671|NCT02388035|effective antibiotics|effective antibiotics
292672|NCT02388009|bioconjugate vaccine|bioconjugate vaccine
292673|NCT02388009|safety|safety
292674|NCT02388009|immunogenicity|immunogenicity
292675|NCT02388009|shigellosis|shigellosis
292676|NCT02387970|Dental implants|dental implants
292677|NCT02387970|Partial edentulism|partial edentulism
292678|NCT02387970|Immediate/delayed provisionalization|immediate/delayed provisionalization
292679|NCT02387957|Wet AMD|wet amd
292680|NCT02387957|subfoveal choroidal neovascularization|subfoveal choroidal neovascularization
292681|NCT02387957|Fovista®|fovista®
292682|NCT02387957|Avastin®|avastin®
292683|NCT02387957|Lucentis®|lucentis®
292684|NCT02387957|Eylea®|eylea®
292685|NCT02387944|Children|children
292686|NCT02387944|Cyanotic congenital heart defect|cyanotic congenital heart defect
292687|NCT02387944|Cardiopulmonary Bypass|cardiopulmonary bypass
292688|NCT02387944|Thromboelastometry|thromboelastometry
292689|NCT02387944|Platelet Function Tests|platelet function tests
292690|NCT02387931|Adolescent|adolescent
292691|NCT02387931|Endometriosis|endometriosis
292692|NCT02387931|Diet|diet
292693|NCT02387931|Nutrition|nutrition
292694|NCT02387931|Pain|pain
292695|NCT02387918|Tonsillectomy|tonsillectomy
292696|NCT02387918|postoperative vomiting (POV)|postoperative vomiting (pov)
292697|NCT02387918|Dexamethasone|dexamethasone
292698|NCT02387918|Acupuncture|acupuncture
292699|NCT02387879|Multiple Myeloma|multiple myeloma
292700|NCT02387879|PASS|pass
292701|NCT02387879|Observational|observational
292702|NCT02387879|Non-interventional|non-interventional
292703|NCT02387879|Relapse|relapse
292704|NCT02387879|Refractory|refractory
292705|NCT02387879|CC-5013|cc-5013
292706|NCT02387879|Lenalidomide|lenalidomide
292707|NCT02387879|Turkey|turkey
292708|NCT02387866|Pharmacokinetic|pharmacokinetic
292709|NCT02387866|Healthy Volunteers|healthy volunteers
292710|NCT02387866|Male|male
292711|NCT02387866|Japanese|japanese
292712|NCT02387866|Caucasian|caucasian
292713|NCT02387866|AG-221|ag-221
292714|NCT02387840|Brain|brain
292715|NCT02387840|Cancer|cancer
292716|NCT02387840|Neurofibromatosis type 1|neurofibromatosis type 1
292717|NCT02387840|NF1|nf1
292718|NCT02387840|Magnetic resonance fingerprinting|magnetic resonance fingerprinting
292719|NCT02387840|MRF|mrf
292720|NCT02387827|long bout physical activity|long bout physical activity
292721|NCT02387827|short bout physical activity|short bout physical activity
292722|NCT02387827|Caloric Restriction|caloric restriction
292723|NCT02387775|esophageal cooling device|esophageal cooling device
292724|NCT02387775|post cardiac arrest|post cardiac arrest
292725|NCT02387775|targetted temperature management|targetted temperature management
292726|NCT02387775|therapeutic hypothermia|therapeutic hypothermia
292727|NCT02387775|cooling|cooling
292728|NCT02387775|rewarming|rewarming
292729|NCT02387762|Acalabrutinib|acalabrutinib
292730|NCT02387749|diabetic peripheral neuropathy|diabetic peripheral neuropathy
292731|NCT02387749|mesenchymal stem cells|mesenchymal stem cells
292732|NCT02387736|BPD|bpd
292733|NCT02387736|DBT|dbt
292734|NCT02387736|Dialectical Behaviour Therapy|dialectical behaviour therapy
292735|NCT02387736|Borderline Personality Disorder|borderline personality disorder
292736|NCT02387736|Suicide|suicide
292737|NCT02387736|Non-suicidal self injury|non-suicidal self injury
292738|NCT02387736|NSSI|nssi
292739|NCT02387736|Randomized Control trials|randomized control trials
292740|NCT02387736|treatment|treatment
292741|NCT02387710|arousal threshold|arousal threshold
292742|NCT02387710|phenotype|phenotype
292743|NCT02387710|tiagabine|tiagabine
292744|NCT02387710|slow wave sleep|slow wave sleep
292745|NCT02387684|chronic hepatitis B|chronic hepatitis b
292746|NCT02387684|interferon|interferon
292747|NCT02387684|peginterferon|peginterferon
292748|NCT02387684|HBsAg loss|hbsag loss
292749|NCT02387658|peripheral arterial disease|peripheral arterial disease
292750|NCT02387658|claudication|claudication
292751|NCT02387658|translesional pressure gradient|translesional pressure gradient
292752|NCT02387658|pressure wire|pressure wire
292753|NCT02387658|six minute walk|six minute walk
292754|NCT02387658|superficial femoral artery|superficial femoral artery
292755|NCT02387658|pressure gradient|pressure gradient
292756|NCT02387658|endovascular|endovascular
292757|NCT02387645|Endometrium|endometrium
292758|NCT02387645|Endometrial Neoplasms|endometrial neoplasms
292759|NCT02387645|Early detection|early detection
292760|NCT02387645|Carcinoma of Endometrium|carcinoma of endometrium
292761|NCT02387645|Gynaecological Cancer|gynaecological cancer
292762|NCT02387606|Respiratory Syncytial Virus Infections|respiratory syncytial virus infections
292763|NCT02387606|Placebo|placebo
292764|NCT02387606|Antiviral activity|antiviral activity
292765|NCT02387606|JNJ-53718678|jnj-53718678
292766|NCT02387593|Adenoma|adenoma
292767|NCT02387593|Colonoscopy|colonoscopy
292768|NCT02387593|Screening|screening
292769|NCT02387580|Malaria|malaria
292770|NCT02387580|Bioavailability|bioavailability
292771|NCT02387580|Formulation|formulation
292772|NCT02387541|Postoperative cognitive dysfunction|postoperative cognitive dysfunction
292773|NCT02387528|MIndfulness|mindfulness
292774|NCT02387528|Primary Health Care|primary health care
292775|NCT02387463|chronic hepatitis B|chronic hepatitis b
292776|NCT02387463|antiviral therapy|antiviral therapy
292777|NCT02387463|peginterferon|peginterferon
292778|NCT02387463|HBeAg seroconversion|hbeag seroconversion
292779|NCT02387463|HBsAg loss|hbsag loss
292780|NCT02387450|Claudication|claudication
292781|NCT02387450|Maximal walking distance|maximal walking distance
292782|NCT02387450|Morbi-mortality|morbi-mortality
292783|NCT02387437|ARDS|ards
292784|NCT02387437|EIT|eit
292785|NCT02387437|recruitment maneuvers|recruitment maneuvers
292786|NCT02387424|depression|depression
292787|NCT02387424|mindfulness|mindfulness
292788|NCT02387424|pregnancy|pregnancy
292789|NCT02387424|prevention|prevention
292790|NCT02387424|cognitive behavioral therapy|cognitive behavioral therapy
292791|NCT02387411|heart failure|heart failure
292792|NCT02387411|aerobic exercise|aerobic exercise
292793|NCT02387411|strength training|strength training
292794|NCT02387411|cardiopulmonary rehabilitation|cardiopulmonary rehabilitation
756104|NCT00418691|Fatigue|fatigue
374073|NCT01987817|OIT|oit
292795|NCT02387411|high-intensity exercise training|high-intensity exercise training
292796|NCT02387333|Radical cystectomy|radical cystectomy
292797|NCT02387333|Urinary diversion|urinary diversion
292798|NCT02387333|Ileal conduit|ileal conduit
292799|NCT02387333|Parastomal hernia|parastomal hernia
292800|NCT02387333|Prophylactic mesh|prophylactic mesh
292801|NCT02387333|Mesh stoma reinforcement technique|mesh stoma reinforcement technique
292802|NCT02387320|Anxiety|anxiety
292803|NCT02387320|Pain|pain
292804|NCT02387320|Nausea|nausea
292805|NCT02387320|Fatigue|fatigue
292806|NCT02387320|Sleep Disturbance|sleep disturbance
292807|NCT02387320|Breast Cancer|breast cancer
292808|NCT02387320|Surgery|surgery
292809|NCT02387294|immunogenicity|immunogenicity
292810|NCT02387294|reduced dos|reduced dos
292811|NCT02387294|Phase III|phase iii
292812|NCT02387294|tolerability|tolerability
292813|NCT02387294|safety|safety
292814|NCT02387281|Freezing of gait|freezing of gait
292815|NCT02387242|Tuberculosis|tuberculosis
292816|NCT02387242|Whole blood Bactericidal Activity|whole blood bactericidal activity
292817|NCT02387242|WBA|wba
292818|NCT02387242|Rifampicin|rifampicin
292819|NCT02387229|Atrial Fibrillation|atrial fibrillation
292820|NCT02387229|Stroke|stroke
292821|NCT02387229|Neurocognitive decline|neurocognitive decline
292822|NCT02387229|Rivaroxaban|rivaroxaban
292823|NCT02387229|Acetylsalicylic acid|acetylsalicylic acid
292824|NCT02387229|Anticoagulation|anticoagulation
292825|NCT02387216|NSCLC|nsclc
292826|NCT02387216|Non-Small Cell Lung Cancer|non-small cell lung cancer
292827|NCT02387216|heregulin|heregulin
292828|NCT02387216|ErbB3|erbb3
292829|NCT02387216|docetaxel|docetaxel
292830|NCT02387203|Pseudomyxoma Peritonei|pseudomyxoma peritonei
292831|NCT02387203|Appendiceal cancer|appendiceal cancer
292832|NCT02387203|CRS/HIPEC|crs/hipec
292833|NCT02387203|PMP|pmp
292834|NCT02387190|Heart Failure|heart failure
292835|NCT02387190|Lung function test|lung function test
292836|NCT02387190|Telenursing|telenursing
292837|NCT02387190|Morbidity|morbidity
292838|NCT02387190|Mortality|mortality
292839|NCT02387190|Quality of life|quality of life
292840|NCT02387164|Type 1 diabetes|type 1 diabetes
292841|NCT02387164|Islet autoantibodies|islet autoantibodies
292842|NCT02387164|glutamate decarboxylase autoantibodies (GADA)|glutamate decarboxylase autoantibodies (gada)
292843|NCT02387164|Immune tolerance|immune tolerance
292844|NCT02387164|Prediabetes|prediabetes
292845|NCT02387164|Glucose tolerance|glucose tolerance
292846|NCT02387164|glutamate decarboxylase|glutamate decarboxylase
292847|NCT02387164|Prevention|prevention
292848|NCT02387164|Children|children
292849|NCT02387151|Mesenchymal Stromal Cells|mesenchymal stromal cells
292850|NCT02387151|Rejection|rejection
292851|NCT02387112|End stage heart disease|end stage heart disease
292852|NCT02387112|Ventricular assist device|ventricular assist device
292853|NCT02387099|Stage IIIB|stage iiib
292854|NCT02387099|Stage IV|stage iv
292855|NCT02387099|Recurrent|recurrent
292856|NCT02387099|Metastatic|metastatic
292857|NCT02387086|gefitinib|gefitinib
292858|NCT02387086|thalidomide|thalidomide
292859|NCT02387086|NSCLC|nsclc
292860|NCT02387086|EGFR mutation|egfr mutation
292861|NCT02387073|outcome assessment|outcome assessment
292862|NCT02387073|self-reported|self-reported
292863|NCT02387073|patient|patient
292864|NCT02387073|clinical outcome|clinical outcome
292865|NCT02387060|Anesthesia|anesthesia
292866|NCT02387060|Spinal and Epidural|spinal and epidural
292867|NCT02387060|Adverse Effect|adverse effect
292868|NCT02387060|Complications|complications
292869|NCT02387034|Osteoarthritis|osteoarthritis
292870|NCT02387034|Sedentary|sedentary
292871|NCT02387034|Physical activity|physical activity
292872|NCT02387034|Health related quality of life|health related quality of life
292873|NCT02387021|analgesia|analgesia
292874|NCT02387021|nerve block|nerve block
292875|NCT02387021|Total knee replacement|total knee replacement
292876|NCT02386995|depth of anesthesia monitors|depth of anesthesia monitors
292877|NCT02386995|deep brain stimulation|deep brain stimulation
292878|NCT02386969|Neuropathic Pain|neuropathic pain
292879|NCT02386969|repetitive transcranial magnetic stimulation (rTMS)|repetitive transcranial magnetic stimulation (rtms)
292880|NCT02386956|manual therapy|manual therapy
292881|NCT02386956|muscle chains|muscle chains
292882|NCT02386956|Dynamic stretching|dynamic stretching
292883|NCT02386956|Active stretching|active stretching
292884|NCT02386930|Cognitive behavior therapy|cognitive behavior therapy
292885|NCT02386930|Lifestyle modification|lifestyle modification
292886|NCT02386930|HbA1c|hba1c
292887|NCT02386930|Carbohydrates|carbohydrates
292888|NCT02386891|food intake|food intake
292889|NCT02386891|indoor thermal environment|indoor thermal environment
292890|NCT02386878|Orphans and vulnerable children (OVC)|orphans and vulnerable children (ovc)
292891|NCT02386878|Program Evaluation|program evaluation
292892|NCT02386878|HIV Prevention|hiv prevention
292893|NCT02386878|Psychosocial Wellbeing|psychosocial wellbeing
292894|NCT02386878|Adolescents|adolescents
292895|NCT02386852|Ginseng|ginseng
292896|NCT02386852|Ginkgo Biloba|ginkgo biloba
292897|NCT02386852|cardiovascular reactivity|cardiovascular reactivity
292898|NCT02386852|cognition|cognition
292899|NCT02386826|INC280|inc280
292900|NCT02386826|c-MET Inhibitors|c-met inhibitors
292901|NCT02386826|bevacizumab|bevacizumab
292902|NCT02386826|Avastin|avastin
292903|NCT02386826|C-Met proto-oncogene|c-met proto-oncogene
292904|NCT02386800|primary myelofibrosis|primary myelofibrosis
292905|NCT02386800|chronic idiopathic myelofibrosis,|chronic idiopathic myelofibrosis,
292906|NCT02386800|post polycythemia vera myelofibrosis,|post polycythemia vera myelofibrosis,
292907|NCT02386800|post essential thrombocythaemia myelofibrosis,|post essential thrombocythaemia myelofibrosis,
292908|NCT02386800|Steroid Refractory Graft Versus Host Disease|steroid refractory graft versus host disease
292909|NCT02386787|Ultrasonography|ultrasonography
292910|NCT02386787|Non-elective surgery|non-elective surgery
292911|NCT02386787|Anesthesia|anesthesia
292912|NCT02386774|In vivo confocal microscopy|in vivo confocal microscopy
292913|NCT02386774|corneal disease|corneal disease
292914|NCT02386774|Blepharitis|blepharitis
292915|NCT02386774|Lacrimal Apparatus Diseases|lacrimal apparatus diseases
292916|NCT02386774|Microscopy, Confocal|microscopy, confocal
292917|NCT02386748|Cesarean section|cesarean section
292918|NCT02386748|Chewing gums|chewing gums
292919|NCT02386748|Intestinal motility|intestinal motility
292920|NCT02386735|Corticosteroid treatment|corticosteroid treatment
292921|NCT02386735|COPD|copd
292922|NCT02386735|Primary Health Care|primary health care
292923|NCT02386735|Randomized controlled trial|randomized controlled trial
292924|NCT02386722|Adherence of inhaled medication|adherence of inhaled medication
292925|NCT02386722|pharmaceutical care intervention|pharmaceutical care intervention
292926|NCT02386683|Protective mechanical ventilation|protective mechanical ventilation
292927|NCT02386683|ventilator-induced lung injury|ventilator-induced lung injury
292928|NCT02386683|neurosurgery|neurosurgery
292929|NCT02386657|Sickle Cell Disease|sickle cell disease
292930|NCT02386657|Vaso-occlusive crisis|vaso-occlusive crisis
292931|NCT02386657|Emergency management|emergency management
292932|NCT02386631|gait|gait
292933|NCT02386631|orthotics|orthotics
292934|NCT02386631|kinetics|kinetics
292935|NCT02386631|hallux valgus|hallux valgus
292936|NCT02386631|bunions|bunions
292937|NCT02386618|colorectal cancer|colorectal cancer
292938|NCT02386618|laterally spreading tumors|laterally spreading tumors
292939|NCT02386618|endoscopic mucosal resestion|endoscopic mucosal resestion
292940|NCT02386618|local residual neoplasia|local residual neoplasia
292941|NCT02386605|recovery|recovery
292942|NCT02386605|rehabilitation|rehabilitation
292943|NCT02386553|NURTURE|nurture
292944|NCT02386540|Community Health Workers|community health workers
292945|NCT02386540|Community Health Workers: utilization|community health workers: utilization
292946|NCT02386540|Emergency Service|emergency service
292947|NCT02386540|Primary Health Care/utilization|primary health care/utilization
292948|NCT02386540|Health Services Accessibility|health services accessibility
292949|NCT02386514|sexually transmitted infection|sexually transmitted infection
292950|NCT02386514|gonorrhea|gonorrhea
292951|NCT02386514|chlamydia|chlamydia
292952|NCT02386514|presumptive therapy|presumptive therapy
292953|NCT02386462|laryngeal mask airway|laryngeal mask airway
292954|NCT02386462|circulatory reflexes|circulatory reflexes
292955|NCT02386436|GSK2330811|gsk2330811
292956|NCT02386436|Dose Escalation|dose escalation
292957|NCT02386436|Safety|safety
292958|NCT02386436|First Time in Human|first time in human
292959|NCT02386436|Pharmacodynamics|pharmacodynamics
292960|NCT02386436|Pharmacokinetics|pharmacokinetics
292961|NCT02386423|RLS|rls
292962|NCT02386423|Willis-Ekbom|willis-ekbom
292963|NCT02386384|pregnancy failure|pregnancy failure
292964|NCT02386358|Chronic Chagas Disease|chronic chagas disease
292965|NCT02386358|Randomized Clinical Trial double blind|randomized clinical trial double blind
292966|NCT02386358|Benznidazole vs Placebo|benznidazole vs placebo
292967|NCT02386358|Adult patients|adult patients
292968|NCT02386345|FIRM procedure|firm procedure
292969|NCT02386319|Melatonin|melatonin
292970|NCT02386319|Analgesic|analgesic
292971|NCT02386319|Surgery|surgery
292972|NCT02386319|Pharmacokinetic|pharmacokinetic
292973|NCT02386319|Anxiolytic|anxiolytic
292974|NCT02386280|Primary Prevention|primary prevention
292975|NCT02386280|Substance-Related Disorders|substance-related disorders
292976|NCT02386280|Family|family
292977|NCT02386254|premorbid|premorbid
292978|NCT02386254|scoring system|scoring system
292979|NCT02386254|ECOG|ecog
292980|NCT02386254|ICU|icu
292981|NCT02386254|morbidity|morbidity
292982|NCT02386254|mortality|mortality
292983|NCT02386241|brain tumor|brain tumor
292984|NCT02386228|miRNA|mirna
292985|NCT02386228|posthemorrhagic hydrocephalus (PHH)|posthemorrhagic hydrocephalus (phh)
292986|NCT02386215|HIV self-testing|hiv self-testing
292987|NCT02386215|randomized controlled trial|randomized controlled trial
292988|NCT02386215|Kenya|kenya
292989|NCT02386189|Continuity of Patient Care|continuity of patient care
292990|NCT02386189|Health Records, Personal|health records, personal
292991|NCT02386189|Veterans|veterans
292992|NCT02386189|Patient Participation|patient participation
292993|NCT02386189|Chronic Disease|chronic disease
292994|NCT02386137|MR-HIFU|mr-hifu
292995|NCT02386137|HIFU|hifu
292996|NCT02386137|Fibroid treatment|fibroid treatment
292997|NCT02386137|MR Perfusion|mr perfusion
292998|NCT02386137|CEUS perfusion|ceus perfusion
292999|NCT02386137|Diffusion weighted imaging|diffusion weighted imaging
293000|NCT02386137|ARFI|arfi
293001|NCT02386137|Fibroid stiffness|fibroid stiffness
293002|NCT02386124|frailty|frailty
293003|NCT02386124|elderly|elderly
293004|NCT02386124|acute coronary syndrome|acute coronary syndrome
293005|NCT02386124|acute heart failure|acute heart failure
293006|NCT02386124|arrhythmias|arrhythmias
293007|NCT02386111|Sutent|sutent
293008|NCT02386085|Osteopathic Manipulative Medicine|osteopathic manipulative medicine
293009|NCT02386085|Osteopathic Manipulation|osteopathic manipulation
293010|NCT02386085|adverse effects|adverse effects
293011|NCT02386085|side effects|side effects
293012|NCT02386085|undesirable effects|undesirable effects
293013|NCT02386072|Betanis®|betanis®
293014|NCT02386072|Myrbetriq®|myrbetriq®
293015|NCT02386072|Quality of Life|quality of life
293016|NCT02386072|Antimuscarinics|antimuscarinics
293017|NCT02386072|Betmiga®|betmiga®
293018|NCT02386072|Overactive Bladder|overactive bladder
293019|NCT02386072|Observational|observational
293020|NCT02386059|ondansetron|ondansetron
293021|NCT02386059|dexamethasone|dexamethasone
293022|NCT02386059|vitrectomy|vitrectomy
293023|NCT02386059|local anesthesia|local anesthesia
293024|NCT02386046|Caffeine use|caffeine use
293025|NCT02386046|Normative data|normative data
293026|NCT02385968|Modic|modic
293027|NCT02385968|Microbiology|microbiology
293028|NCT02385968|Immunology|immunology
293029|NCT02385942|u-health|u-health
293030|NCT02385942|chronic wound management|chronic wound management
293031|NCT02385942|pressure ulcer|pressure ulcer
293032|NCT02385929|Head and Neck Cancer|head and neck cancer
293033|NCT02385929|Intervention|intervention
293034|NCT02385929|Rehabilitation|rehabilitation
293035|NCT02385929|Late Effects|late effects
293036|NCT02385929|Dysphagia|dysphagia
293037|NCT02385916|EstroSense|estrosense
293038|NCT02385916|estrogen|estrogen
293039|NCT02385903|Flammacerium|flammacerium
293040|NCT02385903|Ischemic wound|ischemic wound
293041|NCT02385903|Lower limb|lower limb
293042|NCT02385903|Arteriopathy|arteriopathy
293043|NCT02385903|Amputation|amputation
293044|NCT02385903|Dressing|dressing
293045|NCT02385838|Nutrition labelling|nutrition labelling
293046|NCT02385838|Front-of-pack nutrition labels|front-of-pack nutrition labels
293047|NCT02385838|Purchasing intentions|purchasing intentions
293048|NCT02385838|Nutritional quality|nutritional quality
293049|NCT02385838|Randomized controlled trial (RCT)|randomized controlled trial (rct)
293050|NCT02385812|Lung Cancer|lung cancer
293051|NCT02385812|Mesothelioma|mesothelioma
293052|NCT02385812|Asbestos|asbestos
293053|NCT02385812|Screening|screening
293054|NCT02385799|Autism Spectrum Disorder|autism spectrum disorder
293055|NCT02385799|Behavior|behavior
293056|NCT02385799|sertraline|sertraline
293057|NCT02385799|treatment|treatment
293058|NCT02385786|mindfulness-based cognitive therapy|mindfulness-based cognitive therapy
293059|NCT02385786|depression|depression
293060|NCT02385786|treatment|treatment
293061|NCT02385786|mindfulness meditation|mindfulness meditation
293062|NCT02385786|psychotherapy|psychotherapy
293063|NCT02385773|colostrum|colostrum
293064|NCT02385773|Immunoglobulin Y (IgY)|immunoglobulin y (igy)
293065|NCT02385760|Facial Acne|facial acne
293066|NCT02385747|perimenopausal bleeding|perimenopausal bleeding
293067|NCT02385747|postmenopausal bleeding|postmenopausal bleeding
293068|NCT02385747|hysteroscopy|hysteroscopy
293069|NCT02385747|Steroid receptors|steroid receptors
293070|NCT02385734|Multiple gingival recession|multiple gingival recession
293071|NCT02385734|Concentrated growth factor|concentrated growth factor
293072|NCT02385734|Coronally advanced flap|coronally advanced flap
293073|NCT02385721|Hypertension|hypertension
293074|NCT02385721|Fimasartan|fimasartan
293075|NCT02385695|Disc Degeneration Disease|disc degeneration disease
293076|NCT02385695|DDD|ddd
293077|NCT02385695|multilevel lumbar Disc Degeneration Disease|multilevel lumbar disc degeneration disease
293078|NCT02385669|vaccine|vaccine
293079|NCT02385669|peptide|peptide
293080|NCT02385669|ipilimumab|ipilimumab
293081|NCT02385669|Yervoy|yervoy
293082|NCT02385669|Montanide ISA-51|montanide isa-51
293083|NCT02385643|alcohol dependence|alcohol dependence
293084|NCT02385643|abstinence|abstinence
293085|NCT02385643|relapse prevention|relapse prevention
293086|NCT02385643|mobile support system|mobile support system
293087|NCT02385630|Longitudinal Studies|longitudinal studies
293088|NCT02385630|Esophagectomy|esophagectomy
293089|NCT02385630|Gastrectomy|gastrectomy
293090|NCT02385630|Hunger|hunger
293091|NCT02385630|Appetite|appetite
756200|NCT00418223|Child birth|child birth
374428|NCT01986023|SMS|sms
293092|NCT02385630|Glucagon-like Peptide 1|glucagon-like peptide 1
293093|NCT02385630|Peptide YY|peptide yy
293094|NCT02385630|Ghrelin|ghrelin
293095|NCT02385630|Satiety Response|satiety response
293096|NCT02385630|Feeding Behavior|feeding behavior
293097|NCT02385630|Meals|meals
293098|NCT02385630|Postprandial Period|postprandial period
293099|NCT02385617|Glucagon-Like Peptide 1|glucagon-like peptide 1
293100|NCT02385617|Peptide YY|peptide yy
293101|NCT02385617|Ghrelin|ghrelin
293102|NCT02385617|Satiety Response|satiety response
293103|NCT02385617|Appetite|appetite
293104|NCT02385617|Hunger|hunger
293105|NCT02385617|Somatostatin|somatostatin
293106|NCT02385617|Octreotide|octreotide
293107|NCT02385617|Anastomosis, Roux-en-Y|anastomosis, roux-en-y
293108|NCT02385617|Digestive System Surgical Procedures|digestive system surgical procedures
293109|NCT02385617|Pharmacologic Actions|pharmacologic actions
293110|NCT02385617|Physiological Effects of Drugs|physiological effects of drugs
293111|NCT02385617|Endocrine System Diseases|endocrine system diseases
293112|NCT02385617|Enteroendocrine Cells|enteroendocrine cells
293113|NCT02385617|Gastrointestinal Agents|gastrointestinal agents
293114|NCT02385604|Positron-Emission Tomography|positron-emission tomography
293115|NCT02385604|Neoadjuvant Therapy|neoadjuvant therapy
293116|NCT02385604|Chemoradiotherapy|chemoradiotherapy
293117|NCT02385604|Esophagectomy|esophagectomy
293118|NCT02385604|Response Evaluation Criteria in Solid Tumors|response evaluation criteria in solid tumors
293119|NCT02385604|Treatment Outcome|treatment outcome
293120|NCT02385604|Survival|survival
293121|NCT02385604|Recurrence|recurrence
293122|NCT02385604|Disease-Free Survival|disease-free survival
293123|NCT02385604|Progression-Free Survival|progression-free survival
293124|NCT02385604|Prognosis|prognosis
293125|NCT02385604|Neoplasm Grading|neoplasm grading
293126|NCT02385604|Adenocarcinoma|adenocarcinoma
293127|NCT02385604|Squamous Cell Carcinoma|squamous cell carcinoma
293128|NCT02385604|Neoplasm Metastasis|neoplasm metastasis
293129|NCT02385591|physical activity|physical activity
293130|NCT02385591|Latinos|latinos
293131|NCT02385591|overweight|overweight
293132|NCT02385591|SMS|sms
293133|NCT02385591|mHealth|mhealth
293134|NCT02385578|VS (vessel plus surface) classification system|vs (vessel plus surface) classification system
293135|NCT02385578|Magnified endoscopy with narrow band imaging (ME-NBI)|magnified endoscopy with narrow band imaging (me-nbi)
293136|NCT02385578|the rate of detection|the rate of detection
293137|NCT02385552|colonoscopy|colonoscopy
293138|NCT02385552|quality improvement|quality improvement
293139|NCT02385552|adenoma detection rate|adenoma detection rate
293140|NCT02385526|Vagus Nerve Stimulation|vagus nerve stimulation
293141|NCT02385526|ASCEND|ascend
293142|NCT02385526|VNS Titration to Improve Tolerance and Accelerate Adaptation|vns titration to improve tolerance and accelerate adaptation
293143|NCT02385513|Immunogenicity|immunogenicity
293144|NCT02385487|Myocardial Infarction|myocardial infarction
293145|NCT02385487|Inflammation|inflammation
293146|NCT02385487|Critical Illness|critical illness
293147|NCT02385487|Necrosis|necrosis
293148|NCT02385487|Sepsis|sepsis
293149|NCT02385487|Respiratory Insufficiency|respiratory insufficiency
293150|NCT02385487|Myocardial Ischemia|myocardial ischemia
293151|NCT02385487|Cardiovascular Diseases|cardiovascular diseases
293152|NCT02385487|Heart Diseases|heart diseases
293153|NCT02385487|Vascular Diseases|vascular diseases
293154|NCT02385474|silver diamine fluoride|silver diamine fluoride
293155|NCT02385474|randomized clinical trial|randomized clinical trial
293156|NCT02385474|caries|caries
293157|NCT02385474|children|children
293158|NCT02385474|fluoride|fluoride
293159|NCT02385448|dienogest|dienogest
293160|NCT02385448|combined oral contraceptive pills|combined oral contraceptive pills
293161|NCT02385448|endometriosis|endometriosis
293162|NCT02385435|caudal block|caudal block
293163|NCT02385422|secondary prophylaxis|secondary prophylaxis
293164|NCT02385422|Propranolol|propranolol
293165|NCT02385422|Carvedilol|carvedilol
293166|NCT02385422|comparative effectiveness research|comparative effectiveness research
293167|NCT02385409|Patient Blood Management|patient blood management
293168|NCT02385409|Preoperative anemia|preoperative anemia
293169|NCT02385409|Hip replacement|hip replacement
293170|NCT02385409|Knee replacement|knee replacement
293171|NCT02385396|Polycystic Ovary Syndrome|polycystic ovary syndrome
293172|NCT02385396|Infertility|infertility
293173|NCT02385396|Myo-inositol|myo-inositol
293174|NCT02385396|Intracytoplasmic sperm injection|intracytoplasmic sperm injection
293175|NCT02385383|Patient Blood Management|patient blood management
293176|NCT02385383|Preoperative anemia|preoperative anemia
293177|NCT02385383|IV Iron|iv iron
293178|NCT02385357|Muscle function|muscle function
293179|NCT02385357|Anaerobic power|anaerobic power
293180|NCT02385357|Muscle damage|muscle damage
293181|NCT02385331|Neutrophils|neutrophils
293182|NCT02385331|necroptosis|necroptosis
293183|NCT02385331|apoptosis|apoptosis
293184|NCT02385305|Pressure support ventilation|pressure support ventilation
293185|NCT02385305|respiratory drive|respiratory drive
293186|NCT02385305|Physiology|physiology
293187|NCT02385279|CAD|cad
293188|NCT02385279|ACS|acs
293189|NCT02385279|All comers|all comers
293190|NCT02385279|PCI|pci
293191|NCT02385266|Interstitial cystitis with Painful Bladder Syndrome|interstitial cystitis with painful bladder syndrome
293192|NCT02385266|Urological Chronic Pelvic Pain Syndrome|urological chronic pelvic pain syndrome
293193|NCT02385253|Training|training
293194|NCT02385253|Primary Health Care|primary health care
293195|NCT02385253|Skin Cancer|skin cancer
293196|NCT02385253|Primary Care Physicians|primary care physicians
293197|NCT02385253|Surveillance|surveillance
293198|NCT02385253|Education|education
293199|NCT02385214|Malignant|malignant
293200|NCT02385214|Melanoma|melanoma
293201|NCT02385214|Cancer|cancer
293202|NCT02385214|Surgery|surgery
293203|NCT02385188|Extramammary Paget's disease|extramammary paget's disease
293204|NCT02385188|Vulva|vulva
293205|NCT02385188|Genital, female|genital, female
293206|NCT02385188|imiquimod|imiquimod
293207|NCT02385175|Eustachian tube|eustachian tube
293208|NCT02385175|test accuracy|test accuracy
293209|NCT02385175|clinical test|clinical test
293210|NCT02385175|questionnaire|questionnaire
293211|NCT02385162|Mucolipidoses|mucolipidoses
293212|NCT02385162|Metabolic Diseases|metabolic diseases
293213|NCT02385162|Lysosomal Storage Diseases|lysosomal storage diseases
293214|NCT02385149|resilience|resilience
293215|NCT02385149|challenge test|challenge test
293216|NCT02385149|whole grain wheat|whole grain wheat
293217|NCT02385149|metabolic flexibility|metabolic flexibility
293218|NCT02385149|cardio-metabolic|cardio-metabolic
293219|NCT02385149|liver and adipose tissue|liver and adipose tissue
293220|NCT02385136|NSCLC|nsclc
293221|NCT02385136|Radiotherpy|radiotherpy
293222|NCT02385136|Temozolomide|temozolomide
293223|NCT02385123|ex-vivo|ex-vivo
293224|NCT02385123|Healthy Volunteers|healthy volunteers
293225|NCT02385123|Immune Response|immune response
293226|NCT02385123|Influenza|influenza
293227|NCT02385123|plasmablasts|plasmablasts
293228|NCT02385123|Vaccine|vaccine
293229|NCT02385110|Leukemia|leukemia
293230|NCT02385110|Hemophagocytic lymphohistiocytosis|hemophagocytic lymphohistiocytosis
293231|NCT02385110|HLH|hlh
293232|NCT02385110|Alemtuzumab|alemtuzumab
293233|NCT02385110|CAMPATH-1H|campath-1h
293234|NCT02385110|Campath|campath
293235|NCT02385110|Etoposide|etoposide
293236|NCT02385110|VePesid|vepesid
293237|NCT02385110|Dexamethasone|dexamethasone
293238|NCT02385110|Decadron|decadron
293239|NCT02385110|Methotrexate|methotrexate
293240|NCT02385110|Phone call|phone call
293241|NCT02385071|Healthy|healthy
293243|NCT02385071|Bioavailability|bioavailability
293244|NCT02385058|Helminthiasis|helminthiasis
293245|NCT02385058|Amoebiasis|amoebiasis
293246|NCT02385058|Mebendazole|mebendazole
293247|NCT02385058|Quinfamide|quinfamide
293248|NCT02385058|Mexican population|mexican population
293249|NCT02385019|Allogeneic hematopoietic stem cell transplantation|allogeneic hematopoietic stem cell transplantation
293250|NCT02385019|Graft vs host disease|graft vs host disease
293251|NCT02385019|Regulatory T cells|regulatory t cells
293252|NCT02385006|Thromboelastography|thromboelastography
293253|NCT02385006|simulatneous pancreas-kidney transplantation|simulatneous pancreas-kidney transplantation
293254|NCT02384993|Alzheimer's Disease|alzheimer's disease
293255|NCT02384993|Dementia|dementia
293256|NCT02384993|aerobic exercise|aerobic exercise
293257|NCT02384993|physical activity|physical activity
293258|NCT02384993|exercise|exercise
293259|NCT02384993|neuroimaging|neuroimaging
293260|NCT02384980|Intermittent Claudication|intermittent claudication
293261|NCT02384980|Functional Electrical Stimulation|functional electrical stimulation
293262|NCT02384954|Lymphoma|lymphoma
293263|NCT02384954|indolent B Cell|indolent b cell
293264|NCT02384954|non-Hodgkin Lymphoma|non-hodgkin lymphoma
293265|NCT02384954|Cancer|cancer
293266|NCT02384954|Immunotherapy|immunotherapy
293267|NCT02384954|Relapsed|relapsed
293268|NCT02384954|Refractory|refractory
293269|NCT02384954|Rituximab|rituximab
293270|NCT02384954|Interleukin-15|interleukin-15
293271|NCT02384954|Absolute Lymphocyte Count|absolute lymphocyte count
293272|NCT02384954|White Blood Cell|white blood cell
293273|NCT02384954|Follicular Lymphoma|follicular lymphoma
293274|NCT02384954|Marginal Zone Lymphoma|marginal zone lymphoma
293275|NCT02384954|Small Lymphocytic Lymphoma|small lymphocytic lymphoma
293276|NCT02384954|Lymphoplasmacytic Lymphoma|lymphoplasmacytic lymphoma
293277|NCT02384954|anti-CD20|anti-cd20
293278|NCT02384928|Acupuncture|acupuncture
293279|NCT02384928|Pharmacopuncture|pharmacopuncture
293280|NCT02384928|Usual Care|usual care
293281|NCT02384902|glycemic index|glycemic index
293282|NCT02384902|diabetic nephropathy|diabetic nephropathy
293283|NCT02384902|low glycemic load|low glycemic load
293284|NCT02384902|inflammation|inflammation
293285|NCT02384876|pediatric|pediatric
293286|NCT02384876|intraoperative arterial hypotension|intraoperative arterial hypotension
293287|NCT02384876|ephedrine|ephedrine
293288|NCT02384876|general anesthesia|general anesthesia
293289|NCT02384863|Chest Pain|chest pain
293290|NCT02384863|Acute Coronary Syndrome|acute coronary syndrome
293291|NCT02384863|Cardiac|cardiac
293292|NCT02384863|Emergency Department|emergency department
293293|NCT02384863|Cardiac Testing|cardiac testing
293294|NCT02384863|Healthcare Utilization|healthcare utilization
293295|NCT02384863|Patient Centered Outcomes|patient centered outcomes
293296|NCT02384863|Shared Decision Making|shared decision making
293297|NCT02384863|Unnecessary hospital admissions|unnecessary hospital admissions
293298|NCT02384863|Decision Aid|decision aid
293299|NCT02384850|metastatic|metastatic
293300|NCT02384837|national Cather Lad|national cather lad
293301|NCT02384837|Interventional Imaging Training Base|interventional imaging training base
293302|NCT02384811|Esophageal squamous cell carcinoma|esophageal squamous cell carcinoma
293303|NCT02384811|postoperative radiotherapy|postoperative radiotherapy
293304|NCT02384759|cancer, colorectal,|cancer, colorectal,
293305|NCT02384746|metastatic breast cancer|metastatic breast cancer
293306|NCT02384746|ER-positive|er-positive
293307|NCT02384746|HER2-negative|her2-negative
293308|NCT02384746|Fulvestrant|fulvestrant
293309|NCT02384746|MLN9708|mln9708
293310|NCT02384733|Radiation induced morbidity, recurrence|radiation induced morbidity, recurrence
293311|NCT02384694|cardiorespiratory fitness|cardiorespiratory fitness
293312|NCT02384694|weight|weight
293313|NCT02384694|quality of life|quality of life
293314|NCT02384694|depression|depression
293315|NCT02384694|menopausal symptoms|menopausal symptoms
293316|NCT02384694|exercise barriers|exercise barriers
293317|NCT02384694|executive functions|executive functions
293318|NCT02384681|Speech intelligibility|speech intelligibility
293319|NCT02384681|Short-term memory|short-term memory
293320|NCT02384681|Working memory|working memory
293321|NCT02384681|Perceived mental task load|perceived mental task load
293322|NCT02384668|Cholecalciferol|cholecalciferol
293323|NCT02384668|Vitamin D3|vitamin d3
293324|NCT02384668|Arterial stiffness|arterial stiffness
293325|NCT02384668|Quality of Life|quality of life
293326|NCT02384668|Bone density and geometry|bone density and geometry
293327|NCT02384668|Muscle strength and balance|muscle strength and balance
293328|NCT02384655|Preterms|preterms
293329|NCT02384655|Breastfeeding|breastfeeding
293330|NCT02384655|Lactation|lactation
293331|NCT02384655|Macronutrients|macronutrients
293332|NCT02384642|Adolescent Health|adolescent health
293333|NCT02384642|Democratic Republic of Congo|democratic republic of congo
293334|NCT02384642|Sexual Violence|sexual violence
293335|NCT02384616|Lung Volume Measurements|lung volume measurements
293336|NCT02384616|airway resistance|airway resistance
293337|NCT02384616|general anesthesia|general anesthesia
293338|NCT02384564|Laryngoscopy|laryngoscopy
293339|NCT02384564|Video Laryngoscopy|video laryngoscopy
293340|NCT02384564|Tracheal intubation|tracheal intubation
293341|NCT02384551|GERD|gerd
293342|NCT02384551|diet|diet
293343|NCT02384551|carbohydrate|carbohydrate
293344|NCT02384551|obesity|obesity
293345|NCT02384538|Osteoarthritis|osteoarthritis
293346|NCT02384538|Joint diseases|joint diseases
293347|NCT02384538|Musculoskeletal diseases|musculoskeletal diseases
293348|NCT02384538|Rheumatic diseases|rheumatic diseases
293349|NCT02384538|Arthritis|arthritis
293350|NCT02384538|Osteoarthritis, Hand|osteoarthritis, hand
293351|NCT02384525|Septic AKI|septic aki
293352|NCT02384525|CRRT|crrt
293353|NCT02384525|BIA|bia
293354|NCT02384512|Parkinson's disease|parkinson's disease
293355|NCT02384512|akinesia|akinesia
293356|NCT02384512|Azilect®|azilect®
293357|NCT02384512|Rasagiline|rasagiline
293358|NCT02384512|Combination therapy with L-dopa|combination therapy with l-dopa
293359|NCT02384512|Wearing-off Questionnaire-32|wearing-off questionnaire-32
293360|NCT02384512|Quality of life|quality of life
293361|NCT02384512|Daily practice|daily practice
293362|NCT02384460|Amicus Therapeutics|amicus therapeutics
293363|NCT02384460|Scioderm, Inc.|scioderm, inc.
293364|NCT02384460|Simplex|simplex
293365|NCT02384460|Recessive Dystrophic|recessive dystrophic
293366|NCT02384460|Junctional non-Herlitz|junctional non-herlitz
293367|NCT02384460|Epidermolysis Bullosa|epidermolysis bullosa
293368|NCT02384460|SD-101 6%|sd-101 6%
293369|NCT02384460|SD-101-6.0|sd-101-6.0
293370|NCT02384460|Allantoin 6%|allantoin 6%
293371|NCT02384460|Zorblisa|zorblisa
293372|NCT02384447|above knee amputation|above knee amputation
293373|NCT02384447|sciatic nerve|sciatic nerve
293374|NCT02384447|ultrasonography|ultrasonography
293375|NCT02384447|histology|histology
293376|NCT02384408|menopause|menopause
293377|NCT02384408|drospirenone|drospirenone
293378|NCT02384408|tibolone|tibolone
293379|NCT02384408|Bcl-2|bcl-2
293380|NCT02384408|steroid receptors|steroid receptors
293381|NCT02384395|Dolutegravir|dolutegravir
293382|NCT02384395|Abacavir|abacavir
293383|NCT02384395|Lamivudine|lamivudine
293384|NCT02384395|acute HIV infection|acute hiv infection
293385|NCT02384395|human leukocyte antigen|human leukocyte antigen
293386|NCT02384395|latent HIV reservoir|latent hiv reservoir
293387|NCT02384395|integrase-based regimen|integrase-based regimen
293388|NCT02384395|viremia|viremia
293389|NCT02384395|antiretroviral therapy|antiretroviral therapy
293390|NCT02384395|fixed dose combination|fixed dose combination
293391|NCT02384382|Cancer of the Prostate|cancer of the prostate
293392|NCT02384356|Non-communicable diseases|non-communicable diseases
293393|NCT02384356|Chronic disease|chronic disease
293394|NCT02384356|Mobile health|mobile health
293395|NCT02384356|Diabetes Mellitus|diabetes mellitus
293396|NCT02384356|Hypertension|hypertension
293397|NCT02384356|Bolivia|bolivia
293398|NCT02384356|Longitudinal survey|longitudinal survey
293399|NCT02384356|Health indicators|health indicators
293400|NCT02384356|Primary care|primary care
293401|NCT02384356|Ambulatory care|ambulatory care
293402|NCT02384343|Dexmedetomidine|dexmedetomidine
293403|NCT02384343|Cesarean section|cesarean section
293404|NCT02384343|Anesthesia, Spinal|anesthesia, spinal
293405|NCT02384343|Anesthesia, Epidural|anesthesia, epidural
293406|NCT02384304|randomized controlled trial|randomized controlled trial
293407|NCT02384304|alcohol|alcohol
293408|NCT02384304|internet|internet
293409|NCT02384304|internet based therapy|internet based therapy
293410|NCT02384304|cognitive behavior therapy|cognitive behavior therapy
293411|NCT02384278|alcohol use disorder|alcohol use disorder
293412|NCT02384278|internet|internet
293413|NCT02384278|cognitive behavior therapy|cognitive behavior therapy
293414|NCT02384278|relapse prevention|relapse prevention
293415|NCT02384265|Diabetes|diabetes
293416|NCT02384265|Disparities|disparities
293417|NCT02384265|Behavioral|behavioral
293418|NCT02384265|Text messaging|text messaging
293419|NCT02384265|Social networks|social networks
293420|NCT02384265|African American|african american
293421|NCT02384265|Female|female
293422|NCT02384252|obese cardiomyopathy|obese cardiomyopathy
293423|NCT02384252|mitochondria|mitochondria
293424|NCT02384252|contractile dysfunction|contractile dysfunction
293425|NCT02384226|mobile application|mobile application
293426|NCT02384226|postpartum|postpartum
293427|NCT02384226|weight loss|weight loss
293428|NCT02384187|Gabapentin|gabapentin
293429|NCT02384187|PONV|ponv
293430|NCT02384187|Adenotonsillectomy|adenotonsillectomy
293431|NCT02384187|Pediatrics|pediatrics
293432|NCT02384174|Aging|aging
293433|NCT02384174|Resistant starch|resistant starch
293434|NCT02384174|Dietary fibre|dietary fibre
293435|NCT02384174|Immune system|immune system
293436|NCT02384174|Bacteria|bacteria
293437|NCT02384174|older subjects|older subjects
293438|NCT02384122|Angiodysplasias|angiodysplasias
293439|NCT02384122|Sandostatin LAR|sandostatin lar
293440|NCT02384122|Gastrointestinal|gastrointestinal
293441|NCT02384122|Somatostatin|somatostatin
293442|NCT02384122|Octreotide|octreotide
293443|NCT02384096|stimulation|stimulation
293444|NCT02384096|implantable|implantable
293445|NCT02384096|pulse generator|pulse generator
293446|NCT02384096|back pain|back pain
293447|NCT02384096|chronic pain|chronic pain
293448|NCT02384096|leg pain|leg pain
293449|NCT02384083|Multiple Myeloma|multiple myeloma
293450|NCT02384083|Pethema|pethema
293451|NCT02384083|Filanesib|filanesib
293452|NCT02384083|Pomalidomide|pomalidomide
293453|NCT02384044|Sensitivity|sensitivity
293454|NCT02383979|Phantom limb pain|phantom limb pain
293455|NCT02383979|Mirror therapy|mirror therapy
293456|NCT02383979|Elective amputation|elective amputation
293457|NCT02383979|Residual limb pain|residual limb pain
293458|NCT02383979|Functional MRI|functional mri
293459|NCT02383953|twins|twins
293461|NCT02383953|UC|uc
293462|NCT02383953|CD|cd
293463|NCT02383875|nutrition economics|nutrition economics
293464|NCT02383875|food expenditure|food expenditure
293465|NCT02383875|nutritional quality|nutritional quality
293466|NCT02383875|low income|low income
293467|NCT02383862|Sleep|sleep
293468|NCT02383862|Pain|pain
293469|NCT02383862|Anxiety|anxiety
293470|NCT02383862|Depression|depression
293471|NCT02383862|Fatigue|fatigue
293472|NCT02383862|PROMIS|promis
293473|NCT02383862|primary care|primary care
293474|NCT02383836|Patent Foramen Ovale|patent foramen ovale
293475|NCT02383823|glucose, cholesterol, estrogen, gender, age|glucose, cholesterol, estrogen, gender, age
293476|NCT02383810|Chemotherapy Induced Diarrhea (CID)|chemotherapy induced diarrhea (cid)
293477|NCT02383771|Ticagrelor|ticagrelor
293478|NCT02383771|Aspirin|aspirin
293479|NCT02383771|Peri-operative treatment|peri-operative treatment
293480|NCT02383758|Behavioral Symptoms|behavioral symptoms
293481|NCT02383758|Child Development Disorders, Pervasive|child development disorders, pervasive
293482|NCT02383758|Bowel Incontinence|bowel incontinence
293483|NCT02383758|Constipation|constipation
293484|NCT02383745|Acute EEG|acute eeg
293485|NCT02383745|status epilepticus|status epilepticus
293486|NCT02383745|seizure|seizure
293487|NCT02383706|Sleep Apnea, Obstructive|sleep apnea, obstructive
293488|NCT02383706|Pregnancy|pregnancy
293489|NCT02383706|Obesity, Morbid|obesity, morbid
293490|NCT02383706|Complications, pregnancy|complications, pregnancy
293491|NCT02383693|depression|depression
756394|NCT00417365|odor|odor
293492|NCT02383693|Repetitive Transcranial Magnetic Stimulation|repetitive transcranial magnetic stimulation
293493|NCT02383693|tolerability|tolerability
293494|NCT02383693|efficiency|efficiency
293495|NCT02383693|TMS|tms
293496|NCT02383693|refractory|refractory
293497|NCT02383680|Methotrexate therapy|methotrexate therapy
293498|NCT02383654|Amyotrophic Lateral Sclerosis|amyotrophic lateral sclerosis
293499|NCT02383654|Autologous Adipose-Tissue Derived Stem Cells (ADSCs)|autologous adipose-tissue derived stem cells (adscs)
293500|NCT02383641|Wolman disease|wolman disease
293501|NCT02383641|Biomarker|biomarker
293502|NCT02383628|ICG Dye|icg dye
293503|NCT02383628|endoscopic neurosurgery|endoscopic neurosurgery
293504|NCT02383628|tissue perfusion|tissue perfusion
293505|NCT02383602|6,000 Thai MSM and TG from study sites in Bangkok, Chiang Mai, Chonburi and Songkhla|6,000 thai msm and tg from study sites in bangkok, chiang mai, chonburi and songkhla
293506|NCT02383550|Multiple Sclerosis|multiple sclerosis
293507|NCT02383550|Cognition|cognition
293508|NCT02383498|Overall Response Rate|overall response rate
293509|NCT02383498|Immune Activation|immune activation
293510|NCT02383498|Tumor Infiltrating Lymphocytes|tumor infiltrating lymphocytes
293511|NCT02383498|T Cell Response|t cell response
293512|NCT02383498|Cross-Over|cross-over
293513|NCT02383485|arterial stiffness|arterial stiffness
293514|NCT02383472|Concussion|concussion
293515|NCT02383472|Mild Traumatic Brain Injury|mild traumatic brain injury
293516|NCT02383472|MTBI|mtbi
293517|NCT02383472|LED|led
293518|NCT02383472|Light Emitting Diode|light emitting diode
293519|NCT02383472|Headache|headache
293520|NCT02383472|Brain Concussion|brain concussion
293521|NCT02383446|Echeclon|echeclon
293522|NCT02383446|Elan|elan
293523|NCT02383446|TTA|tta
293524|NCT02383446|Transtibial Amputee|transtibial amputee
293525|NCT02383394|second trimesteric pregnancy loss|second trimesteric pregnancy loss
293526|NCT02383368|Pharmacokinetics|pharmacokinetics
293527|NCT02383368|ASP4132|asp4132
293528|NCT02383368|Lymphoma|lymphoma
293529|NCT02383368|Refractory Solid Tumors|refractory solid tumors
293530|NCT02383355|Persistent immune activation|persistent immune activation
293531|NCT02383355|Platelet hyperreactivity|platelet hyperreactivity
293532|NCT02383342|Pain Processing|pain processing
293533|NCT02383342|Genetic Factors|genetic factors
293534|NCT02383342|Biomarkers|biomarkers
293535|NCT02383329|malnutrition|malnutrition
293536|NCT02383329|Underweight|underweight
293537|NCT02383329|Oral Nutrition Supplements|oral nutrition supplements
293538|NCT02383329|Children|children
293539|NCT02383316|Insulin sensitivity|insulin sensitivity
293540|NCT02383316|Metabolism|metabolism
293541|NCT02383316|Noonan syndrome|noonan syndrome
293542|NCT02383316|Shp2|shp2
293543|NCT02383303|savings|savings
293544|NCT02383303|assets|assets
293545|NCT02383303|material hardship|material hardship
293546|NCT02383303|poverty|poverty
293547|NCT02383303|Individual Development Account|individual development account
293548|NCT02383264|feeding intolerance|feeding intolerance
293549|NCT02383264|preterm infants|preterm infants
293550|NCT02383264|near infrared spectroscopy|near infrared spectroscopy
293551|NCT02383238|Dapagliflozin|dapagliflozin
293552|NCT02383238|diabetes mellitus|diabetes mellitus
293553|NCT02383238|vascular|vascular
293554|NCT02383225|American Indian|american indian
293555|NCT02383225|Adolescent|adolescent
293556|NCT02383225|Prevention|prevention
293557|NCT02383212|Advanced cancerous growth|advanced cancerous growth
293558|NCT02383173|end of life|end of life
293559|NCT02383173|palliative care|palliative care
293560|NCT02383173|implementation|implementation
293561|NCT02383160|Low-intensity pulsed ultrasound|low-intensity pulsed ultrasound
293562|NCT02383160|Nonunion|nonunion
293563|NCT02383160|Scaphoid|scaphoid
293564|NCT02383160|Operative|operative
293565|NCT02383147|Adult|adult
293566|NCT02383147|Aged|aged
293567|NCT02383147|Alpha Rhythm|alpha rhythm
293568|NCT02383147|Auditory Cortex|auditory cortex
293569|NCT02383147|Chronic|chronic
293570|NCT02383147|Electroencephalography|electroencephalography
293571|NCT02383147|Female|female
293572|NCT02383147|Humans|humans
293573|NCT02383147|Male|male
293574|NCT02383147|Neurofeedback|neurofeedback
293575|NCT02383147|Prospective Studies|prospective studies
293576|NCT02383147|Questionnaires|questionnaires
293577|NCT02383147|Tinnitus|tinnitus
293578|NCT02383147|Treatment Outcome|treatment outcome
293579|NCT02383095|Schizophrenia|schizophrenia
293580|NCT02383095|Art-therapy|art-therapy
293581|NCT02383095|Visual organization|visual organization
293582|NCT02383069|Pulmonary rehabilitation|pulmonary rehabilitation
293583|NCT02383069|Asthma|asthma
293584|NCT02383069|Children|children
293585|NCT02383069|Teenager|teenager
293586|NCT02383069|Physical capacity|physical capacity
293587|NCT02383056|wound|wound
293588|NCT02383056|secondary intention healing|secondary intention healing
293589|NCT02383056|lower extremity|lower extremity
293590|NCT02383030|Breast cancer|breast cancer
293591|NCT02383030|Metastatic|metastatic
293592|NCT02383030|HER2 negative|her2 negative
293593|NCT02383030|postmenopausal|postmenopausal
293594|NCT02383030|maintenance therapy|maintenance therapy
293595|NCT02383030|fulvestrant|fulvestrant
293596|NCT02383017|Multi-ingredient performance supplement, High Intensity Interval Training, Concurrent training|multi-ingredient performance supplement, high intensity interval training, concurrent training
293597|NCT02383004|myringotomy tubes|myringotomy tubes
293598|NCT02383004|acupuncture|acupuncture
293599|NCT02383004|emergence delirium|emergence delirium
293600|NCT02383004|pediatrics|pediatrics
293601|NCT02383004|general anesthesia|general anesthesia
293602|NCT02382991|Moderately active amputees|moderately active amputees
293603|NCT02382991|C-leg Compact|c-leg compact
293604|NCT02382991|Knee prosthesis|knee prosthesis
293605|NCT02382991|Kenevo|kenevo
293606|NCT02382991|Microprocessor controlled knee|microprocessor controlled knee
293607|NCT02382991|Amputation|amputation
293608|NCT02382991|3C60|3c60
293609|NCT02382991|Timed Get Up and Go (TGUG)|timed get up and go (tgug)
293610|NCT02382991|Locomotors Capacities Index (LCI)|locomotors capacities index (lci)
293611|NCT02382991|QUEST|quest
293612|NCT02382991|Short Form survey (SF-36)|short form survey (sf-36)
293613|NCT02382952|Abdominal surgery|abdominal surgery
293614|NCT02382952|Pelvic surgery|pelvic surgery
293615|NCT02382952|Stoma takedown|stoma takedown
293616|NCT02382952|Bowel resection|bowel resection
293617|NCT02382952|Lysis of abdominal adhesions|lysis of abdominal adhesions
293618|NCT02382926|capacitive electrocardiography|capacitive electrocardiography
293619|NCT02382926|Eulerian Magnification Method|eulerian magnification method
293620|NCT02382900|quadrivalent|quadrivalent
293621|NCT02382900|vaccine|vaccine
293622|NCT02382887|intubation|intubation
293623|NCT02382887|difficult airway|difficult airway
293624|NCT02382887|fiberscopy|fiberscopy
293625|NCT02382887|Airtraq|airtraq
293626|NCT02382887|general anesthesia|general anesthesia
293627|NCT02382874|Idiopathic nephrotic syndrome|idiopathic nephrotic syndrome
293628|NCT02382874|adipose derived mesenchymal stromal cell|adipose derived mesenchymal stromal cell
293629|NCT02382874|Focal segmental glomerulosclerosis|focal segmental glomerulosclerosis
293630|NCT02382861|Neurally adjusted ventilatory assist|neurally adjusted ventilatory assist
293631|NCT02382861|Weaning|weaning
293632|NCT02382861|Mechanical ventilation|mechanical ventilation
293633|NCT02382861|Extubation|extubation
293634|NCT02382848|Eating Disorders|eating disorders
293635|NCT02382848|Bulimia Nervosa|bulimia nervosa
293636|NCT02382848|Nightmares|nightmares
293637|NCT02382848|Post Traumatic Stress Disorder|post traumatic stress disorder
293638|NCT02382835|metal-on-metal|metal-on-metal
293639|NCT02382809|Alveolar osteitis|alveolar osteitis
293640|NCT02382809|Third molar|third molar
293641|NCT02382809|Dry socket|dry socket
293642|NCT02382809|Mouthwash|mouthwash
293643|NCT02382809|third molar extraction|third molar extraction
293644|NCT02382783|Rheumatoid Arthritis|rheumatoid arthritis
293645|NCT02382783|Disease Activity|disease activity
293646|NCT02382783|Flare|flare
293647|NCT02382783|Management of Flares|management of flares
293648|NCT02382783|Pfizer|pfizer
293649|NCT02382744|Saphenous Nerve|saphenous nerve
293650|NCT02382744|Nerve Block|nerve block
293651|NCT02382744|Ultrasound guided|ultrasound guided
293652|NCT02382744|Neurostimulation|neurostimulation
293653|NCT02382744|Regional Anesthesia|regional anesthesia
293654|NCT02382744|Ropivacaine|ropivacaine
293655|NCT02382744|Foot Surgery|foot surgery
293656|NCT02382744|Nerve Stimulation|nerve stimulation
293657|NCT02382744|Ankle Surgery|ankle surgery
293658|NCT02382718|fish allergy|fish allergy
293659|NCT02382718|parvalbumin|parvalbumin
293660|NCT02382718|immunotherapy|immunotherapy
293661|NCT02382718|mCyp c 1|mcyp c 1
293662|NCT02382705|capsule endoscopy|capsule endoscopy
293663|NCT02382705|battery life|battery life
293664|NCT02382705|completion rate|completion rate
293665|NCT02382705|diagnostic yield|diagnostic yield
293666|NCT02382640|Drug therapy|drug therapy
293667|NCT02382614|Endobronchial Valve|endobronchial valve
293668|NCT02382614|Minimally Invasive|minimally invasive
293669|NCT02382614|Intrabronchial Valves|intrabronchial valves
293670|NCT02382614|Digital Thoracic Drainage System|digital thoracic drainage system
293671|NCT02382614|Spiration Valve System|spiration valve system
293672|NCT02382614|Prolonged Air Leak|prolonged air leak
293673|NCT02382614|Persistent Air Leak|persistent air leak
293674|NCT02382601|Pregnancy|pregnancy
293675|NCT02382601|IUGR|iugr
293676|NCT02382601|Small for gestational age|small for gestational age
293677|NCT02382562|Depression|depression
293678|NCT02382562|Asthma|asthma
293679|NCT02382562|Urticaria|urticaria
293680|NCT02382549|vaccine|vaccine
293682|NCT02382549|dabrafenib|dabrafenib
293683|NCT02382549|trametinib|trametinib
293684|NCT02382549|Montanide ISA-51|montanide isa-51
293685|NCT02382549|MEKINIST|mekinist
293686|NCT02382549|Tafinlar|tafinlar
293687|NCT02382536|Diabetes|diabetes
293688|NCT02382536|Insulin therapy|insulin therapy
293689|NCT02382536|insulin pump|insulin pump
293690|NCT02382536|Infusion sets|infusion sets
293691|NCT02382523|acthar|acthar
293692|NCT02382523|proteinuria|proteinuria
293693|NCT02382523|IgA nephropathy|iga nephropathy
293694|NCT02382484|Hypertension Resistant to Conventional Therapy|hypertension resistant to conventional therapy
293695|NCT02382471|atherosclerotic|atherosclerotic
293696|NCT02382471|BDNF|bdnf
293697|NCT02382471|Follistatin|follistatin
293698|NCT02382471|Irisin|irisin
293699|NCT02382432|Anesthesia|anesthesia
293700|NCT02382432|dexmedetomidine|dexmedetomidine
293701|NCT02382432|pethidine|pethidine
293702|NCT02382432|shivering|shivering
293703|NCT02382432|spinal|spinal
293704|NCT02382406|MK-3475|mk-3475
293705|NCT02382406|Pembrolizumab|pembrolizumab
293706|NCT02382406|Carboplatin|carboplatin
293707|NCT02382406|Nab-paclitaxel|nab-paclitaxel
293708|NCT02382393|cognitive assessment|cognitive assessment
293709|NCT02382393|Brain Performance Test|brain performance test
293710|NCT02382393|Lumosity|lumosity
293711|NCT02382393|concurrent validity|concurrent validity
293712|NCT02382393|computerized assessment|computerized assessment
293713|NCT02382380|Magnetic Resonance Imaging|magnetic resonance imaging
293714|NCT02382380|Contrast Agent|contrast agent
293715|NCT02382380|Gadoterate|gadoterate
293716|NCT02382341|ACL|acl
293717|NCT02382341|BIOSURE|biosure
293718|NCT02382341|HEALICOIL|healicoil
293719|NCT02382341|PEEK|peek
293720|NCT02382341|In-Growth|in-growth
293721|NCT02382315|fear of cancer recurrence|fear of cancer recurrence
293722|NCT02382315|psychosocial intervention|psychosocial intervention
293723|NCT02382315|randomized controlled clinical trial|randomized controlled clinical trial
293724|NCT02382302|U-health|u-health
293725|NCT02382302|chronic wound management|chronic wound management
293726|NCT02382289|Radiofrequency|radiofrequency
293727|NCT02382289|monopolar|monopolar
293728|NCT02382289|bipolar|bipolar
293729|NCT02382289|Sacroiliac Joint Arthropathy|sacroiliac joint arthropathy
293730|NCT02382289|three different modalities|three different modalities
293731|NCT02382263|Advanced pancreatic cancer|advanced pancreatic cancer
293732|NCT02382263|Fragile|fragile
293733|NCT02382263|Nab-paclitaxel|nab-paclitaxel
293734|NCT02382237|denutrition in Head and Neck cancer or oesophageal cancer|denutrition in head and neck cancer or oesophageal cancer
293735|NCT02382224|generalized anxiety disorder|generalized anxiety disorder
293736|NCT02382224|anxiety|anxiety
293737|NCT02382224|worry exposure|worry exposure
293738|NCT02382224|treatment|treatment
293739|NCT02382211|CMV|cmv
293740|NCT02382198|droooling, sialorrhea, parkinson's disease, parkinsons|droooling, sialorrhea, parkinson's disease, parkinsons
293741|NCT02382185|Cardiac output|cardiac output
293742|NCT02382120|carbon dioxide|carbon dioxide
293743|NCT02382120|cardiac output|cardiac output
293744|NCT02382120|ventilation|ventilation
293745|NCT02382120|thermodilution|thermodilution
293746|NCT02382107|TB|tb
293747|NCT02382107|Tuberculosis|tuberculosis
293748|NCT02382107|Diagnostic study|diagnostic study
293749|NCT02382094|curative intention|curative intention
293750|NCT02382094|radiation Therapy|radiation therapy
294160|NCT02380092|Knee|knee
293751|NCT02382094|health related quality of life|health related quality of life
293752|NCT02382055|Eating Disorders|eating disorders
293753|NCT02382055|Psychotherapy|psychotherapy
293754|NCT02382055|Anorexia Nervosa|anorexia nervosa
293755|NCT02382055|Treatment|treatment
293756|NCT02382042|Rural Health|rural health
293757|NCT02382042|Veterans|veterans
293758|NCT02382042|Substance Abuse|substance abuse
293759|NCT02382003|Anxiety|anxiety
293760|NCT02382003|Cognitive bias|cognitive bias
293761|NCT02382003|Telemedicine|telemedicine
293762|NCT02381990|Prostate|prostate
293763|NCT02381990|PSA|psa
293764|NCT02381990|FUSION|fusion
293765|NCT02381990|Ultrasound|ultrasound
293766|NCT02381990|MRI|mri
293767|NCT02381990|Cancer|cancer
293768|NCT02381990|Cryotherapy|cryotherapy
293769|NCT02381990|Outcomes|outcomes
293770|NCT02381990|Recurrence|recurrence
293771|NCT02381990|QOL, Quality of Life|qol, quality of life
293772|NCT02381990|Urinary function|urinary function
293773|NCT02381990|Sexual Function|sexual function
293774|NCT02381964|cerebral blood flow|cerebral blood flow
293775|NCT02381964|cognitive function|cognitive function
293776|NCT02381964|vitamins|vitamins
293777|NCT02381964|energy expenditure|energy expenditure
293778|NCT02381964|NIRS|nirs
293779|NCT02381964|Indirect calorimetry|indirect calorimetry
293780|NCT02381938|inactivity|inactivity
293781|NCT02381938|behavior change|behavior change
293782|NCT02381938|worksite wellness|worksite wellness
293783|NCT02381938|child care|child care
293784|NCT02381925|CT|ct
293785|NCT02381925|Scintigraphy|scintigraphy
293786|NCT02381925|Ultrasound|ultrasound
293787|NCT02381899|chronic lymphocytic leukemia|chronic lymphocytic leukemia
293788|NCT02381899|bendamustine|bendamustine
293789|NCT02381899|rituximab|rituximab
293790|NCT02381886|IDHR132 mutations|idhr132 mutations
293791|NCT02381886|IDH305|idh305
293792|NCT02381886|IDH|idh
293793|NCT02381886|IDH1|idh1
293794|NCT02381886|AML|aml
293795|NCT02381886|Acute Myeloid Leukemia|acute myeloid leukemia
293796|NCT02381886|Leukemia|leukemia
293797|NCT02381886|Myeloid|myeloid
293798|NCT02381886|Acute|acute
293799|NCT02381886|MDS|mds
293800|NCT02381886|Myelodysplastic Syndrome|myelodysplastic syndrome
293801|NCT02381886|Glioma|glioma
293802|NCT02381886|Oligodendroglioma|oligodendroglioma
293803|NCT02381886|Astrocytoma|astrocytoma
293804|NCT02381886|Glioblastoma|glioblastoma
293805|NCT02381886|Cholangiocarcinoma|cholangiocarcinoma
293806|NCT02381886|Solid Tumors|solid tumors
293807|NCT02381873|Arthroplasty|arthroplasty
293808|NCT02381873|Replacement|replacement
293809|NCT02381873|Knee|knee
293810|NCT02381873|Osteoarthritis|osteoarthritis
293811|NCT02381847|gastric cancer|gastric cancer
293812|NCT02381847|intraperitoneal chemoperfusion|intraperitoneal chemoperfusion
293813|NCT02381834|Urine Specimen Collection|urine specimen collection
293814|NCT02381834|Infant|infant
293815|NCT02381834|Neonate|neonate
293816|NCT02381834|Bacterial Infection|bacterial infection
293817|NCT02381821|junctional zone|junctional zone
293818|NCT02381821|Implantation|implantation
293819|NCT02381821|Intracytoplasmic sperm injection|intracytoplasmic sperm injection
293820|NCT02381717|ultrasound|ultrasound
293821|NCT02381717|bupivacaine|bupivacaine
293822|NCT02381717|femoral nerve block|femoral nerve block
293823|NCT02381717|pain reduction|pain reduction
293824|NCT02381678|Heart Valve Replacement|heart valve replacement
293825|NCT02381678|Perimount 2900|perimount 2900
293826|NCT02381678|China|china
293827|NCT02381678|Perimount 6900P|perimount 6900p
293828|NCT02381626|HEPA filter|hepa filter
293829|NCT02381626|14-247|14-247
293830|NCT02381613|Fish|fish
293831|NCT02381613|Herring|herring
293832|NCT02381613|Meat|meat
293833|NCT02381613|Beef|beef
293834|NCT02381600|vitamin D|vitamin d
293835|NCT02381600|aging|aging
293836|NCT02381600|cognitive function|cognitive function
293837|NCT02381600|depression|depression
293838|NCT02381600|executive function|executive function
293839|NCT02381574|Lumbar Total Disk Replacement|lumbar total disk replacement
293840|NCT02381522|remote ischemic preconditioning|remote ischemic preconditioning
293841|NCT02381509|inferior vena cava filters|inferior vena cava filters
293842|NCT02381496|ACT-453859|act-453859
293843|NCT02381496|ACT-463036|act-463036
293844|NCT02381496|Setipiprant|setipiprant
293845|NCT02381496|Tolerability|tolerability
293846|NCT02381496|safety|safety
293847|NCT02381496|pharmacodynamics|pharmacodynamics
293848|NCT02381496|pharmacokinetics|pharmacokinetics
293849|NCT02381470|Beta lactams|beta lactams
293850|NCT02381470|adjunctive therapy|adjunctive therapy
293851|NCT02381470|drug-sensitive tuberculosis|drug-sensitive tuberculosis
293852|NCT02381457|Microdeletion Syndrome|microdeletion syndrome
293853|NCT02381457|Aneuploidy|aneuploidy
293854|NCT02381457|22q|22q
293855|NCT02381457|Non-Invasive Prenatal Screening|non-invasive prenatal screening
293856|NCT02381457|DiGeorge Syndrome|digeorge syndrome
293857|NCT02381444|Advanced Parkinson's Disease|advanced parkinson's disease
293858|NCT02381444|Levodopa Carbidopa Intestinal Gel|levodopa carbidopa intestinal gel
293859|NCT02381444|Observational Study|observational study
293860|NCT02381444|Quality of life|quality of life
293861|NCT02381444|Jejunal Percutaneous Endoscopic Gastrostomy|jejunal percutaneous endoscopic gastrostomy
293862|NCT02381431|imaging|imaging
293863|NCT02381431|diagnostic|diagnostic
293864|NCT02381431|pediatrics|pediatrics
293865|NCT02381418|Influenza|influenza
293866|NCT02381418|Vaccine|vaccine
293867|NCT02381418|Committee for Medicinal Products for Human Use (CHMP) criteria|committee for medicinal products for human use (chmp) criteria
293868|NCT02381392|emergency medicine|emergency medicine
293869|NCT02381392|infrared|infrared
293870|NCT02381392|intravenous|intravenous
293871|NCT02381379|CML|cml
293872|NCT02381379|peginterferon|peginterferon
293873|NCT02381379|stop|stop
293874|NCT02381379|BCR-ABL|bcr-abl
293875|NCT02381366|Mesenchymal Stem Cells|mesenchymal stem cells
293876|NCT02381366|Human Umbilical Cord Blood|human umbilical cord blood
293877|NCT02381366|Premature Infants|premature infants
293878|NCT02381366|Bronchopulmonary Dysplasia|bronchopulmonary dysplasia
293879|NCT02381366|Chronic Lung Disease|chronic lung disease
293880|NCT02381366|Cell Therapy|cell therapy
293881|NCT02381353|Enucleation|enucleation
293882|NCT02381353|Evisceration|evisceration
293883|NCT02381353|Exparel|exparel
293884|NCT02381353|bupivacaine|bupivacaine
293885|NCT02381340|Obesity|obesity
293886|NCT02381340|Bariatric surgery|bariatric surgery
293887|NCT02381340|Gastric plication|gastric plication
293888|NCT02381340|Minimal invasive surgery|minimal invasive surgery
293889|NCT02381340|gastrointestinal hormones|gastrointestinal hormones
293890|NCT02381340|food-reward|food-reward
293891|NCT02381340|satiety|satiety
293892|NCT02381340|microbiota|microbiota
293893|NCT02381327|Speed of eating|speed of eating
293894|NCT02381327|body weight|body weight
293895|NCT02381327|food intake|food intake
293896|NCT02381314|Other B7-H3 expressing cancers|other b7-h3 expressing cancers
293897|NCT02381301|Biological Markers|biological markers
712547|NCT00579774|dietary AGEs|dietary ages
293898|NCT02381301|Multidetector Computed Tomography|multidetector computed tomography
293899|NCT02381288|Drug therapy|drug therapy
293900|NCT02381262|Fitbit|fitbit
293901|NCT02381249|Esophagectomy|esophagectomy
293902|NCT02381249|Gastrectomy|gastrectomy
293903|NCT02381249|Octreotide|octreotide
293904|NCT02381249|Somatostatin|somatostatin
293905|NCT02381249|Appetite|appetite
293906|NCT02381249|Hunger|hunger
293907|NCT02381249|Glucagon-Like Peptide 1|glucagon-like peptide 1
293908|NCT02381249|Peptide YY|peptide yy
293909|NCT02381249|Reinforcement|reinforcement
293910|NCT02381249|Reward|reward
293911|NCT02381249|Psychological Phenomena and Processes|psychological phenomena and processes
293912|NCT02381249|Gastrointestinal Agents|gastrointestinal agents
293913|NCT02381249|Nutritional Status|nutritional status
293914|NCT02381249|Pancreaticoduodenectomy|pancreaticoduodenectomy
293915|NCT02381249|Whipple Procedure|whipple procedure
293916|NCT02381210|Congo Red Dot Test|congo red dot test
293917|NCT02381197|Congo Red Dot Test|congo red dot test
293918|NCT02381171|myofacial pain|myofacial pain
293919|NCT02381171|neuromodulation|neuromodulation
293920|NCT02381171|repetitive transcranial magnetic stimulation|repetitive transcranial magnetic stimulation
293921|NCT02381171|electroacupuncture|electroacupuncture
293922|NCT02381158|Wheezing|wheezing
293923|NCT02381158|Children|children
293924|NCT02381145|Polyphenols|polyphenols
293925|NCT02381145|Resveratrol|resveratrol
293926|NCT02381145|Epigallocatechin-gallate|epigallocatechin-gallate
293927|NCT02381145|Insulin sensitivity|insulin sensitivity
293928|NCT02381145|mitochondrial function|mitochondrial function
293929|NCT02381145|lipid oxidation|lipid oxidation
293930|NCT02381145|tissue lipolysis|tissue lipolysis
293931|NCT02381119|dietary services|dietary services
293932|NCT02381119|personalized advice|personalized advice
293933|NCT02381119|biological markers|biological markers
293934|NCT02381106|arterial contractility|arterial contractility
293935|NCT02381106|Uterine contractility|uterine contractility
293936|NCT02381080|B-Cell Chronic Lymphocytic Leukemia|b-cell chronic lymphocytic leukemia
293937|NCT02381080|Chronic Lymphocytic Leukemia|chronic lymphocytic leukemia
293938|NCT02381080|Small Lymphocytic Lymphoma|small lymphocytic lymphoma
293939|NCT02381080|Marginal Zone Lymphoma|marginal zone lymphoma
293940|NCT02381080|Mantle Cell Lymphoma|mantle cell lymphoma
293941|NCT02381080|Follicular Lymphoma|follicular lymphoma
293942|NCT02381080|Waldenstrom's Macroglobulinemia|waldenstrom's macroglobulinemia
293943|NCT02381080|Ibrutinib|ibrutinib
293944|NCT02381080|IMBRUVICA|imbruvica
293945|NCT02381080|PCI-32765|pci-32765
293946|NCT02381080|JNJ-54179060|jnj-54179060
293947|NCT02381067|Cervical Fusion|cervical fusion
293948|NCT02381067|NuCel|nucel
293949|NCT02381067|Amniotic Allograft|amniotic allograft
293950|NCT02381067|Prospective|prospective
293951|NCT02381054|Patient reported outcomes|patient reported outcomes
293952|NCT02381041|Rhinoplasty|rhinoplasty
293953|NCT02381041|Topical Vasonconstrictor|topical vasonconstrictor
293954|NCT02381041|Cocaine|cocaine
293955|NCT02381041|Adrenaline|adrenaline
293956|NCT02381028|Atopic eczema|atopic eczema
293957|NCT02381028|Human milk|human milk
293958|NCT02381028|Topical treatment|topical treatment
293960|NCT02381015|Genetic testing|genetic testing
293961|NCT02381015|Genomic testing|genomic testing
293962|NCT02381015|Chemoprevention|chemoprevention
293963|NCT02381015|Prostate Specific Antigen|prostate specific antigen
293964|NCT02381015|Prostate Cancer|prostate cancer
293965|NCT02381015|Predictive Genetic Testing|predictive genetic testing
293966|NCT02381015|Genetic Counseling|genetic counseling
293967|NCT02381015|Prostate-Specific Antigen|prostate-specific antigen
293968|NCT02381002|Serum ferritin, physical exercise, Diet|serum ferritin, physical exercise, diet
293969|NCT02380989|Ayurveda|ayurveda
293970|NCT02380989|Acute pain|acute pain
293971|NCT02380989|Sports Injury|sports injury
293972|NCT02380963|Soy|soy
293973|NCT02380963|Obesity|obesity
293974|NCT02380963|Weight Loss|weight loss
293975|NCT02380963|Muscle|muscle
293976|NCT02380963|Cardiovascular Disease|cardiovascular disease
293977|NCT02380963|Colorado Diet|colorado diet
293978|NCT02380937|real-time MRI|real-time mri
293979|NCT02380937|electrophysiology study|electrophysiology study
293980|NCT02380937|atrial flutter|atrial flutter
293981|NCT02380937|ablation|ablation
293982|NCT02380937|active tracking|active tracking
293983|NCT02380924|subjects|subjects
293984|NCT02380911|Dyslipidemia|dyslipidemia
293985|NCT02380911|Global cardiovascular risk|global cardiovascular risk
293986|NCT02380911|Statins|statins
293987|NCT02380911|Educational interventions|educational interventions
293988|NCT02380885|severe mental illness|severe mental illness
293989|NCT02380885|social cognition|social cognition
293990|NCT02380885|intervention|intervention
293991|NCT02380872|Gingival recession|gingival recession
293992|NCT02380872|fibrin|fibrin
293993|NCT02380872|connective tissue|connective tissue
293994|NCT02380872|gingival crevicular fluid|gingival crevicular fluid
293995|NCT02380872|matrix metalloproteinase|matrix metalloproteinase
293996|NCT02380872|cytokine|cytokine
293997|NCT02380859|problems of gait and balance|problems of gait and balance
293998|NCT02380820|Mattress|mattress
293999|NCT02380820|Preventing bed sores|preventing bed sores
294000|NCT02380820|Skin pressure|skin pressure
294001|NCT02380807|Paraspinal Muscles|paraspinal muscles
294002|NCT02380807|Trigger Points|trigger points
294003|NCT02380807|Randomized Controlled Trial|randomized controlled trial
294004|NCT02380807|Mobility Limitation|mobility limitation
294005|NCT02380794|Danshen Gegen Capsule|danshen gegen capsule
294006|NCT02380768|Supraglottic airway|supraglottic airway
294007|NCT02380768|Laryngeal mask airway|laryngeal mask airway
294008|NCT02380768|Children|children
294009|NCT02380755|Flow-mediated dilatation|flow-mediated dilatation
294010|NCT02380755|Clomiphene citrate|clomiphene citrate
294011|NCT02380755|sICAM-1|sicam-1
294012|NCT02380755|sVCAM-1|svcam-1
294013|NCT02380755|sE- Selectin|se- selectin
294014|NCT02380755|Endothelial function|endothelial function
294015|NCT02380755|Cardiovascular risk|cardiovascular risk
294016|NCT02380755|Endocrine System Diseases|endocrine system diseases
294017|NCT02380755|Selective Estrogen Receptor Modulators|selective estrogen receptor modulators
294018|NCT02380755|Estrogen Receptor Modulators|estrogen receptor modulators
294019|NCT02380755|Infertility, Male|infertility, male
294020|NCT02380755|Endothelial Progenitor Cells|endothelial progenitor cells
294021|NCT02380755|Obesity|obesity
294022|NCT02380755|Testosterone|testosterone
294023|NCT02380742|Pessary|pessary
294024|NCT02380742|Pain|pain
294025|NCT02380742|EMLA|emla
294026|NCT02380742|lidocaine|lidocaine
294027|NCT02380742|prilocaine|prilocaine
294028|NCT02380729|Health care delivery|health care delivery
294029|NCT02380729|Human Phenotype Ontology|human phenotype ontology
294030|NCT02380729|Mutation prioritization|mutation prioritization
294031|NCT02380729|Next Generation Sequencing|next generation sequencing
294032|NCT02380729|Mutation detection|mutation detection
294033|NCT02380729|Bioinformatic analysis|bioinformatic analysis
294034|NCT02380729|Quality of life|quality of life
294035|NCT02380703|aggression|aggression
294036|NCT02380703|dementia|dementia
294037|NCT02380703|Alzheimer's disease|alzheimer's disease
294038|NCT02380703|pain|pain
294039|NCT02380703|depression|depression
294040|NCT02380703|caregiver|caregiver
294041|NCT02380703|behavioral health|behavioral health
294042|NCT02380703|counseling|counseling
294043|NCT02380690|self-management|self-management
294044|NCT02380690|peer support|peer support
294045|NCT02380690|social support|social support
294046|NCT02380664|swimmers|swimmers
294047|NCT02380664|adolescent swimmers|adolescent swimmers
294048|NCT02380664|whole-body vibration|whole-body vibration
294049|NCT02380664|bone and bones|bone and bones
294050|NCT02380664|body composition|body composition
294051|NCT02380625|Ebola|ebola
294052|NCT02380625|EVD|evd
294053|NCT02380625|Adaptive design|adaptive design
294054|NCT02380625|therapeutics|therapeutics
294055|NCT02380612|Second Degree Burn Injuries|second degree burn injuries
294056|NCT02380599|Spinal Manipulation|spinal manipulation
294057|NCT02380599|Mobilization|mobilization
294058|NCT02380599|Autonomic Nervous System|autonomic nervous system
294059|NCT02380573|methylene blue|methylene blue
294060|NCT02380573|fMRI|fmri
294061|NCT02380560|myometrial thickness|myometrial thickness
294062|NCT02380560|Preterm premature rupture of membranes|preterm premature rupture of membranes
294063|NCT02380560|Preterm Labour|preterm labour
294064|NCT02380547|Sonography|sonography
294065|NCT02380547|Diaphragmatic function|diaphragmatic function
294066|NCT02380547|Non invasive ventilation|non invasive ventilation
294067|NCT02380547|Critical care patients|critical care patients
294068|NCT02380547|Extubation after 24 hours of invasive ventilation|extubation after 24 hours of invasive ventilation
294069|NCT02380534|High level of Lp(a)|high level of lp(a)
294070|NCT02380521|Exenatide once weekly|exenatide once weekly
294071|NCT02380521|T2DM|t2dm
294072|NCT02380521|IMT|imt
294073|NCT02380521|Atherogenic lipoproteins|atherogenic lipoproteins
294074|NCT02380508|BCG study|bcg study
294075|NCT02380495|Adolescents|adolescents
294076|NCT02380495|Respiratory Pathology|respiratory pathology
294077|NCT02380482|Traumatic brain injury|traumatic brain injury
294078|NCT02380482|Myocardial dysfunction|myocardial dysfunction
294079|NCT02380482|Transthoracic echocardiography|transthoracic echocardiography
294080|NCT02380482|Speckle tracking|speckle tracking
294081|NCT02380469|Caregivers|caregivers
294082|NCT02380469|Cancer|cancer
294083|NCT02380469|Information|information
294084|NCT02380469|Intervention|intervention
294085|NCT02380469|Randomised trial|randomised trial
294086|NCT02380443|colorectal cancer|colorectal cancer
294087|NCT02380443|KRAS mutant|kras mutant
294088|NCT02380443|BRAF mutant|braf mutant
294089|NCT02380443|metastatic|metastatic
294090|NCT02380443|liver metastasis|liver metastasis
294091|NCT02380443|AlloStim®|allostim®
294092|NCT02380443|cryoablation|cryoablation
294093|NCT02380443|cancer vaccine|cancer vaccine
294094|NCT02380443|immunotherapy|immunotherapy
294095|NCT02380430|Ambulatory surgery|ambulatory surgery
294096|NCT02380430|Pain management|pain management
294097|NCT02380430|Nausea and vomiting management|nausea and vomiting management
294098|NCT02380430|Questionnaire|questionnaire
294099|NCT02380430|Survey|survey
294100|NCT02380430|Management|management
294101|NCT02380404|Edentulous maxilla|edentulous maxilla
294102|NCT02380391|Platelet reactivity|platelet reactivity
294103|NCT02380391|Acute coronary syndrome|acute coronary syndrome
294104|NCT02380391|Antiplatelet treatment|antiplatelet treatment
294105|NCT02380391|Antiretroviral treatment|antiretroviral treatment
294106|NCT02380391|HIV|hiv
294107|NCT02380365|lung transplantation|lung transplantation
294108|NCT02380365|electrocardiography|electrocardiography
294109|NCT02380365|macrolides|macrolides
294110|NCT02380365|QTc interval|qtc interval
294111|NCT02380365|arrhythmia|arrhythmia
294112|NCT02380352|antibiotic stewardship|antibiotic stewardship
294113|NCT02380352|non-inferiority|non-inferiority
294114|NCT02380352|randomized controlled trial|randomized controlled trial
294115|NCT02380313|Metastatic Castration-Resistant Prostate Cancer|metastatic castration-resistant prostate cancer
294116|NCT02380313|Enzalutamide|enzalutamide
294117|NCT02380313|Abiraterone|abiraterone
294118|NCT02380313|Dose-Finding|dose-finding
294119|NCT02380313|Afuresertib|afuresertib
294120|NCT02380287|interleukin-17|interleukin-17
294121|NCT02380287|maximum tolerated dose|maximum tolerated dose
294122|NCT02380287|novel monoclonal antibody|novel monoclonal antibody
294123|NCT02380274|Prostate Cancer|prostate cancer
294124|NCT02380274|Castration-resistant Prostate Cancer|castration-resistant prostate cancer
294125|NCT02380274|Metastatic Prostate Cancer|metastatic prostate cancer
294126|NCT02380222|Systemic mastocytosis|systemic mastocytosis
294127|NCT02380222|Patient-reported outcome (PRO)|patient-reported outcome (pro)
294128|NCT02380209|breast cancer|breast cancer
294129|NCT02380209|CEST MRI|cest mri
294130|NCT02380183|anesthesia|anesthesia
294131|NCT02380183|nerve block|nerve block
294132|NCT02380183|needle guidance|needle guidance
294133|NCT02380170|sepsis|sepsis
294134|NCT02380170|urinary tract infection|urinary tract infection
294135|NCT02380170|resistance|resistance
294136|NCT02380170|pathogens|pathogens
294137|NCT02380170|mortality|mortality
294138|NCT02380170|health economics|health economics
294139|NCT02380157|Blood pressure|blood pressure
294140|NCT02380157|Potassium, Dietary|potassium, dietary
294141|NCT02380157|Renin-angiotensin-aldosterone system|renin-angiotensin-aldosterone system
294142|NCT02380157|Sympathetic nervous system|sympathetic nervous system
294143|NCT02380144|carotenoid|carotenoid
294144|NCT02380144|bioavailability|bioavailability
294145|NCT02380144|beta-cryptoxanthin|beta-cryptoxanthin
294146|NCT02380144|flavonoid|flavonoid
294147|NCT02380144|hesperidin|hesperidin
294148|NCT02380144|narirutin|narirutin
294149|NCT02380144|randomized cross-over|randomized cross-over
294150|NCT02380144|Pharmacokinetics|pharmacokinetics
294151|NCT02380144|micronutrients|micronutrients
294152|NCT02380144|Oranges/Orange Juice|oranges/orange juice
294153|NCT02380131|XELOX|xelox
294154|NCT02380131|Herceptin|herceptin
294155|NCT02380131|Potentially Resectable Gastric Cancer|potentially resectable gastric cancer
294156|NCT02380118|emergency|emergency
294157|NCT02380118|emergency medicine|emergency medicine
294158|NCT02380118|sedation|sedation
294159|NCT02380118|acute agitation|acute agitation
294161|NCT02380092|Post-Market Surveillance|post-market surveillance
294162|NCT02380092|Legion|legion
294163|NCT02380092|Verilast|verilast
294164|NCT02380092|Degenerative Joint Disease|degenerative joint disease
294165|NCT02380079|Homozygous Sickle Cell Disease S/Beta 0 Thalassemia|homozygous sickle cell disease s/beta 0 thalassemia
294166|NCT02380053|Beta-blocker|beta-blocker
294167|NCT02380053|Cardiopulmonary exercise testing|cardiopulmonary exercise testing
294168|NCT02380027|Prostate biopsy|prostate biopsy
294169|NCT02380027|MRI|mri
294170|NCT02380027|transrectal|transrectal
294171|NCT02380027|Detection|detection
294172|NCT02380001|Postoperative pain|postoperative pain
294173|NCT02380001|Dexketoprofen trometamol|dexketoprofen trometamol
294174|NCT02380001|third molar surgery|third molar surgery
294175|NCT02379962|biobanking|biobanking
294176|NCT02379962|research participation|research participation
294177|NCT02379962|China|china
294178|NCT02379949|virtual reality exposure therapy|virtual reality exposure therapy
294179|NCT02379949|social phobia|social phobia
294180|NCT02379949|social anxiety disorder|social anxiety disorder
294181|NCT02379949|cognitive behavioral therapy|cognitive behavioral therapy
294182|NCT02379936|Classification|classification
294183|NCT02379936|HIE|hie
294184|NCT02379936|Infections|infections
294185|NCT02379936|Lactate dehydrogenase|lactate dehydrogenase
294186|NCT02379936|Intensive Care|intensive care
294187|NCT02379884|Mechanical ventilation|mechanical ventilation
294188|NCT02379884|Elderly|elderly
294189|NCT02379884|Mortality|mortality
294190|NCT02379884|Health services|health services
294191|NCT02379871|Thoracic Spinal Manipulation, Autonomic Nervous System|thoracic spinal manipulation, autonomic nervous system
294192|NCT02379858|GI Tract Recovery|gi tract recovery
294193|NCT02379858|Hospital Discharge|hospital discharge
294194|NCT02379832|preeclampsia|preeclampsia
294195|NCT02379832|preterm birth|preterm birth
294196|NCT02379832|pregnancy|pregnancy
294197|NCT02379832|placenta|placenta
294198|NCT02379832|intra-uterine growth restriction|intra-uterine growth restriction
294199|NCT02379832|fetal growth restriction|fetal growth restriction
294200|NCT02379832|ultrasound|ultrasound
294201|NCT02379832|doppler|doppler
294202|NCT02379832|biomarkers|biomarkers
294203|NCT02379832|serum|serum
294204|NCT02379832|PAPP-A|papp-a
294205|NCT02379832|PlGF|plgf
294206|NCT02379832|sFlt-1|sflt-1
294207|NCT02379832|endoglin|endoglin
294208|NCT02379793|LEO 80185 gel|leo 80185 gel
294209|NCT02379793|calcipotriol|calcipotriol
294210|NCT02379793|betamethasone|betamethasone
294211|NCT02379754|vestibular schwannoma|vestibular schwannoma
294212|NCT02379754|acoustic neuroma|acoustic neuroma
294213|NCT02379754|cerebellopontine angle tumour|cerebellopontine angle tumour
294214|NCT02379754|gentamicin|gentamicin
294215|NCT02379754|rehabilitation|rehabilitation
294216|NCT02379754|postural balance|postural balance
294217|NCT02379741|Antibodies|antibodies
294218|NCT02379741|Antibodies, Monoclonal|antibodies, monoclonal
294219|NCT02379741|Antineoplastic agent|antineoplastic agent
294220|NCT02379741|Physiological effects of drugs|physiological effects of drugs
294221|NCT02379741|Therapeutic uses|therapeutic uses
294222|NCT02379741|Clinical Trial, Phase I|clinical trial, phase i
294223|NCT02379741|Immunotherapy, Active|immunotherapy, active
294224|NCT02379741|CD40 Antigen|cd40 antigen
294225|NCT02379741|Immunologic Factors|immunologic factors
294226|NCT02379741|Injections, Intralesional|injections, intralesional
294227|NCT02379728|positional therapy|positional therapy
294228|NCT02379728|tennis ball technique|tennis ball technique
294229|NCT02379728|sleep pregnancy|sleep pregnancy
294230|NCT02379728|supine position|supine position
294231|NCT02379728|supine|supine
294232|NCT02379728|sleep position|sleep position
294233|NCT02379728|low birth weight|low birth weight
294234|NCT02379728|stillbirth|stillbirth
294235|NCT02379728|intrauterine growth restriction|intrauterine growth restriction
294236|NCT02379715|Remifentanil|remifentanil
294237|NCT02379715|smooth induction|smooth induction
294238|NCT02379715|desflurane|desflurane
294239|NCT02379689|psychosocial state|psychosocial state
294240|NCT02379637|N-acetylcysteine|n-acetylcysteine
294241|NCT02379637|adults|adults
294242|NCT02379637|cough and cold|cough and cold
294243|NCT02379572|5-ALA|5-ala
294244|NCT02379572|Intraoperative MRI|intraoperative mri
294245|NCT02379572|Extent of resection|extent of resection
294246|NCT02379559|prostate cancer|prostate cancer
294247|NCT02379559|African-American|african-american
294248|NCT02379559|Metabolic Syndrome|metabolic syndrome
294249|NCT02379559|Exercise|exercise
294250|NCT02379559|Men's Health|men's health
294251|NCT02379546|reflex, oculocardiac|reflex, oculocardiac
294252|NCT02379546|monitoring, intraoperative|monitoring, intraoperative
294253|NCT02379520|recurrent cancer|recurrent cancer
294254|NCT02379520|refractory cancer|refractory cancer
294255|NCT02379520|virus specific T-cells|virus specific t-cells
294256|NCT02379520|gene therapy|gene therapy
294257|NCT02379520|HPV|hpv
294258|NCT02379507|mild to moderate|mild to moderate
294259|NCT02379468|Diabetic|diabetic
294260|NCT02379468|Foot|foot
294261|NCT02379468|Ulcer|ulcer
294262|NCT02379455|Polypharmacy|polypharmacy
294263|NCT02379455|Geriatrics|geriatrics
294264|NCT02379455|Elderly|elderly
294265|NCT02379455|Drug review|drug review
294266|NCT02379442|Graft-Versus-Host Disease|graft-versus-host disease
294267|NCT02379442|Corticosteroids|corticosteroids
294268|NCT02379442|Mesenchymal Stromal Cell|mesenchymal stromal cell
294269|NCT02379442|Adoptive Cellular Therapy|adoptive cellular therapy
294270|NCT02379429|Specimen Collection|specimen collection
294271|NCT02379429|Urine|urine
294272|NCT02379429|Blood|blood
294273|NCT02379429|Saliva|saliva
294274|NCT02379416|Drug Efflux|drug efflux
294275|NCT02379416|Taxanes|taxanes
294276|NCT02379416|Combination|combination
294277|NCT02379416|Bcr-Abl Kinase Inhibitors|bcr-abl kinase inhibitors
294278|NCT02379416|Neoplasms|neoplasms
294279|NCT02379403|Flavonoid|flavonoid
294280|NCT02379403|Vascular|vascular
294281|NCT02379403|Biomarkers|biomarkers
294282|NCT02379403|Arterial Stiffness|arterial stiffness
294283|NCT02379403|Nutrigenomics|nutrigenomics
294284|NCT02379364|Physiotherapy|physiotherapy
294285|NCT02379364|Patellofemoral Pain Syndrome|patellofemoral pain syndrome
294286|NCT02379364|Manual therapy|manual therapy
294287|NCT02379351|Non-stress Test|non-stress test
294288|NCT02379351|Fetal Monitoring|fetal monitoring
294289|NCT02379351|Telemedicine|telemedicine
294290|NCT02379338|Dopamine D3 receptor|dopamine d3 receptor
294291|NCT02379312|Foams|foams
294292|NCT02379312|Satiety|satiety
294293|NCT02379312|Appetite|appetite
294294|NCT02379247|HER-2 Negative|her-2 negative
294295|NCT02379247|Metastatic Breast Cancer|metastatic breast cancer
294296|NCT02379234|CVVH|cvvh
756395|NCT00417365|douching|douching
294297|NCT02379234|Renal replacement therapy|renal replacement therapy
294298|NCT02379234|High fidelity simulation|high fidelity simulation
294299|NCT02379234|Nurse training|nurse training
294300|NCT02379208|Visual Field Tests|visual field tests
294301|NCT02379208|Ocular Hypertension|ocular hypertension
294302|NCT02379208|Glaucoma, Open-Angle|glaucoma, open-angle
294303|NCT02379208|Quality of Life|quality of life
294304|NCT02379208|Glaucoma progression|glaucoma progression
294305|NCT02379208|Early glaucoma|early glaucoma
294306|NCT02379208|Frequency Doubling Technology (FDT)|frequency doubling technology (fdt)
294307|NCT02379208|RareBit|rarebit
294308|NCT02379208|Octopus 900 perimetry|octopus 900 perimetry
294309|NCT02379182|dysphagia|dysphagia
294310|NCT02379182|VitalStim|vitalstim
294311|NCT02379182|electrical stimulation|electrical stimulation
294312|NCT02379169|macular pigment optical density, age related macular degeneration, dry eye, vision|macular pigment optical density, age related macular degeneration, dry eye, vision
294313|NCT02379156|Quadriplegia|quadriplegia
294314|NCT02379156|Spinal Cord Injury|spinal cord injury
294315|NCT02379156|Body Temperature Regulation|body temperature regulation
294443|NCT02378467|Inhaled Saline|inhaled saline
294316|NCT02379156|Mild Cognitive Impairment|mild cognitive impairment
294317|NCT02379143|SWD, EPA, SAFE PRACTICE|swd, epa, safe practice
294318|NCT02379130|Premature|premature
294319|NCT02379130|Family Nurture Intervention|family nurture intervention
294320|NCT02379091|Drug therapy|drug therapy
294321|NCT02379078|Shared decision-making|shared decision-making
294322|NCT02379078|Priority setting|priority setting
294323|NCT02379078|Patient decision aid|patient decision aid
294324|NCT02379078|Interprofessional care|interprofessional care
294325|NCT02379078|Diabetes mellitus|diabetes mellitus
294326|NCT02379078|Patient education|patient education
294327|NCT02379078|Medical informatics|medical informatics
294328|NCT02379078|Toolkit development|toolkit development
294329|NCT02379078|Study protocol|study protocol
294330|NCT02379078|User-centred design|user-centred design
294331|NCT02379078|Qualitative methods|qualitative methods
294332|NCT02379013|Fatigue|fatigue
294333|NCT02379013|functional MRI|functional mri
294334|NCT02378987|cerebral palsy|cerebral palsy
294335|NCT02378987|language|language
294336|NCT02378987|acoustic|acoustic
294337|NCT02378987|motor speech|motor speech
294338|NCT02378987|follow-up|follow-up
294339|NCT02378974|Cerebral Infarction|cerebral infarction
294340|NCT02378974|Mesenchymal Stem Cells|mesenchymal stem cells
294341|NCT02378974|Stroke|stroke
294342|NCT02378948|Esophagectomy|esophagectomy
294343|NCT02378948|Nutrition|nutrition
294344|NCT02378948|Oral feeding|oral feeding
294345|NCT02378948|Enteral feeding|enteral feeding
294346|NCT02378948|Pulmonary complications|pulmonary complications
294347|NCT02378948|Anastomotic leakage|anastomotic leakage
294348|NCT02378948|Quality of life|quality of life
294349|NCT02378896|Cognitive Behavioral Therapy|cognitive behavioral therapy
294350|NCT02378883|Apollo|apollo
294351|NCT02378883|Onyx|onyx
294352|NCT02378883|Arteriovenous malformation|arteriovenous malformation
294353|NCT02378883|AVM|avm
294354|NCT02378883|Onyx™ Liquid Embolic System|onyx™ liquid embolic system
294355|NCT02378883|Apollo™ Onyx™ Delivery Microcatheter|apollo™ onyx™ delivery microcatheter
294356|NCT02378883|Brain Diseases|brain diseases
294357|NCT02378870|CRPC|crpc
294358|NCT02378857|Univentricular heart defect|univentricular heart defect
294359|NCT02378857|Fontan circulation|fontan circulation
294360|NCT02378831|diagnosing sleep|diagnosing sleep
294361|NCT02378818|Schizophrenia|schizophrenia
294362|NCT02378818|Negative symptoms|negative symptoms
294363|NCT02378818|Lack of motivation|lack of motivation
294364|NCT02378818|Cognitive characterization|cognitive characterization
294365|NCT02378818|Computational psychiatry|computational psychiatry
294366|NCT02378818|Depression|depression
294367|NCT02378805|Alport syndrome|alport syndrome
294368|NCT02378805|thin basement membrane disease|thin basement membrane disease
294369|NCT02378805|familial benign hematuria|familial benign hematuria
294370|NCT02378792|PINS VNS Refractory Epilepsy|pins vns refractory epilepsy
294371|NCT02378779|Premature ejaculation|premature ejaculation
294372|NCT02378779|general practice|general practice
294373|NCT02378779|sexual dysfunction|sexual dysfunction
294374|NCT02378766|tailored web-based intervention|tailored web-based intervention
294375|NCT02378766|health behavior|health behavior
294376|NCT02378766|hiv comorbidities|hiv comorbidities
294377|NCT02378766|online trial|online trial
294378|NCT02378753|Ebola|ebola
294379|NCT02378753|Sierra Leone|sierra leone
294380|NCT02378753|vaccine|vaccine
294381|NCT02378753|rVSVΔG-ZEBOV|rvsvδg-zebov
294382|NCT02378740|Anesthesia|anesthesia
294383|NCT02378740|Cervical Fusion|cervical fusion
294384|NCT02378740|Quality of Recovery|quality of recovery
294385|NCT02378740|Ketamine Infusion|ketamine infusion
294386|NCT02378714|Smoking Cessation|smoking cessation
294387|NCT02378714|Major Depressive Disorder|major depressive disorder
294388|NCT02378714|Nicotine Dependence|nicotine dependence
294389|NCT02378714|Varenicline|varenicline
294390|NCT02378714|Behavioral Activation Therapy|behavioral activation therapy
294391|NCT02378714|Cigarette Smoking|cigarette smoking
294392|NCT02378701|Leukemia|leukemia
294393|NCT02378701|Myelodysplastic syndrome|myelodysplastic syndrome
294394|NCT02378701|MDS|mds
294395|NCT02378701|Low- or intermediate-1-risk|low- or intermediate-1-risk
294396|NCT02378701|Chronic Myelomonocytic Leukemia -1|chronic myelomonocytic leukemia -1
294397|NCT02378701|CMML-1|cmml-1
294398|NCT02378701|Quality of Life in Myelodysplasia Scale|quality of life in myelodysplasia scale
294399|NCT02378701|QUALMS-1|qualms-1
294400|NCT02378701|Anemia Subset of FACT|anemia subset of fact
294401|NCT02378701|FACT-An|fact-an
294402|NCT02378701|Questionnaires|questionnaires
294403|NCT02378701|Surveys|surveys
294404|NCT02378688|Crohn's Disease|crohn's disease
294405|NCT02378675|Adipocytokines|adipocytokines
294406|NCT02378662|Peritoneal Dialysis|peritoneal dialysis
294407|NCT02378662|End Stage Renal Disease|end stage renal disease
294408|NCT02378662|Anemia|anemia
294409|NCT02378649|Pulmonary Hypertension|pulmonary hypertension
294410|NCT02378623|paradoxical embolism|paradoxical embolism
294411|NCT02378623|lead thrombus|lead thrombus
294412|NCT02378623|ICD|icd
294413|NCT02378623|Pacemaker|pacemaker
294414|NCT02378623|Cognitive decline|cognitive decline
294415|NCT02378623|Stroke|stroke
294416|NCT02378623|TIA|tia
294417|NCT02378597|Resiliency burnout stress|resiliency burnout stress
294418|NCT02378571|Medication adherence|medication adherence
294419|NCT02378571|Hospital readmissions|hospital readmissions
294420|NCT02378558|Breast Surgery|breast surgery
294421|NCT02378545|Sepsis|sepsis
294422|NCT02378545|Hyperoxia|hyperoxia
294423|NCT02378545|Sepsis Six|sepsis six
294424|NCT02378545|Oxygen delivery|oxygen delivery
294425|NCT02378532|Glioblastoma|glioblastoma
294426|NCT02378532|Chloroquine|chloroquine
294427|NCT02378532|Autophagy|autophagy
294428|NCT02378532|EGFRvIII|egfrviii
294429|NCT02378532|Radiotherapy|radiotherapy
294430|NCT02378532|Temozolomide|temozolomide
294431|NCT02378519|Low back pain,|low back pain,
294432|NCT02378519|neck pain,|neck pain,
294433|NCT02378519|chronic pain|chronic pain
294434|NCT02378519|SSED|ssed
294435|NCT02378519|Pilot project|pilot project
294436|NCT02378519|interactive web-based self-help programme|interactive web-based self-help programme
294437|NCT02378519|CBT-coaching|cbt-coaching
294438|NCT02378519|physiotherapy|physiotherapy
294439|NCT02378493|Antibiogramme|antibiogramme
294440|NCT02378493|Antibiofilmogramme|antibiofilmogramme
294441|NCT02378467|Cystic Fibrosis|cystic fibrosis
294442|NCT02378467|Hypertonic Saline|hypertonic saline
294444|NCT02378467|Digestive System Diseases|digestive system diseases
294445|NCT02378467|Genetic Diseases, Inborn|genetic diseases, inborn
294446|NCT02378467|Lung Diseases|lung diseases
294447|NCT02378467|Pancreatic Diseases|pancreatic diseases
294448|NCT02378467|Pathologic Processes|pathologic processes
294449|NCT02378467|Respiratory Tract Diseases|respiratory tract diseases
294450|NCT02378454|Lung Clearance Index|lung clearance index
294451|NCT02378454|Cystic Fibrosis|cystic fibrosis
294452|NCT02378454|Multiple Breath Nitrogen Washout|multiple breath nitrogen washout
294453|NCT02378441|volunteers|volunteers
294454|NCT02378428|Neuroblastoma|neuroblastoma
294455|NCT02378415|Depression|depression
294456|NCT02378402|Creatine|creatine
294457|NCT02378402|heart failure|heart failure
294458|NCT02378402|lipid|lipid
294460|NCT02378402|myocardium|myocardium
294461|NCT02378324|Attendance|attendance
294462|NCT02378324|Screening without fee|screening without fee
294463|NCT02378311|Bike|bike
294464|NCT02378311|Bicycle|bicycle
294465|NCT02378311|Scooter|scooter
294466|NCT02378311|Handlebar|handlebar
294467|NCT02378285|recent lateral humeral epicondylitis|recent lateral humeral epicondylitis
294468|NCT02378285|platelet-rich plasma|platelet-rich plasma
294469|NCT02378285|infiltration|infiltration
294470|NCT02378285|tennis elbow|tennis elbow
294471|NCT02378285|ultrasonography|ultrasonography
294472|NCT02378272|Care Manager|care manager
294473|NCT02378272|Primary Care|primary care
294474|NCT02378272|Depressive symptoms|depressive symptoms
294475|NCT02378272|quality of life|quality of life
294476|NCT02378272|return to work|return to work
294477|NCT02378246|Iodine|iodine
294478|NCT02378246|Double-Blind Method|double-blind method
294479|NCT02378246|Randomized Controlled Tria|randomized controlled tria
294480|NCT02378246|Cognitive Development|cognitive development
294481|NCT02378233|Iodine|iodine
294482|NCT02378233|Double-Blind Method|double-blind method
294483|NCT02378233|Randomized Controlled Trial|randomized controlled trial
294484|NCT02378220|Home Care Agencies|home care agencies
294485|NCT02378220|Home Health Care Agencies|home health care agencies
294486|NCT02378220|Home Health Care Nursing|home health care nursing
294487|NCT02378220|Home Health Nurses|home health nurses
294488|NCT02378220|CYP 2D6|cyp 2d6
294489|NCT02378220|CYP 2C9|cyp 2c9
294490|NCT02378220|CYP 2C19|cyp 2c19
294491|NCT02378220|CYP 3A4|cyp 3a4
294492|NCT02378220|CYP 3A5|cyp 3a5
294493|NCT02378194|in stage 3 or 4 steps|in stage 3 or 4 steps
294494|NCT02378168|postconditioning|postconditioning
294495|NCT02378168|six month follow up|six month follow up
294496|NCT02378168|cardiac event|cardiac event
294497|NCT02378168|non-cardiac event|non-cardiac event
294498|NCT02378155|cardioversion|cardioversion
294499|NCT02378155|atrial fibrillation|atrial fibrillation
294500|NCT02378129|Dentin Sensitivity|dentin sensitivity
294501|NCT02378129|Dentin Desensitizing Agents|dentin desensitizing agents
294502|NCT02378129|Glass Ionomer Cements|glass ionomer cements
294503|NCT02378129|Randomized Controlled Trial|randomized controlled trial
294504|NCT02378103|Aortic Dissection|aortic dissection
294505|NCT02378103|Chinese XinJiang Province|chinese xinjiang province
294506|NCT02378077|Obesity|obesity
294507|NCT02378077|Insulin Resistance|insulin resistance
294508|NCT02378064|Fluorodeoxyglucose F18|fluorodeoxyglucose f18
294509|NCT02378064|Positron-Emission Tomography and Computed Tomography|positron-emission tomography and computed tomography
294510|NCT02378064|Plaque, Atherosclerotic|plaque, atherosclerotic
294511|NCT02378064|Renin-Angiotensin System|renin-angiotensin system
294512|NCT02378038|PNT2258|pnt2258
294513|NCT02378038|Richter's Transformation|richter's transformation
294514|NCT02378038|NHL|nhl
294515|NCT02378038|Non-Hodgkin's Lymphoma|non-hodgkin's lymphoma
294516|NCT02378038|Lymphoma|lymphoma
294517|NCT02378038|DLBCL|dlbcl
294518|NCT02378038|Diffuse Large B-cell Lymphoma|diffuse large b-cell lymphoma
294519|NCT02378038|Lymphoma, Large B-cell, Diffuse|lymphoma, large b-cell, diffuse
294520|NCT02378038|Lymphoma, Non-Hodgkin|lymphoma, non-hodgkin
294521|NCT02378038|Lymphoma, B-cell|lymphoma, b-cell
294522|NCT02378025|Chronic Pain|chronic pain
294523|NCT02378025|Veterans|veterans
294524|NCT02378025|Gulf War Illness|gulf war illness
294525|NCT02377973|growth,|growth,
294526|NCT02377973|infancy,|infancy,
294527|NCT02377973|children,|children,
294528|NCT02377973|diet,|diet,
294529|NCT02377973|breastfeeding|breastfeeding
294530|NCT02377973|complementary feeding|complementary feeding
294531|NCT02377973|early life programming|early life programming
294532|NCT02377973|tracking|tracking
294533|NCT02377973|physical activity|physical activity
294534|NCT02377960|SMS|sms
294535|NCT02377960|text message|text message
294536|NCT02377960|mHealth|mhealth
294537|NCT02377960|IMB|imb
294538|NCT02377947|Lactulose Retention Enema|lactulose retention enema
294539|NCT02377947|Hepatic Encephalopathy, Grade 3 or 4 West Haven Criteria|hepatic encephalopathy, grade 3 or 4 west haven criteria
294540|NCT02377947|The Retro Study|the retro study
294541|NCT02377934|Pulmonary Hypertension|pulmonary hypertension
294542|NCT02377934|Cardiac MRT|cardiac mrt
294543|NCT02377934|Radiotherapy|radiotherapy
294544|NCT02377921|GNE Myopathy|gne myopathy
294545|NCT02377921|GNEM|gnem
294546|NCT02377921|HIBM|hibm
294547|NCT02377921|Nonaka|nonaka
294548|NCT02377921|Hereditary Inclusion Body Myopathy|hereditary inclusion body myopathy
294549|NCT02377921|DMRV|dmrv
294550|NCT02377882|Intra-operative neuromonitoring|intra-operative neuromonitoring
294551|NCT02377882|Neuromuscular blocking agent|neuromuscular blocking agent
294552|NCT02377882|Rocuronium|rocuronium
294553|NCT02377882|Thyroid surgery|thyroid surgery
294554|NCT02377856|acute hepatitis C|acute hepatitis c
294555|NCT02377856|treatment|treatment
294556|NCT02377856|SVR|svr
294557|NCT02377843|vaccine|vaccine
294558|NCT02377843|physician training|physician training
294559|NCT02377843|adolescent health|adolescent health
294560|NCT02377817|positional therapy|positional therapy
294561|NCT02377817|tennis ball technique|tennis ball technique
294562|NCT02377817|sleep in pregnancy|sleep in pregnancy
294563|NCT02377817|supine|supine
294564|NCT02377817|polysomnography|polysomnography
294565|NCT02377817|sleep position|sleep position
294566|NCT02377817|supine position|supine position
294567|NCT02377804|dry needling|dry needling
294568|NCT02377804|spasticity|spasticity
294569|NCT02377804|pain|pain
294570|NCT02377791|tacrolimus|tacrolimus
294571|NCT02377791|Cytochrome P-450 CYP3A|cytochrome p-450 cyp3a
294572|NCT02377791|Kidney transplant|kidney transplant
294573|NCT02377791|FK506|fk506
294574|NCT02377791|Prograf|prograf
294575|NCT02377791|Rejection|rejection
294576|NCT02377791|Gene Polymorphism|gene polymorphism
294577|NCT02377765|Neuromodulation|neuromodulation
294578|NCT02377765|Detrusor overactivity|detrusor overactivity
294579|NCT02377765|Urinary urgency|urinary urgency
294580|NCT02377765|Urgency urinary incontinence|urgency urinary incontinence
294581|NCT02377726|Randomized Controlled Trial|randomized controlled trial
294582|NCT02377726|Alcohol|alcohol
294583|NCT02377726|Internet|internet
294584|NCT02377726|Internet based therapy|internet based therapy
294585|NCT02377726|Cognitive behavioral therapy|cognitive behavioral therapy
294586|NCT02377713|KHK6640|khk6640
294587|NCT02377713|Phase 1|phase 1
294588|NCT02377713|Japanese|japanese
294589|NCT02377713|single dose|single dose
294590|NCT02377713|Alzheimer's disease|alzheimer's disease
294591|NCT02377687|Emergency surgery|emergency surgery
294592|NCT02377687|HRQoL|hrqol
294593|NCT02377687|Elderly|elderly
294594|NCT02377648|Cardiac Allograft Vasculopathy|cardiac allograft vasculopathy
294595|NCT02377648|Heart Transplant|heart transplant
294596|NCT02377648|Bioresorbable Vascular Scaffold|bioresorbable vascular scaffold
294597|NCT02377635|Arsenic|arsenic
294598|NCT02377635|Arsenicosis|arsenicosis
294599|NCT02377609|Dry Blood Spot (DBS)|dry blood spot (dbs)
294600|NCT02377609|Validation|validation
294601|NCT02377609|Tacrolimus|tacrolimus
294602|NCT02377609|Bioanalytical assay method cross-validation|bioanalytical assay method cross-validation
294603|NCT02377596|Feeding|feeding
294604|NCT02377596|difficulties|difficulties
294605|NCT02377596|disorders|disorders
294606|NCT02377596|childhood|childhood
294607|NCT02377596|eating|eating
294608|NCT02377557|Dermatologic Agent|dermatologic agent
294609|NCT02377531|early glucose screen, perinatal outcome|early glucose screen, perinatal outcome
294610|NCT02377505|Treatment-Resistant Schizophrenia|treatment-resistant schizophrenia
294611|NCT02377505|Deep Brain Stimulation|deep brain stimulation
294612|NCT02377466|Spontaneous Preterm Labor|spontaneous preterm labor
294613|NCT02377466|GSK221149|gsk221149
294614|NCT02377466|Retosiban|retosiban
294615|NCT02377453|stroke|stroke
294616|NCT02377453|participation|participation
294617|NCT02377453|brain imaging|brain imaging
294618|NCT02377453|biomechanical|biomechanical
294619|NCT02377440|ACE inhibitor|ace inhibitor
294620|NCT02377427|pharmacokinetics|pharmacokinetics
294621|NCT02377427|pediatric|pediatric
294622|NCT02377427|Mepolizumab|mepolizumab
294623|NCT02377427|subcutaneous|subcutaneous
294624|NCT02377427|eosinophilic asthma|eosinophilic asthma
294625|NCT02377427|pharmacodynamics|pharmacodynamics
294626|NCT02377414|Preterm labor|preterm labor
294627|NCT02377414|Retosiban|retosiban
294628|NCT02377414|Pharmacokinetics|pharmacokinetics
294629|NCT02377414|Safety|safety
294630|NCT02377414|Infusion|infusion
294631|NCT02377414|GSK2847065|gsk2847065
294632|NCT02377401|healthy volunteer|healthy volunteer
294633|NCT02377401|Zanamivir|zanamivir
294634|NCT02377401|pharmacokinetics|pharmacokinetics
294635|NCT02377401|intravenous|intravenous
294636|NCT02377388|diabetes mellitus|diabetes mellitus
294637|NCT02377388|platelet function testing|platelet function testing
294638|NCT02377388|acute coronary syndromes|acute coronary syndromes
294639|NCT02377388|saxagliptin|saxagliptin
294640|NCT02377388|sitagliptin|sitagliptin
294641|NCT02377388|dpp-4 inhibitors|dpp-4 inhibitors
294642|NCT02377375|Deep Brain Stimulation|deep brain stimulation
294643|NCT02377375|OCD|ocd
294644|NCT02377336|GS-6615|gs-6615
294645|NCT02377336|coronary heart disease|coronary heart disease
294646|NCT02377336|angina pectoris|angina pectoris
294647|NCT02377336|late sodium current|late sodium current
294648|NCT02377336|myocardial ischemia|myocardial ischemia
294649|NCT02377336|coronary artery disease|coronary artery disease
294650|NCT02377336|chronic stable angina|chronic stable angina
294651|NCT02377323|Multiple Sclerosis|multiple sclerosis
294652|NCT02377323|Patient-reported outcomes|patient-reported outcomes
294653|NCT02377323|Employment status|employment status
294654|NCT02377323|Quality of Life|quality of life
294655|NCT02377323|Cognition|cognition
294656|NCT02377323|Rebif|rebif
294657|NCT02377297|dental atraumatic restorative treatment|dental atraumatic restorative treatment
294658|NCT02377297|primary tooth|primary tooth
294659|NCT02377297|occlusal restoration|occlusal restoration
294660|NCT02377297|glass-ionomer cement|glass-ionomer cement
294661|NCT02377271|Bosentan|bosentan
294662|NCT02377258|Lymphoma|lymphoma
294663|NCT02377258|safety|safety
294664|NCT02377258|biologic therapies|biologic therapies
294665|NCT02377245|Juvenile|juvenile
294666|NCT02377245|Inflammatory|inflammatory
294667|NCT02377245|Rheumatism|rheumatism
294860|NCT02376335|Fatigue|fatigue
294668|NCT02377245|Pediatric-Onset inflammatory diseases|pediatric-onset inflammatory diseases
294670|NCT02377206|[18F]DPA-714|[18f]dpa-714
294671|NCT02377206|cognitive decline|cognitive decline
294672|NCT02377193|kidney transplant|kidney transplant
294673|NCT02377193|luminex method|luminex method
294674|NCT02377193|simulect ATG|simulect atg
294675|NCT02377193|immunosuppression|immunosuppression
294676|NCT02377180|musculoskeletal pain|musculoskeletal pain
294677|NCT02377180|regional anesthesia|regional anesthesia
294678|NCT02377180|diagnostic nerve block|diagnostic nerve block
294679|NCT02377180|intramuscular capsaicin|intramuscular capsaicin
294680|NCT02377180|referred pain|referred pain
294681|NCT02377180|hyperalgesia|hyperalgesia
294682|NCT02377180|experimental pain|experimental pain
294683|NCT02377180|central hypersensitivity|central hypersensitivity
294684|NCT02377180|human experimental pain|human experimental pain
294685|NCT02377154|keratometry|keratometry
294686|NCT02377154|verion|verion
294687|NCT02377154|iol|iol
294688|NCT02377154|intraocular lens|intraocular lens
294689|NCT02377154|iolmaster|iolmaster
294690|NCT02377154|lenstar|lenstar
294691|NCT02377154|pentacam|pentacam
294692|NCT02377154|IOL calculation|iol calculation
294693|NCT02377154|VERION Image Guided System|verion image guided system
294694|NCT02377141|Oesophageal Variceal Bleed|oesophageal variceal bleed
294695|NCT02377141|TIPSS|tipss
294696|NCT02377141|Endoscopic Variceal Band Ligation|endoscopic variceal band ligation
294697|NCT02377141|Decompensated Liver Disease|decompensated liver disease
294698|NCT02377128|Study|study
294699|NCT02377128|focus|focus
294700|NCT02377128|ovarian|ovarian
294701|NCT02377128|reserve|reserve
294702|NCT02377115|Postoperative delirium|postoperative delirium
294703|NCT02377115|Postoperative cognitive decline|postoperative cognitive decline
294704|NCT02377115|Postoperative cognitive dysfunction|postoperative cognitive dysfunction
294705|NCT02377115|Risk assessment|risk assessment
294706|NCT02377115|Tablet computer|tablet computer
294707|NCT02377115|Clinical screening tool|clinical screening tool
294708|NCT02377089|Trigeminal Nerve Stimulation|trigeminal nerve stimulation
294709|NCT02377089|Post-Traumatic Stress Disorder|post-traumatic stress disorder
294710|NCT02377063|colonic flora|colonic flora
294711|NCT02377063|microbiomes|microbiomes
294712|NCT02377050|Nutritional support|nutritional support
294713|NCT02377037|Sitting|sitting
294714|NCT02377037|Standing|standing
294715|NCT02377037|Transitions|transitions
294716|NCT02376998|Thoracic Aorta|thoracic aorta
294717|NCT02376998|Trauma|trauma
294718|NCT02376998|Endovascular|endovascular
294719|NCT02376959|Anxiety|anxiety
294720|NCT02376959|Complementary Therapies|complementary therapies
294721|NCT02376959|energy therapies|energy therapies
294722|NCT02376933|vertebral bodies|vertebral bodies
294723|NCT02376933|vertebral fracture|vertebral fracture
294724|NCT02376933|vertebral augmentation|vertebral augmentation
294725|NCT02376933|radiotherapy|radiotherapy
294726|NCT02376933|vertebroplasty|vertebroplasty
294727|NCT02376933|kyphoplasty|kyphoplasty
294728|NCT02376920|occular melanoma|occular melanoma
294729|NCT02376920|melanoma of eye|melanoma of eye
294730|NCT02376920|DecisionDx-UM|decisiondx-um
294731|NCT02376907|distal malignant biliary obstruction|distal malignant biliary obstruction
294732|NCT02376907|endoscopic retrograde cholangiopancreatography|endoscopic retrograde cholangiopancreatography
294733|NCT02376907|endoscopic ultrasound|endoscopic ultrasound
294734|NCT02376907|gastric outlet obstruction|gastric outlet obstruction
294735|NCT02376907|stent|stent
294736|NCT02376881|Erythropoietin -Methanol - Optic Neuropathy|erythropoietin -methanol - optic neuropathy
294737|NCT02376855|Health Services Accessibility|health services accessibility
294738|NCT02376842|severe sepsis infection|severe sepsis infection
294739|NCT02376829|Orthodontic|orthodontic
294740|NCT02376829|Orthodontic Treatment|orthodontic treatment
294741|NCT02376829|Clear Aligners|clear aligners
294742|NCT02376829|Malocclusion|malocclusion
294743|NCT02376816|DMD|dmd
294744|NCT02376816|muscular dystrophy|muscular dystrophy
294745|NCT02376816|dystrophin|dystrophin
294746|NCT02376803|Randomized controlled trial|randomized controlled trial
294747|NCT02376803|Warfarin|warfarin
294748|NCT02376803|Time in therapeutic range|time in therapeutic range
294749|NCT02376803|Bleeding|bleeding
294750|NCT02376803|Thromboembolic|thromboembolic
294751|NCT02376803|Hemorrhage|hemorrhage
294752|NCT02376803|Anticoagulant|anticoagulant
294753|NCT02376803|TTR|ttr
294754|NCT02376803|Chronobiology|chronobiology
294755|NCT02376803|Chronotherapeutic|chronotherapeutic
294756|NCT02376803|Coumadin|coumadin
294757|NCT02376803|INR|inr
294758|NCT02376803|International normalized ratio|international normalized ratio
294759|NCT02376803|RCT|rct
294760|NCT02376790|Psoriatic Arthritis|psoriatic arthritis
294761|NCT02376790|Arthritis, Psoriasis|arthritis, psoriasis
294762|NCT02376790|Etanercept|etanercept
294763|NCT02376790|Enbrel|enbrel
294764|NCT02376790|Methotrexate|methotrexate
294765|NCT02376790|Minimal Disease Activity|minimal disease activity
294766|NCT02376777|Anticoagulants|anticoagulants
294767|NCT02376777|Antithrombins|antithrombins
294768|NCT02376777|Atrial Fibrillation|atrial fibrillation
294769|NCT02376777|Intracranial haemorrhage|intracranial haemorrhage
294770|NCT02376777|Gastrointestinal haemorrhage|gastrointestinal haemorrhage
294771|NCT02376777|Myocardial infarction|myocardial infarction
294772|NCT02376777|Stroke|stroke
294773|NCT02376777|Venous thrombosis|venous thrombosis
294774|NCT02376777|Primary care|primary care
294775|NCT02376751|Cholesteryl Ester Storage Disease|cholesteryl ester storage disease
294776|NCT02376751|Acid lipase disease|acid lipase disease
294777|NCT02376751|Cholesterol ester hydrolase deficiency|cholesterol ester hydrolase deficiency
294778|NCT02376751|LIPA Deficiency|lipa deficiency
294779|NCT02376751|Wolman disease|wolman disease
294780|NCT02376751|Lysosomal Storage Disease|lysosomal storage disease
294781|NCT02376725|Goniosynechialysis|goniosynechialysis
294782|NCT02376712|Acute Kidney Injury|acute kidney injury
294783|NCT02376712|Differential diagnosis|differential diagnosis
294784|NCT02376712|Urinary indices|urinary indices
294785|NCT02376712|Renal Blood Flow|renal blood flow
294786|NCT02376712|Transesophageal Echocardiography|transesophageal echocardiography
294787|NCT02376699|CD40 Antigen|cd40 antigen
294788|NCT02376699|Drug Therapy|drug therapy
294789|NCT02376699|Follicular Lymphoma|follicular lymphoma
294790|NCT02376699|Hodgkin Disease|hodgkin disease
294791|NCT02376699|Immunotherapy|immunotherapy
756396|NCT00417365|BV|bv
294792|NCT02376699|Indolent Lymphoma|indolent lymphoma
294793|NCT02376699|Lymphoma|lymphoma
294794|NCT02376699|Lymphoma, B-Cell|lymphoma, b-cell
294795|NCT02376699|Lymphoma, Large B-Cell, Diffuse|lymphoma, large b-cell, diffuse
294796|NCT02376699|Lymphoma, Non-Hodgkin|lymphoma, non-hodgkin
294797|NCT02376699|Monoclonal Antibody|monoclonal antibody
294798|NCT02376699|Neoplasms|neoplasms
294799|NCT02376699|Neoplasm Metastasis|neoplasm metastasis
294800|NCT02376699|Solid tumor|solid tumor
294801|NCT02376686|sleep Quality|sleep quality
294802|NCT02376686|Depression|depression
294803|NCT02376686|Music|music
294804|NCT02376686|quality of life|quality of life
294805|NCT02376673|Pediatric Health Literacy|pediatric health literacy
294806|NCT02376673|Home Literacy Orientation|home literacy orientation
294807|NCT02376673|safe sleep|safe sleep
294808|NCT02376647|Patients|patients
294809|NCT02376647|ARDS diagnosis|ards diagnosis
294810|NCT02376621|omega-3 based dietary supplements|omega-3 based dietary supplements
294811|NCT02376621|Bioavailability|bioavailability
294812|NCT02376595|Rocuronium|rocuronium
294813|NCT02376595|Pharmacokinetics|pharmacokinetics
294814|NCT02376595|Pharmacodynamics|pharmacodynamics
294815|NCT02376582|HIV/AIDS vaccine|hiv/aids vaccine
294816|NCT02376582|helminth infection|helminth infection
294817|NCT02376582|Impact of co-infection|impact of co-infection
294818|NCT02376556|Dry eye syndrome|dry eye syndrome
294819|NCT02376556|Blepharoplasty|blepharoplasty
294820|NCT02376556|Muller muscle resection surgery|muller muscle resection surgery
294821|NCT02376517|Health Behavior|health behavior
294822|NCT02376517|Melanin Index|melanin index
294823|NCT02376517|Spectrophotometry|spectrophotometry
294824|NCT02376517|Sun Protective Clothing|sun protective clothing
294825|NCT02376517|Education|education
294826|NCT02376517|Primary Prevention|primary prevention
294827|NCT02376439|siblings|siblings
294828|NCT02376439|overweight|overweight
294829|NCT02376439|adolescent|adolescent
294830|NCT02376426|Healthy|healthy
294831|NCT02376426|Ebola viruses|ebola viruses
294832|NCT02376426|Ebola Viral Disease (EVD)|ebola viral disease (evd)
294833|NCT02376426|Filoviruses|filoviruses
294834|NCT02376426|Monovalent vaccine|monovalent vaccine
294835|NCT02376426|Human adenovirus serotype 26 (Ad26) expressing the Ebola virus Mayinga variant glycoprotein (Ad26.ZEBOV)|human adenovirus serotype 26 (ad26) expressing the ebola virus mayinga variant glycoprotein (ad26.zebov)
294836|NCT02376426|Modified Vaccinia Virus Ankara - Bavarian Nordic (MVA-BN) Filo-vector|modified vaccinia virus ankara - bavarian nordic (mva-bn) filo-vector
294837|NCT02376426|Safety|safety
294838|NCT02376426|Immunogenicity|immunogenicity
294839|NCT02376413|Morbidity|morbidity
294840|NCT02376413|The Breast Cancer Treatment Outcome Scale|the breast cancer treatment outcome scale
294841|NCT02376413|Disease free survival|disease free survival
294842|NCT02376413|Positivity cavity margin rate|positivity cavity margin rate
294843|NCT02376413|Harvard/NSABP/RTOG breast cosmesis grading scale|harvard/nsabp/rtog breast cosmesis grading scale
294844|NCT02376400|Healthy|healthy
294845|NCT02376400|Ebola viruses|ebola viruses
294846|NCT02376400|Ebola Viral Disease (EVD)|ebola viral disease (evd)
294847|NCT02376400|Filoviruses|filoviruses
294848|NCT02376400|Monovalent vaccine|monovalent vaccine
294849|NCT02376400|Human adenovirus serotype 26 (Ad26) expressing the Ebola virus Mayinga variant glycoprotein (Ad26.ZEBOV)|human adenovirus serotype 26 (ad26) expressing the ebola virus mayinga variant glycoprotein (ad26.zebov)
294850|NCT02376400|Modified Vaccinia Virus Ankara - Bavarian Nordic Filo-vector (MVA-BN Filo)|modified vaccinia virus ankara - bavarian nordic filo-vector (mva-bn filo)
294851|NCT02376400|Safety|safety
294852|NCT02376400|Immunogenicity|immunogenicity
294853|NCT02376374|transmission|transmission
294854|NCT02376374|vaccine|vaccine
294855|NCT02376361|Surveillance|surveillance
294856|NCT02376348|VMMC|vmmc
294857|NCT02376348|Adult males|adult males
294858|NCT02376348|HIV Prevention|hiv prevention
294859|NCT02376348|Africa|africa
294861|NCT02376335|Primary Biliary Cirrhosis|primary biliary cirrhosis
294862|NCT02376335|Rituximab|rituximab
294863|NCT02376335|PBC-40|pbc-40
294864|NCT02376296|metastatic prostate cancer|metastatic prostate cancer
294865|NCT02376296|castrate resistant prostate cancer|castrate resistant prostate cancer
294866|NCT02376296|CRPC|crpc
294867|NCT02376296|hormone sensitive prostate cancer|hormone sensitive prostate cancer
294868|NCT02376283|STEMI|stemi
294869|NCT02376283|NSTEMI|nstemi
294870|NCT02376283|PPCI|ppci
294871|NCT02376257|Cognitive behavior therapy (CBT)|cognitive behavior therapy (cbt)
294872|NCT02376257|d-cycloserine (DCS)|d-cycloserine (dcs)
294873|NCT02376257|Modafinil|modafinil
294874|NCT02376244|High intensity Interval Exercise training|high intensity interval exercise training
294875|NCT02376244|Cardiac rehabilitation|cardiac rehabilitation
294876|NCT02376244|cardiac revascularisation|cardiac revascularisation
294877|NCT02376244|Percutaneous coronary interventions|percutaneous coronary interventions
294878|NCT02376244|Cardiac surgery|cardiac surgery
294879|NCT02376231|EOC Epithelial ovarian cancer|eoc epithelial ovarian cancer
294880|NCT02376231|Surgery|surgery
294881|NCT02376231|nil macroscopic residual disease|nil macroscopic residual disease
756397|NCT00417365|vaginitis|vaginitis
294882|NCT02376231|Stage 3/4 Epithelial Ovarian Cancer requiring surgery|stage 3/4 epithelial ovarian cancer requiring surgery
294883|NCT02376205|Anterior Cervical Discectomy and Fusion|anterior cervical discectomy and fusion
294884|NCT02376205|Dysphagia|dysphagia
294885|NCT02376192|Microcirculation|microcirculation
294886|NCT02376192|Sidestream Dark Field (SDF) Imaging|sidestream dark field (sdf) imaging
294887|NCT02376192|Spinal Anesthesia|spinal anesthesia
294888|NCT02376192|Phenylephrine|phenylephrine
294889|NCT02376166|Prostate Cancer|prostate cancer
294890|NCT02376140|micronutrient deficiency|micronutrient deficiency
294891|NCT02376140|24-H recall|24-h recall
294892|NCT02376140|West Africa|west africa
294893|NCT02376140|Food consumption|food consumption
294894|NCT02376127|Dynamic Contrast-Enhanced Perfusion|dynamic contrast-enhanced perfusion
294895|NCT02376127|14-203|14-203
294896|NCT02376114|ocular blood flow|ocular blood flow
294897|NCT02376114|ginkgo biloba|ginkgo biloba
294898|NCT02376114|glaucoma|glaucoma
294899|NCT02376114|vasospasm|vasospasm
294900|NCT02376062|Continuing Medical Education|continuing medical education
294901|NCT02376062|Chronic Diseases|chronic diseases
294902|NCT02376062|Nepal|nepal
294903|NCT02376062|Implementation Research|implementation research
294904|NCT02376049|Atopic Dermatitis|atopic dermatitis
294905|NCT02376049|Eczema|eczema
294906|NCT02376049|AD|ad
294907|NCT02376036|Normal healthy volunteer|normal healthy volunteer
294908|NCT02376023|Cervical Cancer|cervical cancer
294909|NCT02376023|Women|women
294910|NCT02376023|Latina|latina
294911|NCT02376023|Chile|chile
294912|NCT02376023|Text Message|text message
294913|NCT02376023|Technology|technology
294914|NCT02376023|Screening|screening
294915|NCT02376023|Cancer Prevention|cancer prevention
294916|NCT02376023|Health Disparities|health disparities
294917|NCT02376023|Mobile Health|mobile health
294918|NCT02376010|atherosclerosis|atherosclerosis
294919|NCT02376010|coronary artery disease|coronary artery disease
294920|NCT02376010|cardiac CT|cardiac ct
294921|NCT02376010|computed tomographic angiography|computed tomographic angiography
294922|NCT02375971|intravitreal ranibizumab|intravitreal ranibizumab
294923|NCT02375971|laser ablation therapy|laser ablation therapy
294924|NCT02375971|retinopathy of prematurity|retinopathy of prematurity
294925|NCT02375971|preterm infants|preterm infants
294926|NCT02375971|RAINBOW|rainbow
294927|NCT02375958|PCA062|pca062
294928|NCT02375958|Triple Negative Breast Cancer|triple negative breast cancer
294929|NCT02375958|Head & Neck Cancer|head & neck cancer
294930|NCT02375958|Esophageal Cancer|esophageal cancer
294931|NCT02375958|pCAD, pcadherin, solid-tumors|pcad, pcadherin, solid-tumors
294932|NCT02375945|lymphedema|lymphedema
294933|NCT02375945|post operative compression treatment|post operative compression treatment
294934|NCT02375945|compression therapy|compression therapy
294935|NCT02375945|adjustable fulcro wraps|adjustable fulcro wraps
294936|NCT02375945|edema|edema
294937|NCT02375932|Electronic Medical Records|electronic medical records
294938|NCT02375932|Primary Health Care|primary health care
294939|NCT02375932|Diabetes Mellitus, Type 2|diabetes mellitus, type 2
294940|NCT02375919|PERC rule|perc rule
294941|NCT02375919|emergency department|emergency department
294942|NCT02375919|pulmonary embolism|pulmonary embolism
294943|NCT02375906|HDV, hepatitis delta|hdv, hepatitis delta
294944|NCT02375893|Coronary disease|coronary disease
294945|NCT02375893|Bile acids|bile acids
294946|NCT02375893|Gut microbiota|gut microbiota
294947|NCT02375893|Risk factors|risk factors
294948|NCT02375893|Atherosclerosis|atherosclerosis
294949|NCT02375854|preterm|preterm
294950|NCT02375854|acute kidney injury|acute kidney injury
294951|NCT02375854|biomarkers|biomarkers
294952|NCT02375854|chronic kidney disease|chronic kidney disease
294953|NCT02375841|Communication|communication
294954|NCT02375841|Physicians|physicians
294955|NCT02375841|Patients|patients
294956|NCT02375841|Caregivers|caregivers
294957|NCT02375841|15-034|15-034
294958|NCT02375828|Acceptability|acceptability
294960|NCT02375828|Neonatal diabetes|neonatal diabetes
294961|NCT02375815|statin|statin
294962|NCT02375815|decision aid|decision aid
294963|NCT02375802|Stem cells|stem cells
294964|NCT02375789|Migraine Headache|migraine headache
294965|NCT02375789|Cooling|cooling
294966|NCT02375789|Intranasal|intranasal
294967|NCT02375789|Rhinochill|rhinochill
294968|NCT02375724|COPD|copd
294969|NCT02375711|Chronic renal disease|chronic renal disease
294970|NCT02375711|Hepatitis B vaccine|hepatitis b vaccine
294971|NCT02375711|Biological Aging|biological aging
294972|NCT02375685|Uveitis|uveitis
294973|NCT02375685|Non-infectious Uveitis|non-infectious uveitis
294974|NCT02375685|Intermediate Uveitis|intermediate uveitis
294975|NCT02375685|Posterior Uveitis|posterior uveitis
294976|NCT02375685|Behçet's disease uveitis|behçet's disease uveitis
294977|NCT02375672|Pembrolizumab|pembrolizumab
294978|NCT02375672|MK-3475|mk-3475
294979|NCT02375607|Pain management|pain management
294980|NCT02375581|Radiotherapy|radiotherapy
294981|NCT02375581|Icotinib|icotinib
756398|NCT00417365|vaginal|vaginal
294982|NCT02375568|mesenchymal stem cells|mesenchymal stem cells
294983|NCT02375555|Multiple Myeloma|multiple myeloma
294984|NCT02375516|Drug abuse|drug abuse
294985|NCT02375503|Calcium|calcium
294986|NCT02375503|Vitamin D|vitamin d
294987|NCT02375503|Parathyroid Hormone|parathyroid hormone
294988|NCT02375503|Bone|bone
294989|NCT02375503|Microarchitecture|microarchitecture
294990|NCT02375490|Exercise|exercise
294991|NCT02375490|Eating Behavior|eating behavior
294992|NCT02375490|Preschool Child|preschool child
294993|NCT02375490|Early Childcare Center|early childcare center
294994|NCT02375490|Obesity|obesity
294995|NCT02375490|Physical Literacy|physical literacy
294996|NCT02375477|Clostridium difficile|clostridium difficile
294997|NCT02375477|C. difficile|c. difficile
294998|NCT02375477|adherence|adherence
294999|NCT02375464|neuroendocrine tumor|neuroendocrine tumor
295000|NCT02375464|carcinoid tumor|carcinoid tumor
295001|NCT02375438|nutrition|nutrition
295002|NCT02375438|mitochondrial cytopathy|mitochondrial cytopathy
295003|NCT02375438|malnutrition|malnutrition
295004|NCT02375438|energy intake|energy intake
295005|NCT02375438|nutritional risk|nutritional risk
295006|NCT02375425|BV, HSV|bv, hsv
295007|NCT02375425|contraceptive|contraceptive
295008|NCT02375425|ex vivo challenge model|ex vivo challenge model
295009|NCT02375412|heart rate variability|heart rate variability
295010|NCT02375412|post-operative outcome|post-operative outcome
295011|NCT02375373|Gut Microbiota|gut microbiota
295012|NCT02375347|Gut Microbiota|gut microbiota
295013|NCT02375321|OSA|osa
295014|NCT02375321|Depression|depression
295015|NCT02375321|Quality of Life|quality of life
295016|NCT02375321|CPAP|cpap
295017|NCT02375308|Hypnotherapy; Cognitive Behavioral Therapy; Efficacy|hypnotherapy; cognitive behavioral therapy; efficacy
295018|NCT02375295|struvite|struvite
295019|NCT02375295|infection|infection
295020|NCT02375295|stones|stones
295021|NCT02375295|calculi|calculi
295022|NCT02375295|antibiotics|antibiotics
295023|NCT02375282|ambulation|ambulation
295024|NCT02375282|cardiac rehabilitation|cardiac rehabilitation
295025|NCT02375269|Visceral Surgery|visceral surgery
295026|NCT02375269|Comprehensive Complication Index|comprehensive complication index
295027|NCT02375269|Patient undergoing abdominal surgery|patient undergoing abdominal surgery
295028|NCT02375230|Neonatal Resuscitation|neonatal resuscitation
295029|NCT02375230|Respiratory Function Tests|respiratory function tests
295030|NCT02375230|Neonatal Simulation|neonatal simulation
295031|NCT02375230|Resuscitation Teaching|resuscitation teaching
295032|NCT02375178|anti-infective agents|anti-infective agents
295033|NCT02375178|local/therapeutic use|local/therapeutic use
295034|NCT02375178|chlorhexidine|chlorhexidine
295035|NCT02375178|dental desinfectants|dental desinfectants
295036|NCT02375178|polyhexamethylene biguanide|polyhexamethylene biguanide
295037|NCT02375178|mouthrinse|mouthrinse
295038|NCT02375152|neurosurgery|neurosurgery
295039|NCT02375152|capsulotomy|capsulotomy
295040|NCT02375113|Obesity prevention|obesity prevention
295041|NCT02375113|Soy supplementation|soy supplementation
295042|NCT02375074|Supported Employment|supported employment
295043|NCT02375074|Vocational Rehabilitation|vocational rehabilitation
295044|NCT02375074|Youth|youth
295045|NCT02375074|Sick leave|sick leave
295046|NCT02375074|Disability|disability
295047|NCT02375074|Coping|coping
295048|NCT02375074|Work|work
295049|NCT02375074|Occupational|occupational
295050|NCT02375074|Labor market participation|labor market participation
295051|NCT02375074|Randomized Controlled Trial|randomized controlled trial
295052|NCT02375061|Best Possible Self|best possible self
295053|NCT02375061|Positive Psychology|positive psychology
295054|NCT02375061|Optimism|optimism
295055|NCT02375061|Positive Technologies|positive technologies
295056|NCT02375061|Future thinking|future thinking
295057|NCT02375061|Pain Catastrophizing|pain catastrophizing
295058|NCT02374983|Gamma Knife Radiosurgery|gamma knife radiosurgery
295059|NCT02374983|Radiation Dosimetry|radiation dosimetry
295060|NCT02374957|leg pain|leg pain
295061|NCT02374957|claudication|claudication
295062|NCT02374931|desmoid|desmoid
295063|NCT02374931|FES-PET|fes-pet
295064|NCT02374931|aggressive fibromatosis|aggressive fibromatosis
295065|NCT02374918|Mild traumatic brain injury|mild traumatic brain injury
295066|NCT02374918|Concussion|concussion
295067|NCT02374918|Sleep problems|sleep problems
295068|NCT02374918|Brain imaging|brain imaging
295069|NCT02374918|fMRI|fmri
295070|NCT02374905|drinksmeter|drinksmeter
295071|NCT02374905|alcohol counselling|alcohol counselling
295072|NCT02374892|Intervention|intervention
295073|NCT02374892|Congenital Heart Disease|congenital heart disease
295074|NCT02374892|Adolescent|adolescent
295075|NCT02374892|Education|education
295076|NCT02374892|Self-management|self-management
295077|NCT02374866|Obesity|obesity
295078|NCT02374866|Morbid Obesity|morbid obesity
295079|NCT02374866|Therapeutic education|therapeutic education
295080|NCT02374840|Pharmacogenomics|pharmacogenomics
295081|NCT02374840|Adverse Drug Reactions|adverse drug reactions
756399|NCT00417365|yeast|yeast
295082|NCT02374840|Pharmacogenetics|pharmacogenetics
295083|NCT02374827|complete salpingectomy|complete salpingectomy
295084|NCT02374827|standard tubal ligation|standard tubal ligation
295085|NCT02374827|cesarean delivery|cesarean delivery
295086|NCT02374827|feasibility|feasibility
295087|NCT02374827|safety|safety
295088|NCT02374827|partial salpingectomy|partial salpingectomy
295089|NCT02374801|CRT-D device|crt-d device
295090|NCT02374801|Severe HF (NYHA Class III or ambulatory IV)|severe hf (nyha class iii or ambulatory iv)
295091|NCT02374801|Stable, optimal drug regimen|stable, optimal drug regimen
295092|NCT02374801|Sinus rhythm|sinus rhythm
295093|NCT02374801|Heart Failure|heart failure
295094|NCT02374775|axial plaque stress|axial plaque stress
295095|NCT02374775|pressure|pressure
295096|NCT02374775|pressure gradient|pressure gradient
295097|NCT02374775|coronary plaque|coronary plaque
295098|NCT02374775|plaque rupture|plaque rupture
295099|NCT02374775|acute coronary syndrome|acute coronary syndrome
295100|NCT02374775|acute myocardial infarction|acute myocardial infarction
295101|NCT02374775|computational fluid dynamics|computational fluid dynamics
295102|NCT02374775|coronary computed tomography angiography|coronary computed tomography angiography
295103|NCT02374775|wall shear stress|wall shear stress
295104|NCT02374762|Arteriovenous Fistula|arteriovenous fistula
295105|NCT02374762|Hemodialysis|hemodialysis
295106|NCT02374762|Vascular Access|vascular access
295107|NCT02374749|Axial Spondyloarthritis|axial spondyloarthritis
295108|NCT02374749|Education|education
295109|NCT02374749|Co-morbidities|co-morbidities
295110|NCT02374749|Nurse|nurse
295111|NCT02374736|recipients|recipients
295112|NCT02374736|Subclinical Antibody-mediated rejection (ABMR)|subclinical antibody-mediated rejection (abmr)
295113|NCT02374736|Intravenous immunoglobulins (IVIg)|intravenous immunoglobulins (ivig)
295114|NCT02374736|Donor-specific antibodies (DSA)|donor-specific antibodies (dsa)
295115|NCT02374723|improve|improve
295116|NCT02374723|vision|vision
295117|NCT02374697|Second opinion|second opinion
295118|NCT02374684|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal
295119|NCT02374671|Near Vision|near vision
295120|NCT02374671|Reading Vision|reading vision
295121|NCT02374671|Reading Glasses|reading glasses
295122|NCT02374671|Reading|reading
295123|NCT02374671|Readers|readers
295124|NCT02374671|Presbyopic|presbyopic
295125|NCT02374619|eccentric exercise|eccentric exercise
295126|NCT02374619|pro-oxidants|pro-oxidants
295127|NCT02374619|free radicals|free radicals
295128|NCT02374619|adults|adults
295129|NCT02374619|children|children
295130|NCT02374606|outcomes measures|outcomes measures
295131|NCT02374606|strength measurement|strength measurement
295132|NCT02374606|disease progression|disease progression
295133|NCT02374567|geriatric psychiatry|geriatric psychiatry
295134|NCT02374567|pharmacovigilance|pharmacovigilance
295135|NCT02374554|Respiratory Rate|respiratory rate
295136|NCT02374554|Structured Light Plethysmography|structured light plethysmography
295137|NCT02374554|Capnography|capnography
295138|NCT02374541|Patient Navigation|patient navigation
295139|NCT02374541|Health Disparities|health disparities
295140|NCT02374541|Coordination of Services|coordination of services
295141|NCT02374541|Early Intervention (Education)|early intervention (education)
295142|NCT02374541|Health Services Accessibility|health services accessibility
295143|NCT02374541|Patient Advocacy|patient advocacy
295144|NCT02374528|Negative pressure wound therapy|negative pressure wound therapy
295145|NCT02374528|wound|wound
295146|NCT02374528|split-thickness skin grafting|split-thickness skin grafting
295147|NCT02374502|Spondylarthropathies|spondylarthropathies
295148|NCT02374502|Motor Activity|motor activity
295149|NCT02374502|Physical Therapists|physical therapists
295150|NCT02374502|Accelerometry|accelerometry
295151|NCT02374476|VT|vt
295152|NCT02374476|Refractory VT|refractory vt
295153|NCT02374476|VT Storm|vt storm
295154|NCT02374476|Ventricular Fibrillation|ventricular fibrillation
295155|NCT02374476|V Fib|v fib
295156|NCT02374476|VF|vf
295157|NCT02374463|Balance|balance
295158|NCT02374463|Fall Risk|fall risk
295159|NCT02374463|Older Adults|older adults
295160|NCT02374463|Tai Chi|tai chi
295161|NCT02374463|Multimodal Balance Intervention|multimodal balance intervention
295163|NCT02374450|Surveillance study|surveillance study
295164|NCT02374450|Adverse Events of Specific Interest (AESI)|adverse events of specific interest (aesi)
295165|NCT02374450|Children|children
295166|NCT02374450|Infants|infants
295167|NCT02374450|Adverse events (AE) leading to hospitalisation or death|adverse events (ae) leading to hospitalisation or death
295168|NCT02374450|Meningitis|meningitis
295169|NCT02374450|Epidemiology|epidemiology
295170|NCT02374450|Africa|africa
295171|NCT02374398|Tranexamic Acid|tranexamic acid
295172|NCT02374398|Blood Loss|blood loss
295173|NCT02374398|Aquamantys System|aquamantys system
295174|NCT02374398|TKA|tka
295175|NCT02374372|hemodialysis|hemodialysis
295176|NCT02374372|beta microglobulin|beta microglobulin
295177|NCT02374372|amyloidosis|amyloidosis
295178|NCT02374307|Falls|falls
295179|NCT02374307|Home care|home care
377078|NCT01974128|MI|mi
295180|NCT02374307|Older people|older people
295181|NCT02374307|Falls prevention|falls prevention
295182|NCT02374307|Quality of life|quality of life
295183|NCT02374307|Exercise|exercise
295184|NCT02374307|Balance|balance
295185|NCT02374307|Preventative care|preventative care
295186|NCT02374307|Community health services|community health services
295187|NCT02374307|Home-help services|home-help services
295188|NCT02374281|Newborn|newborn
295189|NCT02374281|Neonatal Screening|neonatal screening
295190|NCT02374281|Autonomic Nervous System|autonomic nervous system
295191|NCT02374281|Pain|pain
295192|NCT02374281|non-nutritive sucking|non-nutritive sucking
295193|NCT02374281|sucrose administration|sucrose administration
295194|NCT02374281|nociceptive action|nociceptive action
295195|NCT02374281|Electro acoustical characteristics of crying|electro acoustical characteristics of crying
295196|NCT02374255|Advanced cancer|advanced cancer
295197|NCT02374255|goals of care|goals of care
295198|NCT02374255|quality of care|quality of care
295199|NCT02374255|end of life discussions|end of life discussions
295200|NCT02374242|Brain|brain
295201|NCT02374242|Metastases|metastases
295202|NCT02374242|Immunotherapy|immunotherapy
295203|NCT02374242|Intracranial response|intracranial response
295204|NCT02374242|Nivolumab|nivolumab
295205|NCT02374242|Ipilimumab|ipilimumab
295206|NCT02374242|Biomarkers|biomarkers
295207|NCT02374242|Immune related response criteria|immune related response criteria
295208|NCT02374229|pulmonary hypertension|pulmonary hypertension
295209|NCT02374229|pulmonary artery denervation|pulmonary artery denervation
295210|NCT02374229|mitral valve disease|mitral valve disease
295211|NCT02374216|Dental Implants|dental implants
295212|NCT02374216|Periodontal Bone Loss|periodontal bone loss
295213|NCT02374216|Implant-Supported Dental Prosthesis|implant-supported dental prosthesis
295214|NCT02374216|Dental Prosthesis Failure|dental prosthesis failure
295215|NCT02374203|Indirect Calorimetry|indirect calorimetry
295216|NCT02374203|Harris-Benedict equation|harris-benedict equation
295217|NCT02374203|critical elderly|critical elderly
295218|NCT02374203|mNUTRIC score|mnutric score
295219|NCT02374203|high nutritional risk|high nutritional risk
295220|NCT02374164|Drug therapy|drug therapy
295221|NCT02374151|intrauterine pressure catheter|intrauterine pressure catheter
295222|NCT02374151|electrohysterography|electrohysterography
295223|NCT02374138|psychosocial stress|psychosocial stress
295224|NCT02374099|Breast Cancer|breast cancer
295225|NCT02374099|Her2 -|her2 -
295226|NCT02374099|ER+|er+
295227|NCT02374099|CC-486 (ORAL AZACITIDINE)|cc-486 (oral azacitidine)
295228|NCT02374099|Metastatic Breast Cancer|metastatic breast cancer
295229|NCT02374099|Oral Azacitidine|oral azacitidine
295230|NCT02374099|Fulvestrant|fulvestrant
295231|NCT02374099|Epigenetics|epigenetics
295232|NCT02374021|rheumatoid arthritis|rheumatoid arthritis
295233|NCT02374008|Peripheral nerve block|peripheral nerve block
295234|NCT02374008|Total knee Arthroplasty|total knee arthroplasty
295235|NCT02374008|Dexamethasone|dexamethasone
295236|NCT02373995|Graves|graves
295237|NCT02373995|Orbithopaty|orbithopaty
295238|NCT02373995|euthyroidism|euthyroidism
295239|NCT02373995|microbiome|microbiome
295240|NCT02373943|vitamin A|vitamin a
295241|NCT02373943|human|human
295242|NCT02373943|bioavailability|bioavailability
295243|NCT02373943|fortified maize|fortified maize
295244|NCT02373943|cross-over|cross-over
295245|NCT02373943|beta-carotene|beta-carotene
295246|NCT02373930|Dolutegravir|dolutegravir
295247|NCT02373930|safety|safety
295248|NCT02373930|Rilpivirine|rilpivirine
295249|NCT02373930|fixed dose combination|fixed dose combination
295250|NCT02373930|relative bioavailability|relative bioavailability
295251|NCT02373865|Diabetes mellitus type 2|diabetes mellitus type 2
295252|NCT02373865|nocturnal hypoglycemia|nocturnal hypoglycemia
295253|NCT02373865|metformin monotherapy|metformin monotherapy
295254|NCT02373800|Induced|induced
295255|NCT02373800|pre-term labor|pre-term labor
295256|NCT02373787|Resorbable|resorbable
295257|NCT02373787|Collagen membrane|collagen membrane
295258|NCT02373787|NobelReplace CC|nobelreplace cc
295259|NCT02373774|infant|infant
295260|NCT02373774|lumbar puncture|lumbar puncture
295261|NCT02373774|patient safety|patient safety
295262|NCT02373774|ultrasound|ultrasound
295263|NCT02373735|stroke volume variation|stroke volume variation
295264|NCT02373735|radical cystectomy|radical cystectomy
295265|NCT02373735|blood loss|blood loss
295266|NCT02373735|postoperative complications|postoperative complications
295267|NCT02373696|Pain|pain
295268|NCT02373696|Caesarean section|caesarean section
295269|NCT02373670|Positive deviance|positive deviance
295270|NCT02373670|Peer mentors|peer mentors
295271|NCT02373657|trachoma|trachoma
295272|NCT02373657|soil transmitted helminths|soil transmitted helminths
295273|NCT02373657|water|water
295274|NCT02373657|hand washing|hand washing
295275|NCT02373592|Diabetic Neuropathies|diabetic neuropathies
295276|NCT02373592|Thermometry|thermometry
295277|NCT02373592|Diabetes Mellitus, Type 2|diabetes mellitus, type 2
295278|NCT02373592|Foot Ulcer|foot ulcer
295279|NCT02373592|Telemedicine|telemedicine
295280|NCT02373579|omega-3 fatty acids|omega-3 fatty acids
295281|NCT02373579|methotrexate|methotrexate
295282|NCT02373579|hepatotoxicity|hepatotoxicity
295283|NCT02373566|burns|burns
295284|NCT02373566|dermal substitute|dermal substitute
295285|NCT02373566|scar quality|scar quality
295286|NCT02373566|reconstruction|reconstruction
295287|NCT02373566|wound healing|wound healing
295288|NCT02373566|wound closure|wound closure
295289|NCT02373553|posture|posture
295290|NCT02373553|postural|postural
295291|NCT02373553|kinetics|kinetics
295292|NCT02373540|spinal cord stimulation|spinal cord stimulation
295293|NCT02373540|chronic pain|chronic pain
295294|NCT02373540|failed back surgery syndrome|failed back surgery syndrome
295295|NCT02373501|caesarean delivery|caesarean delivery
295296|NCT02373501|uterine incision repair|uterine incision repair
295297|NCT02373488|Constipation|constipation
295298|NCT02373488|connective tissue manipulation|connective tissue manipulation
295299|NCT02373488|abdominal massage|abdominal massage
295300|NCT02373488|bowel movements|bowel movements
295301|NCT02373488|quality of life|quality of life
295302|NCT02373475|spine surgery|spine surgery
295303|NCT02373475|prone position|prone position
295304|NCT02373475|intraoperative lung protective strategies|intraoperative lung protective strategies
295305|NCT02373475|postoperative pulmonary complications|postoperative pulmonary complications
295306|NCT02373449|Ketamine|ketamine
295307|NCT02373449|fMRI|fmri
295308|NCT02373449|refractory neuropathic pain|refractory neuropathic pain
295309|NCT02373436|Upper Extremity|upper extremity
295310|NCT02373436|Rehabilitation|rehabilitation
295311|NCT02373397|Wound healing|wound healing
295312|NCT02373397|nerve regeneration|nerve regeneration
295313|NCT02373397|re-epithelialization|re-epithelialization
295314|NCT02373397|corneal epithelium|corneal epithelium
295315|NCT02373397|laser corneal surgery|laser corneal surgery
295316|NCT02373384|Radiolucent renal stones|radiolucent renal stones
295317|NCT02373384|Oral dissolution therapy|oral dissolution therapy
295318|NCT02373384|Systemic chemolysis|systemic chemolysis
295319|NCT02373384|Renal uric acid stones|renal uric acid stones
295320|NCT02373384|Alkalinization|alkalinization
295321|NCT02373358|Complex trauma|complex trauma
295322|NCT02373358|Yoga|yoga
295323|NCT02373345|psychological factors|psychological factors
295324|NCT02373345|functional disability|functional disability
295325|NCT02373345|pain thresholds|pain thresholds
295326|NCT02373345|tolerance thresholds|tolerance thresholds
295327|NCT02373345|motor adaptations|motor adaptations
295328|NCT02373345|natural course|natural course
295329|NCT02373332|platelets|platelets
295330|NCT02373332|12-lipoxygenase|12-lipoxygenase
295331|NCT02373332|fatty acids|fatty acids
295332|NCT02373332|DGLA|dgla
295333|NCT02373332|DHA|dha
295334|NCT02373332|EPA|epa
295335|NCT02373332|12-LOX|12-lox
295336|NCT02373319|Cardiovascular risk|cardiovascular risk
295337|NCT02373319|Cholesterol|cholesterol
295338|NCT02373319|Hypertension|hypertension
295339|NCT02373319|Diabetes|diabetes
295340|NCT02373319|Smoking|smoking
295341|NCT02373319|Preventive Medicine|preventive medicine
295342|NCT02373319|Epidemiology|epidemiology
295343|NCT02373319|Public Health|public health
295344|NCT02373319|Diet|diet
295345|NCT02373319|Physical Activity|physical activity
295346|NCT02373306|Risk stratification|risk stratification
295347|NCT02373306|ICD intervention|icd intervention
295348|NCT02373306|occurrence during one-year follow-up after NIPS|occurrence during one-year follow-up after nips
295349|NCT02373293|Acute pancreatitis|acute pancreatitis
295350|NCT02373280|Helicobacter pylori|helicobacter pylori
295351|NCT02373280|tailored therapy|tailored therapy
295352|NCT02373280|eradication|eradication
295353|NCT02373241|Anemia, Sickle Cell|anemia, sickle cell
295354|NCT02373241|Sickle Cell Disease|sickle cell disease
295355|NCT02373241|Kidney Disease|kidney disease
295356|NCT02373241|Hypertension|hypertension
295357|NCT02373241|Proteinuria|proteinuria
295358|NCT02373241|Losartan|losartan
295359|NCT02373241|Antihypertensive Agents|antihypertensive agents
295360|NCT02373241|Blood Pressure|blood pressure
295361|NCT02373111|Anti-aging|anti-aging
295362|NCT02373111|Isoflavones|isoflavones
295363|NCT02373111|Astaxanthine|astaxanthine
295364|NCT02373111|Skin aging|skin aging
295365|NCT02373098|Fingolimod,cytokine,chemokine,RRMS|fingolimod,cytokine,chemokine,rrms
295366|NCT02373085|Asymptomatic Bacteriuria|asymptomatic bacteriuria
295367|NCT02373085|Kidney transplant recipients|kidney transplant recipients
295368|NCT02373085|Pyelonephritis|pyelonephritis
295369|NCT02373072|Pakinson's Disease, Movement Disorders|pakinson's disease, movement disorders
295370|NCT02373033|Folate|folate
295371|NCT02373033|folic acid|folic acid
295372|NCT02373033|intervention trial|intervention trial
295373|NCT02373033|folate status|folate status
295374|NCT02373033|women in childbearing age|women in childbearing age
295375|NCT02373033|food folate|food folate
295376|NCT02372994|chronic disease|chronic disease
756400|NCT00417365|ecosystem|ecosystem
295377|NCT02372994|continuity of patient care|continuity of patient care
295378|NCT02372994|patient engagement|patient engagement
295379|NCT02372994|cost effectiveness analysis|cost effectiveness analysis
295380|NCT02372994|user-centred design|user-centred design
295381|NCT02372994|Interdisciplinary Health Team|interdisciplinary health team
295382|NCT02372994|Medical Informatics|medical informatics
295383|NCT02372994|Patient-centred care|patient-centred care
295384|NCT02372942|efficacy|efficacy
295385|NCT02372942|prevention|prevention
295386|NCT02372890|Otorhinolaryngeal Neoplasms|otorhinolaryngeal neoplasms
295387|NCT02372890|Cancer of Head and Neck|cancer of head and neck
295388|NCT02372890|Head and Neck Squamous Cell Carcinoma|head and neck squamous cell carcinoma
295389|NCT02372890|Positron Emission Tomography|positron emission tomography
295390|NCT02372890|PET/CT|pet/ct
295391|NCT02372890|FDG|fdg
295392|NCT02372877|Sickle Cell Disease|sickle cell disease
295393|NCT02372877|Hemoglobin (Hb) S Disease|hemoglobin (hb) s disease
295394|NCT02372877|Hb S Disease|hb s disease
295395|NCT02372877|Congenital Hemolytic Anemia|congenital hemolytic anemia
295396|NCT02372864|Ovariectomy|ovariectomy
295397|NCT02372864|Mindfulness|mindfulness
295398|NCT02372864|Postmenopause|postmenopause
295399|NCT02372864|Hot Flashes|hot flashes
295400|NCT02372851|Arsenic|arsenic
295401|NCT02372851|Household water treatment|household water treatment
295402|NCT02372851|Point of use water treatment|point of use water treatment
295403|NCT02372851|Water Quality|water quality
295404|NCT02372851|Total Urinary Arsenic|total urinary arsenic
295405|NCT02372851|West Bengal|west bengal
295406|NCT02372851|Thermotolerant coliforms|thermotolerant coliforms
295407|NCT02372851|Compliance|compliance
295408|NCT02372851|Diarrhoea|diarrhoea
295409|NCT02372825|Free iliac crest transfer|free iliac crest transfer
295410|NCT02372825|Bone reconstruction|bone reconstruction
295411|NCT02372825|Ankle reconstruction|ankle reconstruction
295412|NCT02372825|Heel reconstruction|heel reconstruction
295413|NCT02372812|effect of dexamethasone|effect of dexamethasone
295414|NCT02372812|general surgery|general surgery
295415|NCT02372812|post operative|post operative
295416|NCT02372786|7% lidocaine / 7% tetracaine cream|7% lidocaine / 7% tetracaine cream
295417|NCT02372786|2,5% lidocaine / 2,5% prilocaine cream|2,5% lidocaine / 2,5% prilocaine cream
295418|NCT02372773|Frontotemporal Dementia|frontotemporal dementia
295419|NCT02372773|MAPT|mapt
295420|NCT02372773|PGRN|pgrn
295421|NCT02372773|C9ORF72|c9orf72
295422|NCT02372760|Bronchoscopic anesthesia lidocaine|bronchoscopic anesthesia lidocaine
295423|NCT02372760|Spray Catheter|spray catheter
295424|NCT02372760|brochoalveolar lavage|brochoalveolar lavage
295425|NCT02372747|Totally laparoscopic gastrectomy|totally laparoscopic gastrectomy
295426|NCT02372747|laparoscopic distal gastrectomy|laparoscopic distal gastrectomy
295427|NCT02372747|Intracorporeal anastomosis|intracorporeal anastomosis
295428|NCT02372747|Delta-Shaped Anastomosis|delta-shaped anastomosis
295429|NCT02372747|Billroth II Anastomosis|billroth ii anastomosis
295430|NCT02372747|Gastric cancer|gastric cancer
295431|NCT02372721|acute kidney injury|acute kidney injury
295432|NCT02372656|Simvastatin, Metformin, Chronic periodontitis|simvastatin, metformin, chronic periodontitis
295433|NCT02372643|clitoris|clitoris
295434|NCT02372643|sexuality|sexuality
295435|NCT02372643|vascularization|vascularization
295436|NCT02372643|doppler|doppler
295437|NCT02372643|ultrasound|ultrasound
295438|NCT02372643|reference|reference
295439|NCT02372643|female|female
295440|NCT02372643|Pilot Projects|pilot projects
295441|NCT02372643|Vagina/ultrasonography|vagina/ultrasonography
295442|NCT02372643|Urethra/ultrasonography|urethra/ultrasonography
295443|NCT02372643|Regional Blood Flow/physiology|regional blood flow/physiology
295444|NCT02372643|Arteries/ultrasonography|arteries/ultrasonography
295445|NCT02372643|Clitoris/ultrasonography|clitoris/ultrasonography
295446|NCT02372643|Reference values|reference values
295447|NCT02372643|Clitoris/blood supply|clitoris/blood supply
295448|NCT02372617|cerebral palsy|cerebral palsy
295449|NCT02372617|hip|hip
295450|NCT02372617|luxation|luxation
295451|NCT02372617|subluxation|subluxation
295452|NCT02372604|Chronic spontaneous urticaria|chronic spontaneous urticaria
295453|NCT02372604|Levocetirizine|levocetirizine
295454|NCT02372604|H1-antihistamine|h1-antihistamine
295455|NCT02372604|Fourfold dosage|fourfold dosage
295456|NCT02372604|Efficacy|efficacy
295457|NCT02372604|Tolerance|tolerance
295755|NCT02370784|Raynaud|raynaud
295458|NCT02372604|UAS7 (Urticaria activity score)|uas7 (urticaria activity score)
295459|NCT02372604|resistant|resistant
295460|NCT02372591|Quantitative Sensory Testing|quantitative sensory testing
295461|NCT02372591|Hydromorphone|hydromorphone
295462|NCT02372591|Buprenorphine|buprenorphine
295463|NCT02372578|Painful diabetic peripheral neuropathy (PDPN)|painful diabetic peripheral neuropathy (pdpn)
295464|NCT02372578|ASP3662|asp3662
295465|NCT02372565|African American|african american
295466|NCT02372565|Women|women
295467|NCT02372565|Physical Activity|physical activity
295468|NCT02372565|Social Media|social media
295469|NCT02372565|Exercise|exercise
295470|NCT02372565|Facebook|facebook
295471|NCT02372565|Text message|text message
295472|NCT02372539|dexamethasone|dexamethasone
295473|NCT02372526|Glucagon-like Peptide-1|glucagon-like peptide-1
295474|NCT02372526|Glucose-dependent insulinotropic peptide|glucose-dependent insulinotropic peptide
295475|NCT02372526|Glucagon|glucagon
295476|NCT02372526|Peptide YY 3-36|peptide yy 3-36
295477|NCT02372526|Ghrelin|ghrelin
295478|NCT02372526|Body Weight|body weight
295479|NCT02372526|Obesity|obesity
295480|NCT02372526|Overnutrition|overnutrition
295481|NCT02372526|Overweight|overweight
295482|NCT02372526|Gastrointestinal Agents|gastrointestinal agents
295483|NCT02372526|GLP-1 secretagogue|glp-1 secretagogue
295484|NCT02372513|Cholesteryl Ester Storage Disease|cholesteryl ester storage disease
295485|NCT02372513|Children|children
295486|NCT02372513|Liver disease|liver disease
295487|NCT02372474|POF|pof
295488|NCT02372474|ESS|ess
295489|NCT02372474|stem cell therapy|stem cell therapy
295490|NCT02372461|Amoxicillin|amoxicillin
295491|NCT02372461|Placebo|placebo
295492|NCT02372435|PJI|pji
295493|NCT02372422|Twins|twins
295494|NCT02372422|Twin gestation|twin gestation
295495|NCT02372422|Preterm birth|preterm birth
295496|NCT02372422|Prevention|prevention
295497|NCT02372396|PTSD|ptsd
295498|NCT02372396|Psychotherapy|psychotherapy
295499|NCT02372396|Operation Enduring Freedom/Operation Iraqi Freedom (OEF/OIF)|operation enduring freedom/operation iraqi freedom (oef/oif)
295500|NCT02372396|Veterans|veterans
295501|NCT02372383|Cystic Fibrosis|cystic fibrosis
295502|NCT02372383|Pharmacokinetics|pharmacokinetics
295503|NCT02372383|Pharmacodynamics|pharmacodynamics
295504|NCT02372383|Nontuberculous Mycobacteria|nontuberculous mycobacteria
295505|NCT02372383|Treatment|treatment
295506|NCT02372357|chemotherapy|chemotherapy
295507|NCT02372357|stem cell transplantation|stem cell transplantation
295508|NCT02372344|the effect of food timing on PK|the effect of food timing on pk
295509|NCT02372344|the effect of food timing on Safety and Tolerability|the effect of food timing on safety and tolerability
295510|NCT02372344|AZD0585|azd0585
295511|NCT02372344|Japanese|japanese
295512|NCT02372331|pancreaticoduodenectomy|pancreaticoduodenectomy
295513|NCT02372331|ERAS|eras
295514|NCT02372331|Whipple's operation|whipple's operation
295515|NCT02372331|Fast track|fast track
295516|NCT02372318|opiod receptor modulator nalmefene|opiod receptor modulator nalmefene
295517|NCT02372318|cue-reactivity|cue-reactivity
295518|NCT02372318|fMRI|fmri
295519|NCT02372318|resting-state networks|resting-state networks
295520|NCT02372292|cardiorenal syndrome, decompensated heart failure, renal resistivity index, venous impedance index, kidney failure|cardiorenal syndrome, decompensated heart failure, renal resistivity index, venous impedance index, kidney failure
295521|NCT02372279|Embryo development|embryo development
295522|NCT02372279|Implantation|implantation
295523|NCT02372279|In vitro fertilization|in vitro fertilization
295524|NCT02372266|Infant, Newborn|infant, newborn
295525|NCT02372266|hospital discharge|hospital discharge
295526|NCT02372266|Early newborn discharge|early newborn discharge
295527|NCT02372266|Newborn length of stay|newborn length of stay
295528|NCT02372266|Maternity length of stay|maternity length of stay
295529|NCT02372253|verapamil|verapamil
295530|NCT02372253|type 1 diabetes|type 1 diabetes
295531|NCT02372253|diabetes|diabetes
295532|NCT02372253|beta cells|beta cells
295533|NCT02372253|beta cell function|beta cell function
295534|NCT02372253|insulin|insulin
295535|NCT02372214|Endovascular Procedures|endovascular procedures
295536|NCT02372214|3D printing|3d printing
295537|NCT02372214|Simulation|simulation
295538|NCT02372214|Training|training
295539|NCT02372214|Learning curve|learning curve
295540|NCT02372214|Education|education
295541|NCT02372201|irritable bowel disease|irritable bowel disease
295542|NCT02372201|microbiota|microbiota
295543|NCT02372201|hydro colon therapy|hydro colon therapy
295544|NCT02372201|food intolerance|food intolerance
295545|NCT02372175|Dengue|dengue
295546|NCT02372162|Hepatocellular Carcinoma|hepatocellular carcinoma
295547|NCT02372162|Molecular Diagnostics|molecular diagnostics
295548|NCT02372162|Sorafenib|sorafenib
295549|NCT02372162|Therapeutic chemoembolization|therapeutic chemoembolization
295550|NCT02372162|Next-generation sequencing|next-generation sequencing
295551|NCT02372162|Sequence analysis, DNA|sequence analysis, dna
295552|NCT02372162|Sequence analysis, RNA|sequence analysis, rna
295553|NCT02372162|Metabolomics|metabolomics
295554|NCT02372123|Dysmenorrhea|dysmenorrhea
295555|NCT02372123|Primary dysmenorrhea|primary dysmenorrhea
295556|NCT02372123|physiotherapy|physiotherapy
295557|NCT02372123|massage|massage
295558|NCT02372123|connective tissue massage|connective tissue massage
295559|NCT02372123|connective tissue manipulation|connective tissue manipulation
295560|NCT02372084|Hepatic impairment,|hepatic impairment,
295561|NCT02372084|osilodrostat,|osilodrostat,
295562|NCT02372084|LCI699|lci699
295563|NCT02372032|Herniation|herniation
295564|NCT02372032|Discectomy|discectomy
295565|NCT02372032|Ozone|ozone
295566|NCT02372019|Social Anxiety Disorder|social anxiety disorder
295567|NCT02372019|Social Phobia|social phobia
295568|NCT02372019|Reconsolidation|reconsolidation
295569|NCT02372019|Cognitive Bias Modification|cognitive bias modification
295570|NCT02372019|Interpretation Bias|interpretation bias
295571|NCT02371980|Drug therapy|drug therapy
295572|NCT02371928|Shoulder|shoulder
295573|NCT02371928|Instability|instability
295574|NCT02371928|Neuromuscular|neuromuscular
295575|NCT02371928|Physiotherapy|physiotherapy
295576|NCT02371928|Exercise|exercise
295577|NCT02371928|Dislocation|dislocation
295578|NCT02371928|Recurrence|recurrence
295579|NCT02371915|Rural access|rural access
295580|NCT02371915|Telehealth|telehealth
295581|NCT02371902|Elbow pain|elbow pain
295582|NCT02371902|lateral epicondylitis|lateral epicondylitis
295583|NCT02371902|conservative treatment|conservative treatment
295584|NCT02371902|shock wave treatment|shock wave treatment
295585|NCT02371902|therapeutic ultrasound|therapeutic ultrasound
295586|NCT02371850|Bioequivalence|bioequivalence
295587|NCT02371850|Therapeutic Equivalency|therapeutic equivalency
295588|NCT02371824|Magnetic Resonance Imaging|magnetic resonance imaging
295589|NCT02371824|Bone Marrow|bone marrow
295590|NCT02371824|Hip|hip
295591|NCT02371824|Lumbar Vertebrae|lumbar vertebrae
295592|NCT02371785|Peripheral Arterial Disease|peripheral arterial disease
295593|NCT02371785|Critical Limb Ischemia|critical limb ischemia
295594|NCT02371785|Claudication|claudication
295595|NCT02371785|Percutaneous Vascular Intervention|percutaneous vascular intervention
295596|NCT02371785|Peripheral Vascular Intervention|peripheral vascular intervention
295597|NCT02371772|Warfarin|warfarin
295598|NCT02371772|Self Care|self care
295599|NCT02371772|Conventional care|conventional care
295600|NCT02371733|pulmonary arterial hypertension|pulmonary arterial hypertension
295601|NCT02371733|aerobic exercise training|aerobic exercise training
295602|NCT02371733|upper extremity|upper extremity
295603|NCT02371733|exercise capacity|exercise capacity
295604|NCT02371694|Lipid|lipid
295605|NCT02371694|Carbohydrate counting|carbohydrate counting
295606|NCT02371694|Adolescent|adolescent
295607|NCT02371694|Continuous glucose monitoring|continuous glucose monitoring
295608|NCT02371694|Insulin requirements|insulin requirements
295609|NCT02371681|Treatment-Response|treatment-response
295610|NCT02371681|Radiological Imaging|radiological imaging
295611|NCT02371681|Biomarkers|biomarkers
295612|NCT02371681|Antitubercular Agents|antitubercular agents
295613|NCT02371681|Log-CFU Reduction|log-cfu reduction
295614|NCT02371668|Influenza A|influenza a
295615|NCT02371668|H1N1|h1n1
295616|NCT02371668|Challenge Model|challenge model
295617|NCT02371668|Human Immunoglobulin and H1N1|human immunoglobulin and h1n1
295618|NCT02371668|Efficacy and Safety in H1N1|efficacy and safety in h1n1
295619|NCT02371655|Bowel cleansing|bowel cleansing
295620|NCT02371655|CTcolonography|ctcolonography
295621|NCT02371655|Bowel preparation|bowel preparation
295622|NCT02371655|Faecal and fluid tagging|faecal and fluid tagging
295623|NCT02371642|Echocardiography|echocardiography
295624|NCT02371629|Anticholinergic|anticholinergic
295625|NCT02371629|Antimuscarinic|antimuscarinic
295626|NCT02371629|Chronic Obstructive Airway Disease|chronic obstructive airway disease
295627|NCT02371629|Chronic Obstructive Lung Disease|chronic obstructive lung disease
295628|NCT02371629|Chronic Obstructive Pulmonary Disease|chronic obstructive pulmonary disease
295629|NCT02371629|COPD|copd
295630|NCT02371629|LAMA|lama
295631|NCT02371629|Lung Disease|lung disease
295632|NCT02371629|Lung Diseases, Obstructive|lung diseases, obstructive
295633|NCT02371629|Lung Function|lung function
295634|NCT02371629|Muscarinic receptor antagonist|muscarinic receptor antagonist
295635|NCT02371629|Pulmonary Disease, Chronic Obstructive|pulmonary disease, chronic obstructive
295636|NCT02371629|Respiratory Tract Diseases|respiratory tract diseases
295637|NCT02371603|Prolyl hydroxylase inhibitor|prolyl hydroxylase inhibitor
295638|NCT02371603|GSK1278863|gsk1278863
295639|NCT02371603|Anemia|anemia
295640|NCT02371603|Drug interaction|drug interaction
295641|NCT02371590|cancer|cancer
295642|NCT02371590|lenalidomide|lenalidomide
295643|NCT02371590|obinutuzumab|obinutuzumab
295644|NCT02371590|CLL|cll
295645|NCT02371577|Revlimid|revlimid
295646|NCT02371551|Diffusion Magnetic Resonance Imaging|diffusion magnetic resonance imaging
295647|NCT02371551|Medical Sonography|medical sonography
295648|NCT02371551|Computed Tomography, X-Ray|computed tomography, x-ray
295649|NCT02371538|stem cell transplant|stem cell transplant
295650|NCT02371538|human breastmilk|human breastmilk
295651|NCT02371525|adherence|adherence
295652|NCT02371525|prevention|prevention
295653|NCT02371512|Mitral Valve Insufficiency|mitral valve insufficiency
295654|NCT02371499|Irritable Bowel Syndrome|irritable bowel syndrome
295655|NCT02371499|Lactobacillus casei dg|lactobacillus casei dg
295656|NCT02371499|microbiota|microbiota
295657|NCT02371486|cesarean section defect|cesarean section defect
295658|NCT02371486|implantation|implantation
295659|NCT02371486|ivf|ivf
295660|NCT02371473|Acetazolamide|acetazolamide
295661|NCT02371473|Central Sleep Apnea|central sleep apnea
295662|NCT02371473|Opium Abuse|opium abuse
295663|NCT02371460|Neonatal Prematurity|neonatal prematurity
295664|NCT02371460|Omega-3 Fatty Acids|omega-3 fatty acids
295665|NCT02371460|Breastfeeding|breastfeeding
295666|NCT02371447|bladder cancer|bladder cancer
295667|NCT02371447|recurrent non-muscle invasive bladder cancer|recurrent non-muscle invasive bladder cancer
295668|NCT02371447|VPM1002BC|vpm1002bc
295669|NCT02371447|BCG therapy|bcg therapy
295670|NCT02371369|PLX3397|plx3397
295671|NCT02371369|Pexidartinib|pexidartinib
295672|NCT02371369|Colony Stimulating Factor 1 Receptor (CSF-1R) inhibitor|colony stimulating factor 1 receptor (csf-1r) inhibitor
295673|NCT02371330|Thrombocytopenia|thrombocytopenia
295674|NCT02371330|Neonate|neonate
295675|NCT02371330|PFA-100|pfa-100
295676|NCT02371330|Neo-BAT|neo-bat
295677|NCT02371330|Hemorrhage|hemorrhage
295678|NCT02371317|Randomized clinical trial|randomized clinical trial
295679|NCT02371317|Early medical intervention|early medical intervention
295680|NCT02371317|Intervention studies|intervention studies
295681|NCT02371317|Blood pressure|blood pressure
295682|NCT02371317|Stress Management|stress management
295683|NCT02371304|local therapy|local therapy
295684|NCT02371304|adjuvant chemoradiotherapy|adjuvant chemoradiotherapy
295685|NCT02371304|rectal preserving|rectal preserving
295686|NCT02371291|Memory Flexibility|memory flexibility
295687|NCT02371278|Leucine|leucine
295688|NCT02371278|Protein|protein
295689|NCT02371278|Diet|diet
295690|NCT02371278|Muscle protein synthesis|muscle protein synthesis
295691|NCT02371265|HIV|hiv
295692|NCT02371265|Mozambique|mozambique
295693|NCT02371265|antenatal care|antenatal care
295694|NCT02371265|adherence|adherence
295695|NCT02371265|retention|retention
295696|NCT02371265|pregnancy|pregnancy
295697|NCT02371265|HIV-positive mothers retained in ART after 90 days|hiv-positive mothers retained in art after 90 days
295698|NCT02371252|Osteoporosis|osteoporosis
295699|NCT02371252|Bisphosphonates|bisphosphonates
295700|NCT02371252|Alendronate|alendronate
295701|NCT02371252|Bone mineral density|bone mineral density
295702|NCT02371252|Bone markers|bone markers
295703|NCT02371239|Glucose regulation|glucose regulation
295704|NCT02371239|Glucose|glucose
295705|NCT02371239|Lipids|lipids
295706|NCT02371226|MPS I|mps i
295707|NCT02371213|Social Networking|social networking
295708|NCT02371213|Mobile phone|mobile phone
295709|NCT02371213|Antenatal Care|antenatal care
295710|NCT02371213|Health education|health education
295711|NCT02371213|Maternal outcome|maternal outcome
295712|NCT02371213|Neonatal outcome|neonatal outcome
295713|NCT02371174|HER2-Negative Inoperable or Recurrent Breast Cancer|her2-negative inoperable or recurrent breast cancer
295714|NCT02371174|Japan|japan
295715|NCT02371174|Eribulin Mesylate|eribulin mesylate
295716|NCT02371135|Gut Microbiome|gut microbiome
295717|NCT02371135|15-016|15-016
295718|NCT02371083|Pelvic organ prolapse managed by vaginal pessary|pelvic organ prolapse managed by vaginal pessary
295719|NCT02370979|Dolutegravir|dolutegravir
295720|NCT02370979|Proviral HIV-1 DNA|proviral hiv-1 dna
295721|NCT02370979|Reservoir|reservoir
295722|NCT02370953|Toric IOL alignment|toric iol alignment
295723|NCT02370953|VERION digital marker|verion digital marker
295724|NCT02370953|Manual ink-marking|manual ink-marking
295725|NCT02370953|Randomized controlled trial|randomized controlled trial
295726|NCT02370940|Iron bioavailability|iron bioavailability
295727|NCT02370940|phytate|phytate
295728|NCT02370940|serum iron curve|serum iron curve
295729|NCT02370940|hepcidin|hepcidin
295730|NCT02370940|iron status|iron status
295731|NCT02370914|Concussion|concussion
295732|NCT02370888|Lenalidomide|lenalidomide
295733|NCT02370888|Hematopoietic Stem Cell Transplantation|hematopoietic stem cell transplantation
295734|NCT02370888|Peripheral Blood Stem Cell Transplantation|peripheral blood stem cell transplantation
295735|NCT02370862|Spinal Cord Injury|spinal cord injury
295736|NCT02370862|Neurogenic Bowel|neurogenic bowel
295737|NCT02370862|Bowel Evacuation|bowel evacuation
295738|NCT02370862|Gut Motility|gut motility
295739|NCT02370849|nimotuzumab|nimotuzumab
295740|NCT02370849|gastric adenocarcinoma|gastric adenocarcinoma
295741|NCT02370849|Cisplatin|cisplatin
295743|NCT02370849|epidermal growth factor receptor|epidermal growth factor receptor
295744|NCT02370836|distress|distress
295745|NCT02370823|Osteoarthritis|osteoarthritis
295746|NCT02370823|Knee|knee
295747|NCT02370810|tinnitus treatment, internet-intervention, CBT|tinnitus treatment, internet-intervention, cbt
295748|NCT02370797|IOERT|ioert
295749|NCT02370797|Radiation|radiation
295750|NCT02370797|Single fraction|single fraction
295751|NCT02370797|Lumpectomy|lumpectomy
295752|NCT02370797|Radiation therapy|radiation therapy
295753|NCT02370797|Avera|avera
295754|NCT02370784|early diffuse scleroderma|early diffuse scleroderma
295756|NCT02370758|Quantiferon-CMV|quantiferon-cmv
295757|NCT02370758|Quantiferon-Monitor|quantiferon-monitor
295758|NCT02370758|Solid Organ Transplants|solid organ transplants
295759|NCT02370758|CMV Disease|cmv disease
295760|NCT02370745|Incretin|incretin
295761|NCT02370745|GLP-1|glp-1
295762|NCT02370745|Skeletal muscle metabolism|skeletal muscle metabolism
295763|NCT02370745|Microvascular recruitment|microvascular recruitment
295764|NCT02370745|Amino Acids|amino acids
295765|NCT02370745|Microvascular blood flow|microvascular blood flow
295766|NCT02370732|Alcohol|alcohol
295767|NCT02370732|Bariatric Surgery|bariatric surgery
295768|NCT02370732|Roux en Y Gastric bypass|roux en y gastric bypass
295769|NCT02370732|Alcohol impairment|alcohol impairment
295770|NCT02370732|Alcohol reinforcement|alcohol reinforcement
295771|NCT02370732|Alcohol pharmacokinetics|alcohol pharmacokinetics
295772|NCT02370719|Diabetes mellitus|diabetes mellitus
295773|NCT02370719|Randomized controlled trial|randomized controlled trial
295774|NCT02370719|Primary care|primary care
295775|NCT02370719|Physical activity|physical activity
295776|NCT02370719|Lifestyle|lifestyle
295777|NCT02370719|Blood glucose|blood glucose
295778|NCT02370719|Mobile health|mobile health
295779|NCT02370719|Hb A1c|hb a1c
295780|NCT02370719|Self-management|self-management
295781|NCT02370706|PIM447|pim447
295782|NCT02370706|LGH447|lgh447
295783|NCT02370706|PIM inhibitor|pim inhibitor
295784|NCT02370706|LEE011|lee011
295785|NCT02370706|CDK 4/6 inhibitor|cdk 4/6 inhibitor
295786|NCT02370706|ruxolitinib|ruxolitinib
295787|NCT02370706|INC424|inc424
295788|NCT02370706|Jakavi®|jakavi®
295789|NCT02370706|Jakafi®|jakafi®
295790|NCT02370706|INCB18424|incb18424
295791|NCT02370706|JAK inhibitor|jak inhibitor
295792|NCT02370706|myelofibrosis|myelofibrosis
295793|NCT02370706|PMF|pmf
295794|NCT02370706|PPV-MF|ppv-mf
295795|NCT02370706|PET-MF|pet-mf
295796|NCT02370693|mycophenolate|mycophenolate
295797|NCT02370693|lung scarring|lung scarring
295798|NCT02370680|Antiplatelet|antiplatelet
295799|NCT02370680|Antiplatelet therapy|antiplatelet therapy
295800|NCT02370680|platelet turnover|platelet turnover
295801|NCT02370680|high platelet turnover|high platelet turnover
295802|NCT02370680|platelet aggregation|platelet aggregation
295803|NCT02370680|cardiovascular disease|cardiovascular disease
295804|NCT02370680|coronary artery disease|coronary artery disease
295805|NCT02370680|diabetes mellitus|diabetes mellitus
295806|NCT02370667|Exercise|exercise
295807|NCT02370667|Magnetic Resonance Imaging|magnetic resonance imaging
295808|NCT02370654|COPD|copd
295809|NCT02370654|Tai chi|tai chi
295810|NCT02370654|Pulmonary rehabilitation|pulmonary rehabilitation
295811|NCT02370641|urolithin A|urolithin a
295812|NCT02370641|microflora|microflora
295813|NCT02370628|percutaneous vertebroplasty|percutaneous vertebroplasty
295814|NCT02370628|facet block|facet block
295815|NCT02370602|Drug therapy|drug therapy
295816|NCT02370589|Ebola|ebola
295817|NCT02370537|omega-3 carboxylic acid|omega-3 carboxylic acid
295818|NCT02370498|Gastric cancer|gastric cancer
295819|NCT02370498|Gastroesophageal junction cancer|gastroesophageal junction cancer
295820|NCT02370498|PD1|pd1
295821|NCT02370498|PD-1|pd-1
295822|NCT02370498|PDL1|pdl1
295823|NCT02370498|PD-L1|pd-l1
295824|NCT02370472|Ultrasound|ultrasound
295825|NCT02370472|Image|image
295826|NCT02370472|Learning Tool|learning tool
295827|NCT02370472|Ultrasound Guide Procedures|ultrasound guide procedures
295828|NCT02370472|Simulated Setting|simulated setting
295829|NCT02370459|Papillomavirus Vaccines|papillomavirus vaccines
295830|NCT02370459|Immunization|immunization
295831|NCT02370459|Quality Improvement|quality improvement
295832|NCT02370459|Adolescent Health Services|adolescent health services
295833|NCT02370446|Medication Log|medication log
295834|NCT02370446|15-008|15-008
295835|NCT02370433|Spinal Cord Injury|spinal cord injury
295836|NCT02370433|Neurogenic Bowel|neurogenic bowel
295837|NCT02370433|Bowel Evacuation|bowel evacuation
295838|NCT02370420|Platelet-rich plasma|platelet-rich plasma
295839|NCT02370420|Osteoarthritis|osteoarthritis
295840|NCT02370407|surgical education|surgical education
295841|NCT02370407|minimally invasive surgical procedures|minimally invasive surgical procedures
295842|NCT02370407|laparoscopic simulation|laparoscopic simulation
295843|NCT02370407|robotic simulation|robotic simulation
295844|NCT02370407|medical education|medical education
295845|NCT02370394|Intimate Partner Violence|intimate partner violence
295846|NCT02370394|Perinatal Women|perinatal women
295847|NCT02370394|Mental Health|mental health
295848|NCT02370316|metacognition|metacognition
295850|NCT02370316|Psychotherapy|psychotherapy
295851|NCT02370251|Fat Emulsions, Intravenous|fat emulsions, intravenous
295852|NCT02370251|Parenteral-Nutrition-Associated Liver Disease|parenteral-nutrition-associated liver disease
295853|NCT02370251|Cholestasis|cholestasis
295854|NCT02370251|Omegaven|omegaven
295855|NCT02370251|Fish Oil|fish oil
295856|NCT02370238|Triple negative metastatic breast cancer|triple negative metastatic breast cancer
295857|NCT02370238|Cancer Stem Cells|cancer stem cells
295858|NCT02370225|sjogren's syndrome|sjogren's syndrome
295859|NCT02370225|aerobic exercise|aerobic exercise
295860|NCT02370225|fatigue|fatigue
295861|NCT02370212|Creatine|creatine
295862|NCT02370212|interval training|interval training
295863|NCT02370212|effects on performance|effects on performance
295864|NCT02370173|PTSD|ptsd
295865|NCT02370173|Stress|stress
295866|NCT02370173|Sleep Problems|sleep problems
295867|NCT02370173|Brain imaging|brain imaging
295868|NCT02370173|fMRI|fmri
295869|NCT02370147|smoking reduction intervention|smoking reduction intervention
295870|NCT02370147|no intention to quit|no intention to quit
295871|NCT02370147|randomized controlled trial|randomized controlled trial
295872|NCT02370147|telephone follow-up intervention|telephone follow-up intervention
295873|NCT02370121|Gymnema Sylvestre|gymnema sylvestre
295874|NCT02370121|Insulin Secretion|insulin secretion
295875|NCT02370121|Insulin Sensitivity|insulin sensitivity
295876|NCT02370121|Central Obesity|central obesity
295877|NCT02370108|electrical muscle stimulation|electrical muscle stimulation
295878|NCT02370108|parkinson's disease|parkinson's disease
295879|NCT02370108|rest tremor|rest tremor
295880|NCT02370108|tremor reduction|tremor reduction
295881|NCT02370095|ARDS|ards
295882|NCT02370095|Acute Lung Injury|acute lung injury
295883|NCT02370095|Acute Respiratory Failure|acute respiratory failure
295884|NCT02370082|lumpectomy|lumpectomy
295885|NCT02370082|breast conserving surgery|breast conserving surgery
295886|NCT02370030|sepsis|sepsis
295887|NCT02370030|citrulline|citrulline
295888|NCT02370030|endothelial|endothelial
295889|NCT02370030|toxemia|toxemia
295890|NCT02370030|endothelial determination of progression|endothelial determination of progression
295891|NCT02370030|with vs without citrulline|with vs without citrulline
295892|NCT02370017|Autologous Ex vivo-expanded NK cell enriched lymphocytes|autologous ex vivo-expanded nk cell enriched lymphocytes
295893|NCT02370004|Asthma|asthma
295894|NCT02370004|RFST|rfst
295895|NCT02370004|Bronchial Diseases|bronchial diseases
295896|NCT02370004|Respiratory Tract Diseases|respiratory tract diseases
295897|NCT02370004|Lung Diseases, Obstructive|lung diseases, obstructive
295898|NCT02370004|Lung Diseases|lung diseases
295899|NCT02369991|latissimus dorsi flap|latissimus dorsi flap
295900|NCT02369991|bone transport|bone transport
295901|NCT02369991|bone reconstruction|bone reconstruction
295902|NCT02369991|tibia|tibia
295903|NCT02369991|tibial fracture|tibial fracture
295904|NCT02369978|Trypanocidal therapy|trypanocidal therapy
295905|NCT02369978|Benznidazole|benznidazole
295906|NCT02369978|Nifurtimox|nifurtimox
295907|NCT02369978|Polymerase chain reaction|polymerase chain reaction
295908|NCT02369978|Randomized trial|randomized trial
295909|NCT02369965|HIV-1|hiv-1
295910|NCT02369965|AIDS|aids
295911|NCT02369965|Albuvirtide|albuvirtide
295912|NCT02369965|Treatment-experienced|treatment-experienced
295913|NCT02369965|Fusion inhibitor|fusion inhibitor
295914|NCT02369939|anal carcinoma|anal carcinoma
295915|NCT02369939|hyperthermia|hyperthermia
295916|NCT02369939|radiotherapy|radiotherapy
295917|NCT02369939|chemotherapy|chemotherapy
295918|NCT02369939|radiochemotherapy|radiochemotherapy
295919|NCT02369926|multiple sclerosis|multiple sclerosis
295920|NCT02369926|telemedicine|telemedicine
295921|NCT02369926|remote monitoring|remote monitoring
295922|NCT02369926|lisinopril|lisinopril
295923|NCT02369900|Esmolol|esmolol
295924|NCT02369900|Septic Shock|septic shock
295925|NCT02369900|Hypotension|hypotension
295926|NCT02369900|Tachycardia|tachycardia
295927|NCT02369887|MSM/TG who agree to start PrEP|msm/tg who agree to start prep
295928|NCT02369874|Head and Neck cancer; MEDI4736; Tremelimumab|head and neck cancer; medi4736; tremelimumab
295929|NCT02369822|Vitamin C|vitamin c
295930|NCT02369822|convulsions status|convulsions status
295931|NCT02369822|EEG|eeg
295932|NCT02369822|children|children
295933|NCT02369809|Ischemia|ischemia
295934|NCT02369796|Drug therapy|drug therapy
295935|NCT02369770|Acute Stroke|acute stroke
295936|NCT02369770|Robotic therapy|robotic therapy
295937|NCT02369770|Ankle impairment|ankle impairment
295938|NCT02369744|Ureteral calculus|ureteral calculus
295939|NCT02369744|Ureterolithiasis|ureterolithiasis
295940|NCT02369744|Ureteral stone|ureteral stone
295941|NCT02369744|Kidney stone|kidney stone
295942|NCT02369744|Medical expulsive therapy|medical expulsive therapy
295943|NCT02369744|tamsulosin|tamsulosin
295944|NCT02369744|silodosin|silodosin
295945|NCT02369744|rapaflo|rapaflo
295946|NCT02369744|flomax|flomax
295947|NCT02369679|upper limb|upper limb
295948|NCT02369679|lymphedema|lymphedema
295949|NCT02369666|Inflammation|inflammation
295950|NCT02369666|Lycopene|lycopene
295951|NCT02369666|Exercise|exercise
295952|NCT02369653|Anticoagulation|anticoagulation
295953|NCT02369614|rTMS - repetitive transcranial magnetic stimulation|rtms - repetitive transcranial magnetic stimulation
295954|NCT02369614|CAPS - Clinician Administered PTSD Scale|caps - clinician administered ptsd scale
295955|NCT02369601|amniorrhexis|amniorrhexis
295956|NCT02369601|Ruptured membranes|ruptured membranes
295957|NCT02369601|Alfa-fetoprotein|alfa-fetoprotein
295958|NCT02369562|Dental implants|dental implants
296566|NCT02366247|Adefovir|adefovir
295959|NCT02369562|Periodontal Bone Loss|periodontal bone loss
295960|NCT02369549|Chronic Kidney Disease (CKD)|chronic kidney disease (ckd)
295961|NCT02369549|Micro-particle curcumin|micro-particle curcumin
295962|NCT02369549|Albuminuria|albuminuria
295964|NCT02369536|nutraceutical mixture|nutraceutical mixture
295965|NCT02369523|Primary Total Knee Arthroplasty|primary total knee arthroplasty
295966|NCT02369510|spinal anesthesia|spinal anesthesia
295967|NCT02369510|epinephrine|epinephrine
295968|NCT02369510|bupivacaine|bupivacaine
295969|NCT02369510|repeat cesarean|repeat cesarean
295970|NCT02369484|Stage IIIb/ IV NSCLC harbouring HER2 exon 20 mutations|stage iiib/ iv nsclc harbouring her2 exon 20 mutations
295971|NCT02369471|Cannabidivarin|cannabidivarin
295973|NCT02369471|GWP42006|gwp42006
295974|NCT02369432|Drug carriers|drug carriers
295975|NCT02369432|Polymeric microparticles|polymeric microparticles
295976|NCT02369432|Preferential accumulation in inflamed skin|preferential accumulation in inflamed skin
295977|NCT02369432|Atopic dermatitis|atopic dermatitis
295978|NCT02369432|Pilosebaceous follicles|pilosebaceous follicles
295979|NCT02369432|Selective drug delivery|selective drug delivery
295980|NCT02369432|Drug reservoir|drug reservoir
295981|NCT02369419|frailty|frailty
295982|NCT02369419|Heart failure|heart failure
295983|NCT02369419|cardiac resynchronization therapy|cardiac resynchronization therapy
295984|NCT02369406|Botswana|botswana
295985|NCT02369406|Immunology|immunology
295986|NCT02369406|Antiretroviral Therapy|antiretroviral therapy
295987|NCT02369393|Internet based treatment|internet based treatment
295988|NCT02369393|Depression|depression
295989|NCT02369393|Efficacy|efficacy
295990|NCT02369393|Cost-effectiveness|cost-effectiveness
295991|NCT02369393|Behavioral Activation|behavioral activation
295992|NCT02369393|Self-applied|self-applied
295993|NCT02369393|Ecological Momentary Assessment|ecological momentary assessment
295994|NCT02369393|Physical Activity|physical activity
295995|NCT02369354|Kidney Transplant|kidney transplant
295996|NCT02369354|African Americans|african americans
295997|NCT02369341|Southern Hemisphere influenza vaccine|southern hemisphere influenza vaccine
295998|NCT02369341|Elderly|elderly
295999|NCT02369341|Seasonal flu|seasonal flu
296000|NCT02369341|Fluarix Tetra|fluarix tetra
296001|NCT02369341|Adults|adults
296002|NCT02369341|Immunogenicity|immunogenicity
296003|NCT02369341|Reactogenicity|reactogenicity
296004|NCT02369341|Influenza|influenza
296005|NCT02369315|child development|child development
296006|NCT02369315|music training|music training
296007|NCT02369315|self-regulation|self-regulation
296008|NCT02369315|exposure to violence|exposure to violence
296009|NCT02369276|neck dissection surgery|neck dissection surgery
296010|NCT02369276|shoulder disability|shoulder disability
296011|NCT02369276|musculoskeletal ultrasonography|musculoskeletal ultrasonography
296012|NCT02369263|Deep Vein Thrombosis|deep vein thrombosis
296013|NCT02369263|DVT|dvt
296014|NCT02369263|Leg Swelling|leg swelling
296015|NCT02369263|Leg Pain|leg pain
296016|NCT02369263|Blood Clot|blood clot
296017|NCT02369250|regeneration|regeneration
296018|NCT02369250|surgical therapy|surgical therapy
296019|NCT02369250|furcation defect|furcation defect
296020|NCT02369211|acetaminophen|acetaminophen
296021|NCT02369172|Herpes|herpes
296022|NCT02369172|volunteers|volunteers
296023|NCT02369172|drug-drug interaction|drug-drug interaction
296024|NCT02369120|patient education|patient education
296025|NCT02369120|pain cognitions|pain cognitions
296026|NCT02369107|acupuncture|acupuncture
296027|NCT02369107|chemotherapy-induced nausea and vomiting|chemotherapy-induced nausea and vomiting
296028|NCT02369094|Frailty|frailty
296029|NCT02369094|Frail elderly|frail elderly
296030|NCT02369094|Acupressure|acupressure
296031|NCT02369094|Pragmatic Randomised Controlled Trial|pragmatic randomised controlled trial
296032|NCT02369081|Hypertension|hypertension
296033|NCT02369055|Rehabilitation|rehabilitation
296034|NCT02369029|Phase I|phase i
296035|NCT02369029|Dose escalation|dose escalation
296036|NCT02369029|NUT-midline carcinoma|nut-midline carcinoma
296037|NCT02369029|Acute Leucemia|acute leucemia
296038|NCT02369029|Lymphoma|lymphoma
296039|NCT02369029|Melanoma|melanoma
296040|NCT02369029|Myeloma|myeloma
296041|NCT02369029|HCC|hcc
296042|NCT02369029|NSCLC|nsclc
296043|NCT02369016|indolent Non-Hodgkin lymphoma|indolent non-hodgkin lymphoma
296044|NCT02369016|rituximab-refractory|rituximab-refractory
296045|NCT02369003|Deep Brain Stimulation|deep brain stimulation
296046|NCT02369003|Schwann Cells|schwann cells
296047|NCT02368990|NSCLC|nsclc
296048|NCT02368990|T790M|t790m
296049|NCT02368990|EGFR|egfr
296050|NCT02368990|TKI Resistance|tki resistance
296051|NCT02368990|Non Small Cell Lung Cancer|non small cell lung cancer
296052|NCT02368990|AZD9291|azd9291
296053|NCT02368990|Clovis|clovis
296054|NCT02368977|Colonoscopy|colonoscopy
296055|NCT02368977|Polyps|polyps
296056|NCT02368977|Adenomas|adenomas
296057|NCT02368964|double triggering|double triggering
296058|NCT02368964|Oocyte maturation|oocyte maturation
296059|NCT02368964|GNRH Agonist|gnrh agonist
296060|NCT02368964|hCG|hcg
296061|NCT02368964|IVF treatment|ivf treatment
296062|NCT02368964|immature oocytes|immature oocytes
296063|NCT02368951|Phase 1|phase 1
296064|NCT02368951|Solid Tumors|solid tumors
296065|NCT02368951|FGFR2|fgfr2
296066|NCT02368951|Antibody drug conjugate|antibody drug conjugate
296067|NCT02368938|Cardiovascular risk factors|cardiovascular risk factors
296068|NCT02368938|Prospective study|prospective study
296069|NCT02368938|Mortality|mortality
296070|NCT02368938|Cardiovascular events|cardiovascular events
296071|NCT02368938|Asymptomatic target organ damage|asymptomatic target organ damage
296072|NCT02368938|elderly Chinese|elderly chinese
296073|NCT02368925|Rhytids|rhytids
296074|NCT02368925|Skin Laxity|skin laxity
296075|NCT02368912|Phase 1|phase 1
296076|NCT02368912|ASP1707|asp1707
296077|NCT02368912|Dose escalation|dose escalation
296078|NCT02368912|Food effect|food effect
296079|NCT02368912|Maximum tolerated dose (MTD)|maximum tolerated dose (mtd)
296080|NCT02368912|Healthy subjects|healthy subjects
296081|NCT02368912|Single ascending dose|single ascending dose
296082|NCT02368912|Multiple ascending dose|multiple ascending dose
296083|NCT02368899|technology|technology
296084|NCT02368899|information science|information science
296085|NCT02368899|health care|health care
296086|NCT02368873|prevention|prevention
296087|NCT02368847|Aged|aged
296088|NCT02368847|Psychiatric Hospitals|psychiatric hospitals
296089|NCT02368821|cytotrophoblast|cytotrophoblast
296090|NCT02368821|syncytiotrophoblast|syncytiotrophoblast
296091|NCT02368821|placentas|placentas
296092|NCT02368821|intrauterine growth restriction|intrauterine growth restriction
296093|NCT02368821|preeclampsia|preeclampsia
296094|NCT02368821|placenta accrete|placenta accrete
296095|NCT02368808|orphans and vulnerable children|orphans and vulnerable children
296096|NCT02368808|South Africa|south africa
296097|NCT02368808|peer support group|peer support group
296098|NCT02368795|Endoscopic Retrograde Cholangiopancreatography|endoscopic retrograde cholangiopancreatography
296099|NCT02368795|Pancreatic duct stenting|pancreatic duct stenting
296100|NCT02368795|Post-ERCP pancreatitis|post-ercp pancreatitis
296101|NCT02368782|transient evoked otoacoustic emissions|transient evoked otoacoustic emissions
296102|NCT02368782|distortion product otoacoustic emissions|distortion product otoacoustic emissions
296103|NCT02368782|ketamine|ketamine
296104|NCT02368782|propofol|propofol
296105|NCT02368782|child|child
296106|NCT02368704|Endoplasmic Reticulum|endoplasmic reticulum
296107|NCT02368678|Halitosis|halitosis
296108|NCT02368678|Sulfur compounds|sulfur compounds
296109|NCT02368678|Periodontitis|periodontitis
296110|NCT02368678|Periodontal treatment|periodontal treatment
296111|NCT02368600|lifestyle intervention|lifestyle intervention
296112|NCT02368600|gestational diabetes mellitus|gestational diabetes mellitus
296113|NCT02368600|Chinese|chinese
296114|NCT02368600|prevention|prevention
296115|NCT02368587|intracoronary infusion|intracoronary infusion
296116|NCT02368587|intravenous infusion|intravenous infusion
296117|NCT02368587|Wharton's jelly-derived mesenchymal stem cells|wharton's jelly-derived mesenchymal stem cells
296118|NCT02368587|ischemic Cardiomyopathy|ischemic cardiomyopathy
296119|NCT02368587|heart function|heart function
296120|NCT02368548|Pharmaceutical care|pharmaceutical care
296121|NCT02368548|Emergency Service|emergency service
296122|NCT02368535|teamwork|teamwork
296123|NCT02368509|sensory test|sensory test
296124|NCT02368509|olfaction|olfaction
296125|NCT02368509|gustation|gustation
296126|NCT02368509|taste|taste
296127|NCT02368509|cancer|cancer
296128|NCT02368496|Long-term parenteral nutrition|long-term parenteral nutrition
296129|NCT02368496|HR-pQCT|hr-pqct
296130|NCT02368496|DXA|dxa
296131|NCT02368496|Bone trophicity|bone trophicity
296132|NCT02368457|Mandibular osteoradionecrosis|mandibular osteoradionecrosis
296133|NCT02368457|Tocopherol|tocopherol
296134|NCT02368457|pentoxifylline|pentoxifylline
296135|NCT02368457|vitamine E|vitamine e
296136|NCT02368457|wounds and injuries|wounds and injuries
296137|NCT02368457|antioxidants|antioxidants
296138|NCT02368457|free radical scavengers|free radical scavengers
296139|NCT02368457|radiation-protective agents|radiation-protective agents
296140|NCT02368457|vasodilatadors agents|vasodilatadors agents
296141|NCT02368457|osteonecrosis|osteonecrosis
296142|NCT02368457|mandible|mandible
296143|NCT02368457|extraoral fistula|extraoral fistula
296144|NCT02368457|exposed bone|exposed bone
296145|NCT02368457|necrotic bone|necrotic bone
296146|NCT02368457|head and neck radiotherapy|head and neck radiotherapy
296147|NCT02368444|Posttraumatic Stress|posttraumatic stress
296148|NCT02368444|Sleep|sleep
296149|NCT02368431|Alcohol Use Disorder|alcohol use disorder
296150|NCT02368431|Alcoholism|alcoholism
296151|NCT02368431|Alcohol Dependence|alcohol dependence
296152|NCT02368431|Zonisamide|zonisamide
296153|NCT02368431|Alcoholic Intoxication|alcoholic intoxication
296154|NCT02368431|Drinking Behaviors|drinking behaviors
296155|NCT02368431|Anticonvulsants|anticonvulsants
296156|NCT02368418|Cardiovascular disease|cardiovascular disease
296157|NCT02368418|Rural health|rural health
296158|NCT02368418|China|china
296159|NCT02368418|Cohort study|cohort study
296762|NCT02364895|Screening|screening
296160|NCT02368392|in-hospital cardiac arrest|in-hospital cardiac arrest
296161|NCT02368392|quality of life after cardiac arrest|quality of life after cardiac arrest
378344|NCT01968551|HIV|hiv
296162|NCT02368392|survival after cardiac arrest|survival after cardiac arrest
296163|NCT02368392|resources for cardiac arrest|resources for cardiac arrest
296164|NCT02368379|Metyrapone|metyrapone
296165|NCT02368379|ACTH stimulation test|acth stimulation test
296166|NCT02368314|Deep vein thrombosis|deep vein thrombosis
296167|NCT02368314|Prophylaxis|prophylaxis
296168|NCT02368314|Sodium enoxaparin|sodium enoxaparin
296169|NCT02368288|chronic hepatitic B|chronic hepatitic b
296170|NCT02368288|peginterferon|peginterferon
296171|NCT02368288|HBsAg|hbsag
296172|NCT02368288|entecavir|entecavir
296173|NCT02368262|Cerebral Palsy|cerebral palsy
296174|NCT02368262|Risk factors|risk factors
296175|NCT02368262|Child|child
296176|NCT02368262|urinary incontinence|urinary incontinence
296177|NCT02368236|Early Detection of Cancer|early detection of cancer
296178|NCT02368236|Intervention Studies|intervention studies
296179|NCT02368236|Randomized Controlled Trial|randomized controlled trial
296180|NCT02368236|Colorectal Neoplasms|colorectal neoplasms
296181|NCT02368236|Colonic Neoplasms|colonic neoplasms
296182|NCT02368223|Children|children
296183|NCT02368223|Rehabilitation|rehabilitation
296184|NCT02368223|Telerehabilitation|telerehabilitation
296185|NCT02368223|Upper limb therapy|upper limb therapy
296186|NCT02368197|dialysis fistula|dialysis fistula
296187|NCT02368197|cephalic arch stenosis|cephalic arch stenosis
296188|NCT02368197|balloon angioplasty|balloon angioplasty
296189|NCT02368197|drug eluting balloon|drug eluting balloon
296190|NCT02368184|noninvasive physiologic monitoring|noninvasive physiologic monitoring
296191|NCT02368184|acute decompensated heart failure (ADHF)|acute decompensated heart failure (adhf)
296192|NCT02368158|myocard infarction|myocard infarction
296193|NCT02368158|arrhythmia|arrhythmia
296194|NCT02368158|fitness of driving|fitness of driving
296195|NCT02368145|stroke|stroke
296196|NCT02368145|acute stroke|acute stroke
296197|NCT02368145|post stroke depression|post stroke depression
296198|NCT02368132|Caregivers|caregivers
296199|NCT02368132|Dementia|dementia
296200|NCT02368106|patient registry|patient registry
296201|NCT02368106|radiation oncology|radiation oncology
296202|NCT02368106|technology assessment|technology assessment
296203|NCT02368093|Rheumatoid arthritis|rheumatoid arthritis
296204|NCT02368080|Lung Clearance Index|lung clearance index
296205|NCT02368080|Cystic Fibrosis|cystic fibrosis
296206|NCT02368080|Multiple Breath Nitrogen Washout|multiple breath nitrogen washout
296207|NCT02368054|Epinephrine|epinephrine
296208|NCT02368054|Bupivacaine|bupivacaine
296209|NCT02368054|Stroke Volume|stroke volume
296210|NCT02368054|Cardiac Output|cardiac output
296211|NCT02368054|Heart Rate|heart rate
296212|NCT02368054|Hemodynamics|hemodynamics
296213|NCT02368054|Total Peripheral Resistance|total peripheral resistance
296214|NCT02368054|Blood Pressure|blood pressure
296215|NCT02368054|Paracervical block|paracervical block
296217|NCT02368054|Adrenaline|adrenaline
296218|NCT02368054|Conization|conization
296219|NCT02368054|PulsCO|pulsco
296220|NCT02368028|Plaque|plaque
296221|NCT02368028|Saliva|saliva
296222|NCT02368028|Dental Caries|dental caries
296223|NCT02368015|Penetration|penetration
296224|NCT02368015|Cefazolin|cefazolin
296225|NCT02368015|Hepatic cyst|hepatic cyst
296226|NCT02368002|obesity|obesity
296227|NCT02368002|diet, reducing|diet, reducing
296228|NCT02367989|Glucose response|glucose response
296229|NCT02367989|Insulin response|insulin response
296230|NCT02367989|Satiety|satiety
296231|NCT02367963|Peer education|peer education
296232|NCT02367963|Comprehensive health intervention|comprehensive health intervention
296233|NCT02367963|Lifestyle|lifestyle
296234|NCT02367963|Adult|adult
296235|NCT02367963|Mid age|mid age
296236|NCT02367963|Male|male
296237|NCT02367963|Female|female
296238|NCT02367963|Human|human
296239|NCT02367963|Clinical trial|clinical trial
296240|NCT02367963|Prevention and control|prevention and control
296241|NCT02367963|Cardiovascular Disease|cardiovascular disease
296242|NCT02367963|Behavior|behavior
296243|NCT02367963|Risk Factors|risk factors
296244|NCT02367963|Healthy lifestyle|healthy lifestyle
296245|NCT02367963|Healthy people program|healthy people program
296246|NCT02367963|Peer-group|peer-group
296247|NCT02367937|Phase I drug-drug interaction|phase i drug-drug interaction
296248|NCT02367898|Cognitive Training|cognitive training
296249|NCT02367898|Lumosity|lumosity
296250|NCT02367898|Crossword Puzzles|crossword puzzles
296251|NCT02367885|Prevention|prevention
296252|NCT02367872|Drug therapy|drug therapy
296253|NCT02367859|ameloblastoma|ameloblastoma
296254|NCT02367859|BRAF|braf
296255|NCT02367859|odontogenic cancer|odontogenic cancer
296256|NCT02367859|adamantinoma|adamantinoma
296257|NCT02367846|Calcium Tracer|calcium tracer
296258|NCT02367846|Oral Contraceptives|oral contraceptives
296259|NCT02367846|Contraceptive Vaginal Ring|contraceptive vaginal ring
296260|NCT02367846|Impact of contraceptives on bone health using 41Ca|impact of contraceptives on bone health using 41ca
757094|NCT00415701|Propofol|propofol
378455|NCT01968018|Cancer|cancer
296261|NCT02367833|Insulin-like growth factor-1|insulin-like growth factor-1
296262|NCT02367833|Combined oral contraceptive|combined oral contraceptive
296263|NCT02367833|Contraceptive Vaginal Ring|contraceptive vaginal ring
296264|NCT02367833|Transdermal Contraceptive|transdermal contraceptive
296265|NCT02367807|HIV prevention|hiv prevention
296266|NCT02367807|PrEP|prep
296267|NCT02367807|young men who have sex with men|young men who have sex with men
296268|NCT02367807|Truvada|truvada
296269|NCT02367768|trauma blue|trauma blue
296270|NCT02367768|major trauma|major trauma
296271|NCT02367768|cohort study|cohort study
296272|NCT02367768|prognostic factor|prognostic factor
296273|NCT02367768|Healing Time|healing time
296274|NCT02367768|Post Operative|post operative
296275|NCT02367755|cardiopulmonary resuscitation|cardiopulmonary resuscitation
296276|NCT02367755|cardiac arrest|cardiac arrest
296277|NCT02367755|therapeutic hypothermia|therapeutic hypothermia
296278|NCT02367755|propofol|propofol
296279|NCT02367755|lorazepam|lorazepam
296280|NCT02367755|cerebral perfusion|cerebral perfusion
296281|NCT02367755|electroencephalography|electroencephalography
296282|NCT02367742|Diet|diet
296283|NCT02367742|Physical Activity|physical activity
296284|NCT02367742|NAFLD|nafld
296285|NCT02367703|Mini-laparoscopy|mini-laparoscopy
296286|NCT02367703|hysterectomy|hysterectomy
296287|NCT02367703|Benign uterine diseases|benign uterine diseases
296288|NCT02367703|Operative time|operative time
296289|NCT02367690|Diabetes|diabetes
296290|NCT02367690|Foot Ulcers|foot ulcers
296291|NCT02367690|DFU|dfu
296292|NCT02367690|KPT-330|kpt-330
296293|NCT02367690|Selinexor|selinexor
296294|NCT02367690|Karyopharm|karyopharm
296295|NCT02367677|Photo|photo
296296|NCT02367664|Japanese encephalitis|japanese encephalitis
296297|NCT02367664|immunogenicity|immunogenicity
296298|NCT02367664|safety|safety
296299|NCT02367664|vaccine|vaccine
296300|NCT02367651|Soft tissue sarcoma|soft tissue sarcoma
296301|NCT02367651|Pazopanib|pazopanib
296302|NCT02367651|Tyrosine kinase inhibitor|tyrosine kinase inhibitor
296303|NCT02367599|PrEP|prep
296304|NCT02367599|Pre exposure Prophylaxis|pre exposure prophylaxis
296305|NCT02367599|Truvada|truvada
296306|NCT02367599|CCTG|cctg
296307|NCT02367599|595|595
296308|NCT02367599|Vitamin D|vitamin d
296309|NCT02367599|Bone mineral density|bone mineral density
296310|NCT02367521|TBI Depression|tbi depression
296311|NCT02367521|co-morbid psychiatric symptoms|co-morbid psychiatric symptoms
296312|NCT02367508|advance care planning|advance care planning
296313|NCT02367508|coping skills|coping skills
296314|NCT02367508|mindfulness|mindfulness
296315|NCT02367508|meditation|meditation
296316|NCT02367508|cancer|cancer
296317|NCT02367508|adult|adult
296318|NCT02367508|caregivers|caregivers
296319|NCT02367508|oncology providers|oncology providers
296320|NCT02367508|advance directives|advance directives
296321|NCT02367508|anxiety|anxiety
296322|NCT02367508|depression|depression
296323|NCT02367508|quality of life|quality of life
296324|NCT02367508|pilot project|pilot project
296325|NCT02367495|Coronary Restenosis|coronary restenosis
296326|NCT02367495|restenosis|restenosis
296327|NCT02367495|paclitaxel-coated balloon|paclitaxel-coated balloon
296328|NCT02367495|drug-eluting stent|drug-eluting stent
296329|NCT02367495|drug-coated balloon|drug-coated balloon
296330|NCT02367495|coronary angiography|coronary angiography
296331|NCT02367482|rGBM|rgbm
296332|NCT02367482|Recurrent GBM|recurrent gbm
296333|NCT02367482|Recurrent Glioblastoma|recurrent glioblastoma
296334|NCT02367469|recurrent brain tumors|recurrent brain tumors
296335|NCT02367469|brain tumors|brain tumors
296336|NCT02367469|Newly diagnosed brain tumors|newly diagnosed brain tumors
296337|NCT02367456|MDS|mds
296338|NCT02367456|AML|aml
296339|NCT02367456|CMML|cmml
296340|NCT02367443|radiotherapy|radiotherapy
296341|NCT02367443|therapeutic use|therapeutic use
296342|NCT02367443|Radiation|radiation
296343|NCT02367443|non-small cell lung cancer|non-small cell lung cancer
296344|NCT02367443|chemotherapy|chemotherapy
296345|NCT02367417|Revision|revision
296346|NCT02367417|Knee Joint|knee joint
296347|NCT02367417|PMCF|pmcf
296348|NCT02367417|Endo-Modell SL|endo-modell sl
296349|NCT02367378|Minimally invasive surgery|minimally invasive surgery
296350|NCT02367365|Neovascular Age-Related Macular Degeneration|neovascular age-related macular degeneration
296351|NCT02367365|anti-vascular endothelial growth factor|anti-vascular endothelial growth factor
296352|NCT02367365|neovascular lesion morphology|neovascular lesion morphology
296353|NCT02367365|indocyanine green angiography|indocyanine green angiography
296354|NCT02367365|persistent disease activity|persistent disease activity
296355|NCT02367352|Drug therapy|drug therapy
296356|NCT02367352|Dose escalation|dose escalation
296357|NCT02367352|Dose expansion|dose expansion
296358|NCT02367339|Critical Care|critical care
296359|NCT02367339|Nursing staff|nursing staff
296360|NCT02367339|Medical staff|medical staff
758221|NCT00411814|antibody,|antibody,
296361|NCT02367339|Extended-spectrum betalactamase|extended-spectrum betalactamase
296362|NCT02367339|Digestive tract colonization|digestive tract colonization
297063|NCT02363192|Pharmacy|pharmacy
296363|NCT02367339|Cross-contamination|cross-contamination
296364|NCT02367326|score|score
296365|NCT02367326|inflammatory bowel disease|inflammatory bowel disease
296366|NCT02367326|crohn's disease|crohn's disease
296367|NCT02367326|ulcerative colitis|ulcerative colitis
296368|NCT02367326|clinical response|clinical response
296369|NCT02367326|thiopurines|thiopurines
296370|NCT02367313|Symptomatic Human Rhinovirus Infection|symptomatic human rhinovirus infection
296371|NCT02367313|Moderate to Severe Asthma|moderate to severe asthma
296372|NCT02367313|Antiviral|antiviral
296373|NCT02367313|Cold|cold
296374|NCT02367313|Aviragen Therapeutics, Inc.|aviragen therapeutics, inc.
296375|NCT02367313|Aviragen Therapeutics|aviragen therapeutics
296376|NCT02367313|Aviragen|aviragen
296377|NCT02367287|Diet|diet
296378|NCT02367287|Phenotype|phenotype
296379|NCT02367287|Immunology|immunology
296380|NCT02367287|Microbiota|microbiota
296381|NCT02367287|Metabolomics|metabolomics
296382|NCT02367287|Physical activity|physical activity
296383|NCT02367287|Neuroendocrine system|neuroendocrine system
296384|NCT02367287|Nutritional Physiological Phenomena|nutritional physiological phenomena
296385|NCT02367248|Brain hemorrhage|brain hemorrhage
296386|NCT02367248|Cerebral Hemorrhage|cerebral hemorrhage
296387|NCT02367248|Deferoxamine|deferoxamine
296388|NCT02367248|Xingnaojing injection|xingnaojing injection
296389|NCT02367248|Hematoma edema|hematoma edema
296390|NCT02367235|robotic|robotic
296391|NCT02367235|sacrocolpopexy|sacrocolpopexy
296392|NCT02367235|Colpassist|colpassist
296393|NCT02367235|vaginal positioning device|vaginal positioning device
296394|NCT02367209|FD MRI|fd mri
296395|NCT02367209|COPD|copd
296396|NCT02367209|SPECT/CT|spect/ct
296397|NCT02367209|DCE MRI|dce mri
296398|NCT02367196|CC-90002|cc-90002
296399|NCT02367196|Monoclonal|monoclonal
296400|NCT02367196|Antibody|antibody
296401|NCT02367196|CD47|cd47
296402|NCT02367196|Advanced|advanced
296403|NCT02367196|Solid Cancers|solid cancers
296404|NCT02367196|Hematologic Cancers|hematologic cancers
296405|NCT02367183|Crohn's Disease|crohn's disease
296406|NCT02367183|Active Crohn's Disease|active crohn's disease
296407|NCT02367183|GED-0301|ged-0301
296408|NCT02367183|Endoscopic|endoscopic
296409|NCT02367183|Double-Blind|double-blind
296410|NCT02367183|IBD|ibd
296411|NCT02367183|Mongersen|mongersen
296412|NCT02367170|respiratory dysfunction|respiratory dysfunction
296413|NCT02367170|chronic critical illness|chronic critical illness
296414|NCT02367170|diaphragm weakness|diaphragm weakness
296415|NCT02367170|sepsis|sepsis
296416|NCT02367170|ventilator dependance|ventilator dependance
296417|NCT02367118|chronic rhinosinusitis without nasal polyps prednisone|chronic rhinosinusitis without nasal polyps prednisone
296418|NCT02367105|Obesity|obesity
296419|NCT02367105|Hypogonadism|hypogonadism
296420|NCT02367105|Frailty|frailty
296421|NCT02367092|Liver Transplantation|liver transplantation
296422|NCT02367066|patients|patients
296423|NCT02367066|glycaemic control on metformin|glycaemic control on metformin
296424|NCT02367040|Clinical trial, Phase III|clinical trial, phase iii
296425|NCT02367040|Phosphatidylinositol-3-kinase|phosphatidylinositol-3-kinase
296426|NCT02367040|Non-Hodgkin's lymphoma|non-hodgkin's lymphoma
296427|NCT02367040|Indolent B-cell non-Hodgkin's lymphoma|indolent b-cell non-hodgkin's lymphoma
296428|NCT02367027|Biological Availability|biological availability
296429|NCT02367027|Relative Bioavailability Trial|relative bioavailability trial
296430|NCT02367014|Mitochondrial Myopathy|mitochondrial myopathy
296431|NCT02367014|Primary Mitochondrial Disease|primary mitochondrial disease
296432|NCT02367014|Bendavia™|bendavia™
296433|NCT02367014|elamipretide|elamipretide
296434|NCT02367001|general practitioner|general practitioner
296435|NCT02367001|screening|screening
296436|NCT02367001|participation|participation
296437|NCT02367001|organized screening|organized screening
296438|NCT02366988|Chronic pancreatitis|chronic pancreatitis
296439|NCT02366988|Clinical Trial|clinical trial
296440|NCT02366988|Bile stricture|bile stricture
296441|NCT02366988|Endoscopy|endoscopy
296442|NCT02366988|Surgery|surgery
296443|NCT02366975|BPH/LUTS|bph/luts
296444|NCT02366975|TRT|trt
296445|NCT02366975|Metabolic Syndrome|metabolic syndrome
296446|NCT02366962|Influenza|influenza
296447|NCT02366962|Vaccine|vaccine
296448|NCT02366962|ASP7374|asp7374
296449|NCT02366949|Phase 1|phase 1
296450|NCT02366949|Solid tumors|solid tumors
296451|NCT02366949|Breast cancer|breast cancer
296452|NCT02366949|Paclitaxel|paclitaxel
296453|NCT02366949|MPS-1 inhibitor|mps-1 inhibitor
296454|NCT02366949|Oncology|oncology
296455|NCT02366884|malignant|malignant
296456|NCT02366884|atavistic chemotherapy|atavistic chemotherapy
296457|NCT02366884|cancer|cancer
296458|NCT02366858|19 gauge|19 gauge
296459|NCT02366858|22 gauge|22 gauge
296460|NCT02366858|core tissue|core tissue
758222|NCT00411814|male,|male,
296461|NCT02366806|Breast Cancer|breast cancer
296462|NCT02366806|AJCC Stage 1, 2, 3|ajcc stage 1, 2, 3
296463|NCT02366806|Educational Design|educational design
296464|NCT02366806|Radiation Therapy Treatment|radiation therapy treatment
296763|NCT02364869|P-cresyl sulfate|p-cresyl sulfate
296465|NCT02366793|accessory mobilization, nerve mobilization.|accessory mobilization, nerve mobilization.
296466|NCT02366780|Lactation|lactation
296467|NCT02366780|Breastmilk|breastmilk
296468|NCT02366780|Macronutrients|macronutrients
296469|NCT02366767|Insulin Infusion Systems|insulin infusion systems
296470|NCT02366767|Continuous Glucose Monitors|continuous glucose monitors
296471|NCT02366754|Transcranial Magnetic Stimulation|transcranial magnetic stimulation
296472|NCT02366741|SCLC|sclc
296473|NCT02366741|Neuro-cognitive function|neuro-cognitive function
296474|NCT02366741|PCI|pci
296475|NCT02366741|Hippocampal sparing|hippocampal sparing
296476|NCT02366676|Recurrent cystitis|recurrent cystitis
296477|NCT02366676|hyaluronic acid|hyaluronic acid
296478|NCT02366676|chondroitin sulphate|chondroitin sulphate
296479|NCT02366663|Non-Hodgkin's lymphoma|non-hodgkin's lymphoma
296480|NCT02366663|autologous stem cell transplantation|autologous stem cell transplantation
296481|NCT02366663|radioimmunotherapy|radioimmunotherapy
296482|NCT02366663|Zevalin|zevalin
296483|NCT02366663|Lymphoma|lymphoma
296484|NCT02366663|Lymphoma, Large B-Cell, Diffuse|lymphoma, large b-cell, diffuse
296485|NCT02366663|Lymphoma, Non-Hodgkin|lymphoma, non-hodgkin
296486|NCT02366663|Immune System Diseases|immune system diseases
296487|NCT02366663|Immunoproliferative Disorders|immunoproliferative disorders
296488|NCT02366663|Lymphatic Diseases|lymphatic diseases
296489|NCT02366663|Lymphoma, B-Cell|lymphoma, b-cell
296490|NCT02366663|Lymphoproliferative Disorders|lymphoproliferative disorders
296491|NCT02366663|Neoplasms|neoplasms
296492|NCT02366663|Neoplasms by Histologic Type|neoplasms by histologic type
296493|NCT02366663|Antibodies, Monoclonal|antibodies, monoclonal
296494|NCT02366663|Immunologic Factors|immunologic factors
296495|NCT02366663|Pharmacologic Actions|pharmacologic actions
296496|NCT02366663|Physiological Effects of Drugs|physiological effects of drugs
296497|NCT02366637|COPD|copd
296498|NCT02366637|Sputum|sputum
296499|NCT02366611|Cancer Pain|cancer pain
296500|NCT02366611|EEG|eeg
296501|NCT02366611|fNIRS|fnirs
296502|NCT02366611|tDCS|tdcs
296503|NCT02366546|Adoptive cell transfer|adoptive cell transfer
296504|NCT02366546|Cell therapy|cell therapy
296505|NCT02366546|Immunotherapy|immunotherapy
296506|NCT02366546|NY-ESO-1|ny-eso-1
296507|NCT02366546|Esophageal cancer|esophageal cancer
296508|NCT02366546|Melanoma|melanoma
296509|NCT02366546|Head and neck cancer|head and neck cancer
296510|NCT02366546|Ovarian cancer|ovarian cancer
296511|NCT02366546|Synovial sarcoma|synovial sarcoma
296512|NCT02366546|TCR gene therapy|tcr gene therapy
296513|NCT02366533|Linkage to care|linkage to care
296514|NCT02366533|HIV|hiv
296515|NCT02366533|Efficacy of linkage to care program|efficacy of linkage to care program
296516|NCT02366520|Child|child
296517|NCT02366520|Child Behavior|child behavior
296518|NCT02366520|Dental Anxiety/prevention & control|dental anxiety/prevention & control
296519|NCT02366520|Dental Anxiety/psychology|dental anxiety/psychology
296520|NCT02366520|Cooperative Behavior|cooperative behavior
296521|NCT02366520|Dental Care/psychology*|dental care/psychology*
296522|NCT02366520|Humans|humans
296523|NCT02366520|Videotape Recording|videotape recording
296524|NCT02366507|hypotension|hypotension
296525|NCT02366507|doppler|doppler
296526|NCT02366507|shock|shock
296527|NCT02366494|prostate cancer|prostate cancer
296528|NCT02366494|treatment response|treatment response
296529|NCT02366494|androgen deprivation therapy|androgen deprivation therapy
296530|NCT02366481|Vitamin K|vitamin k
296531|NCT02366481|Vitamin K2|vitamin k2
296532|NCT02366481|Menaquinone-7|menaquinone-7
296533|NCT02366481|Osteocalcin|osteocalcin
296534|NCT02366481|Adults|adults
296535|NCT02366481|Obesity|obesity
296536|NCT02366481|Insulin resistance|insulin resistance
296537|NCT02366481|Insulin sensitivity|insulin sensitivity
296538|NCT02366481|Beta-cell function|beta-cell function
296539|NCT02366481|Prediabetes|prediabetes
296540|NCT02366468|Diabetic macular edema|diabetic macular edema
296541|NCT02366468|Visual impairment|visual impairment
296542|NCT02366442|dual/multitasking|dual/multitasking
296543|NCT02366442|Executive function|executive function
296544|NCT02366442|Affective function|affective function
296545|NCT02366442|Balance|balance
296546|NCT02366416|Exercise, Physical|exercise, physical
296547|NCT02366403|PTSD|ptsd
296548|NCT02366403|Meditation|meditation
296549|NCT02366403|Yoga|yoga
296550|NCT02366403|Cognitive Therapy|cognitive therapy
296551|NCT02366390|Psychoeducative|psychoeducative
296552|NCT02366390|HADS|hads
296553|NCT02366390|COPD|copd
296554|NCT02366390|dyspnea|dyspnea
296555|NCT02366364|NRX-1074|nrx-1074
296556|NCT02366364|NMDA Receptor Modulator|nmda receptor modulator
296557|NCT02366364|Major Depressive Disorder|major depressive disorder
296558|NCT02366364|Glycine Site Modulator|glycine site modulator
378835|NCT01966757|NCL|ncl
296559|NCT02366312|Keratocystic odontogenic tumor|keratocystic odontogenic tumor
296560|NCT02366312|KCOT|kcot
296561|NCT02366273|Diabetes|diabetes
296562|NCT02366273|Psoriasis|psoriasis
296563|NCT02366273|Inflammation|inflammation
296564|NCT02366273|Insulin-resistance|insulin-resistance
296565|NCT02366247|Polyethylene Glycol Thymosin alpha1|polyethylene glycol thymosin alpha1
296567|NCT02366247|Hepatitis B e Antigens positive|hepatitis b e antigens positive
296568|NCT02366208|Polyethylene Glycol Thymosin alpha1|polyethylene glycol thymosin alpha1
296569|NCT02366208|Adefovir|adefovir
296570|NCT02366208|Hepatitis B e Antigens positive|hepatitis b e antigens positive
296571|NCT02366195|T-VEC|t-vec
296572|NCT02366195|CD8+ cell density|cd8+ cell density
296573|NCT02366195|objective response rate|objective response rate
296574|NCT02366195|unresected|unresected
296575|NCT02366195|Melanoma|melanoma
296576|NCT02366130|Breast cancer|breast cancer
296577|NCT02366130|Hormone-positive bone-dominant metastatic breast cancer|hormone-positive bone-dominant metastatic breast cancer
296578|NCT02366130|Ra-223 dichloride|ra-223 dichloride
296579|NCT02366130|Xofigo|xofigo
296580|NCT02366130|Radium-223 chloride|radium-223 chloride
296581|NCT02366130|Radium-223 dichloride|radium-223 dichloride
296582|NCT02366130|Alpharadin|alpharadin
296583|NCT02366130|Denosumab|denosumab
296584|NCT02366130|AMG 162|amg 162
296585|NCT02366130|Prolia|prolia
296586|NCT02366130|Hormone therapy|hormone therapy
296587|NCT02366117|Quirc|quirc
296588|NCT02366117|Quality Indiciator in Rehabilitative Care|quality indiciator in rehabilitative care
296589|NCT02366104|Cardiovascular Diseases|cardiovascular diseases
296590|NCT02366104|Aged|aged
296591|NCT02366104|Primary Prevention|primary prevention
296592|NCT02366052|Histologically confirmed NASH|histologically confirmed nash
296593|NCT02366052|Hepatocyte Injury determined by M30 antigen|hepatocyte injury determined by m30 antigen
296594|NCT02366026|HIV|hiv
296595|NCT02366013|HIV|hiv
296596|NCT02366013|HIV Prevention|hiv prevention
296597|NCT02366013|HIV Vaccine|hiv vaccine
296598|NCT02366013|Healthy|healthy
296599|NCT02366000|Parent-child communication|parent-child communication
296600|NCT02366000|Health risk behaviors|health risk behaviors
296601|NCT02366000|Randomized controlled trial|randomized controlled trial
296602|NCT02365987|interesterified|interesterified
296603|NCT02365987|postprandial|postprandial
296604|NCT02365974|arterial stiffness|arterial stiffness
296605|NCT02365974|resistant hypertension|resistant hypertension
296606|NCT02365974|sympathetic system|sympathetic system
296607|NCT02365974|blood pressure|blood pressure
296608|NCT02365974|transcutaneous electrical nerve stimulation|transcutaneous electrical nerve stimulation
296609|NCT02365961|Hip Arthroscopy|hip arthroscopy
296610|NCT02365948|Pharmacokinetics|pharmacokinetics
296611|NCT02365948|Certolizumab Pegol|certolizumab pegol
296612|NCT02365948|Healthy Chinese subjects|healthy chinese subjects
296613|NCT02365935|adjuvant chemotherapy|adjuvant chemotherapy
296614|NCT02365922|FTLD, PSP, CBD, PPA, FTD, FTD-ALS, CBS, ALS, svPPA, nfvPPA, oPSP|ftld, psp, cbd, ppa, ftd, ftd-als, cbs, als, svppa, nfvppa, opsp
296615|NCT02365883|Prostate Cancer|prostate cancer
296616|NCT02365883|Transrectal Imaging|transrectal imaging
296617|NCT02365870|Anxiety Disorders|anxiety disorders
296618|NCT02365870|Parkinson Disease|parkinson disease
296619|NCT02365870|rotigotine|rotigotine
296620|NCT02365857|spinal anesthesia|spinal anesthesia
296621|NCT02365857|caesarian section|caesarian section
296622|NCT02365857|Dexmedetomidine|dexmedetomidine
296623|NCT02365844|Narrow Band Imaging|narrow band imaging
296624|NCT02365844|oropharyngeal carcinoma|oropharyngeal carcinoma
296625|NCT02365831|MBC|mbc
296626|NCT02365831|breast|breast
296627|NCT02365831|metastatic|metastatic
296628|NCT02365831|cancer|cancer
296629|NCT02365831|HER2|her2
296630|NCT02365818|Bladder Cancer|bladder cancer
296631|NCT02365805|BRCA 1 levels|brca 1 levels
296632|NCT02365805|HER2 Negative|her2 negative
296633|NCT02365792|Clinical Decision Support|clinical decision support
296634|NCT02365792|Clinical Practice Guidelines|clinical practice guidelines
296635|NCT02365792|Emergency Medical Services|emergency medical services
296636|NCT02365779|salpingectomy|salpingectomy
296637|NCT02365779|optical biopsy|optical biopsy
296638|NCT02365779|Cellvizio®|cellvizio®
296639|NCT02365766|MK-3475|mk-3475
296640|NCT02365766|Gemcitabine|gemcitabine
296641|NCT02365766|Cisplatin|cisplatin
296642|NCT02365766|Pembrolizumab|pembrolizumab
296643|NCT02365766|Neoadjuvant Bladder Cancer|neoadjuvant bladder cancer
296644|NCT02365753|lower transverse cesarean delivery|lower transverse cesarean delivery
296645|NCT02365753|Pregnant women|pregnant women
296646|NCT02365740|Type 1 Diabetes mellitus|type 1 diabetes mellitus
296647|NCT02365740|Gastric Emptying|gastric emptying
296648|NCT02365740|Insulin Infusion Pump|insulin infusion pump
296649|NCT02365701|Functional Dyspepsia|functional dyspepsia
296650|NCT02365688|Open Abdominal Surgical Procedure|open abdominal surgical procedure
296651|NCT02365675|Pemphigus|pemphigus
296652|NCT02365675|Pemphigoid|pemphigoid
296653|NCT02365675|Wound Healing|wound healing
296654|NCT02365675|Itch|itch
378955|NCT01966276|fatigue|fatigue
296655|NCT02365675|Pain|pain
296656|NCT02365675|Wound dressing|wound dressing
296657|NCT02365675|Topical treatment|topical treatment
296658|NCT02365662|Oncology|oncology
296659|NCT02365662|Cancer|cancer
296660|NCT02365662|Solid Tumor types likely to exhibit elevated levels of Epidermal Growth Factor Receptor|solid tumor types likely to exhibit elevated levels of epidermal growth factor receptor
296661|NCT02365662|Solid Tumors|solid tumors
296662|NCT02365649|Crohn's Disease|crohn's disease
296961|NCT02363738|Bipolar|bipolar
296663|NCT02365623|Pulmonary Multi-Drug Resistant Tuberculosis (MDR-TB)|pulmonary multi-drug resistant tuberculosis (mdr-tb)
296664|NCT02365623|TMC207|tmc207
296665|NCT02365623|Bedaquiline|bedaquiline
296666|NCT02365610|Cannabidivarin|cannabidivarin
296667|NCT02365610|CBDV|cbdv
296668|NCT02365610|GWP42006|gwp42006
296669|NCT02365597|Urothelial Cancer|urothelial cancer
296670|NCT02365597|JNJ-42756493|jnj-42756493
296671|NCT02365597|Erdafitinib|erdafitinib
296672|NCT02365597|Tyrosine Kinase Inhibitor|tyrosine kinase inhibitor
296673|NCT02365532|drug-induced long QT syndrome|drug-induced long qt syndrome
296674|NCT02365532|DILQTS|dilqts
296675|NCT02365532|prolonged QT|prolonged qt
296676|NCT02365519|LME636|lme636
296677|NCT02365519|dry eye disease|dry eye disease
296678|NCT02365519|efficacy|efficacy
296679|NCT02365519|ocular discomfort|ocular discomfort
296680|NCT02365506|Congenital Long QT Syndrome|congenital long qt syndrome
296681|NCT02365506|LQTS|lqts
296682|NCT02365506|Long QT2 Syndrome|long qt2 syndrome
296683|NCT02365506|LQT2|lqt2
296684|NCT02365506|Sudden Cardiac Death|sudden cardiac death
296685|NCT02365493|Methicillin-Resistant Staphylococcus aureus (MRSA)|methicillin-resistant staphylococcus aureus (mrsa)
296686|NCT02365467|TEVAR|tevar
296687|NCT02365467|Thoracic Aneurysm|thoracic aneurysm
296688|NCT02365467|Endovascular Aortic Repair|endovascular aortic repair
296689|NCT02365467|Type B Dissection|type b dissection
296691|NCT02365441|GIST|gist
296692|NCT02365441|Advanced|advanced
296693|NCT02365428|Maternal welfare|maternal welfare
296694|NCT02365402|chronic hepatitis B|chronic hepatitis b
296695|NCT02365402|peginterferon|peginterferon
296696|NCT02365402|sustained viral response|sustained viral response
296697|NCT02365402|entecavir|entecavir
296698|NCT02365402|HBeAg|hbeag
296699|NCT02365337|Vitamin D|vitamin d
296700|NCT02365337|time lapse monitoring|time lapse monitoring
296701|NCT02365337|embryo|embryo
296702|NCT02365324|culinary skills|culinary skills
296703|NCT02365324|menu planning|menu planning
296704|NCT02365324|grocery shopping|grocery shopping
296705|NCT02365324|children|children
296706|NCT02365324|healthy eating|healthy eating
296707|NCT02365324|physical activity|physical activity
296708|NCT02365272|pharmacokinetics|pharmacokinetics
296709|NCT02365272|aminoglycosides|aminoglycosides
296710|NCT02365246|atopic dermatitis|atopic dermatitis
296711|NCT02365246|immunoadsorption|immunoadsorption
296712|NCT02365233|Type II Diabetes|type ii diabetes
296713|NCT02365233|Nonalcoholic fatty liver|nonalcoholic fatty liver
296714|NCT02365194|Ventral Hernia|ventral hernia
296715|NCT02365194|Prehabilitation|prehabilitation
296716|NCT02365181|Shoulder arthroplasty|shoulder arthroplasty
296717|NCT02365168|Fish allergy|fish allergy
296718|NCT02365155|Frailty|frailty
296719|NCT02365155|Heart failure|heart failure
296720|NCT02365155|Physical activity|physical activity
296721|NCT02365155|Cognitive state|cognitive state
296722|NCT02365142|Knee Osteoarthritis|knee osteoarthritis
296723|NCT02365142|Mesenchimal stem cell|mesenchimal stem cell
296724|NCT02365142|Osteoarthritis|osteoarthritis
296725|NCT02365129|BRITE adipose tissue|brite adipose tissue
296726|NCT02365129|physical activity|physical activity
296727|NCT02365129|Thermogenesis|thermogenesis
296728|NCT02365129|Body Temperature Regulation|body temperature regulation
296729|NCT02365129|Energy Metabolism|energy metabolism
296730|NCT02365116|Peer Mentorship|peer mentorship
296731|NCT02365116|Psychiatric Hospitalization|psychiatric hospitalization
296732|NCT02365116|Suicide Risk|suicide risk
296733|NCT02365103|Anemia, Iron-Deficiency|anemia, iron-deficiency
296734|NCT02365103|Iron, Bioavailability|iron, bioavailability
296735|NCT02365103|Hepcidins|hepcidins
296736|NCT02365103|Intestinal, Absorption|intestinal, absorption
296737|NCT02365103|Isotope Labeling, Stable|isotope labeling, stable
296738|NCT02365077|Adverse Effect of Glucocorticoids|adverse effect of glucocorticoids
296739|NCT02365077|Femur Head Necrosis|femur head necrosis
296740|NCT02365077|Susceptibility|susceptibility
296741|NCT02365077|GWAS|gwas
296742|NCT02365025|Sleep patterns|sleep patterns
296743|NCT02365025|Electronic Media Exposure|electronic media exposure
296744|NCT02365025|Parental Intervention|parental intervention
296745|NCT02364934|rocuronium|rocuronium
296746|NCT02364934|sex|sex
296747|NCT02364934|elderly|elderly
296748|NCT02364934|Close-loop infusion system|close-loop infusion system
296749|NCT02364921|venous ulcer|venous ulcer
296750|NCT02364921|wound healing|wound healing
296751|NCT02364921|compression bandages|compression bandages
296752|NCT02364908|systemic lupus erythematosus|systemic lupus erythematosus
296753|NCT02364908|antimalarials|antimalarials
296754|NCT02364908|therapeutic education|therapeutic education
296755|NCT02364908|Coping questionnaire|coping questionnaire
296756|NCT02364908|MASRI questionnaire|masri questionnaire
296757|NCT02364908|morisky medication adherence scale|morisky medication adherence scale
296758|NCT02364908|lupus Quality Of Life|lupus quality of life
296759|NCT02364908|internal medicine|internal medicine
296760|NCT02364895|Mailed invitation|mailed invitation
296761|NCT02364895|Fecal Occult Blood Test|fecal occult blood test
296764|NCT02364869|Indoxyl sulfate|indoxyl sulfate
296765|NCT02364869|Intestine|intestine
296766|NCT02364869|Endothelial function|endothelial function
296767|NCT02364856|Autonomic Nervous System|autonomic nervous system
296768|NCT02364856|Cerebral Palsy|cerebral palsy
296769|NCT02364856|Pain|pain
296770|NCT02364856|Children|children
296771|NCT02364843|Threonine|threonine
296772|NCT02364843|enteral feedings|enteral feedings
296773|NCT02364843|infants|infants
296774|NCT02364843|amino acid|amino acid
296775|NCT02364843|requirements|requirements
296776|NCT02364830|Pimpinella anisum L.|pimpinella anisum l.
296777|NCT02364830|Peppermint oil|peppermint oil
296778|NCT02364830|Irritable Bowel Syndrome|irritable bowel syndrome
296779|NCT02364817|Attention Deficit Disorder with Hyperactivity|attention deficit disorder with hyperactivity
296780|NCT02364817|Alcohol Dependence|alcohol dependence
296781|NCT02364817|Adults|adults
296782|NCT02364817|Treatment outcome|treatment outcome
296783|NCT02364817|Mental Health|mental health
296784|NCT02364791|pulmonary resection|pulmonary resection
296785|NCT02364791|chest tube|chest tube
296786|NCT02364791|segmentectomy|segmentectomy
296787|NCT02364791|lobectomy|lobectomy
296788|NCT02364778|CAD|cad
296789|NCT02364765|Maxillofacial Orthognathic Surgery|maxillofacial orthognathic surgery
296790|NCT02364765|Hemoglobin|hemoglobin
296791|NCT02364765|Red Blood Cells|red blood cells
296792|NCT02364765|Hematocrit|hematocrit
296793|NCT02364765|Blood Platelets|blood platelets
296794|NCT02364765|Body Weight|body weight
296795|NCT02364765|Operative Time|operative time
296796|NCT02364765|Age Groups|age groups
296797|NCT02364765|Gender|gender
296798|NCT02364726|Acupuncture|acupuncture
296799|NCT02364726|Paclitaxel|paclitaxel
296800|NCT02364726|15-011|15-011
296801|NCT02364700|stroke, robotics, hand rehabilitation|stroke, robotics, hand rehabilitation
296802|NCT02364674|HRCT|hrct
296803|NCT02364674|High Resolution Computed Tomography scans|high resolution computed tomography scans
296804|NCT02364674|Functional Respiratory Imaging|functional respiratory imaging
296805|NCT02364674|FRI|fri
296806|NCT02364674|Computed Tomography|computed tomography
296807|NCT02364674|CT|ct
296808|NCT02364674|Bronchiolitis Obliterans|bronchiolitis obliterans
296809|NCT02364674|BOS|bos
296810|NCT02364674|Lung Transplant|lung transplant
296811|NCT02364661|Hepatitis B virus|hepatitis b virus
296812|NCT02364661|Metabolovirus|metabolovirus
296813|NCT02364648|Endothelium, vascular|endothelium, vascular
296814|NCT02364648|MitoQ|mitoq
296815|NCT02364648|Mitochondria|mitochondria
296816|NCT02364648|Oxidative Stress|oxidative stress
296817|NCT02364648|Chronic Renal Insufficiency|chronic renal insufficiency
296818|NCT02364648|Cardiovascular Disease|cardiovascular disease
296819|NCT02364635|Phase I pharmacokinetics and safety study|phase i pharmacokinetics and safety study
296820|NCT02364622|flexible intubating stylet|flexible intubating stylet
296821|NCT02364622|double-lumen endobronchial tube|double-lumen endobronchial tube
296822|NCT02364596|Staphylococcus aureus vaccine|staphylococcus aureus vaccine
296823|NCT02364596|Staphylococcal infection|staphylococcal infection
296824|NCT02364570|CVD|cvd
296825|NCT02364570|Hyperglycemia|hyperglycemia
296826|NCT02364570|Postprandial|postprandial
296827|NCT02364570|Vascular Function|vascular function
296828|NCT02364531|Prostatic Neoplasms|prostatic neoplasms
296829|NCT02364531|Prostate Cancer|prostate cancer
296830|NCT02364531|Metastatic|metastatic
296831|NCT02364531|Observational|observational
296832|NCT02364531|Abiraterone Acetate|abiraterone acetate
296833|NCT02364531|ZYTIGA|zytiga
296834|NCT02364518|Snoring|snoring
296835|NCT02364518|snoreplasy|snoreplasy
296836|NCT02364518|Tranquill|tranquill
296837|NCT02364518|Sutures|sutures
296838|NCT02364505|caregivers|caregivers
296839|NCT02364492|[C04.588.180]|[c04.588.180]
296840|NCT02364440|skin laxity|skin laxity
296841|NCT02364440|Ultherapy™ System|ultherapy™ system
296842|NCT02364440|rhytids|rhytids
296843|NCT02364427|Pulse wave velocity|pulse wave velocity
296844|NCT02364427|Arterial stiffness|arterial stiffness
296845|NCT02364427|AKI|aki
296846|NCT02364401|Atrial Fibrillation|atrial fibrillation
296847|NCT02364401|Catheter ablation|catheter ablation
296848|NCT02364388|breast imaging diagnosis|breast imaging diagnosis
296849|NCT02364388|breast ultrasound|breast ultrasound
296850|NCT02364388|Imagio|imagio
296851|NCT02364388|Seno Medical Instruments, Inc.|seno medical instruments, inc.
296852|NCT02364388|Seno|seno
296853|NCT02364388|opto-acoustics|opto-acoustics
296854|NCT02364388|OA|oa
296855|NCT02364336|Chronic Hepatitis B|chronic hepatitis b
296856|NCT02364310|Hypertension|hypertension
296857|NCT02364310|baroreceptor stimulation|baroreceptor stimulation
296858|NCT02364310|Hypertension resistant|hypertension resistant
296859|NCT02364297|Bleeding gastric varices|bleeding gastric varices
296860|NCT02364297|Transjugular intrahepatic portosystemic shunt (TIPS)|transjugular intrahepatic portosystemic shunt (tips)
296861|NCT02364297|Injection of adhesives|injection of adhesives
296862|NCT02364271|High-sensitive troponin|high-sensitive troponin
296863|NCT02364271|Coronary Artery Calcium Score|coronary artery calcium score
296864|NCT02364271|TIMI score|timi score
296865|NCT02364271|Heart-type fatty acid binding protein|heart-type fatty acid binding protein
296866|NCT02364271|Major adverse cardiac event|major adverse cardiac event
296867|NCT02364271|HEART score|heart score
296868|NCT02364245|Cerebral Palsy.|cerebral palsy.
296869|NCT02364245|Upper Extremity|upper extremity
296870|NCT02364245|Kinect|kinect
296871|NCT02364245|Virtual reality|virtual reality
296872|NCT02364219|prewarming|prewarming
296873|NCT02364219|perioperative hypothermia|perioperative hypothermia
296874|NCT02364219|microdialysis|microdialysis
296875|NCT02364219|tissue oxygen saturation|tissue oxygen saturation
296876|NCT02364219|cytoreductive surgery|cytoreductive surgery
296877|NCT02364206|newly diagnosed glioblastoma|newly diagnosed glioblastoma
296878|NCT02364206|p38 MAPK inhibitor|p38 mapk inhibitor
296879|NCT02364206|temozolomide|temozolomide
296880|NCT02364206|radiotherapy|radiotherapy
296881|NCT02364193|Intrathoracic blood volume|intrathoracic blood volume
296882|NCT02364193|Extravascular lung water|extravascular lung water
296883|NCT02364154|biomarker|biomarker
296884|NCT02364154|screening|screening
296885|NCT02364154|coloscopy|coloscopy
296886|NCT02364141|stroke|stroke
296887|NCT02364141|upper extremity|upper extremity
296888|NCT02364141|motor learning|motor learning
296889|NCT02364141|rehabilitation|rehabilitation
296890|NCT02364115|Spinal metastases|spinal metastases
296891|NCT02364115|Spinal metastatic disease|spinal metastatic disease
296892|NCT02364115|Stereotactic Body Radiotherapy|stereotactic body radiotherapy
296893|NCT02364115|Response|response
296894|NCT02364115|Bone metastases|bone metastases
296895|NCT02364089|Adrenal Incidentaloma|adrenal incidentaloma
296896|NCT02364089|Subclinical Cushing's syndrome|subclinical cushing's syndrome
296897|NCT02364089|Hypertension|hypertension
296898|NCT02364089|Cardiovascular Risk Factors|cardiovascular risk factors
296899|NCT02364089|Metabolic Syndrome|metabolic syndrome
296900|NCT02364089|Surgery of adrenal tumor|surgery of adrenal tumor
296901|NCT02364076|Pembrolizumab|pembrolizumab
296902|NCT02364076|Epacadostat|epacadostat
296903|NCT02364063|Urinary incontinence|urinary incontinence
296904|NCT02364063|cerebral palsy|cerebral palsy
296905|NCT02364063|urotherapy|urotherapy
296906|NCT02364063|child|child
296907|NCT02364037|intrauterine device|intrauterine device
296908|NCT02364037|subdermal implant|subdermal implant
296909|NCT02364037|contraceptive counseling|contraceptive counseling
296910|NCT02364024|Colon and rectum carcinoma|colon and rectum carcinoma
296911|NCT02364024|Immune response|immune response
296912|NCT02364024|Biomarker|biomarker
296913|NCT02364024|Prognosis|prognosis
296914|NCT02364011|Biomechanics|biomechanics
296915|NCT02364011|Primary Total Knee Arthroplasty|primary total knee arthroplasty
296916|NCT02364011|TKA Bearings|tka bearings
296917|NCT02364011|Osteoarthritis|osteoarthritis
296918|NCT02364011|Total Knee Replacement|total knee replacement
296919|NCT02363998|detoxification|detoxification
296920|NCT02363998|agonist taper|agonist taper
296921|NCT02363998|methadone step down|methadone step down
296922|NCT02363998|buprenorphine step down|buprenorphine step down
296923|NCT02363998|opioid withdrawal syndrome|opioid withdrawal syndrome
296924|NCT02363959|Hyperbaric Oxygen|hyperbaric oxygen
296925|NCT02363959|Lung Transplantation|lung transplantation
296926|NCT02363959|Central Airway Stenosis|central airway stenosis
296927|NCT02363959|Airway Exudative Plaques|airway exudative plaques
296928|NCT02363959|Hyperbaric Oxygen Therapy|hyperbaric oxygen therapy
296929|NCT02363959|Post-Lung Transplantation|post-lung transplantation
296930|NCT02363959|Airway Ischemia|airway ischemia
296931|NCT02363959|Endobronchial Biopsy|endobronchial biopsy
296932|NCT02363959|Bronchoscopy|bronchoscopy
296933|NCT02363946|alpha-1 antitrypsin|alpha-1 antitrypsin
296934|NCT02363946|AATD|aatd
296935|NCT02363933|Perampanel|perampanel
296936|NCT02363933|Seizures|seizures
296937|NCT02363920|COPD patients|copd patients
296938|NCT02363907|diabetes mellitus|diabetes mellitus
296939|NCT02363907|pediatric|pediatric
296940|NCT02363907|continuous glucose monitoring system|continuous glucose monitoring system
296942|NCT02363855|Neoplasm Metastasis|neoplasm metastasis
296943|NCT02363855|Metastatic castration-resistant prostate cancer|metastatic castration-resistant prostate cancer
296944|NCT02363855|Castration-resistant prostate cancer (CRPC)|castration-resistant prostate cancer (crpc)
296945|NCT02363842|Pressure Ulcer|pressure ulcer
296946|NCT02363842|Skin IQ MCM coverlet|skin iq mcm coverlet
712548|NCT00579761|Endocarditis|endocarditis
296947|NCT02363842|Pressure redistribution surfaces|pressure redistribution surfaces
296948|NCT02363829|clinical stages IIA, IIB, IIIA, IIIB, IVA|clinical stages iia, iib, iiia, iiib, iva
296949|NCT02363829|invasive carcinoma|invasive carcinoma
296950|NCT02363829|uterine cervix|uterine cervix
296951|NCT02363790|Ventral Hernia|ventral hernia
296952|NCT02363790|Laparoscopic|laparoscopic
296953|NCT02363764|respiratory sampling|respiratory sampling
296954|NCT02363751|Bellini|bellini
296955|NCT02363751|Metastatic|metastatic
296956|NCT02363751|Chemotherapy|chemotherapy
296957|NCT02363751|Bevacizumab|bevacizumab
296958|NCT02363738|Bipolar Disorder|bipolar disorder
296959|NCT02363738|Bipolar Depression|bipolar depression
296960|NCT02363738|Inflammation|inflammation
296962|NCT02363725|Acute myocardial infarction|acute myocardial infarction
296963|NCT02363725|Inflammation|inflammation
296964|NCT02363725|CRP|crp
296965|NCT02363725|Colchicine|colchicine
296966|NCT02363712|Osteoarthritis, knee|osteoarthritis, knee
296967|NCT02363712|therapy|therapy
296968|NCT02363712|shoe|shoe
296969|NCT02363712|Randomized Controlled Trial|randomized controlled trial
296970|NCT02363699|cholelithiasis|cholelithiasis
296971|NCT02363699|Cytokines|cytokines
296972|NCT02363699|under general anesthesia|under general anesthesia
296973|NCT02363673|Autism Spectrum Disorder|autism spectrum disorder
296974|NCT02363673|Children|children
296975|NCT02363673|Homoeopathy|homoeopathy
296976|NCT02363660|HIV-uninfected|hiv-uninfected
296977|NCT02363647|medullary thyroid cancer|medullary thyroid cancer
296978|NCT02363647|thyroid cancer|thyroid cancer
296979|NCT02363647|personalized therapy|personalized therapy
296980|NCT02363647|personalized chemotherapy|personalized chemotherapy
296981|NCT02363647|individualized treatment|individualized treatment
296982|NCT02363647|colon cancer|colon cancer
296983|NCT02363647|colorectal cancer|colorectal cancer
296984|NCT02363634|magnesium status|magnesium status
296985|NCT02363634|sleep quality|sleep quality
296986|NCT02363608|Canine-Assisted|canine-assisted
296987|NCT02363608|15-010|15-010
296988|NCT02363608|post surgery patients|post surgery patients
296989|NCT02363595|Genomic Predictors|genomic predictors
296990|NCT02363595|14-277|14-277
296991|NCT02363569|post coital bleeding|post coital bleeding
296992|NCT02363569|vaginal bleeding|vaginal bleeding
296993|NCT02363556|Cervical Dilation|cervical dilation
296994|NCT02363556|Dilation and Evacuation|dilation and evacuation
296995|NCT02363556|Misoprostol|misoprostol
296996|NCT02363556|Misoprostol-Dilapan|misoprostol-dilapan
296997|NCT02363556|Abortion|abortion
296998|NCT02363530|cataract surgery|cataract surgery
296999|NCT02363530|cornea protect|cornea protect
297000|NCT02363530|xerophthalmia|xerophthalmia
297001|NCT02363530|Corneal clarity|corneal clarity
297002|NCT02363517|Hepatitis|hepatitis
297003|NCT02363517|Viral|viral
297004|NCT02363517|Non-A|non-a
297005|NCT02363517|Non-B|non-b
297006|NCT02363517|Parenterally-Transmitted|parenterally-transmitted
297007|NCT02363504|Magnetic Resonance Imaging|magnetic resonance imaging
297008|NCT02363504|Noradrenaline|noradrenaline
297009|NCT02363504|locus coeruleus|locus coeruleus
297010|NCT02363504|memory|memory
297011|NCT02363465|skin thickness|skin thickness
297012|NCT02363465|high-frequency ultrasound|high-frequency ultrasound
297013|NCT02363452|Aicardi-Goutières syndrome|aicardi-goutières syndrome
297014|NCT02363452|Reverse transcriptase inhibitors|reverse transcriptase inhibitors
297015|NCT02363452|open single study|open single study
297016|NCT02363452|interferon signature|interferon signature
297017|NCT02363426|intravaginal culture|intravaginal culture
297018|NCT02363426|in vitro fertilization|in vitro fertilization
297019|NCT02363426|blastocyst|blastocyst
297020|NCT02363426|pregnancy|pregnancy
297021|NCT02363413|NIV|niv
297022|NCT02363413|Overlap Syndrom|overlap syndrom
297023|NCT02363413|home|home
297024|NCT02363413|hospital|hospital
297025|NCT02363400|Nasopharyngeal carcinoma (NPC)|nasopharyngeal carcinoma (npc)
297026|NCT02363400|Epstein-Barr virus (EBV)|epstein-barr virus (ebv)
297027|NCT02363400|radiotherapy (RT)|radiotherapy (rt)
297028|NCT02363400|Plasma EBV DNA(pEBV DNA)|plasma ebv dna(pebv dna)
297029|NCT02363400|Adjuvant Chemotherapy|adjuvant chemotherapy
297030|NCT02363387|HIV|hiv
297031|NCT02363387|antiretroviral medications|antiretroviral medications
297032|NCT02363387|incentives|incentives
297033|NCT02363374|Rectal cancer stage II|rectal cancer stage ii
297034|NCT02363374|Rectal cancer stage III|rectal cancer stage iii
297035|NCT02363374|Multimodality treatment of locally advanced rectal cancer|multimodality treatment of locally advanced rectal cancer
297036|NCT02363348|L arginine|l arginine
297037|NCT02363348|Preeclampsia|preeclampsia
297038|NCT02363335|GLP-1|glp-1
297039|NCT02363335|Phosphodiesterase Inhibitor|phosphodiesterase inhibitor
297040|NCT02363335|GLP|glp
297041|NCT02363322|Medical Countermeasures|medical countermeasures
297042|NCT02363322|VHF|vhf
297043|NCT02363322|EVD|evd
297044|NCT02363309|13C|13c
297045|NCT02363309|Fatty Liver|fatty liver
297046|NCT02363309|Acetate|acetate
297047|NCT02363309|Breath Tests|breath tests
297048|NCT02363309|Palmitate|palmitate
297049|NCT02363296|Paired Associative Stimulation (PAS)|paired associative stimulation (pas)
297050|NCT02363296|Brain Cooling - Selected|brain cooling - selected
297051|NCT02363296|Brain Cooling Helmet|brain cooling helmet
297052|NCT02363296|Repetitive TMS (rTMS)|repetitive tms (rtms)
297053|NCT02363296|EEG phasxe-triggered TMS|eeg phasxe-triggered tms
297054|NCT02363270|Analgesia|analgesia
297055|NCT02363270|ketamine|ketamine
297056|NCT02363257|Smoke free bus policy|smoke free bus policy
297057|NCT02363257|BEST commuters|best commuters
297058|NCT02363257|BEST employee|best employee
297059|NCT02363244|Pap,HPVDNA|pap,hpvdna
297060|NCT02363218|Liver Neoplasms|liver neoplasms
297061|NCT02363218|Stereotactic Body Radiotherapy|stereotactic body radiotherapy
297062|NCT02363218|CyberKnife|cyberknife
297064|NCT02363179|Emergency Service, Hospital|emergency service, hospital
297065|NCT02363140|Musculoskeletal System|musculoskeletal system
297066|NCT02363127|Reproductive Techniques|reproductive techniques
297067|NCT02363127|Infertility|infertility
297068|NCT02363127|Reproductive Techniques Assisted|reproductive techniques assisted
297069|NCT02363088|cervical screening|cervical screening
297070|NCT02363088|uptake|uptake
297071|NCT02363088|SMS messages|sms messages
297072|NCT02363088|text messages|text messages
297073|NCT02363088|reminder|reminder
297074|NCT02363075|dexamfetamine sulphate|dexamfetamine sulphate
297075|NCT02363075|severe asthenia|severe asthenia
297076|NCT02363075|glioma|glioma
297077|NCT02363075|MFI-20|mfi-20
297078|NCT02363075|double-blind|double-blind
297079|NCT02363075|stabilisation phase|stabilisation phase
297080|NCT02363062|frontotemporal lobar degeneration|frontotemporal lobar degeneration
297081|NCT02363062|genes|genes
297082|NCT02363062|whole exome sequencing|whole exome sequencing
297083|NCT02363049|Colectomy|colectomy
297084|NCT02363049|primary tumor resection|primary tumor resection
297085|NCT02363049|Asymptomatic primary colon cancer|asymptomatic primary colon cancer
297086|NCT02363049|Unresectable synchronous liver metastasis|unresectable synchronous liver metastasis
297087|NCT02363049|TNM Staging Primary Tumor (T)|tnm staging primary tumor (t)
297088|NCT02363049|Unresectable|unresectable
297089|NCT02363023|Ventilator associated pneumonia|ventilator associated pneumonia
297090|NCT02363023|Bronchoalveolar lavage|bronchoalveolar lavage
297091|NCT02363010|Obesity|obesity
297092|NCT02363010|Weight loss|weight loss
297093|NCT02363010|Overweight|overweight
297094|NCT02362997|Classical Hodgkin Lymphoma (cHL)|classical hodgkin lymphoma (chl)
297095|NCT02362997|Diffuse Large B Cell Lymphoma (DLBCL)|diffuse large b cell lymphoma (dlbcl)
297096|NCT02362997|Peripheral T-cell lymphoma (PTCL)|peripheral t-cell lymphoma (ptcl)
297097|NCT02362984|DLBS1033|dlbs1033
297098|NCT02362984|acute ischemic stroke|acute ischemic stroke
297099|NCT02362984|MRS|mrs
297100|NCT02362984|mNIHSS|mnihss
297101|NCT02362919|Influenza vaccination|influenza vaccination
297102|NCT02362919|Elderly individuals|elderly individuals
297103|NCT02362919|Prospective cohort study|prospective cohort study
297104|NCT02362919|response|response
297105|NCT02362906|pneumonia|pneumonia
297106|NCT02362906|pediatrics|pediatrics
297107|NCT02362893|Hypertension|hypertension
297108|NCT02362893|Adherence|adherence
297109|NCT02362893|Direct Observed Therapy (DOT)|direct observed therapy (dot)
297110|NCT02362893|RCT|rct
297111|NCT02362854|dental implant|dental implant
297112|NCT02362854|laser|laser
297113|NCT02362854|diode laser|diode laser
297114|NCT02362854|peri-implantitis|peri-implantitis
297115|NCT02362854|bacterial count|bacterial count
297116|NCT02362828|Post-Dural Puncture Headache|post-dural puncture headache
297117|NCT02362828|Blood Patch, epidural|blood patch, epidural
297118|NCT02362828|Obstetrics|obstetrics
297119|NCT02362828|European Society of Anaesthesiology (ESA)|european society of anaesthesiology (esa)
297120|NCT02362828|epidemiology|epidemiology
297121|NCT02362828|Accidental Dural Puncture (ADP)|accidental dural puncture (adp)
297122|NCT02362828|Anaesthesia|anaesthesia
297123|NCT02362828|childbirth complication|childbirth complication
297124|NCT02362828|epidural analgesia|epidural analgesia
297125|NCT02362828|postdural puncture headache|postdural puncture headache
297126|NCT02362828|prophylactic epidural blood patch|prophylactic epidural blood patch
297127|NCT02362828|epidural|epidural
297128|NCT02362776|NMR spectroscopy|nmr spectroscopy
297129|NCT02362776|metabolic changes|metabolic changes
297130|NCT02362776|blood plasma|blood plasma
297131|NCT02362776|biomarker|biomarker
297132|NCT02362776|cancer|cancer
297133|NCT02362750|comparative effectiveness|comparative effectiveness
297134|NCT02362750|survivorship|survivorship
297135|NCT02362750|Patient-Centered Outcomes Research|patient-centered outcomes research
297136|NCT02362685|Metabolic myopathies|metabolic myopathies
297137|NCT02362685|Exercise testing|exercise testing
297138|NCT02362685|Blood sample|blood sample
297139|NCT02362685|Muscle biopsy|muscle biopsy
297140|NCT02362685|Genetic analysis|genetic analysis
297141|NCT02362685|Cycloergometer|cycloergometer
297142|NCT02362685|Grip-test|grip-test
297143|NCT02362685|Exercise physiology|exercise physiology
297144|NCT02362685|Muscle physiology|muscle physiology
297145|NCT02362659|non-valvular|non-valvular
297146|NCT02362659|atrial fibrillation|atrial fibrillation
297147|NCT02362659|percutaneous coronary intervention|percutaneous coronary intervention
297148|NCT02362646|Heart Failure|heart failure
297149|NCT02362646|Left Ventricular Assist Device|left ventricular assist device
297150|NCT02362646|Heart Transplantation|heart transplantation
297151|NCT02362646|Cardiomyopathy, Destination Therapy|cardiomyopathy, destination therapy
297152|NCT02362646|Cell Therapy|cell therapy
297153|NCT02362646|Bridge to Transplant|bridge to transplant
297154|NCT02362620|metastatic Castration Resistant Prostate Cancer|metastatic castration resistant prostate cancer
297155|NCT02362620|Taxanes|taxanes
297156|NCT02362620|Biomarkers|biomarkers
297157|NCT02362594|Programmed Cell Death-1 (PD-1)|programmed cell death-1 (pd-1)
297158|NCT02362594|Programmed Cell Death 1 (PD1)|programmed cell death 1 (pd1)
297159|NCT02362594|Programmed Cell Death-Ligand 1 (PD-L1, PDL1)|programmed cell death-ligand 1 (pd-l1, pdl1)
297160|NCT02362594|Programmed Cell Death-Ligand 2 (PD-L2, PDL2)|programmed cell death-ligand 2 (pd-l2, pdl2)
297161|NCT02362581|Prophylaxis treatment|prophylaxis treatment
297162|NCT02362581|On demand treatment|on demand treatment
297163|NCT02362581|Severe hemophilia A|severe hemophilia a
297164|NCT02362581|Moderate hemophilia A|moderate hemophilia a
297165|NCT02362568|Intubation; Difficult|intubation; difficult
297166|NCT02362555|Ossification of nuchal ligament|ossification of nuchal ligament
297167|NCT02362490|chronic hepatitis B|chronic hepatitis b
297168|NCT02362490|interferon|interferon
297169|NCT02362490|Nucleotide analogues|nucleotide analogues
297170|NCT02362490|HBsAg|hbsag
297171|NCT02362464|Multi-epitope|multi-epitope
297172|NCT02362464|Tarp Peptide|tarp peptide
297173|NCT02362464|Dendritic Cell Vaccine|dendritic cell vaccine
297174|NCT02362464|D0 Prostate Cancer|d0 prostate cancer
297175|NCT02362451|Dendritic Cell Vaccine|dendritic cell vaccine
297176|NCT02362451|Multi Epitope Tarp Peptide|multi epitope tarp peptide
297177|NCT02362451|Autolougous Dendritic Cell|autolougous dendritic cell
297178|NCT02362451|D0 Prostate Cancer|d0 prostate cancer
297179|NCT02362451|Vaccine Therapy|vaccine therapy
297180|NCT02362438|Intrathecal|intrathecal
297181|NCT02362438|AAVp Mediated Gene Transfer|aavp mediated gene transfer
297182|NCT02362438|Phase 1|phase 1
297183|NCT02362438|Safety Study|safety study
297184|NCT02362438|Giant Axonal Neuropathy|giant axonal neuropathy
297185|NCT02362425|Neuromuscular Disease|neuromuscular disease
297186|NCT02362425|Clinical Trial|clinical trial
297187|NCT02362425|Ryanodine Receptor Type 1|ryanodine receptor type 1
297188|NCT02362425|Myopathy|myopathy
297189|NCT02362412|major depressive episodes|major depressive episodes
297190|NCT02362412|FK949E|fk949e
297191|NCT02362412|quetiapine|quetiapine
297192|NCT02362412|bipolar depression|bipolar depression
297193|NCT02362412|bipolar disorder|bipolar disorder
297194|NCT02362373|epilepsy|epilepsy
297195|NCT02362373|contraception|contraception
297196|NCT02362373|drug interaction|drug interaction
297197|NCT02362360|Ostomy|ostomy
297198|NCT02362334|dual Sheimpflug analyzer|dual sheimpflug analyzer
297199|NCT02362334|intraocular lens power|intraocular lens power
297200|NCT02362334|optical low-coherence reflectometry|optical low-coherence reflectometry
297201|NCT02362321|[C10.228.140.300.535.450.400.120]|[c10.228.140.300.535.450.400.120]
297202|NCT02362295|palliative care|palliative care
297203|NCT02362295|vulnerable population|vulnerable population
297204|NCT02362295|qualitative research|qualitative research
297205|NCT02362282|stroke|stroke
297206|NCT02362282|walking|walking
297207|NCT02362282|cognition|cognition
297208|NCT02362282|rehabilitation|rehabilitation
297209|NCT02362256|Opioid detoxification|opioid detoxification
297210|NCT02362256|Opioid antagonist induction|opioid antagonist induction
297211|NCT02362256|Conscious sedation|conscious sedation
297212|NCT02362243|low back pain|low back pain
297213|NCT02362243|low back injury|low back injury
297214|NCT02362243|firefighter|firefighter
297215|NCT02362243|prevention|prevention
297216|NCT02362243|physical fitness|physical fitness
297217|NCT02362243|exercise training|exercise training
297218|NCT02362243|worksite|worksite
297219|NCT02362243|web-based|web-based
297220|NCT02362165|multiple myeloma|multiple myeloma
297221|NCT02362165|cyclophosphamide|cyclophosphamide
297222|NCT02362165|bortezomib|bortezomib
297223|NCT02362165|doxorubicin|doxorubicin
297224|NCT02362165|peripheral neuropathy|peripheral neuropathy
297225|NCT02362152|Actinic keratosis|actinic keratosis
297226|NCT02362152|Solar keratosis|solar keratosis
297227|NCT02362152|Field treatment|field treatment
297228|NCT02362152|Ingenol mebutate|ingenol mebutate
297229|NCT02362152|Picato|picato
297230|NCT02362126|Endoscopic full thickness resection|endoscopic full thickness resection
297231|NCT02362126|EFTR|eftr
297232|NCT02362126|FTRD|ftrd
297233|NCT02362126|OTSC|otsc
297234|NCT02362087|pain|pain
297235|NCT02362061|junctional zone|junctional zone
297236|NCT02362061|implantation|implantation
297237|NCT02362061|three D ultraosund|three d ultraosund
297238|NCT02362061|Assisted Reproductive Technology|assisted reproductive technology
297239|NCT02362061|Pregnancy|pregnancy
297240|NCT02362035|Bruton tyrosine kinase inhibitor|bruton tyrosine kinase inhibitor
297241|NCT02362035|Btk|btk
297242|NCT02362035|B-Cell Malignancies|b-cell malignancies
297243|NCT02362035|Mantle Cell|mantle cell
297244|NCT02362035|Multiple Myeloma|multiple myeloma
297245|NCT02362035|CLL|cll
297246|NCT02362035|SLL|sll
297247|NCT02362035|DLBCL|dlbcl
297248|NCT02362035|Follicular|follicular
297249|NCT02362035|Waldenstrom|waldenstrom
297250|NCT02362035|Burkitt lymphoma|burkitt lymphoma
297251|NCT02362035|marginal zone lymphomas|marginal zone lymphomas
297252|NCT02362035|hairy cell leukemia|hairy cell leukemia
297253|NCT02362035|B cell acute lymphoid leukemia|b cell acute lymphoid leukemia
297254|NCT02362035|Acalabrutinib|acalabrutinib
297255|NCT02362035|ACP-196|acp-196
297256|NCT02362009|Myomas|myomas
297257|NCT02362009|Leiomyomas|leiomyomas
297258|NCT02362009|Fibromas|fibromas
297259|NCT02361970|sepsis|sepsis
297260|NCT02361970|gamma delta T cells|gamma delta t cells
297261|NCT02361970|immunosuppression|immunosuppression
297262|NCT02361944|oxygen|oxygen
297263|NCT02361944|hyperoxia|hyperoxia
297264|NCT02361944|reactive oxygen species|reactive oxygen species
297265|NCT02361944|oxidative stress|oxidative stress
297266|NCT02361944|oxidative damage|oxidative damage
297267|NCT02361944|endothelial function|endothelial function
297268|NCT02361944|vascular reactivity|vascular reactivity
297269|NCT02361944|mitochondrial function|mitochondrial function
297270|NCT02361944|surgery|surgery
297271|NCT02361944|anesthesia|anesthesia
297272|NCT02361944|kidney injury|kidney injury
297273|NCT02361944|renal failure|renal failure
297274|NCT02361944|delirium|delirium
297275|NCT02361944|myocardial injury|myocardial injury
297276|NCT02361944|arrythmia|arrythmia
297277|NCT02361931|erythropoietin|erythropoietin
297278|NCT02361931|diabetic chronic wounds|diabetic chronic wounds
297279|NCT02361931|wound healing|wound healing
297280|NCT02361931|chronic wounds|chronic wounds
297281|NCT02361931|topical treatment|topical treatment
297282|NCT02361931|re-epithelization|re-epithelization
297283|NCT02361931|inflammation|inflammation
297284|NCT02361905|fibroid|fibroid
297285|NCT02361905|cellular leiomyomas|cellular leiomyomas
297286|NCT02361905|GnRH analogue|gnrh analogue
297287|NCT02361905|ulipristal acetate|ulipristal acetate
297288|NCT02361892|ovarian reserve|ovarian reserve
297289|NCT02361892|infertility|infertility
297290|NCT02361892|leiomyomas|leiomyomas
297291|NCT02361892|ulipristal acetate|ulipristal acetate
297292|NCT02361879|fibroids|fibroids
297293|NCT02361879|gnrh analogue|gnrh analogue
297294|NCT02361879|ulipristal acetate|ulipristal acetate
297295|NCT02361879|hysteroscopy|hysteroscopy
297296|NCT02361840|Troponin I|troponin i
297297|NCT02361840|Pediatric shock|pediatric shock
297298|NCT02361827|Vitamin D|vitamin d
297299|NCT02361827|IVF outcome|ivf outcome
297300|NCT02361814|flexor tendon|flexor tendon
297301|NCT02361814|finger|finger
297302|NCT02361814|amniotic membrane|amniotic membrane
297303|NCT02361814|allograft|allograft
297304|NCT02361814|tendon injury|tendon injury
297305|NCT02361801|cardiac surgery|cardiac surgery
297306|NCT02361801|dobutamine|dobutamine
297307|NCT02361788|neonatal hyperbilirubinemia|neonatal hyperbilirubinemia
297308|NCT02361788|etiology|etiology
297309|NCT02361788|incidence|incidence
297310|NCT02361788|risk factors|risk factors
297311|NCT02361762|Executive Function|executive function
297312|NCT02361762|Theory of Mind|theory of mind
297313|NCT02361762|Individual Differences|individual differences
297314|NCT02361762|Social Skills|social skills
297315|NCT02361762|Executive Control|executive control
297316|NCT02361723|Advanced Solid Tumors|advanced solid tumors
297317|NCT02361710|Vitamin D|vitamin d
297318|NCT02361710|pregnancy rate|pregnancy rate
297319|NCT02361710|eFET|efet
297320|NCT02361697|pediatric multiple sclerosis|pediatric multiple sclerosis
297321|NCT02361697|clinically isolated syndrome in children|clinically isolated syndrome in children
297322|NCT02361697|biomarker|biomarker
297323|NCT02361697|magnetic resonance imaging|magnetic resonance imaging
297324|NCT02361697|diffusion weighted imaging|diffusion weighted imaging
297325|NCT02361684|cost-effectiveness|cost-effectiveness
297326|NCT02361684|blended treatment|blended treatment
297327|NCT02361684|Internet based treatment|internet based treatment
297328|NCT02361684|Efficacy|efficacy
297329|NCT02361684|Depression|depression
297330|NCT02361684|cognitive behavioural therapy|cognitive behavioural therapy
297331|NCT02361645|nonsteroidal antiinflammatory drugs|nonsteroidal antiinflammatory drugs
297332|NCT02361645|prostaglandin E2|prostaglandin e2
297333|NCT02361645|vitrectomy|vitrectomy
297334|NCT02361606|adolescents|adolescents
297335|NCT02361606|cognitive behavioral internet intervention|cognitive behavioral internet intervention
297715|NCT02359383|infecTion|infection
297336|NCT02361593|endoscopic sclerotherapy, esophageal varices, transparent cap|endoscopic sclerotherapy, esophageal varices, transparent cap
297337|NCT02361567|Post Operative Pain|post operative pain
297338|NCT02361567|Addiction|addiction
758747|NCT00410059|OSI-774|osi-774
297339|NCT02361528|Septic shock|septic shock
297340|NCT02361528|Severe sepsis|severe sepsis
297341|NCT02361528|GM-CSF|gm-csf
297342|NCT02361528|Immunosuppression|immunosuppression
297343|NCT02361528|Hospital-acquired infections|hospital-acquired infections
297344|NCT02361528|ICU-acquired infections|icu-acquired infections
297345|NCT02361528|HLA-DR|hla-dr
297346|NCT02361528|Monocytes|monocytes
297347|NCT02361515|Prostate|prostate
297348|NCT02361515|Hypofractionated radiotherapy|hypofractionated radiotherapy
297349|NCT02361515|Stereotactic irradiation|stereotactic irradiation
297350|NCT02361515|Spacer|spacer
297351|NCT02361515|Rectal and bladder toxicities|rectal and bladder toxicities
297352|NCT02361476|Anaesthesia|anaesthesia
297353|NCT02361476|Children|children
297354|NCT02361476|Clonidine|clonidine
297355|NCT02361476|Sevoflurane|sevoflurane
297356|NCT02361476|Postoperative agitation|postoperative agitation
297357|NCT02361476|Prevention|prevention
297358|NCT02361476|Pharmacokinetics|pharmacokinetics
297359|NCT02361476|Safety|safety
297360|NCT02361463|Laparoscopy;|laparoscopy;
297361|NCT02361463|Training;|training;
297362|NCT02361463|Three-Dimensional|three-dimensional
297363|NCT02361450|Faecal incontinence|faecal incontinence
297364|NCT02361450|Spina Bifida|spina bifida
297365|NCT02361450|Enema|enema
297366|NCT02361450|Constipation|constipation
297367|NCT02361450|Myelomeningocele|myelomeningocele
297368|NCT02361450|Human|human
297369|NCT02361437|diabetes type II|diabetes type ii
297370|NCT02361437|diabetic ulcers|diabetic ulcers
297371|NCT02361424|PXT00864|pxt00864
297372|NCT02361424|mild AD|mild ad
297373|NCT02361424|phase 2a|phase 2a
297374|NCT02361359|Arthroplasty|arthroplasty
297375|NCT02361346|CD20|cd20
297376|NCT02361346|immunotoxin|immunotoxin
297377|NCT02361346|NHL|nhl
297378|NCT02361346|non-Hodgkin's lymphoma|non-hodgkin's lymphoma
297379|NCT02361346|lymphoma|lymphoma
297380|NCT02361346|cancer|cancer
297381|NCT02361346|antibodies|antibodies
297382|NCT02361346|immunotherapy|immunotherapy
297383|NCT02361346|safety|safety
297384|NCT02361346|pharmacokinetics|pharmacokinetics
297385|NCT02361346|maximum tolerated dose|maximum tolerated dose
297386|NCT02361346|MT-3724|mt-3724
297387|NCT02361346|relapsed|relapsed
297388|NCT02361346|refractory|refractory
297389|NCT02361346|leukemia|leukemia
297390|NCT02361346|CLL|cll
297391|NCT02361346|SLL|sll
297392|NCT02361346|DLBCL|dlbcl
297393|NCT02361346|efficacy|efficacy
297394|NCT02361320|Pancreatic cancer|pancreatic cancer
297395|NCT02361320|Pancreatic ductal adenocarcinoma|pancreatic ductal adenocarcinoma
297396|NCT02361320|PDAC|pdac
297397|NCT02361320|Computed tomography|computed tomography
297398|NCT02361320|CT|ct
297399|NCT02361320|Questionnaire|questionnaire
297400|NCT02361320|Survey|survey
297401|NCT02361268|end-stage renal disease|end-stage renal disease
297402|NCT02361268|hemodialysis|hemodialysis
297403|NCT02361268|yoga|yoga
297404|NCT02361268|mind-body medicine|mind-body medicine
297405|NCT02361268|meditation|meditation
297406|NCT02361242|PXT00864|pxt00864
297407|NCT02361242|mild AD|mild ad
297408|NCT02361242|phase 2a|phase 2a
297409|NCT02361138|SHR3824 Type 2 diabetes mellitus SGLT2|shr3824 type 2 diabetes mellitus sglt2
297410|NCT02361125|Fatigue|fatigue
297411|NCT02361125|Cancer related fatigue|cancer related fatigue
297412|NCT02361125|Methylphenidate|methylphenidate
297413|NCT02361125|Methylphenidate Hydrochloride|methylphenidate hydrochloride
297414|NCT02361125|Ritalin|ritalin
297415|NCT02361125|Concerta|concerta
297416|NCT02361125|Fatigue evaluations|fatigue evaluations
297417|NCT02361086|castration-resistant prostate cancer|castration-resistant prostate cancer
297418|NCT02361086|CYP17|cyp17
297419|NCT02361086|P450c17a|p450c17a
297420|NCT02361086|lyase|lyase
297421|NCT02361073|Stress-induced cardiomyopathy|stress-induced cardiomyopathy
297422|NCT02361073|ERP|erp
297423|NCT02361034|Safety and pharmacokinetics of drug in healthy volunteers|safety and pharmacokinetics of drug in healthy volunteers
297424|NCT02361021|Critical Care|critical care
297425|NCT02361021|Non invasive ventilation|non invasive ventilation
297426|NCT02361021|Electrical impedance tomography|electrical impedance tomography
297427|NCT02361021|End expiratory lung volume|end expiratory lung volume
297428|NCT02361021|Lung ultrasound score|lung ultrasound score
297429|NCT02361008|Infundibular Ventricular Septal Defect|infundibular ventricular septal defect
297430|NCT02361008|occlusion|occlusion
297431|NCT02361008|TEE-guided|tee-guided
297432|NCT02361008|asymmetric occluder|asymmetric occluder
297433|NCT02361008|surgical repair|surgical repair
297434|NCT02360982|Delirium|delirium
297435|NCT02360982|regional anesthesia|regional anesthesia
297436|NCT02360982|general anesthesia|general anesthesia
297437|NCT02360969|strabismus|strabismus
297438|NCT02360969|surgical procedure|surgical procedure
297439|NCT02360969|anesthesia|anesthesia
297440|NCT02360969|squint|squint
297441|NCT02360969|child|child
297442|NCT02360956|Olmesartan medoxomil|olmesartan medoxomil
297443|NCT02360956|Epicardial adipose tissue|epicardial adipose tissue
379952|NCT01962025|Cost|cost
297444|NCT02360956|Multidetector Computed Tomography|multidetector computed tomography
297445|NCT02360943|elderly patients|elderly patients
297446|NCT02360943|Pulmonary embolism|pulmonary embolism
297447|NCT02360943|Anticoagulant treatments|anticoagulant treatments
297448|NCT02360930|Acute Lymphoblastic Leukemia|acute lymphoblastic leukemia
297449|NCT02360930|Pharmacokinetics|pharmacokinetics
297450|NCT02360930|Vincristine|vincristine
297451|NCT02360917|Cognitive Dysfunction|cognitive dysfunction
297452|NCT02360917|Cancer Survivorship|cancer survivorship
297453|NCT02360891|multimodal biomarkers|multimodal biomarkers
297454|NCT02360891|prognosis|prognosis
297455|NCT02360891|endophenotypes|endophenotypes
297456|NCT02360878|DJBS|djbs
297457|NCT02360878|Duodenal-jejunal bypass sleeve|duodenal-jejunal bypass sleeve
297458|NCT02360878|Duodenal-jejunal bypass liner|duodenal-jejunal bypass liner
297459|NCT02360878|Endobarrier|endobarrier
297460|NCT02360878|Obesity|obesity
297461|NCT02360878|Type 2 diabetes|type 2 diabetes
297462|NCT02360878|Incretin hormones|incretin hormones
297863|NCT02358733|IMSI|imsi
297463|NCT02360878|Postprandial glucose metabolism|postprandial glucose metabolism
297464|NCT02360813|Cognitive remediation therapy|cognitive remediation therapy
297465|NCT02360813|Psychiatric rehabilitation|psychiatric rehabilitation
297466|NCT02360813|Forensic mental health|forensic mental health
297467|NCT02360813|Forensic psychiatry|forensic psychiatry
297468|NCT02360813|Clinical psychology|clinical psychology
297469|NCT02360813|Randomized controlled trial|randomized controlled trial
297470|NCT02360813|Principle driven intervention|principle driven intervention
297471|NCT02360813|Psychological Intervention|psychological intervention
297472|NCT02360813|Cognitive enhancement|cognitive enhancement
297473|NCT02360800|Bleeding|bleeding
297474|NCT02360800|Heart Surgery|heart surgery
297475|NCT02360800|Reoperation|reoperation
297476|NCT02360787|Almonds|almonds
297477|NCT02360787|Energy restriction|energy restriction
297478|NCT02360787|Obesity|obesity
297479|NCT02360787|Body weight|body weight
297480|NCT02360787|Body fat|body fat
297481|NCT02360787|Blood pressure|blood pressure
297482|NCT02360787|Cognitive function|cognitive function
297483|NCT02360774|Canagliflozin|canagliflozin
297484|NCT02360774|Obesity|obesity
297485|NCT02360774|Weight Loss|weight loss
297486|NCT02360774|Body Weight|body weight
297487|NCT02360774|Body Weight Changes|body weight changes
297488|NCT02360774|Overweight|overweight
297489|NCT02360774|Sodium-glucose transporter subtype 2 inhibitor|sodium-glucose transporter subtype 2 inhibitor
297490|NCT02360761|Lung cancer;Elderly;Sublobar resection;Lobectomy|lung cancer;elderly;sublobar resection;lobectomy
297491|NCT02360696|Duodenal Eosinophilia|duodenal eosinophilia
297492|NCT02360696|Functional Dyspepsia|functional dyspepsia
297493|NCT02360696|Mucosal Eosinophilia|mucosal eosinophilia
297494|NCT02360683|Subthalamic neurostimulation|subthalamic neurostimulation
297495|NCT02360657|Alzheimer's Disease|alzheimer's disease
297496|NCT02360657|Alzheimer Dementia|alzheimer dementia
297497|NCT02360657|JNJ-54861911|jnj-54861911
297498|NCT02360657|Beta Secretase Inhibitor|beta secretase inhibitor
297499|NCT02360631|smoking|smoking
297500|NCT02360631|quit smoking|quit smoking
297501|NCT02360631|smoking treatment|smoking treatment
297502|NCT02360618|Bladder Cancer|bladder cancer
297503|NCT02360618|Metformin|metformin
297504|NCT02360618|Simvastatin|simvastatin
297505|NCT02360618|Combination Therapy|combination therapy
297506|NCT02360605|colorectal cancer screening|colorectal cancer screening
297507|NCT02360605|low literacy|low literacy
297508|NCT02360605|community clinics|community clinics
297509|NCT02360605|Fecal Immunochemical Test|fecal immunochemical test
297510|NCT02360579|Autologous Adoptive Cell Transfer|autologous adoptive cell transfer
297511|NCT02360579|Autologous Adoptive Cell Therapy|autologous adoptive cell therapy
297512|NCT02360579|Cellular Immuno-therapy|cellular immuno-therapy
297513|NCT02360579|Cell Therapy|cell therapy
297514|NCT02360579|Tumor Infiltrating Lymphocytes|tumor infiltrating lymphocytes
297516|NCT02360579|LN-144|ln-144
297517|NCT02360579|IL-2|il-2
297518|NCT02360579|Melanoma|melanoma
297519|NCT02360579|Lifileucel|lifileucel
297520|NCT02360579|innovaTIL-01|innovatil-01
297521|NCT02360566|Psychosis|psychosis
297522|NCT02360566|Schizophrenia|schizophrenia
297523|NCT02360566|Participatory Video|participatory video
297524|NCT02360566|Narrative|narrative
297525|NCT02360540|Pulmonary Embolism|pulmonary embolism
297526|NCT02360540|Diagnostic strategy|diagnostic strategy
297527|NCT02360540|Exclusion|exclusion
297528|NCT02360540|Clinical probability|clinical probability
297529|NCT02360540|Implicit Judgment (Gestalt)|implicit judgment (gestalt)
297530|NCT02360540|PERC|perc
297531|NCT02360501|nasopharyngeal carcinoma|nasopharyngeal carcinoma
297532|NCT02360501|induction chemotherapy|induction chemotherapy
297533|NCT02360501|docetaxel|docetaxel
297534|NCT02360501|xeloda|xeloda
297535|NCT02360475|Vaccine|vaccine
297536|NCT02360475|Immunogenicity|immunogenicity
297537|NCT02360475|Safety|safety
712549|NCT00579761|neurological deficit|neurological deficit
297538|NCT02360475|Respiratory syncytial virus (RSV)|respiratory syncytial virus (rsv)
297539|NCT02360475|Reactogenicity|reactogenicity
297540|NCT02360462|Transcranial Direct Current Stimulation|transcranial direct current stimulation
297541|NCT02360462|tDCS|tdcs
297542|NCT02360462|Hallux Valgus|hallux valgus
297543|NCT02360462|Chronic Pain|chronic pain
297544|NCT02360449|Pivotal Response Treatment|pivotal response treatment
297545|NCT02360449|Applied Behavior Analysis|applied behavior analysis
297546|NCT02360449|Peer Initiation|peer initiation
297547|NCT02360449|Social Skills Group|social skills group
297548|NCT02360436|Rett|rett
297549|NCT02360436|MeCP2|mecp2
297550|NCT02360436|Glutathione|glutathione
297551|NCT02360436|Cysteine|cysteine
297552|NCT02360436|ROS|ros
297553|NCT02360384|wireless motility capsule|wireless motility capsule
297554|NCT02360332|Autism|autism
297555|NCT02360332|transition to adulthood|transition to adulthood
297556|NCT02360332|employment|employment
297557|NCT02360332|High School Seniors|high school seniors
297558|NCT02360319|First episode or recent onset|first episode or recent onset
297559|NCT02360293|Exercise|exercise
297560|NCT02360293|App-mediated|app-mediated
297561|NCT02360293|Veterans|veterans
297562|NCT02360280|Depressive Disorder, Treatment-Resistant|depressive disorder, treatment-resistant
297563|NCT02360267|Bipolar Disorder|bipolar disorder
297564|NCT02360267|Pediatric|pediatric
297565|NCT02360267|Offspring|offspring
297566|NCT02360267|Depression|depression
297567|NCT02360267|Mania|mania
297568|NCT02360267|Children of parents who suffer from Bipolar disorder|children of parents who suffer from bipolar disorder
297569|NCT02360228|tACS|tacs
297570|NCT02360228|tDCS|tdcs
297571|NCT02360228|sham|sham
297572|NCT02360228|auditory hallucinations|auditory hallucinations
297573|NCT02360228|Schizophrenia|schizophrenia
297574|NCT02360228|Schizoaffective Disorder|schizoaffective disorder
297575|NCT02360176|single port surgery|single port surgery
297576|NCT02360176|bariatric surgery|bariatric surgery
297577|NCT02360176|sleeve gastrectomy|sleeve gastrectomy
297578|NCT02360176|randomise prospective study|randomise prospective study
297579|NCT02360176|complication rate|complication rate
297580|NCT02360150|cardiac angiography|cardiac angiography
297581|NCT02360150|cardiac MRI|cardiac mri
297582|NCT02360137|carotids|carotids
297583|NCT02360137|plaque|plaque
297584|NCT02360137|characteristics|characteristics
297585|NCT02360137|stroke|stroke
297586|NCT02360111|GVHD Prophylaxis|gvhd prophylaxis
297587|NCT02360111|Cyclophosphamide|cyclophosphamide
297588|NCT02360111|Renal Insufficiency|renal insufficiency
297589|NCT02360111|Hematopoietic Stem Cell Transplant|hematopoietic stem cell transplant
297590|NCT02360111|14-273|14-273
297591|NCT02360098|Emergence from Anesthesia|emergence from anesthesia
297592|NCT02360098|Anterior temporal lobectomy|anterior temporal lobectomy
297593|NCT02360098|Amygdalohippocampectomy|amygdalohippocampectomy
297594|NCT02360098|Anesthesia|anesthesia
297595|NCT02360085|Cervical Myelopathy|cervical myelopathy
297596|NCT02360085|Hypotension|hypotension
297597|NCT02360072|child|child
297598|NCT02360072|allergic rhinitis|allergic rhinitis
297599|NCT02360072|asthma|asthma
297600|NCT02360072|nitric oxide|nitric oxide
297601|NCT02360072|bronchial hyper-responsiveness|bronchial hyper-responsiveness
297602|NCT02360059|Breast cancer|breast cancer
297603|NCT02360059|Neuropathy|neuropathy
297604|NCT02360059|Paclitaxel|paclitaxel
297605|NCT02360059|Metformin|metformin
297606|NCT02360059|Metformin ER|metformin er
297607|NCT02360059|Placebo|placebo
297608|NCT02360059|Sugar pill|sugar pill
297609|NCT02360059|Questionnaires|questionnaires
297610|NCT02360059|Sensory tests|sensory tests
297611|NCT02360059|Fine-motor tests|fine-motor tests
297612|NCT02360059|Surveys|surveys
297613|NCT02360020|coronary stent|coronary stent
297614|NCT02360020|outcome|outcome
297615|NCT02360007|opioids|opioids
297616|NCT02360007|buprenorphine|buprenorphine
297617|NCT02360007|interim treatment|interim treatment
297618|NCT02360007|opioid dependence|opioid dependence
297619|NCT02359994|hemostasis|hemostasis
297620|NCT02359981|Weight loss, Fitness|weight loss, fitness
297621|NCT02359968|resectable esophageal|resectable esophageal
297622|NCT02359968|junctional cancer|junctional cancer
297623|NCT02359968|FOLFOX|folfox
297624|NCT02359968|paclitaxel-carboplatin|paclitaxel-carboplatin
297625|NCT02359942|Helicobacter pylori infection|helicobacter pylori infection
297626|NCT02359942|Eradication|eradication
297627|NCT02359942|Urea breath test|urea breath test
297628|NCT02359929|graft versus host disease|graft versus host disease
297629|NCT02359929|GVHD|gvhd
297630|NCT02359890|Interventional|interventional
297631|NCT02359890|Radiofrequency ablation|radiofrequency ablation
297632|NCT02359890|Paroxysmal Atrial Fibrillation|paroxysmal atrial fibrillation
297633|NCT02359877|pegylated interferon beta|pegylated interferon beta
297634|NCT02359877|Volunteers|volunteers
297635|NCT02359864|radiation treatment|radiation treatment
297636|NCT02359838|Hematologic Malignancy|hematologic malignancy
297637|NCT02359838|Geriatric Assessment|geriatric assessment
297638|NCT02359838|Geriatric Oncology|geriatric oncology
297639|NCT02359838|Frailty|frailty
297640|NCT02359812|Stroke|stroke
297641|NCT02359812|Upper extremity|upper extremity
297642|NCT02359812|Rehabilitation|rehabilitation
297643|NCT02359812|Robot|robot
297644|NCT02359812|Hemiplegia|hemiplegia
297645|NCT02359812|Spasticity|spasticity
297647|NCT02359812|Hand|hand
297648|NCT02359799|Cerebral palsy|cerebral palsy
297649|NCT02359799|Ankle Impairments|ankle impairments
297650|NCT02359799|Robotic rehabilitation|robotic rehabilitation
297651|NCT02359773|Magnetocardiography|magnetocardiography
297652|NCT02359773|Myocardial Infarction|myocardial infarction
297653|NCT02359773|Non-ischaemic chest pain|non-ischaemic chest pain
297654|NCT02359760|Rapid orthodontics|rapid orthodontics
297655|NCT02359760|accelerated orthodontics|accelerated orthodontics
297656|NCT02359760|Piezocision|piezocision
297657|NCT02359760|flapless corticotomies|flapless corticotomies
297658|NCT02359760|minimaly invasive|minimaly invasive
297659|NCT02359747|free gDNA|free gdna
297660|NCT02359747|culture media|culture media
297661|NCT02359734|Patient safety|patient safety
297662|NCT02359734|Medication errors|medication errors
297663|NCT02359734|Smart infusion pump|smart infusion pump
297766|NCT02359175|Immune cells|immune cells
297664|NCT02359721|Colony forming units Antimicrobial agents|colony forming units antimicrobial agents
297665|NCT02359721|Microbial colonization|microbial colonization
297666|NCT02359695|Poor ovarian response|poor ovarian response
297667|NCT02359695|IVF|ivf
297668|NCT02359695|Growth hormone|growth hormone
297669|NCT02359643|Kawasaki disease|kawasaki disease
297670|NCT02359617|continuous glucose sensor|continuous glucose sensor
297671|NCT02359617|subcutaneous insulin infusion|subcutaneous insulin infusion
297672|NCT02359617|closed-loop glucose control|closed-loop glucose control
297673|NCT02359617|type 1 diabetes|type 1 diabetes
297674|NCT02359604|infant|infant
297675|NCT02359604|ppi|ppi
297676|NCT02359604|proton pump inhibitor|proton pump inhibitor
297677|NCT02359604|microbiome|microbiome
297678|NCT02359604|Microbiota|microbiota
297679|NCT02359578|lymphatic system|lymphatic system
297680|NCT02359578|occlusion pressure|occlusion pressure
297681|NCT02359578|Indocyanine Green|indocyanine green
297682|NCT02359526|Chronic Diabetic Macular Edema|chronic diabetic macular edema
297683|NCT02359526|Iluvien|iluvien
297684|NCT02359526|Intra-vitreal injections|intra-vitreal injections
297685|NCT02359526|Pilot study|pilot study
297686|NCT02359513|bulimia|bulimia
297687|NCT02359513|serotoninergic brain activity|serotoninergic brain activity
297688|NCT02359513|fluoxetine|fluoxetine
297689|NCT02359513|serotoninergic antidepressant|serotoninergic antidepressant
297690|NCT02359513|brain serotonin profile|brain serotonin profile
297691|NCT02359513|positon emission tomography|positon emission tomography
297692|NCT02359500|68Ga- DOTATOC|68ga- dotatoc
297693|NCT02359500|Diagnosis|diagnosis
297694|NCT02359500|Somatostatin Receptor-Positive Neuroendocrine Tumors|somatostatin receptor-positive neuroendocrine tumors
297695|NCT02359487|Namibia|namibia
297696|NCT02359487|Alcohol|alcohol
297697|NCT02359487|HIV|hiv
297698|NCT02359487|Sexual risk|sexual risk
297699|NCT02359474|high-risk soft tissue sarcoma|high-risk soft tissue sarcoma
297700|NCT02359474|trabectedin|trabectedin
297701|NCT02359461|Vascular function|vascular function
297702|NCT02359461|Pulsatile cuts|pulsatile cuts
297703|NCT02359461|Type 2 diabetes|type 2 diabetes
297704|NCT02359461|Endothelium|endothelium
297705|NCT02359461|Cardiovascular risk|cardiovascular risk
297706|NCT02359461|Vasomotricity|vasomotricity
297707|NCT02359461|FMD (Flow Mediated Dilatation)|fmd (flow mediated dilatation)
297708|NCT02359435|Helicobacter pylori|helicobacter pylori
297709|NCT02359435|Proton pump inhibitor|proton pump inhibitor
297710|NCT02359435|Eradication|eradication
297711|NCT02359396|Randomized open-label study|randomized open-label study
297712|NCT02359396|Chinese Herbal|chinese herbal
297713|NCT02359396|Constipation/drug therapy|constipation/drug therapy
297714|NCT02359383|pleural disease|pleural disease
297716|NCT02359383|chest physiotherapy|chest physiotherapy
297717|NCT02359370|Laryngoscopy|laryngoscopy
297718|NCT02359370|Tracheal Intubation|tracheal intubation
297719|NCT02359370|Lidocaine|lidocaine
297720|NCT02359370|Magnesium Sulphate|magnesium sulphate
297721|NCT02359370|Cardiovascular Physiological Phenomena|cardiovascular physiological phenomena
297722|NCT02359331|Helicobacter pylori|helicobacter pylori
297723|NCT02359331|resistance|resistance
297724|NCT02359331|rescue therapy|rescue therapy
297725|NCT02359318|White spot lesion|white spot lesion
297726|NCT02359318|Resin Infiltration|resin infiltration
297727|NCT02359318|Icon|icon
297728|NCT02359318|Debonding|debonding
297729|NCT02359318|Enamel damages|enamel damages
297730|NCT02359318|Orthodontic white spots|orthodontic white spots
297731|NCT02359318|Orthodontics|orthodontics
297732|NCT02359266|Mood|mood
297733|NCT02359266|Vitamin D deficiency|vitamin d deficiency
297734|NCT02359266|Adjuvant treatment|adjuvant treatment
297735|NCT02359253|Stroke|stroke
297736|NCT02359253|Spasticity|spasticity
297737|NCT02359253|Arm|arm
297738|NCT02359253|Hand|hand
297739|NCT02359253|Robotic therapy|robotic therapy
297740|NCT02359227|Chronic Heart Failure|chronic heart failure
297741|NCT02359227|Natriuretic Peptides|natriuretic peptides
297742|NCT02359227|Cenderitide|cenderitide
297743|NCT02359214|Vitamin D|vitamin d
297744|NCT02359214|Cardiovascular disease|cardiovascular disease
297745|NCT02359214|Diabetes|diabetes
297746|NCT02359214|Obesity|obesity
297747|NCT02359214|Cardiometabolic|cardiometabolic
297748|NCT02359214|Bone disease|bone disease
297749|NCT02359201|Nicotine replacement therapy|nicotine replacement therapy
297750|NCT02359201|craving|craving
297751|NCT02359201|Healthy moderately dependant smokers|healthy moderately dependant smokers
297752|NCT02359188|Vagus Nerve Stimulation|vagus nerve stimulation
297753|NCT02359175|Pain|pain
297754|NCT02359175|Pain Measurement|pain measurement
297755|NCT02359175|VAS|vas
297756|NCT02359175|Visual Analog Pain Scale|visual analog pain scale
297757|NCT02359175|Analgesics|analgesics
297758|NCT02359175|Opioid|opioid
297759|NCT02359175|Epidural analgesia|epidural analgesia
297760|NCT02359175|VATS|vats
297761|NCT02359175|Video-assisted Thoracic Surgery|video-assisted thoracic surgery
297762|NCT02359175|Lobectomy|lobectomy
297763|NCT02359175|Wedge Resection|wedge resection
297764|NCT02359175|Segmental Resection|segmental resection
297765|NCT02359175|Cytokins|cytokins
297767|NCT02359162|NK/T-cell lymphoma|nk/t-cell lymphoma
297768|NCT02359162|induction chemotherapy|induction chemotherapy
297769|NCT02359162|survival|survival
297770|NCT02359149|Intravitreal injections|intravitreal injections
297771|NCT02359149|Nurses|nurses
297772|NCT02359149|Physicians|physicians
297773|NCT02359136|Arthroplasty, Replacement, Hip|arthroplasty, replacement, hip
297774|NCT02359136|Anesthesia, Local|anesthesia, local
297775|NCT02359136|Ropivacaine|ropivacaine
297776|NCT02359136|Randomized controlled trial|randomized controlled trial
297777|NCT02359110|laparoscopy|laparoscopy
297778|NCT02359110|postoperative pain|postoperative pain
297779|NCT02359110|gynecology|gynecology
297780|NCT02359110|gabapentin|gabapentin
297781|NCT02359084|Autism Spectrum Disorder (ASD)|autism spectrum disorder (asd)
297782|NCT02359084|Family navigation|family navigation
297783|NCT02359071|handoff|handoff
297784|NCT02359071|signoff|signoff
297785|NCT02359071|handover|handover
297786|NCT02359071|sign-out|sign-out
297787|NCT02359071|shift change|shift change
297788|NCT02359071|Emergency Department|emergency department
297789|NCT02359045|Omega-3-carboxylic acids,|omega-3-carboxylic acids,
297790|NCT02359045|Phase I,|phase i,
297791|NCT02359045|Healthy Subjects,|healthy subjects,
297792|NCT02359045|Pharmacokinetics,|pharmacokinetics,
297793|NCT02359045|Relative bioavailability|relative bioavailability
297794|NCT02359032|Healthy subjects|healthy subjects
297795|NCT02359032|Pharmacokinetics of ASP6858|pharmacokinetics of asp6858
297796|NCT02359032|ASP6858|asp6858
297797|NCT02359032|Pharmacodynamics of ASP6858|pharmacodynamics of asp6858
297798|NCT02359006|Analgesia|analgesia
297799|NCT02359006|pain analgesia|pain analgesia
297800|NCT02359006|methadone|methadone
297801|NCT02359006|opiates|opiates
297802|NCT02358993|Urinary Tract Infections|urinary tract infections
297803|NCT02358993|Catheter-Related Infections|catheter-related infections
297804|NCT02358993|Pelvic Reconstructive Surgery|pelvic reconstructive surgery
297805|NCT02358993|Urogynecology|urogynecology
297806|NCT02358993|Urinary catheterization|urinary catheterization
297807|NCT02358993|Post-operative Infections|post-operative infections
297808|NCT02358993|Methenamine hippurate|methenamine hippurate
297809|NCT02358980|Multiple Myeloma|multiple myeloma
297810|NCT02358980|Cast Nephropathy|cast nephropathy
297811|NCT02358980|Acute kidney injury|acute kidney injury
297812|NCT02358980|KIDNEY THERAPY|kidney therapy
297813|NCT02358980|HFR|hfr
297814|NCT02358967|ESRD|esrd
297815|NCT02358967|dyslipidemia|dyslipidemia
297816|NCT02358967|oxidative stress|oxidative stress
297817|NCT02358967|inflammation|inflammation
297818|NCT02358967|Hemodialysis|hemodialysis
297819|NCT02358967|CKD|ckd
297820|NCT02358954|quantitative sensory testing|quantitative sensory testing
297821|NCT02358954|contact heat evoked potentials|contact heat evoked potentials
297822|NCT02358954|vection stimulation|vection stimulation
297823|NCT02358954|3D-turntable|3d-turntable
297824|NCT02358954|Volunteers|volunteers
297825|NCT02358941|ADHD, neurofeedback, computerized cognitive training, school|adhd, neurofeedback, computerized cognitive training, school
297826|NCT02358928|NAFLD|nafld
297827|NCT02358928|Metabolic syndrome|metabolic syndrome
297828|NCT02358928|Hepatic Magnetic Resonance Spectroscopy|hepatic magnetic resonance spectroscopy
297829|NCT02358928|Obesity|obesity
297830|NCT02358902|Transcranial Direct Current Stimulation|transcranial direct current stimulation
297831|NCT02358902|Exercise|exercise
297832|NCT02358902|Fibromyalgia|fibromyalgia
297833|NCT02358876|Parkinson's disease|parkinson's disease
297834|NCT02358876|Deep brain stimulation|deep brain stimulation
297835|NCT02358876|Bradykinesia|bradykinesia
297836|NCT02358850|Tonsillectomy|tonsillectomy
297837|NCT02358850|Adenoidectomy|adenoidectomy
712550|NCT00579748|OCT imaging|oct imaging
297838|NCT02358837|elastosonography|elastosonography
297839|NCT02358837|comparing conventional sonography with ductosonography|comparing conventional sonography with ductosonography
297840|NCT02358824|Hypertension|hypertension
297841|NCT02358824|CKD-828|ckd-828
297842|NCT02358824|Telmisartan|telmisartan
297843|NCT02358824|S-amlodipine|s-amlodipine
297844|NCT02358824|Pharmacokinetic|pharmacokinetic
297845|NCT02358811|Obstructive Sleep Apnea|obstructive sleep apnea
297846|NCT02358811|Voxel-Based Morphometry|voxel-based morphometry
297847|NCT02358811|Polysomnography|polysomnography
297848|NCT02358811|Magnetic resonance imaging|magnetic resonance imaging
297849|NCT02358798|Time evolution of respiratory function|time evolution of respiratory function
297850|NCT02358798|Longitudinal multicenter monitoring of large cohorts|longitudinal multicenter monitoring of large cohorts
297851|NCT02358798|Preschool aged children|preschool aged children
297852|NCT02358798|Detection of cystic fibrosis in neonatal period|detection of cystic fibrosis in neonatal period
297853|NCT02358772|stroke|stroke
297854|NCT02358772|thrombolysis|thrombolysis
297855|NCT02358772|STEMO|stemo
297856|NCT02358759|Abnormal zygote fertilization|abnormal zygote fertilization
297857|NCT02358759|3PNs correction|3pns correction
297858|NCT02358759|Giant oocyte management|giant oocyte management
297859|NCT02358759|triploidy fertilization|triploidy fertilization
297860|NCT02358759|Maternal nucleus removal|maternal nucleus removal
297861|NCT02358746|epicardial catheter ablation|epicardial catheter ablation
297862|NCT02358733|POR|por
297864|NCT02358720|bone metastases|bone metastases
297865|NCT02358707|ibuprofen phonophoresis|ibuprofen phonophoresis
297866|NCT02358707|High performance liquid chromatography|high performance liquid chromatography
297867|NCT02358694|IBS|ibs
297868|NCT02358694|IBS-D|ibs-d
297869|NCT02358694|SBI|sbi
297870|NCT02358681|Intranasal|intranasal
297871|NCT02358681|Ketorolac|ketorolac
297872|NCT02358681|Pediatric|pediatric
297873|NCT02358681|Migraine|migraine
297874|NCT02358681|Headache|headache
297875|NCT02358655|Oral anticoagulant|oral anticoagulant
297876|NCT02358655|Knowledge translation|knowledge translation
297877|NCT02358655|Emergency department|emergency department
297878|NCT02358642|Rate of Pneumonia|rate of pneumonia
297879|NCT02358642|Mortality rate|mortality rate
297880|NCT02358603|Chronotropic Incompetence|chronotropic incompetence
297881|NCT02358603|Heart Failure|heart failure
297882|NCT02358564|IBS|ibs
297883|NCT02358564|Irritable Bowel Syndrome|irritable bowel syndrome
297884|NCT02358564|Visceral Hypersensitivity|visceral hypersensitivity
297885|NCT02358564|Permeability|permeability
297886|NCT02358564|Small Bowel|small bowel
297887|NCT02358564|Lactulose|lactulose
297888|NCT02358564|Mannitol|mannitol
297889|NCT02358551|Pacemaker|pacemaker
297890|NCT02358551|Axillary Vein|axillary vein
297891|NCT02358551|Subclavian vein|subclavian vein
297892|NCT02358551|Clinical Study|clinical study
297893|NCT02358551|Cardiovascular implantable electronic devices|cardiovascular implantable electronic devices
297894|NCT02358538|PCDH19|pcdh19
297895|NCT02358538|ganaxolone|ganaxolone
297896|NCT02358538|neurosteroid|neurosteroid
297897|NCT02358538|CDKL5|cdkl5
297898|NCT02358538|LGS|lgs
297899|NCT02358538|CSWS|csws
297900|NCT02358512|Intensive Care|intensive care
297901|NCT02358512|Recovery of Function|recovery of function
297902|NCT02358512|Survivors|survivors
297903|NCT02358512|Outcome Assessment (Health Care)|outcome assessment (health care)
297904|NCT02358512|Medical Economics|medical economics
297905|NCT02358499|triazoles|triazoles
297906|NCT02358499|fungi|fungi
297907|NCT02358499|transplantation, hematopoietic stem cell|transplantation, hematopoietic stem cell
297908|NCT02358499|leukemia|leukemia
297909|NCT02358499|pediatrics|pediatrics
297910|NCT02358499|pharmacokinetics|pharmacokinetics
297911|NCT02358499|bone marrow failure syndrome|bone marrow failure syndrome
297912|NCT02358486|Functional Dyspepsia|functional dyspepsia
297913|NCT02358486|Acupuncture|acupuncture
297914|NCT02358486|Functional MRI|functional mri
297915|NCT02358473|Nonsmall Cell Lung Cancer|nonsmall cell lung cancer
297916|NCT02358473|NSCLC|nsclc
297917|NCT02358473|Non-Small-Cell Lung Carcinoma|non-small-cell lung carcinoma
297918|NCT02358473|Carcinoma, Non-Small Cell Lung|carcinoma, non-small cell lung
297919|NCT02358473|KW-0761|kw-0761
297920|NCT02358473|Mogamulizumab|mogamulizumab
297921|NCT02358460|neonatal|neonatal
297922|NCT02358460|respiratory|respiratory
297923|NCT02358460|mechanical ventilation|mechanical ventilation
297924|NCT02358447|total knee arthroplasty|total knee arthroplasty
297925|NCT02358447|total knee prothesis|total knee prothesis
297926|NCT02358447|Spectrometry, X-Ray Emission|spectrometry, x-ray emission
297927|NCT02358447|SPECT/CT|spect/ct
297928|NCT02358447|measurement of TKA component position|measurement of tka component position
297929|NCT02358434|Implant|implant
297930|NCT02358421|Rotterdam's diagnostic criteria of PCOS|rotterdam's diagnostic criteria of pcos
297931|NCT02358421|Risk of OHSS|risk of ohss
297932|NCT02358356|midgut|midgut
297933|NCT02358356|pancreatic|pancreatic
297934|NCT02358356|neuroendocrine|neuroendocrine
297935|NCT02358356|advanced|advanced
297936|NCT02358356|unresectable low|unresectable low
297937|NCT02358356|intermediate grade|intermediate grade
297938|NCT02358356|mNETs|mnets
297939|NCT02358356|pNETs|pnets
297940|NCT02358343|Comorbid Depression|comorbid depression
297941|NCT02358343|Major Depressive Disorder|major depressive disorder
297942|NCT02358343|Dysthymia|dysthymia
297943|NCT02358343|Cognitive Behavioral therapy (CBT)|cognitive behavioral therapy (cbt)
297944|NCT02358343|Sertraline|sertraline
297945|NCT02358343|Engagement Interview|engagement interview
297946|NCT02358343|End Stage Renal Disease (ESRD)|end stage renal disease (esrd)
297947|NCT02358343|Hemodialysis|hemodialysis
297948|NCT02358317|Autism|autism
297949|NCT02358317|Postural Stability|postural stability
297950|NCT02358317|Exergaming|exergaming
297951|NCT02358317|White Matter|white matter
297952|NCT02358252|Heart Rate Variability|heart rate variability
297953|NCT02358252|orthostatic hypotension|orthostatic hypotension
297954|NCT02358252|stroke|stroke
297955|NCT02358252|integrated intelligent biosensor system|integrated intelligent biosensor system
297956|NCT02358239|dizziness and vertigo|dizziness and vertigo
297957|NCT02358239|emergency department (ED)|emergency department (ed)
297958|NCT02358239|clinical trial|clinical trial
297959|NCT02358239|acupuncture|acupuncture
297960|NCT02358226|Substance-Related Disorders|substance-related disorders
297961|NCT02358226|Human Immunodeficiency Virus|human immunodeficiency virus
297962|NCT02358226|Alcoholism|alcoholism
297963|NCT02358226|South Africa|south africa
297964|NCT02358226|Men|men
297965|NCT02358226|Soccer|soccer
297966|NCT02358226|Vocational Training|vocational training
297967|NCT02358213|reproductibility|reproductibility
297968|NCT02358174|Hemorrhoids|hemorrhoids
297969|NCT02358174|MMP|mmp
297970|NCT02358174|NGAL|ngal
297971|NCT02358174|Matrix Metalloproteinases|matrix metalloproteinases
297972|NCT02358161|Pancreatic cancer|pancreatic cancer
297973|NCT02358161|LDE225|lde225
297974|NCT02358161|Gemcitabine|gemcitabine
297975|NCT02358161|nab paclitaxel|nab paclitaxel
297976|NCT02358148|Acute Coronary Syndrome|acute coronary syndrome
297977|NCT02358148|Chest Pain|chest pain
297978|NCT02358148|ACS|acs
297979|NCT02358148|Risk Stratification Score|risk stratification score
297980|NCT02358148|HEART Score|heart score
297981|NCT02358148|Modified TIMI|modified timi
297982|NCT02358148|Coronary Artery Disease|coronary artery disease
297983|NCT02358148|Risk Factors|risk factors
297984|NCT02358148|Myocardial Infarction|myocardial infarction
297985|NCT02358135|Pragmatic|pragmatic
297986|NCT02358135|Equivalency|equivalency
297987|NCT02358135|Teledermatology|teledermatology
297988|NCT02358109|Cost-Benefit Analysis, Exercise,Women,Diseases/Prevention|cost-benefit analysis, exercise,women,diseases/prevention
297989|NCT02358096|Chronic Kidney Disease|chronic kidney disease
297990|NCT02358096|Type 2 Diabetes|type 2 diabetes
297991|NCT02358096|ASP8232|asp8232
297992|NCT02358070|Hepatocellular Carcinoma|hepatocellular carcinoma
297993|NCT02358057|Deep sedation|deep sedation
297994|NCT02358057|Dexmedetomidine|dexmedetomidine
297995|NCT02358057|Emergency Service, Hospital|emergency service, hospital
297996|NCT02358031|Programmed Cell Death Receptor 1 (PD-1)|programmed cell death receptor 1 (pd-1)
297997|NCT02358031|Programmed Cell Death Receptor Ligand 1 (PD-L1)|programmed cell death receptor ligand 1 (pd-l1)
297998|NCT02358031|Programmed Cell Death Receptor Ligand 2 (PD-L2)|programmed cell death receptor ligand 2 (pd-l2)
297999|NCT02358031|PD1|pd1
298000|NCT02358031|PD-1|pd-1
298001|NCT02358031|PDL1|pdl1
298002|NCT02358031|PD-L1|pd-l1
298003|NCT02358031|PDL2|pdl2
298004|NCT02358018|68Ga-DOTATOC|68ga-dotatoc
298005|NCT02358018|PET/CT scan|pet/ct scan
298006|NCT02358018|14-226|14-226
298007|NCT02357992|Lung cancer|lung cancer
298008|NCT02357992|Non-small cell lung cancer|non-small cell lung cancer
298009|NCT02357992|NSCLC|nsclc
298010|NCT02357992|Squamous cell carcinoma|squamous cell carcinoma
298011|NCT02357992|Adenocarcinoma with or without BAC features|adenocarcinoma with or without bac features
298012|NCT02357992|Large cell carcinoma with or without neuroendocrine features|large cell carcinoma with or without neuroendocrine features
298013|NCT02357992|Neuroendocrine carcinoma|neuroendocrine carcinoma
298014|NCT02357992|Bronchioloalveolar cell carcinoma|bronchioloalveolar cell carcinoma
298015|NCT02357992|Stereotactic radiotherapy (SRT)|stereotactic radiotherapy (srt)
298016|NCT02357992|SRT|srt
298017|NCT02357992|Stereotactic ablative radiotherapy|stereotactic ablative radiotherapy
298018|NCT02357992|SABR|sabr
298019|NCT02357992|Radiation therapy|radiation therapy
298020|NCT02357992|XRT|xrt
298021|NCT02357979|caries|caries
298022|NCT02357979|prevention|prevention
298023|NCT02357979|laser|laser
298024|NCT02357979|fluoride|fluoride
298025|NCT02357966|Staph|staph
298026|NCT02357966|antibody|antibody
298027|NCT02357940|Eczema|eczema
298028|NCT02357940|Skin Irritation|skin irritation
298029|NCT02357927|fears of recurrence|fears of recurrence
298030|NCT02357927|cancer|cancer
298031|NCT02357927|brief intervention|brief intervention
298032|NCT02357927|telephone counseling|telephone counseling
298033|NCT02357927|following primary cancer treatment|following primary cancer treatment
298034|NCT02357914|Ultrasound|ultrasound
298035|NCT02357914|Shoulder|shoulder
298036|NCT02357914|Spinal Cord Injury|spinal cord injury
298037|NCT02357914|Fluoroscopy|fluoroscopy
298038|NCT02357888|Nicotine replacement therapy|nicotine replacement therapy
298039|NCT02357888|craving|craving
298040|NCT02357862|Cardiovascular Diseases|cardiovascular diseases
298041|NCT02357862|Heart Valve Diseases|heart valve diseases
298042|NCT02357862|Mitral Valve Annuloplasty|mitral valve annuloplasty
298043|NCT02357862|Tricuspid Valve Insufficiency|tricuspid valve insufficiency
298044|NCT02357823|Pneumococcal vaccine|pneumococcal vaccine
298045|NCT02357823|HIV infection|hiv infection
298046|NCT02357823|13-valent Pneumococcal Conjugate Vaccine|13-valent pneumococcal conjugate vaccine
298047|NCT02357823|23-valent Pneumococcal Polysaccharide Vaccine|23-valent pneumococcal polysaccharide vaccine
298048|NCT02357784|Sacral Neuromodulation|sacral neuromodulation
298049|NCT02357784|SNM|snm
298050|NCT02357784|Dual Incontinence|dual incontinence
298051|NCT02357784|Current Perception Threshold Testing|current perception threshold testing
298052|NCT02357784|CPT Testing|cpt testing
298053|NCT02357784|Fecal Incontinence|fecal incontinence
298054|NCT02357784|Urinary Incontinence|urinary incontinence
298055|NCT02357784|Afferent Nerve Sensation|afferent nerve sensation
298056|NCT02357784|InterStim|interstim
298057|NCT02357771|misalignment of the two dental arches|misalignment of the two dental arches
298058|NCT02357771|mal-align teeth|mal-align teeth
298059|NCT02357758|Antibiotic Prophylaxis|antibiotic prophylaxis
298060|NCT02357758|Urinary Microbiota|urinary microbiota
298061|NCT02357745|neopterin|neopterin
298062|NCT02357745|plasma|plasma
298063|NCT02357745|urine|urine
298064|NCT02357745|saliva|saliva
298065|NCT02357745|menopause|menopause
298066|NCT02357745|periodontitis|periodontitis
298067|NCT02357732|Metastatic Melanoma|metastatic melanoma
298068|NCT02357719|Sleep Apnea Syndromes|sleep apnea syndromes
298069|NCT02357719|Polysomnography|polysomnography
298070|NCT02357719|Holter ECG|holter ecg
298071|NCT02357719|Thoracic impedance|thoracic impedance
298072|NCT02357719|Heart rate variability|heart rate variability
298073|NCT02357719|Nasal flow|nasal flow
298074|NCT02357693|nausea, postoperative|nausea, postoperative
298075|NCT02357693|postoperative nausea|postoperative nausea
298076|NCT02357693|postoperative vomiting|postoperative vomiting
298077|NCT02357693|vomiting, postoperative|vomiting, postoperative
298078|NCT02357641|acute coronary disease, echographic strain analysis, cut off|acute coronary disease, echographic strain analysis, cut off
298079|NCT02357602|Participants|participants
298080|NCT02357602|HIV-1 negative|hiv-1 negative
298081|NCT02357589|3D|3d
298082|NCT02357589|laparoscopy|laparoscopy
298083|NCT02357589|cholecystectomy|cholecystectomy
298084|NCT02357563|fibroid|fibroid
298085|NCT02357563|GnRH analogue|gnrh analogue
298086|NCT02357563|ulipristal acetate|ulipristal acetate
298087|NCT02357537|Telemedicine|telemedicine
298088|NCT02357524|Effects on coagulation tests in healthy volunteers|effects on coagulation tests in healthy volunteers
298089|NCT02357511|sensitivity|sensitivity
298090|NCT02357511|specificity|specificity
298091|NCT02357511|novel blood pressure monitor|novel blood pressure monitor
298092|NCT02357511|Saturation|saturation
298093|NCT02357498|pituitary|pituitary
298094|NCT02357498|adenoma|adenoma
298095|NCT02357498|transsphenoidal surgery|transsphenoidal surgery
298096|NCT02357485|ADSC|adsc
298097|NCT02357485|osteoarthritis|osteoarthritis
298098|NCT02357485|knee|knee
298099|NCT02357485|adipose|adipose
298100|NCT02357472|Reproductive aging|reproductive aging
298101|NCT02357472|DHEA|dhea
298102|NCT02357472|poor ovarian responder|poor ovarian responder
298103|NCT02357459|osteoarthritis|osteoarthritis
298104|NCT02357459|knee|knee
298105|NCT02357459|pain|pain
298106|NCT02357459|corticosteroid|corticosteroid
298107|NCT02357459|intra-articular|intra-articular
298108|NCT02357459|injection|injection
298109|NCT02357420|Diabetes Mellitus|diabetes mellitus
298110|NCT02357420|Delayed Gastric Emptying|delayed gastric emptying
298111|NCT02357420|Vomiting|vomiting
298112|NCT02357420|Gastroparesis|gastroparesis
298113|NCT02357420|Gastrointestinal Motility Disorder|gastrointestinal motility disorder
298114|NCT02357407|fluoroquinolones|fluoroquinolones
298115|NCT02357407|pharmacokinetic|pharmacokinetic
298116|NCT02357407|infections|infections
298117|NCT02357394|arabin pessary|arabin pessary
298118|NCT02357394|short cervix|short cervix
298119|NCT02357368|HIV-negative|hiv-negative
298120|NCT02357329|fat taste|fat taste
298121|NCT02357329|food preference|food preference
298122|NCT02357329|consumption|consumption
298123|NCT02357329|free fatty acids|free fatty acids
298124|NCT02357316|Taste responses of healthy individuals|taste responses of healthy individuals
298125|NCT02357303|Randomized controlled trial|randomized controlled trial
298126|NCT02357303|Endoscopy|endoscopy
298127|NCT02357303|Gastric mucosa|gastric mucosa
298128|NCT02357303|Simethicone|simethicone
298129|NCT02357303|Acetylcysteine|acetylcysteine
298130|NCT02357290|mania|mania
298131|NCT02357290|temper tantrum|temper tantrum
298132|NCT02357290|irritability|irritability
298133|NCT02357290|mood|mood
298134|NCT02357290|bipolar|bipolar
298135|NCT02357277|Osteoporosis|osteoporosis
298136|NCT02357277|Glucocorticoids|glucocorticoids
298137|NCT02357277|Postmenopausal|postmenopausal
298138|NCT02357238|Uveitis|uveitis
298139|NCT02357238|Infectious|infectious
298140|NCT02357225|Pompe disease|pompe disease
298141|NCT02357225|Pyridostigmine|pyridostigmine
298142|NCT02357212|Non-St elevation acute coronary syndrome|non-st elevation acute coronary syndrome
298143|NCT02357199|Mouth Diseases|mouth diseases
298144|NCT02357199|Renal Insufficiency, Chronic|renal insufficiency, chronic
298145|NCT02357199|Intervention Studies|intervention studies
298146|NCT02357186|Mild head injury - clinical decision rule - Child|mild head injury - clinical decision rule - child
298147|NCT02357173|smoking|smoking
298148|NCT02357173|nicotine|nicotine
298149|NCT02357173|tobacco products|tobacco products
298150|NCT02357173|electronic cigarette|electronic cigarette
298151|NCT02357147|Amatuximab|amatuximab
298152|NCT02357147|Pemetrexed|pemetrexed
298153|NCT02357147|Cisplatin|cisplatin
298154|NCT02357147|Unresectable Malignant Pleural Mesothelioma|unresectable malignant pleural mesothelioma
298155|NCT02357147|ARTEMIS|artemis
298156|NCT02357108|Supportive Care|supportive care
298157|NCT02357108|treatment options|treatment options
298158|NCT02357108|doctor's compassion|doctor's compassion
298159|NCT02357095|Caesarean Scar Pregnancy|caesarean scar pregnancy
298160|NCT02357095|uterine artery chemo-embolization|uterine artery chemo-embolization
298161|NCT02357095|treatment|treatment
298162|NCT02357030|Gulf War Illness|gulf war illness
298163|NCT02357030|nutrients|nutrients
298164|NCT02357030|methylphenidate|methylphenidate
298165|NCT02357030|mitochondria|mitochondria
298166|NCT02356991|Famitinib|famitinib
298167|NCT02356991|Phase II|phase ii
298168|NCT02356991|NSCLC|nsclc
298169|NCT02356978|Rare disease|rare disease
298170|NCT02356978|Crigler-Najjar disease|crigler-najjar disease
298171|NCT02356978|Paediatric|paediatric
298172|NCT02356978|Experimental device|experimental device
298173|NCT02356965|Third molar extraction|third molar extraction
298174|NCT02356965|Wisdom tooth extraction|wisdom tooth extraction
298175|NCT02356952|Metabolic Syndrome X|metabolic syndrome x
298176|NCT02356952|Low Glycemic Index Mediterranean Diet|low glycemic index mediterranean diet
298177|NCT02356952|Low Glycemic Index Diet|low glycemic index diet
298178|NCT02356952|Randomized Clinical Trial|randomized clinical trial
298179|NCT02356926|Adverse events|adverse events
298180|NCT02356926|Medical errors|medical errors
298181|NCT02356926|Emergency department|emergency department
298182|NCT02356926|Cross checking|cross checking
298183|NCT02356900|interval training|interval training
298184|NCT02356900|hyperbaric oxygen|hyperbaric oxygen
298185|NCT02356900|VO2 max|vo2 max
298186|NCT02356900|altitude|altitude
298187|NCT02356900|exercise performance|exercise performance
298188|NCT02356900|mitochondrial oxidative capacity|mitochondrial oxidative capacity
298189|NCT02356900|mitochondrial biogenesis|mitochondrial biogenesis
298190|NCT02356861|treatment|treatment
298191|NCT02356861|photobiomodulation|photobiomodulation
298192|NCT02356861|Veterans|veterans
298193|NCT02356861|brain-injury|brain-injury
298194|NCT02356861|TBI|tbi
298195|NCT02356861|PTSD|ptsd
298196|NCT02356848|self-care|self-care
298197|NCT02356848|self-monitoring|self-monitoring
298198|NCT02356848|secondary prevention|secondary prevention
298199|NCT02356848|foot ulcer|foot ulcer
298200|NCT02356848|Diabetic Foot Ulcer|diabetic foot ulcer
298201|NCT02356809|Gene therapy, plasmid, vegf, systemic scleroderma,secondary raynaud's phenomenon|gene therapy, plasmid, vegf, systemic scleroderma,secondary raynaud's phenomenon
298202|NCT02356757|self-care|self-care
298203|NCT02356757|self-monitoring|self-monitoring
298204|NCT02356757|medication adherence|medication adherence
298205|NCT02356757|diet|diet
298206|NCT02356757|physical activity|physical activity
298207|NCT02356757|primary prevention|primary prevention
298208|NCT02356744|Maternal outcome|maternal outcome
298209|NCT02356744|Fetal outcome|fetal outcome
298210|NCT02356744|bariatric surgery|bariatric surgery
298211|NCT02356744|Third Trimester|third trimester
298212|NCT02356731|seizures,|seizures,
298213|NCT02356731|quality of life|quality of life
298214|NCT02356640|Celiac plexus neurolysis|celiac plexus neurolysis
298215|NCT02356640|Celiac ganglion neurolysis|celiac ganglion neurolysis
298216|NCT02356640|Pancreatic cancer|pancreatic cancer
298217|NCT02356627|Occupational therapy|occupational therapy
298218|NCT02356627|Adaptive intervention|adaptive intervention
298219|NCT02356627|Home-based|home-based
298220|NCT02356627|Assistive Technology|assistive technology
298221|NCT02356627|Home modification|home modification
298222|NCT02356627|Clinical effectiveness|clinical effectiveness
298223|NCT02356627|Cost-effectiveness|cost-effectiveness
298224|NCT02356627|Cost-utility|cost-utility
298225|NCT02356614|Lap Band|lap band
298226|NCT02356601|MRI|mri
298227|NCT02356601|Lumbar spine|lumbar spine
298228|NCT02356601|Ultrasound|ultrasound
298229|NCT02356575|surgery|surgery
298230|NCT02356575|chemotherapy|chemotherapy
298231|NCT02356575|radiation|radiation
298232|NCT02356575|Acupuncture|acupuncture
298233|NCT02356575|16-947|16-947
298234|NCT02356562|Hepatitis C|hepatitis c
298235|NCT02356562|Interferon-Free|interferon-free
298236|NCT02356562|Treatment Experienced|treatment experienced
298237|NCT02356562|Chronic Hepatitis C|chronic hepatitis c
298238|NCT02356562|Hepatitis C Virus|hepatitis c virus
298239|NCT02356510|myocardial infarction|myocardial infarction
298240|NCT02356510|TIMI flow|timi flow
298241|NCT02356510|culprit lesion|culprit lesion
298242|NCT02356510|culprit vessel|culprit vessel
298243|NCT02356497|Bone metastases|bone metastases
298244|NCT02356497|Metastatic bone disease|metastatic bone disease
298245|NCT02356497|Multi-trial facility|multi-trial facility
298246|NCT02356458|Mantle cell lymphoma|mantle cell lymphoma
298247|NCT02356458|Relapsed|relapsed
298248|NCT02356458|Refractory|refractory
298249|NCT02356458|Cancer|cancer
298250|NCT02356458|Lymphoma|lymphoma
298251|NCT02356458|Ibrutinib Imbruvica|ibrutinib imbruvica
298252|NCT02356458|Bortezomib Velcade|bortezomib velcade
298253|NCT02356432|non-valvular atrial fibrillation|non-valvular atrial fibrillation
298254|NCT02356432|cerebral microbleeds|cerebral microbleeds
298255|NCT02356432|warfarin|warfarin
298256|NCT02356432|NOACs|noacs
298257|NCT02356432|acute ischemic stroke|acute ischemic stroke
298258|NCT02356406|Radiosurgery|radiosurgery
298259|NCT02356406|Celiac Plexus|celiac plexus
298260|NCT02356406|Pain|pain
298261|NCT02356406|Quality of Life|quality of life
298262|NCT02356393|Desalinated Sea Water|desalinated sea water
298263|NCT02356393|Magnesium|magnesium
298264|NCT02356393|Drinking Water|drinking water
298265|NCT02356367|telemonitoring|telemonitoring
298266|NCT02356367|Adaptive servo-ventilation|adaptive servo-ventilation
298267|NCT02356354|molecular factors|molecular factors
298268|NCT02356354|cutaneous innervation|cutaneous innervation
298269|NCT02356354|skin biopsy|skin biopsy
298270|NCT02356354|post-burn scar|post-burn scar
298271|NCT02356315|Brain|brain
298272|NCT02356315|Brain Stem|brain stem
298273|NCT02356315|Spinal Cord|spinal cord
298274|NCT02356315|Neurophysiology|neurophysiology
298275|NCT02356315|Magnetic Resonance Imaging|magnetic resonance imaging
298276|NCT02356289|Hypertrophic Cardiomyopathy|hypertrophic cardiomyopathy
298277|NCT02356276|locally advanced gastric cancer|locally advanced gastric cancer
298278|NCT02356276|Hyperthermic Intraperitoneal Chemotherapy|hyperthermic intraperitoneal chemotherapy
298279|NCT02356276|radical gastrectomy with D2 lymphadenectomy|radical gastrectomy with d2 lymphadenectomy
298280|NCT02356263|stressful events|stressful events
298281|NCT02356263|psychological stress|psychological stress
298282|NCT02356263|life experiences|life experiences
298283|NCT02356250|liver biopsy f 4|liver biopsy f 4
298284|NCT02356237|Episiotomy|episiotomy
298285|NCT02356237|Obstetric Anal Sphincter Injury|obstetric anal sphincter injury
298286|NCT02356224|SHR3824 Type 2 diabetes mellitus SGLT2|shr3824 type 2 diabetes mellitus sglt2
298287|NCT02356211|falls|falls
298288|NCT02356185|Alcohol Drinking|alcohol drinking
298289|NCT02356185|Injecting drug|injecting drug
298290|NCT02356185|Antiretroviral therapy|antiretroviral therapy
298291|NCT02356185|sub-Saharan Africa|sub-saharan africa
298292|NCT02356172|Quality of Life|quality of life
298293|NCT02356172|Depression|depression
298294|NCT02356172|Kallmann Syndrome|kallmann syndrome
298295|NCT02356172|Hypogonadotropic Hypogonadism|hypogonadotropic hypogonadism
298296|NCT02356159|Hematopoietic Stem Cell Transplant|hematopoietic stem cell transplant
298297|NCT02356159|Lymphoma|lymphoma
298298|NCT02356159|Leukemia|leukemia
298299|NCT02356159|Unrelated Donors|unrelated donors
298300|NCT02356146|Kidney transplantation|kidney transplantation
298301|NCT02356146|genotype|genotype
298302|NCT02356146|tacrolimus|tacrolimus
298303|NCT02356146|CYP3A5|cyp3a5
298304|NCT02356133|Near-Infrared Spectroscopy|near-infrared spectroscopy
298305|NCT02356094|glaucoma|glaucoma
298306|NCT02356094|primary open angle glaucoma|primary open angle glaucoma
298307|NCT02356094|cornea|cornea
298308|NCT02356068|liver transplantation, rotem, bleeding, transfusion|liver transplantation, rotem, bleeding, transfusion
298309|NCT02356055|activities of daily living|activities of daily living
298310|NCT02356055|massed practice|massed practice
298311|NCT02356055|occupational therapy|occupational therapy
298312|NCT02356029|Cardiopulmonary Arrest|cardiopulmonary arrest
298313|NCT02356029|Emergency Medical Services|emergency medical services
298314|NCT02356029|Medical Futility|medical futility
298315|NCT02356029|Decision Making|decision making
298316|NCT02356029|Emotional Stress|emotional stress
298317|NCT02356029|Burnout, Professional|burnout, professional
298318|NCT02356016|Sarcopenic Obesity|sarcopenic obesity
298319|NCT02356016|community dwelling elderly women|community dwelling elderly women
298320|NCT02356016|electromyostimulation|electromyostimulation
298321|NCT02356016|exercise|exercise
298322|NCT02356016|dietary supplements|dietary supplements
298323|NCT02356003|Tourette Syndrome|tourette syndrome
298324|NCT02356003|Children|children
298325|NCT02356003|Tics|tics
298326|NCT02355977|Chronic periodontitis|chronic periodontitis
298327|NCT02355977|Minocycline|minocycline
298328|NCT02355977|Surface and root planning|surface and root planning
298329|NCT02355977|Pocket depth|pocket depth
298330|NCT02355977|Sulcus bleeding index|sulcus bleeding index
298331|NCT02355977|Prevotella intermedia|prevotella intermedia
298332|NCT02355912|Transfemoral|transfemoral
298333|NCT02355873|heparin-coated|heparin-coated
298334|NCT02355873|surface-treated polyacrylonitrile membrane hemofilter|surface-treated polyacrylonitrile membrane hemofilter
298335|NCT02355873|critical ill|critical ill
298336|NCT02355873|acute kidney injury|acute kidney injury
298337|NCT02355873|chronic kidney disease|chronic kidney disease
298338|NCT02355873|continuous renal replacement therapy|continuous renal replacement therapy
298339|NCT02355834|Fecal Incontinence (FI)|fecal incontinence (fi)
298340|NCT02355834|Inflammatory bowel disease (IBD)|inflammatory bowel disease (ibd)
298341|NCT02355834|bowel control|bowel control
298342|NCT02355834|Chronic diarrhoea|chronic diarrhoea
298343|NCT02355834|rectal inflammation|rectal inflammation
298344|NCT02355821|cellular aging|cellular aging
298345|NCT02355821|vascular aging|vascular aging
298346|NCT02355821|bone metabolism|bone metabolism
298347|NCT02355821|collagen type 1 C-telopeptide|collagen type 1 c-telopeptide
298348|NCT02355821|nuclear factor kappa-B ligand (RANKL)|nuclear factor kappa-b ligand (rankl)
298349|NCT02355821|pulse wave velocity|pulse wave velocity
298350|NCT02355821|telomerase activity|telomerase activity
298351|NCT02355795|weight change|weight change
298352|NCT02355795|diet|diet
298353|NCT02355795|dietary fat|dietary fat
298354|NCT02355795|feeding design|feeding design
298355|NCT02355782|TMA, aHUS, TTP, stem cell transplant-associated TMA|tma, ahus, ttp, stem cell transplant-associated tma
298356|NCT02355769|heart failure|heart failure
298357|NCT02355769|renal failure|renal failure
298358|NCT02355769|prognosis|prognosis
298359|NCT02355769|impedance cardiography|impedance cardiography
298360|NCT02355717|children, bone|children, bone
298361|NCT02355717|Simple obesity|simple obesity
298362|NCT02355717|cardiovascular disease|cardiovascular disease
298363|NCT02355717|osteoporosis|osteoporosis
298364|NCT02355717|diabetes|diabetes
298365|NCT02355704|Kidney Transplantation|kidney transplantation
298366|NCT02355704|Atorvastatin|atorvastatin
298367|NCT02355704|C-Reactive Protein|c-reactive protein
298368|NCT02355704|Biopsy|biopsy
298369|NCT02355704|Interleukin|interleukin
298370|NCT02355652|Total knee arthroplasty|total knee arthroplasty
298371|NCT02355652|IKS Score|iks score
298372|NCT02355652|cemented, uncemented|cemented, uncemented
298373|NCT02355626|Anxiety|anxiety
298374|NCT02355626|level of anxiety|level of anxiety
298375|NCT02355626|delirium|delirium
298376|NCT02355626|agitation|agitation
298377|NCT02355626|tools for measuring anxiety|tools for measuring anxiety
298378|NCT02355626|neuroendocrine system|neuroendocrine system
298379|NCT02355613|Radiosurgery, brain, metastases|radiosurgery, brain, metastases
298380|NCT02355600|Oocyte|oocyte
298381|NCT02355600|Tamoxifen|tamoxifen
298382|NCT02355600|Fertility preservation|fertility preservation
298383|NCT02355587|melanoma|melanoma
298384|NCT02355587|cutaneous melanoma|cutaneous melanoma
298385|NCT02355587|DecisionDx-Melanoma|decisiondx-melanoma
298386|NCT02355574|melanoma|melanoma
298387|NCT02355574|cutaneous melanoma|cutaneous melanoma
298388|NCT02355574|DecisionDx-Melanoma|decisiondx-melanoma
298389|NCT02355561|Bioavailability|bioavailability
298390|NCT02355561|Healthy Participants|healthy participants
298391|NCT02355561|JNJ-54861911|jnj-54861911
298392|NCT02355561|Food Effect|food effect
298393|NCT02355535|refractory|refractory
298394|NCT02355535|intolerant|intolerant
298395|NCT02355535|solid tumors|solid tumors
298396|NCT02355535|PNET|pnet
298397|NCT02355535|neuroendocrine|neuroendocrine
298398|NCT02355522|saline infusion sonohysterography|saline infusion sonohysterography
298399|NCT02355509|Acarbose|acarbose
298400|NCT02355509|Postprandial lipemia|postprandial lipemia
298401|NCT02355509|Cardiovascular risk|cardiovascular risk
298402|NCT02355496|Cost Control|cost control
298403|NCT02355496|Data Display|data display
298404|NCT02355496|Diagnostic Tests, Routine|diagnostic tests, routine
298405|NCT02355496|Physician's Practice Patterns|physician's practice patterns
298406|NCT02355470|Sexual assault|sexual assault
298407|NCT02355470|Alcohol consumption|alcohol consumption
298408|NCT02355470|Intimate partner violence|intimate partner violence
298409|NCT02355457|troponin|troponin
298410|NCT02355457|myocardial infarction|myocardial infarction
298411|NCT02355457|acs|acs
298412|NCT02355457|AMI|ami
298413|NCT02355457|biomarker|biomarker
298414|NCT02355457|BACC|bacc
298415|NCT02355457|high-sensitivity|high-sensitivity
298416|NCT02355431|EGFR|egfr
298417|NCT02355431|mutation|mutation
298418|NCT02355405|lung ultrasound|lung ultrasound
298419|NCT02355405|atelectasis|atelectasis
298420|NCT02355405|thoracic computed Tomography|thoracic computed tomography
298421|NCT02355379|Adjuvant chemotherapy in colonic adenocarcinoma in elderly|adjuvant chemotherapy in colonic adenocarcinoma in elderly
298422|NCT02355366|Offspring|offspring
298423|NCT02355366|significant mood symptoms|significant mood symptoms
298424|NCT02355353|DWI-MRI|dwi-mri
298425|NCT02355353|resectable liver metastases|resectable liver metastases
298426|NCT02355340|Bone mineral density|bone mineral density
298427|NCT02355340|Childhood cancer survivors|childhood cancer survivors
298428|NCT02355314|ICU patients|icu patients
298429|NCT02355314|Doppler-based renal|doppler-based renal
298430|NCT02355301|ICF, impairment, activity, satisfaction, quality of care|icf, impairment, activity, satisfaction, quality of care
298431|NCT02355288|Coronary Artery Disease|coronary artery disease
298432|NCT02355288|Diabetes Mellitus|diabetes mellitus
298433|NCT02355288|Minimally Invasive Cardiac Surgery|minimally invasive cardiac surgery
298434|NCT02355288|Percutaneous Coronary Intervention|percutaneous coronary intervention
298435|NCT02355275|Home Exercise|home exercise
298436|NCT02355275|Resistance Exercise|resistance exercise
298437|NCT02355262|Insurance Coverage|insurance coverage
298438|NCT02355262|Insurance Continuity|insurance continuity
298439|NCT02355249|traditional three incisions|traditional three incisions
298440|NCT02355249|minimally invasive thoracol-laparoscopic esophagectomy|minimally invasive thoracol-laparoscopic esophagectomy
298441|NCT02355249|MIE|mie
298442|NCT02355249|esophageal cancer|esophageal cancer
298443|NCT02355236|Naxozol|naxozol
298444|NCT02355236|LDQ|ldq
298445|NCT02355236|GSRS|gsrs
298446|NCT02355236|Osteoarthritis|osteoarthritis
298447|NCT02355236|Gastroprotective|gastroprotective
298448|NCT02355223|Tuberculosis|tuberculosis
298449|NCT02355223|Infection Control|infection control
298450|NCT02355223|Transmission|transmission
298451|NCT02355197|antioxidants|antioxidants
298452|NCT02355197|Gestational diabetes mellitus|gestational diabetes mellitus
298453|NCT02355197|oxidative stress|oxidative stress
298454|NCT02355158|pain|pain
298455|NCT02355158|diabetic neuropathy|diabetic neuropathy
298456|NCT02355158|pain in feet|pain in feet
298457|NCT02355145|type 2 diabetes, add-on diabetes therapy, rationale|type 2 diabetes, add-on diabetes therapy, rationale
298458|NCT02355132|Medicaid|medicaid
298459|NCT02355132|public insurance|public insurance
298460|NCT02355132|cardiovascular disease|cardiovascular disease
298461|NCT02355132|prevention|prevention
298462|NCT02355132|community health centers|community health centers
298463|NCT02355132|electronic health records|electronic health records
298464|NCT02355132|cancer prevention|cancer prevention
298465|NCT02355080|HIV|hiv
298466|NCT02355080|HCV|hcv
298467|NCT02355067|parenting|parenting
298468|NCT02355067|postpartum depression|postpartum depression
298469|NCT02355067|mothers|mothers
298470|NCT02355067|infants|infants
298471|NCT02355067|depression|depression
298472|NCT02355054|Recurrent|recurrent
298473|NCT02355041|diet|diet
298474|NCT02355041|body weight|body weight
298475|NCT02355041|eating|eating
298476|NCT02355041|meal replacement|meal replacement
298477|NCT02355028|LHA510|lha510
298478|NCT02355028|PoC|poc
298479|NCT02355028|Age-related macular degeneration|age-related macular degeneration
298480|NCT02354976|omega-3 carboxylic acid|omega-3 carboxylic acid
298481|NCT02354963|Poor ovarian response|poor ovarian response
298482|NCT02354963|Salvador/Warts/Hippo pathway|salvador/warts/hippo pathway
298483|NCT02354963|Follicular activation|follicular activation
298484|NCT02354963|Poor ovarian reserve|poor ovarian reserve
298485|NCT02354950|GSK1265744|gsk1265744
298486|NCT02354950|healthy controls|healthy controls
298487|NCT02354950|pharmacokinetic|pharmacokinetic
298488|NCT02354950|Hepatic Impairment|hepatic impairment
298489|NCT02354937|Pharmacokinetics|pharmacokinetics
298490|NCT02354937|GSK1265744|gsk1265744
298491|NCT02354937|Severe Renal Impairment|severe renal impairment
298492|NCT02354911|Immunomodulation|immunomodulation
298493|NCT02354872|Nicotine|nicotine
298494|NCT02354859|Cystic Fibrosis|cystic fibrosis
298495|NCT02354859|Gallium Nitrate|gallium nitrate
298496|NCT02354859|IV Gallium|iv gallium
298497|NCT02354859|Pseudomonas aeruginosa|pseudomonas aeruginosa
298498|NCT02354833|Hypotension|hypotension
298499|NCT02354833|Cesarean Delivery|cesarean delivery
298500|NCT02354833|Phenylephrine|phenylephrine
298501|NCT02354833|Spinal Anesthesia|spinal anesthesia
298502|NCT02354833|Norepinephrine|norepinephrine
298503|NCT02354807|BAT activation|bat activation
298504|NCT02354807|quantitative PET imaging|quantitative pet imaging
298505|NCT02354807|Mirabegron effect on BAT|mirabegron effect on bat
298506|NCT02354794|arginine|arginine
298507|NCT02354794|supplementation|supplementation
298508|NCT02354794|metabolic syndrome|metabolic syndrome
298509|NCT02354794|endothelial function|endothelial function
298510|NCT02354781|DMD|dmd
298511|NCT02354781|muscular dystrophy|muscular dystrophy
298512|NCT02354781|Follistatin|follistatin
298513|NCT02354742|Echocardiography|echocardiography
298514|NCT02354742|EGDT|egdt
298515|NCT02354742|Sepsis|sepsis
298516|NCT02354716|esophagus|esophagus
298517|NCT02354716|upper GI|upper gi
298518|NCT02354716|endoscopy|endoscopy
298519|NCT02354716|endoFLIP|endoflip
298520|NCT02354716|functional luminal imaging|functional luminal imaging
758842|NCT00409591|Prophylaxis|prophylaxis
298521|NCT02354716|esophageal stricture|esophageal stricture
298522|NCT02354716|narrow esophagus|narrow esophagus
298523|NCT02354716|narrow caliber esophagus|narrow caliber esophagus
298524|NCT02354716|esophageal narrowing|esophageal narrowing
298525|NCT02354716|eosinophilic esophagitis|eosinophilic esophagitis
298526|NCT02354716|Zenkers diverticulum|zenkers diverticulum
298527|NCT02354716|Schatzki ring|schatzki ring
298528|NCT02354703|alcoholism, treatment, serotonin transporter|alcoholism, treatment, serotonin transporter
298529|NCT02354677|Bronchial epithelium|bronchial epithelium
298530|NCT02354677|COPD|copd
298531|NCT02354677|Repair|repair
298532|NCT02354677|Remodelling|remodelling
298533|NCT02354677|Club Cells|club cells
298534|NCT02354664|respiratory test|respiratory test
298535|NCT02354664|respiratory muscle endurance|respiratory muscle endurance
298536|NCT02354664|spirometry|spirometry
298537|NCT02354651|Pompe disease|pompe disease
298538|NCT02354651|mechanical ventilation|mechanical ventilation
298539|NCT02354651|diaphragm pacing|diaphragm pacing
298540|NCT02354638|Perceptions|perceptions
298541|NCT02354638|Education and evaluate post intervention KAP|education and evaluate post intervention kap
298542|NCT02354625|Schwann cells|schwann cells
298543|NCT02354599|Randomized, double-blind, placebo-controlled, single-dose subcutaneous administration study|randomized, double-blind, placebo-controlled, single-dose subcutaneous administration study
298544|NCT02354586|gBRCAmut|gbrcamut
298545|NCT02354586|BRCA|brca
298546|NCT02354586|PARP inhibitor|parp inhibitor
298547|NCT02354586|HRD|hrd
298548|NCT02354586|Ovarian cancer|ovarian cancer
298549|NCT02354586|Serous Epithelial|serous epithelial
298550|NCT02354586|Fallopian Tube|fallopian tube
298551|NCT02354586|Primary Peritoneal|primary peritoneal
298552|NCT02354560|Erythromycin|erythromycin
298553|NCT02354560|Familial Adenomatous Polyposis (FAP)|familial adenomatous polyposis (fap)
298554|NCT02354560|APC gene|apc gene
298555|NCT02354560|nonsense mutations|nonsense mutations
299255|NCT02350361|lung caner|lung caner
298556|NCT02354534|cervical dysplasia|cervical dysplasia
298557|NCT02354534|HPV|hpv
298558|NCT02354534|Treatment|treatment
298559|NCT02354534|preinvasive|preinvasive
298560|NCT02354534|cervix|cervix
298561|NCT02354534|vaginal suppository|vaginal suppository
298562|NCT02354534|Cornelia Trimble|cornelia trimble
298563|NCT02354534|abnormal pap|abnormal pap
298564|NCT02354534|CIN|cin
298565|NCT02354521|Protein|protein
298566|NCT02354521|Mechanical ventilation|mechanical ventilation
298567|NCT02354521|Children|children
298568|NCT02354521|Outcomes|outcomes
298569|NCT02354508|acromegaly|acromegaly
298570|NCT02354508|GH|gh
298571|NCT02354508|IGF-1|igf-1
298572|NCT02354508|pasireotide LAR|pasireotide lar
298573|NCT02354495|Indirect calorimetry|indirect calorimetry
298574|NCT02354495|Protein|protein
298575|NCT02354495|Mechanical ventilation|mechanical ventilation
298576|NCT02354495|Respiratory failure|respiratory failure
298577|NCT02354469|TBI|tbi
298578|NCT02354469|Mild Traumatic Brain Injury|mild traumatic brain injury
298579|NCT02354469|Post-Concussion Syndrome|post-concussion syndrome
298580|NCT02354469|Recovery of Function|recovery of function
298581|NCT02354469|Motor Activity|motor activity
298582|NCT02354469|Diffusion Tensor Imaging|diffusion tensor imaging
298583|NCT02354469|Neural Injury|neural injury
298584|NCT02354469|Biomarkers|biomarkers
298585|NCT02354456|atrial fibrillation|atrial fibrillation
298586|NCT02354456|epidemiology|epidemiology
298587|NCT02354456|antiocaogulation|antiocaogulation
298588|NCT02354430|pregnancy|pregnancy
298589|NCT02354430|low back pain|low back pain
298590|NCT02354430|sick leave,|sick leave,
298591|NCT02354430|motor activity|motor activity
298592|NCT02354404|Ebola virus|ebola virus
298593|NCT02354404|Filoviridae Infections|filoviridae infections
298594|NCT02354404|Hemorrhagic Fever, Ebola|hemorrhagic fever, ebola
298595|NCT02354404|Viral Diseases|viral diseases
298596|NCT02354404|Hemorrhagic Fevers, Viral|hemorrhagic fevers, viral
298597|NCT02354365|PEEP adjustment|peep adjustment
298598|NCT02354365|Tidal Volume|tidal volume
298599|NCT02354365|Driving Pressure|driving pressure
298600|NCT02354365|Compliance|compliance
298601|NCT02354339|Metabolic Syndrome|metabolic syndrome
298602|NCT02354339|Irvingia gabonensis|irvingia gabonensis
298603|NCT02354339|African mango|african mango
298604|NCT02354339|Insulin resistance|insulin resistance
298605|NCT02354313|MANTLE CELL LYMPHOMA (MCL)|mantle cell lymphoma (mcl)
298606|NCT02354313|Lenalidomide (Len)|lenalidomide (len)
298607|NCT02354313|Rituximab|rituximab
298609|NCT02354313|Revlimid|revlimid
298610|NCT02354313|High dose chemotherapy|high dose chemotherapy
298611|NCT02354313|transplant|transplant
298612|NCT02354261|Basal Cell Carcinoma Nevus Syndrome|basal cell carcinoma nevus syndrome
298613|NCT02354261|BCCNS|bccns
298614|NCT02354261|BCC|bcc
298615|NCT02354261|itraconazole|itraconazole
298616|NCT02354261|basal cell carcinoma|basal cell carcinoma
298617|NCT02354261|locally advanced basal cell carcinoma|locally advanced basal cell carcinoma
298618|NCT02354248|TST|tst
298619|NCT02354248|TMS|tms
758941|NCT00409214|AA|aa
298620|NCT02354248|Stroke patients|stroke patients
298621|NCT02354248|EMG|emg
298622|NCT02354235|MT-2412|mt-2412
298623|NCT02354235|MP-513|mp-513
298624|NCT02354235|TA-7284|ta-7284
298625|NCT02354235|Teneligliptin|teneligliptin
298626|NCT02354235|Canagliflozin|canagliflozin
298627|NCT02354222|MT-2412|mt-2412
298628|NCT02354222|MP-513|mp-513
298629|NCT02354222|TA-7284|ta-7284
298630|NCT02354222|Teneligliptin|teneligliptin
298631|NCT02354222|Canagliflozin|canagliflozin
298632|NCT02354183|Commitment strategies|commitment strategies
298633|NCT02354183|Motivation|motivation
298634|NCT02354183|DBT skills|dbt skills
298635|NCT02354183|Self-harm|self-harm
298636|NCT02354183|Brief intervention|brief intervention
298637|NCT02354170|Central Serous Chorioretinopathy, CSC|central serous chorioretinopathy, csc
298638|NCT02354157|children dietary pattern|children dietary pattern
298639|NCT02354157|control rules|control rules
298640|NCT02354157|instrumental learning|instrumental learning
298641|NCT02354157|food reinforcement|food reinforcement
298642|NCT02354144|Human papillomavirus|human papillomavirus
298643|NCT02354144|Carrageenan|carrageenan
298644|NCT02354144|Microbicide|microbicide
298645|NCT02354144|Anal HPV infection|anal hpv infection
298646|NCT02354131|Ovarian cancer|ovarian cancer
298647|NCT02354131|Niraparib|niraparib
298648|NCT02354131|Bevacizumab|bevacizumab
298649|NCT02354131|PARP|parp
298650|NCT02354131|Phase 2 randomized|phase 2 randomized
298651|NCT02354105|Axial Spondyloarthritis|axial spondyloarthritis
298652|NCT02354105|Radiographic Axial Spondyloarthritis|radiographic axial spondyloarthritis
298653|NCT02354105|Non-radiographic Axial Spondyloarthritis|non-radiographic axial spondyloarthritis
298654|NCT02354105|Ankylosing spondylitis|ankylosing spondylitis
298655|NCT02354105|Diagnosis|diagnosis
298656|NCT02354105|Cimzia|cimzia
298657|NCT02354105|CZP|czp
298658|NCT02354105|Certolizumab Pegol|certolizumab pegol
298659|NCT02354105|CDP870|cdp870
298660|NCT02354092|cervical dilation|cervical dilation
298661|NCT02354092|pain|pain
299256|NCT02350348|neonates|neonates
298662|NCT02354092|paracervical block|paracervical block
298663|NCT02354092|osmotic dilators|osmotic dilators
298664|NCT02354079|Low LDL-C|low ldl-c
298665|NCT02354079|Target Identification|target identification
298666|NCT02354079|Genetic|genetic
298667|NCT02354079|Endocrinology|endocrinology
298668|NCT02354079|Cardiovascular Disease|cardiovascular disease
298669|NCT02354066|Hallux valgus surgery|hallux valgus surgery
298670|NCT02354066|forefoot surgery|forefoot surgery
298671|NCT02354066|brake response time|brake response time
298672|NCT02354066|foot orthoses|foot orthoses
298673|NCT02354053|HIV|hiv
298674|NCT02354053|Triumeq|triumeq
298675|NCT02354053|vulnerable populations|vulnerable populations
298676|NCT02354040|Stroke, Myocardial Infarction, Adherence, Health Literacy, Implementation, Developing Country|stroke, myocardial infarction, adherence, health literacy, implementation, developing country
298677|NCT02354027|SHR3824 metformin drug-drug interaction|shr3824 metformin drug-drug interaction
298678|NCT02354014|Multidrug-Resistant Tuberculosis|multidrug-resistant tuberculosis
298679|NCT02354014|Bedaquiline|bedaquiline
298680|NCT02354014|TMC207|tmc207
298681|NCT02354001|schizophrenia|schizophrenia
298682|NCT02354001|mental illness|mental illness
298683|NCT02354001|serm|serm
298684|NCT02354001|raloxifene|raloxifene
298685|NCT02354001|clinical trial|clinical trial
298686|NCT02353988|AR-positive|ar-positive
298687|NCT02353988|Androgen Antagonists|androgen antagonists
298688|NCT02353988|Bicalutamide|bicalutamide
298689|NCT02353988|TNBC|tnbc
298690|NCT02353988|metastatic|metastatic
298691|NCT02353975|SHR3824|shr3824
298692|NCT02353975|food effect|food effect
298693|NCT02353975|mass|mass
298694|NCT02353975|balance|balance
298695|NCT02353975|Phase I|phase i
298696|NCT02353962|neglect|neglect
298697|NCT02353962|exergames|exergames
298698|NCT02353949|Mild cognitive impairment|mild cognitive impairment
298699|NCT02353949|Alzheimer|alzheimer
298700|NCT02353949|PET|pet
298701|NCT02353949|Amyloid|amyloid
298702|NCT02353949|Frontotemporal|frontotemporal
298703|NCT02353871|Moderate to Severe|moderate to severe
298704|NCT02353858|Rectal Cancer|rectal cancer
298705|NCT02353858|Hyperthermia|hyperthermia
298706|NCT02353858|Radiochemotherapy|radiochemotherapy
298707|NCT02353858|Chemoradiotherapy|chemoradiotherapy
298708|NCT02353858|Deep regional hyperthermia|deep regional hyperthermia
298709|NCT02353858|pathologic complete response|pathologic complete response
298710|NCT02353858|Regression Grade|regression grade
298711|NCT02353858|Locally advanced rectal cancer|locally advanced rectal cancer
298712|NCT02353858|complete response|complete response
298713|NCT02353806|Amlodipine besylate|amlodipine besylate
298714|NCT02353806|Breast milk|breast milk
298715|NCT02353806|Pharmacokinetics|pharmacokinetics
298716|NCT02353806|Chronic hypertension|chronic hypertension
298717|NCT02353806|Pregnancy|pregnancy
298718|NCT02353793|Hypothermia|hypothermia
298719|NCT02353793|(Poly) Trauma|(poly) trauma
298720|NCT02353793|Emergency Room|emergency room
298721|NCT02353793|Warming Blanket|warming blanket
298722|NCT02353780|Rheumatoid arthritis|rheumatoid arthritis
298723|NCT02353780|TNF inhibitors|tnf inhibitors
298724|NCT02353702|Diaphragmatic function|diaphragmatic function
298725|NCT02353702|sniff-test|sniff-test
298726|NCT02353702|pulmonary complications|pulmonary complications
298727|NCT02353702|upper abdominal surgery|upper abdominal surgery
298728|NCT02353663|Rheumatic heart disease|rheumatic heart disease
298729|NCT02353663|Rheumatic fever|rheumatic fever
298730|NCT02353663|Mitral regurgitation|mitral regurgitation
298731|NCT02353663|Aortic regurgitation|aortic regurgitation
298732|NCT02353663|Mitral stenosis|mitral stenosis
298734|NCT02353650|ubiquinol|ubiquinol
298735|NCT02353611|tooth|tooth
298736|NCT02353611|bleaching|bleaching
298737|NCT02353585|vitamin K-antagonist|vitamin k-antagonist
298738|NCT02353585|novel oral anticoagulants|novel oral anticoagulants
298739|NCT02353585|apixaban|apixaban
298740|NCT02353585|dabigatran|dabigatran
298741|NCT02353585|rivaroxaban|rivaroxaban
298742|NCT02353585|edoxaban|edoxaban
298743|NCT02353585|direct oral anticoagulants|direct oral anticoagulants
298744|NCT02353559|acute leukemia|acute leukemia
298745|NCT02353559|traumatic stress|traumatic stress
298746|NCT02353559|quality of life|quality of life
298747|NCT02353559|symptom burden|symptom burden
298748|NCT02353559|psychosocial oncology|psychosocial oncology
298749|NCT02353559|palliative care|palliative care
298750|NCT02353559|intervention|intervention
298751|NCT02353559|hematological malignancies|hematological malignancies
298752|NCT02353559|supportive care|supportive care
298753|NCT02353546|affective symptoms|affective symptoms
298754|NCT02353546|cancer|cancer
298755|NCT02353546|depression|depression
298756|NCT02353546|palliative care|palliative care
298757|NCT02353546|pilot trial|pilot trial
298758|NCT02353546|psychotherapy|psychotherapy
298759|NCT02353533|adenoma|adenoma
298760|NCT02353533|EMR|emr
298761|NCT02353533|FTRD|ftrd
298762|NCT02353533|non- lifting|non- lifting
298763|NCT02353533|colon|colon
298764|NCT02353442|Pain|pain
298765|NCT02353442|Rotator cuff|rotator cuff
298766|NCT02353442|Stretching|stretching
298767|NCT02353442|Mobilization|mobilization
298768|NCT02353442|Scapula|scapula
298769|NCT02353442|Posterior capsule|posterior capsule
298770|NCT02353416|Mediterranean Diet|mediterranean diet
298771|NCT02353416|Low-Glycemic Index|low-glycemic index
298772|NCT02353416|AGEs|ages
298773|NCT02353403|Fructo-oligosaccharides|fructo-oligosaccharides
298774|NCT02353403|Sugar-reduced foods|sugar-reduced foods
298775|NCT02353403|Postprandial glucose response|postprandial glucose response
298776|NCT02353390|presyncope|presyncope
298777|NCT02353390|syncope|syncope
298778|NCT02353390|adolescent|adolescent
298779|NCT02353390|young adult|young adult
298780|NCT02353390|immunization|immunization
298781|NCT02353390|vaccination|vaccination
298782|NCT02353390|water consumption|water consumption
298783|NCT02353364|Advanced maternal age|advanced maternal age
298784|NCT02353364|Aneuploidy|aneuploidy
298785|NCT02353325|Iron deficiency|iron deficiency
298786|NCT02353325|Iron fortification|iron fortification
298787|NCT02353325|Iron encapsulation|iron encapsulation
298788|NCT02353312|Diastolic|diastolic
298789|NCT02353312|Biopterin|biopterin
298790|NCT02353312|Therapeutic Use|therapeutic use
298791|NCT02353312|Drug Therapy|drug therapy
298792|NCT02353312|Quality of Life|quality of life
298793|NCT02353299|Cognition|cognition
298794|NCT02353299|Balance|balance
298795|NCT02353286|Biodegradable stents, ERCP|biodegradable stents, ercp
298796|NCT02353273|WH-1,Diabetic Foot,Ulcer|wh-1,diabetic foot,ulcer
298797|NCT02353234|Phenolics|phenolics
298798|NCT02353234|Aleurone|aleurone
298799|NCT02353234|Bioavailability|bioavailability
298800|NCT02353234|Pharmacokinetics|pharmacokinetics
298801|NCT02353221|Early arthritis|early arthritis
298802|NCT02353221|undiferentiated arthritis|undiferentiated arthritis
298803|NCT02353182|abdominal|abdominal
298804|NCT02353182|lower extremity|lower extremity
298805|NCT02353169|changes in myocardial repolarization in healthy children|changes in myocardial repolarization in healthy children
298806|NCT02353156|Hemorrhoidectomy|hemorrhoidectomy
298807|NCT02353156|postoperative pain|postoperative pain
298808|NCT02353156|Sitz bath|sitz bath
298809|NCT02353156|Electronic bidet|electronic bidet
298810|NCT02353143|Acute Myeloid Leukemia|acute myeloid leukemia
298811|NCT02353143|AML|aml
298812|NCT02353143|Relapsed|relapsed
298813|NCT02353143|Refractory|refractory
298814|NCT02353143|MEN1112|men1112
298815|NCT02353143|Monoclonal antibody|monoclonal antibody
298816|NCT02353130|autism spectrum disorders|autism spectrum disorders
298817|NCT02353130|memantine|memantine
298818|NCT02353130|cortical metrics|cortical metrics
298819|NCT02353130|sensory testing|sensory testing
298820|NCT02353078|Eosinophilic Esophagitis (EOE)|eosinophilic esophagitis (eoe)
298821|NCT02353065|Colles' Fracture|colles' fracture
298822|NCT02353065|ultrasonography|ultrasonography
298823|NCT02353052|morphology standards|morphology standards
298824|NCT02353013|protein intake|protein intake
298825|NCT02353013|body composition|body composition
298826|NCT02352974|Diamyd|diamyd
298827|NCT02352974|Diabetes|diabetes
298828|NCT02352974|Juvenile Diabetes|juvenile diabetes
298829|NCT02352974|Diabetes Type 1|diabetes type 1
298830|NCT02352974|Type 1 Diabetes|type 1 diabetes
298831|NCT02352974|Autoimmune Diabetes|autoimmune diabetes
298832|NCT02352974|Insulin Dependent Diabetes|insulin dependent diabetes
298833|NCT02352974|Type 1 Diabetes Mellitus|type 1 diabetes mellitus
298834|NCT02352974|rhGAD65|rhgad65
298835|NCT02352974|GAD65|gad65
298836|NCT02352974|GAD-Alum|gad-alum
298837|NCT02352974|Diabetes Mellitus|diabetes mellitus
298838|NCT02352974|Diabetes mellitus Type 1|diabetes mellitus type 1
298839|NCT02352974|Glucose Metabolism Disorders|glucose metabolism disorders
298840|NCT02352974|Metabolic Diseases|metabolic diseases
298841|NCT02352974|Vitamin D|vitamin d
298842|NCT02352961|Unrecognised condition|unrecognised condition
298843|NCT02352922|Laparoscopy|laparoscopy
298844|NCT02352922|Robotic Surgical Procedures|robotic surgical procedures
298845|NCT02352922|Hysterectomy|hysterectomy
298846|NCT02352922|Anesthetics, Local|anesthetics, local
298847|NCT02352922|Bupivacaine|bupivacaine
298848|NCT02352922|Pain, Postoperative|pain, postoperative
298849|NCT02352896|Leigh syndrome|leigh syndrome
298850|NCT02352896|Mitochondrial disorders|mitochondrial disorders
298851|NCT02352896|EPI743|epi743
298852|NCT02352896|Vincerinone|vincerinone
298853|NCT02352870|Feasibility study|feasibility study
298854|NCT02352870|Randomised controlled trial|randomised controlled trial
298855|NCT02352870|Cognitive behavioural therapy|cognitive behavioural therapy
298856|NCT02352870|Psychological distress|psychological distress
298857|NCT02352870|Cognitive illness representations|cognitive illness representations
298858|NCT02352870|Common sense model|common sense model
298859|NCT02352857|Fructo-oligosaccharides|fructo-oligosaccharides
298860|NCT02352857|Sugar-reduced foods|sugar-reduced foods
298861|NCT02352857|Postprandial glucose response|postprandial glucose response
298862|NCT02352805|Extracorporeal circulation, ventricular assist device|extracorporeal circulation, ventricular assist device
298863|NCT02352792|Local control|local control
298864|NCT02352779|Cancer Survivor|cancer survivor
298865|NCT02352766|Thyroid cancer|thyroid cancer
298866|NCT02352766|Thyroid nodules|thyroid nodules
298867|NCT02352766|Palpable nodules|palpable nodules
298869|NCT02352753|Amgen, OI, Bone|amgen, oi, bone
298870|NCT02352740|arginine|arginine
298871|NCT02352740|supplementation|supplementation
298872|NCT02352740|metabolic syndrome|metabolic syndrome
298873|NCT02352740|nitric oxide|nitric oxide
298874|NCT02352727|Nocturnal hypokinesia|nocturnal hypokinesia
298875|NCT02352727|Accelerometers|accelerometers
298876|NCT02352714|Adolescents|adolescents
298877|NCT02352714|Women's Health|women's health
298878|NCT02352714|Contraception|contraception
298879|NCT02352714|Reproduction|reproduction
298880|NCT02352714|Comparative Effectiveness Research|comparative effectiveness research
298881|NCT02352714|Pregnancy Prevention|pregnancy prevention
298882|NCT02352714|Intrauterine Device|intrauterine device
298883|NCT02352701|helicobacter pylori|helicobacter pylori
298884|NCT02352701|ilaprazole|ilaprazole
298885|NCT02352701|eradication|eradication
298886|NCT02352701|triple therapy|triple therapy
298887|NCT02352688|elderly|elderly
298888|NCT02352688|enhanced recovery after surgery|enhanced recovery after surgery
298889|NCT02352662|Congenital Heart Disease|congenital heart disease
298890|NCT02352662|Point-of-care coagulation monitoring|point-of-care coagulation monitoring
298891|NCT02352662|Rotaional Thromboelastometry|rotaional thromboelastometry
298892|NCT02352649|Peripheral nerve injury|peripheral nerve injury
298893|NCT02352649|Neurotmesis|neurotmesis
298894|NCT02352649|Gene therapy|gene therapy
298895|NCT02352649|Plasmid|plasmid
298896|NCT02352649|Nerve regeneration therapy|nerve regeneration therapy
298897|NCT02352610|carpometacarpal joints|carpometacarpal joints
298898|NCT02352597|PCOS|pcos
298899|NCT02352597|Phytoestrogens|phytoestrogens
298900|NCT02352597|ovulation induction|ovulation induction
298901|NCT02352584|QIV|qiv
298902|NCT02352584|Quadrivalent Influenza Vaccine|quadrivalent influenza vaccine
298903|NCT02352584|Influenza vaccine|influenza vaccine
298904|NCT02352584|Vaccination|vaccination
298905|NCT02352558|Multiple Myeloma|multiple myeloma
298906|NCT02352558|Lymphoma|lymphoma
298907|NCT02352558|Acute Myeloid Leukemia|acute myeloid leukemia
298908|NCT02352558|Myelo-Dysplastic Syndrome|myelo-dysplastic syndrome
298909|NCT02352558|Chronic Myeloid Leukemia|chronic myeloid leukemia
298910|NCT02352558|Chronic Lymphocytic Leukemia|chronic lymphocytic leukemia
298911|NCT02352532|Dry Needling|dry needling
298912|NCT02352532|Shear Wave Elastography|shear wave elastography
298913|NCT02352532|Ultrasound|ultrasound
298914|NCT02352493|PNH|pnh
298915|NCT02352493|RNAi therapeutic|rnai therapeutic
298916|NCT02352480|Non Healing Wound|non healing wound
298917|NCT02352467|Non Healing Wound|non healing wound
298918|NCT02352454|Non Healing Wound|non healing wound
298919|NCT02352428|Skin Cancer|skin cancer
298920|NCT02352428|Secondary Prevention|secondary prevention
298921|NCT02352428|Population Screening|population screening
381910|NCT01952236|web|web
298922|NCT02352402|CABG|cabg
298923|NCT02352402|Ticagrelor|ticagrelor
298924|NCT02352402|Graft|graft
298925|NCT02352402|Patency|patency
298926|NCT02352389|Childhood|childhood
298927|NCT02352389|Cancer|cancer
298928|NCT02352389|Genetic mutations|genetic mutations
298929|NCT02352376|Noninvasive ventilation|noninvasive ventilation
298930|NCT02352376|Heart rate variability|heart rate variability
298931|NCT02352376|Thoracic surgery|thoracic surgery
298932|NCT02352363|Parkinson's Disease|parkinson's disease
298933|NCT02352363|Motor fluctuations|motor fluctuations
298934|NCT02352363|levodopa|levodopa
298935|NCT02352363|inhaled drugs|inhaled drugs
298936|NCT02352363|OFF episodes|off episodes
298937|NCT02352350|Pre-Hospital Cardiac Arrest|pre-hospital cardiac arrest
298938|NCT02352350|Blood Lactate Level|blood lactate level
298939|NCT02352350|Neurological Injury|neurological injury
298940|NCT02352337|cancer|cancer
298941|NCT02352337|pancreatic cancer|pancreatic cancer
298942|NCT02352337|metastatic pancreatic cancer|metastatic pancreatic cancer
298943|NCT02352324|cardiac output|cardiac output
298944|NCT02352324|coronary artery bypass grafting|coronary artery bypass grafting
298945|NCT02352324|minimally invasive hemodynamic monitoring|minimally invasive hemodynamic monitoring
298946|NCT02352324|fluid responsiveness|fluid responsiveness
298947|NCT02352272|sleep extension|sleep extension
298948|NCT02352272|attention|attention
298949|NCT02352272|physical performance|physical performance
298950|NCT02352259|Liver metastases of colorectal cancer Electrochemotherapy|liver metastases of colorectal cancer electrochemotherapy
298951|NCT02352259|Bleomycin|bleomycin
298952|NCT02352259|Electrochemotherapy|electrochemotherapy
298953|NCT02352246|intermittent sprinting|intermittent sprinting
298954|NCT02352246|abdominal fat mass|abdominal fat mass
298955|NCT02352246|type 2 diabetes|type 2 diabetes
298956|NCT02352246|postmenopausal women|postmenopausal women
298957|NCT02352233|retroview colonoscope|retroview colonoscope
298958|NCT02352233|retroflexion colonoscopy|retroflexion colonoscopy
298959|NCT02352233|colonoscopy|colonoscopy
298960|NCT02352207|Neonatal respiratory distress|neonatal respiratory distress
298961|NCT02352207|prenatal lung malformation|prenatal lung malformation
298962|NCT02352207|KRAS mutation|kras mutation
298963|NCT02352207|pregnant woman|pregnant woman
299056|NCT02351596|Core Stability|core stability
299057|NCT02351596|Balance|balance
298964|NCT02352194|Multiple Sclerosis, Physical therapy, Physical capacity, Fatigue|multiple sclerosis, physical therapy, physical capacity, fatigue
298965|NCT02352181|Cirrhosis, transplantation, transfusion, Rotem®|cirrhosis, transplantation, transfusion, rotem®
298966|NCT02352168|allergic rhinitis；airway inflammation；hyperreactivity|allergic rhinitis；airway inflammation；hyperreactivity
298967|NCT02352155|haemostasis|haemostasis
298968|NCT02352142|Separation stress|separation stress
298969|NCT02352142|Family Nurture|family nurture
298970|NCT02352142|Maternal Confidence|maternal confidence
298971|NCT02352142|Maternal Competence|maternal competence
298972|NCT02352142|Calming Cycle|calming cycle
298973|NCT02352142|Kangaroo Care|kangaroo care
298974|NCT02352142|Infant Neurodevelopment|infant neurodevelopment
298975|NCT02352142|Infant Psychological Development|infant psychological development
298976|NCT02352142|Post-partum depression|post-partum depression
298977|NCT02352142|Mother-infant Co-regulation|mother-infant co-regulation
298978|NCT02352116|Postoperative Experience|postoperative experience
298979|NCT02352116|Postoperative Behavioral Changes|postoperative behavioral changes
298980|NCT02352116|Maladaptive Behavioral Changes|maladaptive behavioral changes
298981|NCT02352103|prostate cancer|prostate cancer
298982|NCT02352103|Urinary continence|urinary continence
298983|NCT02352103|robotic assisted radical prostatectomy|robotic assisted radical prostatectomy
298984|NCT02352103|Vattikuti Urology Institute (VIP) radical prostatectomy|vattikuti urology institute (vip) radical prostatectomy
298985|NCT02352103|Retzius sparing radical prostatectomy|retzius sparing radical prostatectomy
298986|NCT02352090|Contraception, oral|contraception, oral
298987|NCT02352090|Ethinyl Estradiol|ethinyl estradiol
298988|NCT02352090|Estradiol Valerate|estradiol valerate
298989|NCT02352090|Dienogest|dienogest
298990|NCT02352090|Insulin resistance|insulin resistance
298991|NCT02352090|Chronic inflammation|chronic inflammation
298992|NCT02352090|Coagulation|coagulation
298993|NCT02352051|attention deficit-hyperactivity disorder (ADHD).|attention deficit-hyperactivity disorder (adhd).
298994|NCT02352051|executive functions|executive functions
298995|NCT02352038|malocclusion|malocclusion
298996|NCT02352038|low-level laser therapy|low-level laser therapy
298997|NCT02352025|S-equol|s-equol
298998|NCT02352025|breast cancer|breast cancer
298999|NCT02352025|triple negative|triple negative
299000|NCT02352012|Interventional Treatment|interventional treatment
299001|NCT02352012|Refractory Pneumothorax|refractory pneumothorax
299002|NCT02352012|Bronchoscope|bronchoscope
299003|NCT02351999|Atrial fibrillation|atrial fibrillation
299004|NCT02351999|Transseptal puncture|transseptal puncture
299005|NCT02351999|Atrial fibrillation ablation|atrial fibrillation ablation
299006|NCT02351986|subacromial impingement|subacromial impingement
299007|NCT02351986|physical therapy|physical therapy
299008|NCT02351986|cryotherapy|cryotherapy
299009|NCT02351960|Drug therapy|drug therapy
299010|NCT02351960|GERD|gerd
299011|NCT02351960|Dexlansoprazole|dexlansoprazole
299012|NCT02351947|stroke|stroke
299013|NCT02351947|Cerebrovascular accident|cerebrovascular accident
299014|NCT02351947|rehabilitation|rehabilitation
299015|NCT02351947|motor learning|motor learning
299016|NCT02351947|fMRI|fmri
299017|NCT02351947|plasticity|plasticity
299018|NCT02351934|colorectal surgery|colorectal surgery
299019|NCT02351934|volume status|volume status
299020|NCT02351921|transcranial magnetic stimulation|transcranial magnetic stimulation
299021|NCT02351921|spinal cord injury|spinal cord injury
299022|NCT02351921|motor cortex|motor cortex
299023|NCT02351921|somatosensory cortex|somatosensory cortex
299024|NCT02351895|infection control|infection control
299025|NCT02351895|Prevention of hospital acquired infection|prevention of hospital acquired infection
299026|NCT02351856|laminopathy|laminopathy
299027|NCT02351856|ARRY-797|arry-797
299028|NCT02351804|US-guided peripheral nerve block|us-guided peripheral nerve block
299029|NCT02351804|Anesthetics, Local|anesthetics, local
299030|NCT02351804|duration|duration
299031|NCT02351804|Sensation|sensation
299032|NCT02351804|adductor canal block|adductor canal block
299033|NCT02351804|lower limb|lower limb
299034|NCT02351804|Adjuvants, Anesthesia|adjuvants, anesthesia
299035|NCT02351778|Developing Countries|developing countries
299036|NCT02351778|Quality of Life|quality of life
299037|NCT02351778|Mixed Methods|mixed methods
299038|NCT02351778|Validation|validation
299039|NCT02351778|Caregiver Burden|caregiver burden
299040|NCT02351726|aortic valve replacement|aortic valve replacement
299041|NCT02351726|aortic stenosis|aortic stenosis
299042|NCT02351726|aortic steno-insufficiency|aortic steno-insufficiency
299043|NCT02351713|primary prevention|primary prevention
299044|NCT02351687|Moderate Acute Malnutrition|moderate acute malnutrition
299045|NCT02351674|Heart Rate|heart rate
299046|NCT02351674|Percutaneous coronary intervention|percutaneous coronary intervention
299047|NCT02351674|outcome|outcome
299048|NCT02351648|readmission|readmission
299049|NCT02351648|care transition|care transition
299050|NCT02351635|Calprotectin|calprotectin
299051|NCT02351635|Diagnosis|diagnosis
299052|NCT02351609|smoking cessation|smoking cessation
299053|NCT02351609|patient navigation|patient navigation
299054|NCT02351609|financial incentives|financial incentives
299055|NCT02351609|health disparities|health disparities
299058|NCT02351596|Core Control|core control
299059|NCT02351505|Small Cell Lung Cancer|small cell lung cancer
299060|NCT02351492|Bile duct obstruction|bile duct obstruction
299061|NCT02351492|intraoperative cholangiography|intraoperative cholangiography
299062|NCT02351492|MRCP|mrcp
299063|NCT02351479|hula|hula
299064|NCT02351479|breast cancer|breast cancer
299065|NCT02351479|female|female
299066|NCT02351479|hawaii|hawaii
299067|NCT02351479|physical activity|physical activity
299068|NCT02351479|cervical cancer|cervical cancer
299069|NCT02351479|ovarian cancer|ovarian cancer
299070|NCT02351479|endometrial cancer|endometrial cancer
299071|NCT02351466|Brain Growth and Development|brain growth and development
299072|NCT02351466|Cognition|cognition
299073|NCT02351466|Children|children
299074|NCT02351466|Continuous Glucose Monitoring|continuous glucose monitoring
299075|NCT02351466|MRI|mri
299076|NCT02351466|Functional MRI|functional mri
299077|NCT02351440|duloxetine|duloxetine
299078|NCT02351414|Osteoarthritis|osteoarthritis
299079|NCT02351414|Ankylosis|ankylosis
299080|NCT02351414|Revision procedures|revision procedures
299081|NCT02351414|Correction of functional deformity|correction of functional deformity
299082|NCT02351414|Rheumatoid arthritis|rheumatoid arthritis
299083|NCT02351414|Arthritis|arthritis
299084|NCT02351388|Alzheimer's disease|alzheimer's disease
299085|NCT02351388|Depressive symptoms|depressive symptoms
299086|NCT02351388|Neuropsychiatric symptoms|neuropsychiatric symptoms
299087|NCT02351388|Behavioral and Psychological Symptoms of Dementia|behavioral and psychological symptoms of dementia
299088|NCT02351388|Neuromodulation|neuromodulation
299089|NCT02351388|Transcranial Direct Current Stimulation|transcranial direct current stimulation
299090|NCT02351375|microbiota|microbiota
299091|NCT02351375|small intestine|small intestine
299092|NCT02351375|diet|diet
299093|NCT02351375|feces|feces
299094|NCT02351362|Retention|retention
299095|NCT02351362|Attrition|attrition
299096|NCT02351362|Incentive|incentive
299097|NCT02351362|Pregnant women|pregnant women
299098|NCT02351349|frailty|frailty
299099|NCT02351349|CKD|ckd
299100|NCT02351349|Physical Therapy Modalities|physical therapy modalities
299101|NCT02351349|Elder Nutritional Physiological Phenomena|elder nutritional physiological phenomena
299102|NCT02351336|Threatened preterm birth|threatened preterm birth
299103|NCT02351336|Fetal adrenal gland volume|fetal adrenal gland volume
299104|NCT02351336|Fetal zone enlargement|fetal zone enlargement
299105|NCT02351336|Prediction of preterm birth|prediction of preterm birth
299106|NCT02351297|High protein diet|high protein diet
299107|NCT02351297|Microbiota|microbiota
299108|NCT02351297|Rectal biopsies|rectal biopsies
299109|NCT02351297|Metabolomics|metabolomics
299110|NCT02351297|Bacterial metabolites|bacterial metabolites
299111|NCT02351297|volunteers|volunteers
299112|NCT02351284|HIV, vitamin D, osteoporosis|hiv, vitamin d, osteoporosis
299113|NCT02351258|Pediatrics|pediatrics
299114|NCT02351258|Medical Oncology|medical oncology
299115|NCT02351258|Catheters|catheters
299116|NCT02351258|Infection|infection
299117|NCT02351206|X-Rays|x-rays
299118|NCT02351206|Magnetic Resonance Imaging|magnetic resonance imaging
299119|NCT02351206|Sensitivity and Specificity|sensitivity and specificity
299120|NCT02351180|Chronic lung allograft dysfunction|chronic lung allograft dysfunction
299121|NCT02351180|Community-acquired respiratory viral infection|community-acquired respiratory viral infection
299122|NCT02351167|Smoking cessation|smoking cessation
299123|NCT02351167|Counseling|counseling
299124|NCT02351167|Genetics and Genomics|genetics and genomics
299125|NCT02351141|Noble Gas MRI|noble gas mri
299126|NCT02351141|Pulmonary Function|pulmonary function
299127|NCT02351141|Quality of Life Questionnaires|quality of life questionnaires
299128|NCT02351128|lanreotide|lanreotide
299129|NCT02351102|Congenital CMV|congenital cmv
299130|NCT02351102|Congenital Cytomegalovirus|congenital cytomegalovirus
299131|NCT02351063|Heart failure|heart failure
299132|NCT02351063|BNP|bnp
299133|NCT02351063|home testing|home testing
299134|NCT02351063|remote monitoring|remote monitoring
299135|NCT02351050|sonolysis, brain infarction, coronary angioplasty|sonolysis, brain infarction, coronary angioplasty
299136|NCT02351037|Acute Myeloid Leukemia|acute myeloid leukemia
299137|NCT02351037|AML|aml
299138|NCT02351037|Ibrutinib|ibrutinib
299139|NCT02351037|Cytarabine|cytarabine
299140|NCT02351037|LD-AraC|ld-arac
299141|NCT02351037|Azacitidine|azacitidine
299142|NCT02350985|Migraine|migraine
299143|NCT02350985|Migrainous Vertigo|migrainous vertigo
299144|NCT02350985|Headache Disorders|headache disorders
299145|NCT02350985|Central Nervous System Origin Vertigo|central nervous system origin vertigo
299146|NCT02350985|Paroxysmal Vertigo|paroxysmal vertigo
299147|NCT02350985|Adrenergic beta-Antagonist|adrenergic beta-antagonist
299148|NCT02350985|Vasodilator Agent|vasodilator agent
299149|NCT02350985|Anti Arrhythmia Agent|anti arrhythmia agent
299150|NCT02350985|Serotonin Uptake Inhibitor|serotonin uptake inhibitor
299151|NCT02350985|Antidepressive Agent|antidepressive agent
299152|NCT02350985|Propranolol|propranolol
299153|NCT02350985|Venlafaxine|venlafaxine
299154|NCT02350959|Plaque|plaque
299155|NCT02350959|coronary computed tomography angiography|coronary computed tomography angiography
299156|NCT02350933|tracheal damages|tracheal damages
299157|NCT02350920|IBD|ibd
299158|NCT02350920|Crohn's disease|crohn's disease
299159|NCT02350920|ulcerative colitis|ulcerative colitis
299160|NCT02350920|ACT|act
299161|NCT02350907|antimicrobial resistance|antimicrobial resistance
299162|NCT02350907|point-of-care testing|point-of-care testing
299163|NCT02350907|Neisseria gonorrhoeae|neisseria gonorrhoeae
299164|NCT02350868|without Standard Treatment|without standard treatment
299165|NCT02350855|Nutrition intervention|nutrition intervention
299166|NCT02350855|Palliative care|palliative care
299167|NCT02350855|Public Health|public health
299168|NCT02350855|Quality of life|quality of life
299169|NCT02350855|Tailored food formula|tailored food formula
299170|NCT02350855|Body weight|body weight
299171|NCT02350842|non-Left Bundle Branch Block morphology|non-left bundle branch block morphology
299172|NCT02350842|Triple-site biventricular pacing|triple-site biventricular pacing
299173|NCT02350842|cardiac resynchronization therapy|cardiac resynchronization therapy
299174|NCT02350803|distraction osteogenesis|distraction osteogenesis
299175|NCT02350803|mini plate|mini plate
299176|NCT02350803|Lefort 1 osteotomy|lefort 1 osteotomy
299177|NCT02350790|Robotics|robotics
299178|NCT02350790|Laparoscopy|laparoscopy
299179|NCT02350790|Endometriosis|endometriosis
299180|NCT02350790|Argon|argon
299181|NCT02350790|Gynecology|gynecology
299182|NCT02350777|T-cell Depleted Hematopoietic Stem Cell|t-cell depleted hematopoietic stem cell
299183|NCT02350777|Allogeneic Hematopoietic Stem Cell Transplantation|allogeneic hematopoietic stem cell transplantation
299184|NCT02350777|CliniMACS Cell Selection System|clinimacs cell selection system
299185|NCT02350777|14-228|14-228
299186|NCT02350777|HSCT|hsct
299187|NCT02350764|Nivolumab|nivolumab
299188|NCT02350764|Lung|lung
299189|NCT02350764|ipilimumab|ipilimumab
299190|NCT02350764|NSCLC|nsclc
299191|NCT02350764|14-137|14-137
299192|NCT02350751|Influenza, Flu, Flu A, Influenza A|influenza, flu, flu a, influenza a
299193|NCT02350738|Mild cognitive impairment|mild cognitive impairment
299194|NCT02350738|Dementia|dementia
299195|NCT02350738|Cognitive training|cognitive training
299196|NCT02350738|Cognitive rehabilitation|cognitive rehabilitation
299197|NCT02350738|Cognitive therapy|cognitive therapy
299198|NCT02350725|Chronic Fluid Overload|chronic fluid overload
299199|NCT02350712|Recurrent or metastatic squamous cell carcinoma of the head and neck|recurrent or metastatic squamous cell carcinoma of the head and neck
299200|NCT02350712|SCCHN|scchn
299201|NCT02350647|Rotator cuff|rotator cuff
299202|NCT02350647|Ossification|ossification
299203|NCT02350647|Suture anchors|suture anchors
299204|NCT02350621|cervical foraminal stenosis minimal invasive foraminotomy|cervical foraminal stenosis minimal invasive foraminotomy
299205|NCT02350582|breast cancer|breast cancer
299206|NCT02350582|telerehabilitation|telerehabilitation
299207|NCT02350582|strength|strength
299208|NCT02350582|fatigue|fatigue
299209|NCT02350582|quality of life|quality of life
299210|NCT02350569|liver transplant|liver transplant
299211|NCT02350569|hepatitis C|hepatitis c
299212|NCT02350569|Gilead|gilead
299213|NCT02350569|Communicable Diseases|communicable diseases
299214|NCT02350569|Infection|infection
299215|NCT02350569|Liver Diseases|liver diseases
299216|NCT02350569|RNA Virus Infections|rna virus infections
299217|NCT02350543|Aspirin usage|aspirin usage
299218|NCT02350543|Transurethral resection of bladder tumor (TURBT)|transurethral resection of bladder tumor (turbt)
299219|NCT02350530|Colorectal cancer|colorectal cancer
299220|NCT02350530|Metastatic colorectal cancer|metastatic colorectal cancer
299221|NCT02350530|Liver metastases|liver metastases
299222|NCT02350530|Liver resection|liver resection
299223|NCT02350530|Liver ablation|liver ablation
299224|NCT02350530|Conversion therapy|conversion therapy
299225|NCT02350530|FOLFOXIRI|folfoxiri
299226|NCT02350530|Oxaliplatin|oxaliplatin
299227|NCT02350530|Irinotecan|irinotecan
299228|NCT02350530|Fluorouracil|fluorouracil
299229|NCT02350530|Bevacizumab|bevacizumab
299230|NCT02350530|RAS mutation|ras mutation
299231|NCT02350491|Pregnancy|pregnancy
299232|NCT02350491|miRNA|mirna
299233|NCT02350491|Rheumatoid Arthritis (RA)|rheumatoid arthritis (ra)
299234|NCT02350491|Systemic Lupus Erythematosus (SLE)|systemic lupus erythematosus (sle)
299235|NCT02350465|sarcopenia|sarcopenia
299236|NCT02350465|aging|aging
299237|NCT02350465|myosteatosis|myosteatosis
299238|NCT02350465|exercise|exercise
299239|NCT02350465|screening|screening
299240|NCT02350452|laparoscopic surgery|laparoscopic surgery
299241|NCT02350452|diode laser|diode laser
299242|NCT02350452|AMH|amh
299243|NCT02350452|AFC|afc
299244|NCT02350439|Coronary artery disease|coronary artery disease
299245|NCT02350439|Fractional floe reserve|fractional floe reserve
299246|NCT02350400|Drug eluting beads|drug eluting beads
299247|NCT02350400|Irinotecan|irinotecan
299248|NCT02350400|Pharmacogenetics|pharmacogenetics
299249|NCT02350400|Pharmacokinetics|pharmacokinetics
299250|NCT02350374|diabetes|diabetes
299251|NCT02350374|children|children
299252|NCT02350361|endostar|endostar
299253|NCT02350361|angiogenesis|angiogenesis
299254|NCT02350361|EGFR-TKI|egfr-tki
299257|NCT02350348|infants|infants
299258|NCT02350348|anaesthesia|anaesthesia
299259|NCT02350348|mortality|mortality
299260|NCT02350348|adverse effects|adverse effects
299261|NCT02350348|Epidemiological Study|epidemiological study
299262|NCT02350348|European Society of Anaesthesiology|european society of anaesthesiology
299263|NCT02350335|aneurysm|aneurysm
299264|NCT02350335|nicotine replacement therapy|nicotine replacement therapy
299265|NCT02350335|cerebral vasospasm|cerebral vasospasm
299266|NCT02350335|outcome|outcome
299267|NCT02350322|Diet|diet
299268|NCT02350322|concentration|concentration
299269|NCT02350322|seafood|seafood
299270|NCT02350322|youths|youths
299271|NCT02350322|Norway|norway
299272|NCT02350322|Nutrient status in blood|nutrient status in blood
299273|NCT02350322|Inflammatory markers|inflammatory markers
299274|NCT02350309|Insomnia Disorder|insomnia disorder
299275|NCT02350309|E2006|e2006
299276|NCT02350309|Multiple Sleep Latency Test|multiple sleep latency test
299277|NCT02350296|headache|headache
299278|NCT02350296|dental pain|dental pain
299279|NCT02350296|neuralgia|neuralgia
299280|NCT02350296|dysmenorrhoea|dysmenorrhoea
299281|NCT02350296|muscular and osteoarticular pain|muscular and osteoarticular pain
299282|NCT02350283|Acute Ischemic Stroke|acute ischemic stroke
299283|NCT02350283|Endovascular therapy|endovascular therapy
299284|NCT02350283|Solitaire|solitaire
299285|NCT02350283|Standard Medical Management|standard medical management
299286|NCT02350270|cognitively healthy individuals|cognitively healthy individuals
299287|NCT02350257|cognitive behavior therapy|cognitive behavior therapy
299288|NCT02350257|child|child
299289|NCT02350257|randomized controlled trial|randomized controlled trial
299290|NCT02350257|internet|internet
299291|NCT02350244|musculoskeletal diseases|musculoskeletal diseases
299292|NCT02350244|eyestrain|eyestrain
299293|NCT02350244|occupational diseases|occupational diseases
299294|NCT02350244|computer work|computer work
299295|NCT02350244|muscle stretching exercise|muscle stretching exercise
299296|NCT02350244|computer software application|computer software application
299297|NCT02350244|MSDs|msds
299298|NCT02350231|preterm birth|preterm birth
299299|NCT02350231|Twin pregnancy|twin pregnancy
299300|NCT02350231|progesterone|progesterone
299301|NCT02350218|Transplantation|transplantation
299302|NCT02350218|Living donor|living donor
299303|NCT02350218|Eglandin|eglandin
299304|NCT02350218|Alprostadil|alprostadil
299305|NCT02350205|Burn wounds|burn wounds
299306|NCT02350205|Burns|burns
299307|NCT02350205|Skin substitute|skin substitute
299308|NCT02350192|ehealth|ehealth
299309|NCT02350192|intervention|intervention
299310|NCT02350192|effectiveness|effectiveness
299311|NCT02350192|randomized controlled trial|randomized controlled trial
299312|NCT02350166|colorectal cancer|colorectal cancer
299313|NCT02350166|hepatectomy|hepatectomy
299314|NCT02350166|laparoscopic surgery|laparoscopic surgery
299315|NCT02350166|laparotomy|laparotomy
299316|NCT02350166|complications|complications
299317|NCT02350153|Mortality|mortality
299318|NCT02350153|Morbidity|morbidity
299319|NCT02350153|Incidence|incidence
299320|NCT02350153|Prevalence|prevalence
299321|NCT02350140|HIV|hiv
299322|NCT02350140|Prevention of mother-to-child HIV transmission|prevention of mother-to-child hiv transmission
299323|NCT02350140|PMTCT|pmtct
299324|NCT02350140|mobile health (mHealth)|mobile health (mhealth)
299325|NCT02350140|mobile phone|mobile phone
299326|NCT02350140|text messaging|text messaging
299327|NCT02350140|short message services (SMS)|short message services (sms)
299328|NCT02350127|dementia|dementia
299329|NCT02350127|clinical trial|clinical trial
299330|NCT02350127|behavioral intervention|behavioral intervention
299331|NCT02350127|exercise|exercise
299332|NCT02350127|complementary and alternative medicine|complementary and alternative medicine
299333|NCT02350127|cognition|cognition
299334|NCT02350127|function|function
299335|NCT02350127|quality of life|quality of life
299336|NCT02350114|Heart failure|heart failure
299337|NCT02350114|6 Minute Walk Test|6 minute walk test
299338|NCT02350088|fast-track surgery|fast-track surgery
299339|NCT02350075|short implants|short implants
299340|NCT02350075|sinus floor elevation|sinus floor elevation
299341|NCT02350075|randomized controlled trial|randomized controlled trial
299342|NCT02350036|Preeclampsia|preeclampsia
299343|NCT02350036|placental protein 13|placental protein 13
299344|NCT02350036|Uterine artery doppler|uterine artery doppler
299345|NCT02350023|alopecia areata|alopecia areata
299346|NCT02350023|betamethasone|betamethasone
299347|NCT02350023|latanoprost|latanoprost
299348|NCT02350023|topical steroid|topical steroid
299349|NCT02350023|prostaglandin|prostaglandin
299350|NCT02350010|Etiology|etiology
299351|NCT02350010|Prognostic risk factors|prognostic risk factors
299352|NCT02350010|Intracerebral Hemorrhage|intracerebral hemorrhage
299353|NCT02350010|non-invasive imaging|non-invasive imaging
299354|NCT02350010|CT angiography|ct angiography
299355|NCT02349997|central sleep apnea|central sleep apnea
299356|NCT02349997|Cheyne-Stokes respiration|cheyne-stokes respiration
299357|NCT02349997|obstructive sleep apnea|obstructive sleep apnea
299358|NCT02349997|chronic heart failure|chronic heart failure
299359|NCT02349997|fluid shift|fluid shift
299360|NCT02349919|postinfectious cough, postviral cough|postinfectious cough, postviral cough
299361|NCT02349906|non-malignant diseases, allogeneic stem cell transplantation|non-malignant diseases, allogeneic stem cell transplantation
299362|NCT02349854|pruritus|pruritus
299364|NCT02349854|skin|skin
299365|NCT02349854|scalp|scalp
299366|NCT02349854|seborrheic dermatitis|seborrheic dermatitis
299367|NCT02349828|antiviral|antiviral
299368|NCT02349828|herpes simplex virus|herpes simplex virus
299369|NCT02349828|herpes|herpes
299370|NCT02349828|burn patients|burn patients
299371|NCT02349828|HSV|hsv
299372|NCT02349828|acyclovir|acyclovir
299373|NCT02349815|Drug Utilization Study|drug utilization study
299374|NCT02349802|Auto-injector Device, device-related injection, Auto-injector|auto-injector device, device-related injection, auto-injector
299375|NCT02349789|Gait|gait
299376|NCT02349789|Cerebellum|cerebellum
299377|NCT02349789|Non invasive electrical stimulation|non invasive electrical stimulation
299378|NCT02349789|tDCS|tdcs
299379|NCT02349789|TMS|tms
299380|NCT02349789|Balance|balance
299381|NCT02349763|Dexamethasone|dexamethasone
299382|NCT02349763|Hypersensitivity reaction|hypersensitivity reaction
299383|NCT02349763|Paclitaxel|paclitaxel
299384|NCT02349750|Endometrial Scratch Injury|endometrial scratch injury
299385|NCT02349750|Unexplained infertility|unexplained infertility
299386|NCT02349750|intrauterine insemenation|intrauterine insemenation
299387|NCT02349750|ovulation induction|ovulation induction
299388|NCT02349737|Bioelectrical Impedance Analysis|bioelectrical impedance analysis
299389|NCT02349737|Body composition|body composition
299390|NCT02349737|ICD|icd
299391|NCT02349724|CEA|cea
299392|NCT02349724|CAR T|car t
299393|NCT02349711|probiotic|probiotic
299394|NCT02349711|allergy|allergy
299395|NCT02349711|immune|immune
299396|NCT02349698|CAR T|car t
299397|NCT02349698|Leukemia|leukemia
299398|NCT02349698|Lymphoma|lymphoma
299399|NCT02349685|Helicobacter pylori|helicobacter pylori
299400|NCT02349685|Personalized therapy|personalized therapy
299401|NCT02349685|antimicrobial susceptibility|antimicrobial susceptibility
299402|NCT02349685|rescue therapy|rescue therapy
299403|NCT02349685|culture|culture
299404|NCT02349672|HIE|hie
299405|NCT02349672|Neonates|neonates
299406|NCT02349633|EGFRm - Epidermal Growth Factor Receptor Mutation|egfrm - epidermal growth factor receptor mutation
299407|NCT02349633|Advanced EGFRm (del19 or L858R +/- T790M NSCLC|advanced egfrm (del19 or l858r +/- t790m nsclc
299408|NCT02349581|Anesthetics, Local|anesthetics, local
299409|NCT02349581|Mastectomy|mastectomy
299410|NCT02349581|Neuralgia|neuralgia
299411|NCT02349581|Nerve block|nerve block
299412|NCT02349542|Liposomal Bupivacaine|liposomal bupivacaine
299413|NCT02349542|Simultaneous Bilateral Total Knee Arthroplasty|simultaneous bilateral total knee arthroplasty
299414|NCT02349542|Safety|safety
299415|NCT02349529|Epilepsy|epilepsy
299416|NCT02349529|psychosocial|psychosocial
299417|NCT02349503|Adrenocortical function|adrenocortical function
299418|NCT02349503|Adrenal hyperplasia, Congenital|adrenal hyperplasia, congenital
299419|NCT02349503|21-hydroxylase deficiency|21-hydroxylase deficiency
299420|NCT02349503|Adrenogenital Syndrome|adrenogenital syndrome
299421|NCT02349503|Adolescents|adolescents
299422|NCT02349503|Female|female
299423|NCT02349503|Hyperplasia|hyperplasia
299424|NCT02349503|Adrenal Gland Diseases|adrenal gland diseases
299425|NCT02349503|Congenital Abnormalities|congenital abnormalities
299426|NCT02349503|Adrenocortical Hyperfunction|adrenocortical hyperfunction
299427|NCT02349503|Disorders of Sex Development|disorders of sex development
299428|NCT02349503|Endocrine System Diseases|endocrine system diseases
299429|NCT02349503|Genetic Diseases, Inborn|genetic diseases, inborn
299430|NCT02349503|Gonadal Disorders|gonadal disorders
299431|NCT02349503|Metabolic Diseases|metabolic diseases
299432|NCT02349503|Metabolism, Inborn Errors|metabolism, inborn errors
299433|NCT02349503|Pathologic Processes|pathologic processes
299434|NCT02349503|Steroid Metabolism, Inborn Errors|steroid metabolism, inborn errors
299435|NCT02349503|Urogenital Abnormalities|urogenital abnormalities
299436|NCT02349503|Corticotropin Releasing Factor|corticotropin releasing factor
299437|NCT02349490|gastrointestinal hemorrhage|gastrointestinal hemorrhage
299438|NCT02349490|endoscopy|endoscopy
299439|NCT02349490|hemostasis|hemostasis
299440|NCT02349451|Safety|safety
299441|NCT02349451|Efficacy|efficacy
299442|NCT02349451|Methotrexate|methotrexate
299443|NCT02349373|Overuse injury|overuse injury
299444|NCT02349373|Running related injury|running related injury
299445|NCT02349373|Running pattern|running pattern
299446|NCT02349360|safety|safety
299447|NCT02349360|tolerability|tolerability
299448|NCT02349321|physical or sexual intimate partner violence|physical or sexual intimate partner violence
299449|NCT02349321|adolescents|adolescents
299450|NCT02349321|primary prevention|primary prevention
299451|NCT02349321|randomised controlled trial|randomised controlled trial
299452|NCT02349321|school|school
299453|NCT02349321|South Africa|south africa
299454|NCT02349321|parenting|parenting
299455|NCT02349282|muscle strength|muscle strength
299456|NCT02349282|physical performance|physical performance
299457|NCT02349282|vitamin D3|vitamin d3
299458|NCT02349282|Cholecalciferol|cholecalciferol
299459|NCT02349282|Calcifediol|calcifediol
299460|NCT02349269|Atrial fibrillation|atrial fibrillation
299461|NCT02349269|CABG|cabg
299462|NCT02349269|Stroke|stroke
299463|NCT02349256|MUS|mus
299464|NCT02349256|British South Asians|british south asians
299465|NCT02349256|Somatic Symptoms|somatic symptoms
299466|NCT02349256|Qualitative interviews|qualitative interviews
299467|NCT02349243|obese|obese
299468|NCT02349243|weight loss|weight loss
299469|NCT02349243|entacapone|entacapone
299470|NCT02349217|Breast cancer|breast cancer
299471|NCT02349217|Breast cancer survivors|breast cancer survivors
299472|NCT02349217|Breast cancer partners|breast cancer partners
299473|NCT02349217|Mindfulness-Based Relationship Enhancement|mindfulness-based relationship enhancement
299474|NCT02349217|MBRE|mbre
299475|NCT02349217|Standard of care|standard of care
299476|NCT02349217|Pain Assessment|pain assessment
299477|NCT02349217|Questionnaires|questionnaires
299478|NCT02349217|Surveys|surveys
299479|NCT02349217|Neurocognitive Tests|neurocognitive tests
299480|NCT02349217|Cortisol Tests|cortisol tests
299481|NCT02349217|Saliva tests|saliva tests
299482|NCT02349217|Interviews|interviews
299483|NCT02349217|Meditation|meditation
299484|NCT02349217|Yoga|yoga
299485|NCT02349217|Self-help materials|self-help materials
299486|NCT02349204|Simulator|simulator
299487|NCT02349204|Music|music
299488|NCT02349204|Mozart Effect|mozart effect
299489|NCT02349191|Alzheimers|alzheimers
299490|NCT02349191|dementia|dementia
299491|NCT02349191|omental transposition|omental transposition
299492|NCT02349191|neurological|neurological
299493|NCT02349152|Cardiopulmonary bypass|cardiopulmonary bypass
299494|NCT02349152|Heart surgery|heart surgery
299495|NCT02349126|Hepatitis B|hepatitis b
299496|NCT02349126|HBV infection|hbv infection
299497|NCT02349126|Hepatitis B Surface Antigen|hepatitis b surface antigen
299498|NCT02349113|estrogen, aging|estrogen, aging
299499|NCT02349087|EEG|eeg
299500|NCT02349087|cardiac arrest|cardiac arrest
299501|NCT02349087|resuscitation|resuscitation
299502|NCT02349087|seizures|seizures
382599|NCT01948921|EGD|egd
299503|NCT02349061|Systemic Lupus Erythematosus|systemic lupus erythematosus
299504|NCT02349061|Ustekinumab|ustekinumab
299505|NCT02349048|Hepatitis C virus|hepatitis c virus
299506|NCT02349048|Hepatitis C virus genotype 1|hepatitis c virus genotype 1
299507|NCT02349048|Chronic Hepatitis C Virus Genotype 1 Infection|chronic hepatitis c virus genotype 1 infection
299508|NCT02349048|Liver fibrosis|liver fibrosis
299509|NCT02349048|Cirrhosis|cirrhosis
299510|NCT02349048|Simeprevir|simeprevir
299511|NCT02349048|Daclatasvir|daclatasvir
299512|NCT02349048|Sofosbuvir|sofosbuvir
299513|NCT02349035|Transradial amputee|transradial amputee
299514|NCT02349022|[89Zr]Df-IAB2M|[89zr]df-iab2m
299515|NCT02349022|Prostate cancer|prostate cancer
299516|NCT02349022|PET scan|pet scan
299517|NCT02349009|systemic sclerosis|systemic sclerosis
299518|NCT02349009|scleroderma|scleroderma
299519|NCT02348970|mandibular advancement devices ONIRIS®|mandibular advancement devices oniris®
299520|NCT02348970|obstructive sleep apnea and hypopneas|obstructive sleep apnea and hypopneas
299521|NCT02348957|Chronic myeloid leukemia|chronic myeloid leukemia
299522|NCT02348957|Dasatinib|dasatinib
299523|NCT02348957|Any line|any line
299524|NCT02348957|Chronic phase|chronic phase
299525|NCT02348944|Biological markers|biological markers
299526|NCT02348944|Cartilage|cartilage
299527|NCT02348840|Midwives|midwives
299528|NCT02348840|Pregnant Women|pregnant women
299529|NCT02348827|Unipolar depression|unipolar depression
299530|NCT02348827|Family Therapies|family therapies
299531|NCT02348827|Psychoeducation|psychoeducation
299532|NCT02348827|Family psychoeducation|family psychoeducation
299533|NCT02348814|NAFLD, NASH|nafld, nash
299534|NCT02348788|Vivax|vivax
299535|NCT02348788|Malaria|malaria
299536|NCT02348788|artemether-lumefantrine|artemether-lumefantrine
299537|NCT02348788|chloroquine|chloroquine
299538|NCT02348788|RCT|rct
299539|NCT02348749|18F-MFBG Imaging|18f-mfbg imaging
299540|NCT02348749|14-138|14-138
299541|NCT02348749|PET/MR|pet/mr
299542|NCT02348749|PET/CT scan|pet/ct scan
299543|NCT02348736|airway|airway
299544|NCT02348736|videolaryngoscope|videolaryngoscope
299545|NCT02348697|Cartilage Defect in the Knee|cartilage defect in the knee
299546|NCT02348697|MACT|mact
299547|NCT02348684|Breast Cancer|breast cancer
299548|NCT02348658|Pharmacological therapy|pharmacological therapy
299549|NCT02348645|Pilot projects|pilot projects
299550|NCT02348645|Feasibility studies|feasibility studies
299551|NCT02348645|Intervention studies|intervention studies
299552|NCT02348645|Orthopedics|orthopedics
299553|NCT02348645|Orthopedic Procedures|orthopedic procedures
299554|NCT02348645|Neurosurgical Procedures|neurosurgical procedures
299555|NCT02348645|Neurosurgery|neurosurgery
299556|NCT02348645|Spine|spine
299557|NCT02348645|Spinal Fusion|spinal fusion
299558|NCT02348645|Spondylodesis|spondylodesis
299658|NCT02348073|Children|children
299559|NCT02348645|Spondylosyndesis|spondylosyndesis
299560|NCT02348645|Laminectomy|laminectomy
299561|NCT02348645|Foraminotomy|foraminotomy
299562|NCT02348645|Decompression, surgical|decompression, surgical
299563|NCT02348645|Low Back Pain|low back pain
299564|NCT02348645|Quality of Life|quality of life
299565|NCT02348580|teaching|teaching
299566|NCT02348580|education|education
299567|NCT02348580|active learning|active learning
299568|NCT02348580|time on task|time on task
299569|NCT02348580|financial education|financial education
299570|NCT02348580|social education|social education
299571|NCT02348580|rights based education|rights based education
299572|NCT02348580|primary school|primary school
299573|NCT02348580|life-skills|life-skills
299574|NCT02348567|Health care, accreditation, unannounced survey, cluster randomized controlled trial, quality improvement, organisational development|health care, accreditation, unannounced survey, cluster randomized controlled trial, quality improvement, organisational development
299575|NCT02348554|obesity|obesity
299576|NCT02348554|energy expenditure|energy expenditure
299577|NCT02348554|daily living physical activity|daily living physical activity
299578|NCT02348554|smartphone|smartphone
299579|NCT02348554|accelerometry|accelerometry
299580|NCT02348554|prediction algorithm|prediction algorithm
299581|NCT02348528|Multiple Myeloma|multiple myeloma
299582|NCT02348528|Relapsed|relapsed
299583|NCT02348528|Refractory|refractory
299584|NCT02348528|Lenalidomide|lenalidomide
299585|NCT02348528|Dexamethasone|dexamethasone
299586|NCT02348528|open-label|open-label
299587|NCT02348528|CC-5013-MM-021|cc-5013-mm-021
299588|NCT02348502|HBsAg loss|hbsag loss
299589|NCT02348502|interferon|interferon
299590|NCT02348502|HBV reaction|hbv reaction
299591|NCT02348502|Hepatitis B|hepatitis b
299593|NCT02348489|Acute Myeloid Leukemia|acute myeloid leukemia
299594|NCT02348489|SGI-110|sgi-110
299595|NCT02348489|DNA Hypomethylating Agen|dna hypomethylating agen
299596|NCT02348437|Pronator quadratus|pronator quadratus
299597|NCT02348437|Distal radius fracture|distal radius fracture
299599|NCT02348437|Volar plating|volar plating
299600|NCT02348437|PRWE|prwe
299601|NCT02348424|genitourinary|genitourinary
299602|NCT02348424|Neisseriaceae|neisseriaceae
299603|NCT02348424|pharyngeal|pharyngeal
299604|NCT02348424|Solithromycin|solithromycin
299605|NCT02348411|Medication-refractory|medication-refractory
299606|NCT02348398|Cervical Cancer|cervical cancer
299607|NCT02348398|Recurrent cervical cancer|recurrent cervical cancer
299608|NCT02348398|Squamous cervical cancer|squamous cervical cancer
299609|NCT02348398|Adenocarcinoma of the cervix|adenocarcinoma of the cervix
299610|NCT02348398|Adenosquamous cervical cancer|adenosquamous cervical cancer
299611|NCT02348398|Persistent cervical cancer|persistent cervical cancer
299612|NCT02348398|Pazopanib|pazopanib
299613|NCT02348398|GW786034|gw786034
299614|NCT02348398|Topotecan|topotecan
299615|NCT02348398|Hycamtin|hycamtin
299616|NCT02348385|amphetamine|amphetamine
299617|NCT02348385|cigarette smokers|cigarette smokers
299618|NCT02348359|Vascular Endothelial Growth Factor (VEGF)|vascular endothelial growth factor (vegf)
299619|NCT02348359|Platelet Derived Growth Factor (PDGF)|platelet derived growth factor (pdgf)
299620|NCT02348359|AMD|amd
299621|NCT02348346|self-disinfecting surfaces|self-disinfecting surfaces
299622|NCT02348346|titanium dioxide|titanium dioxide
299623|NCT02348281|triple negative breast cancer|triple negative breast cancer
299624|NCT02348281|androgen receptor|androgen receptor
299625|NCT02348281|bicalutamide|bicalutamide
299626|NCT02348268|Neck Pain|neck pain
299627|NCT02348268|Myofascial release|myofascial release
299628|NCT02348268|Manual therapy|manual therapy
299629|NCT02348242|Intensive care|intensive care
299630|NCT02348242|corneal damage|corneal damage
299631|NCT02348242|prevention|prevention
299632|NCT02348242|nursing protocol|nursing protocol
299633|NCT02348229|Enhanced recovery after surgery|enhanced recovery after surgery
299634|NCT02348229|laparoscopic gastrectomy|laparoscopic gastrectomy
299635|NCT02348229|advanced gastric cancer|advanced gastric cancer
299636|NCT02348229|C-reactive,visceral proteins|c-reactive,visceral proteins
299637|NCT02348177|Human immunideficiency virus|human immunideficiency virus
299638|NCT02348177|Tuberculosis|tuberculosis
299639|NCT02348177|superboosting|superboosting
299640|NCT02348177|lopinavir/ritonavir 1:1|lopinavir/ritonavir 1:1
299641|NCT02348177|Pediatric TB/HIV co-infection|pediatric tb/hiv co-infection
299642|NCT02348164|Carotenoids|carotenoids
299643|NCT02348164|absorption|absorption
299644|NCT02348164|citrus|citrus
299645|NCT02348151|COPD|copd
299646|NCT02348151|SWTi|swti
299647|NCT02348151|Treadmill|treadmill
299648|NCT02348138|Isometric Handgrip|isometric handgrip
299649|NCT02348112|stress urinary incontinence|stress urinary incontinence
299650|NCT02348112|Altis 522|altis 522
299651|NCT02348112|urinary incontinence|urinary incontinence
299652|NCT02348099|Diabetes|diabetes
299653|NCT02348099|Lipohypertrophy|lipohypertrophy
299654|NCT02348099|Ultrasound|ultrasound
299655|NCT02348073|Epilepsy|epilepsy
299656|NCT02348073|Attention Deficit Disorders|attention deficit disorders
299657|NCT02348073|VAYARIN|vayarin
299659|NCT02348073|Polyunsaturated n-3 fatty acid supplementation|polyunsaturated n-3 fatty acid supplementation
299660|NCT02348034|Surgical Site Infection (SSI)|surgical site infection (ssi)
299661|NCT02348034|Negative Pressure Wound Therapy (NPWT)|negative pressure wound therapy (npwt)
299662|NCT02348008|MK-3475|mk-3475
299663|NCT02348008|Pembrolizumab|pembrolizumab
299664|NCT02348008|Bevacizumab|bevacizumab
299665|NCT02347995|Exercise|exercise
299666|NCT02347995|Protein|protein
299667|NCT02347995|Nutrition|nutrition
299668|NCT02347995|Stroke|stroke
299669|NCT02347982|Turkey|turkey
299670|NCT02347982|Epidemiologic|epidemiologic
299671|NCT02347969|antioxidant|antioxidant
299672|NCT02347969|skin radiance|skin radiance
299673|NCT02347969|skin elasticity|skin elasticity
299674|NCT02347969|skin firmness|skin firmness
299675|NCT02347969|skin hydration|skin hydration
299676|NCT02347956|robot surgery|robot surgery
299677|NCT02347956|reduced port|reduced port
299678|NCT02347956|single-site|single-site
299679|NCT02347956|safety|safety
299680|NCT02347956|feasibility|feasibility
299681|NCT02347930|acute kidney injury|acute kidney injury
299682|NCT02347930|ultrasound technology|ultrasound technology
299683|NCT02347904|Esophageal cancer|esophageal cancer
299684|NCT02347904|Adjuvant treatment|adjuvant treatment
299685|NCT02347904|S-1|s-1
299686|NCT02347904|Oxaliplatin|oxaliplatin
299687|NCT02347904|Feasibility|feasibility
299688|NCT02347891|Inflammatory Myositis|inflammatory myositis
299689|NCT02347891|Dermatomyositis|dermatomyositis
299690|NCT02347891|Polymyositis|polymyositis
299691|NCT02347891|Muscle Pain|muscle pain
299692|NCT02347891|Myositis|myositis
299693|NCT02347891|Refractory myositis|refractory myositis
299694|NCT02347878|leukemia|leukemia
299695|NCT02347878|lymphoma|lymphoma
299696|NCT02347878|lumbar puncture|lumbar puncture
299697|NCT02347878|intrathecal treatment|intrathecal treatment
299698|NCT02347878|post-lumbar puncture headache|post-lumbar puncture headache
299699|NCT02347865|osteoporosis post menopausal women|osteoporosis post menopausal women
299700|NCT02347826|coned wires, wire lift,|coned wires, wire lift,
299701|NCT02347826|patient|patient
382837|NCT01947907|hGH|hgh
299702|NCT02347826|discomfort|discomfort
299703|NCT02347813|squamous cell carcinoma|squamous cell carcinoma
299704|NCT02347813|pioglitazone|pioglitazone
299705|NCT02347813|PPARgamma|ppargamma
299706|NCT02347813|skin cancer|skin cancer
299707|NCT02347774|Chronic Obstructive Pulmonary Disease|chronic obstructive pulmonary disease
299708|NCT02347774|COPD|copd
299709|NCT02347761|Chronic Obstructive Pulmonary Disease|chronic obstructive pulmonary disease
299710|NCT02347748|Pain|pain
299711|NCT02347748|Anesthesia Recovery Period|anesthesia recovery period
299712|NCT02347748|Postoperative Period|postoperative period
299713|NCT02347748|Adaptation, Psychological|adaptation, psychological
299714|NCT02347748|Relaxation|relaxation
299715|NCT02347748|Stress, Psychological|stress, psychological
299716|NCT02347735|Colorectal carcinoma|colorectal carcinoma
299717|NCT02347735|Anastomotic leakage|anastomotic leakage
299718|NCT02347735|Markers|markers
299719|NCT02347735|Diagnosis|diagnosis
299720|NCT02347722|biomarkers|biomarkers
299721|NCT02347722|diagnosis|diagnosis
299722|NCT02347722|etiology of heart failure|etiology of heart failure
299723|NCT02347709|Diabetic Foot Ulcer|diabetic foot ulcer
299724|NCT02347709|DFU|dfu
299725|NCT02347709|Type 2 Diabetes|type 2 diabetes
299726|NCT02347709|Neuropathy|neuropathy
299727|NCT02347696|Diet|diet
299728|NCT02347696|Physical Activity|physical activity
299729|NCT02347696|Trial|trial
299730|NCT02347696|Lipidomics|lipidomics
299731|NCT02347696|Occidental Diseases|occidental diseases
299732|NCT02347657|Homozygous for the F508del CFTR Mutation|homozygous for the f508del cftr mutation
299733|NCT02347566|COPD|copd
299734|NCT02347566|Physical Activity|physical activity
299735|NCT02347566|Accelerometer|accelerometer
299736|NCT02347540|Heart Failure|heart failure
299737|NCT02347540|Diastolic Dysfunction|diastolic dysfunction
299738|NCT02347540|Pre-Eclampsia|pre-eclampsia
299739|NCT02347540|Endothelial dysfunction|endothelial dysfunction
299740|NCT02347540|Biological Markers|biological markers
299741|NCT02347540|MicroRNAs|micrornas
299742|NCT02347540|Circulating cells|circulating cells
299743|NCT02347488|ETT Holder, bite guard, airway, endotracheal tube|ett holder, bite guard, airway, endotracheal tube
299744|NCT02347462|BiPAP|bipap
299745|NCT02347449|Early-stage Breast cancer, node positive|early-stage breast cancer, node positive
299746|NCT02347449|Prognosis|prognosis
299747|NCT02347449|Oncotype Dx|oncotype dx
299748|NCT02347436|Transurethral Resection of Prostate|transurethral resection of prostate
299749|NCT02347423|Poliomyelitis immunization|poliomyelitis immunization
299750|NCT02347423|primary series|primary series
299751|NCT02347371|Heart transplant|heart transplant
299752|NCT02347371|Cardiac allograft vasculopathy|cardiac allograft vasculopathy
299753|NCT02347371|Chronic rejection|chronic rejection
299754|NCT02347371|Immunosuppressant therapy|immunosuppressant therapy
299755|NCT02347345|HCV, injection drug use|hcv, injection drug use
299756|NCT02347332|Vinflunin|vinflunin
299757|NCT02347332|Vinflunin + Methotrexate|vinflunin + methotrexate
299858|NCT02346825|Children|children
299758|NCT02347332|Metastatic Squamous Cell Carcinoma of the Head and Neck|metastatic squamous cell carcinoma of the head and neck
299759|NCT02347280|clostridium difficile|clostridium difficile
299760|NCT02347280|colitis|colitis
299761|NCT02347280|colon|colon
299762|NCT02347267|Beverages sweetened caloric, no caloric|beverages sweetened caloric, no caloric
299763|NCT02347267|Weight|weight
299764|NCT02347267|Fat percentage|fat percentage
299765|NCT02347267|Body Composition|body composition
299766|NCT02347267|Blood pressure|blood pressure
299767|NCT02347267|Sugar|sugar
299768|NCT02347267|Sodium|sodium
299769|NCT02347267|Dietary intake|dietary intake
299770|NCT02347228|OB318|ob318
299771|NCT02347228|Advanced Solid Malignancies|advanced solid malignancies
299772|NCT02347228|Antrodia cinnamomea|antrodia cinnamomea
299773|NCT02347228|Antrodia camphorata|antrodia camphorata
299774|NCT02347202|Counseling|counseling
299775|NCT02347163|triple neg|triple neg
299776|NCT02347163|breast cancer|breast cancer
299777|NCT02347163|zoledronate|zoledronate
299778|NCT02347163|mevalonate pathway|mevalonate pathway
299779|NCT02347124|smoking cessation|smoking cessation
299780|NCT02347124|oral health care|oral health care
299781|NCT02347124|tobacco quitlines|tobacco quitlines
299782|NCT02347098|plaque|plaque
299783|NCT02347098|LDL|ldl
299784|NCT02347098|statin|statin
299785|NCT02347098|endothelial|endothelial
299786|NCT02347098|apheresis|apheresis
299787|NCT02347098|acute coronary artery syndrome|acute coronary artery syndrome
299788|NCT02347033|Sertraline|sertraline
299789|NCT02347033|Selective Serotonin Reuptake Inhibitor (SSRI)|selective serotonin reuptake inhibitor (ssri)
299790|NCT02347033|Cognitive Behavioural Therapy (CBT)|cognitive behavioural therapy (cbt)
299791|NCT02347033|Increasing Access to Psychological Therapies (IAPT)|increasing access to psychological therapies (iapt)
299792|NCT02347020|Obesity|obesity
299793|NCT02347020|Metabolic Disorders|metabolic disorders
299794|NCT02347007|Obesity|obesity
299795|NCT02347007|Overweight|overweight
299796|NCT02347007|Body Weight|body weight
299797|NCT02347007|Cardiovascular Diseases|cardiovascular diseases
299798|NCT02347007|Cholesterol|cholesterol
299799|NCT02347007|Almonds|almonds
299800|NCT02347007|Visceral Adiposity|visceral adiposity
299801|NCT02347007|Quality of Life|quality of life
299802|NCT02347007|Hispanic Americans|hispanic americans
299803|NCT02347007|African Continental Ancestry Group|african continental ancestry group
299804|NCT02347007|Metabolic Syndrome X|metabolic syndrome x
299805|NCT02346994|Body Weight|body weight
299806|NCT02346994|Obesity in Adolescence|obesity in adolescence
299807|NCT02346994|Obesity in Childhood|obesity in childhood
299808|NCT02346994|Childhood Onset Obesity|childhood onset obesity
299809|NCT02346994|Childhood Obesity|childhood obesity
299810|NCT02346994|Child Obesity|child obesity
299811|NCT02346994|Adolescent Obesity|adolescent obesity
299812|NCT02346994|Teenagers|teenagers
299813|NCT02346994|Teens|teens
299814|NCT02346994|Youth|youth
299815|NCT02346994|Adolescents|adolescents
299816|NCT02346994|Adolescence|adolescence
299817|NCT02346968|Kidney Transplantation|kidney transplantation
299818|NCT02346968|Delayed Graft Function|delayed graft function
299819|NCT02346968|C-terminal fragment of agrin|c-terminal fragment of agrin
299820|NCT02346968|Dialysis|dialysis
299821|NCT02346955|Cancer|cancer
299822|NCT02346955|Oncology|oncology
299823|NCT02346955|cCAM Biotherapeutics Ltd|ccam biotherapeutics ltd
299824|NCT02346955|Immunomodulatory therapy|immunomodulatory therapy
299825|NCT02346955|CM-24|cm-24
299826|NCT02346955|Carcinoembryonic Antigen-related Cell Adhesion Molecule 1 (CEACAM1)|carcinoembryonic antigen-related cell adhesion molecule 1 (ceacam1)
299827|NCT02346955|NSCLC (adenocarcinoma)|nsclc (adenocarcinoma)
299828|NCT02346955|Uveal|uveal
299829|NCT02346955|Acral|acral
299830|NCT02346955|Mucosal|mucosal
299831|NCT02346955|Cutaneous|cutaneous
299832|NCT02346955|Colorectal|colorectal
299833|NCT02346955|Gastric|gastric
299834|NCT02346955|Ovarian|ovarian
299835|NCT02346955|Bladder|bladder
299836|NCT02346955|MK-6018-001|mk-6018-001
299837|NCT02346929|Hematoma block|hematoma block
299838|NCT02346929|distal radius fracture reduction|distal radius fracture reduction
299839|NCT02346929|ultrasound|ultrasound
299840|NCT02346929|ultrasound guided hematoma block|ultrasound guided hematoma block
299841|NCT02346929|traditional hematoma block for analgesia|traditional hematoma block for analgesia
299842|NCT02346929|bupivacaine|bupivacaine
299843|NCT02346929|pain reduction|pain reduction
299844|NCT02346929|wrist fracture|wrist fracture
299845|NCT02346890|Volunteer|volunteer
299846|NCT02346877|Enbrel|enbrel
299847|NCT02346877|Rheumatoid Arthritis|rheumatoid arthritis
299848|NCT02346864|head elevated position|head elevated position
299849|NCT02346864|preterm|preterm
299850|NCT02346864|three-stair-position|three-stair-position
299851|NCT02346838|Prediabetes, prebiotics, metabolic endotoxemia|prediabetes, prebiotics, metabolic endotoxemia
299852|NCT02346825|P-CIMT|p-cimt
299853|NCT02346825|Pediatric Constraint Induced Movement Therapy|pediatric constraint induced movement therapy
299854|NCT02346825|Hemiparesis|hemiparesis
299855|NCT02346825|Cerebral Palsy|cerebral palsy
299856|NCT02346825|Infants|infants
299857|NCT02346825|Toddlers|toddlers
299859|NCT02346786|Drinking Water|drinking water
299860|NCT02346786|Mineral water|mineral water
299861|NCT02346786|Sports|sports
299862|NCT02346786|Accident prevention|accident prevention
299863|NCT02346747|Stage III|stage iii
299864|NCT02346747|Stage IV|stage iv
299865|NCT02346747|Ovarian Cancer|ovarian cancer
299866|NCT02346747|Maintenance|maintenance
299867|NCT02346747|Immunotherapy|immunotherapy
299868|NCT02346747|primary peritoneal cancer|primary peritoneal cancer
299869|NCT02346747|fallopian tube cancer|fallopian tube cancer
299870|NCT02346747|endometrioid ovarian cancer|endometrioid ovarian cancer
299871|NCT02346747|high-grade serous ovarian cancer|high-grade serous ovarian cancer
299872|NCT02346734|Multiple Sclerosis|multiple sclerosis
299873|NCT02346734|Telerehablitation|telerehablitation
299874|NCT02346721|Sofosbuvir|sofosbuvir
299875|NCT02346721|SOF/GS-5816|sof/gs-5816
299876|NCT02346721|GS-5816|gs-5816
299877|NCT02346721|Hepatitis C|hepatitis c
299878|NCT02346721|HCV|hcv
299879|NCT02346721|Cirrhosis|cirrhosis
299880|NCT02346721|Velpatasvir|velpatasvir
299881|NCT02346708|Parkinson's|parkinson's
299882|NCT02346708|TMS|tms
299883|NCT02346708|Kluger|kluger
299884|NCT02346695|LV deformation|lv deformation
299885|NCT02346695|Endothelial glycocalyx|endothelial glycocalyx
299886|NCT02346695|Coronary flow reserve|coronary flow reserve
299887|NCT02346682|major depression disorder|major depression disorder
299888|NCT02346682|biochemistry|biochemistry
299889|NCT02346682|TCM diagnosis|tcm diagnosis
299890|NCT02346682|Neurological|neurological
299891|NCT02346682|metabonomics|metabonomics
299892|NCT02346682|neuroimaging|neuroimaging
299893|NCT02346669|Microbiota|microbiota
299894|NCT02346669|Diabetes Mellitus, Type 2|diabetes mellitus, type 2
299895|NCT02346669|Obesity|obesity
299896|NCT02346617|CMV|cmv
299897|NCT02346617|T cell therapy|t cell therapy
299898|NCT02346604|exercise|exercise
299899|NCT02346591|Positive psychology|positive psychology
299900|NCT02346591|Wellbeing|wellbeing
299901|NCT02346591|Stress reduction|stress reduction
299902|NCT02346591|Relaxation|relaxation
299903|NCT02346591|Gratitude|gratitude
299904|NCT02346591|Mobile app|mobile app
299905|NCT02346591|Intervention|intervention
299906|NCT02346591|Altruism|altruism
299907|NCT02346591|Psychological well-being|psychological well-being
299908|NCT02346591|Social well-being|social well-being
299909|NCT02346591|Physical well-being|physical well-being
299910|NCT02346591|Workplace engagement|workplace engagement
299911|NCT02346552|laparoscopic Cholecystectomy|laparoscopic cholecystectomy
299912|NCT02346552|laparoscope holder|laparoscope holder
299913|NCT02346552|Nissen fundoplication|nissen fundoplication
299914|NCT02346552|paraesophageal hernia|paraesophageal hernia
299915|NCT02346552|sleeve surgery|sleeve surgery
299916|NCT02346539|Nicotine|nicotine
299917|NCT02346539|Depression|depression
299918|NCT02346526|Prostate Cancer|prostate cancer
299919|NCT02346526|Castration-resistant prostate cancer|castration-resistant prostate cancer
299920|NCT02346526|Castration-resistant prostate cancer metastatic to bone|castration-resistant prostate cancer metastatic to bone
299921|NCT02346513|Hip Replacement Arthroplasty|hip replacement arthroplasty
299922|NCT02346513|Ceramic on Metal Articulation|ceramic on metal articulation
299923|NCT02346513|Serum level of Cobalt and Chromium|serum level of cobalt and chromium
299924|NCT02346500|Benign Prostatic Hyperplasia|benign prostatic hyperplasia
299925|NCT02346500|Lower urinary tract symptoms|lower urinary tract symptoms
299926|NCT02346500|Photoselective laser vaporization of the prostate|photoselective laser vaporization of the prostate
299927|NCT02346500|Transrectal Ultrasound|transrectal ultrasound
299928|NCT02346487|children|children
299929|NCT02346474|Subcutaneous Fat|subcutaneous fat
299930|NCT02346474|Visceral Fat|visceral fat
299931|NCT02346461|Hereditary Inclusion Body Myopathy (HIBM)|hereditary inclusion body myopathy (hibm)
299932|NCT02346461|Sialic Acid (N-acetylneuraminic acid, Neu5Ac)|sialic acid (n-acetylneuraminic acid, neu5ac)
299933|NCT02346461|GNE Myopathy|gne myopathy
299934|NCT02346461|N-Acetyl-D-mannosamine (ManNAc)|n-acetyl-d-mannosamine (mannac)
299935|NCT02346461|GNE Gene|gne gene
299936|NCT02346448|endoscopic sphincterotomy|endoscopic sphincterotomy
299937|NCT02346448|balloon dilation|balloon dilation
299938|NCT02346448|adverse events|adverse events
299939|NCT02346448|pancreatitis|pancreatitis
299940|NCT02346448|bleeding|bleeding
299941|NCT02346435|small renal mass|small renal mass
299942|NCT02346435|active surveillance|active surveillance
299943|NCT02346422|Heart Failure|heart failure
299944|NCT02346422|Cardiomyopathies|cardiomyopathies
299945|NCT02346422|Heart Diseases|heart diseases
299946|NCT02346422|Cardiovascular Diseases|cardiovascular diseases
299947|NCT02346422|Cardiomegaly|cardiomegaly
299948|NCT02346422|Gene Therapy|gene therapy
299949|NCT02346396|neuropathic pain|neuropathic pain
299950|NCT02346396|neurostimulation|neurostimulation
299951|NCT02346396|ambulatory use|ambulatory use
299952|NCT02346396|tDCS|tdcs
299953|NCT02346383|back pain|back pain
299954|NCT02346383|neuromodulation|neuromodulation
299955|NCT02346383|spinal peripheral neuromodulation|spinal peripheral neuromodulation
299956|NCT02346383|spinal cord stimulation|spinal cord stimulation
299957|NCT02346383|postlaminectomy pain syndrome|postlaminectomy pain syndrome
299958|NCT02346370|Recurrent, previously treated, locally advanced or metastatic NSCLC (non small cell lung cancer)|recurrent, previously treated, locally advanced or metastatic nsclc (non small cell lung cancer)
299959|NCT02346357|hip arthroscopy|hip arthroscopy
299960|NCT02346357|analgesia|analgesia
299961|NCT02346344|type 2 diabetes|type 2 diabetes
299962|NCT02346344|beta cell function|beta cell function
299963|NCT02346344|meal tolerance test|meal tolerance test
299964|NCT02346344|maximum stimulation test|maximum stimulation test
299965|NCT02346344|method standardization|method standardization
299966|NCT02346344|insulin secretion|insulin secretion
299967|NCT02346344|prediabetes|prediabetes
299968|NCT02346344|insulin sensitivity|insulin sensitivity
299969|NCT02346318|Radiotherapy|radiotherapy
299970|NCT02346318|Adverse Effect|adverse effect
299971|NCT02346318|Dermatitis or Eczema|dermatitis or eczema
299972|NCT02346292|COPD|copd
299973|NCT02346292|Spirometry|spirometry
299974|NCT02346292|severe and very severe COPD|severe and very severe copd
299975|NCT02346292|COPD exacerbations|copd exacerbations
299976|NCT02346292|therapy schemes|therapy schemes
299977|NCT02346292|therapy changes|therapy changes
299978|NCT02346279|Multiple Sclerosis|multiple sclerosis
299979|NCT02346279|Rehabilitation|rehabilitation
299980|NCT02346279|Questionnaire|questionnaire
299981|NCT02346279|Patient-Reported Outcome|patient-reported outcome
299982|NCT02346279|Responsiveness|responsiveness
299983|NCT02346279|Minimal Important Clinical Difference|minimal important clinical difference
299984|NCT02346266|Stroke|stroke
299985|NCT02346266|Stroke Prevention|stroke prevention
299986|NCT02346266|Children|children
299987|NCT02346266|Education|education
299988|NCT02346240|Certolizumab Pegol|certolizumab pegol
299989|NCT02346240|Cimzia|cimzia
299990|NCT02346240|Psoriasis|psoriasis
759145|NCT00408512|gene|gene
299991|NCT02346227|Human Papillomavirus|human papillomavirus
299992|NCT02346227|Uterine cervix|uterine cervix
299993|NCT02346227|Infection|infection
299994|NCT02346227|Antiviral Drug|antiviral drug
299995|NCT02346227|Therapeutic use|therapeutic use
299996|NCT02346214|Gestational Age|gestational age
299997|NCT02346214|Anterior Lens Capsule Vascularity|anterior lens capsule vascularity
299998|NCT02346214|Preterm|preterm
299999|NCT02346214|Method-comparison|method-comparison
300000|NCT02346188|blood lead, iron, zinc, child, cognition, behavior, Mexico|blood lead, iron, zinc, child, cognition, behavior, mexico
300001|NCT02346175|SHR3824 Type 2 diabetes mellitus SGLT2|shr3824 type 2 diabetes mellitus sglt2
300002|NCT02346162|Pre-pregnancy|pre-pregnancy
300003|NCT02346162|Weight management|weight management
300004|NCT02346136|Tai Chi|tai chi
300005|NCT02346136|Cluster randomized controlled trial|cluster randomized controlled trial
300006|NCT02346136|Intervention|intervention
300007|NCT02346136|Elderly|elderly
300008|NCT02346136|Mobility|mobility
300009|NCT02346136|Health care utilization|health care utilization
300010|NCT02346123|Chagas disease|chagas disease
300011|NCT02346123|Polymorphisms|polymorphisms
300012|NCT02346123|Biomarkers|biomarkers
300013|NCT02346097|Cardiac Resynchronization Therapy|cardiac resynchronization therapy
300014|NCT02346097|Heart Failure|heart failure
300015|NCT02346097|Ejection Fraction|ejection fraction
300016|NCT02346097|Narrow|narrow
300017|NCT02346097|Pacemaker|pacemaker
300018|NCT02346097|Electrophysiology|electrophysiology
300019|NCT02346097|Electrical activation mapping|electrical activation mapping
300020|NCT02346097|Coronary Sinus|coronary sinus
300021|NCT02346097|Mapping|mapping
300022|NCT02346097|QRS|qrs
300023|NCT02346097|QRS width|qrs width
300024|NCT02346097|Pacing Interval|pacing interval
300025|NCT02346097|Left Ventricular Lead|left ventricular lead
300026|NCT02346097|Cardiac CT|cardiac ct
300027|NCT02346097|Echocardiography|echocardiography
300028|NCT02346097|Myocardial Scintigraphy|myocardial scintigraphy
300029|NCT02346097|6 Minutes Walk Test|6 minutes walk test
300030|NCT02346097|Imaging|imaging
300031|NCT02346097|Left ventricular ejection fraction|left ventricular ejection fraction
300032|NCT02346097|Epicardial veins|epicardial veins
300033|NCT02346097|Resynchronization|resynchronization
300034|NCT02346097|ImagingCRT|imagingcrt
300035|NCT02346097|Optimal electrical resynchronization|optimal electrical resynchronization
300036|NCT02346097|Cardiac computed tomography|cardiac computed tomography
300037|NCT02346071|Bodily distress syndrome|bodily distress syndrome
300038|NCT02346071|Medically unexplained symptoms|medically unexplained symptoms
300039|NCT02346071|Functional somatic symptoms|functional somatic symptoms
300040|NCT02346071|Functional somatic syndromes|functional somatic syndromes
300041|NCT02346071|Treatment|treatment
300042|NCT02346071|Acceptance and Commitment Therapy|acceptance and commitment therapy
300043|NCT02346045|hypertension|hypertension
300044|NCT02346032|second line|second line
300045|NCT02346006|Exercise|exercise
300046|NCT02346006|Visual Acuity|visual acuity
300047|NCT02346006|Blood Vessels|blood vessels
300048|NCT02346006|Retina|retina
300049|NCT02346006|Choroid|choroid
300050|NCT02345993|formoterol/beclomethasone in asthmatic crisis|formoterol/beclomethasone in asthmatic crisis
300051|NCT02345993|asthmatic crisis treatment|asthmatic crisis treatment
300357|NCT02344368|Anesthesia|anesthesia
300052|NCT02345967|diabetes mellitus requiring insulin|diabetes mellitus requiring insulin
300053|NCT02345954|Uterus Prolapse|uterus prolapse
300054|NCT02345954|Laparoscopic Sacropexy|laparoscopic sacropexy
300055|NCT02345954|Laparoscopic Hysteropexy|laparoscopic hysteropexy
300056|NCT02345928|Safety|safety
300057|NCT02345928|Efficacy|efficacy
300058|NCT02345928|CNTO 7160|cnto 7160
300059|NCT02345928|Healthy|healthy
300060|NCT02345928|Asthma|asthma
300061|NCT02345928|Atopic Dermatitis|atopic dermatitis
300062|NCT02345876|Dyslexia, Medial olivocochlear system, Maturation, Auditory Processing|dyslexia, medial olivocochlear system, maturation, auditory processing
300063|NCT02345863|CLL|cll
300064|NCT02345850|Acute Leukemia|acute leukemia
300065|NCT02345850|Myelodysplasia|myelodysplasia
300066|NCT02345850|GVHD Prophylaxis|gvhd prophylaxis
300067|NCT02345850|Chronic GVHD|chronic gvhd
300068|NCT02345824|CDK4/6 Inhibitor|cdk4/6 inhibitor
300069|NCT02345824|LEE011|lee011
300070|NCT02345824|Recurrent Glioblastoma|recurrent glioblastoma
300071|NCT02345824|Anaplastic Glioma|anaplastic glioma
300072|NCT02345824|Ribociclib|ribociclib
300073|NCT02345759|CKD patients|ckd patients
300074|NCT02345759|protein-restricted diets|protein-restricted diets
300075|NCT02345759|compliance|compliance
300076|NCT02345759|psychological aspects|psychological aspects
300077|NCT02345707|Cabotegravir|cabotegravir
300078|NCT02345707|Human Immunodeficiency Virus|human immunodeficiency virus
300079|NCT02345707|Bioavailability|bioavailability
300080|NCT02345707|Pharmacokinetics|pharmacokinetics
300081|NCT02345694|Obstructive Sleep Apnea Syndrome|obstructive sleep apnea syndrome
300082|NCT02345694|Gait|gait
300083|NCT02345694|Posture|posture
300084|NCT02345694|Continuous Positive Airway Pressure|continuous positive airway pressure
383309|NCT01945619|CMV|cmv
300085|NCT02345681|furosemide|furosemide
300086|NCT02345681|under strict conditions|under strict conditions
300087|NCT02345681|normalize|normalize
300088|NCT02345681|ICU patients|icu patients
300089|NCT02345681|fluid balance|fluid balance
300090|NCT02345668|Transdiagnostic Internet-based Protocol|transdiagnostic internet-based protocol
300091|NCT02345668|Treatment as Usual (TAU)|treatment as usual (tau)
300092|NCT02345655|Substances consumption|substances consumption
300093|NCT02345655|Opiate|opiate
300094|NCT02345655|Family practice|family practice
300095|NCT02345629|Refractory cancer pain|refractory cancer pain
300096|NCT02345629|Cordotomy|cordotomy
300097|NCT02345629|Sharpness pain sensory testing|sharpness pain sensory testing
300098|NCT02345629|Heat pain sensory testing|heat pain sensory testing
300099|NCT02345629|Symptom questionnaire|symptom questionnaire
300100|NCT02345629|Advanced cancers|advanced cancers
300102|NCT02345616|Cardiac surgery|cardiac surgery
300103|NCT02345616|Pulmonary hypertension|pulmonary hypertension
300104|NCT02345616|Nitric oxide|nitric oxide
300105|NCT02345616|Induction anesthesia|induction anesthesia
300106|NCT02345577|Kidney transplantation|kidney transplantation
300107|NCT02345577|Stochastic whole body vibration therapy|stochastic whole body vibration therapy
300108|NCT02345577|Muscle strength|muscle strength
300109|NCT02345577|Intramuscular lipid content|intramuscular lipid content
300110|NCT02345577|Intramyocellular lipid content|intramyocellular lipid content
300111|NCT02345577|Short Physical Performance Battery Test|short physical performance battery test
300112|NCT02345577|Prospective, randomised , double blind,placebo-controlled trial|prospective, randomised , double blind,placebo-controlled trial
300113|NCT02345577|Physical Therapy Modalities|physical therapy modalities
300114|NCT02345551|Exercise|exercise
300115|NCT02345551|Sleep|sleep
300116|NCT02345551|Telemedicine|telemedicine
300117|NCT02345551|Behavior|behavior
300118|NCT02345551|Shift work|shift work
300119|NCT02345512|Falls|falls
300120|NCT02345499|Radical cystectomy|radical cystectomy
300121|NCT02345499|Laparoscopy|laparoscopy
300122|NCT02345486|Pilot Projects|pilot projects
300123|NCT02345486|Plasmalyte A|plasmalyte a
300124|NCT02345486|Ringer's lactate|ringer's lactate
300125|NCT02345486|Sodium Chloride|sodium chloride
300126|NCT02345486|Critical Care|critical care
300127|NCT02345486|"Resuscitation"|"resuscitation"
300128|NCT02345473|Bladder cancer|bladder cancer
300129|NCT02345473|Circulating cancer cells|circulating cancer cells
300130|NCT02345421|LAL D|lal d
300131|NCT02345421|CESD|cesd
300132|NCT02345421|NASH|nash
300133|NCT02345421|NAFLD|nafld
300134|NCT02345421|Wilson's|wilson's
300135|NCT02345421|Niemann Pick|niemann pick
300136|NCT02345421|Familial Hypercholesterolemia|familial hypercholesterolemia
300137|NCT02345395|Brain Aneurysm|brain aneurysm
300138|NCT02345395|Pterional Craniotomy|pterional craniotomy
300139|NCT02345395|MiniPterional Craniotomy|minipterional craniotomy
300140|NCT02345395|Transpalpebral Approach|transpalpebral approach
300141|NCT02345395|Unruptured Brain Aneurysm|unruptured brain aneurysm
300142|NCT02345382|Advanced acute leukemia|advanced acute leukemia
300143|NCT02345356|Pharmacogenomics|pharmacogenomics
300144|NCT02345356|Warfarin|warfarin
300145|NCT02345356|Caribbean Hispanics|caribbean hispanics
300146|NCT02345356|Polymorphisms|polymorphisms
300147|NCT02345356|Dosing Algorithm|dosing algorithm
300148|NCT02345278|Immunotherapy|immunotherapy
300754|NCT02341950|videogame|videogame
300149|NCT02345278|Allergic rhinitis/rhinoconjunctivitis|allergic rhinitis/rhinoconjunctivitis
300150|NCT02345252|HIV|hiv
300151|NCT02345226|HIV|hiv
300152|NCT02345213|DLB|dlb
300153|NCT02345213|Dementia with Lewy bodies|dementia with lewy bodies
300154|NCT02345213|Lewy Body Disease|lewy body disease
300155|NCT02345213|Dementia|dementia
300156|NCT02345213|E2020|e2020
300157|NCT02345213|Donepezil|donepezil
300158|NCT02345213|Aricept|aricept
300159|NCT02345200|dystrophy|dystrophy
300160|NCT02345200|body composition|body composition
300161|NCT02345200|malnutrition|malnutrition
300162|NCT02345174|zirconium|zirconium
300163|NCT02345174|oncology|oncology
300164|NCT02345174|mAb|mab
300165|NCT02345174|receptor occupancy|receptor occupancy
300166|NCT02345174|dose|dose
300167|NCT02345174|PET|pet
300168|NCT02345174|HER3|her3
300169|NCT02345174|89-Zr|89-zr
300170|NCT02345174|biodistribution|biodistribution
300171|NCT02345174|tumours|tumours
300172|NCT02345161|Triple Therapy|triple therapy
300173|NCT02345161|Formoterol|formoterol
300174|NCT02345161|Respiratory|respiratory
300175|NCT02345161|COPD|copd
300176|NCT02345161|Budesonide|budesonide
300177|NCT02345161|Vilanterol|vilanterol
300178|NCT02345161|Fluticasone Furoate|fluticasone furoate
300179|NCT02345161|Umeclidinium|umeclidinium
300180|NCT02345161|Lung Function|lung function
300181|NCT02345148|Healthy|healthy
300182|NCT02345148|Esketamine|esketamine
300183|NCT02345148|JNJ-54135419|jnj-54135419
300184|NCT02345122|At-risk Drinking|at-risk drinking
300185|NCT02345122|Depression|depression
383440|NCT01945008|HCV|hcv
300186|NCT02345122|Anxiety|anxiety
300187|NCT02345122|Alcohol Drinking|alcohol drinking
300188|NCT02345109|weight|weight
300189|NCT02345109|total body water|total body water
300190|NCT02345109|body fat|body fat
300191|NCT02345109|muscle mass|muscle mass
300192|NCT02345109|bone mass|bone mass
300193|NCT02345109|BMI|bmi
300194|NCT02345109|visceral fat|visceral fat
300195|NCT02345109|calories|calories
300196|NCT02345083|Frailty|frailty
300197|NCT02345083|Pre-frailty|pre-frailty
300198|NCT02345083|Fit|fit
300199|NCT02345083|Robust|robust
300200|NCT02345083|Elderly|elderly
300201|NCT02345083|Sociodemography status|sociodemography status
300202|NCT02345083|Functional status|functional status
300203|NCT02345083|Cognitive status|cognitive status
300204|NCT02345083|Nutrition status|nutrition status
300205|NCT02345083|Comorbidity|comorbidity
300206|NCT02345083|Polypharmacy|polypharmacy
300207|NCT02345083|Mortality|mortality
300208|NCT02345083|Depression status|depression status
300209|NCT02345083|Health-related quality of life|health-related quality of life
300210|NCT02345083|Fall incidence|fall incidence
300211|NCT02345083|Hospitality|hospitality
300212|NCT02345057|Diabetic Nephropathy|diabetic nephropathy
300213|NCT02345057|mineralocorticoid receptor antagonist|mineralocorticoid receptor antagonist
300214|NCT02345057|CS-3150|cs-3150
300215|NCT02345057|Japanese|japanese
300216|NCT02345044|Essential hypertension|essential hypertension
300217|NCT02345044|mineralocorticoid receptor antagonist|mineralocorticoid receptor antagonist
300218|NCT02345044|CS-3150|cs-3150
300219|NCT02345044|Japanese|japanese
300220|NCT02345031|hearing loss|hearing loss
300221|NCT02345031|speech-in-noise|speech-in-noise
300222|NCT02345018|Mechano-chemical ablation|mechano-chemical ablation
300223|NCT02345018|Treatment large varicose veins|treatment large varicose veins
300224|NCT02345018|Below-knee and branches|below-knee and branches
300225|NCT02345018|Endovenous|endovenous
300226|NCT02345005|Vascular diseases|vascular diseases
300227|NCT02345005|Aneurysm|aneurysm
300228|NCT02345005|Treatment Efficacy|treatment efficacy
300229|NCT02345005|Medical device|medical device
300230|NCT02345005|Population Register|population register
300231|NCT02344979|NSCLC|nsclc
300232|NCT02344979|Chemotherapy|chemotherapy
300233|NCT02344979|thrombocytopenia|thrombocytopenia
300234|NCT02344979|rhTPO|rhtpo
300235|NCT02344940|operable|operable
300236|NCT02344940|premenopausal|premenopausal
300237|NCT02344940|endocrine therapy|endocrine therapy
300238|NCT02344940|safety|safety
300239|NCT02344940|tamoxifen|tamoxifen
300240|NCT02344940|toremifene|toremifene
300241|NCT02344927|Cancer|cancer
300242|NCT02344927|End-of-life care|end-of-life care
300243|NCT02344927|Clinically-assisted hydration|clinically-assisted hydration
300244|NCT02344914|dental support|dental support
300245|NCT02344914|second stage of labor|second stage of labor
300246|NCT02344901|non-valvular atrial fibrillation|non-valvular atrial fibrillation
300247|NCT02344901|stroke prevention|stroke prevention
300248|NCT02344901|novel oral anticoagulants|novel oral anticoagulants
300249|NCT02344901|warfarin|warfarin
300250|NCT02344888|PCOS|pcos
300251|NCT02344888|Clomiphene citrate resistant|clomiphene citrate resistant
300252|NCT02344888|Prednisolone|prednisolone
300253|NCT02344823|cirrhosis|cirrhosis
300254|NCT02344823|erectile dysfunction|erectile dysfunction
300255|NCT02344823|portal hypertension|portal hypertension
300256|NCT02344797|Perioperative|perioperative
300257|NCT02344797|Postoperative Complications/prevention & control|postoperative complications/prevention & control
300259|NCT02344784|ADHD|adhd
300260|NCT02344784|PPI|ppi
300261|NCT02344771|Endothelial dysfunction|endothelial dysfunction
300262|NCT02344771|General Surgery|general surgery
300263|NCT02344771|Perioperative Care|perioperative care
300264|NCT02344745|Lavender|lavender
300265|NCT02344745|Aromatherapy|aromatherapy
300266|NCT02344745|Urodynamics|urodynamics
300267|NCT02344732|epithelium, cornea, diabetes, vitrectomy, oxygen|epithelium, cornea, diabetes, vitrectomy, oxygen
300268|NCT02344719|cirrhosis|cirrhosis
300269|NCT02344719|portal hypertension|portal hypertension
300270|NCT02344719|taurin|taurin
300271|NCT02344706|Emergency Care, Prehospital|emergency care, prehospital
300272|NCT02344706|Coma|coma
300273|NCT02344706|Electroencephalography|electroencephalography
300274|NCT02344693|Electroencephalography|electroencephalography
300275|NCT02344654|Fluorescence|fluorescence
300276|NCT02344654|Cholangiography|cholangiography
300277|NCT02344654|Indocyanine Green|indocyanine green
300278|NCT02344654|Cholecystectomy, Laparoscopic|cholecystectomy, laparoscopic
300279|NCT02344615|nerve stimulator|nerve stimulator
300280|NCT02344615|ultrasound|ultrasound
300281|NCT02344602|Diabetic Nephropathy|diabetic nephropathy
300282|NCT02344602|Diabetes Mellitus|diabetes mellitus
300283|NCT02344602|Diabetes Complications|diabetes complications
300284|NCT02344602|Uric Acid|uric acid
300285|NCT02344602|Febuxostat|febuxostat
300286|NCT02344602|Uloric|uloric
300287|NCT02344602|Glomerular Filtration Rate|glomerular filtration rate
300288|NCT02344602|Kidney Disease|kidney disease
300289|NCT02344602|Vascular Disease|vascular disease
300290|NCT02344602|Cardiovascular Diseases|cardiovascular diseases
300291|NCT02344602|Endothelial Function|endothelial function
300292|NCT02344602|Arterial Stiffness|arterial stiffness
300293|NCT02344602|Pharmacologic Actions|pharmacologic actions
300294|NCT02344602|Gout Suppressants|gout suppressants
300295|NCT02344602|Therapeutic Uses|therapeutic uses
300296|NCT02344602|Free Radical Scavengers|free radical scavengers
300297|NCT02344602|Antioxidants|antioxidants
300298|NCT02344602|Protective Agents|protective agents
300299|NCT02344602|Physiological Effects of Drugs|physiological effects of drugs
300300|NCT02344602|Angiotensin II Infusion|angiotensin ii infusion
300301|NCT02344602|Flow-mediated Dilation|flow-mediated dilation
300302|NCT02344602|Flow-mediated Constriction|flow-mediated constriction
300303|NCT02344602|Nitroglycerin|nitroglycerin
300304|NCT02344602|Hyperglycemia|hyperglycemia
300305|NCT02344602|Renin-angiotensin-aldosterone System|renin-angiotensin-aldosterone system
300306|NCT02344602|Nitric Oxide|nitric oxide
300307|NCT02344602|cGMP|cgmp
300308|NCT02344602|Oxidative Stress|oxidative stress
300309|NCT02344602|Renal Haemodynamic Function|renal haemodynamic function
300310|NCT02344602|Inulin Clearance|inulin clearance
300311|NCT02344602|PAH Clearance|pah clearance
300312|NCT02344602|Skin Biopsy|skin biopsy
300313|NCT02344602|T1R mRNA Expression|t1r mrna expression
300314|NCT02344602|Cytokines|cytokines
300315|NCT02344602|Chemokines|chemokines
300316|NCT02344589|ACB|acb
300317|NCT02344589|Adductor Canal Block|adductor canal block
300318|NCT02344589|Peripheral Nerve Block|peripheral nerve block
300319|NCT02344576|heart failure|heart failure
300320|NCT02344576|heart-assist devices|heart-assist devices
300321|NCT02344576|decision making|decision making
300322|NCT02344576|decision support techniques|decision support techniques
300323|NCT02344576|hospice care|hospice care
300324|NCT02344576|palliative care|palliative care
300325|NCT02344576|caregivers|caregivers
300326|NCT02344563|volunteers|volunteers
300327|NCT02344550|metastatic breast cancer|metastatic breast cancer
300328|NCT02344550|HER2 negative|her2 negative
300329|NCT02344550|hormone-receptor positive|hormone-receptor positive
300330|NCT02344537|Lyme DIsease|lyme disease
300331|NCT02344537|Kundalini Yoga|kundalini yoga
300332|NCT02344498|Liver cirrhosis|liver cirrhosis
300333|NCT02344498|Antiviral agents|antiviral agents
300334|NCT02344498|Liver diseases|liver diseases
300335|NCT02344472|MBC|mbc
300336|NCT02344472|HER2|her2
300337|NCT02344472|CTC|ctc
300338|NCT02344472|endocrine therapy|endocrine therapy
300339|NCT02344472|Pertuzumab|pertuzumab
300340|NCT02344472|Trastuzumab|trastuzumab
300341|NCT02344472|HER2 therapy|her2 therapy
300342|NCT02344472|Ribociclib|ribociclib
300343|NCT02344446|physical therapy intervention|physical therapy intervention
300344|NCT02344433|Family health history|family health history
300345|NCT02344433|Genetic literacy|genetic literacy
300346|NCT02344433|Health literacy|health literacy
300347|NCT02344433|Relational agent|relational agent
300348|NCT02344433|Common chronic conditions|common chronic conditions
300349|NCT02344420|Heart Failure|heart failure
300351|NCT02344407|Zaire Ebola Virus Disease|zaire ebola virus disease
300352|NCT02344394|Atrial Fibrillation|atrial fibrillation
300353|NCT02344394|Anti-Arrhythmia Agents|anti-arrhythmia agents
300354|NCT02344394|Catheter Ablation|catheter ablation
300355|NCT02344394|surgical hybrid ablation|surgical hybrid ablation
300356|NCT02344368|Sucrose|sucrose
300358|NCT02344368|Blood specimen collection|blood specimen collection
300359|NCT02344368|Injections, Intravenous|injections, intravenous
300360|NCT02344355|Ascorbic Acid|ascorbic acid
300361|NCT02344355|temozolomide|temozolomide
300362|NCT02344355|radiation|radiation
300363|NCT02344342|telemonitoring|telemonitoring
300364|NCT02344290|HIV|hiv
300365|NCT02344290|Cardiovascular Disease|cardiovascular disease
300366|NCT02344290|Myocardial Infarction|myocardial infarction
300367|NCT02344290|Inflammation|inflammation
300368|NCT02344290|Statin|statin
300369|NCT02344290|Computerized Tomography|computerized tomography
300370|NCT02344290|Cholesterol|cholesterol
300371|NCT02344277|Subcutaneaous Implantable Cardiac Defibrillator|subcutaneaous implantable cardiac defibrillator
300372|NCT02344277|Brugada syndrome|brugada syndrome
300373|NCT02344277|Effectiveness|effectiveness
300374|NCT02344277|Safety|safety
300375|NCT02344264|US guided nerve block|us guided nerve block
300376|NCT02344264|Total hip Arthroplasty|total hip arthroplasty
300377|NCT02344264|NCFL|ncfl
300378|NCT02344264|nervus cutaneous femoralis lateralis|nervus cutaneous femoralis lateralis
300379|NCT02344251|Drug study|drug study
300380|NCT02344251|Medication compliance|medication compliance
300381|NCT02344238|Medication compliance|medication compliance
300382|NCT02344238|Technology|technology
300383|NCT02344238|Drug study|drug study
300384|NCT02344186|diabetes, endoplasmic reticulum stress, obesity, GLP1 analogs|diabetes, endoplasmic reticulum stress, obesity, glp1 analogs
759246|NCT00407992|Migraine|migraine
300385|NCT02344160|Total Hip Arthroplasty|total hip arthroplasty
300386|NCT02344160|THA|tha
300387|NCT02344095|recurrent, persistent|recurrent, persistent
300388|NCT02344069|Fibrinogen|fibrinogen
300389|NCT02344056|Having Lunch|having lunch
300390|NCT02344056|Skipping Lunch|skipping lunch
300391|NCT02344030|airway|airway
300392|NCT02344030|videolaryngoscope|videolaryngoscope
300393|NCT02344004|ALIS|alis
300394|NCT02344004|ARIKAYCE|arikayce
300395|NCT02343978|Chronic Constipation|chronic constipation
300396|NCT02343978|CC|cc
300397|NCT02343965|Touch-massage|touch-massage
300398|NCT02343965|anxiety|anxiety
300399|NCT02343965|leukemia|leukemia
300400|NCT02343965|haematology|haematology
300401|NCT02343965|cancerology|cancerology
300402|NCT02343965|supportive care|supportive care
300403|NCT02343965|complementary therapy|complementary therapy
300404|NCT02343952|Pembrolizumab|pembrolizumab
300405|NCT02343952|MK-3475|mk-3475
300406|NCT02343874|Alcohol consumption|alcohol consumption
300407|NCT02343874|Primary health care|primary health care
300408|NCT02343874|health care costs|health care costs
300409|NCT02343874|health service utilization|health service utilization
300410|NCT02343861|Behavioral Research|behavioral research
300411|NCT02343861|Emollients|emollients
300412|NCT02343822|PRP|prp
300413|NCT02343822|Platelet Rich Plasma|platelet rich plasma
300414|NCT02343822|Lateral Epicondylitis|lateral epicondylitis
300415|NCT02343822|Lateral Epicondylopathy|lateral epicondylopathy
300416|NCT02343822|Lateral Epicondylosis|lateral epicondylosis
300417|NCT02343822|Chronic Lateral Epicondylitis|chronic lateral epicondylitis
300418|NCT02343822|PRPLE|prple
300419|NCT02343822|Multiple PRP Injections|multiple prp injections
300420|NCT02343822|Multiple PRP|multiple prp
300421|NCT02343822|Platelet-Rich Plasma|platelet-rich plasma
300422|NCT02343822|Tennis Elbow|tennis elbow
300423|NCT02343822|Double Blinded Randomized Controlled|double blinded randomized controlled
300424|NCT02343822|Multiple vs Single PRP injections|multiple vs single prp injections
300425|NCT02343822|prp tennis elbow|prp tennis elbow
300426|NCT02343809|Physiotherapy|physiotherapy
300427|NCT02343809|Lateral epicondylitis|lateral epicondylitis
300428|NCT02343809|Manual therapy|manual therapy
300429|NCT02343796|Fiberglass reinforced resins|fiberglass reinforced resins
300430|NCT02343783|Atopic Dermatitis|atopic dermatitis
300431|NCT02343783|Asthma|asthma
300432|NCT02343783|Healthy|healthy
300433|NCT02343783|Skin Blisters|skin blisters
300434|NCT02343783|Adult Participants|adult participants
300435|NCT02343744|Generalized Pustular Psoriasis|generalized pustular psoriasis
300436|NCT02343744|Erythrodermic Psoriasis|erythrodermic psoriasis
300437|NCT02343744|Guselkumab|guselkumab
300438|NCT02343744|CNTO1959|cnto1959
300439|NCT02343731|microbiome|microbiome
300440|NCT02343731|hygiene hypothesis|hygiene hypothesis
300441|NCT02343731|human-animal interaction|human-animal interaction
300442|NCT02343731|microbiota|microbiota
300443|NCT02343731|connections between human-canine microbiome|connections between human-canine microbiome
300444|NCT02343653|Malnutrition|malnutrition
300445|NCT02343653|Muscle mass|muscle mass
300446|NCT02343653|Nutrition|nutrition
300447|NCT02343640|Baseball|baseball
300448|NCT02343640|Ulnar collateral ligament|ulnar collateral ligament
300449|NCT02343614|Intermediate risk|intermediate risk
300450|NCT02343614|Cox-2 inhibitors|cox-2 inhibitors
300451|NCT02343588|Chinese multi-centered school based obesity intervention|chinese multi-centered school based obesity intervention
300452|NCT02343575|Hyperactive delirium|hyperactive delirium
300453|NCT02343575|Mixed delirium|mixed delirium
300454|NCT02343575|Anti-psychotic|anti-psychotic
300455|NCT02343575|Haldol|haldol
300755|NCT02341950|health|health
300456|NCT02343575|Valproic Acid|valproic acid
300457|NCT02343536|Phase 1|phase 1
300458|NCT02343536|Oral Azacitidine (CC-486)|oral azacitidine (cc-486)
300459|NCT02343536|R-CHOP|r-chop
300460|NCT02343536|Diffuse Large B-cell Lymphoma|diffuse large b-cell lymphoma
300461|NCT02343536|Grade 3B Follicular Lymphoma|grade 3b follicular lymphoma
300462|NCT02343536|Follicular Lymphoma|follicular lymphoma
300463|NCT02343536|Transformed Lymphoma|transformed lymphoma
300464|NCT02343523|Wearable device|wearable device
300465|NCT02343523|Wrist-watch|wrist-watch
300466|NCT02343523|Longitudinal monitoring|longitudinal monitoring
300467|NCT02343523|Congestive Heart Failure|congestive heart failure
300468|NCT02343510|Fallopian tubal cancer, high grade serous , ovarian cancer|fallopian tubal cancer, high grade serous , ovarian cancer
300469|NCT02343484|pulsed radiofrequency|pulsed radiofrequency
300470|NCT02343484|gelified ethanol|gelified ethanol
300471|NCT02343471|Whey proteins|whey proteins
300472|NCT02343471|Postprandial lipemia|postprandial lipemia
300473|NCT02343471|Pre-meal|pre-meal
300474|NCT02343471|Type 2 diabetes|type 2 diabetes
300476|NCT02343432|Anesthesia|anesthesia
300477|NCT02343432|Adverse Effect|adverse effect
300478|NCT02343432|Spinal|spinal
300479|NCT02343432|Epidural|epidural
300480|NCT02343419|Bronchial Hyperreactivity|bronchial hyperreactivity
300481|NCT02343419|Bronchial Provocation Tests|bronchial provocation tests
383821|NCT01943396|AMD|amd
300482|NCT02343419|Methacholine Chloride|methacholine chloride
300483|NCT02343419|Respiratory Function Tests|respiratory function tests
300484|NCT02343419|Spirometry|spirometry
300485|NCT02343419|Airway Resistance|airway resistance
300486|NCT02343419|Plethysmography|plethysmography
300487|NCT02343406|Glioblastoma Multiforme|glioblastoma multiforme
300488|NCT02343406|Epithelial Growth Factor vIII mutation|epithelial growth factor viii mutation
300489|NCT02343406|Temozolomide|temozolomide
300490|NCT02343406|Lomustine|lomustine
300491|NCT02343406|ABT-414|abt-414
300492|NCT02343406|European Organization for Research and Treatment of Cancer|european organization for research and treatment of cancer
300493|NCT02343406|recurrent glioblastoma|recurrent glioblastoma
300494|NCT02343406|Epithelial Growth Factor|epithelial growth factor
300495|NCT02343406|Brain Tumor|brain tumor
300496|NCT02343406|Brain Tumor Group|brain tumor group
300497|NCT02343406|Antibody Drug Conjugate|antibody drug conjugate
300498|NCT02343406|EORTC|eortc
300499|NCT02343406|Pediatric High Grade Gliomas|pediatric high grade gliomas
300500|NCT02343406|Pediatric diffuse Intrinsic Pontine Glioma|pediatric diffuse intrinsic pontine glioma
300501|NCT02343406|Pediatric WHO grade III glioma|pediatric who grade iii glioma
300502|NCT02343406|Pediatric WHO grade IV glioma|pediatric who grade iv glioma
300503|NCT02343406|EGFR amplification|egfr amplification
300504|NCT02343406|Children|children
300505|NCT02343393|Endothelial Dysfunction|endothelial dysfunction
300506|NCT02343393|Biomarkers|biomarkers
300507|NCT02343393|Hydralazine-Isosorbide Dinitrate|hydralazine-isosorbide dinitrate
300508|NCT02343380|diet-induced thermogenesis|diet-induced thermogenesis
300509|NCT02343380|glucose|glucose
300510|NCT02343380|respiratory quotient|respiratory quotient
300511|NCT02343367|Hispanic|hispanic
300512|NCT02343367|overweight|overweight
300513|NCT02343367|families|families
300514|NCT02343367|pediatric|pediatric
300515|NCT02343367|primary care|primary care
300516|NCT02343354|behavioural|behavioural
300517|NCT02343354|diabetes prevention|diabetes prevention
300518|NCT02343354|physical activity|physical activity
300519|NCT02343354|healthy eating|healthy eating
300520|NCT02343354|gestational diabetes|gestational diabetes
300521|NCT02343341|early childhood education|early childhood education
300522|NCT02343341|cardiovascular health|cardiovascular health
300523|NCT02343341|behavior change|behavior change
300524|NCT02343341|community-based|community-based
300525|NCT02343341|family-based|family-based
300526|NCT02343341|prevention|prevention
300527|NCT02343315|low back pain|low back pain
300528|NCT02343315|home exercises|home exercises
300529|NCT02343315|chronic pain|chronic pain
300530|NCT02343315|supervised exercise|supervised exercise
300531|NCT02343315|core stability exercises|core stability exercises
300532|NCT02343315|spinal stabilization exercises|spinal stabilization exercises
300533|NCT02343302|Pancreatic Fistula|pancreatic fistula
300534|NCT02343289|Healthy|healthy
300535|NCT02343289|Pharmacokinetics|pharmacokinetics
300536|NCT02343289|Esketamine|esketamine
300537|NCT02343289|JNJ-54135419|jnj-54135419
300538|NCT02343276|Radial Spasm|radial spasm
300539|NCT02343263|Tonsillectomy|tonsillectomy
300540|NCT02343263|Adenotonsillectomy|adenotonsillectomy
300541|NCT02343263|Pain|pain
300542|NCT02343263|Hemorrhage|hemorrhage
300543|NCT02343237|Fibromyalgia syndrome|fibromyalgia syndrome
300544|NCT02343237|pain|pain
300545|NCT02343237|quality of life|quality of life
300546|NCT02343237|osteopathic treatment|osteopathic treatment
300547|NCT02343211|Paraneoplastic Neurological Syndromes|paraneoplastic neurological syndromes
300548|NCT02343211|Onconeural antibodies|onconeural antibodies
300549|NCT02343211|Cancer|cancer
300550|NCT02343185|diaphragm|diaphragm
300551|NCT02343185|osteopathic treatment|osteopathic treatment
300552|NCT02343185|myofascial release|myofascial release
300553|NCT02343172|Liposarcoma,|liposarcoma,
300554|NCT02343172|MDM2 inhibition,|mdm2 inhibition,
300555|NCT02343172|cdk4 inhibition,|cdk4 inhibition,
300556|NCT02343172|HDM201,|hdm201,
300557|NCT02343172|LEE011|lee011
300558|NCT02343133|HemaMax, NM-IL-12, HSARS, Safety|hemamax, nm-il-12, hsars, safety
300559|NCT02343107|Obesity|obesity
300560|NCT02343107|Type 2 diabetes|type 2 diabetes
300561|NCT02343107|Metabolic syndrome|metabolic syndrome
300562|NCT02343107|e-coaching|e-coaching
300563|NCT02343107|Telehealth|telehealth
300564|NCT02343094|Proteinuria|proteinuria
300565|NCT02343094|Lipocalin 2|lipocalin 2
300566|NCT02343094|Neutrophil gelatinase associated lipocalin|neutrophil gelatinase associated lipocalin
300567|NCT02343094|ELISA|elisa
300568|NCT02343081|brain neoplasm|brain neoplasm
300569|NCT02343081|bioequivalence|bioequivalence
300570|NCT02343081|temozolomide|temozolomide
300571|NCT02343042|Selinexor|selinexor
300572|NCT02343042|KCP-330|kcp-330
300573|NCT02343042|STOMP|stomp
300574|NCT02343042|Multiple Myeloma|multiple myeloma
300575|NCT02343042|Relapsed/Refractory|relapsed/refractory
300576|NCT02343042|Dexamethasone|dexamethasone
300577|NCT02343042|Pomalidomide|pomalidomide
300578|NCT02343042|Bortezomib|bortezomib
300579|NCT02343042|Karyopharm|karyopharm
300580|NCT02343042|Lenalidomide|lenalidomide
300581|NCT02343042|Daratumumab|daratumumab
300582|NCT02343042|Newly Diagnosed|newly diagnosed
300583|NCT02343042|Carfilzomib|carfilzomib
300584|NCT02343029|Aerobic Exercise Training|aerobic exercise training
300585|NCT02343029|prevention|prevention
300586|NCT02343029|magnetic resonance spectroscopic imaging|magnetic resonance spectroscopic imaging
300587|NCT02343029|psychometric tests|psychometric tests
300588|NCT02343029|cognition|cognition
300589|NCT02343029|dementia|dementia
300590|NCT02343029|cognitive impairment|cognitive impairment
300591|NCT02343003|cooled radiofrequency ablation|cooled radiofrequency ablation
300592|NCT02343003|knee pain|knee pain
300593|NCT02343003|osteoarthritis|osteoarthritis
300594|NCT02343003|pain management|pain management
300595|NCT02342990|working memory training|working memory training
300596|NCT02342990|home-based training|home-based training
300597|NCT02342990|periventricular leukomalacia|periventricular leukomalacia
300598|NCT02342990|bilateral cerebral palsy|bilateral cerebral palsy
300599|NCT02342990|neuropsychological profile|neuropsychological profile
300600|NCT02342990|high density EEG|high density eeg
300601|NCT02342990|slow waves activities|slow waves activities
300602|NCT02342977|total hip arthroplasty|total hip arthroplasty
300603|NCT02342964|Cystic fibrosis|cystic fibrosis
300604|NCT02342964|hepatic fibrosis|hepatic fibrosis
300605|NCT02342964|hepatic cirrhosis|hepatic cirrhosis
300606|NCT02342964|non-invasive methods of measurement|non-invasive methods of measurement
300607|NCT02342964|hepatic elasticity|hepatic elasticity
300608|NCT02342951|Cystic fibrosis,|cystic fibrosis,
300609|NCT02342951|lung clearance index,|lung clearance index,
300610|NCT02342951|pulmonary function|pulmonary function
300611|NCT02342938|Epilepsy surgery|epilepsy surgery
300612|NCT02342938|High frequency activity|high frequency activity
300613|NCT02342938|icEEG|iceeg
300614|NCT02342938|fMRI|fmri
300615|NCT02342938|MEG|meg
300616|NCT02342886|Tuberculosis|tuberculosis
300617|NCT02342886|Multi Drug-Resistant Tuberculosis|multi drug-resistant tuberculosis
300618|NCT02342886|Drug-sensitive Tuberculosis|drug-sensitive tuberculosis
300619|NCT02342886|PA-824|pa-824
300620|NCT02342886|Moxifloxacin|moxifloxacin
300621|NCT02342886|Pyrazinamide|pyrazinamide
300622|NCT02342886|Rifampicin|rifampicin
300623|NCT02342886|Isoniazid|isoniazid
300624|NCT02342886|Ethambutol|ethambutol
300625|NCT02342886|HRZE|hrze
300626|NCT02342886|HR|hr
300627|NCT02342886|Pretomanid|pretomanid
300628|NCT02342886|NC-006|nc-006
300629|NCT02342886|STAND|stand
300630|NCT02342873|ultrasound|ultrasound
300631|NCT02342873|nerve stimulator|nerve stimulator
300632|NCT02342860|Water|water
300633|NCT02342860|sanitation|sanitation
300634|NCT02342860|hygiene access in school|hygiene access in school
300635|NCT02342756|ARDS, HFOV|ards, hfov
300636|NCT02342691|Safety and efficacy of BLXA4|safety and efficacy of blxa4
300637|NCT02342665|Non Hodgkin's Lymphomas|non hodgkin's lymphomas
300638|NCT02342626|Prostate|prostate
300639|NCT02342626|Cancer|cancer
300640|NCT02342626|Adenocarcinoma|adenocarcinoma
300641|NCT02342587|Lapatinib|lapatinib
300642|NCT02342561|Infection|infection
300643|NCT02342561|Drape|drape
300644|NCT02342561|Ioban|ioban
300645|NCT02342561|Arthroplasty|arthroplasty
300646|NCT02342561|Knee|knee
300647|NCT02342561|Cylinder Sampling|cylinder sampling
300648|NCT02342561|Bacteria|bacteria
300649|NCT02342548|Huntington; chorea; total motor score; CAG repeat: total functional capacity; motor cognitive and behavioral symptoms|huntington; chorea; total motor score; cag repeat: total functional capacity; motor cognitive and behavioral symptoms
300650|NCT02342522|Cardioprotection|cardioprotection
300651|NCT02342522|STEMI|stemi
300652|NCT02342522|PPCI|ppci
300653|NCT02342522|Myocardial reperfusion injury|myocardial reperfusion injury
300654|NCT02342522|Myocardial infarct size|myocardial infarct size
300655|NCT02342522|ST-elevation myocardial infarction|st-elevation myocardial infarction
300656|NCT02342522|Remote Ischaemic Conditioning|remote ischaemic conditioning
300657|NCT02342522|Cardiovascular mortality|cardiovascular mortality
300658|NCT02342509|et Control|et control
300659|NCT02342509|inhalational sedation|inhalational sedation
300660|NCT02342509|conserve volatile anesthetics|conserve volatile anesthetics
300661|NCT02342470|prevention|prevention
300662|NCT02342470|Recurrent peptic ulcer|recurrent peptic ulcer
300663|NCT02342444|Trauma|trauma
300664|NCT02342444|Surgery|surgery
300665|NCT02342444|Enoxaparin|enoxaparin
300666|NCT02342444|DVTs|dvts
300667|NCT02342444|Thromboembolic events|thromboembolic events
300668|NCT02342431|Thermoregulation|thermoregulation
300669|NCT02342431|Pediatric Anesthesia|pediatric anesthesia
300670|NCT02342431|Cardiac Catheterization|cardiac catheterization
300671|NCT02342405|Oxidative stress|oxidative stress
300672|NCT02342405|Nitrogen oxide|nitrogen oxide
300673|NCT02342405|Reactive oxygen species|reactive oxygen species
300674|NCT02342392|pterygium|pterygium
300675|NCT02342392|ranibizumab|ranibizumab
300676|NCT02342392|anti-VEGF|anti-vegf
300677|NCT02342392|recurrence|recurrence
300678|NCT02342392|vascularity|vascularity
300679|NCT02342392|size|size
300680|NCT02342366|Sodium Oxybate, Altruism, Neurostreroids, Liquid Ecstasy|sodium oxybate, altruism, neurostreroids, liquid ecstasy
300681|NCT02342340|Beans, Lentils, Bioavailability, Phytochemical Absorption|beans, lentils, bioavailability, phytochemical absorption
300682|NCT02342288|Intraoperative ocular pressure|intraoperative ocular pressure
300683|NCT02342275|Infantile hemangioma|infantile hemangioma
300684|NCT02342275|Propranolol|propranolol
300685|NCT02342275|Atenolol|atenolol
300686|NCT02342275|Efficacy|efficacy
300687|NCT02342275|Safety|safety
300688|NCT02342249|Influenza A|influenza a
300689|NCT02342236|Biological Markers|biological markers
300690|NCT02342223|human immunodeficiency virus|human immunodeficiency virus
300691|NCT02342223|facial lipoatrophy|facial lipoatrophy
300692|NCT02342223|facial lipodystrophy|facial lipodystrophy
300693|NCT02342223|hyaluronic acid|hyaluronic acid
300694|NCT02342223|dermal filler|dermal filler
300695|NCT02342223|filler agent|filler agent
300696|NCT02342210|Mindfulness|mindfulness
300697|NCT02342210|Group Therapy|group therapy
300698|NCT02342197|Low responders|low responders
300699|NCT02342197|Minidose long protocol|minidose long protocol
300700|NCT02342197|Microdose flare protocol|microdose flare protocol
300701|NCT02342197|Oocyte yield|oocyte yield
300702|NCT02342171|Ebola Viral Disease|ebola viral disease
300703|NCT02342171|Convalescent Plasma|convalescent plasma
300704|NCT02342171|Developing Countries|developing countries
300705|NCT02342145|beta-Thalassemia major|beta-thalassemia major
300706|NCT02342119|kidney transplantation|kidney transplantation
300707|NCT02342119|race disparities|race disparities
300708|NCT02342119|living donor kidney transplantation|living donor kidney transplantation
300709|NCT02342119|transplant evaluation|transplant evaluation
300710|NCT02342093|Ambulatory Blood Pressure Monitoring|ambulatory blood pressure monitoring
300711|NCT02342093|Drospirenone|drospirenone
300712|NCT02342093|Oral contraceptive|oral contraceptive
300713|NCT02342080|Rehabilitation|rehabilitation
300714|NCT02342080|Walking|walking
300715|NCT02342080|Robotics|robotics
300716|NCT02342080|Neuronal Plasticity|neuronal plasticity
300717|NCT02342054|Cancer|cancer
300718|NCT02342054|Prostate Cancer|prostate cancer
300719|NCT02342054|Brachytherapy|brachytherapy
300720|NCT02342054|Dose escalation|dose escalation
300721|NCT02342054|High Dose Rate|high dose rate
300722|NCT02342054|MRI-TRUS fusion|mri-trus fusion
300723|NCT02342054|Detection of DILs by MRI|detection of dils by mri
300724|NCT02342054|SINGLE FRACTION|single fraction
300725|NCT02342041|SUVN-G3031|suvn-g3031
300726|NCT02342041|histamine 3 (H3) receptor inverse agonist|histamine 3 (h3) receptor inverse agonist
300727|NCT02342041|first in human|first in human
300728|NCT02342041|safety|safety
300729|NCT02342041|pharmacokinetics|pharmacokinetics
300730|NCT02342041|tolerability|tolerability
300731|NCT02342041|single dose|single dose
300732|NCT02342041|repeat dose|repeat dose
300733|NCT02342028|sleep apnea|sleep apnea
300734|NCT02342028|intermittent hypoxia|intermittent hypoxia
300735|NCT02342028|regulatory T cell|regulatory t cell
300736|NCT02342028|autoimmunity|autoimmunity
300737|NCT02342002|mifepristone|mifepristone
300738|NCT02342002|misoprostol|misoprostol
300739|NCT02342002|obstetrics|obstetrics
300740|NCT02342002|reproductive health|reproductive health
300741|NCT02342002|pregnancy|pregnancy
300742|NCT02342002|abortion|abortion
300743|NCT02342002|missed abortion|missed abortion
300744|NCT02341989|Chemotherapy, adjuvant|chemotherapy, adjuvant
300745|NCT02341989|Recurrence|recurrence
300746|NCT02341989|Carboplatin|carboplatin
300747|NCT02341989|Bleomycin|bleomycin
300748|NCT02341989|Etoposide|etoposide
300749|NCT02341989|Cisplatin|cisplatin
300750|NCT02341976|whole body vibration|whole body vibration
300751|NCT02341976|pelvic floor muscle|pelvic floor muscle
300752|NCT02341976|urinary incontinence|urinary incontinence
300753|NCT02341976|Urinary sphincter|urinary sphincter
300756|NCT02341950|behavior|behavior
300757|NCT02341950|mobile|mobile
300758|NCT02341950|spinal|spinal
300759|NCT02341950|cord|cord
300760|NCT02341950|dysfunction|dysfunction
300761|NCT02341911|triple negative breast cancer|triple negative breast cancer
300762|NCT02341911|fine line chemotherapy|fine line chemotherapy
300763|NCT02341898|nursing home care|nursing home care
300764|NCT02341898|physical restraints|physical restraints
300765|NCT02341898|dementia|dementia
300766|NCT02341898|implementation research|implementation research
300767|NCT02341898|cluster-randomized controlled trial|cluster-randomized controlled trial
300768|NCT02341885|Kidney|kidney
300769|NCT02341885|Renal replacement|renal replacement
300770|NCT02341885|Acute kidney injury|acute kidney injury
300771|NCT02341885|chronic kidney disease|chronic kidney disease
300772|NCT02341885|Epidemiology|epidemiology
300773|NCT02341885|Prevalence|prevalence
300774|NCT02341872|White spot lesions|white spot lesions
300775|NCT02341872|remineralization|remineralization
300776|NCT02341872|QLF|qlf
300777|NCT02341872|antibacterial|antibacterial
300778|NCT02341846|cancer pain|cancer pain
300779|NCT02341833|Anesthetic preconditioning|anesthetic preconditioning
300780|NCT02341833|Sevoflurane|sevoflurane
300781|NCT02341833|Liver transplantation|liver transplantation
300782|NCT02341833|brain-death donors|brain-death donors
300783|NCT02341820|breast cancer|breast cancer
300784|NCT02341820|breast conserving surgery|breast conserving surgery
300785|NCT02341820|cosmesis|cosmesis
300786|NCT02341807|Choroideremia|choroideremia
300787|NCT02341807|AAV|aav
300788|NCT02341807|Gene therapy|gene therapy
300789|NCT02341807|CHM|chm
300790|NCT02341807|Adeno-associated virus|adeno-associated virus
300791|NCT02341807|Adeno-associated viral vector|adeno-associated viral vector
300792|NCT02341794|intracranial arterial disease|intracranial arterial disease
300793|NCT02341794|dyslipidemia|dyslipidemia
300794|NCT02341794|rosuvastatin|rosuvastatin
300795|NCT02341781|MANTLE CELL LYMPHOMA|mantle cell lymphoma
300796|NCT02341781|Multicenter|multicenter
300797|NCT02341781|Observational|observational
300798|NCT02341781|Lenalidomide (Revlimid®)|lenalidomide (revlimid®)
300799|NCT02341781|Relapsed or progressed|relapsed or progressed
300800|NCT02341781|Ibrutinib|ibrutinib
300801|NCT02341768|clinical and device functional information|clinical and device functional information
300802|NCT02341768|"real world ICD patient population"|"real world icd patient population"
300803|NCT02341742|Physical activity|physical activity
300804|NCT02341742|Bone health|bone health
300805|NCT02341742|Pediatrics|pediatrics
300806|NCT02341742|Bone|bone
300807|NCT02341729|semi-urgent CABG|semi-urgent cabg
300808|NCT02341729|reanimation|reanimation
300809|NCT02341729|ticagrelor|ticagrelor
300810|NCT02341729|crushed tablet|crushed tablet
300811|NCT02341716|intermittent claudication|intermittent claudication
300812|NCT02341716|exercise therapy|exercise therapy
300813|NCT02341716|physiotherapy|physiotherapy
300814|NCT02341690|Type 2 diabetes|type 2 diabetes
300815|NCT02341690|Interval Walking Training|interval walking training
300816|NCT02341690|Motivation|motivation
300817|NCT02341677|Prostatic Neoplasms|prostatic neoplasms
300818|NCT02341677|Diagnostic Techniques and Procedures|diagnostic techniques and procedures
300819|NCT02341677|Magnetic Resonance Imaging|magnetic resonance imaging
300820|NCT02341677|Ultrasonography|ultrasonography
300821|NCT02341677|Biopsy|biopsy
300822|NCT02341677|Image Fusion|image fusion
300823|NCT02341664|Mobile Tablet Device|mobile tablet device
300824|NCT02341664|Outpatient Clinic|outpatient clinic
300825|NCT02341664|Tobacco|tobacco
300826|NCT02341664|Health|health
300827|NCT02341664|Barriers|barriers
300828|NCT02341664|Prevention|prevention
300829|NCT02341664|Prescribing Practices|prescribing practices
300830|NCT02341664|Informed Consent|informed consent
300831|NCT02341664|Statin|statin
300832|NCT02341664|Lipid Panel|lipid panel
300833|NCT02341664|Low Density Lipoprotein-C|low density lipoprotein-c
300834|NCT02341664|Blood Draw|blood draw
300835|NCT02341664|ACC/AHA Guidelines|acc/aha guidelines
300836|NCT02341664|Adult Treatment Panel Guidelines (ATPIII)|adult treatment panel guidelines (atpiii)
300837|NCT02341664|Atherosclerotic Cardiovascular Disease (ASCVD)|atherosclerotic cardiovascular disease (ascvd)
300838|NCT02341664|Cholesterol-lowering therapies|cholesterol-lowering therapies
300839|NCT02341664|Cholesterol Management|cholesterol management
300840|NCT02341664|Cardiovascular Risk|cardiovascular risk
300841|NCT02341664|10-year CVD Risk|10-year cvd risk
300842|NCT02341664|Labs|labs
300843|NCT02341664|Coronary revascularization|coronary revascularization
300844|NCT02341664|Arterial revascularization|arterial revascularization
300845|NCT02341664|Imaging|imaging
300846|NCT02341651|High blood pressure|high blood pressure
300847|NCT02341651|Cardiovascular diseases|cardiovascular diseases
300848|NCT02341651|Antihypertensive agents|antihypertensive agents
300849|NCT02341651|Pharmacological treatment|pharmacological treatment
300850|NCT02341651|Non-pharmacological treatment|non-pharmacological treatment
300851|NCT02341651|Community health care workers|community health care workers
300852|NCT02341651|Treatment algorithm|treatment algorithm
300955|NCT02341040|food allergy|food allergy
300853|NCT02341651|Public and private healthcare providers|public and private healthcare providers
300854|NCT02341651|Strategy|strategy
300855|NCT02341651|Referral loops|referral loops
300856|NCT02341651|Intervention|intervention
300857|NCT02341612|exercise-induced muscle damage|exercise-induced muscle damage
300858|NCT02341612|skeletal muscle injury recovery|skeletal muscle injury recovery
300859|NCT02341612|cryotherapy|cryotherapy
300860|NCT02341612|recovery of function|recovery of function
300861|NCT02341612|rehabilitation|rehabilitation
300862|NCT02341586|Malaria|malaria
300863|NCT02341586|Cambodia|cambodia
300864|NCT02341586|Iron|iron
300865|NCT02341586|Childbearing Age|childbearing age
300866|NCT02341586|Women|women
300867|NCT02341586|Home Fortification|home fortification
300868|NCT02341573|Traditional Chinese Medicine|traditional chinese medicine
300869|NCT02341573|Randomized Controlled Trial|randomized controlled trial
300870|NCT02341560|NAION|naion
300871|NCT02341495|Azacitidine|azacitidine
300872|NCT02341495|Vidaza|vidaza
300873|NCT02341495|Deferasirox|deferasirox
300874|NCT02341495|Exjade|exjade
300875|NCT02341495|Cholecalciferol|cholecalciferol
300876|NCT02341495|Vitamin D|vitamin d
300877|NCT02341482|Itraconazole|itraconazole
300878|NCT02341482|Healthy Volunteers|healthy volunteers
300879|NCT02341482|Drug-drug interaction|drug-drug interaction
300880|NCT02341482|PF-04958242|pf-04958242
300881|NCT02341469|Burkina Faso|burkina faso
300882|NCT02341469|cluster randomised|cluster randomised
300883|NCT02341469|stepped-wedge|stepped-wedge
300884|NCT02341469|IMCI|imci
300885|NCT02341443|bilateral double mandibular fractures|bilateral double mandibular fractures
300886|NCT02341443|rigid fixation|rigid fixation
300887|NCT02341443|no-rigid fixation|no-rigid fixation
300888|NCT02341443|jaw|jaw
300889|NCT02341430|hernia|hernia
300890|NCT02341430|synthetic mesh|synthetic mesh
300891|NCT02341417|Chronic Kidney Disease, Dialysis, Secondary Hyperparathyroidism, Pediatric|chronic kidney disease, dialysis, secondary hyperparathyroidism, pediatric
300892|NCT02341391|chondrocyte cells|chondrocyte cells
300893|NCT02341391|Osteoarthritis|osteoarthritis
300894|NCT02341391|gene therapy|gene therapy
300895|NCT02341378|chondrocyte cells|chondrocyte cells
300896|NCT02341378|Osteoarthritis|osteoarthritis
300897|NCT02341378|gene therapy|gene therapy
300898|NCT02341365|Egg donation|egg donation
300899|NCT02341365|vitaminD|vitamind
300900|NCT02341365|ovarian reserve|ovarian reserve
300901|NCT02341365|ovarian stimulation|ovarian stimulation
300902|NCT02341326|Lung|lung
300903|NCT02341326|COPD|copd
300904|NCT02341326|smoking|smoking
300905|NCT02341326|Non-smoker|non-smoker
300906|NCT02341313|Hypoglycaemia|hypoglycaemia
300907|NCT02341300|Pregnancy|pregnancy
300908|NCT02341300|Cast-Iron pots|cast-iron pots
300909|NCT02341300|Iron-deficiency anemia|iron-deficiency anemia
300910|NCT02341274|Tacrolimus|tacrolimus
300911|NCT02341274|Drug Formulation|drug formulation
300912|NCT02341274|Absorption|absorption
300913|NCT02341274|Bioavailability|bioavailability
300914|NCT02341274|Healthy Volunteer|healthy volunteer
300915|NCT02341248|Enteral Nutrition|enteral nutrition
300916|NCT02341248|Pediatrics|pediatrics
300917|NCT02341248|Microbiota|microbiota
300918|NCT02341248|Metabolomics|metabolomics
300919|NCT02341235|video game|video game
300920|NCT02341235|narrative|narrative
300921|NCT02341235|story|story
300922|NCT02341235|survivorship|survivorship
300923|NCT02341235|cancer survivor|cancer survivor
300924|NCT02341235|mhealth|mhealth
300925|NCT02341235|physical activity|physical activity
300926|NCT02341235|women|women
300927|NCT02341235|women's health|women's health
300928|NCT02341222|hernia prosthetic surgery|hernia prosthetic surgery
300929|NCT02341222|incisional hernia prosthesis|incisional hernia prosthesis
300930|NCT02341222|prosthesis mesh fixation|prosthesis mesh fixation
300931|NCT02341222|prosthesis mesh biocompatibility|prosthesis mesh biocompatibility
300932|NCT02341209|CTCL|ctcl
300933|NCT02341209|Sezary Syndrome (SS)|sezary syndrome (ss)
300934|NCT02341209|Mycosis Fungoides (MF)|mycosis fungoides (mf)
300935|NCT02341209|Cutaneous T-cell Lymphoma|cutaneous t-cell lymphoma
300936|NCT02341209|MF|mf
300937|NCT02341209|SS|ss
300938|NCT02341131|Schizophrenia|schizophrenia
300939|NCT02341131|Cognitive Remediation|cognitive remediation
300940|NCT02341131|BDNF|bdnf
300941|NCT02341118|BRCA1/2 Mutational Status|brca1/2 mutational status
300942|NCT02341092|Traumatic brain injury|traumatic brain injury
300943|NCT02341079|Total Knee Arthroplasty|total knee arthroplasty
300944|NCT02341079|Osteoarthritis|osteoarthritis
300945|NCT02341079|Femoral Nerve Blockade|femoral nerve blockade
300946|NCT02341079|Liposomal Bupivacaine|liposomal bupivacaine
300947|NCT02341066|Cardiovascular risk score|cardiovascular risk score
300948|NCT02341066|Framingham risk score 2-year|framingham risk score 2-year
300949|NCT02341066|Endothelial dysfunction|endothelial dysfunction
300950|NCT02341066|EndoPAT|endopat
300951|NCT02341066|Rheumatoid arthritis|rheumatoid arthritis
300952|NCT02341053|SMA|sma
300953|NCT02341053|Neuromuscular disability|neuromuscular disability
300954|NCT02341040|wheat allergy|wheat allergy
300956|NCT02341040|pediatric|pediatric
300957|NCT02341027|Immediate postpartum contraception|immediate postpartum contraception
300958|NCT02341027|Contraceptive implants|contraceptive implants
300959|NCT02341027|Breastfeeding|breastfeeding
300960|NCT02341027|Jadelle|jadelle
300961|NCT02341027|Lactation|lactation
300962|NCT02341027|Levonorgestrel|levonorgestrel
300963|NCT02341014|Carfilzomib|carfilzomib
300964|NCT02341014|Romidepsin|romidepsin
300965|NCT02341014|Lenalidomide|lenalidomide
300966|NCT02341014|Lymphomas|lymphomas
300967|NCT02341014|14-179|14-179
300968|NCT02341001|Bariatric surgery|bariatric surgery
300969|NCT02341001|Sleeve gastrectomy|sleeve gastrectomy
300970|NCT02341001|Text messaging|text messaging
300971|NCT02341001|Weight loss|weight loss
300972|NCT02341001|BAROS|baros
300973|NCT02341001|Follow-up care|follow-up care
300974|NCT02340975|Gastric Adenocarcinoma|gastric adenocarcinoma
300975|NCT02340975|Gastroesophageal Junction Adenocarcinoma|gastroesophageal junction adenocarcinoma
300976|NCT02340975|Immunotherapy|immunotherapy
300977|NCT02340975|Antibodies, Monoclonal|antibodies, monoclonal
300978|NCT02340975|Tremelimumab|tremelimumab
300979|NCT02340975|MEDI4736|medi4736
300980|NCT02340923|DMD|dmd
300981|NCT02340923|Duchenne Muscular Dystrophy|duchenne muscular dystrophy
300982|NCT02340923|EIM|eim
300983|NCT02340910|spasticity|spasticity
300984|NCT02340910|whole body vibration|whole body vibration
300985|NCT02340910|walking|walking
300986|NCT02340871|Neurogenetics|neurogenetics
300987|NCT02340871|genetic testing|genetic testing
300988|NCT02340845|breast,colon, ovary, uterus, cervix, lung|breast,colon, ovary, uterus, cervix, lung
300989|NCT02340845|Treatments|treatments
300990|NCT02340806|epidural bolus|epidural bolus
300991|NCT02340806|pain management|pain management
300992|NCT02340806|labor analgesia|labor analgesia
300993|NCT02340793|Weight loss|weight loss
300994|NCT02340767|Suspicious Occlusal Caries|suspicious occlusal caries
300995|NCT02340754|mindfulness|mindfulness
300996|NCT02340754|meditation|meditation
300997|NCT02340754|stress, psychological|stress, psychological
300998|NCT02340754|quality of life|quality of life
300999|NCT02340754|randomized controlled trial|randomized controlled trial
301000|NCT02340741|carbon dioxide|carbon dioxide
301001|NCT02340741|postoperative cerebrovascular complications|postoperative cerebrovascular complications
301002|NCT02340741|air embolism|air embolism
301003|NCT02340728|Stent Placement|stent placement
301004|NCT02340728|Biliary Obstruction|biliary obstruction
301005|NCT02340728|14-260|14-260
301006|NCT02340715|Anal canal|anal canal
301007|NCT02340715|Brain|brain
301008|NCT02340715|Breast|breast
301009|NCT02340715|Cervix|cervix
301010|NCT02340715|Esophagus|esophagus
301011|NCT02340715|Gynecology|gynecology
301012|NCT02340715|Head and Neck|head and neck
301013|NCT02340715|Lung|lung
301014|NCT02340715|Pancreas|pancreas
301015|NCT02340715|Primary liver or liver metastases|primary liver or liver metastases
301016|NCT02340715|Prostate cancer|prostate cancer
301017|NCT02340715|Sarcoma|sarcoma
301018|NCT02340702|COPD and heart failure|copd and heart failure
301019|NCT02340689|PH|ph
301020|NCT02340689|PH type 1|ph type 1
301021|NCT02340689|Primary Hyperoxaluria|primary hyperoxaluria
301022|NCT02340689|Hyperoxaluria|hyperoxaluria
301023|NCT02340689|Primary Oxalosis|primary oxalosis
301024|NCT02340689|PH type 2|ph type 2
301025|NCT02340689|PH type 3|ph type 3
301026|NCT02340689|Genetic testing for PH|genetic testing for ph
301027|NCT02340689|Genetic testing for Primary Hyperoxaluria|genetic testing for primary hyperoxaluria
301028|NCT02340689|Hereditary study for PH|hereditary study for ph
301029|NCT02340689|Hereditary study for Primary Hyperoxaluria|hereditary study for primary hyperoxaluria
301030|NCT02340689|AGXT|agxt
301031|NCT02340689|GRHPR|grhpr
301032|NCT02340689|HOGA1|hoga1
301033|NCT02340676|chronic graft-versus-host-disease|chronic graft-versus-host-disease
301034|NCT02340663|dental orthotic|dental orthotic
301035|NCT02340663|bite splint|bite splint
301036|NCT02340663|oral parafunction|oral parafunction
301037|NCT02340663|clenching|clenching
301038|NCT02340663|grinding|grinding
301039|NCT02340650|suspicious bladder lesion, normal bladder tissue|suspicious bladder lesion, normal bladder tissue
301040|NCT02340585|Next Generation Neuroform Stent System|next generation neuroform stent system
301041|NCT02340585|Wide Neck, Intracranial, Saccular Aneurysms|wide neck, intracranial, saccular aneurysms
301042|NCT02340585|Cerebral Aneurysms|cerebral aneurysms
301043|NCT02340572|Healthy Subjects|healthy subjects
301044|NCT02340559|meta-cognition|meta-cognition
301045|NCT02340559|positive symptoms|positive symptoms
301046|NCT02340559|early phases|early phases
301047|NCT02340559|schizophrenia|schizophrenia
301048|NCT02340533|adenomyosis|adenomyosis
301049|NCT02340481|Diarrhea|diarrhea
301050|NCT02340481|Flatulence|flatulence
301051|NCT02340481|Abdominal discomfort|abdominal discomfort
301052|NCT02340481|Loperamide hydrochloride|loperamide hydrochloride
301053|NCT02340481|Simethicone|simethicone
301054|NCT02340481|Placebo|placebo
301055|NCT02340442|arteriovenous ratio|arteriovenous ratio
301056|NCT02340442|retinal flicker stimulation|retinal flicker stimulation
301655|NCT02336802|Fear|fear
301057|NCT02340442|Dynamic vessel analyzer|dynamic vessel analyzer
301058|NCT02340416|orthopedic surgeries|orthopedic surgeries
301059|NCT02340416|general anesthesia|general anesthesia
301060|NCT02340403|Neuropathy|neuropathy
301061|NCT02340403|Oxaliplatin|oxaliplatin
301062|NCT02340403|Insula|insula
301063|NCT02340403|choline|choline
301064|NCT02340390|G7 Acetabular System|g7 acetabular system
301065|NCT02340377|core body temperature|core body temperature
301066|NCT02340377|whole-body hyperthermia|whole-body hyperthermia
301067|NCT02340377|rectal body temperature|rectal body temperature
301068|NCT02340364|Hospital Readmissions|hospital readmissions
301069|NCT02340364|Patient Navigation|patient navigation
301070|NCT02340351|acupuncture|acupuncture
301071|NCT02340351|auricular acupuncture|auricular acupuncture
301072|NCT02340351|NADA|nada
301073|NCT02340351|anxiety|anxiety
301074|NCT02340351|depression|depression
759247|NCT00407940|Thrombosis|thrombosis
301075|NCT02340299|High Frequency Oscillation Ventilation|high frequency oscillation ventilation
301076|NCT02340299|Nasal Continuous Positive Airway Pressure|nasal continuous positive airway pressure
301077|NCT02340299|Airway Extubation|airway extubation
301078|NCT02340299|Prematurity|prematurity
301079|NCT02340273|tendinopathy|tendinopathy
301080|NCT02340273|ultrasound|ultrasound
301081|NCT02340273|pain|pain
301082|NCT02340273|heat|heat
301083|NCT02340273|strength|strength
301084|NCT02340273|LITUS|litus
301085|NCT02340273|long duration|long duration
301086|NCT02340273|therapeutic ultrasound|therapeutic ultrasound
301087|NCT02340273|tendonopathy|tendonopathy
301088|NCT02340260|Exercise|exercise
301089|NCT02340260|Risk factors|risk factors
301090|NCT02340260|Exercise therapy|exercise therapy
301091|NCT02340260|Hemoglobin A, Glycosylated|hemoglobin a, glycosylated
301092|NCT02340208|Non-Small Cell Lung Cancer|non-small cell lung cancer
301093|NCT02340208|Neoplasms|neoplasms
301094|NCT02340208|Immunoconjugate|immunoconjugate
301095|NCT02340208|Tumor microenvironment alkalinization|tumor microenvironment alkalinization
301096|NCT02340195|Kidney impairment|kidney impairment
301097|NCT02340182|gut flora|gut flora
301098|NCT02340182|antibiotics|antibiotics
301099|NCT02340182|systemic immune response|systemic immune response
301100|NCT02340182|Volunteers|volunteers
301101|NCT02340091|facial nasolabial fold wrinkles|facial nasolabial fold wrinkles
301102|NCT02340078|the facial nasolabial fold|the facial nasolabial fold
301103|NCT02340065|colonoscopy|colonoscopy
301104|NCT02340065|adenoma detection rate|adenoma detection rate
301105|NCT02340065|Endocuff-assisted colonoscopy|endocuff-assisted colonoscopy
301106|NCT02340052|postoperative pain treatment|postoperative pain treatment
301107|NCT02340039|Polyphenol|polyphenol
301108|NCT02340039|Fruit|fruit
301109|NCT02340039|Metabolic|metabolic
301110|NCT02340026|Delay in motor skill development|delay in motor skill development
301111|NCT02340000|acute sinusitis|acute sinusitis
301112|NCT02340000|amoxicillin/clavulanate|amoxicillin/clavulanate
301113|NCT02340000|adults|adults
301114|NCT02340000|outcomes|outcomes
301115|NCT02339961|Systemic Sclerosis|systemic sclerosis
301116|NCT02339961|Pulmonary hypertension|pulmonary hypertension
301117|NCT02339961|Lung Doppler Signals|lung doppler signals
301118|NCT02339948|Locally confined|locally confined
301119|NCT02339935|Autism Spectrum Disorder|autism spectrum disorder
301120|NCT02339935|Autism|autism
301121|NCT02339909|Screening|screening
301122|NCT02339909|Incentives|incentives
301123|NCT02339896|rabies|rabies
301124|NCT02339896|modified TRC intradermal rabies vaccine|modified trc intradermal rabies vaccine
301125|NCT02339896|SPEEDA|speeda
301126|NCT02339883|Physiological Measures|physiological measures
301127|NCT02339883|MRI|mri
301128|NCT02339883|Magnetic Resonance Imaging (MRI)|magnetic resonance imaging (mri)
301129|NCT02339883|Cognitive Testing|cognitive testing
301130|NCT02339857|coronary artery bypass grafting|coronary artery bypass grafting
301131|NCT02339857|saphenous vein|saphenous vein
301132|NCT02339857|grafts|grafts
301133|NCT02339844|glutamate|glutamate
301134|NCT02339844|dopamine|dopamine
301135|NCT02339844|cognition|cognition
301136|NCT02339844|cortical thickness|cortical thickness
301137|NCT02339844|ppi|ppi
301138|NCT02339844|p50|p50
301139|NCT02339831|Knee|knee
301140|NCT02339831|Arthroplasty|arthroplasty
301141|NCT02339831|CPM|cpm
301142|NCT02339831|Camoped|camoped
301143|NCT02339831|Active vs Passive Motion Device|active vs passive motion device
301144|NCT02339805|Minimal residual disease, NGS, NHL, DNA sequencing|minimal residual disease, ngs, nhl, dna sequencing
301145|NCT02339792|COMPREHENSIVE GERIATRIC ASSESSMENT (CGA)|comprehensive geriatric assessment (cga)
301146|NCT02339792|MEDICATION APPROPRIATENESS PRESCRIBING|medication appropriateness prescribing
301147|NCT02339792|DRUG INTERACTIONS|drug interactions
301148|NCT02339792|E-LEARNING|e-learning
301149|NCT02339779|fat grafting|fat grafting
301150|NCT02339779|fat injection|fat injection
301151|NCT02339779|lipoaspirate|lipoaspirate
301152|NCT02339779|fat transfer|fat transfer
301153|NCT02339779|lipofilling|lipofilling
301154|NCT02339779|liposculpturing|liposculpturing
301155|NCT02339779|lipoinjection|lipoinjection
301156|NCT02339779|lipotransfer|lipotransfer
301157|NCT02339779|breast reconstruction|breast reconstruction
301158|NCT02339779|external pre-expansion|external pre-expansion
301159|NCT02339779|BRAVA|brava
301160|NCT02339779|EVE|eve
301161|NCT02339766|Cesarean|cesarean
301162|NCT02339766|Quadratus Lumborum Block|quadratus lumborum block
301163|NCT02339766|Analgesia|analgesia
301164|NCT02339766|Ultrasonography|ultrasonography
301165|NCT02339727|Omega-3|omega-3
301166|NCT02339727|Omega-6|omega-6
301167|NCT02339714|allergic rhinitis|allergic rhinitis
301168|NCT02339714|acupuncture|acupuncture
301169|NCT02339714|moxibustion|moxibustion
301170|NCT02339714|efficacy|efficacy
301171|NCT02339714|safety|safety
301172|NCT02339649|sepsis|sepsis
301173|NCT02339649|septic shock|septic shock
301174|NCT02339649|ICU|icu
301175|NCT02339649|long-term outcome|long-term outcome
301176|NCT02339649|neurocognitive|neurocognitive
301177|NCT02339649|inflammatory|inflammatory
301178|NCT02339649|MRI|mri
301179|NCT02339649|EEG|eeg
301180|NCT02339649|brain imaging|brain imaging
301181|NCT02339649|serum biomarkers|serum biomarkers
301182|NCT02339649|CSF|csf
301183|NCT02339636|subclinical, enthesitis, synovitis|subclinical, enthesitis, synovitis
301184|NCT02339623|Threatened preterm birth - fetal adrenal gland volume|threatened preterm birth - fetal adrenal gland volume
301185|NCT02339610|Osteoarthritis|osteoarthritis
301186|NCT02339610|Post-traumatic Arthritis|post-traumatic arthritis
301187|NCT02339584|OAG|oag
301188|NCT02339584|OHT|oht
301189|NCT02339532|HER2-positive|her2-positive
301190|NCT02339532|non-metastatic|non-metastatic
301191|NCT02339532|TOP2A|top2a
301192|NCT02339519|Laryngeal Masks|laryngeal masks
301193|NCT02339506|stress|stress
301194|NCT02339506|ACTH|acth
301195|NCT02339506|cosyntropin|cosyntropin
301196|NCT02339506|baroreflex sensitivity|baroreflex sensitivity
301197|NCT02339506|cardiovagal|cardiovagal
301198|NCT02339480|Massage therapy|massage therapy
301199|NCT02339480|Simple obesity|simple obesity
301200|NCT02339480|Energy metabolism|energy metabolism
301201|NCT02339480|Mechanism|mechanism
301202|NCT02339467|decreased outdoor walking ability|decreased outdoor walking ability
301203|NCT02339467|Older adult|older adult
301204|NCT02339454|Cardiac Shock wave therapy|cardiac shock wave therapy
301205|NCT02339454|stable angina|stable angina
301206|NCT02339454|exercise tolerance|exercise tolerance
301207|NCT02339441|Systemic sclerosis|systemic sclerosis
301208|NCT02339428|Colonoscopy|colonoscopy
301209|NCT02339428|diagnostic|diagnostic
301210|NCT02339428|diclophenac|diclophenac
301211|NCT02339428|randomized controlled trial|randomized controlled trial
301212|NCT02339402|Cystic fibrosis, Myotonic dystrophy, Noonan, Huntingtons|cystic fibrosis, myotonic dystrophy, noonan, huntingtons
301213|NCT02339363|mindfulness|mindfulness
301214|NCT02339363|adolescents|adolescents
301215|NCT02339363|working memory|working memory
301216|NCT02339363|stress|stress
301217|NCT02339363|anxiety|anxiety
301218|NCT02339311|The study focus is on lifestyle changes and patient activation in diabetic patients by regular monthly visit by the CHRs|the study focus is on lifestyle changes and patient activation in diabetic patients by regular monthly visit by the chrs
301219|NCT02339298|Music Therapy|music therapy
301220|NCT02339285|tACS|tacs
301221|NCT02339285|Major Depressive Disorder|major depressive disorder
301222|NCT02339285|MDD|mdd
301223|NCT02339285|mood symptoms|mood symptoms
301224|NCT02339285|sham|sham
301225|NCT02339272|meiosis|meiosis
301226|NCT02339272|synapsis|synapsis
301227|NCT02339272|recombination|recombination
301228|NCT02339272|sperm aneuploidy|sperm aneuploidy
301229|NCT02339259|Rickettsial disease|rickettsial disease
301230|NCT02339259|Febrile|febrile
301231|NCT02339259|Murine typhus|murine typhus
301232|NCT02339259|Scrub typhus|scrub typhus
301233|NCT02339259|Diagnostic test|diagnostic test
301234|NCT02339259|Clinical features|clinical features
301235|NCT02339233|Epidural Stimulation|epidural stimulation
301236|NCT02339220|Constraint-Induced Movement Therapy|constraint-induced movement therapy
301237|NCT02339220|Physical Therapy|physical therapy
301238|NCT02339220|Rehabilitation|rehabilitation
301239|NCT02339220|Occupational Therapy|occupational therapy
301240|NCT02339220|Fitness Training|fitness training
301241|NCT02339220|Recovery of Function|recovery of function
301242|NCT02339220|Neuroplasticity|neuroplasticity
301243|NCT02339220|Exercise Therapy|exercise therapy
301244|NCT02339220|Brain Injuries|brain injuries
301245|NCT02339220|Traumatic Brain Injury|traumatic brain injury
301246|NCT02339220|Physical Therapy Modalities|physical therapy modalities
301247|NCT02339220|Neuroimaging|neuroimaging
301248|NCT02339194|complete denture|complete denture
301249|NCT02339194|quality of life|quality of life
301250|NCT02339194|patient satisfaction|patient satisfaction
301251|NCT02339155|Anthrax Vaccine Adsorbed|anthrax vaccine adsorbed
301252|NCT02339155|Raxibacumab|raxibacumab
301253|NCT02339155|Immunogenicity|immunogenicity
301254|NCT02339103|arteriovenous anastomoses|arteriovenous anastomoses
301255|NCT02339103|accidental hypothermia|accidental hypothermia
301256|NCT02339103|rewarming|rewarming
301257|NCT02339090|VRS-317|vrs-317
301258|NCT02339090|Growth Hormone Deficiency|growth hormone deficiency
301259|NCT02339090|Long Acting Recombinant Growth Hormone|long acting recombinant growth hormone
301260|NCT02339090|Long Acting Growth Hormone|long acting growth hormone
301261|NCT02339090|Pediatric Growth Hormone Deficiency|pediatric growth hormone deficiency
301262|NCT02339090|Growth Hormone Replacement Therapy|growth hormone replacement therapy
301263|NCT02339090|Versartis|versartis
301264|NCT02339090|Xten|xten
301265|NCT02339090|Human Growth Hormone|human growth hormone
301266|NCT02339090|somavaratan|somavaratan
301267|NCT02339090|growth failure|growth failure
301268|NCT02339077|Group B Streptococcus, stillborn|group b streptococcus, stillborn
301269|NCT02339064|Parkinson's disease,|parkinson's disease,
301270|NCT02339064|apomorphine|apomorphine
301271|NCT02339064|Apokyn|apokyn
301272|NCT02339064|dopamine agonist|dopamine agonist
301273|NCT02339064|levodopa|levodopa
301274|NCT02339064|advanced|advanced
301275|NCT02339064|PD|pd
301276|NCT02339064|carbidopa|carbidopa
301277|NCT02339064|pramipexole|pramipexole
301278|NCT02339064|ropinirole|ropinirole
301279|NCT02339064|rotigotine|rotigotine
301280|NCT02339064|MAO-B inhibitors|mao-b inhibitors
301281|NCT02339064|COMT inhibitors|comt inhibitors
301282|NCT02339064|off|off
301283|NCT02339064|dyskinesia|dyskinesia
301284|NCT02339051|Basic Science|basic science
301285|NCT02339038|Community Based Research|community based research
301286|NCT02339038|Hepatitis C Virus and Human Immunodeficiency Virus|hepatitis c virus and human immunodeficiency virus
301287|NCT02339038|Ledipasvir/Sofosbuvir|ledipasvir/sofosbuvir
301288|NCT02339038|Fixed Dose Combination|fixed dose combination
301289|NCT02339038|Sustained Viral Response|sustained viral response
301290|NCT02339025|Cohort|cohort
301291|NCT02339025|Participation|participation
301292|NCT02339025|Biobank|biobank
301293|NCT02339012|Genome Wide Association|genome wide association
301294|NCT02339012|Biomarkers|biomarkers
301295|NCT02339012|Methylation|methylation
301296|NCT02339012|Phenotype|phenotype
301297|NCT02339012|Cytometry|cytometry
301298|NCT02338999|Autoimmunity Pathogenesis|autoimmunity pathogenesis
301299|NCT02338999|Arteriosclerosis|arteriosclerosis
301300|NCT02338999|Adult|adult
301301|NCT02338986|High Titer Antibodies|high titer antibodies
301302|NCT02338986|Convalescent Volunteers|convalescent volunteers
301303|NCT02338986|Apheresis|apheresis
301304|NCT02338986|Males|males
301305|NCT02338986|Quantitative IgG|quantitative igg
301306|NCT02338973|Macular Edema|macular edema
301307|NCT02338973|Rod-Cone Dystrophy|rod-cone dystrophy
301308|NCT02338973|Inherited Retinal Degeneration|inherited retinal degeneration
301309|NCT02338973|Enhanced S-Cone Syndrome|enhanced s-cone syndrome
301310|NCT02338973|Interferon Gamma|interferon gamma
301311|NCT02338960|HSDD Female|hsdd female
301312|NCT02338960|Sexual Desire Disorder|sexual desire disorder
301313|NCT02338960|decreased desire|decreased desire
301314|NCT02338960|female sexual dysfunction|female sexual dysfunction
301315|NCT02338947|Frail elderly|frail elderly
301316|NCT02338947|Coronary artery bypass surgery|coronary artery bypass surgery
301317|NCT02338947|Off-pump|off-pump
301318|NCT02338947|On-pump|on-pump
301319|NCT02338947|Randomized controlled trial|randomized controlled trial
301320|NCT02338921|triple combination therapy|triple combination therapy
301321|NCT02338921|sitagliptin|sitagliptin
301322|NCT02338921|dapagliflozin|dapagliflozin
301323|NCT02338921|lobeglitazone|lobeglitazone
301324|NCT02338908|dry needling|dry needling
301325|NCT02338908|trigger point|trigger point
301326|NCT02338908|eccentric exercise|eccentric exercise
301327|NCT02338895|acute kidney injury, oliguria,renal ultrasound|acute kidney injury, oliguria,renal ultrasound
301328|NCT02338882|Lenses|lenses
301329|NCT02338882|Intraocular|intraocular
301330|NCT02338856|Obesity|obesity
301331|NCT02338830|Twins|twins
301332|NCT02338830|Preterm labor|preterm labor
301333|NCT02338830|Progesterone|progesterone
301334|NCT02338830|Short cervix|short cervix
301335|NCT02338804|mix vaccine, breast neoplasms, immunotherapy|mix vaccine, breast neoplasms, immunotherapy
301336|NCT02338778|mix vaccine, liver neoplasms, immunotherapy|mix vaccine, liver neoplasms, immunotherapy
301337|NCT02338752|mix vaccine, pancreatic neoplasms, immunotherapy|mix vaccine, pancreatic neoplasms, immunotherapy
301338|NCT02338739|Retention|retention
301339|NCT02338739|Lost to follow up|lost to follow up
301340|NCT02338739|Adaptive strategies|adaptive strategies
301341|NCT02338739|Dynamic regime|dynamic regime
301342|NCT02338739|Sequentially randomized trial|sequentially randomized trial
301343|NCT02338739|Sequential multiple assignment randomized trial|sequential multiple assignment randomized trial
301344|NCT02338739|Engagement in care|engagement in care
301345|NCT02338739|Kenya|kenya
301346|NCT02338726|urinary incontinence|urinary incontinence
301347|NCT02338726|pelvic floor|pelvic floor
301348|NCT02338726|quality of life|quality of life
301349|NCT02338726|elderly women|elderly women
301350|NCT02338713|Drug therapy|drug therapy
301351|NCT02338700|mix vaccine, prostate carcinoma, immunotherapy|mix vaccine, prostate carcinoma, immunotherapy
301352|NCT02338687|Calcium|calcium
301353|NCT02338687|Dietary supplements|dietary supplements
301354|NCT02338687|Hypertension, Pregnancy-Induced|hypertension, pregnancy-induced
301355|NCT02338687|Pre-Eclampsia|pre-eclampsia
301356|NCT02338687|Nutritional education|nutritional education
301357|NCT02338687|Diet therapy|diet therapy
301358|NCT02338687|Diet records|diet records
301359|NCT02338687|Hospitalization|hospitalization
301360|NCT02338687|Maternal mortality|maternal mortality
301361|NCT02338635|ER stress|er stress
301362|NCT02338635|Peritoneal Dialysis|peritoneal dialysis
301363|NCT02338622|olaparib|olaparib
301364|NCT02338622|AZD5363|azd5363
301365|NCT02338622|intrapatient dose escalation|intrapatient dose escalation
301366|NCT02338622|advanced solid tumours|advanced solid tumours
301367|NCT02338609|TSC-associated SEGA,|tsc-associated sega,
301368|NCT02338609|height,|height,
301369|NCT02338609|weight,|weight,
384937|NCT01938274|Hip|hip
301370|NCT02338609|Tanner Stage,|tanner stage,
301371|NCT02338609|growth development,|growth development,
301372|NCT02338609|everolimus,|everolimus,
301373|NCT02338609|RAD001|rad001
301374|NCT02338557|MRP, MIRROR THERAPY, STROKE|mrp, mirror therapy, stroke
301375|NCT02338518|gastric cancer|gastric cancer
301376|NCT02338518|neoadjuvant chemotherapy|neoadjuvant chemotherapy
301377|NCT02338518|efficacy|efficacy
301378|NCT02338518|safety|safety
301379|NCT02338505|Robotic Surgery|robotic surgery
301380|NCT02338505|Telelap-ALFX|telelap-alfx
301381|NCT02338505|Gynecological disease|gynecological disease
301382|NCT02338453|Social Anxiety|social anxiety
301383|NCT02338453|Attention Modification|attention modification
301384|NCT02338453|Dot-Probe|dot-probe
301385|NCT02338453|GCBT|gcbt
301386|NCT02338362|Corticosteroids|corticosteroids
301387|NCT02338362|Bronchodilator Agents|bronchodilator agents
301388|NCT02338362|Intraocular Pressure|intraocular pressure
301389|NCT02338323|Hyperuricemia|hyperuricemia
301390|NCT02338323|Renal Function|renal function
301391|NCT02338323|Chronic kidney disease|chronic kidney disease
301392|NCT02338323|Febuxostat|febuxostat
301393|NCT02338323|Benzbromarone|benzbromarone
301394|NCT02338297|Hepatocellular Carcinoma|hepatocellular carcinoma
301395|NCT02338297|Arterioportal shunts|arterioportal shunts
301396|NCT02338297|Transarterial Chemoembolization|transarterial chemoembolization
301397|NCT02338297|Ethanol|ethanol
301398|NCT02338297|Gelfoam|gelfoam
301399|NCT02338297|Polyvinyl Alcohol Foam Embolization Particles (PVA)|polyvinyl alcohol foam embolization particles (pva)
301400|NCT02338284|increased intracranial pressure|increased intracranial pressure
301401|NCT02338284|optic nerve sheath diameter|optic nerve sheath diameter
301402|NCT02338271|Low back pain|low back pain
301403|NCT02338271|Mesenchymal stromal stem cell|mesenchymal stromal stem cell
301404|NCT02338271|Hyaluronic acid|hyaluronic acid
301405|NCT02338219|postpartum pelvic floor|postpartum pelvic floor
301406|NCT02338206|infertility|infertility
301407|NCT02338193|GDM|gdm
301408|NCT02338193|T2DM|t2dm
301409|NCT02338193|prediabetes|prediabetes
301410|NCT02338180|dental caries|dental caries
301411|NCT02338180|risk assessment|risk assessment
301412|NCT02338180|approximal sealant|approximal sealant
301413|NCT02338180|permanent molar|permanent molar
301414|NCT02338180|preventive dentistry|preventive dentistry
301415|NCT02338180|adolescent|adolescent
301416|NCT02338154|Aortic Valve Replacement|aortic valve replacement
301417|NCT02338154|Aortic Stenosis|aortic stenosis
301418|NCT02338154|EDWARDS INTUITY|edwards intuity
301419|NCT02338141|cervical cancer|cervical cancer
301420|NCT02338141|colposcopy|colposcopy
301421|NCT02338141|human papillomavirus|human papillomavirus
301422|NCT02338141|human immunodeficiency virus|human immunodeficiency virus
301423|NCT02338128|peritoneal dialysis|peritoneal dialysis
301424|NCT02338128|hyperuricemia|hyperuricemia
301425|NCT02338128|cardiovascular|cardiovascular
301426|NCT02338128|Febuxostat|febuxostat
301427|NCT02338089|Uterine contraction|uterine contraction
301428|NCT02338089|Oxytocin desensitization|oxytocin desensitization
301429|NCT02338063|Adolescent Risk Behavior|adolescent risk behavior
301430|NCT02338063|Emotion Regulation|emotion regulation
301431|NCT02338063|Health Promotion|health promotion
301432|NCT02338063|Intervention|intervention
301433|NCT02338063|Mental Health|mental health
301434|NCT02338050|ALL|all
301435|NCT02338050|Moxetumomab Pasudotox|moxetumomab pasudotox
301436|NCT02338050|Moxe|moxe
301437|NCT02338050|CAT-8015, HA22|cat-8015, ha22
301438|NCT02338024|Enrollment in HIV care|enrollment in hiv care
301439|NCT02338024|Recently detected HIV-positive|recently detected hiv-positive
301440|NCT02338024|specialized health care clinics|specialized health care clinics
301441|NCT02338024|Ukraine|ukraine
301442|NCT02337998|Neurology|neurology
301443|NCT02337998|Sports Medicine|sports medicine
301444|NCT02337972|diabetic macular edema|diabetic macular edema
301445|NCT02337972|Intravitreal injection|intravitreal injection
301446|NCT02337972|conjunctival flora|conjunctival flora
301447|NCT02337959|Healthy Volunteers|healthy volunteers
301448|NCT02337946|Metastatic colorectal cancer, Panitumumab, mFOLFOX6, First-line|metastatic colorectal cancer, panitumumab, mfolfox6, first-line
301449|NCT02337933|Metabolic Syndrome|metabolic syndrome
301450|NCT02337933|Central Obesity|central obesity
301451|NCT02337933|Insulin Sensitivity|insulin sensitivity
301452|NCT02337933|Ursolic Acid|ursolic acid
301453|NCT02337933|Triterpenoid|triterpenoid
301454|NCT02337894|Protein kinetics|protein kinetics
301455|NCT02337894|liver steatosis|liver steatosis
301456|NCT02337868|dose-ranging|dose-ranging
301457|NCT02337868|double blind|double blind
301458|NCT02337868|female|female
301459|NCT02337868|healthy|healthy
301460|NCT02337868|HydroVax|hydrovax
301461|NCT02337868|male|male
301462|NCT02337868|Placebo-Controlled|placebo-controlled
301463|NCT02337868|Vaccine|vaccine
301464|NCT02337868|West Nile Virus|west nile virus
301465|NCT02337855|Intestinal|intestinal
301466|NCT02337855|Pichia pastoris|pichia pastoris
301467|NCT02337855|S. mansoni|s. mansoni
301468|NCT02337855|Schistosomiasis|schistosomiasis
301469|NCT02337855|Sm-TSP-2/Alhydrogel|sm-tsp-2/alhydrogel
301470|NCT02337855|Sm-TSP-2/Alhydrogel/GLA-AF|sm-tsp-2/alhydrogel/gla-af
301471|NCT02337855|vaccine|vaccine
301472|NCT02337842|NoV, CIN-1, GII4. Norovirus, challenge, FUT-2 gene, HBGA-blocking Ab|nov, cin-1, gii4. norovirus, challenge, fut-2 gene, hbga-blocking ab
301473|NCT02337829|Relapsed/refractory CLL|relapsed/refractory cll
301474|NCT02337829|SLL|sll
301475|NCT02337829|Btk|btk
301476|NCT02337829|Chronic Lymphocytic Leukemia|chronic lymphocytic leukemia
301477|NCT02337829|Small Lymphocytic Lymphoma|small lymphocytic lymphoma
301478|NCT02337829|Leukemia|leukemia
301479|NCT02337829|Lymphoma|lymphoma
301480|NCT02337829|Lymphocytic|lymphocytic
301481|NCT02337829|ACP-196|acp-196
301482|NCT02337829|acalabrutinib|acalabrutinib
301483|NCT02337829|Treatment naive CLL with 17p deletion, TP53 mutation or NOTCH1 mutation|treatment naive cll with 17p deletion, tp53 mutation or notch1 mutation
301484|NCT02337829|17p deletion|17p deletion
301485|NCT02337829|TP53 mutation|tp53 mutation
301486|NCT02337829|NOTCH1 mutation|notch1 mutation
301487|NCT02337816|Endometriosis|endometriosis
301488|NCT02337816|Metabolomics|metabolomics
301489|NCT02337803|Physical Activity|physical activity
301490|NCT02337790|Hypertension|hypertension
301491|NCT02337790|Heart Failure|heart failure
301492|NCT02337790|Fluids|fluids
301493|NCT02337777|Magnetic Resonance Imaging|magnetic resonance imaging
301494|NCT02337777|Magnetic Resonance Angiography|magnetic resonance angiography
301495|NCT02337777|Diffusion Tensor Imaging|diffusion tensor imaging
301496|NCT02337777|IDEAL|ideal
301497|NCT02337777|T2* mapping|t2* mapping
301498|NCT02337777|Magnetic ResonanceCine|magnetic resonancecine
301499|NCT02337777|BOLD|bold
301500|NCT02337777|phase contrast|phase contrast
301501|NCT02337777|diffusion-weighted imaging|diffusion-weighted imaging
301502|NCT02337777|Functional Magnetic Resonance Imaging|functional magnetic resonance imaging
301503|NCT02337712|Small cell lung cancer|small cell lung cancer
301504|NCT02337712|Radiotherapy|radiotherapy
301505|NCT02337712|Dose fractionation|dose fractionation
301506|NCT02337673|Postoperative Pulmonary Complication|postoperative pulmonary complication
301507|NCT02337673|Electrical Impedance Tomography|electrical impedance tomography
301508|NCT02337673|Splenectomy|splenectomy
301509|NCT02337673|Gastric surgery|gastric surgery
301510|NCT02337673|Gastrectomy|gastrectomy
301511|NCT02337673|Pancreatic surgery|pancreatic surgery
301512|NCT02337673|Pancreatectomy|pancreatectomy
301513|NCT02337673|Liver surgery|liver surgery
301514|NCT02337673|Hemihepatectomy|hemihepatectomy
301515|NCT02337673|Cholecystectomy|cholecystectomy
301516|NCT02337673|Acute Respiratory Distress Syndrome|acute respiratory distress syndrome
301517|NCT02337673|Hypoxemia|hypoxemia
301518|NCT02337673|Atelectasis|atelectasis
301519|NCT02337673|Pulmonary obstruction|pulmonary obstruction
301520|NCT02337673|Pneumonia|pneumonia
301521|NCT02337673|Pneumothorax|pneumothorax
301522|NCT02337673|Pleural effusion|pleural effusion
301523|NCT02337673|Pulmonary edema|pulmonary edema
301524|NCT02337621|sunken chest|sunken chest
301525|NCT02337621|caved-in chest|caved-in chest
301526|NCT02337621|chest deformity|chest deformity
301527|NCT02337621|sunken sternum|sunken sternum
301528|NCT02337608|moderate to severe ulcerative colitis|moderate to severe ulcerative colitis
301529|NCT02337608|GLPG1205|glpg1205
301530|NCT02337595|CD45RA-depletion|cd45ra-depletion
301531|NCT02337595|TCR-alpha/beta depletion|tcr-alpha/beta depletion
301532|NCT02337595|Hematopoietic Stem Cell Transplantation|hematopoietic stem cell transplantation
301533|NCT02337595|immune reconstitution|immune reconstitution
301534|NCT02337595|Graft Enhancement, Immunologic|graft enhancement, immunologic
301535|NCT02337595|Immunocompromized Host|immunocompromized host
301536|NCT02337491|Recurrent|recurrent
301537|NCT02337452|Hereditary cancer-causing mutation|hereditary cancer-causing mutation
301538|NCT02337452|Gene mutation|gene mutation
301539|NCT02337452|Family member with genetic mutation|family member with genetic mutation
301540|NCT02337452|Questionnaire|questionnaire
301541|NCT02337452|Surveys|surveys
301542|NCT02337452|Registry|registry
301543|NCT02337452|Database|database
301544|NCT02337452|Communication|communication
301545|NCT02337413|Constipation|constipation
301546|NCT02337374|Urodynamics|urodynamics
301547|NCT02337374|Midurethral sling|midurethral sling
301548|NCT02337374|Transobturator tape (TOT)|transobturator tape (tot)
301549|NCT02337374|Tension free vaginal tape (TVT)|tension free vaginal tape (tvt)
301550|NCT02337361|risky alcohol use|risky alcohol use
301551|NCT02337361|pregnancy|pregnancy
301552|NCT02337348|coronary stents|coronary stents
301553|NCT02337335|Hemodialyisis|hemodialyisis
301554|NCT02337335|Predictive Model|predictive model
301555|NCT02337335|ESAs|esas
301556|NCT02337335|patients|patients
301557|NCT02337322|Acquired Immune Deficiency Syndrome Virus|acquired immune deficiency syndrome virus
301558|NCT02337322|HIV|hiv
301559|NCT02337322|HIV-1|hiv-1
301560|NCT02337322|Antiretroviral treatment|antiretroviral treatment
301561|NCT02337322|HIV Advanced Disease|hiv advanced disease
301562|NCT02337322|AIDS|aids
301563|NCT02337322|Dolutegravir|dolutegravir
301564|NCT02337322|Darunavir|darunavir
301565|NCT02337296|Motivational Interviewing|motivational interviewing
301566|NCT02337296|Cognitive Behavioral Therapy|cognitive behavioral therapy
301567|NCT02337296|Cancer|cancer
301568|NCT02337296|Oral Agents|oral agents
301569|NCT02337296|Adherence|adherence
301570|NCT02337270|Tuberculosis|tuberculosis
301571|NCT02337270|Vaccine|vaccine
301572|NCT02337270|Aerosol|aerosol
301573|NCT02337270|Adenovirus|adenovirus
301574|NCT02337270|Immunogenicity|immunogenicity
301575|NCT02337244|Osteoarthritis|osteoarthritis
301576|NCT02337244|Rheumatoid arthritis|rheumatoid arthritis
301577|NCT02337244|Traumatic arthritis|traumatic arthritis
301578|NCT02337244|Polyarthritis|polyarthritis
301579|NCT02337244|Total knee arthroplasty|total knee arthroplasty
301580|NCT02337192|Orthodontic, Photochemoterapy|orthodontic, photochemoterapy
301581|NCT02337166|alveolar bone loss|alveolar bone loss
301582|NCT02337166|periodontal attachment loss|periodontal attachment loss
301583|NCT02337153|Orthodontique Bone Stretching|orthodontique bone stretching
301584|NCT02337140|TAVI|tavi
301585|NCT02337140|complete AV-block|complete av-block
301586|NCT02337140|HV-interval|hv-interval
301587|NCT02337140|permanent pacemaker|permanent pacemaker
301588|NCT02337140|valve implantation|valve implantation
301589|NCT02337140|severe|severe
301590|NCT02337140|conduction|conduction
301591|NCT02337140|disorders|disorders
301592|NCT02337114|Acceptance and Commitment Therapy|acceptance and commitment therapy
301593|NCT02337101|Brain concussion|brain concussion
301594|NCT02337101|Mild Traumatic Brain Injury|mild traumatic brain injury
301595|NCT02337101|Post-concussion symptoms|post-concussion symptoms
301596|NCT02337101|Therapy|therapy
301597|NCT02337101|Randomised controlled trial|randomised controlled trial
301598|NCT02337101|Cognitive assessment|cognitive assessment
301599|NCT02337088|delayed cord clamping|delayed cord clamping
301600|NCT02337075|condition|condition
301601|NCT02337075|preventing|preventing
301602|NCT02337075|physical activity|physical activity
301603|NCT02337049|Preeclampsia. Cardiovascular Disease (CVD) Risk.|preeclampsia. cardiovascular disease (cvd) risk.
301604|NCT02337036|Liver transplantation|liver transplantation
301605|NCT02337036|Child|child
301606|NCT02337036|Tacrolimus|tacrolimus
301607|NCT02337036|Pharmacokinetic|pharmacokinetic
301608|NCT02337023|Brain scintigraphy|brain scintigraphy
301609|NCT02336997|skin regeneration|skin regeneration
301610|NCT02336997|mechanical stretch|mechanical stretch
301611|NCT02336984|Ductal carcinoma in situ (DCIS)|ductal carcinoma in situ (dcis)
301612|NCT02336958|cervical plexus|cervical plexus
301613|NCT02336958|regional anesthesia|regional anesthesia
301614|NCT02336958|ultrasound|ultrasound
301615|NCT02336958|carotid surgery|carotid surgery
301616|NCT02336932|vitamin d|vitamin d
301617|NCT02336932|free hormone|free hormone
301618|NCT02336932|surgical stress|surgical stress
301619|NCT02336919|discharge|discharge
301620|NCT02336919|mHealth|mhealth
301621|NCT02336919|telehealth|telehealth
301622|NCT02336919|text messaging|text messaging
301623|NCT02336906|Lower urinary tract dysfunction|lower urinary tract dysfunction
301624|NCT02336906|constipation|constipation
301625|NCT02336893|Communication Barriers|communication barriers
301626|NCT02336893|Total Communication Methods|total communication methods
301627|NCT02336893|Quality Improvement|quality improvement
301628|NCT02336893|Quality of Health Care|quality of health care
301629|NCT02336893|Critical Care|critical care
301630|NCT02336867|Complex anal fistula, clip,|complex anal fistula, clip,
301631|NCT02336854|pharmacokinetics|pharmacokinetics
301632|NCT02336841|Guided Self-Help|guided self-help
301633|NCT02336841|Peer Mentoring|peer mentoring
301634|NCT02336841|Anorexia Nervosa|anorexia nervosa
301635|NCT02336841|Eating Disorders|eating disorders
301636|NCT02336828|MEWS|mews
301637|NCT02336828|deteriorate|deteriorate
301638|NCT02336828|oncology|oncology
301639|NCT02336828|ICU|icu
301640|NCT02336828|predicting outcomes|predicting outcomes
301641|NCT02336828|MEWS in predicting outcomes in oncology patients|mews in predicting outcomes in oncology patients
301642|NCT02336815|Multiple myeloma|multiple myeloma
301643|NCT02336815|Karyopharm|karyopharm
301644|NCT02336815|KPT-330|kpt-330
301645|NCT02336815|Selinexor|selinexor
301646|NCT02336815|Refractory|refractory
301647|NCT02336815|Bortezomib|bortezomib
301648|NCT02336815|Carfilzomib|carfilzomib
301649|NCT02336815|Lenalidomide|lenalidomide
301650|NCT02336815|Pomalidomide|pomalidomide
301651|NCT02336815|Dexamethasone|dexamethasone
301652|NCT02336815|STORM|storm
301653|NCT02336815|Daratumumab|daratumumab
301654|NCT02336802|Anxiety|anxiety
301656|NCT02336802|Avoidance|avoidance
301657|NCT02336776|Chronic Kidney Disease|chronic kidney disease
301658|NCT02336776|Electrical Stimulation|electrical stimulation
301659|NCT02336737|breast cancer|breast cancer
301660|NCT02336737|sentinel lymph node biopsy|sentinel lymph node biopsy
301661|NCT02336724|gastrointestinal stromal tumor|gastrointestinal stromal tumor
301662|NCT02336724|famitinib|famitinib
301663|NCT02336698|Osteoarthritis|osteoarthritis
301664|NCT02336698|Pain|pain
301665|NCT02336698|Fulranumab|fulranumab
301666|NCT02336698|JNJ-42160443|jnj-42160443
301667|NCT02336698|Monotherapy|monotherapy
301668|NCT02336698|Hip|hip
301669|NCT02336698|Knee|knee
301670|NCT02336698|Joint replacement surgery|joint replacement surgery
301671|NCT02336685|Osteoarthritis|osteoarthritis
301672|NCT02336685|Pain|pain
301673|NCT02336685|Fulranumab|fulranumab
301674|NCT02336685|JNJ-42160443|jnj-42160443
301675|NCT02336685|Adjunctive therapy|adjunctive therapy
301676|NCT02336685|Opioid|opioid
301677|NCT02336685|Hip|hip
301678|NCT02336685|Knee|knee
301679|NCT02336685|Joint replacement surgery|joint replacement surgery
301680|NCT02336672|Pancreatic adenocarcinoma|pancreatic adenocarcinoma
301681|NCT02336672|Cryothermoablation|cryothermoablation
301682|NCT02336633|Huntington disease|huntington disease
301683|NCT02336633|Neurodegenerative disease|neurodegenerative disease
301684|NCT02336633|Volumetric MRI|volumetric mri
301685|NCT02336633|31P MR spectroscopy|31p mr spectroscopy
301686|NCT02336633|metabolism|metabolism
301687|NCT02336633|Caudate atrophy|caudate atrophy
301688|NCT02336620|Severe sepsis, Balanced Salt Solution, Normal Saline|severe sepsis, balanced salt solution, normal saline
301689|NCT02336581|Acceptance and Commitment Therapy|acceptance and commitment therapy
301690|NCT02336581|Mindfulness|mindfulness
301691|NCT02336581|Inpatients|inpatients
301692|NCT02336581|Psychiatric Hospitalization|psychiatric hospitalization
301693|NCT02336568|PTSD, Oxytocin|ptsd, oxytocin
301694|NCT02336542|diagnosis of Tuberculosis|diagnosis of tuberculosis
301695|NCT02336542|ESAT6|esat6
301696|NCT02336542|CFP10|cfp10
301697|NCT02336542|skin test|skin test
301698|NCT02336542|diagnostic test|diagnostic test
301699|NCT02336529|postoperative|postoperative
301700|NCT02336477|non-dystrophic myotonias|non-dystrophic myotonias
301701|NCT02336477|paramyotonia congenita|paramyotonia congenita
301702|NCT02336477|myotonia congenita|myotonia congenita
301703|NCT02336477|Mexiletine|mexiletine
301704|NCT02336477|Randomized clinical trial|randomized clinical trial
301705|NCT02336451|ALK-positive|alk-positive
301706|NCT02336451|NSCLC|nsclc
301707|NCT02336451|brain metastasis|brain metastasis
301708|NCT02336451|metastatic to the brain and/or to leptomeninges.|metastatic to the brain and/or to leptomeninges.
301709|NCT02336425|Asthma|asthma
301710|NCT02336412|Medication adherence|medication adherence
301711|NCT02336399|HBsAg loss, interferon, HBV reaction|hbsag loss, interferon, hbv reaction
301712|NCT02336386|Bortezomib|bortezomib
301713|NCT02336373|Hemoglobin SC disease|hemoglobin sc disease
301714|NCT02336373|hydroxyurea|hydroxyurea
301715|NCT02336373|quality of life|quality of life
301716|NCT02336373|viscosity|viscosity
301717|NCT02336373|red cell density|red cell density
301718|NCT02336347|Pharmacokinetics|pharmacokinetics
301719|NCT02336347|Healthy Volunteers|healthy volunteers
301720|NCT02336347|deuterated dextromethorphan|deuterated dextromethorphan
301721|NCT02336347|deuterated dextromethorphan with quinidine|deuterated dextromethorphan with quinidine
301722|NCT02336282|Adult survivor of acute lymphoblastic leukemia|adult survivor of acute lymphoblastic leukemia
301723|NCT02336282|Executive dysfunction|executive dysfunction
301724|NCT02336282|Transcranial direct current stimulation|transcranial direct current stimulation
301725|NCT02336282|Cancer prevention and control|cancer prevention and control
301726|NCT02336269|Pharmacogenomics|pharmacogenomics
301727|NCT02336256|inguinal hernia repair|inguinal hernia repair
301728|NCT02336256|totally extraperitoneal (TEP)|totally extraperitoneal (tep)
301729|NCT02336256|single incision laparoscopic surgery (SILS)|single incision laparoscopic surgery (sils)
301860|NCT02335307|CYP2D6|cyp2d6
301730|NCT02336256|plasma total antioxidant status|plasma total antioxidant status
301731|NCT02336243|docosahexaenoic acid|docosahexaenoic acid
301732|NCT02336243|premature birth|premature birth
301733|NCT02336243|placentation disorders|placentation disorders
301734|NCT02336243|preeclampsia|preeclampsia
301735|NCT02336243|fetal growth|fetal growth
301736|NCT02336230|GVHD|gvhd
301737|NCT02336191|living donor liver transplantation|living donor liver transplantation
301738|NCT02336191|graft function|graft function
301739|NCT02336191|thromboelastometry|thromboelastometry
301740|NCT02336165|Glioblastoma|glioblastoma
301741|NCT02336165|Immunotherapy|immunotherapy
301742|NCT02336165|T Cell|t cell
301743|NCT02336165|PD-L1|pd-l1
301744|NCT02336165|MEDI4736|medi4736
301745|NCT02336165|Radiation|radiation
301746|NCT02336165|Radiotherapy|radiotherapy
301747|NCT02336165|GBM|gbm
301748|NCT02336100|Diagnostic technique and procedure|diagnostic technique and procedure
301749|NCT02336074|HIV|hiv
301750|NCT02336074|Vaccine|vaccine
301751|NCT02336074|Cure|cure
301752|NCT02336074|Early Intervention|early intervention
301753|NCT02336074|Infection|infection
301754|NCT02336074|Primary infection|primary infection
301755|NCT02336074|Reservoir|reservoir
301756|NCT02336074|Vorinostat|vorinostat
301757|NCT02336074|HDAC|hdac
301758|NCT02336022|general anesthesia|general anesthesia
301759|NCT02336009|wrist arthritis|wrist arthritis
760485|NCT00402740|PROTECT|protect
385425|NCT01935661|ERP|erp
301760|NCT02336009|total wrist arthroplasty|total wrist arthroplasty
301761|NCT02335970|Pain|pain
301762|NCT02335970|Range of motion|range of motion
301763|NCT02335970|Quality of life|quality of life
301764|NCT02335944|non small cell lung cancer|non small cell lung cancer
301765|NCT02335944|NSCLC|nsclc
301766|NCT02335944|EGF816|egf816
301767|NCT02335944|INC280|inc280
301768|NCT02335944|tyrosine kinase inhibitor|tyrosine kinase inhibitor
301769|NCT02335944|c-MET|c-met
301770|NCT02335918|Opdivo®|opdivo®
301771|NCT02335866|Platelet rich fibrin|platelet rich fibrin
301772|NCT02335866|Gingival Recession|gingival recession
301773|NCT02335853|urinary bladder|urinary bladder
301774|NCT02335853|nerve growth factor|nerve growth factor
301775|NCT02335853|overactive bladder|overactive bladder
301776|NCT02335827|irreversible electroporation|irreversible electroporation
301777|NCT02335827|renal tumor|renal tumor
301778|NCT02335801|heart failure|heart failure
301779|NCT02335801|growth hormone|growth hormone
301780|NCT02335801|testosterone|testosterone
301781|NCT02335801|insulin resistance|insulin resistance
301782|NCT02335801|thyroid hormones|thyroid hormones
301783|NCT02335801|survival|survival
301784|NCT02335788|Therapeutic|therapeutic
301785|NCT02335788|Embolization|embolization
301786|NCT02335736|infertility|infertility
301787|NCT02335684|Heart-assist devices|heart-assist devices
301788|NCT02335684|exercise capacity|exercise capacity
301789|NCT02335671|Early Stage Breast Cancer|early stage breast cancer
301790|NCT02335671|Breast Conserving Surgery|breast conserving surgery
301791|NCT02335671|Breast Cancer Stage I|breast cancer stage i
301792|NCT02335671|Breast Cancer Stage II|breast cancer stage ii
301793|NCT02335645|ACL reconstruction|acl reconstruction
301794|NCT02335645|Running Mechanics|running mechanics
301795|NCT02335645|Physical Therapy|physical therapy
301796|NCT02335645|Knee|knee
301797|NCT02335645|Video Analysis|video analysis
301798|NCT02335645|Body Weight Supported Treadmill|body weight supported treadmill
301799|NCT02335632|Hepatitis|hepatitis
301800|NCT02335632|Probiotics|probiotics
301801|NCT02335632|Lipopolysaccharides|lipopolysaccharides
301802|NCT02335632|Cytokines|cytokines
301803|NCT02335632|Alcoholics|alcoholics
301804|NCT02335593|Hemodialysis patients|hemodialysis patients
301805|NCT02335593|Zinc|zinc
301806|NCT02335593|Anemia|anemia
301807|NCT02335593|Oxidative stress|oxidative stress
301808|NCT02335580|Prognosis|prognosis
301809|NCT02335554|Subthreshold|subthreshold
301810|NCT02335554|Employees|employees
301811|NCT02335554|Internet|internet
301812|NCT02335554|Mobile|mobile
301813|NCT02335554|cognitive-behavioral|cognitive-behavioral
301814|NCT02335515|Gastroretentive System|gastroretentive system
301815|NCT02335515|Gastric Retention Time (GRT)|gastric retention time (grt)
301816|NCT02335515|capsule|capsule
301817|NCT02335515|Soctec|soctec
301818|NCT02335515|Gastroenterology|gastroenterology
301819|NCT02335476|optical coherence tomography|optical coherence tomography
301820|NCT02335463|optical coherence tomography|optical coherence tomography
301821|NCT02335450|exercise|exercise
301822|NCT02335450|motivational interviewing|motivational interviewing
301823|NCT02335424|P-D1|p-d1
301824|NCT02335424|PD-1|pd-1
301825|NCT02335424|PD1|pd1
301826|NCT02335424|P-DL1|p-dl1
301827|NCT02335424|PD-L1|pd-l1
301828|NCT02335424|PDL-1|pdl-1
301829|NCT02335424|PDL1|pdl1
301830|NCT02335424|Bladder cancer|bladder cancer
301831|NCT02335411|Gastric cancer|gastric cancer
301832|NCT02335411|Gastroesophageal junction cancer|gastroesophageal junction cancer
301833|NCT02335411|PD1|pd1
301834|NCT02335411|PD-1|pd-1
301835|NCT02335411|PDL1|pdl1
301836|NCT02335411|PD-L1|pd-l1
301837|NCT02335398|methadone|methadone
301838|NCT02335398|chronic pain|chronic pain
301839|NCT02335398|noncancer pain|noncancer pain
301840|NCT02335398|cancer pain|cancer pain
301841|NCT02335398|QTc prolongation|qtc prolongation
301842|NCT02335372|Cervical cancer|cervical cancer
301843|NCT02335372|Cervical neoplasia|cervical neoplasia
301844|NCT02335372|Cervical cancer screening|cervical cancer screening
301845|NCT02335372|Colposcopy|colposcopy
301846|NCT02335372|Wide-field white light imaging|wide-field white light imaging
301847|NCT02335372|Wide-field fluorescence imaging|wide-field fluorescence imaging
301848|NCT02335372|Acetic acid|acetic acid
301849|NCT02335372|Proflavine solution|proflavine solution
301850|NCT02335333|Delayed Graft Function|delayed graft function
301851|NCT02335333|Slow Graft Function|slow graft function
301852|NCT02335333|Renal Transplant|renal transplant
301853|NCT02335333|Extended Criteria Donor|extended criteria donor
301854|NCT02335333|Biomarker of Aging|biomarker of aging
301855|NCT02335333|Kidney Transplant|kidney transplant
301856|NCT02335320|VHC|vhc
301857|NCT02335320|IL28-B|il28-b
301858|NCT02335320|point of care|point of care
301859|NCT02335307|Pain|pain
301861|NCT02335294|Pain|pain
301862|NCT02335294|abdominoplasty|abdominoplasty
760486|NCT00402740|XACT|xact
301864|NCT02335281|Standardized Fecal Microbiota Transplantation|standardized fecal microbiota transplantation
301865|NCT02335281|Inflammatory Bowel Disease|inflammatory bowel disease
301866|NCT02335281|Ulcerative Colitis|ulcerative colitis
301867|NCT02335281|Crohn's Disease|crohn's disease
301868|NCT02335268|MDS classified as IPSS low/int-1|mds classified as ipss low/int-1
301869|NCT02335242|Sildenafil|sildenafil
301870|NCT02335242|Magnetic Resonance Imaging|magnetic resonance imaging
301871|NCT02335242|Dermatology|dermatology
301872|NCT02335242|Pediatrics|pediatrics
301873|NCT02335190|Sacroiliac joint|sacroiliac joint
301874|NCT02335190|Radiofrequency ablation|radiofrequency ablation
301875|NCT02335190|Ultrasound|ultrasound
301876|NCT02335177|Falls|falls
301877|NCT02335177|Elderly|elderly
301878|NCT02335177|Physical activities|physical activities
301879|NCT02335177|Technologies for autonomy|technologies for autonomy
301880|NCT02335177|Impact of intervention|impact of intervention
301881|NCT02335177|autonomy|autonomy
301882|NCT02335177|physical activity program|physical activity program
301883|NCT02335151|Circulating Tumor Cells|circulating tumor cells
301884|NCT02335151|Anesthesia and immunity|anesthesia and immunity
301885|NCT02335151|Cell Search System|cell search system
301886|NCT02335138|HIV|hiv
301887|NCT02335138|MSM|msm
301888|NCT02335138|Couples|couples
301889|NCT02335138|Home Testing|home testing
301890|NCT02335138|Sexual Agreements|sexual agreements
301891|NCT02335112|irreversible electroporation|irreversible electroporation
301892|NCT02335112|Unresectable Head and Neck Neoplasms|unresectable head and neck neoplasms
301893|NCT02335099|hemodialysis|hemodialysis
301894|NCT02335099|vascular access|vascular access
301895|NCT02335099|vascular access patency|vascular access patency
301896|NCT02335099|ticagrelor|ticagrelor
301897|NCT02335099|brilinta|brilinta
301898|NCT02335073|Prognosis|prognosis
301899|NCT02335060|cannabis|cannabis
301900|NCT02335060|Marijuana|marijuana
301901|NCT02335060|THC|thc
301902|NCT02335060|N-acetylcysteine|n-acetylcysteine
301903|NCT02335060|Psychotic Disorders|psychotic disorders
301904|NCT02335047|reliability|reliability
301905|NCT02335047|clinical test|clinical test
301906|NCT02335047|physical therapy|physical therapy
301907|NCT02335034|Osteoarthritis|osteoarthritis
301908|NCT02335034|Knee|knee
301909|NCT02335034|Education|education
301910|NCT02335034|Quality of life|quality of life
301911|NCT02335034|Treatment outcome|treatment outcome
301912|NCT02335034|Musculoskeletal pain|musculoskeletal pain
301913|NCT02334995|solitery rectal ulcer|solitery rectal ulcer
301914|NCT02334995|biofeedback|biofeedback
301915|NCT02334995|dissynergy|dissynergy
301916|NCT02334982|Drug therapy|drug therapy
301917|NCT02334969|ischemic stroke；Naoxintong Capsule|ischemic stroke；naoxintong capsule
301918|NCT02334956|MRI|mri
301919|NCT02334956|Executive Deficits|executive deficits
301920|NCT02334943|Immune Activation|immune activation
301921|NCT02334943|HIV-1 infected subjects|hiv-1 infected subjects
301922|NCT02334943|Undetectable viral load|undetectable viral load
301923|NCT02334943|Causes of Immune Activation in HIV-1 infected patients|causes of immune activation in hiv-1 infected patients
301924|NCT02334943|Forms of Immune Activation|forms of immune activation
301925|NCT02334943|Emergent non-AIDS related comorbidities|emergent non-aids related comorbidities
301926|NCT02334930|propranolol|propranolol
301927|NCT02334930|betablocker|betablocker
301928|NCT02334930|angiogenesis|angiogenesis
301929|NCT02334917|Suture Comparison|suture comparison
301930|NCT02334891|congestive heart failure|congestive heart failure
301931|NCT02334891|heart failure, diastolic|heart failure, diastolic
301932|NCT02334891|heart failure, systolic|heart failure, systolic
301933|NCT02334891|elderly frail|elderly frail
301934|NCT02334891|guideline adherence|guideline adherence
301935|NCT02334878|Stem Cells|stem cells
301936|NCT02334878|Mesenchymal|mesenchymal
301937|NCT02334826|multivessel coronary artery disease|multivessel coronary artery disease
301938|NCT02334826|revascularization|revascularization
301939|NCT02334826|bioresorbable vascular scaffold|bioresorbable vascular scaffold
301940|NCT02334826|percutaneous coronary intervention|percutaneous coronary intervention
301941|NCT02334826|coronary artery bypass grafting|coronary artery bypass grafting
301942|NCT02334800|Palbociclib, PD-0332991, Hepatic Impairment|palbociclib, pd-0332991, hepatic impairment
301943|NCT02334761|Biopsy|biopsy
301944|NCT02334748|Juvenile Rheumatoid arthritis (JRA) chronic|juvenile rheumatoid arthritis (jra) chronic
301945|NCT02334748|systemic inflammatory disorder|systemic inflammatory disorder
301946|NCT02334748|painful joints|painful joints
301947|NCT02334748|inflammation of the synovial membrane|inflammation of the synovial membrane
301948|NCT02334748|auto-immune rheumatoid disease|auto-immune rheumatoid disease
301949|NCT02334748|reactive rheumatoid arthritis|reactive rheumatoid arthritis
301950|NCT02334748|Systemic Juvenile Rheumatoid arthritis (SJRA)|systemic juvenile rheumatoid arthritis (sjra)
301951|NCT02334748|Hereditary Periodic Fevers|hereditary periodic fevers
301952|NCT02334748|Hereditary periodic fever syndrome(HPFS)|hereditary periodic fever syndrome(hpfs)
301953|NCT02334748|Familial Mediterranean fever syndrome(FMFS)|familial mediterranean fever syndrome(fmfs)
301954|NCT02334748|Hyperimmunoglobulinemia D|hyperimmunoglobulinemia d
385718|NCT01934309|HIV|hiv
301955|NCT02334748|Tumor necrosis factor (TNF) receptor-associated periodic syndrome (TRAPS)|tumor necrosis factor (tnf) receptor-associated periodic syndrome (traps)
301956|NCT02334748|Muckle-Wells syndrome (MWS)|muckle-wells syndrome (mws)
301957|NCT02334748|Familial cold auto inflammatory syndrome|familial cold auto inflammatory syndrome
301958|NCT02334735|Melanoma|melanoma
301959|NCT02334735|Immunotherapy|immunotherapy
301960|NCT02334735|DC Vaccine|dc vaccine
301961|NCT02334735|Adjuvant Therapy|adjuvant therapy
301962|NCT02334735|Immunogenicity|immunogenicity
301963|NCT02334696|Vascular Access|vascular access
301964|NCT02334683|Comparison|comparison
301965|NCT02334683|Botulinum toxin treatments|botulinum toxin treatments
301966|NCT02334683|Ultrasound|ultrasound
301967|NCT02334683|Electrophysiologic|electrophysiologic
301968|NCT02334683|Spasticity|spasticity
301969|NCT02334683|Focal dystonia|focal dystonia
301970|NCT02334670|cryptococcal meningitis|cryptococcal meningitis
301971|NCT02334670|HIV|hiv
301972|NCT02334670|AIDS|aids
301973|NCT02334670|Fluconazole|fluconazole
301974|NCT02334657|non-aneurysmal|non-aneurysmal
301975|NCT02334644|Treatment|treatment
301976|NCT02334644|Natural Health Product|natural health product
301977|NCT02334644|Anxiety|anxiety
301978|NCT02334592|the effect of tanning|the effect of tanning
301979|NCT02334592|vitamin D production|vitamin d production
301980|NCT02334579|Radiation|radiation
302109|NCT02333903|Body Composition|body composition
301981|NCT02334579|Stereotactic Radiosurgery|stereotactic radiosurgery
301982|NCT02334579|Radiotherapy|radiotherapy
301983|NCT02334579|Prostate Tumor|prostate tumor
301984|NCT02334579|Prostate Surgery|prostate surgery
301985|NCT02334579|CyberKnife|cyberknife
301986|NCT02334566|PTSD|ptsd
301987|NCT02334566|Refugee children mental health|refugee children mental health
301988|NCT02334566|community health care|community health care
301989|NCT02334553|COPD|copd
301990|NCT02334553|Chronic bronchitis|chronic bronchitis
301991|NCT02334553|Cystic fibrosis|cystic fibrosis
301992|NCT02334553|Bronchoconstriction|bronchoconstriction
301993|NCT02334553|Perfluorocarbons|perfluorocarbons
301994|NCT02334553|Carbon dioxide|carbon dioxide
301995|NCT02334527|metastatic urothelial carcinoma (UC)|metastatic urothelial carcinoma (uc)
301996|NCT02334527|LCCC 1406|lccc 1406
301997|NCT02334527|Lineberger|lineberger
301998|NCT02334527|palbociclib|palbociclib
301999|NCT02334514|Influenza|influenza
302000|NCT02334514|Viral shedding|viral shedding
302001|NCT02334514|oseltamivir|oseltamivir
302002|NCT02334514|Polymerase Chain Reaction|polymerase chain reaction
302003|NCT02334501|Healthy Volunteers|healthy volunteers
302004|NCT02334462|Assays|assays
302005|NCT02334462|Antibody|antibody
302006|NCT02334462|Reactogenicity|reactogenicity
302007|NCT02334462|Mosquito|mosquito
302008|NCT02334462|Responses|responses
302009|NCT02334449|healthy volunteers|healthy volunteers
302010|NCT02334410|fractures|fractures
302011|NCT02334410|immobilisation|immobilisation
302012|NCT02334410|paraplegia|paraplegia
302013|NCT02334410|tetraplegia|tetraplegia
302014|NCT02334397|Prenatal Exercise|prenatal exercise
302015|NCT02334397|Prenatal Education|prenatal education
302016|NCT02334397|Pregnancy|pregnancy
302017|NCT02334397|Exercise and Birth Outcomes|exercise and birth outcomes
302018|NCT02334397|Education and Birth Outcomes|education and birth outcomes
302019|NCT02334397|Maternal Quality of Life|maternal quality of life
302020|NCT02334397|Birth Satisfaction|birth satisfaction
302021|NCT02334371|Magnetic Resonance Imaging|magnetic resonance imaging
302022|NCT02334371|Positron-Emission Tomography|positron-emission tomography
302023|NCT02334332|Caregiver|caregiver
302024|NCT02334293|Omegaven|omegaven
302025|NCT02334293|parenteral nutrition|parenteral nutrition
302026|NCT02334293|liver disease|liver disease
302027|NCT02334293|liver injury|liver injury
302028|NCT02334280|Community mental health|community mental health
302029|NCT02334280|Health coach|health coach
302030|NCT02334280|Weight loss|weight loss
302031|NCT02334280|Fitness|fitness
302032|NCT02334280|Serious mental illness|serious mental illness
302033|NCT02334280|Health promotion|health promotion
302034|NCT02334254|safety|safety
302035|NCT02334254|rivaroxaban|rivaroxaban
302036|NCT02334254|ticagrel|ticagrel
302037|NCT02334254|triple antithrombotic regimen|triple antithrombotic regimen
302038|NCT02334254|undergoing PCI|undergoing pci
302039|NCT02334241|Sorbact|sorbact
302040|NCT02334241|Best local Cares|best local cares
302041|NCT02334241|DFU|dfu
302042|NCT02334202|Adolescent|adolescent
302043|NCT02334202|Obesity/Psychology|obesity/psychology
302044|NCT02334202|Loss of Control Eating|loss of control eating
302045|NCT02334202|Child|child
302046|NCT02334202|Female|female
302047|NCT02334202|Follow-Up Studies|follow-up studies
302048|NCT02334202|Health Behavior|health behavior
302049|NCT02334202|Health Education|health education
302050|NCT02334202|Humans|humans
302051|NCT02334202|Intervention Studies|intervention studies
302052|NCT02334202|Prospective Studies|prospective studies
302053|NCT02334202|Psychotherapy|psychotherapy
302054|NCT02334202|Risk Factors|risk factors
302055|NCT02334202|Weight Loss|weight loss
302056|NCT02334202|Weight Gain|weight gain
302057|NCT02334202|Military|military
302058|NCT02334163|Hepatic Encephalopathy|hepatic encephalopathy
302059|NCT02334163|Nitazoxanide|nitazoxanide
302060|NCT02334163|Serum ammonia|serum ammonia
302061|NCT02334150|combined spinal-epidural analgesia|combined spinal-epidural analgesia
302062|NCT02334150|pelvic floor muscle|pelvic floor muscle
302063|NCT02334150|postpartum electrophysiological function|postpartum electrophysiological function
302064|NCT02334111|Parenting Support for Mothers in Recovery|parenting support for mothers in recovery
302065|NCT02334111|Neonatal Abstinence Syndrome|neonatal abstinence syndrome
302066|NCT02334111|Social Determinants of Health|social determinants of health
302067|NCT02334111|Child Development|child development
302068|NCT02334111|Child Abuse|child abuse
302069|NCT02334111|Child Neglect|child neglect
302070|NCT02334111|Primary Care|primary care
302071|NCT02334098|Aggression|aggression
302072|NCT02334098|Omega-3 supplementation|omega-3 supplementation
302073|NCT02334098|Neurocognition|neurocognition
302074|NCT02334098|Attention|attention
302075|NCT02334098|Antisocial|antisocial
302076|NCT02334059|opioid sparing|opioid sparing
302077|NCT02334059|ketamine|ketamine
302079|NCT02334059|magnesium|magnesium
302080|NCT02334046|tracheal extubation|tracheal extubation
302081|NCT02334046|remifentanil|remifentanil
302082|NCT02334033|hypertension|hypertension
302083|NCT02334033|blood pressure|blood pressure
302084|NCT02334033|cystatin C|cystatin c
302085|NCT02334033|real-life|real-life
302086|NCT02334033|kidney|kidney
302087|NCT02334020|Mental illness|mental illness
302088|NCT02334020|training|training
302089|NCT02334020|support|support
302090|NCT02334020|Mental Health|mental health
302091|NCT02334007|venous thromboembolism prophylaxis|venous thromboembolism prophylaxis
302092|NCT02334007|deep vein thrombosis|deep vein thrombosis
302093|NCT02334007|pulmonary embolism|pulmonary embolism
302094|NCT02334007|lung resection|lung resection
302095|NCT02334007|low molecular weight heparin|low molecular weight heparin
302096|NCT02333968|Cancer pain|cancer pain
302097|NCT02333968|Self-management|self-management
302098|NCT02333968|Randomized controlled trial|randomized controlled trial
302099|NCT02333942|Aging|aging
302100|NCT02333942|Diagnostic Equipment|diagnostic equipment
302101|NCT02333929|rivaroxaban|rivaroxaban
302102|NCT02333929|NOAC|noac
302103|NCT02333929|anti-Xa activity|anti-xa activity
302104|NCT02333929|method comparison|method comparison
302105|NCT02333929|LCMS|lcms
302106|NCT02333903|Obesity|obesity
302107|NCT02333903|Sleeve gastrectomy|sleeve gastrectomy
302108|NCT02333903|Personalized physical activity program|personalized physical activity program
302110|NCT02333903|Fat mass|fat mass
302111|NCT02333903|Lean mass|lean mass
302112|NCT02333890|breast|breast
302113|NCT02333851|Type 2 diabetes mellitus treatment|type 2 diabetes mellitus treatment
302114|NCT02333851|Hospitalized patients|hospitalized patients
302115|NCT02333838|Cord Cell Transplantation|cord cell transplantation
302116|NCT02333838|High risk myeloid malignancies|high risk myeloid malignancies
302117|NCT02333799|Tuberculosis|tuberculosis
302118|NCT02333799|MDR-TB|mdr-tb
302119|NCT02333799|XDR-TB|xdr-tb
302120|NCT02333799|Multi-drug resistant|multi-drug resistant
302121|NCT02333799|Extensively drug resistant|extensively drug resistant
302122|NCT02333799|Bedaquiline|bedaquiline
302123|NCT02333799|PA-824|pa-824
302124|NCT02333799|Linezolid|linezolid
302125|NCT02333799|TB|tb
302126|NCT02333799|Pretomanid|pretomanid
302127|NCT02333799|TMC-207|tmc-207
302128|NCT02333799|NiX-TB|nix-tb
302129|NCT02333773|irreversible electroporation|irreversible electroporation
302130|NCT02333773|Portal venous tumor emboli|portal venous tumor emboli
302131|NCT02333734|Type 2 diabetes|type 2 diabetes
302132|NCT02333734|Interval training|interval training
302133|NCT02333734|Insulin resistance|insulin resistance
302134|NCT02333734|fat metabolism|fat metabolism
302135|NCT02333721|Stomach Neoplasms|stomach neoplasms
302136|NCT02333721|Laparoscopy|laparoscopy
302137|NCT02333695|SCI, Spinal Cord Injury, Stroke|sci, spinal cord injury, stroke
302138|NCT02333669|Lung fluid absorption disorders|lung fluid absorption disorders
302139|NCT02333669|Neonatal respiratory distress syndrome|neonatal respiratory distress syndrome
302140|NCT02333669|Single nucleotide polymorphism|single nucleotide polymorphism
302141|NCT02333669|SCNN1A|scnn1a
302142|NCT02333630|asthma|asthma
302143|NCT02333617|Manual Therapy|manual therapy
302144|NCT02333617|Physical Therapy|physical therapy
302145|NCT02333617|Dry Needling|dry needling
302146|NCT02333617|Gluteus Medius|gluteus medius
302147|NCT02333604|cancer|cancer
302148|NCT02333604|cancer survivorship|cancer survivorship
302149|NCT02333604|psychosocial needs|psychosocial needs
302150|NCT02333604|cancer experience|cancer experience
302151|NCT02333604|metastatic breast cancer|metastatic breast cancer
302152|NCT02333604|multiple myeloma|multiple myeloma
302153|NCT02333604|chronic myeloid leukemia|chronic myeloid leukemia
302154|NCT02333604|breast cancer|breast cancer
302155|NCT02333604|Prostate|prostate
302156|NCT02333604|Colon|colon
302157|NCT02333604|Kidney|kidney
302158|NCT02333604|Lung|lung
302159|NCT02333604|Melanoma|melanoma
302160|NCT02333604|Caregiver|caregiver
302161|NCT02333604|gastric cancer|gastric cancer
302162|NCT02333604|stomach cancer|stomach cancer
302163|NCT02333604|chronic lymphocytic leukemia|chronic lymphocytic leukemia
302164|NCT02333552|Frailty|frailty
302165|NCT02333552|Pre-frailty|pre-frailty
302166|NCT02333552|Fit|fit
302167|NCT02333552|Robust|robust
302168|NCT02333552|Elderly|elderly
302169|NCT02333552|Sociodemography status|sociodemography status
302170|NCT02333552|Functional status|functional status
302171|NCT02333552|Cognitive status|cognitive status
302172|NCT02333552|Nutrition status|nutrition status
302173|NCT02333552|Comorbidity|comorbidity
302174|NCT02333552|Mortality|mortality
302175|NCT02333552|Depression status|depression status
302176|NCT02333526|ulcerative colitis|ulcerative colitis
302177|NCT02333526|Clostidium difficile-associated colitis|clostidium difficile-associated colitis
302178|NCT02333526|Syndecan-1|syndecan-1
302179|NCT02333526|biomarker|biomarker
302180|NCT02333474|mix vaccine, lung neoplasms, immunotherapy|mix vaccine, lung neoplasms, immunotherapy
302181|NCT02333435|Prostatectomy|prostatectomy
302182|NCT02333435|Omega-3 fatty acids|omega-3 fatty acids
302183|NCT02333435|Quality of life|quality of life
302184|NCT02333435|inflammation|inflammation
302185|NCT02333435|cellular proliferation|cellular proliferation
302186|NCT02333422|NIRS Neurofeedback|nirs neurofeedback
302187|NCT02333422|Attention Deficit Hyperactivity Disorder|attention deficit hyperactivity disorder
302188|NCT02333422|Near Infrared Spectroscopy|near infrared spectroscopy
302189|NCT02333422|ADHD|adhd
302190|NCT02333409|Cancer of pancreas|cancer of pancreas
302191|NCT02333409|Acupuncture|acupuncture
302192|NCT02333409|Pain|pain
302193|NCT02333396|Navigator|navigator
302194|NCT02333396|Intervention Study|intervention study
302195|NCT02333396|Randomized Controlled Trial|randomized controlled trial
302196|NCT02333396|Pediatric Intensive Care Unit|pediatric intensive care unit
302197|NCT02333396|Decision Making|decision making
302198|NCT02333383|Bath Ankylosing Spondylitis Disease Activity Index (BASDAI) score|bath ankylosing spondylitis disease activity index (basdai) score
302199|NCT02333383|EAMs|eams
302200|NCT02333383|Adalimumab|adalimumab
302201|NCT02333370|Advanced breast cancer|advanced breast cancer
302202|NCT02333370|Hormone receptor positive|hormone receptor positive
302203|NCT02333370|HER2-negative|her2-negative
302204|NCT02333370|LEE011,|lee011,
302205|NCT02333370|Letrozole|letrozole
302206|NCT02333370|Tamoxifen|tamoxifen
302207|NCT02333370|Fulvestrant|fulvestrant
302208|NCT02333370|Postmenopausal Asian women|postmenopausal asian women
302209|NCT02333370|Pre and Postmenopausal Japanese women|pre and postmenopausal japanese women
302210|NCT02333344|prosthetic fixation|prosthetic fixation
302211|NCT02333331|Sarcopenia, muscle wasting, elderly, strength, physical function, muscle, gait speed|sarcopenia, muscle wasting, elderly, strength, physical function, muscle, gait speed
302212|NCT02333305|Ataxia with Oculomotor Apraxia type 1|ataxia with oculomotor apraxia type 1
302213|NCT02333305|CoQ10|coq10
302214|NCT02333305|hypoalbuminemia|hypoalbuminemia
302215|NCT02333266|Candida bloodstream infection|candida bloodstream infection
302216|NCT02333266|Detection fungal cells|detection fungal cells
302217|NCT02333266|Fiber-Optic Surface Plasmon Resonance (FO-SPR)|fiber-optic surface plasmon resonance (fo-spr)
302218|NCT02333253|poor responders|poor responders
302219|NCT02333253|GnRH antagonist|gnrh antagonist
302220|NCT02333253|Conventional protocol|conventional protocol
302221|NCT02333240|Pregnancy|pregnancy
302222|NCT02333240|Postnatal Care|postnatal care
302223|NCT02333240|Blood Pressure Monitoring, Home|blood pressure monitoring, home
302224|NCT02333240|Self Care|self care
302225|NCT02333240|Pregnancy Complications, Cardiovascular|pregnancy complications, cardiovascular
302226|NCT02333240|Qualitative Research|qualitative research
302227|NCT02333240|Antihypertensive Agents|antihypertensive agents
302228|NCT02333214|Virtual Reality Therapy|virtual reality therapy
302229|NCT02333214|Video Game|video game
302230|NCT02333214|Physical Exercise|physical exercise
302231|NCT02333214|Aged|aged
302232|NCT02333214|Frailty|frailty
302233|NCT02333201|Deglutition Disorders|deglutition disorders
302234|NCT02333201|Dysphagia|dysphagia
302235|NCT02333201|Mechanical Ventilation|mechanical ventilation
302236|NCT02333201|Sepsis|sepsis
302237|NCT02333175|Parkinson's disease, Late stage|parkinson's disease, late stage
302238|NCT02333149|Melatonin|melatonin
302239|NCT02333071|HSDD|hsdd
302240|NCT02333071|Female Sexual Desire Disorder|female sexual desire disorder
302242|NCT02333058|AML|aml
302243|NCT02333058|MDS|mds
302244|NCT02333058|JMML|jmml
302245|NCT02333045|HIV-negative|hiv-negative
302246|NCT02333045|Women|women
302247|NCT02333045|At-risk|at-risk
302248|NCT02333019|risk|risk
302249|NCT02333006|Anosognosia|anosognosia
302250|NCT02332993|FPP (Fermented Papaya Preparation)|fpp (fermented papaya preparation)
302251|NCT02332993|Negative Pressure Therapy|negative pressure therapy
386084|NCT01932710|AML|aml
302252|NCT02332993|Wound Vac|wound vac
302253|NCT02332993|Wound|wound
302254|NCT02332993|Type II Diabetic|type ii diabetic
302255|NCT02332954|Depression|depression
302256|NCT02332954|Major Depressive Disorder|major depressive disorder
302257|NCT02332954|Cognition|cognition
302258|NCT02332954|Cognitive symptoms|cognitive symptoms
302259|NCT02332954|vortioxetine|vortioxetine
302260|NCT02332954|real life|real life
302261|NCT02332954|naturalistic|naturalistic
302262|NCT02332915|apraxia|apraxia
302263|NCT02332915|aphasia|aphasia
302264|NCT02332915|rehabilitation|rehabilitation
302265|NCT02332915|efficacy|efficacy
302266|NCT02332915|intensity|intensity
302267|NCT02332902|Neurofibroma|neurofibroma
302268|NCT02332902|NF-1|nf-1
302269|NCT02332902|Everolimus|everolimus
302270|NCT02332902|mTOR inhibitor|mtor inhibitor
302271|NCT02332863|Pancreatic cancer|pancreatic cancer
302272|NCT02332863|Image guided radiation therapy|image guided radiation therapy
302273|NCT02332863|Fiducial marker placement|fiducial marker placement
302274|NCT02332863|Endoscopic ultrasound|endoscopic ultrasound
302275|NCT02332850|Relapsed|relapsed
302276|NCT02332850|Refractory|refractory
302277|NCT02332837|informed consent, public led trials, shared decision making,|informed consent, public led trials, shared decision making,
302278|NCT02332824|Pharmacological therapy|pharmacological therapy
302279|NCT02332798|Multiple ascending doses|multiple ascending doses
302280|NCT02332798|safety|safety
302281|NCT02332798|tolerability|tolerability
302282|NCT02332798|pharmacokinetics|pharmacokinetics
302283|NCT02332798|cognitive impairment associated with schizophrenia (CIAS)|cognitive impairment associated with schizophrenia (cias)
302284|NCT02332785|Colon Serrated Polyps|colon serrated polyps
302285|NCT02332785|Serrated polyp|serrated polyp
302286|NCT02332785|Hyperplastic polyps above sigmoid colon|hyperplastic polyps above sigmoid colon
302287|NCT02332785|Sessile serrated adenoma|sessile serrated adenoma
302288|NCT02332785|Traditional serrated adenoma|traditional serrated adenoma
302289|NCT02332785|Colonoscopy|colonoscopy
302290|NCT02332785|Endoscopy|endoscopy
302291|NCT02332785|Data collection|data collection
302292|NCT02332785|Data review|data review
302293|NCT02332772|Colon Polyps|colon polyps
302294|NCT02332772|Large polyps|large polyps
302295|NCT02332772|Flat lesions|flat lesions
302296|NCT02332772|Endoscopy|endoscopy
302297|NCT02332772|Colonoscopic resection|colonoscopic resection
302298|NCT02332772|Colonoscopy|colonoscopy
302299|NCT02332772|Data review|data review
302300|NCT02332772|Data collection|data collection
302301|NCT02332668|PD1|pd1
302302|NCT02332668|PD-1|pd-1
302303|NCT02332668|PDL1|pdl1
302304|NCT02332668|PD-L1|pd-l1
302305|NCT02332668|cHL|chl
302306|NCT02332668|MSI-H|msi-h
302307|NCT02332655|Sturge-Weber syndrome|sturge-weber syndrome
302308|NCT02332655|SWS|sws
302309|NCT02332655|Drug resistant epilepsy|drug resistant epilepsy
302310|NCT02332629|Glucocorticoid|glucocorticoid
302311|NCT02332629|Endothelial barrier|endothelial barrier
302312|NCT02332629|Glycocalyx|glycocalyx
302313|NCT02332629|Knee arthroplasty, total|knee arthroplasty, total
302314|NCT02332616|Glucocorticoid|glucocorticoid
302315|NCT02332616|Complement activation|complement activation
302316|NCT02332616|Knee arthroplasty, total|knee arthroplasty, total
302317|NCT02332603|Glucocorticoid|glucocorticoid
302318|NCT02332603|Glucose homeostasis|glucose homeostasis
302319|NCT02332603|Knee arthroplasty, total|knee arthroplasty, total
302320|NCT02332603|Hip arthroplasty, total|hip arthroplasty, total
302321|NCT02332564|Circulation, Collateral|circulation, collateral
302322|NCT02332564|Coronary Artery Disease|coronary artery disease
302323|NCT02332564|Internal Mammary-Coronary Artery Anastomosis|internal mammary-coronary artery anastomosis
302324|NCT02332564|Ischemia|ischemia
302325|NCT02332538|LASER|laser
302326|NCT02332538|PROSTATE|prostate
302327|NCT02332538|BIPOLAR|bipolar
302328|NCT02332538|HYPERPLASIA|hyperplasia
302329|NCT02332538|VAPORIZATION|vaporization
302330|NCT02332525|Oral Vibrational Stimulation|oral vibrational stimulation
302331|NCT02332525|Cognitive Function|cognitive function
302332|NCT02332525|Mild Cognitive Impairment|mild cognitive impairment
302333|NCT02332525|cognitive normal elderly|cognitive normal elderly
302334|NCT02332512|Non-squamous non-small cell lung cancer|non-squamous non-small cell lung cancer
302335|NCT02332512|Wild-type EGFR|wild-type egfr
302336|NCT02332512|3rd/4th line treatment|3rd/4th line treatment
302337|NCT02332512|apatinib|apatinib
302338|NCT02332499|Anlotinib|anlotinib
302339|NCT02332499|Metastatic Colorectal Cancer （mCRC）|metastatic colorectal cancer （mcrc）
302340|NCT02332499|ALTER0703|alter0703
302341|NCT02332447|Tonic-clonic seizures|tonic-clonic seizures
302342|NCT02332447|Naloxone|naloxone
302343|NCT02332447|SUDEP|sudep
302344|NCT02332421|canine retraction|canine retraction
302345|NCT02332421|acceleration of tooth movement|acceleration of tooth movement
302346|NCT02332421|dentoalveolar distraction osteogenesis|dentoalveolar distraction osteogenesis
302347|NCT02332408|vertebral hemangioma|vertebral hemangioma
302348|NCT02332408|conventional radiotherapy|conventional radiotherapy
302349|NCT02332408|Cyber Knife radiotherapy|cyber knife radiotherapy
302350|NCT02332408|randomized trial|randomized trial
302351|NCT02332408|radioablation|radioablation
302353|NCT02332395|pain catastrophizing|pain catastrophizing
302354|NCT02332395|cesarean section|cesarean section
302355|NCT02332369|Cataract|cataract
302356|NCT02332356|Crohn Disease|crohn disease
302357|NCT02332356|Inflammatory Bowel Diseases|inflammatory bowel diseases
302358|NCT02332356|Disease Attributes|disease attributes
302359|NCT02332343|Retina|retina
302360|NCT02332343|Retinal pigment epithelium|retinal pigment epithelium
302361|NCT02332317|Advanced cancer|advanced cancer
302362|NCT02332317|Early integration|early integration
302363|NCT02332317|Palliative rehabilitation|palliative rehabilitation
302364|NCT02332304|Respiratory Distress Syndrome, Newborn|respiratory distress syndrome, newborn
302365|NCT02332291|Depression|depression
302366|NCT02332291|Geriatrics|geriatrics
302367|NCT02332291|Elderly|elderly
302368|NCT02332291|MRI|mri
302369|NCT02332291|Antidepressants|antidepressants
302370|NCT02332278|Cesarean section|cesarean section
302371|NCT02332278|Early feeding|early feeding
302372|NCT02332265|Food Security|food security
302373|NCT02332265|Microfinance|microfinance
302374|NCT02332265|Village Savings and Loans|village savings and loans
302375|NCT02332265|HIV|hiv
302376|NCT02332265|Quasi-experimental design|quasi-experimental design
302377|NCT02332265|Malawi|malawi
302378|NCT02332265|Structural intervention|structural intervention
302379|NCT02332252|Surgical Wound Infection|surgical wound infection
302380|NCT02332252|Electrocautery|electrocautery
302381|NCT02332252|Scalpel|scalpel
302382|NCT02332239|depression|depression
302383|NCT02332239|violence|violence
302384|NCT02332239|emergency department|emergency department
302385|NCT02332239|mhealth|mhealth
302386|NCT02332239|text message|text message
302387|NCT02332213|Volatile organic compounds|volatile organic compounds
302388|NCT02332213|Nanosensor technology|nanosensor technology
302389|NCT02332213|GC-MS|gc-ms
302390|NCT02332213|Breath-testing|breath-testing
302391|NCT02332213|Digestive cancer|digestive cancer
302392|NCT02332213|Precancerous lesions|precancerous lesions
302393|NCT02332213|Colorectal cancer|colorectal cancer
302394|NCT02332213|Adenoma|adenoma
302395|NCT02332213|Gastric cancer|gastric cancer
302396|NCT02332213|Atrophic gastritis|atrophic gastritis
302397|NCT02332213|OLGIM|olgim
302398|NCT02332200|Spondylolysis|spondylolysis
302399|NCT02332200|Spondylolisthesis|spondylolisthesis
302400|NCT02332200|Low Back Pain|low back pain
302401|NCT02332174|pharmacokinetics|pharmacokinetics
302402|NCT02332174|food effect|food effect
302403|NCT02332174|sex effect|sex effect
302404|NCT02332174|tolerability|tolerability
302405|NCT02332135|microwave ablation|microwave ablation
302406|NCT02332135|maintenance hemodialysis|maintenance hemodialysis
302407|NCT02332135|mild-to-moderate Secondary Hyperparathyroidism|mild-to-moderate secondary hyperparathyroidism
302408|NCT02332122|COPD|copd
302409|NCT02332122|Chronic Obstructive Pulmonary Disease|chronic obstructive pulmonary disease
302410|NCT02332122|Aspergillus fumigatus|aspergillus fumigatus
302411|NCT02332122|Bronchiectasis|bronchiectasis
302412|NCT02332122|Sensitization|sensitization
302413|NCT02332122|Vitamin D|vitamin d
302414|NCT02332109|Fuchs endothelial dystrophy|fuchs endothelial dystrophy
302415|NCT02332109|oedema|oedema
302416|NCT02332109|sodium chloride|sodium chloride
302417|NCT02332109|hyaluronan|hyaluronan
302418|NCT02332109|sodium hyaluronate|sodium hyaluronate
302419|NCT02332070|acute kidney injury|acute kidney injury
302420|NCT02332070|coronary angiography|coronary angiography
302421|NCT02332070|cardiac surgery|cardiac surgery
302422|NCT02332070|adverse events|adverse events
302423|NCT02332070|iodinated contrast|iodinated contrast
302424|NCT02332070|Thoracic Surgery|thoracic surgery
302425|NCT02332057|IUD,Diclofenac , Lidocaine|iud,diclofenac , lidocaine
302426|NCT02332031|Sorafenib, levothyroxine, drug interaction, pharmacokinetics, healthy volunteer|sorafenib, levothyroxine, drug interaction, pharmacokinetics, healthy volunteer
302427|NCT02331992|Continuous Positive Airway Pressure|continuous positive airway pressure
302428|NCT02331966|FGF-23|fgf-23
302429|NCT02331966|GROWTH FACTORS RECEPTORS|growth factors receptors
302430|NCT02331966|RECURRENCES|recurrences
302431|NCT02331953|spine surgery|spine surgery
302432|NCT02331953|cerebral oximetry|cerebral oximetry
302433|NCT02331953|postoperative delirium|postoperative delirium
302434|NCT02331940|Chronic obstructive pulmonary disease|chronic obstructive pulmonary disease
302435|NCT02331940|sleeping oxygen saturation|sleeping oxygen saturation
302436|NCT02331940|sleep quality|sleep quality
302437|NCT02331927|colorectal cancer|colorectal cancer
302438|NCT02331927|marker-driven|marker-driven
302439|NCT02331927|bevacizumab|bevacizumab
302440|NCT02331927|aflibercept|aflibercept
302441|NCT02331927|cytokines|cytokines
302442|NCT02331927|angiogenic factors|angiogenic factors
302443|NCT02331927|CAF|caf
302444|NCT02331914|GIST|gist
302445|NCT02331914|Bio-databank|bio-databank
760487|NCT00402740|EMBOSHIELD|emboshield
302446|NCT02331862|urinary tract infection|urinary tract infection
302447|NCT02331862|methylprednisolone|methylprednisolone
302448|NCT02331849|Eosinophilic esophagitis (EoE)|eosinophilic esophagitis (eoe)
302449|NCT02331849|GERD|gerd
302450|NCT02331849|esophageal motility|esophageal motility
302451|NCT02331836|adenoma detection rate|adenoma detection rate
302452|NCT02331836|polyp detection rate|polyp detection rate
302453|NCT02331836|withdrawal time|withdrawal time
302454|NCT02331836|coecal and ileum intubation rate|coecal and ileum intubation rate
302455|NCT02331797|endoscope|endoscope
302456|NCT02331797|microscope|microscope
302457|NCT02331797|transcanal|transcanal
302458|NCT02331719|intracerebral hemorrhage|intracerebral hemorrhage
302459|NCT02331719|subcortical intracerebral hemorrhage|subcortical intracerebral hemorrhage
302460|NCT02331719|ICH|ich
302461|NCT02331719|parafascicular minimally invasive subcortical access|parafascicular minimally invasive subcortical access
302462|NCT02331693|EGFR|egfr
302463|NCT02331693|CAR T cells|car t cells
302464|NCT02331693|glioma|glioma
302465|NCT02331680|Undergoing Hemodialysis|undergoing hemodialysis
302466|NCT02331680|Undergoing Hemodiafiltration|undergoing hemodiafiltration
302467|NCT02331667|Diet|diet
302468|NCT02331667|Vitamin-D|vitamin-d
302469|NCT02331667|Meat|meat
302470|NCT02331667|Fatty fish|fatty fish
302471|NCT02331667|Iodine|iodine
302472|NCT02331667|fatty acid|fatty acid
302473|NCT02331667|Intervention study|intervention study
302474|NCT02331667|Wechsler Preschool and Primary Scale of Intelligence|wechsler preschool and primary scale of intelligence
302475|NCT02331667|Strengths and Difficulties Questionnaire|strengths and difficulties questionnaire
302476|NCT02331667|Nine hole peg test|nine hole peg test
302477|NCT02331654|Chronic pain|chronic pain
302478|NCT02331654|Direct Current Stimulation|direct current stimulation
302479|NCT02331641|hepatectomy|hepatectomy
302480|NCT02331641|hepatic resection|hepatic resection
302481|NCT02331628|TBI Traumatic Brain Injury|tbi traumatic brain injury
302482|NCT02331628|HO Heterotopic Ossification|ho heterotopic ossification
302483|NCT02331628|NHO Neurogenic Heterotopic Ossification|nho neurogenic heterotopic ossification
302484|NCT02331628|ESWT Extracorporeal Shock Wave Therapy|eswt extracorporeal shock wave therapy
302485|NCT02331615|Traumatic Brain Injury|traumatic brain injury
302486|NCT02331615|Executive function difficulties|executive function difficulties
302487|NCT02331615|Transcranial direct current stimulation|transcranial direct current stimulation
302488|NCT02331602|atrial fibrillation|atrial fibrillation
302489|NCT02331602|anticoagulation|anticoagulation
302490|NCT02331602|inflammation|inflammation
302491|NCT02331589|Fatigue|fatigue
302492|NCT02331589|Panax ginseng|panax ginseng
302493|NCT02331589|Chronic hepatitis|chronic hepatitis
302494|NCT02331589|Non-alcoholic Fatty Liver Disease|non-alcoholic fatty liver disease
302495|NCT02331589|Adiponectin|adiponectin
302496|NCT02331563|dexmedetomidine|dexmedetomidine
302497|NCT02331550|Low-Grade Squamous Intraepithelial Lesions|low-grade squamous intraepithelial lesions
302498|NCT02331524|exercise|exercise
302499|NCT02331524|daily activity|daily activity
302500|NCT02331485|Prevention of wound infection and wound complication|prevention of wound infection and wound complication
302501|NCT02331472|interstitial cystitis|interstitial cystitis
302502|NCT02331472|biomarker|biomarker
302503|NCT02331459|mood|mood
302504|NCT02331459|cognitive state|cognitive state
302505|NCT02331459|physical activity|physical activity
302506|NCT02331459|frailty|frailty
302507|NCT02331394|Chinese herbs|chinese herbs
302508|NCT02331394|lung cancer|lung cancer
302509|NCT02331394|quality of life|quality of life
302510|NCT02331368|Multiple Myeloma|multiple myeloma
302511|NCT02331368|Anti-PD-1|anti-pd-1
302512|NCT02331368|Pembrolizumab|pembrolizumab
302513|NCT02331368|Post-transplant|post-transplant
302514|NCT02331368|Maintenance|maintenance
302515|NCT02331355|amputation, hand, forearm, arm, traumatic, transplantation|amputation, hand, forearm, arm, traumatic, transplantation
302516|NCT02331342|Agreement of NICOM and Innocor|agreement of nicom and innocor
302517|NCT02331329|Accuracy of NICOM|accuracy of nicom
302518|NCT02331329|precision of NICOM|precision of nicom
302519|NCT02331316|obesity|obesity
302520|NCT02331316|diet|diet
302521|NCT02331316|weight|weight
302522|NCT02331316|hunger|hunger
302523|NCT02331316|public led trial|public led trial
302524|NCT02331264|Cardiac Toxicity|cardiac toxicity
302525|NCT02331264|Metal on Metal Hip Implants|metal on metal hip implants
302526|NCT02331186|Obesity|obesity
302527|NCT02331186|Bariatric surgery|bariatric surgery
302528|NCT02331186|Urinary incontinence|urinary incontinence
302529|NCT02331186|Pelvic floor|pelvic floor
302530|NCT02331173|XLRS|xlrs
302531|NCT02331173|RS1|rs1
302532|NCT02331173|maculoschisis|maculoschisis
302533|NCT02331160|Pregnancy|pregnancy
302534|NCT02331160|Breech Presentation|breech presentation
302535|NCT02331160|Version, fetal|version, fetal
302536|NCT02331160|Musculoskeletal Manipulations|musculoskeletal manipulations
302537|NCT02331160|Medicine, Traditional|medicine, traditional
302538|NCT02331134|Tissue|tissue
302539|NCT02331134|Hematopoietic Stem Cell|hematopoietic stem cell
302540|NCT02331134|Melanoma|melanoma
302541|NCT02331134|Squamous Head and Neck Cancer|squamous head and neck cancer
302542|NCT02331121|children|children
302543|NCT02331121|parents|parents
302544|NCT02331121|internet|internet
302545|NCT02331121|video|video
302546|NCT02331121|training|training
302547|NCT02331121|interactive|interactive
302548|NCT02331082|Infant Mortality|infant mortality
302549|NCT02331082|Under-two mortality|under-two mortality
302550|NCT02331082|Maternal Mortality|maternal mortality
302551|NCT02331082|Implementation Research|implementation research
302552|NCT02331082|Health Systems Strengthening|health systems strengthening
302553|NCT02331082|Chronic Disease Management|chronic disease management
302554|NCT02331082|Commuity Health Workers|commuity health workers
302555|NCT02331069|radial neuropathy|radial neuropathy
302556|NCT02331056|Stroke volume variation|stroke volume variation
302557|NCT02331056|fluid responsiveness|fluid responsiveness
302558|NCT02331056|One-lung ventilation|one-lung ventilation
302559|NCT02331056|thoracotomy|thoracotomy
302560|NCT02331030|brachio-axillary|brachio-axillary
302561|NCT02331030|brachio-basilic|brachio-basilic
302562|NCT02331030|interfascial plane block|interfascial plane block
302563|NCT02331030|Pecs II block|pecs ii block
302564|NCT02331030|supraclavicular brachial plexus block|supraclavicular brachial plexus block
302565|NCT02331017|Bimodal|bimodal
302566|NCT02331017|Cochlear Implant|cochlear implant
302567|NCT02331017|Hearing aid|hearing aid
302568|NCT02331017|Auditory Perception|auditory perception
302569|NCT02331004|Frail Elderly|frail elderly
302570|NCT02331004|Motor Skills|motor skills
302571|NCT02331004|Upper Extremity|upper extremity
302572|NCT02330991|glioblastoma|glioblastoma
302573|NCT02330991|relapse|relapse
302574|NCT02330991|Temozolomide|temozolomide
302575|NCT02330991|glioblastoma at first relapse|glioblastoma at first relapse
302576|NCT02330965|clinical research|clinical research
302577|NCT02330965|mechanistic studies|mechanistic studies
302578|NCT02330965|blood draw|blood draw
302579|NCT02330965|CSF by lumbar puncture (optional)|csf by lumbar puncture (optional)
302580|NCT02330952|Double-blind method|double-blind method
302581|NCT02330952|Randomized Controlled trials|randomized controlled trials
302582|NCT02330939|Postprandial glycemia|postprandial glycemia
302583|NCT02330939|Momounsaturated fatty acids|momounsaturated fatty acids
302584|NCT02330939|Saturated fatty acids|saturated fatty acids
302585|NCT02330939|Glycemic index|glycemic index
302586|NCT02330939|Glycemic load|glycemic load
302587|NCT02330939|Sensor augmented pump system|sensor augmented pump system
302588|NCT02330926|Combined modality treatment|combined modality treatment
302589|NCT02330926|Diet therapy|diet therapy
302590|NCT02330926|Exercise therapy|exercise therapy
302591|NCT02330926|Ibuprofen|ibuprofen
302592|NCT02330926|Dietary supplements|dietary supplements
302593|NCT02330913|total gastrectomy|total gastrectomy
302594|NCT02330913|intracorporeal|intracorporeal
302595|NCT02330913|totally laparoscopic|totally laparoscopic
302596|NCT02330913|esophagojejunostomy|esophagojejunostomy
302597|NCT02330913|anastomosis|anastomosis
302598|NCT02330900|Implantable cardioverter defibrillator|implantable cardioverter defibrillator
302599|NCT02330900|Electromagnetic interference|electromagnetic interference
302600|NCT02330900|Cell phone|cell phone
302601|NCT02330887|Maternal Mortality|maternal mortality
302602|NCT02330887|Institutional Birth Rate|institutional birth rate
302603|NCT02330887|Neonatal Mortality Rate|neonatal mortality rate
302604|NCT02330887|Preterm Birth|preterm birth
302605|NCT02330887|Stillbirth|stillbirth
302606|NCT02330887|Infant, Small for Gestational Age|infant, small for gestational age
302607|NCT02330887|Nepal|nepal
302608|NCT02330887|Implementation Research|implementation research
302609|NCT02330887|Global Health|global health
302610|NCT02330874|Risk|risk
302611|NCT02330874|score|score
302612|NCT02330874|readmission|readmission
302613|NCT02330874|ICU|icu
302614|NCT02330861|Coronary Circulation|coronary circulation
302615|NCT02330848|Obesity|obesity
302616|NCT02330848|Walnuts|walnuts
302617|NCT02330848|Endothelial Function|endothelial function
302618|NCT02330848|Adults at risk|adults at risk
302619|NCT02330835|school|school
302620|NCT02330835|bus|bus
302621|NCT02330835|school bus|school bus
302622|NCT02330835|driver|driver
302623|NCT02330835|training|training
302624|NCT02330835|behavior|behavior
302625|NCT02330835|management|management
302626|NCT02330835|interactive|interactive
302627|NCT02330835|computer|computer
302628|NCT02330809|headache|headache
302629|NCT02330809|hunger intensity|hunger intensity
302630|NCT02330809|public led online trial|public led online trial
302631|NCT02330809|water intake|water intake
302632|NCT02330783|Metastatic Renal Cell Carcinoma|metastatic renal cell carcinoma
302633|NCT02330783|Third-line treatment|third-line treatment
302634|NCT02330783|Sorafenib|sorafenib
302635|NCT02330783|Bevacizumab|bevacizumab
302636|NCT02330770|GnRHa trigger|gnrha trigger
302637|NCT02330770|Luteal phase support|luteal phase support
302638|NCT02330770|OHSS|ohss
302639|NCT02330757|Frozen-thawed embryo transfer|frozen-thawed embryo transfer
302640|NCT02330757|FET protocols|fet protocols
302641|NCT02330705|Intrauterine insemination|intrauterine insemination
302642|NCT02330705|IUI|iui
302643|NCT02330705|HCG|hcg
302644|NCT02330679|Major Depression, Neuroimaging, Desvenlafaxine, Machine learning|major depression, neuroimaging, desvenlafaxine, machine learning
302645|NCT02330653|Colitis|colitis
302646|NCT02330653|Fecal Microbiota Transplant|fecal microbiota transplant
302647|NCT02330653|Ulcerative colitis|ulcerative colitis
302648|NCT02330653|inflammatory bowel disease|inflammatory bowel disease
302649|NCT02330640|CABG|cabg
302650|NCT02330640|antiplatelet therapy|antiplatelet therapy
302651|NCT02330640|ticagrelor|ticagrelor
302652|NCT02330614|personality|personality
302653|NCT02330614|bleaching|bleaching
302654|NCT02330588|Obesity|obesity
302655|NCT02330588|Prevention|prevention
302656|NCT02330588|Pediatric|pediatric
302657|NCT02330588|Parents|parents
302658|NCT02330588|Primary Care|primary care
302659|NCT02330588|eHealth|ehealth
302660|NCT02330588|Internet|internet
302661|NCT02330562|Marizomib|marizomib
302662|NCT02330562|Bevacizumab|bevacizumab
302663|NCT02330562|Avastin|avastin
302664|NCT02330562|Grade IV malignant glioma|grade iv malignant glioma
302665|NCT02330562|proteasome inhibitor|proteasome inhibitor
302666|NCT02330562|glioblastoma|glioblastoma
302667|NCT02330562|brain tumor|brain tumor
302668|NCT02330562|malignant glioma|malignant glioma
302669|NCT02330562|brain cancer|brain cancer
302670|NCT02330562|gliosarcoma|gliosarcoma
302671|NCT02330562|BEV|bev
302672|NCT02330536|Circulatory and Respiratory Physiological Phenomena|circulatory and respiratory physiological phenomena
302673|NCT02330536|Thoracoscopy|thoracoscopy
302674|NCT02330510|Alzheimer's Disease|alzheimer's disease
302675|NCT02330510|White Matter Hyperintensities|white matter hyperintensities
302676|NCT02330510|Vascular Cognitive Impairment|vascular cognitive impairment
302677|NCT02330510|Amyloid Imaging|amyloid imaging
302678|NCT02330510|Transient Ischemic Attack|transient ischemic attack
302679|NCT02330484|Community management， incentives, Medication Adherence|community management， incentives, medication adherence
302680|NCT02330471|conization|conization
302681|NCT02330471|LLETZ|lletz
302682|NCT02330471|cervical dysplasia|cervical dysplasia
302683|NCT02330471|cervical intraepithelial neoplasia|cervical intraepithelial neoplasia
302684|NCT02330458|Inflammatory Bowel Disease|inflammatory bowel disease
302685|NCT02330458|Crohn's disease|crohn's disease
302686|NCT02330458|Pediatric IBD|pediatric ibd
302687|NCT02330458|small bowel ultrasound|small bowel ultrasound
302688|NCT02330458|infliximab|infliximab
302689|NCT02330419|Naltrexone|naltrexone
302690|NCT02330406|Dipeptidyl-Peptidase 4 Inhibitors|dipeptidyl-peptidase 4 inhibitors
302691|NCT02330406|LDL Cholesterol|ldl cholesterol
302692|NCT02330406|Glycosylated Hemoglobin|glycosylated hemoglobin
302693|NCT02330406|Diabetes Mellitus|diabetes mellitus
302694|NCT02330406|Coronary Disease|coronary disease
302695|NCT02330380|psoriasis, comparative effects, inflammation|psoriasis, comparative effects, inflammation
302696|NCT02330354|preschool|preschool
302697|NCT02330354|behavior change|behavior change
302698|NCT02330354|social marketing|social marketing
302699|NCT02330354|child care providers|child care providers
302700|NCT02330354|nutrition|nutrition
302701|NCT02330354|child care centers|child care centers
302702|NCT02330354|physical activity|physical activity
302703|NCT02330341|Glucose Intolerance|glucose intolerance
302704|NCT02330341|Artemisia dracunculus|artemisia dracunculus
302705|NCT02330341|Insulin|insulin
302706|NCT02330328|Chest Pain|chest pain
302707|NCT02330328|Telemetry|telemetry
302708|NCT02330315|transcranial direct current stimulation|transcranial direct current stimulation
302709|NCT02330315|transcranial ultrasound|transcranial ultrasound
302710|NCT02330315|non-invasive brain stimulation|non-invasive brain stimulation
302711|NCT02330250|Systemic Lupus Erythematosus|systemic lupus erythematosus
302712|NCT02330250|Pharmaceutical care|pharmaceutical care
302713|NCT02330250|Pharmaceutical services|pharmaceutical services
302714|NCT02330250|Medication adherence|medication adherence
302715|NCT02330224|Blood pressure|blood pressure
302716|NCT02330224|Lipids|lipids
302717|NCT02330224|Cardiovascular|cardiovascular
302718|NCT02330224|Health services|health services
302719|NCT02330224|Hypertension|hypertension
302720|NCT02330198|self-reported outcome instrument|self-reported outcome instrument
302721|NCT02330185|spinal anesthesia|spinal anesthesia
302722|NCT02330185|ultrasonography|ultrasonography
302723|NCT02330185|anatomical landmark|anatomical landmark
302724|NCT02330159|Pilonidal|pilonidal
302725|NCT02330159|Quality of Life|quality of life
302726|NCT02330133|mid-life women|mid-life women
302727|NCT02330133|unintended pregnancy|unintended pregnancy
302728|NCT02330133|STI/HIV prevention|sti/hiv prevention
302729|NCT02330133|intervention|intervention
302730|NCT02330133|interactive|interactive
302731|NCT02330133|CD-ROM|cd-rom
302732|NCT02330133|multimedia|multimedia
302733|NCT02330133|video|video
302734|NCT02330120|peak airway pressure|peak airway pressure
302735|NCT02330120|airway resistance|airway resistance
302736|NCT02330120|sedation|sedation
302737|NCT02330120|intensive care|intensive care
302738|NCT02330094|aSAH|asah
302740|NCT02330081|pathogen reduction technology|pathogen reduction technology
302741|NCT02330081|whole blood|whole blood
302742|NCT02330081|Platelets|platelets
302743|NCT02330081|Mirasol|mirasol
302744|NCT02330042|Diabetes|diabetes
302745|NCT02330042|OCT|oct
302746|NCT02330042|Angiography|angiography
302747|NCT02330042|Diabetic retinopathy|diabetic retinopathy
302748|NCT02330029|Irritable bowel syndrome,|irritable bowel syndrome,
302749|NCT02330029|Pinaverium|pinaverium
302750|NCT02330029|Herbal medication for IBS,|herbal medication for ibs,
302751|NCT02330029|Tong Xie Yao Fang (Formula for pain and diarrhea)|tong xie yao fang (formula for pain and diarrhea)
302752|NCT02330003|Influenza|influenza
302753|NCT02330003|Influenza vaccine|influenza vaccine
302754|NCT02330003|Split influenza vaccine|split influenza vaccine
302755|NCT02330003|Seasonal influenza vaccine|seasonal influenza vaccine
302756|NCT02329990|phosphorus intake|phosphorus intake
302757|NCT02329977|duodenal-biliary reflux|duodenal-biliary reflux
302758|NCT02329964|Rocuronium|rocuronium
302759|NCT02329964|Sugammadex|sugammadex
302760|NCT02329964|Succinylcholine|succinylcholine
302761|NCT02329964|Cisatracurium|cisatracurium
302762|NCT02329964|Neostigmine|neostigmine
302763|NCT02329964|acceleromyography (TOF-Watch®)|acceleromyography (tof-watch®)
302764|NCT02329912|postoperative ileus|postoperative ileus
302765|NCT02329912|SmartPill|smartpill
302766|NCT02329912|gastrointestinal transit|gastrointestinal transit
302767|NCT02329912|prokinetic drugs|prokinetic drugs
302768|NCT02329886|chronic diseases|chronic diseases
302769|NCT02329886|risk factors|risk factors
302770|NCT02329886|health outcomes|health outcomes
302771|NCT02329873|Acute exacerbation of chronic obstructive pulmonary disease|acute exacerbation of chronic obstructive pulmonary disease
302772|NCT02329873|Older adults|older adults
302773|NCT02329873|Respiratory rehabilitation exercise|respiratory rehabilitation exercise
302774|NCT02329847|Hematologic Neoplasms|hematologic neoplasms
302775|NCT02329847|JNJ54179060|jnj54179060
302776|NCT02329847|Ibrutinib|ibrutinib
302777|NCT02329847|Nivolumab|nivolumab
302779|NCT02329821|hartmann solution|hartmann solution
302780|NCT02329821|hepatocellular carcinoma|hepatocellular carcinoma
302781|NCT02329808|TDM|tdm
302782|NCT02329808|dried blood spot|dried blood spot
302783|NCT02329808|immunosuppressive|immunosuppressive
302784|NCT02329808|antifungal|antifungal
302785|NCT02329769|Duchenne muscular dystrophy|duchenne muscular dystrophy
302786|NCT02329769|DMD|dmd
302787|NCT02329769|BioMarin|biomarin
302788|NCT02329769|PRO044|pro044
302789|NCT02329756|Tranexamic Acid|tranexamic acid
302790|NCT02329730|diagnosis of Tuberculosis (TB)|diagnosis of tuberculosis (tb)
302791|NCT02329730|ESAT6|esat6
302792|NCT02329730|CFP10|cfp10
302793|NCT02329730|Phase IIa Clinical Trial|phase iia clinical trial
302794|NCT02329704|IUI/AIH|iui/aih
302795|NCT02329704|Semen preparation|semen preparation
302796|NCT02329704|Semen processing|semen processing
302797|NCT02329704|ICSI/IVF|icsi/ivf
302798|NCT02329704|ART|art
302799|NCT02329704|Density Gradient|density gradient
302800|NCT02329704|Swimming down|swimming down
302801|NCT02329704|hyaluronan affinity testing|hyaluronan affinity testing
302802|NCT02329704|Sperm vitality testin|sperm vitality testin
302803|NCT02329691|safety climate|safety climate
302804|NCT02329691|surgery|surgery
302805|NCT02329678|Apicomarginal defects|apicomarginal defects
302806|NCT02329678|clinical study/trial|clinical study/trial
302807|NCT02329678|collagen membrane|collagen membrane
302808|NCT02329678|guided tissue regeneration|guided tissue regeneration
302809|NCT02329678|endodontic microsurgery|endodontic microsurgery
302810|NCT02329652|Neuroprosthesis|neuroprosthesis
302811|NCT02329652|Functional Electrical Stimulation|functional electrical stimulation
302812|NCT02329639|bevacizumab|bevacizumab
302813|NCT02329639|paclitaxel|paclitaxel
302814|NCT02329639|pharmacogenetics|pharmacogenetics
302815|NCT02329639|breast cancer|breast cancer
302816|NCT02329561|Pharmacokinetics|pharmacokinetics
302817|NCT02329561|Opioid|opioid
302818|NCT02329561|Geriatric|geriatric
302819|NCT02329561|Pharmacodynamics|pharmacodynamics
302820|NCT02329548|Alizarin|alizarin
302821|NCT02329548|Orthostatic|orthostatic
302822|NCT02329548|POTS|pots
302823|NCT02329548|Tilt table testing|tilt table testing
302824|NCT02329548|Syncope|syncope
302825|NCT02329548|Anxiety|anxiety
302826|NCT02329522|Haemodynamics|haemodynamics
302827|NCT02329522|Chronic obstructive pulmonary disease|chronic obstructive pulmonary disease
302828|NCT02329522|Ultrasonic Cardiac Output Monitor|ultrasonic cardiac output monitor
302829|NCT02329522|severity|severity
302830|NCT02329509|operative procedures|operative procedures
302831|NCT02329483|Infertility|infertility
302832|NCT02329483|Ovulation induction|ovulation induction
302833|NCT02329483|Low-dose step-up protocol|low-dose step-up protocol
302834|NCT02329483|Ovarian high responder|ovarian high responder
302835|NCT02329483|Androgens|androgens
302836|NCT02329483|Androstenedione|androstenedione
302837|NCT02329483|Testosterone|testosterone
302838|NCT02329483|rhFSH|rhfsh
302839|NCT02329457|double-blind, randomized, intradermal, VZVv, HSCT|double-blind, randomized, intradermal, vzvv, hsct
302840|NCT02329431|child mental health, mental health services, Latino families|child mental health, mental health services, latino families
302841|NCT02329340|child safety|child safety
302842|NCT02329340|injury|injury
302843|NCT02329340|prevention|prevention
302844|NCT02329340|computer|computer
302845|NCT02329340|internet|internet
302846|NCT02329327|Factor Xa Inhibitors|factor xa inhibitors
302847|NCT02329327|Major|major
302848|NCT02329327|Bleeding|bleeding
302849|NCT02329327|Anticoagulant|anticoagulant
302850|NCT02329301|malaria|malaria
302851|NCT02329301|malaria, falciparum|malaria, falciparum
302852|NCT02329301|antimalarials|antimalarials
302853|NCT02329262|exercise|exercise
302854|NCT02329262|mentors|mentors
302855|NCT02329262|health education|health education
302856|NCT02329262|obesity|obesity
302857|NCT02329249|smoking cessation|smoking cessation
302858|NCT02329249|coach-supported|coach-supported
302859|NCT02329249|tobacco use cessation|tobacco use cessation
302860|NCT02329249|online|online
302861|NCT02329249|internet-based|internet-based
302862|NCT02329249|tailored|tailored
302863|NCT02329223|Chronic spontaneous uriticaria|chronic spontaneous uriticaria
302864|NCT02329223|Omalizumab|omalizumab
302865|NCT02329197|Infertility|infertility
302866|NCT02329197|Invitro fertilization|invitro fertilization
302867|NCT02329145|renal denervation|renal denervation
302868|NCT02329132|diabetic macular edema|diabetic macular edema
302869|NCT02329132|VEGF|vegf
302870|NCT02329132|ranibizumab|ranibizumab
302871|NCT02329132|oxygen consumption|oxygen consumption
302872|NCT02329054|Ebola Virus Disease|ebola virus disease
302873|NCT02329054|Antivirals|antivirals
302874|NCT02329054|Mortality|mortality
302875|NCT02329054|Viral load|viral load
302876|NCT02329054|Proof-of-concept|proof-of-concept
302877|NCT02329054|Phase II trial|phase ii trial
302878|NCT02329054|Guinea|guinea
302879|NCT02329054|Adults|adults
302880|NCT02329054|Children|children
302881|NCT02329041|videolaryngoscope|videolaryngoscope
302882|NCT02329041|double-lumen tube|double-lumen tube
302883|NCT02329041|intubation|intubation
302884|NCT02329028|Emergency Care, Prehospital|emergency care, prehospital
302885|NCT02329028|Electroencephalography|electroencephalography
302886|NCT02329028|Coma|coma
302887|NCT02329015|stress|stress
302888|NCT02329015|alternative|alternative
302889|NCT02329015|complementary|complementary
302890|NCT02329015|self-regulation|self-regulation
302891|NCT02329002|Retinoblastoma|retinoblastoma
302892|NCT02329002|Second primary tumor|second primary tumor
302893|NCT02329002|Screening|screening
302894|NCT02329002|Magnetic resonance imaging|magnetic resonance imaging
302895|NCT02328989|prematurity|prematurity
302896|NCT02328989|short cervix|short cervix
302897|NCT02328989|twin pregnancy|twin pregnancy
302898|NCT02328989|pessary|pessary
302899|NCT02328963|Cytomegalovirus infection and disease|cytomegalovirus infection and disease
302900|NCT02328963|CMV-seropositive recipients|cmv-seropositive recipients
302901|NCT02328963|Everolimus|everolimus
302902|NCT02328963|preemptive strategy|preemptive strategy
302903|NCT02328963|mTOR inhibitor|mtor inhibitor
302904|NCT02328898|Polymer free stent|polymer free stent
302905|NCT02328898|percutaneous coronary intervention|percutaneous coronary intervention
302906|NCT02328885|high-risk acute leukemia|high-risk acute leukemia
302907|NCT02328885|graft versus leukemia|graft versus leukemia
302908|NCT02328885|DLI|dli
302909|NCT02328885|UCBT|ucbt
302910|NCT02328872|screening|screening
302911|NCT02328872|cervical screening|cervical screening
302912|NCT02328872|Human Papillomavirus (HPV)|human papillomavirus (hpv)
302913|NCT02328872|cancer prevention|cancer prevention
302914|NCT02328859|Gait|gait
302915|NCT02328859|Rehabilitation|rehabilitation
302916|NCT02328859|Virtual Reality|virtual reality
302917|NCT02328833|Depression|depression
302918|NCT02328833|Clinical Practice Guideline|clinical practice guideline
302919|NCT02328833|Implementation|implementation
302920|NCT02328833|Primary Care|primary care
302921|NCT02328833|Computerized Guideline|computerized guideline
302922|NCT02328820|Fractional Flow Reserve, Myocardial|fractional flow reserve, myocardial
302923|NCT02328820|Coronary Flow Reserve|coronary flow reserve
302924|NCT02328807|adenocarcinoma|adenocarcinoma
302925|NCT02328807|prostate|prostate
302926|NCT02328807|ENCAGE™|encage™
302927|NCT02328807|focal bipolar radiofrequency ablation|focal bipolar radiofrequency ablation
302928|NCT02328807|radiofrequency ablation (RFA)|radiofrequency ablation (rfa)
302929|NCT02328807|radiotherapy|radiotherapy
302930|NCT02328794|smoking cessation|smoking cessation
302931|NCT02328794|behavioral economics|behavioral economics
302932|NCT02328794|e-cigarettes|e-cigarettes
302933|NCT02328794|NRT|nrt
302934|NCT02328781|vertebral artery stenosis|vertebral artery stenosis
302935|NCT02328781|drug-eluting stent|drug-eluting stent
302936|NCT02328703|Reiki|reiki
302937|NCT02328703|Neuropathic Pain|neuropathic pain
760793|NCT00401648|epileptic|epileptic
302938|NCT02328703|Military Service Members|military service members
302939|NCT02328703|Extermity Trauma|extermity trauma
302940|NCT02328690|binaural beat technology|binaural beat technology
302941|NCT02328690|sound technology|sound technology
302942|NCT02328690|cardiovascular stress response|cardiovascular stress response
302943|NCT02328690|military|military
302944|NCT02328690|music|music
302945|NCT02328690|anxiety|anxiety
302946|NCT02328690|stress|stress
302947|NCT02328677|Colorectal cancer|colorectal cancer
302948|NCT02328677|rectosigmoid|rectosigmoid
302949|NCT02328677|rectum|rectum
302950|NCT02328677|colon|colon
302951|NCT02328664|Endoscopic resection|endoscopic resection
302952|NCT02328664|Pathology|pathology
302953|NCT02328664|Rescue surgery|rescue surgery
302954|NCT02328651|Mild and Moderate Severe Patients With hand_foot-mouth Disease|mild and moderate severe patients with hand_foot-mouth disease
302955|NCT02328638|ASD|asd
302956|NCT02328625|Scleroderma|scleroderma
302957|NCT02328625|Device|device
302958|NCT02328625|ADRCs|adrcs
302959|NCT02328625|adipose derived regenerative cells|adipose derived regenerative cells
302960|NCT02328625|hand|hand
302961|NCT02328547|fecal microbiota transplantation|fecal microbiota transplantation
302962|NCT02328547|diarrhea-predominant|diarrhea-predominant
302963|NCT02328534|ICSI/IVF|icsi/ivf
302964|NCT02328534|Semen processing|semen processing
302965|NCT02328534|Semen preparation|semen preparation
302966|NCT02328534|Swim down|swim down
302967|NCT02328534|Density gradient|density gradient
302968|NCT02328534|Silica solution|silica solution
302969|NCT02328521|Neointima|neointima
302970|NCT02328521|Tomography, Optical Coherence|tomography, optical coherence
302971|NCT02328521|drug-eluting stents|drug-eluting stents
302972|NCT02328521|Nicorandil|nicorandil
302973|NCT02328508|hyperbaric oxygen therapy|hyperbaric oxygen therapy
302974|NCT02328508|diabetic foot ulcer|diabetic foot ulcer
302975|NCT02328508|wound healing|wound healing
302976|NCT02328508|inflammation|inflammation
302977|NCT02328508|glycemic control|glycemic control
302978|NCT02328508|amputation|amputation
302979|NCT02328508|bacterial infection|bacterial infection
302980|NCT02328508|quality of life|quality of life
302981|NCT02328495|Misoprostol, Office hysteroscopy ,Pain|misoprostol, office hysteroscopy ,pain
302982|NCT02328469|aseptic meningitis|aseptic meningitis
302983|NCT02328469|tick-borne encephalitis|tick-borne encephalitis
302984|NCT02328469|Lyme neuroborreliosis|lyme neuroborreliosis
302985|NCT02328469|inflammation|inflammation
302986|NCT02328469|outcome|outcome
302987|NCT02328443|CYP3A|cyp3a
302988|NCT02328443|Metabolomics|metabolomics
302989|NCT02328404|Vitamin D|vitamin d
302990|NCT02328404|deficiency|deficiency
302991|NCT02328404|hypovitaminosis D|hypovitaminosis d
302992|NCT02328404|Biodal|biodal
302993|NCT02328404|25 hydroxy Vitamin D|25 hydroxy vitamin d
302994|NCT02328404|25hydroxyvitamin D|25hydroxyvitamin d
302995|NCT02328404|25(OH)D|25(oh)d
302996|NCT02328404|PCOS|pcos
302997|NCT02328404|insulin resistance|insulin resistance
302998|NCT02328404|BMI|bmi
302999|NCT02328404|chromium levels|chromium levels
303000|NCT02328404|vitamin D 3|vitamin d 3
303001|NCT02328404|cholecalciferol|cholecalciferol
303002|NCT02328404|50,000 IU|50,000 iu
303003|NCT02328365|Colorectal Cancer|colorectal cancer
303004|NCT02328365|Comorbidity|comorbidity
303005|NCT02328365|Perioperative Care|perioperative care
303006|NCT02328365|Surgery|surgery
303007|NCT02328352|Buckypaper (BP) of Multi-Walled Carbon Nanotubes (MWCNTs)|buckypaper (bp) of multi-walled carbon nanotubes (mwcnts)
303008|NCT02328352|surgical hernia prosthesis|surgical hernia prosthesis
303009|NCT02328352|abdominal wall defects surgery|abdominal wall defects surgery
303010|NCT02328352|prosthesis adhesion|prosthesis adhesion
303011|NCT02328352|disaster preparation and recovery hernia|disaster preparation and recovery hernia
303012|NCT02328352|Abdominal Wall Disaster Surgery|abdominal wall disaster surgery
303013|NCT02328352|Fixation of prosthetic materials in general surgery|fixation of prosthetic materials in general surgery
303014|NCT02328326|Diabetes|diabetes
303015|NCT02328326|diabetes self-management|diabetes self-management
303016|NCT02328326|patient activation|patient activation
303017|NCT02328326|social support|social support
303018|NCT02328313|Cancer|cancer
303019|NCT02328313|Breast Cancer|breast cancer
303020|NCT02328313|Geriatric|geriatric
303021|NCT02328313|Advance Age|advance age
303022|NCT02328313|Exercise|exercise
303023|NCT02328313|Physical Activity|physical activity
303024|NCT02328313|Genetic Marker|genetic marker
303025|NCT02328313|p16|p16
303026|NCT02328313|Chemotherapy|chemotherapy
303027|NCT02328313|Breast Cancer Treatment|breast cancer treatment
303028|NCT02328287|Spinal Fusion|spinal fusion
303029|NCT02328287|Revision Surgery|revision surgery
303030|NCT02328287|Pseudarthrosis|pseudarthrosis
303031|NCT02328287|Cell Therapy|cell therapy
303032|NCT02328287|Bone Graft|bone graft
303033|NCT02328235|skeletal muscle, metabolism, physiology|skeletal muscle, metabolism, physiology
303034|NCT02328222|Early steroid withdrawal|early steroid withdrawal
303035|NCT02328222|Acute allograft rejection|acute allograft rejection
303036|NCT02328222|Mycophenolate|mycophenolate
303037|NCT02328222|Tacrolimus|tacrolimus
303038|NCT02328222|Basiliximab|basiliximab
303039|NCT02328196|Outcome and Process Assessment (Health Care)|outcome and process assessment (health care)
303040|NCT02328196|Rasch analysis|rasch analysis
303041|NCT02328196|Meal time performance|meal time performance
303042|NCT02328183|polymyxin B|polymyxin b
303043|NCT02328183|carbapenem resistant bacteria|carbapenem resistant bacteria
303044|NCT02328170|immunoglobulin E, food hypersensitivities, child, allergens|immunoglobulin e, food hypersensitivities, child, allergens
303045|NCT02328144|Hemorrhoidectomy|hemorrhoidectomy
303046|NCT02328144|Postoperative pain|postoperative pain
303047|NCT02328144|Metronidazole|metronidazole
303048|NCT02328118|Lucentis|lucentis
303049|NCT02328118|Ranibizumab|ranibizumab
303050|NCT02328118|Triamcinolone Acetonide|triamcinolone acetonide
303051|NCT02328118|Vitrectomy|vitrectomy
303052|NCT02328118|PDR|pdr
303053|NCT02328079|Facial Palsy (acute), Acyclovir, Prednisolone|facial palsy (acute), acyclovir, prednisolone
303054|NCT02328066|NBI|nbi
303055|NCT02328066|NICE classification|nice classification
303056|NCT02328066|deep submucosal invasion|deep submucosal invasion
303057|NCT02328066|Colonic Polyps [C23.300.825.411.235]|colonic polyps [c23.300.825.411.235]
303058|NCT02328066|Colonoscopy [E01.370.372.250.250.200]|colonoscopy [e01.370.372.250.250.200]
303059|NCT02328053|fungal keratitis|fungal keratitis
303060|NCT02328053|collagen cross linking|collagen cross linking
303061|NCT02328040|Diabetes Mellitus, Type 1|diabetes mellitus, type 1
303062|NCT02328040|Closed loop|closed loop
303063|NCT02328040|Artificial Pancreas|artificial pancreas
303064|NCT02328040|Insulin|insulin
303065|NCT02328040|Sitagliptin|sitagliptin
303066|NCT02328040|Januvia|januvia
303067|NCT02328014|Bruton tyrosine kinase inhibitor|bruton tyrosine kinase inhibitor
303068|NCT02328014|Btk|btk
303069|NCT02328014|B-Cell Malignancies|b-cell malignancies
303070|NCT02328014|Mantle Cell|mantle cell
303071|NCT02328014|Multiple Myeloma|multiple myeloma
303072|NCT02328014|CLL|cll
303073|NCT02328014|SLL|sll
303074|NCT02328014|DLBCL|dlbcl
303075|NCT02328014|Follicular|follicular
303076|NCT02328014|Waldenstrom|waldenstrom
303077|NCT02328014|B-All|b-all
303078|NCT02327988|cryotherapy|cryotherapy
303079|NCT02327988|laser therapy|laser therapy
303080|NCT02327988|eccentric exercise|eccentric exercise
303081|NCT02327988|delayed onset muscle soreness|delayed onset muscle soreness
303082|NCT02327988|muscle damage|muscle damage
303083|NCT02327988|dynamometry|dynamometry
303084|NCT02327988|electromyography|electromyography
303085|NCT02327923|Laparoscopic cholecystectomy|laparoscopic cholecystectomy
303086|NCT02327923|lidocaine infusion|lidocaine infusion
303087|NCT02327923|Esmolol infusion|esmolol infusion
303088|NCT02327923|Postoperative opioid consumption|postoperative opioid consumption
303089|NCT02327923|Multimodal analgesia|multimodal analgesia
303090|NCT02327910|Elderly patients，|elderly patients，
303091|NCT02327910|General anesthesia，|general anesthesia，
303092|NCT02327910|Transcutaneous partial pressure of carbon dioxide(TcPCO2)，|transcutaneous partial pressure of carbon dioxide(tcpco2)，
303093|NCT02327910|Train-of-four(TOF)，|train-of-four(tof)，
303094|NCT02327910|Extubation|extubation
303095|NCT02327910|，Respiratory events|，respiratory events
303096|NCT02327897|Atopic Asthma|atopic asthma
303097|NCT02327897|Exposures|exposures
303098|NCT02327897|Disease Progression|disease progression
303099|NCT02327884|Genetics|genetics
303100|NCT02327884|Dry Mouth|dry mouth
303101|NCT02327884|Sjogren's Syndrome|sjogren's syndrome
303102|NCT02327884|Gland Dysfuntion|gland dysfuntion
303103|NCT02327884|Induced Pluripotent Stem Cell (iPS) Cell Lines|induced pluripotent stem cell (ips) cell lines
303104|NCT02327871|Therapeutic hypothermia|therapeutic hypothermia
303105|NCT02327871|patients|patients
303106|NCT02327871|Safety, Efficacy|safety, efficacy
303107|NCT02327845|natural history, biomarkers, phenotype, genotype|natural history, biomarkers, phenotype, genotype
303108|NCT02327832|Confirmation|confirmation
303109|NCT02327832|safety|safety
303110|NCT02327793|Perfusion|perfusion
303111|NCT02327793|Blood pressure|blood pressure
303112|NCT02327767|Active Assistance|active assistance
303113|NCT02327767|Resonance|resonance
303114|NCT02327767|Stroke|stroke
303115|NCT02327767|Arm Rehabilitation|arm rehabilitation
303116|NCT02327741|Dual antiplatelet therapy|dual antiplatelet therapy
303117|NCT02327741|clopidogrel|clopidogrel
303118|NCT02327741|percutaneous coronary intervention|percutaneous coronary intervention
303119|NCT02327728|blepharospasm|blepharospasm
303120|NCT02327728|botulinum A|botulinum a
303121|NCT02327728|injection pattern|injection pattern
303122|NCT02327728|tear|tear
303123|NCT02327715|Hepatitis B virus|hepatitis b virus
303124|NCT02327715|Emtricitabine|emtricitabine
303125|NCT02327715|Pregnancy|pregnancy
303126|NCT02327715|Vertical transmission|vertical transmission
303127|NCT02327702|Hepatitis B, chronic|hepatitis b, chronic
303128|NCT02327702|Emtricitabine|emtricitabine
303129|NCT02327702|Pregnancy|pregnancy
303130|NCT02327689|Hepatitis B virus|hepatitis b virus
303131|NCT02327689|Cirrhosis|cirrhosis
303132|NCT02327689|Emtricitabine|emtricitabine
303133|NCT02327689|Adefovir dipivoxil|adefovir dipivoxil
303134|NCT02327676|Hepatitis B, chronic|hepatitis b, chronic
303135|NCT02327676|Emtricitabine|emtricitabine
303136|NCT02327676|Child|child
303137|NCT02327663|Hepatitis B, chronic|hepatitis b, chronic
303138|NCT02327663|Emtricitabine|emtricitabine
303139|NCT02327663|Adefovir dipivixil|adefovir dipivixil
303140|NCT02327663|HBeAg|hbeag
303141|NCT02327637|Preterm Premature Rupture of the Membranes|preterm premature rupture of the membranes
303142|NCT02327637|Bedrest|bedrest
303143|NCT02327637|Physical Activity|physical activity
303144|NCT02327585|Executive function training|executive function training
303145|NCT02327585|child|child
303146|NCT02327559|childbirth|childbirth
303147|NCT02327559|mindfulness|mindfulness
303148|NCT02327559|fear of labor|fear of labor
303149|NCT02327559|labor pain|labor pain
303150|NCT02327559|coping|coping
303151|NCT02327559|self-efficacy|self-efficacy
303152|NCT02327559|childbirth satisfaction|childbirth satisfaction
303153|NCT02327559|depression|depression
303154|NCT02327546|Pharmacokinetics|pharmacokinetics
303155|NCT02327546|Anemia|anemia
303156|NCT02327546|Chronic kidney disease|chronic kidney disease
303158|NCT02327546|Chronic renal insufficiency|chronic renal insufficiency
303159|NCT02327546|Renal impairment|renal impairment
303160|NCT02327546|Ferrous sulfate|ferrous sulfate
303161|NCT02327546|Iron|iron
303162|NCT02327546|Drug-drug interaction|drug-drug interaction
303163|NCT02327546|End stage renal disease|end stage renal disease
303164|NCT02327546|Dialysis|dialysis
303165|NCT02327546|Erythropoietin|erythropoietin
303166|NCT02327546|Oral anemia treatment|oral anemia treatment
303167|NCT02327546|Hypoxia-induciable factor|hypoxia-induciable factor
303168|NCT02327546|HIF|hif
303169|NCT02327546|Hypoxia-induciable factor prolyl-hydroxylase inhibitor|hypoxia-induciable factor prolyl-hydroxylase inhibitor
303170|NCT02327546|HIF-PHI|hif-phi
303171|NCT02327533|generalized aggressive periodontitis|generalized aggressive periodontitis
303172|NCT02327533|microarray analysis|microarray analysis
303173|NCT02327520|Clostridium difficile infection|clostridium difficile infection
303174|NCT02327520|burden|burden
303175|NCT02327520|nationwide study|nationwide study
303176|NCT02327520|South East Asia|south east asia
303177|NCT02327520|Thailand|thailand
303178|NCT02327520|Epidemiology|epidemiology
303179|NCT02327520|Outcome Assessment (Health Care) [N04.761.559.590]|outcome assessment (health care) [n04.761.559.590]
303180|NCT02327507|children|children
303181|NCT02327507|fluoridated toothpaste|fluoridated toothpaste
303182|NCT02327507|health education|health education
303183|NCT02327507|Medicaid|medicaid
303184|NCT02327494|Neuromuscular blockade|neuromuscular blockade
303185|NCT02327494|Laparoscopy|laparoscopy
303186|NCT02327494|Oxygen measurements|oxygen measurements
303187|NCT02327481|Stomach Neoplasms Laparoscopy|stomach neoplasms laparoscopy
303188|NCT02327442|chemokine receptor|chemokine receptor
303189|NCT02327442|galium|galium
303190|NCT02327442|dosimetry|dosimetry
303191|NCT02327442|glioma|glioma
303192|NCT02327403|Proteinuria|proteinuria
303193|NCT02327403|Kidney transplantation|kidney transplantation
303194|NCT02327403|Allograft dysfunction|allograft dysfunction
303195|NCT02327403|B7-1|b7-1
303196|NCT02327403|Belatacept|belatacept
303197|NCT02327377|Irritable bowel syndrome|irritable bowel syndrome
303198|NCT02327377|Intervention studies|intervention studies
303199|NCT02327377|Visceral pain|visceral pain
303200|NCT02327377|Chronic pain|chronic pain
303201|NCT02327377|Abdominal pain|abdominal pain
303202|NCT02327377|Dyspepsia|dyspepsia
303203|NCT02327377|Nausea|nausea
303204|NCT02327377|Nociception|nociception
303205|NCT02327377|Parents|parents
303206|NCT02327377|Coping behavior|coping behavior
303207|NCT02327377|Anxiety|anxiety
303208|NCT02327377|Depression|depression
303209|NCT02327377|Catastrophization|catastrophization
303210|NCT02327377|Reinforcement (psychology)|reinforcement (psychology)
303211|NCT02327377|Self efficacy|self efficacy
303212|NCT02327377|Health services overutilization|health services overutilization
303213|NCT02327377|Questionnaires|questionnaires
303214|NCT02327377|Self report|self report
303215|NCT02327377|Health surveys|health surveys
303216|NCT02327377|Prospective studies|prospective studies
303217|NCT02327377|Adolescent health|adolescent health
303218|NCT02327377|Mental health services|mental health services
303219|NCT02327377|Health services accessibility|health services accessibility
303220|NCT02327377|Health diaries|health diaries
303221|NCT02327377|National Institute of Child Health & Human Development (US.)|national institute of child health & human development (us.)
303222|NCT02327377|Telemedicine|telemedicine
303223|NCT02327377|E-Health|e-health
303224|NCT02327377|Web-based intervention|web-based intervention
303225|NCT02327377|Parenting education|parenting education
303226|NCT02327325|Low Back Pain|low back pain
303227|NCT02327325|Exercise|exercise
303228|NCT02327325|Cognitive Behavioral Therapy|cognitive behavioral therapy
303229|NCT02327325|Aged|aged
303230|NCT02327299|Iron deficiency|iron deficiency
303231|NCT02327299|Iron fortification|iron fortification
303232|NCT02327286|Diabetes Mellitus|diabetes mellitus
303233|NCT02327286|Gestational diabetes|gestational diabetes
303234|NCT02327273|subjects|subjects
303235|NCT02327221|Crohn Disease|crohn disease
303236|NCT02327221|Cell therapy|cell therapy
303237|NCT02327221|Regulatory T lymphocytes|regulatory t lymphocytes
303238|NCT02327221|Treg|treg
303239|NCT02327221|Autologous|autologous
303240|NCT02327221|Antigen specific T regulatory lymphocytes|antigen specific t regulatory lymphocytes
303241|NCT02327208|Military Training|military training
303242|NCT02327208|Whey Protein|whey protein
303243|NCT02327208|Body Composition|body composition
303244|NCT02327182|MT-4666|mt-4666
303245|NCT02327182|α7 nicotinic acetylcholine receptor agonist|α7 nicotinic acetylcholine receptor agonist
303246|NCT02327182|Alzheimer's Disease|alzheimer's disease
303247|NCT02327182|Cognitive function|cognitive function
303248|NCT02327182|Dementia|dementia
303249|NCT02327182|Central Nervous System Agents|central nervous system agents
303250|NCT02327169|Drug therapy|drug therapy
303251|NCT02327156|Dexmedetomidine|dexmedetomidine
303252|NCT02327104|mindfulness|mindfulness
303253|NCT02327104|tobacco dependence|tobacco dependence
303254|NCT02327104|relapse prevention|relapse prevention
303255|NCT02327091|Alfacalcidol|alfacalcidol
303256|NCT02327091|Falls|falls
303257|NCT02327091|Handgrip|handgrip
303258|NCT02327091|Muscle strength|muscle strength
303259|NCT02327091|Sarcopenia|sarcopenia
303261|NCT02327065|FNA|fna
303262|NCT02327065|FNB|fnb
303263|NCT02327052|Chagas disease|chagas disease
303264|NCT02327052|longitudinal global strain|longitudinal global strain
303265|NCT02327052|speckle tracking|speckle tracking
303266|NCT02327026|Out-of-hospital cardiac arrest|out-of-hospital cardiac arrest
303267|NCT02327026|Bag-valve-mask ventilation|bag-valve-mask ventilation
303268|NCT02327026|Tracheal intubation|tracheal intubation
303269|NCT02326961|osteoarthritis|osteoarthritis
303270|NCT02326961|knee|knee
303271|NCT02326961|adipose derived regenerative cells|adipose derived regenerative cells
303272|NCT02326961|ADRC|adrc
303273|NCT02326961|Celution|celution
303274|NCT02326961|arthritis|arthritis
303275|NCT02326948|Gallbladder cancer|gallbladder cancer
303276|NCT02326948|Case-control study|case-control study
303277|NCT02326948|Risk factor|risk factor
303278|NCT02326948|Alcohol consumption|alcohol consumption
303279|NCT02326948|Polypoid lesions of gallbladder|polypoid lesions of gallbladder
303280|NCT02326948|Biliary stone|biliary stone
303281|NCT02326935|MS|ms
303282|NCT02326935|Multiple Sclerosis, Relapsing-Remitting|multiple sclerosis, relapsing-remitting
303283|NCT02326935|Multiple Sclerosis, Chronic Progressive|multiple sclerosis, chronic progressive
303284|NCT02326935|Myelitis|myelitis
303285|NCT02326922|Dysfunctional uterine bleeding|dysfunctional uterine bleeding
303286|NCT02326922|Metraplant-E|metraplant-e
303287|NCT02326922|Levonorgestrel-releasing intrauterine device|levonorgestrel-releasing intrauterine device
303288|NCT02326922|Endometrial decidualization|endometrial decidualization
303289|NCT02326909|Upper Urinary Tract|upper urinary tract
303290|NCT02326909|Optical Coherence Tomography|optical coherence tomography
303291|NCT02326909|Transitional Cell Carcinoma|transitional cell carcinoma
303292|NCT02326909|Urothelial Cell Carcinoma|urothelial cell carcinoma
303293|NCT02326909|Diagnostic accuracy|diagnostic accuracy
303294|NCT02326896|intubation|intubation
303295|NCT02326896|intensive care unit|intensive care unit
303296|NCT02326896|MACOCHA Score|macocha score
303297|NCT02326870|laparoscopic Cholecystectomy|laparoscopic cholecystectomy
303298|NCT02326870|laparoscope holder|laparoscope holder
303299|NCT02326870|gynecological laparoscopy procedures|gynecological laparoscopy procedures
303300|NCT02326870|fundoplication surgery|fundoplication surgery
303301|NCT02326870|laparoscopic adnexal surgery|laparoscopic adnexal surgery
303302|NCT02326870|excision of endometriosis lesion|excision of endometriosis lesion
303303|NCT02326870|diagnostic laparoscopy procedures|diagnostic laparoscopy procedures
303304|NCT02326870|right hemicolectomy|right hemicolectomy
303305|NCT02326870|Diaphragmatic hernia|diaphragmatic hernia
303306|NCT02326857|Molecular Profiles of Breast Cancer in Latin American Women|molecular profiles of breast cancer in latin american women
303307|NCT02326857|AJCC 7 Clinical Stage II to III|ajcc 7 clinical stage ii to iii
303308|NCT02326857|Breast Cancer Observational Study|breast cancer observational study
303309|NCT02326857|Prospective Cohort|prospective cohort
303310|NCT02326857|Epidemiological, Histological, and Clinical Data|epidemiological, histological, and clinical data
303311|NCT02326844|Germline BRCA1/2 Mutations (gBRCAm)|germline brca1/2 mutations (gbrcam)
303312|NCT02326844|DNA Damaging Agents|dna damaging agents
303313|NCT02326844|FOX03a, 53BP1 and RAD51|fox03a, 53bp1 and rad51
303314|NCT02326818|Dystonia|dystonia
303315|NCT02326818|Botulinum Toxin|botulinum toxin
303316|NCT02326818|Musician's Dystonia|musician's dystonia
303317|NCT02326818|Spasticity|spasticity
303318|NCT02326792|Exercise|exercise
303319|NCT02326792|Training|training
303320|NCT02326792|Low back Pain|low back pain
303321|NCT02326792|Physical Therapy|physical therapy
303322|NCT02326779|esophageal cancer|esophageal cancer
303323|NCT02326779|aspirin|aspirin
303324|NCT02326779|survival|survival
303325|NCT02326740|Pyoderma Gangrenosum|pyoderma gangrenosum
303326|NCT02326740|Classic Pyoderma Gangrenosum|classic pyoderma gangrenosum
303327|NCT02326727|Epidural Analgesia|epidural analgesia
303328|NCT02326727|Natural Killer Cells|natural killer cells
303329|NCT02326675|Etoposide|etoposide
303330|NCT02326675|Cryotherapy|cryotherapy
303331|NCT02326662|spinal cord injury|spinal cord injury
303332|NCT02326662|neural stem cells|neural stem cells
303333|NCT02326662|paraplegia|paraplegia
303334|NCT02326662|transplantation|transplantation
303335|NCT02326649|cardiac output|cardiac output
303336|NCT02326610|Small for gestational age (SGA)|small for gestational age (sga)
303337|NCT02326610|Human growth hormone (hGH)|human growth hormone (hgh)
303338|NCT02326597|Hydroxyurea|hydroxyurea
303339|NCT02326597|Bone marrow transplant|bone marrow transplant
303340|NCT02326597|Chronic blood transfusion|chronic blood transfusion
303341|NCT02326597|Treatment options for sickle cell disease|treatment options for sickle cell disease
303342|NCT02326597|Decision making|decision making
303343|NCT02326584|Acute Myeloid Leukemia|acute myeloid leukemia
303344|NCT02326584|Antibody-Drug Conjugate|antibody-drug conjugate
303345|NCT02326584|CD33 Antigen|cd33 antigen
303346|NCT02326584|Drug Therapy|drug therapy
303347|NCT02326584|Acute Myelogenous Leukemia|acute myelogenous leukemia
303348|NCT02326571|EEG|eeg
303349|NCT02326571|Cortical Spreading Depression|cortical spreading depression
303350|NCT02326571|Cerebral Hemorrhage|cerebral hemorrhage
303351|NCT02326571|miRNA|mirna
303352|NCT02326571|Reactivity in EEG|reactivity in eeg
303353|NCT02326571|Multimodal monitoring|multimodal monitoring
303354|NCT02326558|zero ischemia|zero ischemia
303355|NCT02326558|microwave|microwave
303356|NCT02326558|ablation|ablation
303357|NCT02326558|enucleation|enucleation
303358|NCT02326558|renal cell carcinoma|renal cell carcinoma
303359|NCT02326545|Video Games|video games
303360|NCT02326545|Child|child
303361|NCT02326545|Adolescent|adolescent
303362|NCT02326532|Rheumatoid Arthritis|rheumatoid arthritis
303363|NCT02326532|Veterans|veterans
303364|NCT02326506|Extracorporeal Membrane Oxygenation|extracorporeal membrane oxygenation
303365|NCT02326506|Cardiopulmonary Bypass|cardiopulmonary bypass
303366|NCT02326493|Cardiac Resynchronization Therapy|cardiac resynchronization therapy
303367|NCT02326493|LV lead position|lv lead position
303368|NCT02326493|Device programming|device programming
303369|NCT02326493|Optimization|optimization
303370|NCT02326493|Vectorcardiography|vectorcardiography
303371|NCT02326480|Childhood Obesity|childhood obesity
303372|NCT02326480|Genetics|genetics
303373|NCT02326467|chlorhexidine|chlorhexidine
303374|NCT02326467|safety|safety
303375|NCT02326467|bath|bath
303376|NCT02326467|rash|rash
303377|NCT02326467|infant|infant
303378|NCT02326441|advanced malignancies|advanced malignancies
303379|NCT02326441|refractory therapies|refractory therapies
303380|NCT02326441|phase 1|phase 1
303381|NCT02326428|Stroke|stroke
303382|NCT02326428|Cerebrovascular Accident|cerebrovascular accident
303383|NCT02326428|Brain ischemia|brain ischemia
303384|NCT02326428|Intravenous thrombolysis|intravenous thrombolysis
303385|NCT02326428|Stroke thrombectomy|stroke thrombectomy
303386|NCT02326428|Stent-retriever|stent-retriever
303387|NCT02326415|Acute Appendicitis|acute appendicitis
303388|NCT02326415|Appendectomy|appendectomy
303389|NCT02326415|Fast-Track|fast-track
303390|NCT02326415|Clinical Pathway|clinical pathway
303391|NCT02326402|Circulatory support|circulatory support
303392|NCT02326402|Extracorporeal circulatory support|extracorporeal circulatory support
303393|NCT02326402|Extracorporeal bypass|extracorporeal bypass
303394|NCT02326389|Cognitive functioning|cognitive functioning
303395|NCT02326363|substance abuse|substance abuse
303396|NCT02326363|Mental Health Disorders|mental health disorders
303397|NCT02326350|Acute Respiratory Distress syndrome|acute respiratory distress syndrome
303398|NCT02326350|Aspirin|aspirin
303399|NCT02326298|Certolizumab Pegol|certolizumab pegol
303400|NCT02326298|Cimzia|cimzia
303401|NCT02326298|Psoriasis|psoriasis
303402|NCT02326285|induction therapy|induction therapy
303403|NCT02326285|NSCLC|nsclc
303404|NCT02326285|Non-small Cell Lung Cancer|non-small cell lung cancer
303405|NCT02326285|curative surgery|curative surgery
303406|NCT02326272|Certolizumab Pegol|certolizumab pegol
303407|NCT02326272|Cimzia|cimzia
303408|NCT02326272|Psoriasis|psoriasis
303409|NCT02326259|Diabetic Retinopathy|diabetic retinopathy
303410|NCT02326259|Disease Progression|disease progression
303411|NCT02326246|MRI|mri
303412|NCT02326246|active surveillance|active surveillance
303413|NCT02326207|Infant, Newborn|infant, newborn
303414|NCT02326207|Neonatal intensive care unit|neonatal intensive care unit
303415|NCT02326207|Ventilator circuit|ventilator circuit
303416|NCT02326194|Safety,immunogenicity,Ebola|safety,immunogenicity,ebola
303417|NCT02326181|respiratory muscle training|respiratory muscle training
303418|NCT02326181|respiratory muscle strength|respiratory muscle strength
303419|NCT02326181|respiratory endurance test|respiratory endurance test
761082|NCT00400556|retinoids|retinoids
303420|NCT02326181|6-minute walking test|6-minute walking test
303421|NCT02326142|Premature Obstetric Labor|premature obstetric labor
303422|NCT02326142|Premature Birth|premature birth
303423|NCT02326103|alcoholic|alcoholic
303424|NCT02326103|hepatitis|hepatitis
303425|NCT02326103|cirrhosis|cirrhosis
303426|NCT02326103|cholesterol metabolites|cholesterol metabolites
303427|NCT02326103|ciprofloxacin|ciprofloxacin
303428|NCT02326077|sonopartogram|sonopartogram
303429|NCT02326077|transperineal ultrasound|transperineal ultrasound
303430|NCT02326077|intrapartum ultrasound|intrapartum ultrasound
303431|NCT02326077|labor|labor
303432|NCT02326077|delivery|delivery
303433|NCT02326077|partogram|partogram
303434|NCT02326077|ultrasound|ultrasound
303435|NCT02326051|Antiphospholipid syndrome|antiphospholipid syndrome
303436|NCT02326051|APS|aps
303437|NCT02326051|LMWH|lmwh
303438|NCT02326038|Memory|memory
303439|NCT02326038|Attention|attention
303440|NCT02326038|MCI|mci
303441|NCT02326038|Ritalin|ritalin
303442|NCT02325999|Endoscopic Submucosal Dissection|endoscopic submucosal dissection
303443|NCT02325999|Laparoscopic Regional Lymph node Dissection|laparoscopic regional lymph node dissection
303444|NCT02325999|early gastric cancer|early gastric cancer
303445|NCT02325999|Disease-free survival|disease-free survival
303446|NCT02325986|radiotherapy|radiotherapy
303447|NCT02325986|esophageal carcinoma|esophageal carcinoma
303448|NCT02325986|chemotherapy|chemotherapy
303449|NCT02325973|STEMI|stemi
303450|NCT02325973|IMR|imr
303451|NCT02325973|FFR|ffr
303452|NCT02325973|microcirculatory|microcirculatory
303453|NCT02325960|exenatide|exenatide
303454|NCT02325960|insulin glargine|insulin glargine
303455|NCT02325947|Post stroke hand paresis brain injury|post stroke hand paresis brain injury
303456|NCT02325934|Stribild|stribild
303457|NCT02325934|pharmacokinetics|pharmacokinetics
303458|NCT02325934|Crushing|crushing
303459|NCT02325934|Drip feed|drip feed
303460|NCT02325921|Magnetic Resonance Imaging|magnetic resonance imaging
303461|NCT02325921|Diffusion Weighted MRI|diffusion weighted mri
303462|NCT02325921|Diffusion Tensor Imaging|diffusion tensor imaging
303463|NCT02325908|Hemodialysis|hemodialysis
303464|NCT02325908|Estimated Dry Weight|estimated dry weight
303465|NCT02325895|Osteoporosis|osteoporosis
303466|NCT02325895|Dried plum|dried plum
303467|NCT02325895|functional food|functional food
303468|NCT02325869|Acute Coronary Syndrome, Coronary Occlusion, catheter|acute coronary syndrome, coronary occlusion, catheter
303469|NCT02325856|Hemodialysis|hemodialysis
303470|NCT02325856|Body Composition Monitor|body composition monitor
303471|NCT02325830|Functional mitral regurgitation|functional mitral regurgitation
303472|NCT02325830|Secondary mitral regurgitation|secondary mitral regurgitation
303473|NCT02325830|Percutaneous mitral repair|percutaneous mitral repair
303474|NCT02325817|Bifurcation Lesions|bifurcation lesions
303475|NCT02325817|drug eluting balloon|drug eluting balloon
303476|NCT02325817|paclitaxel|paclitaxel
303477|NCT02325817|drug coated balloon|drug coated balloon
303478|NCT02325804|overweight and obesity|overweight and obesity
303479|NCT02325804|adipose tissue|adipose tissue
303480|NCT02325804|weight loss program|weight loss program
303481|NCT02325804|low-calorie diet|low-calorie diet
303482|NCT02325804|circuit-based exercise|circuit-based exercise
303483|NCT02325804|metabolic cardiovascular syndrome|metabolic cardiovascular syndrome
303484|NCT02325765|congential cardiac surgery|congential cardiac surgery
303485|NCT02325765|nuclearsome|nuclearsome
303486|NCT02325765|systemic inflammation response syndrome|systemic inflammation response syndrome
303487|NCT02325752|readmission|readmission
303488|NCT02325752|chronic diseases|chronic diseases
303489|NCT02325739|FGF401, PDR001, PD-1, FGFR4, FGF19, HCC|fgf401, pdr001, pd-1, fgfr4, fgf19, hcc
303490|NCT02325726|Cardiac surgery|cardiac surgery
303491|NCT02325726|Extracorporeal circulation|extracorporeal circulation
303492|NCT02325726|Renal failure|renal failure
303493|NCT02325713|ODT-PZQ|odt-pzq
303494|NCT02325713|Bio-availability|bio-availability
303495|NCT02325713|Praziquantel|praziquantel
303496|NCT02325713|Cysticide|cysticide
303497|NCT02325713|Pharmacokinetics|pharmacokinetics
303498|NCT02325687|Obstructive Sleep Apnea|obstructive sleep apnea
303499|NCT02325687|Arthroplasty, Replacement, Knee|arthroplasty, replacement, knee
303500|NCT02325687|Cerebrospinal Fluid|cerebrospinal fluid
303501|NCT02325687|Inflammation|inflammation
303502|NCT02325687|TNF-alpha|tnf-alpha
303503|NCT02325687|Interleukin-6 (IL-6)|interleukin-6 (il-6)
303504|NCT02325687|Interleukin-8 (IL-8)|interleukin-8 (il-8)
303505|NCT02325687|Interleukin-10 (IL-10)|interleukin-10 (il-10)
303506|NCT02325687|Cytokines|cytokines
303507|NCT02325687|Neurotrophins|neurotrophins
303508|NCT02325687|BDNF|bdnf
303509|NCT02325687|Beta-NGF|beta-ngf
303510|NCT02325687|Proteomic Analysis|proteomic analysis
303511|NCT02325674|Lipodystrophy|lipodystrophy
303512|NCT02325674|Metreleptin Registry|metreleptin registry
303513|NCT02325635|Adenoma Detection|adenoma detection
303514|NCT02325635|Adenoma Prediction|adenoma prediction
303515|NCT02325596|Chronic rhinosinusitis|chronic rhinosinusitis
303516|NCT02325596|microRNA|microrna
303517|NCT02325596|dendritic cell|dendritic cell
303518|NCT02325596|helper T cell|helper t cell
303519|NCT02325583|Intraoral 30% glucose, newborn, MRI|intraoral 30% glucose, newborn, mri
303520|NCT02325544|dissociative seizures,|dissociative seizures,
303521|NCT02325544|psychogenic nonepileptic seizures|psychogenic nonepileptic seizures
303522|NCT02325531|implementation strategies|implementation strategies
303523|NCT02325531|diabetes mellitus|diabetes mellitus
303524|NCT02325531|cardiovascular disease|cardiovascular disease
303525|NCT02325531|community health centers|community health centers
303526|NCT02325531|quality improvement|quality improvement
303527|NCT02325531|translational medical research|translational medical research
303528|NCT02325518|Open-angle glaucoma (OAG)|open-angle glaucoma (oag)
303529|NCT02325518|Ocular hypertension (OHT)|ocular hypertension (oht)
303530|NCT02325518|AZORGA®|azorga®
303531|NCT02325518|COSOPT®|cosopt®
303532|NCT02325492|bariatric surgery|bariatric surgery
303533|NCT02325492|NASH|nash
303534|NCT02325492|ARAMCHOL|aramchol
303535|NCT02325479|Low Molecular Weight (LMWH) Heparin ICSI Enaoxaprin sodium|low molecular weight (lmwh) heparin icsi enaoxaprin sodium
303536|NCT02325466|Peripheral Artery Disease|peripheral artery disease
303537|NCT02325466|Type 2 Diabetes|type 2 diabetes
303538|NCT02325466|Blood Viscosity|blood viscosity
303539|NCT02325466|Ticagrelor|ticagrelor
303540|NCT02325466|Aspirin|aspirin
303541|NCT02325453|Robotic Surgery|robotic surgery
303542|NCT02325453|Laparoscopic Surgery|laparoscopic surgery
303543|NCT02325453|Minimally Invasive Surgery|minimally invasive surgery
303544|NCT02325453|Robotic Gastrectomy|robotic gastrectomy
303545|NCT02325453|Laparoscopic Gastrectomy|laparoscopic gastrectomy
303546|NCT02325453|Open Gastrectomy|open gastrectomy
303547|NCT02325453|Gastric Surgery|gastric surgery
303548|NCT02325440|RRMS (relapsing remitting multiple sclerosis)|rrms (relapsing remitting multiple sclerosis)
303549|NCT02325440|Cluster of differentiation 49d (CD49d)|cluster of differentiation 49d (cd49d)
303550|NCT02325440|immune function|immune function
303551|NCT02325440|disease activity|disease activity
303552|NCT02325427|stroke|stroke
303553|NCT02325427|rehabilitation|rehabilitation
303554|NCT02325427|upper limb|upper limb
303555|NCT02325427|TMS|tms
303556|NCT02325427|tDCS|tdcs
303557|NCT02325414|Osteoporosis|osteoporosis
303558|NCT02325414|Spinal Cord Injury|spinal cord injury
303559|NCT02325414|Bone Diseases|bone diseases
303560|NCT02325414|Metabolic Bone Diseases|metabolic bone diseases
303561|NCT02325414|Musculoskeletal Diseases|musculoskeletal diseases
303562|NCT02325414|Spinal Cord Diseases|spinal cord diseases
303563|NCT02325414|Central Nervous System Diseases|central nervous system diseases
303564|NCT02325414|Nervous System Diseases|nervous system diseases
303565|NCT02325414|Nervous System|nervous system
303566|NCT02325414|Wounds and Injuries|wounds and injuries
303567|NCT02325414|Bone Density Conservation Agents|bone density conservation agents
303568|NCT02325414|Physiological Effects of Drugs|physiological effects of drugs
303569|NCT02325414|Pharmacologic Actions|pharmacologic actions
303570|NCT02325414|Department of Defense|department of defense
303571|NCT02325388|pressure ulcer|pressure ulcer
303572|NCT02325388|decubitus ulcer|decubitus ulcer
303573|NCT02325388|bed sore|bed sore
303574|NCT02325388|continuous pressure mapping|continuous pressure mapping
303575|NCT02325388|interface pressure imaging|interface pressure imaging
303576|NCT02325375|Amyotrophic Lateral Sclerosis|amyotrophic lateral sclerosis
303577|NCT02325375|spinal fluid|spinal fluid
303578|NCT02325375|CD163|cd163
303579|NCT02325362|Cystic fibrosis|cystic fibrosis
303580|NCT02325362|CFTR|cftr
303581|NCT02325362|F508del mutation|f508del mutation
303582|NCT02325362|Miglustat|miglustat
303583|NCT02325362|Total Chloride Secretion|total chloride secretion
303584|NCT02325362|Nasal Potential Difference|nasal potential difference
303585|NCT02325349|Angiogenesis|angiogenesis
303586|NCT02325349|Integrins|integrins
303587|NCT02325349|RGD PET/CT|rgd pet/ct
303588|NCT02325349|FDG PET/CT|fdg pet/ct
303589|NCT02325349|Predictive value|predictive value
303590|NCT02325349|Therapeutic response|therapeutic response
303591|NCT02325349|Efficacy|efficacy
303592|NCT02325349|Tolerability|tolerability
303593|NCT02325336|Medication Errors|medication errors
303594|NCT02325336|nurses|nurses
303595|NCT02325336|hospital|hospital
303596|NCT02325323|stomach cancer|stomach cancer
303597|NCT02325323|gastric intestinal metaplasia|gastric intestinal metaplasia
303598|NCT02325323|prospective cohort|prospective cohort
303599|NCT02325323|low grade dysplasia|low grade dysplasia
303600|NCT02325323|high grade dysplasia|high grade dysplasia
303601|NCT02325323|prognosis factor|prognosis factor
303602|NCT02325323|gastric cancer risks|gastric cancer risks
303603|NCT02325310|Vaccine strain excretion in breast milk|vaccine strain excretion in breast milk
303604|NCT02325310|Postpartum vaccination|postpartum vaccination
303605|NCT02325310|Breastfeeding women|breastfeeding women
303606|NCT02325310|Measles-mumps-rubella vaccine|measles-mumps-rubella vaccine
303607|NCT02325310|Breast milk|breast milk
303608|NCT02325310|Vaccinology|vaccinology
303609|NCT02325297|Intensive care unit|intensive care unit
303610|NCT02325258|Sepsis diagnosis|sepsis diagnosis
303611|NCT02325258|Sepsis drug therapy|sepsis drug therapy
303612|NCT02325258|Sepsis outcome|sepsis outcome
303613|NCT02325245|Frailty|frailty
303614|NCT02325245|Pre-frailty|pre-frailty
303615|NCT02325245|Metformin|metformin
303616|NCT02325245|Elderly|elderly
303617|NCT02325245|Quality of life|quality of life
303618|NCT02325245|Handgrip|handgrip
303619|NCT02325245|Gait speed|gait speed
303620|NCT02325245|Myostatin|myostatin
303621|NCT02325219|Psoriasis|psoriasis
303622|NCT02325219|CNTO 1959|cnto 1959
303623|NCT02325219|Guselkumab|guselkumab
303624|NCT02325219|Placebo|placebo
303625|NCT02325180|ACT|act
303626|NCT02325180|Plasmodium falciparum|plasmodium falciparum
303627|NCT02325180|malaria|malaria
303628|NCT02325180|efficacy|efficacy
303629|NCT02325180|Indonesia|indonesia
303630|NCT02325167|informal caregivers|informal caregivers
303631|NCT02325167|mental stress|mental stress
303632|NCT02325167|quality of life|quality of life
303927|NCT02323529|NTBC|ntbc
303633|NCT02325167|psychotherapeutic intervention|psychotherapeutic intervention
303634|NCT02325128|social anxiety|social anxiety
303635|NCT02325128|exposure therapy|exposure therapy
303636|NCT02325128|extinction|extinction
303637|NCT02325128|sleep-dependent memory consolidation|sleep-dependent memory consolidation
303638|NCT02325115|well-being, mental health, schizophrenia, quality of life|well-being, mental health, schizophrenia, quality of life
303639|NCT02325089|Elderly|elderly
303640|NCT02325089|Obstructive Sleep Apnea|obstructive sleep apnea
303641|NCT02325089|Mandibular advancement oral appliance|mandibular advancement oral appliance
303642|NCT02325089|Hypertension|hypertension
303643|NCT02325089|Cardiovascular disease|cardiovascular disease
303644|NCT02325089|Quality of life|quality of life
303645|NCT02325076|Airway Management|airway management
303646|NCT02325076|intubation|intubation
303647|NCT02325076|pulmonary function test|pulmonary function test
303648|NCT02325050|Healthy|healthy
303649|NCT02325050|Ebola viruses|ebola viruses
303650|NCT02325050|Ebola Viral Disease (EVD)|ebola viral disease (evd)
303651|NCT02325050|Filoviruses|filoviruses
303652|NCT02325050|monovalent vaccine|monovalent vaccine
303653|NCT02325050|Human adenovirus serotype 26 (Ad26) expressing the Ebola virus Mayinga variant glycoprotein (Ad26.ZEBOV)|human adenovirus serotype 26 (ad26) expressing the ebola virus mayinga variant glycoprotein (ad26.zebov)
303654|NCT02325050|Modified Vaccinia Virus Ankara - Bavarian Nordic (MVA-BN) Filo-vector|modified vaccinia virus ankara - bavarian nordic (mva-bn) filo-vector
303655|NCT02325050|Safety|safety
303656|NCT02325050|Immunogenicity|immunogenicity
303657|NCT02325024|Sativex|sativex
303658|NCT02325024|GW-1000-02|gw-1000-02
303659|NCT02325024|Nabiximols|nabiximols
303660|NCT02325024|Pharmacokinetics|pharmacokinetics
303661|NCT02325024|Renal Insufficiency|renal insufficiency
303662|NCT02325024|Chronic Kidney Failure|chronic kidney failure
303663|NCT02325011|Sativex|sativex
303664|NCT02325011|GW-1000-02|gw-1000-02
303665|NCT02325011|Nabiximols|nabiximols
303666|NCT02325011|Fluconazole|fluconazole
303667|NCT02325011|Pharmacokinetics|pharmacokinetics
303668|NCT02325011|Drug-drug interaction|drug-drug interaction
303669|NCT02324998|Radical Prostatectomy|radical prostatectomy
303670|NCT02324998|Prostate Cancer|prostate cancer
303671|NCT02324998|PARP inhibition|parp inhibition
303672|NCT02324998|Olaparib|olaparib
303673|NCT02324998|Degarelix|degarelix
303674|NCT02324998|Neoadjuvant|neoadjuvant
303675|NCT02324998|Pharmacodynamics|pharmacodynamics
303676|NCT02324998|Pharmacokinetics|pharmacokinetics
303677|NCT02324998|Biomarkers|biomarkers
303678|NCT02324985|muscle soreness|muscle soreness
303679|NCT02324972|Atopic dermatitis|atopic dermatitis
303680|NCT02324972|Eczema|eczema
303681|NCT02324972|AD|ad
303682|NCT02324972|AQX-1125|aqx-1125
303683|NCT02324972|SHIP1|ship1
303684|NCT02324946|Sleep Apnea Syndromes|sleep apnea syndromes
303685|NCT02324946|Perioperative Period|perioperative period
303686|NCT02324946|Mass Screening|mass screening
303687|NCT02324920|Syncope|syncope
303688|NCT02324920|Closed Loop Stimulation|closed loop stimulation
303689|NCT02324920|CLS|cls
303690|NCT02324894|screening|screening
303691|NCT02324894|MRI|mri
303692|NCT02324881|smartphone|smartphone
303693|NCT02324881|application|application
303694|NCT02324881|pain management|pain management
303695|NCT02324868|Bandages|bandages
303696|NCT02324868|Catheter|catheter
303697|NCT02324855|Autogenic drainage|autogenic drainage
303698|NCT02324855|Positive expiratory pressure|positive expiratory pressure
303699|NCT02324855|Airway clearance technique|airway clearance technique
303700|NCT02324855|Quality of life|quality of life
303701|NCT02324855|Exacerbations|exacerbations
303702|NCT02324855|Chest physiotherapy|chest physiotherapy
303703|NCT02324829|Total joint replacement|total joint replacement
303704|NCT02324829|Physiotherapy|physiotherapy
303705|NCT02324829|Kalman filtering|kalman filtering
303706|NCT02324829|Kinematic modeling|kinematic modeling
303707|NCT02324829|Hidden Markov model|hidden markov model
303708|NCT02324829|Motion segmentation|motion segmentation
303709|NCT02324790|OSA, Oral Pressure Therapy (OPT)|osa, oral pressure therapy (opt)
303710|NCT02324764|transradial coronary angiography|transradial coronary angiography
303711|NCT02324764|radial artery occlusion|radial artery occlusion
303712|NCT02324764|coronary heart disease|coronary heart disease
303713|NCT02324764|Glidesheath Slender|glidesheath slender
303714|NCT02324738|Mefloquine/Dihydroartemisinin-piperaquine|mefloquine/dihydroartemisinin-piperaquine
303715|NCT02324738|drug interaction|drug interaction
303716|NCT02324725|naltrexone|naltrexone
303717|NCT02324725|neuroimaging|neuroimaging
303718|NCT02324725|heroin|heroin
303719|NCT02324725|addiction|addiction
303720|NCT02324725|dependence|dependence
303721|NCT02324725|opioid|opioid
303722|NCT02324725|Vivitrol®|vivitrol®
303723|NCT02324725|functional magnetic resonance imaging|functional magnetic resonance imaging
303724|NCT02324699|Vedolizumab|vedolizumab
303725|NCT02324699|Corticosteroids|corticosteroids
303726|NCT02324699|Prednisone|prednisone
303727|NCT02324699|Crohn's disease|crohn's disease
303728|NCT02324686|Warfarin|warfarin
303729|NCT02324686|International Normalized Ratio|international normalized ratio
303730|NCT02324686|Vitamin K|vitamin k
303731|NCT02324673|Treatment-resistant seizures|treatment-resistant seizures
303732|NCT02324660|screening procedure|screening procedure
303733|NCT02324660|peak expiratory flow|peak expiratory flow
303734|NCT02324660|respiratory health screening questionnaire|respiratory health screening questionnaire
303735|NCT02324647|Urinary steroid profiling|urinary steroid profiling
303736|NCT02324647|Adrenal incidentaloma|adrenal incidentaloma
303737|NCT02324647|Adrenocortical carcinoma|adrenocortical carcinoma
303738|NCT02324647|cost-effectiveness|cost-effectiveness
303739|NCT02324621|protocol specific|protocol specific
303740|NCT02324595|Ovarian Cancer|ovarian cancer
303741|NCT02324595|Laparoscopy|laparoscopy
303742|NCT02324595|Neoadjuvant Chemotherapy|neoadjuvant chemotherapy
303743|NCT02324595|Robotic|robotic
303744|NCT02324595|Interval Debulking Surgery|interval debulking surgery
303745|NCT02324582|Urinary Bladder Neoplasms|urinary bladder neoplasms
303746|NCT02324582|Mycobacterium bovis|mycobacterium bovis
303747|NCT02324582|Programmed Cell Death 1 Receptor|programmed cell death 1 receptor
303748|NCT02324582|pembrolizumab|pembrolizumab
303749|NCT02324569|Pharmacological therapy|pharmacological therapy
303750|NCT02324556|Rectal Cancer|rectal cancer
303751|NCT02324556|Surgery|surgery
303752|NCT02324556|Laparoscopy|laparoscopy
303753|NCT02324517|response to various potential therapies as managed by lab assays|response to various potential therapies as managed by lab assays
303754|NCT02324504|Peripherally Inserted Central Catheter (PICC)|peripherally inserted central catheter (picc)
303755|NCT02324504|Electrocardiographic guidance|electrocardiographic guidance
303756|NCT02324504|Reposition|reposition
303757|NCT02324478|autonomic nervous system|autonomic nervous system
303758|NCT02324478|heart rate variability|heart rate variability
303759|NCT02324478|laparoscopic surgery|laparoscopic surgery
303760|NCT02324478|general anesthesia|general anesthesia
303761|NCT02324478|photoplethysmography|photoplethysmography
303762|NCT02324439|ovarian cancer|ovarian cancer
303763|NCT02324439|flaxseed|flaxseed
303764|NCT02324439|dietary supplement|dietary supplement
303765|NCT02324439|organic dietary supplement|organic dietary supplement
303766|NCT02324439|recurrence|recurrence
303767|NCT02324426|Parkinson's Disease|parkinson's disease
303768|NCT02324426|Reduced Glutathione|reduced glutathione
303770|NCT02324426|Glutathione|glutathione
303771|NCT02324426|Uptake|uptake
303772|NCT02324426|Intranasal|intranasal
303773|NCT02324426|(in)GSH|(in)gsh
303774|NCT02324387|Breast Cancer|breast cancer
303775|NCT02324387|Molecular breast imaging|molecular breast imaging
303776|NCT02324387|MBI|mbi
303777|NCT02324387|Tc99m sestamibi|tc99m sestamibi
303778|NCT02324387|Neoadjuvant chemotherapy|neoadjuvant chemotherapy
303779|NCT02324387|NAC|nac
303780|NCT02324374|colon cancer|colon cancer
303781|NCT02324361|Pediatric|pediatric
303782|NCT02324361|Obesity|obesity
303783|NCT02324361|Intervention|intervention
303784|NCT02324361|Information and Communication Technologies|information and communication technologies
303785|NCT02324361|Social Media|social media
303786|NCT02324361|Text Messaging|text messaging
303787|NCT02324361|Mobile Health|mobile health
303788|NCT02324335|Oral Mucositis|oral mucositis
303789|NCT02324335|Brilacidin|brilacidin
303790|NCT02324335|Chemoradiation|chemoradiation
303791|NCT02324322|Device: Robotic Exoskeleton|device: robotic exoskeleton
303792|NCT02324296|small cell lung cancer|small cell lung cancer
303793|NCT02324296|extended disease|extended disease
303794|NCT02324296|limited disease|limited disease
303795|NCT02324296|chemotherapy|chemotherapy
303796|NCT02324296|cisplatin|cisplatin
303797|NCT02324296|etoposide|etoposide
303798|NCT02324296|ifosfamide|ifosfamide
303799|NCT02324283|one-lung ventilation, oxygenation|one-lung ventilation, oxygenation
303800|NCT02324270|Pain due to ankle sprain|pain due to ankle sprain
303801|NCT02324244|Cytomegalovirus|cytomegalovirus
303802|NCT02324244|critical patient|critical patient
303803|NCT02324244|ICU|icu
388052|NCT01923818|TIA|tia
303804|NCT02324244|immunocompetent|immunocompetent
303805|NCT02324244|clinical suspicion|clinical suspicion
303806|NCT02324244|risk factors|risk factors
303807|NCT02324218|Diabetes mellitus|diabetes mellitus
303808|NCT02324218|Hepatitis B|hepatitis b
303809|NCT02324218|Incidence|incidence
303810|NCT02324192|Ultrasonography|ultrasonography
303811|NCT02324192|clinical|clinical
303812|NCT02324192|hand|hand
303813|NCT02324166|cefazolin|cefazolin
303814|NCT02324166|lidocaine|lidocaine
303815|NCT02324153|Post-operative Delirium|post-operative delirium
303816|NCT02324114|Cancer|cancer
303817|NCT02324075|sanitation, toilet, urban, behavior change|sanitation, toilet, urban, behavior change
303818|NCT02324062|Cancer Genetics|cancer genetics
303819|NCT02324062|Multi-gene cancer panel testing|multi-gene cancer panel testing
303820|NCT02324049|MPS IIIB|mps iiib
303821|NCT02324049|Mucopolysaccharidosis|mucopolysaccharidosis
303822|NCT02324049|Mucopolysaccharidosis type IIIB|mucopolysaccharidosis type iiib
303823|NCT02324049|Sanfilippo Syndrome|sanfilippo syndrome
303824|NCT02324049|Metabolism, Inborn Errors|metabolism, inborn errors
303825|NCT02324049|Metabolic Diseases|metabolic diseases
303826|NCT02324049|Genetic Diseases, Inborn|genetic diseases, inborn
303928|NCT02323503|CRT-D|crt-d
303827|NCT02324049|Carbohydrate Metabolism, Inborn Errors|carbohydrate metabolism, inborn errors
303828|NCT02324049|Connective Tissue Diseases|connective tissue diseases
303829|NCT02324049|Lysosomal Storage Diseases|lysosomal storage diseases
303830|NCT02324049|Mucinoses|mucinoses
303831|NCT02324049|Mucopolysaccharidoses|mucopolysaccharidoses
303832|NCT02324049|Pathologic Processes|pathologic processes
303833|NCT02324023|ultrasound|ultrasound
303834|NCT02324023|perfusion|perfusion
303835|NCT02324023|endoscopic|endoscopic
303836|NCT02324010|gastric emptying|gastric emptying
303837|NCT02324010|glycemia|glycemia
303838|NCT02324010|appetite|appetite
303839|NCT02324010|incretin hormones|incretin hormones
303840|NCT02323997|HPV|hpv
303841|NCT02323997|cervical cancer|cervical cancer
303842|NCT02323997|human papillomavirus|human papillomavirus
303843|NCT02323997|cervical pre-cancer|cervical pre-cancer
303844|NCT02323997|cervical neoplasia|cervical neoplasia
303845|NCT02323945|acute intermittent hypoxia|acute intermittent hypoxia
303846|NCT02323945|incomplete spinal cord injury|incomplete spinal cord injury
303847|NCT02323945|strength|strength
303848|NCT02323945|walking|walking
303849|NCT02323945|breathing|breathing
303850|NCT02323919|myocardial infarction|myocardial infarction
303851|NCT02323919|coronary artery bypass graft (CABG)|coronary artery bypass graft (cabg)
303852|NCT02323919|angioplasty|angioplasty
303853|NCT02323919|exercise|exercise
303854|NCT02323919|cardiac patient|cardiac patient
303855|NCT02323919|physical activity|physical activity
303856|NCT02323906|Hepatocellular|hepatocellular
303857|NCT02323906|Carcinoma|carcinoma
303858|NCT02323906|Phase 1|phase 1
303859|NCT02323906|CC-122|cc-122
303860|NCT02323906|Sorafenib,|sorafenib,
303861|NCT02323906|Nexavar|nexavar
303862|NCT02323906|Unresectable Hepatocellular Carcinoma|unresectable hepatocellular carcinoma
303863|NCT02323906|Unresectable HCCAdvanced,|unresectable hccadvanced,
303864|NCT02323906|Hepatocellular Carcinoma|hepatocellular carcinoma
303865|NCT02323906|liver cancer|liver cancer
303866|NCT02323893|Positron Emission Tomography|positron emission tomography
303867|NCT02323893|Cancer Immunotherapy|cancer immunotherapy
303868|NCT02323867|Transplant|transplant
303869|NCT02323867|Alternative Donor|alternative donor
303870|NCT02323854|primary, recurrent, metastatic lung tumor, ablation|primary, recurrent, metastatic lung tumor, ablation
303871|NCT02323841|cervical cancer|cervical cancer
303872|NCT02323841|neoadjuvant chemotherapy|neoadjuvant chemotherapy
303873|NCT02323841|Adverse Effects|adverse effects
303874|NCT02323815|child acute malnutrition prevention|child acute malnutrition prevention
303875|NCT02323815|behavior change communication|behavior change communication
303876|NCT02323815|lipid-based nutrient supplement|lipid-based nutrient supplement
303877|NCT02323815|screening coverage|screening coverage
303878|NCT02323763|Magnetic Resonance Imaging|magnetic resonance imaging
303879|NCT02323763|Bipolar Disorder|bipolar disorder
303880|NCT02323763|Suicidal Ideation|suicidal ideation
303881|NCT02323698|hypoxia|hypoxia
303882|NCT02323698|spinal cord injury|spinal cord injury
303883|NCT02323698|rehabilitation|rehabilitation
303884|NCT02323698|strength|strength
303885|NCT02323698|walk|walk
303886|NCT02323698|function|function
303887|NCT02323698|low oxygen|low oxygen
303888|NCT02323685|DCI|dci
303889|NCT02323685|Delayed Cerebral Ischemia|delayed cerebral ischemia
303890|NCT02323685|SAH|sah
303891|NCT02323685|Subarachnoid Hemorrhage|subarachnoid hemorrhage
303892|NCT02323685|Aneurysmal Subarachnoid Hemorrhage|aneurysmal subarachnoid hemorrhage
303893|NCT02323685|Cerebral Ischemia|cerebral ischemia
303894|NCT02323685|Brain Ischemia|brain ischemia
303895|NCT02323659|Mycosis Fungoides|mycosis fungoides
303896|NCT02323659|Cutaneous T-Cell Lymphoma|cutaneous t-cell lymphoma
303897|NCT02323659|Interferon|interferon
761285|NCT00399633|CGRP|cgrp
303898|NCT02323659|Methotrexate|methotrexate
303899|NCT02323646|uterine fibroids|uterine fibroids
303900|NCT02323646|leiomyoma|leiomyoma
303901|NCT02323646|fibroid tumor|fibroid tumor
303902|NCT02323646|fibroma|fibroma
303903|NCT02323633|Pediatric Attention Deficit Hyperactivity Disorder|pediatric attention deficit hyperactivity disorder
303904|NCT02323620|Acute myocardial Infarction|acute myocardial infarction
303905|NCT02323620|bone marrow|bone marrow
303906|NCT02323620|stem cells|stem cells
303907|NCT02323620|cardiovascular disease|cardiovascular disease
303908|NCT02323620|mortality|mortality
303909|NCT02323581|Thoracoabdominal|thoracoabdominal
303910|NCT02323581|Aneurysm|aneurysm
303911|NCT02323581|Endovascular|endovascular
303912|NCT02323581|Stent-Graft|stent-graft
303913|NCT02323568|ovarian cancer|ovarian cancer
303914|NCT02323568|quality of life|quality of life
303915|NCT02323568|remission more than 3 years|remission more than 3 years
303916|NCT02323555|Cancer|cancer
303917|NCT02323555|chemotherapy|chemotherapy
303918|NCT02323555|Targeted therapy|targeted therapy
303919|NCT02323555|Day Hospital|day hospital
303920|NCT02323542|Starch|starch
303921|NCT02323542|cereal products|cereal products
303922|NCT02323542|glucose kinetics|glucose kinetics
303923|NCT02323542|blood glucose|blood glucose
303924|NCT02323542|blood insulin|blood insulin
303925|NCT02323529|Orfadin|orfadin
303926|NCT02323529|Nitisinone|nitisinone
303929|NCT02323503|replacement|replacement
303930|NCT02323503|primary prevention|primary prevention
303931|NCT02323503|ventricular tachyarrhythmias|ventricular tachyarrhythmias
303932|NCT02323490|meniscus repair|meniscus repair
303933|NCT02323490|bone marrow stimulation|bone marrow stimulation
303934|NCT02323477|cellular therapy|cellular therapy
303935|NCT02323477|chronic ischemic heart disease|chronic ischemic heart disease
303936|NCT02323477|phase 1/2 clinical study|phase 1/2 clinical study
303937|NCT02323477|human umbilical cord multipotent stem cell|human umbilical cord multipotent stem cell
303938|NCT02323477|human umbilical cord mesenchymal stem cell|human umbilical cord mesenchymal stem cell
303939|NCT02323477|ischemic heart disease|ischemic heart disease
303940|NCT02323477|bone marrow mononuclear cell|bone marrow mononuclear cell
303941|NCT02323477|allogeneic stem cell transplantation|allogeneic stem cell transplantation
303942|NCT02323438|biomarkers of tobacco exposure|biomarkers of tobacco exposure
303943|NCT02323438|exposure|exposure
303944|NCT02323438|tobacco|tobacco
303945|NCT02323438|nicotine|nicotine
303946|NCT02323438|nicotine gum|nicotine gum
303947|NCT02323438|electronic cigarette|electronic cigarette
303948|NCT02323438|e-cig|e-cig
303949|NCT02323425|stroke|stroke
303950|NCT02323425|Remote ischemic postconditioning|remote ischemic postconditioning
303951|NCT02323425|symptomatic atherosclerotic intracranial arterial stenosis|symptomatic atherosclerotic intracranial arterial stenosis
303952|NCT02323412|Low back pain|low back pain
303953|NCT02323412|Chronic|chronic
303954|NCT02323412|Modic Changes|modic changes
303956|NCT02323412|epigenetics|epigenetics
303957|NCT02323412|antibiotics|antibiotics
303958|NCT02323412|randomized placebo controlled trial|randomized placebo controlled trial
303959|NCT02323386|Dynamic RSA|dynamic rsa
303960|NCT02323386|Knee|knee
303961|NCT02323386|Total Knee Arthroplasty|total knee arthroplasty
303962|NCT02323386|Kinematic Analysis|kinematic analysis
303963|NCT02323373|Arthroplasty, Replacement, Knee|arthroplasty, replacement, knee
303964|NCT02323373|Tranexamic Acid|tranexamic acid
303965|NCT02323373|Drug Administration Routes|drug administration routes
303966|NCT02323360|SBRT|sbrt
303967|NCT02323360|TACE|tace
303968|NCT02323360|TAE|tae
303969|NCT02323321|heart transplant|heart transplant
303970|NCT02323321|heart preservation|heart preservation
303971|NCT02323321|beating heart transplant|beating heart transplant
303972|NCT02323295|Malignant bone tumors|malignant bone tumors
303973|NCT02323282|Dose-response relationship|dose-response relationship
303974|NCT02323282|Drug|drug
303975|NCT02323256|cochlear implant|cochlear implant
303976|NCT02323256|deafness|deafness
303977|NCT02323256|audiometry|audiometry
303978|NCT02323256|speech perception|speech perception
303979|NCT02323256|severe to profound deafness restored with cochlear implantation|severe to profound deafness restored with cochlear implantation
303980|NCT02323243|Detrusor striated sphincter dyssynergia|detrusor striated sphincter dyssynergia
303981|NCT02323243|Temporary urethral stent|temporary urethral stent
303982|NCT02323217|Imidazoline Receptor 2|imidazoline receptor 2
303983|NCT02323217|(4,5-dihydro-1H-imidazol-2-yl)-1-methyl-1H-indole|(4,5-dihydro-1h-imidazol-2-yl)-1-methyl-1h-indole
303984|NCT02323217|BU99008|bu99008
303985|NCT02323217|Radionuclide Imaging|radionuclide imaging
303986|NCT02323217|Molecular Imaging|molecular imaging
303987|NCT02323217|Healthy Volunteers|healthy volunteers
303988|NCT02323217|Alzheimer Disease|alzheimer disease
303989|NCT02323204|posttraumatic stress|posttraumatic stress
303990|NCT02323178|Chronic myelomonocytic leukemia|chronic myelomonocytic leukemia
303991|NCT02323178|thrombocytopenia|thrombocytopenia
303992|NCT02323178|eltrombopag|eltrombopag
303993|NCT02323152|women|women
303994|NCT02323152|high risk|high risk
388308|NCT01922648|RSV|rsv
303995|NCT02323139|High risk MDS|high risk mds
303996|NCT02323139|Azacitidine|azacitidine
303997|NCT02323139|LDE255|lde255
303998|NCT02323126|Non small cell lung cancer,|non small cell lung cancer,
303999|NCT02323126|NSCLC,|nsclc,
304000|NCT02323126|EGFR-mutated,|egfr-mutated,
304001|NCT02323126|EGF816,|egf816,
304002|NCT02323126|INC280,|inc280,
304003|NCT02323126|Nivolumab,|nivolumab,
304004|NCT02323126|EGFR-T790M NSCLC,|egfr-t790m nsclc,
304005|NCT02323126|EGFR wild-type (wt),|egfr wild-type (wt),
304006|NCT02323126|cMET positive NSCLC,|cmet positive nsclc,
304007|NCT02323126|cMET negative NSCLC|cmet negative nsclc
304008|NCT02323113|Drug therapy|drug therapy
304009|NCT02323100|cystic fibrosis|cystic fibrosis
304010|NCT02323100|corrector|corrector
304011|NCT02323100|glycerol phenylbutyrate|glycerol phenylbutyrate
304012|NCT02323100|nasal potential difference|nasal potential difference
304013|NCT02323087|Antibiotic resistance|antibiotic resistance
304014|NCT02323087|Point of care tests|point of care tests
304015|NCT02323087|Primary Health Care|primary health care
304016|NCT02323022|AML|aml
304017|NCT02323022|cladribine|cladribine
304018|NCT02323022|induction therapy|induction therapy
304019|NCT02323009|Transpulmonary pressure|transpulmonary pressure
304020|NCT02323009|Esophageal balloon|esophageal balloon
304021|NCT02323009|Esophageal pressure monitoring device|esophageal pressure monitoring device
304022|NCT02323009|Cstat|cstat
304023|NCT02323009|Static effective compliance|static effective compliance
304024|NCT02323009|Ventilator weaning|ventilator weaning
304025|NCT02323009|Morbidly Obese Ventilator Dependent Tracheotomized Patients|morbidly obese ventilator dependent tracheotomized patients
304026|NCT02322983|Cerebral Palsy|cerebral palsy
304027|NCT02322983|Dental Care|dental care
304028|NCT02322983|Conscious Sedation|conscious sedation
304029|NCT02322983|Autonomic Nervous System|autonomic nervous system
304030|NCT02322983|Nitrous Oxide|nitrous oxide
304031|NCT02322970|intracranial hypertension|intracranial hypertension
304032|NCT02322970|tcd|tcd
304033|NCT02322970|non invasive|non invasive
304034|NCT02322970|ICP|icp
304035|NCT02322944|acute myocardial infarction|acute myocardial infarction
304036|NCT02322944|quality improvement|quality improvement
304037|NCT02322944|reperfusion therapy|reperfusion therapy
304038|NCT02322905|informal caregivers|informal caregivers
304039|NCT02322905|caregiving|caregiving
304040|NCT02322905|psychotherapy for caregivers|psychotherapy for caregivers
304041|NCT02322905|cancer|cancer
304042|NCT02322905|emotion regulation|emotion regulation
304043|NCT02322905|distress|distress
304044|NCT02322905|inflammation|inflammation
304045|NCT02322892|Thiamine|thiamine
304046|NCT02322892|Vitamin B1|vitamin b1
304047|NCT02322892|Coronary artery bypass grafting|coronary artery bypass grafting
304048|NCT02322892|Cardiac surgery|cardiac surgery
304049|NCT02322892|Lactate|lactate
304050|NCT02322892|Pyruvate dehydrogenase|pyruvate dehydrogenase
304051|NCT02322879|Acetaminophen|acetaminophen
304052|NCT02322879|Propylene glycol|propylene glycol
304053|NCT02322866|acne|acne
304054|NCT02322853|Metastatic breast cancer|metastatic breast cancer
304055|NCT02322853|p38 map kinase|p38 map kinase
304056|NCT02322853|tamoxifen|tamoxifen
304057|NCT02322853|LY2228820|ly2228820
304058|NCT02322853|Postmenopausal woman with advanced or metastatic breast cancer progressing on aromatase inhibitors (AI)|postmenopausal woman with advanced or metastatic breast cancer progressing on aromatase inhibitors (ai)
304059|NCT02322827|hiv/aids|hiv/aids
304060|NCT02322788|Inhalation, Pharmacodynamic, Patients,|inhalation, pharmacodynamic, patients,
304061|NCT02322775|Asthma, Bronchial Diseases, Respiratory Tract Diseases, Lung Diseases, Obstructive Lung Diseases,|asthma, bronchial diseases, respiratory tract diseases, lung diseases, obstructive lung diseases,
304062|NCT02322762|Type 2 diabetes mellitus|type 2 diabetes mellitus
304063|NCT02322762|Anti-diabetic management patterns|anti-diabetic management patterns
304064|NCT02322749|bioequivalence|bioequivalence
304065|NCT02322749|bioavailability|bioavailability
304066|NCT02322749|pharmacokinetics|pharmacokinetics
304067|NCT02322749|Phase I|phase i
304068|NCT02322749|AZD6244|azd6244
304069|NCT02322749|cancer|cancer
304070|NCT02322736|Metastatic Colorectal Cancer, wild type RAS, Panitumumab, Vectibix, Greece|metastatic colorectal cancer, wild type ras, panitumumab, vectibix, greece
304071|NCT02322723|Adalimumab|adalimumab
304072|NCT02322723|real life|real life
304073|NCT02322723|RA|ra
304074|NCT02322723|Humira|humira
304075|NCT02322723|Rheumatoid Arthritis|rheumatoid arthritis
304076|NCT02322723|effectiveness|effectiveness
304077|NCT02322710|non-inferiority|non-inferiority
304078|NCT02322710|randomized|randomized
304079|NCT02322710|TulleGras|tullegras
304080|NCT02322710|Urgotul|urgotul
304081|NCT02322710|healing|healing
304082|NCT02322710|surgical acute wounds|surgical acute wounds
304083|NCT02322710|pain|pain
304084|NCT02322697|Carnitine|carnitine
304085|NCT02322697|hemodialysis|hemodialysis
304086|NCT02322697|fatty acid|fatty acid
304087|NCT02322697|imaging|imaging
304088|NCT02322697|heart|heart
304089|NCT02322684|Bougie|bougie
304090|NCT02322684|Air-Q|air-q
304091|NCT02322684|Insertion|insertion
304092|NCT02322671|chewable tablet|chewable tablet
304093|NCT02322671|montelukast sodium|montelukast sodium
304094|NCT02322671|healthy adult subjects|healthy adult subjects
304095|NCT02322671|relative bioavailability|relative bioavailability
304096|NCT02322671|GW483100|gw483100
304097|NCT02322593|Gastric Cancer|gastric cancer
304098|NCT02322593|Gastrointestinal Diseases|gastrointestinal diseases
304099|NCT02322593|Gastrointestinal Neoplasms|gastrointestinal neoplasms
304100|NCT02322593|First Line Treatment|first line treatment
304101|NCT02322593|Antineoplastic Agents|antineoplastic agents
304102|NCT02322580|anti-TNF|anti-tnf
304103|NCT02322580|therapeutic drug monitoring|therapeutic drug monitoring
304104|NCT02322580|immunogenicity|immunogenicity
304105|NCT02322554|electronic health records|electronic health records
304106|NCT02322554|Qualified Clinical Data Registry|qualified clinical data registry
304107|NCT02322554|PQRS|pqrs
304108|NCT02322554|quality reporting|quality reporting
304109|NCT02322554|cellular based products|cellular based products
304110|NCT02322554|bioengieered skin|bioengieered skin
304111|NCT02322554|USWR|uswr
304112|NCT02322528|Non-invasive instruments|non-invasive instruments
304113|NCT02322528|Environment|environment
304114|NCT02322528|Wavefront|wavefront
304115|NCT02322528|Placido Disk|placido disk
304116|NCT02322528|Ellipsometer|ellipsometer
304117|NCT02322528|Thermal Imaging|thermal imaging
304118|NCT02322515|Knee|knee
304119|NCT02322515|Proprioception|proprioception
304120|NCT02322515|Electromyography|electromyography
304121|NCT02322515|Taping|taping
304122|NCT02322502|laryngeal mask airway|laryngeal mask airway
304123|NCT02322502|desflurane|desflurane
304124|NCT02322502|sevoflurane|sevoflurane
304125|NCT02322502|propofol|propofol
304126|NCT02322489|microcurent|microcurent
304127|NCT02322489|pain|pain
304128|NCT02322489|flexibility|flexibility
304129|NCT02322463|patients who were admitted to the pediatric ED|patients who were admitted to the pediatric ed
304130|NCT02322411|Stroke|stroke
304131|NCT02322411|Deglutition|deglutition
304132|NCT02322411|Deglutition disorders|deglutition disorders
304133|NCT02322411|Resistance training|resistance training
304134|NCT02322385|Autosomal Dominant Polycystic Kidney Disease|autosomal dominant polycystic kidney disease
304135|NCT02322385|PKD 1 gene|pkd 1 gene
304136|NCT02322385|PKD 2 gene|pkd 2 gene
304137|NCT02322385|Truncational mutation|truncational mutation
304138|NCT02322385|Hypomorphic mutation|hypomorphic mutation
304139|NCT02322372|femoral blockade|femoral blockade
304140|NCT02322372|bupivacaine|bupivacaine
304141|NCT02322346|posttonsillectomy pain|posttonsillectomy pain
304142|NCT02322346|levobupivacaine|levobupivacaine
304143|NCT02322320|Multiple Myeloma|multiple myeloma
304144|NCT02322320|Lenalidomide|lenalidomide
304145|NCT02322320|Maintenance Therapy|maintenance therapy
304146|NCT02322320|Progression|progression
304147|NCT02322320|Long-term|long-term
304148|NCT02322320|Anti-Myeloma Agents|anti-myeloma agents
304149|NCT02322320|Hematologic Disorders|hematologic disorders
304150|NCT02322307|Inflammatory Bowel Disease|inflammatory bowel disease
304151|NCT02322307|Crohn's Disease|crohn's disease
304152|NCT02322307|Ulcerative Colitis|ulcerative colitis
304153|NCT02322307|Colitis|colitis
304154|NCT02322307|PRO|pro
304155|NCT02322307|Patient-centric|patient-centric
304156|NCT02322307|HealthPROMISE|healthpromise
304157|NCT02322294|Protein|protein
304158|NCT02322294|mung bean|mung bean
304159|NCT02322294|glucose|glucose
304160|NCT02322294|triglycerides|triglycerides
304161|NCT02322294|insulin|insulin
304162|NCT02322294|body weight,|body weight,
304163|NCT02322294|DXA scan|dxa scan
304164|NCT02322281|cancer|cancer
304165|NCT02322281|metastatic|metastatic
304166|NCT02322281|locally advanced|locally advanced
304167|NCT02322281|lung|lung
304168|NCT02322281|non-small cell lung cancer|non-small cell lung cancer
304169|NCT02322281|NSCLC|nsclc
304170|NCT02322281|epidermal growth factor receptor|epidermal growth factor receptor
304171|NCT02322281|EGFR|egfr
304172|NCT02322281|T790M|t790m
304173|NCT02322281|CO-1686|co-1686
304174|NCT02322281|unresectable|unresectable
304175|NCT02322281|recurrent|recurrent
304176|NCT02322281|EGFR-directed therapy|egfr-directed therapy
304177|NCT02322281|irreversible EGFR inhibitor|irreversible egfr inhibitor
304178|NCT02322281|TIGER|tiger
304179|NCT02322281|Rociletinib|rociletinib
304180|NCT02322268|Type 2 Diabetes Mellitus|type 2 diabetes mellitus
304181|NCT02322268|Cosmos Caudatus|cosmos caudatus
304182|NCT02322268|Ulam Raja|ulam raja
304183|NCT02322268|Metabolomic profiling|metabolomic profiling
304184|NCT02322268|antioxidant|antioxidant
304185|NCT02322255|Natural History Study|natural history study
304186|NCT02322255|Non-interventional Study|non-interventional study
304187|NCT02322255|Observational Study|observational study
304188|NCT02322255|Heterotopic ossification|heterotopic ossification
304189|NCT02322255|Fibrodysplasia Ossificans Progressiva|fibrodysplasia ossificans progressiva
304190|NCT02322255|FOP disease progression|fop disease progression
761286|NCT00399633|Prostanoids|prostanoids
388582|NCT01921205|Vimpat|vimpat
304191|NCT02322255|FOP flare-up progression|fop flare-up progression
304192|NCT02322255|Clementia|clementia
304193|NCT02322255|Myositosis Ossificans Progressiva|myositosis ossificans progressiva
304194|NCT02322255|Munchmeyer's Disease|munchmeyer's disease
304195|NCT02322255|FOP|fop
304196|NCT02322255|Palovarotene|palovarotene
304197|NCT02322229|VMT|vmt
304198|NCT02322229|sVMA|svma
304199|NCT02322229|vitrectomy|vitrectomy
304200|NCT02322229|ocriplasmin|ocriplasmin
304201|NCT02322216|Allergies|allergies
304202|NCT02322216|Ocular|ocular
304203|NCT02322203|Niacin|niacin
304204|NCT02322203|Cholesterol|cholesterol
304205|NCT02322203|High-Density Lipoprotein|high-density lipoprotein
304206|NCT02322203|Low-Density Lipoprotein|low-density lipoprotein
304207|NCT02322203|Lipoproteins|lipoproteins
304208|NCT02322190|Steroid Failure|steroid failure
304209|NCT02322190|Immunomodulation|immunomodulation
304210|NCT02322190|Corticosteroid Therapy|corticosteroid therapy
304211|NCT02322177|Inborn Error of Metabolism|inborn error of metabolism
304212|NCT02322177|Pregnancy|pregnancy
304213|NCT02322177|Amino acid disorder|amino acid disorder
304214|NCT02322177|Fatty acid oxidation disorder|fatty acid oxidation disorder
304215|NCT02322177|Organic Acidemia|organic acidemia
304216|NCT02322164|Skin|skin
304217|NCT02322164|TEMPERATURE|temperature
304218|NCT02322164|Placebo|placebo
304219|NCT02322151|Filgrastim|filgrastim
304220|NCT02322151|Neupogen|neupogen
304221|NCT02322151|Transplant|transplant
304222|NCT02322151|Breast Feeding|breast feeding
304223|NCT02322151|Concentration|concentration
304224|NCT02322125|walking|walking
304225|NCT02322125|locomotion|locomotion
304629|NCT02319967|emergency|emergency
304226|NCT02322125|rehabilitation|rehabilitation
304227|NCT02322112|Dietary Fiber|dietary fiber
304228|NCT02322112|Gastrointestinal Microbiome|gastrointestinal microbiome
304229|NCT02322112|Overweight and Obesity|overweight and obesity
304230|NCT02322112|Personalized Nutrition|personalized nutrition
304231|NCT02322112|Inflammation|inflammation
304232|NCT02322112|Metabolism|metabolism
304233|NCT02322099|human immunodeficiency virus|human immunodeficiency virus
304234|NCT02322099|bone diseases|bone diseases
304235|NCT02322099|osteopenia|osteopenia
304236|NCT02322099|osteoporosis|osteoporosis
304237|NCT02322099|fracture|fracture
304238|NCT02322099|bone turnover|bone turnover
304239|NCT02322099|alendronate|alendronate
304240|NCT02322099|antiretroviral|antiretroviral
304241|NCT02322060|IVA, ovary tissue grafting, POI|iva, ovary tissue grafting, poi
304242|NCT02322034|chronic heart failure|chronic heart failure
304243|NCT02322034|multiple neurohormonal axis disequilibrium|multiple neurohormonal axis disequilibrium
304244|NCT02322034|growth hormone deficiency|growth hormone deficiency
304245|NCT02322034|Insulin-like growth factor-1 (IGF-1)|insulin-like growth factor-1 (igf-1)
304246|NCT02322034|metabolic deficiency syndrome|metabolic deficiency syndrome
304247|NCT02322034|interval training|interval training
304249|NCT02322021|Mild Cognitive Impairment|mild cognitive impairment
304250|NCT02322021|Mild to Moderate Dementia|mild to moderate dementia
304251|NCT02322021|Alzheimer's Disease|alzheimer's disease
304252|NCT02322021|Prodromal Alzheimer's Disease|prodromal alzheimer's disease
304253|NCT02321982|Mohs surgery|mohs surgery
304254|NCT02321982|Preoperative consultation|preoperative consultation
304255|NCT02321969|Chemoprevention|chemoprevention
304256|NCT02321969|Colorectal adenomatous polyp|colorectal adenomatous polyp
304257|NCT02321969|Green tea extract|green tea extract
304258|NCT02321956|ASA class 1,2|asa class 1,2
304259|NCT02321956|age 1-6 years|age 1-6 years
304260|NCT02321956|General anesthesia with ETT|general anesthesia with ett
304261|NCT02321930|Rheumatoid Arthritis|rheumatoid arthritis
304262|NCT02321930|Musculoskeletal Ultrasound|musculoskeletal ultrasound
304263|NCT02321930|Tofacitinib|tofacitinib
304264|NCT02321930|biomarker|biomarker
304265|NCT02321904|Confocal microscopy|confocal microscopy
304266|NCT02321904|Cornea|cornea
304267|NCT02321904|Neuropathy|neuropathy
304268|NCT02321904|Detection|detection
304269|NCT02321904|Diabetes|diabetes
304270|NCT02321839|neovascular age-related macular degeneration|neovascular age-related macular degeneration
304271|NCT02321839|Ranibizumab|ranibizumab
304272|NCT02321839|Treat and extend|treat and extend
304273|NCT02321813|quality of life|quality of life
304274|NCT02321813|colorectal cancer|colorectal cancer
304275|NCT02321813|definitive RCT|definitive rct
304276|NCT02321813|complex intervention|complex intervention
304277|NCT02321800|S-649266|s-649266
304278|NCT02321800|complicated urinary tract infection|complicated urinary tract infection
304279|NCT02321800|cefiderocol|cefiderocol
304280|NCT02321800|acute uncomplicated pyelonephritis|acute uncomplicated pyelonephritis
304281|NCT02321800|Gram-negative pathogens|gram-negative pathogens
304282|NCT02321800|imipenem/cilastatin|imipenem/cilastatin
304283|NCT02321787|Anesthesia, Caudal|anesthesia, caudal
304284|NCT02321787|Ultrasonography|ultrasonography
304285|NCT02321774|Stress|stress
304286|NCT02321774|Virtual Reality|virtual reality
761391|NCT00399217|Polarity|polarity
304287|NCT02321774|Wearable Sensor|wearable sensor
304288|NCT02321774|Wellness|wellness
304289|NCT02321761|Amantadine hydrochloride|amantadine hydrochloride
304290|NCT02321761|Rehabilitation|rehabilitation
304291|NCT02321761|Acquired Brain Injury|acquired brain injury
304292|NCT02321761|TBI|tbi
304293|NCT02321748|HSV|hsv
304294|NCT02321748|Herpes|herpes
304295|NCT02321748|volunteers|volunteers
304296|NCT02321748|drug-drug interaction|drug-drug interaction
304297|NCT02321735|Long-Term Survivor|long-term survivor
304298|NCT02321735|Genomic|genomic
304299|NCT02321735|Survivorship|survivorship
304300|NCT02321735|Quality of Life|quality of life
304301|NCT02321722|Colonoscopy|colonoscopy
304302|NCT02321696|physiotherapy|physiotherapy
304303|NCT02321696|manual therapy|manual therapy
304304|NCT02321696|acupuncture|acupuncture
304305|NCT02321696|eccentric exercise|eccentric exercise
304306|NCT02321670|operative technique|operative technique
304307|NCT02321644|CC-90001|cc-90001
304308|NCT02321644|PHARMACOKINETICS|pharmacokinetics
304309|NCT02321644|PHARMACODYNAMICS|pharmacodynamics
304310|NCT02321644|HEALTHY SUBJECTS|healthy subjects
304311|NCT02321644|SINGLE DOSE|single dose
304312|NCT02321644|MULTIPLE DOSE|multiple dose
304313|NCT02321644|PUNCH BIOPSY|punch biopsy
304314|NCT02321631|Malnourished|malnourished
304315|NCT02321631|Head and Neck Cancer|head and neck cancer
304316|NCT02321631|Surgery|surgery
304317|NCT02321618|Hypertension|hypertension
304318|NCT02321618|High Blood Pressure|high blood pressure
304319|NCT02321618|African American men|african american men
304320|NCT02321618|Black men|black men
304321|NCT02321618|barbershop|barbershop
304322|NCT02321605|Best Possible Self|best possible self
304323|NCT02321605|Positive Psychology|positive psychology
304324|NCT02321605|Optimism|optimism
304325|NCT02321605|Positive Technology|positive technology
304326|NCT02321605|Future Thinking|future thinking
304327|NCT02321592|Hodgkin Lymphoma|hodgkin lymphoma
304328|NCT02321592|AFM13|afm13
304329|NCT02321592|Natural Killer Cells|natural killer cells
304330|NCT02321553|metabolic syndrome|metabolic syndrome
304331|NCT02321553|glucose|glucose
304332|NCT02321553|cholesterol|cholesterol
304333|NCT02321553|brown rice|brown rice
304334|NCT02321553|inflammation|inflammation
304335|NCT02321553|oxidative stress|oxidative stress
304336|NCT02321540|Lung Cancer|lung cancer
304337|NCT02321540|Non-small cell lung cancer|non-small cell lung cancer
304338|NCT02321540|NSCLC|nsclc
304339|NCT02321540|Epidermal growth factor receptor mutations|epidermal growth factor receptor mutations
304340|NCT02321540|EGFR|egfr
304341|NCT02321540|Recurrent non-small cell lung cancer|recurrent non-small cell lung cancer
304342|NCT02321540|Ibrutinib|ibrutinib
304343|NCT02321540|PCI-32765|pci-32765
304344|NCT02321540|Imbruvica|imbruvica
304345|NCT02321527|Breast Cancer|breast cancer
304346|NCT02321527|Microbubble contrast-enhanced ultrasound|microbubble contrast-enhanced ultrasound
304347|NCT02321527|CEUS|ceus
304348|NCT02321527|Sentinel lymph nodes|sentinel lymph nodes
304349|NCT02321527|SLN|sln
304350|NCT02321527|Perflutren Protein-Type A Microspheres Injectable Suspension|perflutren protein-type a microspheres injectable suspension
304351|NCT02321527|OPTISON™|optison™
304352|NCT02321527|Ultrasound|ultrasound
304353|NCT02321527|Breast biopsy|breast biopsy
304354|NCT02321527|Radioactive seed|radioactive seed
304355|NCT02321527|Phone call|phone call
304356|NCT02321527|Fine needle aspiration|fine needle aspiration
304357|NCT02321527|FNA|fna
304358|NCT02321475|Psycho-emotional symptoms|psycho-emotional symptoms
304359|NCT02321462|preparation|preparation
304360|NCT02321423|Nail Dystrophy|nail dystrophy
304361|NCT02321423|Plantar Keratoderma|plantar keratoderma
304362|NCT02321423|Palmar Keratoderma|palmar keratoderma
304363|NCT02321423|Leukokeratosis|leukokeratosis
304364|NCT02321423|Cysts|cysts
304365|NCT02321423|Pain|pain
304366|NCT02321423|KRT17|krt17
304367|NCT02321423|KRT16|krt16
304368|NCT02321423|KRT6A|krt6a
304369|NCT02321423|KRT6B|krt6b
304370|NCT02321423|KRT6C|krt6c
304371|NCT02321397|oxycodone naloxone combination|oxycodone naloxone combination
304372|NCT02321397|severe chronic and non-malignant pain|severe chronic and non-malignant pain
304373|NCT02321397|Malignant and non-malignant pain that requires around-the clock opioid therapy|malignant and non-malignant pain that requires around-the clock opioid therapy
304374|NCT02321358|Behavior Change|behavior change
304375|NCT02321358|Objectively Measured Physical Activity|objectively measured physical activity
304376|NCT02321358|Survivorship|survivorship
304377|NCT02321345|Allogeneic Stem Cell Transplant|allogeneic stem cell transplant
304378|NCT02321345|Hematological Malignancies|hematological malignancies
304379|NCT02321345|Palliative Care|palliative care
304380|NCT02321345|Supportive care|supportive care
304381|NCT02321332|Palmar hyperhidrosis|palmar hyperhidrosis
304382|NCT02321332|Endoscopic thoracic sympathectomy|endoscopic thoracic sympathectomy
304383|NCT02321319|Pediatric|pediatric
304384|NCT02321293|curcumin|curcumin
304385|NCT02321293|lung cancer|lung cancer
304386|NCT02321293|TKI|tki
304387|NCT02321267|AMD|amd
304388|NCT02321267|PCV|pcv
304389|NCT02321267|RAP|rap
304390|NCT02321267|RVO|rvo
304391|NCT02321267|DME|dme
304392|NCT02321267|ERM|erm
304393|NCT02321267|MH|mh
304394|NCT02321267|mCNV|mcnv
304395|NCT02321254|Stroke|stroke
304396|NCT02321254|Upper limb|upper limb
304397|NCT02321254|Robotics|robotics
304398|NCT02321254|Electromyography|electromyography
304399|NCT02321254|Rehabilitation|rehabilitation
304400|NCT02321241|Wet-AMD|wet-amd
304401|NCT02321241|Refractory patients to ranibizumab|refractory patients to ranibizumab
304402|NCT02321241|Real life|real life
304403|NCT02321241|Switch|switch
304404|NCT02321241|Aflibercept|aflibercept
304405|NCT02321228|Salpingectomy|salpingectomy
304406|NCT02321228|Delayed oophorectomy|delayed oophorectomy
304407|NCT02321228|Salpingo-oophorectomy|salpingo-oophorectomy
304408|NCT02321228|Quality of life|quality of life
304409|NCT02321228|Ovarian cancer|ovarian cancer
304410|NCT02321228|BRCA|brca
304411|NCT02321215|AECOPD|aecopd
304412|NCT02321215|COPD|copd
304413|NCT02321215|education|education
304414|NCT02321202|omega-3|omega-3
304415|NCT02321202|Progression|progression
304416|NCT02321202|parenteral nutrition|parenteral nutrition
304417|NCT02321150|Pterygium|pterygium
304418|NCT02321150|Pterygiums|pterygiums
304419|NCT02321150|Pterygia|pterygia
304420|NCT02321150|Graft|graft
304421|NCT02321150|Autograft|autograft
304422|NCT02321150|Excision|excision
304423|NCT02321150|Surgery|surgery
304424|NCT02321150|Eye|eye
304425|NCT02321150|electrocautery|electrocautery
304426|NCT02321150|polyglactin|polyglactin
304427|NCT02321124|Constipation|constipation
304428|NCT02321124|connective tissue manipulation|connective tissue manipulation
304429|NCT02321124|conservative therapy|conservative therapy
304430|NCT02321124|massage|massage
304431|NCT02321124|randomized controlled trial|randomized controlled trial
304432|NCT02321111|Insulin signaling and glucose disposal in muscle|insulin signaling and glucose disposal in muscle
304433|NCT02321111|Hepatic insulin sensitivity|hepatic insulin sensitivity
304434|NCT02321111|TLR4 signaling and inflammatory gene expression|tlr4 signaling and inflammatory gene expression
304435|NCT02321111|Plasma cytokine concentration|plasma cytokine concentration
304436|NCT02321111|Intramyocellular diacylglycerol and ceramide content|intramyocellular diacylglycerol and ceramide content
304437|NCT02321098|Onychomycosis|onychomycosis
304438|NCT02321098|antifungal|antifungal
304439|NCT02321072|oxygen|oxygen
304440|NCT02321072|hypoxia|hypoxia
304441|NCT02321072|hyperoxia|hyperoxia
304442|NCT02321072|critical care|critical care
304443|NCT02321072|intensive care|intensive care
304444|NCT02321059|incisional hernia|incisional hernia
304445|NCT02321059|hernia|hernia
304446|NCT02321059|abdominal wall strength|abdominal wall strength
304447|NCT02321059|validation|validation
304448|NCT02321059|physical activity|physical activity
304449|NCT02321046|Non-Small Cell Lung Cancer, NSCLC, Epidermal growth factor receptor, EGFR|non-small cell lung cancer, nsclc, epidermal growth factor receptor, egfr
304450|NCT02321033|glycemic index|glycemic index
304451|NCT02321033|inactivity|inactivity
304452|NCT02321033|insulin sensitivity|insulin sensitivity
304453|NCT02321033|metabolic flexibility|metabolic flexibility
304454|NCT02321033|arterial stiffness|arterial stiffness
304455|NCT02321033|young men|young men
304456|NCT02320994|stroke|stroke
304457|NCT02320994|aftercare|aftercare
304458|NCT02320981|GERD|gerd
304459|NCT02320981|EGD|egd
304460|NCT02320981|pH testing|ph testing
304461|NCT02320981|eosinophilic esophagitis|eosinophilic esophagitis
304462|NCT02320981|impedance testing|impedance testing
304463|NCT02320955|autologous bone flap|autologous bone flap
304464|NCT02320955|decompressive craniectomy|decompressive craniectomy
304465|NCT02320955|malignant brain swelling|malignant brain swelling
304466|NCT02320955|patient specific implant|patient specific implant
304467|NCT02320955|bone resorption|bone resorption
304468|NCT02320955|aseptic bone necrosis|aseptic bone necrosis
304469|NCT02320942|Bone Marrow Transplantation|bone marrow transplantation
304470|NCT02320942|Exercise|exercise
304471|NCT02320942|Rehabilitation|rehabilitation
304472|NCT02320942|Cancer|cancer
304473|NCT02320929|irrigation|irrigation
304474|NCT02320929|tenosynovitis|tenosynovitis
304475|NCT02320929|purulent|purulent
304476|NCT02320929|closed-catheter|closed-catheter
304477|NCT02320929|flexor tendon|flexor tendon
304478|NCT02320903|Criminal Justice|criminal justice
304479|NCT02320903|Juvenile Delinquency|juvenile delinquency
304480|NCT02320890|transcranial direct current stimulation|transcranial direct current stimulation
304481|NCT02320890|tDCS|tdcs
304482|NCT02320890|Mild Cognitive Impairment|mild cognitive impairment
304483|NCT02320890|MCI|mci
304484|NCT02320864|muscle strength|muscle strength
304485|NCT02320864|muscle weakness|muscle weakness
304486|NCT02320864|hospitalization|hospitalization
304487|NCT02320864|surgery|surgery
304488|NCT02320864|total knee replacement|total knee replacement
304489|NCT02320851|Somatoform disorder|somatoform disorder
304490|NCT02320851|Functional vertigo/dizziness|functional vertigo/dizziness
304491|NCT02320851|Chronic subjective dizziness|chronic subjective dizziness
304492|NCT02320838|Transcutaneous Electric Nerve Stimulation|transcutaneous electric nerve stimulation
304493|NCT02320838|Electric Stimulation Therapy|electric stimulation therapy
304494|NCT02320838|Unmodulated Alternating Currents|unmodulated alternating currents
304495|NCT02320838|Neural Conduction|neural conduction
304496|NCT02320838|Pain Threshold|pain threshold
304497|NCT02320825|Stereotactic Radiosurgery (SRS)|stereotactic radiosurgery (srs)
304498|NCT02320825|Single-Fraction|single-fraction
304499|NCT02320825|Hypofractionated|hypofractionated
304500|NCT02320825|Spinal surgery|spinal surgery
304501|NCT02320825|14-233|14-233
304502|NCT02320799|interpersonal psychotherapy|interpersonal psychotherapy
304503|NCT02320799|HIV|hiv
304504|NCT02320799|women|women
304505|NCT02320799|gender based violence|gender based violence
304506|NCT02320799|mental health|mental health
304507|NCT02320799|africa|africa
304508|NCT02320799|kenya|kenya
304509|NCT02320799|global mental health|global mental health
304510|NCT02320799|HIV treatment adherence|hiv treatment adherence
304511|NCT02320786|Power mobility|power mobility
304512|NCT02320786|Wheelchair skills training|wheelchair skills training
304513|NCT02320786|Spinal Cord Injury|spinal cord injury
304514|NCT02320773|Overactive Bladder|overactive bladder
304515|NCT02320773|Quality of Life|quality of life
304516|NCT02320773|Betanis®|betanis®
304517|NCT02320773|Betmiga®|betmiga®
304518|NCT02320773|Observational|observational
304519|NCT02320773|Myrbetriq®|myrbetriq®
304520|NCT02320747|Volunteers|volunteers
304521|NCT02320734|surgical rating scale|surgical rating scale
304522|NCT02320734|neuromuscular relaxation|neuromuscular relaxation
304523|NCT02320734|Anaesthesia|anaesthesia
304524|NCT02320734|minimally invasive esophagectomy|minimally invasive esophagectomy
304627|NCT02319993|Quality of life|quality of life
304628|NCT02319967|community health worker|community health worker
304525|NCT02320708|Molar,third; Teeth,wisdom; Pain, Postoperative; Dental Surgery; Third molar extraction|molar,third; teeth,wisdom; pain, postoperative; dental surgery; third molar extraction
304526|NCT02320643|Partially absorbable mesh|partially absorbable mesh
304527|NCT02320617|Lung Neoplasms|lung neoplasms
304528|NCT02320617|diffusion weighted MRI|diffusion weighted mri
304529|NCT02320617|ADC value|adc value
304530|NCT02320617|treatment effect|treatment effect
304531|NCT02320604|Liposomal amphotericin B|liposomal amphotericin b
304532|NCT02320604|AmBisome|ambisome
304533|NCT02320604|Pharmacokinetics|pharmacokinetics
304534|NCT02320604|Obesity|obesity
304535|NCT02320604|Bariatric surgery|bariatric surgery
304536|NCT02320578|Neoadjuvant Chemoptherapy|neoadjuvant chemoptherapy
304537|NCT02320578|Laparoscopy 3D|laparoscopy 3d
304538|NCT02320578|Cervical cancer|cervical cancer
304539|NCT02320565|Endometrial Cancer|endometrial cancer
304540|NCT02320565|Laparoscopy 3D|laparoscopy 3d
304541|NCT02320552|Nutritional assessment|nutritional assessment
304542|NCT02320539|MicroRNA|microrna
304543|NCT02320539|Cerebrospinal fluid|cerebrospinal fluid
304544|NCT02320526|Exercise|exercise
304545|NCT02320526|Training|training
304546|NCT02320526|Interval training|interval training
304547|NCT02320526|Systemic inflammation|systemic inflammation
304548|NCT02320526|Glucose disposal|glucose disposal
304549|NCT02320526|Insulin sensitivity|insulin sensitivity
304550|NCT02320526|Glucose effectiveness|glucose effectiveness
304551|NCT02320513|Exercise|exercise
304552|NCT02320461|diabetes mellitus|diabetes mellitus
304553|NCT02320461|cardiovascular diseases|cardiovascular diseases
304554|NCT02320461|cohort studies|cohort studies
304555|NCT02320461|hypertension|hypertension
304556|NCT02320461|obesity|obesity
304557|NCT02320461|smoking|smoking
304558|NCT02320461|social class|social class
304559|NCT02320422|liver transplant|liver transplant
304560|NCT02320422|medication adherence|medication adherence
304561|NCT02320422|intervention|intervention
304562|NCT02320409|Subjects|subjects
304563|NCT02320383|CLL|cll
304564|NCT02320357|Platelet activation|platelet activation
304565|NCT02320357|CD40 ligand|cd40 ligand
304566|NCT02320357|CD154|cd154
304567|NCT02320357|Interferon alpha|interferon alpha
304568|NCT02320357|clopidogrel|clopidogrel
304569|NCT02320318|Irritable Bowel Syndrome|irritable bowel syndrome
304570|NCT02320318|Colon, irritable|colon, irritable
304571|NCT02320318|Bowel disease|bowel disease
304572|NCT02320318|Diarrhea|diarrhea
304573|NCT02320279|Fetal Heart Rate|fetal heart rate
304574|NCT02320279|Fetal EKG|fetal ekg
304575|NCT02320279|FHR tracing|fhr tracing
304576|NCT02320279|fetal R-waves|fetal r-waves
304577|NCT02320266|Deep Brain Stimulation Surgery|deep brain stimulation surgery
304578|NCT02320253|Diabetes|diabetes
304579|NCT02320253|Obesity|obesity
304580|NCT02320253|Primary Care|primary care
304581|NCT02320253|Lifestyle Intervention|lifestyle intervention
304582|NCT02320240|antidepressants|antidepressants
304583|NCT02320240|acute kidney injury|acute kidney injury
304584|NCT02320240|SNRI|snri
304585|NCT02320240|renal failure|renal failure
304586|NCT02320240|duloxetine|duloxetine
304587|NCT02320240|CNODES|cnodes
304588|NCT02320188|modification of treatment planned|modification of treatment planned
304589|NCT02320188|Exercise|exercise
304590|NCT02320175|family centered rounds|family centered rounds
304591|NCT02320175|patient safety|patient safety
304592|NCT02320175|errors|errors
304593|NCT02320175|adverse events|adverse events
304594|NCT02320175|concordance|concordance
304595|NCT02320175|patient experience|patient experience
304596|NCT02320149|acne|acne
304597|NCT02320123|Terminal Care|terminal care
304598|NCT02320123|Decision Making|decision making
304599|NCT02320123|Communication|communication
304600|NCT02320110|Irisin|irisin
304601|NCT02320110|Adiponectin|adiponectin
304602|NCT02320110|Leptin|leptin
304603|NCT02320110|Insulin resistance|insulin resistance
304604|NCT02320110|Body Mass Index|body mass index
304605|NCT02320110|Obesity|obesity
304606|NCT02320110|Metabolic Syndrome|metabolic syndrome
304607|NCT02320110|Lipid Profile|lipid profile
304608|NCT02320110|Diabetes Mellitus|diabetes mellitus
304609|NCT02320084|HT-1|ht-1
304610|NCT02320084|Hereditary Tyrosinemia, Type I|hereditary tyrosinemia, type i
304611|NCT02320084|hypertyrosinemia type 1|hypertyrosinemia type 1
304612|NCT02320084|Orfadin|orfadin
304613|NCT02320084|Long term safety|long term safety
304614|NCT02320084|Hereditary Tyrosinemia Type 1|hereditary tyrosinemia type 1
304615|NCT02320032|Alkermes|alkermes
304616|NCT02320032|Schizophrenia|schizophrenia
304617|NCT02320032|Aripiprazole|aripiprazole
304618|NCT02320032|Aripiprazole lauroxil|aripiprazole lauroxil
304619|NCT02320032|ALKS 9072|alks 9072
304620|NCT02320006|hydrotubation|hydrotubation
304621|NCT02320006|incomplete fallopian tube obstructive infertility|incomplete fallopian tube obstructive infertility
304622|NCT02320006|Acupuncture|acupuncture
304623|NCT02319993|Suan-Zao-Ren Tang|suan-zao-ren tang
304624|NCT02319993|Tian-wang-bu-xin-dan|tian-wang-bu-xin-dan
304625|NCT02319993|Traditional Chinese Medicine|traditional chinese medicine
304626|NCT02319993|Herbs|herbs
304630|NCT02319967|asthma|asthma
304631|NCT02319941|Inhibition of Platelet Reactivity|inhibition of platelet reactivity
304632|NCT02319941|ticagrelor|ticagrelor
304633|NCT02319941|clopidogrel|clopidogrel
304634|NCT02319941|Pharmacodynamics|pharmacodynamics
304635|NCT02319941|Pharmacokinetics|pharmacokinetics
304636|NCT02319915|tranexamic acid|tranexamic acid
304637|NCT02319915|knee prosthesis|knee prosthesis
304638|NCT02319915|pharmacokinetic profile|pharmacokinetic profile
304639|NCT02319863|hepatocellular carcinoma|hepatocellular carcinoma
304640|NCT02319863|prognosis|prognosis
304641|NCT02319850|sarcopenia|sarcopenia
304642|NCT02319850|screening|screening
304643|NCT02319850|geriatrics|geriatrics
304644|NCT02319850|muscle|muscle
304645|NCT02319850|aging|aging
304646|NCT02319850|ultrasound|ultrasound
304647|NCT02319798|Crohn's disease|crohn's disease
304648|NCT02319798|ulcerative colitis|ulcerative colitis
304649|NCT02319798|Inflammatory bowel disease|inflammatory bowel disease
304650|NCT02319798|IBD|ibd
304651|NCT02319772|Healthy volunteers|healthy volunteers
304652|NCT02319772|Ebola virus|ebola virus
304653|NCT02319772|Filovirus|filovirus
304654|NCT02319759|Psoriatic Arthritis|psoriatic arthritis
304655|NCT02319759|Guselkumab|guselkumab
304656|NCT02319759|Ustekinumab|ustekinumab
304657|NCT02319759|Placebo|placebo
304658|NCT02319694|Basal Ganglia|basal ganglia
304659|NCT02319694|Behavior|behavior
304660|NCT02319694|Behavioral|behavioral
304661|NCT02319694|Brain|brain
304662|NCT02319694|Cognitive|cognitive
304663|NCT02319694|Computer Simulation|computer simulation
304664|NCT02319694|Cues|cues
304665|NCT02319694|Data|data
304666|NCT02319694|Deep Brain Stimulation|deep brain stimulation
304667|NCT02319694|Disease|disease
304668|NCT02319681|Caregivers|caregivers
304669|NCT02319681|Anxiety|anxiety
304670|NCT02319681|Depression|depression
304671|NCT02319655|Epiretinal membrane|epiretinal membrane
304672|NCT02319655|Macular pucker|macular pucker
304673|NCT02319655|Membrane peeling|membrane peeling
304674|NCT02319655|pars plana vitrectomy|pars plana vitrectomy
304675|NCT02319655|Air|air
304676|NCT02319655|balanced salt solution|balanced salt solution
304677|NCT02319655|Intraoperative OCT|intraoperative oct
304678|NCT02319655|Hyporeflectivity|hyporeflectivity
304679|NCT02319655|Retina|retina
304680|NCT02319642|Rheumatoid Arthritis|rheumatoid arthritis
304681|NCT02319642|TNFα antagonist|tnfα antagonist
304682|NCT02319642|Certolizumab pegol|certolizumab pegol
304683|NCT02319642|Chinese patients|chinese patients
304684|NCT02319642|Open-label|open-label
304685|NCT02319629|Morbid obesity,|morbid obesity,
304686|NCT02319629|Cholelithiasis|cholelithiasis
304687|NCT02319629|Bariatric surgery|bariatric surgery
304688|NCT02319629|Ursodiol|ursodiol
304689|NCT02319577|NSCLC|nsclc
304690|NCT02319577|EGFR|egfr
304691|NCT02319577|vinorelbine|vinorelbine
304692|NCT02319577|gefitinib|gefitinib
304693|NCT02319564|Wheeze|wheeze
304694|NCT02319564|Asthma|asthma
304695|NCT02319564|Randomized Trial|randomized trial
304696|NCT02319564|Pre-school aged children|pre-school aged children
304697|NCT02319538|Chronic thyroiditis|chronic thyroiditis
304698|NCT02319538|Total thyroidectomy|total thyroidectomy
304699|NCT02319538|Anti-TPO|anti-tpo
304700|NCT02319538|PROMs|proms
304701|NCT02319538|SF36|sf36
304702|NCT02319538|Fatigue questionnaire|fatigue questionnaire
304703|NCT02319538|Fatigue|fatigue
304704|NCT02319538|Autoimmune symptoms|autoimmune symptoms
304705|NCT02319538|HADs|hads
304706|NCT02319538|FSS|fss
304707|NCT02319538|fVAS|fvas
304708|NCT02319525|lupus nephritis|lupus nephritis
304709|NCT02319525|lupus|lupus
304710|NCT02319525|decision-making|decision-making
304711|NCT02319525|minorities|minorities
304712|NCT02319525|immunosuppressive medications|immunosuppressive medications
304713|NCT02319525|decision-aid|decision-aid
304714|NCT02319525|treatment|treatment
304715|NCT02319525|Decision conflict|decision conflict
304716|NCT02319525|SLE|sle
304717|NCT02319486|Retinoblastoma|retinoblastoma
304718|NCT02319486|carboplatin|carboplatin
304719|NCT02319473|system of care|system of care
304720|NCT02319473|acute myocardial infarction|acute myocardial infarction
304721|NCT02319473|registry|registry
304722|NCT02319473|Primary PCI|primary pci
304723|NCT02319473|Fibrinolytic therapy|fibrinolytic therapy
304724|NCT02319460|Vitamin K Reversal Antagonist Therapy of Acute Major Bleeding|vitamin k reversal antagonist therapy of acute major bleeding
304725|NCT02319460|Warfarin Reversal|warfarin reversal
304726|NCT02319447|Living Donation|living donation
304727|NCT02319447|Kidney Transplantation|kidney transplantation
304728|NCT02319421|Alarm fatigue|alarm fatigue
304729|NCT02319395|Parkinson's Disease|parkinson's disease
304730|NCT02319395|Behaviour addiction|behaviour addiction
304731|NCT02319395|Dopamine agonist|dopamine agonist
304732|NCT02319395|Genetic.|genetic.
304733|NCT02319382|Parkinson Disease|parkinson disease
304734|NCT02319382|[18F]DPA-714|[18f]dpa-714
304735|NCT02319382|Positron emission tomography (PET)|positron emission tomography (pet)
304736|NCT02319382|Neuroinflammation|neuroinflammation
304737|NCT02319369|High Risk Myelodysplastic Syndrome|high risk myelodysplastic syndrome
304738|NCT02319343|Glucocorticoid|glucocorticoid
304739|NCT02319343|Quadriceps muscle function|quadriceps muscle function
304740|NCT02319343|Knee arthroplasty, total|knee arthroplasty, total
304741|NCT02319330|HIV|hiv
304742|NCT02319330|Adherence|adherence
304743|NCT02319330|Mental health|mental health
304744|NCT02319330|Depression|depression
304745|NCT02319330|Women|women
304746|NCT02319330|Mobile phone technology|mobile phone technology
304747|NCT02319330|eHealth|ehealth
304748|NCT02319330|India|india
304749|NCT02319304|Pelvic Radiotherapy|pelvic radiotherapy
304750|NCT02319304|Rectal Adenocarcinoma|rectal adenocarcinoma
304751|NCT02319265|sepsis|sepsis
304752|NCT02319265|antioxidant|antioxidant
304753|NCT02319265|melatonin|melatonin
304754|NCT02319265|inflammation|inflammation
304755|NCT02319239|Prostate neoplasms|prostate neoplasms
304756|NCT02319239|Urogenital neoplasms|urogenital neoplasms
304757|NCT02319239|Genital neoplasms, male|genital neoplasms, male
304758|NCT02319239|Radiation therapy|radiation therapy
304759|NCT02319239|PSA|psa
304760|NCT02319239|DW-MRI, diffusion weighted MRI|dw-mri, diffusion weighted mri
304761|NCT02319239|Intra-fractional movement|intra-fractional movement
304762|NCT02319239|Hypofractionated radiotherapy|hypofractionated radiotherapy
304763|NCT02319239|Stereotactic|stereotactic
304764|NCT02319239|Toxicity due to radiotherapy|toxicity due to radiotherapy
304765|NCT02319239|Quality of life|quality of life
304766|NCT02319213|Intra-abdominal pressure,|intra-abdominal pressure,
304767|NCT02319213|intraocular pressure,|intraocular pressure,
304768|NCT02319213|abdominal hypertension,|abdominal hypertension,
304769|NCT02319213|laparoscopy,|laparoscopy,
304770|NCT02319213|critical care|critical care
304771|NCT02319200|Chemoprevention|chemoprevention
304772|NCT02319200|Decompensation of cirrhosis|decompensation of cirrhosis
304773|NCT02319200|Hepatocellular Carcinoma|hepatocellular carcinoma
304774|NCT02319200|Death|death
304775|NCT02319200|Efficacy|efficacy
304776|NCT02319200|Safety|safety
304777|NCT02319187|Esophageal Neoplasms|esophageal neoplasms
304778|NCT02319161|intravenous regional anesthesia|intravenous regional anesthesia
304779|NCT02319135|Acute Myeloid Leukemia|acute myeloid leukemia
304780|NCT02319122|Cerebral Palsy|cerebral palsy
304781|NCT02319122|Muscle structure|muscle structure
304782|NCT02319122|Strength training|strength training
304783|NCT02319096|Whole body vibration therapy|whole body vibration therapy
304784|NCT02319096|pelvic floor muscle training|pelvic floor muscle training
304785|NCT02319096|stress urinary incontinence|stress urinary incontinence
304786|NCT02319083|CABG|cabg
304787|NCT02319083|Coronary artery bypass surgery|coronary artery bypass surgery
304788|NCT02319083|Coronary artery bypass grafting|coronary artery bypass grafting
304789|NCT02319083|Coronary surgery|coronary surgery
304790|NCT02319083|Myocardial infarction|myocardial infarction
304791|NCT02319083|Coronary artery disease|coronary artery disease
304792|NCT02319083|Off-pump|off-pump
304793|NCT02319083|EuroSCORE|euroscore
389312|NCT01918202|PET|pet
304794|NCT02319070|Cost|cost
304795|NCT02319070|Clinical Outcomes|clinical outcomes
304796|NCT02319070|Quality of Life|quality of life
304797|NCT02319070|On Demand Treatment|on demand treatment
304798|NCT02319070|Secondary Prophylaxis|secondary prophylaxis
304799|NCT02319057|Healthy volunteer study|healthy volunteer study
304800|NCT02319044|Head and neck cancer; SCCHN|head and neck cancer; scchn
304801|NCT02319005|Cardiomyopathy|cardiomyopathy
304802|NCT02319005|Heart Failure|heart failure
304803|NCT02319005|FAC|fac
304804|NCT02319005|Amyloid|amyloid
304805|NCT02319005|Transthyretin|transthyretin
304806|NCT02319005|TTR|ttr
304807|NCT02319005|RNAi therapeutic|rnai therapeutic
304808|NCT02318953|Telemedicine|telemedicine
304809|NCT02318953|Ambulatory Surgical Procedures|ambulatory surgical procedures
304810|NCT02318953|Postoperative Care|postoperative care
304811|NCT02318953|Cost Effectiveness|cost effectiveness
304812|NCT02318953|Mobile Applications|mobile applications
304813|NCT02318953|Health Services Research|health services research
304814|NCT02318953|Breast Reconstruction|breast reconstruction
304815|NCT02318940|ultrasound guided|ultrasound guided
304816|NCT02318940|femoral vein|femoral vein
304817|NCT02318940|central venous catheter|central venous catheter
304818|NCT02318940|pediatric|pediatric
304819|NCT02318927|Deep Brain Stimulation|deep brain stimulation
304820|NCT02318914|Pyoderma Gangrenosum|pyoderma gangrenosum
304821|NCT02318914|Classic Pyoderma Gangrenosum|classic pyoderma gangrenosum
304822|NCT02318888|Small bowel obstruction, Surgery, Colorectal cancer|small bowel obstruction, surgery, colorectal cancer
304823|NCT02318875|Inflammation|inflammation
304824|NCT02318875|swell|swell
304825|NCT02318875|pain|pain
304826|NCT02318875|functional impairment|functional impairment
304827|NCT02318875|stiffness|stiffness
304828|NCT02318862|reflux|reflux
304829|NCT02318862|GERD|gerd
304830|NCT02318862|EGD|egd
304831|NCT02318862|pH testing|ph testing
304832|NCT02318849|designated organ donor, college students|designated organ donor, college students
304833|NCT02318836|hepatic, hepatic impairment, lofexidine|hepatic, hepatic impairment, lofexidine
304930|NCT02318225|Misoprostol|misoprostol
304834|NCT02318823|social neuroscience|social neuroscience
304835|NCT02318823|emotion|emotion
304836|NCT02318823|face recognition|face recognition
304837|NCT02318823|empathy|empathy
304838|NCT02318823|beer|beer
304839|NCT02318823|alcohol|alcohol
304840|NCT02318823|social cognition|social cognition
304841|NCT02318810|Muscle relaxants|muscle relaxants
304842|NCT02318797|Chronic disease|chronic disease
304843|NCT02318797|Mental Health|mental health
304844|NCT02318797|Behavioral Health|behavioral health
304845|NCT02318797|Community mental health centers|community mental health centers
304846|NCT02318797|Intervention studies|intervention studies
304847|NCT02318797|Mixed methods|mixed methods
304848|NCT02318797|Qualitative research|qualitative research
304849|NCT02318784|neuroendocrine malignancies|neuroendocrine malignancies
304850|NCT02318784|pancreatic neuroendocrine tumors (PNETs)|pancreatic neuroendocrine tumors (pnets)
304851|NCT02318784|gastrointestinal (GI) carcinoids|gastrointestinal (gi) carcinoids
304852|NCT02318784|carfilzomib|carfilzomib
304853|NCT02318784|Kyprolis|kyprolis
304854|NCT02318784|proteasome inhibitors|proteasome inhibitors
304855|NCT02318758|This is a healthy volunteer study.|this is a healthy volunteer study.
304856|NCT02318745|Family Therapy|family therapy
304857|NCT02318745|Substance abuse prevention|substance abuse prevention
304858|NCT02318745|Minority|minority
304859|NCT02318745|randomized trials|randomized trials
304860|NCT02318745|outcome research|outcome research
304861|NCT02318745|adolescent treatment|adolescent treatment
304862|NCT02318732|violence|violence
304863|NCT02318719|Post-Herpetic Neuralgia|post-herpetic neuralgia
304864|NCT02318719|Developmental Phase III|developmental phase iii
304865|NCT02318706|Diabetic Peripheral Neuropathic Pain|diabetic peripheral neuropathic pain
304866|NCT02318641|oxygen consumption|oxygen consumption
304867|NCT02318641|retinal oximetry|retinal oximetry
304868|NCT02318628|Cardio ankle vascular index|cardio ankle vascular index
304869|NCT02318628|CAVI|cavi
304870|NCT02318628|pulse wave velocity|pulse wave velocity
304871|NCT02318628|PWV|pwv
304872|NCT02318628|Non invasive arterial structure assessment|non invasive arterial structure assessment
304873|NCT02318615|Breast Neoplasm|breast neoplasm
304874|NCT02318615|Lymphedema|lymphedema
304875|NCT02318615|Autologous flap|autologous flap
304876|NCT02318615|lattismus dorsi flap|lattismus dorsi flap
304877|NCT02318602|Lennox-Gastaut syndrome|lennox-gastaut syndrome
304878|NCT02318602|Dravet syndrome|dravet syndrome
304879|NCT02318602|Treatment-resistant seizures|treatment-resistant seizures
304880|NCT02318576|Multiple Sclerosis|multiple sclerosis
304881|NCT02318563|Treatment-resistant seizures|treatment-resistant seizures
304882|NCT02318537|Treatment-resistant seizures|treatment-resistant seizures
304883|NCT02318472|Microdialysis|microdialysis
304884|NCT02318472|Patient related outcome|patient related outcome
304885|NCT02318472|Heel rise test|heel rise test
304886|NCT02318472|Immobilization|immobilization
304887|NCT02318472|functional mobilization|functional mobilization
304888|NCT02318472|Ultrasound|ultrasound
304889|NCT02318446|Anti-epileptic drugs|anti-epileptic drugs
304890|NCT02318446|Folic acid|folic acid
304891|NCT02318446|Homocysteine|homocysteine
304892|NCT02318433|DRF|drf
304893|NCT02318433|PTOA|ptoa
304894|NCT02318433|dexamethasone|dexamethasone
304895|NCT02318420|Obstetrics|obstetrics
304896|NCT02318420|Partogram|partogram
304897|NCT02318420|ePartogram|epartogram
304898|NCT02318420|eHealth|ehealth
304899|NCT02318420|Low-income|low-income
304900|NCT02318420|Quality of care|quality of care
304901|NCT02318420|Perinatal death|perinatal death
304902|NCT02318420|Maternal death|maternal death
304903|NCT02318420|Cesarean section|cesarean section
304904|NCT02318420|Health information technology|health information technology
304905|NCT02318394|advanced solid tumors; immunotherapy; OX40; immuno-oncology|advanced solid tumors; immunotherapy; ox40; immuno-oncology
304906|NCT02318381|suprascapular nerve|suprascapular nerve
304907|NCT02318381|rotator cuff tear|rotator cuff tear
304908|NCT02318381|suprascapular neuropathy|suprascapular neuropathy
304909|NCT02318381|superior transverse scapular ligament|superior transverse scapular ligament
304910|NCT02318355|hemodilution|hemodilution
304911|NCT02318355|hemorrhage|hemorrhage
304912|NCT02318355|trauma|trauma
304913|NCT02318355|lactate|lactate
304914|NCT02318355|base deficit|base deficit
304915|NCT02318355|randomized control trial|randomized control trial
304916|NCT02318329|FGFR2b, FGFR2, FGFR, bladder neoplasms, esophageal cancer|fgfr2b, fgfr2, fgfr, bladder neoplasms, esophageal cancer
304917|NCT02318316|Exhaled breath condensate|exhaled breath condensate
304918|NCT02318316|allogeneic stem cell transplantation|allogeneic stem cell transplantation
304919|NCT02318316|pulmonary complications|pulmonary complications
304920|NCT02318290|Analgesia|analgesia
304921|NCT02318290|Critical Care|critical care
304922|NCT02318290|Hypnotics and Sedatives|hypnotics and sedatives
304923|NCT02318251|Power, rate of force development|power, rate of force development
304924|NCT02318251|involuntary|involuntary
304925|NCT02318251|reflexive|reflexive
304926|NCT02318238|evaluation|evaluation
304927|NCT02318238|exercise tolerance|exercise tolerance
304928|NCT02318238|healthy children|healthy children
304929|NCT02318238|6MWT|6mwt
304931|NCT02318225|Office hysteroscopy|office hysteroscopy
304932|NCT02318225|Pain|pain
304933|NCT02318212|Cervical dilatation|cervical dilatation
304934|NCT02318199|emergence agitation|emergence agitation
304935|NCT02318199|intracranial surgery|intracranial surgery
304936|NCT02318199|general anesthesia|general anesthesia
304937|NCT02318199|incidence|incidence
304938|NCT02318199|risk factor|risk factor
304939|NCT02318186|pharmacokinetic analysis|pharmacokinetic analysis
304940|NCT02318186|remodulin|remodulin
304941|NCT02318186|trepostinil|trepostinil
304942|NCT02318186|pulmonary arterial hypertension|pulmonary arterial hypertension
304943|NCT02318173|Cervical dilatation|cervical dilatation
304944|NCT02318160|Autoimmune Thyroiditis|autoimmune thyroiditis
304945|NCT02318160|Oxidative Status|oxidative status
304946|NCT02318160|Children|children
304947|NCT02318147|Severe acute pancreatitis|severe acute pancreatitis
304948|NCT02318147|Fecal Microbiota Transplantation|fecal microbiota transplantation
304949|NCT02318147|Bacterial Translocation|bacterial translocation
304950|NCT02318147|Infectious Complications|infectious complications
304951|NCT02318134|Severe acute pancreatitis|severe acute pancreatitis
304952|NCT02318134|Fecal Microbiota Transplantation|fecal microbiota transplantation
304953|NCT02318134|Intestinal barrier dysfunction|intestinal barrier dysfunction
304954|NCT02318134|Intestinal flora|intestinal flora
304955|NCT02318121|Labor, prolonged labor, augmentation of labor|labor, prolonged labor, augmentation of labor
304956|NCT02318108|Organizational Innovation|organizational innovation
304957|NCT02318108|Primary Health Care|primary health care
304958|NCT02318095|Cancer of the pancreas|cancer of the pancreas
304959|NCT02318082|Chronic versus Graft Host Disease|chronic versus graft host disease
304960|NCT02318069|immune response|immune response
304961|NCT02318069|TBE-vaccine|tbe-vaccine
304962|NCT02318069|elderly|elderly
304963|NCT02318069|additional doses|additional doses
304964|NCT02318056|hand|hand
304965|NCT02318056|burns|burns
304966|NCT02318056|thermal|thermal
304967|NCT02318056|dressing|dressing
304968|NCT02318056|Aquacel®|aquacel®
304969|NCT02318056|Mepilex® Transfer Ag|mepilex® transfer ag
304970|NCT02318056|Xeroform®|xeroform®
304971|NCT02318056|Bacitracin®|bacitracin®
304972|NCT02318056|partial thickness|partial thickness
304973|NCT02318056|epithelialization|epithelialization
304974|NCT02318056|wound healing|wound healing
304975|NCT02318056|scar|scar
304976|NCT02318056|scarring|scarring
304977|NCT02318043|adenosine monophosphate|adenosine monophosphate
304978|NCT02318043|histamine|histamine
304979|NCT02318043|bronchial provocation test|bronchial provocation test
304980|NCT02318043|asthma symptom score|asthma symptom score
304981|NCT02318043|asthma control|asthma control
304982|NCT02318030|Transplant|transplant
304983|NCT02318030|Adaptive Immunity|adaptive immunity
304984|NCT02318030|EBV|ebv
304985|NCT02318030|Medication Adherence|medication adherence
304986|NCT02318030|Tacrolimus|tacrolimus
304987|NCT02318030|PTLD|ptld
304988|NCT02318017|adhd|adhd
304989|NCT02318017|global network|global network
304990|NCT02318017|eeg|eeg
304991|NCT02318004|telemonitoring|telemonitoring
304992|NCT02317991|gastroesophageal adenocarcinoma|gastroesophageal adenocarcinoma
304993|NCT02317991|nab-paclitaxel|nab-paclitaxel
304994|NCT02317991|Abraxane|abraxane
304995|NCT02317991|ramucirumab|ramucirumab
304996|NCT02317991|Cyramza|cyramza
304997|NCT02317991|GE junction|ge junction
304998|NCT02317913|Kawasaki disease|kawasaki disease
304999|NCT02317913|Epidemiology|epidemiology
305000|NCT02317913|Incidence|incidence
305001|NCT02317913|Coronary arterial lesions|coronary arterial lesions
305002|NCT02317913|Shanghai|shanghai
305003|NCT02317887|Gene Transfer|gene transfer
305004|NCT02317887|X-Linked|x-linked
305005|NCT02317887|Retinoschisis|retinoschisis
305006|NCT02317887|AAV Vector|aav vector
305007|NCT02317848|Diagnosis|diagnosis
305008|NCT02317848|prognostic marker|prognostic marker
305009|NCT02317848|polygraphy|polygraphy
305010|NCT02317848|echocardiography|echocardiography
305011|NCT02317848|ECG|ecg
305012|NCT02317809|Healthy|healthy
305013|NCT02317809|Pergoveris|pergoveris
305014|NCT02317809|Bioequivalence|bioequivalence
305015|NCT02317809|Infertility|infertility
305016|NCT02317770|lidocaine, esophago-gastro-duodenoscopy|lidocaine, esophago-gastro-duodenoscopy
305017|NCT02317757|elderly cancer patients, chemotherapy toxicity|elderly cancer patients, chemotherapy toxicity
305018|NCT02317731|bowel preparation|bowel preparation
305019|NCT02317718|serum vitamin D levels|serum vitamin d levels
305020|NCT02317718|IVF|ivf
305021|NCT02317718|ovarian reserve|ovarian reserve
305022|NCT02317718|25 OHD3|25 ohd3
305023|NCT02317718|pregnancy outcome|pregnancy outcome
305024|NCT02317666|polypharmacy|polypharmacy
305025|NCT02317666|drug burden index|drug burden index
305026|NCT02317666|aged|aged
305027|NCT02317666|medication review|medication review
305028|NCT02317666|cholinergic agents|cholinergic agents
305029|NCT02317640|Testosterone|testosterone
305030|NCT02317640|Electrical Stimulation|electrical stimulation
305031|NCT02317640|Stand Training|stand training
305032|NCT02317614|Incentives|incentives
305033|NCT02317614|Smartphone|smartphone
305034|NCT02317614|Mobile intervention|mobile intervention
305035|NCT02317614|eDOT|edot
305036|NCT02317614|Adherence reinforcement|adherence reinforcement
305037|NCT02317614|Drug users|drug users
305038|NCT02317588|Oxylipins|oxylipins
305039|NCT02317588|Flax oil|flax oil
305040|NCT02317588|Fish oil|fish oil
305041|NCT02317562|Peripheral neuropathy|peripheral neuropathy
305042|NCT02317562|Disimmune disease|disimmune disease
305043|NCT02317562|Neurology chronic disease|neurology chronic disease
305044|NCT02317562|Rare disease|rare disease
305045|NCT02317549|sepsis|sepsis
305046|NCT02317549|septic shock|septic shock
305047|NCT02317549|vasodilatory shock|vasodilatory shock
305048|NCT02317549|circulatory shock|circulatory shock
305049|NCT02317549|Systemic Inflammatory Response Syndrome|systemic inflammatory response syndrome
305050|NCT02317549|SIRS|sirs
305051|NCT02317549|infection|infection
305052|NCT02317549|toxemia|toxemia
305053|NCT02317549|gut barrier breakdown|gut barrier breakdown
305054|NCT02317549|autodigestion|autodigestion
305055|NCT02317549|multiorgan failure|multiorgan failure
305056|NCT02317549|MOF|mof
305057|NCT02317549|multiorgain dysfunction syndrome|multiorgain dysfunction syndrome
305058|NCT02317549|MODS|mods
305059|NCT02317549|hyperlactatemia|hyperlactatemia
305060|NCT02317549|tissue hypoxia|tissue hypoxia
305061|NCT02317536|Muscle function|muscle function
305062|NCT02317536|L-Carnitine|l-carnitine
305063|NCT02317536|Carnipure|carnipure
305064|NCT02317536|DXA|dxa
305065|NCT02317536|anabolism|anabolism
305066|NCT02317536|6 minute walk|6 minute walk
305067|NCT02317536|dynamometry|dynamometry
305068|NCT02317536|muscle biopsy|muscle biopsy
305069|NCT02317523|Dementia|dementia
305070|NCT02317523|Caregiver|caregiver
305071|NCT02317523|Cardiovascular Disease|cardiovascular disease
305072|NCT02317523|Stress|stress
305073|NCT02317523|Depression|depression
305074|NCT02317523|Anxiety|anxiety
305075|NCT02317523|Heart Disease|heart disease
305076|NCT02317523|Carer|carer
305077|NCT02317523|Care Giver|care giver
305078|NCT02317523|Caregiving|caregiving
305079|NCT02317523|Psychotherapy|psychotherapy
305080|NCT02317523|Therapy|therapy
305081|NCT02317523|Behavioral Activation|behavioral activation
305082|NCT02317523|Education|education
305083|NCT02317523|Intervention|intervention
305084|NCT02317523|CBT|cbt
305085|NCT02317523|Cognitive-Behavior Therapy|cognitive-behavior therapy
305086|NCT02317510|Combined anesthesia|combined anesthesia
305087|NCT02317510|General anesthesia|general anesthesia
305088|NCT02317510|Laparoscopic cholecystectomy|laparoscopic cholecystectomy
305089|NCT02317497|Neurocritical care|neurocritical care
305090|NCT02317497|Severe Stroke|severe stroke
305091|NCT02317497|Ischemic stroke|ischemic stroke
305092|NCT02317497|Intracerebral hemorrhage|intracerebral hemorrhage
305093|NCT02317497|Subarachnoid hemorrhage|subarachnoid hemorrhage
305094|NCT02317497|Sedation|sedation
305095|NCT02317497|RASS|rass
305096|NCT02317497|BIS|bis
305097|NCT02317445|helicobacter pylori|helicobacter pylori
305098|NCT02317445|eradication therapy|eradication therapy
305099|NCT02317445|major adverse cardiac events|major adverse cardiac events
305100|NCT02317445|long-term outcome|long-term outcome
305101|NCT02317445|To explore the significance of Hp eradication therapy in preventing major adverse cardiac events (MACE) and upper gastrointestinal bleeding (UGIB).|to explore the significance of hp eradication therapy in preventing major adverse cardiac events (mace) and upper gastrointestinal bleeding (ugib).
305102|NCT02317432|Depression|depression
305103|NCT02317432|Anxiety|anxiety
305104|NCT02317432|Disability|disability
305105|NCT02317432|Ethnic Minority|ethnic minority
305106|NCT02317432|Elders|elders
305107|NCT02317419|Solid Cancers|solid cancers
305108|NCT02317393|Nuclear medicine|nuclear medicine
305109|NCT02317393|Positron emission tomography|positron emission tomography
305110|NCT02317393|avb3 integrin expression|avb3 integrin expression
305111|NCT02317380|Self-Affirmation|self-affirmation
305112|NCT02317380|Weight Loss|weight loss
305113|NCT02317380|Self vs. Other|self vs. other
305114|NCT02317380|Cancer Risk and Prevention|cancer risk and prevention
305115|NCT02317367|Construct Validity|construct validity
305116|NCT02317367|Self-Affirmation|self-affirmation
305117|NCT02317367|Alcohol Consumption|alcohol consumption
305118|NCT02317367|Breast Cancer|breast cancer
305119|NCT02317354|X-Linked|x-linked
305120|NCT02317354|Retinoschisis|retinoschisis
305121|NCT02317341|Fatigue|fatigue
305122|NCT02317341|Ketamine|ketamine
305123|NCT02317341|Cancer|cancer
305124|NCT02317328|Retinal Images|retinal images
305125|NCT02317328|Adaptive Optics|adaptive optics
305126|NCT02317263|MS|ms
305127|NCT02317250|Alzheimer's disease|alzheimer's disease
305128|NCT02317250|Alzheimer disease|alzheimer disease
305129|NCT02317250|MDC|mdc
305130|NCT02317250|Mild Decline in Cognition|mild decline in cognition
305131|NCT02317250|MCI|mci
305132|NCT02317250|Dementia|dementia
305133|NCT02317250|PET|pet
305134|NCT02317250|FDG-PET|fdg-pet
305135|NCT02317250|FDG|fdg
305136|NCT02317250|amyloid|amyloid
305137|NCT02317250|amyloid imaging|amyloid imaging
305138|NCT02317250|CMS|cms
305139|NCT02317250|Coverage with Evidence Development|coverage with evidence development
305140|NCT02317250|CED|ced
305141|NCT02317250|MCI-ID|mci-id
305142|NCT02317224|3-Hole approach|3-hole approach
305143|NCT02317224|extended thymectomy|extended thymectomy
305144|NCT02317224|myasthenia gravis|myasthenia gravis
305145|NCT02317224|safety|safety
305146|NCT02317224|effectiveness|effectiveness
305147|NCT02317198|Elderly|elderly
305148|NCT02317198|P2Y12 inhibitors|p2y12 inhibitors
305149|NCT02317198|clopidogrel|clopidogrel
305150|NCT02317198|ticagrelor|ticagrelor
305151|NCT02317172|Saliva substitute|saliva substitute
305152|NCT02317172|Edible gel|edible gel
305153|NCT02317172|Xerostomia|xerostomia
305154|NCT02317172|Diabetes Mellitus|diabetes mellitus
305155|NCT02317172|Hypertension|hypertension
305156|NCT02317133|Tregs|tregs
305157|NCT02317133|bacterial translocation|bacterial translocation
305158|NCT02317133|cytokines|cytokines
305159|NCT02317107|Gait|gait
305160|NCT02317107|Mild Traumatic Brain Injury|mild traumatic brain injury
305161|NCT02317107|Post-Concussion Syndrome|post-concussion syndrome
305162|NCT02317107|Recovery of Function|recovery of function
305163|NCT02317107|Locomotion|locomotion
305164|NCT02317107|Motor Activity|motor activity
305165|NCT02317068|sick sinus syndrome|sick sinus syndrome
305166|NCT02317068|paroxysmal atrial fibrillation|paroxysmal atrial fibrillation
305167|NCT02317068|atrial pacing|atrial pacing
305168|NCT02317068|high atrial base rate pacing|high atrial base rate pacing
305169|NCT02317055|MRI|mri
305170|NCT02317055|Oxygenation|oxygenation
305171|NCT02317055|nirs|nirs
305172|NCT02317029|Cardioversion|cardioversion
305173|NCT02317029|Cardiac Arrythmias|cardiac arrythmias
305174|NCT02317029|Myocardial Injury|myocardial injury
305175|NCT02317029|Defibrillators|defibrillators
305176|NCT02317029|Biomarkers|biomarkers
305177|NCT02317016|oncology|oncology
305178|NCT02317016|cancer|cancer
305179|NCT02317016|non small cell lung cancer|non small cell lung cancer
305180|NCT02317016|anticancer drug|anticancer drug
305181|NCT02317016|pharmacokinetics|pharmacokinetics
305182|NCT02317016|AZD9291|azd9291
305183|NCT02317016|rosuvastatin|rosuvastatin
305184|NCT02317016|EGFR genes|egfr genes
305185|NCT02317003|physical exercise|physical exercise
305186|NCT02317003|sedentarity|sedentarity
305187|NCT02317003|general practice|general practice
305188|NCT02317003|family medicine|family medicine
305189|NCT02317003|pedometer|pedometer
305190|NCT02316977|Reproducibility of Results|reproducibility of results
305191|NCT02316964|AML|aml
305192|NCT02316964|acute myeloid leukemia|acute myeloid leukemia
305193|NCT02316964|decitabine|decitabine
305194|NCT02316951|Postoperative|postoperative
305195|NCT02316951|Pain|pain
305196|NCT02316951|Symptoms|symptoms
305197|NCT02316951|Video recording|video recording
305198|NCT02316951|Orthopedic surgery|orthopedic surgery
305199|NCT02316912|allergy|allergy
305200|NCT02316899|ASP0456|asp0456
305201|NCT02316899|constipation|constipation
305202|NCT02316899|linaclotide|linaclotide
305203|NCT02316899|irritable bowel syndrome (IBS)|irritable bowel syndrome (ibs)
305204|NCT02316886|coronary intervention|coronary intervention
305205|NCT02316886|Vulnerable Plaque|vulnerable plaque
305206|NCT02316886|Insignificant Stenosis|insignificant stenosis
305207|NCT02316886|Bioresorbable Vascular Scaffold|bioresorbable vascular scaffold
305208|NCT02316886|Everolimus Eluting stent|everolimus eluting stent
305209|NCT02316873|music training, rhythm|music training, rhythm
305210|NCT02316847|Cluster Seizures|cluster seizures
305211|NCT02316847|Seizures|seizures
305212|NCT02316847|Clusters|clusters
305213|NCT02316847|Acute repetitive seizures|acute repetitive seizures
305214|NCT02316821|Diabetes Mellitus|diabetes mellitus
305215|NCT02316821|Diabetes Mellitus, Type 2|diabetes mellitus, type 2
305216|NCT02316821|Diabetic Nephropathies|diabetic nephropathies
305217|NCT02316821|Kidney Diseases|kidney diseases
305218|NCT02316821|Renal Insufficiency, Chronic|renal insufficiency, chronic
305219|NCT02316821|Diabetes Complications|diabetes complications
305220|NCT02316821|Endocrine System Diseases|endocrine system diseases
305221|NCT02316821|Glucose Metabolism Disorders|glucose metabolism disorders
305222|NCT02316821|Metabolic Diseases|metabolic diseases
305223|NCT02316821|Renal Insufficiency|renal insufficiency
305224|NCT02316821|Urologic Diseases|urologic diseases
305225|NCT02316821|bardoxolone methyl|bardoxolone methyl
305226|NCT02316756|Phase 1, Single-Dose Escalation, Double Blind, Placebo-Controlled, Safety, Tolerability, Pharmacokinetics, Pharmacodynamics, PF-06648671, Plasma Abeta|phase 1, single-dose escalation, double blind, placebo-controlled, safety, tolerability, pharmacokinetics, pharmacodynamics, pf-06648671, plasma abeta
305227|NCT02316691|Graves Disease|graves disease
305228|NCT02316691|Rituximab|rituximab
305229|NCT02316678|Patient Preference|patient preference
305230|NCT02316665|Type 1 diabetes|type 1 diabetes
305231|NCT02316665|Sleep apnea syndrome|sleep apnea syndrome
305232|NCT02316665|Nocturnal glycemia|nocturnal glycemia
305233|NCT02316665|Continuous glucose monitoring system|continuous glucose monitoring system
305234|NCT02316665|Continuous positive airway pressure|continuous positive airway pressure
305235|NCT02316665|Sleep habits|sleep habits
305236|NCT02316639|Neuromuscular Training|neuromuscular training
305237|NCT02316639|Skeletally Immature|skeletally immature
305238|NCT02316639|Knee Rehabilitation|knee rehabilitation
305239|NCT02316600|elderly|elderly
305240|NCT02316600|Robust volunteers for the first phase;|robust volunteers for the first phase;
305241|NCT02316600|tele-monitoring|tele-monitoring
305242|NCT02316600|self-management|self-management
305243|NCT02316600|Patient 65 and over|patient 65 and over
305244|NCT02316600|Presenting a frailty syndrome for the second phase|presenting a frailty syndrome for the second phase
305245|NCT02316587|Computerized Tomography|computerized tomography
305246|NCT02316587|Magnetic Resonance Imaging|magnetic resonance imaging
305247|NCT02316587|Echocardiography|echocardiography
305248|NCT02316587|Right Heart Catheterization|right heart catheterization
305249|NCT02316574|Alcohol dependence|alcohol dependence
305250|NCT02316574|Cognitive Behavioral Therapy|cognitive behavioral therapy
305251|NCT02316574|Functional neuroimaging|functional neuroimaging
305252|NCT02316535|colorectal cancer|colorectal cancer
305253|NCT02316535|stage II/III|stage ii/iii
305254|NCT02316535|elderly|elderly
305255|NCT02316535|adjuvant chemotherapy|adjuvant chemotherapy
305256|NCT02316535|capecitabine|capecitabine
305257|NCT02316535|non-inferiority|non-inferiority
305258|NCT02316496|Cancer|cancer
305259|NCT02316496|Colorectal|colorectal
305260|NCT02316496|Metastatic|metastatic
305261|NCT02316496|Thrid-line|thrid-line
305262|NCT02316496|Irinotecan|irinotecan
305263|NCT02316496|Cetuximab|cetuximab
305264|NCT02316470|Clostridium difficile|clostridium difficile
305265|NCT02316470|Valneva|valneva
305266|NCT02316470|Phase 2|phase 2
305267|NCT02316470|Healthy adults|healthy adults
305268|NCT02316457|TNBC|tnbc
305269|NCT02316457|Breast Cancer|breast cancer
305270|NCT02316457|Warehouse|warehouse
305271|NCT02316457|Mutanome|mutanome
305272|NCT02316457|RNA|rna
305273|NCT02316457|Vaccine|vaccine
305274|NCT02316444|Hepatitis B vaccine HIV infection|hepatitis b vaccine hiv infection
305275|NCT02316418|Hairstetics™ anchoring system|hairstetics™ anchoring system
305276|NCT02316418|hair extensions|hair extensions
305277|NCT02316392|Helium|helium
305278|NCT02316392|MRI|mri
305279|NCT02316392|Lung transplantation|lung transplantation
305280|NCT02316379|Respiratory|respiratory
305281|NCT02316314|Friedreich's Ataxia|friedreich's ataxia
305282|NCT02316314|Cardiomyopathy|cardiomyopathy
305283|NCT02316301|Misoprostol, pain, office hysteroscopy|misoprostol, pain, office hysteroscopy
305284|NCT02316249|pelvic organ prolapse|pelvic organ prolapse
305285|NCT02316249|Atrophy of Vagina|atrophy of vagina
305286|NCT02316249|Gellhorn pessary|gellhorn pessary
305287|NCT02316249|Ring with support pessary|ring with support pessary
305288|NCT02316249|Estrace cream|estrace cream
305289|NCT02316249|vaginitis with pessary|vaginitis with pessary
305290|NCT02316249|vaginal ulceration with pessary|vaginal ulceration with pessary
305291|NCT02316249|vaginal erosion with pessary|vaginal erosion with pessary
305292|NCT02316249|pessary complications|pessary complications
305293|NCT02316249|vaginal bleeding with pessary|vaginal bleeding with pessary
305294|NCT02316223|asthma|asthma
305295|NCT02316223|high-risk|high-risk
305296|NCT02316223|adult|adult
305297|NCT02316223|elderly|elderly
305298|NCT02316223|care coordination|care coordination
305299|NCT02316223|community health worker|community health worker
305300|NCT02316223|electronic medical record|electronic medical record
305301|NCT02316197|DNA-PK Inhibitor|dna-pk inhibitor
305302|NCT02316197|Advanced solid tumors|advanced solid tumors
305303|NCT02316197|Chronic lymphocytic Leukemia|chronic lymphocytic leukemia
305304|NCT02316197|Phase I, first-in-human|phase i, first-in-human
305305|NCT02316197|Dose escalation|dose escalation
305306|NCT02316197|Dose expansion|dose expansion
305307|NCT02316197|Safety profile|safety profile
305308|NCT02316197|Tolerability|tolerability
305309|NCT02316197|PK|pk
305310|NCT02316197|Antitumor activity|antitumor activity
305311|NCT02316197|Maximum tolerated dose|maximum tolerated dose
305312|NCT02316197|M3814|m3814
305313|NCT02316184|Alcohol|alcohol
305314|NCT02316171|Coxsackievirus A21|coxsackievirus a21
305315|NCT02316171|bladder cancer|bladder cancer
305316|NCT02316171|CVA21|cva21
305317|NCT02316171|CAVATAK|cavatak
305318|NCT02316158|Burden|burden
305319|NCT02316158|Mental illness|mental illness
305320|NCT02316158|Stress|stress
305321|NCT02316158|Social support|social support
305322|NCT02316145|ADHD|adhd
305323|NCT02316145|Autism spectrum condition|autism spectrum condition
305324|NCT02316145|Tourette's disorder|tourette's disorder
305325|NCT02316145|Internet-based|internet-based
305326|NCT02316145|chat|chat
305327|NCT02316145|coach|coach
305328|NCT02316119|bleeding risk, acute coronary syndrome, platelet agregation,|bleeding risk, acute coronary syndrome, platelet agregation,
305329|NCT02316106|Smoldering multiple myeloma (SMM)|smoldering multiple myeloma (smm)
305330|NCT02316106|Daratumumab|daratumumab
305331|NCT02316080|dental bleaching|dental bleaching
305332|NCT02316080|dentin sensitivity|dentin sensitivity
305333|NCT02316080|biomaterials|biomaterials
305334|NCT02316067|Spinal cord|spinal cord
305335|NCT02316067|Wounds and Injuries|wounds and injuries
305336|NCT02316067|Rehabilitation|rehabilitation
305337|NCT02316054|type 2 diabetes mellitus|type 2 diabetes mellitus
305338|NCT02316054|coronary microvascular disease|coronary microvascular disease
305339|NCT02316054|coronary artery disease|coronary artery disease
305340|NCT02316054|myocardial perfusion imaging|myocardial perfusion imaging
305341|NCT02316054|prognosis|prognosis
305342|NCT02316054|atherosclerosis|atherosclerosis
305343|NCT02316054|myocardial ischemia|myocardial ischemia
305344|NCT02316054|coronary heart disease|coronary heart disease
305345|NCT02316041|Femtosecond laser|femtosecond laser
305346|NCT02316041|Small incision lenticule extraction (SMILE)|small incision lenticule extraction (smile)
305347|NCT02316028|decitabine|decitabine
305348|NCT02316028|colorectal cancer|colorectal cancer
305349|NCT02316028|hepatic arterial infusion|hepatic arterial infusion
305350|NCT02316015|Child, Hospitalized|child, hospitalized
305351|NCT02316015|Nutritional status|nutritional status
305352|NCT02315976|chronic stable angina pectoris|chronic stable angina pectoris
305353|NCT02315976|propatyl nitrate|propatyl nitrate
305354|NCT02315976|Seattle Angina Questionnaire|seattle angina questionnaire
305355|NCT02315911|Tonsillectomy|tonsillectomy
305356|NCT02315911|Adenoidectomy|adenoidectomy
305357|NCT02315911|Adenoidpharyngoplasty|adenoidpharyngoplasty
305358|NCT02315911|OSA|osa
305359|NCT02315898|children, congenital heart disease, metabolomics|children, congenital heart disease, metabolomics
305360|NCT02315885|healthy volunteers|healthy volunteers
305361|NCT02315885|social drinkers|social drinkers
305362|NCT02315885|alcohol|alcohol
305363|NCT02315872|Multiple Sclerosis|multiple sclerosis
305364|NCT02315872|Acthar Gel|acthar gel
305365|NCT02315872|ACTH|acth
305366|NCT02315872|Fatigue|fatigue
305367|NCT02315859|suction work|suction work
305368|NCT02315833|Migraine|migraine
305369|NCT02315833|Aura|aura
305370|NCT02315820|Macrosomia|macrosomia
305371|NCT02315820|Induction of labor|induction of labor
305372|NCT02315820|Expectant management|expectant management
305373|NCT02315820|Shoulder dystocia|shoulder dystocia
305374|NCT02315794|aesthetic outcome|aesthetic outcome
305375|NCT02315794|titanium abutment|titanium abutment
305376|NCT02315794|zirconia abutment|zirconia abutment
305377|NCT02315768|CLL|cll
305378|NCT02315768|Chronic Lymphocytic Leukemia|chronic lymphocytic leukemia
305379|NCT02315768|Ibrutinib|ibrutinib
305380|NCT02315768|Obinutuzumab|obinutuzumab
305381|NCT02315768|Cancer|cancer
305382|NCT02315755|Metastatic renal cell carcinoma, targeted molecular therapy|metastatic renal cell carcinoma, targeted molecular therapy
305383|NCT02315716|Multiple Myeloma|multiple myeloma
305384|NCT02315716|Carfilzomib|carfilzomib
305385|NCT02315703|Healthy|healthy
305386|NCT02315703|Acquired Immuno-Deficiency Syndrome|acquired immuno-deficiency syndrome
305387|NCT02315703|Acquired Immunodeficiency Syndrome Virus|acquired immunodeficiency syndrome virus
305388|NCT02315703|adenovirus serotype 26|adenovirus serotype 26
305389|NCT02315703|Ad26.Mos.HIV|ad26.mos.hiv
305390|NCT02315703|Modified Vaccinia Ankara|modified vaccinia ankara
305391|NCT02315703|Glycoprotein|glycoprotein
305392|NCT02315703|Adjuvant|adjuvant
305393|NCT02315703|Vaccine|vaccine
305394|NCT02315703|Placebo|placebo
305395|NCT02315690|malaria, Swaziland, reactive case detection, focal mass drug administration|malaria, swaziland, reactive case detection, focal mass drug administration
305396|NCT02315677|Epistaxis|epistaxis
305397|NCT02315677|Nasal Intubation|nasal intubation
305398|NCT02315677|Maxillofacial surgery|maxillofacial surgery
305399|NCT02315664|Physical activity|physical activity
305400|NCT02315664|Exercise|exercise
305401|NCT02315664|Osteoarthritis|osteoarthritis
305402|NCT02315664|Knee|knee
305403|NCT02315664|Arthritis|arthritis
305404|NCT02315638|Adeno-associated viral vectors|adeno-associated viral vectors
305405|NCT02315638|Adeno-associated virus|adeno-associated virus
305406|NCT02315638|AAV|aav
305407|NCT02315638|AAV8|aav8
305408|NCT02315638|ddRNAi|ddrnai
305409|NCT02315638|shRNA|shrna
305410|NCT02315638|RNAi|rnai
305411|NCT02315638|Hepatitis|hepatitis
305412|NCT02315638|Chronic Hepatitis C|chronic hepatitis c
305413|NCT02315638|HCV|hcv
305414|NCT02315638|CHC|chc
305415|NCT02315638|Genotype 1|genotype 1
305416|NCT02315625|MEN1|men1
305417|NCT02315625|VHL|vhl
305418|NCT02315625|Neoplasm|neoplasm
305419|NCT02315625|NF1|nf1
305420|NCT02315625|mTOR|mtor
305421|NCT02315612|CD-22 Expressing Tumor|cd-22 expressing tumor
305422|NCT02315612|Chimeric Antigen Receptor|chimeric antigen receptor
305423|NCT02315612|Adoptive Immunotherapy|adoptive immunotherapy
305424|NCT02315612|ALL|all
305425|NCT02315612|Lymphoma|lymphoma
305426|NCT02315599|Replication Competent Retrovirus (RCR)|replication competent retrovirus (rcr)
305427|NCT02315599|Replication Competent Lentivirus (RCL)|replication competent lentivirus (rcl)
305428|NCT02315599|T Cell Persistence|t cell persistence
305429|NCT02315586|Idiopathic Pulmonary Fibrosis|idiopathic pulmonary fibrosis
305430|NCT02315586|Apoliprotein A-1|apoliprotein a-1
305431|NCT02315573|Carpal Tunnel Syndrome|carpal tunnel syndrome
305432|NCT02315573|Anesthetics, Local|anesthetics, local
305433|NCT02315573|Pain Perception|pain perception
305434|NCT02315573|Pain Measurement|pain measurement
305435|NCT02315573|Analgesia|analgesia
305436|NCT02315573|Lidocaine|lidocaine
305437|NCT02315573|Bupivacaine|bupivacaine
305438|NCT02315560|bedwetting|bedwetting
305439|NCT02315547|Microbiota|microbiota
305440|NCT02315547|Airway infection|airway infection
305441|NCT02315547|Bronchiectasis|bronchiectasis
305442|NCT02315547|Airway inflammation|airway inflammation
305443|NCT02315547|Oxidative stress|oxidative stress
305444|NCT02315547|Matrix metalloproteinase|matrix metalloproteinase
305446|NCT02315534|Malignant Glioma|malignant glioma
305447|NCT02315521|lower urinary tract obstruction|lower urinary tract obstruction
305448|NCT02315521|posterior urethral valves|posterior urethral valves
305449|NCT02315521|urethral atresia|urethral atresia
305450|NCT02315521|Prune Belly Syndrome|prune belly syndrome
305451|NCT02315521|Megalo-urethra|megalo-urethra
305452|NCT02315521|Fetal renal function|fetal renal function
305453|NCT02315521|Prenatal Diagnosis|prenatal diagnosis
305454|NCT02315521|Ultrasound|ultrasound
305455|NCT02315482|autonomic nervous system|autonomic nervous system
305456|NCT02315482|heart rate variability|heart rate variability
305457|NCT02315482|prostatectomy|prostatectomy
305458|NCT02315482|steep trendelenburg|steep trendelenburg
305459|NCT02315482|pneumoperitoneum|pneumoperitoneum
305460|NCT02315482|Intervention Affecting Autonomic Nervous System|intervention affecting autonomic nervous system
305461|NCT02315456|capsulorhexis|capsulorhexis
305462|NCT02315456|IOL centration|iol centration
305463|NCT02315443|Stroke|stroke
305464|NCT02315443|Ischemia|ischemia
305465|NCT02315443|Prehospital|prehospital
305466|NCT02315443|NA-1|na-1
305467|NCT02315443|Modified Rankin Scale|modified rankin scale
305468|NCT02315443|Haemorrhagic stroke|haemorrhagic stroke
305469|NCT02315443|Transient ischemic attack|transient ischemic attack
305470|NCT02315417|Pyoderma Gangrenosum|pyoderma gangrenosum
305471|NCT02315417|Classic Pyoderma Gangrenosum|classic pyoderma gangrenosum
305472|NCT02315404|Obscure gastrointestinal bleeding|obscure gastrointestinal bleeding
305473|NCT02315404|Overt gastrointestinal bleeding|overt gastrointestinal bleeding
305474|NCT02315404|Occult gastrointestinal bleeding|occult gastrointestinal bleeding
305475|NCT02315404|Enteroscopy|enteroscopy
305476|NCT02315378|Anxiety, Acute Trauma|anxiety, acute trauma
305477|NCT02315352|Healthy|healthy
305478|NCT02315352|L-PZQ|l-pzq
305479|NCT02315352|PZQ|pzq
305480|NCT02315352|MSC2499550A|msc2499550a
305481|NCT02315352|Praziquantel|praziquantel
305482|NCT02315326|Ibrutinib,|ibrutinib,
305483|NCT02315326|Imbruvica™|imbruvica™
305484|NCT02315326|Bruton's Tyrosine Kinase (BTK) Inhibitor|bruton's tyrosine kinase (btk) inhibitor
305485|NCT02315326|HD-MTX|hd-mtx
305486|NCT02315326|14-184|14-184
305487|NCT02315300|ECG, CGM, Hypoglycaemia, Sudden Cardiac Death|ecg, cgm, hypoglycaemia, sudden cardiac death
305488|NCT02315287|Triple combination|triple combination
305489|NCT02315287|Metformin|metformin
305490|NCT02315287|Sitagliptin|sitagliptin
305491|NCT02315287|Pioglitazone|pioglitazone
305492|NCT02315287|Lobeglitazone|lobeglitazone
305493|NCT02315274|Type 1 diabetes|type 1 diabetes
305494|NCT02315274|Pregnancy|pregnancy
305495|NCT02315274|Glycemic variability|glycemic variability
305496|NCT02315274|Between visit contact|between visit contact
305497|NCT02315261|Epidural analgesia|epidural analgesia
305498|NCT02315261|Pain score|pain score
305499|NCT02315248|bone density|bone density
305500|NCT02315222|Nutriomics|nutriomics
305501|NCT02315222|Dietary supplements|dietary supplements
305502|NCT02315222|Scaling and root planing|scaling and root planing
305503|NCT02315222|full mouth disinfection|full mouth disinfection
305504|NCT02315209|Inguinal Hernia, Quality of Life, Mesh|inguinal hernia, quality of life, mesh
305505|NCT02315183|Post cardiac surgery|post cardiac surgery
305506|NCT02315170|diabetic retinopathy|diabetic retinopathy
305507|NCT02315170|age-related macular edema|age-related macular edema
305508|NCT02315157|Partial Response|partial response
305509|NCT02315144|COPD|copd
305510|NCT02315144|bronchodilation|bronchodilation
305511|NCT02315092|Diabetic Foot Ulcers|diabetic foot ulcers
305512|NCT02315092|Bacteria|bacteria
305513|NCT02315092|Fluorescence|fluorescence
305514|NCT02315079|Ocular Inflammation|ocular inflammation
305515|NCT02315079|Matrix Metalloproteinase 9|matrix metalloproteinase 9
305516|NCT02315066|Immunotherapy|immunotherapy
305517|NCT02315066|PF-04518600|pf-04518600
305518|NCT02315066|PF-05082566|pf-05082566
305519|NCT02315066|solid tumors|solid tumors
305520|NCT02315066|tumors|tumors
305521|NCT02315066|neoplasm metastasis|neoplasm metastasis
305522|NCT02315066|Phase 1|phase 1
305523|NCT02315066|hepatocellular carcinoma|hepatocellular carcinoma
305524|NCT02315066|HCC|hcc
305525|NCT02315066|liver cancer|liver cancer
305526|NCT02315066|ocular melanoma|ocular melanoma
305527|NCT02315066|melanoma|melanoma
305528|NCT02315066|clear cell renal cell carcinoma|clear cell renal cell carcinoma
305529|NCT02315066|RCC|rcc
305530|NCT02315066|kidney cancer|kidney cancer
305531|NCT02315066|head and neck squamous cell carcinoma|head and neck squamous cell carcinoma
305532|NCT02315066|HNSCC|hnscc
305533|NCT02315066|head and neck cancer|head and neck cancer
305534|NCT02315066|cervical cancer|cervical cancer
305535|NCT02315066|cancer of the cervix|cancer of the cervix
305536|NCT02315066|gastric cancer|gastric cancer
305537|NCT02315066|stomach cancer|stomach cancer
305538|NCT02315066|non small cell lung cancer|non small cell lung cancer
305539|NCT02315066|NSCLC|nsclc
305540|NCT02315066|lung cancer|lung cancer
305541|NCT02315066|urothelial bladder carcinoma|urothelial bladder carcinoma
305542|NCT02315066|bladder cancer|bladder cancer
305543|NCT02315066|OX40|ox40
305544|NCT02315066|4-1BB|4-1bb
305545|NCT02315053|NSCLC|nsclc
305546|NCT02315053|CCRT|ccrt
305547|NCT02315053|FDG PET/CT|fdg pet/ct
305548|NCT02315040|Intrauterine insemination (IUI)|intrauterine insemination (iui)
305549|NCT02315040|Insemination method|insemination method
305550|NCT02315040|Slow release insemination (SRI)|slow release insemination (sri)
305551|NCT02315040|EVIE|evie
305552|NCT02315040|Pregnancy rate|pregnancy rate
305553|NCT02315001|Liraglutide|liraglutide
305554|NCT02315001|GLP-1|glp-1
305555|NCT02315001|Ischaemic heart disease|ischaemic heart disease
305556|NCT02315001|Coronary heart disease|coronary heart disease
305557|NCT02315001|Chronic stable angina|chronic stable angina
305558|NCT02314988|Tranexamic acid|tranexamic acid
305559|NCT02314988|Antifibrinolytic|antifibrinolytic
305560|NCT02314988|Perioperative blood loss|perioperative blood loss
305561|NCT02314988|Postoperative drain output|postoperative drain output
305562|NCT02314988|Allogenic transfusion|allogenic transfusion
305563|NCT02314949|T-regulatory cells|t-regulatory cells
305564|NCT02314949|Tolerogenic protocol|tolerogenic protocol
305565|NCT02314949|immunomodulation|immunomodulation
305566|NCT02314936|Constipation|constipation
305567|NCT02314936|Polydextrose|polydextrose
305568|NCT02314936|Dietary Fiber|dietary fiber
305569|NCT02314936|PAC-QoL|pac-qol
305570|NCT02314936|Colonic Transit Time|colonic transit time
305571|NCT02314936|PAC-SYM|pac-sym
305572|NCT02314910|Innervation|innervation
305573|NCT02314910|Jaw Bone|jaw bone
305574|NCT02314910|Implants|implants
305575|NCT02314910|Stereognostic|stereognostic
305576|NCT02314910|Osseoperception|osseoperception
305577|NCT02314871|perioperative analgesia|perioperative analgesia
305578|NCT02314871|minimal residual disease|minimal residual disease
305579|NCT02314871|cancer recurrence|cancer recurrence
305580|NCT02314871|epidural|epidural
305581|NCT02314871|morphine|morphine
305582|NCT02314871|piritramide|piritramide
305583|NCT02314871|colon|colon
305584|NCT02314871|cancer|cancer
305585|NCT02314871|circulating cancer cells|circulating cancer cells
305586|NCT02314871|colon cancer surgery|colon cancer surgery
305587|NCT02314845|Pulmonary Atelectasis|pulmonary atelectasis
305588|NCT02314845|Pulmonary Ventilation|pulmonary ventilation
305589|NCT02314845|Anesthesia, General|anesthesia, general
305590|NCT02314845|Electric Impedance|electric impedance
305591|NCT02314845|Tomography, Spiral Computed|tomography, spiral computed
305592|NCT02314845|Intraoperative Period|intraoperative period
305593|NCT02314832|femoral nerve block|femoral nerve block
305594|NCT02314832|adductor canal block|adductor canal block
305595|NCT02314832|tinetti score|tinetti score
305596|NCT02314832|2- Results to time to up and go (TUG ) test|2- results to time to up and go (tug ) test
305597|NCT02314832|3- Results to Tinetti test|3- results to tinetti test
305598|NCT02314832|4- Ambulation distance|4- ambulation distance
305599|NCT02314832|5- Pain scores at rest and with movement|5- pain scores at rest and with movement
305600|NCT02314819|colorectal cancer|colorectal cancer
305601|NCT02314793|Pharmacokinetics|pharmacokinetics
305602|NCT02314793|ASP2205|asp2205
305603|NCT02314741|poem|poem
305604|NCT02314741|per oral endoscopic myotomy|per oral endoscopic myotomy
305605|NCT02314741|achalasia|achalasia
305606|NCT02314728|Bishop Score|bishop score
305607|NCT02314728|Induction of Labor|induction of labor
305608|NCT02314728|Cervical Ripening|cervical ripening
305609|NCT02314728|Unfavorable Cervix|unfavorable cervix
305610|NCT02314728|Mode of Delivery|mode of delivery
305611|NCT02314728|C-Section|c-section
305612|NCT02314728|Cesarean Section|cesarean section
305613|NCT02314715|Osteoarthritis Knee|osteoarthritis knee
305614|NCT02314702|Osteoarthritis|osteoarthritis
305615|NCT02314702|Avascular necrosis|avascular necrosis
305616|NCT02314702|Ankylosis|ankylosis
305617|NCT02314702|Protrusio acetabuli|protrusio acetabuli
305618|NCT02314702|Painful hip dysplasia|painful hip dysplasia
305619|NCT02314702|Rheumatoid arthritis|rheumatoid arthritis
305620|NCT02314702|Correction of functional deformity|correction of functional deformity
305621|NCT02314702|Revision procedures|revision procedures
305622|NCT02314663|hypercholesterolaemia|hypercholesterolaemia
305623|NCT02314663|medication adherence|medication adherence
305624|NCT02314663|primary health care|primary health care
305625|NCT02314637|DPP-IV inhibitor|dpp-iv inhibitor
305626|NCT02314611|osteoarthritis|osteoarthritis
305627|NCT02314611|avascular necrosis|avascular necrosis
305628|NCT02314611|ankylosis|ankylosis
305629|NCT02314611|protrusio acetabuli|protrusio acetabuli
305630|NCT02314611|painful hip dysplasia|painful hip dysplasia
305631|NCT02314611|rheumatoid arthritis|rheumatoid arthritis
305831|NCT02313350|Sciatica,|sciatica,
305632|NCT02314611|correction of functional deformity|correction of functional deformity
305633|NCT02314611|revision procedures|revision procedures
305634|NCT02314572|Multifocal Intraocular Lens|multifocal intraocular lens
305635|NCT02314572|Binocular Trifocality|binocular trifocality
305636|NCT02314572|Cataract Surgery|cataract surgery
305637|NCT02314572|Spectacle Independence|spectacle independence
305638|NCT02314572|Intermediate Vision|intermediate vision
305639|NCT02314572|Photopic Vision|photopic vision
305640|NCT02314572|Mesopic Vision|mesopic vision
305641|NCT02314572|Scotopic Vision|scotopic vision
305642|NCT02314572|Binocular Vision|binocular vision
305643|NCT02314559|propofol|propofol
305644|NCT02314559|colonoscopy|colonoscopy
305645|NCT02314507|Gua sha|gua sha
305646|NCT02314481|NSCLC|nsclc
305647|NCT02314481|Clonal dominance|clonal dominance
305648|NCT02314481|Clonal evolution|clonal evolution
305649|NCT02314481|Intratumour heterogeneity|intratumour heterogeneity
305650|NCT02314481|Genomic instability|genomic instability
305651|NCT02314481|Drug resistance|drug resistance
305652|NCT02314481|Immunotherapy|immunotherapy
305653|NCT02314481|PDL1|pdl1
305654|NCT02314481|BRAF V600|braf v600
305655|NCT02314481|ALK|alk
305656|NCT02314481|RET|ret
305657|NCT02314481|HER2 amplification|her2 amplification
305658|NCT02314481|MPDL3280A|mpdl3280a
305659|NCT02314481|Vemurafenib|vemurafenib
305660|NCT02314481|Alectinib|alectinib
305661|NCT02314481|T-DM1|t-dm1
305662|NCT02314481|Trastuzumab emtansine|trastuzumab emtansine
305663|NCT02314481|TRACERX|tracerx
305664|NCT02314455|Eosinophilic Esophagitis|eosinophilic esophagitis
305665|NCT02314455|EoE|eoe
305666|NCT02314455|dysphagia|dysphagia
305667|NCT02314442|LDL-C|ldl-c
305668|NCT02314442|RNAi therapeutic|rnai therapeutic
305669|NCT02314416|wounds, stem cells, collagen matrix, maturation|wounds, stem cells, collagen matrix, maturation
305670|NCT02314403|ESRD|esrd
305671|NCT02314390|Depression|depression
305672|NCT02314390|Mindfulness|mindfulness
305673|NCT02314390|MBCT|mbct
305674|NCT02314364|Non-small cell lung cancer|non-small cell lung cancer
305675|NCT02314364|Metastatic|metastatic
305676|NCT02314364|EGFR|egfr
305677|NCT02314364|ALK|alk
305678|NCT02314364|ROS1|ros1
305679|NCT02314364|Stereotactic Body Radiation Therapy|stereotactic body radiation therapy
305680|NCT02314351|migraine disorders|migraine disorders
305681|NCT02314351|migraine with aura|migraine with aura
305682|NCT02314351|migraine without aura|migraine without aura
305683|NCT02314351|pain management|pain management
305684|NCT02314351|emergency department|emergency department
305685|NCT02314325|Factor VIII deficiency|factor viii deficiency
305686|NCT02314325|Arthropathy|arthropathy
305687|NCT02314325|MRI|mri
305688|NCT02314325|XRay|xray
305689|NCT02314325|Joint|joint
305690|NCT02314325|HJHS|hjhs
305691|NCT02314312|Kidney transplantation|kidney transplantation
305692|NCT02314312|ECD|ecd
305693|NCT02314299|Macular edema|macular edema
305694|NCT02314299|Macular degeneration|macular degeneration
305695|NCT02314299|MTP-131|mtp-131
305696|NCT02314299|Ocuvia™|ocuvia™
305697|NCT02314286|Rosuvastatin|rosuvastatin
305698|NCT02314286|severe preeclampsia|severe preeclampsia
305699|NCT02314286|48 hours following delivery|48 hours following delivery
305700|NCT02314260|labour induction|labour induction
305701|NCT02314260|cervical length|cervical length
305702|NCT02314260|trans-vaginal assessment of cervical length|trans-vaginal assessment of cervical length
305703|NCT02314260|Bishop score|bishop score
305704|NCT02314247|PTCL|ptcl
305705|NCT02314247|CTCL|ctcl
305706|NCT02314247|Peripheral T-cell Lymphoma|peripheral t-cell lymphoma
305707|NCT02314247|Cutaneous T-cell Lymphoma|cutaneous t-cell lymphoma
305708|NCT02314247|Karyopharm|karyopharm
305709|NCT02314247|KPT-330|kpt-330
305710|NCT02314247|Selinexor|selinexor
305711|NCT02314221|Exoskeletal-assisted walking|exoskeletal-assisted walking
305712|NCT02314208|spastic paraplegia|spastic paraplegia
305713|NCT02314208|metabolism|metabolism
305714|NCT02314208|oxysterols|oxysterols
305715|NCT02314208|neurogenetics|neurogenetics
305716|NCT02314195|Obsessive Compulsive Disorder|obsessive compulsive disorder
305717|NCT02314195|Music Therapy/methods|music therapy/methods
305718|NCT02314195|Combined Modality Therapy|combined modality therapy
305719|NCT02314195|Anxiety Disorders/therapy|anxiety disorders/therapy
305720|NCT02314182|Rectal adenocarcinoma|rectal adenocarcinoma
305721|NCT02314182|unresectable|unresectable
305722|NCT02314182|surgery|surgery
305723|NCT02314182|chemotherapy|chemotherapy
305724|NCT02314143|dabrafenib|dabrafenib
305725|NCT02314143|MEK|mek
305726|NCT02314143|trametinib|trametinib
305727|NCT02314143|BRAF|braf
305728|NCT02314143|melanoma|melanoma
305729|NCT02314143|Oncology|oncology
305730|NCT02314104|Surgical procedures, Minimally invasive|surgical procedures, minimally invasive
305731|NCT02314104|Nerve block|nerve block
305732|NCT02314104|Anesthetics, Local|anesthetics, local
305733|NCT02314078|Caesarean section|caesarean section
305734|NCT02314078|Emergency|emergency
305735|NCT02314078|Anaesthesia|anaesthesia
305736|NCT02314065|Severe health anxiety|severe health anxiety
305737|NCT02314065|Somatic symptom disorder|somatic symptom disorder
305738|NCT02314065|Illness anxiety disorder|illness anxiety disorder
305739|NCT02314065|Cognitive behavioral therapy|cognitive behavioral therapy
305740|NCT02314065|Internet|internet
305741|NCT02314065|Exposure|exposure
305742|NCT02314013|uncomplicated diverticulitis, economic cost, hospital stay|uncomplicated diverticulitis, economic cost, hospital stay
305865|NCT02313116|Breast cancer|breast cancer
305743|NCT02313974|Lupus Nephritis Treatment|lupus nephritis treatment
305744|NCT02313974|Renal Biopsy in Lupus|renal biopsy in lupus
305745|NCT02313974|Lupus Flare|lupus flare
305746|NCT02313961|ST elevation myocardial infarction|st elevation myocardial infarction
305747|NCT02313961|Reperfusion injury|reperfusion injury
305748|NCT02313961|Remote ischaemic conditioning|remote ischaemic conditioning
305749|NCT02313909|Rivaroxaban|rivaroxaban
305751|NCT02313909|Aspirin|aspirin
305752|NCT02313909|Acetylsalicylic acid (ASA)|acetylsalicylic acid (asa)
305753|NCT02313909|Oral Anticoagulant|oral anticoagulant
305754|NCT02313909|Blood Thinner|blood thinner
305755|NCT02313909|Stroke|stroke
305756|NCT02313909|Ischemic Stroke|ischemic stroke
305757|NCT02313909|Cryptogenic Stroke|cryptogenic stroke
305758|NCT02313909|Embolic stroke of undetermined source|embolic stroke of undetermined source
305759|NCT02313909|ESUS|esus
305760|NCT02313909|Transient Ischemic Attack|transient ischemic attack
305761|NCT02313909|Thromboembolism|thromboembolism
305762|NCT02313909|Cerebrovascular Disease|cerebrovascular disease
305763|NCT02313883|periodontitis|periodontitis
305764|NCT02313883|taurolidine (PerioSept(r))|taurolidine (periosept(r))
305765|NCT02313883|scaling and root planing|scaling and root planing
305766|NCT02313870|Bullous pemphigoid|bullous pemphigoid
305767|NCT02313870|superpotent topical steroids|superpotent topical steroids
305768|NCT02313870|methotrexate|methotrexate
305769|NCT02313870|safety|safety
305770|NCT02313857|Viralym-C|viralym-c
305771|NCT02313857|Viral infections post HSCT|viral infections post hsct
305772|NCT02313857|Virus-specific T cells|virus-specific t cells
305773|NCT02313844|BK virus|bk virus
305774|NCT02313844|Virus specific T cells|virus specific t cells
305775|NCT02313844|Viral infections|viral infections
305776|NCT02313831|autonomic nervous system|autonomic nervous system
305777|NCT02313831|ventilatory anaerobic threshold|ventilatory anaerobic threshold
305778|NCT02313831|oxygen consumption|oxygen consumption
305779|NCT02313831|metabolic profile|metabolic profile
305780|NCT02313831|exercise training|exercise training
305781|NCT02313831|expiratory flow limitation|expiratory flow limitation
305782|NCT02313818|Posttraumatic Stress Disorder|posttraumatic stress disorder
305783|NCT02313818|Cognitive Processing Therapy|cognitive processing therapy
305784|NCT02313818|Active Duty Military|active duty military
305785|NCT02313805|Insulin initiation|insulin initiation
305786|NCT02313805|Insulin checklist|insulin checklist
305787|NCT02313792|Hematopoietic stem cell transplantation|hematopoietic stem cell transplantation
305788|NCT02313792|Palifermin|palifermin
305789|NCT02313740|Influenza|influenza
305790|NCT02313740|Influenza Vaccines|influenza vaccines
305791|NCT02313714|heart failure, heart transplant, electrical stimulation|heart failure, heart transplant, electrical stimulation
305792|NCT02313688|adenocarcinomas of esophagogastric junction|adenocarcinomas of esophagogastric junction
305793|NCT02313688|resection margin|resection margin
305794|NCT02313688|length|length
305795|NCT02313688|prognosis|prognosis
305796|NCT02313675|carpal tunnel syndrome|carpal tunnel syndrome
305797|NCT02313675|opioid analgesics|opioid analgesics
305798|NCT02313675|postoperative pain|postoperative pain
305799|NCT02313675|IV tylenol|iv tylenol
305800|NCT02313675|IV toradol|iv toradol
305801|NCT02313649|liver|liver
305802|NCT02313649|fibrosis|fibrosis
305803|NCT02313649|elastography|elastography
305804|NCT02313649|ShearWave Elastography|shearwave elastography
305805|NCT02313649|ultrasound|ultrasound
305806|NCT02313610|Retreatment Pulmonary Tuberculosis, Qinbudan,|retreatment pulmonary tuberculosis, qinbudan,
305807|NCT02313584|dabigatran|dabigatran
305808|NCT02313571|Epidural Analgesia|epidural analgesia
305809|NCT02313571|Pain|pain
305810|NCT02313558|dentifrice|dentifrice
305811|NCT02313558|gingivitis|gingivitis
305812|NCT02313558|dental plaque|dental plaque
305813|NCT02313519|Infections|infections
305814|NCT02313519|anastomotic leakage|anastomotic leakage
305815|NCT02313506|Physical activity|physical activity
305816|NCT02313506|Exercise|exercise
305817|NCT02313506|Osteoarthritis|osteoarthritis
305818|NCT02313506|Knee|knee
305819|NCT02313506|Arthritis|arthritis
305820|NCT02313441|remote ischemic preconditioning|remote ischemic preconditioning
305821|NCT02313428|Diabetic Foot Ulcer|diabetic foot ulcer
305822|NCT02313428|Topical Oxygen Therapy|topical oxygen therapy
305823|NCT02313428|Medicaid Recipients|medicaid recipients
305824|NCT02313428|Standard of Care|standard of care
305825|NCT02313428|Diabetic Wounds|diabetic wounds
305826|NCT02313363|Health care systems|health care systems
305827|NCT02313363|Mobile applications|mobile applications
305828|NCT02313363|Self-care|self-care
305829|NCT02313363|Diabetes mellitus|diabetes mellitus
305830|NCT02313363|Smartphone|smartphone
305832|NCT02313350|herniated disc,|herniated disc,
305833|NCT02313350|chemonucleolysis.|chemonucleolysis.
305834|NCT02313337|Administration route|administration route
305835|NCT02313337|Preanesthetic medication|preanesthetic medication
305836|NCT02313337|Sedation|sedation
305837|NCT02313324|Coccydynia|coccydynia
305838|NCT02313324|Extracorporeal shock wave therapy|extracorporeal shock wave therapy
305839|NCT02313324|Disability|disability
305840|NCT02313311|Cleavage pattern, timing parameter, time-lapse|cleavage pattern, timing parameter, time-lapse
305841|NCT02313272|neoplasms|neoplasms
305842|NCT02313272|high-grade glioma|high-grade glioma
305843|NCT02313272|recurrent glioma|recurrent glioma
305844|NCT02313272|glioma|glioma
305845|NCT02313272|Hypofractionated Stereotactic Irradiation (HFSRT)|hypofractionated stereotactic irradiation (hfsrt)
305846|NCT02313272|Bevacizumab|bevacizumab
305847|NCT02313272|Pembrolizumab|pembrolizumab
305848|NCT02313272|recurrent high-grade glioma|recurrent high-grade glioma
305849|NCT02313272|Grade III malignant glioma|grade iii malignant glioma
305850|NCT02313272|Grade IV malignant glioma|grade iv malignant glioma
305851|NCT02313272|brain and nervous system|brain and nervous system
305852|NCT02313220|Obesity|obesity
305853|NCT02313220|Dapagliflozin|dapagliflozin
305854|NCT02313220|Exenatide|exenatide
305855|NCT02313220|Combination treatment|combination treatment
305856|NCT02313220|Type 2 diabetes|type 2 diabetes
305857|NCT02313181|breastfeeding|breastfeeding
305858|NCT02313181|lactation|lactation
305859|NCT02313181|newborn|newborn
305860|NCT02313168|difficult airway; prediction, FRONT score.|difficult airway; prediction, front score.
305861|NCT02313155|Prevention|prevention
305862|NCT02313129|Infertility|infertility
305863|NCT02313129|Rheumatoid Arthritis|rheumatoid arthritis
305864|NCT02313116|Lumpectomy|lumpectomy
305866|NCT02313116|Optical coherence tomography|optical coherence tomography
305867|NCT02313116|Tumor margin|tumor margin
305868|NCT02313116|Imaging|imaging
305869|NCT02313103|ESRD|esrd
305870|NCT02313103|End Stage Renal Disease|end stage renal disease
305871|NCT02313103|Normal Healthy Volunteers|normal healthy volunteers
305872|NCT02313103|Renally Impaired|renally impaired
305873|NCT02313077|Healthy|healthy
305874|NCT02313077|Ebola viruses|ebola viruses
305875|NCT02313077|Ebola Viral Disease (EVD)|ebola viral disease (evd)
305876|NCT02313077|Filoviruses|filoviruses
305877|NCT02313077|monovalent vaccine|monovalent vaccine
305878|NCT02313077|Human adenovirus serotype 26 (Ad26) expressing the Ebola virus Mayinga variant glycoprotein (Ad26.ZEBOV)|human adenovirus serotype 26 (ad26) expressing the ebola virus mayinga variant glycoprotein (ad26.zebov)
305879|NCT02313077|Modified Vaccinia Virus Ankara - Bavarian Nordic (MVA-BN) Filo-vector|modified vaccinia virus ankara - bavarian nordic (mva-bn) filo-vector
305880|NCT02313077|Safety|safety
305881|NCT02313077|Immunogenicity|immunogenicity
305882|NCT02313051|metastatic breast cancer, everolimus|metastatic breast cancer, everolimus
305883|NCT02313038|Coronary heart disease|coronary heart disease
305884|NCT02313038|Percutaneous Coronary Intervention|percutaneous coronary intervention
305885|NCT02313038|Drug Eluting Stents|drug eluting stents
305886|NCT02313012|Maximum Tolerated Dose|maximum tolerated dose
305887|NCT02313012|Solid Tumors|solid tumors
305888|NCT02313012|Locally Advanced Tumors|locally advanced tumors
305889|NCT02313012|Metastatic Solid Tumors|metastatic solid tumors
305890|NCT02313012|Relapsed or refractory, BRAFV600 or RAS-mutated solid tumors|relapsed or refractory, brafv600 or ras-mutated solid tumors
305891|NCT02313012|Melanoma|melanoma
305892|NCT02313012|Colorectal Carcinomas Papillary|colorectal carcinomas papillary
305893|NCT02313012|Thyroid carcinomas|thyroid carcinomas
305894|NCT02313012|Pancreatic ductal Adenocarcinomas|pancreatic ductal adenocarcinomas
305895|NCT02313012|Non -small cell lung cancer [NSCLC]|non -small cell lung cancer [nsclc]
305896|NCT02312999|laparotomy|laparotomy
305897|NCT02312999|plasma-Lyte|plasma-lyte
305898|NCT02312999|volulyte|volulyte
305899|NCT02312999|close loop|close loop
305900|NCT02312999|abdominal surgery|abdominal surgery
305901|NCT02312986|infection|infection
305902|NCT02312986|colonization|colonization
305903|NCT02312986|antibiotic resistance|antibiotic resistance
305904|NCT02312973|Chronic kidney disease|chronic kidney disease
305905|NCT02312973|Pharmacokinetics|pharmacokinetics
305906|NCT02312973|Hemodialysis|hemodialysis
305907|NCT02312973|Peritoneal dialysis|peritoneal dialysis
305908|NCT02312973|Erythropoietin|erythropoietin
305909|NCT02312934|Chemo brain|chemo brain
305910|NCT02312934|Chemotherapy-related cognitive impairment|chemotherapy-related cognitive impairment
305911|NCT02312934|CRCI|crci
305912|NCT02312934|Breast cancer|breast cancer
305913|NCT02312934|Chemo fog|chemo fog
305914|NCT02312934|Nicotine|nicotine
305915|NCT02312934|Transdermal nicotine|transdermal nicotine
305916|NCT02312921|managed healthcare|managed healthcare
305917|NCT02312921|child|child
305918|NCT02312921|dental care|dental care
305919|NCT02312908|REM Sleep Behavior Disorder|rem sleep behavior disorder
305920|NCT02312908|Parkinson Disease|parkinson disease
305921|NCT02312908|Placebos|placebos
305922|NCT02312908|Randomized Controlled Trial|randomized controlled trial
305923|NCT02312908|Double-Blind Method|double-blind method
305924|NCT02312908|Clinical Trial|clinical trial
306119|NCT02311647|Tamoxifen|tamoxifen
305925|NCT02312869|Mechanical Ventilation|mechanical ventilation
305926|NCT02312869|Burn patients|burn patients
305927|NCT02312843|Mild Cognitive Impairment|mild cognitive impairment
305928|NCT02312843|Cognitive disorders|cognitive disorders
305929|NCT02312843|Prediabetes|prediabetes
305930|NCT02312843|Exercise|exercise
305931|NCT02312817|Carcinoma, Hepatocellular|carcinoma, hepatocellular
305932|NCT02312817|Liver Neoplasms|liver neoplasms
305933|NCT02312817|Liver Disease|liver disease
305934|NCT02312817|Early Detection of Cancer|early detection of cancer
305935|NCT02312817|Comparative Effectiveness Research|comparative effectiveness research
305936|NCT02312791|Radiation|radiation
305937|NCT02312791|Prognosis|prognosis
305938|NCT02312791|Palliative Care|palliative care
305939|NCT02312778|non-specific low back pain|non-specific low back pain
305940|NCT02312778|center of pressure|center of pressure
305941|NCT02312778|spinal lumbar manipulation|spinal lumbar manipulation
305942|NCT02312778|high velocity and low amplitude manipulation|high velocity and low amplitude manipulation
305943|NCT02312778|postural control|postural control
305944|NCT02312752|Intra-epidermal stimulation in healthy control subjects|intra-epidermal stimulation in healthy control subjects
305945|NCT02312739|pain assessment|pain assessment
305946|NCT02312739|pain measurement|pain measurement
305947|NCT02312739|patient satisfaction|patient satisfaction
305948|NCT02312739|anxiety|anxiety
305949|NCT02312739|analgesia and anesthesia|analgesia and anesthesia
305950|NCT02312739|female sterilization|female sterilization
305951|NCT02312726|mixed methods|mixed methods
305952|NCT02312726|visual analog scale|visual analog scale
305953|NCT02312726|verbal rating score|verbal rating score
305954|NCT02312726|pain assessment|pain assessment
305955|NCT02312726|patient satisfaction|patient satisfaction
305956|NCT02312726|contraceptive devices|contraceptive devices
305957|NCT02312726|postpartum|postpartum
305958|NCT02312713|Osteoarthritis|osteoarthritis
305959|NCT02312713|Knee Osteoarthritis|knee osteoarthritis
305960|NCT02312700|empowerment|empowerment
305961|NCT02312700|communication|communication
305962|NCT02312700|shared decision making|shared decision making
305963|NCT02312687|XLH|xlh
305964|NCT02312687|FGF23|fgf23
305965|NCT02312687|KRN23|krn23
390836|NCT01910818|CO2|co2
305966|NCT02312674|pancreatic carcinoma|pancreatic carcinoma
305967|NCT02312674|hepatocellular carcinoma|hepatocellular carcinoma
305968|NCT02312674|palliative therapy|palliative therapy
305969|NCT02312674|oral nutritional supplements|oral nutritional supplements
305970|NCT02312674|quality of life|quality of life
305971|NCT02312674|nutritional status|nutritional status
305972|NCT02312661|ovarian cancer|ovarian cancer
305973|NCT02312661|metformin|metformin
305974|NCT02312661|carboplatin|carboplatin
305975|NCT02312661|paclitaxel|paclitaxel
305976|NCT02312648|Functional Capacity|functional capacity
305977|NCT02312648|Physical Exertion|physical exertion
305978|NCT02312648|Patient Care|patient care
305979|NCT02312648|Early mobilization|early mobilization
305980|NCT02312635|cognitive rehabilitation, traumatic brain injury|cognitive rehabilitation, traumatic brain injury
305981|NCT02312596|non-healing wound|non-healing wound
305982|NCT02312596|diabetic foot ulcer|diabetic foot ulcer
305983|NCT02312596|platelet rich plasma|platelet rich plasma
305984|NCT02312583|depression|depression
305985|NCT02312583|cognitive-behavior intervention|cognitive-behavior intervention
305986|NCT02312570|non-healing wounds|non-healing wounds
305987|NCT02312570|pressure ulcer|pressure ulcer
305988|NCT02312570|platelet rich plasma|platelet rich plasma
305990|NCT02312531|Intrauterine infection|intrauterine infection
305991|NCT02312531|hepatitis B immunoglobulin|hepatitis b immunoglobulin
305992|NCT02312531|immune barrier|immune barrier
305993|NCT02312531|virus replication|virus replication
305994|NCT02312531|placenta|placenta
305995|NCT02312518|non-healing wounds|non-healing wounds
305996|NCT02312518|venous stasis|venous stasis
305997|NCT02312518|ulcer|ulcer
305998|NCT02312518|platelet rich plasma|platelet rich plasma
305999|NCT02312505|cardiac output monitoring|cardiac output monitoring
306000|NCT02312505|semi-invasive pulse contour analysis|semi-invasive pulse contour analysis
306001|NCT02312505|transpulmonary thermodilution|transpulmonary thermodilution
306002|NCT02312492|fatty acid kinetics|fatty acid kinetics
306003|NCT02312440|tranexamic acid|tranexamic acid
306004|NCT02312440|blood loss|blood loss
306005|NCT02312440|topical administration|topical administration
306006|NCT02312440|intravenous administration|intravenous administration
306007|NCT02312401|MRI|mri
306008|NCT02312401|14-172|14-172
306009|NCT02312388|central venous catheters|central venous catheters
306010|NCT02312362|HFDS|hfds
306011|NCT02312362|ab interno|ab interno
306012|NCT02312362|MIGS|migs
306013|NCT02312362|surgery|surgery
306014|NCT02312349|Celiac Disease|celiac disease
306015|NCT02312349|Gluten free elaborated food|gluten free elaborated food
306016|NCT02312336|ST Elevation Myocardial Infarction|st elevation myocardial infarction
306017|NCT02312336|Transcoronary Cooling|transcoronary cooling
306018|NCT02312258|Drug Therapy|drug therapy
306019|NCT02312219|HIV|hiv
306020|NCT02312219|Inflammation|inflammation
306021|NCT02312219|Atherosclerosis|atherosclerosis
306219|NCT02311114|LHINs|lhins
306022|NCT02312219|Positron-Emission Tomography|positron-emission tomography
306023|NCT02312219|Imaging|imaging
306024|NCT02312219|fluorodeoxyglucose|fluorodeoxyglucose
306025|NCT02312193|hypertension|hypertension
306026|NCT02312193|myogenic tone|myogenic tone
306027|NCT02312167|endomicroscopy|endomicroscopy
306028|NCT02312167|optical biopsy|optical biopsy
306029|NCT02312167|exploratory surgery|exploratory surgery
306030|NCT02312167|resection surgery|resection surgery
306031|NCT02312167|robot-assisted|robot-assisted
306032|NCT02312167|peritoneum carcinosis|peritoneum carcinosis
306033|NCT02312167|inflammatory|inflammatory
306034|NCT02312167|rectum cancer|rectum cancer
306035|NCT02312167|liver cancer|liver cancer
306036|NCT02312167|ovarian cancer|ovarian cancer
306037|NCT02312167|digestive cancer|digestive cancer
306038|NCT02312167|pancreas cancer|pancreas cancer
306039|NCT02312167|duodenum cancer|duodenum cancer
306040|NCT02312128|distal radius fractures|distal radius fractures
306041|NCT02312128|early mobilization|early mobilization
306042|NCT02312128|postoperative treatment|postoperative treatment
306043|NCT02312128|outcome|outcome
306044|NCT02312115|Renal transplant|renal transplant
306045|NCT02312115|Kidney transplant|kidney transplant
306046|NCT02312115|DGF|dgf
306047|NCT02312102|myelodysplastic syndrome|myelodysplastic syndrome
306048|NCT02312102|acute myeloid leukemia|acute myeloid leukemia
306049|NCT02312102|allogeneic stem cell transplantation|allogeneic stem cell transplantation
306050|NCT02312089|Luteal phase support, ICSI, GnRHa|luteal phase support, icsi, gnrha
306051|NCT02312076|Luteal phase support, ICSI, GnRHa|luteal phase support, icsi, gnrha
306052|NCT02312063|DPP-4 inhibitor|dpp-4 inhibitor
306053|NCT02312063|sulfonylurea|sulfonylurea
306054|NCT02312037|Relapsed CD33 AML|relapsed cd33 aml
306055|NCT02312037|Refractory CD33 AML|refractory cd33 aml
306056|NCT02312037|Relapsed CD33 APL|relapsed cd33 apl
306057|NCT02312037|Refractory CD33 APL|refractory cd33 apl
306058|NCT02312037|Relapsed CD33 MDS|relapsed cd33 mds
306059|NCT02312037|Refractory CD33 MDS|refractory cd33 mds
306060|NCT02312024|CytoSorb adsorber|cytosorb adsorber
306061|NCT02312024|sepsis|sepsis
306062|NCT02312024|cytokines|cytokines
306063|NCT02312024|hemofiltration|hemofiltration
306064|NCT02312024|hemadsorption|hemadsorption
306065|NCT02312024|inflammation|inflammation
306066|NCT02312011|Myotonic Dystrophy|myotonic dystrophy
306067|NCT02312011|DM1|dm1
306068|NCT02312011|Adult onset|adult onset
306069|NCT02312011|Neuromuscular Disease|neuromuscular disease
306070|NCT02312011|DMPKRx|dmpkrx
306071|NCT02311985|Liver cirrhosis|liver cirrhosis
306072|NCT02311985|Blood coagulation|blood coagulation
306073|NCT02311985|Thromboelastography|thromboelastography
306074|NCT02311985|Blood transfusion|blood transfusion
306075|NCT02311985|Catheterization, central venous|catheterization, central venous
306076|NCT02311959|Breast|breast
306077|NCT02311959|Invasive carcinoma|invasive carcinoma
306078|NCT02311959|In situ carcinoma|in situ carcinoma
306079|NCT02311959|Mastectomy|mastectomy
306080|NCT02311959|Nipple areola|nipple areola
306081|NCT02311959|Reconstruction|reconstruction
306082|NCT02311959|Local recurrence|local recurrence
306083|NCT02311946|Palbociclib, Rabeprazole, Proton Pump Inhibitor, Drug Interaction Study, DDI|palbociclib, rabeprazole, proton pump inhibitor, drug interaction study, ddi
306084|NCT02311829|Quality of life, PNES, Epilepsy,|quality of life, pnes, epilepsy,
306085|NCT02311816|Bacterial infection, empiric antibiotic therapy|bacterial infection, empiric antibiotic therapy
306086|NCT02311790|cis-C16:1n7 supplement|cis-c16:1n7 supplement
306087|NCT02311790|trans-C16:1n7 supplement|trans-c16:1n7 supplement
306088|NCT02311790|palmitoleic acid supplement|palmitoleic acid supplement
306089|NCT02311751|Autism Spectrum Disorder|autism spectrum disorder
306090|NCT02311751|Executive Function|executive function
306091|NCT02311751|rTMS (Repetitive Transcranial Magnetic Stimulation)|rtms (repetitive transcranial magnetic stimulation)
306092|NCT02311751|MRI (Magnetic Resonance Imaging)|mri (magnetic resonance imaging)
306093|NCT02311751|Healthy Subjects|healthy subjects
306094|NCT02311738|Exercise and Genes in Obese (EGO)|exercise and genes in obese (ego)
306095|NCT02311725|narrative communication|narrative communication
306096|NCT02311725|depression|depression
306097|NCT02311725|antidepressant augmentation|antidepressant augmentation
306098|NCT02311725|primary care|primary care
306099|NCT02311712|Esophageal cancer|esophageal cancer
306100|NCT02311712|Early detection|early detection
306101|NCT02311712|Cytological examination|cytological examination
306102|NCT02311699|Gender|gender
306103|NCT02311699|Physical Violence|physical violence
306104|NCT02311699|Sexual Violence|sexual violence
306105|NCT02311699|HIV|hiv
306106|NCT02311699|AIDS|aids
306107|NCT02311699|Prevention|prevention
306108|NCT02311699|Community Intervention|community intervention
306109|NCT02311699|Ethiopia|ethiopia
306110|NCT02311699|Intimate Partner Violence|intimate partner violence
306112|NCT02311686|Fatty acid ethyl esters|fatty acid ethyl esters
306113|NCT02311686|Ethyl glucoronide|ethyl glucoronide
306114|NCT02311686|Ethyl sulphate|ethyl sulphate
306115|NCT02311686|Pharmacokinetics|pharmacokinetics
306116|NCT02311673|Prader-Willi Syndrome|prader-willi syndrome
306117|NCT02311673|obesity|obesity
306118|NCT02311673|hyperphagia|hyperphagia
306120|NCT02311647|Uterine cavity|uterine cavity
306121|NCT02311647|endometrium|endometrium
306122|NCT02311634|Electrical pudendal nerve stimulation|electrical pudendal nerve stimulation
306123|NCT02311634|Transvaginal electrical stimulation|transvaginal electrical stimulation
306124|NCT02311634|Urge urinary incontinence|urge urinary incontinence
306125|NCT02311634|Comparative study|comparative study
306126|NCT02311621|CAR T cell|car t cell
306127|NCT02311621|pediatric|pediatric
306128|NCT02311621|young adults|young adults
306129|NCT02311608|acute variceal hemorrhage|acute variceal hemorrhage
306130|NCT02311608|terlipressin|terlipressin
306131|NCT02311608|somatostatin|somatostatin
306132|NCT02311608|octreotide|octreotide
306133|NCT02311608|comparative effectiveness research|comparative effectiveness research
306134|NCT02311595|gastric cancer|gastric cancer
306135|NCT02311595|laparoscope|laparoscope
306136|NCT02311569|JAK2|jak2
306137|NCT02311569|Mirabegron|mirabegron
306138|NCT02311569|Primary myelofibrosis|primary myelofibrosis
306139|NCT02311569|beta-3-mimetic drugs|beta-3-mimetic drugs
306140|NCT02311569|Myeloproliferative neoplasm|myeloproliferative neoplasm
306141|NCT02311569|Essential thrombocythemia|essential thrombocythemia
306142|NCT02311569|Polycythemia vera|polycythemia vera
306143|NCT02311569|Betmiga|betmiga
306144|NCT02311569|JAK2-V617F|jak2-v617f
306145|NCT02311543|Axillary Lymph Node Dissection (ALND)|axillary lymph node dissection (alnd)
306146|NCT02311543|Breast Cancer|breast cancer
306147|NCT02311543|TachoSil®|tachosil®
306148|NCT02311543|Lymphatic Drainage|lymphatic drainage
306149|NCT02311543|Surgical Sealing Patch|surgical sealing patch
306150|NCT02311491|nano crystalline|nano crystalline
306151|NCT02311491|archwire|archwire
306152|NCT02311465|Palliative Care|palliative care
306153|NCT02311439|Locally advanced pancreatic cancer|locally advanced pancreatic cancer
306154|NCT02311439|Chemotherapy|chemotherapy
306155|NCT02311439|Radiotherapy|radiotherapy
306156|NCT02311426|Rehabilitation; Functional outcome|rehabilitation; functional outcome
306157|NCT02311413|Allergic rhinoconjunctivitis|allergic rhinoconjunctivitis
306158|NCT02311400|Emotion|emotion
306159|NCT02311400|Self-Affirmation|self-affirmation
306160|NCT02311400|Alcohol Consumption|alcohol consumption
306161|NCT02311387|Incidence|incidence
306162|NCT02311387|Prevalence|prevalence
306163|NCT02311387|Human|human
306164|NCT02311387|Mastomys|mastomys
306165|NCT02311387|Serosurvey|serosurvey
306166|NCT02311374|Human Brain|human brain
306167|NCT02311374|Sleep|sleep
306168|NCT02311374|EEG|eeg
306169|NCT02311374|Magnetic Resonance Imaging (MRI)|magnetic resonance imaging (mri)
306170|NCT02311374|Apparent Diffusion Coefficient|apparent diffusion coefficient
306171|NCT02311361|Anti-PDL1|anti-pdl1
306172|NCT02311361|Anti-CTLA4|anti-ctla4
306173|NCT02311361|Streostatic Body Radiation Therapy (SBRT)|streostatic body radiation therapy (sbrt)
306174|NCT02311361|Monoclonal Antibody|monoclonal antibody
306175|NCT02311361|Antitumor Immunity|antitumor immunity
306176|NCT02311348|Biopsy|biopsy
306177|NCT02311348|Pain|pain
306178|NCT02311335|Hypertriglyceridemia|hypertriglyceridemia
306179|NCT02311335|Atherosclerosis|atherosclerosis
306180|NCT02311335|Genectic Variants|genectic variants
306181|NCT02311335|Hyperalphalipoproteinemia|hyperalphalipoproteinemia
306182|NCT02311335|Dyslipidemia|dyslipidemia
306183|NCT02311322|Growth Disorder|growth disorder
306184|NCT02311322|Growth|growth
306185|NCT02311322|Exome Sequencing|exome sequencing
306186|NCT02311244|All-cause mortality|all-cause mortality
306187|NCT02311244|Cardiovascular mortality|cardiovascular mortality
306188|NCT02311244|Myocardial infarction|myocardial infarction
306189|NCT02311244|Stroke|stroke
306190|NCT02311244|Dialysis|dialysis
306191|NCT02311218|oral, microbiota, lactobacillus reuteri,|oral, microbiota, lactobacillus reuteri,
306192|NCT02311205|Transarterial Chemoembolization (TACE)|transarterial chemoembolization (tace)
306193|NCT02311205|Hepatocellular carcinoma (HCC)|hepatocellular carcinoma (hcc)
306194|NCT02311205|Metastasis|metastasis
306195|NCT02311205|Sorafenib|sorafenib
306196|NCT02311192|Vitreous Haze|vitreous haze
306197|NCT02311192|Ocular ultrasound|ocular ultrasound
306198|NCT02311192|B scan|b scan
306199|NCT02311192|Uveitis|uveitis
306200|NCT02311179|Prosthesis fixation|prosthesis fixation
306201|NCT02311179|hip arthroplasty|hip arthroplasty
306202|NCT02311166|Hip dysplasia|hip dysplasia
306203|NCT02311166|Soft tissue|soft tissue
306204|NCT02311166|Hip|hip
306205|NCT02311166|Self-report|self-report
306206|NCT02311166|Physical activity|physical activity
306207|NCT02311140|cystic fibrosis|cystic fibrosis
306208|NCT02311140|nasal lavage|nasal lavage
306209|NCT02311140|inflammation|inflammation
306210|NCT02311140|Interleukin (IL)-6|interleukin (il)-6
306211|NCT02311140|IL-8|il-8
306212|NCT02311140|pulmonary function|pulmonary function
306213|NCT02311127|Peripherally Inserted Central Catheters|peripherally inserted central catheters
306214|NCT02311127|Securement device|securement device
306215|NCT02311114|Program Evaluation|program evaluation
306216|NCT02311114|Telehomecare|telehomecare
306217|NCT02311114|Chronic Obstructive Pulmonary Disease|chronic obstructive pulmonary disease
306218|NCT02311114|Heart Failure|heart failure
306220|NCT02311114|Local Health Integrative Network|local health integrative network
306221|NCT02311114|OTN|otn
306222|NCT02311114|Ontario Telemedicine Network|ontario telemedicine network
306223|NCT02311101|bladder cancer|bladder cancer
306224|NCT02311101|mitomycin|mitomycin
306225|NCT02311101|BCG|bcg
306226|NCT02311101|intravesical|intravesical
306227|NCT02311101|non-muscle invasive|non-muscle invasive
306228|NCT02311062|training, soccer, eccentric, lengthening, unstable, squatting|training, soccer, eccentric, lengthening, unstable, squatting
306229|NCT02311036|Post Acute Care(PAC)|post acute care(pac)
306230|NCT02311036|Cerebrovascular diseases|cerebrovascular diseases
306231|NCT02311010|transplant|transplant
306232|NCT02311010|immunosuppressive drug|immunosuppressive drug
306233|NCT02310984|Early breast cancer|early breast cancer
306234|NCT02310984|Lumpectomy|lumpectomy
306235|NCT02310984|Breast conserving surgery|breast conserving surgery
306236|NCT02310984|Radiotherapy|radiotherapy
306237|NCT02310984|Cosmesis|cosmesis
306238|NCT02310971|Adenocarcinoma, resected|adenocarcinoma, resected
306239|NCT02310958|Lapraroscopic surgical procedure|lapraroscopic surgical procedure
306240|NCT02310958|infant|infant
306241|NCT02310958|complications|complications
306242|NCT02310958|inguinal hernia|inguinal hernia
306243|NCT02310958|hernia recurrence|hernia recurrence
306244|NCT02310945|pain|pain
306245|NCT02310945|central nervous system sensitization|central nervous system sensitization
306246|NCT02310945|physiotherapy|physiotherapy
306247|NCT02310932|mental health|mental health
306248|NCT02310932|cardiovascular disease|cardiovascular disease
306249|NCT02310932|diabetes|diabetes
306250|NCT02310932|hypertension|hypertension
306251|NCT02310932|high blood pressure|high blood pressure
306252|NCT02310919|Infertility|infertility
306253|NCT02310919|In vitro fertilization|in vitro fertilization
306254|NCT02310919|IVF|ivf
306255|NCT02310906|Duchenne muscular dystrophy|duchenne muscular dystrophy
306256|NCT02310906|Exon Skipping|exon skipping
306257|NCT02310906|DMD|dmd
306258|NCT02310906|Exon 53|exon 53
306259|NCT02310906|Ambulatory|ambulatory
306260|NCT02310906|Pediatric|pediatric
306261|NCT02310867|hand transplantation, amputation|hand transplantation, amputation
306262|NCT02310854|anterior cruciate ligament rupture|anterior cruciate ligament rupture
306263|NCT02310854|autograft|autograft
306264|NCT02310854|reconstruction|reconstruction
306265|NCT02310854|orthopedic surgery|orthopedic surgery
306266|NCT02310854|dynamic intraligament stabilization|dynamic intraligament stabilization
306267|NCT02310828|Cluster headache|cluster headache
306268|NCT02310828|Migrainous neuralgia|migrainous neuralgia
306269|NCT02310828|Horton's headache|horton's headache
306270|NCT02310828|Histaminic cephalalgia|histaminic cephalalgia
306271|NCT02310802|IVF|ivf
306272|NCT02310802|ICSI|icsi
306273|NCT02310763|Duchenne Muscular Dystrophy, myostatin|duchenne muscular dystrophy, myostatin
306274|NCT02310737|cesarean section|cesarean section
306275|NCT02310737|facial incision|facial incision
306276|NCT02310737|postoperative pain|postoperative pain
306277|NCT02310724|youth onset type 2 diabetes|youth onset type 2 diabetes
306278|NCT02310724|insulin sensitivity|insulin sensitivity
306279|NCT02310724|beta cell function|beta cell function
306280|NCT02310724|macrovascular comorbidities|macrovascular comorbidities
306281|NCT02310724|microvascular comorbidities|microvascular comorbidities
306282|NCT02310711|Breast|breast
306283|NCT02310711|Mastectomy|mastectomy
306284|NCT02310711|Lumpectomy|lumpectomy
306285|NCT02310711|Breast Therapy|breast therapy
306286|NCT02310698|Ultrasound|ultrasound
306287|NCT02310698|Enhanced Mammography|enhanced mammography
306288|NCT02310698|14-240|14-240
306289|NCT02310685|Cardivascular risks (hypertension, sedentary, overweight)|cardivascular risks (hypertension, sedentary, overweight)
306290|NCT02310685|Cardiovascular age|cardiovascular age
306291|NCT02310685|E-health wellness program|e-health wellness program
306292|NCT02310685|Prevention|prevention
306293|NCT02310685|Community pharmacists|community pharmacists
306294|NCT02310685|Lifestyle change|lifestyle change
306295|NCT02310685|Cardiometabolic age|cardiometabolic age
306296|NCT02310672|Pulmonary Arterial Hypertension|pulmonary arterial hypertension
306297|NCT02310633|TBI|tbi
306298|NCT02310633|memory disorder|memory disorder
306299|NCT02310633|injury, brain, traumatic|injury, brain, traumatic
306300|NCT02310633|rehabilitation|rehabilitation
306301|NCT02310607|Post-partum women|post-partum women
306302|NCT02310581|Bunionectomy|bunionectomy
306303|NCT02310568|PF 06372865|pf 06372865
306304|NCT02310568|generalized anxiety disorder|generalized anxiety disorder
306305|NCT02310568|outpatient|outpatient
306306|NCT02310568|safety|safety
306307|NCT02310568|efficacy|efficacy
306308|NCT02310568|suboptimal response|suboptimal response
306309|NCT02310555|Metabolic surgery|metabolic surgery
306310|NCT02310529|Maternal depression|maternal depression
306311|NCT02310529|Interpersonal Psycotherapy|interpersonal psycotherapy
306312|NCT02310503|Mohs Surgery|mohs surgery
306313|NCT02310490|Nasolabial Folds|nasolabial folds
306314|NCT02310477|regorafenib, cohort, metastatic colorectal cancer|regorafenib, cohort, metastatic colorectal cancer
306315|NCT02310438|Music therapy|music therapy
306316|NCT02310438|stroke|stroke
306317|NCT02310438|hemiparesis|hemiparesis
306318|NCT02310438|neurologic music therapy|neurologic music therapy
306319|NCT02310412|INTERCEPT|intercept
306320|NCT02310412|platelet|platelet
306321|NCT02310412|pathogen inactivation|pathogen inactivation
306322|NCT02310412|platelet components stored|platelet components stored
306323|NCT02310412|therapeutic efficacy|therapeutic efficacy
306324|NCT02310399|Auditory Brainstem Implant|auditory brainstem implant
306325|NCT02310399|Deafness|deafness
306326|NCT02310399|Hearing Loss|hearing loss
306328|NCT02310386|Fibromyalgia|fibromyalgia
306329|NCT02310386|Electromagnetic field therapy|electromagnetic field therapy
306330|NCT02310386|Randomized controlled trial|randomized controlled trial
306331|NCT02310373|Nicotine-free hookah|nicotine-free hookah
306332|NCT02310373|Waterpipe|waterpipe
306333|NCT02310373|Smoking|smoking
306334|NCT02310373|Sympathetic|sympathetic
306335|NCT02310321|Acute Myeloid Leukemia|acute myeloid leukemia
306336|NCT02310321|Cytarabine|cytarabine
306337|NCT02310321|Idarubicin|idarubicin
306338|NCT02310321|ASP2215|asp2215
306339|NCT02310308|Xylitol|xylitol
306340|NCT02310308|Magnolia|magnolia
306341|NCT02310308|chewing gum|chewing gum
306342|NCT02310295|Diabetic retinopathy|diabetic retinopathy
306343|NCT02310295|Macular edema|macular edema
306344|NCT02310295|Anti-VEGF|anti-vegf
306345|NCT02310295|Triamcinolone|triamcinolone
306346|NCT02310282|Telemedicine|telemedicine
306347|NCT02310282|Emergency medicine|emergency medicine
306348|NCT02310282|Stroke|stroke
306349|NCT02310282|Stroke syndromes|stroke syndromes
306350|NCT02310269|Cushing's disease,|cushing's disease,
306351|NCT02310269|pasireotide s.c.|pasireotide s.c.
306352|NCT02310269|Signifor|signifor
306353|NCT02310256|Mitochondria, muscle|mitochondria, muscle
306354|NCT02310256|Exercise|exercise
306355|NCT02310256|Blood Flow Velocity|blood flow velocity
306356|NCT02310243|Acute myeloid leukemia|acute myeloid leukemia
306357|NCT02310243|Acute lymphoblastic leukemia|acute lymphoblastic leukemia
306358|NCT02310243|MLL-rearranged leukemia|mll-rearranged leukemia
306359|NCT02310243|Palbociclib (PD-0332991-00)|palbociclib (pd-0332991-00)
306360|NCT02310230|Endoscopy, Upper|endoscopy, upper
306361|NCT02310230|Minute Ventilation|minute ventilation
306362|NCT02310230|Tidal Volume|tidal volume
306363|NCT02310230|Respiratory Rate|respiratory rate
306364|NCT02310217|Hypertension|hypertension
306365|NCT02310217|Cognitive impairment|cognitive impairment
306366|NCT02310217|Biomarkers|biomarkers
306367|NCT02310191|ischemic stroke|ischemic stroke
306368|NCT02310191|carotid stenting|carotid stenting
306369|NCT02310191|MRI diffusion weighted imaging|mri diffusion weighted imaging
306370|NCT02310191|Laboratory marker|laboratory marker
306371|NCT02310178|weight loss|weight loss
306372|NCT02310178|sleeve gastrectomy|sleeve gastrectomy
306373|NCT02310178|gastric bypass|gastric bypass
306374|NCT02310178|gastric banding|gastric banding
306375|NCT02310178|bariatric procedures|bariatric procedures
306376|NCT02310178|cohort|cohort
306377|NCT02310178|morbid obesity|morbid obesity
306378|NCT02310178|medical and economical impact|medical and economical impact
306379|NCT02310178|severe obesity|severe obesity
306380|NCT02310165|Paracentesis|paracentesis
306381|NCT02310165|Ascites|ascites
306382|NCT02310152|Child|child
306383|NCT02310152|Adolescent|adolescent
306384|NCT02310152|Parents|parents
306385|NCT02310152|Cognitive Therapy|cognitive therapy
306386|NCT02310152|Cognitive Behavior Therapy|cognitive behavior therapy
306387|NCT02310152|Anxiety|anxiety
306388|NCT02310113|NIRS|nirs
306389|NCT02310113|transfusion|transfusion
306390|NCT02310113|RBC|rbc
306391|NCT02310087|male infertility|male infertility
306392|NCT02310087|spermatogenesis|spermatogenesis
306393|NCT02310087|antioxidants|antioxidants
306394|NCT02310087|DNA damage|dna damage
306395|NCT02310087|mitochondrial membrane potential|mitochondrial membrane potential
306396|NCT02310087|apoptosis|apoptosis
306397|NCT02310061|Dialysis|dialysis
306398|NCT02310061|ESRD|esrd
306399|NCT02310061|lung congestion|lung congestion
306400|NCT02310061|heart failure|heart failure
306401|NCT02310061|LW-US|lw-us
306402|NCT02310009|Exercise|exercise
306403|NCT02310009|IL-1RA|il-1ra
306404|NCT02310009|Beta-cell function|beta-cell function
306405|NCT02310009|Type 2 Diabetes|type 2 diabetes
306406|NCT02309996|Randomized Controlled Trial|randomized controlled trial
306407|NCT02309996|Intervention Studies|intervention studies
306408|NCT02309996|Inservice Training|inservice training
306409|NCT02309996|Personnel Management|personnel management
306410|NCT02309996|Work place|work place
306411|NCT02309996|Work accommodation|work accommodation
306412|NCT02309996|Job modification|job modification
306413|NCT02309996|Supervision|supervision
306414|NCT02309996|Administration|administration
306415|NCT02309996|Return to Work|return to work
306416|NCT02309996|Industrial Psychology|industrial psychology
306417|NCT02309996|Human Engineering|human engineering
306418|NCT02309996|Risk Management|risk management
306419|NCT02309996|Organization and Administration|organization and administration
306420|NCT02309996|Work Disability|work disability
306421|NCT02309996|Occupational Diseases|occupational diseases
306422|NCT02309996|Occupational Injury|occupational injury
306423|NCT02309996|Occupational Health|occupational health
306424|NCT02309996|Occupational Exposure|occupational exposure
306425|NCT02309996|Sick Leave|sick leave
306426|NCT02309996|Absenteeism|absenteeism
306427|NCT02309996|Employee Health|employee health
306428|NCT02309983|bone turnover|bone turnover
306429|NCT02309983|muscle atrophy|muscle atrophy
306430|NCT02309983|fiber|fiber
306431|NCT02309957|Knee Cartilage Repair, Osteochondral Defects, BioMatrix CRD|knee cartilage repair, osteochondral defects, biomatrix crd
306432|NCT02309944|Wound Healing|wound healing
306433|NCT02309944|Obesity|obesity
306434|NCT02309944|Gynecologic Surgery|gynecologic surgery
306435|NCT02309944|Gynecologic Neoplasms|gynecologic neoplasms
306436|NCT02309944|Surgical Complications|surgical complications
306437|NCT02309931|Right hemicolectomy|right hemicolectomy
306438|NCT02309931|Side-to-side anastomosis|side-to-side anastomosis
306439|NCT02309931|Orocecal time|orocecal time
306440|NCT02309931|Antipersitaltic|antipersitaltic
306441|NCT02309931|Isoperistaltic|isoperistaltic
306442|NCT02309931|Laparoscopic colectomy|laparoscopic colectomy
306443|NCT02309931|Right laparoscopic hemicolectomy|right laparoscopic hemicolectomy
306444|NCT02309918|acute HCV Genotype 1 Infection|acute hcv genotype 1 infection
306445|NCT02309918|HCV RNA|hcv rna
306446|NCT02309918|LDV/SOF FDC|ldv/sof fdc
306447|NCT02309905|inmates|inmates
306448|NCT02309905|skin lesion|skin lesion
306449|NCT02309905|telemedicine|telemedicine
306450|NCT02309892|Non-Small Cell Lung Cancer|non-small cell lung cancer
306451|NCT02309892|Neoplasms|neoplasms
306452|NCT02309892|Immunoconjugate|immunoconjugate
306453|NCT02309892|Tumor microenvironment alkalinization|tumor microenvironment alkalinization
761392|NCT00399191|anemia|anemia
306454|NCT02309879|Intravenous lidocaine|intravenous lidocaine
306455|NCT02309879|Magnesium sulphate|magnesium sulphate
306456|NCT02309879|Mastectomy|mastectomy
306457|NCT02309879|Pain|pain
306458|NCT02309827|Inflammatory bowel disease|inflammatory bowel disease
306459|NCT02309723|Alzheimer's Disease|alzheimer's disease
306460|NCT02309723|Mild Cognitive Impairment|mild cognitive impairment
306461|NCT02309723|Neuroimaging|neuroimaging
306462|NCT02309723|Diagnostic Tool|diagnostic tool
306463|NCT02309697|Development|development
306464|NCT02309697|Assessments|assessments
306465|NCT02309697|Premature birth|premature birth
306466|NCT02309684|Diabetic Foot Ulcer (DFU)|diabetic foot ulcer (dfu)
306467|NCT02309684|Venous Leg Ulcer (VLU)|venous leg ulcer (vlu)
306468|NCT02309658|cervix neoplasm|cervix neoplasm
306469|NCT02309658|hENT1 protein, human|hent1 protein, human
306470|NCT02309658|Chemotherapy|chemotherapy
306471|NCT02309645|fibrin sealant|fibrin sealant
306472|NCT02309645|CSF leak|csf leak
306473|NCT02309619|esophageal cancer|esophageal cancer
306474|NCT02309619|esophagectomy|esophagectomy
306475|NCT02309619|quality of life|quality of life
306476|NCT02309593|osteoarthritis|osteoarthritis
306477|NCT02309593|avascular necrosis|avascular necrosis
306478|NCT02309593|ankylosis|ankylosis
306479|NCT02309593|protrusio acetabuli|protrusio acetabuli
306480|NCT02309593|painful hip dysplasia|painful hip dysplasia
306481|NCT02309593|rheumatoid arthritis|rheumatoid arthritis
306482|NCT02309593|correction of functional deformity|correction of functional deformity
306483|NCT02309593|revision procedures|revision procedures
306484|NCT02309580|Ibrutinib|ibrutinib
306485|NCT02309580|14-227|14-227
306486|NCT02309567|Anti-p53 antibody|anti-p53 antibody
306487|NCT02309567|PET/CT|pet/ct
306488|NCT02309567|Lung Cancer|lung cancer
306489|NCT02309567|FDG|fdg
306490|NCT02309554|Contraception|contraception
306491|NCT02309554|Post coital test|post coital test
306492|NCT02309554|Vaginal|vaginal
306493|NCT02309554|Diaphragm|diaphragm
306494|NCT02309541|middle ear implant|middle ear implant
306495|NCT02309541|feedback manager|feedback manager
306496|NCT02309541|Sound quality|sound quality
306497|NCT02309502|diabetic retinopathy|diabetic retinopathy
306498|NCT02309502|retina|retina
306499|NCT02309502|Laser|laser
306500|NCT02309502|Pascal|pascal
306501|NCT02309489|Family Planning Services|family planning services
306502|NCT02309489|Maternal Health Services|maternal health services
306503|NCT02309489|Breast Feeding|breast feeding
306504|NCT02309489|Contraception|contraception
306505|NCT02309489|Postnatal care|postnatal care
306506|NCT02309489|Postpartum contraception|postpartum contraception
306507|NCT02309489|Exclusive breastfeeding|exclusive breastfeeding
306508|NCT02309489|Postpartum Period|postpartum period
306509|NCT02309476|diffuse diabetic macular oedema|diffuse diabetic macular oedema
306510|NCT02309476|Pascal|pascal
306511|NCT02309476|Laser|laser
306512|NCT02309476|DMO|dmo
306513|NCT02309437|Nasopharyngeal carcinoma|nasopharyngeal carcinoma
306514|NCT02309437|Pain|pain
306515|NCT02309437|Oxycodone|oxycodone
306516|NCT02309437|Opioids|opioids
306517|NCT02309437|Radiation mucositis|radiation mucositis
306518|NCT02309411|Pediatric|pediatric
306519|NCT02309385|uveitis|uveitis
306520|NCT02309385|acute uveitis|acute uveitis
306521|NCT02309385|anterior uveitis|anterior uveitis
306522|NCT02309385|dexamethasone sodium phosphate|dexamethasone sodium phosphate
306523|NCT02309385|non-infectious uveitis|non-infectious uveitis
306524|NCT02309385|DSP-Visulex|dsp-visulex
306525|NCT02309385|Aciont|aciont
306526|NCT02309346|clindamycin|clindamycin
306527|NCT02309346|septic abortion|septic abortion
306528|NCT02309307|safety and performance|safety and performance
306529|NCT02309294|Patch Test|patch test
306530|NCT02309281|Eylea|eylea
306531|NCT02309268|left atrial appendage closure|left atrial appendage closure
306532|NCT02309255|Secondary coronary prevention|secondary coronary prevention
306533|NCT02309255|Psychosocial factors|psychosocial factors
306534|NCT02309255|Cardiac rehabilitation|cardiac rehabilitation
306535|NCT02309229|sputum colour|sputum colour
306536|NCT02309229|cystic fibrosis|cystic fibrosis
306537|NCT02309229|pollution|pollution
306538|NCT02309190|Transpulmonary pressure - morbid obesity|transpulmonary pressure - morbid obesity
306539|NCT02309177|Pancreatic Cancer|pancreatic cancer
306540|NCT02309177|Breast Cancer|breast cancer
306541|NCT02309177|Metastatic Breast Cancer|metastatic breast cancer
306542|NCT02309177|nab-Paclitaxel|nab-paclitaxel
306543|NCT02309177|Gemcitabine|gemcitabine
306544|NCT02309177|Carboplatin|carboplatin
306545|NCT02309177|Non-Small Cell Lung Cancer|non-small cell lung cancer
306546|NCT02309177|Lung Cancer|lung cancer
306547|NCT02309177|mBC|mbc
306548|NCT02309177|NSCLC|nsclc
306549|NCT02309177|Triple-negative Breast Cancer|triple-negative breast cancer
306550|NCT02309177|Hormone Receptor Positive|hormone receptor positive
306551|NCT02309177|ER+|er+
306552|NCT02309177|PR+|pr+
306553|NCT02309177|TNBC|tnbc
306554|NCT02309177|Nivolumab|nivolumab
306555|NCT02309177|PD-1|pd-1
761488|NCT00398697|gemcitabine|gemcitabine
391553|NCT01907334|asthma|asthma
306556|NCT02309177|Check-point Inhibitor/s|check-point inhibitor/s
306557|NCT02309177|Immune Check-point Inhibitor/s|immune check-point inhibitor/s
306558|NCT02309177|Anti-PD-1|anti-pd-1
306559|NCT02309177|BMS-936558|bms-936558
306560|NCT02309125|immediate gradual loading|immediate gradual loading
306561|NCT02309099|Acoustic Neuroma|acoustic neuroma
306562|NCT02309099|Vestibular Schwannoma|vestibular schwannoma
306563|NCT02309099|Meniere's Disease|meniere's disease
306564|NCT02309060|narrative communication|narrative communication
306565|NCT02309060|depression|depression
306566|NCT02309060|primary care|primary care
306567|NCT02309060|treatment development|treatment development
306568|NCT02309034|Overweight|overweight
306569|NCT02309034|Obesity|obesity
306570|NCT02309034|Cardiometabolic risk factors|cardiometabolic risk factors
306571|NCT02309034|Adolescents|adolescents
306572|NCT02309034|Exercise|exercise
306573|NCT02309021|craving|craving
306574|NCT02309008|Pharmacokinetics|pharmacokinetics
306575|NCT02308995|Endometriosis|endometriosis
306576|NCT02308995|Laparoscopy|laparoscopy
306577|NCT02308995|Barbed sutures|barbed sutures
306578|NCT02308982|encephalitis|encephalitis
306579|NCT02308982|meningoencephalitis|meningoencephalitis
306580|NCT02308982|encephalomyelitis|encephalomyelitis
306581|NCT02308982|brain inflammation|brain inflammation
306582|NCT02308982|intravenous immunoglobulin|intravenous immunoglobulin
306583|NCT02308982|randomised controlled trial|randomised controlled trial
306584|NCT02308982|Central Nervous System Diseases|central nervous system diseases
306585|NCT02308982|Central Nervous System Infection|central nervous system infection
306586|NCT02308969|altered state of consciousness|altered state of consciousness
306587|NCT02308969|functional magnetic resonance imaging (fMRI)|functional magnetic resonance imaging (fmri)
306588|NCT02308969|hallucination|hallucination
306589|NCT02308969|model psychosis|model psychosis
306590|NCT02308969|serotonin receptor|serotonin receptor
306591|NCT02308969|LSD|lsd
306592|NCT02308956|task sharing|task sharing
306593|NCT02308956|task shifting|task shifting
306594|NCT02308956|community mental health care|community mental health care
306595|NCT02308956|primary care|primary care
306596|NCT02308956|Developing country|developing country
306597|NCT02308956|Sub-Saharan Africa|sub-saharan africa
306598|NCT02308956|non-inferiority trial|non-inferiority trial
306599|NCT02308917|IBD|ibd
306600|NCT02308917|Crohn's|crohn's
306601|NCT02308917|Ulcerative|ulcerative
306602|NCT02308917|Colitis|colitis
306603|NCT02308904|Infertility|infertility
306604|NCT02308904|Thalassemia|thalassemia
306605|NCT02308904|Iron overload|iron overload
306606|NCT02308904|Pituitary Iron Load|pituitary iron load
306607|NCT02308904|Oxidative Stress|oxidative stress
306608|NCT02308904|REPRODUCTIVE CAPACITY AND ASSOCIATION TO IRON BURDEN AND CHELATION PATTERNS IN THALASSEMIA MAJOR PATIENTS|reproductive capacity and association to iron burden and chelation patterns in thalassemia major patients
306609|NCT02308891|pancreatitis|pancreatitis
306610|NCT02308891|ERCP|ercp
306611|NCT02308878|Opioid abuse|opioid abuse
306612|NCT02308878|Cognitive Therapy|cognitive therapy
306613|NCT02308878|Executive Function|executive function
306614|NCT02308878|Mobile Health|mobile health
306615|NCT02308878|Rehabilitation|rehabilitation
306616|NCT02308865|Early palliative care|early palliative care
306617|NCT02308865|Lung cancer|lung cancer
306618|NCT02308865|Quality of life|quality of life
306713|NCT02308228|Metformin|metformin
306714|NCT02308228|Strength|strength
306619|NCT02308852|bi-manual , motor skill learning , stroke , chronic patients,neuro-rehabilitative robot|bi-manual , motor skill learning , stroke , chronic patients,neuro-rehabilitative robot
306620|NCT02308839|Aneurysm|aneurysm
306621|NCT02308839|Aorta|aorta
306622|NCT02308839|Abdominal|abdominal
306623|NCT02308800|diabetic foot ulcer|diabetic foot ulcer
306624|NCT02308787|platelet depletion|platelet depletion
306625|NCT02308787|apheresis|apheresis
306626|NCT02308774|osteomyelitis, diabetic foot infection|osteomyelitis, diabetic foot infection
306627|NCT02308735|gestation|gestation
306628|NCT02308735|diabetes|diabetes
306629|NCT02308735|ethanol|ethanol
306630|NCT02308722|Borderline resectable|borderline resectable
306631|NCT02308709|Radiotherapy|radiotherapy
306632|NCT02308709|Pulmonary Functional Imaging|pulmonary functional imaging
306633|NCT02308709|Computed Tomography (CT)|computed tomography (ct)
306634|NCT02308709|Image Registration|image registration
306635|NCT02308709|Functional Image-guided Radiotherapy|functional image-guided radiotherapy
306636|NCT02308696|Older Adults|older adults
306637|NCT02308696|Aging in Place|aging in place
306638|NCT02308683|hscrp|hscrp
306639|NCT02308683|hgba1c|hgba1c
306640|NCT02308683|diabetes mellitus|diabetes mellitus
306641|NCT02308644|Diabetic Retinopathy|diabetic retinopathy
306642|NCT02308644|intravitreal bevacizumab|intravitreal bevacizumab
306643|NCT02308644|Contrast Sensitivity|contrast sensitivity
306644|NCT02308631|Endoscopic, Colostomy, Colopexy|endoscopic, colostomy, colopexy
306645|NCT02308618|Achilles tendon rupture|achilles tendon rupture
306646|NCT02308618|Rehabilitation|rehabilitation
306647|NCT02308618|Immobilization|immobilization
306648|NCT02308618|Muscle architecture|muscle architecture
306649|NCT02308618|Functionality|functionality
306650|NCT02308618|Neuromuscular parameters|neuromuscular parameters
306651|NCT02308618|Weight-Bearing|weight-bearing
306652|NCT02308605|SMARTCap|smartcap
306653|NCT02308592|Pregnancy|pregnancy
306654|NCT02308592|Depression|depression
306655|NCT02308592|Antidepressant Use|antidepressant use
306656|NCT02308592|Decision Aid|decision aid
306657|NCT02308566|Intracranial Embolism|intracranial embolism
306658|NCT02308566|Ultrasonography, Doppler, Transcranial|ultrasonography, doppler, transcranial
306659|NCT02308553|BRAF V600 wildtype|braf v600 wildtype
306660|NCT02308553|cutaneous malignant melanoma|cutaneous malignant melanoma
306661|NCT02308553|nintedanib|nintedanib
306662|NCT02308553|paclitaxel|paclitaxel
306663|NCT02308553|kinase inhibitor|kinase inhibitor
306664|NCT02308527|Children|children
306665|NCT02308527|Young adults|young adults
306666|NCT02308514|cryostimulation|cryostimulation
306667|NCT02308488|prone IMRT to breast, level III & Supraclavicular|prone imrt to breast, level iii & supraclavicular
306668|NCT02308488|acute toxicity of prone IMRT to breast, level III & SCV|acute toxicity of prone imrt to breast, level iii & scv
306669|NCT02308462|children of mentally ill parents|children of mentally ill parents
306670|NCT02308462|family intervention|family intervention
306671|NCT02308462|randomized controlled trial|randomized controlled trial
306672|NCT02308410|Tourniquet|tourniquet
306673|NCT02308410|Postoperative outcome|postoperative outcome
306674|NCT02308410|Total knee arthroplasty|total knee arthroplasty
306675|NCT02308397|non coeliac gluten sensitivity|non coeliac gluten sensitivity
306676|NCT02308397|gluten|gluten
306677|NCT02308397|bread|bread
306678|NCT02308384|iFOBT|ifobt
306679|NCT02308384|FIT|fit
306680|NCT02308384|general practice|general practice
306681|NCT02308384|early diagnosis|early diagnosis
306682|NCT02308371|critically ill pediatric patients|critically ill pediatric patients
306683|NCT02308371|fluid resuscitation|fluid resuscitation
306684|NCT02308358|Osteochondral Defect|osteochondral defect
306685|NCT02308358|Femoral condyle osteochondral defect|femoral condyle osteochondral defect
306686|NCT02308319|Hepatocellular carcinoma, Recurrence|hepatocellular carcinoma, recurrence
306687|NCT02308306|Chronic pain|chronic pain
306688|NCT02308306|Opioid analgesics|opioid analgesics
306689|NCT02308306|Prediction study|prediction study
306690|NCT02308306|Pharmaco-EEG|pharmaco-eeg
306691|NCT02308293|Type 1 Diabetes Mellitus|type 1 diabetes mellitus
306692|NCT02308293|Hypoglycemia unawareness|hypoglycemia unawareness
306693|NCT02308293|Lactate|lactate
306694|NCT02308293|high intensity interval exercise|high intensity interval exercise
306695|NCT02308293|MRS|mrs
306696|NCT02308280|High-risk myeloma|high-risk myeloma
306697|NCT02308280|Non myeloablative allogeneic transplantation|non myeloablative allogeneic transplantation
306698|NCT02308280|Bortezomib|bortezomib
306699|NCT02308267|Cystic Fibrosis|cystic fibrosis
306700|NCT02308267|Mucosal immunity|mucosal immunity
306701|NCT02308254|Blood pressure|blood pressure
306702|NCT02308254|Gastric emptying|gastric emptying
306703|NCT02308254|Glycemia|glycemia
306704|NCT02308254|Appetite|appetite
306705|NCT02308254|Incretin Hormones|incretin hormones
306706|NCT02308254|Superior mesenteric artery blood low|superior mesenteric artery blood low
306707|NCT02308241|Ribavirin|ribavirin
306708|NCT02308241|Human Papillomavirus (HPV)|human papillomavirus (hpv)
306709|NCT02308241|Recurrent/Metastatic (R/M)|recurrent/metastatic (r/m)
306710|NCT02308241|14-211|14-211
306711|NCT02308228|Aging|aging
306712|NCT02308228|Hypertrophy|hypertrophy
306716|NCT02308215|Retina|retina
306717|NCT02308215|AMD|amd
306718|NCT02308215|OCT|oct
306719|NCT02308202|PTSD|ptsd
306720|NCT02308202|treatment|treatment
306721|NCT02308202|virtual reality|virtual reality
306722|NCT02308202|doxazosin|doxazosin
306723|NCT02308189|Exercise|exercise
306724|NCT02308163|Rheumatoid Arthritis|rheumatoid arthritis
306725|NCT02308163|ASP015K|asp015k
306726|NCT02308150|transcatheter aortic valve replacement|transcatheter aortic valve replacement
306727|NCT02308150|asian pacific|asian pacific
306728|NCT02308150|asian|asian
306729|NCT02308111|Primary Biliary Cirrhosis|primary biliary cirrhosis
306730|NCT02308111|PBC|pbc
306731|NCT02308111|Cirrhosis|cirrhosis
306732|NCT02308111|Liver|liver
306733|NCT02308085|Premenopausal|premenopausal
306734|NCT02308085|endocrine responsive|endocrine responsive
306735|NCT02308085|Breast|breast
306736|NCT02308085|Pregnancy|pregnancy
306737|NCT02308072|Squamous Cell Carcinoma|squamous cell carcinoma
306738|NCT02308072|Head and Neck Cancer|head and neck cancer
306739|NCT02308072|Locally Advanced|locally advanced
306740|NCT02308072|Olaparib|olaparib
306741|NCT02308072|Cisplatin|cisplatin
306742|NCT02308072|IMRT|imrt
306743|NCT02308072|Chemoradiotherapy|chemoradiotherapy
306744|NCT02308072|PARP|parp
306745|NCT02308072|HNSCC|hnscc
306746|NCT02307994|infertility|infertility
306747|NCT02307942|Randomized Clinical Trials|randomized clinical trials
306748|NCT02307942|gastric banding|gastric banding
306749|NCT02307942|calorie restriction|calorie restriction
306750|NCT02307942|SPPB|sppb
306751|NCT02307942|physical performance|physical performance
306752|NCT02307942|elderly|elderly
306753|NCT02307916|tympanic membrane perforation|tympanic membrane perforation
306754|NCT02307916|ear drum|ear drum
306755|NCT02307916|hole|hole
306756|NCT02307903|end-stage renal failure (ESRF)|end-stage renal failure (esrf)
306757|NCT02307890|Liver Transplantation|liver transplantation
306758|NCT02307864|Healthy|healthy
306759|NCT02307864|QT interval|qt interval
306760|NCT02307864|QTc interval|qtc interval
306761|NCT02307864|Electrocardiogram|electrocardiogram
306762|NCT02307864|Tramadol hydrochloride|tramadol hydrochloride
306763|NCT02307864|Moxifloxacin|moxifloxacin
306764|NCT02307864|Placebo|placebo
306765|NCT02307838|Multiple Sclerosis, MS, RRMS, relapsing forms of multiple sclerosis, fingolimod, FTY720, Gilenya|multiple sclerosis, ms, rrms, relapsing forms of multiple sclerosis, fingolimod, fty720, gilenya
306766|NCT02307825|Azithromycin|azithromycin
306767|NCT02307825|Endoscopic sinus surgery|endoscopic sinus surgery
306768|NCT02307799|tobacco|tobacco
306769|NCT02307799|spirometry|spirometry
306770|NCT02307799|cohort study|cohort study
306771|NCT02307799|case-control study|case-control study
306772|NCT02307799|prevalence|prevalence
306773|NCT02307773|Upper Gastrointestinal Endoscopy|upper gastrointestinal endoscopy
306774|NCT02307773|Pharyngeal Anesthesia|pharyngeal anesthesia
306775|NCT02307773|Lidocaine|lidocaine
306776|NCT02307773|Belching|belching
306777|NCT02307773|Retching|retching
306778|NCT02307773|Tolerance|tolerance
306779|NCT02307747|infection in ICU|infection in icu
306780|NCT02307734|Lay Health Workers|lay health workers
306781|NCT02307734|Chinese|chinese
306782|NCT02307734|Vietnamese|vietnamese
306783|NCT02307734|Tobacco Use|tobacco use
306784|NCT02307734|Intervention|intervention
306785|NCT02307734|Behavior Change|behavior change
306786|NCT02307734|Social Networks|social networks
306787|NCT02307734|Asians|asians
306788|NCT02307721|Emergency Treatment|emergency treatment
306789|NCT02307721|Morphine Derivates|morphine derivates
306790|NCT02307721|Heroin|heroin
306791|NCT02307721|Antidotes|antidotes
306792|NCT02307721|Administration, Intranasal|administration, intranasal
306793|NCT02307721|Pharmacology|pharmacology
306794|NCT02307721|Naloxone|naloxone
306795|NCT02307721|Healthy volunteers|healthy volunteers
306796|NCT02307695|Saxagliptin|saxagliptin
306797|NCT02307695|Type 1 Diabetes|type 1 diabetes
306798|NCT02307695|Glycemic variability|glycemic variability
306799|NCT02307695|C-Peptide|c-peptide
306801|NCT02307682|CNV|cnv
306802|NCT02307682|IVT|ivt
306803|NCT02307669|Adherence|adherence
306804|NCT02307669|Inhaler|inhaler
306805|NCT02307669|GINA|gina
306806|NCT02307643|Systemic lupus erythematosus|systemic lupus erythematosus
306807|NCT02307630|124I-Humanized 3F8|124i-humanized 3f8
306808|NCT02307630|PET Imaging|pet imaging
306809|NCT02307630|13-147|13-147
306810|NCT02307617|Major depressive disorder|major depressive disorder
306811|NCT02307617|MDD|mdd
306812|NCT02307617|healthy control|healthy control
306813|NCT02307617|selective serotonin reuptake inhibitor|selective serotonin reuptake inhibitor
306814|NCT02307617|SSRI|ssri
306815|NCT02307617|depression|depression
306816|NCT02307617|transcranial magnetic stimulation|transcranial magnetic stimulation
306817|NCT02307617|TMS|tms
306818|NCT02307617|magnetic resonance spectroscopy|magnetic resonance spectroscopy
306819|NCT02307617|MRS|mrs
306820|NCT02307617|adolescent|adolescent
306821|NCT02307617|mild MDD|mild mdd
306822|NCT02307617|mild depression|mild depression
306823|NCT02307617|cortical excitability|cortical excitability
306824|NCT02307617|cortical inhibition|cortical inhibition
306825|NCT02307617|cortical silent period|cortical silent period
306826|NCT02307617|motor threshold|motor threshold
306827|NCT02307617|intracortical facilitation|intracortical facilitation
306828|NCT02307617|intracortical inhibition|intracortical inhibition
306829|NCT02307617|motor cortex|motor cortex
306830|NCT02307617|dorsolateral prefrontal cortex|dorsolateral prefrontal cortex
306831|NCT02307617|DLPFC|dlpfc
306832|NCT02307617|thumb twitch|thumb twitch
306833|NCT02307617|gamma aminobutyric acid|gamma aminobutyric acid
306834|NCT02307617|GABA|gaba
306835|NCT02307617|glutamate|glutamate
306836|NCT02307617|single pulse|single pulse
306837|NCT02307617|paired pulse|paired pulse
306838|NCT02307604|Brain tumor|brain tumor
306839|NCT02307604|Biomarkers|biomarkers
306840|NCT02307604|Screening|screening
306841|NCT02307578|Perampanel|perampanel
306842|NCT02307578|Fycompa|fycompa
306843|NCT02307578|Primary Generalized Tonic-Clonic Seizures|primary generalized tonic-clonic seizures
306844|NCT02307578|E2007-G000-332|e2007-g000-332
306845|NCT02307578|E2007|e2007
306846|NCT02307565|Midodrine|midodrine
306847|NCT02307565|Blood pressure|blood pressure
306848|NCT02307565|Orthostatic hypotension|orthostatic hypotension
306849|NCT02307565|Spinal Cord Injury|spinal cord injury
306850|NCT02307565|Sympathetic vascular control|sympathetic vascular control
391944|NCT01905215|Safety|safety
306851|NCT02307565|Cerebral blood flow velocity|cerebral blood flow velocity
306852|NCT02307565|Cognition function tasks|cognition function tasks
306853|NCT02307565|Quality of Life|quality of life
306854|NCT02307565|MRI|mri
306855|NCT02307565|fMRI|fmri
306856|NCT02307552|Imaging|imaging
306857|NCT02307552|ultrasound|ultrasound
306858|NCT02307552|prostate|prostate
306859|NCT02307552|cancer|cancer
306860|NCT02307552|diagnostic tool|diagnostic tool
306861|NCT02307552|catheter|catheter
306862|NCT02307552|urethra|urethra
306863|NCT02307552|digital rectal exam|digital rectal exam
306864|NCT02307526|Hypotension, Postural|hypotension, postural
306865|NCT02307513|APREMILAST (CC-10004)|apremilast (cc-10004)
306866|NCT02307513|CC-10004|cc-10004
306867|NCT02307513|Efficacy|efficacy
306868|NCT02307513|Safety|safety
306869|NCT02307513|Phase 3|phase 3
306870|NCT02307513|Behçet's Disease|behçet's disease
306871|NCT02307487|TC-3 Gel|tc-3 gel
306872|NCT02307487|MMC|mmc
306873|NCT02307487|NMIBC|nmibc
306874|NCT02307487|Non Muscle Invasive Bladder Cancer|non muscle invasive bladder cancer
306875|NCT02307487|Hydrogel Reverse thermal gelation|hydrogel reverse thermal gelation
306876|NCT02307487|Drug retention|drug retention
306877|NCT02307487|Urinary Bladder Neoplasms|urinary bladder neoplasms
306878|NCT02307487|Urologic Neoplasms|urologic neoplasms
306879|NCT02307487|Urinary Bladder Diseases|urinary bladder diseases
306880|NCT02307487|Urologic Diseases|urologic diseases
306881|NCT02307474|Kidney|kidney
306882|NCT02307474|Renal Cell Carcinoma|renal cell carcinoma
306883|NCT02307474|Cancer|cancer
306884|NCT02307474|Pilot|pilot
306885|NCT02307474|Pazopanib|pazopanib
306886|NCT02307474|stereotactic body radiation therapy|stereotactic body radiation therapy
306887|NCT02307474|SBRT|sbrt
306888|NCT02307461|Phase 1|phase 1
306889|NCT02307461|Bioequivalence|bioequivalence
306890|NCT02307461|Pharmacokinetics|pharmacokinetics
306891|NCT02307461|Food|food
306892|NCT02307461|Healthy Adult|healthy adult
306893|NCT02307435|non union fracture|non union fracture
306894|NCT02307435|bone defect|bone defect
306895|NCT02307435|mesenchymal stem cell|mesenchymal stem cell
306896|NCT02307435|cryopreservation|cryopreservation
306897|NCT02307383|SDD (Selective Digestive Decolonization)|sdd (selective digestive decolonization)
306898|NCT02307383|OXA 48|oxa 48
306899|NCT02307383|carbapenemase|carbapenemase
306900|NCT02307383|probiotics|probiotics
306901|NCT02307331|Total Hip Replacement|total hip replacement
306902|NCT02307318|Radial Artery|radial artery
306903|NCT02307318|Hemostasis|hemostasis
306904|NCT02307318|Angiography|angiography
306905|NCT02307292|Superficial femoral artery|superficial femoral artery
306906|NCT02307292|Self Expanding Stent System|self expanding stent system
306907|NCT02307253|EUS-guided biopsy, EUS-FNB|eus-guided biopsy, eus-fnb
306908|NCT02307240|TNBC|tnbc
306909|NCT02307240|HGSOC|hgsoc
306910|NCT02307240|NMC|nmc
306911|NCT02307188|Atrial Fibrillation|atrial fibrillation
306912|NCT02307188|Atrial Flutter|atrial flutter
306913|NCT02307188|Multipolar Catheter|multipolar catheter
306914|NCT02307188|Atrial Arrhythmia|atrial arrhythmia
306915|NCT02307162|COPD|copd
306916|NCT02307149|melanoma|melanoma
306917|NCT02307149|ipilimumab|ipilimumab
306918|NCT02307149|coxsackievirus A21|coxsackievirus a21
306919|NCT02307149|CAVATAK|cavatak
306920|NCT02307149|CVA21|cva21
306921|NCT02307149|checkpoint inhibitors|checkpoint inhibitors
306922|NCT02307136|intensive care units|intensive care units
306923|NCT02307136|emergency department|emergency department
306924|NCT02307123|Prehospital emergency care (MeSH)|prehospital emergency care (mesh)
307322|NCT02304952|Pain|pain
306925|NCT02307123|Emergency medical services (MeSH)|emergency medical services (mesh)
306926|NCT02307123|Helicopter emergency medical service, Critical care (MeSH)|helicopter emergency medical service, critical care (mesh)
306927|NCT02307123|Airway management (MeSH)|airway management (mesh)
306928|NCT02307123|Endotracheal intubation (MeSH)|endotracheal intubation (mesh)
306929|NCT02307123|Patient outcome|patient outcome
306930|NCT02307110|Diabetes Mellitus 1|diabetes mellitus 1
306931|NCT02307110|long-term intensified insulin therapy|long-term intensified insulin therapy
306932|NCT02307110|diabetic retinopathy|diabetic retinopathy
306933|NCT02307110|diabetic macular edema|diabetic macular edema
306934|NCT02307097|Randomised Controlled Trial|randomised controlled trial
306935|NCT02307097|Cognitive-Behavioural Bibliotherapy|cognitive-behavioural bibliotherapy
306936|NCT02307097|Social Anxiety Disorder|social anxiety disorder
306937|NCT02307097|Cognitive-Behavioural Therapy|cognitive-behavioural therapy
306938|NCT02307097|IAPT|iapt
306939|NCT02307084|surgical site infection|surgical site infection
306940|NCT02307084|long saphenous vein|long saphenous vein
306941|NCT02307084|coronary artery bypass grafting|coronary artery bypass grafting
306942|NCT02307058|Prostate Cancer|prostate cancer
306943|NCT02307045|Arterial stiffness|arterial stiffness
306944|NCT02307045|Endothelial Glycocalyx|endothelial glycocalyx
306945|NCT02307032|Atrial Fibrillation Relapses Prediction|atrial fibrillation relapses prediction
392099|NCT01904552|i-Root|i-root
306946|NCT02307032|P wave Signal Averaged ECG|p wave signal averaged ecg
306947|NCT02307032|P wave Wavelets|p wave wavelets
306948|NCT02307032|Strain|strain
306949|NCT02307032|Tissue Doppler Imaging|tissue doppler imaging
306950|NCT02307019|Caregivers|caregivers
306951|NCT02307019|Apraxias|apraxias
306952|NCT02307019|Stroke|stroke
306953|NCT02307019|Cerebral Stroke|cerebral stroke
306954|NCT02307019|Rehabilitation|rehabilitation
306955|NCT02307019|Pragmatic Clinical Trials as Topic|pragmatic clinical trials as topic
306956|NCT02306993|Sickle Cell Disease (SCD)|sickle cell disease (scd)
306957|NCT02306993|Sickle Cell Trait (SCT)|sickle cell trait (sct)
306958|NCT02306967|oral cancer|oral cancer
306959|NCT02306967|oral dysplasia|oral dysplasia
306960|NCT02306954|Kidney Cancer|kidney cancer
306961|NCT02306954|High Dose IL-2|high dose il-2
306962|NCT02306954|SBRT|sbrt
306963|NCT02306928|Septic shock|septic shock
306964|NCT02306928|Intensive care unit|intensive care unit
306965|NCT02306928|Therapeutic drug monitoring|therapeutic drug monitoring
306966|NCT02306928|Pharmacokinetics|pharmacokinetics
306967|NCT02306928|Critically ill|critically ill
306968|NCT02306915|Lipegfilgrastim, Lonquex, Japanese Bridging|lipegfilgrastim, lonquex, japanese bridging
306969|NCT02306863|Parkinson's Disease|parkinson's disease
306970|NCT02306863|whole-body vibration|whole-body vibration
306971|NCT02306863|WBV|wbv
306972|NCT02306850|immunotherapy|immunotherapy
306973|NCT02306850|PD-1 inhibitor|pd-1 inhibitor
306974|NCT02306850|programmed death 1 inhibitor|programmed death 1 inhibitor
306975|NCT02306850|neoadjuvant|neoadjuvant
306976|NCT02306850|pembrolizumab|pembrolizumab
306977|NCT02306850|MK-3475|mk-3475
306978|NCT02306837|lymphoma, consolidation chemotherapy, auto-HSCT|lymphoma, consolidation chemotherapy, auto-hsct
306979|NCT02306759|analgesia|analgesia
306980|NCT02306759|ketamine|ketamine
306981|NCT02306759|pain|pain
306982|NCT02306746|Enteral nutrition|enteral nutrition
306983|NCT02306746|randomised control trial|randomised control trial
306984|NCT02306746|Critical care|critical care
306985|NCT02306746|Outcome|outcome
306986|NCT02306733|Post partum hemorrhage|post partum hemorrhage
306987|NCT02306733|Ergometrine|ergometrine
306988|NCT02306733|Oxytocin|oxytocin
306989|NCT02306733|Obstetrics|obstetrics
306990|NCT02306694|hemophilia|hemophilia
306991|NCT02306694|bone disease|bone disease
306992|NCT02306694|clinical study|clinical study
306993|NCT02306694|biomarkers|biomarkers
306995|NCT02306655|Coital incontinence|coital incontinence
306996|NCT02306655|Incidence|incidence
306997|NCT02306655|quality of life|quality of life
306998|NCT02306629|Systemic Lupus Erythematosus|systemic lupus erythematosus
306999|NCT02306590|amyotrophic lateral sclerosis|amyotrophic lateral sclerosis
307000|NCT02306590|survival time|survival time
307001|NCT02306590|ALS Functional Rating Scale|als functional rating scale
307002|NCT02306590|quality of life|quality of life
307003|NCT02306590|survival|survival
307004|NCT02306577|STRIBILD|stribild
307005|NCT02306577|HIV|hiv
307006|NCT02306577|Illicit dgug user|illicit dgug user
307007|NCT02306564|ICSI|icsi
307008|NCT02306564|cabergoline|cabergoline
307009|NCT02306564|Subendometrial vascularity|subendometrial vascularity
307010|NCT02306551|Offspring|offspring
307011|NCT02306551|Attachment|attachment
307012|NCT02306551|Risk development|risk development
307013|NCT02306551|Resilience|resilience
307014|NCT02306538|edema|edema
307015|NCT02306538|inflammation|inflammation
307016|NCT02306538|scar|scar
307017|NCT02306538|ejection fraction|ejection fraction
307018|NCT02306538|volumes|volumes
307019|NCT02306512|Melanoma In Situ|melanoma in situ
307020|NCT02306512|Lentigo Maligna|lentigo maligna
307021|NCT02306512|Confocal Microscopy|confocal microscopy
307022|NCT02306512|Direct Immunofluorescence|direct immunofluorescence
307323|NCT02304952|Function|function
307023|NCT02306499|VARICOCELE-AZOOSPERMIA-ICSI|varicocele-azoospermia-icsi
307024|NCT02306460|Neurobehavioral Manifestations|neurobehavioral manifestations
307025|NCT02306460|POCD|pocd
307026|NCT02306460|Atrial Fibrillation|atrial fibrillation
307027|NCT02306460|Anti-Arrhythmia|anti-arrhythmia
307028|NCT02306460|Atrial Appendage Closure|atrial appendage closure
307029|NCT02306434|childbirth fear|childbirth fear
307030|NCT02306434|Internet CBT|internet cbt
307031|NCT02306434|counselling|counselling
307032|NCT02306434|antenatal care|antenatal care
307033|NCT02306434|postnatal care|postnatal care
307034|NCT02306434|childbirth|childbirth
307035|NCT02306434|Cognitive behavioural therapy|cognitive behavioural therapy
307036|NCT02306421|RPH with the simplified Milligan-Morgan surgery|rph with the simplified milligan-morgan surgery
307037|NCT02306421|mixed hemorrhoids|mixed hemorrhoids
307038|NCT02306421|the effectiveness and safety|the effectiveness and safety
307039|NCT02306421|A multi center clinical trial|a multi center clinical trial
307040|NCT02306395|endometrial local injury|endometrial local injury
307041|NCT02306395|repeated implatation failure|repeated implatation failure
307042|NCT02306395|embyo transfer|embyo transfer
761489|NCT00398684|Thailand|thailand
307043|NCT02306382|endoanal ultrasonography|endoanal ultrasonography
307044|NCT02306382|drainage|drainage
307045|NCT02306382|perianal abscess|perianal abscess
307046|NCT02306382|fistulas|fistulas
307047|NCT02306382|incontience|incontience
307048|NCT02306369|ICBT|icbt
307050|NCT02306369|FGID|fgid
307051|NCT02306369|functional abdominal pain|functional abdominal pain
307052|NCT02306369|Adolescents|adolescents
307053|NCT02306369|Children|children
307054|NCT02306369|Treatment|treatment
307055|NCT02306369|CBT|cbt
307056|NCT02306369|Exposure|exposure
307057|NCT02306369|Cognitive Behavior Therapy|cognitive behavior therapy
307058|NCT02306369|Internet|internet
307059|NCT02306369|Computerized|computerized
307060|NCT02306369|Abdominal Pain|abdominal pain
307061|NCT02306369|Functional Pain|functional pain
307062|NCT02306369|Functional Disorders|functional disorders
307063|NCT02306343|rapid acting insulin|rapid acting insulin
307064|NCT02306343|insulin injection|insulin injection
307065|NCT02306343|insulin delivery|insulin delivery
307066|NCT02306343|local heating|local heating
307067|NCT02306343|experimental device|experimental device
307068|NCT02306343|pre and post meal glucose level|pre and post meal glucose level
307069|NCT02306330|Malditof|malditof
307070|NCT02306330|Malditof MS|malditof ms
307071|NCT02306330|matrix-assisted laser desorption ionization-time|matrix-assisted laser desorption ionization-time
307072|NCT02306330|identifying pathogens|identifying pathogens
307073|NCT02306330|randomized diagnostic trial|randomized diagnostic trial
307074|NCT02306304|Abdominal aortic aneurysm|abdominal aortic aneurysm
307075|NCT02306304|Abdominal aortic aneurism|abdominal aortic aneurism
307076|NCT02306304|AAA|aaa
307077|NCT02306304|Screening|screening
307078|NCT02306304|duplex ultra sound|duplex ultra sound
307079|NCT02306304|Israeli Arab men|israeli arab men
307080|NCT02306304|family physician|family physician
307081|NCT02306291|AML|aml
307082|NCT02306291|Acute myeloid leukemia|acute myeloid leukemia
307083|NCT02306291|E-selectin|e-selectin
307084|NCT02306291|relapse refractory|relapse refractory
307085|NCT02306291|elderly newly diagnosed|elderly newly diagnosed
307086|NCT02306291|induction|induction
307087|NCT02306278|gabapentin|gabapentin
307088|NCT02306278|postoperative pain|postoperative pain
307089|NCT02306278|vomiting|vomiting
307090|NCT02306278|nausea|nausea
307091|NCT02306252|Cancer|cancer
307092|NCT02306252|Older Adult|older adult
307093|NCT02306252|Geriatric|geriatric
307094|NCT02306252|Function|function
307095|NCT02306252|Functional Deficit|functional deficit
307096|NCT02306252|Occupational Therapy|occupational therapy
307097|NCT02306252|Physical Therapy|physical therapy
307098|NCT02306252|Supportive Care|supportive care
307099|NCT02306252|Oncology|oncology
307100|NCT02306252|physiology|physiology
307101|NCT02306252|Geriatric Assessment|geriatric assessment
307102|NCT02306252|Health Services for the Aged|health services for the aged
307103|NCT02306252|Physical Therapy Specialty|physical therapy specialty
307104|NCT02306226|TAVI|tavi
307105|NCT02306226|Aortic stenosis|aortic stenosis
307106|NCT02306226|Transcatheter aortic valve replacement|transcatheter aortic valve replacement
307107|NCT02306226|Transcatheter aortic valve implantation|transcatheter aortic valve implantation
307108|NCT02306226|Transfemoral access|transfemoral access
307109|NCT02306200|Aorta|aorta
307110|NCT02306200|Aortic Disease|aortic disease
307111|NCT02306200|Abdominal Aortic Aneurysm (AAA)|abdominal aortic aneurysm (aaa)
307112|NCT02306200|Thoracic Aortic Aneurysm (TAA)|thoracic aortic aneurysm (taa)
307113|NCT02306200|Bicuspid Aortic Valve (BAV)|bicuspid aortic valve (bav)
307114|NCT02306200|Aortic Dissection|aortic dissection
307115|NCT02306187|The changes of bone mineral density and bone turnover markers|the changes of bone mineral density and bone turnover markers
307116|NCT02306174|Hoarding|hoarding
307117|NCT02306135|Cancer|cancer
307118|NCT02306135|Tumor|tumor
307119|NCT02306135|Everolimus|everolimus
307120|NCT02306135|mTOR|mtor
307121|NCT02306135|Temsirolimus|temsirolimus
307122|NCT02306135|Sirolimus|sirolimus
307123|NCT02306135|Rapamycin|rapamycin
307124|NCT02306122|medication adherence|medication adherence
307125|NCT02306122|choice architecture|choice architecture
307126|NCT02306122|pharmacy home|pharmacy home
307127|NCT02306109|Motor Rehabilitation Treatment|motor rehabilitation treatment
307128|NCT02306109|Intensive versus standard|intensive versus standard
307129|NCT02306109|Motor Disability|motor disability
307130|NCT02306096|prognostic and predictive biomarkers|prognostic and predictive biomarkers
307131|NCT02306096|RNA-sequencing|rna-sequencing
307132|NCT02306096|pathological complete response|pathological complete response
307133|NCT02306096|minimal residual disease|minimal residual disease
307134|NCT02306096|molecular subtype|molecular subtype
307135|NCT02306096|gene expression profiling|gene expression profiling
307136|NCT02306096|mutation screening|mutation screening
307137|NCT02306096|BRCA|brca
307138|NCT02306096|translational research|translational research
307139|NCT02306096|genomics|genomics
307140|NCT02306096|transcriptomics|transcriptomics
307141|NCT02306096|proteomics|proteomics
307142|NCT02306096|metabolomics|metabolomics
307143|NCT02306096|liquid biopsy|liquid biopsy
307144|NCT02306096|circulating tumor cells|circulating tumor cells
307145|NCT02306096|circulating tumor DNA|circulating tumor dna
307146|NCT02306044|Bleeding|bleeding
307147|NCT02306044|Platelet indices|platelet indices
307148|NCT02306044|Platelet aggregometry|platelet aggregometry
307149|NCT02306044|Bleeding questionnaire|bleeding questionnaire
307150|NCT02306031|diclofenac|diclofenac
307151|NCT02306031|macular thickness|macular thickness
307152|NCT02306031|phacoemulsification|phacoemulsification
307153|NCT02306031|OCT(Optical coherence tomography )|oct(optical coherence tomography )
307154|NCT02306031|diabetic|diabetic
307155|NCT02306018|liver transplantation|liver transplantation
307156|NCT02306018|cardiac output|cardiac output
307157|NCT02306005|diabetes mellitus type 1, insulin therapy, lipoproteins, HDL|diabetes mellitus type 1, insulin therapy, lipoproteins, hdl
307158|NCT02305966|advanced arthritis|advanced arthritis
307159|NCT02305966|shoulder|shoulder
307160|NCT02305953|Psoriasis|psoriasis
307161|NCT02305953|Vascular Inflammation|vascular inflammation
307162|NCT02305953|Coronary Atherosclerosis|coronary atherosclerosis
307163|NCT02305953|Ascending aorta|ascending aorta
307164|NCT02305953|PET scan|pet scan
307165|NCT02305953|Cytokine|cytokine
307166|NCT02305953|Chemokine|chemokine
307167|NCT02305927|Vitamin D|vitamin d
307168|NCT02305927|Pregnant women|pregnant women
307169|NCT02305914|acute pancreatitis|acute pancreatitis
307170|NCT02305914|chronic pancreatitis|chronic pancreatitis
307171|NCT02305914|pancreatic cancer|pancreatic cancer
307172|NCT02305914|pancreatic disease-associated portal hypertension|pancreatic disease-associated portal hypertension
307173|NCT02305914|autoimmune pancreatitis|autoimmune pancreatitis
307174|NCT02305914|PaO2/FiO2＜200|pao2/fio2＜200
307175|NCT02305914|diabetes mellitus|diabetes mellitus
307176|NCT02305914|blood lipid|blood lipid
307177|NCT02305914|local complications|local complications
307178|NCT02305914|quality of life|quality of life
307179|NCT02305862|Coronary Arteriosclerosis|coronary arteriosclerosis
307180|NCT02305862|Carotid Atherosclerotic Plaque|carotid atherosclerotic plaque
307181|NCT02305862|Rosuvastatin|rosuvastatin
307182|NCT02305849|ASP015K|asp015k
307183|NCT02305849|Rheumatoid Arthritis|rheumatoid arthritis
307184|NCT02305836|Electroacupuncture|electroacupuncture
307185|NCT02305836|Donepezil|donepezil
307186|NCT02305836|Alzheimer's disease|alzheimer's disease
307187|NCT02305836|Randomized controlled trial|randomized controlled trial
307188|NCT02305823|psychosis|psychosis
307189|NCT02305823|antipsychotic agents|antipsychotic agents
307190|NCT02305823|treatment|treatment
307191|NCT02305823|effectiveness|effectiveness
307192|NCT02305784|Cystic fibrosis|cystic fibrosis
307193|NCT02305784|Pulmonary exacerbation|pulmonary exacerbation
307194|NCT02305784|inflammation|inflammation
307195|NCT02305784|Chitinase|chitinase
307196|NCT02305784|cytokine|cytokine
307197|NCT02305784|Cystic fibrosis related diabetes|cystic fibrosis related diabetes
307198|NCT02305758|PARP inhibitor|parp inhibitor
307199|NCT02305758|veliparib|veliparib
307200|NCT02305758|metastatic colorectal cancer|metastatic colorectal cancer
307201|NCT02305758|ABT-888|abt-888
307202|NCT02305758|first line|first line
307203|NCT02305758|previously untreated|previously untreated
307204|NCT02305758|colorectal cancer|colorectal cancer
307205|NCT02305758|colon cancer|colon cancer
307206|NCT02305758|rectal cancer|rectal cancer
307207|NCT02305758|FOLFIRI|folfiri
307208|NCT02305758|fluorouracil|fluorouracil
307209|NCT02305758|5-FU|5-fu
307210|NCT02305758|leucovorin|leucovorin
307211|NCT02305758|irinotecan|irinotecan
307212|NCT02305732|Chikungunya virus|chikungunya virus
307213|NCT02305732|CHIKV|chikv
307214|NCT02305732|Dengue virus|dengue virus
307215|NCT02305732|DENV|denv
307216|NCT02305732|pathogen inactivation|pathogen inactivation
307217|NCT02305732|platelets|platelets
307218|NCT02305732|Puerto Rico|puerto rico
307219|NCT02305706|insertion|insertion
307220|NCT02305706|patient comfort|patient comfort
307221|NCT02305667|Laryngoscope|laryngoscope
307222|NCT02305667|Macintosh|macintosh
307223|NCT02305667|Glidescope®|glidescope®
307224|NCT02305667|King Vision™|king vision™
307225|NCT02305667|Airtraq®|airtraq®
307226|NCT02305667|intubation|intubation
307227|NCT02305667|double lumen tube|double lumen tube
307228|NCT02305654|Penis cancer|penis cancer
307229|NCT02305654|Chemotherapy|chemotherapy
307230|NCT02305654|Chemoradiotherapy|chemoradiotherapy
307231|NCT02305654|Surgery|surgery
307232|NCT02305654|Phase III|phase iii
307233|NCT02305602|extracellular matrix|extracellular matrix
307234|NCT02305589|postoperative delirium|postoperative delirium
307235|NCT02305589|sugammadex|sugammadex
307236|NCT02305589|cholinesterase inhibitor|cholinesterase inhibitor
307237|NCT02305589|hip fracture surgery|hip fracture surgery
307238|NCT02305550|Nitric Oxide|nitric oxide
307239|NCT02305524|endotracheal intubation|endotracheal intubation
307240|NCT02305511|Catheterization|catheterization
307241|NCT02305511|Peripheral|peripheral
307242|NCT02305498|Yoga|yoga
307243|NCT02305498|14-059|14-059
307244|NCT02305485|NeoVas|neovas
307245|NCT02305485|Bioresorbable Coronary Scaffold|bioresorbable coronary scaffold
307246|NCT02305485|Sirolimus|sirolimus
307247|NCT02305485|Randomized Controlled Trial|randomized controlled trial
307248|NCT02305472|NeoVas|neovas
307249|NCT02305472|Bioresorbable Coronary Scaffold|bioresorbable coronary scaffold
307250|NCT02305472|Sirolimus|sirolimus
307251|NCT02305472|Registry Trial|registry trial
307252|NCT02305459|SIRT|sirt
307253|NCT02305459|microcatheter|microcatheter
307254|NCT02305459|primary liver tumor|primary liver tumor
307255|NCT02305459|secondary liver tumor|secondary liver tumor
307256|NCT02305459|radioembolisation|radioembolisation
307257|NCT02305459|QLQ-C30|qlq-c30
307258|NCT02305459|CIRSE|cirse
307259|NCT02305433|elderly|elderly
307260|NCT02305433|functional-based physiotherapy|functional-based physiotherapy
307261|NCT02305433|frailty syndrome|frailty syndrome
307262|NCT02305433|osteoporotic hip fractures|osteoporotic hip fractures
307263|NCT02305433|home-based physiotherapy|home-based physiotherapy
307264|NCT02305433|home-dwelling|home-dwelling
307265|NCT02305433|intervention|intervention
307266|NCT02305433|randomised controlled trial|randomised controlled trial
307267|NCT02305433|costs of social and health care|costs of social and health care
307268|NCT02305433|quality of life|quality of life
307269|NCT02305433|physical functioning|physical functioning
307270|NCT02305433|mobility|mobility
307271|NCT02305433|nutrition|nutrition
307272|NCT02305394|ketamine|ketamine
307273|NCT02305394|Electroconvulsive Therapy|electroconvulsive therapy
307274|NCT02305394|Cognitive Function|cognitive function
307275|NCT02305342|Uncomplicated UTI|uncomplicated uti
307276|NCT02305342|Enoxacin|enoxacin
307277|NCT02305303|Quality of life|quality of life
307278|NCT02305303|post-traumatic stress disorder|post-traumatic stress disorder
307279|NCT02305303|trauma|trauma
307280|NCT02305238|Eylea,|eylea,
307281|NCT02305238|Aflibercept|aflibercept
307282|NCT02305238|Treat and Extend regimen|treat and extend regimen
307283|NCT02305238|Age-related macular degeneration|age-related macular degeneration
307284|NCT02305212|Working Memory|working memory
307285|NCT02305199|Diabetes Mellitus, Type 2|diabetes mellitus, type 2
307286|NCT02305199|Hartmann's solution|hartmann's solution
307287|NCT02305186|Immunotherapy|immunotherapy
307288|NCT02305186|Neoadjuvant|neoadjuvant
307289|NCT02305186|Resectable|resectable
307290|NCT02305186|Borderline resectable|borderline resectable
307291|NCT02305173|dexamethasone|dexamethasone
307292|NCT02305173|pulmonary function|pulmonary function
307293|NCT02305173|spirometry|spirometry
307294|NCT02305173|mastectomy|mastectomy
307295|NCT02305160|Respiratory distress syndrome|respiratory distress syndrome
307296|NCT02305160|Pulmonary surfactant|pulmonary surfactant
307297|NCT02305160|Mortality|mortality
307298|NCT02305160|Prematurity|prematurity
307299|NCT02305147|Parkinson Disease|parkinson disease
307300|NCT02305147|Biomarkers|biomarkers
307301|NCT02305147|Prognostic factors|prognostic factors
307302|NCT02305147|Prodromal features|prodromal features
307303|NCT02305147|Disease progression|disease progression
307304|NCT02305134|Tipepidine, GIRK|tipepidine, girk
307305|NCT02305121|Trochanteric fracture|trochanteric fracture
307306|NCT02305121|Nail|nail
307307|NCT02305121|Fracture reduction|fracture reduction
307308|NCT02305121|Antirotation|antirotation
307309|NCT02305121|trochanteric area with diaphyseal extension|trochanteric area with diaphyseal extension
307310|NCT02305121|trochanteric area with femoral shaft|trochanteric area with femoral shaft
307311|NCT02305043|non-interventional|non-interventional
307312|NCT02305043|advanced gastric cancer|advanced gastric cancer
307313|NCT02305043|Trastuzumab|trastuzumab
307314|NCT02305043|HER2|her2
307315|NCT02304991|Peanut|peanut
307316|NCT02304991|Food Allergy|food allergy
307317|NCT02304978|colorectal cancer|colorectal cancer
307318|NCT02304978|Tissular factor|tissular factor
307319|NCT02304978|TF|tf
307320|NCT02304965|LVAD|lvad
307321|NCT02304952|Lateral epicondylalgia|lateral epicondylalgia
307324|NCT02304952|Physiotherapy|physiotherapy
307325|NCT02304952|Quality of Life|quality of life
307326|NCT02304939|Norepinephrine|norepinephrine
307327|NCT02304939|Intensive Care|intensive care
307328|NCT02304939|Changeovers|changeovers
307329|NCT02304939|Smart pumps|smart pumps
307330|NCT02304939|Quick change|quick change
307331|NCT02304939|Double pumping|double pumping
307332|NCT02304939|Shock|shock
307333|NCT02304926|Dyslipidemia|dyslipidemia
307334|NCT02304926|Simvastatin|simvastatin
307335|NCT02304926|Ezetimibe|ezetimibe
307336|NCT02304926|Lipid profile|lipid profile
307337|NCT02304926|Inflammation|inflammation
307338|NCT02304926|Oxidative stress|oxidative stress
307339|NCT02304926|Endothelial function|endothelial function
307340|NCT02304900|cataract|cataract
307341|NCT02304887|Osteoporosis|osteoporosis
307342|NCT02304887|Bone mineral densisty|bone mineral densisty
307343|NCT02304887|Renal function|renal function
307344|NCT02304887|CKD-MBD|ckd-mbd
307345|NCT02304874|Ferritins|ferritins
307346|NCT02304874|Iron Overload|iron overload
307347|NCT02304874|Metabolic Syndrome|metabolic syndrome
307348|NCT02304874|Venesection therapy|venesection therapy
307349|NCT02304874|Volunteers|volunteers
307350|NCT02304861|cataract|cataract
307351|NCT02304861|viscoelastic (OVD) technology|viscoelastic (ovd) technology
307352|NCT02304861|endothelial cell count|endothelial cell count
307353|NCT02304861|endothelial cell pattern|endothelial cell pattern
307354|NCT02304861|central corneal edema|central corneal edema
307355|NCT02304848|Parkinson's Disease|parkinson's disease
307356|NCT02304848|DBS|dbs
307357|NCT02304848|Deep Brain Stimulation|deep brain stimulation
307358|NCT02304848|Subthalamic Nucleus|subthalamic nucleus
307359|NCT02304822|kidney stones|kidney stones
307360|NCT02304822|retrograde intrarenal surgery|retrograde intrarenal surgery
307361|NCT02304822|ciprofloxacin|ciprofloxacin
307362|NCT02304822|prophylaxis|prophylaxis
307363|NCT02304822|systemic inflammatory response syndrome|systemic inflammatory response syndrome
307364|NCT02304809|metastatic or unresectable locally advanced malignancies.|metastatic or unresectable locally advanced malignancies.
307365|NCT02304809|genomic alterations|genomic alterations
307366|NCT02304809|biological vemurafenib targets BRAF|biological vemurafenib targets braf
307367|NCT02304809|genomic.|genomic.
307368|NCT02304796|Anxiety Disorders|anxiety disorders
307369|NCT02304796|Group Psychotherapy|group psychotherapy
307370|NCT02304796|Cognitive-Behavioral Therapy|cognitive-behavioral therapy
307371|NCT02304796|Dance/Movement Therapy|dance/movement therapy
307372|NCT02304796|CBT|cbt
307373|NCT02304796|DMT|dmt
307374|NCT02304796|Unified Protocol|unified protocol
307375|NCT02304783|Renal colic, Piroxicam|renal colic, piroxicam
307376|NCT02304757|differentiated thyroid cancer|differentiated thyroid cancer
307377|NCT02304757|bone mineral density|bone mineral density
307378|NCT02304757|thyroid stimulating hormone suppression|thyroid stimulating hormone suppression
307379|NCT02304731|Physical Exercise, Atmospheric Pollution, Cognition.|physical exercise, atmospheric pollution, cognition.
307380|NCT02304718|GDM|gdm
307381|NCT02304718|pregnancy outcome|pregnancy outcome
307382|NCT02304718|obesity|obesity
307383|NCT02304718|exercise|exercise
307384|NCT02304718|overweight|overweight
307385|NCT02304640|fatigue|fatigue
307386|NCT02304640|chemotherapy|chemotherapy
307387|NCT02304640|breast cancer|breast cancer
307388|NCT02304640|supportive care|supportive care
307389|NCT02304640|Singapore|singapore
307390|NCT02304523|Colonoscopy preparation|colonoscopy preparation
307391|NCT02304523|Bowel cleansing|bowel cleansing
307392|NCT02304523|Colon cleansing|colon cleansing
307393|NCT02304523|Colonoscopy|colonoscopy
307394|NCT02304523|CDFR0612|cdfr0612
307395|NCT02304523|CDFR0613|cdfr0613
307396|NCT02304510|Prevalence|prevalence
307397|NCT02304510|Menorrhagia|menorrhagia
307398|NCT02304497|Diabetes mellitus|diabetes mellitus
307399|NCT02304497|Platelet rich fibrin|platelet rich fibrin
307400|NCT02304497|growth factor|growth factor
307401|NCT02304445|Radiotherapy|radiotherapy
307402|NCT02304445|Chemoembolization|chemoembolization
307403|NCT02304432|D-cycloserine|d-cycloserine
307404|NCT02304432|Glycine|glycine
307405|NCT02304432|Psychosis|psychosis
307406|NCT02304432|Mutation|mutation
307407|NCT02304432|GABA|gaba
307408|NCT02304406|prevalence of ALK rearrangement, NSCLC, MENA|prevalence of alk rearrangement, nsclc, mena
307409|NCT02304367|TIO|tio
307410|NCT02304367|ENS|ens
307411|NCT02304367|FGF23|fgf23
307412|NCT02304367|KRN23|krn23
307413|NCT02304354|rheumatoid arthritis|rheumatoid arthritis
307414|NCT02304354|T lymphocytes|t lymphocytes
307415|NCT02304354|rituximab|rituximab
307416|NCT02304341|critical illness|critical illness
307417|NCT02304341|disease progression|disease progression
307418|NCT02304341|child|child
307419|NCT02304341|severity of illness index|severity of illness index
307420|NCT02304341|monitoring|monitoring
307421|NCT02304328|SAH|sah
307422|NCT02304328|WFNS|wfns
307423|NCT02304328|hWFNS|hwfns
307424|NCT02304328|grading|grading
307425|NCT02304315|HBV-related liver transplantation|hbv-related liver transplantation
307527|NCT02303587|pneumonia|pneumonia
307426|NCT02304315|Hepatitis B Immuno Globulin|hepatitis b immuno globulin
307427|NCT02304302|Memantine|memantine
307428|NCT02304302|Episodic Memory|episodic memory
307429|NCT02304302|CVLT|cvlt
307430|NCT02304302|Hippocampus dependent memory|hippocampus dependent memory
307431|NCT02304302|Short-term memory|short-term memory
307432|NCT02304263|tenofovir|tenofovir
307433|NCT02304263|aging|aging
307434|NCT02304263|renal function|renal function
307435|NCT02304263|HIV|hiv
307436|NCT02304263|frailty|frailty
307437|NCT02304237|Premature Birth|premature birth
307438|NCT02304237|progesterone|progesterone
307439|NCT02304224|sepsis|sepsis
307440|NCT02304224|melatonin|melatonin
307441|NCT02304224|Human Leukocyte Antigen-DR|human leukocyte antigen-dr
307442|NCT02304224|outcome|outcome
307443|NCT02304211|Microdosing|microdosing
307444|NCT02304211|Phase 0|phase 0
761853|NCT00397215|influenza|influenza
307445|NCT02304211|Exploratory Investigational New Drug (IND)|exploratory investigational new drug (ind)
307446|NCT02304211|Intra-Arterial|intra-arterial
307447|NCT02304211|PET Imaging|pet imaging
307448|NCT02304185|Healthy|healthy
307449|NCT02304185|Acquired Immuno-Deficiency Syndrome|acquired immuno-deficiency syndrome
307450|NCT02304185|Acquired Immunodeficiency Syndrome Virus|acquired immunodeficiency syndrome virus
307451|NCT02304185|Glycoprotein|glycoprotein
307452|NCT02304185|Adjuvant|adjuvant
307453|NCT02304185|Vaccine|vaccine
307454|NCT02304185|Placebo|placebo
307455|NCT02304172|Thyroidectomy|thyroidectomy
307456|NCT02304172|Thunderbeat|thunderbeat
307457|NCT02304159|HCV|hcv
307458|NCT02304159|Genotype 3|genotype 3
307459|NCT02304159|Treatment naive|treatment naive
307460|NCT02304159|Treatment experienced|treatment experienced
307461|NCT02304146|Foam|foam
307462|NCT02304146|UGFS|ugfs
307463|NCT02304146|Stripping|stripping
307464|NCT02304146|Incompetence|incompetence
307465|NCT02304120|proprioception|proprioception
307466|NCT02304120|postural control|postural control
307467|NCT02304120|sensorimotor training|sensorimotor training
307468|NCT02304120|uncontrolled manifold|uncontrolled manifold
307469|NCT02304029|epilepsy|epilepsy
307470|NCT02304029|seizures|seizures
307471|NCT02304003|Shoulder tendinopathy|shoulder tendinopathy
307472|NCT02304003|Subacromial impingement syndrome|subacromial impingement syndrome
307473|NCT02304003|Rotator cuff tendinopathy|rotator cuff tendinopathy
307474|NCT02304003|Supraspinatus tendinopathy|supraspinatus tendinopathy
307475|NCT02303964|Trauma|trauma
307476|NCT02303964|Hemorrhage|hemorrhage
307477|NCT02303964|Plasma|plasma
307478|NCT02303964|Shock|shock
307479|NCT02303964|Polytrauma|polytrauma
307480|NCT02303912|relapsed epithelial ovarian cancer,|relapsed epithelial ovarian cancer,
307481|NCT02303912|relapsed fallopian tube cancer|relapsed fallopian tube cancer
307482|NCT02303912|relapsed primary peritoneal cancer.|relapsed primary peritoneal cancer.
307483|NCT02303860|Healthy volunteer study|healthy volunteer study
307484|NCT02303808|Hyperosmolar agents|hyperosmolar agents
307485|NCT02303808|Hypertonic saline|hypertonic saline
307486|NCT02303808|Airway clearance techniques|airway clearance techniques
307487|NCT02303808|Positive Expiratory Pressure|positive expiratory pressure
307488|NCT02303808|Autogenic drainage|autogenic drainage
307489|NCT02303795|bioprosthetic mitral valve|bioprosthetic mitral valve
307490|NCT02303795|valvular heart disease|valvular heart disease
307491|NCT02303795|anticoagulant agents|anticoagulant agents
307492|NCT02303795|NOACs|noacs
307493|NCT02303795|rivaroxaban|rivaroxaban
307494|NCT02303795|warfarin|warfarin
307495|NCT02303769|Lower Urinary Track Syndrome|lower urinary track syndrome
307496|NCT02303769|Harnal|harnal
307497|NCT02303769|Tamsulosin HCL 0.4mg|tamsulosin hcl 0.4mg
307498|NCT02303743|Bowel preparation; colonoscopy; Smartphone application|bowel preparation; colonoscopy; smartphone application
307499|NCT02303730|Diabetes|diabetes
307500|NCT02303730|Non-alcoholic Fatty Liver Disease|non-alcoholic fatty liver disease
307501|NCT02303717|Left main|left main
307502|NCT02303717|PCI|pci
307503|NCT02303717|DES|des
307504|NCT02303704|Multiperfusion set|multiperfusion set
307505|NCT02303704|Myocardial protection|myocardial protection
307506|NCT02303704|Coronary Artery Bypass Grafting|coronary artery bypass grafting
307507|NCT02303691|anxiety|anxiety
307508|NCT02303691|attention bias modification|attention bias modification
307509|NCT02303691|computer|computer
307510|NCT02303678|D2C7|d2c7
307511|NCT02303678|Randazzo|randazzo
307512|NCT02303678|Bigner|bigner
307513|NCT02303678|Pro00053325|pro00053325
307514|NCT02303678|recurrent malignant glioma|recurrent malignant glioma
307515|NCT02303665|TCM multi-channel therapy|tcm multi-channel therapy
307516|NCT02303665|ART failure|art failure
307517|NCT02303639|implantable cardioverter defibrillator|implantable cardioverter defibrillator
307518|NCT02303639|antiarrhythmic medication|antiarrhythmic medication
307519|NCT02303639|catheter ablation|catheter ablation
307520|NCT02303626|BCX4161|bcx4161
307521|NCT02303626|Prophylaxis|prophylaxis
307522|NCT02303626|Prevention|prevention
307523|NCT02303626|HAE|hae
307524|NCT02303626|Hereditary Angioedema|hereditary angioedema
307525|NCT02303600|Sub-acute cough|sub-acute cough
307526|NCT02303587|Severe mycoplasma pneumoniae|severe mycoplasma pneumoniae
307528|NCT02303587|children|children
307529|NCT02303574|AZD7986, Safety, Tolerability, Pharmacokinetics, Pharmacodynamics, Food Effect, First-in-human, Single Ascending Dose, Multiple Ascending Dose, Healthy Subjects|azd7986, safety, tolerability, pharmacokinetics, pharmacodynamics, food effect, first-in-human, single ascending dose, multiple ascending dose, healthy subjects
307530|NCT02303548|Sodium Bicarbonate|sodium bicarbonate
307531|NCT02303535|Congenital heart disease|congenital heart disease
307532|NCT02303535|European Paediatric Cardiac Code Short List|european paediatric cardiac code short list
307533|NCT02303535|Specific Procedure Definitions|specific procedure definitions
307534|NCT02303535|OPCS|opcs
307535|NCT02303535|paediatric|paediatric
307536|NCT02303535|pediatric|pediatric
307537|NCT02303522|ALL, pediatric, leukemia, childhood, lymphoblastic, lymphoma, acute, Precursor Cell|all, pediatric, leukemia, childhood, lymphoblastic, lymphoma, acute, precursor cell
307538|NCT02303509|Healthy Subjects|healthy subjects
307539|NCT02303509|Mild to moderate Psoriasis|mild to moderate psoriasis
307540|NCT02303509|Subjects|subjects
307541|NCT02303496|platelet rich plasma|platelet rich plasma
307542|NCT02303470|Exercise|exercise
307543|NCT02303457|CO2 laser surgery|co2 laser surgery
307544|NCT02303457|open surgery|open surgery
307545|NCT02303457|multicenter prospective|multicenter prospective
307546|NCT02303457|randomized|randomized
307547|NCT02303457|controlled clinical studies|controlled clinical studies
307548|NCT02303457|T1N0 squamous cell carcinoma of glottis with anterior commissure involved|t1n0 squamous cell carcinoma of glottis with anterior commissure involved
307549|NCT02303444|Progressive radioactive iodine refractory differentiated thyroid carcinoma|progressive radioactive iodine refractory differentiated thyroid carcinoma
307550|NCT02303431|Pediatric|pediatric
307551|NCT02303431|Pharmacokinetics (PK)|pharmacokinetics (pk)
307552|NCT02303431|Pharmacodynamics (PDy)|pharmacodynamics (pdy)
307553|NCT02303431|Anticoagulant|anticoagulant
307554|NCT02303431|Safety|safety
307555|NCT02303418|Obstetrics|obstetrics
307556|NCT02303405|Glucose Control|glucose control
307557|NCT02303405|Inflammation|inflammation
307558|NCT02303379|Training Protocol|training protocol
307559|NCT02303379|Cardiac Rehabilitation|cardiac rehabilitation
307560|NCT02303379|High-Intensity Interval Training|high-intensity interval training
307561|NCT02303379|Continuous Training|continuous training
307562|NCT02303379|Pyramid Training|pyramid training
307563|NCT02303379|Physical Performance|physical performance
307564|NCT02303353|Breast cancer|breast cancer
307565|NCT02303353|Ovarian cancer|ovarian cancer
307566|NCT02303353|Lung cancer|lung cancer
307567|NCT02303353|Colon cancer|colon cancer
307568|NCT02303353|Gastric cancer|gastric cancer
307569|NCT02303353|Pancreatic cancer|pancreatic cancer
307570|NCT02303353|Rectum cancer|rectum cancer
307571|NCT02303353|Plasmacytoma|plasmacytoma
307572|NCT02303340|Cone Beam Computed Tomography|cone beam computed tomography
307573|NCT02303340|Para Thyroid Hormone|para thyroid hormone
307574|NCT02303340|Dual Energy X-ray Absorptiometry|dual energy x-ray absorptiometry
307575|NCT02303340|Digital Imaging and Communication in Medicine|digital imaging and communication in medicine
307576|NCT02303275|Heart Failure|heart failure
307577|NCT02303275|Congestive Heart Failure|congestive heart failure
307578|NCT02303275|Lifestyle Change|lifestyle change
307579|NCT02303236|Exercise|exercise
307580|NCT02303197|head and neck cancer|head and neck cancer
307581|NCT02303197|chemoradiotherapy|chemoradiotherapy
307582|NCT02303197|radioactive stomatitis|radioactive stomatitis
307583|NCT02303184|RVO|rvo
307584|NCT02303184|ME|me
307585|NCT02303184|Central Subfield Thickness|central subfield thickness
307586|NCT02303184|OCT|oct
307587|NCT02303184|optical coherence tomography|optical coherence tomography
307588|NCT02303184|cystoid macular edema|cystoid macular edema
307589|NCT02303184|subretinal fluid|subretinal fluid
307590|NCT02303184|Eylea|eylea
307591|NCT02303184|aflibercept|aflibercept
307592|NCT02303184|anti-VEGF|anti-vegf
307593|NCT02303171|Antiphospholipid syndrome|antiphospholipid syndrome
307594|NCT02303171|APS|aps
307595|NCT02303171|Warfarin|warfarin
307596|NCT02303158|Alzheimer's Disease|alzheimer's disease
307597|NCT02303158|Biomarkers|biomarkers
307598|NCT02303158|Depression|depression
307599|NCT02303158|dementia|dementia
307600|NCT02303158|cerebrospinal fluid|cerebrospinal fluid
307601|NCT02303158|neuropsychological|neuropsychological
307602|NCT02303145|Breast Cancer, Survivors|breast cancer, survivors
307603|NCT02303119|LNH|lnh
307604|NCT02303119|CD20+|cd20+
307605|NCT02303119|follicular|follicular
307606|NCT02303106|AUC exposure to lamotrigine|auc exposure to lamotrigine
307607|NCT02303080|whey protein microgels|whey protein microgels
307608|NCT02303080|thermogenesis|thermogenesis
307609|NCT02303067|Cardiac|cardiac
307610|NCT02303067|Computed Tomography|computed tomography
307611|NCT02303067|Coronary Artery Disease|coronary artery disease
307612|NCT02303054|Prostate Cancer|prostate cancer
307613|NCT02303054|Focal Ablation|focal ablation
307614|NCT02303054|MRI-US Fusion Biopsy|mri-us fusion biopsy
307615|NCT02303054|Focal Therapy|focal therapy
307616|NCT02303028|Pediatric|pediatric
307617|NCT02303028|CNS Tumor|cns tumor
307618|NCT02303028|Solid Tumour|solid tumour
307619|NCT02303015|Germ cell cancer|germ cell cancer
307620|NCT02303015|Late toxicity|late toxicity
307621|NCT02303015|Renal impairment|renal impairment
307622|NCT02303015|Cardiovascular disease|cardiovascular disease
307623|NCT02302963|Diabetes Mellitus, Type 1 (T1DM)|diabetes mellitus, type 1 (t1dm)
307624|NCT02302963|Diabetes Assistant (DiAs)|diabetes assistant (dias)
307625|NCT02302963|Artificial Pancreas (AP) System|artificial pancreas (ap) system
307626|NCT02302963|Closed-Loop Control (CLC)|closed-loop control (clc)
307627|NCT02302963|Unified Safety System (USS) Virginia|unified safety system (uss) virginia
307628|NCT02302963|Sensor Augmented Pump (SAP)|sensor augmented pump (sap)
307629|NCT02302963|Low Blood Glucose Index (LBGI)|low blood glucose index (lbgi)
307630|NCT02302963|Continuous Glucose Monitor (CGM)|continuous glucose monitor (cgm)
307631|NCT02302963|inControl Diabetes Management Platform|incontrol diabetes management platform
307632|NCT02302950|HIV infection|hiv infection
307633|NCT02302950|raltegravir use|raltegravir use
307634|NCT02302950|women|women
307635|NCT02302937|Inguinal Hernia|inguinal hernia
307636|NCT02302937|Primary|primary
307637|NCT02302937|laparoscopic surgery|laparoscopic surgery
307638|NCT02302937|single port surgery|single port surgery
307639|NCT02302911|Early intervention|early intervention
307640|NCT02302898|Roux-en-Y Gastric Bypass Surgery|roux-en-y gastric bypass surgery
307641|NCT02302898|Weight Regain|weight regain
307642|NCT02302885|cancer-free 18-60 year old men and women|cancer-free 18-60 year old men and women
307643|NCT02302859|Cancer Prevention|cancer prevention
307644|NCT02302859|Tobacco Use Cessation|tobacco use cessation
307645|NCT02302859|HIV-positive|hiv-positive
307646|NCT02302859|Nicotine patch|nicotine patch
307647|NCT02302859|NRT|nrt
307648|NCT02302859|Questionnaire|questionnaire
307649|NCT02302859|Survey|survey
307650|NCT02302859|Smartphone|smartphone
307651|NCT02302859|Counseling|counseling
307652|NCT02302859|Saliva test|saliva test
307653|NCT02302859|Saliva cotinine test|saliva cotinine test
307654|NCT02302859|Nicotine replacement therapy|nicotine replacement therapy
307655|NCT02302859|Smoking abstinence|smoking abstinence
307656|NCT02302859|Aids|aids
307657|NCT02302846|Leukemia|leukemia
307658|NCT02302846|Acute myeloid leukemia|acute myeloid leukemia
307659|NCT02302846|AML|aml
307660|NCT02302846|High-risk myelodysplastic syndrome|high-risk myelodysplastic syndrome
307661|NCT02302846|MDS|mds
307662|NCT02302846|Ixazomib|ixazomib
307663|NCT02302846|MLN9708|mln9708
307664|NCT02302820|Advance Care Planning|advance care planning
307665|NCT02302820|Nurse Care Coordination|nurse care coordination
307666|NCT02302820|Comparative Effectiveness|comparative effectiveness
307667|NCT02302820|Advance Directive|advance directive
307668|NCT02302820|Decision Aides|decision aides
307669|NCT02302781|Reasons for Dropout|reasons for dropout
307670|NCT02302781|Subfertility|subfertility
307671|NCT02302781|IVF|ivf
307672|NCT02302781|NON IVF|non ivf
307673|NCT02302742|Triple Negative Breast Cancer|triple negative breast cancer
307674|NCT02302742|TNBC|tnbc
307675|NCT02302742|Hereditary Breast and Ovarian Cancer|hereditary breast and ovarian cancer
307676|NCT02302742|HBOC|hboc
307677|NCT02302742|Prospective Registry|prospective registry
307678|NCT02302729|Micronutrient intervention|micronutrient intervention
307679|NCT02302729|Responsive feeding intervention|responsive feeding intervention
307680|NCT02302729|School readiness intervention|school readiness intervention
307681|NCT02302677|bile acids|bile acids
307682|NCT02302677|sleeve gastrectomy|sleeve gastrectomy
307683|NCT02302677|obesity|obesity
307684|NCT02302677|GLP-1|glp-1
307685|NCT02302677|FGF-19|fgf-19
307686|NCT02302664|Achilles|achilles
307687|NCT02302664|Platelet Rich Plasma|platelet rich plasma
307688|NCT02302664|Patient reported outcome measure|patient reported outcome measure
307689|NCT02302664|Orthopaedic trauma|orthopaedic trauma
307690|NCT02302664|Musculoskeletal|musculoskeletal
307691|NCT02302664|Tendon|tendon
307692|NCT02302664|Sports Injury|sports injury
307693|NCT02302664|Heel-Rise Endurance Test|heel-rise endurance test
307694|NCT02302651|high intensity focused ultrasound|high intensity focused ultrasound
307695|NCT02302651|osteoid osteoma|osteoid osteoma
307696|NCT02302651|bone tumor|bone tumor
307697|NCT02302638|single-step media|single-step media
307698|NCT02302638|embryo development|embryo development
307699|NCT02302638|blastocyst formation|blastocyst formation
307700|NCT02302638|embryo utilization|embryo utilization
307701|NCT02302625|Cognitive behavior therapy|cognitive behavior therapy
307702|NCT02302612|chronic conditions|chronic conditions
307703|NCT02302612|complex patients|complex patients
307704|NCT02302612|engagement|engagement
307705|NCT02302612|activation|activation
307706|NCT02302586|Thoracic paravertebral block|thoracic paravertebral block
307707|NCT02302586|Patient controlled analgesia|patient controlled analgesia
307708|NCT02302586|Video Assisted Thoracoscopic Surgery|video assisted thoracoscopic surgery
307709|NCT02302586|Postoperative acute pain|postoperative acute pain
307710|NCT02302586|Chronic pain|chronic pain
307711|NCT02302573|placenta accreta|placenta accreta
307712|NCT02302573|contrast-enhanced unltrasound|contrast-enhanced unltrasound
307713|NCT02302573|pregnancy|pregnancy
307714|NCT02302573|MRI|mri
307715|NCT02302573|sonovue|sonovue
307716|NCT02302547|HIV-DNA|hiv-dna
307717|NCT02302547|dual therapy|dual therapy
307718|NCT02302547|NRTI|nrti
307719|NCT02302547|virological control|virological control
307720|NCT02302547|truvada®|truvada®
307721|NCT02302534|scoliosis|scoliosis
307722|NCT02302534|MRI (Magnetic Resonance Imaging)|mri (magnetic resonance imaging)
307724|NCT02302508|pharmacokinetics|pharmacokinetics
307725|NCT02302508|drug metabolism|drug metabolism
307726|NCT02302508|platelet reactivity|platelet reactivity
307727|NCT02302508|carboxylesterase|carboxylesterase
307728|NCT02302508|cytochromes p450|cytochromes p450
307729|NCT02302508|type 2 diabetes|type 2 diabetes
307730|NCT02302508|active metabolite|active metabolite
307731|NCT02302495|Carfilzomib weekly|carfilzomib weekly
307732|NCT02302495|and Melphalan and Prednisone|and melphalan and prednisone
307733|NCT02302482|Alzheimer's disease or related disorders|alzheimer's disease or related disorders
307734|NCT02302482|Functional autonomy level|functional autonomy level
307735|NCT02302482|Cognitive function|cognitive function
307736|NCT02302482|Predictive factors|predictive factors
307737|NCT02302469|Lenalidomide|lenalidomide
307738|NCT02302469|Hematology|hematology
307739|NCT02302469|Waldenstrom Macroglobulinemia|waldenstrom macroglobulinemia
307740|NCT02302456|Immediate postpartum hemorrhage|immediate postpartum hemorrhage
307741|NCT02302456|tranexamic acid|tranexamic acid
307742|NCT02302456|prevention|prevention
307743|NCT02302430|Cohesion|cohesion
307744|NCT02302430|Oxytocin|oxytocin
307745|NCT02302430|Trust|trust
307746|NCT02302430|Virtual-reality|virtual-reality
307747|NCT02302417|Asthma|asthma
307748|NCT02302417|Asthma-COPD Overlap Syndrome|asthma-copd overlap syndrome
307749|NCT02302417|Clinical Questionnaire|clinical questionnaire
307750|NCT02302417|COPD|copd
307751|NCT02302417|ACOS|acos
307752|NCT02302404|FTIH|ftih
307753|NCT02302404|pharmacodynamics|pharmacodynamics
307754|NCT02302404|pharmacokinetics|pharmacokinetics
307755|NCT02302404|GSK2982772|gsk2982772
307756|NCT02302404|safety|safety
307757|NCT02302404|Repeat dose|repeat dose
307758|NCT02302404|tolerability|tolerability
307759|NCT02302378|Hypotension|hypotension
307760|NCT02302378|Anesthesia, Spinal [E03.155.086.331]|anesthesia, spinal [e03.155.086.331]
307761|NCT02302365|white blood cell depletion|white blood cell depletion
307762|NCT02302365|apheresis|apheresis
307763|NCT02302352|Probiotics|probiotics
307764|NCT02302352|Immune system|immune system
307765|NCT02302339|Advanced melanoma|advanced melanoma
307766|NCT02302339|Unresectable melanoma|unresectable melanoma
307767|NCT02302339|Metastatic melanoma|metastatic melanoma
307768|NCT02302339|Targeted Treatment for melanoma|targeted treatment for melanoma
307769|NCT02302339|GPNMB|gpnmb
307770|NCT02302339|CDX-011|cdx-011
307771|NCT02302339|Glembatumumab vedotin|glembatumumab vedotin
307772|NCT02302339|Antibody-drug-conjugate|antibody-drug-conjugate
307773|NCT02302339|Skin neoplasm|skin neoplasm
307774|NCT02302339|Varlilumab|varlilumab
307775|NCT02302339|CDX-1127|cdx-1127
307776|NCT02302326|reticulum endoplasmic stress|reticulum endoplasmic stress
307777|NCT02302326|Polycystic Ovary Syndrome|polycystic ovary syndrome
307778|NCT02302326|mitochondrial function|mitochondrial function
307779|NCT02302326|insulin resistance|insulin resistance
307780|NCT02302326|inflammation|inflammation
307781|NCT02302326|myoinositol|myoinositol
307782|NCT02302326|metformin|metformin
307783|NCT02302326|oxidative stress|oxidative stress
307784|NCT02302313|healthy volunteers|healthy volunteers
307785|NCT02302313|critical awareness|critical awareness
307786|NCT02302313|hypnosis|hypnosis
307787|NCT02302313|Analgesia Nociception Index|analgesia nociception index
307788|NCT02302313|numerical verbal scale|numerical verbal scale
307789|NCT02302313|Determine the validity of the index (ANI)|determine the validity of the index (ani)
307790|NCT02302313|nociception in critical awareness|nociception in critical awareness
307791|NCT02302300|Cardiac surgery|cardiac surgery
307792|NCT02302300|Preventive non-invasive ventilation|preventive non-invasive ventilation
307793|NCT02302287|Chronic kidney disease|chronic kidney disease
307794|NCT02302287|mediterranean diet|mediterranean diet
307795|NCT02302287|low-protein diet|low-protein diet
307796|NCT02302287|ketoacids|ketoacids
307797|NCT02302287|intestinal microbiota|intestinal microbiota
307798|NCT02302274|Brugada Syndrome|brugada syndrome
307799|NCT02302274|ARVC|arvc
307800|NCT02302274|flecainide|flecainide
307801|NCT02302274|ST elevation|st elevation
307802|NCT02302261|Pulsus paradoxus|pulsus paradoxus
307803|NCT02302235|Glioblastoma multigorme|glioblastoma multigorme
307804|NCT02302235|Ketogenic Diet|ketogenic diet
307805|NCT02302235|radiotherapy|radiotherapy
307806|NCT02302235|chemotherapy|chemotherapy
307807|NCT02302235|safety|safety
307808|NCT02302235|efficiency|efficiency
307809|NCT02302209|oxytocin|oxytocin
307810|NCT02302209|schizophrenia|schizophrenia
307811|NCT02302209|autism spectrum disorder|autism spectrum disorder
307812|NCT02302183|Hypoxemic, Respiratory distress, infant|hypoxemic, respiratory distress, infant
307813|NCT02302157|Cervical spinal cord injury|cervical spinal cord injury
307814|NCT02302157|AST-OPC1|ast-opc1
307815|NCT02302157|SCiStar|scistar
307816|NCT02302157|OPC1|opc1
307817|NCT02302157|Neural cell|neural cell
307818|NCT02302157|Trauma spinal cord|trauma spinal cord
307819|NCT02302157|stemcell transplant|stemcell transplant
307820|NCT02302157|Cervical spine injury|cervical spine injury
307821|NCT02302157|Paralysis|paralysis
307822|NCT02302157|Quadriplegia|quadriplegia
307823|NCT02302157|Tetraplegia|tetraplegia
307824|NCT02302157|Spine injury|spine injury
307825|NCT02302157|oligodendrocyte progenitor cell|oligodendrocyte progenitor cell
307826|NCT02302157|Subacute spinal cord injury|subacute spinal cord injury
761854|NCT00397215|vaccine|vaccine
307827|NCT02302144|Postural Instability (falling)|postural instability (falling)
307828|NCT02302144|Gait Disturbances (e.g., freezing)|gait disturbances (e.g., freezing)
307829|NCT02302144|Bradykinesia (slowness of movement), rigidity|bradykinesia (slowness of movement), rigidity
307830|NCT02302118|esophageal carcinoma|esophageal carcinoma
307831|NCT02302118|kardia carcinoma|kardia carcinoma
307832|NCT02302092|Drug Therapy|drug therapy
307833|NCT02302079|ASP8232|asp8232
307834|NCT02302079|Diabetes Mellitus|diabetes mellitus
307835|NCT02302079|ranibizumab|ranibizumab
307836|NCT02302079|Diabetic Macular Edema|diabetic macular edema
307837|NCT02302066|Drug therapy|drug therapy
307838|NCT02302053|Hair thinning, hair loss, alopecia, women, oral supplement|hair thinning, hair loss, alopecia, women, oral supplement
307839|NCT02302040|Adolescent|adolescent
307840|NCT02302027|withdrawal therapy|withdrawal therapy
307841|NCT02302027|oxygen therapy|oxygen therapy
307842|NCT02302001|Breast augmentation|breast augmentation
307843|NCT02302001|Breast implants|breast implants
307844|NCT02302001|Silicone implants|silicone implants
307845|NCT02302001|Breast surgery|breast surgery
307846|NCT02301975|Adult|adult
307847|NCT02301975|asthma|asthma
307848|NCT02301975|Fluticasone Propionate|fluticasone propionate
307849|NCT02301975|Adolescents|adolescents
307850|NCT02301975|Salmeterol|salmeterol
307851|NCT02301975|Vilanterol|vilanterol
307852|NCT02301975|ELLIPTA|ellipta
307853|NCT02301975|ACCUHALER/DISKUS|accuhaler/diskus
307854|NCT02301975|Non-inferior|non-inferior
307855|NCT02301975|Fluticasone Furoate|fluticasone furoate
307856|NCT02301962|panitumumab|panitumumab
307857|NCT02301962|previously treated|previously treated
307858|NCT02301962|metastatic colorectal cancer|metastatic colorectal cancer
307859|NCT02301962|fully human antibody|fully human antibody
307860|NCT02301962|wild-type KRAS and wild-type NRAS|wild-type kras and wild-type nras
307861|NCT02301949|gastrointestinal bleeding|gastrointestinal bleeding
307862|NCT02301949|vascular malformation|vascular malformation
307863|NCT02301949|thalidomide retreatment|thalidomide retreatment
307864|NCT02301936|Sickle Cell Disease|sickle cell disease
307865|NCT02301936|Gilead|gilead
307866|NCT02301936|Hepatitis C|hepatitis c
307867|NCT02301923|Continuous Positive Airway Pressure|continuous positive airway pressure
307868|NCT02301910|Myocardial Infarction|myocardial infarction
307869|NCT02301910|Fibrinolysis|fibrinolysis
307870|NCT02301910|Fortelyzin|fortelyzin
307872|NCT02301871|MET|met
307873|NCT02301871|Soft tissue mobilization|soft tissue mobilization
307874|NCT02301871|DNF|dnf
307875|NCT02301871|Static Stretching|static stretching
307876|NCT02301858|molecular pathology|molecular pathology
307877|NCT02301858|functional genomics|functional genomics
307878|NCT02301858|lung cancer|lung cancer
307879|NCT02301858|primary tumor|primary tumor
307880|NCT02301858|metastases|metastases
307881|NCT02301845|Respiration, artificial|respiration, artificial
307882|NCT02301832|acute compartment swelling (ACS)|acute compartment swelling (acs)
307883|NCT02301832|near-infrared spectroscopy (NIRS)|near-infrared spectroscopy (nirs)
307884|NCT02301767|MRI|mri
307885|NCT02301767|Risk Factor|risk factor
307886|NCT02301767|background Parenchymal Enhancement|background parenchymal enhancement
307887|NCT02301767|(IMAGINE) Study|(imagine) study
307888|NCT02301741|chronic low back pain|chronic low back pain
307889|NCT02301728|breast milk|breast milk
307890|NCT02301728|short chain fatty acids|short chain fatty acids
307891|NCT02301728|maternal diet|maternal diet
307892|NCT02301715|Intranasal oxytocin|intranasal oxytocin
307893|NCT02301715|Emotion regulation|emotion regulation
307894|NCT02301715|Attachment|attachment
307895|NCT02301702|Maternal Immunization|maternal immunization
307896|NCT02301702|Tdap|tdap
307897|NCT02301702|Td|td
307898|NCT02301702|Pertussis|pertussis
307899|NCT02301689|Heart failure|heart failure
307900|NCT02301689|Chronic heart failure|chronic heart failure
307901|NCT02301689|Sleep disordered breathing|sleep disordered breathing
307902|NCT02301689|Sleep apnea|sleep apnea
307903|NCT02301689|Positive Airway Pressure|positive airway pressure
307904|NCT02301676|Geriatrics; Cognitive impairment; Interviews, Telephone|geriatrics; cognitive impairment; interviews, telephone
307905|NCT02301650|Hepatitis B virus|hepatitis b virus
307906|NCT02301650|pregnancy|pregnancy
307907|NCT02301650|nucleoside (acid) analogs|nucleoside (acid) analogs
307908|NCT02301650|children|children
307909|NCT02301650|safety|safety
307910|NCT02301624|gMG|gmg
307911|NCT02301624|Myasthenia Gravis|myasthenia gravis
307912|NCT02301624|safety|safety
307913|NCT02301624|efficacy|efficacy
307914|NCT02301598|femtosecond laser|femtosecond laser
307915|NCT02301598|anterior lamellar keratoplasty|anterior lamellar keratoplasty
307916|NCT02301598|atomic-force microscopy|atomic-force microscopy
307917|NCT02301585|shock, septic|shock, septic
307918|NCT02301585|hemodynamics|hemodynamics
307919|NCT02301585|algorithms|algorithms
307920|NCT02301533|HIV infection|hiv infection
307921|NCT02301533|antiretroviral therapy|antiretroviral therapy
307922|NCT02301533|adherence|adherence
307923|NCT02301533|men who have sex with men|men who have sex with men
307924|NCT02301520|Vitamin D|vitamin d
393293|NCT01899092|AAV|aav
307925|NCT02301520|Iodine|iodine
307926|NCT02301520|Lead|lead
307927|NCT02301520|Thyroid function|thyroid function
307928|NCT02301520|point-of-care test|point-of-care test
307929|NCT02301494|CTCL|ctcl
307930|NCT02301494|Mycosis Fungoides|mycosis fungoides
307931|NCT02301494|Cutaneous T-cell Lymphoma|cutaneous t-cell lymphoma
307932|NCT02301494|MF|mf
307933|NCT02301494|topical therapy|topical therapy
307934|NCT02301494|early stage|early stage
307935|NCT02301455|hypertension treatment|hypertension treatment
307936|NCT02301455|stroke prevention|stroke prevention
307937|NCT02301403|smoking|smoking
307938|NCT02301403|cessation|cessation
307939|NCT02301403|tobacco|tobacco
307940|NCT02301390|INTERVENE|intervene
307941|NCT02301390|Ventricular tachycardia|ventricular tachycardia
307942|NCT02301390|India|india
307943|NCT02301364|Buparlisib (BKM120)|buparlisib (bkm120)
307944|NCT02301364|14-177|14-177
307945|NCT02301338|Videoconferencing|videoconferencing
307946|NCT02301338|Following Surgery|following surgery
307947|NCT02301338|14-213|14-213
307948|NCT02301299|stroke|stroke
307949|NCT02301299|barriers|barriers
307950|NCT02301299|community|community
307951|NCT02301286|Acetylsalicylic acid|acetylsalicylic acid
307952|NCT02301286|Colon cancer|colon cancer
307953|NCT02301286|Survival|survival
307954|NCT02301273|Intensive care unit|intensive care unit
307955|NCT02301273|Physiotherapy|physiotherapy
307956|NCT02301273|Upright position|upright position
307957|NCT02301273|Exercise|exercise
307958|NCT02301273|Long term follow up of ICU survivors|long term follow up of icu survivors
307959|NCT02301260|Processing Speed|processing speed
307960|NCT02301260|Intervention|intervention
307961|NCT02301260|Multiple Sclerosis|multiple sclerosis
307962|NCT02301260|Cognition|cognition
307963|NCT02301247|Multiple Sclerosis, Progressive|multiple sclerosis, progressive
307964|NCT02301247|cognition|cognition
307965|NCT02301247|memory|memory
307966|NCT02301247|treatment|treatment
307967|NCT02301234|Osteoarthritis|osteoarthritis
307968|NCT02301234|Pain|pain
307969|NCT02301234|Fulranumab|fulranumab
307970|NCT02301234|JNJ-42160443|jnj-42160443
307971|NCT02301234|Adjunctive therapy|adjunctive therapy
307972|NCT02301234|Celecoxib|celecoxib
307973|NCT02301234|Hip|hip
307974|NCT02301234|Knee|knee
307975|NCT02301234|Joint replacement surgery|joint replacement surgery
307976|NCT02301221|Fecal Microbiota Transplantation|fecal microbiota transplantation
307977|NCT02301221|Slow Transit Constipation|slow transit constipation
307978|NCT02301221|Colonic motility|colonic motility
307979|NCT02301195|Therapeutic Horseback Riding|therapeutic horseback riding
307980|NCT02301169|Pain|pain
307981|NCT02301143|Pancreatic Neoplasms|pancreatic neoplasms
307982|NCT02301143|Pancreatic Cancer|pancreatic cancer
307983|NCT02301143|Locally advanced pacriatic cancer|locally advanced pacriatic cancer
307984|NCT02301143|nab-Paclitaxel|nab-paclitaxel
307985|NCT02301143|Abraxane|abraxane
307986|NCT02301143|Gemcitabine|gemcitabine
307987|NCT02301143|ABI-007|abi-007
307988|NCT02301130|advanced solid tumors|advanced solid tumors
307989|NCT02301130|solid tumors|solid tumors
307990|NCT02301130|mogamulizumab|mogamulizumab
307991|NCT02301130|MEDI4736 (Durvalumab)|medi4736 (durvalumab)
307992|NCT02301130|Tremelimumab|tremelimumab
307993|NCT02301130|POTELIGEO®|poteligeo®
307994|NCT02301130|KW-0761|kw-0761
307995|NCT02301117|Renal|renal
307996|NCT02301117|Kidney Diseases|kidney diseases
307997|NCT02301117|Urologic Diseases|urologic diseases
307998|NCT02301117|Renal Insufficiency|renal insufficiency
307999|NCT02301117|Renal Impairment|renal impairment
308000|NCT02301117|Pharmacokinetics|pharmacokinetics
308001|NCT02301117|Advance Solid Tumor|advance solid tumor
308002|NCT02301117|Creatinine Clearance|creatinine clearance
308003|NCT02301117|Kidney Neoplasms|kidney neoplasms
308004|NCT02301117|Renal Tumor|renal tumor
308005|NCT02301117|Kidney|kidney
308006|NCT02301117|Urology|urology
308007|NCT02301117|Pharmacologic Action|pharmacologic action
308008|NCT02301104|Liver Neoplasms|liver neoplasms
308009|NCT02301104|Hepatic|hepatic
308010|NCT02301104|TAS-102|tas-102
308011|NCT02301104|mCRC|mcrc
308012|NCT02301104|Liver Impairment|liver impairment
308013|NCT02301104|Pharmacologic Actions|pharmacologic actions
308014|NCT02301104|Liver Diseases|liver diseases
308015|NCT02301104|Liver|liver
308016|NCT02301104|LFT|lft
308017|NCT02301104|Advanced Solid Tumor|advanced solid tumor
308018|NCT02301104|Pharmacokinetics|pharmacokinetics
309584|NCT02292368|XQ|xq
308019|NCT02301091|HCC PVTT TACE RFA|hcc pvtt tace rfa
308020|NCT02301078|Dupuytren disease|dupuytren disease
308021|NCT02301078|needle aponeurotomy|needle aponeurotomy
308022|NCT02301078|collagenase|collagenase
308023|NCT02301065|Viral|viral
308024|NCT02301065|Infection|infection
308025|NCT02301065|Allogeneic Stem Cell Transplant|allogeneic stem cell transplant
308026|NCT02301052|hemorrhoids|hemorrhoids
308027|NCT02301052|Allium Ampeloprasum|allium ampeloprasum
308028|NCT02301052|herbal medicine|herbal medicine
308029|NCT02301052|traditional persian medicine|traditional persian medicine
308030|NCT02301000|Clostridium difficile|clostridium difficile
308031|NCT02301000|Intestinal microbiota therapy|intestinal microbiota therapy
308032|NCT02300987|Teratoma,|teratoma,
308033|NCT02300987|Germ Cell tumor,|germ cell tumor,
308034|NCT02300987|incurable teratoma,|incurable teratoma,
308035|NCT02300987|CDK4/6,|cdk4/6,
308036|NCT02300987|LEE011|lee011
308037|NCT02300948|Pregnancy|pregnancy
308038|NCT02300948|Perinatal Vitamins|perinatal vitamins
308039|NCT02300948|folate|folate
308040|NCT02300935|trametinib|trametinib
308041|NCT02300935|nab-paclitaxel|nab-paclitaxel
308042|NCT02300935|Mekinist|mekinist
308043|NCT02300935|Abraxane|abraxane
308044|NCT02300935|unresectable|unresectable
308045|NCT02300935|metastatic|metastatic
308046|NCT02300896|exercise|exercise
308047|NCT02300896|physical fitness|physical fitness
308048|NCT02300896|geriatrics|geriatrics
308049|NCT02300870|Acute rejection, myocardial blood flow|acute rejection, myocardial blood flow
308050|NCT02300831|NSCLC|nsclc
308051|NCT02300831|Lung Cancer|lung cancer
308052|NCT02300831|SELECT-1|select-1
308053|NCT02300831|SELECT-2|select-2
308054|NCT02300831|selumetinib|selumetinib
308055|NCT02300831|biomarker|biomarker
308056|NCT02300831|NIS|nis
308057|NCT02300831|Observational study|observational study
308058|NCT02300831|Disease registry|disease registry
308059|NCT02300831|Clinical Outcomes|clinical outcomes
308060|NCT02300818|Hipertension ocular, Glaucoma, Magnetotherapy, seawater|hipertension ocular, glaucoma, magnetotherapy, seawater
308061|NCT02300805|Endometrial volume , VOCAL , Endometrial , Metrorrhagia|endometrial volume , vocal , endometrial , metrorrhagia
308062|NCT02300792|honey, hepatitis A|honey, hepatitis a
308063|NCT02300779|Colonoscopy|colonoscopy
308064|NCT02300779|Diabetes Mellitus|diabetes mellitus
308065|NCT02300779|Diet|diet
308066|NCT02300779|Polyethylene glycols|polyethylene glycols
308067|NCT02300779|Efficacy|efficacy
308068|NCT02300779|Personal satisfaction|personal satisfaction
308069|NCT02300766|Cerebellar Mutism Syndrome|cerebellar mutism syndrome
308070|NCT02300766|Posterior Fossa Tumor|posterior fossa tumor
308071|NCT02300766|Pediatric cancer|pediatric cancer
308072|NCT02300766|Neurosurgical techniques|neurosurgical techniques
308073|NCT02300727|Mucositis|mucositis
308074|NCT02300727|Neoplasms|neoplasms
308075|NCT02300727|CANCER|cancer
308076|NCT02300727|Curcumin|curcumin
308077|NCT02300727|Drug Therapy|drug therapy
308078|NCT02300727|ANTINEOPLASTIC AGENTS|antineoplastic agents
308079|NCT02300675|therapeutic patient education|therapeutic patient education
308080|NCT02300675|patient adherence|patient adherence
308081|NCT02300675|empowerment|empowerment
308082|NCT02300675|breast cancer|breast cancer
308083|NCT02300675|oral adjuvant endocrine therapy|oral adjuvant endocrine therapy
308084|NCT02300675|side effects|side effects
308085|NCT02300636|Knee joint|knee joint
308086|NCT02300636|Muscle strength|muscle strength
308087|NCT02300636|anterior cruciate ligament|anterior cruciate ligament
308088|NCT02300610|Ureteral Diseases|ureteral diseases
308089|NCT02300610|Urinary Bladder Diseases|urinary bladder diseases
308090|NCT02300610|Transitional Cell Carcinoma|transitional cell carcinoma
308091|NCT02300610|Bladder|bladder
308092|NCT02300610|Carcinoma|carcinoma
308093|NCT02300610|Renal|renal
308094|NCT02300610|Pelvis|pelvis
308095|NCT02300610|Ureter|ureter
308096|NCT02300610|Urethra|urethra
308097|NCT02300597|ADHD|adhd
308098|NCT02300597|Autism Spectrum Disorders|autism spectrum disorders
308099|NCT02300597|controlled|controlled
308100|NCT02300597|Internet based|internet based
308101|NCT02300597|coaching|coaching
308102|NCT02300558|Type 3 long QT syndrome (LQT3)|type 3 long qt syndrome (lqt3)
308103|NCT02300558|Long QT syndrome|long qt syndrome
308104|NCT02300558|Congenital long QT|congenital long qt
308105|NCT02300558|Sudden cardiac death|sudden cardiac death
308106|NCT02300532|Malignant Glioma|malignant glioma
308107|NCT02300532|Glioblastoma Multiforme|glioblastoma multiforme
308108|NCT02300519|Haemophilia|haemophilia
308109|NCT02300519|numerical models|numerical models
308110|NCT02300519|thrombin generation|thrombin generation
308111|NCT02300519|volunteers|volunteers
308112|NCT02300519|endogenous thrombin potential|endogenous thrombin potential
308113|NCT02300506|Malignant Glioma|malignant glioma
308114|NCT02300506|Glioblastoma multiforme|glioblastoma multiforme
308115|NCT02300493|among college students|among college students
308116|NCT02300480|pain|pain
308117|NCT02300480|calot's triangle|calot's triangle
308118|NCT02300480|local block|local block
308119|NCT02300480|analgesia|analgesia
308241|NCT02299570|FMT|fmt
308120|NCT02300480|patient controlled intravenous analgesia|patient controlled intravenous analgesia
308121|NCT02300454|in-stent restenosis|in-stent restenosis
308122|NCT02300454|percutaneous coronary intervention|percutaneous coronary intervention
308123|NCT02300454|balloon|balloon
308124|NCT02300428|iron deficiency|iron deficiency
400511|NCT01866540|influenza, LAIV, immune response|influenza, laiv, immune response
308125|NCT02300389|high risk prostate cancer radiotherapy hypofractionation|high risk prostate cancer radiotherapy hypofractionation
308126|NCT02300376|GFR|gfr
308127|NCT02300376|Bayesian model|bayesian model
308128|NCT02300376|plasma clearance|plasma clearance
308129|NCT02300376|Calcium edetate de sodium|calcium edetate de sodium
308130|NCT02300376|Inulin|inulin
308131|NCT02300337|laryngeal tube|laryngeal tube
308132|NCT02300337|cuff pressure|cuff pressure
308133|NCT02300337|leakage|leakage
308134|NCT02300337|laryngeal mask|laryngeal mask
308135|NCT02300324|bioavailability|bioavailability
308136|NCT02300324|Beneforte|beneforte
308137|NCT02300324|sulforaphane|sulforaphane
308138|NCT02300272|Practice-related learning|practice-related learning
308139|NCT02300272|Sleep|sleep
308140|NCT02300272|Pain|pain
308141|NCT02300272|Circadian Rhythm|circadian rhythm
308142|NCT02300272|Older Adults|older adults
308143|NCT02300246|alveolar socket preservation|alveolar socket preservation
308144|NCT02300246|tooth extraction|tooth extraction
308145|NCT02300246|platelet concentrates|platelet concentrates
308146|NCT02300246|growth factors|growth factors
308147|NCT02300220|Chronic Obstructive Pulmonary Disease (COPD)|chronic obstructive pulmonary disease (copd)
308148|NCT02300207|Electroacupuncture|electroacupuncture
308149|NCT02300207|Cardiovascular function|cardiovascular function
308150|NCT02300207|Orthostatic tolerance|orthostatic tolerance
308151|NCT02300207|Head-down bed rest|head-down bed rest
308152|NCT02300194|Pain management|pain management
308153|NCT02300168|bariatric surgery; neuromuscular blockade|bariatric surgery; neuromuscular blockade
308154|NCT02300155|Pregnancy|pregnancy
308155|NCT02300155|Morning Sickness|morning sickness
308156|NCT02300155|nausea and vomiting|nausea and vomiting
308157|NCT02300155|hyperemesis gravidarum|hyperemesis gravidarum
308158|NCT02300155|perinatal vitamins|perinatal vitamins
308159|NCT02300142|HSV|hsv
308160|NCT02300142|Herpes|herpes
308161|NCT02300142|genital infection|genital infection
308162|NCT02300142|vaccine|vaccine
308163|NCT02300090|COPD, Exacerbation, respiratory disease, lung disease, breathlessness, dyspnoea, sputum, wheezing, cough|copd, exacerbation, respiratory disease, lung disease, breathlessness, dyspnoea, sputum, wheezing, cough
308164|NCT02300077|fentanyl, morphine|fentanyl, morphine
308165|NCT02300077|methadone|methadone
308166|NCT02300051|Compulsive sexual behavior|compulsive sexual behavior
308167|NCT02300051|Intervention|intervention
308168|NCT02300051|Short term psychodynamic group psychotherapy|short term psychodynamic group psychotherapy
308169|NCT02300051|Sexual addiction|sexual addiction
308170|NCT02300051|Hypersexual behavior|hypersexual behavior
308171|NCT02300012|Anterior cruciate ligament|anterior cruciate ligament
308172|NCT02300012|Performance based investigations|performance based investigations
308173|NCT02299973|irritable bowel syndrome|irritable bowel syndrome
308174|NCT02299973|fecal microbiota transplantation|fecal microbiota transplantation
308175|NCT02299973|bloating|bloating
308176|NCT02299960|EndoPAT|endopat
308177|NCT02299960|NICOM|nicom
308178|NCT02299960|circulating endothelial cells|circulating endothelial cells
308179|NCT02299908|Hernia, Inguinal|hernia, inguinal
308180|NCT02299908|Herniorrhaphy|herniorrhaphy
308181|NCT02299908|Abdominal Wall|abdominal wall
308182|NCT02299908|Analgesia|analgesia
308183|NCT02299908|Pain, Postoperative|pain, postoperative
308184|NCT02299895|setting approach|setting approach
308185|NCT02299895|health promotion|health promotion
308186|NCT02299895|organization|organization
308187|NCT02299895|implementation research|implementation research
308188|NCT02299895|qualitative study|qualitative study
308189|NCT02299895|comparison|comparison
308190|NCT02299882|Posterior spine surgery|posterior spine surgery
308191|NCT02299882|infection|infection
308192|NCT02299882|vancomycin|vancomycin
308193|NCT02299882|surgical wound infection|surgical wound infection
308194|NCT02299856|Magnetic Resonance Imaging|magnetic resonance imaging
308195|NCT02299856|Diagnostic Imaging|diagnostic imaging
308196|NCT02299843|RFA|rfa
308197|NCT02299843|ALPPS|alpps
308198|NCT02299843|hepatectomy|hepatectomy
308199|NCT02299843|morbidity and mortality|morbidity and mortality
308200|NCT02299830|neoplasm|neoplasm
308201|NCT02299830|central airway|central airway
308202|NCT02299830|obstruction|obstruction
308203|NCT02299791|clinic-level interventions|clinic-level interventions
308204|NCT02299791|quality improvement|quality improvement
308205|NCT02299791|translational medical research|translational medical research
308206|NCT02299791|community health centers|community health centers
308207|NCT02299765|Advanced Non-small Cell Lung Cancer (NSCLC)|advanced non-small cell lung cancer (nsclc)
308208|NCT02299765|EGFR Mutation|egfr mutation
308209|NCT02299765|gefitinib|gefitinib
308210|NCT02299765|chemotherapy|chemotherapy
308211|NCT02299739|Herbal Medicine|herbal medicine
308212|NCT02299739|Complementary Therapies|complementary therapies
308213|NCT02299739|Liver Function Tests|liver function tests
308214|NCT02299739|Risk Factors|risk factors
308215|NCT02299726|acute heart failure|acute heart failure
308216|NCT02299726|MRA|mra
308217|NCT02299726|emergency department|emergency department
308218|NCT02299713|acupuncture|acupuncture
308219|NCT02299713|knee pain|knee pain
308220|NCT02299700|Janssen Autism Knowledge Engine|janssen autism knowledge engine
308221|NCT02299700|Autism Spectrum Disorder|autism spectrum disorder
308222|NCT02299661|Hypoxia inducible factor prolyl hydroxylase inhibitor.|hypoxia inducible factor prolyl hydroxylase inhibitor.
308223|NCT02299661|Erythropoietin stimulating agent|erythropoietin stimulating agent
308224|NCT02299661|Chronic renal disease|chronic renal disease
308225|NCT02299661|renal anemia|renal anemia
308226|NCT02299635|PF-03084014|pf-03084014
308227|NCT02299635|Notch Alterations|notch alterations
308228|NCT02299609|C14.280.647.500|c14.280.647.500
308229|NCT02299596|Colorectal neoplasm|colorectal neoplasm
308230|NCT02299596|Physical activity|physical activity
308231|NCT02299583|prevention|prevention
308232|NCT02299583|early intervention|early intervention
308233|NCT02299583|trauma-informed practice|trauma-informed practice
308234|NCT02299570|Clostridium difficile|clostridium difficile
308235|NCT02299570|C diff|c diff
308236|NCT02299570|CDI|cdi
308237|NCT02299570|CDAD|cdad
308238|NCT02299570|Fecal transplant|fecal transplant
308239|NCT02299570|Fecal Microbiota Transplant|fecal microbiota transplant
308240|NCT02299570|Diarrhea|diarrhea
308242|NCT02299570|Microbiota restoration therapy|microbiota restoration therapy
308243|NCT02299570|Microbiota suspension|microbiota suspension
308244|NCT02299570|Fecal bacteriotherapy|fecal bacteriotherapy
308245|NCT02299570|C diff diarrhea|c diff diarrhea
308246|NCT02299505|LDK378|ldk378
308247|NCT02299505|ceritinib|ceritinib
308248|NCT02299505|Alk+|alk+
308249|NCT02299505|Alk positive|alk positive
308250|NCT02299505|NSCLC|nsclc
308251|NCT02299505|lung Cancer|lung cancer
308252|NCT02299492|Mental Health Services|mental health services
308253|NCT02299479|insulin pump|insulin pump
308254|NCT02299479|continuous glucose monitor|continuous glucose monitor
308255|NCT02299479|activity monitor|activity monitor
308256|NCT02299466|parenteral nutrition|parenteral nutrition
308257|NCT02299466|complications|complications
308258|NCT02299466|indications|indications
308259|NCT02299466|long-term administration|long-term administration
308260|NCT02299466|HTPN|htpn
308261|NCT02299453|Telemedicine|telemedicine
308262|NCT02299453|Interpersonal Psychotherapy (IPT)|interpersonal psychotherapy (ipt)
308263|NCT02299440|treatment of acute suicidal ideation|treatment of acute suicidal ideation
308264|NCT02299440|ketamine|ketamine
308265|NCT02299440|low-dose ketamine|low-dose ketamine
308266|NCT02299414|Pregnancy|pregnancy
308267|NCT02299414|Chronic hypertension|chronic hypertension
308268|NCT02299401|Medical abortion|medical abortion
308269|NCT02299401|Induced abortion|induced abortion
308270|NCT02299401|Pregnancy test|pregnancy test
308271|NCT02299401|Semi-quantitative pregnancy test|semi-quantitative pregnancy test
308272|NCT02299388|Type 2 Diabetes Mellitus|type 2 diabetes mellitus
308273|NCT02299388|Hypertension|hypertension
308274|NCT02299388|ambulatory blood pressure monitoring|ambulatory blood pressure monitoring
308275|NCT02299388|Endothelial Dysfunction|endothelial dysfunction
308276|NCT02299388|Pulse pressure|pulse pressure
308277|NCT02299388|Renin-angiotensin system|renin-angiotensin system
308278|NCT02299388|heart rate variability|heart rate variability
308279|NCT02299375|Phase II clinical study|phase ii clinical study
308280|NCT02299375|losmapimod|losmapimod
308281|NCT02299375|exacerbations|exacerbations
308282|NCT02299375|COPD|copd
308283|NCT02299375|eosinophil sub-group|eosinophil sub-group
308284|NCT02299362|Early Onset Scoliosis|early onset scoliosis
308285|NCT02299362|EOS|eos
308286|NCT02299362|Pulmonary function|pulmonary function
308287|NCT02299362|Infantile Idiopathic Scoliosis|infantile idiopathic scoliosis
308288|NCT02299362|MCGR|mcgr
308289|NCT02299362|Magnetically controlled growing rods|magnetically controlled growing rods
308290|NCT02299362|Growing rods|growing rods
308291|NCT02299362|Growth friendly spine surgery|growth friendly spine surgery
308292|NCT02299362|Cast|cast
308293|NCT02299310|Chronic kidney disease, Anti-hypertensive drugs|chronic kidney disease, anti-hypertensive drugs
308294|NCT02299297|Alopecia Areata|alopecia areata
308295|NCT02299284|Spastic|spastic
308296|NCT02299284|Hemiplegia|hemiplegia
308297|NCT02299245|telomere|telomere
308298|NCT02299245|telomerase|telomerase
308299|NCT02299245|statin|statin
308300|NCT02299245|percutaneous coronary intervention|percutaneous coronary intervention
308301|NCT02299245|acute coronary syndrome|acute coronary syndrome
308302|NCT02299232|dexmedetomidine|dexmedetomidine
308303|NCT02299232|sedation|sedation
308304|NCT02299232|MRI|mri
308305|NCT02299219|Adolescent|adolescent
308306|NCT02299219|Internet Self-Management|internet self-management
308307|NCT02299219|Managing Cancer|managing cancer
308308|NCT02299193|cognitive behavioral therapy for insomnia|cognitive behavioral therapy for insomnia
308309|NCT02299193|sleep hygiene|sleep hygiene
308310|NCT02299180|Advanced care planning|advanced care planning
308311|NCT02299180|End of life care|end of life care
308312|NCT02299167|Perianal surgery|perianal surgery
308313|NCT02299167|hyperbaric bupivacaine|hyperbaric bupivacaine
308314|NCT02299167|saddle block|saddle block
393799|NCT01896219|CT|ct
308315|NCT02299115|Vigabatrin|vigabatrin
308316|NCT02299115|Prednisolone|prednisolone
308317|NCT02299102|Aspiration Procedures|aspiration procedures
308318|NCT02299102|Bone Marrow|bone marrow
308319|NCT02299102|To compare powered ported bone marrow aspiration procedures to manual standard bone marrow aspiration procedures|to compare powered ported bone marrow aspiration procedures to manual standard bone marrow aspiration procedures
308320|NCT02299089|acromegaly|acromegaly
308321|NCT02299089|neuroendocrine tumour (NET)|neuroendocrine tumour (net)
308322|NCT02299089|carcinoid syndrome|carcinoid syndrome
308323|NCT02299089|octreotide|octreotide
308324|NCT02299089|Sandostatin LAR|sandostatin lar
308325|NCT02299076|Tobacco smoking cessation|tobacco smoking cessation
308326|NCT02299076|Motivation|motivation
308327|NCT02299063|Mitochondria|mitochondria
308328|NCT02299063|Dexmedetomidine|dexmedetomidine
308329|NCT02299063|Heart Defects, Congenital|heart defects, congenital
308330|NCT02299050|Type 2 Diabetes|type 2 diabetes
308331|NCT02299050|T2DM|t2dm
308332|NCT02299050|Cycloset|cycloset
308333|NCT02299050|Glycemic Control|glycemic control
308334|NCT02299050|GLP-1|glp-1
308335|NCT02299024|opioids|opioids
308336|NCT02299024|health literacy|health literacy
308337|NCT02299011|Biomatrix drug eluting stent|biomatrix drug eluting stent
308338|NCT02299011|Orsiro drug eluting stent|orsiro drug eluting stent
308339|NCT02299011|Coronary artery disease|coronary artery disease
308340|NCT02298985|curcumin; schizophrenia; neuroprotection|curcumin; schizophrenia; neuroprotection
308341|NCT02298946|Anti-PD1 Therapy|anti-pd1 therapy
308342|NCT02298946|Anti-Tumor Immunity|anti-tumor immunity
308343|NCT02298946|Liver Metastatic|liver metastatic
308344|NCT02298946|B7-DC Fc Fusion Protein|b7-dc fc fusion protein
308345|NCT02298933|Complement Inhibition|complement inhibition
308346|NCT02298933|Platelet Refractoriness|platelet refractoriness
308347|NCT02298933|Eculizumab|eculizumab
308348|NCT02298907|colorectal cancer|colorectal cancer
308349|NCT02298907|surgery|surgery
308350|NCT02298907|cardiopulmonary exercise testing|cardiopulmonary exercise testing
308351|NCT02298907|perioperative|perioperative
308352|NCT02298907|fitness|fitness
308353|NCT02298894|Low Density Lipoprotein (LDL)|low density lipoprotein (ldl)
308354|NCT02298894|Lipoprotein|lipoprotein
308355|NCT02298894|Nuclear Magnetic Resonance (NMR)|nuclear magnetic resonance (nmr)
308356|NCT02298894|Vertical Auto Profile (VAP)|vertical auto profile (vap)
308357|NCT02298894|Ion mobility|ion mobility
308358|NCT02298894|Apoliproprotein B (ApoB)|apoliproprotein b (apob)
308359|NCT02298881|Dry Eye|dry eye
308360|NCT02298881|Microbiome|microbiome
308361|NCT02298855|Gynaecological cancer|gynaecological cancer
308362|NCT02298855|Nurse-led care|nurse-led care
308363|NCT02298855|Aftercare|aftercare
308364|NCT02298855|Patient self-management|patient self-management
308365|NCT02298855|Quality of life|quality of life
308366|NCT02298855|Relapse free interval|relapse free interval
308367|NCT02298855|Watch and wait|watch and wait
308368|NCT02298842|Healthy Adults|healthy adults
308369|NCT02298829|curvature|curvature
308370|NCT02298829|bend|bend
308371|NCT02298816|Monoclonal gammopathy of undetermined significance (MGUS)|monoclonal gammopathy of undetermined significance (mgus)
308372|NCT02298816|Smoldering multiple myeloma (SMM)|smoldering multiple myeloma (smm)
308373|NCT02298816|Multiple myeloma (MM)|multiple myeloma (mm)
308374|NCT02298816|Waldenstroms Macroglobulinemia (WM)|waldenstroms macroglobulinemia (wm)
308375|NCT02298816|Monoclonal B-cell lymphocytosis (MBL)|monoclonal b-cell lymphocytosis (mbl)
308376|NCT02298816|Chronic lymphocytic leukemia (CLL)|chronic lymphocytic leukemia (cll)
308377|NCT02298816|B-Cell Non-Hodgkin lymphoma (NHL)|b-cell non-hodgkin lymphoma (nhl)
308378|NCT02298816|B-Cell Hematologic Malignancies|b-cell hematologic malignancies
308379|NCT02298816|immunization|immunization
308380|NCT02298816|Vaccination|vaccination
308381|NCT02298816|Influenza, Human|influenza, human
308382|NCT02298816|Pneumonia|pneumonia
308383|NCT02298790|Dietary Habits|dietary habits
308384|NCT02298790|Circadian|circadian
308385|NCT02298790|Metabolism|metabolism
308386|NCT02298790|Feeding Behavior|feeding behavior
308387|NCT02298738|Atrial fibrillation, hypertension, vitamin D|atrial fibrillation, hypertension, vitamin d
308388|NCT02298725|Insulin Resistance|insulin resistance
308389|NCT02298725|Obesity|obesity
308390|NCT02298725|US Dietary Guidelines|us dietary guidelines
308391|NCT02298712|Iduronidase|iduronidase
308392|NCT02298712|Lysosomal Storage Diseases|lysosomal storage diseases
308393|NCT02298712|Genetic Diseases, Inborn|genetic diseases, inborn
308394|NCT02298712|Biomarker|biomarker
308395|NCT02298712|Hurler-Scheie Syndrome|hurler-scheie syndrome
308396|NCT02298712|MPS I|mps i
308397|NCT02298699|Sly Disease|sly disease
308398|NCT02298699|Biomarker|biomarker
308399|NCT02298686|Sanfilippo Disease Type A-B-C-D|sanfilippo disease type a-b-c-d
308400|NCT02298686|Biomarker|biomarker
308401|NCT02298673|Mucolipidosis Disorder type I,II,III, IV|mucolipidosis disorder type i,ii,iii, iv
308402|NCT02298673|Biomarker|biomarker
308403|NCT02298660|Autonomic Dysreflexia|autonomic dysreflexia
308404|NCT02298660|Spinal Cord Injury|spinal cord injury
308405|NCT02298660|OnabotulinumtoxinA|onabotulinumtoxina
308406|NCT02298660|Neurogenic detrusor overactivity|neurogenic detrusor overactivity
308407|NCT02298660|Urodynamics|urodynamics
308408|NCT02298660|Cardiovascular|cardiovascular
308409|NCT02298660|Quality of life|quality of life
308410|NCT02298660|Blood pressure|blood pressure
308411|NCT02298660|Twenty-four hour ambulatory blood pressure monitoring|twenty-four hour ambulatory blood pressure monitoring
308412|NCT02298647|Gangliosidosis|gangliosidosis
308413|NCT02298647|Biomarker|biomarker
308414|NCT02298634|Lysosomal Storage Diseases|lysosomal storage diseases
308415|NCT02298634|Lipogranulomatosis|lipogranulomatosis
308416|NCT02298634|Farber disease|farber disease
308417|NCT02298634|Biomarker|biomarker
308418|NCT02298608|Renal mass|renal mass
308419|NCT02298608|Kidney cancer|kidney cancer
308420|NCT02298608|Irreversibel Electroporation|irreversibel electroporation
308421|NCT02298608|Ablation|ablation
308422|NCT02298608|Safety|safety
308423|NCT02298608|Efficacy|efficacy
308424|NCT02298608|IRE|ire
308425|NCT02298595|Carcinoma|carcinoma
308426|NCT02298595|Squamous|squamous
308427|NCT02298595|Oropharyngeal|oropharyngeal
308428|NCT02298595|HPV|hpv
308429|NCT02298595|Resectable|resectable
308430|NCT02298582|safety|safety
308431|NCT02298582|procedural pain|procedural pain
308432|NCT02298582|intranasal fentanyl|intranasal fentanyl
308433|NCT02298582|elderly|elderly
308434|NCT02298569|patient discharge|patient discharge
308435|NCT02298569|hospital readmission|hospital readmission
308436|NCT02298569|postnatal care|postnatal care
308437|NCT02298569|Home Care Services|home care services
308438|NCT02298569|Cost-Benefit Analysis|cost-benefit analysis
308439|NCT02298569|Personal satisfaction|personal satisfaction
308440|NCT02298569|Community Care Networks|community care networks
308441|NCT02298556|Hypertension|hypertension
308442|NCT02298556|Diabetes Mellitus|diabetes mellitus
308443|NCT02298556|ACE Inhibitors|ace inhibitors
308444|NCT02298556|Calcium Channel Blockers|calcium channel blockers
308445|NCT02298517|Morbid obesity|morbid obesity
308446|NCT02298517|bariatric surgery|bariatric surgery
308447|NCT02298517|Respiratory muscle endurance|respiratory muscle endurance
308448|NCT02298517|Respiratory muscle strength|respiratory muscle strength
308449|NCT02298517|spirometry|spirometry
308450|NCT02298517|physiotherapy|physiotherapy
308451|NCT02298478|Self-help|self-help
308452|NCT02298478|Computer-aided Treatment|computer-aided treatment
308453|NCT02298478|Internet|internet
308454|NCT02298478|Flying phobia|flying phobia
308455|NCT02298478|minimal contact therapies|minimal contact therapies
308456|NCT02298478|Cognitive-Behavioural Treatment|cognitive-behavioural treatment
308457|NCT02298478|Waiting list control group|waiting list control group
308458|NCT02298465|ESWL|eswl
308459|NCT02298465|distal ureteric stone|distal ureteric stone
308460|NCT02298465|transgluteal|transgluteal
308461|NCT02298465|supine ESWL|supine eswl
308462|NCT02298439|NAFLD|nafld
308463|NCT02298426|Body Constitution Classification|body constitution classification
308464|NCT02298426|Health Management|health management
308465|NCT02298426|Obese Population|obese population
308466|NCT02298374|Rehabilitation|rehabilitation
308467|NCT02298374|Evaluation studies|evaluation studies
308468|NCT02298374|Home care services|home care services
308469|NCT02298361|Adolescent|adolescent
308470|NCT02298361|Child|child
308471|NCT02298361|Child Health Services/organization & administration*|child health services/organization & administration*
308472|NCT02298361|Child, Preschool|child, preschool
308473|NCT02298361|Cohort Studies|cohort studies
308474|NCT02298361|Community Health Centers/organization & administration|community health centers/organization & administration
308475|NCT02298361|Community Health Centers/standards|community health centers/standards
308476|NCT02298361|Electronic Health Records|electronic health records
308477|NCT02298361|Feasibility Studies|feasibility studies
308478|NCT02298361|Female|female
308479|NCT02298361|Health Services Accessibility/economics|health services accessibility/economics
308480|NCT02298361|Humans|humans
308481|NCT02298361|Infant|infant
308482|NCT02298361|Infant, Newborn|infant, newborn
308483|NCT02298361|Insurance Coverage|insurance coverage
308484|NCT02298361|Insurance Coverage/statistics & numerical data|insurance coverage/statistics & numerical data
308485|NCT02298361|Insurance Coverage/trends|insurance coverage/trends
308486|NCT02298361|Insurance, Health|insurance, health
308487|NCT02298361|Insurance, Health/legislation & jurisprudence|insurance, health/legislation & jurisprudence
308488|NCT02298361|Insurance, Health/statistics & numerical data|insurance, health/statistics & numerical data
308489|NCT02298361|Insurance, Health/trends|insurance, health/trends
308490|NCT02298361|Logistic Models|logistic models
308491|NCT02298361|Longitudinal Studies|longitudinal studies
308492|NCT02298361|Male|male
308493|NCT02298361|Medicaid|medicaid
308494|NCT02298361|Medicaid/statistics & numerical data|medicaid/statistics & numerical data
308495|NCT02298361|Medicaid/trends|medicaid/trends
308496|NCT02298361|Medicaid/utilization|medicaid/utilization
308497|NCT02298361|Medically Uninsured|medically uninsured
761949|NCT00396825|Care giving|care giving
308498|NCT02298361|Medicare/statistics & numerical data|medicare/statistics & numerical data
308499|NCT02298361|Medicare/trends|medicare/trends
308500|NCT02298361|Medicare/utilization|medicare/utilization
308501|NCT02298361|Multivariate Analysis|multivariate analysis
308502|NCT02298361|Oregon|oregon
308503|NCT02298361|Patient Protection and Affordable Care Act|patient protection and affordable care act
308504|NCT02298361|Patient-Centered Care|patient-centered care
308505|NCT02298361|Pediatrics/legislation & jurisprudence|pediatrics/legislation & jurisprudence
308506|NCT02298361|Pediatrics/standards|pediatrics/standards
308507|NCT02298361|Population Surveillance/methods|population surveillance/methods
308508|NCT02298361|Primary Health Care/economics|primary health care/economics
308509|NCT02298361|Quality Assurance, Health Care/legislation & jurisprudence|quality assurance, health care/legislation & jurisprudence
308510|NCT02298361|Quality Assurance, Health Care/methods|quality assurance, health care/methods
308511|NCT02298361|Quality Indicators, Health Care|quality indicators, health care
308512|NCT02298361|Retrospective Studies|retrospective studies
308513|NCT02298361|Socioeconomic Factors|socioeconomic factors
308514|NCT02298361|United States|united states
308515|NCT02298361|Young Adult|young adult
308516|NCT02298348|Neuroblastoma|neuroblastoma
308517|NCT02298348|NANT|nant
308518|NCT02298348|Sorafenib|sorafenib
308519|NCT02298348|Relapse|relapse
308520|NCT02298335|Prednisone|prednisone
308521|NCT02298335|idiopathic nephrotic syndrome|idiopathic nephrotic syndrome
308522|NCT02298335|prospective|prospective
308524|NCT02298309|HIV|hiv
308525|NCT02298309|Test and Treat|test and treat
308526|NCT02298309|Linkage|linkage
308527|NCT02298283|Hodgkin lymphoma|hodgkin lymphoma
308528|NCT02298283|HL|hl
308529|NCT02298283|brentuximab vedotin|brentuximab vedotin
308530|NCT02298270|Neurofibromatosis|neurofibromatosis
308531|NCT02298270|NF I|nf i
308532|NCT02298270|NF 2|nf 2
308533|NCT02298270|Schwannomatosis|schwannomatosis
308534|NCT02298270|Stress Management|stress management
308535|NCT02298270|Resiliency|resiliency
308536|NCT02298270|Skype|skype
308537|NCT02298244|Pulmonary Hypertension|pulmonary hypertension
308538|NCT02298244|Atrial Fibrillation|atrial fibrillation
308539|NCT02298244|Pulmonary Arterial Denervation|pulmonary arterial denervation
308540|NCT02298244|Safety|safety
308541|NCT02298244|Pulmonary Arterial GP Ablation|pulmonary arterial gp ablation
308542|NCT02298231|Traumatic Brain Injury|traumatic brain injury
308543|NCT02298231|Balance|balance
308544|NCT02298231|TBI|tbi
308545|NCT02298231|Veterans|veterans
308546|NCT02298231|Virtual Reality|virtual reality
308547|NCT02298179|Antibodies|antibodies
308548|NCT02298179|Respiratory syncytial virus|respiratory syncytial virus
308549|NCT02298179|Safety|safety
308550|NCT02298179|Healthy adults|healthy adults
308551|NCT02298179|Immunogenicity|immunogenicity
308552|NCT02298166|Acute myeloid leukemia|acute myeloid leukemia
308553|NCT02298166|FLT3 mutations|flt3 mutations
308554|NCT02298166|Crenolanib|crenolanib
308555|NCT02298166|Relapsed|relapsed
308556|NCT02298166|Refractory|refractory
308557|NCT02298140|SMS reminders|sms reminders
308558|NCT02298140|Provider's compliance|provider's compliance
308559|NCT02298140|malaria|malaria
308560|NCT02298127|smoking cessation|smoking cessation
308561|NCT02298127|auricular acupressure|auricular acupressure
308562|NCT02298127|primary care settings|primary care settings
308563|NCT02298127|randomized controlled trial|randomized controlled trial
308564|NCT02298114|electrical stimulation|electrical stimulation
308565|NCT02298114|intensive care unit|intensive care unit
308566|NCT02298114|muscular atrophy|muscular atrophy
308567|NCT02298101|Aerosol delivery|aerosol delivery
308568|NCT02298101|Lung deposition|lung deposition
308569|NCT02298101|SPECT|spect
308570|NCT02298101|subjects|subjects
308571|NCT02298075|Immune thrombocytopenia|immune thrombocytopenia
308572|NCT02298075|Primary|primary
308573|NCT02298075|Thrombopoietin receptor agonist|thrombopoietin receptor agonist
308574|NCT02298062|Kawasaki disease coronary artery lesion, IVIG- resistant, Infliximab|kawasaki disease coronary artery lesion, ivig- resistant, infliximab
308575|NCT02298049|fMRI|fmri
308576|NCT02298049|reward|reward
308577|NCT02298049|satiation|satiation
308578|NCT02298036|Health Anxiety|health anxiety
308579|NCT02298036|Urgent Care|urgent care
308580|NCT02298036|Medically Unexplained|medically unexplained
308581|NCT02298023|adipose derived mesenchymal stem cell|adipose derived mesenchymal stem cell
308582|NCT02298023|allogeneic stem cell|allogeneic stem cell
308583|NCT02298023|Rotator cuff tear|rotator cuff tear
308584|NCT02297997|sarcopenia|sarcopenia
308585|NCT02297997|cetylpyridinium chloride|cetylpyridinium chloride
308586|NCT02297984|Neuroglobin|neuroglobin
308587|NCT02297984|HIF-α|hif-α
308588|NCT02297984|Acute ischemic stroke|acute ischemic stroke
308589|NCT02297984|Prognosis|prognosis
308590|NCT02297932|Exercise|exercise
308591|NCT02297919|Web-based education, Adolescent, Obesity|web-based education, adolescent, obesity
308592|NCT02297906|Intranasal|intranasal
308593|NCT02297906|Ketorolac|ketorolac
308594|NCT02297906|Pharmacokinetics|pharmacokinetics
308595|NCT02297906|Pediatric|pediatric
308596|NCT02297880|low calorie sweetener satiety, intake, hunger|low calorie sweetener satiety, intake, hunger
308597|NCT02297815|antibiotic use|antibiotic use
308598|NCT02297815|effectiveness|effectiveness
308599|NCT02297815|acute respiratory infections|acute respiratory infections
308600|NCT02297815|pediatrics|pediatrics
308601|NCT02297776|cardiac arrest|cardiac arrest
308602|NCT02297776|biomarker|biomarker
308603|NCT02297776|microRNA|microrna
308604|NCT02297776|circRNA|circrna
308605|NCT02297776|NSE|nse
308606|NCT02297776|CPC|cpc
308607|NCT02297750|The focus of the study is double-wire technique versus single wire technique in patients undergoing ERCP with biliary cannulation as the primary objective.|the focus of the study is double-wire technique versus single wire technique in patients undergoing ercp with biliary cannulation as the primary objective.
308608|NCT02297737|Tai Chi|tai chi
308609|NCT02297698|Breast cancer, NeuVax|breast cancer, neuvax
308610|NCT02297685|Transcutaneous electrical nerve stimulation (TENS)|transcutaneous electrical nerve stimulation (tens)
308611|NCT02297685|Interferential currents therapy|interferential currents therapy
308612|NCT02297685|Therapeutic exercises|therapeutic exercises
308613|NCT02297685|Low back pain|low back pain
308614|NCT02297685|Rehabilitation|rehabilitation
308615|NCT02297672|breast cancer|breast cancer
308616|NCT02297672|brachytherapy|brachytherapy
308617|NCT02297672|partial breast radiotherapy|partial breast radiotherapy
308618|NCT02297672|palladium 103|palladium 103
308619|NCT02297659|damage control|damage control
308620|NCT02297659|resuscitation|resuscitation
308621|NCT02297659|laparotomy|laparotomy
308622|NCT02297646|Prevention|prevention
308623|NCT02297646|Exercise|exercise
308624|NCT02297646|Health|health
308625|NCT02297646|Endurance|endurance
308626|NCT02297633|COPD|copd
308627|NCT02297633|reactive oxygen metabolites|reactive oxygen metabolites
308628|NCT02297620|SGLT-2 inhibitor|sglt-2 inhibitor
308629|NCT02297620|Elderly patients|elderly patients
308630|NCT02297620|ASP1941|asp1941
308631|NCT02297607|Esophageal Cancer|esophageal cancer
308632|NCT02297607|Esophagectomy|esophagectomy
308633|NCT02297581|Geriatrics [MeSH]|geriatrics [mesh]
308634|NCT02297581|Osteoporotic fractures [MeSH]|osteoporotic fractures [mesh]
308635|NCT02297581|Hip fractures [MeSH]|hip fractures [mesh]
308636|NCT02297581|Cost benefit analysis [MeSH]|cost benefit analysis [mesh]
308637|NCT02297581|Quality of life [MeSH]|quality of life [mesh]
308638|NCT02297581|Mortality [MeSH]|mortality [mesh]
308639|NCT02297581|Complications|complications
308640|NCT02297568|Breast-fed infant|breast-fed infant
308641|NCT02297568|vitamin D supplementation|vitamin d supplementation
308642|NCT02297568|Lactation|lactation
308643|NCT02297555|Obesity|obesity
308644|NCT02297555|Metabolic Syndrome|metabolic syndrome
308645|NCT02297555|ENDOBARRIER®|endobarrier®
308646|NCT02297542|Influenza Vaccine|influenza vaccine
308647|NCT02297529|unresected, Melanoma, expanded access, EU|unresected, melanoma, expanded access, eu
308648|NCT02297490|Environmental Exposure Chamber|environmental exposure chamber
308649|NCT02297490|Specific Immunotherapy|specific immunotherapy
308650|NCT02297490|SIT|sit
308651|NCT02297490|SCIT|scit
308652|NCT02297464|Risk|risk
308653|NCT02297438|breast cancer|breast cancer
308654|NCT02297438|postmenopausal women|postmenopausal women
308655|NCT02297438|estrogen-receptor positive|estrogen-receptor positive
308656|NCT02297438|HER2 negative|her2 negative
308657|NCT02297438|locoregionally recurrent|locoregionally recurrent
308658|NCT02297438|metastatic|metastatic
308659|NCT02297425|NSCLC, Non-Small Cell Lung Cancer, EGFRm, Epidermal Grown Factor Receptor mutation|nsclc, non-small cell lung cancer, egfrm, epidermal grown factor receptor mutation
308660|NCT02297399|Colonoscopy|colonoscopy
308661|NCT02297399|Diabetes Mellitus|diabetes mellitus
308662|NCT02297399|Polyethylene glycols|polyethylene glycols
308663|NCT02297399|Ascorbate|ascorbate
308664|NCT02297399|Personal satisfaction|personal satisfaction
308665|NCT02297386|[18F] Dihydro-testosterone|[18f] dihydro-testosterone
308666|NCT02297386|PET Scan|pet scan
308667|NCT02297386|MRI|mri
308668|NCT02297386|14-185|14-185
308669|NCT02297360|Hair loss, hair thinning, women, marine protein supplement|hair loss, hair thinning, women, marine protein supplement
308670|NCT02297334|CytoSorb(TM)|cytosorb(tm)
308671|NCT02297334|cytokines|cytokines
308672|NCT02297334|inflammation|inflammation
308673|NCT02297334|cardiac surgery|cardiac surgery
308674|NCT02297334|extracorporeal bypass|extracorporeal bypass
308675|NCT02297321|tattoos|tattoos
308676|NCT02297321|laser|laser
308677|NCT02297321|whitening|whitening
308678|NCT02297321|patch|patch
308679|NCT02297295|Sequelae of; Amputation, Traumatic, Limb, Lower|sequelae of; amputation, traumatic, limb, lower
308680|NCT02297282|Depression|depression
308681|NCT02297282|Behavioural Activation|behavioural activation
308682|NCT02297269|Deep vein thrombosis|deep vein thrombosis
308683|NCT02297269|Surgery|surgery
308684|NCT02297269|gastrointestinal malignancy|gastrointestinal malignancy
308685|NCT02297230|Locally Advanced Breast Cancer|locally advanced breast cancer
308686|NCT02297191|volunteer|volunteer
308687|NCT02297191|pilot study|pilot study
308688|NCT02297191|adults|adults
308689|NCT02297165|anorexic|anorexic
308690|NCT02297165|olfactory stimulation|olfactory stimulation
308691|NCT02297165|autobiographical memories recovery|autobiographical memories recovery
308692|NCT02297152|Premature ejaculation treatment|premature ejaculation treatment
308693|NCT02297152|Sexual dysfunction|sexual dysfunction
308694|NCT02297152|Intravaginal Ejaculatory Latency time|intravaginal ejaculatory latency time
308695|NCT02297152|Masturbation aid|masturbation aid
308696|NCT02297152|Ejaculatory disorders|ejaculatory disorders
308697|NCT02297113|patients|patients
308698|NCT02297113|departement|departement
308699|NCT02297113|requiring Rapid Sequence Intubation (RSI)|requiring rapid sequence intubation (rsi)
308700|NCT02297100|women|women
308701|NCT02297100|interstitial cystitis|interstitial cystitis
308702|NCT02297100|bladder pain syndrome|bladder pain syndrome
308703|NCT02297100|botox|botox
308704|NCT02297100|onabotulinum toxin A|onabotulinum toxin a
308705|NCT02297074|Bread|bread
308706|NCT02297074|Glycemic index|glycemic index
308707|NCT02297074|Glycemic load|glycemic load
308708|NCT02297074|Insulinemic index|insulinemic index
308709|NCT02297074|Satiety|satiety
308710|NCT02297074|Gastrointestinal hormones|gastrointestinal hormones
308711|NCT02297061|Hip fracture|hip fracture
308712|NCT02297061|Thrombelastography|thrombelastography
308713|NCT02297061|Blood loss|blood loss
308714|NCT02297048|Potassium intake|potassium intake
308715|NCT02297048|Progesterone|progesterone
308716|NCT02297048|steroidogenesis|steroidogenesis
308717|NCT02297048|RU486|ru486
308718|NCT02297048|Synachtene test|synachtene test
308719|NCT02297022|Deep Brain Stimulation|deep brain stimulation
308720|NCT02297022|obesity|obesity
308721|NCT02297022|Prader-Willi syndrome|prader-willi syndrome
308722|NCT02296996|BRAF V600|braf v600
308723|NCT02296996|Rechallenge|rechallenge
308724|NCT02296996|Combination|combination
308725|NCT02296996|Dabrafenib|dabrafenib
308726|NCT02296996|Trametinib|trametinib
308727|NCT02296944|Childrens|childrens
308728|NCT02296944|tempanoplasty|tempanoplasty
308729|NCT02296944|tympanic membrane perforation|tympanic membrane perforation
308730|NCT02296944|retrospective|retrospective
308731|NCT02296944|cohort|cohort
308732|NCT02296918|CLL|cll
308733|NCT02296918|SLL|sll
308734|NCT02296918|PLL|pll
308853|NCT02296021|helicobacter pylori|helicobacter pylori
308735|NCT02296918|Chronic Lymphocytic Leukemia|chronic lymphocytic leukemia
308736|NCT02296918|Small Lymphocytic Lymphoma|small lymphocytic lymphoma
308737|NCT02296918|Prolymphocytic Leukemia|prolymphocytic leukemia
308738|NCT02296918|ACP-196|acp-196
308739|NCT02296918|acalabrutinib|acalabrutinib
308740|NCT02296918|obinutuzumab|obinutuzumab
308741|NCT02296918|rituximab|rituximab
308742|NCT02296918|venetoclax|venetoclax
308743|NCT02296905|Hepatic Impairment|hepatic impairment
308744|NCT02296905|Hepatitis C Virus Infection|hepatitis c virus infection
308745|NCT02296892|Remimazolam, midazolam, bronchoscopy, procedural sedation|remimazolam, midazolam, bronchoscopy, procedural sedation
308746|NCT02296853|Severe Hepatic Impairment|severe hepatic impairment
308747|NCT02296840|analgesia|analgesia
308748|NCT02296840|non-steroidal anti-inflammatory drugs|non-steroidal anti-inflammatory drugs
308749|NCT02296840|narcotic-containing pain medication|narcotic-containing pain medication
308750|NCT02296788|Gut Microbiota|gut microbiota
308751|NCT02296775|Rheumatoid arthritis|rheumatoid arthritis
308752|NCT02296775|Rituximab|rituximab
308753|NCT02296775|Pharmacokinetics|pharmacokinetics
308754|NCT02296736|computerised tomography (CT) scan|computerised tomography (ct) scan
308755|NCT02296736|diagnostic accuracy|diagnostic accuracy
308756|NCT02296736|Pancreatic head malignancy|pancreatic head malignancy
308757|NCT02296710|mitral valve|mitral valve
308758|NCT02296710|valve surgery|valve surgery
308759|NCT02296710|echocardiography|echocardiography
308760|NCT02296697|Pressure Ulcer|pressure ulcer
308761|NCT02296697|Low Level Laser Therapy|low level laser therapy
308762|NCT02296697|Dressings|dressings
308763|NCT02296632|Telemedicine|telemedicine
308764|NCT02296632|Patient Reported Outcomes|patient reported outcomes
308765|NCT02296593|lactate|lactate
308766|NCT02296593|continuous lactate monitoring|continuous lactate monitoring
308767|NCT02296593|continuous blood glucose monitoring|continuous blood glucose monitoring
308768|NCT02296593|EIRUS|eirus
308769|NCT02296593|blood glucose|blood glucose
308770|NCT02296593|cardiac surgery|cardiac surgery
308771|NCT02296593|central veinous catheter|central veinous catheter
308772|NCT02296593|microdialysis|microdialysis
308773|NCT02296554|SLAP Repair|slap repair
308774|NCT02296554|Biceps Tenodesis|biceps tenodesis
308775|NCT02296528|Feeding Tube Dependent|feeding tube dependent
308776|NCT02296502|DSM Diagnosis|dsm diagnosis
308777|NCT02296450|Quality of Life (QoL)|quality of life (qol)
308778|NCT02296450|Assessment|assessment
308779|NCT02296450|14-236|14-236
308780|NCT02296450|Patients and Survivors|patients and survivors
308781|NCT02296424|Juvenile Rheumatoid arthritis (JRA) chronic|juvenile rheumatoid arthritis (jra) chronic
308782|NCT02296424|systemic inflammatory disorder|systemic inflammatory disorder
308783|NCT02296424|painful joints|painful joints
308784|NCT02296424|inflammation of the synovial membrane|inflammation of the synovial membrane
308785|NCT02296424|auto-immune rheumatoid disease|auto-immune rheumatoid disease
308786|NCT02296424|reactive rheumatoid arthritis|reactive rheumatoid arthritis
308787|NCT02296424|Systemic Juvenile Rheumatoid arthritis (SJRA)|systemic juvenile rheumatoid arthritis (sjra)
310258|NCT02288754|cfDNA|cfdna
308788|NCT02296411|Asthma, Anticholinergics|asthma, anticholinergics
308789|NCT02296385|volunteers|volunteers
308790|NCT02296333|Acetaminophen, ondansetron|acetaminophen, ondansetron
308791|NCT02296307|Aged|aged
308792|NCT02296307|Algorithms|algorithms
308793|NCT02296307|CA-125 Antigen/blood*|ca-125 antigen/blood*
308794|NCT02296307|Chi-Square Distribution|chi-square distribution
308795|NCT02296307|Early Detection of Cancer*|early detection of cancer*
308796|NCT02296307|Feasibility Studies|feasibility studies
308797|NCT02296307|Female|female
308798|NCT02296307|Humans|humans
308799|NCT02296307|Logistic Models|logistic models
308800|NCT02296307|Mass Screening/methods*|mass screening/methods*
308801|NCT02296307|Middle Aged|middle aged
308802|NCT02296307|Neoplasm Grading|neoplasm grading
308803|NCT02296307|Neoplasm Invasiveness|neoplasm invasiveness
308804|NCT02296307|Neoplasm Staging|neoplasm staging
308805|NCT02296307|Ovarian Neoplasms/diagnosis*|ovarian neoplasms/diagnosis*
308806|NCT02296307|Ovarian Neoplasms/epidemiology|ovarian neoplasms/epidemiology
308807|NCT02296307|Ovarian Neoplasms/immunology|ovarian neoplasms/immunology
308808|NCT02296307|Ovarian Neoplasms/ultrasonography|ovarian neoplasms/ultrasonography
308809|NCT02296307|Pilot Projects|pilot projects
308810|NCT02296307|Predictive Value of Tests|predictive value of tests
308811|NCT02296307|Prevalence|prevalence
308812|NCT02296307|Prognosis|prognosis
308813|NCT02296307|Prospective Studies|prospective studies
308814|NCT02296307|Quebec/epidemiology|quebec/epidemiology
308815|NCT02296307|Tumor Burden|tumor burden
308816|NCT02296294|Bioimpedance Spectroscopy, Body Composition Monitor, Fluid Therapy|bioimpedance spectroscopy, body composition monitor, fluid therapy
308817|NCT02296268|stroke|stroke
308818|NCT02296268|aerobic exercise|aerobic exercise
308819|NCT02296268|screening|screening
308820|NCT02296268|prescription|prescription
308821|NCT02296255|cervical cancer screening|cervical cancer screening
308822|NCT02296255|young women vaccination|young women vaccination
308823|NCT02296255|impact of HPV vaccination on screening|impact of hpv vaccination on screening
308824|NCT02296216|have been treated or not treated by Gamma Knife Radiosurgery|have been treated or not treated by gamma knife radiosurgery
308825|NCT02296203|cetuximab rechallenge|cetuximab rechallenge
308826|NCT02296177|evidence-based intervention|evidence-based intervention
308827|NCT02296177|mammography|mammography
308828|NCT02296177|underserved population|underserved population
308829|NCT02296164|PROVe|prove
308830|NCT02296164|CTCL|ctcl
308831|NCT02296164|Mechlorethamine|mechlorethamine
308832|NCT02296164|Cutaneous T-cell lymphoma|cutaneous t-cell lymphoma
308833|NCT02296164|Mycosis fungoides cutaneous T-cell lymphoma|mycosis fungoides cutaneous t-cell lymphoma
308834|NCT02296164|Valchlor|valchlor
308835|NCT02296164|Dermatology|dermatology
308836|NCT02296164|MF-CTCL|mf-ctcl
308837|NCT02296164|Mycosis Fungoides|mycosis fungoides
308838|NCT02296164|Oncology|oncology
308839|NCT02296125|Advanced Non-Small Cell Lung Cancer; EGFRm+; AZD9291; TKI; Phase III|advanced non-small cell lung cancer; egfrm+; azd9291; tki; phase iii
308840|NCT02296099|retropubic suburethral sling|retropubic suburethral sling
308841|NCT02296099|stress urinary incontinence|stress urinary incontinence
308842|NCT02296099|liposomal bupivacaine|liposomal bupivacaine
308843|NCT02296086|Geriatrics [MeSH]|geriatrics [mesh]
308844|NCT02296086|Hip fractures [MeSH]|hip fractures [mesh]
308845|NCT02296086|China [MeSH]|china [mesh]
308846|NCT02296086|Early ambulation [MeSH]|early ambulation [mesh]
308847|NCT02296086|Immobilization [MeSH]|immobilization [mesh]
308848|NCT02296073|Pediatric intensive care unit|pediatric intensive care unit
308849|NCT02296073|Sedation|sedation
308850|NCT02296073|Dexmedetomidine|dexmedetomidine
308851|NCT02296073|mechanical ventilation|mechanical ventilation
308852|NCT02296047|COPD, central drive, bronchodilators|copd, central drive, bronchodilators
308854|NCT02296021|berberine-containing quadruple therapy|berberine-containing quadruple therapy
308855|NCT02296021|bismuth-containing quadruple therapy|bismuth-containing quadruple therapy
308856|NCT02296008|high resolution manometry|high resolution manometry
308857|NCT02296008|children|children
308858|NCT02296008|congenital anorectal disorder|congenital anorectal disorder
308859|NCT02296008|surgery|surgery
308860|NCT02295995|Aged|aged
308861|NCT02295995|Exercise|exercise
308862|NCT02295995|Veterans|veterans
308863|NCT02295995|Adherence|adherence
308864|NCT02295995|Clinical Trials, Randomized|clinical trials, randomized
308865|NCT02295982|Laparoscopic nephrectomy|laparoscopic nephrectomy
308866|NCT02295982|one day surgery|one day surgery
308867|NCT02295969|Rhinitis|rhinitis
308868|NCT02295969|Conjunctivitis|conjunctivitis
308869|NCT02295969|Grass pollen|grass pollen
308870|NCT02295969|Sublingual tablet|sublingual tablet
308871|NCT02295969|Allergen immunotherapy|allergen immunotherapy
308872|NCT02295969|Safety|safety
308873|NCT02295956|Pancreatic Cancer|pancreatic cancer
308874|NCT02295956|Pancreatic adenocarcinoma|pancreatic adenocarcinoma
308875|NCT02295956|Preoperative therapy|preoperative therapy
308876|NCT02295956|Questionnaires|questionnaires
308877|NCT02295956|Surveys|surveys
308878|NCT02295956|Exercises|exercises
308879|NCT02295956|Stretching|stretching
308880|NCT02295956|Walking|walking
308881|NCT02295956|Nutrition counseling|nutrition counseling
308882|NCT02295956|Resistance exercise bands|resistance exercise bands
308883|NCT02295956|Phone calls|phone calls
308884|NCT02295956|Booklet|booklet
308885|NCT02295956|Pamphlet|pamphlet
308886|NCT02295930|colorectal cancer,|colorectal cancer,
308887|NCT02295930|bevacizumab|bevacizumab
308888|NCT02295930|cetuximab|cetuximab
308889|NCT02295930|folfoxiri|folfoxiri
308890|NCT02295930|kras wild type|kras wild type
308891|NCT02295904|perineum|perineum
308892|NCT02295904|videoanalysis|videoanalysis
308893|NCT02295865|Psoriasis|psoriasis
308894|NCT02295865|Toreforant|toreforant
308895|NCT02295865|JNJ-38518168|jnj-38518168
308896|NCT02295852|Low-sodium calcium enriched diet|low-sodium calcium enriched diet
308897|NCT02295852|Low-sodium diet|low-sodium diet
308898|NCT02295852|Glucose and lipid metabolims|glucose and lipid metabolims
308899|NCT02295839|Sleep|sleep
308900|NCT02295839|Acute Lymphoblastic Leukemia|acute lymphoblastic leukemia
308901|NCT02295839|Fatigue|fatigue
308902|NCT02295839|Sleep hygiene|sleep hygiene
308903|NCT02295839|Relaxation|relaxation
308904|NCT02295839|RCT|rct
308905|NCT02295800|HIV|hiv
308906|NCT02295800|PMTCT|pmtct
308907|NCT02295800|Antenatal Care|antenatal care
308908|NCT02295787|Depression|depression
308909|NCT02295787|Suicide|suicide
308910|NCT02295787|Suicidal Ideation|suicidal ideation
308911|NCT02295787|Ketamine|ketamine
308912|NCT02295787|Late-Life|late-life
308913|NCT02295761|motor activity|motor activity
308914|NCT02295761|obesity|obesity
308915|NCT02295761|overweight|overweight
308916|NCT02295761|intervention study|intervention study
308917|NCT02295761|health promotion|health promotion
308918|NCT02295761|lifestyle counseling|lifestyle counseling
308919|NCT02295761|adherence|adherence
308920|NCT02295735|Skin, safety, wounds, intensive care|skin, safety, wounds, intensive care
308921|NCT02295722|eligible for high-dose therapy and stem cell transplantation|eligible for high-dose therapy and stem cell transplantation
308922|NCT02295709|ultrasound|ultrasound
308923|NCT02295709|cervical Transformational Epidural Steroid Injection|cervical transformational epidural steroid injection
308924|NCT02295696|Adults, dialogue tools, outpatient clinic visits|adults, dialogue tools, outpatient clinic visits
308925|NCT02295644|Therapeutic ultrasound|therapeutic ultrasound
308926|NCT02295592|hemorrhoids|hemorrhoids
308927|NCT02295592|The recurrence rate|the recurrence rate
308928|NCT02295592|PPH|pph
308929|NCT02295592|TSTstarr+|tststarr+
308930|NCT02295566|Nitric Oxide|nitric oxide
308931|NCT02295566|Pseudomonas Aeruginosa|pseudomonas aeruginosa
308932|NCT02295566|Biofilm|biofilm
308933|NCT02295553|Ketamine|ketamine
308934|NCT02295553|Propofol|propofol
308935|NCT02295553|Children|children
308936|NCT02295553|Pediatrics|pediatrics
308937|NCT02295553|Upper endoscopy|upper endoscopy
308938|NCT02295514|Sepsis|sepsis
308939|NCT02295514|Septic shock|septic shock
308940|NCT02295501|Pathogen inactivation|pathogen inactivation
308941|NCT02295501|ebola|ebola
308942|NCT02295501|convalescent plasma|convalescent plasma
308943|NCT02295501|EBOV|ebov
308944|NCT02295501|amotosalen|amotosalen
308945|NCT02295501|Provide access to the potential therapeutic benefit of EBOV convalescent plasma containing antibodies to EBOV.|provide access to the potential therapeutic benefit of ebov convalescent plasma containing antibodies to ebov.
308946|NCT02295488|hymenoptera puncture|hymenoptera puncture
308947|NCT02295475|Apixaban|apixaban
308948|NCT02295475|Eliquis|eliquis
308949|NCT02295462|nursing homes|nursing homes
308950|NCT02295462|person-centered care|person-centered care
308951|NCT02295462|inappropriate prescriptions|inappropriate prescriptions
308952|NCT02295462|cluster-randomised controlled trial|cluster-randomised controlled trial
308953|NCT02295462|antipsychotic drugs|antipsychotic drugs
308954|NCT02295449|Prostate cancer|prostate cancer
308955|NCT02295449|Contrast-enhanced ultrasound|contrast-enhanced ultrasound
308956|NCT02295436|minodronic acid|minodronic acid
308957|NCT02295436|pharmacokinetics|pharmacokinetics
308958|NCT02295436|tolerability|tolerability
308959|NCT02295436|food|food
308960|NCT02295436|age|age
308961|NCT02295436|Chinese subjects|chinese subjects
308962|NCT02295410|Assessment, PTSD, Veterans|assessment, ptsd, veterans
308963|NCT02295397|Food provocation|food provocation
308964|NCT02295397|Matrix effect|matrix effect
308965|NCT02295397|ED05|ed05
308966|NCT02295397|Allergy|allergy
308967|NCT02295397|Proton Pump Inhibitor|proton pump inhibitor
308968|NCT02295384|Polypharmacy|polypharmacy
308969|NCT02295384|Medication Therapy Management|medication therapy management
308970|NCT02295371|Drug therapy|drug therapy
308971|NCT02295371|Patient safety|patient safety
308972|NCT02295371|Polydrug therapy|polydrug therapy
308973|NCT02295319|Discharge|discharge
308974|NCT02295319|Acute Admission Unit|acute admission unit
308975|NCT02295319|Randomized Controlled Trial|randomized controlled trial
308976|NCT02295306|OSA, polysomnography, ExSpiron monitor|osa, polysomnography, exspiron monitor
308977|NCT02295293|Rhus|rhus
308978|NCT02295293|Cholesterol|cholesterol
308979|NCT02295293|Triglycerides|triglycerides
308980|NCT02295293|Lipids|lipids
308981|NCT02295293|Medicine, Traditional|medicine, traditional
308982|NCT02295293|Herbal medicine|herbal medicine
308983|NCT02295280|headache|headache
308984|NCT02295267|Food allergy|food allergy
308985|NCT02295267|Walnut|walnut
308986|NCT02295267|Components|components
308987|NCT02295267|Allergens|allergens
308988|NCT02295241|Sarcopenia, muscles, aging|sarcopenia, muscles, aging
308989|NCT02295228|Vitamin D, Vitamin D deficiency, Hip Arthroplasty|vitamin d, vitamin d deficiency, hip arthroplasty
308990|NCT02295215|chagas disease|chagas disease
308991|NCT02295215|exercise|exercise
308992|NCT02295215|baroreflex sensitivity|baroreflex sensitivity
308993|NCT02295163|Stellate ganglion block|stellate ganglion block
308994|NCT02295163|hot flushes|hot flushes
308995|NCT02295163|androgen deprivation therapy|androgen deprivation therapy
308996|NCT02295163|prostate cancer|prostate cancer
308997|NCT02295150|Nadroparin|nadroparin
308998|NCT02295150|Anti-Xa activity|anti-xa activity
308999|NCT02295124|Nausea|nausea
309000|NCT02295111|electro-acupuncture|electro-acupuncture
309001|NCT02295111|chronic pelvic pain|chronic pelvic pain
309002|NCT02295111|patient practitioner interactions|patient practitioner interactions
309003|NCT02295111|TCM health consultation|tcm health consultation
309004|NCT02295111|meridian balanced method acupuncture|meridian balanced method acupuncture
309005|NCT02295085|Cohort, Prospective, Biospecimens|cohort, prospective, biospecimens
309006|NCT02295072|Exercise-based Randomized Controlled Trial|exercise-based randomized controlled trial
309007|NCT02295072|Brain structure|brain structure
309008|NCT02295072|Brain function|brain function
309009|NCT02295072|Cognitive function|cognitive function
309010|NCT02295072|Physical fitness|physical fitness
309011|NCT02295072|Body Mass Index|body mass index
309012|NCT02295072|Cardiovascular disease risk factors|cardiovascular disease risk factors
309013|NCT02295072|Mental health|mental health
309014|NCT02295072|Stress|stress
309015|NCT02295072|Neurology|neurology
309016|NCT02295072|Obesity|obesity
309017|NCT02295072|brain|brain
309018|NCT02295072|risk factors|risk factors
309019|NCT02295072|bone|bone
309020|NCT02295072|bones|bones
309021|NCT02295072|body composition|body composition
309022|NCT02295059|Breast cancer|breast cancer
309023|NCT02295059|ERPR negative|erpr negative
309024|NCT02295059|HER-2/neu overexpression positive or negative|her-2/neu overexpression positive or negative
309025|NCT02295033|Boost versus no boost irradiation of early breast cancer|boost versus no boost irradiation of early breast cancer
309026|NCT02294955|catheter ablation|catheter ablation
309027|NCT02294955|atrial fibrillation|atrial fibrillation
309028|NCT02294942|RNTA06|rnta06
309029|NCT02294942|RANCAD|rancad
309030|NCT02294929|catheter ablation|catheter ablation
309031|NCT02294929|cryoballoon|cryoballoon
309032|NCT02294903|Focal radiofrequency ablation|focal radiofrequency ablation
309033|NCT02294903|Prostate cancer|prostate cancer
309034|NCT02294903|Encage|encage
309035|NCT02294864|focus: pulsed radiofrequency (E02.779.468.599)|focus: pulsed radiofrequency (e02.779.468.599)
309036|NCT02294825|deep endometriosis;|deep endometriosis;
309037|NCT02294825|colorectal endometriosis|colorectal endometriosis
309038|NCT02294825|surgery|surgery
309039|NCT02294825|medical treatment|medical treatment
309040|NCT02294825|fertility|fertility
309041|NCT02294812|Hearing Loss|hearing loss
309042|NCT02294812|Speech Perception|speech perception
309043|NCT02294812|Cognitive Training|cognitive training
309044|NCT02294812|Cognitive Fitness|cognitive fitness
309045|NCT02294812|Memory, Short-Term|memory, short-term
309046|NCT02294799|Temporomandibular Joint Disorders|temporomandibular joint disorders
309047|NCT02294799|Magnetic Ressonance Imaging|magnetic ressonance imaging
309048|NCT02294799|Complementary Therapy|complementary therapy
309049|NCT02294799|Physical Therapy Modalities.|physical therapy modalities.
309050|NCT02294786|Randomised|randomised
309051|NCT02294786|Octreotide|octreotide
309052|NCT02294786|Diarrhoea|diarrhoea
309053|NCT02294786|Phase II|phase ii
309054|NCT02294786|Capecitabine|capecitabine
309055|NCT02294786|Quality of life|quality of life
309056|NCT02294786|Metastatic breast cancer|metastatic breast cancer
309057|NCT02294786|HER2|her2
309058|NCT02294786|Lapatinib|lapatinib
309059|NCT02294786|Diarrhoea diary|diarrhoea diary
309060|NCT02294773|Infertility|infertility
309061|NCT02294773|Intrauterine insemination|intrauterine insemination
309062|NCT02294773|Luteinizing hormone surge|luteinizing hormone surge
309063|NCT02294760|Irritable Bowel Syndrome|irritable bowel syndrome
309064|NCT02294760|Sacral Nerve Stimulation|sacral nerve stimulation
309065|NCT02294760|Symptoms|symptoms
309066|NCT02294760|Quality of Life|quality of life
762050|NCT00396513|Metformin|metformin
309067|NCT02294734|functional respiratory capacity|functional respiratory capacity
309068|NCT02294734|High-resolution computed tomography|high-resolution computed tomography
309069|NCT02294734|GSK2269557|gsk2269557
309070|NCT02294734|acute exacerbation of COPD|acute exacerbation of copd
309071|NCT02294734|lung capacity|lung capacity
309072|NCT02294708|macula-off retinal detachment|macula-off retinal detachment
309073|NCT02294708|scleral buckle|scleral buckle
309074|NCT02294708|persistent sub-foveal fluid|persistent sub-foveal fluid
309075|NCT02294708|postoperative postures|postoperative postures
309076|NCT02294708|optical coherence tomography (OCT)|optical coherence tomography (oct)
309077|NCT02294695|Empiric antibiotic therapy|empiric antibiotic therapy
309078|NCT02294682|uncomplicated urogenital gonorrhea|uncomplicated urogenital gonorrhea
309079|NCT02294682|Bacterial Type II Topoisomerase Inhibitors (BTI)|bacterial type ii topoisomerase inhibitors (bti)
309080|NCT02294682|antibiotics|antibiotics
309081|NCT02294682|GSK2140944|gsk2140944
309082|NCT02294682|N. gonorrhoeae|n. gonorrhoeae
309083|NCT02294656|CYSTOID MACULAR EDEMA|cystoid macular edema
309084|NCT02294643|sarpogrelate|sarpogrelate
309085|NCT02294591|Bipolar Disorder|bipolar disorder
309086|NCT02294591|Depression|depression
309087|NCT02294591|Acetylcystein|acetylcystein
309088|NCT02294591|Oxidative Stress|oxidative stress
309090|NCT02294578|Biomarkers|biomarkers
309091|NCT02294578|saliva|saliva
309092|NCT02294578|mRNA|mrna
309093|NCT02294565|Sentinel Lymph Node Biopsy|sentinel lymph node biopsy
309094|NCT02294565|Breast Cancer|breast cancer
309095|NCT02294565|Lymphatic Mapping|lymphatic mapping
309096|NCT02294552|Cyclophosphamide|cyclophosphamide
309097|NCT02294552|Leukemia|leukemia
309098|NCT02294552|Lymphoma|lymphoma
309099|NCT02294552|Myelodysplastic Syndromes|myelodysplastic syndromes
309100|NCT02294552|Chronic Lymphocytic Leukemia|chronic lymphocytic leukemia
309101|NCT02294552|Immunosuppressive Agents|immunosuppressive agents
309102|NCT02294552|Immune System Diseases|immune system diseases
309103|NCT02294552|Busulfan|busulfan
309104|NCT02294552|Fludarabine|fludarabine
309105|NCT02294552|Tacrolimus|tacrolimus
309106|NCT02294552|Mycophenolate mofetil|mycophenolate mofetil
309107|NCT02294552|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating
309108|NCT02294552|Myeloablative Agonists|myeloablative agonists
309109|NCT02294552|Hematopoietic Stem Cell Transplantation|hematopoietic stem cell transplantation
309110|NCT02294552|Allogeneic|allogeneic
309111|NCT02294526|Diet|diet
309112|NCT02294526|Sardine|sardine
309113|NCT02294526|Type 2 diabetes|type 2 diabetes
309114|NCT02294513|Alzheimer disease|alzheimer disease
309115|NCT02294513|Dementia|dementia
309116|NCT02294513|Hearing loss|hearing loss
309117|NCT02294513|Correction of hearing impairment|correction of hearing impairment
309118|NCT02294513|Hearing aids|hearing aids
309119|NCT02294513|Communication|communication
309120|NCT02294513|Family caregivers|family caregivers
309121|NCT02294513|Third-party disability|third-party disability
309122|NCT02294500|ovarian function|ovarian function
309123|NCT02294500|female|female
309124|NCT02294500|Genital Function|genital function
309125|NCT02294487|influenza|influenza
309126|NCT02294487|pneumococcal|pneumococcal
309127|NCT02294487|pneumonia|pneumonia
309128|NCT02294487|vaccine|vaccine
309129|NCT02294487|immunization|immunization
309130|NCT02294487|#CAImmun|#caimmun
309131|NCT02294487|Immuno-oncology|immuno-oncology
309132|NCT02294487|supportive care|supportive care
309133|NCT02294487|vaccination|vaccination
309134|NCT02294487|meningococcal|meningococcal
309135|NCT02294487|HIB|hib
309136|NCT02294461|Enzalutamide|enzalutamide
309137|NCT02294461|Androgen receptor|androgen receptor
309138|NCT02294461|Prostate cancer|prostate cancer
309139|NCT02294461|Xtandi|xtandi
309140|NCT02294448|Cervical radiculopathy|cervical radiculopathy
309141|NCT02294448|Neck pain|neck pain
309142|NCT02294448|Qishe pill|qishe pill
309143|NCT02294448|raditional Chinese medicine|raditional chinese medicine
309144|NCT02294448|healthy Chinese subject|healthy chinese subject
309145|NCT02294448|Population Pharmacokinetics|population pharmacokinetics
309146|NCT02294448|Personalized Medicine|personalized medicine
309147|NCT02294448|Individualized Medicine|individualized medicine
309148|NCT02294435|Thoracoabdominal Aneurysms|thoracoabdominal aneurysms
309149|NCT02294435|Endovascular|endovascular
309150|NCT02294435|Ps-ide|ps-ide
309151|NCT02294435|Early Feasibility|early feasibility
309152|NCT02294435|Aneurysm|aneurysm
309153|NCT02294435|Aortic Aneurysm, Thoracic|aortic aneurysm, thoracic
309154|NCT02294435|Aortic Aneurysm|aortic aneurysm
309155|NCT02294435|Aortic Diseases|aortic diseases
309156|NCT02294435|Cardiovascular Diseases|cardiovascular diseases
309157|NCT02294435|Vascular Diseases|vascular diseases
309158|NCT02294435|Pararenal aneurysm|pararenal aneurysm
309159|NCT02294435|Juxtarenal aneurysm|juxtarenal aneurysm
309160|NCT02294435|Aortic dissection|aortic dissection
309161|NCT02294435|Short neck infrarenal aneurysm|short neck infrarenal aneurysm
309162|NCT02294435|Type 4 thoracoabdominal|type 4 thoracoabdominal
309163|NCT02294435|TAAA|taaa
394927|NCT01891513|Aging|aging
309164|NCT02294422|Loss of resistance|loss of resistance
309165|NCT02294422|Pilot balloon|pilot balloon
309166|NCT02294422|Cuff pressure|cuff pressure
309167|NCT02294422|Endotracheal tube|endotracheal tube
309168|NCT02294409|social anxiety|social anxiety
309169|NCT02294409|psychosis|psychosis
309170|NCT02294409|CBT|cbt
309171|NCT02294409|randomized|randomized
309172|NCT02294409|CRT|crt
309173|NCT02294396|Anticholinergic|anticholinergic
309174|NCT02294396|Overactive Bladder (OAB)|overactive bladder (oab)
309175|NCT02294396|Mirabegron|mirabegron
309176|NCT02294396|YM178|ym178
309177|NCT02294383|Pelvic Floor Biomechanics|pelvic floor biomechanics
309178|NCT02294383|Tissue Elasticity|tissue elasticity
309179|NCT02294383|Tactile Imaging|tactile imaging
309180|NCT02294370|type 2 diabetes|type 2 diabetes
309181|NCT02294370|continuous glucose monitoring|continuous glucose monitoring
309182|NCT02294357|carfilzomib|carfilzomib
309183|NCT02294357|proteasome inhibitor|proteasome inhibitor
309184|NCT02294357|multiple myeloma|multiple myeloma
309185|NCT02294357|relapsed/refractory|relapsed/refractory
309186|NCT02294344|double filtration plasmapheresis|double filtration plasmapheresis
309187|NCT02294344|ANCA-Associated Vasculitis|anca-associated vasculitis
309188|NCT02294305|Depression|depression
309189|NCT02294305|Social Anxiety|social anxiety
309190|NCT02294305|Social Phobia|social phobia
309191|NCT02294305|Major Depression|major depression
309192|NCT02294305|Vortioxetine|vortioxetine
309193|NCT02294279|cough, wheeze, dyspnoea|cough, wheeze, dyspnoea
309194|NCT02294240|Pregnant, malnourished, energy dense biscuits, low birth weight|pregnant, malnourished, energy dense biscuits, low birth weight
309195|NCT02294227|AIN457|ain457
309196|NCT02294227|psoriatic arthritis|psoriatic arthritis
309197|NCT02294227|chronic inflammatory disease|chronic inflammatory disease
309198|NCT02294227|loading regimen|loading regimen
309199|NCT02294227|secukinumab|secukinumab
309200|NCT02294227|self-injection|self-injection
309201|NCT02294214|malaria|malaria
309202|NCT02294214|Spatial Repellents|spatial repellents
309203|NCT02294214|Plasmodium|plasmodium
309204|NCT02294201|Malaria|malaria
309205|NCT02294201|Spatial Repellents|spatial repellents
309206|NCT02294201|Plasmodium|plasmodium
309207|NCT02294188|Malaria|malaria
309208|NCT02294188|Spatial Repellents|spatial repellents
309209|NCT02294188|Plasmodium|plasmodium
309210|NCT02294175|larva|larva
309211|NCT02294175|debridement|debridement
309212|NCT02294175|lower extremity or diabetic foot ulcer|lower extremity or diabetic foot ulcer
309213|NCT02294175|biofilm|biofilm
309214|NCT02294175|infection|infection
309215|NCT02294175|chronic wound|chronic wound
309216|NCT02294149|chemotherapy|chemotherapy
309217|NCT02294149|Omega 3|omega 3
309219|NCT02294136|HCV|hcv
309220|NCT02294136|Adherence|adherence
309221|NCT02294136|Psychiatric|psychiatric
309222|NCT02294136|Behavioral|behavioral
309223|NCT02294136|Intervention|intervention
309224|NCT02294110|failure|failure
309225|NCT02294110|spinal anesthesia|spinal anesthesia
309226|NCT02294071|acetaminophen|acetaminophen
309227|NCT02294071|ibuprofen|ibuprofen
309228|NCT02294058|MS|ms
309229|NCT02294058|RMS|rms
309230|NCT02294058|Multiple Sclerosis|multiple sclerosis
309231|NCT02294058|Relapsing Multiple Sclerosis|relapsing multiple sclerosis
309232|NCT02294045|Knee|knee
309233|NCT02294045|Healthy|healthy
309234|NCT02294045|arthroscopy|arthroscopy
309235|NCT02294045|MRI|mri
309236|NCT02294045|amplification|amplification
309237|NCT02294045|sounds|sounds
309238|NCT02294045|pre-operative|pre-operative
309239|NCT02294045|analyzing|analyzing
309240|NCT02294032|Bcells|bcells
309241|NCT02294032|kidney allograft dysfunction|kidney allograft dysfunction
309242|NCT02294032|antibody mediated rejection|antibody mediated rejection
309243|NCT02294019|ibuprofen 400 mg|ibuprofen 400 mg
309244|NCT02294019|actual use|actual use
309245|NCT02294019|compliance|compliance
309246|NCT02294006|pancreatic|pancreatic
309247|NCT02294006|neuroendocrine|neuroendocrine
309248|NCT02294006|everolimus|everolimus
309249|NCT02294006|metformin|metformin
309250|NCT02294006|octreotide|octreotide
309251|NCT02293941|liver inflammation|liver inflammation
309252|NCT02293928|Hybrid coronary revascularization|hybrid coronary revascularization
309253|NCT02293928|Antiplatelet therapy|antiplatelet therapy
309254|NCT02293928|Aspirin|aspirin
309255|NCT02293928|Clopidogrel|clopidogrel
309256|NCT02293889|Knee osteoarthritis|knee osteoarthritis
309257|NCT02293889|Pain|pain
309258|NCT02293889|Vitamin D|vitamin d
309259|NCT02293889|Physical activity|physical activity
309260|NCT02293889|Pilot study|pilot study
309261|NCT02293889|Qualitative Interview|qualitative interview
309262|NCT02293889|Obesity|obesity
309263|NCT02293889|Older adults|older adults
309264|NCT02293876|Corneal Diseases|corneal diseases
309265|NCT02293876|Corneal Ulcer|corneal ulcer
309266|NCT02293876|Nursing Diagnosis|nursing diagnosis
309267|NCT02293876|Intensive Care Units|intensive care units
309268|NCT02293876|Nursing|nursing
309269|NCT02293876|Randomized Clinical Trial|randomized clinical trial
309270|NCT02293837|interleukin-6 (IL-6) receptor inhibitor|interleukin-6 (il-6) receptor inhibitor
309271|NCT02293824|Infant, Premature|infant, premature
309272|NCT02293824|Caffeine|caffeine
309273|NCT02293824|Pharmacokinetics|pharmacokinetics
309274|NCT02293824|Metabolism|metabolism
309275|NCT02293772|Bedrest|bedrest
309276|NCT02293772|Appetite|appetite
309277|NCT02293759|BPH- LASER- PROSTATE- BLEEDING TENDENCY|bph- laser- prostate- bleeding tendency
309278|NCT02293746|Obstructive Sleep Apnea|obstructive sleep apnea
309279|NCT02293746|OSA|osa
309280|NCT02293746|neurostimulation|neurostimulation
309281|NCT02293746|hypoglossal nerve|hypoglossal nerve
309282|NCT02293746|tongue|tongue
309283|NCT02293746|upper airway stimulation|upper airway stimulation
309284|NCT02293746|surgery|surgery
309285|NCT02293733|Retrospective|retrospective
309286|NCT02293733|EGFR|egfr
309287|NCT02293733|mutation|mutation
309288|NCT02293733|TKI|tki
309289|NCT02293733|NSCLC|nsclc
309290|NCT02293707|Castration-resistant prostate cancer|castration-resistant prostate cancer
309291|NCT02293707|Therapeutic vaccine|therapeutic vaccine
309292|NCT02293707|Telomerase vaccine|telomerase vaccine
309293|NCT02293694|DMPA-SC: depo medroxyprogesterone acetate sub-cutaneous|dmpa-sc: depo medroxyprogesterone acetate sub-cutaneous
309294|NCT02293694|DMPA-IM: depo medroxyprogesterone acetate intramuscular|dmpa-im: depo medroxyprogesterone acetate intramuscular
309295|NCT02293681|Spondylitis, Ankylosing|spondylitis, ankylosing
309296|NCT02293681|Infliximab|infliximab
309297|NCT02293681|Non-steroidal anti-inflammatory drugs|non-steroidal anti-inflammatory drugs
309298|NCT02293681|Disease-modifying anti-rheumatic drugs|disease-modifying anti-rheumatic drugs
309299|NCT02293668|poor responders|poor responders
309300|NCT02293655|ADHD|adhd
309301|NCT02293655|inattention|inattention
309302|NCT02293655|hyperactivity|hyperactivity
309303|NCT02293655|methylphenidate|methylphenidate
309304|NCT02293642|primary cancers of the breast|primary cancers of the breast
309305|NCT02293642|primary cancers of the kidney|primary cancers of the kidney
309306|NCT02293642|primary cancers of the lung|primary cancers of the lung
309307|NCT02293642|primary cancers of the prostate|primary cancers of the prostate
309308|NCT02293629|Subjects|subjects
309309|NCT02293616|ICU|icu
309310|NCT02293616|Respiratory Failure|respiratory failure
309311|NCT02293616|Weakness|weakness
309312|NCT02293616|Nitrate supplementation|nitrate supplementation
309313|NCT02293603|cardiomyopathy|cardiomyopathy
309314|NCT02293603|cardiosphere-derived stem cells|cardiosphere-derived stem cells
309315|NCT02293603|intracoronary infusion|intracoronary infusion
309316|NCT02293603|adult stem cells|adult stem cells
309317|NCT02293603|heart disease|heart disease
309318|NCT02293603|ventricular dysfunction|ventricular dysfunction
309319|NCT02293603|pathological processes|pathological processes
309320|NCT02293603|cardiovascular diseases|cardiovascular diseases
309321|NCT02293603|heart failure|heart failure
309322|NCT02293590|Certolizumab pegol|certolizumab pegol
309323|NCT02293590|DMARD|dmard
309324|NCT02293590|Joint injection|joint injection
309325|NCT02293590|Glucocorticoids|glucocorticoids
309326|NCT02293564|Erosive Osteoarthritis|erosive osteoarthritis
309327|NCT02293564|Osteoarthritis|osteoarthritis
309328|NCT02293564|Osteoarthritis of the Hand|osteoarthritis of the hand
309329|NCT02293538|Symptoms of Contact Lens Related Discomfort|symptoms of contact lens related discomfort
309330|NCT02293512|Tinnitus|tinnitus
309331|NCT02293512|Coping|coping
309332|NCT02293512|Psychoeducational intervention|psychoeducational intervention
309333|NCT02293499|asthma|asthma
309334|NCT02293499|adolescent|adolescent
309335|NCT02293499|intervention|intervention
309336|NCT02293486|Antioxidants|antioxidants
309337|NCT02293486|Protein Carbonylation|protein carbonylation
309338|NCT02293486|Malondialdehyde|malondialdehyde
309339|NCT02293486|Punicaceae|punicaceae
309340|NCT02293486|Athletic Performance|athletic performance
309341|NCT02293460|Peripheral neuropathy|peripheral neuropathy
309342|NCT02293460|Disimmune disease|disimmune disease
309343|NCT02293460|Neurology Chronic disease|neurology chronic disease
309344|NCT02293460|Rare disease|rare disease
309345|NCT02293447|Uterine|uterine
309346|NCT02293447|Fibroid|fibroid
309347|NCT02293447|Embolization|embolization
309348|NCT02293447|Leiomyoma|leiomyoma
309349|NCT02293447|Lidocaine|lidocaine
309350|NCT02293447|Pain|pain
309351|NCT02293434|Malnutrition|malnutrition
309352|NCT02293434|Status Nutritional Weight|status nutritional weight
309353|NCT02293434|Pediatric intensive care|pediatric intensive care
309354|NCT02293408|MPS IIIB|mps iiib
309355|NCT02293408|Mucopolysaccharidosis|mucopolysaccharidosis
309356|NCT02293408|Mucopolysaccharidosis type IIIB|mucopolysaccharidosis type iiib
309357|NCT02293408|Sanfilippo Syndrome Type B|sanfilippo syndrome type b
309358|NCT02293395|Acute Coronary Syndrome|acute coronary syndrome
309359|NCT02293395|Myocardial infarction|myocardial infarction
309360|NCT02293395|Unstable angina|unstable angina
309361|NCT02293395|Acetylsalicylic acid|acetylsalicylic acid
309362|NCT02293395|Rivaroxaban|rivaroxaban
309363|NCT02293395|JNJ-39039039|jnj-39039039
309364|NCT02293395|Bay 59-7939|bay 59-7939
309365|NCT02293395|Xarelto|xarelto
309366|NCT02293395|Clopidogrel|clopidogrel
309367|NCT02293395|Ticagrelor|ticagrelor
309368|NCT02293395|Plavix|plavix
309369|NCT02293395|Brilinta|brilinta
309370|NCT02293395|Effient|effient
309371|NCT02293382|MPS IIIB|mps iiib
309372|NCT02293382|Mucopolysaccharodosis III|mucopolysaccharodosis iii
309373|NCT02293382|Mucopolysaccharidosis type IIIB|mucopolysaccharidosis type iiib
309374|NCT02293382|Sanfilippo Syndrome|sanfilippo syndrome
309375|NCT02293343|histamine profile|histamine profile
309376|NCT02293343|IgE Antibodies|ige antibodies
309377|NCT02293330|continuous versus intermittent bolus sciatic nerve block|continuous versus intermittent bolus sciatic nerve block
309378|NCT02293317|Influenza Prime universal vaccine M-001 Multimeric|influenza prime universal vaccine m-001 multimeric
309379|NCT02293291|Gulf war illness|gulf war illness
309380|NCT02293278|MVPA|mvpa
309381|NCT02293278|sedentary behaviour|sedentary behaviour
309382|NCT02293278|PA intervention|pa intervention
309383|NCT02293278|preschool|preschool
309384|NCT02293278|gross motor|gross motor
309385|NCT02293278|anthropometrics|anthropometrics
309386|NCT02293278|day care|day care
309387|NCT02293265|mepolizumab|mepolizumab
309388|NCT02293265|omalizumab|omalizumab
309389|NCT02293265|SB-240563|sb-240563
309390|NCT02293265|Severe Asthma|severe asthma
309391|NCT02293265|reslizumab|reslizumab
309392|NCT02293252|Home Telemonitoring|home telemonitoring
309393|NCT02293239|whole-body electromyostimulation|whole-body electromyostimulation
309394|NCT02293239|cachexia|cachexia
309395|NCT02293239|cancer|cancer
309396|NCT02293239|skeletal muscle mass|skeletal muscle mass
309397|NCT02293239|nutrition|nutrition
309398|NCT02293213|Category D|category d
309399|NCT02293213|Category X|category x
309400|NCT02293213|Electronic Medical Records|electronic medical records
309401|NCT02293213|Long Acting Reversible Contraception|long acting reversible contraception
309402|NCT02293187|vitamin D|vitamin d
309403|NCT02293187|muscle performance|muscle performance
309404|NCT02293187|falls|falls
309405|NCT02293161|Interleukin-7 Receptor α|interleukin-7 receptor α
309406|NCT02293161|monoclonal antibody|monoclonal antibody
309407|NCT02293148|Prolyl hydroxylase inhibitor|prolyl hydroxylase inhibitor
309408|NCT02293148|GSK1278863|gsk1278863
309409|NCT02293148|Anemia|anemia
309410|NCT02293148|QTc|qtc
309411|NCT02293148|erythropoiesis stimulating agent|erythropoiesis stimulating agent
309412|NCT02293135|Type 2 diabetes ; endothelium stimulation|type 2 diabetes ; endothelium stimulation
309413|NCT02293122|Agreement|agreement
309414|NCT02293122|Repeatability|repeatability
309415|NCT02293122|Reproducibility|reproducibility
309416|NCT02293096|Genotype|genotype
309417|NCT02293096|CYP2D6|cyp2d6
309418|NCT02293096|ADRB1|adrb1
309419|NCT02293057|Adolescent|adolescent
309420|NCT02293057|Juvenile Justice|juvenile justice
309421|NCT02293057|Drug Use|drug use
309422|NCT02293057|Marijuana|marijuana
309423|NCT02293057|Gender Responsive|gender responsive
309424|NCT02293057|Girls|girls
309425|NCT02293057|HIV|hiv
309426|NCT02293057|Sexual Risk|sexual risk
309427|NCT02293044|Sensitivity|sensitivity
309428|NCT02293031|maxillofacial bone defects|maxillofacial bone defects
309429|NCT02293031|alveolar ridge atrophy|alveolar ridge atrophy
309430|NCT02293031|gene-activated matrix|gene-activated matrix
309431|NCT02293031|VEGF gene|vegf gene
309432|NCT02293031|DNA plasmid|dna plasmid
309433|NCT02293031|bone gene therapy|bone gene therapy
309434|NCT02293005|Lung Cancer|lung cancer
309435|NCT02293005|Mesothelioma|mesothelioma
309436|NCT02293005|Unresectable malignant pleural mesothelioma|unresectable malignant pleural mesothelioma
309437|NCT02293005|MPM|mpm
309438|NCT02293005|Alisertib|alisertib
309439|NCT02293005|MLN8237|mln8237
309440|NCT02292992|Electrical impedance tomography|electrical impedance tomography
309441|NCT02292992|Nasal Pillow Continuous Positive Airway Pressure(CPAP)|nasal pillow continuous positive airway pressure(cpap)
309442|NCT02292992|High Flow Nasal Cannula|high flow nasal cannula
309443|NCT02292992|extubation|extubation
309444|NCT02292979|HL|hl
309445|NCT02292966|Hepatitis C|hepatitis c
309446|NCT02292966|Hepatitis|hepatitis
309447|NCT02292966|Asunaprevir|asunaprevir
309448|NCT02292966|Daclatasvir|daclatasvir
309449|NCT02292966|Beclabuvir|beclabuvir
309450|NCT02292966|Neurocognitive function|neurocognitive function
309451|NCT02292966|Brain metabolites|brain metabolites
309452|NCT02292966|Direct acting antiviral therapy|direct acting antiviral therapy
309453|NCT02292953|ICSI|icsi
309454|NCT02292953|Ovum Pickup|ovum pickup
309455|NCT02292953|Embryo Transfer|embryo transfer
309456|NCT02292940|patient outcome assessment|patient outcome assessment
309457|NCT02292940|electronic health records|electronic health records
309458|NCT02292888|Doppler VTI TEE SV volume responsiveness|doppler vti tee sv volume responsiveness
309459|NCT02292875|Grass Allergy|grass allergy
309460|NCT02292875|Rhinoconjunctivitis|rhinoconjunctivitis
309461|NCT02292875|Environmental Exposure Unit|environmental exposure unit
309462|NCT02292875|Immunotherapy|immunotherapy
309463|NCT02292875|ToleroMune Grass|toleromune grass
309464|NCT02292849|Depression|depression
309465|NCT02292823|STEMI|stemi
309466|NCT02292823|heart attack|heart attack
309467|NCT02292823|stent|stent
309468|NCT02292823|Bare Metal Stent|bare metal stent
309469|NCT02292823|myocardial infarction|myocardial infarction
309470|NCT02292823|PCI|pci
309471|NCT02292784|infants|infants
309472|NCT02292784|retosiban|retosiban
309473|NCT02292784|Preterm Labor|preterm labor
309474|NCT02292784|long-term safety follow-up|long-term safety follow-up
309475|NCT02292771|Spontaneous Preterm Labor|spontaneous preterm labor
309476|NCT02292771|retosiban|retosiban
309477|NCT02292771|GSK221149|gsk221149
309478|NCT02292771|atosiban|atosiban
309479|NCT02292745|locally advanced pancreatic cancer|locally advanced pancreatic cancer
309480|NCT02292745|chemotherapy|chemotherapy
309481|NCT02292745|stereotactic radiotherapy|stereotactic radiotherapy
309482|NCT02292732|Pharmacokinetics|pharmacokinetics
309483|NCT02292732|Solid Tumors|solid tumors
309484|NCT02292732|Safety|safety
309485|NCT02292732|Trametinib|trametinib
309486|NCT02292732|MEK Inhibitor|mek inhibitor
309487|NCT02292732|Combined Oral Contraceptive|combined oral contraceptive
309488|NCT02292732|Trametinib's Metabolite M5|trametinib's metabolite m5
309489|NCT02292732|Norethindrone|norethindrone
309490|NCT02292732|Ethinyl Estradiol|ethinyl estradiol
309491|NCT02292719|Hepatitis C Virus|hepatitis c virus
309492|NCT02292719|Genotype 2|genotype 2
309493|NCT02292719|Chronic Hepatitis C|chronic hepatitis c
309494|NCT02292719|Genotype 3|genotype 3
309495|NCT02292719|Non-cirrhotic|non-cirrhotic
309496|NCT02292719|Cirrhotic|cirrhotic
309497|NCT02292706|HCV Cirrhosis registry|hcv cirrhosis registry
309498|NCT02292706|Cirrhosis|cirrhosis
309499|NCT02292706|Hepatitis C|hepatitis c
309500|NCT02292693|intubation|intubation
309501|NCT02292680|dentin|dentin
309502|NCT02292680|environmental exposures|environmental exposures
309503|NCT02292680|neurodevelopmental outcomes|neurodevelopmental outcomes
309504|NCT02292667|Transversus Abdominis Plane Block|transversus abdominis plane block
309505|NCT02292667|Postoperative Pain Management|postoperative pain management
309506|NCT02292667|Open Repair of Aortic Abdominal Aneurysm|open repair of aortic abdominal aneurysm
309507|NCT02292641|Lower Gastrointestinal Tract|lower gastrointestinal tract
309508|NCT02292641|Rectum|rectum
309509|NCT02292641|Diagnostic Imaging|diagnostic imaging
309510|NCT02292641|Magnetic Resonance Imaging|magnetic resonance imaging
309511|NCT02292641|Pelvic Exenteration|pelvic exenteration
309512|NCT02292641|Neoplasms|neoplasms
309513|NCT02292641|Adenocarcinoma|adenocarcinoma
309514|NCT02292641|Carcinoma|carcinoma
309515|NCT02292602|preschool|preschool
309516|NCT02292602|obesity|obesity
309517|NCT02292602|health disparities|health disparities
309518|NCT02292602|intervention|intervention
309519|NCT02292589|Traumatic Brain Injury|traumatic brain injury
309520|NCT02292589|Post concussion syndrome|post concussion syndrome
309521|NCT02292589|Transcranial Direct Current Stimulation|transcranial direct current stimulation
309522|NCT02292589|Neuromodulation|neuromodulation
309523|NCT02292576|volunteers|volunteers
309524|NCT02292563|Nurse; Colonoscopy; Polyp; Adenoma;|nurse; colonoscopy; polyp; adenoma;
309525|NCT02292550|Non-small cell lung cancer|non-small cell lung cancer
309526|NCT02292550|ALK translocation|alk translocation
309527|NCT02292550|ALK-positive|alk-positive
309528|NCT02292550|NSCLC|nsclc
309529|NCT02292550|LEE011|lee011
309530|NCT02292550|CDK4/6 inhibitor|cdk4/6 inhibitor
309531|NCT02292550|EML4-ALK|eml4-alk
309532|NCT02292550|cancer|cancer
309533|NCT02292537|Spinal Muscular Atrophy|spinal muscular atrophy
309534|NCT02292537|SMA|sma
309535|NCT02292537|SMN|smn
309536|NCT02292537|SMNRx|smnrx
309537|NCT02292537|ISIS-SMNRx|isis-smnrx
309538|NCT02292537|ISIS-SMN Rx|isis-smn rx
309539|NCT02292537|ISIS 396443|isis 396443
309540|NCT02292537|CHERISH|cherish
309541|NCT02292537|IONIS-SMNRx|ionis-smnrx
309542|NCT02292537|IONIS-SMN Rx|ionis-smn rx
309543|NCT02292511|subjective cognitive impairment|subjective cognitive impairment
309544|NCT02292511|mind-motor intervention|mind-motor intervention
309545|NCT02292511|square-stepping exercise|square-stepping exercise
309546|NCT02292511|older adults|older adults
309547|NCT02292498|imaging, diagnostic|imaging, diagnostic
309548|NCT02292498|feasibility|feasibility
309549|NCT02292485|Lung Cancer Screening|lung cancer screening
309550|NCT02292485|LCS|lcs
309551|NCT02292485|Survey|survey
309552|NCT02292485|Questionnaire|questionnaire
309553|NCT02292485|Texas Academy of Family Physicians|texas academy of family physicians
309554|NCT02292472|masticatory muscles|masticatory muscles
309555|NCT02292446|Polycythemia Vera|polycythemia vera
309556|NCT02292446|Hematologic Diseases|hematologic diseases
309557|NCT02292446|Myeloproliferative Disorders|myeloproliferative disorders
309558|NCT02292446|INC424|inc424
309559|NCT02292446|Ruxolitinib|ruxolitinib
309560|NCT02292446|hydroxyurea resistant|hydroxyurea resistant
309561|NCT02292446|adult|adult
309562|NCT02292433|Phase 1|phase 1
309563|NCT02292433|type 2 diabetes|type 2 diabetes
309564|NCT02292433|monotherapy|monotherapy
309565|NCT02292433|PF-04937319|pf-04937319
309566|NCT02292420|pulse oximetry plethymographic waveform|pulse oximetry plethymographic waveform
309567|NCT02292420|area under curve|area under curve
309568|NCT02292420|amplitude|amplitude
309569|NCT02292394|Depression|depression
309570|NCT02292394|Depressive symptoms|depressive symptoms
309571|NCT02292394|Prevention|prevention
309572|NCT02292394|Caregivers|caregivers
309573|NCT02292394|Telephone intervention|telephone intervention
309574|NCT02292368|Head and Neck Cancer|head and neck cancer
309575|NCT02292368|Xerostomia|xerostomia
309576|NCT02292368|Radiation-induced Xerostomia|radiation-induced xerostomia
309577|NCT02292368|Acupuncture|acupuncture
309578|NCT02292368|Nasopharyngeal cancer|nasopharyngeal cancer
309579|NCT02292368|Radiation therapy|radiation therapy
309580|NCT02292368|XRT|xrt
309581|NCT02292368|Electroencephalogram|electroencephalogram
309582|NCT02292368|EEG|eeg
309583|NCT02292368|Xerostomia questionnaire|xerostomia questionnaire
309585|NCT02292368|MD Anderson Symptom Inventory - Head & Neck|md anderson symptom inventory - head & neck
309586|NCT02292368|MDASI-HN|mdasi-hn
309587|NCT02292368|Questionnaires|questionnaires
309588|NCT02292368|Surveys|surveys
309589|NCT02292355|Temporomandibular Joint Disorders|temporomandibular joint disorders
309590|NCT02292355|posture|posture
309591|NCT02292355|pain|pain
309592|NCT02292355|clinical trial|clinical trial
309593|NCT02292355|Pilates|pilates
309594|NCT02292342|Flow mediated dilatation|flow mediated dilatation
309595|NCT02292329|flow-mediated dilation|flow-mediated dilation
309596|NCT02292329|Acai polyphenols|acai polyphenols
309597|NCT02292316|middle-aged and aged adults|middle-aged and aged adults
309598|NCT02292316|fall in the previous year|fall in the previous year
309599|NCT02292303|Zinc/pharmacokinetics|zinc/pharmacokinetics
309600|NCT02292290|Diabetes|diabetes
309601|NCT02292290|Liraglutide|liraglutide
309602|NCT02292290|Ramadan|ramadan
309603|NCT02292290|fasting|fasting
309604|NCT02292277|Ticagrelor|ticagrelor
309605|NCT02292277|Pharmacokinetics|pharmacokinetics
309606|NCT02292277|Platelet Aggregation|platelet aggregation
309607|NCT02292277|Platelet Function Tests|platelet function tests
309608|NCT02292251|Stroke|stroke
309609|NCT02292251|Transcranial direct current stimulation|transcranial direct current stimulation
309610|NCT02292238|Alzheimer's disease|alzheimer's disease
309611|NCT02292238|benfotiamine|benfotiamine
309612|NCT02292238|glucose|glucose
309613|NCT02292238|Amyloid|amyloid
309614|NCT02292225|Phase 1b, CLL/SLL, PI3K|phase 1b, cll/sll, pi3k
309615|NCT02292199|Hypertension|hypertension
309616|NCT02292199|TENS|tens
309617|NCT02292199|Sympathetic and Parasympathetic nervous system|sympathetic and parasympathetic nervous system
309618|NCT02292186|Cardiomyopathy|cardiomyopathy
309619|NCT02292186|Heart Failure|heart failure
309620|NCT02292186|FAC|fac
309621|NCT02292186|Amyloid|amyloid
309622|NCT02292186|Transthyretin|transthyretin
309623|NCT02292186|TTR|ttr
309624|NCT02292186|RNAi therapeutic|rnai therapeutic
309625|NCT02292173|Liver Neoplasms|liver neoplasms
309626|NCT02292173|Liver Diseases|liver diseases
309627|NCT02292173|Digestive System Diseases|digestive system diseases
309628|NCT02292173|Advanced|advanced
309629|NCT02292173|Mitogen-Activated Protein Kinase (MEK) Inhibitor|mitogen-activated protein kinase (mek) inhibitor
309630|NCT02292173|Kinase Inhibitor|kinase inhibitor
309631|NCT02292147|Cerebral anoxia|cerebral anoxia
309632|NCT02292147|Functional outcome|functional outcome
309633|NCT02292134|Sleep quality|sleep quality
309634|NCT02292134|Sleep architecture|sleep architecture
309635|NCT02292134|Intensive care unit|intensive care unit
309636|NCT02292134|Light|light
309637|NCT02292134|Noise|noise
309638|NCT02292134|Earplug|earplug
309639|NCT02292134|Sleep mask|sleep mask
309640|NCT02292121|Obesity|obesity
309641|NCT02292121|Intestinal permeability|intestinal permeability
309642|NCT02292121|Adipose tissue inflammation|adipose tissue inflammation
309643|NCT02292121|Low grade systemic inflammation|low grade systemic inflammation
309644|NCT02292121|Bariatric surgery|bariatric surgery
309645|NCT02292108|Hypnosis|hypnosis
309646|NCT02292108|self-hypnosis|self-hypnosis
309647|NCT02292108|obesity|obesity
309648|NCT02292108|high food impulsiveness|high food impulsiveness
309649|NCT02292095|anesthesia|anesthesia
309650|NCT02292095|transverse abdominis plane block|transverse abdominis plane block
309651|NCT02292095|patient controlled intravenous analgesia|patient controlled intravenous analgesia
309652|NCT02292082|Nerve Block|nerve block
309653|NCT02292082|Rehabilitation|rehabilitation
309654|NCT02292082|Knee Replacement, Total|knee replacement, total
309655|NCT02291991|Safety|safety
309656|NCT02291991|Tolerability|tolerability
309657|NCT02291991|Pharmacokinetics|pharmacokinetics
309658|NCT02291991|Pharmacodynamics|pharmacodynamics
309659|NCT02291991|Immunogenecity|immunogenecity
309660|NCT02291978|back pain|back pain
309661|NCT02291978|facet joint|facet joint
309662|NCT02291978|spine|spine
309663|NCT02291965|hematopoietic cell transplant|hematopoietic cell transplant
309664|NCT02291952|Circadian Misalignment, Forced Desynchrony, Metabolism, Meal-timing, Circadian|circadian misalignment, forced desynchrony, metabolism, meal-timing, circadian
309665|NCT02291926|Human Umbilical Cord Mesenchymal Stem Cell|human umbilical cord mesenchymal stem cell
309666|NCT02291926|Mesenchymal Stem Cell|mesenchymal stem cell
309667|NCT02291926|Osteoarthritis|osteoarthritis
309668|NCT02291913|ER-Positive Breast Cancer|er-positive breast cancer
309669|NCT02291913|HER2-Negative Breast Cancer|her2-negative breast cancer
309670|NCT02291913|everolimus|everolimus
309671|NCT02291913|anti-estrogen therapy|anti-estrogen therapy
309672|NCT02291913|PR-Positive Breast Cancer|pr-positive breast cancer
309673|NCT02291913|Afinitor|afinitor
309674|NCT02291900|avascular necrosis, talus, medial femoral condyle|avascular necrosis, talus, medial femoral condyle
309675|NCT02291874|Diabetes|diabetes
309676|NCT02291874|Ipragliflozin|ipragliflozin
309677|NCT02291874|GLP-1 receptor agonist|glp-1 receptor agonist
309678|NCT02291861|Dyskinesias|dyskinesias
309679|NCT02291861|Movement Disorders|movement disorders
309680|NCT02291861|Central Nervous System Diseases|central nervous system diseases
309681|NCT02291861|Nervous System Diseases|nervous system diseases
309682|NCT02291861|Neurologic Manifestations|neurologic manifestations
309683|NCT02291861|Signs and Symptoms|signs and symptoms
309684|NCT02291848|Multiple Myeloma|multiple myeloma
309685|NCT02291848|Cytotoxic T-lymphocytes|cytotoxic t-lymphocytes
309686|NCT02291809|HIV/AIDS|hiv/aids
309687|NCT02291809|Pediatric|pediatric
309689|NCT02291809|HIV-1 Immunogen|hiv-1 immunogen
309690|NCT02291796|Bezafibrate|bezafibrate
309691|NCT02291796|Hyperfibrinogenemia|hyperfibrinogenemia
309692|NCT02291796|Inflammatory response|inflammatory response
309693|NCT02291796|Acute myocardial infarction|acute myocardial infarction
309694|NCT02291796|Mayor cardiovascular events|mayor cardiovascular events
309695|NCT02291770|Chronic Graft-Versus-Host Disease|chronic graft-versus-host disease
309696|NCT02291770|Mesenchymal Stromal Cells|mesenchymal stromal cells
309697|NCT02291744|TFS (time to failure of strategy)|tfs (time to failure of strategy)
309698|NCT02291731|Autologous serum eye drops|autologous serum eye drops
309699|NCT02291731|Silicone-hydrogel contact lens|silicone-hydrogel contact lens
309700|NCT02291731|Persistent epithelial defects|persistent epithelial defects
309701|NCT02291731|Corneal epithelial defects|corneal epithelial defects
309702|NCT02291718|Suspected or confirmed|suspected or confirmed
309703|NCT02291718|TAA|taa
309704|NCT02291718|Computed tomography angiography|computed tomography angiography
309705|NCT02291718|CTA|cta
309706|NCT02291718|Contrast agent|contrast agent
309707|NCT02291718|Radiation dose|radiation dose
309708|NCT02291718|Thoracoabdominal aortic aneurysm|thoracoabdominal aortic aneurysm
309709|NCT02291705|Ultrasound, rectus sheath block, children, inguinal hernia|ultrasound, rectus sheath block, children, inguinal hernia
309710|NCT02291666|Cytochromes p450|cytochromes p450
309711|NCT02291666|drug metabolism|drug metabolism
309712|NCT02291666|pharmacokinetics|pharmacokinetics
309713|NCT02291666|diabetes|diabetes
309714|NCT02291666|probe markers|probe markers
309715|NCT02291614|Amgen|amgen
309716|NCT02291614|Phase 1|phase 1
309717|NCT02291614|Clinical Trial|clinical trial
309718|NCT02291614|Oncology|oncology
309719|NCT02291614|GI adenocarcinoma|gi adenocarcinoma
309720|NCT02291614|Immunotherapy|immunotherapy
309721|NCT02291549|endoscopic sinus surgery|endoscopic sinus surgery
309722|NCT02291549|corticosteroid|corticosteroid
309723|NCT02291549|chronic rhinosinusitis|chronic rhinosinusitis
309724|NCT02291549|mometasone furoate|mometasone furoate
309725|NCT02291549|polyposis|polyposis
309726|NCT02291536|THC and CBD|thc and cbd
309727|NCT02291536|Attentional blink|attentional blink
309728|NCT02291523|Fecal transplant|fecal transplant
309729|NCT02291484|Computed tomography|computed tomography
309730|NCT02291484|Coronary angiography|coronary angiography
309731|NCT02291484|Coronary artery disease|coronary artery disease
309732|NCT02291484|Perfusion imaging|perfusion imaging
309733|NCT02291484|Comparative effectiveness|comparative effectiveness
309734|NCT02291484|Randomized controlled trial|randomized controlled trial
309735|NCT02291484|Cost-effectiveness|cost-effectiveness
309736|NCT02291445|Peppermint oil|peppermint oil
309737|NCT02291445|Menthol|menthol
309738|NCT02291445|Volatile oil|volatile oil
309739|NCT02291445|Plant oil|plant oil
309740|NCT02291445|Visceral pain|visceral pain
309741|NCT02291445|Abdominal pain|abdominal pain
309742|NCT02291445|Irritable bowel syndrome (IBS)|irritable bowel syndrome (ibs)
309743|NCT02291445|Colonic disease|colonic disease
309744|NCT02291432|Urinary Incontinence, Stress|urinary incontinence, stress
309745|NCT02291432|Tissue Therapy (Cell Therapy)|tissue therapy (cell therapy)
309746|NCT02291419|ticagrelor|ticagrelor
309747|NCT02291419|non-cardiac surgery|non-cardiac surgery
309748|NCT02291419|elevated troponin|elevated troponin
309749|NCT02291419|myocardial injury|myocardial injury
309750|NCT02291406|Hysterectomy|hysterectomy
309751|NCT02291406|Insulin resistance|insulin resistance
309752|NCT02291406|Metabolism|metabolism
309753|NCT02291380|Chronic Migraine|chronic migraine
309754|NCT02291380|Botulinum Toxin Type A for Injection|botulinum toxin type a for injection
309755|NCT02291354|Fecal Microbiota Transplantation|fecal microbiota transplantation
309756|NCT02291354|Soluble Dietary Fiber|soluble dietary fiber
395679|NCT01888354|MS|ms
309757|NCT02291354|Slow Transit Constipation|slow transit constipation
309758|NCT02291315|Triple Stable Isotope|triple stable isotope
309759|NCT02291263|Polio|polio
309760|NCT02291263|Inactivated polio vaccine|inactivated polio vaccine
309761|NCT02291263|IPV|ipv
309762|NCT02291263|oral polio vaccine|oral polio vaccine
309763|NCT02291250|anthocyanin|anthocyanin
309764|NCT02291250|blackcurrant|blackcurrant
309765|NCT02291250|greencurrant|greencurrant
309766|NCT02291250|glucose|glucose
309767|NCT02291250|polyphenol|polyphenol
309768|NCT02291250|post prandial glucose|post prandial glucose
309769|NCT02291237|hypertrophic cardiomyopathy|hypertrophic cardiomyopathy
309770|NCT02291237|hcm|hcm
309771|NCT02291237|hocm|hocm
309772|NCT02291237|hypertrophic myocardiopathy|hypertrophic myocardiopathy
309773|NCT02291237|hypertrophic obstructive cardiomyopathies|hypertrophic obstructive cardiomyopathies
309774|NCT02291237|cardiomyopathy|cardiomyopathy
309775|NCT02291237|hypertrophic|hypertrophic
309776|NCT02291237|familial hypertrophic cardiomyopathy|familial hypertrophic cardiomyopathy
309777|NCT02291237|genetic heart disease|genetic heart disease
309778|NCT02291237|echocardiography|echocardiography
309779|NCT02291237|cardiopulmonary exercise testing|cardiopulmonary exercise testing
309780|NCT02291237|exercise Capacity|exercise capacity
309781|NCT02291237|heart failure|heart failure
309782|NCT02291237|angina|angina
309783|NCT02291237|dyspnea|dyspnea
309784|NCT02291237|diastolic dysfunction|diastolic dysfunction
309785|NCT02291237|microvascular ischemia|microvascular ischemia
309786|NCT02291237|late sodium current inhibitor|late sodium current inhibitor
309787|NCT02291237|GS-6615|gs-6615
309788|NCT02291237|late INA|late ina
309789|NCT02291224|dual protection|dual protection
309790|NCT02291224|pregnancy|pregnancy
309791|NCT02291224|reproductive health|reproductive health
309792|NCT02291224|sexually transmitted diseases|sexually transmitted diseases
309793|NCT02291224|condoms|condoms
309794|NCT02291224|contraception|contraception
309795|NCT02291224|adolescent health services|adolescent health services
309796|NCT02291198|colorectal cancer|colorectal cancer
309797|NCT02291198|natural killer cell activity|natural killer cell activity
309798|NCT02291198|screening|screening
309799|NCT02291198|NK cells|nk cells
309800|NCT02291159|stroke|stroke
309801|NCT02291159|spasticity|spasticity
309802|NCT02291159|dry needling|dry needling
309803|NCT02291159|upper motor neuron syndrome|upper motor neuron syndrome
309804|NCT02291159|motor function|motor function
309805|NCT02291146|gardening|gardening
309806|NCT02291146|cooking|cooking
309807|NCT02291146|nutrition education|nutrition education
309808|NCT02291146|Hispanic Americans|hispanic americans
309809|NCT02291133|Primary liver tumors|primary liver tumors
309810|NCT02291133|Bleomycin|bleomycin
309811|NCT02291133|Electrochemotherapy|electrochemotherapy
309812|NCT02291107|Gait orthosis|gait orthosis
309813|NCT02291107|Lokomat|lokomat
309814|NCT02291107|Robotic Rehabilitation|robotic rehabilitation
309815|NCT02291094|Intravenous lidocaine|intravenous lidocaine
309816|NCT02291094|Mastectomy|mastectomy
309817|NCT02291094|Pain|pain
309818|NCT02291081|HIV, AIDS|hiv, aids
309819|NCT02291081|antiretroviral therapy|antiretroviral therapy
309820|NCT02291081|aging|aging
309821|NCT02291081|heart failure|heart failure
309822|NCT02291081|coronary heart disease|coronary heart disease
309823|NCT02291081|myocardial infarction|myocardial infarction
309824|NCT02291081|HIV-associated neurocognitive disorders|hiv-associated neurocognitive disorders
309825|NCT02291042|Bladder|bladder
309826|NCT02291042|Surgery|surgery
309827|NCT02291029|Sjögren's syndrome, CFZ533, ESSDAI|sjögren's syndrome, cfz533, essdai
309828|NCT02291016|COPD|copd
309829|NCT02291016|chronic obstructive pulmonary disease|chronic obstructive pulmonary disease
309830|NCT02291003|circadian|circadian
309831|NCT02291003|sleep|sleep
309832|NCT02290977|RT, TACE|rt, tace
309833|NCT02290964|Acute normovolemic hemodilution|acute normovolemic hemodilution
309834|NCT02290964|allogeneic transfusion|allogeneic transfusion
309835|NCT02290938|adolescents|adolescents
309836|NCT02290938|Native American|native american
309837|NCT02290938|alcohol use|alcohol use
309838|NCT02290938|drug use|drug use
309839|NCT02290938|cultural|cultural
309840|NCT02290938|traditional activities|traditional activities
309841|NCT02290938|cultural identification|cultural identification
309842|NCT02290925|biscuit containing Salacia reticulate|biscuit containing salacia reticulate
309843|NCT02290925|randomised controlled trial|randomised controlled trial
309844|NCT02290912|Alzheimer's disease prevention lifestyle intervention|alzheimer's disease prevention lifestyle intervention
309845|NCT02290899|Attention Deficit Hyperactivity Disorder (ADHD)|attention deficit hyperactivity disorder (adhd)
309846|NCT02290886|safety evaluation|safety evaluation
309847|NCT02290886|intravenous administration|intravenous administration
309848|NCT02290886|3 doses of autologous MSC|3 doses of autologous msc
309850|NCT02290834|Chemotherapy related cognitive impairment|chemotherapy related cognitive impairment
309851|NCT02290834|Chemo-brain|chemo-brain
309852|NCT02290808|physical|physical
395814|NCT01887600|anemia|anemia
309853|NCT02290808|activity|activity
309854|NCT02290808|exercise|exercise
309855|NCT02290808|new-parents|new-parents
309856|NCT02290808|intervention|intervention
309857|NCT02290808|theory-based|theory-based
309858|NCT02290795|Vitreopapillary traction|vitreopapillary traction
309859|NCT02290782|toxicity|toxicity
309860|NCT02290782|outcome|outcome
309861|NCT02290782|TARGIT|targit
309862|NCT02290782|quality of life|quality of life
309863|NCT02290782|intraoperative radiotherapy (IORT)|intraoperative radiotherapy (iort)
309864|NCT02290769|Guide wire cannulation ERCP|guide wire cannulation ercp
309865|NCT02290769|Time of cannulation|time of cannulation
309866|NCT02290769|Rapid exchange guide wire|rapid exchange guide wire
309867|NCT02290769|Guide wire|guide wire
309868|NCT02290756|Early child development|early child development
309869|NCT02290756|Link Workers|link workers
309870|NCT02290756|Community Birth attendants|community birth attendants
309871|NCT02290756|Parenting Program|parenting program
309872|NCT02290730|Lower trapezius|lower trapezius
309873|NCT02290730|Kinesio taping|kinesio taping
309874|NCT02290717|ultraviolet therapy|ultraviolet therapy
309875|NCT02290717|non segmental|non segmental
309876|NCT02290717|vitiligo|vitiligo
309877|NCT02290717|topical corticosteroid|topical corticosteroid
309878|NCT02290717|laser|laser
309879|NCT02290717|fractional|fractional
309880|NCT02290717|CO2|co2
309881|NCT02290717|carbon dioxide|carbon dioxide
309882|NCT02290717|UVB|uvb
309883|NCT02290704|oxygen saturation|oxygen saturation
309884|NCT02290704|retinal vessels|retinal vessels
309885|NCT02290704|thyroid associated ophthalmopathy|thyroid associated ophthalmopathy
309886|NCT02290691|Needle Free, Influenza|needle free, influenza
309887|NCT02290678|Pilot Study|pilot study
309888|NCT02290678|Adventure-based Programming|adventure-based programming
309889|NCT02290665|enema|enema
309890|NCT02290652|Sexual function in Orthopaedic patients|sexual function in orthopaedic patients
309891|NCT02290639|Posttraumatic Stress|posttraumatic stress
309892|NCT02290639|Posttraumatic Stress Disorder|posttraumatic stress disorder
309893|NCT02290639|Military|military
309894|NCT02290639|Primary Care|primary care
309895|NCT02290639|Cognitive Behavioral Therapy|cognitive behavioral therapy
309896|NCT02290639|Prolonged Exposure|prolonged exposure
309897|NCT02290639|Cognitive Processing Therapy|cognitive processing therapy
309898|NCT02290639|Behavioral Health Optimization Program|behavioral health optimization program
309899|NCT02290639|Behavioral Health Consultant|behavioral health consultant
309900|NCT02290626|Elemental diet|elemental diet
309901|NCT02290626|semi-solid diet|semi-solid diet
309902|NCT02290626|gastric emptying|gastric emptying
309903|NCT02290626|GER|ger
309904|NCT02290626|PEG|peg
309905|NCT02290613|pulmonary hypertension|pulmonary hypertension
309906|NCT02290613|systemic sclerosis|systemic sclerosis
309907|NCT02290587|social cognitive|social cognitive
309908|NCT02290587|theory of mind|theory of mind
309909|NCT02290587|cognitive impairment|cognitive impairment
309910|NCT02290587|functional MRI|functional mri
309911|NCT02290587|brain activation network|brain activation network
309912|NCT02290561|Prostatic Neoplasms|prostatic neoplasms
309913|NCT02290561|Therapeutics|therapeutics
309914|NCT02290561|Magnetic Resonance Imaging|magnetic resonance imaging
309915|NCT02290561|Ultrasonography|ultrasonography
309916|NCT02290561|High Intensity Focused Ultrasound|high intensity focused ultrasound
309917|NCT02290561|Image Fusion|image fusion
309918|NCT02290548|high flow nasal cannula|high flow nasal cannula
309919|NCT02290548|extubation failure|extubation failure
309920|NCT02290535|obstructive pulmonary disease|obstructive pulmonary disease
309921|NCT02290535|children|children
309922|NCT02290535|teenager|teenager
309923|NCT02290535|EIT (Electrical Impedance Tomography)|eit (electrical impedance tomography)
309924|NCT02290496|Insomnia|insomnia
309925|NCT02290496|Depression|depression
309926|NCT02290496|Teen|teen
309927|NCT02290496|SSRI|ssri
309928|NCT02290496|CBT|cbt
309929|NCT02290496|Youth|youth
309930|NCT02290470|Nausea|nausea
309931|NCT02290470|Vomiting|vomiting
309932|NCT02290457|resistance training|resistance training
309933|NCT02290457|trunk muscle strength|trunk muscle strength
309934|NCT02290457|physical fitness|physical fitness
309935|NCT02290457|adolescent|adolescent
309936|NCT02290444|Acute Relapsing Multiple Sclerosis|acute relapsing multiple sclerosis
309937|NCT02290444|Relapsing-Remitting Multiple Sclerosis|relapsing-remitting multiple sclerosis
309938|NCT02290444|Multiple Sclerosis, Chronic Progressive|multiple sclerosis, chronic progressive
309939|NCT02290431|LBH589|lbh589
309940|NCT02290431|panobinostat|panobinostat
309941|NCT02290431|bortezomib|bortezomib
309942|NCT02290431|dexamethasone|dexamethasone
309943|NCT02290431|Phase II|phase ii
309944|NCT02290431|bortezomib and dexamethasone|bortezomib and dexamethasone
309945|NCT02290431|Japanese patients|japanese patients
309946|NCT02290431|relapsed/refractory multiple myeloma|relapsed/refractory multiple myeloma
309947|NCT02290431|Panobinostat (PAN)|panobinostat (pan)
309948|NCT02290418|Roux-en-Y Gastric Bypass|roux-en-y gastric bypass
309949|NCT02290418|Omega-Loop Gastric Bypass|omega-loop gastric bypass
309950|NCT02290418|"Mini-Gastric Bypass"|"mini-gastric bypass"
309951|NCT02290405|insomnia|insomnia
309952|NCT02290405|primary insomnia|primary insomnia
309953|NCT02290405|chronic insomnia|chronic insomnia
309954|NCT02290392|African American|african american
309955|NCT02290353|Engagement|engagement
309956|NCT02290353|Motivation|motivation
309957|NCT02290353|Exergaming|exergaming
309958|NCT02290340|Respiratory Syncytial Virus, RSV|respiratory syncytial virus, rsv
309959|NCT02290327|Stress ulcer bleeding|stress ulcer bleeding
309960|NCT02290327|proton pump inhibitors|proton pump inhibitors
309961|NCT02290327|pneumonia|pneumonia
309962|NCT02290327|clostridium difficile infection|clostridium difficile infection
309963|NCT02290262|Heart disease|heart disease
309964|NCT02290262|Phase one rehabilitation|phase one rehabilitation
309965|NCT02290223|Chronic pain|chronic pain
309966|NCT02290223|Analgesics, Opioid|analgesics, opioid
309967|NCT02290223|Cognitive Therapy|cognitive therapy
309968|NCT02290223|Behavior Therapy|behavior therapy
309969|NCT02290223|Mindfulness|mindfulness
309970|NCT02290223|Psychophysiology|psychophysiology
309971|NCT02290223|Biofeedback, Psychology|biofeedback, psychology
309972|NCT02290184|Type 2 diabetes|type 2 diabetes
309973|NCT02290184|cardiovascular disease prevention|cardiovascular disease prevention
309974|NCT02290184|weight loss lifestyle intervention|weight loss lifestyle intervention
309975|NCT02290184|physical activity|physical activity
309976|NCT02290184|diet|diet
309977|NCT02290184|Filipinos|filipinos
309978|NCT02290158|treatment outcomes|treatment outcomes
309979|NCT02290158|Malocclusion/therapy|malocclusion/therapy
309980|NCT02290145|docetaxel, cisplatin, 5-FU, cyclinD1|docetaxel, cisplatin, 5-fu, cyclind1
309981|NCT02290132|acute lymphoblastic leukemia|acute lymphoblastic leukemia
309982|NCT02290132|lymphoblastic lymphoma|lymphoblastic lymphoma
309983|NCT02290132|stem-cell transplant|stem-cell transplant
309984|NCT02290132|T-cell lymphoma|t-cell lymphoma
309985|NCT02290119|Primary PCL-retaining Total Knee Arthroplasty|primary pcl-retaining total knee arthroplasty
309986|NCT02290119|Intraoperative Sensors|intraoperative sensors
309987|NCT02290119|Ligament Balancing|ligament balancing
309988|NCT02290119|Clinical Outcomes|clinical outcomes
309990|NCT02290106|insulin sensitivity|insulin sensitivity
309991|NCT02290106|statin (HMG-CoA Reductase Inhibitor)|statin (hmg-coa reductase inhibitor)
309992|NCT02290106|fatty liver|fatty liver
309993|NCT02290093|Cathartics|cathartics
309994|NCT02290093|Colonoscopy|colonoscopy
309995|NCT02290093|Polyethylene Glycols|polyethylene glycols
309996|NCT02290093|Elderly|elderly
309997|NCT02290080|acute myocardial infarction (AMI)|acute myocardial infarction (ami)
309998|NCT02290080|acute coronary syndrome (ACS)|acute coronary syndrome (acs)
309999|NCT02290080|ST-segment elevation myocardial infarction (STEMI)|st-segment elevation myocardial infarction (stemi)
310000|NCT02290080|Non ST-segment elevation myocardial infarction (NSTEMI)|non st-segment elevation myocardial infarction (nstemi)
310001|NCT02290080|Ischemic Reperfusion injury (IR-injury)|ischemic reperfusion injury (ir-injury)
310002|NCT02290080|Biomarkers|biomarkers
310003|NCT02290080|Oxygen|oxygen
310004|NCT02290080|Apoptosis|apoptosis
310005|NCT02290080|Fluorescence-activated cell sorting (FACS)|fluorescence-activated cell sorting (facs)
310006|NCT02290080|Flow cytometry|flow cytometry
310007|NCT02290080|Matrix metalloproteinase (MMP)|matrix metalloproteinase (mmp)
310008|NCT02290067|blood glucose monitoring system|blood glucose monitoring system
310009|NCT02290067|system accuracy|system accuracy
310010|NCT02290054|analgesia, epidural|analgesia, epidural
310011|NCT02290054|urinary retention|urinary retention
310012|NCT02290041|mesenchymal stem cells|mesenchymal stem cells
310013|NCT02290041|HIV Infection|hiv infection
310014|NCT02290041|discordant immunological response|discordant immunological response
310015|NCT02290028|CRT-D therapy|crt-d therapy
310016|NCT02290028|quadripolar left ventricular lead|quadripolar left ventricular lead
310017|NCT02290015|Single Photon Emission Computed Tomography; Acupuncture|single photon emission computed tomography; acupuncture
310018|NCT02289989|Atopic dermatitis|atopic dermatitis
310019|NCT02289989|Oregano|oregano
310020|NCT02289989|Atopic Dermatitis Quick (ADQ) score|atopic dermatitis quick (adq) score
310021|NCT02289989|Eczema Area and Severity Index score|eczema area and severity index score
310022|NCT02289989|Reflectance confocal microscopy|reflectance confocal microscopy
310023|NCT02289976|talar avascular necrosis|talar avascular necrosis
310024|NCT02289976|osteochondrosis dissecans|osteochondrosis dissecans
310025|NCT02289976|femoral condyle|femoral condyle
310026|NCT02289950|Ovarian Cancer in in first relapse|ovarian cancer in in first relapse
310027|NCT02289950|Platinum-Sensitive|platinum-sensitive
310028|NCT02289937|Postoperative pain|postoperative pain
310029|NCT02289937|regional anaesthesia|regional anaesthesia
310030|NCT02289937|total hip replacement|total hip replacement
310031|NCT02289937|nervus cutaneous femoral lateralis|nervus cutaneous femoral lateralis
310032|NCT02289924|wet AMD|wet amd
310033|NCT02289911|ultrasound|ultrasound
310034|NCT02289898|1st-line metastatic pancreatic ductal adenocarcinoma|1st-line metastatic pancreatic ductal adenocarcinoma
310035|NCT02289885|trauma|trauma
310036|NCT02289885|examination|examination
310037|NCT02289885|knowledge|knowledge
310038|NCT02289885|paramedic|paramedic
310039|NCT02289820|RSV|rsv
310040|NCT02289820|Older adults|older adults
310041|NCT02289820|MEDI7510|medi7510
310042|NCT02289820|Vaccine|vaccine
310043|NCT02289807|Nasopharyngeal carcinoma|nasopharyngeal carcinoma
310044|NCT02289807|Concurrent chemoradiotherapy|concurrent chemoradiotherapy
310045|NCT02289807|intermediate risk|intermediate risk
310046|NCT02289807|intensity-modulated radiotherapy|intensity-modulated radiotherapy
310047|NCT02289794|Bioconjugate vaccine|bioconjugate vaccine
310048|NCT02289794|Urinary tract infections|urinary tract infections
310049|NCT02289755|Urine Oxalate|urine oxalate
310050|NCT02289755|Nephrolithiasis|nephrolithiasis
310051|NCT02289755|Kidney Stones|kidney stones
310052|NCT02289755|Hyperoxaluria|hyperoxaluria
310053|NCT02289755|Enteric Hyperoxaluria|enteric hyperoxaluria
310054|NCT02289755|Idiopathic Hyperoxaluria|idiopathic hyperoxaluria
310055|NCT02289755|Urological Diseases|urological diseases
310056|NCT02289755|Kidney Diseases|kidney diseases
310057|NCT02289742|Dailies AquaComfort Plus® Multifocal (DACP MF)|dailies aquacomfort plus® multifocal (dacp mf)
310058|NCT02289742|Dailies AquaComfort Plus® Toric (DACP Toric)|dailies aquacomfort plus® toric (dacp toric)
310059|NCT02289742|tear film stability|tear film stability
310259|NCT02288754|WGS|wgs
310060|NCT02289742|Non-Invasive Keratograph Break-Up Time (NIK-BUT)|non-invasive keratograph break-up time (nik-but)
310061|NCT02289729|Duodopa|duodopa
310062|NCT02289729|Advanced Parkinson's Disease|advanced parkinson's disease
310063|NCT02289729|Levodopa/Carbidopa intestinal gel|levodopa/carbidopa intestinal gel
310064|NCT02289716|Osteoarthritis|osteoarthritis
310065|NCT02289716|Pain|pain
310066|NCT02289716|Fulranumab|fulranumab
310067|NCT02289716|JNJ-42160443|jnj-42160443
310068|NCT02289716|Monotherapy|monotherapy
310069|NCT02289716|Hip|hip
310070|NCT02289716|Knee|knee
310071|NCT02289716|Joint replacement surgery|joint replacement surgery
310072|NCT02289703|End-Stage Renal Disease|end-stage renal disease
310073|NCT02289703|Healthy|healthy
310074|NCT02289703|Rivaroxaban|rivaroxaban
310075|NCT02289703|BAY 59-7939|bay 59-7939
310076|NCT02289703|JNJ-39039039|jnj-39039039
310077|NCT02289703|Xarelto|xarelto
310078|NCT02289703|Hemodialysis|hemodialysis
310079|NCT02289703|Blood Coagulation|blood coagulation
310080|NCT02289703|Pharmacokinetics|pharmacokinetics
310081|NCT02289690|Extensive Stage Smal Cell Lung Cancer|extensive stage smal cell lung cancer
310082|NCT02289690|ABT-888|abt-888
310083|NCT02289690|Veliparib|veliparib
310084|NCT02289690|PARP - Poly (ADP) ribose polymerase|parp - poly (adp) ribose polymerase
310085|NCT02289677|intubation|intubation
310086|NCT02289677|child|child
310087|NCT02289677|resuscitation|resuscitation
310088|NCT02289677|simulation|simulation
310089|NCT02289677|Endotracheal|endotracheal
310090|NCT02289664|intubation|intubation
310091|NCT02289651|intubation|intubation
310092|NCT02289638|intubation|intubation
310093|NCT02289625|Obstructive Sleep Apnea|obstructive sleep apnea
310094|NCT02289625|cognition|cognition
310095|NCT02289625|neurovascular function|neurovascular function
310096|NCT02289625|brain metabolism|brain metabolism
310097|NCT02289625|exercise training|exercise training
310098|NCT02289612|Risk for Type 2 Diabetes Mellitus|risk for type 2 diabetes mellitus
310099|NCT02289612|Fibre|fibre
310100|NCT02289612|Postprandial Glucose|postprandial glucose
310101|NCT02289612|Postprandial Insulin|postprandial insulin
310102|NCT02289612|Postprandial Acetaminophen|postprandial acetaminophen
310103|NCT02289612|Satiety|satiety
310104|NCT02289599|Healthy Japanese Subjects|healthy japanese subjects
310105|NCT02289599|E2307|e2307
310106|NCT02289599|Pharmacokinetics|pharmacokinetics
310107|NCT02289547|chemotherapy|chemotherapy
310108|NCT02289547|stomach neoplasms|stomach neoplasms
310109|NCT02289521|Transcranial Direct Current stimulation|transcranial direct current stimulation
310110|NCT02289521|Executive function|executive function
310111|NCT02289521|Bilingualism|bilingualism
310112|NCT02289521|Dorsolateral Prefrontal Cortex|dorsolateral prefrontal cortex
310113|NCT02289508|Heart Failure|heart failure
310114|NCT02289508|Hemodynamics|hemodynamics
310115|NCT02289508|Echocardiography|echocardiography
310116|NCT02289508|Diagnostic techniques and procedures|diagnostic techniques and procedures
310117|NCT02289508|Ultrasonography|ultrasonography
310118|NCT02289508|USCOM|uscom
310119|NCT02289495|Single Dose Escalation|single dose escalation
310120|NCT02289495|Repeat Dose Escalation|repeat dose escalation
310121|NCT02289495|GSK2838232|gsk2838232
310122|NCT02289495|Ritonavir|ritonavir
310123|NCT02289482|Ritonavir|ritonavir
310124|NCT02289482|Safety|safety
310125|NCT02289482|Continuation Single Dose Escalation|continuation single dose escalation
310126|NCT02289482|GSK2838232|gsk2838232
310127|NCT02289456|Phase II, LOCALLY ADVANCED OR METASTATIC NON SMALL|phase ii, locally advanced or metastatic non small
310128|NCT02289456|CELL LUNG CANCER (NSCLC) AND AN|cell lung cancer (nsclc) and an
310129|NCT02289456|EASTERN COOPERATIVE ONCOLOGY GROUP|eastern cooperative oncology group
310130|NCT02289456|PERFORMANCE STATUS OF 2|performance status of 2
310131|NCT02289456|(ABOUND.PS2)|(abound.ps2)
310132|NCT02289456|LOCALLY ADVANCED OR METASTATIC NON SMALL|locally advanced or metastatic non small
310133|NCT02289456|CELL LUNG CANCER (NSCLC) SUBJECTS THAT AE NOT CANDIDATES FOR RADIATION OR CURATIVE SURGERY|cell lung cancer (nsclc) subjects that ae not candidates for radiation or curative surgery
310134|NCT02289443|complete dentures|complete dentures
310135|NCT02289443|10-year follow-up|10-year follow-up
310136|NCT02289443|patient report outcomes|patient report outcomes
310137|NCT02289417|Ulcerative Colitis|ulcerative colitis
310138|NCT02289417|Inflammatory Bowel Disease|inflammatory bowel disease
310139|NCT02289391|Dexmedetomidine|dexmedetomidine
310140|NCT02289391|Inflammatory factor|inflammatory factor
310141|NCT02289391|Inflammatory mediator|inflammatory mediator
310142|NCT02289391|Cytokines|cytokines
310143|NCT02289391|Asthma|asthma
310144|NCT02289365|Radiodermatitis|radiodermatitis
310145|NCT02289365|Breast cancer|breast cancer
310146|NCT02289365|Radiotherapy|radiotherapy
310147|NCT02289313|obesity prevention|obesity prevention
310148|NCT02289313|CBPR|cbpr
310149|NCT02289313|high risk youth|high risk youth
310150|NCT02289313|school health|school health
310151|NCT02289287|Self-Management|self-management
310152|NCT02289287|Stroke|stroke
310153|NCT02289287|Intervention|intervention
310154|NCT02289287|Group Processes|group processes
310155|NCT02289261|Chronic pain|chronic pain
310156|NCT02289261|Morphine|morphine
310157|NCT02289261|Dexmedetomidine|dexmedetomidine
310158|NCT02289235|Ginger|ginger
310159|NCT02289235|Medicine, traditional|medicine, traditional
310160|NCT02289235|Herbal medicine|herbal medicine
310161|NCT02289222|Relapsed/Refractory|relapsed/refractory
310162|NCT02289222|MK-3475 & Pomalidomide|mk-3475 & pomalidomide
310163|NCT02289222|Immunotherapy|immunotherapy
310164|NCT02289209|head and neck cancer|head and neck cancer
310165|NCT02289209|reirradiation|reirradiation
310166|NCT02289209|MK-3475|mk-3475
310167|NCT02289209|Anti-PD-1 monoclonal antibody|anti-pd-1 monoclonal antibody
310168|NCT02289209|Squamous cell carcinoma|squamous cell carcinoma
310169|NCT02289209|Keytruda|keytruda
310170|NCT02289209|pembrolizumab|pembrolizumab
310171|NCT02289196|Vaccine|vaccine
310172|NCT02289183|Stomach Neoplasms|stomach neoplasms
310173|NCT02289183|Laparoscopy|laparoscopy
310174|NCT02289183|Billroth I Operation|billroth i operation
310175|NCT02289170|Chronic low back pain|chronic low back pain
310176|NCT02289170|Heating and cooling combination therapeutic device|heating and cooling combination therapeutic device
310177|NCT02289170|Heating and cooling combination therapy|heating and cooling combination therapy
310178|NCT02289170|Contrast therapy|contrast therapy
310179|NCT02289131|oral care|oral care
310180|NCT02289105|Advance Directive|advance directive
310181|NCT02289105|Active Choice|active choice
310182|NCT02289105|Decision making|decision making
310183|NCT02289053|Colorectal Cancer|colorectal cancer
310184|NCT02289040|Acute Kidney Injury|acute kidney injury
310185|NCT02289040|Microvesicles|microvesicles
310186|NCT02289040|microRNA|microrna
310187|NCT02289040|Paediatric cardiac surgery|paediatric cardiac surgery
310188|NCT02289027|Ebola, Ebolavirus|ebola, ebolavirus
310189|NCT02289014|online intervention|online intervention
310190|NCT02289014|stress management|stress management
310191|NCT02289014|cognitive behavioral therapy|cognitive behavioral therapy
310192|NCT02289014|acceptance and mindfulness based intervention|acceptance and mindfulness based intervention
310193|NCT02289001|patient simulation|patient simulation
310194|NCT02289001|simulation|simulation
310195|NCT02289001|teamwork|teamwork
310196|NCT02289001|interdisciplinary health team|interdisciplinary health team
310197|NCT02289001|healthcare team|healthcare team
310198|NCT02289001|nursing|nursing
310199|NCT02289001|training programs|training programs
310200|NCT02288988|GERD|gerd
310201|NCT02288988|Short Esophagus|short esophagus
310202|NCT02288988|Minimally Invasive Surgery|minimally invasive surgery
310203|NCT02288988|Collis gastroplasty|collis gastroplasty
310204|NCT02288975|hemoadsorption|hemoadsorption
310205|NCT02288975|extracorporeal blood purification|extracorporeal blood purification
310206|NCT02288975|CytoSorb|cytosorb
310207|NCT02288975|hemofiltration|hemofiltration
310208|NCT02288975|SIRS|sirs
310209|NCT02288975|sepsis|sepsis
310210|NCT02288975|septic shock|septic shock
310211|NCT02288975|membranes|membranes
310212|NCT02288975|ICU|icu
310213|NCT02288975|dialysis|dialysis
310214|NCT02288975|adsorption|adsorption
310215|NCT02288962|dopamine agonists|dopamine agonists
310216|NCT02288962|cabergoline|cabergoline
310217|NCT02288949|mechanical ventilation, stratificacion, lung severity|mechanical ventilation, stratificacion, lung severity
310218|NCT02288936|Hormone-refractory prostate cancer|hormone-refractory prostate cancer
310219|NCT02288936|Enzalutamide|enzalutamide
310220|NCT02288936|TMPRSS2-ETS fusion gene|tmprss2-ets fusion gene
310221|NCT02288923|Total knee arthroplasty|total knee arthroplasty
310222|NCT02288923|Femoral nerve block|femoral nerve block
310223|NCT02288923|Local infiltration analgesia|local infiltration analgesia
310224|NCT02288910|Liver Perfusion|liver perfusion
310225|NCT02288910|DynaCT Perfusion|dynact perfusion
310226|NCT02288910|Radioembolization|radioembolization
310227|NCT02288910|Chemoembolization|chemoembolization
310228|NCT02288897|Stage III|stage iii
310229|NCT02288897|Stage IIIB|stage iiib
310230|NCT02288897|Stage IIIC|stage iiic
310231|NCT02288897|Stage IV (M1a)|stage iv (m1a)
310232|NCT02288897|Stage 3|stage 3
310233|NCT02288897|Stage 4|stage 4
310234|NCT02288897|IVM1a|ivm1a
310235|NCT02288897|IV(M1a)|iv(m1a)
310236|NCT02288897|IV-M1a|iv-m1a
310237|NCT02288897|in-transit|in-transit
310238|NCT02288897|in transit|in transit
310239|NCT02288897|intransit|intransit
310240|NCT02288897|satellite|satellite
310241|NCT02288897|recurrent|recurrent
310242|NCT02288884|Complications|complications
310243|NCT02288884|Cesarean Section|cesarean section
310244|NCT02288884|Wound|wound
310245|NCT02288884|Infection (Following Delivery)|infection (following delivery)
310246|NCT02288871|aortic valve replacement|aortic valve replacement
310247|NCT02288871|aortic valve bioprosthesis|aortic valve bioprosthesis
310248|NCT02288871|hemodynamics|hemodynamics
310249|NCT02288858|Hair thinning|hair thinning
310250|NCT02288819|loop diuretics|loop diuretics
310251|NCT02288819|heart failure|heart failure
310252|NCT02288819|natriuresis|natriuresis
310253|NCT02288819|urinary analysis|urinary analysis
310254|NCT02288793|attitudes|attitudes
310255|NCT02288793|knowledge|knowledge
310256|NCT02288793|examination|examination
310257|NCT02288754|DNA in Tumors|dna in tumors
310260|NCT02288754|Advanced stage cancer|advanced stage cancer
310261|NCT02288754|Solid tumors|solid tumors
310262|NCT02288741|high-dose chemotherapy|high-dose chemotherapy
310263|NCT02288741|autologous blood stem-cell transplantation|autologous blood stem-cell transplantation
310264|NCT02288741|induction chemotherapy|induction chemotherapy
310265|NCT02288741|elderly patients|elderly patients
310266|NCT02288728|Proximal gastrectomy|proximal gastrectomy
310267|NCT02288728|quality of life|quality of life
310268|NCT02288728|mortality|mortality
310269|NCT02288728|morbidity|morbidity
310270|NCT02288715|cerebral perfusion pressure|cerebral perfusion pressure
310271|NCT02288715|septic encephalopathy|septic encephalopathy
310272|NCT02288676|genomics|genomics
310273|NCT02288676|somatic mutations|somatic mutations
310274|NCT02288676|genetic mutations|genetic mutations
310275|NCT02288676|high-grade serous cancer|high-grade serous cancer
310276|NCT02288676|ovarian cancer|ovarian cancer
310277|NCT02288676|endometrial cancer|endometrial cancer
310278|NCT02288676|DNA tagging|dna tagging
310279|NCT02288598|Stammering|stammering
310280|NCT02288598|Brain stimulation|brain stimulation
310281|NCT02288585|plant sterols|plant sterols
310282|NCT02288585|blood lipids|blood lipids
310283|NCT02288572|metabolic syndrome X|metabolic syndrome x
310284|NCT02288572|obesity|obesity
310285|NCT02288572|insulin resistance|insulin resistance
310286|NCT02288572|dyslipidemia|dyslipidemia
310287|NCT02288572|probiotic bacteria|probiotic bacteria
310288|NCT02288546|nutritional status|nutritional status
310289|NCT02288546|pesticides|pesticides
310290|NCT02288546|nitrate|nitrate
310291|NCT02288533|Minimally Conscious State|minimally conscious state
310292|NCT02288533|tDCS|tdcs
310293|NCT02288520|Methotrexate|methotrexate
310294|NCT02288520|Therapeutic strategy|therapeutic strategy
310295|NCT02288507|sorafenib, yttrium-90 radioembolization|sorafenib, yttrium-90 radioembolization
310296|NCT02288494|hypoalbuminemia|hypoalbuminemia
310297|NCT02288494|-acid base balance|-acid base balance
310298|NCT02288494|acid base disorders|acid base disorders
310299|NCT02288494|critical ill|critical ill
310300|NCT02288494|Stewart approach|stewart approach
310301|NCT02288494|human albumin infusion|human albumin infusion
310302|NCT02288481|Tuberculosis|tuberculosis
310303|NCT02288481|TBA-354|tba-354
310304|NCT02288481|Pulmonary Tuberculosis|pulmonary tuberculosis
310306|NCT02288468|Parkinson's Disease|parkinson's disease
310307|NCT02288455|SUI, incontinence, sphincter|sui, incontinence, sphincter
310308|NCT02288429|pharmacokinetics|pharmacokinetics
310309|NCT02288429|cystic fibrosis|cystic fibrosis
310310|NCT02288429|critical illness|critical illness
310311|NCT02288403|Aerobic Exercise|aerobic exercise
310312|NCT02288403|Oxygen Consumption|oxygen consumption
310313|NCT02288403|Blood Pressure|blood pressure
310314|NCT02288390|VAP|vap
310315|NCT02288390|Oral care|oral care
310316|NCT02288390|Chlorhexidine|chlorhexidine
310317|NCT02288390|Miswak (Sewak)|miswak (sewak)
310318|NCT02288377|Lanreotide|lanreotide
310319|NCT02288377|Duodeno-pancreatic neuroendocrine tumours|duodeno-pancreatic neuroendocrine tumours
310320|NCT02288377|Maintenance treatment|maintenance treatment
310321|NCT02288351|Roux-en-Y gastric bypass|roux-en-y gastric bypass
310322|NCT02288325|Fetzima|fetzima
310323|NCT02288325|Relapse-prevention|relapse-prevention
310324|NCT02288325|Placebo-controlled|placebo-controlled
310325|NCT02288299|Instrumental cough assistance|instrumental cough assistance
310326|NCT02288299|positive pressure insufflation maneuver|positive pressure insufflation maneuver
310327|NCT02288299|home mechanical ventilation|home mechanical ventilation
396438|NCT01884597|PCV|pcv
310328|NCT02288299|prospective evaluation|prospective evaluation
310329|NCT02288260|Acute Coronary Syndrome|acute coronary syndrome
310330|NCT02288260|Russian ACS Registry|russian acs registry
310331|NCT02288260|ticagrelor|ticagrelor
310332|NCT02288247|Metastatic|metastatic
310333|NCT02288247|Castration-resistant|castration-resistant
310334|NCT02288247|Docetaxel|docetaxel
310335|NCT02288247|Chemotherapy- Naïve|chemotherapy- naïve
310336|NCT02288247|Enzalutamide|enzalutamide
310337|NCT02288247|Prostate Cancer|prostate cancer
310338|NCT02288247|Chemotherapy Naïve Metastatic Castration Resistant Prostate Cancer|chemotherapy naïve metastatic castration resistant prostate cancer
310339|NCT02288247|Prednisolone|prednisolone
310340|NCT02288247|Xtandi|xtandi
310341|NCT02288247|Metastatic Castration Resistant Prostate Cancer|metastatic castration resistant prostate cancer
310342|NCT02288234|Registry|registry
310343|NCT02288195|Neoadjuvant Chemotherapy|neoadjuvant chemotherapy
310344|NCT02288195|Preoperative radiotherapy|preoperative radiotherapy
310345|NCT02288195|Chemoradiotherapy|chemoradiotherapy
310346|NCT02288195|Capecitabine|capecitabine
310347|NCT02288195|Oxaliplatin|oxaliplatin
310348|NCT02288182|Sinus augmentation procedure|sinus augmentation procedure
310349|NCT02288169|Symptom management|symptom management
310350|NCT02288169|palliative care|palliative care
310351|NCT02288117|PMCF|pmcf
310352|NCT02288117|Post Market Clinical Follow up|post market clinical follow up
310353|NCT02288117|SP-CL|sp-cl
310354|NCT02288117|anatomic stem|anatomic stem
310355|NCT02288104|Interventional Radiology|interventional radiology
310356|NCT02288104|Liver|liver
310357|NCT02288104|Kidney|kidney
310358|NCT02288104|Confocal endomicroscopy|confocal endomicroscopy
310359|NCT02288104|Optical Biopsy|optical biopsy
310360|NCT02288104|Scanner|scanner
310361|NCT02288104|Fluoroscopy|fluoroscopy
310363|NCT02288104|Computed Tomography|computed tomography
310364|NCT02288104|Radiofrequency Ablation|radiofrequency ablation
310365|NCT02288104|Fluorescein|fluorescein
310366|NCT02288091|ALS|als
310367|NCT02288091|Inosine|inosine
310368|NCT02288091|Uric acid|uric acid
310369|NCT02288091|Urate|urate
310370|NCT02288091|Glutathione|glutathione
310371|NCT02288091|Biomarker|biomarker
310372|NCT02288091|Oxidative stress|oxidative stress
310373|NCT02288091|Oxidative damage|oxidative damage
310374|NCT02288091|proof-of-concept|proof-of-concept
310375|NCT02288078|unresectable colorectal cancer|unresectable colorectal cancer
310376|NCT02288078|regorafenib|regorafenib
310377|NCT02288078|Steroid|steroid
310378|NCT02288078|fatigue and malaise|fatigue and malaise
310379|NCT02288078|Phase 2 randomized, controlled trial (RCT)|phase 2 randomized, controlled trial (rct)
310380|NCT02288052|Handwriting|handwriting
310381|NCT02288052|Motor learning|motor learning
310382|NCT02288039|Pulmonary|pulmonary
310383|NCT02288026|Carcinoma, Non-Small-Cell Lung|carcinoma, non-small-cell lung
310384|NCT02288026|Lung Neoplasms|lung neoplasms
310385|NCT02288026|Carcinoma, Bronchogenic|carcinoma, bronchogenic
310386|NCT02288026|Bronchial Neoplasms|bronchial neoplasms
310387|NCT02288013|Cesarean section|cesarean section
310388|NCT02288013|uterine closure technique|uterine closure technique
310389|NCT02288013|materials used|materials used
310390|NCT02288000|Alzheimer|alzheimer
310391|NCT02288000|Memantine|memantine
310392|NCT02288000|biomarkers|biomarkers
310393|NCT02288000|battery|battery
310394|NCT02288000|cognition|cognition
310395|NCT02288000|imaging|imaging
310396|NCT02288000|neuropsychology|neuropsychology
310397|NCT02287987|Renal function|renal function
310398|NCT02287987|Off-clamp|off-clamp
310399|NCT02287987|Partial nephrectomy|partial nephrectomy
310400|NCT02287987|Robotic|robotic
310401|NCT02287987|Hylar clamping|hylar clamping
310402|NCT02287948|Balance|balance
310403|NCT02287948|Multiple Sclerosis|multiple sclerosis
310404|NCT02287948|Nintendo Wii Fit|nintendo wii fit
310405|NCT02287935|Karydakis procedure|karydakis procedure
310406|NCT02287935|Limberg flap|limberg flap
310407|NCT02287935|recurrent pilonidal sinus|recurrent pilonidal sinus
310408|NCT02287896|RhD-negative pregnant woman|rhd-negative pregnant woman
310409|NCT02287896|anti-RhD antibody|anti-rhd antibody
310410|NCT02287883|Patient activation and engagement|patient activation and engagement
310411|NCT02287883|Patient reported outcomes|patient reported outcomes
310412|NCT02287883|Accountable Care Organizations|accountable care organizations
310413|NCT02287883|Chronic illness|chronic illness
310414|NCT02287883|Vulnerable population|vulnerable population
310415|NCT02287883|Comparison of approaches|comparison of approaches
310416|NCT02287870|Epidural anesthesia|epidural anesthesia
310417|NCT02287870|Chloroprocaine|chloroprocaine
310418|NCT02287870|Lidocaine|lidocaine
310419|NCT02287844|Xylo-oligosaccharides|xylo-oligosaccharides
310420|NCT02287844|Immunonutrition|immunonutrition
310421|NCT02287844|Prebiotics|prebiotics
310422|NCT02287844|Lipopolysaccharides|lipopolysaccharides
310423|NCT02287844|Cytokines|cytokines
310424|NCT02287805|craniosynostosis|craniosynostosis
310425|NCT02287805|simple form|simple form
310426|NCT02287805|complex form|complex form
310427|NCT02287805|diagnostic|diagnostic
310428|NCT02287805|announcement|announcement
310429|NCT02287805|impacts|impacts
310430|NCT02287792|Infective endocarditis|infective endocarditis
310431|NCT02287792|18-FDG PET/CT|18-fdg pet/ct
310432|NCT02287792|Impact|impact
310433|NCT02287792|Patient's management|patient's management
310434|NCT02287792|Diagnostic|diagnostic
310435|NCT02287753|vascular occlusion test|vascular occlusion test
310436|NCT02287753|near infrared spectroscopy|near infrared spectroscopy
310437|NCT02287740|Exercise|exercise
310438|NCT02287714|Instep plantar fasciotomy|instep plantar fasciotomy
310439|NCT02287701|bladder cancer|bladder cancer
310440|NCT02287701|MRI|mri
310441|NCT02287701|PET|pet
310442|NCT02287688|safety of Meningococcal quadrivalent CRM-197 conjugate vaccine|safety of meningococcal quadrivalent crm-197 conjugate vaccine
310443|NCT02287688|Children 2-23 months of age|children 2-23 months of age
310444|NCT02287675|Sentinel Node|sentinel node
310445|NCT02287662|Transcatheter Aortic Valve Replacement|transcatheter aortic valve replacement
310446|NCT02287649|Immune thrombocytopenia|immune thrombocytopenia
310447|NCT02287649|Fc gamma RIIIA V/F158 polymorphism|fc gamma riiia v/f158 polymorphism
310448|NCT02287649|Rituximab|rituximab
310449|NCT02287649|autoreactive B and T cells|autoreactive b and t cells
310450|NCT02287649|ITP|itp
310451|NCT02287610|RA|ra
310452|NCT02287610|Delayed-release prednisone|delayed-release prednisone
310453|NCT02287610|Immediate-release prednisone|immediate-release prednisone
310454|NCT02287610|Non-interventional|non-interventional
310455|NCT02287571|comfort|comfort
310456|NCT02287571|satisfaction|satisfaction
310457|NCT02287558|HHT|hht
310458|NCT02287558|CASE4Z14|case4z14
310459|NCT02287558|Pomalidomide|pomalidomide
310460|NCT02287545|open angle glaucoma|open angle glaucoma
310461|NCT02287545|corneal biomechanics|corneal biomechanics
310462|NCT02287545|trabeculectomy|trabeculectomy
310463|NCT02287506|diagnosis, strategy|diagnosis, strategy
310464|NCT02287480|Ebolavirus Vaccines|ebolavirus vaccines
310465|NCT02287467|Antiviral|antiviral
310466|NCT02287467|IVIG|ivig
310467|NCT02287467|Hemagglutination inhibition (HAI)|hemagglutination inhibition (hai)
310468|NCT02287467|Antibody|antibody
310469|NCT02287454|Multiple Sclerosis, cognitive rehabilitation, REHACOP|multiple sclerosis, cognitive rehabilitation, rehacop
310470|NCT02287376|Migraine with and without aura|migraine with and without aura
310471|NCT02287350|pain|pain
310472|NCT02287350|moderate pain|moderate pain
310473|NCT02287350|mild pain|mild pain
310474|NCT02287350|acute pain|acute pain
310475|NCT02287350|mild acute pain|mild acute pain
310476|NCT02287350|moderate acute pain|moderate acute pain
310477|NCT02287350|mild or moderate acute pain|mild or moderate acute pain
310478|NCT02287350|NSAID|nsaid
310479|NCT02287350|nonsteroidal anti-inflammatory drug|nonsteroidal anti-inflammatory drug
310480|NCT02287337|Neck pain|neck pain
310481|NCT02287324|Cervicalgia|cervicalgia
310482|NCT02287311|EBV positive diseases|ebv positive diseases
310483|NCT02287311|cytotoxic T lymphocytes|cytotoxic t lymphocytes
310484|NCT02287285|Type 2 Diabetes Mellitus|type 2 diabetes mellitus
310485|NCT02287285|Gastric Bypass Surgery|gastric bypass surgery
310486|NCT02287285|Exendin9|exendin9
310487|NCT02287272|COPD- cimetidine- drug-drug interaction|copd- cimetidine- drug-drug interaction
310488|NCT02287233|Myelogenous Leukemia|myelogenous leukemia
310489|NCT02287233|Treatment Naive AML|treatment naive aml
310490|NCT02287233|Untreated AML|untreated aml
310491|NCT02287220|Non-Contact Oximetry|non-contact oximetry
310492|NCT02287220|video plethysmography|video plethysmography
310493|NCT02287220|oxygen desaturation|oxygen desaturation
310494|NCT02287168|Peritoneal lavage|peritoneal lavage
310495|NCT02287168|Dissemination|dissemination
310496|NCT02287168|Gastrectomy|gastrectomy
310497|NCT02287168|Cytology|cytology
310498|NCT02287168|Lavage|lavage
310499|NCT02287155|Health Promotion|health promotion
310500|NCT02287155|Intervention Study|intervention study
310501|NCT02287155|Occupational Therapy|occupational therapy
310502|NCT02287155|Rural Population|rural population
310503|NCT02287155|Quality of life|quality of life
310504|NCT02287155|Sense of coherence|sense of coherence
310505|NCT02287129|Potentially R0 - resectable AEG and primary tumor category|potentially r0 - resectable aeg and primary tumor category
310506|NCT02287129|Histologically confirmed AEG I-III|histologically confirmed aeg i-iii
310507|NCT02287129|Functional operability|functional operability
310508|NCT02287129|Intense FDG tracer uptake of the tumor|intense fdg tracer uptake of the tumor
310509|NCT02287116|preterm infants|preterm infants
310510|NCT02287116|CPAP|cpap
310512|NCT02287116|invasive mechanical ventilation|invasive mechanical ventilation
310513|NCT02287116|we aimed determine that affect the rate of BPD and death of NCPAP therapy with nasal prongs or nasal mask as the initial treatment for RDS.|we aimed determine that affect the rate of bpd and death of ncpap therapy with nasal prongs or nasal mask as the initial treatment for rds.
310514|NCT02287103|Skipping Breakfast|skipping breakfast
310515|NCT02287038|PTSD|ptsd
310516|NCT02287038|ADHD|adhd
310517|NCT02287038|Atomoxetine|atomoxetine
310518|NCT02287038|Combat Trauma|combat trauma
310519|NCT02287038|Cognitive Deficit|cognitive deficit
310520|NCT02286986|Epilepsy|epilepsy
310521|NCT02286986|Dravet syndrome|dravet syndrome
310522|NCT02286986|Seizures|seizures
310523|NCT02286986|Intractable Epilepsy|intractable epilepsy
310524|NCT02286986|Medically Refractory Epilepsy|medically refractory epilepsy
310525|NCT02286973|Tranexamic acid|tranexamic acid
310526|NCT02286947|DMD|dmd
310527|NCT02286947|exon 51|exon 51
310528|NCT02286947|dystrophin|dystrophin
310529|NCT02286947|dystrophy|dystrophy
310530|NCT02286947|eteplirsen|eteplirsen
310531|NCT02286947|Duchenne|duchenne
310532|NCT02286934|Carvedilol|carvedilol
310533|NCT02286934|CYP2D6|cyp2d6
310534|NCT02286934|Isoproterenol Sensitivity Test|isoproterenol sensitivity test
310535|NCT02286921|Testosterone|testosterone
310536|NCT02286921|Enzalutamide|enzalutamide
310537|NCT02286921|Abiraterone|abiraterone
310538|NCT02286921|Androgen Ablative Therapies|androgen ablative therapies
310539|NCT02286921|Bipolar Androgen Therapy|bipolar androgen therapy
310540|NCT02286908|Ejection fraction, Global Strain, Mechanical dispersion|ejection fraction, global strain, mechanical dispersion
310541|NCT02286895|rotavirus|rotavirus
310542|NCT02286895|rotavirus vaccine|rotavirus vaccine
310543|NCT02286895|Mali|mali
310544|NCT02286895|EPI vaccines|epi vaccines
310545|NCT02286882|Single Ascending Dose|single ascending dose
310546|NCT02286882|healthy subjects|healthy subjects
310547|NCT02286869|mechanical ventilation|mechanical ventilation
310548|NCT02286869|autonomic nervous system|autonomic nervous system
310549|NCT02286869|heart rate variability|heart rate variability
310550|NCT02286869|cardioventilatory coupling|cardioventilatory coupling
310551|NCT02286856|malnutrition, diet intervention, Nutritional Assessment|malnutrition, diet intervention, nutritional assessment
310552|NCT02286843|89Zr-trastuzumab|89zr-trastuzumab
310553|NCT02286843|PET/CT|pet/ct
310554|NCT02286843|14-156|14-156
310555|NCT02286843|89Zr-pertuzumab|89zr-pertuzumab
310556|NCT02286843|HER2-targeted|her2-targeted
310557|NCT02286830|osteolysis|osteolysis
310558|NCT02286830|zoledronic acid|zoledronic acid
310559|NCT02286830|osteonecrosis|osteonecrosis
310560|NCT02286830|bone markers|bone markers
310561|NCT02286830|low-dose CT|low-dose ct
310562|NCT02286791|Prevention of dementia|prevention of dementia
310563|NCT02286791|Mindful awareness program|mindful awareness program
310564|NCT02286791|Mild cognitive impairment|mild cognitive impairment
310565|NCT02286791|Mindfulness|mindfulness
310566|NCT02286791|Elderly|elderly
310567|NCT02286791|Cognitive decline|cognitive decline
310568|NCT02286765|Ulthera System|ulthera system
310569|NCT02286765|Ultherapy|ultherapy
310570|NCT02286739|Total Knee Arthroplasty|total knee arthroplasty
310571|NCT02286739|Rotational Alignment|rotational alignment
310572|NCT02286739|Intraoperative Sensors|intraoperative sensors
310573|NCT02286739|Patient Outcomes|patient outcomes
310574|NCT02286739|Soft Tissue Balance|soft tissue balance
310575|NCT02286713|Lung Cancer Screening|lung cancer screening
310576|NCT02286713|heavy smokers|heavy smokers
310577|NCT02286713|state-based smoking cessation quitlines|state-based smoking cessation quitlines
310578|NCT02286713|patient decision aid|patient decision aid
310579|NCT02286713|low-dose computed tomography|low-dose computed tomography
310580|NCT02286713|LDCT|ldct
310581|NCT02286713|standard educational information|standard educational information
310582|NCT02286700|dermatitis, eczema, itch, moisturizer, amino acid|dermatitis, eczema, itch, moisturizer, amino acid
310583|NCT02286674|mYpas|mypas
310584|NCT02286674|anxiety|anxiety
310585|NCT02286674|distraction|distraction
310586|NCT02286674|inhalation induction|inhalation induction
310587|NCT02286648|clinical signs|clinical signs
310588|NCT02286648|child|child
310589|NCT02286648|pulpotomy|pulpotomy
310591|NCT02286583|Female breast cancer|female breast cancer
310592|NCT02286557|Methylphenidate|methylphenidate
310593|NCT02286557|Multiple Sclerosis|multiple sclerosis
310594|NCT02286557|Cognitive Fatigue|cognitive fatigue
310595|NCT02286544|Myocardial Infarction|myocardial infarction
310596|NCT02286544|Oxygen|oxygen
310597|NCT02286544|Inflammation|inflammation
310598|NCT02286544|Acute coronary syndrome (ACS)|acute coronary syndrome (acs)
310599|NCT02286544|ST-segment elevation myocardial infarction (STEMI)|st-segment elevation myocardial infarction (stemi)
310600|NCT02286544|Reperfusion injury (IR-injury)|reperfusion injury (ir-injury)
310601|NCT02286544|Biomarkers|biomarkers
310602|NCT02286544|Normoxemia|normoxemia
310603|NCT02286544|Salmonella typhi|salmonella typhi
310604|NCT02286544|Vaccine-induced inflammation|vaccine-induced inflammation
310605|NCT02286544|Soluble markers of apoptosis|soluble markers of apoptosis
310606|NCT02286544|Leukocyte subset distribution|leukocyte subset distribution
310607|NCT02286544|Matrix metalloproteinase (MMP)|matrix metalloproteinase (mmp)
310608|NCT02286544|Biological Markers|biological markers
310609|NCT02286531|: Low grade glioma|: low grade glioma
310611|NCT02286531|FET|fet
310612|NCT02286531|MRI|mri
310613|NCT02286531|Standardized uptake value|standardized uptake value
310614|NCT02286453|Osteoarthritis of The knee|osteoarthritis of the knee
310615|NCT02286453|Benjakul|benjakul
310616|NCT02286453|Alternative Medicine|alternative medicine
310617|NCT02286440|Depression|depression
310618|NCT02286440|Genotyping|genotyping
310619|NCT02286440|Pharmacokinetic|pharmacokinetic
310620|NCT02286440|Pharmacodynamic|pharmacodynamic
310621|NCT02286414|oral anticoagulants|oral anticoagulants
310622|NCT02286414|Geriatrics|geriatrics
310623|NCT02286414|General Practitioner|general practitioner
310624|NCT02286414|Safety|safety
310625|NCT02286414|Misuse|misuse
310626|NCT02286401|myocardial perfusion|myocardial perfusion
310627|NCT02286401|coronary atherosclerosis|coronary atherosclerosis
310628|NCT02286401|coronary blood flow|coronary blood flow
310629|NCT02286401|fractional flow reserve|fractional flow reserve
310630|NCT02286401|coronary flow reserve|coronary flow reserve
310631|NCT02286388|Deep carious lesion|deep carious lesion
310632|NCT02286388|incomplete caries removal|incomplete caries removal
310633|NCT02286388|antibacterial adhesive system|antibacterial adhesive system
310634|NCT02286388|dental composite resin|dental composite resin
310635|NCT02286388|pulp vitality preservation|pulp vitality preservation
310636|NCT02286388|randomized controlled trial|randomized controlled trial
310637|NCT02286375|health-social partnership|health-social partnership
310638|NCT02286375|self-efficacy|self-efficacy
310639|NCT02286349|Neuromodulation Attention Deficit Hyperactivity Disorder|neuromodulation attention deficit hyperactivity disorder
310640|NCT02286336|minimum effective concentration|minimum effective concentration
310641|NCT02286336|ropivacaine|ropivacaine
310642|NCT02286336|ultrasound-guided supraclavicular block|ultrasound-guided supraclavicular block
310643|NCT02286323|Intubation, Endotracheal|intubation, endotracheal
310644|NCT02286310|Exercise|exercise
310645|NCT02286310|Kinematics|kinematics
310646|NCT02286297|Intubation|intubation
310647|NCT02286284|Early severe preeclampsia|early severe preeclampsia
310648|NCT02286284|Angiogenic factor|angiogenic factor
310649|NCT02286284|Apheresis|apheresis
310650|NCT02286271|Seizure detection|seizure detection
310651|NCT02286258|Inulin|inulin
310652|NCT02286258|Ca-EDTA|ca-edta
310653|NCT02286258|Gd-DOTA|gd-dota
310654|NCT02286258|Chronic kidney disease|chronic kidney disease
310655|NCT02286258|glomerular filtration rate measurement|glomerular filtration rate measurement
310656|NCT02286245|Triage|triage
310657|NCT02286245|Hotline|hotline
310658|NCT02286245|Primary Health Care|primary health care
310659|NCT02286245|Emergency Medical Service Communication Systems|emergency medical service communication systems
310660|NCT02286232|Chronic low back pain|chronic low back pain
310661|NCT02286232|stretching exercises|stretching exercises
310662|NCT02286206|Clozapine|clozapine
310663|NCT02286206|Psychotropic Drugs|psychotropic drugs
310664|NCT02286206|Antipsychotic Agents|antipsychotic agents
310665|NCT02286206|Psychotic Disorders|psychotic disorders
310666|NCT02286206|Schizophrenia|schizophrenia
310667|NCT02286206|Adverse Effects|adverse effects
310668|NCT02286206|Drug Monitoring|drug monitoring
310669|NCT02286180|near infrared spectroscopy|near infrared spectroscopy
310670|NCT02286180|NIRS|nirs
310671|NCT02286180|intern|intern
310672|NCT02286167|modified-Atkins diet|modified-atkins diet
310673|NCT02286167|ketogenic diet|ketogenic diet
310674|NCT02286167|central nervous system malignancy|central nervous system malignancy
310675|NCT02286167|glioma|glioma
310676|NCT02286154|Hydroxyurea|hydroxyurea
310677|NCT02286154|Sickle Cell|sickle cell
310678|NCT02286154|Pharmacokinetics|pharmacokinetics
310679|NCT02286154|dynamics|dynamics
310680|NCT02286154|genomics|genomics
310681|NCT02286128|Type 2 diabetes|type 2 diabetes
310682|NCT02286128|RAGE|rage
310683|NCT02286128|osteoblast|osteoblast
310684|NCT02286115|Chronic Pelvic Pain|chronic pelvic pain
310685|NCT02286115|Interstitial Cystitis|interstitial cystitis
310686|NCT02286115|Vulvodynia|vulvodynia
310687|NCT02286115|Dyspareunia|dyspareunia
310688|NCT02286115|Pelvic Floor Dysfunction|pelvic floor dysfunction
310689|NCT02286115|Emotional Processing|emotional processing
310690|NCT02286089|dry-AMD|dry-amd
310691|NCT02286089|Geographic Atrophy|geographic atrophy
310692|NCT02286076|endometrioma|endometrioma
310693|NCT02286076|laparoscopy|laparoscopy
310694|NCT02286076|ovarian reserve|ovarian reserve
310695|NCT02286037|Secondary Hyperalgesia|secondary hyperalgesia
310696|NCT02286037|Method|method
310697|NCT02286037|Pin-prick|pin-prick
310698|NCT02286037|Monofilament|monofilament
310699|NCT02285998|Influenza|influenza
310700|NCT02285985|Adipose tissue|adipose tissue
310701|NCT02285985|Inflammation|inflammation
310702|NCT02285985|.Obesity|.obesity
310703|NCT02285933|stroke|stroke
310704|NCT02285933|physical therapy specialty|physical therapy specialty
310705|NCT02285933|exercise therapy|exercise therapy
310706|NCT02285933|virtual reality|virtual reality
310707|NCT02285933|man-machine systems|man-machine systems
310708|NCT02285933|randomized control trial|randomized control trial
310709|NCT02285933|inpatients|inpatients
310710|NCT02285933|rehabilitation|rehabilitation
310711|NCT02285920|hemodialysis|hemodialysis
310712|NCT02285920|spironolactone|spironolactone
310713|NCT02285920|cardiac fibrosis|cardiac fibrosis
310714|NCT02285920|diastolic function|diastolic function
762553|NCT00394485|Procaterol|procaterol
310715|NCT02285881|diabetes treatment|diabetes treatment
310716|NCT02285881|personalized medicine|personalized medicine
310717|NCT02285881|shared decision making|shared decision making
310718|NCT02285881|goal setting|goal setting
310719|NCT02285868|Orthopedic rehabilitation|orthopedic rehabilitation
310720|NCT02285868|Rehabilitation outcomes|rehabilitation outcomes
310721|NCT02285868|Physical therapy|physical therapy
310722|NCT02285868|Physical therapy outcomes|physical therapy outcomes
310723|NCT02285855|Lung Cancer|lung cancer
310724|NCT02285855|Non small cell lung cancer|non small cell lung cancer
310725|NCT02285855|Stereotactic body radiotherapy|stereotactic body radiotherapy
310726|NCT02285855|SBRT|sbrt
310728|NCT02285855|Radiation therapy|radiation therapy
310729|NCT02285855|Metformin|metformin
310730|NCT02285855|Metformin ER|metformin er
310731|NCT02285855|Placebo|placebo
310732|NCT02285855|Sugar pill|sugar pill
310733|NCT02285855|Lung adenocarcinoma|lung adenocarcinoma
310734|NCT02285855|Genotypes|genotypes
310735|NCT02285855|Genetic mutations|genetic mutations
310736|NCT02285842|osteoarthritis|osteoarthritis
310737|NCT02285842|avascular necrosis|avascular necrosis
310738|NCT02285842|ankylosis|ankylosis
310739|NCT02285842|protrusio acetabuli|protrusio acetabuli
310740|NCT02285842|painful hip dysplasia|painful hip dysplasia
310741|NCT02285842|rheumatoid arthritis|rheumatoid arthritis
310742|NCT02285842|correction of functional deformity|correction of functional deformity
310743|NCT02285842|revision procedures|revision procedures
310744|NCT02285751|high on treatment platelet reactivity|high on treatment platelet reactivity
310745|NCT02285751|acetylsalicylic acid|acetylsalicylic acid
310746|NCT02285751|clopidogrel|clopidogrel
310747|NCT02285751|prasugrel|prasugrel
310748|NCT02285751|ticagrelor|ticagrelor
310749|NCT02285751|critically ill|critically ill
310750|NCT02285751|pharmacokinetic|pharmacokinetic
310851|NCT02285101|arginase|arginase
310751|NCT02285751|pharmacodynamics|pharmacodynamics
310752|NCT02285738|solid tumor, cancer, simvastatin, aspirin, blood clot, VTE, venous thromboembolism|solid tumor, cancer, simvastatin, aspirin, blood clot, vte, venous thromboembolism
310753|NCT02285712|Peripheral venous catheter|peripheral venous catheter
310754|NCT02285712|ultrasound|ultrasound
310755|NCT02285712|nurse|nurse
310756|NCT02285712|Intensive Care Units|intensive care units
310757|NCT02285699|Selective Serotonin Reuptake Inhibitors|selective serotonin reuptake inhibitors
310758|NCT02285686|troponin|troponin
310759|NCT02285686|biomarkers|biomarkers
310760|NCT02285686|myocardial infarction|myocardial infarction
310761|NCT02285686|critical illness|critical illness
310762|NCT02285673|umbilical cord, mesenchymal stem cell|umbilical cord, mesenchymal stem cell
310763|NCT02285621|Scoliosis|scoliosis
310764|NCT02285621|Spine deformity|spine deformity
310765|NCT02285621|Brace|brace
310766|NCT02285621|3D|3d
310767|NCT02285608|Medication adherence|medication adherence
310768|NCT02285608|Patient education|patient education
310769|NCT02285608|Mood disorders|mood disorders
310770|NCT02285608|Economic assessment|economic assessment
310771|NCT02285608|Mixed methods|mixed methods
310772|NCT02285556|drug carving changes during rehabilitation|drug carving changes during rehabilitation
310773|NCT02285556|community|community
310774|NCT02285556|DNA|dna
310775|NCT02285543|TPF induction chemotherapy, randomized, trial,OSCC|tpf induction chemotherapy, randomized, trial,oscc
310776|NCT02285530|head and neck squamous cell carcinoma, GDF15, TPF|head and neck squamous cell carcinoma, gdf15, tpf
310777|NCT02285504|Postpartum depression|postpartum depression
310778|NCT02285465|Healthy volunteers|healthy volunteers
310779|NCT02285465|Pharmacokinetics|pharmacokinetics
310780|NCT02285465|Pharmacodynamics|pharmacodynamics
310781|NCT02285465|ASP3700|asp3700
310782|NCT02285452|physiologcal phenomena|physiologcal phenomena
310783|NCT02285452|.HRV Parameters|.hrv parameters
310784|NCT02285452|respiratory activity|respiratory activity
310785|NCT02285452|thorax wraps|thorax wraps
310786|NCT02285439|Pediatric Oncology|pediatric oncology
310787|NCT02285439|Ras/Raf pathway|ras/raf pathway
310788|NCT02285439|Low-Grade Glioma|low-grade glioma
310789|NCT02285439|MEK inhibitor|mek inhibitor
310790|NCT02285426|i-scan|i-scan
310791|NCT02285426|histology|histology
310792|NCT02285413|Melanoma|melanoma
310793|NCT02285413|Dendritic cells|dendritic cells
310794|NCT02285413|Cisplatin|cisplatin
310795|NCT02285413|Vaccine|vaccine
310796|NCT02285413|Immunotherapy|immunotherapy
310797|NCT02285400|COPD|copd
310798|NCT02285400|CPAP|cpap
310799|NCT02285400|Central Drive|central drive
310800|NCT02285348|Ataxia Telangiectasia|ataxia telangiectasia
310801|NCT02285348|cerebrospinal fluid|cerebrospinal fluid
310802|NCT02285348|inflammation|inflammation
310803|NCT02285348|proteomic analysis|proteomic analysis
310804|NCT02285309|Cardiac Surgery|cardiac surgery
310805|NCT02285309|Diastolic Dysfunction|diastolic dysfunction
310806|NCT02285309|Enoximone|enoximone
310807|NCT02285296|geriatric assessment|geriatric assessment
310808|NCT02285296|Caregivers|caregivers
310809|NCT02285296|Needs Assessment|needs assessment
310810|NCT02285296|oncology nursing|oncology nursing
397072|NCT01882010|CD4|cd4
310811|NCT02285296|frail elderly|frail elderly
310812|NCT02285296|Medical, psychologic and sociologic approach|medical, psychologic and sociologic approach
310813|NCT02285270|Circadian rhythm|circadian rhythm
310814|NCT02285270|Adipose tissue, brown|adipose tissue, brown
310815|NCT02285270|Metabolism|metabolism
310816|NCT02285257|Sepsis, Severe sepsis, septic shock, epidemiology, outcome|sepsis, severe sepsis, septic shock, epidemiology, outcome
310817|NCT02285231|Anti-hyperglycemic effect|anti-hyperglycemic effect
310818|NCT02285192|18F-FDG Injection|18f-fdg injection
310819|NCT02285192|Positron Lymphography|positron lymphography
310820|NCT02285192|Lymphatic Mapping|lymphatic mapping
310821|NCT02285192|sentinel lymph nodes|sentinel lymph nodes
310822|NCT02285192|PET/CT|pet/ct
310823|NCT02285192|14-222|14-222
310824|NCT02285179|GDC-0032|gdc-0032
310825|NCT02285179|Pi3K inhibitor|pi3k inhibitor
310826|NCT02285179|tamoxifen|tamoxifen
310827|NCT02285179|hormone receptor positive|hormone receptor positive
310828|NCT02285179|RECIST|recist
310829|NCT02285179|pharmacodynamic|pharmacodynamic
310830|NCT02285166|Pharmaocological therapy|pharmaocological therapy
310831|NCT02285153|acetylsalicylic acid|acetylsalicylic acid
310832|NCT02285153|intensive care unit|intensive care unit
310833|NCT02285153|mortality|mortality
310834|NCT02285153|Post mortem examination|post mortem examination
310835|NCT02285153|bleeding|bleeding
310836|NCT02285114|HIV|hiv
310837|NCT02285114|emtricitabine|emtricitabine
310838|NCT02285114|FTC|ftc
310839|NCT02285114|tenofovir|tenofovir
310840|NCT02285114|TDF|tdf
310841|NCT02285114|TAF|taf
310842|NCT02285114|antiretroviral|antiretroviral
310843|NCT02285114|pharmacokinetic|pharmacokinetic
310844|NCT02285114|PK|pk
310845|NCT02285114|adolescents|adolescents
310846|NCT02285114|children|children
310847|NCT02285114|pediatric|pediatric
310848|NCT02285114|Gilead|gilead
310849|NCT02285101|arginine auxotrophic tumors|arginine auxotrophic tumors
310850|NCT02285101|PEG-BCT-100|peg-bct-100
310852|NCT02285075|temocillin|temocillin
310854|NCT02285075|T>MIC|t>mic
310855|NCT02285062|R-CHOP chemotherapy|r-chop chemotherapy
310856|NCT02285062|DLBCL front line therapy|dlbcl front line therapy
310857|NCT02285062|gene expression profiling (GEP) activated B-cell (ABC) type DLBCL biomarkers|gene expression profiling (gep) activated b-cell (abc) type dlbcl biomarkers
310858|NCT02285062|Activated B-Cell (ABC) type|activated b-cell (abc) type
310859|NCT02285062|Diffuse Large B-Cell Lymphoma, not otherwise specified|diffuse large b-cell lymphoma, not otherwise specified
310860|NCT02285062|Diffuse Large B-Cell Lymphoma, associated with chronic inflammation|diffuse large b-cell lymphoma, associated with chronic inflammation
310861|NCT02285062|Diffuse Large B-Cell Lymphoma, Epstein-Barr virus positive (EBS+) of the elderly|diffuse large b-cell lymphoma, epstein-barr virus positive (ebs+) of the elderly
310862|NCT02285062|Diffuse Large B-Cell Lymphoma, T-cell / histiocyte-rich|diffuse large b-cell lymphoma, t-cell / histiocyte-rich
310863|NCT02285049|Chronic urticaria|chronic urticaria
310864|NCT02285049|Urticaria Control Test|urticaria control test
310865|NCT02285023|Chronic urticaria|chronic urticaria
310866|NCT02285023|CU-Q2oL|cu-q2ol
310867|NCT02285010|pregabalin|pregabalin
310868|NCT02285010|postoperative pain|postoperative pain
310869|NCT02285010|abdominal hysterectomy|abdominal hysterectomy
310870|NCT02284984|Antibodies, Monoclonal|antibodies, monoclonal
310871|NCT02284984|mabthera|mabthera
310872|NCT02284984|benlysta|benlysta
310873|NCT02284984|Antinuclear Antibodies|antinuclear antibodies
310874|NCT02284958|walking|walking
310875|NCT02284958|pedometer|pedometer
310876|NCT02284932|COPD|copd
310877|NCT02284932|atrophy|atrophy
310878|NCT02284932|muscle|muscle
310879|NCT02284906|Drug therapy|drug therapy
310880|NCT02284867|uterine natural killer cells|uterine natural killer cells
310881|NCT02284867|CD16|cd16
310882|NCT02284867|CD56|cd56
310883|NCT02284867|Preterm labour|preterm labour
310884|NCT02284815|Gluten|gluten
310885|NCT02284815|T1D|t1d
310886|NCT02284815|Remission|remission
310887|NCT02284789|Hemophilia|hemophilia
310888|NCT02284776|Therapeutic education|therapeutic education
310889|NCT02284750|Bifurcation lesion|bifurcation lesion
310890|NCT02284750|Percutaneous coronary intervention|percutaneous coronary intervention
310891|NCT02284737|Pulmonary arterial hypertension|pulmonary arterial hypertension
310892|NCT02284711|salpingectomy, ovarian reserve, coagulation technique|salpingectomy, ovarian reserve, coagulation technique
310893|NCT02284685|Mental Health Services|mental health services
310894|NCT02284646|Ankylosing spondylitis|ankylosing spondylitis
310895|NCT02284646|Physical training program|physical training program
310896|NCT02284633|EGFR mutation|egfr mutation
310897|NCT02284633|Liquid biopsies|liquid biopsies
310898|NCT02284633|Lung cancer|lung cancer
310899|NCT02284633|erlotinib|erlotinib
310900|NCT02284620|anesthesia|anesthesia
310901|NCT02284620|nerve block|nerve block
310902|NCT02284620|infltration|infltration
310903|NCT02284581|MBC|mbc
310904|NCT02284581|metastatic|metastatic
310905|NCT02284581|breast|breast
310906|NCT02284581|observational|observational
762554|NCT00394485|Tiotropium|tiotropium
310907|NCT02284581|disease management|disease management
310908|NCT02284568|multiple sclerosis|multiple sclerosis
310909|NCT02284568|primary progressive multiple sclerosis|primary progressive multiple sclerosis
310910|NCT02284568|oral immunomodulator|oral immunomodulator
310911|NCT02284529|high-risk stage-Ⅱ Colorectal Cancer,Orectalip,oxaliplatin|high-risk stage-ⅱ colorectal cancer,orectalip,oxaliplatin
310912|NCT02284503|MI reduction|mi reduction
310913|NCT02284503|intensive statin treatment|intensive statin treatment
310914|NCT02284503|NSTE-ACS|nste-acs
310915|NCT02284490|Brain Metastases|brain metastases
310916|NCT02284477|Insulin resistance|insulin resistance
310917|NCT02284477|Pulmonary function|pulmonary function
310918|NCT02284477|Phthalates|phthalates
310919|NCT02284464|Kidney transplant|kidney transplant
310920|NCT02284464|Immunosuppression|immunosuppression
310921|NCT02284464|Steroid withdrawal|steroid withdrawal
310922|NCT02284464|Donor specific antibodies|donor specific antibodies
310923|NCT02284451|HIV/AIDS and HIV Testing Knowledge|hiv/aids and hiv testing knowledge
310924|NCT02284438|ETT|ett
310925|NCT02284438|Biofilm|biofilm
310926|NCT02284438|Mechanical ventilation|mechanical ventilation
310927|NCT02284438|Critical illness|critical illness
310928|NCT02284438|Ventilator-associated pneumonia|ventilator-associated pneumonia
310929|NCT02284412|Neostigmine|neostigmine
310930|NCT02284412|Sugammadex|sugammadex
310931|NCT02284399|aneuploidy|aneuploidy
310932|NCT02284399|Trisomy 21|trisomy 21
310933|NCT02284399|NIPT|nipt
310934|NCT02284386|Total knee arthroplasty|total knee arthroplasty
310935|NCT02284360|wound healing|wound healing
310936|NCT02284360|APOSEC™|aposec™
310937|NCT02284360|Safety|safety
310938|NCT02284334|mitochondrial diseases|mitochondrial diseases
310939|NCT02284334|nutrition|nutrition
310940|NCT02284334|glycemic index|glycemic index
310941|NCT02284308|NSCLC|nsclc
310942|NCT02284295|chronic obstructive pulmonary disease|chronic obstructive pulmonary disease
310943|NCT02284295|silica dust|silica dust
310944|NCT02284295|aromatic hydrocarbons|aromatic hydrocarbons
310945|NCT02284295|genetic|genetic
310946|NCT02284295|occupational|occupational
310947|NCT02284282|Spinal Morphine|spinal morphine
310948|NCT02284282|Laparoscopic GI-surgery|laparoscopic gi-surgery
310949|NCT02284282|Post-operative pain|post-operative pain
310950|NCT02284243|Bunion|bunion
310951|NCT02284243|Bunionectomy|bunionectomy
310952|NCT02284243|Pain|pain
310953|NCT02284243|Analgesia|analgesia
310954|NCT02284243|dexmedetomidine|dexmedetomidine
310955|NCT02284243|intranasal|intranasal
310956|NCT02284191|Radiology|radiology
310957|NCT02284191|Acute Medicine|acute medicine
310958|NCT02284191|Emergency Medicine|emergency medicine
310959|NCT02284191|Cardiology|cardiology
310960|NCT02284178|mechanical ventilation|mechanical ventilation
310961|NCT02284178|aspiration|aspiration
310962|NCT02284178|suctioning|suctioning
310963|NCT02284178|secretions|secretions
310964|NCT02284178|ventilator-associated events|ventilator-associated events
310965|NCT02284152|bottle feeding|bottle feeding
310966|NCT02284152|feeding behavior|feeding behavior
310967|NCT02284152|infants|infants
310968|NCT02284152|mothers|mothers
310969|NCT02284152|responsive feeding|responsive feeding
310970|NCT02284152|maternal feeding practices|maternal feeding practices
310971|NCT02284152|maternal feeding styles|maternal feeding styles
310972|NCT02284139|EGF ointment|egf ointment
310973|NCT02284139|EGFR inhibitor|egfr inhibitor
310974|NCT02284139|Skin side effect|skin side effect
310975|NCT02284126|Vancomycin|vancomycin
310976|NCT02284126|Anti-Infective Agents, Local|anti-infective agents, local
310977|NCT02284126|Craniotomy|craniotomy
310978|NCT02284126|surgical site infection|surgical site infection
310979|NCT02284126|wound prophylaxis|wound prophylaxis
310980|NCT02284126|Anti-Bacterial Agents|anti-bacterial agents
310981|NCT02284126|Neurosurgical Procedures|neurosurgical procedures
310982|NCT02284126|Administration, Topical|administration, topical
310983|NCT02284126|Antibiotic Prophylaxis|antibiotic prophylaxis
310984|NCT02284126|antibiotics|antibiotics
310985|NCT02284126|prophylaxis|prophylaxis
310986|NCT02284126|neurosurgery|neurosurgery
310987|NCT02284126|Bacterial Infections|bacterial infections
310988|NCT02284126|Central Nervous System Infections|central nervous system infections
310989|NCT02284087|transcranial magnetic stimulation|transcranial magnetic stimulation
310990|NCT02284087|movement disorders|movement disorders
310991|NCT02284074|Lipopolysaccharide (LPS)|lipopolysaccharide (lps)
310992|NCT02284074|Biomarkers|biomarkers
310993|NCT02284074|Chemokines|chemokines
310994|NCT02284074|Cytokines|cytokines
310995|NCT02284074|Gene Expression|gene expression
310996|NCT02284074|Nasal Challenge|nasal challenge
310997|NCT02284074|Inflammation|inflammation
310998|NCT02284074|Nasal|nasal
310999|NCT02284074|Nasosorption|nasosorption
311000|NCT02284074|Respiratory|respiratory
311001|NCT02284048|Ticagrelor|ticagrelor
311002|NCT02284048|Coronary Flow Reserve|coronary flow reserve
311003|NCT02284009|New-onset type 1 diabetes mellitus|new-onset type 1 diabetes mellitus
311004|NCT02284009|Albiglutide|albiglutide
311005|NCT02283996|Adhesive Capsulitis|adhesive capsulitis
311006|NCT02283996|Frozen Shoulder|frozen shoulder
311007|NCT02283996|Shoulder Frozen|shoulder frozen
311008|NCT02283996|Physical Therapy|physical therapy
311009|NCT02283996|Corticosteroid Injections|corticosteroid injections
311010|NCT02283996|Hydrodilation, Hydro-dilation|hydrodilation, hydro-dilation
311011|NCT02283996|Watchful Waiting|watchful waiting
311012|NCT02283996|Prospective|prospective
311013|NCT02283996|Glenohumeral Ligament|glenohumeral ligament
311014|NCT02283905|amphotericin-B|amphotericin-b
311015|NCT02283905|continuously infused|continuously infused
311016|NCT02283905|voriconazole|voriconazole
311017|NCT02283892|respiratory complaints|respiratory complaints
311018|NCT02283892|dyspnea|dyspnea
311019|NCT02283892|cough|cough
311020|NCT02283892|checklist|checklist
311021|NCT02283879|Human Umbilical Cord Mesenchymal Stem Cell|human umbilical cord mesenchymal stem cell
311022|NCT02283879|Mesenchymal Stem Cell|mesenchymal stem cell
311023|NCT02283879|Cerebral hemorrhage|cerebral hemorrhage
311024|NCT02283853|Pediatrics|pediatrics
311025|NCT02283749|NCSLC|ncslc
311026|NCT02283749|lung cancer|lung cancer
311027|NCT02283749|non small cell lung cancer|non small cell lung cancer
311028|NCT02283749|bone metastases|bone metastases
311029|NCT02283749|maintenance|maintenance
311030|NCT02283736|Chronic periodontitis|chronic periodontitis
311031|NCT02283736|Probiotics|probiotics
311032|NCT02283736|Non- surgical treatment|non- surgical treatment
311033|NCT02283723|older adults, goal attainment, optimal aging|older adults, goal attainment, optimal aging
311034|NCT02283710|Pentoxifylline|pentoxifylline
311035|NCT02283710|Aminotransferase|aminotransferase
311036|NCT02283710|Steatohepatitis|steatohepatitis
311037|NCT02283697|hypertension|hypertension
311038|NCT02283697|high blood pressure|high blood pressure
311039|NCT02283697|sodium|sodium
311040|NCT02283697|prevention|prevention
311041|NCT02283697|dietary sodium|dietary sodium
311042|NCT02283697|salt|salt
311043|NCT02283684|LASER|laser
311044|NCT02283684|PROSTATE|prostate
311045|NCT02283684|BIPOLAR|bipolar
311046|NCT02283684|HYPERPLASIA|hyperplasia
311047|NCT02283684|VAPORIZATION|vaporization
311048|NCT02283580|COPD|copd
311049|NCT02283580|Healthy adults|healthy adults
311050|NCT02283580|Resistance training|resistance training
311051|NCT02283580|Elastic bands|elastic bands
311052|NCT02283580|Limb muscle function|limb muscle function
311053|NCT02283580|Volunteers|volunteers
311054|NCT02283554|Periodontal Surgery|periodontal surgery
311055|NCT02283554|Periodontal Regeneration|periodontal regeneration
311056|NCT02283554|Growth factors|growth factors
311057|NCT02283554|Clinical trials|clinical trials
311058|NCT02283541|Gait|gait
311059|NCT02283541|late life depression|late life depression
311060|NCT02283541|mind-body therapies|mind-body therapies
311061|NCT02283515|chronic periodontitis|chronic periodontitis
311062|NCT02283515|local drug delivery|local drug delivery
311063|NCT02283515|rosuvastatin|rosuvastatin
311064|NCT02283515|osseo-differentiation|osseo-differentiation
311065|NCT02283502|Uterine fibroid|uterine fibroid
311066|NCT02283502|magnetic resonance imaging|magnetic resonance imaging
311067|NCT02283502|ultrasound|ultrasound
311068|NCT02283502|non-invasive therapy|non-invasive therapy
311069|NCT02283489|Recombinant Human Endostatin Adenovirus|recombinant human endostatin adenovirus
311070|NCT02283489|Head and Neck Malignant Tumor|head and neck malignant tumor
311071|NCT02283489|clinical trial|clinical trial
311072|NCT02283489|randomized|randomized
311073|NCT02283489|Endostatin|endostatin
311074|NCT02283489|gene therapy|gene therapy
311075|NCT02283476|efficacy and safety|efficacy and safety
311076|NCT02283437|Bibliotherapy|bibliotherapy
311077|NCT02283437|Problem-solving|problem-solving
311078|NCT02283437|Randomized Controlled Trial|randomized controlled trial
311079|NCT02283437|Schizophrenia Spectrum Disorders|schizophrenia spectrum disorders
311080|NCT02283437|Family Caregivers|family caregivers
311081|NCT02283385|Elder abuse|elder abuse
311082|NCT02283385|Intervention|intervention
311083|NCT02283385|Treatment|treatment
311084|NCT02283385|Detection|detection
311085|NCT02283359|Distal Esophagus|distal esophagus
311086|NCT02283359|Esophageal|esophageal
311087|NCT02283359|Gastric|gastric
311088|NCT02283359|Carcinoma|carcinoma
311089|NCT02283359|Adenocarcinoma|adenocarcinoma
311090|NCT02283359|Stomach|stomach
311091|NCT02283359|Gastro-esophageal junction|gastro-esophageal junction
311092|NCT02283359|Recurrent|recurrent
311093|NCT02283359|Metastatic|metastatic
311094|NCT02283359|Unresectable|unresectable
311095|NCT02283346|Prostate Cancer|prostate cancer
311096|NCT02283346|HDR brachytherapy|hdr brachytherapy
311097|NCT02283346|hypo fractionated external beam radiotherapy|hypo fractionated external beam radiotherapy
311098|NCT02283346|toxicity|toxicity
311099|NCT02283346|biochemical control|biochemical control
311100|NCT02283333|Behavioral Activation|behavioral activation
311101|NCT02283333|Therapeutic Exposure|therapeutic exposure
311102|NCT02283333|Mental Health|mental health
311103|NCT02283333|Veterans|veterans
311104|NCT02283333|Complicated Grief|complicated grief
311105|NCT02283333|Military|military
397431|NCT01880684|Leg|leg
311106|NCT02283333|Treatment|treatment
311107|NCT02283333|Cognitive Therapy|cognitive therapy
311108|NCT02283333|Bereavement|bereavement
311109|NCT02283333|Complicated Bereavement|complicated bereavement
311110|NCT02283255|Fontan|fontan
311111|NCT02283255|Exercise|exercise
311112|NCT02283255|Pulmonary Function|pulmonary function
311113|NCT02283255|Aerobic Capacity|aerobic capacity
311114|NCT02283255|Skeletal Muscle|skeletal muscle
311115|NCT02283242|Cholinergic Antagonists|cholinergic antagonists
311116|NCT02283242|Inflammation|inflammation
311117|NCT02283242|Oxidative Stress|oxidative stress
311118|NCT02283229|Plagiocephaly|plagiocephaly
311119|NCT02283229|torticollis|torticollis
311120|NCT02283229|occlusal defect|occlusal defect
311121|NCT02283216|neuromodulation|neuromodulation
311122|NCT02283216|noninvasive|noninvasive
311123|NCT02283216|plasticity|plasticity
311124|NCT02283216|transcranial magnetic stimulation|transcranial magnetic stimulation
311125|NCT02283216|hearing|hearing
311126|NCT02283216|hyperacusis|hyperacusis
311127|NCT02283203|Paracetamol|paracetamol
311128|NCT02283203|Management of fever|management of fever
311129|NCT02283203|Infections|infections
311130|NCT02283190|Asparaginase|asparaginase
311131|NCT02283190|Glutamine|glutamine
311132|NCT02283164|Occupational health|occupational health
311133|NCT02283164|Hazardous material handling|hazardous material handling
311134|NCT02283151|Very Low Carbohydrate Diet|very low carbohydrate diet
311135|NCT02283151|Overweight/obese|overweight/obese
311136|NCT02283138|FLV, VOCAL, PA-RI, preterm fetuses, RDS|flv, vocal, pa-ri, preterm fetuses, rds
311137|NCT02283099|Ebola virus, vaccination, phase I, healthy volunteers|ebola virus, vaccination, phase i, healthy volunteers
311138|NCT02283086|Quality Improvement|quality improvement
311139|NCT02283086|Physician Feedback|physician feedback
311140|NCT02283073|Diagnosis|diagnosis
311141|NCT02283060|Atripla|atripla
311142|NCT02283060|Stribild|stribild
311143|NCT02283060|HIV|hiv
311144|NCT02283060|Sleep architecture|sleep architecture
311145|NCT02283060|Neuropsychological performance|neuropsychological performance
311146|NCT02283047|cardiovascular risk, obesity, interval training, diet|cardiovascular risk, obesity, interval training, diet
311147|NCT02283021|expression of L-type calcium subunits|expression of l-type calcium subunits
311148|NCT02282995|Functional dyspepsia|functional dyspepsia
311149|NCT02282995|symptom response|symptom response
311150|NCT02282982|Immunoprophylaxis|immunoprophylaxis
311151|NCT02282982|Palivizumab|palivizumab
311152|NCT02282969|Cancer Prevention|cancer prevention
311153|NCT02282969|Smokers|smokers
311154|NCT02282969|Quit smoking|quit smoking
311155|NCT02282969|Interviews|interviews
311156|NCT02282969|Questionnaires|questionnaires
311157|NCT02282969|Surveys|surveys
311158|NCT02282969|Lung cancer screening|lung cancer screening
311159|NCT02282969|Patient decision aid|patient decision aid
311160|NCT02282943|endometriosis|endometriosis
311161|NCT02282943|CO2 laser vapourisation|co2 laser vapourisation
311162|NCT02282943|Harmonic scalpel|harmonic scalpel
311163|NCT02282943|AFS stage I-III|afs stage i-iii
311164|NCT02282930|ACTH|acth
311165|NCT02282930|Acthar|acthar
311166|NCT02282930|IgA|iga
311167|NCT02282930|Progressive|progressive
311168|NCT02282930|Nephropathy|nephropathy
311169|NCT02282930|renal function|renal function
311170|NCT02282917|NF2|nf2
311171|NCT02282917|Vestibular Schwannoma|vestibular schwannoma
311172|NCT02282917|Schwannoma|schwannoma
311173|NCT02282917|Meningioma|meningioma
311174|NCT02282904|Chronic Granulomatous Disease|chronic granulomatous disease
311175|NCT02282904|Halo-Identical Protocol|halo-identical protocol
311176|NCT02282904|Transplant|transplant
311177|NCT02282891|propofol|propofol
311178|NCT02282891|ketofol|ketofol
311179|NCT02282878|High Sodium Diet|high sodium diet
311180|NCT02282878|Low Sodium Diet|low sodium diet
311181|NCT02282878|MS|ms
311182|NCT02282865|Emergence agitation, Heart rate variability (HRV)|emergence agitation, heart rate variability (hrv)
311183|NCT02282839|Head and neck cancer|head and neck cancer
311184|NCT02282839|Glutamine|glutamine
311185|NCT02282839|Oral mucositis|oral mucositis
311186|NCT02282839|Quality of life|quality of life
311187|NCT02282813|Parathyroid Diseases|parathyroid diseases
311188|NCT02282813|Renal Insufficiency|renal insufficiency
311189|NCT02282813|Kidney Failure, Chronic|kidney failure, chronic
311190|NCT02282813|Hyperparathyroidism, Secondary|hyperparathyroidism, secondary
311191|NCT02282813|Vitamin D|vitamin d
311192|NCT02282813|Hyperparathyroidism|hyperparathyroidism
311193|NCT02282813|Kidney Diseases|kidney diseases
311194|NCT02282813|Kidney Failure|kidney failure
311195|NCT02282813|Renal Insufficiency, Chronic|renal insufficiency, chronic
311196|NCT02282787|local anesthesia|local anesthesia
311197|NCT02282787|peribulbar anesthesia|peribulbar anesthesia
311198|NCT02282787|DEXMEDETOMIDINE|dexmedetomidine
311199|NCT02282787|vitreoretinal surgery|vitreoretinal surgery
311200|NCT02282774|Vitreoretinal surgery|vitreoretinal surgery
311201|NCT02282735|neuroblastoma|neuroblastoma
311202|NCT02282735|end-of-life|end-of-life
762555|NCT00394472|Heartburn|heartburn
311203|NCT02282735|decision-making|decision-making
311204|NCT02282735|parent|parent
311205|NCT02282735|child|child
311206|NCT02282735|prognosis|prognosis
311207|NCT02282735|preferences|preferences
311208|NCT02282735|childhood cancer|childhood cancer
311209|NCT02282735|oncology|oncology
311210|NCT02282722|cancer|cancer
311211|NCT02282722|palliative|palliative
311212|NCT02282722|chemotherapy|chemotherapy
311213|NCT02282722|metastatic|metastatic
311214|NCT02282722|colorectal|colorectal
311215|NCT02282722|communication|communication
311216|NCT02282722|informed consent|informed consent
311217|NCT02282722|video|video
311218|NCT02282722|education|education
311219|NCT02282722|oncology|oncology
311220|NCT02282722|patient-centered|patient-centered
311221|NCT02282722|outcomes research|outcomes research
311222|NCT02282709|Immunity|immunity
311223|NCT02282657|extracorporreal|extracorporreal
311224|NCT02282657|CO2 removal|co2 removal
311225|NCT02282657|ARDS|ards
311226|NCT02282657|lung|lung
311227|NCT02282657|Protective ventilation|protective ventilation
311228|NCT02282631|active school travel|active school travel
311229|NCT02282631|active travel|active travel
311230|NCT02282631|incentive scheme|incentive scheme
311231|NCT02282631|children|children
311232|NCT02282631|school|school
311233|NCT02282631|behaviour change|behaviour change
311234|NCT02282618|Cardiac Sympathetic Blockade|cardiac sympathetic blockade
311235|NCT02282592|Metabolic syndrome|metabolic syndrome
311236|NCT02282592|case-control study|case-control study
311237|NCT02282592|Breast cancer|breast cancer
311238|NCT02282566|Muscle protein synthesis|muscle protein synthesis
311239|NCT02282514|Autoimmune Diseases|autoimmune diseases
311240|NCT02282514|Autologous Hematopoietic Stem Cell Transplantation|autologous hematopoietic stem cell transplantation
311241|NCT02282501|leptin levels|leptin levels
311242|NCT02282501|ghrelin levels|ghrelin levels
311243|NCT02282462|Chest tube|chest tube
311244|NCT02282449|Venous access device|venous access device
311245|NCT02282449|Port catheters|port catheters
311246|NCT02282449|Chemotherapy|chemotherapy
311247|NCT02282410|severe hemophilia A|severe hemophilia a
311248|NCT02282410|moderately severe hemophilia A|moderately severe hemophilia a
311249|NCT02282410|Recombinant Human Coagulation Factor VIII|recombinant human coagulation factor viii
311250|NCT02282410|standard prophylaxis|standard prophylaxis
311251|NCT02282397|Diabetes Mellitus|diabetes mellitus
311252|NCT02282371|Cetuximab|cetuximab
311253|NCT02282371|BYL719|byl719
311254|NCT02282371|IMRT (Intensity-Modulated Radiation Therapy)|imrt (intensity-modulated radiation therapy)
311255|NCT02282371|14-116|14-116
311256|NCT02282358|Mocetinostat|mocetinostat
311257|NCT02282358|14-106|14-106
311258|NCT02282319|spinal or intravenous dexmedetomidine|spinal or intravenous dexmedetomidine
311259|NCT02282293|Chemoprevention|chemoprevention
311260|NCT02282293|Malaria|malaria
311261|NCT02282293|Uganda|uganda
311262|NCT02282293|Dihydroartemisinin-piperaquine|dihydroartemisinin-piperaquine
311263|NCT02282293|Trimethoprim-sulfamethoxazole|trimethoprim-sulfamethoxazole
311264|NCT02282293|Human Immunodeficiency Virus|human immunodeficiency virus
311265|NCT02282267|Epidermal growth factor receptor|epidermal growth factor receptor
311266|NCT02282267|Droplet digital PCR|droplet digital pcr
311267|NCT02282254|Type 1 diabetes|type 1 diabetes
311268|NCT02282254|Hypoglycemia unawareness|hypoglycemia unawareness
311269|NCT02282254|Nocturnal hypoglycemia|nocturnal hypoglycemia
311270|NCT02282254|Closed-loop strategy|closed-loop strategy
311271|NCT02282254|Artificial pancreas|artificial pancreas
311272|NCT02282254|Glucagon|glucagon
311273|NCT02282254|Hypoglycemia|hypoglycemia
311274|NCT02282254|Insulin|insulin
311275|NCT02282241|Melatonin|melatonin
311276|NCT02282241|Sleep|sleep
311277|NCT02282241|Delirium|delirium
311278|NCT02282215|Fever|fever
311279|NCT02282215|Induction chemotherapy|induction chemotherapy
311280|NCT02282215|Infection|infection
311281|NCT02282215|Leukemia|leukemia
311282|NCT02282215|Myeloid progenitor cells|myeloid progenitor cells
311283|NCT02282215|Neutropenia|neutropenia
311284|NCT02282202|Sputum|sputum
311285|NCT02282202|Bronchiectasis|bronchiectasis
311286|NCT02282202|Chronic Obstructive Pulmonary Disease|chronic obstructive pulmonary disease
311287|NCT02282202|Airway clearance therapy|airway clearance therapy
311288|NCT02282202|Oscillatory Positive Expiratory Pressure|oscillatory positive expiratory pressure
311289|NCT02282189|Sputum|sputum
311290|NCT02282189|Airway clearance therapy|airway clearance therapy
311291|NCT02282189|Oscillatory Positive Expiratory Pressure|oscillatory positive expiratory pressure
311292|NCT02282189|Chronic Obstructive Pulmonary Disease|chronic obstructive pulmonary disease
311293|NCT02282176|Neonates|neonates
311294|NCT02282176|Preterm|preterm
311295|NCT02282176|Azithromycin|azithromycin
311296|NCT02282176|Ureaplasma|ureaplasma
311297|NCT02282176|Chronic Lung disease|chronic lung disease
311298|NCT02282176|Bronchopulmonary dysplasia|bronchopulmonary dysplasia
311299|NCT02282150|Fatigue|fatigue
311300|NCT02282150|Quality of Life|quality of life
311301|NCT02282150|Hydrocortisone|hydrocortisone
311302|NCT02282150|Ecological Momentary Assessments|ecological momentary assessments
311303|NCT02282124|weight|weight
311304|NCT02282124|self-management|self-management
311305|NCT02282124|exercise|exercise
311306|NCT02282098|Atrial fibrillation|atrial fibrillation
311307|NCT02282098|Arrhythmias, Cardiac|arrhythmias, cardiac
311308|NCT02282098|Stroke|stroke
311309|NCT02282098|agents, anti inflammatory|agents, anti inflammatory
311310|NCT02282098|D-dimer|d-dimer
311311|NCT02282098|C-reactive protein|c-reactive protein
311312|NCT02282085|Medication Non-Adherence|medication non-adherence
311313|NCT02282085|Antipsychotic|antipsychotic
311314|NCT02282046|type 2 diabetes mellitus|type 2 diabetes mellitus
311315|NCT02282046|dental implant|dental implant
311316|NCT02282020|BRCA, ovarian, platinum, chemotherapy,|brca, ovarian, platinum, chemotherapy,
311317|NCT02282007|Quality of life|quality of life
311318|NCT02281994|PEMF|pemf
311319|NCT02281994|odontoid fracture|odontoid fracture
311320|NCT02281994|IDE|ide
311321|NCT02281994|prospective|prospective
311322|NCT02281955|Human Papillomavirus|human papillomavirus
311323|NCT02281955|Oropharynx|oropharynx
311324|NCT02281955|Oropharyngeal Squamous Cell Carcinoma|oropharyngeal squamous cell carcinoma
311325|NCT02281955|Squamous Cell Carcinoma|squamous cell carcinoma
311326|NCT02281955|Radiation Therapy|radiation therapy
311327|NCT02281955|Chemotherapy|chemotherapy
311328|NCT02281955|p16|p16
311329|NCT02281929|Alcoholic hepatitis|alcoholic hepatitis
311330|NCT02281929|corticotherapy|corticotherapy
311331|NCT02281929|antibiotherapy|antibiotherapy
311332|NCT02281929|survival|survival
311333|NCT02281929|infection|infection
311334|NCT02281929|hepato renal syndrome|hepato renal syndrome
311335|NCT02281916|Crohn disease|crohn disease
311336|NCT02281916|Immunotherapy|immunotherapy
311337|NCT02281916|Helminth antigen|helminth antigen
311338|NCT02281890|neurodevelopmental disability|neurodevelopmental disability
311339|NCT02281877|Total Knee Arthroplasty (TKA)|total knee arthroplasty (tka)
311340|NCT02281877|Gene Expression|gene expression
311341|NCT02281851|Endogenous antioxidants|endogenous antioxidants
311342|NCT02281851|Antioxidant supplements|antioxidant supplements
311343|NCT02281851|Vitamin Supplements|vitamin supplements
311344|NCT02281851|Exercise adaptations|exercise adaptations
311345|NCT02281851|Oxidative stress|oxidative stress
311346|NCT02281851|Redox regulation|redox regulation
311347|NCT02281851|Cycling - exercise|cycling - exercise
311348|NCT02281838|Stroke|stroke
311349|NCT02281838|Hypertension|hypertension
311350|NCT02281825|Attention-Deficit and Hyperactivity Disorder|attention-deficit and hyperactivity disorder
311351|NCT02281825|Anxiety|anxiety
311352|NCT02281825|Impulsivity|impulsivity
311353|NCT02281825|Computer Games|computer games
311354|NCT02281825|Depression|depression
311355|NCT02281812|Ablation Technique|ablation technique
311356|NCT02281812|Breast cancer|breast cancer
311357|NCT02281812|Stage 1|stage 1
311358|NCT02281812|Lumpectomy|lumpectomy
311359|NCT02281799|Azathioprine (AZA)|azathioprine (aza)
311360|NCT02281799|6-mercaptopurine (6-MP)|6-mercaptopurine (6-mp)
311361|NCT02281799|Thiopurine-S-methyltransferase (TPMT)|thiopurine-s-methyltransferase (tpmt)
311362|NCT02281799|Xanthine oxidase (XO)|xanthine oxidase (xo)
311363|NCT02281799|6-thioguanine (6-TGN)|6-thioguanine (6-tgn)
311364|NCT02281799|6-methyl-mercaptopurine (6-MMP)|6-methyl-mercaptopurine (6-mmp)
311365|NCT02281799|inflammatory bowel disease (IBD)|inflammatory bowel disease (ibd)
311366|NCT02281799|acute pancreatitis (AP)|acute pancreatitis (ap)
311367|NCT02281799|inosine triphosphate pyrophosphohydrolase (ITPA)|inosine triphosphate pyrophosphohydrolase (itpa)
311368|NCT02281799|rheumatoid arthritis (RA)|rheumatoid arthritis (ra)
311369|NCT02281799|systemic lupus erythematosis (SLE)|systemic lupus erythematosis (sle)
311370|NCT02281799|Crohn's disease (CD)|crohn's disease (cd)
311371|NCT02281799|ulcerative colitis (UC)|ulcerative colitis (uc)
311372|NCT02281760|Histiocytosis|histiocytosis
311373|NCT02281760|Non Langerhans Cell Histiocytosis|non langerhans cell histiocytosis
311374|NCT02281760|BRAF Inhibitor|braf inhibitor
311375|NCT02281747|Biologic Therapy|biologic therapy
311376|NCT02281747|Rheumatoid Arthritis|rheumatoid arthritis
311377|NCT02281747|Arthroplasty|arthroplasty
311378|NCT02281708|normogram|normogram
311379|NCT02281708|recurrence|recurrence
311380|NCT02281708|adjuvant chemotherapy|adjuvant chemotherapy
311381|NCT02281708|disease free survival|disease free survival
311382|NCT02281708|Quality of life|quality of life
311383|NCT02281682|Keratosis, Actinic|keratosis, actinic
311384|NCT02281682|Treatment Outcome|treatment outcome
311385|NCT02281682|cost-effectiveness|cost-effectiveness
311386|NCT02281682|economic evaluation|economic evaluation
311387|NCT02281682|imiquimod|imiquimod
311388|NCT02281682|photodynamic therapy|photodynamic therapy
311389|NCT02281682|topical fluorouracil|topical fluorouracil
311390|NCT02281682|ingenol mebutate|ingenol mebutate
311391|NCT02281643|Coinfection|coinfection
311392|NCT02281643|Buruli ulcer|buruli ulcer
311393|NCT02281643|Tuberculosis|tuberculosis
311394|NCT02281643|Mansonella perstans|mansonella perstans
762754|NCT00393731|induction|induction
397824|NCT01878942|LSD|lsd
311395|NCT02281630|Chronic Constipation|chronic constipation
311396|NCT02281630|CC|cc
311397|NCT02281578|Sex Workers|sex workers
311398|NCT02281578|Prevention|prevention
311399|NCT02281565|attitudes|attitudes
311400|NCT02281565|blood donation|blood donation
311401|NCT02281565|blood shortage|blood shortage
311402|NCT02281552|Tofacitinib, CP-690,550, Janis kinase, JAK inhibitor, modified release, Xeljanz|tofacitinib, cp-690,550, janis kinase, jak inhibitor, modified release, xeljanz
311403|NCT02281539|Phantom Limb Pain|phantom limb pain
311404|NCT02281539|Augmented Reality|augmented reality
311405|NCT02281539|Myoelectric control|myoelectric control
311406|NCT02281539|Virtual reality|virtual reality
311407|NCT02281539|electromyography|electromyography
311408|NCT02281539|pattern recognition|pattern recognition
311409|NCT02281539|neurorehabilitation|neurorehabilitation
311410|NCT02281513|Nutrition|nutrition
311411|NCT02281487|tubal carcinoma|tubal carcinoma
311412|NCT02281487|ovarian carcinoma|ovarian carcinoma
311413|NCT02281487|tubectomy|tubectomy
311414|NCT02281487|hysterectomy|hysterectomy
311415|NCT02281487|dysplastic changes|dysplastic changes
311416|NCT02281487|Anti Mullerian Hormone|anti mullerian hormone
311417|NCT02281487|Tubal Intraepithelial Carcinoma|tubal intraepithelial carcinoma
311418|NCT02281487|Salpingectomy|salpingectomy
311419|NCT02281461|PrePex|prepex
311420|NCT02281461|Infants|infants
311421|NCT02281461|Early infants|early infants
311422|NCT02281461|Children|children
311423|NCT02281461|Circumcision|circumcision
311424|NCT02281461|HIV|hiv
311425|NCT02281461|AIDS|aids
311426|NCT02281461|Non surgical|non surgical
311427|NCT02281435|Male Circumcision|male circumcision
311428|NCT02281435|HIV Prevention|hiv prevention
311429|NCT02281435|Screen Failure Subjects|screen failure subjects
311430|NCT02281435|PrePex with Incision|prepex with incision
311431|NCT02281409|Mogamulizumab (KW-0761)|mogamulizumab (kw-0761)
311432|NCT02281409|14-135|14-135
311433|NCT02281396|safety|safety
311434|NCT02281396|rabies vaccine|rabies vaccine
311435|NCT02281396|MRC-5 cell|mrc-5 cell
311436|NCT02281383|Bacillus Calmette-Guérin (BCG)|bacillus calmette-guérin (bcg)
311437|NCT02281383|14-174|14-174
311438|NCT02281370|cyclosporine|cyclosporine
311439|NCT02281370|drug-drug interaction|drug-drug interaction
311440|NCT02281370|pharmacokinetics|pharmacokinetics
311441|NCT02281370|eltrombopag|eltrombopag
311442|NCT02281370|SB-497115|sb-497115
311443|NCT02281357|Asthma|asthma
311444|NCT02281357|Reactive Airways|reactive airways
311445|NCT02281357|Repiratory Tract Disease|repiratory tract disease
311446|NCT02281357|Obstructive Lung Disease|obstructive lung disease
311447|NCT02281357|Lung Diseases|lung diseases
311448|NCT02281344|induced blood stage malaria infection|induced blood stage malaria infection
311449|NCT02281318|Asthma control|asthma control
311450|NCT02281318|Lung function|lung function
311451|NCT02281318|Health-related quality of life|health-related quality of life
311452|NCT02281318|Mepolizumab|mepolizumab
311453|NCT02281318|Severe Eosinophilic asthma|severe eosinophilic asthma
311454|NCT02281292|Diabetic Macular Edema|diabetic macular edema
311455|NCT02281292|Intravitreal|intravitreal
311456|NCT02281292|Retina|retina
311457|NCT02281292|Ophthalmology|ophthalmology
311458|NCT02281292|Lucentis|lucentis
311459|NCT02281292|OCT|oct
311460|NCT02281253|L-carnitine|l-carnitine
311461|NCT02281253|fibre|fibre
311462|NCT02281253|bakery product|bakery product
311463|NCT02281253|insulin resistance|insulin resistance
311464|NCT02281240|Hematopoietic Stem Cell Transplantation|hematopoietic stem cell transplantation
311465|NCT02281214|lung cancer, mutations|lung cancer, mutations
311466|NCT02281214|patients|patients
311467|NCT02281214|mutations|mutations
311468|NCT02281175|Benzodiazepine withdrawal|benzodiazepine withdrawal
311469|NCT02281175|PASSE-65+ program|passe-65+ program
311470|NCT02281175|Psychosocial (non-pharmacological) intervention|psychosocial (non-pharmacological) intervention
311471|NCT02281175|Cognitive-Behavioral Therapy (CBT)|cognitive-behavioral therapy (cbt)
311472|NCT02281175|Older adults|older adults
311473|NCT02281149|breast cancer|breast cancer
311474|NCT02281149|radiotherapy|radiotherapy
311475|NCT02281149|intensity modulation|intensity modulation
311476|NCT02281149|toxicity|toxicity
311477|NCT02281136|Actinic keratosis|actinic keratosis
311478|NCT02281110|Diagnostic coronary catheterization|diagnostic coronary catheterization
311479|NCT02281110|Multi-vessel coronary disease|multi-vessel coronary disease
311480|NCT02281110|Percutaneous Coronary Intervention|percutaneous coronary intervention
311481|NCT02281110|Instantaneous wave free ratio|instantaneous wave free ratio
311482|NCT02281110|Fractional flow reserve|fractional flow reserve
311483|NCT02281097|Postural Orthostatic Tachycardia Syndrome|postural orthostatic tachycardia syndrome
311484|NCT02281097|POTS|pots
311485|NCT02281097|Vagal Stimulation|vagal stimulation
311486|NCT02281084|Keywords provided by Celgene:|keywords provided by celgene:
311487|NCT02281084|myelodysplastic syndromes|myelodysplastic syndromes
311488|NCT02281084|MDS|mds
311489|NCT02281084|azacitidine|azacitidine
762755|NCT00393731|misoprostol|misoprostol
311490|NCT02281084|oral azacitidine (CC-486)|oral azacitidine (cc-486)
311491|NCT02281084|decitabine|decitabine
311492|NCT02281084|intermediate-1|intermediate-1
311493|NCT02281084|intermediate-2 and high risk myelodysplastic syndromes (MDS)|intermediate-2 and high risk myelodysplastic syndromes (mds)
311494|NCT02281084|proliferative chronic myelomonocytic leukemia (CMML)|proliferative chronic myelomonocytic leukemia (cmml)
311495|NCT02281084|Chronic|chronic
311496|NCT02281084|iHMA (injectable hypomethylating agents)|ihma (injectable hypomethylating agents)
311497|NCT02281084|PD-L1|pd-l1
311498|NCT02281032|Palliative Care|palliative care
311499|NCT02281032|Nursing Homes|nursing homes
311500|NCT02281032|interRAI Palliative Care instrument|interrai palliative care instrument
311501|NCT02281032|Older adults|older adults
311502|NCT02280980|Stroke|stroke
311503|NCT02280980|Postural Balance|postural balance
311504|NCT02280980|Oculomotor and Gaze Stability Exercises|oculomotor and gaze stability exercises
311505|NCT02280980|Rehabilitation|rehabilitation
311506|NCT02280980|Physical therapy|physical therapy
311507|NCT02280980|Outpatient|outpatient
311508|NCT02280967|Adolescent|adolescent
311509|NCT02280967|Attitude|attitude
311510|NCT02280967|Condom|condom
311511|NCT02280967|Human Papillomavirus Vaccines|human papillomavirus vaccines
311512|NCT02280967|Primary prevention|primary prevention
311513|NCT02280967|School Health|school health
311514|NCT02280954|Solid Tumor|solid tumor
311515|NCT02280915|female|female
311516|NCT02280915|subjects|subjects
311517|NCT02280902|auto-immune diseases|auto-immune diseases
311518|NCT02280902|inflammatory diseases|inflammatory diseases
311519|NCT02280902|risk factors|risk factors
311520|NCT02280902|infections|infections
311521|NCT02280902|cohort study|cohort study
311522|NCT02280889|quality of life|quality of life
311523|NCT02280889|nevus or scar|nevus or scar
311524|NCT02280889|stigmatization|stigmatization
311525|NCT02280889|scar|scar
311526|NCT02280876|MS|ms
311527|NCT02280876|Demyelinating Autoimmune Diseases|demyelinating autoimmune diseases
311528|NCT02280876|CNS|cns
311529|NCT02280876|Nervous System Diseases|nervous system diseases
311530|NCT02280850|Angina|angina
311531|NCT02280837|GLP-1|glp-1
311532|NCT02280824|Transcaval|transcaval
311533|NCT02280824|TAVR|tavr
311534|NCT02280824|AMPLATZER(R) Occluder|amplatzer(r) occluder
311535|NCT02280811|HPV positive|hpv positive
311536|NCT02280811|Metastatic|metastatic
311537|NCT02280811|Diet|diet
311538|NCT02280811|Screening|screening
311539|NCT02280811|Risk Factors|risk factors
311540|NCT02280811|Colorectal adenoma|colorectal adenoma
311541|NCT02280811|Refractory|refractory
311542|NCT02280811|Immunotherapy|immunotherapy
311543|NCT02280811|Reproductive Cancers|reproductive cancers
311544|NCT02280798|ERA|era
311545|NCT02280772|glucomannan|glucomannan
311546|NCT02280772|obesity|obesity
311547|NCT02280772|children|children
311548|NCT02280772|overweight|overweight
311549|NCT02280772|adolescents|adolescents
311550|NCT02280772|treatment|treatment
311551|NCT02280759|diarrhea, gelatin tannate, acute gastroenteritis|diarrhea, gelatin tannate, acute gastroenteritis
311552|NCT02280733|Qualified Clinical Data Registry|qualified clinical data registry
311553|NCT02280733|Quality Measures|quality measures
311554|NCT02280733|Meaningful Use Stage 2|meaningful use stage 2
311555|NCT02280733|Electronic Health Records|electronic health records
311556|NCT02280733|Clinical Data Research Network|clinical data research network
311557|NCT02280733|Real world data|real world data
311558|NCT02280720|titanium-nitride-oxide-coated stent|titanium-nitride-oxide-coated stent
311559|NCT02280720|everolimus-eluting stent|everolimus-eluting stent
311560|NCT02280720|optical coherence tomography|optical coherence tomography
311561|NCT02280720|strut coverage|strut coverage
311562|NCT02280681|reproductive medicine|reproductive medicine
311563|NCT02280681|artificial gametes|artificial gametes
311564|NCT02280681|patient preference|patient preference
311565|NCT02280681|decision making|decision making
311566|NCT02280668|muscle|muscle
311567|NCT02280668|muscle repair|muscle repair
311568|NCT02280668|tissue repair|tissue repair
311569|NCT02280668|eccentric exercise|eccentric exercise
311570|NCT02280668|force loss|force loss
311571|NCT02280668|icing|icing
311572|NCT02280668|cold therapy|cold therapy
311573|NCT02280668|DOMS|doms
311574|NCT02280668|soreness|soreness
311575|NCT02280668|recovery|recovery
311576|NCT02280655|Blood Transfusions|blood transfusions
311577|NCT02280642|Human papillomavirus|human papillomavirus
311578|NCT02280642|Cervical cancer|cervical cancer
311579|NCT02280642|Genital warts|genital warts
311580|NCT02280642|Vaccine|vaccine
311581|NCT02280642|Immunogenicity|immunogenicity
311582|NCT02280564|motivational interviewing|motivational interviewing
311583|NCT02280564|problem solving skills|problem solving skills
311584|NCT02280564|family communication|family communication
311585|NCT02280564|technology support|technology support
311586|NCT02280564|cell phone system|cell phone system
311587|NCT02280551|adolescent|adolescent
311588|NCT02280551|alcohol|alcohol
311589|NCT02280551|parent|parent
311590|NCT02280551|epidemiology|epidemiology
311591|NCT02280538|Knee Osteoarthritis|knee osteoarthritis
311592|NCT02280538|Intra-Articular Hyaluronic Acid|intra-articular hyaluronic acid
311593|NCT02280538|disease modifying|disease modifying
311594|NCT02280525|Leukemia|leukemia
311595|NCT02280525|Chronic Lymphocytic Leukemia|chronic lymphocytic leukemia
311596|NCT02280525|CLL|cll
311597|NCT02280525|Natural Killer Cells|natural killer cells
311598|NCT02280525|NK|nk
311599|NCT02280525|Umbilical Cord Blood|umbilical cord blood
311600|NCT02280525|UCB|ucb
311601|NCT02280525|Lenalidomide|lenalidomide
311602|NCT02280525|CC-5013|cc-5013
311603|NCT02280525|Revlimid|revlimid
311604|NCT02280525|Rituximab|rituximab
311605|NCT02280525|Rituxan|rituxan
311606|NCT02280525|Fludarabine|fludarabine
311607|NCT02280525|Fludarabine phosphate|fludarabine phosphate
311608|NCT02280525|Fludara|fludara
311609|NCT02280525|Cyclophosphamide|cyclophosphamide
311610|NCT02280525|Cytoxan|cytoxan
311611|NCT02280525|Neosar|neosar
311612|NCT02280525|Cytarabine|cytarabine
311613|NCT02280525|Ara-C|ara-c
311614|NCT02280525|Cytosar|cytosar
311615|NCT02280525|DepoCyt|depocyt
311616|NCT02280525|Cytosine Arabinosine Hydrochloride|cytosine arabinosine hydrochloride
311617|NCT02280512|noninvasive cardiac output measurement(NICOM)|noninvasive cardiac output measurement(nicom)
311618|NCT02280512|Leg fractures|leg fractures
311619|NCT02280512|Near-Infrared Spectroscopy (NIRS)|near-infrared spectroscopy (nirs)
311620|NCT02280512|Intensive care unit(ICU)|intensive care unit(icu)
311621|NCT02280486|saxagliptin|saxagliptin
311622|NCT02280486|glimepiride|glimepiride
311623|NCT02280486|metformin monotherapy|metformin monotherapy
311624|NCT02280421|HSV|hsv
311625|NCT02280421|Herpes|herpes
311626|NCT02280421|volunteers|volunteers
311627|NCT02280421|drug-drug interaction|drug-drug interaction
311628|NCT02280421|transplant|transplant
311629|NCT02280382|splinting|splinting
311630|NCT02280369|posture detection|posture detection
311631|NCT02280369|healthy subjects|healthy subjects
311632|NCT02280356|Radiation Therapy|radiation therapy
311633|NCT02280356|Brachytherapy|brachytherapy
311634|NCT02280356|14-163|14-163
311635|NCT02280343|forced oscillation tecnique|forced oscillation tecnique
311636|NCT02280343|lung function|lung function
311637|NCT02280343|asbestosis|asbestosis
311638|NCT02280330|Iodine Deficiency|iodine deficiency
311639|NCT02280330|Micronutrient Powder|micronutrient powder
311640|NCT02280330|Hypothyroidism|hypothyroidism
311641|NCT02280304|Stress Disorders, Post-Traumatic|stress disorders, post-traumatic
311642|NCT02280304|Concussion, Mild|concussion, mild
311643|NCT02280304|Brain Injuries|brain injuries
311644|NCT02280304|Community Integration|community integration
311645|NCT02280304|Meditation|meditation
311646|NCT02280304|Magnetic Resonance Imaging|magnetic resonance imaging
311647|NCT02280278|colon cancer|colon cancer
311648|NCT02280278|cytokine-induced killer cell immunotherapy|cytokine-induced killer cell immunotherapy
311649|NCT02280265|hemophilia A|hemophilia a
311650|NCT02280265|standard prophylaxis|standard prophylaxis
311651|NCT02280265|Recombinant Human Coagulation Factor VIII for injection|recombinant human coagulation factor viii for injection
311652|NCT02280265|ADVATE|advate
311653|NCT02280265|Pediatric|pediatric
311654|NCT02280252|Locally-advanced Breast Cancer|locally-advanced breast cancer
311655|NCT02280252|LABC|labc
311656|NCT02280252|breast cancer|breast cancer
311657|NCT02280252|breast|breast
311658|NCT02280252|cancer|cancer
311659|NCT02280252|metastasis|metastasis
311660|NCT02280252|metastatic|metastatic
311661|NCT02280252|tumor|tumor
311662|NCT02280252|radiation|radiation
311663|NCT02280252|radiation therapy|radiation therapy
311664|NCT02280252|radiotherapy|radiotherapy
311665|NCT02280252|paclitaxel|paclitaxel
311666|NCT02280239|Fever|fever
311667|NCT02280239|Acetaminophen|acetaminophen
311668|NCT02280239|Body Temperature Regulation|body temperature regulation
311669|NCT02280239|Critical Illness|critical illness
311670|NCT02280239|Hypotension|hypotension
311671|NCT02280200|claudication|claudication
311672|NCT02280200|ankle foot orthoses|ankle foot orthoses
311673|NCT02280200|community walking exercise|community walking exercise
311674|NCT02280187|InductOs|inductos
311675|NCT02280187|rhBMP-2|rhbmp-2
311676|NCT02280187|Retrospective|retrospective
311677|NCT02280187|France|france
311678|NCT02280187|Fusion|fusion
311679|NCT02280187|real world use|real world use
311680|NCT02280174|Apo B-48|apo b-48
311681|NCT02280174|TRL|trl
311682|NCT02280174|Linagliptin|linagliptin
311683|NCT02280148|Propofol|propofol
311684|NCT02280148|gastroscopy and colonoscopy|gastroscopy and colonoscopy
311685|NCT02280148|driving simulator|driving simulator
311686|NCT02280148|driving ability|driving ability
311687|NCT02280148|cognitive function|cognitive function
311688|NCT02280148|patients|patients
311689|NCT02280122|activated matrix metalloproteinase 8|activated matrix metalloproteinase 8
311690|NCT02280122|untreated moderate/severe chronic periodontitis|untreated moderate/severe chronic periodontitis
311691|NCT02280122|saliva|saliva
311692|NCT02280122|sensitivity/specificity|sensitivity/specificity
311693|NCT02280109|Tenofovir|tenofovir
311694|NCT02280109|Healthy Volunteers|healthy volunteers
311695|NCT02280109|HIV|hiv
311696|NCT02280109|pharmacokinetics of tenofovir gel and film|pharmacokinetics of tenofovir gel and film
311697|NCT02280096|Cognitive function|cognitive function
311698|NCT02280096|Multiple sclerosis|multiple sclerosis
311699|NCT02280096|4-aminopyridine|4-aminopyridine
311700|NCT02280096|Fatigue|fatigue
311701|NCT02280083|Spasticity, Post-Stroke|spasticity, post-stroke
311702|NCT02280083|Botulinum toxin type A for Injection|botulinum toxin type a for injection
311703|NCT02280083|upper limb spasticity|upper limb spasticity
311704|NCT02280070|resectable rectal cancer|resectable rectal cancer
311705|NCT02280070|SOX|sox
311706|NCT02280070|mFOLFOX6|mfolfox6
311707|NCT02280070|neoadjuvant|neoadjuvant
311708|NCT02280057|PCOS|pcos
311709|NCT02280057|metformin|metformin
311710|NCT02280057|obesity|obesity
311711|NCT02280057|randomized controlled trial|randomized controlled trial
311712|NCT02280044|Campylobacter jejuni|campylobacter jejuni
311713|NCT02280044|rifaximin|rifaximin
311714|NCT02280044|antibiotic prophylaxis|antibiotic prophylaxis
311715|NCT02280044|dysentery|dysentery
311716|NCT02280044|diarrhea|diarrhea
311717|NCT02280031|Twin Pregnancy|twin pregnancy
311718|NCT02280031|Pregnancy Complications|pregnancy complications
311719|NCT02280018|Healthy|healthy
311720|NCT02280018|JNJ-49122944|jnj-49122944
311721|NCT02280018|Placebo|placebo
311722|NCT02280005|Dialysis|dialysis
311723|NCT02280005|Renal Failure|renal failure
311724|NCT02280005|Wearable|wearable
311725|NCT02280005|Artificial Kidney|artificial kidney
311726|NCT02280005|Hemodialysis|hemodialysis
311727|NCT02279992|Malignant Glioma|malignant glioma
311728|NCT02279992|Brain Neoplasms, Malignant|brain neoplasms, malignant
311729|NCT02279992|Brain metastasis|brain metastasis
311730|NCT02279979|PHP|php
311731|NCT02279979|Cardiogenic Shock|cardiogenic shock
311732|NCT02279979|Percutaneous|percutaneous
311733|NCT02279979|Ventricular Assist|ventricular assist
311734|NCT02279979|Heart Pump|heart pump
311735|NCT02279979|Catheter|catheter
311736|NCT02279979|Thoratec Corporation|thoratec corporation
311737|NCT02279940|rivaroxaban|rivaroxaban
311738|NCT02279940|stroke|stroke
311739|NCT02279940|transient ischemic attack|transient ischemic attack
311740|NCT02279940|ischemia|ischemia
311741|NCT02279927|Ureteroscopy|ureteroscopy
311742|NCT02279901|Obstructive Sleep Apnea|obstructive sleep apnea
311743|NCT02279901|CPAP|cpap
311744|NCT02279901|Continuous positive airway pressure|continuous positive airway pressure
311745|NCT02279901|CPAP compliance|cpap compliance
311746|NCT02279901|Telemedicine|telemedicine
311747|NCT02279901|Automated response mechanisms|automated response mechanisms
311748|NCT02279901|Patient engagement|patient engagement
311749|NCT02279901|OSA|osa
311750|NCT02279888|Pulmonary Artery Pressure Monitoring|pulmonary artery pressure monitoring
311751|NCT02279888|Implantable Hemodynamic Monitor|implantable hemodynamic monitor
311752|NCT02279875|Tuberculosis|tuberculosis
311753|NCT02279875|Drug-Sensitive Tuberculosis|drug-sensitive tuberculosis
311754|NCT02279875|Linezolid|linezolid
311755|NCT02279875|HRZE (isoniazid, rifampicin, pyrazinamide, ethambutol)|hrze (isoniazid, rifampicin, pyrazinamide, ethambutol)
311756|NCT02279875|Pulmonary Tuberculosis|pulmonary tuberculosis
311757|NCT02279875|TB|tb
311758|NCT02279849|multi-level intervention|multi-level intervention
311759|NCT02279849|price discounts|price discounts
311760|NCT02279849|communication|communication
311761|NCT02279849|low income population|low income population
311762|NCT02279849|dietary intervention|dietary intervention
311763|NCT02279849|obesity prevention|obesity prevention
311764|NCT02279849|store-based intervention|store-based intervention
311765|NCT02279836|Patients with any indication for colonoscopy in the U.S.A.|patients with any indication for colonoscopy in the u.s.a.
311766|NCT02279823|androgen|androgen
311767|NCT02279823|alopecia|alopecia
311768|NCT02279823|CB-03-01|cb-03-01
311769|NCT02279823|solution|solution
311770|NCT02279823|topical|topical
311771|NCT02279810|organ shortage|organ shortage
311772|NCT02279810|attitudes to organ transplantation|attitudes to organ transplantation
311773|NCT02279797|bone marrow|bone marrow
311774|NCT02279797|attitude|attitude
311775|NCT02279771|colorectal anastomosis|colorectal anastomosis
311776|NCT02279771|anastomotic leak|anastomotic leak
311777|NCT02279771|ileostomy|ileostomy
311778|NCT02279771|complications|complications
311779|NCT02279758|Neuroendocrine Tumors|neuroendocrine tumors
311780|NCT02279758|The Mammalian Target of Rapamycin (mTOR)|the mammalian target of rapamycin (mtor)
311781|NCT02279758|metformin|metformin
311782|NCT02279693|Raypilot dosimetry|raypilot dosimetry
311783|NCT02279693|CBCT (cone beam computed tomography)|cbct (cone beam computed tomography)
311784|NCT02279654|Lenalidomide|lenalidomide
311785|NCT02279654|Revlimid|revlimid
311786|NCT02279654|Transfusion-dependent|transfusion-dependent
311787|NCT02279654|international Prognostic Scoring System (IPSS) low|international prognostic scoring system (ipss) low
311788|NCT02279654|Intermediate-1-risk|intermediate-1-risk
311789|NCT02279654|MDS|mds
311790|NCT02279654|Isolated del(5q)|isolated del(5q)
311791|NCT02279654|Prospective|prospective
311792|NCT02279654|Non-interventional|non-interventional
311793|NCT02279654|Post-authorization safety study (PASS)|post-authorization safety study (pass)
311794|NCT02279654|Disease registry|disease registry
311795|NCT02279628|cesarean section|cesarean section
311796|NCT02279628|spinal anesthesia|spinal anesthesia
311797|NCT02279628|continuous wound infiltration|continuous wound infiltration
311798|NCT02279628|intrathecal morphine|intrathecal morphine
311799|NCT02279628|oral morphine|oral morphine
311800|NCT02279615|Overactive Bladder|overactive bladder
311801|NCT02279615|Benign Prostatic Hyperplasia|benign prostatic hyperplasia
311802|NCT02279615|Combination Therapy|combination therapy
311803|NCT02279615|β3-Adrenoceptor Agonist|β3-adrenoceptor agonist
311804|NCT02279615|Mirabegron|mirabegron
311805|NCT02279615|Myrbetriq|myrbetriq
311806|NCT02279615|α-Adrenoceptor Antagonist|α-adrenoceptor antagonist
311807|NCT02279615|Tamsulosin|tamsulosin
311808|NCT02279615|Flomax|flomax
311809|NCT02279602|Pancreatic|pancreatic
311810|NCT02279602|Gastrointestional|gastrointestional
311811|NCT02279589|hyporesponsiveness|hyporesponsiveness
311812|NCT02279589|vaccination|vaccination
311813|NCT02279589|recommendations|recommendations
311814|NCT02279589|improvement|improvement
311815|NCT02279589|schedule|schedule
311816|NCT02279589|fractional dose|fractional dose
311817|NCT02279589|conjugate polysaccharide vaccine|conjugate polysaccharide vaccine
311818|NCT02279576|Penile squamous cell carcinoma|penile squamous cell carcinoma
311819|NCT02279576|Pazopanib|pazopanib
311820|NCT02279576|Weekly paclitaxel|weekly paclitaxel
311821|NCT02279550|hip fracture, elderly|hip fracture, elderly
311822|NCT02279537|Wet age-related macular Degeneration (Wet-AMD)|wet age-related macular degeneration (wet-amd)
311823|NCT02279537|Naïve patients|naïve patients
311824|NCT02279537|Real life|real life
311825|NCT02279537|Aflibercept|aflibercept
311826|NCT02279524|NASH|nash
311827|NCT02279511|Alzheimer|alzheimer
311828|NCT02279485|Healthy Subjects|healthy subjects
311829|NCT02279485|Bioequivalence|bioequivalence
311830|NCT02279485|Fasted|fasted
311831|NCT02279485|Fed|fed
311832|NCT02279433|Neoplasms|neoplasms
311833|NCT02279433|Lung Neoplasms|lung neoplasms
311834|NCT02279433|Colorectal Neoplasms|colorectal neoplasms
311835|NCT02279433|Neuroendocrine Tumors|neuroendocrine tumors
311836|NCT02279433|Pancreatic Neoplasms|pancreatic neoplasms
311837|NCT02279407|omega-3 carboxylic acid|omega-3 carboxylic acid
311838|NCT02279394|Smoldering myeloma|smoldering myeloma
311839|NCT02279394|Smoldering Multiple Myeloma|smoldering multiple myeloma
311840|NCT02279381|Chlorhexidine|chlorhexidine
311841|NCT02279381|Kangaroo mother care|kangaroo mother care
311842|NCT02279381|RCT|rct
311843|NCT02279342|Coronary artery disease|coronary artery disease
311844|NCT02279342|hyperuricemia|hyperuricemia
312049|NCT02278419|Hepatitis C|hepatitis c
311845|NCT02279342|coronary plaque volume|coronary plaque volume
311846|NCT02279342|IVUS|ivus
311847|NCT02279316|Dalcroze eurhythmics|dalcroze eurhythmics
311848|NCT02279316|home exercise|home exercise
311849|NCT02279316|vitamin D|vitamin d
311850|NCT02279316|mild cognitive impairment|mild cognitive impairment
311851|NCT02279316|MCI|mci
311852|NCT02279316|mild dementia|mild dementia
311853|NCT02279290|Childhood trauma|childhood trauma
311854|NCT02279264|ph|ph
311855|NCT02279264|RightSpot Infant|rightspot infant
311856|NCT02279264|Feeding Tube|feeding tube
311857|NCT02279264|RightBio Metrics|rightbio metrics
311858|NCT02279264|placement|placement
311859|NCT02279264|Nasogastric Tube|nasogastric tube
311860|NCT02279264|NG|ng
311861|NCT02279264|infant|infant
311862|NCT02279251|Anxiety|anxiety
311863|NCT02279251|adolescents|adolescents
311864|NCT02279251|school-based|school-based
311865|NCT02279251|low-intensity CBT|low-intensity cbt
311866|NCT02279225|Phototherapy|phototherapy
311867|NCT02279225|Laser|laser
311868|NCT02279225|Fibromyalgia|fibromyalgia
311869|NCT02279225|DTM/ TMD|dtm/ tmd
311870|NCT02279225|Pain|pain
311871|NCT02279212|Critical illness|critical illness
311872|NCT02279212|pain|pain
311873|NCT02279212|quality of life|quality of life
311874|NCT02279199|hemophilia|hemophilia
311875|NCT02279199|joint health|joint health
311876|NCT02279199|motor development|motor development
311877|NCT02279199|motor proficiency|motor proficiency
311878|NCT02279173|Pediatric|pediatric
311879|NCT02279173|Immune Thrombocytopenia|immune thrombocytopenia
311880|NCT02279173|Amgen|amgen
311881|NCT02279147|Systemic Inflammatory Response Syndrome|systemic inflammatory response syndrome
311882|NCT02279147|Jaundice, Obstructive|jaundice, obstructive
311883|NCT02279147|anti-inflammatory|anti-inflammatory
311884|NCT02279134|StageⅡB-Ⅲ esophageal cancer|stageⅱb-ⅲ esophageal cancer
311885|NCT02279134|adjuvant radiotherapy|adjuvant radiotherapy
311886|NCT02279134|adjuvant chemoradiotherapy|adjuvant chemoradiotherapy
311887|NCT02279121|central venous catheter|central venous catheter
311888|NCT02279121|Taurolidine|taurolidine
311889|NCT02279121|lock-therapy|lock-therapy
311890|NCT02279108|sentinel lymph node|sentinel lymph node
311891|NCT02279108|indocyanine green|indocyanine green
311892|NCT02279108|fluorescence method|fluorescence method
311893|NCT02279108|radioisotope conventional method|radioisotope conventional method
311894|NCT02279108|breast cancer|breast cancer
311895|NCT02279095|Open-label extension study|open-label extension study
311896|NCT02279095|Clinical trial Phase 2|clinical trial phase 2
311897|NCT02279095|Efficacy and safety|efficacy and safety
311898|NCT02279095|Heterotopic ossification|heterotopic ossification
311899|NCT02279095|Fibrodysplasia Ossificans Progressiva|fibrodysplasia ossificans progressiva
311900|NCT02279095|Flare-up|flare-up
311901|NCT02279095|Palovarotene|palovarotene
311902|NCT02279095|Retinoic acid receptor agonist|retinoic acid receptor agonist
311903|NCT02279095|Retinoic acid receptor gamma agonist|retinoic acid receptor gamma agonist
311904|NCT02279095|Clementia|clementia
311905|NCT02279095|Myositis Ossificans Progressiva|myositis ossificans progressiva
311906|NCT02279095|Munchmeyer's Disease|munchmeyer's disease
311907|NCT02279095|FOP|fop
311908|NCT02279069|stroke|stroke
311909|NCT02279069|walking|walking
311910|NCT02279069|rehabilitation|rehabilitation
311911|NCT02279043|IUD|iud
311912|NCT02279043|IUC|iuc
311913|NCT02279043|birth control|birth control
311914|NCT02279043|contraception|contraception
311915|NCT02279043|online|online
311916|NCT02279030|ablation|ablation
311917|NCT02279017|Mobile Technology|mobile technology
311918|NCT02279017|Diet and Fitness|diet and fitness
311919|NCT02279004|Plasma Genotyping|plasma genotyping
311920|NCT02279004|NSCLC|nsclc
311921|NCT02279004|Melanoma|melanoma
311922|NCT02278978|urothelial carcinoma|urothelial carcinoma
311923|NCT02278978|BIBF1120|bibf1120
311924|NCT02278965|Breast Cancer|breast cancer
311925|NCT02278965|Early Stage|early stage
311926|NCT02278939|diabetes prevention|diabetes prevention
311927|NCT02278939|Filipinos|filipinos
311928|NCT02278939|lifestyle intervention|lifestyle intervention
311929|NCT02278926|Ultrasound|ultrasound
311930|NCT02278926|Lypo-hypertrophy|lypo-hypertrophy
311931|NCT02278913|inpatient|inpatient
311932|NCT02278913|hospital|hospital
311933|NCT02278913|randomized trial|randomized trial
311934|NCT02278913|diabetes|diabetes
311935|NCT02278913|analogs|analogs
311936|NCT02278913|human insulin|human insulin
311937|NCT02278900|communication|communication
311938|NCT02278900|shared decision-making|shared decision-making
311939|NCT02278887|melanoma|melanoma
311940|NCT02278887|TIL treatment|til treatment
311941|NCT02278887|tumor infiltrating lymphocytes|tumor infiltrating lymphocytes
311942|NCT02278887|ipilimumab|ipilimumab
311943|NCT02278887|interleukin 2|interleukin 2
311944|NCT02278887|non-myeloablative|non-myeloablative
311945|NCT02278887|randomization|randomization
311946|NCT02278874|Trisomy 13|trisomy 13
311947|NCT02278874|Trisomy 18|trisomy 18
311948|NCT02278874|Trisomy 21|trisomy 21
311949|NCT02278874|Sex Chromosome Abnormalities|sex chromosome abnormalities
311950|NCT02278874|Monosomy X|monosomy x
311951|NCT02278874|XXX|xxx
311952|NCT02278874|XXY|xxy
311953|NCT02278874|XYY|xyy
311954|NCT02278861|actinic keratosis|actinic keratosis
311955|NCT02278861|tretinoin|tretinoin
311956|NCT02278861|isotretinoin|isotretinoin
311957|NCT02278861|cryotherapy|cryotherapy
311958|NCT02278861|sun protection factor|sun protection factor
311959|NCT02278861|clinical clearance|clinical clearance
311960|NCT02278848|Computerised gait analysis|computerised gait analysis
311961|NCT02278848|Ultrasound measurement of cerebral pulsatility|ultrasound measurement of cerebral pulsatility
311962|NCT02278848|MRI flow|mri flow
311963|NCT02278848|Urinary incontinence scale|urinary incontinence scale
311964|NCT02278848|Subtractive lumbar puncture|subtractive lumbar puncture
311965|NCT02278835|Cardiac valve|cardiac valve
311966|NCT02278809|physical activity|physical activity
311967|NCT02278809|screen time|screen time
311968|NCT02278809|vegetables|vegetables
311969|NCT02278809|fruit|fruit
311970|NCT02278809|snacks|snacks
311971|NCT02278809|softdrink|softdrink
311972|NCT02278809|water|water
311973|NCT02278809|fruit juice|fruit juice
311974|NCT02278809|parenting practices|parenting practices
311975|NCT02278809|online videos|online videos
311976|NCT02278809|intervention mapping protocol|intervention mapping protocol
311977|NCT02278796|Diffuse large B-cell lymphomas (DLBC)|diffuse large b-cell lymphomas (dlbc)
311978|NCT02278796|Follicular lymphomas (FL)|follicular lymphomas (fl)
311979|NCT02278796|Mantle cell lymphomas (MCL)|mantle cell lymphomas (mcl)
311980|NCT02278770|diverticular disease|diverticular disease
311981|NCT02278770|MRI|mri
311982|NCT02278770|visceral and subcutaneous fat|visceral and subcutaneous fat
311983|NCT02278770|adipokines|adipokines
311984|NCT02278757|Metabolic syndrome|metabolic syndrome
311985|NCT02278757|Weight loss|weight loss
311986|NCT02278757|Obesity|obesity
311987|NCT02278757|Hypertension|hypertension
311988|NCT02278757|Dyslipidemia|dyslipidemia
762756|NCT00393731|oxytocin|oxytocin
311989|NCT02278744|Single-Fraction Stereotactic Radiosurgery|single-fraction stereotactic radiosurgery
311990|NCT02278744|Salvage Re-Irradiation|salvage re-irradiation
311991|NCT02278744|14-054|14-054
311992|NCT02278731|Physical activity|physical activity
311993|NCT02278731|Rehabilitation|rehabilitation
311994|NCT02278731|Older adults|older adults
311995|NCT02278731|Pilates|pilates
311996|NCT02278731|Proprioceptive neuromuscular facilitation|proprioceptive neuromuscular facilitation
311997|NCT02278705|childhood obesity|childhood obesity
311998|NCT02278705|childhood overweight|childhood overweight
311999|NCT02278705|primary care|primary care
312000|NCT02278705|weight management|weight management
312001|NCT02278692|Vitamin K|vitamin k
312002|NCT02278692|Calciphylaxis|calciphylaxis
312003|NCT02278692|Calcific uremic arteriolopathy|calcific uremic arteriolopathy
312004|NCT02278692|Dialysis|dialysis
312005|NCT02278692|End-stage renal disease|end-stage renal disease
312006|NCT02278653|Restaging|restaging
312007|NCT02278653|Watchful Waiting|watchful waiting
312008|NCT02278653|Quality of Life|quality of life
312009|NCT02278653|Manometry|manometry
312010|NCT02278601|Breakthrough pain|breakthrough pain
312011|NCT02278575|antithrombin, Atenativ, preeclampsia, blood flow.|antithrombin, atenativ, preeclampsia, blood flow.
312012|NCT02278549|Spinal kinematics|spinal kinematics
312013|NCT02278536|Trisomy 13|trisomy 13
312014|NCT02278536|Trisomy 18|trisomy 18
312015|NCT02278536|Trisomy 21|trisomy 21
312016|NCT02278536|Sex Chromosome Abnormalities|sex chromosome abnormalities
312017|NCT02278536|Monosomy X|monosomy x
312018|NCT02278536|XXX|xxx
312019|NCT02278536|XXY|xxy
312020|NCT02278536|XYY|xyy
312021|NCT02278510|topotecan|topotecan
312022|NCT02278510|convection-enhanced delivery|convection-enhanced delivery
312023|NCT02278510|CED|ced
312024|NCT02278510|High Grade Glioma|high grade glioma
312025|NCT02278484|sinus infections|sinus infections
312026|NCT02278484|sinusitis|sinusitis
312027|NCT02278484|chronic sinusitis|chronic sinusitis
312028|NCT02278484|rhinosinusitis|rhinosinusitis
312029|NCT02278484|allergic sinusitis|allergic sinusitis
312030|NCT02278484|allergic rhinitis|allergic rhinitis
312031|NCT02278484|chronic rhinosinusitis|chronic rhinosinusitis
312032|NCT02278484|sinus disease in children|sinus disease in children
312033|NCT02278484|sinus balloon dilation|sinus balloon dilation
312034|NCT02278484|balloon dilatation|balloon dilatation
312035|NCT02278484|sinus disease|sinus disease
312036|NCT02278484|pediatric|pediatric
312037|NCT02278471|combination pill|combination pill
312038|NCT02278471|polypill|polypill
312039|NCT02278471|primary prevention|primary prevention
312040|NCT02278445|Systemic Sclerosis|systemic sclerosis
312041|NCT02278445|Pulmonary hypertension|pulmonary hypertension
312042|NCT02278445|Lung Doppler Signals|lung doppler signals
312043|NCT02278432|risk assessment|risk assessment
312044|NCT02278432|pharmacovigilance|pharmacovigilance
312045|NCT02278432|pharmacoepidemiology|pharmacoepidemiology
312046|NCT02278432|drug toxicity|drug toxicity
312047|NCT02278432|adverse drug reaction reporting system|adverse drug reaction reporting system
312048|NCT02278432|omeprazole|omeprazole
312050|NCT02278419|Simeprevir|simeprevir
312051|NCT02278419|Sofosbuvir|sofosbuvir
312052|NCT02278419|Healthy|healthy
312053|NCT02278406|Parkinson's Disease|parkinson's disease
312054|NCT02278406|Deep brain stimulator|deep brain stimulator
312055|NCT02278406|dbs|dbs
312056|NCT02278393|Japanese healthy volunteers|japanese healthy volunteers
312057|NCT02278393|High LDL-C|high ldl-c
312058|NCT02278393|dairy drinks|dairy drinks
312059|NCT02278393|phytosterols|phytosterols
312060|NCT02278341|ASP1517|asp1517
312061|NCT02278341|FG-4592|fg-4592
312062|NCT02278341|Anemia|anemia
312063|NCT02278341|End Stage Renal Disease (ESRD)|end stage renal disease (esrd)
312064|NCT02278341|Erythropoetin Stimulating Agents (ESAs)|erythropoetin stimulating agents (esas)
312065|NCT02278341|Chronic Kidney Disease|chronic kidney disease
312066|NCT02278341|Hematopoetic Agents|hematopoetic agents
312067|NCT02278341|HIF-PH inhibitor|hif-ph inhibitor
312068|NCT02278341|Hemoglobin|hemoglobin
312069|NCT02278341|Dialysis|dialysis
312070|NCT02278341|roxadustat|roxadustat
312071|NCT02278328|dose titration study|dose titration study
312072|NCT02278328|electrophysiology|electrophysiology
312073|NCT02278315|Multiple Myeloma|multiple myeloma
312074|NCT02278315|Radiopharmaceutical|radiopharmaceutical
312075|NCT02278315|Therapy|therapy
312076|NCT02278315|Phase 1|phase 1
312077|NCT02278263|tranexamic acid|tranexamic acid
312078|NCT02278263|enhanced recovery|enhanced recovery
312079|NCT02278263|arthroplasty|arthroplasty
312080|NCT02278263|perioperative care|perioperative care
312081|NCT02278250|VX14-803-001|vx14-803-001
312082|NCT02278250|VX-803|vx-803
312083|NCT02278250|M4344|m4344
312084|NCT02278250|Advanced Solid Tumor|advanced solid tumor
312085|NCT02278250|Cytotoxic Chemotherapy|cytotoxic chemotherapy
312086|NCT02278250|Gemcitabine|gemcitabine
312087|NCT02278250|Cisplatin|cisplatin
312088|NCT02278250|Carboplatin|carboplatin
312089|NCT02278198|thyroid cancer|thyroid cancer
312090|NCT02278172|vitamin D|vitamin d
398686|NCT01875250|PSA|psa
312091|NCT02278172|athletes|athletes
312092|NCT02278172|fitness|fitness
312093|NCT02278159|end-stage kidney disease|end-stage kidney disease
312094|NCT02278159|peritoneal dialysis|peritoneal dialysis
312095|NCT02278159|home hemodialysis|home hemodialysis
312096|NCT02278159|technique survival|technique survival
312097|NCT02278159|patient survival|patient survival
312098|NCT02278133|metastatic,|metastatic,
312099|NCT02278133|Colorectal cancer,|colorectal cancer,
312100|NCT02278133|WNT974,|wnt974,
312101|NCT02278133|LGX818,|lgx818,
312102|NCT02278133|cetuximab,|cetuximab,
312103|NCT02278133|BRAF-mutant,|braf-mutant,
312104|NCT02278133|mCRC,|mcrc,
312105|NCT02278133|BRAFV600-mutant,|brafv600-mutant,
312106|NCT02278133|KRAS|kras
312107|NCT02278120|LEE011|lee011
312108|NCT02278120|ribociclib|ribociclib
312109|NCT02278120|HR-positive|hr-positive
312110|NCT02278120|HER2-negative|her2-negative
312111|NCT02278120|Advanced breast cancer|advanced breast cancer
312112|NCT02278120|Letrozole|letrozole
312113|NCT02278120|Anastrozole|anastrozole
312114|NCT02278120|Tamoxifen|tamoxifen
312115|NCT02278120|Goserelin|goserelin
312116|NCT02278120|CDK|cdk
312117|NCT02278120|CDK4|cdk4
312118|NCT02278120|CDK6|cdk6
312119|NCT02278120|CDK4/6|cdk4/6
312120|NCT02278120|Phase III|phase iii
312121|NCT02278120|ER-positive|er-positive
312122|NCT02278120|PR-positive|pr-positive
312123|NCT02278120|Premenopausal|premenopausal
312124|NCT02278094|OSAS|osas
312125|NCT02278094|Adult|adult
312126|NCT02278094|Home-based|home-based
312127|NCT02278094|Genioglossus|genioglossus
312128|NCT02278094|Inspiratory muscle|inspiratory muscle
312129|NCT02278094|Exercise|exercise
312130|NCT02278081|Rhinitis (nasal obstruction) and GERD|rhinitis (nasal obstruction) and gerd
312131|NCT02278068|Type 2 diabetes|type 2 diabetes
312132|NCT02278055|Radium-223|radium-223
312133|NCT02278055|14-098|14-098
312134|NCT02278055|Prostate Cancer Clinical Trials Consortium|prostate cancer clinical trials consortium
312135|NCT02278016|procalcitonin|procalcitonin
312136|NCT02278016|interleukin-6|interleukin-6
312137|NCT02278016|agiotensininⅡ|agiotensininⅱ
312138|NCT02278003|Amnesic|amnesic
312139|NCT02278003|Propofol|propofol
312140|NCT02278003|12-006|12-006
312141|NCT02277977|sepsis|sepsis
312142|NCT02277977|septic shock|septic shock
312143|NCT02277977|contrast-enhanced ultrasound|contrast-enhanced ultrasound
312144|NCT02277977|microcirculation|microcirculation
312145|NCT02277964|RRMS|rrms
312146|NCT02277964|Natalizumab|natalizumab
312147|NCT02277964|Fingolimod|fingolimod
312148|NCT02277964|Treatment Change|treatment change
312149|NCT02277964|Disease Activity|disease activity
312150|NCT02277925|Pelvic Organ Prolapse|pelvic organ prolapse
312151|NCT02277925|Vaginal mesh exposure rates|vaginal mesh exposure rates
312152|NCT02277925|Vaginal suture exposure rates|vaginal suture exposure rates
312153|NCT02277912|ICH|ich
312154|NCT02277912|Stroke|stroke
312155|NCT02277912|Navigated|navigated
312156|NCT02277912|Placebo|placebo
312157|NCT02277912|TMS|tms
312158|NCT02277899|childhood obesity|childhood obesity
312159|NCT02277899|overweight|overweight
312160|NCT02277899|communication|communication
312161|NCT02277899|primary care|primary care
312162|NCT02277899|weight management|weight management
312163|NCT02277899|communication methods|communication methods
312164|NCT02277899|patient-centered communication|patient-centered communication
312165|NCT02277886|sodium alginate|sodium alginate
312166|NCT02277886|esomeprazole|esomeprazole
312167|NCT02277886|GERD|gerd
312168|NCT02277873|moon|moon
312169|NCT02277873|parturition|parturition
312170|NCT02277873|moon phases|moon phases
312171|NCT02277860|Exercise|exercise
312172|NCT02277847|Idarubicin|idarubicin
312173|NCT02277847|Cytosine arabinoside|cytosine arabinoside
312174|NCT02277847|Efficacy|efficacy
312175|NCT02277847|Safety|safety
312176|NCT02277821|Essential Hypertension|essential hypertension
312177|NCT02277821|Central Blood Pressure|central blood pressure
312178|NCT02277821|Microcirculation|microcirculation
312179|NCT02277821|Endothelium Stimulation|endothelium stimulation
312180|NCT02277808|Pneumocystis|pneumocystis
312181|NCT02277808|Nebulizer|nebulizer
312182|NCT02277808|Pentamidine|pentamidine
312183|NCT02277795|Early infant male circumcision|early infant male circumcision
312184|NCT02277795|HIV|hiv
312185|NCT02277795|Prevention|prevention
312186|NCT02277795|AccuCirc|accucirc
312187|NCT02277795|Kenya|kenya
312188|NCT02277795|Providers|providers
312189|NCT02277795|Parents|parents
312190|NCT02277782|Labor|labor
312191|NCT02277782|Analgesia|analgesia
312192|NCT02277756|high functioning autism|high functioning autism
312193|NCT02277756|endogenous modulation systems|endogenous modulation systems
312194|NCT02277730|Hypotension|hypotension
312195|NCT02277717|cancer|cancer
312196|NCT02277717|metastasis|metastasis
312197|NCT02277717|HER2|her2
312198|NCT02277717|trastuzumab|trastuzumab
312199|NCT02277717|duocarmycin|duocarmycin
312200|NCT02277717|SYD985|syd985
312201|NCT02277717|antibody-drug conjugate|antibody-drug conjugate
312202|NCT02277717|ADC|adc
312203|NCT02277717|trastuzumab vc-seco-DUBA|trastuzumab vc-seco-duba
312204|NCT02277704|PTSD|ptsd
312205|NCT02277704|Military-related PTSD and other related conditions|military-related ptsd and other related conditions
312206|NCT02277691|Pharmacological therapy|pharmacological therapy
312207|NCT02277691|Drug Therapy|drug therapy
312208|NCT02277678|Pruritus|pruritus
312209|NCT02277665|Cannabis Use Disorder|cannabis use disorder
312210|NCT02277665|Tobacco Use|tobacco use
312211|NCT02277665|Treatment|treatment
312212|NCT02277639|Transplant related mortality|transplant related mortality
312213|NCT02277639|Graft versus host disease|graft versus host disease
312214|NCT02277639|Bone marrow transplant|bone marrow transplant
312215|NCT02277613|stem cells|stem cells
312216|NCT02277587|Plenadren|plenadren
312217|NCT02277587|Addison's disease|addison's disease
312218|NCT02277587|Hydrocortisone|hydrocortisone
312219|NCT02277587|Cortisone Acetate|cortisone acetate
312220|NCT02277587|Monocytes|monocytes
312221|NCT02277587|Natural Killer cells|natural killer cells
312222|NCT02277587|Immunological profile|immunological profile
312223|NCT02277587|Inflammation|inflammation
312224|NCT02277574|Rheumatoid arthritis|rheumatoid arthritis
312225|NCT02277574|Arthritis|arthritis
312226|NCT02277574|Joint diseases|joint diseases
312227|NCT02277574|Musculoskeletal diseases|musculoskeletal diseases
312228|NCT02277548|chemotherapy|chemotherapy
312229|NCT02277548|radiation therapy|radiation therapy
312230|NCT02277535|Malnutrition in the ICU (caloric deficit >4000 kcal or 150 g protein deficit) or >48hrs of admission without receiving nutrition|malnutrition in the icu (caloric deficit >4000 kcal or 150 g protein deficit) or >48hrs of admission without receiving nutrition
312231|NCT02277470|pharmacokinetics, Golimumab, IBD|pharmacokinetics, golimumab, ibd
312232|NCT02277444|Methotrexate|methotrexate
312233|NCT02277444|Anti-TNFα Antibody|anti-tnfα antibody
312234|NCT02277444|Golimumab|golimumab
312235|NCT02277444|Pediatric Participants|pediatric participants
312236|NCT02277379|cardiac surgery ; hemorrhage ; transfusion requirements|cardiac surgery ; hemorrhage ; transfusion requirements
312237|NCT02277366|Lung Neoplasms|lung neoplasms
312238|NCT02277366|Bronchoscopy|bronchoscopy
312239|NCT02277366|Early Detection of Cancer|early detection of cancer
312240|NCT02277353|Fluid responsiveness|fluid responsiveness
312241|NCT02277353|NICOM|nicom
312242|NCT02277353|Prone Position|prone position
312243|NCT02277353|Stroke Volume Variation|stroke volume variation
312244|NCT02277327|Hospitalization|hospitalization
312245|NCT02277327|Readmissions|readmissions
312246|NCT02277327|Medical complexity|medical complexity
312247|NCT02277301|Pilot study|pilot study
312248|NCT02277301|Randomised Controlled Trial|randomised controlled trial
312249|NCT02277301|Parenting|parenting
312250|NCT02277301|Paediatrics|paediatrics
312251|NCT02277301|Mental Health|mental health
312252|NCT02277275|Branched chain amino acid, high protein diet, weight loss|branched chain amino acid, high protein diet, weight loss
312253|NCT02277262|peritonitis patients|peritonitis patients
312254|NCT02277236|sarcopenia|sarcopenia
312255|NCT02277236|aging|aging
312256|NCT02277236|insulin resistance|insulin resistance
312257|NCT02277236|screening|screening
312258|NCT02277184|Intermediate Risk HNSCC|intermediate risk hnscc
312259|NCT02277184|High Risk HNSCC|high risk hnscc
312260|NCT02277184|Previously Untreated, Locally Advanced HNSCC|previously untreated, locally advanced hnscc
312261|NCT02277184|Undifferentiated carcinoma|undifferentiated carcinoma
312262|NCT02277184|Poorly differentiated carcinoma of the oral cavity|poorly differentiated carcinoma of the oral cavity
312263|NCT02277184|Poorly differentiated carcinoma of the oropharynx|poorly differentiated carcinoma of the oropharynx
312264|NCT02277184|Poorly differentiated carcinoma of the larynx|poorly differentiated carcinoma of the larynx
312265|NCT02277184|Poorly differentiated carcinoma of the hypopharynx|poorly differentiated carcinoma of the hypopharynx
312266|NCT02277158|Rectal cancer|rectal cancer
312267|NCT02277158|S-1|s-1
312268|NCT02277158|Chemoradiotherapy|chemoradiotherapy
312269|NCT02277158|Phase I|phase i
312270|NCT02277145|radiation-induced pulmonary fibrosis|radiation-induced pulmonary fibrosis
312271|NCT02277145|MSCs|mscs
312272|NCT02277132|Fetal growth restriction|fetal growth restriction
312273|NCT02277132|Sildenafil|sildenafil
312274|NCT02277080|Pain, opioids, immune system, endocrine system, quality of life|pain, opioids, immune system, endocrine system, quality of life
312275|NCT02277067|PPH|pph
312276|NCT02277041|PPH|pph
312277|NCT02277002|Cabin Air Filtration|cabin air filtration
312278|NCT02277002|Particulate Matter|particulate matter
312279|NCT02277002|Commuter Exposure|commuter exposure
312280|NCT02277002|Traffic Related Air Pollution|traffic related air pollution
312281|NCT02276989|Chronic Pain|chronic pain
312282|NCT02276989|Compliance Marker|compliance marker
312283|NCT02276989|Narcotic Abuse|narcotic abuse
312284|NCT02276989|Opioid related disorders|opioid related disorders
312285|NCT02276989|Opiate substitution treatment|opiate substitution treatment
312286|NCT02276989|Buprenorphrine|buprenorphrine
312287|NCT02276989|Suboxone|suboxone
312288|NCT02276989|Lyrica|lyrica
312289|NCT02276989|Pregabalin|pregabalin
312290|NCT02276989|Acetazolamide|acetazolamide
312291|NCT02276989|Quinine|quinine
312292|NCT02276989|Compliance|compliance
312293|NCT02276976|crebral white matter lesions|crebral white matter lesions
312294|NCT02276976|brain networks|brain networks
312295|NCT02276976|MRI|mri
312296|NCT02276976|DTI|dti
312297|NCT02276976|fMRI|fmri
312298|NCT02276976|cognitive impairment|cognitive impairment
312299|NCT02276976|gene|gene
312300|NCT02276963|Transverse myelitis, optic neuritis, neuromyelitis optica|transverse myelitis, optic neuritis, neuromyelitis optica
312301|NCT02276950|Cardiac Surgery|cardiac surgery
312302|NCT02276950|Epidemiologic Methods|epidemiologic methods
312303|NCT02276950|Blood Transfusions|blood transfusions
312304|NCT02276937|Recombinant Sendai virus|recombinant sendai virus
312305|NCT02276937|fibroblast growth factor-2|fibroblast growth factor-2
312306|NCT02276937|treadmill|treadmill
312307|NCT02276924|Laser Confocal Microscopy|laser confocal microscopy
312308|NCT02276924|Superior Urinary Tract Tumors|superior urinary tract tumors
312309|NCT02276898|pediatric|pediatric
312310|NCT02276898|lung clearance index|lung clearance index
312311|NCT02276898|Multiple Breath Washout|multiple breath washout
312312|NCT02276898|Hypertonic Saline|hypertonic saline
312313|NCT02276885|breast|breast
312314|NCT02276885|cancer|cancer
312315|NCT02276885|breast cancer|breast cancer
312316|NCT02276885|prone|prone
312317|NCT02276885|partial breast irradiation|partial breast irradiation
312318|NCT02276885|PBI|pbi
312319|NCT02276872|pediatric|pediatric
312320|NCT02276872|treprostinil|treprostinil
312321|NCT02276872|transition|transition
312322|NCT02276872|Remodulin|remodulin
312323|NCT02276859|dual-wave bolus|dual-wave bolus
312324|NCT02276859|square bolus|square bolus
312325|NCT02276859|normal bolus|normal bolus
312326|NCT02276859|standard bolus|standard bolus
312327|NCT02276859|high-protein meal|high-protein meal
312328|NCT02276859|prandial insulin requirement|prandial insulin requirement
312329|NCT02276846|Palpitate-Eluting Balloon|palpitate-eluting balloon
312330|NCT02276846|Bifurcation|bifurcation
312331|NCT02276846|OCT|oct
312332|NCT02276846|Transluminal|transluminal
312333|NCT02276820|Adenovirus|adenovirus
312334|NCT02276820|Virus specific T cells|virus specific t cells
312335|NCT02276820|Viral infections|viral infections
312336|NCT02276807|Depression|depression
312337|NCT02276807|Behavioral Symptoms|behavioral symptoms
312338|NCT02276807|Mental Disorders|mental disorders
312339|NCT02276807|Depressive Disorder|depressive disorder
312340|NCT02276807|suicidal ideation|suicidal ideation
312341|NCT02276807|primary health care|primary health care
312342|NCT02276807|Veterans|veterans
312343|NCT02276794|Low back pain|low back pain
312344|NCT02276794|Thrust manipulation|thrust manipulation
312345|NCT02276794|Spinal manipulation|spinal manipulation
312346|NCT02276794|Joint mobilization|joint mobilization
312347|NCT02276794|Non-thrust manipulation|non-thrust manipulation
312348|NCT02276794|proprioception|proprioception
312349|NCT02276794|Postural stability|postural stability
312350|NCT02276794|Baropodometry|baropodometry
312351|NCT02276781|PAD|pad
312352|NCT02276781|Peripheral Arterial Disease|peripheral arterial disease
312353|NCT02276781|Biomarkers|biomarkers
312354|NCT02276768|rectal distension|rectal distension
312355|NCT02276768|rectal compliance|rectal compliance
312356|NCT02276768|visceral pain|visceral pain
312357|NCT02276768|pain intensity|pain intensity
312358|NCT02276768|barostat|barostat
312359|NCT02276768|distender|distender
312360|NCT02276768|VAS (Visual Analog Scale)|vas (visual analog scale)
312361|NCT02276768|rectal sensory threshold|rectal sensory threshold
312362|NCT02276768|analgesia|analgesia
312363|NCT02276768|trimebutine|trimebutine
312364|NCT02276768|pain management|pain management
312365|NCT02276768|peripheral|peripheral
312366|NCT02276768|colon cancer|colon cancer
312367|NCT02276768|H2S (hydrogen sulfide)|h2s (hydrogen sulfide)
312368|NCT02276729|Upper limb|upper limb
312369|NCT02276729|Rehabilitation|rehabilitation
312370|NCT02276729|Occupational Therapy|occupational therapy
312371|NCT02276729|Mirror Box Therapy|mirror box therapy
312372|NCT02276690|iron deficiency|iron deficiency
312373|NCT02276690|dosage of hepcidin|dosage of hepcidin
312374|NCT02276690|usual biomarker (ferritin and transferrin saturation)|usual biomarker (ferritin and transferrin saturation)
312375|NCT02276690|mass spectrometry|mass spectrometry
312376|NCT02276690|immuno-detection|immuno-detection
312377|NCT02276690|anaemia in intensive care unit|anaemia in intensive care unit
312378|NCT02276664|lung cancer prevention|lung cancer prevention
312379|NCT02276560|main tumor ranging from less than 3cm (T1 up to 7cm (T3)|main tumor ranging from less than 3cm (t1 up to 7cm (t3)
312381|NCT02276547|Regurgitation|regurgitation
312382|NCT02276547|Heart valve|heart valve
312383|NCT02276547|Transcatheter|transcatheter
312384|NCT02276547|Transapical|transapical
312385|NCT02276547|Functional|functional
312386|NCT02276547|Degenerative|degenerative
712551|NCT00579748|Barrett's esophagus|barrett's esophagus
399063|NCT01873534|Anemia|anemia
312387|NCT02276547|Symptomatic, severe mitral valve regurgitation, high risk for open mitral valve surgery|symptomatic, severe mitral valve regurgitation, high risk for open mitral valve surgery
312388|NCT02276495|pain management for total knee arthroplasty|pain management for total knee arthroplasty
312389|NCT02276469|severe mental illness|severe mental illness
312390|NCT02276430|Testicular cancer|testicular cancer
312391|NCT02276430|Survivor|survivor
312392|NCT02276430|Cardiovascular disease|cardiovascular disease
312393|NCT02276430|Risk factors|risk factors
312394|NCT02276417|Sepsis|sepsis
312395|NCT02276417|Surgical ICU|surgical icu
312396|NCT02276313|Peripheral|peripheral
312397|NCT02276313|Infrainguinal|infrainguinal
312398|NCT02276313|Drug Releasing Balloon|drug releasing balloon
312399|NCT02276313|Drug Eluting Balloon|drug eluting balloon
312400|NCT02276287|Adherence|adherence
312401|NCT02276287|HAART|haart
312402|NCT02276287|HIV|hiv
312403|NCT02276287|Illness Perception|illness perception
312404|NCT02276287|IPQ-R|ipq-r
312405|NCT02276235|catgut embedding|catgut embedding
312406|NCT02276235|obese women|obese women
312407|NCT02276235|obesity-related hormones|obesity-related hormones
312408|NCT02276222|Chronic Obstructive Pulmonary Disease|chronic obstructive pulmonary disease
312409|NCT02276222|COPD|copd
312410|NCT02276157|cholangioscopy|cholangioscopy
312411|NCT02276105|Carpal Tunnel Syndrome|carpal tunnel syndrome
312412|NCT02276105|Quality of Life|quality of life
312413|NCT02276105|EQ-5D|eq-5d
312414|NCT02276105|SF-12|sf-12
312415|NCT02276105|Michigan Hand Questionnaire|michigan hand questionnaire
312416|NCT02276092|Community-acquired pneumonia|community-acquired pneumonia
312417|NCT02276092|Pragmatic study|pragmatic study
312418|NCT02276092|Multi-center|multi-center
312419|NCT02276092|Time-dependent bias|time-dependent bias
312420|NCT02276092|antimicrobial stewardship|antimicrobial stewardship
312421|NCT02276092|prospective audit and feedback|prospective audit and feedback
312422|NCT02276079|Mild Traumatic Brain Injury|mild traumatic brain injury
312423|NCT02276079|Aerobic Exercise|aerobic exercise
312424|NCT02276079|Brain-Derived Neurotrophic Factor|brain-derived neurotrophic factor
312425|NCT02276066|kidney dysfunction|kidney dysfunction
312426|NCT02276066|chronic critical illness|chronic critical illness
312427|NCT02276066|sepsis|sepsis
312428|NCT02276066|Glomerular filtration rate|glomerular filtration rate
312429|NCT02276053|Epilepsy|epilepsy
312430|NCT02276053|Brain tumor|brain tumor
312431|NCT02276053|lacosamide (LCM)|lacosamide (lcm)
312432|NCT02276053|Anti-Epileptic Drugs (AEDs)|anti-epileptic drugs (aeds)
312433|NCT02276040|Arthroplasty|arthroplasty
312434|NCT02276040|Knee Replacement|knee replacement
312435|NCT02276040|Analgesia|analgesia
312436|NCT02276040|pain|pain
312437|NCT02276027|adenocarcinoma lung cancer,squamous cell lung carcinoma, NSCLC|adenocarcinoma lung cancer,squamous cell lung carcinoma, nsclc
312438|NCT02276014|Beta carotene|beta carotene
312439|NCT02276014|Retinol|retinol
312440|NCT02276001|Adult Volunteers|adult volunteers
312441|NCT02275988|Adult Volunteers|adult volunteers
312442|NCT02275975|Adult Volunteers|adult volunteers
312443|NCT02275962|Adult Volunteers|adult volunteers
312444|NCT02275949|SAH (Subarachnoid Hemorrhage)|sah (subarachnoid hemorrhage)
312445|NCT02275949|Cerebral Vasospasm|cerebral vasospasm
312446|NCT02275949|Acupuncture|acupuncture
312447|NCT02275936|N91115|n91115
312448|NCT02275936|Cavosonstat|cavosonstat
312449|NCT02275910|Solid Tumors|solid tumors
312450|NCT02275910|E7090|e7090
312451|NCT02275897|Lower Segmental Caesarean Section (LSCS)|lower segmental caesarean section (lscs)
312452|NCT02275897|Speed of Injection|speed of injection
312453|NCT02275897|Spinal Anaesthesia|spinal anaesthesia
312454|NCT02275897|Anesthesia|anesthesia
312455|NCT02275884|Parkinson Disease|parkinson disease
312456|NCT02275884|Cacao|cacao
312457|NCT02275884|Biogenic amines|biogenic amines
312458|NCT02275884|Xanthines|xanthines
312459|NCT02275884|Neurodegenerative Diseases|neurodegenerative diseases
312460|NCT02275871|Breast Cancer|breast cancer
312461|NCT02275858|balloon assisted enteroscopy|balloon assisted enteroscopy
312462|NCT02275858|terminal ileum intubation|terminal ileum intubation
312463|NCT02275845|metformin|metformin
312464|NCT02275845|prevention|prevention
312465|NCT02275819|Heart Failure|heart failure
312466|NCT02275819|Exercise|exercise
312467|NCT02275819|Echocardiography|echocardiography
312468|NCT02275741|Vaccine|vaccine
312469|NCT02275741|Antibody response|antibody response
312470|NCT02275741|relaps rate|relaps rate
312471|NCT02275741|expanded disability status scale|expanded disability status scale
312472|NCT02275728|Menopause|menopause
312473|NCT02275728|Stress Urinary Incontinence|stress urinary incontinence
312474|NCT02275728|EMG Biofeedback|emg biofeedback
312475|NCT02275728|Pelvic Floor Muscle Training|pelvic floor muscle training
312476|NCT02275728|Quality of life|quality of life
312477|NCT02275728|Physical Therapie|physical therapie
312478|NCT02275715|autism spectrum disorder (ASD)|autism spectrum disorder (asd)
312479|NCT02275715|feeding problems|feeding problems
762757|NCT00393705|diabetes|diabetes
312480|NCT02275702|Dexamethasone|dexamethasone
312481|NCT02275702|Quality of recovery questionnaire|quality of recovery questionnaire
312483|NCT02275702|Lung cancer|lung cancer
312484|NCT02275702|Video-assisted thoracoscopic|video-assisted thoracoscopic
312485|NCT02275689|Rotator cuff|rotator cuff
312486|NCT02275689|Tendinosis|tendinosis
312487|NCT02275689|Impingement|impingement
312488|NCT02275689|radiofrequency|radiofrequency
312489|NCT02275676|Inflammatory bowel disease|inflammatory bowel disease
312490|NCT02275676|Nutritional Status|nutritional status
312491|NCT02275676|Malnutrition|malnutrition
312492|NCT02275676|Resting Energy Expenditure|resting energy expenditure
312493|NCT02275663|relapsed AML|relapsed aml
312494|NCT02275663|refractory AML|refractory aml
312495|NCT02275663|azacytidine|azacytidine
312496|NCT02275650|calcidiol|calcidiol
312497|NCT02275650|25(oh)d|25(oh)d
312498|NCT02275650|nbUVB|nbuvb
312499|NCT02275650|cyp27A1|cyp27a1
312500|NCT02275650|cyp27B1|cyp27b1
312501|NCT02275650|vitamin D|vitamin d
312502|NCT02275637|Implantable Cardioverter-Defibrillators|implantable cardioverter-defibrillators
312503|NCT02275637|Ventricular Fibrillation|ventricular fibrillation
312504|NCT02275637|ventricular Tachycardia|ventricular tachycardia
312505|NCT02275611|oxytocin|oxytocin
312506|NCT02275611|alcohol withdrawal|alcohol withdrawal
312507|NCT02275611|alcohol dependence|alcohol dependence
312508|NCT02275611|alcoholism|alcoholism
312509|NCT02275585|Portal vein|portal vein
312510|NCT02275585|Thrombosis|thrombosis
312511|NCT02275585|Cirrhosis|cirrhosis
312512|NCT02275481|Chronic obstructive pulmonary disease|chronic obstructive pulmonary disease
312513|NCT02275481|COPD|copd
312514|NCT02275481|Emphysema|emphysema
312515|NCT02275481|Chronic bronchitis|chronic bronchitis
312516|NCT02275468|Chronic Kidney Disease|chronic kidney disease
312517|NCT02275468|eGFR slope|egfr slope
312518|NCT02275468|Herbal medicine Fu-zheng-qu-zhuo Oral liquid|herbal medicine fu-zheng-qu-zhuo oral liquid
312519|NCT02275442|EPICES scale|epices scale
312520|NCT02275442|Precarious situation|precarious situation
312521|NCT02275442|Rural parturient women|rural parturient women
312522|NCT02275442|Access to care|access to care
312523|NCT02275442|Global Initiative for Sentinel E-health Network on Grid|global initiative for sentinel e-health network on grid
312524|NCT02275442|General practice|general practice
312525|NCT02275429|Metabolic Diseases|metabolic diseases
312526|NCT02275429|Athletes|athletes
312527|NCT02275429|Running|running
312528|NCT02275429|Selenium|selenium
312529|NCT02275429|Zinc|zinc
312530|NCT02275429|Iron Metabolism Disorders|iron metabolism disorders
312531|NCT02275429|Water-Electrolyte Imbalance|water-electrolyte imbalance
312532|NCT02275429|Hyperkalemia|hyperkalemia
312533|NCT02275429|Hypernatremia|hypernatremia
312534|NCT02275429|Selenium levels before and after the race|selenium levels before and after the race
312535|NCT02275429|Levels of other electrolytes and markers|levels of other electrolytes and markers
312536|NCT02275390|mental illness|mental illness
312537|NCT02275390|psychoeducation|psychoeducation
312538|NCT02275390|nurse-led clinic|nurse-led clinic
312539|NCT02275390|randomized controlled trial|randomized controlled trial
312540|NCT02275377|Breathing Exercises; Autonomic Control; Blood Pressure.|breathing exercises; autonomic control; blood pressure.
312541|NCT02275351|alopecia|alopecia
312542|NCT02275351|topical|topical
312543|NCT02275351|Samumed|samumed
312544|NCT02275325|Posture|posture
312545|NCT02275325|Unilateral vestibular deafferentation|unilateral vestibular deafferentation
312546|NCT02275325|Medical management|medical management
312547|NCT02275325|Preoperative vestibular rehabilitation|preoperative vestibular rehabilitation
312548|NCT02275325|Neural plasticity|neural plasticity
312549|NCT02275286|sarcoma|sarcoma
312550|NCT02275273|Adnexal Masses|adnexal masses
312551|NCT02275273|Magnetic Resonance Imaging|magnetic resonance imaging
312552|NCT02275273|Anatomopathology|anatomopathology
312553|NCT02275247|Stellate ganglion block|stellate ganglion block
312554|NCT02275247|Aneurysm surgery|aneurysm surgery
312555|NCT02275247|Cognitive recovery|cognitive recovery
312556|NCT02275247|Cerebral vasospasm|cerebral vasospasm
312557|NCT02275234|cardiac arrest|cardiac arrest
312558|NCT02275234|psychological intervention|psychological intervention
312559|NCT02275221|Hepatitis B (HBV)|hepatitis b (hbv)
312560|NCT02275221|Hepatitis C (HCV)|hepatitis c (hcv)
312561|NCT02275195|hepatitis|hepatitis
312562|NCT02275195|alcohol|alcohol
312563|NCT02275182|Dexmedetomidine|dexmedetomidine
312564|NCT02275169|follicle stimulating hormone treatment|follicle stimulating hormone treatment
312565|NCT02275169|azoospermia nonobstructive|azoospermia nonobstructive
312566|NCT02275169|male infertility|male infertility
312567|NCT02275169|follicle stimulating hormone|follicle stimulating hormone
312568|NCT02275156|Subjects with normal renal function or severe renal impairment (RI) or end stage renal disease (ESRD) receiving hemodialysis|subjects with normal renal function or severe renal impairment (ri) or end stage renal disease (esrd) receiving hemodialysis
312569|NCT02275143|Computed Tomography of Thorax, Abdomen and Pelvis|computed tomography of thorax, abdomen and pelvis
312570|NCT02275143|cancer patients|cancer patients
312571|NCT02275143|coronary angiogram evaluation|coronary angiogram evaluation
312572|NCT02275130|glottic insufficiency|glottic insufficiency
312573|NCT02275130|calcium hydroxyapatite|calcium hydroxyapatite
312574|NCT02275130|augmentation of vocal cords with injection technique|augmentation of vocal cords with injection technique
312575|NCT02275117|Migraine Disorders|migraine disorders
312576|NCT02275117|ALD403|ald403
312577|NCT02275104|Ventricular arrhythmias|ventricular arrhythmias
312578|NCT02275104|Persistent atrial fibrillation|persistent atrial fibrillation
312579|NCT02275104|Ablation guidance|ablation guidance
312580|NCT02275104|Software|software
312581|NCT02275104|MRI (Magnetic resonance imaging)|mri (magnetic resonance imaging)
312582|NCT02275091|Children|children
312583|NCT02275091|Cholesterol|cholesterol
312584|NCT02275078|COPD|copd
312585|NCT02275078|Action Plan|action plan
312586|NCT02275078|Telesystem|telesystem
312587|NCT02275078|New technology|new technology
312588|NCT02275065|HIV-1 Infected|hiv-1 infected
312589|NCT02275065|Adults|adults
312590|NCT02275065|Treatment Naive|treatment naive
312591|NCT02275052|shuttle walk test|shuttle walk test
312592|NCT02275052|umeclidinium|umeclidinium
312593|NCT02275052|beta2-agonist|beta2-agonist
312594|NCT02275052|exercise endurance time|exercise endurance time
312595|NCT02275052|anticholinergic|anticholinergic
312596|NCT02275052|combination product|combination product
312597|NCT02275052|vilanterol|vilanterol
312598|NCT02275052|exercise|exercise
312599|NCT02275052|COPD|copd
312600|NCT02275026|General Anesthesia, Postoperative Delirium, Recovery|general anesthesia, postoperative delirium, recovery
312601|NCT02274974|incisional|incisional
312602|NCT02274974|infiltration|infiltration
312603|NCT02274974|cs|cs
312604|NCT02274974|lidocaine|lidocaine
312605|NCT02274974|epinephrine|epinephrine
312606|NCT02274974|Adverse Reaction to Topical or Infiltrative Lidocaine|adverse reaction to topical or infiltrative lidocaine
312607|NCT02274922|Campylobacter diagnosis,|campylobacter diagnosis,
312608|NCT02274922|immuno-chromatographic test, ELISA, PCR, culture, stool|immuno-chromatographic test, elisa, pcr, culture, stool
312609|NCT02274922|ELISA,|elisa,
312610|NCT02274922|PCR,|pcr,
312611|NCT02274922|culture, stool|culture, stool
312612|NCT02274909|electromyography|electromyography
312613|NCT02274909|aged|aged
312614|NCT02274909|muscle strength|muscle strength
312615|NCT02274909|wavelet analysis|wavelet analysis
312616|NCT02274909|pilates|pilates
312617|NCT02274909|proprioceptive neuromuscular facilitation|proprioceptive neuromuscular facilitation
312618|NCT02274857|FIRMap|firmap
312619|NCT02274857|Rotor|rotor
312620|NCT02274857|FIRM-guided procedure|firm-guided procedure
312621|NCT02274857|REAFFIRM|reaffirm
312622|NCT02274805|Brown adipose tissue|brown adipose tissue
312623|NCT02274805|Neck surgery|neck surgery
312624|NCT02274779|Prostate Cancer,Oligometastasis,Radiotherapy,Hormonotherapy|prostate cancer,oligometastasis,radiotherapy,hormonotherapy
312625|NCT02274766|Levodopa-Induced Dyskinesia|levodopa-induced dyskinesia
312626|NCT02274766|LID|lid
312627|NCT02274766|Parkinsonism|parkinsonism
312628|NCT02274766|Parkinson's Disease|parkinson's disease
312629|NCT02274727|Biomarker|biomarker
312630|NCT02274727|Stroke|stroke
312631|NCT02274727|Etiology|etiology
312632|NCT02274727|Outcome|outcome
312633|NCT02274675|Stroke|stroke
312634|NCT02274675|Robot-assisted therapy|robot-assisted therapy
312635|NCT02274675|Rehabilitation|rehabilitation
312636|NCT02274623|Bone Neoplasms|bone neoplasms
312637|NCT02274623|Hypocalcemia|hypocalcemia
312638|NCT02274623|Hyperparathyroidism, Secondary|hyperparathyroidism, secondary
312639|NCT02274610|docetaxel|docetaxel
312640|NCT02274610|Pharmacokinetic|pharmacokinetic
312641|NCT02274597|hypothermia|hypothermia
312642|NCT02274597|pre-hospital|pre-hospital
312643|NCT02274597|epitympanic|epitympanic
312644|NCT02274597|temperature|temperature
312645|NCT02274584|Hodgkin's lymphoma|hodgkin's lymphoma
312646|NCT02274584|Anaplastic large cell lymphoma|anaplastic large cell lymphoma
312647|NCT02274584|CD30 positive lymphoma|cd30 positive lymphoma
312648|NCT02274584|Peripheral T/Natural Killer (NK) cell lymphoma|peripheral t/natural killer (nk) cell lymphoma
312649|NCT02274519|multiple myeloma|multiple myeloma
312650|NCT02274519|plasma cell disorder|plasma cell disorder
312651|NCT02274519|autologous stem cell transplant|autologous stem cell transplant
312652|NCT02274506|Blood And Marrow Transplantation|blood and marrow transplantation
312653|NCT02274506|Leukemia|leukemia
312654|NCT02274506|Lymphoma|lymphoma
312655|NCT02274506|CD19-specific T cells|cd19-specific t cells
312656|NCT02274506|Acute lymphoblastic leukemia|acute lymphoblastic leukemia
312657|NCT02274506|ALL|all
312658|NCT02274506|Biphenotypic leukemia|biphenotypic leukemia
312659|NCT02274506|Non-Hodgkin's Lymphoma|non-hodgkin's lymphoma
312660|NCT02274506|NHL|nhl
312661|NCT02274506|Diffuse large B-cell lymphoma|diffuse large b-cell lymphoma
312662|NCT02274506|Small lymphocytic lymphoma|small lymphocytic lymphoma
312663|NCT02274506|Follicular lymphoma|follicular lymphoma
312664|NCT02274506|Mantle cell lymphoma|mantle cell lymphoma
312665|NCT02274506|Chronic lymphocytic leukemia|chronic lymphocytic leukemia
312666|NCT02274506|CLL|cll
312667|NCT02274493|da Vinci® robotic surgical system|da vinci® robotic surgical system
312668|NCT02274493|latissimus dorsi muscle flap harvest procedures|latissimus dorsi muscle flap harvest procedures
312669|NCT02274493|breast reconstruction|breast reconstruction
312670|NCT02274493|scalp reconstruction|scalp reconstruction
312671|NCT02274493|upper extremity reconstruction|upper extremity reconstruction
312672|NCT02274493|lower extremity reconstruction|lower extremity reconstruction
312673|NCT02274480|MRI|mri
312674|NCT02274480|Diffusion Weighted Imaging|diffusion weighted imaging
312675|NCT02274480|14-191|14-191
312676|NCT02274467|Tsui Test|tsui test
312677|NCT02274467|Labour|labour
312678|NCT02274467|Epidural catheter|epidural catheter
312679|NCT02274454|Uterine contraction|uterine contraction
312680|NCT02274454|Oxytocin desensitization|oxytocin desensitization
312681|NCT02274428|intraventricular hemorrhage|intraventricular hemorrhage
312682|NCT02274415|Streptococcus pneumoniae|streptococcus pneumoniae
312683|NCT02274415|Sickle cell disease|sickle cell disease
312684|NCT02274415|Immunogenicity|immunogenicity
312685|NCT02274415|Antibody response|antibody response
312686|NCT02274402|Prednisone|prednisone
312687|NCT02274402|Glucocorticoids|glucocorticoids
312688|NCT02274402|pharmacokinetics|pharmacokinetics
312689|NCT02274389|Pulmonary Multi-drug Resistant Tuberculosis|pulmonary multi-drug resistant tuberculosis
312690|NCT02274389|Bedaquiline|bedaquiline
312691|NCT02274389|Sirturo|sirturo
312692|NCT02274389|Observational|observational
312693|NCT02274389|Prospective|prospective
312694|NCT02274363|Psoriasis|psoriasis
312695|NCT02274363|Plaque|plaque
312696|NCT02274363|Chronic|chronic
312697|NCT02274350|prostate cancer|prostate cancer
312698|NCT02274350|radiation therapy|radiation therapy
312699|NCT02274350|sexual side effects|sexual side effects
312700|NCT02274337|Epidermal Growth Factor Receptor|epidermal growth factor receptor
312701|NCT02274337|Tyrosine Kinase Inhibitor|tyrosine kinase inhibitor
312702|NCT02274337|T790M mutation|t790m mutation
312703|NCT02274324|parkinson|parkinson
312704|NCT02274324|duodopa|duodopa
312705|NCT02274324|diet|diet
312706|NCT02274324|proteins|proteins
312707|NCT02274324|amino acids|amino acids
312708|NCT02274311|Acromegaly|acromegaly
312709|NCT02274311|SERM|serm
312710|NCT02274311|Clomiphene|clomiphene
312711|NCT02274285|Tetanus|tetanus
312712|NCT02274285|Diphtheria|diphtheria
312713|NCT02274285|Pertussis|pertussis
312714|NCT02274285|Poliomyelitis|poliomyelitis
312715|NCT02274285|Bacterial meningitis|bacterial meningitis
312716|NCT02274285|DTaP-IPV/Hib Combination vaccine|dtap-ipv/hib combination vaccine
312717|NCT02274272|lactobacillus reuteri|lactobacillus reuteri
312718|NCT02274272|type 2 diabetes|type 2 diabetes
312719|NCT02274246|Segmentation|segmentation
312720|NCT02274246|GIMIAS® program|gimias® program
312721|NCT02274246|Atrial fibrillation|atrial fibrillation
312722|NCT02274246|Left atrial fibrosis|left atrial fibrosis
312723|NCT02274246|Healthy volunteers|healthy volunteers
312724|NCT02274233|Chelation|chelation
312725|NCT02274233|Iron Overload|iron overload
312726|NCT02274233|Thalassemia|thalassemia
312727|NCT02274233|Transfusion|transfusion
312728|NCT02274233|Iron Chelation|iron chelation
312729|NCT02274220|systemic inflammation|systemic inflammation
312730|NCT02274220|glucose metabolism|glucose metabolism
312731|NCT02274220|glucose-insulin ratio|glucose-insulin ratio
312732|NCT02274207|Silver dressing|silver dressing
312733|NCT02274207|NPWT|npwt
312734|NCT02274207|DMF|dmf
312735|NCT02274207|foot|foot
312736|NCT02274194|obstructive sleep apnoea|obstructive sleep apnoea
312737|NCT02274194|nasal mask|nasal mask
312738|NCT02274194|oronasal mask|oronasal mask
312739|NCT02274194|breathing route|breathing route
312740|NCT02274194|CPAP|cpap
312741|NCT02274155|Head and Neck Cancer|head and neck cancer
312742|NCT02274155|anti-OX40 antibody|anti-ox40 antibody
312743|NCT02274155|MEDI6469|medi6469
312744|NCT02274155|Immunotherapy|immunotherapy
312745|NCT02274142|dentinal caries|dentinal caries
312746|NCT02274142|occlusal|occlusal
312747|NCT02274142|occluso-proximal|occluso-proximal
312748|NCT02274116|acute intermittent hypoxia|acute intermittent hypoxia
312749|NCT02274116|walking|walking
312750|NCT02274116|spasticity|spasticity
312751|NCT02274116|incomplete spinal cord injury|incomplete spinal cord injury
312752|NCT02274116|breathing|breathing
312753|NCT02274116|strength|strength
312754|NCT02274090|Metformin|metformin
312755|NCT02274090|Pocket depth|pocket depth
312756|NCT02274090|moderate periodontitis|moderate periodontitis
312757|NCT02274090|severe periodontitis|severe periodontitis
312758|NCT02274077|length of stay|length of stay
312759|NCT02274077|nausea|nausea
312760|NCT02274077|emesis|emesis
312761|NCT02274077|bowel function|bowel function
312762|NCT02274077|pain scores|pain scores
312763|NCT02274077|narcotic pain medication|narcotic pain medication
312764|NCT02274077|post operative period|post operative period
312765|NCT02274064|Retention|retention
312766|NCT02274064|Blood Donor Motivation|blood donor motivation
312767|NCT02274025|Patient diagnosed with lung cancer|patient diagnosed with lung cancer
312768|NCT02274012|Gastric|gastric
762758|NCT00393705|type 2|type 2
312769|NCT02274012|Gastroesophageal Junction|gastroesophageal junction
312770|NCT02274012|Gastroesophageal Cancer|gastroesophageal cancer
312771|NCT02274012|Esophageal Cancer|esophageal cancer
312772|NCT02274012|Metastatic|metastatic
312773|NCT02274012|HER2 amplified|her2 amplified
312774|NCT02274012|Afatinib|afatinib
312775|NCT02273999|pulsed electromagnetic fields|pulsed electromagnetic fields
312776|NCT02273999|post operative morbidity|post operative morbidity
312777|NCT02273999|third molar|third molar
312778|NCT02273999|extraction|extraction
312779|NCT02273999|pain|pain
312780|NCT02273986|Adult Volunteers|adult volunteers
312781|NCT02273934|Home-based rehabilitation|home-based rehabilitation
312782|NCT02273934|Activities of daily living|activities of daily living
312783|NCT02273934|Restorative care|restorative care
312784|NCT02273934|Reablement|reablement
312785|NCT02273934|Everyday rehabilitation|everyday rehabilitation
312786|NCT02273921|Dementia, Diagnosis, Electroencephalography|dementia, diagnosis, electroencephalography
312787|NCT02273908|Low-Back Pain|low-back pain
312788|NCT02273908|Neuropathic Pain|neuropathic pain
312789|NCT02273908|Pregabalin|pregabalin
312790|NCT02273895|Scopolamine, AD, EEG, MCI|scopolamine, ad, eeg, mci
312791|NCT02273882|RSV|rsv
312792|NCT02273882|RSVH|rsvh
312793|NCT02273882|Infant|infant
312794|NCT02273882|Gestational Age|gestational age
312795|NCT02273882|wGA|wga
312796|NCT02273882|PRETERM|preterm
312797|NCT02273856|Chronic Lymphocytic Leukaemia (CLL)|chronic lymphocytic leukaemia (cll)
312798|NCT02273856|Indolent Non Hodgkin's Lymphoma (iNHL)|indolent non hodgkin's lymphoma (inhl)
312799|NCT02273843|Preterm|preterm
312800|NCT02273843|late-onset sepsis|late-onset sepsis
312801|NCT02273843|Vitamin D|vitamin d
312802|NCT02273843|Dose|dose
312803|NCT02273843|Interleukin-6|interleukin-6
312804|NCT02273843|Tumor necrosis factor-alpha|tumor necrosis factor-alpha
312805|NCT02273830|oxygen therapy|oxygen therapy
312806|NCT02273830|COPD|copd
312807|NCT02273830|exercise|exercise
312808|NCT02273804|Topiramate|topiramate
312809|NCT02273804|Obesity|obesity
312810|NCT02273804|Children|children
312811|NCT02273804|Adolescents|adolescents
312812|NCT02273791|Frozen-thawed embryo transfer|frozen-thawed embryo transfer
312813|NCT02273791|FET protocols|fet protocols
312814|NCT02273739|solid tumor|solid tumor
312815|NCT02273739|intrahepatic cholangiocarcinoma|intrahepatic cholangiocarcinoma
312816|NCT02273739|ICC|icc
312817|NCT02273739|chondrosarcoma|chondrosarcoma
312818|NCT02273739|angioimmunoblastic T-cell lymphoma|angioimmunoblastic t-cell lymphoma
312819|NCT02273739|AITL|aitl
312820|NCT02273739|IDH|idh
312821|NCT02273739|glioma|glioma
312822|NCT02273739|solid tumor, including intrahepatic cholangiocarcinoma and chondrosarcoma|solid tumor, including intrahepatic cholangiocarcinoma and chondrosarcoma
312823|NCT02273726|Anemia|anemia
312824|NCT02273726|Chronic Kidney Disease|chronic kidney disease
312825|NCT02273726|Dialysis|dialysis
312826|NCT02273726|hemodialysis|hemodialysis
312827|NCT02273726|peritoneal dialysis|peritoneal dialysis
312828|NCT02273726|hemoglobin|hemoglobin
312829|NCT02273726|End stage renal disease|end stage renal disease
312830|NCT02273726|Stable Dialysis|stable dialysis
312831|NCT02273726|erythropoietins|erythropoietins
312832|NCT02273726|erythropoiesis stimulating agent|erythropoiesis stimulating agent
312833|NCT02273713|Esophageal cancer|esophageal cancer
312834|NCT02273713|Metastasized|metastasized
312835|NCT02273713|Nab-paclitaxel|nab-paclitaxel
312836|NCT02273713|Toxicity|toxicity
312837|NCT02273713|First line treatment|first line treatment
312838|NCT02273713|Phase Ib/II|phase ib/ii
312839|NCT02273700|Xarelto®|xarelto®
312840|NCT02273700|protein/peptide profiles|protein/peptide profiles
312841|NCT02273687|diaphragm movement|diaphragm movement
312842|NCT02273687|ultrasound|ultrasound
312843|NCT02273687|emergency room|emergency room
312844|NCT02273674|Borderline Personality Disorder|borderline personality disorder
312845|NCT02273674|Transcranial Magnetic Stimulation, Repetitive|transcranial magnetic stimulation, repetitive
312846|NCT02273648|national|national
312847|NCT02273648|multicenter|multicenter
312848|NCT02273648|observational registry|observational registry
312849|NCT02273648|Orsiro Drug Eluting Stent|orsiro drug eluting stent
312850|NCT02273648|Stenting Treatment of coronary artery disease|stenting treatment of coronary artery disease
312851|NCT02273648|coronary revascularization|coronary revascularization
312852|NCT02273648|PCI|pci
312853|NCT02273648|STEMI|stemi
312854|NCT02273648|NSTEMI|nstemi
312855|NCT02273648|Ischemia|ischemia
312856|NCT02273648|Angina|angina
312857|NCT02273648|Acute Myocardial Infarction|acute myocardial infarction
312858|NCT02273648|Small Vessels|small vessels
312859|NCT02273648|Chronic Total Occlusion|chronic total occlusion
312860|NCT02273622|hydroxytyrosol|hydroxytyrosol
312861|NCT02273622|dietary supplement|dietary supplement
312862|NCT02273622|gene expression regulation|gene expression regulation
312863|NCT02273609|Atrial fibrillation|atrial fibrillation
312864|NCT02273609|Anticoagulation|anticoagulation
312865|NCT02273609|Vitamin K antagonists|vitamin k antagonists
312866|NCT02273609|INR control|inr control
762963|NCT00392951|Autoimmune|autoimmune
312867|NCT02273583|of the extremity|of the extremity
312868|NCT02273570|Hyperparathyroidism, Secondary|hyperparathyroidism, secondary
312869|NCT02273570|Anemia|anemia
312870|NCT02273570|Vascular Stiffness|vascular stiffness
312871|NCT02273570|Vascular Calcification|vascular calcification
312872|NCT02273323|Flow mediated dilation|flow mediated dilation
312873|NCT02273323|tea|tea
312874|NCT02273323|blood pressure|blood pressure
312875|NCT02273297|Body composition|body composition
312876|NCT02273297|Body size|body size
312877|NCT02273284|Pain, Pediatrics, Botulinum Toxin injections, Buzzy|pain, pediatrics, botulinum toxin injections, buzzy
312878|NCT02273271|FLT-PET|flt-pet
312879|NCT02273271|DWI-MRI|dwi-mri
312880|NCT02273232|Peripheral Arterial Disease|peripheral arterial disease
312881|NCT02273232|Peripheral Vascular Disease|peripheral vascular disease
312882|NCT02273232|Claudication|claudication
312883|NCT02273232|Remote Ischemic Preconditioning|remote ischemic preconditioning
312884|NCT02273232|EQ-5D|eq-5d
312885|NCT02273232|Symptoms free distance|symptoms free distance
312886|NCT02273232|ABI|abi
312887|NCT02273232|micro vessel formation|micro vessel formation
312888|NCT02273219|Uveal|uveal
312889|NCT02273219|Melanoma|melanoma
312890|NCT02273219|Advanced uveal melanoma|advanced uveal melanoma
312891|NCT02273206|Depression|depression
312892|NCT02273206|Breast Cancer Screening|breast cancer screening
312893|NCT02273206|Cervical Cancer Screening|cervical cancer screening
312894|NCT02273206|Colorectal Cancer Screening|colorectal cancer screening
312895|NCT02273154|major depressive disorder|major depressive disorder
312896|NCT02273154|Efficacy and safety of buspirone add-one treatment in patients with major depression disorder|efficacy and safety of buspirone add-one treatment in patients with major depression disorder
312897|NCT02273154|buspirone|buspirone
312898|NCT02273154|paroxetine|paroxetine
312899|NCT02273154|anxiety|anxiety
312900|NCT02273128|Osteoporosis|osteoporosis
312901|NCT02273128|Chronic Periodontitis|chronic periodontitis
312902|NCT02273128|Calcitonin gene Polymorphism|calcitonin gene polymorphism
312903|NCT02273115|induction|induction
312904|NCT02273115|Foley catheter|foley catheter
312905|NCT02273115|oxytocin|oxytocin
312906|NCT02273102|Acute Myelogenous Leukemia|acute myelogenous leukemia
312907|NCT02273102|AML|aml
312908|NCT02273102|Myelodysplastic Syndromes|myelodysplastic syndromes
312909|NCT02273102|MDS|mds
312910|NCT02273102|Tranylcypromine|tranylcypromine
312911|NCT02273102|TCP|tcp
312912|NCT02273102|ATRA|atra
312913|NCT02273102|Tretinoin|tretinoin
312914|NCT02273089|Obstructive sleep apnea|obstructive sleep apnea
312915|NCT02273089|arterial stiffness|arterial stiffness
312916|NCT02273089|CPAP|cpap
312917|NCT02273089|excessive daytime sleepiness|excessive daytime sleepiness
312918|NCT02273089|pulse wave velocity|pulse wave velocity
312919|NCT02273063|PTSD|ptsd
312920|NCT02273063|MDD|mdd
312921|NCT02273063|TMS|tms
312922|NCT02273063|5Hz|5hz
312923|NCT02273050|Type 2 Diabetes Mellitus, Dipeptidyl-Peptidase 4 Inhibitors, Saxagliptin, Metformin, Endocrine System Diseases|type 2 diabetes mellitus, dipeptidyl-peptidase 4 inhibitors, saxagliptin, metformin, endocrine system diseases
312924|NCT02273037|Labour|labour
312925|NCT02273037|Birth asphyxia|birth asphyxia
312926|NCT02273037|Fetal Heart Rate Monitor|fetal heart rate monitor
312927|NCT02273037|Doppler Fetal Heart Rate Monitor|doppler fetal heart rate monitor
312928|NCT02273037|Pinard Horn|pinard horn
312929|NCT02273037|Pediatrics|pediatrics
312930|NCT02273037|Uganda|uganda
312931|NCT02273024|Exercise|exercise
312932|NCT02273024|Quality of Life|quality of life
312933|NCT02273024|Fatigue|fatigue
312934|NCT02273024|Symptoms|symptoms
312935|NCT02273024|Prehabilitation|prehabilitation
312936|NCT02273024|Aerobic Capacity|aerobic capacity
312937|NCT02272998|FGFR, RET, KIT|fgfr, ret, kit
312938|NCT02272985|cerebral blood flow|cerebral blood flow
312939|NCT02272985|hemodialysis|hemodialysis
312940|NCT02272972|"fluoroscopy[MeSH], education, medical[MeSH]"|"fluoroscopy[mesh], education, medical[mesh]"
312941|NCT02272959|Anxiety/Anxiety disorders, Clinical trials, treatment, cognition, computer/Internet technology|anxiety/anxiety disorders, clinical trials, treatment, cognition, computer/internet technology
312942|NCT02272907|Bariatric Surgery|bariatric surgery
312943|NCT02272907|Laparoscopy|laparoscopy
312944|NCT02272907|Weight Loss Surgery|weight loss surgery
312945|NCT02272907|Staple Line Reinforcement|staple line reinforcement
312946|NCT02272894|Gastric Cancer|gastric cancer
312947|NCT02272894|D2 Lymphadenectomy|d2 lymphadenectomy
312948|NCT02272894|Superior Mesenteric Vein Lymph Node|superior mesenteric vein lymph node
312949|NCT02272855|HF10|hf10
312950|NCT02272855|HSV-1|hsv-1
312951|NCT02272855|Ipilimumab|ipilimumab
312952|NCT02272855|Oncolytic virus|oncolytic virus
312953|NCT02272855|Phase II|phase ii
312954|NCT02272855|Stage IIIB melanoma|stage iiib melanoma
312955|NCT02272855|Stage IIIC melanoma|stage iiic melanoma
312956|NCT02272855|Stage IV melanoma|stage iv melanoma
312957|NCT02272855|Unresectable malignant melanoma|unresectable malignant melanoma
312958|NCT02272855|Metastatic malignant melanoma|metastatic malignant melanoma
312959|NCT02272855|Combination treatment|combination treatment
312960|NCT02272855|Intratumoral injection|intratumoral injection
312961|NCT02272842|Nepal|nepal
312962|NCT02272842|Cobalamin|cobalamin
312963|NCT02272842|Neurodevelopment|neurodevelopment
312964|NCT02272842|Stunting|stunting
312965|NCT02272842|Growth|growth
312966|NCT02272790|Ovarian, Fallopian Tube, or Primary Peritoneal Cancer|ovarian, fallopian tube, or primary peritoneal cancer
312967|NCT02272777|Nilotinib|nilotinib
312968|NCT02272777|AMN107|amn107
312969|NCT02272777|Tasigna|tasigna
312970|NCT02272777|Imatinib|imatinib
312971|NCT02272777|STI571|sti571
312972|NCT02272777|Gleevec/Glivec|gleevec/glivec
312973|NCT02272777|BCR-ABL Positive|bcr-abl positive
313096|NCT02272244|Colorectal Cancer|colorectal cancer
312974|NCT02272777|Philadelphia chromosome positive (Ph+) chronic myelogenous leukemia in chronic phase (CML-CP)|philadelphia chromosome positive (ph+) chronic myelogenous leukemia in chronic phase (cml-cp)
312975|NCT02272777|Chronic myelogenous leukemia|chronic myelogenous leukemia
312976|NCT02272777|Chronic myeloid leukemia|chronic myeloid leukemia
312977|NCT02272777|Chronic myelocytic leukemia|chronic myelocytic leukemia
312978|NCT02272777|Acute Lymphoblastic Leukemia (ALL) Philadelphia chromosome positive|acute lymphoblastic leukemia (all) philadelphia chromosome positive
312979|NCT02272777|Acute Lymphoid Leukemia|acute lymphoid leukemia
312980|NCT02272777|suboptimal molecular response|suboptimal molecular response
312981|NCT02272751|cancer survivorship|cancer survivorship
312982|NCT02272751|exercise|exercise
312983|NCT02272751|relaxation|relaxation
312984|NCT02272751|mindfulness|mindfulness
312985|NCT02272725|ultramarathon|ultramarathon
312986|NCT02272725|ibuprofen|ibuprofen
312987|NCT02272725|acute kidney injury|acute kidney injury
312988|NCT02272725|exercise-associated hyponatremia|exercise-associated hyponatremia
312989|NCT02272725|exertion|exertion
312990|NCT02272712|cancer survivor|cancer survivor
312991|NCT02272712|computerized treatment|computerized treatment
312992|NCT02272712|symptom management|symptom management
312993|NCT02272699|Esophageal Squamous Cell Carcinoma|esophageal squamous cell carcinoma
312994|NCT02272699|Nimotuzumab|nimotuzumab
312995|NCT02272699|Neoadjuvant treatment|neoadjuvant treatment
312996|NCT02272686|Lymphoma|lymphoma
312997|NCT02272686|Blood And Marrow Transplantation|blood and marrow transplantation
312998|NCT02272686|Post Autologous Stem Cell Transplantation|post autologous stem cell transplantation
313000|NCT02272686|B-cell lymphoma|b-cell lymphoma
313001|NCT02272686|Ibrutinib|ibrutinib
313002|NCT02272686|PCI-32765|pci-32765
313003|NCT02272686|Imbruvica|imbruvica
313004|NCT02272660|preemptive analgesia|preemptive analgesia
313005|NCT02272660|parecoxib sodium|parecoxib sodium
313006|NCT02272660|total knee arthroplasty|total knee arthroplasty
313007|NCT02272660|total hip arthroplasty|total hip arthroplasty
313008|NCT02272647|Normal Healthy Volunteers|normal healthy volunteers
313009|NCT02272634|COPD|copd
313010|NCT02272595|Biologic Markers|biologic markers
313011|NCT02272595|Molecular testing|molecular testing
313012|NCT02272595|Advanced cancers|advanced cancers
313013|NCT02272595|Molecular information|molecular information
313014|NCT02272595|Molecular profiling|molecular profiling
313015|NCT02272595|Genetic Mutation|genetic mutation
313016|NCT02272569|glaucoma|glaucoma
313017|NCT02272569|glaucoma drainage device|glaucoma drainage device
313018|NCT02272569|glaucoma shunt|glaucoma shunt
313019|NCT02272530|Endothelial NO-synthase|endothelial no-synthase
313020|NCT02272530|red blood cell|red blood cell
313021|NCT02272530|erythrocytes|erythrocytes
313022|NCT02272530|Peripheral Blood Mononuclear Cell|peripheral blood mononuclear cell
313023|NCT02272530|cardiovascular disease|cardiovascular disease
313024|NCT02272517|Vortioxetine|vortioxetine
313025|NCT02272517|Cognition|cognition
313027|NCT02272504|AFP|afp
313028|NCT02272504|AFP-L3|afp-l3
313029|NCT02272504|DCP|dcp
313030|NCT02272504|Surveillance|surveillance
313031|NCT02272504|biomarkers|biomarkers
313032|NCT02272478|AML|aml
313033|NCT02272478|MDS|mds
313034|NCT02272465|pre-hospital resuscitation, helicopter, trauma|pre-hospital resuscitation, helicopter, trauma
313035|NCT02272452|High resolution magic angle spinning Nuclear magnetic resonance|high resolution magic angle spinning nuclear magnetic resonance
313036|NCT02272452|Nuclear magnetic resonance|nuclear magnetic resonance
313037|NCT02272452|Spectroscopy|spectroscopy
313038|NCT02272452|Primary brain tumors|primary brain tumors
313039|NCT02272452|Gliomas|gliomas
313040|NCT02272452|extemporaneous analysis|extemporaneous analysis
313041|NCT02272439|Bisphenol A|bisphenol a
313042|NCT02272439|phthalates|phthalates
313043|NCT02272439|infertility|infertility
313044|NCT02272439|human|human
313045|NCT02272426|Stroke|stroke
313046|NCT02272426|Exercise Training|exercise training
313047|NCT02272426|Cognitive Training|cognitive training
313048|NCT02272426|Quality of Life|quality of life
313049|NCT02272400|image guided radiation therapy|image guided radiation therapy
313050|NCT02272400|partial breast irradiation|partial breast irradiation
313051|NCT02272400|breast cancer|breast cancer
313052|NCT02272400|breast|breast
313053|NCT02272400|cancer|cancer
313054|NCT02272400|breast preservation|breast preservation
313055|NCT02272400|IGRT|igrt
313056|NCT02272400|PBI|pbi
313057|NCT02272374|Hemodialysis|hemodialysis
313058|NCT02272374|Arteriovenous fistula|arteriovenous fistula
313059|NCT02272374|Tunneled cuffed catheter|tunneled cuffed catheter
313060|NCT02272374|Arteriovenous graft|arteriovenous graft
313061|NCT02272374|Elderly|elderly
313062|NCT02272374|Very elderly|very elderly
313063|NCT02272348|Therapeutic education|therapeutic education
313064|NCT02272348|Functional insulin therapy|functional insulin therapy
313065|NCT02272335|Breast Cancer|breast cancer
313066|NCT02272335|Health Disparities|health disparities
313067|NCT02272335|Psychosocial Intervention|psychosocial intervention
313068|NCT02272335|Cancer Survivors|cancer survivors
313069|NCT02272322|Anterior prolapse|anterior prolapse
313070|NCT02272296|Injections, Jet|injections, jet
313071|NCT02272296|pharmacology|pharmacology
313072|NCT02272296|Insulin Aspart|insulin aspart
313073|NCT02272296|Equipment and Supplies|equipment and supplies
313074|NCT02272283|PCI optimization|pci optimization
313075|NCT02272283|Coronary Remodeling|coronary remodeling
313076|NCT02272283|Drug-Eluting Stent|drug-eluting stent
313077|NCT02272283|Optical Coherence Tomography|optical coherence tomography
313078|NCT02272283|Intravascular Ultrasound|intravascular ultrasound
313079|NCT02272283|Strut Coverage|strut coverage
313080|NCT02272283|Strut Apposition|strut apposition
313081|NCT02272283|Vascular Healing Pattern|vascular healing pattern
313082|NCT02272257|Musculoskeletal Pain|musculoskeletal pain
313083|NCT02272257|Physical Therapists|physical therapists
313084|NCT02272257|Drug Prescriptions|drug prescriptions
313085|NCT02272257|Humans|humans
313086|NCT02272257|Physical Therapy Modalities|physical therapy modalities
313087|NCT02272257|Referral and Consultation|referral and consultation
313088|NCT02272257|Workers' Compensation|workers' compensation
313089|NCT02272257|United States|united states
313090|NCT02272257|Primary Care|primary care
313091|NCT02272257|Health Services Research|health services research
313092|NCT02272257|Triage|triage
313093|NCT02272257|Acute|acute
313094|NCT02272257|Cost|cost
313095|NCT02272257|Occupational Health|occupational health
313097|NCT02272244|Cancer Screening|cancer screening
313098|NCT02272244|Decision Support|decision support
313099|NCT02272244|Navigation|navigation
313100|NCT02272231|women's health|women's health
313101|NCT02272231|vaginosis, bacterial|vaginosis, bacterial
313102|NCT02272231|african americans|african americans
313103|NCT02272205|Hip replacement|hip replacement
313104|NCT02272205|Knee replacement|knee replacement
313105|NCT02272205|Knee infection|knee infection
313106|NCT02272205|Hip infection|hip infection
313107|NCT02272205|Antibiotic prophylaxis|antibiotic prophylaxis
313108|NCT02272192|autism|autism
313109|NCT02272192|autism spectrum disorder|autism spectrum disorder
313110|NCT02272192|intensive intervention|intensive intervention
313111|NCT02272192|early intervention|early intervention
313112|NCT02272192|Early Start Denver Model|early start denver model
313113|NCT02272179|adolescence|adolescence
313114|NCT02272179|suicidality|suicidality
313115|NCT02272179|depression|depression
313116|NCT02272127|EGFR tyrosine kinase inhibitor|egfr tyrosine kinase inhibitor
313117|NCT02272088|physical activity|physical activity
313118|NCT02272088|energy expenditure|energy expenditure
313119|NCT02272088|compensatory mechanisms|compensatory mechanisms
313120|NCT02272088|adolescent|adolescent
313121|NCT02272075|screeening|screeening
313122|NCT02272062|Coronary artery disease|coronary artery disease
313123|NCT02272062|Angina|angina
313124|NCT02272062|Shared decision-making|shared decision-making
313125|NCT02272062|Patient preferences|patient preferences
313126|NCT02272062|Percutaneous coronary intervention|percutaneous coronary intervention
313127|NCT02272062|Coronary artery bypass graft|coronary artery bypass graft
313128|NCT02272049|Respiratory|respiratory
313129|NCT02272036|Colonoscopy|colonoscopy
313130|NCT02272036|Colonoscopy preparation|colonoscopy preparation
313131|NCT02272036|screening|screening
313132|NCT02272036|New media|new media
313133|NCT02272036|SMS|sms
313134|NCT02272036|Short message service|short message service
313135|NCT02272023|alcohol|alcohol
313136|NCT02272023|women|women
313137|NCT02272023|motivational interviewing|motivational interviewing
313138|NCT02271984|Healthy|healthy
313139|NCT02271984|Praziquantel|praziquantel
313140|NCT02271984|L-PZQ|l-pzq
313141|NCT02271984|PZQ|pzq
313142|NCT02271984|MSC2499550A|msc2499550a
313143|NCT02271984|Bioavailability|bioavailability
313144|NCT02271984|Pharmacokinetics|pharmacokinetics
313145|NCT02271971|Psoriasis|psoriasis
313146|NCT02271971|Vitamin D|vitamin d
313147|NCT02271971|Metabolic syndrome|metabolic syndrome
313148|NCT02271971|Insulin resistance|insulin resistance
313149|NCT02271971|Cholesterol|cholesterol
313150|NCT02271971|Methotrexate|methotrexate
313151|NCT02271971|Dyslipidemia|dyslipidemia
313152|NCT02271971|PASI|pasi
313153|NCT02271971|Psoriasis Area Severity Index|psoriasis area severity index
313154|NCT02271958|Mifepristone|mifepristone
313155|NCT02271958|Endometriosis|endometriosis
313156|NCT02271945|aggressive lymphoma, DLBCL, NHL|aggressive lymphoma, dlbcl, nhl
313157|NCT02271932|appendicitis|appendicitis
313158|NCT02271932|non-operative management|non-operative management
313159|NCT02271932|children|children
313160|NCT02271932|pediatric|pediatric
313161|NCT02271906|Lung Cancer|lung cancer
313162|NCT02271906|Non small cell lung cancer|non small cell lung cancer
313163|NCT02271906|NSCLC|nsclc
313164|NCT02271906|Adenocarcinoma|adenocarcinoma
313165|NCT02271906|Squamous cell carcinoma|squamous cell carcinoma
313166|NCT02271906|BIBW 2992|bibw 2992
313167|NCT02271906|Afatinib|afatinib
313168|NCT02271893|Chemotherapy-induced peripheral neuropathy|chemotherapy-induced peripheral neuropathy
313169|NCT02271880|Medication nonadherence|medication nonadherence
313170|NCT02271802|Butyrate|butyrate
313171|NCT02271802|Interorgan metabolism|interorgan metabolism
313172|NCT02271802|Short-chain fatty acids|short-chain fatty acids
313173|NCT02271802|Gut production|gut production
313174|NCT02271776|Insulin Sensitivity|insulin sensitivity
313175|NCT02271763|cricothyroid membrane|cricothyroid membrane
313176|NCT02271763|ultrasound|ultrasound
313177|NCT02271750|IGF, Neurotrophic factors, Dementia, spinal fluid|igf, neurotrophic factors, dementia, spinal fluid
313178|NCT02271737|Newborn|newborn
313179|NCT02271737|infection|infection
313180|NCT02271737|community health|community health
313181|NCT02271724|CIDP|cidp
313182|NCT02271724|MMN|mmn
313183|NCT02271724|Spinal fluid|spinal fluid
313184|NCT02271724|CD163|cd163
313185|NCT02271724|CD19|cd19
313186|NCT02271698|Knee arthroplasty|knee arthroplasty
313187|NCT02271698|Dexamethasone|dexamethasone
313188|NCT02271698|Acute pain|acute pain
313189|NCT02271698|Chronic pain|chronic pain
313190|NCT02271685|Diagnostic Information|diagnostic information
313191|NCT02271685|Risk Perception|risk perception
313192|NCT02271659|Prostate|prostate
313193|NCT02271659|external beam radiotherapy|external beam radiotherapy
313194|NCT02271659|brachytherapy boost|brachytherapy boost
313195|NCT02271659|economical evaluation|economical evaluation
313196|NCT02271646|paravertebral block|paravertebral block
313197|NCT02271646|ultrasound guided|ultrasound guided
313198|NCT02271633|Nitrate|nitrate
313199|NCT02271633|Bioavailability|bioavailability
313200|NCT02271633|Sports|sports
313201|NCT02271620|1 prevalence|1 prevalence
313202|NCT02271620|2 children|2 children
313203|NCT02271620|3 local allergic rhinitis|3 local allergic rhinitis
313204|NCT02271607|moxibustion|moxibustion
313205|NCT02271555|electroconvulsive therapy|electroconvulsive therapy
313206|NCT02271555|sevoflurane|sevoflurane
313207|NCT02271555|remifentanil|remifentanil
313208|NCT02271542|Propofol|propofol
313209|NCT02271542|Polymorphism|polymorphism
313210|NCT02271542|UGT1A9|ugt1a9
313211|NCT02271542|CYP2B6|cyp2b6
313212|NCT02271529|Peripheral Vascular Disease|peripheral vascular disease
313213|NCT02271529|Femoral Artery|femoral artery
313214|NCT02271529|Drug-Eluting Stent|drug-eluting stent
313215|NCT02271490|Assisted Reproductive Technique|assisted reproductive technique
313216|NCT02271490|ICSI|icsi
313217|NCT02271490|Acrosome Reaction|acrosome reaction
313218|NCT02271490|Pregnancy outcome|pregnancy outcome
313219|NCT02271477|Fluid replacement|fluid replacement
313220|NCT02271477|Trans-Thoracic Echocardiography|trans-thoracic echocardiography
313221|NCT02271477|Spinal Anesthesia|spinal anesthesia
313222|NCT02271477|Empirical Volemic Repletion|empirical volemic repletion
313223|NCT02271464|Metastatic colorectal cancer|metastatic colorectal cancer
313224|NCT02271464|Ist line therapy|ist line therapy
313225|NCT02271464|metronimic therapy|metronimic therapy
313226|NCT02271464|bevacizumab|bevacizumab
313227|NCT02271451|concussion|concussion
313228|NCT02271438|Healthy|healthy
313229|NCT02271438|Ibrutinib|ibrutinib
313230|NCT02271438|Moxifloxacin|moxifloxacin
313231|NCT02271438|Cardiac Repolarization|cardiac repolarization
313232|NCT02271438|Electrocardiogram|electrocardiogram
313233|NCT02271438|QTc interval|qtc interval
313234|NCT02271399|venous thromboembolism|venous thromboembolism
313235|NCT02271399|total knee arthroplasty|total knee arthroplasty
313236|NCT02271386|Evidence-Based Practice|evidence-based practice
313237|NCT02271386|Provider Education|provider education
313238|NCT02271373|Vision, Ocular|vision, ocular
313239|NCT02271373|Physical activity|physical activity
313240|NCT02271373|Schoolchildren|schoolchildren
313241|NCT02271373|Intervention Studies|intervention studies
313242|NCT02271360|infertility ICSI OHSS Calcium Dobesilate Cabergoline|infertility icsi ohss calcium dobesilate cabergoline
313243|NCT02271334|Asthma|asthma
313244|NCT02271334|Albuterol|albuterol
313245|NCT02271321|dementia|dementia
313246|NCT02271321|white noise|white noise
313247|NCT02271321|agitation|agitation
313248|NCT02271321|saliva cortisol|saliva cortisol
313249|NCT02271308|elastic band resistance training|elastic band resistance training
313250|NCT02271308|nursing home residents|nursing home residents
313251|NCT02271308|muscle strength|muscle strength
313252|NCT02271308|flexibility|flexibility
313253|NCT02271308|quality of life|quality of life
313254|NCT02271308|ease of care|ease of care
313255|NCT02271295|Cirrhosis|cirrhosis
313256|NCT02271295|Child B|child b
400205|NCT01868126|Eye|eye
313257|NCT02271295|decompensation|decompensation
313258|NCT02271295|mortality|mortality
313259|NCT02271295|portal thrombosis|portal thrombosis
313260|NCT02271295|anticoagulation|anticoagulation
313261|NCT02271269|glaucoma|glaucoma
313262|NCT02271269|medication adherence|medication adherence
313263|NCT02271269|financial incentives|financial incentives
313264|NCT02271269|behavioral economics|behavioral economics
313265|NCT02271256|Functional intimate apparel|functional intimate apparel
313266|NCT02271256|Adolescent Idiopathic scoliosis|adolescent idiopathic scoliosis
313267|NCT02271243|Central line-associated bloodstream infections|central line-associated bloodstream infections
313268|NCT02271243|mucosal barrier injury|mucosal barrier injury
313269|NCT02271243|laboratory-confirmed bloodstream infection|laboratory-confirmed bloodstream infection
313270|NCT02271217|Post stroke|post stroke
313271|NCT02271217|Ischemic stroke|ischemic stroke
313272|NCT02271126|ECMO|ecmo
313273|NCT02271126|Heparin|heparin
313274|NCT02271126|Thromboelastography|thromboelastography
313275|NCT02271126|Bleeding complications|bleeding complications
313276|NCT02271074|HIV|hiv
313277|NCT02271074|Care|care
313278|NCT02271074|Treatment|treatment
313279|NCT02271074|Retention|retention
313280|NCT02271074|Implementation Science|implementation science
313281|NCT02271048|telemedicine|telemedicine
313282|NCT02271048|ultrasonography|ultrasonography
313283|NCT02271048|echocardiography|echocardiography
313284|NCT02271035|VUR|vur
313285|NCT02271022|ACS, Acute Coronary Syndromes|acs, acute coronary syndromes
313286|NCT02271022|NSTEMI|nstemi
313287|NCT02271022|MI, Myocardial Infarction|mi, myocardial infarction
313288|NCT02270996|antibiotic, antimicrobial, stewardship, child|antibiotic, antimicrobial, stewardship, child
313289|NCT02270983|Opioid-Induced Constipation|opioid-induced constipation
313290|NCT02270983|Linaclotide|linaclotide
313291|NCT02270983|Linzess|linzess
313292|NCT02270944|GBS|gbs
313293|NCT02270944|vaccine comparability|vaccine comparability
313294|NCT02270944|Group B Strep|group b strep
313295|NCT02270918|Xa inhibitor|xa inhibitor
313296|NCT02270918|Prothrombin complex concentrate|prothrombin complex concentrate
313297|NCT02270918|anticoagulation|anticoagulation
313298|NCT02270905|meniscus|meniscus
313299|NCT02270905|meniscectomy|meniscectomy
313300|NCT02270905|decellularised|decellularised
313301|NCT02270905|xenograft|xenograft
313302|NCT02270892|Ulthera, Ulthera System, Ultherapy|ulthera, ulthera system, ultherapy
313303|NCT02270866|aphasia|aphasia
313304|NCT02270866|stroke|stroke
313305|NCT02270853|ApneaLink|apnealink
313306|NCT02270853|bronchial carcinoma|bronchial carcinoma
313307|NCT02270853|sleep apnea screening|sleep apnea screening
313308|NCT02270840|cardiac resynchronization therapy|cardiac resynchronization therapy
313309|NCT02270801|recombinant human thrombopoietin|recombinant human thrombopoietin
313310|NCT02270801|immune thrombocytopenia|immune thrombocytopenia
313311|NCT02270801|pregnancy|pregnancy
313312|NCT02270775|Questionnaire|questionnaire
313313|NCT02270775|Translation|translation
313314|NCT02270762|Early Physical Exercise|early physical exercise
313315|NCT02270762|Early Passive Exercise|early passive exercise
313316|NCT02270762|Alveolar Recruitment|alveolar recruitment
313317|NCT02270762|Electrical Impedance Tomography|electrical impedance tomography
313318|NCT02270762|Oxygenation|oxygenation
313319|NCT02270762|Ventilation|ventilation
313320|NCT02270684|Total Knee Arthroplasty|total knee arthroplasty
313321|NCT02270684|Home monitoring|home monitoring
313322|NCT02270671|Social Anxiety|social anxiety
313323|NCT02270671|Social Phobia|social phobia
313324|NCT02270671|Depression|depression
313325|NCT02270671|Attention Bias Modification Training|attention bias modification training
313326|NCT02270658|continuous positive airway pressure|continuous positive airway pressure
313327|NCT02270658|hypertension|hypertension
313328|NCT02270658|sleep apnea|sleep apnea
313329|NCT02270606|Rectum|rectum
313330|NCT02270541|Telemedicine|telemedicine
313331|NCT02270541|Prehospital|prehospital
313332|NCT02270541|Emergency Medicine|emergency medicine
313333|NCT02270541|Stroke|stroke
313334|NCT02270515|Patient-Centered Care|patient-centered care
313335|NCT02270515|Medical Home|medical home
313336|NCT02270502|critically illness|critically illness
313337|NCT02270502|intensive care unit|intensive care unit
313338|NCT02270502|outcome|outcome
313339|NCT02270502|frailty|frailty
313340|NCT02270476|Cystic Fibrosis|cystic fibrosis
313341|NCT02270476|Infant|infant
313342|NCT02270476|Toddler|toddler
313343|NCT02270476|Children|children
313344|NCT02270476|Newborn screening|newborn screening
313345|NCT02270437|total knee arthroplasty|total knee arthroplasty
313346|NCT02270437|cocktail analgesia|cocktail analgesia
313347|NCT02270437|morphine consumption|morphine consumption
313348|NCT02270424|Pulmonary Disease, Chronic Obstructive|pulmonary disease, chronic obstructive
313349|NCT02270424|Medicine, Chinese Traditional|medicine, chinese traditional
313350|NCT02270424|Humans|humans
313351|NCT02270424|Treatment Outcome|treatment outcome
313352|NCT02270398|Exercise|exercise
313353|NCT02270398|Balance|balance
313354|NCT02270398|Gait|gait
313355|NCT02270398|Community|community
313356|NCT02270398|Rehabilitation|rehabilitation
313357|NCT02270398|Dual-task|dual-task
313358|NCT02270385|pressure ulcer|pressure ulcer
313359|NCT02270385|nursing home|nursing home
313360|NCT02270372|Advanced breast carcinoma|advanced breast carcinoma
313361|NCT02270372|Advanced ovarian carcinoma|advanced ovarian carcinoma
313362|NCT02270372|MUC1|muc1
313363|NCT02270372|vaccine|vaccine
313364|NCT02270372|Phase 1b|phase 1b
313365|NCT02270359|Myocardial Infarction|myocardial infarction
313366|NCT02270359|CAD|cad
313367|NCT02270346|Allogeneic HSCT, Inspiratory Muscle Training, Exercise Capacity|allogeneic hsct, inspiratory muscle training, exercise capacity
313368|NCT02270333|sarcoidosis|sarcoidosis
313369|NCT02270333|inspiratory muscle strength|inspiratory muscle strength
313370|NCT02270333|exercise capacity|exercise capacity
313371|NCT02270333|quality of life|quality of life
313372|NCT02270320|Tai Chi Chuan|tai chi chuan
313373|NCT02270320|cognitive function|cognitive function
313374|NCT02270320|motor function|motor function
313375|NCT02270320|MRI|mri
313376|NCT02270294|Ischemic stroke|ischemic stroke
313377|NCT02270294|Thai traditional massage|thai traditional massage
313378|NCT02270294|Vascular function|vascular function
313379|NCT02270294|Cerebral blood flow|cerebral blood flow
313380|NCT02270294|Cerebrovascular reactivity|cerebrovascular reactivity
313381|NCT02270281|Sepsis|sepsis
313382|NCT02270281|Sedation|sedation
313383|NCT02270281|Microcirculation|microcirculation
313384|NCT02270281|Dexmedetomidine|dexmedetomidine
313385|NCT02270268|Irritable bowel syndrome|irritable bowel syndrome
313386|NCT02270268|Gut microbiota|gut microbiota
313387|NCT02270268|Soluble dietary fiber|soluble dietary fiber
313388|NCT02270255|embolization|embolization
313389|NCT02270255|analgesia|analgesia
313390|NCT02270242|PCI|pci
313391|NCT02270242|DAPT|dapt
313392|NCT02270242|ticagrelor|ticagrelor
313393|NCT02270242|aspirin|aspirin
313394|NCT02270216|isolated systolic hypertension|isolated systolic hypertension
313395|NCT02270216|exercise pressor responses|exercise pressor responses
313396|NCT02270203|si joint|si joint
313397|NCT02270203|si joint injury|si joint injury
313398|NCT02270203|si joint treatment|si joint treatment
313399|NCT02270203|si joint inflammation|si joint inflammation
313400|NCT02270203|si joint problems|si joint problems
313401|NCT02270203|si joint symptoms|si joint symptoms
313402|NCT02270203|hypermobile joint|hypermobile joint
313403|NCT02270203|si joint arthritis|si joint arthritis
313404|NCT02270203|si joint pain treatment|si joint pain treatment
313405|NCT02270203|inflamed si joint|inflamed si joint
313406|NCT02270203|si joint sclerosis|si joint sclerosis
313407|NCT02270203|locked si joint|locked si joint
313408|NCT02270203|si joint injuries|si joint injuries
313409|NCT02270203|si joint disease|si joint disease
313410|NCT02270203|si joint infection|si joint infection
313411|NCT02270203|sacroiliac joint pelvic pain|sacroiliac joint pelvic pain
313412|NCT02270203|sacroiliac joint arthritis treatment|sacroiliac joint arthritis treatment
313413|NCT02270203|si joint pain|si joint pain
313414|NCT02270203|si joint injections|si joint injections
313415|NCT02270177|Headache|headache
313416|NCT02270177|Telemedicine|telemedicine
313417|NCT02270177|Videoconsultation|videoconsultation
313418|NCT02270177|Headache-referrals|headache-referrals
313419|NCT02270164|Lipids|lipids
313420|NCT02270164|Cholesterol|cholesterol
313421|NCT02270164|Dietary Supplements|dietary supplements
313422|NCT02270164|Cynara scolymus|cynara scolymus
313423|NCT02270164|Safety|safety
313424|NCT02270151|Atrial fibrillation|atrial fibrillation
313425|NCT02270151|Screening|screening
313426|NCT02270151|Primary care|primary care
313427|NCT02270151|Diagnostic|diagnostic
313428|NCT02270138|physical activity|physical activity
313429|NCT02270138|music|music
313430|NCT02270138|sedentary lifestyle|sedentary lifestyle
313431|NCT02270125|nasal mucosa|nasal mucosa
313432|NCT02270125|chronic hypertrophic rhinosinusitis|chronic hypertrophic rhinosinusitis
313433|NCT02270125|mucotomy|mucotomy
313434|NCT02270125|nanoparticles|nanoparticles
313435|NCT02270125|scanning electron microscopy|scanning electron microscopy
313436|NCT02270125|Raman microspectroscopy|raman microspectroscopy
313437|NCT02270125|nasal polyposis|nasal polyposis
313641|NCT02269137|outcome|outcome
313438|NCT02270112|atrial fibrillation|atrial fibrillation
313439|NCT02270112|atrial electrophysiology|atrial electrophysiology
313440|NCT02270112|stroke|stroke
313441|NCT02270112|vascular stiffness|vascular stiffness
313442|NCT02270073|Psychotherapy process|psychotherapy process
313443|NCT02270073|Change mechanisms|change mechanisms
313444|NCT02270073|Mindfulness|mindfulness
313445|NCT02270073|Micro-interventions|micro-interventions
313446|NCT02270073|Mindfulness interventions|mindfulness interventions
313447|NCT02270073|Progressive muscle relaxation|progressive muscle relaxation
313448|NCT02270060|Music Therapy|music therapy
313449|NCT02270060|Sickle Cell Disease|sickle cell disease
313450|NCT02270060|Pain|pain
313451|NCT02270047|Ad libitum energy intake|ad libitum energy intake
313452|NCT02270047|Appetite sensation|appetite sensation
313453|NCT02270021|Pap smear|pap smear
313454|NCT02270021|Screening|screening
313455|NCT02270021|Women|women
313456|NCT02270021|Human papillomavirus|human papillomavirus
313457|NCT02270021|Cervical precancer|cervical precancer
313458|NCT02270021|Guideline adherence|guideline adherence
313459|NCT02270008|anal incontinence|anal incontinence
313460|NCT02270008|pregnancy-associated pelvic floor disorders|pregnancy-associated pelvic floor disorders
313461|NCT02269995|Hepatocellular|hepatocellular
313462|NCT02269995|Carcinoma|carcinoma
313463|NCT02269969|Aminoglycoside|aminoglycoside
313464|NCT02269969|Pharmacokinetics|pharmacokinetics
313465|NCT02269969|Once daily dosing|once daily dosing
313466|NCT02269943|Metastatic nasopharyngeal carcinoma|metastatic nasopharyngeal carcinoma
313467|NCT02269943|oral azacitidine|oral azacitidine
313468|NCT02269943|oral AZA|oral aza
313469|NCT02269943|CC-486|cc-486
313470|NCT02269943|metastatic|metastatic
313471|NCT02269943|recurrent|recurrent
313472|NCT02269943|nasopharyngeal carcinoma|nasopharyngeal carcinoma
313473|NCT02269943|nasal|nasal
313474|NCT02269943|solid tumors|solid tumors
313475|NCT02269943|locally advanced|locally advanced
313476|NCT02269943|rare head and neck cancer|rare head and neck cancer
313477|NCT02269943|nasopharynx|nasopharynx
313478|NCT02269943|single chemotherapy agent|single chemotherapy agent
313479|NCT02269943|Epstein-Barr Virus (EBV) + nasopharyngeal carcinoma|epstein-barr virus (ebv) + nasopharyngeal carcinoma
313480|NCT02269943|EBV-DN|ebv-dn
313481|NCT02269943|Celgene|celgene
313482|NCT02269943|Sponsor-study|sponsor-study
313483|NCT02269943|oral chemotherapy|oral chemotherapy
313484|NCT02269943|phase 2|phase 2
313485|NCT02269943|oral Vidaza|oral vidaza
313486|NCT02269943|EBV promoter methylation|ebv promoter methylation
313487|NCT02269943|hypomethylation|hypomethylation
313488|NCT02269943|tumor infiltrating lymphocytes (TILs)|tumor infiltrating lymphocytes (tils)
313489|NCT02269943|EBV gene expression|ebv gene expression
313490|NCT02269943|neoplasms|neoplasms
313491|NCT02269917|Human Immunodeficiency Virus Type 1|human immunodeficiency virus type 1
313492|NCT02269917|Emerald|emerald
313493|NCT02269917|Darunavir|darunavir
313494|NCT02269917|Cobicistat|cobicistat
313495|NCT02269917|Emtricitabine|emtricitabine
313496|NCT02269917|Tenofovir Alafenamide|tenofovir alafenamide
313497|NCT02269891|Menopausal symptoms|menopausal symptoms
313498|NCT02269891|Peri-menopause|peri-menopause
313499|NCT02269891|Nu Femme|nu femme
313500|NCT02269891|Labisia pumila|labisia pumila
313501|NCT02269891|Eurycoma longifolia|eurycoma longifolia
313502|NCT02269891|Hot flash|hot flash
313503|NCT02269891|Joint pain|joint pain
313504|NCT02269852|seasonal trivalent inactivated influenza vaccine|seasonal trivalent inactivated influenza vaccine
313505|NCT02269852|immunogenicity|immunogenicity
313506|NCT02269852|safety|safety
313507|NCT02269852|cross-reactivity|cross-reactivity
313508|NCT02269852|Northern hemisphere 2013-2014 formulation|northern hemisphere 2013-2014 formulation
313509|NCT02269839|Tinnitus|tinnitus
313510|NCT02269839|rTMS|rtms
313511|NCT02269813|MammaPrint|mammaprint
313512|NCT02269813|BluePrint|blueprint
313513|NCT02269813|TargetPrint|targetprint
313514|NCT02269774|Atrial Fibrillation|atrial fibrillation
313515|NCT02269774|Obstructive Sleep Apnea|obstructive sleep apnea
313516|NCT02269774|Atrial Premature Complexes|atrial premature complexes
313517|NCT02269774|Pulmonary Vein Isolation|pulmonary vein isolation
313518|NCT02269774|Mueller Manoeuvre|mueller manoeuvre
313519|NCT02269761|Emergency Departments|emergency departments
313520|NCT02269761|Chest|chest
313521|NCT02269761|Lung|lung
313522|NCT02269761|Cough|cough
313523|NCT02269761|Dyspnea|dyspnea
313524|NCT02269761|Wheezing|wheezing
313525|NCT02269761|Ultrasound|ultrasound
313526|NCT02269761|Ultrasonography|ultrasonography
313527|NCT02269657|Scoliosis|scoliosis
313528|NCT02269657|Postural balance|postural balance
313529|NCT02269657|Lordosis|lordosis
313530|NCT02269657|Kyphosis|kyphosis
313531|NCT02269657|X-rays|x-rays
313532|NCT02269631|Weight loss|weight loss
313533|NCT02269631|Epidemiology|epidemiology
313534|NCT02269631|Nutrition|nutrition
313535|NCT02269618|Telehealth, Home-based, rehabilitation|telehealth, home-based, rehabilitation
313536|NCT02269605|HIV reservoir|hiv reservoir
313537|NCT02269605|Bryostatin|bryostatin
313538|NCT02269592|MGUS|mgus
313539|NCT02269592|Smoldering Myeloma|smoldering myeloma
313540|NCT02269592|Chronic Lymphocytic leukemia|chronic lymphocytic leukemia
313541|NCT02269592|Acute Myeloid Leukemia|acute myeloid leukemia
313542|NCT02269592|Myeloproliferative neoplasms|myeloproliferative neoplasms
313543|NCT02269592|Waldenstrom Macroglobulinemia|waldenstrom macroglobulinemia
313544|NCT02269592|Monoclonal Gammopathy of Undermined Significance|monoclonal gammopathy of undermined significance
313545|NCT02269592|Monoclonal B cell lymphocytosis|monoclonal b cell lymphocytosis
313546|NCT02269592|Smoldering Multiple Myeloma|smoldering multiple myeloma
313547|NCT02269592|Myelodysplastic syndromes|myelodysplastic syndromes
313548|NCT02269579|Newly Diagnosed AML|newly diagnosed aml
313549|NCT02269579|Secondary AML|secondary aml
313550|NCT02269579|Relapsed/Refractory AML|relapsed/refractory aml
313551|NCT02269579|Relapsed/Refractory ALL|relapsed/refractory all
313552|NCT02269566|allergic rhinitis|allergic rhinitis
313553|NCT02269566|immunotherapy|immunotherapy
313554|NCT02269553|Migraine|migraine
313555|NCT02269553|Headache|headache
313556|NCT02269514|adoption|adoption
313557|NCT02269514|electronic cigarettes|electronic cigarettes
313558|NCT02269514|e-cigarettes|e-cigarettes
313559|NCT02269514|combustible cigarettes|combustible cigarettes
313560|NCT02269514|nicotine polacrilex|nicotine polacrilex
313561|NCT02269514|own brand cigarette|own brand cigarette
313562|NCT02269514|subjective measures|subjective measures
313563|NCT02269514|pharmacokinetics|pharmacokinetics
313564|NCT02269514|pharmacodynamics|pharmacodynamics
313565|NCT02269488|Safety|safety
313566|NCT02269488|Tolerability|tolerability
313567|NCT02269488|MEDI3250|medi3250
313568|NCT02269488|Japanese children|japanese children
313569|NCT02269475|Efficacy|efficacy
313570|NCT02269475|Safety|safety
313571|NCT02269475|Tolerability|tolerability
313572|NCT02269475|MEDI3250|medi3250
313573|NCT02269475|Japanese children|japanese children
313574|NCT02269449|transradial intervention|transradial intervention
313575|NCT02269449|radial artery|radial artery
313576|NCT02269410|Bariatric Surgery|bariatric surgery
313577|NCT02269410|Nitrogen Balance|nitrogen balance
313578|NCT02269410|Body composition|body composition
313579|NCT02269410|Protein supplementation|protein supplementation
313580|NCT02269410|Satiety|satiety
313581|NCT02269410|Adherence|adherence
313582|NCT02269397|Epilepsy|epilepsy
313583|NCT02269397|Seizures|seizures
313584|NCT02269397|Diagnosis|diagnosis
313585|NCT02269397|Diagnostic|diagnostic
313586|NCT02269397|Inflammation|inflammation
313587|NCT02269384|Pain|pain
313588|NCT02269384|Memory|memory
313589|NCT02269384|Pressure Pain Threshold|pressure pain threshold
313590|NCT02269384|Electromyography|electromyography
313591|NCT02269384|Heart Rate Variability|heart rate variability
313592|NCT02269319|ABSSSI|absssi
313593|NCT02269319|MRX-I|mrx-i
313594|NCT02269319|Acute Bacterial Skin and Skin Structure Infections|acute bacterial skin and skin structure infections
313595|NCT02269306|PCOS|pcos
313596|NCT02269306|clomiphene citrate|clomiphene citrate
313598|NCT02269306|visceral fat area|visceral fat area
313599|NCT02269306|HOMA-IR|homa-ir
313600|NCT02269293|Selinexor (KPT-330)|selinexor (kpt-330)
313601|NCT02269293|Paclitaxel|paclitaxel
313602|NCT02269293|Carboplatin|carboplatin
313603|NCT02269293|14-110|14-110
313604|NCT02269280|Leukemia|leukemia
313605|NCT02269280|Myelodysplastic syndrome|myelodysplastic syndrome
313606|NCT02269280|MDS|mds
313607|NCT02269280|Low or intermediate-1 risk|low or intermediate-1 risk
313608|NCT02269280|Transfusion-dependent|transfusion-dependent
313609|NCT02269280|Transfusion-independent|transfusion-independent
313610|NCT02269280|Best supportive care|best supportive care
313611|NCT02269280|BSC|bsc
313612|NCT02269280|Azacitidine|azacitidine
313613|NCT02269280|5-Azacytidine|5-azacytidine
313614|NCT02269280|5-AZA|5-aza
313615|NCT02269280|Vidaza|vidaza
313616|NCT02269280|5-AZC|5-azc
313617|NCT02269280|AZA-CR|aza-cr
313618|NCT02269280|Ladakamycin|ladakamycin
313619|NCT02269280|NSC-102816|nsc-102816
313620|NCT02269280|Azacytidine|azacytidine
313621|NCT02269280|Decitabine|decitabine
313622|NCT02269280|Dacogen|dacogen
313623|NCT02269254|Comparative Study|comparative study
313624|NCT02269254|Knee Prosthesis|knee prosthesis
313625|NCT02269254|Prosthesis Design|prosthesis design
313626|NCT02269254|Treatment Outcome|treatment outcome
313627|NCT02269254|Follow-Up Studies|follow-up studies
313628|NCT02269254|Arthroplasty, Replacement, Knee/methods|arthroplasty, replacement, knee/methods
313629|NCT02269241|contraception|contraception
313630|NCT02269241|hormonal oral contraceptive agents|hormonal oral contraceptive agents
313631|NCT02269241|hormonal oral contraceptive|hormonal oral contraceptive
313632|NCT02269241|oral contraceptive|oral contraceptive
313633|NCT02269241|drospirenone|drospirenone
313634|NCT02269241|LF111|lf111
313635|NCT02269241|birth control|birth control
313636|NCT02269150|Recipients|recipients
313637|NCT02269150|Transplantation|transplantation
313638|NCT02269137|status epileptics|status epileptics
313639|NCT02269137|prognosis|prognosis
313640|NCT02269137|risk factor|risk factor
313642|NCT02269098|type 2 diabetes|type 2 diabetes
313643|NCT02269098|hyperglycemia|hyperglycemia
313644|NCT02269098|Emergency Department|emergency department
313645|NCT02269098|Patient Education as Topic|patient education as topic
313646|NCT02269098|Drug Therapy|drug therapy
313647|NCT02269085|Lymphoma|lymphoma
313648|NCT02269085|Mantle cell lymphoma|mantle cell lymphoma
313649|NCT02269085|MCL|mcl
313650|NCT02269085|Relapsed or refractory|relapsed or refractory
313651|NCT02269085|Ibrutinib|ibrutinib
313652|NCT02269085|PCI-32765|pci-32765
313653|NCT02269085|Imbruvica|imbruvica
313654|NCT02269085|Carfilzomib|carfilzomib
313655|NCT02269072|Natriuretic Peptide|natriuretic peptide
313656|NCT02269046|acupuncture|acupuncture
313657|NCT02269046|moxibustion|moxibustion
313658|NCT02269046|hyperlipidemias|hyperlipidemias
313659|NCT02269046|effectiveness|effectiveness
313660|NCT02269033|Breast cancer|breast cancer
313661|NCT02269033|Patient Navigation|patient navigation
313662|NCT02269033|Health Disparities|health disparities
313663|NCT02269033|Latinas|latinas
313664|NCT02269033|Breast Imaging Reporting and Data System, BI-RADS|breast imaging reporting and data system, bi-rads
313665|NCT02269033|underserved|underserved
313666|NCT02269020|Squamous Cell Carcinoma of the Epi-larynx|squamous cell carcinoma of the epi-larynx
313667|NCT02269007|safety, tolerance, quadrivalent influenza vaccine|safety, tolerance, quadrivalent influenza vaccine
313668|NCT02268994|ferric citrate|ferric citrate
313669|NCT02268994|Chronic kidney disease|chronic kidney disease
313670|NCT02268994|Anemia|anemia
313671|NCT02268981|Oxymizer|oxymizer
313672|NCT02268981|Oxygen conserving device|oxygen conserving device
313673|NCT02268981|Conventional nasal cannula (CNC)|conventional nasal cannula (cnc)
313674|NCT02268981|Idiopathic pulmonary fibrosis|idiopathic pulmonary fibrosis
313675|NCT02268968|Topical Lidocaine|topical lidocaine
313676|NCT02268968|Nasal CPAP|nasal cpap
313677|NCT02268968|Pain|pain
313678|NCT02268968|Preterm Infants|preterm infants
313679|NCT02268968|Salivary cortisol|salivary cortisol
313680|NCT02268955|Biliary Colic|biliary colic
313681|NCT02268955|Abdominal pain|abdominal pain
313682|NCT02268955|Intravenous Ibuprofen|intravenous ibuprofen
313683|NCT02268916|diabetes|diabetes
313684|NCT02268916|physical activity|physical activity
313685|NCT02268916|participation|participation
313686|NCT02268903|Pulmonary Embolism|pulmonary embolism
313687|NCT02268903|Right Ventricle failure|right ventricle failure
313688|NCT02268903|Diuretics|diuretics
313689|NCT02268890|Multiple Myeloma|multiple myeloma
313690|NCT02268890|Bortezomib|bortezomib
313691|NCT02268890|Velcade|velcade
313692|NCT02268877|ultrasonography|ultrasonography
313693|NCT02268877|emergency department|emergency department
313694|NCT02268864|Hepatitis C Chronic|hepatitis c chronic
313695|NCT02268864|Simeprevir|simeprevir
313696|NCT02268864|Daclatasvir|daclatasvir
313697|NCT02268851|Mantle Cell Lymphoma|mantle cell lymphoma
313698|NCT02268851|Chronic Lymphocytic Leukemia/Small Lymphocytic Lymphoma|chronic lymphocytic leukemia/small lymphocytic lymphoma
313699|NCT02268838|E6007|e6007
313700|NCT02268838|Healthy Japanese male subjects|healthy japanese male subjects
313701|NCT02268812|Pain Management|pain management
313702|NCT02268812|Europe|europe
313703|NCT02268812|Intrathecal|intrathecal
313704|NCT02268799|Cardioversion|cardioversion
313705|NCT02268799|High Sensitivity Troponin T (Hs-Trop T)|high sensitivity troponin t (hs-trop t)
313706|NCT02268799|Brain Natriuretic Peptide (BNP)|brain natriuretic peptide (bnp)
313707|NCT02268799|Neutrophil Gelatinase-associated Lipocalin (NGAL)|neutrophil gelatinase-associated lipocalin (ngal)
313708|NCT02268786|Preimplantation Genetic Screening|preimplantation genetic screening
313709|NCT02268786|Blastocyst|blastocyst
313710|NCT02268786|Vitrification|vitrification
313711|NCT02268786|In vitro fertilization|in vitro fertilization
313712|NCT02268786|non-invasive prenatal testing|non-invasive prenatal testing
313713|NCT02268786|next generation sequencing|next generation sequencing
313714|NCT02268747|skin squamous cell cancer panHER inhibitor Dacomitinib|skin squamous cell cancer panher inhibitor dacomitinib
313715|NCT02268734|Sporadic Medullary Thyroid Cancer Vandetanib miRNA|sporadic medullary thyroid cancer vandetanib mirna
313716|NCT02268721|Pilot study|pilot study
313717|NCT02268721|Frail elderly|frail elderly
313718|NCT02268721|Malnutrition|malnutrition
313719|NCT02268721|Functionality|functionality
313720|NCT02268721|Life quality|life quality
313721|NCT02268721|Health care technology|health care technology
313722|NCT02268708|COPD|copd
313723|NCT02268708|Surgery, Thoracic|surgery, thoracic
313724|NCT02268695|Recurrent/Metastatic HNSCC|recurrent/metastatic hnscc
313725|NCT02268695|Taxanes|taxanes
313726|NCT02268682|Educator-Guided|educator-guided
313727|NCT02268682|Patient-Guided|patient-guided
313728|NCT02268682|Standard of Care (Control)|standard of care (control)
313729|NCT02268669|primary angioplasty|primary angioplasty
313730|NCT02268669|post-thrombolysis angioplasty|post-thrombolysis angioplasty
313731|NCT02268669|ST elevation acute myocardial infarction|st elevation acute myocardial infarction
313732|NCT02268643|breast cancer|breast cancer
313733|NCT02268643|screening|screening
313734|NCT02268643|ultrasound|ultrasound
313735|NCT02268643|risk model|risk model
313736|NCT02268630|Post-thrombotic syndrome|post-thrombotic syndrome
313737|NCT02268630|Chronic thromboembolic pulmonary hypertension|chronic thromboembolic pulmonary hypertension
313738|NCT02268630|Anticoagulation|anticoagulation
313739|NCT02268630|Rivaroxaban|rivaroxaban
313740|NCT02268617|Treadmill|treadmill
313741|NCT02268617|Walking|walking
313742|NCT02268617|Gait|gait
313743|NCT02268617|Exercise|exercise
313744|NCT02268578|Transcranial Direct Current Stimulation|transcranial direct current stimulation
313745|NCT02268578|TDCS|tdcs
313746|NCT02268578|Memory Dysfunction|memory dysfunction
313747|NCT02268578|Depression|depression
712552|NCT00579735|Breast cancer|breast cancer
400841|NCT01864941|MS|ms
313748|NCT02268565|sleep, insomnia, inflammation, pain|sleep, insomnia, inflammation, pain
313749|NCT02268565|Insomnia symptom induction/placebo|insomnia symptom induction/placebo
313750|NCT02268565|Insomnia symptom induction/aspirin|insomnia symptom induction/aspirin
313751|NCT02268552|Type 1 Spinal Muscular Atrophy|type 1 spinal muscular atrophy
313752|NCT02268539|pilot study|pilot study
313753|NCT02268539|atrial fibrillation|atrial fibrillation
313754|NCT02268539|ablation|ablation
313755|NCT02268539|implanted loop recorder|implanted loop recorder
313756|NCT02268526|Safety, efficacy, pharmacokinetics, CSJ148, HCMV, HCMV viral load,|safety, efficacy, pharmacokinetics, csj148, hcmv, hcmv viral load,
313757|NCT02268526|immunogenicity|immunogenicity
313758|NCT02268513|Cardiovascular Disease|cardiovascular disease
313759|NCT02268513|Social network|social network
313760|NCT02268513|South Asians|south asians
313761|NCT02268487|Early Improvement|early improvement
313762|NCT02268487|Depression|depression
313763|NCT02268487|Antidepressant|antidepressant
313764|NCT02268474|532nm|532nm
313765|NCT02268474|Excel V|excel v
313766|NCT02268474|Cutera|cutera
313767|NCT02268474|Laser|laser
313768|NCT02268474|Laser Light|laser light
313769|NCT02268474|PDL|pdl
313770|NCT02268474|595nm|595nm
313771|NCT02268474|Flash Lamp|flash lamp
313772|NCT02268461|Post-Stroke Spasticity|post-stroke spasticity
313773|NCT02268448|itch atopic dermatitis|itch atopic dermatitis
313774|NCT02268422|Healthy volunteer|healthy volunteer
313775|NCT02268422|crossover|crossover
313776|NCT02268422|open-label|open-label
313777|NCT02268422|randomised|randomised
313778|NCT02268422|bioequivalence|bioequivalence
313779|NCT02268422|pharmacokinetic study|pharmacokinetic study
313780|NCT02268357|Dental Anxiety|dental anxiety
313781|NCT02268357|Tooth Extraction|tooth extraction
313782|NCT02268357|Propranolol|propranolol
313783|NCT02268344|nerve regeneration|nerve regeneration
313784|NCT02268344|spinal accessory nerve|spinal accessory nerve
313785|NCT02268344|shoulder function|shoulder function
313786|NCT02268344|head neck cancer|head neck cancer
313787|NCT02268344|electrical stimulation|electrical stimulation
313788|NCT02268318|Japanese Subjects, High LDL-C, fermented-dairy products, phytosterols|japanese subjects, high ldl-c, fermented-dairy products, phytosterols
313789|NCT02268292|Metabolic syndrome|metabolic syndrome
313790|NCT02268292|Diabetes|diabetes
313791|NCT02268292|Muscle strength|muscle strength
313792|NCT02268292|Aerobic exercise|aerobic exercise
313793|NCT02268292|Bicycle|bicycle
313794|NCT02268292|Brain-derived neurotrophic factor|brain-derived neurotrophic factor
313795|NCT02268266|brain injury, early rehabilitation, tilt table|brain injury, early rehabilitation, tilt table
313796|NCT02268253|MF|mf
313797|NCT02268253|CMML|cmml
313798|NCT02268214|Dapagliflozin|dapagliflozin
313799|NCT02268214|Efficacy|efficacy
313800|NCT02268214|Safety|safety
313801|NCT02268214|Add on to insulin|add on to insulin
313802|NCT02268214|Oral Antidiabetic|oral antidiabetic
313803|NCT02268214|Type 1 diabetes|type 1 diabetes
313804|NCT02268201|tacrolimus|tacrolimus
313805|NCT02268201|immunosuppressive therapy|immunosuppressive therapy
313806|NCT02268188|Cancer Survivors|cancer survivors
313807|NCT02268175|prostate adenocarcinoma|prostate adenocarcinoma
313808|NCT02268175|advanced prostate cancer|advanced prostate cancer
313809|NCT02268175|high risk prostate cancer|high risk prostate cancer
313810|NCT02268162|Lung Neoplasms|lung neoplasms
313811|NCT02268162|Bronchoscopy|bronchoscopy
313812|NCT02268162|Virtual Bronchoscopic Navigation(VBN)|virtual bronchoscopic navigation(vbn)
313813|NCT02268162|Fluoroscopy|fluoroscopy
313814|NCT02268162|Endobronchial Ultrasonography with a Guide Sheath(EBUS-GS)|endobronchial ultrasonography with a guide sheath(ebus-gs)
313815|NCT02268162|Diagnosis|diagnosis
313816|NCT02268123|Male Infertility|male infertility
313817|NCT02268123|Sperm DNA Fragmentation|sperm dna fragmentation
313818|NCT02268123|Sperm Abnormality|sperm abnormality
313819|NCT02268110|diastasis recti|diastasis recti
313820|NCT02268110|physiotherapy|physiotherapy
313821|NCT02268110|exercise therapy|exercise therapy
313822|NCT02268110|abdominal binding|abdominal binding
313823|NCT02268097|patella|patella
313824|NCT02268097|total knee arthroplasty|total knee arthroplasty
313825|NCT02268097|resection|resection
313826|NCT02268084|PTSD|ptsd
313827|NCT02268084|TMS|tms
313828|NCT02268084|EEG|eeg
313829|NCT02268071|Hypertension|hypertension
313830|NCT02268071|Stopping antihypertensive treatment|stopping antihypertensive treatment
313831|NCT02268071|Primary care|primary care
313832|NCT02268071|White coat hypertension|white coat hypertension
313833|NCT02268071|Masked Hypertension|masked hypertension
313834|NCT02268045|Non-Hodgkin Lymphoma|non-hodgkin lymphoma
313835|NCT02268045|DLBCL|dlbcl
313836|NCT02268045|Diffuse large b-cell lymphoma|diffuse large b-cell lymphoma
313837|NCT02268032|Hormone replacement therapy|hormone replacement therapy
313838|NCT02268019|hypospadias|hypospadias
313839|NCT02268019|dehiscence|dehiscence
313840|NCT02268019|urethral stricture|urethral stricture
313841|NCT02268019|side effects|side effects
313842|NCT02268006|rectal carcinoma|rectal carcinoma
313843|NCT02268006|preoperative radiochemotherapy|preoperative radiochemotherapy
313844|NCT02268006|IMRT|imrt
313845|NCT02268006|SIB|sib
313846|NCT02267980|Electroconvulsive therapy; sevoflurane; ketamine|electroconvulsive therapy; sevoflurane; ketamine
313847|NCT02267954|Calories|calories
313848|NCT02267954|Fast Food Literacy|fast food literacy
313849|NCT02267928|Symptom Assessment|symptom assessment
313850|NCT02267915|Relapsed or refractory patients with mantle-cell lymphoma|relapsed or refractory patients with mantle-cell lymphoma
313851|NCT02267915|Progression after high-dose chemotherapy and autologous HPT|progression after high-dose chemotherapy and autologous hpt
313852|NCT02267902|Volunteers|volunteers
313853|NCT02267889|Ganglionated plexi|ganglionated plexi
313854|NCT02267863|AML|aml
313855|NCT02267863|MDS|mds
313856|NCT02267863|Leukemia|leukemia
313857|NCT02267863|Acute Myeloid Leukemia|acute myeloid leukemia
313858|NCT02267863|Aptose|aptose
313859|NCT02267863|APTO-253|apto-253
313860|NCT02267863|Kinase Inhibitor|kinase inhibitor
313861|NCT02267850|Photobiomodulation|photobiomodulation
313862|NCT02267850|Orthodontic treatment|orthodontic treatment
313863|NCT02267850|Malocclusion|malocclusion
313864|NCT02267850|OrthoPulse™|orthopulse™
313865|NCT02267837|Alignment phase|alignment phase
313866|NCT02267837|Photobiomodulation|photobiomodulation
313867|NCT02267837|Orthodontic treatment|orthodontic treatment
313868|NCT02267837|Malocclusion|malocclusion
313869|NCT02267837|OrthoPulse™|orthopulse™
313870|NCT02267824|Alignment phase|alignment phase
313871|NCT02267824|Photobiomodulation|photobiomodulation
313872|NCT02267824|Orthodontic treatment|orthodontic treatment
313873|NCT02267824|Malocclusion|malocclusion
313874|NCT02267824|OrthoPulse™|orthopulse™
313875|NCT02267811|Photobiomodulation|photobiomodulation
313876|NCT02267811|Orthodontic treatment|orthodontic treatment
313877|NCT02267811|Malocclusion|malocclusion
313878|NCT02267811|OrthoPulse™|orthopulse™
313879|NCT02267798|Stroke|stroke
313880|NCT02267798|Rehabilitation|rehabilitation
313881|NCT02267798|Arm motor recovery|arm motor recovery
313882|NCT02267798|biological biomarkers|biological biomarkers
313883|NCT02267785|exercise|exercise
313884|NCT02267785|mild cognitive impairment|mild cognitive impairment
313885|NCT02267785|Parkinson's Disease|parkinson's disease
313886|NCT02267720|Dental Atraumatic Restorative Treatment|dental atraumatic restorative treatment
313887|NCT02267720|Glass ionomer cement|glass ionomer cement
313888|NCT02267720|Occlusal-proximal leasons|occlusal-proximal leasons
313889|NCT02267720|Primary molars|primary molars
313890|NCT02267707|nab®-paclitaxel|nab®-paclitaxel
313891|NCT02267707|ABI-007|abi-007
313892|NCT02267707|Abraxane|abraxane
313893|NCT02267707|Advanced Pancreatic Cancer|advanced pancreatic cancer
313894|NCT02267707|Cholestatic Hyperbilirubinemia|cholestatic hyperbilirubinemia
313895|NCT02267707|Bile Duct Obstruction|bile duct obstruction
313896|NCT02267707|Pancreatic Cancer|pancreatic cancer
313897|NCT02267668|concussion|concussion
313898|NCT02267668|sports concussion|sports concussion
313899|NCT02267668|exercise therapy|exercise therapy
313900|NCT02267655|Inhaled Nitric Oxide (iNO)|inhaled nitric oxide (ino)
313901|NCT02267655|Pulmonary Hypertension (PH)|pulmonary hypertension (ph)
313902|NCT02267655|Chronic Obstructive Pulmonary Disease (COPD)|chronic obstructive pulmonary disease (copd)
313903|NCT02267655|Long Term Oxygen Therapy (LTOT)|long term oxygen therapy (ltot)
313904|NCT02267655|Idiopathic Pulmonary Fibrosis (IPF)|idiopathic pulmonary fibrosis (ipf)
313905|NCT02267629|OCD|ocd
313906|NCT02267616|Levonorgestrel intrauterine device (LNG IUD)|levonorgestrel intrauterine device (lng iud)
313907|NCT02267616|Etonogestrel (ENG) Implant|etonogestrel (eng) implant
313908|NCT02267616|Contraception|contraception
313909|NCT02267564|patellar dislocation|patellar dislocation
313910|NCT02267564|medial patellofemoral ligament|medial patellofemoral ligament
313911|NCT02267564|tibial tubercle transfer|tibial tubercle transfer
313912|NCT02267551|robotic surgery|robotic surgery
313913|NCT02267551|simulation|simulation
313914|NCT02267538|Delirium|delirium
313915|NCT02267538|Cardiac Surgical Procedures|cardiac surgical procedures
313916|NCT02267538|Postoperative Complications|postoperative complications
313917|NCT02267538|Dexmedetomidine|dexmedetomidine
313918|NCT02267538|Prevention|prevention
313919|NCT02267525|Gastroparesis|gastroparesis
313920|NCT02267525|Diabetic|diabetic
313921|NCT02267525|Idiopathic|idiopathic
313922|NCT02267512|Kidney Transplant Patients|kidney transplant patients
313923|NCT02267512|ATG-F|atg-f
313924|NCT02267499|cognitive training|cognitive training
313925|NCT02267499|physical training|physical training
313926|NCT02267499|exercise games|exercise games
313927|NCT02267499|novelty serious games|novelty serious games
313928|NCT02267499|computer training|computer training
313929|NCT02267499|mild cognitive impairment|mild cognitive impairment
313930|NCT02267499|mild dementia|mild dementia
313931|NCT02267499|healthy elderly|healthy elderly
313932|NCT02267486|Alzheimer Dementia, AD|alzheimer dementia, ad
313933|NCT02267486|patients|patients
313934|NCT02267486|cognitive|cognitive
313935|NCT02267460|Peyronie's disease|peyronie's disease
313936|NCT02267460|penile plaque|penile plaque
401056|NCT01864187|Obesity|obesity
313937|NCT02267460|penile curvature|penile curvature
313938|NCT02267447|Cardiovascular diseases|cardiovascular diseases
313939|NCT02267447|Clinical prediction rule|clinical prediction rule
313940|NCT02267447|Population projection|population projection
313941|NCT02267447|Risk stratification|risk stratification
313942|NCT02267447|Health behavior|health behavior
313943|NCT02267408|Heart valve prosthesis|heart valve prosthesis
313944|NCT02267408|Anticoagulation|anticoagulation
313945|NCT02267408|Warfarin|warfarin
313946|NCT02267395|Musicians, Injuries|musicians, injuries
313947|NCT02267369|online|online
313948|NCT02267369|social media|social media
313949|NCT02267369|online social network|online social network
313950|NCT02267369|physical activity|physical activity
313951|NCT02267369|message|message
313952|NCT02267330|Gonadal Radiation Exposure|gonadal radiation exposure
313953|NCT02267330|Fluoroscopic Imaging|fluoroscopic imaging
313954|NCT02267330|Trauma Surgery|trauma surgery
313955|NCT02267330|Pelvis fractures|pelvis fractures
313956|NCT02267330|Femur fractures|femur fractures
313957|NCT02267317|Insulin signaling and glucose disposal in muscle|insulin signaling and glucose disposal in muscle
313958|NCT02267317|Hepatic insulin sensitivity|hepatic insulin sensitivity
313959|NCT02267317|TLR4 signaling and inflammatory gene expression|tlr4 signaling and inflammatory gene expression
313960|NCT02267317|Plasma cytokine concentration|plasma cytokine concentration
313961|NCT02267317|Intramyocellular diacylglycerol and ceramide content|intramyocellular diacylglycerol and ceramide content
313962|NCT02267304|volunteers|volunteers
313963|NCT02267291|Cardiac Catheterization|cardiac catheterization
313964|NCT02267291|Echocardiography|echocardiography
313965|NCT02267291|Noninvasive Ventilation|noninvasive ventilation
313966|NCT02267291|Positive-Pressure Respiration|positive-pressure respiration
313967|NCT02267291|Ventricular Function|ventricular function
313968|NCT02267278|Myeloproliferative Diseases|myeloproliferative diseases
313969|NCT02267278|Myelofibrosis|myelofibrosis
313970|NCT02267278|MF|mf
313971|NCT02267278|Primary or post essential thrombocythemia/polycythemia vera|primary or post essential thrombocythemia/polycythemia vera
313972|NCT02267278|Ruxolitinib|ruxolitinib
313973|NCT02267278|Jakafi|jakafi
313974|NCT02267278|INCB018424|incb018424
313975|NCT02267278|INC424|inc424
313976|NCT02267278|Pracinostat|pracinostat
313977|NCT02267278|Questionnaire|questionnaire
313978|NCT02267278|Survey|survey
313979|NCT02267265|educational intervention|educational intervention
313980|NCT02267265|language development|language development
313981|NCT02267265|universal newborn hearing screening|universal newborn hearing screening
313982|NCT02267265|postpartum|postpartum
313983|NCT02267265|parental attachment|parental attachment
313984|NCT02267265|loss to follow-up|loss to follow-up
313985|NCT02267265|hearing loss|hearing loss
313986|NCT02267265|achievement gap|achievement gap
313987|NCT02267265|language gap|language gap
313988|NCT02267265|school readiness|school readiness
313989|NCT02267239|essential oils|essential oils
313990|NCT02267239|chlorhexidine|chlorhexidine
313991|NCT02267239|microscopy, confocal|microscopy, confocal
313992|NCT02267239|immersion|immersion
313993|NCT02267239|antiseptic|antiseptic
313994|NCT02267200|biomarkers，pulmonary arterial hypertension|biomarkers，pulmonary arterial hypertension
313995|NCT02267187|Craniomaxillofacial (CMF)|craniomaxillofacial (cmf)
313996|NCT02267187|Battle-injured (BI)|battle-injured (bi)
313997|NCT02267187|Facial Trauma|facial trauma
313998|NCT02267187|Fat Grafts|fat grafts
313999|NCT02267187|Autogenous Fat Transfers (AFT)|autogenous fat transfers (aft)
314000|NCT02267187|Wounded Warriors|wounded warriors
314001|NCT02267174|Implementation|implementation
314002|NCT02267174|quality improvement|quality improvement
314003|NCT02267174|patient safety|patient safety
314004|NCT02267174|handoffs|handoffs
314005|NCT02267174|intensive care unit|intensive care unit
314006|NCT02267174|postoperative care|postoperative care
314007|NCT02267174|simulation|simulation
314008|NCT02267161|agenesis|agenesis
314009|NCT02267161|corpus callosum|corpus callosum
314010|NCT02267161|prenatal diagnosis|prenatal diagnosis
314011|NCT02267148|Non-alcoholic fatty liver disease|non-alcoholic fatty liver disease
314012|NCT02267148|Fatty liver|fatty liver
314013|NCT02267148|Steatosis|steatosis
314014|NCT02267148|Fibrosis|fibrosis
314015|NCT02267148|Liver Stiffness|liver stiffness
314016|NCT02267148|Cirrhosis|cirrhosis
314017|NCT02267148|Genetics|genetics
314018|NCT02267148|Single Nucleotide Polymorphism|single nucleotide polymorphism
314019|NCT02267135|scalp psoriasis, plaque psoriasis, secukinumab, AIN457, biologic, monoclonal antibody, psoriasis, AIN457A|scalp psoriasis, plaque psoriasis, secukinumab, ain457, biologic, monoclonal antibody, psoriasis, ain457a
314020|NCT02267096|lung cancer screening|lung cancer screening
314021|NCT02267083|soft tissue sarcoma|soft tissue sarcoma
314022|NCT02267070|cognitive training|cognitive training
314023|NCT02267070|aerobic exercise|aerobic exercise
314024|NCT02267070|neurotrophic factors|neurotrophic factors
314025|NCT02267070|randomized controlled trial|randomized controlled trial
314026|NCT02267057|Pain measurement|pain measurement
314027|NCT02267057|Pain assessment|pain assessment
314028|NCT02267057|Pain management|pain management
314029|NCT02267057|Analgesia|analgesia
314030|NCT02267057|Analgesics|analgesics
314031|NCT02267057|Depressive symptoms|depressive symptoms
314032|NCT02267057|Alzheimer disease|alzheimer disease
314033|NCT02267057|Vascular dementia|vascular dementia
314034|NCT02267057|Multi-infarct dementia|multi-infarct dementia
314035|NCT02267057|Frontotemporal lobar degeneration|frontotemporal lobar degeneration
314036|NCT02267057|Lewy body disease|lewy body disease
314037|NCT02267031|cognitive dysfunction|cognitive dysfunction
314038|NCT02267031|mechanical ventilation|mechanical ventilation
314039|NCT02267031|hyperoxia|hyperoxia
314040|NCT02267031|hypocapnia|hypocapnia
314041|NCT02267018|nCPAP|ncpap
314042|NCT02267018|High-Frequency Oscillator Ventilation|high-frequency oscillator ventilation
314043|NCT02267018|Diaphragm Electrical Activity|diaphragm electrical activity
314044|NCT02266979|peritoneal dialysis|peritoneal dialysis
314045|NCT02266979|nursing staff|nursing staff
314046|NCT02266979|nursing activities|nursing activities
314047|NCT02266979|Personnel Downsizing|personnel downsizing
314048|NCT02266953|Dietary services|dietary services
314049|NCT02266953|Public Health Nursing|public health nursing
314050|NCT02266953|Preschool child|preschool child
314051|NCT02266940|pharmacokinetics|pharmacokinetics
314052|NCT02266901|leaks after bariatric surgery|leaks after bariatric surgery
314053|NCT02266901|fistulae after bariatric surgery|fistulae after bariatric surgery
314054|NCT02266901|abdominal abcesses and bariatric surgery|abdominal abcesses and bariatric surgery
314055|NCT02266901|endoscopic drainage of abcesses|endoscopic drainage of abcesses
314056|NCT02266901|percutaneous drainage of abcesses|percutaneous drainage of abcesses
314057|NCT02266901|gastric bypass|gastric bypass
314058|NCT02266901|sleeve gastrectomy|sleeve gastrectomy
314059|NCT02266901|necrotic collection and bariatric surgery|necrotic collection and bariatric surgery
314060|NCT02266888|B cells|b cells
314061|NCT02266888|lung transplant recipient|lung transplant recipient
314062|NCT02266888|rituximab|rituximab
314063|NCT02266888|placebo|placebo
314064|NCT02266888|standard of care|standard of care
314065|NCT02266836|Stroke|stroke
314066|NCT02266836|Cerebrovascular accident|cerebrovascular accident
314067|NCT02266836|Upper Extremity|upper extremity
314068|NCT02266836|Cerebral Infarction|cerebral infarction
314069|NCT02266836|Brain Infarction|brain infarction
314070|NCT02266836|Brain Ischemia|brain ischemia
314071|NCT02266836|Cerebrovascular Disorders|cerebrovascular disorders
314072|NCT02266836|Cardiovascular Diseases|cardiovascular diseases
314073|NCT02266836|Nervous System Diseases|nervous system diseases
314074|NCT02266836|Central Nervous System Diseases|central nervous system diseases
314075|NCT02266784|smoking, smoking cessation, contingency management, ADHD|smoking, smoking cessation, contingency management, adhd
314076|NCT02266771|Negative Pressure Wound Therapy, Wound VAC, Instillation|negative pressure wound therapy, wound vac, instillation
314077|NCT02266758|Gestational Diabetes|gestational diabetes
314078|NCT02266758|Obesity|obesity
314079|NCT02266758|Pregnancy|pregnancy
314080|NCT02266719|Aortic Aneurysm, Abdominal [C14.907.055.239.075]|aortic aneurysm, abdominal [c14.907.055.239.075]
314081|NCT02266693|Cognitive Behavioural Therapy|cognitive behavioural therapy
314082|NCT02266693|Internet Based|internet based
314083|NCT02266693|CBT|cbt
314084|NCT02266693|Transdiagnostic|transdiagnostic
314085|NCT02266693|MDD|mdd
314086|NCT02266693|PD|pd
314087|NCT02266693|SAD|sad
314088|NCT02266693|GAD|gad
314089|NCT02266693|iCBT|icbt
314090|NCT02266680|Social Anxiety|social anxiety
314091|NCT02266680|Yoga|yoga
314092|NCT02266667|NEMOT device|nemot device
314093|NCT02266667|pediatrics|pediatrics
314094|NCT02266667|surgery|surgery
314095|NCT02266667|progressive scoliosis|progressive scoliosis
314096|NCT02266654|Emergency Medical Services|emergency medical services
314097|NCT02266654|Lactic Acid|lactic acid
314098|NCT02266654|Sepsis|sepsis
314099|NCT02266641|one-carbon metabolism|one-carbon metabolism
314100|NCT02266641|folate|folate
314101|NCT02266641|choline|choline
314102|NCT02266641|DNA methylation|dna methylation
314103|NCT02266641|imprint marker|imprint marker
314104|NCT02266641|cancer risks|cancer risks
314105|NCT02266602|IORT|iort
314106|NCT02266602|Breast Cancer|breast cancer
314107|NCT02266589|coagulopathy|coagulopathy
314108|NCT02266589|hydrocortisone|hydrocortisone
314109|NCT02266589|organ failure|organ failure
314110|NCT02266589|hemodynamic improvement induced by hydrocortisone|hemodynamic improvement induced by hydrocortisone
314111|NCT02266563|Traumatic Brain Injury|traumatic brain injury
314112|NCT02266563|Chronic Traumatic Encephalopathy|chronic traumatic encephalopathy
314113|NCT02266563|Mild Cognitive Impairment|mild cognitive impairment
314114|NCT02266563|PET imaging|pet imaging
314115|NCT02266563|tauopathy|tauopathy
314116|NCT02266563|amyloid|amyloid
314117|NCT02266446|anxiety disorders|anxiety disorders
314118|NCT02266446|cognitive bias modification|cognitive bias modification
314119|NCT02266446|primary care|primary care
314120|NCT02266446|attention|attention
314121|NCT02266446|interpretation|interpretation
314122|NCT02266446|computer|computer
314123|NCT02266433|DeQuervains Tenosynovitis|dequervains tenosynovitis
314124|NCT02266433|Lateral Epicondylitis|lateral epicondylitis
314125|NCT02266433|Tennis Elbow|tennis elbow
314126|NCT02266433|Trigger Finger|trigger finger
314127|NCT02266433|Tenosynovitis|tenosynovitis
314128|NCT02266433|Inflammatory Disease|inflammatory disease
314129|NCT02266433|Dexamethasone|dexamethasone
314130|NCT02266433|Ketorolac|ketorolac
314132|NCT02266420|Triple negative breast cancer|triple negative breast cancer
314133|NCT02266420|immuno-histochemistery|immuno-histochemistery
314134|NCT02266420|genomic profiles|genomic profiles
314135|NCT02266407|Revision TKA|revision tka
314136|NCT02266407|Septic|septic
314137|NCT02266407|Aseptic|aseptic
314138|NCT02266407|Transfusion|transfusion
314139|NCT02266407|Blood Loss|blood loss
314140|NCT02266381|PCNL|pcnl
314141|NCT02266381|MPCNL|mpcnl
314142|NCT02266381|guidance|guidance
314143|NCT02266381|puncture|puncture
314144|NCT02266368|Ureteral stents|ureteral stents
314145|NCT02266368|Double J stent|double j stent
314146|NCT02266368|Antimicoreal coated stent|antimicoreal coated stent
314147|NCT02266368|USSQ|ussq
314148|NCT02266368|UTI|uti
314149|NCT02266355|Oxaliplatin|oxaliplatin
314150|NCT02266355|Omalizumab|omalizumab
314151|NCT02266329|controlled clinical trial|controlled clinical trial
314152|NCT02266329|randomized controlled clinical trial|randomized controlled clinical trial
314153|NCT02266290|ADHESIVE TAPE|adhesive tape
314154|NCT02266290|ANKLE INJURY|ankle injury
314155|NCT02266290|POSTURAL BALANCE|postural balance
314156|NCT02266290|FUNCTIONAL ANKLE INSTABILITY|functional ankle instability
314157|NCT02266277|electronic health record, utilization|electronic health record, utilization
314158|NCT02266277|randomized controlled trial|randomized controlled trial
314159|NCT02266277|pragmatic clinical trial|pragmatic clinical trial
314160|NCT02266277|influenza, prevention and control|influenza, prevention and control
314161|NCT02266277|pneumococcal vaccines|pneumococcal vaccines
314162|NCT02266277|qualitative research|qualitative research
314163|NCT02266225|Chronic disease management|chronic disease management
314164|NCT02266225|Physical activity|physical activity
314165|NCT02266225|Fall prevention|fall prevention
314166|NCT02266225|Strength and balance exercise|strength and balance exercise
314167|NCT02266199|questionnaire|questionnaire
314168|NCT02266199|quality assurance|quality assurance
314169|NCT02266199|qualitative Verification|qualitative verification
314170|NCT02266199|conservative patients|conservative patients
314171|NCT02266199|interview|interview
314172|NCT02266160|tinnitus|tinnitus
314173|NCT02266160|local anaesthetic|local anaesthetic
314174|NCT02266160|EMLA cream 5%|emla cream 5%
314175|NCT02266147|Low Grade B-cell Lymphoma|low grade b-cell lymphoma
314176|NCT02266134|implementation|implementation
314177|NCT02266134|measurement based care|measurement based care
314178|NCT02266134|standardized|standardized
314179|NCT02266134|tailored|tailored
314180|NCT02266121|Multiple Sclerosis|multiple sclerosis
314181|NCT02266121|MS|ms
314182|NCT02266121|Cognitive deficits|cognitive deficits
314183|NCT02266121|Motor deficits|motor deficits
314184|NCT02266121|Fatigue|fatigue
314185|NCT02266121|Nervous System Diseases|nervous system diseases
314186|NCT02266121|Brain Diseases|brain diseases
314187|NCT02266121|Brain stimulation|brain stimulation
314188|NCT02266121|Working memory|working memory
314189|NCT02266121|Motor learning|motor learning
314190|NCT02266121|Central Nervous System Diseases|central nervous system diseases
314191|NCT02266121|Neuropsychological rehabilitation|neuropsychological rehabilitation
314192|NCT02266108|Sexually Transmitted Infections|sexually transmitted infections
314193|NCT02266108|Female Sex Workers|female sex workers
314194|NCT02266095|Osteoarthritis|osteoarthritis
314195|NCT02266095|Thumb spica splint|thumb spica splint
314196|NCT02266095|Oval-8 splint|oval-8 splint
314197|NCT02266095|Tee-Pee splint|tee-pee splint
314198|NCT02266069|implementation|implementation
314199|NCT02266069|anticipatory care planning|anticipatory care planning
314200|NCT02266069|symptom assessment|symptom assessment
314201|NCT02266069|interdisciplinary collaboration|interdisciplinary collaboration
314202|NCT02266056|deep neuromuscular block|deep neuromuscular block
314203|NCT02266056|sugammadex|sugammadex
314204|NCT02266056|laparoscopic colorectal surgery|laparoscopic colorectal surgery
314205|NCT02266056|hemodynamic change|hemodynamic change
314206|NCT02266043|Upper airway obstruction|upper airway obstruction
314207|NCT02266017|pain|pain
314208|NCT02266017|coping|coping
314209|NCT02266017|mhealth|mhealth
314210|NCT02266017|cancer|cancer
314211|NCT02266004|transcranial direct current stimulation|transcranial direct current stimulation
314212|NCT02266004|neuromodulation|neuromodulation
314213|NCT02265978|Emotional Self-Awareness|emotional self-awareness
314214|NCT02265978|Positive Coping|positive coping
314215|NCT02265978|Help-Seeking|help-seeking
314216|NCT02265926|filtering facepiece respirators|filtering facepiece respirators
314217|NCT02265926|N95 masks|n95 masks
314218|NCT02265926|pandemic response|pandemic response
314219|NCT02265926|pregnant healthcare workers|pregnant healthcare workers
314220|NCT02265900|Positron Emission Tomography|positron emission tomography
314221|NCT02265900|Dopamine|dopamine
314222|NCT02265900|Parkinson's Disease|parkinson's disease
314223|NCT02265887|Pulmonary Hypertension|pulmonary hypertension
314224|NCT02265887|Africa|africa
314225|NCT02265887|Heart Disease|heart disease
314226|NCT02265887|Echocardiography|echocardiography
314227|NCT02265861|Polycystic ovary syndrome; Vascular endothelial growth factor; Angiotensin-Ⅱ; Ovarian hyperstimulation syndrome|polycystic ovary syndrome; vascular endothelial growth factor; angiotensin-ⅱ; ovarian hyperstimulation syndrome
314228|NCT02265848|Spinal cord stimulation|spinal cord stimulation
314229|NCT02265848|Chronic pain|chronic pain
314230|NCT02265848|Chronic low back pain|chronic low back pain
314231|NCT02265848|Radiculopathy|radiculopathy
314232|NCT02265848|Complex Regional Pain Syndrome (CRPS)|complex regional pain syndrome (crps)
314233|NCT02265848|High Frequency stimulation|high frequency stimulation
314234|NCT02265822|melatonin|melatonin
314235|NCT02265822|midazolam|midazolam
314236|NCT02265822|children|children
314237|NCT02265809|Interleukin 2|interleukin 2
314238|NCT02265809|Type 1 diabetes|type 1 diabetes
314239|NCT02265809|T regulatory cells|t regulatory cells
314240|NCT02265809|Adaptive trial|adaptive trial
314241|NCT02265796|deferred percutaneous coronary intervention|deferred percutaneous coronary intervention
314242|NCT02265796|fractional flow reserve|fractional flow reserve
314243|NCT02265783|Focus of Study: Healthy Volunteers|focus of study: healthy volunteers
314244|NCT02265757|Behavioral Intervention|behavioral intervention
314245|NCT02265757|Mild Cognitive Impairment|mild cognitive impairment
314246|NCT02265757|HABIT|habit
314247|NCT02265757|Cognitive Rehabilitation|cognitive rehabilitation
314248|NCT02265757|Multi-Component Intervention|multi-component intervention
314249|NCT02265731|relapsed multiple myeloma|relapsed multiple myeloma
314250|NCT02265731|refractory multiple myeloma|refractory multiple myeloma
314251|NCT02265731|Lymphoma, Non-Hodgkin|lymphoma, non-hodgkin
314252|NCT02265731|Lymphoproliferative Disorders|lymphoproliferative disorders
314253|NCT02265731|Lymphatic Diseases|lymphatic diseases
314254|NCT02265731|relapsed chronic lymphocytic leukemia|relapsed chronic lymphocytic leukemia
314255|NCT02265731|small lymphocytic lymphoma|small lymphocytic lymphoma
314256|NCT02265731|relapsed small lymphocytic lymphoma|relapsed small lymphocytic lymphoma
314257|NCT02265731|refractory small lymphocytic lymphoma|refractory small lymphocytic lymphoma
314258|NCT02265731|refractory chronic lymphocytic leukemia|refractory chronic lymphocytic leukemia
314259|NCT02265731|acute myeloid leukemia|acute myeloid leukemia
314260|NCT02265718|Healthy|healthy
314261|NCT02265718|elderly volunteers|elderly volunteers
314262|NCT02265614|PGS|pgs
314263|NCT02265614|blastocyst|blastocyst
314264|NCT02265614|human|human
314265|NCT02265614|IVF|ivf
314266|NCT02265614|vitrification|vitrification
314267|NCT02265614|single embryo transfer|single embryo transfer
314268|NCT02265601|advance care planning|advance care planning
314269|NCT02265601|living wills|living wills
314270|NCT02265601|end of life|end of life
314271|NCT02265601|cancer|cancer
314272|NCT02265588|Inflammatory bowel disease (IBD)|inflammatory bowel disease (ibd)
314273|NCT02265588|Ulcerative colitis|ulcerative colitis
314274|NCT02265588|Crohn's disease|crohn's disease
314275|NCT02265588|Children|children
314276|NCT02265588|Adolescents|adolescents
314277|NCT02265588|Anxiety|anxiety
314278|NCT02265588|Depression|depression
314279|NCT02265588|Cognitive behavioral therapy|cognitive behavioral therapy
314280|NCT02265562|Hysterectomy|hysterectomy
314281|NCT02265562|Misoprostol|misoprostol
314282|NCT02265562|Blood loss|blood loss
314283|NCT02265549|Metastases,|metastases,
314284|NCT02265549|Neoplasm|neoplasm
314285|NCT02265549|Cerebral|cerebral
314286|NCT02265523|Arthroplasties, Replacement, Knee|arthroplasties, replacement, knee
314287|NCT02265458|Respiratory failure|respiratory failure
314288|NCT02265458|NIV|niv
314289|NCT02265458|Musical intervention|musical intervention
314290|NCT02265445|Carbapenems therapy/ESBL infections/Deescalation|carbapenems therapy/esbl infections/deescalation
314291|NCT02265445|due to ESBL-PE|due to esbl-pe
314292|NCT02265432|Physical activity|physical activity
314293|NCT02265432|Sedentary behavior|sedentary behavior
314294|NCT02265419|hyperinflammation, Cytosorb|hyperinflammation, cytosorb
314295|NCT02265354|Tobacco Smoking Cessation|tobacco smoking cessation
314296|NCT02265354|Computer tailored health communication|computer tailored health communication
314297|NCT02265354|messaging|messaging
314298|NCT02265354|collective intelligence|collective intelligence
314299|NCT02265354|recommender systems|recommender systems
314300|NCT02265354|machine learning|machine learning
314301|NCT02265328|Severe Alcoholic Hepatitis in 'Extremis'|severe alcoholic hepatitis in 'extremis'
314302|NCT02265328|Bovine Colostrum|bovine colostrum
314303|NCT02265328|Glucocorticoids|glucocorticoids
314304|NCT02265276|NAFLD, Diabetes, Glitazone|nafld, diabetes, glitazone
314305|NCT02265250|magnetic resonance imaging|magnetic resonance imaging
314306|NCT02265250|positron emission tomography|positron emission tomography
314307|NCT02265237|Compensated Cirrhosis|compensated cirrhosis
314308|NCT02265237|Hepatitis C|hepatitis c
314309|NCT02265237|Hepatitis C Genotype 4|hepatitis c genotype 4
314310|NCT02265237|Chronic Hepatitis C|chronic hepatitis c
314311|NCT02265198|Pulmonary Contusion|pulmonary contusion
314313|NCT02265198|Respiratory Failure|respiratory failure
314314|NCT02265172|Physiotherapy|physiotherapy
314315|NCT02265172|Orthopaedic|orthopaedic
314316|NCT02265172|Primary care|primary care
314317|NCT02265146|Lipid Core Plaques (LCPs)|lipid core plaques (lcps)
314318|NCT02265146|Vulnerable Plaque|vulnerable plaque
314319|NCT02265146|Near Infrared Spectroscopy|near infrared spectroscopy
314320|NCT02265107|endothelial function|endothelial function
314321|NCT02265107|physical training|physical training
314322|NCT02265107|exercise|exercise
314323|NCT02265107|coronary artery bypass|coronary artery bypass
314324|NCT02265094|Autism Spectrum Disorder|autism spectrum disorder
314325|NCT02265094|Development|development
314326|NCT02265094|Memory|memory
314327|NCT02265094|ERD|erd
314328|NCT02265068|Acute coronary syndrome (ACS), Ticagrelor|acute coronary syndrome (acs), ticagrelor
314329|NCT02265029|fibromyalgia|fibromyalgia
314330|NCT02265029|rheumatism|rheumatism
314331|NCT02265029|fatigue syndrom|fatigue syndrom
314332|NCT02265029|pain|pain
314333|NCT02265029|spa treatment in rheumatology|spa treatment in rheumatology
314334|NCT02265016|coronary artery disease|coronary artery disease
314335|NCT02265016|acute coronary syndrome|acute coronary syndrome
314336|NCT02265016|angina pectoris|angina pectoris
314458|NCT02264314|Hearing Aids|hearing aids
314337|NCT02265016|non-ST-segment elevation myocardial infarction|non-st-segment elevation myocardial infarction
314338|NCT02265016|red blood cells|red blood cells
314339|NCT02265016|erythrocytes|erythrocytes
314340|NCT02265003|red blood cells|red blood cells
314341|NCT02265003|endothelial function|endothelial function
314342|NCT02265003|nitric oxide pool in red blood cells|nitric oxide pool in red blood cells
314343|NCT02265003|nitric oxide poll in blood plasma|nitric oxide poll in blood plasma
314344|NCT02265003|nitric oxide synthase III - expression|nitric oxide synthase iii - expression
314345|NCT02265003|oxidative status|oxidative status
314346|NCT02265003|nitric oxide signalling|nitric oxide signalling
314347|NCT02264990|veliparib|veliparib
314348|NCT02264990|carboplatin|carboplatin
314349|NCT02264990|paclitaxel|paclitaxel
314350|NCT02264990|cisplatin|cisplatin
314351|NCT02264990|pemetrexed|pemetrexed
314352|NCT02264990|Poly Adenosine diphosphate (ADP)-ribose Polymerase (PARP)|poly adenosine diphosphate (adp)-ribose polymerase (parp)
314353|NCT02264990|Metastatic|metastatic
314354|NCT02264990|Non-squamous|non-squamous
314355|NCT02264990|Non-small cell lung cancer|non-small cell lung cancer
314356|NCT02264964|Hemodialysis|hemodialysis
314357|NCT02264964|End-Stage Kidney Disease|end-stage kidney disease
314358|NCT02264964|Central Venous Catheterization|central venous catheterization
314359|NCT02264964|Digital Subtraction Angiography|digital subtraction angiography
314360|NCT02264951|Short fatty acids|short fatty acids
314361|NCT02264951|2-oleoyl glycerol|2-oleoyl glycerol
314362|NCT02264951|GLP-1 secretion|glp-1 secretion
314363|NCT02264951|C8-diet oil|c8-diet oil
314364|NCT02264951|GIP secretion|gip secretion
314365|NCT02264925|Essential tremor|essential tremor
314366|NCT02264925|Deep brain stimulation (DBS)|deep brain stimulation (dbs)
314367|NCT02264925|Ventral intermediate Thalamus (VIM)|ventral intermediate thalamus (vim)
314368|NCT02264925|Local field potentials (LFPs)|local field potentials (lfps)
314369|NCT02264925|Closed loop therapy|closed loop therapy
314370|NCT02264912|antiplatelets, percutanous coronary intervention, acute coronary syndromes, laboratory efficacy|antiplatelets, percutanous coronary intervention, acute coronary syndromes, laboratory efficacy
314371|NCT02264899|Alzheimer's disease|alzheimer's disease
314372|NCT02264899|Mild Cognitive Impairment|mild cognitive impairment
314373|NCT02264873|Relapse|relapse
314374|NCT02264873|Autologous stem cell transplant|autologous stem cell transplant
314375|NCT02264847|Clomiphene Citrate|clomiphene citrate
314376|NCT02264847|Ovulation trigger|ovulation trigger
314377|NCT02264847|Human chorionic gonadotrophin|human chorionic gonadotrophin
314378|NCT02264834|epidural|epidural
314379|NCT02264834|primiparous patient|primiparous patient
314380|NCT02264834|deambulation|deambulation
314381|NCT02264821|analgesia|analgesia
314382|NCT02264821|caesarean|caesarean
314383|NCT02264821|wound infiltration|wound infiltration
314384|NCT02264821|intrathecal morphine.|intrathecal morphine.
314385|NCT02264795|Cesarean section|cesarean section
314386|NCT02264795|Lidocaine|lidocaine
314387|NCT02264769|pregnancy|pregnancy
314388|NCT02264769|postpartum hemorrhage|postpartum hemorrhage
314389|NCT02264769|Cesarean delivery|cesarean delivery
314390|NCT02264769|carbetocin|carbetocin
314391|NCT02264756|Community-acquired pneumonia|community-acquired pneumonia
314392|NCT02264756|Pragmatic clinical trial|pragmatic clinical trial
314393|NCT02264756|Antimicrobial stewardship|antimicrobial stewardship
314394|NCT02264756|length of stay|length of stay
314395|NCT02264756|stepped-wedge design|stepped-wedge design
314396|NCT02264756|time-dependent bias|time-dependent bias
314397|NCT02264704|MS|ms
314398|NCT02264704|Exercise|exercise
314399|NCT02264704|Training|training
314400|NCT02264704|Multiple sclerosis|multiple sclerosis
314401|NCT02264704|Immune response|immune response
314402|NCT02264704|Neurotrophin|neurotrophin
314403|NCT02264704|Cytokine|cytokine
314404|NCT02264704|Fatigue|fatigue
314405|NCT02264678|ATM deficient, ATM proficient, HER2 negative, Breast, Gastric, Head & Neck, Lung|atm deficient, atm proficient, her2 negative, breast, gastric, head & neck, lung
314406|NCT02264652|Refractory|refractory
314407|NCT02264652|Partial|partial
314408|NCT02264652|Epilepsy|epilepsy
314409|NCT02264626|acute respiratory failure|acute respiratory failure
314410|NCT02264626|noninvasive ventilation|noninvasive ventilation
314411|NCT02264626|sedation|sedation
314412|NCT02264626|patient/ventilator interaction|patient/ventilator interaction
314413|NCT02264600|Restless Legs Syndrome, Apelin, Oxidative Stress|restless legs syndrome, apelin, oxidative stress
314414|NCT02264535|Allergy|allergy
314415|NCT02264535|Skin test|skin test
314416|NCT02264535|Ginkgolides Meglumine Injection|ginkgolides meglumine injection
314417|NCT02264509|Arterial Insufficiency|arterial insufficiency
314418|NCT02264509|Human Immunodeficiency Virus|human immunodeficiency virus
314419|NCT02264509|Atherosclerosis|atherosclerosis
314420|NCT02264509|Ankle-brachial index|ankle-brachial index
314421|NCT02264509|HAART|haart
314422|NCT02264496|Colorectal cancer|colorectal cancer
314423|NCT02264496|Exercise|exercise
314424|NCT02264496|CPEX|cpex
314425|NCT02264496|Exercise, Physical|exercise, physical
314426|NCT02264496|Exercise, Aerobic|exercise, aerobic
314427|NCT02264496|Surgery|surgery
314428|NCT02264483|Pneumonia in COPD exacerbation|pneumonia in copd exacerbation
314429|NCT02264470|Prediction|prediction
314430|NCT02264470|Falls|falls
314431|NCT02264470|Stroke|stroke
314432|NCT02264457|Lenses, Intraocular|lenses, intraocular
314433|NCT02264444|Cholecystectomy, visualization, single incision|cholecystectomy, visualization, single incision
314434|NCT02264431|Obesity|obesity
314435|NCT02264431|Obstructive Sleep Apnea|obstructive sleep apnea
314436|NCT02264431|Sleep Habits|sleep habits
314437|NCT02264431|Bariatric Surgery|bariatric surgery
314438|NCT02264431|Cohort|cohort
314439|NCT02264418|Solid tumours|solid tumours
314440|NCT02264379|Oligometastases|oligometastases
314441|NCT02264379|Prostate Cancer|prostate cancer
314442|NCT02264379|Stereotactic Radiotherapy|stereotactic radiotherapy
314443|NCT02264379|Hypo fractionation|hypo fractionation
314444|NCT02264379|Normal fractionation|normal fractionation
314445|NCT02264353|Obstructive|obstructive
314446|NCT02264353|Sleep Apnea|sleep apnea
314447|NCT02264353|Arousal threshold|arousal threshold
314448|NCT02264353|Donepezil|donepezil
314449|NCT02264340|Tension-type headache|tension-type headache
314450|NCT02264340|relaxation techniques|relaxation techniques
314451|NCT02264340|physiotherapy|physiotherapy
314452|NCT02264327|Motivational Interviewing|motivational interviewing
314453|NCT02264327|Evidence Based Practice|evidence based practice
314454|NCT02264327|Online Simulation|online simulation
314455|NCT02264327|Workforce development|workforce development
314456|NCT02264327|Training|training
314457|NCT02264314|Aged|aged
314459|NCT02264314|Rehabilitation|rehabilitation
314460|NCT02264288|Peripheral Arterial Disease|peripheral arterial disease
314461|NCT02264288|Diabetic Foot|diabetic foot
314462|NCT02264275|Aerobic Exercise|aerobic exercise
314463|NCT02264275|Exercise|exercise
314464|NCT02264275|Exergame|exergame
314465|NCT02264275|Behavior|behavior
314466|NCT02264275|Video Game|video game
314467|NCT02264275|Inflammatory Bowel Disease|inflammatory bowel disease
314468|NCT02264275|Children|children
314469|NCT02264275|Adolescents|adolescents
314470|NCT02264275|Pediatric|pediatric
314471|NCT02264275|Physical Fitness|physical fitness
314472|NCT02264223|Bioavailability|bioavailability
314473|NCT02264223|Isoflavones|isoflavones
314474|NCT02264223|Plasma|plasma
314475|NCT02264223|Human|human
314476|NCT02264223|Processing|processing
314477|NCT02264223|Cross-over|cross-over
314478|NCT02263950|Cancer|cancer
314479|NCT02263950|Malignant Neoplasm|malignant neoplasm
314480|NCT02263950|Artemether|artemether
314481|NCT02263950|Sublingual|sublingual
314482|NCT02263950|Neoplastic disease|neoplastic disease
314483|NCT02263950|Solid Tumour|solid tumour
314484|NCT02263950|Anti-cancer drug|anti-cancer drug
314485|NCT02263950|Chemotherapy|chemotherapy
314486|NCT02263950|LON002|lon002
314487|NCT02263885|Parkinson's Disease|parkinson's disease
314488|NCT02263885|ExAblate|exablate
314489|NCT02263885|MRgFUS|mrgfus
314490|NCT02263859|Obstructive Sleep Apnea|obstructive sleep apnea
314491|NCT02263846|Breast cancer|breast cancer
314492|NCT02263846|Menopause|menopause
314493|NCT02263846|Estradiol|estradiol
314494|NCT02263846|Follicle stimulating hormone|follicle stimulating hormone
314495|NCT02263820|Acute Kidney Injury|acute kidney injury
314496|NCT02263820|Acute Renal Failure|acute renal failure
314497|NCT02263807|Patella luxation|patella luxation
314498|NCT02263794|Bronchial Thermoplasty|bronchial thermoplasty
314499|NCT02263755|CHB, cohort, fibroscan|chb, cohort, fibroscan
314500|NCT02263742|Healthcare choice and outcomes|healthcare choice and outcomes
314501|NCT02263742|Peer-led whole health|peer-led whole health
314502|NCT02263742|Mental Illness|mental illness
314503|NCT02263742|Peer Health Navigation|peer health navigation
314504|NCT02263742|Health care Coordination|health care coordination
314505|NCT02263716|Physical Activity|physical activity
314506|NCT02263716|Intensive Care|intensive care
314507|NCT02263716|Activities of Daily Living|activities of daily living
314508|NCT02263716|Delirium|delirium
314509|NCT02263716|Sepsis|sepsis
314510|NCT02263716|Mechanical Ventilation|mechanical ventilation
314511|NCT02263716|Critical Care|critical care
314512|NCT02263716|Critical Illness|critical illness
314513|NCT02263716|Aging|aging
314514|NCT02263716|Accelerometery|accelerometery
314515|NCT02263703|HPV vaccine, children, immunocompromised|hpv vaccine, children, immunocompromised
314516|NCT02263677|diabetes|diabetes
314517|NCT02263677|fatty liver|fatty liver
314518|NCT02263664|microcirculation|microcirculation
314519|NCT02263664|esophagectomy|esophagectomy
314520|NCT02263664|side stream dark field|side stream dark field
314521|NCT02263664|microcirculatory derangements|microcirculatory derangements
314522|NCT02263651|Breast cancer|breast cancer
314523|NCT02263651|Mastectomy|mastectomy
314524|NCT02263651|Seroma|seroma
314525|NCT02263651|Quilting suture|quilting suture
314526|NCT02263638|hereditary haemochromatosis|hereditary haemochromatosis
314527|NCT02263638|rheumatism|rheumatism
314528|NCT02263638|anakinra|anakinra
314529|NCT02263625|Indication|indication
314530|NCT02263625|Differences|differences
314531|NCT02263612|Incisional Hernia|incisional hernia
314532|NCT02263612|Complications|complications
314533|NCT02263612|Long-term|long-term
314534|NCT02263586|Ironman|ironman
314535|NCT02263586|Triathlon|triathlon
314536|NCT02263573|PEP'C-R|pep'c-r
314537|NCT02263573|Endurance parameters|endurance parameters
314538|NCT02263573|Maximal cardio-respiratory function|maximal cardio-respiratory function
314539|NCT02263573|Older seniors|older seniors
314540|NCT02263573|Over 70|over 70
314541|NCT02263547|teriflunomide|teriflunomide
314542|NCT02263547|colestipol hcl|colestipol hcl
314543|NCT02263534|stress urinary incontinence|stress urinary incontinence
314544|NCT02263534|tension free vaginal tape|tension free vaginal tape
314545|NCT02263534|single incision minisling|single incision minisling
314546|NCT02263534|midurethral sling|midurethral sling
314547|NCT02263508|Talimogene Laherparepvec|talimogene laherparepvec
314548|NCT02263508|pembrolizumab|pembrolizumab
314549|NCT02263508|KEYNOTE-034|keynote-034
314550|NCT02263508|MASTERKEY-265|masterkey-265
314551|NCT02263495|HER2-Negative|her2-negative
314552|NCT02263482|muscle training|muscle training
314553|NCT02263482|walking test|walking test
314554|NCT02263482|chronic heart failure|chronic heart failure
314555|NCT02263482|functional capacity|functional capacity
314556|NCT02263443|bowel preparation|bowel preparation
314557|NCT02263443|gynecologic surgery|gynecologic surgery
314558|NCT02263443|laparotomy|laparotomy
314559|NCT02263391|transmission|transmission
314560|NCT02263391|prevention|prevention
314561|NCT02263391|women|women
314562|NCT02263391|childbearing age|childbearing age
314563|NCT02263391|HIV testing|hiv testing
314564|NCT02263391|testing strategy|testing strategy
314565|NCT02263378|HPV, L-SIL|hpv, l-sil
314566|NCT02263352|Diabetes, Periodontitis, Oxidative stress, Antioxidant|diabetes, periodontitis, oxidative stress, antioxidant
314567|NCT02263339|Exercise|exercise
314568|NCT02263339|MRI|mri
314569|NCT02263313|Safety and efficacy|safety and efficacy
314570|NCT02263313|Combo stent|combo stent
314571|NCT02263313|Late loss thrombosis|late loss thrombosis
314572|NCT02263313|Late loss catch up|late loss catch up
314573|NCT02263300|Fiberoptic Intubation|fiberoptic intubation
314574|NCT02263300|Medical student|medical student
314575|NCT02263300|Virtual larynx|virtual larynx
314576|NCT02263300|Didactic Training|didactic training
314577|NCT02263300|Medical Education|medical education
314578|NCT02263287|Alzheimer Disease|alzheimer disease
314579|NCT02263287|Lewy Body Disease|lewy body disease
314580|NCT02263261|dermal matrix|dermal matrix
314581|NCT02263235|Alzheimer disease (AD)|alzheimer disease (ad)
314582|NCT02263235|diagnosis biomarkers|diagnosis biomarkers
314583|NCT02263235|cerebrospinal fluid (CSF)|cerebrospinal fluid (csf)
314584|NCT02263235|targeted quantitative proteomics|targeted quantitative proteomics
314585|NCT02263235|mass spectrometry|mass spectrometry
314586|NCT02263235|stable isotope-labelled leucine|stable isotope-labelled leucine
314587|NCT02263183|Metabolic risk|metabolic risk
314588|NCT02263183|Abdominally overweight|abdominally overweight
314589|NCT02263131|Influenza|influenza
314590|NCT02263131|Influenza vaccine|influenza vaccine
314591|NCT02263131|Split influenza vaccine|split influenza vaccine
314592|NCT02263131|Seasonal influenza vaccine|seasonal influenza vaccine
314593|NCT02263118|breastfeeding|breastfeeding
314594|NCT02263118|rural|rural
314595|NCT02263118|m-health|m-health
314596|NCT02263118|mHealth|mhealth
314597|NCT02263118|Patojitos|patojitos
314598|NCT02263118|Guatemala|guatemala
314599|NCT02263118|exclusive breastfeeding|exclusive breastfeeding
314600|NCT02263118|mobile|mobile
314601|NCT02263118|eHealth|ehealth
314602|NCT02263118|e-health|e-health
314603|NCT02263105|recurrent high-grade gliomas|recurrent high-grade gliomas
314604|NCT02263105|cisplatin (CDDP)|cisplatin (cddp)
314605|NCT02263105|temozolomide (TMZ)|temozolomide (tmz)
314606|NCT02263092|Cortical excitability|cortical excitability
314607|NCT02263092|Plasticity|plasticity
314608|NCT02263092|Healthy subjects|healthy subjects
314609|NCT02263040|influenza vaccine|influenza vaccine
314610|NCT02263040|adult|adult
314611|NCT02263040|immunogenicity|immunogenicity
314612|NCT02263040|reactogenicity|reactogenicity
314613|NCT02263027|influenza vaccine|influenza vaccine
314614|NCT02263027|adult|adult
314615|NCT02263027|safety|safety
314616|NCT02263027|reactogenicity|reactogenicity
314617|NCT02263014|Breast Cancer|breast cancer
314618|NCT02263014|Contralateral Prophylactic Mastectomy|contralateral prophylactic mastectomy
314619|NCT02263014|Questionnaires|questionnaires
314620|NCT02263014|Surveys|surveys
314621|NCT02263014|Psychosocial|psychosocial
314622|NCT02263001|Auricular therapy|auricular therapy
314623|NCT02263001|Acupuncture|acupuncture
314624|NCT02263001|Acute, sub-acute pain|acute, sub-acute pain
314625|NCT02263001|Auricular Acupuncture Needles|auricular acupuncture needles
314626|NCT02262988|knee|knee
314627|NCT02262988|joint replacement|joint replacement
314628|NCT02262988|total knee|total knee
314629|NCT02262988|cell therapy|cell therapy
314630|NCT02262975|Alzheimer's disease|alzheimer's disease
314631|NCT02262936|Aged|aged
314632|NCT02262936|Deamino Arginine Vasopressin|deamino arginine vasopressin
314633|NCT02262936|Fesoterodine|fesoterodine
314634|NCT02262936|Randomized Controlled Trial|randomized controlled trial
314635|NCT02262910|metastatic castration-resistant prostate cancer|metastatic castration-resistant prostate cancer
314636|NCT02262910|CRPC|crpc
314637|NCT02262897|small cell lung cancer|small cell lung cancer
314638|NCT02262897|chemotherapy|chemotherapy
314639|NCT02262897|Nab-paclitaxel|nab-paclitaxel
314640|NCT02262871|Cystic fibrosis|cystic fibrosis
314641|NCT02262871|High-flow nasal oxygen cannula|high-flow nasal oxygen cannula
314642|NCT02262871|Non-invasive ventilation|non-invasive ventilation
314643|NCT02262871|Respiratory distress|respiratory distress
314644|NCT02262871|Oxygen therapy|oxygen therapy
314645|NCT02262832|Diabetes|diabetes
314646|NCT02262832|Leptin|leptin
314647|NCT02262832|Lipodystrophy|lipodystrophy
314648|NCT02262832|Hypertriglyceridemia|hypertriglyceridemia
314649|NCT02262819|Skin Blister|skin blister
314650|NCT02262819|Immune Response|immune response
314651|NCT02262819|Suction Device|suction device
314652|NCT02262819|Anti-Microbial|anti-microbial
314653|NCT02262819|Killed Microbe|killed microbe
314654|NCT02262806|Lipodystrophy|lipodystrophy
314655|NCT02262806|Leptin|leptin
314656|NCT02262806|Hypertriglyceridemia|hypertriglyceridemia
314657|NCT02262806|Diabetes|diabetes
314658|NCT02262767|Phase 1, Randomized, Double Blind, Placebo-Controlled, Single-Dose Escalation, Safety, Tolerability, Pharmacokinetic, PF-06649751, Trimethobenzamide|phase 1, randomized, double blind, placebo-controlled, single-dose escalation, safety, tolerability, pharmacokinetic, pf-06649751, trimethobenzamide
314659|NCT02262728|Hepatitis C, Chronic|hepatitis c, chronic
314660|NCT02262728|Simeprevir|simeprevir
314661|NCT02262728|Daclatasvir|daclatasvir
314662|NCT02262728|Sofosbuvir|sofosbuvir
314663|NCT02262728|Decompensated Liver Disease|decompensated liver disease
314664|NCT02262715|Oseltamivir|oseltamivir
314665|NCT02262715|VX-787|vx-787
314666|NCT02262689|GSK2256294|gsk2256294
314667|NCT02262689|normoxic|normoxic
314668|NCT02262689|hypoxic|hypoxic
314669|NCT02262689|Pulmonary artery systolic pressure (PASP)|pulmonary artery systolic pressure (pasp)
314670|NCT02262676|Stroke prevention on Atrial Fibrillation|stroke prevention on atrial fibrillation
314671|NCT02262676|Prevention and Control|prevention and control
314672|NCT02262676|Stroke|stroke
314673|NCT02262507|Brain|brain
314674|NCT02262507|Hearing|hearing
314675|NCT02262507|MTBI|mtbi
314676|NCT02262468|retrospective analysis|retrospective analysis
314677|NCT02262455|Serous tumor|serous tumor
314678|NCT02262455|Granulosa tumor|granulosa tumor
314679|NCT02262455|Clear Cell tumor|clear cell tumor
314680|NCT02262455|Endometrial cancer|endometrial cancer
314681|NCT02262455|Advanced solid tumors|advanced solid tumors
314682|NCT02262455|Adenocarcinoma|adenocarcinoma
314683|NCT02262455|Prostate cancer|prostate cancer
314684|NCT02262455|Head and Neck cancer|head and neck cancer
314685|NCT02262455|Lung cancer|lung cancer
314686|NCT02262455|Non-small cell lung cancer|non-small cell lung cancer
314687|NCT02262455|Small cell lung cancer|small cell lung cancer
314688|NCT02262455|Gastric cancer|gastric cancer
314689|NCT02262455|Kidney cancer|kidney cancer
314690|NCT02262455|Pancreatic cancer|pancreatic cancer
314691|NCT02262455|Breast cancer|breast cancer
314692|NCT02262455|Colorectal cancer|colorectal cancer
314693|NCT02262455|Bladder cancer|bladder cancer
314694|NCT02262455|Esophagus cancer|esophagus cancer
314695|NCT02262455|Liver cancer|liver cancer
314696|NCT02262455|Hepatobiliary cancer|hepatobiliary cancer
402057|NCT01859806|PG|pg
314697|NCT02262455|Skin cancer|skin cancer
314698|NCT02262442|flexible bronchoscopy|flexible bronchoscopy
314699|NCT02262442|anaesthetics|anaesthetics
314700|NCT02262442|transcutaneous pCO2|transcutaneous pco2
314701|NCT02262442|capillary pCO2|capillary pco2
314702|NCT02262442|special atomizing set|special atomizing set
314703|NCT02262416|GnRH agonist|gnrh agonist
314704|NCT02262416|IVF|ivf
314705|NCT02262403|Hookworm|hookworm
314706|NCT02262403|Helminths|helminths
314707|NCT02262403|Treg|treg
314708|NCT02262403|Immune regulation|immune regulation
314709|NCT02262403|Vietnam|vietnam
314710|NCT02262403|Allergic diseases|allergic diseases
314711|NCT02262377|Group Medical Visits|group medical visits
314712|NCT02262377|Integrative Medicine|integrative medicine
314713|NCT02262377|Chronic Pain|chronic pain
314714|NCT02262377|Depression|depression
314715|NCT02262377|MBSR|mbsr
314716|NCT02262377|Mindfulness Based Stress Reduction|mindfulness based stress reduction
314717|NCT02262377|Web based|web based
314718|NCT02262377|Virtual Patient Advocate|virtual patient advocate
314719|NCT02262377|Internet Based|internet based
314720|NCT02262351|Atrial Fibrillation|atrial fibrillation
314721|NCT02262351|Screening|screening
314722|NCT02262351|Family Practice|family practice
314723|NCT02262351|Novel screening technologies|novel screening technologies
314724|NCT02262338|MPS II|mps ii
314725|NCT02262338|Hunter Syndrome|hunter syndrome
314726|NCT02262325|Non-small cell|non-small cell
314727|NCT02262325|Lung Cancer|lung cancer
314728|NCT02262325|Chemoradiation|chemoradiation
314729|NCT02262286|Brain Injury|brain injury
314730|NCT02262273|women|women
314731|NCT02262273|platinum sensitive|platinum sensitive
314732|NCT02262273|recurrent|recurrent
314733|NCT02262273|serous|serous
314734|NCT02262273|ovarian cancer|ovarian cancer
314735|NCT02262273|BRCA|brca
314736|NCT02262273|PARP|parp
314737|NCT02262273|Olaparib|olaparib
314738|NCT02262260|Diabetic macular edema, DME, ranibizumab, wait and extend|diabetic macular edema, dme, ranibizumab, wait and extend
314739|NCT02262247|Transoral|transoral
314740|NCT02262247|Oropharynx|oropharynx
314741|NCT02262247|Hypopharynx|hypopharynx
314742|NCT02262247|Endoscopic|endoscopic
314743|NCT02262247|TORS|tors
314744|NCT02262247|Endoscopic Transoral|endoscopic transoral
314745|NCT02262247|Larynx|larynx
314746|NCT02262234|Spinal cord injury|spinal cord injury
314747|NCT02262234|Chronic pain|chronic pain
314748|NCT02262234|Education|education
314749|NCT02262208|Glycemic variability, exercise, diabetes|glycemic variability, exercise, diabetes
314750|NCT02262182|Atelectasis, Respiratory physiotherapy, end expiratory pressure, EzPAP®, cardiac surgery|atelectasis, respiratory physiotherapy, end expiratory pressure, ezpap®, cardiac surgery
314751|NCT02262169|Non-Bleeding Peptic Ulcers, DLBS2411, Ulcer Healing|non-bleeding peptic ulcers, dlbs2411, ulcer healing
314752|NCT02262156|Cognitive Behavioral Therapy|cognitive behavioral therapy
314753|NCT02262156|Selective serotonin reuptake inhibitor|selective serotonin reuptake inhibitor
314754|NCT02262156|depression|depression
314755|NCT02262156|epilepsy|epilepsy
314756|NCT02262130|Omalizumab|omalizumab
314757|NCT02262130|Efficacy|efficacy
314758|NCT02262130|Safety|safety
314759|NCT02262117|IVF, pregnancy, immune endometrial profile, personalization of treatment|ivf, pregnancy, immune endometrial profile, personalization of treatment
314760|NCT02262104|Exercise|exercise
314761|NCT02262104|dementia|dementia
314762|NCT02262104|nursing home|nursing home
314763|NCT02262078|Preserved Ejection Fraction|preserved ejection fraction
314764|NCT02262065|implant|implant
314765|NCT02262065|allergy|allergy
314766|NCT02262065|particle|particle
314767|NCT02262065|cytokine|cytokine
314768|NCT02262052|Deep vein thrombosis|deep vein thrombosis
314769|NCT02262052|Diagnostic management|diagnostic management
314770|NCT02262052|Recurrent|recurrent
314771|NCT02262052|MRI|mri
314772|NCT02262052|Ipsilateral|ipsilateral
314773|NCT02262039|living|living
314774|NCT02262039|kidney|kidney
314775|NCT02262039|donors|donors
314776|NCT02262013|Pediatric Obesity|pediatric obesity
314777|NCT02262013|Lifestyle Intervention|lifestyle intervention
314778|NCT02262013|Family-based Intervention|family-based intervention
314779|NCT02262013|Motivational Interviewing|motivational interviewing
314780|NCT02262000|Non Small Cell Lung Cancer|non small cell lung cancer
314781|NCT02262000|Surgically inoperable|surgically inoperable
314782|NCT02262000|Radiation Therapy|radiation therapy
314783|NCT02261987|Autogenic drainage|autogenic drainage
314784|NCT02261987|Resistive inspiratory manoeuvre|resistive inspiratory manoeuvre
314785|NCT02261987|Computerized respiratory sounds|computerized respiratory sounds
314786|NCT02261987|Airway clearance techniques|airway clearance techniques
314787|NCT02261987|Mucus clearances|mucus clearances
314788|NCT02261974|Vaginal laxity|vaginal laxity
314789|NCT02261974|Sexual Function|sexual function
314790|NCT02261961|resistance exercise|resistance exercise
314791|NCT02261961|Juven|juven
314792|NCT02261961|exercise training|exercise training
314793|NCT02261961|interleukin-1|interleukin-1
314794|NCT02261961|insulin-like growth factor|insulin-like growth factor
314795|NCT02261948|Cardiac Failure|cardiac failure
314796|NCT02261948|Severe Heart Failure|severe heart failure
314797|NCT02261935|Family caregiver|family caregiver
314798|NCT02261935|Home care nursing practice|home care nursing practice
314799|NCT02261935|Palliative care|palliative care
314800|NCT02261935|End of life care|end of life care
314801|NCT02261935|Family caregiver quality of life|family caregiver quality of life
314802|NCT02261935|Family caregiver grief symptoms|family caregiver grief symptoms
314803|NCT02261935|Family caregiver burden|family caregiver burden
314804|NCT02261935|Family caregiver preparedness for caregiving|family caregiver preparedness for caregiving
314805|NCT02261935|Family caregiver perceived social supports|family caregiver perceived social supports
314806|NCT02261935|Family caregiver health status|family caregiver health status
314807|NCT02261935|Family caregiver satisfaction with healthcare provided|family caregiver satisfaction with healthcare provided
314808|NCT02261909|Emergency Medicine|emergency medicine
314809|NCT02261909|diagnosis|diagnosis
314810|NCT02261896|cyst|cyst
314811|NCT02261896|pancreatic cyst|pancreatic cyst
314812|NCT02261896|EUS-FNA|eus-fna
314813|NCT02261896|antibiotic prophylaxis|antibiotic prophylaxis
314814|NCT02261883|PPHN|pphn
314815|NCT02261870|MRI, T2 quantification|mri, t2 quantification
314816|NCT02261857|Obstructive Sleep Apnea|obstructive sleep apnea
314817|NCT02261857|Craniofacial Abnormalities|craniofacial abnormalities
314818|NCT02261857|Pediatrics|pediatrics
314819|NCT02261857|Computer-Aided Design|computer-aided design
314820|NCT02261857|Continuous Positive Airway Pressure|continuous positive airway pressure
314821|NCT02261857|Three-Dimensional Printing|three-dimensional printing
314822|NCT02261857|Additive Manufacturing|additive manufacturing
314823|NCT02261844|Hepatocellular carcinoma|hepatocellular carcinoma
314824|NCT02261844|Metastatic colorectal cancer|metastatic colorectal cancer
314825|NCT02261844|Metabolism|metabolism
314826|NCT02261844|Hepatic function|hepatic function
314827|NCT02261831|bacterial|bacterial
314828|NCT02261831|gut|gut
314829|NCT02261831|type 2 diabetes.|type 2 diabetes.
314830|NCT02261831|16S rDNA gene|16s rdna gene
314831|NCT02261831|intestinal crypt|intestinal crypt
314832|NCT02261818|depression|depression
314833|NCT02261818|aging|aging
314834|NCT02261818|health services|health services
314835|NCT02261792|Postural headache treatment|postural headache treatment
314836|NCT02261792|Spontaneous intracranial hypotension|spontaneous intracranial hypotension
314837|NCT02261792|Epidural blood patch|epidural blood patch
314838|NCT02261792|Trendelenburg position|trendelenburg position
314839|NCT02261792|Head-Down Tilt|head-down tilt
314840|NCT02261792|Blood Patch, Epidural|blood patch, epidural
314841|NCT02261753|epilepsy surgery, outcome, ketogenic diet, ortical dysplasia|epilepsy surgery, outcome, ketogenic diet, ortical dysplasia
314842|NCT02261740|Pelvic Pain|pelvic pain
314843|NCT02261740|Genital Pain|genital pain
314844|NCT02261727|COPD|copd
314845|NCT02261727|Theophylline|theophylline
314846|NCT02261727|Oral corticosteroids|oral corticosteroids
314847|NCT02261727|COPD exacerbations|copd exacerbations
314848|NCT02261714|Pancreatic cancer, resected|pancreatic cancer, resected
314849|NCT02261714|Vaccine|vaccine
314850|NCT02261714|KRAS|kras
314851|NCT02261701|shoulder surgery|shoulder surgery
314852|NCT02261701|rotator cuff injury|rotator cuff injury
314853|NCT02261701|rehabilitation|rehabilitation
314854|NCT02261701|function|function
314855|NCT02261701|pain|pain
314856|NCT02261701|quality of life|quality of life
314857|NCT02261675|dexmedetomidine|dexmedetomidine
314858|NCT02261675|sevoflurane|sevoflurane
314859|NCT02261675|MAC bar|mac bar
314860|NCT02261675|drug interaction|drug interaction
314861|NCT02261675|anesthesia|anesthesia
314862|NCT02261649|Cerebellar tumor|cerebellar tumor
314863|NCT02261649|Non-malignant low-grade cerebellar astrocytomas|non-malignant low-grade cerebellar astrocytomas
314864|NCT02261610|PCT algorithm|pct algorithm
314865|NCT02261610|Antibiotic|antibiotic
314866|NCT02261610|Pulmonary embolism|pulmonary embolism
314867|NCT02261597|insomnia, inflammation, stress|insomnia, inflammation, stress
314868|NCT02261545|n-3 fatty acid|n-3 fatty acid
314869|NCT02261545|Sirt-1|sirt-1
314870|NCT02261545|AdipoR1|adipor1
314871|NCT02261545|AdipoR2|adipor2
314872|NCT02261545|MCP-1|mcp-1
314873|NCT02261545|Adiponectin|adiponectin
314874|NCT02261545|Resistin|resistin
314875|NCT02261545|T2DM|t2dm
314876|NCT02261506|Intensive care|intensive care
314877|NCT02261506|bacteremia|bacteremia
314878|NCT02261506|bloodstream infection|bloodstream infection
314879|NCT02261506|antimicrobial|antimicrobial
314880|NCT02261506|mortality|mortality
314881|NCT02261506|antimicrobial stewardship|antimicrobial stewardship
314882|NCT02261480|Parvovirus B19 Infection|parvovirus b19 infection
314883|NCT02261454|postoperative ileus|postoperative ileus
314884|NCT02261454|gum chewing|gum chewing
314885|NCT02261454|postoperative care|postoperative care
314886|NCT02261454|abdominal surgery|abdominal surgery
314887|NCT02261454|child|child
314888|NCT02261441|Cardiovascular disease|cardiovascular disease
314889|NCT02261441|Hypertension|hypertension
314890|NCT02261441|Diabetes|diabetes
314891|NCT02261441|Smoking|smoking
314892|NCT02261441|Hypercholesterolemia|hypercholesterolemia
314893|NCT02261441|Cardiovascular risk factor|cardiovascular risk factor
314894|NCT02261428|Nasotracheal suction, tracheal access|nasotracheal suction, tracheal access
314895|NCT02261415|blood transfusion|blood transfusion
314896|NCT02261415|blood loss|blood loss
314897|NCT02261415|feasibility|feasibility
314898|NCT02261415|outcome|outcome
314899|NCT02261415|liver resection|liver resection
314900|NCT02261402|Adherence|adherence
314901|NCT02261402|Morisky Medication Adherence Scale|morisky medication adherence scale
314902|NCT02261402|Beliefs about Medicines Questionnaire|beliefs about medicines questionnaire
314903|NCT02261402|Medication Possession Ratio|medication possession ratio
314904|NCT02261402|Medication-Related Problems|medication-related problems
314905|NCT02261402|Pharmacist|pharmacist
314906|NCT02261402|Pharmacist Intervention|pharmacist intervention
314907|NCT02261402|Pharmacy|pharmacy
314908|NCT02261402|Pharmacy Service|pharmacy service
314909|NCT02261402|Pharmacy Practice|pharmacy practice
314910|NCT02261402|Hypertension|hypertension
314911|NCT02261402|Antihypertensive Agents|antihypertensive agents
314912|NCT02261402|Anticoagulants|anticoagulants
314913|NCT02261402|Statins|statins
314914|NCT02261402|Dyslipidemia|dyslipidemia
314915|NCT02261389|breast cancer|breast cancer
314916|NCT02261389|follow-up|follow-up
314917|NCT02261389|tumor markers|tumor markers
314918|NCT02261376|pharmacokinetics|pharmacokinetics
314919|NCT02261337|Sarcopenia|sarcopenia
314920|NCT02261324|Percutaneous coronary intervention|percutaneous coronary intervention
314921|NCT02261311|Breast|breast
314922|NCT02261220|advanced solid tumors|advanced solid tumors
314923|NCT02261220|durvalumab|durvalumab
314924|NCT02261220|tremelimumab|tremelimumab
314925|NCT02261194|depression|depression
314926|NCT02261194|age-related macular degeneration|age-related macular degeneration
314927|NCT02261194|self-care|self-care
314928|NCT02261194|self-help|self-help
314929|NCT02261181|head neck cancer XONRID radiation induced dermatitis|head neck cancer xonrid radiation induced dermatitis
314930|NCT02261168|Circadian Rhythm|circadian rhythm
314931|NCT02261051|Palliative Care|palliative care
314932|NCT02261051|Hospice|hospice
314933|NCT02261051|End of Life|end of life
314934|NCT02261051|Health Service Utilization|health service utilization
314935|NCT02261051|Quality of Life|quality of life
314936|NCT02261038|total knee arthroplasty|total knee arthroplasty
314937|NCT02261038|total knee prothesis|total knee prothesis
314938|NCT02261038|X-Ray|x-ray
314939|NCT02261038|Kanekasu radiographs|kanekasu radiographs
314940|NCT02261038|femoral component rotation|femoral component rotation
314941|NCT02261038|effects|effects
314942|NCT02261025|aspirin|aspirin
314943|NCT02260908|Trauma|trauma
314944|NCT02260908|Thromboprophylaxis|thromboprophylaxis
314945|NCT02260908|Intracranial haemorrhage|intracranial haemorrhage
314946|NCT02260908|Deep vein thrombosis|deep vein thrombosis
314947|NCT02260856|RCT|rct
314948|NCT02260856|Epiphysiodesis|epiphysiodesis
314949|NCT02260856|Tantalum beads|tantalum beads
314950|NCT02260856|Patient centered outcome data|patient centered outcome data
314951|NCT02260856|Cost effective analysis|cost effective analysis
314952|NCT02260843|Insomnia|insomnia
314953|NCT02260843|Sleeping|sleeping
314954|NCT02260843|Quality|quality
314955|NCT02260817|Prostate Cancer|prostate cancer
314956|NCT02260817|11C Choline|11c choline
314957|NCT02260817|PET Imaging|pet imaging
314958|NCT02260791|Rheumatoid|rheumatoid
314959|NCT02260791|Arthritis|arthritis
314960|NCT02260778|Learning Collaborative|learning collaborative
314961|NCT02260778|Treat-to-Target|treat-to-target
314962|NCT02260778|Arthritis, Rheumatoid|arthritis, rheumatoid
314963|NCT02260765|Treatment as Usual = TAU|treatment as usual = tau
314964|NCT02260726|femoroacetabular impingement|femoroacetabular impingement
314965|NCT02260726|morphometry|morphometry
314966|NCT02260726|dynamic|dynamic
314967|NCT02260726|magnetic resonance imaging|magnetic resonance imaging
314968|NCT02260726|ultrasound|ultrasound
314969|NCT02260726|screening|screening
314970|NCT02260726|diagnosis|diagnosis
314971|NCT02260700|Healthy|healthy
314972|NCT02260700|Bioavailability|bioavailability
314973|NCT02260700|Alzheimer's Disease|alzheimer's disease
314974|NCT02260700|JNJ-54861911|jnj-54861911
314975|NCT02260687|Aflibercept|aflibercept
314976|NCT02260687|Anti-VEGF|anti-vegf
314977|NCT02260674|Alzheimer's Disease|alzheimer's disease
314978|NCT02260674|JNJ-54861911|jnj-54861911
314979|NCT02260674|Placebo|placebo
314980|NCT02260661|AZD8835|azd8835
314981|NCT02260661|Fulvestrant|fulvestrant
314982|NCT02260661|Breast Cancer|breast cancer
314983|NCT02260661|PIK3CA Gene Mutation|pik3ca gene mutation
314984|NCT02260622|Restenosis|restenosis
314985|NCT02260622|Critical Limb Ischemia|critical limb ischemia
314986|NCT02260622|Infrainguinal Percutaneous Transluminal Angioplasty|infrainguinal percutaneous transluminal angioplasty
314987|NCT02260622|Rivaroxaban|rivaroxaban
314988|NCT02260622|Clopidogrel|clopidogrel
314989|NCT02260609|Complex Wound|complex wound
314990|NCT02260609|Diabetic Foot Ulcer|diabetic foot ulcer
314991|NCT02260609|DFU|dfu
314992|NCT02260609|GrafixCORE|grafixcore
314993|NCT02260609|Exposed tendon|exposed tendon
314994|NCT02260609|Exposed bone|exposed bone
314995|NCT02260609|Allograft tissue|allograft tissue
314996|NCT02260570|concussion|concussion
314997|NCT02260570|traumatic brain injury|traumatic brain injury
314998|NCT02260570|MRI|mri
314999|NCT02260570|memory|memory
315000|NCT02260570|tolcapone|tolcapone
315001|NCT02260557|Systemic Sclerosis|systemic sclerosis
315002|NCT02260557|Raynaud's Phenomenon|raynaud's phenomenon
315003|NCT02260531|Metastatic breast cancer and brain metastases|metastatic breast cancer and brain metastases
315004|NCT02260531|HER-2 Positive Breast Cancer|her-2 positive breast cancer
315005|NCT02260531|ER-Positive PR-Positive HER-2 Negative Breast Cancer|er-positive pr-positive her-2 negative breast cancer
315006|NCT02260531|ER-Negative PR-Negative HER2-Negative Breast Cancer|er-negative pr-negative her2-negative breast cancer
315007|NCT02260518|Gestational weight gain|gestational weight gain
315008|NCT02260518|Lifestyle intervention|lifestyle intervention
315009|NCT02260518|Pregnancy|pregnancy
315010|NCT02260518|Postpartum|postpartum
315011|NCT02260518|Physical activity|physical activity
315012|NCT02260518|Nutrition|nutrition
315013|NCT02260505|Gastrointestinal Stromal Tumors|gastrointestinal stromal tumors
315014|NCT02260505|Non-metastatic|non-metastatic
315016|NCT02260505|Imatinib|imatinib
315017|NCT02260505|Adjuvant treatment|adjuvant treatment
315018|NCT02260505|High risk of recurrence|high risk of recurrence
315019|NCT02260505|Tyrosine kinase inhibitor|tyrosine kinase inhibitor
315020|NCT02260505|Disease Free Survival|disease free survival
315021|NCT02260505|Overall survival|overall survival
315022|NCT02260505|Time To Secondary Resistance|time to secondary resistance
315023|NCT02260505|Safety profile|safety profile
315024|NCT02260505|Quality of Life during treatment|quality of life during treatment
315025|NCT02260479|skin disinfection|skin disinfection
315026|NCT02260479|bacterial colonization|bacterial colonization
315027|NCT02260479|perioperative|perioperative
315028|NCT02260479|chlorehexidine|chlorehexidine
315029|NCT02260466|Amyloidosis|amyloidosis
315030|NCT02260466|echocardiography|echocardiography
315031|NCT02260466|magnetic resonance imaging|magnetic resonance imaging
315032|NCT02260466|radionuclide imaging|radionuclide imaging
315033|NCT02260427|elective surgery|elective surgery
315034|NCT02260427|undergoing general anesthesia|undergoing general anesthesia
315035|NCT02260427|elderly adult patients|elderly adult patients
315036|NCT02260414|Endogenous Thrombin Potential|endogenous thrombin potential
315037|NCT02260414|Lymphoma|lymphoma
315038|NCT02260414|Multiple Myeloma|multiple myeloma
315039|NCT02260414|tinzaparin|tinzaparin
315040|NCT02260414|thrombin generation|thrombin generation
315041|NCT02260414|Thromboplastin generation tests|thromboplastin generation tests
315042|NCT02260388|CSPN|cspn
315043|NCT02260388|neuropathy|neuropathy
315044|NCT02260388|pain|pain
315045|NCT02260388|pain management|pain management
315046|NCT02260375|Mesenchymal stromal cells; liver transplantation; tolerance.|mesenchymal stromal cells; liver transplantation; tolerance.
315047|NCT02260349|Prostatic Neoplasms|prostatic neoplasms
315048|NCT02260349|Prostate cancer|prostate cancer
315049|NCT02260349|surgical margins|surgical margins
315050|NCT02260349|indocyanine green|indocyanine green
315051|NCT02260349|characterization|characterization
315052|NCT02260349|prostatectomy|prostatectomy
315053|NCT02260349|peroperative|peroperative
315054|NCT02260349|detection|detection
315055|NCT02260297|Actigraphy|actigraphy
315056|NCT02260297|overweight and obese adults|overweight and obese adults
315057|NCT02260297|sleep disorders|sleep disorders
315058|NCT02260258|Cardiac Arrest, NMB, Neuromuscular Blockade, Rocuronium|cardiac arrest, nmb, neuromuscular blockade, rocuronium
315059|NCT02260219|Ahmed implant|ahmed implant
315060|NCT02260219|Neovascular Glaucoma|neovascular glaucoma
315061|NCT02260219|Intraocular pressure|intraocular pressure
315062|NCT02260206|Pericardial Effusion|pericardial effusion
315063|NCT02260206|Colchicine|colchicine
315064|NCT02260206|arrhythmia Recurrence|arrhythmia recurrence
315065|NCT02260206|pericardiocentesis|pericardiocentesis
315066|NCT02260193|anemia|anemia
315067|NCT02260193|end stage renal disease|end stage renal disease
315068|NCT02260193|chronic kidney disease|chronic kidney disease
315069|NCT02260193|CKD|ckd
315070|NCT02260193|dialysis|dialysis
315071|NCT02260193|chronic renal insufficiency|chronic renal insufficiency
315072|NCT02260193|renal impairment|renal impairment
315073|NCT02260193|erythropoietin|erythropoietin
315074|NCT02260193|kidney|kidney
315075|NCT02260193|oral anemia treatment|oral anemia treatment
315076|NCT02260193|hemoglobin|hemoglobin
315077|NCT02260193|hypoxia-inducible factor|hypoxia-inducible factor
315078|NCT02260193|HIF|hif
315079|NCT02260193|hypoxia-inducible factor propyl-hydroxylase inhibitor|hypoxia-inducible factor propyl-hydroxylase inhibitor
315080|NCT02260193|HIF-PHI|hif-phi
315081|NCT02260193|pharmacokinetics|pharmacokinetics
315082|NCT02260154|Duspatalin|duspatalin
315083|NCT02260154|mebeverine|mebeverine
315084|NCT02260154|cholecystectomy|cholecystectomy
315085|NCT02260154|gastrointestinal spasm|gastrointestinal spasm
315086|NCT02260154|abdominal pain|abdominal pain
315087|NCT02260154|dyspepsia|dyspepsia
315088|NCT02260154|antispasmodics|antispasmodics
315089|NCT02260128|postoperative ileus|postoperative ileus
315090|NCT02260128|chewing gum|chewing gum
315091|NCT02259712|Women|women
315092|NCT02259712|Pelvic floor disorders|pelvic floor disorders
315093|NCT02259712|Urinary incontinence|urinary incontinence
315094|NCT02259712|Fecal incontinence|fecal incontinence
315095|NCT02259712|Physical Therapy Modalities|physical therapy modalities
315096|NCT02259699|Ovarian Cancer|ovarian cancer
315097|NCT02259699|Intraperitoneal chemotherapy|intraperitoneal chemotherapy
315098|NCT02259699|Intravenous chemotherapy|intravenous chemotherapy
315099|NCT02259699|decision making|decision making
315100|NCT02259686|Apelin|apelin
315101|NCT02259686|volunteers|volunteers
315102|NCT02259660|obstructive sleep apnea|obstructive sleep apnea
315103|NCT02259660|osa|osa
315104|NCT02259660|breathing|breathing
315105|NCT02259660|snoring|snoring
315106|NCT02259660|respiratory|respiratory
315107|NCT02259660|exercise|exercise
315108|NCT02259660|inspiratory muscle strength training|inspiratory muscle strength training
315109|NCT02259660|expiratory muscle strength training|expiratory muscle strength training
315110|NCT02259634|Patient Navigation|patient navigation
315111|NCT02259634|Motivational Interviewing|motivational interviewing
315112|NCT02259634|Formerly Incarcerated|formerly incarcerated
315113|NCT02259634|Health Education|health education
315114|NCT02259634|Quality of Life|quality of life
315115|NCT02259634|Healthcare Utilization|healthcare utilization
315116|NCT02259608|Trained innate immunity|trained innate immunity
315117|NCT02259608|Heterologous effects of BCG on immunity|heterologous effects of bcg on immunity
315118|NCT02259595|Hearing Loss|hearing loss
315119|NCT02259595|Sensorineural Hearing Loss|sensorineural hearing loss
315120|NCT02259595|Noise-Induced Hearing Loss|noise-induced hearing loss
315121|NCT02259595|Antioxidant|antioxidant
315122|NCT02259595|NAC|nac
315123|NCT02259595|N-acetylcysteine|n-acetylcysteine
315124|NCT02259595|HPN-07|hpn-07
315125|NCT02259582|Phase 2|phase 2
315126|NCT02259582|histologically|histologically
315127|NCT02259582|confirmed|confirmed
315128|NCT02259582|malignancy|malignancy
315129|NCT02259582|metastatic|metastatic
315130|NCT02259582|pemetrexed|pemetrexed
315131|NCT02259582|carboplatin|carboplatin
315132|NCT02259582|carcinoma|carcinoma
315133|NCT02259582|non small cell lung|non small cell lung
315134|NCT02259582|lung neoplasms|lung neoplasms
315135|NCT02259582|lung diseases|lung diseases
315136|NCT02259569|Gastric insufflation|gastric insufflation
315137|NCT02259569|I-gel|i-gel
315138|NCT02259569|Peak airway pressure|peak airway pressure
315139|NCT02259569|Pressure-controlled ventilation|pressure-controlled ventilation
315140|NCT02259569|Volume-Controlled Ventilation|volume-controlled ventilation
315141|NCT02259569|pediatric patient|pediatric patient
315142|NCT02259543|gingival recession|gingival recession
315143|NCT02259543|soft tissue|soft tissue
315144|NCT02259543|root biomodification|root biomodification
315145|NCT02259543|root coverage|root coverage
315146|NCT02259543|citric acid|citric acid
315147|NCT02259543|tetracycline|tetracycline
315148|NCT02259517|ADHD|adhd
315149|NCT02259517|Intuniv|intuniv
315150|NCT02259517|Non-stimulant|non-stimulant
315151|NCT02259517|Guanfacine extended-release|guanfacine extended-release
315152|NCT02259517|Vyvanse|vyvanse
315153|NCT02259517|Stimulant|stimulant
315154|NCT02259517|Lisdexamfetamine|lisdexamfetamine
315155|NCT02259504|aneurysms|aneurysms
315156|NCT02259491|Wound Healing|wound healing
315157|NCT02259491|Honey|honey
315158|NCT02259491|Skin Grafts|skin grafts
315159|NCT02259491|Free tissue transfer|free tissue transfer
315160|NCT02259478|Intravenous Immunoglobulin (IVIG)|intravenous immunoglobulin (ivig)
315161|NCT02259478|Hemolysis|hemolysis
315162|NCT02259478|Transfusion Medicine|transfusion medicine
315163|NCT02259478|Pharmacovigilance|pharmacovigilance
315164|NCT02259465|microbiota|microbiota
315165|NCT02259465|FODMAP|fodmap
315166|NCT02259465|oligofructose|oligofructose
315167|NCT02259465|Magnetic Resonance Imaging|magnetic resonance imaging
315168|NCT02259465|Metabolomics|metabolomics
315169|NCT02259465|Diet|diet
315170|NCT02259452|Radiation Therapy|radiation therapy
315171|NCT02259413|Hemodialysis|hemodialysis
315172|NCT02259413|End-stage renal disease|end-stage renal disease
315173|NCT02259413|Exercise|exercise
315174|NCT02259413|Symptom Burden|symptom burden
315175|NCT02259400|NIV|niv
315176|NCT02259400|NSIPPV|nsippv
315177|NCT02259400|BiPAP|bipap
315178|NCT02259348|Hematological malignancies|hematological malignancies
315179|NCT02259348|Allogeneic hematopoietic cell transplant|allogeneic hematopoietic cell transplant
315180|NCT02259348|Refractory hematologic malignancy|refractory hematologic malignancy
315181|NCT02259348|Relapsed hematologic malignancy|relapsed hematologic malignancy
315182|NCT02259335|weaning from mechanical ventilation|weaning from mechanical ventilation
315183|NCT02259335|extracorporeal CO2 removal|extracorporeal co2 removal
315184|NCT02259335|post-extubation failure|post-extubation failure
315185|NCT02259322|Bariatric surgery|bariatric surgery
315186|NCT02259322|Weight loss surgery|weight loss surgery
315187|NCT02259322|Behavioral weight loss treatment|behavioral weight loss treatment
315188|NCT02259322|Cognitive behavioral therapy|cognitive behavioral therapy
315189|NCT02259322|Behavioral treatment|behavioral treatment
315190|NCT02259322|Obesity|obesity
315191|NCT02259322|Morbid obesity|morbid obesity
315192|NCT02259322|Binge eating|binge eating
315193|NCT02259322|Binge eating disorder|binge eating disorder
315297|NCT02258945|Food diary|food diary
315194|NCT02259322|Loss of control eating|loss of control eating
315195|NCT02259322|Overeating|overeating
315196|NCT02259309|misoprostol|misoprostol
315198|NCT02259309|cervical|cervical
315199|NCT02259309|immune|immune
315200|NCT02259309|buccal|buccal
315201|NCT02259309|vaginal|vaginal
315202|NCT02259283|achalasia|achalasia
315203|NCT02259283|per oral endoscopic myotoymy|per oral endoscopic myotoymy
315204|NCT02259283|endoscopy|endoscopy
315205|NCT02259270|Acid suppressive therapy|acid suppressive therapy
315206|NCT02259270|Appropriateness|appropriateness
315207|NCT02259270|Long term treatment|long term treatment
315208|NCT02259270|Risk factors|risk factors
315209|NCT02259270|Hospitalisation|hospitalisation
315210|NCT02259270|Non-critically ill|non-critically ill
315211|NCT02259270|Adult|adult
315212|NCT02259257|carotid arteriosclerosis|carotid arteriosclerosis
315213|NCT02259257|contrast-enhanced ultrasound|contrast-enhanced ultrasound
315214|NCT02259257|neovascularization|neovascularization
315215|NCT02259257|quantitative analysis|quantitative analysis
315216|NCT02259257|3D/4D imaging|3d/4d imaging
315217|NCT02259257|CEUS|ceus
315218|NCT02259257|Vasa vasorum|vasa vasorum
315219|NCT02259231|RTA 408|rta 408
315220|NCT02259231|RTA 408 Capsules|rta 408 capsules
315221|NCT02259231|Myeloid-derived suppressor cells (MDSDs)|myeloid-derived suppressor cells (mdsds)
315222|NCT02259231|iNOS|inos
315223|NCT02259231|Melanoma|melanoma
315224|NCT02259231|Checkpoint inhibitor|checkpoint inhibitor
315225|NCT02259231|omaveloxolone|omaveloxolone
315226|NCT02259218|Biomarker|biomarker
315227|NCT02259218|Radiation|radiation
315228|NCT02259205|platelet activating factor|platelet activating factor
315229|NCT02259205|inflammatory markers|inflammatory markers
315230|NCT02259205|yogurt|yogurt
315231|NCT02259205|olive oil|olive oil
315232|NCT02259205|platelet aggregation|platelet aggregation
315233|NCT02259205|oxidative stress|oxidative stress
315234|NCT02259205|endothelial damage|endothelial damage
315235|NCT02259205|bioactive lipids|bioactive lipids
315236|NCT02259192|deaf adult|deaf adult
315237|NCT02259192|single-sided|single-sided
315238|NCT02259192|cochlear implant|cochlear implant
315239|NCT02259179|Obesity|obesity
315240|NCT02259179|Overweight|overweight
315241|NCT02259179|Contrave|contrave
315242|NCT02259179|Antiobesity agents|antiobesity agents
315243|NCT02259179|Antiobesity drugs|antiobesity drugs
315244|NCT02259179|Weight loss drug|weight loss drug
315245|NCT02259179|Bioequivalence|bioequivalence
315246|NCT02259179|Pharmacokinetic|pharmacokinetic
315247|NCT02259153|Lipids|lipids
315248|NCT02259153|Non Cholesterol Sterols|non cholesterol sterols
315249|NCT02259153|Oxysterols|oxysterols
315250|NCT02259153|Cholesterol Metabolism|cholesterol metabolism
315251|NCT02259140|cerebral palsy|cerebral palsy
315252|NCT02259140|randomized controlled trial|randomized controlled trial
315253|NCT02259140|hip dislocation|hip dislocation
315254|NCT02259140|hip subluxation|hip subluxation
315255|NCT02259140|patient centered outcomes|patient centered outcomes
315256|NCT02259140|cost effectiveness analysis|cost effectiveness analysis
315257|NCT02259088|DME|dme
315258|NCT02259088|macular edema|macular edema
315259|NCT02259088|vision impairment|vision impairment
315260|NCT02259088|Chinese|chinese
315261|NCT02259088|diabetes|diabetes
315262|NCT02259075|Migraine with aura|migraine with aura
315263|NCT02259075|Migraine without aura|migraine without aura
315264|NCT02259075|Headache disorders|headache disorders
315265|NCT02259075|Botulinum Toxin Type A|botulinum toxin type a
315266|NCT02259075|Sphenopalatine Ganglion Block|sphenopalatine ganglion block
315267|NCT02259075|Autonomic Nerve Block|autonomic nerve block
315268|NCT02259036|child anxiety|child anxiety
315269|NCT02259036|worries|worries
315270|NCT02259036|fears|fears
315271|NCT02259036|talk therapy|talk therapy
315272|NCT02259023|Stress Perception|stress perception
315273|NCT02259023|Discretionary Calories|discretionary calories
315274|NCT02259023|Health|health
315275|NCT02258997|sickle cell disease|sickle cell disease
315276|NCT02258958|venous thromboembolism prophylaxis|venous thromboembolism prophylaxis
315277|NCT02258958|deep venous thrombosis|deep venous thrombosis
315278|NCT02258958|pulmonary embolus|pulmonary embolus
315279|NCT02258958|thoracic surgery|thoracic surgery
315280|NCT02258958|lung resection|lung resection
315281|NCT02258958|incidence|incidence
315282|NCT02258945|Type 1 diabetes|type 1 diabetes
315283|NCT02258945|CSII|csii
315284|NCT02258945|Continuous subcutaneous insulin infusion|continuous subcutaneous insulin infusion
315285|NCT02258945|Insulin pump|insulin pump
315286|NCT02258945|Nutrition|nutrition
315287|NCT02258945|Eating behaviours|eating behaviours
315288|NCT02258945|Quality of life|quality of life
315289|NCT02258945|Cardiometabolic risks|cardiometabolic risks
315290|NCT02258945|Liverpool|liverpool
315291|NCT02258945|NHS|nhs
315292|NCT02258945|Metabolomics|metabolomics
315293|NCT02258945|Observational|observational
315294|NCT02258945|Lipoproteins|lipoproteins
315295|NCT02258945|Lipids|lipids
315296|NCT02258945|Food|food
315298|NCT02258945|Cross-Sectional|cross-sectional
315299|NCT02258932|Type 1 diabetes|type 1 diabetes
315300|NCT02258932|CSII|csii
315301|NCT02258932|Continuous subcutaneous insulin infusion|continuous subcutaneous insulin infusion
315302|NCT02258932|Insulin pump|insulin pump
315303|NCT02258932|Nutrition|nutrition
315304|NCT02258932|Eating behaviours|eating behaviours
315305|NCT02258932|Quality of life|quality of life
315306|NCT02258932|Cardiometabolic risks|cardiometabolic risks
315307|NCT02258932|Liverpool|liverpool
315308|NCT02258932|NHS|nhs
315309|NCT02258932|Metabolomics|metabolomics
315310|NCT02258932|Observational|observational
315311|NCT02258932|Lipoproteins|lipoproteins
315312|NCT02258932|Lipids|lipids
315313|NCT02258932|Food|food
315314|NCT02258932|Food diary|food diary
315315|NCT02258932|Longitudinal|longitudinal
315316|NCT02258919|Intracerebral hemorrhage|intracerebral hemorrhage
315317|NCT02258919|Decompressive craniectomy|decompressive craniectomy
315318|NCT02258919|Randomized controlled trial|randomized controlled trial
315319|NCT02258919|Acute stroke|acute stroke
315320|NCT02258893|Nitrogen Dioxide|nitrogen dioxide
315321|NCT02258893|Parts per billion|parts per billion
315322|NCT02258880|Acute Stroke|acute stroke
315323|NCT02258880|Outcome Measures|outcome measures
315324|NCT02258880|Physical Performance|physical performance
315325|NCT02258867|Uveitis|uveitis
315326|NCT02258867|Behcet's Disease Uveitis|behcet's disease uveitis
315327|NCT02258867|Behcet's Disease|behcet's disease
315328|NCT02258854|Uveitis|uveitis
315329|NCT02258854|Non-infectious Uveitis|non-infectious uveitis
315330|NCT02258854|Intermediate Uveitis|intermediate uveitis
315331|NCT02258854|Posterior Uveitis|posterior uveitis
315332|NCT02258854|Panuveitis|panuveitis
315333|NCT02258854|Behçet's disease uveitis|behçet's disease uveitis
315334|NCT02258841|domestic violence|domestic violence
315335|NCT02258841|mental health|mental health
315336|NCT02258841|safety planning|safety planning
315337|NCT02258815|pediatric|pediatric
315338|NCT02258815|haploidentical|haploidentical
315339|NCT02258815|stem cell transplantation|stem cell transplantation
315340|NCT02258802|psychoeducational intervention|psychoeducational intervention
315341|NCT02258802|nutrition intervention|nutrition intervention
315342|NCT02258802|malnutrition|malnutrition
315343|NCT02258802|micronutrient deficiency|micronutrient deficiency
315344|NCT02258802|nutrition transition|nutrition transition
315345|NCT02258789|Stroke, rehabilitation, spatial neglect|stroke, rehabilitation, spatial neglect
315346|NCT02258763|Pneumonia|pneumonia
315347|NCT02258763|Child|child
315348|NCT02258763|Outcome|outcome
315349|NCT02258763|Antibiotics|antibiotics
315350|NCT02258763|Etiology|etiology
315351|NCT02258737|Case management|case management
315352|NCT02258737|psychiatric hospitalization|psychiatric hospitalization
315353|NCT02258737|discharge|discharge
315354|NCT02258724|Adult|adult
315355|NCT02258724|Registry|registry
315356|NCT02258724|Grown-up congenital heart disease|grown-up congenital heart disease
315357|NCT02258711|Bipolar disorder|bipolar disorder
315358|NCT02258711|Psychoeducation|psychoeducation
315359|NCT02258711|Smart-phone monitoring|smart-phone monitoring
315360|NCT02258685|Gut microbiota composition|gut microbiota composition
315361|NCT02258672|Preoperative rehabilitation|preoperative rehabilitation
315362|NCT02258672|Minimally invasive surgery|minimally invasive surgery
315363|NCT02258672|Functional capacity|functional capacity
315364|NCT02258646|Exercise|exercise
315365|NCT02258646|Rehabilitation|rehabilitation
315366|NCT02258646|Telemedicine|telemedicine
315367|NCT02258646|Treatment Outcome|treatment outcome
315368|NCT02258646|Costs and Cost Analysis|costs and cost analysis
315369|NCT02258646|Physical Therapists|physical therapists
315370|NCT02258646|Adaptation, Psychological|adaptation, psychological
315371|NCT02258568|Cigarette Smoking|cigarette smoking
315372|NCT02258568|Pregnancy|pregnancy
315373|NCT02258568|Postpartum smoking relapse|postpartum smoking relapse
315374|NCT02258568|Romania|romania
315375|NCT02258555|Chronic lymphocytic leukemia (CLL)|chronic lymphocytic leukemia (cll)
315376|NCT02258555|Follicular lymphoma (FL)|follicular lymphoma (fl)
315377|NCT02258555|Small Lymphocytic Lymphoma (SLL)|small lymphocytic lymphoma (sll)
315378|NCT02258555|Phosphatidylinositol 3 kinase (PI3K)|phosphatidylinositol 3 kinase (pi3k)
315379|NCT02258555|Marginal Zone Lymphoma (MZL)|marginal zone lymphoma (mzl)
400512|NCT01866527|Developmental dysplasia of the hip,|developmental dysplasia of the hip,
315380|NCT02258542|Asthma, Bronchial Diseases, Respiratory Tract Diseases, Lung Diseases, Obstructive Lung Diseases|asthma, bronchial diseases, respiratory tract diseases, lung diseases, obstructive lung diseases
315381|NCT02258529|Cancer|cancer
315382|NCT02258529|Indolent Non-Hodgkin Lymphoma|indolent non-hodgkin lymphoma
315383|NCT02258529|FL|fl
315384|NCT02258529|SLL|sll
315385|NCT02258503|Numerical scale|numerical scale
315386|NCT02258503|Pain in elderly patients admitted in emergency department|pain in elderly patients admitted in emergency department
315387|NCT02258490|chronic myeloid leukemia|chronic myeloid leukemia
315388|NCT02258490|myelodysplastic syndrome|myelodysplastic syndrome
315389|NCT02258490|acute myeloid leukemia|acute myeloid leukemia
315390|NCT02258490|CD34+ cell mobilization therapy|cd34+ cell mobilization therapy
315391|NCT02258490|graft versus host disease|graft versus host disease
315392|NCT02258490|allogeneic hematopoietic stem cell|allogeneic hematopoietic stem cell
315393|NCT02258490|G-CSF|g-csf
315394|NCT02258464|Breast Cancer|breast cancer
315395|NCT02258451|Breast Cancer|breast cancer
315396|NCT02258438|Sedentary Behavior|sedentary behavior
315397|NCT02258425|Homeless Women|homeless women
315398|NCT02258425|Parolees|parolees
315399|NCT02258425|Probationers|probationers
315400|NCT02258425|Community Drug Treatment|community drug treatment
315401|NCT02258425|Recidivism|recidivism
315402|NCT02258412|antimicrobial|antimicrobial
315403|NCT02258412|efficacy|efficacy
315404|NCT02258412|hand|hand
315405|NCT02258412|hygiene|hygiene
315406|NCT02258412|bacteria|bacteria
315407|NCT02258373|Diabetes Mellitus|diabetes mellitus
315408|NCT02258373|Continuous Glucose Monitoring|continuous glucose monitoring
315409|NCT02258360|Thromboelastometry|thromboelastometry
315410|NCT02258360|Haemostasis|haemostasis
315411|NCT02258360|Hypothermia|hypothermia
315412|NCT02258360|Heart Arrest|heart arrest
315413|NCT02258334|Influenza|influenza
315414|NCT02258334|Fluzone® Quadrivalent, Influenza Vaccine|fluzone® quadrivalent, influenza vaccine
315415|NCT02258334|Fluzone® Intradermal, Influenza Vaccine|fluzone® intradermal, influenza vaccine
315416|NCT02258334|Fluzone® High-Dose, Influenza Vaccine|fluzone® high-dose, influenza vaccine
315417|NCT02258295|Lateral Humeral Epicondylitis|lateral humeral epicondylitis
315418|NCT02258295|Tendinitis|tendinitis
315419|NCT02258295|Tendinosis|tendinosis
315420|NCT02258295|Athletic Injuries|athletic injuries
315421|NCT02258295|Elbow Joint|elbow joint
315422|NCT02258295|Sports Medicine|sports medicine
315423|NCT02258204|Cerebral Infarct|cerebral infarct
315424|NCT02258204|Thrombolysis|thrombolysis
315425|NCT02258204|Tissue-type plasminogen activator|tissue-type plasminogen activator
315426|NCT02258204|Neuroprotection|neuroprotection
315427|NCT02258204|Anesthetic agent|anesthetic agent
315428|NCT02258204|Magnetic resonance imaging|magnetic resonance imaging
315429|NCT02258191|NIV|niv
315430|NCT02258191|COPD|copd
315431|NCT02258191|telemonitoring|telemonitoring
315432|NCT02258165|ovarian cancer|ovarian cancer
315433|NCT02258165|imaging|imaging
315434|NCT02258165|gated PET/CT scan|gated pet/ct scan
315435|NCT02258152|PDD|pdd
315436|NCT02258152|Parkinson's Disease Dementia|parkinson's disease dementia
315437|NCT02258152|patients taking a cholinesterase inhibitor.|patients taking a cholinesterase inhibitor.
315438|NCT02258126|overweight children|overweight children
315439|NCT02258126|hepatic fat|hepatic fat
315440|NCT02258126|exercise|exercise
315441|NCT02258126|nutritional education program|nutritional education program
315442|NCT02258126|cardiometabolic risk|cardiometabolic risk
315443|NCT02258087|Prostate, Cancer, Brachytherapy, HDR, LDR, monotherapy|prostate, cancer, brachytherapy, hdr, ldr, monotherapy
315444|NCT02258048|Cirrhosis|cirrhosis
315445|NCT02258035|vitamin D binding protein (DBP)|vitamin d binding protein (dbp)
315446|NCT02257996|Psychoanalytic Psychotherapy|psychoanalytic psychotherapy
315447|NCT02257996|Telepsychology|telepsychology
315448|NCT02257996|Online Therapy|online therapy
315449|NCT02257996|Web conferencing|web conferencing
315450|NCT02257996|RCT|rct
315451|NCT02257996|HIPAA|hipaa
315452|NCT02257983|hearing|hearing
315453|NCT02257983|noise|noise
315454|NCT02257983|oxidative stress|oxidative stress
315455|NCT02257970|Lymphedema|lymphedema
315456|NCT02257970|edema|edema
315457|NCT02257970|swelling|swelling
315458|NCT02257931|infection|infection
315459|NCT02257931|bacteria|bacteria
315460|NCT02257931|gram-negative|gram-negative
315461|NCT02257931|HSCT|hsct
315462|NCT02257931|allogeneic|allogeneic
315463|NCT02257931|autologous|autologous
315464|NCT02257931|recipients, of all ages, for any indications|recipients, of all ages, for any indications
315465|NCT02257918|antibiotic|antibiotic
315466|NCT02257918|antimicrobial|antimicrobial
315467|NCT02257918|AZD0914|azd0914
315468|NCT02257918|Ceftriaxone|ceftriaxone
315469|NCT02257918|drug-resistant|drug-resistant
315470|NCT02257918|sexually transmitted infection|sexually transmitted infection
315471|NCT02257918|urogenital gonorrhoea|urogenital gonorrhoea
315472|NCT02257905|AL Amyloidosis|al amyloidosis
315473|NCT02257905|Amyloidosis|amyloidosis
315474|NCT02257905|allogeneic|allogeneic
315475|NCT02257905|HSCT|hsct
315476|NCT02257892|CTLA4|ctla4
315477|NCT02257892|PI3KCD|pi3kcd
315478|NCT02257892|MAG T1|mag t1
315479|NCT02257892|Rare Immune Disorders|rare immune disorders
315480|NCT02257892|Genetic Testing|genetic testing
315481|NCT02257879|Midazolam|midazolam
315482|NCT02257879|CYP3A|cyp3a
315483|NCT02257879|Loperamide|loperamide
315484|NCT02257866|Autoimmunity|autoimmunity
315485|NCT02257866|Adult and Pediatric Disease|adult and pediatric disease
315486|NCT02257866|Vasculitis|vasculitis
315487|NCT02257866|Rheumatic Disease|rheumatic disease
315488|NCT02257866|Polyarteritis Nodosa|polyarteritis nodosa
315489|NCT02257866|Takayasu's Arthritis|takayasu's arthritis
315490|NCT02257866|Giant Cell Arthritis|giant cell arthritis
315491|NCT02257866|Relapsing Polychondritis|relapsing polychondritis
315492|NCT02257866|Antineutrophil Cytoplasmic Antibodies|antineutrophil cytoplasmic antibodies
315493|NCT02257853|Caregiver Stress|caregiver stress
315494|NCT02257853|Cancer Caregivers|cancer caregivers
315495|NCT02257853|Yoga-Based Stress Reduction Intervention|yoga-based stress reduction intervention
315496|NCT02257853|HSCT Caregivers|hsct caregivers
315497|NCT02257827|Hypofractionated schedule|hypofractionated schedule
315498|NCT02257827|Intensity Modulated Radiotherapy|intensity modulated radiotherapy
315499|NCT02257827|Conformal radiotherapy|conformal radiotherapy
315501|NCT02257801|Cognition|cognition
315502|NCT02257801|Execute Function|execute function
315503|NCT02257801|Attention|attention
315504|NCT02257801|Mood|mood
315505|NCT02257762|Ready-to-use supplementary food (RUSF)|ready-to-use supplementary food (rusf)
315506|NCT02257762|Lipid-based nutrient supplement (LNS)|lipid-based nutrient supplement (lns)
315507|NCT02257762|Multiple micronutrients (MMN)|multiple micronutrients (mmn)
315508|NCT02257762|Complementary feeding|complementary feeding
315509|NCT02257762|Home fortification|home fortification
315510|NCT02257762|Efficacy/impact|efficacy/impact
315511|NCT02257762|Infant and young child feeding (IYCF)|infant and young child feeding (iycf)
315512|NCT02257762|Cambodia|cambodia
315513|NCT02257762|Cluster randomised controlled trial|cluster randomised controlled trial
315514|NCT02257749|Concussion|concussion
315515|NCT02257749|Persistent Symptoms|persistent symptoms
315516|NCT02257749|Children|children
315517|NCT02257749|Exercise|exercise
315518|NCT02257749|Adolescents|adolescents
315519|NCT02257749|Active Rehabilitation|active rehabilitation
315520|NCT02257749|Education|education
315521|NCT02257736|Prostatic neoplasms|prostatic neoplasms
315522|NCT02257736|JN56021927|jn56021927
315523|NCT02257736|ZYTIGA|zytiga
315524|NCT02257736|Prednisone|prednisone
315525|NCT02257736|Abiraterone acetate|abiraterone acetate
315526|NCT02257736|Apalutamide|apalutamide
315527|NCT02257723|Inpatient care|inpatient care
315528|NCT02257723|Complementary and alternative medicine|complementary and alternative medicine
315529|NCT02257723|Integrated medicine|integrated medicine
315530|NCT02257710|national|national
315531|NCT02257710|Multicenter|multicenter
315532|NCT02257710|Observational registry|observational registry
315533|NCT02257710|Orsiro Drug Eluting Stent (DES)|orsiro drug eluting stent (des)
315534|NCT02257710|Stenting|stenting
315535|NCT02257710|Treatment of coronary artery disease|treatment of coronary artery disease
315536|NCT02257710|Coronary revascularization|coronary revascularization
315537|NCT02257710|Coronary Intervention|coronary intervention
315538|NCT02257710|STEMI|stemi
315539|NCT02257710|NSTEMI|nstemi
315540|NCT02257710|Ischemia|ischemia
315541|NCT02257710|Angina|angina
315542|NCT02257710|Acute Myocardial Infarction (AMI)|acute myocardial infarction (ami)
315543|NCT02257710|Small Vessels|small vessels
315544|NCT02257710|Chronic Total Occlusion|chronic total occlusion
315545|NCT02257684|ALL|all
315546|NCT02257684|LBL|lbl
315547|NCT02257658|Men who have Sex with Men|men who have sex with men
315548|NCT02257658|HIV-positive|hiv-positive
315549|NCT02257658|Syphilis|syphilis
315550|NCT02257658|Contingency Management|contingency management
315551|NCT02257619|Stage IIIb, IV, or Recurrent Non-Small Cell Lung Cancer|stage iiib, iv, or recurrent non-small cell lung cancer
315552|NCT02257593|macronutrient|macronutrient
315553|NCT02257593|malnutrition|malnutrition
315554|NCT02257593|birth weight|birth weight
315555|NCT02257593|protein leverage|protein leverage
315556|NCT02257580|E-Aminocaproic Acid|e-aminocaproic acid
315557|NCT02257580|Bilateral Varus Rotational Osteotomy|bilateral varus rotational osteotomy
315558|NCT02257580|Blood Loss and Transfusion|blood loss and transfusion
315559|NCT02257580|Complications|complications
315560|NCT02257580|Safety|safety
315561|NCT02257554|expectations|expectations
315562|NCT02257541|BGJ398|bgj398
315563|NCT02257541|Imatinib Mesylate|imatinib mesylate
315564|NCT02257541|14-140|14-140
315565|NCT02257502|aflibercept|aflibercept
315566|NCT02257502|iodiopathic choroidal neovascularization|iodiopathic choroidal neovascularization
315567|NCT02257502|young patient|young patient
315568|NCT02257476|carfilzomib|carfilzomib
315569|NCT02257476|advanced solid malignancies|advanced solid malignancies
315570|NCT02257476|advanced solid cancers|advanced solid cancers
315571|NCT02257476|prostate|prostate
315572|NCT02257476|bladder|bladder
315573|NCT02257476|colon|colon
315574|NCT02257476|breast|breast
315575|NCT02257476|lung|lung
315576|NCT02257463|COPD|copd
315577|NCT02257463|inspiratory muscle training|inspiratory muscle training
315578|NCT02257463|dyspnea|dyspnea
315579|NCT02257463|Quality of Life|quality of life
315580|NCT02257450|Primary Aldosteronism|primary aldosteronism
315581|NCT02257450|Hyperaldosteronism|hyperaldosteronism
315582|NCT02257437|Ready-to-use supplementary food (RUSF)|ready-to-use supplementary food (rusf)
315583|NCT02257437|Lipid-based nutrient supplement (LNS)|lipid-based nutrient supplement (lns)
315584|NCT02257437|Multiple micronutrients (MMN)|multiple micronutrients (mmn)
315585|NCT02257437|Complementary feeding|complementary feeding
315586|NCT02257437|Home fortification|home fortification
315587|NCT02257437|Acceptability|acceptability
315588|NCT02257437|Infant and young child feeding (IYCF)|infant and young child feeding (iycf)
315589|NCT02257437|Cambodia|cambodia
315590|NCT02257437|Cross-over studies|cross-over studies
315591|NCT02257411|child|child
315592|NCT02257411|ear based|ear based
315593|NCT02257411|Proseal LMA|proseal lma
315594|NCT02257398|TQTc|tqtc
315595|NCT02257398|Moxifloxacin|moxifloxacin
315596|NCT02257398|GSK2140944|gsk2140944
315597|NCT02257385|indacaterol|indacaterol
315598|NCT02257385|efficacy|efficacy
315599|NCT02257385|FEV1|fev1
315600|NCT02257385|ELLIPTA|ellipta
315601|NCT02257385|non inferiority|non inferiority
315602|NCT02257385|vilanterol|vilanterol
315603|NCT02257385|COPD|copd
315604|NCT02257385|safety|safety
315605|NCT02257385|tiotropium|tiotropium
315606|NCT02257385|umeclidinium bromide|umeclidinium bromide
315607|NCT02257385|GSK573719|gsk573719
315608|NCT02257372|FEV1|fev1
315609|NCT02257372|DPI|dpi
315610|NCT02257372|ICS/LABA|ics/laba
315611|NCT02257372|UMEC|umec
315612|NCT02257372|COPD|copd
315613|NCT02257359|Epelsiban|epelsiban
315614|NCT02257359|Healthy Female Volunteers|healthy female volunteers
315615|NCT02257359|Safety|safety
315616|NCT02257359|Tolerability|tolerability
315617|NCT02257359|Oxytocin|oxytocin
315618|NCT02257359|Pharmacokinetics|pharmacokinetics
315619|NCT02257346|Pregnancy|pregnancy
315620|NCT02257346|Lidocaine|lidocaine
315621|NCT02257346|Quality|quality
315622|NCT02257346|Recovery|recovery
315623|NCT02257333|Retinal Vein Occlusion|retinal vein occlusion
315624|NCT02257333|Atherosclerosis|atherosclerosis
315625|NCT02257333|Risk Factors|risk factors
315626|NCT02257333|Major Adverse Cardiovascular Events|major adverse cardiovascular events
315627|NCT02257307|ROP|rop
315628|NCT02257307|retinopathy|retinopathy
315629|NCT02257307|Referral warranted retinopathy|referral warranted retinopathy
315630|NCT02257281|Sodium lauryl sulfate|sodium lauryl sulfate
315631|NCT02257281|Skin irritants|skin irritants
315632|NCT02257281|inflammation|inflammation
315633|NCT02257281|therapeutic ultrasound|therapeutic ultrasound
315634|NCT02257268|health behavior; risk factors;|health behavior; risk factors;
315635|NCT02257255|cesarean section|cesarean section
315636|NCT02257255|pain, postoperative/diagnosis|pain, postoperative/diagnosis
315637|NCT02257255|pain measurement/methods|pain measurement/methods
315638|NCT02257242|Bendamustine|bendamustine
315639|NCT02257242|Rituximab|rituximab
315640|NCT02257242|Vincristine sulfate|vincristine sulfate
315641|NCT02257242|Vincristine sulfate liposome injection|vincristine sulfate liposome injection
315642|NCT02257242|Phase I|phase i
315643|NCT02257242|Escalation With Overdose Control|escalation with overdose control
315644|NCT02257229|Clubfoot, deformity, correction, management, gait|clubfoot, deformity, correction, management, gait
315645|NCT02257203|Dietary sucrose|dietary sucrose
315646|NCT02257190|Glycemic control|glycemic control
315647|NCT02257190|Exercise|exercise
315648|NCT02257164|anterior cruciate ligament reconstruction|anterior cruciate ligament reconstruction
315649|NCT02257164|femoral nerve block|femoral nerve block
315650|NCT02257164|articular injection and obturator nerve block|articular injection and obturator nerve block
315651|NCT02257151|Volunteers|volunteers
315652|NCT02257125|rehabilitation|rehabilitation
315653|NCT02257125|virtual reality|virtual reality
315654|NCT02257125|stroke|stroke
315655|NCT02257125|upper extremity|upper extremity
315656|NCT02257125|arm|arm
315657|NCT02257125|feedback|feedback
315658|NCT02257125|reward|reward
315659|NCT02257060|Endocardial Ablation|endocardial ablation
315660|NCT02257060|Atrial Flutter|atrial flutter
315661|NCT02257060|Cavotricuspid Isthmus|cavotricuspid isthmus
315662|NCT02256995|Pregnancy|pregnancy
315663|NCT02256995|Preeclampsia|preeclampsia
315664|NCT02256995|Eclampsia|eclampsia
315665|NCT02256995|Proteinuria|proteinuria
315666|NCT02256982|unresectable intrahepatic cholangiocarcinoma|unresectable intrahepatic cholangiocarcinoma
315667|NCT02256982|resectable intrahepatic cholangiocarcinoma|resectable intrahepatic cholangiocarcinoma
315668|NCT02256956|Pharmacogenetics of Amitriptyline|pharmacogenetics of amitriptyline
315669|NCT02256943|Pharmacogenetics of Amitriptyline|pharmacogenetics of amitriptyline
315670|NCT02256904|Alignment|alignment
315671|NCT02256904|Kinematic|kinematic
403317|NCT01854554|QOL|qol
315672|NCT02256904|knee|knee
315673|NCT02256904|satisfaction|satisfaction
315674|NCT02256904|function|function
315675|NCT02256904|survivorship|survivorship
315676|NCT02256891|Rotator cuff tear|rotator cuff tear
315677|NCT02256891|Rotator cuff injury|rotator cuff injury
315678|NCT02256891|Shoulder pain|shoulder pain
315679|NCT02256891|Shoulder injury|shoulder injury
315680|NCT02256865|Sleep Restriction|sleep restriction
315681|NCT02256865|Insulin Resistance|insulin resistance
315682|NCT02256865|Testosterone|testosterone
315683|NCT02256865|Cortisol|cortisol
315684|NCT02256839|Tuberculosis|tuberculosis
315685|NCT02256839|TB|tb
315686|NCT02256683|atrial fibrillation|atrial fibrillation
315687|NCT02256683|atrial flutter|atrial flutter
315688|NCT02256683|Atrial-Appendage Thrombus|atrial-appendage thrombus
315689|NCT02256683|Thrombus resolution|thrombus resolution
315690|NCT02256683|Dabigatran|dabigatran
315691|NCT02256683|Phenprocoumon|phenprocoumon
315692|NCT02256683|Transesophageal Echocardiography|transesophageal echocardiography
315693|NCT02256670|Hormone Receptor Positive|hormone receptor positive
315694|NCT02256618|neonatal encephalopathy|neonatal encephalopathy
315695|NCT02256618|hypoxic-ischemic encephalopathy|hypoxic-ischemic encephalopathy
315696|NCT02256618|newborn infants|newborn infants
315697|NCT02256618|neonates|neonates
315698|NCT02256618|umbilical cord blood cells|umbilical cord blood cells
315699|NCT02256592|inflammation|inflammation
315700|NCT02256592|microbiome|microbiome
315701|NCT02256592|immune activation|immune activation
315702|NCT02256592|fecal microbiota transplantation|fecal microbiota transplantation
315703|NCT02256592|dysbiosis|dysbiosis
315704|NCT02256579|TDF:Tenofovir, Urine beta2microglobulin|tdf:tenofovir, urine beta2microglobulin
315705|NCT02256566|cognitive training|cognitive training
315706|NCT02256566|depression|depression
315707|NCT02256566|bipolar depression|bipolar depression
315708|NCT02256566|anxiety|anxiety
315709|NCT02256566|ptsd|ptsd
315710|NCT02256566|generalized anxiety|generalized anxiety
315711|NCT02256566|social phobia|social phobia
315712|NCT02256514|therapeutic vaccine|therapeutic vaccine
315713|NCT02256501|Dilated cardiomyopathy pediatric heart failure cell therapy|dilated cardiomyopathy pediatric heart failure cell therapy
315714|NCT02256449|Coronary artery disease; angioplasty; bioresorbable device|coronary artery disease; angioplasty; bioresorbable device
315715|NCT02256436|P-D1|p-d1
315716|NCT02256436|PD-1|pd-1
315717|NCT02256436|PD1|pd1
315718|NCT02256436|P-DL1|p-dl1
315719|NCT02256436|PD-L1|pd-l1
315720|NCT02256436|PDL-1|pdl-1
315721|NCT02256436|PDL1|pdl1
315722|NCT02256436|Bladder cancer|bladder cancer
315723|NCT02256423|Ibuprofen|ibuprofen
315724|NCT02256423|healthy volunteer study|healthy volunteer study
315725|NCT02256423|pharmacokinetics|pharmacokinetics
315726|NCT02256410|low back pain|low back pain
315727|NCT02256410|chronic pain|chronic pain
315728|NCT02256410|sensitization|sensitization
315729|NCT02256410|treatment|treatment
315730|NCT02256410|trigger points|trigger points
315731|NCT02256397|Asthma|asthma
315732|NCT02256384|Respiration Rate|respiration rate
315733|NCT02256384|Respiratory Acoustic Monitor|respiratory acoustic monitor
315734|NCT02256384|postoperative|postoperative
315735|NCT02256371|Neuropathic pain|neuropathic pain
315736|NCT02256371|Hypnosis|hypnosis
315737|NCT02256371|Relaxation|relaxation
315738|NCT02256358|child, ketamine, midazolam|child, ketamine, midazolam
315739|NCT02256319|Deep brain stimulation|deep brain stimulation
315740|NCT02256319|Dexmedetomidine|dexmedetomidine
315741|NCT02256319|Propofol|propofol
315742|NCT02256293|Type 1 Diabetes|type 1 diabetes
315743|NCT02256280|Neuromuscular blockade|neuromuscular blockade
315744|NCT02256280|Thoracic surgery|thoracic surgery
315745|NCT02256254|Oxidative stress|oxidative stress
315746|NCT02256254|Simvastatin|simvastatin
315747|NCT02256228|Analgesia|analgesia
315748|NCT02256228|Local infiltration analgesia|local infiltration analgesia
315749|NCT02256228|Pain, relief|pain, relief
315750|NCT02256228|Pain, Postoperative|pain, postoperative
315751|NCT02256228|Intra-peritoneal analgesia|intra-peritoneal analgesia
315752|NCT02256228|Ropivacaine|ropivacaine
315753|NCT02256228|Saline|saline
315754|NCT02256228|Therapeutic Uses|therapeutic uses
315755|NCT02256228|Analgesics, Non-Narcotic|analgesics, non-narcotic
315756|NCT02256228|Analgesics|analgesics
315757|NCT02256228|Opioids|opioids
315758|NCT02256228|Morphine|morphine
315759|NCT02256228|Pain|pain
315760|NCT02256228|Postoperative Complications|postoperative complications
315761|NCT02256228|Physiological Effects of Drugs|physiological effects of drugs
315762|NCT02256228|Anesthetics, Local|anesthetics, local
315763|NCT02256228|Anesthetic|anesthetic
315764|NCT02256228|Cytoreductive|cytoreductive
315765|NCT02256228|Surgery|surgery
315766|NCT02256228|Cancer|cancer
315767|NCT02256215|Vitamin D|vitamin d
315768|NCT02256163|Thoracic Aortic Aneurysm (TAA)|thoracic aortic aneurysm (taa)
315769|NCT02256163|gene|gene
315770|NCT02256163|familial TAA|familial taa
315771|NCT02256163|blood collection|blood collection
315772|NCT02256137|Frailty phenotype|frailty phenotype
315773|NCT02256137|Physical fitness|physical fitness
315774|NCT02256137|Childhood cancer|childhood cancer
315775|NCT02256137|Late onset of chronic health conditions|late onset of chronic health conditions
315776|NCT02256137|Physical frailty|physical frailty
315777|NCT02256124|Neurofibromatosis type 1|neurofibromatosis type 1
315778|NCT02256124|NF1|nf1
315779|NCT02256124|Cognition|cognition
315780|NCT02256124|Learning problems|learning problems
315781|NCT02256124|Lamotrigine|lamotrigine
315782|NCT02256124|Transcranial magnetic stimulation|transcranial magnetic stimulation
315783|NCT02256124|TMS|tms
315784|NCT02256098|Comparative Study|comparative study
315785|NCT02256098|Knee Prosthesis|knee prosthesis
315786|NCT02256098|Prosthesis Design|prosthesis design
315787|NCT02256098|Treatment Outcome|treatment outcome
315788|NCT02256098|Follow-Up Studies|follow-up studies
315789|NCT02256098|Arthroplasty, Replacement, Knee/methods|arthroplasty, replacement, knee/methods
315790|NCT02256085|Dissociative|dissociative
315791|NCT02256085|Dissociation|dissociation
315792|NCT02256085|Depersonalization|depersonalization
315793|NCT02256085|Depersonalization Disorder|depersonalization disorder
315794|NCT02256085|Transcranial Magnetic Stimulation|transcranial magnetic stimulation
315796|NCT02256085|DPD|dpd
315797|NCT02256085|rTMS|rtms
315798|NCT02256085|Behavioral Symptoms|behavioral symptoms
315799|NCT02256072|aging, geriatrics, aging in place, home services|aging, geriatrics, aging in place, home services
315800|NCT02256033|Mild hepatic impairment|mild hepatic impairment
315801|NCT02256033|Healthy volunteer|healthy volunteer
315802|NCT02256033|Istradefylline|istradefylline
315803|NCT02256020|Wheel-chair dependent, music aerobic exercise, depression, insomnia|wheel-chair dependent, music aerobic exercise, depression, insomnia
315804|NCT02256007|Videogames; stroke|videogames; stroke
315805|NCT02255981|macular, degeneration, acupuncture, visual acuity, OCT|macular, degeneration, acupuncture, visual acuity, oct
315806|NCT02255968|Normal Volunteers|normal volunteers
315807|NCT02255968|Safety|safety
315808|NCT02255968|Pharmacokinetics|pharmacokinetics
315809|NCT02255955|naproxen sodium codeine|naproxen sodium codeine
315810|NCT02255955|paracetamol codeine|paracetamol codeine
315811|NCT02255955|disk surgery|disk surgery
315812|NCT02255929|Benign Essential Tremor|benign essential tremor
315813|NCT02255929|Tremor|tremor
315814|NCT02255929|Neurologic Manifestations|neurologic manifestations
315815|NCT02255929|Nervous System Diseases|nervous system diseases
315816|NCT02255929|Movement Disorders|movement disorders
315817|NCT02255929|Central Nervous System Diseases|central nervous system diseases
315818|NCT02255916|oncology|oncology
315819|NCT02255916|psychology|psychology
315820|NCT02255916|cancer|cancer
315821|NCT02255916|music|music
315822|NCT02255916|sound-bed|sound-bed
315823|NCT02255877|Bi lateral knee surgery|bi lateral knee surgery
315824|NCT02255877|uni compartmental|uni compartmental
315825|NCT02255864|Stents|stents
315826|NCT02255864|Angioplasty|angioplasty
315827|NCT02255864|Coronary Vessels|coronary vessels
315828|NCT02255864|Coronary Artery Disease|coronary artery disease
315829|NCT02255864|Angina Pectoris|angina pectoris
315830|NCT02255864|Myocardial Ischemia|myocardial ischemia
315831|NCT02255864|Myocardial Infarction|myocardial infarction
315832|NCT02255864|Myocardial Revascularization|myocardial revascularization
315833|NCT02255851|selected for TAVR by heart team consensus|selected for tavr by heart team consensus
315834|NCT02255851|treated with CE-Marked TAVR devices|treated with ce-marked tavr devices
315835|NCT02255799|traumatic brain injury|traumatic brain injury
315836|NCT02255799|TBI|tbi
315837|NCT02255799|brain injury|brain injury
315838|NCT02255799|memory|memory
315839|NCT02255799|verbal memory deficits|verbal memory deficits
315840|NCT02255799|memory problems|memory problems
315841|NCT02255799|cognition|cognition
315842|NCT02255799|cognitive impairment|cognitive impairment
315843|NCT02255799|neuropsychiatric symptoms|neuropsychiatric symptoms
315844|NCT02255799|donepezil|donepezil
315845|NCT02255799|acetylcholinesterase inhibitor|acetylcholinesterase inhibitor
315846|NCT02255786|Group Therapy|group therapy
315847|NCT02255786|Parents|parents
315848|NCT02255786|Autism|autism
315849|NCT02255786|Quality of Life|quality of life
315850|NCT02255773|Head and Neck Cancer|head and neck cancer
315851|NCT02255773|HNC|hnc
315852|NCT02255773|Moderate to severe fatigue|moderate to severe fatigue
315853|NCT02255773|Computerized tasks|computerized tasks
315854|NCT02255773|Questionnaires|questionnaires
315855|NCT02255773|Surveys|surveys
315856|NCT02255773|Disease-free adult males|disease-free adult males
315857|NCT02255773|Cancer survivors|cancer survivors
315858|NCT02255760|MEDI3902|medi3902
315859|NCT02255760|Safety,|safety,
315860|NCT02255760|Pharmacokinetics,|pharmacokinetics,
315861|NCT02255760|Healthy Volunteers|healthy volunteers
315862|NCT02255747|infants and children with constipation|infants and children with constipation
315863|NCT02255734|Volunteers|volunteers
315864|NCT02255695|posture|posture
315865|NCT02255695|child|child
315866|NCT02255695|prevention|prevention
315867|NCT02255695|muscle strength|muscle strength
315868|NCT02255695|muscle stretching exercises|muscle stretching exercises
315869|NCT02255695|exercise therapy|exercise therapy
315870|NCT02255695|disease management|disease management
315871|NCT02255695|musculoskeletal pain|musculoskeletal pain
315872|NCT02255695|adolescent|adolescent
315873|NCT02255695|spinal curvatures|spinal curvatures
315874|NCT02255682|physical activity|physical activity
315875|NCT02255682|statin therapy|statin therapy
315876|NCT02255682|diabetes mellitus|diabetes mellitus
315877|NCT02255682|cardiovascular disease|cardiovascular disease
315878|NCT02255682|Q10-supplementation|q10-supplementation
315879|NCT02255643|motor cortex stimulation|motor cortex stimulation
315880|NCT02255643|chronic neuropathic pain|chronic neuropathic pain
315881|NCT02255630|salbutamol|salbutamol
315882|NCT02255630|exercise-induced bronchoconstriction|exercise-induced bronchoconstriction
315883|NCT02255630|anaerobic power|anaerobic power
315884|NCT02255604|Allergic Rhinitis|allergic rhinitis
315885|NCT02255604|Allergen immunotherapy|allergen immunotherapy
315886|NCT02255591|Hip surgery anesthesia|hip surgery anesthesia
315887|NCT02255591|Perioperative analgesia|perioperative analgesia
315888|NCT02255565|Quillivant|quillivant
315889|NCT02255552|DMD, Duchenne, Eteplirsen, dystrophy, dystrophin, exon 51|dmd, duchenne, eteplirsen, dystrophy, dystrophin, exon 51
315890|NCT02255500|Total knee arthroplasty|total knee arthroplasty
315891|NCT02255487|surgical device|surgical device
315892|NCT02255487|surgical irrigation device|surgical irrigation device
315893|NCT02255487|surgical site infection prophylaxis|surgical site infection prophylaxis
315894|NCT02255474|pediatrics|pediatrics
315895|NCT02255474|refractive error - myopia|refractive error - myopia
315896|NCT02255474|contact lenses|contact lenses
315897|NCT02255474|intervention|intervention
315898|NCT02255435|RTA 408|rta 408
315899|NCT02255435|RTA 408 Capsules|rta 408 capsules
315900|NCT02255435|Oxidative Stress|oxidative stress
315901|NCT02255435|Mitochondrial dysfunction|mitochondrial dysfunction
315902|NCT02255435|omaveloxolone|omaveloxolone
315903|NCT02255422|omaveloxolone|omaveloxolone
315904|NCT02255422|RTA 408 capsules|rta 408 capsules
315905|NCT02255422|mitochondrial myopathies|mitochondrial myopathies
315906|NCT02255383|Osteoarthritis|osteoarthritis
315907|NCT02255383|Rheumatoid Arthritis|rheumatoid arthritis
315908|NCT02255383|Traumatic Arthritis|traumatic arthritis
315909|NCT02255383|Polyarthritis|polyarthritis
315910|NCT02255383|Total Knee Arthroplasty|total knee arthroplasty
315911|NCT02255370|Curcumin. Crohn's disease. Post-operative recurrence. Thiopurines . Rutgeerts endoscopic score|curcumin. crohn's disease. post-operative recurrence. thiopurines . rutgeerts endoscopic score
315912|NCT02255357|Oxytocin|oxytocin
315913|NCT02255357|Vasopressin|vasopressin
315914|NCT02255357|Cocaine|cocaine
315915|NCT02255344|Acute Coronary Syndromes|acute coronary syndromes
315916|NCT02255344|Risk Model|risk model
315917|NCT02255344|National Registry|national registry
315918|NCT02255344|Comprehensive Care Program|comprehensive care program
315919|NCT02255344|Major Cardiovascular Events|major cardiovascular events
315920|NCT02255331|Arthroplasty|arthroplasty
315921|NCT02255331|Replacement|replacement
315922|NCT02255331|Hip|hip
315923|NCT02255331|MRI|mri
315924|NCT02255318|Taurolock®|taurolock®
315925|NCT02255318|infections related to chambers implantable catheter|infections related to chambers implantable catheter
315926|NCT02255318|patients with cancer receiving parenteral nutrition|patients with cancer receiving parenteral nutrition
315927|NCT02255305|CDI|cdi
315928|NCT02255305|C difficile|c difficile
315929|NCT02255305|C diff|c diff
315930|NCT02255305|Clostridium difficile|clostridium difficile
315931|NCT02255253|Telmisartan|telmisartan
315932|NCT02255253|Hydrochlorothiazide|hydrochlorothiazide
315933|NCT02255253|Efficacy|efficacy
315934|NCT02255253|hypertension|hypertension
315935|NCT02255253|high sodium intake|high sodium intake
315936|NCT02255240|breast cancer|breast cancer
315937|NCT02255240|cancer|cancer
315938|NCT02255240|survivorship|survivorship
315939|NCT02255240|cancer survivor|cancer survivor
315940|NCT02255240|physical activity|physical activity
315941|NCT02255240|video game|video game
315942|NCT02255240|women|women
315943|NCT02255240|women's health|women's health
315944|NCT02255227|vaccination|vaccination
315945|NCT02255227|randomized|randomized
315946|NCT02255227|anti-pneumococcal|anti-pneumococcal
315947|NCT02255227|Pneumo 23|pneumo 23
315948|NCT02255227|Prevenar 13|prevenar 13
315949|NCT02255227|Chronic Inflammatory Bowel Disease|chronic inflammatory bowel disease
315950|NCT02255188|Haemostas, prosthesis|haemostas, prosthesis
315951|NCT02255175|Reproductive Affective Disorder|reproductive affective disorder
315952|NCT02255175|Depression|depression
315953|NCT02255175|Perimenopause|perimenopause
315954|NCT02255175|Estrogen|estrogen
315955|NCT02255175|Estradiol treatment|estradiol treatment
315956|NCT02255175|Mood Disorders|mood disorders
315957|NCT02255175|Estrogen Replacement Therapy|estrogen replacement therapy
315958|NCT02255175|Sex Steroids|sex steroids
315959|NCT02255175|Depressive disorder|depressive disorder
315960|NCT02255175|Mental Disorders|mental disorders
315961|NCT02255175|Estradiol|estradiol
315962|NCT02255175|Hormones|hormones
315963|NCT02255175|Physiological effects of drugs|physiological effects of drugs
315964|NCT02255175|Reproductive Control Agents|reproductive control agents
315965|NCT02255162|Acute Myeloid Leukemia (AML)|acute myeloid leukemia (aml)
315966|NCT02255162|Acute Myelocytic Leukemia|acute myelocytic leukemia
315967|NCT02255162|Acute Myelogenous Leukemia|acute myelogenous leukemia
315968|NCT02255162|Acute Granulocytic Leukemia|acute granulocytic leukemia
315969|NCT02255162|Acute Non-Lymphocytic Leukemia|acute non-lymphocytic leukemia
315970|NCT02255136|Interleukin|interleukin
315971|NCT02255136|Immunoglobulin|immunoglobulin
315972|NCT02255136|Homeopathy|homeopathy
315973|NCT02255136|Allergic Rhinitis|allergic rhinitis
315974|NCT02255136|Asthma|asthma
315975|NCT02255110|Locally Advanced Unresectable or Metastatic Soft Tissue Sarcoma|locally advanced unresectable or metastatic soft tissue sarcoma
315976|NCT02255110|TH-302|th-302
315977|NCT02255110|Doxorubicin|doxorubicin
315978|NCT02255110|Evofosfamide|evofosfamide
315979|NCT02255097|PD-1|pd-1
315981|NCT02255097|PD-L1|pd-l1
315982|NCT02255097|PDL1|pdl1
315983|NCT02255084|Cervical cancer screening|cervical cancer screening
315984|NCT02255084|High Risk Human papillomavirus Infection|high risk human papillomavirus infection
315985|NCT02255084|vaginal self-sampling|vaginal self-sampling
315986|NCT02255084|pap smear|pap smear
315987|NCT02255084|general practitioner|general practitioner
315988|NCT02255071|GERD|gerd
315989|NCT02255071|Neiguan|neiguan
315990|NCT02255071|Acupressure|acupressure
315991|NCT02255071|P6|p6
315992|NCT02255032|uveitis|uveitis
315993|NCT02255032|macular edema|macular edema
315994|NCT02255032|UME|ume
315995|NCT02255032|posterior uveitis|posterior uveitis
315996|NCT02255032|anterior uveitis|anterior uveitis
315997|NCT02255032|panuveitis|panuveitis
315998|NCT02255032|intermediate uveitis|intermediate uveitis
315999|NCT02255032|noninfectious uveitis|noninfectious uveitis
316000|NCT02255032|triamcinolone acetonide|triamcinolone acetonide
316001|NCT02255032|suprachoroidal space|suprachoroidal space
316002|NCT02255032|injection|injection
316003|NCT02255032|microneedle|microneedle
316004|NCT02255032|intravitreal injection|intravitreal injection
316005|NCT02255032|corticosteroid|corticosteroid
316006|NCT02255032|CME|cme
316007|NCT02255032|choroid|choroid
316008|NCT02255032|retina|retina
316009|NCT02255032|microinjection|microinjection
316010|NCT02255032|SCS|scs
316011|NCT02255006|volunteer|volunteer
316012|NCT02255006|BMI(25 kg/m2)|bmi(25 kg/m2)
316013|NCT02254980|Total hip arthroplasty|total hip arthroplasty
316014|NCT02254980|Cemented acetabular cup|cemented acetabular cup
316015|NCT02254980|Vitamin-E|vitamin-e
316016|NCT02254980|Radiostereometry|radiostereometry
316017|NCT02254980|Fixation of cemented acetabular component in total hip arthroplasty|fixation of cemented acetabular component in total hip arthroplasty
316018|NCT02254967|Aged|aged
316019|NCT02254967|Fidaxomicin|fidaxomicin
316020|NCT02254967|Clostridium Difficile|clostridium difficile
316021|NCT02254967|Vancomycin|vancomycin
316022|NCT02254954|glioblastoma|glioblastoma
316023|NCT02254941|Metastatic Colon Cancer|metastatic colon cancer
316024|NCT02254941|Monoclonal antibodies|monoclonal antibodies
316025|NCT02254941|Chemotherapy|chemotherapy
316026|NCT02254941|First line|first line
316027|NCT02254928|poor ovarian response|poor ovarian response
316028|NCT02254928|controlled ovarian stimulation|controlled ovarian stimulation
316029|NCT02254928|randomised clinical trial|randomised clinical trial
316030|NCT02254928|corifollitropin alfa|corifollitropin alfa
316031|NCT02254928|recombinant follicle-stimulating hormone (rFSH)|recombinant follicle-stimulating hormone (rfsh)
316032|NCT02254928|human menopausal gonadotropin (HMG)|human menopausal gonadotropin (hmg)
316033|NCT02254915|Synergo|synergo
316034|NCT02254915|RITE|rite
316035|NCT02254915|SHTC|shtc
316036|NCT02254915|Non Muscle Invasive Bladder Cancer|non muscle invasive bladder cancer
316037|NCT02254915|NMIBC|nmibc
316038|NCT02254915|Superficial Bladder Cancer|superficial bladder cancer
316039|NCT02254915|Urothelial Cell Cancer|urothelial cell cancer
316040|NCT02254915|Transitional Cell Cancer|transitional cell cancer
316041|NCT02254915|Mitomycin|mitomycin
316042|NCT02254902|sedentary lifestyle|sedentary lifestyle
316043|NCT02254902|physical activity|physical activity
316044|NCT02254902|Somali women|somali women
316045|NCT02254902|prevention|prevention
316046|NCT02254876|Stroke|stroke
316047|NCT02254876|Hemiplegia|hemiplegia
316048|NCT02254876|Painful shoulder Syndrome|painful shoulder syndrome
316049|NCT02254876|NeuroMuscolar Taping|neuromuscolar taping
316050|NCT02254863|Adrenoleukodystrophy|adrenoleukodystrophy
316051|NCT02254863|Batten Disease|batten disease
316052|NCT02254863|Hunter Syndrome|hunter syndrome
316053|NCT02254863|Krabbe|krabbe
316054|NCT02254863|Metachromatic Leukodystrophy|metachromatic leukodystrophy
316055|NCT02254863|ALD|ald
316056|NCT02254863|MLD|mld
316057|NCT02254863|PMD|pmd
316058|NCT02254850|Mesoglycan|mesoglycan
316059|NCT02254850|Metabolic Syndrome|metabolic syndrome
400513|NCT01866527|DDH,|ddh,
316060|NCT02254850|Flow Mediated Dilation|flow mediated dilation
316061|NCT02254824|Xuezhikang|xuezhikang
316062|NCT02254824|atorvastatin|atorvastatin
316063|NCT02254785|poor prognosis|poor prognosis
316064|NCT02254785|castrate-resistant prostate cancer|castrate-resistant prostate cancer
316065|NCT02254785|cabazitaxel|cabazitaxel
316066|NCT02254785|abiraterone|abiraterone
316067|NCT02254785|enzalutamide|enzalutamide
316068|NCT02254733|CBSST|cbsst
316069|NCT02254733|Schizoaffective Disorder|schizoaffective disorder
316070|NCT02254733|Psychotic Disorder|psychotic disorder
316071|NCT02254733|Cognitive Behavioral Therapy|cognitive behavioral therapy
316072|NCT02254733|Social Skills Training|social skills training
316073|NCT02254733|Assertive Community Treatment|assertive community treatment
316074|NCT02254694|sagittal balance|sagittal balance
316075|NCT02254694|posture|posture
316076|NCT02254694|lumbar lordosis|lumbar lordosis
316077|NCT02254694|high heeled shoes|high heeled shoes
316078|NCT02254681|low-dose radiotherapy|low-dose radiotherapy
316079|NCT02254681|gemcitabine|gemcitabine
316080|NCT02254681|cisplatin|cisplatin
316081|NCT02254681|cholangiocarcinoma|cholangiocarcinoma
316082|NCT02254668|intima|intima
316083|NCT02254668|thickness|thickness
316084|NCT02254668|transplantation|transplantation
316085|NCT02254668|cardiology|cardiology
316086|NCT02254668|immunosuppression|immunosuppression
316087|NCT02254655|puerarin|puerarin
316088|NCT02254655|rheumatoid arthritis|rheumatoid arthritis
316089|NCT02254655|atherosclerosis|atherosclerosis
316090|NCT02254655|carotid intima-media thickness|carotid intima-media thickness
316091|NCT02254629|Fecal microflora|fecal microflora
316092|NCT02254629|IBS|ibs
316093|NCT02254629|Sequential treatment|sequential treatment
316094|NCT02254629|Probiotic|probiotic
316095|NCT02254629|Laxative|laxative
316096|NCT02254616|Stroke Rehabilitation|stroke rehabilitation
316097|NCT02254616|Hybrid therapy|hybrid therapy
316098|NCT02254616|Mirror Therapy|mirror therapy
316099|NCT02254616|Transcranial Direct Current Stimulation|transcranial direct current stimulation
316100|NCT02254603|Obesity, ayuveda yoga exercise, acupuncture.|obesity, ayuveda yoga exercise, acupuncture.
316101|NCT02254590|IEDL|iedl
316102|NCT02254590|irrigation endoscopic decompressive laminotomy|irrigation endoscopic decompressive laminotomy
316103|NCT02254590|irrigation endoscopic decompression|irrigation endoscopic decompression
316104|NCT02254590|minimally invasive spine surgery|minimally invasive spine surgery
316105|NCT02254590|endoscopic decompression|endoscopic decompression
316106|NCT02254590|spinal stenosis|spinal stenosis
316107|NCT02254577|Infertility|infertility
316108|NCT02254577|Progesterone|progesterone
316109|NCT02254577|ART|art
316110|NCT02254577|IVF|ivf
316111|NCT02254577|FET|fet
316112|NCT02254577|FBT|fbt
316113|NCT02254577|Frozen Embryo Transfer|frozen embryo transfer
316114|NCT02254551|relapsed multiple myeloma|relapsed multiple myeloma
316115|NCT02254551|refractory multiple myeloma|refractory multiple myeloma
316116|NCT02254551|LDE225|lde225
316117|NCT02254551|Sonidegib|sonidegib
316118|NCT02254551|bortezomib|bortezomib
316119|NCT02254551|smoothened (SMO) inhibitors|smoothened (smo) inhibitors
316120|NCT02254551|Velcade|velcade
316121|NCT02254473|Knee|knee
316122|NCT02254473|Osteoarthritis|osteoarthritis
316123|NCT02254447|relative bio-availability|relative bio-availability
316124|NCT02254447|fasting|fasting
316125|NCT02254447|GW615775|gw615775
316126|NCT02254447|Candesartan cilexetil|candesartan cilexetil
316127|NCT02254447|ATACAND|atacand
316128|NCT02254434|eltrombopag 50 mg|eltrombopag 50 mg
316129|NCT02254434|healthy volunteers|healthy volunteers
316130|NCT02254434|pharmacokinetic|pharmacokinetic
316131|NCT02254434|single-dose|single-dose
316132|NCT02254434|Open-label|open-label
316133|NCT02254434|fasting|fasting
316134|NCT02254421|Respiratory Syncytial Virus (RSV)|respiratory syncytial virus (rsv)
316135|NCT02254421|Antiviral|antiviral
316136|NCT02254421|Hematopoietic Cell Transplant (HCT)|hematopoietic cell transplant (hct)
316137|NCT02254421|Lower respiratory tract infection|lower respiratory tract infection
316138|NCT02254408|Respiratory Syncytial Virus (RSV)|respiratory syncytial virus (rsv)
316139|NCT02254408|Antiviral|antiviral
316140|NCT02254408|Hematopoietic Cell Transplant (HCT)|hematopoietic cell transplant (hct)
316141|NCT02254408|Upper respiratory tract infection|upper respiratory tract infection
316142|NCT02254382|diastolic heart failure|diastolic heart failure
316143|NCT02254356|drug-eluting stent, paclitaxel-eluting stent, peripheral artery disease, peripheral vascular disease, superficial femoral artery, popliteal artery|drug-eluting stent, paclitaxel-eluting stent, peripheral artery disease, peripheral vascular disease, superficial femoral artery, popliteal artery
316144|NCT02254343|stroke rehabilitation|stroke rehabilitation
316145|NCT02254343|robot-assisted therapy|robot-assisted therapy
316146|NCT02254330|Adenoviral conjunctivitis diagnosed with AdenoPlus™ Test|adenoviral conjunctivitis diagnosed with adenoplus™ test
316147|NCT02254317|Impaired Glucose Tolerance|impaired glucose tolerance
316148|NCT02254317|Oral Glucose Tolerance Test|oral glucose tolerance test
316149|NCT02254317|Grape Seed Extract|grape seed extract
316150|NCT02254304|Relapsing multiple sclerosis|relapsing multiple sclerosis
762964|NCT00392951|Cytopenias|cytopenias
316151|NCT02254304|Clinically isolated syndrome|clinically isolated syndrome
316152|NCT02254304|RMS|rms
316153|NCT02254304|CIS|cis
316154|NCT02254304|RebiSmart™|rebismart™
316155|NCT02254304|Rebif®|rebif®
316156|NCT02254304|Interferon beta-1a|interferon beta-1a
316157|NCT02254252|Slow coronary flow phenomenon|slow coronary flow phenomenon
316158|NCT02254252|Angina pectoris|angina pectoris
316159|NCT02254252|chest pain|chest pain
316160|NCT02254252|nicroandil|nicroandil
316161|NCT02254213|Intra-individual stability, EEG|intra-individual stability, eeg
316162|NCT02254200|exercise|exercise
316163|NCT02254200|fat oxidation|fat oxidation
316164|NCT02254200|indirect calorimetry|indirect calorimetry
316165|NCT02254200|insulin sensitivity|insulin sensitivity
316166|NCT02254200|weight management|weight management
316167|NCT02253810|Dysplasia, Congenital Hip|dysplasia, congenital hip
316168|NCT02253810|Osteotomy|osteotomy
316169|NCT02253810|Blood Transfusion|blood transfusion
316170|NCT02253810|Tranexamic Acid|tranexamic acid
316171|NCT02253758|Magnetic Resonance Imaging|magnetic resonance imaging
316172|NCT02253758|Electroencephalography|electroencephalography
316173|NCT02253758|Conscious Sedation|conscious sedation
316174|NCT02253758|Deep Sedation|deep sedation
316175|NCT02253758|Arousal|arousal
316176|NCT02253758|Consciousness|consciousness
316177|NCT02253745|ADHD|adhd
316178|NCT02253745|Attention Deficit/ Hyperactivity Disorder|attention deficit/ hyperactivity disorder
316179|NCT02253732|MicroRNAs|micrornas
316180|NCT02253732|exercise|exercise
316181|NCT02253732|skeletal muscle|skeletal muscle
316182|NCT02253732|metabolism|metabolism
316183|NCT02253719|cervical neoplasia|cervical neoplasia
316184|NCT02253719|cervical cancer'|cervical cancer'
316185|NCT02253719|visual inspection acetic acid|visual inspection acetic acid
316186|NCT02253719|cryotherapy|cryotherapy
316187|NCT02253706|bronchoscopy|bronchoscopy
316189|NCT02253706|oxygen supplementation|oxygen supplementation
316190|NCT02253706|safety|safety
316191|NCT02253693|Hemophilia A|hemophilia a
316192|NCT02253693|Hemophilic arthropathy|hemophilic arthropathy
316193|NCT02253693|Accelerometry|accelerometry
316194|NCT02253680|Osteoarthritis|osteoarthritis
316195|NCT02253680|Total knee replacement|total knee replacement
316196|NCT02253680|Enhanced recovery|enhanced recovery
316197|NCT02253680|Compression bandages|compression bandages
316198|NCT02253667|Palliative care|palliative care
316199|NCT02253667|Lung disease|lung disease
316200|NCT02253667|Acute Respiratory Distress Syndrome|acute respiratory distress syndrome
316201|NCT02253667|High-flow oxygen nasal cannula|high-flow oxygen nasal cannula
316202|NCT02253667|Dyspnoea|dyspnoea
316203|NCT02253667|Opioids|opioids
316204|NCT02253654|Chronic Kidney Disease|chronic kidney disease
316205|NCT02253654|Anemia|anemia
316206|NCT02253654|Hemodialysis|hemodialysis
316207|NCT02253654|Red Blood Cell Transfusion|red blood cell transfusion
316208|NCT02253641|African American, Women|african american, women
316209|NCT02253641|Weight Loss|weight loss
316210|NCT02253628|Coffee|coffee
316212|NCT02253628|Alpha-amylase|alpha-amylase
316213|NCT02253628|Cortisol|cortisol
316214|NCT02253628|Self-reported gastrointestinal symptoms|self-reported gastrointestinal symptoms
316215|NCT02253628|Self-reported stress|self-reported stress
316216|NCT02253628|Blood pressure|blood pressure
316217|NCT02253615|Aging|aging
316218|NCT02253615|Resistance training|resistance training
316219|NCT02253615|Muscle strength|muscle strength
316220|NCT02253615|Functional performance|functional performance
316221|NCT02253615|Postural balance|postural balance
316222|NCT02253602|Esophageal Neoplasms|esophageal neoplasms
316223|NCT02253602|Lymph Nodes|lymph nodes
316224|NCT02253602|USPIO|uspio
316225|NCT02253602|Magnetic Resonance Imaging|magnetic resonance imaging
316226|NCT02253576|infant|infant
316227|NCT02253576|bronchiolitis|bronchiolitis
316228|NCT02253576|hypertonic saline|hypertonic saline
316229|NCT02253537|Tuberculosis|tuberculosis
316230|NCT02253537|TB|tb
316231|NCT02253524|Metoclopramide|metoclopramide
316232|NCT02253524|Dimenhydrinate|dimenhydrinate
316233|NCT02253524|emergency medicine|emergency medicine
316234|NCT02253511|Hepatocellular carcinoma|hepatocellular carcinoma
316235|NCT02253511|Hepotectomy|hepotectomy
316236|NCT02253511|Recurrence-free survival|recurrence-free survival
316237|NCT02253511|Overall survival|overall survival
316238|NCT02253485|Mother-to-child transmission|mother-to-child transmission
316239|NCT02253446|Dysmenorrhea|dysmenorrhea
316240|NCT02253446|Piroxicam|piroxicam
316241|NCT02253446|Diclofenac Sodium|diclofenac sodium
316242|NCT02253446|Emergency department|emergency department
316243|NCT02253433|asthma|asthma
316244|NCT02253433|environmental triggers|environmental triggers
316245|NCT02253433|home-based intervention|home-based intervention
316246|NCT02253433|asthma home visits|asthma home visits
316247|NCT02253420|Phase 1|phase 1
316248|NCT02253420|Advanced solid tumor|advanced solid tumor
316249|NCT02253420|non-Hodgkin's lymphoma|non-hodgkin's lymphoma
316250|NCT02253420|PI3 Kinase inhibitor|pi3 kinase inhibitor
316251|NCT02253420|Drug-drug Interaction|drug-drug interaction
316252|NCT02253394|Pulmonary Arterial Hypertension (PAH)|pulmonary arterial hypertension (pah)
316253|NCT02253394|Ambrisentan|ambrisentan
316254|NCT02253394|Spironolactone|spironolactone
316255|NCT02253394|Selective Endothelin A (ETA) inhibition|selective endothelin a (eta) inhibition
316256|NCT02253394|Aldosterone antagonism|aldosterone antagonism
316257|NCT02253394|Cardiac output (CO)|cardiac output (co)
316258|NCT02253394|Right ventricular (RV) function|right ventricular (rv) function
316259|NCT02253394|Heart failure|heart failure
316260|NCT02253394|Quality of life|quality of life
316261|NCT02253394|Pro-inflammatory cytokine|pro-inflammatory cytokine
316262|NCT02253394|Interleukin-6 (IL-6)|interleukin-6 (il-6)
316263|NCT02253394|Troponin-I|troponin-i
316264|NCT02253394|N-terminal pro-brain natriuretic peptide (NT-BNP)|n-terminal pro-brain natriuretic peptide (nt-bnp)
316265|NCT02253394|Collagen metabolism|collagen metabolism
316266|NCT02253394|N-terminal procollagen type I|n-terminal procollagen type i
316267|NCT02253394|Collagen III|collagen iii
316268|NCT02253394|Echocardiography|echocardiography
316269|NCT02253394|WHO Functional Class|who functional class
316270|NCT02253394|Cardiopulmonary Exercise Test with Innocor|cardiopulmonary exercise test with innocor
316271|NCT02253394|Peak oxygen consumption (pVO2)|peak oxygen consumption (pvo2)
316272|NCT02253394|Liver function markers (AST/ALT)|liver function markers (ast/alt)
316273|NCT02253394|Renal function markers (creatinine and potassium)|renal function markers (creatinine and potassium)
316274|NCT02253381|lateral decubitus position|lateral decubitus position
316275|NCT02253381|hypotension|hypotension
316276|NCT02253381|cesarean section|cesarean section
316277|NCT02253329|Neuromuscular electrical stimulation|neuromuscular electrical stimulation
316278|NCT02253329|Ageing|ageing
316279|NCT02253329|Protein ingestion|protein ingestion
316280|NCT02253316|Multiple Myeloma|multiple myeloma
316281|NCT02253316|Autologous Stem Cell Transplantation|autologous stem cell transplantation
316282|NCT02253316|Ixazomib|ixazomib
316283|NCT02253316|Lenalidomide|lenalidomide
316284|NCT02253316|Dexamethasone|dexamethasone
316285|NCT02253277|CML, Ph+ ALL|cml, ph+ all
316286|NCT02253251|Breast Cancer|breast cancer
316287|NCT02253251|Cancer Risk|cancer risk
316288|NCT02253251|Family Breast and Ovarian Cancer|family breast and ovarian cancer
316289|NCT02253251|Genetic Cancer Risk|genetic cancer risk
316290|NCT02253251|Cancer Treatment|cancer treatment
316291|NCT02253251|Familial multiple primary cancer risk|familial multiple primary cancer risk
316292|NCT02253251|Autoimmunity|autoimmunity
316293|NCT02253251|Endometriosis|endometriosis
316294|NCT02253238|Head and Neck Cancer|head and neck cancer
316295|NCT02253238|Dehydration|dehydration
316296|NCT02253238|Sensor-based home monitoring|sensor-based home monitoring
316297|NCT02253238|Radiation therapy|radiation therapy
316299|NCT02253238|XRT|xrt
316300|NCT02253238|Oropharyngeal cancer|oropharyngeal cancer
316301|NCT02253238|Hypopharyngeal cancer|hypopharyngeal cancer
316302|NCT02253238|Nasopharyngeal cancer|nasopharyngeal cancer
316303|NCT02253238|Salivary gland cancer|salivary gland cancer
316304|NCT02253238|Oral cavity cancer|oral cavity cancer
316305|NCT02253238|Questionnaires|questionnaires
316306|NCT02253238|Surveys|surveys
316307|NCT02253238|Quality of life|quality of life
316308|NCT02253238|QOL|qol
316309|NCT02253238|Phone calls|phone calls
316310|NCT02253238|Self-monitoring devices|self-monitoring devices
316311|NCT02253238|CYberinfrastructure for COmparative effectiveness REsearch|cyberinfrastructure for comparative effectiveness research
316312|NCT02253238|CYCORE|cycore
316313|NCT02253238|Emergency room visits|emergency room visits
316314|NCT02253238|ER|er
316315|NCT02253238|Emergency room visits with hospitalization|emergency room visits with hospitalization
316316|NCT02253238|ERHV|erhv
316317|NCT02253225|Bipolar Disorder|bipolar disorder
316318|NCT02253225|Major Depression|major depression
316319|NCT02253225|Rumination|rumination
316320|NCT02253225|Self Processing|self processing
316321|NCT02253212|Blood brain barrier (BBB)|blood brain barrier (bbb)
316322|NCT02253212|Disruption|disruption
316323|NCT02253212|Low intensity pulsed ultrasound (LIPU)|low intensity pulsed ultrasound (lipu)
316324|NCT02253212|Sonocloud device|sonocloud device
316325|NCT02253212|Glioblastoma (GBM)|glioblastoma (gbm)
316326|NCT02253212|Brain Cancer|brain cancer
316327|NCT02253212|Carboplatin|carboplatin
316328|NCT02253212|Therapeutic Ultrasound|therapeutic ultrasound
316329|NCT02253173|VVA|vva
316330|NCT02253173|Painful Sex|painful sex
316331|NCT02253173|Postmenopausal|postmenopausal
316332|NCT02253160|MNCs|mncs
316333|NCT02253160|Mononuclear Cells|mononuclear cells
316334|NCT02253160|Apheresis|apheresis
316335|NCT02253160|Spectra Optia|spectra optia
316336|NCT02253147|Nasolabial folds|nasolabial folds
316337|NCT02253147|Dermal filler|dermal filler
316338|NCT02253147|Hyaluronic acid (HA)|hyaluronic acid (ha)
316339|NCT02253147|Wrinkles|wrinkles
316340|NCT02253134|Syncopal events|syncopal events
316341|NCT02253134|Palpitation events|palpitation events
316342|NCT02253121|COPD|copd
316343|NCT02253121|acute exacerbation|acute exacerbation
316344|NCT02253121|glucocorticoid therapy|glucocorticoid therapy
316345|NCT02253121|hyperglycemia|hyperglycemia
316346|NCT02253108|DES|des
316347|NCT02253108|Angina pectoris|angina pectoris
316348|NCT02253108|Stent|stent
316349|NCT02253108|Optical coherence tomography|optical coherence tomography
316350|NCT02253108|Stent thrombosis|stent thrombosis
316351|NCT02253056|Fasting|fasting
316352|NCT02253056|Caloric Restriction|caloric restriction
316353|NCT02253056|Focus is to observe effects of fasting in healthy volunteers.|focus is to observe effects of fasting in healthy volunteers.
316354|NCT02253043|Alzheimer's Disease|alzheimer's disease
316355|NCT02253030|AMD|amd
316356|NCT02253030|OCT|oct
316357|NCT02253030|Angiography|angiography
316358|NCT02253030|Macular degeneration|macular degeneration
316359|NCT02253017|Therapeutic strategies|therapeutic strategies
316360|NCT02253017|Pediatrics|pediatrics
316361|NCT02253017|Cataract|cataract
316362|NCT02253017|Surgery|surgery
316363|NCT02253017|Intra-ocular lens|intra-ocular lens
316364|NCT02252991|Breast cancer|breast cancer
316365|NCT02252991|Fatigue|fatigue
316366|NCT02252991|Physical activity|physical activity
316367|NCT02252965|Diabetes Mellitus, Type 2|diabetes mellitus, type 2
316368|NCT02252965|Metformin XR|metformin xr
316369|NCT02252965|Metformin IR|metformin ir
316370|NCT02252952|Sugar Sweetened Beverages, Diet Beverages, ectopic fat, Functional MRI|sugar sweetened beverages, diet beverages, ectopic fat, functional mri
316371|NCT02252926|Anesthetics, Local|anesthetics, local
316372|NCT02252926|Bupivacaine|bupivacaine
316373|NCT02252926|Lozenge|lozenge
316374|NCT02252926|Administration, Topical|administration, topical
316375|NCT02252900|Brain damages|brain damages
316376|NCT02252900|MRI|mri
316377|NCT02252900|infectious endocarditis|infectious endocarditis
316378|NCT02252887|Gemcitabine,|gemcitabine,
316379|NCT02252887|Trastuzumab|trastuzumab
316380|NCT02252887|Pertuzumab|pertuzumab
316381|NCT02252887|14-124|14-124
316382|NCT02252874|balance|balance
316383|NCT02252874|visual function|visual function
316384|NCT02252874|community-dwelling older adults|community-dwelling older adults
316385|NCT02252874|action video-game|action video-game
316386|NCT02252822|Eating Disorders|eating disorders
316387|NCT02252822|Self Help|self help
316388|NCT02252822|Anonymous CBT|anonymous cbt
316389|NCT02252809|inflammation endotoxin anti-TNF corticosteroids|inflammation endotoxin anti-tnf corticosteroids
316390|NCT02252796|Non-small Cell Lung Cancer|non-small cell lung cancer
316391|NCT02252796|Radiotherapy Therapy|radiotherapy therapy
316392|NCT02252783|Coronary Artery Disease|coronary artery disease
316393|NCT02252783|Myocardial Ischemia|myocardial ischemia
316394|NCT02252783|Coronary Disease|coronary disease
316395|NCT02252783|Heart Diseases|heart diseases
316396|NCT02252783|Cardiovascular Diseases|cardiovascular diseases
316397|NCT02252783|Arteriosclerosis|arteriosclerosis
316398|NCT02252783|Arterial Occlusive Diseases|arterial occlusive diseases
316399|NCT02252783|Vascular Diseases|vascular diseases
316400|NCT02252770|ASA|asa
316401|NCT02252770|ASLD|asld
316402|NCT02252770|UCD|ucd
316403|NCT02252757|mHealth, hypertension, atherosclerotic disease, diabetes, obesity, metabolic syndrome, cardiotoxins, cardiomyopathy, dsypnea|mhealth, hypertension, atherosclerotic disease, diabetes, obesity, metabolic syndrome, cardiotoxins, cardiomyopathy, dsypnea
316404|NCT02252744|dry eye disease|dry eye disease
316405|NCT02252744|rheumatoid arthritis|rheumatoid arthritis
316406|NCT02252731|Phase I|phase i
316407|NCT02252731|FG-4592|fg-4592
316408|NCT02252731|Warfarin|warfarin
316409|NCT02252731|Pharmacokinetics|pharmacokinetics
316410|NCT02252731|Pharmacodynamics|pharmacodynamics
316411|NCT02252705|Pulmonary arterial hypertension|pulmonary arterial hypertension
316412|NCT02252705|Mortality|mortality
316413|NCT02252705|Survival|survival
316414|NCT02252692|Bioavailability|bioavailability
316415|NCT02252692|pharmacokinetics|pharmacokinetics
316416|NCT02252692|enalapril|enalapril
316417|NCT02252692|enalaprilat|enalaprilat
316418|NCT02252679|Bone Turnover Markers|bone turnover markers
316419|NCT02252679|Calcium Isotopes|calcium isotopes
316420|NCT02252666|MS|ms
316421|NCT02252666|balance|balance
316422|NCT02252666|standing|standing
316423|NCT02252666|control|control
316424|NCT02252666|movement|movement
316425|NCT02252653|Cardiomyopathy|cardiomyopathy
316426|NCT02252653|Heart Failure|heart failure
316427|NCT02252653|FAC|fac
316428|NCT02252653|Amyloid|amyloid
316429|NCT02252653|Transthyretin (TTR)|transthyretin (ttr)
316430|NCT02252640|Plasmodium Falciparum|plasmodium falciparum
316431|NCT02252640|Malaria|malaria
316432|NCT02252640|Vaccine|vaccine
316433|NCT02252640|Plasmodium|plasmodium
316434|NCT02252640|Falciparum|falciparum
316435|NCT02252614|naproxen sodium+codein, paracetamol+codein,lumbar disc surgery|naproxen sodium+codein, paracetamol+codein,lumbar disc surgery
316436|NCT02252601|Cystic Fibrosis|cystic fibrosis
316437|NCT02252601|Hearing Loss|hearing loss
316438|NCT02252601|High Frequency Digit Triplet Test|high frequency digit triplet test
316439|NCT02252588|COPD|copd
316440|NCT02252588|Bacteria|bacteria
316441|NCT02252562|Hand hygiene|hand hygiene
316442|NCT02252562|Hospital acquired infections (HAI)|hospital acquired infections (hai)
316443|NCT02252562|Healthcare acquired infections (HCAI)|healthcare acquired infections (hcai)
316444|NCT02252536|alcohol use disorder|alcohol use disorder
316445|NCT02252536|alcoholism|alcoholism
316446|NCT02252536|alcohol dependence|alcohol dependence
316447|NCT02252536|drinking alcohol|drinking alcohol
316448|NCT02252523|Feasibility study|feasibility study
316449|NCT02252497|hip arthroplasty|hip arthroplasty
316450|NCT02252497|Tranexamic acid|tranexamic acid
316451|NCT02252497|randomized control trial|randomized control trial
316452|NCT02252484|prostate cancer|prostate cancer
316453|NCT02252484|prostatectomy|prostatectomy
316454|NCT02252484|weight loss|weight loss
316455|NCT02252484|prevent weight gain|prevent weight gain
316456|NCT02252471|alcohol-exposed pregnancy|alcohol-exposed pregnancy
316457|NCT02252471|nicotine-exposed pregnancy|nicotine-exposed pregnancy
316458|NCT02252471|tobacco-exposed pregnancy|tobacco-exposed pregnancy
316459|NCT02252471|alcohol|alcohol
316460|NCT02252471|contraception|contraception
316461|NCT02252471|smoking|smoking
316462|NCT02252471|pregnancy|pregnancy
316463|NCT02252471|HIV|hiv
316464|NCT02252471|prevention|prevention
316465|NCT02252458|Opioid induced hyperalgesia|opioid induced hyperalgesia
316466|NCT02252458|Fentanyl|fentanyl
316467|NCT02252432|KETAMINE|ketamine
316468|NCT02252432|METHADONE|methadone
316469|NCT02252432|POSTOPERATIVE PAIN|postoperative pain
316470|NCT02252432|OPIOID REQUIREMENTS|opioid requirements
316471|NCT02252432|Length of hospital stay|length of hospital stay
316472|NCT02252432|Perioperative outcomes|perioperative outcomes
316473|NCT02252419|Postoperative Period|postoperative period
316474|NCT02252419|Anesthesia, General|anesthesia, general
316475|NCT02252419|Intubation, Intratracheal|intubation, intratracheal
316476|NCT02252419|Dexamethasone|dexamethasone
316477|NCT02252419|Acetaminophen|acetaminophen
316478|NCT02252406|Stable Angina|stable angina
316479|NCT02252406|Metabolic Syndrome|metabolic syndrome
316480|NCT02252406|Women|women
316481|NCT02252406|Biomarkers|biomarkers
316482|NCT02252367|Phosphodiesterase 5 Inhibitors|phosphodiesterase 5 inhibitors
316483|NCT02252367|BPH/LUTS|bph/luts
316484|NCT02252354|Drug therapy|drug therapy
316485|NCT02252341|smoking|smoking
316486|NCT02252341|inflammation|inflammation
316487|NCT02252341|oxidative stress|oxidative stress
316489|NCT02252341|treatment|treatment
316490|NCT02252328|Uveitis|uveitis
316491|NCT02252328|Simvastatin|simvastatin
316492|NCT02252328|Visual acuity|visual acuity
316493|NCT02252328|Corticosteroids|corticosteroids
316494|NCT02252328|Immunosuppression|immunosuppression
316495|NCT02252302|Exercise-induced bronchoconstriction|exercise-induced bronchoconstriction
316496|NCT02252302|Air pollution|air pollution
316497|NCT02252302|Exercise|exercise
316498|NCT02252302|Inhaled beta-2-agonist|inhaled beta-2-agonist
316499|NCT02252302|Cognitive Function|cognitive function
316500|NCT02252289|Asthma|asthma
316501|NCT02252289|children|children
316502|NCT02252289|fluctuation analysis|fluctuation analysis
316503|NCT02252289|exacerbations|exacerbations
316504|NCT02252276|Manual therapy|manual therapy
316505|NCT02252276|proprioception|proprioception
316506|NCT02252276|exercises|exercises
316507|NCT02252276|ankle sprain|ankle sprain
316508|NCT02252250|rectal cancer|rectal cancer
316509|NCT02252250|laparoscopic|laparoscopic
316510|NCT02252250|NOTES|notes
316511|NCT02252237|Prednisone|prednisone
316512|NCT02252237|Prednisolone|prednisolone
316513|NCT02252237|Methylprednisolone|methylprednisolone
316514|NCT02252237|Glucocorticoids|glucocorticoids
316515|NCT02252237|pharmacokinetics|pharmacokinetics
316516|NCT02252211|EphA2 positive cancer|epha2 positive cancer
316517|NCT02252211|DS-8895a monoclonal antibody|ds-8895a monoclonal antibody
316518|NCT02252172|Multiple Myeloma|multiple myeloma
316519|NCT02252172|Daratumumab|daratumumab
316520|NCT02252172|JNJ-54767414|jnj-54767414
316521|NCT02252172|Lenalidomide|lenalidomide
316522|NCT02252172|Dexamethasone|dexamethasone
316523|NCT02252159|Polycythemia|polycythemia
316524|NCT02252159|Polycythemia Vera|polycythemia vera
316525|NCT02252159|Hematologic Diseases|hematologic diseases
316526|NCT02252159|Myeloproliferative Disorders|myeloproliferative disorders
316527|NCT02252159|Bone Marrow Diseases|bone marrow diseases
316528|NCT02252159|Hydroxyurea|hydroxyurea
316529|NCT02252159|Antineoplastic Agents|antineoplastic agents
316530|NCT02252159|Therapeutic Uses|therapeutic uses
316531|NCT02252159|Pharmacologic Actions|pharmacologic actions
316532|NCT02252159|Antisickling Agents|antisickling agents
316533|NCT02252159|Hematologic Agents|hematologic agents
316534|NCT02252159|Enzyme Inhibitors|enzyme inhibitors
316535|NCT02252159|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action
316536|NCT02252159|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors
316537|NCT02252146|DLBCL|dlbcl
316538|NCT02252146|MYD88 L265P|myd88 l265p
316539|NCT02252146|Lymphoma|lymphoma
316540|NCT02252146|Diffuse Large B Cell Lymphoma|diffuse large b cell lymphoma
316541|NCT02252146|Idera|idera
316542|NCT02252146|IMO 8400|imo 8400
316543|NCT02252133|Contact lenses|contact lenses
316544|NCT02252133|Myopia|myopia
404451|NCT01849991|Crying|crying
316545|NCT02252107|Decitabine|decitabine
316546|NCT02252107|Hematopoietic stem cell transplantation (HSCT)|hematopoietic stem cell transplantation (hsct)
316547|NCT02252107|Conditioning|conditioning
316548|NCT02252107|AML|aml
316549|NCT02252081|metformin|metformin
316550|NCT02252081|cardiovascular disease|cardiovascular disease
316551|NCT02252081|Chronic Kidney Disease|chronic kidney disease
316552|NCT02252081|Metabolic Syndrome|metabolic syndrome
316553|NCT02252042|Squamous cell carcinoma|squamous cell carcinoma
316554|NCT02252042|Head and neck carcinoma|head and neck carcinoma
316555|NCT02252042|PD1|pd1
316556|NCT02252042|PD-1|pd-1
316557|NCT02252042|PDL1|pdl1
316558|NCT02252042|PD-L1|pd-l1
316559|NCT02252029|Rotavirus|rotavirus
316560|NCT02252029|Vaccine|vaccine
316561|NCT02252003|Children|children
316562|NCT02252003|Pain|pain
316563|NCT02252003|Pain scale evaluation|pain scale evaluation
316564|NCT02251964|IMID|imid
316565|NCT02251964|Interstitial Pneumonitis|interstitial pneumonitis
316566|NCT02251964|rituximab|rituximab
316567|NCT02251964|Immuno PET|immuno pet
316568|NCT02251964|PET/CT|pet/ct
316569|NCT02251951|Cancer|cancer
316570|NCT02251951|Stomach|stomach
316571|NCT02251951|Gastro-Esophageal Junction|gastro-esophageal junction
316572|NCT02251951|Salvage treatment|salvage treatment
316573|NCT02251951|Nab-paclitaxel|nab-paclitaxel
316574|NCT02251925|infertility froze emberyo transfer hormone replacement|infertility froze emberyo transfer hormone replacement
316575|NCT02251912|Alcohol dependence|alcohol dependence
316576|NCT02251912|Alcohol|alcohol
316577|NCT02251912|Oxytocin|oxytocin
316578|NCT02251912|Intranasal administration|intranasal administration
316579|NCT02251847|cholesterol|cholesterol
316580|NCT02251834|Healthcare Disparities|healthcare disparities
316581|NCT02251834|stroke|stroke
316582|NCT02251834|Hispanic Americans|hispanic americans
316583|NCT02251834|community health worker|community health worker
316584|NCT02251834|Mobile Health|mobile health
316585|NCT02251834|Transient Ischemic Attack (TIA)|transient ischemic attack (tia)
316586|NCT02251834|hypertension|hypertension
316587|NCT02251834|Randomized Controlled Trial|randomized controlled trial
316588|NCT02251834|high cholesterol|high cholesterol
316589|NCT02251834|behavioral|behavioral
316590|NCT02251834|exercise|exercise
316591|NCT02251834|diabetes|diabetes
316592|NCT02251834|diet|diet
316593|NCT02251808|Parkinson's Disease, Deep brain stimulation|parkinson's disease, deep brain stimulation
316594|NCT02251743|ADHD|adhd
316595|NCT02251743|Attention-Deficit/Hyperactivity Disorder|attention-deficit/hyperactivity disorder
316596|NCT02251743|neurofeedback|neurofeedback
316597|NCT02251743|EEG|eeg
316598|NCT02251730|radiation therapy,Smoking pattern,head and neck cancer|radiation therapy,smoking pattern,head and neck cancer
316599|NCT02251717|renal transplant|renal transplant
316600|NCT02251704|Malaria|malaria
316601|NCT02251704|MTI|mti
316602|NCT02251704|Surveillance study|surveillance study
316603|NCT02251704|Africa|africa
316604|NCT02251704|RTSS, adjuvant|rtss, adjuvant
316605|NCT02251704|Epidemiology|epidemiology
316606|NCT02251691|Compliance|compliance
316607|NCT02251678|Plaque|plaque
316608|NCT02251678|Psoriasis|psoriasis
316609|NCT02251678|Biomarkers|biomarkers
316610|NCT02251678|CRP|crp
316611|NCT02251678|αTNF|αtnf
316612|NCT02251678|Interleuken|interleuken
316613|NCT02251665|Acute ischemic stroke|acute ischemic stroke
316614|NCT02251665|Acute intracerebral hemorrhage|acute intracerebral hemorrhage
316615|NCT02251665|Transient ischemic attack|transient ischemic attack
316616|NCT02251652|Actinic|actinic
316617|NCT02251639|Oral cancer|oral cancer
316618|NCT02251639|Pre-cancer|pre-cancer
316619|NCT02251639|Widefield Fluorescence Imaging|widefield fluorescence imaging
316620|NCT02251639|VELScope|velscope
316621|NCT02251639|Point Spectroscopy System|point spectroscopy system
316622|NCT02251639|Oral brush biopsy|oral brush biopsy
316623|NCT02251639|Questionnaire|questionnaire
316624|NCT02251639|Survey|survey
316625|NCT02251639|Diagnostic aid|diagnostic aid
316626|NCT02251639|Screening|screening
316627|NCT02251626|MGH|mgh
316628|NCT02251626|Burn patient|burn patient
316629|NCT02251626|Adult|adult
316630|NCT02251626|CoQ10|coq10
316631|NCT02251626|Ubiquinol|ubiquinol
316632|NCT02251600|Pediatric|pediatric
316633|NCT02251600|Adolescent|adolescent
316634|NCT02251600|Deflazacort|deflazacort
316635|NCT02251561|contact lenses|contact lenses
316636|NCT02251561|contact lens solution|contact lens solution
316637|NCT02251561|corneal staining|corneal staining
316638|NCT02251561|fluorescein|fluorescein
316639|NCT02251548|Chronic lymphocytic leukemia|chronic lymphocytic leukemia
316640|NCT02251548|Leukemia|leukemia
316641|NCT02251535|kinematic analysis|kinematic analysis
316642|NCT02251535|femoral rollback|femoral rollback
316643|NCT02251535|mobile bearing|mobile bearing
316644|NCT02251535|cruciate retaining Primary Total Knee Arthroplasty|cruciate retaining primary total knee arthroplasty
316645|NCT02251496|Malnutrition|malnutrition
316646|NCT02251496|Chronic obstructive pulmonary disease|chronic obstructive pulmonary disease
316647|NCT02251496|Nutrition Therapy|nutrition therapy
316648|NCT02251496|Oral Nutrition Supplement|oral nutrition supplement
316649|NCT02251496|Food|food
316650|NCT02251483|DIBS|dibs
316651|NCT02251483|SIBO|sibo
316652|NCT02251470|stroke|stroke
316653|NCT02251470|balance|balance
316654|NCT02251470|exer-gaming|exer-gaming
316655|NCT02251470|home-based exercises|home-based exercises
316656|NCT02251470|Wii|wii
316657|NCT02251470|postural balance|postural balance
316658|NCT02251470|Nintendo|nintendo
316659|NCT02251470|balance board|balance board
316660|NCT02251470|Wii-Fit|wii-fit
316661|NCT02251470|home|home
316662|NCT02251470|feasibility|feasibility
316663|NCT02251457|Myotonia Congenita|myotonia congenita
316664|NCT02251457|ranolazine|ranolazine
316665|NCT02251457|Ohio State|ohio state
316666|NCT02251457|Open Label|open label
316667|NCT02251457|Paramyotonia Congenita|paramyotonia congenita
316668|NCT02251457|Myotonic Dystrophy 1|myotonic dystrophy 1
316669|NCT02251431|diabetes mellitus|diabetes mellitus
316670|NCT02251431|chronic kidney disease|chronic kidney disease
316671|NCT02251431|diastolic function|diastolic function
316672|NCT02251431|cardiac fibrosis|cardiac fibrosis
316673|NCT02251431|cardiac strain|cardiac strain
316674|NCT02251431|cardiac biomarker|cardiac biomarker
316675|NCT02251431|renal biomarker|renal biomarker
316676|NCT02251418|Foot ulcer, diabetic|foot ulcer, diabetic
316677|NCT02251418|ESWT (Extracorporeal Shockwave Therapy)|eswt (extracorporeal shockwave therapy)
316678|NCT02251418|Endocrinology|endocrinology
316679|NCT02251418|Dermatology|dermatology
316680|NCT02251418|Wound healing|wound healing
316681|NCT02251418|Ischemia|ischemia
316682|NCT02251418|Neovascularization, Physiologic|neovascularization, physiologic
316683|NCT02251418|Pain management|pain management
316684|NCT02251405|Melamine|melamine
316685|NCT02251405|Melamine tableware|melamine tableware
316686|NCT02251392|chamomilla|chamomilla
316687|NCT02251392|matricaria|matricaria
316688|NCT02251392|chamomile|chamomile
316689|NCT02251392|chamomila|chamomila
316690|NCT02251392|recutita|recutita
316691|NCT02251392|Breast Neoplasms|breast neoplasms
316692|NCT02251392|head and neck neoplasms|head and neck neoplasms
316693|NCT02251392|radiotherapy|radiotherapy
316694|NCT02251366|Age-Related Macular Degeneration|age-related macular degeneration
316695|NCT02251353|breast cancer, intervention to metastasis|breast cancer, intervention to metastasis
316696|NCT02251314|BRAF mutant melanoma|braf mutant melanoma
316697|NCT02251314|circulation tumour DNA|circulation tumour dna
316698|NCT02251314|tumour heterogeneity|tumour heterogeneity
316699|NCT02251314|liquid biopsy|liquid biopsy
316700|NCT02251288|H7N9 pandemic|h7n9 pandemic
316701|NCT02251288|inactivated influenza vaccine (pIIV)|inactivated influenza vaccine (piiv)
316702|NCT02251288|live attenuated influenza vaccine (pLAIV)|live attenuated influenza vaccine (plaiv)
316703|NCT02251288|MF59 adjuvant|mf59 adjuvant
316704|NCT02251275|ADPKD|adpkd
316705|NCT02251262|Pacemaker|pacemaker
316706|NCT02251262|Endocarditis|endocarditis
316707|NCT02251262|18FDG-PET-CT|18fdg-pet-ct
316708|NCT02251262|Diagnostic accuracy|diagnostic accuracy
316709|NCT02251262|Pacing or defibrillation lead|pacing or defibrillation lead
316710|NCT02251236|Stribild|stribild
316711|NCT02251236|Genvoya|genvoya
316712|NCT02251236|elvitegravir|elvitegravir
316713|NCT02251236|Cerebrospinal Fluid|cerebrospinal fluid
316714|NCT02251236|HIV|hiv
316715|NCT02251093|mycosis|mycosis
316716|NCT02251093|vulvovaginal candidiasis|vulvovaginal candidiasis
316717|NCT02251093|lcr35|lcr35
316718|NCT02251093|Lcr Regenerans®|lcr regenerans®
316719|NCT02251080|adherence|adherence
316720|NCT02251080|internet-based|internet-based
316721|NCT02251054|Overactive Bladder|overactive bladder
316722|NCT02251054|Multimedia|multimedia
316723|NCT02251054|Behavioral Therapy|behavioral therapy
316724|NCT02251041|Liver|liver
316725|NCT02251041|Transplantation|transplantation
316726|NCT02251041|Ischemia-reperfusion|ischemia-reperfusion
316727|NCT02251041|Effectiveness|effectiveness
316728|NCT02251028|whiplash, prevention, pain, cognitive-behavioural therapy|whiplash, prevention, pain, cognitive-behavioural therapy
316729|NCT02251015|Postural balance|postural balance
316730|NCT02251015|Temporomandibular disorders|temporomandibular disorders
316731|NCT02251015|splints|splints
316732|NCT02250989|Endothelial disfunction|endothelial disfunction
316733|NCT02250989|Intercellular Adhesion Molecule-1|intercellular adhesion molecule-1
316734|NCT02250989|Vascular Cell Adhesion Molecule-1|vascular cell adhesion molecule-1
316735|NCT02250989|8-epi-prostaglandin F2alpha|8-epi-prostaglandin f2alpha
316736|NCT02250989|Nitric Oxide|nitric oxide
316737|NCT02250989|Plasminogen Activator Inhibitor 1|plasminogen activator inhibitor 1
316738|NCT02250989|Endothelin-1|endothelin-1
316739|NCT02250989|Tumor Necrosis Factor-alpha|tumor necrosis factor-alpha
316740|NCT02250989|Glucose|glucose
316741|NCT02250989|Insulin|insulin
316742|NCT02250989|C-peptide|c-peptide
316743|NCT02250989|C-reactive protein|c-reactive protein
316744|NCT02250989|3-nitrotyrosine|3-nitrotyrosine
316745|NCT02250963|Dobutamine Stress Echocardiography|dobutamine stress echocardiography
316746|NCT02250963|Computed tomography coronary angiography|computed tomography coronary angiography
316747|NCT02250950|self-determination theory|self-determination theory
316748|NCT02250950|motivational interviewing|motivational interviewing
316749|NCT02250950|exercise|exercise
316750|NCT02250950|physical activity|physical activity
316751|NCT02250911|Caregivers of patients|caregivers of patients
316752|NCT02250911|CCC = Care for the Cancer Caregivers|ccc = care for the cancer caregivers
316753|NCT02250911|MCP-C = Meaning-Centered Psychotherapy for Cancer Caregivers|mcp-c = meaning-centered psychotherapy for cancer caregivers
316754|NCT02250911|14-208|14-208
316755|NCT02250898|Post Breast Surgery|post breast surgery
316756|NCT02250898|Myofascial Massage|myofascial massage
316757|NCT02250898|Pain|pain
316758|NCT02250898|Mobility Limitations|mobility limitations
316759|NCT02250885|Selinexor|selinexor
316760|NCT02250885|phase 2|phase 2
316761|NCT02250885|Gabrail|gabrail
316762|NCT02250872|Cisplatin|cisplatin
316763|NCT02250872|Nephrotoxicity|nephrotoxicity
316764|NCT02250872|Gemigliptin|gemigliptin
316765|NCT02250872|DPP4 inhibitor|dpp4 inhibitor
316766|NCT02250846|EGFR mutations|egfr mutations
316767|NCT02250846|asymptomatic brain metastases|asymptomatic brain metastases
316768|NCT02250846|EGFR-TKI|egfr-tki
316769|NCT02250846|Erlotinib|erlotinib
316770|NCT02250833|Hypertension|hypertension
316771|NCT02250833|CKD-828|ckd-828
316772|NCT02250833|Telmisartan|telmisartan
316773|NCT02250833|S-amlodipine|s-amlodipine
316774|NCT02250833|Pharmacokinetic|pharmacokinetic
316775|NCT02250820|Pediatric|pediatric
316776|NCT02250820|Sedation|sedation
316777|NCT02250820|Transthoracic echocardiography|transthoracic echocardiography
316779|NCT02250820|Dexmedetomidine|dexmedetomidine
316780|NCT02250820|Pentobarbital|pentobarbital
316781|NCT02250807|Chronic hepatitis C|chronic hepatitis c
316782|NCT02250807|Genotype 4 chronic hepatitis C|genotype 4 chronic hepatitis c
316783|NCT02250807|Simeprevir|simeprevir
316784|NCT02250807|Sofosbuvir|sofosbuvir
316785|NCT02250794|diabetes mellitus|diabetes mellitus
316786|NCT02250794|inpatient management|inpatient management
316787|NCT02250794|metformin|metformin
316788|NCT02250794|sitagliptin|sitagliptin
316789|NCT02250768|GM-CSF, repeated implantation failure|gm-csf, repeated implantation failure
316790|NCT02250755|MRI perfusion|mri perfusion
316791|NCT02250755|therapeutic response|therapeutic response
316792|NCT02250755|chemotherapy|chemotherapy
316793|NCT02250755|brain metastases|brain metastases
316794|NCT02250742|ultrasound imaging|ultrasound imaging
316795|NCT02250742|acupuncture|acupuncture
316796|NCT02250742|back muscles|back muscles
316797|NCT02250742|spine|spine
316798|NCT02250742|muscle strength|muscle strength
316799|NCT02250729|anaphylaxis|anaphylaxis
316800|NCT02250729|pholcodine|pholcodine
316801|NCT02250729|neuromuscular blocking agents|neuromuscular blocking agents
316802|NCT02250716|CIN1|cin1
316803|NCT02250716|HIV seropositive women|hiv seropositive women
316804|NCT02250716|Cryotherapy|cryotherapy
316805|NCT02250703|Premedication|premedication
316806|NCT02250690|idiopathic PD|idiopathic pd
316807|NCT02250690|Hoehn and Yahr stage I to III|hoehn and yahr stage i to iii
316808|NCT02250690|stable medication usage|stable medication usage
316809|NCT02250690|age 40 to 80 years|age 40 to 80 years
316810|NCT02250690|absence of cognitive impairment|absence of cognitive impairment
316811|NCT02250677|physical activity|physical activity
316812|NCT02250677|Statin therapy|statin therapy
316813|NCT02250677|cardiovascular disease|cardiovascular disease
316814|NCT02250677|diabetes mellitus|diabetes mellitus
316815|NCT02250664|Biomarkers of exposure|biomarkers of exposure
316816|NCT02250664|Compensatory smoking|compensatory smoking
316817|NCT02250664|Nicotine dependence|nicotine dependence
316818|NCT02250664|Reduced nicotine cigarettes|reduced nicotine cigarettes
316819|NCT02250664|Tobacco withdrawal|tobacco withdrawal
316820|NCT02250664|Women|women
316821|NCT02250664|Health disparities|health disparities
316822|NCT02250664|Vulnerable populations|vulnerable populations
316823|NCT02250612|SYL040012|syl040012
316824|NCT02250612|bamosiran|bamosiran
316825|NCT02250612|siRNA|sirna
316826|NCT02250612|RNAi|rnai
316827|NCT02250612|Glaucoma|glaucoma
316828|NCT02250612|Ocular hypertension|ocular hypertension
316829|NCT02250599|Metastatic Nasopharyngeal Carcinoma|metastatic nasopharyngeal carcinoma
316830|NCT02250599|treatment|treatment
316831|NCT02250586|concerned significant other|concerned significant other
316832|NCT02250586|internet-delivered cognitive-behavioral therapy,|internet-delivered cognitive-behavioral therapy,
316833|NCT02250586|treatment-refusing problem gambler|treatment-refusing problem gambler
316834|NCT02250534|Biomarkers of exposure|biomarkers of exposure
316835|NCT02250534|Compensatory smoking|compensatory smoking
316836|NCT02250534|Nicotine dependence|nicotine dependence
316837|NCT02250534|Reduced nicotine cigarettes|reduced nicotine cigarettes
316838|NCT02250534|Tobacco withdrawal|tobacco withdrawal
316839|NCT02250534|Women|women
762965|NCT00392951|Treatment|treatment
404836|NCT01848301|OCT|oct
316840|NCT02250534|Health disparities|health disparities
316841|NCT02250534|Vulnerable populations|vulnerable populations
316842|NCT02250521|BMI < 50 kg/m2|bmi < 50 kg/m2
316843|NCT02250521|Mallampatti class: III-IV|mallampatti class: iii-iv
316844|NCT02250521|Reduced mouth opening < 4 cm|reduced mouth opening < 4 cm
316845|NCT02250521|Neck circumference > 40 cm for females and > 43 cm for males|neck circumference > 40 cm for females and > 43 cm for males
316846|NCT02250521|Thyromental distance < 6 cm|thyromental distance < 6 cm
316847|NCT02250521|Ratio of the patient's height to thyromental distance ≥ 23.5|ratio of the patient's height to thyromental distance ≥ 23.5
316848|NCT02250521|Sternomental distance < 12 cm|sternomental distance < 12 cm
316849|NCT02250443|Inclusion Body Myositis (IBM)|inclusion body myositis (ibm)
316850|NCT02250430|acne|acne
316851|NCT02250365|stroke, acute|stroke, acute
316852|NCT02250365|upper extremity|upper extremity
316853|NCT02250365|rehabilitation|rehabilitation
316854|NCT02250365|electric stimulation therapy|electric stimulation therapy
316855|NCT02250339|Child Mental Health|child mental health
316856|NCT02250339|Parenting|parenting
316857|NCT02250339|Family Issues|family issues
316858|NCT02250326|Cancer of the lung|cancer of the lung
316859|NCT02250326|lung neoplasm|lung neoplasm
316860|NCT02250326|NSCLC - non-small cell lung cancer|nsclc - non-small cell lung cancer
316861|NCT02250326|Nonsquamou|nonsquamou
316862|NCT02250326|squamous|squamous
316863|NCT02250326|squamous NSCLC|squamous nsclc
316864|NCT02250326|Tumor|tumor
316865|NCT02250326|locally advanced NSCLC|locally advanced nsclc
316866|NCT02250326|metastatic NSCLC|metastatic nsclc
316867|NCT02250326|advanced lung cancer|advanced lung cancer
316868|NCT02250326|metastatic lung cancer|metastatic lung cancer
316869|NCT02250326|non-squamous NSCLC|non-squamous nsclc
316870|NCT02250326|lung cancer|lung cancer
316871|NCT02250326|Abraxane|abraxane
316872|NCT02250326|ABI-007|abi-007
316873|NCT02250326|nab-paclitaxel|nab-paclitaxel
316874|NCT02250326|albumin-bound paclitaxel|albumin-bound paclitaxel
316875|NCT02250326|taxanes|taxanes
316876|NCT02250326|CC-486|cc-486
316877|NCT02250326|oral azacitidine|oral azacitidine
316878|NCT02250326|azacitidine|azacitidine
316879|NCT02250326|second line treatment of lung cancer|second line treatment of lung cancer
316880|NCT02250326|second line treatment|second line treatment
316881|NCT02250326|Celgene|celgene
316882|NCT02250326|abound.2L|abound.2l
316883|NCT02250326|third line treatment|third line treatment
316884|NCT02250326|durvalumab|durvalumab
316885|NCT02250326|immunotherapy|immunotherapy
316886|NCT02250326|MEDI4736|medi4736
316887|NCT02250313|prostate cancer|prostate cancer
316888|NCT02250287|autosomal dominant polycystic kidney disease|autosomal dominant polycystic kidney disease
316889|NCT02250287|magnetic resonance imaging parameters|magnetic resonance imaging parameters
316890|NCT02250287|magnetic resonance elastography|magnetic resonance elastography
316891|NCT02250287|apparent diffusion coefficient|apparent diffusion coefficient
316892|NCT02250287|blood oxygen level determinations|blood oxygen level determinations
316893|NCT02250287|diffusion weighted imaging|diffusion weighted imaging
316894|NCT02250274|Immune response to influenza vaccine|immune response to influenza vaccine
316895|NCT02250274|PCR confirmed Influenza A virus|pcr confirmed influenza a virus
316896|NCT02250274|PCR confirmed Influenza B virus|pcr confirmed influenza b virus
316897|NCT02250261|walking|walking
316898|NCT02250261|cycling|cycling
316899|NCT02250261|intervention|intervention
316900|NCT02250261|physical activity|physical activity
316901|NCT02250261|environment|environment
316902|NCT02250261|promotion|promotion
316903|NCT02250248|Degenerative disc disease|degenerative disc disease
316904|NCT02250248|Lumbar spine|lumbar spine
316905|NCT02250209|Gastric Cancer|gastric cancer
316906|NCT02250209|HER2-positive|her2-positive
316907|NCT02250209|Trastuzumab|trastuzumab
316908|NCT02250209|XELOX|xelox
316909|NCT02250209|Stage III|stage iii
316910|NCT02250209|D2 Gastrectomy|d2 gastrectomy
316911|NCT02250196|Bowel preparation|bowel preparation
316912|NCT02250196|Polyethylene glycol with ascorbic acid|polyethylene glycol with ascorbic acid
316913|NCT02250196|Sodium picosulfate with magnesium citrate|sodium picosulfate with magnesium citrate
316914|NCT02250183|Medihoney|medihoney
316915|NCT02250183|Santyl|santyl
316916|NCT02250183|Burns|burns
316917|NCT02250144|Patellofemoral pain syndrome|patellofemoral pain syndrome
316918|NCT02250144|Feet orthoses|feet orthoses
316919|NCT02250144|KOOS|koos
316920|NCT02250131|cardiopulmonary bypass|cardiopulmonary bypass
316921|NCT02250118|pleural|pleural
316922|NCT02250118|effusion|effusion
316923|NCT02250118|breast|breast
316924|NCT02250118|cancer|cancer
316925|NCT02250092|Cerebral Palsy|cerebral palsy
316926|NCT02250092|Hemiparesis|hemiparesis
316927|NCT02250092|Stroke|stroke
316928|NCT02250092|Non-Invasive Brain Stimulation|non-invasive brain stimulation
316929|NCT02250092|Transcranial Direct Current Stimulation|transcranial direct current stimulation
316930|NCT02250092|Constraint-Induced Movement Therapy|constraint-induced movement therapy
316931|NCT02250092|Diffusion Tensor Imaging|diffusion tensor imaging
316932|NCT02250092|Congenital Hemiparesis|congenital hemiparesis
316933|NCT02250092|Bimanual Therapy|bimanual therapy
316934|NCT02250053|stage II and stage III colon cancer survivors, who have completed curative treatment i.e., surgical resection and chemotherapy for their colon cancer|stage ii and stage iii colon cancer survivors, who have completed curative treatment i.e., surgical resection and chemotherapy for their colon cancer
316935|NCT02250040|Stroke|stroke
316936|NCT02250040|Rehabilitation|rehabilitation
316937|NCT02250040|Physiotherapy|physiotherapy
316938|NCT02250040|Functional Recovery|functional recovery
316939|NCT02250027|acute bronchitis|acute bronchitis
316940|NCT02250027|acute exacerbations of chronic bronchitis|acute exacerbations of chronic bronchitis
316941|NCT02250001|HCV|hcv
316942|NCT02249962|prospective|prospective
316943|NCT02249962|cohort|cohort
316944|NCT02249936|Volunteers|volunteers
316945|NCT02249923|Pulmonary Arterial Hypertension (PAH)|pulmonary arterial hypertension (pah)
316946|NCT02249923|Pulmonary Vascular Disease (PVD)|pulmonary vascular disease (pvd)
316947|NCT02249923|Registry|registry
316948|NCT02249923|Pediatric|pediatric
316949|NCT02249884|radiodermatitis|radiodermatitis
316950|NCT02249884|head and neck neoplasms|head and neck neoplasms
316951|NCT02249884|Breast Neoplasms|breast neoplasms
316952|NCT02249884|Urea|urea
316953|NCT02249884|Matricaria|matricaria
316954|NCT02249884|chamomilla|chamomilla
316955|NCT02249884|chamomile|chamomile
316956|NCT02249858|cervical spine|cervical spine
316957|NCT02249858|OMT|omt
316958|NCT02249858|HVLA|hvla
316959|NCT02249858|ultrasound|ultrasound
316960|NCT02249845|dehydration|dehydration
316961|NCT02249845|children|children
316962|NCT02249845|gastroenteritis|gastroenteritis
316963|NCT02249832|stroke|stroke
316965|NCT02249832|cerebrovascular accident|cerebrovascular accident
316966|NCT02249832|cerebral stroke|cerebral stroke
316967|NCT02249832|robotic therapy|robotic therapy
316968|NCT02249832|anklebot|anklebot
316969|NCT02249832|physical therapy|physical therapy
316970|NCT02249819|stroke|stroke
316971|NCT02249819|aphasia|aphasia
316972|NCT02249819|CVA|cva
316973|NCT02249819|apraxia|apraxia
316974|NCT02249819|cerebrovascular accident|cerebrovascular accident
316975|NCT02249819|cerebral stroke|cerebral stroke
316976|NCT02249819|speech therapy|speech therapy
316977|NCT02249819|aphasia therapy|aphasia therapy
316978|NCT02249819|non-invasive brain stimulation|non-invasive brain stimulation
316979|NCT02249819|transcranial direct current stimulation|transcranial direct current stimulation
316980|NCT02249819|tDCS|tdcs
316981|NCT02249806|Pulmonary Hypertension|pulmonary hypertension
316982|NCT02249806|Chronic thromboembolic pulmonary hypertension|chronic thromboembolic pulmonary hypertension
316983|NCT02249806|Pulmonary arterial hypertension|pulmonary arterial hypertension
316984|NCT02249806|Outcome|outcome
316985|NCT02249793|circadian|circadian
316986|NCT02249793|oscillation|oscillation
316987|NCT02249793|clock|clock
316988|NCT02249793|human|human
316989|NCT02249793|social behavior|social behavior
316990|NCT02249793|cell phone with internet access (so-called smartphone)|cell phone with internet access (so-called smartphone)
316991|NCT02249793|social sensing|social sensing
316992|NCT02249793|behavioral feature|behavioral feature
316993|NCT02249793|Ginger.io|ginger.io
316994|NCT02249793|blood pressure|blood pressure
316995|NCT02249793|metabolism|metabolism
316996|NCT02249793|metabolomics|metabolomics
316997|NCT02249793|gut bacteria|gut bacteria
316998|NCT02249793|microbiome|microbiome
316999|NCT02249780|Parathyroid gland angiography|parathyroid gland angiography
317000|NCT02249780|Parathyroid gland indocyanine green angiography|parathyroid gland indocyanine green angiography
317001|NCT02249780|Parathyroid gland indocyanine green fluoroscopy|parathyroid gland indocyanine green fluoroscopy
317002|NCT02249754|Nutrition education|nutrition education
317003|NCT02249754|Maternal counselling|maternal counselling
317004|NCT02249754|Complementary feeding|complementary feeding
317005|NCT02249754|Infant growth|infant growth
317006|NCT02249754|Micronutrients|micronutrients
317007|NCT02249754|Tanzania|tanzania
317008|NCT02249715|Parkinson|parkinson
317009|NCT02249715|TMS|tms
317010|NCT02249715|BNA|bna
317011|NCT02249702|trabectedin|trabectedin
317012|NCT02249702|uterine leiomyosarcoma|uterine leiomyosarcoma
317013|NCT02249676|Autologous mesenchymal stem cells|autologous mesenchymal stem cells
317014|NCT02249676|neuromyelitis optica|neuromyelitis optica
317015|NCT02249676|treatment|treatment
317016|NCT02249663|Bioequivalence|bioequivalence
317017|NCT02249650|metastatic colorectal cancer|metastatic colorectal cancer
317018|NCT02249650|TSB-9-W1|tsb-9-w1
317019|NCT02249624|Twin to twin transfusion syndrome|twin to twin transfusion syndrome
317020|NCT02249624|Developmental disabilities|developmental disabilities
317021|NCT02249624|Magnetic resonance imaging|magnetic resonance imaging
317022|NCT02249611|Physical activity|physical activity
317023|NCT02249611|mobile activity sensor and feedback system|mobile activity sensor and feedback system
317024|NCT02249611|self-management of health|self-management of health
317025|NCT02249572|Vestibular schwannoma|vestibular schwannoma
317026|NCT02249572|Radiosurgery|radiosurgery
317027|NCT02249572|Neurosurgery|neurosurgery
317028|NCT02249572|Randomized|randomized
317029|NCT02249533|Spot Light|spot light
317030|NCT02249533|High School RIO|high school rio
317031|NCT02249533|Concussion|concussion
317032|NCT02249533|Injury Prevention|injury prevention
317033|NCT02249533|Football|football
317034|NCT02249533|Pop Warner|pop warner
317035|NCT02249533|High School|high school
317036|NCT02249533|Middle School|middle school
317037|NCT02249520|Magnetic Resonance Imaging|magnetic resonance imaging
317038|NCT02249520|MRI|mri
317039|NCT02249520|Positron Emission Tomography|positron emission tomography
317040|NCT02249520|PET|pet
317041|NCT02249520|PET-MR|pet-mr
317042|NCT02249520|mMR|mmr
317043|NCT02249507|Resistant Hypertension|resistant hypertension
317044|NCT02249507|Aerobic Exercise|aerobic exercise
317045|NCT02249494|Nutritional Knowledge|nutritional knowledge
317046|NCT02249494|Nutritional Counseling|nutritional counseling
317047|NCT02249481|Anaesthetic|anaesthetic
317048|NCT02249481|total knee replacement|total knee replacement
317049|NCT02249481|Femoral nerve catheter|femoral nerve catheter
317050|NCT02249481|Adductor canal catheter|adductor canal catheter
317051|NCT02249429|Non Hodgkin Lymphoma|non hodgkin lymphoma
317052|NCT02249377|Baker's Cyst|baker's cyst
317053|NCT02249325|group B Streptococcus colonization|group b streptococcus colonization
317054|NCT02249325|Probiotic|probiotic
317055|NCT02249325|Pregnancy|pregnancy
317056|NCT02249299|ADHD,|adhd,
317057|NCT02249299|Cannabis,|cannabis,
317058|NCT02249299|Sativex,|sativex,
317059|NCT02249299|Endocannabinoid,|endocannabinoid,
317060|NCT02249299|Cognition|cognition
317061|NCT02249286|Child Centered Counseling|child centered counseling
317062|NCT02249286|Home based food production|home based food production
317063|NCT02249286|Nutrition|nutrition
317064|NCT02249286|Health|health
317065|NCT02249286|IYCF|iycf
317066|NCT02249260|Exercise, cardiac rehabilitation, quality of life|exercise, cardiac rehabilitation, quality of life
317067|NCT02249234|Scrotal pain|scrotal pain
317068|NCT02249234|Botox|botox
317069|NCT02249221|Influenza vaccine|influenza vaccine
317070|NCT02249221|Vaccination|vaccination
317458|NCT02247440|Thailand|thailand
317071|NCT02249221|cell-culture based influenza vaccine|cell-culture based influenza vaccine
317072|NCT02249221|cell culture derived influenza vaccine|cell culture derived influenza vaccine
317073|NCT02249221|CCIV|cciv
317074|NCT02249208|Breast Cancer|breast cancer
317075|NCT02249208|Sentinel Lymph Node|sentinel lymph node
317076|NCT02249208|Neoadjuvant Chemotherapy|neoadjuvant chemotherapy
317077|NCT02249208|Clinically Node-Positive with biopsy-proven cN1|clinically node-positive with biopsy-proven cn1
317078|NCT02249208|False-negative Rate|false-negative rate
317079|NCT02249195|ECG loop recorder, pregnant women, arrhythmias|ecg loop recorder, pregnant women, arrhythmias
317080|NCT02249169|IBS|ibs
317081|NCT02249156|Health economics|health economics
317082|NCT02249156|Financial incentives|financial incentives
317083|NCT02249156|Health care spending|health care spending
317084|NCT02249143|Continuous positive airway pressure|continuous positive airway pressure
317085|NCT02249143|Prematurity|prematurity
317086|NCT02249143|Respiratory distress syndrome|respiratory distress syndrome
317087|NCT02249143|Bronchopulmonary dysplasia|bronchopulmonary dysplasia
317088|NCT02249078|Crohn's Disease|crohn's disease
317089|NCT02249013|Ovarian Cancer|ovarian cancer
317090|NCT02248974|End-Stage Heart Failure|end-stage heart failure
317091|NCT02248974|Left Ventricular Assist Device|left ventricular assist device
317092|NCT02248974|Decision Aid|decision aid
317093|NCT02248974|Medical Decision-Making|medical decision-making
317094|NCT02248948|Omega-3|omega-3
317095|NCT02248948|ADHD|adhd
317096|NCT02248948|Quality of Life|quality of life
317097|NCT02248948|Inattention|inattention
317098|NCT02248948|Hyperactivity|hyperactivity
317099|NCT02248935|Robotic Assisted Laparoscopic Sacrocolpopexy|robotic assisted laparoscopic sacrocolpopexy
317100|NCT02248935|Y Mesh|y mesh
317101|NCT02248935|Pelvic Organ Prolapse|pelvic organ prolapse
317102|NCT02248922|Cystic Fibrosis, Pseudomonas aeruginosa, Lung Clearance Index, Multiple Breath Washout, Inhaled Tobramycin, Inhaled Antibiotics.|cystic fibrosis, pseudomonas aeruginosa, lung clearance index, multiple breath washout, inhaled tobramycin, inhaled antibiotics.
317103|NCT02248909|COPD, Primary Care, Spirometry, Risk factors|copd, primary care, spirometry, risk factors
317104|NCT02248870|femoral neck|femoral neck
317105|NCT02248857|UMS|ums
317106|NCT02248857|medication schedule|medication schedule
317107|NCT02248857|diabetes|diabetes
317108|NCT02248857|drug labeling|drug labeling
317109|NCT02248831|Dyspnea|dyspnea
317110|NCT02248831|Acute decompensated heart failure|acute decompensated heart failure
317111|NCT02248831|Doppler ultrasound|doppler ultrasound
317112|NCT02248831|Lung Doppler signals|lung doppler signals
317113|NCT02248805|colon cancer|colon cancer
317114|NCT02248805|colorectal carcinoma|colorectal carcinoma
317115|NCT02248805|stage IV colorectal cancer|stage iv colorectal cancer
317116|NCT02248779|Diabetes Risk|diabetes risk
317117|NCT02248779|14-202|14-202
317118|NCT02248753|Atrial fibrillation|atrial fibrillation
762966|NCT00392951|Sirolimus|sirolimus
405240|NCT01846507|HMB|hmb
317119|NCT02248753|Electrical cardioversion|electrical cardioversion
317120|NCT02248753|Pharmacological cardioversion|pharmacological cardioversion
317121|NCT02248753|Rhythm control|rhythm control
317122|NCT02248753|Rate control|rate control
317123|NCT02248740|chronic venous insufficiency|chronic venous insufficiency
317124|NCT02248740|varicose vein|varicose vein
317125|NCT02248740|small saphenous vein|small saphenous vein
317126|NCT02248701|Testosterone|testosterone
317127|NCT02248701|Testosterone enanthate|testosterone enanthate
317128|NCT02248701|Testosterone undecanoate|testosterone undecanoate
317129|NCT02248701|Testosterone 17 beta-cypionate|testosterone 17 beta-cypionate
317130|NCT02248701|Methyltestosterone|methyltestosterone
317131|NCT02248701|Androgens|androgens
317132|NCT02248701|Hormones|hormones
317133|NCT02248701|Hormone Substitutes, and Hormone Antagonists|hormone substitutes, and hormone antagonists
317134|NCT02248701|Physiologic Effects of Drugs|physiologic effects of drugs
317135|NCT02248701|Pharmacologic Actions|pharmacologic actions
317136|NCT02248701|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal
317137|NCT02248701|Antineoplastic Agents|antineoplastic agents
317138|NCT02248701|Therapeutic Uses|therapeutic uses
317139|NCT02248701|Anabolic Agents|anabolic agents
317140|NCT02248701|Testosterone Replacement Therapy|testosterone replacement therapy
317141|NCT02248701|Dual Energy X ray Absorptiometry|dual energy x ray absorptiometry
317142|NCT02248701|Lean Tissue Mass|lean tissue mass
317143|NCT02248701|Body Composition|body composition
317144|NCT02248701|Lipid and Glucose profile|lipid and glucose profile
317145|NCT02248701|Muscle Strength|muscle strength
317146|NCT02248701|5-alpha Reductase|5-alpha reductase
317147|NCT02248701|Muscle Mass|muscle mass
317148|NCT02248701|Bone Mineral Density|bone mineral density
317149|NCT02248701|Adipose Tissue|adipose tissue
317150|NCT02248701|Body Fat|body fat
317151|NCT02248701|Density, Bone|density, bone
317152|NCT02248701|Bone Formation|bone formation
317153|NCT02248701|Bone Resorption|bone resorption
317154|NCT02248701|Bone Density Conservation Agents|bone density conservation agents
317155|NCT02248701|Magnetic Resonance Imaging|magnetic resonance imaging
317156|NCT02248701|Muscle, Skeletal|muscle, skeletal
317157|NCT02248701|Bone and Bones|bone and bones
317158|NCT02248701|Gait|gait
317159|NCT02248701|Walking|walking
317160|NCT02248701|Locomotion|locomotion
317161|NCT02248701|Motor Activity|motor activity
317162|NCT02248688|Bariatric Embolization|bariatric embolization
317163|NCT02248688|Gastric Artery Emboliziation|gastric artery emboliziation
317164|NCT02248688|Left Gastric Artery Embolization|left gastric artery embolization
317165|NCT02248688|Morbid Obesity|morbid obesity
317167|NCT02248688|Weight Loss|weight loss
317168|NCT02248688|Ghrelin|ghrelin
317169|NCT02248688|Embolization|embolization
317170|NCT02248675|sleep disorders|sleep disorders
317171|NCT02248675|insomnia|insomnia
317172|NCT02248675|suicidal ideation|suicidal ideation
317173|NCT02248675|Depression|depression
317174|NCT02248675|Depressive disorders|depressive disorders
317175|NCT02248675|PTSD|ptsd
317176|NCT02248675|anxiety disorders|anxiety disorders
317177|NCT02248675|suicide|suicide
317178|NCT02248675|cognitive behavioral therapy|cognitive behavioral therapy
317179|NCT02248662|DCIS|dcis
317180|NCT02248662|PCORI|pcori
317181|NCT02248662|ductal carcinoma in situ|ductal carcinoma in situ
317182|NCT02248662|radiation|radiation
317183|NCT02248662|oncology|oncology
317184|NCT02248662|patient-centered|patient-centered
317185|NCT02248662|decision aid|decision aid
317186|NCT02248662|decision-making|decision-making
317187|NCT02248649|Parkinson's disease|parkinson's disease
317188|NCT02248649|Exercise therapy|exercise therapy
317189|NCT02248649|Mild cognitive impairment|mild cognitive impairment
317190|NCT02248636|Alzheimer's disease|alzheimer's disease
317191|NCT02248636|Cholinesterase inhibitor|cholinesterase inhibitor
317192|NCT02248636|Discontinuation|discontinuation
317193|NCT02248623|Anaesthesia|anaesthesia
317194|NCT02248623|Isolated forearm test|isolated forearm test
317195|NCT02248623|Responsiveness|responsiveness
317196|NCT02248623|Laryngoscopy|laryngoscopy
317197|NCT02248623|Intubation|intubation
317198|NCT02248610|Pulmonary embolism|pulmonary embolism
317199|NCT02248610|PE|pe
317200|NCT02248610|Deep vein thrombosis|deep vein thrombosis
317201|NCT02248610|DVT|dvt
317202|NCT02248610|Rivaroxaban|rivaroxaban
317203|NCT02248610|Venous thromboembolism|venous thromboembolism
317204|NCT02248610|Chronic thromboembolic pulmonary hypertension|chronic thromboembolic pulmonary hypertension
317205|NCT02248610|Post thrombotic limb syndrome|post thrombotic limb syndrome
317206|NCT02248610|Root cause analysis|root cause analysis
317207|NCT02248571|breast cancer|breast cancer
317208|NCT02248571|advanced|advanced
317209|NCT02248571|inoperable|inoperable
317210|NCT02248571|metastatic|metastatic
317211|NCT02248571|HER2/neu-negative|her2/neu-negative
317212|NCT02248571|hormone receptor positive|hormone receptor positive
317213|NCT02248571|HR+|hr+
317214|NCT02248571|female|female
317215|NCT02248571|postmenopausal|postmenopausal
317216|NCT02248558|Contest|contest
317217|NCT02248558|Crowdsourcing|crowdsourcing
317218|NCT02248558|Innovation|innovation
317219|NCT02248558|Randomized controlled trial|randomized controlled trial
317220|NCT02248558|China|china
317221|NCT02248558|Social entrepreneurship|social entrepreneurship
317222|NCT02248545|Non-Celiac Wheat Sensitivity|non-celiac wheat sensitivity
317223|NCT02248545|Autoimmune diseases|autoimmune diseases
317224|NCT02248545|Anti-nuclear antibodies|anti-nuclear antibodies
317225|NCT02248545|Celiac disease|celiac disease
317226|NCT02248545|Irritable bowel syndrome|irritable bowel syndrome
317227|NCT02248519|Gastric cancer|gastric cancer
317228|NCT02248519|Gastrectomy|gastrectomy
317229|NCT02248519|Laparoscopy|laparoscopy
317230|NCT02248506|Candidiasis|candidiasis
317231|NCT02248493|Pain, Postoperative|pain, postoperative
317232|NCT02248493|Paracetamol|paracetamol
317233|NCT02248493|Administration, Intravenous|administration, intravenous
317234|NCT02248493|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal
317235|NCT02248493|Child|child
317236|NCT02248493|Adolescent|adolescent
317237|NCT02248467|Testosterone replacement therapy|testosterone replacement therapy
317238|NCT02248428|multiple myeloma|multiple myeloma
317239|NCT02248428|Clarithromycin|clarithromycin
317240|NCT02248428|CTd|ctd
317241|NCT02248415|Cardioplegic Solutions|cardioplegic solutions
317242|NCT02248415|Myocardial Ischemia|myocardial ischemia
317243|NCT02248389|carcinoma, renal cell|carcinoma, renal cell
317244|NCT02248389|ablation|ablation
317245|NCT02248389|laparoscopic surgery|laparoscopic surgery
317246|NCT02248389|high intensity focused ultrasound|high intensity focused ultrasound
317247|NCT02248376|Uterine synechiae Scraping surgery Natural miscarriage|uterine synechiae scraping surgery natural miscarriage
317248|NCT02248363|Rehabilitation|rehabilitation
317249|NCT02248363|Effectiveness|effectiveness
317250|NCT02248363|Determinants|determinants
317251|NCT02248363|Prediction|prediction
317252|NCT02248350|prostate cancer|prostate cancer
317253|NCT02248350|physical activity|physical activity
317254|NCT02248350|exercise|exercise
317255|NCT02248350|intervention|intervention
317256|NCT02248350|side effects|side effects
317257|NCT02248350|androgen deprivation therapy|androgen deprivation therapy
317258|NCT02248337|Colon preparation; Colonoscopy; Inflammatory bowel disease|colon preparation; colonoscopy; inflammatory bowel disease
317355|NCT02247830|Radiodermatitis|radiodermatitis
317259|NCT02248324|Age-related macular degeneration, genetic polymorphisms|age-related macular degeneration, genetic polymorphisms
317260|NCT02248298|Ablative fractional laser|ablative fractional laser
317261|NCT02248298|Actinic keratosis|actinic keratosis
317262|NCT02248298|Efficacy|efficacy
317263|NCT02248298|Photodynamic therapy|photodynamic therapy
317264|NCT02248298|Short incubation time|short incubation time
317265|NCT02248285|multiplex|multiplex
317266|NCT02248285|polymerase chain reaction|polymerase chain reaction
317268|NCT02248285|BioFire Diagnostics|biofire diagnostics
317269|NCT02248285|Infectious gastroenteritis|infectious gastroenteritis
317270|NCT02248285|Diarrheal disease|diarrheal disease
317271|NCT02248285|Emergency department|emergency department
317272|NCT02248285|rapid diagnostics|rapid diagnostics
317273|NCT02248285|FilmArray|filmarray
317274|NCT02248285|FilmArray GI Panel|filmarray gi panel
317275|NCT02248272|Polycystic ovary syndrome|polycystic ovary syndrome
317276|NCT02248272|Type 2 Diabetes|type 2 diabetes
317277|NCT02248272|Hyperinsulinemia|hyperinsulinemia
317278|NCT02248272|Meal frequency|meal frequency
317279|NCT02248246|Hemostasis|hemostasis
317280|NCT02248246|Harmonic ACE®+7 Shears|harmonic ace®+7 shears
317281|NCT02248246|Laparoscopic|laparoscopic
317282|NCT02248246|Inferior mesenteric artery|inferior mesenteric artery
317283|NCT02248246|Inferior mesenteric vein|inferior mesenteric vein
317284|NCT02248246|Observational|observational
317285|NCT02248233|nimodipine|nimodipine
317286|NCT02248233|acute massive cerebral infarction|acute massive cerebral infarction
317287|NCT02248233|Cerebral Infarction|cerebral infarction
317288|NCT02248233|optimal therapeutic time window|optimal therapeutic time window
317289|NCT02248233|optimal dose|optimal dose
317290|NCT02248233|multi-center|multi-center
317291|NCT02248194|Dysfunction uterine bleeding|dysfunction uterine bleeding
317292|NCT02248194|Hysteroscopic endometrial ablation|hysteroscopic endometrial ablation
317293|NCT02248194|Tactile endometrial ablation|tactile endometrial ablation
317294|NCT02248194|Hysteroscopic difficulties|hysteroscopic difficulties
317295|NCT02248194|Quality of life|quality of life
317296|NCT02248194|Satisfaction|satisfaction
317297|NCT02248090|Phase 1|phase 1
317298|NCT02248090|Safety|safety
317299|NCT02248090|Tolerability|tolerability
317300|NCT02248090|Pharmacokinetics|pharmacokinetics
317301|NCT02248090|Ascending Doses|ascending doses
317302|NCT02248090|Estrogen Receptor Positive|estrogen receptor positive
317303|NCT02248090|Her2 Negative|her2 negative
317304|NCT02248090|Advanced Breast Cancer|advanced breast cancer
317305|NCT02248064|Chronic obstructive pulmonary disease|chronic obstructive pulmonary disease
317306|NCT02248064|Long term oxygen therapy|long term oxygen therapy
317307|NCT02248064|Auto-titrating oxygen system|auto-titrating oxygen system
317308|NCT02248064|Intelligent oxygen therapy|intelligent oxygen therapy
317309|NCT02248064|Idiopathic pulmonary fibrosis|idiopathic pulmonary fibrosis
317310|NCT02248025|Fluid responsiveness|fluid responsiveness
317311|NCT02248025|capillary refill time|capillary refill time
317312|NCT02248025|microcirculation|microcirculation
317313|NCT02248025|circulatory failure|circulatory failure
317314|NCT02248025|passive leg raising|passive leg raising
317315|NCT02248012|Gastroenteropancreatic|gastroenteropancreatic
317316|NCT02248012|Neuroendocrine carcinoma|neuroendocrine carcinoma
317317|NCT02248012|Chemotherapy|chemotherapy
317318|NCT02247999|Cervical Cancer|cervical cancer
317319|NCT02247999|HIV/AIDS|hiv/aids
317320|NCT02247999|HPV|hpv
317321|NCT02247999|Biomarkers|biomarkers
317322|NCT02247999|Screening|screening
317323|NCT02247986|Conduct Disorder|conduct disorder
317324|NCT02247986|Methylphenidate|methylphenidate
317325|NCT02247986|Disruptive Behavior Disorders|disruptive behavior disorders
317326|NCT02247947|CPR|cpr
317327|NCT02247934|Primary sclerosing cholangitis|primary sclerosing cholangitis
317328|NCT02247934|PSC|psc
317329|NCT02247921|caregiver delivered rehabilitation|caregiver delivered rehabilitation
317330|NCT02247921|nurse-organized service|nurse-organized service
317331|NCT02247921|disabled stroke patients|disabled stroke patients
317332|NCT02247908|Cigarette smoking|cigarette smoking
317333|NCT02247908|Smoke|smoke
317334|NCT02247908|Smoking|smoking
317335|NCT02247908|Tobacco Use|tobacco use
317336|NCT02247895|ICU Acquired weakness|icu acquired weakness
317337|NCT02247895|Critical illness|critical illness
317338|NCT02247895|Mechanical ventilation|mechanical ventilation
317339|NCT02247882|Osteoarthritis|osteoarthritis
317340|NCT02247882|Patient Education|patient education
317341|NCT02247882|Aquatic Exercise|aquatic exercise
317342|NCT02247882|kinetic|kinetic
317343|NCT02247869|HL|hl
317344|NCT02247869|Hodgkin Lymphoma|hodgkin lymphoma
317345|NCT02247869|First line therapy|first line therapy
317346|NCT02247856|nebulizers,|nebulizers,
317347|NCT02247856|noninvasive ventilation|noninvasive ventilation
317348|NCT02247856|COPD|copd
317349|NCT02247856|scintigraphy,|scintigraphy,
317350|NCT02247856|aerosol|aerosol
317351|NCT02247843|Sickle Cell Disease (SCD)|sickle cell disease (scd)
317352|NCT02247843|Gene Therapy|gene therapy
317353|NCT02247843|Lentiviral Vector|lentiviral vector
317354|NCT02247843|Beta Globin|beta globin
317356|NCT02247830|Head and neck neoplasms|head and neck neoplasms
317357|NCT02247830|Radiotherapy|radiotherapy
317358|NCT02247830|Urea|urea
317359|NCT02247830|Matricaria|matricaria
317360|NCT02247830|Breast Neoplasms|breast neoplasms
317361|NCT02247830|chamomilla|chamomilla
317362|NCT02247830|chamomile|chamomile
317363|NCT02247778|clavicle|clavicle
317364|NCT02247778|surgical intervention|surgical intervention
317365|NCT02247778|mini-incision|mini-incision
317366|NCT02247778|plate osteosynthesis|plate osteosynthesis
317367|NCT02247752|hepatitis|hepatitis
317368|NCT02247752|HBV|hbv
317369|NCT02247752|chronic hepatitis|chronic hepatitis
317370|NCT02247752|HCC|hcc
317371|NCT02247752|cirrhosis|cirrhosis
317372|NCT02247752|quantitative HBsAg|quantitative hbsag
317373|NCT02247752|HBsAg inactive carriers|hbsag inactive carriers
317374|NCT02247739|HAE|hae
317375|NCT02247739|Hereditary Angioedema|hereditary angioedema
317376|NCT02247739|Prophylaxis|prophylaxis
317377|NCT02247726|RSV|rsv
317378|NCT02247726|Third Trimester|third trimester
317379|NCT02247726|Maternal Immunization|maternal immunization
317380|NCT02247713|PET|pet
317381|NCT02247713|radiotherapy|radiotherapy
317382|NCT02247713|international|international
317383|NCT02247713|NSCLC|nsclc
317384|NCT02247713|overall survival|overall survival
317385|NCT02247713|low and middle income countries|low and middle income countries
317386|NCT02247700|Pediatrics|pediatrics
317387|NCT02247700|ARDS|ards
317388|NCT02247700|ARF|arf
317389|NCT02247700|ALI|ali
317390|NCT02247700|Respiratory|respiratory
317391|NCT02247700|Mechanical ventilation|mechanical ventilation
317392|NCT02247700|Ventilation|ventilation
317393|NCT02247700|Noninvasive monitoring|noninvasive monitoring
317394|NCT02247700|electrical impedance tomography|electrical impedance tomography
317395|NCT02247700|EIT|eit
317396|NCT02247687|HIV-1|hiv-1
317397|NCT02247687|antiretroviral treatment|antiretroviral treatment
317398|NCT02247687|viral load|viral load
317399|NCT02247674|Stroke, Cerebrovascular accident, Rehabilitation, Upper extremity|stroke, cerebrovascular accident, rehabilitation, upper extremity
317400|NCT02247661|Femoral neck fracture,surgical approach, limp, abductor strenght, trochanteric pain|femoral neck fracture,surgical approach, limp, abductor strenght, trochanteric pain
317401|NCT02247648|tramadol|tramadol
317402|NCT02247648|shoulder surgery|shoulder surgery
317403|NCT02247648|pain|pain
317404|NCT02247648|interscalen block|interscalen block
317405|NCT02247648|BUPRENORPHINE/HYDROMORPHONE [VA Drug Interaction]|buprenorphine/hydromorphone [va drug interaction]
317406|NCT02247635|Treatment adherence|treatment adherence
762967|NCT00392951|Rapamycin|rapamycin
317407|NCT02247635|Behavioral model of health care|behavioral model of health care
317408|NCT02247635|Healthy lifestyle|healthy lifestyle
317409|NCT02247635|Chronic metabolic diseases|chronic metabolic diseases
317410|NCT02247635|Metabolic syndrome|metabolic syndrome
317411|NCT02247635|Obesity|obesity
317412|NCT02247622|telomeres|telomeres
317413|NCT02247622|PSC|psc
317414|NCT02247609|B cell lymphoma|b cell lymphoma
317415|NCT02247609|non-Hodgkin's lymphoma|non-hodgkin's lymphoma
317416|NCT02247609|Burkitt lymphoma|burkitt lymphoma
317417|NCT02247609|diffused large B cell lymphoma|diffused large b cell lymphoma
317418|NCT02247609|B cell malignancy|b cell malignancy
317419|NCT02247596|Resveratrol|resveratrol
317420|NCT02247596|obesity|obesity
317421|NCT02247596|insulin resistance|insulin resistance
317422|NCT02247596|energy expenditure|energy expenditure
317423|NCT02247596|diabetes|diabetes
317424|NCT02247570|Vestibular Rehabilitation|vestibular rehabilitation
317425|NCT02247570|PTSD|ptsd
317426|NCT02247570|DSM-IV|dsm-iv
317427|NCT02247557|IC/PBS|ic/pbs
317428|NCT02247557|VAS|vas
317429|NCT02247557|Botulinum Toxin A|botulinum toxin a
317430|NCT02247557|Lipotoxin|lipotoxin
317431|NCT02247544|STS, leiomyosarcoma, liposarcoma, trabectedin|sts, leiomyosarcoma, liposarcoma, trabectedin
317432|NCT02247518|Male|male
317433|NCT02247518|Volunteers|volunteers
317434|NCT02247492|International|international
317435|NCT02247492|Multicenter|multicenter
317436|NCT02247492|Observational registry|observational registry
317437|NCT02247492|Orsiro Drug Eluting Stent (DES)|orsiro drug eluting stent (des)
317438|NCT02247492|Stenting|stenting
317439|NCT02247492|Treatment of coronary artery disease|treatment of coronary artery disease
317440|NCT02247492|Coronary revascularization|coronary revascularization
317441|NCT02247492|Percutaneous Coronary Intervention (PCI)|percutaneous coronary intervention (pci)
317442|NCT02247492|STEMI|stemi
317443|NCT02247492|NSTEMI|nstemi
317444|NCT02247492|Ischemia|ischemia
317445|NCT02247492|Angina|angina
317446|NCT02247492|Acute Myocardial Infarction (AMI)|acute myocardial infarction (ami)
317447|NCT02247492|Small Vessels|small vessels
317448|NCT02247492|Chronic Total Occlusion (CTO|chronic total occlusion (cto
317449|NCT02247466|Neuromuscular Blockade|neuromuscular blockade
317450|NCT02247466|Laparoscopy|laparoscopy
317451|NCT02247453|lung cancer|lung cancer
317452|NCT02247453|clinical trial|clinical trial
317453|NCT02247453|screening|screening
317454|NCT02247453|microRNA|microrna
317455|NCT02247453|biomarkers|biomarkers
317456|NCT02247440|HCV|hcv
317457|NCT02247440|HIV|hiv
317459|NCT02247440|pegylated interferon|pegylated interferon
317460|NCT02247440|ribavirin|ribavirin
317461|NCT02247427|Heart failure|heart failure
317462|NCT02247427|Super responder|super responder
317463|NCT02247414|Cirrhosis|cirrhosis
317464|NCT02247414|Hypertension|hypertension
317465|NCT02247414|venous thrombosis|venous thrombosis
317466|NCT02247414|Warfarin|warfarin
317467|NCT02247414|Splenectomy|splenectomy
317468|NCT02247414|Azygoportal Disconnection|azygoportal disconnection
317469|NCT02247414|Laparoscopy|laparoscopy
317470|NCT02247401|Genotype 4|genotype 4
317471|NCT02247401|non-responder|non-responder
317472|NCT02247401|treatment experienced|treatment experienced
317473|NCT02247401|HCV|hcv
317474|NCT02247401|naive|naive
317475|NCT02247401|relapser|relapser
317476|NCT02247401|hepatitis infection|hepatitis infection
317477|NCT02247401|compensated cirrhosis|compensated cirrhosis
317478|NCT02247401|hepatitis c|hepatitis c
317479|NCT02247401|Cirrhosis|cirrhosis
317480|NCT02247401|Egypt|egypt
317481|NCT02247401|null responder|null responder
317482|NCT02247401|partial responder|partial responder
317483|NCT02247388|Alcohol Dependence|alcohol dependence
317484|NCT02247388|Alcoholism|alcoholism
317485|NCT02247388|AB-CASI|ab-casi
317486|NCT02247388|Emergency Department|emergency department
317487|NCT02247362|Safety|safety
317488|NCT02247362|Immunogenicity|immunogenicity
317489|NCT02247336|colorectal cancer|colorectal cancer
317490|NCT02247336|early detection of cancer|early detection of cancer
317491|NCT02247297|Pancreatic stone protein (PSP)|pancreatic stone protein (psp)
317492|NCT02247297|premature rupture of membranes (PPROM)|premature rupture of membranes (pprom)
317493|NCT02247297|amniotic infection syndrome (AIS)|amniotic infection syndrome (ais)
317494|NCT02247297|hemolysis, elevated liver enzymes, and low platelets (HELLP)|hemolysis, elevated liver enzymes, and low platelets (hellp)
317495|NCT02247297|preeclampsia|preeclampsia
317496|NCT02247297|pregnancy|pregnancy
317497|NCT02247271|peer coaches|peer coaches
317498|NCT02247245|CHF|chf
317499|NCT02247245|AF|af
317500|NCT02247245|SR|sr
317501|NCT02247245|HFREF|hfref
317502|NCT02247245|CRT|crt
317503|NCT02247219|Health education|health education
317504|NCT02247219|Health services research|health services research
317505|NCT02247206|Tourette Syndrome|tourette syndrome
317506|NCT02247206|tic disorders|tic disorders
317507|NCT02247206|behavior therapy|behavior therapy
317508|NCT02247206|web-based videoconferencing|web-based videoconferencing
317509|NCT02247206|VoIP|voip
317510|NCT02247193|Botulinum Toxin|botulinum toxin
317511|NCT02247193|Botox|botox
317512|NCT02247193|Craniofacial deformity|craniofacial deformity
317513|NCT02247167|obstructive sleep apnoea, oxidative stress, FMD|obstructive sleep apnoea, oxidative stress, fmd
317514|NCT02247128|Transcatheter Aortic Valve Implantation (TAVI)|transcatheter aortic valve implantation (tavi)
317515|NCT02247128|Transcatheter Aortic Valve Replacement (TAVR)|transcatheter aortic valve replacement (tavr)
317516|NCT02247128|Aortic Valve Disease|aortic valve disease
317517|NCT02247128|Aortic Stenosis|aortic stenosis
317518|NCT02247128|Myocardial Infarction|myocardial infarction
317519|NCT02247128|Ischemic stroke|ischemic stroke
317520|NCT02247128|Bleeding|bleeding
317521|NCT02247128|Thrombosis|thrombosis
317522|NCT02247128|Myocardial Ischemia|myocardial ischemia
317523|NCT02247128|Heart Diseases|heart diseases
317524|NCT02247128|Cardiovascular Diseases|cardiovascular diseases
317525|NCT02247128|Vascular Diseases|vascular diseases
317526|NCT02247128|Embolism and Thrombosis|embolism and thrombosis
317527|NCT02247128|Aspirin|aspirin
317528|NCT02247128|Clopidogrel|clopidogrel
317529|NCT02247128|Prasugrel|prasugrel
317530|NCT02247128|Ticagrelor|ticagrelor
317531|NCT02247128|Antithrombotic treatment|antithrombotic treatment
317532|NCT02247128|Oral anticoagulation|oral anticoagulation
317533|NCT02247128|Warfarin|warfarin
317534|NCT02247128|Platelet Aggregation Inhibitors|platelet aggregation inhibitors
317535|NCT02247128|Genetic Testing|genetic testing
317536|NCT02247128|Cytochrome P450 2C19 (CYP2C19)|cytochrome p450 2c19 (cyp2c19)
317537|NCT02247128|Prostaglandin-endoperoxide synthase 2(PTGS2)|prostaglandin-endoperoxide synthase 2(ptgs2)
317538|NCT02247115|endoscopic ultrasound|endoscopic ultrasound
317539|NCT02247115|endoscopic retrograde cholangiopancreatography|endoscopic retrograde cholangiopancreatography
317540|NCT02247115|competency|competency
317541|NCT02247089|Night Shift work|night shift work
317542|NCT02247089|Stress|stress
317543|NCT02247089|Autonomic nervous system (ANS)|autonomic nervous system (ans)
317544|NCT02247089|Heart rate variability (HRV)|heart rate variability (hrv)
317545|NCT02247089|Pre-ejection period (PEP)|pre-ejection period (pep)
317546|NCT02247089|Inflammation|inflammation
317547|NCT02247089|Pro-inflammatory cytokines|pro-inflammatory cytokines
317548|NCT02247089|Massage Therapy|massage therapy
317549|NCT02247050|Costs and Cost Analysis|costs and cost analysis
317550|NCT02247050|Professional Practice|professional practice
317551|NCT02247050|Attitude of Health Personnel|attitude of health personnel
317552|NCT02247050|Health Knowledge, Attitudes, and Practice|health knowledge, attitudes, and practice
317553|NCT02247050|Decision Making|decision making
317554|NCT02247050|Practice Guidelines as Topic|practice guidelines as topic
317555|NCT02247050|Physician-Patient Relations|physician-patient relations
317556|NCT02247050|Physician's Role|physician's role
317557|NCT02247050|Health Care|health care
317558|NCT02247050|Quality of Health Care|quality of health care
317559|NCT02247050|Quality Assurance|quality assurance
317560|NCT02247050|Physicians, Primary Care|physicians, primary care
317561|NCT02247050|Evidence-Based Medicine|evidence-based medicine
317562|NCT02247050|Evidence-Based Practice|evidence-based practice
317563|NCT02247050|Decision Support Systems, Clinical|decision support systems, clinical
317564|NCT02247050|Reminder Systems|reminder systems
317565|NCT02247050|Judgment|judgment
317566|NCT02247050|Cognition|cognition
317567|NCT02247050|Patient Care|patient care
317568|NCT02247050|Health Services Misuse|health services misuse
317569|NCT02247050|Unnecessary Procedures|unnecessary procedures
317570|NCT02247050|Prescribing Patterns, Physician|prescribing patterns, physician
317571|NCT02247050|Inappropriate Prescribing|inappropriate prescribing
317572|NCT02247050|Over Prescribing|over prescribing
317573|NCT02247050|Low Back Pain|low back pain
317574|NCT02247050|Sinusitis|sinusitis
317575|NCT02247050|Infections, Upper Respiratory|infections, upper respiratory
317576|NCT02247050|Generalized Headache|generalized headache
317577|NCT02247050|Imaging, Diagnostic|imaging, diagnostic
317578|NCT02247050|Antibiotics|antibiotics
317580|NCT02247050|Overuse of Low-Value Services|overuse of low-value services
317581|NCT02247050|Pragmatic Trial|pragmatic trial
317582|NCT02247050|Stepped Wedge Design|stepped wedge design
317583|NCT02247050|Cluster Randomized Trial|cluster randomized trial
317584|NCT02247050|Choosing Wisely|choosing wisely
317585|NCT02247037|Triple Negative Breast Cancer|triple negative breast cancer
317586|NCT02247037|Patient Derived Xenograft|patient derived xenograft
317587|NCT02247037|Neoadjuvant Chemotherapy|neoadjuvant chemotherapy
317588|NCT02247037|Therapeutic Resistance|therapeutic resistance
317589|NCT02247011|bone mineral density|bone mineral density
317590|NCT02247011|25(OH)D|25(oh)d
317591|NCT02246985|Processed foods|processed foods
317592|NCT02246985|Carotenoids in plasma, urine and faeces|carotenoids in plasma, urine and faeces
317593|NCT02246985|alpha-carotene|alpha-carotene
317594|NCT02246985|beta-carotene|beta-carotene
317595|NCT02246985|Vitamin A|vitamin a
317596|NCT02246985|Lycopene|lycopene
317597|NCT02246985|Gut absorption|gut absorption
317598|NCT02246985|Bread|bread
317599|NCT02246985|Mayonnaise|mayonnaise
317600|NCT02246985|Bioavailability|bioavailability
317601|NCT02246985|Fruits and Vegetables|fruits and vegetables
317602|NCT02246985|Inflammation|inflammation
317603|NCT02246985|Oxidative Stress|oxidative stress
317604|NCT02246972|PTSD|ptsd
317605|NCT02246972|Military sexual trauma|military sexual trauma
317606|NCT02246972|Veterans|veterans
317607|NCT02246972|Women in the military|women in the military
317608|NCT02246972|Sexual assault|sexual assault
317609|NCT02246946|pleural effusion|pleural effusion
317610|NCT02246946|chest tube|chest tube
317611|NCT02246946|respiratory therapy|respiratory therapy
317612|NCT02246946|intermittent positive-pressure breathing|intermittent positive-pressure breathing
317613|NCT02246946|lung function|lung function
317614|NCT02246946|pulmonary complications|pulmonary complications
317615|NCT02246920|Bioequivalence|bioequivalence
317616|NCT02246920|Allergic Rhinitis|allergic rhinitis
317617|NCT02246907|Health related quality of life|health related quality of life
317618|NCT02246855|Subjects|subjects
317619|NCT02246842|Volunteers|volunteers
317620|NCT02246829|wet AMD, SD-OCT, intravitreal injection, central retinal thickness,|wet amd, sd-oct, intravitreal injection, central retinal thickness,
317621|NCT02246816|Short Bowel Syndrome|short bowel syndrome
317622|NCT02246816|SBS|sbs
317623|NCT02246816|Chronic Diarrhea|chronic diarrhea
317624|NCT02246816|Short Bowel|short bowel
317625|NCT02246816|Short Gut|short gut
317626|NCT02246816|Short Gut Syndrome|short gut syndrome
317627|NCT02246816|Anti-Diarrheal|anti-diarrheal
317628|NCT02246816|Opium Tincture|opium tincture
317629|NCT02246816|loperamide|loperamide
317630|NCT02246816|diphenoxylate|diphenoxylate
317631|NCT02246816|ileostomies|ileostomies
317632|NCT02246816|tincture of opium|tincture of opium
317633|NCT02246816|DTO|dto
317634|NCT02246816|codeine|codeine
317635|NCT02246816|morphine|morphine
317636|NCT02246816|opiate|opiate
317637|NCT02246803|paroxysmal atrial fibrillation, CABG, pulmonary vein isolation|paroxysmal atrial fibrillation, cabg, pulmonary vein isolation
317638|NCT02246790|ablation, CABG|ablation, cabg
317639|NCT02246790|Long-standing persistent Atrial Fibrillation|long-standing persistent atrial fibrillation
317640|NCT02246777|Glaucoma|glaucoma
317641|NCT02246764|Ocular hypertension.|ocular hypertension.
317642|NCT02246764|Glaucoma|glaucoma
317643|NCT02246751|postural control|postural control
317644|NCT02246751|Targeted Training|targeted training
317645|NCT02246751|cerebral palsy|cerebral palsy
317646|NCT02246751|sensorimotor control|sensorimotor control
317647|NCT02246751|trunk segments|trunk segments
317648|NCT02246725|Colorectal Neoplasms|colorectal neoplasms
317649|NCT02246725|Depression|depression
317650|NCT02246725|Intestinal Neoplasms|intestinal neoplasms
317651|NCT02246725|Gastrointestinal Neoplasms|gastrointestinal neoplasms
317652|NCT02246725|Digestive System Neoplasms|digestive system neoplasms
317653|NCT02246725|Digestive System Diseases|digestive system diseases
317654|NCT02246725|Gastrointestinal Diseases|gastrointestinal diseases
317655|NCT02246725|Intestinal Diseases|intestinal diseases
317656|NCT02246725|Palliative chemotherapy|palliative chemotherapy
317657|NCT02246725|Palliative care|palliative care
317658|NCT02246725|Palliative treatment|palliative treatment
317659|NCT02246725|Quality of life|quality of life
317660|NCT02246725|Quality of life for relatives|quality of life for relatives
317661|NCT02246725|Survival|survival
317662|NCT02246712|tramadol|tramadol
317663|NCT02246712|pharmacokinetics|pharmacokinetics
317664|NCT02246712|enantiomers|enantiomers
317665|NCT02246712|metabolism|metabolism
317666|NCT02246712|diabetes|diabetes
317667|NCT02246699|obesity|obesity
317668|NCT02246699|overweight|overweight
317669|NCT02246699|chitosan|chitosan
317670|NCT02246699|fungal chitosan|fungal chitosan
317671|NCT02246699|weight management|weight management
317672|NCT02246686|Iberogast N|iberogast n
317673|NCT02246686|Mild to moderate ulcerative colitis|mild to moderate ulcerative colitis
317674|NCT02246686|add-on therapy|add-on therapy
317675|NCT02246686|efficacy|efficacy
317676|NCT02246660|Peripheral Artery Disease|peripheral artery disease
317677|NCT02246660|Peripheral Arterial Disease|peripheral arterial disease
317678|NCT02246660|PAD|pad
317679|NCT02246634|Colorectal Neoplasms|colorectal neoplasms
317680|NCT02246634|Neoplasm Metastases|neoplasm metastases
317681|NCT02246634|Magnetic Resonance Imaging|magnetic resonance imaging
317682|NCT02246634|Diffusion Weighted MRI|diffusion weighted mri
317683|NCT02246634|Hepatic Neoplasms|hepatic neoplasms
317684|NCT02246634|Tumors|tumors
317685|NCT02246634|Neoplasms, Rectal|neoplasms, rectal
317686|NCT02246621|MONARCH 3|monarch 3
317687|NCT02246595|Sepsis|sepsis
317688|NCT02246595|Severe Sepsis|severe sepsis
317689|NCT02246595|Septic Shock|septic shock
317690|NCT02246595|Systemic Inflammatory Response Syndrome|systemic inflammatory response syndrome
317691|NCT02246595|Organ Dysfunction|organ dysfunction
317692|NCT02246582|Type 1 Diabetes|type 1 diabetes
317693|NCT02246582|Type 2 Diabetes|type 2 diabetes
317694|NCT02246582|Enlite 3|enlite 3
317695|NCT02246569|Chronic obstructive pulmonary disease (COPD)|chronic obstructive pulmonary disease (copd)
317696|NCT02246569|endoscopic lung volume reduction|endoscopic lung volume reduction
317697|NCT02246569|RePneu®Coils|repneu®coils
317698|NCT02246569|physical capacity|physical capacity
317699|NCT02246569|quality of life|quality of life
317700|NCT02246556|Amblyopia|amblyopia
317701|NCT02246556|Dichoptic|dichoptic
317702|NCT02246556|Virtual reality|virtual reality
317703|NCT02246556|Stereopsis|stereopsis
317704|NCT02246556|Stereo vision|stereo vision
317705|NCT02246556|Visual acuity|visual acuity
317706|NCT02246556|Binocular|binocular
317707|NCT02246543|Appetite|appetite
317708|NCT02246543|Gut Hormones|gut hormones
317709|NCT02246543|Protein|protein
317710|NCT02246543|Energy Density|energy density
317711|NCT02246543|Gastric Emptying|gastric emptying
317712|NCT02246465|Hypertrophic scar|hypertrophic scar
317713|NCT02246465|Cicatrix|cicatrix
317714|NCT02246465|Scar prevention|scar prevention
317715|NCT02246465|Scar revision|scar revision
317716|NCT02246452|Children and adolescents|children and adolescents
317717|NCT02246452|Cancer|cancer
317718|NCT02246452|Malnutrition|malnutrition
317719|NCT02246452|BMI percentile|bmi percentile
317720|NCT02246452|BMI-SDS|bmi-sds
317721|NCT02246439|Gastroenteritis|gastroenteritis
317722|NCT02246439|Gastritis|gastritis
317723|NCT02246439|Vomiting|vomiting
317724|NCT02246439|Nausea|nausea
317725|NCT02246439|Diarrhea|diarrhea
317726|NCT02246413|BMI|bmi
317727|NCT02246413|Depressive symptoms|depressive symptoms
317728|NCT02246413|Integrated therapy|integrated therapy
317729|NCT02246413|Cardiometabolic risk|cardiometabolic risk
317730|NCT02246413|Self-regulation|self-regulation
317731|NCT02246413|Behavior change|behavior change
317732|NCT02246413|Precision medicine|precision medicine
317733|NCT02246413|Lifestyle|lifestyle
317734|NCT02246400|eCMP|ecmp
317735|NCT02246400|eHealth|ehealth
317736|NCT02246400|mHealth|mhealth
317737|NCT02246400|Lifestyle intervention|lifestyle intervention
317738|NCT02246400|Cardiometabolic risk reduction|cardiometabolic risk reduction
317739|NCT02246400|PAMF|pamf
317740|NCT02246387|Pelvic Organ Prolapse|pelvic organ prolapse
317741|NCT02246387|Gynecologic Surgery Procedures|gynecologic surgery procedures
317742|NCT02246387|Treatment Outcome|treatment outcome
317743|NCT02246374|Parkinson's Disease|parkinson's disease
317744|NCT02246374|ExAblate|exablate
317745|NCT02246374|MRgFUS|mrgfus
317746|NCT02246361|Ankle sprain|ankle sprain
317747|NCT02246361|Infectious colitis|infectious colitis
317748|NCT02246361|Diverticulitis|diverticulitis
317749|NCT02246361|Pyelonephritis|pyelonephritis
317750|NCT02246361|Prostatitis|prostatitis
317751|NCT02246361|Pneumonitis|pneumonitis
317752|NCT02246361|Patient Information Leaflet (PIL)|patient information leaflet (pil)
318143|NCT02244502|Novocure|novocure
317753|NCT02246361|Doctor Patient Communication|doctor patient communication
317754|NCT02246361|Adherence|adherence
317755|NCT02246361|Satisfaction|satisfaction
317757|NCT02246361|Doctor Patient Communication scale|doctor patient communication scale
317758|NCT02246361|Adherence scale|adherence scale
317759|NCT02246361|Satisfaction scale|satisfaction scale
317760|NCT02246348|Systemic Sclerosis|systemic sclerosis
317761|NCT02246348|Pulmonary hypertension|pulmonary hypertension
317762|NCT02246348|Lung Doppler signals|lung doppler signals
317763|NCT02246322|Pancreatic cancer|pancreatic cancer
317764|NCT02246322|Neuroendocrine tumors|neuroendocrine tumors
317765|NCT02246322|Lymphadenopathies|lymphadenopathies
317766|NCT02246322|GIST|gist
317767|NCT02246322|Gastrointestinal wall neoplasia|gastrointestinal wall neoplasia
317768|NCT02246309|Infertility|infertility
317769|NCT02246309|Embryo Culture|embryo culture
317770|NCT02246309|Laboratory Technique|laboratory technique
317771|NCT02246296|severe acute malnutrition|severe acute malnutrition
317772|NCT02246296|wasting|wasting
317773|NCT02246296|kwashiorkor|kwashiorkor
317774|NCT02246296|nutrition|nutrition
317775|NCT02246296|feeding|feeding
317776|NCT02246296|milk|milk
317777|NCT02246283|schizophrenia|schizophrenia
317778|NCT02246283|elderly|elderly
317779|NCT02246283|lifelong|lifelong
317780|NCT02246283|quality of life|quality of life
317781|NCT02246283|register|register
317782|NCT02246283|questionaire|questionaire
317783|NCT02246218|Urea Cycle Disorder|urea cycle disorder
317784|NCT02246218|UCD|ucd
317785|NCT02246218|Buphenyl|buphenyl
317786|NCT02246218|Glycerol Phenylbutyrate|glycerol phenylbutyrate
317787|NCT02246218|Ravicti|ravicti
317788|NCT02246218|Hyperammonemia|hyperammonemia
317789|NCT02246218|Sodium Phenylbutyrate|sodium phenylbutyrate
317790|NCT02246218|GPB|gpb
317791|NCT02246218|HPN-100|hpn-100
317792|NCT02246205|pancreaticoduodenectomy|pancreaticoduodenectomy
317793|NCT02246205|delayed gastric emptying|delayed gastric emptying
317794|NCT02246205|Roux en-Y reconstruction|roux en-y reconstruction
317795|NCT02246179|Fractional laser|fractional laser
317796|NCT02246179|Topical anesthesia|topical anesthesia
317797|NCT02246179|Drug delivery|drug delivery
317798|NCT02246153|Laparoscopic gastrectomy|laparoscopic gastrectomy
317799|NCT02246153|Advanced gastric cancer|advanced gastric cancer
317800|NCT02246153|Elderly patients|elderly patients
317801|NCT02246153|Morbidity|morbidity
317802|NCT02246153|Mortality|mortality
317803|NCT02246127|advanced pNET|advanced pnet
317804|NCT02246127|everolimus|everolimus
317805|NCT02246127|STZ-5FU|stz-5fu
317806|NCT02246127|treatment sequence|treatment sequence
317807|NCT02246114|Pregnancy|pregnancy
317808|NCT02246114|Smoking|smoking
317809|NCT02246114|Smoking cessation|smoking cessation
317810|NCT02246101|cardiac disease|cardiac disease
317811|NCT02246101|cardiopulmonary disease|cardiopulmonary disease
317812|NCT02246101|renal disease|renal disease
317813|NCT02246101|albuminuria|albuminuria
317814|NCT02246101|cardiovascular disease|cardiovascular disease
317815|NCT02246101|CVD|cvd
317816|NCT02246101|particulate matter|particulate matter
317817|NCT02246088|Osteoarthritis, Central Nervous System Sensitization|osteoarthritis, central nervous system sensitization
317818|NCT02246075|Alzheimer's disease|alzheimer's disease
317819|NCT02246075|Cognition|cognition
317820|NCT02246075|Alpha-7 nAChR|alpha-7 nachr
317821|NCT02246062|Anxiety|anxiety
317822|NCT02246062|Anesthesia|anesthesia
317823|NCT02246062|Evaluation|evaluation
317824|NCT02246062|Preoperative care|preoperative care
317825|NCT02246062|Child|child
317826|NCT02246049|Metastatic colorectal cancer, bevacizumab, FOLFOXIRI|metastatic colorectal cancer, bevacizumab, folfoxiri
317827|NCT02246010|diarrhea|diarrhea
317828|NCT02246010|developing world|developing world
317829|NCT02246010|lactose-free diet|lactose-free diet
317830|NCT02246010|Clinical trial|clinical trial
317953|NCT02245321|hemoglobin recovery|hemoglobin recovery
317831|NCT02245997|Reduced-dose Radiotherapy|reduced-dose radiotherapy
317832|NCT02245997|14-186|14-186
317833|NCT02245984|clinical competence, nursing process, nursing student|clinical competence, nursing process, nursing student
317834|NCT02245945|HIV|hiv
317835|NCT02245945|prevention|prevention
317836|NCT02245932|Pulmonary disease, Chronic Obstructive|pulmonary disease, chronic obstructive
317837|NCT02245932|Cardiovascular diseases|cardiovascular diseases
317838|NCT02245932|Metabolism|metabolism
317839|NCT02245932|Resveratrol|resveratrol
317840|NCT02245919|Low Back Pain|low back pain
317841|NCT02245919|Chronic Pain|chronic pain
317842|NCT02245919|Cognitive Behavioral Therapy|cognitive behavioral therapy
317843|NCT02245919|Primary Health Care|primary health care
317844|NCT02245919|Physical Therapy|physical therapy
317845|NCT02245906|Brazilian fruit peel|brazilian fruit peel
317846|NCT02245906|Functional food|functional food
317847|NCT02245906|Cardiometabolic risk|cardiometabolic risk
317848|NCT02245906|Metabolic syndrome|metabolic syndrome
317849|NCT02245906|Inflammation|inflammation
317850|NCT02245906|Appetite|appetite
317851|NCT02245906|Gut hormone|gut hormone
317852|NCT02245880|cervical spine|cervical spine
317853|NCT02245880|intubating laryngeal mask airway|intubating laryngeal mask airway
317854|NCT02245880|Glidescope videolaryngoscope|glidescope videolaryngoscope
317855|NCT02245880|collar|collar
317856|NCT02245867|Amyloidosis|amyloidosis
317857|NCT02245867|Relapse|relapse
317858|NCT02245867|Refractory|refractory
317859|NCT02245854|diminutive polyps|diminutive polyps
317860|NCT02245854|small polyps|small polyps
317861|NCT02245854|cold snare polypectomy|cold snare polypectomy
317862|NCT02245854|complications|complications
317863|NCT02245854|bleeding|bleeding
317864|NCT02245841|dermatomyositis|dermatomyositis
317865|NCT02245841|Acthar gel|acthar gel
317866|NCT02245828|healthy subjects, inhaled|healthy subjects, inhaled
317867|NCT02245815|Necrotizing enterocolitis|necrotizing enterocolitis
317868|NCT02245815|Probiotics|probiotics
317869|NCT02245815|Secreting IgA|secreting iga
317870|NCT02245815|Preterm newborns|preterm newborns
317871|NCT02245802|Bleeding peptic ulcer|bleeding peptic ulcer
317872|NCT02245802|Prediction model|prediction model
317873|NCT02245802|Mortality|mortality
317874|NCT02245802|Prediction of in-hospital mortality for bleeding peptic ulcer|prediction of in-hospital mortality for bleeding peptic ulcer
317875|NCT02245776|Incurable Neurological Disorders|incurable neurological disorders
317876|NCT02245776|Autologous mononuclear cell therapy|autologous mononuclear cell therapy
317877|NCT02245776|Stem cells|stem cells
317878|NCT02245750|hysteroscopy - recurrent implantation failure|hysteroscopy - recurrent implantation failure
317879|NCT02245737|Alzheimer's disease|alzheimer's disease
317880|NCT02245737|Dementia|dementia
317881|NCT02245737|Brain Diseases|brain diseases
317882|NCT02245737|Neurogenerative Diseases|neurogenerative diseases
317883|NCT02245737|Central Nervous System Diseases|central nervous system diseases
317884|NCT02245737|Nervous System Diseases|nervous system diseases
317885|NCT02245737|Mental Disorders|mental disorders
317886|NCT02245737|Delirium, Dementia, Amnestic, Cognitive Disorders|delirium, dementia, amnestic, cognitive disorders
317887|NCT02245737|Tauopathies|tauopathies
317888|NCT02245724|Mental retardation|mental retardation
317889|NCT02245724|Autologous mononuclear cell therapy|autologous mononuclear cell therapy
317890|NCT02245724|Stem cell|stem cell
317891|NCT02245711|Limb Girdle Muscular Dystrophy|limb girdle muscular dystrophy
317892|NCT02245711|Autologous Bone Marrow Mononuclear cell therapy|autologous bone marrow mononuclear cell therapy
317893|NCT02245711|Stem Cell|stem cell
317894|NCT02245698|Chronic Stroke|chronic stroke
317895|NCT02245698|Subacute stroke|subacute stroke
317896|NCT02245698|Autologous Bone Marrow Mononuclear Cell therapy|autologous bone marrow mononuclear cell therapy
317897|NCT02245698|Stem cell|stem cell
317898|NCT02245685|Substitution Therapy|substitution therapy
317899|NCT02245685|Specialized Care Center for Addicts|specialized care center for addicts
317900|NCT02245672|Asthma|asthma
317901|NCT02245672|fluticasone|fluticasone
317902|NCT02245672|salmeterol|salmeterol
317903|NCT02245672|CRC749|crc749
317904|NCT02245672|Diskus|diskus
317905|NCT02245672|Advair|advair
317906|NCT02245672|FEV1|fev1
317907|NCT02245672|MGR001|mgr001
317908|NCT02245620|Skeletal muscle dysfunction, MTP-131, Bendavia™|skeletal muscle dysfunction, mtp-131, bendavia™
317909|NCT02245620|elamipretide|elamipretide
317910|NCT02245607|Psychotic Disorders|psychotic disorders
317911|NCT02245607|Cognitive Training|cognitive training
317912|NCT02245607|Mental Disorders|mental disorders
317913|NCT02245607|Schizophrenia and Disorders with Psychotic Features|schizophrenia and disorders with psychotic features
317914|NCT02245594|Gastrointestinal motility|gastrointestinal motility
317915|NCT02245594|Motility Tracking System (MTS)|motility tracking system (mts)
317916|NCT02245594|Transit time|transit time
317917|NCT02245594|Sleep pattern|sleep pattern
317918|NCT02245568|Dementia|dementia
317919|NCT02245568|Alzheimer Disease|alzheimer disease
317920|NCT02245568|bvFTD|bvftd
317921|NCT02245568|Frontotemporal Dementia|frontotemporal dementia
317922|NCT02245568|Neurodegenerative Diseases|neurodegenerative diseases
317923|NCT02245568|Brain Diseases|brain diseases
317924|NCT02245568|Cognitive Disorders|cognitive disorders
317925|NCT02245516|Intraretinal Fluid|intraretinal fluid
317926|NCT02245516|Subretinal Fluid|subretinal fluid
317927|NCT02245516|Retinal Vein Occlusion|retinal vein occlusion
317928|NCT02245516|Diabetic Macular Edema|diabetic macular edema
317929|NCT02245477|Serum VEGF, FGR|serum vegf, fgr
317930|NCT02245425|Neck pain|neck pain
317931|NCT02245425|Thoracic spine manipulation|thoracic spine manipulation
317932|NCT02245425|Range of Motion|range of motion
317933|NCT02245425|Disability|disability
317934|NCT02245412|GIGVHD|gigvhd
317935|NCT02245399|Weight loss|weight loss
317936|NCT02245399|Diabetes|diabetes
317937|NCT02245399|Cardiovascular disease (CVD) risk|cardiovascular disease (cvd) risk
317938|NCT02245399|Weight loss diet|weight loss diet
317939|NCT02245399|mediterranean type diet|mediterranean type diet
317940|NCT02245399|Canola oil|canola oil
317941|NCT02245399|Low-carbohydrate diet|low-carbohydrate diet
317942|NCT02245399|Glycemic index|glycemic index
317943|NCT02245373|Depression|depression
317944|NCT02245373|Primary Care|primary care
317945|NCT02245373|Cost-effectiveness|cost-effectiveness
317946|NCT02245373|Pharmacological treatment|pharmacological treatment
317947|NCT02245373|Watchful-waiting or Active Monitoring.|watchful-waiting or active monitoring.
317949|NCT02245347|TB|tb
317950|NCT02245347|Tuberculosis|tuberculosis
317951|NCT02245347|MDR TB|mdr tb
317952|NCT02245347|Drug resistant TB|drug resistant tb
317954|NCT02245321|iron recovery|iron recovery
317955|NCT02245321|iron supplements|iron supplements
317956|NCT02245308|Tobacco use cessation|tobacco use cessation
317957|NCT02245308|Homelessness|homelessness
317958|NCT02245308|Veterans|veterans
317959|NCT02245295|Bronchial endoscopy|bronchial endoscopy
317960|NCT02245295|ultrasound|ultrasound
317961|NCT02245295|EBUS|ebus
317962|NCT02245295|anesthesia|anesthesia
317963|NCT02245295|lung cancer|lung cancer
317964|NCT02245295|diagnosis including staging|diagnosis including staging
317965|NCT02245256|delirium|delirium
317966|NCT02245256|incidence|incidence
317967|NCT02245256|dexmedetomidine|dexmedetomidine
317968|NCT02245243|Hepatic Impairment, single dose, intravenous|hepatic impairment, single dose, intravenous
317969|NCT02245230|Hypertension|hypertension
317970|NCT02245230|Autonomic Nervous System|autonomic nervous system
317971|NCT02245230|Renin-Angiotensin System|renin-angiotensin system
317972|NCT02245230|Angiotensin (1-7)|angiotensin (1-7)
317973|NCT02245230|Ganglionic Blockers|ganglionic blockers
317974|NCT02245230|Trimethaphan|trimethaphan
317975|NCT02245230|Blood Pressure|blood pressure
317976|NCT02245230|Hemodynamics|hemodynamics
317977|NCT02245191|Vasopressor|vasopressor
317978|NCT02245191|Cesarian delivery|cesarian delivery
317979|NCT02245191|Hypotension|hypotension
317980|NCT02245191|Maternal cardiac output|maternal cardiac output
317981|NCT02245191|Uteroplacental blood flow|uteroplacental blood flow
317982|NCT02245191|Cerebral fetal blood flow|cerebral fetal blood flow
317983|NCT02245191|Preeclampsia|preeclampsia
317984|NCT02245165|Nitric oxide|nitric oxide
317985|NCT02245165|Nitric oxide synthase|nitric oxide synthase
317986|NCT02245165|Gastrointestinal motility|gastrointestinal motility
317987|NCT02245165|Gut peptide hormones|gut peptide hormones
317988|NCT02245152|child acute malnutrition|child acute malnutrition
317989|NCT02245152|prevention|prevention
317990|NCT02245152|behavior change communication|behavior change communication
317991|NCT02245152|lipid-based nutrient supplement|lipid-based nutrient supplement
317992|NCT02245152|screening coverage|screening coverage
317993|NCT02245139|diarrhea|diarrhea
317994|NCT02245139|vomiting|vomiting
317995|NCT02245139|fever|fever
317996|NCT02245139|abdominal pain|abdominal pain
317997|NCT02245139|oliguria|oliguria
317998|NCT02245126|Pain, Visual analogue scale|pain, visual analogue scale
317999|NCT02245087|atorvastatin|atorvastatin
318000|NCT02245087|coronary artery disease|coronary artery disease
318001|NCT02245087|myocardial infarction|myocardial infarction
318002|NCT02245087|stroke|stroke
318003|NCT02245087|revascularization|revascularization
318004|NCT02245074|Infantile asthma|infantile asthma
318005|NCT02245074|Induced sputum|induced sputum
318006|NCT02245074|Phenotypes|phenotypes
318007|NCT02245074|Eosinophils|eosinophils
318008|NCT02245074|Neutrophils|neutrophils
318009|NCT02245061|pharmacoresistant focal epilepsy|pharmacoresistant focal epilepsy
318010|NCT02245061|cortical excitability|cortical excitability
318011|NCT02245061|paired pulses|paired pulses
318012|NCT02245061|TMS|tms
318013|NCT02245061|SEEG|seeg
318014|NCT02245061|DES|des
318015|NCT02245048|Cardiovascular Risk Stratification|cardiovascular risk stratification
318016|NCT02245048|Carotid intima-media thickness (CIMT)|carotid intima-media thickness (cimt)
318017|NCT02245048|Stress echocardiography (SE)|stress echocardiography (se)
318018|NCT02245035|Glutathione|glutathione
318019|NCT02245035|Dairy consumption|dairy consumption
318020|NCT02245035|Brain|brain
318021|NCT02245035|Humans|humans
318022|NCT02245022|HIV|hiv
318023|NCT02245022|Prevention of mother to child transmission|prevention of mother to child transmission
318024|NCT02245022|Africa|africa
318025|NCT02245022|Uganda|uganda
318026|NCT02245022|Pharmacokinetics|pharmacokinetics
318027|NCT02245022|Pregnancy|pregnancy
318028|NCT02245022|Breastfeeding|breastfeeding
318029|NCT02244996|Retinitis pigmentosa|retinitis pigmentosa
318030|NCT02244996|Lycium barbarum|lycium barbarum
318031|NCT02244996|Antioxidation|antioxidation
318032|NCT02244996|Visual field|visual field
318033|NCT02244996|Electroretinogram|electroretinogram
318034|NCT02244970|Mindfulness|mindfulness
318035|NCT02244970|Depressive mood|depressive mood
318036|NCT02244970|anxiety|anxiety
318037|NCT02244970|early psychosis|early psychosis
318038|NCT02244944|nonalcoholic fatty liver disease|nonalcoholic fatty liver disease
318039|NCT02244944|NAFLD|nafld
318040|NCT02244931|Spinal cord injuries, paraplegic, manual wheelchairs, assisting propelling device|spinal cord injuries, paraplegic, manual wheelchairs, assisting propelling device
318041|NCT02244905|Positive Deviance|positive deviance
318042|NCT02244905|Infection Control|infection control
318043|NCT02244905|Healthcare-Associated Infections|healthcare-associated infections
318044|NCT02244905|Staff Engagement|staff engagement
318045|NCT02244905|Cluster Randomized Controlled Trial|cluster randomized controlled trial
318046|NCT02244892|Disability glare|disability glare
318047|NCT02244892|Corneal scar|corneal scar
318048|NCT02244892|Corneal haze|corneal haze
318049|NCT02244892|Scheimpflug densitometry|scheimpflug densitometry
318050|NCT02244892|Contrast sensitivity|contrast sensitivity
318051|NCT02244879|resveratrol|resveratrol
318052|NCT02244879|type 2 diabetes mellitus|type 2 diabetes mellitus
318053|NCT02244879|inflammation|inflammation
318054|NCT02244879|insulin resistance|insulin resistance
318055|NCT02244879|body composition|body composition
318056|NCT02244879|bone mass|bone mass
318057|NCT02244866|IVF|ivf
318058|NCT02244866|LH supplementation|lh supplementation
318059|NCT02244866|ovarian stimulation|ovarian stimulation
318060|NCT02244866|poor responder|poor responder
318061|NCT02244840|Bidet, Sitz bath, Anal resting pressure|bidet, sitz bath, anal resting pressure
318062|NCT02244814|glucose|glucose
318063|NCT02244814|insulin resistance|insulin resistance
318064|NCT02244814|dietary carbohydrate|dietary carbohydrate
318065|NCT02244814|dietary fat|dietary fat
318066|NCT02244814|adiposity|adiposity
318067|NCT02244814|Air displacement plethysmography|air displacement plethysmography
318068|NCT02244814|Dual X-ray Absorptiometry|dual x-ray absorptiometry
318069|NCT02244814|continuous glucose monitoring|continuous glucose monitoring
318070|NCT02244775|osteo-arthritis|osteo-arthritis
318071|NCT02244775|post traumatic arthritis|post traumatic arthritis
318072|NCT02244736|Arterial stiffness|arterial stiffness
318073|NCT02244736|Endothelial glycocalyx|endothelial glycocalyx
318074|NCT02244736|Coronary flow reserve|coronary flow reserve
318075|NCT02244723|Ventilator-Associated Pneumonia|ventilator-associated pneumonia
318076|NCT02244723|diagnosis|diagnosis
318077|NCT02244710|Circulating Endothelial Cells|circulating endothelial cells
318078|NCT02244710|Endothelial Progenitor Cells|endothelial progenitor cells
318079|NCT02244710|Acute coronary syndrome (ACS)|acute coronary syndrome (acs)
318080|NCT02244710|Ticagrelor|ticagrelor
318081|NCT02244697|Stridor|stridor
318082|NCT02244697|Vocal Cord Paralysis (VCP)|vocal cord paralysis (vcp)
318083|NCT02244697|Ultrasound (US)|ultrasound (us)
318084|NCT02244684|Folate|folate
318085|NCT02244684|Folic Acid|folic acid
318086|NCT02244684|One-Carbon Nutrients|one-carbon nutrients
318087|NCT02244684|Epigenetics|epigenetics
318088|NCT02244684|Pregnancy|pregnancy
318089|NCT02244684|Fetal Health|fetal health
318090|NCT02244658|chemotherapy-induced thrombocytopenia|chemotherapy-induced thrombocytopenia
318091|NCT02244658|recombinant human thrombopoietin|recombinant human thrombopoietin
318092|NCT02244658|acute myelocytic leukemia|acute myelocytic leukemia
318093|NCT02244645|Low back pain, physical therapy, yoga.|low back pain, physical therapy, yoga.
318094|NCT02244632|Colorectal cancer|colorectal cancer
318095|NCT02244632|Colorectal carcinoma|colorectal carcinoma
318096|NCT02244632|Colorectal tumors|colorectal tumors
318097|NCT02244632|Intestinal Neoplasm|intestinal neoplasm
318098|NCT02244632|Gastrointestinal Neoplasm|gastrointestinal neoplasm
318099|NCT02244632|Gastrointestinal disease|gastrointestinal disease
318100|NCT02244632|5,10-methylenetetrahydrofolate|5,10-methylenetetrahydrofolate
318101|NCT02244632|Tetrahydrofolates|tetrahydrofolates
318102|NCT02244632|Therapeutic uses|therapeutic uses
318103|NCT02244632|Pharmacokinetics|pharmacokinetics
318104|NCT02244632|Pharmacodynamics|pharmacodynamics
318105|NCT02244632|Safety assessments|safety assessments
318106|NCT02244619|Hip replacement|hip replacement
318107|NCT02244619|Knee replacement|knee replacement
318108|NCT02244619|randomized trial|randomized trial
318109|NCT02244619|acetaminophen|acetaminophen
318110|NCT02244619|post-op pain management|post-op pain management
318111|NCT02244606|Invasive Candidiasis|invasive candidiasis
318112|NCT02244606|Invasive Candida infections|invasive candida infections
318113|NCT02244606|Candidemia|candidemia
318114|NCT02244606|SCY-078|scy-078
318115|NCT02244606|Micafungin|micafungin
318116|NCT02244606|Fluconazole|fluconazole
318117|NCT02244606|Echinocandin|echinocandin
318118|NCT02244593|breast cancer survivors|breast cancer survivors
318119|NCT02244593|FAST MRI|fast mri
318120|NCT02244593|mammography screening|mammography screening
318121|NCT02244580|Subtyping of Invasive breast cancer|subtyping of invasive breast cancer
318122|NCT02244567|PCOS|pcos
318123|NCT02244554|tattoo removal|tattoo removal
318124|NCT02244554|Q-switched laser|q-switched laser
318125|NCT02244554|Nd:YAG laser|nd:yag laser
318126|NCT02244554|nanosecond laser|nanosecond laser
318127|NCT02244554|picosecond laser|picosecond laser
318128|NCT02244554|laser therapy|laser therapy
318129|NCT02244554|tattoo|tattoo
318130|NCT02244554|pulsed-laser|pulsed-laser
318131|NCT02244554|laser treatment|laser treatment
318132|NCT02244554|remove tattoo|remove tattoo
318133|NCT02244554|tattoo clearing|tattoo clearing
318134|NCT02244554|tattoo lightening|tattoo lightening
318135|NCT02244554|tattoo lighten|tattoo lighten
318136|NCT02244554|resistant tattoo|resistant tattoo
318137|NCT02244515|children|children
318138|NCT02244502|Ovarian Carcinoma|ovarian carcinoma
318139|NCT02244502|Treatment|treatment
318140|NCT02244502|Minimal toxicity|minimal toxicity
318141|NCT02244502|TTFields|ttfields
318142|NCT02244502|Tumor Treating Fields|tumor treating fields
318144|NCT02244502|Paclitaxel|paclitaxel
318145|NCT02244502|Weekly paclitaxel|weekly paclitaxel
318146|NCT02244476|mouth feel|mouth feel
318147|NCT02244476|acoustic tribology|acoustic tribology
318148|NCT02244476|vibration spectrum|vibration spectrum
318149|NCT02244476|sensory perception|sensory perception
318150|NCT02244463|Anaplastic Thyroid Cancer|anaplastic thyroid cancer
318151|NCT02244463|Thyroid Cancer|thyroid cancer
318152|NCT02244450|Neonatal screening|neonatal screening
318153|NCT02244450|severe combined immunodeficiency|severe combined immunodeficiency
318154|NCT02244450|T-cell Receptor Excision Circle|t-cell receptor excision circle
318155|NCT02244437|altitude, altitude illnesses, headache|altitude, altitude illnesses, headache
318156|NCT02244424|Infant|infant
318157|NCT02244424|Obesity|obesity
318158|NCT02244424|Adolescent|adolescent
318159|NCT02244424|Social media|social media
318160|NCT02244424|Prevention|prevention
318161|NCT02244411|EQUAL|equal
318162|NCT02244411|Exercise|exercise
318163|NCT02244411|Diet|diet
318164|NCT02244411|Physical activity|physical activity
318165|NCT02244411|14-164|14-164
318166|NCT02244385|vascular disease|vascular disease
318167|NCT02244385|pregnancy|pregnancy
318168|NCT02244385|chronic hypertension|chronic hypertension
318169|NCT02244385|diabetes|diabetes
318170|NCT02244385|obesity|obesity
318171|NCT02244372|Cordyceps sinensis mycelium culture extract(Paecilomyces hepiali, CBG-CS-2)|cordyceps sinensis mycelium culture extract(paecilomyces hepiali, cbg-cs-2)
318172|NCT02244372|immunity|immunity
318173|NCT02244359|Shared Decision making|shared decision making
318174|NCT02244359|Patient Centred care|patient centred care
318175|NCT02244359|Interprofessionalism|interprofessionalism
318176|NCT02244359|Home care|home care
318177|NCT02244359|Frail elderly|frail elderly
318178|NCT02244164|Type 2 Diabetes|type 2 diabetes
318179|NCT02244164|Incretinomimetics|incretinomimetics
318180|NCT02244164|DPP-4 inhibitors|dpp-4 inhibitors
318181|NCT02244164|Pancreas|pancreas
318182|NCT02244164|PanIN|panin
318183|NCT02244164|RMN|rmn
318184|NCT02244164|Lipasemia|lipasemia
400514|NCT01866527|avascular necrosis,|avascular necrosis,
318185|NCT02244151|ovulation induction,oocyte maturation timing and collection|ovulation induction,oocyte maturation timing and collection
318186|NCT02244138|Adolescent|adolescent
318187|NCT02244138|Screening|screening
318188|NCT02244138|Primary Care|primary care
318189|NCT02244138|Computer Decision Support Systems|computer decision support systems
318190|NCT02244125|Myeloma|myeloma
318191|NCT02244125|Multiple Myeloma|multiple myeloma
318192|NCT02244125|Relapse|relapse
318193|NCT02244125|Refractory|refractory
318194|NCT02244125|PCD|pcd
318195|NCT02244125|IFM/DFCI 2009|ifm/dfci 2009
318196|NCT02244125|Transplantation|transplantation
318197|NCT02244125|Autologous|autologous
318198|NCT02244125|Pomalidomide|pomalidomide
318199|NCT02244125|Immunoglobulin|immunoglobulin
318200|NCT02244125|Ig|ig
318201|NCT02244125|Free light Chain|free light chain
318202|NCT02244099|Controlled substance prescribing|controlled substance prescribing
318203|NCT02244099|Controlled substance treatment agreements|controlled substance treatment agreements
318204|NCT02244099|Opioid use|opioid use
318205|NCT02244086|obstetric pain, bupivacaine, analgesic efficacy|obstetric pain, bupivacaine, analgesic efficacy
318206|NCT02244073|blood glucose target|blood glucose target
318208|NCT02244073|insulin|insulin
318209|NCT02244073|hypoglycemia|hypoglycemia
318210|NCT02244073|hyperglycemia|hyperglycemia
318211|NCT02244073|glycated hemoglobin|glycated hemoglobin
318212|NCT02244060|Vignette|vignette
318213|NCT02244060|Priming effect|priming effect
318214|NCT02244021|HD|hd
318215|NCT02244021|Hodgkin's Lymphoma|hodgkin's lymphoma
318216|NCT02244021|RELAPSED-REFRACTORY|relapsed-refractory
318217|NCT02244008|Mobilization|mobilization
318218|NCT02244008|Joint Range of Motion|joint range of motion
318219|NCT02244008|Ankle|ankle
318220|NCT02244008|Manual Therapy|manual therapy
318221|NCT02243995|Training program|training program
318222|NCT02243995|Resistance training|resistance training
318223|NCT02243995|Endurance training|endurance training
318224|NCT02243995|Muscle strength|muscle strength
318225|NCT02243995|Exercise capacity|exercise capacity
318226|NCT02243995|Fatigue|fatigue
318227|NCT02243995|Quality of life|quality of life
318228|NCT02243982|Parkinson, dementia, FDDNP, tau, beta-amyloid|parkinson, dementia, fddnp, tau, beta-amyloid
318229|NCT02243969|n-3 polyunsaturated fatty acids|n-3 polyunsaturated fatty acids
318230|NCT02243969|Alpha-linolenic acid|alpha-linolenic acid
318231|NCT02243969|Blood pressure|blood pressure
318232|NCT02243969|Vascular function|vascular function
318233|NCT02243943|Neuromuscular block|neuromuscular block
318234|NCT02243943|neuromuscular reversal|neuromuscular reversal
318235|NCT02243943|postoperative conditions|postoperative conditions
318236|NCT02243943|respiratory failure|respiratory failure
318237|NCT02243930|Sigmoidoscopy with or without cap|sigmoidoscopy with or without cap
318238|NCT02243930|Pain during sigmoidoscopy|pain during sigmoidoscopy
318239|NCT02243930|Sigmoidoscopy and time|sigmoidoscopy and time
318240|NCT02243904|Autonomic nervous function|autonomic nervous function
318241|NCT02243904|Blood pressure|blood pressure
318242|NCT02243904|Cardiovascular regulation|cardiovascular regulation
318243|NCT02243904|Lead|lead
318244|NCT02243904|Occupational exposure|occupational exposure
318245|NCT02243904|Renal function|renal function
318246|NCT02243852|Growth Hormone Deficiency (GHD)|growth hormone deficiency (ghd)
318247|NCT02243852|Growth Hormone Replacement Therapy|growth hormone replacement therapy
318248|NCT02243852|Fibroblast Growth Factor 21 (FGF21)|fibroblast growth factor 21 (fgf21)
318249|NCT02243852|Visceral Fat|visceral fat
318250|NCT02243852|Subcutaneous Fat|subcutaneous fat
318251|NCT02243839|Prosthetic valve|prosthetic valve
318252|NCT02243839|Thrombosis|thrombosis
318253|NCT02243839|Surgery|surgery
318254|NCT02243839|Thrombolytic therapy|thrombolytic therapy
318255|NCT02243839|Transesophageal echocardiography|transesophageal echocardiography
318256|NCT02243826|Lumbar puncture|lumbar puncture
318257|NCT02243826|Adults|adults
318258|NCT02243826|Nitrous oxide|nitrous oxide
318259|NCT02243826|Procedural pain|procedural pain
318260|NCT02243826|Procedural anxiety|procedural anxiety
318261|NCT02243813|Psilocybin|psilocybin
318262|NCT02243813|Pharmacologic Actions|pharmacologic actions
318263|NCT02243813|Psychotropic Drugs|psychotropic drugs
318264|NCT02243800|Vitamin D|vitamin d
318265|NCT02243800|Rheumatoid arthritis|rheumatoid arthritis
318266|NCT02243800|Cholecalciferol|cholecalciferol
318267|NCT02243774|Vaccination|vaccination
318268|NCT02243774|Immunization|immunization
318269|NCT02243774|Randomized Controlled Trial|randomized controlled trial
318270|NCT02243774|Prevention & Control|prevention & control
318271|NCT02243774|Preventive Measures|preventive measures
318272|NCT02243774|Health Promotion|health promotion
318273|NCT02243774|Medicare|medicare
318274|NCT02243774|Intention Prompts|intention prompts
318275|NCT02243774|Letters|letters
318276|NCT02243761|Concurrent Disorders|concurrent disorders
318277|NCT02243761|Mental Health|mental health
318278|NCT02243761|Addictions|addictions
318279|NCT02243761|Caregiver Burden|caregiver burden
318280|NCT02243722|laryngeal electromyography|laryngeal electromyography
762968|NCT00392951|Lymph Nodes|lymph nodes
318281|NCT02243722|intrinsic laryngeal muscles|intrinsic laryngeal muscles
318282|NCT02243722|recurrent laryngeal nerve|recurrent laryngeal nerve
318283|NCT02243722|superior laryngeal nerve|superior laryngeal nerve
318284|NCT02243722|laryngeal sensation|laryngeal sensation
318285|NCT02243722|tone language|tone language
318286|NCT02243709|Stress, alcohol craving, alcohol use disorders|stress, alcohol craving, alcohol use disorders
318287|NCT02243670|opioid addiction|opioid addiction
318288|NCT02243670|opioid substitution therapy|opioid substitution therapy
318289|NCT02243670|addiction|addiction
318290|NCT02243670|buprenorphine maintenance treatment|buprenorphine maintenance treatment
318291|NCT02243670|opioid dependence|opioid dependence
318292|NCT02243670|substitution treatment|substitution treatment
318293|NCT02243670|noncompliance|noncompliance
318294|NCT02243670|opiate addiction|opiate addiction
318295|NCT02243670|Zubzolv® maintenance|zubzolv® maintenance
318296|NCT02243670|adherence monitoring|adherence monitoring
318297|NCT02243670|directly observed therapy|directly observed therapy
318298|NCT02243670|medication adherence|medication adherence
318299|NCT02243670|adherence|adherence
318300|NCT02243670|mobile|mobile
318301|NCT02243670|electronic monitoring|electronic monitoring
318302|NCT02243670|wireless|wireless
318303|NCT02243670|mobile device|mobile device
318304|NCT02243670|artificial intelligence|artificial intelligence
318305|NCT02243670|facial recognition|facial recognition
318306|NCT02243670|computer vision|computer vision
318307|NCT02243670|visual confirmation|visual confirmation
318308|NCT02243670|sublingual buprenorphine/naloxone|sublingual buprenorphine/naloxone
318309|NCT02243670|nonadherence|nonadherence
318310|NCT02243657|ASP3652|asp3652
318311|NCT02243657|Age|age
318312|NCT02243657|Gender|gender
318313|NCT02243657|Pharmacokinetics|pharmacokinetics
318314|NCT02243657|Pharmacodynamics|pharmacodynamics
318315|NCT02243657|Phase 1|phase 1
318316|NCT02243657|Multiple Ascending Doses (MAD)|multiple ascending doses (mad)
318317|NCT02243644|parenchymal neurocysticercosis upto five lesions|parenchymal neurocysticercosis upto five lesions
318318|NCT02243631|ATP|atp
318319|NCT02243631|Probenecid|probenecid
318320|NCT02243631|Chondrocalcinosis|chondrocalcinosis
318321|NCT02243527|Exercise|exercise
318322|NCT02243514|Hypertension|hypertension
318323|NCT02243514|Heart failure|heart failure
318324|NCT02243514|Sympathetic hyperactivity|sympathetic hyperactivity
318325|NCT02243514|Renal nerve|renal nerve
318326|NCT02243514|Remodeling|remodeling
318327|NCT02243514|Nerve remodeling|nerve remodeling
318328|NCT02243488|Menstruation|menstruation
318329|NCT02243488|MHM|mhm
318330|NCT02243488|Menstrual Hygiene Management|menstrual hygiene management
318331|NCT02243488|Girls Education|girls education
318332|NCT02243488|Absenteeism|absenteeism
318333|NCT02243488|Access to Education|access to education
318334|NCT02243488|Menstrual Health Education|menstrual health education
318335|NCT02243488|Reusable Sanitary Product|reusable sanitary product
318336|NCT02243462|Shivering|shivering
318337|NCT02243462|Hypothermia|hypothermia
318338|NCT02243462|Postoperative|postoperative
318339|NCT02243462|Temperature|temperature
318340|NCT02243462|Forced air warmer|forced air warmer
318341|NCT02243449|mechanical ventilation|mechanical ventilation
318343|NCT02243449|elderly|elderly
318344|NCT02243449|critically ill|critically ill
318345|NCT02243449|screening|screening
318346|NCT02243449|spontaneous breathing trial|spontaneous breathing trial
318347|NCT02243449|invasive ventilation|invasive ventilation
318348|NCT02243436|CLASSICAL HODGKIN LYMPHOMA|classical hodgkin lymphoma
318349|NCT02243436|HODGKIN LYMPHOMA|hodgkin lymphoma
318350|NCT02243436|LYMPHOMA|lymphoma
318351|NCT02243436|HL|hl
318352|NCT02243423|Aortocaval compression|aortocaval compression
318353|NCT02243423|Cesarean Section|cesarean section
318354|NCT02243423|Spinal Anesthesia|spinal anesthesia
318355|NCT02243423|Phenylephrine|phenylephrine
318356|NCT02243384|Early Hepatocellular Carcinoma|early hepatocellular carcinoma
318357|NCT02243384|Laparoscopic Hepatectomy|laparoscopic hepatectomy
318358|NCT02243384|Radiofrequency Ablation|radiofrequency ablation
318359|NCT02243384|Micrometastases|micrometastases
318360|NCT02243358|Pancreatic, cancer|pancreatic, cancer
318361|NCT02243345|decompression|decompression
318362|NCT02243345|recompression|recompression
318363|NCT02243345|delayed|delayed
318364|NCT02243345|late|late
318365|NCT02243332|Knee|knee
318366|NCT02243332|Pain|pain
318367|NCT02243332|Joint|joint
318368|NCT02243332|Rehabilitation|rehabilitation
318369|NCT02243332|Patellofemoral Pain Syndrome|patellofemoral pain syndrome
318370|NCT02243332|Anterior Knee Pain Syndrome|anterior knee pain syndrome
318371|NCT02243332|Knee Pain|knee pain
318372|NCT02243332|Quadriceps|quadriceps
318373|NCT02243306|pharmacokinetics|pharmacokinetics
318374|NCT02243306|Chronic kidney disease|chronic kidney disease
318375|NCT02243306|peritoneal dialysis|peritoneal dialysis
318376|NCT02243306|hemoglobin|hemoglobin
318377|NCT02243306|Anemia|anemia
318378|NCT02243306|GSK1278863|gsk1278863
318379|NCT02243306|Prolyl hydroxylase inhibitor|prolyl hydroxylase inhibitor
318380|NCT02243306|erythropoiesis stimulating agents|erythropoiesis stimulating agents
318381|NCT02243293|Hepatitis C Virus (HCV)|hepatitis c virus (hcv)
318382|NCT02243293|Hepatitis C|hepatitis c
318383|NCT02243293|Chronic Hepatitis C|chronic hepatitis c
318384|NCT02243293|interferon free|interferon free
318385|NCT02243293|Hepatitis C Genotype 2|hepatitis c genotype 2
318386|NCT02243293|Hepatitis C Genotype 3|hepatitis c genotype 3
318387|NCT02243293|Hepatitis C Genotype 4|hepatitis c genotype 4
318388|NCT02243293|Hepatitis C Genotype 5|hepatitis c genotype 5
318389|NCT02243293|Hepatitis C Genotype 6|hepatitis c genotype 6
318390|NCT02243280|HCV GT4|hcv gt4
318391|NCT02243280|Hepatitis C virus|hepatitis c virus
318392|NCT02243280|HCV GT1|hcv gt1
318393|NCT02243280|HCV|hcv
318394|NCT02243280|Compensated Cirrhosis|compensated cirrhosis
318395|NCT02243280|HCV GT6|hcv gt6
318396|NCT02243280|Hepatitis C Genotype 4 (GT 4)|hepatitis c genotype 4 (gt 4)
318397|NCT02243280|Hepatitis C Genotype 1 (GT1)|hepatitis c genotype 1 (gt1)
318398|NCT02243280|RBV|rbv
318399|NCT02243280|Cirrhotic|cirrhotic
318400|NCT02243280|Hepatitis C|hepatitis c
318401|NCT02243280|Interferon (IFN) Free|interferon (ifn) free
318402|NCT02243280|IFN free|ifn free
318403|NCT02243280|HCV GT5|hcv gt5
318404|NCT02243280|Chronic Hepatitis C|chronic hepatitis c
318405|NCT02243280|Ribavirin|ribavirin
318406|NCT02243280|Child Pugh A|child pugh a
318407|NCT02243280|Hepatitis C Genotype 5 (GT 5)|hepatitis c genotype 5 (gt 5)
318408|NCT02243280|Hepatitis C Genotype 6 (GT 6)|hepatitis c genotype 6 (gt 6)
318409|NCT02243280|ABT-493|abt-493
318410|NCT02243280|ABT-530|abt-530
318411|NCT02243280|glecaprevir|glecaprevir
318412|NCT02243280|pibrentasvir|pibrentasvir
318413|NCT02243267|Colon Cancer Colon Cancer Prevention|colon cancer colon cancer prevention
318414|NCT02243241|Healthy volunteers|healthy volunteers
318415|NCT02243241|Opioid|opioid
318416|NCT02243241|ECG|ecg
318417|NCT02243241|QTcI|qtci
318418|NCT02243228|granulocyte-macrophage colony stimulating factor(GM-CSF)|granulocyte-macrophage colony stimulating factor(gm-csf)
318419|NCT02243228|Autoimmune pulmonary alveolar proteinosis (PAP)|autoimmune pulmonary alveolar proteinosis (pap)
318420|NCT02243215|Laparoscopy|laparoscopy
318421|NCT02243215|Training|training
318422|NCT02243215|Off-site|off-site
318423|NCT02243215|Box trainer|box trainer
318424|NCT02243215|Virtual Reality Simulator|virtual reality simulator
318425|NCT02243202|Obesity|obesity
318426|NCT02243202|Overweight|overweight
318427|NCT02243202|Canagliflozin|canagliflozin
318428|NCT02243202|Phentermine|phentermine
318429|NCT02243202|INVOKANA®|invokana®
318430|NCT02243189|Healthy|healthy
318431|NCT02243189|Asthma|asthma
318432|NCT02243189|JNJ-43260295|jnj-43260295
318433|NCT02243189|Nasal Allergen Challenge|nasal allergen challenge
318434|NCT02243176|Saxagliptin|saxagliptin
318435|NCT02243176|Acarbose|acarbose
318436|NCT02243176|Type 2 Diabetes|type 2 diabetes
318437|NCT02243176|Metformin|metformin
318438|NCT02243124|Anemia|anemia
318439|NCT02243124|Transfusion|transfusion
318440|NCT02243124|AML|aml
318441|NCT02243124|MDS|mds
318442|NCT02243124|CLL|cll
318443|NCT02243124|p53|p53
318444|NCT02243124|erythropoiesis|erythropoiesis
318445|NCT02243111|Systemic sclerosis, pulmonary hypertension|systemic sclerosis, pulmonary hypertension
318446|NCT02243072|Insulin Dependent Diabetes Mellitus|insulin dependent diabetes mellitus
318447|NCT02243072|family therapy|family therapy
318448|NCT02243072|adolescents|adolescents
318449|NCT02243072|regimen adherence|regimen adherence
318450|NCT02243072|metabolic control|metabolic control
318451|NCT02243059|Magnetic Resonance Imaging|magnetic resonance imaging
318452|NCT02243059|Gadofosveset trisodium|gadofosveset trisodium
318453|NCT02243059|Nodal imaging|nodal imaging
318454|NCT02243033|Prostate cancer|prostate cancer
318455|NCT02243033|Focal therapy|focal therapy
318456|NCT02243033|Laser therapy|laser therapy
318457|NCT02243033|Transrectal|transrectal
318458|NCT02243033|MRI-guided|mri-guided
318459|NCT02243007|Resectable pancreatic cancer|resectable pancreatic cancer
318460|NCT02243007|Pancreatic Ductal Carcinoma|pancreatic ductal carcinoma
318461|NCT02242968|Licensed Vaccines|licensed vaccines
318462|NCT02242968|Blood Draw|blood draw
318463|NCT02242968|Investigational Vaccines|investigational vaccines
318464|NCT02242968|Healthy Volunteers|healthy volunteers
318465|NCT02242968|Eligibility Screening|eligibility screening
318466|NCT02242955|Alcohol-dependence|alcohol-dependence
318467|NCT02242955|Relapse|relapse
318468|NCT02242955|Detoxification|detoxification
318469|NCT02242955|Diazepam|diazepam
318470|NCT02242955|Benzodiazepines|benzodiazepines
318471|NCT02242955|Anxiety|anxiety
318472|NCT02242929|Nodular Basal Cell Carcinoma|nodular basal cell carcinoma
318473|NCT02242929|Treatment|treatment
318474|NCT02242929|Imiquimod|imiquimod
318475|NCT02242929|Curettage|curettage
318476|NCT02242929|Surgery|surgery
318477|NCT02242916|reccurent Head and Neck tumors|reccurent head and neck tumors
318478|NCT02242916|re-irradiation|re-irradiation
318479|NCT02242916|photon|photon
318480|NCT02242916|proton|proton
318481|NCT02242916|carbon-ion|carbon-ion
318482|NCT02242890|intrauterine contraception (IUC)|intrauterine contraception (iuc)
318483|NCT02242890|social networks|social networks
318484|NCT02242890|social influence|social influence
318485|NCT02242890|diffusion of innovation|diffusion of innovation
318486|NCT02242890|intrauterine device (IUD)|intrauterine device (iud)
318487|NCT02242890|LARC|larc
318488|NCT02242799|Malaria|malaria
318489|NCT02242799|HIV|hiv
318490|NCT02242799|Dolutegravir|dolutegravir
318491|NCT02242799|Artemisinin|artemisinin
318492|NCT02242799|Pharmacokinetics|pharmacokinetics
318493|NCT02242799|Interactions|interactions
318494|NCT02242773|Prostate Cancer|prostate cancer
318495|NCT02242773|Active Surveillance|active surveillance
318496|NCT02242773|MRI-Guided Biopsy|mri-guided biopsy
318497|NCT02242773|Multi-parametric MRI|multi-parametric mri
318498|NCT02242773|MP-MRI|mp-mri
318499|NCT02242760|acne|acne
318500|NCT02242747|actinic keratosis|actinic keratosis
318501|NCT02242747|field cancerization|field cancerization
318502|NCT02242747|ingenol mebutate|ingenol mebutate
318503|NCT02242747|5-fluorouracil|5-fluorouracil
318504|NCT02242747|tolerability|tolerability
318505|NCT02242747|safety|safety
318506|NCT02242695|vulvovaginal candidiasis|vulvovaginal candidiasis
318507|NCT02242695|vulvovaginal candidosis|vulvovaginal candidosis
318508|NCT02242695|mycotic vaginal infection|mycotic vaginal infection
318509|NCT02242695|dequalinium chloride|dequalinium chloride
318510|NCT02242695|Fluomizin|fluomizin
318511|NCT02242695|clotrimazole|clotrimazole
318512|NCT02242695|canesten|canesten
318513|NCT02242656|Short Bowel Syndrome|short bowel syndrome
318514|NCT02242656|SBS|sbs
318515|NCT02242656|Chronic Diarrhea|chronic diarrhea
318516|NCT02242656|Short Bowel|short bowel
318517|NCT02242656|Short Gut|short gut
318518|NCT02242656|Short Gut Syndrome|short gut syndrome
318519|NCT02242656|Anti-Diarrheal|anti-diarrheal
318520|NCT02242656|Opium Tincture|opium tincture
318521|NCT02242656|loperamide|loperamide
318522|NCT02242656|diphenoxylate|diphenoxylate
318523|NCT02242656|ileostomies|ileostomies
318524|NCT02242656|tincture of opium|tincture of opium
318525|NCT02242656|DTO|dto
318526|NCT02242656|codeine|codeine
318527|NCT02242656|morphine|morphine
318528|NCT02242656|opiate|opiate
318529|NCT02242643|Fluzone Quadrivalent|fluzone quadrivalent
318530|NCT02242643|Comparator|comparator
318531|NCT02242643|Children|children
318532|NCT02242643|Seasonal influenza|seasonal influenza
318533|NCT02242643|Safety|safety
318534|NCT02242643|Immunogenicity|immunogenicity
318535|NCT02242630|Subacromial bursitis|subacromial bursitis
318536|NCT02242630|Triamcinolone|triamcinolone
318537|NCT02242630|Methylprednisolone|methylprednisolone
318538|NCT02242630|Shoulder pain|shoulder pain
318539|NCT02242617|Adherence|adherence
318540|NCT02242617|CPAP|cpap
318541|NCT02242617|Oral Appliance|oral appliance
318542|NCT02242617|Mandibular Advancement Splints|mandibular advancement splints
318543|NCT02242617|Preference|preference
318544|NCT02242591|Knee surgery|knee surgery
318545|NCT02242591|Saphenous nerve|saphenous nerve
318546|NCT02242591|Perineural block|perineural block
318547|NCT02242591|Adductor Canal Block|adductor canal block
318548|NCT02242591|Postoperative Pain|postoperative pain
318549|NCT02242591|Mobilization|mobilization
318550|NCT02242578|Negative symptoms|negative symptoms
318551|NCT02242565|HIV prevention|hiv prevention
318552|NCT02242565|ShangRing|shangring
318553|NCT02242565|adverse events|adverse events
318554|NCT02242565|wound healing|wound healing
318555|NCT02242565|voluntary medical male circumcision (VMMC)|voluntary medical male circumcision (vmmc)
318556|NCT02242565|medical device|medical device
318557|NCT02242565|Zambia|zambia
318558|NCT02242526|hiatal hernia, recurrence, biologic mesh, synthetic mesh|hiatal hernia, recurrence, biologic mesh, synthetic mesh
318559|NCT02242513|Pulsed mode radiofrequency|pulsed mode radiofrequency
318560|NCT02242513|Plantar Fasciitis|plantar fasciitis
318561|NCT02242513|Ultrasound-guided|ultrasound-guided
318562|NCT02242500|Gingival recession/surgery|gingival recession/surgery
318563|NCT02242500|Collagen/therapeutic use|collagen/therapeutic use
318564|NCT02242500|Root coverage|root coverage
318565|NCT02242500|Treatment outcome|treatment outcome
318566|NCT02242487|Parkinson's Disease|parkinson's disease
318567|NCT02242487|Motor fluctuations|motor fluctuations
318568|NCT02242487|levodopa|levodopa
318569|NCT02242487|inhaled drugs|inhaled drugs
318570|NCT02242487|OFF episodes|off episodes
318571|NCT02242474|Rheumatoid arthritis|rheumatoid arthritis
318572|NCT02242474|Surgical Wound Infection|surgical wound infection
318573|NCT02242474|Surgical Site Infection|surgical site infection
318574|NCT02242474|Antirheumatic Agents|antirheumatic agents
318575|NCT02242474|Perioperative Care|perioperative care
318576|NCT02242474|Anti-TNF|anti-tnf
318577|NCT02242474|Anti-TNF-alpha|anti-tnf-alpha
318578|NCT02242461|COPD, Rhodiola L., clinical trial, biomarkers, spirometry|copd, rhodiola l., clinical trial, biomarkers, spirometry
318579|NCT02242448|Healthy Volunteer|healthy volunteer
318580|NCT02242448|Contrast|contrast
762969|NCT00392951|Spleen|spleen
318581|NCT02242409|Metastatic pancreatic cancer|metastatic pancreatic cancer
318582|NCT02242409|Second Line treatment|second line treatment
318583|NCT02242409|Gemcitabine|gemcitabine
318584|NCT02242409|Nab-paclitaxel|nab-paclitaxel
318585|NCT02242188|Breastfeeding|breastfeeding
318586|NCT02242188|Iron supplementation|iron supplementation
318587|NCT02242188|Psychomotor development|psychomotor development
318588|NCT02242188|Safety|safety
318589|NCT02242188|infants|infants
318590|NCT02242162|phrenic nerves magnetic stimulations|phrenic nerves magnetic stimulations
318591|NCT02242149|Fat liver|fat liver
318592|NCT02242149|Diabetes|diabetes
318593|NCT02242149|Diacerein|diacerein
318594|NCT02242149|Transient elastography|transient elastography
318595|NCT02242149|Treatment|treatment
318596|NCT02242136|Posttraumatic Stress Disorder|posttraumatic stress disorder
318597|NCT02242136|Aggressive Behavior|aggressive behavior
318598|NCT02242136|Appetitive Aggression|appetitive aggression
318599|NCT02242136|Treatment|treatment
318600|NCT02242136|FORNET|fornet
318601|NCT02242123|Celiac Disease|celiac disease
318602|NCT02242123|Gluten-free diet|gluten-free diet
318603|NCT02242123|EmA assay|ema assay
318604|NCT02242123|Duodenal culture medium|duodenal culture medium
318605|NCT02242110|Nightmares|nightmares
318606|NCT02242110|Sleep|sleep
318607|NCT02242110|PTSD|ptsd
318608|NCT02242110|Exposure, Relaxation, and Rescripting Therapy|exposure, relaxation, and rescripting therapy
318609|NCT02242071|Motor Neuron Disease|motor neuron disease
318610|NCT02242071|Amyotrophic Lateral Sclerosis|amyotrophic lateral sclerosis
318611|NCT02242071|Autologous Mononuclear Cell therapy|autologous mononuclear cell therapy
318612|NCT02242071|Stem cells|stem cells
318613|NCT02242032|dry eye disease|dry eye disease
318614|NCT02241993|glucose sensor|glucose sensor
318615|NCT02241993|Inter-sensor distance|inter-sensor distance
318616|NCT02241967|total knee arthroplasty|total knee arthroplasty
318617|NCT02241967|pain|pain
318618|NCT02241967|post-surgical pain|post-surgical pain
318619|NCT02241967|opioid|opioid
318620|NCT02241967|transcranial direct current stimulation|transcranial direct current stimulation
318621|NCT02241967|tDCS|tdcs
318622|NCT02241967|brain stimulation|brain stimulation
318623|NCT02241967|total hip arthroplasty|total hip arthroplasty
318625|NCT02241967|THA|tha
318626|NCT02241928|Muscular Dystrophy|muscular dystrophy
318627|NCT02241928|Autologous Mononuclear cell therapy|autologous mononuclear cell therapy
318628|NCT02241928|Stem Cell|stem cell
318629|NCT02241889|diabetes|diabetes
318630|NCT02241889|closed-loop|closed-loop
318631|NCT02241889|bi-hormonal|bi-hormonal
318632|NCT02241889|exercise|exercise
318633|NCT02241863|bipolar disorders|bipolar disorders
318634|NCT02241863|medication adherence|medication adherence
318635|NCT02241863|psychological intervention|psychological intervention
318636|NCT02241863|multifaceted intervention|multifaceted intervention
318637|NCT02241850|High Intensity Training|high intensity training
318638|NCT02241850|Genetic Polymorphisms|genetic polymorphisms
318639|NCT02241850|Genome Wide association study|genome wide association study
318640|NCT02241850|Single Nucleotide Polymorphism genotype|single nucleotide polymorphism genotype
318641|NCT02241850|Subjects|subjects
318642|NCT02241837|heart failure|heart failure
318643|NCT02241837|percutaneous|percutaneous
318644|NCT02241837|interventional cardiology|interventional cardiology
318645|NCT02241837|apical remodeling|apical remodeling
318646|NCT02241837|LV dilatation|lv dilatation
318647|NCT02241837|akinesis|akinesis
318648|NCT02241837|dyskinesis|dyskinesis
318649|NCT02241837|myocardial infarction|myocardial infarction
318650|NCT02241824|Lumbar Orthosis|lumbar orthosis
318651|NCT02241824|Lumbar brace|lumbar brace
318652|NCT02241811|Diabetic|diabetic
318653|NCT02241811|Foot|foot
318654|NCT02241811|Wound|wound
318655|NCT02241811|Sodium pentaborate pentahydrate|sodium pentaborate pentahydrate
318656|NCT02241811|Hydrogel|hydrogel
318657|NCT02241798|epilepsy|epilepsy
318658|NCT02241798|oxygen saturation|oxygen saturation
318659|NCT02241798|transcutaneous carbon dioxide|transcutaneous carbon dioxide
318660|NCT02241798|sudep|sudep
318661|NCT02241798|pre-oxygenation|pre-oxygenation
318662|NCT02241733|exercise|exercise
318663|NCT02241733|pulmonary rehabilitation|pulmonary rehabilitation
318664|NCT02241733|dynamic hyperinflation|dynamic hyperinflation
318665|NCT02241707|Varicose vein|varicose vein
318666|NCT02241707|Endovenous ablation|endovenous ablation
318667|NCT02241707|Compression|compression
318668|NCT02241681|Medium Chain Triglycerides|medium chain triglycerides
318669|NCT02241681|Medium Chain Triglycerides metabolites|medium chain triglycerides metabolites
318670|NCT02241681|Peptamen 1.5|peptamen 1.5
318671|NCT02241668|Brain tumor|brain tumor
318672|NCT02241668|3'-Deoxy-3'-18f-Fluorothymidine|3'-deoxy-3'-18f-fluorothymidine
318673|NCT02241668|Fluoro-L-Thymidine Positron Emission Tomography|fluoro-l-thymidine positron emission tomography
318674|NCT02241668|FLT PET|flt pet
318675|NCT02241668|Magnetic resonance imaging|magnetic resonance imaging
318676|NCT02241668|MRI|mri
318677|NCT02241655|Anesthesia|anesthesia
318678|NCT02241655|Electroencephalography|electroencephalography
407285|NCT01836939|ova|ova
318679|NCT02241655|Burst suppression|burst suppression
318680|NCT02241655|Surgery|surgery
318681|NCT02241655|Delirium|delirium
318682|NCT02241655|Falls|falls
318683|NCT02241655|Health related quality of life|health related quality of life
318684|NCT02241642|Percutaneous vascular closure device|percutaneous vascular closure device
318685|NCT02241642|vascular closure device|vascular closure device
318686|NCT02241642|Large hole closure device|large hole closure device
318687|NCT02241629|motion sickness|motion sickness
318688|NCT02241603|Insulin resistance|insulin resistance
318689|NCT02241603|Consummatory Reward|consummatory reward
318690|NCT02241577|peri-implantitis|peri-implantitis
318691|NCT02241577|dental implants|dental implants
318692|NCT02241577|randomized controlled trial|randomized controlled trial
318693|NCT02241577|non-surgical periodontal treatment|non-surgical periodontal treatment
318694|NCT02241577|will be defined by the presence of alveolar bone loss of at least 3mm, pocket depth of at least 5mm and bleeding on probing.|will be defined by the presence of alveolar bone loss of at least 3mm, pocket depth of at least 5mm and bleeding on probing.
318695|NCT02241564|Immunosuppression|immunosuppression
318696|NCT02241551|Borderline|borderline
318697|NCT02241551|Resectable|resectable
318698|NCT02241551|Pancreatic|pancreatic
318699|NCT02241551|Cancer|cancer
318700|NCT02241551|Neoadjuvant|neoadjuvant
318701|NCT02241551|Chemotheraphy|chemotheraphy
318702|NCT02241551|Gemcitabine|gemcitabine
318703|NCT02241551|Nab-Paclitaxel|nab-paclitaxel
318704|NCT02241551|mFOFIRINOX|mfofirinox
318705|NCT02241551|Sterotatic Body Radiation Therapy|sterotatic body radiation therapy
318706|NCT02241538|Pilates-based exercises|pilates-based exercises
318707|NCT02241525|Pulmonary|pulmonary
318708|NCT02241525|Thromboembolic|thromboembolic
318710|NCT02241512|post-ERCP pancreatitis|post-ercp pancreatitis
318711|NCT02241512|pediatric|pediatric
318712|NCT02241512|ibuprofen|ibuprofen
318713|NCT02241499|Digestive System Diseases|digestive system diseases
318714|NCT02241499|Esophageal cancer|esophageal cancer
318715|NCT02241499|Intestinal Neoplasms|intestinal neoplasms
318716|NCT02241499|Gastrointestinal Neoplasms|gastrointestinal neoplasms
318717|NCT02241499|Digestive System Neoplasms|digestive system neoplasms
318718|NCT02241499|Endoscopic response|endoscopic response
318719|NCT02241499|Fluorouracil|fluorouracil
318720|NCT02241499|Metabolic response|metabolic response
318721|NCT02241499|Oxaliplatin|oxaliplatin
318722|NCT02241499|Radiotherapy|radiotherapy
318723|NCT02241486|Burn pain|burn pain
318724|NCT02241486|Procedural pain|procedural pain
318725|NCT02241486|Sublingual fentanyl|sublingual fentanyl
318726|NCT02241486|Morphine|morphine
318727|NCT02241473|gait|gait
318728|NCT02241473|physical activity|physical activity
318729|NCT02241473|energy cost|energy cost
318730|NCT02241473|efficiency|efficiency
318731|NCT02241460|Premature Ejaculation|premature ejaculation
318732|NCT02241460|Lidocaine|lidocaine
318733|NCT02241447|aortic valve Stenosis|aortic valve stenosis
318734|NCT02241447|Echo|echo
318735|NCT02241447|TAVI|tavi
318736|NCT02241447|SAVR|savr
318737|NCT02241447|referral|referral
318738|NCT02241434|Duchenne muscular dystrophy|duchenne muscular dystrophy
318739|NCT02241434|Autologous Bone marrow Mononuclear cell therapy|autologous bone marrow mononuclear cell therapy
318740|NCT02241434|Stem Cells|stem cells
318741|NCT02241421|Impaired glucose tolerance|impaired glucose tolerance
318742|NCT02241421|Glucose Metabolism Disorders|glucose metabolism disorders
318743|NCT02241421|Metabolic Diseases|metabolic diseases
318744|NCT02241421|Endocrine System Diseases|endocrine system diseases
318745|NCT02241421|Hyperinsulinism|hyperinsulinism
318746|NCT02241421|Lipid metabolism|lipid metabolism
318747|NCT02241421|Anti Bacterial Agents|anti bacterial agents
318748|NCT02241421|Gastro Intestinal Tract|gastro intestinal tract
318749|NCT02241395|Cerebral Palsy|cerebral palsy
318750|NCT02241395|autologous bone marrow mononuclear cells|autologous bone marrow mononuclear cells
318751|NCT02241395|stem cell|stem cell
318752|NCT02241369|Aerodigestive Lesions and Malignancies|aerodigestive lesions and malignancies
318753|NCT02241369|Human Papillomavirus|human papillomavirus
318754|NCT02241369|Squamous Cell Carcinoma|squamous cell carcinoma
318755|NCT02241356|Down syndrome|down syndrome
318756|NCT02241356|visual functions|visual functions
318757|NCT02241356|bifocals|bifocals
318758|NCT02241356|children|children
318759|NCT02241356|visual acuity at near|visual acuity at near
318760|NCT02241343|Artificially and reversibly achieved with a blood pressure cuff|artificially and reversibly achieved with a blood pressure cuff
318761|NCT02241330|Zinc|zinc
318762|NCT02241330|deficiency|deficiency
318763|NCT02241330|biofortification|biofortification
318764|NCT02241330|wheat|wheat
318765|NCT02241317|Diabetes mellitus|diabetes mellitus
318766|NCT02241317|Hypoglycaemia|hypoglycaemia
318767|NCT02241317|staff training|staff training
318768|NCT02241317|Education|education
318769|NCT02241317|blood glucose|blood glucose
318770|NCT02241304|electromyography|electromyography
318771|NCT02241304|neuromuscular blockade|neuromuscular blockade
763235|NCT00392041|Lunesta|lunesta
318772|NCT02241291|Percutaneous Coronary Intervention|percutaneous coronary intervention
318773|NCT02241291|Registries|registries
318774|NCT02241278|colon surgery|colon surgery
318775|NCT02241278|ketamine|ketamine
318776|NCT02241278|patient-controlled-analgesia|patient-controlled-analgesia
318777|NCT02241278|preemptive analgesia|preemptive analgesia
318778|NCT02241265|asthma|asthma
318779|NCT02241265|thermoplasty|thermoplasty
318780|NCT02241252|ECG|ecg
318781|NCT02241252|QT interval|qt interval
318782|NCT02241252|Sotalol|sotalol
318783|NCT02241252|Dofetilide|dofetilide
318784|NCT02241252|iPhone|iphone
318785|NCT02241226|wellbeing|wellbeing
318786|NCT02241226|meditation|meditation
318787|NCT02241226|Ayurveda|ayurveda
318788|NCT02241226|yoga|yoga
318789|NCT02241226|herbs|herbs
318790|NCT02241226|health|health
318791|NCT02241226|longevity|longevity
318792|NCT02241226|individuals|individuals
318793|NCT02241213|Stroke|stroke
318794|NCT02241213|Aphasia|aphasia
318795|NCT02241213|Broca|broca
318796|NCT02241187|PEGPH20|pegph20
318797|NCT02241187|Cetuximab|cetuximab
318798|NCT02241187|14-039|14-039
318799|NCT02241174|Atopic Dermatitis|atopic dermatitis
318800|NCT02241161|skin eythema|skin eythema
318801|NCT02241161|rejuvenating cream|rejuvenating cream
318802|NCT02241161|rejuvenating serum|rejuvenating serum
318803|NCT02241161|antioxidant serum|antioxidant serum
318804|NCT02241135|Rav G protein|rav g protein
318805|NCT02241135|rabies|rabies
318806|NCT02241135|VNT|vnt
318807|NCT02241135|immunogenicity|immunogenicity
318808|NCT02241135|PrEP vaccination|prep vaccination
318809|NCT02241135|mRNA|mrna
318810|NCT02241135|CV7201|cv7201
318811|NCT02241122|prostate cancer|prostate cancer
318812|NCT02241122|PSA|psa
318813|NCT02241122|MRI|mri
318814|NCT02241122|biopsy|biopsy
318815|NCT02241122|biomarker|biomarker
318816|NCT02241109|aortic stenosis progression|aortic stenosis progression
318817|NCT02241109|aortic valve sclerosis progression|aortic valve sclerosis progression
318818|NCT02241109|calcification propensity|calcification propensity
318819|NCT02241070|mindfulness meditation|mindfulness meditation
318820|NCT02241070|mental health promotion|mental health promotion
318821|NCT02241070|worker|worker
318822|NCT02241057|temperature profile|temperature profile
318823|NCT02241057|air activated 3-cell patch|air activated 3-cell patch
318824|NCT02241057|adhesion|adhesion
318825|NCT02241044|argon plasma coagulation, bleeding peptic ulcer|argon plasma coagulation, bleeding peptic ulcer
318826|NCT02241031|Megakaryocytic Progenitor Products|megakaryocytic progenitor products
318827|NCT02241031|Hematological Diseases|hematological diseases
318828|NCT02241031|Thrombocytopenia|thrombocytopenia
318829|NCT02241018|Hematopoietic Stem Cell Transplantation|hematopoietic stem cell transplantation
318830|NCT02241018|Mesenchymal Stem Cells|mesenchymal stem cells
318831|NCT02241018|CD25 Monoclonal Antibody|cd25 monoclonal antibody
318832|NCT02241018|Acute Graft-versus-host disease|acute graft-versus-host disease
318833|NCT02241005|Health-care associated infection|health-care associated infection
318834|NCT02241005|Skin integrity|skin integrity
318835|NCT02241005|Antimicrobial resistance|antimicrobial resistance
318836|NCT02240992|Poor Graft Function|poor graft function
318837|NCT02240992|Delayed platelet engraftment|delayed platelet engraftment
318838|NCT02240992|Peripheral Blood Stem Cell|peripheral blood stem cell
318839|NCT02240992|Mesenchymal Stem Cells|mesenchymal stem cells
318840|NCT02240992|Allogeneic hematopoietic stem cell transplantation|allogeneic hematopoietic stem cell transplantation
318841|NCT02240979|arterial waveform|arterial waveform
318842|NCT02240979|cardiac magnetic resonance imaging|cardiac magnetic resonance imaging
318843|NCT02240979|echocardiography|echocardiography
318844|NCT02240979|intrinsic frequency measures of cardiac function|intrinsic frequency measures of cardiac function
318845|NCT02240966|Testicular Neoplasms|testicular neoplasms
318846|NCT02240966|Hypogonadism|hypogonadism
318847|NCT02240966|Metabolic Syndrome|metabolic syndrome
318848|NCT02240966|Treatment related late effects|treatment related late effects
318849|NCT02240953|Anticoagulation|anticoagulation
318850|NCT02240953|Prosthetic Heart Valves|prosthetic heart valves
318851|NCT02240953|Acetylsalicylic acid|acetylsalicylic acid
318852|NCT02240953|Warfarin|warfarin
318853|NCT02240953|Thrombosis|thrombosis
318854|NCT02240940|Heart Failure|heart failure
318855|NCT02240940|Volume Reduction|volume reduction
318856|NCT02240940|Pressure Reduction|pressure reduction
318857|NCT02240940|Ischemic Heart Failure|ischemic heart failure
318858|NCT02240940|LAD Infarct|lad infarct
318859|NCT02240927|Anticoagulation|anticoagulation
318860|NCT02240927|Prosthetic Heart Valves|prosthetic heart valves
318861|NCT02240927|Pregnancy|pregnancy
318862|NCT02240927|Warfarin|warfarin
318863|NCT02240927|Thrombosis|thrombosis
318864|NCT02240914|Iliac Vein Obstruction|iliac vein obstruction
318865|NCT02240914|May-Thurner Syndrome|may-thurner syndrome
318866|NCT02240914|Cockett Syndrome|cockett syndrome
318867|NCT02240914|Vascular Ultrasound|vascular ultrasound
318868|NCT02240914|IVUS|ivus
318869|NCT02240901|Laryngeal mask airway|laryngeal mask airway
318870|NCT02240901|endotracheal intubation|endotracheal intubation
318871|NCT02240901|postoperative pulmonary complications|postoperative pulmonary complications
318872|NCT02240901|elderly patients|elderly patients
318873|NCT02240888|pneumococcal|pneumococcal
318874|NCT02240888|vaccination|vaccination
318875|NCT02240888|antibody|antibody
318876|NCT02240888|response|response
318877|NCT02240888|immunosuppressive|immunosuppressive
318878|NCT02240888|treatment|treatment
318879|NCT02240888|inflammatory|inflammatory
318880|NCT02240888|rheumatic|rheumatic
318881|NCT02240888|disease|disease
318882|NCT02240875|Ebola|ebola
318883|NCT02240875|Zaire|zaire
318884|NCT02240849|Neck pain|neck pain
318885|NCT02240849|functional pillow|functional pillow
318886|NCT02240849|sleep|sleep
318887|NCT02240849|cervical lordosis|cervical lordosis
318888|NCT02240823|Erectile Function|erectile function
318889|NCT02240823|Mesenchymal Stromal Cells|mesenchymal stromal cells
318890|NCT02240823|Stem Cell|stem cell
318891|NCT02240797|Anorexia Nervosa|anorexia nervosa
318892|NCT02240797|Neuroimaging|neuroimaging
318893|NCT02240797|Positron emission tomography (PET)|positron emission tomography (pet)
318894|NCT02240797|[11C]PKAB|[11c]pkab
318895|NCT02240784|Porphyria|porphyria
318896|NCT02240784|AIP|aip
318897|NCT02240784|VP|vp
318898|NCT02240784|HCP|hcp
318899|NCT02240784|Variegate|variegate
318900|NCT02240784|Coproporphyria|coproporphyria
318901|NCT02240771|Transarterial chemotherapy|transarterial chemotherapy
318902|NCT02240771|Thalidomide|thalidomide
318903|NCT02240771|Capecitabine|capecitabine
318904|NCT02240758|glioma, confocal laser endomicroscopy|glioma, confocal laser endomicroscopy
318905|NCT02240745|Echocardiography, Stress|echocardiography, stress
318906|NCT02240745|Echocardiography, Three-Dimensional|echocardiography, three-dimensional
318907|NCT02240745|Coronary Artery Disease|coronary artery disease
318908|NCT02240745|Fractional Flow Reserve, Myocardial|fractional flow reserve, myocardial
318909|NCT02240745|Coronary Circulation|coronary circulation
318910|NCT02240615|Epiphora|epiphora
318911|NCT02240615|Lacrimal Stent|lacrimal stent
318912|NCT02240615|Lacrimal System|lacrimal system
318913|NCT02240602|acute pain|acute pain
318914|NCT02240602|postoperative|postoperative
318915|NCT02240602|surgery|surgery
318916|NCT02240589|Traumatic Brain Injury|traumatic brain injury
318917|NCT02240589|Memantine|memantine
318918|NCT02240589|Memory|memory
318919|NCT02240576|surgery for nasal fracture|surgery for nasal fracture
318920|NCT02240563|autoimmune thyroiditis|autoimmune thyroiditis
318921|NCT02240563|LLLT|lllt
318922|NCT02240563|safety|safety
318923|NCT02240563|ultrasound|ultrasound
318924|NCT02240550|Open Inguinal Hernia|open inguinal hernia
318925|NCT02240537|AML|aml
318926|NCT02240537|MM|mm
318927|NCT02240537|MDS|mds
318928|NCT02240537|sMM|smm
318929|NCT02240524|Gastric adenocarcinoma|gastric adenocarcinoma
318930|NCT02240524|HIPEC|hipec
318931|NCT02240524|Paclitaxel|paclitaxel
318932|NCT02240524|Oxaliplatin|oxaliplatin
318933|NCT02240524|Capecitabine|capecitabine
318934|NCT02240511|Body Composition|body composition
318935|NCT02240511|Amino Acids Supplementation|amino acids supplementation
318936|NCT02240511|Resistance Exercise|resistance exercise
318937|NCT02240498|Abscess|abscess
318938|NCT02240498|Drainage|drainage
318939|NCT02240485|Pathological gambling|pathological gambling
318940|NCT02240485|Treatment|treatment
318941|NCT02240485|Marital relationship|marital relationship
318942|NCT02240472|sentinel node biopsy, lymph node metastasis, survival|sentinel node biopsy, lymph node metastasis, survival
318943|NCT02240459|crossover study|crossover study
318944|NCT02240459|placebo controlled|placebo controlled
318945|NCT02240459|double blind|double blind
318946|NCT02240459|overactive bladder|overactive bladder
318947|NCT02240420|Type 2 diabetes prevention in the post-partum|type 2 diabetes prevention in the post-partum
318948|NCT02240420|Behavior change among Latinas,|behavior change among latinas,
318949|NCT02240420|Health Coaching, Motivational interviewing techniques|health coaching, motivational interviewing techniques
318950|NCT02240407|Pompe Disease|pompe disease
318951|NCT02240407|Gene Therapy|gene therapy
318952|NCT02240407|Repeated dosing|repeated dosing
318953|NCT02240407|Immune modulation|immune modulation
318954|NCT02240394|TCD Traumatic brain injury increased intracranial pressure|tcd traumatic brain injury increased intracranial pressure
318955|NCT02240368|Depth anesthesia monitors|depth anesthesia monitors
318956|NCT02240368|Children anesthesia|children anesthesia
318957|NCT02240368|Bispectral monitor|bispectral monitor
318958|NCT02240368|Entropy monitor|entropy monitor
318959|NCT02240342|Ovarian reserve|ovarian reserve
318960|NCT02240342|Poor response|poor response
318961|NCT02240342|Follicle recruitment|follicle recruitment
318962|NCT02240342|Bone marrow transplant|bone marrow transplant
318963|NCT02240329|respiratory|respiratory
318964|NCT02240329|cough|cough
318965|NCT02240303|pain|pain
318966|NCT02240303|mobility|mobility
318967|NCT02240303|brain|brain
318968|NCT02240303|cognition|cognition
318969|NCT02240290|C14|c14
318970|NCT02240290|Dosimetry|dosimetry
318971|NCT02240290|Mass balance|mass balance
318972|NCT02240290|ADME|adme
318973|NCT02240277|Septic Shock|septic shock
318974|NCT02240277|Meropenem|meropenem
318975|NCT02240277|Ciprofloxacin|ciprofloxacin
318976|NCT02240277|Pharmacokinetics|pharmacokinetics
318977|NCT02240264|Omega-3 fatty acids|omega-3 fatty acids
318978|NCT02240264|Cognitive function|cognitive function
318979|NCT02240264|Academic performance|academic performance
318980|NCT02240264|Mental health|mental health
318981|NCT02240264|Eye tracking|eye tracking
318982|NCT02240264|Krill oil|krill oil
318983|NCT02240264|LCPUFA|lcpufa
318984|NCT02240251|Inferior Vena Cava Filter|inferior vena cava filter
318985|NCT02240251|IVC Filter|ivc filter
318986|NCT02240251|IVC filter removal|ivc filter removal
318987|NCT02240251|Excimer Laser|excimer laser
318988|NCT02240225|COPD;SRI;Reliability;validity;|copd;sri;reliability;validity;
318989|NCT02240212|second line treatment|second line treatment
318990|NCT02240212|oncology|oncology
318991|NCT02240212|AKT inhibitor|akt inhibitor
318992|NCT02240212|paclitaxel|paclitaxel
318993|NCT02240212|HER2 (ErbB2) negative advanced gastric cancer|her2 (erbb2) negative advanced gastric cancer
318994|NCT02240212|Afuresertib|afuresertib
318995|NCT02240186|Microprocessor-controlled knee|microprocessor-controlled knee
318996|NCT02240186|prosthesis|prosthesis
318997|NCT02240186|amputation|amputation
318998|NCT02240173|antipsychotic Jobelyn schizophrenia sorghum bicolor|antipsychotic jobelyn schizophrenia sorghum bicolor
318999|NCT02240160|Sativex|sativex
319000|NCT02240160|Pharmacokinetics|pharmacokinetics
319001|NCT02240160|Oral pH|oral ph
319002|NCT02240147|adult congenital heart disease|adult congenital heart disease
319003|NCT02240147|exercise capacity|exercise capacity
319004|NCT02240147|exercise training|exercise training
319005|NCT02240147|physical activity|physical activity
319006|NCT02240121|Crohn's Disease|crohn's disease
319007|NCT02240121|Rifaximin|rifaximin
319008|NCT02240121|Clinical remission with endoscopic response|clinical remission with endoscopic response
319009|NCT02240121|Inflammatory Bowel Disease|inflammatory bowel disease
319010|NCT02240108|Crohn's Disease|crohn's disease
319011|NCT02240108|Rifaximin|rifaximin
319012|NCT02240108|Clinical remission with endoscopic response|clinical remission with endoscopic response
319013|NCT02240108|Inflammatory Bowel Disease|inflammatory bowel disease
319014|NCT02240082|Shiftwork|shiftwork
319015|NCT02240082|Sleep disruption|sleep disruption
319016|NCT02240082|Stress|stress
319017|NCT02240030|Parkinson's Disease|parkinson's disease
319018|NCT02240030|Motor fluctuations|motor fluctuations
319019|NCT02240030|levodopa|levodopa
319020|NCT02240030|inhaled drugs|inhaled drugs
319021|NCT02240030|OFF episodes|off episodes
319022|NCT02240017|Urothelial cancer, renal function impaired.|urothelial cancer, renal function impaired.
319023|NCT02239991|Point of care|point of care
319024|NCT02239991|perioperative hemostasis|perioperative hemostasis
319025|NCT02239991|thromboelastometry|thromboelastometry
319026|NCT02239991|bleeding risk|bleeding risk
319027|NCT02239991|end-stage liver disease|end-stage liver disease
319028|NCT02239991|hepatic coagulopathy|hepatic coagulopathy
319029|NCT02239991|whole blood coagulation|whole blood coagulation
319030|NCT02239978|Parkinson Disease|parkinson disease
319031|NCT02239978|Posture Balance|posture balance
319032|NCT02239978|Learning|learning
319033|NCT02239978|Dopamine|dopamine
319034|NCT02239965|Neuromuscular blockade|neuromuscular blockade
319035|NCT02239965|Neuromuscular monitoring|neuromuscular monitoring
319036|NCT02239965|Focus group interview|focus group interview
319037|NCT02239965|Clinical observation|clinical observation
319038|NCT02239939|older adults, body composition, weight loss, muscle mass|older adults, body composition, weight loss, muscle mass
319039|NCT02239926|IBS-D|ibs-d
319040|NCT02239913|Cocaine|cocaine
319041|NCT02239913|Pharmacotherapy|pharmacotherapy
319042|NCT02239913|Phentermine|phentermine
319043|NCT02239913|Topiramate|topiramate
319044|NCT02239913|Self-Administration|self-administration
319045|NCT02239900|Liver Cancer|liver cancer
319046|NCT02239900|Lung Cancer|lung cancer
319047|NCT02239900|Adrenal Gland|adrenal gland
319048|NCT02239900|Metastasis|metastasis
319049|NCT02239900|Advanced Solid Malignancies|advanced solid malignancies
319050|NCT02239900|Ipilimumab|ipilimumab
319051|NCT02239900|Yervoy|yervoy
319052|NCT02239900|BMS-734016|bms-734016
319053|NCT02239900|MDX010|mdx010
319054|NCT02239900|Stereotactic Body Radiation Therapy|stereotactic body radiation therapy
319055|NCT02239900|SBRT|sbrt
319057|NCT02239887|LAA occlusion|laa occlusion
319058|NCT02239887|Non-valvular Atrial Fibrillation|non-valvular atrial fibrillation
319059|NCT02239887|Percutaneous|percutaneous
319060|NCT02239887|Oral Anticoagulation|oral anticoagulation
319061|NCT02239887|Occluder|occluder
319062|NCT02239887|WAVECREST|wavecrest
319063|NCT02239874|mammographic breast density, breast disease, breast tissue|mammographic breast density, breast disease, breast tissue
319064|NCT02239861|Rhabdomyosarcoma|rhabdomyosarcoma
319065|NCT02239861|cytotoxic T lymphocytes|cytotoxic t lymphocytes
319066|NCT02239822|Electrodes, Implanted|electrodes, implanted
763236|NCT00392028|Ertapenem|ertapenem
319067|NCT02239822|Electric Stimulation Therapy|electric stimulation therapy
319068|NCT02239809|Electrodes, Implanted|electrodes, implanted
319069|NCT02239809|Electric Stimulation Therapy|electric stimulation therapy
319070|NCT02239796|transcutaneous posterior tibial nerve stimulation|transcutaneous posterior tibial nerve stimulation
319071|NCT02239796|Randomised controlled trial|randomised controlled trial
319072|NCT02239796|Feasibility|feasibility
319073|NCT02239783|osteoarthritis|osteoarthritis
319074|NCT02239783|avascular necrosis|avascular necrosis
319075|NCT02239783|ankylosis|ankylosis
319076|NCT02239783|protrusio acetabuli|protrusio acetabuli
319077|NCT02239783|painful hip dysplasia|painful hip dysplasia
319078|NCT02239783|rheumatoid arthritis|rheumatoid arthritis
319079|NCT02239783|correction of functional deformity|correction of functional deformity
319080|NCT02239783|revision procedures|revision procedures
319081|NCT02239770|Nicotine|nicotine
319082|NCT02239770|Random Delivery|random delivery
319083|NCT02239770|Smoking Cessation|smoking cessation
319084|NCT02239770|Plasma Nicotine|plasma nicotine
319085|NCT02239770|Oral Film|oral film
319086|NCT02239757|Transradial Approach, Primary PCI, ST-segment elevation myocardial infarction|transradial approach, primary pci, st-segment elevation myocardial infarction
319087|NCT02239744|air pollution|air pollution
319088|NCT02239744|air purification|air purification
319089|NCT02239744|intervention|intervention
319090|NCT02239744|randomized controlled trial|randomized controlled trial
319091|NCT02239744|cardiovascular health|cardiovascular health
319092|NCT02239744|pulmonary health|pulmonary health
319093|NCT02239731|EGFRI|egfri
319094|NCT02239731|Epidermal Growth Factor Receptor Inhibition|epidermal growth factor receptor inhibition
319095|NCT02239731|Skin toxicity|skin toxicity
319096|NCT02239731|Topical|topical
319097|NCT02239731|Doxycycline|doxycycline
319098|NCT02239731|Foam|foam
319099|NCT02239731|Phase II|phase ii
319100|NCT02239731|Cetuximab|cetuximab
319101|NCT02239731|Panitumumab|panitumumab
319102|NCT02239731|Vectibix|vectibix
319103|NCT02239731|Erbitux|erbitux
319104|NCT02239731|Rash|rash
319105|NCT02239718|Resin bonded bridges|resin bonded bridges
319106|NCT02239718|Clinical trial|clinical trial
319107|NCT02239718|Prospective|prospective
319108|NCT02239718|Survival|survival
319109|NCT02239718|Oral health related quality of life|oral health related quality of life
319110|NCT02239705|Trans pulmonary thermodilution|trans pulmonary thermodilution
319111|NCT02239705|Hemodynamic|hemodynamic
319112|NCT02239679|Actinic Keratosis|actinic keratosis
319113|NCT02239666|Dermatology, plaque psoriasis, biologic treatment, biologic naive|dermatology, plaque psoriasis, biologic treatment, biologic naive
319114|NCT02239614|dengue fever|dengue fever
319115|NCT02239614|dengue|dengue
319116|NCT02239601|Physical Therapy|physical therapy
319117|NCT02239601|Physiotherapy|physiotherapy
319118|NCT02239601|Breast Cancer|breast cancer
319119|NCT02239601|Chemotherapy Induced Peripheral Neuropathy (CIPN)|chemotherapy induced peripheral neuropathy (cipn)
319120|NCT02239601|Nerve gliding exercises|nerve gliding exercises
319121|NCT02239601|Nerve Entrapment|nerve entrapment
319122|NCT02239575|Assorted cancers (oncology)|assorted cancers (oncology)
319123|NCT02239562|sPIF|spif
319124|NCT02239562|synthetic PreImplantation Factor|synthetic preimplantation factor
319125|NCT02239562|Autoimmune|autoimmune
319126|NCT02239562|Liver|liver
319127|NCT02239562|Hepatitis|hepatitis
319128|NCT02239549|Colonic Polyps|colonic polyps
319129|NCT02239549|Polypectomy|polypectomy
319130|NCT02239536|neoplastic colorectal polyp|neoplastic colorectal polyp
319131|NCT02239536|hot snare polypectomy|hot snare polypectomy
319132|NCT02239536|hot snare polypectomy after saline injection|hot snare polypectomy after saline injection
319133|NCT02239523|Pathologic fracture|pathologic fracture
319134|NCT02239523|Insufficiency fracture|insufficiency fracture
319135|NCT02239523|Secondary fracture|secondary fracture
319136|NCT02239523|Fracture with bone fragility|fracture with bone fragility
319137|NCT02239523|Osteoporosis|osteoporosis
319138|NCT02239523|Bone loss|bone loss
319139|NCT02239523|Osteopenia|osteopenia
319140|NCT02239523|Metabolic Bone Disease|metabolic bone disease
319141|NCT02239523|Fragility fracture|fragility fracture
319142|NCT02239510|constipation|constipation
319143|NCT02239510|bowel habits|bowel habits
319144|NCT02239497|postoperatory pain|postoperatory pain
319145|NCT02239497|orthopaedic surgery|orthopaedic surgery
319146|NCT02239497|femoral block|femoral block
319147|NCT02239432|Adenocarcinoma of the Lung|adenocarcinoma of the lung
319148|NCT02239432|Adenocarcinoma, Bronchiolo-Alveolar|adenocarcinoma, bronchiolo-alveolar
319149|NCT02239419|Critical Limb Ischemia|critical limb ischemia
319150|NCT02239419|Limb Ischemia|limb ischemia
319151|NCT02239419|Wound Care|wound care
319152|NCT02239419|Hemodialysis|hemodialysis
319153|NCT02239419|Dialysis|dialysis
319154|NCT02239419|Skin Ulceration|skin ulceration
319155|NCT02239406|metal on metal total hip|metal on metal total hip
319156|NCT02239406|avasuclar necrosis|avasuclar necrosis
319157|NCT02239406|acetabular revision|acetabular revision
319158|NCT02239406|bone vascularity|bone vascularity
319159|NCT02239393|Multiple Sclerosis|multiple sclerosis
319160|NCT02239393|Mesenchymal Stem Cells|mesenchymal stem cells
319161|NCT02239393|MSC|msc
319162|NCT02239380|Lorazepam|lorazepam
319163|NCT02239380|Status Epilepticus|status epilepticus
319164|NCT02239341|hospitalized|hospitalized
319165|NCT02239341|activity restriction|activity restriction
319166|NCT02239341|bed rest|bed rest
319167|NCT02239341|antepartum|antepartum
319168|NCT02239341|pregnant|pregnant
319169|NCT02239341|high risk|high risk
319170|NCT02239328|Lung cancer|lung cancer
319171|NCT02239328|esophageal cancer|esophageal cancer
319172|NCT02239315|Breast cancers|breast cancers
319173|NCT02239315|Neoadjuvant chemotherapy|neoadjuvant chemotherapy
319174|NCT02239315|RNA Disruption Assay™ (RDA) score|rna disruption assay™ (rda) score
319175|NCT02239315|Pathological Complete Response (pCR)|pathological complete response (pcr)
319176|NCT02239315|Fine Needle Aspiration Biopsy|fine needle aspiration biopsy
319177|NCT02239302|Obstructed defaecation syndrome|obstructed defaecation syndrome
319178|NCT02239302|Transperineal Ultrasound|transperineal ultrasound
319179|NCT02239302|Endovaginal Ultrasound|endovaginal ultrasound
319180|NCT02239302|Evacuation Proctography|evacuation proctography
319181|NCT02239289|Low back pain|low back pain
319182|NCT02239289|Rehabilitation|rehabilitation
319183|NCT02239289|Biofeedback|biofeedback
319184|NCT02239289|Electromyography|electromyography
319185|NCT02239289|Kinematic|kinematic
319186|NCT02239276|Stiripentol|stiripentol
319187|NCT02239276|Dravet syndrome|dravet syndrome
319188|NCT02239276|Epilepsy|epilepsy
319189|NCT02239276|Epileptic Encephalopathies|epileptic encephalopathies
319190|NCT02239250|Child health|child health
319191|NCT02239250|Pneumonia|pneumonia
319192|NCT02239250|Diarrhoea|diarrhoea
319193|NCT02239250|Household air pollution|household air pollution
319194|NCT02239250|PM2.5|pm2.5
319195|NCT02239250|Stove intervention|stove intervention
319196|NCT02239250|Biomass fuel|biomass fuel
319197|NCT02239250|Monitoring and evaluation|monitoring and evaluation
319198|NCT02239250|Water filter|water filter
319199|NCT02239250|Compliance|compliance
319200|NCT02239250|Thermotolerant coliforms|thermotolerant coliforms
319201|NCT02239250|Rwanda|rwanda
319202|NCT02239224|FSHD|fshd
319203|NCT02239211|BUTEO|buteo
319204|NCT02239211|Primary sclerosing cholangitis|primary sclerosing cholangitis
319206|NCT02239211|VAP-1|vap-1
319207|NCT02239211|BTT1023|btt1023
319208|NCT02239211|Human monoclonal antibody|human monoclonal antibody
319209|NCT02239198|HDL|hdl
319210|NCT02239198|nutrition bar|nutrition bar
319211|NCT02239185|Laparoscopy|laparoscopy
319212|NCT02239185|purse string|purse string
319213|NCT02239185|hernial sac|hernial sac
319214|NCT02239159|transcutaneous electric acupoint stimulation|transcutaneous electric acupoint stimulation
319215|NCT02239159|elderly patients|elderly patients
319216|NCT02239133|Pelvic Organ Prolapse|pelvic organ prolapse
319217|NCT02239133|POP|pop
319218|NCT02239107|polycystic ovary syndrome|polycystic ovary syndrome
319219|NCT02239107|laparoscopic drilling|laparoscopic drilling
319220|NCT02239107|clomiphene citrate|clomiphene citrate
319221|NCT02239107|n acetyl cysteine|n acetyl cysteine
319222|NCT02239107|insulin resistance|insulin resistance
319223|NCT02239094|Bipolar Disorder|bipolar disorder
319224|NCT02239094|depression|depression
319225|NCT02239094|Bipolar depression|bipolar depression
319226|NCT02239081|Pharmacokinetics|pharmacokinetics
319227|NCT02239081|Safety|safety
319228|NCT02239068|CT, sedation, oral contrast|ct, sedation, oral contrast
319229|NCT02239055|Borderline Personality Disorder|borderline personality disorder
319230|NCT02239055|Mentalization Based Treatment|mentalization based treatment
319231|NCT02239055|MBT Skills Training|mbt skills training
319232|NCT02239055|Staff Nurse Perceptions|staff nurse perceptions
319233|NCT02239055|Acute Mental Health|acute mental health
319234|NCT02239042|Gingival recessions|gingival recessions
319235|NCT02239029|Platelet rich plasma|platelet rich plasma
319236|NCT02239029|Osteoarthritis of knee|osteoarthritis of knee
319237|NCT02239029|Balance|balance
319238|NCT02239029|Strength|strength
319239|NCT02239016|Sickle cell disease|sickle cell disease
319240|NCT02239016|Hgb SS|hgb ss
319241|NCT02239016|Hgb SC|hgb sc
319242|NCT02239016|Sβ-Thalassemia|sβ-thalassemia
319243|NCT02238977|depression|depression
319244|NCT02238977|ESRD|esrd
319245|NCT02238977|hemodialysis|hemodialysis
319246|NCT02238951|care coordination, mobile health, chemotherapy, technology|care coordination, mobile health, chemotherapy, technology
319247|NCT02238938|piecemeal polypectomy|piecemeal polypectomy
319248|NCT02238938|piecemeal endoscopic mucosal resection (EMR)|piecemeal endoscopic mucosal resection (emr)
319249|NCT02238938|endoscopic submucosal dissection (ESD)|endoscopic submucosal dissection (esd)
319250|NCT02238938|endoscopic en-bloc resection|endoscopic en-bloc resection
319251|NCT02238925|Newly Diagnosed AML|newly diagnosed aml
319252|NCT02238925|Secondary AML|secondary aml
319253|NCT02238925|Relapsed/Refractory AML|relapsed/refractory aml
319254|NCT02238925|Relapsed/Refractory ALL|relapsed/refractory all
319255|NCT02238925|MDS|mds
319256|NCT02238912|tinea|tinea
319257|NCT02238886|Quality of Life|quality of life
407994|NCT01833442|OCD|ocd
319258|NCT02238886|Enteral nutrition|enteral nutrition
319259|NCT02238886|Nutrition Therapy|nutrition therapy
319260|NCT02238886|Parenteral nutrition, total|parenteral nutrition, total
319261|NCT02238873|lymphoma|lymphoma
319262|NCT02238873|neutropenia|neutropenia
319263|NCT02238873|pegfilgrastim|pegfilgrastim
319264|NCT02238860|Hepatitis B|hepatitis b
319265|NCT02238860|cirrhosis|cirrhosis
319266|NCT02238860|Entacavir|entacavir
319267|NCT02238860|enofovir|enofovir
319268|NCT02238847|Pancreatic|pancreatic
319269|NCT02238847|Pancreatic Cancer|pancreatic cancer
319270|NCT02238847|Preoperative Biliary Drainage|preoperative biliary drainage
319271|NCT02238847|Neoadjuvant Therapy|neoadjuvant therapy
319272|NCT02238834|Phase I|phase i
319273|NCT02238834|Safety and tolerability|safety and tolerability
319274|NCT02238834|Pharmacokinetic|pharmacokinetic
319275|NCT02238834|Randomized|randomized
319276|NCT02238834|Double Blind|double blind
319277|NCT02238834|Placebo-Controlled|placebo-controlled
319278|NCT02238834|Single- & Multiple Dose Escalation|single- & multiple dose escalation
319279|NCT02238834|FP-025|fp-025
319280|NCT02238834|MMP-12 inhibitor|mmp-12 inhibitor
319281|NCT02238821|resectable colorectal cancer|resectable colorectal cancer
319282|NCT02238808|ER+ breast cancer|er+ breast cancer
319283|NCT02238808|Luminal A|luminal a
319284|NCT02238808|Estradiol|estradiol
319285|NCT02238795|Purpura fulminans, Sepsis, Epidemiology, Morbidity, Therapy|purpura fulminans, sepsis, epidemiology, morbidity, therapy
319286|NCT02238782|bioavailability|bioavailability
319287|NCT02238782|pharmacokinetics|pharmacokinetics
319288|NCT02238782|I phase|i phase
319289|NCT02238782|AZD6244|azd6244
319290|NCT02238782|cancer|cancer
319291|NCT02238769|Hepatocellular Carcinoma, 18F-FluoroethylCholine PET|hepatocellular carcinoma, 18f-fluoroethylcholine pet
319292|NCT02238730|Depression|depression
319293|NCT02238730|Depressive Disorder|depressive disorder
319294|NCT02238730|Treatment Resistant Depressive Disorder|treatment resistant depressive disorder
319295|NCT02238730|Bipolar Disorder|bipolar disorder
319296|NCT02238730|Major Depressive Disorder|major depressive disorder
319297|NCT02238730|Electroconvulsive therapy|electroconvulsive therapy
319298|NCT02238717|Pain|pain
319299|NCT02238717|evoked pain|evoked pain
319300|NCT02238717|healthy volunteer|healthy volunteer
319301|NCT02238717|pharmacodynamics|pharmacodynamics
319302|NCT02238704|Adherence|adherence
319303|NCT02238704|Calcium supplementation|calcium supplementation
319304|NCT02238704|Prevention of preeclampsia|prevention of preeclampsia
319305|NCT02238704|Adherence to calcium supplementation|adherence to calcium supplementation
319306|NCT02238691|PEEP|peep
319307|NCT02238691|Air insufflation|air insufflation
319308|NCT02238691|Mask ventilation|mask ventilation
319309|NCT02238691|Esophageal manometry|esophageal manometry
319310|NCT02238691|Esophageal impedance|esophageal impedance
319311|NCT02238652|Nursing homes|nursing homes
319312|NCT02238652|Dementia|dementia
319313|NCT02238652|Quality of Life|quality of life
319314|NCT02238652|Geriatrics|geriatrics
319315|NCT02238652|Aged|aged
319316|NCT02238652|Activities of Daily Living|activities of daily living
319317|NCT02238652|Pain|pain
319318|NCT02238652|Pain management|pain management
319319|NCT02238652|Advance Care Planning|advance care planning
319320|NCT02238652|Patient Safety|patient safety
319321|NCT02238652|Costs and Cost Analysis|costs and cost analysis
319322|NCT02238652|Medication Errors|medication errors
319323|NCT02238652|Medical Order Entry Systems|medical order entry systems
319324|NCT02238652|Medication Reconciliation|medication reconciliation
319325|NCT02238652|Medication Therapy Management|medication therapy management
319326|NCT02238652|Depression|depression
319327|NCT02238652|Psychotropic Drugs|psychotropic drugs
319328|NCT02238652|Informed Consent|informed consent
319329|NCT02238652|Presumed Consent|presumed consent
319330|NCT02238652|Anxiety|anxiety
319331|NCT02238652|Apathy|apathy
319332|NCT02238652|Hospitalization|hospitalization
319333|NCT02238652|Mortality|mortality
319334|NCT02238639|Venous thromboembolism|venous thromboembolism
319335|NCT02238639|COPD exacerbations|copd exacerbations
319336|NCT02238639|Anticoagulation|anticoagulation
319337|NCT02238639|Mortality|mortality
319338|NCT02238626|amyotrophic lateral sclerosis|amyotrophic lateral sclerosis
319339|NCT02238626|pharmacotherapy|pharmacotherapy
319340|NCT02238626|intervention|intervention
319341|NCT02238626|prospective|prospective
319342|NCT02238626|safety endpoint|safety endpoint
319343|NCT02238626|preliminary efficacy|preliminary efficacy
319344|NCT02238626|ibudilast|ibudilast
319345|NCT02238613|Radioactive stents|radioactive stents
319346|NCT02238613|Brachytherapy|brachytherapy
319347|NCT02238613|Biliary obstruction|biliary obstruction
319348|NCT02238613|Intrahepatic Cholangiocarcinoma|intrahepatic cholangiocarcinoma
319349|NCT02238613|Cholangiocarcinoma of the Extrahepatic Bile Duct|cholangiocarcinoma of the extrahepatic bile duct
319350|NCT02238613|ampullary carcinoma|ampullary carcinoma
319351|NCT02238587|Gandoerma Spores Powder Capsules, head-and-neck cancer.|gandoerma spores powder capsules, head-and-neck cancer.
408113|NCT01832935|NPH|nph
319352|NCT02238561|non-invasive|non-invasive
319353|NCT02238561|measurement of oxygen|measurement of oxygen
319354|NCT02238561|consumption|consumption
319355|NCT02238561|delivery|delivery
319356|NCT02238561|post-operative complications|post-operative complications
319357|NCT02238548|immunity|immunity
319358|NCT02238548|vaccination|vaccination
319359|NCT02238548|milk|milk
319360|NCT02238522|Chronic lymphocytic leukemia|chronic lymphocytic leukemia
319361|NCT02238522|B-prolymphocytic leukemia|b-prolymphocytic leukemia
319362|NCT02238522|Non-Hodgkin's lymphoma|non-hodgkin's lymphoma
319363|NCT02238522|follicular lymphoma|follicular lymphoma
319364|NCT02238522|mantle cell lymphoma|mantle cell lymphoma
319365|NCT02238522|marginal zone lymphoma|marginal zone lymphoma
319366|NCT02238522|small lymphocytic lymphoma|small lymphocytic lymphoma
319367|NCT02238522|diffuse large B-cell lymphoma|diffuse large b-cell lymphoma
319368|NCT02238522|unclassifiable lymphoma|unclassifiable lymphoma
319369|NCT02238522|T-cell lymphoma|t-cell lymphoma
319370|NCT02238522|Richter's syndrome|richter's syndrome
319371|NCT02238522|Waldenström's macroglobulinemia|waldenström's macroglobulinemia
319372|NCT02238509|Breast cancer|breast cancer
319373|NCT02238509|HER2 Positive|her2 positive
319374|NCT02238509|HER2+|her2+
319375|NCT02238509|MBC|mbc
319376|NCT02238509|Metastatic|metastatic
319377|NCT02238509|Metastatic breast cancer|metastatic breast cancer
319378|NCT02238509|Chemotherapy|chemotherapy
319379|NCT02238509|Lapatinib|lapatinib
319380|NCT02238509|Trastuzumab|trastuzumab
319381|NCT02238509|anti HER2 therapies|anti her2 therapies
319382|NCT02238496|Glioblastoma|glioblastoma
319383|NCT02238496|Anaplastic Astrocytoma|anaplastic astrocytoma
319384|NCT02238496|Anaplastic Oligodendroglioma|anaplastic oligodendroglioma
319385|NCT02238496|Mixed Glioma|mixed glioma
319386|NCT02238496|akt-Oncogene Protein|akt-oncogene protein
319387|NCT02238496|mTOR Protein|mtor protein
319388|NCT02238496|Glioma|glioma
319389|NCT02238496|Brain Neoplasms|brain neoplasms
319390|NCT02238496|Brain Tumor, Recurrent|brain tumor, recurrent
319391|NCT02238483|Chronic Obstructive Pulmonary Disease|chronic obstructive pulmonary disease
319392|NCT02238483|COPD patients|copd patients
319393|NCT02238483|Exacerbations|exacerbations
319394|NCT02238483|ICS|ics
319395|NCT02238483|LABA|laba
319396|NCT02238470|Ischemic stroke|ischemic stroke
319397|NCT02238470|Intracerebral hemorrhage|intracerebral hemorrhage
319398|NCT02238470|Subdural hemorrhage|subdural hemorrhage
319399|NCT02238470|Microbleed|microbleed
319400|NCT02238470|Leukoaraiosis|leukoaraiosis
319401|NCT02238470|Oral anticoagulants|oral anticoagulants
319402|NCT02238457|Heart failure|heart failure
319403|NCT02238457|Losartan|losartan
319404|NCT02238444|Warfarin|warfarin
319405|NCT02238444|Portal Vein|portal vein
319406|NCT02238444|Anticoagulants|anticoagulants
319407|NCT02238444|Cirrhosis|cirrhosis
319408|NCT02238444|Hypertension|hypertension
319409|NCT02238444|Venous Thrombosis|venous thrombosis
319410|NCT02238444|Splenectomy|splenectomy
319411|NCT02238431|Lucrin depot,|lucrin depot,
319412|NCT02238431|frozen embryo transfer,|frozen embryo transfer,
319413|NCT02238431|artificial cycle,|artificial cycle,
319414|NCT02238431|pregnancy,|pregnancy,
319415|NCT02238431|cancellation|cancellation
319416|NCT02238418|Vitamin D, Calciuria, Paediatrics, Nephrology|vitamin d, calciuria, paediatrics, nephrology
319417|NCT02238392|paroxysmal atrial fibrillation|paroxysmal atrial fibrillation
319418|NCT02238392|pulmonary vein isolation|pulmonary vein isolation
319419|NCT02238392|adenosine|adenosine
319420|NCT02238392|AF terminatin|af terminatin
319421|NCT02238379|Intranasal oxytocin|intranasal oxytocin
319422|NCT02238379|Social perception|social perception
319423|NCT02238379|EEG/ERP|eeg/erp
319424|NCT02238340|Postoperatory pain|postoperatory pain
319425|NCT02238340|Oxycodone|oxycodone
319426|NCT02238327|Antiretroviral therapy|antiretroviral therapy
319427|NCT02238327|pulmonary function|pulmonary function
319428|NCT02238327|biomarkers|biomarkers
319429|NCT02238301|Intrauterine growth restriction|intrauterine growth restriction
319430|NCT02238301|BOLD effect|bold effect
319431|NCT02238288|anticoagulation|anticoagulation
319432|NCT02238288|extraction|extraction
319433|NCT02238288|epsilon amino caproic|epsilon amino caproic
319434|NCT02238054|Cardiology|cardiology
319435|NCT02238054|Intracoronary angioplasty|intracoronary angioplasty
319436|NCT02238054|Bioresorbable stent|bioresorbable stent
319437|NCT02238041|Glucose monitoring|glucose monitoring
319438|NCT02238041|Intensive care unit|intensive care unit
319439|NCT02238028|Heart rate variability|heart rate variability
319440|NCT02238028|Blood pressure|blood pressure
319441|NCT02238028|Circulating biomarkers|circulating biomarkers
319442|NCT02238028|Respirator|respirator
319443|NCT02238028|Fine particulate matter|fine particulate matter
319444|NCT02238015|cataract ,tear film,SS-OCT|cataract ,tear film,ss-oct
319445|NCT02238002|shallow anterior chamber|shallow anterior chamber
319446|NCT02238002|narrow angle|narrow angle
319447|NCT02238002|SS-OCT|ss-oct
763433|NCT00391183|Stenting|stenting
319448|NCT02237989|knee osteoarthritis, native collagen type 2, paracetamol|knee osteoarthritis, native collagen type 2, paracetamol
319449|NCT02237937|Depression, Affective Disorder|depression, affective disorder
319450|NCT02237924|nasopharyngeal carcinoma|nasopharyngeal carcinoma
319451|NCT02237924|endostar|endostar
319452|NCT02237924|IMRT|imrt
319453|NCT02237924|chemoradiation|chemoradiation
319454|NCT02237911|total knee replacement|total knee replacement
319455|NCT02237911|rehabilitation|rehabilitation
319456|NCT02237911|exercise program|exercise program
319457|NCT02237911|total knee arthroplasty|total knee arthroplasty
319458|NCT02237898|Tobacco cessation|tobacco cessation
319459|NCT02237885|Military Veterans|military veterans
319460|NCT02237872|Brown Adipose Tissue|brown adipose tissue
319461|NCT02237859|cdiff|cdiff
319462|NCT02237859|vancomycin|vancomycin
319463|NCT02237859|infection|infection
319464|NCT02237859|clostridium difficile|clostridium difficile
319465|NCT02237846|osteoarthritis|osteoarthritis
319466|NCT02237846|knee|knee
319467|NCT02237846|stem cells|stem cells
319468|NCT02237846|mesenchymal|mesenchymal
319469|NCT02237846|umbilical cord|umbilical cord
319470|NCT02237833|septic shock|septic shock
319471|NCT02237833|cerebral oximetry|cerebral oximetry
319472|NCT02237833|vasopressor|vasopressor
319473|NCT02237833|norepinephrine|norepinephrine
319474|NCT02237807|Fed Conditions|fed conditions
319475|NCT02237781|AMH|amh
319476|NCT02237781|IVF|ivf
319477|NCT02237781|ovarian stimulation|ovarian stimulation
319478|NCT02237768|Fasting conditions|fasting conditions
319479|NCT02237755|Clomiphene citrate|clomiphene citrate
319480|NCT02237755|IVF|ivf
319481|NCT02237755|Pregnancy Rates|pregnancy rates
319482|NCT02237755|Ovarian Reserve|ovarian reserve
319483|NCT02237729|healthy subjects|healthy subjects
319484|NCT02237729|immunology|immunology
319485|NCT02237729|PK|pk
319486|NCT02237729|Phase 1|phase 1
319487|NCT02237729|bioequivalence|bioequivalence
319488|NCT02237729|biosimilarity|biosimilarity
319489|NCT02237729|adalimumab|adalimumab
319490|NCT02237729|single dose.|single dose.
319491|NCT02237703|Post-traumatic Stress Disorder (PTSD)|post-traumatic stress disorder (ptsd)
319492|NCT02237703|Positron emission tomography (PET)|positron emission tomography (pet)
319493|NCT02237703|Neuroimaging|neuroimaging
319494|NCT02237703|Kappa opioid receptor (KOR)|kappa opioid receptor (kor)
319495|NCT02237677|Post-traumatic stress disorder (PTSD)|post-traumatic stress disorder (ptsd)
319496|NCT02237677|Trauma|trauma
319497|NCT02237677|Neuroimaging|neuroimaging
319498|NCT02237677|Positron emission tomography (PET)|positron emission tomography (pet)
319499|NCT02237677|[11C]OMAR|[11c]omar
319500|NCT02237677|Endocannabinoid|endocannabinoid
319501|NCT02237664|Thoracoscopy|thoracoscopy
319502|NCT02237664|Patient-controlled analgesia|patient-controlled analgesia
319503|NCT02237664|Paravertebral analgesia|paravertebral analgesia
319504|NCT02237651|anesthesia|anesthesia
319505|NCT02237651|bronchosocopy|bronchosocopy
319506|NCT02237651|lung transplantation|lung transplantation
319507|NCT02237638|VEGF|vegf
319508|NCT02237638|Vaccine|vaccine
319509|NCT02237638|Angiogenesis|angiogenesis
319510|NCT02237625|Hypophosphatasia|hypophosphatasia
319511|NCT02237625|HPP|hpp
319512|NCT02237599|SSEP|ssep
319513|NCT02237599|neuropraxia|neuropraxia
319514|NCT02237599|intraoperative|intraoperative
319515|NCT02237599|automated|automated
319516|NCT02237586|Plasmodium falciparum malaria|plasmodium falciparum malaria
319517|NCT02237586|Malaria|malaria
319518|NCT02237586|PfSPZ Challenge|pfspz challenge
319519|NCT02237586|Controlled Human Malaria Infection (CHMI)|controlled human malaria infection (chmi)
319520|NCT02237586|Sickle Cell Trait|sickle cell trait
319521|NCT02237586|Sporozoites|sporozoites
319522|NCT02237573|general practice|general practice
319523|NCT02237573|viral infections|viral infections
319524|NCT02237573|consultation reports|consultation reports
319525|NCT02237573|drug prescription|drug prescription
319526|NCT02237560|MCI|mci
319527|NCT02237560|Exergaming|exergaming
319528|NCT02237560|Cognition|cognition
319529|NCT02237560|Exercise|exercise
319530|NCT02237560|Older Adults|older adults
319531|NCT02237547|spinal cord injury|spinal cord injury
319532|NCT02237547|mesenchymal|mesenchymal
319533|NCT02237547|bone marrow|bone marrow
319534|NCT02237547|mononuclear cells|mononuclear cells
319535|NCT02237547|stem cells|stem cells
319536|NCT02237547|umbilical cord|umbilical cord
319537|NCT02237534|Lanthanum|lanthanum
319538|NCT02237534|Calcium Carbonate|calcium carbonate
319539|NCT02237534|Vascular Calcification|vascular calcification
319540|NCT02237521|Incretin hormones|incretin hormones
319541|NCT02237521|End-stage renal disease|end-stage renal disease
319542|NCT02237521|ESRD|esrd
319543|NCT02237521|GLP-1|glp-1
319544|NCT02237521|GIP|gip
319545|NCT02237521|Insulin|insulin
319546|NCT02237521|Glucagon|glucagon
319547|NCT02237469|Breast cancer|breast cancer
319548|NCT02237469|Breast conserving surgery.|breast conserving surgery.
319549|NCT02237469|Radiotherapy.|radiotherapy.
763434|NCT00391183|Survival|survival
408416|NCT01831726|Trk|trk
319550|NCT02237469|Treatment planning.|treatment planning.
319551|NCT02237469|Prone.|prone.
319552|NCT02237456|Myocardial infarction|myocardial infarction
319553|NCT02237456|Atherosclerosis|atherosclerosis
319554|NCT02237456|PCI|pci
319555|NCT02237456|OCT|oct
319556|NCT02237456|Optical coherence tomography|optical coherence tomography
319557|NCT02237456|Stent|stent
319558|NCT02237456|Bioresorbable stents|bioresorbable stents
319559|NCT02237443|Patient Safety|patient safety
319560|NCT02237430|Coronary angiography (CAG)|coronary angiography (cag)
319561|NCT02237417|MRI|mri
319562|NCT02237417|Imaging|imaging
319563|NCT02237417|Antipsychotic|antipsychotic
319564|NCT02237404|Follow-Up studies|follow-up studies
319565|NCT02237404|Biological Pacemakers|biological pacemakers
319566|NCT02237404|Telemedicine|telemedicine
319567|NCT02237404|Efficiency|efficiency
319568|NCT02237391|High Frequency Emergency Department Visits|high frequency emergency department visits
319569|NCT02237391|Healthcare Utilization|healthcare utilization
319570|NCT02237391|Chronic Pain|chronic pain
319571|NCT02237391|Interdisciplinary|interdisciplinary
319572|NCT02237378|FDG lung and RV uptake|fdg lung and rv uptake
319573|NCT02237365|neurological disability|neurological disability
319574|NCT02237365|tuberculous meningitis (TBM)|tuberculous meningitis (tbm)
319575|NCT02237365|safety|safety
319576|NCT02237365|aspirin|aspirin
319577|NCT02237365|efficacy|efficacy
319578|NCT02237352|Diabetes mellitus|diabetes mellitus
319579|NCT02237352|Diabetic nephropathy|diabetic nephropathy
319580|NCT02237352|Social Factors|social factors
319581|NCT02237352|Biological Factors|biological factors
319582|NCT02237352|VEGF-A|vegf-a
319583|NCT02237352|Tenascin C|tenascin c
319584|NCT02237352|Disease characterization|disease characterization
319585|NCT02237352|Mechanisms|mechanisms
319586|NCT02237352|Kidney|kidney
319587|NCT02237352|Chronic kidney disease|chronic kidney disease
319588|NCT02237352|Secondary nephropathy|secondary nephropathy
319589|NCT02237352|South America|south america
319590|NCT02237352|Hispanics|hispanics
319591|NCT02237352|Ecuador|ecuador
319592|NCT02237352|Biomarkers|biomarkers
319593|NCT02237339|Allopurinol|allopurinol
319594|NCT02237339|Cardiac MRI (CMR)|cardiac mri (cmr)
319595|NCT02237339|Flow mediated dilatation (FMD)|flow mediated dilatation (fmd)
319596|NCT02237339|Pulse wave analysis (PWA)|pulse wave analysis (pwa)
319597|NCT02237339|Endothelial function|endothelial function
319598|NCT02237339|Scar|scar
319599|NCT02237339|Hypertrophy|hypertrophy
319600|NCT02237339|Hypertension|hypertension
319601|NCT02237326|Visual Inspection with Acetic Acid|visual inspection with acetic acid
319602|NCT02237326|Visual Inspection with Lugol's Iodine|visual inspection with lugol's iodine
319603|NCT02237326|Cervical Intraepithelial neoplasia|cervical intraepithelial neoplasia
319604|NCT02237326|Cervical Cancer Screening|cervical cancer screening
319605|NCT02237326|HIV infected women|hiv infected women
319606|NCT02237313|psychological support|psychological support
319607|NCT02237313|therapeutic education|therapeutic education
319608|NCT02237313|vulnerability of patients|vulnerability of patients
319609|NCT02237300|Bulimia nervosa|bulimia nervosa
319610|NCT02237300|Binge eating disorder|binge eating disorder
319611|NCT02237300|Food craving|food craving
319612|NCT02237300|Anxiety|anxiety
319613|NCT02237300|Bingeing|bingeing
319614|NCT02237300|Cue Exposure Therapy|cue exposure therapy
319615|NCT02237300|Virtual Reality|virtual reality
319616|NCT02237274|Fontan circulation|fontan circulation
319617|NCT02237274|High altitude exposure|high altitude exposure
319618|NCT02237261|Newly diagnosed symptomatic multiple myeloma|newly diagnosed symptomatic multiple myeloma
319619|NCT02237248|Adolescent Idiopathic Scoliosis|adolescent idiopathic scoliosis
319620|NCT02237248|Functional Movement Screen|functional movement screen
319621|NCT02237248|Y Balance Test|y balance test
319622|NCT02237235|Schizophrenia|schizophrenia
319623|NCT02237235|Schizoaffective disorder|schizoaffective disorder
319624|NCT02237235|Cognition|cognition
319625|NCT02237235|Magnesium|magnesium
319626|NCT02237235|Imaging|imaging
319627|NCT02237235|Negative symptoms|negative symptoms
319628|NCT02237222|Outcome Assessment|outcome assessment
319629|NCT02237222|Gait|gait
319630|NCT02237222|Neuromuscular Diseases|neuromuscular diseases
319631|NCT02237222|Psychometrics|psychometrics
319632|NCT02237222|Clinical Assessment Tools|clinical assessment tools
319633|NCT02237196|cat-allergic|cat-allergic
319634|NCT02237196|cat immunotherapy|cat immunotherapy
319635|NCT02237196|anti-thymic stromal lymphopoietin (anti-TSLP)|anti-thymic stromal lymphopoietin (anti-tslp)
319636|NCT02237170|Sipuleucel-T|sipuleucel-t
319637|NCT02237170|Castration Resistant Prostate Cancer|castration resistant prostate cancer
319638|NCT02237170|Provenge|provenge
319639|NCT02237157|pancreatic cancer|pancreatic cancer
319640|NCT02237157|unresectable|unresectable
319641|NCT02237157|gemcitabine|gemcitabine
319642|NCT02237157|device|device
319643|NCT02237157|local delivery|local delivery
319644|NCT02237157|chemoembolization|chemoembolization
319645|NCT02237131|Endometriosis|endometriosis
319646|NCT02237131|Oral contraceptives|oral contraceptives
319647|NCT02237131|Laparoscopy|laparoscopy
319648|NCT02237118|Acute|acute
319649|NCT02237118|wound|wound
319650|NCT02237118|management|management
319651|NCT02237118|measured|measured
319652|NCT02237118|Visual analoge scale|visual analoge scale
319653|NCT02237066|OCT|oct
319654|NCT02237066|PTA|pta
319655|NCT02237066|Balloon|balloon
319656|NCT02237053|Energy expenditure|energy expenditure
319657|NCT02237053|Glucagon|glucagon
319658|NCT02237053|Octreotide|octreotide
319659|NCT02237053|Weight loss|weight loss
319660|NCT02237040|Children|children
319661|NCT02237040|mandible|mandible
319662|NCT02237040|condylar fracture|condylar fracture
319663|NCT02237040|conservative treatment|conservative treatment
319664|NCT02237040|functional treatment|functional treatment
319665|NCT02237027|HIV|hiv
319666|NCT02237027|Early treatment as prevention (TasP)|early treatment as prevention (tasp)
319667|NCT02237027|Pre-exposure prophylaxis (PrEP)|pre-exposure prophylaxis (prep)
319668|NCT02237027|antiretroviral treatment|antiretroviral treatment
319669|NCT02237027|prevention|prevention
319670|NCT02237027|feasibility|feasibility
319671|NCT02237027|female sex workers|female sex workers
319672|NCT02237027|Benin|benin
319673|NCT02237027|West Africa|west africa
319674|NCT02237001|meniscal|meniscal
319675|NCT02237001|meniscus|meniscus
319676|NCT02237001|repair|repair
319677|NCT02237001|knee|knee
319678|NCT02237001|arthroscopy knee|arthroscopy knee
319679|NCT02237001|horizontal|horizontal
319680|NCT02236988|Apremilast|apremilast
319681|NCT02236988|Healthy male subjects|healthy male subjects
319682|NCT02236988|Pharmacokinetics|pharmacokinetics
319683|NCT02236949|pediatric pain|pediatric pain
319684|NCT02236949|intervention sustainability|intervention sustainability
319685|NCT02236936|Squamous Cell Carcinoma|squamous cell carcinoma
319686|NCT02236936|Head and neck|head and neck
319687|NCT02236936|SCCHN|scchn
319688|NCT02236936|Parenteral nutrition|parenteral nutrition
319689|NCT02236936|Larynx|larynx
319690|NCT02236936|Hypopharynx|hypopharynx
319691|NCT02236936|Cavum oris|cavum oris
319692|NCT02236936|Radiotherapy|radiotherapy
319693|NCT02236936|Cetuximab|cetuximab
319694|NCT02236936|Cisplatin|cisplatin
319695|NCT02236923|cardiovascular|cardiovascular
319696|NCT02236923|surgery|surgery
319697|NCT02236923|ascending aorta|ascending aorta
319698|NCT02236923|aortic dissection|aortic dissection
319699|NCT02236910|somatostatin receptor positive tumour|somatostatin receptor positive tumour
319700|NCT02236884|rectal cancer|rectal cancer
319701|NCT02236884|no scar|no scar
319702|NCT02236884|NOTES|notes
319703|NCT02236884|TaTME|tatme
319704|NCT02236884|feasibility|feasibility
319705|NCT02236884|safety|safety
319706|NCT02236871|Adolescents|adolescents
319707|NCT02236871|Dairy|dairy
319708|NCT02236871|Bone|bone
319709|NCT02236858|COPD|copd
319710|NCT02236845|Insomnia, medical device, sleep latency|insomnia, medical device, sleep latency
319711|NCT02236806|Breast cancer|breast cancer
319712|NCT02236806|Adjuvant chemotherapy|adjuvant chemotherapy
319713|NCT02236806|Neoadjuvant chemotherapy|neoadjuvant chemotherapy
319714|NCT02236806|Cardioprotection|cardioprotection
319715|NCT02236806|Anthracyclines|anthracyclines
319716|NCT02236780|in vitro fertilisation|in vitro fertilisation
319717|NCT02236780|environmental conditions|environmental conditions
319718|NCT02236780|pregnancy|pregnancy
319719|NCT02236780|live birth rate|live birth rate
319720|NCT02236754|dihydrotetrabenazine|dihydrotetrabenazine
319721|NCT02236754|beta cell mass|beta cell mass
319722|NCT02236754|diabetes mellitus|diabetes mellitus
319723|NCT02236702|Major Depressive Disorder|major depressive disorder
319724|NCT02236702|Anhedonia|anhedonia
319725|NCT02236702|Positron Emission Tomography (PET)|positron emission tomography (pet)
319726|NCT02236702|Kappa Opioid Receptor (KOR)|kappa opioid receptor (kor)
319727|NCT02236676|motor learning TBI|motor learning tbi
319728|NCT02236663|Intimate Partner Violence|intimate partner violence
319729|NCT02236663|Dating Violence|dating violence
319730|NCT02236663|Relationships|relationships
319731|NCT02236663|Safety Planning|safety planning
319732|NCT02236663|College|college
319733|NCT02236663|Student|student
319734|NCT02236663|App|app
319735|NCT02236650|Parental Resilience|parental resilience
319736|NCT02236650|Parental Stress|parental stress
319737|NCT02236650|Family Adaptation|family adaptation
319738|NCT02236650|Autistic Disorder|autistic disorder
319739|NCT02236650|Behavior|behavior
319740|NCT02236650|Child Behavior|child behavior
319741|NCT02236650|Child Development Disorders|child development disorders
319742|NCT02236650|Pervasive Developmental Disabilities|pervasive developmental disabilities
319743|NCT02236650|Caregivers|caregivers
319745|NCT02236650|Parenting|parenting
319746|NCT02236650|Primary Health Care|primary health care
319747|NCT02236637|Adenocarcinoma of the Prostate|adenocarcinoma of the prostate
319748|NCT02236637|Registry|registry
400515|NCT01866527|late detected cases|late detected cases
408606|NCT01830868|ZNS|zns
319749|NCT02236637|metastatic castration-resistant prostate cancer|metastatic castration-resistant prostate cancer
319750|NCT02236611|COPD|copd
319751|NCT02236611|inhaler ease of use|inhaler ease of use
319752|NCT02236611|glycopyrronium|glycopyrronium
319753|NCT02236611|umeclidinium|umeclidinium
319754|NCT02236611|novel dry powder inhaler|novel dry powder inhaler
319755|NCT02236611|long-acting muscarinic antagonist|long-acting muscarinic antagonist
319756|NCT02236611|inhaler errors|inhaler errors
319757|NCT02236598|borderline hypokalemia|borderline hypokalemia
319758|NCT02236598|glucose tolerance|glucose tolerance
319759|NCT02236598|insulin secretion|insulin secretion
319760|NCT02236598|insulin sensitivity|insulin sensitivity
319761|NCT02236598|fasting glucose|fasting glucose
319762|NCT02236598|African American|african american
319763|NCT02236585|uterine artery embolization, epidural , patient-controlled analgesia|uterine artery embolization, epidural , patient-controlled analgesia
319764|NCT02236572|Postmenopausal|postmenopausal
319765|NCT02236572|ER-positive, PR-positive, HER2-negative|er-positive, pr-positive, her2-negative
319766|NCT02236572|Low and intermediate risk|low and intermediate risk
319767|NCT02236559|high flow therapy|high flow therapy
319768|NCT02236559|high flow nasal cannula|high flow nasal cannula
319769|NCT02236559|acute respiratory failure|acute respiratory failure
319770|NCT02236559|noninvasive ventilation|noninvasive ventilation
319771|NCT02236546|fluorodeoxyglucose|fluorodeoxyglucose
319772|NCT02236546|FDG|fdg
319773|NCT02236546|PET/CT|pet/ct
319774|NCT02236546|melanoma|melanoma
319775|NCT02236546|imaging biomarkers|imaging biomarkers
319776|NCT02236546|cancer imaging|cancer imaging
319777|NCT02236520|Na+ MRI|na+ mri
319778|NCT02236520|salt stores|salt stores
319779|NCT02236494|alcoholism|alcoholism
319780|NCT02236494|dangerous behavior|dangerous behavior
319781|NCT02236494|aged|aged
319782|NCT02236494|emergency medicine|emergency medicine
319783|NCT02236455|complementary medicine|complementary medicine
319784|NCT02236455|state anxiety|state anxiety
319785|NCT02236455|acute pain|acute pain
319786|NCT02236455|self-efficacy|self-efficacy
319787|NCT02236455|surgery|surgery
319788|NCT02236455|medical music intervention|medical music intervention
319789|NCT02236455|nature therapy|nature therapy
319790|NCT02236455|relaxation technique|relaxation technique
319791|NCT02236442|Cephalalgia|cephalalgia
319792|NCT02236442|Headache|headache
319793|NCT02236442|Migraine|migraine
319794|NCT02236442|Pain|pain
319795|NCT02236442|Global|global
319796|NCT02236442|Treatment|treatment
319797|NCT02236442|Oxygen|oxygen
319798|NCT02236442|Emergency|emergency
319799|NCT02236442|Treatment of cephalalgia in emergency department|treatment of cephalalgia in emergency department
319800|NCT02236429|bacterial vaginitis|bacterial vaginitis
319801|NCT02236429|vaginal flora|vaginal flora
319802|NCT02236429|microbiome|microbiome
319803|NCT02236416|Dementia|dementia
319804|NCT02236416|Prevention|prevention
319805|NCT02236416|Physical Activity|physical activity
319806|NCT02236403|Blepharitis , Demodex, Ivermectin, Metronidazole|blepharitis , demodex, ivermectin, metronidazole
319807|NCT02236390|Nightmare|nightmare
319808|NCT02236390|PTSD|ptsd
319809|NCT02236390|Sleep|sleep
319810|NCT02236390|Emotion Regulation|emotion regulation
319811|NCT02236390|Exposure Relaxation and Rescripting Therapy|exposure relaxation and rescripting therapy
319812|NCT02236390|Cognitive Processing Therapy|cognitive processing therapy
319813|NCT02236377|ERRT|errt
319814|NCT02236377|Nightmares|nightmares
319815|NCT02236377|Sleep|sleep
319816|NCT02236377|Trauma|trauma
319817|NCT02236377|PTSD|ptsd
319818|NCT02236351|patching|patching
319819|NCT02236351|pediatric ophthalmology|pediatric ophthalmology
319820|NCT02236338|chronic venous insufficiency|chronic venous insufficiency
319821|NCT02236338|varicose vein|varicose vein
319822|NCT02236338|greater saphenous vein|greater saphenous vein
319823|NCT02236299|Right Coronary Artery|right coronary artery
319824|NCT02236299|Percutaneous Coronary Intervention|percutaneous coronary intervention
319825|NCT02236299|Diastolic Dysfunction|diastolic dysfunction
319826|NCT02236299|Glucagon-like peptide-1|glucagon-like peptide-1
319827|NCT02236299|GLP-1|glp-1
319828|NCT02236299|Stunning|stunning
319829|NCT02236299|Cardioprotection|cardioprotection
319830|NCT02236286|freezing of gait (FOG)|freezing of gait (fog)
319831|NCT02236286|balance|balance
319832|NCT02236286|gait|gait
319833|NCT02236286|exercise|exercise
319834|NCT02236273|Human papillomavirus|human papillomavirus
319835|NCT02236273|vaccination|vaccination
319836|NCT02236273|text message|text message
319837|NCT02236273|reminder|reminder
319838|NCT02236247|ivabradine|ivabradine
319839|NCT02236247|heart rate|heart rate
319840|NCT02236247|heart failure|heart failure
319841|NCT02236234|HIV|hiv
319842|NCT02236234|HPV|hpv
319843|NCT02236234|Clinical trial|clinical trial
319844|NCT02236234|outcome|outcome
319845|NCT02236195|Urothelial|urothelial
319846|NCT02236195|Bladder|bladder
319847|NCT02236195|HDAC|hdac
319848|NCT02236195|MGCD0103|mgcd0103
319849|NCT02236195|Mocetinostat|mocetinostat
319850|NCT02236195|CREBBP|crebbp
319851|NCT02236195|EP300|ep300
319852|NCT02236195|Mirati|mirati
319853|NCT02236195|MethylGene|methylgene
319854|NCT02236143|Healthy|healthy
319855|NCT02236130|pediatric regional|pediatric regional
319856|NCT02236117|heart rate variability|heart rate variability
319857|NCT02236117|children|children
319858|NCT02236117|progressive test|progressive test
319859|NCT02236104|neuromuscular disorders|neuromuscular disorders
319860|NCT02236104|mechanical insufflation-exsufflation|mechanical insufflation-exsufflation
319861|NCT02236104|respiratory parameters|respiratory parameters
319862|NCT02236104|plethysmography opto electronic|plethysmography opto electronic
319863|NCT02236104|Vital capacity|vital capacity
319864|NCT02236091|cerebral palsy|cerebral palsy
319865|NCT02236091|stroke|stroke
319866|NCT02236091|traumatic brain injury|traumatic brain injury
319867|NCT02236065|Umbilical cord blood|umbilical cord blood
319868|NCT02236065|Granulocyte-colony stimulating factor|granulocyte-colony stimulating factor
319869|NCT02236065|Brain injury|brain injury
319870|NCT02236065|Neurodegenerative disorder|neurodegenerative disorder
319871|NCT02236065|Efficacy|efficacy
319872|NCT02236065|Safety|safety
319873|NCT02236052|Influenza|influenza
319874|NCT02236052|Human|human
319875|NCT02236052|RNA Virus Infections|rna virus infections
319876|NCT02236052|Immunologic|immunologic
319877|NCT02236052|Immunogenic Factors|immunogenic factors
319878|NCT02236052|Physiological Effects of Drugs|physiological effects of drugs
319879|NCT02236052|Virus diseases|virus diseases
319880|NCT02236052|Orthomyxoviridae Infections|orthomyxoviridae infections
319881|NCT02236052|Infection|infection
319882|NCT02236039|Diesel exhaust|diesel exhaust
319883|NCT02236039|Air pollution|air pollution
319884|NCT02236039|Airway responsivness|airway responsivness
319885|NCT02236026|Nestorone use as an IV solution on heart rate;|nestorone use as an iv solution on heart rate;
319886|NCT02236026|Abnormality in Heart Rate or Rhythm, Unspecified as to Time of Onset|abnormality in heart rate or rhythm, unspecified as to time of onset
319887|NCT02236013|ASP2215|asp2215
319888|NCT02236013|Daunorubicin|daunorubicin
319889|NCT02236013|Gilteritinib|gilteritinib
319890|NCT02236013|Acute Myeloid Leukemia|acute myeloid leukemia
319891|NCT02236013|Idarubicin|idarubicin
319892|NCT02236013|Cytarabine|cytarabine
319893|NCT02236000|NSABP|nsabp
319894|NCT02236000|Trastuzumab Emtansine|trastuzumab emtansine
319895|NCT02236000|T DM1|t dm1
319896|NCT02236000|Neratinib|neratinib
319897|NCT02236000|Metastatic Breast Cancer|metastatic breast cancer
319898|NCT02236000|HER2 positive|her2 positive
319899|NCT02236000|Dose Escalation|dose escalation
319900|NCT02235974|stroke|stroke
319901|NCT02235974|critical periods|critical periods
319902|NCT02235974|sensitive periods|sensitive periods
319903|NCT02235974|hemiparesis|hemiparesis
319904|NCT02235974|upper extremity|upper extremity
319905|NCT02235974|physical rehabilitation|physical rehabilitation
319906|NCT02235974|arm therapy|arm therapy
319907|NCT02235974|occupational therapy|occupational therapy
319908|NCT02235974|physical therapy|physical therapy
319909|NCT02235974|task oriented training|task oriented training
319910|NCT02235974|patient focused|patient focused
319911|NCT02235974|arm function|arm function
319912|NCT02235974|hand function|hand function
319913|NCT02235974|neurorehabilitation|neurorehabilitation
319914|NCT02235974|motor learning|motor learning
319915|NCT02235974|motor control|motor control
319916|NCT02235974|motor function|motor function
319917|NCT02235974|motor recovery|motor recovery
319918|NCT02235974|skill acquisition|skill acquisition
319919|NCT02235974|skill training|skill training
319920|NCT02235948|arsenic induced health problem|arsenic induced health problem
319921|NCT02235948|modifying effects|modifying effects
319922|NCT02235948|folic acid|folic acid
319923|NCT02235948|oxidative damage|oxidative damage
319924|NCT02235948|clinical trial|clinical trial
319925|NCT02235922|Aged|aged
319926|NCT02235922|Exercise|exercise
319927|NCT02235922|Cognition|cognition
319928|NCT02235922|Functional capacity|functional capacity
319929|NCT02235909|Pediatric Hypertension|pediatric hypertension
319930|NCT02235909|High Blood Pressure|high blood pressure
319931|NCT02235909|Hypertension|hypertension
319932|NCT02235909|Pediatric|pediatric
319933|NCT02235909|Primary Hypertension|primary hypertension
319934|NCT02235909|Secondary Hypertension|secondary hypertension
319935|NCT02235896|risk factors, African American, lipids, blood pressure|risk factors, african american, lipids, blood pressure
319936|NCT02235883|Coronary artery disease|coronary artery disease
319937|NCT02235883|FFR|ffr
319938|NCT02235883|diagnosis|diagnosis
319939|NCT02235883|computational model|computational model
319940|NCT02235883|non-invasive|non-invasive
319941|NCT02235870|Weight Loss|weight loss
319942|NCT02235870|Obesity|obesity
319943|NCT02235870|BMI|bmi
319944|NCT02235857|pediatric, renal transplantation, recurrence, drug-resistant|pediatric, renal transplantation, recurrence, drug-resistant
319945|NCT02235844|Mesenchymal|mesenchymal
319946|NCT02235844|Stem Cells|stem cells
319947|NCT02235844|Umbilical Cord|umbilical cord
319948|NCT02235844|Duchenne's|duchenne's
319949|NCT02235844|Muscular Dystrophy|muscular dystrophy
319950|NCT02235831|DACP MF|dacp mf
319951|NCT02235831|DAILIES AquaComfort Plus® Multifocal|dailies aquacomfort plus® multifocal
319952|NCT02235831|presbyopia|presbyopia
319953|NCT02235831|visual performance|visual performance
319954|NCT02235818|tennis elbow, treatment, lateral epicondylitis, immediate effects|tennis elbow, treatment, lateral epicondylitis, immediate effects
319955|NCT02235805|Metabolic Syndrome|metabolic syndrome
319956|NCT02235805|Obesity|obesity
319957|NCT02235805|Magnesium Supplementation|magnesium supplementation
319958|NCT02235805|Vascular Stiffness|vascular stiffness
319959|NCT02235805|Vascular Function|vascular function
319960|NCT02235779|ILD|ild
319961|NCT02235779|Pulmonary fibrosis|pulmonary fibrosis
319962|NCT02235779|Cryobiopsy|cryobiopsy
319963|NCT02235779|Transbronchial|transbronchial
319964|NCT02235766|Cardiac Resynchronization Therapy|cardiac resynchronization therapy
319965|NCT02235766|Satellite Tele-Echocardiography|satellite tele-echocardiography
319966|NCT02235740|Open label|open label
319967|NCT02235740|carfilzomib|carfilzomib
319968|NCT02235740|Phase I|phase i
319969|NCT02235740|clinical activity|clinical activity
319970|NCT02235740|pharmacokinetics|pharmacokinetics
319971|NCT02235740|afuresertib|afuresertib
319972|NCT02235740|relapsed|relapsed
319973|NCT02235740|refractory|refractory
319974|NCT02235740|safety|safety
319975|NCT02235740|multiple myeloma|multiple myeloma
319976|NCT02235714|Airway inflammation|airway inflammation
319977|NCT02235714|Tetraplegia|tetraplegia
319978|NCT02235714|Asthma|asthma
319979|NCT02235714|Exhaled breath condensate|exhaled breath condensate
319980|NCT02235714|Spirometry|spirometry
319981|NCT02235714|Pulmonary Function Testing|pulmonary function testing
319982|NCT02235701|soft tissue sarcoma|soft tissue sarcoma
319983|NCT02235701|aldoxorubicin|aldoxorubicin
319984|NCT02235701|ifosfamide|ifosfamide
319985|NCT02235701|mesna|mesna
319986|NCT02235701|phase 1|phase 1
319987|NCT02235701|INNO-206|inno-206
319988|NCT02235688|aldoxorubicin|aldoxorubicin
319989|NCT02235688|INNO-206|inno-206
319990|NCT02235688|solid tumors|solid tumors
319991|NCT02235688|gemcitabine|gemcitabine
319992|NCT02235688|phase 1|phase 1
319993|NCT02235675|Angioplasty|angioplasty
319994|NCT02235675|Peripheral Artery Disease|peripheral artery disease
319995|NCT02235675|Critical Limb Ischemia|critical limb ischemia
319996|NCT02235675|CLI|cli
319997|NCT02235675|PAD|pad
319998|NCT02235662|HIV|hiv
319999|NCT02235662|LNG|lng
320000|NCT02235662|IVR|ivr
320001|NCT02235662|Contraception|contraception
320002|NCT02235662|Prevention|prevention
320003|NCT02235623|Laparoscopic Surgery|laparoscopic surgery
320004|NCT02235623|Orchiopexy|orchiopexy
320005|NCT02235610|Lung Transplantation|lung transplantation
320006|NCT02235610|Ex Vivo Lung Perfusion|ex vivo lung perfusion
320007|NCT02235610|EVLP|evlp
320008|NCT02235597|patient access|patient access
320009|NCT02235597|patient centered care|patient centered care
320010|NCT02235597|scheduling|scheduling
320011|NCT02235597|access barriers|access barriers
320012|NCT02235597|improve efficiency|improve efficiency
320013|NCT02235597|decision making tools|decision making tools
320014|NCT02235597|underserved|underserved
320015|NCT02235584|Incretin hormones|incretin hormones
320016|NCT02235584|GLP-1|glp-1
320017|NCT02235584|GIP|gip
320018|NCT02235584|Dexamethasone|dexamethasone
320019|NCT02235558|Acute Ischemic Stoke|acute ischemic stoke
320020|NCT02235558|Thrombectomy|thrombectomy
320021|NCT02235558|Intraarterial Pharmacotherapy|intraarterial pharmacotherapy
320022|NCT02235558|Neuroprotection|neuroprotection
320023|NCT02235545|HV Lead|hv lead
320024|NCT02235545|ICD|icd
320025|NCT02235545|CRT-D System|crt-d system
320026|NCT02235545|Treatment of Heart Failure|treatment of heart failure
320027|NCT02235545|Treamtent of life-threatening ventricular tachyarrhythmia|treamtent of life-threatening ventricular tachyarrhythmia
320028|NCT02235545|Optisure|optisure
320029|NCT02235532|clinical trial|clinical trial
320030|NCT02235532|oral hygiene|oral hygiene
320031|NCT02235532|Gingivitis|gingivitis
320032|NCT02235532|Aloevera|aloevera
320033|NCT02235532|Toothpaste|toothpaste
320034|NCT02235532|anti-inflammatory agents|anti-inflammatory agents
320035|NCT02235493|HPP|hpp
320036|NCT02235493|Soft Bones|soft bones
320037|NCT02235493|low Alkaline Phosphatase|low alkaline phosphatase
320038|NCT02235493|genetic metabolic disorder|genetic metabolic disorder
320039|NCT02235493|alkaline phosphatase|alkaline phosphatase
320040|NCT02235493|tissue non-specific alkaline phosphatase|tissue non-specific alkaline phosphatase
320041|NCT02235493|rickets|rickets
320042|NCT02235493|osteomalacia|osteomalacia
320043|NCT02235467|autism|autism
320044|NCT02235467|videomodeling|videomodeling
320045|NCT02235467|behavioral therapy|behavioral therapy
320046|NCT02235467|parental training|parental training
320047|NCT02235454|glaucoma|glaucoma
320048|NCT02235454|OCT|oct
320049|NCT02235454|spectral domain optical coherence tomography|spectral domain optical coherence tomography
320050|NCT02235441|Gastrointestinal malignancy|gastrointestinal malignancy
320051|NCT02235441|Cardiopulmonary fitness|cardiopulmonary fitness
320052|NCT02235441|Chemoradiation therapy|chemoradiation therapy
320053|NCT02235376|Critical Care|critical care
320054|NCT02235376|Brain injured patients|brain injured patients
320055|NCT02235376|Mechanical Ventilation|mechanical ventilation
320056|NCT02235376|Weaning|weaning
320057|NCT02235376|Extubation|extubation
320058|NCT02235376|Prognostic score|prognostic score
320059|NCT02235376|Clinical examination|clinical examination
320060|NCT02235363|face lift|face lift
320061|NCT02235363|thread lift|thread lift
320062|NCT02235363|retaining ligament|retaining ligament
320063|NCT02235363|V-Loc sutures|v-loc sutures
320064|NCT02235363|tensiometer|tensiometer
320065|NCT02235363|FACE-Q|face-q
320066|NCT02235350|Adult|adult
320067|NCT02235350|Male|male
320068|NCT02235350|Female|female
320069|NCT02235350|Neuronal Plasticity|neuronal plasticity
320070|NCT02235350|Imitative Behavior/physiology|imitative behavior/physiology
320071|NCT02235350|Magnetic Resonance Imaging|magnetic resonance imaging
320072|NCT02235350|Psychomotor Disorders/rehabilitation|psychomotor disorders/rehabilitation
320073|NCT02235350|Follow-up Studies|follow-up studies
320074|NCT02235350|Video Recording|video recording
320075|NCT02235350|Physical Therapy Modalities|physical therapy modalities
320076|NCT02235350|Recovery of Function|recovery of function
320077|NCT02235350|Action Observation Treatment|action observation treatment
320078|NCT02235350|Mirror Neuron System|mirror neuron system
320079|NCT02235350|Stroke/rehabilitation|stroke/rehabilitation
320080|NCT02235350|Upper Limb|upper limb
320081|NCT02235337|Concussion|concussion
320082|NCT02235337|Sports related concussion|sports related concussion
320083|NCT02235337|mTBI|mtbi
320084|NCT02235337|Vitamin B|vitamin b
320085|NCT02235337|Riboflavin|riboflavin
320086|NCT02235311|Proton pump inhibitor|proton pump inhibitor
320087|NCT02235311|Upper gastrointestinal bleed|upper gastrointestinal bleed
320088|NCT02235311|Ulcer healing|ulcer healing
320089|NCT02235298|epicardial fat|epicardial fat
320090|NCT02235298|diabetes|diabetes
320091|NCT02235298|dapagliflozin|dapagliflozin
320092|NCT02235285|capsular contracture|capsular contracture
320093|NCT02235285|reoperation|reoperation
320094|NCT02235285|breast augmentation|breast augmentation
320095|NCT02235246|perioperative intravenous magnesium|perioperative intravenous magnesium
320096|NCT02235246|endoscopic submucosal dissection|endoscopic submucosal dissection
320097|NCT02235220|Bruxism|bruxism
320098|NCT02235207|sedentary work|sedentary work
320099|NCT02235207|musculoskeletal pain|musculoskeletal pain
320100|NCT02235207|neuromuscular exercise|neuromuscular exercise
320101|NCT02235207|physical fitness|physical fitness
320102|NCT02235207|quality of life|quality of life
320103|NCT02235207|work ability|work ability
320104|NCT02235181|Twin Pregnancy|twin pregnancy
320105|NCT02235181|Prevention of Preterm birth|prevention of preterm birth
320106|NCT02235181|Short Cervix|short cervix
320107|NCT02235181|Arabin cervical pessary|arabin cervical pessary
320108|NCT02235116|Number of patients|number of patients
320109|NCT02235116|full body skin exam|full body skin exam
320110|NCT02235116|Survey|survey
320111|NCT02235116|preferences|preferences
320112|NCT02235090|Spinal muscular atrophy|spinal muscular atrophy
320113|NCT02235090|Neuromuscular disorders|neuromuscular disorders
320114|NCT02235090|Outcome measures|outcome measures
320115|NCT02235090|Visit-free clinical trial design|visit-free clinical trial design
320116|NCT02235077|Heart Failure|heart failure
320117|NCT02235077|Heart Diseases|heart diseases
320118|NCT02235077|Cardiovascular Diseases|cardiovascular diseases
320119|NCT02235077|Spironolactone|spironolactone
320120|NCT02235077|Aldactone|aldactone
320121|NCT02235025|mild COPD|mild copd
320122|NCT02235025|dyspnea|dyspnea
320123|NCT02235025|exercise|exercise
320124|NCT02235025|respiratory mechanics|respiratory mechanics
320125|NCT02235012|Schizophrenia|schizophrenia
320126|NCT02235012|Ketamine|ketamine
320127|NCT02235012|Cognitive biases|cognitive biases
320128|NCT02235012|Uncertainty|uncertainty
320129|NCT02234999|Pharmacokinetics, Healthy Subjects|pharmacokinetics, healthy subjects
320130|NCT02234986|Advanced Fibrolamellar Carcinoma|advanced fibrolamellar carcinoma
320131|NCT02234947|type 1 diabetes|type 1 diabetes
320132|NCT02234947|pancreas volume|pancreas volume
320133|NCT02234934|Gene Therapy|gene therapy
320134|NCT02234934|X-Linked Chronic Granulomatous Disease (X-CGD)|x-linked chronic granulomatous disease (x-cgd)
320135|NCT02234934|Lentiviral Vector|lentiviral vector
320136|NCT02234921|Prostate|prostate
320137|NCT02234921|Adenocarcinoma|adenocarcinoma
320138|NCT02234921|Metastatic|metastatic
320139|NCT02234921|DRibble|dribble
320140|NCT02234921|Immunotherapy|immunotherapy
320141|NCT02234921|Microbiome|microbiome
320142|NCT02234908|Tuberculosis|tuberculosis
320143|NCT02234908|Drug-resistant tuberculosis|drug-resistant tuberculosis
320144|NCT02234908|Incentives|incentives
320145|NCT02234908|Symptom screening|symptom screening
320146|NCT02234895|osteoarthritis|osteoarthritis
320148|NCT02234895|biomechanics|biomechanics
320149|NCT02234895|treatment|treatment
320150|NCT02234895|symptoms|symptoms
320151|NCT02234869|Peginterferon Beta-1a|peginterferon beta-1a
320152|NCT02234869|Relapsing Multiple Sclerosis|relapsing multiple sclerosis
320153|NCT02234869|RMS|rms
320154|NCT02234869|flu-like symptoms|flu-like symptoms
320155|NCT02234856|Hysterectomy|hysterectomy
320156|NCT02234856|Laparoscopy|laparoscopy
320157|NCT02234856|Surgical assessment|surgical assessment
320158|NCT02234856|Education|education
320159|NCT02234843|Pediatric|pediatric
320160|NCT02234830|PCI|pci
320161|NCT02234804|Coronary angiography (CAG)|coronary angiography (cag)
320162|NCT02234804|Percutaneous coronary intervention (PCI)|percutaneous coronary intervention (pci)
320163|NCT02234804|OCT|oct
320164|NCT02234804|Stent|stent
320165|NCT02234778|critical limb ischemia|critical limb ischemia
320166|NCT02234778|autologous stromal vascular fraction|autologous stromal vascular fraction
320167|NCT02234765|OSA|osa
320168|NCT02234765|OSAS|osas
320169|NCT02234765|Sleep apnea|sleep apnea
320170|NCT02234765|Management|management
320171|NCT02234765|Primary Care|primary care
320172|NCT02234765|Sleep Unit|sleep unit
320173|NCT02234765|Cost-Effectiveness|cost-effectiveness
320174|NCT02234765|ESS|ess
320175|NCT02234752|Schizophrenia|schizophrenia
320176|NCT02234752|Schizoaffective Disorder|schizoaffective disorder
320177|NCT02234752|Cognition|cognition
320178|NCT02234752|Cognitive Impairment|cognitive impairment
320179|NCT02234752|Galantamine|galantamine
320180|NCT02234752|Memantine|memantine
320181|NCT02234739|voriconazole|voriconazole
320182|NCT02234739|COPD|copd
320183|NCT02234739|invasive pulmonary aspergillosis|invasive pulmonary aspergillosis
320184|NCT02234739|efficacy|efficacy
320185|NCT02234739|safety|safety
320186|NCT02234726|child health|child health
320187|NCT02234726|child development|child development
320188|NCT02234726|malnutrition|malnutrition
320189|NCT02234726|stunting|stunting
320190|NCT02234726|community-based health services|community-based health services
320191|NCT02234687|post-traumatic stress disorder|post-traumatic stress disorder
320192|NCT02234674|Pulsating suit|pulsating suit
320193|NCT02234674|lymphedema|lymphedema
320194|NCT02234674|leg volume|leg volume
320195|NCT02234661|Low income|low income
320196|NCT02234661|Education|education
320197|NCT02234661|Poverty|poverty
320198|NCT02234661|Children|children
320199|NCT02234661|Parents|parents
320200|NCT02234661|Head Start|head start
320201|NCT02234648|Vascular Function|vascular function
320202|NCT02234648|tart Montmorency cherries|tart montmorency cherries
320203|NCT02234648|Arterial Stiffness|arterial stiffness
320204|NCT02234648|Blood Flow|blood flow
320205|NCT02234635|visual acuity|visual acuity
320206|NCT02234635|objective visual quality|objective visual quality
320207|NCT02234635|multifocal intraocular lens|multifocal intraocular lens
320208|NCT02234635|tear-film quality dynamics|tear-film quality dynamics
320209|NCT02234622|Stress Disorders, Post-Traumatic|stress disorders, post-traumatic
320210|NCT02234622|Yoga|yoga
320211|NCT02234622|Veterans|veterans
320212|NCT02234609|dentistry|dentistry
320213|NCT02234609|dental caries|dental caries
320214|NCT02234609|atraumatic restorative Treatment|atraumatic restorative treatment
320215|NCT02234609|effectiveness|effectiveness
320216|NCT02234596|Nintedanib|nintedanib
320217|NCT02234596|14-094|14-094
320218|NCT02234583|pain|pain
320219|NCT02234583|fibromyalgia|fibromyalgia
320220|NCT02234570|neurocysticercosis|neurocysticercosis
320221|NCT02234570|pork tapeworm|pork tapeworm
320222|NCT02234570|Taenia solium|taenia solium
320223|NCT02234557|Motor Control|motor control
320224|NCT02234557|Attention|attention
320225|NCT02234557|Cognitive Control|cognitive control
320226|NCT02234544|vitamin D|vitamin d
320227|NCT02234544|absorption|absorption
320228|NCT02234544|ezetimibe|ezetimibe
320229|NCT02234531|Virtual Reality,|virtual reality,
320230|NCT02234531|Enhanced Feedback,|enhanced feedback,
320231|NCT02234531|Stroke,|stroke,
320232|NCT02234531|Rehabilitation,|rehabilitation,
320233|NCT02234531|Motor Learning|motor learning
320234|NCT02234505|prosthetics|prosthetics
320235|NCT02234505|amputation|amputation
320236|NCT02234505|gait stability|gait stability
320237|NCT02234505|step variability|step variability
320238|NCT02234505|load cell|load cell
320239|NCT02234492|Human immunodeficiency virus (HIV)|human immunodeficiency virus (hiv)
320240|NCT02234492|Statin therapy|statin therapy
320241|NCT02234492|Cardiovascular disease (CVD)|cardiovascular disease (cvd)
320242|NCT02234492|Coronary Flow Reserve (CFR)|coronary flow reserve (cfr)
320243|NCT02234492|Positron Emission Tomography (PET)|positron emission tomography (pet)
320244|NCT02234492|Myocardial contrast echocardiography (MCE)|myocardial contrast echocardiography (mce)
320245|NCT02234479|Breast Cancer|breast cancer
320246|NCT02234479|Radiation Dermatitis|radiation dermatitis
320247|NCT02234466|Quality of Recovery (QOR40)|quality of recovery (qor40)
320248|NCT02234466|Breast Surgery|breast surgery
409236|NCT01828034|13-004|13-004
320249|NCT02234466|Clinically significant Nausea and Vomiting|clinically significant nausea and vomiting
320250|NCT02234466|Postoperative Nausea and Vomiting|postoperative nausea and vomiting
320251|NCT02234453|cancer|cancer
320252|NCT02234453|chemotherapy|chemotherapy
320253|NCT02234453|home|home
320254|NCT02234453|blood count|blood count
320255|NCT02234453|remote|remote
320256|NCT02234427|aspirin, atherosclerosis|aspirin, atherosclerosis
320257|NCT02234414|vertebral fracture assessment (vfa)|vertebral fracture assessment (vfa)
320258|NCT02234414|vitamin D|vitamin d
320259|NCT02234401|Cystic Fibrosis|cystic fibrosis
320260|NCT02234401|Noninvasive ventilation|noninvasive ventilation
320261|NCT02234401|Non invasive ventilation|non invasive ventilation
320262|NCT02234401|Acute respiratory exacerbation|acute respiratory exacerbation
320263|NCT02234401|Bi level pressure support|bi level pressure support
320264|NCT02234388|connective tissue disease|connective tissue disease
320265|NCT02234388|registry|registry
320266|NCT02234388|hospital for special surgery|hospital for special surgery
320267|NCT02234375|Pulmonary embolism|pulmonary embolism
320268|NCT02234375|Contrast|contrast
320269|NCT02234375|Computed tomography|computed tomography
320270|NCT02234375|Gadolinium|gadolinium
320271|NCT02234349|bile acids|bile acids
320272|NCT02234349|pancreas kidney transplantation|pancreas kidney transplantation
320273|NCT02234349|incretins|incretins
320274|NCT02234349|intestinal flora|intestinal flora
320275|NCT02234336|Echocardiography|echocardiography
320276|NCT02234336|hypertrophic cardiomyopathy|hypertrophic cardiomyopathy
320277|NCT02234336|cardiomyopathy|cardiomyopathy
320278|NCT02234336|magnetic resonance imaging|magnetic resonance imaging
320279|NCT02234336|contrast|contrast
320280|NCT02234323|prophylaxis treatment|prophylaxis treatment
320281|NCT02234323|Hemophilia A|hemophilia a
320282|NCT02234323|Hemophilia|hemophilia
320283|NCT02234323|episodic treatment|episodic treatment
320284|NCT02234310|prophylaxis treatment|prophylaxis treatment
320285|NCT02234310|episodic treatment|episodic treatment
320286|NCT02234297|Glioma|glioma
320287|NCT02234297|Tumor Paint|tumor paint
320288|NCT02234297|BLZ100|blz100
320289|NCT02234284|Chronic Obstructive Pulmonary Disease|chronic obstructive pulmonary disease
320290|NCT02234284|Health Coaching|health coaching
320291|NCT02234284|Health Disparities|health disparities
320292|NCT02234284|Self-management|self-management
320293|NCT02234284|Chronic Disease Model|chronic disease model
320294|NCT02234245|Follow-Up studies|follow-up studies
320295|NCT02234245|Biological Pacemakers|biological pacemakers
320296|NCT02234245|Telemedicine|telemedicine
320297|NCT02234245|Efficiency|efficiency
320298|NCT02234232|Hemodialysis|hemodialysis
320299|NCT02234232|Exercise, aerobic|exercise, aerobic
320300|NCT02234232|Exercise, resistance|exercise, resistance
320301|NCT02234232|Intradialytic|intradialytic
320302|NCT02234232|Randomized Controlled Trial|randomized controlled trial
320303|NCT02234232|Safety|safety
320304|NCT02234232|Quality of life|quality of life
320305|NCT02234232|Physical performance|physical performance
320306|NCT02234206|Hypospermatogenesis, Low Sperm Count, Oligozoospermia|hypospermatogenesis, low sperm count, oligozoospermia
320307|NCT02234193|wound healing|wound healing
320308|NCT02234128|Ex Vivo Lung Perfusion|ex vivo lung perfusion
320309|NCT02234128|EVLP|evlp
320310|NCT02234128|Lung Transplant|lung transplant
320311|NCT02234128|Lung Transplantation|lung transplantation
320312|NCT02234128|Toronto EVLP System™|toronto evlp system™
320313|NCT02234128|PERFUSIX|perfusix
320314|NCT02234115|Prostate Neoplasm Cancer Carcinoma|prostate neoplasm cancer carcinoma
320315|NCT02234076|Posttraumatic Stress Disorder|posttraumatic stress disorder
320316|NCT02234076|Depression|depression
320317|NCT02234076|Treatment|treatment
320318|NCT02234076|VRET|vret
320319|NCT02234063|Hypertension|hypertension
320320|NCT02234063|Chronic Kidney Disease|chronic kidney disease
320321|NCT02234063|End Stage Renal Disease|end stage renal disease
320322|NCT02234063|APOL1|apol1
320323|NCT02234063|Genomics|genomics
320324|NCT02234063|Genetics|genetics
320325|NCT02234063|Community-engaged|community-engaged
320326|NCT02234050|Grade 2 Chordoid meningioma|grade 2 chordoid meningioma
320327|NCT02234050|Grade 2 Clear cell meningioma|grade 2 clear cell meningioma
320328|NCT02234050|Grade 2 Atypical meningioma|grade 2 atypical meningioma
320329|NCT02234050|Grade 3 Papillary meningioma|grade 3 papillary meningioma
320330|NCT02234050|Grade 3 Rhabdoid meningioma|grade 3 rhabdoid meningioma
320331|NCT02234050|Grade 3 Anaplastic meningioma|grade 3 anaplastic meningioma
320332|NCT02234050|Grade 3 Malignant meningioma|grade 3 malignant meningioma
320333|NCT02234037|AML|aml
320334|NCT02233998|Plaque|plaque
320335|NCT02233998|Bleeding|bleeding
320336|NCT02233998|Gums|gums
320337|NCT02233998|Gingiva|gingiva
320338|NCT02233998|Gingival Inflammation|gingival inflammation
320339|NCT02233998|Gingival Bleeding|gingival bleeding
320340|NCT02233985|bronchiolitis|bronchiolitis
320341|NCT02233985|hypertonic|hypertonic
320342|NCT02233985|saline|saline
409378|NCT01827462|elderly|elderly
320343|NCT02233985|salbutamol|salbutamol
320344|NCT02233972|Pharmacokinetics|pharmacokinetics
320345|NCT02233972|Ginkgolides Meglumine Injection|ginkgolides meglumine injection
320346|NCT02233946|Substance Abuse|substance abuse
320347|NCT02233946|Prevention|prevention
320348|NCT02233946|Youth|youth
320349|NCT02233946|Alcohol|alcohol
320350|NCT02233946|Drugs|drugs
320351|NCT02233933|radiation proctitis|radiation proctitis
320352|NCT02233933|bleeding|bleeding
320353|NCT02233933|therapy|therapy
320354|NCT02233868|Imaging Studies|imaging studies
320355|NCT02233868|Alcohol Use Disorder (AUD)|alcohol use disorder (aud)
320356|NCT02233868|Inflammation|inflammation
320357|NCT02233855|Seizures|seizures
320358|NCT02233855|Cestode|cestode
320359|NCT02233855|Hydrocephalus|hydrocephalus
320360|NCT02233855|Taenia Solium|taenia solium
320361|NCT02233855|Helminth|helminth
320362|NCT02233842|Qualitative Data|qualitative data
320363|NCT02233842|Questionnaire|questionnaire
320364|NCT02233829|C-11 Raclopride|c-11 raclopride
320365|NCT02233829|015 PET|015 pet
320366|NCT02233829|Circadian Rhythm|circadian rhythm
320367|NCT02233816|Influenza|influenza
320368|NCT02233816|Human|human
320369|NCT02233816|RNA Virus Infections|rna virus infections
320370|NCT02233816|Immunologic|immunologic
320371|NCT02233816|Immunogenic Factors|immunogenic factors
320372|NCT02233816|Physiological Effects of Drugs|physiological effects of drugs
320373|NCT02233816|Virus diseases|virus diseases
320374|NCT02233816|Orthomyxoviridae Infections|orthomyxoviridae infections
320375|NCT02233816|Infection|infection
320376|NCT02233803|tolerability|tolerability
320377|NCT02233803|NEUMOTEROL|neumoterol
320378|NCT02233803|efficacy|efficacy
320379|NCT02233803|budesonide/formoterol fumarate 400/12 mcg|budesonide/formoterol fumarate 400/12 mcg
320380|NCT02233803|safety|safety
320381|NCT02233803|Asthma|asthma
320382|NCT02233803|pharmacodynamics|pharmacodynamics
320383|NCT02233790|Myocardial infarction|myocardial infarction
320384|NCT02233790|No-Reflow Phenomenon|no-reflow phenomenon
320385|NCT02233790|Ticagrelor|ticagrelor
320386|NCT02233790|Clopidogrel|clopidogrel
320387|NCT02233790|Single-Photon Emission Computerized Tomography|single-photon emission computerized tomography
320388|NCT02233777|Pregabalin|pregabalin
320389|NCT02233777|Bioequivalence|bioequivalence
320390|NCT02233777|Bioavailability|bioavailability
320391|NCT02233777|Pharmacokinetic|pharmacokinetic
320392|NCT02233777|Antiepileptic|antiepileptic
320393|NCT02233764|iron|iron
320394|NCT02233764|zinc|zinc
320395|NCT02233764|pearl millet|pearl millet
320396|NCT02233764|India|india
320397|NCT02233764|children|children
320398|NCT02233764|trial|trial
320399|NCT02233764|randomized|randomized
320400|NCT02233751|Healthy Adult Males|healthy adult males
320401|NCT02233738|Alcoholism|alcoholism
320402|NCT02233738|Substance-related disorders|substance-related disorders
320403|NCT02233738|Dual Diagnosis|dual diagnosis
320404|NCT02233725|Prostatic Neoplasms|prostatic neoplasms
320405|NCT02233725|Magnetic Resonance Imaging|magnetic resonance imaging
320406|NCT02233725|MRI / Ultrasound Fusion|mri / ultrasound fusion
320407|NCT02233725|Contrast-Enhanced Ultrasound (CEUS)|contrast-enhanced ultrasound (ceus)
320408|NCT02233712|gastric cancer, stomach neoplasms,|gastric cancer, stomach neoplasms,
320409|NCT02233673|Obesity|obesity
320410|NCT02233673|Pregnancy|pregnancy
320411|NCT02233647|cocaine|cocaine
320412|NCT02233647|phendimetrazine|phendimetrazine
320413|NCT02233647|pharmacotherapy|pharmacotherapy
320414|NCT02233634|Coronary Angiography|coronary angiography
320415|NCT02233634|Magnetic Resonance Imaging|magnetic resonance imaging
320416|NCT02233634|Oxygen|oxygen
320417|NCT02233634|Hyperoxia|hyperoxia
320418|NCT02233634|Carbon Dioxide|carbon dioxide
320419|NCT02233634|Apnea|apnea
320420|NCT02233634|Hyperventilation|hyperventilation
320421|NCT02233608|Prostate cancer|prostate cancer
320422|NCT02233608|Radical prostatectomy|radical prostatectomy
320423|NCT02233608|Pelvic floor muscle exercises|pelvic floor muscle exercises
320424|NCT02233608|Pfilates|pfilates
320425|NCT02233608|Hypopressives|hypopressives
320426|NCT02233608|Urinary Incontinence|urinary incontinence
320428|NCT02233595|PET|pet
320429|NCT02233595|rectal cancer|rectal cancer
320430|NCT02233595|adjuvant chemotherapy|adjuvant chemotherapy
320431|NCT02233582|altitude|altitude
320432|NCT02233582|mountain sickness|mountain sickness
320433|NCT02233582|ibuprofen|ibuprofen
320434|NCT02233582|hypoxia|hypoxia
320435|NCT02233569|Laparoscopic hernia repair|laparoscopic hernia repair
320436|NCT02233569|Ventral hernia|ventral hernia
320437|NCT02233569|Incisional hernia|incisional hernia
320438|NCT02233569|IPOM|ipom
320439|NCT02233556|event-related potential|event-related potential
320440|NCT02233556|mismatch negativity|mismatch negativity
320441|NCT02233556|NMDA|nmda
320442|NCT02233556|Glutamate|glutamate
320443|NCT02233543|COPD|copd
320444|NCT02233543|QVA149|qva149
320445|NCT02233543|nocturnal oxygen levels|nocturnal oxygen levels
400516|NCT01866514|EZ-IO|ez-io
409491|NCT01827046|ICH|ich
320446|NCT02233543|combination bronchodilator|combination bronchodilator
320447|NCT02233530|Dementia|dementia
320448|NCT02233530|Cognitive Stimulation Therapy|cognitive stimulation therapy
320449|NCT02233530|Quality of life|quality of life
320450|NCT02233530|Cognitive impairment|cognitive impairment
320451|NCT02233530|Africa|africa
320452|NCT02233530|Tanzania|tanzania
320453|NCT02233530|Nigeria|nigeria
320454|NCT02233530|Low- and Middle-income countries|low- and middle-income countries
320455|NCT02233530|Non-pharmacological intervention|non-pharmacological intervention
320456|NCT02233530|Task-shifting|task-shifting
320457|NCT02233530|Cognitive screening|cognitive screening
320458|NCT02233517|Veterans|veterans
320459|NCT02233517|Cognitive-Behavioral Therapy|cognitive-behavioral therapy
320460|NCT02233517|Aggression|aggression
320461|NCT02233517|Anger|anger
320462|NCT02233517|Posttraumatic Stress Disorder|posttraumatic stress disorder
320463|NCT02233517|Combat Disorders|combat disorders
320464|NCT02233491|PTDM|ptdm
320465|NCT02233491|kidney transplant|kidney transplant
320466|NCT02233491|lifestyle intervention|lifestyle intervention
320467|NCT02233491|diet|diet
320468|NCT02233491|exercise|exercise
320469|NCT02233478|Pomegranate polyphenols|pomegranate polyphenols
320470|NCT02233478|Soy Protein|soy protein
320471|NCT02233478|Ellagitannins|ellagitannins
320472|NCT02233465|parastomal|parastomal
320473|NCT02233465|hernia|hernia
320474|NCT02233465|mesh|mesh
320475|NCT02233465|parastomal hernia-repair with mesh|parastomal hernia-repair with mesh
320476|NCT02233452|Neuropathic pain|neuropathic pain
320477|NCT02233452|Methadone|methadone
320478|NCT02233452|Ketamine|ketamine
320479|NCT02233452|Multimodal analgesia|multimodal analgesia
320480|NCT02233439|galactagogues|galactagogues
320481|NCT02233439|herbs|herbs
320482|NCT02233439|breastfeeding|breastfeeding
320483|NCT02233439|supplements|supplements
320484|NCT02233439|Silybum marianum|silybum marianum
320485|NCT02233439|Galega officinalis|galega officinalis
320486|NCT02233426|allergic rhinitis|allergic rhinitis
320487|NCT02233426|nasal steroid|nasal steroid
320488|NCT02233426|hypertonic saline|hypertonic saline
320489|NCT02233426|eosinophil|eosinophil
320490|NCT02233426|symptom score|symptom score
320491|NCT02233413|Traumatic brain injury|traumatic brain injury
320492|NCT02233413|TBI|tbi
320493|NCT02233413|Low-level light therapy|low-level light therapy
320494|NCT02233413|LLLT|lllt
320495|NCT02233413|LLLT helmet|lllt helmet
320496|NCT02233400|Acetaminophen|acetaminophen
320497|NCT02233400|Gastric Bypass|gastric bypass
320498|NCT02233400|Sleeve Gastrectomy|sleeve gastrectomy
320499|NCT02233400|Pain|pain
320500|NCT02233400|Cost|cost
320501|NCT02233387|cervix cancer|cervix cancer
320502|NCT02233387|[18F] HX4 PET imaging|[18f] hx4 pet imaging
320503|NCT02233387|hypoxia|hypoxia
320504|NCT02233387|phase II trial|phase ii trial
320505|NCT02233374|Rectal Cancer|rectal cancer
320506|NCT02233374|Magnetic Resonance Imaging|magnetic resonance imaging
320507|NCT02233374|Positron Emission Tomography|positron emission tomography
320508|NCT02233374|pathologic complete response|pathologic complete response
320509|NCT02233374|Diffusion-weighted magnetic resonance imaging|diffusion-weighted magnetic resonance imaging
320510|NCT02233374|Microstructural Imaging|microstructural imaging
320511|NCT02233374|FDG PET|fdg pet
320512|NCT02233361|Hearing rehabilitation|hearing rehabilitation
320513|NCT02233361|Elderly|elderly
320514|NCT02233361|Hearing aid use|hearing aid use
320515|NCT02233322|ADHR|adhr
320516|NCT02233322|Rickets|rickets
320517|NCT02233322|Hypophosphatemia|hypophosphatemia
320518|NCT02233283|LH pulsatility|lh pulsatility
320519|NCT02233283|Insulin sensitivity|insulin sensitivity
320520|NCT02233283|Metabolism|metabolism
320521|NCT02233283|hypercaloric feeding|hypercaloric feeding
320522|NCT02233257|Adrenoleukodystrophy|adrenoleukodystrophy
320523|NCT02233257|Lorenzo's oil|lorenzo's oil
320524|NCT02233257|erucic acid|erucic acid
320525|NCT02233244|Drug Interaction|drug interaction
320526|NCT02233205|microbubble|microbubble
320527|NCT02233205|chemotherapy|chemotherapy
320528|NCT02233205|alimentary|alimentary
320529|NCT02233192|PrEP|prep
320530|NCT02233192|conception|conception
320531|NCT02233192|HIV|hiv
320532|NCT02233192|serodiscordant|serodiscordant
320533|NCT02233179|Diabetic foot ulcer|diabetic foot ulcer
320534|NCT02233153|Senior|senior
320535|NCT02233153|Elderly|elderly
320536|NCT02233153|Acute Care|acute care
320537|NCT02233153|Emergency Surgery|emergency surgery
320538|NCT02233140|Diabetes|diabetes
320539|NCT02233140|Ankle equinus|ankle equinus
320540|NCT02233140|ankle dorsiflexion|ankle dorsiflexion
320541|NCT02233140|dynamic plantar pressure|dynamic plantar pressure
320542|NCT02233140|shockwave therapy|shockwave therapy
320543|NCT02233127|Birth cohort|birth cohort
320544|NCT02233127|Pakistan|pakistan
320545|NCT02233127|Child mortality|child mortality
320546|NCT02233088|Prediabetic State|prediabetic state
320547|NCT02233088|Hypertension|hypertension
320548|NCT02233088|Enlarged Waist Elevated Triglycerides|enlarged waist elevated triglycerides
320549|NCT02233088|HDL Cholesterol, Low Serum|hdl cholesterol, low serum
320550|NCT02233062|Crohn's Disease|crohn's disease
321347|NCT02229513|obstetrics|obstetrics
320551|NCT02233062|semen quality|semen quality
320552|NCT02233062|enteral nutrition|enteral nutrition
320553|NCT02233062|CDAI score higher than 150|cdai score higher than 150
320554|NCT02233049|Children|children
320555|NCT02233049|adolescents|adolescents
320556|NCT02233049|young adults|young adults
320557|NCT02233049|newly diagnosed|newly diagnosed
320558|NCT02233036|Young Adults|young adults
320559|NCT02233036|Transfer|transfer
320560|NCT02233036|Chronic Disease|chronic disease
320561|NCT02232997|Chronic kidney disease|chronic kidney disease
320562|NCT02232997|contrast induced nephropathy|contrast induced nephropathy
320563|NCT02232997|diabetes mellitus|diabetes mellitus
320564|NCT02232997|congestive heart failure|congestive heart failure
320565|NCT02232997|hypertension|hypertension
320566|NCT02232984|Heart Failure|heart failure
320567|NCT02232984|Cardiac Resynchronization Therapy (CRT)|cardiac resynchronization therapy (crt)
320568|NCT02232984|CRT-D|crt-d
320569|NCT02232984|Quadripolar pacing|quadripolar pacing
320570|NCT02232971|glucagon|glucagon
320571|NCT02232971|insulin pump|insulin pump
320572|NCT02232971|artificial pancreas|artificial pancreas
320573|NCT02232971|closed-loop|closed-loop
320574|NCT02232958|Hyperbaric Oxygen|hyperbaric oxygen
320575|NCT02232958|Small Vessel Disease of the Brain|small vessel disease of the brain
320576|NCT02232958|Impaired Brain Circuit Connections|impaired brain circuit connections
320577|NCT02232945|influenza A (H1N1,H3N2)|influenza a (h1n1,h3n2)
320578|NCT02232945|influenza B virus|influenza b virus
320579|NCT02232932|Hilar cholangiocarcinoma|hilar cholangiocarcinoma
320580|NCT02232932|Liver transplantation|liver transplantation
320581|NCT02232932|Radiochemotherapy|radiochemotherapy
320582|NCT02232919|Deep Brain Stimulation|deep brain stimulation
320583|NCT02232906|Chronic kidney disease|chronic kidney disease
320584|NCT02232906|CKD|ckd
320585|NCT02232906|non-dialysis-dependent|non-dialysis-dependent
320586|NCT02232906|ND-CKD|nd-ckd
320587|NCT02232906|Erythropoiesis-stimulating agent|erythropoiesis-stimulating agent
320588|NCT02232906|Ferric carboxymaltose|ferric carboxymaltose
320589|NCT02232906|Iron|iron
320590|NCT02232893|Gastrointestinal Quality of Life Index (GIQLI)|gastrointestinal quality of life index (giqli)
320591|NCT02232893|Abdominal Discomfort|abdominal discomfort
320592|NCT02232893|Abdominal Bloating|abdominal bloating
320593|NCT02232893|Laparoscopic colectomy|laparoscopic colectomy
320594|NCT02232893|Postoperative ileus (POI)|postoperative ileus (poi)
320595|NCT02232880|hypertension|hypertension
320596|NCT02232880|inflammation|inflammation
320597|NCT02232867|rehabilitation|rehabilitation
320598|NCT02232867|stroke|stroke
320599|NCT02232867|walking|walking
320600|NCT02232867|interlimb connections|interlimb connections
320601|NCT02232854|Depression|depression
320602|NCT02232841|Electrical impedance tomography|electrical impedance tomography
320603|NCT02232841|lung imaging|lung imaging
320604|NCT02232789|Mephedrone|mephedrone
320605|NCT02232789|3,4-methylenedioxymethamphetamine|3,4-methylenedioxymethamphetamine
320606|NCT02232789|Abuse liability|abuse liability
320607|NCT02232789|Human Pharmacology|human pharmacology
320608|NCT02232776|Losartan|losartan
320609|NCT02232776|Ig A nephropathy|ig a nephropathy
320610|NCT02232776|children|children
320611|NCT02232776|proteinuria|proteinuria
320612|NCT02232763|Losartan|losartan
320613|NCT02232763|children|children
320614|NCT02232763|proteinuria|proteinuria
320615|NCT02232737|Biomarkers of exposure|biomarkers of exposure
320616|NCT02232737|Compensatory smoking|compensatory smoking
320617|NCT02232737|Nicotine dependence|nicotine dependence
320618|NCT02232737|Reduced nicotine cigarettes|reduced nicotine cigarettes
320619|NCT02232737|Tobacco withdrawal|tobacco withdrawal
320620|NCT02232737|Women|women
320621|NCT02232737|Health disparaties|health disparaties
320622|NCT02232737|Vulnerable populations|vulnerable populations
320623|NCT02232724|Prostate Cancer|prostate cancer
320624|NCT02232724|Staging|staging
320625|NCT02232724|PET/CT|pet/ct
320626|NCT02232711|multiplex, polymerase chain reaction, PCR, BioFire, respiratory infection, infectious disease, point of care, CLIA waived, rapid diagnostics|multiplex, polymerase chain reaction, pcr, biofire, respiratory infection, infectious disease, point of care, clia waived, rapid diagnostics
320627|NCT02232698|Sensing Technology|sensing technology
320628|NCT02232698|Type 1 Diabetes,|type 1 diabetes,
320629|NCT02232685|Prostate cancer|prostate cancer
320630|NCT02232685|Staging|staging
320631|NCT02232685|PET/CT|pet/ct
320632|NCT02232672|Prostate Cancer|prostate cancer
320633|NCT02232672|Staging|staging
320634|NCT02232672|PET/CT|pet/ct
320635|NCT02232659|SynCardia|syncardia
320636|NCT02232659|Total Artificial Heart|total artificial heart
320637|NCT02232659|Biventricular heart failure|biventricular heart failure
320638|NCT02232659|Ineligible for cardiac transplant|ineligible for cardiac transplant
320639|NCT02232568|Patient blood management|patient blood management
320640|NCT02232568|RBC transfusion|rbc transfusion
320641|NCT02232568|Restrictive transfusion strategy|restrictive transfusion strategy
320642|NCT02232529|modified release formulation|modified release formulation
320643|NCT02232529|pharmacokinetics|pharmacokinetics
320644|NCT02232490|AFP|afp
320645|NCT02232490|alpha-fetoprotein|alpha-fetoprotein
321749|NCT02227927|GERD|gerd
320646|NCT02232490|cancer vaccine|cancer vaccine
320647|NCT02232490|cirrhosis|cirrhosis
320648|NCT02232490|hepatitis|hepatitis
320649|NCT02232490|HCC|hcc
320650|NCT02232490|hepatocellular carcinoma|hepatocellular carcinoma
320651|NCT02232490|immunotherapy|immunotherapy
320652|NCT02232490|liver tumor|liver tumor
320653|NCT02232490|Cholangiocarcinoma|cholangiocarcinoma
320654|NCT02232464|Adult ADHD|adult adhd
320655|NCT02232464|diffusion spectrum imaging|diffusion spectrum imaging
320656|NCT02232464|resting-state fMRI|resting-state fmri
320657|NCT02232464|frontostriatal circuitries|frontostriatal circuitries
320658|NCT02232464|frontoparietal circuitries|frontoparietal circuitries
320659|NCT02232464|executive function|executive function
320660|NCT02232451|loop|loop
320661|NCT02232451|ERCP|ercp
320662|NCT02232451|cannulation|cannulation
320663|NCT02232451|biliary|biliary
320664|NCT02232451|wire|wire
320665|NCT02232438|Depression|depression
320666|NCT02232438|Psychotherapy|psychotherapy
320667|NCT02232438|Anxiety|anxiety
320668|NCT02232438|Cancer|cancer
320669|NCT02232412|Anemia|anemia
320670|NCT02232412|NIRS|nirs
320671|NCT02232412|Near Infrared Spectroscopy|near infrared spectroscopy
320672|NCT02232412|RBC transfusion|rbc transfusion
320673|NCT02232412|critical ill|critical ill
320674|NCT02232412|regional cerebral oxygen saturation|regional cerebral oxygen saturation
320675|NCT02232412|tissue oxygenation|tissue oxygenation
320676|NCT02232386|Chronic lymphocyte leukemia|chronic lymphocyte leukemia
320677|NCT02232386|Adults|adults
320678|NCT02232386|Ibrutinib|ibrutinib
320679|NCT02232373|FODMAPs|fodmaps
320680|NCT02232373|microbiota|microbiota
320681|NCT02232373|oligofructose|oligofructose
320682|NCT02232373|IBS|ibs
320683|NCT02232373|Irritable bowel syndrome|irritable bowel syndrome
320684|NCT02232360|Atherosclerotic plaque|atherosclerotic plaque
320685|NCT02232360|Virtual histology intravascular ultrasound|virtual histology intravascular ultrasound
320686|NCT02232360|Plaque composition|plaque composition
320687|NCT02232360|Rosuvastatin|rosuvastatin
320688|NCT02232360|Fenofibrate|fenofibrate
320689|NCT02232360|Coronary artery disease|coronary artery disease
320690|NCT02232347|traumatic brain injury|traumatic brain injury
320691|NCT02232347|ketamine|ketamine
320692|NCT02232347|microdialysis|microdialysis
320693|NCT02232347|PtiO2|ptio2
320694|NCT02232347|glutamate|glutamate
320695|NCT02232334|Idiopathic Gastroparesis, Nausea, Vomiting, Abdominal Pain, Gastrectomy, Osteopathy, Gastroparesis Cardinal Symptom Index, GCSI|idiopathic gastroparesis, nausea, vomiting, abdominal pain, gastrectomy, osteopathy, gastroparesis cardinal symptom index, gcsi
320696|NCT02232295|Upper extremity, motor imagery, mirror therapy|upper extremity, motor imagery, mirror therapy
320697|NCT02232282|Painful Bladder Syndrome|painful bladder syndrome
320698|NCT02232282|Interstitial Cystitis|interstitial cystitis
320699|NCT02232282|Suprapubic Pain|suprapubic pain
320700|NCT02232282|Urinary Urgency|urinary urgency
320701|NCT02232269|Coffee|coffee
320702|NCT02232269|Grapefruit Juice|grapefruit juice
320703|NCT02232269|Felodipine|felodipine
320704|NCT02232269|Calcium Channel Blocker|calcium channel blocker
320705|NCT02232269|Hemodynamics|hemodynamics
320706|NCT02232269|CYP3A4|cyp3a4
320707|NCT02232256|Chronic non-cancer pain|chronic non-cancer pain
320708|NCT02232256|Insomnia|insomnia
320709|NCT02232256|California poppy|california poppy
320710|NCT02232256|Eschscholzia californica|eschscholzia californica
320711|NCT02232256|Pain|pain
320712|NCT02232256|Sleep quality|sleep quality
320713|NCT02232243|Cancer|cancer
320714|NCT02232243|Surgery|surgery
320715|NCT02232243|Hydroxychloroquine|hydroxychloroquine
320716|NCT02232217|Children|children
320717|NCT02232217|Sleep|sleep
320718|NCT02232217|Obesity|obesity
320719|NCT02232204|insomnia|insomnia
320720|NCT02232204|implantable cardioverter defibrillator|implantable cardioverter defibrillator
320721|NCT02232204|cardiac arrhythmia|cardiac arrhythmia
320722|NCT02232204|cognitive behavioral treatment|cognitive behavioral treatment
320723|NCT02232178|unilateral inguinal hernioplasty|unilateral inguinal hernioplasty
320724|NCT02232165|acute spinal cord injury|acute spinal cord injury
320725|NCT02232165|hemodynamic therapy|hemodynamic therapy
320726|NCT02232165|functional outcome|functional outcome
320727|NCT02232126|Hospital readmissions|hospital readmissions
320728|NCT02232126|Randomized controlled trial|randomized controlled trial
320729|NCT02232126|Older adults|older adults
320730|NCT02232126|Care transitions|care transitions
320731|NCT02232126|Social work|social work
320732|NCT02232113|malnutrition, inflammation, and anemia (MIA) syndrome,|malnutrition, inflammation, and anemia (mia) syndrome,
320733|NCT02232113|hemodialysis,|hemodialysis,
320734|NCT02232113|erythropoietin stimulating agent (ESA),|erythropoietin stimulating agent (esa),
320735|NCT02232113|cost-effectiveness,|cost-effectiveness,
320736|NCT02232113|pharmacokinetics,|pharmacokinetics,
320737|NCT02232113|endothelial dysfunction|endothelial dysfunction
320738|NCT02232100|Attentional bias modification training|attentional bias modification training
320739|NCT02232100|Chronic pain|chronic pain
320740|NCT02232100|Visual-probe task|visual-probe task
320741|NCT02232100|Internet-delivered therapy|internet-delivered therapy
320742|NCT02232087|long-acting beta agonist (LABA)|long-acting beta agonist (laba)
320743|NCT02232087|corticosteroid|corticosteroid
320745|NCT02232087|inhaler|inhaler
320746|NCT02232074|Patient Navigation|patient navigation
320747|NCT02232074|Medical Legal Partnership|medical legal partnership
320748|NCT02232074|Healthcare Disparities|healthcare disparities
320749|NCT02232061|multiple sclerosis, fingolimod,|multiple sclerosis, fingolimod,
320750|NCT02232035|diazepam|diazepam
320751|NCT02232035|active phase|active phase
320752|NCT02232022|Stroke|stroke
320753|NCT02232022|Ischemic stroke|ischemic stroke
320754|NCT02232022|Atrial fibrillation|atrial fibrillation
320755|NCT02232022|Insertable cardiac monitor|insertable cardiac monitor
320756|NCT02232022|Non-cryptogenic|non-cryptogenic
320757|NCT02232009|Neonate|neonate
320758|NCT02232009|Infant|infant
320759|NCT02231983|Clinical Characteristics|clinical characteristics
320760|NCT02231983|Genetic Profiles|genetic profiles
320761|NCT02231970|Obesity|obesity
320762|NCT02231970|Endoscopic sleeve gastroplasty|endoscopic sleeve gastroplasty
320763|NCT02231970|Weight loss|weight loss
320764|NCT02231892|Repetitive TMS (rTMS)|repetitive tms (rtms)
320765|NCT02231892|Parameter Development|parameter development
320766|NCT02231892|Cognitive Tasks|cognitive tasks
320767|NCT02231892|MRI (Magnetic Resonance Imaging)|mri (magnetic resonance imaging)
320768|NCT02231879|Immunodeficiency|immunodeficiency
320769|NCT02231879|Neutropenia|neutropenia
320770|NCT02231879|Mozobil|mozobil
320771|NCT02231879|Myelokathexis|myelokathexis
320772|NCT02231879|Warts|warts
320773|NCT02231866|Filovirus|filovirus
320774|NCT02231866|Healthy|healthy
320775|NCT02231866|Ebola Hemorrhagic Fever|ebola hemorrhagic fever
320776|NCT02231866|Immunity|immunity
320777|NCT02231866|Ebola Virus|ebola virus
320778|NCT02231853|BK Virus|bk virus
320779|NCT02231853|Cytotoxic T Cells|cytotoxic t cells
320780|NCT02231853|EBV|ebv
320781|NCT02231853|Adenovirus|adenovirus
320782|NCT02231853|CMV|cmv
320783|NCT02231840|Phenotypes|phenotypes
320784|NCT02231840|Alcohol Use|alcohol use
320785|NCT02231840|Alcohol|alcohol
320786|NCT02231840|Alcohol Dependence|alcohol dependence
320787|NCT02231840|Genetics|genetics
320788|NCT02231827|subjects|subjects
320789|NCT02231814|Crohn's disease|crohn's disease
320790|NCT02231814|Mild to moderate Crohn's Disease|mild to moderate crohn's disease
320791|NCT02231814|Diet|diet
320792|NCT02231814|Enteral Nutrition|enteral nutrition
320793|NCT02231801|Preterm|preterm
320794|NCT02231801|Kangaroo Care|kangaroo care
320795|NCT02231801|Skin-to-Skin|skin-to-skin
320796|NCT02231801|Vital Sign|vital sign
320797|NCT02231801|Heart Rate|heart rate
320798|NCT02231801|Respiratory Rate|respiratory rate
320799|NCT02231801|Oxygen Saturation|oxygen saturation
320800|NCT02231788|Telminuvo|telminuvo
320801|NCT02231788|Telmitrend|telmitrend
320802|NCT02231788|Hypertension|hypertension
320803|NCT02231788|24hr ABPM|24hr abpm
320804|NCT02231788|Telmisartan|telmisartan
320805|NCT02231788|S-amlodipine|s-amlodipine
320806|NCT02231736|Type 2 Diabetes|type 2 diabetes
320807|NCT02231736|Chromosomal damage|chromosomal damage
320808|NCT02231736|Micronuclei|micronuclei
320809|NCT02231736|DNA damage|dna damage
320810|NCT02231736|HbA1c|hba1c
320811|NCT02231736|Comet Assay|comet assay
320812|NCT02231736|Glycemic control|glycemic control
320813|NCT02231723|Digestive System Neoplasms|digestive system neoplasms
320814|NCT02231723|Endocrine Gland Neoplasms|endocrine gland neoplasms
320815|NCT02231723|Pancreatic neoplasms|pancreatic neoplasms
320816|NCT02231723|Pancreatic cancer, adult|pancreatic cancer, adult
320817|NCT02231723|Pancreatic cancer|pancreatic cancer
320818|NCT02231723|Pancreas cancer|pancreas cancer
320819|NCT02231723|Pancreatic diseases|pancreatic diseases
320820|NCT02231723|Adenoma, Islet Cell|adenoma, islet cell
320821|NCT02231723|Carcinoma, Islet Cell|carcinoma, islet cell
320822|NCT02231723|Carcinoma, Pancreatic Ductal|carcinoma, pancreatic ductal
320823|NCT02231723|Gemcitabine|gemcitabine
320824|NCT02231723|Gemzar|gemzar
320825|NCT02231723|Nab-paclitaxel|nab-paclitaxel
320826|NCT02231723|Paclitaxel|paclitaxel
320827|NCT02231723|Abraxane|abraxane
320828|NCT02231723|Oxaliplatin|oxaliplatin
320829|NCT02231723|Leucovorin|leucovorin
320830|NCT02231723|Irinotecan|irinotecan
320831|NCT02231723|Fluorouracil|fluorouracil
320832|NCT02231723|5-FU|5-fu
320833|NCT02231723|MM-398|mm-398
320834|NCT02231710|Severe Combined Immune Deficiency|severe combined immune deficiency
320835|NCT02231710|Congenital T-cell Defect|congenital t-cell defect
320836|NCT02231710|Congenital T-cell Deficiency|congenital t-cell deficiency
320837|NCT02231710|Chronic Granulomatous Disease|chronic granulomatous disease
320838|NCT02231710|Shwachman Diamond Syndrome|shwachman diamond syndrome
320839|NCT02231710|Diamond Blackfan Anemia|diamond blackfan anemia
320840|NCT02231710|Dyskeratosis Congenita|dyskeratosis congenita
320841|NCT02231710|Fanconi Anemia|fanconi anemia
320842|NCT02231710|Sickle Cell Disease|sickle cell disease
320843|NCT02231710|Thalassemia|thalassemia
320844|NCT02231710|Mucopolysaccharidosis|mucopolysaccharidosis
320845|NCT02231710|Sphingolipidoses|sphingolipidoses
320846|NCT02231697|XLMTM|xlmtm
320847|NCT02231645|Parkinson's disease|parkinson's disease
320848|NCT02231645|Deep brain stimulation|deep brain stimulation
320849|NCT02231645|Subthalamic nucleus|subthalamic nucleus
320850|NCT02231645|decision-making|decision-making
320851|NCT02231645|cognition|cognition
320852|NCT02231645|behavior|behavior
320853|NCT02231632|Poliomyelitis|poliomyelitis
320855|NCT02231632|Safety|safety
320856|NCT02231632|efficacy|efficacy
320857|NCT02231619|feasibility|feasibility
320858|NCT02231619|self assessment|self assessment
320859|NCT02231619|medical abortion|medical abortion
320860|NCT02231619|low sensitivity urine pregnancy test|low sensitivity urine pregnancy test
320861|NCT02231619|South Africa|south africa
320862|NCT02231606|Myopia Prevalence|myopia prevalence
320863|NCT02231606|Proportion of Purchase of free Spectacles|proportion of purchase of free spectacles
320864|NCT02231606|Proportion of Purchase of update Spectacles|proportion of purchase of update spectacles
320865|NCT02231606|Proportion of Wearing Spectacles|proportion of wearing spectacles
320866|NCT02231580|Neurodegenerative genetic disorder|neurodegenerative genetic disorder
320867|NCT02231567|hip replacement|hip replacement
320868|NCT02231567|neurocognitive rehabilitation|neurocognitive rehabilitation
320869|NCT02231567|WOMAC questionnaire|womac questionnaire
320870|NCT02231554|low back pain|low back pain
320871|NCT02231554|quality of life|quality of life
320872|NCT02231554|rehabilitation|rehabilitation
320873|NCT02231554|exercise|exercise
320874|NCT02231541|Fibromylgia|fibromylgia
320875|NCT02231541|Magnetic Fields|magnetic fields
320876|NCT02231541|Pain|pain
320877|NCT02231541|Visual Analogue scale|visual analogue scale
320878|NCT02231528|anesthesia|anesthesia
320879|NCT02231528|central venous catheter|central venous catheter
320880|NCT02231528|jugular vein|jugular vein
320881|NCT02231528|ultrasound guidance|ultrasound guidance
320882|NCT02231502|Bioavailability in healthy individuals|bioavailability in healthy individuals
320883|NCT02231489|Healthy|healthy
320884|NCT02231489|JNJ-42756493|jnj-42756493
320885|NCT02231489|JNJ-61818549|jnj-61818549
320886|NCT02231463|ultrasound|ultrasound
320887|NCT02231450|AE58054|ae58054
320888|NCT02231450|Hepatic impairment|hepatic impairment
320889|NCT02231411|Delayed Cord Clamping|delayed cord clamping
320890|NCT02231411|Pulmonary Ventilation|pulmonary ventilation
320891|NCT02231398|Cardiovascular disease|cardiovascular disease
320892|NCT02231398|Pregnant women|pregnant women
320893|NCT02231398|Nulliparity|nulliparity
320894|NCT02231398|Pregnancy outcomes|pregnancy outcomes
320895|NCT02231398|Pregnancy complications|pregnancy complications
320896|NCT02231398|Sleep disordered breathing|sleep disordered breathing
320897|NCT02231385|Colorectal cancer|colorectal cancer
320898|NCT02231385|Serrated adenomas|serrated adenomas
320899|NCT02231385|Screening|screening
320900|NCT02231385|Adenoma detection rate|adenoma detection rate
320901|NCT02231385|Polypectomy|polypectomy
320902|NCT02231307|sublingual immunotherapy|sublingual immunotherapy
320903|NCT02231307|birch pollen|birch pollen
320904|NCT02231307|allergic rhinitis / rhinoconjunctivitis|allergic rhinitis / rhinoconjunctivitis
320905|NCT02231307|efficacy|efficacy
320906|NCT02231281|HIV Infections|hiv infections
320907|NCT02231281|Acquired Immunodeficiency Syndrome|acquired immunodeficiency syndrome
320908|NCT02231281|Immunologic Deficiency Syndromes|immunologic deficiency syndromes
320909|NCT02231281|Immune System Diseases|immune system diseases
320910|NCT02231281|Lentivirus Infections|lentivirus infections
320911|NCT02231281|Retroviridae Infections|retroviridae infections
320912|NCT02231281|Virus Diseases|virus diseases
320913|NCT02231281|RNA Virus Infections|rna virus infections
320914|NCT02231281|Sexually Transmitted Diseases, Viral|sexually transmitted diseases, viral
320915|NCT02231281|Slow Virus Diseases|slow virus diseases
320916|NCT02231281|Therapeutic Uses|therapeutic uses
320917|NCT02231281|Pharmacologic Actions|pharmacologic actions
320918|NCT02231281|Antiretroviral therapy|antiretroviral therapy
320919|NCT02231281|Early therapy|early therapy
320920|NCT02231242|brain|brain
320921|NCT02231242|children|children
320922|NCT02231242|cerebral palsy|cerebral palsy
320923|NCT02231242|bone marrow stem cells|bone marrow stem cells
320924|NCT02231242|intrathecal autologous total nucleated cells|intrathecal autologous total nucleated cells
320925|NCT02231242|quadriparesis|quadriparesis
320926|NCT02231229|Pulmonary tuberculosis|pulmonary tuberculosis
320927|NCT02231229|Mycobacterium tuberculosis (MTB)|mycobacterium tuberculosis (mtb)
320928|NCT02231229|Drug Resistance (DR)|drug resistance (dr)
320929|NCT02231229|Isoniazid (INH or H)|isoniazid (inh or h)
320930|NCT02231229|Rifampicin (RIF or RMP or R)|rifampicin (rif or rmp or r)
320931|NCT02231229|Pyrazinamide (PZA or Z)|pyrazinamide (pza or z)
320932|NCT02231229|Ethambutol (EMB or E)|ethambutol (emb or e)
320933|NCT02231229|Fast-TB|fast-tb
320934|NCT02231229|Isoniazid, Rifampicin, Pyrazinamide (HRZ)|isoniazid, rifampicin, pyrazinamide (hrz)
320935|NCT02231229|Isoniazid, Rifampicin, Pyrazinamide, Ethambutol (HRZE)|isoniazid, rifampicin, pyrazinamide, ethambutol (hrze)
320936|NCT02231229|drug susceptibility testing (DST)|drug susceptibility testing (dst)
320937|NCT02231229|Acid-Fast Bacilli (AFB+)|acid-fast bacilli (afb+)
320938|NCT02231229|Polymerase Chain Reaction (PCR)|polymerase chain reaction (pcr)
320939|NCT02231216|rhinoseptoplasty|rhinoseptoplasty
320940|NCT02231203|fish oil|fish oil
320941|NCT02231203|omega-3 fatty acids|omega-3 fatty acids
320942|NCT02231203|postoperative inflammatory response|postoperative inflammatory response
320943|NCT02231203|erythrocyte function|erythrocyte function
320944|NCT02231190|muscle soreness|muscle soreness
320945|NCT02231190|Muscle damage and recovery|muscle damage and recovery
320946|NCT02231190|muscle function|muscle function
320947|NCT02231190|eccentric exercise|eccentric exercise
320948|NCT02231151|CPR quality assessment|cpr quality assessment
320949|NCT02231151|Visual CPR assessment|visual cpr assessment
320950|NCT02231151|Position relative to patient|position relative to patient
320951|NCT02231138|Abelmoschus manihot|abelmoschus manihot
320952|NCT02231138|Chronic Kidney Disease|chronic kidney disease
320953|NCT02231138|proteinuria|proteinuria
320954|NCT02231138|efficacy|efficacy
320955|NCT02231138|safety|safety
320956|NCT02231125|Abelmoschus manihot|abelmoschus manihot
320957|NCT02231125|IgA Nephropathy|iga nephropathy
320958|NCT02231125|proteinuria|proteinuria
320959|NCT02231125|efficacy|efficacy
320960|NCT02231125|safety|safety
320961|NCT02231112|Korean|korean
320962|NCT02231112|Left side|left side
320963|NCT02231099|recurrent pelvic organ prolapse|recurrent pelvic organ prolapse
320964|NCT02231099|mesh|mesh
320965|NCT02231086|Chemotherapy, Adjuvant|chemotherapy, adjuvant
320966|NCT02231086|Laparoscopy|laparoscopy
320967|NCT02231086|Peritoneal Lavage|peritoneal lavage
320969|NCT02231073|Freezing of gait|freezing of gait
320970|NCT02231073|Idiopathic Parkinson's disease|idiopathic parkinson's disease
320971|NCT02231073|Exercise|exercise
320972|NCT02231073|parkinsonism|parkinsonism
320973|NCT02231060|Outcome Prediction|outcome prediction
320974|NCT02231060|Anoxic-Ischemic Encephalopathy|anoxic-ischemic encephalopathy
320975|NCT02231060|Coma|coma
320976|NCT02231060|Vegetative State|vegetative state
320977|NCT02231060|Minimally Conscious State|minimally conscious state
320978|NCT02231060|Chronic Disorders of Consciousness|chronic disorders of consciousness
320979|NCT02231047|Diarrhea|diarrhea
320980|NCT02231047|Pneumonia|pneumonia
320981|NCT02231047|Child, Preschool|child, preschool
320982|NCT02231047|Infant|infant
320983|NCT02231047|Dietary Supplements|dietary supplements
320984|NCT02231047|Colostrums|colostrums
320985|NCT02231047|Developing Countries|developing countries
320986|NCT02231021|Diabetes Mellitus, Type 2|diabetes mellitus, type 2
320987|NCT02231021|alogliptin|alogliptin
320988|NCT02231021|pioglitazone|pioglitazone
320989|NCT02231021|DPP4 inhibitor|dpp4 inhibitor
320990|NCT02231021|thiazolidinedione|thiazolidinedione
320991|NCT02231008|SMS|sms
320992|NCT02230969|peginterferon|peginterferon
320993|NCT02230969|relapsing|relapsing
320994|NCT02230969|pegylated|pegylated
320995|NCT02230969|Subcutaneous|subcutaneous
320996|NCT02230969|Injectable|injectable
320997|NCT02230969|Multiple Sclerosis|multiple sclerosis
320998|NCT02230943|rheumatoid|rheumatoid
320999|NCT02230943|arthritis|arthritis
321000|NCT02230943|osteoarthritis|osteoarthritis
321001|NCT02230943|gout|gout
321002|NCT02230930|Parkinson's disease|parkinson's disease
321003|NCT02230930|Apomorphine|apomorphine
321004|NCT02230930|Infusion|infusion
321005|NCT02230930|Skin reactions|skin reactions
321006|NCT02230930|Subcutaneous nodules|subcutaneous nodules
321007|NCT02230930|Hydrocortisone|hydrocortisone
321008|NCT02230930|Massage|massage
321009|NCT02230930|Dilution|dilution
321010|NCT02230904|Rotigotine patch|rotigotine patch
321011|NCT02230904|Neupro|neupro
321012|NCT02230904|Parkinson's Disease|parkinson's disease
321013|NCT02230891|heart failure|heart failure
321014|NCT02230891|biomarkers|biomarkers
321015|NCT02230891|troponin|troponin
321016|NCT02230891|BNP|bnp
321017|NCT02230891|carvedilol|carvedilol
321018|NCT02230891|spironolactone|spironolactone
321019|NCT02230891|prevention|prevention
321020|NCT02230878|JNJ-42847922|jnj-42847922
321021|NCT02230878|Phase 1|phase 1
321022|NCT02230878|Healthy|healthy
321023|NCT02230878|Placebo|placebo
321024|NCT02230865|Funnel chest (Pectus excavatum)|funnel chest (pectus excavatum)
321025|NCT02230852|Telemedicine|telemedicine
321026|NCT02230852|Prehospital|prehospital
321027|NCT02230852|Emergency Medicine|emergency medicine
321028|NCT02230852|Stroke|stroke
321029|NCT02230839|insulin resistance|insulin resistance
321030|NCT02230839|muscle|muscle
321031|NCT02230839|health education|health education
321032|NCT02230839|exercise|exercise
321033|NCT02230826|Arthroplasty|arthroplasty
321034|NCT02230826|Hip Replacement|hip replacement
321035|NCT02230826|Acetabular cup|acetabular cup
321036|NCT02230826|Femoral stem|femoral stem
321037|NCT02230813|Cohort Study,|cohort study,
321038|NCT02230813|Cellulitis,|cellulitis,
321039|NCT02230813|Skin and Soft Tissue Infection,|skin and soft tissue infection,
321040|NCT02230813|Emergency Department,|emergency department,
321041|NCT02230813|Clinical Prediction Rule|clinical prediction rule
321042|NCT02230787|Pilot study|pilot study
321043|NCT02230787|randomized clinical trial|randomized clinical trial
321044|NCT02230787|periodontal disease|periodontal disease
321045|NCT02230787|gingival recession|gingival recession
321046|NCT02230787|Emdogain|emdogain
321047|NCT02230787|connective tissue|connective tissue
321048|NCT02230787|wound healing|wound healing
321049|NCT02230787|inflammation|inflammation
321050|NCT02230774|hydration|hydration
321051|NCT02230774|cognitive function|cognitive function
321052|NCT02230774|doctors|doctors
321053|NCT02230774|nurses|nurses
321054|NCT02230774|Nurses and Doctors oncall|nurses and doctors oncall
321055|NCT02230761|steatoblepharon|steatoblepharon
321056|NCT02230761|blepharoptosis|blepharoptosis
321057|NCT02230761|dermatochalasis|dermatochalasis
321058|NCT02230761|blepharoplasty|blepharoplasty
321059|NCT02230761|periorbital|periorbital
321060|NCT02230761|orbital|orbital
321061|NCT02230761|eyelid|eyelid
321062|NCT02230761|eyebags|eyebags
321063|NCT02230761|eye bags|eye bags
321064|NCT02230748|LAA|laa
321065|NCT02230748|LAA-Occluder|laa-occluder
321066|NCT02230748|Atrial Fibrillation|atrial fibrillation
321067|NCT02230748|AF|af
321068|NCT02230735|Robotic|robotic
321069|NCT02230735|Hysterectomy|hysterectomy
321070|NCT02230735|Uterosacral|uterosacral
321071|NCT02230735|Bupivacaine|bupivacaine
321072|NCT02230735|Robotic hysterectomy pain control|robotic hysterectomy pain control
321073|NCT02230722|opioids|opioids
321074|NCT02230722|chronic pain|chronic pain
321075|NCT02230722|collaborative care|collaborative care
321076|NCT02230709|Neck pain|neck pain
321077|NCT02230709|Myofascial pain syndrome|myofascial pain syndrome
321078|NCT02230709|Soreness|soreness
321079|NCT02230683|Liver Cirrhosis|liver cirrhosis
321080|NCT02230683|Hepatic Cirrhosis|hepatic cirrhosis
321081|NCT02230683|Portal Hypertension|portal hypertension
321082|NCT02230670|Liver Cirrhosis|liver cirrhosis
321083|NCT02230670|Hepatic Cirrhosis|hepatic cirrhosis
321084|NCT02230605|Delirium|delirium
321085|NCT02230605|Post Operative Delirium|post operative delirium
321086|NCT02230605|PD|pd
321087|NCT02230605|POD|pod
321088|NCT02230605|Anesthesia|anesthesia
321089|NCT02230605|Anesthesiology|anesthesiology
321090|NCT02230605|Post Operative Recovery|post operative recovery
321091|NCT02230605|Post Anesthesia Care Unit|post anesthesia care unit
321092|NCT02230605|PACU|pacu
321093|NCT02230605|Cognition|cognition
321094|NCT02230605|Cognitive Impairment|cognitive impairment
321095|NCT02230605|Memory|memory
321096|NCT02230605|Thinking|thinking
321097|NCT02230605|Confusion Assessment Method|confusion assessment method
321098|NCT02230605|CAM|cam
321099|NCT02230605|Neurobics|neurobics
321100|NCT02230605|Neuroplasticity|neuroplasticity
321101|NCT02230605|Lumosity|lumosity
321102|NCT02230605|Brain Games|brain games
321103|NCT02230605|Cognitive Exercise|cognitive exercise
321104|NCT02230605|Cognitive Training|cognitive training
321105|NCT02230605|Perioperative Cognitive Protection|perioperative cognitive protection
321106|NCT02230605|Cognitive Reserve|cognitive reserve
321107|NCT02230605|Neurobics Trial|neurobics trial
321108|NCT02230605|Surgery|surgery
321109|NCT02230605|Elderly Patients|elderly patients
321110|NCT02230592|PET|pet
321111|NCT02230592|Metabolic Glutamate Receptors|metabolic glutamate receptors
321112|NCT02230592|Brain Imaging|brain imaging
321113|NCT02230579|safety|safety
321114|NCT02230579|tolerability|tolerability
321115|NCT02230579|malaria|malaria
321116|NCT02230566|MPS 7|mps 7
321117|NCT02230566|Sly Syndrome|sly syndrome
321118|NCT02230566|Mucopolysaccharidosis|mucopolysaccharidosis
321119|NCT02230566|MPS VII|mps vii
321120|NCT02230566|Enzyme Replacement Therapy|enzyme replacement therapy
321121|NCT02230566|Mucopolysaccharidosis type 7|mucopolysaccharidosis type 7
321122|NCT02230566|rare disease|rare disease
321123|NCT02230566|lysosomal storage disease|lysosomal storage disease
321124|NCT02230566|metabolic disorder|metabolic disorder
321125|NCT02230514|Nonunion fracture|nonunion fracture
321126|NCT02230514|Long bones|long bones
321127|NCT02230514|Pseudoarthrosis|pseudoarthrosis
321128|NCT02230514|Cell therapy|cell therapy
321129|NCT02230514|Tissue engineering|tissue engineering
321130|NCT02230514|Mesenchymal stromal cells|mesenchymal stromal cells
321131|NCT02230488|Inpatient Diabetes Management|inpatient diabetes management
321132|NCT02230488|Prevent <31 day readmission in patients with Diabetes|prevent <31 day readmission in patients with diabetes
321133|NCT02230488|CDEs role in transition of care of inpatients with diabetes|cdes role in transition of care of inpatients with diabetes
321134|NCT02230475|Allergic Rhinitis|allergic rhinitis
321135|NCT02230475|NMR|nmr
321136|NCT02230462|patient satisfaction|patient satisfaction
321137|NCT02230462|Mohs surgery|mohs surgery
321138|NCT02230436|Pancreatectomy|pancreatectomy
321139|NCT02230436|Time of drain removal|time of drain removal
321140|NCT02230423|Functional nasal surgery|functional nasal surgery
321141|NCT02230423|Empty Nose Syndrome (ENS)|empty nose syndrome (ens)
321142|NCT02230410|Barrett's|barrett's
321143|NCT02230410|high grade dysplasia|high grade dysplasia
321144|NCT02230410|ablation|ablation
321145|NCT02230410|cyrotherapy|cyrotherapy
321146|NCT02230397|skin aging|skin aging
321147|NCT02230397|anti-aging cream|anti-aging cream
321148|NCT02230397|wrinkles|wrinkles
321149|NCT02230384|Attempt at Smoking Cessation|attempt at smoking cessation
321150|NCT02230384|Schizophrenia or Schizoaffective disorder|schizophrenia or schizoaffective disorder
321151|NCT02230384|Novel nicotinergic drug|novel nicotinergic drug
321152|NCT02230371|Myofascial pain|myofascial pain
321153|NCT02230371|TMD|tmd
321154|NCT02230371|5-HT3|5-ht3
321155|NCT02230371|Granisetron|granisetron
321156|NCT02230371|Placebo-controlled|placebo-controlled
321157|NCT02230371|Patients|patients
321158|NCT02230371|Randomized|randomized
321159|NCT02230371|Double-blind|double-blind
321160|NCT02230358|carotid endarterectomy|carotid endarterectomy
321161|NCT02230358|cardiac output|cardiac output
321162|NCT02230358|trans-cranial Doppler|trans-cranial doppler
321163|NCT02230358|CEA|cea
321164|NCT02230358|regional anesthesia|regional anesthesia
321165|NCT02230358|general anesthesia|general anesthesia
321166|NCT02230345|Probiotic|probiotic
321167|NCT02230345|Yoghourt|yoghourt
321168|NCT02230345|Inflammation|inflammation
321169|NCT02230345|Metabolomics|metabolomics
321170|NCT02230319|Cryotherapy|cryotherapy
321171|NCT02230319|Cold therapy|cold therapy
321172|NCT02230319|Peripheral Neuropathy|peripheral neuropathy
321173|NCT02230319|Paclitaxel|paclitaxel
321174|NCT02230319|Breast Cancer|breast cancer
321175|NCT02230319|Symptom management|symptom management
321176|NCT02230319|Prevention|prevention
321177|NCT02230293|ambulatory care,|ambulatory care,
321178|NCT02230293|hypertension,|hypertension,
321179|NCT02230293|health personnel,|health personnel,
321180|NCT02230293|clinical trial|clinical trial
321181|NCT02230280|Mobile health technology|mobile health technology
321182|NCT02230280|Multiple chronic conditions|multiple chronic conditions
321183|NCT02230280|Older adults|older adults
321184|NCT02230280|Home and community care|home and community care
321185|NCT02230280|Effectiveness|effectiveness
321186|NCT02230280|Cost analysis|cost analysis
321187|NCT02230280|Interprofessional Stroke Rehabilitation|interprofessional stroke rehabilitation
321188|NCT02230267|boot camp|boot camp
321189|NCT02230267|exercise|exercise
321190|NCT02230267|balance training|balance training
321191|NCT02230267|fall prevention|fall prevention
321192|NCT02230267|falling|falling
321193|NCT02230267|strength training|strength training
321194|NCT02230254|Coronary Artery Disease|coronary artery disease
321195|NCT02230241|Dyslipidaemia|dyslipidaemia
321196|NCT02230241|LDL-C goals|ldl-c goals
321197|NCT02230241|Guidelines|guidelines
321198|NCT02230215|Total Knee Replacement|total knee replacement
321199|NCT02230215|Visionaire|visionaire
321200|NCT02230189|Asthma|asthma
321201|NCT02230189|Allergen challenge|allergen challenge
321202|NCT02230163|Chikungunya virus|chikungunya virus
321203|NCT02230163|Human anti-CHIKV hyperimmune intravenous immunoglobulins|human anti-chikv hyperimmune intravenous immunoglobulins
321204|NCT02230163|Neonates|neonates
321205|NCT02230150|Adhesion, Knowledge, Nursing|adhesion, knowledge, nursing
321206|NCT02230137|adolescents|adolescents
321207|NCT02230137|type 1 diabetes|type 1 diabetes
321208|NCT02230137|poorly controlled|poorly controlled
321209|NCT02230137|SMS|sms
321210|NCT02230137|Improve glycaemic control|improve glycaemic control
321211|NCT02230137|HbA1c reduction|hba1c reduction
321212|NCT02230137|poorly controlled type 1 diabetic adolescents|poorly controlled type 1 diabetic adolescents
321213|NCT02230124|Hydrocephalus|hydrocephalus
321214|NCT02230111|Women|women
321215|NCT02230111|Caloric restriction|caloric restriction
321216|NCT02230111|Cognitive dietary restraint|cognitive dietary restraint
321217|NCT02230111|Eating behaviours|eating behaviours
321218|NCT02230111|Food habits|food habits
321219|NCT02230111|Appetite sensations|appetite sensations
321220|NCT02230111|Stress|stress
321221|NCT02230111|Weight management|weight management
321222|NCT02230098|remote ischemic conditioning|remote ischemic conditioning
321223|NCT02230098|ischemic heart disease|ischemic heart disease
321224|NCT02230072|myelomeningocele|myelomeningocele
321225|NCT02230072|MMC|mmc
321226|NCT02230072|NTD|ntd
321227|NCT02230072|neural|neural
321228|NCT02230072|defect|defect
321229|NCT02230072|Spina bifida|spina bifida
321230|NCT02230072|Neural Tube Defect|neural tube defect
321231|NCT02230059|Prostatic Neoplasms|prostatic neoplasms
321232|NCT02230059|observational Study|observational study
321233|NCT02230059|Metastatic castration-resistant prostate cancer|metastatic castration-resistant prostate cancer
321234|NCT02230046|Healthy,|healthy,
321235|NCT02230046|Abiraterone Acetate,|abiraterone acetate,
321236|NCT02230046|Bioequivalence.|bioequivalence.
321237|NCT02230033|JNJ-56021927|jnj-56021927
321238|NCT02230033|Itraconazole|itraconazole
321239|NCT02230033|Gemfibrozil|gemfibrozil
321240|NCT02229994|Dyspnea|dyspnea
321241|NCT02229994|Self-administered questionnaire|self-administered questionnaire
321242|NCT02229994|Chronic respiratory disease|chronic respiratory disease
321243|NCT02229994|COPD|copd
321244|NCT02229994|Diffuse interstitial lung diseases|diffuse interstitial lung diseases
321245|NCT02229994|Pulmonary arterial hypertension|pulmonary arterial hypertension
321246|NCT02229994|Cystic fibrosis|cystic fibrosis
321247|NCT02229981|Lymphoma|lymphoma
321248|NCT02229981|B-cell Lymphomas|b-cell lymphomas
321249|NCT02229981|Diffuse Large B-cell Lymphoma|diffuse large b-cell lymphoma
321250|NCT02229981|Lymphosarcoma|lymphosarcoma
321251|NCT02229981|Kaposi's Sarcoma-associated Herpesvirus|kaposi's sarcoma-associated herpesvirus
321252|NCT02229981|KHSV|khsv
321253|NCT02229981|Human Immunodeficiency Virus|human immunodeficiency virus
321254|NCT02229981|HIV|hiv
321255|NCT02229981|Epstein-Barr Virus|epstein-barr virus
321256|NCT02229981|EBV|ebv
321257|NCT02229981|Kaposi sarcoma|kaposi sarcoma
321258|NCT02229968|craniosynostosis|craniosynostosis
321259|NCT02229968|craniofacial|craniofacial
321260|NCT02229968|amicar|amicar
321261|NCT02229968|epsilon aminocaproic acid|epsilon aminocaproic acid
321262|NCT02229968|ε-aminocaproic acid|ε-aminocaproic acid
321263|NCT02229955|Dry Eye Syndromes|dry eye syndromes
321264|NCT02229942|Chronic Fatigue Syndrome (CFS)|chronic fatigue syndrome (cfs)
321265|NCT02229942|Myalgic Encephalitis (ME)|myalgic encephalitis (me)
321266|NCT02229942|Rituximab|rituximab
321267|NCT02229942|B-lymphocyte depletion|b-lymphocyte depletion
321268|NCT02229942|B-cell depletion|b-cell depletion
321269|NCT02229929|Pruritus|pruritus
321270|NCT02229929|uremic pruritus|uremic pruritus
321271|NCT02229929|kappa opioid|kappa opioid
321272|NCT02229929|CR845|cr845
321273|NCT02229916|Testicular Neoplasms|testicular neoplasms
321274|NCT02229916|Testicular Cancer|testicular cancer
321275|NCT02229916|Cohort Study|cohort study
321276|NCT02229903|OCD|ocd
321277|NCT02229864|Absorb™ BVS|absorb™ bvs
321278|NCT02229864|Angioplasty|angioplasty
321279|NCT02229864|Bioabsorbable|bioabsorbable
321280|NCT02229864|BVS|bvs
321281|NCT02229864|Coronary Artery Disease|coronary artery disease
321282|NCT02229864|Coronary Artery Endothelial Responsiveness|coronary artery endothelial responsiveness
321283|NCT02229864|Coronary artery restenosis|coronary artery restenosis
321284|NCT02229864|Coronary artery stenosis|coronary artery stenosis
321285|NCT02229864|Coronary scaffold|coronary scaffold
321286|NCT02229864|Coronary Stent|coronary stent
321287|NCT02229864|Drug eluting stents|drug eluting stents
321288|NCT02229864|Everolimus|everolimus
321289|NCT02229864|Myocardial ischemia|myocardial ischemia
321290|NCT02229864|Stent thrombosis|stent thrombosis
321291|NCT02229864|Stents|stents
321292|NCT02229708|Pregnancy|pregnancy
321293|NCT02229708|Weight control|weight control
321294|NCT02229708|Behavioral|behavioral
321295|NCT02229708|technology-based intervention|technology-based intervention
321296|NCT02229695|Trauma|trauma
321297|NCT02229695|Sepsis|sepsis
321298|NCT02229695|Temporary abdominal closure|temporary abdominal closure
321299|NCT02229695|Bogota bag|bogota bag
321300|NCT02229695|Vacuum assisted closure|vacuum assisted closure
321301|NCT02229682|extranodal NK/T-cell lymphoma,nasal-type,|extranodal nk/t-cell lymphoma,nasal-type,
321302|NCT02229682|radiotherapy,|radiotherapy,
321303|NCT02229682|intensity-modulated radiation treatment,|intensity-modulated radiation treatment,
321304|NCT02229682|asparaginase-based chemotherapy,|asparaginase-based chemotherapy,
321305|NCT02229682|loco-regional control,|loco-regional control,
321306|NCT02229682|survival|survival
321307|NCT02229656|olaparib|olaparib
321308|NCT02229656|radiotherapy|radiotherapy
321309|NCT02229656|Laryngeal SCC|laryngeal scc
321310|NCT02229656|oropharyngeal SCC|oropharyngeal scc
321311|NCT02229643|Traumatic brain injury|traumatic brain injury
321312|NCT02229643|Neuroglobin|neuroglobin
321313|NCT02229643|Nogo-A|nogo-a
321314|NCT02229643|Prognosis|prognosis
321315|NCT02229630|intra-uterine growth restriction|intra-uterine growth restriction
321316|NCT02229630|MRI|mri
321317|NCT02229630|apparent diffusion coefficient|apparent diffusion coefficient
321318|NCT02229617|Intramuscular testosterone|intramuscular testosterone
321319|NCT02229617|Subcutaneous testosterone|subcutaneous testosterone
321320|NCT02229604|electroacupuncture|electroacupuncture
321321|NCT02229604|diminished ovarian reserve|diminished ovarian reserve
321322|NCT02229604|cohort study|cohort study
321323|NCT02229578|Burn pain|burn pain
321324|NCT02229578|lidocaine|lidocaine
321325|NCT02229578|donor site pain|donor site pain
321326|NCT02229578|Narcotic use|narcotic use
321327|NCT02229565|prostate cancer|prostate cancer
321328|NCT02229565|prostate biopsy|prostate biopsy
321329|NCT02229565|prostatectomy|prostatectomy
321330|NCT02229526|Fish oil supplementation|fish oil supplementation
321331|NCT02229526|RCT|rct
321332|NCT02229526|High risk pregnancies|high risk pregnancies
321333|NCT02229526|Twin pregnancy|twin pregnancy
321334|NCT02229526|Preterm birth|preterm birth
321335|NCT02229526|Intrauterine growth retardation|intrauterine growth retardation
321336|NCT02229526|Pregnancy induced hypertension|pregnancy induced hypertension
321337|NCT02229513|postpartum hemorrhage|postpartum hemorrhage
321338|NCT02229513|uterine atony|uterine atony
321339|NCT02229513|cesarean section|cesarean section
321340|NCT02229513|cesarean hysterectomy|cesarean hysterectomy
321341|NCT02229513|acute blood loss anemia|acute blood loss anemia
321342|NCT02229513|uterotonics|uterotonics
321343|NCT02229513|obstetric hemorrhage|obstetric hemorrhage
321344|NCT02229513|severe hemorrhage|severe hemorrhage
321345|NCT02229513|blood transfusion|blood transfusion
321346|NCT02229513|obstetric emergencies|obstetric emergencies
321348|NCT02229513|massive hemorrhage|massive hemorrhage
321349|NCT02229513|hemorrhage|hemorrhage
321350|NCT02229513|uterine cooling|uterine cooling
321351|NCT02229500|Propionate|propionate
321352|NCT02229500|Microbiome|microbiome
321353|NCT02229500|Dietary Fibre|dietary fibre
321354|NCT02229500|Short chain fatty acids|short chain fatty acids
321355|NCT02229487|Prediabetes|prediabetes
321356|NCT02229487|Short sleepers|short sleepers
321358|NCT02229474|Dementia|dementia
321359|NCT02229474|Cognitive Stimulation Therapy|cognitive stimulation therapy
321360|NCT02229474|Quality of life|quality of life
321361|NCT02229474|Cognitive impairment|cognitive impairment
321362|NCT02229474|Africa|africa
321363|NCT02229474|Tanzania|tanzania
321364|NCT02229474|Nigeria|nigeria
321365|NCT02229474|Low- and Middle-income countries|low- and middle-income countries
321366|NCT02229474|Non-pharmacological intervention|non-pharmacological intervention
321367|NCT02229474|Task-shifting|task-shifting
321368|NCT02229474|Cognitive screening|cognitive screening
321369|NCT02229448|Immunoglobulin G|immunoglobulin g
321370|NCT02229448|focus|focus
321371|NCT02229448|study|study
321372|NCT02229448|detect|detect
321373|NCT02229448|patients|patients
321374|NCT02229435|Chronic kidney disease|chronic kidney disease
321375|NCT02229435|Urological care|urological care
321376|NCT02229435|Nephrological care|nephrological care
321377|NCT02229409|adults|adults
321378|NCT02229396|Diabetes Mellitus|diabetes mellitus
321379|NCT02229396|Exenatide|exenatide
321380|NCT02229396|Dapagliflozin|dapagliflozin
321381|NCT02229396|Diabetes medication|diabetes medication
321382|NCT02229396|Treatment efficacy|treatment efficacy
321383|NCT02229396|Placebo|placebo
321384|NCT02229396|Metabolism|metabolism
321385|NCT02229396|Cardiovascular metabolic|cardiovascular metabolic
321386|NCT02229383|Diabetes Mellitus|diabetes mellitus
321387|NCT02229383|Exenatide|exenatide
321388|NCT02229383|Diabetes drug|diabetes drug
321389|NCT02229383|Treatment efficacy|treatment efficacy
321390|NCT02229383|Placebo|placebo
321391|NCT02229383|Metabolism|metabolism
321392|NCT02229383|Cardiovascilar metabolic|cardiovascilar metabolic
321393|NCT02229370|extracranial|extracranial
321394|NCT02229370|carotid|carotid
321395|NCT02229370|artery|artery
321396|NCT02229370|aneurysm|aneurysm
321397|NCT02229370|registry|registry
321398|NCT02229370|CAR|car
321399|NCT02229357|H5N2 Vaccine|h5n2 vaccine
321400|NCT02229344|colitis, ulcerative|colitis, ulcerative
321401|NCT02229344|MOSAIK|mosaik
321402|NCT02229344|REMICADE|remicade
321403|NCT02229344|Infliximab|infliximab
321404|NCT02229331|haemophilia|haemophilia
321405|NCT02229331|arthropathy|arthropathy
321406|NCT02229331|pediatrics|pediatrics
321407|NCT02229331|ankle|ankle
321408|NCT02229331|biomechanics|biomechanics
321409|NCT02229305|Anxiety|anxiety
321410|NCT02229305|Trauma|trauma
321411|NCT02229305|Depression|depression
321412|NCT02229305|Problem Behavior|problem behavior
321413|NCT02229305|evidence-based treatments|evidence-based treatments
321414|NCT02229279|Surgical Procedures, Operative|surgical procedures, operative
321415|NCT02229266|AML|aml
321416|NCT02229266|high-risk AML|high-risk aml
321417|NCT02229266|acute myeloid leukemia|acute myeloid leukemia
321418|NCT02229266|NK cells|nk cells
321419|NCT02229266|haploidentical natural killer cells|haploidentical natural killer cells
321420|NCT02229266|immunotherapy|immunotherapy
321421|NCT02229240|Albiglutide|albiglutide
321422|NCT02229240|Add-on to basal-bolus insulin therapy|add-on to basal-bolus insulin therapy
321423|NCT02229240|Glucagon-like peptide-1 receptor agonist|glucagon-like peptide-1 receptor agonist
321424|NCT02229240|Type 2 diabetes mellitus|type 2 diabetes mellitus
321425|NCT02229227|switch study|switch study
321426|NCT02229227|albiglutide|albiglutide
321427|NCT02229227|glucagon-like peptide-1 receptor agonist|glucagon-like peptide-1 receptor agonist
321428|NCT02229227|Type 2 diabetes mellitus|type 2 diabetes mellitus
321429|NCT02229227|basal-bolus insulin therapy|basal-bolus insulin therapy
321430|NCT02229214|Renal function|renal function
321431|NCT02229214|Glomerular Filtration Rate|glomerular filtration rate
321432|NCT02229214|Kidney function|kidney function
321433|NCT02229214|Qsymia|qsymia
321434|NCT02229214|Iohexol|iohexol
321435|NCT02229214|Serum Creatinine|serum creatinine
321436|NCT02229214|Creatinine clearance|creatinine clearance
321437|NCT02229214|Renal Clearance|renal clearance
321438|NCT02229214|VI-0521|vi-0521
321439|NCT02229214|Healthy volunteers|healthy volunteers
321440|NCT02229201|propofol|propofol
321441|NCT02229201|sevoflurane|sevoflurane
321442|NCT02229201|Interleukin 6|interleukin 6
321443|NCT02229201|Interleukin 10|interleukin 10
321444|NCT02229188|Depression; mood; cognitive training|depression; mood; cognitive training
321445|NCT02229175|Diabetic Macular Edema|diabetic macular edema
321446|NCT02229175|Diabetic Retinopathy|diabetic retinopathy
321447|NCT02229175|Type 1 Diabetes|type 1 diabetes
321448|NCT02229175|Type 2 Diabetes|type 2 diabetes
321449|NCT02229175|Macular Edema|macular edema
321450|NCT02229175|bevacizumab|bevacizumab
321451|NCT02229175|intravitreal injection|intravitreal injection
321452|NCT02229175|Avastin|avastin
321453|NCT02229175|PASCAL Endpoint Management (EpM) system|pascal endpoint management (epm) system
321454|NCT02229175|Subthreshold focal laser treatments|subthreshold focal laser treatments
321455|NCT02229162|umbilical cord|umbilical cord
321456|NCT02229162|cesarean section|cesarean section
321457|NCT02229162|Blood Loss, Surgical|blood loss, surgical
321458|NCT02229149|breast cancer|breast cancer
321459|NCT02229149|metastatic breast cancer|metastatic breast cancer
321460|NCT02229149|HER2+ breast cancer|her2+ breast cancer
321461|NCT02229136|Mouth sores from chemotherapy|mouth sores from chemotherapy
321462|NCT02229136|mouth sores|mouth sores
321463|NCT02229136|hormone receptor-positive metastatic breast cancer|hormone receptor-positive metastatic breast cancer
321464|NCT02229136|metastatic breast cancer|metastatic breast cancer
321465|NCT02229123|seizures|seizures
321466|NCT02229123|neonates|neonates
321467|NCT02229123|anticonvulsant treatment|anticonvulsant treatment
321468|NCT02229123|levetiracetam|levetiracetam
321469|NCT02229123|hypoxic-ischemic encephalopathy|hypoxic-ischemic encephalopathy
321470|NCT02229123|electroencephalography|electroencephalography
321471|NCT02229110|type 2 diabetes mellitus|type 2 diabetes mellitus
321472|NCT02229110|e-Health|e-health
321473|NCT02229110|allocation of care|allocation of care
321474|NCT02229110|clinical inertia|clinical inertia
321475|NCT02229110|quality of care|quality of care
321476|NCT02229110|patient satisfaction|patient satisfaction
321477|NCT02229097|type 1 diabetes|type 1 diabetes
321478|NCT02229071|Donafenib|donafenib
321479|NCT02229071|HCC|hcc
321480|NCT02229071|Advanced|advanced
321481|NCT02229071|inoperable|inoperable
321482|NCT02229071|Phase 1B|phase 1b
321483|NCT02229058|Gastric Cancer|gastric cancer
321484|NCT02229058|Albumin Bound Paclitaxel|albumin bound paclitaxel
321485|NCT02229058|S-1|s-1
321486|NCT02229058|First Line|first line
321487|NCT02229045|gastric caner|gastric caner
321488|NCT02229045|Albumin Bound Paclitaxel|albumin bound paclitaxel
321489|NCT02229045|5-FU/CF|5-fu/cf
321490|NCT02229045|taxanes naive|taxanes naive
321491|NCT02229032|Dravet Syndrome|dravet syndrome
321492|NCT02229032|cannabidiol therapy|cannabidiol therapy
321493|NCT02229032|Charlotte's Web|charlotte's web
321494|NCT02229019|Volunteers|volunteers
321495|NCT02229019|Mealtime assistance|mealtime assistance
321496|NCT02229019|Older adults|older adults
321497|NCT02229019|Nutrition|nutrition
321498|NCT02229019|Nursing|nursing
321499|NCT02229006|Aortic aneurysm, abdominal|aortic aneurysm, abdominal
321500|NCT02229006|Sodium Fluoride|sodium fluoride
321501|NCT02229006|Positron Emission Tomography|positron emission tomography
321502|NCT02228980|Influenza|influenza
321503|NCT02228980|Trivalent influenza vaccine|trivalent influenza vaccine
321504|NCT02228980|Sanofi Pasteur Shenzhen trivalent influenza vaccine|sanofi pasteur shenzhen trivalent influenza vaccine
321505|NCT02228967|Alcohol Use|alcohol use
321506|NCT02228967|SBIRT|sbirt
321507|NCT02228967|Military|military
321508|NCT02228967|Health Behavior|health behavior
321509|NCT02228967|Emergency Room|emergency room
321510|NCT02228967|Health Promotion|health promotion
321511|NCT02228967|Formative Research|formative research
321512|NCT02228967|Randomized Trial|randomized trial
321513|NCT02228954|Clear-cell metastatic renal cell carcinoma|clear-cell metastatic renal cell carcinoma
321514|NCT02228954|Positron-Emission Tomography|positron-emission tomography
321515|NCT02228928|Peripheral Nerve Injury|peripheral nerve injury
321516|NCT02228928|Postherpetic Neuralgia|postherpetic neuralgia
321517|NCT02228889|Hernia|hernia
321518|NCT02228889|Abdominal wall reconstruction|abdominal wall reconstruction
321519|NCT02228889|Abdominal wall defect|abdominal wall defect
321520|NCT02228889|Porcine mesh|porcine mesh
321521|NCT02228889|Component separation|component separation
321522|NCT02228889|Abdominal wall tumor|abdominal wall tumor
321523|NCT02228889|Desmoid|desmoid
321524|NCT02228863|Stroke|stroke
321525|NCT02228863|Spasticity|spasticity
321526|NCT02228850|Secondary Raynaud's Phenomenon|secondary raynaud's phenomenon
321527|NCT02228850|Secondary Raynaud's Disease|secondary raynaud's disease
321528|NCT02228850|Scleroderma|scleroderma
321529|NCT02228850|Raynaud's Disease secondary to systemic sclerosis|raynaud's disease secondary to systemic sclerosis
321530|NCT02228850|CREST|crest
321531|NCT02228850|Apricus Biosciences|apricus biosciences
321532|NCT02228850|laser doppler|laser doppler
321533|NCT02228850|thermography|thermography
321534|NCT02228824|Smoking|smoking
321535|NCT02228824|Non-daily smokers|non-daily smokers
321536|NCT02228824|Ecological Momentary Assessment|ecological momentary assessment
321537|NCT02228824|Biomarkers|biomarkers
321538|NCT02228798|anticoagulant|anticoagulant
321539|NCT02228798|atrial fibrillation|atrial fibrillation
321540|NCT02228798|surgery|surgery
321541|NCT02228798|oral anticoagulant|oral anticoagulant
321542|NCT02228798|discontinue|discontinue
321543|NCT02228798|DOAC|doac
321544|NCT02228798|NOAC|noac
321545|NCT02228798|blood thinner|blood thinner
321546|NCT02228798|interruption|interruption
321547|NCT02228772|Acute lymphoblastic Leukemia|acute lymphoblastic leukemia
321548|NCT02228772|Lymphoblastic lymphoma|lymphoblastic lymphoma
321549|NCT02228772|B-cell Adult Acute Lymphoblastic Leukemia|b-cell adult acute lymphoblastic leukemia
321550|NCT02228772|T-cell Adult Acute Lymphoblastic Leukemia|t-cell adult acute lymphoblastic leukemia
321551|NCT02228759|Ambulatory home regional|ambulatory home regional
321552|NCT02228759|adductor canal block|adductor canal block
321553|NCT02228759|Postoperative pain|postoperative pain
321554|NCT02228759|total knee arthroplasty|total knee arthroplasty
321555|NCT02228759|Home regional|home regional
321556|NCT02228759|Fast track arthroplasty|fast track arthroplasty
321557|NCT02228720|Chronic Sinusitis|chronic sinusitis
321558|NCT02228720|Endoscopic Sinus Surgery|endoscopic sinus surgery
321559|NCT02228694|ADC|adc
321560|NCT02228694|Pre installation|pre installation
321561|NCT02228694|Post installation|post installation
321562|NCT02228694|Safety|safety
321563|NCT02228694|Time|time
321564|NCT02228668|AVANT|avant
321565|NCT02228668|GERCOR|gercor
321566|NCT02228668|Follow up|follow up
321567|NCT02228668|Colon cancer|colon cancer
321568|NCT02228668|Bevacizumab|bevacizumab
321569|NCT02228668|Overall survival|overall survival
321570|NCT02228655|Chronic Kidney Disease|chronic kidney disease
321571|NCT02228655|CKD|ckd
321572|NCT02228655|Anemia of Chronic Illness|anemia of chronic illness
321573|NCT02228642|Type 1 diabetes|type 1 diabetes
321574|NCT02228642|Type 2 diabetes|type 2 diabetes
321575|NCT02228642|Hypoglycemia|hypoglycemia
321576|NCT02228642|Cognition disorders|cognition disorders
321577|NCT02228642|Inpatient|inpatient
321578|NCT02228629|Diabetes|diabetes
321579|NCT02228629|Foot complications|foot complications
321580|NCT02228629|plantar keratoma|plantar keratoma
321581|NCT02228629|plantar pressure|plantar pressure
321582|NCT02228616|Constipation|constipation
321583|NCT02228616|Chronic constipation|chronic constipation
321584|NCT02228616|Prucalopride|prucalopride
321585|NCT02228616|Women|women
321586|NCT02228603|exercise therapy|exercise therapy
321587|NCT02228603|rehabilitation|rehabilitation
321588|NCT02228590|Parkinson's Disease|parkinson's disease
321589|NCT02228564|Lack of perfusion in the extremities|lack of perfusion in the extremities
321590|NCT02228564|Atherosclerosis|atherosclerosis
321591|NCT02228564|Intermittent claudication|intermittent claudication
321592|NCT02228564|BOLSTER|bolster
321593|NCT02228551|Augmented renal clearance|augmented renal clearance
321594|NCT02228551|non-critically ill|non-critically ill
321595|NCT02228551|surgery|surgery
321596|NCT02228551|prevalence|prevalence
321597|NCT02228551|risk factors|risk factors
321598|NCT02228538|total knee arthroplasty|total knee arthroplasty
321599|NCT02228538|osteoarthritis|osteoarthritis
321600|NCT02228525|Selinexor (KPT-330)|selinexor (kpt-330)
321601|NCT02228525|Selective Inhibitor of Nuclear Export (SINE)|selective inhibitor of nuclear export (sine)
321602|NCT02228525|14-005|14-005
321603|NCT02228512|HHV8|hhv8
321604|NCT02228512|PEL|pel
321605|NCT02228512|Immune Modulation|immune modulation
321606|NCT02228512|CC-4047|cc-4047
321607|NCT02228512|IMiD|imid
321608|NCT02228499|asthma|asthma
321609|NCT02228499|academics|academics
321610|NCT02228499|GPA|gpa
321611|NCT02228499|attendance|attendance
321612|NCT02228447|Adolescent|adolescent
321613|NCT02228447|Randomized controlled trial|randomized controlled trial
321614|NCT02228447|Eating behavior|eating behavior
321615|NCT02228447|Physical Activity|physical activity
321616|NCT02228447|Sedentary lifestyle|sedentary lifestyle
321617|NCT02228434|Childhood obesity, intervention, effectiveness, comparison|childhood obesity, intervention, effectiveness, comparison
321618|NCT02228408|hemodialysis|hemodialysis
321619|NCT02228408|ESRD|esrd
321620|NCT02228408|Cardiovascular Disease|cardiovascular disease
321621|NCT02228408|Isosorbide Dinitrate|isosorbide dinitrate
321622|NCT02228408|Hydralazine|hydralazine
321623|NCT02228395|Single ascending doses|single ascending doses
321624|NCT02228395|pharmacokinetics|pharmacokinetics
321625|NCT02228395|safety|safety
321626|NCT02228395|tolerability|tolerability
321627|NCT02228395|healthy volunteers|healthy volunteers
321628|NCT02228395|cognitive impairment associated with schizophrenia (CIAS)|cognitive impairment associated with schizophrenia (cias)
321629|NCT02228382|Bosutinib|bosutinib
321630|NCT02228382|Chronic Myeloid Leukemia|chronic myeloid leukemia
321631|NCT02228382|CML|cml
321632|NCT02228382|Leukemia|leukemia
321633|NCT02228382|Myelogenous|myelogenous
321634|NCT02228382|Chronic|chronic
321635|NCT02228382|BC-ABL Positive|bc-abl positive
321636|NCT02228369|Non Small Cell Lung Cancer, EGFR, Tyrosine kinase inhibitor,EGFR mutation positive, Brain Metastasis, Leptomeningeal Metastasis|non small cell lung cancer, egfr, tyrosine kinase inhibitor,egfr mutation positive, brain metastasis, leptomeningeal metastasis
321637|NCT02228356|Neoplasm Metastasis|neoplasm metastasis
321638|NCT02228356|oligometastatic cancer|oligometastatic cancer
321639|NCT02228356|Stereotactic Body Radiation Therapy|stereotactic body radiation therapy
321640|NCT02228356|SBRT|sbrt
321641|NCT02228356|Real-time Tumor Tracking (RTTT)|real-time tumor tracking (rttt)
321642|NCT02228356|ITV|itv
321643|NCT02228356|Internal Target Volume|internal target volume
321644|NCT02228356|Respiratory Motion Management|respiratory motion management
321645|NCT02228356|Image-guided Radiotherapy|image-guided radiotherapy
321646|NCT02228356|IGRT|igrt
321750|NCT02227927|Gastroparesis|gastroparesis
321647|NCT02228330|Transurethral resection of bladder tumors|transurethral resection of bladder tumors
321648|NCT02228330|Obturator nerve reflex|obturator nerve reflex
321649|NCT02228330|Obturator nerve block|obturator nerve block
321650|NCT02228317|Emergency Medical Dispatch|emergency medical dispatch
321651|NCT02228317|Telemedicine|telemedicine
321652|NCT02228317|Emergency Medical Services|emergency medical services
321653|NCT02228317|Pre-hospital|pre-hospital
321654|NCT02228304|Wet AMD|wet amd
321655|NCT02228304|Wet Age Related Macular Degeneration|wet age related macular degeneration
321656|NCT02228304|Recurrent CNV Secondary to AMD|recurrent cnv secondary to amd
321657|NCT02228304|Active subfoveal CNV|active subfoveal cnv
321658|NCT02228291|Polyphenols|polyphenols
321659|NCT02228291|Endothelial function|endothelial function
321660|NCT02228291|Gut barrier function|gut barrier function
321661|NCT02228278|Pediatric|pediatric
321662|NCT02228278|Obesity|obesity
321663|NCT02228278|Overweight|overweight
321664|NCT02228278|Texting|texting
321665|NCT02228278|Text message|text message
321666|NCT02228278|SMS|sms
321667|NCT02228278|Diet|diet
321668|NCT02228278|Weight Loss|weight loss
321669|NCT02228278|Nutrition|nutrition
321670|NCT02228278|Physical activity|physical activity
321671|NCT02228278|BMI z-score|bmi z-score
321672|NCT02228278|BMI|bmi
321673|NCT02228252|Proteins|proteins
321674|NCT02228252|Postprandial lipemia|postprandial lipemia
321675|NCT02228252|Pre-meal|pre-meal
321676|NCT02228252|Metabolic syndrome|metabolic syndrome
321677|NCT02228239|Healthy|healthy
321678|NCT02228239|Esketamine|esketamine
321679|NCT02228239|Mirtazapine|mirtazapine
321680|NCT02228239|Psychomotor.|psychomotor.
321681|NCT02228226|Arthroscopic Bankart repair|arthroscopic bankart repair
321682|NCT02228226|Bone hole|bone hole
321683|NCT02228226|Ossification|ossification
321684|NCT02228226|Suture anchor|suture anchor
321685|NCT02228226|Shoulder dislocation|shoulder dislocation
321686|NCT02228213|multiple sclerosis|multiple sclerosis
321687|NCT02228213|SPMS|spms
321688|NCT02228200|Oncology Nursing|oncology nursing
321689|NCT02228200|Advanced Practice Nursing|advanced practice nursing
321690|NCT02228200|Nurse-led care|nurse-led care
321691|NCT02228200|Chemotherapy|chemotherapy
321692|NCT02228174|Abnormal Uterine Bleeding associated with fibroids|abnormal uterine bleeding associated with fibroids
321693|NCT02228174|AUB-L|aub-l
321694|NCT02228174|Fibroids|fibroids
321695|NCT02228174|Heavy menstrual bleeding|heavy menstrual bleeding
321696|NCT02228174|HMB|hmb
321697|NCT02228174|Myoma|myoma
321698|NCT02228174|Menorrhagia|menorrhagia
321699|NCT02228161|Yoga|yoga
321700|NCT02228161|Work-related Stress,|work-related stress,
321701|NCT02228161|Stress Adaptation.|stress adaptation.
321702|NCT02228148|Post linguistically deafness, severe to profound deafness|post linguistically deafness, severe to profound deafness
321703|NCT02228122|Chronic wounds|chronic wounds
321704|NCT02228122|Biofilms|biofilms
321705|NCT02228122|Bacteria|bacteria
321706|NCT02228096|relapsed/refractory|relapsed/refractory
321707|NCT02228096|Philadelphia chromosome positive acute lymphoblastic leukemia|philadelphia chromosome positive acute lymphoblastic leukemia
321708|NCT02228096|Pharmaceuticals|pharmaceuticals
321709|NCT02228096|Philadelphia chromosome positive|philadelphia chromosome positive
321710|NCT02228096|Acute Lymphoid Leukemia (ALL)|acute lymphoid leukemia (all)
321711|NCT02228096|Acute Lymphocytic Leukemia (ALL)|acute lymphocytic leukemia (all)
321712|NCT02228083|dental|dental
321713|NCT02228083|epinephrine|epinephrine
321714|NCT02228083|local anesthetic|local anesthetic
321715|NCT02228083|lidocaine|lidocaine
321716|NCT02228083|cardiac arrhythmias|cardiac arrhythmias
321717|NCT02228083|procedure|procedure
321718|NCT02228070|strabismus|strabismus
321719|NCT02228070|oculomotor palsy|oculomotor palsy
321720|NCT02228070|abducens palsy|abducens palsy
321721|NCT02228070|trochlear palsy|trochlear palsy
321722|NCT02228057|arterial patency|arterial patency
321723|NCT02228057|upper extremity|upper extremity
321724|NCT02228057|anastomosis|anastomosis
321725|NCT02228057|sensibility|sensibility
321726|NCT02228057|pain|pain
321727|NCT02228057|cold intolerance|cold intolerance
321728|NCT02228044|suicide|suicide
321729|NCT02228044|alcohol|alcohol
321730|NCT02228044|marijuana|marijuana
321731|NCT02228044|HIV|hiv
321732|NCT02228044|prevention|prevention
321733|NCT02228044|adolescent|adolescent
321734|NCT02228031|Mirror neurons|mirror neurons
321735|NCT02228031|Imitation|imitation
321736|NCT02228031|Oxytocin|oxytocin
321737|NCT02227992|Fibrin Sealant|fibrin sealant
321738|NCT02227992|Hemostatics|hemostatics
321739|NCT02227992|Coagulants|coagulants
321740|NCT02227966|Mild Cognitive Impairment|mild cognitive impairment
321741|NCT02227966|MCI|mci
321742|NCT02227966|tDCS|tdcs
321743|NCT02227966|transcranial Direct Current Stimulation|transcranial direct current stimulation
321744|NCT02227953|Alzheimer's Disease|alzheimer's disease
321745|NCT02227953|AD|ad
321746|NCT02227953|tDCS|tdcs
321747|NCT02227953|transcranial direct current stimulation|transcranial direct current stimulation
321748|NCT02227927|Gastroesophageal Reflux Disease|gastroesophageal reflux disease
321751|NCT02227927|Domperidone|domperidone
321752|NCT02227888|CF|cf
321753|NCT02227888|F508Del|f508del
321754|NCT02227888|Cavosonstat|cavosonstat
321755|NCT02227888|N91115|n91115
321756|NCT02227849|insulin resistance|insulin resistance
321757|NCT02227836|Allergy Patch testing|allergy patch testing
321758|NCT02227836|Eosinophilic Esophagitis|eosinophilic esophagitis
321759|NCT02227836|EoE|eoe
321760|NCT02227823|spinal muscular atrophy type 3|spinal muscular atrophy type 3
321761|NCT02227823|electromyography|electromyography
321762|NCT02227823|fatigability|fatigability
321763|NCT02227823|decrement|decrement
321764|NCT02227810|Prolong mechanical ventilator,|prolong mechanical ventilator,
321765|NCT02227810|Electrical stimulation,|electrical stimulation,
321766|NCT02227810|Activities of daily life,|activities of daily life,
321767|NCT02227810|Hospitalization outcomes.|hospitalization outcomes.
321768|NCT02227797|stem cell transplant|stem cell transplant
321769|NCT02227797|hematopoietic stem cell transplant|hematopoietic stem cell transplant
321770|NCT02227797|fungal infection|fungal infection
321771|NCT02227797|voriconazole|voriconazole
321772|NCT02227797|pediatric|pediatric
321773|NCT02227719|after augmentation|after augmentation
321774|NCT02227719|procedure|procedure
321775|NCT02227706|Fibrin Sealant|fibrin sealant
321776|NCT02227706|Hemostatics|hemostatics
321777|NCT02227706|Coagulants|coagulants
321778|NCT02227693|Thrombocytopenia|thrombocytopenia
321779|NCT02227693|Chronic Liver Disease|chronic liver disease
321780|NCT02227680|music therapy|music therapy
321781|NCT02227680|massage therapy|massage therapy
321782|NCT02227667|MEDI4736|medi4736
321783|NCT02227667|14-109|14-109
321784|NCT02227654|Ovary|ovary
321785|NCT02227654|Cancer|cancer
321786|NCT02227654|Morphology|morphology
321787|NCT02227654|Surgery|surgery
321788|NCT02227641|CMV|cmv
321789|NCT02227641|Cytomegalovirus|cytomegalovirus
321790|NCT02227641|EBV|ebv
321791|NCT02227641|Epstein Barr Virus|epstein barr virus
321792|NCT02227641|virus|virus
321793|NCT02227641|T cell|t cell
321794|NCT02227641|adoptive transfer|adoptive transfer
321795|NCT02227641|transplantation|transplantation
321796|NCT02227641|allogeneic|allogeneic
321797|NCT02227589|adolescent,|adolescent,
321798|NCT02227589|alcohol abuse|alcohol abuse
321799|NCT02227589|depression,|depression,
321800|NCT02227589|cognitive behavior therapy|cognitive behavior therapy
321801|NCT02227589|cannabis abuse|cannabis abuse
321802|NCT02227576|glioblastoma, thrombocytopenia, temozolomide, chemotherapy|glioblastoma, thrombocytopenia, temozolomide, chemotherapy
321803|NCT02227563|dorsolateral prefrontal cortex|dorsolateral prefrontal cortex
321804|NCT02227563|left superior temporal gyrus|left superior temporal gyrus
321805|NCT02227563|auditory hallucinations|auditory hallucinations
321806|NCT02227563|transcranial direct current stimulation (tDCS)|transcranial direct current stimulation (tdcs)
321807|NCT02227550|Atrilal fibrillation|atrilal fibrillation
321808|NCT02227550|anticoagulation|anticoagulation
321809|NCT02227550|prevention of peri-procedural complication|prevention of peri-procedural complication
321810|NCT02227550|catheter ablation|catheter ablation
321811|NCT02227537|Adolescence Idiopathic Scoliosis|adolescence idiopathic scoliosis
321812|NCT02227537|nighttime Bracing|nighttime bracing
321813|NCT02227537|Providence|providence
321814|NCT02227524|Multiple Sclerosis|multiple sclerosis
321815|NCT02227524|Walking|walking
321816|NCT02227524|Gait|gait
321817|NCT02227511|fruit, nuts, liver fat, insulin, glucose|fruit, nuts, liver fat, insulin, glucose
321818|NCT02227511|Focus of the study is to compare the often given advice to eat fruit, containing large amount of glucose and fructose, with nuts that are more rich in fat.|focus of the study is to compare the often given advice to eat fruit, containing large amount of glucose and fructose, with nuts that are more rich in fat.
321819|NCT02227485|Gingivitis|gingivitis
321820|NCT02227485|Diabetes mellitus|diabetes mellitus
321821|NCT02227485|Medicine, Traditional|medicine, traditional
321822|NCT02227485|Herbal medicine|herbal medicine
321823|NCT02227485|Punica granatum|punica granatum
321824|NCT02227446|Surgical site infection risk prevention|surgical site infection risk prevention
400517|NCT01866514|IO|io
763535|NCT00390832|STEMI|stemi
411256|NCT01818440|Liver|liver
321825|NCT02227446|Bacterial species type and antibacterial sensitives|bacterial species type and antibacterial sensitives
321826|NCT02227433|Hodgkin Lymphoma, Elderly Patients, brentuximab vedotin (BV)|hodgkin lymphoma, elderly patients, brentuximab vedotin (bv)
321827|NCT02227407|SCI|sci
321828|NCT02227407|SMA|sma
321829|NCT02227407|Paralysis|paralysis
321830|NCT02227394|Asthma|asthma
321831|NCT02227394|Functional Respiratory Imaging|functional respiratory imaging
321832|NCT02227394|Computational Fluid Dynamic|computational fluid dynamic
321833|NCT02227368|Myocardial Infarction|myocardial infarction
321834|NCT02227368|Peripheral Arterial disease|peripheral arterial disease
321835|NCT02227368|Mycardial Ischemia|mycardial ischemia
321836|NCT02227368|Heart Diseases|heart diseases
321837|NCT02227368|Cardiovascular Diseases|cardiovascular diseases
321838|NCT02227368|Vascular Diseases|vascular diseases
321839|NCT02227368|Altherosclerosis|altherosclerosis
321840|NCT02227368|Arteriosclerosis|arteriosclerosis
321841|NCT02227368|Arterial Occlusive Diseases|arterial occlusive diseases
321842|NCT02227368|Peripheral Vascular Diseases|peripheral vascular diseases
321843|NCT02227368|Ticagrelor|ticagrelor
321844|NCT02227368|Ticlopidine|ticlopidine
321845|NCT02227368|Platelet Aggregation inhibitors|platelet aggregation inhibitors
321846|NCT02227368|Hematologic Agents|hematologic agents
321847|NCT02227368|Therapeutic Uses|therapeutic uses
321848|NCT02227368|Pharmacologic Actions|pharmacologic actions
321849|NCT02227368|Purinegic P2Y Receptor Antagonists|purinegic p2y receptor antagonists
321850|NCT02227368|Purinegic P2 Receptor Antagonists|purinegic p2 receptor antagonists
321851|NCT02227368|Purinergic Antagonists|purinergic antagonists
321852|NCT02227368|Purinergic Agents|purinergic agents
321853|NCT02227368|Neurotransmitter Agents|neurotransmitter agents
321854|NCT02227368|Molecular Mechanisms of Pharmacological Actions|molecular mechanisms of pharmacological actions
321855|NCT02227368|Physiological Effects of Drugs|physiological effects of drugs
321856|NCT02227368|Fibrinolytic Agents|fibrinolytic agents
321857|NCT02227368|Crardiovascular Agents|crardiovascular agents
321858|NCT02227355|Parkinson's Disease|parkinson's disease
321859|NCT02227355|Neupro®|neupro®
321860|NCT02227355|Rotigotine|rotigotine
321861|NCT02227355|Transdermal patch|transdermal patch
321862|NCT02227355|NEUPART|neupart
321863|NCT02227355|Levodopa|levodopa
321864|NCT02227355|Noninterventional|noninterventional
321865|NCT02227355|Combination therapy|combination therapy
321866|NCT02227329|Home Parenteral Nutrition|home parenteral nutrition
321867|NCT02227329|Infection Prevention|infection prevention
321868|NCT02227329|CRBSI|crbsi
321869|NCT02227329|Ethanol Lock Therapy|ethanol lock therapy
321870|NCT02227316|Uterine Fibroid Embolization|uterine fibroid embolization
321871|NCT02227316|Pain|pain
321872|NCT02227316|UFE|ufe
321873|NCT02227316|Fibroids|fibroids
321874|NCT02227316|Adenomyosis|adenomyosis
321875|NCT02227316|Bleeding|bleeding
321876|NCT02227316|IV Acetaminophen|iv acetaminophen
321877|NCT02227316|IV Ibuprofen|iv ibuprofen
321878|NCT02227316|Menorrhagia|menorrhagia
321879|NCT02227316|Leiomyoma|leiomyoma
321880|NCT02227316|Patient Satisfaction|patient satisfaction
321881|NCT02227290|Tinea Corporis|tinea corporis
321882|NCT02227290|Ringworm|ringworm
321883|NCT02227277|HIV|hiv
321884|NCT02227277|HIV-1|hiv-1
321885|NCT02227277|Pegintron|pegintron
321886|NCT02227277|Peg-IFN-α2b|peg-ifn-α2b
321887|NCT02227277|Viral suppression|viral suppression
321888|NCT02227277|ART cessation|art cessation
321889|NCT02227277|Immune function|immune function
321890|NCT02227277|Innate immunity|innate immunity
321891|NCT02227277|Toxicity|toxicity
321892|NCT02227277|Immune-based therapy|immune-based therapy
321893|NCT02227277|Treatment interruption|treatment interruption
321894|NCT02227277|HIV Cure|hiv cure
321895|NCT02227277|HIV Eradication|hiv eradication
321896|NCT02227277|BEAT-HIV|beat-hiv
321897|NCT02227277|HIV Cure Trial|hiv cure trial
321898|NCT02227277|Cure Trial|cure trial
321899|NCT02227264|Primary hyperparathyroidism|primary hyperparathyroidism
321900|NCT02227264|Calcimimetic Agents|calcimimetic agents
321901|NCT02227264|Parathyroid adenomectomy|parathyroid adenomectomy
321902|NCT02227251|Diffuse large B-cell Lymphoma|diffuse large b-cell lymphoma
321903|NCT02227251|DLBCL|dlbcl
321904|NCT02227251|Karyopharm|karyopharm
321905|NCT02227251|KPT-330|kpt-330
321906|NCT02227251|selinexor|selinexor
321907|NCT02227238|integrase inhibitor|integrase inhibitor
321908|NCT02227238|non-inferiority|non-inferiority
321909|NCT02227238|dolutegravir|dolutegravir
321910|NCT02227238|lopinavir/ritonavir|lopinavir/ritonavir
321911|NCT02227238|second-line treatment|second-line treatment
321912|NCT02227238|HIV-1|hiv-1
321913|NCT02227238|antiretroviral therapy-experienced|antiretroviral therapy-experienced
321914|NCT02227225|Postoperative Delirium|postoperative delirium
321915|NCT02227186|Influenza vaccination rates|influenza vaccination rates
321916|NCT02227147|Neurotrophic Keratitis|neurotrophic keratitis
400518|NCT01866514|Intraosseous Vascular Access|intraosseous vascular access
400519|NCT01866501|Intraosseous Vascular Access|intraosseous vascular access
411400|NCT01817712|IPS|ips
321917|NCT02227108|pediatric cancer,pediatric acute lymphoblastic leukemia, lymphoblastic lymphoma, B-cell leukemia, ALL, moxetumomab pasudotox, CD22|pediatric cancer,pediatric acute lymphoblastic leukemia, lymphoblastic lymphoma, b-cell leukemia, all, moxetumomab pasudotox, cd22
321918|NCT02227082|radiotherapy|radiotherapy
321919|NCT02227082|olaparib|olaparib
321920|NCT02227082|breast cancer|breast cancer
321921|NCT02227082|locally advanced breast cancer|locally advanced breast cancer
321922|NCT02227056|Acquired pediatric brain injury|acquired pediatric brain injury
321923|NCT02227056|Methylphenidate|methylphenidate
321924|NCT02227056|Traumatic brain injury|traumatic brain injury
321925|NCT02227056|Cerebrovascular event|cerebrovascular event
321926|NCT02227056|Hypoxic ischemic brain injury|hypoxic ischemic brain injury
321927|NCT02227056|Function (ecologic)|function (ecologic)
321928|NCT02227004|MRI|mri
321929|NCT02227004|Magnetic Resonance Imaging|magnetic resonance imaging
321930|NCT02227004|pacemakers|pacemakers
321931|NCT02227004|ICD|icd
321932|NCT02226965|PNT2258|pnt2258
321933|NCT02226965|DLBCL|dlbcl
321934|NCT02226965|Diffuse Large B-cell Lymphoma|diffuse large b-cell lymphoma
321935|NCT02226965|NHL|nhl
321936|NCT02226965|Non-Hodgkin's Lymphoma|non-hodgkin's lymphoma
321937|NCT02226965|Lymphoma|lymphoma
321938|NCT02226913|Buffered|buffered
321939|NCT02226913|inferior alveolar nerve block|inferior alveolar nerve block
321940|NCT02226913|irreversible pulpitis|irreversible pulpitis
321941|NCT02226913|local anesthesia|local anesthesia
321942|NCT02226913|sodium bicarbonate|sodium bicarbonate
321943|NCT02226900|Multivessel Coronary Artery Disease|multivessel coronary artery disease
321944|NCT02226900|Hybrid Revascularization|hybrid revascularization
321945|NCT02226887|Loop ileostomy|loop ileostomy
321946|NCT02226887|Eventration|eventration
321947|NCT02226874|Dose Estimation|dose estimation
321948|NCT02226874|Dose Reconstruction|dose reconstruction
321949|NCT02226874|Methods|methods
321950|NCT02226874|Fallout|fallout
321951|NCT02226874|Radiation Exposure|radiation exposure
321952|NCT02226861|Acute Lymphoblastic Leukemia (ALL)|acute lymphoblastic leukemia (all)
321953|NCT02226861|MDS|mds
321954|NCT02226861|Chronic Myelogenous Leukemia (CML)|chronic myelogenous leukemia (cml)
321955|NCT02226861|Chronic Lymphocytic Leukemia (CLL)|chronic lymphocytic leukemia (cll)
321956|NCT02226861|Acute Myelogenous Leukemia (AML)|acute myelogenous leukemia (aml)
321957|NCT02226848|Endothelial Progenitor Cells|endothelial progenitor cells
321958|NCT02226848|Angiogenesis|angiogenesis
321959|NCT02226848|Traumatic Brain Injury|traumatic brain injury
321960|NCT02226835|OCT|oct
321961|NCT02226835|Alzheimer's Disease|alzheimer's disease
321962|NCT02226835|Age-Related Macular Degeneration (AMD)|age-related macular degeneration (amd)
321963|NCT02226822|Type 2 diabetes mellitus|type 2 diabetes mellitus
321964|NCT02226809|Muscle relaxants|muscle relaxants
321965|NCT02226809|Postoperative complications, respiratory|postoperative complications, respiratory
321966|NCT02226809|General anesthesia|general anesthesia
321967|NCT02226809|Postanesthesia care unit|postanesthesia care unit
321968|NCT02226809|Neuromuscular block reversal|neuromuscular block reversal
321969|NCT02226796|Broca's Aphasia|broca's aphasia
321970|NCT02226796|Transcranial Direct Current Stimulation|transcranial direct current stimulation
321971|NCT02226783|Phase I|phase i
321972|NCT02226783|Healthy subjects|healthy subjects
321973|NCT02226783|PK|pk
321974|NCT02226783|PD|pd
321975|NCT02226757|NSCLC|nsclc
321976|NCT02226757|HER2-expression|her2-expression
321977|NCT02226757|EGFR-mutation|egfr-mutation
321978|NCT02226757|Trastuzumab|trastuzumab
321979|NCT02226757|Paclitaxel|paclitaxel
321980|NCT02226744|breathing|breathing
321981|NCT02226744|mind-body practices|mind-body practices
321982|NCT02226744|yoga|yoga
321983|NCT02226744|meditation|meditation
321984|NCT02226731|Immediate postpartum hemorrhage|immediate postpartum hemorrhage
321985|NCT02226731|Intrauterine balloon tamponade|intrauterine balloon tamponade
321986|NCT02226705|Rhinocerebral Mucormycosis|rhinocerebral mucormycosis
321987|NCT02226705|Surgery|surgery
321988|NCT02226705|Fungal Infection|fungal infection
321989|NCT02226705|Survival|survival
321990|NCT02226692|chronic low back pain|chronic low back pain
321991|NCT02226692|prognostic factors|prognostic factors
321992|NCT02226692|disabling low back pain|disabling low back pain
321993|NCT02226692|lumbar muscle activity|lumbar muscle activity
321994|NCT02226692|start back screening tool|start back screening tool
321995|NCT02226692|physical evaluation|physical evaluation
321996|NCT02226679|crossover|crossover
321997|NCT02226679|rollover study|rollover study
321998|NCT02226679|open label|open label
321999|NCT02226666|MRI|mri
322000|NCT02226666|Eovist|eovist
322001|NCT02226666|MultiHance|multihance
322002|NCT02226601|drowsiness|drowsiness
322003|NCT02226601|loopiness|loopiness
322004|NCT02226601|nausea|nausea
322005|NCT02226575|Sense of coherence|sense of coherence
322006|NCT02226549|hepatitis C|hepatitis c
322007|NCT02226549|Gilead|gilead
322008|NCT02226549|GS-9451|gs-9451
322009|NCT02226536|Posture|posture
322010|NCT02226536|Vertigo|vertigo
322011|NCT02226536|glucose metabolism|glucose metabolism
322012|NCT02226536|diet|diet
322013|NCT02226536|scales|scales
322014|NCT02226536|dinamic posturography|dinamic posturography
322015|NCT02226523|immunomagnetic reduction|immunomagnetic reduction
322016|NCT02226523|acute coronary syndrome|acute coronary syndrome
322017|NCT02226523|serum biomarkers|serum biomarkers
322018|NCT02226484|Gastroesophageal reflux disease|gastroesophageal reflux disease
322019|NCT02226484|GERD|gerd
322020|NCT02226484|Acid reflux|acid reflux
322021|NCT02226484|Reflux|reflux
322022|NCT02226484|Quercetin|quercetin
322023|NCT02226458|Autism|autism
322024|NCT02226458|Mitochondrial Disorders|mitochondrial disorders
322025|NCT02226458|EPI-743|epi-743
322026|NCT02226458|EPI743|epi743
322027|NCT02226458|Rett syndrome|rett syndrome
322028|NCT02226458|Angelman syndrome|angelman syndrome
322029|NCT02226445|Adults|adults
322030|NCT02226445|Outpatients|outpatients
322031|NCT02226432|Barthel Scale|barthel scale
322032|NCT02226432|Disability|disability
322033|NCT02226432|Modified Ashworth Scale|modified ashworth scale
322034|NCT02226432|Right Arm|right arm
322035|NCT02226432|Neuromodulation|neuromodulation
322036|NCT02226432|Spasticity|spasticity
322037|NCT02226432|Stroke|stroke
322038|NCT02226419|Fatty acid oxidation disorder|fatty acid oxidation disorder
322039|NCT02226419|Primary carnitine deficiency|primary carnitine deficiency
322040|NCT02226419|Exercise|exercise
322041|NCT02226419|L-carnitine treatment|l-carnitine treatment
322042|NCT02226419|Stable isotopes|stable isotopes
322043|NCT02226419|Carnitine transporter deficiency|carnitine transporter deficiency
322044|NCT02226406|Early Physical Exercise|early physical exercise
322045|NCT02226406|Alveolar Recruitment|alveolar recruitment
322046|NCT02226406|Electrical Impedance Tomography|electrical impedance tomography
322047|NCT02226406|Oxygenation|oxygenation
322048|NCT02226406|Ventilation|ventilation
322049|NCT02226393|Toddlers; Preschoolers; PTSD|toddlers; preschoolers; ptsd
322050|NCT02226367|prazosin|prazosin
322051|NCT02226367|alcohol use disorders|alcohol use disorders
322052|NCT02226367|posttraumatic stress disorder|posttraumatic stress disorder
322053|NCT02226367|PTSD|ptsd
322054|NCT02226367|combat trauma|combat trauma
322055|NCT02226367|military|military
322056|NCT02226367|alpha-1 adrenoreceptor antagonist|alpha-1 adrenoreceptor antagonist
322057|NCT02226354|Dietary vegetable oil|dietary vegetable oil
322058|NCT02226354|Stearidonic acid|stearidonic acid
322059|NCT02226354|Tissue|tissue
322060|NCT02226354|Fatty Acid|fatty acid
322061|NCT02226354|composition|composition
322062|NCT02226341|Lupus|lupus
322063|NCT02226341|Lupus Nephritis|lupus nephritis
322064|NCT02226341|ACTHar|acthar
322065|NCT02226341|Columbia|columbia
322066|NCT02226341|Rheumatology|rheumatology
322067|NCT02226341|CUMC|cumc
322068|NCT02226341|Autoimmune|autoimmune
322069|NCT02226341|SLE|sle
322070|NCT02226341|Proliferative Lupus Nephritis|proliferative lupus nephritis
322071|NCT02226315|noninvasive prenatal testing|noninvasive prenatal testing
322072|NCT02226302|Endometrial cancer|endometrial cancer
322073|NCT02226302|Obesity|obesity
322074|NCT02226289|bevacizumab|bevacizumab
322075|NCT02226289|refractory|refractory
322076|NCT02226289|colorectal cancer|colorectal cancer
322077|NCT02226289|metastatic|metastatic
322078|NCT02226263|Necrotizing enterocolitis|necrotizing enterocolitis
322079|NCT02226263|Probiotics|probiotics
322080|NCT02226263|Preterm newborns|preterm newborns
322081|NCT02226250|sugar-based beverage|sugar-based beverage
322082|NCT02226250|Time Influence|time influence
322083|NCT02226237|urinary incontinence|urinary incontinence
322084|NCT02226237|erectile dysfunction|erectile dysfunction
322085|NCT02226237|Retropubic Prostatectomy|retropubic prostatectomy
322086|NCT02226237|Physiotherapy|physiotherapy
322087|NCT02226224|gastrointestinal neoplasms|gastrointestinal neoplasms
322088|NCT02226224|endosonography|endosonography
322089|NCT02226224|in vitro|in vitro
322090|NCT02226224|Staging|staging
322091|NCT02226198|LDL-C|ldl-c
322092|NCT02226198|HoFH|hofh
322093|NCT02226198|Hyperlipidemia|hyperlipidemia
322094|NCT02226172|Primary myelofibrosis|primary myelofibrosis
322095|NCT02226172|Secondary myelofibrosis|secondary myelofibrosis
322096|NCT02226172|PMF|pmf
322097|NCT02226172|PET-MF|pet-mf
322098|NCT02226172|PPV-MF|ppv-mf
322099|NCT02226172|Ruxolitinib resistant or intolerant|ruxolitinib resistant or intolerant
322100|NCT02226172|previously treated myelofibrosis|previously treated myelofibrosis
322101|NCT02226172|smoothened inhibitor|smoothened inhibitor
322102|NCT02226172|oral|oral
322103|NCT02226172|single agent.|single agent.
322104|NCT02226159|cervical|cervical
322105|NCT02226159|radicular pain|radicular pain
322106|NCT02226159|transforaminal epidural steroid injections|transforaminal epidural steroid injections
322107|NCT02226146|Pemphigoid Bullous|pemphigoid bullous
322108|NCT02226146|Bullous|bullous
322109|NCT02226146|Blisters|blisters
322110|NCT02226146|SKIN DISEASES|skin diseases
322111|NCT02226146|BP|bp
322112|NCT02226120|LCZ696|lcz696
322113|NCT02226120|chronic heart failure|chronic heart failure
322114|NCT02226120|ARNI|arni
322115|NCT02226120|Congestive heart failure (CHF)|congestive heart failure (chf)
322116|NCT02226120|heart failure (HF)|heart failure (hf)
322117|NCT02226120|acute heart failure syndrome|acute heart failure syndrome
322118|NCT02226120|congestive cardiac failure (CCF)|congestive cardiac failure (ccf)
322119|NCT02226107|Lay health worker|lay health worker
322120|NCT02226107|Patient navigation|patient navigation
322121|NCT02226107|Screening colonoscopy|screening colonoscopy
322122|NCT02226107|Colon cancer|colon cancer
322123|NCT02226107|Training|training
322124|NCT02226107|Hispanic|hispanic
322125|NCT02226107|Latino|latino
322126|NCT02226094|intra-ocular pressure|intra-ocular pressure
322127|NCT02226094|primary open-angle glaucoma|primary open-angle glaucoma
322128|NCT02226094|intra ocular pressure|intra ocular pressure
322129|NCT02226094|primary open angle glaucoma|primary open angle glaucoma
322130|NCT02226094|glaucoma|glaucoma
322131|NCT02226094|deep wave trabeculoplasty|deep wave trabeculoplasty
322132|NCT02226094|ocular hypertension|ocular hypertension
322133|NCT02226081|breast lesion|breast lesion
322134|NCT02226081|ultrasound|ultrasound
322135|NCT02226081|BI-RADS|bi-rads
322136|NCT02226081|women|women
322137|NCT02226081|malignancy|malignancy
322138|NCT02226068|Atopic dermatitis|atopic dermatitis
322139|NCT02226068|Ciclosporine|ciclosporine
322140|NCT02226068|Extracorporal photopheresis|extracorporal photopheresis
322141|NCT02226055|Chronic kidney disease of unknown origin|chronic kidney disease of unknown origin
322142|NCT02226055|Chronic kidney disease of unknown aetiology|chronic kidney disease of unknown aetiology
322143|NCT02226055|Sri Lanka|sri lanka
322144|NCT02226055|CKDu|ckdu
322145|NCT02226055|Arterial stiffness|arterial stiffness
322146|NCT02226055|Cardiovascular risk|cardiovascular risk
322147|NCT02226055|North Central Province|north central province
322148|NCT02226029|MRI, fat fraction, stomach, lipid emulsion|mri, fat fraction, stomach, lipid emulsion
322149|NCT02226016|ptosis|ptosis
322150|NCT02226016|blepharochalasis|blepharochalasis
322151|NCT02226016|dermatochalasis|dermatochalasis
322152|NCT02225990|stroke|stroke
322153|NCT02225990|stroke rehabilitation|stroke rehabilitation
322154|NCT02225990|stroke therapy|stroke therapy
322155|NCT02225964|APOEε4|apoeε4
322156|NCT02225938|Intensive Care|intensive care
322157|NCT02225938|Recovery|recovery
322158|NCT02225938|Long term outcome|long term outcome
322159|NCT02225938|Function|function
322160|NCT02225925|brachytherapy|brachytherapy
322161|NCT02225886|Renal anaemia|renal anaemia
322162|NCT02225886|Intravenous ascorbic acid|intravenous ascorbic acid
322163|NCT02225886|Intravenous iron administration|intravenous iron administration
322164|NCT02225860|ADPKD|adpkd
322165|NCT02225860|Copeptin|copeptin
322166|NCT02225860|Vasopressin|vasopressin
322167|NCT02225860|Diet|diet
322168|NCT02225860|Water|water
322169|NCT02225847|Gardening|gardening
322170|NCT02225847|Therapeutic Horticulture|therapeutic horticulture
322171|NCT02225847|Functional Magnetic Resonance Imaging|functional magnetic resonance imaging
322172|NCT02225847|Psychometric Assessment|psychometric assessment
322173|NCT02225847|Stress|stress
322174|NCT02225847|Depression|depression
322175|NCT02225847|Anxiety|anxiety
322176|NCT02225847|Quality of Life|quality of life
322177|NCT02225847|Wellness|wellness
322178|NCT02225834|Atorvastatin, ischemic stroke, cytokines|atorvastatin, ischemic stroke, cytokines
322179|NCT02225821|Implant Removal|implant removal
322180|NCT02225821|Antibiotic Prophylaxis|antibiotic prophylaxis
322181|NCT02225821|Postoperative wound infection|postoperative wound infection
322182|NCT02225821|Orthopedics|orthopedics
322183|NCT02225808|CBT|cbt
322184|NCT02225808|autism|autism
322185|NCT02225808|anxiety|anxiety
322186|NCT02225808|treatment|treatment
322187|NCT02225808|fMRI|fmri
322188|NCT02225795|Crohn's Disease|crohn's disease
322189|NCT02225795|Hematopoietic stem cell transplantation|hematopoietic stem cell transplantation
322190|NCT02225795|Children|children
322191|NCT02225795|Young Adults|young adults
322192|NCT02225782|Alteplase; Hemodialysis Catheter; Occlusion; Renal Failure|alteplase; hemodialysis catheter; occlusion; renal failure
322193|NCT02225769|fever|fever
322194|NCT02225769|point-of-care tests|point-of-care tests
322195|NCT02225769|clinical algorithms|clinical algorithms
322196|NCT02225769|electronic support|electronic support
322197|NCT02225769|host biomarkers|host biomarkers
322198|NCT02225756|Drug therapy|drug therapy
322199|NCT02225756|Prevention and control|prevention and control
322200|NCT02225756|Healing|healing
322201|NCT02225756|Tissue regeneration|tissue regeneration
322202|NCT02225756|Therapy|therapy
322203|NCT02225743|Hypothermia|hypothermia
322204|NCT02225743|Total Hip Joint Prosthesis|total hip joint prosthesis
322205|NCT02225743|Total Knee Joint Prosthesis|total knee joint prosthesis
322206|NCT02225717|Preterm labor|preterm labor
322207|NCT02225717|cervicovaginal secretions|cervicovaginal secretions
322208|NCT02225717|markers of fetal membranes remodelling|markers of fetal membranes remodelling
322209|NCT02225717|Multiplex test|multiplex test
322210|NCT02225691|type 1 diabetes|type 1 diabetes
322211|NCT02225691|type 2 diabetes|type 2 diabetes
411754|NCT01816100|MEG|meg
322212|NCT02225691|paired testing|paired testing
322213|NCT02225678|healthy volunteers|healthy volunteers
322214|NCT02225678|asthma|asthma
322215|NCT02225678|sputum eosinophils|sputum eosinophils
322216|NCT02225639|ADHD|adhd
322217|NCT02225639|Adult|adult
322218|NCT02225613|Cruciate ligament injury|cruciate ligament injury
322219|NCT02225613|Balance control|balance control
322220|NCT02225613|Rehabilitation|rehabilitation
322221|NCT02225613|Spa therapy|spa therapy
322222|NCT02225613|Sport|sport
322223|NCT02225600|Borderline Personality Disorder|borderline personality disorder
322224|NCT02225600|BPD|bpd
322225|NCT02225600|Intranasal oxytocin|intranasal oxytocin
322226|NCT02225574|Leukemia|leukemia
322227|NCT02225574|Advanced phase chronic myeloid leukemia|advanced phase chronic myeloid leukemia
322228|NCT02225574|refractory chronic phase chronic myeloid leukemia|refractory chronic phase chronic myeloid leukemia
322230|NCT02225574|Accelerated phase|accelerated phase
322231|NCT02225574|(AP)|(ap)
322232|NCT02225574|Blast phase|blast phase
322233|NCT02225574|(BP)|(bp)
322234|NCT02225574|Philadelphia-positive acute leukemia|philadelphia-positive acute leukemia
322235|NCT02225574|MEK-162|mek-162
322236|NCT02225574|Nilotinib|nilotinib
322237|NCT02225574|AMN107|amn107
322238|NCT02225574|Tasigna|tasigna
322239|NCT02225574|Questionnaires|questionnaires
322240|NCT02225574|Surveys|surveys
322241|NCT02225561|Cardiopulmonary resuscitation|cardiopulmonary resuscitation
322242|NCT02225561|Nitroprusside|nitroprusside
322243|NCT02225561|Transthoracic|transthoracic
322244|NCT02225561|Impedances|impedances
322245|NCT02225535|low back pain|low back pain
322246|NCT02225535|telehealth|telehealth
322247|NCT02225535|videoconferencing|videoconferencing
322248|NCT02225535|access to physical therapy|access to physical therapy
322249|NCT02225535|interprofessional care|interprofessional care
322250|NCT02225535|rural health|rural health
322251|NCT02225522|Intensive Care Units, Neonatal|intensive care units, neonatal
322252|NCT02225522|Infant, Newborn|infant, newborn
322253|NCT02225522|Genetic Diseases, Inborn|genetic diseases, inborn
322254|NCT02225509|Thyroid cancer|thyroid cancer
322255|NCT02225509|Thyroid cancer diagnostic|thyroid cancer diagnostic
322256|NCT02225509|Thyroid nodule|thyroid nodule
322257|NCT02225509|Fine needle aspiration biopsy|fine needle aspiration biopsy
322258|NCT02225509|Indeterminate cytological result|indeterminate cytological result
322259|NCT02225509|Molecular diagnostic|molecular diagnostic
322260|NCT02225509|Transcriptomics|transcriptomics
322261|NCT02225509|Molecular signature|molecular signature
322262|NCT02225496|Oropharyngeal cancer|oropharyngeal cancer
322263|NCT02225496|Oropharynx|oropharynx
322264|NCT02225496|Human papilloma virus|human papilloma virus
322265|NCT02225496|HPV positive|hpv positive
322266|NCT02225496|Squamous cell carcinoma|squamous cell carcinoma
322268|NCT02225496|Transoral robotic surgery|transoral robotic surgery
322269|NCT02225496|TORS|tors
322270|NCT02225496|Intuitive Surgical da Vinci Surgical System|intuitive surgical da vinci surgical system
322271|NCT02225496|Modified barium swallow|modified barium swallow
322272|NCT02225496|MBS|mbs
322273|NCT02225496|Questionnaires|questionnaires
322274|NCT02225496|Surveys|surveys
322275|NCT02225496|Speech and swallowing function|speech and swallowing function
322276|NCT02225470|Locally Recurrent or Metastatic Breast Cancer|locally recurrent or metastatic breast cancer
322277|NCT02225457|insulin resistance|insulin resistance
322278|NCT02225457|type 2 diabetes|type 2 diabetes
322279|NCT02225457|obesity|obesity
322280|NCT02225457|polyphenols|polyphenols
322281|NCT02225457|adipose tissue|adipose tissue
322282|NCT02225457|overfeeding|overfeeding
322283|NCT02225444|degenerative lumbosacral spine disease|degenerative lumbosacral spine disease
322284|NCT02225444|posterolateral fusion evaluation|posterolateral fusion evaluation
322285|NCT02225444|OsteoAMP|osteoamp
322286|NCT02225444|autograft|autograft
322287|NCT02225431|Contrast-induced nephropathy|contrast-induced nephropathy
322288|NCT02225431|Contrast-Induced acute kidney injury|contrast-induced acute kidney injury
322289|NCT02225431|Contrast media|contrast media
322290|NCT02225431|Angiography|angiography
322291|NCT02225431|Coronary percutaneous intervention|coronary percutaneous intervention
322292|NCT02225418|Laparoscopic|laparoscopic
322293|NCT02225418|Cholecystectomy|cholecystectomy
322294|NCT02225418|Postoperative|postoperative
322295|NCT02225418|Pain|pain
322296|NCT02225418|Quadratus lumborum|quadratus lumborum
322297|NCT02225418|Ultrasound|ultrasound
322298|NCT02225392|Bronchial thermoplasty|bronchial thermoplasty
322299|NCT02225392|Severe asthma|severe asthma
322300|NCT02225379|Type 1 Diabetes|type 1 diabetes
322301|NCT02225379|Hypoglycemia detection|hypoglycemia detection
322302|NCT02225379|Non-invasive sensor|non-invasive sensor
322303|NCT02225379|Nocturnal hypoglycemia|nocturnal hypoglycemia
322304|NCT02225366|Melanoma|melanoma
322305|NCT02225366|Metastatic|metastatic
322306|NCT02225366|Antimicrobial peptide|antimicrobial peptide
322307|NCT02225366|LL37|ll37
322308|NCT02225366|Photographs|photographs
322309|NCT02225353|Preterm birth|preterm birth
411890|NCT01815580|HIV|hiv
322310|NCT02225353|Short cervix|short cervix
322311|NCT02225353|Cervical Pessaries|cervical pessaries
322312|NCT02225353|Progesterone|progesterone
322313|NCT02225314|Parkinson's Disease|parkinson's disease
322314|NCT02225314|Mild Cognitive Impairment|mild cognitive impairment
322315|NCT02225301|Child maltreatment|child maltreatment
322316|NCT02225301|Child Care|child care
322317|NCT02225301|Knowledge|knowledge
322318|NCT02225301|Attitude|attitude
322319|NCT02225288|Healthy Subjects|healthy subjects
322320|NCT02225288|Japanese|japanese
322321|NCT02225288|Males|males
322322|NCT02225262|Prostate cancer|prostate cancer
322323|NCT02225262|CyberKnife|cyberknife
322324|NCT02225262|Stereotactic|stereotactic
322325|NCT02225262|Radiation|radiation
322326|NCT02225236|executive functioning|executive functioning
322327|NCT02225236|metacognition|metacognition
322328|NCT02225236|self-regulation|self-regulation
322329|NCT02225236|preschoolers|preschoolers
322330|NCT02225223|metastatic lesions|metastatic lesions
322331|NCT02225223|vertebral body|vertebral body
322332|NCT02225223|ablation|ablation
322333|NCT02225223|radiation|radiation
322334|NCT02225223|targeted radio-frequency ablation|targeted radio-frequency ablation
322335|NCT02225223|radio-frequency targeted vertebral augmentation|radio-frequency targeted vertebral augmentation
322336|NCT02225223|radiofrequency kyphoplasty|radiofrequency kyphoplasty
322337|NCT02225223|spine|spine
322338|NCT02225223|vertebral augmentation|vertebral augmentation
322339|NCT02225223|kyphoplasty|kyphoplasty
322340|NCT02225223|spinal ablation|spinal ablation
322341|NCT02225223|pain|pain
322342|NCT02225223|quality of life|quality of life
322343|NCT02225223|spinal tumors|spinal tumors
322344|NCT02225210|Dexmedetomidine ,Delirium ,Haemodynamic, Mechanical ventilation|dexmedetomidine ,delirium ,haemodynamic, mechanical ventilation
322345|NCT02225197|Perioptic|perioptic
322346|NCT02225197|Stereotactic|stereotactic
322347|NCT02225197|Radiation|radiation
322348|NCT02225197|Benign brain tumor|benign brain tumor
322349|NCT02225197|Optic apparatus|optic apparatus
322350|NCT02225184|Opioid Dependence|opioid dependence
322351|NCT02225184|OPRM1|oprm1
322352|NCT02225184|Outcome|outcome
322353|NCT02225184|Treatment|treatment
322354|NCT02225171|Assisted Reproductive Technology|assisted reproductive technology
322355|NCT02225171|Behavior|behavior
322356|NCT02225171|Health Care Provider|health care provider
322357|NCT02225171|Ethical Concerns|ethical concerns
322358|NCT02225171|Decision Making|decision making
322359|NCT02225158|Immunity|immunity
322360|NCT02225158|Co-Infection|co-infection
322361|NCT02225158|Parasite|parasite
322362|NCT02225158|Mycobacteria|mycobacteria
322363|NCT02225145|Bone Marrow Transplant|bone marrow transplant
322364|NCT02225145|Fertility|fertility
322365|NCT02225145|Ovary|ovary
322366|NCT02225132|Hydroxyurea|hydroxyurea
322367|NCT02225132|Sickle Cell Disease|sickle cell disease
322368|NCT02225132|Fetal Hemoglobin Induction|fetal hemoglobin induction
322369|NCT02225119|Retinal Images|retinal images
322370|NCT02225119|Retinal Pigment Epithelium|retinal pigment epithelium
322371|NCT02225106|Dopamine Receptors|dopamine receptors
322372|NCT02225106|Methylphenidate|methylphenidate
322373|NCT02225106|Traumatic Brain Injury|traumatic brain injury
322374|NCT02225106|C-11 Raclopride|c-11 raclopride
322375|NCT02225106|Dopamine Release|dopamine release
322376|NCT02225093|Safety|safety
322377|NCT02225093|Dextromethorphan|dextromethorphan
322378|NCT02225093|CYP2D6|cyp2d6
322379|NCT02225093|Phase 1|phase 1
322380|NCT02225093|Prostate cancer|prostate cancer
322381|NCT02225093|CYP1A2|cyp1a2
322382|NCT02225093|Pharmacokinetics|pharmacokinetics
322383|NCT02225093|Drug-drug interactions|drug-drug interactions
322384|NCT02225093|Caffeine|caffeine
322385|NCT02225093|Enzalutamide|enzalutamide
322386|NCT02225067|Patients|patients
322387|NCT02225067|Volunteers|volunteers
322388|NCT02225054|duration of analgesia|duration of analgesia
322389|NCT02225041|intensive care|intensive care
322390|NCT02225041|critical care|critical care
322391|NCT02225041|child|child
322392|NCT02225041|family|family
322393|NCT02225041|survivors|survivors
322394|NCT02225028|physical activity|physical activity
322395|NCT02225028|physical fitness|physical fitness
322396|NCT02225028|exercise program|exercise program
322397|NCT02225028|telephone coaching|telephone coaching
322398|NCT02225028|motivational counseling|motivational counseling
322399|NCT02225028|stretching|stretching
322400|NCT02225028|fitness improvement|fitness improvement
322401|NCT02225028|exercise coaching|exercise coaching
322402|NCT02225028|toning|toning
322403|NCT02225028|SCI|sci
322404|NCT02225028|spinal cord injury|spinal cord injury
322405|NCT02225028|home-based|home-based
322406|NCT02225028|home exercise|home exercise
322407|NCT02225015|Cancer|cancer
322408|NCT02225015|Breast cancer|breast cancer
322409|NCT02225015|Ovarian cancer|ovarian cancer
322410|NCT02225015|BRCA Mutation|brca mutation
322411|NCT02225015|BRCA1 Gene Mutation|brca1 gene mutation
322412|NCT02225015|BRCA2 Gene Mutation|brca2 gene mutation
322413|NCT02225015|Telephone genetic counselling|telephone genetic counselling
322414|NCT02225015|Cancer prevention|cancer prevention
322415|NCT02225002|relapsed|relapsed
322416|NCT02225002|refractory to standard therapy|refractory to standard therapy
322417|NCT02225002|no effective therapy exists|no effective therapy exists
322418|NCT02224976|exercise training|exercise training
322419|NCT02224963|Aging,|aging,
322420|NCT02224963|Macular Degeneration,|macular degeneration,
322421|NCT02224963|Preparation for Future Care,|preparation for future care,
322422|NCT02224963|Psychological Well-being,|psychological well-being,
322423|NCT02224963|Problem Solving|problem solving
322424|NCT02224963|Prevention|prevention
322425|NCT02224963|Mental Health Promotion|mental health promotion
322426|NCT02224950|Atopic dermatitis|atopic dermatitis
322427|NCT02224950|eczema|eczema
322428|NCT02224950|alternative therapy|alternative therapy
322429|NCT02224950|complementary therapy|complementary therapy
322430|NCT02224950|moisturizer|moisturizer
322431|NCT02224937|Melatonin|melatonin
322432|NCT02224937|Cognitive parameters|cognitive parameters
322433|NCT02224937|pharmacodynamic|pharmacodynamic
322434|NCT02224937|pharmacokinetics|pharmacokinetics
322435|NCT02224924|Experimental: autologous blood patch injection (ABPI)|experimental: autologous blood patch injection (abpi)
322436|NCT02224924|Experimental: BioSentry (formerly known as Bio-Seal) hydrogel Tract Plug|experimental: biosentry (formerly known as bio-seal) hydrogel tract plug
322437|NCT02224924|14-141|14-141
322438|NCT02224911|focal therapy|focal therapy
322439|NCT02224911|prostate cancer treatment|prostate cancer treatment
322440|NCT02224911|laser treatment|laser treatment
322441|NCT02224885|Interventional radiology|interventional radiology
322442|NCT02224885|Lung|lung
322443|NCT02224885|Liver|liver
322444|NCT02224885|Confocal endomicroscopy|confocal endomicroscopy
322445|NCT02224885|Optical biopsy|optical biopsy
322446|NCT02224885|Scanner|scanner
322447|NCT02224885|Fluoroscopy|fluoroscopy
322449|NCT02224885|Computed Tomography|computed tomography
322450|NCT02224885|Radiofrequency Ablation|radiofrequency ablation
322451|NCT02224885|Fluorescein|fluorescein
322452|NCT02224872|bone marrow transplant|bone marrow transplant
322453|NCT02224872|thymoglobulin|thymoglobulin
322454|NCT02224872|cyclophosphamide|cyclophosphamide
322455|NCT02224872|fludarabine|fludarabine
322456|NCT02224872|tacrolimus|tacrolimus
322457|NCT02224872|Mycophenolic Acid Mofetil|mycophenolic acid mofetil
322458|NCT02224872|chemotherapy|chemotherapy
322459|NCT02224872|GVHD|gvhd
322460|NCT02224872|haploidentical|haploidentical
322461|NCT02224833|appropriateness|appropriateness
322462|NCT02224833|elderly|elderly
322463|NCT02224833|polypharmacy|polypharmacy
322464|NCT02224833|primary care|primary care
322465|NCT02224820|transplantation|transplantation
322466|NCT02224820|sensitised patients|sensitised patients
322467|NCT02224820|HLA-antibodies|hla-antibodies
322468|NCT02224807|breast cancer|breast cancer
322469|NCT02224807|diet|diet
322470|NCT02224807|exercise|exercise
322471|NCT02224807|weight loss|weight loss
322472|NCT02224794|abdominal|abdominal
322473|NCT02224794|aortic|aortic
322474|NCT02224794|aneurysm|aneurysm
322475|NCT02224755|Heart Failure|heart failure
322476|NCT02224755|Left Ventricular Assist Device|left ventricular assist device
322477|NCT02224755|Ventricular Dysfunction|ventricular dysfunction
322478|NCT02224755|Cardiomyopathy|cardiomyopathy
322479|NCT02224755|Heart Disease|heart disease
322480|NCT02224755|Cardiovascular Disease|cardiovascular disease
322481|NCT02224755|Heart-assist devices|heart-assist devices
322482|NCT02224755|Thoratec Corporation|thoratec corporation
322483|NCT02224703|Cannabidiol|cannabidiol
322484|NCT02224703|CBD|cbd
322485|NCT02224703|GWP42003-P|gwp42003-p
322486|NCT02224703|Epidiolex|epidiolex
322487|NCT02224690|Cannabidiol|cannabidiol
322488|NCT02224690|CBD|cbd
322489|NCT02224690|Epidiolex|epidiolex
322490|NCT02224690|GWP42003-P|gwp42003-p
322491|NCT02224677|CFM|cfm
322492|NCT02224677|facial asymmetry|facial asymmetry
322493|NCT02224677|skin tag|skin tag
322494|NCT02224677|facial tag|facial tag
322495|NCT02224677|missing ear|missing ear
322496|NCT02224677|small ear|small ear
322497|NCT02224677|anotia|anotia
322498|NCT02224677|microtia|microtia
322499|NCT02224677|epibulbar dermoid|epibulbar dermoid
322500|NCT02224677|coloboma|coloboma
322501|NCT02224677|macrostomia|macrostomia
322502|NCT02224677|lateral cleft|lateral cleft
322503|NCT02224677|infant|infant
322504|NCT02224677|toddler|toddler
322505|NCT02224677|baby|baby
322506|NCT02224677|neurodevelopment|neurodevelopment
322507|NCT02224677|cognition|cognition
322508|NCT02224677|socialization|socialization
322509|NCT02224638|skin ulcers|skin ulcers
322510|NCT02224612|Pediatric Face Masks|pediatric face masks
322511|NCT02224612|children|children
322512|NCT02224599|Immunotherapy|immunotherapy
322513|NCT02224599|TAPA-Pulsed Dendritic Cell Therapy|tapa-pulsed dendritic cell therapy
322514|NCT02224599|Dendritic Cell Therapy|dendritic cell therapy
322515|NCT02224573|Cannabidiol|cannabidiol
322516|NCT02224573|CBD|cbd
322517|NCT02224573|GWP42003-P|gwp42003-p
322518|NCT02224573|GWPCARE5|gwpcare5
322519|NCT02224560|Cannabidiol|cannabidiol
322520|NCT02224560|CBD|cbd
322521|NCT02224560|Epidiolex|epidiolex
322522|NCT02224560|GWP42003-P|gwp42003-p
322523|NCT02224547|non-small cell lung cancer|non-small cell lung cancer
322524|NCT02224547|lung carcinoma|lung carcinoma
322525|NCT02224547|NSCLC|nsclc
322526|NCT02224534|ST elevation myocardial infarction.|st elevation myocardial infarction.
322527|NCT02224534|Ticagrelor|ticagrelor
322528|NCT02224534|Left ventricular remodeling|left ventricular remodeling
322529|NCT02224534|Platelet reactivity|platelet reactivity
322530|NCT02224521|FLAP inhibitor|flap inhibitor
322531|NCT02224521|Chronic Obstructive Pulmonary Disease (COPD)|chronic obstructive pulmonary disease (copd)
322532|NCT02224521|COPD|copd
322533|NCT02224521|Bioavailability|bioavailability
322534|NCT02224469|Brain-Computer Interface|brain-computer interface
322535|NCT02224469|Motor Cortex|motor cortex
322536|NCT02224469|Dorsolateral Prefrontal Cortex|dorsolateral prefrontal cortex
322537|NCT02224469|Quality of Life|quality of life
322538|NCT02224456|Tenofovir disoproxil fumarate|tenofovir disoproxil fumarate
322539|NCT02224456|hepatocellular carcinoma|hepatocellular carcinoma
322540|NCT02224456|chronic hepatitis B|chronic hepatitis b
322541|NCT02224456|Cirrhosis|cirrhosis
322542|NCT02224443|Dexmedetomidine,postoperative cognitive dysfunction|dexmedetomidine,postoperative cognitive dysfunction
322543|NCT02224430|biomarker of relapse|biomarker of relapse
322544|NCT02224430|schizophrenia|schizophrenia
322545|NCT02224430|schizoaffective disorder|schizoaffective disorder
322546|NCT02224430|on-body sensors|on-body sensors
322547|NCT02224430|smartphone|smartphone
322548|NCT02224430|observational|observational
322549|NCT02224417|Diabetes|diabetes
322550|NCT02224417|Treatment medication adherence|treatment medication adherence
322551|NCT02224417|Physical activity|physical activity
322552|NCT02224417|Financial incentives|financial incentives
322553|NCT02224417|Outcome incentives|outcome incentives
322554|NCT02224417|Process incentives|process incentives
322555|NCT02224417|HbA1c|hba1c
322556|NCT02224378|fluid responsiveness|fluid responsiveness
322557|NCT02224378|atrial fibrillation|atrial fibrillation
322558|NCT02224378|passive leg raising|passive leg raising
322559|NCT02224378|central venous pressure|central venous pressure
322560|NCT02224378|valvular heart surgery|valvular heart surgery
322561|NCT02224365|Diabetes|diabetes
322562|NCT02224365|Arterial Stiffness|arterial stiffness
322563|NCT02224365|Blood Pressure|blood pressure
322564|NCT02224365|Endothelial Function|endothelial function
322565|NCT02224365|Body Composition|body composition
322566|NCT02224365|Glycemic Control|glycemic control
322567|NCT02224365|Apples|apples
322568|NCT02224365|Functional Foods|functional foods
322569|NCT02224365|Polyphenols|polyphenols
322570|NCT02224365|Fiber|fiber
322571|NCT02224352|Electric Stimulation|electric stimulation
322572|NCT02224352|Respiration|respiration
322573|NCT02224352|Abdominal wall|abdominal wall
322574|NCT02224352|Lung Diseases|lung diseases
322575|NCT02224352|Respiratory Tract Diseases|respiratory tract diseases
322576|NCT02224352|COPD|copd
322577|NCT02224339|Atherosclerosis|atherosclerosis
322578|NCT02224339|carotid plaque|carotid plaque
322579|NCT02224339|Contrast-enhanced ultrasound|contrast-enhanced ultrasound
322580|NCT02224339|Major Adverse Cardiovascular Events|major adverse cardiovascular events
322581|NCT02224326|Alzheimer´s disease|alzheimer´s disease
322582|NCT02224326|early diagnosis|early diagnosis
322583|NCT02224326|evoked potentials|evoked potentials
322584|NCT02224326|near-infrared spectroscopy|near-infrared spectroscopy
322585|NCT02224313|vaginal cytokine|vaginal cytokine
322586|NCT02224287|Urolithiasis|urolithiasis
322587|NCT02224287|Kidney Stones|kidney stones
322588|NCT02224287|Ureteroscopy|ureteroscopy
322589|NCT02224287|Fluoroscopy|fluoroscopy
322590|NCT02224274|Antiplatelet Therapy|antiplatelet therapy
322591|NCT02224274|Cardiac Arrest|cardiac arrest
322592|NCT02224274|Therapeutic hypothermia|therapeutic hypothermia
322593|NCT02224274|Myocardial infarction (ST-Elevation Myocardial Infarction and Non-ST-Elevation Myocardial Infarction)|myocardial infarction (st-elevation myocardial infarction and non-st-elevation myocardial infarction)
322594|NCT02224261|Axillary web syndrome|axillary web syndrome
322595|NCT02224261|cording|cording
322596|NCT02224261|physical therapy|physical therapy
322597|NCT02224261|breast cancer|breast cancer
322598|NCT02224248|cardiorespiratory fitness|cardiorespiratory fitness
322599|NCT02224248|exercise tolerance|exercise tolerance
322600|NCT02224248|exercise test|exercise test
322601|NCT02224248|health behavior|health behavior
322602|NCT02224248|motor activity|motor activity
322603|NCT02224248|motivation|motivation
322604|NCT02224248|intention|intention
322605|NCT02224248|self-rated health|self-rated health
322606|NCT02224235|Stable angina|stable angina
322607|NCT02224235|PCI|pci
322608|NCT02224235|Percutaneous Coronary Intervention|percutaneous coronary intervention
322609|NCT02224209|Carotid artery stenosis|carotid artery stenosis
400520|NCT01866501|IO Access|io access
322610|NCT02224209|High risk of hyperperfusion|high risk of hyperperfusion
322611|NCT02224209|Staged angioplasty|staged angioplasty
322612|NCT02224209|Routine single-stage stenting|routine single-stage stenting
322613|NCT02224196|manual ventilation|manual ventilation
322614|NCT02224196|pressure-controlled ventilation|pressure-controlled ventilation
322615|NCT02224196|peak airway pressure|peak airway pressure
322616|NCT02224196|antral area|antral area
322617|NCT02224183|low back pain|low back pain
322618|NCT02224183|yoga|yoga
322619|NCT02224183|education|education
322620|NCT02224183|Veterans|veterans
322621|NCT02224183|cost-effectiveness|cost-effectiveness
322622|NCT02224183|military|military
322623|NCT02224183|back pain|back pain
322624|NCT02224170|Dexamethasone|dexamethasone
322625|NCT02224170|Lidocaine|lidocaine
322626|NCT02224170|Quality of Recovery|quality of recovery
322627|NCT02224170|Laparoscopic cholecystectomy|laparoscopic cholecystectomy
322628|NCT02224144|Kidney Transplantation|kidney transplantation
322629|NCT02224144|Calcitriol|calcitriol
322630|NCT02224144|Bone Mineral Density|bone mineral density
322631|NCT02224144|Bone Mass and Strength|bone mass and strength
322632|NCT02224144|Vascular Calcifications|vascular calcifications
322633|NCT02224144|Hyperparathyroidism|hyperparathyroidism
322634|NCT02224144|Parathyroid Hormone|parathyroid hormone
322635|NCT02224131|platelet function test|platelet function test
322636|NCT02224131|stent;|stent;
322637|NCT02224118|Healthy|healthy
322638|NCT02224118|Diabetes Mellitus, Type 2|diabetes mellitus, type 2
322639|NCT02224118|CNTO 3649|cnto 3649
322640|NCT02224092|heart health|heart health
322641|NCT02224092|general well-being|general well-being
322642|NCT02224066|Aortic stenosis|aortic stenosis
322643|NCT02224066|TAVI|tavi
322644|NCT02224066|TAVR|tavr
322645|NCT02224066|Transcatheter aortic valve implantation|transcatheter aortic valve implantation
322646|NCT02224066|Ticagrelor|ticagrelor
322647|NCT02224066|Antiplatelet reactivity|antiplatelet reactivity
322743|NCT02223585|to protein-based|to protein-based
322744|NCT02223585|diet|diet
322648|NCT02224053|oncology, cancer, non small cell lung cancer, anticancer druge, omeprazole, healthy volunteer|oncology, cancer, non small cell lung cancer, anticancer druge, omeprazole, healthy volunteer
322649|NCT02224001|tip plasty|tip plasty
322650|NCT02224001|septal cartilage|septal cartilage
322651|NCT02223988|Patients|patients
322652|NCT02223988|mechanical|mechanical
322653|NCT02223988|ventilation|ventilation
322654|NCT02223988|tracheostomy|tracheostomy
322655|NCT02223975|Spectrum Analysis, vibrational|spectrum analysis, vibrational
322656|NCT02223975|Spectrum Analysis, infrared|spectrum analysis, infrared
322657|NCT02223975|Spectrum Analysis, Raman|spectrum analysis, raman
322658|NCT02223975|Spectrum Analysis|spectrum analysis
322659|NCT02223975|Fourier transform infrared spectroscopy|fourier transform infrared spectroscopy
322660|NCT02223975|Raman probe|raman probe
322662|NCT02223975|Diagnosis|diagnosis
322663|NCT02223975|Cancer|cancer
322664|NCT02223975|Multivariate analysis|multivariate analysis
322665|NCT02223975|Vulval Intraepithelial Neoplasia|vulval intraepithelial neoplasia
322666|NCT02223975|Vulvar Neoplasm|vulvar neoplasm
322667|NCT02223975|Vulva|vulva
322668|NCT02223975|Vulvar Diseases|vulvar diseases
322669|NCT02223962|physical activity|physical activity
322670|NCT02223962|COPD|copd
322671|NCT02223962|activity monitors|activity monitors
322672|NCT02223949|Obesity|obesity
322673|NCT02223949|Labor complications|labor complications
322674|NCT02223949|Induction of labor|induction of labor
322675|NCT02223949|Mechanical cervical ripening|mechanical cervical ripening
322676|NCT02223936|nuchal translucency, neurological developpment, anxiety, depression, prenatal diagnosis, normal karyotype|nuchal translucency, neurological developpment, anxiety, depression, prenatal diagnosis, normal karyotype
322677|NCT02223923|Phase 1|phase 1
322678|NCT02223923|Maximimum tolerated dose|maximimum tolerated dose
322679|NCT02223923|ATR Inhibitor|atr inhibitor
322680|NCT02223923|Radiotherapy|radiotherapy
322681|NCT02223910|brain computer interface|brain computer interface
322682|NCT02223910|neurofeedback|neurofeedback
322683|NCT02223910|functional connectivity|functional connectivity
322684|NCT02223897|Liver transplantation|liver transplantation
322685|NCT02223897|Biliary complication|biliary complication
322686|NCT02223897|mesenchymal stem cells|mesenchymal stem cells
322687|NCT02223884|Malignant melanoma, second-line treatment, docetaxel, carboplatin|malignant melanoma, second-line treatment, docetaxel, carboplatin
322688|NCT02223871|Malaria|malaria
322689|NCT02223871|ACT-451840|act-451840
322690|NCT02223858|Health Status Disparities|health status disparities
322691|NCT02223858|Arthritis|arthritis
322692|NCT02223858|Psychology|psychology
322693|NCT02223858|Pain Management|pain management
322694|NCT02223858|Affect|affect
322695|NCT02223845|Music, Anxiety, IVF|music, anxiety, ivf
322696|NCT02223832|ACT-128800|act-128800
322697|NCT02223832|Safety|safety
322698|NCT02223832|Tolerability|tolerability
322699|NCT02223832|Pharmacokinetics|pharmacokinetics
322700|NCT02223819|Crizotinib|crizotinib
322701|NCT02223819|14-063|14-063
322702|NCT02223806|Postpartum hemorrhage|postpartum hemorrhage
322703|NCT02223806|Uterine tonus assessment|uterine tonus assessment
322704|NCT02223806|Active management of third stage of labor|active management of third stage of labor
322705|NCT02223793|Vascular screening|vascular screening
322706|NCT02223793|Cardiovascular risk factors|cardiovascular risk factors
322707|NCT02223793|Blood pressure|blood pressure
322708|NCT02223793|Lipids|lipids
322709|NCT02223793|Lifestyle|lifestyle
322710|NCT02223793|Identifying unknown risk|identifying unknown risk
322711|NCT02223793|Low socioeconomic status|low socioeconomic status
322712|NCT02223793|low threshold|low threshold
322713|NCT02223780|COPD|copd
322714|NCT02223780|palliative care|palliative care
322715|NCT02223767|TMS|tms
322716|NCT02223767|VR|vr
322717|NCT02223767|Exposure therapy|exposure therapy
322718|NCT02223767|TMS augmentations of exposure therapy|tms augmentations of exposure therapy
322719|NCT02223741|Cerebral palsy|cerebral palsy
322720|NCT02223741|GMFM-66|gmfm-66
322721|NCT02223741|PEDI|pedi
322722|NCT02223702|Aggressive periodontitis|aggressive periodontitis
322723|NCT02223702|amoxicillin|amoxicillin
322724|NCT02223702|metronidazole|metronidazole
322725|NCT02223702|moxifloxacin|moxifloxacin
322726|NCT02223702|nonsurgical periodontal debridement.|nonsurgical periodontal debridement.
322727|NCT02223689|SkinAffix|skinaffix
322728|NCT02223676|Pharmacy|pharmacy
322729|NCT02223676|Length-of-stay|length-of-stay
322730|NCT02223676|Emergency Department|emergency department
322731|NCT02223650|Intermittent Exotropia|intermittent exotropia
322732|NCT02223650|IXT|ixt
322733|NCT02223650|overminus|overminus
322734|NCT02223624|eccentric|eccentric
322735|NCT02223624|exercise|exercise
322736|NCT02223624|heart disease|heart disease
322737|NCT02223624|chronic heart failure|chronic heart failure
322738|NCT02223624|rehabilitation|rehabilitation
322739|NCT02223611|Stage Ⅱ-ⅢA NSCLC S1 capsule Completely resection|stage ⅱ-ⅲa nsclc s1 capsule completely resection
322740|NCT02223598|Lymphoid Hematological Malignancies|lymphoid hematological malignancies
322741|NCT02223585|Gut microbial|gut microbial
322742|NCT02223585|response|response
322745|NCT02223585|challenges|challenges
322746|NCT02223585|population|population
322747|NCT02223533|analgesia|analgesia
322748|NCT02223533|post-operative|post-operative
322749|NCT02223533|wound catheter infusion|wound catheter infusion
322750|NCT02223533|laparoscopic colon surgery|laparoscopic colon surgery
322751|NCT02223520|Staphylococcus aureus|staphylococcus aureus
322752|NCT02223520|Infection|infection
322753|NCT02223520|Colonization|colonization
322754|NCT02223520|Transmission|transmission
322755|NCT02223520|Neonate|neonate
322756|NCT02223468|Intestinal Microbiota|intestinal microbiota
322757|NCT02223468|Liver Transplant|liver transplant
322758|NCT02223468|Acute Rejection|acute rejection
322759|NCT02223468|Infection|infection
322760|NCT02223455|Methicillin-resistant Staphylococcus aureus (MRSA)|methicillin-resistant staphylococcus aureus (mrsa)
322761|NCT02223455|Infection Control (IC)|infection control (ic)
322762|NCT02223455|Hospital-associated infections (HAI)|hospital-associated infections (hai)
322763|NCT02223455|Hand Hygiene (HH)|hand hygiene (hh)
322764|NCT02223455|Compliance|compliance
322765|NCT02223455|Health Care Workers (HCWs)|health care workers (hcws)
322766|NCT02223442|chronic pain|chronic pain
322767|NCT02223442|central analgesic drugs|central analgesic drugs
322768|NCT02223442|adherence to therapy|adherence to therapy
322769|NCT02223442|side effects|side effects
322770|NCT02223442|quality of life|quality of life
322771|NCT02223442|MOR-NRI drugs|mor-nri drugs
322772|NCT02223429|Paternal nurturance|paternal nurturance
322773|NCT02223429|Oxytocin|oxytocin
322774|NCT02223429|Vasopressin|vasopressin
322775|NCT02223429|fMRI|fmri
322776|NCT02223429|Neurobiology|neurobiology
322777|NCT02223416|female|female
322778|NCT02223416|volunteers|volunteers
322779|NCT02223403|Nitrate-rich beetroot juice|nitrate-rich beetroot juice
322780|NCT02223403|heart failure|heart failure
322781|NCT02223403|exercise performance|exercise performance
322782|NCT02223403|oxygen consumption|oxygen consumption
322783|NCT02223390|South Africa|south africa
322784|NCT02223390|HIV|hiv
322785|NCT02223390|Mental health|mental health
322786|NCT02223390|Trauma|trauma
322787|NCT02223390|Women|women
322788|NCT02223351|HSV|hsv
322789|NCT02223351|HIV|hiv
322790|NCT02223351|Herpes|herpes
322791|NCT02223351|volunteers|volunteers
322792|NCT02223351|drug-drug interaction|drug-drug interaction
322793|NCT02223325|Elderly|elderly
322794|NCT02223325|Prognosis|prognosis
322795|NCT02223299|Depression|depression
322796|NCT02223299|SSRI|ssri
322797|NCT02223299|Nutritional Supplements|nutritional supplements
322798|NCT02223299|Beck Depression Scale|beck depression scale
322799|NCT02223299|L-tyrosine|l-tyrosine
322800|NCT02223299|L-tryptophan|l-tryptophan
322801|NCT02223286|Corus CAD|corus cad
322802|NCT02223286|ASGES|asges
322803|NCT02223286|Age/Sex/Gene Expression Score|age/sex/gene expression score
322804|NCT02223286|Gene Expression|gene expression
322805|NCT02223286|GES|ges
322806|NCT02223286|CAD|cad
322807|NCT02223286|CVD|cvd
322808|NCT02223286|CHD|chd
322809|NCT02223286|Precision Medicine|precision medicine
322810|NCT02223286|Clinical Utility|clinical utility
322811|NCT02223286|Coronary Artery Disease|coronary artery disease
322812|NCT02223286|Angina Pectoris|angina pectoris
322813|NCT02223286|Chest Pain|chest pain
322814|NCT02223286|Cardiovascular Disease|cardiovascular disease
322815|NCT02223286|Coronary Heart Disease|coronary heart disease
322816|NCT02223286|UCU-CARD|ucu-card
322817|NCT02223273|stroke,|stroke,
322818|NCT02223273|quality improvement|quality improvement
322819|NCT02223247|solid tumors|solid tumors
322820|NCT02223247|cancer|cancer
322821|NCT02223221|In Vitro Fertilization|in vitro fertilization
322822|NCT02223221|Intracytoplasmic Sperm Injections|intracytoplasmic sperm injections
322823|NCT02223221|Infertility, Female|infertility, female
322824|NCT02223221|Abortion, Habitual|abortion, habitual
322825|NCT02223221|recurrent pregnancy loss|recurrent pregnancy loss
322826|NCT02223221|comprehensive chromosome screening|comprehensive chromosome screening
322827|NCT02223221|preimplantation genetic screening|preimplantation genetic screening
322828|NCT02223221|SNP array|snp array
322829|NCT02223208|PTCL|ptcl
322830|NCT02223208|PTCL-NOS|ptcl-nos
322831|NCT02223208|AITL|aitl
322832|NCT02223208|ALCL|alcl
322833|NCT02223195|Juvenile Idiopathic Arthritis|juvenile idiopathic arthritis
322834|NCT02223195|Saliva|saliva
322835|NCT02223182|Milk Allergy,|milk allergy,
322836|NCT02223182|Viaskin Milk,|viaskin milk,
322837|NCT02223182|Specific Immunotherapy,|specific immunotherapy,
322838|NCT02223182|Epicutaneous ImmunoTherapy (EPIT)|epicutaneous immunotherapy (epit)
322839|NCT02223182|IgE-Mediated Cow's Milk Allergy|ige-mediated cow's milk allergy
322840|NCT02223169|Blood Pressure|blood pressure
322841|NCT02223169|Hypertension|hypertension
322842|NCT02223169|Cardiovascular disease|cardiovascular disease
322843|NCT02223143|Lipid lowering therapy|lipid lowering therapy
322844|NCT02223130|HIV|hiv
322845|NCT02223130|Discrimination|discrimination
322846|NCT02223130|Coping|coping
322847|NCT02223130|Medical Mistrust|medical mistrust
322848|NCT02223130|HIV Outcomes|hiv outcomes
322849|NCT02223130|Cognitive Behavioral Therapy|cognitive behavioral therapy
322850|NCT02223091|complementary therapies|complementary therapies
322851|NCT02223091|consultants|consultants
322852|NCT02223091|medical oncology|medical oncology
322853|NCT02223091|breast-cancer|breast-cancer
322854|NCT02223091|education|education
322855|NCT02223052|CC-486|cc-486
322856|NCT02223052|Oral Azacitidine|oral azacitidine
322857|NCT02223052|Soli Tumor Malignancy|soli tumor malignancy
322858|NCT02223052|Hematological Malignancy|hematological malignancy
322859|NCT02223052|Leukemia|leukemia
322860|NCT02223052|Lymphoma|lymphoma
322861|NCT02223052|Multiple Myeloma|multiple myeloma
322862|NCT02223052|Acute Myeloid Leukemia|acute myeloid leukemia
322863|NCT02223052|Myelodysplastic Syndromes|myelodysplastic syndromes
322864|NCT02223052|Neoplasms|neoplasms
322865|NCT02223052|Melanoma|melanoma
322866|NCT02223052|Breast Cancer|breast cancer
322867|NCT02223052|Metastatic Breast Cancer|metastatic breast cancer
322868|NCT02223052|Non-Small Cell Lung Cancer|non-small cell lung cancer
322869|NCT02223052|Small Cell Lung Cancer|small cell lung cancer
322870|NCT02223052|Renal Cell Carcinoma|renal cell carcinoma
322871|NCT02223052|Glioblastoma Multiforme|glioblastoma multiforme
322872|NCT02223052|Brain Cancer|brain cancer
322873|NCT02223052|Kidney Cancer|kidney cancer
322874|NCT02223052|Lung cancer|lung cancer
322875|NCT02223052|Blood Cancer|blood cancer
322876|NCT02223052|Thyroid Cancer|thyroid cancer
322877|NCT02223052|Bone Cancer|bone cancer
322878|NCT02223052|Bone Metastasis|bone metastasis
322879|NCT02223052|Testicular Cancer|testicular cancer
322880|NCT02223052|Prostate Cancer|prostate cancer
322881|NCT02223052|Bladder Cancer|bladder cancer
322882|NCT02223052|Ovarian Cancer|ovarian cancer
322883|NCT02223052|Skin Cancer|skin cancer
322884|NCT02223052|Cancer general|cancer general
322885|NCT02223052|Survival|survival
322886|NCT02223052|Chemotherapy|chemotherapy
322887|NCT02223052|Targeted Therapy|targeted therapy
322888|NCT02223052|Genitourinary|genitourinary
322889|NCT02223052|MM|mm
322890|NCT02223052|MDS|mds
322891|NCT02223052|AML|aml
322892|NCT02223052|NHL|nhl
322893|NCT02223052|HL|hl
322894|NCT02223052|MBC|mbc
322895|NCT02223052|NSCLC|nsclc
322896|NCT02223052|SCLC|sclc
322897|NCT02223052|GBM|gbm
322898|NCT02223039|Psoriasis|psoriasis
322899|NCT02223039|Dermatology|dermatology
322900|NCT02223039|Monoclonal antibody|monoclonal antibody
322901|NCT02222935|Balance training|balance training
322902|NCT02222935|low back pain|low back pain
322903|NCT02222935|balance test|balance test
322904|NCT02222935|routine back exercise|routine back exercise
322905|NCT02222922|ADC|adc
322906|NCT02222922|PF-06647020|pf-06647020
322907|NCT02222922|solid tumors|solid tumors
322908|NCT02222922|tumors|tumors
322909|NCT02222922|neoplasm metastasis|neoplasm metastasis
322910|NCT02222922|TNBC|tnbc
322911|NCT02222922|triple negative breast cancer|triple negative breast cancer
322912|NCT02222922|NSCLC|nsclc
322913|NCT02222922|non small cell lung cancer|non small cell lung cancer
322914|NCT02222922|advanced metastatic breast cancer|advanced metastatic breast cancer
322915|NCT02222922|ovarian cancer|ovarian cancer
322916|NCT02222922|OVCA|ovca
322917|NCT02222909|Community Based Organization|community based organization
322918|NCT02222909|Reverse Innovation|reverse innovation
322919|NCT02222909|Social Services|social services
322920|NCT02222909|Referral|referral
322921|NCT02222909|Chronic disease|chronic disease
322922|NCT02222870|Influenza|influenza
322923|NCT02222870|Influenza virus vaccine|influenza virus vaccine
322924|NCT02222870|Quadrivalent Influenza Virus Vaccine (No Preservative)|quadrivalent influenza virus vaccine (no preservative)
322925|NCT02222870|Fluzone®|fluzone®
322926|NCT02222857|Acute retinal necrosis|acute retinal necrosis
322927|NCT02222857|Retinal detachment|retinal detachment
322928|NCT02222857|Laser photocoagulation|laser photocoagulation
322929|NCT02222857|Vitrectomy|vitrectomy
322930|NCT02222844|Cancer|cancer
322931|NCT02222844|Colorectal Neoplasms|colorectal neoplasms
322932|NCT02222844|Colon, Sigmoid|colon, sigmoid
322933|NCT02222844|Magnetic Resonance Imaging|magnetic resonance imaging
322934|NCT02222844|General Surgery|general surgery
322935|NCT02222844|Postoperative Complications|postoperative complications
322936|NCT02222831|IVF|ivf
322937|NCT02222831|Embryo Quality|embryo quality
322938|NCT02222831|Time Lapse Culture|time lapse culture
322939|NCT02222831|Preimplantation factor|preimplantation factor
322940|NCT02222805|Cord clamping|cord clamping
322941|NCT02222805|Iron deficiency|iron deficiency
322942|NCT02222805|Anemia|anemia
322943|NCT02222805|Iron|iron
322944|NCT02222805|Hyperbilirubinemia|hyperbilirubinemia
322945|NCT02222805|Jaundice|jaundice
322946|NCT02222805|Neurodevelopment|neurodevelopment
322947|NCT02222792|Staphylococci, Streptococci, P acnes and Gram-negative bacteria|staphylococci, streptococci, p acnes and gram-negative bacteria
322948|NCT02222740|Safety|safety
322949|NCT02222740|Tolerability|tolerability
322950|NCT02222740|Pharmacokinetics|pharmacokinetics
322951|NCT02222714|ischemic stroke|ischemic stroke
322952|NCT02222714|stroke|stroke
322953|NCT02222714|APC|apc
322954|NCT02222714|3K3A|3k3a
322955|NCT02222714|3K3A-APC|3k3a-apc
322956|NCT02222714|activated protein C|activated protein c
322957|NCT02222714|RHAPSODY|rhapsody
322958|NCT02222701|composite|composite
322959|NCT02222701|dental|dental
322960|NCT02222701|longevity|longevity
322961|NCT02222688|cancer|cancer
322962|NCT02222688|CLL|cll
322963|NCT02222662|Massage|massage
322964|NCT02222662|effectiveness|effectiveness
322965|NCT02222662|autism|autism
322966|NCT02222662|parent stress|parent stress
322967|NCT02222649|Elderly|elderly
322968|NCT02222649|vitamin D insufficiency|vitamin d insufficiency
322969|NCT02222649|High dose vitamin D3 supplementation|high dose vitamin d3 supplementation
322970|NCT02222649|Polymorphism of the VDR gene|polymorphism of the vdr gene
322971|NCT02222636|The efficacy and safety of intranasal dexmedetomidine|the efficacy and safety of intranasal dexmedetomidine
322972|NCT02222623|insulin|insulin
322973|NCT02222623|basal|basal
322974|NCT02222623|diabetes|diabetes
322975|NCT02222623|hospital|hospital
322976|NCT02222623|glucose|glucose
322977|NCT02222623|hypoglycemia|hypoglycemia
322978|NCT02222623|glargine|glargine
322979|NCT02222623|NPH|nph
322980|NCT02222623|neutral protamine hagedorn|neutral protamine hagedorn
322981|NCT02222610|Radiation Retinopathy|radiation retinopathy
322982|NCT02222597|head injury|head injury
322983|NCT02222597|infrascanner|infrascanner
322984|NCT02222597|intracranial hemorrhage|intracranial hemorrhage
322985|NCT02222584|inflammatory bowel disease|inflammatory bowel disease
322986|NCT02222584|physical activity|physical activity
322987|NCT02222584|disease activity|disease activity
322988|NCT02222584|quality of life|quality of life
322989|NCT02222558|hypogonadism|hypogonadism
322990|NCT02222558|Gonadal Disorders|gonadal disorders
322991|NCT02222558|Endocrine System Diseases|endocrine system diseases
322992|NCT02222558|Testosterone|testosterone
322993|NCT02222558|Testosterone enanthate|testosterone enanthate
322994|NCT02222558|Testosterone undecanoate|testosterone undecanoate
322995|NCT02222558|Testosterone 17 beta-cypionate|testosterone 17 beta-cypionate
322996|NCT02222558|Methyltestosterone|methyltestosterone
322997|NCT02222558|Androgens|androgens
322998|NCT02222558|Hormones|hormones
322999|NCT02222558|Hormones,|hormones,
323000|NCT02222558|Hormone Substitutes,|hormone substitutes,
323001|NCT02222558|Hormone Antagonists|hormone antagonists
323002|NCT02222558|Physiological Effects of Drugs|physiological effects of drugs
323003|NCT02222558|Pharmacologic Actions|pharmacologic actions
323004|NCT02222558|Therapeutic Uses|therapeutic uses
323005|NCT02222558|Anabolic Agents|anabolic agents
323006|NCT02222558|dihydrotestosterone|dihydrotestosterone
323007|NCT02222545|TMA, aHUS, HSCT-associated TMA, TTP|tma, ahus, hsct-associated tma, ttp
323008|NCT02222532|tetronine|tetronine
323009|NCT02222532|congenital heart disease|congenital heart disease
323010|NCT02222532|cardiopulmonary bypass|cardiopulmonary bypass
323011|NCT02222532|euthyroid sick syndrome|euthyroid sick syndrome
323012|NCT02222519|statins|statins
323013|NCT02222519|nondepolarizing muscle relaxants|nondepolarizing muscle relaxants
323014|NCT02222519|rocuronium|rocuronium
323015|NCT02222519|myalgia|myalgia
323016|NCT02222493|Phase 3|phase 3
323017|NCT02222493|infliximab|infliximab
323018|NCT02222493|rheumatoid arthritis|rheumatoid arthritis
323019|NCT02222480|Patients|patients
323020|NCT02222480|with mild|with mild
323021|NCT02222480|moderate|moderate
323022|NCT02222480|essential|essential
323023|NCT02222441|Palbociclib|palbociclib
323024|NCT02222441|Modafinil|modafinil
323025|NCT02222441|Pioglitazone|pioglitazone
323026|NCT02222441|Pharmacokinetics|pharmacokinetics
323027|NCT02222441|Drug-Drug Interaction Study|drug-drug interaction study
323028|NCT02222441|Healthy Volunteers|healthy volunteers
323029|NCT02222441|CYP3A Inducers|cyp3a inducers
323030|NCT02222415|Muscle mass|muscle mass
323031|NCT02222415|Strength|strength
323032|NCT02222415|Cross-sectional area|cross-sectional area
323033|NCT02222415|Protein|protein
323034|NCT02222402|Quality of Life|quality of life
323035|NCT02222402|Exercise|exercise
323036|NCT02222402|Functional Capacity|functional capacity
323037|NCT02222376|Diabetic ulcer, diabetic foot|diabetic ulcer, diabetic foot
323038|NCT02222363|Phase I|phase i
323039|NCT02222363|Iron chelator|iron chelator
323040|NCT02222363|Refractory advanced solid tumors|refractory advanced solid tumors
323041|NCT02222363|Dose escalation study|dose escalation study
323042|NCT02222363|Safety and tolerability|safety and tolerability
323043|NCT02222363|Tumor response by RECIST 1.1|tumor response by recist 1.1
323044|NCT02222363|Progression-free survival|progression-free survival
323045|NCT02222363|Overall survival Pharmacokinetics|overall survival pharmacokinetics
323046|NCT02222350|type 2 diabetes mellitus|type 2 diabetes mellitus
323047|NCT02222337|behavioral intervention|behavioral intervention
323048|NCT02222337|quality of life|quality of life
323049|NCT02222337|breast cancer|breast cancer
323050|NCT02222337|Latina|latina
323051|NCT02222337|caregiver|caregiver
323052|NCT02222337|PCORI|pcori
323053|NCT02222324|QTc Interval|qtc interval
323255|NCT02221245|Pathway|pathway
323054|NCT02222324|Healthy Subjects|healthy subjects
323056|NCT02222272|chronic myeloid leukemia|chronic myeloid leukemia
323057|NCT02222272|dasatinib|dasatinib
323058|NCT02222272|nilotinib|nilotinib
323059|NCT02222272|tki|tki
323060|NCT02222272|second generation tki|second generation tki
323061|NCT02222272|2nd generation tki|2nd generation tki
323062|NCT02222259|Geriatric Oncology|geriatric oncology
323063|NCT02222259|Quality of Life|quality of life
323064|NCT02222259|Comprehensive Geriatric Assessment|comprehensive geriatric assessment
323065|NCT02222259|Functional Status|functional status
323066|NCT02222259|Chemotherapy|chemotherapy
323067|NCT02222259|Older Adults|older adults
323068|NCT02222246|Sickle Cell Disease|sickle cell disease
323069|NCT02222246|Emergency Department|emergency department
323070|NCT02222246|Vaso-occlusive Crisis|vaso-occlusive crisis
323071|NCT02222246|Pain Management|pain management
323072|NCT02222246|Pilot Project|pilot project
323073|NCT02222207|neovascular Age-related Macular Degeneration|neovascular age-related macular degeneration
323074|NCT02222194|Lung cancer|lung cancer
323075|NCT02222194|Surgery|surgery
323076|NCT02222194|Videomediastinoscopy|videomediastinoscopy
323077|NCT02222181|elderly, medication adherence,pharmaceutical care|elderly, medication adherence,pharmaceutical care
323078|NCT02222155|ANCA-associated vasculitis|anca-associated vasculitis
323079|NCT02222155|complement|complement
323080|NCT02222155|vasculitis|vasculitis
323081|NCT02222155|C5aR|c5ar
323082|NCT02222142|Ischemic heart disease|ischemic heart disease
323083|NCT02222142|Off pump coronary artery bypass graft|off pump coronary artery bypass graft
323084|NCT02222142|Isoflurane|isoflurane
323085|NCT02222142|Propofol|propofol
323086|NCT02222129|Randomized controlled trial|randomized controlled trial
323087|NCT02222129|anesthetics-local|anesthetics-local
323088|NCT02222129|bupivacaine|bupivacaine
323089|NCT02222129|analgesia|analgesia
323090|NCT02222129|Pain, Postoperative|pain, postoperative
323091|NCT02222116|STEMI|stemi
323092|NCT02222116|BMS|bms
323093|NCT02222116|DES|des
323094|NCT02222116|mesh|mesh
323095|NCT02222090|patients with atrial fibrillation (AF) recommend the use of novel oral anticoagulants (NOACs) in patients with non-valvular AF|patients with atrial fibrillation (af) recommend the use of novel oral anticoagulants (noacs) in patients with non-valvular af
323096|NCT02222077|Central blood pressure|central blood pressure
323097|NCT02222077|Ambulatory blood pressure monitoring|ambulatory blood pressure monitoring
323098|NCT02222077|Target-organ damage|target-organ damage
323099|NCT02222077|Adolescents and young adults|adolescents and young adults
323100|NCT02222051|neck pain|neck pain
323101|NCT02222051|chronic pain|chronic pain
323102|NCT02221986|Interdisciplinary rehabilitation|interdisciplinary rehabilitation
323103|NCT02221986|Neurooncology|neurooncology
323104|NCT02221986|Physiotherapy|physiotherapy
764198|NCT00388271|Xatral|xatral
323105|NCT02221986|Occupational therapy|occupational therapy
323106|NCT02221986|Neurorehabilitation|neurorehabilitation
323107|NCT02221986|Glioma|glioma
323108|NCT02221960|Recurrent or metastatic solid tumors, MEDI6383, OX40|recurrent or metastatic solid tumors, medi6383, ox40
323109|NCT02221947|Alzheimer's|alzheimer's
323110|NCT02221947|bryostatin|bryostatin
323111|NCT02221947|PKC epsilon|pkc epsilon
323112|NCT02221934|Pain|pain
323113|NCT02221934|Chronic|chronic
323114|NCT02221934|Amputation|amputation
323115|NCT02221934|Phantom Pain|phantom pain
323116|NCT02221934|Stump Pain|stump pain
323117|NCT02221908|Systolic Blood pressure < 100 mm Hg|systolic blood pressure < 100 mm hg
323118|NCT02221895|postpartum appointment|postpartum appointment
323119|NCT02221895|breastfeeding|breastfeeding
323120|NCT02221895|postpartum contraception|postpartum contraception
323121|NCT02221895|postpartum cervical cancer screening|postpartum cervical cancer screening
323122|NCT02221895|postpartum depression screening|postpartum depression screening
323123|NCT02221856|Conventional orthodontic treatment|conventional orthodontic treatment
323124|NCT02221856|Motion View|motion view
323125|NCT02221843|sun behavior|sun behavior
323126|NCT02221843|immunosuppression|immunosuppression
323127|NCT02221843|skin neoplasms|skin neoplasms
323128|NCT02221843|sunbit|sunbit
323129|NCT02221843|uv sensor|uv sensor
323130|NCT02221843|uv dosimeter|uv dosimeter
323131|NCT02221843|solar radiation|solar radiation
323132|NCT02221843|uv exposition|uv exposition
323133|NCT02221843|uv index|uv index
323134|NCT02221804|Physical Inactivity|physical inactivity
323135|NCT02221804|Skeletal Muscle|skeletal muscle
323136|NCT02221804|Cachexia|cachexia
323137|NCT02221791|Flavan-3-ol|flavan-3-ol
323138|NCT02221791|Flavonoids|flavonoids
323139|NCT02221791|Epicatechin|epicatechin
323140|NCT02221791|Cocoa|cocoa
323141|NCT02221791|Chocolate|chocolate
323142|NCT02221791|Endothelial function|endothelial function
323143|NCT02221791|Bioavailability|bioavailability
323144|NCT02221778|Carcinoma, Hepatocellular|carcinoma, hepatocellular
323145|NCT02221778|SBRT|sbrt
323146|NCT02221765|Obesity|obesity
323147|NCT02221765|Overnutrition|overnutrition
323148|NCT02221765|Nutrition Disorders|nutrition disorders
323149|NCT02221765|Overweight|overweight
323150|NCT02221765|Body Weight|body weight
323151|NCT02221765|Signs and Symptoms|signs and symptoms
323256|NCT02221245|Chemo-naive|chemo-naive
323152|NCT02221752|iron deficiency|iron deficiency
323153|NCT02221752|iron deficiency anemia|iron deficiency anemia
323154|NCT02221752|infant|infant
323155|NCT02221752|pregnancy|pregnancy
323156|NCT02221739|lung cancer|lung cancer
323157|NCT02221739|NSCLC|nsclc
323158|NCT02221739|lung|lung
323159|NCT02221739|cancer|cancer
323160|NCT02221739|radiation|radiation
323161|NCT02221739|immunotherapy|immunotherapy
323162|NCT02221739|metastatic|metastatic
323163|NCT02221726|Healthy|healthy
323164|NCT02221726|JNJ-35685-AAA-G-023|jnj-35685-aaa-g-023
323165|NCT02221726|Placebo|placebo
323166|NCT02221726|Transdermal delivery device system|transdermal delivery device system
323167|NCT02221713|diverticulitis|diverticulitis
323168|NCT02221713|diverticulosis|diverticulosis
323169|NCT02221713|diverticular disease|diverticular disease
323170|NCT02221687|synbiotic formula|synbiotic formula
323171|NCT02221687|infant formula|infant formula
323172|NCT02221687|diarrhea|diarrhea
323173|NCT02221674|Post-surgical pain|post-surgical pain
323174|NCT02221674|Opioid|opioid
323175|NCT02221661|Alzheimer|alzheimer
323176|NCT02221661|cognitive impairment|cognitive impairment
323177|NCT02221661|blood test|blood test
323178|NCT02221648|Back|back
323179|NCT02221648|Pain|pain
323180|NCT02221648|Muscle|muscle
323181|NCT02221635|Schizoaffective Disorder|schizoaffective disorder
323182|NCT02221635|Repetitive transcranial magnetic stimulation (rTMS)|repetitive transcranial magnetic stimulation (rtms)
323183|NCT02221622|Alzheimer's disease|alzheimer's disease
323184|NCT02221622|Mild Cognitive Impairment|mild cognitive impairment
323185|NCT02221622|Dementia|dementia
323186|NCT02221622|Regenerative therapeutic|regenerative therapeutic
323187|NCT02221609|Low Back Pain, Mechanical Low Back Pain, Low Back Ache, Low Backache, Lower Back Pain, Lumbago|low back pain, mechanical low back pain, low back ache, low backache, lower back pain, lumbago
323188|NCT02221596|Vitamin D|vitamin d
323189|NCT02221596|25(OH)D|25(oh)d
323190|NCT02221596|Aerobic training|aerobic training
323191|NCT02221596|Near-infrared spectroscopy|near-infrared spectroscopy
323192|NCT02221596|Diffuse correlation spectroscopy|diffuse correlation spectroscopy
323194|NCT02221583|End stage renal disease|end stage renal disease
323195|NCT02221583|Renal transplant candidate|renal transplant candidate
323196|NCT02221583|Laparoscopic sleeve gastrectomy|laparoscopic sleeve gastrectomy
323197|NCT02221583|Immunosuppressants|immunosuppressants
323198|NCT02221544|Parkinson's disease, rTMS, Freezing of Gait|parkinson's disease, rtms, freezing of gait
323199|NCT02221518|OCD|ocd
323200|NCT02221518|Functional Magnetic Resonance Imaging (fMRI)|functional magnetic resonance imaging (fmri)
323201|NCT02221505|LOP628,|lop628,
323202|NCT02221505|cKit,|ckit,
323203|NCT02221505|ADC,|adc,
323204|NCT02221505|Antibody drug conjugates,|antibody drug conjugates,
323205|NCT02221505|maytansine|maytansine
323206|NCT02221466|diabetes|diabetes
323207|NCT02221466|foot|foot
323208|NCT02221466|wounds|wounds
323209|NCT02221466|nitric oxide|nitric oxide
323210|NCT02221466|endothelium|endothelium
323211|NCT02221466|infection|infection
323212|NCT02221466|biological markers|biological markers
323213|NCT02221466|observational study|observational study
323214|NCT02221466|hyperbaric oxygen|hyperbaric oxygen
323215|NCT02221466|ulcers|ulcers
323216|NCT02221466|cytokines|cytokines
323217|NCT02221466|inflammation|inflammation
323218|NCT02221453|Diabetic Macular Edema|diabetic macular edema
323219|NCT02221453|Ocular Cytokines|ocular cytokines
323220|NCT02221453|Triamcinolone Acetonide|triamcinolone acetonide
323221|NCT02221427|First time mothers|first time mothers
323222|NCT02221427|Labour progression|labour progression
323223|NCT02221427|Prolonged labour|prolonged labour
323224|NCT02221427|Oxytocin|oxytocin
323225|NCT02221427|Mode of delivery|mode of delivery
323226|NCT02221427|Maternal birth outcome|maternal birth outcome
323227|NCT02221427|Neonatal birth outcome|neonatal birth outcome
323228|NCT02221349|Sensitivity|sensitivity
323229|NCT02221336|Bipolar disorder|bipolar disorder
323230|NCT02221336|Daily electronic monitoring|daily electronic monitoring
323231|NCT02221336|Smartphones|smartphones
323232|NCT02221336|Subjective and objective smartphone data|subjective and objective smartphone data
323233|NCT02221336|Feedback loop|feedback loop
323234|NCT02221310|targeted therapy|targeted therapy
323235|NCT02221310|leukemia|leukemia
323236|NCT02221310|MDS|mds
323237|NCT02221310|immune therapy|immune therapy
323238|NCT02221284|Pharmacological therapy|pharmacological therapy
323239|NCT02221258|Rheumatoid Arthritis|rheumatoid arthritis
323240|NCT02221258|Rheumatic Disease|rheumatic disease
323241|NCT02221258|RA|ra
323242|NCT02221258|Stem cell|stem cell
323243|NCT02221258|Cell therapy|cell therapy
323244|NCT02221258|furestem|furestem
323245|NCT02221258|Umbilical cord Blood|umbilical cord blood
323246|NCT02221258|hUCB-MSC|hucb-msc
323247|NCT02221258|UCB-MSC|ucb-msc
323248|NCT02221245|Esophageal cancer|esophageal cancer
323249|NCT02221245|Cancer Stem Cell|cancer stem cell
323250|NCT02221245|CSC|csc
323251|NCT02221245|Wnt|wnt
323252|NCT02221245|Hegdehog|hegdehog
323253|NCT02221245|Notch|notch
323254|NCT02221245|Signaling|signaling
323257|NCT02221232|ZuraPrep|zuraprep
323258|NCT02221232|Antimicrobial|antimicrobial
323259|NCT02221232|Bio-Science Laboratories|bio-science laboratories
323260|NCT02221232|Zurex Pharma|zurex pharma
323261|NCT02221232|Surgical/Patient preoperative skin preparation|surgical/patient preoperative skin preparation
323262|NCT02221219|infant|infant
323263|NCT02221219|brain injury|brain injury
323264|NCT02221219|renal|renal
323265|NCT02221219|indomethacin|indomethacin
323266|NCT02221206|Mini-Screw implant anchorage|mini-screw implant anchorage
323267|NCT02221206|retraction of maxillary incisors|retraction of maxillary incisors
323268|NCT02221180|Bioequivalence|bioequivalence
323269|NCT02221180|Metformin|metformin
323270|NCT02221180|Canagliflozin|canagliflozin
323271|NCT02221180|Healthy|healthy
323272|NCT02221167|breastfeeding|breastfeeding
323273|NCT02221167|donor milk|donor milk
323274|NCT02221167|formula|formula
323275|NCT02221167|exclusive breastfeeding|exclusive breastfeeding
323276|NCT02221167|newborn|newborn
323277|NCT02221154|in vitro fertilization|in vitro fertilization
323278|NCT02221154|ovarian hyperstimulation|ovarian hyperstimulation
323279|NCT02221154|pregnancy|pregnancy
323280|NCT02221115|Google Glass device|google glass device
323281|NCT02221115|Evaluation|evaluation
323282|NCT02221115|patient's|patient's
323283|NCT02221115|response|response
323284|NCT02221115|to new technology|to new technology
323285|NCT02221115|clinical setting|clinical setting
323286|NCT02221102|edoxaban|edoxaban
323287|NCT02221102|aspirin|aspirin
323288|NCT02221102|new oral anticoagulant|new oral anticoagulant
323289|NCT02221102|TIA|tia
323290|NCT02221102|acute minor ischemic stroke|acute minor ischemic stroke
323291|NCT02221089|Effect of Retaron on imparied retinal vascular reactivity after LPS administration in healthy subjects|effect of retaron on imparied retinal vascular reactivity after lps administration in healthy subjects
323292|NCT02221076|Cellvizio|cellvizio
323293|NCT02221076|Endomicroscopy|endomicroscopy
323294|NCT02221076|Robot-assisted procedure|robot-assisted procedure
323295|NCT02221076|Cervix cancer|cervix cancer
323296|NCT02221076|Endocervix cancer|endocervix cancer
323297|NCT02221076|Endometrium cancer|endometrium cancer
323298|NCT02221076|Ovarian cancer|ovarian cancer
323299|NCT02221076|Tubal cancer|tubal cancer
323300|NCT02221076|Colposcopy|colposcopy
323301|NCT02221076|Hysteroscopy|hysteroscopy
323302|NCT02221063|thiamin|thiamin
323303|NCT02221063|thiamin diphosphate|thiamin diphosphate
323304|NCT02221063|beriberi|beriberi
323305|NCT02221063|Cambodia|cambodia
323306|NCT02221063|fish sauce|fish sauce
323307|NCT02221063|fortification|fortification
323308|NCT02221063|pregnancy|pregnancy
323309|NCT02221063|breastfeeding|breastfeeding
323310|NCT02221063|childbearing age|childbearing age
323311|NCT02221037|PaO2/FiO2|pao2/fio2
323312|NCT02221037|Peri-operative lung injury|peri-operative lung injury
323313|NCT02221037|EVLWI|evlwi
323314|NCT02221037|ARDS|ards
323315|NCT02221037|PVPI|pvpi
323316|NCT02221037|SOFA scores|sofa scores
323317|NCT02221037|GSK2862277|gsk2862277
323318|NCT02221037|Oesophagectomy|oesophagectomy
323319|NCT02221024|Peripheral intravenous catheter|peripheral intravenous catheter
323320|NCT02221024|Peripheral intravenous lock|peripheral intravenous lock
323321|NCT02221024|Normal saline|normal saline
323322|NCT02221024|Patency|patency
323323|NCT02221024|Management|management
323324|NCT02221024|of peripheral|of peripheral
323325|NCT02221024|intravenous catheter|intravenous catheter
323326|NCT02221011|Shock wave|shock wave
323327|NCT02221011|Spasticity|spasticity
323328|NCT02221011|Effect|effect
323329|NCT02220998|Hepatitis C|hepatitis c
323330|NCT02220998|HCV|hcv
323331|NCT02220998|cirrhosis|cirrhosis
323332|NCT02220998|Sofosbuvir|sofosbuvir
323333|NCT02220998|Sovaldi|sovaldi
323334|NCT02220998|SOF/VEL|sof/vel
323335|NCT02220998|GS-5816|gs-5816
323336|NCT02220998|GS-7977|gs-7977
323337|NCT02220998|liver|liver
323338|NCT02220998|Treatment naive|treatment naive
323339|NCT02220998|Treatment Experience|treatment experience
323340|NCT02220998|genotype 2|genotype 2
323341|NCT02220972|Epilepsy|epilepsy
323342|NCT02220972|Partial Onset Seizures|partial onset seizures
323343|NCT02220972|Insomnia|insomnia
323344|NCT02220959|morbid obesity surgery|morbid obesity surgery
323345|NCT02220959|walk test|walk test
323346|NCT02220959|exercise|exercise
323347|NCT02220946|Vaginal Electrical Stimulation|vaginal electrical stimulation
323348|NCT02220933|Multiple Sclerosis|multiple sclerosis
323349|NCT02220933|MS|ms
323350|NCT02220933|EDSS|edss
323351|NCT02220920|insulin resistance|insulin resistance
323352|NCT02220907|MT-2412|mt-2412
323353|NCT02220907|MP-513|mp-513
323354|NCT02220907|TA-7284|ta-7284
323355|NCT02220907|Teneligliptin|teneligliptin
323356|NCT02220907|Canagliflozin|canagliflozin
323357|NCT02220894|PD-1|pd-1
323358|NCT02220894|PD1|pd1
323359|NCT02220894|PD-L1|pd-l1
323360|NCT02220894|PDL1|pdl1
323361|NCT02220881|Hallux valgus, Mold making silicone toe separator, Toe separator|hallux valgus, mold making silicone toe separator, toe separator
323362|NCT02220868|HIV|hiv
323363|NCT02220868|HCV|hcv
323364|NCT02220868|DAA|daa
323365|NCT02220829|alpha-blocker|alpha-blocker
323366|NCT02220829|symptomatic urinary problems|symptomatic urinary problems
323367|NCT02220829|radiation therapy|radiation therapy
323368|NCT02220829|prostate cancer|prostate cancer
323369|NCT02220816|Attention|attention
323370|NCT02220816|Competitive|competitive
323371|NCT02220816|Training|training
323372|NCT02220803|Acetazolamide|acetazolamide
323373|NCT02220803|Zonegran|zonegran
323374|NCT02220803|Obstructive Sleep apnea|obstructive sleep apnea
323375|NCT02220803|Apnea|apnea
323376|NCT02220803|Respiration Disorders|respiration disorders
323377|NCT02220803|Sleep Disorders|sleep disorders
323378|NCT02220803|Cardiovascular|cardiovascular
323379|NCT02220803|Hypertension|hypertension
323380|NCT02220803|Carbonic Anhydrase|carbonic anhydrase
323381|NCT02220803|Carbonic Anhydrase Inhibitors|carbonic anhydrase inhibitors
323382|NCT02220803|Enzyme Inhibitors|enzyme inhibitors
323383|NCT02220803|Sulfonamides|sulfonamides
323384|NCT02220803|Therapeutic Uses|therapeutic uses
323385|NCT02220803|Pharmacologic Actions|pharmacologic actions
323386|NCT02220803|Vascular stifness|vascular stifness
323387|NCT02220790|IPFN|ipfn
323388|NCT02220790|Pediatric|pediatric
323389|NCT02220790|Fungal|fungal
323390|NCT02220790|Biomarker Assays|biomarker assays
323391|NCT02220790|Candida|candida
323392|NCT02220790|Pediatric ICU patient|pediatric icu patient
323393|NCT02220777|MTD (Maximum Tolerated Dose)|mtd (maximum tolerated dose)
323394|NCT02220777|Food effect|food effect
323395|NCT02220777|Postmenopausal subjects|postmenopausal subjects
323396|NCT02220777|Vasectomized subjects|vasectomized subjects
323397|NCT02220777|FIH (First In Humans)|fih (first in humans)
323398|NCT02220777|SAD (Single Ascending Dose)|sad (single ascending dose)
323399|NCT02220777|DDI (Drug-Drug Interaction)|ddi (drug-drug interaction)
323400|NCT02220764|prospective study|prospective study
323401|NCT02220764|chipping|chipping
323402|NCT02220764|survival rate|survival rate
323403|NCT02220764|fracture resistance|fracture resistance
323404|NCT02220764|zirconia|zirconia
323405|NCT02220751|Periodontal Attachment Loss|periodontal attachment loss
323406|NCT02220751|Genes|genes
323407|NCT02220751|Saliva|saliva
323408|NCT02220751|Diagnosis|diagnosis
323409|NCT02220738|Alzheimer's Disease|alzheimer's disease
323410|NCT02220725|Andexanet alpha|andexanet alpha
323411|NCT02220725|Anticoagulation|anticoagulation
323412|NCT02220725|Antidote|antidote
323413|NCT02220725|Rivaroxaban|rivaroxaban
323414|NCT02220725|Anti-fXa inhibitor|anti-fxa inhibitor
323415|NCT02220725|PRT4445|prt4445
323416|NCT02220725|Xarelto|xarelto
323417|NCT02220725|Reversal agent|reversal agent
323418|NCT02220712|Aripiprazole|aripiprazole
323419|NCT02220712|Deltoid|deltoid
323420|NCT02220699|Ostoporosis|ostoporosis
323421|NCT02220699|Primary Prevention|primary prevention
323422|NCT02220699|Health Promotion|health promotion
323423|NCT02220699|General Practice|general practice
323424|NCT02220699|Secondary screening|secondary screening
323425|NCT02220699|Patients at increased risk of osteoporosis|patients at increased risk of osteoporosis
323426|NCT02220686|VAPOR|vapor
323427|NCT02220686|smoking cessation|smoking cessation
323428|NCT02220686|PAD|pad
323429|NCT02220621|Intrauterine adhesion|intrauterine adhesion
323430|NCT02220621|crosslinked hyaluronan gel|crosslinked hyaluronan gel
323431|NCT02220621|hysteroscopy|hysteroscopy
323432|NCT02220621|clinical trial|clinical trial
323433|NCT02220608|Multiple Myeloma|multiple myeloma
323434|NCT02220608|G-CSF|g-csf
323435|NCT02220608|Bortezomib|bortezomib
323436|NCT02220595|Stenting|stenting
323437|NCT02220595|Endarterectomy|endarterectomy
323438|NCT02220595|Cognition|cognition
323439|NCT02220582|Cardiac Magnetic Resonance (CMR)|cardiac magnetic resonance (cmr)
323440|NCT02220582|Cardiovascular Diseases|cardiovascular diseases
323441|NCT02220582|socio-environmental factors|socio-environmental factors
323442|NCT02220582|Contextual factors|contextual factors
323443|NCT02220543|Cognitive behavioral therapy|cognitive behavioral therapy
323444|NCT02220543|Primary health care|primary health care
323445|NCT02220543|Physical Therapy|physical therapy
323446|NCT02220530|Sedation.|sedation.
323447|NCT02220530|Colonoscopy quality.|colonoscopy quality.
323448|NCT02220530|Scientific and technical quality.|scientific and technical quality.
323449|NCT02220530|Perceived quality (patient's satisfaction).|perceived quality (patient's satisfaction).
323450|NCT02220530|Safety|safety
323451|NCT02220517|MRI/US fusion-guided prostate biopsy|mri/us fusion-guided prostate biopsy
323452|NCT02220517|MR-guided in-bore prostate biopsy|mr-guided in-bore prostate biopsy
323453|NCT02220517|prostate cancer|prostate cancer
323454|NCT02220504|Treatment|treatment
323455|NCT02220504|Maintenance|maintenance
323456|NCT02220478|hip|hip
323457|NCT02220478|Signature|signature
323458|NCT02220465|sedentary|sedentary
323459|NCT02220465|smoking|smoking
323460|NCT02220465|cue reactivity|cue reactivity
323461|NCT02220465|physical activity|physical activity
323462|NCT02220439|rotavirus|rotavirus
323463|NCT02220439|immunogenicity|immunogenicity
323464|NCT02220439|enteric vaccine|enteric vaccine
323465|NCT02220439|vaccine immunogenicity|vaccine immunogenicity
323466|NCT02220439|rotavirus vaccine|rotavirus vaccine
323467|NCT02220439|gut microbiome|gut microbiome
323468|NCT02220439|microbiome|microbiome
323469|NCT02220426|Brown adipose tissue|brown adipose tissue
323470|NCT02220426|Hyperpolarized xenon gas MRI|hyperpolarized xenon gas mri
323471|NCT02220413|Breastmilk|breastmilk
323472|NCT02220413|Lactogenesis|lactogenesis
323473|NCT02220413|Obesity|obesity
323474|NCT02220400|Postoperative cognitive dysfunction|postoperative cognitive dysfunction
323475|NCT02220400|Ketamine|ketamine
323476|NCT02220400|Surgery|surgery
323477|NCT02220387|occupational COPD|occupational copd
323478|NCT02220387|phenotype|phenotype
323479|NCT02220387|genetic|genetic
323480|NCT02220374|Osteoarthritis|osteoarthritis
323481|NCT02220374|Finger|finger
323482|NCT02220374|Supportive|supportive
323483|NCT02220374|Tape|tape
323484|NCT02220374|Pain|pain
323485|NCT02220374|Function|function
323486|NCT02220374|Trial|trial
323487|NCT02220348|Linzess|linzess
323488|NCT02220335|pulmonary hypertension|pulmonary hypertension
323489|NCT02220335|pulmonary arterial denervation|pulmonary arterial denervation
323490|NCT02220335|left heart failure|left heart failure
323491|NCT02220335|6-min walk distance|6-min walk distance
323492|NCT02220322|cortical thickness|cortical thickness
323493|NCT02220322|age|age
323494|NCT02220309|Anxiety|anxiety
323495|NCT02220309|Depression|depression
323496|NCT02220309|Social Anxiety Disorder|social anxiety disorder
323497|NCT02220309|Bipolar disorder II|bipolar disorder ii
323499|NCT02220309|GAD|gad
323500|NCT02220309|Phobia|phobia
323501|NCT02220283|Acute kidney injury,aortic dissection|acute kidney injury,aortic dissection
323502|NCT02220257|diabetes mellitus type 1|diabetes mellitus type 1
323503|NCT02220257|remission, honeymoon|remission, honeymoon
323504|NCT02220257|microangiopathy|microangiopathy
323505|NCT02220244|multiple sclerosis (MS)|multiple sclerosis (ms)
323506|NCT02220244|optic neuritis|optic neuritis
323507|NCT02220244|visual defect|visual defect
323508|NCT02220244|visual loss|visual loss
323509|NCT02220244|relapsing remitting multiple sclerosis (RRMS)|relapsing remitting multiple sclerosis (rrms)
323510|NCT02220244|primary progressive multiple sclerosis (PPMS)|primary progressive multiple sclerosis (ppms)
323511|NCT02220244|secondary progressive multiple sclerosis (SPMS)|secondary progressive multiple sclerosis (spms)
323512|NCT02220231|mediastinal mass, one-lung ventilation, capnothorax, transesophageal echocardiography|mediastinal mass, one-lung ventilation, capnothorax, transesophageal echocardiography
413398|NCT01808677|PBT|pbt
323513|NCT02220218|Healthy|healthy
323514|NCT02220218|Metformin|metformin
323515|NCT02220218|Canagliflozin|canagliflozin
323516|NCT02220218|JNJ-28431754|jnj-28431754
323517|NCT02220205|IUD|iud
323518|NCT02220205|training|training
323519|NCT02220205|simulation|simulation
323520|NCT02220192|cervical neoplasia|cervical neoplasia
323521|NCT02220192|cervix|cervix
323522|NCT02220192|high-grade dysplasia|high-grade dysplasia
323523|NCT02220192|LEEP (loop electrosurgical excision procedure)|leep (loop electrosurgical excision procedure)
323524|NCT02220192|precancerous cells|precancerous cells
323525|NCT02220192|colposcopy|colposcopy
323526|NCT02220166|Celiac Disease|celiac disease
323527|NCT02220166|Gluten|gluten
323528|NCT02220166|Gluten free diet|gluten free diet
323529|NCT02220166|Triticum monococcum|triticum monococcum
323530|NCT02220153|Monoclonal antibody|monoclonal antibody
323531|NCT02220153|subjects|subjects
323532|NCT02220153|First in human|first in human
323533|NCT02220127|Brain|brain
323534|NCT02220127|Neoplasm Micrometastasis|neoplasm micrometastasis
323535|NCT02220127|Gamma Knife Radiosurgery|gamma knife radiosurgery
323536|NCT02220114|Infantile spasms|infantile spasms
323537|NCT02220114|vigabatrin|vigabatrin
323538|NCT02220114|soluble tablets|soluble tablets
323539|NCT02220114|acceptability|acceptability
323540|NCT02220114|adherence|adherence
323541|NCT02220114|pharmacokinetics|pharmacokinetics
323542|NCT02220101|hypothermia|hypothermia
323543|NCT02220101|core temperature|core temperature
323544|NCT02220101|temperature measurement methods|temperature measurement methods
323545|NCT02220088|Hepatocellular Carcinoma|hepatocellular carcinoma
323546|NCT02220088|TACE|tace
323547|NCT02220088|TACE failure|tace failure
323548|NCT02220088|TACE refractoriness|tace refractoriness
323549|NCT02220088|TAI|tai
323550|NCT02220088|Sorafenib|sorafenib
323551|NCT02220075|fiberoptic, LMA, caudal block|fiberoptic, lma, caudal block
323552|NCT02220036|Diabetic nephropathy|diabetic nephropathy
323553|NCT02220036|Renal function|renal function
323554|NCT02220036|Insulin resistance|insulin resistance
323555|NCT02220036|Metabolic profile|metabolic profile
323556|NCT02220036|Serum magnesium level|serum magnesium level
323557|NCT02220010|Post operative pancreatic fistulas|post operative pancreatic fistulas
323558|NCT02220010|Pancreatic stenting|pancreatic stenting
323559|NCT02219997|Cataract|cataract
323560|NCT02219997|Intraocular lens (IOL)|intraocular lens (iol)
323561|NCT02219997|AcrySof|acrysof
323562|NCT02219984|Anticoagulation|anticoagulation
323563|NCT02219984|vitamin K antagonists|vitamin k antagonists
323564|NCT02219984|Warfarin|warfarin
323951|NCT02218320|raltegravir|raltegravir
323565|NCT02219984|low molecular weight heparin|low molecular weight heparin
323566|NCT02219984|fondaparinux|fondaparinux
323567|NCT02219984|antithrombotics|antithrombotics
323568|NCT02219984|Direct oral anticoagulants|direct oral anticoagulants
323569|NCT02219984|dabigatran|dabigatran
323570|NCT02219984|rivaroxaban|rivaroxaban
323571|NCT02219984|apixaban|apixaban
323572|NCT02219984|edoxaban|edoxaban
323573|NCT02219984|atrial fibrillation|atrial fibrillation
323574|NCT02219984|venous thromboembolism|venous thromboembolism
323575|NCT02219971|Healthy|healthy
323576|NCT02219958|Hypertension|hypertension
323577|NCT02219945|pulmonary tuberculosis; electronic nose; diagnostic accuracy|pulmonary tuberculosis; electronic nose; diagnostic accuracy
323578|NCT02219932|Fampridine|fampridine
323579|NCT02219919|Carpal Tunnel Syndrome|carpal tunnel syndrome
323580|NCT02219919|Pain|pain
323581|NCT02219919|Sensitivity|sensitivity
323582|NCT02219919|Pain Thresholds|pain thresholds
323583|NCT02219919|Sensitization|sensitization
323584|NCT02219919|Physical Therapy|physical therapy
323585|NCT02219893|Peritoneal Carcinomatosis|peritoneal carcinomatosis
323586|NCT02219893|Peritoneal Metastasis|peritoneal metastasis
323587|NCT02219893|Colorectal Cancer|colorectal cancer
323588|NCT02219893|Cytoreductive surgery|cytoreductive surgery
323589|NCT02219893|HIPEC|hipec
323590|NCT02219893|Intraperitoneal treatment|intraperitoneal treatment
323591|NCT02219893|Immunotoxin|immunotoxin
323592|NCT02219893|MOC31PE|moc31pe
323593|NCT02219880|Kava|kava
323594|NCT02219880|Anxiety|anxiety
323595|NCT02219880|Generalized Anxiety Disorder|generalized anxiety disorder
323596|NCT02219880|Psychiatric|psychiatric
323597|NCT02219880|Anxiolytic|anxiolytic
323598|NCT02219880|GABA|gaba
323599|NCT02219880|Kavalactones|kavalactones
323600|NCT02219867|ketamine|ketamine
323601|NCT02219867|MDD|mdd
323602|NCT02219841|Obesity, low-calorie diet, exercise, atrial fibrillation|obesity, low-calorie diet, exercise, atrial fibrillation
323603|NCT02219828|pericarditis|pericarditis
323604|NCT02219828|recurrent pericarditis|recurrent pericarditis
323605|NCT02219828|corticosteroids|corticosteroids
323606|NCT02219828|anakinra|anakinra
323607|NCT02219815|Preoperative Care|preoperative care
323608|NCT02219815|Exercise Therapy|exercise therapy
323609|NCT02219815|Cardiac Surgery|cardiac surgery
323610|NCT02219815|Frailty|frailty
764199|NCT00388271|ESWL|eswl
323611|NCT02219802|Coronary artery disease|coronary artery disease
323612|NCT02219802|Acute myocardial infarction|acute myocardial infarction
323613|NCT02219802|Drug-coated balloon|drug-coated balloon
323614|NCT02219802|Drug-eluting stent|drug-eluting stent
323615|NCT02219776|Infection,|infection,
323616|NCT02219776|Proprionbacterium Acne,|proprionbacterium acne,
323617|NCT02219776|Shoulder,|shoulder,
323618|NCT02219776|skin preparation|skin preparation
323619|NCT02219750|premix insuiln, basal-plus insulin|premix insuiln, basal-plus insulin
323620|NCT02219711|MGCD516|mgcd516
323621|NCT02219711|MET|met
323622|NCT02219711|AXL|axl
323623|NCT02219711|RET|ret
323624|NCT02219711|TRK|trk
323625|NCT02219711|NTRK|ntrk
323626|NCT02219711|DDR2|ddr2
323627|NCT02219711|KDR|kdr
323628|NCT02219711|VEGFR|vegfr
323629|NCT02219711|PDGFRA|pdgfra
323630|NCT02219711|KIT|kit
323631|NCT02219711|Tyrosine kinase inhibitor|tyrosine kinase inhibitor
323632|NCT02219711|NSCLC|nsclc
323633|NCT02219711|Non-small cell lung cancer|non-small cell lung cancer
323634|NCT02219711|Head and neck cancer|head and neck cancer
323635|NCT02219711|Renal cell carcinoma|renal cell carcinoma
323636|NCT02219711|Prostate cancer|prostate cancer
323637|NCT02219711|Phase 1|phase 1
323638|NCT02219711|CBL|cbl
323639|NCT02219672|Triptolide wilfordii HIV-1 reservoir acute hiv infection|triptolide wilfordii hiv-1 reservoir acute hiv infection
323640|NCT02219659|sedation strategy|sedation strategy
323641|NCT02219659|mechanical ventilation|mechanical ventilation
323642|NCT02219659|ventilator weaning|ventilator weaning
323643|NCT02219646|T2DM|t2dm
323644|NCT02219646|ED|ed
323645|NCT02219620|creative arts|creative arts
323646|NCT02219620|older adults|older adults
323647|NCT02219620|intervention study|intervention study
323648|NCT02219594|gemstone CT|gemstone ct
323649|NCT02219594|320-detector row spiral CT|320-detector row spiral ct
323650|NCT02219594|optical coherence tomography(OCT)|optical coherence tomography(oct)
323651|NCT02219594|in-stent restenosis|in-stent restenosis
323652|NCT02219594|coronary heart disease|coronary heart disease
323653|NCT02219581|Osteoarthritis|osteoarthritis
323654|NCT02219581|Postoperative pain|postoperative pain
323655|NCT02219581|Total knee arthroplasty|total knee arthroplasty
323656|NCT02219581|Orthopaedics|orthopaedics
323657|NCT02219581|Inflammation|inflammation
323658|NCT02219568|obscure gastrointestinal bleeding, CT enterography|obscure gastrointestinal bleeding, ct enterography
323659|NCT02219555|Carpal tunnel|carpal tunnel
323660|NCT02219542|cytokine Transversus Abdominis Plane Block|cytokine transversus abdominis plane block
323661|NCT02219503|Hepatitis C|hepatitis c
323662|NCT02219503|Chronic Hepatitis C|chronic hepatitis c
323663|NCT02219503|Compensated Cirrhosis|compensated cirrhosis
323664|NCT02219503|Cirrhotic|cirrhotic
323665|NCT02219503|Hepatitis C Genotype 1b|hepatitis c genotype 1b
323666|NCT02219503|Hepatitis C Virus|hepatitis c virus
323667|NCT02219503|Interferon-Free|interferon-free
323668|NCT02219503|Child Pugh A|child pugh a
323669|NCT02219503|Ribavirin-Free|ribavirin-free
323670|NCT02219490|Hepatitis C Genotype 1|hepatitis c genotype 1
323671|NCT02219490|Compensated Cirrhosis|compensated cirrhosis
323672|NCT02219490|Cirrhosis|cirrhosis
323673|NCT02219490|Naive|naive
323674|NCT02219490|Treatment-Experienced|treatment-experienced
323675|NCT02219490|Relapser|relapser
323676|NCT02219490|Null responder|null responder
323677|NCT02219490|Non responder|non responder
323678|NCT02219477|Cirrhosis|cirrhosis
323679|NCT02219477|Hepatitis C|hepatitis c
323680|NCT02219477|Child-Pugh B|child-pugh b
323681|NCT02219477|Hepatitis C Genotype 4|hepatitis c genotype 4
323682|NCT02219477|Interferon-Free|interferon-free
323683|NCT02219477|Hepatitis C Genotype 1|hepatitis c genotype 1
323684|NCT02219477|Chronic Hepatitis C|chronic hepatitis c
323685|NCT02219477|Decompensated Cirrhosis|decompensated cirrhosis
323686|NCT02219477|Hepatitis C Virus|hepatitis c virus
323687|NCT02219464|nasopharyngeal catheter|nasopharyngeal catheter
323688|NCT02219464|nasal cannula|nasal cannula
323689|NCT02219451|Chronic heart failure|chronic heart failure
323690|NCT02219451|exercise training|exercise training
323691|NCT02219451|Sympathetic modulation|sympathetic modulation
323692|NCT02219451|arterial baroreflex control|arterial baroreflex control
323693|NCT02219425|Infertility|infertility
323694|NCT02219425|Endometrium|endometrium
323695|NCT02219425|Endometrial biopsy|endometrial biopsy
323696|NCT02219425|Gene expression|gene expression
323697|NCT02219412|ticagrelor|ticagrelor
323698|NCT02219412|platelet aggregation rate|platelet aggregation rate
323699|NCT02219412|ADP antagonist|adp antagonist
323700|NCT02219412|antiplatelet therapy|antiplatelet therapy
323701|NCT02219399|Pregnancy|pregnancy
323702|NCT02219399|DHA|dha
323703|NCT02219399|Gestational Length|gestational length
323704|NCT02219399|Cognitive Development|cognitive development
323705|NCT02219386|Myofascial pain syndromes,physiotherapy,muscle stretching exercises,neck pain,dry needling|myofascial pain syndromes,physiotherapy,muscle stretching exercises,neck pain,dry needling
323706|NCT02219360|acute|acute
323707|NCT02219360|exacerbation|exacerbation
323708|NCT02219360|chronic obstructive pulmonary disease|chronic obstructive pulmonary disease
323709|NCT02219347|rheumatoid arthritis|rheumatoid arthritis
323710|NCT02219347|biological markers|biological markers
323711|NCT02219347|remission|remission
323712|NCT02219347|ultrasonography|ultrasonography
323713|NCT02219347|microarray|microarray
323714|NCT02219347|survival analysis|survival analysis
323715|NCT02219347|T cell|t cell
323716|NCT02219334|Children|children
323717|NCT02219334|Nasal suction devices|nasal suction devices
323718|NCT02219334|Suctioning|suctioning
323719|NCT02219321|Pain, Opioid dependence, Lidocaine infusion|pain, opioid dependence, lidocaine infusion
323720|NCT02219308|Contraception|contraception
323721|NCT02219308|Pain|pain
323722|NCT02219308|Intrauterine Device|intrauterine device
323723|NCT02219308|Paracervical Block|paracervical block
323724|NCT02219295|SGLT1 (sodium dependent glucose transporter)|sglt1 (sodium dependent glucose transporter)
323725|NCT02219295|Glut-transporters|glut-transporters
323726|NCT02219295|taste receptors genes|taste receptors genes
323727|NCT02219295|sweet taste receptor T1R2T1R3|sweet taste receptor t1r2t1r3
323728|NCT02219295|bitter taste receptors of the hTAS2gene family|bitter taste receptors of the htas2gene family
323729|NCT02219282|laryngeal mask airway, edentulate geriatric patients|laryngeal mask airway, edentulate geriatric patients
323730|NCT02219269|contraception|contraception
323731|NCT02219269|family planning|family planning
323732|NCT02219269|complex medical conditions|complex medical conditions
323733|NCT02219256|Drug therapy|drug therapy
323734|NCT02219243|Social Anxiety Disorder|social anxiety disorder
323735|NCT02219243|Cognitive Training|cognitive training
323736|NCT02219243|Interpretation Modification Program|interpretation modification program
323737|NCT02219204|Acupuncture|acupuncture
323738|NCT02219204|Herbal treatment|herbal treatment
323739|NCT02219191|Puerarin tablet|puerarin tablet
323740|NCT02219191|rheumatoid arthritis|rheumatoid arthritis
323741|NCT02219191|metabolism syndrome|metabolism syndrome
323742|NCT02219165|Paediatrics|paediatrics
323743|NCT02219165|Toxic Shock Syndrome|toxic shock syndrome
323744|NCT02219165|Intravenous human immunoglobulin|intravenous human immunoglobulin
323745|NCT02219165|feasibility|feasibility
323746|NCT02219139|Edentulous|edentulous
323747|NCT02219139|Roxolid|roxolid
323748|NCT02219139|SLAclive surface|slaclive surface
323749|NCT02219139|Titanium/zirconium|titanium/zirconium
323750|NCT02219113|Damage of articular cartilage|damage of articular cartilage
323751|NCT02219113|Cartilage degeneration|cartilage degeneration
323752|NCT02219113|Intraarticular injection|intraarticular injection
323753|NCT02219113|ADRC|adrc
323754|NCT02219113|Adipose-derived regenerative cells|adipose-derived regenerative cells
323755|NCT02219113|Adipose tissue|adipose tissue
323756|NCT02219113|Stem cells|stem cells
323757|NCT02219087|Total knee arthroplasty|total knee arthroplasty
323758|NCT02219087|Total joint arthroplasty|total joint arthroplasty
323759|NCT02219087|Knee replacement|knee replacement
323952|NCT02218320|Isentress|isentress
323760|NCT02219087|Osteoarthritis of the knee|osteoarthritis of the knee
323761|NCT02219061|Measles|measles
323762|NCT02219061|Meningitis C|meningitis c
323763|NCT02219061|waning|waning
323764|NCT02219061|Geometric Mean Titer|geometric mean titer
323765|NCT02219061|China|china
323766|NCT02219048|Asthma|asthma
323767|NCT02219048|Staged withdrawal of background therapy|staged withdrawal of background therapy
323768|NCT02219035|presentation with|presentation with
323769|NCT02219022|Rheumatoid arthritis|rheumatoid arthritis
323770|NCT02219022|Progressive resistance exercise|progressive resistance exercise
323771|NCT02219022|Pain|pain
323772|NCT02219022|Functional capacity|functional capacity
323773|NCT02219022|Quality of life|quality of life
323774|NCT02219022|Muscle strength|muscle strength
323775|NCT02219009|OPC-14597 Digital|opc-14597 digital
323776|NCT02219009|Aripiprazole|aripiprazole
323777|NCT02219009|Medical Information Device #1 System (MIND1)|medical information device #1 system (mind1)
323778|NCT02219009|Treatment Adherence|treatment adherence
323779|NCT02219009|Ingestible Event Marker|ingestible event marker
323780|NCT02218996|Anxiety|anxiety
323781|NCT02218996|Children|children
323782|NCT02218996|Adolescent|adolescent
323783|NCT02218996|Effectiveness|effectiveness
323784|NCT02218996|Outpatient|outpatient
323785|NCT02218983|trauma|trauma
323786|NCT02218983|echo|echo
323787|NCT02218983|echocardiogram|echocardiogram
323788|NCT02218983|ultrasound|ultrasound
323789|NCT02218983|inferior vena cava collapsibility|inferior vena cava collapsibility
323790|NCT02218970|rehabilitation|rehabilitation
323791|NCT02218970|strength training|strength training
323792|NCT02218970|muscle strength|muscle strength
323793|NCT02218970|physical fitness|physical fitness
323794|NCT02218957|Bariatric surgery|bariatric surgery
323795|NCT02218957|Roux-en-Y Gastric Bypass|roux-en-y gastric bypass
323796|NCT02218931|Pre-eclampsia|pre-eclampsia
323797|NCT02218931|Gestational diabetes|gestational diabetes
323798|NCT02218931|Stillbirth|stillbirth
323799|NCT02218931|Small for gestational age|small for gestational age
323800|NCT02218931|Admission to neonatal intensive care unit|admission to neonatal intensive care unit
323801|NCT02218931|Obesity|obesity
323802|NCT02218931|Raised Lipids|raised lipids
323803|NCT02218931|High Blood Pressure|high blood pressure
323804|NCT02218931|Cardiovascular risk|cardiovascular risk
323805|NCT02218931|Insulin resistance|insulin resistance
323806|NCT02218931|Mediterranean dietary pattern|mediterranean dietary pattern
323807|NCT02218931|Dietary interventions|dietary interventions
323808|NCT02218918|Ground walk|ground walk
323809|NCT02218918|treadmill walk|treadmill walk
323810|NCT02218918|Functional walk capacity|functional walk capacity
323811|NCT02218918|COPD|copd
323812|NCT02218918|Quality of Life|quality of life
323813|NCT02218905|Correlation|correlation
323814|NCT02218905|Sit to stand repetitions|sit to stand repetitions
323815|NCT02218905|Anthropometric variables|anthropometric variables
323816|NCT02218905|Age|age
323817|NCT02218905|Height|height
323818|NCT02218905|weight|weight
323819|NCT02218905|Gender|gender
323820|NCT02218905|Regression|regression
323821|NCT02218866|Bariatric surgery|bariatric surgery
323822|NCT02218866|Obesity|obesity
323823|NCT02218866|Neuropathy|neuropathy
323824|NCT02218853|Bipolar disorder|bipolar disorder
323825|NCT02218853|Psychosis|psychosis
323826|NCT02218853|Schizophrenia|schizophrenia
323827|NCT02218840|cigar smoker|cigar smoker
323828|NCT02218840|smoking|smoking
323829|NCT02218840|behavioral pharmacology|behavioral pharmacology
323830|NCT02218840|smoking topography|smoking topography
323831|NCT02218827|Dry Eye|dry eye
323832|NCT02218827|Inflammatory reaction|inflammatory reaction
323833|NCT02218827|steroids|steroids
323834|NCT02218814|Femoral Nerve Block|femoral nerve block
323835|NCT02218814|Adductor Canal Nerve Block|adductor canal nerve block
323836|NCT02218801|Liver metastasis|liver metastasis
323837|NCT02218801|Colorectal carcinoma|colorectal carcinoma
323838|NCT02218801|Unresectable|unresectable
323839|NCT02218801|Borderline resectable|borderline resectable
323840|NCT02218801|Initially unresectable|initially unresectable
323841|NCT02218788|Nasolabial folds|nasolabial folds
323842|NCT02218788|Marionette lines|marionette lines
323843|NCT02218788|Cheek bones|cheek bones
323844|NCT02218788|Jaw lines|jaw lines
323845|NCT02218775|Kappa opioid receptor|kappa opioid receptor
323846|NCT02218775|Mu opioid receptor|mu opioid receptor
323847|NCT02218775|LY2456302|ly2456302
323848|NCT02218775|Anhedonia|anhedonia
323849|NCT02218775|Mood and Anxiety Spectrum Disorders|mood and anxiety spectrum disorders
323850|NCT02218762|Fluticasone propionate/salmeterol in a capsule-based inhaler|fluticasone propionate/salmeterol in a capsule-based inhaler
323851|NCT02218762|replicated cross-over design|replicated cross-over design
323852|NCT02218762|Respiratory|respiratory
323853|NCT02218762|asthma|asthma
323854|NCT02218762|safety|safety
323855|NCT02218762|pharmacokinetics|pharmacokinetics
323856|NCT02218762|Fluticasone propionate/salmeterol|fluticasone propionate/salmeterol
323857|NCT02218762|pharmacodynamics|pharmacodynamics
323953|NCT02218320|dolutegravir|dolutegravir
323954|NCT02218320|Tivicay|tivicay
323858|NCT02218762|Fluticasone propionate/salmeterol in a multi-dose dry powder inhaler|fluticasone propionate/salmeterol in a multi-dose dry powder inhaler
323859|NCT02218736|Anhedonia|anhedonia
323860|NCT02218736|Mood and Anxiety Spectrum Disorders|mood and anxiety spectrum disorders
323861|NCT02218736|CERC-501 (investigational product)|cerc-501 (investigational product)
323862|NCT02218736|Kappa Opioid Receptor (KOR)|kappa opioid receptor (kor)
323863|NCT02218723|healthy volunteer|healthy volunteer
323864|NCT02218723|Asthma|asthma
323865|NCT02218723|inhaled corticosteroid|inhaled corticosteroid
323866|NCT02218723|UD-DPI|ud-dpi
323867|NCT02218723|ELLIPTA DPI|ellipta dpi
323868|NCT02218723|Fluticasone furoate|fluticasone furoate
323869|NCT02218697|Immunogenicity|immunogenicity
323870|NCT02218697|Influsplit Tetra (Fluarix Tetra) 2014/2015 season|influsplit tetra (fluarix tetra) 2014/2015 season
323871|NCT02218697|Safety|safety
323872|NCT02218697|Adults|adults
323873|NCT02218697|Pneumovax 23/Pneumovax|pneumovax 23/pneumovax
323874|NCT02218697|Co-administration|co-administration
323875|NCT02218697|Elderly|elderly
323876|NCT02218697|Seasonal influenza|seasonal influenza
323877|NCT02218697|Pneumococcal infection|pneumococcal infection
323878|NCT02218632|Galactosaemia|galactosaemia
323879|NCT02218632|Dysglycosylation|dysglycosylation
323880|NCT02218632|Diet|diet
323881|NCT02218619|type 1 diabetes (T1D)|type 1 diabetes (t1d)
323882|NCT02218619|endoplasmic reticulum (ER) stress|endoplasmic reticulum (er) stress
323883|NCT02218619|induced pluripotential stem (iPS) cells|induced pluripotential stem (ips) cells
323884|NCT02218619|Tauroursodeoxycholic Acid (TUDCA)|tauroursodeoxycholic acid (tudca)
323885|NCT02218606|Abiraterone Acetate|abiraterone acetate
323886|NCT02218606|CABAZITAXEL|cabazitaxel
323887|NCT02218606|CASTRATION RESISTANT|castration resistant
323888|NCT02218606|14-046|14-046
323889|NCT02218606|Prostate Cancer Clinical Trials Consortium|prostate cancer clinical trials consortium
323890|NCT02218580|massage therapy|massage therapy
323891|NCT02218580|juvenile arthritis|juvenile arthritis
323892|NCT02218580|pain|pain
323893|NCT02218554|BRONJ|bronj
323894|NCT02218528|subjects|subjects
323895|NCT02218515|Autogenous bone graft|autogenous bone graft
323896|NCT02218515|Chronic periodontitis|chronic periodontitis
323897|NCT02218515|Enamel matrix derivatives|enamel matrix derivatives
323898|NCT02218515|Gingival crevicular fluid|gingival crevicular fluid
323899|NCT02218515|Periodontal flap surgery|periodontal flap surgery
323900|NCT02218502|Ovarian cancer|ovarian cancer
323901|NCT02218502|Diagnosis|diagnosis
323902|NCT02218502|Risk of Malignancy Index|risk of malignancy index
323903|NCT02218502|RMI|rmi
323904|NCT02218502|Ultrasound|ultrasound
323905|NCT02218502|Simple ultrasound-based rules|simple ultrasound-based rules
323906|NCT02218502|DW-MRI|dw-mri
323907|NCT02218502|Subjective assessment|subjective assessment
323908|NCT02218489|Pain|pain
323909|NCT02218489|Corticosteroid|corticosteroid
323910|NCT02218489|Meibomian Gland Disease|meibomian gland disease
323911|NCT02218489|Blepharitis|blepharitis
323912|NCT02218489|Eyelid|eyelid
323913|NCT02218489|Ocular Discomfort|ocular discomfort
323914|NCT02218463|Vulvar disease, adhesions, topical therapy|vulvar disease, adhesions, topical therapy
323915|NCT02218463|Labial adhesions prepubertal girls|labial adhesions prepubertal girls
323916|NCT02218463|Labial agglutination|labial agglutination
323917|NCT02218463|Labial fusion|labial fusion
323918|NCT02218437|Mesenchymal Stem Cells (MSC)|mesenchymal stem cells (msc)
323919|NCT02218437|Umbilical Cord|umbilical cord
323920|NCT02218437|thymocyte globulin (ATG)|thymocyte globulin (atg)
323921|NCT02218437|Severe Aplastic Anemia (SAA)|severe aplastic anemia (saa)
323922|NCT02218398|airway resistance|airway resistance
323923|NCT02218398|lung compliance|lung compliance
323924|NCT02218398|Duration of mechanical ventilation|duration of mechanical ventilation
323925|NCT02218385|Nipple Aspirate Fluid|nipple aspirate fluid
323926|NCT02218385|Breast Health Screening|breast health screening
323927|NCT02218385|Cytology|cytology
323928|NCT02218372|Clostridium difficile-associated Diarrhea (CDAD)|clostridium difficile-associated diarrhea (cdad)
323929|NCT02218372|vancomycin|vancomycin
323930|NCT02218372|Clostridium difficile infection|clostridium difficile infection
323931|NCT02218372|fidaxomicin|fidaxomicin
323932|NCT02218359|Gram-negative pneumonia|gram-negative pneumonia
323933|NCT02218359|Aerosol antibiotics|aerosol antibiotics
323934|NCT02218359|Mechanical ventilation|mechanical ventilation
323935|NCT02218359|Amikacin|amikacin
323936|NCT02218359|Fosfomycin|fosfomycin
323937|NCT02218359|Pneumonia, Bacterial|pneumonia, bacterial
323938|NCT02218359|Pneumonia|pneumonia
323939|NCT02218359|Bacterial Infections|bacterial infections
323940|NCT02218359|Lung Diseases|lung diseases
323941|NCT02218359|Respiratory Tract Diseases|respiratory tract diseases
323942|NCT02218359|Respiratory Tract Infections|respiratory tract infections
323943|NCT02218359|Anti-Bacterial Agents|anti-bacterial agents
323944|NCT02218359|Anti-Infective Agents|anti-infective agents
323945|NCT02218359|Therapeutic Uses|therapeutic uses
323946|NCT02218359|Pharmacologic Actions|pharmacologic actions
323947|NCT02218359|MRSA|mrsa
323948|NCT02218346|Healthy volunteers|healthy volunteers
323949|NCT02218320|HIV|hiv
323950|NCT02218320|Gut-associated lymphoid tissue|gut-associated lymphoid tissue
323955|NCT02218320|pharmacodynamics|pharmacodynamics
323956|NCT02218294|BCX4161|bcx4161
323957|NCT02218294|BioCryst|biocryst
323958|NCT02218294|hereditary angioedema|hereditary angioedema
323959|NCT02218294|mass balance|mass balance
323960|NCT02218294|kallikrein inhibitor|kallikrein inhibitor
323961|NCT02218294|ADME|adme
323962|NCT02218268|type I diabetes|type i diabetes
323963|NCT02218268|healthy|healthy
323964|NCT02218268|children|children
323965|NCT02218268|adolescents|adolescents
323966|NCT02218268|young adults|young adults
323967|NCT02218255|In Vitro Fertilization|in vitro fertilization
323968|NCT02218242|Lung|lung
323969|NCT02218242|Cancer|cancer
323970|NCT02218242|Ultrasound|ultrasound
323971|NCT02218242|Staging|staging
323972|NCT02218229|shock wave|shock wave
323973|NCT02218229|carpal tunnel syndrome|carpal tunnel syndrome
323974|NCT02218216|Mild Traumatic Brain Injury|mild traumatic brain injury
323975|NCT02218203|chronic pain|chronic pain
323976|NCT02218203|central neuropathic pain|central neuropathic pain
323977|NCT02218203|spinal cord injury|spinal cord injury
323978|NCT02218203|dextromethorphan|dextromethorphan
323979|NCT02218203|lidocaine|lidocaine
323980|NCT02218203|combination therapy|combination therapy
323981|NCT02218203|analgesia|analgesia
323982|NCT02218190|Alvimopan|alvimopan
323983|NCT02218190|Ileus|ileus
323984|NCT02218190|Posterior spinal fusion|posterior spinal fusion
323985|NCT02218177|wet Age Related Macular Degeneration|wet age related macular degeneration
323986|NCT02218177|Ranibizumab|ranibizumab
323987|NCT02218177|Aflibercept|aflibercept
323988|NCT02218177|Combination Photodynamic Therapy|combination photodynamic therapy
323989|NCT02218177|Cytokine analysis|cytokine analysis
323990|NCT02218164|metastatic|metastatic
323991|NCT02218164|cutaneous|cutaneous
323992|NCT02218164|skin cancer|skin cancer
323993|NCT02218151|Hematopoietic|hematopoietic
323994|NCT02218151|Stem Cell|stem cell
323995|NCT02218151|Transplant|transplant
323996|NCT02218151|patient-centered|patient-centered
414010|NCT01805739|CT|ct
323997|NCT02218151|Microbiota|microbiota
323998|NCT02218151|GVHD|gvhd
323999|NCT02218138|Adolescent|adolescent
324000|NCT02218138|Diabetes|diabetes
324001|NCT02218138|Depression|depression
324002|NCT02218138|Obesity|obesity
324003|NCT02218138|Stress|stress
324004|NCT02218125|Healthy|healthy
324005|NCT02218125|Human immunodeficiency virus type 1 (HIV-1) infection|human immunodeficiency virus type 1 (hiv-1) infection
324006|NCT02218125|Acquired immunodeficiency syndrome (AIDS)|acquired immunodeficiency syndrome (aids)
324007|NCT02218125|recombinant adenovirus (rAd) vector-based vaccines|recombinant adenovirus (rad) vector-based vaccines
324008|NCT02218125|Vaccination|vaccination
324009|NCT02218125|Ad26.ENVA.01|ad26.enva.01
324010|NCT02218125|Recombinant|recombinant
324011|NCT02218125|Modified Vaccinia Ankara (MVA) vector-based vaccines|modified vaccinia ankara (mva) vector-based vaccines
324012|NCT02218112|Blood pressure|blood pressure
324013|NCT02218112|Obesity|obesity
324014|NCT02218112|Glomerular filtration rate|glomerular filtration rate
324015|NCT02218112|Renal Sodium handling|renal sodium handling
324016|NCT02218099|ASP8232|asp8232
324017|NCT02218099|Multiple doses|multiple doses
324018|NCT02218099|Phase 1|phase 1
324019|NCT02218099|Single dose|single dose
324020|NCT02218086|postural control|postural control
324021|NCT02218086|postural balance|postural balance
324022|NCT02218086|slackline|slackline
324023|NCT02218073|Healthy|healthy
324024|NCT02218073|JNJ-42756493|jnj-42756493
324025|NCT02218073|JNJ-61818549|jnj-61818549
324026|NCT02218073|Isotope|isotope
324027|NCT02218047|Pegylated-Proline-interferon alpha-2b (AOP2014)|pegylated-proline-interferon alpha-2b (aop2014)
324028|NCT02218047|Polycythemia Vera|polycythemia vera
324029|NCT02218047|PROUD-PV|proud-pv
324030|NCT02218047|CONTINUATION-PV|continuation-pv
324031|NCT02218047|AOP Orphan|aop orphan
324032|NCT02218047|Polycythemia|polycythemia
324033|NCT02218047|Hematologic Diseases|hematologic diseases
324034|NCT02218047|Myeloproliferative Disorders|myeloproliferative disorders
324035|NCT02218047|Bone Marrow Diseases|bone marrow diseases
324036|NCT02218047|Interferon-alpha|interferon-alpha
324037|NCT02218047|Peginterferon alfa-2b|peginterferon alfa-2b
324038|NCT02218021|Alkermes|alkermes
324039|NCT02218021|ALKS 33|alks 33
324040|NCT02218021|ALKS 5461|alks 5461
324041|NCT02218021|Samidorphan|samidorphan
324042|NCT02218008|Major depressive disorder (MDD)|major depressive disorder (mdd)
324043|NCT02218008|depression|depression
324044|NCT02218008|Alkermes|alkermes
324045|NCT02218008|ALKS 5461|alks 5461
324046|NCT02218008|samidorphan|samidorphan
324047|NCT02217995|Mindfulness-Based Cognitive Therapy|mindfulness-based cognitive therapy
324048|NCT02217995|Mindfulness|mindfulness
324049|NCT02217969|Anesthesia|anesthesia
324050|NCT02217969|Hypotension|hypotension
324051|NCT02217930|TQT|tqt
324052|NCT02217917|Healthy subjects|healthy subjects
324053|NCT02217917|Randomized|randomized
324054|NCT02217917|Double-blind|double-blind
324055|NCT02217917|Single ascending dose|single ascending dose
324056|NCT02217917|Multiple ascending dose|multiple ascending dose
324155|NCT02217358|direct laryngoscopy|direct laryngoscopy
324057|NCT02217878|ST-segment elevation myocardial infarction|st-segment elevation myocardial infarction
324058|NCT02217878|non-ST-segment elevation myocardial infarction|non-st-segment elevation myocardial infarction
324059|NCT02217878|ticagrelor|ticagrelor
324060|NCT02217878|morphine|morphine
324061|NCT02217878|pharmacokinetics|pharmacokinetics
324062|NCT02217878|pharmacodynamics|pharmacodynamics
324063|NCT02217878|drug interactions|drug interactions
324064|NCT02217878|VASP assay|vasp assay
324065|NCT02217878|Multiple Electrode Aggregometry|multiple electrode aggregometry
324066|NCT02217878|VerifyNow|verifynow
324067|NCT02217865|Colorectal Cancer|colorectal cancer
324069|NCT02217865|Curative resection of colorectal cancer|curative resection of colorectal cancer
324070|NCT02217865|Caregivers|caregivers
324071|NCT02217865|Interviews|interviews
324072|NCT02217865|Focus groups|focus groups
324073|NCT02217865|Questionnaires|questionnaires
324074|NCT02217865|Surveys|surveys
324075|NCT02217852|hypertension|hypertension
324076|NCT02217852|Tibetan|tibetan
324077|NCT02217852|Nitrendipine|nitrendipine
324078|NCT02217852|hydrochlorothiazide|hydrochlorothiazide
324079|NCT02217852|captopril|captopril
324080|NCT02217852|Beijing hypotensive No.0|beijing hypotensive no.0
324081|NCT02217774|Computer-Aided Design/instrumentation|computer-aided design/instrumentation
324082|NCT02217774|Cone-Beam Computed Tomography|cone-beam computed tomography
324083|NCT02217774|Dental Implant|dental implant
324084|NCT02217774|MGuide|mguide
324085|NCT02217761|Pharmacokinetics|pharmacokinetics
324086|NCT02217761|Antifungal Agents|antifungal agents
324087|NCT02217735|Parkinson's Disease|parkinson's disease
324088|NCT02217735|Caregivers|caregivers
324089|NCT02217735|Expressive Writing|expressive writing
324090|NCT02217735|Complementary Medicine|complementary medicine
324091|NCT02217735|Cortisol|cortisol
324092|NCT02217696|Electroencephalography (EEG)|electroencephalography (eeg)
764456|NCT00387517|Diastolic|diastolic
324093|NCT02217696|Magnetic Resonance Imaging (MRI)|magnetic resonance imaging (mri)
324094|NCT02217696|Multimodal Neuroimaging|multimodal neuroimaging
324095|NCT02217696|Development|development
324096|NCT02217696|Prediction|prediction
324097|NCT02217696|Intervention|intervention
324098|NCT02217683|Catheterization, Swan-Ganz|catheterization, swan-ganz
324099|NCT02217683|Cardiac Surgical Procedures|cardiac surgical procedures
324100|NCT02217683|Blood Transfusion|blood transfusion
324101|NCT02217683|Nitric Oxide|nitric oxide
324102|NCT02217657|Smart-Touch|smart-touch
324103|NCT02217657|Contact force|contact force
324104|NCT02217605|NAFLD|nafld
324105|NCT02217605|Oral Fructose Challenge|oral fructose challenge
324106|NCT02217605|31P MRS|31p mrs
324107|NCT02217605|Liver|liver
324108|NCT02217605|Subjects|subjects
324109|NCT02217579|Weight loss|weight loss
324110|NCT02217579|Appetite|appetite
324111|NCT02217579|Overweight|overweight
324112|NCT02217579|Obesity|obesity
324113|NCT02217579|Dietary fiber|dietary fiber
324114|NCT02217579|Dietary protein|dietary protein
324115|NCT02217566|Prostatic neoplasms|prostatic neoplasms
324116|NCT02217566|Diethylstilbestrol therapy|diethylstilbestrol therapy
324117|NCT02217566|Abiraterone acetate|abiraterone acetate
324118|NCT02217566|Prednisone|prednisone
324119|NCT02217566|Androgen deprivation therapy|androgen deprivation therapy
324120|NCT02217553|platelet|platelet
324121|NCT02217553|P-selectin|p-selectin
324122|NCT02217553|platelet-fibrinogen binding|platelet-fibrinogen binding
324123|NCT02217553|platelet-monocye aggregate formation|platelet-monocye aggregate formation
324124|NCT02217553|vitamin D|vitamin d
324125|NCT02217540|Shoulder, disability evaluation, physiotherapy modalities|shoulder, disability evaluation, physiotherapy modalities
324126|NCT02217527|crossover|crossover
324127|NCT02217501|peripheral arterial disease, antiplatelet therapy|peripheral arterial disease, antiplatelet therapy
324128|NCT02217462|pregnancy|pregnancy
324129|NCT02217462|gestational weight gain|gestational weight gain
324130|NCT02217462|dietary intake|dietary intake
324131|NCT02217462|food reward|food reward
324132|NCT02217423|Physical Therapy Modalities|physical therapy modalities
324133|NCT02217423|Respiration Disorders|respiration disorders
324134|NCT02217423|Respiratory Therapy|respiratory therapy
324135|NCT02217410|renal, de novo,|renal, de novo,
324136|NCT02217397|Apnea-hyponea Index, CPAP, Obstructive Sleep Apnea, Oral Appliance|apnea-hyponea index, cpap, obstructive sleep apnea, oral appliance
324137|NCT02217384|Microbiome|microbiome
324138|NCT02217384|DNA sequencing|dna sequencing
324139|NCT02217384|Leptin|leptin
324140|NCT02217384|Adiponectin|adiponectin
324141|NCT02217384|Insulin|insulin
324142|NCT02217384|IGF-I|igf-i
324143|NCT02217371|ADHD Patient|adhd patient
324144|NCT02217371|Healthy subjects|healthy subjects
324145|NCT02217371|Sleepiness|sleepiness
324146|NCT02217371|PSG|psg
324147|NCT02217371|MWT|mwt
324148|NCT02217371|EEG|eeg
324149|NCT02217371|cognitive tests|cognitive tests
324150|NCT02217358|squamous cell carcinoma of the head and neck|squamous cell carcinoma of the head and neck
324151|NCT02217358|NBI endoscopy|nbi endoscopy
324152|NCT02217358|videoendoscopy|videoendoscopy
324153|NCT02217358|white light endoscopy|white light endoscopy
324154|NCT02217358|magnifying endoscopy|magnifying endoscopy
324156|NCT02217332|Sinusitis|sinusitis
324157|NCT02217332|Rhinosinusitis|rhinosinusitis
324158|NCT02217332|CRS|crs
324159|NCT02217332|CRSwNP|crswnp
324160|NCT02217332|CSNP-E|csnp-e
324161|NCT02217332|Nasal polyps|nasal polyps
324162|NCT02217332|Nasal polyposis|nasal polyposis
324163|NCT02217332|Eosinophilia|eosinophilia
324164|NCT02217332|Asthma|asthma
324165|NCT02217319|Volatile Anesthetic|volatile anesthetic
324166|NCT02217319|Cardioprotection|cardioprotection
324167|NCT02217319|Lung surgery|lung surgery
324168|NCT02217319|non cardiac surgery|non cardiac surgery
324169|NCT02217293|Pulsed radiofrequency|pulsed radiofrequency
324170|NCT02217293|Ultrasound-guided|ultrasound-guided
324171|NCT02217293|Carpal tunnel syndrome|carpal tunnel syndrome
324172|NCT02217280|Cervical Radiculopathy|cervical radiculopathy
324173|NCT02217267|Peripheral neuropathy|peripheral neuropathy
324174|NCT02217215|Spectroscopy|spectroscopy
324175|NCT02217215|HPV|hpv
324176|NCT02217202|knee replacement|knee replacement
324177|NCT02217202|knee arthroplasty|knee arthroplasty
324178|NCT02217202|revision|revision
324179|NCT02217202|high risk|high risk
324180|NCT02217189|Zinc supplementation.|zinc supplementation.
324181|NCT02217189|Oxidative stress.|oxidative stress.
324182|NCT02217189|Superoxide radical scavengers.|superoxide radical scavengers.
324183|NCT02217189|Asthenospermia.|asthenospermia.
324184|NCT02217189|Oxido-sensitive index.|oxido-sensitive index.
324185|NCT02217137|Dry Eye|dry eye
324186|NCT02217137|Rheumatoid Arthritis|rheumatoid arthritis
324187|NCT02217137|Systemic Lupus Erythematosus|systemic lupus erythematosus
324188|NCT02217137|Tear cytokines and immune response|tear cytokines and immune response
324189|NCT02217124|apple|apple
324190|NCT02217124|high fiber|high fiber
324191|NCT02217124|body composition|body composition
324192|NCT02217124|children|children
324193|NCT02217111|vocal fold nodules|vocal fold nodules
324194|NCT02217111|pediatric|pediatric
324195|NCT02217111|voice therapy|voice therapy
324196|NCT02217111|acoustic|acoustic
324197|NCT02217111|aerodynamic|aerodynamic
324198|NCT02217111|quality of life|quality of life
324199|NCT02217111|Adventures in Voice|adventures in voice
324200|NCT02217098|ART|art
324201|NCT02217098|Occlusal|occlusal
324202|NCT02217098|Occlusoproximal|occlusoproximal
324203|NCT02217098|Primary teeth|primary teeth
324204|NCT02217085|Colorectal Cancer Screening|colorectal cancer screening
324205|NCT02217085|Colon Cancer Screening|colon cancer screening
324206|NCT02217085|Polyps|polyps
324207|NCT02217085|Colonoscopy|colonoscopy
324208|NCT02217072|academic performance|academic performance
324209|NCT02217072|cognitive development|cognitive development
324210|NCT02217072|children in care|children in care
324211|NCT02217072|prevention of school failure|prevention of school failure
324212|NCT02217059|Emergency Medical Services|emergency medical services
324213|NCT02217059|Emergency Care|emergency care
324214|NCT02217059|Hypertension|hypertension
324215|NCT02217059|BpTRU|bptru
324216|NCT02217059|Blood pressure|blood pressure
324217|NCT02217046|Infection|infection
324218|NCT02217046|prevention|prevention
324219|NCT02217046|cardiac devices|cardiac devices
324220|NCT02217033|Breast Cancer|breast cancer
324221|NCT02217033|Stage I breast cancer|stage i breast cancer
324222|NCT02217033|Stage II breast cancer|stage ii breast cancer
324223|NCT02217033|Water study|water study
324224|NCT02217033|'R'|'r'
324225|NCT02217033|Electro-kinetically altered beverage|electro-kinetically altered beverage
324226|NCT02217033|altered beverage|altered beverage
324227|NCT02217033|Insomnia|insomnia
324228|NCT02217033|Fatigue|fatigue
324229|NCT02217033|Depression|depression
324230|NCT02217033|Adjuvant chemotherapy|adjuvant chemotherapy
324231|NCT02217020|Rectal Cancer|rectal cancer
324232|NCT02217020|Locally advanced rectal cancer|locally advanced rectal cancer
324233|NCT02217020|Neoadjuvant|neoadjuvant
324234|NCT02217020|chemotherapy|chemotherapy
324235|NCT02217020|FOLFOXIRI|folfoxiri
324236|NCT02217007|Tourette|tourette
324237|NCT02217007|Tourette's|tourette's
324238|NCT02217007|tic|tic
324239|NCT02216994|Intestinal dysganglinosis|intestinal dysganglinosis
324240|NCT02216994|Hirschsprung disease|hirschsprung disease
324241|NCT02216994|Hirschsprung disease allied disorders|hirschsprung disease allied disorders
324242|NCT02216994|diagnostic scoring system|diagnostic scoring system
324243|NCT02216994|Prospective study|prospective study
324244|NCT02216981|Obsessive Compulsive Disorder (OCD)|obsessive compulsive disorder (ocd)
324245|NCT02216981|Cognitive Behavioural Therapy (CBT)|cognitive behavioural therapy (cbt)
324246|NCT02216981|Intensive therapy|intensive therapy
324247|NCT02216981|Intensive treatment|intensive treatment
324248|NCT02216981|Treatment Resistant|treatment resistant
324249|NCT02216968|vegetables|vegetables
324250|NCT02216968|Head Start|head start
324251|NCT02216968|preschool|preschool
324252|NCT02216968|children|children
324253|NCT02216968|theater|theater
324254|NCT02216968|puppet|puppet
324255|NCT02216942|Endodontics|endodontics
324256|NCT02216942|Deciduous teeth|deciduous teeth
324257|NCT02216942|Iodoform pastes|iodoform pastes
324258|NCT02216942|Treatment Refusal|treatment refusal
324259|NCT02216929|intubation|intubation
324260|NCT02216929|intensive care|intensive care
324261|NCT02216929|withholding treatment|withholding treatment
324262|NCT02216929|cancer|cancer
324263|NCT02216929|terminal care|terminal care
324264|NCT02216929|APACHE|apache
324265|NCT02216903|Atrial fibrillation, sleep apnea|atrial fibrillation, sleep apnea
324266|NCT02216890|Renal Cell Carcinoma|renal cell carcinoma
324267|NCT02216890|Mantle-Cell Lymphoma|mantle-cell lymphoma
324268|NCT02216890|Diffuse, Large B-Cell, Lymphoma|diffuse, large b-cell, lymphoma
324269|NCT02216890|Follicular Lymphoma, Grade 3|follicular lymphoma, grade 3
324270|NCT02216890|Antibody-Drug Conjugate|antibody-drug conjugate
324271|NCT02216890|CD70 Antigen|cd70 antigen
324272|NCT02216890|Drug Therapy|drug therapy
324273|NCT02216877|Chronic Kidney Disease|chronic kidney disease
324274|NCT02216877|Hypomagnesemia|hypomagnesemia
324275|NCT02216851|hyaluronic acid|hyaluronic acid
324276|NCT02216851|no-treatment control|no-treatment control
324277|NCT02216851|enhancement|enhancement
324278|NCT02216812|Finger stiffness|finger stiffness
324279|NCT02216812|Range of motion|range of motion
324280|NCT02216812|Distal radius fracture|distal radius fracture
324281|NCT02216812|Vitamin C|vitamin c
324282|NCT02216799|Parenteral nutrition|parenteral nutrition
324283|NCT02216799|Hyperglycemia|hyperglycemia
324284|NCT02216799|Glargine insulin|glargine insulin
324285|NCT02216799|Regular insulin|regular insulin
324286|NCT02216773|Liver hypertrophy|liver hypertrophy
324287|NCT02216773|Liver resection|liver resection
324288|NCT02216773|Liver metastases|liver metastases
324289|NCT02216773|Portal vein ligation|portal vein ligation
324290|NCT02216773|Portal vein embolization|portal vein embolization
324291|NCT02216773|Radiofrequency splitting|radiofrequency splitting
414390|NCT01804296|TMS|tms
324292|NCT02216760|Monomorphic Ventricular Tachycardia|monomorphic ventricular tachycardia
324293|NCT02216760|Myocardial infarction|myocardial infarction
324294|NCT02216760|Dilated cardiomyopathy|dilated cardiomyopathy
324295|NCT02216760|Catheter ablation|catheter ablation
324296|NCT02216760|Substrate mapping|substrate mapping
324297|NCT02216760|Ripple Conduction channels|ripple conduction channels
324298|NCT02216747|Idiopathic Nephrotic syndrome relapse|idiopathic nephrotic syndrome relapse
324299|NCT02216734|HIV/AIDS|hiv/aids
324300|NCT02216734|Prevention of mother-to-child transmission|prevention of mother-to-child transmission
324301|NCT02216734|Mother support groups|mother support groups
324302|NCT02216734|Retention-in-care|retention-in-care
324303|NCT02216734|Male participation|male participation
324304|NCT02216734|Anti-retroviral treatment|anti-retroviral treatment
324305|NCT02216734|Infants|infants
324306|NCT02216721|bone mineral density|bone mineral density
324307|NCT02216721|bone turnover markers|bone turnover markers
324308|NCT02216721|primary aldosteronism treatment|primary aldosteronism treatment
324309|NCT02216708|Severe malnutrition|severe malnutrition
324310|NCT02216708|severe dehydration|severe dehydration
324311|NCT02216708|cholera|cholera
324312|NCT02216695|acute kidney injury|acute kidney injury
324313|NCT02216695|epidemiology|epidemiology
324314|NCT02216695|mortality|mortality
324315|NCT02216682|Acetaminophen|acetaminophen
324316|NCT02216682|Total knee replacement|total knee replacement
324317|NCT02216682|Numeric rating scale|numeric rating scale
324318|NCT02216669|Solid tumors|solid tumors
324319|NCT02216669|Head and Neck Neoplasms|head and neck neoplasms
324320|NCT02216643|Stroke|stroke
324321|NCT02216643|Ischemic Stroke|ischemic stroke
324322|NCT02216643|Thrombectomy|thrombectomy
324323|NCT02216643|Reperfusion Therapy|reperfusion therapy
324324|NCT02216643|Treatment|treatment
324325|NCT02216630|COPD|copd
324326|NCT02216604|Exercise|exercise
324327|NCT02216604|Pediatric oncology|pediatric oncology
324328|NCT02216604|Physical Performance|physical performance
324329|NCT02216604|Quality of Life|quality of life
324330|NCT02216604|Feasibility|feasibility
324331|NCT02216604|during primary|during primary
324332|NCT02216604|anticancer treatment|anticancer treatment
324333|NCT02216591|HIV|hiv
324334|NCT02216591|Medication Adherence|medication adherence
324335|NCT02216591|Working Memory|working memory
324336|NCT02216578|tyrosine kinase inhibitor|tyrosine kinase inhibitor
324337|NCT02216578|progressed|progressed
324338|NCT02216578|(GIST)|(gist)
324339|NCT02216565|Stroke|stroke
324340|NCT02216565|Endovascular treatment|endovascular treatment
324341|NCT02216565|Tandem carotid occlusions|tandem carotid occlusions
324342|NCT02216565|Fibrinolysis|fibrinolysis
324343|NCT02216552|Pediatrics|pediatrics
324344|NCT02216552|Adolescents|adolescents
324345|NCT02216552|NAFLD|nafld
324346|NCT02216552|Spectroscopy|spectroscopy
324347|NCT02216552|Type 2 diabetes|type 2 diabetes
324348|NCT02216539|All terminal|all terminal
324349|NCT02216539|leading|leading
324350|NCT02216539|indication|indication
324351|NCT02216539|lung transplantation|lung transplantation
324352|NCT02216526|Skin health|skin health
324353|NCT02216526|Nursing|nursing
324354|NCT02216526|Long-term care|long-term care
324355|NCT02216513|subarachnoid hemorrhage|subarachnoid hemorrhage
324356|NCT02216513|SAH|sah
324357|NCT02216513|DFO|dfo
324358|NCT02216513|cerebral autoregulation|cerebral autoregulation
324359|NCT02216513|delayed cerebral ischemia|delayed cerebral ischemia
324360|NCT02216500|Ketogenic Therapy|ketogenic therapy
324361|NCT02216500|Ketogenic Diet|ketogenic diet
324362|NCT02216487|mCRC|mcrc
324363|NCT02216487|colorectal cancer|colorectal cancer
324364|NCT02216448|Arthroscopy skills|arthroscopy skills
324365|NCT02216448|Knee|knee
324366|NCT02216448|Virtual reality|virtual reality
324367|NCT02216448|Simulator|simulator
324368|NCT02216422|Chronic Hepatitis C|chronic hepatitis c
324369|NCT02216422|Hepatitis C|hepatitis c
324370|NCT02216422|Hepatitis C Virus|hepatitis c virus
324371|NCT02216422|Hepatitis C Genotype 1b|hepatitis c genotype 1b
324372|NCT02216422|Interferon-Free|interferon-free
324373|NCT02216396|dementia|dementia
324374|NCT02216396|care home|care home
324375|NCT02216396|agitation|agitation
324376|NCT02216396|coping|coping
324377|NCT02216383|Post partum haemorrhage|post partum haemorrhage
324378|NCT02216383|Active Management of Third Stage of Labour|active management of third stage of labour
324379|NCT02216383|Carbetocin|carbetocin
324380|NCT02216383|Syntocinon|syntocinon
324381|NCT02216383|Syntometrine|syntometrine
324382|NCT02216383|Birth experience|birth experience
324383|NCT02216383|Labour|labour
324384|NCT02216370|Cryptogenic stroke /TIA|cryptogenic stroke /tia
324385|NCT02216370|Atrial Fibrillation|atrial fibrillation
324386|NCT02216370|Implantable Loop Recorder|implantable loop recorder
324387|NCT02216370|Genetic Mutation|genetic mutation
324388|NCT02216357|Samster's triad|samster's triad
324389|NCT02216357|Acetylsalicylic acid triad|acetylsalicylic acid triad
324390|NCT02216357|Widal's triad|widal's triad
324391|NCT02216357|Francis' triad|francis' triad
324392|NCT02216357|Aspirin triad|aspirin triad
324393|NCT02216357|Aspirin-induced asthma and rhinitis (AIAR)|aspirin-induced asthma and rhinitis (aiar)
324394|NCT02216344|Patient safety monitors|patient safety monitors
324395|NCT02216331|tuberculosis|tuberculosis
324396|NCT02216331|PK|pk
324397|NCT02216331|TMC207|tmc207
324398|NCT02216331|bedaquiline|bedaquiline
324399|NCT02216331|rifapentine|rifapentine
324400|NCT02216331|rifampicin|rifampicin
324401|NCT02216331|drug drug interaction|drug drug interaction
324402|NCT02216318|sleep|sleep
324403|NCT02216318|circadian|circadian
324404|NCT02216318|melatonine|melatonine
324405|NCT02216318|pupil response|pupil response
324406|NCT02216305|HAL-RAR|hal-rar
324407|NCT02216305|Hemorrhoids|hemorrhoids
324408|NCT02216305|Hemorrhoid artery ligation|hemorrhoid artery ligation
324409|NCT02216305|Anal repair|anal repair
324410|NCT02216305|Quality of Life|quality of life
324411|NCT02216305|Postoperative Complications|postoperative complications
324412|NCT02216292|preterm single donor milk|preterm single donor milk
324413|NCT02216292|human milk|human milk
324414|NCT02216292|very lo birth weight infants|very lo birth weight infants
324415|NCT02216292|enteral feedings|enteral feedings
324416|NCT02216292|NEC|nec
324417|NCT02216279|Pulmonary|pulmonary
324418|NCT02216279|Hypertension|hypertension
324419|NCT02216279|PH|ph
324420|NCT02216279|PulmoBind|pulmobind
324421|NCT02216279|Imaging|imaging
324422|NCT02216266|Delirium|delirium
324423|NCT02216266|CAM-ICU|cam-icu
324424|NCT02216253|Urinary tract infection|urinary tract infection
324425|NCT02216253|Pelvic organ prolapse|pelvic organ prolapse
324426|NCT02216253|Urinary incontinence|urinary incontinence
324427|NCT02216253|Stress urinary incontinence|stress urinary incontinence
324428|NCT02216253|Mixed Urinary incontinence|mixed urinary incontinence
324429|NCT02216253|L-methionine|l-methionine
324430|NCT02216253|Placebo|placebo
324431|NCT02216227|MRSA|mrsa
324432|NCT02216227|surgical site infection|surgical site infection
324433|NCT02216214|Urinary Incontinence|urinary incontinence
324434|NCT02216214|Mirabegron|mirabegron
324435|NCT02216214|Overactive Bladder|overactive bladder
324436|NCT02216175|Cow's milk allergy|cow's milk allergy
324437|NCT02216175|Desensitisation|desensitisation
324438|NCT02216175|Safety|safety
324439|NCT02216162|oncogeriatrics|oncogeriatrics
324440|NCT02216162|adjuvant endocrine therapy|adjuvant endocrine therapy
324441|NCT02216162|compliance|compliance
324442|NCT02216162|elderly|elderly
324443|NCT02216162|Taï Chi|taï chi
324444|NCT02216162|Physical training|physical training
324445|NCT02216149|fluoropyrimidine|fluoropyrimidine
324446|NCT02216149|S-1|s-1
324447|NCT02216149|Teysuno|teysuno
324448|NCT02216149|oxaliplatin|oxaliplatin
324449|NCT02216149|coronary artery flow|coronary artery flow
324450|NCT02216149|coronary artery dysfunction|coronary artery dysfunction
324451|NCT02216149|gastrointestinal tract cancer|gastrointestinal tract cancer
324452|NCT02216136|Mastectomy|mastectomy
324453|NCT02216136|Breast Cancer|breast cancer
324454|NCT02216136|Reconstruction|reconstruction
324455|NCT02216136|Lumpectomy|lumpectomy
324456|NCT02216136|Breast Conservation Therapy|breast conservation therapy
324457|NCT02216123|Tafenoquine|tafenoquine
324458|NCT02216123|Plasmodium vivax|plasmodium vivax
324459|NCT02216123|Hemolysis|hemolysis
324460|NCT02216123|Primaquine|primaquine
324461|NCT02216123|Chloroquine|chloroquine
324462|NCT02216123|Glucose-6-phosphate dehydrogenase (G6PD)|glucose-6-phosphate dehydrogenase (g6pd)
324463|NCT02216123|Relapse|relapse
324464|NCT02216110|Endoscopic submucosal dissection|endoscopic submucosal dissection
324465|NCT02216110|Gastrectomy|gastrectomy
324466|NCT02216110|Survival|survival
324467|NCT02216110|Outcome|outcome
324468|NCT02216045|Hepatitis C ,Chronic Hepatitis C ,camel milk|hepatitis c ,chronic hepatitis c ,camel milk
324469|NCT02216019|cardiac surgery|cardiac surgery
324470|NCT02216019|infectious complication|infectious complication
324471|NCT02216006|Atelectasis|atelectasis
324472|NCT02216006|Fresh gas flow|fresh gas flow
324473|NCT02216006|Prevention|prevention
324474|NCT02216006|Oxygenation|oxygenation
324475|NCT02216006|Anaesthesia|anaesthesia
324476|NCT02215993|Ticagrelor|ticagrelor
324477|NCT02215993|Prasugrel|prasugrel
324478|NCT02215993|VerifyNow|verifynow
324479|NCT02215993|Acute coronary syndrome|acute coronary syndrome
324480|NCT02215980|Multiple myeloma|multiple myeloma
324481|NCT02215980|Diagnosis|diagnosis
324482|NCT02215980|Elderly and unfit patients|elderly and unfit patients
324483|NCT02215980|Lenalidomide plus steroids|lenalidomide plus steroids
324484|NCT02215967|Immunotherapy|immunotherapy
324485|NCT02215967|Anti-BCMA-CAR|anti-bcma-car
324486|NCT02215967|Gene Therapy|gene therapy
324487|NCT02215967|Adoptive T Cell Therapy|adoptive t cell therapy
324488|NCT02215967|Plasma Cell Malignancy|plasma cell malignancy
324489|NCT02215915|Percutaneous coronary intervention|percutaneous coronary intervention
324490|NCT02215915|Drug-eluting stent|drug-eluting stent
324491|NCT02215915|Intravascular ultrasound|intravascular ultrasound
324492|NCT02215902|ESRD|esrd
324493|NCT02215902|Hepatitis C|hepatitis c
324494|NCT02215889|Liver metastases|liver metastases
324495|NCT02215889|Transplantation|transplantation
324496|NCT02215876|Her 2-negative breast cancer|her 2-negative breast cancer
324497|NCT02215876|neoadjuvant doxorubicin/cyclophosphamide followed by Eribulin chemotherapy|neoadjuvant doxorubicin/cyclophosphamide followed by eribulin chemotherapy
324498|NCT02215863|Immunogenicity, Safety, MF59, Influenza vaccine, Pneumococcal vaccine|immunogenicity, safety, mf59, influenza vaccine, pneumococcal vaccine
324499|NCT02215837|Gastric cancer|gastric cancer
324500|NCT02215837|D-CIK|d-cik
324501|NCT02215837|Autologous tumor lysate|autologous tumor lysate
324502|NCT02215811|Extracorporeal membrane oxygenation|extracorporeal membrane oxygenation
324503|NCT02215785|Funtional constipation|funtional constipation
324504|NCT02215785|Kiwifruit|kiwifruit
324505|NCT02215785|Health promotion|health promotion
324506|NCT02215707|PfSPZ Vaccine|pfspz vaccine
324507|NCT02215707|Plasmodium falciparum|plasmodium falciparum
324508|NCT02215707|Malaria|malaria
324509|NCT02215707|Controlled Human Malaria Infection (CHMI)|controlled human malaria infection (chmi)
324510|NCT02215694|Apolipoprotein A-V|apolipoprotein a-v
324511|NCT02215694|LDL particle size|ldl particle size
324512|NCT02215694|probiotic|probiotic
324513|NCT02215694|triglyceride|triglyceride
324514|NCT02215681|otitis media with effusion|otitis media with effusion
324515|NCT02215681|acupuncture|acupuncture
324516|NCT02215681|inflammatory markers|inflammatory markers
324517|NCT02215655|phosphate binder adherence|phosphate binder adherence
324518|NCT02215655|autonomous motivation|autonomous motivation
324519|NCT02215629|Leukemia|leukemia
324520|NCT02215629|Acute Leukemia|acute leukemia
324521|NCT02215629|Relapsed Leukemia|relapsed leukemia
324522|NCT02215629|Refractory Leukemia|refractory leukemia
324523|NCT02215629|Acute Myeloid Leukemia|acute myeloid leukemia
324524|NCT02215629|B-Cell Acute Lymphoblastic Leukemia|b-cell acute lymphoblastic leukemia
324525|NCT02215590|Postural balance|postural balance
324526|NCT02215590|Motor Learning and Motor Control|motor learning and motor control
324527|NCT02215590|Community integration|community integration
324528|NCT02215590|Quality of life|quality of life
324529|NCT02215590|Functional ambulation|functional ambulation
324530|NCT02215577|cancer, colorectal|cancer, colorectal
324531|NCT02215577|hepatectomy|hepatectomy
324532|NCT02215577|portal vein|portal vein
324533|NCT02215577|embolization|embolization
324534|NCT02215577|two-stage|two-stage
324535|NCT02215564|Bordetella pertussis|bordetella pertussis
324536|NCT02215564|Carriage rates in young adults|carriage rates in young adults
324537|NCT02215551|laminectomy|laminectomy
324538|NCT02215538|ADHD|adhd
324539|NCT02215538|adult|adult
324540|NCT02215538|WRAADDS|wraadds
324541|NCT02215538|OROS MPH|oros mph
324542|NCT02215538|emotional dysregulation|emotional dysregulation
324543|NCT02215525|HCV|hcv
324544|NCT02215525|UVA|uva
324545|NCT02215525|Herbal therapy|herbal therapy
324546|NCT02215499|JZP-386, Xyrem, sodium oxybate|jzp-386, xyrem, sodium oxybate
324547|NCT02215486|Head massage therapy|head massage therapy
324548|NCT02215486|Massage therapy|massage therapy
324549|NCT02215486|Autonomic nervous system (ANS)|autonomic nervous system (ans)
324550|NCT02215486|Heart rate variability (HRV)|heart rate variability (hrv)
324551|NCT02215486|Pre-ejection period (PEP)|pre-ejection period (pep)
324552|NCT02215473|gingivitis|gingivitis
324553|NCT02215473|periodontitis|periodontitis
324554|NCT02215473|mouth rinse|mouth rinse
324555|NCT02215473|bacteremia|bacteremia
324556|NCT02215447|NAB-paclitaxel|nab-paclitaxel
324557|NCT02215447|Gastrointestinal Neuroendocrine Carcinomas|gastrointestinal neuroendocrine carcinomas
324558|NCT02215447|phase II|phase ii
324559|NCT02215447|carboplatin|carboplatin
324560|NCT02215434|Libido; Sexual Dysfunction; testosterone|libido; sexual dysfunction; testosterone
324561|NCT02215421|vegetables|vegetables
324562|NCT02215421|dietary intake|dietary intake
324563|NCT02215421|preschoolers|preschoolers
324564|NCT02215421|parents|parents
324565|NCT02215421|video game|video game
324566|NCT02215408|Diabetes|diabetes
324567|NCT02215408|Hyperlipidemia|hyperlipidemia
324568|NCT02215408|Hypertension|hypertension
324569|NCT02215408|Cardiovascular Disease|cardiovascular disease
324570|NCT02215395|Nestorone|nestorone
324571|NCT02215395|miconazole nitrate|miconazole nitrate
324572|NCT02215382|two reversal methods|two reversal methods
324573|NCT02215382|changes in IOP|changes in iop
324574|NCT02215382|heart rate|heart rate
324575|NCT02215382|blood pressure|blood pressure
324576|NCT02215382|tracheal extubation|tracheal extubation
324577|NCT02215330|Central serous chorioretinopathy|central serous chorioretinopathy
324578|NCT02215330|Eplerenone|eplerenone
324579|NCT02215330|Photodynamic Therapy|photodynamic therapy
324580|NCT02215330|Macula|macula
324581|NCT02215330|Retina|retina
324582|NCT02215317|Sleep Apnea|sleep apnea
324583|NCT02215317|Stent|stent
324584|NCT02215317|Coronary Artery Disease|coronary artery disease
324585|NCT02215317|Percutaneous Coronary Intervention|percutaneous coronary intervention
324586|NCT02215304|Dietary supplementation|dietary supplementation
324587|NCT02215304|Probiotics|probiotics
414766|NCT01802918|HIV|hiv
324588|NCT02215304|Safety/Efficiency|safety/efficiency
324589|NCT02215304|Healthy infants|healthy infants
324590|NCT02215291|Undergoing Esophagogastroduodenoscopy (EGD) or endoscopy|undergoing esophagogastroduodenoscopy (egd) or endoscopy
324591|NCT02215278|iron biofortification|iron biofortification
324592|NCT02215278|lpa bean|lpa bean
324593|NCT02215278|stable iron isotope study|stable iron isotope study
324594|NCT02215278|phytic acid|phytic acid
324595|NCT02215265|Human papillomavirus HPV positive oropharyngeal cancer|human papillomavirus hpv positive oropharyngeal cancer
324596|NCT02215239|health lifestyle|health lifestyle
324597|NCT02215239|health promotion|health promotion
324598|NCT02215239|occupational health|occupational health
324599|NCT02215239|Work site health promotion|work site health promotion
324600|NCT02215226|Group B Streptococcus, early onset disease, late onset disease, anticapsular antibodies, serotype specific|group b streptococcus, early onset disease, late onset disease, anticapsular antibodies, serotype specific
324601|NCT02215213|Vitamin D|vitamin d
324602|NCT02215213|pregnancy|pregnancy
324603|NCT02215213|Pakistan|pakistan
324604|NCT02215200|Type 1 Diabetes TrialNet|type 1 diabetes trialnet
324605|NCT02215174|Rosuvastatin|rosuvastatin
324606|NCT02215174|PK|pk
324607|NCT02215174|Interethnic|interethnic
324608|NCT02215174|Morbid obese|morbid obese
324609|NCT02215135|Corifollitropin alfa|corifollitropin alfa
324610|NCT02215135|polycystic ovarian syndrome (PCOS)|polycystic ovarian syndrome (pcos)
324611|NCT02215135|controlled ovarian hyperstimulation (COS)|controlled ovarian hyperstimulation (cos)
324612|NCT02215135|GnRH antagonist protocol|gnrh antagonist protocol
324613|NCT02215135|Ovarian hyperstimulation syndrome (OHSS)|ovarian hyperstimulation syndrome (ohss)
324614|NCT02215122|Fluticasone Propionate|fluticasone propionate
324615|NCT02215122|Salmeterol|salmeterol
324616|NCT02215122|Pharmacokinetics|pharmacokinetics
324617|NCT02215122|Healthy Subjects|healthy subjects
324618|NCT02215122|MGR001|mgr001
324619|NCT02215122|CRC749|crc749
324620|NCT02215122|Dry Powder Inhaler|dry powder inhaler
324621|NCT02215122|generic|generic
324622|NCT02215122|Advair Diskus|advair diskus
324623|NCT02215122|Seretide Accuhaler|seretide accuhaler
324624|NCT02215096|enzalutamide|enzalutamide
324625|NCT02215096|metastatic castration-resistant prostate cancer|metastatic castration-resistant prostate cancer
324626|NCT02215096|GSK2636771|gsk2636771
324627|NCT02215096|PI3K-beta|pi3k-beta
324628|NCT02215096|PTEN deficiency|pten deficiency
324629|NCT02215083|peripheral neuropathy|peripheral neuropathy
324630|NCT02215083|breast cancer|breast cancer
324631|NCT02215083|taxane induced peripheral neuropathy|taxane induced peripheral neuropathy
324632|NCT02215083|chemotherapy induced peripheral neuropathy|chemotherapy induced peripheral neuropathy
324633|NCT02215070|Allogeneic Stem Cell Transplantation|allogeneic stem cell transplantation
324634|NCT02215070|Acute Myeloid Leukemia|acute myeloid leukemia
324635|NCT02215070|Acute Lymphoid Leukemia|acute lymphoid leukemia
324636|NCT02215070|Acute Non-Lymphocytic Leukemia|acute non-lymphocytic leukemia
324637|NCT02215070|Myelodysplastic Syndrome|myelodysplastic syndrome
324638|NCT02215070|Chronic Myeloid Leukemia|chronic myeloid leukemia
324639|NCT02215070|Lymphoma|lymphoma
324640|NCT02215057|topical anesthesia|topical anesthesia
324641|NCT02215057|intracameral lidocaine|intracameral lidocaine
324642|NCT02215057|implantable collamer lens|implantable collamer lens
324643|NCT02214875|Retention|retention
324644|NCT02214862|Unclassifiable Parkinsonism, [F18]-FDDNP-PET, Tauopathy, PSP,MSA|unclassifiable parkinsonism, [f18]-fddnp-pet, tauopathy, psp,msa
324645|NCT02214849|Breastfeeding|breastfeeding
324646|NCT02214849|Breastfeeding peer counseling|breastfeeding peer counseling
324647|NCT02214849|Exclusive breastfeeding|exclusive breastfeeding
324648|NCT02214849|Formula supplementation|formula supplementation
324649|NCT02214849|Mobile health|mobile health
324650|NCT02214849|WIC program|wic program
324651|NCT02214836|kidney stones|kidney stones
324652|NCT02214836|ultrasound imaging|ultrasound imaging
324653|NCT02214836|ureter stones|ureter stones
324654|NCT02214810|Bupivacaine|bupivacaine
324655|NCT02214810|multimodal|multimodal
324656|NCT02214810|exparel|exparel
324657|NCT02214810|open reduction|open reduction
324658|NCT02214810|internal fixation|internal fixation
324659|NCT02214810|post-surgical pain control|post-surgical pain control
324660|NCT02214797|Presbyopia|presbyopia
324661|NCT02214797|Refractive Error|refractive error
324662|NCT02214797|Contact Lenses|contact lenses
324663|NCT02214784|Stress urinary Incontinence|stress urinary incontinence
324665|NCT02214784|Continence|continence
324666|NCT02214771|Clostridium difficile infection CDI|clostridium difficile infection cdi
324667|NCT02214771|Observational|observational
324668|NCT02214771|Fidaxomicin recurrence|fidaxomicin recurrence
324669|NCT02214771|France|france
324670|NCT02214758|Home care clients, nutrition, oral health, medication|home care clients, nutrition, oral health, medication
324671|NCT02214745|Israeli Arab population|israeli arab population
324672|NCT02214745|Israeli/ethnology|israeli/ethnology
324673|NCT02214732|Pregnancy|pregnancy
324674|NCT02214732|Postpartum|postpartum
324675|NCT02214732|Mindfulness Based Cognitive Therapy|mindfulness based cognitive therapy
414884|NCT01802398|Syncope|syncope
324676|NCT02214732|Depression|depression
324677|NCT02214732|Anxiety|anxiety
324678|NCT02214732|Stress|stress
324679|NCT02214732|MBCT|mbct
324680|NCT02214732|Actigraphy|actigraphy
324681|NCT02214719|type 1 diabetes, insulin therapy, bolus calculator|type 1 diabetes, insulin therapy, bolus calculator
324682|NCT02214693|patients|patients
324683|NCT02214680|Pupil diameter|pupil diameter
324684|NCT02214680|Brimonidine|brimonidine
324685|NCT02214680|Timolol|timolol
324686|NCT02214680|Combigan|combigan
324687|NCT02214667|Jail|jail
324688|NCT02214667|co-occurring disorders|co-occurring disorders
324689|NCT02214667|implementation|implementation
324690|NCT02214667|acceptability|acceptability
324691|NCT02214667|feasibility|feasibility
324692|NCT02214667|fidelity|fidelity
324693|NCT02214628|Wet AMD|wet amd
324694|NCT02214628|Choroidal neovascularization|choroidal neovascularization
324695|NCT02214628|Fovista®|fovista®
324696|NCT02214628|E10030|e10030
324697|NCT02214628|Avastin®|avastin®
324698|NCT02214628|Eylea®|eylea®
324699|NCT02214602|non muscle invasive bladder cancer|non muscle invasive bladder cancer
324700|NCT02214602|intermediate and high risk|intermediate and high risk
324701|NCT02214602|immediate single instillation|immediate single instillation
324702|NCT02214602|Intravesical chemotherapy|intravesical chemotherapy
324703|NCT02214602|Disease prevention|disease prevention
324704|NCT02214576|Respiratory Distress Syndrome, Adult|respiratory distress syndrome, adult
324705|NCT02214576|intubation, intratracheal|intubation, intratracheal
324706|NCT02214576|Oxygen Inhalation Therapy|oxygen inhalation therapy
324707|NCT02214576|Positive-Pressure Respiration|positive-pressure respiration
324708|NCT02214576|laryngoscopy|laryngoscopy
324709|NCT02214563|Vitamin D|vitamin d
324710|NCT02214563|Cholecalciferol|cholecalciferol
324711|NCT02214563|Hepcidins|hepcidins
324712|NCT02214563|Renal Dialysis|renal dialysis
324713|NCT02214550|Cystitis, Interstitial|cystitis, interstitial
324714|NCT02214550|Dysmenorrhea|dysmenorrhea
324715|NCT02214550|Migraine Disorders|migraine disorders
324716|NCT02214550|Cross Organ Sensitization|cross organ sensitization
324717|NCT02214550|Pelvic Pain|pelvic pain
324718|NCT02214550|Endometriosis|endometriosis
324719|NCT02214550|Contraceptives, Oral|contraceptives, oral
324720|NCT02214550|Birth Control Pills|birth control pills
324721|NCT02214550|Painful Bladder Syndrome|painful bladder syndrome
324722|NCT02214550|Visceral Pain|visceral pain
324723|NCT02214550|Chronic Pain|chronic pain
324724|NCT02214524|perioperative hypothermia|perioperative hypothermia
324725|NCT02214524|Tympanic temperature|tympanic temperature
324726|NCT02214524|Blood loss|blood loss
324727|NCT02214524|Blood Coagulation Disorders|blood coagulation disorders
324728|NCT02214524|Major surgery|major surgery
324729|NCT02214511|major depressive disorder|major depressive disorder
324730|NCT02214511|social rejection|social rejection
324731|NCT02214511|rapid facial reaction|rapid facial reaction
324732|NCT02214511|facial mimicry|facial mimicry
324733|NCT02214511|prosocial behavior|prosocial behavior
324734|NCT02214511|inflammation|inflammation
324735|NCT02214511|self esteem|self esteem
324736|NCT02214498|Dipper|dipper
324737|NCT02214498|Non-dipper|non-dipper
324738|NCT02214498|Chronopharmacology|chronopharmacology
324739|NCT02214485|frailty|frailty
324740|NCT02214485|exercise|exercise
324741|NCT02214485|intervention|intervention
324742|NCT02214472|Rumination síndrome|rumination síndrome
324743|NCT02214472|Regurgitation|regurgitation
324744|NCT02214472|Vomiting|vomiting
324745|NCT02214472|Biofeedback|biofeedback
324746|NCT02214472|Electromyography|electromyography
324747|NCT02214472|Abdominal accommodation|abdominal accommodation
324748|NCT02214459|mHealth|mhealth
324749|NCT02214459|Hypertension|hypertension
324750|NCT02214459|Mobile|mobile
324751|NCT02214459|smartphone|smartphone
324752|NCT02214459|diet|diet
324753|NCT02214459|lifestyle|lifestyle
324754|NCT02214459|bluetooth|bluetooth
324755|NCT02214459|physical acitvity|physical acitvity
324756|NCT02214459|behavior change|behavior change
324757|NCT02214459|motivational interviewing|motivational interviewing
324758|NCT02214446|truth telling|truth telling
324759|NCT02214446|hope|hope
324760|NCT02214446|quality of life|quality of life
324761|NCT02214446|care burden|care burden
324762|NCT02214446|children with cancer|children with cancer
324763|NCT02214433|Antibiotic|antibiotic
324764|NCT02214433|Antibiotic Resistant Bacterial Infection|antibiotic resistant bacterial infection
324765|NCT02214381|breast cancer|breast cancer
324766|NCT02214381|elderly|elderly
324767|NCT02214329|Postural Balance|postural balance
324768|NCT02214329|Gait|gait
324769|NCT02214329|Fall risk|fall risk
324770|NCT02214303|Allergic asthma|allergic asthma
324771|NCT02214303|Allergic rhinitis|allergic rhinitis
324772|NCT02214303|Healthy subjects|healthy subjects
324773|NCT02214290|Cardiovascular|cardiovascular
324774|NCT02214290|Caffeine|caffeine
324775|NCT02214290|L-citrulline|l-citrulline
324776|NCT02214290|Arterial Function|arterial function
324777|NCT02214290|Hemodynamics|hemodynamics
324778|NCT02214290|Blood Pressure|blood pressure
324779|NCT02214290|Pulse Wave Velocity|pulse wave velocity
324780|NCT02214290|Pulse Wave Analysis|pulse wave analysis
324781|NCT02214277|Embolic Protection|embolic protection
324782|NCT02214277|Edwards SAPIEN THV|edwards sapien thv
324783|NCT02214277|Edwards SAPIEN XT|edwards sapien xt
324784|NCT02214277|TAVR|tavr
324785|NCT02214277|Transfemoral|transfemoral
324786|NCT02214277|Transapical|transapical
324787|NCT02214277|Heart Valve Diseases|heart valve diseases
324788|NCT02214277|Heart Diseases|heart diseases
324789|NCT02214277|TAVI|tavi
324790|NCT02214277|Aortic Stenosis|aortic stenosis
324791|NCT02214277|Aortic Valve|aortic valve
324792|NCT02214277|Transcatheter Heart Valve|transcatheter heart valve
324793|NCT02214251|Parkinson's disease|parkinson's disease
324794|NCT02214251|freezing of gait|freezing of gait
324795|NCT02214251|movement disorders|movement disorders
324796|NCT02214251|neuroscience|neuroscience
324797|NCT02214251|neural|neural
324798|NCT02214251|mechanism|mechanism
324799|NCT02214212|traumatic brain injury|traumatic brain injury
324800|NCT02214212|TBI|tbi
324801|NCT02214212|Sleep|sleep
324802|NCT02214212|Bright White Light Therapy|bright white light therapy
324803|NCT02214212|Red Light Therapy|red light therapy
324804|NCT02214212|Recovery|recovery
324805|NCT02214212|Central Nervous System Diseases|central nervous system diseases
324806|NCT02214212|Brain Diseases|brain diseases
324807|NCT02214212|Nervous System Diseases|nervous system diseases
324808|NCT02214212|Signs and Symptoms|signs and symptoms
324809|NCT02214212|Rehabilitation|rehabilitation
324810|NCT02214212|Actigraphy|actigraphy
324811|NCT02214199|Shoulder Pain|shoulder pain
324812|NCT02214199|Shoulder Impingement Syndrome|shoulder impingement syndrome
324813|NCT02214199|Exercise therapy|exercise therapy
324814|NCT02214199|Randomized Controlled Trial|randomized controlled trial
324815|NCT02214186|Pre-Eclampsia|pre-eclampsia
324816|NCT02214186|Acute Kidney Injury|acute kidney injury
324817|NCT02214186|Fluid Therapy|fluid therapy
324818|NCT02214186|Anesthesia, Spinal|anesthesia, spinal
324819|NCT02214173|HIV, BRM4, hydrolyzed rice bran, metabolic syndrome|hiv, brm4, hydrolyzed rice bran, metabolic syndrome
324820|NCT02214160|Long-Chain Fatty Acid Oxidation Disorders (LC-FAOD)|long-chain fatty acid oxidation disorders (lc-faod)
324821|NCT02214160|carnitine palmitoyltransferase (CPT I or CPT II) deficiency|carnitine palmitoyltransferase (cpt i or cpt ii) deficiency
324822|NCT02214160|very long chain acyl-CoA dehydrogenase (VLCAD) deficiency|very long chain acyl-coa dehydrogenase (vlcad) deficiency
324823|NCT02214160|long-chain 3-hydroxy-acyl-CoA dehydrogenase (LCHAD) deficiency|long-chain 3-hydroxy-acyl-coa dehydrogenase (lchad) deficiency
324824|NCT02214160|trifunctional protein (TFP) deficiency|trifunctional protein (tfp) deficiency
324825|NCT02214160|carnitine-acylcarnitine translocase (CACT) deficiency|carnitine-acylcarnitine translocase (cact) deficiency
324826|NCT02214160|Triheptanoin|triheptanoin
324827|NCT02214160|UX007|ux007
324828|NCT02214160|C7|c7
324829|NCT02214147|Drug Therapy|drug therapy
324830|NCT02214134|Lung cancer|lung cancer
324831|NCT02214134|Malignant pleural mesothelioma|malignant pleural mesothelioma
324832|NCT02214134|Thymic malignancy|thymic malignancy
324833|NCT02214134|Biomarkers|biomarkers
324834|NCT02214134|Screening|screening
324835|NCT02214121|sickle cell anemia|sickle cell anemia
324836|NCT02214121|paediatric|paediatric
324837|NCT02214108|BMI|bmi
324838|NCT02214108|Obesity|obesity
324839|NCT02214108|overweight|overweight
324840|NCT02214108|child|child
324841|NCT02214108|Physical activity|physical activity
324842|NCT02214095|Cytokines|cytokines
324843|NCT02214095|interleukin-1β|interleukin-1β
324844|NCT02214095|chronic periodontitis|chronic periodontitis
324845|NCT02214095|host modulation|host modulation
324846|NCT02214095|glucosamine sulphate.|glucosamine sulphate.
324847|NCT02214056|mobile screening team|mobile screening team
324848|NCT02214056|feasibility|feasibility
324849|NCT02214030|Femoral compression device|femoral compression device
324850|NCT02214030|manual compression|manual compression
324851|NCT02214030|arterial hemostasis|arterial hemostasis
324852|NCT02214030|coronary intervention|coronary intervention
324853|NCT02214030|coronary artery disease|coronary artery disease
324854|NCT02214017|diabetes|diabetes
324855|NCT02214017|telemedicine|telemedicine
324856|NCT02214017|glycemia|glycemia
324857|NCT02214017|lipids|lipids
324858|NCT02214017|blood pressure|blood pressure
324859|NCT02214004|Breast cancer|breast cancer
324860|NCT02214004|HER2|her2
324861|NCT02214004|ER|er
324862|NCT02214004|Postmenopausal|postmenopausal
324863|NCT02214004|Trastuzumab|trastuzumab
324864|NCT02214004|Letrozole|letrozole
324865|NCT02214004|Neoadjuvant endocrine treatment|neoadjuvant endocrine treatment
324866|NCT02213991|Breast Cancer|breast cancer
324867|NCT02213991|Breast Conservative Surgery|breast conservative surgery
324868|NCT02213991|Intraoperative Radiotherapy|intraoperative radiotherapy
324869|NCT02213991|Local Toxicity|local toxicity
324870|NCT02213991|Whole breast radiotherapy|whole breast radiotherapy
324871|NCT02213965|Intravenous Catheter|intravenous catheter
324872|NCT02213965|Vasofix safety|vasofix safety
324873|NCT02213965|Introcan safety|introcan safety
324874|NCT02213952|Ulcer|ulcer
324875|NCT02213952|Platelet-Rich Plasma|platelet-rich plasma
324876|NCT02213939|Myocardial revascularization|myocardial revascularization
324877|NCT02213939|Cytosorb|cytosorb
324878|NCT02213939|Inflammatory response|inflammatory response
324879|NCT02213939|Cardiopulmonary bypass|cardiopulmonary bypass
324880|NCT02213926|Bruton tyrosine kinase inhibitor|bruton tyrosine kinase inhibitor
324882|NCT02213926|Mantle Cell Lymphoma|mantle cell lymphoma
324883|NCT02213926|MCL|mcl
324884|NCT02213926|ACP-196|acp-196
324885|NCT02213926|Acalabrutinib|acalabrutinib
324886|NCT02213926|ACE-LY-004|ace-ly-004
324887|NCT02213926|Calquence|calquence
324888|NCT02213900|delirium|delirium
324889|NCT02213900|confusion|confusion
324890|NCT02213900|surgery|surgery
324891|NCT02213900|cognitive Impairment|cognitive impairment
324892|NCT02213900|post-traumatic Stress disorder|post-traumatic stress disorder
324893|NCT02213900|depression|depression
324894|NCT02213900|anxiety|anxiety
324895|NCT02213887|Drug Interactions|drug interactions
324896|NCT02213887|Pantoprazole|pantoprazole
324897|NCT02213887|Proton Pump Inhibitors|proton pump inhibitors
324898|NCT02213887|Psychotropic Drugs|psychotropic drugs
324899|NCT02213887|Antipsychotic Agents|antipsychotic agents
324900|NCT02213887|Aripiprazole|aripiprazole
324901|NCT02213887|Asenapine|asenapine
324902|NCT02213887|Clozapine|clozapine
324903|NCT02213887|Lurasidone|lurasidone
324904|NCT02213887|Olanzapine|olanzapine
324905|NCT02213887|9-hydroxy-risperidone|9-hydroxy-risperidone
324906|NCT02213887|Quetiapine|quetiapine
324907|NCT02213887|Risperidone|risperidone
324908|NCT02213887|Ziprasidone|ziprasidone
324909|NCT02213887|Valproic Acid|valproic acid
324910|NCT02213887|Lithium|lithium
324911|NCT02213887|Gastrins|gastrins
324912|NCT02213887|Psychotic Disorders|psychotic disorders
324913|NCT02213887|Gastroesophageal Reflux|gastroesophageal reflux
324914|NCT02213874|Pregnant Women|pregnant women
324915|NCT02213874|Women's Health|women's health
324916|NCT02213874|Contraception|contraception
324917|NCT02213874|Trust in Health Care|trust in health care
324918|NCT02213861|CTCL|ctcl
324919|NCT02213861|Cutaneous T-Cell Lymphoma|cutaneous t-cell lymphoma
324920|NCT02213861|Early-stage|early-stage
324921|NCT02213861|SHAPE|shape
324922|NCT02213861|SHP-141|shp-141
324923|NCT02213861|topical|topical
324924|NCT02213861|Histone deacetylase inhibitor|histone deacetylase inhibitor
324925|NCT02213861|CAILS|cails
324926|NCT02213861|mSWAT|mswat
324927|NCT02213861|mycosis fungoides|mycosis fungoides
324928|NCT02213848|Neuromuscular blockade reversal|neuromuscular blockade reversal
324929|NCT02213848|TOF ratio|tof ratio
324930|NCT02213848|Calcium chloride|calcium chloride
324931|NCT02213835|Crohn's disease and Ulcerative colitis|crohn's disease and ulcerative colitis
324932|NCT02213822|genome|genome
324933|NCT02213822|transcriptome|transcriptome
324934|NCT02213822|molecular|molecular
324935|NCT02213822|proteome|proteome
324936|NCT02213822|oncogenic mutations|oncogenic mutations
324937|NCT02213822|sequencing|sequencing
324938|NCT02213822|solid tumor|solid tumor
324939|NCT02213822|hematological malignancy|hematological malignancy
324940|NCT02213822|cancer|cancer
324941|NCT02213822|analysis|analysis
324942|NCT02213822|genetic|genetic
324943|NCT02213822|mutation|mutation
324944|NCT02213796|meropenem, early phase, severe sepsis and septic shock, critically ill, population pharmacokinetics|meropenem, early phase, severe sepsis and septic shock, critically ill, population pharmacokinetics
324945|NCT02213783|Imipenem|imipenem
324946|NCT02213783|Febrile neutropenia|febrile neutropenia
324947|NCT02213783|Gram-negative infection|gram-negative infection
324948|NCT02213783|Pharmacodynamic|pharmacodynamic
324949|NCT02213783|Monte Carlo Simulation|monte carlo simulation
324950|NCT02213757|Hematuria|hematuria
324951|NCT02213757|Menopause|menopause
324952|NCT02213757|Urinalysis|urinalysis
324953|NCT02213744|HER2-positive|her2-positive
324954|NCT02213744|HER2+|her2+
324955|NCT02213744|HER2|her2
324956|NCT02213744|Locally Advanced Breast Cancer|locally advanced breast cancer
324957|NCT02213744|Metastatic Breast Cancer|metastatic breast cancer
324958|NCT02213744|trastuzumab|trastuzumab
324959|NCT02213744|Herceptin|herceptin
324960|NCT02213744|pertuzumab|pertuzumab
324961|NCT02213744|ado-trastuzumab emtansine|ado-trastuzumab emtansine
324962|NCT02213744|TDM-1|tdm-1
324963|NCT02213744|Perjeta|perjeta
324964|NCT02213744|Kadcyla|kadcyla
324965|NCT02213731|Atrial Fibrillation|atrial fibrillation
324966|NCT02213731|Persistent Atrial Fibrillation|persistent atrial fibrillation
324967|NCT02213731|Cryoablation|cryoablation
324968|NCT02213731|Cryoballoon|cryoballoon
324969|NCT02213731|Pulmonary Vein Isolation|pulmonary vein isolation
324970|NCT02213718|Desflurane|desflurane
324971|NCT02213718|myocardial function|myocardial function
324972|NCT02213718|Coronary Artery Bypass Surgery|coronary artery bypass surgery
764457|NCT00387517|systolic|systolic
324973|NCT02213705|SYSTEMIC SCLERODERMA|systemic scleroderma
324974|NCT02213705|TRANSPLANTATION|transplantation
324975|NCT02213705|ALLOGENEIC MESENCHYMAL STEM CELLS|allogeneic mesenchymal stem cells
324976|NCT02213705|ADULT|adult
324977|NCT02213692|Liver Resection|liver resection
324978|NCT02213692|Harmonic Scalpel|harmonic scalpel
324979|NCT02213692|Crush-clamping|crush-clamping
324980|NCT02213692|A Prospective Randomized Study|a prospective randomized study
324981|NCT02213679|Creatine|creatine
324982|NCT02213679|Guanidinoacetic acid|guanidinoacetic acid
324983|NCT02213679|Intervention|intervention
324984|NCT02213679|Fatigue|fatigue
324985|NCT02213679|Muscle strength|muscle strength
324986|NCT02213666|Atrial fibrillation ablation|atrial fibrillation ablation
324987|NCT02213666|Intracardiac echocardiography|intracardiac echocardiography
324988|NCT02213666|Thrombus|thrombus
324989|NCT02213666|Left atrial appendage|left atrial appendage
324990|NCT02213666|Right atrial appendage|right atrial appendage
324991|NCT02213653|Functional iron deficiency|functional iron deficiency
324992|NCT02213653|Metastatic|metastatic
324993|NCT02213640|Neurologic neglect syndrome|neurologic neglect syndrome
324994|NCT02213640|post stroke|post stroke
324995|NCT02213640|transcranial direct current stimulation (tDCS)|transcranial direct current stimulation (tdcs)
324996|NCT02213640|prismatic adaptation|prismatic adaptation
324997|NCT02213627|Corifollitropin alfa, recombinant FSH, HP-hMG, apoptosis, oocyte donation|corifollitropin alfa, recombinant fsh, hp-hmg, apoptosis, oocyte donation
324998|NCT02213601|Yoga|yoga
324999|NCT02213601|Complementary and Alternative Medicine Interventions|complementary and alternative medicine interventions
325000|NCT02213601|Treatment|treatment
325001|NCT02213601|Postpartum Depression|postpartum depression
325002|NCT02213588|Antioxidant|antioxidant
325003|NCT02213575|Resistent Hypertension|resistent hypertension
325004|NCT02213536|Metastatic brain cancer|metastatic brain cancer
325005|NCT02213536|Whole brain radiotherapy|whole brain radiotherapy
325006|NCT02213536|Scalp sparing whole brain radiotherapy|scalp sparing whole brain radiotherapy
325007|NCT02213536|Prophylactic whole brain radiotherapy|prophylactic whole brain radiotherapy
325008|NCT02213523|antioxidant|antioxidant
325009|NCT02213510|pacemaker|pacemaker
325010|NCT02213510|implantable cardioverter defibrillator|implantable cardioverter defibrillator
325011|NCT02213510|ICD|icd
325012|NCT02213510|surgical wound closure|surgical wound closure
325013|NCT02213510|sutures|sutures
325014|NCT02213510|Zipline|zipline
325015|NCT02213510|Zips|zips
325016|NCT02213510|CIED|cied
325017|NCT02213510|cardiovascular implantable electronic devices|cardiovascular implantable electronic devices
325018|NCT02213510|arrhythmia|arrhythmia
325019|NCT02213497|Patients with esophageal cancer to be treated with concurrent preoperative chemoradiation with carboplatin and paclitaxel.|patients with esophageal cancer to be treated with concurrent preoperative chemoradiation with carboplatin and paclitaxel.
325020|NCT02213484|aortopathy syndrome|aortopathy syndrome
325021|NCT02213484|aortic aneurysm|aortic aneurysm
325022|NCT02213484|aortic dissection|aortic dissection
325023|NCT02213484|connective tissue disorder|connective tissue disorder
325024|NCT02213458|Pragmatic Clinical Trial|pragmatic clinical trial
325025|NCT02213458|Family Caregivers|family caregivers
325026|NCT02213458|Patient Care Management|patient care management
325027|NCT02213432|influenza vaccine|influenza vaccine
325028|NCT02213432|cancer|cancer
325029|NCT02213419|Cystic Tumors of the Pancreas|cystic tumors of the pancreas
325030|NCT02213419|Endoscopic Ultrasound|endoscopic ultrasound
325031|NCT02213419|Ethanol|ethanol
325032|NCT02213393|undernutrition|undernutrition
325033|NCT02213393|nutritional status|nutritional status
325034|NCT02213393|elderly patients|elderly patients
325035|NCT02213393|protein|protein
325036|NCT02213393|enriched products|enriched products
325037|NCT02213393|recovery|recovery
325038|NCT02213393|physical function|physical function
325039|NCT02213393|quality of life|quality of life
325040|NCT02213393|activities of daily living|activities of daily living
325041|NCT02213380|delirium|delirium
325042|NCT02213380|general anesthesia|general anesthesia
325043|NCT02213380|regional anesthesia|regional anesthesia
325044|NCT02213380|elderly patient|elderly patient
325045|NCT02213380|hip fracture|hip fracture
325147|NCT02212977|Port Catheter|port catheter
325046|NCT02213354|Influenza, H7N9, Elderly, Vaccine, MF59 Adjuvant|influenza, h7n9, elderly, vaccine, mf59 adjuvant
325047|NCT02213341|Milk Allergy|milk allergy
325048|NCT02213341|Egg Allergy|egg allergy
325049|NCT02213341|Peanut Allergy|peanut allergy
325050|NCT02213341|Infant Vaccination|infant vaccination
325051|NCT02213315|Healthy Volunteers, Rheumatoid Arthritis, mavrilimumab|healthy volunteers, rheumatoid arthritis, mavrilimumab
325052|NCT02213302|premedication|premedication
325053|NCT02213302|preoperative anxiety|preoperative anxiety
325054|NCT02213302|salivary cortisol level|salivary cortisol level
325055|NCT02213302|anxiety visual analog scale|anxiety visual analog scale
325056|NCT02213289|Gastric|gastric
325057|NCT02213289|Esophagogastric|esophagogastric
325058|NCT02213276|Glucose infusion|glucose infusion
325059|NCT02213276|Bone markers|bone markers
325060|NCT02213276|Inflammatory markers|inflammatory markers
325061|NCT02213263|rituximab|rituximab
325062|NCT02213263|follicular lymphoma|follicular lymphoma
325063|NCT02213263|Non-Hodgkin lymphoma|non-hodgkin lymphoma
325064|NCT02213263|Non-Hodgkin's lymphoma|non-hodgkin's lymphoma
325065|NCT02213224|Perindopril,Telmisartan, Efficacy, NAFLD|perindopril,telmisartan, efficacy, nafld
325066|NCT02213211|Malawi|malawi
325067|NCT02213211|Case management|case management
325068|NCT02213211|Rapid diagnostic tests|rapid diagnostic tests
325069|NCT02213211|Artemether lumefantrine|artemether lumefantrine
325070|NCT02213211|School children|school children
325071|NCT02213211|School health services|school health services
325072|NCT02213211|Attendance|attendance
325073|NCT02213211|Anaemia|anaemia
325074|NCT02213211|Parasitic diseases|parasitic diseases
325075|NCT02213198|Serious mental illness transitions shared decision making|serious mental illness transitions shared decision making
325076|NCT02213185|Sterile water injections|sterile water injections
325077|NCT02213185|Pain|pain
325078|NCT02213185|VAS|vas
325079|NCT02213185|Complementary method|complementary method
325080|NCT02213172|IBS|ibs
325081|NCT02213172|Probiotic|probiotic
325082|NCT02213172|Constipation|constipation
325083|NCT02213172|Bifidobacterium longum|bifidobacterium longum
325084|NCT02213172|Lactobacillus paracasei|lactobacillus paracasei
325085|NCT02213172|Lallemand Health Solutions|lallemand health solutions
325086|NCT02213159|Dexmedetomidine|dexmedetomidine
325087|NCT02213159|bariatric surgery|bariatric surgery
325088|NCT02213159|postoperative pain|postoperative pain
325089|NCT02213159|morphine consumption|morphine consumption
325090|NCT02213159|Quality of recovery|quality of recovery
325091|NCT02213133|Squamous|squamous
325092|NCT02213133|SCC|scc
325093|NCT02213133|Carcinoma|carcinoma
325094|NCT02213133|KPT-330|kpt-330
325095|NCT02213133|SINE|sine
325096|NCT02213133|Selinexor|selinexor
325097|NCT02213133|Karyopharm|karyopharm
325098|NCT02213133|Karyopharm Therapeutics|karyopharm therapeutics
325099|NCT02213133|Lung|lung
325100|NCT02213133|Head|head
325101|NCT02213133|Neck|neck
325102|NCT02213133|Esophageal|esophageal
325103|NCT02213120|Vertigo, Dizziness|vertigo, dizziness
325104|NCT02213107|prostate|prostate
325105|NCT02213094|preeclampsia|preeclampsia
325106|NCT02213094|pregnancy-induced hypertension|pregnancy-induced hypertension
325107|NCT02213094|nicotinamide|nicotinamide
325108|NCT02213081|Endometriosis|endometriosis
325109|NCT02213081|chronic pelvic pain|chronic pelvic pain
325110|NCT02213081|dysmenorrhea|dysmenorrhea
325111|NCT02213081|dyschezia|dyschezia
325112|NCT02213081|bleeding|bleeding
325113|NCT02213081|ulipristal|ulipristal
325114|NCT02213081|progesterone|progesterone
325115|NCT02213068|Kidney|kidney
325116|NCT02213068|Renal|renal
325117|NCT02213068|Transplant|transplant
325118|NCT02213068|EBV|ebv
325119|NCT02213068|Immunosuppressants|immunosuppressants
325120|NCT02213068|Belatacept|belatacept
325121|NCT02213055|Lice|lice
325122|NCT02213042|biomarker|biomarker
325123|NCT02213042|Lapatinib|lapatinib
325124|NCT02213042|Prosigna|prosigna
325125|NCT02213042|ErbB2|erbb2
325126|NCT02213042|PAM50|pam50
325127|NCT02213042|HER2|her2
325128|NCT02213042|HER2-overexpressing metastatic breast cancer|her2-overexpressing metastatic breast cancer
325129|NCT02213042|HER2-enriched|her2-enriched
325130|NCT02213042|Trastuzumab|trastuzumab
325131|NCT02213029|epelsiban|epelsiban
325132|NCT02213029|pharmacokinetics|pharmacokinetics
325133|NCT02213029|patient reported pain / discomfort|patient reported pain / discomfort
325134|NCT02213029|pharmacodynamics|pharmacodynamics
325135|NCT02213029|oxytocin infusions|oxytocin infusions
325136|NCT02213029|Uterine contractions|uterine contractions
325137|NCT02213016|Stimulation magnetic transcranial, major depression, cognitive impairment|stimulation magnetic transcranial, major depression, cognitive impairment
325138|NCT02213003|islet transplantation|islet transplantation
325139|NCT02212990|Fever|fever
325140|NCT02212990|Antipyretics|antipyretics
325141|NCT02212990|Acetaminophen|acetaminophen
325142|NCT02212990|Ibuprofen|ibuprofen
325143|NCT02212990|Influenza vaccine|influenza vaccine
325144|NCT02212990|Influenza|influenza
325145|NCT02212990|Body temperature changes|body temperature changes
325146|NCT02212990|Signs and symptoms|signs and symptoms
325148|NCT02212977|Octyl 2-cyanoacrylate|octyl 2-cyanoacrylate
325149|NCT02212977|2-octylcyanoacrylate|2-octylcyanoacrylate
325150|NCT02212964|Radiation Injury|radiation injury
325151|NCT02212964|Radiation Necrosis|radiation necrosis
325152|NCT02212964|Ultra-high field MRI|ultra-high field mri
325153|NCT02212964|Susceptibility Weighted Imaging|susceptibility weighted imaging
325154|NCT02212964|Post-treatment radiographic imaging change|post-treatment radiographic imaging change
325155|NCT02212912|acute ischemic stroke, performance measure, acute treatment|acute ischemic stroke, performance measure, acute treatment
325156|NCT02212899|Spinal Surgery|spinal surgery
325157|NCT02212899|Spinal Fusion|spinal fusion
325158|NCT02212899|Deformity Correction|deformity correction
325159|NCT02212899|Spinal Instrumentation|spinal instrumentation
325160|NCT02212886|Glatiramer acetate|glatiramer acetate
325161|NCT02212886|Copaxone|copaxone
325162|NCT02212886|Multiple sclerosis|multiple sclerosis
325163|NCT02212886|Relapsing remitting multiple sclerosis|relapsing remitting multiple sclerosis
325164|NCT02212886|RRMS|rrms
325165|NCT02212886|GA Depot|ga depot
325166|NCT02212886|Monthly injection|monthly injection
325167|NCT02212873|school based intervention|school based intervention
325168|NCT02212873|overweight|overweight
325169|NCT02212873|obese|obese
325170|NCT02212873|BMI z score|bmi z score
325171|NCT02212873|fat mass|fat mass
325172|NCT02212860|neoadjuvant|neoadjuvant
325173|NCT02212860|radiation|radiation
325174|NCT02212860|breast|breast
325175|NCT02212860|cancer|cancer
325176|NCT02212860|hypofractionation|hypofractionation
325177|NCT02212860|stereotactic|stereotactic
325178|NCT02212860|preoperative|preoperative
325179|NCT02212834|Breast|breast
325180|NCT02212834|Cancer|cancer
325181|NCT02212834|Surveillance|surveillance
325182|NCT02212834|Imaging|imaging
325183|NCT02212834|Comparative|comparative
325184|NCT02212834|Effectiveness|effectiveness
325185|NCT02212808|Cluster-randomized crossover trial|cluster-randomized crossover trial
325186|NCT02212808|Antimicrobial stewardship|antimicrobial stewardship
325187|NCT02212808|Community hospitals|community hospitals
325188|NCT02212808|Feasibility|feasibility
325189|NCT02212795|healthy|healthy
325190|NCT02212782|Healthy|healthy
325191|NCT02212769|healthy|healthy
325192|NCT02212756|healthy|healthy
325193|NCT02212717|Acute cholecystitis|acute cholecystitis
325194|NCT02212717|EUS-guided gallbladder drainage|eus-guided gallbladder drainage
325195|NCT02212717|Percutaneous cholecystostomy|percutaneous cholecystostomy
325196|NCT02212704|vestibular|vestibular
325197|NCT02212704|proprioception|proprioception
325198|NCT02212704|spatial orientation|spatial orientation
325199|NCT02212704|bayesian|bayesian
325200|NCT02212691|Sickle Cell|sickle cell
325201|NCT02212652|Bariatric surgery|bariatric surgery
325202|NCT02212652|Vitamin D deficiency|vitamin d deficiency
325203|NCT02212652|Vitamin D insufficiency|vitamin d insufficiency
325204|NCT02212652|Adverse surgical outcomes|adverse surgical outcomes
325205|NCT02212652|Clinical outcomes|clinical outcomes
325206|NCT02212639|Kaposi' s sarcoma|kaposi' s sarcoma
325207|NCT02212639|Digoxin|digoxin
325208|NCT02212613|Major Depressive Disorder|major depressive disorder
325209|NCT02212613|Mental Disorders, nonpsychotic episode, antipsychotic|mental disorders, nonpsychotic episode, antipsychotic
325210|NCT02212613|Mood Disorder, psychotic disorder|mood disorder, psychotic disorder
325211|NCT02212587|inhaled antibiotics|inhaled antibiotics
325212|NCT02212574|Wnt|wnt
325213|NCT02212574|Medulloblastoma|medulloblastoma
325214|NCT02212574|Chemotherapy|chemotherapy
325215|NCT02212548|SpaceOAR Hydrogel Image Guided Modulated Radiotherapy|spaceoar hydrogel image guided modulated radiotherapy
325216|NCT02212535|Sickle cell disease|sickle cell disease
325217|NCT02212535|Open monocenter study|open monocenter study
325218|NCT02212535|Phase I/II|phase i/ii
325219|NCT02212535|hematopoietic stem cells|hematopoietic stem cells
325220|NCT02212535|Plerixafor|plerixafor
325221|NCT02212522|Diabetes Mellitus|diabetes mellitus
325222|NCT02212522|Insulin-Dependent|insulin-dependent
325223|NCT02212522|Genome-Wide Association Study|genome-wide association study
325224|NCT02212522|Environment-Wide Association Study|environment-wide association study
325225|NCT02212522|Predisposition|predisposition
325226|NCT02212522|Complications|complications
325227|NCT02212483|Asthma|asthma
325228|NCT02212483|Medical Indoor Environment Counselors|medical indoor environment counselors
325229|NCT02212483|Pediatric|pediatric
325230|NCT02212483|Environment|environment
325231|NCT02212483|Clinical effectiveness|clinical effectiveness
325232|NCT02212483|Economical impact|economical impact
325233|NCT02212444|plantar fasciitis|plantar fasciitis
325234|NCT02212444|dynamic elastomeric fabric orthoses (DEFO)|dynamic elastomeric fabric orthoses (defo)
325235|NCT02212444|feasibility|feasibility
325236|NCT02212444|Physiotherapy|physiotherapy
325237|NCT02212444|Musculoskeletal|musculoskeletal
325238|NCT02212431|Cystic Fibrosis|cystic fibrosis
325239|NCT02212431|Cysteamine|cysteamine
325240|NCT02212431|Pharmacokinetics|pharmacokinetics
325241|NCT02212405|Deep rTMS|deep rtms
325242|NCT02212405|Insular cortex|insular cortex
325243|NCT02212405|PET|pet
325244|NCT02212405|[11C]-PHNO|[11c]-phno
325245|NCT02212392|acute pancreatitis|acute pancreatitis
325246|NCT02212379|Raltegravir|raltegravir
325247|NCT02212379|Etravirine|etravirine
325248|NCT02212379|aged, 45 and over|aged, 45 and over
325249|NCT02212379|Viral load|viral load
325250|NCT02212379|Efficacy|efficacy
325251|NCT02212379|Safety|safety
325252|NCT02212366|TDCS|tdcs
325253|NCT02212366|Depression|depression
325254|NCT02212366|Brain Stimulation|brain stimulation
325255|NCT02212366|Memory|memory
325256|NCT02212366|Cognition|cognition
325257|NCT02212366|EEG|eeg
325258|NCT02212340|propofol|propofol
325259|NCT02212340|desflurane|desflurane
325260|NCT02212340|quality of recovery|quality of recovery
325261|NCT02212340|vitrectomy|vitrectomy
325262|NCT02212327|Na+ MRI|na+ mri
325263|NCT02212327|salt stores|salt stores
325264|NCT02212314|Response Inhibition, Williams Syndrome|response inhibition, williams syndrome
325265|NCT02212275|ASD|asd
325266|NCT02212275|autism|autism
325267|NCT02212275|typical development|typical development
325268|NCT02212275|sensory testing|sensory testing
325269|NCT02212275|the cortical metric|the cortical metric
325270|NCT02212249|soluble VE-cadherin|soluble ve-cadherin
325271|NCT02212249|antibody|antibody
325272|NCT02212249|systemic slerosis|systemic slerosis
325273|NCT02212236|Distress|distress
325274|NCT02212236|Depression|depression
325275|NCT02212236|Anxiety|anxiety
325276|NCT02212236|Stress|stress
325277|NCT02212236|Coping|coping
325278|NCT02212236|Illness perceptions|illness perceptions
325279|NCT02212236|Stem cell transplantation|stem cell transplantation
325280|NCT02212236|Bone marrow transplantation|bone marrow transplantation
325281|NCT02212223|Vitamin D|vitamin d
325282|NCT02212223|Serum 25-hydroxyvitamin D (25OHD)|serum 25-hydroxyvitamin d (25ohd)
325283|NCT02212223|Dietary supplement|dietary supplement
325284|NCT02212223|Ethnicity|ethnicity
325285|NCT02212223|Immigrant|immigrant
325286|NCT02212197|prostate cancer|prostate cancer
325287|NCT02212197|leuprolide|leuprolide
325288|NCT02212184|Diaphragm|diaphragm
325289|NCT02212184|COPD|copd
325290|NCT02212184|Musculoskeletal Manipulations|musculoskeletal manipulations
325291|NCT02212184|Ultrasonography|ultrasonography
325292|NCT02212184|Optoelectronic Plethysmography.|optoelectronic plethysmography.
325293|NCT02212158|Type 1 diabetes|type 1 diabetes
325294|NCT02212158|adolescents|adolescents
325295|NCT02212158|HA1c|ha1c
325296|NCT02212158|psychological intervention|psychological intervention
325297|NCT02212145|prevention|prevention
325298|NCT02212145|cardiovascular disease|cardiovascular disease
325299|NCT02212145|risk factors|risk factors
325300|NCT02212132|metamemory|metamemory
325301|NCT02212132|memory complaints|memory complaints
325302|NCT02212132|performance mnemonic|performance mnemonic
325303|NCT02212132|cancer|cancer
325304|NCT02212119|Dementia|dementia
325305|NCT02212119|Paratonia|paratonia
325306|NCT02212119|Caregiver Burden|caregiver burden
325307|NCT02212119|Botulinum toxin|botulinum toxin
325308|NCT02212093|Pneumonia, mechanical ventilation, ICU, mortality|pneumonia, mechanical ventilation, icu, mortality
325309|NCT02212041|electronic cigarettes|electronic cigarettes
325310|NCT02212041|smoking|smoking
325311|NCT02212041|schizophrenia|schizophrenia
325312|NCT02212041|serious mental illness|serious mental illness
325313|NCT02212028|ST-elevation myocardial infarction|st-elevation myocardial infarction
325314|NCT02212028|prasugrel|prasugrel
325315|NCT02212028|pharmacodynamic|pharmacodynamic
325316|NCT02212028|pharmacokinetic|pharmacokinetic
325317|NCT02212002|Group B Streptococcus|group b streptococcus
325318|NCT02212002|Intrapartum Antibiotic Prophylaxis|intrapartum antibiotic prophylaxis
325319|NCT02212002|term infants|term infants
325320|NCT02212002|vaginal delivery|vaginal delivery
325321|NCT02212002|gut microbiota|gut microbiota
325322|NCT02212002|feeding|feeding
325323|NCT02212002|molecular analysis|molecular analysis
325324|NCT02212002|real-time PCR|real-time pcr
325325|NCT02211846|Pharmacokinetics|pharmacokinetics
325326|NCT02211846|Mirabegron|mirabegron
325327|NCT02211846|Neurogenic detrusor overactivity (NDO)|neurogenic detrusor overactivity (ndo)
325328|NCT02211846|Overactive bladder (OAB)|overactive bladder (oab)
325329|NCT02211820|Encephalopathy|encephalopathy
325330|NCT02211820|Imaging Studies|imaging studies
325331|NCT02211820|Dementia|dementia
325332|NCT02211820|Cerebellar Cortical Atrophy|cerebellar cortical atrophy
325333|NCT02211794|Total Knee Arthroplasty|total knee arthroplasty
325334|NCT02211794|degenerative joint disease|degenerative joint disease
325335|NCT02211781|Tribal Communities|tribal communities
325336|NCT02211781|Radiation|radiation
325337|NCT02211781|Cancer|cancer
325338|NCT02211768|Genetic Analysis|genetic analysis
325339|NCT02211768|Biopsy|biopsy
325340|NCT02211768|FDG-PET|fdg-pet
325341|NCT02211768|FLT-PET|flt-pet
325342|NCT02211755|Purine Nucleoside Inhibitor|purine nucleoside inhibitor
325343|NCT02211755|Proteasome Inhibitor|proteasome inhibitor
325344|NCT02211755|Combination Treatment|combination treatment
325345|NCT02211755|Solid Tumors|solid tumors
325346|NCT02211755|Hematologic|hematologic
325347|NCT02211742|dapagliflozin|dapagliflozin
325348|NCT02211742|fasting glucose|fasting glucose
325349|NCT02211742|postprandial glucose excursion|postprandial glucose excursion
325350|NCT02211742|euglycemic hyperinsulinemic clamp|euglycemic hyperinsulinemic clamp
325351|NCT02211742|euglycemic oral glucose tolerance test|euglycemic oral glucose tolerance test
325352|NCT02211703|perioperative hypothermia|perioperative hypothermia
325353|NCT02211703|Epidemiology|epidemiology
325354|NCT02211703|Tympanic temperature|tympanic temperature
325355|NCT02211651|adipose tissue|adipose tissue
325356|NCT02211651|placenta|placenta
325357|NCT02211651|pregnancy|pregnancy
325358|NCT02211651|umbilical cord|umbilical cord
325359|NCT02211638|Drug Therapy|drug therapy
325360|NCT02211625|Healthy|healthy
325361|NCT02211625|Pharmacodynamics (PD)|pharmacodynamics (pd)
325362|NCT02211625|Pharmacokinetics (PK)|pharmacokinetics (pk)
325363|NCT02211612|Overfeeding|overfeeding
325364|NCT02211612|Weight gain|weight gain
325365|NCT02211612|Liver fat|liver fat
325366|NCT02211612|Pancreatic fat|pancreatic fat
325367|NCT02211612|Ectopic fat|ectopic fat
325368|NCT02211612|Skeletal muscle|skeletal muscle
325369|NCT02211612|Adipose tissue|adipose tissue
325370|NCT02211612|Gene expression|gene expression
325371|NCT02211612|DNA methylation|dna methylation
325372|NCT02211612|Palmitate|palmitate
325373|NCT02211612|Linoleic acid|linoleic acid
325374|NCT02211612|Saturated fat|saturated fat
325375|NCT02211612|Polyunsaturated fat|polyunsaturated fat
325376|NCT02211612|Metabolism|metabolism
325377|NCT02211612|Insulin sensitivity|insulin sensitivity
325378|NCT02211599|protein|protein
325379|NCT02211599|carbohydrate|carbohydrate
325380|NCT02211599|lipid|lipid
325381|NCT02211599|oxidation|oxidation
325382|NCT02211599|fat|fat
325383|NCT02211599|sugar|sugar
325384|NCT02211599|juice|juice
325385|NCT02211599|obesity|obesity
325386|NCT02211573|Autonomic Nervous System, Body composition, Oxygen Uptake,|autonomic nervous system, body composition, oxygen uptake,
325387|NCT02211573|Water Based Physical Training.|water based physical training.
325388|NCT02211534|Pulsed Electromagnetic Energy Fields|pulsed electromagnetic energy fields
325389|NCT02211534|Total Knee Arthroplasty|total knee arthroplasty
325390|NCT02211534|Pain Intensity|pain intensity
325391|NCT02211521|Osteoarthritis, platelet-rich plasma, hyaluronic acid|osteoarthritis, platelet-rich plasma, hyaluronic acid
325392|NCT02211508|fibromyalgia|fibromyalgia
325393|NCT02211508|pain|pain
325394|NCT02211508|stimulation|stimulation
325395|NCT02211482|HIV-1 infected patients|hiv-1 infected patients
325396|NCT02211482|dual therapy|dual therapy
325397|NCT02211456|Endocardial pacing|endocardial pacing
325398|NCT02211456|Multi site pacing|multi site pacing
325399|NCT02211443|Full human anti-EGFR monoclonal antibody (SCT200) ;|full human anti-egfr monoclonal antibody (sct200) ;
325400|NCT02211443|metastatic colorectal cancer （mCRC）;|metastatic colorectal cancer （mcrc）;
325401|NCT02211443|Escalating doses ;|escalating doses ;
325402|NCT02211443|single dose and multiple doses;|single dose and multiple doses;
325403|NCT02211443|safety, tolerability and pharmacokinetics.|safety, tolerability and pharmacokinetics.
325404|NCT02211430|smoking cessation|smoking cessation
325405|NCT02211430|pregnancy|pregnancy
325406|NCT02211430|postpartum|postpartum
325407|NCT02211430|intervention|intervention
325408|NCT02211391|Nighttime Eating|nighttime eating
325409|NCT02211391|Protein|protein
325410|NCT02211391|Obesity|obesity
325411|NCT02211391|Lipolysis|lipolysis
325412|NCT02211391|Metabolism|metabolism
325413|NCT02211378|stress|stress
325414|NCT02211378|performance|performance
325415|NCT02211378|cortisol|cortisol
325416|NCT02211365|Hypertension|hypertension
325417|NCT02211365|CVD|cvd
325418|NCT02211352|blood pressure, ginseng|blood pressure, ginseng
325419|NCT02211339|Social skills|social skills
325420|NCT02211339|Social communication|social communication
325421|NCT02211339|Cognitive communication|cognitive communication
325422|NCT02211339|Traumatic brain injury|traumatic brain injury
325423|NCT02211339|Acquired brain injury|acquired brain injury
325424|NCT02211339|Communication partner training|communication partner training
325425|NCT02211339|Peer partner training|peer partner training
325426|NCT02211339|Peer mentoring|peer mentoring
325427|NCT02211339|Rehabilitation|rehabilitation
325428|NCT02211326|AF or DVT|af or dvt
325429|NCT02211326|Age Over 18 Years, Acquired|age over 18 years, acquired
325430|NCT02211300|glucose monitoring|glucose monitoring
325431|NCT02211300|OptiScanner|optiscanner
325432|NCT02211287|Dementia|dementia
325433|NCT02211287|Decision-making|decision-making
325434|NCT02211287|Communication|communication
325435|NCT02211287|Advance Care Planning|advance care planning
325436|NCT02211274|Quality of Life|quality of life
325437|NCT02211274|Nursing Homes|nursing homes
325438|NCT02211274|Housing for the Elderly|housing for the elderly
325439|NCT02211274|Homes for the Aged|homes for the aged
325440|NCT02211261|first in human|first in human
325441|NCT02211261|single dose|single dose
325442|NCT02211261|multiple dose|multiple dose
325443|NCT02211261|escalation|escalation
325444|NCT02211261|safety study|safety study
325445|NCT02211261|Type 2 Diabetes Mellitus|type 2 diabetes mellitus
325446|NCT02211248|Cardiac Frequency Variability|cardiac frequency variability
325447|NCT02211248|multidisciplinary care|multidisciplinary care
325448|NCT02211248|clinical trial|clinical trial
325449|NCT02211235|Cystic Fibrosis|cystic fibrosis
325450|NCT02211235|Healthy Controls|healthy controls
325451|NCT02211235|Diabetes|diabetes
325452|NCT02211235|Cystic Fibrosis Related Diabetes (CFRD)|cystic fibrosis related diabetes (cfrd)
325453|NCT02211235|CFRD|cfrd
325454|NCT02211222|Thyroid Cancer|thyroid cancer
325455|NCT02211222|Radioiodine-Refractory|radioiodine-refractory
325456|NCT02211222|Differentiated|differentiated
325457|NCT02211183|Massive Rotator Cuff Tear|massive rotator cuff tear
325458|NCT02211183|Sub-acromial spacer|sub-acromial spacer
325459|NCT02211183|Best repair of rotator cuff|best repair of rotator cuff
325460|NCT02211105|GastroEsophageal Reflux Disease|gastroesophageal reflux disease
325461|NCT02211105|Transoral Incisionless Fundoplication|transoral incisionless fundoplication
325462|NCT02211105|Laparoscopic Nissen Fundoplication|laparoscopic nissen fundoplication
325463|NCT02211092|Family Caregivers|family caregivers
325464|NCT02211092|Advanced Cancer|advanced cancer
325465|NCT02211092|Palliative Care|palliative care
325466|NCT02211092|Support|support
325467|NCT02211092|Self Care|self care
325468|NCT02211092|Physical Activity|physical activity
325469|NCT02211079|Healthy|healthy
325470|NCT02211079|JNJ-54861911|jnj-54861911
325471|NCT02211079|Caffeine|caffeine
325472|NCT02211079|Midazolam|midazolam
325473|NCT02211079|Tolbutamide|tolbutamide
325474|NCT02211079|Cytochrome P450 3A4|cytochrome p450 3a4
325475|NCT02211079|Cytochrome P450 2C9|cytochrome p450 2c9
325476|NCT02211079|Cytochrome P450 1A2|cytochrome p450 1a2
325477|NCT02211079|Alzheimer's disease|alzheimer's disease
325478|NCT02211053|Organ donation|organ donation
325479|NCT02211053|Brain dead|brain dead
325480|NCT02211053|Levothyroxine|levothyroxine
325481|NCT02211040|Intervention Mapping Protocol|intervention mapping protocol
325482|NCT02211040|physical activity|physical activity
325483|NCT02211040|fruit intake|fruit intake
325484|NCT02211040|vegetable intake|vegetable intake
325485|NCT02211040|computer tailoring|computer tailoring
325486|NCT02211040|eHealth|ehealth
325487|NCT02211040|self-regulation|self-regulation
325488|NCT02211040|goal setting|goal setting
325489|NCT02211040|problem solving|problem solving
325490|NCT02211040|general practice|general practice
325491|NCT02211027|Squamous Cell Carcinoma|squamous cell carcinoma
325492|NCT02211027|Head & Neck Cancer|head & neck cancer
325493|NCT02211027|Vaccine|vaccine
325494|NCT02211027|Carcinoma|carcinoma
325495|NCT02211027|Immunization|immunization
325496|NCT02211027|Autologous Tumor|autologous tumor
325497|NCT02211014|Bruton tyrosine kinase inhibitor|bruton tyrosine kinase inhibitor
325498|NCT02211014|Btk|btk
325499|NCT02211014|Multiple Myeloma|multiple myeloma
325500|NCT02211014|MM|mm
325501|NCT02211014|ACP-196|acp-196
325502|NCT02211014|acalabrutinib|acalabrutinib
325503|NCT02211001|Exercise Movement Techniques|exercise movement techniques
325504|NCT02211001|Exercise Therapy|exercise therapy
325505|NCT02211001|Physical Therapy Modalities.|physical therapy modalities.
325506|NCT02210988|Acupuncture therapy, Acute stroke, Randomized controlled trials|acupuncture therapy, acute stroke, randomized controlled trials
325507|NCT02210975|GERD|gerd
325508|NCT02210975|LES|les
325509|NCT02210975|Sleeve Gastrectomy|sleeve gastrectomy
325510|NCT02210975|Electrical Stimulation Therapy|electrical stimulation therapy
325511|NCT02210962|early psychosis|early psychosis
325512|NCT02210962|chronic schizophrenia|chronic schizophrenia
325513|NCT02210962|first episode psychosis|first episode psychosis
325514|NCT02210962|omega-3 and omega-6 essential fatty acids|omega-3 and omega-6 essential fatty acids
325515|NCT02210962|relapse prevention|relapse prevention
325516|NCT02210962|efficacy|efficacy
325517|NCT02210949|Blood transfusion|blood transfusion
325518|NCT02210949|Erythropoietin|erythropoietin
325519|NCT02210949|Iron suppletion|iron suppletion
325520|NCT02210923|Baroreflex|baroreflex
325521|NCT02210923|Electrical stimulation|electrical stimulation
325522|NCT02210923|Carotid body|carotid body
325523|NCT02210923|Chemoreceptors|chemoreceptors
325524|NCT02210923|Resistant hypertension|resistant hypertension
325525|NCT02210910|Massive Rotator Cuff Tear, Sub-acromial spacer, Best repair of rotator cuff|massive rotator cuff tear, sub-acromial spacer, best repair of rotator cuff
325526|NCT02210884|Vitamin D supplementation|vitamin d supplementation
325527|NCT02210884|Lactation|lactation
325528|NCT02210884|25 hydroxyvitamin D|25 hydroxyvitamin d
325529|NCT02210884|Breast feeding|breast feeding
325530|NCT02210845|Diabetes|diabetes
325531|NCT02210845|Supervised Exercise|supervised exercise
325532|NCT02210845|Weight loss|weight loss
325533|NCT02210832|smoking|smoking
325534|NCT02210832|pregnancy|pregnancy
325535|NCT02210832|cessation|cessation
325536|NCT02210832|incentives|incentives
325537|NCT02210819|Thromboembolism|thromboembolism
325538|NCT02210819|Embolism and Thrombosis|embolism and thrombosis
325539|NCT02210819|Vascular Diseases|vascular diseases
325540|NCT02210819|Cardiovascular Diseases|cardiovascular diseases
325541|NCT02210819|Thrombosis|thrombosis
325542|NCT02210806|Asthma|asthma
325543|NCT02210806|Mild-to-moderate persistent asthma|mild-to-moderate persistent asthma
325544|NCT02210806|Mild asthma|mild asthma
325545|NCT02210806|Moderate asthma|moderate asthma
325546|NCT02210806|Persistent asthma|persistent asthma
325547|NCT02210793|Transepithelial PRK|transepithelial prk
325548|NCT02210793|Dry eye|dry eye
325549|NCT02210793|Schirmer test|schirmer test
325550|NCT02210793|Tear break up time|tear break up time
325551|NCT02210793|Dry eye after advanced surface ablation technique|dry eye after advanced surface ablation technique
325552|NCT02210754|Nicotine|nicotine
325553|NCT02210754|Pharmacokinetics|pharmacokinetics
325554|NCT02210754|Pharmacodynamics|pharmacodynamics
325555|NCT02210754|blu e-cigs|blu e-cigs
325556|NCT02210754|Tolerability|tolerability
325557|NCT02210754|Safety|safety
325558|NCT02210754|Smoke urge|smoke urge
325559|NCT02210741|immune repertoire|immune repertoire
325560|NCT02210741|Graves' disease|graves' disease
325561|NCT02210728|cognitive behavioral therapy|cognitive behavioral therapy
325562|NCT02210728|stimulant medication|stimulant medication
325563|NCT02210728|efficacy|efficacy
325564|NCT02210728|symptoms|symptoms
325565|NCT02210728|functional outcomes|functional outcomes
325566|NCT02210663|Breast cancer|breast cancer
325567|NCT02210663|PARP|parp
325568|NCT02210663|Primary peritoneal cancer|primary peritoneal cancer
325569|NCT02210663|Fallopian tube|fallopian tube
325570|NCT02210663|Ovarian cancer|ovarian cancer
325571|NCT02210663|veliparib|veliparib
325572|NCT02210663|ABT-888|abt-888
325573|NCT02210663|BRCA|brca
325574|NCT02210650|kidney stone|kidney stone
325575|NCT02210637|Appointments and Schedules|appointments and schedules
325576|NCT02210637|Outpatient Clinics, Hospital/Economics|outpatient clinics, hospital/economics
325577|NCT02210637|Emergency Department|emergency department
325578|NCT02210637|Hospitalization|hospitalization
325579|NCT02210637|Mortality|mortality
325580|NCT02210624|Anoxic Brain Injury|anoxic brain injury
325581|NCT02210624|Autologous bone marrow derived stem cell|autologous bone marrow derived stem cell
325582|NCT02210624|stoke|stoke
325583|NCT02210598|labor, induced|labor, induced
325584|NCT02210598|catheter|catheter
325585|NCT02210598|oxytocin|oxytocin
325586|NCT02210598|Cesarean section|cesarean section
325587|NCT02210572|Intestinal microbiota|intestinal microbiota
325588|NCT02210572|Intestinal gas|intestinal gas
325589|NCT02210572|Dietary intervention|dietary intervention
325590|NCT02210572|Low-FODMAPs diet|low-fodmaps diet
325591|NCT02210572|Prebiotics|prebiotics
325592|NCT02210559|locally|locally
325593|NCT02210559|advanced|advanced
325594|NCT02210559|pancreatic|pancreatic
325595|NCT02210559|cancer|cancer
325596|NCT02210559|unresectable|unresectable
325597|NCT02210559|pancreatic cancer|pancreatic cancer
325598|NCT02210546|breast cancer|breast cancer
325599|NCT02210546|intermediate risk|intermediate risk
325600|NCT02210507|vitamin A|vitamin a
325601|NCT02210507|retinol|retinol
325602|NCT02210507|carotenoids|carotenoids
325603|NCT02210481|vitrectomy,|vitrectomy,
325604|NCT02210481|macular thinning,|macular thinning,
325605|NCT02210481|retinal detachment,|retinal detachment,
325606|NCT02210481|epimacular membrane,|epimacular membrane,
325607|NCT02210481|intravitreal glucose,|intravitreal glucose,
325608|NCT02210481|OCT|oct
325609|NCT02210468|Osteoarthritis|osteoarthritis
325610|NCT02210468|Protease Inhibitors|protease inhibitors
325611|NCT02210468|Alpha-2-macroglobulin|alpha-2-macroglobulin
325612|NCT02210468|Autologous treatment|autologous treatment
325613|NCT02210468|APIC-CF|apic-cf
325614|NCT02210468|Pain due to Mild to Moderate osteoarthritis (OA) of the knee|pain due to mild to moderate osteoarthritis (oa) of the knee
325615|NCT02210455|FASD|fasd
325616|NCT02210455|pFAS|pfas
325617|NCT02210455|ARND|arnd
325618|NCT02210455|Fetal Alcohol Syndrome|fetal alcohol syndrome
325619|NCT02210455|Partial Fetal Alcohol Syndrome|partial fetal alcohol syndrome
325620|NCT02210455|Alcohol Related Neurodevelopmental Disorder|alcohol related neurodevelopmental disorder
325621|NCT02210455|Static Encephalopathy (Alcohol Exposed)|static encephalopathy (alcohol exposed)
325622|NCT02210455|Neurobehavioural Disorder (Alcohol Exposed)|neurobehavioural disorder (alcohol exposed)
325623|NCT02210442|educational games|educational games
325624|NCT02210442|clinical practice guideline|clinical practice guideline
325625|NCT02210442|family medicine|family medicine
325626|NCT02210442|primary health care|primary health care
325627|NCT02210442|cluster clinical trial|cluster clinical trial
325628|NCT02210429|Supraclavicular Block|supraclavicular block
325629|NCT02210429|Supraclavicular Catheter|supraclavicular catheter
325630|NCT02210429|Pediatric Anesthesia|pediatric anesthesia
325631|NCT02210429|Regional Anesthesia|regional anesthesia
325632|NCT02210429|Supracondylar Elbow Fracture|supracondylar elbow fracture
325633|NCT02210390|Psycho-education, Bipolar , cultural adaptation, Pakistan|psycho-education, bipolar , cultural adaptation, pakistan
325634|NCT02210377|Auto-moxibusition, intra-dialytic hypotension, hemodialysis|auto-moxibusition, intra-dialytic hypotension, hemodialysis
325635|NCT02210325|gonorrhea|gonorrhea
325636|NCT02210325|chlamydia|chlamydia
325637|NCT02210325|solithromycin|solithromycin
325638|NCT02210299|Healthy young children (2-6 months ; 12-18 months)|healthy young children (2-6 months ; 12-18 months)
325639|NCT02210286|dementia|dementia
325640|NCT02210286|magnesium|magnesium
325641|NCT02210286|learning|learning
325642|NCT02210286|memory|memory
325745|NCT02209766|D5884|d5884
325643|NCT02210286|Alzheimer's disease|alzheimer's disease
325644|NCT02210273|Stress Urinary Incontinence|stress urinary incontinence
325645|NCT02210273|SUI|sui
325646|NCT02210260|Cancer|cancer
325647|NCT02210260|Colorectal|colorectal
325648|NCT02210260|Pain relief|pain relief
325649|NCT02210234|wheat bran|wheat bran
325650|NCT02210234|healthy immunity|healthy immunity
325651|NCT02210234|T cells|t cells
325652|NCT02210221|TBI|tbi
325653|NCT02210195|Cannabis Treatment|cannabis treatment
325654|NCT02210195|Alcohol Treatment|alcohol treatment
325655|NCT02210195|Alcohol-Related Disorders|alcohol-related disorders
325656|NCT02210195|Cannabis-Related Disorders|cannabis-related disorders
325657|NCT02210195|Substance-Related Disorders|substance-related disorders
325658|NCT02210195|Emend|emend
325659|NCT02210195|NK1 receptor antagonist|nk1 receptor antagonist
325660|NCT02210195|Alcohol|alcohol
325661|NCT02210195|Cannabis|cannabis
325662|NCT02210195|aprepitant|aprepitant
325663|NCT02210182|Hepatocellular carcinoma|hepatocellular carcinoma
325664|NCT02210182|Oral Pentamidine|oral pentamidine
325665|NCT02210182|Endo-exonuclease|endo-exonuclease
325666|NCT02210156|Respiratory tract infection|respiratory tract infection
325667|NCT02210156|Incidence|incidence
325668|NCT02210156|Dietary supplements|dietary supplements
325669|NCT02210156|Micronutrients|micronutrients
325670|NCT02210156|Plant extracts|plant extracts
325671|NCT02210104|Melanoma|melanoma
325672|NCT02210104|Sarcoma|sarcoma
325673|NCT02210104|Mixed round cell liposarcoma|mixed round cell liposarcoma
325674|NCT02210104|Advanced|advanced
325675|NCT02210104|Metastatic|metastatic
325676|NCT02210104|Immunotherapy|immunotherapy
325677|NCT02210104|Ipilimumab|ipilimumab
325678|NCT02210104|Yervoy|yervoy
325679|NCT02210104|BMS-734016|bms-734016
325680|NCT02210104|MDX010|mdx010
325681|NCT02210104|Cyclophosphamide|cyclophosphamide
325682|NCT02210104|Cytoxan|cytoxan
325683|NCT02210104|Neosar|neosar
325684|NCT02210104|CD4+T Cells|cd4+t cells
325685|NCT02210065|Leukemia|leukemia
325686|NCT02210065|Lymphoma|lymphoma
325687|NCT02210065|Blood And Marrow Transplantation|blood and marrow transplantation
325688|NCT02210065|Hematological malignancies|hematological malignancies
325689|NCT02210065|Cytotoxic T cells|cytotoxic t cells
325690|NCT02210065|CTL|ctl
325691|NCT02210065|Cytomegalovirus|cytomegalovirus
325692|NCT02210065|CMV|cmv
325693|NCT02210065|Allogeneic hematopoietic stem cell transplantation|allogeneic hematopoietic stem cell transplantation
325694|NCT02210065|HSCT|hsct
325695|NCT02210052|radiofrequency ablation|radiofrequency ablation
325696|NCT02210039|SECM|secm
325697|NCT02210039|Esophagus|esophagus
325698|NCT02210039|Imaging|imaging
325699|NCT02210026|bubble nasal continuous positive airway pressure (Bn-CPAP)|bubble nasal continuous positive airway pressure (bn-cpap)
325700|NCT02210026|work of breathing|work of breathing
325701|NCT02210026|pressure-rate products|pressure-rate products
325702|NCT02210013|AMH, AFC, aging, ethnicity|amh, afc, aging, ethnicity
325703|NCT02210000|repeat dose|repeat dose
325704|NCT02210000|phase II|phase ii
325705|NCT02210000|GCSI-DD|gcsi-dd
325706|NCT02210000|pharmacodynamics|pharmacodynamics
325707|NCT02210000|gastroparesis|gastroparesis
325708|NCT02210000|type 1 and type 2 diabetes mellitus|type 1 and type 2 diabetes mellitus
325709|NCT02210000|camicinal|camicinal
325710|NCT02210000|GSK962040|gsk962040
325711|NCT02210000|symptoms|symptoms
325712|NCT02210000|gut motility|gut motility
325713|NCT02209974|emphysema|emphysema
325714|NCT02209974|CRP|crp
325715|NCT02209974|interleukin-8|interleukin-8
325716|NCT02209974|dynamic hyperinflation|dynamic hyperinflation
325717|NCT02209935|pediatric|pediatric
325718|NCT02209935|acute neurologic disease|acute neurologic disease
325719|NCT02209935|critical care|critical care
325720|NCT02209935|rehabilitation|rehabilitation
325721|NCT02209935|outcome|outcome
325722|NCT02209922|tDCS, stroke, postural control|tdcs, stroke, postural control
325723|NCT02209909|preoperative aspirin use|preoperative aspirin use
325724|NCT02209909|platelet activation|platelet activation
325725|NCT02209909|off pump coronary artery bypass|off pump coronary artery bypass
325726|NCT02209896|Peripheral Neuropathic Pain|peripheral neuropathic pain
325727|NCT02209896|PNP|pnp
325728|NCT02209883|sevoflurane, anesthesia, washout time,COPD|sevoflurane, anesthesia, washout time,copd
325729|NCT02209870|Cardiopulmonary resuscitation|cardiopulmonary resuscitation
325730|NCT02209870|Teamwork|teamwork
325731|NCT02209870|electronic checklist|electronic checklist
325732|NCT02209857|Breastcancer|breastcancer
325733|NCT02209857|Adjuvant chemotherapy|adjuvant chemotherapy
325734|NCT02209857|70-gene expression profile|70-gene expression profile
325735|NCT02209857|MammaPrint|mammaprint
325736|NCT02209818|Low level laser therapy|low level laser therapy
325737|NCT02209818|Elastomeric separator|elastomeric separator
325738|NCT02209818|Placebo|placebo
325739|NCT02209818|Visual analog scale|visual analog scale
325740|NCT02209818|Laser irradiation|laser irradiation
325741|NCT02209766|Safety|safety
325742|NCT02209766|Tolerability|tolerability
325743|NCT02209766|Pharmacokinetics|pharmacokinetics
325744|NCT02209766|Pharmacodynamics|pharmacodynamics
325746|NCT02209766|Japanese|japanese
325747|NCT02209766|Caucasian|caucasian
325748|NCT02209740|renal toxicity, HIV, antiretroviral, outcome|renal toxicity, hiv, antiretroviral, outcome
325749|NCT02209675|hepatitis C recurrence|hepatitis c recurrence
325750|NCT02209675|Rejection|rejection
765067|NCT00385255|Tdap,|tdap,
416296|NCT01795989|MRI|mri
325751|NCT02209675|Liver Transplantation|liver transplantation
325752|NCT02209675|Liver biopsy|liver biopsy
325753|NCT02209662|APIC-PRP|apic-prp
325754|NCT02209662|Chronic Wounds|chronic wounds
325755|NCT02209662|Diabetic foot ulcer|diabetic foot ulcer
325756|NCT02209636|hyperphosphatemia|hyperphosphatemia
325757|NCT02209636|vascular dysfunction|vascular dysfunction
325758|NCT02209636|chronic kidney disease|chronic kidney disease
325759|NCT02209636|cardiovascular disease|cardiovascular disease
325760|NCT02209636|endothelial dysfunction|endothelial dysfunction
325761|NCT02209610|Heart Failure|heart failure
325762|NCT02209597|Major Depressive Disorder|major depressive disorder
325763|NCT02209597|MDD|mdd
325764|NCT02209597|bupropion XL|bupropion xl
325765|NCT02209597|Wellbutrin XL|wellbutrin xl
325766|NCT02209571|Breath Tests|breath tests
325767|NCT02209545|fibroids, leiomyomata, blood loss, misoprostol|fibroids, leiomyomata, blood loss, misoprostol
325768|NCT02209532|Lymph node mapping|lymph node mapping
325769|NCT02209532|Endometrial cancer|endometrial cancer
325770|NCT02209532|Uterine cancer|uterine cancer
325771|NCT02209532|Cervical cancer|cervical cancer
325772|NCT02209519|bacterial vaginosis|bacterial vaginosis
325773|NCT02209519|recurrence|recurrence
325774|NCT02209519|male partner|male partner
325775|NCT02209506|MLN3126|mln3126
325776|NCT02209493|Dietary intervention|dietary intervention
325777|NCT02209493|Hypercholesterolemic adults|hypercholesterolemic adults
325778|NCT02209493|Vegetable intake|vegetable intake
325779|NCT02209493|Functional food|functional food
325780|NCT02209493|Prevention|prevention
325781|NCT02209467|walking|walking
325782|NCT02209467|postural balance|postural balance
325783|NCT02209467|falls|falls
325784|NCT02209454|Dexketoprofen|dexketoprofen
325785|NCT02209454|Bioavailability|bioavailability
325786|NCT02209454|Comparative|comparative
325787|NCT02209454|Pharmacokinetic|pharmacokinetic
325788|NCT02209441|sorafenib, gastric cancer, FOLFOX4|sorafenib, gastric cancer, folfox4
325789|NCT02209428|Temozolomide|temozolomide
325790|NCT02209428|IDH mutation|idh mutation
325791|NCT02209428|Low grade glioma|low grade glioma
325792|NCT02209389|breast cancer|breast cancer
325793|NCT02209389|cancer associated auto antibodies|cancer associated auto antibodies
325794|NCT02209389|breast cancer blood test|breast cancer blood test
325795|NCT02209363|Parkinson's disease|parkinson's disease
325796|NCT02209363|OSA|osa
325797|NCT02209363|CPAP|cpap
325798|NCT02209363|cognition|cognition
325799|NCT02209311|Alveolar Bone Loss|alveolar bone loss
325800|NCT02209311|Alveolar Bone Atrophy|alveolar bone atrophy
325801|NCT02209311|Dental Implantation|dental implantation
325802|NCT02209311|Bone Tissue Reconstruction|bone tissue reconstruction
325803|NCT02209311|Sinus Lift|sinus lift
325804|NCT02209311|Autologous Multipotent Mesenchymal Stem Cell|autologous multipotent mesenchymal stem cell
325805|NCT02209311|Autologous MMSCs|autologous mmscs
325806|NCT02209311|Synthetic Tricalcium Phosphate|synthetic tricalcium phosphate
325807|NCT02209311|Tissue Engineered Construction|tissue engineered construction
325808|NCT02209311|Oral Mucosa|oral mucosa
325809|NCT02209285|Older adults|older adults
325810|NCT02209285|Home and community care|home and community care
325811|NCT02209285|Effectiveness|effectiveness
325812|NCT02209285|Cost analysis|cost analysis
325813|NCT02209285|Stroke|stroke
325814|NCT02209285|TIA|tia
325815|NCT02209285|Hypertension|hypertension
325816|NCT02209285|Cardiovascular disease|cardiovascular disease
325817|NCT02209220|Obstructive sleep apnea|obstructive sleep apnea
325818|NCT02209220|Treatment compliance|treatment compliance
325819|NCT02209220|Automatic positive airway pressure|automatic positive airway pressure
325820|NCT02209220|Continuous positive airway pressure|continuous positive airway pressure
325821|NCT02209220|Bariatric surgery|bariatric surgery
325822|NCT02209207|chronic obstructive pulmonary disease|chronic obstructive pulmonary disease
325823|NCT02209207|endurance training|endurance training
325824|NCT02209207|interval training|interval training
325825|NCT02209207|continuous training|continuous training
325826|NCT02209207|walking training|walking training
325827|NCT02209194|aneurysms|aneurysms
325828|NCT02209194|vascular disease|vascular disease
325829|NCT02209194|E-liac Stent Graft|e-liac stent graft
325830|NCT02209194|E-liac Stent Graft System|e-liac stent graft system
325831|NCT02209194|iliac aneurysm|iliac aneurysm
325832|NCT02209194|branched stent graft|branched stent graft
325833|NCT02209194|self expanding stent graft|self expanding stent graft
325834|NCT02209181|dental pain|dental pain
325835|NCT02209181|post-surgical dental pain|post-surgical dental pain
325836|NCT02209168|AMH, ACF, VIT D, Ethnicity|amh, acf, vit d, ethnicity
325837|NCT02209142|Major depression|major depression
325838|NCT02209129|digital breast tomosynthesis|digital breast tomosynthesis
325839|NCT02209116|ADHD|adhd
325840|NCT02209116|QB Test|qb test
325841|NCT02209116|Activity|activity
325842|NCT02209116|Attention|attention
325843|NCT02209116|Children|children
325844|NCT02209116|Clinical Decision Making|clinical decision making
325845|NCT02209103|Polyphenols|polyphenols
416453|NCT01795261|HIV|hiv
325846|NCT02209103|Orange|orange
325847|NCT02209103|Sleep|sleep
325848|NCT02209103|Fatigue|fatigue
325849|NCT02209090|occiput-posterior|occiput-posterior
325850|NCT02209090|occipitoposterior|occipitoposterior
325851|NCT02209090|labour|labour
325852|NCT02209064|Subxiphoid|subxiphoid
325853|NCT02209064|Access|access
325854|NCT02209051|Diabetic Foot Ulcers|diabetic foot ulcers
325855|NCT02209051|AMNIOEXCEL|amnioexcel
325856|NCT02209051|Wagner Grade 1 or 2 foot ulcers|wagner grade 1 or 2 foot ulcers
325857|NCT02209051|Wound|wound
325858|NCT02209051|Foot health|foot health
325859|NCT02209051|Ulcer|ulcer
325860|NCT02209051|Foot Ulcer|foot ulcer
325861|NCT02209051|Diabetic Foot|diabetic foot
325862|NCT02209051|Foot Diseases|foot diseases
325863|NCT02209051|Skin Diseases|skin diseases
325864|NCT02209051|Leg Ulcer|leg ulcer
325865|NCT02209051|Skin Ulcer|skin ulcer
325866|NCT02209051|Diabetic Angiopathies|diabetic angiopathies
325867|NCT02209051|Vascular Diseases|vascular diseases
325868|NCT02209051|Cardiovascular Diseases|cardiovascular diseases
325869|NCT02209051|Diabetes Complications|diabetes complications
325870|NCT02209051|Diabetes Mellitus|diabetes mellitus
325871|NCT02209051|Endocrine System Diseases|endocrine system diseases
325872|NCT02209051|Diabetic Neuropathies|diabetic neuropathies
325873|NCT02209038|end stage renal disease|end stage renal disease
325874|NCT02209038|hemodialysis|hemodialysis
325875|NCT02209038|dialysis|dialysis
325876|NCT02209025|Atherosclerosis|atherosclerosis
325877|NCT02209025|Cholesterol|cholesterol
325878|NCT02209025|Cholesterol, HDL|cholesterol, hdl
325879|NCT02209025|Apolipoprotein A-I|apolipoprotein a-i
325880|NCT02209025|Theobromine|theobromine
325881|NCT02209012|Actinic Keratosis|actinic keratosis
325882|NCT02208999|medullary neurostimulation|medullary neurostimulation
325883|NCT02208999|pain|pain
325884|NCT02208999|Precision|precision
325885|NCT02208999|rechargeable|rechargeable
325886|NCT02208999|implantable|implantable
325887|NCT02208986|GnRH antagonist|gnrh antagonist
325888|NCT02208986|GnRH agonist trigger|gnrh agonist trigger
325889|NCT02208986|Oocyte donor|oocyte donor
325890|NCT02208973|Adenosine A1 receptor antagonist|adenosine a1 receptor antagonist
325891|NCT02208973|adenosine receptor modulator|adenosine receptor modulator
325892|NCT02208973|Asthma|asthma
325893|NCT02208973|COPD|copd
325894|NCT02208960|Neurodevelopment|neurodevelopment
325895|NCT02208960|Neonatal kit|neonatal kit
325896|NCT02208960|Kenya|kenya
325897|NCT02208960|Cluster Randomized Controlled Trial|cluster randomized controlled trial
325898|NCT02208960|Chlorhexidine|chlorhexidine
325899|NCT02208960|ThermoSpot|thermospot
325900|NCT02208947|advance care planning|advance care planning
325901|NCT02208947|decision making|decision making
325902|NCT02208947|patient engagement|patient engagement
325903|NCT02208947|patient education|patient education
325904|NCT02208947|financial incentives|financial incentives
325905|NCT02208947|behavioral economics|behavioral economics
325906|NCT02208934|PDE10 inhibitor|pde10 inhibitor
325907|NCT02208934|Huntington's disease|huntington's disease
325908|NCT02208934|phosphodiesterase 10 inhibitor|phosphodiesterase 10 inhibitor
325909|NCT02208934|psychiatric disorders|psychiatric disorders
325910|NCT02208921|Type 2 Diabetes|type 2 diabetes
325911|NCT02208908|Oral care|oral care
325912|NCT02208908|cancer|cancer
325913|NCT02208908|palliative|palliative
325914|NCT02208908|training|training
325915|NCT02208895|pleural|pleural
325916|NCT02208895|glucose|glucose
325917|NCT02208895|glucometer|glucometer
325918|NCT02208895|i-STAT|i-stat
325919|NCT02208869|familial hypercholesterolemia|familial hypercholesterolemia
325920|NCT02208869|cholesterol|cholesterol
325921|NCT02208869|prevention|prevention
325922|NCT02208869|registry|registry
325923|NCT02208869|atherosclerosis|atherosclerosis
325924|NCT02208869|treatment|treatment
325925|NCT02208869|prevalence|prevalence
325926|NCT02208830|bronchiectasis|bronchiectasis
325927|NCT02208830|functional capacity|functional capacity
325928|NCT02208830|lung functional|lung functional
325929|NCT02208817|capillary refill|capillary refill
325930|NCT02208817|paediatric early warning score|paediatric early warning score
325931|NCT02208817|photoplethysmography|photoplethysmography
325932|NCT02208804|Colorectal Cancer Liver Metastases|colorectal cancer liver metastases
325933|NCT02208791|Kidney Transplantation|kidney transplantation
325934|NCT02208791|Graft Rejection|graft rejection
325935|NCT02208791|Immunossupression|immunossupression
325936|NCT02208778|Osteoarthritis|osteoarthritis
325937|NCT02208778|Chronic Pain|chronic pain
325938|NCT02208778|Pain relief|pain relief
325939|NCT02208765|Coronary Circulation|coronary circulation
325940|NCT02208765|Coronary Artery Disease|coronary artery disease
325941|NCT02208765|Myocardial perfusion imaging|myocardial perfusion imaging
325942|NCT02208765|Prognosis|prognosis
325943|NCT02208752|rotator cuff tears|rotator cuff tears
325944|NCT02208752|ultrasound measure|ultrasound measure
325945|NCT02208752|pain|pain
325946|NCT02208752|range of motion|range of motion
325947|NCT02208752|muscle force|muscle force
325948|NCT02208739|Chronic periodontitis|chronic periodontitis
325949|NCT02208739|periodontal pathogens|periodontal pathogens
325950|NCT02208739|inflammatory mediators|inflammatory mediators
325951|NCT02208739|Non surgical periodontal therapy|non surgical periodontal therapy
325952|NCT02208739|Oral hygiene instructions|oral hygiene instructions
325953|NCT02208739|Polymerase chain reaction|polymerase chain reaction
325954|NCT02208739|Elisa|elisa
325955|NCT02208726|anxiety|anxiety
325956|NCT02208726|students|students
325957|NCT02208726|examinations|examinations
325958|NCT02208726|Homeopathy|homeopathy
325959|NCT02208713|FSHD muscle derived stem cell adipose derived mesenchymal stem cell intramuscular injection|fshd muscle derived stem cell adipose derived mesenchymal stem cell intramuscular injection
325960|NCT02208687|Social Participation|social participation
325961|NCT02208687|Fatigue|fatigue
325962|NCT02208687|Self-Management|self-management
325963|NCT02208687|Rehabilitation|rehabilitation
325964|NCT02208687|Physical therapy|physical therapy
325965|NCT02208687|Occupational therapy|occupational therapy
325966|NCT02208687|Group intervention|group intervention
325967|NCT02208687|Exercise|exercise
325968|NCT02208674|chronic kidney disease|chronic kidney disease
325969|NCT02208674|albuminuria|albuminuria
325970|NCT02208674|hypertension|hypertension
325971|NCT02208674|dyslipidemia|dyslipidemia
325972|NCT02208674|cardiovascular disease|cardiovascular disease
325973|NCT02208674|pragmatic trial|pragmatic trial
325974|NCT02208674|cluster randomized trial|cluster randomized trial
325975|NCT02208661|Morquio A syndrome|morquio a syndrome
325976|NCT02208661|Mucopolysaccharidosis IV A|mucopolysaccharidosis iv a
325977|NCT02208661|Psychological health|psychological health
325978|NCT02208648|coronary calcification|coronary calcification
325979|NCT02208648|Computed Tomography|computed tomography
325980|NCT02208648|Coronary artery calcium|coronary artery calcium
325981|NCT02208648|calcium scores|calcium scores
325982|NCT02208648|post-operative mortality|post-operative mortality
325983|NCT02208635|Zinc Absorption|zinc absorption
325984|NCT02208635|Biofortification|biofortification
325985|NCT02208635|Maize|maize
325986|NCT02208635|Zambia|zambia
325987|NCT02208635|Stable isotopes of Zn|stable isotopes of zn
325988|NCT02208622|Zinc absorption|zinc absorption
325989|NCT02208622|Iron Absorption|iron absorption
325990|NCT02208622|Whey Protein|whey protein
325991|NCT02208622|Mexico|mexico
325992|NCT02208622|Stable isotopes|stable isotopes
325993|NCT02208609|Zinc Absorption|zinc absorption
325994|NCT02208609|Maize|maize
325995|NCT02208609|Amaranth|amaranth
325996|NCT02208609|Guatemala|guatemala
325997|NCT02208609|Stable isotopes of Zn|stable isotopes of zn
325998|NCT02208583|Molecular phenotypic；CRPC; personalized treatment|molecular phenotypic；crpc; personalized treatment
325999|NCT02208570|Hypotension during anesthesia induction|hypotension during anesthesia induction
326000|NCT02208557|Incisional hernia|incisional hernia
326001|NCT02208557|prevention|prevention
326002|NCT02208557|laparotomy closure|laparotomy closure
326003|NCT02208557|absorbable mesh|absorbable mesh
326004|NCT02208544|Thyroid Nodule|thyroid nodule
326005|NCT02208544|Indeterminate Cytology|indeterminate cytology
326006|NCT02208544|FDG-PET/CT|fdg-pet/ct
326007|NCT02208544|Diagnostic Thyroid Surgery|diagnostic thyroid surgery
326008|NCT02208544|Efficacy|efficacy
326009|NCT02208544|Cost-Effectiveness|cost-effectiveness
326010|NCT02208544|Quality-of-Life|quality-of-life
326011|NCT02208544|Thyroidectomy|thyroidectomy
326012|NCT02208531|Early Childhood Development (ECD)|early childhood development (ecd)
326013|NCT02208531|Psychosocial stimulation|psychosocial stimulation
326014|NCT02208531|Malnutrition|malnutrition
326015|NCT02208531|Bangladesh|bangladesh
326016|NCT02208531|Scaling up ECD|scaling up ecd
326017|NCT02208518|Endoscopic Ultrasound elastography|endoscopic ultrasound elastography
326018|NCT02208518|Quantitative elastography|quantitative elastography
326019|NCT02208518|Qualitative elastography|qualitative elastography
326020|NCT02208518|Endoscopic Ultrasound|endoscopic ultrasound
326021|NCT02208518|Elastography|elastography
326022|NCT02208492|Levetiracetam, Carabamazepine|levetiracetam, carabamazepine
326023|NCT02208479|cardiac surgery|cardiac surgery
326024|NCT02208479|diaphragm dysfunction|diaphragm dysfunction
326025|NCT02208479|mechanical ventilation weaning|mechanical ventilation weaning
326026|NCT02208479|respiratory paralysis|respiratory paralysis
326027|NCT02208479|muscle weakness|muscle weakness
326028|NCT02208479|cardiac bypass|cardiac bypass
326029|NCT02208479|valvular surgery|valvular surgery
326030|NCT02208479|respiratory insufficiency|respiratory insufficiency
326031|NCT02208466|repetitive transcranial magnetic stimulation|repetitive transcranial magnetic stimulation
326032|NCT02208466|rTMS|rtms
326033|NCT02208466|TMS|tms
326034|NCT02208466|fluoxetine|fluoxetine
326035|NCT02208453|Massive Rotator Cuff Tear|massive rotator cuff tear
326036|NCT02208453|Local anesthesia|local anesthesia
326037|NCT02208453|Sub-acromial spacer|sub-acromial spacer
326038|NCT02208440|Full-thickness/Massive Rotator Cuff Tear, Sub-acromial spacer|full-thickness/massive rotator cuff tear, sub-acromial spacer
326039|NCT02208427|isoniazid, LTBI, rifapentine, TST|isoniazid, ltbi, rifapentine, tst
326040|NCT02208414|Food Allergies|food allergies
326041|NCT02208388|Computed tomography perfusion|computed tomography perfusion
326042|NCT02208388|Fractional flow reserve|fractional flow reserve
326043|NCT02208362|chimeric antigen receptor|chimeric antigen receptor
326044|NCT02208362|glioblastoma|glioblastoma
326045|NCT02208349|intubation, laryngoscopy, prehospital, emergency medical services|intubation, laryngoscopy, prehospital, emergency medical services
326046|NCT02208323|Hypoxia|hypoxia
326047|NCT02208323|Respiratory Distress|respiratory distress
326048|NCT02208310|Crohn's disease|crohn's disease
326049|NCT02208310|Vitamin D deficiency|vitamin d deficiency
326050|NCT02208284|Single Ascending Dose|single ascending dose
326051|NCT02208284|healthy subjects|healthy subjects
326052|NCT02208284|Hyperlipidemia|hyperlipidemia
326053|NCT02208284|Lipid Metabolism Disorders|lipid metabolism disorders
326054|NCT02208284|Metabolic Diseases|metabolic diseases
326055|NCT02208271|tissue necrosis|tissue necrosis
326056|NCT02208271|metal on metal total hip|metal on metal total hip
326057|NCT02208271|biomarker|biomarker
326058|NCT02208258|fecal incontinence, consure medical, semi formed stool, stool management system|fecal incontinence, consure medical, semi formed stool, stool management system
326059|NCT02208232|IOL rotation|iol rotation
326060|NCT02208219|Stroke|stroke
326061|NCT02208219|Paresis|paresis
326062|NCT02208219|Upper extremity|upper extremity
326063|NCT02208219|Motor deficits|motor deficits
326064|NCT02208219|Music Therapy|music therapy
326065|NCT02208219|Neurorehabilitation|neurorehabilitation
326066|NCT02208206|Neuropathic pain|neuropathic pain
326067|NCT02208206|Phenotype|phenotype
326068|NCT02208206|Genotype|genotype
326069|NCT02208206|Biomarkers|biomarkers
326071|NCT02208206|Diabetes mellitus|diabetes mellitus
326072|NCT02208206|Breast cancer|breast cancer
326073|NCT02208206|Genomics|genomics
326074|NCT02208206|Quantitative sensory testing|quantitative sensory testing
326075|NCT02208193|Alzheimer disease Art Healing gardens Discourse analysis|alzheimer disease art healing gardens discourse analysis
326076|NCT02208180|Return of results|return of results
326077|NCT02208180|Genomics|genomics
326078|NCT02208167|Antigen Expanded Specific T Cell Therapy|antigen expanded specific t cell therapy
326079|NCT02208167|HXTC|hxtc
326080|NCT02208167|Antiretroviral Therapy|antiretroviral therapy
326081|NCT02208167|Acute HIV infection|acute hiv infection
326082|NCT02208167|Chronic HIV infection|chronic hiv infection
326083|NCT02208167|Leukapheresis|leukapheresis
326084|NCT02208154|ICU acquired bacteraemia|icu acquired bacteraemia
326085|NCT02208154|colonization|colonization
326086|NCT02208154|decolonization|decolonization
326087|NCT02208154|selective decontamination|selective decontamination
326088|NCT02208154|multidrug resistant bacteria|multidrug resistant bacteria
326089|NCT02208141|children|children
326090|NCT02208141|obesity|obesity
326091|NCT02208141|adipose tissue dysfunction|adipose tissue dysfunction
326092|NCT02208141|inflammation|inflammation
326093|NCT02208141|macrophage infiltration|macrophage infiltration
326094|NCT02208141|insulin resistance|insulin resistance
326095|NCT02208141|dyslipidemia|dyslipidemia
326096|NCT02208128|Renal cell carcinoma|renal cell carcinoma
326097|NCT02208128|Biomarkers|biomarkers
326098|NCT02208128|Molecular modifications|molecular modifications
326099|NCT02208115|Type 1 Diabetes Mellitus|type 1 diabetes mellitus
326100|NCT02208115|Exercise|exercise
326101|NCT02208115|Appetite|appetite
326102|NCT02208102|atrial fibrillation, catheter ablation, blood-biomarkers|atrial fibrillation, catheter ablation, blood-biomarkers
326103|NCT02208089|Keratoconus|keratoconus
326104|NCT02208089|Corneal collagen cross-linking|corneal collagen cross-linking
326105|NCT02208089|Photorefractive keratectomy|photorefractive keratectomy
326106|NCT02208076|Growth disorders|growth disorders
326107|NCT02208076|Saizen|saizen
326108|NCT02208076|Easypod|easypod
326109|NCT02208076|Growth hormone|growth hormone
326110|NCT02208076|Pediatric subject|pediatric subject
326111|NCT02208063|Bacteremia|bacteremia
326112|NCT02208063|Staphylococcus aureus|staphylococcus aureus
326239|NCT02207478|Peripheral lung lesions|peripheral lung lesions
326113|NCT02208050|Secondary Progressive Multiple Sclerosis|secondary progressive multiple sclerosis
326114|NCT02208050|Primary Progressive Multiple Sclerosis|primary progressive multiple sclerosis
326115|NCT02208050|Multiple Sclerosis|multiple sclerosis
326116|NCT02208050|Upper limb function|upper limb function
326117|NCT02208050|Mobility|mobility
326118|NCT02208050|Fampridine|fampridine
326119|NCT02208050|DASH|dash
326120|NCT02208050|AMSQ|amsq
326121|NCT02208050|MSWS-12|msws-12
326122|NCT02208050|MSIS-29|msis-29
326123|NCT02208050|SF-36|sf-36
326124|NCT02208050|9HPT|9hpt
326125|NCT02208050|25FTW|25ftw
326126|NCT02208050|JTT|jtt
326127|NCT02208037|Acute Lymphoblastic Leukemia/Lymphoma|acute lymphoblastic leukemia/lymphoma
326128|NCT02208037|Acute Myelogenous Leukemia|acute myelogenous leukemia
326129|NCT02208037|Mantel-Cell Lymphoma|mantel-cell lymphoma
326130|NCT02208037|Hematopoietic Transplant|hematopoietic transplant
326131|NCT02208037|GVHD Prophylaxis|gvhd prophylaxis
326132|NCT02207998|osteoarthritis, physiotherapy, homeopathy, complex|osteoarthritis, physiotherapy, homeopathy, complex
326133|NCT02207985|Pancreatic adenocarcinoma|pancreatic adenocarcinoma
326134|NCT02207985|Hematopoietic stem cell transplantation|hematopoietic stem cell transplantation
326135|NCT02207972|Pregnant|pregnant
326136|NCT02207972|labor|labor
326137|NCT02207972|Epidural|epidural
326138|NCT02207959|Gastric cancer|gastric cancer
326139|NCT02207959|Neoplasia|neoplasia
326140|NCT02207959|Endoscopic imaging|endoscopic imaging
326141|NCT02207959|In vivo imaging|in vivo imaging
326142|NCT02207933|anterioposterior|anterioposterior
326143|NCT02207933|weight|weight
326144|NCT02207933|shifting|shifting
326145|NCT02207933|training|training
326146|NCT02207933|patient|patient
326147|NCT02207894|Haemophilia A, factor VIII, development of inhibitor|haemophilia a, factor viii, development of inhibitor
326148|NCT02207881|herpes labialis|herpes labialis
326149|NCT02207881|cold sore|cold sore
326150|NCT02207829|COPD|copd
326151|NCT02207829|inhaler critical errors|inhaler critical errors
326152|NCT02207829|double-dummy|double-dummy
326153|NCT02207829|novel dry powder inhaler|novel dry powder inhaler
326154|NCT02207829|inhaler preference|inhaler preference
326155|NCT02207829|tiotropium|tiotropium
326156|NCT02207829|umeclidinium|umeclidinium
326157|NCT02207829|long-acting muscarinic antagonist|long-acting muscarinic antagonist
326158|NCT02207816|Infants|infants
326159|NCT02207816|Efficacy|efficacy
326160|NCT02207816|Children|children
326161|NCT02207816|Malaria|malaria
326162|NCT02207816|Plasmodium falciparum|plasmodium falciparum
326163|NCT02207816|Safety|safety
326164|NCT02207816|Surveillance|surveillance
326165|NCT02207816|Immunogenicity|immunogenicity
326166|NCT02207816|RTS,S/AS01E|rts,s/as01e
326167|NCT02207816|Africa|africa
326168|NCT02207803|Brain Injuries|brain injuries
326169|NCT02207803|Caregivers|caregivers
326170|NCT02207803|Intervention Studies|intervention studies
326171|NCT02207803|Latin America|latin america
326172|NCT02207790|Clinical Trial, Phase I|clinical trial, phase i
326173|NCT02207790|Healthy Volunteers|healthy volunteers
326174|NCT02207777|Obesity|obesity
326175|NCT02207777|Roux-en-Y gastric bypass (RYGB)|roux-en-y gastric bypass (rygb)
326176|NCT02207777|Type 2 Diabetes|type 2 diabetes
326177|NCT02207777|Sleeve Gastrectomy (SG)|sleeve gastrectomy (sg)
326178|NCT02207777|Weight Loss|weight loss
326179|NCT02207777|Low-Calorie Diet|low-calorie diet
326180|NCT02207751|Chronic Kidney Disease|chronic kidney disease
326181|NCT02207751|Peritoneal Dialysis Access|peritoneal dialysis access
326182|NCT02207751|Peritoneal Dialysis Catheter|peritoneal dialysis catheter
326183|NCT02207751|Catheter Function|catheter function
326184|NCT02207738|acne|acne
326185|NCT02207738|acne scar|acne scar
326186|NCT02207738|microneedling radiofrequency|microneedling radiofrequency
326187|NCT02207738|bipolar radiofrequency|bipolar radiofrequency
326188|NCT02207725|Andexanet alpha|andexanet alpha
326189|NCT02207725|Anticoagulation|anticoagulation
326190|NCT02207725|Antidote|antidote
326191|NCT02207725|Apixaban|apixaban
326192|NCT02207725|Anti-fXa inhibitor|anti-fxa inhibitor
326193|NCT02207725|PRT4445|prt4445
326194|NCT02207725|Eliquis|eliquis
326195|NCT02207725|Reversal agent|reversal agent
326196|NCT02207712|Diabetes|diabetes
326197|NCT02207712|Macular Oedema|macular oedema
326198|NCT02207712|Diabetic retinopathy|diabetic retinopathy
326199|NCT02207712|Noctura|noctura
326200|NCT02207686|CNS hemangioblastoma|cns hemangioblastoma
326201|NCT02207686|Renal Cell Carcinoma|renal cell carcinoma
326202|NCT02207686|VHL germline mutation|vhl germline mutation
326203|NCT02207686|VHL somatic mutation|vhl somatic mutation
326204|NCT02207686|Tumor development|tumor development
326205|NCT02207673|epilepsy surgery|epilepsy surgery
326206|NCT02207673|biomarker|biomarker
326207|NCT02207673|high frequency oscillations (HFOs)|high frequency oscillations (hfos)
326208|NCT02207673|acute electrocorticography (aECoG)|acute electrocorticography (aecog)
326209|NCT02207660|cisplatin|cisplatin
326210|NCT02207660|Cervical cancer|cervical cancer
326211|NCT02207660|metastasis|metastasis
326212|NCT02207660|recurrence|recurrence
326213|NCT02207634|High cholesterol|high cholesterol
326214|NCT02207634|Treatment for high cholesterol|treatment for high cholesterol
326215|NCT02207634|Lowering cholesterol|lowering cholesterol
326216|NCT02207634|Lowering high cholesterol|lowering high cholesterol
326217|NCT02207634|Hypercholesterolemia|hypercholesterolemia
326218|NCT02207621|Glaucoma|glaucoma
326219|NCT02207608|BCG|bcg
326220|NCT02207608|hyaluronic acid|hyaluronic acid
326221|NCT02207608|non-muscle invasive bladder cancer|non-muscle invasive bladder cancer
326222|NCT02207608|non bacterial cystitis|non bacterial cystitis
326223|NCT02207582|depression; trns|depression; trns
326224|NCT02207556|AL amyloidosis|al amyloidosis
326225|NCT02207556|amyloidosis|amyloidosis
326226|NCT02207556|light chain amyloidosis|light chain amyloidosis
326227|NCT02207543|Cancer|cancer
326228|NCT02207543|Palliative care|palliative care
326229|NCT02207543|home|home
326230|NCT02207530|Head and neck cancer; SCCHN|head and neck cancer; scchn
326231|NCT02207517|convergence insufficiency|convergence insufficiency
326232|NCT02207517|vision therapy|vision therapy
326233|NCT02207517|reading|reading
326234|NCT02207517|attention|attention
326235|NCT02207504|Castration-resistant Prostate Cancer|castration-resistant prostate cancer
326236|NCT02207491|Glaucoma|glaucoma
326237|NCT02207478|Electromagnetic navigation bronchoscopy with a guide sheath|electromagnetic navigation bronchoscopy with a guide sheath
326238|NCT02207478|Transbronchial lung biopsy|transbronchial lung biopsy
326240|NCT02207478|Solitary pulmonary nodule|solitary pulmonary nodule
326241|NCT02207452|Hyperpolarised helium-3|hyperpolarised helium-3
326242|NCT02207452|Lung Imaging|lung imaging
326243|NCT02207452|Magnetic Resonance Imaging|magnetic resonance imaging
326244|NCT02207426|Healthy volunteers|healthy volunteers
326245|NCT02207413|Quadrivalent influenza vaccine|quadrivalent influenza vaccine
326247|NCT02207413|Children|children
326248|NCT02207413|Adults|adults
326249|NCT02207413|Immunogenicity|immunogenicity
326250|NCT02207322|Hematopoietic stem cell transplantation (HSCT)|hematopoietic stem cell transplantation (hsct)
326251|NCT02207322|autologous stem cell transplant|autologous stem cell transplant
326252|NCT02207322|allogeneic stem cell transplant|allogeneic stem cell transplant
326253|NCT02207309|high-risk soft tissue sarcoma|high-risk soft tissue sarcoma
326254|NCT02207309|pazopanib|pazopanib
326255|NCT02207309|retroperitoneal soft tissue sarcoma|retroperitoneal soft tissue sarcoma
326256|NCT02207309|visceral soft tissue sarcoma|visceral soft tissue sarcoma
326257|NCT02207309|votrient|votrient
326258|NCT02207270|Coronary artery disease|coronary artery disease
326259|NCT02207270|Costs|costs
326260|NCT02207270|Cost minimization|cost minimization
326261|NCT02207270|Percutaneous coronary intervention|percutaneous coronary intervention
326262|NCT02207270|Risk score|risk score
326263|NCT02207270|Same day discharge|same day discharge
326264|NCT02207257|PER977|per977
326265|NCT02207257|anticoagulation reversal|anticoagulation reversal
326266|NCT02207257|pharmacokinetics|pharmacokinetics
326267|NCT02207257|edoxaban|edoxaban
326268|NCT02207257|whole blood clotting time|whole blood clotting time
326269|NCT02207257|D-dimer|d-dimer
326270|NCT02207257|prothrombin fragments 1 and 2|prothrombin fragments 1 and 2
326271|NCT02207257|tissue factor pathway inhibitor|tissue factor pathway inhibitor
326272|NCT02207257|prothrombin time|prothrombin time
326273|NCT02207244|Psoriasis|psoriasis
326274|NCT02207244|Plaque-type psoriasis|plaque-type psoriasis
326275|NCT02207244|Guselkumab|guselkumab
326276|NCT02207244|Adalimumab|adalimumab
326277|NCT02207244|CNTO 1959|cnto 1959
326278|NCT02207244|Monoclonal antibody|monoclonal antibody
326279|NCT02207231|Psoriasis|psoriasis
326280|NCT02207231|Plaque-type psoriasis|plaque-type psoriasis
326281|NCT02207231|Guselkumab|guselkumab
326282|NCT02207231|Adalimumab|adalimumab
326283|NCT02207231|CNTO 1959|cnto 1959
326284|NCT02207231|Monoclonal antibody|monoclonal antibody
326285|NCT02207192|obesity, lung volumes, postural changes|obesity, lung volumes, postural changes
326286|NCT02207179|Intraoperative|intraoperative
326287|NCT02207179|Cancer margin|cancer margin
326288|NCT02207179|Spectroscopy|spectroscopy
326289|NCT02207179|Polarization|polarization
326290|NCT02207166|hypertension|hypertension
326291|NCT02207166|device|device
326292|NCT02207166|errors|errors
326293|NCT02207166|human factor engineering|human factor engineering
326294|NCT02207166|usability engineering|usability engineering
326295|NCT02207153|Chronic Hemodialysis|chronic hemodialysis
326296|NCT02207153|Chronic Peritoneal Dialysis|chronic peritoneal dialysis
326297|NCT02207127|obstructive sleep apnea|obstructive sleep apnea
326298|NCT02207127|sleep apnea|sleep apnea
326299|NCT02207114|Sepsis|sepsis
326300|NCT02207114|Systemic Inflammatory Response Syndrome (SIRS)|systemic inflammatory response syndrome (sirs)
326301|NCT02207114|Antibiotic use|antibiotic use
326302|NCT02207114|Intensive Care Unit|intensive care unit
326303|NCT02207101|Young athletes|young athletes
326304|NCT02207101|Cardiac endurance|cardiac endurance
326305|NCT02207101|Herbal|herbal
326306|NCT02207101|Ejection Fraction|ejection fraction
326307|NCT02207101|Basic Research|basic research
326308|NCT02207101|Cardiovascular Injury|cardiovascular injury
326309|NCT02207088|Chronic Hepatitis C|chronic hepatitis c
326310|NCT02207088|Hepatitis C|hepatitis c
326311|NCT02207088|End-stage renal disease|end-stage renal disease
326312|NCT02207088|Hepatitis C Genotype 1|hepatitis c genotype 1
326313|NCT02207088|Severe Renal Impairment|severe renal impairment
326314|NCT02207088|renal disease|renal disease
326315|NCT02207088|Compensated Cirrhosis|compensated cirrhosis
326316|NCT02207088|Renal impairment|renal impairment
326317|NCT02207088|dialysis|dialysis
326318|NCT02207088|Hepatitis C Virus|hepatitis c virus
326319|NCT02207088|cirrhosis|cirrhosis
326320|NCT02207075|SPMS|spms
326321|NCT02207075|Myelin Water Fraction|myelin water fraction
326322|NCT02207075|activated microglia|activated microglia
326323|NCT02207036|Tobacco|tobacco
326324|NCT02207036|cigarettes|cigarettes
326325|NCT02207036|cessation|cessation
326326|NCT02207036|intervention|intervention
326327|NCT02207036|young adults|young adults
326328|NCT02207036|Internet|internet
326329|NCT02207036|social media|social media
326330|NCT02207036|mobile health|mobile health
326331|NCT02207023|Stroke|stroke
326332|NCT02207023|Telehealth|telehealth
326333|NCT02207023|Rehabilitation|rehabilitation
326334|NCT02207023|Stroke Coach|stroke coach
326335|NCT02207023|Randomized controlled trial|randomized controlled trial
326336|NCT02207023|Lifestyle behaviours|lifestyle behaviours
326337|NCT02207023|Secondary prevention|secondary prevention
326338|NCT02207023|Chronic disease self-management|chronic disease self-management
326339|NCT02207010|Glioblastoma|glioblastoma
326340|NCT02207010|GBM|gbm
326341|NCT02207010|first recurrence|first recurrence
326342|NCT02206997|perioperative hypothermia|perioperative hypothermia
326343|NCT02206997|prewarming|prewarming
326344|NCT02206997|treatment guideline|treatment guideline
326345|NCT02206958|Toileting disability|toileting disability
326346|NCT02206958|Functional urinary incontinence|functional urinary incontinence
326347|NCT02206958|Urinary incontinence|urinary incontinence
326348|NCT02206958|Frailty|frailty
326349|NCT02206958|Physical activity|physical activity
326350|NCT02206932|Hepatitis C|hepatitis c
326351|NCT02206932|HIV|hiv
326352|NCT02206932|Simeprevir|simeprevir
326353|NCT02206932|Sofosbuvir|sofosbuvir
326354|NCT02206919|Flow mediated dilation|flow mediated dilation
326355|NCT02206919|Magnetic Resonance Imaging MRI|magnetic resonance imaging mri
326356|NCT02206919|Diabetes|diabetes
326357|NCT02206919|Endothelial dysfunction|endothelial dysfunction
326358|NCT02206919|Popliteal artery|popliteal artery
326359|NCT02206919|Atherosclerosis|atherosclerosis
326360|NCT02206919|Cardiovascular disease|cardiovascular disease
326361|NCT02206919|Vascular disease|vascular disease
326362|NCT02206906|Medication Adherence|medication adherence
326363|NCT02206906|Incentives|incentives
326364|NCT02206906|Real-time Medication Monitoring|real-time medication monitoring
326365|NCT02206880|Thoracic Surgery|thoracic surgery
326366|NCT02206880|Delirium|delirium
326367|NCT02206880|Cardiopulmonary Bypass|cardiopulmonary bypass
326368|NCT02206880|Intensive Care|intensive care
326369|NCT02206854|Pharmakokinetic|pharmakokinetic
326370|NCT02206854|capsules|capsules
326371|NCT02206854|R-Flurbiprofen|r-flurbiprofen
326372|NCT02206841|fibrosis|fibrosis
326373|NCT02206841|markers|markers
326374|NCT02206828|HERNIA|hernia
326375|NCT02206828|SYMCHRO|symchro
326376|NCT02206828|SOFRADIM|sofradim
326377|NCT02206828|REGISTRY|registry
326378|NCT02206828|SYMBOTEX|symbotex
326379|NCT02206802|Alopecia|alopecia
326380|NCT02206802|Androgenetic Alopecia|androgenetic alopecia
326381|NCT02206802|Female Pattern Hair Loss|female pattern hair loss
326382|NCT02206802|Hair Loss|hair loss
326383|NCT02206802|Minoxidil|minoxidil
326384|NCT02206802|Hair Thinning|hair thinning
326385|NCT02206776|OCD|ocd
326386|NCT02206750|Controlled Human exposure study|controlled human exposure study
326387|NCT02206750|Air Pollution|air pollution
326388|NCT02206750|Cardiovascular|cardiovascular
326389|NCT02206750|Social factors|social factors
326390|NCT02206750|Cognitive function|cognitive function
326391|NCT02206724|Metastatic prostate cancer|metastatic prostate cancer
326392|NCT02206698|Intraabdominal Injury|intraabdominal injury
326393|NCT02206698|CT Abdomen and Pelvis|ct abdomen and pelvis
326394|NCT02206698|Pediatric trauma|pediatric trauma
326395|NCT02206698|blunt abdominal injury|blunt abdominal injury
326396|NCT02206698|blunt trauma|blunt trauma
326397|NCT02206698|clinical prediction model|clinical prediction model
326398|NCT02206633|dehydration|dehydration
326399|NCT02206607|Phase 1|phase 1
326400|NCT02206607|bioavailability|bioavailability
326401|NCT02206607|type 2 diabetes mellitus|type 2 diabetes mellitus
326402|NCT02206607|PF-04937319|pf-04937319
326403|NCT02206581|dehydration|dehydration
326404|NCT02206568|diabetes mellitus|diabetes mellitus
326405|NCT02206568|phase 1|phase 1
326406|NCT02206568|insulin lispro|insulin lispro
326407|NCT02206568|male subjects|male subjects
326408|NCT02206555|HIV|hiv
326409|NCT02206555|prevention|prevention
326410|NCT02206555|prophylaxis|prophylaxis
326411|NCT02206555|antiretroviral|antiretroviral
326412|NCT02206555|biomedical|biomedical
326413|NCT02206555|bio-behavioural|bio-behavioural
326414|NCT02206555|evaluation|evaluation
326415|NCT02206555|demonstration study|demonstration study
326416|NCT02206542|acupuncture,frozen shoulder,robot,sonography,MRI|acupuncture,frozen shoulder,robot,sonography,mri
326417|NCT02206529|obesity|obesity
326418|NCT02206529|child|child
326419|NCT02206529|weight management|weight management
326420|NCT02206529|behavioral|behavioral
326421|NCT02206529|social networks|social networks
326422|NCT02206529|social support|social support
326423|NCT02206503|LENALIDOMIDE|lenalidomide
326424|NCT02206503|BIOCHEMICAL PROGRESSION|biochemical progression
326425|NCT02206503|RELAPSED/REFRACTORY MM|relapsed/refractory mm
326426|NCT02206503|WITHOUT CRAB|without crab
326427|NCT02206490|Gulf War Illness|gulf war illness
326428|NCT02206490|treatment|treatment
326429|NCT02206490|dextromethorphan|dextromethorphan
417135|NCT01792375|Trial|trial
326430|NCT02206490|naltrexone|naltrexone
326431|NCT02206477|breast capsular contructure|breast capsular contructure
326432|NCT02206477|dimethyl sulfoxide|dimethyl sulfoxide
326433|NCT02206477|radiotherapy|radiotherapy
326434|NCT02206477|breast reconstruction|breast reconstruction
326435|NCT02206464|A/Anhui/1/2013 (H7N9)|a/anhui/1/2013 (h7n9)
326436|NCT02206464|Antibody Response|antibody response
326437|NCT02206464|Avian Influenza|avian influenza
326438|NCT02206464|A/Shanghai/2/2013 (H7N9)|a/shanghai/2/2013 (h7n9)
326439|NCT02206464|Immunogenicity|immunogenicity
326440|NCT02206451|Assay|assay
326441|NCT02206451|Infection|infection
326442|NCT02206451|Direct Skin Feed|direct skin feed
326443|NCT02206451|Midgut|midgut
326444|NCT02206451|Parasite|parasite
326445|NCT02206438|supraglottic airway devices|supraglottic airway devices
326446|NCT02206438|the classic laryngeal mask airway|the classic laryngeal mask airway
326447|NCT02206438|the self-pressurised air-Q intubating laryngeal airway in adult patients|the self-pressurised air-q intubating laryngeal airway in adult patients
326448|NCT02206438|elective surgery of short duration (less than 2 hr) undergoing general anesthesia using supraglottic airway in adult patients|elective surgery of short duration (less than 2 hr) undergoing general anesthesia using supraglottic airway in adult patients
326449|NCT02206425|multiple myeloma|multiple myeloma
326450|NCT02206425|Relapsed/refractory|relapsed/refractory
326451|NCT02206425|Ixazomib|ixazomib
326452|NCT02206425|Proteasome inhibitor|proteasome inhibitor
326453|NCT02206425|Oral|oral
326454|NCT02206412|high mobility group box 1|high mobility group box 1
326455|NCT02206412|prognostic biomarker|prognostic biomarker
326456|NCT02206412|off-pump coronary artery bypass graft|off-pump coronary artery bypass graft
326457|NCT02206412|patients|patients
326458|NCT02206373|creatinine|creatinine
326459|NCT02206373|glomerular filtration rate|glomerular filtration rate
326460|NCT02206373|renal insufficiency, chronic|renal insufficiency, chronic
326461|NCT02206360|Pancreatic Cancer|pancreatic cancer
326462|NCT02206360|Pancreatic Cancer Screening|pancreatic cancer screening
326463|NCT02206360|Pancreas Cancer|pancreas cancer
326464|NCT02206360|Pancreatic Adenocarcinoma|pancreatic adenocarcinoma
326465|NCT02206360|Pancreatic Adenocarcinoma screening|pancreatic adenocarcinoma screening
326466|NCT02206360|Familial Pancreatic Cancer|familial pancreatic cancer
326467|NCT02206360|BRCA 1/2|brca 1/2
326468|NCT02206360|HNPCC|hnpcc
326469|NCT02206360|Lynch Syndrome|lynch syndrome
326470|NCT02206360|Hereditary Pancreatitis|hereditary pancreatitis
326471|NCT02206360|FAMMM|fammm
326472|NCT02206360|Familial atypical multiple mole melanoma|familial atypical multiple mole melanoma
326473|NCT02206360|Peutz Jeghers Syndrome|peutz jeghers syndrome
326474|NCT02206360|MRI|mri
326475|NCT02206360|Magnetic Resonance Imaging|magnetic resonance imaging
326476|NCT02206360|EUS|eus
326477|NCT02206360|Endoscopic Ultrasound|endoscopic ultrasound
326478|NCT02206360|Early detection|early detection
326479|NCT02206360|Screening|screening
326480|NCT02206308|Chimeric anti-CD20 monoclonal antibody(SCT400)|chimeric anti-cd20 monoclonal antibody(sct400)
326481|NCT02206308|escalating doses|escalating doses
326482|NCT02206308|safety|safety
326483|NCT02206308|pharmacokinetics and pharmacodynamics|pharmacokinetics and pharmacodynamics
326484|NCT02206295|selexipag|selexipag
326485|NCT02206295|ACT-333679|act-333679
326486|NCT02206243|Benign prostatic hyperplasia|benign prostatic hyperplasia
326487|NCT02206243|BPH|bph
326488|NCT02206230|glioblastoma|glioblastoma
326489|NCT02206230|radiotherapy|radiotherapy
326490|NCT02206230|hypofractionated radiotherapy|hypofractionated radiotherapy
326491|NCT02206204|Selexipag|selexipag
326492|NCT02206204|ACT-333679|act-333679
326493|NCT02206152|Diabetes|diabetes
326494|NCT02206152|Hypoglycemia|hypoglycemia
326495|NCT02206152|Unawareness|unawareness
326496|NCT02206152|HAAF|haaf
326497|NCT02206126|Obstructive sleep apnea|obstructive sleep apnea
326498|NCT02206126|Weight loss|weight loss
326499|NCT02206126|Obesity|obesity
326500|NCT02206126|Sympathetic activity|sympathetic activity
326501|NCT02206126|Metabolic profile|metabolic profile
326502|NCT02206126|Endothelial function|endothelial function
326503|NCT02206113|Standing workstation|standing workstation
326504|NCT02206100|PER977|per977
326505|NCT02206100|enoxaparin|enoxaparin
326506|NCT02206100|anticoagulation reversal|anticoagulation reversal
326507|NCT02206100|whole blood clotting time|whole blood clotting time
326508|NCT02206087|PER977|per977
326509|NCT02206087|heparin|heparin
326510|NCT02206087|anticoagulation reversal|anticoagulation reversal
326511|NCT02206087|whole blood clotting time|whole blood clotting time
326512|NCT02206048|Cervix Carcinoma|cervix carcinoma
326513|NCT02206048|Cervical adenocarcinoma in situ|cervical adenocarcinoma in situ
326514|NCT02206048|AIS|ais
326515|NCT02206048|Cervical intraepithelial neoplasia|cervical intraepithelial neoplasia
326516|NCT02206048|CIN|cin
326517|NCT02206048|microinvasive carcinoma of the cervix|microinvasive carcinoma of the cervix
326518|NCT02206048|cold knife cone of the cervix|cold knife cone of the cervix
326519|NCT02206048|CKC|ckc
765166|NCT00384735|bone tumor|bone tumor
326520|NCT02206048|High-Resolution Microendoscopy|high-resolution microendoscopy
326521|NCT02206048|HRME|hrme
326522|NCT02206048|Proflavine|proflavine
326523|NCT02206022|Central Venous Catheter|central venous catheter
326524|NCT02206022|Remifentanil|remifentanil
326525|NCT02206022|local anesthesia|local anesthesia
326526|NCT02206022|pain|pain
326527|NCT02205996|Type 2 diabetes|type 2 diabetes
326528|NCT02205996|Hypoglycaemia|hypoglycaemia
326529|NCT02205996|Platelets|platelets
326530|NCT02205996|Inflammation|inflammation
326531|NCT02205983|enrolling|enrolling
326532|NCT02205983|adult|adult
326533|NCT02205983|volunteers|volunteers
326534|NCT02205970|TENS|tens
326535|NCT02205970|Dysmenorrhea|dysmenorrhea
326536|NCT02205970|analgesia|analgesia
326537|NCT02205970|interactive|interactive
326538|NCT02205957|anesthesiology and intensive care, quality, training|anesthesiology and intensive care, quality, training
326539|NCT02205944|chronic kidney disease|chronic kidney disease
326540|NCT02205944|hemodialysis|hemodialysis
326541|NCT02205944|vascular access|vascular access
326542|NCT02205944|arteriovenous fistula|arteriovenous fistula
326543|NCT02205944|forearm exercise|forearm exercise
326544|NCT02205931|Epilepsy|epilepsy
326545|NCT02205931|Ketogenic diet|ketogenic diet
326546|NCT02205931|Antiepileptic drugs|antiepileptic drugs
326547|NCT02205931|Randomised controlled trial|randomised controlled trial
326548|NCT02205905|PER977|per977
326549|NCT02205905|metabolic disposition|metabolic disposition
326550|NCT02205905|mass balance|mass balance
326551|NCT02205905|metabolites|metabolites
326552|NCT02205905|radiolabeled|radiolabeled
326553|NCT02205892|natural product|natural product
326554|NCT02205892|clinical trial|clinical trial
326555|NCT02205879|pregabalin|pregabalin
326556|NCT02205879|patients|patients
326557|NCT02205879|treatment|treatment
326558|NCT02205853|Oncology Service Hospital|oncology service hospital
326559|NCT02205853|Patient-centred|patient-centred
326560|NCT02205853|Exercise|exercise
326561|NCT02205853|Neoplasms|neoplasms
326562|NCT02205853|Rehabilitation|rehabilitation
326563|NCT02205853|Qualitative Research|qualitative research
326564|NCT02205853|Health Plan Implementation|health plan implementation
326565|NCT02205853|Quality of Health Care|quality of health care
326566|NCT02205853|Guidelines|guidelines
326567|NCT02205853|Quality of Life|quality of life
326568|NCT02205827|whole blood clotting time|whole blood clotting time
326569|NCT02205814|Osteoarthritis, Knee|osteoarthritis, knee
326570|NCT02205814|Arthritis|arthritis
326571|NCT02205814|WOMAC|womac
326572|NCT02205814|Injections, intra-articular|injections, intra-articular
326573|NCT02205814|Fasitibant|fasitibant
326574|NCT02205814|MEN 16132|men 16132
326575|NCT02205762|Langerhans cell histiocytosis|langerhans cell histiocytosis
326576|NCT02205749|biobanks|biobanks
326577|NCT02205749|informed consent|informed consent
326578|NCT02205749|health literacy|health literacy
326579|NCT02205736|Breast health education|breast health education
326580|NCT02205736|Latino women|latino women
326581|NCT02205736|Group education|group education
326582|NCT02205736|Breast cancer|breast cancer
326583|NCT02205723|Asthma|asthma
326584|NCT02205723|Asthma exacerbations|asthma exacerbations
326585|NCT02205723|Pediatric|pediatric
326586|NCT02205697|Fruit|fruit
326587|NCT02205697|Vegetable|vegetable
326588|NCT02205684|Physical activity|physical activity
326589|NCT02205684|Exercise|exercise
326590|NCT02205684|High intensity training|high intensity training
326591|NCT02205684|Schizophrenia|schizophrenia
326592|NCT02205684|Symptoms|symptoms
326593|NCT02205684|Well-being|well-being
326594|NCT02205684|Cognition|cognition
326595|NCT02205684|Hippocampal volume|hippocampal volume
326596|NCT02205684|Neuroplasticity|neuroplasticity
326597|NCT02205684|Smoking|smoking
326598|NCT02205684|Substance use|substance use
326599|NCT02205684|Metabolic indices|metabolic indices
326600|NCT02205671|caregiving|caregiving
326601|NCT02205671|chronic illness|chronic illness
326602|NCT02205671|patient education|patient education
326603|NCT02205671|self management|self management
326604|NCT02205658|Sensory Processing|sensory processing
326605|NCT02205658|Autism|autism
326606|NCT02205645|medial|medial
326607|NCT02205645|meniscus|meniscus
326608|NCT02205645|scaffold|scaffold
326609|NCT02205645|repair|repair
326610|NCT02205645|tear|tear
326611|NCT02205645|injury|injury
326612|NCT02205619|Residual cementum|residual cementum
326613|NCT02205619|root surface instrumentation|root surface instrumentation
326614|NCT02205619|ultrasonic scaling|ultrasonic scaling
326615|NCT02205619|air polishing with glycine|air polishing with glycine
326616|NCT02205593|psoriasis|psoriasis
326617|NCT02205593|atopic dermatitis|atopic dermatitis
326619|NCT02205593|patient education|patient education
326620|NCT02205593|stress reduction|stress reduction
326621|NCT02205593|quality of life|quality of life
326622|NCT02205554|Analgesia|analgesia
326623|NCT02205554|Pharmacokinetics|pharmacokinetics
326624|NCT02205554|Treatment|treatment
326625|NCT02205541|Eculizumab|eculizumab
326626|NCT02205541|Shiga-toxin|shiga-toxin
326627|NCT02205541|hemolytic and uremic syndrome|hemolytic and uremic syndrome
326628|NCT02205541|pediatric|pediatric
326629|NCT02205476|Phase 2|phase 2
326630|NCT02205476|open-label|open-label
326631|NCT02205476|safety|safety
326632|NCT02205476|hypertrophic scar revision surgery|hypertrophic scar revision surgery
326633|NCT02205463|Esophagus|esophagus
326634|NCT02205463|Gastroesophageal Junction|gastroesophageal junction
326635|NCT02205463|Stomach|stomach
326636|NCT02205463|Gastric|gastric
326637|NCT02205463|Cancer|cancer
326638|NCT02205463|HER2|her2
326639|NCT02205463|Metastatic|metastatic
326640|NCT02205463|Adenocarcinoma|adenocarcinoma
326641|NCT02205450|Prader-Willi Syndrome|prader-willi syndrome
326642|NCT02205450|Growth Hormone|growth hormone
326643|NCT02205450|Children|children
326644|NCT02205437|Schizophrenia|schizophrenia
326645|NCT02205437|Psychosis|psychosis
326646|NCT02205437|Antipsychotics|antipsychotics
326647|NCT02205437|Treatment response|treatment response
326648|NCT02205437|Metabolic side effects|metabolic side effects
326649|NCT02205437|Gene expression|gene expression
326650|NCT02205437|RNA|rna
326651|NCT02205437|Genes|genes
326652|NCT02205424|Ischaemic stroke|ischaemic stroke
326653|NCT02205424|Alzheimer's disease|alzheimer's disease
326654|NCT02205424|Brain volume|brain volume
326655|NCT02205424|Cortical thickness|cortical thickness
326656|NCT02205424|Magnetic Resonance Imaging|magnetic resonance imaging
326657|NCT02205411|heart assist device|heart assist device
326658|NCT02205411|ventricular assist device|ventricular assist device
326659|NCT02205398|INC280|inc280
326660|NCT02205398|c-MET inhibitor|c-met inhibitor
326661|NCT02205398|cetuximab|cetuximab
326662|NCT02205398|metastatic colorectal cancer|metastatic colorectal cancer
326663|NCT02205398|head and neck|head and neck
326664|NCT02205398|squamous cell carcinoma|squamous cell carcinoma
326665|NCT02205398|resistance to cetuximab/panitumumab|resistance to cetuximab/panitumumab
326666|NCT02205398|SCCHN,|scchn,
326667|NCT02205398|cancer|cancer
326668|NCT02205398|oral and nasal cavity|oral and nasal cavity
326669|NCT02205398|paranasal sinuses|paranasal sinuses
326670|NCT02205398|pharynx|pharynx
326671|NCT02205398|larynx|larynx
326672|NCT02205398|parotid glands|parotid glands
326673|NCT02205398|lympth nodes of neck|lympth nodes of neck
326674|NCT02205398|mucosal lining|mucosal lining
326675|NCT02205398|epithelium|epithelium
326676|NCT02205398|colon|colon
326677|NCT02205398|large intestine|large intestine
326678|NCT02205398|rectal cancer|rectal cancer
326679|NCT02205385|Neuroma|neuroma
326680|NCT02205385|Amputee|amputee
326681|NCT02205385|Amputation Stump|amputation stump
326682|NCT02205385|Assessment, Pain|assessment, pain
326683|NCT02205372|Diabetic Nephropathy|diabetic nephropathy
326684|NCT02205359|AdaptivCRT|adaptivcrt
326685|NCT02205359|aCRT|acrt
326686|NCT02205346|obstructive sleep apnea|obstructive sleep apnea
326687|NCT02205333|Advanced Solid tumors|advanced solid tumors
326688|NCT02205333|Diffuse Large B-cell Lymphoma|diffuse large b-cell lymphoma
326689|NCT02205333|programmed death 1|programmed death 1
326690|NCT02205333|programmed dealth ligand 1|programmed dealth ligand 1
326691|NCT02205333|cytotoxic T-lymphocyte-associated antigen-4|cytotoxic t-lymphocyte-associated antigen-4
326692|NCT02205333|OX40 ligand|ox40 ligand
326693|NCT02205320|Pegfilgrastim|pegfilgrastim
326694|NCT02205320|Pharmacokinetics|pharmacokinetics
326695|NCT02205320|Pharmacodynamics|pharmacodynamics
326696|NCT02205320|Healthy volunteers|healthy volunteers
326697|NCT02205307|Rectal cancer|rectal cancer
326698|NCT02205307|Rectal neoplasm|rectal neoplasm
326699|NCT02205307|Colorectal surgery|colorectal surgery
326700|NCT02205307|Anastomosis|anastomosis
326701|NCT02205294|Osteopathic treatment|osteopathic treatment
326702|NCT02205294|Deep Vein Thrombosis|deep vein thrombosis
326703|NCT02205294|Proximal Leg DVT|proximal leg dvt
326704|NCT02205281|Overweight|overweight
326705|NCT02205281|Obese|obese
326706|NCT02205281|Pregnancy|pregnancy
326707|NCT02205281|Weight Gain|weight gain
326708|NCT02205281|Weight Loss|weight loss
326709|NCT02205268|Attention Deficit Disorder with Hyperactivity|attention deficit disorder with hyperactivity
326710|NCT02205268|Attention Deficit Hyperactivity Disorder|attention deficit hyperactivity disorder
326711|NCT02205268|Biofeedback|biofeedback
326712|NCT02205268|Neurofeedback Training|neurofeedback training
326713|NCT02205268|Prefrontal Cortex|prefrontal cortex
326714|NCT02205268|Near infrared spectroscopy|near infrared spectroscopy
326715|NCT02205255|AECOPD|aecopd
326716|NCT02205255|Chronic Obstructive Pulmonary Disease|chronic obstructive pulmonary disease
326717|NCT02205255|Acute exacerbation|acute exacerbation
326718|NCT02205255|Hospitalization|hospitalization
326719|NCT02205255|Azithromycin|azithromycin
326720|NCT02205255|Macrolides|macrolides
326721|NCT02205255|Randomized Controlled Trial|randomized controlled trial
326722|NCT02205255|Placebo|placebo
326723|NCT02205255|Economic Impact|economic impact
326724|NCT02205255|Cost-effectiveness|cost-effectiveness
326725|NCT02205255|EQ5D|eq5d
326726|NCT02205242|AECOPD|aecopd
326727|NCT02205242|Chronic Obstructive Pulmonary Disease|chronic obstructive pulmonary disease
326728|NCT02205242|Acute exacerbation|acute exacerbation
326729|NCT02205242|Hospitalization|hospitalization
326730|NCT02205242|Azithromycin|azithromycin
326731|NCT02205242|Macrolides|macrolides
326732|NCT02205242|Randomized Controlled Trial|randomized controlled trial
326733|NCT02205242|Placebo|placebo
326734|NCT02205242|Physical Activity|physical activity
326735|NCT02205242|PRO-Active|pro-active
326736|NCT02205242|Activity Monitor|activity monitor
326737|NCT02205216|tDCS|tdcs
326738|NCT02205216|FOG|fog
326739|NCT02205216|Freezing of Gait|freezing of gait
326740|NCT02205216|Parkinson|parkinson
326741|NCT02205216|Rehabilitation|rehabilitation
326742|NCT02205203|Anxiety|anxiety
326743|NCT02205203|Social Anxiety|social anxiety
326744|NCT02205203|Social Phobia|social phobia
326745|NCT02205203|Separation Anxiety|separation anxiety
326746|NCT02205203|Generalized Anxiety|generalized anxiety
326747|NCT02205203|GAD|gad
326748|NCT02205203|Phobia|phobia
326749|NCT02205203|Panic|panic
326750|NCT02205203|Agoraphobia|agoraphobia
326751|NCT02205203|Obsessive Compulsive Disorder|obsessive compulsive disorder
326752|NCT02205203|OCD|ocd
326753|NCT02205203|Child|child
326754|NCT02205203|Adolescent|adolescent
326755|NCT02205203|Smartphone|smartphone
326756|NCT02205203|Teen|teen
326757|NCT02205203|Youth|youth
326758|NCT02205190|Fimasartan|fimasartan
326759|NCT02205177|Anxiety|anxiety
326760|NCT02205177|Social Anxiety|social anxiety
326761|NCT02205177|Social Phobia|social phobia
326762|NCT02205177|Separation Anxiety|separation anxiety
326763|NCT02205177|Generalized Anxiety|generalized anxiety
326764|NCT02205177|GAD|gad
326765|NCT02205177|Phobia|phobia
326766|NCT02205177|Panic|panic
326767|NCT02205177|Agoraphobia|agoraphobia
326768|NCT02205177|Obsessive Compulsive Disorder|obsessive compulsive disorder
326769|NCT02205177|OCD|ocd
326770|NCT02205177|Child|child
326771|NCT02205177|Adolescent|adolescent
326772|NCT02205177|Smartphone|smartphone
326773|NCT02205177|Teen|teen
326774|NCT02205177|Youth|youth
326775|NCT02205164|palonosetron|palonosetron
326776|NCT02205164|aprepitant|aprepitant
326777|NCT02205164|CINV|cinv
326778|NCT02205164|AML|aml
326779|NCT02205164|multiple-days|multiple-days
326780|NCT02205151|Fimasartan|fimasartan
326781|NCT02205138|Spinal Fusion|spinal fusion
326782|NCT02205138|Lumbar Interbody Fusion|lumbar interbody fusion
326783|NCT02205138|Degenerative Disc Disease|degenerative disc disease
326784|NCT02205138|Cell Therapy|cell therapy
326785|NCT02205138|Bone Graft|bone graft
326786|NCT02205125|polyp|polyp
326787|NCT02205125|colon|colon
326788|NCT02205125|polypectomy|polypectomy
326789|NCT02205125|snare|snare
326790|NCT02205112|intravenous nemonoxacin|intravenous nemonoxacin
326791|NCT02205112|community-acquired pneumonia|community-acquired pneumonia
326792|NCT02205099|Schizophrenia|schizophrenia
326793|NCT02205047|Neoadjuvant chemotherapy|neoadjuvant chemotherapy
326794|NCT02205034|Prader Willi|prader willi
326795|NCT02205008|advanced gastric cancer|advanced gastric cancer
326796|NCT02205008|serosal invasion|serosal invasion
326797|NCT02205008|peritoneal recurrence|peritoneal recurrence
326798|NCT02205008|intraperitoneal chemotherapy|intraperitoneal chemotherapy
326799|NCT02204995|Osteoarthritis|osteoarthritis
326800|NCT02204995|Thumb|thumb
326801|NCT02204995|LRTI|lrti
326802|NCT02204995|Trapeziectomy|trapeziectomy
326803|NCT02204982|Phase 3, Follicular Lymphoma, FL, PI3K|phase 3, follicular lymphoma, fl, pi3k
326804|NCT02204956|Smoking cessation|smoking cessation
326805|NCT02204956|Tobacco use cessation|tobacco use cessation
326806|NCT02204956|Psychiatric comorbidity|psychiatric comorbidity
326807|NCT02204930|Haemostat|haemostat
326808|NCT02204930|Liver surgery|liver surgery
326809|NCT02204930|Primary liver cancer|primary liver cancer
326810|NCT02204930|Metastatic liver cancer|metastatic liver cancer
326811|NCT02204930|Benign liver disease such as adenoma|benign liver disease such as adenoma
326812|NCT02204930|Hepatitis-related or alcoholic-related liver cirrhosis|hepatitis-related or alcoholic-related liver cirrhosis
326813|NCT02204930|Living donation for liver transplant|living donation for liver transplant
326814|NCT02204917|Ultrasound|ultrasound
326815|NCT02204917|Ultrasound Contrast Agents|ultrasound contrast agents
326816|NCT02204917|Optison|optison
326817|NCT02204917|contrast enhanced Voiding Urosonography (ceVUS)|contrast enhanced voiding urosonography (cevus)
326818|NCT02204917|ceVUS|cevus
326819|NCT02204917|Vesicoureteral Reflux|vesicoureteral reflux
326820|NCT02204917|Children|children
326821|NCT02204917|Kidney|kidney
326822|NCT02204917|Bladder|bladder
326823|NCT02204917|Urethra|urethra
326824|NCT02204917|Voiding Cystourethrography (VCUG)|voiding cystourethrography (vcug)
326825|NCT02204917|VCUG|vcug
326826|NCT02204917|Safety|safety
326827|NCT02204917|Urinary tract|urinary tract
326828|NCT02204904|X-linked Adrenoleukodystrophy|x-linked adrenoleukodystrophy
326829|NCT02204904|Hematopoietic Stem Cells|hematopoietic stem cells
326830|NCT02204891|Abdominal pain|abdominal pain
326831|NCT02204891|Abdominal discomfort|abdominal discomfort
326832|NCT02204891|Flatulence|flatulence
326833|NCT02204891|Diarrhea|diarrhea
326834|NCT02204891|Bacterial overgrowth|bacterial overgrowth
326835|NCT02204891|Cytokines|cytokines
326836|NCT02204865|Sleep-Disordered Breathing|sleep-disordered breathing
326837|NCT02204865|Sleep Apnoea|sleep apnoea
326838|NCT02204865|Heart failure|heart failure
326839|NCT02204839|T1DM, Exercise, Hypoglycaemia|t1dm, exercise, hypoglycaemia
326936|NCT02204397|Ustekinumab|ustekinumab
326937|NCT02204384|Dietary fiber|dietary fiber
326840|NCT02204826|Effects of Korean Red Ginseng on semen parameters in male infertility patients: a randomized, placebo-controlled, double-blind clinical study|effects of korean red ginseng on semen parameters in male infertility patients: a randomized, placebo-controlled, double-blind clinical study
326841|NCT02204813|Gastric Bypass|gastric bypass
326842|NCT02204813|RYGB|rygb
326843|NCT02204813|GLP-1|glp-1
326844|NCT02204813|Xenin|xenin
326845|NCT02204813|Insulin Secretion|insulin secretion
326846|NCT02204813|Glucose Homeostasis|glucose homeostasis
326847|NCT02204813|Vertical Sleeve|vertical sleeve
326848|NCT02204813|Lap Band|lap band
326849|NCT02204800|Tumor growth rate in maximal dimension, biomarker assessment based on driver gene alterations (specifically CRG)|tumor growth rate in maximal dimension, biomarker assessment based on driver gene alterations (specifically crg)
326850|NCT02204774|aortic aneurysm|aortic aneurysm
326851|NCT02204774|obstructive sleep apnea|obstructive sleep apnea
326852|NCT02204735|Meal Time|meal time
326853|NCT02204735|Weight Loss|weight loss
326854|NCT02204735|Circadian Rhythm|circadian rhythm
326855|NCT02204709|obese|obese
326856|NCT02204709|omega-3 fatty acids|omega-3 fatty acids
326857|NCT02204709|fish|fish
326858|NCT02204696|sleep apnea|sleep apnea
326859|NCT02204696|obstructive sleep apnea|obstructive sleep apnea
326860|NCT02204696|sleepiness|sleepiness
326861|NCT02204696|quality of life|quality of life
326862|NCT02204683|AMD|amd
326863|NCT02204683|Neovascularization|neovascularization
326864|NCT02204683|macular degeneration|macular degeneration
326865|NCT02204683|wet macular degeneration|wet macular degeneration
326866|NCT02204683|vitrectomy|vitrectomy
326867|NCT02204670|Irisin|irisin
326868|NCT02204670|Obesity|obesity
326869|NCT02204670|Exercise|exercise
326870|NCT02204670|Myokine|myokine
326871|NCT02204670|Impaired Glucose Tolerance|impaired glucose tolerance
326872|NCT02204657|Continuous glucose monitoring in GDM|continuous glucose monitoring in gdm
326873|NCT02204631|Head and Neck Cancer|head and neck cancer
326874|NCT02204618|single sided deafness|single sided deafness
326875|NCT02204618|Asymmetrical hearing loss|asymmetrical hearing loss
326876|NCT02204618|Cost-utility|cost-utility
326877|NCT02204618|Tinnitus|tinnitus
326878|NCT02204618|Cochlear implants|cochlear implants
326879|NCT02204618|Bone conduction device|bone conduction device
326880|NCT02204618|Dichotic hearing|dichotic hearing
326881|NCT02204618|Squelch effect.|squelch effect.
326882|NCT02204605|patients|patients
326883|NCT02204605|puzzling|puzzling
326884|NCT02204605|conditions|conditions
326885|NCT02204579|Autosomal Dominant Hypocalcemia|autosomal dominant hypocalcemia
326886|NCT02204579|Hypocalcemia|hypocalcemia
326887|NCT02204579|ADH|adh
326888|NCT02204579|Hypoparathyroidism|hypoparathyroidism
326889|NCT02204566|OFDI|ofdi
326890|NCT02204566|RF Ablation|rf ablation
326891|NCT02204566|Atrial Fibrillation|atrial fibrillation
326892|NCT02204566|Imaging|imaging
326893|NCT02204566|Esophagus|esophagus
326894|NCT02204553|Multiple Myeloma|multiple myeloma
326895|NCT02204553|Panobinostat|panobinostat
326896|NCT02204553|LBH589|lbh589
326897|NCT02204553|Expanded Access|expanded access
326898|NCT02204553|EAP, ETP|eap, etp
326899|NCT02204553|Expanded Treatment|expanded treatment
326900|NCT02204553|Bortezomib|bortezomib
326901|NCT02204553|HDAC|hdac
326902|NCT02204553|histone deacetylace inhibitor|histone deacetylace inhibitor
326903|NCT02204540|Webcams, video monitoring, compliance, adherence|webcams, video monitoring, compliance, adherence
326904|NCT02204527|hypertension|hypertension
326905|NCT02204527|diabetes mellitus|diabetes mellitus
326906|NCT02204527|vitamin D|vitamin d
326907|NCT02204501|Aviragen Therapeutics, Inc.|aviragen therapeutics, inc.
326908|NCT02204501|Aviragen Therapeutics|aviragen therapeutics
326909|NCT02204501|Aviragen|aviragen
326910|NCT02204488|Osteoarthritis|osteoarthritis
326911|NCT02204488|Thumb|thumb
326912|NCT02204488|Total joint arthroplasty|total joint arthroplasty
326913|NCT02204488|Trapeziectomy|trapeziectomy
326914|NCT02204462|PET|pet
326915|NCT02204462|Positron Emission Tomography|positron emission tomography
326916|NCT02204462|Breast Cancer|breast cancer
326917|NCT02204462|Imaging|imaging
326918|NCT02204449|cardiac rehabilitation|cardiac rehabilitation
326919|NCT02204449|peer mentorship|peer mentorship
326920|NCT02204449|healthcare utilization|healthcare utilization
326921|NCT02204449|continuity of cardiac care|continuity of cardiac care
326922|NCT02204436|hyperpigmentation|hyperpigmentation
326923|NCT02204436|depigmenting treatment|depigmenting treatment
326924|NCT02204436|hand|hand
326925|NCT02204423|Upper extremity dysfunction|upper extremity dysfunction
326926|NCT02204423|Trans-Radial Percutaneous Coronary Interventions|trans-radial percutaneous coronary interventions
326927|NCT02204410|ADHD|adhd
326928|NCT02204410|Attention Deficit Hyperactivity Disorder|attention deficit hyperactivity disorder
326929|NCT02204410|DESR|desr
326930|NCT02204410|Deficient Emotional Self-Regulation|deficient emotional self-regulation
326931|NCT02204410|Emotional Dysregulation|emotional dysregulation
326932|NCT02204410|Omega-3 Fatty Acids|omega-3 fatty acids
326933|NCT02204410|Fish Oil|fish oil
326934|NCT02204397|Type 1 Diabetes mellitus|type 1 diabetes mellitus
326935|NCT02204397|INGAP|ingap
326938|NCT02204384|Dietary Supplements|dietary supplements
326939|NCT02204384|Type 2 diabetes|type 2 diabetes
326940|NCT02204384|Postprandial Period|postprandial period
326941|NCT02204384|Plasma insulin|plasma insulin
326942|NCT02204384|Plasma glucose|plasma glucose
326943|NCT02204384|Area Under Curve|area under curve
326944|NCT02204384|Soluble fiber|soluble fiber
326945|NCT02204371|Pazopanib|pazopanib
326946|NCT02204371|hereditary haemorrhagic telangiectasia|hereditary haemorrhagic telangiectasia
326947|NCT02204371|bleeding|bleeding
326948|NCT02204319|provoked or non-provoked vulvar vestibulitis|provoked or non-provoked vulvar vestibulitis
326949|NCT02204319|low level laser light device|low level laser light device
326950|NCT02204293|Adult-Onset Still´s Disease|adult-onset still´s disease
326951|NCT02204293|Canakinumab|canakinumab
326952|NCT02204293|Joint involvement|joint involvement
326953|NCT02204293|AOSD|aosd
326954|NCT02204280|UbA52;diabetic nephropathy ;diabetic;ELISA|uba52;diabetic nephropathy ;diabetic;elisa
326955|NCT02204267|Stroke|stroke
326956|NCT02204267|atrial fibrillation|atrial fibrillation
326957|NCT02204267|ECG|ecg
326958|NCT02204241|Multiple myeloma|multiple myeloma
326959|NCT02204241|Diagnosis|diagnosis
326960|NCT02204241|CCyd|ccyd
326961|NCT02204228|osteoarthritis|osteoarthritis
326962|NCT02204228|rheumatoid arthritis|rheumatoid arthritis
326963|NCT02204228|post traumatic arthritis|post traumatic arthritis
326964|NCT02204228|avascular necrosis|avascular necrosis
326965|NCT02204228|severe fractures|severe fractures
326966|NCT02204215|Weakness|weakness
326967|NCT02204215|Mechanical Ventilation|mechanical ventilation
326968|NCT02204215|Acupuncture Therapy|acupuncture therapy
326969|NCT02204202|acute lung transplant rejection|acute lung transplant rejection
326970|NCT02204202|neutrophilic lung inflammation|neutrophilic lung inflammation
326971|NCT02204202|positron emission tomography imaging|positron emission tomography imaging
326972|NCT02204202|[18F] fluorodeoxyglucose|[18f] fluorodeoxyglucose
326973|NCT02204202|[18F] ISO-1|[18f] iso-1
326974|NCT02204189|acute pancreatitis|acute pancreatitis
326975|NCT02204189|gastrointestinal dysfunction|gastrointestinal dysfunction
326976|NCT02204189|TongFuSan|tongfusan
326977|NCT02204189|ShenQue acupoint|shenque acupoint
326978|NCT02204150|Optical Coherence Tomography|optical coherence tomography
326979|NCT02204150|Barrett's Esophagus|barrett's esophagus
326980|NCT02204150|Esophagus|esophagus
326981|NCT02204150|Imaging|imaging
326982|NCT02204124|Whipple procedure|whipple procedure
326983|NCT02204111|Palliative Treatment|palliative treatment
326984|NCT02204111|Trabectedin|trabectedin
326985|NCT02204111|Patient Reported Outcome|patient reported outcome
326986|NCT02204085|Refractory acute myeloid leukemia|refractory acute myeloid leukemia
326987|NCT02204085|Relapsed acute myeloid leukemia|relapsed acute myeloid leukemia
326988|NCT02204020|Acute Myeloid Leukemia (AML)|acute myeloid leukemia (aml)
326989|NCT02204020|Myelodysplastic Syndrome (MDS)|myelodysplastic syndrome (mds)
326990|NCT02204020|allogeneic|allogeneic
326991|NCT02204020|5-azacytidine (5-aza)|5-azacytidine (5-aza)
326992|NCT02204020|hematopoietic|hematopoietic
326993|NCT02204020|transplantation|transplantation
326994|NCT02204020|transplant|transplant
326995|NCT02204020|graft-versus-tumor|graft-versus-tumor
326996|NCT02204020|graft-versus-host disease (GVHD)|graft-versus-host disease (gvhd)
326997|NCT02204020|epigenetic|epigenetic
326998|NCT02204020|maintenance|maintenance
326999|NCT02204020|hypomethylation|hypomethylation
327000|NCT02204020|relapse|relapse
327001|NCT02204007|Acetabular Shell|acetabular shell
327002|NCT02204007|Total Hip Arthroplasty|total hip arthroplasty
327003|NCT02204007|3D imaging|3d imaging
327004|NCT02203994|extracorporal shock wave therapy (ESWT)|extracorporal shock wave therapy (eswt)
327005|NCT02203994|spasticity|spasticity
327006|NCT02203994|spinal cord injury|spinal cord injury
327007|NCT02203981|normal Eyes|normal eyes
327008|NCT02203968|Fibrinogen replacement|fibrinogen replacement
327009|NCT02203968|Trauma coagulopathy|trauma coagulopathy
327010|NCT02203968|Hypofibrinogenemia|hypofibrinogenemia
327011|NCT02203968|Early trauma coagulopathy|early trauma coagulopathy
327012|NCT02203968|Haemorrhage|haemorrhage
327013|NCT02203968|Fibrinogen concentrate|fibrinogen concentrate
327014|NCT02203968|Feasibility trial|feasibility trial
327015|NCT02203968|Clinical trials|clinical trials
327016|NCT02203942|Bacterial Vaginosis|bacterial vaginosis
327017|NCT02203942|Vulvovaginal Candidiasis|vulvovaginal candidiasis
327018|NCT02203942|Trichomoniasis|trichomoniasis
327019|NCT02203929|Macular Holes|macular holes
327020|NCT02203929|Progression|progression
327021|NCT02203916|Drug therapy|drug therapy
327022|NCT02203890|Growth|growth
327023|NCT02203890|Hematology|hematology
327024|NCT02203890|Hydration|hydration
327025|NCT02203890|Oxidation|oxidation
327026|NCT02203890|Infection|infection
327027|NCT02203890|Inflammation|inflammation
327028|NCT02203890|Guatemalan children|guatemalan children
327029|NCT02203851|BI 655066|bi 655066
327030|NCT02203851|risankizumab|risankizumab
327031|NCT02203838|Schizophrenia|schizophrenia
327032|NCT02203838|Schizophrenic|schizophrenic
327033|NCT02203838|Schizophrenias|schizophrenias
327034|NCT02203838|Risperidone|risperidone
327136|NCT02203357|hepatitis B|hepatitis b
327035|NCT02203838|Long-acting Risperidone|long-acting risperidone
327036|NCT02203838|Atrigel|atrigel
327037|NCT02203838|Subcutaneous|subcutaneous
327038|NCT02203825|Acute Myeloid Leukemia|acute myeloid leukemia
327039|NCT02203825|NKG2D|nkg2d
327040|NCT02203825|Multiple Myeloma|multiple myeloma
327041|NCT02203825|Cell Therapy|cell therapy
327042|NCT02203799|Peanut Allergy|peanut allergy
327043|NCT02203799|Anaphylaxis|anaphylaxis
327044|NCT02203799|Desensitization|desensitization
327045|NCT02203799|Food Allergy|food allergy
327046|NCT02203799|Oral Immunotherapy|oral immunotherapy
327047|NCT02203786|amphetamine|amphetamine
327048|NCT02203786|d1 and d2 receptors|d1 and d2 receptors
327049|NCT02203786|dopamine antagonists|dopamine antagonists
327050|NCT02203786|pathological gambling|pathological gambling
327051|NCT02203786|priming|priming
327052|NCT02203786|reinforcement|reinforcement
327053|NCT02203773|Acute Myelogenous Leukemia|acute myelogenous leukemia
327055|NCT02203773|Myelogenous Leukemia|myelogenous leukemia
327056|NCT02203773|ABT-199|abt-199
327057|NCT02203773|GDC-0199|gdc-0199
327058|NCT02203773|Treatment Naive AML|treatment naive aml
327059|NCT02203773|Untreated AML|untreated aml
327060|NCT02203760|Relapsed/metastatic uterine leiomyosarcomas/carcinosarcomas|relapsed/metastatic uterine leiomyosarcomas/carcinosarcomas
327061|NCT02203734|Pregnancy|pregnancy
327062|NCT02203734|Depression|depression
327063|NCT02203734|Massage|massage
327064|NCT02203708|BPD (Borderline Personality Disorder)|bpd (borderline personality disorder)
327065|NCT02203708|Mother/child|mother/child
327066|NCT02203695|Salvage Radiation Therapy (SRT)|salvage radiation therapy (srt)
327067|NCT02203695|Enzalutamide|enzalutamide
327068|NCT02203682|Graves' orbitopathy|graves' orbitopathy
327069|NCT02203682|Graves´ ophthalmopathy|graves´ ophthalmopathy
327070|NCT02203682|Thyroid eye disease|thyroid eye disease
327071|NCT02203682|Thyroid-associated ophthalmopathy|thyroid-associated ophthalmopathy
327072|NCT02203682|Doxycycline|doxycycline
327073|NCT02203682|EUGOGO|eugogo
327074|NCT02203682|CAS|cas
327075|NCT02203669|breast reconstruction|breast reconstruction
327076|NCT02203669|occupational therapy|occupational therapy
327077|NCT02203669|physical therapy|physical therapy
327078|NCT02203669|upper extremity morbidity|upper extremity morbidity
327079|NCT02203656|intervention studies|intervention studies
327080|NCT02203656|nutrition|nutrition
327081|NCT02203656|exercise|exercise
327082|NCT02203656|testosterone|testosterone
327083|NCT02203656|patient readmission|patient readmission
327084|NCT02203630|Septic shock|septic shock
327085|NCT02203630|Vasopressor Agents|vasopressor agents
327086|NCT02203630|Phenylephrine|phenylephrine
327087|NCT02203630|Norepinephrine|norepinephrine
327088|NCT02203630|Tachycardia|tachycardia
327089|NCT02203630|Heart Rate|heart rate
327090|NCT02203630|Arrhythmia|arrhythmia
327091|NCT02203630|Catecholamine|catecholamine
327092|NCT02203617|anticipatory guidance|anticipatory guidance
327093|NCT02203617|baby books|baby books
327094|NCT02203617|safety|safety
327095|NCT02203591|surgical skin prep|surgical skin prep
327096|NCT02203591|CHG|chg
327097|NCT02203591|IPA|ipa
327098|NCT02203552|Breast Cancer|breast cancer
327099|NCT02203539|circadian rhythm|circadian rhythm
327100|NCT02203539|light exposure|light exposure
327101|NCT02203539|exercise capacity|exercise capacity
327102|NCT02203539|endurance|endurance
327103|NCT02203539|strength|strength
327104|NCT02203539|reaction|reaction
327105|NCT02203526|Tyrosine Kinase Inhibitor|tyrosine kinase inhibitor
327106|NCT02203526|ABC DLBCL|abc dlbcl
327107|NCT02203526|Lymphoma in Brain and CNS|lymphoma in brain and cns
327108|NCT02203526|Diffuse Large B-Cell Lymphomas in CNS|diffuse large b-cell lymphomas in cns
327109|NCT02203513|p53 Dysfunction|p53 dysfunction
327110|NCT02203513|Cell Cycle Arrest|cell cycle arrest
327111|NCT02203513|Checkpoint Kinases|checkpoint kinases
327112|NCT02203513|DNA Damage Repair Pathways|dna damage repair pathways
327113|NCT02203513|Hereditary Breast and Ovarian Cancer Syndrome|hereditary breast and ovarian cancer syndrome
327114|NCT02203461|ART, HIV, insulin resistance|art, hiv, insulin resistance
327115|NCT02203435|code blue|code blue
327116|NCT02203435|Cardiopulmonary Resuscitation|cardiopulmonary resuscitation
327117|NCT02203435|APACHE|apache
327118|NCT02203422|Immune Thrombocytopenia|immune thrombocytopenia
767245|NCT00377091|heparin|heparin
327119|NCT02203422|Recombinant Human Thrombopoietin|recombinant human thrombopoietin
327120|NCT02203422|Cyclosporin A|cyclosporin a
327121|NCT02203409|liver tumor|liver tumor
327122|NCT02203409|Two stage hepatectomy|two stage hepatectomy
327123|NCT02203409|Hypertrophy|hypertrophy
327124|NCT02203409|laparoscopy|laparoscopy
327125|NCT02203409|ALPPS|alpps
327126|NCT02203396|SAA|saa
327127|NCT02203396|Immunosuppressive treatment|immunosuppressive treatment
327128|NCT02203396|ATG|atg
327129|NCT02203396|Cyclosporine|cyclosporine
327130|NCT02203396|Levamisole|levamisole
327131|NCT02203383|Cardiac Resynchronization Therapy|cardiac resynchronization therapy
327132|NCT02203383|Central Sleep Apnoea|central sleep apnoea
327133|NCT02203383|Sleep Disordered Breathing|sleep disordered breathing
327134|NCT02203383|Heart Failure|heart failure
327135|NCT02203383|Hypercapnic Ventilatory Response|hypercapnic ventilatory response
327137|NCT02203357|hepatitis B vaccine|hepatitis b vaccine
327138|NCT02203357|immunogenicity|immunogenicity
327139|NCT02203357|adults|adults
327140|NCT02203318|cryptorchidism, undescended testis, hypertrophy of contralateral testis|cryptorchidism, undescended testis, hypertrophy of contralateral testis
327141|NCT02203305|Unilateral hearing loss|unilateral hearing loss
327142|NCT02203305|Single Sided Deafness|single sided deafness
327143|NCT02203305|Asymmetric hearing loss|asymmetric hearing loss
327144|NCT02203292|Traumatic Brain Injury|traumatic brain injury
327145|NCT02203292|Blood Transfusion|blood transfusion
327146|NCT02203279|Chair-side hard relining|chair-side hard relining
327147|NCT02203279|complete denture|complete denture
327148|NCT02203279|patients' satisfaction|patients' satisfaction
327149|NCT02203279|supporting tissues|supporting tissues
327150|NCT02203279|autopolymerized reline resins|autopolymerized reline resins
327151|NCT02203279|heat cured relining material|heat cured relining material
327152|NCT02203266|Medication Adherence|medication adherence
327153|NCT02203266|Patient Compliance|patient compliance
327154|NCT02203253|solid tumor|solid tumor
327155|NCT02203253|chemotherapy-induced delayed nausea and vomiting|chemotherapy-induced delayed nausea and vomiting
327156|NCT02203253|thalidomide|thalidomide
327157|NCT02203253|prevention|prevention
327158|NCT02203240|Cacao|cacao
327159|NCT02203240|Polyphenols|polyphenols
327160|NCT02203240|Prediabetic State|prediabetic state
327161|NCT02203240|Blood Glucose|blood glucose
327162|NCT02203240|Glucose Intolerance|glucose intolerance
327163|NCT02203240|Diabetes Mellitus, Type 2|diabetes mellitus, type 2
327164|NCT02203240|Obesity|obesity
327165|NCT02203240|Muscle, Skeletal|muscle, skeletal
327166|NCT02203240|Endotoxins|endotoxins
327167|NCT02203240|Gut Permeability|gut permeability
327168|NCT02203240|Incretins|incretins
327169|NCT02203240|Metabolic Flexibility|metabolic flexibility
327170|NCT02203227|Dietary supplements|dietary supplements
327171|NCT02203227|Cotinine level|cotinine level
327172|NCT02203227|Malondialdehyde|malondialdehyde
327173|NCT02203227|Chronic smokers|chronic smokers
327174|NCT02203227|Hyperlipidemia|hyperlipidemia
327175|NCT02203214|Ligamys|ligamys
327177|NCT02203214|healing|healing
327178|NCT02203201|Not-celiac gluten sensitivity|not-celiac gluten sensitivity
327179|NCT02203201|Celiac Disease|celiac disease
327180|NCT02203201|Gluten-free diet|gluten-free diet
327181|NCT02203201|EMA assay|ema assay
327182|NCT02203201|Duodenal culture medium|duodenal culture medium
327183|NCT02203175|propofol|propofol
327184|NCT02203175|pretreatment|pretreatment
327185|NCT02203175|mixture|mixture
327186|NCT02203162|cough|cough
327187|NCT02203162|cough reflex sensitivity|cough reflex sensitivity
327188|NCT02203162|electronic cigarette|electronic cigarette
327189|NCT02203162|capsaicin|capsaicin
327190|NCT02203136|Bladder cancer|bladder cancer
327191|NCT02203136|Muscle invasive bladder cancer|muscle invasive bladder cancer
327192|NCT02203136|MIBC|mibc
327193|NCT02203136|Biopsy specimen molecular profiling|biopsy specimen molecular profiling
327194|NCT02203136|Bladder surgery|bladder surgery
327195|NCT02203136|Magnetic resonance imaging|magnetic resonance imaging
327196|NCT02203136|MRI|mri
327197|NCT02203136|Trans urethral resection of bladder|trans urethral resection of bladder
327198|NCT02203110|simultaneous bacterial and viral pneumonia|simultaneous bacterial and viral pneumonia
327199|NCT02203097|Target controlled infusion|target controlled infusion
327200|NCT02203097|propofol|propofol
327201|NCT02203097|cerebral vasoreactivity|cerebral vasoreactivity
327202|NCT02203097|arterial stiffness|arterial stiffness
327203|NCT02203097|Transcranial Doppler|transcranial doppler
327204|NCT02203097|SphygmoCor|sphygmocor
327205|NCT02203084|Cystic Fibrosis|cystic fibrosis
327206|NCT02203084|Diabetes Mellitus Type I|diabetes mellitus type i
327207|NCT02203084|Chronic Renal Insufficiency|chronic renal insufficiency
327208|NCT02203084|The influence of socioeconomic variables upon outcome in children with three chronic medical diseases.|the influence of socioeconomic variables upon outcome in children with three chronic medical diseases.
327209|NCT02203071|sports|sports
327210|NCT02203071|injury|injury
327211|NCT02203071|knee|knee
327212|NCT02203071|pain|pain
327213|NCT02203071|cartilage|cartilage
327214|NCT02203058|Inspiratory capacity|inspiratory capacity
418156|NCT01787526|fatigue|fatigue
327215|NCT02203058|Positive-pressure respiration|positive-pressure respiration
327216|NCT02203058|Exercise|exercise
327217|NCT02203058|Activities of daily living|activities of daily living
327218|NCT02203058|COPD.|copd.
327219|NCT02203045|Total Knee Arthroplasty|total knee arthroplasty
327220|NCT02203032|Psoriasis|psoriasis
327221|NCT02203032|Plaque-type psoriasis|plaque-type psoriasis
327222|NCT02203032|Guselkumab|guselkumab
327223|NCT02203032|Ustekinumab|ustekinumab
327224|NCT02203032|CNTO 1959|cnto 1959
327225|NCT02203032|Monoclonal antibody|monoclonal antibody
327226|NCT02203019|Dexmedetomidine|dexmedetomidine
327227|NCT02203019|Propofol|propofol
327228|NCT02203019|Sepsis|sepsis
327229|NCT02203019|Mechanical Ventilation|mechanical ventilation
327230|NCT02203019|Respiratory Failure|respiratory failure
327231|NCT02203006|HIV,|hiv,
327232|NCT02203006|infection,|infection,
327233|NCT02203006|cohort|cohort
327234|NCT02202967|Aspirin|aspirin
327235|NCT02202967|Intestinal bleeding|intestinal bleeding
327236|NCT02202967|Misoprostol|misoprostol
327237|NCT02202967|NSAIDs|nsaids
327238|NCT02202967|Small intestine|small intestine
327239|NCT02202967|Video capsule endoscopy|video capsule endoscopy
327240|NCT02202954|Stroke|stroke
327241|NCT02202954|Muscle Spasticity|muscle spasticity
327242|NCT02202954|Rehabilitation|rehabilitation
327243|NCT02202928|Colorectal cancer|colorectal cancer
327244|NCT02202928|DC-CIK|dc-cik
327245|NCT02202928|Autologous tumor lysate|autologous tumor lysate
327246|NCT02202902|Cushing's syndrome|cushing's syndrome
327247|NCT02202902|cardiac steatosis|cardiac steatosis
327248|NCT02202902|intramyocardial triglyceride content|intramyocardial triglyceride content
327249|NCT02202902|1H magnetic resonance spectroscopy and cardiac magnetic resonance imaging|1h magnetic resonance spectroscopy and cardiac magnetic resonance imaging
327250|NCT02202902|Left Ventricularly hypertrophy|left ventricularly hypertrophy
327251|NCT02202889|Adolescents|adolescents
327252|NCT02202889|Bone mass|bone mass
327253|NCT02202889|Calcium|calcium
327254|NCT02202889|Perceived milk intolerance|perceived milk intolerance
327255|NCT02202889|lactose maldigestion|lactose maldigestion
327256|NCT02202863|Dietary intervention|dietary intervention
327257|NCT02202863|Wine grape pomace flour|wine grape pomace flour
327258|NCT02202863|Metabolic Syndrome|metabolic syndrome
327259|NCT02202863|Oxidative stress|oxidative stress
327260|NCT02202863|Antioxidants|antioxidants
327261|NCT02202863|Fiber|fiber
327262|NCT02202785|Drug therapy|drug therapy
327263|NCT02202772|Urothelial|urothelial
327264|NCT02202772|Cisplatin|cisplatin
327265|NCT02202772|Gemcitabine|gemcitabine
327266|NCT02202772|Cabazitaxel|cabazitaxel
327267|NCT02202772|Bladder|bladder
327268|NCT02202772|Carcinoma|carcinoma
327269|NCT02202772|Bacillus Calmette-Guerin|bacillus calmette-guerin
327270|NCT02202772|Intravesical|intravesical
327271|NCT02202772|Recurrent|recurrent
327272|NCT02202772|Non-muscle|non-muscle
327273|NCT02202772|Invasive|invasive
327274|NCT02202772|Cancer|cancer
327275|NCT02202759|Drug therapy|drug therapy
327276|NCT02202746|Breast cancer|breast cancer
327277|NCT02202746|Metastatic breast cancer|metastatic breast cancer
327279|NCT02202746|HER2 positive|her2 positive
327280|NCT02202746|HER2+|her2+
327281|NCT02202746|Estrogen receptor positive|estrogen receptor positive
327282|NCT02202746|ER+|er+
327283|NCT02202746|Triple negative|triple negative
327284|NCT02202746|FGFR1|fgfr1
327285|NCT02202746|11q|11q
327286|NCT02202746|FGF aberrant|fgf aberrant
327287|NCT02202746|Biomarker negative|biomarker negative
327288|NCT02202746|FGF non-aberrant|fgf non-aberrant
327289|NCT02202733|cooking skills|cooking skills
327290|NCT02202733|eating out|eating out
327291|NCT02202733|foods prepared away from home|foods prepared away from home
327292|NCT02202720|Sevoflurane|sevoflurane
327293|NCT02202720|RASS score|rass score
327294|NCT02202720|Sedation|sedation
327295|NCT02202720|Minimal alveolar concentration (MAC)|minimal alveolar concentration (mac)
327296|NCT02202694|CBT, Psychosis, cultural adaptation, Pakistan|cbt, psychosis, cultural adaptation, pakistan
327297|NCT02202681|Duodenum|duodenum
327298|NCT02202681|Optical Frequency Domain Imaging (OFDI)|optical frequency domain imaging (ofdi)
327299|NCT02202681|Optical Coherence Tomography|optical coherence tomography
327300|NCT02202681|Imaging|imaging
327301|NCT02202681|Celiac Disease|celiac disease
327302|NCT02202668|Foot ulcer, diabetic|foot ulcer, diabetic
327303|NCT02202668|Spectrum analysis, Raman|spectrum analysis, raman
327304|NCT02202655|non- small cell lung cancer;|non- small cell lung cancer;
327305|NCT02202655|lymphocyte subsets|lymphocyte subsets
327306|NCT02202616|COPD,|copd,
327307|NCT02202616|QVA149,|qva149,
327308|NCT02202616|Tiotropium,|tiotropium,
327309|NCT02202616|FDC,|fdc,
327310|NCT02202616|GlycOpyrronium With IndacatERol,|glycopyrronium with indacaterol,
327311|NCT02202616|POWER|power
327312|NCT02202590|SECM|secm
327313|NCT02202590|Esophagus|esophagus
327314|NCT02202590|Eosinophilic Esophagitis|eosinophilic esophagitis
327315|NCT02202590|Allergy|allergy
327316|NCT02202577|Surgical site infection|surgical site infection
327317|NCT02202577|Surgical site antisepsis|surgical site antisepsis
327318|NCT02202577|Cesarean Delivery|cesarean delivery
327319|NCT02202564|hepatocellular carcinoma|hepatocellular carcinoma
327320|NCT02202564|liver transplantation|liver transplantation
327321|NCT02202564|adenovirus-thymidine kinase|adenovirus-thymidine kinase
327322|NCT02202564|gene therapy|gene therapy
327323|NCT02202551|Levodopa Induced Dyskinesia|levodopa induced dyskinesia
327324|NCT02202551|LID|lid
327325|NCT02202551|Parkinsonism|parkinsonism
327326|NCT02202551|Parkinson's Disease|parkinson's disease
327327|NCT02202538|SCI|sci
327328|NCT02202538|Indego|indego
327329|NCT02202538|Walking|walking
327330|NCT02202499|pharmacotherapy|pharmacotherapy
327331|NCT02202473|Oxymatrine Capsules, lamivudine, chronic Hepatitis B|oxymatrine capsules, lamivudine, chronic hepatitis b
327332|NCT02202447|EC1169|ec1169
327333|NCT02202447|prostate cancer|prostate cancer
327334|NCT02202447|EC0652|ec0652
327335|NCT02202421|Autism|autism
327336|NCT02202421|Applied Behavior Analysis|applied behavior analysis
327337|NCT02202395|Hydroxytriptolide|hydroxytriptolide
327338|NCT02202395|Rheumatoid Arthritis|rheumatoid arthritis
327339|NCT02202395|Methotrexate|methotrexate
327340|NCT02202395|T8|t8
327341|NCT02202395|LTS|lts
327342|NCT02202369|Multimodal Analgesia|multimodal analgesia
327343|NCT02202369|Pain Management|pain management
327344|NCT02202356|RSV|rsv
327345|NCT02202356|Respiratory Syncytial Virus|respiratory syncytial virus
327346|NCT02202343|Nutrition|nutrition
327347|NCT02202343|Food|food
327348|NCT02202343|Security|security
327349|NCT02202343|School|school
327350|NCT02202343|Health|health
327351|NCT02202317|Liver Cancer|liver cancer
327352|NCT02202317|Hepatic Tumors|hepatic tumors
327353|NCT02202317|Primary Liver Tumors|primary liver tumors
327354|NCT02202317|Metastatic Liver Tumors|metastatic liver tumors
327355|NCT02202317|Yttrium-90|yttrium-90
327356|NCT02202317|Y-90|y-90
327357|NCT02202291|Raynaud's phenomenon, Vasospasm, Genetics|raynaud's phenomenon, vasospasm, genetics
327358|NCT02202278|ovarian hyperstimulation|ovarian hyperstimulation
327359|NCT02202278|Oxidative Stress|oxidative stress
327360|NCT02202278|IMA|ima
327361|NCT02202278|OHSS|ohss
327362|NCT02202278|ICSI|icsi
327363|NCT02202278|long agonist protocol|long agonist protocol
327364|NCT02202278|TAC|tac
327365|NCT02202278|TOS|tos
327366|NCT02202278|OSI|osi
327367|NCT02202278|MDA|mda
327368|NCT02202265|Heart Diseases|heart diseases
327369|NCT02202252|Patient comfort|patient comfort
327370|NCT02202252|Drains|drains
327371|NCT02202252|Breast cancer|breast cancer
327372|NCT02202252|Modified radical mastectomy|modified radical mastectomy
327373|NCT02202252|Seroma|seroma
327374|NCT02202200|Melanoma|melanoma
327375|NCT02202200|BRAF mutated|braf mutated
327376|NCT02202174|supraglottic airway|supraglottic airway
327377|NCT02202174|children|children
327378|NCT02202174|safety|safety
327379|NCT02202174|efficacy|efficacy
327380|NCT02202161|pharmacokinetic|pharmacokinetic
327381|NCT02202161|intestinal bile acid transporter inhibitor|intestinal bile acid transporter inhibitor
327382|NCT02202161|metformin|metformin
327383|NCT02202161|sitagliptin|sitagliptin
327384|NCT02202161|GSK2330672|gsk2330672
327385|NCT02202161|pharmacodynamic|pharmacodynamic
327386|NCT02202148|Fibroscan|fibroscan
327387|NCT02202148|alcohol dependence|alcohol dependence
327388|NCT02202148|alcohol withdrawal|alcohol withdrawal
327389|NCT02202148|controlled attenuation parameter|controlled attenuation parameter
327390|NCT02202148|BDNF|bdnf
327391|NCT02202135|complicated skin and soft tissue infections (cSSTI)|complicated skin and soft tissue infections (cssti)
327392|NCT02202135|skin infection|skin infection
327393|NCT02202135|ceftaroline|ceftaroline
327394|NCT02202135|wound infection|wound infection
327395|NCT02202135|cellulitis|cellulitis
327396|NCT02202135|burn infection|burn infection
327397|NCT02202135|bacterial infection|bacterial infection
327398|NCT02202135|vancomycin|vancomycin
327399|NCT02202122|Femoral Neck Fractures|femoral neck fractures
327400|NCT02202122|Obstructive Sleep Apnea|obstructive sleep apnea
327401|NCT02202122|Perioperative Complications|perioperative complications
327402|NCT02202109|Screen|screen
327403|NCT02202109|self-sampler|self-sampler
327404|NCT02202109|cervical, cancer|cervical, cancer
327405|NCT02202109|women|women
327406|NCT02202109|community health workers|community health workers
327407|NCT02202109|Hispanic/ Latinas|hispanic/ latinas
327408|NCT02202109|Haitian|haitian
327409|NCT02202109|Focus of study is cervical cancer|focus of study is cervical cancer
327410|NCT02202083|Oxytocin|oxytocin
327411|NCT02202083|Cook Balloon|cook balloon
327412|NCT02202070|onabotulinumtoxinA|onabotulinumtoxina
327413|NCT02202070|Temporomandibular Joint Disorders|temporomandibular joint disorders
327414|NCT02202070|Bruxism|bruxism
327415|NCT02202070|Temporomandibular Joint Dysfunction Syndrome|temporomandibular joint dysfunction syndrome
327416|NCT02202070|Myofascial Pain Dysfunction Syndrome, Temporomandibular Joint|myofascial pain dysfunction syndrome, temporomandibular joint
327417|NCT02202057|respiratory sensation|respiratory sensation
327418|NCT02202057|somatosensation|somatosensation
327419|NCT02202057|resistive load|resistive load
327420|NCT02202057|magnitude estimation|magnitude estimation
327421|NCT02202044|Bladder Cancer|bladder cancer
327422|NCT02202018|Knowledge Translation|knowledge translation
327423|NCT02202018|Chronic Kidney Disease|chronic kidney disease
327424|NCT02202018|Dialysis|dialysis
327425|NCT02202018|Home dialysis|home dialysis
327426|NCT02202018|Cluster randomized trial|cluster randomized trial
327427|NCT02202005|Bioequivalence|bioequivalence
327428|NCT02201979|breast|breast
327429|NCT02201979|ptosis|ptosis
327430|NCT02201979|sagging|sagging
327431|NCT02201979|implant|implant
327432|NCT02201979|lift|lift
327433|NCT02201966|low back pain|low back pain
327434|NCT02201966|pediatric|pediatric
327435|NCT02201966|gymnasts|gymnasts
327436|NCT02201953|Sofosbuvir|sofosbuvir
327437|NCT02201953|Velpatasvir|velpatasvir
327438|NCT02201953|SOF/VEL|sof/vel
327439|NCT02201953|GS-5816|gs-5816
327440|NCT02201953|Hepatitis C|hepatitis c
327441|NCT02201953|HCV|hcv
327442|NCT02201953|Cirrhosis|cirrhosis
327443|NCT02201953|Genotype 3|genotype 3
327444|NCT02201940|Sofosbuvir|sofosbuvir
327445|NCT02201940|SOF/VEL|sof/vel
327446|NCT02201940|Velpatasvir|velpatasvir
327447|NCT02201940|Hepatitis C|hepatitis c
327448|NCT02201940|HCV|hcv
327449|NCT02201940|cirrhosis|cirrhosis
327450|NCT02201927|galvanic vestibular stimulation|galvanic vestibular stimulation
327451|NCT02201927|right parietal lobe lesion|right parietal lobe lesion
327452|NCT02201927|egocentric space|egocentric space
327453|NCT02201901|Sofosbuvir|sofosbuvir
327454|NCT02201901|Velpatasvir|velpatasvir
327455|NCT02201901|SOF/VEL|sof/vel
327456|NCT02201901|GS-5816|gs-5816
327457|NCT02201901|Hepatitis C|hepatitis c
327458|NCT02201901|HCV|hcv
327459|NCT02201901|Cirrhosis|cirrhosis
327460|NCT02201901|CPT-B|cpt-b
327461|NCT02201888|Schizophrenia|schizophrenia
327462|NCT02201888|Rehabilitation|rehabilitation
327463|NCT02201888|Cognition|cognition
327464|NCT02201875|hypoxia|hypoxia
327465|NCT02201875|exercise|exercise
327466|NCT02201875|periodic breathing|periodic breathing
327467|NCT02201875|hypercapnia|hypercapnia
327468|NCT02201875|apneas|apneas
327469|NCT02201875|cardiac failure|cardiac failure
327470|NCT02201862|Aneuploidy|aneuploidy
327471|NCT02201862|Down Syndrome|down syndrome
327472|NCT02201862|amniocentesis|amniocentesis
327473|NCT02201862|chronic villus sampling|chronic villus sampling
327474|NCT02201862|Trisomy|trisomy
327475|NCT02201862|non-invasive prenatal testing|non-invasive prenatal testing
327476|NCT02201862|Chromosome disorders|chromosome disorders
327477|NCT02201849|Alkermes|alkermes
327478|NCT02201849|ALKS 8700|alks 8700
327479|NCT02201810|smoking cessation|smoking cessation
327480|NCT02201810|quit line|quit line
327481|NCT02201810|nicotine replacement therapy|nicotine replacement therapy
327482|NCT02201810|tobacco intervention|tobacco intervention
327483|NCT02201797|Reproducibility of Results|reproducibility of results
327484|NCT02201797|Liver neoplasm|liver neoplasm
327485|NCT02201797|Neoplasm metastasis|neoplasm metastasis
327486|NCT02201797|Regional Perfusion|regional perfusion
327487|NCT02201797|Perfusion Magnetic Resonance Imaging|perfusion magnetic resonance imaging
327488|NCT02201784|Subarachnoid block|subarachnoid block
327489|NCT02201784|intrathecal|intrathecal
327490|NCT02201784|spinal anesthesia|spinal anesthesia
327491|NCT02201784|isobaric|isobaric
327492|NCT02201784|levobupivacaine|levobupivacaine
327493|NCT02201784|ropivacaine|ropivacaine
327494|NCT02201771|CABG|cabg
327495|NCT02201771|Antiplatelet|antiplatelet
327496|NCT02201771|Ticagrelor|ticagrelor
327497|NCT02201758|Inflammatory Bowel Disease (IBD), ulcerative colitis (UC), flaxseed lignan-enriched complex (FLC)|inflammatory bowel disease (ibd), ulcerative colitis (uc), flaxseed lignan-enriched complex (flc)
327498|NCT02201732|Incomplete miscarriage|incomplete miscarriage
327499|NCT02201732|Hysteroscopy|hysteroscopy
327500|NCT02201732|curettage, pregnancy|curettage, pregnancy
327501|NCT02201732|RCT|rct
327502|NCT02201719|Adenomyosis|adenomyosis
327503|NCT02201719|Dysmenorrhea|dysmenorrhea
327504|NCT02201719|Chronic pelvic pain|chronic pelvic pain
327505|NCT02201719|Infertility|infertility
327506|NCT02201719|Sensitivity histology|sensitivity histology
327507|NCT02201719|womens health|womens health
327508|NCT02201719|junction zone|junction zone
327509|NCT02201706|Retinal detachment|retinal detachment
327510|NCT02201706|silicone oil|silicone oil
327511|NCT02201706|retinectomy|retinectomy
327512|NCT02201693|Crohn's disease,|crohn's disease,
327513|NCT02201693|pediatric GETAID (Therapeutic study group of inflammatory bowel diseases of the child),|pediatric getaid (therapeutic study group of inflammatory bowel diseases of the child),
327514|NCT02201693|enteral nutrition,|enteral nutrition,
327515|NCT02201693|randomized multicenter study|randomized multicenter study
327516|NCT02201680|anxiety|anxiety
327517|NCT02201680|preoperative|preoperative
327518|NCT02201667|non-ST elevation acute coronary syndrome|non-st elevation acute coronary syndrome
767452|NCT00376883|response|response
327519|NCT02201667|myocardial perfusion|myocardial perfusion
327520|NCT02201667|magnetic Resonance Imaging|magnetic resonance imaging
327521|NCT02201667|antiplatelet|antiplatelet
327522|NCT02201641|Indirect pulp capping|indirect pulp capping
327523|NCT02201641|reversible pulpitis|reversible pulpitis
327524|NCT02201641|periapical radiolucency|periapical radiolucency
327525|NCT02201641|periapical radiographs|periapical radiographs
327526|NCT02201641|cone beam computed tomography|cone beam computed tomography
327527|NCT02201641|calcium silicate cements|calcium silicate cements
327528|NCT02201641|glass ionomer cements|glass ionomer cements
327529|NCT02201641|caries|caries
327530|NCT02201628|Oesophageal|oesophageal
327531|NCT02201628|Nasopharyngeal|nasopharyngeal
327532|NCT02201628|temperature|temperature
327533|NCT02201628|Intubation, endotracheal|intubation, endotracheal
327534|NCT02201628|Pediatric|pediatric
327535|NCT02201628|Anesthesia|anesthesia
327536|NCT02201628|Hypothermia|hypothermia
327537|NCT02201615|Perineal Massage; Episiotomy; Perineal Laceration|perineal massage; episiotomy; perineal laceration
327538|NCT02201602|sulphonylureas|sulphonylureas
327539|NCT02201602|gliclazide|gliclazide
327540|NCT02201602|glibenclamide|glibenclamide
327541|NCT02201589|Lesions in the ascending thoracic aorta|lesions in the ascending thoracic aorta
327542|NCT02201576|Chronic antibody-mediated rejection,|chronic antibody-mediated rejection,
327543|NCT02201576|transplant rejection, kidney transplantation,|transplant rejection, kidney transplantation,
327544|NCT02201576|proteasome inhibitor,|proteasome inhibitor,
327545|NCT02201576|anti-HLA antibodies,|anti-hla antibodies,
327546|NCT02201576|immunosuppressive agents|immunosuppressive agents
327547|NCT02201563|Adverse radiation effects (ARE)|adverse radiation effects (are)
327548|NCT02201563|Radiosurgery|radiosurgery
327549|NCT02201563|Brain metastases|brain metastases
327550|NCT02201563|Minocycline|minocycline
327551|NCT02201537|Ultrasound functional imaging|ultrasound functional imaging
327552|NCT02201537|Chronic kidney Nephropathy|chronic kidney nephropathy
327553|NCT02201524|Phase 2|phase 2
327554|NCT02201524|randomized|randomized
327555|NCT02201524|double-blind|double-blind
327556|NCT02201524|placebo|placebo
327557|NCT02201524|plaque|plaque
327558|NCT02201524|psoriasis|psoriasis
327559|NCT02201524|safety|safety
327560|NCT02201524|efficacy|efficacy
327561|NCT02201524|JAK|jak
327562|NCT02201524|janus kinase|janus kinase
327563|NCT02201524|moderate|moderate
327564|NCT02201524|severe|severe
327565|NCT02201511|relative bioavailbility|relative bioavailbility
327566|NCT02201511|food effect|food effect
327567|NCT02201511|pharmacokinetics|pharmacokinetics
327568|NCT02201511|ALTERATION OF COGNITIVE FUNCTIONS|alteration of cognitive functions
327569|NCT02201485|Budd-Chiari syndrome|budd-chiari syndrome
327570|NCT02201485|percutaneous recanalization|percutaneous recanalization
327571|NCT02201485|treatment|treatment
327572|NCT02201485|reocclusion|reocclusion
327573|NCT02201485|patency|patency
327574|NCT02201472|liver|liver
327575|NCT02201472|mre|mre
327576|NCT02201472|mri|mri
327577|NCT02201472|neonatal|neonatal
327578|NCT02201472|mr touch|mr touch
327579|NCT02201459|Peg-IFN, nilotinib, MR4.5, CML, chronic phase, first-line|peg-ifn, nilotinib, mr4.5, cml, chronic phase, first-line
327580|NCT02201433|breastfeeding|breastfeeding
327581|NCT02201433|fathers|fathers
327582|NCT02201433|preterm newborns|preterm newborns
327583|NCT02201433|partner influence|partner influence
327584|NCT02201394|Antiplatelet|antiplatelet
327585|NCT02201394|Ticagrelor|ticagrelor
327586|NCT02201394|Platelets|platelets
327587|NCT02201394|Thrombosis|thrombosis
327588|NCT02201394|Coronary artery disease|coronary artery disease
327589|NCT02201381|Cancer|cancer
327590|NCT02201381|Cancer Treatments|cancer treatments
327591|NCT02201381|Cancer Palliative Care|cancer palliative care
327592|NCT02201381|Metabolic|metabolic
327593|NCT02201381|Metabolism|metabolism
327594|NCT02201381|Existing Medicines|existing medicines
327595|NCT02201381|Licensed Medicines|licensed medicines
327596|NCT02201381|Real World|real world
327597|NCT02201381|Breast Cancer|breast cancer
327598|NCT02201381|Triple Negative Breast Cancer|triple negative breast cancer
327599|NCT02201381|Colon Cancer|colon cancer
327600|NCT02201381|Prostrate Cancer|prostrate cancer
327601|NCT02201381|Brain Cancer|brain cancer
327602|NCT02201381|Ovarian Cancer|ovarian cancer
327603|NCT02201381|Pancreatic Cancer|pancreatic cancer
327604|NCT02201381|AML|aml
327605|NCT02201381|CML|cml
327606|NCT02201381|Leukemea|leukemea
327607|NCT02201381|Metformin|metformin
327608|NCT02201381|Statins|statins
327609|NCT02201381|Mebendazole|mebendazole
327610|NCT02201381|Doxycycline|doxycycline
327611|NCT02201381|Ibuprofen|ibuprofen
327612|NCT02201381|Metastatic|metastatic
327613|NCT02201368|Triglycerides; Lipid Metabolism; Fatty Acids.|triglycerides; lipid metabolism; fatty acids.
327614|NCT02201355|Head and Neck cancer|head and neck cancer
327615|NCT02201342|Fontan|fontan
327616|NCT02201342|Pharmacokinetics|pharmacokinetics
327617|NCT02201342|Pharmacodynamics|pharmacodynamics
327618|NCT02201342|Exercise capacity|exercise capacity
327619|NCT02201342|Maximal Oxygen Consumption|maximal oxygen consumption
327620|NCT02201342|Vascular function|vascular function
327621|NCT02201342|EndoPAT|endopat
327622|NCT02201342|Myocardial performance|myocardial performance
327623|NCT02201316|Healthy adult human subjects|healthy adult human subjects
327624|NCT02201316|Mosapride citrate anhydrous|mosapride citrate anhydrous
327625|NCT02201316|Bioequivalence|bioequivalence
327626|NCT02201316|Dyspepsia|dyspepsia
327627|NCT02201303|CD11b|cd11b
327628|NCT02201303|Neutrophils|neutrophils
327629|NCT02201303|CXCL1|cxcl1
327630|NCT02201303|Danirixin|danirixin
327631|NCT02201303|Respiratory Syncytial Virus|respiratory syncytial virus
327632|NCT02201303|Children|children
327633|NCT02201303|CXCR2|cxcr2
327634|NCT02201290|Chronic immune thrombocytopenic purpura, ITP, eltrombopag olamine, thrombopoietin receptor agonist, pediatrics|chronic immune thrombocytopenic purpura, itp, eltrombopag olamine, thrombopoietin receptor agonist, pediatrics
327635|NCT02201277|IVC|ivc
327636|NCT02201277|IVC Filter|ivc filter
327637|NCT02201277|Filter|filter
327638|NCT02201277|Option|option
327639|NCT02201277|Denali|denali
327640|NCT02201277|filter tilt|filter tilt
327641|NCT02201277|filter migration|filter migration
327642|NCT02201277|filter fracture|filter fracture
327643|NCT02201277|filter thrombus|filter thrombus
327644|NCT02201277|filter penetration|filter penetration
327645|NCT02201264|myocardial infarction|myocardial infarction
327646|NCT02201264|Angioplasty|angioplasty
327647|NCT02201264|Stent|stent
327648|NCT02201251|Epilepsy|epilepsy
327649|NCT02201251|Topiramate|topiramate
327650|NCT02201251|Levetiracetam|levetiracetam
327651|NCT02201251|Pediatric|pediatric
327652|NCT02201212|TSC1|tsc1
327653|NCT02201212|TSC2|tsc2
327654|NCT02201212|Tuberous Sclerosis Complex|tuberous sclerosis complex
327655|NCT02201212|MTOR|mtor
327656|NCT02201186|honey enema for pouchitis|honey enema for pouchitis
327657|NCT02201160|NAFLD|nafld
327658|NCT02201160|Fatty acid composition|fatty acid composition
327659|NCT02201160|Omega 3 supplementation|omega 3 supplementation
327660|NCT02201160|Metabolism|metabolism
327661|NCT02201134|Cardiac arrest|cardiac arrest
327662|NCT02201134|Therapeutic hypothermia|therapeutic hypothermia
327663|NCT02201134|Sevoflurane|sevoflurane
327664|NCT02201134|Sedation|sedation
327665|NCT02201134|Patient resuscitated from cardiac arrest|patient resuscitated from cardiac arrest
327666|NCT02201134|Requiring sedation|requiring sedation
327667|NCT02201134|Adult patients|adult patients
327668|NCT02201134|Patient covered by french health care system|patient covered by french health care system
327669|NCT02201095|caesarean section|caesarean section
327670|NCT02201095|perioperative hypothermia|perioperative hypothermia
327671|NCT02201095|active warming|active warming
327672|NCT02201095|forced air warming|forced air warming
327673|NCT02201095|conduction mattress warming|conduction mattress warming
327674|NCT02201095|thermal comfort|thermal comfort
327675|NCT02201095|Prevention of|prevention of
327676|NCT02201069|nutrition|nutrition
327677|NCT02201069|physical activity|physical activity
327678|NCT02201069|sleep|sleep
327679|NCT02201069|weight loss|weight loss
327680|NCT02201056|Drug Therapy|drug therapy
327681|NCT02201043|ankylosing spondylitis|ankylosing spondylitis
327682|NCT02201043|thalidomide|thalidomide
327683|NCT02200952|OHSS|ohss
327684|NCT02200952|Oocytes triggering|oocytes triggering
327685|NCT02200952|GnRh agonist triggering|gnrh agonist triggering
327686|NCT02200952|Luteal phase supplementation|luteal phase supplementation
327687|NCT02200952|recombinant LH|recombinant lh
327688|NCT02200900|High flow nasal cannula|high flow nasal cannula
327689|NCT02200900|Continuous Positive Airway Pressure|continuous positive airway pressure
327690|NCT02200900|Respiratory physiology|respiratory physiology
327691|NCT02200887|Dyskinesia|dyskinesia
327692|NCT02200887|Slow Wave Sleep|slow wave sleep
327693|NCT02200874|disease related malnutrition|disease related malnutrition
327694|NCT02200874|influence of Nutrition Support Team|influence of nutrition support team
327695|NCT02200874|length of hospital stay|length of hospital stay
327696|NCT02200874|quality of life|quality of life
327697|NCT02200874|body composition|body composition
327698|NCT02200874|health care costs|health care costs
327699|NCT02200861|sedation,|sedation,
327700|NCT02200861|tooth extraction,|tooth extraction,
327701|NCT02200848|Lenalidomide|lenalidomide
327702|NCT02200848|Ibrutinib|ibrutinib
327703|NCT02200848|Rituximab|rituximab
327705|NCT02200848|SLL|sll
327706|NCT02200835|aortic dissection|aortic dissection
327707|NCT02200835|Chinese patients|chinese patients
327708|NCT02200835|gender differences|gender differences
327709|NCT02200822|neurohumoral blocker therapy|neurohumoral blocker therapy
327710|NCT02200822|renin-angiotensin-aldosterone system (RAAS)|renin-angiotensin-aldosterone system (raas)
327711|NCT02200822|RAAS-blocker|raas-blocker
327712|NCT02200822|beta blocker|beta blocker
327713|NCT02200822|spironolactone|spironolactone
327714|NCT02200822|angiotensin converting enzyme inhibitor (ACE-I)|angiotensin converting enzyme inhibitor (ace-i)
327715|NCT02200822|angiotensin receptor blocker (ARB)|angiotensin receptor blocker (arb)
327716|NCT02200822|cardiac resynchronization therapy (CRT)|cardiac resynchronization therapy (crt)
327717|NCT02200822|heart failure|heart failure
327718|NCT02200822|dyssynchrony|dyssynchrony
327719|NCT02200822|left bundle branch block|left bundle branch block
327720|NCT02200809|MR-guided therapy|mr-guided therapy
327721|NCT02200809|Focal laser ablation|focal laser ablation
327722|NCT02200809|Prostate cancer|prostate cancer
327723|NCT02200796|Dietary Protein|dietary protein
327724|NCT02200796|Satiety|satiety
327725|NCT02200796|Food Intake|food intake
327726|NCT02200796|Thermic Effect of Food|thermic effect of food
327727|NCT02200796|Diet Induced Thermogenesis|diet induced thermogenesis
327728|NCT02200783|Cardiac catheterization|cardiac catheterization
327729|NCT02200783|Radiation Protection|radiation protection
327730|NCT02200783|Radial artery|radial artery
327731|NCT02200783|Femoral artery|femoral artery
327732|NCT02200770|NMO, NMOSD, Neuromyelitis Optica, Neuromyelitis Optica Spectrum Disorders, autoimmune, demyelination, MEDI-551, monoclonal antibody, Devic's syndrome, B-cell|nmo, nmosd, neuromyelitis optica, neuromyelitis optica spectrum disorders, autoimmune, demyelination, medi-551, monoclonal antibody, devic's syndrome, b-cell
327733|NCT02200744|Procedural sedation|procedural sedation
327734|NCT02200744|emergency department|emergency department
327735|NCT02200744|adults|adults
327736|NCT02200744|propofol|propofol
327737|NCT02200744|recall assessment|recall assessment
327738|NCT02200731|Childhood cancer|childhood cancer
327739|NCT02200731|Psychosocial intervention|psychosocial intervention
327740|NCT02200731|Family|family
327741|NCT02200731|Siblings|siblings
327742|NCT02200731|Childhood cancer survivors|childhood cancer survivors
327743|NCT02200731|Cogntive Behavioural|cogntive behavioural
327744|NCT02200731|Manualized|manualized
327745|NCT02200718|Multiple Sclerosis Pediatric MS NeuroVax Vaccine Therapeutic|multiple sclerosis pediatric ms neurovax vaccine therapeutic
327746|NCT02200705|cryoablation, cryotherapy, breast cancer|cryoablation, cryotherapy, breast cancer
327747|NCT02200692|plasma transfusion|plasma transfusion
327748|NCT02200692|allergic transfusion reaction|allergic transfusion reaction
327749|NCT02200692|transfusion reaction|transfusion reaction
327750|NCT02200692|blood transfusion|blood transfusion
327751|NCT02200692|Solvent detergent plasma|solvent detergent plasma
327752|NCT02200679|Autism spectrum disorders|autism spectrum disorders
327753|NCT02200679|Prevalence|prevalence
327754|NCT02200679|Diagnosis|diagnosis
327755|NCT02200679|Screen|screen
327756|NCT02200679|Risk Factor|risk factor
327758|NCT02200679|ASRS|asrs
327759|NCT02200666|Type 2 diabetes mellitus|type 2 diabetes mellitus
327760|NCT02200666|Diabetes|diabetes
327761|NCT02200666|Forxiga|forxiga
327762|NCT02200666|Long-term use|long-term use
327763|NCT02200627|Type 2 diabetes mellitus|type 2 diabetes mellitus
327764|NCT02200627|Diabetes|diabetes
327765|NCT02200627|Forxiga|forxiga
327766|NCT02200627|Elderly|elderly
327767|NCT02200601|Seipher Wellness|seipher wellness
327768|NCT02200601|algorithm|algorithm
327769|NCT02200601|secure samples of SGC waveform|secure samples of sgc waveform
327770|NCT02200601|volunteers|volunteers
327771|NCT02200601|validation|validation
327772|NCT02200601|heart health algorithm|heart health algorithm
327773|NCT02200588|psychosis|psychosis
327774|NCT02200588|schizophrenia|schizophrenia
327775|NCT02200549|pulmonary rehabilitation|pulmonary rehabilitation
327776|NCT02200549|inspiratory muscle training|inspiratory muscle training
327777|NCT02200549|exercise training|exercise training
327778|NCT02200523|EEG|eeg
327779|NCT02200523|electrode|electrode
327780|NCT02200510|Anemia, Sickle Cell|anemia, sickle cell
327781|NCT02200510|Transition to Adult Care|transition to adult care
327782|NCT02200510|Self Care|self care
327783|NCT02200510|Personal Electronic Health Records|personal electronic health records
327784|NCT02200510|Adolescent|adolescent
327785|NCT02200510|Young Adult|young adult
327786|NCT02200510|Disease Management|disease management
327787|NCT02200510|Physician-Patient Relations|physician-patient relations
327788|NCT02200484|obesity|obesity
327789|NCT02200484|adolescents, females|adolescents, females
327790|NCT02200484|child development|child development
327791|NCT02200484|weight loss programs|weight loss programs
327792|NCT02200484|child rearing|child rearing
327793|NCT02200484|parenting|parenting
327794|NCT02200471|Cosmetic dermatology|cosmetic dermatology
327795|NCT02200471|near-infrared|near-infrared
327796|NCT02200471|patient preference|patient preference
327797|NCT02200471|physician preference|physician preference
327798|NCT02200445|Ulcerative colitis|ulcerative colitis
327799|NCT02200445|Inflammatory bowel disease|inflammatory bowel disease
327800|NCT02200445|Interleukin 2|interleukin 2
327801|NCT02200445|Interleukin-2|interleukin-2
327802|NCT02200445|IL-2|il-2
327803|NCT02200445|Regulatory T Cells|regulatory t cells
327804|NCT02200445|Tregs|tregs
327805|NCT02200445|T-Lymphocytes, Regulatory|t-lymphocytes, regulatory
327806|NCT02200432|Smoking Cessation|smoking cessation
327807|NCT02200432|Persuasive Communication Tailoring|persuasive communication tailoring
327808|NCT02200432|Health Behavior Change|health behavior change
767453|NCT00376883|survival|survival
327809|NCT02200432|Patient decision support|patient decision support
327810|NCT02200419|Rotem|rotem
327811|NCT02200419|Point of care coagulation tests|point of care coagulation tests
327812|NCT02200419|Cardiac surgery|cardiac surgery
327813|NCT02200419|Vascular surgery|vascular surgery
327814|NCT02200419|Cardiopulmonary bypass|cardiopulmonary bypass
327815|NCT02200419|Blood products|blood products
327816|NCT02200419|Transfusion|transfusion
327817|NCT02200419|Viscoelastic coagulation|viscoelastic coagulation
327818|NCT02200406|Desvenlafaxine|desvenlafaxine
327819|NCT02200406|Opioid-dependent|opioid-dependent
327820|NCT02200406|Addiction|addiction
327821|NCT02200406|Depression|depression
327822|NCT02200406|Methadone|methadone
327823|NCT02200406|Comorbidity|comorbidity
327824|NCT02200393|Spinal cord injury|spinal cord injury
327825|NCT02200393|Tetraplegia|tetraplegia
327826|NCT02200393|Ventilator|ventilator
327827|NCT02200367|Primary health care|primary health care
327828|NCT02200367|Computer communication network|computer communication network
327829|NCT02200367|Depression|depression
327830|NCT02200328|Clostridium difficile infection|clostridium difficile infection
327831|NCT02200328|Diarrhea|diarrhea
327832|NCT02200328|Flagyl|flagyl
327833|NCT02200328|Metronidazole|metronidazole
327834|NCT02200315|Stomach neoplasms|stomach neoplasms
327835|NCT02200315|Surgical site infection|surgical site infection
327836|NCT02200315|Laparoscopic gastrectomy|laparoscopic gastrectomy
327837|NCT02200315|Antimicrobial prophylaxis|antimicrobial prophylaxis
327838|NCT02200289|Birth cohort|birth cohort
327839|NCT02200289|Ghana|ghana
327840|NCT02200289|Biomass|biomass
327841|NCT02200289|Cook stove|cook stove
327842|NCT02200289|Oxidative stress|oxidative stress
327843|NCT02200289|Lung development|lung development
327844|NCT02200263|ocular albinism (OA)|ocular albinism (oa)
327845|NCT02200263|oculocutaneous albinism (OCA)|oculocutaneous albinism (oca)
327846|NCT02200263|macular pigment|macular pigment
327847|NCT02200263|visual function|visual function
327848|NCT02200237|EV71 Vaccine|ev71 vaccine
327849|NCT02200211|Amblyopia|amblyopia
327850|NCT02200198|undernutrition|undernutrition
327851|NCT02200198|abdominal surgery|abdominal surgery
327852|NCT02200198|respiratory muscles|respiratory muscles
327853|NCT02200198|muscles strength|muscles strength
327854|NCT02200198|pulmonary complication|pulmonary complication
327855|NCT02200198|perioperative care|perioperative care
327856|NCT02200185|post traumatic pain|post traumatic pain
327857|NCT02200185|titrated morphine|titrated morphine
327858|NCT02200185|nebulised morphine|nebulised morphine
327859|NCT02200172|Cancer|cancer
327860|NCT02200172|Melatonin|melatonin
327861|NCT02200172|Delirium|delirium
327862|NCT02200172|Feasibility Studies|feasibility studies
327863|NCT02200172|Palliative Care|palliative care
327864|NCT02200159|Sedation|sedation
327865|NCT02200159|Dexmedetomidine|dexmedetomidine
327866|NCT02200159|ICU|icu
327867|NCT02200159|Delirium|delirium
327868|NCT02200146|sarcoidosis|sarcoidosis
327869|NCT02200146|treatment|treatment
327870|NCT02200146|lung|lung
327871|NCT02200146|glucocorticoids|glucocorticoids
327872|NCT02200146|hydroxychloroquine|hydroxychloroquine
327873|NCT02200133|Hematopoietic cell transplant (HCT) survivors|hematopoietic cell transplant (hct) survivors
327874|NCT02200133|Survivorship Care Plan|survivorship care plan
327875|NCT02200107|Osteoarthritis Knee|osteoarthritis knee
327876|NCT02200107|Self Care|self care
327877|NCT02200107|Treatment Outcome|treatment outcome
327878|NCT02200107|Patient Education as Topic|patient education as topic
327879|NCT02200107|Physical Therapy Modalities|physical therapy modalities
327880|NCT02200081|Extensive disease|extensive disease
327881|NCT02200081|After first line therapy|after first line therapy
327882|NCT02200081|Immuno therapy|immuno therapy
327883|NCT02200068|Perceived Efficacy of Patient Physician Interactions|perceived efficacy of patient physician interactions
327884|NCT02200068|Patient Reported Outcomes|patient reported outcomes
327885|NCT02200068|Personal Health Record|personal health record
327886|NCT02200055|Electrical Bioimpedance|electrical bioimpedance
327887|NCT02200055|Major Intra-abdominal Surgical Procedures|major intra-abdominal surgical procedures
327888|NCT02200055|Total Body Volume|total body volume
327889|NCT02200055|Fluid Resuscitation|fluid resuscitation
327890|NCT02200029|Intrahepatic Cholestasis|intrahepatic cholestasis
327891|NCT02200016|Postoperative pain|postoperative pain
327892|NCT02200016|Regional anesteshia|regional anesteshia
327893|NCT02200016|Nerve catheters|nerve catheters
327894|NCT02200016|Sciatic nerve catheters|sciatic nerve catheters
327895|NCT02200003|attention bias modification, anxiety, event-related potentials|attention bias modification, anxiety, event-related potentials
327896|NCT02199990|cognitive function; propofol; etomidate;|cognitive function; propofol; etomidate;
327897|NCT02199977|Malaria|malaria
327898|NCT02199977|Antimalarial subsidy|antimalarial subsidy
327899|NCT02199977|Malaria rapid diagnostic test (RDT)|malaria rapid diagnostic test (rdt)
327900|NCT02199977|public-private partnership|public-private partnership
327901|NCT02199964|Dry eye|dry eye
327902|NCT02199964|environmental stress|environmental stress
327903|NCT02199964|artificial tears|artificial tears
327904|NCT02199964|cyclosporin|cyclosporin
327905|NCT02199964|Restasis|restasis
327906|NCT02199951|Uncomplicated Malaria|uncomplicated malaria
327907|NCT02199951|dihydroartemisinin|dihydroartemisinin
327908|NCT02199951|piperaquine|piperaquine
327909|NCT02199925|Autism|autism
327910|NCT02199925|Autism spectrum|autism spectrum
327911|NCT02199925|Autism children|autism children
327912|NCT02199912|cachexia|cachexia
327913|NCT02199912|nutrition|nutrition
327914|NCT02199912|cancer|cancer
327915|NCT02199912|colorectal tumor|colorectal tumor
327916|NCT02199834|diabetes|diabetes
327917|NCT02199834|peer support|peer support
327918|NCT02199834|personalized feedback report|personalized feedback report
327919|NCT02199795|stroke|stroke
327920|NCT02199795|hemiplegia|hemiplegia
327921|NCT02199795|footdrop|footdrop
327922|NCT02199795|electrical stimulation|electrical stimulation
327923|NCT02199769|Clinical decision support|clinical decision support
327924|NCT02199769|Diabetes screening|diabetes screening
327925|NCT02199756|Uterine contractions|uterine contractions
327926|NCT02199756|Indomethacin|indomethacin
327927|NCT02199756|Nanovectors|nanovectors
327928|NCT02199743|schizophrenia|schizophrenia
327929|NCT02199743|schizoaffective|schizoaffective
327930|NCT02199743|cognition|cognition
327931|NCT02199743|lurasidone|lurasidone
327932|NCT02199743|Latuda|latuda
327933|NCT02199717|Physical Activity|physical activity
327934|NCT02199717|Accelerometer|accelerometer
327935|NCT02199717|Exercise|exercise
327936|NCT02199717|Obesity|obesity
327937|NCT02199717|BMI|bmi
327938|NCT02199704|Parenting|parenting
327939|NCT02199704|Psychosis|psychosis
327940|NCT02199704|Schizophrenia|schizophrenia
327941|NCT02199704|Delusions|delusions
327942|NCT02199704|Hallucinations|hallucinations
327943|NCT02199691|Meningitis|meningitis
327944|NCT02199691|Meningococcal Meningitis|meningococcal meningitis
327945|NCT02199691|MenACYW conjugate vaccine|menacyw conjugate vaccine
327946|NCT02199691|MENVEO vaccine|menveo vaccine
327947|NCT02199691|Adacel®|adacel®
327948|NCT02199691|GARDASIL®|gardasil®
327949|NCT02199639|Haemophilia|haemophilia
327950|NCT02199639|Arthropathy|arthropathy
327951|NCT02199639|Range of Movement|range of movement
327952|NCT02199639|Strength|strength
327953|NCT02199639|Proprioception|proprioception
327954|NCT02199639|Gait|gait
327955|NCT02199639|Quality of Life|quality of life
327956|NCT02199613|HIV|hiv
327957|NCT02199613|antiretroviral therapy|antiretroviral therapy
327958|NCT02199587|Medical clown|medical clown
327959|NCT02199587|Growth hormone|growth hormone
327960|NCT02199587|Precocious puberty|precocious puberty
327961|NCT02199548|Adolescent|adolescent
327962|NCT02199548|Decision-making|decision-making
327963|NCT02199548|Social network|social network
327964|NCT02199535|operating room,|operating room,
327965|NCT02199535|risk factors|risk factors
327966|NCT02199535|anesthesiologists|anesthesiologists
327967|NCT02199509|Levetiracetam|levetiracetam
327968|NCT02199509|Cranial Dystonia|cranial dystonia
327969|NCT02199509|Oromandibular Dystonia|oromandibular dystonia
327970|NCT02199496|Malabsorption|malabsorption
327971|NCT02199496|Enteropathy|enteropathy
327972|NCT02199496|Diarrhea|diarrhea
327973|NCT02199496|IL-12|il-12
327974|NCT02199483|Energy Expenditure|energy expenditure
327975|NCT02199483|Behavioral Weight Loss Treatment|behavioral weight loss treatment
327976|NCT02199483|Neurocognitive Function|neurocognitive function
327977|NCT02199483|Weight Loss|weight loss
327978|NCT02199470|β-CELLS,|β-cells,
327979|NCT02199470|MIXED MEAL TEST,|mixed meal test,
327980|NCT02199470|C-PEPTİDE|c-peptide
327981|NCT02199431|Lu AF11167|lu af11167
327982|NCT02199431|Interaction|interaction
327983|NCT02199405|Spondylosis, Massage Therapy, Exercise Therapy ,Treatment Efficacy|spondylosis, massage therapy, exercise therapy ,treatment efficacy
327984|NCT02199392|P-glycoprotein|p-glycoprotein
327985|NCT02199392|Healthy Volunteers|healthy volunteers
327986|NCT02199379|renal impairment|renal impairment
327987|NCT02199379|disease severity|disease severity
327988|NCT02199366|Cardiac MRI|cardiac mri
327989|NCT02199366|Radiation|radiation
327990|NCT02199366|Proton Radiation|proton radiation
327991|NCT02199366|Breast Cancer|breast cancer
327992|NCT02199353|Activities of daily living, Occupational Therapy, Dementia|activities of daily living, occupational therapy, dementia
327993|NCT02199340|Exercise testing|exercise testing
327994|NCT02199340|Children|children
327995|NCT02199340|Exercise capacity|exercise capacity
327996|NCT02199327|Conjunctival-corneal intraepithelial neoplasia|conjunctival-corneal intraepithelial neoplasia
327997|NCT02199327|Mitomycin C|mitomycin c
327998|NCT02199327|Interferon alfa 2b|interferon alfa 2b
327999|NCT02199314|intra|intra
328000|NCT02199314|operative|operative
328001|NCT02199314|neurophysiologic|neurophysiologic
328002|NCT02199314|monitoring|monitoring
328003|NCT02199314|transcranial|transcranial
328004|NCT02199314|motor|motor
328005|NCT02199314|evoked|evoked
328006|NCT02199314|potential|potential
328007|NCT02199314|anesthesia|anesthesia
328008|NCT02199314|pulses|pulses
328009|NCT02199301|Kidney transplantation|kidney transplantation
328010|NCT02199301|Tolerance induction|tolerance induction
328011|NCT02199301|Immunosuppression withdrawal|immunosuppression withdrawal
328012|NCT02199301|Bone marrow transplantation|bone marrow transplantation
328013|NCT02199301|Transplantation conditioning|transplantation conditioning
328014|NCT02199301|Hematopoietic stem cell transplantation|hematopoietic stem cell transplantation
328015|NCT02199301|Living donor|living donor
328016|NCT02199301|Haplotype|haplotype
328017|NCT02199301|Immune tolerance|immune tolerance
328018|NCT02199275|Non-urgent surgery|non-urgent surgery
328019|NCT02199275|General anesthesia|general anesthesia
328020|NCT02199275|Enterocyte damage|enterocyte damage
328021|NCT02199275|Intestinal fatty acid-binding protein|intestinal fatty acid-binding protein
328022|NCT02199262|Intensive care unit|intensive care unit
328023|NCT02199262|Incidents|incidents
328024|NCT02199262|prevention|prevention
328025|NCT02199262|music|music
328026|NCT02199262|reflexology|reflexology
328027|NCT02199249|open anatomic reduction|open anatomic reduction
328028|NCT02199249|syndesmosis screw fixation, syndesmosis Tightrope fixation|syndesmosis screw fixation, syndesmosis tightrope fixation
328029|NCT02199236|High-Dose-Rate Brachytherapy|high-dose-rate brachytherapy
328030|NCT02199236|oral capecitabine|oral capecitabine
328031|NCT02199236|infusional 5-FU|infusional 5-fu
328032|NCT02199236|Questionnaires|questionnaires
328033|NCT02199236|14-104|14-104
328133|NCT02198768|prospective|prospective
328034|NCT02199210|Massive transfusion protocols|massive transfusion protocols
328035|NCT02199210|Self-regulatory learning|self-regulatory learning
328036|NCT02199210|Forethought|forethought
328037|NCT02199210|Clinical expertise|clinical expertise
328038|NCT02199210|Simulation|simulation
328039|NCT02199210|Education|education
328040|NCT02199171|hyperthermic intraoperative intraperitoneal chemotherapy (HIPEC) carboplatin|hyperthermic intraoperative intraperitoneal chemotherapy (hipec) carboplatin
328041|NCT02199171|intraperitoneal (IP) chemotherapy|intraperitoneal (ip) chemotherapy
328042|NCT02199171|cytoreductive surgery|cytoreductive surgery
328043|NCT02199158|iridoplasty|iridoplasty
328044|NCT02199158|angle|angle
328045|NCT02199158|glaucoma|glaucoma
328046|NCT02199158|anterior chamber|anterior chamber
328047|NCT02199158|laser treatment|laser treatment
328048|NCT02199132|Nasopharyngeal Carcinoma|nasopharyngeal carcinoma
328049|NCT02199119|children|children
328050|NCT02199119|television|television
328051|NCT02199119|exercise|exercise
328052|NCT02199119|food intake|food intake
328053|NCT02199119|appetite|appetite
328054|NCT02199119|satiation|satiation
328055|NCT02199093|MeSH terms:|mesh terms:
328056|NCT02199093|Apraxias|apraxias
328057|NCT02199093|Apraxia, Ideomotor|apraxia, ideomotor
328058|NCT02199093|Stroke|stroke
328059|NCT02199093|Cerebral Stroke|cerebral stroke
328060|NCT02199093|Rehabilitation|rehabilitation
328061|NCT02199093|Occupational therapy|occupational therapy
328062|NCT02199093|Treatment Outcome|treatment outcome
328063|NCT02199093|Activities of Daily Living|activities of daily living
328064|NCT02199054|Snack Foods|snack foods
328065|NCT02199054|Safflower Oil|safflower oil
328066|NCT02199054|Soy|soy
328067|NCT02199054|Postmenopausal women|postmenopausal women
328068|NCT02199054|Metabolic Syndrome|metabolic syndrome
328069|NCT02199041|Cord Blood|cord blood
328070|NCT02199041|Haploidentical|haploidentical
328071|NCT02199041|Reduced Intensity Regimen|reduced intensity regimen
328072|NCT02199028|hyaluronidase|hyaluronidase
328073|NCT02199028|infusion sets|infusion sets
328074|NCT02199028|insulin pump|insulin pump
328075|NCT02199028|Continuous glucose monitor|continuous glucose monitor
328076|NCT02199015|Dysarthria|dysarthria
328077|NCT02199015|Electrical Stimulation|electrical stimulation
328078|NCT02199015|Lateral Cord Stimulation|lateral cord stimulation
328079|NCT02199015|Spasticity|spasticity
328080|NCT02199015|Treatment|treatment
328081|NCT02199002|acid pocket|acid pocket
328082|NCT02199002|GERD|gerd
328083|NCT02199002|Barrett|barrett
328084|NCT02198963|Skin irritation potential of RUT058-60.|skin irritation potential of rut058-60.
328085|NCT02198950|sepsis|sepsis
328086|NCT02198950|diagnosis|diagnosis
328087|NCT02198950|biomarker|biomarker
328088|NCT02198937|smokers|smokers
328089|NCT02198937|non-smokers|non-smokers
328090|NCT02198924|sequential administration|sequential administration
328091|NCT02198924|pain control|pain control
328092|NCT02198924|inflammation control|inflammation control
328093|NCT02198924|function recovery|function recovery
328094|NCT02198911|Habituation|habituation
328095|NCT02198911|Orosensory cues|orosensory cues
328096|NCT02198911|Satiation|satiation
328097|NCT02198885|FAST|fast
328098|NCT02198885|Thoracoabdominal Trauma|thoracoabdominal trauma
328099|NCT02198885|Prehospital care|prehospital care
328100|NCT02198885|ultrasound|ultrasound
328101|NCT02198885|NanoMaxx Ultrasound|nanomaxx ultrasound
328102|NCT02198885|RP-Xpress|rp-xpress
328103|NCT02198872|Autonomic Nervous System, Body composition, Oxygen Uptake,|autonomic nervous system, body composition, oxygen uptake,
328104|NCT02198872|Water Based Physical Training, Land Based Physical Training.|water based physical training, land based physical training.
328105|NCT02198859|Prostate Cancer|prostate cancer
328106|NCT02198859|Lithium|lithium
328107|NCT02198859|Androgen|androgen
328108|NCT02198859|PSA|psa
328109|NCT02198833|Urinary Tract Infection|urinary tract infection
328110|NCT02198833|Bacteriuria|bacteriuria
328111|NCT02198833|Transurethral Foley Catheter|transurethral foley catheter
328112|NCT02198833|Suprapubic Foley Catheter|suprapubic foley catheter
328113|NCT02198833|Spinal Cord injury|spinal cord injury
328114|NCT02198820|Femoral Neck Fractures|femoral neck fractures
328115|NCT02198820|Perioperative Care|perioperative care
328116|NCT02198820|Perioperative Period|perioperative period
328117|NCT02198820|Postoperative Complications|postoperative complications
328118|NCT02198794|Dyskinesias|dyskinesias
328119|NCT02198794|Movement Disorders|movement disorders
328120|NCT02198794|Central Nervous System Diseases|central nervous system diseases
328121|NCT02198794|Nervous System Diseases|nervous system diseases
328122|NCT02198794|Neurologic Manifestations|neurologic manifestations
328123|NCT02198794|Signs and Symptoms|signs and symptoms
328124|NCT02198781|atrial fibrilation|atrial fibrilation
328125|NCT02198781|atrial-ventricula|atrial-ventricula
328126|NCT02198781|right ventricle|right ventricle
328127|NCT02198781|left ventricle|left ventricle
328128|NCT02198781|surrogate marker|surrogate marker
328129|NCT02198781|ventricular dysfunction|ventricular dysfunction
328130|NCT02198781|pacing|pacing
328131|NCT02198768|ankle fracture|ankle fracture
328132|NCT02198768|ankle fracture-dislocation|ankle fracture-dislocation
328134|NCT02198768|observational|observational
328135|NCT02198755|high resolution ultrasound|high resolution ultrasound
328136|NCT02198755|osteomyelitis|osteomyelitis
328137|NCT02198716|Percutaneous coronary intervention|percutaneous coronary intervention
328138|NCT02198716|Elderly|elderly
328139|NCT02198716|Angina|angina
328140|NCT02198703|Probiotics|probiotics
328141|NCT02198703|AB-Life|ab-life
328142|NCT02198703|LDL-cholesterol|ldl-cholesterol
328143|NCT02198703|Hypercholesterolemia|hypercholesterolemia
328144|NCT02198690|Mammography, Older women, decision making|mammography, older women, decision making
328145|NCT02198664|Characterized Peanut Allergen|characterized peanut allergen
328146|NCT02198664|Peanut|peanut
328148|NCT02198664|Oral Desensitization|oral desensitization
328149|NCT02198664|Peanut Allergen|peanut allergen
328150|NCT02198664|Peanut-Allergic Children|peanut-allergic children
328151|NCT02198664|Children|children
328152|NCT02198664|Peanut-Allergic Adults|peanut-allergic adults
328153|NCT02198651|Rheumatoid Arthritis|rheumatoid arthritis
328154|NCT02198651|Adalimumab|adalimumab
328155|NCT02198651|Taper|taper
328156|NCT02198651|Flare|flare
328157|NCT02198651|Arthritis|arthritis
328158|NCT02198651|Anti-rheumatic drugs|anti-rheumatic drugs
328159|NCT02198651|Remission|remission
328160|NCT02198651|Magnetic Resonance Imaging|magnetic resonance imaging
328161|NCT02198651|Ultrasound|ultrasound
328162|NCT02198651|Biomarker|biomarker
328163|NCT02198651|Drug Level|drug level
328164|NCT02198651|Reduced dose|reduced dose
328165|NCT02198638|Influenza|influenza
328166|NCT02198638|Vaccination rate|vaccination rate
328167|NCT02198638|Hospital acquired infection|hospital acquired infection
328168|NCT02198625|Moderate FiO2|moderate fio2
328169|NCT02198625|Protective lung ventilation|protective lung ventilation
328170|NCT02198625|Postoperative pulmonary complications|postoperative pulmonary complications
328171|NCT02198625|Positive end-expiratory pressure|positive end-expiratory pressure
328172|NCT02198625|recruitment maneuvers|recruitment maneuvers
328173|NCT02198599|Multiple sclerosis|multiple sclerosis
328174|NCT02198599|Stroke|stroke
328175|NCT02198599|Nursing|nursing
328176|NCT02198599|Mobility|mobility
328177|NCT02198599|Rehabilitation|rehabilitation
328178|NCT02198586|Alzheimer's, MRI, APOE|alzheimer's, mri, apoe
328179|NCT02198573|malaria|malaria
328180|NCT02198573|K13|k13
328181|NCT02198573|pfmrp1|pfmrp1
328182|NCT02198573|Myanmar|myanmar
328183|NCT02198560|Normal (Eyes without pathologies)|normal (eyes without pathologies)
328184|NCT02198547|Local anesthetic adjuvant,|local anesthetic adjuvant,
328185|NCT02198547|Magnesium solfatus,|magnesium solfatus,
328186|NCT02198547|Sciatic block|sciatic block
328187|NCT02198534|visual acuity|visual acuity
328188|NCT02198534|Landolt C|landolt c
328189|NCT02198534|ETDRS charts|etdrs charts
328190|NCT02198534|Freiburg Visual Acuity Test|freiburg visual acuity test
328191|NCT02198534|FrACT|fract
328192|NCT02198534|Comparison|comparison
328193|NCT02198534|acceptance|acceptance
328194|NCT02198534|Test retest reliability|test retest reliability
328195|NCT02198534|duration|duration
328196|NCT02198534|questionnaire|questionnaire
328197|NCT02198521|Patients undergoing staged bilateral open Carpal Tunnel Release (CTR) have no difference in overall pain intensity of pain between sides.|patients undergoing staged bilateral open carpal tunnel release (ctr) have no difference in overall pain intensity of pain between sides.
328198|NCT02198482|Acute Myeloid Leukemia (AML)|acute myeloid leukemia (aml)
328199|NCT02198482|Volasertib|volasertib
767454|NCT00376870|PCI|pci
328200|NCT02198482|High-risk Myelodysplastic Syndrome (MDS)|high-risk myelodysplastic syndrome (mds)
328201|NCT02198469|actinic cheilitis|actinic cheilitis
328202|NCT02198469|Er:YAG ablative fractional laser|er:yag ablative fractional laser
328203|NCT02198469|methyl aminolevulinate photodynamic therapy|methyl aminolevulinate photodynamic therapy
328204|NCT02198456|pulmonary arterial hypertension|pulmonary arterial hypertension
328205|NCT02198430|Haemophilia|haemophilia
328206|NCT02198430|Arthropathy|arthropathy
328207|NCT02198430|Range of motion|range of motion
328208|NCT02198430|Strength|strength
328209|NCT02198430|Proprioception|proprioception
328210|NCT02198430|Gait|gait
328211|NCT02198430|Quality of Life.|quality of life.
328212|NCT02198417|Polycystic Ovary Syndrome|polycystic ovary syndrome
328213|NCT02198417|PCOS|pcos
328214|NCT02198417|Acne|acne
328215|NCT02198417|Infertility|infertility
328216|NCT02198417|Irregular menses|irregular menses
328217|NCT02198417|Irregular period|irregular period
328218|NCT02198417|Mitochondria|mitochondria
328219|NCT02198417|Metabolism|metabolism
328220|NCT02198378|premixed nitrous oxide and oxygen|premixed nitrous oxide and oxygen
328221|NCT02198378|pain|pain
328222|NCT02198378|prehospital setting|prehospital setting
328223|NCT02198378|acute coronary syndrome|acute coronary syndrome
328224|NCT02198365|mRNA,|mrna,
328225|NCT02198365|DNA,|dna,
328226|NCT02198365|integrated HPV DNA|integrated hpv dna
328227|NCT02198365|human papillomavirus,|human papillomavirus,
328228|NCT02198365|cervical neoplasia|cervical neoplasia
328229|NCT02198300|dedicated bifurcation stent|dedicated bifurcation stent
328230|NCT02198300|sirolimus eluting stent|sirolimus eluting stent
328231|NCT02198261|alopecia|alopecia
328232|NCT02198261|androgenetic alopecia|androgenetic alopecia
328233|NCT02198261|hair loss|hair loss
328234|NCT02198261|minoxidil|minoxidil
328235|NCT02198261|5% minoxidil foam|5% minoxidil foam
328236|NCT02198261|male pattern hair loss|male pattern hair loss
328237|NCT02198209|liraglutide|liraglutide
328238|NCT02198209|GLP-1|glp-1
328239|NCT02198209|liver glucokinase|liver glucokinase
328240|NCT02198170|Healthy Volunteers|healthy volunteers
328241|NCT02198157|duration of second stage|duration of second stage
328242|NCT02198157|urinary catheterization|urinary catheterization
328243|NCT02198157|epidural anaesthesia|epidural anaesthesia
328244|NCT02198144|Hypertension|hypertension
328245|NCT02198144|High Blood Pressure|high blood pressure
328246|NCT02198144|African American Men|african american men
328247|NCT02198144|Black Men|black men
328248|NCT02198118|breast cancer|breast cancer
328249|NCT02198118|physiotherapy|physiotherapy
328250|NCT02198118|radiotherapy|radiotherapy
328251|NCT02198105|PAD|pad
328252|NCT02198105|femoropoliteal stenosis/occlusion|femoropoliteal stenosis/occlusion
328253|NCT02198105|cutting-balloon|cutting-balloon
328254|NCT02198105|drug-coated-balloon|drug-coated-balloon
328255|NCT02198092|familial adenomatous polyposis|familial adenomatous polyposis
328256|NCT02198092|multiple adenomatous polyposis|multiple adenomatous polyposis
328257|NCT02198092|lynch syndrome|lynch syndrome
328258|NCT02198092|hnpcc|hnpcc
328259|NCT02198092|colorectal cancer|colorectal cancer
328260|NCT02198092|genetic syndrome|genetic syndrome
328261|NCT02198092|epigenomics|epigenomics
328262|NCT02198092|septin9|septin9
328263|NCT02198079|non-tuberculous mycobacteria|non-tuberculous mycobacteria
328264|NCT02198079|Pediatrics|pediatrics
328265|NCT02198079|Cystic Fibrosis|cystic fibrosis
328266|NCT02198066|Sternotomy incision|sternotomy incision
328267|NCT02198066|Silver dressing|silver dressing
328268|NCT02198066|Sternal wound infection|sternal wound infection
328269|NCT02198040|Elbow|elbow
328270|NCT02198040|Joint disease|joint disease
328271|NCT02198040|Hemophilia|hemophilia
328272|NCT02198040|Physiotherapy modalities|physiotherapy modalities
328273|NCT02198027|Percutaneous nephrolithotomy|percutaneous nephrolithotomy
328274|NCT02198027|postoperative analgesia|postoperative analgesia
328275|NCT02198027|peritubal block|peritubal block
328276|NCT02198027|pain|pain
328277|NCT02198027|Visual Analog Pain Scale|visual analog pain scale
328278|NCT02198014|Knee|knee
328279|NCT02198014|Joint disease|joint disease
328280|NCT02198014|Haemophilia|haemophilia
328281|NCT02198014|Physiotherapy modalities|physiotherapy modalities
328282|NCT02198001|Platelets|platelets
328283|NCT02198001|fibrin|fibrin
328284|NCT02198001|growth factors|growth factors
328285|NCT02198001|bisphosphonates|bisphosphonates
328286|NCT02198001|tooth extraction|tooth extraction
328287|NCT02197988|Surgery|surgery
328288|NCT02197988|Abdominal|abdominal
328289|NCT02197988|Epidural Anesthesia|epidural anesthesia
328290|NCT02197988|Transversus Abdominis Plane Block|transversus abdominis plane block
328291|NCT02197988|TAP block|tap block
328292|NCT02197975|Healthy Volunteers|healthy volunteers
328293|NCT02197962|Osteoarthritis|osteoarthritis
328294|NCT02197962|Radial shockwaves|radial shockwaves
328295|NCT02197936|Peristalsis|peristalsis
328296|NCT02197936|ultrasound|ultrasound
328297|NCT02197923|Menorrhagia|menorrhagia
328298|NCT02197923|Dysmenorrhea|dysmenorrhea
328299|NCT02197923|Pelvic pain|pelvic pain
328300|NCT02197923|expression profiling|expression profiling
328301|NCT02197923|uterine biopsies|uterine biopsies
328302|NCT02197923|serum hormones|serum hormones
328303|NCT02197897|Tamoxifen citrate|tamoxifen citrate
328304|NCT02197897|Bladder Cancer|bladder cancer
328305|NCT02197884|Healthy|healthy
328306|NCT02197884|JNJ-54861911|jnj-54861911
328307|NCT02197884|Cytochrome P450 3A4 inhibitor|cytochrome p450 3a4 inhibitor
328308|NCT02197884|Itraconazole|itraconazole
328309|NCT02197884|Clarithromycin|clarithromycin
328310|NCT02197884|Alzheimer's disease|alzheimer's disease
328311|NCT02197871|COPD|copd
328312|NCT02197871|malnutrition|malnutrition
328313|NCT02197871|nutrition supplementation|nutrition supplementation
328314|NCT02197858|invasive arterial pressure|invasive arterial pressure
328315|NCT02197858|extended hemodynamic monitoring|extended hemodynamic monitoring
328316|NCT02197858|propofol|propofol
328317|NCT02197858|remifentanil|remifentanil
328318|NCT02197845|sickle cell disease|sickle cell disease
328319|NCT02197845|hydroxyurea|hydroxyurea
328320|NCT02197845|patient navigator|patient navigator
328321|NCT02197845|community health worker|community health worker
328322|NCT02197845|public health worker|public health worker
328323|NCT02197845|fetal hemoglobin|fetal hemoglobin
328324|NCT02197845|health services research|health services research
328325|NCT02197832|Frozen thawed embryo transfer|frozen thawed embryo transfer
328326|NCT02197832|Endometrial injury|endometrial injury
328327|NCT02197832|Ongoing pregnancy rates|ongoing pregnancy rates
328328|NCT02197780|Diagnostic accuracy|diagnostic accuracy
328329|NCT02197780|Fecal biomarker|fecal biomarker
328330|NCT02197780|Clinical Decision Rule|clinical decision rule
328512|NCT02196857|Azacytidine|azacytidine
328331|NCT02197780|Cohort Study|cohort study
328332|NCT02197767|fibrillary glomerulonephritis|fibrillary glomerulonephritis
328333|NCT02197767|rituximab|rituximab
328334|NCT02197767|Rituxan|rituxan
328335|NCT02197767|MabThera|mabthera
328336|NCT02197767|Zytux™|zytux™
328337|NCT02197754|pharmacokinetics|pharmacokinetics
328338|NCT02197754|polyphenol metabolites|polyphenol metabolites
328339|NCT02197754|lean individuals|lean individuals
328340|NCT02197754|obese individuals|obese individuals
328341|NCT02197728|hysterectomy, uterine manipulator, thermal damage, laparoscopy, colpotomy|hysterectomy, uterine manipulator, thermal damage, laparoscopy, colpotomy
328342|NCT02197715|Pregnancy|pregnancy
328343|NCT02197715|Contraceptive Methods|contraceptive methods
328344|NCT02197715|Family Planning Services|family planning services
328345|NCT02197702|RCT|rct
328346|NCT02197702|asthma|asthma
328347|NCT02197702|pediatric|pediatric
328348|NCT02197702|virus|virus
328349|NCT02197702|corticosteroid|corticosteroid
328350|NCT02197689|Personalized Medication Management|personalized medication management
328351|NCT02197689|Medication Adherence|medication adherence
328352|NCT02197689|SMS Medication Reminder|sms medication reminder
328353|NCT02197663|acupuncture|acupuncture
328354|NCT02197663|stroke|stroke
328355|NCT02197663|Randomized Controlled Trial|randomized controlled trial
328356|NCT02197650|ALL L-asparaginase encapsulated erythrocytes|all l-asparaginase encapsulated erythrocytes
328357|NCT02197624|Non-heme iron absorption; HFE|non-heme iron absorption; hfe
328358|NCT02197611|Haemophilia|haemophilia
328359|NCT02197611|Adherence of Treatment|adherence of treatment
328360|NCT02197611|Knowledge of Illness|knowledge of illness
328361|NCT02197611|Medical-patient Relationship|medical-patient relationship
328362|NCT02197611|Illness Behavior|illness behavior
328363|NCT02197611|Treatment Difficulties.|treatment difficulties.
328364|NCT02197598|nalmefene, alcohol consumption, liver effects|nalmefene, alcohol consumption, liver effects
328365|NCT02197585|Male patients|male patients
328366|NCT02197585|Age > 18 year|age > 18 year
328367|NCT02197585|Primary hernia|primary hernia
328368|NCT02197585|glue|glue
328369|NCT02197572|Drug therapy|drug therapy
328370|NCT02197559|Ischemic Stroke, restenosis,bare-metal stents, drug -eluting stents|ischemic stroke, restenosis,bare-metal stents, drug -eluting stents
328371|NCT02197546|Injection pain|injection pain
328372|NCT02197546|local anesthesia|local anesthesia
328373|NCT02197546|acupuncture|acupuncture
328374|NCT02197481|BiClamp forceps hepatectomy|biclamp forceps hepatectomy
328375|NCT02197481|Clamp crushing technique|clamp crushing technique
328376|NCT02197481|Liver parenchyma transection|liver parenchyma transection
328377|NCT02197481|Randomized controlled trial|randomized controlled trial
328378|NCT02197468|Gut microbiome|gut microbiome
328379|NCT02197468|Necrotizing enterocolitis|necrotizing enterocolitis
328380|NCT02197468|Antibiotics|antibiotics
328381|NCT02197429|Vulvodynia|vulvodynia
328382|NCT02197429|Acupuncture|acupuncture
328383|NCT02197429|Provoked Vestibulodynia|provoked vestibulodynia
328384|NCT02197429|Vulvar Vestibulitis|vulvar vestibulitis
328385|NCT02197429|Vulvar Pain|vulvar pain
328386|NCT02197429|Dyspareunia|dyspareunia
328387|NCT02197429|Female Sexual Function|female sexual function
328388|NCT02197403|Dexmedetomidine|dexmedetomidine
328389|NCT02197403|Sedation|sedation
328390|NCT02197403|Paradoxical excitement response|paradoxical excitement response
419658|NCT01780298|FEV|fev
328391|NCT02197403|Alcohol drinkers|alcohol drinkers
328392|NCT02197390|Childhood obesity|childhood obesity
328393|NCT02197390|Latino|latino
328394|NCT02197390|Hispanic|hispanic
328395|NCT02197377|Laryngeal mask airway, edentulous geriatric patient|laryngeal mask airway, edentulous geriatric patient
328396|NCT02197364|Interstitial Lung Disease|interstitial lung disease
328397|NCT02197364|Diagnosis|diagnosis
328398|NCT02197364|Krebs Von Den Lungen-6|krebs von den lungen-6
328399|NCT02197351|stomach neoplasms|stomach neoplasms
328400|NCT02197351|narrow band imaging|narrow band imaging
328401|NCT02197351|gastroscopy|gastroscopy
328402|NCT02197338|cholangiopancreatography, endoscopic retrograde|cholangiopancreatography, endoscopic retrograde
328403|NCT02197325|NSTEMI and STEMI|nstemi and stemi
328404|NCT02197312|yttrium-oxide|yttrium-oxide
328405|NCT02197312|Y-TZP|y-tzp
328406|NCT02197312|bridge|bridge
328407|NCT02197312|NobelProcera|nobelprocera
328408|NCT02197312|Shaded Zirconia|shaded zirconia
328409|NCT02197273|Total knee arthroplasty|total knee arthroplasty
328410|NCT02197273|Total shoulder arthroplasty|total shoulder arthroplasty
328411|NCT02197273|Total hip arthroplasty|total hip arthroplasty
328412|NCT02197273|Total joint arthroplasty|total joint arthroplasty
328413|NCT02197273|Hip replacement|hip replacement
328414|NCT02197273|Knee replacement|knee replacement
328415|NCT02197273|Shoulder replacement|shoulder replacement
328416|NCT02197260|Periodontitis|periodontitis
328417|NCT02197260|amoxicillin|amoxicillin
328418|NCT02197260|metronidazole|metronidazole
328419|NCT02197260|case management|case management
328420|NCT02197247|oncology, cancer, non small cell lung cancer, anticancer drug, pharmacokinetics, AZD9291, rifampicin, CYP P450 inducer, EGFR genes|oncology, cancer, non small cell lung cancer, anticancer drug, pharmacokinetics, azd9291, rifampicin, cyp p450 inducer, egfr genes
328513|NCT02196857|5-Azacytidine|5-azacytidine
328514|NCT02196857|5-AZA|5-aza
328421|NCT02197234|oncology, cancer, non small cell lung cancer, anticancer drug, pharmacokinetics, AZD9291, simvastatin, EGFR genes|oncology, cancer, non small cell lung cancer, anticancer drug, pharmacokinetics, azd9291, simvastatin, egfr genes
328422|NCT02197208|Frozen-thawed embryo transfer|frozen-thawed embryo transfer
328423|NCT02197208|natural cycle|natural cycle
328424|NCT02197208|spontaneous ovulation|spontaneous ovulation
328425|NCT02197208|hCG induced natural cycles|hcg induced natural cycles
328426|NCT02197182|Bacterial Vaginosis (BV)|bacterial vaginosis (bv)
328427|NCT02197182|Amsel's criteria|amsel's criteria
328428|NCT02197182|Pap smear|pap smear
328429|NCT02197169|Brain|brain
328430|NCT02197169|Brain Cancer|brain cancer
328431|NCT02197169|Brain Neoplasms|brain neoplasms
328432|NCT02197169|Central Nervous System Diseases|central nervous system diseases
328433|NCT02197169|Central Nervous System Neoplasms|central nervous system neoplasms
328434|NCT02197169|CNS|cns
328435|NCT02197169|Conditionally Replication-Competent Adenovirus|conditionally replication-competent adenovirus
328436|NCT02197169|DNX-2401|dnx-2401
328437|NCT02197169|Delta-24-RGD|delta-24-rgd
328438|NCT02197169|Glioma|glioma
328439|NCT02197169|Glioblastoma|glioblastoma
328440|NCT02197169|Gliosarcoma|gliosarcoma
328441|NCT02197169|Interferon gamma|interferon gamma
328442|NCT02197169|Malignant brain tumor|malignant brain tumor
328443|NCT02197169|Neoplasms, Neuroepithelial|neoplasms, neuroepithelial
328444|NCT02197169|Neuroectodermal Tumors|neuroectodermal tumors
328445|NCT02197169|Neoplasms, Germ Cell and Embryonal|neoplasms, germ cell and embryonal
328446|NCT02197169|Neoplasms by Histologic Type|neoplasms by histologic type
328447|NCT02197169|Neoplasms, Glandular and Epithelial|neoplasms, glandular and epithelial
328448|NCT02197169|Neoplasms, Nerve Tissue|neoplasms, nerve tissue
328449|NCT02197169|Nervous System Diseases|nervous system diseases
328450|NCT02197169|Alcyone Lifesciences|alcyone lifesciences
328451|NCT02197169|AMC™|amc™
328452|NCT02197169|Cannula|cannula
328453|NCT02197169|Alcyone MEMS Cannula (AMC™) System|alcyone mems cannula (amc™) system
328454|NCT02197143|esomeprazole|esomeprazole
328455|NCT02197143|ranitidine|ranitidine
328456|NCT02197143|hydrotalcid|hydrotalcid
328457|NCT02197143|treatment of dyspepsia|treatment of dyspepsia
328458|NCT02197143|emergancy medicine|emergancy medicine
328459|NCT02197130|Huntington; chorea; total motor score; CAG repeat: total functional capacity; motor cognitive and behavioral symptoms|huntington; chorea; total motor score; cag repeat: total functional capacity; motor cognitive and behavioral symptoms
328460|NCT02197117|ST-segment elevation myocardial infarction (STEMI); thrombolysis, remote ischemic conditioning, myocardial infarct size, cardioprotection|st-segment elevation myocardial infarction (stemi); thrombolysis, remote ischemic conditioning, myocardial infarct size, cardioprotection
328461|NCT02197065|hip fracture|hip fracture
328462|NCT02197065|myocardial ischemia|myocardial ischemia
328463|NCT02197065|statin|statin
328464|NCT02197065|surgery|surgery
328465|NCT02197065|troponin|troponin
328466|NCT02197065|complication|complication
328467|NCT02197065|arthroplasty|arthroplasty
328468|NCT02197065|hip|hip
328469|NCT02197065|knee|knee
328470|NCT02197065|orthopedic|orthopedic
328471|NCT02197065|atorvastatin|atorvastatin
328472|NCT02197065|cardiovascular|cardiovascular
328473|NCT02197039|Peptic ulcer hemorrhage, second-look endoscopy|peptic ulcer hemorrhage, second-look endoscopy
328474|NCT02197000|BRCA mutation|brca mutation
328475|NCT02197000|Breast cancer|breast cancer
328476|NCT02197000|Estrogen metabolism|estrogen metabolism
328477|NCT02197000|3,3-Diindolylmethane|3,3-diindolylmethane
328478|NCT02197000|Breast density|breast density
328479|NCT02196987|Pain|pain
328480|NCT02196987|Catheter|catheter
328481|NCT02196987|Urethra|urethra
328482|NCT02196987|Urination|urination
328483|NCT02196974|bronchoscopy|bronchoscopy
328484|NCT02196974|lung nodule|lung nodule
328485|NCT02196974|diagnosis|diagnosis
328486|NCT02196974|cryobiopsy|cryobiopsy
328487|NCT02196961|Merkel cell carcinoma|merkel cell carcinoma
328488|NCT02196961|Adjuvant|adjuvant
328489|NCT02196961|Nivolumab|nivolumab
328490|NCT02196948|Supraspinatus, tendinopathy, pain, disability, EPTE|supraspinatus, tendinopathy, pain, disability, epte
328491|NCT02196935|Cholangitis|cholangitis
328492|NCT02196935|Choledocholithiasis|choledocholithiasis
328493|NCT02196935|Gastrointestinal Neoplasms|gastrointestinal neoplasms
328494|NCT02196935|Medically underserved area|medically underserved area
328495|NCT02196935|Anesthesia|anesthesia
328496|NCT02196922|Chronic Heart Failure|chronic heart failure
328497|NCT02196922|Telehealth|telehealth
328498|NCT02196922|Self Management|self management
328499|NCT02196909|HIBM|hibm
328500|NCT02196909|GNE|gne
328501|NCT02196870|Airway pressure stress index|airway pressure stress index
328502|NCT02196870|Transpulmonary pressure stress index|transpulmonary pressure stress index
328503|NCT02196870|Acute Respiratory Failure|acute respiratory failure
328504|NCT02196870|Chest wall elastance|chest wall elastance
328505|NCT02196870|Lung stress|lung stress
328506|NCT02196857|Leukemia|leukemia
328507|NCT02196857|Acute myeloid leukemia|acute myeloid leukemia
328508|NCT02196857|AML|aml
328509|NCT02196857|High risk myelodysplastic syndrome|high risk myelodysplastic syndrome
328510|NCT02196857|MDS|mds
328511|NCT02196857|FLT3-ITD mutation|flt3-itd mutation
328515|NCT02196857|Vidaza|vidaza
328516|NCT02196857|5-AZC|5-azc
328517|NCT02196857|AZA-CR|aza-cr
328518|NCT02196857|Ladakamycin|ladakamycin
328519|NCT02196857|NSC-102816|nsc-102816
328520|NCT02196857|Sorafenib|sorafenib
328521|NCT02196857|Nexavar|nexavar
328522|NCT02196857|BAY 43-9006|bay 43-9006
328523|NCT02196844|Lung cancer|lung cancer
328524|NCT02196844|Hatha Yoga|hatha yoga
328525|NCT02196844|Questionnaires|questionnaires
328526|NCT02196844|Surveys|surveys
328527|NCT02196844|Walk Test|walk test
328528|NCT02196844|Caregiver|caregiver
328529|NCT02196831|Human immunodeficiency virus (HIV)|human immunodeficiency virus (hiv)
328530|NCT02196831|Nonalcoholic fatty liver disease (NAFLD)|nonalcoholic fatty liver disease (nafld)
328531|NCT02196831|Nonalcoholic steatohepatitis (NASH)|nonalcoholic steatohepatitis (nash)
328532|NCT02196831|Growth hormone releasing hormone|growth hormone releasing hormone
328533|NCT02196831|tesamorelin|tesamorelin
328534|NCT02196805|bioequivalence|bioequivalence
328535|NCT02196805|imported PROBUCOL table|imported probucol table
328536|NCT02196805|Lorelco|lorelco
328537|NCT02196805|marketed PROBUCOL tablet|marketed probucol tablet
328538|NCT02196805|Chang Tai|chang tai
328539|NCT02196792|Joint Diseases|joint diseases
328540|NCT02196792|Musculoskeletal Diseases|musculoskeletal diseases
328541|NCT02196792|radiostereometric analysis|radiostereometric analysis
328542|NCT02196792|Total hip arthroplasty|total hip arthroplasty
328543|NCT02196779|Abdominoplasty|abdominoplasty
328544|NCT02196779|circulation|circulation
328545|NCT02196779|skin|skin
328546|NCT02196779|dissection|dissection
328547|NCT02196779|laser|laser
328548|NCT02196779|fluorescence|fluorescence
328549|NCT02196779|imaging|imaging
328550|NCT02196753|Positron emission tomography combined with computed tomography|positron emission tomography combined with computed tomography
328551|NCT02196753|PET CT|pet ct
328552|NCT02196753|Cardiovascular Implantable Electronic Device|cardiovascular implantable electronic device
328553|NCT02196753|Infective endocarditis|infective endocarditis
328554|NCT02196753|Generator pocket infection|generator pocket infection
328555|NCT02196753|Fever of unknown origin|fever of unknown origin
328556|NCT02196740|periapical periodontitis,primary teeth|periapical periodontitis,primary teeth
328557|NCT02196727|Postoperative pain|postoperative pain
328558|NCT02196727|Multimodal analgesia|multimodal analgesia
328559|NCT02196727|Bascom Cleft Lift|bascom cleft lift
328560|NCT02196727|Day-case.|day-case.
328561|NCT02196714|Japanese Healthy Volunteers|japanese healthy volunteers
328562|NCT02196701|methotrexate|methotrexate
328563|NCT02196701|adalimumab|adalimumab
328564|NCT02196701|biologic|biologic
328565|NCT02196701|psoriasis|psoriasis
328566|NCT02196701|Tumor necrosis factor (TNF)-α inhibitor|tumor necrosis factor (tnf)-α inhibitor
328567|NCT02196688|Colorectal cancer|colorectal cancer
328568|NCT02196688|Fruquintinib|fruquintinib
328569|NCT02196688|013|013
328570|NCT02196610|End-Stage Renal Disease,|end-stage renal disease,
328571|NCT02196610|arterial or vascular stiffness,|arterial or vascular stiffness,
328572|NCT02196610|hemodialysis,|hemodialysis,
328573|NCT02196610|Pulse wave velocity|pulse wave velocity
328574|NCT02196610|Renal insufficiency,|renal insufficiency,
328575|NCT02196610|tonometry|tonometry
328576|NCT02196597|anorectal manometry|anorectal manometry
328577|NCT02196571|GDM|gdm
328578|NCT02196571|Exercise|exercise
328579|NCT02196571|Diabetes|diabetes
328580|NCT02196571|Pregnancy|pregnancy
328581|NCT02196558|Rheumatoid Arthritis|rheumatoid arthritis
328582|NCT02196558|Japanese subjects|japanese subjects
328583|NCT02196532|retinal nerve fiber layer thickness|retinal nerve fiber layer thickness
328584|NCT02196532|optical coherence tomography|optical coherence tomography
328585|NCT02196532|migraine|migraine
328586|NCT02196506|OPC-34712|opc-34712
328587|NCT02196506|brexpiprazole|brexpiprazole
328588|NCT02196506|Major Depressive Disorder|major depressive disorder
328589|NCT02196506|Adjunctive Treatment|adjunctive treatment
328590|NCT02196506|Anxious Distress|anxious distress
328591|NCT02196493|Productive|productive
328592|NCT02196493|Cough|cough
328593|NCT02196493|Bronchitis|bronchitis
328594|NCT02196493|Azithromycin|azithromycin
328595|NCT02196467|myoblast|myoblast
328596|NCT02196467|transplantation|transplantation
328597|NCT02196467|strength|strength
328598|NCT02196467|tacrolimus|tacrolimus
328599|NCT02196467|immunosuppression|immunosuppression
328600|NCT02196454|HPV vaccine|hpv vaccine
328601|NCT02196454|vaccination|vaccination
328602|NCT02196454|immunization|immunization
328603|NCT02196454|video|video
328604|NCT02196454|health education|health education
328605|NCT02196454|communication|communication
328606|NCT02196441|deep topical fornix nerve block|deep topical fornix nerve block
328607|NCT02196441|topical anesthesia|topical anesthesia
328608|NCT02196441|implantable contact lens procedure|implantable contact lens procedure
328609|NCT02196428|Ambient Assisted Living (AAL)|ambient assisted living (aal)
328610|NCT02196428|Telemonitoring|telemonitoring
328611|NCT02196428|Teleconsultation|teleconsultation
328612|NCT02196415|Hindfoot Alignment|hindfoot alignment
328613|NCT02196415|Rearfoot|rearfoot
328614|NCT02196415|Malalignment|malalignment
328615|NCT02196415|biplanar radiography|biplanar radiography
328616|NCT02196415|3D measurement|3d measurement
328617|NCT02196376|Postural orthostatic syndrome|postural orthostatic syndrome
328618|NCT02196376|orthostatic intolerance|orthostatic intolerance
328619|NCT02196376|autonomic dysfunction|autonomic dysfunction
328620|NCT02196350|personalized treatment|personalized treatment
328621|NCT02196350|prevention|prevention
328622|NCT02196350|improved diagnosis|improved diagnosis
328623|NCT02196337|Iodine deficiency|iodine deficiency
328624|NCT02196324|Prurigo Nodularis|prurigo nodularis
328625|NCT02196324|Atopic Dermatitis|atopic dermatitis
328626|NCT02196324|Lichen-simplex chronicus|lichen-simplex chronicus
328627|NCT02196311|Supracondylar humerus fractures, external fixation, open reduction, and internal fixation.|supracondylar humerus fractures, external fixation, open reduction, and internal fixation.
328628|NCT02196298|physical therapy|physical therapy
328629|NCT02196298|gait|gait
328630|NCT02196298|pediatric rehabilitation|pediatric rehabilitation
328631|NCT02196298|gross motor function|gross motor function
328632|NCT02196298|participation|participation
328633|NCT02196285|Double|double
328634|NCT02196285|Viral|viral
328635|NCT02196285|Vaccine|vaccine
328636|NCT02196285|Measles|measles
328637|NCT02196285|Rubella|rubella
328638|NCT02196285|Safety|safety
328639|NCT02196285|Efficacy|efficacy
328640|NCT02196285|Imunogenicity|imunogenicity
328641|NCT02196259|Pre-Post|pre-post
328642|NCT02196233|Trigger Finger|trigger finger
328643|NCT02196233|Prospective Clinical Research|prospective clinical research
328644|NCT02196233|Randomized|randomized
328645|NCT02196233|Questionnaires|questionnaires
328646|NCT02196233|Transverse|transverse
328647|NCT02196233|Longitudinal|longitudinal
328648|NCT02196207|Severe Hemophilia A|severe hemophilia a
328649|NCT02196207|Hemophilia Inhibitor Formation|hemophilia inhibitor formation
328650|NCT02196207|Eloctate|eloctate
328651|NCT02196207|Emicizumab|emicizumab
328652|NCT02196207|Inhibitor Prevention|inhibitor prevention
328653|NCT02196207|Inhibitor Eradication|inhibitor eradication
328654|NCT02196155|plantar fasciitis|plantar fasciitis
328655|NCT02196155|Botulinum toxin A|botulinum toxin a
328656|NCT02196155|Cortisone|cortisone
328657|NCT02196155|RCT|rct
328658|NCT02196142|Cortisol|cortisol
328659|NCT02196142|Alcohol Craving|alcohol craving
328660|NCT02196142|Alcohol Dependence|alcohol dependence
328661|NCT02196129|low back pain|low back pain
328662|NCT02196129|pharmacoacupuncture|pharmacoacupuncture
328663|NCT02196129|sinbaro-3|sinbaro-3
328664|NCT02196116|Alzheimer disease|alzheimer disease
328665|NCT02196116|amyloid load|amyloid load
328666|NCT02196116|educational level|educational level
328667|NCT02196116|cognitive performances|cognitive performances
328668|NCT02196103|TOLAC|tolac
328669|NCT02196103|PROM|prom
328670|NCT02196103|Previous Cesarian section|previous cesarian section
328671|NCT02196103|Mechanical cervical ripening|mechanical cervical ripening
767455|NCT00376870|STENT|stent
328672|NCT02196090|OCD, Exposure and Response Prevention, Vagal Stimulation|ocd, exposure and response prevention, vagal stimulation
328673|NCT02196077|Budesonide and formoterol inhalation aerosol|budesonide and formoterol inhalation aerosol
328674|NCT02196064|HIV HCV antiretroviral|hiv hcv antiretroviral
328675|NCT02196051|Insulin resistance|insulin resistance
328676|NCT02196051|Exercise|exercise
328677|NCT02196051|de novo lipogenesis|de novo lipogenesis
328678|NCT02196051|NAFLD|nafld
328679|NCT02196051|Magnetic Resonance Spectroscopy|magnetic resonance spectroscopy
328680|NCT02196038|heart failure|heart failure
328681|NCT02196025|Insomnia|insomnia
328682|NCT02196012|overweight|overweight
328683|NCT02196012|obesity|obesity
328684|NCT02196012|Technology|technology
328685|NCT02196012|College Students|college students
328686|NCT02195986|vaginal dryness|vaginal dryness
328687|NCT02195986|vaginal and/or vulvar irritation/itching|vaginal and/or vulvar irritation/itching
328688|NCT02195986|dysuria|dysuria
328689|NCT02195986|vaginal pain and bleeding associated with sexual activity|vaginal pain and bleeding associated with sexual activity
328690|NCT02195986|vaginal atrophy|vaginal atrophy
328691|NCT02195973|ovarian cancer|ovarian cancer
328692|NCT02195973|platinum resistant|platinum resistant
328693|NCT02195973|LED225|led225
328694|NCT02195973|Sonidegib|sonidegib
328695|NCT02195973|Paclitaxel|paclitaxel
328696|NCT02195960|skin toxicity, radiotherapy, antioxidants|skin toxicity, radiotherapy, antioxidants
328697|NCT02195947|Growth hormone|growth hormone
328698|NCT02195947|IVF/ICSI|ivf/icsi
328699|NCT02195947|Poor responder|poor responder
328700|NCT02195947|Antagonist protocol|antagonist protocol
328701|NCT02195934|Cardiovascular disease, blood orange juice, anthocyanins|cardiovascular disease, blood orange juice, anthocyanins
328702|NCT02195895|Teriparatide|teriparatide
328703|NCT02195895|Alendronate|alendronate
328704|NCT02195895|Alendronic Acid|alendronic acid
328705|NCT02195895|Osteoporosis|osteoporosis
328706|NCT02195895|Bone Fracture|bone fracture
328707|NCT02195895|Bone Loss|bone loss
328708|NCT02195895|Spinal Cord Injury|spinal cord injury
328709|NCT02195895|Bone Diseases|bone diseases
328710|NCT02195895|Metabolic Bone Diseases|metabolic bone diseases
328711|NCT02195895|Musculoskeletal Diseases|musculoskeletal diseases
328712|NCT02195895|Spinal Cord Diseases|spinal cord diseases
328713|NCT02195895|Central Nervous System Diseases|central nervous system diseases
328714|NCT02195895|Nervous System Diseases|nervous system diseases
328715|NCT02195895|Nervous System|nervous system
328716|NCT02195895|Wounds and Injuries|wounds and injuries
328717|NCT02195895|Bone Density Conservation Agents|bone density conservation agents
328718|NCT02195895|Physiological Effects of Drugs|physiological effects of drugs
328719|NCT02195895|Pharmacologic Actions|pharmacologic actions
328720|NCT02195882|strength training|strength training
328721|NCT02195882|scapular stabilization|scapular stabilization
328722|NCT02195882|kayakers.|kayakers.
328723|NCT02195869|PCYC1129|pcyc1129
328724|NCT02195869|PCYC1129CA|pcyc1129ca
328725|NCT02195869|1129|1129
328726|NCT02195869|Ibrutinib|ibrutinib
328727|NCT02195869|PCI32765|pci32765
328728|NCT02195869|IMBRUVICA|imbruvica
328729|NCT02195869|Pharmacyclics|pharmacyclics
328730|NCT02195869|PCYC|pcyc
328731|NCT02195869|GVHD|gvhd
328732|NCT02195869|Steroid dependent|steroid dependent
328733|NCT02195869|refractory|refractory
328734|NCT02195869|chronic|chronic
328735|NCT02195869|graft versus host disease|graft versus host disease
328736|NCT02195869|chronic graft versus host disease|chronic graft versus host disease
328737|NCT02195869|immunology|immunology
328738|NCT02195856|Diabetes|diabetes
328739|NCT02195856|Nitrate|nitrate
328740|NCT02195856|Nitrite|nitrite
328741|NCT02195856|Hepatic|hepatic
328743|NCT02195856|Incretin|incretin
328744|NCT02195856|Insulin|insulin
328745|NCT02195856|Glucose|glucose
328746|NCT02195843|CRT-D|crt-d
328747|NCT02195843|Heart Failure|heart failure
328748|NCT02195843|Middle East|middle east
328749|NCT02195843|Quadripolar|quadripolar
328750|NCT02195830|Sepsis|sepsis
328751|NCT02195830|ultrasound|ultrasound
328752|NCT02195830|inferior vena cava collapsibility|inferior vena cava collapsibility
328753|NCT02195778|Health Literacy|health literacy
328754|NCT02195778|Adult|adult
328755|NCT02195778|UAE|uae
328756|NCT02195778|Disease|disease
328757|NCT02195778|Age|age
328758|NCT02195765|Chronic Periodontitis|chronic periodontitis
328759|NCT02195765|Periodontal disease|periodontal disease
328760|NCT02195752|Compounded pain cream|compounded pain cream
328761|NCT02195752|Ordinary care|ordinary care
328762|NCT02195752|Compounding|compounding
328763|NCT02195752|Topical treatment|topical treatment
328764|NCT02195752|Analgesia|analgesia
328765|NCT02195739|smoking|smoking
328766|NCT02195739|smoking cessation|smoking cessation
328767|NCT02195739|cardiovascular disease|cardiovascular disease
328768|NCT02195739|pharmacological intervention|pharmacological intervention
328769|NCT02195739|UK primary care population|uk primary care population
328770|NCT02195739|nicotine replacement therapy|nicotine replacement therapy
328771|NCT02195700|Dyskinesias|dyskinesias
328772|NCT02195700|Movement Disorders|movement disorders
328773|NCT02195700|Central Nervous System Diseases|central nervous system diseases
328774|NCT02195700|Nervous System Diseases|nervous system diseases
328775|NCT02195700|Neurologic Manifestations|neurologic manifestations
328776|NCT02195700|Signs and Symptoms|signs and symptoms
328777|NCT02195661|Epilepsy|epilepsy
328778|NCT02195661|Electroencephalogram|electroencephalogram
328779|NCT02195661|children|children
328780|NCT02195661|sedation|sedation
328781|NCT02195648|Tension-Type Headache|tension-type headache
328782|NCT02195648|Physical Therapy Modalities|physical therapy modalities
328783|NCT02195648|Musculoskeletal Manipulations|musculoskeletal manipulations
328784|NCT02195648|Sub-occipital muscle inhibition technique|sub-occipital muscle inhibition technique
328785|NCT02195609|Vasomotor Symptoms Associated With Menopause|vasomotor symptoms associated with menopause
328786|NCT02195609|Menopause|menopause
328787|NCT02195609|Hot Flashes|hot flashes
328788|NCT02195609|Postmenopausal Women|postmenopausal women
328789|NCT02195596|Alzheimer disease, exercise, cognition|alzheimer disease, exercise, cognition
328790|NCT02195570|contingency management|contingency management
328791|NCT02195570|smoking cessation|smoking cessation
328792|NCT02195570|prenatal tobacco exposure|prenatal tobacco exposure
328793|NCT02195570|maternal smoking|maternal smoking
328794|NCT02195531|Adherence|adherence
328795|NCT02195518|Chronic Hepatitis B|chronic hepatitis b
328796|NCT02195518|Tenofovir disoproxil fumarate|tenofovir disoproxil fumarate
328797|NCT02195518|Failure of multiple NAs treatment|failure of multiple nas treatment
328798|NCT02195479|Multiple Myeloma|multiple myeloma
328799|NCT02195479|Bortezomib|bortezomib
328800|NCT02195479|Velcade|velcade
328801|NCT02195479|Melphalan|melphalan
328802|NCT02195479|Prednisone|prednisone
328803|NCT02195479|Daratumumab|daratumumab
328804|NCT02195453|Non-small cell lung cancer|non-small cell lung cancer
328805|NCT02195453|FACT-L scale|fact-l scale
328806|NCT02195453|Yangzhengxiaoji|yangzhengxiaoji
328807|NCT02195440|Hepatitis C virus, cirrhosis|hepatitis c virus, cirrhosis
328808|NCT02195427|Nasolabial folds|nasolabial folds
328809|NCT02195427|Dermal filler|dermal filler
328810|NCT02195427|Hyaluronic acid (HA)|hyaluronic acid (ha)
328811|NCT02195427|Wrinkles|wrinkles
328812|NCT02195414|NeoVas|neovas
328813|NCT02195414|Bioresorbable scaffold|bioresorbable scaffold
328814|NCT02195414|Sirolimus|sirolimus
328815|NCT02195414|First-in-Man|first-in-man
328816|NCT02195401|autism, cleanroom, immune dysregulation, toxins|autism, cleanroom, immune dysregulation, toxins
328817|NCT02195388|Arterial stiffness,|arterial stiffness,
328818|NCT02195388|endothelial function,|endothelial function,
328819|NCT02195388|autonomic nervous system,|autonomic nervous system,
328820|NCT02195388|acute coronary syndrome,|acute coronary syndrome,
328821|NCT02195388|arterial hypertension,|arterial hypertension,
328822|NCT02195388|pulse wave velocity,|pulse wave velocity,
328823|NCT02195388|augmentation index,|augmentation index,
328824|NCT02195388|arterial stiffness index,|arterial stiffness index,
328825|NCT02195388|heart rate variability,|heart rate variability,
328826|NCT02195388|heart rate turbulence,|heart rate turbulence,
328827|NCT02195388|vascular endothelial growth factor,|vascular endothelial growth factor,
328828|NCT02195388|asymmetric dimethylarginine|asymmetric dimethylarginine
328829|NCT02195375|Chronic Obstructive Pulmonary Disease|chronic obstructive pulmonary disease
328830|NCT02195375|FEV1 ≤ 50%|fev1 ≤ 50%
328831|NCT02195349|Tuberculin Purified Protein Derivative|tuberculin purified protein derivative
328832|NCT02195349|Delayed Type Hypersensitivity|delayed type hypersensitivity
328833|NCT02195349|Biopsy|biopsy
328834|NCT02195349|Induration|induration
328835|NCT02195349|First time in human|first time in human
328836|NCT02195349|T-cells|t-cells
328837|NCT02195349|LAG-3|lag-3
328838|NCT02195349|safety|safety
328839|NCT02195349|GSK2831781|gsk2831781
328840|NCT02195349|psoriasis|psoriasis
328841|NCT02195323|autologous bone marrow mesenchymal stem cells chronic kidney disease|autologous bone marrow mesenchymal stem cells chronic kidney disease
328842|NCT02195310|Sternotomy|sternotomy
328843|NCT02195310|Surgical site Occurences|surgical site occurences
328844|NCT02195310|Negative Pressure Wound Therapy|negative pressure wound therapy
328845|NCT02195310|Surgical Site Infection|surgical site infection
328846|NCT02195297|cellulitis|cellulitis
328847|NCT02195297|anticellulitis|anticellulitis
328848|NCT02195284|Inhaler preference|inhaler preference
328849|NCT02195284|Overall inhaler error|overall inhaler error
328850|NCT02195284|DISKUS/ACCUHALER|diskus/accuhaler
328851|NCT02195284|MDI|mdi
328852|NCT02195284|TURBUHALER|turbuhaler
328853|NCT02195284|ELLIPTA|ellipta
328854|NCT02195284|Ease of use|ease of use
328855|NCT02195284|Critical inhaler error|critical inhaler error
328856|NCT02195271|Melatonin|melatonin
328857|NCT02195271|Transcranial Direct Current Stimulation|transcranial direct current stimulation
328858|NCT02195271|Neuroplasticity|neuroplasticity
328859|NCT02195271|Analgesia|analgesia
328860|NCT02195271|Pain|pain
328861|NCT02195245|CO2 filter|co2 filter
328862|NCT02195245|anesthesia|anesthesia
328863|NCT02195245|device|device
767456|NCT00376870|Coronary|coronary
328864|NCT02195232|Venous Thromboembolic Events in Cancer Patients|venous thromboembolic events in cancer patients
328865|NCT02195232|Thromboembolism of Vein in Colorectal Cancer|thromboembolism of vein in colorectal cancer
328866|NCT02195232|Thromboembolism of Vein in Pancreatic Cancer|thromboembolism of vein in pancreatic cancer
328867|NCT02195232|Thromboembolism of Vein in Non-small Cell Lung Cancer|thromboembolism of vein in non-small cell lung cancer
328868|NCT02195219|conservative|conservative
328869|NCT02195219|treatment|treatment
328870|NCT02195219|surgical|surgical
328871|NCT02195219|Acromioclavicular|acromioclavicular
328872|NCT02195219|Joint|joint
328873|NCT02195219|dislocation|dislocation
328874|NCT02195206|Hyperpolarized gas magnetic resonance imaging|hyperpolarized gas magnetic resonance imaging
328875|NCT02195206|Hyperpolarized Xenon-129 magnetic resonance imaging|hyperpolarized xenon-129 magnetic resonance imaging
328876|NCT02195206|Lung Imaging|lung imaging
328877|NCT02195206|Healthy Adults|healthy adults
328878|NCT02195193|Health Services Research|health services research
328879|NCT02195193|Acute Coronary Syndromes|acute coronary syndromes
328880|NCT02195193|Depression|depression
328881|NCT02195193|Integrated care|integrated care
328882|NCT02195180|Pancreas|pancreas
328883|NCT02195180|adenocarcinoma|adenocarcinoma
328884|NCT02195180|cancer|cancer
328885|NCT02195180|asparaginase|asparaginase
328886|NCT02195180|erythrocytes|erythrocytes
328887|NCT02195180|red blood cell|red blood cell
328888|NCT02195180|Encapsulation|encapsulation
328889|NCT02195180|folfox|folfox
328890|NCT02195180|gemcitabine|gemcitabine
328891|NCT02195154|18F-DTBZ|18f-dtbz
328892|NCT02195141|Preoperative Chemoradiotherapy|preoperative chemoradiotherapy
328893|NCT02195141|Locally Advanced Rectal Cancer|locally advanced rectal cancer
328894|NCT02195141|boost|boost
328895|NCT02195141|IMRT|imrt
328896|NCT02195102|transcatheter aortic valve Replacement|transcatheter aortic valve replacement
328897|NCT02195089|Treatment of Cervical Intraepithelial Neoplasia(CIN3)|treatment of cervical intraepithelial neoplasia(cin3)
328898|NCT02195076|Lung cancer|lung cancer
328899|NCT02195076|Breast Cancer|breast cancer
328900|NCT02195076|Biosensors|biosensors
328901|NCT02195076|Volatile Organic Compounds|volatile organic compounds
328902|NCT02195076|Odor|odor
328903|NCT02195076|Urine Sample|urine sample
328904|NCT02195076|Exhaled Breath Samples|exhaled breath samples
328905|NCT02195063|Pain management|pain management
328906|NCT02195063|Scar care|scar care
328907|NCT02195063|Wound care|wound care
328908|NCT02195063|UDT|udt
328909|NCT02195063|Urinary drug testing|urinary drug testing
328910|NCT02195037|Delayed Cord Clamping|delayed cord clamping
328911|NCT02195024|pacemaker|pacemaker
328912|NCT02195024|magnetic resonance imaging|magnetic resonance imaging
328913|NCT02195024|MRI conditional|mri conditional
328914|NCT02195024|pacemaker leads|pacemaker leads
328915|NCT02195011|Regorafenib|regorafenib
328916|NCT02195011|90Y|90y
328917|NCT02195011|Radioembolization|radioembolization
328918|NCT02195011|SIR-Spheres Microspheres|sir-spheres microspheres
328919|NCT02195011|Metastatic Colorectal Cancer|metastatic colorectal cancer
328920|NCT02195011|Liver Metastases|liver metastases
328921|NCT02195011|SIRT|sirt
328922|NCT02195011|Refractory|refractory
328923|NCT02194985|Fabry disease|fabry disease
328924|NCT02194985|Lysosomal storage disease|lysosomal storage disease
328925|NCT02194985|migalastat HCl|migalastat hcl
328926|NCT02194985|AT1001|at1001
328927|NCT02194972|constipation|constipation
328928|NCT02194972|colon transit time|colon transit time
328929|NCT02194972|gut microbiota|gut microbiota
328930|NCT02194972|soluble dietary fiber|soluble dietary fiber
328931|NCT02194972|disturbance of gut microbiota in constipation|disturbance of gut microbiota in constipation
328932|NCT02194959|Patient Navigation|patient navigation
328933|NCT02194959|Screening Colonoscopy|screening colonoscopy
328934|NCT02194959|Colorectal Cancer Screening|colorectal cancer screening
328935|NCT02194959|African Americans|african americans
328936|NCT02194946|Chronic Kidney Disease,|chronic kidney disease,
328937|NCT02194946|End-Stage Renal Disease,|end-stage renal disease,
328938|NCT02194946|Traditional Chinese Medicine,|traditional chinese medicine,
328939|NCT02194946|dialysis initiation.|dialysis initiation.
328940|NCT02194933|Schizophrenia|schizophrenia
328941|NCT02194933|Mental Disorders, Antipsychotic,|mental disorders, antipsychotic,
328942|NCT02194933|Psychotic disorder, Impulsivity|psychotic disorder, impulsivity
328943|NCT02194907|Emotional Aging|emotional aging
328944|NCT02194907|Neurofeedback|neurofeedback
328945|NCT02194894|Acetaminophen, Non-alcoholic Fatty Liver Disease (NAFLD)|acetaminophen, non-alcoholic fatty liver disease (nafld)
328946|NCT02194881|Cystic fibrosis|cystic fibrosis
328947|NCT02194881|CFTR|cftr
328948|NCT02194881|G551D mutation|g551d mutation
328949|NCT02194881|Novel treatments|novel treatments
328950|NCT02194881|Potentiator|potentiator
328951|NCT02194881|Ivacaftor|ivacaftor
328952|NCT02194868|Allogeneic hematopoietic stem cell transplantation,|allogeneic hematopoietic stem cell transplantation,
328953|NCT02194868|Immunoregulatory T lymphocytes,|immunoregulatory t lymphocytes,
328954|NCT02194868|acute graft versus host disease|acute graft versus host disease
328955|NCT02194855|rocuronium|rocuronium
328956|NCT02194855|cisatracurium|cisatracurium
328957|NCT02194855|pharmacokinetic|pharmacokinetic
328958|NCT02194842|metastatic|metastatic
328959|NCT02194842|prostate cancer|prostate cancer
328960|NCT02194816|Parkinson's Disease|parkinson's disease
328961|NCT02194816|PD|pd
328962|NCT02194816|Complementary and Alternative|complementary and alternative
328963|NCT02194816|CAM|cam
328964|NCT02194790|Chronic Kidney Disease|chronic kidney disease
328965|NCT02194790|Diabetic Nephropathy|diabetic nephropathy
328966|NCT02194790|Integrated Chronic Kidney Disease Care|integrated chronic kidney disease care
328967|NCT02194725|Stress and Coping Model|stress and coping model
328968|NCT02194725|Coping|coping
328969|NCT02194712|circulating anodic antigen|circulating anodic antigen
328970|NCT02194686|cilostazol|cilostazol
328971|NCT02194686|progenitor cells|progenitor cells
328972|NCT02194686|cardiovascular disease|cardiovascular disease
328973|NCT02194686|risk factors|risk factors
328974|NCT02194686|angiogenesis|angiogenesis
328975|NCT02194686|biological markers|biological markers
328976|NCT02194686|endothelial function|endothelial function
328977|NCT02194660|Fractures Liaison Service|fractures liaison service
328978|NCT02194660|Osteoporosis|osteoporosis
328979|NCT02194660|Fracture|fracture
328980|NCT02194660|Medication adherence|medication adherence
328981|NCT02194647|Osteoporosis|osteoporosis
328982|NCT02194647|Medication Monitoring|medication monitoring
328983|NCT02194647|Education|education
328984|NCT02194647|Adherence|adherence
328985|NCT02194647|Management|management
328986|NCT02194595|type 2 diabetes|type 2 diabetes
328987|NCT02194595|beta-cell function|beta-cell function
328988|NCT02194595|GLP-1|glp-1
328989|NCT02194595|insulin|insulin
328990|NCT02194582|FSGS|fsgs
328991|NCT02194582|NS|ns
328992|NCT02194582|Kidney disease|kidney disease
328993|NCT02194582|Kidney failure|kidney failure
328994|NCT02194582|Renal disease|renal disease
328995|NCT02194582|nephrotic syndrome|nephrotic syndrome
328996|NCT02194582|focal segmental glomerulosclerosis|focal segmental glomerulosclerosis
328997|NCT02194582|familial kidney disease|familial kidney disease
328998|NCT02194582|minimal change disease|minimal change disease
328999|NCT02194582|proteinuria|proteinuria
329000|NCT02194543|Cataract|cataract
329001|NCT02194543|HD 3D|hd 3d
329002|NCT02194543|Microscope|microscope
329003|NCT02194530|Peanut allergic individuals|peanut allergic individuals
329004|NCT02194530|Allergic/atopic individuals (not allergic to peanut)|allergic/atopic individuals (not allergic to peanut)
329005|NCT02194530|Non-allergic individuals|non-allergic individuals
329006|NCT02194517|diabetes|diabetes
329007|NCT02194517|diet control toolset|diet control toolset
329008|NCT02194517|food exchanges|food exchanges
329010|NCT02194517|FP|fp
329011|NCT02194504|Metabolic health|metabolic health
329012|NCT02194504|Phenotyping|phenotyping
329013|NCT02194504|Abdominal obesity|abdominal obesity
329014|NCT02194504|Abdominal adiposity|abdominal adiposity
329015|NCT02194504|Liver fat|liver fat
329016|NCT02194504|Belly fat|belly fat
329017|NCT02194491|[11C]AS2471907|[11c]as2471907
329018|NCT02194491|ASP3662|asp3662
329019|NCT02194491|Positron Emission Tomography (PET)|positron emission tomography (pet)
329020|NCT02194491|Brain enzyme occupancy|brain enzyme occupancy
329021|NCT02194478|Stress|stress
329022|NCT02194478|Meditation|meditation
329023|NCT02194478|Mind body|mind body
329024|NCT02194439|Acute Graft Versus Host Disease|acute graft versus host disease
329025|NCT02194439|Affect|affect
329026|NCT02194439|Anti-inflammatory|anti-inflammatory
329027|NCT02194439|Anti-inflammatory Agents|anti-inflammatory agents
329028|NCT02194439|Antigen-Presenting Cells|antigen-presenting cells
329029|NCT02194439|Alloantigen|alloantigen
329030|NCT02194439|Allogeneic|allogeneic
329031|NCT02194439|Allograft rejection|allograft rejection
329032|NCT02194439|Allograft Tolerance|allograft tolerance
329033|NCT02194439|Antigens|antigens
329034|NCT02194439|Autoimmunity|autoimmunity
329035|NCT02194439|Biomarkers|biomarkers
329036|NCT02194439|Biospecimen Repository|biospecimen repository
329037|NCT02194439|BMT|bmt
329038|NCT02194439|Bone Marrow Transplantation|bone marrow transplantation
329039|NCT02194439|Cell Transplantation|cell transplantation
329040|NCT02194439|Cells|cells
329041|NCT02194439|Clonal Expansion|clonal expansion
329042|NCT02194439|Complex|complex
329043|NCT02194439|Cytokine|cytokine
329044|NCT02194439|Data|data
329045|NCT02194439|Development|development
329046|NCT02194439|Environment|environment
329047|NCT02194439|Failure (biologic function)|failure (biologic function)
329048|NCT02194439|Genomics|genomics
329049|NCT02194439|Graft-vs-Host Disease|graft-vs-host disease
329050|NCT02194439|Graft-vs-Leukemia|graft-vs-leukemia
329051|NCT02194439|GVHD|gvhd
329052|NCT02194439|GVL|gvl
329053|NCT02194439|Hematopoietic|hematopoietic
329054|NCT02194439|Hematopoietic Stem Cell Transplantation|hematopoietic stem cell transplantation
329055|NCT02194439|HCT|hct
329056|NCT02194439|HSCT|hsct
329057|NCT02194439|IL-33 Receptor|il-33 receptor
329058|NCT02194439|Immune Reconstitution|immune reconstitution
329059|NCT02194439|Immune Response|immune response
329060|NCT02194439|Inflammatory|inflammatory
329061|NCT02194439|Modeling|modeling
329062|NCT02194439|Novel|novel
329063|NCT02194439|Novel therapeutics|novel therapeutics
329064|NCT02194439|Outcome|outcome
329065|NCT02194439|Pathway interactions|pathway interactions
329066|NCT02194439|Peptides|peptides
329067|NCT02194439|Prevent|prevent
329068|NCT02194439|Process|process
329069|NCT02194439|Production|production
329070|NCT02194439|Proteomics|proteomics
329071|NCT02194439|Regulatory T-Lymphocyte|regulatory t-lymphocyte
329072|NCT02194439|Response|response
329073|NCT02194439|Role|role
329074|NCT02194439|Signal|signal
329075|NCT02194439|ST2|st2
329076|NCT02194439|Transduction|transduction
329077|NCT02194439|T-cell response|t-cell response
329078|NCT02194439|T-cell Activation|t-cell activation
329079|NCT02194439|T-Lymphocytes|t-lymphocytes
329080|NCT02194439|Tissues|tissues
329081|NCT02194400|RSLV-132|rslv-132
329082|NCT02194400|Systemic Lupus Erythematosus|systemic lupus erythematosus
329083|NCT02194400|Lupus|lupus
329084|NCT02194400|SLE|sle
329085|NCT02194400|Resolve|resolve
329086|NCT02194374|Leukemia|leukemia
329087|NCT02194374|Chronic lymphocytic leukemia|chronic lymphocytic leukemia
329088|NCT02194374|CLL|cll
329089|NCT02194374|Small lymphocytic lymphoma|small lymphocytic lymphoma
329090|NCT02194374|SLL|sll
329091|NCT02194374|B cell|b cell
329092|NCT02194374|ROR1-specific T cells|ror1-specific t cells
329093|NCT02194374|Fludarabine|fludarabine
329094|NCT02194374|Fludarabine Phosphate|fludarabine phosphate
329095|NCT02194374|Fludara|fludara
329096|NCT02194374|Cyclophosphamide|cyclophosphamide
329097|NCT02194374|Cytoxan|cytoxan
329098|NCT02194374|Neosar|neosar
329099|NCT02194374|Rituximab|rituximab
329100|NCT02194374|Rituxan|rituxan
329101|NCT02194374|Bendamustine|bendamustine
329102|NCT02194374|Bendamustine Hydrochloride|bendamustine hydrochloride
329103|NCT02194374|Bendamustine HCL|bendamustine hcl
329104|NCT02194374|CEP-18083|cep-18083
329105|NCT02194374|SDX-105|sdx-105
329106|NCT02194374|Treanda|treanda
329107|NCT02194231|Mesothelioma|mesothelioma
329108|NCT02194231|MPM|mpm
329109|NCT02194231|Trabectedin|trabectedin
329110|NCT02194192|prevention of hypotension|prevention of hypotension
329111|NCT02194192|spinal anesthesia|spinal anesthesia
329112|NCT02194192|cesarean section|cesarean section
329113|NCT02194192|ephedrine|ephedrine
329114|NCT02194192|ondansetron|ondansetron
329115|NCT02194140|ultrasound|ultrasound
329116|NCT02194140|iodinated contrast material|iodinated contrast material
329117|NCT02194140|computed tomography|computed tomography
329118|NCT02194114|Chronic Renal Failure|chronic renal failure
329119|NCT02194114|End-Stage Renal Disease|end-stage renal disease
329120|NCT02194114|Nitrogen Balance|nitrogen balance
329121|NCT02194114|Dietary Protein Intake|dietary protein intake
329122|NCT02194101|oxygen delivery|oxygen delivery
329123|NCT02194101|proximal femoral fracture|proximal femoral fracture
329124|NCT02194101|goal-directed therapy|goal-directed therapy
329125|NCT02194062|Chronic rhinosinusitis with polyps|chronic rhinosinusitis with polyps
329126|NCT02194062|Nasal steroids|nasal steroids
329127|NCT02194062|Functional endoscopic sinus surgery|functional endoscopic sinus surgery
329128|NCT02194062|SNOT-22|snot-22
329129|NCT02194062|Lund-Kennedy|lund-kennedy
329130|NCT02194036|Ownership of body|ownership of body
329131|NCT02194036|Bodily and mental balance|bodily and mental balance
329132|NCT02194036|Learning|learning
329133|NCT02194036|Body image|body image
329134|NCT02194036|Sensations|sensations
329135|NCT02194036|Expectations|expectations
329136|NCT02194023|chlorhexidine digluconate|chlorhexidine digluconate
329137|NCT02194023|gingivitis|gingivitis
329138|NCT02194023|cetylpyridinium chloride|cetylpyridinium chloride
329139|NCT02194023|mouthrinse|mouthrinse
329140|NCT02194023|dental plaque|dental plaque
329141|NCT02194023|de novo|de novo
329142|NCT02194023|in vivo|in vivo
329143|NCT02194010|Outcome Measure|outcome measure
329144|NCT02194010|Patient Reported Questionnaires|patient reported questionnaires
329145|NCT02193984|Diabetes|diabetes
329146|NCT02193984|Peer support|peer support
329147|NCT02193984|Hispanic|hispanic
329148|NCT02193984|Latino|latino
329149|NCT02193971|Acute coronary syndrome|acute coronary syndrome
329150|NCT02193971|Drug eluting stent|drug eluting stent
329151|NCT02193971|Everolimus|everolimus
329152|NCT02193971|Prasugrel|prasugrel
329153|NCT02193958|Acute Myeloid Leukemia|acute myeloid leukemia
329154|NCT02193958|Chronic Myelomonocytic Leukemia|chronic myelomonocytic leukemia
329155|NCT02193958|Myelodysplastic Syndrome|myelodysplastic syndrome
329156|NCT02193932|EEG triggered|eeg triggered
329157|NCT02193932|fMRI|fmri
329158|NCT02193932|epilepsy|epilepsy
329159|NCT02193932|intractable|intractable
329160|NCT02193919|psoriasis|psoriasis
329161|NCT02193906|Cognitive training|cognitive training
329162|NCT02193906|Multiple sclerosis|multiple sclerosis
420672|NCT01775930|RCC|rcc
329163|NCT02193906|Cognitive deficits|cognitive deficits
329164|NCT02193893|cell-based therapy|cell-based therapy
329165|NCT02193893|autologous bone marrow-derived stem/progenitor cells|autologous bone marrow-derived stem/progenitor cells
329166|NCT02193893|stem cell infusion, stem cell transplantation|stem cell infusion, stem cell transplantation
329167|NCT02193893|biological therapy with neurotrophic factors|biological therapy with neurotrophic factors
329168|NCT02193893|bioactive neurotrophic factors|bioactive neurotrophic factors
329169|NCT02193880|stem cell transplant|stem cell transplant
329170|NCT02193867|LIPA|lipa
329171|NCT02193867|Wolman Disease|wolman disease
329172|NCT02193867|Wolman Phenotype|wolman phenotype
329173|NCT02193867|Acid Lipase Deficiency|acid lipase deficiency
329174|NCT02193867|Acid Cholesteryl Hydrolase|acid cholesteryl hydrolase
329175|NCT02193867|Acid Lipase Disease Deficiency, type 2|acid lipase disease deficiency, type 2
329176|NCT02193867|Cholesteryl Ester Storage Disease (CESD)|cholesteryl ester storage disease (cesd)
329177|NCT02193867|Cholesteryl Ester Hydrolase Deficiency|cholesteryl ester hydrolase deficiency
329178|NCT02193867|Early Onset Lysosomal Acid Lipase Deficiency (Wolman Disease)|early onset lysosomal acid lipase deficiency (wolman disease)
329179|NCT02193867|LAL Deficiency|lal deficiency
329180|NCT02193867|Late Onset Lysosomal Acid Lipase Deficiency (CESD)|late onset lysosomal acid lipase deficiency (cesd)
329181|NCT02193867|Wolman Disease (early onset LAL Deficiency)|wolman disease (early onset lal deficiency)
329182|NCT02193867|Related Disorders:|related disorders:
329183|NCT02193867|Non-alcoholic Fatty Liver Disease (NAFLD)|non-alcoholic fatty liver disease (nafld)
329184|NCT02193867|Non-alcoholic Steatohepatitis (NASH)|non-alcoholic steatohepatitis (nash)
329185|NCT02193867|Alcoholic Liver Disease|alcoholic liver disease
329186|NCT02193867|Cryptogenic Cirrhosis|cryptogenic cirrhosis
329187|NCT02193867|Niemann-Pick Disease (NPD) Type C|niemann-pick disease (npd) type c
329188|NCT02193867|Chanarin Dorfman Syndrome|chanarin dorfman syndrome
329189|NCT02193854|Telemedicine|telemedicine
329190|NCT02193854|Mobile phone|mobile phone
329191|NCT02193854|Rural physicians|rural physicians
329192|NCT02193854|Mongolia|mongolia
329193|NCT02193841|Simple bone cyst|simple bone cyst
329194|NCT02193841|Unicameral bone cyst|unicameral bone cyst
329195|NCT02193828|Dupuytren's nodules|dupuytren's nodules
329196|NCT02193815|psoriasis|psoriasis
329197|NCT02193815|plaque|plaque
329198|NCT02193815|vulgaris|vulgaris
329199|NCT02193815|phase 1|phase 1
329200|NCT02193815|randomized|randomized
329201|NCT02193815|double-blind|double-blind
329202|NCT02193815|topical|topical
329203|NCT02193815|safety|safety
329204|NCT02193802|Crohn's disease|crohn's disease
329205|NCT02193802|small bowel (SB)|small bowel (sb)
329206|NCT02193802|capsule endoscopy|capsule endoscopy
329207|NCT02193802|ileocolonoscopy|ileocolonoscopy
329208|NCT02193802|anti-TNF-alpha antibodies|anti-tnf-alpha antibodies
329209|NCT02193789|Anastomosis site structure|anastomosis site structure
329210|NCT02193789|Stent insertion|stent insertion
329211|NCT02193789|Stent migration|stent migration
329212|NCT02193776|Tuberculosis|tuberculosis
329213|NCT02193776|Multi Drug-Resistant Tuberculosis|multi drug-resistant tuberculosis
329214|NCT02193776|Drug-Sensitive Tuberculosis|drug-sensitive tuberculosis
329215|NCT02193776|PA-824|pa-824
329216|NCT02193776|Bedaquiline|bedaquiline
329217|NCT02193776|Moxifloxacin|moxifloxacin
329218|NCT02193776|Pyrazinamide|pyrazinamide
329219|NCT02193776|Quinolone|quinolone
329220|NCT02193776|Pretomanid|pretomanid
329221|NCT02193776|NC-005|nc-005
329222|NCT02193763|pediatric|pediatric
329223|NCT02193763|lumbar puncture|lumbar puncture
329224|NCT02193763|ultrasonography|ultrasonography
329225|NCT02193763|efficacy|efficacy
329226|NCT02193750|Crohn's Disease|crohn's disease
329227|NCT02193724|Heritable Retinoblastoma|heritable retinoblastoma
329228|NCT02193724|Familial Retinoblastoma|familial retinoblastoma
329229|NCT02193724|Pluripotent Stem Cells|pluripotent stem cells
329230|NCT02193698|POEMS syndrome|poems syndrome
329231|NCT02193698|lenalidomide|lenalidomide
329232|NCT02193685|(HAEC) Hirschsprung Associated Entrocolistis|(haec) hirschsprung associated entrocolistis
329233|NCT02193685|(HD) Hirschsprung Disease|(hd) hirschsprung disease
329234|NCT02193685|(IBD) Inflammatory Bowel Disease|(ibd) inflammatory bowel disease
329235|NCT02193685|Children|children
329236|NCT02193672|Advanced cancers|advanced cancers
329237|NCT02193672|PET/CT|pet/ct
329238|NCT02193672|Positron emission tomography / computed tomography|positron emission tomography / computed tomography
329239|NCT02193672|[18F]Fluciclatide|[18f]fluciclatide
329240|NCT02193672|Chemotherapy|chemotherapy
329241|NCT02193672|Phone calls|phone calls
329242|NCT02193659|breakfast cereal|breakfast cereal
329243|NCT02193659|omega-3|omega-3
329244|NCT02193659|cholesterol|cholesterol
329245|NCT02193659|lipidic profile|lipidic profile
329246|NCT02193659|consumption|consumption
329247|NCT02193659|acceptability|acceptability
329248|NCT02193646|Colonoscopy|colonoscopy
329249|NCT02193646|Adenoma|adenoma
329251|NCT02193646|Screening Colon Cancer|screening colon cancer
329252|NCT02193620|Analgesic|analgesic
329253|NCT02193620|Narcotics|narcotics
329254|NCT02193620|Opioids|opioids
329255|NCT02193620|Pain relief after surgery|pain relief after surgery
329256|NCT02193607|Occult stress incontinence|occult stress incontinence
329257|NCT02193607|Pelvic Organ Prolapse|pelvic organ prolapse
329258|NCT02193607|Surgical Intervention|surgical intervention
329259|NCT02193607|TVT-O(Tension-free vaginal tape-obturator)|tvt-o(tension-free vaginal tape-obturator)
329260|NCT02193607|Improved Reconstructive Pelvic Surgery|improved reconstructive pelvic surgery
329261|NCT02193607|Combined Surgery|combined surgery
329262|NCT02193607|Two-step Approach|two-step approach
329263|NCT02193607|Prophylactic Incontinence Procedure|prophylactic incontinence procedure
329264|NCT02193607|Randomized Controlled Trial|randomized controlled trial
329265|NCT02193594|Preoperative concurrent chemoradiotherapy|preoperative concurrent chemoradiotherapy
329266|NCT02193594|Neoadjuvant chemoradiotherapy|neoadjuvant chemoradiotherapy
329267|NCT02193594|Gastroesophageal junction adenocarcinoma|gastroesophageal junction adenocarcinoma
329268|NCT02193568|Supratentorial Glioma|supratentorial glioma
329269|NCT02193568|Craniotomy|craniotomy
329270|NCT02193555|Presbyopia|presbyopia
329271|NCT02193555|Refractive error correction|refractive error correction
329272|NCT02193555|Contact lenses|contact lenses
329273|NCT02193542|regional anesthesia|regional anesthesia
329274|NCT02193542|general anesthesia|general anesthesia
329275|NCT02193542|obstetric|obstetric
329276|NCT02193529|sleeve gastrectomy, dietary intake, morbid obesity.|sleeve gastrectomy, dietary intake, morbid obesity.
329277|NCT02193503|cancer|cancer
329278|NCT02193503|solid tumors|solid tumors
329279|NCT02193503|gene therapy|gene therapy
329280|NCT02193503|cell therapy|cell therapy
329281|NCT02193503|encapsulation|encapsulation
329282|NCT02193490|DNase, Pulmozyme, dry eye disease, treatment|dnase, pulmozyme, dry eye disease, treatment
329283|NCT02193464|inflammatory bowel disease, registry, incidence, Korea|inflammatory bowel disease, registry, incidence, korea
329284|NCT02193451|Lower urinary tract symptoms|lower urinary tract symptoms
329285|NCT02193451|Male LUTS|male luts
329286|NCT02193451|Voiding dysfunction|voiding dysfunction
329287|NCT02193451|Benign prostate obstruction|benign prostate obstruction
329288|NCT02193451|Detrusor underactivity|detrusor underactivity
329289|NCT02193438|Heart rate variability|heart rate variability
329290|NCT02193438|Resting energy expenditure|resting energy expenditure
329291|NCT02193438|Facial thermography|facial thermography
329292|NCT02193438|Blood pressure|blood pressure
329293|NCT02193438|Spices ingestion|spices ingestion
329294|NCT02193425|fMRI|fmri
329295|NCT02193425|Brain Connectivity|brain connectivity
329296|NCT02193425|PET|pet
329297|NCT02193425|18FDG|18fdg
329298|NCT02193412|analgesia nociception index|analgesia nociception index
329299|NCT02193412|heart rate variability|heart rate variability
329300|NCT02193412|autonomic nervous system|autonomic nervous system
329301|NCT02193412|specificity|specificity
329302|NCT02193412|systemic venous return|systemic venous return
329303|NCT02193412|pulse pressure variation|pulse pressure variation
329304|NCT02193412|Intraoperative Monitoring|intraoperative monitoring
329305|NCT02193399|Stem cell transplantation|stem cell transplantation
329306|NCT02193399|Fatigue|fatigue
329307|NCT02193399|Physiotherapy|physiotherapy
329308|NCT02193399|Quality of Life|quality of life
329309|NCT02193399|Cancer|cancer
329310|NCT02193399|Psychosocial aspects|psychosocial aspects
329311|NCT02193386|Cerebral Palsy|cerebral palsy
329312|NCT02193386|Physical Therapy|physical therapy
329313|NCT02193386|gait analysis|gait analysis
329314|NCT02193386|gross motor function|gross motor function
329315|NCT02193373|Osteopathic Manipulative Medicine|osteopathic manipulative medicine
329316|NCT02193373|Autonomic Nervous System|autonomic nervous system
329317|NCT02193373|Heart Rate Variability|heart rate variability
329318|NCT02193373|Sub-Occipital Release|sub-occipital release
329319|NCT02193373|Rib-Raising|rib-raising
329320|NCT02193373|Stellate Ganglion Release|stellate ganglion release
329321|NCT02193360|Inflammation|inflammation
329322|NCT02193360|PBC|pbc
329323|NCT02193347|Immunotherapy|immunotherapy
329324|NCT02193347|Adult|adult
329325|NCT02193334|Hepatocyte Growth Factor|hepatocyte growth factor
329326|NCT02193334|HGF|hgf
329327|NCT02193334|KP-100IT|kp-100it
329328|NCT02193334|Intrathecal injection|intrathecal injection
329329|NCT02193321|Atrial Fibrillation|atrial fibrillation
329330|NCT02193321|Amniotic Membrane|amniotic membrane
329331|NCT02193295|Weight Reduction|weight reduction
329332|NCT02193295|Caloric Restriction|caloric restriction
329333|NCT02193295|Euglycemic Hyperinsulinemic Clamp|euglycemic hyperinsulinemic clamp
329334|NCT02193295|Magnetic Resonance Spectroscopy|magnetic resonance spectroscopy
329335|NCT02193269|Abstinent cocaine users|abstinent cocaine users
329336|NCT02193269|minocycline|minocycline
329337|NCT02193269|antibiotic|antibiotic
329338|NCT02193256|varenicline|varenicline
329339|NCT02193256|prazosin|prazosin
329340|NCT02193256|cigarette smoking|cigarette smoking
329341|NCT02193256|alcohol drinking|alcohol drinking
329342|NCT02193256|sleep|sleep
329343|NCT02193256|dreams|dreams
329344|NCT02193243|Congenital Heart Disease|congenital heart disease
768229|NCT00374205|Arsucam|arsucam
329345|NCT02193243|Six Minute Walk Test|six minute walk test
329346|NCT02193243|Exercise Testing|exercise testing
329347|NCT02193243|Peak oxygen uptake|peak oxygen uptake
329348|NCT02193230|Atopic dermatitis, Feasibility, Adherence to treatment|atopic dermatitis, feasibility, adherence to treatment
329349|NCT02193204|Alcohol dependence|alcohol dependence
329350|NCT02193204|Stress|stress
329351|NCT02193204|Cytokines|cytokines
329352|NCT02193204|Depressive Symptomatology|depressive symptomatology
329353|NCT02193191|Plerixafor|plerixafor
329354|NCT02193191|13-229|13-229
329355|NCT02193152|Advanced Non-Small Cell Lung Cancer|advanced non-small cell lung cancer
329356|NCT02193152|NSCLC|nsclc
329357|NCT02193152|Pazopanib|pazopanib
329358|NCT02193126|Long term foster care|long term foster care
329359|NCT02193126|child abuse and neglect|child abuse and neglect
329360|NCT02193126|trauma|trauma
329361|NCT02193113|Diabetic Macular Edema|diabetic macular edema
329362|NCT02193113|DME|dme
329363|NCT02193113|Plasma Kallikrein inhibitor|plasma kallikrein inhibitor
329364|NCT02193113|KVD001|kvd001
329365|NCT02193113|KVD001-001|kvd001-001
329366|NCT02193113|Intravitreal|intravitreal
329367|NCT02193113|IVT|ivt
329368|NCT02193113|Diabetes mellitus|diabetes mellitus
329369|NCT02193087|Drug therapy|drug therapy
329370|NCT02193074|Spinal Muscular Atrophy|spinal muscular atrophy
329371|NCT02193074|SMA|sma
329372|NCT02193074|SMN|smn
329373|NCT02193074|SMNRx|smnrx
329374|NCT02193074|ISIS-SMNRx|isis-smnrx
329375|NCT02193074|ISIS-SMN Rx|isis-smn rx
329376|NCT02193074|ISIS 396443|isis 396443
329377|NCT02193074|IONIS-SMNRx|ionis-smnrx
329378|NCT02193074|IONIS-SMN Rx|ionis-smn rx
329379|NCT02193074|Spinraza|spinraza
329380|NCT02193074|ENDEAR|endear
329381|NCT02193061|Rotavirus|rotavirus
329382|NCT02193061|immunological behavior|immunological behavior
329383|NCT02193061|Rotarix|rotarix
329384|NCT02193061|RotaTeq|rotateq
329385|NCT02193061|vaccine interchangeability|vaccine interchangeability
329386|NCT02193035|Microparticles|microparticles
329387|NCT02193035|Severe aortic stenosis|severe aortic stenosis
329388|NCT02193035|Calcified aortic stenosis|calcified aortic stenosis
329389|NCT02193035|transcatheter aortic valve replacement|transcatheter aortic valve replacement
329390|NCT02193022|Bangladesh, PKDL, Visceral Leishmaniasis, Children, Miltefosine|bangladesh, pkdl, visceral leishmaniasis, children, miltefosine
329391|NCT02192996|VLBW preterm|vlbw preterm
329392|NCT02192996|GUT microbiota|gut microbiota
329393|NCT02192996|probiotics supplementation|probiotics supplementation
329394|NCT02192996|immune compounds|immune compounds
329395|NCT02192970|Retinal detachment|retinal detachment
329396|NCT02192970|Proliferative vitreoretinopathy|proliferative vitreoretinopathy
329397|NCT02192957|cardioversion|cardioversion
329398|NCT02192957|electrical cardioversion|electrical cardioversion
329606|NCT02191982|Elderly|elderly
329399|NCT02192957|atrial fibrillation|atrial fibrillation
329400|NCT02192957|cardioversion protocol|cardioversion protocol
329401|NCT02192944|ECG|ecg
329402|NCT02192944|Pharmacokinetic profile|pharmacokinetic profile
329403|NCT02192892|Young children|young children
329404|NCT02192892|Acceptability|acceptability
329405|NCT02192892|Food intake|food intake
329406|NCT02192892|Energy dense porridge|energy dense porridge
329407|NCT02192879|thoracic epidural|thoracic epidural
329408|NCT02192879|continuous paravertebral catheter|continuous paravertebral catheter
329409|NCT02192879|PCA|pca
329410|NCT02192879|liver resection|liver resection
329411|NCT02192879|pain management|pain management
329412|NCT02192853|Diabetes Mellitus|diabetes mellitus
329413|NCT02192853|Glucagon-like peptide 1|glucagon-like peptide 1
329414|NCT02192853|Dipeptidyl peptidase 4|dipeptidyl peptidase 4
329415|NCT02192853|Dipeptidyl peptidase 4 inhibitor|dipeptidyl peptidase 4 inhibitor
329416|NCT02192853|sitagliptin|sitagliptin
329417|NCT02192853|Enzyme activity|enzyme activity
329418|NCT02192840|provisional T stenting|provisional t stenting
329419|NCT02192840|dedicated bifurcation stent|dedicated bifurcation stent
329420|NCT02192827|Pediatric|pediatric
329421|NCT02192827|Asthma|asthma
329422|NCT02192827|Exacerbation|exacerbation
329423|NCT02192827|Dexamethasone|dexamethasone
329424|NCT02192814|Lacosamide|lacosamide
329425|NCT02192814|LCM|lcm
329426|NCT02192814|Epilepsy|epilepsy
329427|NCT02192814|Partial-onset seizures|partial-onset seizures
329428|NCT02192814|iv|iv
329429|NCT02192801|Classic Bladder Exstrophy|classic bladder exstrophy
329430|NCT02192801|Renal function|renal function
329431|NCT02192801|GFR|gfr
329432|NCT02192801|Proteinuria|proteinuria
329433|NCT02192788|SBRT|sbrt
329434|NCT02192788|Oligometastases|oligometastases
329435|NCT02192788|Prostate Cancer|prostate cancer
329436|NCT02192775|Measles virus|measles virus
329437|NCT02192775|Sodium Iodide Symporter|sodium iodide symporter
329438|NCT02192775|Cyclophosphamide|cyclophosphamide
329439|NCT02192775|Refractory multiple myeloma|refractory multiple myeloma
329440|NCT02192749|autism|autism
329441|NCT02192749|umbilical cord|umbilical cord
329442|NCT02192749|mesenchymal|mesenchymal
329443|NCT02192749|stem cells|stem cells
329444|NCT02192736|asthma|asthma
329445|NCT02192736|umbilical cord|umbilical cord
329446|NCT02192736|mesenchymal|mesenchymal
329447|NCT02192736|stem cells|stem cells
329448|NCT02192736|trophic factors|trophic factors
329449|NCT02192710|outpatient surgery|outpatient surgery
329450|NCT02192710|anaesthesia|anaesthesia
329451|NCT02192710|midazolam|midazolam
329452|NCT02192710|electronic tab|electronic tab
329453|NCT02192697|safety|safety
329454|NCT02192697|pharmacokinetics|pharmacokinetics
329455|NCT02192697|tolerability|tolerability
329456|NCT02192697|ASP8273|asp8273
329457|NCT02192697|Non-small Cell Lung Cancer|non-small cell lung cancer
329458|NCT02192697|T790M resistance mutation|t790m resistance mutation
329459|NCT02192697|NSCLC|nsclc
329460|NCT02192697|Epidermal Growth Factor Receptor mutations|epidermal growth factor receptor mutations
329461|NCT02192697|irreversible EGFR inhibitor|irreversible egfr inhibitor
329462|NCT02192697|antitumor activity|antitumor activity
329463|NCT02192697|EGFR|egfr
329464|NCT02192684|obstructive sleep apnea|obstructive sleep apnea
329465|NCT02192684|insulin sensitivity|insulin sensitivity
329466|NCT02192684|cardiovascular risk|cardiovascular risk
329467|NCT02192684|positive airway pressure therapy|positive airway pressure therapy
329468|NCT02192671|hepatocellular carcinoma|hepatocellular carcinoma
329469|NCT02192671|radiofrequency ablation|radiofrequency ablation
329470|NCT02192671|hepatic resection|hepatic resection
329471|NCT02192671|portal hypertension|portal hypertension
329472|NCT02192671|Milan criteria|milan criteria
329473|NCT02192671|randomized critical trial|randomized critical trial
329474|NCT02192619|APL|apl
329475|NCT02192619|acute promyelocytic leukemia|acute promyelocytic leukemia
329476|NCT02192619|AML M3|aml m3
329477|NCT02192606|Laparoscopy|laparoscopy
329478|NCT02192606|3D Visual System|3d visual system
329479|NCT02192606|Total Hysterectomy|total hysterectomy
329480|NCT02192567|Advanced solid malignant tumor|advanced solid malignant tumor
329481|NCT02192567|phase 1|phase 1
329482|NCT02192567|oncology|oncology
329483|NCT02192554|OPC-34712|opc-34712
329484|NCT02192554|brexpiprazole|brexpiprazole
329485|NCT02192554|Dementia|dementia
329486|NCT02192554|Alzheimer's Disease|alzheimer's disease
329487|NCT02192554|Cognitive Disorders|cognitive disorders
329488|NCT02192554|Memory|memory
329489|NCT02192554|Agitation|agitation
329490|NCT02192541|Urothelial Carcinomas|urothelial carcinomas
329491|NCT02192541|Non-Squamous Non-Small Cell Lung Carcinomas|non-squamous non-small cell lung carcinomas
329492|NCT02192541|Refractory Gastrointestinal Carcinomas|refractory gastrointestinal carcinomas
329493|NCT02192541|Hsp90 Inhibitor|hsp90 inhibitor
329494|NCT02192541|Sarcomas|sarcomas
329495|NCT02192528|vitamin D|vitamin d
329496|NCT02192528|25-hydroxyvitamin D|25-hydroxyvitamin d
329497|NCT02192528|1,25-dihydroxyvitamin D|1,25-dihydroxyvitamin d
329498|NCT02192528|MACCE|macce
329499|NCT02192528|mortality|mortality
329500|NCT02192528|cardiac|cardiac
329607|NCT02191982|Geriatric|geriatric
329501|NCT02192528|cerebrovascular|cerebrovascular
329502|NCT02192515|Healthy Subjects|healthy subjects
329503|NCT02192515|Japanese Adult|japanese adult
329504|NCT02192489|Chronic Cutaneous Sarcoidosis|chronic cutaneous sarcoidosis
329505|NCT02192489|Cutaneous Sarcoidosis|cutaneous sarcoidosis
329506|NCT02192489|Skin Sarcoidosis|skin sarcoidosis
329507|NCT02192489|Sarcoidosis|sarcoidosis
329508|NCT02192476|Stroke, subluxation|stroke, subluxation
329509|NCT02192450|Diabetes Mellitus|diabetes mellitus
329510|NCT02192450|Hypoglycaemia|hypoglycaemia
329511|NCT02192450|Glucose Metabolism Disorders|glucose metabolism disorders
329512|NCT02192450|Metabolic Diseases|metabolic diseases
329513|NCT02192450|Endocrine System Diseases|endocrine system diseases
329514|NCT02192450|Autoimmune Diseases|autoimmune diseases
329515|NCT02192450|Insulin|insulin
329516|NCT02192450|Hypoglycaemic Agents|hypoglycaemic agents
329517|NCT02192450|Physiological Effetcs of Drugs|physiological effetcs of drugs
329518|NCT02192437|methionine|methionine
329519|NCT02192437|cysteine|cysteine
329520|NCT02192437|sulfur amino acid restriction|sulfur amino acid restriction
329521|NCT02192424|beta-cell function,|beta-cell function,
329522|NCT02192424|type 2 diabetes,|type 2 diabetes,
329523|NCT02192424|intermittent insulin|intermittent insulin
329524|NCT02192411|lidocaine|lidocaine
329525|NCT02192411|tumescent|tumescent
329526|NCT02192411|endovenous|endovenous
329527|NCT02192411|laser|laser
329528|NCT02192411|pain|pain
329529|NCT02192398|Pain|pain
329530|NCT02192398|Pain management|pain management
329531|NCT02192398|Neck|neck
329532|NCT02192398|Back|back
329533|NCT02192372|creatinine|creatinine
329534|NCT02192372|glomerular filtration rate|glomerular filtration rate
329535|NCT02192372|metabolic syndrome|metabolic syndrome
329536|NCT02192346|metastatic|metastatic
329537|NCT02192346|refractory|refractory
329538|NCT02192346|progressive|progressive
329539|NCT02192320|Atorvastatin|atorvastatin
329540|NCT02192320|Atorvastatin and Dexamethasone|atorvastatin and dexamethasone
329541|NCT02192320|Chronic Subdural Hematoma|chronic subdural hematoma
329542|NCT02192320|conservative treatment|conservative treatment
329543|NCT02192307|Sensitivity|sensitivity
329544|NCT02192294|Bosutinib|bosutinib
329545|NCT02192294|absolute bioavailability|absolute bioavailability
329546|NCT02192281|Physical activity|physical activity
329547|NCT02192281|Recess|recess
329548|NCT02192281|Accelerometer|accelerometer
329549|NCT02192281|Play|play
329550|NCT02192255|diabetes type 2|diabetes type 2
329551|NCT02192255|primary care|primary care
329552|NCT02192255|chronic disease care improvement|chronic disease care improvement
329553|NCT02192255|adherence, randomized trial|adherence, randomized trial
329554|NCT02192255|BP control|bp control
329555|NCT02192255|lipid control|lipid control
329556|NCT02192255|glucose control|glucose control
329557|NCT02192255|natural language processing.|natural language processing.
329558|NCT02192242|acute ischemic pain|acute ischemic pain
329559|NCT02192242|model|model
329560|NCT02192242|S100|s100
329561|NCT02192242|interleukine 6|interleukine 6
329562|NCT02192216|Body composition|body composition
329563|NCT02192216|Chemotherapy|chemotherapy
329564|NCT02192216|Muscle mass|muscle mass
329565|NCT02192216|Muscle function|muscle function
329566|NCT02192216|Exercise|exercise
329567|NCT02192177|Apoptosis|apoptosis
329568|NCT02192177|intrahepatic cholestasis|intrahepatic cholestasis
329569|NCT02192177|obstetric outcomes|obstetric outcomes
329570|NCT02192164|plaque psoriasis|plaque psoriasis
329571|NCT02192164|smoking|smoking
329572|NCT02192164|etanercept|etanercept
329573|NCT02192151|Analgesic|analgesic
329574|NCT02192151|Narcotics|narcotics
329575|NCT02192151|Opioids|opioids
329576|NCT02192151|Non-scheduled substanse|non-scheduled substanse
329577|NCT02192138|Pleural effusion|pleural effusion
329578|NCT02192138|Pleural fluid|pleural fluid
329579|NCT02192138|Thoracentesis|thoracentesis
329580|NCT02192138|Intrapleural pressure|intrapleural pressure
329581|NCT02192138|Pleural manometry|pleural manometry
329582|NCT02192125|stroke|stroke
329583|NCT02192125|rehabilitation|rehabilitation
329584|NCT02192125|balance|balance
329585|NCT02192125|training|training
329586|NCT02192125|posture|posture
329587|NCT02192086|Kidney transplantation|kidney transplantation
329588|NCT02192060|Biofilm|biofilm
329589|NCT02192060|Triclosan|triclosan
329590|NCT02192060|Crossover|crossover
329591|NCT02192060|Clinical trial|clinical trial
329592|NCT02192034|Colonoscopy|colonoscopy
329593|NCT02192034|Colon cancer|colon cancer
329594|NCT02192034|screening|screening
329595|NCT02192034|navigation|navigation
329596|NCT02192021|CTCL|ctcl
329597|NCT02192021|Cutaneous T-cell Lymphoma|cutaneous t-cell lymphoma
329598|NCT02192021|Mycosis Fungoides|mycosis fungoides
329599|NCT02192008|Challenge|challenge
329600|NCT02192008|Re-challenge|re-challenge
329601|NCT02192008|Controlled Infection|controlled infection
329602|NCT02192008|Enteric fever|enteric fever
329603|NCT02191982|Cancer|cancer
329604|NCT02191982|Chemotherapy|chemotherapy
329605|NCT02191982|Fatigue|fatigue
329608|NCT02191982|Any Cancer|any cancer
329609|NCT02191982|Cancer Treatment|cancer treatment
329610|NCT02191982|Weakness|weakness
329611|NCT02191982|Tiredness|tiredness
329612|NCT02191969|Chemotherapy|chemotherapy
329613|NCT02191969|Adjuvant Chemotherapy|adjuvant chemotherapy
329614|NCT02191969|Cancer Therapy|cancer therapy
329615|NCT02191969|Fatigue|fatigue
329616|NCT02191969|Physical Activity|physical activity
329617|NCT02191969|Physical Function|physical function
329618|NCT02191969|Tiredness|tiredness
329619|NCT02191969|Colon Cancer|colon cancer
329620|NCT02191969|Rectal Cancer|rectal cancer
329621|NCT02191969|Walk With Ease|walk with ease
329622|NCT02191969|Colorectal Cancer|colorectal cancer
329623|NCT02191969|Geriatric Assessment|geriatric assessment
329624|NCT02191969|Geriatric|geriatric
329625|NCT02191969|Elderly|elderly
329626|NCT02191956|Disruptive behavior disorders|disruptive behavior disorders
329627|NCT02191956|Early Onset|early onset
329628|NCT02191956|Young Children|young children
329629|NCT02191956|Parenting|parenting
329630|NCT02191956|Behavioral Parent Training|behavioral parent training
329631|NCT02191943|caries|caries
329632|NCT02191943|proximal|proximal
329633|NCT02191943|non-cavitated|non-cavitated
329634|NCT02191943|fluoridation|fluoridation
329635|NCT02191878|Liver Cancer|liver cancer
329636|NCT02191878|Liver Neoplasms|liver neoplasms
329637|NCT02191878|Liver Epithelial Neoplasms|liver epithelial neoplasms
329638|NCT02191878|Liver Cancer, malignant|liver cancer, malignant
329639|NCT02191839|cardiac surgery|cardiac surgery
329640|NCT02191839|alpha 1 antitrypsin|alpha 1 antitrypsin
329641|NCT02191839|inflammation|inflammation
329642|NCT02191839|post operative bleeding|post operative bleeding
329643|NCT02191839|organ function|organ function
329644|NCT02191826|Transthyretin|transthyretin
329645|NCT02191826|TTR|ttr
329646|NCT02191826|Amyloidosis|amyloidosis
329647|NCT02191826|SOM0226|som0226
329648|NCT02191826|Familiar Amyloid Polyneuropathy|familiar amyloid polyneuropathy
329649|NCT02191774|Medical abortion|medical abortion
329650|NCT02191774|Home abortion|home abortion
329651|NCT02191683|Anaemia|anaemia
329652|NCT02191683|Pregnancy|pregnancy
329653|NCT02191683|Foetal programming|foetal programming
329654|NCT02191683|Epigenetics|epigenetics
329655|NCT02191683|Non-communicable diseases|non-communicable diseases
329656|NCT02191683|Tanzania|tanzania
329657|NCT02191657|HIV|hiv
329658|NCT02191657|deferiprone|deferiprone
329659|NCT02191657|iron chelation|iron chelation
329660|NCT02191631|OCD|ocd
329661|NCT02191631|adolescents|adolescents
329662|NCT02191631|pediatric|pediatric
329663|NCT02191631|internet|internet
329664|NCT02191631|online|online
329665|NCT02191631|CBT|cbt
329666|NCT02191618|Aneurysm|aneurysm
329667|NCT02191618|Intracranial Aneurysm|intracranial aneurysm
329668|NCT02191618|Vascular Diseases|vascular diseases
329669|NCT02191618|Cardiovascular Diseases|cardiovascular diseases
329670|NCT02191618|Intracranial Arterial Diseases|intracranial arterial diseases
329671|NCT02191618|Cerebrovascular Disorders|cerebrovascular disorders
329672|NCT02191618|Brain Diseases|brain diseases
329673|NCT02191618|Central Nervous System Diseases|central nervous system diseases
329674|NCT02191618|Nervous System Diseases|nervous system diseases
329675|NCT02191605|Computerized Brief Intervention|computerized brief intervention
329676|NCT02191592|Tinnitus|tinnitus
329677|NCT02191592|EMA|ema
329678|NCT02191592|Bothersome|bothersome
329679|NCT02191566|Stomach Cancer|stomach cancer
329680|NCT02191553|mindfulness meditation|mindfulness meditation
329681|NCT02191553|alpha rhythm|alpha rhythm
329682|NCT02191553|EEG|eeg
329683|NCT02191553|brain mapping|brain mapping
329684|NCT02191553|emotion|emotion
329685|NCT02191553|attention|attention
329686|NCT02191527|PMTCT|pmtct
329687|NCT02191527|HIV|hiv
329688|NCT02191527|Syphilis|syphilis
329689|NCT02191527|Anemia during pregnancy|anemia during pregnancy
329690|NCT02191527|Point of care diagnostics|point of care diagnostics
329691|NCT02191514|Prehospital|prehospital
329692|NCT02191514|EMS|ems
329693|NCT02191514|EMD|emd
329694|NCT02191514|Stroke|stroke
329695|NCT02191514|Dispatch|dispatch
329696|NCT02191501|Obesity Treatment|obesity treatment
329697|NCT02191501|Endoscopy|endoscopy
329698|NCT02191501|Pyloric Suturing|pyloric suturing
329699|NCT02191501|Pyloric restriction|pyloric restriction
329700|NCT02191488|Fluorescence|fluorescence
329701|NCT02191488|Brain Tumors|brain tumors
329702|NCT02191488|Brain Metastases|brain metastases
329703|NCT02191488|Malignant Glioma|malignant glioma
329704|NCT02191488|Brain Lesions|brain lesions
329705|NCT02191475|sepsis shock|sepsis shock
329706|NCT02191475|Tigecycline|tigecycline
329707|NCT02191475|Piperacillin / tazobactam|piperacillin / tazobactam
329708|NCT02191475|Abdominal infection|abdominal infection
329709|NCT02191462|Pharmacokinetics|pharmacokinetics
329710|NCT02191462|Niagen|niagen
329711|NCT02191462|Nicotinamide riboside|nicotinamide riboside
329712|NCT02191436|Haemophilia|haemophilia
329713|NCT02191436|Adherence|adherence
329714|NCT02191436|Family Functioning|family functioning
329715|NCT02191436|Quality of Life|quality of life
329716|NCT02191436|Anxiety|anxiety
329717|NCT02191436|Illness Behavior|illness behavior
329718|NCT02191436|Coping Strategies|coping strategies
329719|NCT02191423|postpartum Depression|postpartum depression
329720|NCT02191423|Diadic psychotherapy|diadic psychotherapy
329721|NCT02191423|Oxytocin|oxytocin
329722|NCT02191423|fMRI|fmri
329723|NCT02191423|attachment|attachment
329724|NCT02191423|empathy|empathy
329725|NCT02191410|Video-assisted thoracoscopic surgery|video-assisted thoracoscopic surgery
329726|NCT02191410|one-lung ventilation|one-lung ventilation
329727|NCT02191410|continuous positive-airway ventilation|continuous positive-airway ventilation
329728|NCT02191410|high-frequency positive-pressure ventilation|high-frequency positive-pressure ventilation
329729|NCT02191410|stroke volume variation|stroke volume variation
329730|NCT02191410|fluid responsiveness|fluid responsiveness
329731|NCT02191397|Escitalopram|escitalopram
329732|NCT02191397|Major depressive disorder|major depressive disorder
329733|NCT02191397|Non-inferiority|non-inferiority
329734|NCT02191397|Bupropion|bupropion
329735|NCT02191371|oxygenation|oxygenation
329736|NCT02191371|microcirculation|microcirculation
329737|NCT02191371|one-lung ventilation|one-lung ventilation
329738|NCT02191371|thoracic surgery|thoracic surgery
329739|NCT02191358|Cytochrome drug interactions|cytochrome drug interactions
329740|NCT02191358|Drug-drug interaction|drug-drug interaction
329741|NCT02191358|Drug-gene interaction|drug-gene interaction
329742|NCT02191358|Drug-drug-gene interaction|drug-drug-gene interaction
329743|NCT02191358|Drug Metabolism|drug metabolism
329744|NCT02191358|Elderly|elderly
329745|NCT02191358|Geriatric medicine|geriatric medicine
329746|NCT02191358|Geriatrics|geriatrics
329747|NCT02191358|Personalized medicine|personalized medicine
329748|NCT02191358|Pharmacist|pharmacist
329749|NCT02191358|Pharmacogenetics|pharmacogenetics
329750|NCT02191358|Pharmacogenomics|pharmacogenomics
329751|NCT02191358|Pharmacokinetics|pharmacokinetics
329752|NCT02191358|Polymorphism|polymorphism
329753|NCT02191358|Polypharmacy|polypharmacy
329754|NCT02191358|Precision medicine|precision medicine
329755|NCT02191358|Seniors|seniors
329756|NCT02191358|YouScript|youscript
329757|NCT02191358|CYP2C9|cyp2c9
329758|NCT02191358|CYP2C19|cyp2c19
329759|NCT02191358|CYP2D6|cyp2d6
329760|NCT02191358|CYP3A4|cyp3a4
329761|NCT02191358|CYP3A5|cyp3a5
329762|NCT02191358|VKORC1|vkorc1
329763|NCT02191358|Amitriptyline|amitriptyline
329764|NCT02191358|Aripiprazole|aripiprazole
329765|NCT02191358|Atomoxetine|atomoxetine
329766|NCT02191358|Carvedilol|carvedilol
329767|NCT02191358|Celecoxib|celecoxib
329768|NCT02191358|Citalopram|citalopram
329769|NCT02191358|Clobazam|clobazam
329770|NCT02191358|Clomipramine|clomipramine
329771|NCT02191358|Clopidogrel|clopidogrel
329772|NCT02191358|Clozapine|clozapine
329773|NCT02191358|Codeine|codeine
329774|NCT02191358|Desipramine|desipramine
329775|NCT02191358|Dextromethorphan|dextromethorphan
329776|NCT02191358|Diazepam|diazepam
329777|NCT02191358|Doxepin|doxepin
329778|NCT02191358|Escitalopram|escitalopram
329779|NCT02191358|Esomeprazole|esomeprazole
329780|NCT02191358|Fesoterodine|fesoterodine
329781|NCT02191358|Flecainide|flecainide
329782|NCT02191358|Fluoxetine|fluoxetine
329783|NCT02191358|Flurbiprofen|flurbiprofen
329784|NCT02191358|Fluvoxamine|fluvoxamine
329785|NCT02191358|Haloperidol|haloperidol
329786|NCT02191358|Hydrocodone|hydrocodone
329787|NCT02191358|Ibuprofen|ibuprofen
329788|NCT02191358|Iloperidone|iloperidone
329789|NCT02191358|Imipramine|imipramine
329790|NCT02191358|Indomethacin|indomethacin
329791|NCT02191358|Meloxicam|meloxicam
329792|NCT02191358|Metoprolol|metoprolol
329793|NCT02191358|Mexiletine|mexiletine
329794|NCT02191358|Nortriptyline|nortriptyline
329795|NCT02191358|Omeprazole|omeprazole
329796|NCT02191358|Oxycodone|oxycodone
329797|NCT02191358|Paroxetine|paroxetine
329798|NCT02191358|Perphenazine|perphenazine
329799|NCT02191358|Phenobarbital|phenobarbital
329800|NCT02191358|Phenytoin|phenytoin
329801|NCT02191358|Pimozide|pimozide
329802|NCT02191358|Piroxicam|piroxicam
329803|NCT02191358|Proguanil|proguanil
329804|NCT02191358|Propafenone|propafenone
329805|NCT02191358|Propranolol|propranolol
329806|NCT02191358|Risperidone|risperidone
329807|NCT02191358|Sertraline|sertraline
329808|NCT02191358|Tetrabenazine|tetrabenazine
329809|NCT02191358|Thioridazine|thioridazine
329810|NCT02191358|Timolol|timolol
329811|NCT02191358|Tolterodine|tolterodine
329812|NCT02191358|Torsemide|torsemide
329813|NCT02191358|Tramadol|tramadol
329814|NCT02191358|Trimipramine|trimipramine
329815|NCT02191358|Venlafaxine|venlafaxine
329816|NCT02191358|Voriconazole|voriconazole
329817|NCT02191358|Vortioxetine|vortioxetine
329818|NCT02191345|guided imagery|guided imagery
329819|NCT02191345|burnout|burnout
329820|NCT02191345|compassion fatigue|compassion fatigue
329821|NCT02191345|state anxiety|state anxiety
329822|NCT02191267|CTE|cte
330220|NCT02189499|Stents|stents
329823|NCT02191267|Positron Emission Topography|positron emission topography
329824|NCT02191267|Tau|tau
329825|NCT02191267|Beta-amyloid|beta-amyloid
329826|NCT02191267|Magnetic Resonance Imaging|magnetic resonance imaging
329827|NCT02191267|Magnetic Resonance Spectroscopy|magnetic resonance spectroscopy
329828|NCT02191267|Diffusion Tensor Imaging|diffusion tensor imaging
329829|NCT02191150|Anaemia, Chronic Kidney Disease, Switching, Aranesp, Darbepoetin Alfa, Epoetin Alfa Biosimilars, Haemodialysis.|anaemia, chronic kidney disease, switching, aranesp, darbepoetin alfa, epoetin alfa biosimilars, haemodialysis.
329830|NCT02191137|Pulmonary Hypertension,Riociguat,Living with Pulmonary Hypertension Questionnaire|pulmonary hypertension,riociguat,living with pulmonary hypertension questionnaire
329831|NCT02191124|Measurement-based care|measurement-based care
329832|NCT02191124|Unipolar depression|unipolar depression
329833|NCT02191124|Outpatients|outpatients
329834|NCT02191111|Pharmacist|pharmacist
329835|NCT02191111|Pharmacy practice|pharmacy practice
329836|NCT02191111|Patient care|patient care
329837|NCT02191111|Community pharmacy|community pharmacy
329838|NCT02191111|Hypertension|hypertension
329839|NCT02191111|Diabetes|diabetes
329840|NCT02191111|Dyslipidemia|dyslipidemia
329841|NCT02191111|Pharmaceutical care|pharmaceutical care
329842|NCT02191098|HIV|hiv
329843|NCT02191098|ART|art
329844|NCT02191072|urticaria,omalizumab|urticaria,omalizumab
329845|NCT02191059|Non Small Cell Lung Cancer|non small cell lung cancer
329846|NCT02191059|Wild Type EGFR|wild type egfr
329847|NCT02191059|Icotinib|icotinib
329848|NCT02191059|Second-line Treatment|second-line treatment
329849|NCT02191046|nasal irrigation|nasal irrigation
329850|NCT02191046|sinusitis|sinusitis
329851|NCT02191046|children|children
329852|NCT02191046|buffered hypertonic saline|buffered hypertonic saline
329853|NCT02191046|nasal irrigation device|nasal irrigation device
329854|NCT02191033|cigarette smoking|cigarette smoking
329855|NCT02191033|tobacco use cessation products|tobacco use cessation products
329856|NCT02191020|Total Glucosides of Paeony(TGP)|total glucosides of paeony(tgp)
329857|NCT02191020|Acitretin Capsules|acitretin capsules
329858|NCT02191020|Psoriasis Vulgaris|psoriasis vulgaris
329859|NCT02190994|Hydrocortisone|hydrocortisone
329860|NCT02190994|Pituitary adenomas|pituitary adenomas
329861|NCT02190994|Replacement therapy|replacement therapy
329862|NCT02190981|Small bowel obstruction|small bowel obstruction
329863|NCT02190981|Ultrasound|ultrasound
329864|NCT02190981|Emergency department|emergency department
329865|NCT02190968|Mindfulness Based Cognitive Therapy|mindfulness based cognitive therapy
329866|NCT02190968|Internet interventions|internet interventions
329867|NCT02190968|Residual depressive symptoms|residual depressive symptoms
329868|NCT02190968|Depressive relapse prevention|depressive relapse prevention
329869|NCT02190903|delirium|delirium
329870|NCT02190903|hip fracture|hip fracture
329871|NCT02190903|general anesthesia|general anesthesia
329872|NCT02190903|spinal anesthesia|spinal anesthesia
329873|NCT02190903|postoperative complications|postoperative complications
329874|NCT02190877|Heart Failure|heart failure
329875|NCT02190877|Impedance|impedance
329876|NCT02190877|Fluids|fluids
329877|NCT02190851|urinary disorders|urinary disorders
329878|NCT02190851|Parkinson's disease|parkinson's disease
329879|NCT02190838|Melanoma|melanoma
329880|NCT02190838|Melatonin|melatonin
329881|NCT02190838|Metformin|metformin
329882|NCT02190838|Dacarbazine|dacarbazine
329883|NCT02190812|wrist muscle strength|wrist muscle strength
329884|NCT02190799|Corona Virus|corona virus
329885|NCT02190799|Convalescent plasma|convalescent plasma
329886|NCT02190799|Serology|serology
329887|NCT02190786|Hyperuricemia|hyperuricemia
329888|NCT02190773|Chronic Periodontitis, Aggressive Periodontitis, RANKL/OPG ratio, Gingival crevicular fluid|chronic periodontitis, aggressive periodontitis, rankl/opg ratio, gingival crevicular fluid
329889|NCT02190747|Intervention study|intervention study
329890|NCT02190747|Clinical trial Phase 2|clinical trial phase 2
329891|NCT02190747|Efficacy and safety|efficacy and safety
329892|NCT02190747|Heterotopic ossification|heterotopic ossification
329893|NCT02190747|Flare-up|flare-up
329894|NCT02190747|Palovarotene|palovarotene
329895|NCT02190747|Retinoic acid receptor agonist|retinoic acid receptor agonist
329896|NCT02190747|Retinoic acid receptor gamma agonist|retinoic acid receptor gamma agonist
329897|NCT02190747|Clementia|clementia
329898|NCT02190747|Myositis Ossificans Progressiva|myositis ossificans progressiva
329899|NCT02190747|Munchmeyer's Disease|munchmeyer's disease
329900|NCT02190747|FOP|fop
329901|NCT02190734|Stroke|stroke
329902|NCT02190734|Pusher Syndrome|pusher syndrome
329903|NCT02190734|Lateropulsion|lateropulsion
329904|NCT02190734|Pushing Behaviors|pushing behaviors
329905|NCT02190734|Burke Lateropulsion Scale|burke lateropulsion scale
329906|NCT02190721|Neutropenia|neutropenia
329907|NCT02190708|PQ912|pq912
329908|NCT02190708|Midazolam|midazolam
329909|NCT02190708|Omeprazole|omeprazole
329910|NCT02190708|Pharmacokinetics|pharmacokinetics
329911|NCT02190708|Drug Interaction|drug interaction
329912|NCT02190682|postoperative|postoperative
329913|NCT02190682|chronic|chronic
329914|NCT02190682|pain|pain
329915|NCT02190682|software|software
329916|NCT02190656|Rectal cancer|rectal cancer
329917|NCT02190656|Anterior Resection Syndrome|anterior resection syndrome
329918|NCT02190656|Functional outcomes|functional outcomes
329919|NCT02190643|Smoking|smoking
329921|NCT02190643|Latino|latino
329922|NCT02190643|Cessation|cessation
329923|NCT02190643|Nicotine patch|nicotine patch
329924|NCT02190617|Asthma|asthma
329925|NCT02190617|Guidelines|guidelines
329926|NCT02190617|Community Health Worker|community health worker
329927|NCT02190604|FEV1- Forced Expiratory volume|fev1- forced expiratory volume
329928|NCT02190604|LCI - Lung Clearance Index|lci - lung clearance index
329929|NCT02190604|CFTR - cystic fibrosis transmembrane conductance regulator|cftr - cystic fibrosis transmembrane conductance regulator
329930|NCT02190604|cystic fibrosis|cystic fibrosis
329931|NCT02190604|allergic bronchopulmonary aspergillosis|allergic bronchopulmonary aspergillosis
329932|NCT02190591|epidural|epidural
329933|NCT02190591|pregnant|pregnant
329934|NCT02190591|Cesarean Section|cesarean section
329935|NCT02190591|forceps|forceps
329936|NCT02190591|vaginal|vaginal
329937|NCT02190565|pregnancy, lactation, food supplement, anaemia|pregnancy, lactation, food supplement, anaemia
329938|NCT02190552|Brain|brain
329939|NCT02190552|Brain Clot|brain clot
329940|NCT02190552|Brain Diseases|brain diseases
329941|NCT02190552|Brain Infarction|brain infarction
329942|NCT02190552|Cerebral Ischemia|cerebral ischemia
329943|NCT02190552|Cerebrovascular Disorders|cerebrovascular disorders
329944|NCT02190552|EmboTrap® Revascularization Device|embotrap® revascularization device
329945|NCT02190552|EmboTrap|embotrap
329946|NCT02190552|Ischemia|ischemia
329947|NCT02190552|Ischemic|ischemic
329948|NCT02190552|Ischemic Stroke|ischemic stroke
329949|NCT02190552|Mechanical Thrombectomy|mechanical thrombectomy
329950|NCT02190552|Neurovascular Intervention|neurovascular intervention
329951|NCT02190552|Revascularization|revascularization
329952|NCT02190552|Stent Retriever|stent retriever
329953|NCT02190552|Stroke|stroke
329954|NCT02190552|Vascular Diseases|vascular diseases
768230|NCT00374192|Menopause|menopause
329955|NCT02190539|Breast cancer|breast cancer
329956|NCT02190539|complementary medicine|complementary medicine
329957|NCT02190539|homeopathy|homeopathy
329958|NCT02190539|quality of life|quality of life
329959|NCT02190526|mesalamine|mesalamine
329960|NCT02190526|amitriptyline|amitriptyline
329961|NCT02190526|Severity of Illness Index|severity of illness index
329962|NCT02190500|stroke|stroke
329963|NCT02190500|tpa|tpa
329964|NCT02190500|emergency medical service|emergency medical service
329965|NCT02190500|ems|ems
329966|NCT02190500|mobile|mobile
329967|NCT02190500|ct scan|ct scan
329968|NCT02190474|fibromyalgia|fibromyalgia
329969|NCT02190474|juvenile fibromyalgia|juvenile fibromyalgia
329970|NCT02190474|juvenile primary fibromyalgia syndrome (JPFS)|juvenile primary fibromyalgia syndrome (jpfs)
329971|NCT02190474|adolescent pain|adolescent pain
329972|NCT02190474|mindfulness|mindfulness
329973|NCT02190474|MBSR|mbsr
329974|NCT02190461|Early Respiratory Rehabilitation|early respiratory rehabilitation
329975|NCT02190461|Chronic Obstructive Pulmonary Disease|chronic obstructive pulmonary disease
329976|NCT02190461|Re-admitted patients|re-admitted patients
329977|NCT02190461|Open clinical trial|open clinical trial
329978|NCT02190461|Exacerbations|exacerbations
329979|NCT02190448|galactogogue|galactogogue
329980|NCT02190448|lactation|lactation
329981|NCT02190448|milk production|milk production
329982|NCT02190448|breastfeeding|breastfeeding
329983|NCT02190435|Computer-assisted navigation|computer-assisted navigation
329984|NCT02190435|ADAPT|adapt
329985|NCT02190435|Intramedullary nail|intramedullary nail
329986|NCT02190435|Intertrochanteric femur fracture|intertrochanteric femur fracture
329987|NCT02190422|reproductive technologies, assisted|reproductive technologies, assisted
329988|NCT02190422|echocardiography|echocardiography
329989|NCT02190422|cardiology|cardiology
329990|NCT02190422|pediatrics|pediatrics
329991|NCT02190409|Dental Implant,|dental implant,
329992|NCT02190396|Calcium|calcium
329993|NCT02190396|Vitamin D|vitamin d
329994|NCT02190396|Placental calcification.|placental calcification.
329995|NCT02190383|Tic-Disorder, Tourette-Disorder, Habit Reversal Training|tic-disorder, tourette-disorder, habit reversal training
329996|NCT02190370|Tic-Disorder, Tourette-Disorder, Resources activation|tic-disorder, tourette-disorder, resources activation
329997|NCT02190357|Cirrhosis|cirrhosis
329998|NCT02190344|Eight|eight
329999|NCT02190344|Channel|channel
330000|NCT02190344|Paddle|paddle
330001|NCT02190344|Coil|coil
330002|NCT02190344|MRI|mri
330003|NCT02190344|Prostate|prostate
330004|NCT02190344|Healthy Male|healthy male
330005|NCT02190331|Detraining|detraining
330006|NCT02190331|Neck|neck
330007|NCT02190331|Exercise|exercise
330008|NCT02190331|Posture|posture
330009|NCT02190331|Rehabilitation|rehabilitation
330010|NCT02190318|peritoneal dialysis；|peritoneal dialysis；
330011|NCT02190318|residual renal function；|residual renal function；
330012|NCT02190318|RAAS|raas
330013|NCT02190279|Prostate Specific Membrane Antigen|prostate specific membrane antigen
330014|NCT02190279|Radiolabeled PET Agent|radiolabeled pet agent
330015|NCT02190279|Imaging|imaging
330016|NCT02190279|NaF|naf
330017|NCT02190266|Extrapulmonary|extrapulmonary
330018|NCT02190266|Immunodeficiency|immunodeficiency
330019|NCT02190266|Genetics|genetics
330020|NCT02190266|Infection|infection
330021|NCT02190266|Fungal|fungal
330022|NCT02190253|Renal Threshold|renal threshold
330023|NCT02190253|Liver Transplant|liver transplant
330024|NCT02190253|Transplantation|transplantation
330025|NCT02190253|Hepatitis E|hepatitis e
330026|NCT02190240|Complementary and Alternative Medicine|complementary and alternative medicine
330027|NCT02190240|Integrative Medicine|integrative medicine
330028|NCT02190240|Pain Management|pain management
330029|NCT02190227|Breast Cancer|breast cancer
330030|NCT02190227|Chemotherapy|chemotherapy
330031|NCT02190227|Neoadjuvant|neoadjuvant
330032|NCT02190227|RNA Disruption Assay|rna disruption assay
330033|NCT02190227|Biopsies|biopsies
330034|NCT02190227|Response|response
330035|NCT02190214|Hyperthyroidism|hyperthyroidism
330036|NCT02190214|Hypothyroidism|hypothyroidism
330037|NCT02190214|Autoimmune thyroid disorders|autoimmune thyroid disorders
330038|NCT02190214|Iodine deficiency|iodine deficiency
330039|NCT02190214|Genetic susceptibility|genetic susceptibility
330040|NCT02190201|videolaryngoscope|videolaryngoscope
330041|NCT02190201|double lumen intubation|double lumen intubation
330042|NCT02190188|wedge insoles,|wedge insoles,
330043|NCT02190188|knee brace,|knee brace,
330044|NCT02190188|orthotic device|orthotic device
330045|NCT02190188|goal|goal
330046|NCT02190162|Patients undergoing tonsillectomy with or without adenoidectomy|patients undergoing tonsillectomy with or without adenoidectomy
330047|NCT02190149|Factor VIII Deficiency|factor viii deficiency
330048|NCT02190149|Factor FIX Deficiency|factor fix deficiency
330049|NCT02190136|obesity|obesity
330050|NCT02190136|protein-rich whole foods diet|protein-rich whole foods diet
330051|NCT02190136|aerobic fitness|aerobic fitness
330052|NCT02190136|resistance training|resistance training
330053|NCT02190136|stretching/yoga training|stretching/yoga training
330054|NCT02190136|glycemia|glycemia
330055|NCT02190136|mood state|mood state
330056|NCT02190123|Acute Coronary Syndrome (ACS)|acute coronary syndrome (acs)
330057|NCT02190123|Oral antiplatelets (ticagrelor, prasugrel, clopidogrel) (OAP)|oral antiplatelets (ticagrelor, prasugrel, clopidogrel) (oap)
330058|NCT02190123|Treatment persistence.|treatment persistence.
330059|NCT02190110|Pulmonary embolism|pulmonary embolism
330060|NCT02190110|diagnosis|diagnosis
330061|NCT02190110|emergency medicine|emergency medicine
330062|NCT02190110|ultrasonography|ultrasonography
330063|NCT02190097|PCOS|pcos
330064|NCT02190097|insulin sensitivity|insulin sensitivity
330065|NCT02190097|paleolithic diet|paleolithic diet
330066|NCT02190084|apathy|apathy
330067|NCT02190084|Alzheimer's|alzheimer's
330068|NCT02190084|executive function|executive function
330069|NCT02190071|EUS-FNA|eus-fna
330070|NCT02190071|cytopathology|cytopathology
330071|NCT02190071|slide smear|slide smear
330072|NCT02190058|safety|safety
330073|NCT02190058|pharmacokinetics|pharmacokinetics
330074|NCT02190058|DS-1971a|ds-1971a
330075|NCT02190045|Balance|balance
330076|NCT02190045|gait|gait
330077|NCT02190045|Wii-Fit|wii-fit
330078|NCT02190019|Mild Cognitive Impairment|mild cognitive impairment
330079|NCT02190019|apathy|apathy
330080|NCT02190019|executive function|executive function
330081|NCT02190006|Polycystic ovarian syndrome|polycystic ovarian syndrome
330082|NCT02190006|Follicle output rate|follicle output rate
330083|NCT02190006|preovulatory count|preovulatory count
330084|NCT02190006|ICSI|icsi
330085|NCT02189993|Mortality|mortality
330086|NCT02189993|Long term follow-up|long term follow-up
330087|NCT02189993|Parenteral Nutrition, Total|parenteral nutrition, total
330088|NCT02189980|Nausea|nausea
330089|NCT02189980|Post-operative|post-operative
330090|NCT02189967|non-small cell lung cancer|non-small cell lung cancer
330091|NCT02189967|radiotherapy|radiotherapy
330092|NCT02189967|accelerated fractionation|accelerated fractionation
330093|NCT02189967|conventional fractionation|conventional fractionation
330094|NCT02189967|postoperative|postoperative
330095|NCT02189954|elderly; laryngeal masks; postoperative complications|elderly; laryngeal masks; postoperative complications
330096|NCT02189941|Deferiprone|deferiprone
330097|NCT02189941|Deferiprone sustained-release tablets|deferiprone sustained-release tablets
330098|NCT02189941|Pharmacokinetics|pharmacokinetics
330099|NCT02189902|Vitamin D|vitamin d
330100|NCT02189889|Active preoperative anemia management|active preoperative anemia management
330101|NCT02189889|Erythrocyte transfusion|erythrocyte transfusion
330102|NCT02189889|RBC transfusion|rbc transfusion
330103|NCT02189889|Red cell transfusion|red cell transfusion
330104|NCT02189889|Transfusion in cardiac surgery|transfusion in cardiac surgery
330105|NCT02189889|Anemia treatment with erythropoietin|anemia treatment with erythropoietin
330106|NCT02189889|Anemic cardiac surgery patients|anemic cardiac surgery patients
330107|NCT02189889|Erythrocyte stimulating agent (ESA)|erythrocyte stimulating agent (esa)
330108|NCT02189889|Iron deficiency anemia|iron deficiency anemia
330109|NCT02189889|EPO|epo
330110|NCT02189889|Feraheme|feraheme
330111|NCT02189876|HIV Prevention|hiv prevention
330112|NCT02189876|Behavioral Intervention|behavioral intervention
330113|NCT02189876|Condom Use|condom use
330114|NCT02189876|African American|african american
330115|NCT02189876|Sexually Transmitted Disease|sexually transmitted disease
330116|NCT02189876|Sexually Transmitted Infection|sexually transmitted infection
330117|NCT02189876|Internet|internet
330118|NCT02189863|Driving Simulator|driving simulator
330119|NCT02189863|Air Optix Aqua|air optix aqua
330120|NCT02189863|AOAMF|aoamf
330121|NCT02189850|colonoscopy|colonoscopy
330122|NCT02189850|pediatric|pediatric
330123|NCT02189837|Raised cholesterol|raised cholesterol
330124|NCT02189837|Cholesterol|cholesterol
330125|NCT02189837|Elevated Cholesterol|elevated cholesterol
330126|NCT02189837|Hyperlipidemias|hyperlipidemias
330127|NCT02189837|Dyslipidemias|dyslipidemias
330128|NCT02189837|Lipid Metabolism Disorders|lipid metabolism disorders
330129|NCT02189837|Metabolic Diseases|metabolic diseases
330130|NCT02189811|IPV|ipv
330131|NCT02189811|OPV|opv
330132|NCT02189811|tOPV|topv
330133|NCT02189811|bOPV|bopv
330134|NCT02189811|Polio|polio
330135|NCT02189811|Endgame|endgame
330136|NCT02189811|Pakistan|pakistan
330137|NCT02189798|Cochlear Implant|cochlear implant
330138|NCT02189798|HiRes™ 90K Advantage implant|hires™ 90k advantage implant
330139|NCT02189798|Cochlear Implantation|cochlear implantation
330140|NCT02189798|HiFocus™ Mid-Scala electrode|hifocus™ mid-scala electrode
330141|NCT02189798|Listening Benefits|listening benefits
330142|NCT02189798|Adults|adults
330143|NCT02189798|Cochlear Implant Benefit|cochlear implant benefit
330144|NCT02189798|Electrical Stimulation|electrical stimulation
330145|NCT02189798|Electro-Acoustic Stimulation (EAS)|electro-acoustic stimulation (eas)
330146|NCT02189785|social|social
330147|NCT02189785|rejection|rejection
330148|NCT02189785|acceptance|acceptance
330149|NCT02189785|PET|pet
330150|NCT02189785|opioid|opioid
330151|NCT02189785|fMRI|fmri
330152|NCT02189785|reward|reward
330153|NCT02189785|exclusion|exclusion
330154|NCT02189772|ADHD|adhd
330155|NCT02189772|Inattention|inattention
330156|NCT02189772|MDX|mdx
330157|NCT02189759|Hypothermia|hypothermia
330158|NCT02189759|Hyperthermia|hyperthermia
330159|NCT02189759|Kangaroo Mother Care|kangaroo mother care
330160|NCT02189759|Newborn|newborn
330161|NCT02189746|Hypothermia|hypothermia
330162|NCT02189746|Newborn|newborn
330163|NCT02189746|Hyperthermia|hyperthermia
330164|NCT02189746|Kangaroo mother care|kangaroo mother care
330165|NCT02189720|Amifampridine Phosphate|amifampridine phosphate
330166|NCT02189720|Amifampridine|amifampridine
330167|NCT02189720|3,4-Diaminopyridine Phosphate|3,4-diaminopyridine phosphate
330168|NCT02189720|3,4-Diaminopyridine|3,4-diaminopyridine
330169|NCT02189720|3,4-DAP|3,4-dap
330170|NCT02189720|CMS|cms
330171|NCT02189720|Congenital Myasthenic Syndrome|congenital myasthenic syndrome
330172|NCT02189720|Neuromuscular|neuromuscular
330173|NCT02189720|Expanded Access|expanded access
330174|NCT02189720|Firdapse®|firdapse®
330175|NCT02189707|Gastrointestinal disorder|gastrointestinal disorder
330176|NCT02189707|Constipation|constipation
330177|NCT02189707|Probiotics|probiotics
330178|NCT02189707|Dietary supplement|dietary supplement
330179|NCT02189694|Type 1 diabetes|type 1 diabetes
330180|NCT02189694|Hypoglycemia|hypoglycemia
330181|NCT02189694|Insulin|insulin
330182|NCT02189694|Glucagon|glucagon
330183|NCT02189694|Closed-loop system|closed-loop system
330184|NCT02189694|Artificial pancreas|artificial pancreas
330185|NCT02189681|spinal anaesthesia|spinal anaesthesia
330186|NCT02189681|ultrasound|ultrasound
330187|NCT02189681|paramedian|paramedian
330188|NCT02189668|Appendicitis|appendicitis
330189|NCT02189668|Non-operative|non-operative
330190|NCT02189668|Children|children
330191|NCT02189668|Appendicolith|appendicolith
330192|NCT02189668|fecalith|fecalith
330193|NCT02189668|Pediatrics|pediatrics
330194|NCT02189655|shivering spinal anesthesia|shivering spinal anesthesia
330195|NCT02189629|Acne vulgaris|acne vulgaris
330196|NCT02189629|Safety|safety
330197|NCT02189629|Face|face
330198|NCT02189629|Trunk|trunk
330199|NCT02189616|asthma management|asthma management
330200|NCT02189616|SMS reminder|sms reminder
330201|NCT02189616|SMS consultation|sms consultation
330202|NCT02189603|hepatitis E|hepatitis e
330203|NCT02189603|Immunogenicity|immunogenicity
330204|NCT02189603|vaccine|vaccine
330205|NCT02189603|safety|safety
330206|NCT02189590|supraglottic airway|supraglottic airway
330207|NCT02189590|children|children
330208|NCT02189590|fiberoptic guided tracheal intubation|fiberoptic guided tracheal intubation
330209|NCT02189590|air-Q|air-q
330210|NCT02189590|i-gel|i-gel
330211|NCT02189577|Chronic Obstructive Pulmonary disease|chronic obstructive pulmonary disease
330212|NCT02189577|COPD|copd
330213|NCT02189538|Infections, Enteral nutrition, SIRS, critically ill|infections, enteral nutrition, sirs, critically ill
330214|NCT02189525|traumatic brain injury|traumatic brain injury
330215|NCT02189525|sports head injury|sports head injury
330216|NCT02189525|sports concussion|sports concussion
330217|NCT02189512|brain-death organ donors|brain-death organ donors
330218|NCT02189512|intestinal manipulation|intestinal manipulation
330219|NCT02189512|monocytes|monocytes
330221|NCT02189499|Angioplasty|angioplasty
330222|NCT02189499|Coronary Vessels|coronary vessels
330223|NCT02189499|Coronary Artery Disease|coronary artery disease
330224|NCT02189499|Angina Pectoris|angina pectoris
330225|NCT02189499|Myocardial Ischemia|myocardial ischemia
330226|NCT02189499|Myocardial Infarction|myocardial infarction
330227|NCT02189499|Myocardial Revascularization|myocardial revascularization
330228|NCT02189486|Prostate Cancer|prostate cancer
330229|NCT02189486|Radical Prostatectomy|radical prostatectomy
330230|NCT02189486|Prostate biopsy|prostate biopsy
330231|NCT02189486|Upgrading|upgrading
330232|NCT02189486|Upgrading Reference set|upgrading reference set
330233|NCT02189473|metastatic epidural spinal cord compression|metastatic epidural spinal cord compression
330234|NCT02189473|motor function|motor function
330235|NCT02189473|ambulatory status|ambulatory status
330236|NCT02189473|pain|pain
330237|NCT02189473|quality of life|quality of life
330238|NCT02189473|overall survival|overall survival
330239|NCT02189473|local control|local control
330240|NCT02189473|toxicity|toxicity
330241|NCT02189460|Cognition|cognition
330242|NCT02189447|Keratoconus|keratoconus
330243|NCT02189447|Ectasia|ectasia
330244|NCT02189447|Corneal Cross-linking|corneal cross-linking
330245|NCT02189421|peroral cholangioscopy|peroral cholangioscopy
330246|NCT02189421|ultra-slim upper endoscope|ultra-slim upper endoscope
330247|NCT02189421|multibending endoscope|multibending endoscope
330248|NCT02189408|Platelet rich plasma|platelet rich plasma
330249|NCT02189408|Autologous conditioned plasma|autologous conditioned plasma
330250|NCT02189408|Outerbridge|outerbridge
330251|NCT02189395|Type 2 diabetes|type 2 diabetes
330252|NCT02189395|Uncontrolled blood glucose|uncontrolled blood glucose
330253|NCT02189395|insulin|insulin
330254|NCT02189395|glargine|glargine
330256|NCT02189382|Sensitivity|sensitivity
422039|NCT01769937|SLE|sle
330257|NCT02189356|Pregnancy-related low back and pelvic pain|pregnancy-related low back and pelvic pain
330258|NCT02189356|exercise program|exercise program
330259|NCT02189356|nurse|nurse
330260|NCT02189343|Multiple Myeloma|multiple myeloma
330261|NCT02189343|Relapsed and Refractory|relapsed and refractory
330262|NCT02189343|Refractory Disease|refractory disease
330263|NCT02189343|Progressive Disease|progressive disease
330264|NCT02189343|Pomalidomide|pomalidomide
330265|NCT02189343|Dexamethasone|dexamethasone
330266|NCT02189343|Proteasome Inhibitor|proteasome inhibitor
330267|NCT02189343|Ricolinostat|ricolinostat
330268|NCT02189304|Healthy volunteers|healthy volunteers
330269|NCT02189291|Indwelling catheter|indwelling catheter
330270|NCT02189291|Hospital stay|hospital stay
330271|NCT02189291|Urinary tract infection|urinary tract infection
330272|NCT02189291|Sacrocolpopexy|sacrocolpopexy
330273|NCT02189278|Breast Cancer|breast cancer
330274|NCT02189278|Surveillance|surveillance
330275|NCT02189278|Mammography|mammography
330276|NCT02189278|Adherence|adherence
330277|NCT02189265|Live birth [MeSH]|live birth [mesh]
330278|NCT02189265|Infant [MeSH]|infant [mesh]
330279|NCT02189265|Infant, newborn [MeSH]|infant, newborn [mesh]
330280|NCT02189265|Second-hand smoke|second-hand smoke
330281|NCT02189265|Tobacco smoke pollution [MeSH]|tobacco smoke pollution [mesh]
330282|NCT02189265|Smoke-free|smoke-free
330283|NCT02189265|Smoke-free policy [MeSH]|smoke-free policy [mesh]
330284|NCT02189226|probe-based confocal laser endomicroscopy (pCLE), early gastric cancer (EGC), endoscopic submucosal dissection (ESD), margin|probe-based confocal laser endomicroscopy (pcle), early gastric cancer (egc), endoscopic submucosal dissection (esd), margin
330285|NCT02189213|anxiety|anxiety
330286|NCT02189213|SSRI|ssri
330287|NCT02189213|biomarker|biomarker
330288|NCT02189213|sleep|sleep
330289|NCT02189213|children|children
330290|NCT02189213|adolescents|adolescents
330291|NCT02189213|young adults|young adults
330292|NCT02189200|nutritional counseling|nutritional counseling
330293|NCT02189200|oat bran|oat bran
330294|NCT02189200|dyslipidemia|dyslipidemia
330295|NCT02189200|cardiovascular disease|cardiovascular disease
330296|NCT02189187|Weight Loss|weight loss
330297|NCT02189187|Body Weight Changes|body weight changes
330298|NCT02189187|Body Weight|body weight
330299|NCT02189187|Magnetic Resonance Imaging|magnetic resonance imaging
330300|NCT02189187|Emotions|emotions
330301|NCT02189187|Emotion regulation|emotion regulation
330302|NCT02189187|Health Behavior|health behavior
330303|NCT02189187|Eating behavior|eating behavior
330304|NCT02189174|Solid tumor,|solid tumor,
330305|NCT02189174|breast cancer,|breast cancer,
330306|NCT02189174|lung cancer,|lung cancer,
330307|NCT02189174|endometrial cancer|endometrial cancer
330308|NCT02189161|anal intraepithelial neoplasia|anal intraepithelial neoplasia
330309|NCT02189161|AIN|ain
330310|NCT02189161|Radiofrequency Ablation|radiofrequency ablation
330311|NCT02189161|RFA|rfa
330312|NCT02189148|Prediction|prediction
330313|NCT02189148|Preeclampsia|preeclampsia
330314|NCT02189148|Preterm birth|preterm birth
330315|NCT02189148|Pregnancy|pregnancy
330316|NCT02189148|Placenta|placenta
330317|NCT02189148|Intra-uterine growth restriction|intra-uterine growth restriction
330318|NCT02189148|fetal growth restriction|fetal growth restriction
330319|NCT02189148|Ultrasound|ultrasound
330320|NCT02189148|Doppler|doppler
330321|NCT02189148|Biomarkers|biomarkers
330322|NCT02189148|PAPP-A|papp-a
330323|NCT02189148|Placental growth factor (PlGF)|placental growth factor (plgf)
330324|NCT02189109|glioblastoma|glioblastoma
330325|NCT02189109|multiforme|multiforme
330326|NCT02189109|radiation|radiation
330327|NCT02189109|radiation therapy|radiation therapy
330328|NCT02189096|Sepsis|sepsis
330329|NCT02189096|National Early Warning Score|national early warning score
330330|NCT02189096|Lactate|lactate
330331|NCT02189083|Leiomyoma|leiomyoma
330332|NCT02189083|Medicine, Chinese Traditional|medicine, chinese traditional
330333|NCT02189083|Randomized Controlled Trial|randomized controlled trial
330334|NCT02189070|Follow-up|follow-up
330335|NCT02189070|Percutaneous coronary intervention|percutaneous coronary intervention
330336|NCT02189070|Patient preference|patient preference
330337|NCT02189070|DUTCH PEERS|dutch peers
330338|NCT02189070|TWENTE|twente
330339|NCT02189057|Bipolar|bipolar
330340|NCT02189057|Unipolar|unipolar
330341|NCT02189057|Genotyping|genotyping
330342|NCT02189057|Pharmacokinetic|pharmacokinetic
330343|NCT02189057|Pharmacodynamic|pharmacodynamic
330344|NCT02189044|aged;|aged;
330345|NCT02189044|breathing exercises;|breathing exercises;
330346|NCT02189044|muscle strength.|muscle strength.
330347|NCT02189031|Upper limb Amputee|upper limb amputee
330348|NCT02189031|Targeted Muscle Reinnervation|targeted muscle reinnervation
330349|NCT02189031|Prosthetic|prosthetic
330350|NCT02189018|Peripheral arterial disease|peripheral arterial disease
330351|NCT02189018|Endovascular|endovascular
330352|NCT02189018|Exercise|exercise
330353|NCT02189018|Perfusion|perfusion
330354|NCT02189018|Functional capacity|functional capacity
330355|NCT02189005|High blood sugar|high blood sugar
330356|NCT02189005|High HbA1C|high hba1c
330357|NCT02189005|hyperglycemia|hyperglycemia
330358|NCT02189005|Pre-Diabetes|pre-diabetes
330359|NCT02189005|Natural Supplement for Diabetes|natural supplement for diabetes
330360|NCT02188992|Sepsis|sepsis
330361|NCT02188992|Immune activation|immune activation
330362|NCT02188992|Systemic Inflammation|systemic inflammation
330363|NCT02188992|Emergency Medicine|emergency medicine
330364|NCT02188992|Critical Care|critical care
330365|NCT02188979|airway|airway
330366|NCT02188979|equipment - laryngoscopes|equipment - laryngoscopes
330367|NCT02188979|intubation - tracheal|intubation - tracheal
330368|NCT02188979|obesity.|obesity.
330369|NCT02188966|Geographic Information System|geographic information system
330370|NCT02188966|Emergency Care Information Systems|emergency care information systems
330371|NCT02188966|Telemedicine|telemedicine
330372|NCT02188966|Emergency Hospital Service|emergency hospital service
330373|NCT02188953|aflatoxin|aflatoxin
330374|NCT02188953|Kenya|kenya
330375|NCT02188940|Asthma|asthma
330376|NCT02188940|Obesity|obesity
330377|NCT02188940|Clinical control|clinical control
330378|NCT02188940|Exercise|exercise
330379|NCT02188940|Weight-loss|weight-loss
330380|NCT02188927|Advanced notification letter|advanced notification letter
330381|NCT02188927|Standard invitation|standard invitation
330382|NCT02188927|Participation rate|participation rate
330383|NCT02188927|Colonoscopy|colonoscopy
330384|NCT02188927|Screening|screening
330385|NCT02188927|Colorectal Neoplasms|colorectal neoplasms
330386|NCT02188927|Digestive System Diseases|digestive system diseases
330387|NCT02188914|Inhalant use disorder|inhalant use disorder
330388|NCT02188914|Positron emission tomography|positron emission tomography
330389|NCT02188914|Magnetic Resonance Imaging|magnetic resonance imaging
330390|NCT02188914|Executive functions assessment|executive functions assessment
330391|NCT02188914|Transcriptome|transcriptome
330393|NCT02188901|Sonazoid|sonazoid
330394|NCT02188901|Ultrasonography|ultrasonography
330395|NCT02188901|Screening|screening
330396|NCT02188888|septic shock|septic shock
330397|NCT02188888|esmolol|esmolol
330398|NCT02188888|tachycardia|tachycardia
330399|NCT02188888|betablockers|betablockers
330400|NCT02188875|Fitbit One|fitbit one
330401|NCT02188875|wearable sensor|wearable sensor
330402|NCT02188875|wearable device|wearable device
330403|NCT02188875|web-based intervention|web-based intervention
330404|NCT02188875|SMS text messages|sms text messages
330405|NCT02188875|randomized controlled trial|randomized controlled trial
330406|NCT02188875|physical activity|physical activity
330407|NCT02188875|behavioral intervention|behavioral intervention
330408|NCT02188875|text message prompts|text message prompts
330409|NCT02188875|text messaging|text messaging
330410|NCT02188875|technology|technology
330411|NCT02188875|exercise|exercise
330412|NCT02188862|Rheumatic heart disease|rheumatic heart disease
330413|NCT02188862|Acute rheumatic fever|acute rheumatic fever
330414|NCT02188862|Group A streptococcal disease|group a streptococcal disease
330415|NCT02188862|Streptococcus pyogenes|streptococcus pyogenes
330416|NCT02188862|Genetics|genetics
330417|NCT02188862|Oceania|oceania
330418|NCT02188849|creatine|creatine
330419|NCT02188849|resistance training|resistance training
330420|NCT02188849|older women|older women
330421|NCT02188849|muscle strength|muscle strength
330422|NCT02188823|prediabetes|prediabetes
330423|NCT02188823|obesity|obesity
330424|NCT02188823|mindful eating|mindful eating
330425|NCT02188823|positive affect|positive affect
330426|NCT02188823|low carbohydrate|low carbohydrate
330427|NCT02188823|ketogenic|ketogenic
330428|NCT02188823|diet|diet
330429|NCT02188810|PAL|pal
330430|NCT02188810|fluviral|fluviral
330431|NCT02188810|healthy volunteer|healthy volunteer
330432|NCT02188810|adjuvant|adjuvant
330433|NCT02188810|TH1 immune response|th1 immune response
330434|NCT02188797|homeless|homeless
330435|NCT02188797|young adults|young adults
330436|NCT02188797|substance use|substance use
330437|NCT02188797|HIV risk|hiv risk
330438|NCT02188797|sexual risk behavior|sexual risk behavior
330439|NCT02188797|group motivational interviewing|group motivational interviewing
330440|NCT02188771|Moderate to Severe OA|moderate to severe oa
330441|NCT02188771|VAS score of ≥ 5|vas score of ≥ 5
330442|NCT02188771|grade III-IV Kellgren Lawrence of OA|grade iii-iv kellgren lawrence of oa
330443|NCT02188771|subjects who failed conservative treatment|subjects who failed conservative treatment
330444|NCT02188771|subjects who candidates for total knee replacement (TKR)|subjects who candidates for total knee replacement (tkr)
330445|NCT02188771|subject 45 and 75 years old|subject 45 and 75 years old
330446|NCT02188771|subject is experiencing pain in the intended study knee with a VAS score of ≥ 5|subject is experiencing pain in the intended study knee with a vas score of ≥ 5
330447|NCT02188771|subject has a Body Mass Index (BMI) between 18.5 and 35|subject has a body mass index (bmi) between 18.5 and 35
330448|NCT02188758|iron|iron
330449|NCT02188758|hepcidin-25|hepcidin-25
330450|NCT02188758|pulmonary exacerbation|pulmonary exacerbation
768231|NCT00374192|Insomnia|insomnia
330451|NCT02188758|interleukin-6|interleukin-6
330452|NCT02188745|metastatic|metastatic
330453|NCT02188745|locally advanced|locally advanced
330454|NCT02188745|ER+|er+
330455|NCT02188745|Estrogen therapy|estrogen therapy
330456|NCT02188745|Estradiol therapy|estradiol therapy
330457|NCT02188732|Community Mental Health|community mental health
330458|NCT02188732|Serious Mental Illness|serious mental illness
330459|NCT02188732|Medical Comorbidity|medical comorbidity
330460|NCT02188732|Self-Management|self-management
330461|NCT02188732|Automated Telehealth|automated telehealth
330462|NCT02188732|Early Mortality|early mortality
330463|NCT02188719|Donor-Alloantigen-Reactive Regulatory T Cell Therapy|donor-alloantigen-reactive regulatory t cell therapy
330464|NCT02188719|Tregs|tregs
330465|NCT02188719|Cell- and Tissue-Based Therapy|cell- and tissue-based therapy
330466|NCT02188719|Immunotherapy, Adoptive|immunotherapy, adoptive
330467|NCT02188719|Liver Transplantation|liver transplantation
330468|NCT02188680|fructose test|fructose test
330469|NCT02188667|Chronic Noncancer Pain|chronic noncancer pain
330470|NCT02188667|Musculoskeletal Pain|musculoskeletal pain
330471|NCT02188667|Neuropathic Pain|neuropathic pain
330472|NCT02188667|Headache Pain|headache pain
330473|NCT02188654|psoriatic arthritis|psoriatic arthritis
330474|NCT02188654|inflammation|inflammation
330475|NCT02188654|metabolic syndrome|metabolic syndrome
330476|NCT02188654|metformin|metformin
330477|NCT02188641|Psoriatic arthritis|psoriatic arthritis
330478|NCT02188641|inflammation|inflammation
330479|NCT02188641|obesity|obesity
330480|NCT02188641|diet|diet
330481|NCT02188641|exercise|exercise
330482|NCT02188628|Motor recovery, robotics, stroke rehabilitation|motor recovery, robotics, stroke rehabilitation
330483|NCT02188615|Squamous Cell Esophageal Carcinoma|squamous cell esophageal carcinoma
330484|NCT02188615|minimally invasive esophagectomy|minimally invasive esophagectomy
330485|NCT02188615|laparoscopy|laparoscopy
330486|NCT02188615|thoracoscopy|thoracoscopy
330487|NCT02188576|Craniofacial Surgery|craniofacial surgery
330488|NCT02188576|tranexamic acid|tranexamic acid
330489|NCT02188576|Antifibrinolytic|antifibrinolytic
330490|NCT02188563|Smoking cessation|smoking cessation
330491|NCT02188563|Head and neck neoplasms|head and neck neoplasms
330492|NCT02188563|Lung neoplasms|lung neoplasms
330493|NCT02188563|Thoracic neoplasms|thoracic neoplasms
330494|NCT02188563|Radiation|radiation
330495|NCT02188550|relapse or refractory or persistent epithelial ovarian fallopian tube|relapse or refractory or persistent epithelial ovarian fallopian tube
330496|NCT02188550|primary peritoneal carcinoma or endometrial cancer|primary peritoneal carcinoma or endometrial cancer
330497|NCT02188537|Myeloma|myeloma
330498|NCT02188537|proteasome inhibitor-nonresponsive myeloma|proteasome inhibitor-nonresponsive myeloma
330499|NCT02188537|Nelfinavir|nelfinavir
330500|NCT02188537|bortezomib|bortezomib
330501|NCT02188537|bortezomib-sensitizing drug|bortezomib-sensitizing drug
330502|NCT02188524|balance, exercise, compensatory stepping, tai chi|balance, exercise, compensatory stepping, tai chi
330503|NCT02188511|E-Cigarettes|e-cigarettes
330504|NCT02188511|Lung|lung
330505|NCT02188511|Non-Smokers|non-smokers
330506|NCT02188511|Lung Biology|lung biology
330507|NCT02188472|Oxidative Stress|oxidative stress
330508|NCT02188472|antibiotics|antibiotics
330509|NCT02188446|Radical cystectomy|radical cystectomy
330510|NCT02188446|Bladder cancer|bladder cancer
330511|NCT02188446|Smoking cessation|smoking cessation
330512|NCT02188446|Alcohol cessation|alcohol cessation
330513|NCT02188446|Postoperative complications|postoperative complications
330613|NCT02188043|Motivational Intervention|motivational intervention
330614|NCT02188043|Health expenditures|health expenditures
330514|NCT02188433|Effectiveness of quit immediately (QI) and cut down to quit (CDTQ) interventions in achieving smoking abstinence|effectiveness of quit immediately (qi) and cut down to quit (cdtq) interventions in achieving smoking abstinence
330515|NCT02188420|PAS|pas
330516|NCT02188420|TMS|tms
330517|NCT02188420|Stroke|stroke
330518|NCT02188420|Paired Associative Stimulation|paired associative stimulation
330519|NCT02188420|Transcranial Magnetic Stimulation|transcranial magnetic stimulation
330520|NCT02188407|thoracotomy|thoracotomy
330521|NCT02188407|one-lung ventilation (OLV)|one-lung ventilation (olv)
330522|NCT02188407|total intravenous anaesthesia (TIVA)|total intravenous anaesthesia (tiva)
330523|NCT02188407|volatile induced and maintained anaesthesia (VIMA)|volatile induced and maintained anaesthesia (vima)
330524|NCT02188407|cytokines|cytokines
330525|NCT02188407|interleukine (IL)|interleukine (il)
330526|NCT02188394|migraine,|migraine,
330527|NCT02188394|pressure pain,|pressure pain,
330528|NCT02188394|anesthetic blocks|anesthetic blocks
330529|NCT02188394|patients|patients
330530|NCT02188381|Resistant Hypertension (RH)|resistant hypertension (rh)
330531|NCT02188381|Uncontrolled Hypertension|uncontrolled hypertension
330532|NCT02188368|Pomalidomide|pomalidomide
330533|NCT02188368|Lenalidomide refractory|lenalidomide refractory
330534|NCT02188368|multiple myeloma|multiple myeloma
330535|NCT02188355|Ultimaster|ultimaster
330536|NCT02188355|registry|registry
330537|NCT02188355|DES|des
330538|NCT02188355|DAPT|dapt
768232|NCT00374192|Depression|depression
330539|NCT02188329|Early care and education|early care and education
330540|NCT02188329|ECE|ece
330541|NCT02188329|workforce|workforce
330542|NCT02188329|child care|child care
330543|NCT02188329|caregivers|caregivers
330544|NCT02188329|home-based providers|home-based providers
330545|NCT02188329|center-based providers|center-based providers
330546|NCT02188316|Cold forceps polypectomy|cold forceps polypectomy
330547|NCT02188316|Diminutive colorectal polyp|diminutive colorectal polyp
330548|NCT02188316|Hot biopsy forceps electrocauterization|hot biopsy forceps electrocauterization
330549|NCT02188316|Jumbo forceps.|jumbo forceps.
330550|NCT02188290|Haploidentical donor|haploidentical donor
330551|NCT02188290|Unrelated donor|unrelated donor
330552|NCT02188290|Umbilical cord blood|umbilical cord blood
330553|NCT02188290|Graft versus host disease|graft versus host disease
330554|NCT02188290|Transplant-related mortality|transplant-related mortality
330555|NCT02188290|Hematologic malignancy|hematologic malignancy
330556|NCT02188290|Hematopoietic Stem Cell Transplantation|hematopoietic stem cell transplantation
330557|NCT02188251|Activamp|activamp
330558|NCT02188251|Gynostemma pentaphyllum|gynostemma pentaphyllum
330559|NCT02188251|Body weight|body weight
330560|NCT02188251|Fat Loss|fat loss
330561|NCT02188251|Metabolic markers|metabolic markers
330562|NCT02188251|Overweight participants|overweight participants
330563|NCT02188251|DXA|dxa
330564|NCT02188251|AMPK|ampk
330565|NCT02188238|saliva|saliva
330566|NCT02188238|protein|protein
330567|NCT02188238|oral health|oral health
330568|NCT02188238|film|film
330569|NCT02188238|pellicle|pellicle
330570|NCT02188225|Hot flash|hot flash
330571|NCT02188225|Acupuncture|acupuncture
330572|NCT02188225|Fluoxetine|fluoxetine
330573|NCT02188225|Quality of life|quality of life
330574|NCT02188199|Hip|hip
330575|NCT02188199|Knee|knee
330576|NCT02188199|Hip replacement|hip replacement
330577|NCT02188199|Knee replacement|knee replacement
330578|NCT02188199|Total Joint|total joint
330579|NCT02188186|triple combination|triple combination
330580|NCT02188186|metformin|metformin
330581|NCT02188186|sitagliptin|sitagliptin
330582|NCT02188186|thiazolidinedione|thiazolidinedione
330583|NCT02188160|Pain|pain
330584|NCT02188160|Corticosteroid|corticosteroid
330585|NCT02188160|Dry Eye|dry eye
330586|NCT02188160|Hyperemia|hyperemia
330587|NCT02188160|Ocular Discomfort|ocular discomfort
330588|NCT02188147|Syncope|syncope
330589|NCT02188147|Sudden Cardiac Arrest|sudden cardiac arrest
330590|NCT02188147|Sudden Cardiac Death|sudden cardiac death
330591|NCT02188147|Cardiac Arrest|cardiac arrest
330592|NCT02188147|Emergency Service|emergency service
330593|NCT02188147|Emergency Department|emergency department
330594|NCT02188147|Ambulatory Electrocardiography|ambulatory electrocardiography
330595|NCT02188147|Holter|holter
330596|NCT02188147|Holter Electrocardiography|holter electrocardiography
330597|NCT02188147|Holter Monitoring|holter monitoring
330598|NCT02188134|Adverse events,|adverse events,
330599|NCT02188134|adverse drug reactions,|adverse drug reactions,
330600|NCT02188134|medication error,|medication error,
330601|NCT02188134|noncompliance|noncompliance
330602|NCT02188108|quality of life|quality of life
330603|NCT02188108|QOL|qol
330604|NCT02188108|urolithiasis|urolithiasis
330605|NCT02188108|nephrolithiasis|nephrolithiasis
330606|NCT02188108|kidney stones|kidney stones
330607|NCT02188108|patient-reported outcomes|patient-reported outcomes
330608|NCT02188069|Non-atherosclerotic Coronary Artery Disease|non-atherosclerotic coronary artery disease
330609|NCT02188056|Venous|venous
330610|NCT02188056|Thromboembolic|thromboembolic
330611|NCT02188056|Pulmonary embolism|pulmonary embolism
330612|NCT02188043|Alcohol use disorder|alcohol use disorder
330615|NCT02188043|efficacy study|efficacy study
330616|NCT02188030|musculoskeletal symptom|musculoskeletal symptom
330617|NCT02188030|industrial workers|industrial workers
330618|NCT02188030|physical-activity program|physical-activity program
330619|NCT02188030|resistance training|resistance training
330620|NCT02188030|randomized controlled trial|randomized controlled trial
330621|NCT02188017|prednisone, methotrexate, sarcoidosis, azathioprine|prednisone, methotrexate, sarcoidosis, azathioprine
330622|NCT02188004|HPV|hpv
330623|NCT02188004|genital warts|genital warts
330753|NCT02187406|athletic tape|athletic tape
330624|NCT02187991|metastatic breast cancer|metastatic breast cancer
330625|NCT02187991|Human Epidermal Growth Factor Receptor 2-negative (HER2-) breast cancer|human epidermal growth factor receptor 2-negative (her2-) breast cancer
330626|NCT02187991|Estrogen Receptor-positive (ER+) breast cancer|estrogen receptor-positive (er+) breast cancer
330627|NCT02187991|Triple Negative breast cancer|triple negative breast cancer
330628|NCT02187991|alisertib|alisertib
330629|NCT02187991|paclitaxel|paclitaxel
330630|NCT02187978|Early total enteral feeding (ETEF)|early total enteral feeding (etef)
330631|NCT02187978|Conventional enteral feeding (CEF)|conventional enteral feeding (cef)
330632|NCT02187978|VLBW infants|vlbw infants
330633|NCT02187978|NEC|nec
330634|NCT02187978|Preterm infants|preterm infants
330635|NCT02187926|Drug therapy|drug therapy
330636|NCT02187900|Tripterygium Wilfordii HOOK. f.|tripterygium wilfordii hook. f.
330637|NCT02187900|Mycophenolate mofetil|mycophenolate mofetil
330638|NCT02187887|alcohol|alcohol
330639|NCT02187887|young adult veterans|young adult veterans
330640|NCT02187887|brief intervention|brief intervention
330641|NCT02187887|online|online
330642|NCT02187887|perceived norms|perceived norms
330643|NCT02187835|complexity|complexity
330644|NCT02187835|electroencephalogram|electroencephalogram
330645|NCT02187835|entropy|entropy
330646|NCT02187835|negative symptoms|negative symptoms
330647|NCT02187835|schizophrenia.|schizophrenia.
330648|NCT02187822|Brain|brain
330649|NCT02187822|Advanced solid tumors|advanced solid tumors
330650|NCT02187822|Fractionated Stereotactic Radiotherapy (FSRT)|fractionated stereotactic radiotherapy (fsrt)
330651|NCT02187822|Brain lesions|brain lesions
330652|NCT02187822|Primary solid malignancy|primary solid malignancy
330653|NCT02187796|HIV|hiv
330654|NCT02187796|Dementia|dementia
330655|NCT02187796|HAND|hand
330656|NCT02187796|COGNISION System|cognision system
330657|NCT02187796|ERP|erp
330658|NCT02187796|event-related potentials|event-related potentials
330659|NCT02187783|Solid malignancy|solid malignancy
330660|NCT02187783|Hematologic malignancy|hematologic malignancy
330661|NCT02187783|Mutations|mutations
330662|NCT02187783|Amplifications|amplifications
330663|NCT02187783|Signature|signature
330664|NCT02187783|CDK4|cdk4
330665|NCT02187783|CDK6|cdk6
330666|NCT02187783|CDK4/6|cdk4/6
330667|NCT02187783|Cyclin D1|cyclin d1
330668|NCT02187783|CCND,|ccnd,
330669|NCT02187783|Cyclin D3|cyclin d3
330670|NCT02187783|p16 mutation|p16 mutation
330671|NCT02187783|CDKN2A|cdkn2a
330672|NCT02187783|LEE011|lee011
330673|NCT02187783|Breast cancer|breast cancer
330674|NCT02187783|Ovarian cancer|ovarian cancer
330675|NCT02187783|Lymphoma|lymphoma
330676|NCT02187783|Mesothelioma|mesothelioma
330677|NCT02187783|Pancreatic neuroendocrine|pancreatic neuroendocrine
330678|NCT02187783|Leukemia|leukemia
330679|NCT02187783|Tumor|tumor
330680|NCT02187757|Dyslipidemia|dyslipidemia
330681|NCT02187757|High cholesterol|high cholesterol
330682|NCT02187757|High LDL|high ldl
330683|NCT02187757|Triglycerides|triglycerides
330684|NCT02187744|Biosimilars|biosimilars
330685|NCT02187744|Non-inferiority|non-inferiority
330686|NCT02187744|Neoadjuvant Setting|neoadjuvant setting
330687|NCT02187744|Early Breast Cancer|early breast cancer
330688|NCT02187744|PK|pk
330689|NCT02187744|Phase 3|phase 3
330690|NCT02187744|Trastuzumab|trastuzumab
330691|NCT02187744|Herceptin|herceptin
330692|NCT02187744|HER2 Positive|her2 positive
330693|NCT02187731|Multiple Myeloma|multiple myeloma
330694|NCT02187731|Functional Imaging|functional imaging
330695|NCT02187731|PET/CT|pet/ct
330696|NCT02187731|Diffusion Weighted MRI|diffusion weighted mri
330697|NCT02187718|Sentinel Lymph Node Biopsy|sentinel lymph node biopsy
330698|NCT02187718|Local Anaesthesia|local anaesthesia
330699|NCT02187692|schizophrenia;|schizophrenia;
330700|NCT02187692|meta-cognition;|meta-cognition;
330701|NCT02187692|general functioning;|general functioning;
330702|NCT02187692|positive symptoms;|positive symptoms;
330703|NCT02187692|insight;|insight;
330704|NCT02187679|Tourette Syndrome|tourette syndrome
330705|NCT02187679|Tourette's Syndrome|tourette's syndrome
330706|NCT02187679|Chronic Vocal Tic|chronic vocal tic
330707|NCT02187679|Vocal Tic|vocal tic
330708|NCT02187666|Cervical|cervical
330709|NCT02187666|Lumbar|lumbar
330710|NCT02187666|Spine|spine
330711|NCT02187666|Spinal Disease|spinal disease
330712|NCT02187653|IOM|iom
330713|NCT02187653|IONM|ionm
330714|NCT02187653|Intraoperative Monitoring|intraoperative monitoring
330715|NCT02187653|Intraoperative Neuromonitoring|intraoperative neuromonitoring
330716|NCT02187653|Spine|spine
330717|NCT02187653|Lumbar|lumbar
330718|NCT02187653|Cervical|cervical
330719|NCT02187640|Acupressure|acupressure
330720|NCT02187640|Self-administration|self-administration
330721|NCT02187640|Psychiatric in-patients|psychiatric in-patients
330722|NCT02187640|Constipation|constipation
330723|NCT02187640|Self-administered acupressure program|self-administered acupressure program
330724|NCT02187640|Sham control group|sham control group
330725|NCT02187614|Acute Renal colic|acute renal colic
330726|NCT02187614|Acute Ureteric Colic|acute ureteric colic
330727|NCT02187614|Renal or Ureteral Calculi|renal or ureteral calculi
330728|NCT02187614|Urolithiasis|urolithiasis
330729|NCT02187614|Kidney or Ureteral stones|kidney or ureteral stones
330730|NCT02187601|CLD|cld
330731|NCT02187549|Hyaluronic Acid|hyaluronic acid
330732|NCT02187549|Osteoarthritis|osteoarthritis
330733|NCT02187549|Knee|knee
330734|NCT02187549|Hyaluronan|hyaluronan
330735|NCT02187549|Viscoelastic|viscoelastic
330736|NCT02187549|Hydrogel|hydrogel
330737|NCT02187510|Hemodynamics|hemodynamics
330738|NCT02187510|Premature Infant|premature infant
330739|NCT02187510|Umbilical cord|umbilical cord
330740|NCT02187510|Milking|milking
330741|NCT02187510|Delayed clamping|delayed clamping
330742|NCT02187471|pain|pain
330743|NCT02187471|fibromyalgia|fibromyalgia
330744|NCT02187445|Sickle Cell Disease|sickle cell disease
330745|NCT02187445|Budesonide inhalation suspension|budesonide inhalation suspension
330746|NCT02187445|Acute Chest Syndrome|acute chest syndrome
330747|NCT02187419|Sleep|sleep
330748|NCT02187419|Menopause|menopause
330749|NCT02187419|Hypnosis|hypnosis
330750|NCT02187419|Relaxation|relaxation
330751|NCT02187419|Hypnotic Relaxation Therapy|hypnotic relaxation therapy
330752|NCT02187419|Hot Flash|hot flash
330754|NCT02187406|tennis|tennis
330755|NCT02187406|warm-up exercise|warm-up exercise
330756|NCT02187393|Epithelial cell function of cells from individuals with various genotypes|epithelial cell function of cells from individuals with various genotypes
330757|NCT02187302|nanopharmaceutical,|nanopharmaceutical,
330758|NCT02187289|NCSG|ncsg
330759|NCT02187289|Compression bandages|compression bandages
330760|NCT02187289|devices|devices
330761|NCT02187289|Night time compression|night time compression
330762|NCT02187289|Breast cancer treatment side effects|breast cancer treatment side effects
330763|NCT02187289|Compression therapy|compression therapy
330764|NCT02187289|Reid Sleeve|reid sleeve
330765|NCT02187289|Comprefit|comprefit
330766|NCT02187289|Medassist|medassist
330767|NCT02187289|Tribute|tribute
330768|NCT02187289|Comprilan|comprilan
330769|NCT02187276|Predictive factors of response|predictive factors of response
330770|NCT02187276|mild and moderate|mild and moderate
330771|NCT02187276|Alzheimer disease|alzheimer disease
330772|NCT02187276|mixed dementia|mixed dementia
330773|NCT02187276|APOE|apoe
330774|NCT02187276|polymorphisms of CYP 2D6|polymorphisms of cyp 2d6
330775|NCT02187263|hereditary cardiomyopathy,|hereditary cardiomyopathy,
330776|NCT02187263|inflammatory cardiomyopathy,|inflammatory cardiomyopathy,
330777|NCT02187263|registry,|registry,
330778|NCT02187263|biomaterial,|biomaterial,
330779|NCT02187263|clinical trial|clinical trial
330780|NCT02187263|Patients|patients
330781|NCT02187250|PCOS|pcos
330782|NCT02187250|PDE-4 inhibitor|pde-4 inhibitor
330783|NCT02187250|roflumilast|roflumilast
330784|NCT02187250|liraglutide|liraglutide
330785|NCT02187250|metformin|metformin
330786|NCT02187250|obesity|obesity
330787|NCT02187224|Alcohol Dependence|alcohol dependence
330788|NCT02187224|Post-Traumatic stress disorder (PTSD)|post-traumatic stress disorder (ptsd)
330789|NCT02187224|Progesterone|progesterone
330790|NCT02187211|Alcohol Dependence|alcohol dependence
330791|NCT02187211|Minocycline|minocycline
330792|NCT02187198|Opioid Dependence|opioid dependence
330793|NCT02187198|Buprenorphine|buprenorphine
330794|NCT02187185|Inflammatory biomarkers|inflammatory biomarkers
330795|NCT02187185|Periodontitis|periodontitis
330796|NCT02187172|Psoriasis|psoriasis
330797|NCT02187172|Cardiovascular Disease|cardiovascular disease
330798|NCT02187172|Vascular Inflammation|vascular inflammation
330799|NCT02187172|Lipid Biomarkers|lipid biomarkers
330800|NCT02187172|FDG-PET/CT|fdg-pet/ct
330801|NCT02187159|pain|pain
330802|NCT02187159|fibromyalgia|fibromyalgia
330803|NCT02187146|Vitamin D|vitamin d
330804|NCT02187146|Infertility|infertility
330805|NCT02187146|IVF|ivf
330806|NCT02187146|ART|art
330807|NCT02187133|Relapsed|relapsed
330808|NCT02187133|Refractory|refractory
330809|NCT02187120|Wounds and Injuries|wounds and injuries
330810|NCT02187120|Acute Coagulopathy|acute coagulopathy
330811|NCT02187120|Tranexamic Acid|tranexamic acid
330812|NCT02187120|Emergency Medical Services|emergency medical services
330813|NCT02187107|HIV|hiv
330814|NCT02187107|AIDS|aids
330815|NCT02187107|TMC114|tmc114
330816|NCT02187107|Ritonavir|ritonavir
330817|NCT02187107|Norvir|norvir
330818|NCT02187107|Darunavir|darunavir
330819|NCT02187081|HCC|hcc
330820|NCT02187081|RFA|rfa
330821|NCT02187081|Sorafenib|sorafenib
330822|NCT02187081|Tumor recurrence|tumor recurrence
330823|NCT02187081|Overall survival|overall survival
330824|NCT02187068|Anaesthetics iv|anaesthetics iv
330825|NCT02187068|Dexmedetomidine|dexmedetomidine
330826|NCT02187068|Pharmacokinetic|pharmacokinetic
330827|NCT02187042|sunitinib|sunitinib
330828|NCT02187042|call center|call center
330829|NCT02187042|management of patients|management of patients
330830|NCT02187042|nurses|nurses
330831|NCT02187042|metastatic renal carcinoma|metastatic renal carcinoma
330832|NCT02187029|Hyperuricemia|hyperuricemia
330833|NCT02187029|gout|gout
330834|NCT02187029|serum uric acid|serum uric acid
330835|NCT02187016|Gingivitis|gingivitis
330836|NCT02187016|plaque|plaque
330837|NCT02187016|interproximal cleaning|interproximal cleaning
330838|NCT02187016|dental floss|dental floss
330839|NCT02187003|Sickle Cell Anemia|sickle cell anemia
330840|NCT02187003|Sickle Cell Disease|sickle cell disease
330841|NCT02187003|Sickle Cell Disorders|sickle cell disorders
330842|NCT02187003|pain crisis|pain crisis
330843|NCT02187003|vaso-occlusive crisis|vaso-occlusive crisis
330844|NCT02187003|rivipansel|rivipansel
330845|NCT02187003|GMI-1070|gmi-1070
330846|NCT02187003|selectin inhibitor|selectin inhibitor
330847|NCT02187003|SCD|scd
330848|NCT02187003|VOC|voc
330849|NCT02186977|immunogenicity|immunogenicity
330850|NCT02186977|safety|safety
330851|NCT02186977|proof of concept|proof of concept
330852|NCT02186951|ventilator-associated pneumonia|ventilator-associated pneumonia
330853|NCT02186951|cardiac arrests with shockable rhythm|cardiac arrests with shockable rhythm
330854|NCT02186951|Mild therapeutic hypothermia|mild therapeutic hypothermia
330855|NCT02186951|preventive antibiotics|preventive antibiotics
330856|NCT02186938|head and neck cancer|head and neck cancer
330857|NCT02186938|patients requiring a free flap surgery|patients requiring a free flap surgery
330858|NCT02186925|Kidney Cancer|kidney cancer
330859|NCT02186925|Prostate Cancer|prostate cancer
330860|NCT02186925|Bladder Cancer|bladder cancer
330861|NCT02186912|edentulous|edentulous
330862|NCT02186912|Nobel Active|nobel active
330863|NCT02186912|Nobel Procera|nobel procera
330864|NCT02186912|IBO|ibo
330865|NCT02186912|CAD/CAM|cad/cam
330866|NCT02186886|Ulcerative Colitis|ulcerative colitis
330867|NCT02186886|Golimumab|golimumab
330868|NCT02186886|Physiological Intermolecular Modification Spectroscopy|physiological intermolecular modification spectroscopy
330869|NCT02186886|PIMS|pims
330870|NCT02186873|Ankylosing Spondylitis|ankylosing spondylitis
330871|NCT02186873|Golimumab|golimumab
330872|NCT02186873|SIMPONI|simponi
330873|NCT02186834|Relapsed|relapsed
330874|NCT02186834|Refractory|refractory
330875|NCT02186834|Myeloma|myeloma
330876|NCT02186821|hematological malignancy|hematological malignancy
330877|NCT02186821|solid tumor malignancy|solid tumor malignancy
330878|NCT02186821|mutation|mutation
330879|NCT02186821|translocation|translocation
330880|NCT02186821|rearrangement|rearrangement
330881|NCT02186821|amplification|amplification
330882|NCT02186821|ALK|alk
330883|NCT02186821|ROS1|ros1
330884|NCT02186821|NSCLC|nsclc
330885|NCT02186821|B-cell lymphoma|b-cell lymphoma
330886|NCT02186795|Arthroplasty|arthroplasty
330887|NCT02186795|Replacement, Hip|replacement, hip
330888|NCT02186782|Clomiphene citrate|clomiphene citrate
330889|NCT02186782|Estradiol|estradiol
330890|NCT02186782|Endometrial thickness|endometrial thickness
330891|NCT02186756|Fibromyalgia|fibromyalgia
330892|NCT02186756|Complementary Therapies|complementary therapies
330893|NCT02186756|Biofeedback|biofeedback
330894|NCT02186756|Randomized controlled trial|randomized controlled trial
330895|NCT02186756|Relaxation Therapy|relaxation therapy
330896|NCT02186743|Irritable Bowel Syndrome|irritable bowel syndrome
330898|NCT02186743|Diet|diet
330899|NCT02186743|Food sensitivity|food sensitivity
330900|NCT02186730|Computerised Cognitive Behaviour Therapy|computerised cognitive behaviour therapy
330901|NCT02186730|Adolescents|adolescents
330902|NCT02186730|Depression|depression
330903|NCT02186730|Low Mood|low mood
330904|NCT02186704|Atrial Fibrillation|atrial fibrillation
330905|NCT02186704|Implantable Defibrillators|implantable defibrillators
330906|NCT02186704|Implanted Electrodes|implanted electrodes
330907|NCT02186691|pulmonary valve replacement|pulmonary valve replacement
330908|NCT02186691|tetralogy of Fallot|tetralogy of fallot
330909|NCT02186652|obese|obese
330910|NCT02186652|children|children
330911|NCT02186652|adolescents|adolescents
330912|NCT02186652|GERD|gerd
330913|NCT02186652|pharmacokinetic|pharmacokinetic
330914|NCT02186639|exhaled breath|exhaled breath
330915|NCT02186639|volatile organic compounds (VOCs)|volatile organic compounds (vocs)
330916|NCT02186639|SESI-MS|sesi-ms
330917|NCT02186626|West Nile Virus, vaccine|west nile virus, vaccine
330918|NCT02186613|Breast Feeding|breast feeding
330919|NCT02186613|Telephone|telephone
330920|NCT02186613|Education|education
330921|NCT02186613|Primary Health Care|primary health care
330922|NCT02186600|Low bone mass|low bone mass
330923|NCT02186600|Post-menopausal women|post-menopausal women
330924|NCT02186600|Bone mineral density|bone mineral density
330925|NCT02186600|Bone structure|bone structure
330926|NCT02186600|Bone turnover|bone turnover
330927|NCT02186600|Bone-loading exercises|bone-loading exercises
330928|NCT02186600|calcium and vitamin D|calcium and vitamin d
330929|NCT02186600|risedronate|risedronate
330930|NCT02186574|Non-Hodgkin|non-hodgkin
330931|NCT02186574|Lymphoma|lymphoma
330932|NCT02186574|Hepatitis B|hepatitis b
330933|NCT02186574|Tenofovir|tenofovir
330934|NCT02186574|Viread|viread
330935|NCT02186561|Intracranial aneurysm|intracranial aneurysm
330936|NCT02186561|brain aneurysm|brain aneurysm
330937|NCT02186522|Sepsis|sepsis
330938|NCT02186522|Septic shock|septic shock
330939|NCT02186522|Critical care|critical care
330940|NCT02186522|Immune dysfunction|immune dysfunction
330941|NCT02186522|Inflammatory markers|inflammatory markers
330942|NCT02186522|Neutrophil|neutrophil
330943|NCT02186522|Monocyte|monocyte
330944|NCT02186522|Tregs|tregs
330945|NCT02186470|Breast Cancer|breast cancer
330946|NCT02186470|Early Stage Breast Cancer|early stage breast cancer
330947|NCT02186470|Hormone responsive breast cancer|hormone responsive breast cancer
330948|NCT02186457|Pancreatoduodenectomy|pancreatoduodenectomy
330949|NCT02186457|Whipple|whipple
768233|NCT00374192|Anxiety|anxiety
330950|NCT02186444|newly diagnosed prostate cancer|newly diagnosed prostate cancer
330951|NCT02186444|prostate|prostate
330952|NCT02186431|Contact lenses|contact lenses
330953|NCT02186418|sickle cell disease|sickle cell disease
330954|NCT02186418|sickle cell anemia|sickle cell anemia
330955|NCT02186418|hemoglobinopathies|hemoglobinopathies
330956|NCT02186418|hematopoietic stem cell|hematopoietic stem cell
330957|NCT02186418|gene transfer|gene transfer
330958|NCT02186418|gene therapy|gene therapy
330959|NCT02186392|Depression|depression
330960|NCT02186392|Anxiety|anxiety
330961|NCT02186392|Stroke|stroke
330962|NCT02186392|Cerebral Infarction|cerebral infarction
330963|NCT02186392|Sleep disorders|sleep disorders
330964|NCT02186392|Circadian Rhythm disorders|circadian rhythm disorders
330965|NCT02186392|Circadian Light|circadian light
330966|NCT02186392|Light therapy|light therapy
330967|NCT02186392|Melatonin|melatonin
330968|NCT02186392|Sleep|sleep
330969|NCT02186392|Sleep apnea|sleep apnea
330970|NCT02186392|Coagulation disturbances|coagulation disturbances
330971|NCT02186392|Bone metabolism|bone metabolism
330972|NCT02186392|Rehabilitation|rehabilitation
330973|NCT02186392|Mood disorders|mood disorders
330974|NCT02186392|Mental disorders|mental disorders
330975|NCT02186392|Neurologic Manifestations|neurologic manifestations
330976|NCT02186392|Signs and Symptoms Cerebrovascular Disorders|signs and symptoms cerebrovascular disorders
330977|NCT02186392|Brain Diseases|brain diseases
330978|NCT02186392|Vascular Disease|vascular disease
330979|NCT02186392|Brain Infarction|brain infarction
330980|NCT02186392|Brain Ischemia|brain ischemia
330981|NCT02186379|Obesity|obesity
330982|NCT02186379|Obesity Prevention|obesity prevention
330983|NCT02186379|Childhood obesity prevention|childhood obesity prevention
330984|NCT02186379|Rapid Eating Style|rapid eating style
330985|NCT02186366|Anxiety Disorders, Massage Therapy, Treatment Efficacy|anxiety disorders, massage therapy, treatment efficacy
330986|NCT02186353|Whole grains|whole grains
330987|NCT02186353|Food processing|food processing
330988|NCT02186353|Cardiometabolic risk factors|cardiometabolic risk factors
330989|NCT02186327|Integrative Health Coaching|integrative health coaching
330990|NCT02186314|atrial fibrillation, heart failure, pacemaker|atrial fibrillation, heart failure, pacemaker
330991|NCT02186301|cancer|cancer
330992|NCT02186301|metastatic|metastatic
330993|NCT02186301|locally advanced|locally advanced
330994|NCT02186301|lung|lung
330995|NCT02186301|non-small cell lung cancer|non-small cell lung cancer
330996|NCT02186301|NSCLC|nsclc
330997|NCT02186301|epidermal growth factor receptor|epidermal growth factor receptor
330998|NCT02186301|EGFR|egfr
330999|NCT02186301|T790M|t790m
331000|NCT02186301|CO-1686|co-1686
331001|NCT02186301|unresectable|unresectable
331002|NCT02186301|recurrent|recurrent
331003|NCT02186301|EGFR-directed therapy|egfr-directed therapy
331004|NCT02186301|irreversible EGFR inhibitor|irreversible egfr inhibitor
331005|NCT02186301|TIGER|tiger
331006|NCT02186301|rociletinib|rociletinib
331007|NCT02186288|Critical Care|critical care
331008|NCT02186288|High-flow nasal cannula oxygen|high-flow nasal cannula oxygen
331009|NCT02186288|Electrical impedance tomography|electrical impedance tomography
331010|NCT02186288|End expiratory lung volume|end expiratory lung volume
331011|NCT02186288|End expiratory lung impedance|end expiratory lung impedance
331012|NCT02186288|Diaphragmatic ultrasound|diaphragmatic ultrasound
331013|NCT02186275|Crohn|crohn
331014|NCT02186275|vitamin D|vitamin d
331015|NCT02186275|remission|remission
331016|NCT02186275|inflammation|inflammation
331017|NCT02186275|tolerance|tolerance
331018|NCT02186262|Glioma|glioma
331019|NCT02186262|MRI|mri
331020|NCT02186262|Rotating frame relaxation|rotating frame relaxation
331021|NCT02186262|DWI|dwi
331022|NCT02186262|treatment response|treatment response
331023|NCT02186236|Detection of Oncogenic Tumor Mutations|detection of oncogenic tumor mutations
331024|NCT02186236|blood|blood
331025|NCT02186236|urine|urine
331026|NCT02186236|14-114|14-114
331027|NCT02186223|Pulmonary Embolism|pulmonary embolism
331028|NCT02186223|PE|pe
331029|NCT02186223|DVT|dvt
331030|NCT02186223|Deep Vein Thrombosis|deep vein thrombosis
331031|NCT02186223|VTE|vte
331032|NCT02186223|Venous Thromboembolism|venous thromboembolism
331033|NCT02186223|prophylaxis|prophylaxis
331034|NCT02186223|thromboprophylaxis|thromboprophylaxis
331035|NCT02186223|contraindications to thromboprophylaxis|contraindications to thromboprophylaxis
331036|NCT02186223|prophylactic|prophylactic
331037|NCT02186223|prevention|prevention
331038|NCT02186223|Inferior vena cava filter|inferior vena cava filter
331039|NCT02186223|IVC filter|ivc filter
331040|NCT02186223|filter|filter
331041|NCT02186223|prevention of pulmonary embolism|prevention of pulmonary embolism
331042|NCT02186223|trauma|trauma
331043|NCT02186223|critically-ill|critically-ill
331044|NCT02186210|microcirculation|microcirculation
331045|NCT02186210|off-pump coronary artery bypass surgery|off-pump coronary artery bypass surgery
331046|NCT02186210|tissue oxygen saturation|tissue oxygen saturation
331047|NCT02186210|vascular occlusion test|vascular occlusion test
423091|NCT01765283|CN,|cn,
331048|NCT02186210|recovery slope|recovery slope
331049|NCT02186197|Volume Responsiveness|volume responsiveness
331050|NCT02186184|Myopia progression|myopia progression
331051|NCT02186184|Orthokeratology|orthokeratology
331052|NCT02186171|Osteoporosis in men|osteoporosis in men
331053|NCT02186158|Pneumonia|pneumonia
331054|NCT02186158|Elderly|elderly
331055|NCT02186158|Ascorbic acid|ascorbic acid
331056|NCT02186158|Vitamin C|vitamin c
331057|NCT02186158|Hospitalized patient|hospitalized patient
331058|NCT02186132|heart rate|heart rate
331059|NCT02186132|neostigmine|neostigmine
331060|NCT02186132|atropine|atropine
331061|NCT02186132|dosage|dosage
331062|NCT02186093|Coronary Artery Disease|coronary artery disease
331063|NCT02186093|Angina, Stable|angina, stable
331064|NCT02186093|Fractional Flow Reserve, Myocardial|fractional flow reserve, myocardial
331065|NCT02186093|Coronary Angiography|coronary angiography
331066|NCT02186080|diabetes mellitus|diabetes mellitus
331067|NCT02186080|metabolic endotoxemia|metabolic endotoxemia
331068|NCT02186080|gemigliptin|gemigliptin
331069|NCT02186080|DPP-4 inhibitor|dpp-4 inhibitor
331070|NCT02186067|Hypertension|hypertension
331071|NCT02186067|Uncontrolled Hypertension|uncontrolled hypertension
331072|NCT02186054|Abdominal-Pelvic MRI (magnetic resonance image)|abdominal-pelvic mri (magnetic resonance image)
331073|NCT02186054|T2W (T2 weighted)|t2w (t2 weighted)
331074|NCT02186054|FSE Flex (recently developed MRI pulse sequence)|fse flex (recently developed mri pulse sequence)
331075|NCT02186054|Enhanced single shot FSE (fast spin echo).|enhanced single shot fse (fast spin echo).
331076|NCT02186028|oral daily supplementation with vitamin D for 6 months|oral daily supplementation with vitamin d for 6 months
331077|NCT02186015|Metastatic Breast Cancer|metastatic breast cancer
331078|NCT02186015|MBC|mbc
331079|NCT02186015|Vitamin D Supplementation|vitamin d supplementation
331080|NCT02186015|Symptom Management|symptom management
331081|NCT02186002|ACT-451840|act-451840
331082|NCT02186002|Safety|safety
331083|NCT02186002|Tolerability|tolerability
331084|NCT02186002|Pharmacokinetics|pharmacokinetics
331085|NCT02185989|Critical Illness/*rehabilitation|critical illness/*rehabilitation
331086|NCT02185989|Humans|humans
331087|NCT02185989|*Intensive Care Units|*intensive care units
331088|NCT02185989|Muscle Weakness/diagnosis/*etiology/physiopathology/prevention & control|muscle weakness/diagnosis/*etiology/physiopathology/prevention & control
331089|NCT02185989|Polyneuropathies/diagnosis/*etiology/physiopathology|polyneuropathies/diagnosis/*etiology/physiopathology
331090|NCT02185976|preoperative anxiety|preoperative anxiety
331091|NCT02185976|paediatric patients|paediatric patients
331092|NCT02185976|Cartoon|cartoon
331093|NCT02185963|Diabetes|diabetes
331094|NCT02185963|Dyslipidemia|dyslipidemia
331095|NCT02185963|HDL function|hdl function
331096|NCT02185963|Cholesterol efflux|cholesterol efflux
331097|NCT02185963|MCA assay|mca assay
331098|NCT02185963|MCP-1|mcp-1
331099|NCT02185950|Burn|burn
331100|NCT02185950|Skin graft|skin graft
331101|NCT02185950|Elasticity|elasticity
331102|NCT02185950|Skin|skin
331103|NCT02185950|Physical therapy modalities|physical therapy modalities
331104|NCT02185937|imatinib|imatinib
331105|NCT02185937|gastrectomy|gastrectomy
331106|NCT02185937|gastrointestinal stromal tumor|gastrointestinal stromal tumor
331107|NCT02185937|pharmacokinetics|pharmacokinetics
331108|NCT02185924|PARECOXIB|parecoxib
331109|NCT02185924|CONTINUOUS FEMORAL BLOCK|continuous femoral block
331110|NCT02185911|chronic kidney disease,|chronic kidney disease,
331111|NCT02185911|anaemia correction/maintenance,|anaemia correction/maintenance,
331112|NCT02185911|non dialysis,|non dialysis,
331113|NCT02185898|electronic cigarettes|electronic cigarettes
331114|NCT02185898|e-cigarettes|e-cigarettes
331115|NCT02185898|combustible cigarettes|combustible cigarettes
331116|NCT02185898|second-hand smoke|second-hand smoke
331117|NCT02185898|environmental tobacco smoke|environmental tobacco smoke
331118|NCT02185898|tobacco-burning|tobacco-burning
331119|NCT02185885|Ischemic stroke|ischemic stroke
331120|NCT02185885|Embolic stroke|embolic stroke
331121|NCT02185885|Postoperative Cognitive Dysfunction|postoperative cognitive dysfunction
331122|NCT02185885|Cardiac Bypass Surgery|cardiac bypass surgery
331123|NCT02185885|Cardiac Anaesthesia|cardiac anaesthesia
331124|NCT02185872|Exercise|exercise
331125|NCT02185872|Physical Fitness|physical fitness
331126|NCT02185872|Body Composition, Beneficial|body composition, beneficial
331127|NCT02185859|Lidocaine|lidocaine
331128|NCT02185859|Magnesium|magnesium
331129|NCT02185859|Mastectomy|mastectomy
331130|NCT02185859|Functional Recovery|functional recovery
331131|NCT02185846|Fed condition|fed condition
331132|NCT02185833|Fasting condition|fasting condition
331133|NCT02185820|Multiple myeloma|multiple myeloma
331134|NCT02185820|Relapsed and/or refractory|relapsed and/or refractory
331135|NCT02185820|CPD|cpd
331136|NCT02185807|cataract|cataract
331137|NCT02185807|surgery|surgery
331138|NCT02185807|consent process|consent process
331139|NCT02185807|video-assisted|video-assisted
331140|NCT02185794|HCV genotype 1 (GT-1)|hcv genotype 1 (gt-1)
331141|NCT02185794|HCV genotype 2 (GT-2)|hcv genotype 2 (gt-2)
331142|NCT02185794|HCV genotype 3 (GT-3)|hcv genotype 3 (gt-3)
331143|NCT02185794|HCV genotype 4 (GT-4)|hcv genotype 4 (gt-4)
331144|NCT02185794|HCV|hcv
331145|NCT02185794|Sustained Virologic Response|sustained virologic response
331146|NCT02185794|Direct Acting Antiviral|direct acting antiviral
331147|NCT02185794|Combination Therapy|combination therapy
331148|NCT02185794|Open Label|open label
331149|NCT02185794|Hepatitis|hepatitis
331150|NCT02185794|Hepatitis, Chronic|hepatitis, chronic
331151|NCT02185794|Hepatitis C|hepatitis c
331152|NCT02185794|Hepatitis C, Chronic|hepatitis c, chronic
331153|NCT02185794|Liver Diseases|liver diseases
331154|NCT02185794|Digestive System Diseases|digestive system diseases
331155|NCT02185794|Hepatitis, Viral, Human|hepatitis, viral, human
331156|NCT02185794|Virus Diseases|virus diseases
331157|NCT02185794|Enterovirus Infections|enterovirus infections
331158|NCT02185794|Picornaviridae Infections|picornaviridae infections
331159|NCT02185794|RNA Virus Infections|rna virus infections
331160|NCT02185794|Flaviviridae Infections|flaviviridae infections
331161|NCT02185794|Antiviral Agents|antiviral agents
331162|NCT02185794|Anti-Infective Agents|anti-infective agents
331163|NCT02185794|Therapeutic Uses|therapeutic uses
331164|NCT02185794|Pharmacologic Actions|pharmacologic actions
331165|NCT02185794|Antimetabolites|antimetabolites
331166|NCT02185794|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action
331167|NCT02185781|Phase I|phase i
331168|NCT02185781|Adoptive immunotherapy|adoptive immunotherapy
331169|NCT02185781|Enriched and expanded autologous natural killer (NK) cells|enriched and expanded autologous natural killer (nk) cells
331170|NCT02185781|Ph+ acute lymphoblastic leukemia|ph+ acute lymphoblastic leukemia
331171|NCT02185781|≥60 years|≥60 years
331172|NCT02185781|Not eligible for other post-CHR treatment modalities|not eligible for other post-chr treatment modalities
331173|NCT02185768|Liver cancer|liver cancer
331174|NCT02185755|Internet-Based Glucose Monitoring System|internet-based glucose monitoring system
331175|NCT02185755|Type 2 Diabetes|type 2 diabetes
331176|NCT02185742|HIV|hiv
331177|NCT02185742|jail|jail
331178|NCT02185742|detainee|detainee
331179|NCT02185742|Linkage and Retention|linkage and retention
331180|NCT02185742|Treatment as Prevention|treatment as prevention
331181|NCT02185742|Strength Based Case Management|strength based case management
331182|NCT02185742|releases|releases
331183|NCT02185729|Intravenous Feeding|intravenous feeding
331184|NCT02185729|Lipid Emulsions, Intravenous|lipid emulsions, intravenous
331185|NCT02185716|Transversus abdominis plane block|transversus abdominis plane block
331186|NCT02185716|levobupivacaine|levobupivacaine
331187|NCT02185690|Lung cancer|lung cancer
331188|NCT02185690|Non small cell lung cancer|non small cell lung cancer
331189|NCT02185690|non squamous|non squamous
331190|NCT02185690|pemetrexed|pemetrexed
331191|NCT02185690|carboplatin|carboplatin
331192|NCT02185690|binimetinib|binimetinib
331193|NCT02185690|chemotherapy|chemotherapy
331194|NCT02185690|combination chemotherapy|combination chemotherapy
331195|NCT02185690|Phase 1|phase 1
331196|NCT02185690|Princess Margaret Cancer Centre|princess margaret cancer centre
331197|NCT02185690|carcinoma|carcinoma
331198|NCT02185677|dysexecutive syndrome|dysexecutive syndrome
331199|NCT02185677|multiple system atrophy|multiple system atrophy
331200|NCT02185677|imaging study|imaging study
331201|NCT02185664|internal jugular vein|internal jugular vein
331202|NCT02185664|landmark|landmark
331203|NCT02185664|ultrasound|ultrasound
331204|NCT02185664|static|static
331205|NCT02185664|cardiac surgery|cardiac surgery
331206|NCT02185651|Pompe Disease|pompe disease
331207|NCT02185651|Enzyme Replacement Therapy|enzyme replacement therapy
331208|NCT02185651|Infusion Associated Reaction|infusion associated reaction
331209|NCT02185638|obesity|obesity
331210|NCT02185638|herbal bioactive compounds|herbal bioactive compounds
331211|NCT02185638|appetite|appetite
331212|NCT02185638|GLP-1|glp-1
331213|NCT02185638|ghrelin|ghrelin
331214|NCT02185638|CCK|cck
331215|NCT02185599|colposcopy|colposcopy
331216|NCT02185599|CIN|cin
331217|NCT02185599|cervical neoplasia|cervical neoplasia
331218|NCT02185599|cervical dysplasia|cervical dysplasia
331219|NCT02185599|cervical cancer|cervical cancer
331220|NCT02185599|CIN2+|cin2+
331221|NCT02185573|Bulk fill|bulk fill
331222|NCT02185573|SonicFill|sonicfill
331223|NCT02185573|resin composite application|resin composite application
331224|NCT02185573|class II restoration|class ii restoration
331225|NCT02185560|Sorafenib|sorafenib
331226|NCT02185560|Differentiated Thyroid Carcinoma,|differentiated thyroid carcinoma,
331227|NCT02185560|Japan|japan
331228|NCT02185560|Post Marketing Surveillance|post marketing surveillance
331229|NCT02185560|Drug Use Investigation|drug use investigation
331230|NCT02185547|women|women
331231|NCT02185534|Clopidogrel, Zyllt, Plavix, Phase I, Healthy Subjects, Pharmacokinetics, Bioequivalence|clopidogrel, zyllt, plavix, phase i, healthy subjects, pharmacokinetics, bioequivalence
331232|NCT02185521|Hemodynamics|hemodynamics
331233|NCT02185521|Medical Informatics|medical informatics
331234|NCT02185508|IONM|ionm
331235|NCT02185508|Lumbar Disk Disease|lumbar disk disease
331236|NCT02185508|Degenerative Spine Disease|degenerative spine disease
331237|NCT02185508|Radiculopathy|radiculopathy
331238|NCT02185508|Intraoperative Neurophysiological Monitoring|intraoperative neurophysiological monitoring
331239|NCT02185508|Somatosensory Evoked Potentials|somatosensory evoked potentials
331240|NCT02185508|Electromyography|electromyography
331241|NCT02185482|Psychological counselling|psychological counselling
331242|NCT02185482|Randomized single blind study|randomized single blind study
331243|NCT02185482|Depression|depression
331244|NCT02185482|Diabetes|diabetes
331245|NCT02185469|Corneal Endothelial Cell Loss|corneal endothelial cell loss
331246|NCT02185469|pneumatic retinopexy|pneumatic retinopexy
331247|NCT02185469|vitrectomy|vitrectomy
331248|NCT02185443|SBRT|sbrt
331249|NCT02185443|radiation|radiation
331250|NCT02185443|Neoplasm Metastasis|neoplasm metastasis
331251|NCT02185443|Colorectal Neoplasms|colorectal neoplasms
331252|NCT02185443|Anal Canal|anal canal
331253|NCT02185443|Neuroendocrine Tumors|neuroendocrine tumors
331254|NCT02185417|Hypertension|hypertension
331255|NCT02185417|Diuretic|diuretic
331256|NCT02185417|Comparative Effectiveness Research|comparative effectiveness research
331257|NCT02185417|Point of Care Research|point of care research
331258|NCT02185391|Coronary Disease|coronary disease
331259|NCT02185391|Audience Response System|audience response system
331260|NCT02185365|T1-rho MRI|t1-rho mri
331261|NCT02185365|dGEMRIC MRI|dgemric mri
331263|NCT02185365|Developmental dysplasia of the hip|developmental dysplasia of the hip
331264|NCT02185352|Bevacizumab|bevacizumab
331265|NCT02185352|Brain Metastases|brain metastases
331266|NCT02185352|Breast Cancer|breast cancer
331267|NCT02185352|Chemotherapy|chemotherapy
331268|NCT02185352|Whole Brain Radiotherapy|whole brain radiotherapy
331269|NCT02185339|Respiratory mechanics|respiratory mechanics
331270|NCT02185339|Respiratory function test|respiratory function test
331271|NCT02185339|Hemodynamics|hemodynamics
331272|NCT02185326|Poor responders|poor responders
331273|NCT02185326|Poor ovarian response|poor ovarian response
331274|NCT02185326|IVF/ICSI|ivf/icsi
331275|NCT02185326|Microflare protocol|microflare protocol
331276|NCT02185326|Growth hormone|growth hormone
331277|NCT02185326|Oral contraceptive pills|oral contraceptive pills
331278|NCT02185300|GSK1349572|gsk1349572
331279|NCT02185300|granule|granule
331280|NCT02185300|pediatric|pediatric
331281|NCT02185300|CONTREX mineral water|contrex mineral water
331282|NCT02185300|free-acid|free-acid
331283|NCT02185300|chelating|chelating
331284|NCT02185300|cations|cations
331285|NCT02185300|divalent|divalent
331286|NCT02185300|dolutegravir|dolutegravir
331287|NCT02185300|dispersible tablet|dispersible tablet
331288|NCT02185300|relative bioavailability|relative bioavailability
331289|NCT02185274|Transsexualism|transsexualism
331290|NCT02185274|Cross-sex hormone treatment|cross-sex hormone treatment
331291|NCT02185274|Sex hormones|sex hormones
331292|NCT02185274|Mood|mood
331293|NCT02185274|Stress|stress
331294|NCT02185274|Cortisol|cortisol
331295|NCT02185274|Cardiovascular|cardiovascular
331296|NCT02185274|Metabolome|metabolome
331297|NCT02185261|Relapse|relapse
331298|NCT02185261|Minimal residual disease|minimal residual disease
331299|NCT02185261|Graft-versus-host disease|graft-versus-host disease
331300|NCT02185261|Acute leukemia|acute leukemia
331301|NCT02185261|Interferon Alfa-2b|interferon alfa-2b
331302|NCT02185248|Pediatric Obesity|pediatric obesity
331303|NCT02185248|Body Mass Index|body mass index
331304|NCT02185248|Weight Perception|weight perception
331305|NCT02185248|Counseling|counseling
331306|NCT02185248|Health Behavior|health behavior
331307|NCT02185235|Electrical stimulation|electrical stimulation
331308|NCT02185235|Biofeedback|biofeedback
331309|NCT02185222|Vitamin D|vitamin d
331310|NCT02185222|Cholecalciferol|cholecalciferol
331311|NCT02185222|25-hydroxyvitamin D|25-hydroxyvitamin d
331312|NCT02185222|Memory complaint|memory complaint
331313|NCT02185222|Subjective memory complaint|subjective memory complaint
331314|NCT02185222|Mild cognitive impairment|mild cognitive impairment
331315|NCT02185222|Preventive therapy|preventive therapy
331316|NCT02185222|Cognitive disorders|cognitive disorders
331317|NCT02185196|Vitamin D,|vitamin d,
331318|NCT02185196|Severe pneumonia,|severe pneumonia,
331319|NCT02185196|Under-five children,|under-five children,
331320|NCT02185196|Randomised|randomised
331321|NCT02185196|Controlled|controlled
331322|NCT02185196|Trial (RCT)|trial (rct)
331323|NCT02185196|Morbidity|morbidity
331324|NCT02185170|Prostate|prostate
331325|NCT02185170|Cancer|cancer
331326|NCT02185170|Medical Device|medical device
331327|NCT02185170|Fluorescence|fluorescence
331328|NCT02185157|elderly|elderly
331329|NCT02185157|dual-task training|dual-task training
331330|NCT02185157|aerobic training|aerobic training
331331|NCT02185157|gait|gait
331332|NCT02185157|cognition|cognition
331333|NCT02185144|HIV, mental health, substance abuse|hiv, mental health, substance abuse
331334|NCT02185131|Major Depressive Disorder|major depressive disorder
331335|NCT02185131|Alcohol Use Disorder|alcohol use disorder
331336|NCT02185092|exacerbations|exacerbations
331337|NCT02185092|COPD|copd
331338|NCT02185092|pneumonia|pneumonia
331339|NCT02185092|probiotic|probiotic
331340|NCT02185079|labor|labor
331341|NCT02185079|epidural|epidural
331342|NCT02185040|Lupus, Systemic Lupus, SLE|lupus, systemic lupus, sle
331343|NCT02185027|Oral anticoagulants|oral anticoagulants
331344|NCT02185027|Surgery|surgery
331345|NCT02185027|Haemorrhage|haemorrhage
331346|NCT02185027|Emergency|emergency
331347|NCT02185014|Crohn's Disease|crohn's disease
331348|NCT02185001|Medial patellofemoral ligament|medial patellofemoral ligament
331349|NCT02185001|MPFL|mpfl
331350|NCT02185001|Repair|repair
331351|NCT02185001|Patellar dislocation|patellar dislocation
331352|NCT02185001|Knee|knee
331353|NCT02184988|Glabellar Lines|glabellar lines
331354|NCT02184988|Botulinum purifies neurotoxin, Type A (DWP-450)|botulinum purifies neurotoxin, type a (dwp-450)
331355|NCT02184975|cold knife conization|cold knife conization
331356|NCT02184975|lateral hemostatic sutures|lateral hemostatic sutures
331357|NCT02184975|cervix|cervix
331359|NCT02184949|Coronary angioplasty|coronary angioplasty
331360|NCT02184949|Percutaneous transluminal coronary angioplasty|percutaneous transluminal coronary angioplasty
331361|NCT02184949|PTCA|ptca
331362|NCT02184936|CT Angiography, CT Perfusion, Ischemic Stroke, Collaterals|ct angiography, ct perfusion, ischemic stroke, collaterals
331363|NCT02184910|atrophic gastritis, pepsinogen, Helicobacter pylori|atrophic gastritis, pepsinogen, helicobacter pylori
331364|NCT02184884|off-pump coronary artery bypass surgery, clopidogrel responsiveness, ischemic outcome|off-pump coronary artery bypass surgery, clopidogrel responsiveness, ischemic outcome
331365|NCT02184871|intrahepatic cholangiocarcinoma|intrahepatic cholangiocarcinoma
331366|NCT02184871|RNAseq|rnaseq
331367|NCT02184871|risk factors|risk factors
331368|NCT02184871|asbestos|asbestos
331369|NCT02184845|single tooth implant|single tooth implant
331370|NCT02184845|supported restoration(s)|supported restoration(s)
331371|NCT02184845|maxillary lateral incisor|maxillary lateral incisor
331372|NCT02184845|mandibular central incisor|mandibular central incisor
331373|NCT02184845|lateral incisor|lateral incisor
331374|NCT02184845|areas of the mouth|areas of the mouth
331375|NCT02184819|coronary artery bypass graft|coronary artery bypass graft
331376|NCT02184819|left ventricular dysfunction|left ventricular dysfunction
331377|NCT02184819|low cardiac output syndrome|low cardiac output syndrome
331378|NCT02184819|levosimendan|levosimendan
331379|NCT02184819|mortality|mortality
331380|NCT02184819|inotropic agents|inotropic agents
331381|NCT02184819|cardiac mechanical assist devices|cardiac mechanical assist devices
331382|NCT02184819|renal replacement therapy|renal replacement therapy
331383|NCT02184819|mechanical ventilation duration|mechanical ventilation duration
331384|NCT02184819|ICU stay|icu stay
331385|NCT02184806|Ovarian tissue transplantation|ovarian tissue transplantation
331386|NCT02184806|Cryopreserved ovarian tissue|cryopreserved ovarian tissue
331387|NCT02184793|mechanical ventilation|mechanical ventilation
331388|NCT02184793|semirecumbent position|semirecumbent position
331389|NCT02184793|electronic monitoring device|electronic monitoring device
331390|NCT02184780|Neurodevelopment|neurodevelopment
331391|NCT02184780|General Anaesthesia|general anaesthesia
331392|NCT02184780|Infants|infants
331393|NCT02184780|Epidural|epidural
331394|NCT02184780|Spinal|spinal
331395|NCT02184780|Anxiety and depression|anxiety and depression
331396|NCT02184754|Magnetic endoscope imaging|magnetic endoscope imaging
331397|NCT02184754|single-balloon-enteroscopy|single-balloon-enteroscopy
331398|NCT02184741|IVIG|ivig
331399|NCT02184741|Unexplained Recurrent miscarriage|unexplained recurrent miscarriage
331400|NCT02184741|Recurrent abortion|recurrent abortion
331401|NCT02184741|Intravenous immunoglobulin|intravenous immunoglobulin
331402|NCT02184728|end-tidal CO2|end-tidal co2
331403|NCT02184728|capnometer|capnometer
331404|NCT02184715|virtual reality system, children, developmental delay|virtual reality system, children, developmental delay
331405|NCT02184676|Type 1 diabetes|type 1 diabetes
331406|NCT02184676|risk assessment|risk assessment
331407|NCT02184676|immunological marker|immunological marker
331408|NCT02184676|children|children
331409|NCT02184676|relatives|relatives
331410|NCT02184676|autoantibodies|autoantibodies
331411|NCT02184676|lymphocytes|lymphocytes
331412|NCT02184676|T cells|t cells
331413|NCT02184676|epitopes|epitopes
331414|NCT02184676|Children born to mother/father with type 1 diabetes and their parents|children born to mother/father with type 1 diabetes and their parents
331415|NCT02184663|Unresectable|unresectable
331416|NCT02184663|Pancreatic cancer|pancreatic cancer
331417|NCT02184663|GERCOR|gercor
331418|NCT02184663|Adapted physical activity (APA)|adapted physical activity (apa)
331419|NCT02184663|Quality of life|quality of life
331420|NCT02184663|Fatigue|fatigue
331421|NCT02184650|Premature infants|premature infants
331422|NCT02184650|Nutritional status|nutritional status
331423|NCT02184650|Polyunsaturated fatty acids status|polyunsaturated fatty acids status
331424|NCT02184637|Malaria|malaria
331425|NCT02184637|Artemisinin-based Combination Therapies (ACT)|artemisinin-based combination therapies (act)
331426|NCT02184624|BREEZHALER|breezhaler
331427|NCT02184624|DISKUS/ACCUHALER|diskus/accuhaler
331428|NCT02184624|MDI|mdi
331429|NCT02184624|Inhaler preference|inhaler preference
331430|NCT02184624|Overall inhaler error|overall inhaler error
331431|NCT02184624|HANDIHALER|handihaler
331432|NCT02184624|Ease of use|ease of use
331433|NCT02184624|TURBUHALER|turbuhaler
331434|NCT02184624|ELLIPTA|ellipta
331435|NCT02184624|Critical inhaler error|critical inhaler error
331436|NCT02184611|lung function|lung function
331437|NCT02184611|Umeclidinium|umeclidinium
331438|NCT02184611|GSK573719|gsk573719
331439|NCT02184611|anticholinergic|anticholinergic
331440|NCT02184611|novel dry powder inhaler|novel dry powder inhaler
331441|NCT02184611|long-acting muscarinic receptor antagonist|long-acting muscarinic receptor antagonist
331442|NCT02184611|Chronic Obstructive Pulmonary Disease|chronic obstructive pulmonary disease
331443|NCT02184598|ADHD|adhd
331444|NCT02184598|Cognitive training|cognitive training
331445|NCT02184598|fMRI|fmri
331446|NCT02184598|Cognitive function|cognitive function
331447|NCT02184585|bioavailability|bioavailability
331448|NCT02184585|crossover design|crossover design
331449|NCT02184585|healthy male volunteers|healthy male volunteers
331450|NCT02184585|tamsulosin hydrochloride|tamsulosin hydrochloride
331451|NCT02184585|Dutasteride|dutasteride
331452|NCT02184572|Rubella|rubella
331453|NCT02184572|Healthy children|healthy children
331454|NCT02184572|Measles|measles
331455|NCT02184572|Safety|safety
331456|NCT02184572|Mumps|mumps
331457|NCT02184572|12 to 15 months|12 to 15 months
331458|NCT02184572|Immunogenicity|immunogenicity
331459|NCT02184507|insulin resistance|insulin resistance
331460|NCT02184507|blood glucose|blood glucose
331461|NCT02184507|CABG|cabg
331462|NCT02184507|oxidative stress|oxidative stress
331463|NCT02184494|Parkinson's Disease|parkinson's disease
331464|NCT02184494|Multiple Sclerosis|multiple sclerosis
331465|NCT02184494|Fatigue|fatigue
331466|NCT02184494|Resting Energy Expenditure|resting energy expenditure
331467|NCT02184494|Whole Body Vibration|whole body vibration
331468|NCT02184494|Exercise|exercise
331469|NCT02184494|Blood Lactate|blood lactate
331470|NCT02184481|Depression|depression
331471|NCT02184481|Anxiety|anxiety
331472|NCT02184481|Working memory|working memory
331473|NCT02184481|Rumination|rumination
331474|NCT02184481|Cognitive training|cognitive training
331475|NCT02184481|Executive functioning|executive functioning
331476|NCT02184468|Cardiac Arrest|cardiac arrest
331477|NCT02184468|Out-of-Hospital Cardiac Arrest|out-of-hospital cardiac arrest
331478|NCT02184468|Firefighters|firefighters
331479|NCT02184468|Police|police
331480|NCT02184468|Defibrillators|defibrillators
331481|NCT02184468|Survival|survival
331482|NCT02184455|Diabetic|diabetic
331483|NCT02184455|Chronic Ulcer|chronic ulcer
331484|NCT02184455|Wound Healing|wound healing
331485|NCT02184455|Leg|leg
331486|NCT02184442|SAPIEN|sapien
331487|NCT02184442|TAVR|tavr
331488|NCT02184442|THV|thv
331489|NCT02184442|Aortic Stenosis|aortic stenosis
331490|NCT02184442|Heart Valve Disease|heart valve disease
331491|NCT02184442|Aortic Valve|aortic valve
331492|NCT02184442|Retroflex|retroflex
331493|NCT02184442|SAPIEN XT|sapien xt
331494|NCT02184429|First in human|first in human
331495|NCT02184429|single ascending dose study|single ascending dose study
331496|NCT02184429|multiple ascending dose study|multiple ascending dose study
331497|NCT02184429|safety and tolerability|safety and tolerability
331498|NCT02184429|pharmacokinetics|pharmacokinetics
331499|NCT02184429|food effect|food effect
331500|NCT02184429|Parkinson's Disease|parkinson's disease
331501|NCT02184416|Inlyta|inlyta
331502|NCT02184416|axitinib|axitinib
331503|NCT02184416|Sutent|sutent
331504|NCT02184416|sunitinib|sunitinib
331505|NCT02184416|renal|renal
331506|NCT02184390|Internet|internet
331507|NCT02184390|Education|education
331508|NCT02184377|quantitative laryngeal electromyography|quantitative laryngeal electromyography
331509|NCT02184377|cricothyroid muscle|cricothyroid muscle
331510|NCT02184377|unilateral vocal fold paralysis|unilateral vocal fold paralysis
331511|NCT02184377|superior laryngeal nerve|superior laryngeal nerve
331512|NCT02184377|lexical tone|lexical tone
331513|NCT02184377|Mandarin|mandarin
331514|NCT02184221|Deep-brain magnetic stimulation|deep-brain magnetic stimulation
331515|NCT02184221|Brain derived neurotropic factor|brain derived neurotropic factor
331516|NCT02184221|Effectiveness|effectiveness
331517|NCT02184221|Safety|safety
331518|NCT02184208|ARDS|ards
331519|NCT02184208|ALI|ali
331520|NCT02184208|mechanical ventilation|mechanical ventilation
331521|NCT02184195|BRCA, metastatic adenocarcinoma pancreas, maintenance olaparib monotherapy, first line platinum chemotherapy, pancreatic cancer, PARP inhibitor|brca, metastatic adenocarcinoma pancreas, maintenance olaparib monotherapy, first line platinum chemotherapy, pancreatic cancer, parp inhibitor
331522|NCT02184169|hemodynamics|hemodynamics
331523|NCT02184169|neonatal|neonatal
331524|NCT02184169|cardiac disease|cardiac disease
331525|NCT02184169|congenital heart disease|congenital heart disease
331526|NCT02184169|volumetric oxygen consumption|volumetric oxygen consumption
331527|NCT02184117|Fractional Flow Reserve, Myocardial|fractional flow reserve, myocardial
331528|NCT02184117|Adenosine|adenosine
331529|NCT02184117|Contrast Media|contrast media
331530|NCT02184104|caffeine|caffeine
331531|NCT02184104|pharmacokinetics|pharmacokinetics
331532|NCT02184104|pharmacodynamics|pharmacodynamics
331533|NCT02184026|nightmare|nightmare
331534|NCT02184026|PTSD|ptsd
331535|NCT02184026|trauma|trauma
331536|NCT02184026|children|children
331537|NCT02184026|Children Age 8 to 13|children age 8 to 13
331538|NCT02184013|Atrial fibrillation|atrial fibrillation
331539|NCT02184013|Catheter ablation|catheter ablation
331540|NCT02184013|Delayed gadolinium enhanced MRI|delayed gadolinium enhanced mri
331541|NCT02184013|C-metahydroxyepherdrine (HED) PET scan|c-metahydroxyepherdrine (hed) pet scan
331542|NCT02184013|ECGI mapping|ecgi mapping
331543|NCT02184013|Atrial Fibrosis|atrial fibrosis
331544|NCT02184013|Atrial sympathetic denervation|atrial sympathetic denervation
331545|NCT02184000|strain elastography|strain elastography
331546|NCT02184000|hepatopathy|hepatopathy
331547|NCT02184000|liver fibrosis|liver fibrosis
331548|NCT02183987|Knowledge Translation|knowledge translation
331549|NCT02183987|Chronic Kidney Disease|chronic kidney disease
331550|NCT02183987|Dialysis|dialysis
331551|NCT02183987|Intent-to-defer|intent-to-defer
331552|NCT02183987|Early dialysis|early dialysis
331553|NCT02183987|Cluster randomized trial|cluster randomized trial
331554|NCT02183974|otitis media with effusion|otitis media with effusion
331555|NCT02183974|Laryngopharyngeal Reflux|laryngopharyngeal reflux
331556|NCT02183961|otitis media with effusion|otitis media with effusion
331557|NCT02183961|peptest|peptest
331558|NCT02183961|restech|restech
331559|NCT02183961|oropharyngeal pH monitoring|oropharyngeal ph monitoring
331560|NCT02183961|laryngopharyngeal reflux|laryngopharyngeal reflux
331561|NCT02183948|treatment|treatment
331562|NCT02183948|mask face exoressions|mask face exoressions
331563|NCT02183948|genier|genier
331564|NCT02183935|Obesity|obesity
331565|NCT02183935|Diabetes|diabetes
331566|NCT02183935|Metabolic syndrome|metabolic syndrome
331567|NCT02183935|Gut hormones|gut hormones
331568|NCT02183935|Adipokines|adipokines
331569|NCT02183935|Appetite|appetite
331570|NCT02183935|Adolescent|adolescent
331571|NCT02183896|Femoroacetabular impingement (FAI)|femoroacetabular impingement (fai)
331572|NCT02183896|Chondral lesions|chondral lesions
331573|NCT02183896|Hip|hip
331574|NCT02183896|Microfracture|microfracture
331575|NCT02183896|Platelet-rich plasma (PRP)|platelet-rich plasma (prp)
331576|NCT02183883|Non-small cell lung cancer|non-small cell lung cancer
331577|NCT02183883|NSCLC|nsclc
331578|NCT02183883|Afatinib|afatinib
331579|NCT02183883|Intra-tumour heterogeneity|intra-tumour heterogeneity
331580|NCT02183883|Clonal dominance|clonal dominance
331581|NCT02183883|Drug resistance|drug resistance
331582|NCT02183883|EGFR|egfr
331583|NCT02183883|HER2|her2
331584|NCT02183883|Phase 2|phase 2
331585|NCT02183870|lung cancer|lung cancer
331586|NCT02183870|adenocarcinoma|adenocarcinoma
331587|NCT02183870|NSCLC|nsclc
331588|NCT02183870|ROS1|ros1
331589|NCT02183870|ROS1 translocation|ros1 translocation
331590|NCT02183870|crizotinib|crizotinib
331591|NCT02183870|phase II|phase ii
331592|NCT02183857|children|children
331593|NCT02183857|congenital heart disease|congenital heart disease
331594|NCT02183844|Medical Informatics|medical informatics
331595|NCT02183844|Patient-Centered|patient-centered
331596|NCT02183844|Healthcare Preferences|healthcare preferences
331597|NCT02183844|Health Education|health education
331598|NCT02183844|Quality Improvement|quality improvement
331599|NCT02183844|Weight Loss|weight loss
331600|NCT02183844|Personal Satisfaction|personal satisfaction
331601|NCT02183844|Humans|humans
331602|NCT02183844|Cognition|cognition
331603|NCT02183844|Body Weight|body weight
331604|NCT02183818|Smoking|smoking
331605|NCT02183818|COPD|copd
331606|NCT02183818|Non-Smokers|non-smokers
331607|NCT02183818|Smokers|smokers
331608|NCT02183805|triple negative breast cancer|triple negative breast cancer
331609|NCT02183805|autologous hematopoietic stem-cell transplantation|autologous hematopoietic stem-cell transplantation
331610|NCT02183779|post-occlusive hyperaemia|post-occlusive hyperaemia
331611|NCT02183779|laser-speckle contrast imaging|laser-speckle contrast imaging
331612|NCT02183779|epoxyeicosatrienoic acid|epoxyeicosatrienoic acid
331613|NCT02183779|nitrous oxide|nitrous oxide
331614|NCT02183753|LAIV|laiv
331615|NCT02183753|Flumist|flumist
331616|NCT02183753|wood smoke|wood smoke
331617|NCT02183740|Education|education
331618|NCT02183740|Nurses|nurses
331619|NCT02183740|Nursing homes|nursing homes
331620|NCT02183740|Fecal incontinence|fecal incontinence
331621|NCT02183740|Cluster-randomized controlled trial|cluster-randomized controlled trial
331622|NCT02183727|ACL|acl
331623|NCT02183727|knee injury|knee injury
331624|NCT02183727|anterior cruciate ligament|anterior cruciate ligament
331625|NCT02183597|Magnetic Resonance Imaging|magnetic resonance imaging
331626|NCT02183597|Data Accuracy|data accuracy
331627|NCT02183597|Reproducibility of Results|reproducibility of results
331628|NCT02183597|Diagnosis|diagnosis
331629|NCT02183558|PCOS|pcos
331630|NCT02183558|GDM|gdm
331631|NCT02183558|OGTT|ogtt
331632|NCT02183558|Glucose metabolism|glucose metabolism
331633|NCT02183519|Cough|cough
331634|NCT02183519|Reflex|reflex
331635|NCT02183519|Voluntary|voluntary
331636|NCT02183519|Healthy older adults|healthy older adults
331637|NCT02183519|Parkinson's disease|parkinson's disease
331638|NCT02183519|Respiratory kinematics|respiratory kinematics
331639|NCT02183519|Cueing|cueing
331640|NCT02183454|intracoronary stent|intracoronary stent
331641|NCT02183454|drug eluting stent|drug eluting stent
331642|NCT02183454|sirolimus|sirolimus
331643|NCT02183454|endothelial progenitor cells|endothelial progenitor cells
331644|NCT02183272|Depression|depression
331645|NCT02183272|Suicidal Ideation|suicidal ideation
331646|NCT02183272|Ketamine|ketamine
331647|NCT02183272|Emergency Department|emergency department
331648|NCT02183207|percutaneous endoscopic gastrostomy|percutaneous endoscopic gastrostomy
331649|NCT02183207|Introducer method|introducer method
331650|NCT02182999|Hallux valgus surgery|hallux valgus surgery
331651|NCT02182999|wound infiltration|wound infiltration
331652|NCT02182999|pain|pain
331653|NCT02182986|Biomarkers|biomarkers
331654|NCT02182986|Post-Transplant Lymphoproliferative Disorders (PTLDs)|post-transplant lymphoproliferative disorders (ptlds)
331655|NCT02182973|neonatal abstinence syndrome, infant opiate withdrawal|neonatal abstinence syndrome, infant opiate withdrawal
331656|NCT02182947|Pediatric|pediatric
331657|NCT02182947|Inflammatory Bowel Disease|inflammatory bowel disease
331658|NCT02182947|Wirless capsule endoscopy|wirless capsule endoscopy
331659|NCT02182947|MRE|mre
331660|NCT02182947|Crohn's Disease|crohn's disease
331661|NCT02182947|Indeterminant Colitis|indeterminant colitis
331662|NCT02182947|Small bowel Crohn's Disease|small bowel crohn's disease
331663|NCT02182908|Aneurysm of abdominal aorta|aneurysm of abdominal aorta
331664|NCT02182908|18F-fluorodesoxyglucose (FDG-F18)|18f-fluorodesoxyglucose (fdg-f18)
331665|NCT02182843|Cellentra ACDF|cellentra acdf
331666|NCT02182817|General Anaesthesia|general anaesthesia
331667|NCT02182817|Neurocognitive Development|neurocognitive development
331668|NCT02182817|Behaviour|behaviour
331669|NCT02182804|Confocal Laser Endomicroscopy|confocal laser endomicroscopy
331670|NCT02182804|Narrow Band Imaging|narrow band imaging
331671|NCT02182804|Lugol Chromoendoscopy|lugol chromoendoscopy
331672|NCT02182804|Esophageal Neoplasm|esophageal neoplasm
331673|NCT02182804|Head and Neck Cancer|head and neck cancer
331674|NCT02182687|Hepatocellular carcinoma (HCC)|hepatocellular carcinoma (hcc)
331675|NCT02182687|Orthotopic liver transplant|orthotopic liver transplant
331676|NCT02182687|Bridge to transplant|bridge to transplant
331677|NCT02182687|stereotactic body radiation therapy (SBRT)|stereotactic body radiation therapy (sbrt)
331678|NCT02182687|trans-arterial chemoembolization (TACE)|trans-arterial chemoembolization (tace)
331679|NCT02182596|Acute Myeloid Leukemia|acute myeloid leukemia
331680|NCT02182596|First relapsing AML|first relapsing aml
331681|NCT02182466|Colon capsule endoscopy|colon capsule endoscopy
331682|NCT02182466|Colonoscopy|colonoscopy
331683|NCT02182466|Screening colonoscopy|screening colonoscopy
331684|NCT02182440|SA-AKI|sa-aki
331685|NCT02182440|Sepsis|sepsis
331686|NCT02182440|AKI|aki
331687|NCT02182440|Recombinant Alkaline Phosphatase|recombinant alkaline phosphatase
331688|NCT02182440|recAP|recap
331689|NCT02182167|Drug Induced Hepatitis (DIH)|drug induced hepatitis (dih)
331690|NCT02182167|Toxic Liver|toxic liver
331691|NCT02182167|Drug Induced Liver Injury (DILI)|drug induced liver injury (dili)
331692|NCT02182115|Staphylococcus aureus infection|staphylococcus aureus infection
331693|NCT02182115|Decolonization|decolonization
331694|NCT02182115|Surgical site infection|surgical site infection
331695|NCT02181894|Infant|infant
331696|NCT02181894|Newborn|newborn
331697|NCT02181894|Neonate|neonate
331698|NCT02181894|Intubation|intubation
331699|NCT02181894|Neonatal resuscitation|neonatal resuscitation
331700|NCT02181842|Pharmacological therapy|pharmacological therapy
331701|NCT02181829|Whole Lung IMRT|whole lung imrt
331702|NCT02181829|14-075|14-075
331703|NCT02181816|Pharmacological therapy|pharmacological therapy
331704|NCT02181790|psoriasis|psoriasis
331705|NCT02181790|palmoplantar|palmoplantar
331706|NCT02181790|acitretin|acitretin
331707|NCT02181790|retinoids|retinoids
331708|NCT02181790|laser treatment|laser treatment
331709|NCT02181777|Psychosis|psychosis
331710|NCT02181777|Schizophrenia|schizophrenia
331711|NCT02181777|Social Skills|social skills
331712|NCT02181777|Therapy|therapy
331713|NCT02181764|XLH|xlh
331714|NCT02181751|Child Sexual Abuse|child sexual abuse
331715|NCT02181751|CSA|csa
331716|NCT02181751|Treatment|treatment
331717|NCT02181751|Prevention|prevention
331718|NCT02181751|PTSD|ptsd
331719|NCT02181751|Post Traumatic Stress Disorder|post traumatic stress disorder
331720|NCT02181751|Depression|depression
331721|NCT02181751|Anxiety|anxiety
331722|NCT02181751|Quality of Life|quality of life
331723|NCT02181751|Attachment|attachment
331724|NCT02181751|Cognitive Behavioural Therapy|cognitive behavioural therapy
331725|NCT02181751|Group Therapy|group therapy
331726|NCT02181725|Chronic Pain|chronic pain
331727|NCT02181725|Adolescent|adolescent
331728|NCT02181725|Graded Exposure|graded exposure
331729|NCT02181712|Bronchiolitis obliterans|bronchiolitis obliterans
331730|NCT02181712|lung transplant|lung transplant
331731|NCT02181712|mesenchymal stem cell|mesenchymal stem cell
331732|NCT02181712|cell therapy|cell therapy
331733|NCT02181686|Heart Failure|heart failure
331734|NCT02181686|Iperia ICD family|iperia icd family
331735|NCT02181686|Sentus QP left ventricular lead|sentus qp left ventricular lead
331736|NCT02181686|Quadripolar CRT-D system|quadripolar crt-d system
331737|NCT02181673|Psoriatic arthritis|psoriatic arthritis
331738|NCT02181673|Golimumab|golimumab
331739|NCT02181673|Simponi|simponi
331740|NCT02181660|AML|aml
331741|NCT02181660|Acute myeloid leukemia|acute myeloid leukemia
331742|NCT02181660|Gilteritinib|gilteritinib
331743|NCT02181660|ASP2215|asp2215
331744|NCT02181634|Advanced Cholangiocarcinoma|advanced cholangiocarcinoma
331745|NCT02181634|Metastatic Cholangiocarcinoma|metastatic cholangiocarcinoma
331746|NCT02181634|CCA|cca
331747|NCT02181634|Bile Duct Cancer|bile duct cancer
331748|NCT02181634|Nab-Paclitaxel|nab-paclitaxel
331749|NCT02181634|Abraxane®|abraxane®
331750|NCT02181634|Gemcitabine|gemcitabine
331751|NCT02181634|Gemzar®|gemzar®
331752|NCT02181608|Alcohol Dependence|alcohol dependence
331753|NCT02181608|Fear Conditioning|fear conditioning
331754|NCT02181608|Stress|stress
331755|NCT02181608|Alcohol|alcohol
331756|NCT02181595|Reading|reading
331757|NCT02181595|FACIT-SP|facit-sp
331758|NCT02181595|Primary Ovarian Insufficiency|primary ovarian insufficiency
331759|NCT02181582|Health Humans|health humans
331760|NCT02181582|Receptor Occupancy|receptor occupancy
331761|NCT02181569|Addiction Severity Index|addiction severity index
331762|NCT02181569|Addiction|addiction
331763|NCT02181569|Sleep Measures|sleep measures
331764|NCT02181569|Sleep Disorders|sleep disorders
331765|NCT02181556|colorectal cancer|colorectal cancer
331766|NCT02181556|Metastatic|metastatic
331767|NCT02181543|Clonidine|clonidine
331768|NCT02181543|Psychomotor agitation|psychomotor agitation
331769|NCT02181543|Anesthesia recovery period|anesthesia recovery period
331770|NCT02181543|Tonsillectomy|tonsillectomy
331771|NCT02181543|Child, preschool|child, preschool
331772|NCT02181478|Total Body Irradiation|total body irradiation
331773|NCT02181478|Human Mesenchymal Stromal Cells|human mesenchymal stromal cells
331774|NCT02181478|hMSC|hmsc
331775|NCT02181478|Cyclophosphamide|cyclophosphamide
331776|NCT02181478|Fludarabine|fludarabine
331777|NCT02181478|Dimethyl Sulfoxide|dimethyl sulfoxide
331778|NCT02181478|DMSO|dmso
331779|NCT02181478|Cyclosporine|cyclosporine
331780|NCT02181478|Mycophenolate Mofetil|mycophenolate mofetil
331781|NCT02181478|MMF|mmf
331782|NCT02181478|Granulocyte- Colony Stimulating Factor|granulocyte- colony stimulating factor
331783|NCT02181478|G-CSF|g-csf
331784|NCT02181478|GVHD|gvhd
331785|NCT02181478|Cancer|cancer
331786|NCT02181478|feasibility|feasibility
331787|NCT02181452|liver|liver
331788|NCT02181452|fibrosis|fibrosis
331789|NCT02181452|ShearWave Elastography|shearwave elastography
331790|NCT02181452|ultrasound|ultrasound
331791|NCT02181426|Knee Arthroscopy|knee arthroscopy
331792|NCT02181413|Drug therapy|drug therapy
331793|NCT02181413|Ixazomib citrate|ixazomib citrate
331794|NCT02181400|diabetic retinopathy|diabetic retinopathy
331795|NCT02181400|diabetic macular edema|diabetic macular edema
331796|NCT02181400|diabetic macular oedema|diabetic macular oedema
331797|NCT02181400|near infrared light therapy|near infrared light therapy
331798|NCT02181387|labor pain|labor pain
331799|NCT02181387|acetaminophen|acetaminophen
331800|NCT02181374|atrial fibrillation|atrial fibrillation
331801|NCT02181374|NT-proBNP|nt-probnp
331802|NCT02181374|Cardioembolic Stroke|cardioembolic stroke
331803|NCT02181361|atrial fibrillation|atrial fibrillation
331804|NCT02181361|cardioembolic stroke|cardioembolic stroke
331805|NCT02181361|Hirudin|hirudin
331806|NCT02181361|aspirin|aspirin
331807|NCT02181361|warfarin|warfarin
331808|NCT02181348|Vitamin E, Hemoglobin, mild anemia|vitamin e, hemoglobin, mild anemia
331809|NCT02181296|Shoulder arthroscopy|shoulder arthroscopy
331810|NCT02181296|Interscalene block|interscalene block
331811|NCT02181296|Drug concentration|drug concentration
331812|NCT02181296|0.1% ropivacaine or 0.2% ropivacaine|0.1% ropivacaine or 0.2% ropivacaine
331813|NCT02181283|alcohol|alcohol
331814|NCT02181283|prescribed drugs|prescribed drugs
331815|NCT02181283|National Guard|national guard
331816|NCT02181270|NAFLD|nafld
331817|NCT02181270|obesity|obesity
331818|NCT02181270|ck18|ck18
331819|NCT02181270|blood lipids|blood lipids
331820|NCT02181270|high intensity exercise training|high intensity exercise training
331821|NCT02181270|individuals|individuals
331822|NCT02181270|>5% liver fat|>5% liver fat
331823|NCT02181257|Bronchiolitis Obliterans Syndrome|bronchiolitis obliterans syndrome
331824|NCT02181257|Lung Transplantation|lung transplantation
331825|NCT02181257|Extracorporeal Photopheresis|extracorporeal photopheresis
331826|NCT02181257|Methoxsalen|methoxsalen
331827|NCT02181244|egg|egg
331828|NCT02181244|oatmeal|oatmeal
331829|NCT02181244|atherogenic dyslipidemia|atherogenic dyslipidemia
331830|NCT02181244|glycosylated hemoglobin|glycosylated hemoglobin
331831|NCT02181244|inflammatory markers|inflammatory markers
331832|NCT02181231|depression|depression
331833|NCT02181231|older adult|older adult
331834|NCT02181231|buprenorphine|buprenorphine
331835|NCT02181231|Effexor XR|effexor xr
331836|NCT02181231|treatment resistant|treatment resistant
331837|NCT02181231|venlafaxine|venlafaxine
331838|NCT02181231|Saint Louis|saint louis
331839|NCT02181231|late life|late life
331840|NCT02181231|major depression|major depression
331841|NCT02181192|biochemical recurrence|biochemical recurrence
331842|NCT02181192|prostate carcinoma|prostate carcinoma
331843|NCT02181192|prostate cancer|prostate cancer
331844|NCT02181192|PSA|psa
331845|NCT02181192|postoperative|postoperative
331846|NCT02181192|radiotherapy|radiotherapy
331847|NCT02181192|imaging diagnostic|imaging diagnostic
331848|NCT02181192|PET/CT|pet/ct
331849|NCT02181192|social economic aspects|social economic aspects
331850|NCT02181192|quality of life|quality of life
331851|NCT02181179|yoga|yoga
331852|NCT02181179|exercise intervention|exercise intervention
331853|NCT02181179|smoking|smoking
331854|NCT02181179|stress|stress
331855|NCT02181179|mind-body|mind-body
331856|NCT02181179|intervention|intervention
331857|NCT02181166|Breast Neoplasms|breast neoplasms
331858|NCT02181166|Mastectomy|mastectomy
331859|NCT02181166|Myofascial pain syndromes|myofascial pain syndromes
331860|NCT02181166|Physical Therapy Modalities|physical therapy modalities
331861|NCT02181153|inflammatory bowel disease|inflammatory bowel disease
331862|NCT02181153|siblings|siblings
331863|NCT02181140|fine needle aspiration|fine needle aspiration
331864|NCT02181140|core biopsy|core biopsy
331865|NCT02181140|endoscopic ultrasound|endoscopic ultrasound
331866|NCT02181140|space occupying process mediastinal, perigastral, perihilar|space occupying process mediastinal, perigastral, perihilar
331867|NCT02181140|suspect lymph nodes mediastinal, perigastral or perihilar|suspect lymph nodes mediastinal, perigastral or perihilar
331868|NCT02181140|diagnostic accuracy of EUS guided core biopsy|diagnostic accuracy of eus guided core biopsy
331869|NCT02181127|bionic pancreas|bionic pancreas
331870|NCT02181127|artificial pancreas|artificial pancreas
331871|NCT02181127|insulin|insulin
331872|NCT02181127|glucagon|glucagon
331873|NCT02181127|continuous glucose monitoring (CGM)|continuous glucose monitoring (cgm)
331874|NCT02181127|outpatient|outpatient
331875|NCT02181127|insulin pump|insulin pump
331876|NCT02181127|glucagon pump|glucagon pump
331877|NCT02181114|Coaching|coaching
331878|NCT02181114|Educational Materials|educational materials
331879|NCT02181114|Expert System|expert system
331880|NCT02181114|Living Donor Kidney Transplant|living donor kidney transplant
331881|NCT02181088|Malaria|malaria
331882|NCT02181088|Plasmodium falciparum|plasmodium falciparum
331883|NCT02181088|RH5|rh5
331884|NCT02181075|ThermoDox|thermodox
331885|NCT02181075|High Intensity Focused Ultrasound|high intensity focused ultrasound
331886|NCT02181075|Lyso thermosensitive Liposomal|lyso thermosensitive liposomal
331887|NCT02181075|Non invasive drug delivery|non invasive drug delivery
331888|NCT02181075|Hepatic metastatic disease|hepatic metastatic disease
331889|NCT02181075|Liver tumour(s)|liver tumour(s)
331890|NCT02181075|Targeted Release of Chemotherapy|targeted release of chemotherapy
331891|NCT02181062|Stroke|stroke
331892|NCT02181062|Stroke prevention|stroke prevention
331893|NCT02181062|older adults|older adults
331894|NCT02181062|self efficacy|self efficacy
331895|NCT02181062|walking|walking
331896|NCT02181062|minorities|minorities
331897|NCT02181062|minority older adults|minority older adults
331898|NCT02181062|hypertension|hypertension
331899|NCT02181062|high blood pressure|high blood pressure
331900|NCT02181062|elderly|elderly
331901|NCT02181062|sedentary lifestyle|sedentary lifestyle
331902|NCT02181049|Childhood cancer survivors|childhood cancer survivors
331903|NCT02181049|Cardiac|cardiac
331904|NCT02181049|Vascular|vascular
331905|NCT02181049|Cardiovascular|cardiovascular
331906|NCT02181049|Late-sequelae|late-sequelae
331907|NCT02181036|Family work shop|family work shop
331908|NCT02181036|speech developmental delays|speech developmental delays
331909|NCT02181036|children|children
331910|NCT02181023|COPD|copd
331911|NCT02181023|Hyperinflation|hyperinflation
331912|NCT02181023|Aclidinium|aclidinium
331913|NCT02181023|Glycopyrronium|glycopyrronium
331914|NCT02181023|Volume distribution|volume distribution
331915|NCT02181023|Anticholinergic|anticholinergic
331916|NCT02181023|Pharmacokinetics|pharmacokinetics
331917|NCT02181023|Single Breath Nitrogen Test|single breath nitrogen test
331918|NCT02181023|Phase III|phase iii
331919|NCT02181010|African American|african american
331920|NCT02181010|Adolescents|adolescents
331921|NCT02181010|Urban|urban
331922|NCT02181010|Food Desert|food desert
331923|NCT02181010|Food Insecurity|food insecurity
331924|NCT02181010|Obesity|obesity
331925|NCT02181010|Baltimore City|baltimore city
331926|NCT02181010|Peer mentors|peer mentors
331927|NCT02181010|Multi level|multi level
331928|NCT02181010|Policy|policy
331929|NCT02181010|Caregivers|caregivers
331930|NCT02181010|Systems|systems
331931|NCT02181010|Agent Based Model|agent based model
331932|NCT02181010|Systems Dynamic Model|systems dynamic model
331933|NCT02181010|Corner Store|corner store
331934|NCT02181010|Carryout|carryout
331935|NCT02181010|Recreation Center|recreation center
331936|NCT02181010|Text Messaging|text messaging
331937|NCT02181010|Social Media|social media
331938|NCT02181010|Mapping|mapping
331939|NCT02180997|α1-blockers|α1-blockers
331940|NCT02180997|antimuscarinic agent|antimuscarinic agent
331941|NCT02180984|Binge Eating|binge eating
331942|NCT02180984|Obesity|obesity
331943|NCT02180984|TMS|tms
331944|NCT02180984|Neuroimage|neuroimage
331945|NCT02180984|Neuromodulation|neuromodulation
331946|NCT02180984|Biomarkers|biomarkers
331947|NCT02180984|Eating Disorders|eating disorders
331948|NCT02180984|Cognition|cognition
331949|NCT02180984|Endocrine|endocrine
331950|NCT02180984|Hormones|hormones
331951|NCT02180984|BDNF|bdnf
331952|NCT02180984|Inflammatory biomarkers|inflammatory biomarkers
331953|NCT02180971|Multi-detector computed tomography angiography|multi-detector computed tomography angiography
331954|NCT02180971|Coronary vessel distensibility|coronary vessel distensibility
331955|NCT02180971|Coronary spasm|coronary spasm
331956|NCT02180958|cerebral arteriovenous malformations|cerebral arteriovenous malformations
331957|NCT02180958|cAVM|cavm
331958|NCT02180958|ONYX|onyx
331959|NCT02180945|dAVF|davf
331960|NCT02180945|Arteriovenous fistula|arteriovenous fistula
331961|NCT02180945|ONYX|onyx
331962|NCT02180919|Telemonitoring|telemonitoring
331963|NCT02180919|COPD|copd
331964|NCT02180919|Heart failure|heart failure
331965|NCT02180919|Exacerbation|exacerbation
331966|NCT02180919|Respiratory failure|respiratory failure
331967|NCT02180919|Prevention|prevention
331968|NCT02180919|Self monitoring|self monitoring
331969|NCT02180906|Fasciitis|fasciitis
331970|NCT02180906|Gangrene|gangrene
331971|NCT02180906|Fasciitis, Necrotizing|fasciitis, necrotizing
331972|NCT02180906|Soft Tissue Infections|soft tissue infections
331973|NCT02180906|Fournier's Gangrene|fournier's gangrene
331974|NCT02180906|Streptococcal septic shock syndrome|streptococcal septic shock syndrome
331975|NCT02180906|Flesh eating bacteria|flesh eating bacteria
331976|NCT02180906|Meleneys ulcer|meleneys ulcer
331977|NCT02180906|Wounds and Injuries|wounds and injuries
331978|NCT02180906|Streptococcus pyogenes|streptococcus pyogenes
331979|NCT02180906|Staphylococcus aureus|staphylococcus aureus
331980|NCT02180906|Immunopathogenesis|immunopathogenesis
331981|NCT02180906|Soft Tissue Infections/blood|soft tissue infections/blood
331982|NCT02180906|Necrosis/blood|necrosis/blood
331983|NCT02180906|Necrosis/diagnosis|necrosis/diagnosis
331984|NCT02180906|Necrosis/mortality|necrosis/mortality
331985|NCT02180906|Necrosis/surgery|necrosis/surgery
331986|NCT02180906|Prognosis|prognosis
331987|NCT02180906|Risk Factors|risk factors
331988|NCT02180906|Bacterial Infections|bacterial infections
331989|NCT02180906|Infection|infection
331990|NCT02180906|Skin Diseases, Bacterial|skin diseases, bacterial
331991|NCT02180906|Observational study|observational study
331992|NCT02180906|Biological markers|biological markers
331993|NCT02180880|Neuralgia|neuralgia
331994|NCT02180880|Spinal cord|spinal cord
331995|NCT02180880|Oxcarbazepine|oxcarbazepine
331996|NCT02180880|Pregabalin|pregabalin
331997|NCT02180880|Drug therapy|drug therapy
331998|NCT02180880|Algorithms|algorithms
331999|NCT02180854|Early warning score|early warning score
332000|NCT02180854|Rapid response systems|rapid response systems
332001|NCT02180854|Medical emergency team|medical emergency team
332002|NCT02180841|soy|soy
332003|NCT02180841|hypertension|hypertension
332004|NCT02180841|HDL-C|hdl-c
332005|NCT02180841|cholesterol efflux|cholesterol efflux
332006|NCT02180841|cardiovascular disease|cardiovascular disease
332007|NCT02180815|Obstructive Sleep Apnea|obstructive sleep apnea
332008|NCT02180815|Obstructive Sleep Apnea due to primary tongue base closure|obstructive sleep apnea due to primary tongue base closure
332009|NCT02180815|Minimally invasive surgery|minimally invasive surgery
332010|NCT02180815|ReVENT Sleep Apnea System|revent sleep apnea system
332011|NCT02180815|Tongue implants|tongue implants
332012|NCT02180802|obese adolescents|obese adolescents
332013|NCT02180802|BMI ≥ 95th percentile for age and gender|bmi ≥ 95th percentile for age and gender
332014|NCT02180789|tamsulosin,|tamsulosin,
332015|NCT02180789|benign prostatic hyperplasia,|benign prostatic hyperplasia,
332122|NCT02180243|meditation|meditation
332016|NCT02180789|α1-adrenoceptor antagonists|α1-adrenoceptor antagonists
332017|NCT02180763|Primary Immunodeficiency, PID|primary immunodeficiency, pid
332018|NCT02180750|Children|children
332019|NCT02180750|HIV|hiv
332020|NCT02180750|orphans|orphans
332021|NCT02180737|dexmedetomedine|dexmedetomedine
332022|NCT02180737|sedation|sedation
332023|NCT02180737|interventional radiology|interventional radiology
332024|NCT02180724|Bruton tyrosine kinase inhibitor|bruton tyrosine kinase inhibitor
332025|NCT02180724|Btk|btk
332026|NCT02180724|Waldenström Macroglobulinemia|waldenström macroglobulinemia
332027|NCT02180724|WM|wm
332028|NCT02180724|Waldenström|waldenström
332029|NCT02180724|Macroglobulinemia|macroglobulinemia
332030|NCT02180711|Bruton tyrosine kinase inhibitor|bruton tyrosine kinase inhibitor
332031|NCT02180711|Btk|btk
332032|NCT02180711|Follicular Lymphoma|follicular lymphoma
332033|NCT02180711|FL|fl
332034|NCT02180711|acalabrutinib|acalabrutinib
332035|NCT02180711|ACP-196|acp-196
332036|NCT02180711|MZL|mzl
332037|NCT02180711|Marginal Zone Lymphoma|marginal zone lymphoma
332038|NCT02180672|Obstructive sleep apnea syndrome|obstructive sleep apnea syndrome
332039|NCT02180672|OSA|osa
332040|NCT02180672|sleep apnea|sleep apnea
332041|NCT02180672|nasal steroids|nasal steroids
332042|NCT02180672|corticosteroids|corticosteroids
332043|NCT02180646|GLP-1|glp-1
332044|NCT02180646|GIP|gip
332045|NCT02180646|second meal phenomena|second meal phenomena
332046|NCT02180646|type 2 diabetes|type 2 diabetes
332047|NCT02180633|Idiopathic Macular Hole|idiopathic macular hole
332048|NCT02180620|GIP|gip
332049|NCT02180620|GLP-1|glp-1
332050|NCT02180620|exercise timing|exercise timing
332051|NCT02180620|resistance exercise|resistance exercise
332052|NCT02180620|glucose concentrations|glucose concentrations
332053|NCT02180607|depression|depression
332054|NCT02180607|social|social
332055|NCT02180607|rejection|rejection
332056|NCT02180607|acceptance|acceptance
332057|NCT02180607|fMRI|fmri
332058|NCT02180607|reward|reward
332059|NCT02180607|exclusion|exclusion
332060|NCT02180581|Infections|infections
332061|NCT02180581|Allergy|allergy
332062|NCT02180581|Immune function|immune function
332063|NCT02180581|Microbiota|microbiota
332064|NCT02180581|Infant|infant
332065|NCT02180568|Ground-glass-opacity (GGO)|ground-glass-opacity (ggo)
332066|NCT02180568|Lung localization|lung localization
332067|NCT02180568|Lipiodol|lipiodol
332068|NCT02180568|Hook wire|hook wire
332069|NCT02180568|Video assisted thoracic surgery (VATS)|video assisted thoracic surgery (vats)
332070|NCT02180542|stroke|stroke
332071|NCT02180542|Ischemic stroke|ischemic stroke
332072|NCT02180542|Cerebral infarction|cerebral infarction
332073|NCT02180542|recurrent stroke|recurrent stroke
332074|NCT02180542|atrial fibrillation|atrial fibrillation
332075|NCT02180542|premature atrial complexes|premature atrial complexes
332076|NCT02180542|heart rhythm monitoring|heart rhythm monitoring
332077|NCT02180542|left atrial function|left atrial function
332078|NCT02180542|carotid artery|carotid artery
332079|NCT02180542|plaque morphology|plaque morphology
332080|NCT02180529|methylphenidate, elderly, mild cognitive impairment|methylphenidate, elderly, mild cognitive impairment
332081|NCT02180464|psoriasis, topical|psoriasis, topical
332082|NCT02180438|HIV-2|hiv-2
332083|NCT02180425|acne|acne
332084|NCT02180425|lipid|lipid
332085|NCT02180425|tretinoin|tretinoin
332086|NCT02180425|isotretinoin|isotretinoin
332087|NCT02180412|Acute porphyria|acute porphyria
332088|NCT02180412|Hemin|hemin
332089|NCT02180399|Sepsis|sepsis
332090|NCT02180399|Capillary blood lactate|capillary blood lactate
332091|NCT02180399|Serial measurement of capillary|serial measurement of capillary
332092|NCT02180386|Audiovisual distraction|audiovisual distraction
332093|NCT02180386|Pediatric dentistry|pediatric dentistry
332094|NCT02180360|Capoeira training|capoeira training
332095|NCT02180360|Range of motion|range of motion
332096|NCT02180360|Flexibility|flexibility
332097|NCT02180360|beginners|beginners
332098|NCT02180347|Pediatrics|pediatrics
332099|NCT02180347|Contact lenses|contact lenses
332100|NCT02180334|Gastric Emptying|gastric emptying
332101|NCT02180334|Gastrointestinal Motility|gastrointestinal motility
332102|NCT02180334|Incretins|incretins
332103|NCT02180334|Glucagon-Like Peptide 1|glucagon-like peptide 1
332104|NCT02180334|Diabetes Mellitus|diabetes mellitus
332105|NCT02180321|Tranexamic acid|tranexamic acid
332106|NCT02180321|pharmacokinetics|pharmacokinetics
332107|NCT02180321|craniosynostosis|craniosynostosis
332108|NCT02180308|Head cancer|head cancer
332109|NCT02180308|Neck cancer|neck cancer
332110|NCT02180308|MRI|mri
332111|NCT02180308|PET|pet
332112|NCT02180282|Acne Treatment|acne treatment
332113|NCT02180269|Healthy|healthy
332114|NCT02180269|JNJ-54861911|jnj-54861911
332115|NCT02180269|Alzheimer's disease|alzheimer's disease
332116|NCT02180256|IVF|ivf
332117|NCT02180256|ICSI|icsi
332118|NCT02180256|Embryo transfer|embryo transfer
332119|NCT02180256|Assisted reproduction|assisted reproduction
332120|NCT02180256|Endometrial injury|endometrial injury
332121|NCT02180256|Endometrial scratching|endometrial scratching
332123|NCT02180243|acupuncture|acupuncture
332124|NCT02180243|Gulf War Veterans' Illness|gulf war veterans' illness
332125|NCT02180243|Gulf War health education|gulf war health education
332126|NCT02180243|iRest yoga|irest yoga
332127|NCT02180230|Short implants|short implants
768234|NCT00374192|Sleep|sleep
332128|NCT02180230|prospective multicenter study|prospective multicenter study
332129|NCT02180230|maxilla & mandible|maxilla & mandible
332130|NCT02180217|LCI699|lci699
332131|NCT02180217|Cushing's disease|cushing's disease
332132|NCT02180204|Cerebral Infarction|cerebral infarction
332133|NCT02180204|Ischemic Stroke|ischemic stroke
332134|NCT02180204|Thrombolysis|thrombolysis
332135|NCT02180191|Gut microbiota|gut microbiota
332136|NCT02180178|microvascular disease|microvascular disease
332137|NCT02180178|coronary artery disease|coronary artery disease
332138|NCT02180178|Coronary artery disease, with or without microvascular dysfuntion|coronary artery disease, with or without microvascular dysfuntion
332139|NCT02180152|Perinatal outcomes|perinatal outcomes
332140|NCT02180113|Cirrhotic patients|cirrhotic patients
332141|NCT02180113|Fibroscan|fibroscan
332142|NCT02180113|Liver Stiffness Measurement|liver stiffness measurement
332143|NCT02180113|Oesophageal Varices|oesophageal varices
332144|NCT02180113|Portal Hypertension|portal hypertension
332145|NCT02180113|Spleen Stiffness Measurement|spleen stiffness measurement
332146|NCT02180087|Cardiac surgery|cardiac surgery
332147|NCT02180087|Post-operative pain|post-operative pain
332148|NCT02180087|Kétoprofène|kétoprofène
332149|NCT02180087|Minimum analgesic dose|minimum analgesic dose
332150|NCT02180087|Morphin consumption|morphin consumption
332151|NCT02180087|Morphin secondary effects|morphin secondary effects
332152|NCT02180087|Patient comfort and satisfaction|patient comfort and satisfaction
332153|NCT02180087|Renal fonction|renal fonction
332154|NCT02180074|Hydrogen Sulfide Pools,|hydrogen sulfide pools,
332156|NCT02180061|PD-1|pd-1
332157|NCT02180061|PDL1|pdl1
332158|NCT02180061|PD-L1|pd-l1
332159|NCT02180035|diet therapy|diet therapy
332160|NCT02180035|symbiotic|symbiotic
332161|NCT02180035|dyslipidemia|dyslipidemia
332162|NCT02180035|gastrointestinal symptoms|gastrointestinal symptoms
332163|NCT02180035|body composition|body composition
332164|NCT02180035|adherence|adherence
332165|NCT02180035|HIV|hiv
332166|NCT02180035|HAART|haart
332167|NCT02180022|Quercetin|quercetin
332168|NCT02180022|Endothelial function|endothelial function
332169|NCT02180022|Onion peel extract|onion peel extract
332170|NCT02180022|volunteers|volunteers
332171|NCT02179996|Vaccination|vaccination
332172|NCT02179996|Very preterm-born infants|very preterm-born infants
332173|NCT02179996|Hib immunisation|hib immunisation
332174|NCT02179996|Pertussis immunisation|pertussis immunisation
332175|NCT02179983|Bronchiectasis|bronchiectasis
332176|NCT02179983|rehabilitation|rehabilitation
332177|NCT02179983|exercise|exercise
332178|NCT02179983|exacerbations|exacerbations
332179|NCT02179970|Advanced pancreatic cancer|advanced pancreatic cancer
332180|NCT02179970|Advanced ovarian cancer|advanced ovarian cancer
332181|NCT02179970|Advanced colorectal cancer|advanced colorectal cancer
332182|NCT02179970|Metastatic pancreatic cancer|metastatic pancreatic cancer
332183|NCT02179970|Metastatic ovarian cancer|metastatic ovarian cancer
332184|NCT02179970|Metastatic colorectal cancer|metastatic colorectal cancer
332185|NCT02179957|Stenoses|stenoses
332186|NCT02179957|Ischaemia|ischaemia
332187|NCT02179957|haemodynamics|haemodynamics
332188|NCT02179957|fractional flow reserve (FFR)|fractional flow reserve (ffr)
332189|NCT02179957|computed tomography (CT)|computed tomography (ct)
332190|NCT02179957|cardiac|cardiac
332191|NCT02179944|medication abortion|medication abortion
332192|NCT02179944|serum hCG|serum hcg
332193|NCT02179918|Advanced Solid Tumors|advanced solid tumors
332194|NCT02179905|MRI|mri
332195|NCT02179905|Heart rate variability|heart rate variability
332196|NCT02179905|Fatty acid|fatty acid
332197|NCT02179892|anesthesia|anesthesia
332198|NCT02179892|surgery|surgery
332199|NCT02179892|pain|pain
332200|NCT02179879|labor,epidural,analgesia|labor,epidural,analgesia
332201|NCT02179853|Kawasaki disease|kawasaki disease
332202|NCT02179853|Anakinra|anakinra
332203|NCT02179853|IL-1|il-1
332204|NCT02179840|Cerebral microvascular circulation|cerebral microvascular circulation
332205|NCT02179840|Cerebral autoregulation|cerebral autoregulation
332206|NCT02179814|bulimia nervosa|bulimia nervosa
332207|NCT02179814|dopamine|dopamine
332208|NCT02179814|reward|reward
332209|NCT02179814|catechol-O-methyltransferase|catechol-o-methyltransferase
332210|NCT02179814|gene|gene
332211|NCT02179814|catecholamines|catecholamines
332212|NCT02179814|alpha-methyl-para-tyrosine|alpha-methyl-para-tyrosine
332213|NCT02179814|magnetic resonance imaging|magnetic resonance imaging
332214|NCT02179801|Abdominal aortic aneurysm|abdominal aortic aneurysm
332215|NCT02179801|AAA|aaa
332216|NCT02179801|Screening|screening
332217|NCT02179788|lactation|lactation
332218|NCT02179788|breastfeeding|breastfeeding
332219|NCT02179788|human milk|human milk
332220|NCT02179788|insulin|insulin
332221|NCT02179788|metformin|metformin
332222|NCT02179788|prediabetes|prediabetes
332223|NCT02179788|pre-diabetes|pre-diabetes
332224|NCT02179788|insulin resistance|insulin resistance
332225|NCT02179762|cancer survivor|cancer survivor
332226|NCT02179762|prostate cancer|prostate cancer
332227|NCT02179762|exercise|exercise
332228|NCT02179762|Active surveillance|active surveillance
332229|NCT02179762|EASE|ease
332230|NCT02179749|Alcohol-Related Disorders|alcohol-related disorders
332231|NCT02179749|Substance-Related Disorders|substance-related disorders
332232|NCT02179749|Mental Disorders|mental disorders
332233|NCT02179749|Mifepristone|mifepristone
332234|NCT02179749|Glucocorticoid Antagonists|glucocorticoid antagonists
332235|NCT02179749|Alcohol Treatment|alcohol treatment
332236|NCT02179749|Alcohol|alcohol
332237|NCT02179736|Correction of moderate to severe nasolabial folds|correction of moderate to severe nasolabial folds
332238|NCT02179723|wound healing|wound healing
332239|NCT02179723|cosmetic results|cosmetic results
332240|NCT02179723|trocar incision|trocar incision
332241|NCT02179710|adherence|adherence
332242|NCT02179710|cystic fibrosis|cystic fibrosis
332243|NCT02179710|adolescents|adolescents
332244|NCT02179710|adults|adults
332245|NCT02179697|Groups:|groups:
332246|NCT02179697|Group 1 (2 Treatment Arms (Randomized between 2 treatments))|group 1 (2 treatment arms (randomized between 2 treatments))
332247|NCT02179697|Treatment 1: Surgery + Bracing|treatment 1: surgery + bracing
332248|NCT02179697|Treatment 2: Bracing Alone|treatment 2: bracing alone
332249|NCT02179697|Group 2|group 2
332250|NCT02179697|The patient will decide which group is best for themselves.|the patient will decide which group is best for themselves.
332251|NCT02179684|Cranial Nerve fascial paresis|cranial nerve fascial paresis
332252|NCT02179671|Lung cancer; NSCLC|lung cancer; nsclc
332253|NCT02179658|Clostridium|clostridium
332254|NCT02179658|Infections|infections
332255|NCT02179658|Difficile|difficile
332256|NCT02179658|Vancomycin|vancomycin
332257|NCT02179658|Fidaxomicin|fidaxomicin
332258|NCT02179632|disclosure|disclosure
332259|NCT02179632|conflicts of interest|conflicts of interest
332260|NCT02179632|trust|trust
332261|NCT02179632|patient doctor relationship|patient doctor relationship
332262|NCT02179593|Maxillary expansion|maxillary expansion
332263|NCT02179593|Orthognathic surgery|orthognathic surgery
332264|NCT02179593|Symmetry|symmetry
332265|NCT02179593|Palatal expansion technique|palatal expansion technique
332266|NCT02179593|Maxilla abnormality|maxilla abnormality
332267|NCT02179580|Traditional Chinese Medicine|traditional chinese medicine
332268|NCT02179580|Clinical trial|clinical trial
332269|NCT02179580|Good Clinical Practice|good clinical practice
332270|NCT02179567|Metastatic NSCLC|metastatic nsclc
332271|NCT02179567|Elderly|elderly
332272|NCT02179567|1st Line|1st line
332273|NCT02179567|Bevacizumab-based treatment|bevacizumab-based treatment
332274|NCT02179541|Otitis media with effusion, viscosity, RGB (red-green-blue).|otitis media with effusion, viscosity, rgb (red-green-blue).
332275|NCT02179515|Immune Response|immune response
332276|NCT02179515|Maximum Tolerated Dose|maximum tolerated dose
332277|NCT02179515|Vaccine Therapy|vaccine therapy
332278|NCT02179515|Increased Expression of Brachyury|increased expression of brachyury
332279|NCT02179515|Immunotherapy|immunotherapy
332280|NCT02179489|Peritoneal carcinomatosis|peritoneal carcinomatosis
332281|NCT02179489|HIPEC|hipec
332282|NCT02179489|controlled clinical trial|controlled clinical trial
332283|NCT02179489|colorectal cancer|colorectal cancer
332284|NCT02179476|Facet joint|facet joint
332285|NCT02179476|facet joint pain|facet joint pain
332286|NCT02179476|facet joint disease|facet joint disease
332287|NCT02179476|lumbar pain|lumbar pain
332288|NCT02179476|back pain|back pain
332289|NCT02179463|Gastric Cancer|gastric cancer
332290|NCT02179463|Neoadjuvant chemotherapy|neoadjuvant chemotherapy
332291|NCT02179463|Response Evaluation|response evaluation
332292|NCT02179437|TIVA|tiva
332293|NCT02179437|Propofol|propofol
332294|NCT02179437|Postoperative pain|postoperative pain
332295|NCT02179437|Liver resection surgery|liver resection surgery
332296|NCT02179437|Retrospective study|retrospective study
332297|NCT02179424|smoking cessation interventions|smoking cessation interventions
332298|NCT02179398|Fever without source|fever without source
332299|NCT02179398|Antibiotic prescription|antibiotic prescription
332300|NCT02179398|Serious bacterial infection|serious bacterial infection
332301|NCT02179385|Type 2 diabetes|type 2 diabetes
332302|NCT02179385|Type II diabetes|type ii diabetes
332303|NCT02179359|Stem Cell Transplant|stem cell transplant
332304|NCT02179346|cartilage defect|cartilage defect
332305|NCT02179346|hip|hip
332306|NCT02179346|impingement|impingement
332307|NCT02179320|Myofascial Pain Syndrome|myofascial pain syndrome
332308|NCT02179320|Dry needling|dry needling
332309|NCT02179320|Clinical Trial|clinical trial
332310|NCT02179307|muscle hypertrophy|muscle hypertrophy
332311|NCT02179307|strength|strength
332312|NCT02179307|resistance training|resistance training
332313|NCT02179307|exercise|exercise
332314|NCT02179307|physical fitness|physical fitness
332315|NCT02179307|health|health
332316|NCT02179307|physical conditioning|physical conditioning
332317|NCT02179294|Pain relief|pain relief
332318|NCT02179294|Labour|labour
332319|NCT02179294|Child birth|child birth
332320|NCT02179294|Anaesthetics|anaesthetics
332321|NCT02179268|Antidepressants|antidepressants
332322|NCT02179268|bone mineral density|bone mineral density
768235|NCT00374192|Lunesta|lunesta
332323|NCT02179268|bone turnover markers|bone turnover markers
332324|NCT02179255|DOR|dor
332325|NCT02179255|Premature Ovarian Failure (POF)|premature ovarian failure (pof)
332326|NCT02179255|Ovarian Failure|ovarian failure
332327|NCT02179255|Human Growth Hormone|human growth hormone
332328|NCT02179242|cardiac rehab|cardiac rehab
332329|NCT02179242|heart failure|heart failure
332330|NCT02179242|KCCQ|kccq
332331|NCT02179242|6 minute walk test|6 minute walk test
332332|NCT02179242|readmission|readmission
332333|NCT02179229|Kidney transplantation|kidney transplantation
332334|NCT02179229|pCresol|pcresol
332335|NCT02179229|Immunosuppressant drugs|immunosuppressant drugs
332336|NCT02179216|Orthostatic hypotension in the elderly|orthostatic hypotension in the elderly
332337|NCT02179216|Efficacity of Hydration|efficacity of hydration
332338|NCT02179216|Difference between hydratation and venous contention|difference between hydratation and venous contention
332339|NCT02179177|Vaso-occlusive crisis|vaso-occlusive crisis
332340|NCT02179177|Reduction in hospitalizations|reduction in hospitalizations
332341|NCT02179177|Sickle Cell Disease|sickle cell disease
332342|NCT02179151|Prader-Willi Syndrome|prader-willi syndrome
332343|NCT02179151|Obesity|obesity
332344|NCT02179151|Hyperphagia|hyperphagia
332345|NCT02179125|COPD|copd
332346|NCT02179125|Endobronchial treatment|endobronchial treatment
332347|NCT02179112|Surgery|surgery
332348|NCT02179112|Specialties, Surgical|specialties, surgical
332349|NCT02179112|Geography, Medical|geography, medical
332350|NCT02179112|Developing Countries|developing countries
332351|NCT02179112|Developed Countries|developed countries
332352|NCT02179112|Laparotomy|laparotomy
332353|NCT02179112|Outcome and Process Assessment (Health Care)|outcome and process assessment (health care)
332354|NCT02179112|Treatment Outcome|treatment outcome
332355|NCT02179112|Quality of Health Care|quality of health care
332356|NCT02179099|overactive bladder|overactive bladder
332357|NCT02179099|OAB|oab
332358|NCT02179099|urgency|urgency
332359|NCT02179099|botulinum toxin|botulinum toxin
332360|NCT02179099|BTX|btx
332361|NCT02179099|botox|botox
332362|NCT02179099|intravesical|intravesical
332363|NCT02179099|TheraCoat|theracoat
332364|NCT02179099|TCGel|tcgel
332365|NCT02179099|TC-3 Gel|tc-3 gel
332366|NCT02179060|Sudden cardiac arrest, RhinoChill -cooling, MRI|sudden cardiac arrest, rhinochill -cooling, mri
332367|NCT02179047|SYNTAX ,NGAL,Cystatin C,Galectin-3,Copeptin.MR-ProANP,sST2.|syntax ,ngal,cystatin c,galectin-3,copeptin.mr-proanp,sst2.
332368|NCT02179034|tobacco|tobacco
332369|NCT02179034|electronic cigarettes|electronic cigarettes
332370|NCT02179034|menthol|menthol
332371|NCT02179034|flavors|flavors
332372|NCT02179021|Thromboelastometry|thromboelastometry
332373|NCT02179021|Haemostasis|haemostasis
332374|NCT02179021|Hypothermia|hypothermia
332375|NCT02179021|Heart arrest|heart arrest
332376|NCT02179008|Santen|santen
332377|NCT02179008|Eye|eye
332378|NCT02179008|Glaucoma|glaucoma
332379|NCT02179008|Ocular hypertension|ocular hypertension
332380|NCT02178982|mechanical ventilation|mechanical ventilation
332381|NCT02178982|ARDS|ards
332382|NCT02178982|Ventilator strategy|ventilator strategy
332383|NCT02178982|outcome|outcome
332384|NCT02178943|Molecular Diagnostics|molecular diagnostics
332385|NCT02178943|Heart Transplantation|heart transplantation
332386|NCT02178943|Risk Factors|risk factors
332387|NCT02178943|Prognosis|prognosis
332388|NCT02178930|HIV|hiv
332389|NCT02178930|cardiovascular disease|cardiovascular disease
332390|NCT02178930|self-management|self-management
332391|NCT02178930|HIV co-morbidities|hiv co-morbidities
332392|NCT02178930|self-efficacy|self-efficacy
332393|NCT02178930|coronary heart disease risk|coronary heart disease risk
332394|NCT02178930|quality of life|quality of life
332395|NCT02178904|Ischemia|ischemia
332396|NCT02178904|Dual Energy Computed Tomography|dual energy computed tomography
332397|NCT02178904|Computed Tomographic Perfusion|computed tomographic perfusion
332398|NCT02178904|Fractional Flow Rate|fractional flow rate
332399|NCT02178904|Invasive Coronary Angiography|invasive coronary angiography
332400|NCT02178904|Coronary Artery Stenosis|coronary artery stenosis
332401|NCT02178891|short implants|short implants
332402|NCT02178891|Nobel Biocare|nobel biocare
332403|NCT02178891|partially edentulous|partially edentulous
332404|NCT02178891|maxilla or mandible|maxilla or mandible
332405|NCT02178878|Labor pain and progress, variation, genetic|labor pain and progress, variation, genetic
332406|NCT02178865|translocation|translocation
332407|NCT02178839|Non Alcoholic Fatty Liver Disease(NAFLD)|non alcoholic fatty liver disease(nafld)
332408|NCT02178839|β- glucan|β- glucan
332409|NCT02178839|Appetite|appetite
332410|NCT02178839|Insulin Resistance|insulin resistance
332411|NCT02178826|Nocturnal Enuresis|nocturnal enuresis
332412|NCT02178826|Rapid Maxillary Expansion|rapid maxillary expansion
332413|NCT02178826|Orthodontics|orthodontics
332414|NCT02178826|Polysomnography|polysomnography
332415|NCT02178826|Quality of life|quality of life
332416|NCT02178813|Minocycline|minocycline
332417|NCT02178813|Neuroprotection|neuroprotection
332418|NCT02178813|Stroke|stroke
332419|NCT02178787|cerebral blood flow|cerebral blood flow
332420|NCT02178787|near infrared spectroscopy|near infrared spectroscopy
332421|NCT02178787|transcranial Doppler|transcranial doppler
332422|NCT02178787|diabetes mellitus|diabetes mellitus
332423|NCT02178787|cerebral autoregulation|cerebral autoregulation
332424|NCT02178774|Near-Infrared Spectroscopy (NIRS)|near-infrared spectroscopy (nirs)
332425|NCT02178774|spinal anesthesia|spinal anesthesia
332426|NCT02178774|cesarean section|cesarean section
332427|NCT02178761|Erectile dysfunction|erectile dysfunction
332428|NCT02178761|Lower Urinary Tract Symptoms|lower urinary tract symptoms
332429|NCT02178761|Peripheral Arterial Disease|peripheral arterial disease
332430|NCT02178761|Angioplasty|angioplasty
332431|NCT02178761|Multidetector Computed Tomography|multidetector computed tomography
332432|NCT02178748|Tuberculosis|tuberculosis
332433|NCT02178748|Phase II|phase ii
332434|NCT02178748|MVA85A|mva85a
332435|NCT02178748|Schistosoma mansoni|schistosoma mansoni
332436|NCT02178735|pelvic organ prolapse, vaginal mesh, urodynamic studies|pelvic organ prolapse, vaginal mesh, urodynamic studies
332437|NCT02178709|Pancreatic|pancreatic
332438|NCT02178709|Cancer|cancer
332439|NCT02178709|Resectable|resectable
332440|NCT02178683|TACROLIMUS|tacrolimus
332441|NCT02178683|MYCOPHENOLATE MOFETIL|mycophenolate mofetil
332442|NCT02178683|FLUDARABINE|fludarabine
332443|NCT02178683|HLA-MATCHED|hla-matched
332444|NCT02178683|MIS-MATCHED|mis-matched
332445|NCT02178657|Stroke|stroke
332446|NCT02178657|Cell therapy|cell therapy
332447|NCT02178657|Bone marrow|bone marrow
332448|NCT02178605|rhBMP-2|rhbmp-2
332449|NCT02178605|arthrodesis|arthrodesis
332450|NCT02178605|cervical|cervical
332451|NCT02178592|integrase inhibitor|integrase inhibitor
332452|NCT02178592|Mycobacterium tuberculosis|mycobacterium tuberculosis
332453|NCT02178592|rifampicin-sensitive|rifampicin-sensitive
332454|NCT02178592|dolutegravir|dolutegravir
332455|NCT02178592|antiretroviral therapy-naïve|antiretroviral therapy-naïve
332456|NCT02178592|HIV-1 infection|hiv-1 infection
332457|NCT02178592|efavirenz|efavirenz
332458|NCT02178592|co-infection|co-infection
332459|NCT02178579|Heart Failure|heart failure
332460|NCT02178579|Cardiac Toxicity|cardiac toxicity
332461|NCT02178579|Multiple Myeloma|multiple myeloma
332462|NCT02178579|Bortezomib|bortezomib
332463|NCT02178579|Carfilzomib|carfilzomib
332464|NCT02178566|COPD|copd
332465|NCT02178566|Trepostinil|trepostinil
332466|NCT02178566|Pulmonary Rehabilitation|pulmonary rehabilitation
332467|NCT02178553|Thoracotomy|thoracotomy
332468|NCT02178553|Pain|pain
332469|NCT02178540|Human factors, TOBI® Podhaler™, Instructions For use, IFU, CF patients|human factors, tobi® podhaler™, instructions for use, ifu, cf patients
332470|NCT02178527|Geriatrics|geriatrics
332471|NCT02178527|Accidental Falls|accidental falls
332472|NCT02178527|Podiatry|podiatry
332473|NCT02178527|Exercise Therapy|exercise therapy
332474|NCT02178527|Orthotic Devices|orthotic devices
332475|NCT02178527|Foot|foot
332476|NCT02178501|OMEGA-3 PUFA|omega-3 pufa
332477|NCT02178501|type 2 diabetes|type 2 diabetes
332478|NCT02178501|cardiovascular diseases|cardiovascular diseases
332479|NCT02178475|NHL|nhl
332480|NCT02178475|Breast Cancer|breast cancer
332481|NCT02178423|children, ultrasound, central catheter|children, ultrasound, central catheter
332482|NCT02178410|Atrial Fibrillation|atrial fibrillation
332483|NCT02178410|Vitamin D3|vitamin d3
332484|NCT02178410|Omega-3 fatty acids|omega-3 fatty acids
332485|NCT02178410|Fish oil|fish oil
332486|NCT02178397|erlotinib|erlotinib
332487|NCT02178397|lung cancer|lung cancer
332488|NCT02178397|EGFR mutation|egfr mutation
332489|NCT02178384|Loading Forces|loading forces
332490|NCT02178384|Removable partial dentures|removable partial dentures
332491|NCT02178384|Bilateral distal extension|bilateral distal extension
332492|NCT02178371|Upper extremity|upper extremity
332493|NCT02178371|Physical therapy modalities|physical therapy modalities
332494|NCT02178358|transforming growth factor beta (TGF-β)|transforming growth factor beta (tgf-β)
332495|NCT02178345|MRI|mri
332496|NCT02178345|14-126|14-126
332497|NCT02178332|Children|children
332498|NCT02178332|socio-emotional|socio-emotional
332499|NCT02178332|socio-emotional skills|socio-emotional skills
332500|NCT02178332|psychiatric symptoms|psychiatric symptoms
332501|NCT02178332|SDQ|sdq
332502|NCT02178332|Finland|finland
332503|NCT02178332|School|school
332504|NCT02178332|School community|school community
332505|NCT02178332|Teacher|teacher
332506|NCT02178332|Whole school approach|whole school approach
332507|NCT02178332|Intervention|intervention
332508|NCT02178332|Effectiveness study|effectiveness study
332509|NCT02178332|Cluster randomised trial|cluster randomised trial
332510|NCT02178319|portal hypertension|portal hypertension
332511|NCT02178319|Randomized clinical trial|randomized clinical trial
332512|NCT02178319|laparoscopic|laparoscopic
332513|NCT02178319|open|open
332514|NCT02178267|Newborn, preterm, probiotic, resistant microorganisms|newborn, preterm, probiotic, resistant microorganisms
332515|NCT02178254|Pseudomonas aeruginosa, ZTI-101, phosphonic acid derivative, Monurol, fosfomycin tromethamine|pseudomonas aeruginosa, zti-101, phosphonic acid derivative, monurol, fosfomycin tromethamine
332516|NCT02178228|Anastomotic Leaks|anastomotic leaks
332616|NCT02177695|SWOG|swog
332517|NCT02178228|Bowel Resection|bowel resection
332518|NCT02178228|Postoperative Complication|postoperative complication
332519|NCT02178215|atopic dermatitis|atopic dermatitis
332520|NCT02178215|skin barrier function|skin barrier function
332521|NCT02178215|transepidermal water loss|transepidermal water loss
332522|NCT02178215|skin pH|skin ph
332523|NCT02178215|stratum corneum hydration|stratum corneum hydration
332524|NCT02178215|sebum|sebum
332525|NCT02178215|wrinkle|wrinkle
332526|NCT02178202|Harmonic technique, Low Back Pain, McKenzie exercise, Pain, Disability|harmonic technique, low back pain, mckenzie exercise, pain, disability
332527|NCT02178189|prenatal opioid exposure|prenatal opioid exposure
332528|NCT02178189|infant|infant
332529|NCT02178189|weight gain|weight gain
332530|NCT02178189|infant formula|infant formula
332531|NCT02178150|Magnesium|magnesium
332532|NCT02178150|Insulin Resistance|insulin resistance
332533|NCT02178150|Lipid profile|lipid profile
332534|NCT02178150|Sex hormones|sex hormones
332535|NCT02178150|Inflammatory factors|inflammatory factors
332536|NCT02178111|episiotomy, vaginal delivery, randomized, perineum|episiotomy, vaginal delivery, randomized, perineum
332538|NCT02178098|Cholesterol|cholesterol
332539|NCT02178085|glaucoma|glaucoma
332540|NCT02178085|phase-contrast MRI|phase-contrast mri
332541|NCT02178085|blood flow|blood flow
332542|NCT02178085|cerebrospinal fluid|cerebrospinal fluid
332543|NCT02178072|HNSCC|hnscc
332544|NCT02178059|Healthy volunteers, pharmacokinetic, inhalation|healthy volunteers, pharmacokinetic, inhalation
332545|NCT02178046|Gingivitis|gingivitis
332546|NCT02178033|adenoma detection rate, screening colonoscopy|adenoma detection rate, screening colonoscopy
332547|NCT02178020|Knee Arthroplasty|knee arthroplasty
332548|NCT02178020|Osteolysis|osteolysis
332549|NCT02178020|Radiolucent Lines|radiolucent lines
332550|NCT02177994|Elective Cesarean Section|elective cesarean section
332551|NCT02177994|Antibiotic prophylaxis|antibiotic prophylaxis
332552|NCT02177994|Timing of Antibiotic prophylaxis|timing of antibiotic prophylaxis
332553|NCT02177994|post cesarean section infection|post cesarean section infection
332554|NCT02177981|Remote Ischemic Preconditioning|remote ischemic preconditioning
332555|NCT02177981|Coronary Artery Bypass Grafting|coronary artery bypass grafting
332556|NCT02177981|Diffusion Weighted Magnetic Resonance Imaging|diffusion weighted magnetic resonance imaging
332557|NCT02177981|Resting State Functional Magnetic Resonance Imaging|resting state functional magnetic resonance imaging
332558|NCT02177981|Postoperative Cognitive Dysfunction|postoperative cognitive dysfunction
332559|NCT02177968|fall|fall
332560|NCT02177968|elderly|elderly
332561|NCT02177968|characteristics|characteristics
332562|NCT02177955|Third Molar|third molar
332563|NCT02177955|Anty-anxiety drugs|anty-anxiety drugs
332564|NCT02177955|hemodynamic|hemodynamic
332565|NCT02177955|Benzodiazepines|benzodiazepines
332566|NCT02177929|Spinal cord injury,|spinal cord injury,
332567|NCT02177929|adaptive sport,|adaptive sport,
332568|NCT02177929|dynamometry,|dynamometry,
332569|NCT02177929|electromyography,|electromyography,
332570|NCT02177929|force platform.|force platform.
332571|NCT02177916|lung transplantation|lung transplantation
332572|NCT02177903|hypothermia|hypothermia
332573|NCT02177903|surgical site infection|surgical site infection
332574|NCT02177903|opioid usage|opioid usage
332575|NCT02177903|blood loss|blood loss
332576|NCT02177903|pain severity|pain severity
332577|NCT02177903|anxiety|anxiety
332578|NCT02177903|Length of Stay|length of stay
332579|NCT02177877|Epilepsy|epilepsy
332580|NCT02177877|Seizures|seizures
332581|NCT02177877|Wrist accelerometer|wrist accelerometer
332582|NCT02177877|Epilepsy diary|epilepsy diary
332583|NCT02177877|Seizure detection|seizure detection
332584|NCT02177877|Biosensor|biosensor
332585|NCT02177851|Iron bio-availability|iron bio-availability
332586|NCT02177851|Hepcidin|hepcidin
332587|NCT02177851|Iron absorption|iron absorption
332588|NCT02177812|Oncology|oncology
332589|NCT02177812|LSD1|lsd1
332590|NCT02177812|GSK2879552|gsk2879552
332591|NCT02177812|Acute myeloid leukemia|acute myeloid leukemia
332592|NCT02177799|Gastroenteritis|gastroenteritis
332593|NCT02177799|Hospitalized|hospitalized
332594|NCT02177799|Children|children
332595|NCT02177786|Diabetic Kidney Disease|diabetic kidney disease
332596|NCT02177786|Gilead|gilead
332597|NCT02177760|SCID|scid
332598|NCT02177760|severe combined immunodeficiency|severe combined immunodeficiency
332599|NCT02177760|maternal engraftment|maternal engraftment
332600|NCT02177760|aGVHD prophylaxis|agvhd prophylaxis
332601|NCT02177760|sirolimus|sirolimus
332602|NCT02177734|Adjuvant|adjuvant
332603|NCT02177734|Safety|safety
332604|NCT02177734|Influenza|influenza
332605|NCT02177734|H7N9|h7n9
332606|NCT02177734|Immunogenicity|immunogenicity
332607|NCT02177734|Adults|adults
332608|NCT02177721|Raxibacumab|raxibacumab
332609|NCT02177721|anthrax|anthrax
332610|NCT02177721|anti-toxin|anti-toxin
332611|NCT02177695|Bladder Cancer|bladder cancer
332612|NCT02177695|Neoadjuvant Chemotherapy|neoadjuvant chemotherapy
332613|NCT02177695|Coexpression Extrapolation|coexpression extrapolation
332614|NCT02177695|COXEN|coxen
332615|NCT02177695|S1314|s1314
332617|NCT02177682|AKT inhibitor|akt inhibitor
332618|NCT02177682|Afuresertib|afuresertib
332619|NCT02177682|multiple myeloma|multiple myeloma
332620|NCT02177669|Normal, healthy individuals without ocular disease|normal, healthy individuals without ocular disease
332621|NCT02177669|Ages 20-89|ages 20-89
332622|NCT02177669|English speaking|english speaking
332623|NCT02177669|Visual acuity better than 20/25|visual acuity better than 20/25
332624|NCT02177656|heart failure|heart failure
332625|NCT02177656|self-care|self-care
332626|NCT02177656|self-care maintenance|self-care maintenance
332627|NCT02177656|self-care management|self-care management
332628|NCT02177656|self-efficacy|self-efficacy
332629|NCT02177656|quality of life|quality of life
332630|NCT02177656|symptoms|symptoms
332631|NCT02177643|Diabetes|diabetes
332632|NCT02177643|Diacerein|diacerein
332633|NCT02177630|myocarditis, myocardial inflammation, imaging, magnetic resonance|myocarditis, myocardial inflammation, imaging, magnetic resonance
332634|NCT02177617|Cervical Dystonia|cervical dystonia
332635|NCT02177617|Botox|botox
332636|NCT02177578|Subventricular Zone|subventricular zone
332637|NCT02177578|progenitor cell|progenitor cell
332638|NCT02177578|radiation therapy|radiation therapy
332639|NCT02177578|temozolomide|temozolomide
332640|NCT02177565|Non-union|non-union
332641|NCT02177565|fracture|fracture
332642|NCT02177565|bone marrow stem cells|bone marrow stem cells
332643|NCT02177552|Esophageal cancer|esophageal cancer
332644|NCT02177552|Gastric cancer|gastric cancer
332645|NCT02177539|cycloplegia|cycloplegia
332646|NCT02177539|refraction in children|refraction in children
332647|NCT02177539|cycloplegic agents|cycloplegic agents
332648|NCT02177539|cycloplegic schemes|cycloplegic schemes
332649|NCT02177539|cyclopentolate|cyclopentolate
332651|NCT02177526|MRI|mri
332652|NCT02177513|Cannabis|cannabis
332653|NCT02177513|Pharmacodynamics|pharmacodynamics
332654|NCT02177513|Marijuana|marijuana
332655|NCT02177513|Cannabinoids|cannabinoids
332656|NCT02177513|Vaporized|vaporized
332657|NCT02177474|depressive symptoms|depressive symptoms
332658|NCT02177474|perceived social support|perceived social support
332659|NCT02177474|coronary heart disease|coronary heart disease
332660|NCT02177474|peer support|peer support
332661|NCT02177474|women|women
332662|NCT02177279|Wheat bran cereals, bran phytochemicals, phytochemicals bioavailability|wheat bran cereals, bran phytochemicals, phytochemicals bioavailability
332663|NCT02177240|GlideScope®|glidescope®
332664|NCT02177240|GlideRite®|gliderite®
332665|NCT02177240|Flex-it®|flex-it®
332666|NCT02177240|Difficult intubation|difficult intubation
332667|NCT02177227|Total Knee Arthroplasty (TKA)|total knee arthroplasty (tka)
332668|NCT02177227|Attune|attune
332669|NCT02177227|Primary Total Knee Prosthesis|primary total knee prosthesis
332670|NCT02177227|TruMatch|trumatch
332671|NCT02177188|Hypovolaemic shock|hypovolaemic shock
332672|NCT02177188|Monitoring|monitoring
332673|NCT02177188|Haemorrhage|haemorrhage
332674|NCT02177188|Transthoracic Echocardiography|transthoracic echocardiography
332675|NCT02177175|Carvedilol|carvedilol
332676|NCT02177175|Anthracycline|anthracycline
332677|NCT02177175|HER2|her2
332678|NCT02177175|14-099|14-099
332679|NCT02177136|PSC|psc
332680|NCT02177123|glaucoma shunt|glaucoma shunt
332681|NCT02177123|glaucoma drainage device|glaucoma drainage device
332682|NCT02177110|advanced melanoma|advanced melanoma
332683|NCT02177110|metastatic melanoma|metastatic melanoma
332684|NCT02177110|fresh frozen tissue|fresh frozen tissue
332685|NCT02177110|FFPE tissue|ffpe tissue
332686|NCT02177097|Pain|pain
332687|NCT02177097|Infection|infection
332688|NCT02177097|Inflammation|inflammation
332689|NCT02177097|Prosthesis|prosthesis
332690|NCT02177084|PTNS|ptns
332691|NCT02177084|rectal cancer|rectal cancer
332692|NCT02177084|low anterior resection syndrome|low anterior resection syndrome
332693|NCT02177071|CROHN DISEASE|crohn disease
332694|NCT02177071|INFLIXIMAB|infliximab
332695|NCT02177071|COMBINATION THERAPY|combination therapy
332696|NCT02177071|steroid free remission|steroid free remission
332697|NCT02177071|anti-metabolites|anti-metabolites
332698|NCT02177058|Nursing homes|nursing homes
332699|NCT02177058|Hospitalizations|hospitalizations
332700|NCT02177032|Rabies vaccines|rabies vaccines
332701|NCT02177032|intradermal|intradermal
332702|NCT02177032|human rabies immunoglobulins|human rabies immunoglobulins
332703|NCT02177019|frequent headaches|frequent headaches
332704|NCT02177019|personalized health plan|personalized health plan
332705|NCT02176993|Acute stroke|acute stroke
332706|NCT02176993|Therapeutic Hypothermia|therapeutic hypothermia
332707|NCT02176980|HCV|hcv
332708|NCT02176980|hepatitis C|hepatitis c
332709|NCT02176980|alcohol|alcohol
332710|NCT02176980|integrated care|integrated care
332711|NCT02176941|Telomere Length|telomere length
332712|NCT02176941|Arterial Aging|arterial aging
332713|NCT02176941|Endothelial Progenitor Cells|endothelial progenitor cells
768536|NCT00373087|Entacapone|entacapone
425134|NCT01755611|Acne|acne
332714|NCT02176941|Inflammation|inflammation
332715|NCT02176941|Atherosclerosis|atherosclerosis
332716|NCT02176889|Lactospore|lactospore
332717|NCT02176889|Bacillus coagulans|bacillus coagulans
332718|NCT02176889|Safety|safety
332719|NCT02176889|Probiotic|probiotic
332720|NCT02176889|Healthy Adults|healthy adults
332721|NCT02176889|Tolerability|tolerability
332722|NCT02176876|rheumatoid arthritis|rheumatoid arthritis
332723|NCT02176876|RA|ra
332724|NCT02176876|GS-5745|gs-5745
332725|NCT02176876|MMP9|mmp9
332726|NCT02176876|phase 1|phase 1
332727|NCT02176863|FORCE|force
332728|NCT02176863|post-polio syndrome|post-polio syndrome
332729|NCT02176863|Flebogamma|flebogamma
332730|NCT02176863|Immune Globulin Intravenous|immune globulin intravenous
332731|NCT02176863|IGIV|igiv
332732|NCT02176837|subarachnoid hemorrhage|subarachnoid hemorrhage
332733|NCT02176837|vasospasm|vasospasm
332734|NCT02176837|nitrite|nitrite
332735|NCT02176837|sodium nitrite|sodium nitrite
332736|NCT02176811|Non-alcoholic Fatty Liver Disease|non-alcoholic fatty liver disease
332737|NCT02176811|Betatrophin|betatrophin
332738|NCT02176785|Sleep|sleep
332739|NCT02176785|Transcranial Electric Stimulation|transcranial electric stimulation
332740|NCT02176720|Glioma|glioma
332741|NCT02176720|Glioblastoma|glioblastoma
332742|NCT02176720|Glioblastoma multiforme|glioblastoma multiforme
332743|NCT02176720|GBM|gbm
332744|NCT02176720|Recurrence|recurrence
332745|NCT02176720|PET|pet
332746|NCT02176720|FDOPA|fdopa
332747|NCT02176707|Lung Function|lung function
332748|NCT02176707|Exercise Capacity|exercise capacity
332749|NCT02176694|persistent asthma|persistent asthma
332750|NCT02176694|adherence|adherence
332751|NCT02176694|text message reminders|text message reminders
332752|NCT02176655|Delayed Alcohol Induced Headache|delayed alcohol induced headache
332753|NCT02176642|Urinary Urge Incontinence|urinary urge incontinence
332754|NCT02176642|Posterior Tibial Nerve Stimulation|posterior tibial nerve stimulation
332755|NCT02176642|PTNS|ptns
332756|NCT02176642|Neuromodulation|neuromodulation
332757|NCT02176642|Oxybutynin|oxybutynin
332758|NCT02176642|Anticholinergic Medication|anticholinergic medication
332759|NCT02176629|Virtual Reality|virtual reality
332760|NCT02176629|mild cognitive impairment|mild cognitive impairment
332761|NCT02176629|Alzheimer's disease|alzheimer's disease
332762|NCT02176603|phenylketonuria, endothelial dysfunction, CKD|phenylketonuria, endothelial dysfunction, ckd
332763|NCT02176590|PATHS Social Emotional Learning|paths social emotional learning
332764|NCT02176590|Coping Power|coping power
332765|NCT02176590|Power PATH|power path
332766|NCT02176590|Head Start|head start
332767|NCT02176486|Drug Therapy|drug therapy
332768|NCT02176473|Depression|depression
332769|NCT02176460|Knee Osteoarthritis|knee osteoarthritis
332770|NCT02176460|Double-blind|double-blind
332771|NCT02176460|placebo-controlled|placebo-controlled
332772|NCT02176460|randomized|randomized
332773|NCT02176460|colchicine|colchicine
332774|NCT02176434|End stage renal disease|end stage renal disease
332775|NCT02176434|Transplantation|transplantation
332776|NCT02176434|Tolerance|tolerance
332777|NCT02176408|Major Depressive Disorder|major depressive disorder
332778|NCT02176408|Depression|depression
332779|NCT02176408|MDD|mdd
332780|NCT02176408|Exercise|exercise
332781|NCT02176408|Physical Activity|physical activity
332782|NCT02176408|Treatment|treatment
332783|NCT02176408|Behavioral Activation|behavioral activation
332784|NCT02176395|Acute Ischemic Stroke|acute ischemic stroke
332785|NCT02176395|Randomized Controlled Trial|randomized controlled trial
332786|NCT02176395|Traditional Chinese Medicine|traditional chinese medicine
332787|NCT02176395|Proteomics|proteomics
332788|NCT02176369|Non small cell lung cancer (NSCLC)|non small cell lung cancer (nsclc)
332789|NCT02176369|Lung tumor in advanced phase|lung tumor in advanced phase
332790|NCT02176343|Cataract|cataract
332791|NCT02176343|Intraocular lens|intraocular lens
332792|NCT02176343|ACRYSOF IQ ReSTOR + 2.5 D Multifocal Toric IOL|acrysof iq restor + 2.5 d multifocal toric iol
332793|NCT02176330|Randomised Controlled Trial|randomised controlled trial
332794|NCT02176330|Virtual Clinic|virtual clinic
332795|NCT02176330|ePAQ-PF|epaq-pf
332796|NCT02176330|Pelvic Floor Disorders|pelvic floor disorders
332797|NCT02176330|Economic Analysis|economic analysis
332798|NCT02176317|Autism Spectrum Disorder|autism spectrum disorder
332799|NCT02176317|ASD|asd
332800|NCT02176317|Umbilical cord blood|umbilical cord blood
332801|NCT02176317|Autologous cord blood|autologous cord blood
332802|NCT02176317|cord blood|cord blood
332803|NCT02176304|knee|knee
332804|NCT02176304|arthritis|arthritis
332805|NCT02176304|injections|injections
332806|NCT02176304|corticosteroids|corticosteroids
332807|NCT02176291|Buprenorphine|buprenorphine
332808|NCT02176291|Receptors, opioid|receptors, opioid
332809|NCT02176291|Receptors, opioid kappa and mu|receptors, opioid kappa and mu
332810|NCT02176278|Diabetic Kidney Disease|diabetic kidney disease
332811|NCT02176278|Diabetes|diabetes
332812|NCT02176278|Asian|asian
332813|NCT02176278|Joint Asia Diabetes Evaluation (JADE) Program|joint asia diabetes evaluation (jade) program
332814|NCT02176265|CAD|cad
332815|NCT02176265|PCI|pci
332816|NCT02176265|bioactive coronary stent|bioactive coronary stent
332817|NCT02176265|OCT|oct
332818|NCT02176226|Major Depressive Disorder|major depressive disorder
332819|NCT02176226|Anxiety Disorders|anxiety disorders
332820|NCT02176226|Behavior Therapy|behavior therapy
332821|NCT02176226|Technology Assisted|technology assisted
332822|NCT02176226|Mobile Phone|mobile phone
332823|NCT02176226|Cellular Phone|cellular phone
332824|NCT02176226|Smartphone|smartphone
332825|NCT02176226|App|app
332826|NCT02176213|Relapsed|relapsed
332827|NCT02176213|Refractory|refractory
332828|NCT02176213|Multiple Myeloma|multiple myeloma
332829|NCT02176213|Pomalidomide|pomalidomide
332830|NCT02176213|Cyclophosphamide|cyclophosphamide
332831|NCT02176213|Dexamethasone|dexamethasone
332832|NCT02176174|Ethnic group|ethnic group
332833|NCT02176174|Cardiovascular disease|cardiovascular disease
332834|NCT02176174|Atherosclerosis|atherosclerosis
332835|NCT02176161|Prostate Cancer|prostate cancer
332836|NCT02176161|Prostate Cancer Recurrent|prostate cancer recurrent
332837|NCT02176148|cutaneous lupus|cutaneous lupus
332838|NCT02176148|systemic lupus|systemic lupus
332839|NCT02176148|systemic therapy|systemic therapy
332840|NCT02176148|medication|medication
332841|NCT02176135|HIV|hiv
332842|NCT02176135|HAART suppressed|haart suppressed
332843|NCT02176135|Auranofin|auranofin
332844|NCT02176135|HIV latent reservoir|hiv latent reservoir
332845|NCT02176057|trachoma|trachoma
332846|NCT02176044|Nitric Oxide|nitric oxide
332847|NCT02176044|Sodium Nitroprusside|sodium nitroprusside
332848|NCT02176044|Spatial Working Memory|spatial working memory
332849|NCT02176044|Psychosis|psychosis
332850|NCT02176044|Schizophrenia|schizophrenia
332851|NCT02176031|Graft Versus Host Disease|graft versus host disease
332852|NCT02176018|Episodic Migraine|episodic migraine
332853|NCT02176018|Migraine|migraine
332854|NCT02176018|Headache|headache
332855|NCT02175979|postoperative ileus|postoperative ileus
332856|NCT02175979|anastomotic leak|anastomotic leak
332857|NCT02175979|colorectal surgery|colorectal surgery
332858|NCT02175979|inflammation|inflammation
332859|NCT02175953|caregiver burden|caregiver burden
332860|NCT02175953|stress|stress
332861|NCT02175953|depression|depression
332862|NCT02175953|dementia|dementia
332863|NCT02175927|Helicobacter pylori|helicobacter pylori
332864|NCT02175927|Treatment Failure|treatment failure
332865|NCT02175927|second-line therapy|second-line therapy
332866|NCT02175914|Erythromycin|erythromycin
332867|NCT02175914|Familial Adenomatous Polyposis (FAP).|familial adenomatous polyposis (fap).
332868|NCT02175914|APC gene|apc gene
332869|NCT02175914|nonsense mutations|nonsense mutations
332870|NCT02175901|helicobacter pylori eradication|helicobacter pylori eradication
332871|NCT02175901|antibiotic|antibiotic
332872|NCT02175888|Iron bio availability|iron bio availability
332873|NCT02175888|Hepcidin|hepcidin
332874|NCT02175888|Iron absorption|iron absorption
332875|NCT02175875|ticagrelor|ticagrelor
332876|NCT02175875|platelet function test|platelet function test
332877|NCT02175875|comatose|comatose
332878|NCT02175875|PCI|pci
332879|NCT02175875|naso-gastric tube|naso-gastric tube
332880|NCT02175862|Helicopter Emergency Medical Service|helicopter emergency medical service
332881|NCT02175862|Trauma|trauma
332882|NCT02175862|Early retirement|early retirement
332883|NCT02175862|ISS|iss
332884|NCT02175862|Quality of life|quality of life
332885|NCT02175849|Multi-Drug Resistant Tuberculosis|multi-drug resistant tuberculosis
332886|NCT02175849|Social Network Analysis|social network analysis
332887|NCT02175836|Arrhythmic Sudden Cardiac Death|arrhythmic sudden cardiac death
332888|NCT02175836|Heart Failure|heart failure
332889|NCT02175836|Risk Stratification|risk stratification
332890|NCT02175836|Autonomic Nervous System|autonomic nervous system
332891|NCT02175836|Heart Rate|heart rate
332892|NCT02175836|Repolarization|repolarization
332893|NCT02175823|Cancer survivors|cancer survivors
332894|NCT02175823|circadian rhythm|circadian rhythm
332895|NCT02175823|Elderly Patients|elderly patients
332896|NCT02175823|frailty|frailty
332897|NCT02175810|Obesity|obesity
332898|NCT02175810|Bariatric surgery|bariatric surgery
332899|NCT02175810|physical activity|physical activity
332900|NCT02175810|cardiopulmonary exercise test|cardiopulmonary exercise test
332901|NCT02175797|Pacemaker, leads and MRI exam|pacemaker, leads and mri exam
332902|NCT02175784|Blood glucose|blood glucose
332903|NCT02175784|insulin|insulin
332904|NCT02175784|ipragliflozin|ipragliflozin
332905|NCT02175784|SGLT2 inhibitor|sglt2 inhibitor
332906|NCT02175732|Type 1 Diabetes|type 1 diabetes
332907|NCT02175732|Distress|distress
332908|NCT02175719|Torticollis|torticollis
332909|NCT02175719|rimabotulinumtoxinB|rimabotulinumtoxinb
332910|NCT02175693|Torticollis|torticollis
332911|NCT02175693|rimabotulinumtoxinB|rimabotulinumtoxinb
332912|NCT02175680|HIV-1|hiv-1
332913|NCT02175680|HIV|hiv
768889|NCT00371904|antibody|antibody
332914|NCT02175680|Treatment Substitution|treatment substitution
332915|NCT02175680|PRO 140|pro 140
332916|NCT02175680|PRO140|pro140
332917|NCT02175680|CytoDyn|cytodyn
332918|NCT02175680|Amarex|amarex
332919|NCT02175667|Global postural reeducation|global postural reeducation
332920|NCT02175667|Stabilometry|stabilometry
332921|NCT02175667|Postural Sway|postural sway
332922|NCT02175667|Range of motion|range of motion
332923|NCT02175667|Personality traits|personality traits
332924|NCT02175654|metastatic colorectal cancer|metastatic colorectal cancer
332925|NCT02175654|RAS/BRAF mutation|ras/braf mutation
332926|NCT02175654|Regorafenib|regorafenib
332927|NCT02175654|FOLFOXIRI|folfoxiri
332928|NCT02175654|Bevacizumab|bevacizumab
332929|NCT02175641|Healthy lifestyle Intervention|healthy lifestyle intervention
332930|NCT02175641|Serious Mental Illness|serious mental illness
332931|NCT02175641|Effectiveness trial|effectiveness trial
332932|NCT02175641|Supportive housing|supportive housing
332933|NCT02175641|Racial and Ethnic Health Disparities|racial and ethnic health disparities
332934|NCT02175628|Ultrasound|ultrasound
332935|NCT02175628|Breast|breast
332936|NCT02175628|Angiography|angiography
332937|NCT02175615|CYCLOSPORINE|cyclosporine
332938|NCT02175615|ACUTE GRAFT VERSUS HOST DISEASE|acute graft versus host disease
332939|NCT02175615|PROPHYLAXIS|prophylaxis
332940|NCT02175615|CHILDREN|children
332941|NCT02175615|HAEMATOPOIETIC STEM CELL TRANSPLANT|haematopoietic stem cell transplant
332942|NCT02175589|Familial Mediterranean Fever|familial mediterranean fever
332943|NCT02175589|Monozygous|monozygous
332944|NCT02175589|MEFV|mefv
332945|NCT02175589|Colchicine|colchicine
332946|NCT02175589|Serum Amyloid A|serum amyloid a
332947|NCT02175563|Chest|chest
332948|NCT02175563|Compression|compression
332949|NCT02175550|partially edentulous|partially edentulous
332950|NCT02175550|maxilla|maxilla
332951|NCT02175550|implants|implants
332952|NCT02175550|Conical connection|conical connection
332953|NCT02175550|Nobel Biocare|nobel biocare
332954|NCT02175550|NobelReplace|nobelreplace
332955|NCT02175550|Immediate loading|immediate loading
332956|NCT02175550|One- stage surgery|one- stage surgery
332957|NCT02175550|Two- stage surgery|two- stage surgery
332958|NCT02175550|supported restoration|supported restoration
332959|NCT02175550|patients|patients
332960|NCT02175537|Diabetes Mellitus, Type II|diabetes mellitus, type ii
332961|NCT02175537|Disease management|disease management
332962|NCT02175537|Obesity|obesity
332963|NCT02175537|Social Network|social network
332964|NCT02175537|Chronic disease|chronic disease
332965|NCT02175537|Prevention and control|prevention and control
332966|NCT02175537|Education|education
332967|NCT02175524|nut chewing|nut chewing
332968|NCT02175511|Home Blood Pressure|home blood pressure
332969|NCT02175511|Computerized physician order entry (CPOE)|computerized physician order entry (cpoe)
332970|NCT02175511|Telemonitoring|telemonitoring
332971|NCT02175511|Hypertension|hypertension
332972|NCT02175498|Homoeopathy Similimum female infertility|homoeopathy similimum female infertility
332973|NCT02175472|Parkinson's disease|parkinson's disease
332974|NCT02175472|Light therapy|light therapy
332975|NCT02175472|Circadian rhythm|circadian rhythm
332976|NCT02175446|Breast cancer|breast cancer
332977|NCT02175446|HER2Negative|her2negative
332978|NCT02175446|Second line treatment|second line treatment
332979|NCT02175446|HER2-|her2-
332980|NCT02175446|MBC|mbc
332981|NCT02175446|Metastatic|metastatic
332982|NCT02175446|Metastatic breast cancer|metastatic breast cancer
332983|NCT02175446|bevacizumab|bevacizumab
332984|NCT02175446|eribulin|eribulin
332985|NCT02175446|Human Epidermal Growth Factor Receptor 2-Negative|human epidermal growth factor receptor 2-negative
332986|NCT02175433|Refractory or relapsed chronic lymphocytic leukemia (CLL) prolymphocytic leukemia (PLL)|refractory or relapsed chronic lymphocytic leukemia (cll) prolymphocytic leukemia (pll)
332987|NCT02175433|Relapsed lymphoid malignancy|relapsed lymphoid malignancy
332988|NCT02175433|Refractory lymphoid malignancy|refractory lymphoid malignancy
332989|NCT02175433|Pharmacokinetics of AGS67E|pharmacokinetics of ags67e
332990|NCT02175433|hairy cell leukemia (HCL)|hairy cell leukemia (hcl)
332991|NCT02175433|AGS67C|ags67c
332992|NCT02175433|non-Hodgkin lymphoma (NHL)|non-hodgkin lymphoma (nhl)
332993|NCT02175433|AGS67E|ags67e
332994|NCT02175420|BCG|bcg
332995|NCT02175420|Salmonella|salmonella
332996|NCT02175420|Trained immunity|trained immunity
332997|NCT02175420|Non-specific effect vaccines|non-specific effect vaccines
332998|NCT02175407|Healthy subjects|healthy subjects
332999|NCT02175407|ASP1707|asp1707
333000|NCT02175407|Itraconazole|itraconazole
333001|NCT02175381|Metastatic NSCLC|metastatic nsclc
333002|NCT02175381|Elderly|elderly
333003|NCT02175381|1st Line|1st line
333004|NCT02175381|Platinum-based treatment|platinum-based treatment
333005|NCT02175368|total etch protocol|total etch protocol
333006|NCT02175368|direct filling therapy|direct filling therapy
333007|NCT02175329|CAD/CAM, three-unit posterior bridges, zirconia framework|cad/cam, three-unit posterior bridges, zirconia framework
333008|NCT02175277|Myelodysplastic Syndrome (MDS)|myelodysplastic syndrome (mds)
333009|NCT02175277|Darbepoetin alfa|darbepoetin alfa
333010|NCT02175277|low risk MDS|low risk mds
333011|NCT02175277|intermediate-1 risk MDS|intermediate-1 risk mds
333012|NCT02175277|International Prognostic Scoring System (IPSS)|international prognostic scoring system (ipss)
333013|NCT02175264|Isolated non syndromic CDH|isolated non syndromic cdh
333014|NCT02175251|rTMS|rtms
333015|NCT02175251|Schizophrenia|schizophrenia
333016|NCT02175251|high frequency rTMS|high frequency rtms
333017|NCT02175251|low frequency rTMS|low frequency rtms
333019|NCT02175251|SAPS SANS PANSS|saps sans panss
333020|NCT02175251|GAF|gaf
333021|NCT02175251|UKU|uku
333022|NCT02175225|Brain hemorrhage|brain hemorrhage
333023|NCT02175225|Cerebral hemorrhage|cerebral hemorrhage
333024|NCT02175225|Bleeding in the brain|bleeding in the brain
333025|NCT02175225|Deferoxamine|deferoxamine
333026|NCT02175225|iDEF trial|idef trial
333027|NCT02175212|Patients with prostate adenocarcinoma|patients with prostate adenocarcinoma
333028|NCT02175199|Contact lens|contact lens
333029|NCT02175199|Vision care|vision care
333030|NCT02175199|Daily wear|daily wear
333031|NCT02175199|Color contact lens|color contact lens
333032|NCT02175186|Gastritis|gastritis
333033|NCT02175186|Gastroduodenal Ulcer|gastroduodenal ulcer
333034|NCT02175186|Percutaneous Coronary Revascularization|percutaneous coronary revascularization
333035|NCT02175186|Dual Antiplatelet Therapy|dual antiplatelet therapy
333036|NCT02175173|Epileptic encephalopathy, Lennox-Gastaut type|epileptic encephalopathy, lennox-gastaut type
333037|NCT02175160|Driver reaction time|driver reaction time
333038|NCT02175134|tuberculosis|tuberculosis
333039|NCT02175134|peritonitis|peritonitis
333040|NCT02175134|laparoscopy|laparoscopy
333041|NCT02175108|Cerebral palsy|cerebral palsy
333042|NCT02175108|Adolescents|adolescents
333043|NCT02175108|Adults|adults
333044|NCT02175108|Diet|diet
333045|NCT02175108|Activity|activity
333046|NCT02175108|Metabolic Syndrome|metabolic syndrome
333047|NCT02175095|regorafenib|regorafenib
333048|NCT02175095|fluorothymidine|fluorothymidine
333049|NCT02175095|positron emission tomography|positron emission tomography
333050|NCT02175095|metastatic colorectal cancer|metastatic colorectal cancer
333051|NCT02175082|Parkinson Disease|parkinson disease
333052|NCT02175082|Exercise|exercise
333053|NCT02175082|Rehabilitation|rehabilitation
333054|NCT02175082|Physical Therapy|physical therapy
333055|NCT02175082|Cycling|cycling
333056|NCT02175069|Shoulder surgery|shoulder surgery
333057|NCT02175056|First In Human|first in human
333058|NCT02175056|CAPS, SoJIA, AOSD, Bechet Disease, Rheumatoid arthritis|caps, sojia, aosd, bechet disease, rheumatoid arthritis
333059|NCT02175043|atrial fibrillation, catheter ablation, recurrence|atrial fibrillation, catheter ablation, recurrence
333060|NCT02175030|Emergency contraception|emergency contraception
333061|NCT02175030|Levonorgestrel IUD|levonorgestrel iud
333062|NCT02175030|Copper IUD|copper iud
333063|NCT02175017|ONO-4538|ono-4538
333064|NCT02175017|Advanced non-small cell lung cancer|advanced non-small cell lung cancer
333065|NCT02175004|FAP|fap
333066|NCT02175004|Familial Amyloid Polyneuropathy|familial amyloid polyneuropathy
333067|NCT02175004|TTR|ttr
333068|NCT02175004|Transthyretin|transthyretin
333069|NCT02175004|Amyloidosis|amyloidosis
333070|NCT02174978|Malaria vaccine|malaria vaccine
333071|NCT02174952|Parenting interventions|parenting interventions
333072|NCT02174952|ADHD|adhd
333073|NCT02174952|Family functioning|family functioning
333074|NCT02174952|Parent Training|parent training
333075|NCT02174939|cilostazol|cilostazol
333076|NCT02174939|progenitor cells|progenitor cells
333077|NCT02174939|coronary artery disease|coronary artery disease
333078|NCT02174939|myocardial infarction|myocardial infarction
333079|NCT02174939|angiogenesis|angiogenesis
333080|NCT02174939|biological markers|biological markers
333081|NCT02174939|endothelial function|endothelial function
333082|NCT02174913|Awakening time|awakening time
333083|NCT02174913|Bispectral index|bispectral index
333084|NCT02174913|clinical signs|clinical signs
333085|NCT02174913|neurophysiologic monitoring|neurophysiologic monitoring
333086|NCT02174913|spine surgery|spine surgery
333087|NCT02174900|G6PD deficiency|g6pd deficiency
333088|NCT02174900|safety|safety
333089|NCT02174900|transmission|transmission
333090|NCT02174887|pancreatic adenocarcinoma|pancreatic adenocarcinoma
333091|NCT02174887|liver metastases|liver metastases
333092|NCT02174861|Chronic Migraine|chronic migraine
333093|NCT02174848|Pantothenate Kinase-Associated Neurodegeneration|pantothenate kinase-associated neurodegeneration
333094|NCT02174848|PKAN|pkan
333095|NCT02174848|Neurodegeneration with Brain Iron Accumulation|neurodegeneration with brain iron accumulation
333096|NCT02174848|NBIA|nbia
333097|NCT02174848|Deferiprone|deferiprone
333098|NCT02174848|Ferriprox|ferriprox
333099|NCT02174835|Pharmacokinetics|pharmacokinetics
333100|NCT02174835|Healthy Volunteers|healthy volunteers
333101|NCT02174835|deuterated dextromethorphan|deuterated dextromethorphan
333102|NCT02174835|deuterated dextromethorphan with quinidine|deuterated dextromethorphan with quinidine
333103|NCT02174822|Drug-drug interaction|drug-drug interaction
333104|NCT02174822|Pharmacokinetics|pharmacokinetics
333105|NCT02174822|Healthy Volunteers|healthy volunteers
333106|NCT02174822|deuterated dextromethorphan|deuterated dextromethorphan
333107|NCT02174822|deuterated dextromethorphan with quinidine|deuterated dextromethorphan with quinidine
333108|NCT02174809|Pregnancy|pregnancy
333109|NCT02174809|Gestational Weight Gain|gestational weight gain
333110|NCT02174809|Primary Care|primary care
333111|NCT02174809|Guidelines|guidelines
333112|NCT02174796|Pectus excavatum|pectus excavatum
333113|NCT02174796|cardiac output|cardiac output
333114|NCT02174796|transthoracic impedancemetry|transthoracic impedancemetry
333115|NCT02174783|Weight Loss|weight loss
333116|NCT02174783|Diet, Mediterranean|diet, mediterranean
333117|NCT02174783|Diet, Reducing|diet, reducing
333118|NCT02174783|protein sparing modified diet|protein sparing modified diet
333119|NCT02174744|Pain in elderly patients having communication disorders|pain in elderly patients having communication disorders
333120|NCT02174744|Numerical scale|numerical scale
333121|NCT02174744|Algoplus® scale|algoplus® scale
333122|NCT02174744|Doloplus® scale|doloplus® scale
333123|NCT02174731|Renal,|renal,
333124|NCT02174731|CKD,|ckd,
333125|NCT02174731|Epoetin alfa,|epoetin alfa,
333126|NCT02174731|Roxadustat,|roxadustat,
333127|NCT02174731|dialysis,|dialysis,
333128|NCT02174731|anemia|anemia
333129|NCT02174718|Cholecalciferol|cholecalciferol
333130|NCT02174718|Transdermal patch|transdermal patch
333131|NCT02174705|vaccination|vaccination
333132|NCT02174705|pain management|pain management
333133|NCT02174705|sucrose|sucrose
333134|NCT02174705|rotavirus|rotavirus
333135|NCT02174666|Aglycones|aglycones
333136|NCT02174666|Isoflavones|isoflavones
333137|NCT02174666|Red clover|red clover
333138|NCT02174666|Osteopenia|osteopenia
333139|NCT02174666|Menopause|menopause
333140|NCT02174666|Bone turnover|bone turnover
333141|NCT02174666|Bone mineral density|bone mineral density
333142|NCT02174640|Coffee|coffee
333143|NCT02174640|Polyphenolics|polyphenolics
333144|NCT02174627|Renal,|renal,
333145|NCT02174627|CKD,|ckd,
333146|NCT02174627|Roxadustat,|roxadustat,
333147|NCT02174627|anemia,|anemia,
333148|NCT02174627|non-dialysis|non-dialysis
333149|NCT02174614|Cocaine use disorder|cocaine use disorder
333150|NCT02174601|bowel preparation|bowel preparation
333151|NCT02174601|coolprep|coolprep
333152|NCT02174601|colonoscopy|colonoscopy
333153|NCT02174601|prediction model|prediction model
333154|NCT02174588|sedation, propofol, midazolam|sedation, propofol, midazolam
333155|NCT02174575|Hepatectomy|hepatectomy
333156|NCT02174562|Type 2 diabetes|type 2 diabetes
333157|NCT02174562|Mild Cognitive Impairment|mild cognitive impairment
333158|NCT02174549|Hypoxia|hypoxia
333159|NCT02174549|Embolization|embolization
333160|NCT02174549|Tirapazamine|tirapazamine
333161|NCT02174523|pharmacokinetic|pharmacokinetic
333162|NCT02174523|lurasidone|lurasidone
333163|NCT02174523|multiple dose|multiple dose
333164|NCT02174510|pharmacokinetic|pharmacokinetic
333165|NCT02174510|lurasidone|lurasidone
333166|NCT02174510|single dose|single dose
333167|NCT02174497|Pediatric Colonoscopy|pediatric colonoscopy
333168|NCT02174497|Bowel Preparation|bowel preparation
333169|NCT02174497|Safety|safety
333170|NCT02174497|Tolerability|tolerability
333171|NCT02174484|Pacemaker|pacemaker
333172|NCT02174484|Remote monitoring|remote monitoring
333173|NCT02174484|Remote follow-up|remote follow-up
333174|NCT02174484|Home monitoring|home monitoring
333175|NCT02174484|Periodic IEGM|periodic iegm
333176|NCT02174484|Intracardiac electrogram|intracardiac electrogram
333177|NCT02174471|Aortic Stenosis|aortic stenosis
333178|NCT02174471|Aortic Valve Replacement|aortic valve replacement
333179|NCT02174471|T1 Mapping|t1 mapping
333180|NCT02174471|Extracellular Volume Fraction|extracellular volume fraction
333181|NCT02174471|Cardiovascular Magnetic Resonance|cardiovascular magnetic resonance
333182|NCT02174471|Diffuse Myocardial Fibrosis|diffuse myocardial fibrosis
333183|NCT02174458|Bariatric surgery; Body contouring; Quality of life|bariatric surgery; body contouring; quality of life
333184|NCT02174445|Patients with CML in chronic phase|patients with cml in chronic phase
333185|NCT02174445|Imatinib|imatinib
333186|NCT02174445|Nilotinib|nilotinib
333187|NCT02174432|Itch|itch
333188|NCT02174432|Chronic Itch|chronic itch
333189|NCT02174432|Nalbupine|nalbupine
333190|NCT02174419|Itch|itch
333191|NCT02174419|Chronic Itch|chronic itch
333192|NCT02174419|nalbuphine|nalbuphine
333193|NCT02174406|Ultrasound|ultrasound
333194|NCT02174406|Digital Breast Tomosynthesis|digital breast tomosynthesis
333195|NCT02174406|14-119|14-119
333196|NCT02174367|Chronic plaque psoriasis|chronic plaque psoriasis
333197|NCT02174367|Liver fibrosis|liver fibrosis
333198|NCT02174367|Fatty liver disease|fatty liver disease
333199|NCT02174367|Non-alcoholic fatty liver disease|non-alcoholic fatty liver disease
333200|NCT02174367|Transient elastography|transient elastography
333201|NCT02174367|Fibroscan|fibroscan
333202|NCT02174367|Procollagen-3 N-Terminal peptide|procollagen-3 n-terminal peptide
333203|NCT02174367|Alanine aminotransferase|alanine aminotransferase
768890|NCT00371904|rejection|rejection
333204|NCT02174367|Liver function tests|liver function tests
333205|NCT02174354|Psoriasis|psoriasis
333206|NCT02174354|Methotrexate|methotrexate
333207|NCT02174354|Methotrexate Polyglutamates|methotrexate polyglutamates
333208|NCT02174354|Injury of Liver|injury of liver
333209|NCT02174341|Chikungunya fever|chikungunya fever
333210|NCT02174341|Chikungunya Virus|chikungunya virus
333211|NCT02174328|See incidence of Pre-Eclampsia in acetylsalicylic acid group|see incidence of pre-eclampsia in acetylsalicylic acid group
333212|NCT02174328|See incidence of Pre-Eclampsia in placebo group|see incidence of pre-eclampsia in placebo group
333213|NCT02174289|Heart Failure|heart failure
333214|NCT02174289|Cardiac Resynchronisation Therapy|cardiac resynchronisation therapy
333215|NCT02174289|Transseptal left ventricular endocardial lead|transseptal left ventricular endocardial lead
333216|NCT02174250|PD|pd
333217|NCT02174237|Phase 1, safety, tolerability, PK, PD|phase 1, safety, tolerability, pk, pd
333218|NCT02174224|Violence|violence
333219|NCT02174224|At-risk youth|at-risk youth
333220|NCT02174224|Intentional Injury|intentional injury
333221|NCT02174224|Violence Intervention|violence intervention
333222|NCT02174224|Youth|youth
333223|NCT02174224|recidivism|recidivism
333224|NCT02174198|Immediate implant|immediate implant
333225|NCT02174198|bone graft|bone graft
333226|NCT02174198|immediate restoration|immediate restoration
333227|NCT02174185|bladder cancer|bladder cancer
333228|NCT02174185|conduit diversion|conduit diversion
333229|NCT02174185|orthotopic neobladder|orthotopic neobladder
333230|NCT02174185|health-related quality of life|health-related quality of life
333231|NCT02174185|validated questionnaire|validated questionnaire
333232|NCT02174146|leptin|leptin
333233|NCT02174146|visfatin|visfatin
333234|NCT02174146|chronic periodontitis|chronic periodontitis
333235|NCT02174146|diabetes mellitus|diabetes mellitus
333236|NCT02174146|non-surgical periodontal therapy|non-surgical periodontal therapy
333237|NCT02174133|left ventricular assist device|left ventricular assist device
333238|NCT02174133|endothelial function|endothelial function
333239|NCT02174133|microvascular perfusion|microvascular perfusion
333240|NCT02174133|microparticles|microparticles
333241|NCT02174107|Health economics|health economics
333242|NCT02174107|Percutaneous vertebroplasty|percutaneous vertebroplasty
333243|NCT02174107|Radiation therapy|radiation therapy
333244|NCT02174107|Painful spine metastases|painful spine metastases
333245|NCT02174081|mechanical ventilation, ARDS, Ventilator strategy, outcome|mechanical ventilation, ards, ventilator strategy, outcome
333246|NCT02174068|Paracetamol|paracetamol
333247|NCT02174068|Nefopam|nefopam
333248|NCT02174068|Pharmacokinetic|pharmacokinetic
333249|NCT02174068|Drug interaction|drug interaction
333250|NCT02174055|Depression|depression
333251|NCT02174055|14-101|14-101
333252|NCT02174029|Atrophy|atrophy
333253|NCT02174029|Ventilator|ventilator
333254|NCT02174029|Induced|induced
333255|NCT02174029|Diaphragm|diaphragm
333256|NCT02174029|Dysfunction|dysfunction
333257|NCT02174016|Intensive Care Units|intensive care units
333258|NCT02174016|Pediatric|pediatric
333259|NCT02174003|whole body hyperthermia|whole body hyperthermia
333260|NCT02174003|depression|depression
333261|NCT02174003|fibromyalgia|fibromyalgia
333262|NCT02174003|rheumatoid arthritis|rheumatoid arthritis
333263|NCT02174003|perimenopausal symptoms|perimenopausal symptoms
333264|NCT02174003|open treatment|open treatment
333265|NCT02173990|adenocarcinoma|adenocarcinoma
333266|NCT02173990|colon and/or rectum|colon and/or rectum
333267|NCT02173977|GnRH Agonist|gnrh agonist
333268|NCT02173977|GnRH Antagonist|gnrh antagonist
333269|NCT02173977|OHSS|ohss
333270|NCT02173964|fluorodeoxyglucose|fluorodeoxyglucose
333271|NCT02173964|positron emission tomography|positron emission tomography
333272|NCT02173964|computed tomography|computed tomography
333273|NCT02173964|bowel|bowel
333274|NCT02173964|pinaverium bromide|pinaverium bromide
333275|NCT02173951|young minimally transfused beta thalassemia major|young minimally transfused beta thalassemia major
333276|NCT02173951|labile plasma iron (LPI)|labile plasma iron (lpi)
333277|NCT02173951|Transferrin saturation (TSAT)|transferrin saturation (tsat)
333278|NCT02173951|Deferiprone|deferiprone
333279|NCT02173951|Transfusional iron loading rate|transfusional iron loading rate
333280|NCT02173951|Transfusion units|transfusion units
333281|NCT02173938|Smokers|smokers
333282|NCT02173938|outpatient|outpatient
333283|NCT02173938|Tobacco Dependence Treatment Program|tobacco dependence treatment program
333284|NCT02173873|Age related macular degeneration|age related macular degeneration
333285|NCT02173873|central retinal vein occlusion|central retinal vein occlusion
333286|NCT02173860|Coronary artery disease|coronary artery disease
333287|NCT02173860|Valvular heart disease|valvular heart disease
333288|NCT02173860|Fractional flow reserve|fractional flow reserve
333289|NCT02173860|Coronary artery bypass surgery|coronary artery bypass surgery
333290|NCT02173860|Coronary graft failure or patency|coronary graft failure or patency
333291|NCT02173847|anvil-shaped corneal graft|anvil-shaped corneal graft
333292|NCT02173847|penetrating keratoplasty|penetrating keratoplasty
333293|NCT02173847|femtosecond laser|femtosecond laser
333294|NCT02173847|laser welding|laser welding
425893|NCT01752062|CML|cml
333295|NCT02173834|Brown Adipose Tissue|brown adipose tissue
333296|NCT02173834|Weight|weight
333297|NCT02173834|Sympathetic Nervous System|sympathetic nervous system
333298|NCT02173756|chemotherapy|chemotherapy
333299|NCT02173756|mucositis|mucositis
333300|NCT02173756|systemic opioids|systemic opioids
333301|NCT02173756|morphine|morphine
333302|NCT02173743|plasma, calcific tendinitis, rotator cuff, PRP|plasma, calcific tendinitis, rotator cuff, prp
333303|NCT02173704|Meningitis|meningitis
333304|NCT02173704|Infants|infants
333305|NCT02173704|Meningococcal B Recombinant Vaccine|meningococcal b recombinant vaccine
333306|NCT02173626|Mindfulness|mindfulness
333307|NCT02173613|infection lung elderly patients|infection lung elderly patients
333308|NCT02173600|Cardiovascular risk|cardiovascular risk
333309|NCT02173600|Primary prevention|primary prevention
333310|NCT02173600|Intensive dietary counselling|intensive dietary counselling
333311|NCT02173600|Physical exercise|physical exercise
333312|NCT02173587|Anti-inflammation, Rheumatoid arthritis, Thick shell mussel lipid extract, Chinese|anti-inflammation, rheumatoid arthritis, thick shell mussel lipid extract, chinese
333313|NCT02173574|Hepatitis C Virus, Viral, Antiviral, Infection, Infectious disease, alisporivir, EDP239, DEB025|hepatitis c virus, viral, antiviral, infection, infectious disease, alisporivir, edp239, deb025
333314|NCT02173561|Posttraumatic Stress Disorder|posttraumatic stress disorder
333315|NCT02173561|Cognitive Processing Therapy|cognitive processing therapy
333316|NCT02173561|combat|combat
333317|NCT02173561|military|military
333318|NCT02173561|CPT|cpt
333319|NCT02173561|group therapy|group therapy
333320|NCT02173548|heart failure|heart failure
333321|NCT02173548|HFpEF|hfpef
333322|NCT02173548|diastole|diastole
333323|NCT02173548|diastolic heart failure|diastolic heart failure
333324|NCT02173548|inflammation|inflammation
333325|NCT02173548|interleukin-1|interleukin-1
333326|NCT02173548|C-reactive protein|c-reactive protein
333327|NCT02173522|Prostate cancer|prostate cancer
333328|NCT02173522|Prostate artery embolization|prostate artery embolization
333329|NCT02173522|Robot-assisted laparoscopic radical prostatectomy|robot-assisted laparoscopic radical prostatectomy
333330|NCT02173496|Wet age-related macular degeneration|wet age-related macular degeneration
333331|NCT02173496|Assessment modalities for preclinical, pre-symptomatic ARMD|assessment modalities for preclinical, pre-symptomatic armd
333332|NCT02173457|Chiglitazar|chiglitazar
333333|NCT02173457|Sitagliptin|sitagliptin
333334|NCT02173457|diabetes|diabetes
333335|NCT02173457|type 2 diabetes|type 2 diabetes
333336|NCT02173444|in-vitro fertilization|in-vitro fertilization
333337|NCT02173444|ovarian stimulation|ovarian stimulation
333338|NCT02173431|BMI|bmi
333339|NCT02173431|Pressure|pressure
333340|NCT02173431|Bedsore|bedsore
333341|NCT02173418|Postoperative pain|postoperative pain
333342|NCT02173418|Acute postoperative pain|acute postoperative pain
333343|NCT02173418|Chronic postoperative pain|chronic postoperative pain
333344|NCT02173418|Shoulder pain|shoulder pain
333345|NCT02173418|Thoracotomy|thoracotomy
333346|NCT02173418|Thoracoscopy|thoracoscopy
333347|NCT02173405|Myofascial Pain Syndromes|myofascial pain syndromes
333348|NCT02173405|Pelvic pain|pelvic pain
333349|NCT02173405|Trigger points + injections|trigger points + injections
333350|NCT02173405|Myofascial Trigger Point Pain|myofascial trigger point pain
333351|NCT02173405|Trigger Point Pain, Myofascial|trigger point pain, myofascial
333352|NCT02173405|Botulinum Toxins, Type A|botulinum toxins, type a
333353|NCT02173405|Botulinum Neurotoxin A|botulinum neurotoxin a
333354|NCT02173405|Botulinum Toxin Type A|botulinum toxin type a
333355|NCT02173405|Clostridium botulinum A Toxin|clostridium botulinum a toxin
333356|NCT02173405|Clostridium Botulinum Toxin Type A|clostridium botulinum toxin type a
333357|NCT02173405|Oculinum|oculinum
333358|NCT02173379|Absorb™ BVS|absorb™ bvs
333359|NCT02173379|Angioplasty|angioplasty
333360|NCT02173379|Bioabsorbable|bioabsorbable
333361|NCT02173379|BVS|bvs
333362|NCT02173379|Coronary Artery Disease|coronary artery disease
333363|NCT02173379|Coronary Artery Endothelial Responsiveness|coronary artery endothelial responsiveness
333364|NCT02173379|Coronary artery restenosis|coronary artery restenosis
333365|NCT02173379|Coronary artery stenosis|coronary artery stenosis
333366|NCT02173379|Coronary scaffold|coronary scaffold
333367|NCT02173379|Coronary Stent|coronary stent
333368|NCT02173379|Drug eluting stents|drug eluting stents
333369|NCT02173379|Everolimus|everolimus
333370|NCT02173379|Myocardial ischemia|myocardial ischemia
333371|NCT02173379|Stent thrombosis|stent thrombosis
333372|NCT02173379|Stents|stents
333373|NCT02173353|Ultrasound use during radiation therapy for Pancreas cancer|ultrasound use during radiation therapy for pancreas cancer
333374|NCT02173314|Long term foster care|long term foster care
333375|NCT02173314|child abuse and neglect|child abuse and neglect
333376|NCT02173262|Breast|breast
333377|NCT02173236|Dental Implant Platform Switching|dental implant platform switching
333378|NCT02173236|Early Dental Implant Loading|early dental implant loading
333379|NCT02173210|Premature birth|premature birth
333380|NCT02173210|Premature delivery|premature delivery
333381|NCT02173210|Metabolomics|metabolomics
333382|NCT02173210|Microbiota|microbiota
333383|NCT02173210|Genetics|genetics
333384|NCT02173210|17 hydroxyprogesterone caproate|17 hydroxyprogesterone caproate
333385|NCT02173197|Occupational Therapy|occupational therapy
333386|NCT02173197|Complex patients|complex patients
333387|NCT02173197|Occupational performance problem|occupational performance problem
333388|NCT02173197|Rehabilitation Complexity Scale|rehabilitation complexity scale
333389|NCT02173184|bacterial vaginosis|bacterial vaginosis
333390|NCT02173184|Gynevac Lactobacillus vaccine|gynevac lactobacillus vaccine
333391|NCT02173171|Melanoma|melanoma
333392|NCT02173171|talimogene laherparepvec|talimogene laherparepvec
333393|NCT02173145|idiopathic pulmonary fibrosis|idiopathic pulmonary fibrosis
333394|NCT02173145|cough|cough
333395|NCT02173145|immunomodulation|immunomodulation
333396|NCT02173145|macrolide|macrolide
333397|NCT02173119|Hepatocellular|hepatocellular
333398|NCT02173119|Carcinoma|carcinoma
333399|NCT02173119|HCC|hcc
333400|NCT02173119|lipiodol|lipiodol
333401|NCT02173093|Neuroblastoma|neuroblastoma
333402|NCT02173093|Solid tumor|solid tumor
333403|NCT02173093|Immunotherapy targeting GD2|immunotherapy targeting gd2
333404|NCT02173093|Bispecific antibodies|bispecific antibodies
333405|NCT02173093|Activated T cells|activated t cells
333406|NCT02173080|autosomal dominant polycystic liver disease|autosomal dominant polycystic liver disease
333407|NCT02173080|autosomal dominant polycystic kidney disease|autosomal dominant polycystic kidney disease
333408|NCT02173080|quality of life|quality of life
333409|NCT02173080|patient reported outcome tool|patient reported outcome tool
333410|NCT02173067|Diabetes mellitus|diabetes mellitus
333411|NCT02173067|Epinephrine|epinephrine
333412|NCT02173067|Anesthesia, Dental|anesthesia, dental
333413|NCT02173067|lidocaine|lidocaine
333414|NCT02173067|Ambulatory Surgical Procedures|ambulatory surgical procedures
333415|NCT02173054|Acne|acne
333416|NCT02173054|Moisturizer|moisturizer
333417|NCT02173054|Efficacy|efficacy
333418|NCT02173054|Irritation|irritation
333419|NCT02173041|Prevention and Awareness Groups (PAG),|prevention and awareness groups (pag),
333420|NCT02173041|Substance Use Disorder,|substance use disorder,
333421|NCT02173041|Community based intervention|community based intervention
333422|NCT02173028|Beta Blocker Intolerance;|beta blocker intolerance;
333423|NCT02173028|Remote Patient Management system;|remote patient management system;
333424|NCT02173028|Cardiac Resynchronization Therapy|cardiac resynchronization therapy
333425|NCT02173015|accidental falls|accidental falls
333426|NCT02173015|older adults|older adults
333427|NCT02173015|long-term care|long-term care
333428|NCT02173015|nursing home|nursing home
333429|NCT02173015|postural balance|postural balance
333430|NCT02173002|Telemedicine|telemedicine
333431|NCT02173002|Patient empowerment|patient empowerment
333432|NCT02173002|Integrated care|integrated care
333433|NCT02172989|Near-infrared fluorescence|near-infrared fluorescence
333434|NCT02172989|Indocyanine green, ICG|indocyanine green, icg
333435|NCT02172989|Radio-guided surgery|radio-guided surgery
333436|NCT02172989|breast cancer|breast cancer
333437|NCT02172976|pancreas cancer|pancreas cancer
333438|NCT02172976|neoadjuvant chemotherapy|neoadjuvant chemotherapy
333439|NCT02172976|Folfirinox|folfirinox
333440|NCT02172976|gemcitabine|gemcitabine
333441|NCT02172963|Stem Cell Transplantation|stem cell transplantation
333442|NCT02172963|Decidual Stromal Cells|decidual stromal cells
333443|NCT02172937|Stem Cell Transplantation|stem cell transplantation
333444|NCT02172937|Decidual Stromal Cells|decidual stromal cells
333445|NCT02172924|Stem Cell Transplantation|stem cell transplantation
333446|NCT02172924|Decidual Stromal Cells|decidual stromal cells
333447|NCT02172911|Cervical cancer|cervical cancer
333448|NCT02172911|Papillomavirus|papillomavirus
333449|NCT02172911|Chemoradiation|chemoradiation
333450|NCT02172911|Recurrent cervical cancer|recurrent cervical cancer
333451|NCT02172911|Persistent cervical cancer|persistent cervical cancer
333452|NCT02172885|Mesenchymal stem cell based therapy|mesenchymal stem cell based therapy
333453|NCT02172885|cell infusion|cell infusion
333454|NCT02172872|Newly diagnosed|newly diagnosed
333455|NCT02172872|AML|aml
333456|NCT02172872|Elderly|elderly
333457|NCT02172872|Decitabine|decitabine
333458|NCT02172872|Transplant|transplant
333459|NCT02172859|lumiVida™, cognition, mood, sleep, tryptophane|lumivida™, cognition, mood, sleep, tryptophane
333460|NCT02172820|cardiac rehabilitation|cardiac rehabilitation
333461|NCT02172820|contingency management|contingency management
333462|NCT02172768|pharmacokinetics|pharmacokinetics
333463|NCT02172768|alternate dosing|alternate dosing
333464|NCT02172768|micafungin|micafungin
333465|NCT02172755|Eslicarbazepine acetate|eslicarbazepine acetate
333466|NCT02172755|BIA 2-093|bia 2-093
333467|NCT02172742|Eslicarbazepine acetate|eslicarbazepine acetate
333468|NCT02172742|BIA 2-093|bia 2-093
333469|NCT02172729|adductor canal block|adductor canal block
333470|NCT02172729|healthy volunteers|healthy volunteers
333471|NCT02172729|US-guided peripheral nerve block|us-guided peripheral nerve block
333472|NCT02172729|lower limb|lower limb
333473|NCT02172729|duration|duration
333474|NCT02172729|Muscle Strength|muscle strength
333475|NCT02172729|Anesthetics, Local|anesthetics, local
333476|NCT02172729|Sensation|sensation
333477|NCT02172703|TBI|tbi
333478|NCT02172703|SAH|sah
333479|NCT02172703|ICP|icp
333480|NCT02172703|non invasive measurement|non invasive measurement
333481|NCT02172690|Gastric Cancer|gastric cancer
333482|NCT02172690|Laparoscopic Staging|laparoscopic staging
333483|NCT02172690|Cytology|cytology
333484|NCT02172690|Peritoneal Metastases|peritoneal metastases
333485|NCT02172664|noncarious cervical lesions|noncarious cervical lesions
333486|NCT02172664|dental adhesive|dental adhesive
333487|NCT02172664|retention|retention
333488|NCT02172664|enamel margin discoloration|enamel margin discoloration
333489|NCT02172664|self etch|self etch
333490|NCT02172664|selective etch procedures|selective etch procedures
333491|NCT02172651|Vitamin D|vitamin d
333492|NCT02172651|Stage I-III colon cancer|stage i-iii colon cancer
333493|NCT02172651|Stage IV colon cancer|stage iv colon cancer
333494|NCT02172651|Resectable liver metastases|resectable liver metastases
333495|NCT02172638|Enhanced Recovery After Surgery|enhanced recovery after surgery
333496|NCT02172638|ERAS|eras
333497|NCT02172638|Fast-Track|fast-track
333498|NCT02172638|Ovarian cancer|ovarian cancer
333499|NCT02172638|Gynecologic surgery|gynecologic surgery
333500|NCT02172638|Gynecology oncology|gynecology oncology
333501|NCT02172638|Median length of stay|median length of stay
333502|NCT02172638|Readmission rate|readmission rate
333503|NCT02172638|Surgery related complications|surgery related complications
333504|NCT02172638|Cost|cost
333505|NCT02172625|Athletic performance|athletic performance
333506|NCT02172625|Running|running
333507|NCT02172625|Dietary supplementation|dietary supplementation
333508|NCT02172625|Quality of life|quality of life
333509|NCT02172625|Running performance|running performance
333510|NCT02172625|oxidative damage|oxidative damage
333511|NCT02172612|Anticholinergic drugs|anticholinergic drugs
333512|NCT02172599|sit-stand workstation|sit-stand workstation
333513|NCT02172599|workplace|workplace
333514|NCT02172599|multi-component intervention|multi-component intervention
333515|NCT02172599|randomised control trial design|randomised control trial design
333516|NCT02172599|physical activity|physical activity
333517|NCT02172599|sitting|sitting
333518|NCT02172599|sedentary behaviour|sedentary behaviour
333519|NCT02172599|process evaluation|process evaluation
333520|NCT02172599|health|health
333521|NCT02172365|Chronic myeloid leukemia|chronic myeloid leukemia
333522|NCT02172365|Allogeneic hematopoietic cell transplantation|allogeneic hematopoietic cell transplantation
333523|NCT02172365|Tyrosine kinase inhibitor|tyrosine kinase inhibitor
333524|NCT02172365|TKI failure|tki failure
333525|NCT02172183|cognitive-behavioral therapy, adolescents, ADHD.|cognitive-behavioral therapy, adolescents, adhd.
333526|NCT02172092|Diabetes|diabetes
333527|NCT02172092|Ketoacidosis|ketoacidosis
333528|NCT02172092|fluid shift|fluid shift
333529|NCT02172079|shoulder impingement, manual therapy, pain, motion.|shoulder impingement, manual therapy, pain, motion.
333530|NCT02172066|Posttraumatic Stress Disorder|posttraumatic stress disorder
333531|NCT02172066|Childhood maltreatment|childhood maltreatment
333532|NCT02172053|Workplace|workplace
333533|NCT02172053|Industrial workers|industrial workers
333534|NCT02172053|Resistance exercise|resistance exercise
333535|NCT02172053|Fatigue|fatigue
333536|NCT02172053|Occupational risk|occupational risk
333537|NCT02172053|Physical therapy|physical therapy
333538|NCT02172040|High blood pressure|high blood pressure
333539|NCT02172040|Systolic blood pressure|systolic blood pressure
333540|NCT02172040|Diastolic blood pressure|diastolic blood pressure
333541|NCT02172040|Antihypertensive|antihypertensive
333542|NCT02172014|Mechanical Ventilation|mechanical ventilation
333543|NCT02172014|Sedation|sedation
333544|NCT02172014|Fentanyl|fentanyl
333545|NCT02172014|Midazolam|midazolam
333546|NCT02172014|Comfort behavior scale|comfort behavior scale
333548|NCT02172001|Iron deficiency|iron deficiency
333549|NCT02172001|iron deficiency anemia and who are intolerant or unresponsive to oral iron therapy|iron deficiency anemia and who are intolerant or unresponsive to oral iron therapy
333550|NCT02171988|Postural Orthostatic Tachycardia Syndrome|postural orthostatic tachycardia syndrome
333551|NCT02171988|propranolol|propranolol
333552|NCT02171988|bisoprolol|bisoprolol
333553|NCT02171988|pyridostigmine|pyridostigmine
333554|NCT02171975|Spinal anaesthesia|spinal anaesthesia
333555|NCT02171975|Ultrasound pre-procedure guided|ultrasound pre-procedure guided
333556|NCT02171975|Paramedian spinal|paramedian spinal
333557|NCT02171962|Zilver® PTX® Drug-Eluting Peripheral Stent|zilver® ptx® drug-eluting peripheral stent
333558|NCT02171962|Above-the-Knee Femoropopliteal Artery|above-the-knee femoropopliteal artery
333559|NCT02171962|Chinese patient|chinese patient
333560|NCT02171949|Chronic hepatitis|chronic hepatitis
333561|NCT02171949|Hepatic cirrhosis|hepatic cirrhosis
333562|NCT02171936|Pain|pain
333563|NCT02171936|Precariousness|precariousness
333564|NCT02171936|EPICES Score|epices score
333565|NCT02171936|CETD|cetd
333566|NCT02171923|depression|depression
333567|NCT02171910|Cholangiopancreatography, Endoscopic Retrograde|cholangiopancreatography, endoscopic retrograde
333568|NCT02171910|Sedation|sedation
426275|NCT01750008|RFA|rfa
333569|NCT02171871|EFFECTS,|effects,
333570|NCT02171871|PASSIVE SMOKING ,|passive smoking ,
333571|NCT02171871|RESPIRATORY SYSTEM MECHANICS,|respiratory system mechanics,
333572|NCT02171871|DIFFERENT BODY POSITIONS.|different body positions.
333573|NCT02171858|Stroke|stroke
333574|NCT02171858|National Institutes of Health Stroke Scale|national institutes of health stroke scale
333575|NCT02171858|Serum high sensitivity C-Reactive Protein|serum high sensitivity c-reactive protein
333576|NCT02171845|Male foetuses of 10 to 37 weeks|male foetuses of 10 to 37 weeks
333577|NCT02171819|Influenza|influenza
333578|NCT02171819|Avian|avian
333579|NCT02171819|H5N1|h5n1
333580|NCT02171819|Vaccine|vaccine
333581|NCT02171390|Hypogonadism|hypogonadism
333582|NCT02171390|Endothelial dysfunction|endothelial dysfunction
333583|NCT02171390|Insulin resistance|insulin resistance
333584|NCT02171390|Inflammation|inflammation
333585|NCT02171390|Testosterone replacement therapy|testosterone replacement therapy
333586|NCT02171377|COPD|copd
333587|NCT02171377|electrical stimulation|electrical stimulation
333588|NCT02171377|Rehabilitation|rehabilitation
333589|NCT02171377|exercise test|exercise test
333590|NCT02171364|Atrial fibrillation, Virtual ablation, electrocardiography, electroanatomical mapping data|atrial fibrillation, virtual ablation, electrocardiography, electroanatomical mapping data
333591|NCT02171351|sympathetic nerve reactivity|sympathetic nerve reactivity
333592|NCT02171351|neuromuscular electrostimulation|neuromuscular electrostimulation
333593|NCT02171338|Procalcitonin|procalcitonin
333594|NCT02171338|Antibiotic therapy|antibiotic therapy
333595|NCT02171338|Lower respiratory tract diseases|lower respiratory tract diseases
333596|NCT02171325|irinotecan|irinotecan
333597|NCT02171325|Small Cell Lung Cancer|small cell lung cancer
333598|NCT02171312|Dizziness|dizziness
333599|NCT02171312|Imbalance|imbalance
333600|NCT02171286|KRAS|kras
333601|NCT02171286|EGFR|egfr
333602|NCT02171286|BRAF|braf
333603|NCT02171286|NRAS and HRAS|nras and hras
333604|NCT02171286|PIK3CA|pik3ca
333605|NCT02171286|RAS-RAF-MEK-MAPK|ras-raf-mek-mapk
333606|NCT02171286|HER2|her2
333607|NCT02171286|IDH1 and IDH2|idh1 and idh2
333608|NCT02171286|ALK|alk
333609|NCT02171286|TP53|tp53
333610|NCT02171286|c-KIT|c-kit
333611|NCT02171286|STAT1&3|stat1&3
333612|NCT02171286|PDGFRA|pdgfra
333613|NCT02171286|Metastatic colorectal cancer|metastatic colorectal cancer
333614|NCT02171286|Advanced non-small cell lung cancer|advanced non-small cell lung cancer
333615|NCT02171286|Advanced melanoma|advanced melanoma
333616|NCT02171286|Gastrointestingal Struma Tumor|gastrointestingal struma tumor
333617|NCT02171286|Candidate genes implicated as potential prognostic and predictive biomarkers in patients with solid tumours|candidate genes implicated as potential prognostic and predictive biomarkers in patients with solid tumours
333618|NCT02171286|Circulating Tumor DNA|circulating tumor dna
333619|NCT02171273|Sleep|sleep
333620|NCT02171273|Aging|aging
333621|NCT02171273|Metabolism|metabolism
333622|NCT02171273|Circadian|circadian
333623|NCT02171273|Genetic|genetic
333624|NCT02171273|Alertness|alertness
333625|NCT02171260|Tumors|tumors
333626|NCT02171260|Lymphomas|lymphomas
333627|NCT02171260|Solid Tumors|solid tumors
333628|NCT02171260|Pediatric|pediatric
333629|NCT02171247|coronary computed tomographic angiography|coronary computed tomographic angiography
333630|NCT02171247|contrast|contrast
333631|NCT02171234|Epilepsy|epilepsy
333632|NCT02171234|BIA 2-093|bia 2-093
333633|NCT02171234|Eslicarbazepine acetate|eslicarbazepine acetate
333634|NCT02171221|Refractory or relapsed tumors|refractory or relapsed tumors
333635|NCT02171221|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic
333636|NCT02171221|Fluorouracil|fluorouracil
333637|NCT02171195|Eslicarbazepine acetate|eslicarbazepine acetate
333638|NCT02171195|BIA 2-093|bia 2-093
333639|NCT02171195|Epilepsy|epilepsy
333640|NCT02171182|Qutenza|qutenza
333641|NCT02171182|8% capsaicin patch|8% capsaicin patch
333642|NCT02171182|Non-interventional|non-interventional
333643|NCT02171182|Post-operative peripheral neuropathic pain|post-operative peripheral neuropathic pain
333644|NCT02171182|Observational|observational
333645|NCT02171182|Czech Republic|czech republic
333646|NCT02171143|ASP2409|asp2409
333647|NCT02171143|Rheumatoid Arthritis|rheumatoid arthritis
333648|NCT02171143|methotrexate|methotrexate
333649|NCT02171130|Diabetes Mellitus|diabetes mellitus
333650|NCT02171130|Hypoglycemia|hypoglycemia
333651|NCT02171130|Glucagon|glucagon
333652|NCT02171130|Anti-glucagon Antibody|anti-glucagon antibody
333653|NCT02171130|Immunogenicity|immunogenicity
333654|NCT02171117|Acute Myeloid Leukemia|acute myeloid leukemia
333655|NCT02171117|microtransplantation|microtransplantation
333656|NCT02171117|elderly patients|elderly patients
333657|NCT02171117|HLA-mismatched|hla-mismatched
333658|NCT02171117|donor|donor
333659|NCT02171117|Peripheral|peripheral
333660|NCT02171117|stem cell|stem cell
333661|NCT02171117|infusion|infusion
333662|NCT02171104|allogeneic hematopoietic cell transplantation|allogeneic hematopoietic cell transplantation
333663|NCT02171104|bone marrow transplantation|bone marrow transplantation
333664|NCT02171104|IMD|imd
333665|NCT02171104|AMACRD|amacrd
333666|NCT02171104|MNGIE|mngie
333667|NCT02171104|HDLS|hdls
333668|NCT02171104|OP|op
333669|NCT02171104|ALD|ald
333670|NCT02171091|endotracheal|endotracheal
333671|NCT02171091|intubation|intubation
333672|NCT02171091|airway|airway
333673|NCT02171091|inflammation|inflammation
333674|NCT02171078|Breast Cancer|breast cancer
333675|NCT02171078|Breast Neoplasms|breast neoplasms
333676|NCT02171078|Health Services Research|health services research
333677|NCT02171078|Surveillance|surveillance
333678|NCT02171078|Diagnostic Imaging|diagnostic imaging
333679|NCT02171078|Magnetic Resonance Imaging|magnetic resonance imaging
333680|NCT02171078|Mammography|mammography
333681|NCT02171078|Toxicity|toxicity
333682|NCT02171078|Adverse Effects|adverse effects
333683|NCT02171078|Side Effects|side effects
333684|NCT02171078|Recurrence|recurrence
333685|NCT02171065|NIRS/IVUS|nirs/ivus
333686|NCT02171065|multimodality imaging|multimodality imaging
333687|NCT02171065|PROSPECT|prospect
333688|NCT02170961|Acute heart failure|acute heart failure
333689|NCT02170961|RAAS|raas
333690|NCT02170961|MMP3|mmp3
333691|NCT02170961|MMP12|mmp12
333692|NCT02170961|Polymorphysm|polymorphysm
333693|NCT02170948|ultrasound-guided regional anesthesia|ultrasound-guided regional anesthesia
333694|NCT02170948|nerve block|nerve block
333695|NCT02170948|ankle block|ankle block
333696|NCT02170948|dexmedetomidine|dexmedetomidine
333697|NCT02170948|Precedex|precedex
333698|NCT02170948|ankle surgery|ankle surgery
333699|NCT02170948|forefoot surgery|forefoot surgery
333700|NCT02170948|duration|duration
333701|NCT02170948|anesthetic duration following ankle block for forefoot surgery|anesthetic duration following ankle block for forefoot surgery
333702|NCT02170883|asthma|asthma
333703|NCT02170883|mHealth|mhealth
333704|NCT02170883|cluster randomized controlled trial|cluster randomized controlled trial
333705|NCT02170883|pharmacy practice|pharmacy practice
333706|NCT02170883|pharmacist|pharmacist
333707|NCT02170857|Hyaluronic acid|hyaluronic acid
333708|NCT02170857|infra-bony defects|infra-bony defects
333709|NCT02170857|chronic periodontitis|chronic periodontitis
333710|NCT02170857|experimental|experimental
333711|NCT02170857|radiographic|radiographic
333712|NCT02170857|clinical|clinical
333713|NCT02170857|periodontal surgical treatment|periodontal surgical treatment
333714|NCT02170857|open flap curettage|open flap curettage
333715|NCT02170818|Education|education
333716|NCT02170818|Curriculum|curriculum
333717|NCT02170818|Anesthesiology|anesthesiology
333718|NCT02170818|Operating Rooms|operating rooms
333719|NCT02170779|multiple sclerosis|multiple sclerosis
333720|NCT02170779|spasticity|spasticity
333721|NCT02170779|stretching|stretching
333722|NCT02170779|exercise|exercise
333723|NCT02170779|rehabilitation|rehabilitation
333724|NCT02170714|Acute severe colitis|acute severe colitis
333725|NCT02170714|Children|children
333726|NCT02170714|Infliximab|infliximab
333727|NCT02170714|colectomy|colectomy
333728|NCT02170688|IV contrast|iv contrast
333729|NCT02170688|contrast dosing|contrast dosing
333730|NCT02170662|male pattern hair loss|male pattern hair loss
333731|NCT02170662|androgenetic alopecia|androgenetic alopecia
333732|NCT02170662|bimatoprost|bimatoprost
333733|NCT02170649|BIA 2-093|bia 2-093
333734|NCT02170649|Eslicarbazepine acetate|eslicarbazepine acetate
333735|NCT02170558|Trabecular Metal|trabecular metal
333736|NCT02170558|Metal reduction CT|metal reduction ct
333737|NCT02170558|TM- Ardis|tm- ardis
333738|NCT02170545|avascular necrosis|avascular necrosis
333739|NCT02170545|humeral head fracture|humeral head fracture
333740|NCT02170545|proximal arm fracture|proximal arm fracture
333741|NCT02170545|arthroplasty|arthroplasty
333742|NCT02170532|asthma|asthma
333743|NCT02170519|pulmonary hypertension|pulmonary hypertension
333744|NCT02170493|Insole Sensor|insole sensor
333745|NCT02170493|Optimial Limb Loading|optimial limb loading
333746|NCT02170493|42IIIB|42iiib
333747|NCT02170493|IIIC|iiic
333748|NCT02170493|Lower Extremity Fractures|lower extremity fractures
333749|NCT02170467|Intestinal permeability - Anorexia nervosa- Re feeding - auto-antibodies α-MSH|intestinal permeability - anorexia nervosa- re feeding - auto-antibodies α-msh
333750|NCT02170454|neuromodulation|neuromodulation
333751|NCT02170454|swallowing|swallowing
333752|NCT02170454|magnetic stimulation|magnetic stimulation
333753|NCT02170454|healthy subjects|healthy subjects
333754|NCT02170441|Tuberculosis|tuberculosis
333755|NCT02170441|Multi-drug resistant tuberculosis|multi-drug resistant tuberculosis
333756|NCT02170441|Extensively drug-resistant tuberculosis|extensively drug-resistant tuberculosis
333757|NCT02170441|Drug-resistant tuberculosis|drug-resistant tuberculosis
333758|NCT02170441|Mycobacterial Growth Indicator Tube Drug Susceptibility Test|mycobacterial growth indicator tube drug susceptibility test
333759|NCT02170441|Line Probe Assay|line probe assay
333760|NCT02170441|Microscopic Observation Drug Susceptibility Assay|microscopic observation drug susceptibility assay
768891|NCT00371878|Vaccine|vaccine
333761|NCT02170441|Pyrosequencing|pyrosequencing
333762|NCT02170428|growth,|growth,
333763|NCT02170428|infancy,|infancy,
333764|NCT02170428|children,|children,
333765|NCT02170428|diet,|diet,
333766|NCT02170428|breastfeeding|breastfeeding
333767|NCT02170428|complementary feeding|complementary feeding
333768|NCT02170428|early life programming|early life programming
333769|NCT02170428|tracking|tracking
333770|NCT02170428|physical activity|physical activity
333771|NCT02170415|Persistent post-surgical pain|persistent post-surgical pain
333772|NCT02170415|Breast surgery|breast surgery
333773|NCT02170415|Complex intervention|complex intervention
333774|NCT02170415|Pain treatment|pain treatment
333775|NCT02170376|Parkinson's disease (PD)|parkinson's disease (pd)
333776|NCT02170376|BIA 9-1067|bia 9-1067
333777|NCT02170376|Opicapone|opicapone
333778|NCT02170363|Heart Failure|heart failure
333779|NCT02170363|Ventricular Dysfunction|ventricular dysfunction
333780|NCT02170363|Cardiomyopathies|cardiomyopathies
333781|NCT02170363|Heart Disease|heart disease
333782|NCT02170363|Cardiovascular Disease|cardiovascular disease
333783|NCT02170363|Heart-assist devices|heart-assist devices
333784|NCT02170363|Thoratec Corporation|thoratec corporation
333785|NCT02170311|Z-213, Ferric carboxymaltose, Iron, Iron-deficiency-anemia|z-213, ferric carboxymaltose, iron, iron-deficiency-anemia
333786|NCT02170298|ADHD|adhd
333787|NCT02170298|Attention Deficit Hyperactivity Disorder|attention deficit hyperactivity disorder
333788|NCT02170298|Vyvanse|vyvanse
333789|NCT02170298|Lisdexamfetamine|lisdexamfetamine
333790|NCT02170285|perinatal stroke|perinatal stroke
333791|NCT02170285|hemiparetic cerebral palsy|hemiparetic cerebral palsy
333792|NCT02170285|brain stimulation|brain stimulation
333793|NCT02170285|tDCS|tdcs
333794|NCT02170285|constraint-induced movement therapy|constraint-induced movement therapy
333795|NCT02170285|hand arm bimanual intensive therapy|hand arm bimanual intensive therapy
333796|NCT02170259|Tension-type headache|tension-type headache
333797|NCT02170259|Depression|depression
333798|NCT02170259|Anxiety|anxiety
333799|NCT02170259|Manual therapy|manual therapy
333800|NCT02170259|Spinal manipulation|spinal manipulation
333801|NCT02170259|Patients diagnosed with tension-type headache|patients diagnosed with tension-type headache
333802|NCT02170246|Acute HIV infection|acute hiv infection
333803|NCT02170246|Central nervous system|central nervous system
333804|NCT02170246|Antiretroviral therapy|antiretroviral therapy
333805|NCT02170246|Telmisartan|telmisartan
333806|NCT02170246|Cerebrospinal fluid|cerebrospinal fluid
333807|NCT02170220|Drug therapy|drug therapy
333808|NCT02170207|Pharmacological therapy|pharmacological therapy
333809|NCT02170194|smart phone apps|smart phone apps
333810|NCT02170194|subthreshold PTSD|subthreshold ptsd
333811|NCT02170194|resilience enhancement|resilience enhancement
333812|NCT02170194|military veterans|military veterans
333813|NCT02170194|natural disasters|natural disasters
333814|NCT02170194|terrorism|terrorism
333815|NCT02170194|shootings|shootings
333816|NCT02170194|fMRI|fmri
333817|NCT02170194|physiology|physiology
333818|NCT02170181|SBRT|sbrt
333819|NCT02170181|prostate cancer|prostate cancer
333820|NCT02170181|lung cancer|lung cancer
333821|NCT02170181|bladder cancer|bladder cancer
333822|NCT02170181|kidney cancer|kidney cancer
333823|NCT02170181|oligometastatic disease|oligometastatic disease
333824|NCT02170168|Community health services|community health services
333825|NCT02170168|Models, organizational|models, organizational
333826|NCT02170168|Referral and consultation|referral and consultation
333827|NCT02170168|Palliative medicine|palliative medicine
333828|NCT02170168|Terminal care|terminal care
333829|NCT02170142|MRI|mri
333830|NCT02170142|perinatal brain|perinatal brain
333831|NCT02170142|development, neonates|development, neonates
333832|NCT02170103|segment elevation myocardial infarctions (STEMIs),|segment elevation myocardial infarctions (stemis),
333833|NCT02170103|sonothrombolysis|sonothrombolysis
333834|NCT02170103|reperfusion|reperfusion
333835|NCT02170103|percutaneous intervention (PCI),|percutaneous intervention (pci),
333836|NCT02170103|antithrombotic therapy,|antithrombotic therapy,
333837|NCT02170103|antiplatelet therapy,|antiplatelet therapy,
333838|NCT02170090|adjuvant chemotherapy|adjuvant chemotherapy
333839|NCT02170090|cholangiocarcinoma|cholangiocarcinoma
333840|NCT02170090|muscle invasive gall bladder carcinoma|muscle invasive gall bladder carcinoma
333841|NCT02170090|translational research|translational research
333842|NCT02170090|multidisciplinary|multidisciplinary
333843|NCT02170090|AIO, DGAV, DGVS|aio, dgav, dgvs
333844|NCT02170077|Epilepsy|epilepsy
333845|NCT02170077|BIA 2-093|bia 2-093
333846|NCT02170064|Epilepsy|epilepsy
333847|NCT02170064|BIA 2-093|bia 2-093
333848|NCT02170051|negative symptoms|negative symptoms
333849|NCT02170051|cognition|cognition
333850|NCT02170051|functioning|functioning
333851|NCT02170051|defeatist attitudes|defeatist attitudes
333852|NCT02170051|psychosocial treatment|psychosocial treatment
333853|NCT02170038|Drug Kinetics|drug kinetics
333854|NCT02170025|Cystic fibrosis|cystic fibrosis
333855|NCT02170025|delta F508|delta f508
333856|NCT02170025|Safety|safety
333857|NCT02170025|Tolerability|tolerability
333858|NCT02170025|Sweat Chloride|sweat chloride
333859|NCT02170025|Pharmacokinetics|pharmacokinetics
333860|NCT02170012|Multiple dose|multiple dose
333861|NCT02170012|safety|safety
333862|NCT02170012|tolerability|tolerability
333863|NCT02170012|PK|pk
333864|NCT02169973|Healthy|healthy
333865|NCT02169973|Positron Emission Tomography|positron emission tomography
333866|NCT02169973|11C-MK-3168|11c-mk-3168
333867|NCT02169973|JNJ-42165279|jnj-42165279
333868|NCT02169973|Human Brain|human brain
333869|NCT02169895|Parkinson's disease (PD)|parkinson's disease (pd)
333870|NCT02169895|Opicapone|opicapone
333871|NCT02169895|Bia 9-1067|bia 9-1067
333872|NCT02169882|Tuberculous meningitis|tuberculous meningitis
333873|NCT02169882|Rifampicin|rifampicin
333874|NCT02169882|Dose finding study|dose finding study
333875|NCT02169882|Pharmacokinetics|pharmacokinetics
334000|NCT02169362|Second degree burns|second degree burns
333876|NCT02169869|intrauterine device, postpartum, contraception, Mirena, Paragard, intrauterine system|intrauterine device, postpartum, contraception, mirena, paragard, intrauterine system
333877|NCT02169856|Cholecystectomy|cholecystectomy
333878|NCT02169856|Laparoscopic|laparoscopic
333879|NCT02169856|Postoperative Nausea and Vomiting|postoperative nausea and vomiting
333880|NCT02169843|Dexmedetomidine,|dexmedetomidine,
333881|NCT02169843|agitation,|agitation,
333882|NCT02169843|AFPS,|afps,
333883|NCT02169843|NRS,|nrs,
333884|NCT02169843|mean arterial pressure|mean arterial pressure
333885|NCT02169843|heart rate(HR)|heart rate(hr)
333886|NCT02169830|vestibular migraines, nortriptyline and topiramate|vestibular migraines, nortriptyline and topiramate
333887|NCT02169791|hematologic malignancies|hematologic malignancies
333888|NCT02169778|Weight loss|weight loss
333889|NCT02169778|Intermittent energy restriction|intermittent energy restriction
333890|NCT02169778|Metabolic compensation|metabolic compensation
333891|NCT02169778|Diet therapy|diet therapy
333892|NCT02169765|Hepatocellular Carcinoma|hepatocellular carcinoma
333893|NCT02169765|Liver Cancer|liver cancer
333894|NCT02169752|Pre-Pulmonary Atrial Hypertension|pre-pulmonary atrial hypertension
333895|NCT02169739|ischemic preconditioning|ischemic preconditioning
333896|NCT02169739|remote ischemic preconditioning|remote ischemic preconditioning
333897|NCT02169739|ischemic stroke|ischemic stroke
333898|NCT02169739|white matter disease|white matter disease
333899|NCT02169739|cerebral small vessel disease|cerebral small vessel disease
333900|NCT02169739|cognitive decline|cognitive decline
333901|NCT02169739|leukoaraiosis|leukoaraiosis
333902|NCT02169739|diffusion tensor imaging|diffusion tensor imaging
333903|NCT02169739|white matter hyper intensity score|white matter hyper intensity score
333904|NCT02169739|European scale of age-related white matter change|european scale of age-related white matter change
333905|NCT02169713|Healthy subjects|healthy subjects
333906|NCT02169713|Mirabegron|mirabegron
333907|NCT02169713|Solifenacin|solifenacin
333908|NCT02169713|Tamsulosin HCl|tamsulosin hcl
333909|NCT02169700|Ischemic compression|ischemic compression
333910|NCT02169700|Myofascial trigger points|myofascial trigger points
333911|NCT02169700|Post-needling soreness|post-needling soreness
333912|NCT02169687|Thyroid, HIFU, hyperfunctioning, autonomous|thyroid, hifu, hyperfunctioning, autonomous
333913|NCT02169674|Hepatitis B|hepatitis b
333914|NCT02169674|Vaccine|vaccine
333915|NCT02169674|Immunogenicity|immunogenicity
333916|NCT02169661|Oxidative stress|oxidative stress
333917|NCT02169661|Lipid peroxides|lipid peroxides
333918|NCT02169661|Phytochemicals|phytochemicals
333919|NCT02169661|Ready meals|ready meals
333920|NCT02169661|Beetroot|beetroot
333921|NCT02169661|Blood pressure|blood pressure
333922|NCT02169648|macular edema|macular edema
333923|NCT02169648|branch retinal vein occlusion|branch retinal vein occlusion
333924|NCT02169648|central retinal vein occlusion|central retinal vein occlusion
333925|NCT02169648|ranibizumab|ranibizumab
333926|NCT02169648|cytokines|cytokines
333927|NCT02169648|visual acuity|visual acuity
333928|NCT02169648|central macular thickness|central macular thickness
333929|NCT02169635|macular buckle|macular buckle
333930|NCT02169635|high myopia|high myopia
333931|NCT02169635|posterior staphyloma|posterior staphyloma
333932|NCT02169609|Neuroblastoma|neuroblastoma
333933|NCT02169609|Immunotherapy|immunotherapy
333934|NCT02169609|Dinutuximab|dinutuximab
333935|NCT02169596|Acute Coronary Syndrome|acute coronary syndrome
333936|NCT02169596|Nitric oxide|nitric oxide
333937|NCT02169596|Ticagrelor|ticagrelor
333938|NCT02169596|Antiplatelet agents|antiplatelet agents
333939|NCT02169596|Endothelial function|endothelial function
333940|NCT02169583|GSK1325756|gsk1325756
333941|NCT02169583|Safety|safety
333942|NCT02169583|Bioavailability|bioavailability
333943|NCT02169583|Pharmacokinetics|pharmacokinetics
333944|NCT02169570|Type 2 Diabetes Mellitus|type 2 diabetes mellitus
333945|NCT02169570|Pulmonary Tuberculosis|pulmonary tuberculosis
333946|NCT02169570|Vitamin D|vitamin d
333947|NCT02169570|Calcium|calcium
333948|NCT02169531|Diabetes Mellitus Type 2|diabetes mellitus type 2
333949|NCT02169531|Hyperglycemia|hyperglycemia
768892|NCT00371878|Lung|lung
333950|NCT02169531|Immunotherapy|immunotherapy
333951|NCT02169531|Autologous|autologous
333952|NCT02169518|PON1 activity|pon1 activity
333953|NCT02169518|HDL functionality|hdl functionality
333954|NCT02169518|LDL oxidation|ldl oxidation
333955|NCT02169518|Diabetes Mellitus Type 1|diabetes mellitus type 1
333956|NCT02169518|Obesity|obesity
333957|NCT02169518|Diabetes Mellitus Type 2|diabetes mellitus type 2
333958|NCT02169518|Bariatric Surgery|bariatric surgery
333959|NCT02169505|Lymphoma|lymphoma
333960|NCT02169505|Hodgkin lymphoma|hodgkin lymphoma
333962|NCT02169505|CD30 positive Hodgkin Lymphoma|cd30 positive hodgkin lymphoma
333963|NCT02169505|Anaplastic large cell lymphoma|anaplastic large cell lymphoma
333964|NCT02169505|ALCL|alcl
333965|NCT02169505|Allogeneic Stem Cell Transplantation|allogeneic stem cell transplantation
333966|NCT02169505|ASCT|asct
333967|NCT02169505|Graft-versus-host disease|graft-versus-host disease
333968|NCT02169505|GVHD|gvhd
333969|NCT02169505|Brentuximab Vedotin|brentuximab vedotin
333970|NCT02169505|SGN-35|sgn-35
333971|NCT02169505|Adcetris|adcetris
333972|NCT02169492|Thrombectomy|thrombectomy
333973|NCT02169492|Stroke|stroke
333974|NCT02169492|ReVive SE|revive se
333975|NCT02169479|Parkinson's disease (PD)|parkinson's disease (pd)
333976|NCT02169479|Opicapone|opicapone
333977|NCT02169479|BIA 9-1067|bia 9-1067
333978|NCT02169466|Parkinson's disease (PD)|parkinson's disease (pd)
333979|NCT02169466|Opicapone|opicapone
333980|NCT02169466|BIA 9-1067|bia 9-1067
333981|NCT02169453|Parkinson's disease (PD)|parkinson's disease (pd)
333982|NCT02169453|BIA 9-1067|bia 9-1067
333983|NCT02169453|Opicapone|opicapone
333984|NCT02169440|Parkinson's disease (PD)|parkinson's disease (pd)
333985|NCT02169440|BIA 9-1067|bia 9-1067
333986|NCT02169440|Opicapone|opicapone
333987|NCT02169427|Parkinson's disease (PD)|parkinson's disease (pd)
333988|NCT02169427|BIA 9-1067|bia 9-1067
333989|NCT02169427|Opicapone|opicapone
333990|NCT02169414|Parkinson's disease (PD)|parkinson's disease (pd)
333991|NCT02169414|BIA 9-1067|bia 9-1067
333992|NCT02169414|Opicapone|opicapone
333993|NCT02169388|Gut microflora|gut microflora
333994|NCT02169388|colorectal cancer|colorectal cancer
333995|NCT02169388|Chemotherapy|chemotherapy
333996|NCT02169388|Immunity|immunity
333997|NCT02169388|Nutrition|nutrition
333998|NCT02169362|Burns|burns
333999|NCT02169362|Thermal burns|thermal burns
334001|NCT02169362|Partial thickness burns|partial thickness burns
334002|NCT02169362|Deep partial thickness burns|deep partial thickness burns
334003|NCT02169362|Acute burns|acute burns
334004|NCT02169362|Burn wounds|burn wounds
334005|NCT02169336|Bunion|bunion
334006|NCT02169336|Bunionectomy|bunionectomy
334007|NCT02169336|Pain|pain
334008|NCT02169336|Analgesia|analgesia
334009|NCT02169336|dexmedetomidine|dexmedetomidine
334010|NCT02169336|intranasal|intranasal
334011|NCT02169323|Non-eosinophilic Asthma|non-eosinophilic asthma
334012|NCT02169323|Inhaled corticosteroids|inhaled corticosteroids
334013|NCT02169323|Step-down|step-down
334014|NCT02169310|Traumatic Brain Injury|traumatic brain injury
334015|NCT02169310|Decision-Making|decision-making
334016|NCT02169310|Dopaminergic Network|dopaminergic network
334017|NCT02169310|Brain Imaging|brain imaging
334018|NCT02169310|Non-Invasive Brain Stimulation|non-invasive brain stimulation
334019|NCT02169297|Pain Management|pain management
334020|NCT02169297|Anesthesia: Nerve Block|anesthesia: nerve block
334021|NCT02169258|coronary artery disease|coronary artery disease
334022|NCT02169258|peripheral artery disease|peripheral artery disease
334023|NCT02169258|percutaneous transluminal angioplasty|percutaneous transluminal angioplasty
334024|NCT02169258|coronary angiography|coronary angiography
334025|NCT02169258|revascularization|revascularization
334026|NCT02169258|gene polymorphisms|gene polymorphisms
334027|NCT02169258|microRNAs|micrornas
334028|NCT02169232|Awake intubation|awake intubation
334029|NCT02169232|Videolaryngoscope|videolaryngoscope
334030|NCT02169232|Fiberoptic|fiberoptic
334031|NCT02169206|Frozen shoulder|frozen shoulder
334032|NCT02169206|scapulothoracic angle|scapulothoracic angle
334033|NCT02169206|scapulohumeral angle|scapulohumeral angle
334034|NCT02169206|acromiohumeral distance|acromiohumeral distance
334035|NCT02169206|center equator distance|center equator distance
334036|NCT02169206|shoulder radiography|shoulder radiography
334037|NCT02169193|microaspiration|microaspiration
334038|NCT02169193|mechanical ventilation|mechanical ventilation
334039|NCT02169193|enteral feeding|enteral feeding
334040|NCT02169193|99m technetium|99m technetium
334041|NCT02169193|pepsin|pepsin
334042|NCT02169180|Ibrutinib|ibrutinib
334043|NCT02169180|IMBRUVICA|imbruvica
334044|NCT02169180|PCI-32765|pci-32765
334045|NCT02169180|JNJ-54179060|jnj-54179060
334046|NCT02169180|Lymphoma, Mantle-cell|lymphoma, mantle-cell
334047|NCT02169167|Diabetes complications|diabetes complications
334048|NCT02169167|Diabetic foot|diabetic foot
334049|NCT02169167|Foot ulcer|foot ulcer
334050|NCT02169167|Wound healing|wound healing
334051|NCT02169167|Wound infection|wound infection
334052|NCT02169141|pharmacokinetics|pharmacokinetics
334053|NCT02169141|pharmacodynamics|pharmacodynamics
334054|NCT02169141|MDR-TB|mdr-tb
334055|NCT02169141|Levofloxacin|levofloxacin
334056|NCT02169141|Capreomycin|capreomycin
334057|NCT02169102|Low power laser|low power laser
334058|NCT02169102|Pulpitis|pulpitis
334059|NCT02169102|Pain|pain
334060|NCT02169076|Ventricular Assist Device, Cardiac Resynchronization Therapy|ventricular assist device, cardiac resynchronization therapy
334061|NCT02169050|Vitamin D deficiency|vitamin d deficiency
334062|NCT02169050|Inflammation|inflammation
334063|NCT02169050|Obesity|obesity
334064|NCT02169037|Rotor|rotor
334065|NCT02169037|FIRM|firm
334066|NCT02169037|Paroxysmal Atrial Fibrillation|paroxysmal atrial fibrillation
334067|NCT02169037|Atrial tachyarrhythmia|atrial tachyarrhythmia
334068|NCT02169037|Ablation|ablation
334069|NCT02169037|Contact mapping|contact mapping
334070|NCT02169037|Clinical trial|clinical trial
334071|NCT02169037|Signal processing.|signal processing.
334072|NCT02169024|prenatal care|prenatal care
334073|NCT02169024|group care|group care
334074|NCT02169024|Expect With Me|expect with me
334075|NCT02169024|evaluation studies|evaluation studies
334076|NCT02169024|group prenatal care|group prenatal care
334077|NCT02169011|Breast reconstruction|breast reconstruction
334078|NCT02169011|Breast cancer|breast cancer
334079|NCT02168998|Medical clown|medical clown
334080|NCT02168998|Pediatric emergency medicine|pediatric emergency medicine
334081|NCT02168985|Child violence|child violence
334082|NCT02168985|HIV AIDS conflicted couples|hiv aids conflicted couples
334083|NCT02168985|Intimate partner violence|intimate partner violence
334084|NCT02168985|Tanzania|tanzania
334085|NCT02168985|Marriage counseling|marriage counseling
334086|NCT02168985|Child maltreatment|child maltreatment
334087|NCT02168985|Couples communication|couples communication
334088|NCT02168972|atrial fibrillation|atrial fibrillation
334089|NCT02168972|global|global
334090|NCT02168972|radiofrequency RF ablation|radiofrequency rf ablation
334091|NCT02168972|left atrium anatomical and electrophysiological mapping|left atrium anatomical and electrophysiological mapping
334092|NCT02168959|Femoral Nerve Block|femoral nerve block
334093|NCT02168959|Pain Control|pain control
334094|NCT02168959|Tibial Plateau Fracture|tibial plateau fracture
334095|NCT02168959|Prospective|prospective
334096|NCT02168959|Randomized|randomized
334097|NCT02168933|psoriasis|psoriasis
334098|NCT02168933|nail|nail
334099|NCT02168933|laser|laser
334100|NCT02168933|excimer|excimer
334101|NCT02168933|treatment|treatment
334102|NCT02168920|Alzeheimer|alzeheimer
334103|NCT02168894|Peripheral neuropathy|peripheral neuropathy
334104|NCT02168894|Chemotherapy-Induced Peripheral Neuropathy|chemotherapy-induced peripheral neuropathy
334105|NCT02168894|Cancer Survivors|cancer survivors
334106|NCT02168894|Acupuncture|acupuncture
334107|NCT02168894|Electrical stimulation|electrical stimulation
334108|NCT02168894|Nerve function tests|nerve function tests
334109|NCT02168894|Hand function tests|hand function tests
334110|NCT02168894|Balance tests|balance tests
334111|NCT02168894|Questionnaires|questionnaires
334112|NCT02168894|Surveys|surveys
334113|NCT02168881|labour|labour
334114|NCT02168881|induction|induction
334115|NCT02168881|misoprostol|misoprostol
334116|NCT02168881|dinoprostone|dinoprostone
334117|NCT02168868|Autoimmune Diseases|autoimmune diseases
334118|NCT02168868|Child Development Disorders, Pervasive|child development disorders, pervasive
334119|NCT02168868|Inflammation|inflammation
334120|NCT02168868|Risk Factors|risk factors
334121|NCT02168855|Smoking cessation|smoking cessation
334122|NCT02168855|Non-daily smokers|non-daily smokers
334123|NCT02168855|Ecological Momentary Assessment|ecological momentary assessment
334124|NCT02168855|nicotine replacement therapy|nicotine replacement therapy
334125|NCT02168842|Parkinson|parkinson
334126|NCT02168842|Parkinson Disease|parkinson disease
334127|NCT02168842|Parkinson's Disease|parkinson's disease
334128|NCT02168829|AF ablation|af ablation
334129|NCT02168829|Anticoagulation AF ablation|anticoagulation af ablation
334130|NCT02168829|Stroke prevention|stroke prevention
334131|NCT02168816|Osteomyelitis|osteomyelitis
334132|NCT02168816|Diabetes|diabetes
334133|NCT02168816|Foot Infection|foot infection
334134|NCT02168803|abnormal cholesterol|abnormal cholesterol
334135|NCT02168790|amniotic membrane holder, aminiotic membrane transplantation|amniotic membrane holder, aminiotic membrane transplantation
334136|NCT02168777|Patients with Cancer|patients with cancer
334137|NCT02168751|one lung ventilation|one lung ventilation
334138|NCT02168751|inflammatory response|inflammatory response
334139|NCT02168751|thoracic surgery|thoracic surgery
334140|NCT02168738|nutrition|nutrition
334141|NCT02168725|briciclib|briciclib
334142|NCT02168725|Dose escalation|dose escalation
334143|NCT02168725|Maximum tolerated dose|maximum tolerated dose
334144|NCT02168712|Coronary Heart Disease|coronary heart disease
334145|NCT02168712|Interval exercise training|interval exercise training
334146|NCT02168712|Continuous exercise training|continuous exercise training
334147|NCT02168712|Quality of life|quality of life
427112|NCT01746147|MDS|mds
334149|NCT02168699|children|children
334150|NCT02168699|infants|infants
334151|NCT02168699|musculocutaneous nerve|musculocutaneous nerve
334152|NCT02168699|ultrasonography|ultrasonography
334153|NCT02168686|alpha-1 antitrypsin deficiency|alpha-1 antitrypsin deficiency
334154|NCT02168686|alpha1-antitrypsin deficiency|alpha1-antitrypsin deficiency
334155|NCT02168686|alpha-1-antitrypsin deficiency|alpha-1-antitrypsin deficiency
334156|NCT02168686|alpha1AT|alpha1at
334157|NCT02168686|A1AT|a1at
334158|NCT02168686|ADVM-043|advm-043
334159|NCT02168686|AAVrh.10halpha1AT|aavrh.10halpha1at
334160|NCT02168686|AAVrh.10hA1AT|aavrh.10ha1at
334161|NCT02168686|Gene transfer vector|gene transfer vector
334162|NCT02168686|Gene therapy|gene therapy
334163|NCT02168686|Lung disease|lung disease
334164|NCT02168686|Emphysema|emphysema
334165|NCT02168686|COPD|copd
334166|NCT02168686|ADVANCE study|advance study
334167|NCT02168686|ADVM-043-01|advm-043-01
334168|NCT02168673|COPD|copd
334169|NCT02168673|Cigarette Smoke|cigarette smoke
334170|NCT02168673|Smoker|smoker
334171|NCT02168673|Nonsmoker|nonsmoker
334172|NCT02168673|ODF2|odf2
334173|NCT02168673|Cilia|cilia
334174|NCT02168660|Obesity|obesity
334175|NCT02168660|Insulin Resistance|insulin resistance
334176|NCT02168660|Vitamin D Deficiency|vitamin d deficiency
334177|NCT02168660|Children|children
334178|NCT02168660|Adolescents|adolescents
334179|NCT02168647|Excessive gestational weight gain|excessive gestational weight gain
334180|NCT02168647|Insulin resistance|insulin resistance
334181|NCT02168647|Physical activity|physical activity
334182|NCT02168647|Behavioral prenatal lifestyle intervention|behavioral prenatal lifestyle intervention
334183|NCT02168647|Reduced carbohydrate intake|reduced carbohydrate intake
334184|NCT02168647|Self-determination theory|self-determination theory
334185|NCT02168647|Motivational interviewing|motivational interviewing
334186|NCT02168621|Chronic periodontitis|chronic periodontitis
334187|NCT02168621|Non-surgical therapy|non-surgical therapy
334188|NCT02168621|Ultrasonic debridement|ultrasonic debridement
334189|NCT02168621|Scaling and root planing|scaling and root planing
334190|NCT02168608|hepatic ischemia reperfusion injury|hepatic ischemia reperfusion injury
334191|NCT02168608|ischemia precondition|ischemia precondition
334192|NCT02168608|remote ischemia precondition|remote ischemia precondition
334193|NCT02168608|anti-inflammation|anti-inflammation
334194|NCT02168595|healthy volunteers, GMI-1271|healthy volunteers, gmi-1271
334195|NCT02168582|Physical Therapy Modalities|physical therapy modalities
334196|NCT02168582|Prognosis|prognosis
334197|NCT02168582|Patient Selection|patient selection
334198|NCT02168569|treatment|treatment
334199|NCT02168569|artemisin-based combinations|artemisin-based combinations
334200|NCT02168569|children|children
334201|NCT02168556|Urodynamics, Anxiety|urodynamics, anxiety
334202|NCT02168517|Obesity|obesity
334203|NCT02168517|Pain|pain
334204|NCT02168517|Fertility|fertility
334205|NCT02168478|Neo-Synalar|neo-synalar
334206|NCT02168478|Patch Test|patch test
334207|NCT02168478|Sodium lauryl sulfate|sodium lauryl sulfate
334208|NCT02168478|Saline|saline
334209|NCT02168478|Presensitization|presensitization
334210|NCT02168465|self-efficacy|self-efficacy
334211|NCT02168465|self-management|self-management
334212|NCT02168465|web-based intervention research|web-based intervention research
334213|NCT02168452|Neoadjuvant chemotherapy|neoadjuvant chemotherapy
334214|NCT02168452|Indocyanine green (ICG)|indocyanine green (icg)
334215|NCT02168452|Radioisotope (RI)|radioisotope (ri)
334216|NCT02168452|Near infrared fluorescence camera|near infrared fluorescence camera
334217|NCT02168439|Dexmedetomidine|dexmedetomidine
334218|NCT02168439|Midazolam|midazolam
334219|NCT02168413|cortical excitability|cortical excitability
334220|NCT02168413|robotized TMS|robotized tms
334221|NCT02168413|EEG|eeg
334222|NCT02168413|EMG|emg
334223|NCT02168387|atelectasis|atelectasis
334224|NCT02168387|continuous high frequency oscillator|continuous high frequency oscillator
334225|NCT02168387|acetylcysteine|acetylcysteine
334226|NCT02168387|dornase alfa|dornase alfa
334227|NCT02168374|Glass ionomer cement|glass ionomer cement
334228|NCT02168374|Indirect pulp therapy|indirect pulp therapy
334229|NCT02168361|cirrhosis|cirrhosis
334230|NCT02168322|growth factors|growth factors
334231|NCT02168322|periodontal regeneration|periodontal regeneration
334232|NCT02168322|modefied perforated membranes|modefied perforated membranes
334233|NCT02168296|Pharmacokinetics|pharmacokinetics
334234|NCT02168296|Blood glucose|blood glucose
334235|NCT02168296|subjects|subjects
334236|NCT02168283|cardiovascular disease|cardiovascular disease
334237|NCT02168283|hypertension|hypertension
334238|NCT02168257|Nasal Cannula|nasal cannula
334239|NCT02168244|psoriasis|psoriasis
334240|NCT02168244|biologics|biologics
334241|NCT02168244|subcutaneous|subcutaneous
334242|NCT02168244|pain|pain
334243|NCT02168244|heat|heat
334244|NCT02168244|ice|ice
334245|NCT02168231|Complex abdominal wall hernia|complex abdominal wall hernia
334246|NCT02168231|Biologic mesh|biologic mesh
334247|NCT02168231|Strattice|strattice
334248|NCT02168218|protein synthesis|protein synthesis
334249|NCT02168218|intrahepatic fat|intrahepatic fat
334250|NCT02168218|lean body mass|lean body mass
334251|NCT02168218|IGF1|igf1
334252|NCT02168218|energy metabolism|energy metabolism
334253|NCT02168205|Healthy volunteer|healthy volunteer
334254|NCT02168205|Pharmacokinetics|pharmacokinetics
334255|NCT02168205|Pomalyst|pomalyst
334256|NCT02168205|Pomalidomide|pomalidomide
334257|NCT02168205|Food effect|food effect
334258|NCT02168205|smoker|smoker
334259|NCT02168192|Breaking bad news skills|breaking bad news skills
334260|NCT02168192|Communications skills|communications skills
334261|NCT02168192|Medical education|medical education
334262|NCT02168192|Obstetrics|obstetrics
334263|NCT02168192|Simulation|simulation
334264|NCT02168166|Neurological Disorders|neurological disorders
334265|NCT02168166|Neuroscience|neuroscience
334266|NCT02168166|Neuropsychology|neuropsychology
334267|NCT02168166|EEG|eeg
334268|NCT02168166|Cognitive remediation|cognitive remediation
334269|NCT02168166|Cognitive Response|cognitive response
334270|NCT02168153|Chiropractic Manipulative Therapy|chiropractic manipulative therapy
334271|NCT02168153|Reaction Times|reaction times
334272|NCT02168153|Response Times|response times
334273|NCT02168153|Special Forces|special forces
334274|NCT02168153|Biomechanical Assessments|biomechanical assessments
334275|NCT02168114|Duchenne Muscular Dystrophy|duchenne muscular dystrophy
334276|NCT02168114|Exercise|exercise
334277|NCT02168114|Optical Imaging|optical imaging
334278|NCT02168114|Magnetic Resonance|magnetic resonance
334279|NCT02168101|MLN9708|mln9708
334280|NCT02168101|allogeneic stem cell transplant|allogeneic stem cell transplant
334281|NCT02168101|multiple myeloma|multiple myeloma
334282|NCT02168101|ixazomib|ixazomib
334283|NCT02168101|autologous stem cell transplant|autologous stem cell transplant
334284|NCT02168088|Sudden unexplained death|sudden unexplained death
334285|NCT02168049|cardiac, respiratory, monitoring|cardiac, respiratory, monitoring
334286|NCT02168036|lung disease|lung disease
334287|NCT02168036|mediastinal lymph node|mediastinal lymph node
334288|NCT02168036|bronchoscopy|bronchoscopy
334289|NCT02168036|Endobronchial-Guided Transbronchial Needle Aspiration|endobronchial-guided transbronchial needle aspiration
334290|NCT02168023|surgical site infection|surgical site infection
334291|NCT02168023|dialkylcarbamoylchloride impregnated dressing|dialkylcarbamoylchloride impregnated dressing
334292|NCT02168023|caesarean section|caesarean section
334293|NCT02168023|wound dehiscence|wound dehiscence
334294|NCT02167984|esophageal swallow|esophageal swallow
334295|NCT02167984|gastroesophageal reflux|gastroesophageal reflux
334296|NCT02167984|esophageal impedance|esophageal impedance
334297|NCT02167984|newborn|newborn
334298|NCT02167984|preterm|preterm
334299|NCT02167971|traumatic brain injury|traumatic brain injury
334300|NCT02167971|diffuse axonal injury|diffuse axonal injury
334301|NCT02167971|repetitive transcranial magnetic stimulation|repetitive transcranial magnetic stimulation
334302|NCT02167971|neuromodulation|neuromodulation
334303|NCT02167971|cognitive rehabilitation|cognitive rehabilitation
334304|NCT02167945|Hepatitis C Genotype 1|hepatitis c genotype 1
334305|NCT02167945|Compensated Cirrhosis|compensated cirrhosis
334306|NCT02167945|Cirrhosis|cirrhosis
334307|NCT02167945|Naïve|naïve
334308|NCT02167945|Hepatitis C|hepatitis c
334309|NCT02167945|Hepatitis C Virus|hepatitis c virus
334310|NCT02167945|Treatment-Experienced|treatment-experienced
334311|NCT02167945|Relapser|relapser
334312|NCT02167945|Null responder|null responder
334313|NCT02167945|Non responder|non responder
334314|NCT02167932|Breast Cancer|breast cancer
334315|NCT02167932|Walk With Ease|walk with ease
334316|NCT02167932|Physical Activity|physical activity
334317|NCT02167932|Walking|walking
334318|NCT02167932|Younger Women|younger women
334319|NCT02167932|Cancer|cancer
334320|NCT02167932|p16|p16
334321|NCT02167932|Aging|aging
334322|NCT02167932|Biomarkers|biomarkers
334323|NCT02167932|Biomarkers of Aging|biomarkers of aging
334324|NCT02167932|Chemotherapy|chemotherapy
334325|NCT02167932|Chemotherapy Treatment|chemotherapy treatment
334326|NCT02167932|Adjuvant Chemotherapy|adjuvant chemotherapy
334327|NCT02167932|Neoadjuvant Chemotherapy|neoadjuvant chemotherapy
334328|NCT02167919|Prostate|prostate
334329|NCT02167919|Men|men
334330|NCT02167919|Hyperplasia|hyperplasia
334331|NCT02167893|Pharmacological therapy|pharmacological therapy
334332|NCT02167867|body contouring|body contouring
334333|NCT02167867|circumference reduction|circumference reduction
334334|NCT02167867|body shaping|body shaping
334335|NCT02167867|low level laser|low level laser
334336|NCT02167854|LJM716|ljm716
334337|NCT02167854|BYL719 [Alpelisib]|byl719 [alpelisib]
334338|NCT02167854|TRASTUZUMAB|trastuzumab
334339|NCT02167854|HER2+|her2+
334340|NCT02167854|14-057|14-057
334341|NCT02167841|Breech presentation,|breech presentation,
334342|NCT02167841|External cephalic version,|external cephalic version,
334343|NCT02167841|Maternal posture,|maternal posture,
334344|NCT02167841|Pregnancy,|pregnancy,
334345|NCT02167841|Caesarean section.|caesarean section.
334346|NCT02167828|HIV|hiv
334347|NCT02167828|AIDS|aids
334348|NCT02167828|treatment adherence|treatment adherence
334349|NCT02167828|social network|social network
334350|NCT02167802|severe infection, pediatrics, sub-optimal care, term care|severe infection, pediatrics, sub-optimal care, term care
334351|NCT02167789|HF, diagnosis|hf, diagnosis
334352|NCT02167763|contraception|contraception
334353|NCT02167763|IUD|iud
334354|NCT02167763|copper|copper
334355|NCT02167750|cognitive|cognitive
334356|NCT02167750|phytochmicals|phytochmicals
334357|NCT02167750|caffeine|caffeine
334358|NCT02167750|cognitive performance after ingestion of test beverage|cognitive performance after ingestion of test beverage
334359|NCT02167737|Accident Prevention|accident prevention
334360|NCT02167737|Accidental Falls|accidental falls
334361|NCT02167737|Geriatric Health Services|geriatric health services
334362|NCT02167737|Gender Differences|gender differences
334363|NCT02167698|Pediatric acute respiratory distress syndrome|pediatric acute respiratory distress syndrome
334364|NCT02167698|Mechanical ventilation|mechanical ventilation
334365|NCT02167698|Airway pressure release ventilation|airway pressure release ventilation
334366|NCT02167698|Conventional low-tidal volume ventilation|conventional low-tidal volume ventilation
334367|NCT02167672|total abdominal hysterectomy, total laparoscopic hysterectomy, vaginal hysterectomy|total abdominal hysterectomy, total laparoscopic hysterectomy, vaginal hysterectomy
334368|NCT02167659|Lymphedema|lymphedema
334369|NCT02167659|Breast cancer|breast cancer
334370|NCT02167659|Bioimpedance Spectroscopy|bioimpedance spectroscopy
334371|NCT02167659|L-Dex|l-dex
334372|NCT02167646|Soft tissue defect|soft tissue defect
334373|NCT02167646|dorsal branch of the digital nerve|dorsal branch of the digital nerve
334374|NCT02167646|dorsal branch of the digital artery|dorsal branch of the digital artery
334375|NCT02167646|dorsal digital flap|dorsal digital flap
334376|NCT02167633|Radiosurgery|radiosurgery
334377|NCT02167633|Laminectomy|laminectomy
334378|NCT02167633|Radiotherapy|radiotherapy
334379|NCT02167633|Spinal Cord Compression|spinal cord compression
334380|NCT02167633|Neoplasm Metastasis|neoplasm metastasis
334381|NCT02167633|Randomized Controlled Trial|randomized controlled trial
334382|NCT02167607|Purple Potatoes|purple potatoes
334383|NCT02167607|Polyphenolics|polyphenolics
334384|NCT02167581|Maxillofacial surgery|maxillofacial surgery
334385|NCT02167581|Epithelial odontogenic tumours|epithelial odontogenic tumours
334386|NCT02167568|corpus callosum agenesis/dysgenesis|corpus callosum agenesis/dysgenesis
334387|NCT02167568|mental deficiency/ Intellectual deficiency|mental deficiency/ intellectual deficiency
334388|NCT02167568|genetic and phenotypic characterization|genetic and phenotypic characterization
334389|NCT02167555|Wild Blueberries|wild blueberries
334390|NCT02167555|Polyphenolics|polyphenolics
334391|NCT02167542|Severe hypoxemic respiratory failure|severe hypoxemic respiratory failure
334392|NCT02167542|Fiberoptic bronchoscopy|fiberoptic bronchoscopy
334393|NCT02167542|Noninvasive possitive pressure ventilation|noninvasive possitive pressure ventilation
334394|NCT02167542|Continuous positive airway pressure|continuous positive airway pressure
334395|NCT02167529|Quality of life-Thyroidectomy-Morbidity|quality of life-thyroidectomy-morbidity
334396|NCT02167516|Xinfeng capsule|xinfeng capsule
334397|NCT02167516|Knee osteoarthritis|knee osteoarthritis
334398|NCT02167516|Randomized controlled trials|randomized controlled trials
334399|NCT02167516|Double-blind|double-blind
334400|NCT02167490|BC; conservative surgery; SNB; AD; axillary US imaging|bc; conservative surgery; snb; ad; axillary us imaging
334401|NCT02167477|Intubation, Endotracheal|intubation, endotracheal
334402|NCT02167464|Hypertension|hypertension
334403|NCT02167451|stem cell transplant|stem cell transplant
334404|NCT02167451|GVHD prevention|gvhd prevention
334405|NCT02167438|Cesarean|cesarean
334406|NCT02167438|Section|section
334407|NCT02167438|second|second
334408|NCT02167438|stage|stage
334409|NCT02167438|labor|labor
334410|NCT02167425|People who Inject Drugs|people who inject drugs
334411|NCT02167425|HIV|hiv
334412|NCT02167425|Methadone|methadone
334413|NCT02167425|Sub Saharan Africa|sub saharan africa
334414|NCT02167425|Tanzania|tanzania
334415|NCT02167425|Implementation Science|implementation science
334416|NCT02167412|POTS|pots
334417|NCT02167412|Syncope|syncope
334418|NCT02167386|Men who have sex with men (MSM)|men who have sex with men (msm)
334419|NCT02167386|Black/African-American|black/african-american
334420|NCT02167360|adult patients|adult patients
334421|NCT02167360|B-cell ALL|b-cell all
334422|NCT02167360|chemo-refractory|chemo-refractory
334423|NCT02167360|relapsed after allogeneic SCT|relapsed after allogeneic sct
334424|NCT02167360|ineligible for allogeneic SCT|ineligible for allogeneic sct
334425|NCT02167347|CBT, Psychosis, cultural adaptation, Pakistan|cbt, psychosis, cultural adaptation, pakistan
334426|NCT02167334|panendoscopy|panendoscopy
334427|NCT02167334|preoxygenation|preoxygenation
334428|NCT02167334|non invasive ventilation|non invasive ventilation
334429|NCT02167295|betel nut|betel nut
334430|NCT02167295|dependence|dependence
334431|NCT02167295|withdraw|withdraw
334432|NCT02167295|deprivation test|deprivation test
334433|NCT02167269|enclosed afferent reservoir|enclosed afferent reservoir
334434|NCT02167269|Jackson Rees system|jackson rees system
334435|NCT02167269|anesthesia breathing circuit|anesthesia breathing circuit
334436|NCT02167269|spontaneous breathing|spontaneous breathing
334437|NCT02167269|pediatric anesthesia|pediatric anesthesia
334438|NCT02167230|Coronary Artery Disease|coronary artery disease
334439|NCT02167230|Percutaneous Coronary Intervention|percutaneous coronary intervention
334440|NCT02167230|Bifurcation|bifurcation
334441|NCT02167230|Jailed-balloon technique|jailed-balloon technique
334442|NCT02167217|Duchenne Muscular Dystrophy|duchenne muscular dystrophy
334443|NCT02167217|Corticosteroids|corticosteroids
334444|NCT02167217|Infants|infants
334445|NCT02167217|Young Children|young children
334446|NCT02167217|Toddlers|toddlers
334447|NCT02167165|Atrial Fibrillation|atrial fibrillation
334448|NCT02167165|Digoxin|digoxin
334449|NCT02167165|SNP|snp
334450|NCT02167139|Rheumatoid Arthritis, Adalimumab|rheumatoid arthritis, adalimumab
334451|NCT02167126|Athletic Performance;|athletic performance;
334452|NCT02167126|Muscle Strength;|muscle strength;
334453|NCT02167126|Isometric Contraction;|isometric contraction;
334454|NCT02167126|Kinesio Taping|kinesio taping
334455|NCT02167100|HIV|hiv
334456|NCT02167100|Highly Active Antiretroviral Therapy|highly active antiretroviral therapy
334457|NCT02167100|Patient Care|patient care
334458|NCT02167100|Patient Care Management|patient care management
334459|NCT02167100|Lost to Follow-Up|lost to follow-up
334460|NCT02167087|Sentinel node mapping|sentinel node mapping
334461|NCT02167087|lymphatic mapping|lymphatic mapping
334462|NCT02167087|lymphatic metastasis|lymphatic metastasis
334463|NCT02167087|Aberrant lymphatic drainage|aberrant lymphatic drainage
334464|NCT02167087|indocyanine green|indocyanine green
334465|NCT02167087|ICG|icg
334466|NCT02167087|near infrared|near infrared
334467|NCT02167087|colon cancer|colon cancer
334468|NCT02167087|laparoscopic surgery|laparoscopic surgery
334469|NCT02167074|Diagnostic accuracy|diagnostic accuracy
334760|NCT02165657|UVB|uvb
334470|NCT02167074|Endoscopic Ultrasound-Guided Fine Needle Aspiration|endoscopic ultrasound-guided fine needle aspiration
334471|NCT02167074|EUS-FNA|eus-fna
334472|NCT02167074|Endoscopic Ultrasound-Guided Fine Needle Biopsy|endoscopic ultrasound-guided fine needle biopsy
334473|NCT02167074|EUS-FNB|eus-fnb
334474|NCT02167074|Pancreatic mass|pancreatic mass
334475|NCT02167074|Lymph node|lymph node
334476|NCT02167048|Attention Deficit Hyperactivity Disorders|attention deficit hyperactivity disorders
334477|NCT02167048|Executive Function|executive function
334478|NCT02167048|Methylphenidate|methylphenidate
334479|NCT02167048|Psychostimulants|psychostimulants
334480|NCT02167048|Adolescent|adolescent
334481|NCT02167048|Child|child
334482|NCT02167048|Working Memory|working memory
334483|NCT02167048|Prefrontal Cortex|prefrontal cortex
334484|NCT02167048|Attention|attention
334485|NCT02167048|Cognitive Function|cognitive function
334486|NCT02167048|Inhibition|inhibition
334487|NCT02167035|Open-Angle Glaucoma|open-angle glaucoma
334488|NCT02167035|Ocular Hypertension|ocular hypertension
334489|NCT02167022|intense therapy|intense therapy
334490|NCT02167022|brain plasticity|brain plasticity
334491|NCT02167022|Perception-Action approach|perception-action approach
334492|NCT02167009|ARTERY EMBOLIZATION|artery embolization
334493|NCT02167009|BPH|bph
334494|NCT02166970|Hilar tumor|hilar tumor
334495|NCT02166970|Metal stent|metal stent
334496|NCT02166970|Single|single
334497|NCT02166970|Multiple|multiple
334498|NCT02166957|Esophageal disruption|esophageal disruption
334499|NCT02166957|anterograde-retrograde endoscopy|anterograde-retrograde endoscopy
334500|NCT02166957|rendez-vous technique|rendez-vous technique
334501|NCT02166957|NOTES|notes
334502|NCT02166957|recanalization|recanalization
334503|NCT02166957|dilatations|dilatations
334504|NCT02166957|Stenting|stenting
334505|NCT02166957|radiation therapy|radiation therapy
334506|NCT02166957|head and neck carcinoma|head and neck carcinoma
334507|NCT02166944|amyotrophic lateral sclerosis|amyotrophic lateral sclerosis
334508|NCT02166944|ALS functional ration scale|als functional ration scale
334509|NCT02166944|TAR-DNA-binding protein-43|tar-dna-binding protein-43
334510|NCT02166944|tamoxifen|tamoxifen
334511|NCT02166944|mTOR|mtor
334512|NCT02166931|Essence of Chicken|essence of chicken
334513|NCT02166931|stress|stress
334514|NCT02166931|cognitive function|cognitive function
334515|NCT02166918|Schizophrenia|schizophrenia
334516|NCT02166918|Real-Life Functioning|real-life functioning
334517|NCT02166918|Schizophrenia Endophenotypes|schizophrenia endophenotypes
334518|NCT02166892|Childhood obesity|childhood obesity
334519|NCT02166892|Plate|plate
334520|NCT02166892|Food consumption|food consumption
334521|NCT02166879|Obstructive Sleep Apnea-Hypopnea Syndrome|obstructive sleep apnea-hypopnea syndrome
334522|NCT02166879|Obstructive sleep apnea|obstructive sleep apnea
334523|NCT02166879|OSA|osa
334524|NCT02166879|Chart review|chart review
334525|NCT02166879|Questionnaire|questionnaire
334526|NCT02166879|Survey|survey
334527|NCT02166853|Acute respiratory distress syndrome (ARDS)|acute respiratory distress syndrome (ards)
334528|NCT02166853|Sevoflurane|sevoflurane
334529|NCT02166853|Mechanical ventilation|mechanical ventilation
334530|NCT02166853|Intensive Care Unit (ICU)|intensive care unit (icu)
334531|NCT02166853|Prospective study|prospective study
334532|NCT02166853|Lung injury|lung injury
334533|NCT02166853|Gas exchange|gas exchange
334534|NCT02166853|Inflammation|inflammation
334535|NCT02166853|Receptor for advanced glycation end-produts (RAGE)|receptor for advanced glycation end-produts (rage)
334536|NCT02166853|sRAGE|srage
334537|NCT02166827|TMS|tms
334538|NCT02166827|Cognitive Stimulation|cognitive stimulation
334539|NCT02166827|NeuroAD|neuroad
334540|NCT02166801|Cerebral palsy|cerebral palsy
334541|NCT02166801|Children|children
334542|NCT02166801|Early Intervention|early intervention
334543|NCT02166801|Communication|communication
334544|NCT02166801|Gross motor function|gross motor function
334545|NCT02166801|Hand function|hand function
334546|NCT02166788|metastatic melanoma|metastatic melanoma
334547|NCT02166788|groin lymph nodes|groin lymph nodes
334548|NCT02166788|surgery|surgery
334549|NCT02166788|lymphadenectomy|lymphadenectomy
334550|NCT02166762|Cardiac Resynchronization Therapy|cardiac resynchronization therapy
334551|NCT02166762|Biventricular implantable cardioverter defibrillators|biventricular implantable cardioverter defibrillators
334552|NCT02166762|Heart failure|heart failure
334553|NCT02166762|Cardiomyopathy|cardiomyopathy
334554|NCT02166762|QLV|qlv
334555|NCT02166762|LV lead placement|lv lead placement
334556|NCT02166762|Arrhythmia|arrhythmia
334557|NCT02166749|Hysterectomy, long term follow up, subjective outcome|hysterectomy, long term follow up, subjective outcome
334558|NCT02166736|Instantaneous wave Free Ratio|instantaneous wave free ratio
334559|NCT02166736|Fractional Flow Reserve|fractional flow reserve
334560|NCT02166723|persistent atrial fibrillation|persistent atrial fibrillation
334561|NCT02166723|Cryoballoon ablation|cryoballoon ablation
334562|NCT02166710|Knee arthroplasty|knee arthroplasty
334563|NCT02166710|Adductor canal block|adductor canal block
334564|NCT02166710|Quadriceps strength|quadriceps strength
334565|NCT02166697|Pharmacological therapy|pharmacological therapy
334761|NCT02165657|Psoriasis|psoriasis
334566|NCT02166684|Do-it-yourself devices|do-it-yourself devices
334567|NCT02166684|User-experiences|user-experiences
334568|NCT02166684|Health behavior|health behavior
334569|NCT02166684|Self-measurement|self-measurement
334570|NCT02166684|Methodology, Evaluation|methodology, evaluation
334571|NCT02166684|Personal health records|personal health records
334572|NCT02166684|Blood Glucose Self-Monitoring|blood glucose self-monitoring
334573|NCT02166684|Self Blood Pressure Monitoring|self blood pressure monitoring
334574|NCT02166658|Patients with breast or lung cancer and recurrent or progressive brain|patients with breast or lung cancer and recurrent or progressive brain
334575|NCT02166658|metastases|metastases
334576|NCT02166645|patient positioning|patient positioning
334577|NCT02166645|premature infant|premature infant
334578|NCT02166645|mechanical ventilation|mechanical ventilation
334579|NCT02166645|airway extubation|airway extubation
334580|NCT02166632|Knee arthroplasty|knee arthroplasty
334581|NCT02166632|Exparel|exparel
334582|NCT02166632|Bupivacaine liposome|bupivacaine liposome
334583|NCT02166632|Total knee replacement|total knee replacement
334584|NCT02166632|Pain control|pain control
334585|NCT02166619|Stroke|stroke
334586|NCT02166619|Rehabilitation|rehabilitation
334587|NCT02166619|Electric stimulation therapy|electric stimulation therapy
334588|NCT02166619|Neuroplasticity|neuroplasticity
334589|NCT02166567|intracytoplasmic sperm injection|intracytoplasmic sperm injection
334590|NCT02166567|Male infertility|male infertility
334591|NCT02166567|apoptosis|apoptosis
334592|NCT02166567|flow cytometry and sorting|flow cytometry and sorting
334593|NCT02166567|DNA fragmentation|dna fragmentation
334594|NCT02166554|Adhesions|adhesions
334595|NCT02166554|Hyaluronan|hyaluronan
334596|NCT02166554|Gynaecological surgery|gynaecological surgery
334597|NCT02166554|Clinical outcomes|clinical outcomes
334598|NCT02166541|cerebral palsy, spastic, diplegic,|cerebral palsy, spastic, diplegic,
334599|NCT02166541|children,|children,
334600|NCT02166541|intervention study,|intervention study,
334601|NCT02166541|manipulation, spinal|manipulation, spinal
334602|NCT02166541|randomized controlled trial|randomized controlled trial
334603|NCT02166528|female pelvic floor dysfunction|female pelvic floor dysfunction
334604|NCT02166528|pelvic organ prolaps|pelvic organ prolaps
334605|NCT02166528|urinary incontinence|urinary incontinence
334606|NCT02166528|massively parallel sequencing|massively parallel sequencing
334607|NCT02166515|cervical cancer|cervical cancer
334608|NCT02166515|ovarian cancer|ovarian cancer
334609|NCT02166515|endometrial cancer|endometrial cancer
334610|NCT02166515|high-throughput sequencing|high-throughput sequencing
334611|NCT02166502|pediatric|pediatric
334612|NCT02166502|HIV|hiv
334613|NCT02166502|prevention|prevention
334614|NCT02166502|prophylaxis|prophylaxis
334615|NCT02166502|nevirapine|nevirapine
334616|NCT02166489|autologous mesenchymal stem cells|autologous mesenchymal stem cells
334617|NCT02166489|polycystic kidney disease|polycystic kidney disease
334618|NCT02166489|intravenous injection|intravenous injection
334619|NCT02166489|CRF|crf
334620|NCT02166450|Denture stomatitis|denture stomatitis
334621|NCT02166450|Dentures|dentures
334622|NCT02166450|Denture wearers|denture wearers
334623|NCT02166437|osteoporosis|osteoporosis
334624|NCT02166437|BMD|bmd
334625|NCT02166437|teriparatide|teriparatide
334626|NCT02166437|bisphosphonate|bisphosphonate
334627|NCT02166437|denosmab|denosmab
334628|NCT02166424|Pregnancy|pregnancy
334629|NCT02166424|Depression|depression
334630|NCT02166424|omega-3 fatty acids|omega-3 fatty acids
334631|NCT02166411|Myomectomy ,Laparoscopy , Barbed sutures|myomectomy ,laparoscopy , barbed sutures
334632|NCT02166398|Amlodipine basylate, Losartan potassium|amlodipine basylate, losartan potassium
334633|NCT02166359|Icodextrin|icodextrin
334634|NCT02166359|Triglyceride|triglyceride
334635|NCT02166346|Transverse myelitis|transverse myelitis
334636|NCT02166333|vitamin D|vitamin d
334637|NCT02166333|falls|falls
334638|NCT02166333|high risk of falling|high risk of falling
334639|NCT02166333|insufficient or deficient serum vitamin D levels|insufficient or deficient serum vitamin d levels
334640|NCT02166333|10-29 ng/ml|10-29 ng/ml
334641|NCT02166307|formaldehyde; Maillard Reaction; cross-linkage; human aging|formaldehyde; maillard reaction; cross-linkage; human aging
334642|NCT02166294|Foot|foot
334643|NCT02166294|Ulcer|ulcer
334644|NCT02166294|Diabetes|diabetes
334645|NCT02166294|Amputation|amputation
334646|NCT02166294|Limb salvage|limb salvage
334647|NCT02166281|Insomnia|insomnia
334648|NCT02166281|Anxiety|anxiety
334649|NCT02166281|Depression|depression
334650|NCT02166281|Restless leg syndrome|restless leg syndrome
334651|NCT02166281|Aromatase inhibitor|aromatase inhibitor
334652|NCT02166281|Body composition|body composition
334653|NCT02166268|Allergic rhinoconjunctivitis|allergic rhinoconjunctivitis
334654|NCT02166268|Allergic rhinitis|allergic rhinitis
334655|NCT02166268|Allergy|allergy
334656|NCT02166268|Grass pollen|grass pollen
334657|NCT02166242|non-small cell lung cancer|non-small cell lung cancer
334658|NCT02166242|thioredoxin reductase|thioredoxin reductase
334659|NCT02166216|Prolonged high intensity exercise|prolonged high intensity exercise
334660|NCT02166216|Healthy subjects|healthy subjects
334866|NCT02165150|Depression|depression
334661|NCT02166216|Cardiovascular risk markers|cardiovascular risk markers
334662|NCT02166216|Troponin|troponin
334663|NCT02166216|Leisure sports athletes|leisure sports athletes
334664|NCT02166216|Cycling|cycling
334665|NCT02166216|CT coronary angiography|ct coronary angiography
334666|NCT02166216|Outcomes|outcomes
334667|NCT02166190|Pancreatic cancer|pancreatic cancer
334668|NCT02166190|cholangiocarcinoma|cholangiocarcinoma
334669|NCT02166190|radiofrequency ablation|radiofrequency ablation
334670|NCT02166164|Pain|pain
334671|NCT02166164|Secondary hyperalgesia|secondary hyperalgesia
334672|NCT02166164|thermal sensitization|thermal sensitization
334673|NCT02166164|Catastrophization|catastrophization
334674|NCT02166164|Anxiety|anxiety
334675|NCT02166125|gastric bypass|gastric bypass
334676|NCT02166125|sleeve gastrectomy|sleeve gastrectomy
334677|NCT02166125|esophageal stent|esophageal stent
334678|NCT02166125|suturing|suturing
334679|NCT02166112|Hernia of Abdominal Wall|hernia of abdominal wall
334680|NCT02166112|Biologic implant|biologic implant
334681|NCT02166112|Infected Hernioplasty Mesh|infected hernioplasty mesh
334682|NCT02166047|Hepatitis B|hepatitis b
334683|NCT02166047|HBV|hbv
334684|NCT02166047|GS-9620|gs-9620
334685|NCT02166047|TLR-7 Agonist|tlr-7 agonist
334686|NCT02166034|children|children
334687|NCT02166034|fruit|fruit
334688|NCT02166034|vegetable|vegetable
334689|NCT02166034|diet|diet
334690|NCT02166034|school|school
334691|NCT02166034|garden|garden
334692|NCT02166021|Multiple Sclerosis (MS)|multiple sclerosis (ms)
334693|NCT02166021|Stem Cells|stem cells
334694|NCT02166008|Repamipide|repamipide
334695|NCT02166008|Dual antiplatelet|dual antiplatelet
334696|NCT02166008|Peptic ulcer|peptic ulcer
334697|NCT02165995|Brain Tumor|brain tumor
334698|NCT02165995|Glioma|glioma
334699|NCT02165995|Tumor resection|tumor resection
334700|NCT02165995|Navigated Transcranial Magnetic Stimulation|navigated transcranial magnetic stimulation
334701|NCT02165995|nTMS|ntms
334702|NCT02165995|Brain mapping|brain mapping
334703|NCT02165995|Motor function|motor function
334704|NCT02165995|Speech function|speech function
334705|NCT02165995|Speech mapping|speech mapping
334706|NCT02165969|tumor|tumor
334707|NCT02165969|inflammatory process|inflammatory process
334708|NCT02165969|fracture|fracture
334709|NCT02165969|defect|defect
334710|NCT02165956|Cereals|cereals
334711|NCT02165956|Obesity|obesity
334712|NCT02165956|Complementary Feeding|complementary feeding
334713|NCT02165930|Bioavailability|bioavailability
334714|NCT02165930|oxycodone|oxycodone
334715|NCT02165930|ethanol interaction|ethanol interaction
334716|NCT02165930|healthy volunteers|healthy volunteers
334717|NCT02165917|Endometriosis|endometriosis
334718|NCT02165917|Adhesions|adhesions
334719|NCT02165917|Hyalobarrier®|hyalobarrier®
334720|NCT02165917|Hyaluronic acid|hyaluronic acid
334721|NCT02165917|Antiadhesion agent|antiadhesion agent
334722|NCT02165917|Adhesionbarrier|adhesionbarrier
334723|NCT02165917|Pregnancy rate|pregnancy rate
334724|NCT02165904|Analyze clinical efficacy of subarachnoid administration of|analyze clinical efficacy of subarachnoid administration of
334725|NCT02165904|"autologous BMSC expanded in vitro"|"autologous bmsc expanded in vitro"
334726|NCT02165878|Chronic kidney disease(CKD)|chronic kidney disease(ckd)
334727|NCT02165865|hand transplantation|hand transplantation
334728|NCT02165865|hand allotransplantation|hand allotransplantation
334729|NCT02165865|upper extremity transplantation|upper extremity transplantation
334730|NCT02165865|upper extremity amputation|upper extremity amputation
334731|NCT02165865|hand amputation|hand amputation
334732|NCT02165865|vascularized composite allotransplantation|vascularized composite allotransplantation
334733|NCT02165865|composite tissue allotransplantation|composite tissue allotransplantation
334734|NCT02165865|variance component analysis (VCA)|variance component analysis (vca)
334735|NCT02165865|composite tissue allograft (CTA)|composite tissue allograft (cta)
334736|NCT02165852|ampulla of Vater|ampulla of vater
334737|NCT02165852|adenoma|adenoma
334738|NCT02165852|papillectomy|papillectomy
334739|NCT02165852|injection|injection
334740|NCT02165852|non-injection|non-injection
334741|NCT02165826|Drug therapy|drug therapy
334742|NCT02165774|sacral neuromodulation, neurogenic lower urinary tract dysfunction|sacral neuromodulation, neurogenic lower urinary tract dysfunction
334743|NCT02165761|Hemodialysis|hemodialysis
334744|NCT02165761|End Stage Renal Disease|end stage renal disease
334745|NCT02165761|Vascular Graft|vascular graft
334746|NCT02165722|Influenza|influenza
334747|NCT02165722|HPV|hpv
334748|NCT02165722|Tdap|tdap
334749|NCT02165722|MCV|mcv
334750|NCT02165722|vaccination|vaccination
334751|NCT02165722|adolescents|adolescents
334752|NCT02165696|compression bandage, manual lymphatic drainage, lymphedema, breast cancer, qualitative research.|compression bandage, manual lymphatic drainage, lymphedema, breast cancer, qualitative research.
334753|NCT02165683|Cancer|cancer
334754|NCT02165683|Pediatric|pediatric
334755|NCT02165683|PET Scan|pet scan
334756|NCT02165670|Ischemic heart disesase|ischemic heart disesase
334757|NCT02165670|Myocardial infarction|myocardial infarction
334758|NCT02165670|Angina pectoris|angina pectoris
334759|NCT02165657|Excimer laser|excimer laser
334762|NCT02165644|Subarachnoid Hemorrhage|subarachnoid hemorrhage
334763|NCT02165644|Vasospasm|vasospasm
334764|NCT02165644|Acetazolamide|acetazolamide
334765|NCT02165618|frailty|frailty
334766|NCT02165618|geriatric, elderly|geriatric, elderly
334767|NCT02165618|polypharmacy|polypharmacy
334768|NCT02165605|external beam radiotherapy|external beam radiotherapy
334769|NCT02165605|breast cancer|breast cancer
334770|NCT02165592|Hemophilia|hemophilia
334771|NCT02165592|Arthropathy|arthropathy
334772|NCT02165592|Range of Motion|range of motion
334773|NCT02165592|Strength|strength
334774|NCT02165592|Proprioception|proprioception
334775|NCT02165592|Gait|gait
334776|NCT02165592|Quality of Life|quality of life
334777|NCT02165579|procalcitonin|procalcitonin
334778|NCT02165579|biomarkers|biomarkers
334779|NCT02165579|Osteomyelitis|osteomyelitis
334780|NCT02165579|diabetes|diabetes
334781|NCT02165579|foot ulcer(s)|foot ulcer(s)
334782|NCT02165579|Infectious Disease Society of America stage 3 infection|infectious disease society of america stage 3 infection
334783|NCT02165566|intensive insulin therapy|intensive insulin therapy
334784|NCT02165566|critical care patients|critical care patients
334785|NCT02165566|blood glucose concentration>180 mg/dl|blood glucose concentration>180 mg/dl
334786|NCT02165553|Hibiscus sabdariffa calyces|hibiscus sabdariffa calyces
334787|NCT02165553|Blood Pressure|blood pressure
334788|NCT02165553|Vascular Function|vascular function
334789|NCT02165553|Inflammation|inflammation
334790|NCT02165553|Cardiometabolic risk markers|cardiometabolic risk markers
334791|NCT02165553|Systemic antioxidant capacity|systemic antioxidant capacity
334792|NCT02165540|Doula|doula
334793|NCT02165540|Pain management|pain management
334794|NCT02165540|Miscarriage|miscarriage
334795|NCT02165540|Abortion|abortion
334796|NCT02165514|spinal curvatures|spinal curvatures
334797|NCT02165488|ketamine|ketamine
334798|NCT02165488|abuse|abuse
334799|NCT02165488|abdominal discomfort|abdominal discomfort
334800|NCT02165488|cholangiopathy|cholangiopathy
334801|NCT02165462|Haemophilia|haemophilia
334802|NCT02165462|Arthropathy|arthropathy
334803|NCT02165462|Bilateral deficit phenomenon|bilateral deficit phenomenon
334804|NCT02165462|Proprioception|proprioception
334805|NCT02165449|ketamine|ketamine
334806|NCT02165449|major depression|major depression
334807|NCT02165449|imaging|imaging
334808|NCT02165449|gene expression|gene expression
334809|NCT02165423|pediatric|pediatric
334810|NCT02165423|solid organ transplant|solid organ transplant
334811|NCT02165423|parents|parents
334812|NCT02165423|heart|heart
334813|NCT02165423|kidney|kidney
334814|NCT02165423|liver|liver
334815|NCT02165410|Autism, mental retardation, Magnetic Resonance Imaging|autism, mental retardation, magnetic resonance imaging
334816|NCT02165397|Ibrutinib|ibrutinib
769385|NCT00369798|HV|hv
334817|NCT02165397|Pharmacyclics|pharmacyclics
334818|NCT02165397|PCYC|pcyc
334819|NCT02165397|Lymphoma|lymphoma
334820|NCT02165397|Btk inhibitor|btk inhibitor
334821|NCT02165397|WM|wm
334822|NCT02165397|Rituximab|rituximab
334823|NCT02165397|Rituxan|rituxan
334824|NCT02165397|Waldenström's|waldenström's
334825|NCT02165397|Waldenstrom Macroglobulinemia|waldenstrom macroglobulinemia
334826|NCT02165397|non-Hodgkin lymphoma|non-hodgkin lymphoma
334827|NCT02165397|NHL|nhl
334828|NCT02165384|tympanostomy|tympanostomy
334829|NCT02165384|myringotomy|myringotomy
334830|NCT02165384|otitis media|otitis media
334831|NCT02165384|ear tubes|ear tubes
334832|NCT02165384|ear infection|ear infection
334833|NCT02165358|BMD|bmd
334834|NCT02165358|LGMD2I|lgmd2i
334835|NCT02165358|Calf enlargement|calf enlargement
334836|NCT02165358|Muscular dystrophy|muscular dystrophy
334837|NCT02165358|MRI|mri
334838|NCT02165306|epilepsy|epilepsy
334839|NCT02165280|Pelvic Organ Prolapse|pelvic organ prolapse
334840|NCT02165280|Surgery|surgery
334841|NCT02165254|physical activity|physical activity
334842|NCT02165254|coronary heart disease|coronary heart disease
334843|NCT02165254|exercise|exercise
334844|NCT02165254|affect|affect
334845|NCT02165254|mind/body therapies|mind/body therapies
334846|NCT02165254|stress, psychological|stress, psychological
334847|NCT02165241|Hypertension|hypertension
334848|NCT02165241|Cardiac remodeling|cardiac remodeling
334849|NCT02165241|Immune system|immune system
334850|NCT02165202|HIV Pre-exposure Prophylaxis;|hiv pre-exposure prophylaxis;
334851|NCT02165202|long-acting injectable;|long-acting injectable;
334852|NCT02165202|HIV PrEP;|hiv prep;
334853|NCT02165202|biomedical HIV prevention research|biomedical hiv prevention research
334854|NCT02165189|Simeprevir|simeprevir
334855|NCT02165189|Sofosbuvir|sofosbuvir
334856|NCT02165189|Ribavirin|ribavirin
334857|NCT02165189|Hepatitits C|hepatitits c
334858|NCT02165189|Hepatitis C virus ribonucleic acid|hepatitis c virus ribonucleic acid
334859|NCT02165176|cannabis|cannabis
334860|NCT02165176|toxicology|toxicology
334861|NCT02165176|intoxication|intoxication
334862|NCT02165150|Elastic Band|elastic band
334863|NCT02165150|Institutional Elders|institutional elders
334864|NCT02165150|Functional Fitness|functional fitness
334865|NCT02165150|Sleep Quality|sleep quality
334867|NCT02165137|trauma|trauma
334868|NCT02165137|major trauma|major trauma
334869|NCT02165137|multiple trauma|multiple trauma
334870|NCT02165137|outcome|outcome
334871|NCT02165137|quality|quality
334872|NCT02165137|process Management|process management
334873|NCT02165137|emergency room|emergency room
334874|NCT02165137|trauma center|trauma center
334875|NCT02165124|Obesity|obesity
334876|NCT02165124|Morbid Obesity|morbid obesity
334877|NCT02165124|Bariatric Surgery|bariatric surgery
334878|NCT02165124|Embolization|embolization
334879|NCT02165124|Minimally Invasive|minimally invasive
334880|NCT02165124|Weight Loss|weight loss
334881|NCT02165111|Scleroderma, Systemic|scleroderma, systemic
334882|NCT02165111|Raynaud Disease|raynaud disease
334883|NCT02165111|Botulinum Toxins, Type A|botulinum toxins, type a
334884|NCT02165085|Biomarkers|biomarkers
334885|NCT02165085|Ehlers-Danlos syndrome, vascular type|ehlers-danlos syndrome, vascular type
334886|NCT02165085|Pathophysiology|pathophysiology
334887|NCT02165072|Inferior vena cava|inferior vena cava
334888|NCT02165072|Kidney injury|kidney injury
334889|NCT02165072|Ultrasound|ultrasound
334890|NCT02165059|Nausea|nausea
334891|NCT02165059|Vomiting|vomiting
334892|NCT02165059|Functional dyspepsia|functional dyspepsia
334893|NCT02165059|Bloating|bloating
334894|NCT02165059|Regurgitation|regurgitation
334895|NCT02165059|Retching|retching
334896|NCT02165020|Prostate|prostate
334897|NCT02165020|Hypofractionated radiotherapy|hypofractionated radiotherapy
334898|NCT02165020|Hyaluronic acid|hyaluronic acid
334899|NCT02165020|Spacer|spacer
334900|NCT02165020|Rectum toxicity|rectum toxicity
334901|NCT02165020|Rectal toxicities after hypofractionated irradiation and injection of hyaluronic acid in patients with low- to intermediate-risk Prostate Cancer|rectal toxicities after hypofractionated irradiation and injection of hyaluronic acid in patients with low- to intermediate-risk prostate cancer
334902|NCT02164994|Astigmatism, arcuate incisions, astigmatic keratotomy|astigmatism, arcuate incisions, astigmatic keratotomy
334903|NCT02164968|Device investigation|device investigation
334904|NCT02164955|Pomalidomide|pomalidomide
334905|NCT02164955|Multiple Myeloma|multiple myeloma
334906|NCT02164955|Relapsed, Refractory|relapsed, refractory
334907|NCT02164955|Observational|observational
334908|NCT02164955|Imnovid|imnovid
334909|NCT02164955|Registry|registry
334910|NCT02164955|Post-approval|post-approval
334911|NCT02164955|Safety|safety
334912|NCT02164929|TAP block|tap block
334913|NCT02164929|Paravertebral block|paravertebral block
334914|NCT02164929|Epidural|epidural
334915|NCT02164929|Laparoscopic colectomy|laparoscopic colectomy
334916|NCT02164916|BRAF Mutant|braf mutant
334917|NCT02164916|Metastatic|metastatic
334918|NCT02164903|Quality of Life|quality of life
428033|NCT01742143|12-223|12-223
334919|NCT02164903|Chronic Myeloid Leukemia|chronic myeloid leukemia
334920|NCT02164903|Imatinib|imatinib
334921|NCT02164903|Dasatinib|dasatinib
334922|NCT02164877|Dietary fiber|dietary fiber
334923|NCT02164851|shock, emergencies, inflammation, infection|shock, emergencies, inflammation, infection
334924|NCT02164851|pathologic process|pathologic process
334925|NCT02164799|Shock|shock
334926|NCT02164799|Predicting diagnosis|predicting diagnosis
334927|NCT02164799|Predicting adverse outcomes|predicting adverse outcomes
334928|NCT02164786|Acute severe disease|acute severe disease
334929|NCT02164786|Intensive care unit|intensive care unit
334930|NCT02164786|adult|adult
334931|NCT02164786|cohort study|cohort study
334932|NCT02164786|metabolomics|metabolomics
334933|NCT02164786|NMR|nmr
334934|NCT02164786|High Performance Liquid Chromatography|high performance liquid chromatography
334935|NCT02164773|sevoflurane|sevoflurane
334936|NCT02164773|pediatric|pediatric
334937|NCT02164773|lower abdominal surgery|lower abdominal surgery
334938|NCT02164773|caudal|caudal
334939|NCT02164773|magnesium sulfate|magnesium sulfate
334940|NCT02164773|Magnesium Sulfate Causing Adverse Effects in Therapeutic Use|magnesium sulfate causing adverse effects in therapeutic use
334941|NCT02164773|Agitation States as Acute Reaction to Exceptional Stress|agitation states as acute reaction to exceptional stress
334942|NCT02164760|burns|burns
334943|NCT02164760|dermal substitute|dermal substitute
334944|NCT02164760|scar quality|scar quality
334945|NCT02164760|reconstruction|reconstruction
334946|NCT02164760|wound healing|wound healing
334947|NCT02164760|wound closure|wound closure
334948|NCT02164734|surfactant|surfactant
334949|NCT02164721|Heart failure|heart failure
334950|NCT02164721|Chemotherapy-induced cardiomyopathy|chemotherapy-induced cardiomyopathy
334951|NCT02164721|Cardiac resynchronization therapy|cardiac resynchronization therapy
334952|NCT02164708|mindfulness meditation, mental health, self-criticism|mindfulness meditation, mental health, self-criticism
334953|NCT02164695|ST-segment elevation myocardial infarction|st-segment elevation myocardial infarction
334954|NCT02164695|Remote ischemic perconditioning|remote ischemic perconditioning
334955|NCT02164695|Primary percutaneous coronary intervention|primary percutaneous coronary intervention
334956|NCT02164695|Cardiac magnetic resonance|cardiac magnetic resonance
334957|NCT02164682|Hypospadias repair|hypospadias repair
334958|NCT02164682|Caudal block|caudal block
334959|NCT02164682|Postoperative complications|postoperative complications
334960|NCT02164669|Inflammation|inflammation
334961|NCT02164669|Coronary artery bypass graft|coronary artery bypass graft
334962|NCT02164669|Magnetic Resonance Imaging|magnetic resonance imaging
334963|NCT02164643|Alzheimer's disease|alzheimer's disease
334964|NCT02164643|Mild Cognitive Impairment|mild cognitive impairment
334965|NCT02164630|Temporomandibular Joint Disorder|temporomandibular joint disorder
334967|NCT02164630|Hope|hope
334968|NCT02164630|Resilience|resilience
334969|NCT02164630|Cognitive Behavior Therapy|cognitive behavior therapy
334970|NCT02164617|Dementia|dementia
334971|NCT02164617|Wheelchair-bound seniors|wheelchair-bound seniors
334972|NCT02164617|Long-term care facilities|long-term care facilities
334973|NCT02164617|Elastic band exercise|elastic band exercise
334974|NCT02164617|Functional fitness|functional fitness
334975|NCT02164617|Daily life function|daily life function
334976|NCT02164617|Depression|depression
334977|NCT02164617|Problem behaviors|problem behaviors
334978|NCT02164604|ranibizumab|ranibizumab
334979|NCT02164604|intravitreal therapy|intravitreal therapy
334980|NCT02164604|ROP|rop
334981|NCT02164604|Plus disease|plus disease
334982|NCT02164604|stage 3 plus|stage 3 plus
334983|NCT02164591|gastroparesis|gastroparesis
334984|NCT02164591|gastric electrical stimulator|gastric electrical stimulator
334985|NCT02164591|GES|ges
334986|NCT02164591|vomiting|vomiting
334987|NCT02164591|nausea|nausea
334988|NCT02164591|bloating|bloating
334989|NCT02164591|postprandial fullness|postprandial fullness
334990|NCT02164591|epigastric pain|epigastric pain
334991|NCT02164552|PCOS|pcos
334992|NCT02164552|vitamin D|vitamin d
334993|NCT02164552|insulin resistance|insulin resistance
334994|NCT02164552|glycemic control|glycemic control
334995|NCT02164539|GSK573719|gsk573719
334996|NCT02164539|asthma|asthma
334997|NCT02164539|UMEC|umec
334998|NCT02164539|FF|ff
334999|NCT02164539|GSK2829332|gsk2829332
335000|NCT02164539|persistent obstruction|persistent obstruction
335001|NCT02164539|GW685698|gw685698
335002|NCT02164539|Fluticasone Furoate|fluticasone furoate
335003|NCT02164539|COPD|copd
335004|NCT02164539|umeclidinium bromide|umeclidinium bromide
335005|NCT02164526|Pulmonary Hypertension|pulmonary hypertension
335006|NCT02164526|Left Heart Disease|left heart disease
335007|NCT02164526|Heart failure|heart failure
335008|NCT02164526|Registry|registry
335009|NCT02164526|China|china
335010|NCT02164513|COPD|copd
335011|NCT02164513|umeclidinium|umeclidinium
335012|NCT02164513|fluticasone furoate|fluticasone furoate
335013|NCT02164513|vilanterol|vilanterol
428159|NCT01741519|PK|pk
335014|NCT02164513|triple therapy|triple therapy
335015|NCT02164513|exacerbation|exacerbation
335016|NCT02164487|B1 adolescents Eating disorders Thaimine|b1 adolescents eating disorders thaimine
335017|NCT02164461|Adenocarcinoma|adenocarcinoma
335018|NCT02164461|Carcinoma|carcinoma
335019|NCT02164461|Carcinoma, Squamous Cell|carcinoma, squamous cell
335020|NCT02164461|Uterine Cervical Neoplasms|uterine cervical neoplasms
335021|NCT02164461|Small Cell Lung Carcinoma|small cell lung carcinoma
335022|NCT02164461|Carcinoma, Small Cell|carcinoma, small cell
335023|NCT02164461|Carcinoma, Adenosquamous|carcinoma, adenosquamous
335024|NCT02164461|Neoplasms, Glandular and Epithelial|neoplasms, glandular and epithelial
335025|NCT02164461|Neoplasms by Histologic Type|neoplasms by histologic type
335026|NCT02164461|Neoplasms|neoplasms
335027|NCT02164461|Neoplasms, Squamous Cell|neoplasms, squamous cell
335028|NCT02164461|Uterine Neoplasms|uterine neoplasms
335029|NCT02164461|Genital Neoplasms, Female|genital neoplasms, female
335030|NCT02164461|Urogenital Neoplasms|urogenital neoplasms
335031|NCT02164461|Neoplasms by Site|neoplasms by site
335032|NCT02164461|Uterine Cervical Diseases|uterine cervical diseases
335033|NCT02164461|Uterine Diseases|uterine diseases
335034|NCT02164461|Genital Diseases, Female|genital diseases, female
335035|NCT02164448|dexmedetomidine|dexmedetomidine
335036|NCT02164448|postoperative bowel movement|postoperative bowel movement
335037|NCT02164448|laparoscopic gastrectomy|laparoscopic gastrectomy
335038|NCT02164435|Uncontrolled hypertension|uncontrolled hypertension
335039|NCT02164435|Renal denervation|renal denervation
335040|NCT02164435|Renal artery|renal artery
335041|NCT02164422|Alcohol|alcohol
335042|NCT02164422|Drinkers|drinkers
335043|NCT02164422|Guanfacine|guanfacine
335044|NCT02164383|Smoking Cessation|smoking cessation
335045|NCT02164383|Smoking|smoking
335046|NCT02164383|Nicotine|nicotine
335047|NCT02164357|Ischaemic Stroke|ischaemic stroke
335048|NCT02164357|Main artery occlusion|main artery occlusion
335049|NCT02164357|Endovascular treatment|endovascular treatment
335050|NCT02164357|Intravenous Thrombolytic Therapy|intravenous thrombolytic therapy
335051|NCT02164344|HIV|hiv
335052|NCT02164344|Gut|gut
335053|NCT02164344|probiotics|probiotics
335054|NCT02164344|immune activation|immune activation
335055|NCT02164305|Rotator cuff muscle|rotator cuff muscle
335056|NCT02164305|Excitability|excitability
335057|NCT02164305|Proprioception|proprioception
335058|NCT02164305|Kinematics|kinematics
335059|NCT02164305|Muscle activity|muscle activity
335060|NCT02164305|Electromyography|electromyography
335061|NCT02164292|Liver tumor|liver tumor
335063|NCT02164292|Two-stage hepatectomy|two-stage hepatectomy
335064|NCT02164292|Morbidity|morbidity
335065|NCT02164292|Hypertrophy|hypertrophy
335066|NCT02164279|Microalbuminuria|microalbuminuria
335067|NCT02164279|diabetic nephropathy|diabetic nephropathy
335068|NCT02164279|type I diabetes|type i diabetes
335069|NCT02164279|early predictive urinary biomarkers|early predictive urinary biomarkers
335070|NCT02164240|Gastrointestinal Stromal Tumor|gastrointestinal stromal tumor
335071|NCT02164227|anxiety|anxiety
335072|NCT02164227|breathing exercise|breathing exercise
335073|NCT02164227|labour|labour
335074|NCT02164201|Type A Aortic Dissection (where the use of BioFoam is limited to the anastomotic site)|type a aortic dissection (where the use of biofoam is limited to the anastomotic site)
335075|NCT02164188|Stress|stress
335076|NCT02164188|Well-being|well-being
335077|NCT02164188|Functional magnetic resonance imaging|functional magnetic resonance imaging
335078|NCT02164188|Positive psychology|positive psychology
335079|NCT02164175|HeRO Graft|hero graft
335080|NCT02164162|Parkinson's disease, Lokomat, gait training, rehabilitation.|parkinson's disease, lokomat, gait training, rehabilitation.
335081|NCT02164149|Colon cancer|colon cancer
335082|NCT02164149|Quality of surgery|quality of surgery
335083|NCT02164149|Length of tumour feeding artery|length of tumour feeding artery
335084|NCT02164123|Autonomic effects|autonomic effects
335085|NCT02164123|spinal mobilization|spinal mobilization
335086|NCT02164123|clinical trial|clinical trial
335087|NCT02164097|ICE|ice
335088|NCT02164097|ODSH|odsh
335089|NCT02164097|platelet recovery|platelet recovery
335090|NCT02164097|recurrent solid tumor|recurrent solid tumor
335091|NCT02164084|acne|acne
335092|NCT02164071|Haematological malignancy|haematological malignancy
335093|NCT02164071|Elderly|elderly
335094|NCT02164071|Health Status|health status
335095|NCT02164071|Scale validation|scale validation
335096|NCT02164058|Myocardial infarction|myocardial infarction
335097|NCT02164058|STEMI|stemi
335098|NCT02164058|ST elevation MI|st elevation mi
335099|NCT02164058|Acute MI|acute mi
335100|NCT02164019|Pathologic Fractures|pathologic fractures
335101|NCT02164019|hip replacements|hip replacements
335102|NCT02164019|12-287|12-287
335103|NCT02164006|Hodgkin's|hodgkin's
335104|NCT02163980|dexmedetomidine|dexmedetomidine
335105|NCT02163980|caudal block|caudal block
335106|NCT02163980|children|children
400521|NCT01866501|IO Vascular Access|io vascular access
400522|NCT01866501|EZ-IO|ez-io
428318|NCT01740791|HCV|hcv
335107|NCT02163980|children (1-6 years) undergoing ambulatory orchipexy|children (1-6 years) undergoing ambulatory orchipexy
335108|NCT02163967|cranial electrical stimulation|cranial electrical stimulation
335109|NCT02163967|CES|ces
335110|NCT02163967|heart rate variability|heart rate variability
335111|NCT02163967|parasympathetic|parasympathetic
335112|NCT02163967|Vagal|vagal
335113|NCT02163954|platelet|platelet
335114|NCT02163954|ticagrelor|ticagrelor
335115|NCT02163954|clopidogrel|clopidogrel
335116|NCT02163954|end stage renal disease|end stage renal disease
335117|NCT02163954|hemodialysis|hemodialysis
335118|NCT02163941|PTSD|ptsd
335119|NCT02163941|empathy|empathy
335120|NCT02163941|meditation|meditation
335121|NCT02163941|compassion|compassion
335122|NCT02163941|inflammation|inflammation
335123|NCT02163941|oxytocin|oxytocin
335124|NCT02163941|fMRI|fmri
335125|NCT02163928|Antioxidants|antioxidants
335126|NCT02163928|Carotenoids|carotenoids
335127|NCT02163928|Diet|diet
335128|NCT02163915|Drug therapy|drug therapy
335129|NCT02163889|Candida|candida
335130|NCT02163889|Blood culture|blood culture
335131|NCT02163889|Antifungal therapy|antifungal therapy
335132|NCT02163889|Sepsis|sepsis
335133|NCT02163876|spine|spine
335134|NCT02163876|injury|injury
335135|NCT02163876|trauma|trauma
335136|NCT02163876|spine injury|spine injury
335137|NCT02163876|cervical spine injury|cervical spine injury
335138|NCT02163876|cervical spine|cervical spine
335139|NCT02163876|stemcells transplantation|stemcells transplantation
335140|NCT02163863|Peripheral arterial disease (PAD)|peripheral arterial disease (pad)
335141|NCT02163863|Peripheral vascular disease (PVD)|peripheral vascular disease (pvd)
335142|NCT02163863|Biomimetic stent|biomimetic stent
335143|NCT02163863|Helical centerline|helical centerline
335144|NCT02163837|sleep quality|sleep quality
335145|NCT02163837|physical activity|physical activity
335146|NCT02163837|daytime sleepiness|daytime sleepiness
335147|NCT02163837|actigraphy|actigraphy
335148|NCT02163837|quality of life|quality of life
335149|NCT02163824|postsurgical|postsurgical
335150|NCT02163824|postoperative|postoperative
335151|NCT02163824|ocular|ocular
335152|NCT02163824|cataract|cataract
335153|NCT02163824|inflammation|inflammation
335154|NCT02163824|pain|pain
335155|NCT02163824|corticosteroid|corticosteroid
335156|NCT02163811|Self-management|self-management
335157|NCT02163811|Functional status|functional status
335158|NCT02163811|Depression|depression
335159|NCT02163798|Tai Chi|tai chi
335160|NCT02163798|Walking|walking
335161|NCT02163798|Physical activity|physical activity
335162|NCT02163798|Randomized controlled trial|randomized controlled trial
335163|NCT02163798|Chinese population|chinese population
335164|NCT02163798|Exercise|exercise
335165|NCT02163798|Body composition|body composition
335166|NCT02163798|Cardiovascular risk factor|cardiovascular risk factor
335167|NCT02163798|Energy expenditure|energy expenditure
335169|NCT02163798|SF-12|sf-12
335170|NCT02163785|Inferior rectal cancer|inferior rectal cancer
335171|NCT02163785|Abdominoperineal resection|abdominoperineal resection
335172|NCT02163785|Miles operation|miles operation
335173|NCT02163785|Supine Miles operation|supine miles operation
335174|NCT02163785|Prone Miles operation|prone miles operation
335175|NCT02163785|Total mesorectal excision|total mesorectal excision
335176|NCT02163785|Circumferential radial margin|circumferential radial margin
335177|NCT02163746|Hidradenitis suppurativa|hidradenitis suppurativa
335178|NCT02163733|oncology, cancer, non small cell lung cancer, anticancer drug, pharmacokinetics, AZD9291, EGFR sensitivity mutation, food effect|oncology, cancer, non small cell lung cancer, anticancer drug, pharmacokinetics, azd9291, egfr sensitivity mutation, food effect
335179|NCT02163720|ovarian cancer|ovarian cancer
335180|NCT02163720|fallopian tube or primary peritoneal|fallopian tube or primary peritoneal
335181|NCT02163720|relapse|relapse
335182|NCT02163720|platinum-sensitive|platinum-sensitive
335183|NCT02163720|Yondelis®-Caelyx®|yondelis®-caelyx®
335184|NCT02163707|Psilocybin|psilocybin
335185|NCT02163707|Pharmacokinetics|pharmacokinetics
335186|NCT02163694|PARP Inhibitor|parp inhibitor
335187|NCT02163694|Veliparib|veliparib
335188|NCT02163694|BRCA1|brca1
335189|NCT02163694|BRCA2|brca2
335190|NCT02163694|HER2-negative|her2-negative
335191|NCT02163694|Locally recurrent|locally recurrent
335192|NCT02163694|Breast Cancer|breast cancer
335193|NCT02163694|Metastatic Breast Cancer|metastatic breast cancer
335194|NCT02163694|ABT-888|abt-888
335195|NCT02163694|Genetic breast cancer|genetic breast cancer
335196|NCT02163694|Paclitaxel|paclitaxel
335197|NCT02163694|BRCA Mutation|brca mutation
335198|NCT02163694|PARP|parp
335199|NCT02163694|Carboplatin|carboplatin
335200|NCT02163694|BROCADE3|brocade3
335201|NCT02163668|Yoga|yoga
335202|NCT02163668|Bone turnover markers|bone turnover markers
335203|NCT02163668|Bone strength|bone strength
335204|NCT02163668|Bone mineral density|bone mineral density
400523|NCT01866488|Labor induction|labor induction
335205|NCT02163655|preeclampsia, very high blood pressure, diuretics|preeclampsia, very high blood pressure, diuretics
335206|NCT02163642|Bronchiectasis|bronchiectasis
335207|NCT02163642|Immunity|immunity
335208|NCT02163629|Psychotherapeutic intervention|psychotherapeutic intervention
335209|NCT02163629|stress management|stress management
335210|NCT02163629|cardiac transplantation|cardiac transplantation
335211|NCT02163629|quality of life|quality of life
335212|NCT02163616|Primary postpartum hemorrhage|primary postpartum hemorrhage
335214|NCT02163616|uterine atony|uterine atony
335215|NCT02163616|high fever|high fever
335216|NCT02163616|hyperpyrexia|hyperpyrexia
335217|NCT02163616|shock index|shock index
335218|NCT02163590|Spinal mobilisation|spinal mobilisation
335219|NCT02163590|Pressure pain threshold|pressure pain threshold
335220|NCT02163590|Thoracic spine|thoracic spine
335221|NCT02163577|X-linked hypophosphatemia|x-linked hypophosphatemia
335222|NCT02163577|XLH|xlh
335223|NCT02163577|FGF23|fgf23
335224|NCT02163577|KRN23|krn23
335225|NCT02163564|Adolescent|adolescent
335226|NCT02163564|Depression|depression
335227|NCT02163564|Insomnia|insomnia
335228|NCT02163551|dyspnea|dyspnea
335229|NCT02163551|respiratory sensation|respiratory sensation
335230|NCT02163551|event-related potentials|event-related potentials
335231|NCT02163551|spinal cord injury|spinal cord injury
335232|NCT02163538|energy device|energy device
335233|NCT02163538|laparoscopic|laparoscopic
335234|NCT02163538|hysterectomy|hysterectomy
335235|NCT02163538|enseal|enseal
335236|NCT02163538|ligasure|ligasure
335237|NCT02163538|raw tlx|raw tlx
335238|NCT02163525|Fibroids|fibroids
335239|NCT02163525|Myomas|myomas
335240|NCT02163525|leiomyomata|leiomyomata
335241|NCT02163525|menorrhagia|menorrhagia
335242|NCT02163525|Acessa Procedure|acessa procedure
335243|NCT02163525|Radiofrequency Ablation (RFA)|radiofrequency ablation (rfa)
335244|NCT02163525|GFA|gfa
335245|NCT02163525|Acessa|acessa
335246|NCT02163512|Hepatic cirrhosis|hepatic cirrhosis
335247|NCT02163512|Ascites|ascites
335248|NCT02163512|Beta blockers treatment|beta blockers treatment
335249|NCT02163486|I-gel|i-gel
335250|NCT02163486|oropharyngeal leak pressure|oropharyngeal leak pressure
335251|NCT02163486|head position|head position
335252|NCT02163460|ventral hernia|ventral hernia
335253|NCT02163460|seroma|seroma
335254|NCT02163460|drainage|drainage
335255|NCT02163460|infection|infection
335256|NCT02163447|Chemoprevention|chemoprevention
335257|NCT02163447|Malaria|malaria
335258|NCT02163447|Uganda|uganda
335259|NCT02163447|Sulfadoxine-pyrimethamine|sulfadoxine-pyrimethamine
335260|NCT02163447|Dihydroartemisinin-piperaquine|dihydroartemisinin-piperaquine
335261|NCT02163434|pregnancy|pregnancy
335262|NCT02163434|nausea|nausea
335263|NCT02163434|vomiting|vomiting
335264|NCT02163434|hyperemesis|hyperemesis
335265|NCT02163434|treatment|treatment
335266|NCT02163434|gabapentin|gabapentin
335267|NCT02163434|metoclopramide|metoclopramide
335268|NCT02163434|safety|safety
335269|NCT02163421|Drug therapy|drug therapy
335270|NCT02163408|MRI|mri
335271|NCT02163408|Plaque Characterization|plaque characterization
335272|NCT02163395|Ceramic implant|ceramic implant
335273|NCT02163382|Nava|nava
335274|NCT02163382|Non Invasive Ventilation|non invasive ventilation
335275|NCT02163356|neuroblastoma|neuroblastoma
335276|NCT02163356|recurrent|recurrent
335277|NCT02163356|resistant|resistant
335278|NCT02163343|Serum metal ion levels|serum metal ion levels
335279|NCT02163343|Cathcart/Corail hemiarthroplasty|cathcart/corail hemiarthroplasty
335280|NCT02163343|Hip replacement|hip replacement
335281|NCT02163291|advanced gastric cancer|advanced gastric cancer
335282|NCT02163291|neoadjuvant chemotherapy|neoadjuvant chemotherapy
335283|NCT02163291|safety|safety
335284|NCT02163291|feasibility|feasibility
335285|NCT02163278|DBPR108|dbpr108
335286|NCT02163278|DPP4|dpp4
335287|NCT02163278|Diabetes|diabetes
335288|NCT02163278|Glucagon-like peptide-1 (GLP-1)|glucagon-like peptide-1 (glp-1)
335289|NCT02163278|Incretins|incretins
335290|NCT02163239|FloShield|floshield
335291|NCT02163239|MID|mid
335292|NCT02163239|Minimally invasive surgery|minimally invasive surgery
335293|NCT02163239|Minimally Invasive devices|minimally invasive devices
335294|NCT02163239|Robot-assisted Laparoscopic Surgery|robot-assisted laparoscopic surgery
335295|NCT02163239|Single-site Laparoscopic Surgery|single-site laparoscopic surgery
335296|NCT02163239|Single Incision Laparoscopic Surgery|single incision laparoscopic surgery
335297|NCT02163239|Cannula|cannula
335298|NCT02163239|Blunt Obturator|blunt obturator
335299|NCT02163239|Cholecystectomy|cholecystectomy
335300|NCT02163239|Benign hysterectomy|benign hysterectomy
335301|NCT02163239|Salpingo-oophorectomy|salpingo-oophorectomy
335302|NCT02163226|Bone metastases|bone metastases
335303|NCT02163226|Hypofractionated Radiation Therapy|hypofractionated radiation therapy
335304|NCT02163226|Standard Radiation Therapy|standard radiation therapy
335305|NCT02163226|XRT|xrt
335306|NCT02163226|Pain control|pain control
335307|NCT02163226|Palliation of symptoms|palliation of symptoms
335308|NCT02163226|Questionnaire|questionnaire
335309|NCT02163226|Survey|survey
335310|NCT02163213|diarrhea|diarrhea
335311|NCT02163213|irritable bowel syndrome|irritable bowel syndrome
335312|NCT02163200|Bedsores|bedsores
335313|NCT02163200|pressure|pressure
335314|NCT02163200|hip|hip
335315|NCT02163187|Neuromodulation (SNM)|neuromodulation (snm)
335316|NCT02163187|sphincter preservation|sphincter preservation
335317|NCT02163187|rectal polyp|rectal polyp
335318|NCT02163187|InterStimTM|interstimtm
335319|NCT02163187|14-100|14-100
335320|NCT02163174|neonatal|neonatal
335321|NCT02163174|pentoxifylline|pentoxifylline
335322|NCT02163174|randomized controlled trial|randomized controlled trial
335323|NCT02163161|Phase I|phase i
335324|NCT02163161|Open Label|open label
335325|NCT02163161|Single dose|single dose
335326|NCT02163161|Crossover|crossover
335327|NCT02163161|Bioavailability|bioavailability
335328|NCT02163161|Fasting|fasting
335329|NCT02163161|Fed|fed
335330|NCT02163161|PF-04965842|pf-04965842
335331|NCT02163161|Healthy|healthy
335332|NCT02163122|Cat Allergy|cat allergy
335333|NCT02163122|Feld1|feld1
335334|NCT02163109|Oxygen consumption|oxygen consumption
335335|NCT02163109|Pulmonary gas exchange|pulmonary gas exchange
335336|NCT02163109|Cardiac output|cardiac output
335337|NCT02163070|whey protein|whey protein
335338|NCT02163070|malnutrition|malnutrition
335339|NCT02163070|oxidative stress|oxidative stress
335340|NCT02163070|hemodialysis|hemodialysis
335341|NCT02163057|Head and neck squamous cell cancer|head and neck squamous cell cancer
335342|NCT02163057|Papillomavirus|papillomavirus
335343|NCT02163031|heart transplant|heart transplant
335344|NCT02163031|radial approach|radial approach
335345|NCT02163031|catheterization|catheterization
335346|NCT02163005|GDL contrast agent|gdl contrast agent
335347|NCT02162992|Antibodies, Antinuclear|antibodies, antinuclear
335348|NCT02162992|SS-A antigen|ss-a antigen
335349|NCT02162992|Lupus Erythematosus, Systemic|lupus erythematosus, systemic
335350|NCT02162992|Atrioventricular Block|atrioventricular block
335351|NCT02162992|Sudden death|sudden death
335352|NCT02162979|Parkinson's disease|parkinson's disease
335353|NCT02162979|PD|pd
335354|NCT02162979|dyskinesia|dyskinesia
335355|NCT02162979|treatment|treatment
335356|NCT02162979|motor complications|motor complications
335357|NCT02162966|colistin|colistin
335358|NCT02162966|ICU|icu
335359|NCT02162966|critical care|critical care
335360|NCT02162953|eye disease|eye disease
335361|NCT02162953|retinal|retinal
335362|NCT02162953|best1|best1
335363|NCT02162940|low back pain|low back pain
335364|NCT02162940|epidural steroid injection|epidural steroid injection
335365|NCT02162940|statin|statin
335366|NCT02162940|quality of life|quality of life
335367|NCT02162927|muscular strength|muscular strength
335368|NCT02162927|muscular endurance|muscular endurance
335369|NCT02162927|muscular power|muscular power
335370|NCT02162927|rowing|rowing
335371|NCT02162927|CrossFit|crossfit
335372|NCT02162927|dietary nitrate|dietary nitrate
335373|NCT02162914|Intra-hepatic|intra-hepatic
335374|NCT02162914|Hilar|hilar
335375|NCT02162914|Locally Advanced|locally advanced
335376|NCT02162914|Non Resectable|non resectable
335377|NCT02162914|Metastatic|metastatic
335378|NCT02162914|Regorafenib|regorafenib
335379|NCT02162914|Placebo|placebo
335380|NCT02162901|Diabetes prevention|diabetes prevention
335381|NCT02162875|Schistosoma mansoni|schistosoma mansoni
335382|NCT02162875|treatment|treatment
335383|NCT02162875|school children|school children
335384|NCT02162875|adults|adults
335385|NCT02162862|Inflammatory Bowel Disease|inflammatory bowel disease
335386|NCT02162862|Physical Illness|physical illness
335387|NCT02162862|Wellbutrin|wellbutrin
335388|NCT02162849|Tobacco Use Cessation|tobacco use cessation
335389|NCT02162849|Smoking Cessation|smoking cessation
335390|NCT02162849|Cancer Prevention|cancer prevention
335391|NCT02162849|Behavioral Counseling|behavioral counseling
335392|NCT02162849|Nicotine Replacement Therapy|nicotine replacement therapy
335393|NCT02162849|NRT|nrt
335394|NCT02162849|Nicotine patch|nicotine patch
335395|NCT02162849|Placebo patch|placebo patch
335396|NCT02162849|Placebo pill|placebo pill
335397|NCT02162849|Sugar pill|sugar pill
335398|NCT02162849|Varenicline|varenicline
335399|NCT02162849|Chantix|chantix
335400|NCT02162849|Questionnaires|questionnaires
335401|NCT02162849|Surveys|surveys
335402|NCT02162849|Saliva test|saliva test
335403|NCT02162836|Prostatic Neoplasms, Castration-Resistant|prostatic neoplasms, castration-resistant
335404|NCT02162836|Metastatic Castration-Resistant Prostate Cancer|metastatic castration-resistant prostate cancer
335405|NCT02162836|Prostate Cancer|prostate cancer
335406|NCT02162836|Androgen Receptor|androgen receptor
335407|NCT02162836|JNJ-56021927|jnj-56021927
335408|NCT02162823|The MeSH name is Carcinoma, Pancreatic Ductal|the mesh name is carcinoma, pancreatic ductal
335409|NCT02162810|hypospadias|hypospadias
335410|NCT02162797|HIV|hiv
335411|NCT02162797|AIDS|aids
335412|NCT02162797|zinc|zinc
335413|NCT02162797|zinc supplement|zinc supplement
400524|NCT01866488|Misoprostol|misoprostol
335414|NCT02162797|immunological deficiency|immunological deficiency
335415|NCT02162771|Advanced Follicular Lymphoma|advanced follicular lymphoma
335416|NCT02162758|Drug therapy|drug therapy
335417|NCT02162745|Bronchiolitis|bronchiolitis
335418|NCT02162745|Normal saline solution|normal saline solution
335419|NCT02162745|Hypertonic solution|hypertonic solution
335420|NCT02162745|Nasal irrigation|nasal irrigation
335421|NCT02162680|local anesthesia|local anesthesia
335422|NCT02162680|intravenous catheter|intravenous catheter
335423|NCT02162654|neuroprotection|neuroprotection
335424|NCT02162654|ischemic preconditioning|ischemic preconditioning
335425|NCT02162654|cerebral aneurysm|cerebral aneurysm
335426|NCT02162628|Pelvic Floor Disorder|pelvic floor disorder
335427|NCT02162628|Pelvic Organ Prolapse|pelvic organ prolapse
335428|NCT02162628|Sexual Dysfunction|sexual dysfunction
335429|NCT02162628|Mesh|mesh
335430|NCT02162628|POP|pop
335431|NCT02162628|Transvaginal|transvaginal
335432|NCT02162628|Total Repair|total repair
335433|NCT02162628|Uterine Prolapse|uterine prolapse
335434|NCT02162628|Cystocele|cystocele
335435|NCT02162628|Rectocele|rectocele
335436|NCT02162628|Enterocele|enterocele
335437|NCT02162628|Vaginal Vault Prolapse|vaginal vault prolapse
335438|NCT02162628|Native Tissue Repair|native tissue repair
335439|NCT02162628|Repair Augmented with Mesh|repair augmented with mesh
335440|NCT02162628|Pathological Conditions, Anatomical|pathological conditions, anatomical
335441|NCT02162628|Exair Prolapse Repair System|exair prolapse repair system
335442|NCT02162628|Vaginal Mesh|vaginal mesh
335443|NCT02162628|Transvaginal Mesh|transvaginal mesh
335444|NCT02162615|Pelvic Floor Disorder|pelvic floor disorder
335445|NCT02162615|Pelvic Organ Prolapse|pelvic organ prolapse
335446|NCT02162615|Sexual Dysfunction|sexual dysfunction
335447|NCT02162615|Mesh|mesh
335448|NCT02162615|POP|pop
335449|NCT02162615|Transvaginal|transvaginal
335450|NCT02162615|Anterior|anterior
335451|NCT02162615|Posterior|posterior
335452|NCT02162615|Apical|apical
335453|NCT02162615|Uterine Prolapse|uterine prolapse
335454|NCT02162615|Cystocele|cystocele
335455|NCT02162615|Rectocele|rectocele
335456|NCT02162615|Enterocele|enterocele
335457|NCT02162615|Vaginal Vault Prolapse|vaginal vault prolapse
335458|NCT02162615|Native Tissue Repair|native tissue repair
335459|NCT02162615|Repair Augmented with Mesh|repair augmented with mesh
335460|NCT02162615|Pathological Conditions, Anatomical|pathological conditions, anatomical
335461|NCT02162615|Restorelle Direct Fix|restorelle direct fix
335462|NCT02162615|Vaginal Mesh|vaginal mesh
335463|NCT02162615|Transvaginal Mesh|transvaginal mesh
335464|NCT02162576|asthma|asthma
335465|NCT02162576|asthma control|asthma control
335466|NCT02162576|healthcare utilization costs|healthcare utilization costs
335467|NCT02162576|community hotspots|community hotspots
335468|NCT02162576|public health research|public health research
335469|NCT02162563|Colorectal cancer|colorectal cancer
335470|NCT02162563|Chemotherapy|chemotherapy
335471|NCT02162563|Anti-EGFR|anti-egfr
335472|NCT02162563|Liver metastases|liver metastases
335473|NCT02162563|R0 R1 liver resection|r0 r1 liver resection
335474|NCT02162563|Resectability of liver|resectability of liver
335475|NCT02162563|Liver expert panel|liver expert panel
335476|NCT02162550|Type 2 Diabetes|type 2 diabetes
335477|NCT02162550|Cardiovascular Disease|cardiovascular disease
335478|NCT02162550|Hyperglycemia|hyperglycemia
335479|NCT02162550|Carotid Plaque|carotid plaque
335480|NCT02162550|Endothelial function|endothelial function
335481|NCT02162550|Incretins|incretins
335482|NCT02162550|Atherosclerosis|atherosclerosis
335483|NCT02162537|Strategy|strategy
335484|NCT02162537|Radiotherapy|radiotherapy
335485|NCT02162537|Chemotherapy|chemotherapy
335486|NCT02162537|Cisplatin|cisplatin
335487|NCT02162524|aerobic exercise|aerobic exercise
335488|NCT02162524|obesity|obesity
335489|NCT02162524|energy balance|energy balance
335490|NCT02162511|Haplocompatible|haplocompatible
335491|NCT02162511|Stem cell transplant|stem cell transplant
335492|NCT02162511|Borderline organ function|borderline organ function
335493|NCT02162511|Alternative donor stem cell transplant|alternative donor stem cell transplant
335494|NCT02162498|Peer support|peer support
335495|NCT02162498|Adherence|adherence
335496|NCT02162498|Exclusive breastfeeding|exclusive breastfeeding
335497|NCT02162498|Early infant diagnosis|early infant diagnosis
335498|NCT02162498|Stigma and disclosure|stigma and disclosure
335499|NCT02162472|videocapillaroscopy, psoriasis, systemic agent|videocapillaroscopy, psoriasis, systemic agent
335500|NCT02162459|Adolescent|adolescent
335501|NCT02162459|supplements|supplements
335502|NCT02162459|strength|strength
335503|NCT02162459|whey protein|whey protein
335504|NCT02162459|bench press strength|bench press strength
335505|NCT02162459|squat strength|squat strength
335506|NCT02162420|severe aplastic anemia|severe aplastic anemia
335507|NCT02162420|Hematopoietic Stem Cell Transplant|hematopoietic stem cell transplant
335508|NCT02162381|Humphrey visual fields|humphrey visual fields
335509|NCT02162381|methylphenidate|methylphenidate
400525|NCT01866488|Cytotec|cytotec
335510|NCT02162381|attention deficit disorder|attention deficit disorder
335511|NCT02162381|MoCa questionnaire|moca questionnaire
335512|NCT02162368|laryngeal mask, prone position, spine surgery|laryngeal mask, prone position, spine surgery
335513|NCT02162342|upper extremity|upper extremity
335514|NCT02162342|muscle activity|muscle activity
335515|NCT02162342|kinematics|kinematics
335516|NCT02162342|motion capture|motion capture
335517|NCT02162342|Electromyography|electromyography
335518|NCT02162329|Breast Cancer|breast cancer
335519|NCT02162329|Cognitive function|cognitive function
335520|NCT02162329|Questionnaires|questionnaires
335521|NCT02162329|Surveys|surveys
335522|NCT02162329|Electroencephalography|electroencephalography
335524|NCT02162329|Magnetic resonance imaging|magnetic resonance imaging
335525|NCT02162329|fMRI|fmri
335526|NCT02162329|Tibetan meditation|tibetan meditation
335527|NCT02162329|Quality of life|quality of life
335528|NCT02162329|QOL|qol
335529|NCT02162303|Atherosclerosis|atherosclerosis
335530|NCT02162303|Vascular|vascular
335531|NCT02162303|Cardiovascular|cardiovascular
335532|NCT02162303|Coronary artery disease|coronary artery disease
335533|NCT02162303|Imaging|imaging
335534|NCT02162303|PET|pet
335535|NCT02162303|Scan|scan
335536|NCT02162303|anti-inflammatory|anti-inflammatory
335537|NCT02162277|To decrease|to decrease
335538|NCT02162277|number|number
335539|NCT02162277|osteoporotic|osteoporotic
335540|NCT02162277|patients in|patients in
335541|NCT02162277|Kami-Ina area|kami-ina area
335542|NCT02162277|Nagano prefecture|nagano prefecture
335543|NCT02162264|Alzheimer's Disease|alzheimer's disease
335544|NCT02162264|donepezil hydrochloride|donepezil hydrochloride
335545|NCT02162251|Alzheimer's Disease|alzheimer's disease
335546|NCT02162251|donepezil hydrochloride|donepezil hydrochloride
335547|NCT02162238|zinc|zinc
335548|NCT02162238|diet|diet
335549|NCT02162238|water|water
335550|NCT02162238|morbidity|morbidity
335551|NCT02162238|growth|growth
335552|NCT02162225|Erythrocyte Deformability|erythrocyte deformability
335553|NCT02162225|Platelet Activation|platelet activation
335554|NCT02162225|Platelet Aggregation|platelet aggregation
335555|NCT02162225|Nitrite|nitrite
335556|NCT02162225|Sickle Cell Anemia|sickle cell anemia
335557|NCT02162225|Diet Therapy|diet therapy
335558|NCT02162199|Antibiotic|antibiotic
335559|NCT02162199|Antibiotic Resistant Bacterial Infection|antibiotic resistant bacterial infection
335560|NCT02162186|Arthroplasty, Replacement, Hip/methods|arthroplasty, replacement, hip/methods
335561|NCT02162186|Hip Joint/physiopathology|hip joint/physiopathology
335562|NCT02162186|Hip Joint/radiography|hip joint/radiography
335563|NCT02162186|Hip Joint/surgery|hip joint/surgery
335564|NCT02162186|Hip Prosthesis|hip prosthesis
335565|NCT02162186|Outcome Assessment (Health Care)|outcome assessment (health care)
335566|NCT02162186|Female|female
335567|NCT02162186|Male|male
335568|NCT02162186|Adult|adult
335569|NCT02162173|Familial adenomatous polyposis syndrome|familial adenomatous polyposis syndrome
335570|NCT02162173|Non-ampullary polyp|non-ampullary polyp
335571|NCT02162173|Ampullary polyp|ampullary polyp
335572|NCT02162173|Narrow band imaging endoscopy|narrow band imaging endoscopy
335573|NCT02162173|Confocal laser endomicroscopy|confocal laser endomicroscopy
335574|NCT02162160|probiotic|probiotic
335575|NCT02162160|post-menopausal|post-menopausal
335576|NCT02162160|atrophic vaginitis|atrophic vaginitis
335577|NCT02162147|patient safety|patient safety
335578|NCT02162147|pediatrics|pediatrics
335579|NCT02162147|emergency medicine|emergency medicine
335580|NCT02162134|cholecystectomy|cholecystectomy
335581|NCT02162134|laparoscopic|laparoscopic
335582|NCT02162134|postoperative|postoperative
335583|NCT02162134|ileus|ileus
335584|NCT02162134|chewing gum|chewing gum
335585|NCT02162095|Chronic obstructive pulmonary disease|chronic obstructive pulmonary disease
335586|NCT02162095|Coronary artery disease|coronary artery disease
335587|NCT02162095|Coronary calcium score|coronary calcium score
335588|NCT02162043|Glaucoma|glaucoma
335589|NCT02162043|Perimetry|perimetry
335590|NCT02162043|Diagnostic self-evaluation|diagnostic self-evaluation
335591|NCT02162043|Screening|screening
335592|NCT02162043|Visual fields|visual fields
335593|NCT02162017|Acute ischemic stroke|acute ischemic stroke
335594|NCT02162017|Acute intracerebral haemorrhage|acute intracerebral haemorrhage
335595|NCT02162017|Head position|head position
335596|NCT02162017|Lying flat head position|lying flat head position
335597|NCT02162017|Sitting up head position|sitting up head position
335598|NCT02162017|Death|death
335599|NCT02162017|Disability|disability
335600|NCT02162017|Clinical trial|clinical trial
335601|NCT02162004|Type 1 diabetes|type 1 diabetes
335602|NCT02162004|Continuous Glucose Monitoring|continuous glucose monitoring
335603|NCT02162004|Insulin pump|insulin pump
335604|NCT02162004|Sensor-augmented pump|sensor-augmented pump
335605|NCT02162004|Continuous correction of high blood glucose|continuous correction of high blood glucose
335606|NCT02161991|aprepitant|aprepitant
335607|NCT02161991|non-small cell lung cancer|non-small cell lung cancer
335608|NCT02161978|antiangiogenic|antiangiogenic
335609|NCT02161978|cancer|cancer
335610|NCT02161978|vascular|vascular
335611|NCT02161978|biomarker|biomarker
335612|NCT02161978|tyrosine kinase inhibitor|tyrosine kinase inhibitor
335613|NCT02161965|Anticoagulation|anticoagulation
335614|NCT02161965|Coronary and peripheral calcification|coronary and peripheral calcification
335615|NCT02161965|Arterial stiffness|arterial stiffness
335616|NCT02161965|Biomarker|biomarker
335617|NCT02161952|Fibrosis, necroinflammation, hepatitis C chronic|fibrosis, necroinflammation, hepatitis c chronic
335618|NCT02161926|Obesity|obesity
335619|NCT02161926|dietary restrictions|dietary restrictions
335620|NCT02161926|metabolism|metabolism
335621|NCT02161926|nutrition|nutrition
335622|NCT02161926|elderly|elderly
335623|NCT02161874|edentulism|edentulism
335624|NCT02161874|dental implants|dental implants
335625|NCT02161874|clinical study|clinical study
335626|NCT02161874|endosseous|endosseous
335627|NCT02161874|randomized|randomized
335628|NCT02161874|crestal bone level|crestal bone level
335629|NCT02161874|T3|t3
335630|NCT02161874|Nanotite Certain|nanotite certain
335631|NCT02161874|Nanotite Certain Prevail|nanotite certain prevail
335632|NCT02161874|Tapered|tapered
335633|NCT02161861|tripeptide FEE|tripeptide fee
335634|NCT02161861|fertilization rates|fertilization rates
335635|NCT02161861|embryos|embryos
335636|NCT02161861|oocytes|oocytes
335637|NCT02161835|Congenital myotonia|congenital myotonia
335638|NCT02161835|Myotonia congenita|myotonia congenita
335639|NCT02161835|Thomsons disease|thomsons disease
335640|NCT02161835|Becker type|becker type
335641|NCT02161835|Training|training
335642|NCT02161835|Exercise|exercise
335643|NCT02161822|locally advanced rectal cancer, neoadjuvant chemoradiation|locally advanced rectal cancer, neoadjuvant chemoradiation
335644|NCT02161809|MVPA|mvpa
335645|NCT02161809|Healthy Eating|healthy eating
335646|NCT02161809|children|children
335647|NCT02161809|childhood obesity|childhood obesity
335648|NCT02161796|Phase 1|phase 1
335649|NCT02161796|FG-4592|fg-4592
335650|NCT02161796|Age/gender comparison|age/gender comparison
335651|NCT02161783|Hematopoietic stem cell transplant|hematopoietic stem cell transplant
335652|NCT02161770|oncology, cancer, neoplasm, anticancer drug, pharmacokinetics, area under curve, AZD9291, solid tumour, mild hepatic impairment, moderate hepatic impairment|oncology, cancer, neoplasm, anticancer drug, pharmacokinetics, area under curve, azd9291, solid tumour, mild hepatic impairment, moderate hepatic impairment
335653|NCT02161757|Asthma|asthma
335654|NCT02161757|Reactive Airways|reactive airways
335655|NCT02161757|Respiratory Tract Disease|respiratory tract disease
335656|NCT02161757|Obstructive Lung Disease|obstructive lung disease
335657|NCT02161757|Lung Diseases|lung diseases
335658|NCT02161744|Adipose derived stem cells|adipose derived stem cells
335659|NCT02161744|Stromal vascular fraction cells|stromal vascular fraction cells
335660|NCT02161744|Pulmonary Function Tests|pulmonary function tests
335661|NCT02161744|Chronic Obstructive Pulmonary Disease|chronic obstructive pulmonary disease
335662|NCT02161718|Alkermes|alkermes
335663|NCT02161718|Schizophrenia|schizophrenia
335664|NCT02161718|Alcohol Use Disorder|alcohol use disorder
335665|NCT02161718|ALKS 3831|alks 3831
335666|NCT02161705|Immediate breast reconstruction|immediate breast reconstruction
335667|NCT02161705|pain control|pain control
335668|NCT02161705|post mastectomy pain control|post mastectomy pain control
335669|NCT02161679|Antibody drug conjugate|antibody drug conjugate
335670|NCT02161679|IMMU-132|immu-132
335671|NCT02161679|Triple-negative breast cancer|triple-negative breast cancer
335672|NCT02161679|Safety and tolerability|safety and tolerability
335673|NCT02161679|Progression Free Survival (PFS)|progression free survival (pfs)
335674|NCT02161666|Obesity|obesity
335675|NCT02161666|Gastric Bypass|gastric bypass
335676|NCT02161666|Bariatric Surgery|bariatric surgery
335677|NCT02161666|Incretin Function|incretin function
335678|NCT02161666|Islet Function|islet function
335679|NCT02161653|Severe alcoholic hepatitis|severe alcoholic hepatitis
335680|NCT02161653|survival|survival
335681|NCT02161653|oxidative stress|oxidative stress
335682|NCT02161627|spinal cord stimulation|spinal cord stimulation
335683|NCT02161627|automatic control|automatic control
335684|NCT02161614|hormone replacement therapy|hormone replacement therapy
335685|NCT02161614|Dopplervelocimetry|dopplervelocimetry
335686|NCT02161614|Flow-mediated dilation|flow-mediated dilation
335687|NCT02161614|menopause|menopause
335688|NCT02161614|Estradiol valerate|estradiol valerate
335689|NCT02161601|Cricoid pressure|cricoid pressure
335690|NCT02161601|Rapid Sequence Induction|rapid sequence induction
335691|NCT02161575|Macular degeneration|macular degeneration
335692|NCT02161575|age-related macular degeneration (ARMD)|age-related macular degeneration (armd)
335693|NCT02161575|vision loss|vision loss
335694|NCT02161575|macula damage|macula damage
335695|NCT02161575|retina damage|retina damage
335696|NCT02161575|dry macular degeneration|dry macular degeneration
335697|NCT02161575|wet macular degeneration|wet macular degeneration
335698|NCT02161575|AMD|amd
400526|NCT01866488|Cook Obstetric Double Balloon Catheter|cook obstetric double balloon catheter
400527|NCT01866475|IO access|io access
335699|NCT02161562|chronic spontaneous urticaria, CSU, chronic idiopathic urticaria, CIU, hives, angioedema, itch|chronic spontaneous urticaria, csu, chronic idiopathic urticaria, ciu, hives, angioedema, itch
335700|NCT02161523|mast cells, lung cancer, cancer associated fibroblasts (CAF)|mast cells, lung cancer, cancer associated fibroblasts (caf)
335701|NCT02161497|Medical History Taking|medical history taking
335702|NCT02161497|Electronic Health Records|electronic health records
335703|NCT02161497|Pediatrics|pediatrics
335704|NCT02161497|Parents|parents
335705|NCT02161484|Peripheral Nerve Block|peripheral nerve block
335706|NCT02161484|Total Hip Replacement|total hip replacement
335707|NCT02161471|Atria, Heart|atria, heart
335708|NCT02161471|Function, Atrial|function, atrial
335709|NCT02161471|Heart Defects, Congenital|heart defects, congenital
335710|NCT02161471|Cardiovascular Abnormalities|cardiovascular abnormalities
335711|NCT02161471|Congenital Abnormalities|congenital abnormalities
335712|NCT02161471|Tetralogy, Fallot|tetralogy, fallot
335713|NCT02161471|Transposition of Great Arteries|transposition of great arteries
335714|NCT02161471|Coarctation of the Aorta|coarctation of the aorta
335715|NCT02161458|Escitalopram|escitalopram
335716|NCT02161458|Amyloid Beta|amyloid beta
335717|NCT02161458|Cerebrospinal Fluid|cerebrospinal fluid
335718|NCT02161445|impedance|impedance
335719|NCT02161445|pep|pep
335720|NCT02161445|tevg|tevg
335721|NCT02161445|dyspnea|dyspnea
335722|NCT02161445|AHF|ahf
335723|NCT02161445|BNP|bnp
335724|NCT02161419|Small Cell Lung Carcinoma,|small cell lung carcinoma,
335725|NCT02161419|First line|first line
335726|NCT02161419|Extensive disease|extensive disease
335727|NCT02161419|Small cell lung cancer|small cell lung cancer
335728|NCT02161406|Scleroderma|scleroderma
335729|NCT02161393|Physical Activity|physical activity
335730|NCT02161393|Pulmonary Rehabilitation|pulmonary rehabilitation
335731|NCT02161393|Chronic obstructive pulmonary disease|chronic obstructive pulmonary disease
335732|NCT02161380|Gene therapy|gene therapy
335733|NCT02161380|Mitochondrial Genes|mitochondrial genes
335734|NCT02161380|Leber's|leber's
335735|NCT02161380|AAV2 Viral vectors|aav2 viral vectors
335736|NCT02161367|colorectal surgery|colorectal surgery
335737|NCT02161367|postoperative ileus|postoperative ileus
335738|NCT02161367|simethicone|simethicone
335739|NCT02161367|randomized controlled trial|randomized controlled trial
335740|NCT02161367|double blind|double blind
335741|NCT02161367|pilot study|pilot study
335742|NCT02161367|anti-foaming agent|anti-foaming agent
335743|NCT02161367|abdominal pain|abdominal pain
335744|NCT02161367|abdominal distention|abdominal distention
335745|NCT02161367|nausea vomiting|nausea vomiting
335746|NCT02161367|flatus|flatus
335747|NCT02161367|bowel movement|bowel movement
335748|NCT02161367|placebo|placebo
335749|NCT02161367|postoperative complications|postoperative complications
335750|NCT02161367|polydimethylsiloxane|polydimethylsiloxane
335751|NCT02161367|hydrated silica gel|hydrated silica gel
335752|NCT02161367|gas bubbles|gas bubbles
335753|NCT02161367|intestinal tract|intestinal tract
335754|NCT02161354|Dental Pain|dental pain
335755|NCT02161354|Acute Pain|acute pain
335756|NCT02161354|Mild Pain|mild pain
335757|NCT02161354|Moderate Pain|moderate pain
335758|NCT02161341|Bacterial microbiome|bacterial microbiome
335759|NCT02161341|Gene expression|gene expression
335760|NCT02161315|SAID, Progestogens, nSAID-resistanced, LSBC|said, progestogens, nsaid-resistanced, lsbc
335761|NCT02161302|Endometriosis|endometriosis
335762|NCT02161302|Transcranial Direct Current Stimulation|transcranial direct current stimulation
335763|NCT02161302|tDCS|tdcs
335764|NCT02161302|Near Infrared Spectroscopy|near infrared spectroscopy
335765|NCT02161302|NIRS|nirs
335766|NCT02161302|Chronic Pelvic Pain|chronic pelvic pain
335767|NCT02161289|100 HIV-negagtve MSM|100 hiv-negagtve msm
335768|NCT02161263|LASIK|lasik
335769|NCT02161263|Satisfaction|satisfaction
335770|NCT02161237|Acute rejection|acute rejection
335771|NCT02161237|Advagraf|advagraf
335772|NCT02161237|Renal function|renal function
335773|NCT02161224|Phase 1|phase 1
335774|NCT02161224|FG-4592|fg-4592
335775|NCT02161224|Single dose|single dose
335776|NCT02161224|Moderate hepatic impairment|moderate hepatic impairment
335777|NCT02161211|alcohol|alcohol
335778|NCT02161211|anxiety|anxiety
335779|NCT02161198|Panax ginseng CA|panax ginseng ca
335780|NCT02161198|ginsan|ginsan
335781|NCT02161198|polysaccharide|polysaccharide
335782|NCT02161198|immunity|immunity
335783|NCT02161198|natural killer cell|natural killer cell
335784|NCT02161185|Epilepsy|epilepsy
335785|NCT02161185|seizure cluster|seizure cluster
335786|NCT02161185|acute repetitive seizures|acute repetitive seizures
335787|NCT02161185|open-label|open-label
335788|NCT02161185|intranasal Midazolam|intranasal midazolam
335789|NCT02161185|USL261|usl261
335790|NCT02161185|Upsher-Smith|upsher-smith
335791|NCT02161172|Mild traumatic brain injury|mild traumatic brain injury
335792|NCT02161172|Cognitive outcome|cognitive outcome
335793|NCT02161172|Psychological outcome|psychological outcome
335794|NCT02161133|Veterans|veterans
335795|NCT02161133|neuropsychology|neuropsychology
335796|NCT02161133|fatigue|fatigue
335797|NCT02161133|Chronic Multisymptom Illness|chronic multisymptom illness
335798|NCT02161133|Gulf War Illness|gulf war illness
335799|NCT02161133|behavioral treatment|behavioral treatment
335800|NCT02161120|IBS, irritable bowel syndrome, functional gastrointestinal disorder, diet, bread, rye, FODMAP, microbiota|ibs, irritable bowel syndrome, functional gastrointestinal disorder, diet, bread, rye, fodmap, microbiota
335801|NCT02161107|Grass|grass
335802|NCT02161107|Allergy|allergy
335803|NCT02161107|rhinoconjunctivitis|rhinoconjunctivitis
335804|NCT02161107|rhinitis|rhinitis
335805|NCT02161107|asthma|asthma
335806|NCT02161094|Community management incentives|community management incentives
335807|NCT02161081|Myocardial ischemia|myocardial ischemia
335808|NCT02161081|Coronary artery disease|coronary artery disease
335809|NCT02161081|Myocardial CT perfusion|myocardial ct perfusion
335810|NCT02161081|Modified scan protocol|modified scan protocol
335811|NCT02161081|Diagnostic performance|diagnostic performance
335812|NCT02161081|Radiation dose|radiation dose
335813|NCT02161068|ADPKD|adpkd
335814|NCT02161068|Chart Review|chart review
335815|NCT02161068|PKD Genotyping|pkd genotyping
335816|NCT02161055|Insulin|insulin
335817|NCT02161055|Hyperglycemia|hyperglycemia
335818|NCT02161055|Postoperative Mortality|postoperative mortality
335819|NCT02161055|Intensive insulin therapy|intensive insulin therapy
335820|NCT02161055|Non-intensive insulin therapy|non-intensive insulin therapy
335821|NCT02161055|Brain Injuries|brain injuries
335822|NCT02161055|Wounds and Injuries|wounds and injuries
335823|NCT02161055|Craniocerebral Trauma|craniocerebral trauma
335824|NCT02161055|Trauma, Nervous System|trauma, nervous system
335825|NCT02161042|Blood transfusion|blood transfusion
335826|NCT02161042|Storage Lesion|storage lesion
335827|NCT02161042|Endothelial dysfunction|endothelial dysfunction
335828|NCT02161042|Nitric Oxide|nitric oxide
335829|NCT02161029|Gastric tumor|gastric tumor
335830|NCT02161003|Fecal Incontinence|fecal incontinence
335831|NCT02161003|Posterior Sagittal Ano-rectoplasty|posterior sagittal ano-rectoplasty
335832|NCT02161003|Mesenchymal Stem Cell|mesenchymal stem cell
335833|NCT02160990|Obesity|obesity
335834|NCT02160977|Surgical procedures|surgical procedures
335835|NCT02160977|Minimally invasive|minimally invasive
335836|NCT02160977|Arthroplasty|arthroplasty
335837|NCT02160977|Knee|knee
335838|NCT02160964|Inferior Vena Cava|inferior vena cava
335839|NCT02160951|Multiple Myeloma,|multiple myeloma,
335840|NCT02160951|Phase I,|phase i,
335841|NCT02160951|PIM,|pim,
335842|NCT02160951|Japanese patients,|japanese patients,
335843|NCT02160951|LGH447|lgh447
335844|NCT02160938|microarray|microarray
335845|NCT02160938|prenatal|prenatal
335846|NCT02160938|copy number variant|copy number variant
335847|NCT02160938|CNV|cnv
335848|NCT02160938|microdeletion|microdeletion
335849|NCT02160938|microduplication|microduplication
335850|NCT02160938|genetic|genetic
335851|NCT02160899|High Lipoprotein(a)|high lipoprotein(a)
335852|NCT02160847|children|children
335853|NCT02160847|pediatric obesity|pediatric obesity
335854|NCT02160847|parent training|parent training
335855|NCT02160847|home-based|home-based
335856|NCT02160847|nutrition|nutrition
335857|NCT02160847|physical activity|physical activity
335858|NCT02160847|parent-child interaction|parent-child interaction
335859|NCT02160847|parenting|parenting
335860|NCT02160834|Sedentary behavior|sedentary behavior
335861|NCT02160834|Physical activity|physical activity
335862|NCT02160834|Obesity|obesity
336647|NCT02157181|HCL variant|hcl variant
335863|NCT02160834|Mobile health|mobile health
335864|NCT02160834|Smartphone|smartphone
335865|NCT02160834|Time spent sedentary|time spent sedentary
335866|NCT02160821|Transversus Abdominis Plane Block|transversus abdominis plane block
335867|NCT02160821|Caudal Epidural|caudal epidural
335868|NCT02160821|Pediatric Pain control|pediatric pain control
335869|NCT02160821|Pain control for Lower Abdominal Surgery|pain control for lower abdominal surgery
335870|NCT02160795|Periconceptional|periconceptional
335871|NCT02160795|Folic Acid|folic acid
335872|NCT02160795|Leukemia|leukemia
335873|NCT02160795|Childhood Cancer|childhood cancer
335874|NCT02160769|Tear Lipid Thickness|tear lipid thickness
335875|NCT02160769|Pterygium surgery|pterygium surgery
335876|NCT02160756|Healthy|healthy
335877|NCT02160756|JNJ-56021927|jnj-56021927
335878|NCT02160756|JNJ-56142060|jnj-56142060
335879|NCT02160756|ARN-509|arn-509
335880|NCT02160730|Cushings disease|cushings disease
335881|NCT02160730|R-roscovitine|r-roscovitine
335882|NCT02160717|Turner Syndrome|turner syndrome
335883|NCT02160717|Diabetes|diabetes
335884|NCT02160704|Sperm density|sperm density
335885|NCT02160704|Testosterone|testosterone
335886|NCT02160704|Hypogonadism|hypogonadism
335887|NCT02160652|Ureteral Obstruction|ureteral obstruction
335888|NCT02160652|HYDRONEPHROSIS|hydronephrosis
335889|NCT02160652|nephrostomy tube|nephrostomy tube
335890|NCT02160639|diabetes self management education|diabetes self management education
335891|NCT02160639|diabetes self management support|diabetes self management support
335892|NCT02160639|type 2 diabetes|type 2 diabetes
335893|NCT02160626|Seborrheic keratosis|seborrheic keratosis
335894|NCT02160626|A101|a101
335895|NCT02160613|Osteoprotegerin|osteoprotegerin
335896|NCT02160613|Biomarker|biomarker
335897|NCT02160613|Chronic periodontitis|chronic periodontitis
335898|NCT02160613|Open flap debridement|open flap debridement
335899|NCT02160561|mechanical|mechanical
335900|NCT02160561|ventilation|ventilation
335901|NCT02160561|acute|acute
335902|NCT02160561|respiratory|respiratory
335903|NCT02160561|failure|failure
335904|NCT02160548|Organophosphate, insectiside, Salbutamol, Atropine|organophosphate, insectiside, salbutamol, atropine
335905|NCT02160535|Mild Traumatic Brain Injury|mild traumatic brain injury
335906|NCT02160535|Concussion|concussion
335907|NCT02160535|Post Concussive Headache|post concussive headache
335908|NCT02160522|Intubation|intubation
335909|NCT02160522|cuff|cuff
335910|NCT02160522|cuffed|cuffed
335911|NCT02160522|endotracheal|endotracheal
335912|NCT02160522|tube|tube
335913|NCT02160522|pressure|pressure
335914|NCT02160522|pediatric|pediatric
335915|NCT02160522|child|child
335916|NCT02160522|children|children
335917|NCT02160522|emergency|emergency
335918|NCT02160509|real time, ultrasonography, handheld|real time, ultrasonography, handheld
335919|NCT02160496|Weight Loss|weight loss
335920|NCT02160496|Obesity|obesity
335921|NCT02160496|Overweight|overweight
335922|NCT02160496|Diet, Reducing|diet, reducing
335923|NCT02160496|Lipids|lipids
335924|NCT02160483|Chronic pelvic pain|chronic pelvic pain
335925|NCT02160483|Endometriosis|endometriosis
335926|NCT02160457|Cerebral palsy|cerebral palsy
335927|NCT02160457|Instrumented gait analysis|instrumented gait analysis
335928|NCT02160457|Gait Deviation Index|gait deviation index
335929|NCT02160444|CBT|cbt
335930|NCT02160444|Parent Training|parent training
335931|NCT02160444|Anxiety Disorders in Children|anxiety disorders in children
335932|NCT02160431|Children|children
335933|NCT02160431|OCD|ocd
335934|NCT02160431|CBT|cbt
335935|NCT02160431|Neuropsychological profiles|neuropsychological profiles
335936|NCT02160405|Iron levels|iron levels
335937|NCT02160392|HIV|hiv
335938|NCT02160392|female|female
335939|NCT02160392|genital tract|genital tract
335940|NCT02160379|roux-en-Y-gastric bypass|roux-en-y-gastric bypass
335941|NCT02160379|brain responses to food|brain responses to food
335942|NCT02160379|gastrointestinal hormones|gastrointestinal hormones
335943|NCT02160379|bile acids|bile acids
335944|NCT02160366|Advanced Cancers|advanced cancers
335945|NCT02160366|Molecular profiling|molecular profiling
335946|NCT02160366|Biomarker data|biomarker data
335947|NCT02160366|Data analysis|data analysis
335948|NCT02160366|Tumor marker|tumor marker
335949|NCT02160340|Posterior Vitreous Detachment|posterior vitreous detachment
335950|NCT02160340|Vitreomacular Traction|vitreomacular traction
335951|NCT02160340|Vitreous|vitreous
335952|NCT02160314|stress urinary incontinence, SUI, pessary|stress urinary incontinence, sui, pessary
335953|NCT02160301|pain|pain
335954|NCT02160301|postoperative|postoperative
335955|NCT02160301|multimodal|multimodal
335956|NCT02160301|satisfaction|satisfaction
335957|NCT02160301|narcotic|narcotic
335958|NCT02160288|Botox|botox
335959|NCT02160288|Obstructed Defecation Syndrome|obstructed defecation syndrome
335960|NCT02160288|ODS|ods
335961|NCT02160288|Outlet-Type Constipation|outlet-type constipation
335962|NCT02160288|injection|injection
335963|NCT02160275|Artificial pancreas|artificial pancreas
335964|NCT02160275|Bi-hormonal closed loop|bi-hormonal closed loop
335965|NCT02160275|Diabetes Type 1|diabetes type 1
335966|NCT02160249|Schizophrenia|schizophrenia
335967|NCT02160249|Psychotic disorders|psychotic disorders
335968|NCT02160249|Schizophrenia spectrum disorder (schizophrenia, schizoaffective disorder or schizophreniform disorder) using DSM-IV criteria|schizophrenia spectrum disorder (schizophrenia, schizoaffective disorder or schizophreniform disorder) using dsm-iv criteria
335969|NCT02160236|dexketoprofen trometamol|dexketoprofen trometamol
335970|NCT02160236|tenoxicam|tenoxicam
335971|NCT02160236|postoperative pain|postoperative pain
335972|NCT02160223|sugammadex|sugammadex
335973|NCT02160223|neostigmine|neostigmine
335974|NCT02160223|obstructive sleep apnea|obstructive sleep apnea
335975|NCT02160197|Ankle Fractures|ankle fractures
335976|NCT02160197|Fracture Fixation|fracture fixation
335977|NCT02160197|Early Ambulation|early ambulation
335978|NCT02160197|Fracture Healing|fracture healing
335979|NCT02160197|Return to Work|return to work
335980|NCT02160171|Decision Support Algorithm|decision support algorithm
335981|NCT02160171|Neonatal Seizures|neonatal seizures
335982|NCT02160171|EEG|eeg
335983|NCT02160158|Fesoterodine|fesoterodine
335984|NCT02160158|SR3|sr3
335985|NCT02160158|SR4|sr4
335986|NCT02160158|bioavailability|bioavailability
335987|NCT02160158|pharmacokinetics|pharmacokinetics
335988|NCT02160158|sprinkle|sprinkle
335989|NCT02160158|applesauce|applesauce
335990|NCT02160145|Chronic Kidney Disease|chronic kidney disease
335991|NCT02160145|Autosomal Dominant Polycystic Kidney Disease|autosomal dominant polycystic kidney disease
335992|NCT02160119|Autism Spectrum Disorders|autism spectrum disorders
335993|NCT02160119|Emotion|emotion
335994|NCT02160119|Attention|attention
335995|NCT02160119|Event-related potential|event-related potential
335996|NCT02160119|Functional neuroimaging|functional neuroimaging
335997|NCT02160119|Diffusion Tensor Imaging|diffusion tensor imaging
335998|NCT02160119|Development|development
335999|NCT02160106|Cancer|cancer
336000|NCT02160106|advanced solid tumors|advanced solid tumors
336001|NCT02160106|metastatic|metastatic
336002|NCT02160106|phase I|phase i
336003|NCT02160106|transforming growth factor beta|transforming growth factor beta
336004|NCT02160106|TGF-β|tgf-β
336005|NCT02160106|first-in-human|first-in-human
336006|NCT02160106|TEW-7197|tew-7197
336007|NCT02160106|activin receptor-like kinase 5|activin receptor-like kinase 5
336008|NCT02160106|ALK5|alk5
336009|NCT02160106|Smad2|smad2
336010|NCT02160106|Smad3|smad3
336011|NCT02160106|phospho-Smad|phospho-smad
336012|NCT02160106|phospho Smad|phospho smad
336013|NCT02160106|psmad|psmad
336014|NCT02160106|serine / threonine kinase inhibitor|serine / threonine kinase inhibitor
336015|NCT02160106|pharmacokinetics|pharmacokinetics
336016|NCT02160106|MedPacto|medpacto
336017|NCT02160106|National OncoVenture|national oncoventure
336018|NCT02160093|sarcopenia|sarcopenia
336019|NCT02160093|frailty|frailty
336020|NCT02160093|chronic disease control|chronic disease control
336021|NCT02160093|aging psychology|aging psychology
336022|NCT02160080|Boceprevir;|boceprevir;
336023|NCT02160080|Liver pre-transplant|liver pre-transplant
336024|NCT02160067|Healthy Volunteers|healthy volunteers
336025|NCT02160067|Pharmacokinetics|pharmacokinetics
336026|NCT02160054|tacrolimus|tacrolimus
336027|NCT02160054|cyclosporine|cyclosporine
336028|NCT02160054|Graceptor®|graceptor®
336029|NCT02160054|kidney transplantation|kidney transplantation
336030|NCT02160041|Solid tumor malignancy|solid tumor malignancy
336031|NCT02160041|hematologic malignancy|hematologic malignancy
336032|NCT02160041|mutation|mutation
336033|NCT02160041|translocations|translocations
336034|NCT02160041|amplifications,|amplifications,
336035|NCT02160041|fusions|fusions
336036|NCT02160041|signature|signature
336037|NCT02160041|FGFR|fgfr
336038|NCT02160041|ligand|ligand
336039|NCT02160041|BGJ398|bgj398
336040|NCT02160028|Information|information
336041|NCT02160028|Pain|pain
336042|NCT02160028|Stress|stress
336043|NCT02160028|Fear|fear
336044|NCT02160028|Placebo analgesia|placebo analgesia
336045|NCT02160002|Incubator Weaning|incubator weaning
336046|NCT02160002|Moderately Preterm Infants|moderately preterm infants
336047|NCT02160002|Growth Velocity|growth velocity
336048|NCT02159976|Helicobacter pylori|helicobacter pylori
336049|NCT02159963|FSHD|fshd
336050|NCT02159963|HIT|hit
336051|NCT02159963|Training|training
336052|NCT02159963|Exercise|exercise
336053|NCT02159963|10-20-30 interval training|10-20-30 interval training
336054|NCT02159937|cancer|cancer
336055|NCT02159937|in vitro|in vitro
336056|NCT02159937|peptides|peptides
336057|NCT02159937|dendritic cells|dendritic cells
336058|NCT02159924|Smartphone measurements|smartphone measurements
336059|NCT02159924|Orientation|orientation
336060|NCT02159924|Range of motion|range of motion
336061|NCT02159924|Median nerve neurodynamic test|median nerve neurodynamic test
336062|NCT02159924|Posture|posture
336063|NCT02159924|Thoracic spine|thoracic spine
336064|NCT02159924|Shoulder girdle|shoulder girdle
336065|NCT02159911|Cervical|cervical
336066|NCT02159911|Hysteroscopy|hysteroscopy
336067|NCT02159911|Misoprostol|misoprostol
336068|NCT02159911|Oral|oral
336648|NCT02157181|HCL relapse|hcl relapse
336069|NCT02159898|Esophageal Cancer|esophageal cancer
336070|NCT02159898|Dysphagia|dysphagia
336071|NCT02159898|Regurgitation|regurgitation
336072|NCT02159885|obstructive sleep apnea|obstructive sleep apnea
336073|NCT02159885|adherence|adherence
336074|NCT02159885|telemedicine|telemedicine
336075|NCT02159885|auto-titrating continuous positive airway pressure|auto-titrating continuous positive airway pressure
336076|NCT02159872|Leukemia|leukemia
336077|NCT02159872|Myelodysplastic Syndrome|myelodysplastic syndrome
336079|NCT02159872|Omacetaxine|omacetaxine
336080|NCT02159872|Synribo|synribo
336081|NCT02159872|Homoharringtonine|homoharringtonine
336082|NCT02159859|ertapenem|ertapenem
336083|NCT02159859|pharmacokinetic|pharmacokinetic
336084|NCT02159859|pharmacodynamics|pharmacodynamics
336085|NCT02159859|hemodialysis|hemodialysis
336086|NCT02159859|requires hemodialysis three times a week|requires hemodialysis three times a week
336087|NCT02159846|Herbs|herbs
336088|NCT02159846|Diabetes Mellitus|diabetes mellitus
336089|NCT02159846|HbA1c|hba1c
336090|NCT02159846|Lipid Profile|lipid profile
336091|NCT02159833|Food allergy|food allergy
336092|NCT02159833|Diagnosis|diagnosis
336093|NCT02159807|Pain control|pain control
336094|NCT02159807|labor|labor
336095|NCT02159807|epidural|epidural
336096|NCT02159807|pregnant|pregnant
336097|NCT02159794|Transcatheter Aortic Valve Replacement|transcatheter aortic valve replacement
336098|NCT02159794|Aortic valve stenosis|aortic valve stenosis
336099|NCT02159794|Severe aortic stenosis|severe aortic stenosis
336100|NCT02159768|tracheal intubation|tracheal intubation
336101|NCT02159742|Adult subjects|adult subjects
336102|NCT02159742|history|history
336103|NCT02159742|treatment|treatment
336104|NCT02159742|photodynamic therapy|photodynamic therapy
336105|NCT02159716|Subjects|subjects
336106|NCT02159703|T1-2 N2 M0,|t1-2 n2 m0,
336107|NCT02159703|stage IVa SCCA|stage iva scca
336108|NCT02159703|oropharynx|oropharynx
336109|NCT02159703|negative for PNI,|negative for pni,
336110|NCT02159703|negative surgical margins|negative surgical margins
336111|NCT02159690|prostate cancer|prostate cancer
336112|NCT02159690|prostatectomy|prostatectomy
336113|NCT02159690|localized prostate cancer|localized prostate cancer
336114|NCT02159677|EIM|eim
336115|NCT02159664|didgeridoo|didgeridoo
336116|NCT02159664|sleep apnea|sleep apnea
336117|NCT02159664|drug induced sleep endoscopy|drug induced sleep endoscopy
336118|NCT02159651|tacrolimus|tacrolimus
336119|NCT02159651|interstitial pneumonia|interstitial pneumonia
336120|NCT02159651|prograf|prograf
336121|NCT02159638|Diabetes Mellitus|diabetes mellitus
336122|NCT02159638|Diabetes Mellitus, Type 1|diabetes mellitus, type 1
336123|NCT02159638|Diabetes Mellitus, Insulin-Dependent|diabetes mellitus, insulin-dependent
336124|NCT02159638|Endocrine System Diseases|endocrine system diseases
336125|NCT02159638|Blood glucose|blood glucose
336126|NCT02159638|Blood Glucose, Self-Monitoring|blood glucose, self-monitoring
336127|NCT02159625|Abdominal Compression Elastic Support|abdominal compression elastic support
336128|NCT02159625|Hemodialysis|hemodialysis
336129|NCT02159625|hypotension|hypotension
336130|NCT02159625|occurrence rate|occurrence rate
336131|NCT02159612|FSHD|fshd
336132|NCT02159612|MRI|mri
336133|NCT02159612|Disease progression|disease progression
336134|NCT02159586|gastroparesis|gastroparesis
336135|NCT02159586|gastric electrical stimulator|gastric electrical stimulator
336136|NCT02159586|GES|ges
336137|NCT02159586|vomiting|vomiting
336138|NCT02159586|nausea|nausea
336139|NCT02159586|bloating|bloating
336140|NCT02159586|postprandial fullness|postprandial fullness
336141|NCT02159586|epigastric pain|epigastric pain
336142|NCT02159547|migraine, emergency department, dexketoprofen, placebo|migraine, emergency department, dexketoprofen, placebo
336143|NCT02159521|deep vein thrombosis|deep vein thrombosis
336144|NCT02159521|post-thrombotic syndrome|post-thrombotic syndrome
336145|NCT02159521|chronic deep vein thrombosis|chronic deep vein thrombosis
336146|NCT02159508|nutritional status|nutritional status
336147|NCT02159508|nutritional intervention|nutritional intervention
336148|NCT02159508|handgrip strength|handgrip strength
336149|NCT02159508|patient-generated subjective global assessment|patient-generated subjective global assessment
336150|NCT02159508|chemoradiotherapy|chemoradiotherapy
336151|NCT02159508|survival|survival
336152|NCT02159469|Hypogonadism|hypogonadism
336153|NCT02159469|Testosterone enanthate|testosterone enanthate
336154|NCT02159443|Hu14.18K322A|hu14.18k322a
336155|NCT02159443|Human anti-human antibodies (HAHA)|human anti-human antibodies (haha)
336156|NCT02159443|Pretreatment anti-therapeutic antibodies (PATA)|pretreatment anti-therapeutic antibodies (pata)
336157|NCT02159417|Evolution of the sport, HbA1C, IMC|evolution of the sport, hba1c, imc
336158|NCT02159391|Accident Prevention|accident prevention
336159|NCT02159391|Alcohol Drinking|alcohol drinking
336160|NCT02159391|Substance-Related Disorders|substance-related disorders
336161|NCT02159391|Motivational Interviewing|motivational interviewing
336162|NCT02159391|Adult|adult
336163|NCT02159391|Humans|humans
336164|NCT02159391|Intervention Studies|intervention studies
336165|NCT02159391|Recurrence|recurrence
336166|NCT02159391|Risk Factors|risk factors
336167|NCT02159391|Trauma Centers|trauma centers
336168|NCT02159391|Wounds and Injuries/epidemiology|wounds and injuries/epidemiology
336169|NCT02159391|Wounds and Injuries/etiology*|wounds and injuries/etiology*
336170|NCT02159391|Wounds and Injuries/prevention & control*|wounds and injuries/prevention & control*
336171|NCT02159378|Gestational Diabetes|gestational diabetes
336172|NCT02159378|Fructosamines|fructosamines
336173|NCT02159378|Insulin treatment|insulin treatment
336174|NCT02159339|DNA methylation|dna methylation
336175|NCT02159313|Biological Availability|biological availability
336176|NCT02159300|Fibromyalgia|fibromyalgia
336177|NCT02159300|Pain|pain
336178|NCT02159287|ischemic stroke|ischemic stroke
336179|NCT02159287|atrial fibrillation|atrial fibrillation
336180|NCT02159287|bridging therapy|bridging therapy
336181|NCT02159274|Late symptoms|late symptoms
336182|NCT02159274|Shoulder function|shoulder function
336183|NCT02159274|Cosmetic results|cosmetic results
336184|NCT02159274|EORTC|eortc
336185|NCT02159274|Lymphoedema|lymphoedema
336186|NCT02159261|Personal Satisfaction|personal satisfaction
336187|NCT02159248|pancreatic, gemcitabine, radiation, tolfenamic acid|pancreatic, gemcitabine, radiation, tolfenamic acid
336188|NCT02159235|cadmium|cadmium
336189|NCT02159235|lead|lead
336190|NCT02159235|mercury|mercury
336191|NCT02159235|zinc|zinc
336192|NCT02159235|endostatin|endostatin
336193|NCT02159235|angiostatin|angiostatin
336194|NCT02159235|VEGF|vegf
336196|NCT02159235|osteopontin|osteopontin
336197|NCT02159209|Acute Kidney Injury|acute kidney injury
336198|NCT02159209|Adverse Drug Reaction|adverse drug reaction
336199|NCT02159209|Acute Kidney Failure|acute kidney failure
336200|NCT02159209|Kidney|kidney
336201|NCT02159209|Kidneys|kidneys
336202|NCT02159196|mechanical ventilation|mechanical ventilation
336203|NCT02159196|nebulisation|nebulisation
336204|NCT02159196|respiratory failure|respiratory failure
336205|NCT02159170|Use of NGF injection as a model of non-inflammatory neuropathic pain in healthy subjects|use of ngf injection as a model of non-inflammatory neuropathic pain in healthy subjects
336206|NCT02159157|breast cancer, exercise|breast cancer, exercise
336207|NCT02159144|Brown adipose tissue|brown adipose tissue
336208|NCT02159144|Subcutaneous white adipose tissue|subcutaneous white adipose tissue
336209|NCT02159144|White adipose tissue|white adipose tissue
336210|NCT02159131|ethinyl estradiol|ethinyl estradiol
336211|NCT02159131|GSK1265744|gsk1265744
336212|NCT02159131|pharmacokinetics|pharmacokinetics
336213|NCT02159131|oral contraceptive|oral contraceptive
336214|NCT02159131|oral contraceptive containing levonorgestrel and ethinyl estradiol|oral contraceptive containing levonorgestrel and ethinyl estradiol
336215|NCT02159131|levonorgestrel|levonorgestrel
336216|NCT02159118|bone marrow aspiration|bone marrow aspiration
336217|NCT02159118|bone marrow biopsy|bone marrow biopsy
336218|NCT02159118|OnControl|oncontrol
336219|NCT02159118|powered bone marrow aspiration and biopsy device|powered bone marrow aspiration and biopsy device
336220|NCT02159118|standard manual bone marrow aspiration and biopsy device|standard manual bone marrow aspiration and biopsy device
336221|NCT02159105|postpartum hemorrhage|postpartum hemorrhage
336222|NCT02159105|postsurgical bleeding|postsurgical bleeding
336223|NCT02159105|abdominal ultrasound|abdominal ultrasound
336224|NCT02159105|FAST scan|fast scan
336225|NCT02159105|non-invasive hemoglobin measurement|non-invasive hemoglobin measurement
336226|NCT02159092|Waterpipe|waterpipe
336227|NCT02159092|Smoking cessation|smoking cessation
336228|NCT02159092|Contingency management|contingency management
336229|NCT02159092|Dependence|dependence
336230|NCT02159079|Sepsis|sepsis
336231|NCT02159079|Severe Sepsis|severe sepsis
336232|NCT02159079|Septic Shock|septic shock
336233|NCT02159079|Conservative Fluid Management|conservative fluid management
336234|NCT02159079|Fluid Balance|fluid balance
336235|NCT02159079|Fluid Restriction|fluid restriction
336236|NCT02159066|Melanoma|melanoma
336237|NCT02159053|AIN457, ankylosing spondylitis, chronic inflammatory disease, inflammatory back pain, secukinumab, self-injection|ain457, ankylosing spondylitis, chronic inflammatory disease, inflammatory back pain, secukinumab, self-injection
336238|NCT02159040|Int-2 MDS|int-2 mds
336239|NCT02159027|Human Immunodeficiency Virus|human immunodeficiency virus
336240|NCT02159027|AIDS Dementia Complex|aids dementia complex
336241|NCT02159014|Physical activity intervention|physical activity intervention
336242|NCT02159014|Aerobic dance|aerobic dance
336243|NCT02159014|Nutritional intervention|nutritional intervention
336244|NCT02159014|Online participation|online participation
336245|NCT02159014|Primary Care settings|primary care settings
336246|NCT02159014|General Practice Physical Activity Questionnaire GPPAQ|general practice physical activity questionnaire gppaq
336247|NCT02159014|Qrisk2|qrisk2
336248|NCT02159014|QDS Diabetes|qds diabetes
336249|NCT02159001|clozapine|clozapine
336250|NCT02159001|ECT|ect
336251|NCT02159001|PANSS|panss
336252|NCT02159001|schizoaffective disorder|schizoaffective disorder
336253|NCT02159001|schizophrenia|schizophrenia
336254|NCT02159001|treatment|treatment
336255|NCT02158988|Gastric cancer|gastric cancer
336256|NCT02158988|cancer of the esophagogastric junction|cancer of the esophagogastric junction
336257|NCT02158988|peritoneal carcinomatosis|peritoneal carcinomatosis
336258|NCT02158988|hyperthermic intraperitoneal chemotherapy|hyperthermic intraperitoneal chemotherapy
336260|NCT02158962|Partner abuse|partner abuse
336261|NCT02158962|Abuse African Caribbean women|abuse african caribbean women
336262|NCT02158962|Intimate Partner Violence|intimate partner violence
336263|NCT02158949|alcohol|alcohol
336264|NCT02158949|mHealth|mhealth
336265|NCT02158949|SBIRT|sbirt
336266|NCT02158936|thrombocytopenia|thrombocytopenia
336267|NCT02158936|myelodysplastic syndromes|myelodysplastic syndromes
336268|NCT02158936|MDS|mds
336269|NCT02158936|thrombopoietin|thrombopoietin
336270|NCT02158936|azacitidine|azacitidine
336271|NCT02158936|Eltrombopag|eltrombopag
336272|NCT02158936|myelodysplastic syndromes (MDS)|myelodysplastic syndromes (mds)
336273|NCT02158923|ventilation|ventilation
336274|NCT02158923|lung|lung
336275|NCT02158923|lung complications|lung complications
336276|NCT02158923|postoperative complications|postoperative complications
336277|NCT02158923|perioperative lung protective ventilation|perioperative lung protective ventilation
336278|NCT02158910|Alzheimer's disease|alzheimer's disease
336279|NCT02158884|Major extremity trauma|major extremity trauma
336280|NCT02158884|wounded warriors|wounded warriors
336281|NCT02158884|IDEO|ideo
336282|NCT02158884|return to run|return to run
336283|NCT02158871|Education|education
336284|NCT02158871|Early intervention|early intervention
336285|NCT02158871|Workplace|workplace
336286|NCT02158871|Stigma|stigma
336287|NCT02158871|Mental Health Literacy|mental health literacy
336288|NCT02158858|Phase 1|phase 1
336289|NCT02158858|Phase 2|phase 2
336290|NCT02158858|Oncology|oncology
336291|NCT02158858|BET Inhibitor|bet inhibitor
336292|NCT02158858|Ruxolitinib|ruxolitinib
336293|NCT02158845|endometriosis|endometriosis
336294|NCT02158845|blood coagulation|blood coagulation
336295|NCT02158845|levonorgestrel|levonorgestrel
336296|NCT02158845|GnRH agonist|gnrh agonist
336297|NCT02158845|progesterone-releasing intrauterine device|progesterone-releasing intrauterine device
336298|NCT02158832|Lymphoedema|lymphoedema
336299|NCT02158832|Edema|edema
336300|NCT02158832|Oedema|oedema
336301|NCT02158832|Cancer|cancer
336302|NCT02158832|Breast Cancer|breast cancer
336303|NCT02158819|Visionaire|visionaire
336304|NCT02158819|Health Economics|health economics
336305|NCT02158819|Degenerative arthritis|degenerative arthritis
336306|NCT02158819|total knee arthroplasty|total knee arthroplasty
336307|NCT02158806|Venous ulcer, varicose ulcer, gravitational ulcer, aspirin|venous ulcer, varicose ulcer, gravitational ulcer, aspirin
336308|NCT02158793|face transplant|face transplant
336309|NCT02158793|Craniomaxillofacial Allotransplantation|craniomaxillofacial allotransplantation
336310|NCT02158793|facial disfigurement|facial disfigurement
336311|NCT02158793|facial trauma|facial trauma
336312|NCT02158754|Corus CAD|corus cad
336313|NCT02158754|ASGES|asges
336314|NCT02158754|Coronary Artery Disease|coronary artery disease
336315|NCT02158754|Gene Expression|gene expression
336316|NCT02158754|Age/Sex/Gene Expression Score|age/sex/gene expression score
336317|NCT02158754|GES|ges
336318|NCT02158754|Angina Pectoris|angina pectoris
336319|NCT02158754|Chest Pain|chest pain
336320|NCT02158754|Cardiovascular Disease|cardiovascular disease
336321|NCT02158754|CAD|cad
336322|NCT02158754|CVD|cvd
336323|NCT02158754|CHD|chd
336324|NCT02158754|Coronary Heart Disease|coronary heart disease
336325|NCT02158754|Precision Medicine|precision medicine
336326|NCT02158754|Clinical Utility|clinical utility
336327|NCT02158741|Self-Management|self-management
336328|NCT02158741|Home Visits|home visits
336329|NCT02158702|Relapsed Myeloma Patients|relapsed myeloma patients
336330|NCT02158702|Relapsed after use of Bortezomib and Lenalidomide|relapsed after use of bortezomib and lenalidomide
336331|NCT02158702|Pomalidomide and Dexamethasone|pomalidomide and dexamethasone
336332|NCT02158702|Efficacy and Safety|efficacy and safety
336333|NCT02158689|Poor responders|poor responders
336334|NCT02158689|letrozole|letrozole
336335|NCT02158689|human menopausal gonadotropin|human menopausal gonadotropin
336336|NCT02158676|Roux-en-y gastric bypass|roux-en-y gastric bypass
336337|NCT02158676|Inflammatory markers|inflammatory markers
336338|NCT02158676|Nutritional status|nutritional status
336339|NCT02158676|Fatty acids|fatty acids
336340|NCT02158676|Glucose|glucose
336341|NCT02158676|Prebiotic|prebiotic
336342|NCT02158676|Synbiotic|synbiotic
336343|NCT02158663|Transcranial Magnetic Stimulation|transcranial magnetic stimulation
336344|NCT02158663|TMS|tms
336345|NCT02158663|PTSD|ptsd
336346|NCT02158650|informed consent|informed consent
336347|NCT02158650|video-based|video-based
336348|NCT02158637|PRO-CTCAE|pro-ctcae
336349|NCT02158637|Patient-Reported Outcomes|patient-reported outcomes
336350|NCT02158637|Common Terminology Criteria for Adverse Events|common terminology criteria for adverse events
336351|NCT02158637|Questionnaire|questionnaire
336352|NCT02158637|Adverse Events|adverse events
336353|NCT02158637|Symptoms|symptoms
336354|NCT02158611|Individual Counseling service|individual counseling service
336355|NCT02158611|Group Counseling service|group counseling service
336356|NCT02158585|Lamotrigine|lamotrigine
336357|NCT02158585|Lamictal|lamictal
336358|NCT02158585|Anticonvulsant|anticonvulsant
336359|NCT02158585|Ménière's disease|ménière's disease
336360|NCT02158585|Vertigo attack|vertigo attack
336361|NCT02158585|Dizziness|dizziness
336362|NCT02158585|Vestibular disorder|vestibular disorder
336363|NCT02158572|prevention of pregnancy|prevention of pregnancy
336364|NCT02158546|Major Depressive Disorder|major depressive disorder
336365|NCT02158546|Depression|depression
336366|NCT02158546|Alkermes|alkermes
336367|NCT02158546|ALKS 5461|alks 5461
336368|NCT02158546|Samidorphan|samidorphan
336369|NCT02158533|Major Depressive Disorder|major depressive disorder
336370|NCT02158533|Depression|depression
336371|NCT02158533|Alkermes|alkermes
336372|NCT02158533|ALKS 5461|alks 5461
336373|NCT02158533|Samidorphan|samidorphan
336374|NCT02158507|metastatic|metastatic
336375|NCT02158507|triple negative breast cancer (TNBC)|triple negative breast cancer (tnbc)
336376|NCT02158507|Veliparib|veliparib
336377|NCT02158507|Lapatinib|lapatinib
336378|NCT02158507|estrogen receptor (ER) negative|estrogen receptor (er) negative
336379|NCT02158507|progesterone receptor (PR) negative|progesterone receptor (pr) negative
336380|NCT02158507|human epidermal growth factor receptor 2 (HER-2-Neu) negative|human epidermal growth factor receptor 2 (her-2-neu) negative
772606|NCT00357799|Children|children
336381|NCT02158494|Cranial Nerve Noninvasive Neuromodulation|cranial nerve noninvasive neuromodulation
336382|NCT02158494|Portable Neuromodulation Stimulator (PoNS)|portable neuromodulation stimulator (pons)
336383|NCT02158494|Balance and Gait Training|balance and gait training
336384|NCT02158494|Breathing Awareness Training|breathing awareness training
336385|NCT02158481|Vascular function|vascular function
336386|NCT02158481|Dietary ingredients|dietary ingredients
336387|NCT02158481|Acute glucose load|acute glucose load
336388|NCT02158481|Oxidative stress|oxidative stress
336389|NCT02158468|STEMI, reperfusion, preconditioning, postconditioning, reperfusion injury, myocardial salvage|stemi, reperfusion, preconditioning, postconditioning, reperfusion injury, myocardial salvage
336390|NCT02158455|CABG|cabg
336391|NCT02158455|Saphenous vein|saphenous vein
336392|NCT02158455|Radial artery|radial artery
336393|NCT02158442|Diabetes|diabetes
336394|NCT02158442|Lower limb infection|lower limb infection
336395|NCT02158442|Significant wound infections|significant wound infections
336396|NCT02158442|Intravenous antibiotics|intravenous antibiotics
336397|NCT02158442|Timentin|timentin
336398|NCT02158429|substance use disorders|substance use disorders
336399|NCT02158429|pregnancy|pregnancy
336400|NCT02158429|maternal attachment|maternal attachment
336401|NCT02158429|paternal attachment|paternal attachment
336402|NCT02158429|three dimensional ultrasound|three dimensional ultrasound
336403|NCT02158416|platelet|platelet
336404|NCT02158416|transfusion|transfusion
336405|NCT02158416|ThromboLUX|thrombolux
336406|NCT02158416|corrected count increment|corrected count increment
336407|NCT02158416|thrombocytopenic|thrombocytopenic
336408|NCT02158403|HeartMate II|heartmate ii
336409|NCT02158403|heart assist device|heart assist device
336410|NCT02158403|pump thrombosis|pump thrombosis
336411|NCT02158403|hypercoagulable disorder|hypercoagulable disorder
336412|NCT02158403|thrombus|thrombus
336413|NCT02158403|Thoratec Corporation|thoratec corporation
336414|NCT02158390|Down syndrome|down syndrome
336415|NCT02158390|Language intervention|language intervention
336416|NCT02158390|Communication intervention|communication intervention
336417|NCT02158377|Dental implants|dental implants
336418|NCT02158377|Trabecular Metal dental implants|trabecular metal dental implants
336419|NCT02158377|TSV dental implants|tsv dental implants
336420|NCT02158377|Zimmer Dental|zimmer dental
336421|NCT02158377|Implant stability|implant stability
336422|NCT02158377|Implant stability quotient (ISQ)|implant stability quotient (isq)
336423|NCT02158377|Resonance Frequency Analysis (RFA)|resonance frequency analysis (rfa)
336424|NCT02158364|Pharmacological therapy|pharmacological therapy
336425|NCT02158351|Simple steatosis (SS)|simple steatosis (ss)
336426|NCT02158351|Non-alcoholic steatohepatitis (NASH)|non-alcoholic steatohepatitis (nash)
336427|NCT02158351|Gut microbiota (GM)|gut microbiota (gm)
336428|NCT02158351|Non alcoholic fatty liver disease (NAFLD)|non alcoholic fatty liver disease (nafld)
336429|NCT02158338|asthma|asthma
336430|NCT02158338|maternal bonding|maternal bonding
336431|NCT02158338|maternal bonding disruptions|maternal bonding disruptions
336432|NCT02158338|mother-infant interaction|mother-infant interaction
336433|NCT02158312|neuroplasticity|neuroplasticity
336434|NCT02158273|Alcohol|alcohol
336435|NCT02158273|Relapse|relapse
336436|NCT02158260|Capsule endoscopy|capsule endoscopy
336437|NCT02158260|Patient position changing|patient position changing
336438|NCT02158234|squamous cell carcinoma|squamous cell carcinoma
336439|NCT02158234|head and neck cancer|head and neck cancer
336440|NCT02158234|paranasal sinuses|paranasal sinuses
336441|NCT02158234|nasal cavity|nasal cavity
336442|NCT02158234|nasopharynx|nasopharynx
336443|NCT02158234|oropharynx|oropharynx
336444|NCT02158234|oral cavity|oral cavity
336445|NCT02158234|larynx|larynx
336446|NCT02158234|hypopharynx|hypopharynx
336447|NCT02158234|salivary glands|salivary glands
336448|NCT02158234|cervical lymph nodes|cervical lymph nodes
336449|NCT02158208|before any treatment|before any treatment
336450|NCT02158208|at the diagnosis|at the diagnosis
336451|NCT02158182|Hepatic Encephalopathy|hepatic encephalopathy
336452|NCT02158182|Acute Variceal Bleeding|acute variceal bleeding
336453|NCT02158182|Cirrhosis|cirrhosis
336454|NCT02158130|Physical Inactivity|physical inactivity
336455|NCT02158130|Aerobic Exercise Detraining|aerobic exercise detraining
336456|NCT02158130|Body Weight|body weight
336457|NCT02158130|Energy Expenditure|energy expenditure
336458|NCT02158130|Metabolic Syndrome|metabolic syndrome
336459|NCT02158117|Emergency Treatment|emergency treatment
336460|NCT02158117|Morphine Derivates|morphine derivates
336461|NCT02158117|Heroin|heroin
336462|NCT02158117|Antidotes|antidotes
336463|NCT02158117|Administration, Intranasal|administration, intranasal
336464|NCT02158091|Chronic Lymphocytic Leukemia|chronic lymphocytic leukemia
336465|NCT02158078|Diabetes Mellitus|diabetes mellitus
336466|NCT02158078|Diabetes Mellitus, Type 2|diabetes mellitus, type 2
336467|NCT02158078|Glucose Metabolism Disorders|glucose metabolism disorders
336468|NCT02158078|Metabolic Diseases|metabolic diseases
336469|NCT02158078|Endocrine System Diseases|endocrine system diseases
336470|NCT02158078|Insulin|insulin
712553|NCT00579709|Thymus Transplantation|thymus transplantation
336471|NCT02158078|Continuous subcutaneous insulin infusion (CSII)|continuous subcutaneous insulin infusion (csii)
336472|NCT02158078|Insulin pumps|insulin pumps
336473|NCT02158065|Chronic obstructive pulmonary disease (COPD)|chronic obstructive pulmonary disease (copd)
336474|NCT02158065|physical activity|physical activity
336475|NCT02158065|PROactive|proactive
336476|NCT02158065|telecoaching|telecoaching
336477|NCT02158052|HLA matched|hla matched
336478|NCT02158052|bone marrow transplantation|bone marrow transplantation
336479|NCT02158052|kidney transplantation|kidney transplantation
336480|NCT02158039|Intraductal Papillary Mucinous Neoplasm|intraductal papillary mucinous neoplasm
336481|NCT02158039|Mucinous Cystic Neoplasm|mucinous cystic neoplasm
336482|NCT02158039|Endoscopic Ultrasound|endoscopic ultrasound
336483|NCT02158039|Ethanol|ethanol
336484|NCT02158026|Follicular sensitivity index|follicular sensitivity index
336485|NCT02158026|ICSI|icsi
336487|NCT02157987|telangietasia hereditary hemorragic|telangietasia hereditary hemorragic
336488|NCT02157987|epistaxis|epistaxis
336489|NCT02157987|safety|safety
336490|NCT02157987|quality of life|quality of life
336491|NCT02157987|bevacizumab|bevacizumab
336492|NCT02157987|spray|spray
336493|NCT02157948|postmenopausal osteoporosis|postmenopausal osteoporosis
336494|NCT02157948|osteoporosis|osteoporosis
336495|NCT02157948|postmenopausal|postmenopausal
336496|NCT02157948|denosumab|denosumab
336497|NCT02157948|women|women
336498|NCT02157935|COPD, turbuhaler, pMDI|copd, turbuhaler, pmdi
336499|NCT02157922|Cystic fibrosis|cystic fibrosis
336500|NCT02157922|mucolytic|mucolytic
336501|NCT02157922|mucociliary clearance|mucociliary clearance
336502|NCT02157922|lung clearance|lung clearance
336503|NCT02157909|Lens fit|lens fit
336504|NCT02157909|contact lenses|contact lenses
336505|NCT02157909|myopia|myopia
336506|NCT02157896|Acute ischemic stroke|acute ischemic stroke
336507|NCT02157896|Vascular endothelial growth factor|vascular endothelial growth factor
336508|NCT02157896|Endostatin|endostatin
336509|NCT02157883|oncology, cancer, non small cell lung cancer, anticancer drug, pharmacokinetics, AZD9291, intraconazole, EGFR sensitivity mutation|oncology, cancer, non small cell lung cancer, anticancer drug, pharmacokinetics, azd9291, intraconazole, egfr sensitivity mutation
336510|NCT02157857|NSCLC, SCLC, lung cancer, EBUS-TBNA|nsclc, sclc, lung cancer, ebus-tbna
336511|NCT02157844|Obstructive Sleep Apnea|obstructive sleep apnea
336512|NCT02157844|Chronic Obstructive Pulmonary Disease|chronic obstructive pulmonary disease
336513|NCT02157844|Obesity|obesity
336514|NCT02157844|Hepatic fat metabolism|hepatic fat metabolism
336515|NCT02157844|fat digestion|fat digestion
336516|NCT02157844|whole body protein synthesis|whole body protein synthesis
336517|NCT02157844|protein digestion|protein digestion
336518|NCT02157844|amino acid metabolism|amino acid metabolism
336519|NCT02157844|adipose tissue fat metabolism|adipose tissue fat metabolism
336520|NCT02157844|lipolysis|lipolysis
336521|NCT02157831|Subjects with Clinical Benefit After a Single Infusion of CP - 870, 893|subjects with clinical benefit after a single infusion of cp - 870, 893
336522|NCT02157805|Meat processes|meat processes
336523|NCT02157805|Amino acids bioavailability|amino acids bioavailability
336524|NCT02157805|Digestion rate|digestion rate
336525|NCT02157805|Protein synthesis|protein synthesis
336526|NCT02157805|Aging|aging
336527|NCT02157805|Sarcopenia|sarcopenia
336528|NCT02157792|Solid Tumor|solid tumor
336529|NCT02157792|Advanced Solid Tumor|advanced solid tumor
336530|NCT02157792|VX12-970-001|vx12-970-001
336531|NCT02157792|M6620|m6620
336532|NCT02157792|VX-970|vx-970
336533|NCT02157792|Gemcitabine|gemcitabine
336534|NCT02157792|Cisplatin|cisplatin
336535|NCT02157792|Etoposide|etoposide
336536|NCT02157792|Carboplatin|carboplatin
336537|NCT02157792|Irinotecan|irinotecan
336538|NCT02157779|Veterans|veterans
336539|NCT02157779|Anger|anger
336540|NCT02157779|Cognitive Behavioral Therapy|cognitive behavioral therapy
336541|NCT02157779|Treatment|treatment
336542|NCT02157766|Mental Health|mental health
336543|NCT02157766|Asthma|asthma
336544|NCT02157766|Mindfulness|mindfulness
336545|NCT02157766|Compassion|compassion
336546|NCT02157766|Meditation|meditation
336547|NCT02157753|Osteoporotic fracture|osteoporotic fracture
336548|NCT02157753|treatment for osteoporosis|treatment for osteoporosis
336549|NCT02157753|adherence and compliance|adherence and compliance
336550|NCT02157701|Dietary herbs|dietary herbs
336551|NCT02157701|Polyherbal capsule|polyherbal capsule
336552|NCT02157701|Functional exercise capacity|functional exercise capacity
336553|NCT02157701|Joint health|joint health
336554|NCT02157688|folliculitis decalvans|folliculitis decalvans
336555|NCT02157688|Staphylococcus Aureus|staphylococcus aureus
336556|NCT02157688|antibiotics|antibiotics
336557|NCT02157675|Delayed onset muscle soreness|delayed onset muscle soreness
336558|NCT02157675|Muscle damage|muscle damage
336559|NCT02157675|Eccentric exercise|eccentric exercise
336560|NCT02157636|Phase 1|phase 1
336561|NCT02157636|Oncology|oncology
336562|NCT02157636|BET Inhibitor|bet inhibitor
336563|NCT02157623|Basal Cell Nevus Syndrome|basal cell nevus syndrome
336564|NCT02157623|Gorlin's Syndrome|gorlin's syndrome
336565|NCT02157610|Cervical Cancer|cervical cancer
336566|NCT02157610|Cervical Cancer Survivors|cervical cancer survivors
336567|NCT02157610|Smoking Cessation|smoking cessation
336568|NCT02157610|Motivation And Problem-Solving|motivation and problem-solving
336569|NCT02157610|MAPS|maps
336570|NCT02157610|Saliva test|saliva test
336571|NCT02157610|Self help materials|self help materials
336572|NCT02157610|Pamphlets|pamphlets
336573|NCT02157610|Texas Quitline|texas quitline
336574|NCT02157610|Nicotine patch|nicotine patch
336575|NCT02157610|Questionnaires|questionnaires
336576|NCT02157610|Surveys|surveys
336577|NCT02157610|Telephone counseling sessions|telephone counseling sessions
336578|NCT02157571|prulifloxacin|prulifloxacin
336579|NCT02157571|AECB|aecb
336580|NCT02157571|Levofloxacin|levofloxacin
336581|NCT02157545|muscle relaxants|muscle relaxants
336582|NCT02157545|pyridostigmine|pyridostigmine
336583|NCT02157545|pharmacodynamics|pharmacodynamics
336584|NCT02157545|potency|potency
336585|NCT02157532|Severe stroke|severe stroke
336586|NCT02157532|IV tPA|iv tpa
336587|NCT02157532|mechanical thrombectomy|mechanical thrombectomy
336588|NCT02157519|Oral Chemotherapy|oral chemotherapy
336589|NCT02157519|Cancer|cancer
336590|NCT02157506|Acute Heart failure|acute heart failure
336591|NCT02157506|Hemodynamics|hemodynamics
336592|NCT02157506|Pharmacokinetics|pharmacokinetics
336593|NCT02157506|Renal Function|renal function
336594|NCT02157493|American Indian|american indian
336595|NCT02157493|Adolescents|adolescents
336596|NCT02157493|Entrepreneurship|entrepreneurship
336597|NCT02157493|Paraprofessional|paraprofessional
336598|NCT02157493|Life skills|life skills
336599|NCT02157480|glucose profile|glucose profile
336600|NCT02157480|continuous glucose monitoring|continuous glucose monitoring
336601|NCT02157480|electrostimulation|electrostimulation
336602|NCT02157441|Postpartum Hemorrhage|postpartum hemorrhage
336603|NCT02157441|Placenta Previa|placenta previa
336604|NCT02157441|uterine cavity|uterine cavity
336605|NCT02157402|Adolescent|adolescent
336606|NCT02157376|SUP|sup
336607|NCT02157376|Upper GI bleeding|upper gi bleeding
336608|NCT02157376|Seriously ill patients|seriously ill patients
336609|NCT02157350|Eye Diseases|eye diseases
336610|NCT02157350|Proliferative Diabetic Retinopathy|proliferative diabetic retinopathy
336611|NCT02157350|Retinal Vessel Geometry|retinal vessel geometry
336612|NCT02157350|Retinal Oxymetry|retinal oxymetry
336613|NCT02157350|Retina Ischemia|retina ischemia
336614|NCT02157350|Panretinal Photocoagulation|panretinal photocoagulation
336615|NCT02157350|Lasers, Semiconductor|lasers, semiconductor
336616|NCT02157350|Fluorescein Angiography|fluorescein angiography
336617|NCT02157337|aortic surgery|aortic surgery
336618|NCT02157337|postoperative acute kidney injury|postoperative acute kidney injury
336619|NCT02157337|statin|statin
336620|NCT02157337|the patient undergoing aortic surgery|the patient undergoing aortic surgery
336621|NCT02157324|Bruton tyrosine kinase inhibitor|bruton tyrosine kinase inhibitor
336623|NCT02157311|HIV-1|hiv-1
336624|NCT02157311|simplification,|simplification,
336625|NCT02157311|treatment discontinuation|treatment discontinuation
336626|NCT02157311|virological success|virological success
336627|NCT02157311|four days a week|four days a week
336628|NCT02157298|Japanese patients with type 2 diabetes with inadequate glycemic control on insulin|japanese patients with type 2 diabetes with inadequate glycemic control on insulin
336629|NCT02157285|Unintended pregnancy in adolescence|unintended pregnancy in adolescence
336630|NCT02157285|LARC|larc
336631|NCT02157285|contraception|contraception
336632|NCT02157272|Antiphospholipid|antiphospholipid
336633|NCT02157272|Syndrome|syndrome
336634|NCT02157272|Rivaroxaban|rivaroxaban
336635|NCT02157272|Warfarin|warfarin
336636|NCT02157272|Thrombosis|thrombosis
336637|NCT02157272|Treatment|treatment
336638|NCT02157246|hypoxia|hypoxia
336639|NCT02157246|rectal cancer|rectal cancer
336640|NCT02157207|antioxidants|antioxidants
336641|NCT02157207|Caucasians|caucasians
336642|NCT02157207|healthy|healthy
336643|NCT02157207|African Americans|african americans
336644|NCT02157207|vascular|vascular
336645|NCT02157207|aging|aging
336646|NCT02157207|racial differences|racial differences
336649|NCT02157181|Risk stratified|risk stratified
336650|NCT02157168|Affordable Care Act|affordable care act
336651|NCT02157168|Medically underserved minorities|medically underserved minorities
336652|NCT02157168|Community health workers|community health workers
336653|NCT02157168|Health disparities among Mexican origin|health disparities among mexican origin
336654|NCT02157142|Severe aortic stenosis|severe aortic stenosis
336655|NCT02157142|Aortic valve stenosis|aortic valve stenosis
336656|NCT02157142|Transcatheter aortic valve replacement|transcatheter aortic valve replacement
336657|NCT02157129|Tracheostomy|tracheostomy
336658|NCT02157129|inflammation|inflammation
336659|NCT02157129|mucous congestion|mucous congestion
336660|NCT02157129|inhalation therapy|inhalation therapy
336661|NCT02157129|phospholipids|phospholipids
336662|NCT02157116|Dose-Dense Chemotherapy|dose-dense chemotherapy
336663|NCT02157103|GBM|gbm
336664|NCT02157103|Glioblastoma|glioblastoma
336665|NCT02157103|Bevacizumab|bevacizumab
336666|NCT02157103|Avastin|avastin
336667|NCT02157103|Subcutaneous|subcutaneous
336668|NCT02157090|HSL of lips|hsl of lips
336669|NCT02157090|perioral skin|perioral skin
336670|NCT02157090|duration of HSL symptoms not more than three days|duration of hsl symptoms not more than three days
336671|NCT02157090|not acyclovir or other cold sore therapies|not acyclovir or other cold sore therapies
336672|NCT02157077|Eye diseases|eye diseases
336673|NCT02157077|Vision Impairment and Blindness|vision impairment and blindness
336674|NCT02157077|Eyes and Vision|eyes and vision
336675|NCT02157077|Seniors|seniors
336676|NCT02157077|Neovascular Age-Related Macular Degeneration (AMD)|neovascular age-related macular degeneration (amd)
336677|NCT02157077|Retinal Disease|retinal disease
336678|NCT02157038|whiplash|whiplash
336679|NCT02157038|neck pain|neck pain
336680|NCT02157038|chronic pain|chronic pain
336681|NCT02157038|motor vehicle accident|motor vehicle accident
336682|NCT02157038|car accident|car accident
336683|NCT02157038|MRI|mri
336684|NCT02157038|DNA|dna
336685|NCT02157038|RNA|rna
336686|NCT02157025|Humphrey visual fields|humphrey visual fields
336687|NCT02157025|perimetry|perimetry
336688|NCT02157025|pediatrics|pediatrics
336689|NCT02156973|cardiac computed tomography|cardiac computed tomography
336690|NCT02156973|Image quality|image quality
336691|NCT02156947|Power Doppler sonography|power doppler sonography
336692|NCT02156947|cholecystitis, adhesion|cholecystitis, adhesion
336693|NCT02156934|autologous stress urinary incontinence muscle derived cells|autologous stress urinary incontinence muscle derived cells
336694|NCT02156908|cognitive remediation|cognitive remediation
336695|NCT02156895|Korean PMS of Axitinib|korean pms of axitinib
336696|NCT02156895|Metastatic RCC ; 2nd line only|metastatic rcc ; 2nd line only
336697|NCT02156882|TB|tb
336698|NCT02156882|Tuberculosis|tuberculosis
336699|NCT02156882|MaTuTU - Maputo Tuberculosis Trial Unit|matutu - maputo tuberculosis trial unit
336700|NCT02156882|Clinical Trial Capacity Development|clinical trial capacity development
336701|NCT02156869|Prostate cancer|prostate cancer
336702|NCT02156869|Screening|screening
336703|NCT02156869|Decision aids|decision aids
336704|NCT02156856|hemodynamic monitoring|hemodynamic monitoring
336705|NCT02156856|cardiac output|cardiac output
336706|NCT02156856|cardiac surgery|cardiac surgery
336707|NCT02156843|Diabetic Kidney Disease|diabetic kidney disease
336708|NCT02156843|Nephropathy|nephropathy
336709|NCT02156843|Diabetic Nephropathy|diabetic nephropathy
336710|NCT02156843|Kidney Disease|kidney disease
336711|NCT02156843|Type 2 Diabetes|type 2 diabetes
336712|NCT02156817|Amplitude integrated electroencephalogram|amplitude integrated electroencephalogram
336713|NCT02156817|Heart rate variability|heart rate variability
336714|NCT02156817|Respiratory rate variability|respiratory rate variability
336715|NCT02156817|Preterm Infants|preterm infants
336716|NCT02156817|Length of Hospital Stay|length of hospital stay
336717|NCT02156791|Seasonal allergic rhinoconjunctivitis|seasonal allergic rhinoconjunctivitis
336718|NCT02156791|Grass pollen|grass pollen
336719|NCT02156791|Allergen specific immunotherapy|allergen specific immunotherapy
336720|NCT02156778|Post-Stroke Disease Management|post-stroke disease management
336721|NCT02156778|Post-Stroke Complication|post-stroke complication
336722|NCT02156778|Risk Factor Control|risk factor control
336723|NCT02156778|Quality-of-Life|quality-of-life
336724|NCT02156765|Atrial Fibrillation|atrial fibrillation
336725|NCT02156765|Screening|screening
336726|NCT02156765|Stroke patients|stroke patients
336727|NCT02156726|chronic lymphocytic leukemia|chronic lymphocytic leukemia
336728|NCT02156726|fludarabine|fludarabine
336729|NCT02156726|rituximab|rituximab
336730|NCT02156726|elderly|elderly
336731|NCT02156726|comorbid|comorbid
336732|NCT02156726|FCR|fcr
336733|NCT02156726|CIRS|cirs
336734|NCT02156713|Hemiparesis|hemiparesis
336735|NCT02156713|Occupational Therapy|occupational therapy
336736|NCT02156700|shear wave elastography|shear wave elastography
336737|NCT02156700|haemangiomas|haemangiomas
336738|NCT02156700|metastases|metastases
336739|NCT02156700|hepatocellular carcinoma|hepatocellular carcinoma
336740|NCT02156700|focal nodular hyperplasia|focal nodular hyperplasia
336741|NCT02156700|cholangiocellular carcinoma|cholangiocellular carcinoma
336742|NCT02156674|Maroteaux-Lamy Syndrome|maroteaux-lamy syndrome
336842|NCT02156141|Exercise|exercise
336743|NCT02156674|mucopolysaccharide VI|mucopolysaccharide vi
336744|NCT02156674|MPS VI|mps vi
336745|NCT02156648|Invasive ductal|invasive ductal
336746|NCT02156648|HER2-neu positive|her2-neu positive
336747|NCT02156635|Rehabilitation|rehabilitation
336748|NCT02156635|Direct Current Stimulation|direct current stimulation
336749|NCT02156635|Acute Stroke|acute stroke
336750|NCT02156622|HIV|hiv
336751|NCT02156622|Depression|depression
336752|NCT02156622|Measurement-based care|measurement-based care
336753|NCT02156622|Outcomes|outcomes
336754|NCT02156622|Viral load|viral load
336755|NCT02156609|HeartMate PHP|heartmate php
336756|NCT02156609|HeartMate PHP CE Mark|heartmate php ce mark
336757|NCT02156609|Percutaneous coronary intervention|percutaneous coronary intervention
336758|NCT02156609|PCI|pci
773432|NCT00354978|Bevacizumab|bevacizumab
336759|NCT02156609|Percutaneous ventricular assist|percutaneous ventricular assist
336760|NCT02156609|Thoratec Corporation|thoratec corporation
336761|NCT02156596|renal colic|renal colic
336762|NCT02156596|nebulised morphine|nebulised morphine
336763|NCT02156596|Intravenous NSAID|intravenous nsaid
336764|NCT02156583|Ventricular Assist Device|ventricular assist device
336765|NCT02156583|Skeletal Muscle|skeletal muscle
336766|NCT02156583|Frailty|frailty
336767|NCT02156583|Older adults|older adults
336768|NCT02156570|Hepatitis C|hepatitis c
336769|NCT02156570|Acute/early chronic|acute/early chronic
336770|NCT02156570|Recently acquired|recently acquired
336771|NCT02156570|Directly acting antiviral therapy|directly acting antiviral therapy
336772|NCT02156570|Sofosbuvir|sofosbuvir
336773|NCT02156570|Ribavirin|ribavirin
336774|NCT02156531|Anxiety|anxiety
336775|NCT02156531|Youth Anxiety|youth anxiety
336776|NCT02156531|CBM|cbm
336777|NCT02156531|Cognitive Bias Modification|cognitive bias modification
336778|NCT02156531|Adolescents|adolescents
336779|NCT02156518|radiation therapy, laryngeal cancer, voice therapy, vocal function exercises|radiation therapy, laryngeal cancer, voice therapy, vocal function exercises
336780|NCT02156505|stent|stent
336781|NCT02156505|gastric outlet obstruction|gastric outlet obstruction
336782|NCT02156505|restenosis|restenosis
336783|NCT02156479|CMV|cmv
336784|NCT02156479|T-Track CMV|t-track cmv
336785|NCT02156479|allo-HSCT|allo-hsct
336786|NCT02156479|CMI|cmi
336787|NCT02156466|Psoriasis|psoriasis
336788|NCT02156466|MSB0010841|msb0010841
336789|NCT02156466|Anti-IL17A/F Nanobody|anti-il17a/f nanobody
336790|NCT02156466|M1095|m1095
336791|NCT02156453|Functional recovery|functional recovery
336792|NCT02156453|Total knee arthroplasty|total knee arthroplasty
336793|NCT02156440|Ostearthritis|ostearthritis
336794|NCT02156440|Knee|knee
336795|NCT02156440|SierraSil|sierrasil
336796|NCT02156414|Prostatectomy|prostatectomy
336797|NCT02156414|Extended Lymphadenectomy|extended lymphadenectomy
336798|NCT02156414|Pelvic lymph node dissection|pelvic lymph node dissection
336799|NCT02156414|Prostatic Neoplasm|prostatic neoplasm
336800|NCT02156414|Prospective Studies|prospective studies
336801|NCT02156401|Venous thromboembolism|venous thromboembolism
336802|NCT02156401|Deep vein thrombosis|deep vein thrombosis
336803|NCT02156401|Pulmonary embolism|pulmonary embolism
336804|NCT02156401|Cohort study/epidemiology|cohort study/epidemiology
336805|NCT02156401|Outcome|outcome
336806|NCT02156401|Prognosis|prognosis
336807|NCT02156375|Healthy|healthy
336808|NCT02156375|Ustekinumab|ustekinumab
336809|NCT02156375|STELARA®|stelara®
336810|NCT02156362|Thyroid carcinoma|thyroid carcinoma
336811|NCT02156362|predictive factors|predictive factors
336812|NCT02156362|refractory|refractory
336813|NCT02156362|Differentiated|differentiated
336814|NCT02156362|follicular origin|follicular origin
336815|NCT02156349|Diabetes|diabetes
336816|NCT02156336|Diabetic Peripheral Neuropathic Pain|diabetic peripheral neuropathic pain
336817|NCT02156336|Ranexa|ranexa
336818|NCT02156336|Ranolazine|ranolazine
336819|NCT02156336|Neurology|neurology
336820|NCT02156284|Fear; Thoracic Surgery; Nursing Care; Preoperative Care|fear; thoracic surgery; nursing care; preoperative care
336821|NCT02156271|Insomnia|insomnia
336822|NCT02156258|Imaging|imaging
336823|NCT02156258|Mammography|mammography
336824|NCT02156232|hepatic encephalopathy (HE)|hepatic encephalopathy (he)
336825|NCT02156232|vericeal bleeding|vericeal bleeding
336826|NCT02156232|spontaneous portosystemic shunts (SPSS)|spontaneous portosystemic shunts (spss)
336827|NCT02156232|transjugular intrahepatic portosystemic shunt (TIPS)|transjugular intrahepatic portosystemic shunt (tips)
336828|NCT02156232|embolization|embolization
336829|NCT02156180|exhaled breath|exhaled breath
336830|NCT02156180|volatile organic compounds|volatile organic compounds
336831|NCT02156180|surgery|surgery
336832|NCT02156180|chemotherapy|chemotherapy
336833|NCT02156180|radiotherapy|radiotherapy
336834|NCT02156167|Otosclerosis, cochlear implant, acoustic stimulation|otosclerosis, cochlear implant, acoustic stimulation
336835|NCT02156141|Kennedy's disease|kennedy's disease
336836|NCT02156141|Spinal and bulbar muscular atrophy|spinal and bulbar muscular atrophy
336837|NCT02156141|High Intensity Training|high intensity training
336838|NCT02156141|High Intensity Interval Training|high intensity interval training
336839|NCT02156141|HIT|hit
336840|NCT02156141|HIIT|hiit
336841|NCT02156141|Training|training
336843|NCT02156141|10-20-30|10-20-30
336844|NCT02156128|Cognitive therapy|cognitive therapy
336845|NCT02156115|Lymphangiomatosis|lymphangiomatosis
336846|NCT02156115|Lymphangiogenesis|lymphangiogenesis
336847|NCT02156115|Smooth Muscle Cell|smooth muscle cell
336848|NCT02156115|Vascular Anomalies|vascular anomalies
336849|NCT02156102|Genetic Disorders|genetic disorders
336850|NCT02156102|Health contributors|health contributors
336851|NCT02156102|Multifactorial|multifactorial
336852|NCT02156102|African American|african american
336853|NCT02156089|fMRI|fmri
336854|NCT02156089|Reward Processing|reward processing
336855|NCT02156089|Nutrition|nutrition
336856|NCT02156089|Omega-3 Fatty Acids|omega-3 fatty acids
336857|NCT02156089|ADHD|adhd
336858|NCT02156063|Recurrent Pregnancy Loss|recurrent pregnancy loss
336859|NCT02156063|Recurrent Miscarriage|recurrent miscarriage
336860|NCT02156063|Miscarriage|miscarriage
336861|NCT02156063|Pregnancy Loss|pregnancy loss
336862|NCT02156063|Repeated Pregnancy Loss|repeated pregnancy loss
336863|NCT02156037|Hispanic|hispanic
336864|NCT02156037|clinical decision support|clinical decision support
336865|NCT02156037|diabetes|diabetes
336866|NCT02156037|Hba1c|hba1c
336867|NCT02156037|psychosocial|psychosocial
336868|NCT02156024|clinical trials|clinical trials
336869|NCT02156024|Gastrodia and Uncaria Drink|gastrodia and uncaria drink
336870|NCT02156011|In vivo knee joint kinematics|in vivo knee joint kinematics
336871|NCT02156011|In vivo knee joint loading|in vivo knee joint loading
336872|NCT02156011|Video-fluoroscopy|video-fluoroscopy
336873|NCT02156011|Instrumented implants|instrumented implants
336874|NCT02156011|Optical motion capture|optical motion capture
336875|NCT02156011|Ground reaction forces|ground reaction forces
336876|NCT02156011|Electromyography|electromyography
336877|NCT02155998|prostate adenocarcinoma, locally advanced prostate cancer with high and very high risk of recurrence, adjuvant endocrine treatment, prostate specific antigen|prostate adenocarcinoma, locally advanced prostate cancer with high and very high risk of recurrence, adjuvant endocrine treatment, prostate specific antigen
336878|NCT02155972|Bipolar|bipolar
336879|NCT02155972|Depression|depression
336880|NCT02155972|Probiotic|probiotic
336881|NCT02155972|ALIGN|align
336882|NCT02155972|HAMD|hamd
336883|NCT02155972|STAI|stai
336884|NCT02155972|YMRS|ymrs
336885|NCT02155972|CGI|cgi
336886|NCT02155972|SDS|sds
336887|NCT02155972|WHOQOL-BREF|whoqol-bref
336888|NCT02155972|C-SSRS|c-ssrs
336889|NCT02155972|TSES|tses
336890|NCT02155959|astigmatism|astigmatism
336891|NCT02155959|cataract|cataract
336892|NCT02155959|toric|toric
336893|NCT02155959|lens|lens
336894|NCT02155946|Aging|aging
336895|NCT02155946|Alzheimer's Disease/Dementia|alzheimer's disease/dementia
336896|NCT02155946|Cognitive Disorders|cognitive disorders
336897|NCT02155946|Imaging|imaging
336898|NCT02155946|Magnetic Resonance Imaging (MRI)|magnetic resonance imaging (mri)
336899|NCT02155946|Neurology|neurology
336900|NCT02155946|Physical Medicine & Rehabilitation|physical medicine & rehabilitation
336901|NCT02155946|transcranial direct current stimulation|transcranial direct current stimulation
336902|NCT02155920|Ependymoma|ependymoma
336903|NCT02155920|Anaplastic Ependymoma|anaplastic ependymoma
336904|NCT02155894|Rheumatoid arthritis, treat to target, telemedicine|rheumatoid arthritis, treat to target, telemedicine
336905|NCT02155881|Drug therapy|drug therapy
336906|NCT02155868|Cerebral near-infrared spectroscopy monitoring|cerebral near-infrared spectroscopy monitoring
336907|NCT02155868|Postoperative complications|postoperative complications
336908|NCT02155868|Cardiac surgery|cardiac surgery
336909|NCT02155855|type 1 diabetes, home glucose monitor, upload, cloud|type 1 diabetes, home glucose monitor, upload, cloud
336910|NCT02155842|exercise therapy|exercise therapy
336911|NCT02155829|PTSD|ptsd
336912|NCT02155829|TBI|tbi
336913|NCT02155829|Riluzole|riluzole
336914|NCT02155829|Rilutek|rilutek
336915|NCT02155829|augmentation|augmentation
336916|NCT02155829|supplement|supplement
336917|NCT02155829|double blinded|double blinded
336918|NCT02155829|clinical trial|clinical trial
336919|NCT02155829|placebo|placebo
336920|NCT02155829|RCT|rct
336921|NCT02155829|Randomized Control Trial|randomized control trial
336922|NCT02155816|inflammation|inflammation
336923|NCT02155816|lipoproteins|lipoproteins
336924|NCT02155816|omega 3|omega 3
336925|NCT02155816|omega 7|omega 7
336926|NCT02155803|Sarcoidosis-Associated Calcium Dysregulation|sarcoidosis-associated calcium dysregulation
336927|NCT02155803|Sarcoidosis-Associated hypercalciuria|sarcoidosis-associated hypercalciuria
336928|NCT02155803|hypercalcemia|hypercalcemia
336929|NCT02155803|hypercalciuria|hypercalciuria
336930|NCT02155803|nephrocalcinosis|nephrocalcinosis
336931|NCT02155803|nephrolithiasis|nephrolithiasis
336932|NCT02155803|interstitial nephritis|interstitial nephritis
336933|NCT02155803|glomerulonephritis|glomerulonephritis
336934|NCT02155803|acute kidney disease|acute kidney disease
336935|NCT02155803|chronic kidney disease|chronic kidney disease
336936|NCT02155790|safety, performance, hypertension, renal denervation|safety, performance, hypertension, renal denervation
336937|NCT02155777|BRCA1|brca1
336938|NCT02155777|BRCA2|brca2
336939|NCT02155777|Risk-reducing surgery|risk-reducing surgery
336940|NCT02155777|Oral Contraceptives|oral contraceptives
336941|NCT02155764|tooth|tooth
336942|NCT02155764|extraction|extraction
336943|NCT02155764|alveolar socket|alveolar socket
336944|NCT02155764|socket preservation|socket preservation
336945|NCT02155764|ridge preservation|ridge preservation
336946|NCT02155764|bone graft|bone graft
336947|NCT02155764|tricalcium phosphate|tricalcium phosphate
336948|NCT02155764|octacalcium phosphate|octacalcium phosphate
336949|NCT02155764|xenograft|xenograft
336950|NCT02155764|bio oss|bio oss
336951|NCT02155751|Obesity prevention|obesity prevention
336952|NCT02155751|Nutrition and exercise in pregnancy|nutrition and exercise in pregnancy
336953|NCT02155751|Postpartum|postpartum
336954|NCT02155751|Maternal obesity risk|maternal obesity risk
336955|NCT02155738|IV acetaminophen|iv acetaminophen
336956|NCT02155738|Postoperative pain|postoperative pain
336957|NCT02155738|Pelvic organ prolapse surgery|pelvic organ prolapse surgery
336958|NCT02155738|Pelvic organ prolapse repair|pelvic organ prolapse repair
336959|NCT02155725|PPH|pph
336960|NCT02155725|fibrinogen|fibrinogen
336961|NCT02155725|vaginal delivery|vaginal delivery
336962|NCT02155699|UHR, Remediation, Exercise, Intervention, Psychosis|uhr, remediation, exercise, intervention, psychosis
336963|NCT02155686|Elderly|elderly
336964|NCT02155686|Prevention|prevention
336965|NCT02155686|Multiple chronic disease|multiple chronic disease
336966|NCT02155686|Telemonitoring|telemonitoring
336967|NCT02155686|Geriatric teleexpertise|geriatric teleexpertise
336968|NCT02155686|Home heath care|home heath care
336969|NCT02155686|Medico-economics|medico-economics
336970|NCT02155660|Obstructive Lung Diseases|obstructive lung diseases
336971|NCT02155660|Chronic Obstructive Pulmonary Disease|chronic obstructive pulmonary disease
336972|NCT02155660|Lung Disease|lung disease
336973|NCT02155660|Bronchial Diseases|bronchial diseases
336974|NCT02155660|COPD Exacerbation|copd exacerbation
336975|NCT02155660|Respiratory Tract Diseases|respiratory tract diseases
336976|NCT02155647|Carcinoma, Merkel Cell|carcinoma, merkel cell
336977|NCT02155647|MSB0010718C|msb0010718c
336978|NCT02155647|avelumab|avelumab
336979|NCT02155647|Bavencio|bavencio
336980|NCT02155647|anti PD-L1|anti pd-l1
336981|NCT02155647|JAVELIN Merkel 200|javelin merkel 200
336982|NCT02155634|Newly Diagnosed Multiple Myeloma|newly diagnosed multiple myeloma
336983|NCT02155634|Multiple Myeloma|multiple myeloma
336984|NCT02155634|Lenalidomide|lenalidomide
336985|NCT02155634|Revlimid|revlimid
336986|NCT02155634|Phase III|phase iii
336987|NCT02155634|Phase IIIb|phase iiib
336988|NCT02155634|Plasma Cell Dyscrasia|plasma cell dyscrasia
336989|NCT02155621|cancer genomics|cancer genomics
336990|NCT02155621|precision medicine|precision medicine
336991|NCT02155621|metastatic cancer|metastatic cancer
336992|NCT02155621|clinical decision-making|clinical decision-making
336993|NCT02155608|ADHD|adhd
336994|NCT02155608|neuromodulation|neuromodulation
336995|NCT02155608|trigeminal nerve stimulation|trigeminal nerve stimulation
336996|NCT02155608|cognition|cognition
336997|NCT02155582|Solid tumors|solid tumors
336998|NCT02155569|Cesarean, extraperitoneal|cesarean, extraperitoneal
336999|NCT02155569|Cesarean|cesarean
337000|NCT02155569|Pain|pain
337001|NCT02155517|TCI,Schnider Model, Cortinez Model, BIS, Cardiac Output.|tci,schnider model, cortinez model, bis, cardiac output.
337002|NCT02155504|Healthy volunteers|healthy volunteers
337003|NCT02155504|Pharmacokinetics|pharmacokinetics
337004|NCT02155504|ASP3700|asp3700
337005|NCT02155504|Itraconazole|itraconazole
337006|NCT02155504|Drug-drug interaction|drug-drug interaction
337007|NCT02155491|venous, thromboembolism, embolism, DVT, Pulmonary Embolism, thrombosis|venous, thromboembolism, embolism, dvt, pulmonary embolism, thrombosis
337008|NCT02155465|Ruxolitinib|ruxolitinib
337009|NCT02155465|Erlotinib|erlotinib
337010|NCT02155465|EGFR-mutant|egfr-mutant
337011|NCT02155465|14-043|14-043
337012|NCT02155452|ALA|ala
337013|NCT02155452|Malignant gliomas|malignant gliomas
337014|NCT02155439|Prospective, randomized controlled trial - pilot study|prospective, randomized controlled trial - pilot study
337015|NCT02155413|Acute pain|acute pain
337016|NCT02155413|Audit|audit
337017|NCT02155413|Safety|safety
337018|NCT02155413|Tolerability|tolerability
337019|NCT02155400|perioperative hypothermia|perioperative hypothermia
337020|NCT02155400|thermal compression|thermal compression
337021|NCT02155400|forced air warming|forced air warming
337022|NCT02155387|EVLW|evlw
337023|NCT02155387|EVLWI|evlwi
337024|NCT02155387|PVPI|pvpi
337025|NCT02155387|MICS|mics
337026|NCT02155374|Glucocorticoid induced hyperglycemia, insulin, chemotherapy|glucocorticoid induced hyperglycemia, insulin, chemotherapy
337027|NCT02155361|Diabetes mellitus|diabetes mellitus
337028|NCT02155361|Diabetes complications|diabetes complications
337029|NCT02155361|Pain|pain
337030|NCT02155309|scopolamine|scopolamine
337031|NCT02155309|motion|motion
337032|NCT02155309|sickness|sickness
337033|NCT02155296|positive youth development|positive youth development
337034|NCT02155296|restorative practices|restorative practices
337035|NCT02155296|school climate|school climate
337036|NCT02155296|social competency|social competency
337037|NCT02155283|Chronic Low Back Pain|chronic low back pain
337038|NCT02155283|Mild-to-Moderate Chronic Low Back Pain|mild-to-moderate chronic low back pain
337039|NCT02155283|Continuous Passive Motion Devices|continuous passive motion devices
337040|NCT02155270|Cataract|cataract
337041|NCT02155270|Incision|incision
337042|NCT02155270|Precut|precut
337043|NCT02155270|Corneal|corneal
337044|NCT02155270|OCT|oct
337045|NCT02155270|Intraoperative OCT|intraoperative oct
337046|NCT02155270|Imaging|imaging
337047|NCT02155270|Astigmatism|astigmatism
337048|NCT02155270|Clear corneal incision|clear corneal incision
773433|NCT00354978|Avastin|avastin
337049|NCT02155257|Osteoarthritis|osteoarthritis
337050|NCT02155257|Knee pain|knee pain
337051|NCT02155257|Hip pain|hip pain
337052|NCT02155257|Total Knee Replacement Surgery|total knee replacement surgery
337053|NCT02155244|CBDS|cbds
337054|NCT02155244|ERCP|ercp
337055|NCT02155244|Dindo-Clavien classification|dindo-clavien classification
337056|NCT02155231|Male with history of anal sex with men or previous participants of the MSM VCT study|male with history of anal sex with men or previous participants of the msm vct study
337057|NCT02155218|Magnetic Resonance Angiography|magnetic resonance angiography
337058|NCT02155218|Contrast Media|contrast media
337059|NCT02155192|CNTO1959PSO2001|cnto1959pso2001
337060|NCT02155192|C0743T08|c0743t08
337061|NCT02155192|C0743T09|c0743t09
337062|NCT02155192|C0743T12|c0743t12
337063|NCT02155192|Psoriasis|psoriasis
337064|NCT02155192|Pharmacogenomics|pharmacogenomics
337065|NCT02155166|Levonorgestrel-releasing intrauterine system|levonorgestrel-releasing intrauterine system
337066|NCT02155166|anesthesia|anesthesia
337067|NCT02155166|pain|pain
337068|NCT02155166|nulliparous|nulliparous
337069|NCT02155140|enteral feeding|enteral feeding
337070|NCT02155140|Discharged|discharged
337071|NCT02155140|surgical resection of an upper gastrointestinal malignancy|surgical resection of an upper gastrointestinal malignancy
337072|NCT02155140|Nutritional supplementation via a jejunostomy|nutritional supplementation via a jejunostomy
337073|NCT02155127|chronic kidney disease|chronic kidney disease
337074|NCT02155127|physical function|physical function
337075|NCT02155114|Hepcidins|hepcidins
337076|NCT02155114|Homeostasis|homeostasis
337077|NCT02155114|Iron/administration & dosage|iron/administration & dosage
337078|NCT02155114|Biological Markers/blood|biological markers/blood
337079|NCT02155101|Efficacy|efficacy
337080|NCT02155101|Safety|safety
337081|NCT02155101|Darunavir|darunavir
337082|NCT02155101|HIV-1 RNA level|hiv-1 rna level
337083|NCT02155101|Cameroon|cameroon
337084|NCT02155088|Locally Advanced|locally advanced
337085|NCT02155088|Metastatic|metastatic
337086|NCT02155088|Recurrent|recurrent
337087|NCT02155088|Pancreas|pancreas
337088|NCT02155075|Breast neoplasm|breast neoplasm
337089|NCT02155075|Breast implants|breast implants
337090|NCT02155075|Mammography|mammography
337091|NCT02155075|Breast imaging|breast imaging
337092|NCT02155075|Imaging augmented breast|imaging augmented breast
337093|NCT02155062|Nutritional biomarker|nutritional biomarker
337094|NCT02155062|Dietary assessment|dietary assessment
337095|NCT02155062|Whole grain|whole grain
337096|NCT02155062|Wheat|wheat
337097|NCT02155062|Rye|rye
337098|NCT02155062|Alkylresorcinol|alkylresorcinol
337099|NCT02155062|Urine|urine
337100|NCT02155049|TED|ted
337101|NCT02155049|Prostaglandin Analogues|prostaglandin analogues
337102|NCT02155036|exercise|exercise
337103|NCT02155036|rehabilitation|rehabilitation
337104|NCT02155036|kidney function|kidney function
337105|NCT02155036|cardiovascular disease risk|cardiovascular disease risk
337106|NCT02155010|Dexmedetomidine|dexmedetomidine
337107|NCT02155010|Spinal anesthesia|spinal anesthesia
337108|NCT02154971|HIV Seropositivity|hiv seropositivity
337109|NCT02154971|Audiometry|audiometry
337110|NCT02154971|Hearing Loss|hearing loss
337111|NCT02154958|Follicular output rate|follicular output rate
337112|NCT02154958|IVF|ivf
337113|NCT02154958|ICSI|icsi
337114|NCT02154932|Myomectomy, Misoprostol|myomectomy, misoprostol
337115|NCT02154906|periodontal disease|periodontal disease
337116|NCT02154906|periodontitis|periodontitis
337117|NCT02154893|Ultrasound|ultrasound
337118|NCT02154893|Laser|laser
337119|NCT02154893|Therapeutic exercise|therapeutic exercise
337120|NCT02154893|Rehabilitation|rehabilitation
337121|NCT02154893|Osteoarthritis|osteoarthritis
337122|NCT02154880|HIV|hiv
337123|NCT02154880|lung|lung
337124|NCT02154880|aging|aging
337125|NCT02154867|IBS-D|ibs-d
337126|NCT02154867|FMT|fmt
337127|NCT02154867|metagenomics|metagenomics
337128|NCT02154867|gut microbiome|gut microbiome
337129|NCT02154854|Renal|renal
337130|NCT02154854|Transplantation|transplantation
337131|NCT02154854|Tacrolimus|tacrolimus
337132|NCT02154854|Arterial stiffness|arterial stiffness
337133|NCT02154854|Vascular fibrose plasma markers|vascular fibrose plasma markers
337134|NCT02154841|Postoperative|postoperative
337135|NCT02154841|nutrition|nutrition
337136|NCT02154841|taste|taste
337137|NCT02154841|perception|perception
337138|NCT02154841|preference|preference
337139|NCT02154841|choice|choice
337140|NCT02154828|Children|children
337141|NCT02154828|aged|aged
337650|NCT02152332|RSC-385896|rsc-385896
337142|NCT02154828|3 to 6 years|3 to 6 years
337143|NCT02154815|End Stage Renal Disease|end stage renal disease
337144|NCT02154815|Renal transplantation|renal transplantation
337145|NCT02154815|Dialysis|dialysis
337146|NCT02154815|Pre-emptive transplantation|pre-emptive transplantation
337147|NCT02154815|Psychological adjustment|psychological adjustment
337148|NCT02154815|Quality of life.|quality of life.
337149|NCT02154776|LEE011,|lee011,
337150|NCT02154776|buparlisib,|buparlisib,
337151|NCT02154776|letrozole,|letrozole,
337152|NCT02154776|HR +,|hr +,
337153|NCT02154776|HER2 - negative,|her2 - negative,
337154|NCT02154776|post-menopausal,|post-menopausal,
337155|NCT02154776|breast cancer,|breast cancer,
337156|NCT02154776|CDK 4/6,|cdk 4/6,
337157|NCT02154776|PI3K,|pi3k,
337158|NCT02154776|MTD|mtd
337159|NCT02154763|Bariatric surgery|bariatric surgery
337160|NCT02154763|Bariatrics|bariatrics
337161|NCT02154763|Local anesthetic|local anesthetic
337162|NCT02154763|Ropivacaine|ropivacaine
337163|NCT02154763|Intraperitoneal|intraperitoneal
337164|NCT02154750|Atrioventricular delay|atrioventricular delay
337165|NCT02154750|AV delay|av delay
337166|NCT02154750|Pacemaker|pacemaker
337167|NCT02154750|Sick Sinus Syndrome|sick sinus syndrome
337168|NCT02154750|Bradycardia|bradycardia
337169|NCT02154750|PR interval|pr interval
337170|NCT02154750|Atrioventricular block|atrioventricular block
337171|NCT02154750|AV block|av block
337172|NCT02154750|Echocardiography|echocardiography
337173|NCT02154750|Arrhythmia|arrhythmia
337174|NCT02154750|AV optimization|av optimization
337175|NCT02154737|Pancreatic|pancreatic
337176|NCT02154737|Gemcitabine|gemcitabine
337177|NCT02154737|Gemzar|gemzar
337178|NCT02154737|erlotinib|erlotinib
337179|NCT02154737|Tarceva|tarceva
337180|NCT02154711|mitochondrial disease|mitochondrial disease
337181|NCT02154711|magnetic resonance imaging|magnetic resonance imaging
337182|NCT02154711|magnetic resonance spectroscopy|magnetic resonance spectroscopy
337183|NCT02154711|creatine|creatine
337184|NCT02154711|phosphocreatine|phosphocreatine
337185|NCT02154685|Smoking|smoking
337186|NCT02154685|Nicotine|nicotine
337187|NCT02154685|Addiction|addiction
337188|NCT02154685|Cessation|cessation
337189|NCT02154620|Distal radius fracture|distal radius fracture
337190|NCT02154620|wrist fracture|wrist fracture
337191|NCT02154620|volar plate|volar plate
337192|NCT02154620|surgical treatment|surgical treatment
337193|NCT02154620|plaster immobilisation|plaster immobilisation
337194|NCT02154607|oral lichen planus|oral lichen planus
337195|NCT02154607|recurrence|recurrence
337196|NCT02154607|Treatment|treatment
337197|NCT02154607|cancer|cancer
337198|NCT02154607|Primary disease Management|primary disease management
337199|NCT02154594|Acacia|acacia
337200|NCT02154594|Chlorhexidine|chlorhexidine
337201|NCT02154594|Gingivitis|gingivitis
337202|NCT02154594|Orthodontic appliances.|orthodontic appliances.
337203|NCT02154581|Dental implants|dental implants
337204|NCT02154581|Esthetic score|esthetic score
337205|NCT02154581|Immediate implants|immediate implants
337206|NCT02154581|Gingival biotype|gingival biotype
337207|NCT02154568|Hyperpolarized gas MRI|hyperpolarized gas mri
337208|NCT02154542|Nava|nava
337209|NCT02154542|Mechanical ventilation|mechanical ventilation
337210|NCT02154477|hypogonadotropic hypogonadism|hypogonadotropic hypogonadism
337211|NCT02154464|Morphine-sparing|morphine-sparing
337212|NCT02154464|Paracetamol|paracetamol
337213|NCT02154464|Obesity|obesity
337214|NCT02154464|Gastric banding|gastric banding
337215|NCT02154425|Cimzia®|cimzia®
337216|NCT02154425|CZP|czp
337217|NCT02154425|Breastfeeding|breastfeeding
337218|NCT02154425|Nursing|nursing
337219|NCT02154425|Autoimmune diseases and pregnancy|autoimmune diseases and pregnancy
337220|NCT02154412|Respiration|respiration
337221|NCT02154412|Motor control|motor control
337222|NCT02154412|Blood Pressure|blood pressure
337223|NCT02154412|Orthostatic Hypotension|orthostatic hypotension
337224|NCT02154386|bone augmentation|bone augmentation
337225|NCT02154386|tooth extraction|tooth extraction
337226|NCT02154386|dental implant|dental implant
337227|NCT02154360|HIV infection|hiv infection
337228|NCT02154360|NK-1R antagonists|nk-1r antagonists
337229|NCT02154360|aprepitant|aprepitant
337230|NCT02154360|ritonavir boosting|ritonavir boosting
337231|NCT02154347|Type 2 Diabetes Mellitus|type 2 diabetes mellitus
337232|NCT02154347|HbA1c|hba1c
337233|NCT02154334|Allergic Rhinitis|allergic rhinitis
337234|NCT02154334|Healthy|healthy
337235|NCT02154334|Esketamine|esketamine
337236|NCT02154334|Mometasone|mometasone
337237|NCT02154334|Oxymetazoline|oxymetazoline
337238|NCT02154334|Phase 1|phase 1
337239|NCT02154308|Influenza|influenza
337240|NCT02154308|Influenza vaccine|influenza vaccine
337241|NCT02154308|Split influenza vaccine|split influenza vaccine
337242|NCT02154308|Seasonal influenza vaccine|seasonal influenza vaccine
337243|NCT02154282|hepatic encephalopathy|hepatic encephalopathy
337244|NCT02154282|covert hepatic encephalopathy|covert hepatic encephalopathy
337245|NCT02154282|cirrhosis|cirrhosis
337246|NCT02154269|Chagas disease|chagas disease
337247|NCT02154269|G-CSF|g-csf
337248|NCT02154269|Cell therapy|cell therapy
337249|NCT02154256|walking|walking
337250|NCT02154256|incentives|incentives
337251|NCT02154256|exercise|exercise
337252|NCT02154256|habits|habits
337253|NCT02154230|weight loss|weight loss
337254|NCT02154230|sulphate-bicarbonate-calcium water|sulphate-bicarbonate-calcium water
337255|NCT02154230|gut microbiota|gut microbiota
773621|NCT00354354|Exercise|exercise
337256|NCT02154230|body composition|body composition
337257|NCT02154230|bile salts|bile salts
337258|NCT02154191|Lumbosacral Region|lumbosacral region
337259|NCT02154191|Sedentary Lifestyle|sedentary lifestyle
337260|NCT02154191|Surgical Procedure, Operative|surgical procedure, operative
337261|NCT02154178|empiric antifungal therapy|empiric antifungal therapy
337262|NCT02154178|biomarkers|biomarkers
337263|NCT02154178|invasive fungal infection|invasive fungal infection
337264|NCT02154178|Candida|candida
337265|NCT02154165|Neonatal hyperbilirubinemia|neonatal hyperbilirubinemia
337266|NCT02154165|Phototherapy|phototherapy
337267|NCT02154165|Light emitting diodes|light emitting diodes
337268|NCT02154165|Blue light|blue light
337269|NCT02154165|Turquoise light|turquoise light
337270|NCT02154152|Bed wetting|bed wetting
337271|NCT02154152|Primary Enuresis|primary enuresis
337272|NCT02154152|Frequency|frequency
337273|NCT02154152|Efficacy|efficacy
337274|NCT02154152|Homoeopathic Medicine|homoeopathic medicine
337275|NCT02154152|Causticum 200c|causticum 200c
337276|NCT02154139|Pharmacological therapy|pharmacological therapy
337277|NCT02154113|Syneron|syneron
337278|NCT02154113|Velashape|velashape
337279|NCT02154113|ELOS|elos
337280|NCT02154113|Ultrashape|ultrashape
337281|NCT02154100|Metabolic Syndrome|metabolic syndrome
337282|NCT02154100|Arterial Stiffness|arterial stiffness
337283|NCT02154100|Blood Pressure|blood pressure
337284|NCT02154100|Endothelial Function|endothelial function
337285|NCT02154100|Tart Cherries|tart cherries
337286|NCT02154087|Venous leg ulcer|venous leg ulcer
337287|NCT02154087|Ulcer|ulcer
337288|NCT02154087|Venous stasis|venous stasis
337289|NCT02154087|Compression|compression
337290|NCT02154074|Dexmedetomidine perioperative blood glucose and insulin|dexmedetomidine perioperative blood glucose and insulin
337291|NCT02154061|Flu Vaccine, Intestinal Microbiome, Antibiotics|flu vaccine, intestinal microbiome, antibiotics
337292|NCT02154035|Viral Suppression|viral suppression
337293|NCT02154035|Functional Cure|functional cure
337294|NCT02154022|PK|pk
337295|NCT02154009|Autonomic Nervous System|autonomic nervous system
337296|NCT02154009|Catecholamines|catecholamines
337297|NCT02154009|Dysautonomia|dysautonomia
337298|NCT02154009|Parasympathetic Cholinergic System|parasympathetic cholinergic system
337299|NCT02154009|Sympathetic Adrenergic System|sympathetic adrenergic system
337300|NCT02153996|Malaria Immunity Longevity|malaria immunity longevity
337301|NCT02153983|Obesity|obesity
337302|NCT02153983|Colchicine|colchicine
337303|NCT02153983|Inflammation|inflammation
337304|NCT02153983|Metabolic Syndrome|metabolic syndrome
337305|NCT02153983|Dyslipidemia|dyslipidemia
337306|NCT02153970|Clinical Outcomes Measures|clinical outcomes measures
337307|NCT02153970|Proxy Reported Outcome|proxy reported outcome
337308|NCT02153970|Pediatric|pediatric
337309|NCT02153970|Neuromuscular Disease|neuromuscular disease
337310|NCT02153970|Cerebral Palsy|cerebral palsy
337311|NCT02153957|Exercise|exercise
337312|NCT02153957|Memory|memory
337313|NCT02153957|BDNF|bdnf
337314|NCT02153957|Zamzee|zamzee
337315|NCT02153957|QOL|qol
337316|NCT02153944|Startle|startle
337317|NCT02153944|Induced-Threat|induced-threat
337318|NCT02153944|Memory|memory
337319|NCT02153944|Stimulant|stimulant
337320|NCT02153944|Cognitive Interference|cognitive interference
337321|NCT02153931|Children's Tumor Foundation|children's tumor foundation
337322|NCT02153931|Social Support|social support
337323|NCT02153931|Online|online
337324|NCT02153931|Anxiety|anxiety
337325|NCT02153931|Depression|depression
337326|NCT02153918|Surgery|surgery
337327|NCT02153918|Neoadjuvant|neoadjuvant
337328|NCT02153918|CD8 Cell Infiltrate Response|cd8 cell infiltrate response
337329|NCT02153918|CD4 Cell Infiltrate Response|cd4 cell infiltrate response
337330|NCT02153918|Vaccine|vaccine
337331|NCT02153905|Melanoma|melanoma
337332|NCT02153905|Immunotherapy|immunotherapy
337333|NCT02153905|Metastatic Cancer|metastatic cancer
337334|NCT02153905|Gene Therapy|gene therapy
337335|NCT02153905|T Cells|t cells
337336|NCT02153892|Functional Mitral Regurgitation|functional mitral regurgitation
337337|NCT02153892|Heart Failure|heart failure
337338|NCT02153892|Ventricular Reshaping|ventricular reshaping
337339|NCT02153879|HDL|hdl
337340|NCT02153879|Niacin|niacin
337341|NCT02153879|Fenofibrate|fenofibrate
337342|NCT02153879|Diabetes|diabetes
337343|NCT02153879|Metabolomics|metabolomics
337344|NCT02153866|rotavirus vaccine|rotavirus vaccine
337345|NCT02153840|Stable Plaque Psoriasis|stable plaque psoriasis
337346|NCT02153827|Shoulder|shoulder
337347|NCT02153827|Eccentric Training|eccentric training
337348|NCT02153827|Subacromial Impingement Syndrome|subacromial impingement syndrome
337349|NCT02153814|Infertility|infertility
337350|NCT02153814|In vitro fertilization|in vitro fertilization
337351|NCT02153814|Endometrial injury|endometrial injury
337352|NCT02153801|High Ligation, Low ligation, Genito-urinary function, laparoscopy, rectal cancer, aterior resection, Total mesorectal Excision, anastomotic leak.|high ligation, low ligation, genito-urinary function, laparoscopy, rectal cancer, aterior resection, total mesorectal excision, anastomotic leak.
337353|NCT02153788|Insomnia|insomnia
337355|NCT02153775|Progressive muscle relaxation|progressive muscle relaxation
337356|NCT02153775|Cigarette|cigarette
337357|NCT02153775|Smoking|smoking
337358|NCT02153775|Craving|craving
337359|NCT02153762|Atopic Dermatitis|atopic dermatitis
337360|NCT02153762|AD|ad
337361|NCT02153723|Treatment trial, Rett syndrome, Glatiramer acetate|treatment trial, rett syndrome, glatiramer acetate
337362|NCT02153710|Aphasia|aphasia
337363|NCT02153710|Anomia|anomia
337364|NCT02153697|solar lentigines|solar lentigines
337365|NCT02153697|Q-switches Laser|q-switches laser
337366|NCT02153697|bleaching cream|bleaching cream
337367|NCT02153684|smoking|smoking
337368|NCT02153684|small airway dysfunction|small airway dysfunction
337369|NCT02153684|mild COPD|mild copd
337370|NCT02153684|dyspnea|dyspnea
337371|NCT02153684|exercise|exercise
337372|NCT02153684|clinical outcomes|clinical outcomes
337373|NCT02153671|LAIV H5N2|laiv h5n2
337374|NCT02153671|Influenza vaccine|influenza vaccine
337375|NCT02153671|Russia|russia
337376|NCT02153658|PrePex|prepex
337377|NCT02153658|Odor|odor
337378|NCT02153658|Cleaning technique|cleaning technique
337379|NCT02153658|Male Circumcision|male circumcision
337380|NCT02153658|HIV|hiv
337381|NCT02153658|AIDS|aids
337382|NCT02153658|Chlorhexidine|chlorhexidine
337383|NCT02153658|Soap|soap
337384|NCT02153645|Parkinson's Disease|parkinson's disease
337385|NCT02153645|Levodopa Induced Dyskinesias (LID)|levodopa induced dyskinesias (lid)
337386|NCT02153645|Dyskinesias|dyskinesias
337387|NCT02153645|Parkinsonism|parkinsonism
337388|NCT02153632|Parkinson's Disease|parkinson's disease
337389|NCT02153632|Levodopa Induced Dyskinesia (LID)|levodopa induced dyskinesia (lid)
337390|NCT02153632|LID|lid
337391|NCT02153632|Parkinsonism|parkinsonism
337392|NCT02153632|Dyskinesia|dyskinesia
337393|NCT02153619|Grief|grief
337394|NCT02153619|bereavement|bereavement
337395|NCT02153619|questionnaires|questionnaires
337396|NCT02153619|therapy sessions|therapy sessions
337397|NCT02153619|14-102|14-102
337398|NCT02153606|Glycerin Suppositories|glycerin suppositories
337399|NCT02153606|Enteral Nutrition|enteral nutrition
337400|NCT02153606|Enterocolitis, Necrotizing|enterocolitis, necrotizing
337401|NCT02153606|Infant, Premature|infant, premature
337402|NCT02153606|Meconium|meconium
337403|NCT02153593|Clinical trial|clinical trial
337404|NCT02153593|Randomized|randomized
337405|NCT02153593|Fibrin glue|fibrin glue
337406|NCT02153593|Tranexamic acid|tranexamic acid
337407|NCT02153593|Blood loss|blood loss
337408|NCT02153567|Functional dyspepsia|functional dyspepsia
337409|NCT02153567|symptom response|symptom response
337410|NCT02153567|postprandial fullness|postprandial fullness
337411|NCT02153567|Anxiety|anxiety
337412|NCT02153567|Depression|depression
337413|NCT02153528|Bangladesh|bangladesh
337414|NCT02153528|Rimfapicin|rimfapicin
337415|NCT02153515|Finger prick with diabetic lancet|finger prick with diabetic lancet
337416|NCT02153515|Fingerprick|fingerprick
337417|NCT02153515|Fresh|fresh
337418|NCT02153515|Your own blood|your own blood
337419|NCT02153515|autologous blood|autologous blood
337420|NCT02153515|Dry eyes|dry eyes
337421|NCT02153515|Sjogren's disease with dry eyes|sjogren's disease with dry eyes
337422|NCT02153515|Persistent corneal epithelial defects|persistent corneal epithelial defects
337423|NCT02153515|Chronic corneal ulcers|chronic corneal ulcers
337424|NCT02153463|Tourette Syndrome|tourette syndrome
337425|NCT02153463|Persistent Tic Disorder|persistent tic disorder
337426|NCT02153463|Physical Activity|physical activity
337427|NCT02153463|Quality of Life|quality of life
337428|NCT02153450|pancreatic cancer|pancreatic cancer
337429|NCT02153450|Radiation|radiation
337430|NCT02153450|Metformin|metformin
337431|NCT02153450|Pancreatic Adenocarcinomas|pancreatic adenocarcinomas
337432|NCT02153411|Asthma control|asthma control
337433|NCT02153398|Gastric ulcer (GU)|gastric ulcer (gu)
337434|NCT02153398|Duodenal ulcer (DU)|duodenal ulcer (du)
337435|NCT02153398|Anastomotic ulcer (AU)|anastomotic ulcer (au)
337436|NCT02153398|Non-erosive reflux esophagitis disease (NERD)|non-erosive reflux esophagitis disease (nerd)
337437|NCT02153398|Reflux esophagitis (RE)|reflux esophagitis (re)
337438|NCT02153398|Zollinger-Ellison syndrome|zollinger-ellison syndrome
337439|NCT02153385|Yoga, heart rate variability, stress, mood, women|yoga, heart rate variability, stress, mood, women
337440|NCT02153372|large bone defect, bone marrow-derived mononuclear cells|large bone defect, bone marrow-derived mononuclear cells
337441|NCT02153359|asthma|asthma
337442|NCT02153359|HEPA|hepa
337443|NCT02153359|air pollutants|air pollutants
337444|NCT02153359|lung function|lung function
337445|NCT02153359|home environment|home environment
337446|NCT02153359|respiratory symptoms|respiratory symptoms
337447|NCT02153346|indirect cost|indirect cost
337448|NCT02153346|asthma|asthma
337449|NCT02153333|Human rotavirus (HRV) vaccine|human rotavirus (hrv) vaccine
337450|NCT02153333|Serologic response|serologic response
337451|NCT02153333|Porcine circovirus type 1 (PCV-1)|porcine circovirus type 1 (pcv-1)
337452|NCT02153333|Laboratory evaluations|laboratory evaluations
337453|NCT02153320|HBsAg|hbsag
431386|NCT01727232|ITP|itp
337454|NCT02153320|Persistence of the immune response|persistence of the immune response
337455|NCT02153320|Adjuvants|adjuvants
337456|NCT02153294|low tidal volume|low tidal volume
337457|NCT02153294|high tidal volume|high tidal volume
337458|NCT02153294|protective ventilation|protective ventilation
337459|NCT02153294|ARDS|ards
337460|NCT02153281|Depression|depression
337461|NCT02153281|Positron Emission Tomography (PET)|positron emission tomography (pet)
337462|NCT02153281|MAO-B|mao-b
337463|NCT02153268|Safety|safety
337464|NCT02153268|efficacy|efficacy
337465|NCT02153268|BonoFill|bonofill
337466|NCT02153268|bone filler|bone filler
337467|NCT02153268|autologous adipose tissue derived cells (HATDCs)|autologous adipose tissue derived cells (hatdcs)
337468|NCT02153268|Bone augmentation|bone augmentation
337469|NCT02153268|sinus augmentation|sinus augmentation
337470|NCT02153268|Bone grafting after removal of cysts from jaws|bone grafting after removal of cysts from jaws
337471|NCT02153255|Morquio|morquio
337472|NCT02153255|Mucopolysaccharidosis|mucopolysaccharidosis
337473|NCT02153255|Galactosamine-6-Sulfatase|galactosamine-6-sulfatase
337474|NCT02153255|GALNS|galns
337475|NCT02153242|Pacing|pacing
337476|NCT02153242|Haemodynamics|haemodynamics
337477|NCT02153242|Pilot|pilot
337478|NCT02153229|Histological diagnosis of MPM|histological diagnosis of mpm
337479|NCT02153229|epitheliod subtype|epitheliod subtype
337480|NCT02153229|limited to the hemithorax|limited to the hemithorax
337481|NCT02153229|macroscopically complete resection of the tumor|macroscopically complete resection of the tumor
337482|NCT02153203|Autism spectrum disorder|autism spectrum disorder
337483|NCT02153203|Problem behavior|problem behavior
337484|NCT02153190|Type 1 Diabetes,|type 1 diabetes,
337485|NCT02153190|T1DM,|t1dm,
337486|NCT02153190|Artificial Pancreas|artificial pancreas
337487|NCT02153177|Randomized Controlled Trial (RCT)|randomized controlled trial (rct)
337488|NCT02153177|RCT|rct
337489|NCT02153177|rotator cuff tear|rotator cuff tear
337490|NCT02153177|NSAIDs|nsaids
337491|NCT02153177|non-steroidal anti-inflammatory drugs|non-steroidal anti-inflammatory drugs
337492|NCT02153177|rotator cuff repair|rotator cuff repair
337493|NCT02153164|Enthalpy|enthalpy
337494|NCT02153164|Trendelenberg position|trendelenberg position
337495|NCT02153164|Mechanical ventilation|mechanical ventilation
337496|NCT02153138|vegetarian diet|vegetarian diet
337497|NCT02153138|vegan|vegan
337498|NCT02153138|cardiovascular diseases|cardiovascular diseases
337499|NCT02153138|endothelial function|endothelial function
337500|NCT02153138|carotid intima-media thickness|carotid intima-media thickness
337501|NCT02153112|Drug therapy|drug therapy
337502|NCT02153099|Drug therapy|drug therapy
337503|NCT02153086|Pharmacological therapy|pharmacological therapy
337504|NCT02153073|Pharmacological therapy|pharmacological therapy
337505|NCT02153060|immune thrombocytopenia|immune thrombocytopenia
337506|NCT02153060|dexamethasone|dexamethasone
337507|NCT02153060|efficacy|efficacy
337508|NCT02153060|safety|safety
337509|NCT02153047|Smoking cessation|smoking cessation
337510|NCT02153047|Spirometry|spirometry
337511|NCT02153047|Primary health care|primary health care
337512|NCT02153034|Buruli ulcer|buruli ulcer
337513|NCT02153034|Mycobacterium ulcerans disease|mycobacterium ulcerans disease
337514|NCT02153034|M. ulcerans disease|m. ulcerans disease
337515|NCT02153021|anthropometric parameters;|anthropometric parameters;
337516|NCT02153021|biochemical parameters;|biochemical parameters;
337517|NCT02153021|inflammatory markers|inflammatory markers
337518|NCT02153021|neuropeptide markers|neuropeptide markers
337519|NCT02153021|phototherapy|phototherapy
337520|NCT02153008|Strep throat|strep throat
337521|NCT02152956|AML|aml
337522|NCT02152956|leukemia|leukemia
337523|NCT02152956|myelogenous|myelogenous
337524|NCT02152956|myeloid|myeloid
337525|NCT02152956|refractory|refractory
337526|NCT02152930|Fish oil supplements|fish oil supplements
337527|NCT02152930|Supervised Exercise Training|supervised exercise training
337528|NCT02152930|Walking distance|walking distance
337529|NCT02152930|Hemorheological factors|hemorheological factors
337530|NCT02152930|Cardiovascular risk|cardiovascular risk
337531|NCT02152904|Peptic ulcer bleeding|peptic ulcer bleeding
337532|NCT02152904|rebleeding|rebleeding
337533|NCT02152904|mortality|mortality
337534|NCT02152904|nationwide|nationwide
337535|NCT02152891|Emergency Medical Services|emergency medical services
337536|NCT02152891|Elderly|elderly
337537|NCT02152878|transcranial direct current stimulation|transcranial direct current stimulation
337538|NCT02152878|non invasive brain stimulation|non invasive brain stimulation
337539|NCT02152878|bipolar disorder|bipolar disorder
337540|NCT02152878|depression|depression
337541|NCT02152865|medication|medication
337542|NCT02152852|Type 2 Diabetes|type 2 diabetes
337543|NCT02152826|Sensitivity|sensitivity
337544|NCT02152813|Electrical stimulation, exercise, stroke , rehabilitation|electrical stimulation, exercise, stroke , rehabilitation
337545|NCT02152787|emergence agitation|emergence agitation
337546|NCT02152787|propofol|propofol
337547|NCT02152787|strabismus surgery|strabismus surgery
337548|NCT02152787|children|children
337549|NCT02152787|elective strabismus surgery|elective strabismus surgery
337550|NCT02152761|bimagrumab|bimagrumab
337551|NCT02152761|BYM338|bym338
337552|NCT02152761|hip fracture|hip fracture
337553|NCT02152761|elderly|elderly
337554|NCT02152761|controlled clinical trial|controlled clinical trial
337555|NCT02152761|randomized|randomized
337556|NCT02152761|muscle wasting|muscle wasting
337557|NCT02152761|atrophy|atrophy
337558|NCT02152748|glioblastoma|glioblastoma
337559|NCT02152748|morphological and molecular changes|morphological and molecular changes
337560|NCT02152748|progression|progression
337561|NCT02152748|therapy-resistance|therapy-resistance
337562|NCT02152722|Breath test|breath test
337563|NCT02152722|Volatile Organic Compounds|volatile organic compounds
337564|NCT02152722|VOC|voc
337565|NCT02152722|oxidative stress|oxidative stress
337566|NCT02152722|radiation biodosimetry|radiation biodosimetry
337567|NCT02152722|metabolomics|metabolomics
337568|NCT02152722|GCxGC TOF-MS|gcxgc tof-ms
337569|NCT02152709|Safety|safety
337570|NCT02152709|Immunogenicity|immunogenicity
337571|NCT02152709|Vaccine|vaccine
337572|NCT02152709|Hepatitis B|hepatitis b
337573|NCT02152657|Spinal cord injury|spinal cord injury
337574|NCT02152657|Stem cell transplantation|stem cell transplantation
337575|NCT02152657|Mesenchymal stem cell|mesenchymal stem cell
337576|NCT02152644|amyloidosis-carpal tunnel|amyloidosis-carpal tunnel
337577|NCT02152631|Therapy, Platinum, Kras +|therapy, platinum, kras +
337578|NCT02152618|Serious emotional disturbance|serious emotional disturbance
337579|NCT02152618|foster care|foster care
337580|NCT02152618|child protective services|child protective services
337581|NCT02152605|SGRQ|sgrq
337582|NCT02152605|vilanterol|vilanterol
337583|NCT02152605|long-acting beta2-agonist|long-acting beta2-agonist
337584|NCT02152605|long-acting muscarinic antagonist|long-acting muscarinic antagonist
337585|NCT02152605|COPD|copd
337586|NCT02152605|umeclidinium|umeclidinium
337587|NCT02152592|Postoperative pain|postoperative pain
337588|NCT02152592|Ambulatory surgery|ambulatory surgery
337589|NCT02152592|NSAIDS|nsaids
337590|NCT02152592|CR Oxycodone|cr oxycodone
337591|NCT02152592|Compliance to study medication|compliance to study medication
337592|NCT02152579|Stable Angina|stable angina
337593|NCT02152553|Biomarker|biomarker
337594|NCT02152553|Glucocorticoids|glucocorticoids
337595|NCT02152553|Metabolism|metabolism
337596|NCT02152553|Pharmacology|pharmacology
337597|NCT02152553|Metabolomics|metabolomics
337598|NCT02152540|TBI|tbi
337599|NCT02152540|Transcranial Magnetic Stimulation, Repetitive|transcranial magnetic stimulation, repetitive
337600|NCT02152540|magnetic resonance imaging functional|magnetic resonance imaging functional
337601|NCT02152540|Quality of life|quality of life
337602|NCT02152540|Executive Function|executive function
337603|NCT02152540|Veterans|veterans
337604|NCT02152501|obese|obese
337605|NCT02152501|overweight|overweight
337606|NCT02152501|exercise|exercise
337607|NCT02152501|energy expenditure differences|energy expenditure differences
337608|NCT02152501|relative reinforcing values (RRV)|relative reinforcing values (rrv)
337609|NCT02152501|food|food
337610|NCT02152501|physical activity|physical activity
337611|NCT02152501|biological|biological
337612|NCT02152501|neurobehavioral|neurobehavioral
337613|NCT02152501|behavioral|behavioral
337614|NCT02152488|cerebral blood flow|cerebral blood flow
337615|NCT02152488|position|position
337616|NCT02152488|cervical spine|cervical spine
337617|NCT02152475|Blue-LED|blue-led
337618|NCT02152475|Curcumin|curcumin
337619|NCT02152475|PDT|pdt
337620|NCT02152475|Oral disinfection|oral disinfection
337621|NCT02152462|exergaming|exergaming
337622|NCT02152462|breast cancer|breast cancer
337623|NCT02152462|African American women|african american women
337624|NCT02152462|obesity|obesity
337625|NCT02152423|enoxaparin|enoxaparin
337626|NCT02152423|Enoxamed|enoxamed
337627|NCT02152423|lovenox|lovenox
337628|NCT02152423|anti Xa|anti xa
337629|NCT02152423|acute coronary syndrome|acute coronary syndrome
337630|NCT02152410|acupuncture|acupuncture
337631|NCT02152410|renal colic|renal colic
337632|NCT02152358|Cytomegalovirus|cytomegalovirus
337633|NCT02152358|Herpes simplex virus|herpes simplex virus
337634|NCT02152358|ICU|icu
337635|NCT02152358|mechanical ventilation|mechanical ventilation
337636|NCT02152358|mortality|mortality
337637|NCT02152358|ventilator-free days|ventilator-free days
337638|NCT02152358|PCR|pcr
337639|NCT02152345|kidney|kidney
337640|NCT02152345|renal|renal
337641|NCT02152345|transplant|transplant
337642|NCT02152345|belatacept|belatacept
337643|NCT02152345|delayed graft function|delayed graft function
337644|NCT02152345|thymoglobulin|thymoglobulin
337645|NCT02152345|tacrolimus|tacrolimus
337646|NCT02152345|kidney function|kidney function
337647|NCT02152345|immunosuppression|immunosuppression
337648|NCT02152345|NGAL|ngal
337649|NCT02152332|JNJ-54861912|jnj-54861912
337651|NCT02152332|MTS-0385896A|mts-0385896a
337652|NCT02152332|Phase 1|phase 1
337653|NCT02152332|Moxifloxacin|moxifloxacin
337654|NCT02152332|Placebo|placebo
337655|NCT02152332|Healthy|healthy
337656|NCT02152319|Parkinson's disease|parkinson's disease
337657|NCT02152319|Telemedicine|telemedicine
337658|NCT02152319|Telehealth|telehealth
337659|NCT02152319|Kinesia|kinesia
337660|NCT02152319|Tremor|tremor
337661|NCT02152319|Bradykinesia|bradykinesia
337662|NCT02152319|Dyskinesia|dyskinesia
337663|NCT02152306|Fimasartan|fimasartan
337664|NCT02152306|Fimasartan and Amlodipine|fimasartan and amlodipine
337665|NCT02152306|Antihypertension|antihypertension
337666|NCT02152267|Temporomandibular|temporomandibular
337667|NCT02152267|Musculoskeletal Diseases|musculoskeletal diseases
337668|NCT02152267|Electrical Stimulation of the Brain|electrical stimulation of the brain
337669|NCT02152267|Prefrontal Cortex|prefrontal cortex
337670|NCT02152241|IBD|ibd
337671|NCT02152241|Crohn|crohn
337672|NCT02152241|Colitis|colitis
337673|NCT02152241|Function|function
337674|NCT02152176|pain|pain
337675|NCT02152176|analgesia|analgesia
337676|NCT02152176|morphine|morphine
337677|NCT02152176|PCA|pca
337678|NCT02152176|Nurse|nurse
337679|NCT02152163|Assessing the efficacy of IV Ibuprofen for Treatment of Pain in Orthopedic Trauma Patients|assessing the efficacy of iv ibuprofen for treatment of pain in orthopedic trauma patients
337680|NCT02152150|iron|iron
337681|NCT02152150|anemia|anemia
337682|NCT02152150|bio-fortification|bio-fortification
337683|NCT02152150|children|children
337684|NCT02152150|India|india
337685|NCT02152124|Acromegaly|acromegaly
337686|NCT02152124|Acromegaly treatment|acromegaly treatment
337687|NCT02152124|Long-acting somatostatin analogs|long-acting somatostatin analogs
337688|NCT02152124|Pegvisomant|pegvisomant
337689|NCT02152124|Insulin sensitivity|insulin sensitivity
337690|NCT02152124|Gut hormones|gut hormones
337691|NCT02152124|Lipid metabolism|lipid metabolism
337692|NCT02152124|Adipokines|adipokines
337693|NCT02152111|Obesity|obesity
337694|NCT02152111|Coconut flour|coconut flour
337695|NCT02152111|Diet quality|diet quality
337696|NCT02152111|Cardiovascular risk factor|cardiovascular risk factor
337697|NCT02152085|Walking|walking
337698|NCT02152085|Mobility|mobility
337699|NCT02152085|Neuromuscular electrical stimulation|neuromuscular electrical stimulation
337700|NCT02152085|Multiple sclerosis|multiple sclerosis
337701|NCT02152059|Small cell lung cancer|small cell lung cancer
337702|NCT02152059|BIBF1120|bibf1120
337703|NCT02152059|nintedanib|nintedanib
337704|NCT02152059|platinum-sensitive|platinum-sensitive
337705|NCT02152033|Substance Abuse|substance abuse
337706|NCT02152033|Continuing Care|continuing care
337707|NCT02152033|Recovery|recovery
337708|NCT02152033|Substance Abuse Treatment|substance abuse treatment
337709|NCT02152033|Parent|parent
337710|NCT02152033|Family|family
337711|NCT02152033|Young Adult|young adult
337712|NCT02152007|pachyonychia congenita|pachyonychia congenita
337713|NCT02151994|BIA 5-1058|bia 5-1058
337714|NCT02151994|hypertension|hypertension
337715|NCT02151994|chronic heart failure|chronic heart failure
337716|NCT02151994|cardiovascular disorders|cardiovascular disorders
337717|NCT02151981|Advanced Non-Small Cell Lung Cancer; T790M Mutation Positive|advanced non-small cell lung cancer; t790m mutation positive
337718|NCT02151942|elective endovascular AAA repair|elective endovascular aaa repair
337719|NCT02151929|myocardial infarction|myocardial infarction
337720|NCT02151929|primary PCI|primary pci
337721|NCT02151929|stent|stent
337722|NCT02151916|dental caries|dental caries
337723|NCT02151916|early childhood caries|early childhood caries
337724|NCT02151916|topical fluorides|topical fluorides
337725|NCT02151916|fluoride varnish|fluoride varnish
337726|NCT02151903|NHL|nhl
337727|NCT02151903|Immunocytokine|immunocytokine
337728|NCT02151903|Lymphoma|lymphoma
337729|NCT02151903|Non-Hodgkin|non-hodgkin
337730|NCT02151903|B-cell|b-cell
337731|NCT02151903|IL (interleukin)|il (interleukin)
337732|NCT02151890|POF|pof
337733|NCT02151890|ESS|ess
337734|NCT02151890|stem cell|stem cell
337735|NCT02151877|Ischemia/reperfusion injury|ischemia/reperfusion injury
337736|NCT02151864|liver cancer|liver cancer
337737|NCT02151864|cirrhosis|cirrhosis
337738|NCT02151864|Child-Pugh A|child-pugh a
337739|NCT02151864|Hedgehog|hedgehog
337740|NCT02151851|Rheumatoid Arthritis|rheumatoid arthritis
337741|NCT02151851|TNFα antagonist|tnfα antagonist
337742|NCT02151851|Certolizumab Pegol|certolizumab pegol
337743|NCT02151851|Chinese patients|chinese patients
337744|NCT02151838|HIV-infected pregnant women who request HAART from the TRCSPMTCT|hiv-infected pregnant women who request haart from the trcspmtct
337745|NCT02151825|Gut microbiota|gut microbiota
337746|NCT02151825|Probiotics|probiotics
337747|NCT02151825|Prebiotics|prebiotics
337748|NCT02151825|Synbiotic|synbiotic
337749|NCT02151825|Bifidobacterium lactis BB-12|bifidobacterium lactis bb-12
337750|NCT02151825|Lactobacillus acidophilus LA-5|lactobacillus acidophilus la-5
337751|NCT02151825|Lactobacillus casei 431|lactobacillus casei 431
337752|NCT02151825|Inulin|inulin
337753|NCT02151825|GOS|gos
431684|NCT01725919|motor|motor
337754|NCT02151825|Body Weight|body weight
337755|NCT02151825|Overweight|overweight
337756|NCT02151825|Adiposity|adiposity
337757|NCT02151825|Obesity|obesity
337758|NCT02151825|ANGPTL4|angptl4
337759|NCT02151786|Pharmacological therapy|pharmacological therapy
337760|NCT02151773|Pharmacological therapy|pharmacological therapy
337761|NCT02151760|Metastatic Prostate Cancer|metastatic prostate cancer
337762|NCT02151747|breast neoplasms, BRCA1, Sanger, NGS, Next generation sequencing|breast neoplasms, brca1, sanger, ngs, next generation sequencing
337763|NCT02151721|Vorinostat|vorinostat
337764|NCT02151721|Gefitinib|gefitinib
337765|NCT02151721|BIM polymorphism|bim polymorphism
337766|NCT02151721|EGFR-TKI resistance|egfr-tki resistance
337767|NCT02151708|accommodation, emptying,motilitone|accommodation, emptying,motilitone
337768|NCT02151682|chronic pain|chronic pain
337769|NCT02151682|opioid|opioid
337770|NCT02151669|Mediterranean diet|mediterranean diet
337771|NCT02151669|Smoking/tobacco|smoking/tobacco
337772|NCT02151669|Spirometry|spirometry
337773|NCT02151656|Schizophrenia|schizophrenia
337774|NCT02151656|Mental disorders|mental disorders
337775|NCT02151656|Antipsychotic Drugs|antipsychotic drugs
337776|NCT02151643|Dialysis Dependent Chronic Kidney Disease|dialysis dependent chronic kidney disease
337777|NCT02151630|wart|wart
337778|NCT02151630|verruca vulgaris|verruca vulgaris
337779|NCT02151630|topical therapy|topical therapy
337780|NCT02151630|pyruvic acid|pyruvic acid
337781|NCT02151630|salicylic acid|salicylic acid
337782|NCT02151617|Multiple dose|multiple dose
337783|NCT02151617|safety|safety
337784|NCT02151617|tolerability|tolerability
337786|NCT02151591|Quit smoking|quit smoking
337787|NCT02151591|Quit drinking|quit drinking
337788|NCT02151578|Impact of home management of malaria and pneumonia on child mortality|impact of home management of malaria and pneumonia on child mortality
337789|NCT02151578|home management of malaria and pneumonia|home management of malaria and pneumonia
337790|NCT02151565|back pain|back pain
337791|NCT02151565|sciatica|sciatica
337792|NCT02151565|electrotherapy|electrotherapy
337793|NCT02151565|HTEMS|htems
337794|NCT02151565|TENS|tens
337795|NCT02151552|lung inflammation|lung inflammation
337796|NCT02151552|positron emission tomography|positron emission tomography
337797|NCT02151552|inducible nitric oxide synthase|inducible nitric oxide synthase
337798|NCT02151513|Cancer-associated pain|cancer-associated pain
337799|NCT02151513|Immune function|immune function
337800|NCT02151500|Medically Unexplained Symptoms (MUPS)|medically unexplained symptoms (mups)
337801|NCT02151500|Somatoform disorders|somatoform disorders
337802|NCT02151500|Chronic pain|chronic pain
337803|NCT02151500|Somatic symptoms|somatic symptoms
337804|NCT02151500|Emotional processing|emotional processing
337805|NCT02151500|Primary Care|primary care
337806|NCT02151487|Supraclavicular block|supraclavicular block
337807|NCT02151487|Ropivacaine|ropivacaine
337808|NCT02151487|Dexamethasone|dexamethasone
337809|NCT02151487|Clonidine|clonidine
337810|NCT02151487|Postoperative analgesia|postoperative analgesia
337811|NCT02151461|Diabetes|diabetes
337812|NCT02151461|Type 2 Diabetes|type 2 diabetes
337813|NCT02151435|Idiopathic Pulmonary Fibrosis|idiopathic pulmonary fibrosis
337814|NCT02151435|Biomarkers|biomarkers
337815|NCT02151435|Forced Vital Capacity|forced vital capacity
337816|NCT02151435|Diffusion Capacity for Carbon Monoxide|diffusion capacity for carbon monoxide
337817|NCT02151435|Prognosis|prognosis
337818|NCT02151422|Adults|adults
337819|NCT02151422|age 18-65|age 18-65
337820|NCT02151422|physician-diagnosed|physician-diagnosed
337821|NCT02151422|persistent asthma|persistent asthma
337822|NCT02151396|ADHD, hyperactivity, inattention, working memory|adhd, hyperactivity, inattention, working memory
337823|NCT02151383|Acute heart failure|acute heart failure
337824|NCT02151383|RELAX−AHF−PEDIATRIC PK|relax−ahf−pediatric pk
337825|NCT02151383|AHF|ahf
337826|NCT02151357|first in man|first in man
337827|NCT02151357|dose escalating|dose escalating
337828|NCT02151357|MTD|mtd
337829|NCT02151357|DLT|dlt
337830|NCT02151331|Chronic care model|chronic care model
337831|NCT02151331|Mood disorders|mood disorders
337832|NCT02151331|Adaptive implementation|adaptive implementation
337833|NCT02151279|Shrimp allergy|shrimp allergy
337834|NCT02151279|Chitosan|chitosan
337835|NCT02151279|fining agent|fining agent
337836|NCT02151266|Heart failure|heart failure
337837|NCT02151266|Exercise|exercise
337838|NCT02151266|Cognitive training|cognitive training
337839|NCT02151253|Nocturia|nocturia
337840|NCT02151253|Daytime sleepiness|daytime sleepiness
337841|NCT02151240|herpes zoster, Foscarnet Sodium, Acyclovir, Postherpetic neuralgia|herpes zoster, foscarnet sodium, acyclovir, postherpetic neuralgia
337842|NCT02151227|Meta-Analysis|meta-analysis
337843|NCT02151227|Metabolic Syndrome|metabolic syndrome
337844|NCT02151227|Magnesium|magnesium
337845|NCT02151227|Dose Response Effect|dose response effect
337846|NCT02151227|Systematic Review|systematic review
337847|NCT02151214|Palliative Phase of Cancer|palliative phase of cancer
337848|NCT02151214|Quality of life|quality of life
337849|NCT02151214|Parenteral nutrition|parenteral nutrition
337850|NCT02151214|Undernutrition|undernutrition
337851|NCT02151201|pregnancy vaccination influenza education|pregnancy vaccination influenza education
337852|NCT02151149|NSCLC advanced non-small cell lung cancer squamous adenocarcinoma large cell carcinoma lung cancer elderly first line treatment abraxane carbo nab-paclitaxel|nsclc advanced non-small cell lung cancer squamous adenocarcinoma large cell carcinoma lung cancer elderly first line treatment abraxane carbo nab-paclitaxel
337853|NCT02151136|Sucrose|sucrose
337854|NCT02151136|Pain|pain
337855|NCT02151123|Colonic Neoplasms|colonic neoplasms
337856|NCT02151123|Colon Cancer|colon cancer
337857|NCT02151123|Microbiome|microbiome
337858|NCT02151110|Healthy Male|healthy male
337859|NCT02151110|Healthy Female of non child bearing potential|healthy female of non child bearing potential
337860|NCT02151097|Prostatectomy|prostatectomy
337861|NCT02151097|Prostate cancer|prostate cancer
337862|NCT02151097|Cerenkov Luminescence Imaging|cerenkov luminescence imaging
337863|NCT02151084|randomized|randomized
337864|NCT02151084|selumetinib|selumetinib
337865|NCT02151084|tablets|tablets
337866|NCT02151084|cisplatin|cisplatin
337867|NCT02151084|gemcitabine|gemcitabine
337868|NCT02151084|non-resectable|non-resectable
337869|NCT02151084|recurrent|recurrent
337870|NCT02151084|metstatic|metstatic
337871|NCT02151071|Breast Cancer|breast cancer
337872|NCT02151071|Mastectomy, Segmental|mastectomy, segmental
337873|NCT02151071|Breast Conserving Surgery|breast conserving surgery
337874|NCT02151071|Cerenkov Luminescence Imaging|cerenkov luminescence imaging
337875|NCT02151071|Beta particle detection|beta particle detection
337876|NCT02151058|Staining|staining
337877|NCT02151058|Intensity|intensity
337878|NCT02151058|Area|area
337879|NCT02151045|Epidural infiltration of Corticoids|epidural infiltration of corticoids
337880|NCT02151045|L3-L4 stage|l3-l4 stage
337881|NCT02151045|On contact of disco radicular conflict|on contact of disco radicular conflict
337882|NCT02151045|Scan control|scan control
337883|NCT02151032|Colorectal Cancer|colorectal cancer
337884|NCT02151032|Colorectal cancer screening|colorectal cancer screening
337885|NCT02151032|Multimedia|multimedia
337886|NCT02151032|Booklet|booklet
337887|NCT02151032|Pamphlet|pamphlet
337888|NCT02151032|Audio CD|audio cd
337889|NCT02151032|Video with animated images|video with animated images
337890|NCT02151032|Video with non-moving images|video with non-moving images
337891|NCT02151032|Questionnaires|questionnaires
337892|NCT02151032|Surveys|surveys
337893|NCT02151006|DHEA|dhea
337894|NCT02151006|IVF|ivf
337895|NCT02151006|ICSI|icsi
337896|NCT02150993|Africa|africa
337897|NCT02150993|Antiretroviral Treatment|antiretroviral treatment
337898|NCT02150993|HIV-2|hiv-2
337899|NCT02150993|firsts line ART|firsts line art
337900|NCT02150993|Adults|adults
337901|NCT02150980|Fractures|fractures
337902|NCT02150980|burden of fractures|burden of fractures
337903|NCT02150980|orthopaedic fractures|orthopaedic fractures
337904|NCT02150980|orthopaedic injuries|orthopaedic injuries
337905|NCT02150980|orthopaedic trauma|orthopaedic trauma
337906|NCT02150980|observational study|observational study
337907|NCT02150980|outcomes of fracture care|outcomes of fracture care
337908|NCT02150980|epidemiology|epidemiology
337909|NCT02150967|cholangiocarcinoma,|cholangiocarcinoma,
337910|NCT02150967|FGFR2 gene fusion,|fgfr2 gene fusion,
337911|NCT02150967|FGFR genetic alteration|fgfr genetic alteration
337912|NCT02150954|induction of labor|induction of labor
337913|NCT02150954|pitocin|pitocin
337914|NCT02150954|foley bulb|foley bulb
337915|NCT02150941|Upper gastrointestinal tract|upper gastrointestinal tract
337916|NCT02150941|Endoscopy|endoscopy
337917|NCT02150941|Endoscopic Hemostasis|endoscopic hemostasis
337918|NCT02150915|Acupoints|acupoints
337919|NCT02150915|Acupuncture therapy|acupuncture therapy
337920|NCT02150915|Median nerve|median nerve
337921|NCT02150915|Biomechanics|biomechanics
337922|NCT02150902|Catheter ablation for atrial fibrillation|catheter ablation for atrial fibrillation
337923|NCT02150902|treatment for atrial fibrillation|treatment for atrial fibrillation
337924|NCT02150902|comparison of catheter ablation techniques for atrial fibrillation|comparison of catheter ablation techniques for atrial fibrillation
337925|NCT02150889|insulin resistance|insulin resistance
337926|NCT02150889|lipid metabolism|lipid metabolism
337927|NCT02150889|diabetes|diabetes
337928|NCT02150876|DES|des
337929|NCT02150876|SDF|sdf
337930|NCT02150876|MACE|mace
337931|NCT02150876|SYNERGY|synergy
337932|NCT02150863|actinic keratosis|actinic keratosis
337933|NCT02150863|field cancerization|field cancerization
337934|NCT02150863|organ transplant patients|organ transplant patients
337935|NCT02150850|Femoral Fractures|femoral fractures
337936|NCT02150850|Subtrochanteric Fractures|subtrochanteric fractures
337937|NCT02150850|Osteoporotic Fractures|osteoporotic fractures
337938|NCT02150850|Fractures, Spontaneous|fractures, spontaneous
337939|NCT02150850|Stress Fractures|stress fractures
337940|NCT02150850|Bone Fractures|bone fractures
337941|NCT02150850|Hip Fractures|hip fractures
337942|NCT02150850|Osteoporosis|osteoporosis
337943|NCT02150837|Obesity|obesity
337944|NCT02150837|Weight Loss|weight loss
337945|NCT02150837|Meal replacements|meal replacements
337946|NCT02150837|Weight maintenance|weight maintenance
338145|NCT02149901|Osmopressor|osmopressor
337947|NCT02150798|Diet Therapy|diet therapy
337948|NCT02150798|Diet, Carbohydrate Restricted|diet, carbohydrate restricted
337949|NCT02150798|Fatty Acids, Omega 3|fatty acids, omega 3
337950|NCT02150798|Oximetry|oximetry
337951|NCT02150798|phase angle|phase angle
337952|NCT02150798|Triglycerides, blood|triglycerides, blood
337953|NCT02150798|Lipids, blood|lipids, blood
337954|NCT02150798|Hand Strength|hand strength
337955|NCT02150798|Body Composition|body composition
337956|NCT02150798|Electric Impedance|electric impedance
337957|NCT02150785|Thrombolysis|thrombolysis
337958|NCT02150785|Safety of Streptokinase|safety of streptokinase
337959|NCT02150785|tissue plasminogen activator tPA|tissue plasminogen activator tpa
337960|NCT02150785|Stroke treatment|stroke treatment
337961|NCT02150759|Dexmedetomidine|dexmedetomidine
337962|NCT02150759|Ketamine|ketamine
337963|NCT02150759|Pain|pain
337964|NCT02150746|Pancreatic ductal adenocarcinoma|pancreatic ductal adenocarcinoma
337965|NCT02150746|Pancreatic cancer|pancreatic cancer
337966|NCT02150746|PDAC|pdac
337967|NCT02150746|Circulating tumor cells|circulating tumor cells
337968|NCT02150720|Hip fractures|hip fractures
337969|NCT02150720|Clinical Trial|clinical trial
337970|NCT02150720|Randomized|randomized
337971|NCT02150720|Fibrin glue|fibrin glue
337972|NCT02150720|Tranexamic acid|tranexamic acid
337973|NCT02150720|Blood loss|blood loss
337974|NCT02150681|preconception|preconception
337975|NCT02150681|pregnancy|pregnancy
337976|NCT02150681|postpartum|postpartum
337977|NCT02150681|women|women
337978|NCT02150668|ADHD|adhd
337979|NCT02150668|Homework|homework
337980|NCT02150668|School|school
337981|NCT02150668|Organization|organization
337982|NCT02150668|Time-management|time-management
337983|NCT02150616|Pulmonary hypertension|pulmonary hypertension
337984|NCT02150616|Interstitial lung disease|interstitial lung disease
337985|NCT02150616|Pulmonary fibrosis|pulmonary fibrosis
337986|NCT02150603|Heart defects, congenital|heart defects, congenital
337987|NCT02150603|Patient-reported outcomes|patient-reported outcomes
337988|NCT02150603|Health status|health status
337989|NCT02150603|Factors, psychosocial|factors, psychosocial
337990|NCT02150603|Health behavior|health behavior
337991|NCT02150603|Quality of life|quality of life
337992|NCT02150603|Sense of coherence|sense of coherence
337993|NCT02150603|Illness perceptions|illness perceptions
337994|NCT02150603|Depression|depression
337995|NCT02150603|Anxiety|anxiety
337996|NCT02150590|airway disease|airway disease
337997|NCT02150590|bronchitis|bronchitis
337998|NCT02150590|emphysema|emphysema
337999|NCT02150590|lung|lung
338000|NCT02150577|Screening|screening
338001|NCT02150577|Mood Stabilizers|mood stabilizers
338002|NCT02150577|Computer delivered psychotherapy|computer delivered psychotherapy
338003|NCT02150577|Peer Support|peer support
338004|NCT02150577|Telepsychiatry|telepsychiatry
338005|NCT02150577|Implementation|implementation
338006|NCT02150577|Rural|rural
338007|NCT02150564|Malignant gliomas|malignant gliomas
338008|NCT02150564|Sono RCT|sono rct
338009|NCT02150551|Crohn disease|crohn disease
338010|NCT02150551|ulcerative colitis|ulcerative colitis
338011|NCT02150551|mesenchymal stromal cells|mesenchymal stromal cells
338012|NCT02150551|inflammatory bowel diseases|inflammatory bowel diseases
338013|NCT02150538|Cardiac Resynchronization therapy|cardiac resynchronization therapy
338014|NCT02150538|Minimized Right ventricular pacing|minimized right ventricular pacing
338015|NCT02150538|Prolonged AV conduction|prolonged av conduction
338016|NCT02150525|breast cancer|breast cancer
338017|NCT02150525|vaginal dryness|vaginal dryness
338018|NCT02150525|dyspareunia|dyspareunia
338019|NCT02150525|genital irritation|genital irritation
338020|NCT02150512|Septic shock|septic shock
338021|NCT02150512|Critically ill patients|critically ill patients
338022|NCT02150512|Transpulmonary thermodilution|transpulmonary thermodilution
338023|NCT02150512|Fluid resuscitation|fluid resuscitation
338024|NCT02150499|Acute Asthma exacerbation|acute asthma exacerbation
338025|NCT02150473|rheumatoid Arthritis|rheumatoid arthritis
338026|NCT02150460|ophthalmic surgery, peribulbar local anaesthesia|ophthalmic surgery, peribulbar local anaesthesia
338027|NCT02150447|Gastric cancer bleeding|gastric cancer bleeding
338028|NCT02150447|Proton pump inhibitor|proton pump inhibitor
338029|NCT02150434|Oxygen therapy|oxygen therapy
338030|NCT02150434|Hypoxemia|hypoxemia
338031|NCT02150434|COPD|copd
338032|NCT02150434|Closed-loop|closed-loop
338033|NCT02150434|Automated titration,|automated titration,
338034|NCT02150382|hypertension|hypertension
338035|NCT02150382|rural|rural
338036|NCT02150382|China|china
338037|NCT02150382|protocol-based treatment|protocol-based treatment
338038|NCT02150343|Cat allergy|cat allergy
338039|NCT02150343|Rhinoconjunctivitis|rhinoconjunctivitis
338040|NCT02150330|Dehydroepiandrosterone|dehydroepiandrosterone
338041|NCT02150330|DHEAS|dheas
338042|NCT02150330|Gene expression of cumulus cells.|gene expression of cumulus cells.
338043|NCT02150330|Folliculogenesis.|folliculogenesis.
338044|NCT02150330|Oocyte maturation.|oocyte maturation.
338045|NCT02150330|Ovarian hyper-stimulation protocol.|ovarian hyper-stimulation protocol.
338146|NCT02149888|HIV|hiv
338046|NCT02150330|Artificial reproduction technology.|artificial reproduction technology.
338047|NCT02150317|Carcinoma, Hepatocellular|carcinoma, hepatocellular
338048|NCT02150317|Chemoembolization, Therapeutic|chemoembolization, therapeutic
338049|NCT02150317|Sorafenib|sorafenib
338050|NCT02150278|Driving|driving
338051|NCT02150278|Alcohol consumption|alcohol consumption
338052|NCT02150278|Risk perception|risk perception
338053|NCT02150252|Clinical trial|clinical trial
338054|NCT02150252|Ischemic stroke|ischemic stroke
338055|NCT02150252|Bu-Yang-Huan-Wu Tang (BYHWT）|bu-yang-huan-wu tang (byhwt）
338056|NCT02150252|Gait parameter|gait parameter
338057|NCT02150252|Quality of life|quality of life
338058|NCT02150239|pain|pain
338059|NCT02150239|postoperative|postoperative
338060|NCT02150213|Adrenocortical Adenoma,|adrenocortical adenoma,
338061|NCT02150213|Endometrial Stromal sarcomas|endometrial stromal sarcomas
338062|NCT02150213|BGG492|bgg492
338063|NCT02150187|Androgenetic Alopecia|androgenetic alopecia
338064|NCT02150187|Male|male
338065|NCT02150187|Baldness|baldness
338066|NCT02150187|hair loss pattern|hair loss pattern
338067|NCT02150174|Schizophrenia|schizophrenia
338068|NCT02150174|Episodic memory deficits|episodic memory deficits
338069|NCT02150148|breast cancer|breast cancer
338070|NCT02150148|prostate cancer|prostate cancer
338071|NCT02150148|colorectal cancer|colorectal cancer
338072|NCT02150148|small intestine cancer|small intestine cancer
338073|NCT02150148|thyroid cancer|thyroid cancer
338074|NCT02150148|Hodgkin lymphoma|hodgkin lymphoma
338075|NCT02150148|non-Hodgkin lymphoma|non-hodgkin lymphoma
338076|NCT02150148|endometrial cancer|endometrial cancer
338077|NCT02150148|kidney cancer|kidney cancer
338078|NCT02150148|cervical cancer|cervical cancer
338079|NCT02150148|diet|diet
338080|NCT02150148|exercise|exercise
338081|NCT02150148|physical activity|physical activity
338082|NCT02150148|garden|garden
338083|NCT02150135|Pancreatic cancer|pancreatic cancer
338084|NCT02150135|Quality of life|quality of life
338085|NCT02150135|Pain|pain
338086|NCT02150122|Vitamin D|vitamin d
338087|NCT02150122|Serum 25-hydroxyvitamin D (25OHD)|serum 25-hydroxyvitamin d (25ohd)
338088|NCT02150122|Adolescents|adolescents
338089|NCT02150096|chronic non-specific low back pain|chronic non-specific low back pain
338090|NCT02150096|clinical trial|clinical trial
338091|NCT02150096|disability|disability
338092|NCT02150096|women|women
338093|NCT02150083|midurethral sling|midurethral sling
338094|NCT02150083|voiding study|voiding study
338095|NCT02150083|voiding trial|voiding trial
338096|NCT02150083|retrograde voiding trial|retrograde voiding trial
338097|NCT02150070|Healthy subjects|healthy subjects
338098|NCT02150070|ASP2408|asp2408
338099|NCT02150070|Rheumatoid arthritis|rheumatoid arthritis
338100|NCT02150070|Safety and Tolerability|safety and tolerability
338101|NCT02150070|Pharmacokinetics|pharmacokinetics
338102|NCT02150057|knee osteoarthritis unicompartmental unloading brace|knee osteoarthritis unicompartmental unloading brace
338103|NCT02150031|prevention and control|prevention and control
338104|NCT02150031|chlorhexidine|chlorhexidine
338105|NCT02150031|therapeutic irrigation|therapeutic irrigation
338106|NCT02150031|mouthwashes|mouthwashes
338107|NCT02150031|culture|culture
338108|NCT02150018|- Critical Care|- critical care
338109|NCT02150018|Non invasive ventilation|non invasive ventilation
338110|NCT02150018|Electrical impedance tomography|electrical impedance tomography
338111|NCT02150018|End expiratory lung volume|end expiratory lung volume
338112|NCT02150018|End expiratory lung impedance|end expiratory lung impedance
338113|NCT02150005|periodontal diseases|periodontal diseases
338114|NCT02150005|cardiovascular diseases|cardiovascular diseases
338115|NCT02150005|periodontitis treatment|periodontitis treatment
338116|NCT02149992|gestational diabetes|gestational diabetes
338117|NCT02149992|myoinositol|myoinositol
338118|NCT02149979|Incision|incision
338119|NCT02149979|Wound Closure|wound closure
338120|NCT02149979|Laser Tissue Soldering|laser tissue soldering
338121|NCT02149966|safety and tolerability|safety and tolerability
338122|NCT02149966|pharmacokinetic study|pharmacokinetic study
338123|NCT02149953|Pregnancy|pregnancy
338124|NCT02149953|Glycine requirements|glycine requirements
338125|NCT02149953|Indicator Amino Acid Oxidation (IAAO) method|indicator amino acid oxidation (iaao) method
338126|NCT02149953|Stable isotopes|stable isotopes
338127|NCT02149940|Elderly|elderly
338128|NCT02149940|Frailty|frailty
338129|NCT02149940|Polypharmacy|polypharmacy
338130|NCT02149940|Medication review|medication review
338131|NCT02149940|Clinical pharmacy services|clinical pharmacy services
338132|NCT02149927|EEG|eeg
338133|NCT02149927|fMRI|fmri
338134|NCT02149927|connectivity|connectivity
338135|NCT02149927|sevoflurane|sevoflurane
338136|NCT02149914|Ryodoraku|ryodoraku
774377|NCT00351936|Obesity|obesity
338137|NCT02149914|Meridian energy|meridian energy
338138|NCT02149914|Heart rate variability|heart rate variability
338139|NCT02149914|Autonomic Nervous System|autonomic nervous system
338140|NCT02149914|GERD|gerd
338141|NCT02149901|Pure Autonomic Failure|pure autonomic failure
338142|NCT02149901|Multiple System Atrophy|multiple system atrophy
338143|NCT02149901|Pseudoephedrine|pseudoephedrine
338144|NCT02149901|Water|water
338147|NCT02149888|Pre-Exposure Prophylaxis|pre-exposure prophylaxis
338148|NCT02149888|PrEP|prep
338149|NCT02149888|Human Immunodeficiency Virus|human immunodeficiency virus
338150|NCT02149875|Acute ischemic stroke|acute ischemic stroke
338151|NCT02149875|Dl-3-n-butylphthalide|dl-3-n-butylphthalide
338152|NCT02149875|Cerebrolysin|cerebrolysin
338153|NCT02149862|Bladder cancer|bladder cancer
338154|NCT02149862|Diagnostic|diagnostic
338155|NCT02149862|Infrared|infrared
338156|NCT02149862|Spectrum|spectrum
338157|NCT02149862|Urina|urina
338158|NCT02149862|Patients with an indication of partial or total bladder resection|patients with an indication of partial or total bladder resection
338159|NCT02149862|or|or
338160|NCT02149862|"Lithiasic patients should be operated a urinary calculation, without catheter double J"|"lithiasic patients should be operated a urinary calculation, without catheter double j"
338161|NCT02149849|Ipsilateral shoulder pain|ipsilateral shoulder pain
338162|NCT02149849|Surgical positioning|surgical positioning
338163|NCT02149849|Lung cancer|lung cancer
338164|NCT02149849|Thoracotomy|thoracotomy
338165|NCT02149849|Video assisted thoracic surgery|video assisted thoracic surgery
338166|NCT02149836|major depressive disorder|major depressive disorder
338167|NCT02149836|depression|depression
338168|NCT02149836|treatment resistent depression|treatment resistent depression
338169|NCT02149823|Oxytocin, Social Cognition|oxytocin, social cognition
338170|NCT02149823|Borderline Personality Disorder|borderline personality disorder
338171|NCT02149823|Schizotypal Personality Disorder|schizotypal personality disorder
338172|NCT02149823|Social Cognition|social cognition
338173|NCT02149823|BPD|bpd
338174|NCT02149823|SPD|spd
338175|NCT02149823|MASC|masc
338176|NCT02149823|Autism Spectrum Disorder|autism spectrum disorder
338177|NCT02149823|Schizophrenia|schizophrenia
338178|NCT02149823|Schizoaffective Disorder|schizoaffective disorder
338179|NCT02149823|Bipolar Disorder|bipolar disorder
338180|NCT02149810|MDD|mdd
338181|NCT02149784|Metastasis colorectal cancer|metastasis colorectal cancer
338182|NCT02149784|Chemotherapy|chemotherapy
338183|NCT02149784|Resection of primary tumor|resection of primary tumor
338184|NCT02149771|hepatocellular carcinoma|hepatocellular carcinoma
338185|NCT02149771|portal vein tumor thrombosis|portal vein tumor thrombosis
338186|NCT02149771|stents|stents
338187|NCT02149771|chemoembolization|chemoembolization
338188|NCT02149758|Cyclooxygenase two inhibitors|cyclooxygenase two inhibitors
338189|NCT02149758|Etoricoxib|etoricoxib
338190|NCT02149758|Periodontitis|periodontitis
338191|NCT02149758|Superoxide dismutase|superoxide dismutase
338192|NCT02149758|Saliva|saliva
338193|NCT02149732|Limbal stem cell deficiency|limbal stem cell deficiency
338194|NCT02149732|Cultivated oral mucosal cell sheet transplantation|cultivated oral mucosal cell sheet transplantation
338195|NCT02149732|Ocular surface reconstruction|ocular surface reconstruction
338196|NCT02149719|Peanut allergy|peanut allergy
338197|NCT02149719|Desensitisation|desensitisation
338198|NCT02149719|Safety|safety
338199|NCT02149706|Secondary Progress Multiple Sclerosis|secondary progress multiple sclerosis
338200|NCT02149706|SPMS|spms
338201|NCT02149706|Multiple Sclerosis|multiple sclerosis
338202|NCT02149706|NeuroVax|neurovax
338203|NCT02149693|Flipped classroom|flipped classroom
338204|NCT02149693|High-fidelity simulation|high-fidelity simulation
338205|NCT02149693|Medical education reform|medical education reform
338206|NCT02149693|Medical teamwork|medical teamwork
338207|NCT02149693|Resuscitation training|resuscitation training
338208|NCT02149680|Post-dural puncture headache|post-dural puncture headache
338209|NCT02149680|epidural blood patch|epidural blood patch
338210|NCT02149680|labour analgesia|labour analgesia
338211|NCT02149680|epidural analgesia|epidural analgesia
338212|NCT02149667|osteoarthritis|osteoarthritis
338213|NCT02149667|avascular necrosis|avascular necrosis
338214|NCT02149667|ankylosis|ankylosis
338215|NCT02149667|protrusio acetabuli|protrusio acetabuli
338216|NCT02149667|painful hip dysplasia|painful hip dysplasia
338217|NCT02149667|rheumatoid arthritis|rheumatoid arthritis
338218|NCT02149667|correction of functional deformity|correction of functional deformity
338219|NCT02149667|revision procedures|revision procedures
338220|NCT02149654|Transcatheter aortic valve implantation|transcatheter aortic valve implantation
338221|NCT02149654|Transcatheter aortic valve replacement|transcatheter aortic valve replacement
338222|NCT02149654|Engager transcatheter aortic valve implantation system|engager transcatheter aortic valve implantation system
338223|NCT02149654|Engager bioprosthesis|engager bioprosthesis
338224|NCT02149615|idiopathic intracranial hypertension|idiopathic intracranial hypertension
338225|NCT02149615|optic disc swelling|optic disc swelling
338226|NCT02149615|antiacne medication|antiacne medication
338227|NCT02149615|isotretinoin|isotretinoin
338228|NCT02149602|involvement of bilateral parapharyngeal spaces|involvement of bilateral parapharyngeal spaces
338229|NCT02149589|ARDS|ards
338230|NCT02149589|PEEP|peep
338231|NCT02149589|Recruitment manoeuvres|recruitment manoeuvres
338232|NCT02149589|Lung Morphology|lung morphology
338233|NCT02149576|Retrospective Review|retrospective review
338234|NCT02149576|Pilot Study|pilot study
338235|NCT02149576|Early Stage NSCLC|early stage nsclc
338236|NCT02149576|Post-Surgical Surveillance|post-surgical surveillance
338237|NCT02149576|Re-intervention Rates|re-intervention rates
338238|NCT02149550|Plasmodium falciparum|plasmodium falciparum
338239|NCT02149550|malaria|malaria
338240|NCT02149537|sickle cell disease|sickle cell disease
338241|NCT02149537|sickle cell anemia|sickle cell anemia
338242|NCT02149537|hydroxyurea|hydroxyurea
338243|NCT02149537|Nigeria|nigeria
338244|NCT02149537|low income country|low income country
338245|NCT02149537|middle income country|middle income country
338246|NCT02149537|developing country|developing country
338247|NCT02149524|HER2 Positive Breast Cancer|her2 positive breast cancer
338248|NCT02149524|Trastuzumab|trastuzumab
338249|NCT02149524|Biosimilar|biosimilar
338250|NCT02149498|Parkinson|parkinson
338251|NCT02149498|EEG|eeg
338252|NCT02149498|BNA|bna
338253|NCT02149485|PGD,|pgd,
338254|NCT02149485|follow up|follow up
338255|NCT02149459|Radiotherapy|radiotherapy
338256|NCT02149459|Ketosis|ketosis
338257|NCT02149459|Metformin|metformin
338258|NCT02149459|Magnetic Resonance Imaging|magnetic resonance imaging
338259|NCT02149459|Metabolome|metabolome
338260|NCT02149459|Insulin|insulin
338261|NCT02149459|recurrent brain tumors|recurrent brain tumors
338262|NCT02149459|gliomas|gliomas
338263|NCT02149459|glioblastomas|glioblastomas
338264|NCT02149459|astrocytomas|astrocytomas
338265|NCT02149446|Left sided pancreatic resections|left sided pancreatic resections
338266|NCT02149446|Distal pancreatic resections|distal pancreatic resections
338267|NCT02149446|Reinforced staple line|reinforced staple line
338268|NCT02149446|Post operative pancreatic fistula|post operative pancreatic fistula
338269|NCT02149433|Pneumocystis Jiroveci|pneumocystis jiroveci
338270|NCT02149433|Steroids|steroids
338271|NCT02149433|Infants|infants
338272|NCT02149420|primary Sjögren's syndrome, pharmacodynamics|primary sjögren's syndrome, pharmacodynamics
338273|NCT02149394|Thirst|thirst
338274|NCT02149394|Ice|ice
338275|NCT02149394|Water|water
338276|NCT02149394|Perioperative Nursing|perioperative nursing
338277|NCT02149394|Recovery Room|recovery room
338278|NCT02149381|Depression|depression
338279|NCT02149381|treatment as usual|treatment as usual
338280|NCT02149381|CBASP|cbasp
338281|NCT02149381|befriending|befriending
338282|NCT02149355|teeth position|teeth position
338283|NCT02149355|jaw alignment|jaw alignment
338284|NCT02149342|Actinic keratoses|actinic keratoses
338285|NCT02149342|Daylight-PDT|daylight-pdt
338286|NCT02149342|Hexylaminolaevulinate|hexylaminolaevulinate
338287|NCT02149342|HAL|hal
338288|NCT02149342|Methylaminolaevulinate|methylaminolaevulinate
338289|NCT02149342|MAL|mal
338290|NCT02149342|Hyperspectral imaging|hyperspectral imaging
338291|NCT02149329|fever|fever
338292|NCT02149329|neutropenia|neutropenia
338293|NCT02149329|febrile neutropenia|febrile neutropenia
338294|NCT02149329|carbapenem|carbapenem
338295|NCT02149329|imipenem|imipenem
338296|NCT02149329|meropenem|meropenem
338297|NCT02149329|antibiotic stewardship|antibiotic stewardship
338298|NCT02149329|hematology|hematology
338299|NCT02149329|oncology|oncology
338300|NCT02149290|Heart Failure|heart failure
338301|NCT02149290|Six minute walk test|six minute walk test
338302|NCT02149277|Infertility|infertility
338303|NCT02149277|IVF|ivf
338304|NCT02149277|Embryo transfer|embryo transfer
338305|NCT02149251|Pre-genetic diagnosis|pre-genetic diagnosis
338306|NCT02149251|ICSI|icsi
338307|NCT02149238|flavanols|flavanols
338308|NCT02149238|cardiovascular effects|cardiovascular effects
338309|NCT02149238|nutrition-nutrition interaction|nutrition-nutrition interaction
338310|NCT02149225|Actively personalized peptide vaccinations|actively personalized peptide vaccinations
338311|NCT02149225|Newly diagnosed Glioblastoma|newly diagnosed glioblastoma
338312|NCT02149225|Concurrent to first line temozolomide maintenance therapy|concurrent to first line temozolomide maintenance therapy
338313|NCT02149212|Iliac|iliac
338314|NCT02149212|Vein|vein
338315|NCT02149212|Stent|stent
338316|NCT02149160|Histone deacetylase inhibitor|histone deacetylase inhibitor
338317|NCT02149160|Frontotemporal dementia|frontotemporal dementia
338318|NCT02149160|Granulin|granulin
338319|NCT02149147|physical activity|physical activity
338320|NCT02149147|environmental factors|environmental factors
338321|NCT02149147|variety|variety
338322|NCT02149147|MVPA|mvpa
338323|NCT02149095|treprostinil|treprostinil
338324|NCT02149082|Intracranial hematoma|intracranial hematoma
338325|NCT02149082|traumatic brain injury|traumatic brain injury
338326|NCT02149082|Near infrared spectroscopy|near infrared spectroscopy
338327|NCT02149082|NIRS|nirs
712554|NCT00579709|DiGeorge Anomaly|digeorge anomaly
338328|NCT02149056|Platelets/Lymphocytes Rate;Serological Index;|platelets/lymphocytes rate;serological index;
338329|NCT02149043|Inflammatory bowel disease|inflammatory bowel disease
338330|NCT02149043|Ulcerative Colitis|ulcerative colitis
338331|NCT02149043|Thermography|thermography
338332|NCT02149043|Endoscopy|endoscopy
338333|NCT02149043|CRP|crp
338334|NCT02149043|Fecal Calprotectin|fecal calprotectin
338335|NCT02149017|amyloid plaque|amyloid plaque
338336|NCT02149017|Positron-Emission Tomography|positron-emission tomography
338337|NCT02149017|radiopharmaceuticals|radiopharmaceuticals
338338|NCT02149004|Human immunodeficiency virus (HIV)|human immunodeficiency virus (hiv)
338339|NCT02149004|Prevention|prevention
338340|NCT02149004|Long-term life|long-term life
338341|NCT02149004|Cure|cure
338342|NCT02149004|Cohort|cohort
338343|NCT02148965|motor activity|motor activity
338344|NCT02148965|clinical trials|clinical trials
338345|NCT02148965|pregnancy|pregnancy
338346|NCT02148965|hypertension|hypertension
338347|NCT02148965|cohort studies|cohort studies
338348|NCT02148952|Maternal Health|maternal health
338349|NCT02148952|Maternal Death|maternal death
338350|NCT02148952|Maternal Morbidity|maternal morbidity
338351|NCT02148952|Stillbirth|stillbirth
338352|NCT02148952|Neonatal Mortality|neonatal mortality
338353|NCT02148952|Quality Improvement|quality improvement
338354|NCT02148952|Resource Limited Settings|resource limited settings
338355|NCT02148952|Checklist|checklist
338356|NCT02148952|Safe Childbirth|safe childbirth
338357|NCT02148939|ischemic stroke|ischemic stroke
338358|NCT02148939|Antiplatelet Effects|antiplatelet effects
338359|NCT02148939|aspirin|aspirin
338360|NCT02148939|metamizole|metamizole
338361|NCT02148939|dipyrone|dipyrone
338362|NCT02148900|Marfan syndrome|marfan syndrome
338363|NCT02148900|blood test|blood test
338364|NCT02148900|aortic root size|aortic root size
338365|NCT02148900|Marfan related disorders|marfan related disorders
338366|NCT02148874|pregnant|pregnant
338367|NCT02148874|flu shot|flu shot
338368|NCT02148874|influenza|influenza
338369|NCT02148874|vaccine|vaccine
338370|NCT02148848|Osteoporosis|osteoporosis
338371|NCT02148848|Femoral neck fracture|femoral neck fracture
338372|NCT02148848|hemiarthroplasty|hemiarthroplasty
338373|NCT02148835|Omega-3 Index|omega-3 index
338374|NCT02148835|Bioavailability|bioavailability
338375|NCT02148835|Eicosapentaenoic acid|eicosapentaenoic acid
338376|NCT02148835|Docosahexaenoic acid|docosahexaenoic acid
338377|NCT02148835|Fortified food|fortified food
338378|NCT02148822|Visceral leishmaniasis|visceral leishmaniasis
338379|NCT02148822|kala azar|kala azar
338380|NCT02148822|malnutrition|malnutrition
338381|NCT02148822|stunting|stunting
338382|NCT02148822|thinness|thinness
338383|NCT02148822|Leishmania donovani|leishmania donovani
338384|NCT02148796|Wheezing|wheezing
338385|NCT02148796|Lower respiratory tract illness|lower respiratory tract illness
338386|NCT02148796|Asthma|asthma
338387|NCT02148796|Atopy|atopy
338388|NCT02148783|Traumatic brain injury|traumatic brain injury
338389|NCT02148783|Attention deficit and memory problems|attention deficit and memory problems
338390|NCT02148783|Methylphenidate|methylphenidate
338391|NCT02148783|Dopamine receptor imaging|dopamine receptor imaging
338392|NCT02148783|Motivation and reward|motivation and reward
338393|NCT02148783|Positron emission tomography|positron emission tomography
338394|NCT02148783|Transcranial magnetic stimulation|transcranial magnetic stimulation
338395|NCT02148770|rt-fmri|rt-fmri
338396|NCT02148770|self-control|self-control
338397|NCT02148770|eating behaviour|eating behaviour
338398|NCT02148770|overweight|overweight
338399|NCT02148770|neurofeedback|neurofeedback
338400|NCT02148757|DVT|dvt
338401|NCT02148731|Colon cancer|colon cancer
338402|NCT02148731|Elderly patients|elderly patients
338403|NCT02148718|Crohn's Disease|crohn's disease
338404|NCT02148705|fire/flame|fire/flame
338405|NCT02148705|scalds|scalds
338406|NCT02148705|contact|contact
338407|NCT02148679|Heart Failure|heart failure
338408|NCT02148679|Diet|diet
338409|NCT02148653|Cardiometabolic risk|cardiometabolic risk
338410|NCT02148653|Diet|diet
338411|NCT02148653|Dietary prevention|dietary prevention
338412|NCT02148653|Functional diet|functional diet
338413|NCT02148653|Functional foods|functional foods
338414|NCT02148653|Metabolic Syndrome|metabolic syndrome
338415|NCT02148653|Overweight|overweight
338416|NCT02148627|antibody|antibody
338417|NCT02148627|autoimmune|autoimmune
338418|NCT02148601|Fecal microbiota transplantation|fecal microbiota transplantation
338419|NCT02148601|Recurrent C. difficile infection|recurrent c. difficile infection
338420|NCT02148601|Colonoscopy|colonoscopy
338421|NCT02148601|Randomized clinical trial|randomized clinical trial
338422|NCT02148588|Central Post Stroke Pain|central post stroke pain
338423|NCT02148588|Nerve block|nerve block
338424|NCT02148575|Palliative Care|palliative care
338425|NCT02148575|Self-management|self-management
338426|NCT02148575|Breast Cancer|breast cancer
338427|NCT02148549|Borderline resectable pancreatic cancer|borderline resectable pancreatic cancer
338428|NCT02148549|R0 resection|r0 resection
338429|NCT02148549|Resection rate|resection rate
338430|NCT02148549|Optimal schedule|optimal schedule
338431|NCT02148523|Medication Adherence|medication adherence
338432|NCT02148523|High Blood Pressure|high blood pressure
338433|NCT02148523|Diabetes|diabetes
338434|NCT02148523|Statins|statins
338435|NCT02148510|human|human
338436|NCT02148510|sleep apnea|sleep apnea
338437|NCT02148510|adults|adults
338438|NCT02148510|oral appliance|oral appliance
338439|NCT02148510|efficacy|efficacy
338440|NCT02148510|safety|safety
338441|NCT02148510|polygraphy|polygraphy
338442|NCT02148510|bruxism|bruxism
338443|NCT02148510|cost|cost
338444|NCT02148497|volunteers|volunteers
338445|NCT02148484|PTSD|ptsd
338446|NCT02148484|Cognitive Behavioral Treatment|cognitive behavioral treatment
338447|NCT02148484|Child Sexual Abuse|child sexual abuse
338448|NCT02148471|Nonalcoholic fatty liver disease|nonalcoholic fatty liver disease
338449|NCT02148471|Steatosis|steatosis
338450|NCT02148471|Nonalcoholic steatohepatitis|nonalcoholic steatohepatitis
338451|NCT02148458|Intermittent fasting|intermittent fasting
338452|NCT02148458|Mediterranean diet|mediterranean diet
338453|NCT02148458|overweight|overweight
338454|NCT02148458|Calorie restriction|calorie restriction
338455|NCT02148445|smoking cessation|smoking cessation
338456|NCT02148445|tobacco use cessation products|tobacco use cessation products
338457|NCT02148445|nicotine|nicotine
338458|NCT02148432|sleep apnea syndrome, fiberoptic bronchoscopy, IV sedation|sleep apnea syndrome, fiberoptic bronchoscopy, iv sedation
338459|NCT02148419|quality of life|quality of life
338460|NCT02148419|maltreatment|maltreatment
338461|NCT02148419|neglect|neglect
338462|NCT02148419|childhood|childhood
338463|NCT02148406|Yoga|yoga
338464|NCT02148406|Mind-body therapies|mind-body therapies
338465|NCT02148406|Fatigue|fatigue
338466|NCT02148406|Colorectal cancer|colorectal cancer
338467|NCT02148406|Depressive symptoms|depressive symptoms
338468|NCT02148380|Lung adenocarcinoma,EGFR mutation, chemotherapy, gefitinib|lung adenocarcinoma,egfr mutation, chemotherapy, gefitinib
338469|NCT02148367|Traumatic brain injury|traumatic brain injury
338470|NCT02148367|Endothelial progenitor cells|endothelial progenitor cells
338471|NCT02148367|Cerebrovascular reactivity|cerebrovascular reactivity
338472|NCT02148367|Angiogenesis|angiogenesis
338473|NCT02148354|Depression|depression
338474|NCT02148354|Self-applied treatment|self-applied treatment
338475|NCT02148354|Internet|internet
338476|NCT02148354|Support by the therapist|support by the therapist
338477|NCT02148354|Cognitive-Behavioural Treatment|cognitive-behavioural treatment
338478|NCT02148354|Positive Psychology|positive psychology
338479|NCT02148354|Behavioral Activation|behavioral activation
338480|NCT02148328|Healthy participants|healthy participants
338481|NCT02148328|Immunogenicity|immunogenicity
338482|NCT02148328|Influenza|influenza
338483|NCT02148328|Prevention|prevention
338484|NCT02148328|Safety|safety
338485|NCT02148315|physical activity|physical activity
338486|NCT02148315|children|children
338487|NCT02148315|school|school
338488|NCT02148315|garden|garden
338489|NCT02148302|Venous Leg Ulcerations|venous leg ulcerations
338490|NCT02148302|Epidermal Grafts|epidermal grafts
338491|NCT02148302|Chronic wounds|chronic wounds
338492|NCT02148302|Clinical trial|clinical trial
338493|NCT02148302|Protease levels in chronic wounds|protease levels in chronic wounds
338494|NCT02148289|COPD, beetroot, dietary nitrate, nitric oxide|copd, beetroot, dietary nitrate, nitric oxide
338495|NCT02148276|Social harm detection|social harm detection
338496|NCT02148276|Instrument development|instrument development
338497|NCT02148276|HIV-related clinical trials|hiv-related clinical trials
338498|NCT02148276|Substance abuse|substance abuse
338499|NCT02148276|Research participation|research participation
338500|NCT02148263|Contact Lenses|contact lenses
338501|NCT02148263|Neophytes|neophytes
338502|NCT02148263|Contact Lens Adaptation|contact lens adaptation
338503|NCT02148263|Randomized|randomized
338504|NCT02148250|Type 2 diabetes|type 2 diabetes
338505|NCT02148250|Insulin resistance|insulin resistance
338506|NCT02148250|High insulin requirements|high insulin requirements
338508|NCT02148237|Breastfeeding duration|breastfeeding duration
338509|NCT02148237|Puerto Rican mothers|puerto rican mothers
338510|NCT02148237|WIC program|wic program
338511|NCT02148237|Home-based individual breastfeeding consultation|home-based individual breastfeeding consultation
338512|NCT02148224|glycemic index|glycemic index
338513|NCT02148224|body composition|body composition
338514|NCT02148211|Fluarix Quadrivalent|fluarix quadrivalent
338515|NCT02148211|Fluarix|fluarix
338516|NCT02148211|FluLaval|flulaval
338517|NCT02148211|FluLaval Quadrivalent|flulaval quadrivalent
338518|NCT02148211|Pregnancy Registry|pregnancy registry
338519|NCT02148211|Pregnancy outcome|pregnancy outcome
338520|NCT02148185|Crohn's disease|crohn's disease
338521|NCT02148172|Knee|knee
338522|NCT02148172|plyometrics|plyometrics
338523|NCT02148172|motor learning|motor learning
338524|NCT02148172|psychological factors|psychological factors
338525|NCT02148159|anorexia|anorexia
338526|NCT02148159|cachexia|cachexia
338527|NCT02148159|cancer|cancer
338528|NCT02148159|unintentional weigh loss|unintentional weigh loss
338529|NCT02148159|gastrointestinal tract|gastrointestinal tract
338530|NCT02148159|adults|adults
338531|NCT02148146|short bowel syndrome|short bowel syndrome
338532|NCT02148146|intestinal failure|intestinal failure
338533|NCT02148146|total parenteral nutrition associated cholestasis|total parenteral nutrition associated cholestasis
338534|NCT02148133|Eltrombopag|eltrombopag
338535|NCT02148133|Aplastic Anemia (AA)|aplastic anemia (aa)
338536|NCT02148133|Thrombocytopenia|thrombocytopenia
338537|NCT02148133|Thrombopoietin|thrombopoietin
338538|NCT02148133|Bone Marrow|bone marrow
338539|NCT02148133|Bone Marrow Biopsy|bone marrow biopsy
338540|NCT02148133|Hematopoietic Stem Cells|hematopoietic stem cells
338541|NCT02148133|Mature Blood Cells|mature blood cells
338542|NCT02148133|Pancytopenia|pancytopenia
338543|NCT02148133|Leukopenia|leukopenia
338544|NCT02148133|Platelets|platelets
338545|NCT02148094|HIV|hiv
338546|NCT02148094|AIDS|aids
338547|NCT02148094|India|india
338548|NCT02148094|Prevention|prevention
338549|NCT02148094|Female sex workers|female sex workers
338550|NCT02148094|PrEP|prep
338551|NCT02148094|Pre-exposure prophylaxis|pre-exposure prophylaxis
338552|NCT02148094|Truvada|truvada
338553|NCT02148094|Tenofovir|tenofovir
338554|NCT02148081|pediatrics, critical illness, recovery, function, health|pediatrics, critical illness, recovery, function, health
338555|NCT02148068|Obesity|obesity
338556|NCT02148068|Bariatric Surgery|bariatric surgery
338557|NCT02148068|Roux-en-y Gastric Bypass|roux-en-y gastric bypass
338558|NCT02148068|Sleeve Gastrectomy|sleeve gastrectomy
338559|NCT02148055|spontaneous intrauterine death|spontaneous intrauterine death
338560|NCT02148055|fetal MRI|fetal mri
338561|NCT02148055|autopsy|autopsy
338562|NCT02148042|Anorexia|anorexia
338563|NCT02148042|Generalized anxiety|generalized anxiety
338564|NCT02148042|Fear|fear
338565|NCT02148029|Deep vein thrombosis|deep vein thrombosis
338566|NCT02148029|Post thrombotic syndrome|post thrombotic syndrome
338567|NCT02148029|Thrombus resolution|thrombus resolution
338568|NCT02148016|Corneal disorders|corneal disorders
338569|NCT02148016|Chemical injury|chemical injury
338570|NCT02148016|Pterygium|pterygium
338571|NCT02148016|Refractive error|refractive error
338572|NCT02148016|Myopia|myopia
338573|NCT02148016|Hyperopia|hyperopia
338574|NCT02148016|Cornea|cornea
338575|NCT02148016|Monocular|monocular
338576|NCT02148016|Transparent|transparent
338577|NCT02148016|Transplantation|transplantation
338578|NCT02148016|Visual function|visual function
338579|NCT02147990|cancer|cancer
338580|NCT02147990|metastatic|metastatic
338581|NCT02147990|locally advanced|locally advanced
338582|NCT02147990|lung|lung
338583|NCT02147990|non-small cell lung cancer|non-small cell lung cancer
338584|NCT02147990|NSCLC|nsclc
338585|NCT02147990|epidermal growth factor receptor|epidermal growth factor receptor
338586|NCT02147990|EGFR|egfr
338587|NCT02147990|T790M|t790m
338588|NCT02147990|CO-1686|co-1686
338589|NCT02147990|unresectable|unresectable
338590|NCT02147990|recurrent|recurrent
338591|NCT02147990|EGFR-directed therapy|egfr-directed therapy
338592|NCT02147990|irreversible EGFR inhibitor|irreversible egfr inhibitor
338593|NCT02147990|TIGER|tiger
338594|NCT02147990|Rociletinib|rociletinib
338595|NCT02147977|Renal Dialysis|renal dialysis
338596|NCT02147977|Arrhythmias Cardiac|arrhythmias cardiac
338597|NCT02147977|Death Sudden Cardiac|death sudden cardiac
338598|NCT02147977|Fatty Acids Omega 3|fatty acids omega 3
338599|NCT02147964|intratesticular androgens|intratesticular androgens
338600|NCT02147964|testosterone|testosterone
338601|NCT02147964|dutasteride|dutasteride
338602|NCT02147964|gonadotropin suppression|gonadotropin suppression
338603|NCT02147964|male contraception|male contraception
338604|NCT02147964|spermatogenesis|spermatogenesis
338605|NCT02147951|Melanoma|melanoma
338606|NCT02147938|France|france
338607|NCT02147938|Tacrolimus|tacrolimus
338608|NCT02147938|Prograf|prograf
338609|NCT02147938|Observational|observational
338610|NCT02147938|Advagraf|advagraf
338611|NCT02147925|Non-alcoholic fatty liver disease|non-alcoholic fatty liver disease
338612|NCT02147925|Glucagon-like peptide-1 receptor agonists|glucagon-like peptide-1 receptor agonists
338613|NCT02147925|Diabetes mellitus, type 2|diabetes mellitus, type 2
338614|NCT02147912|Depression|depression
338615|NCT02147912|COPD|copd
338616|NCT02147912|Aerobic Exercise|aerobic exercise
338617|NCT02147912|Anxiety|anxiety
338618|NCT02147912|Quality of life|quality of life
338619|NCT02147912|neurocognitive functioning|neurocognitive functioning
338620|NCT02147886|Bioblast, Randomized, parallel-group, and dose-controlled|bioblast, randomized, parallel-group, and dose-controlled
338621|NCT02147873|MDS|mds
338622|NCT02147873|CMML|cmml
338623|NCT02147873|myelodysplastic syndrome|myelodysplastic syndrome
338624|NCT02147873|chronic myelomonocytic leukemia|chronic myelomonocytic leukemia
338625|NCT02147873|TL32711|tl32711
338626|NCT02147873|TL32711-0094|tl32711-0094
338627|NCT02147873|azacitidine|azacitidine
338628|NCT02147873|birinapant|birinapant
338629|NCT02147873|higher risk|higher risk
338630|NCT02147873|naive|naive
338631|NCT02147873|double blind|double blind
338632|NCT02147873|placebo|placebo
338633|NCT02147873|placebo controlled|placebo controlled
338634|NCT02147873|randomized|randomized
338635|NCT02147860|Diabetes Mellitus, Type 1|diabetes mellitus, type 1
338636|NCT02147860|Artificial Pancreas Project (APP)|artificial pancreas project (app)
338637|NCT02147860|Diabetes Assistant (DiAs)|diabetes assistant (dias)
338638|NCT02147860|Closed-Loop Control (CLC)|closed-loop control (clc)
338639|NCT02147860|Continuous Glucose Monitor (CGM)|continuous glucose monitor (cgm)
338640|NCT02147860|Insulin Pump|insulin pump
338641|NCT02147847|Presbycusis|presbycusis
338642|NCT02147847|Hearing In Noise|hearing in noise
338643|NCT02147847|Hearing Impairment|hearing impairment
338644|NCT02147847|Hearing Loss|hearing loss
338646|NCT02147847|Plasticity|plasticity
338647|NCT02147847|Video Games|video games
338648|NCT02147847|Perceptual Learning|perceptual learning
338649|NCT02147834|deferred percutaneous coronary intervention|deferred percutaneous coronary intervention
338650|NCT02147834|fractional flow reserve|fractional flow reserve
338651|NCT02147795|Patient Blood Management|patient blood management
338652|NCT02147795|Red Blood Cell Transfusion Practice|red blood cell transfusion practice
338653|NCT02147795|Patient Safety|patient safety
338655|NCT02147795|Clinical Outcome|clinical outcome
338656|NCT02147795|perioperative care|perioperative care
338657|NCT02147782|chronic renal insufficient, renal osteodystrophy, bone mineral density, bone turnover, kidney function|chronic renal insufficient, renal osteodystrophy, bone mineral density, bone turnover, kidney function
338658|NCT02147769|cerebral autoregulation|cerebral autoregulation
338659|NCT02147769|preterm|preterm
338660|NCT02147769|near-infrared spectroscopy|near-infrared spectroscopy
338661|NCT02147756|Skin pigmentation, skin texture disorders, fractional laser, CO2, fractional CO2, Syneron, Solta.|skin pigmentation, skin texture disorders, fractional laser, co2, fractional co2, syneron, solta.
338662|NCT02147743|Adolescents|adolescents
338663|NCT02147743|Family-Based treatment|family-based treatment
338664|NCT02147743|Multidimensional Family Therapy|multidimensional family therapy
338665|NCT02147730|chronic pain|chronic pain
338666|NCT02147717|preterm newborns|preterm newborns
338667|NCT02147717|Transfontanellar ultrafast doppler|transfontanellar ultrafast doppler
338668|NCT02147717|Acupuncture|acupuncture
338669|NCT02147717|perioperative pain|perioperative pain
338670|NCT02147717|surgery of the ductus arteriosus|surgery of the ductus arteriosus
338671|NCT02147665|Hookah|hookah
338672|NCT02147665|waterpipe|waterpipe
338673|NCT02147665|smoking|smoking
338674|NCT02147665|sympathetic|sympathetic
338675|NCT02147652|moderate dementia|moderate dementia
338676|NCT02147652|severe dementia|severe dementia
338677|NCT02147652|Alzheimer's disease|alzheimer's disease
338678|NCT02147652|Vascular dementia|vascular dementia
338679|NCT02147652|agitation|agitation
338680|NCT02147652|personalized music therapy|personalized music therapy
338681|NCT02147626|preeclampsia|preeclampsia
338682|NCT02147626|cardiovascular disease|cardiovascular disease
338683|NCT02147626|health behaviors|health behaviors
338684|NCT02147626|behavioral intervention|behavioral intervention
338685|NCT02147626|web-based|web-based
338686|NCT02147626|Hypertension|hypertension
338687|NCT02147626|Post-partum Weight Retention|post-partum weight retention
338688|NCT02147600|adalimumab|adalimumab
338689|NCT02147600|biologicals|biologicals
338690|NCT02147600|immunogenicity|immunogenicity
338691|NCT02147574|slow-transit constipation|slow-transit constipation
338692|NCT02147574|laparoscope Sub-total Colectomy|laparoscope sub-total colectomy
338693|NCT02147574|anti-peristaltic anastomosis|anti-peristaltic anastomosis
338694|NCT02147522|community health worker|community health worker
338695|NCT02147522|promotoras|promotoras
338696|NCT02147522|self-care behaviors activation|self-care behaviors activation
338697|NCT02147522|depression|depression
338698|NCT02147522|low-income patients|low-income patients
338699|NCT02147522|safety-net care|safety-net care
338700|NCT02147509|Dry eye|dry eye
338701|NCT02147509|Therapeutic bandage contact lenses|therapeutic bandage contact lenses
338702|NCT02147509|The quality of life|the quality of life
338703|NCT02147496|Food intake|food intake
338704|NCT02147496|Appetite|appetite
338705|NCT02147496|Blood glucose|blood glucose
338706|NCT02147496|Insulin|insulin
338707|NCT02147496|Dairy|dairy
338708|NCT02147496|Milk|milk
338709|NCT02147483|Mindfulness|mindfulness
338710|NCT02147483|Alcohol use disorders|alcohol use disorders
338711|NCT02147470|cirrhosis of the liver|cirrhosis of the liver
338712|NCT02147470|Acute kidney injury|acute kidney injury
338713|NCT02147457|Prematurity|prematurity
338714|NCT02147457|Extremely low birth weight|extremely low birth weight
338715|NCT02147457|Phenotyping|phenotyping
338716|NCT02147444|Rivaroxaban|rivaroxaban
338717|NCT02147444|Non-valvular atrial fibrillation|non-valvular atrial fibrillation
338718|NCT02147444|NOAC|noac
338719|NCT02147444|Xa inhibitor|xa inhibitor
338720|NCT02147418|Head and neck cancer|head and neck cancer
338721|NCT02147418|Throat cancer|throat cancer
774378|NCT00351936|Olanzapine|olanzapine
338722|NCT02147418|Human papillomavirus|human papillomavirus
338723|NCT02147418|HPV|hpv
338724|NCT02147418|Exosome|exosome
338725|NCT02147418|Diagnostic|diagnostic
338726|NCT02147418|Early Detection|early detection
338727|NCT02147405|FDG PET/CT Scan|fdg pet/ct scan
338728|NCT02147405|Lymph Node Biopsy|lymph node biopsy
338729|NCT02147405|Apheresis|apheresis
338730|NCT02147392|PET Imaging|pet imaging
338731|NCT02147379|Bipolar Disorder|bipolar disorder
338732|NCT02147379|Cognition|cognition
338733|NCT02147379|Euthymic|euthymic
338734|NCT02147379|Lurasidone|lurasidone
338735|NCT02147366|Hypertension,ambulatory pressure,autonomic function,music|hypertension,ambulatory pressure,autonomic function,music
338736|NCT02147353|External Genital Warts|external genital warts
338737|NCT02147353|Sinecatechins|sinecatechins
338738|NCT02147353|Cryotherapy|cryotherapy
338739|NCT02147340|Heart Failure patients|heart failure patients
338740|NCT02147340|Remote Patient Management|remote patient management
338741|NCT02147340|External Sensors|external sensors
338742|NCT02147327|vitamin D|vitamin d
338743|NCT02147327|cord blood|cord blood
338744|NCT02147327|neonatal sepsis|neonatal sepsis
338745|NCT02147327|neonatal morbidity|neonatal morbidity
338746|NCT02147314|diabetes|diabetes
338747|NCT02147314|glucometer|glucometer
338748|NCT02147314|Yofimeter|yofimeter
338749|NCT02147314|diabetes monitoring|diabetes monitoring
338750|NCT02147275|hypertension|hypertension
338751|NCT02147275|cerebral oxygen saturation|cerebral oxygen saturation
338752|NCT02147275|near-infrared spectroscopy|near-infrared spectroscopy
338753|NCT02147275|cognitive function|cognitive function
338754|NCT02147262|chronic atrophic acrodermatitis|chronic atrophic acrodermatitis
338755|NCT02147262|Lyme borreliosis|lyme borreliosis
338756|NCT02147262|molecular characteristics|molecular characteristics
338757|NCT02147262|outcome|outcome
338758|NCT02147249|erythema migrans|erythema migrans
338759|NCT02147249|Lyme borreliosis|lyme borreliosis
338760|NCT02147249|inflammation|inflammation
338761|NCT02147249|outcome|outcome
338762|NCT02147236|autism|autism
338763|NCT02147236|pervasive developmental disorders|pervasive developmental disorders
338764|NCT02147236|social skills intervention|social skills intervention
338765|NCT02147223|flavanols|flavanols
338766|NCT02147223|sex-related cardiovascular effects|sex-related cardiovascular effects
338767|NCT02147210|Chronic transplant glomerulopathy|chronic transplant glomerulopathy
338768|NCT02147210|antibody mediated rejection|antibody mediated rejection
338769|NCT02147210|Ephrin-B1|ephrin-b1
338770|NCT02147184|SSRI|ssri
338771|NCT02147184|serotonin transporter|serotonin transporter
338772|NCT02147184|DXA|dxa
338773|NCT02147184|pQCT|pqct
338774|NCT02147184|bone mass|bone mass
338775|NCT02147184|adolescents|adolescents
338776|NCT02147171|Retinal ageing, macular pigment, visual function|retinal ageing, macular pigment, visual function
338777|NCT02147145|GIST|gist
338778|NCT02147145|endoscopy|endoscopy
338779|NCT02147145|endoscopic ultrasound|endoscopic ultrasound
338780|NCT02147132|Cigarette|cigarette
338781|NCT02147132|Methadone|methadone
338782|NCT02147132|Smoking|smoking
338783|NCT02147132|Cessation|cessation
338784|NCT02147132|Varenicline|varenicline
338785|NCT02147132|Nicotine|nicotine
338786|NCT02147106|Neuroendocrine tumor|neuroendocrine tumor
338787|NCT02147106|Videoconsultation|videoconsultation
338788|NCT02147106|Feasibility|feasibility
338789|NCT02147080|prevention or control|prevention or control
338790|NCT02147067|microvascular angina|microvascular angina
338791|NCT02147067|coronary microvascular disease|coronary microvascular disease
338792|NCT02147067|coronary physiology|coronary physiology
338793|NCT02147067|ranolazine|ranolazine
338794|NCT02147054|Organophosphate poisoning|organophosphate poisoning
338795|NCT02147054|Intermediate syndrome|intermediate syndrome
338796|NCT02147054|Rocuronium|rocuronium
338797|NCT02147041|diabetes mellitus|diabetes mellitus
338798|NCT02147041|hyperlipidemia|hyperlipidemia
338799|NCT02147041|green tea|green tea
338800|NCT02147041|epigallocatechin gallate|epigallocatechin gallate
338801|NCT02147028|whole brain RT|whole brain rt
338802|NCT02147028|hippocampal sparing|hippocampal sparing
338803|NCT02147028|neurocognitive function|neurocognitive function
338804|NCT02147015|Acute Exacerbations|acute exacerbations
338805|NCT02147015|Corticosteroids|corticosteroids
338806|NCT02147015|Chronic Obstructive Pulmonary Disease|chronic obstructive pulmonary disease
338807|NCT02147015|Doses|doses
338808|NCT02147002|Chronic Kidney Disease|chronic kidney disease
338809|NCT02147002|Cardiovascular Complications|cardiovascular complications
338810|NCT02146989|Cerebral Palsy|cerebral palsy
338811|NCT02146989|child|child
338812|NCT02146989|upper extremity|upper extremity
338813|NCT02146989|strength, reproducibility|strength, reproducibility
338814|NCT02146976|postoperative|postoperative
338815|NCT02146976|sleep quality|sleep quality
338816|NCT02146976|propofol|propofol
338817|NCT02146976|sevoflurane|sevoflurane
338818|NCT02146950|LCS-12|lcs-12
338819|NCT02146950|Intrauterine Device (IUD)|intrauterine device (iud)
338820|NCT02146950|Intrauterine System (IUS)|intrauterine system (ius)
338821|NCT02146950|Levonorgestrel|levonorgestrel
338822|NCT02146950|Pearl Index|pearl index
338823|NCT02146950|Hormonal Contraception|hormonal contraception
338824|NCT02146937|active surveillance|active surveillance
338825|NCT02146937|MRI/transrectal ultrasound fusion guided biopsy|mri/transrectal ultrasound fusion guided biopsy
338826|NCT02146937|biopsy|biopsy
338827|NCT02146911|Smoking Cessation Medication|smoking cessation medication
338828|NCT02146911|Smoking Treatment|smoking treatment
338829|NCT02146911|Tobacco Treatment|tobacco treatment
338830|NCT02146911|Quitting Smoking|quitting smoking
338831|NCT02146911|Bupropion|bupropion
338832|NCT02146911|Varenicline|varenicline
338833|NCT02146911|Efficacy|efficacy
338834|NCT02146911|Pharmacogenetics of Smoking Treatment|pharmacogenetics of smoking treatment
338835|NCT02146911|Genetics analysis|genetics analysis
338836|NCT02146911|Smoking Personality|smoking personality
338837|NCT02146911|Dependence|dependence
338838|NCT02146911|Addiction|addiction
338839|NCT02146911|Cigarettes|cigarettes
338840|NCT02146911|Primary Care Physicians|primary care physicians
338841|NCT02146911|Biochemical Confirmation|biochemical confirmation
338842|NCT02146898|spinal anesthesia|spinal anesthesia
338843|NCT02146898|hypotension|hypotension
338844|NCT02146898|pregnancy|pregnancy
338845|NCT02146872|Coronary Artery Disease|coronary artery disease
338846|NCT02146872|Myocardial Infarction|myocardial infarction
338847|NCT02146872|Atherosclerosis|atherosclerosis
338848|NCT02146872|High-Throughput Nucleotide Sequencing|high-throughput nucleotide sequencing
338849|NCT02146872|Sequence Analysis, DNA|sequence analysis, dna
338850|NCT02146872|Genetic Testing|genetic testing
338851|NCT02146872|Genetic Linkage|genetic linkage
338852|NCT02146859|residual neuromuscular blockade|residual neuromuscular blockade
338853|NCT02146846|cml|cml
338854|NCT02146833|castrate-resistant prostate cancer|castrate-resistant prostate cancer
338855|NCT02146833|prostate cancer|prostate cancer
338856|NCT02146833|Karyopharm|karyopharm
338857|NCT02146833|KPT-330|kpt-330
338858|NCT02146833|selinexor|selinexor
338859|NCT02146820|Pigmented Lesions, Skin Pigment, Picosecond Laser, Syneron|pigmented lesions, skin pigment, picosecond laser, syneron
338860|NCT02146807|Tattoos, Picosecond Laser, Syneron|tattoos, picosecond laser, syneron
338861|NCT02146742|ASP1707|asp1707
338862|NCT02146742|Japanese subjects|japanese subjects
338863|NCT02146742|Safety|safety
338864|NCT02146742|Pharmacokinetics|pharmacokinetics
338865|NCT02146742|Pharmacodynamics|pharmacodynamics
338866|NCT02146729|Randomized|randomized
338867|NCT02146729|Thoracolumbar fractures|thoracolumbar fractures
338868|NCT02146729|Spine Trauma|spine trauma
338869|NCT02146729|Percutaneous Pedicle Screw Fixation|percutaneous pedicle screw fixation
338870|NCT02146729|Functional Outcome|functional outcome
338871|NCT02146716|RESC, alcohol withdrawal syndrome|resc, alcohol withdrawal syndrome
338872|NCT02146703|biliary tract neoplasm|biliary tract neoplasm
338873|NCT02146703|gemcitabine|gemcitabine
338874|NCT02146703|S-1|s-1
338875|NCT02146690|pathology|pathology
338876|NCT02146690|newborn|newborn
339003|NCT02146040|treatment|treatment
338877|NCT02146690|osteopathic manipulative treatment|osteopathic manipulative treatment
338878|NCT02146690|pain|pain
338879|NCT02146677|prematurity|prematurity
338880|NCT02146677|newborns|newborns
338881|NCT02146677|pain|pain
338882|NCT02146677|cost|cost
338883|NCT02146664|Acute NSTEMI|acute nstemi
338884|NCT02146664|DLBS1033|dlbs1033
338885|NCT02146664|SPECT|spect
338886|NCT02146664|Infarct size|infarct size
338887|NCT02146664|Left ventricular function|left ventricular function
338888|NCT02146638|post operative analgesia, morphine, fentanyl|post operative analgesia, morphine, fentanyl
338889|NCT02146573|Intensive Care Units, Pediatric|intensive care units, pediatric
338890|NCT02146573|Communication|communication
338891|NCT02146573|Health personnel|health personnel
338892|NCT02146573|Decision making|decision making
338893|NCT02146573|Critical Care|critical care
338894|NCT02146573|Length of Stay|length of stay
338895|NCT02146573|Iatrogenic Disease|iatrogenic disease
338896|NCT02146560|Surgery|surgery
338897|NCT02146560|Non-cardiac|non-cardiac
338898|NCT02146560|Elective|elective
338899|NCT02146560|Adult|adult
338900|NCT02146560|Patients|patients
338901|NCT02146560|Troponin|troponin
338902|NCT02146560|Myocardial|myocardial
338903|NCT02146560|Injury|injury
338904|NCT02146560|Postoperative|postoperative
338905|NCT02146560|Recovery|recovery
338906|NCT02146560|Outcome|outcome
338907|NCT02146547|depot, oral, antipsychotics, paliperidone, aripiprazole|depot, oral, antipsychotics, paliperidone, aripiprazole
338908|NCT02146521|z-axis limited CT|z-axis limited ct
338909|NCT02146521|computed tomography|computed tomography
338910|NCT02146521|CT|ct
338911|NCT02146521|abdominal non-traumatic pain and tenderness|abdominal non-traumatic pain and tenderness
338912|NCT02146521|emergency patients|emergency patients
338913|NCT02146508|Esophageal cancer|esophageal cancer
338914|NCT02146508|Radiofrequency, catheter ablation|radiofrequency, catheter ablation
338915|NCT02146508|Endoscopic mucosal resection|endoscopic mucosal resection
338916|NCT02146508|Esophageal squamous dysplasia|esophageal squamous dysplasia
338917|NCT02146508|Cancer prevention|cancer prevention
338918|NCT02146482|back pain|back pain
338919|NCT02146482|low back pain|low back pain
338920|NCT02146482|sit-stand workstation|sit-stand workstation
338921|NCT02146482|standing desk|standing desk
338922|NCT02146469|varicella vaccination|varicella vaccination
338923|NCT02146443|Manual dexterity|manual dexterity
338924|NCT02146443|hand to eye coordination|hand to eye coordination
338925|NCT02146443|stress|stress
338926|NCT02146443|fatigue|fatigue
338927|NCT02146430|pain|pain
338928|NCT02146430|fibromyalgia|fibromyalgia
338929|NCT02146417|Low pressure pneumoperitoneum|low pressure pneumoperitoneum
338930|NCT02146417|Deep neuromuscular block|deep neuromuscular block
338931|NCT02146404|Type 1 Diabetes Mellitus|type 1 diabetes mellitus
338932|NCT02146404|Hypoglycemia unawareness|hypoglycemia unawareness
338933|NCT02146404|1H MRS|1h mrs
338934|NCT02146404|Lactate|lactate
338935|NCT02146352|Pancreatic pseudocyst|pancreatic pseudocyst
338936|NCT02146339|nutrition|nutrition
338937|NCT02146339|milk|milk
338938|NCT02146339|polar lipids|polar lipids
338939|NCT02146339|cardiometabolic risk|cardiometabolic risk
338940|NCT02146300|birch pollen|birch pollen
338941|NCT02146300|allergy|allergy
338942|NCT02146300|breathing|breathing
338943|NCT02146300|pattern|pattern
338944|NCT02146300|exposure|exposure
338945|NCT02146287|cycled light|cycled light
338946|NCT02146287|preterm infants|preterm infants
338947|NCT02146287|infant neurodevelopment|infant neurodevelopment
338948|NCT02146287|infant sleep|infant sleep
338949|NCT02146274|PROSPER|prosper
338950|NCT02146274|Stroke|stroke
338951|NCT02146274|Ischemic Stroke|ischemic stroke
338952|NCT02146261|Volunteers|volunteers
338953|NCT02146261|Japanese|japanese
338954|NCT02146261|Males|males
338955|NCT02146248|hysterosalpingography, DMPA, combined oral contraceptive, tubal patency|hysterosalpingography, dmpa, combined oral contraceptive, tubal patency
338956|NCT02146235|Music Therapy|music therapy
338957|NCT02146235|Pulmonary Disease|pulmonary disease
338958|NCT02146235|COPD|copd
338959|NCT02146235|Music Visualization|music visualization
338960|NCT02146235|Therapeutic Singing|therapeutic singing
338961|NCT02146235|Wind-playing|wind-playing
338962|NCT02146235|Lung Condition|lung condition
338963|NCT02146196|Heart failure|heart failure
338964|NCT02146196|robotic assisted gait therapy|robotic assisted gait therapy
338965|NCT02146183|Stevio glycosides|stevio glycosides
338966|NCT02146183|sport|sport
338967|NCT02146183|glycogen|glycogen
338968|NCT02146170|Sample Acquisition|sample acquisition
338969|NCT02146170|Generic and Epigenetic Alterations|generic and epigenetic alterations
338970|NCT02146170|Mig6 Expression|mig6 expression
338971|NCT02146170|Proteomic Analysis|proteomic analysis
338972|NCT02146170|Genomic Analysis|genomic analysis
338973|NCT02146144|Idiopathic epimacular membrane|idiopathic epimacular membrane
338974|NCT02146144|internal limiting membrane peeling|internal limiting membrane peeling
338975|NCT02146144|microscotomas|microscotomas
338976|NCT02146131|Peripheral pulmonary lesions|peripheral pulmonary lesions
338977|NCT02146131|Solitary pulmonary lesions|solitary pulmonary lesions
338978|NCT02146131|Multiple pulmonary lesions|multiple pulmonary lesions
338979|NCT02146118|Erlotinib|erlotinib
338980|NCT02146118|Silybin-phytosome|silybin-phytosome
338981|NCT02146118|EGFR mutant lung adenocarcinoma|egfr mutant lung adenocarcinoma
338982|NCT02146092|lung resection|lung resection
338983|NCT02146092|incentive spirometry|incentive spirometry
338984|NCT02146092|physiotherapy|physiotherapy
338985|NCT02146092|quality improvement|quality improvement
338986|NCT02146092|outcomes|outcomes
338987|NCT02146092|post operative complications|post operative complications
338988|NCT02146066|GBM|gbm
338989|NCT02146066|Brain tumor|brain tumor
338990|NCT02146066|glioblastoma|glioblastoma
338991|NCT02146066|Brain tumor WHO grade IV|brain tumor who grade iv
338992|NCT02146053|healthy participants|healthy participants
338993|NCT02146053|gastrointestinal side-effects associated with oral iron|gastrointestinal side-effects associated with oral iron
338994|NCT02146040|anticoagulation|anticoagulation
338995|NCT02146040|atrial fibrillation|atrial fibrillation
338996|NCT02146040|cardioversion|cardioversion
338997|NCT02146040|complications|complications
338998|NCT02146040|hemorrhage|hemorrhage
338999|NCT02146040|medications|medications
339000|NCT02146040|thromboembolism|thromboembolism
339001|NCT02146040|TIA|tia
339002|NCT02146040|stroke|stroke
339004|NCT02146027|HIV|hiv
339005|NCT02146027|Lactobacillus casei Shirota|lactobacillus casei shirota
339006|NCT02146027|NK cell|nk cell
339007|NCT02146027|CD4|cd4
339008|NCT02146027|Lymphocyte|lymphocyte
339009|NCT02146027|Cell activation|cell activation
339010|NCT02146027|Antiretroviral therapy|antiretroviral therapy
339011|NCT02146027|Immune discordants|immune discordants
339012|NCT02146014|cigarette smoking, smoking|cigarette smoking, smoking
339013|NCT02146001|sedentary behavior|sedentary behavior
339014|NCT02146001|physical activity|physical activity
339015|NCT02146001|older adults|older adults
339016|NCT02145988|DLBS1033|dlbs1033
339017|NCT02145988|Peripheral arterial disease|peripheral arterial disease
339018|NCT02145988|Ankle-brachial index|ankle-brachial index
339019|NCT02145975|Severe postoperative pain|severe postoperative pain
339020|NCT02145975|Morphine|morphine
339021|NCT02145975|Fentanyl|fentanyl
339022|NCT02145975|Time to titration of pain|time to titration of pain
339023|NCT02145975|Pain and PACU|pain and pacu
339024|NCT02145975|Anesthesiology|anesthesiology
339025|NCT02145962|diabetic foot ulcer healing|diabetic foot ulcer healing
339026|NCT02145962|magnetic therapy|magnetic therapy
339027|NCT02145962|safety and efficacy|safety and efficacy
339028|NCT02145962|wound care|wound care
339029|NCT02145949|aging|aging
339030|NCT02145949|clinical|clinical
339031|NCT02145949|translational|translational
339032|NCT02145949|functional mobility|functional mobility
339033|NCT02145949|total knee arthroplasty|total knee arthroplasty
339034|NCT02145936|fatty acid|fatty acid
339035|NCT02145923|Hodgkin Lymphoma|hodgkin lymphoma
339036|NCT02145923|Non-Hodgkin's Lymphomas|non-hodgkin's lymphomas
339130|NCT02145468|Myocardial infarction|myocardial infarction
339037|NCT02145923|Allogeneic Mesenchymal Stem Cell Transplantation|allogeneic mesenchymal stem cell transplantation
339038|NCT02145923|Autologous Peripheral Blood Stem Cell Transplantation|autologous peripheral blood stem cell transplantation
339039|NCT02145923|Neutropenic Enterocolitis|neutropenic enterocolitis
339040|NCT02145923|Myeloablative Chemotherapy|myeloablative chemotherapy
339041|NCT02145923|Bone Marrow Aplasia|bone marrow aplasia
339042|NCT02145897|CLI|cli
339043|NCT02145884|hemangioma|hemangioma
339044|NCT02145884|birthmark|birthmark
339045|NCT02145884|strawberry hemangioma|strawberry hemangioma
339046|NCT02145884|timolol|timolol
339047|NCT02145871|Radical Cystectomy|radical cystectomy
339048|NCT02145871|Perioperative Fluid Management|perioperative fluid management
339049|NCT02145871|EV1000|ev1000
339050|NCT02145871|14-069|14-069
339051|NCT02145858|atrial fibrillation, pericardial effusion, pleural effusion|atrial fibrillation, pericardial effusion, pleural effusion
339052|NCT02145845|critical limb ischemia|critical limb ischemia
339053|NCT02145845|wound healing|wound healing
339054|NCT02145845|amputation|amputation
339055|NCT02145832|TINN|tinn
339056|NCT02145832|Pharmacokinetic|pharmacokinetic
339057|NCT02145832|Neonates|neonates
339058|NCT02145832|Antifungal|antifungal
339059|NCT02145832|Fluconazole|fluconazole
339060|NCT02145832|Micafungin|micafungin
339061|NCT02145806|Urinary incontinence|urinary incontinence
339062|NCT02145806|Validation study|validation study
339063|NCT02145806|Pregnant women|pregnant women
339064|NCT02145806|Postpartum period|postpartum period
339065|NCT02145793|primary care|primary care
339066|NCT02145793|pediatrics|pediatrics
339067|NCT02145793|parenting|parenting
339068|NCT02145793|education|education
339069|NCT02145780|Overfeeding|overfeeding
339070|NCT02145780|Fat distribution|fat distribution
339071|NCT02145780|Subcutaneous and visceral adipose tissue|subcutaneous and visceral adipose tissue
339072|NCT02145780|Insulin sensitivity|insulin sensitivity
339073|NCT02145780|Insulin resistance|insulin resistance
339074|NCT02145780|Peripheral and hepatic insulin sensitivity|peripheral and hepatic insulin sensitivity
339075|NCT02145780|Stable isotopes|stable isotopes
339076|NCT02145780|Lipid oxidation|lipid oxidation
339077|NCT02145780|Energy expenditure|energy expenditure
339078|NCT02145780|Muscle and subcutaneous adipose tissue gene expression|muscle and subcutaneous adipose tissue gene expression
339079|NCT02145754|erythema migrans|erythema migrans
339080|NCT02145754|Lyme borreliosis|lyme borreliosis
339081|NCT02145754|Borrelia burgdorferi|borrelia burgdorferi
339082|NCT02145754|skin culture|skin culture
339083|NCT02145754|culture media|culture media
339084|NCT02145728|Non-specific chronic low back pain|non-specific chronic low back pain
339085|NCT02145728|Cognitive functional therapy|cognitive functional therapy
339086|NCT02145728|Exercise classes|exercise classes
339087|NCT02145702|ESRD|esrd
339088|NCT02145702|Kidney Failure|kidney failure
339089|NCT02145702|Exercise|exercise
339090|NCT02145702|Cognitive impairment|cognitive impairment
339091|NCT02145637|Cancer, Lung cancer, Head and neck squamous cell carcinoma, Afatinib, Ruxolitinib, EGFR, JAK, STAT|cancer, lung cancer, head and neck squamous cell carcinoma, afatinib, ruxolitinib, egfr, jak, stat
339092|NCT02145624|pertussis|pertussis
339093|NCT02145624|maternal vaccination|maternal vaccination
339094|NCT02145624|maternal immunisation|maternal immunisation
339095|NCT02145624|immune response|immune response
339096|NCT02145611|hypertension, diabetes, endothelial function|hypertension, diabetes, endothelial function
339097|NCT02145598|Multiple Myeloma|multiple myeloma
339098|NCT02145598|Revlimid|revlimid
339099|NCT02145598|Lenalidomide maintenance|lenalidomide maintenance
339100|NCT02145585|Cardiac surgery|cardiac surgery
339101|NCT02145585|Robotic pharmacological anesthesia|robotic pharmacological anesthesia
339102|NCT02145585|Anesthesia|anesthesia
339103|NCT02145546|Pacing dependent|pacing dependent
339104|NCT02145546|Atrial Fibrillation|atrial fibrillation
339105|NCT02145546|Amiodarone|amiodarone
339106|NCT02145546|Propafenone|propafenone
339107|NCT02145546|Sotalol|sotalol
339108|NCT02145546|AF burden|af burden
433464|NCT01717742|tPA|tpa
339109|NCT02145533|MMP|mmp
339110|NCT02145533|NGAL|ngal
339111|NCT02145533|Arterial Aneurysms|arterial aneurysms
339112|NCT02145520|bronchiolitis|bronchiolitis
339113|NCT02145507|Leukoreduction|leukoreduction
339114|NCT02145507|Red Blood Cell post-leukoreduction recovery|red blood cell post-leukoreduction recovery
339115|NCT02145507|Packed red blood cell post storage hemolysis|packed red blood cell post storage hemolysis
339116|NCT02145507|Red blood cell recovery|red blood cell recovery
339117|NCT02145507|Plasma clotting factors|plasma clotting factors
339118|NCT02145507|2,3-DPG rejuvenation|2,3-dpg rejuvenation
339119|NCT02145494|SBRT (stereotactic body radiotherapy)|sbrt (stereotactic body radiotherapy)
339120|NCT02145494|Focal boost|focal boost
339121|NCT02145494|Prostate|prostate
339122|NCT02145481|coronary artery disease|coronary artery disease
339123|NCT02145481|decision quality|decision quality
339124|NCT02145481|decision making|decision making
339125|NCT02145481|survey|survey
339126|NCT02145481|measure development|measure development
339127|NCT02145481|patient-centered care|patient-centered care
339128|NCT02145481|cardiology|cardiology
339129|NCT02145481|heart disease|heart disease
339631|NCT02143466|Savolitinib|savolitinib
339131|NCT02145468|Acute coronary syndrome|acute coronary syndrome
339132|NCT02145468|Cardiovascular disease|cardiovascular disease
339133|NCT02145468|p38 mitogen-activated protein kinase (MAPK) inhibitor|p38 mitogen-activated protein kinase (mapk) inhibitor
339134|NCT02145468|NSTEMI|nstemi
339135|NCT02145468|Losmapimod|losmapimod
339136|NCT02145468|STEMI|stemi
339137|NCT02145455|Arthroplasty, Replacement, Knee/methods|arthroplasty, replacement, knee/methods
339138|NCT02145455|Knee Joint/physiopathology|knee joint/physiopathology
339139|NCT02145455|Knee Joint/radiography|knee joint/radiography
339140|NCT02145455|Knee Joint/surgery|knee joint/surgery
339141|NCT02145455|Knee Prosthesis|knee prosthesis
339142|NCT02145455|Outcome Assessment (Health Care)|outcome assessment (health care)
339143|NCT02145455|Female|female
339144|NCT02145455|Male|male
339145|NCT02145455|Adult|adult
339146|NCT02145442|Impaired fasting glucose|impaired fasting glucose
339147|NCT02145442|Prediabetes|prediabetes
339148|NCT02145442|Obesity|obesity
339149|NCT02145442|Overweight|overweight
339150|NCT02145442|Insulin sensitivity|insulin sensitivity
339151|NCT02145442|Weight loss|weight loss
339152|NCT02145442|Nutritional supplement|nutritional supplement
339153|NCT02145442|Waist|waist
339154|NCT02145442|Body composition|body composition
339155|NCT02145429|Prevention of depression and anxiety disorder|prevention of depression and anxiety disorder
339156|NCT02145429|Depression Prevention|depression prevention
339157|NCT02145416|Imaging|imaging
339158|NCT02145416|Chemoradiotherapy|chemoradiotherapy
339159|NCT02145403|Allogeneic Transplantation|allogeneic transplantation
339160|NCT02145403|Carfilzomib|carfilzomib
339161|NCT02145403|Relapse|relapse
339162|NCT02145403|Graft-Versus-Host Disease|graft-versus-host disease
339163|NCT02145403|Multiple Myeloma|multiple myeloma
339164|NCT02145403|Lymphoma|lymphoma
339165|NCT02145403|Leukemia|leukemia
339166|NCT02145390|Bladder Cancer|bladder cancer
339167|NCT02145390|Bladder Carcinoma|bladder carcinoma
339168|NCT02145390|Transition Cell Cancer|transition cell cancer
339169|NCT02145390|TCC|tcc
339170|NCT02145390|Muscle Invasive Bladder Carcinoma|muscle invasive bladder carcinoma
339171|NCT02145377|Cholera|cholera
339172|NCT02145377|Vaccine|vaccine
339173|NCT02145377|Mali|mali
339174|NCT02145364|Ulthera System®|ulthera system®
339175|NCT02145364|Ultherapy®|ultherapy®
339176|NCT02145364|Ulthera, Inc.|ulthera, inc.
339177|NCT02145351|HFpEF|hfpef
339178|NCT02145351|Heart failure|heart failure
339179|NCT02145351|Heart failure with preserved ejection fraction|heart failure with preserved ejection fraction
339180|NCT02145351|Chronotropic incompetence|chronotropic incompetence
339181|NCT02145338|Urinary tract infection|urinary tract infection
339182|NCT02145338|Clean intermittent self-catheterisation|clean intermittent self-catheterisation
339183|NCT02145338|Antibiotic prophylaxis|antibiotic prophylaxis
339184|NCT02145325|Kidney transplant|kidney transplant
339185|NCT02145325|Regulatory T cells|regulatory t cells
339186|NCT02145325|Leukopheresis|leukopheresis
339187|NCT02145325|Immune cells|immune cells
339188|NCT02145325|Stem Cells|stem cells
339189|NCT02145325|Tolerance|tolerance
339190|NCT02145273|Maternal Depression|maternal depression
339191|NCT02145273|Interpersonal Psychotherapy|interpersonal psychotherapy
339192|NCT02145273|School Readiness|school readiness
339193|NCT02145260|Hemodialysis|hemodialysis
339194|NCT02145260|Hypotension|hypotension
339195|NCT02145260|Hospitalization|hospitalization
339196|NCT02145208|BPH|bph
339197|NCT02145195|Vitamin D|vitamin d
339198|NCT02145195|Children|children
339199|NCT02145195|Supplements|supplements
339200|NCT02145195|Cardiometabolic markers|cardiometabolic markers
339201|NCT02145195|Immune defense|immune defense
339202|NCT02145195|Bone turnover|bone turnover
339203|NCT02145195|Muscle strength|muscle strength
339204|NCT02145182|DGF|dgf
339205|NCT02145182|Dialysis|dialysis
433615|NCT01717118|HPV|hpv
339206|NCT02145182|Kidney|kidney
339207|NCT02145182|Kidney Transplantation|kidney transplantation
339208|NCT02145182|eGFR|egfr
339209|NCT02145182|Complement|complement
339210|NCT02145182|Eculizumab|eculizumab
339211|NCT02145169|procedural sedation|procedural sedation
339212|NCT02145169|emergence reaction|emergence reaction
339213|NCT02145169|nitrous oxide|nitrous oxide
339214|NCT02145169|ketamine|ketamine
339215|NCT02145156|HPV vaccination|hpv vaccination
339216|NCT02145156|Tailored health messaging|tailored health messaging
339217|NCT02145143|Radioiodine (RAI) Incorporation|radioiodine (rai) incorporation
339218|NCT02145143|Vemurafenib|vemurafenib
339219|NCT02145143|14-031|14-031
339220|NCT02145130|Skin|skin
339221|NCT02145130|Tissue-engineering|tissue-engineering
339222|NCT02145130|Autologous|autologous
339223|NCT02145130|Dermis|dermis
339224|NCT02145130|Epidermis|epidermis
339225|NCT02145117|MBSR|mbsr
339226|NCT02145117|fMRI|fmri
339227|NCT02145117|PTH|pth
339228|NCT02145091|Psilocybin|psilocybin
339229|NCT02145091|Hallucinogens|hallucinogens
339230|NCT02145091|Pharmacologic Actions|pharmacologic actions
339231|NCT02145091|Central Nervous System Agents|central nervous system agents
339232|NCT02145091|Therapeutic Uses|therapeutic uses
339233|NCT02145091|Psychotropic Drugs|psychotropic drugs
339234|NCT02145065|paclitaxel coated balloon|paclitaxel coated balloon
339235|NCT02145065|restenosis|restenosis
339236|NCT02145065|Femoropopliteal artery disease|femoropopliteal artery disease
339237|NCT02145052|Fascial closure|fascial closure
339238|NCT02145052|Interrupted suture|interrupted suture
339239|NCT02145052|Running suture|running suture
339240|NCT02145052|Continuous suture|continuous suture
339241|NCT02145039|Acute Lymphoblastic Leukemia (ALL)|acute lymphoblastic leukemia (all)
339242|NCT02145039|Acute Myelogenous Leukemia (AML)|acute myelogenous leukemia (aml)
339243|NCT02145039|Burkitt's lymphoma|burkitt's lymphoma
339244|NCT02145039|Natural killer cell malignancies|natural killer cell malignancies
339245|NCT02145039|Chronic myelogenous leukemia|chronic myelogenous leukemia
339246|NCT02145039|Myelodysplastic syndrome|myelodysplastic syndrome
339247|NCT02145039|Large-cell lymphoma|large-cell lymphoma
339248|NCT02145039|Hodgkin lymphoma|hodgkin lymphoma
339249|NCT02145039|Multiple myeloma|multiple myeloma
339250|NCT02145039|Chronic lymphocytic leukemia (CLL)|chronic lymphocytic leukemia (cll)
339251|NCT02145039|Small lymphocytic lymphoma (SLL)|small lymphocytic lymphoma (sll)
339252|NCT02145039|Marginal zone B-cell lymphoma|marginal zone b-cell lymphoma
339253|NCT02145039|Follicular lymphoma|follicular lymphoma
339254|NCT02145039|Lymphoplasmacytic lymphoma|lymphoplasmacytic lymphoma
339255|NCT02145039|Mantle-cell lymphoma|mantle-cell lymphoma
339256|NCT02145039|Prolymphocytic leukemia|prolymphocytic leukemia
339257|NCT02145039|Refractory leukemia|refractory leukemia
339258|NCT02145039|MDS|mds
339259|NCT02145039|Bone marrow failure syndromes|bone marrow failure syndromes
339260|NCT02145039|Myeloproliferative syndromes|myeloproliferative syndromes
339261|NCT02145013|portal hypertension, hepatocellular carcinoma, resection|portal hypertension, hepatocellular carcinoma, resection
339262|NCT02145000|Rotavirus|rotavirus
339263|NCT02145000|Gastroenteritis|gastroenteritis
339264|NCT02145000|Diarrhea|diarrhea
339265|NCT02145000|Vaccine|vaccine
339266|NCT02145000|Niger|niger
339267|NCT02144974|Total pelvic exenteration.|total pelvic exenteration.
339268|NCT02144961|breast reconstruction|breast reconstruction
339269|NCT02144961|Deep Inferior Epigastric Artery Perforator (DIEP)|deep inferior epigastric artery perforator (diep)
339270|NCT02144961|Indocyanine Green Angiography (IGA)|indocyanine green angiography (iga)
339271|NCT02144961|autologous tissue transfer|autologous tissue transfer
339272|NCT02144948|diabetes|diabetes
339273|NCT02144935|pediatrics|pediatrics
339274|NCT02144922|Hypertension|hypertension
339275|NCT02144922|Statin|statin
339276|NCT02144909|Diabetes self management|diabetes self management
339277|NCT02144909|support group|support group
339278|NCT02144909|semi structured support group|semi structured support group
339279|NCT02144883|telephone counseling|telephone counseling
339280|NCT02144870|Tic-Disorder, Tourette-Disorder, Habit Reversal Training, Resources activation|tic-disorder, tourette-disorder, habit reversal training, resources activation
339281|NCT02144844|Antepartum depressive symptoms|antepartum depressive symptoms
339282|NCT02144844|Antepartum depression|antepartum depression
339283|NCT02144844|Cognitive behavioral intervention|cognitive behavioral intervention
339284|NCT02144844|Feasibility|feasibility
339285|NCT02144844|randomized clinical trial|randomized clinical trial
339286|NCT02144831|TIA|tia
339287|NCT02144831|stroke prevention|stroke prevention
339288|NCT02144831|ASA|asa
339289|NCT02144831|clopidogrel|clopidogrel
339290|NCT02144831|dual antiplatelet treatment|dual antiplatelet treatment
339291|NCT02144753|IBS-C|ibs-c
339292|NCT02144753|Constipation|constipation
339293|NCT02144753|IBS|ibs
339294|NCT02144740|Flow-mediated dilation|flow-mediated dilation
339295|NCT02144688|Human Immunodeficiency Virus|human immunodeficiency virus
339296|NCT02144688|HIV|hiv
339297|NCT02144688|Cognitive symptoms|cognitive symptoms
339298|NCT02144688|Cognitive evaluation|cognitive evaluation
339299|NCT02144688|Neuropsychological testing|neuropsychological testing
339300|NCT02144688|Quality of life|quality of life
339301|NCT02144688|Anxiety|anxiety
339302|NCT02144688|Viral load|viral load
339303|NCT02144688|Antiretroviral|antiretroviral
339304|NCT02144688|Cerebrospinal fluid|cerebrospinal fluid
339305|NCT02144688|Lumbar puncture|lumbar puncture
339306|NCT02144688|Magnetic resonance imaging|magnetic resonance imaging
339307|NCT02144688|MRI|mri
339308|NCT02144649|Prostate Cancer|prostate cancer
339309|NCT02144649|Tangerine Juice|tangerine juice
339310|NCT02144649|Tomato Juice|tomato juice
339311|NCT02144623|Chronic Lymphocytic Leukemia|chronic lymphocytic leukemia
339312|NCT02144623|Valproate|valproate
339313|NCT02144623|Cluster of differentiation antigen 20|cluster of differentiation antigen 20
339314|NCT02144623|Lymphomas|lymphomas
339315|NCT02144623|B-cell lymphomas|b-cell lymphomas
339316|NCT02144623|Translational research|translational research
339317|NCT02144623|Monoclonal antibodies|monoclonal antibodies
339318|NCT02144610|CLI|cli
339319|NCT02144597|morbid obesity|morbid obesity
339320|NCT02144597|gastric bypass|gastric bypass
339321|NCT02144597|bariatrics|bariatrics
339322|NCT02144597|diet|diet
339323|NCT02144597|caloric restriction|caloric restriction
339324|NCT02144597|liver fat|liver fat
339325|NCT02144597|appetite|appetite
339326|NCT02144584|ischemic stroke|ischemic stroke
339327|NCT02144584|memantine|memantine
339328|NCT02144584|upper extremity weakness|upper extremity weakness
339329|NCT02144584|motor recovery|motor recovery
339330|NCT02144558|Sperm parameters|sperm parameters
339331|NCT02144558|Spinal cord injuries|spinal cord injuries
339332|NCT02144558|Oxidative stress|oxidative stress
339333|NCT02144558|Inflammatory syndrome|inflammatory syndrome
339334|NCT02144545|Surgery|surgery
339335|NCT02144545|Morbid Obesity|morbid obesity
339336|NCT02144545|Bariatric surgery|bariatric surgery
339337|NCT02144545|Sleeve gastrectomy|sleeve gastrectomy
339338|NCT02144545|Bougie Size|bougie size
339339|NCT02144545|Distance from pylorus|distance from pylorus
339340|NCT02144545|Hormones|hormones
339341|NCT02144545|Gastric remanent|gastric remanent
339342|NCT02144532|Ehlers-Danlos syndrome|ehlers-danlos syndrome
339343|NCT02144532|hypermobility|hypermobility
339344|NCT02144532|Compression garment|compression garment
339345|NCT02144532|pain|pain
339346|NCT02144532|isokinetic evaluation|isokinetic evaluation
339347|NCT02144506|Elderly, home-based exercises programm|elderly, home-based exercises programm
339348|NCT02144493|common bile duct stones|common bile duct stones
339349|NCT02144493|diverticulum|diverticulum
339350|NCT02144480|coronary bypass surgery|coronary bypass surgery
339351|NCT02144480|rehabilitation|rehabilitation
339352|NCT02144480|exercise training|exercise training
339353|NCT02144480|platelet activation|platelet activation
339354|NCT02144480|cardiopulmonary fitness|cardiopulmonary fitness
339355|NCT02144467|Multiple-MRI, Gene, Cognition|multiple-mri, gene, cognition
339356|NCT02144454|Cardiovascular disease|cardiovascular disease
339357|NCT02144454|Fatty acids|fatty acids
339358|NCT02144454|Vascular function|vascular function
339359|NCT02144454|Blood pressure|blood pressure
339360|NCT02144454|Plasma lipids|plasma lipids
339361|NCT02144454|Insulin resistance|insulin resistance
339362|NCT02144454|Endothelial activation|endothelial activation
339363|NCT02144441|Diabetes Mellitus|diabetes mellitus
339364|NCT02144441|Insulin|insulin
339365|NCT02144441|Self Administration|self administration
339366|NCT02144441|Patient Satisfaction|patient satisfaction
339367|NCT02144441|Glucose|glucose
339368|NCT02144441|Hypoglycemia|hypoglycemia
339369|NCT02144441|Hyperglycemia|hyperglycemia
339370|NCT02144415|abuse liability|abuse liability
339371|NCT02144415|recreational drug user|recreational drug user
339372|NCT02144415|stimulant|stimulant
339373|NCT02144415|d-amphetamine|d-amphetamine
339374|NCT02144415|ADHD|adhd
339375|NCT02144389|Arachidonic acid|arachidonic acid
339376|NCT02144389|Bilharzia|bilharzia
339377|NCT02144389|Mansoni|mansoni
339378|NCT02144389|Schistosomiasis|schistosomiasis
339379|NCT02144389|Polyunsaturated fatty acid|polyunsaturated fatty acid
339380|NCT02144376|Constipation|constipation
339381|NCT02144376|psyllium|psyllium
339382|NCT02144376|ispaghula|ispaghula
339383|NCT02144376|Magnetic Resonance Imaging|magnetic resonance imaging
339384|NCT02144376|MRI|mri
339385|NCT02144376|microbiota|microbiota
339386|NCT02144363|Preterm|preterm
339387|NCT02144363|RDS|rds
339388|NCT02144363|Mechanical Ventilation|mechanical ventilation
339389|NCT02144363|Extubation failure|extubation failure
339390|NCT02144350|hyperbaric oxygen|hyperbaric oxygen
339391|NCT02144337|Physical activity|physical activity
339392|NCT02144337|Type 1 Diabetes Mellitus|type 1 diabetes mellitus
339393|NCT02144337|Children|children
339394|NCT02144337|Intervention|intervention
339395|NCT02144324|Maxillary protraction|maxillary protraction
339396|NCT02144324|Modified Tandem Appliance|modified tandem appliance
339397|NCT02144324|Face mask therapy|face mask therapy
774479|NCT00351559|transplant|transplant
339398|NCT02144324|Class III malocclusion|class iii malocclusion
339399|NCT02144324|Maxillary deficiency|maxillary deficiency
339400|NCT02144311|MRI|mri
339401|NCT02144311|FDG PET/CT|fdg pet/ct
339402|NCT02144311|histologic heterogeneity|histologic heterogeneity
339403|NCT02144311|14-061|14-061
339404|NCT02144298|microcirculation|microcirculation
339405|NCT02144298|coronary artery bypass grafting|coronary artery bypass grafting
339406|NCT02144298|cold blood cardioplegia|cold blood cardioplegia
339407|NCT02144298|cristalloid cardioplegia|cristalloid cardioplegia
339408|NCT02144285|Renal dialysis|renal dialysis
339409|NCT02144272|Antibody|antibody
339410|NCT02144272|Tumor Necrosis Factor alpha|tumor necrosis factor alpha
339411|NCT02144272|Interleukin-17|interleukin-17
339412|NCT02144233|Pain|pain
339413|NCT02144233|Temporomandibular joint disorders|temporomandibular joint disorders
339414|NCT02144233|Occlusal adjustment|occlusal adjustment
339415|NCT02144233|Therapy|therapy
339416|NCT02144233|Randomized clinical trial|randomized clinical trial
339417|NCT02144233|Mastication|mastication
339418|NCT02144233|Habitual chewing side|habitual chewing side
339419|NCT02144233|Handedness preference|handedness preference
339420|NCT02144233|Hemimandibular retrognathia|hemimandibular retrognathia
339421|NCT02144220|Telemedicine|telemedicine
339422|NCT02144220|Virtual care visit|virtual care visit
339423|NCT02144220|Remote visit|remote visit
339424|NCT02144220|Video-conferencing|video-conferencing
339425|NCT02144194|Oral Vinorelbine|oral vinorelbine
339426|NCT02144194|Oral Chemotherapy|oral chemotherapy
339632|NCT02143466|Selumetinib|selumetinib
339427|NCT02144194|Metastatic Breast Cancer|metastatic breast cancer
339428|NCT02144194|Advanced Breast Cancer|advanced breast cancer
339429|NCT02144194|Maintenance treatment|maintenance treatment
339430|NCT02144181|Ulthera® System|ulthera® system
339431|NCT02144181|Ultherapy® Treatment|ultherapy® treatment
339432|NCT02144181|Ulthera, Inc.|ulthera, inc.
339433|NCT02144168|Prebiotics|prebiotics
339434|NCT02144168|diarrhoea|diarrhoea
339435|NCT02144168|Enteral nutrition|enteral nutrition
339436|NCT02144168|Fibre|fibre
339437|NCT02144168|Bifidobacteria|bifidobacteria
339438|NCT02144168|SCFA|scfa
339439|NCT02144155|Oxytocin|oxytocin
339440|NCT02144142|Microbiome|microbiome
339441|NCT02144142|Atopic dermatitis|atopic dermatitis
339442|NCT02144142|Eczema|eczema
339443|NCT02144142|Bacteriotherapy|bacteriotherapy
339444|NCT02144129|Whole Body Electromyostimulation|whole body electromyostimulation
339445|NCT02144129|Inflammatory Bowel Disease|inflammatory bowel disease
339446|NCT02144129|Lean Body Mass|lean body mass
339447|NCT02144129|Muscle Strength|muscle strength
339448|NCT02144116|dance-movement therapy|dance-movement therapy
339449|NCT02144116|balance|balance
339450|NCT02144116|Fibromyalgia|fibromyalgia
339451|NCT02144103|Glaucomatous Neurodegeneration|glaucomatous neurodegeneration
339452|NCT02144103|Retinal Degeneration|retinal degeneration
339453|NCT02144103|Primary Open-Angle Glaucoma|primary open-angle glaucoma
339454|NCT02144103|Optic Neuropathy|optic neuropathy
339455|NCT02144103|Intraocular pressure|intraocular pressure
339456|NCT02144103|Retinal ganglion cell degeneration|retinal ganglion cell degeneration
339457|NCT02144103|Optic nerve atrophy|optic nerve atrophy
339458|NCT02144103|Subtenon injection|subtenon injection
339459|NCT02144103|Glaucomatous damage|glaucomatous damage
339460|NCT02144103|ADRC|adrc
339461|NCT02144103|Adipose-derived regenerative cells|adipose-derived regenerative cells
339462|NCT02144103|Fat tissue|fat tissue
339463|NCT02144103|Stem cells|stem cells
339464|NCT02144090|Angiography|angiography
339465|NCT02144090|Angioplasty|angioplasty
339466|NCT02144090|Coronary artery disease|coronary artery disease
339467|NCT02144090|Diagnostic|diagnostic
339468|NCT02144090|Fractional flow reserve|fractional flow reserve
339469|NCT02144077|Photodynamic Therapy|photodynamic therapy
339470|NCT02144077|PDT|pdt
339471|NCT02144077|non-aggressive BCC|non-aggressive bcc
339472|NCT02144064|Aspirin, heparin, pregnancy, recurrent pregnancy loss|aspirin, heparin, pregnancy, recurrent pregnancy loss
339473|NCT02144051|solid tumor, prostate cancer, breast cancer, bladder cancer, ovarian cancer, gastric cancer, salivary duct cancer|solid tumor, prostate cancer, breast cancer, bladder cancer, ovarian cancer, gastric cancer, salivary duct cancer
339474|NCT02144038|multiple myeloma,|multiple myeloma,
339475|NCT02144038|relapsed and refractory,|relapsed and refractory,
339476|NCT02144038|LGH447,|lgh447,
339477|NCT02144038|pan-PIM inhibitor,|pan-pim inhibitor,
339478|NCT02144038|PIM Kinase,|pim kinase,
339479|NCT02144038|BYL719,|byl719,
339480|NCT02144038|PI3K inhibitor|pi3k inhibitor
339481|NCT02144025|Ocular Graft-Versus-Host-Disease|ocular graft-versus-host-disease
339482|NCT02144025|Topical Cyclosporine|topical cyclosporine
339483|NCT02143986|sepsis|sepsis
339484|NCT02143986|Macrophagic activation syndrome|macrophagic activation syndrome
339485|NCT02143986|Ferritin|ferritin
339486|NCT02143986|Still's disease|still's disease
339487|NCT02143973|Uremic|uremic
339488|NCT02143973|Pruritus|pruritus
339489|NCT02143973|Itch|itch
339490|NCT02143973|Chronic Itch|chronic itch
339491|NCT02143973|Nalbuphine|nalbuphine
339492|NCT02143960|Syneron|syneron
339493|NCT02143960|Velashape|velashape
339494|NCT02143960|ELOS|elos
339495|NCT02143960|Zeltiq|zeltiq
339496|NCT02143960|Cryolipolysis|cryolipolysis
339497|NCT02143947|Orthoses|orthoses
339498|NCT02143947|Foot|foot
339499|NCT02143947|Kinematics|kinematics
339500|NCT02143947|EMG|emg
339501|NCT02143947|Biomechanics|biomechanics
339502|NCT02143934|Plasmodium vivax|plasmodium vivax
339503|NCT02143934|Hypnozoites|hypnozoites
339504|NCT02143934|Primaquine|primaquine
339505|NCT02143934|Liver-stage|liver-stage
339506|NCT02143934|Blood-stage|blood-stage
339507|NCT02143934|Plasmodium falciparum|plasmodium falciparum
339508|NCT02143921|NGO zinc scale|ngo zinc scale
339509|NCT02143921|compliance with WHO zinc treatment recommendations|compliance with who zinc treatment recommendations
339510|NCT02143908|Diarrhea|diarrhea
339511|NCT02143908|L-lysine supplementation|l-lysine supplementation
339512|NCT02143908|immune status|immune status
339513|NCT02143908|adults|adults
339514|NCT02143908|Bangladesh|bangladesh
339515|NCT02143908|aged 18-45 years|aged 18-45 years
339516|NCT02143908|urban community|urban community
339517|NCT02143882|Live attenuated influenza vaccine|live attenuated influenza vaccine
339518|NCT02143882|fluenz|fluenz
339519|NCT02143882|pandemrix|pandemrix
339520|NCT02143882|pandemic influenza vaccine|pandemic influenza vaccine
339521|NCT02143882|immunogenicity|immunogenicity
339522|NCT02143869|Gastrointestinal cancer|gastrointestinal cancer
339523|NCT02143869|Lung cancer|lung cancer
339524|NCT02143869|Bioelectrical Impedance analysis|bioelectrical impedance analysis
339525|NCT02143869|Body composition|body composition
339526|NCT02143869|Perioperative|perioperative
339527|NCT02143830|marrow aplasia|marrow aplasia
339528|NCT02143830|cytopenia|cytopenia
339529|NCT02143830|myelodysplasia|myelodysplasia
339530|NCT02143830|AML|aml
339531|NCT02143830|bone marrow transplant|bone marrow transplant
339532|NCT02143830|cytoreductive regimen|cytoreductive regimen
339533|NCT02143830|T-cell reduction|t-cell reduction
339534|NCT02143817|whole body vibration training|whole body vibration training
339535|NCT02143817|L-citrulline|l-citrulline
339536|NCT02143817|hypertension|hypertension
339537|NCT02143817|obesity|obesity
339538|NCT02143817|arterial function|arterial function
339539|NCT02143817|arterial stiffness|arterial stiffness
339540|NCT02143817|autonomic function|autonomic function
339541|NCT02143817|endothelial function|endothelial function
339542|NCT02143804|Oncolytic virus|oncolytic virus
339543|NCT02143804|GMCSF|gmcsf
339544|NCT02143804|pRb|prb
339545|NCT02143804|PDL1|pdl1
339546|NCT02143804|Immunotherapy|immunotherapy
339547|NCT02143804|Adenovirus|adenovirus
339548|NCT02143791|SCS|scs
339549|NCT02143791|Burst stimulation|burst stimulation
339550|NCT02143778|MBT|mbt
339551|NCT02143778|CSPH|csph
339552|NCT02143778|HVPG|hvpg
339553|NCT02143765|Mitiglinide|mitiglinide
339554|NCT02143765|Acarbose|acarbose
339555|NCT02143765|Type 2 Diabetes Mellitus|type 2 diabetes mellitus
339556|NCT02143752|Smoking|smoking
339557|NCT02143752|Tobacco|tobacco
339558|NCT02143752|Addiction|addiction
339559|NCT02143752|Mindfulness|mindfulness
339560|NCT02143752|Meditation|meditation
339561|NCT02143739|asthma|asthma
339562|NCT02143713|Endometriosis-associated pain|endometriosis-associated pain
339563|NCT02143713|Elagolix|elagolix
339564|NCT02143713|Gonadotropin-releasing Hormone Antagonist|gonadotropin-releasing hormone antagonist
339565|NCT02143713|Dysmenorrhea (DYS)|dysmenorrhea (dys)
339566|NCT02143713|Non-menstrual Pelvic Pain (NMPP)|non-menstrual pelvic pain (nmpp)
339567|NCT02143713|Dyspareunia|dyspareunia
339568|NCT02143700|exacerbation|exacerbation
339569|NCT02143700|cognitive|cognitive
339570|NCT02143700|chronic obstructive pulmonary disease|chronic obstructive pulmonary disease
339571|NCT02143687|Pulmonary hypertension|pulmonary hypertension
339572|NCT02143687|Interstitial lung disease|interstitial lung disease
339573|NCT02143687|Pulmonary fibrosis|pulmonary fibrosis
339574|NCT02143674|Stretching exercise muscle|stretching exercise muscle
339575|NCT02143674|Elderly|elderly
339576|NCT02143674|Techniques and exercise|techniques and exercise
339577|NCT02143674|Physiotherapy|physiotherapy
339578|NCT02143648|uremic|uremic
339579|NCT02143648|pruritus|pruritus
339580|NCT02143648|itch|itch
339581|NCT02143648|chronic itch|chronic itch
339582|NCT02143648|nalbuphine|nalbuphine
339583|NCT02143635|HDM201,TP53wt, p53, MDM2, HDM2, advanced tumors, BLRM (Bayesian logistic regression model)|hdm201,tp53wt, p53, mdm2, hdm2, advanced tumors, blrm (bayesian logistic regression model)
339584|NCT02143622|Head and neck cancer|head and neck cancer
339585|NCT02143609|airway disease|airway disease
339586|NCT02143609|bronchitis|bronchitis
339587|NCT02143609|emphysema|emphysema
339588|NCT02143609|lung|lung
339589|NCT02143596|stroke|stroke
339590|NCT02143596|dehydration|dehydration
339591|NCT02143596|prognosis|prognosis
339592|NCT02143583|rhinoconjunctivitis|rhinoconjunctivitis
339593|NCT02143583|birch pollen|birch pollen
339594|NCT02143583|desensitization|desensitization
339595|NCT02143583|allergen immunotherapy|allergen immunotherapy
339596|NCT02143570|Urinary Bladder, Overactive|urinary bladder, overactive
339597|NCT02143570|Darifenacin|darifenacin
339598|NCT02143570|Physiotherapy|physiotherapy
339599|NCT02143570|Quality of Life|quality of life
339600|NCT02143557|breast milk|breast milk
339601|NCT02143557|infants|infants
339602|NCT02143557|chylothorax|chylothorax
339603|NCT02143557|cardiac surgery|cardiac surgery
339604|NCT02143557|modified breast milk|modified breast milk
339605|NCT02143544|Intra-aortic balloon counterpulsation|intra-aortic balloon counterpulsation
339606|NCT02143544|Cardiac surgery|cardiac surgery
339607|NCT02143544|High-risk patients|high-risk patients
339608|NCT02143518|Human Hookworm|human hookworm
339609|NCT02143518|Necator americanus|necator americanus
339610|NCT02143518|Hookworm|hookworm
339611|NCT02143518|Hookworm Disease|hookworm disease
339612|NCT02143518|Iron-deficiency anemia|iron-deficiency anemia
339613|NCT02143518|Soil-transmitted helminth infection|soil-transmitted helminth infection
339614|NCT02143518|Neglected Tropical Disease|neglected tropical disease
339615|NCT02143518|Na-GST-1|na-gst-1
339616|NCT02143518|CpG|cpg
339617|NCT02143479|France|france
339618|NCT02143479|Prograf|prograf
339619|NCT02143479|Pharmaco-epidemiology|pharmaco-epidemiology
339620|NCT02143479|Tacrolimus|tacrolimus
339621|NCT02143479|Observational|observational
339622|NCT02143466|Phase I|phase i
339623|NCT02143466|Safety|safety
339624|NCT02143466|Tolerability|tolerability
339625|NCT02143466|Efficacy|efficacy
339626|NCT02143466|Anti-tumour|anti-tumour
339627|NCT02143466|AZD9291|azd9291
339628|NCT02143466|AZD6094|azd6094
339629|NCT02143466|MEDI4736|medi4736
339630|NCT02143466|Osimertinib|osimertinib
339633|NCT02143466|Durvalumab|durvalumab
339634|NCT02143466|Ascending Doses|ascending doses
339635|NCT02143466|Expansion cohorts|expansion cohorts
339636|NCT02143466|EGFR|egfr
339637|NCT02143466|Advanced Non-Small Cell Lung Cancer|advanced non-small cell lung cancer
339638|NCT02143466|Tyrosine Kinase Inhibitors|tyrosine kinase inhibitors
339639|NCT02143453|exercise|exercise
339640|NCT02143453|overweight|overweight
339641|NCT02143453|children|children
339642|NCT02143427|social skills training,|social skills training,
339643|NCT02143427|computer based,|computer based,
339644|NCT02143427|social competence training,|social competence training,
339645|NCT02143427|Oppositional Defiant Disorder|oppositional defiant disorder
339646|NCT02143427|peer related aggressive behavior|peer related aggressive behavior
339647|NCT02143427|randomized controlled trial|randomized controlled trial
339648|NCT02143388|Local advanced|local advanced
339649|NCT02143388|high risk|high risk
339650|NCT02143388|nasopharyngeal carcinoma|nasopharyngeal carcinoma
339651|NCT02143362|Intraoperative wake up|intraoperative wake up
339652|NCT02143362|Closed loop of target controlled infusion|closed loop of target controlled infusion
339653|NCT02143362|Dexmedetomidine|dexmedetomidine
339654|NCT02143362|Propofol|propofol
339655|NCT02143349|obesity|obesity
339656|NCT02143349|herbal remedies|herbal remedies
339657|NCT02143349|metabolic disorders|metabolic disorders
339658|NCT02143336|Surgical site infections|surgical site infections
339659|NCT02143336|Skin closure techniques|skin closure techniques
339660|NCT02143336|Colorectal surgery|colorectal surgery
339661|NCT02143323|GST, DILI, biomarker|gst, dili, biomarker
339662|NCT02143297|Sleep Apnea/Hypopnea Syndrome|sleep apnea/hypopnea syndrome
339663|NCT02143297|Pulse Oximetry|pulse oximetry
339664|NCT02143297|Nonlinear Dynamics|nonlinear dynamics
339665|NCT02143297|Fourier Analysis|fourier analysis
339666|NCT02143297|Neural Networks (Computer)|neural networks (computer)
339667|NCT02143271|Secondary Hyperparathyroidism in Patients Receiving Peritoneal Dialysis|secondary hyperparathyroidism in patients receiving peritoneal dialysis
339668|NCT02143258|stenting venous sinus|stenting venous sinus
339669|NCT02143258|intracranial hypertension|intracranial hypertension
339670|NCT02143258|quality of life|quality of life
339671|NCT02143258|headache|headache
339672|NCT02143258|visual impairment|visual impairment
339673|NCT02143232|knee replacement|knee replacement
339674|NCT02143232|hip replacement|hip replacement
339675|NCT02143232|patient monitor|patient monitor
339676|NCT02143219|Pancreatic metastatic cancer|pancreatic metastatic cancer
339677|NCT02143219|FOLFIRINOX|folfirinox
339678|NCT02143219|toxicity|toxicity
339679|NCT02143219|efficacy|efficacy
339680|NCT02143206|Chronic Obstructive Pulmonary Disease|chronic obstructive pulmonary disease
339681|NCT02143206|Pain|pain
339682|NCT02143206|Arthritis|arthritis
339683|NCT02143206|Dyspnea|dyspnea
339684|NCT02143206|Exercise|exercise
339685|NCT02143206|Aerobic|aerobic
339686|NCT02143193|Breastfeeding|breastfeeding
339687|NCT02143193|Newborn|newborn
339688|NCT02143193|Formula|formula
339689|NCT02143193|Temperature|temperature
339690|NCT02143193|Initial Bath|initial bath
339691|NCT02143180|real-time tissue elastography|real-time tissue elastography
339692|NCT02143180|hepatic fibrosis|hepatic fibrosis
339693|NCT02143154|vancomycin, GBS|vancomycin, gbs
339694|NCT02143141|postoperative pain|postoperative pain
774876|NCT00349804|temperature|temperature
339695|NCT02143141|narcotic side effects|narcotic side effects
339696|NCT02143128|score|score
339697|NCT02143128|postoperative|postoperative
339698|NCT02143128|pain|pain
339699|NCT02143128|nausea|nausea
339700|NCT02143128|mental status|mental status
339701|NCT02143128|tool|tool
339702|NCT02143115|Colorectal cancer surveillance|colorectal cancer surveillance
339703|NCT02143089|CCSWI|ccswi
339704|NCT02143076|Medication Adherence|medication adherence
339705|NCT02143076|Hydroxyurea|hydroxyurea
339706|NCT02143050|Unresectable melanoma Stage IIIC and Stage IV BRAF V600E+|unresectable melanoma stage iiic and stage iv braf v600e+
339707|NCT02143024|depression|depression
339708|NCT02143024|family|family
339709|NCT02143024|primary health care|primary health care
339710|NCT02143011|sugar|sugar
339711|NCT02143011|sucrose|sucrose
339712|NCT02143011|fruit juice|fruit juice
339713|NCT02143011|orange juice|orange juice
339714|NCT02143011|metabolism|metabolism
339715|NCT02143011|immune cell aging|immune cell aging
339716|NCT02143011|lipids|lipids
339717|NCT02142998|GERD|gerd
339718|NCT02142998|Laparoscopic|laparoscopic
339719|NCT02142998|sleeve|sleeve
339720|NCT02142998|gastrectomy|gastrectomy
339721|NCT02142972|Low back pain|low back pain
339722|NCT02142972|Oswestry questionnaire|oswestry questionnaire
339723|NCT02142972|Post-partum Depression|post-partum depression
339724|NCT02142972|Pelvic pain|pelvic pain
339725|NCT02142959|RTA 408|rta 408
339726|NCT02142959|RTA 408 Lotion|rta 408 lotion
339727|NCT02142959|Breast cancer|breast cancer
339728|NCT02142959|Radiation therapy|radiation therapy
339729|NCT02142959|Radiation dermatitis|radiation dermatitis
339730|NCT02142959|Oxidative stress|oxidative stress
339731|NCT02142959|Inflammation|inflammation
339732|NCT02142959|omaveloxolone|omaveloxolone
339733|NCT02142933|colonization|colonization
339734|NCT02142933|screening|screening
339735|NCT02142933|group B streptococci|group b streptococci
339736|NCT02142933|extended-spectrum beta-lactamase|extended-spectrum beta-lactamase
339737|NCT02142933|enterobacteriaceae|enterobacteriaceae
339738|NCT02142920|Healthy Volunteers|healthy volunteers
339739|NCT02142907|Breast conservative surgery|breast conservative surgery
339740|NCT02142907|boost radiation|boost radiation
339741|NCT02142907|acute toxicity|acute toxicity
339742|NCT02142907|cosmesis|cosmesis
339743|NCT02142907|local control|local control
339744|NCT02142894|Tuberculosis|tuberculosis
339745|NCT02142894|TB|tb
339746|NCT02142868|Expanded Access|expanded access
339747|NCT02142868|Advanced Breast Cancer|advanced breast cancer
339748|NCT02142855|volunteers|volunteers
339749|NCT02142855|young (18-30 y)|young (18-30 y)
339750|NCT02142855|older (65-75 y)|older (65-75 y)
339751|NCT02142855|age groups|age groups
339752|NCT02142842|Adipose stem cell|adipose stem cell
339753|NCT02142842|Platelet rich plasma|platelet rich plasma
339754|NCT02142842|Knee Osteoarthritis|knee osteoarthritis
339755|NCT02142842|Injured cartilage|injured cartilage
339756|NCT02142829|bariatric surgery, postoperative pain|bariatric surgery, postoperative pain
339757|NCT02142777|S-equol|s-equol
339758|NCT02142777|COX activity|cox activity
339759|NCT02142764|Multiple Sclerosis|multiple sclerosis
339760|NCT02142764|CD8+ T-cells|cd8+ t-cells
339761|NCT02142764|Class I Major Histocompatibility Complex (MHC)|class i major histocompatibility complex (mhc)
339762|NCT02142764|pentamers|pentamers
339763|NCT02142751|Escherichia coli|escherichia coli
339764|NCT02142751|Extended-spectrum β-lactamases (ESBLs)|extended-spectrum β-lactamases (esbls)
339765|NCT02142751|Bacteremia|bacteremia
339766|NCT02142751|Urinary tract infection|urinary tract infection
339767|NCT02142751|Bloodstream infection|bloodstream infection
339768|NCT02142751|Fosfomycin|fosfomycin
339769|NCT02142751|Meropenem|meropenem
339770|NCT02142751|Pharmacokinetics|pharmacokinetics
339771|NCT02142751|intestinal colonization|intestinal colonization
339772|NCT02142751|Recurrence|recurrence
339773|NCT02142751|multidrug resistance E.coli|multidrug resistance e.coli
339774|NCT02142751|Ceftriaxone|ceftriaxone
339775|NCT02142738|PD-1|pd-1
339776|NCT02142738|PD1|pd1
339777|NCT02142738|PD-L1|pd-l1
339778|NCT02142738|PDL1|pdl1
339779|NCT02142712|Ischemic Stroke|ischemic stroke
339780|NCT02142712|Brain Edema|brain edema
339781|NCT02142712|Diphenhydramine|diphenhydramine
339782|NCT02142712|Dextromethorphan|dextromethorphan
339783|NCT02142712|Famotidine|famotidine
339784|NCT02142699|Acute kidney injury|acute kidney injury
339785|NCT02142699|Cardiac surgery|cardiac surgery
339786|NCT02142699|Ischaemia reperfusion injury|ischaemia reperfusion injury
339787|NCT02142699|hemearginate|hemearginate
339788|NCT02142686|Hysteroscopy|hysteroscopy
339789|NCT02142686|Filling pressures|filling pressures
339790|NCT02142673|Operative hysteroscopy|operative hysteroscopy
339791|NCT02142673|Filling pressure|filling pressure
339792|NCT02142660|Adhesion barrier system|adhesion barrier system
339793|NCT02142660|Bariatric surgery|bariatric surgery
339794|NCT02142647|infant growth|infant growth
339795|NCT02142647|dietary protein|dietary protein
339796|NCT02142647|body composition|body composition
339797|NCT02142647|gut microbiome|gut microbiome
339798|NCT02142608|Prostate cancer|prostate cancer
339799|NCT02142608|Ultrasound Imaging|ultrasound imaging
339800|NCT02142595|dexmedetomidine|dexmedetomidine
339801|NCT02142595|midazolam|midazolam
339802|NCT02142595|sleep quality|sleep quality
339803|NCT02142595|delirium|delirium
339804|NCT02142582|Home Parenteral Nutrition|home parenteral nutrition
339805|NCT02142582|Compliance|compliance
339806|NCT02142582|Short Bowel Syndrome|short bowel syndrome
339807|NCT02142582|Oral Rehydration Solution|oral rehydration solution
339808|NCT02142569|Monacolin K|monacolin k
339809|NCT02142569|Cholesterol|cholesterol
339810|NCT02142569|Tocotrienol-enriched fraction of palm oil (TRF)|tocotrienol-enriched fraction of palm oil (trf)
339811|NCT02142569|Chinese Red Yeast Rice (CRYR|chinese red yeast rice (cryr
339812|NCT02142530|NHL|nhl
339813|NCT02142530|DLBCL|dlbcl
339814|NCT02142530|PTCL|ptcl
339815|NCT02142530|Marginal zone lymphoma|marginal zone lymphoma
339816|NCT02142530|lymphoplasmacytic lymphoma|lymphoplasmacytic lymphoma
339817|NCT02142530|Waldenstrom's macroglobulinemia|waldenstrom's macroglobulinemia
339818|NCT02142517|pancreaticoduodenectomy, pancreatic fistula|pancreaticoduodenectomy, pancreatic fistula
339819|NCT02142504|Drug therapy|drug therapy
339820|NCT02142491|Egg allergy|egg allergy
339821|NCT02142491|live attenuated influenza vaccine|live attenuated influenza vaccine
339822|NCT02142478|physical activity|physical activity
339823|NCT02142478|behaviour change|behaviour change
339824|NCT02142478|exercise referral|exercise referral
339825|NCT02142478|self-determination theory|self-determination theory
339826|NCT02142478|mixed-method|mixed-method
339827|NCT02142478|evaluation|evaluation
339828|NCT02142478|qualitative|qualitative
339829|NCT02142452|Pregnancy|pregnancy
339830|NCT02142452|Obesity/Overweight|obesity/overweight
339831|NCT02142452|postpartum|postpartum
339832|NCT02142452|mobile health|mobile health
339833|NCT02142452|cardiovascular disease|cardiovascular disease
339834|NCT02142439|Anorexia|anorexia
339835|NCT02142439|Bulimia|bulimia
339836|NCT02142439|Physical activity|physical activity
339837|NCT02142439|Treatment|treatment
339838|NCT02142426|wound chronic|wound chronic
339839|NCT02142413|Stroke|stroke
339840|NCT02142413|Atrial fibrillation|atrial fibrillation
339841|NCT02142413|Holter ECG|holter ecg
339842|NCT02142413|cardiac MRI|cardiac mri
339843|NCT02142335|B-Raf, inoperable stage III melanoma, metastatic stage IV melanoma,|b-raf, inoperable stage iii melanoma, metastatic stage iv melanoma,
339844|NCT02142296|Pigment Epithelial Detachment|pigment epithelial detachment
339845|NCT02142296|Age-related Macular degeneration|age-related macular degeneration
339846|NCT02142283|Mechanical thrombectomy|mechanical thrombectomy
339847|NCT02142283|Acute ischemic stroke|acute ischemic stroke
339848|NCT02142283|Wake up stroke|wake up stroke
339849|NCT02142283|Late presenting stroke|late presenting stroke
339850|NCT02142257|Obesity|obesity
339851|NCT02142257|Gastric Bypass|gastric bypass
339852|NCT02142257|Aspiration Therapy|aspiration therapy
339853|NCT02142257|AspireAssist|aspireassist
339854|NCT02142244|Sentinel node biopsy|sentinel node biopsy
339855|NCT02142244|Near infra red light|near infra red light
339856|NCT02142244|Indocyanine green|indocyanine green
339857|NCT02142244|micrometastasis|micrometastasis
339858|NCT02142231|acupuncture|acupuncture
339859|NCT02142231|test anxiety|test anxiety
339860|NCT02142231|neuroenhancer|neuroenhancer
339861|NCT02142231|placebo|placebo
339862|NCT02142179|Asthma|asthma
339863|NCT02142179|Knowledge|knowledge
339864|NCT02142179|School-Based Service|school-based service
339865|NCT02142179|Adolescents|adolescents
339866|NCT02142166|aneurysmal subarachnoid hemorrhage (ASH)|aneurysmal subarachnoid hemorrhage (ash)
339867|NCT02142166|biomarker|biomarker
339868|NCT02142153|First in man|first in man
339869|NCT02142153|Antifungal|antifungal
339870|NCT02142153|Intravenous infusion|intravenous infusion
339871|NCT02142153|Healthy volunteers|healthy volunteers
339872|NCT02142140|Treatment of ADHD|treatment of adhd
339873|NCT02142140|Long-term treatment follow-up|long-term treatment follow-up
339874|NCT02142127|GFT505|gft505
339875|NCT02142127|Mass balance|mass balance
339876|NCT02142127|Pharmacokinetics|pharmacokinetics
339877|NCT02142127|Metabolites|metabolites
339878|NCT02142127|Healthy subjects|healthy subjects
339879|NCT02142127|Healthy male volunteers|healthy male volunteers
339880|NCT02142114|Intravitreal injection|intravitreal injection
339881|NCT02142114|Needle size|needle size
339882|NCT02142114|Pain|pain
339883|NCT02142114|Intraocular pressure|intraocular pressure
339884|NCT02142114|Pain following an Intravitreal injection|pain following an intravitreal injection
339885|NCT02142101|Gut Microbiota|gut microbiota
339886|NCT02142101|Polycystic kidney disease|polycystic kidney disease
339887|NCT02142101|Chronic kidney disease|chronic kidney disease
339888|NCT02142101|Uremic metabolites|uremic metabolites
339889|NCT02142088|Glycaemic Control|glycaemic control
339890|NCT02142088|Glucose Monitoring|glucose monitoring
339891|NCT02142088|Intravascular Glucose Monitoring|intravascular glucose monitoring
339892|NCT02142075|Pharmacokinetics|pharmacokinetics
339893|NCT02142062|Venous outflow obstruction|venous outflow obstruction
339894|NCT02142062|Iliac Vein|iliac vein
339895|NCT02142062|Common Femoral Vein|common femoral vein
339896|NCT02142062|Iliac Compression|iliac compression
339897|NCT02142049|DLBCL|dlbcl
339898|NCT02142049|ABC|abc
339899|NCT02142049|GCB|gcb
339900|NCT02142049|Primary Mediastinal B-cell lymphoma|primary mediastinal b-cell lymphoma
339901|NCT02142049|Pharmacyclics|pharmacyclics
339902|NCT02142049|Lenalidomide|lenalidomide
339903|NCT02142049|lymphoma|lymphoma
339904|NCT02142049|Rituximab|rituximab
339905|NCT02142049|EPOCH|epoch
339906|NCT02142049|Recommended Phase 2 Dose(RP2D)|recommended phase 2 dose(rp2d)
339907|NCT02142036|Metastatic disease|metastatic disease
339908|NCT02142036|Metastasis|metastasis
339909|NCT02142036|Targeted therapy|targeted therapy
339910|NCT02142036|Solid tumor|solid tumor
339911|NCT02142036|Personalized medicine|personalized medicine
339912|NCT02142036|N-of-1 trial|n-of-1 trial
339913|NCT02141997|efficacy|efficacy
339914|NCT02141997|Methotrexate|methotrexate
339915|NCT02141997|safety|safety
339916|NCT02141984|Korean regulatory required Postmarketing Surveillance|korean regulatory required postmarketing surveillance
339917|NCT02141971|Down syndrome|down syndrome
339918|NCT02141971|Alzheimer's disease|alzheimer's disease
339919|NCT02141971|biomarkers|biomarkers
339920|NCT02141971|amyloid|amyloid
339921|NCT02141971|tau|tau
339922|NCT02141945|Cancer|cancer
339923|NCT02141945|Colon Cancer|colon cancer
339924|NCT02141945|Colorectal Cancer|colorectal cancer
339925|NCT02141945|Neoplasm|neoplasm
339926|NCT02141945|Colorectal Neoplasm|colorectal neoplasm
339927|NCT02141945|Intestinal Neoplasms|intestinal neoplasms
339928|NCT02141945|Gastrointestinal Neoplasms|gastrointestinal neoplasms
339929|NCT02141945|Digestive System Neoplasms|digestive system neoplasms
339930|NCT02141945|Neoplasms by Site|neoplasms by site
339931|NCT02141945|Neoplasms|neoplasms
340336|NCT02140008|the i-gel|the i-gel
339932|NCT02141945|Colonic Diseases|colonic diseases
339933|NCT02141945|Digestive System Diseases|digestive system diseases
339934|NCT02141945|Gastrointestinal Diseases|gastrointestinal diseases
339935|NCT02141945|Intestinal Diseases|intestinal diseases
339936|NCT02141945|Rectal Diseases|rectal diseases
339937|NCT02141932|Hand-held|hand-held
339938|NCT02141932|Ultrasound|ultrasound
339939|NCT02141932|Diagnosis|diagnosis
339940|NCT02141932|Cardiovascular|cardiovascular
339941|NCT02141932|Carotid artery stenosis|carotid artery stenosis
339942|NCT02141919|renal cancer|renal cancer
339943|NCT02141880|Obesity|obesity
339944|NCT02141867|Surgery|surgery
339945|NCT02141867|Mortality|mortality
339946|NCT02141841|intrathecal;|intrathecal;
339947|NCT02141841|bupivacaine;|bupivacaine;
339948|NCT02141841|concentration;|concentration;
339949|NCT02141828|Leukemia|leukemia
339950|NCT02141828|Advanced hematologic malignancies|advanced hematologic malignancies
339951|NCT02141828|Epizyme|epizyme
339952|NCT02141828|Phase 1b|phase 1b
339953|NCT02141828|MLL gene|mll gene
339954|NCT02141828|11q23|11q23
339955|NCT02141828|Ambiguous lineage|ambiguous lineage
339956|NCT02141828|ALL|all
339957|NCT02141828|AML|aml
339958|NCT02141828|Acute leukemias|acute leukemias
339959|NCT02141828|MLL-r|mll-r
339960|NCT02141763|Psoriatic Arthritis|psoriatic arthritis
339961|NCT02141724|Neuromuscular|neuromuscular
339962|NCT02141724|Wheelchair|wheelchair
339963|NCT02141724|Pain|pain
339964|NCT02141724|Bedsore|bedsore
339965|NCT02141724|Trouble postural|trouble postural
339966|NCT02141711|Drug therapy|drug therapy
339967|NCT02141698|Drug therapy|drug therapy
339968|NCT02141685|in vitro fertilization|in vitro fertilization
339969|NCT02141685|assisted reproduction techniques|assisted reproduction techniques
339970|NCT02141685|noninvasive imaging of embryos|noninvasive imaging of embryos
339971|NCT02141685|time lapse imaging of embryos|time lapse imaging of embryos
339972|NCT02141685|traditional morphological grading of embryos|traditional morphological grading of embryos
339973|NCT02141685|prediction of blastocysts|prediction of blastocysts
339974|NCT02141685|infertility|infertility
339975|NCT02141685|preimplantation genetic diagnosis|preimplantation genetic diagnosis
339976|NCT02141685|array-Comparative Genomic Hybridization|array-comparative genomic hybridization
339977|NCT02141672|lupus nephritis|lupus nephritis
339978|NCT02141672|calcineurin inhibitors|calcineurin inhibitors
339979|NCT02141672|voclosporin|voclosporin
339980|NCT02141646|HIV/AIDS, motivational interviewing, behavioral skills training, MRI|hiv/aids, motivational interviewing, behavioral skills training, mri
339981|NCT02141633|smokers|smokers
339982|NCT02141633|airway blood flow|airway blood flow
339983|NCT02141633|fluticasone|fluticasone
339984|NCT02141633|echocardiogram|echocardiogram
339985|NCT02141607|shock|shock
339986|NCT02141607|heart failure|heart failure
339987|NCT02141607|inflammation|inflammation
339988|NCT02141607|biomarkers|biomarkers
339989|NCT02141607|cardiovascular instability|cardiovascular instability
339990|NCT02141607|metabolic pathways|metabolic pathways
339991|NCT02141607|proteolysis|proteolysis
775054|NCT00349024|chordoma|chordoma
339992|NCT02141581|Intramuscular inactivated trivalent influenza vaccine|intramuscular inactivated trivalent influenza vaccine
339993|NCT02141581|Intradermal inactivated trivalent influenza vaccine|intradermal inactivated trivalent influenza vaccine
339994|NCT02141581|Live, attenuated influenza vaccine|live, attenuated influenza vaccine
339995|NCT02141581|Young adults|young adults
339996|NCT02141568|Cost-effective|cost-effective
339997|NCT02141568|Unexplained Medical Symptoms|unexplained medical symptoms
339998|NCT02141568|Frequent Attenders|frequent attenders
339999|NCT02141555|misoprostol, early pregnancy loss, missed abortion|misoprostol, early pregnancy loss, missed abortion
340000|NCT02141542|Metastatic Melanoma|metastatic melanoma
340001|NCT02141529|Intraarticular|intraarticular
340002|NCT02141529|pulsed radiofrequency|pulsed radiofrequency
340003|NCT02141529|osteoarthritis|osteoarthritis
340004|NCT02141516|Meningitis|meningitis
340005|NCT02141516|vaccination|vaccination
340006|NCT02141516|complement deficiency|complement deficiency
340007|NCT02141516|asplenia|asplenia
340008|NCT02141516|splenic dysfunction|splenic dysfunction
340009|NCT02141503|Biomarkers|biomarkers
340010|NCT02141503|Alpha-Manosidosis|alpha-manosidosis
340011|NCT02141490|Lymph Node|lymph node
340012|NCT02141490|Biopsy|biopsy
340013|NCT02141490|Metastatic Nodes|metastatic nodes
340014|NCT02141490|Imaging Agent|imaging agent
340015|NCT02141477|Leukemia|leukemia
340016|NCT02141477|Acute Myelogenous Leukemia|acute myelogenous leukemia
340017|NCT02141477|AML|aml
340018|NCT02141477|High Risk Myelodysplastic Syndrome|high risk myelodysplastic syndrome
340019|NCT02141477|MDS|mds
340020|NCT02141477|Omacetaxine|omacetaxine
340021|NCT02141477|Synribo|synribo
340022|NCT02141477|Homoharringtonine|homoharringtonine
340023|NCT02141477|Decitabine|decitabine
340024|NCT02141477|Dacogen|dacogen
340025|NCT02141451|DLBCL|dlbcl
340026|NCT02141438|Radium-223|radium-223
340027|NCT02141438|CRPC|crpc
340028|NCT02141438|Phase IV|phase iv
340029|NCT02141438|Safety study|safety study
340030|NCT02141425|Healthy volunteers|healthy volunteers
340031|NCT02141425|ASP015K|asp015k
340032|NCT02141412|optimal dose of dexmedetomidine|optimal dose of dexmedetomidine
340033|NCT02141412|prevent shivering|prevent shivering
340034|NCT02141412|improve quality of emergence|improve quality of emergence
340035|NCT02141412|anesthesia|anesthesia
340036|NCT02141412|without delay|without delay
340037|NCT02141412|recovery|recovery
340038|NCT02141386|Multiple Sclerosis|multiple sclerosis
340039|NCT02141386|Cognitive remediation|cognitive remediation
340040|NCT02141386|Plasticity-based, adaptive, computerized cognitive remediation|plasticity-based, adaptive, computerized cognitive remediation
340041|NCT02141386|Cognitive impairment|cognitive impairment
340043|NCT02141373|axillary|axillary
340044|NCT02141373|dissection|dissection
340045|NCT02141360|Mild Traumatic Brain Injury|mild traumatic brain injury
340046|NCT02141321|IUD|iud
340047|NCT02141321|Misoprostol|misoprostol
340048|NCT02141321|Rectal administration|rectal administration
340049|NCT02141308|Retina|retina
340050|NCT02141308|Optical coherence tomography|optical coherence tomography
340051|NCT02141308|Imaging|imaging
340052|NCT02141282|Oncology|oncology
340053|NCT02141282|Chronic Lymphocytic Leukemia|chronic lymphocytic leukemia
340054|NCT02141282|Cancer of the blood and bone marrow|cancer of the blood and bone marrow
340055|NCT02141269|Transthoracic echocardiogram|transthoracic echocardiogram
340056|NCT02141269|Hand-held Echocardiography|hand-held echocardiography
340057|NCT02141256|elderly|elderly
340058|NCT02141256|protein enrichment|protein enrichment
340059|NCT02141256|undernutrition|undernutrition
340060|NCT02141217|Odontogenic (Dental) Infections|odontogenic (dental) infections
340061|NCT02141217|Dental infections, periapical abscess|dental infections, periapical abscess
340062|NCT02141217|Bacterial infection|bacterial infection
340063|NCT02141204|Rotarix|rotarix
340064|NCT02141204|HRV|hrv
340065|NCT02141204|Healthy infants|healthy infants
340066|NCT02141204|Liquid formulation|liquid formulation
340067|NCT02141204|Lyophilized formulation|lyophilized formulation
340068|NCT02141204|Human rotavirus vaccine|human rotavirus vaccine
340069|NCT02141191|cystic fibrosis|cystic fibrosis
340070|NCT02141191|hypertonic saline|hypertonic saline
340071|NCT02141191|nebulizer|nebulizer
340072|NCT02141191|nasal cannula|nasal cannula
340073|NCT02141165|sleep apnea|sleep apnea
340074|NCT02141165|portable monitor|portable monitor
340075|NCT02141165|primary care|primary care
340076|NCT02141165|cost-effectiveness|cost-effectiveness
340077|NCT02141165|OSAS|osas
340078|NCT02141139|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal
340079|NCT02141139|Inflammation|inflammation
340080|NCT02141139|Perioperative Period|perioperative period
340081|NCT02141126|Older adults|older adults
340082|NCT02141126|Strength training|strength training
340083|NCT02141126|Muscle mass|muscle mass
340084|NCT02141126|Function|function
340085|NCT02141126|Inpatients|inpatients
340086|NCT02141100|thioguanine|thioguanine
340087|NCT02141100|mercaptopurine|mercaptopurine
340088|NCT02141100|methotrexate|methotrexate
340089|NCT02141048|Parenting programme|parenting programme
340090|NCT02141048|Randomised controlled trial|randomised controlled trial
340091|NCT02141048|South Africa|south africa
340092|NCT02141048|Positive parenting|positive parenting
340093|NCT02141048|Child behaviour problems|child behaviour problems
340094|NCT02141048|Implementation fidelity|implementation fidelity
340095|NCT02141048|Low- and middle-income country|low- and middle-income country
340096|NCT02141035|Acetyl-l-carnitine|acetyl-l-carnitine
340097|NCT02141035|Carpal tunnel syndrome|carpal tunnel syndrome
340098|NCT02141035|Motor unit number estimation|motor unit number estimation
340099|NCT02141035|Compression neuropathy|compression neuropathy
340100|NCT02141022|Multiple Sclerosis|multiple sclerosis
340101|NCT02141022|Cognition|cognition
340102|NCT02141022|Cognitive Remediation|cognitive remediation
340103|NCT02141022|Gilenya|gilenya
340104|NCT02141022|Computerized Cognitive Exercise|computerized cognitive exercise
340105|NCT02141009|Vaccination, prevnar, PCV13|vaccination, prevnar, pcv13
340106|NCT02140996|MUC-1 vector vaccine; epithelial cancers; immunotherapy; safety; antigen specific vaccine, dendritic cell activation|muc-1 vector vaccine; epithelial cancers; immunotherapy; safety; antigen specific vaccine, dendritic cell activation
340107|NCT02140983|Insulin Resistance|insulin resistance
340108|NCT02140983|Family History of Dementia|family history of dementia
340109|NCT02140983|Cognition|cognition
340110|NCT02140970|ureteral stent|ureteral stent
340111|NCT02140970|stent pain|stent pain
340112|NCT02140970|ureteral spasm|ureteral spasm
340113|NCT02140970|NSAID|nsaid
340114|NCT02140970|ibuprofen|ibuprofen
340115|NCT02140970|placebo|placebo
340116|NCT02140970|ureteropelvic junction obstruction|ureteropelvic junction obstruction
340117|NCT02140970|urolithiasis|urolithiasis
340118|NCT02140957|Toddler Bottle Use|toddler bottle use
340119|NCT02140957|Educational Intervention|educational intervention
340120|NCT02140957|Pediatrics|pediatrics
340121|NCT02140957|Iron Deficiency|iron deficiency
340122|NCT02140944|Cord blood transplantation|cord blood transplantation
340123|NCT02140944|CCR5Δ32|ccr5δ32
340124|NCT02140944|HIV cure|hiv cure
340125|NCT02140931|Cell therapy|cell therapy
340126|NCT02140931|Autologous|autologous
340127|NCT02140918|Fludrocortisone|fludrocortisone
340128|NCT02140918|Mineralocorticoids|mineralocorticoids
340129|NCT02140918|Hemodynamics|hemodynamics
340130|NCT02140918|Pharmacokinetics|pharmacokinetics
340131|NCT02140905|Hemodialysis|hemodialysis
340132|NCT02140905|Heart failure|heart failure
340133|NCT02140905|Impedance|impedance
340134|NCT02140905|Fluids|fluids
340135|NCT02140879|pregnancy|pregnancy
340136|NCT02140879|inflammation|inflammation
340137|NCT02140879|infant assessment|infant assessment
340138|NCT02140853|MDR gram-negative bacilli|mdr gram-negative bacilli
340139|NCT02140853|Mortality|mortality
340140|NCT02140853|Therapy|therapy
340141|NCT02140840|TMTB|tmtb
340142|NCT02140840|Mekinist|mekinist
340143|NCT02140840|Trametinib|trametinib
340144|NCT02140840|relapse|relapse
340145|NCT02140840|refractory|refractory
340146|NCT02140840|response rate|response rate
340147|NCT02140827|bowel preparation|bowel preparation
340148|NCT02140827|instant messaging program|instant messaging program
340149|NCT02140814|PKD|pkd
340150|NCT02140814|niacinamide|niacinamide
340151|NCT02140814|Vitamin B3|vitamin b3
340152|NCT02140814|Vitamin B|vitamin b
340153|NCT02140801|Percutaneous coronary intervention|percutaneous coronary intervention
340154|NCT02140801|Drug-eluting stent|drug-eluting stent
340155|NCT02140801|Thrombosis|thrombosis
340156|NCT02140788|schizophrenia|schizophrenia
340157|NCT02140788|schizo-affective disorder|schizo-affective disorder
340158|NCT02140775|HIV|hiv
340159|NCT02140775|AIDS|aids
340160|NCT02140775|Fatigue|fatigue
340161|NCT02140775|armodafinil|armodafinil
340162|NCT02140775|Unemployment|unemployment
340163|NCT02140762|Meningitis ABCWY|meningitis abcwy
340164|NCT02140762|Adolescents|adolescents
340165|NCT02140762|Vaccination|vaccination
340166|NCT02140762|Meningococcal disease|meningococcal disease
340167|NCT02140749|Bifidobacteria|bifidobacteria
340168|NCT02140749|Bristol Stool Scale|bristol stool scale
340169|NCT02140749|Constipation|constipation
340170|NCT02140749|Diet|diet
340171|NCT02140749|Fructooligosacchardes|fructooligosacchardes
340172|NCT02140749|Microbiota|microbiota
340173|NCT02140749|Oligofructose|oligofructose
340174|NCT02140736|Chemotherapy-induced anemia|chemotherapy-induced anemia
340175|NCT02140736|Epoetin biosimilar|epoetin biosimilar
340176|NCT02140723|preoperative short course radiotherapy|preoperative short course radiotherapy
340177|NCT02140723|delay of surgery|delay of surgery
340178|NCT02140723|rectal cancer|rectal cancer
340179|NCT02140723|TP53|tp53
340180|NCT02140723|predictive marker|predictive marker
340181|NCT02140723|MRT imaging|mrt imaging
340182|NCT02140710|premature infant|premature infant
340183|NCT02140710|visceral osteopathy|visceral osteopathy
340184|NCT02140710|alternative medicine|alternative medicine
340185|NCT02140710|meconium passage|meconium passage
340186|NCT02140710|enteral feedings|enteral feedings
340187|NCT02140710|hospital stay|hospital stay
340188|NCT02140684|Real-world|real-world
340189|NCT02140684|observational|observational
340190|NCT02140684|Nitric oxide|nitric oxide
340191|NCT02140684|Inhaled corticosteroid|inhaled corticosteroid
340192|NCT02140684|UK|uk
340193|NCT02140671|asthma management|asthma management
340194|NCT02140671|anti-inflammatory therapy|anti-inflammatory therapy
340195|NCT02140671|compliance|compliance
340196|NCT02140671|hospital admission|hospital admission
340197|NCT02140671|educations|educations
340198|NCT02140671|self-management|self-management
340199|NCT02140671|guidelines|guidelines
340200|NCT02140671|exacerbations|exacerbations
340201|NCT02140671|diagnostic accuracy|diagnostic accuracy
340202|NCT02140671|symptom control|symptom control
340203|NCT02140658|ischemic stroke|ischemic stroke
340204|NCT02140658|Statins Medication Persistence|statins medication persistence
340205|NCT02140658|outcome|outcome
340206|NCT02140632|Carpal tunnel syndrome|carpal tunnel syndrome
340207|NCT02140632|Local steroid injection|local steroid injection
340208|NCT02140632|Wrist splinting|wrist splinting
340209|NCT02140619|ischemic stroke|ischemic stroke
340210|NCT02140619|Medication Persistence|medication persistence
340211|NCT02140619|outcome|outcome
340212|NCT02140606|AML|aml
340213|NCT02140606|phase1|phase1
340214|NCT02140606|MTD|mtd
340215|NCT02140606|Cafusertib|cafusertib
340216|NCT02140580|Minimally-invasive surfactant therapy|minimally-invasive surfactant therapy
340217|NCT02140541|Asthma|asthma
340218|NCT02140541|Blood eosinophils|blood eosinophils
340219|NCT02140541|Sputum eosinophils|sputum eosinophils
340220|NCT02140541|Clinical predictor|clinical predictor
340221|NCT02140541|UK primary care|uk primary care
340222|NCT02140541|Global Initiative for Asthma (GINA)|global initiative for asthma (gina)
340223|NCT02140528|Allogenic adipose derived mesenchymal stem cell tibial fracture|allogenic adipose derived mesenchymal stem cell tibial fracture
340224|NCT02140515|Gonal-F Luveris Assisted Reproductive Technology Hypogonadotropic Hypogonadism|gonal-f luveris assisted reproductive technology hypogonadotropic hypogonadism
340225|NCT02140502|Enterobacterial Infections|enterobacterial infections
340226|NCT02140502|Prostate cancer|prostate cancer
340227|NCT02140502|Biopsy|biopsy
340335|NCT02140008|supraglottic airway devices|supraglottic airway devices
340228|NCT02140502|Incidence of fluoroquinolone resistant enteric bacteria|incidence of fluoroquinolone resistant enteric bacteria
340229|NCT02140476|Thyroid goiter|thyroid goiter
340230|NCT02140476|Papillary thyroid cancer|papillary thyroid cancer
340231|NCT02140476|Bipolar device|bipolar device
340232|NCT02140476|Sealing and cutting device|sealing and cutting device
340233|NCT02140476|Thyroidectomy|thyroidectomy
340234|NCT02140450|intraocular pressure, intravitreal injection, short term|intraocular pressure, intravitreal injection, short term
340235|NCT02140437|Fulvestrant|fulvestrant
340236|NCT02140437|Anastrozole|anastrozole
340237|NCT02140437|Luminal A-like|luminal a-like
340238|NCT02140437|Postmenopausal|postmenopausal
340239|NCT02140437|Advanced breast cancer|advanced breast cancer
340240|NCT02140424|type 1 diabetes|type 1 diabetes
340241|NCT02140424|osteoporosis|osteoporosis
340242|NCT02140424|children|children
340243|NCT02140398|infertility|infertility
340244|NCT02140398|PCOS|pcos
340245|NCT02140398|scratching|scratching
340246|NCT02140398|endometrial receptivity|endometrial receptivity
340247|NCT02140372|colchicine|colchicine
340248|NCT02140372|platelet activity|platelet activity
340249|NCT02140372|neutrophil|neutrophil
340250|NCT02140359|homelessness|homelessness
340251|NCT02140359|housing first|housing first
340252|NCT02140359|social networks|social networks
340253|NCT02140359|drug abuse|drug abuse
340254|NCT02140359|alcohol use|alcohol use
340255|NCT02140359|HIV|hiv
340256|NCT02140333|erlotinib|erlotinib
340257|NCT02140333|EGFR mutation|egfr mutation
340258|NCT02140307|Health Promotion|health promotion
340259|NCT02140307|Prevention|prevention
340260|NCT02140307|Relaxation Response|relaxation response
340261|NCT02140307|Meditation|meditation
340262|NCT02140307|Cortisol|cortisol
340263|NCT02140281|Phase I, Healthy Volunteers|phase i, healthy volunteers
340264|NCT02140268|Phase I|phase i
340265|NCT02140268|Healthy|healthy
340266|NCT02140268|Pharmacokinetics|pharmacokinetics
340267|NCT02140255|HIV Remission|hiv remission
340268|NCT02140242|AML|aml
340269|NCT02140242|leukemia|leukemia
340270|NCT02140242|induction treatment|induction treatment
340271|NCT02140242|daunorubicin|daunorubicin
340272|NCT02140242|7+3|7+3
340273|NCT02140229|Rheumatoid Arthritis|rheumatoid arthritis
340274|NCT02140229|Remission,|remission,
340275|NCT02140229|DAS28,|das28,
340276|NCT02140229|ACR/EULAR,|acr/eular,
340277|NCT02140229|RAPID, Randomized study,|rapid, randomized study,
340278|NCT02140229|Longitudinal follow-up|longitudinal follow-up
340279|NCT02140216|Blood transfusion|blood transfusion
340280|NCT02140216|Immune|immune
340281|NCT02140216|Surgery|surgery
340282|NCT02140203|Metabolic Syndrome|metabolic syndrome
340283|NCT02140203|Waist circumference|waist circumference
340284|NCT02140203|blood pressure|blood pressure
340285|NCT02140203|triglyceride|triglyceride
340286|NCT02140203|HDL|hdl
340287|NCT02140177|Screening|screening
340288|NCT02140177|Adults|adults
340289|NCT02140177|Medical Inpatients|medical inpatients
340290|NCT02140177|Suicide|suicide
340291|NCT02140164|Cystoid Macular Edema|cystoid macular edema
340292|NCT02140164|Minocycline|minocycline
340293|NCT02140164|Microglia|microglia
340294|NCT02140164|Retinitis Pigmentosa|retinitis pigmentosa
340295|NCT02140151|amd|amd
340296|NCT02140151|non-exudative macular degeneration|non-exudative macular degeneration
340297|NCT02140151|exudative macular degeneration|exudative macular degeneration
340298|NCT02140151|age-related macular degeneration|age-related macular degeneration
340299|NCT02140151|ranibizumab|ranibizumab
340300|NCT02140151|anti-VEGF|anti-vegf
340301|NCT02140125|ASP2408|asp2408
340302|NCT02140112|T. suis ova|t. suis ova
340303|NCT02140112|Trichuris suis ova|trichuris suis ova
340304|NCT02140112|Autism Spectrum Disorder|autism spectrum disorder
340305|NCT02140112|ASD|asd
340306|NCT02140099|Mental health|mental health
340307|NCT02140099|Violence|violence
340308|NCT02140099|Substance use|substance use
340309|NCT02140099|Adolescent|adolescent
340310|NCT02140099|Prevention|prevention
340311|NCT02140086|asthma|asthma
340312|NCT02140086|Buteyko|buteyko
340313|NCT02140086|remedial breathing|remedial breathing
340314|NCT02140086|children|children
340315|NCT02140073|GERD|gerd
340316|NCT02140073|Omez|omez
340317|NCT02140073|Omez DSR|omez dsr
340318|NCT02140073|heartburn|heartburn
340319|NCT02140073|esophagitis|esophagitis
340320|NCT02140073|omeprazole|omeprazole
340321|NCT02140073|omeprazole+domperidone|omeprazole+domperidone
340322|NCT02140060|Glaucoma|glaucoma
340323|NCT02140060|Ocular|ocular
340324|NCT02140060|Hypertension|hypertension
340325|NCT02140060|OAG|oag
340326|NCT02140060|POAG|poag
340327|NCT02140060|OHT|oht
340328|NCT02140047|Haemophilus influenza type b|haemophilus influenza type b
340329|NCT02140047|Hib|hib
340330|NCT02140034|Extensive Peritoneal Lavage|extensive peritoneal lavage
340331|NCT02140034|Overall Survival|overall survival
340332|NCT02140034|Disease Free Survival|disease free survival
340333|NCT02140034|Peritoneal Recurrence Rate|peritoneal recurrence rate
340334|NCT02140034|T3 and T4 Gastric Cancer|t3 and t4 gastric cancer
340337|NCT02140008|the self-pressurised air-Q intubating laryngeal airway,|the self-pressurised air-q intubating laryngeal airway,
340338|NCT02140008|children|children
340339|NCT02139995|transfusion|transfusion
340340|NCT02139995|trigger|trigger
340341|NCT02139995|critically-ill|critically-ill
340342|NCT02139982|hemodynamics|hemodynamics
340343|NCT02139982|anaesthetics|anaesthetics
340344|NCT02139982|brachial plexus|brachial plexus
340345|NCT02139982|peripheral nerves|peripheral nerves
340346|NCT02139982|skin temperature|skin temperature
340347|NCT02139982|sympathetic nervous system|sympathetic nervous system
340348|NCT02139982|dose-response relationship|dose-response relationship
340349|NCT02139943|Diabetes Mellitus, Type 1|diabetes mellitus, type 1
340350|NCT02139943|Canagliflozin|canagliflozin
340351|NCT02139943|Continuous Glucose Monitoring|continuous glucose monitoring
340352|NCT02139930|smoking|smoking
340353|NCT02139930|nicotine reduction|nicotine reduction
340354|NCT02139917|transitional palliative care|transitional palliative care
340355|NCT02139917|end stage renal failure|end stage renal failure
340356|NCT02139904|Mesothelioma|mesothelioma
340357|NCT02139904|Vinorelbine|vinorelbine
340358|NCT02139904|BRCA1|brca1
340359|NCT02139891|Cardiac Resynchronization Therapy|cardiac resynchronization therapy
340360|NCT02139891|non responders|non responders
340361|NCT02139891|MultiPoint Pacing (MPP)|multipoint pacing (mpp)
340362|NCT02139813|Obesity -|obesity -
340363|NCT02139813|Bariatric surgery|bariatric surgery
340364|NCT02139813|Gastric bypass|gastric bypass
340365|NCT02139800|Neonatal resuscitation|neonatal resuscitation
340366|NCT02139800|Extreme Low Gestational Age Newborn (ELGAN)|extreme low gestational age newborn (elgan)
340367|NCT02139800|Delivery Room|delivery room
340368|NCT02139800|Continuous positive airway pressure (CPAP)|continuous positive airway pressure (cpap)
340369|NCT02139800|Positive pressure ventilation (PPV)|positive pressure ventilation (ppv)
340370|NCT02139800|Sustained inflation|sustained inflation
340371|NCT02139787|Hypertension, obesity|hypertension, obesity
340372|NCT02139787|Dietary behaviors|dietary behaviors
340373|NCT02139787|Physical activity behaviors|physical activity behaviors
340374|NCT02139787|Radio story, entertainment health education|radio story, entertainment health education
340375|NCT02139787|Immigrants|immigrants
340376|NCT02139787|Somali, Latino, Hmong|somali, latino, hmong
340377|NCT02139787|Families with 3-18 year old children|families with 3-18 year old children
340378|NCT02139774|Prostate Cancer|prostate cancer
340379|NCT02139774|Elderly|elderly
340380|NCT02139774|Geriatric|geriatric
340381|NCT02139774|Radiation|radiation
340382|NCT02139774|Arthritis|arthritis
340383|NCT02139774|Exercise|exercise
340384|NCT02139774|Walking|walking
340385|NCT02139774|Endocrine Therapy|endocrine therapy
340386|NCT02139774|Androgen Deprivation Therapy|androgen deprivation therapy
340387|NCT02139774|Active Surveillance|active surveillance
340388|NCT02139774|Men|men
340389|NCT02139761|Cocaine|cocaine
340390|NCT02139761|Treatment|treatment
340391|NCT02139748|Dental Implants|dental implants
340392|NCT02139748|Alveolar Bone Grafting|alveolar bone grafting
340393|NCT02139748|Acellular Dermis|acellular dermis
340394|NCT02139735|Temporomandibular Joint Disorders,|temporomandibular joint disorders,
340395|NCT02139735|Ultrasonics,|ultrasonics,
340396|NCT02139735|Electromyography,|electromyography,
340397|NCT02139735|Pain Measurement,|pain measurement,
340398|NCT02139735|Muscle Stretching Exercise|muscle stretching exercise
340399|NCT02139722|hepatitis B|hepatitis b
340400|NCT02139722|hepatitis C|hepatitis c
340401|NCT02139722|screening|screening
340402|NCT02139722|Asian Americans|asian americans
340403|NCT02139722|mobile technology|mobile technology
340404|NCT02139657|Rabies|rabies
340405|NCT02139657|Rabies virus|rabies virus
340406|NCT02139657|Rhabdoviridae|rhabdoviridae
340407|NCT02139657|Rabies immune globulin|rabies immune globulin
340408|NCT02139657|Rabies antibodies|rabies antibodies
340409|NCT02139657|Passive rabies immunization|passive rabies immunization
340410|NCT02139644|fluticasone propionate|fluticasone propionate
340411|NCT02139644|multidose dry powder inhaler|multidose dry powder inhaler
340412|NCT02139631|hemodynamic|hemodynamic
340413|NCT02139631|mechanical ventilation|mechanical ventilation
340414|NCT02139631|respiration with positive pressure|respiration with positive pressure
340415|NCT02139618|Randomized-controlled-trial|randomized-controlled-trial
340416|NCT02139618|Methyl-Aminolevulinate|methyl-aminolevulinate
340417|NCT02139618|Daylight|daylight
340418|NCT02139618|Photodynamic-therapy|photodynamic-therapy
340419|NCT02139605|D2 versus D3 Lymphadenectomy|d2 versus d3 lymphadenectomy
340420|NCT02139592|Pharmacological therapy|pharmacological therapy
340421|NCT02139579|chemotherapy|chemotherapy
340422|NCT02139579|EGFR-TKI resistance|egfr-tki resistance
340423|NCT02139579|Bevacizumab|bevacizumab
340424|NCT02139553|Rhythmic versus discrete movements|rhythmic versus discrete movements
340425|NCT02139553|Rehabilitation|rehabilitation
340426|NCT02139540|Treatment|treatment
340427|NCT02139527|arthroplasty|arthroplasty
340428|NCT02139527|spinal|spinal
340429|NCT02139527|CHARITE|charite
340430|NCT02139527|PRODISC-L|prodisc-l
340431|NCT02139527|PRODISC|prodisc
340432|NCT02139527|disc|disc
340433|NCT02139527|replacement|replacement
340434|NCT02139527|lumbar|lumbar
340435|NCT02139514|Social Skills|social skills
340436|NCT02139514|Adults|adults
340437|NCT02139501|Recombinant Human Thrombopoietin|recombinant human thrombopoietin
340438|NCT02139501|Dose and frequency|dose and frequency
340439|NCT02139501|Immune Thrombocytopenia|immune thrombocytopenia
340440|NCT02139488|Esophageal cancer|esophageal cancer
340441|NCT02139488|Chemoradiation|chemoradiation
340442|NCT02139475|bowel cleansing, colorectal cancer surgery|bowel cleansing, colorectal cancer surgery
340443|NCT02139462|FBT, fidelity, training|fbt, fidelity, training
340444|NCT02139449|CRT, heart failure, ICD|crt, heart failure, icd
340445|NCT02139423|Congenital cytomegalovirus infection|congenital cytomegalovirus infection
340446|NCT02139423|newborn universal hearing screening|newborn universal hearing screening
340447|NCT02139410|sarcopenia|sarcopenia
340448|NCT02139410|mortality|mortality
340449|NCT02139384|procalcitonin|procalcitonin
340450|NCT02139384|community acquired pneumonia|community acquired pneumonia
340451|NCT02139384|pneumonia score|pneumonia score
340452|NCT02139371|Positron Emission Tomography|positron emission tomography
340453|NCT02139371|Uroplasminogen Plasminogen Activator Receptor|uroplasminogen plasminogen activator receptor
340454|NCT02139371|Breast cancer|breast cancer
340455|NCT02139371|Prostate cancer|prostate cancer
340456|NCT02139371|Urinary bladder cancer|urinary bladder cancer
340457|NCT02139371|Biodistribution|biodistribution
340458|NCT02139371|Radiation exposure|radiation exposure
340459|NCT02139358|Breast - Female|breast - female
340460|NCT02139358|Metastatic|metastatic
340461|NCT02139358|HER2+|her2+
340462|NCT02139345|Osteoarthritis|osteoarthritis
340463|NCT02139345|Rheumatoid arthritis|rheumatoid arthritis
340464|NCT02139345|Post-traumatic arthritis|post-traumatic arthritis
340465|NCT02139345|Avascular necrosis|avascular necrosis
340466|NCT02139345|AVN|avn
340467|NCT02139332|Attachment theory|attachment theory
340468|NCT02139332|Parent- child relationship|parent- child relationship
340469|NCT02139332|Child mental health|child mental health
340470|NCT02139332|Behavioral health|behavioral health
340471|NCT02139293|vagus nerve stimulation effects on heart rate variability and peripheral blood perfusion|vagus nerve stimulation effects on heart rate variability and peripheral blood perfusion
340472|NCT02139280|Cyclophosphamide|cyclophosphamide
340473|NCT02139280|Hematopoietic|hematopoietic
340474|NCT02139280|Stem Cell|stem cell
340475|NCT02139280|Mobilization|mobilization
340476|NCT02139280|Hematologic Malignancy|hematologic malignancy
340477|NCT02139267|CIN3|cin3
340478|NCT02139267|Cervical Intraepithelial Neoplasia|cervical intraepithelial neoplasia
340479|NCT02139267|High-Risk HPV|high-risk hpv
340480|NCT02139267|HPV Infection|hpv infection
340481|NCT02139267|Neoplasm|neoplasm
340482|NCT02139267|Precancerous Diseases|precancerous diseases
340483|NCT02139267|Uterine Diseases|uterine diseases
340484|NCT02139267|Genital Diseases, Female|genital diseases, female
340485|NCT02139254|Gestational Diabetes|gestational diabetes
340486|NCT02139254|HbA1c|hba1c
340487|NCT02139254|Glucose|glucose
340488|NCT02139254|First Trimenon|first trimenon
340489|NCT02139228|Haemophilus influenzae type b|haemophilus influenzae type b
340490|NCT02139228|persistency|persistency
340491|NCT02139228|children|children
340492|NCT02139228|CRM197|crm197
340493|NCT02139228|anti-PRP antibody|anti-prp antibody
340494|NCT02139202|Acute|acute
340495|NCT02139202|Myocardial|myocardial
340496|NCT02139202|Infarction|infarction
340497|NCT02139202|AMI|ami
340498|NCT02139176|couple HIV testing and counseling|couple hiv testing and counseling
340499|NCT02139176|disclosure|disclosure
340500|NCT02139176|discordant|discordant
340501|NCT02139176|HIV|hiv
340502|NCT02139176|Malawi|malawi
340503|NCT02139163|Community acquired pneumonia|community acquired pneumonia
340504|NCT02139163|CAP|cap
340505|NCT02139163|CAPNETZ|capnetz
340506|NCT02139163|age ≥18|age ≥18
340507|NCT02139163|infiltrate on chest X-ray|infiltrate on chest x-ray
340632|NCT02138695|atrial fibrillation|atrial fibrillation
340508|NCT02139163|cough or production of purulent sputum|cough or production of purulent sputum
340509|NCT02139163|pathologic lung auscultation|pathologic lung auscultation
340510|NCT02139163|fever|fever
340511|NCT02139150|FLT PET Imaging|flt pet imaging
340512|NCT02139150|3'deoxy-3' [18F] fluorothymidine ([18F] FLT)|3'deoxy-3' [18f] fluorothymidine ([18f] flt)
340513|NCT02139150|CT|ct
340514|NCT02139150|scans|scans
340515|NCT02139150|14-050|14-050
340516|NCT02139098|sleep architecture|sleep architecture
340517|NCT02139098|conditioning of pharmacological responses|conditioning of pharmacological responses
340518|NCT02139098|insomnia|insomnia
340519|NCT02139085|varicose veins|varicose veins
340520|NCT02139085|catheter ablation|catheter ablation
340521|NCT02139085|Catheter Ablation, Electrical|catheter ablation, electrical
340522|NCT02139085|Catheter Ablation, Radiofrequency|catheter ablation, radiofrequency
340523|NCT02139072|Anticoagulation|anticoagulation
340524|NCT02139072|International normalized ratio|international normalized ratio
340525|NCT02139072|Warfarin|warfarin
340526|NCT02139059|anuria|anuria
340527|NCT02139059|children|children
340528|NCT02139059|ureteroscopy|ureteroscopy
341409|NCT02134678|depression|depression
340529|NCT02139059|initial urinary drainage|initial urinary drainage
340530|NCT02139059|ureteric stones|ureteric stones
340531|NCT02139046|Drug therapy|drug therapy
340532|NCT02139033|Dry Eye, Dry Eye Syndrome, Retaine, KCS, Keratoconjunctivitis sicca|dry eye, dry eye syndrome, retaine, kcs, keratoconjunctivitis sicca
340533|NCT02139020|Targeted therapies|targeted therapies
340534|NCT02139020|Plasma samples|plasma samples
340535|NCT02138981|Hepatocellular Carcinoma|hepatocellular carcinoma
340536|NCT02138981|Milan Criteria|milan criteria
340537|NCT02138968|Pre-frailty|pre-frailty
340538|NCT02138968|Frail|frail
340539|NCT02138968|Exercise|exercise
340540|NCT02138968|Nutritional assessment|nutritional assessment
340541|NCT02138968|Functional capacity|functional capacity
340542|NCT02138942|automated vascular filling|automated vascular filling
340543|NCT02138942|Learning Intravenous Resuscitator (LIR)|learning intravenous resuscitator (lir)
340544|NCT02138942|General Surgery|general surgery
340545|NCT02138942|Fluid Therapy|fluid therapy
340546|NCT02138929|Esophageal Cancer|esophageal cancer
340547|NCT02138929|Advanced adenocarcinoma of the esophagus|advanced adenocarcinoma of the esophagus
340548|NCT02138929|Advanced adenocarcinoma of the gastroesophageal junction|advanced adenocarcinoma of the gastroesophageal junction
340549|NCT02138929|GEJ|gej
340550|NCT02138929|Metastatic|metastatic
340551|NCT02138929|Everolimus|everolimus
340552|NCT02138929|Afinitor|afinitor
340553|NCT02138929|Zortress|zortress
340554|NCT02138929|RAD001|rad001
340555|NCT02138929|LDE 225|lde 225
340556|NCT02138916|Obstructive Lung Diseases|obstructive lung diseases
340557|NCT02138916|Chronic Obstructive Pulmonary Disease|chronic obstructive pulmonary disease
340558|NCT02138916|Lung Disease|lung disease
340559|NCT02138916|Bronchial Diseases|bronchial diseases
340560|NCT02138916|COPD Exacerbation|copd exacerbation
340561|NCT02138916|Respiratory Tract Diseases|respiratory tract diseases
340562|NCT02138903|weaning|weaning
340563|NCT02138903|Cardiac|cardiac
340564|NCT02138903|Echocardiography|echocardiography
340565|NCT02138903|Mechanical Ventilation|mechanical ventilation
340566|NCT02138890|Autologous Protein Solution|autologous protein solution
340567|NCT02138890|APS|aps
340568|NCT02138890|Osteoarthritis|osteoarthritis
340569|NCT02138890|Intra Articular Injection|intra articular injection
340570|NCT02138877|Pelviureteric junction obstruction|pelviureteric junction obstruction
340571|NCT02138877|pyeloplasty|pyeloplasty
340572|NCT02138877|Neonate affected by hydronephrosis|neonate affected by hydronephrosis
340573|NCT02138877|obstructive uropathy|obstructive uropathy
340574|NCT02138877|urinary stent|urinary stent
340575|NCT02138864|carbon monoxide intoxication|carbon monoxide intoxication
340576|NCT02138864|Parkinsonism|parkinsonism
435347|NCT01709214|Chronic|chronic
340577|NCT02138864|18F-DTBZ AV-133|18f-dtbz av-133
340578|NCT02138838|Chronic Kidney Disease, Secondary Hyperparathyroidism, Dialysis, Pediatric|chronic kidney disease, secondary hyperparathyroidism, dialysis, pediatric
340579|NCT02138812|Phase 1|phase 1
340580|NCT02138812|Solid tumors|solid tumors
340581|NCT02138812|Breast cancer|breast cancer
340582|NCT02138812|Paclitaxel|paclitaxel
340583|NCT02138812|Mps-1 inhibitor|mps-1 inhibitor
340584|NCT02138812|Taxanes|taxanes
340585|NCT02138799|Phase I|phase i
340586|NCT02138799|Pharmacokinetics|pharmacokinetics
340587|NCT02138799|Safety|safety
340588|NCT02138799|Drug-drug interactions|drug-drug interactions
340589|NCT02138799|Enzalutamide|enzalutamide
340590|NCT02138799|Rifampin|rifampin
340591|NCT02138799|CYP3A4|cyp3a4
340592|NCT02138799|CYP2D8|cyp2d8
340593|NCT02138799|Enzyme induction|enzyme induction
340594|NCT02138786|Richter's Transformation|richter's transformation
340595|NCT02138786|Richter's Syndrome|richter's syndrome
340596|NCT02138786|Karyopharm|karyopharm
340597|NCT02138786|selinexor|selinexor
340598|NCT02138786|KPT-330|kpt-330
340599|NCT02138786|SIRRT|sirrt
340600|NCT02138786|CLL|cll
340601|NCT02138773|prolonged release formulation|prolonged release formulation
340602|NCT02138773|adrenergic blocker|adrenergic blocker
340603|NCT02138773|Bioequivalence|bioequivalence
340604|NCT02138760|prostate cancer|prostate cancer
340605|NCT02138760|prostate biopsy|prostate biopsy
340606|NCT02138760|magnetic resonance imaging guidance|magnetic resonance imaging guidance
340607|NCT02138760|detection rates|detection rates
340608|NCT02138760|performance|performance
340609|NCT02138747|Overactive bladder (OAB)|overactive bladder (oab)
340610|NCT02138747|tolterodine ER|tolterodine er
340611|NCT02138747|mirabegron|mirabegron
340612|NCT02138734|antitumor|antitumor
340613|NCT02138734|BCG|bcg
340614|NCT02138734|bladder cancer|bladder cancer
340615|NCT02138734|cancer|cancer
340616|NCT02138734|immunotherapy|immunotherapy
340617|NCT02138734|instillation|instillation
340618|NCT02138734|interleukin-15|interleukin-15
340619|NCT02138734|intravesical|intravesical
340620|NCT02138734|naive|naive
340621|NCT02138734|non-muscle invasive|non-muscle invasive
340622|NCT02138734|transitional cell carcinoma|transitional cell carcinoma
340623|NCT02138734|ALT-803|alt-803
340624|NCT02138734|N-803|n-803
340625|NCT02138721|Metastatic Prostate Cancer|metastatic prostate cancer
340626|NCT02138721|Prostatectomy|prostatectomy
340627|NCT02138708|Pulmonary arterial hypertension,|pulmonary arterial hypertension,
340628|NCT02138708|congenital heart disease,|congenital heart disease,
340629|NCT02138708|heart shunt,|heart shunt,
340630|NCT02138708|acetylcholine|acetylcholine
340631|NCT02138708|Pharmacological test of pulmonary vascular reactivity (acetylcholine) in|pharmacological test of pulmonary vascular reactivity (acetylcholine) in
340633|NCT02138695|catheter ablation|catheter ablation
340634|NCT02138695|recurrence|recurrence
340635|NCT02138682|DaT-SPECT scan|dat-spect scan
340636|NCT02138682|Parkinson's|parkinson's
340637|NCT02138682|Diagnostic|diagnostic
340638|NCT02138669|Cornea|cornea
340639|NCT02138669|Keratoconus|keratoconus
340640|NCT02138669|Steep cornea|steep cornea
340641|NCT02138656|Crying|crying
340642|NCT02138656|Chiropractic|chiropractic
340643|NCT02138656|Infant|infant
340644|NCT02138656|pediatric|pediatric
340645|NCT02138656|Infantile colic|infantile colic
340646|NCT02138656|Clinical Trial|clinical trial
340647|NCT02138643|Achalasia|achalasia
340648|NCT02138643|Megaesophagus|megaesophagus
340649|NCT02138643|Peropal endoscopic myotomy(POEM)|peropal endoscopic myotomy(poem)
340650|NCT02138643|Laparoscopic Heller myotomy|laparoscopic heller myotomy
340651|NCT02138630|Exercise|exercise
340652|NCT02138617|Colon Cancer|colon cancer
340653|NCT02138617|Irinotecan|irinotecan
340654|NCT02138617|FOLFIRI|folfiri
340655|NCT02138617|Genotyping|genotyping
340656|NCT02138617|UGT1A1|ugt1a1
340657|NCT02138604|chest pain|chest pain
340658|NCT02138604|myocardial ischemia|myocardial ischemia
340659|NCT02138604|acute myocardial dysfunction|acute myocardial dysfunction
340660|NCT02138604|plethesmography|plethesmography
340661|NCT02138604|non invasive dP/dt|non invasive dp/dt
340662|NCT02138591|vitamin d deficiency|vitamin d deficiency
340663|NCT02138591|cathelicidin antimicrobial peptide|cathelicidin antimicrobial peptide
340664|NCT02138591|resistin, human|resistin, human
340665|NCT02138591|protein, human|protein, human
340666|NCT02138591|1,25-dihydroxy-16,23-diene vitamin D3|1,25-dihydroxy-16,23-diene vitamin d3
340667|NCT02138591|Cholecalciferol|cholecalciferol
340668|NCT02138591|Nutritional Status|nutritional status
340669|NCT02138591|length of stay|length of stay
340670|NCT02138539|hyperpigmentation|hyperpigmentation
340671|NCT02138539|melasma|melasma
340672|NCT02138539|sun spots|sun spots
340673|NCT02138539|dark spots|dark spots
340674|NCT02138526|cancer|cancer
340675|NCT02138526|pazopanib|pazopanib
340676|NCT02138526|food|food
340677|NCT02138526|pharmacokinetics|pharmacokinetics
340678|NCT02138513|Mindfulness|mindfulness
340679|NCT02138513|MBCT|mbct
340680|NCT02138513|Cancer|cancer
340681|NCT02138513|Oncology|oncology
340682|NCT02138513|E-health|e-health
340683|NCT02138513|Cost-effectiveness|cost-effectiveness
340684|NCT02138500|PF-06372865|pf-06372865
340685|NCT02138500|phase 1|phase 1
340686|NCT02138500|open-label|open-label
340687|NCT02138500|GABA-A receptor occupancy|gaba-a receptor occupancy
340688|NCT02138500|positron emission tomography|positron emission tomography
340689|NCT02138500|healthy subjects|healthy subjects
340690|NCT02138487|pelvic organ prolapse|pelvic organ prolapse
340691|NCT02138487|reconstructive pelvic surgery|reconstructive pelvic surgery
340692|NCT02138487|postoperative restrictions|postoperative restrictions
340693|NCT02138487|patient satisfaction|patient satisfaction
340694|NCT02138474|Lacticum acidum homaccord|lacticum acidum homaccord
340695|NCT02138474|homeopathy|homeopathy
340696|NCT02138474|chronic tension-type headaches|chronic tension-type headaches
340697|NCT02138461|glaucoma|glaucoma
340698|NCT02138461|bimatoprost|bimatoprost
340699|NCT02138461|latanoprost|latanoprost
340700|NCT02138461|tolerability|tolerability
340701|NCT02138448|Cancer Screenings|cancer screenings
340702|NCT02138448|Health Information Technology|health information technology
340703|NCT02138448|Patient Health Record|patient health record
340704|NCT02138448|Preventive Services|preventive services
340705|NCT02138422|colorectal cancer|colorectal cancer
340706|NCT02138383|advanced pancreatic cancer|advanced pancreatic cancer
340707|NCT02138383|pancreas|pancreas
340708|NCT02138383|malignant neoplasm|malignant neoplasm
340709|NCT02138383|endocrine system|endocrine system
340710|NCT02138357|Restless Legs Syndrome|restless legs syndrome
340711|NCT02138357|Willis Ekbom Disease|willis ekbom disease
340712|NCT02138357|Twitchy Legs|twitchy legs
340713|NCT02138357|Periodic Limb Movements|periodic limb movements
340714|NCT02138357|Leg Movements|leg movements
340715|NCT02138357|Augmentation|augmentation
340716|NCT02138357|Requip|requip
340717|NCT02138357|ropinirole|ropinirole
340718|NCT02138357|Mirapex|mirapex
340719|NCT02138357|pramipexole|pramipexole
340720|NCT02138357|gabapentin|gabapentin
340721|NCT02138357|Horizant|horizant
340722|NCT02138357|Neupro|neupro
340723|NCT02138357|rotigotine|rotigotine
340724|NCT02138331|Diabetes Mellitus Type 1|diabetes mellitus type 1
340725|NCT02138331|Microvesicles|microvesicles
340726|NCT02138331|Exosomes|exosomes
340727|NCT02138331|Cord Blood|cord blood
340728|NCT02138331|Mesenchymal Stem Cells|mesenchymal stem cells
340729|NCT02138305|Fractional Flow Reserve (FFR)|fractional flow reserve (ffr)
340730|NCT02138305|Instantaneous Wave Free Ratio (iFR)|instantaneous wave free ratio (ifr)
340731|NCT02138305|Coronary Flow Reserve (CFR)|coronary flow reserve (cfr)
340732|NCT02138305|Hyperemic Stenosis Resistance Index (HSR)|hyperemic stenosis resistance index (hsr)
340733|NCT02138305|Hyperemic microvascular resistance (HMR)|hyperemic microvascular resistance (hmr)
340734|NCT02138305|Wave intensity analysis (WIA)|wave intensity analysis (wia)
340735|NCT02138305|Myocardial Perfusion|myocardial perfusion
340736|NCT02138305|SPY NIRF Regional Myocardial Perfusion Analysis|spy nirf regional myocardial perfusion analysis
340737|NCT02138253|liver transplant|liver transplant
340738|NCT02138253|hepatitis C|hepatitis c
340739|NCT02138253|liver fibrosis|liver fibrosis
340740|NCT02138253|hepatic fibrosis|hepatic fibrosis
340741|NCT02138253|liver cirrhosis|liver cirrhosis
340742|NCT02138253|hepatic cirrhosis|hepatic cirrhosis
340743|NCT02138227|Organ donation request|organ donation request
340744|NCT02138227|Effective Communication|effective communication
340745|NCT02138201|diffusion tensor imaging fiber tracking|diffusion tensor imaging fiber tracking
340746|NCT02138201|magnetic resonance Imaging|magnetic resonance imaging
340747|NCT02138201|spinal cord injury|spinal cord injury
340748|NCT02138201|neurogenic lower urinary tract dysfunction|neurogenic lower urinary tract dysfunction
340749|NCT02138175|bleeding|bleeding
340750|NCT02138175|blood loss|blood loss
340751|NCT02138175|hemoglobin|hemoglobin
340752|NCT02138175|hemoglobin monitoring|hemoglobin monitoring
340753|NCT02138175|noninvasive monitoring|noninvasive monitoring
340755|NCT02138162|Pharmacokinetics|pharmacokinetics
340756|NCT02138162|Safety|safety
340757|NCT02138162|Severe hepatic impairment|severe hepatic impairment
340758|NCT02138162|Enzalutamide|enzalutamide
340759|NCT02138149|spinal cord injury|spinal cord injury
340760|NCT02138149|neurogenic lower urinary tract dysfunction|neurogenic lower urinary tract dysfunction
340761|NCT02138149|nerve growth factor|nerve growth factor
340762|NCT02138149|neurogenic detrusor overactivity|neurogenic detrusor overactivity
340763|NCT02138149|urodynamics|urodynamics
340764|NCT02138123|dense cataract|dense cataract
340765|NCT02138123|phacoemulsification|phacoemulsification
340766|NCT02138123|lens-shell technique|lens-shell technique
340767|NCT02138123|intraocular lens|intraocular lens
340768|NCT02138110|Spinal Cord Injury (SCI)|spinal cord injury (sci)
340769|NCT02138110|Complete (AIS A) Traumatic Acute Spinal Cord Injury|complete (ais a) traumatic acute spinal cord injury
340770|NCT02138071|low back pain|low back pain
340771|NCT02138071|lumbar pain|lumbar pain
712555|NCT00579709|DiGeorge Syndrome|digeorge syndrome
340772|NCT02138058|compulsive buying, compulsive shopping, topiramate|compulsive buying, compulsive shopping, topiramate
340773|NCT02138045|Diabetes Mellitus, Type 1|diabetes mellitus, type 1
340774|NCT02138045|Diabetic Neuropathy|diabetic neuropathy
340775|NCT02138045|Liraglutide|liraglutide
340776|NCT02138032|message framing|message framing
340777|NCT02138032|smoking cessation|smoking cessation
340778|NCT02138032|peripheral artery disease|peripheral artery disease
340779|NCT02138019|corneal ulcers|corneal ulcers
340780|NCT02138019|conjunctival closure in strabismus surgery|conjunctival closure in strabismus surgery
340781|NCT02138019|surgery for retinal detachment|surgery for retinal detachment
340782|NCT02138019|cataract surgery|cataract surgery
340783|NCT02138019|mucous membrane grafting|mucous membrane grafting
340784|NCT02137954|cancer|cancer
340785|NCT02137954|pain|pain
340786|NCT02137941|Stress|stress
340787|NCT02137941|occupations|occupations
340788|NCT02137941|biomarkers|biomarkers
340789|NCT02137941|firefighters|firefighters
340790|NCT02137928|Retinoblastoma|retinoblastoma
340791|NCT02137928|carboplatin|carboplatin
340792|NCT02137915|AMD|amd
340793|NCT02137902|Tobacco dependence|tobacco dependence
340794|NCT02137902|Cardiovascular disease|cardiovascular disease
340795|NCT02137902|Risk behaviors|risk behaviors
340796|NCT02137902|Smoking|smoking
340797|NCT02137902|Physical activity|physical activity
340798|NCT02137902|Alaska Native people|alaska native people
340799|NCT02137889|CLL|cll
340800|NCT02137876|B cells|b cells
340801|NCT02137876|Thymoglubulin|thymoglubulin
340802|NCT02137876|humoral rejections|humoral rejections
340803|NCT02137876|transplant|transplant
340804|NCT02137876|rATG|ratg
340805|NCT02137863|Contrast induced nephropathy|contrast induced nephropathy
340806|NCT02137863|Diabetes Mellitus|diabetes mellitus
340807|NCT02137863|Dexmedetomidine|dexmedetomidine
340808|NCT02137837|Metastatic breast cancer|metastatic breast cancer
340809|NCT02137837|Invasive breast carcinoma|invasive breast carcinoma
340810|NCT02137837|estrogen receptor-positive breast cancer|estrogen receptor-positive breast cancer
340811|NCT02137837|HER2-negative breast cancer|her2-negative breast cancer
340812|NCT02137837|Stage IV breast cancer|stage iv breast cancer
340813|NCT02137837|progesterone receptor-positive breast cancer|progesterone receptor-positive breast cancer
340814|NCT02137811|cancer|cancer
340815|NCT02137811|CorrectChemo|correctchemo
340816|NCT02137811|assay|assay
340817|NCT02137811|lab test|lab test
340818|NCT02137811|MICK assay|mick assay
340819|NCT02137811|apoptosis|apoptosis
340820|NCT02137811|increase survival|increase survival
340821|NCT02137811|increase response rates|increase response rates
340822|NCT02137811|decrease time to progression|decrease time to progression
340823|NCT02137811|chemotherapy|chemotherapy
340824|NCT02137811|cancer treatment|cancer treatment
340825|NCT02137798|fluoroscopy exposure|fluoroscopy exposure
340826|NCT02137798|paroxysmal atrial fibrillation Ablation|paroxysmal atrial fibrillation ablation
340827|NCT02137798|fluoroscopy|fluoroscopy
340828|NCT02137798|Atrial Fibrillation Ablation|atrial fibrillation ablation
340829|NCT02137785|Actinic Keratosis|actinic keratosis
340830|NCT02137759|Glioblastoma|glioblastoma
340831|NCT02137746|Prostate Cancer|prostate cancer
340832|NCT02137746|Radical Prostatectomy|radical prostatectomy
340833|NCT02137720|Diabetes|diabetes
340834|NCT02137720|Treatment Adherence|treatment adherence
340835|NCT02137720|Self-management|self-management
340836|NCT02137720|Emotional Distress|emotional distress
340837|NCT02137720|Diabetes-related Distress|diabetes-related distress
340838|NCT02137707|Multiple Sclerosis, Relapsing-Remitting|multiple sclerosis, relapsing-remitting
340839|NCT02137707|Gilenya|gilenya
340840|NCT02137707|Fingolimod|fingolimod
340841|NCT02137694|Papillomavirus|papillomavirus
340842|NCT02137694|Vaginal auto-takings|vaginal auto-takings
340843|NCT02137694|Urinary test|urinary test
340844|NCT02137681|immune thrombocytopenia|immune thrombocytopenia
340845|NCT02137681|rituximab|rituximab
340846|NCT02137681|efficacy|efficacy
340847|NCT02137681|safety|safety
340848|NCT02137642|constipation|constipation
340849|NCT02137629|Myelodysplastic syndromes|myelodysplastic syndromes
340850|NCT02137629|Vidaza|vidaza
340851|NCT02137629|Observational study|observational study
340852|NCT02137629|Korea|korea
340853|NCT02137616|psychosis|psychosis
340854|NCT02137616|syndrome|syndrome
340855|NCT02137616|risk|risk
340856|NCT02137616|antipsychotic|antipsychotic
340857|NCT02137603|Suppurative appendicitis, appendicitis, pediatric|suppurative appendicitis, appendicitis, pediatric
340858|NCT02137590|Spanish Black Radish|spanish black radish
340859|NCT02137590|Phase I detoxification enzymes|phase i detoxification enzymes
340860|NCT02137590|Phase II detoxification enzymes|phase ii detoxification enzymes
340861|NCT02137590|Acetaminophen|acetaminophen
340862|NCT02137577|drug eluting balloon catheter|drug eluting balloon catheter
340863|NCT02137551|adherence|adherence
340864|NCT02137551|healthcare costs|healthcare costs
340865|NCT02137551|appointment based model|appointment based model
340866|NCT02137551|accountable care organization|accountable care organization
340867|NCT02137512|Artificial Pancreas|artificial pancreas
340868|NCT02137499|Deep venous obstruction|deep venous obstruction
340869|NCT02137499|Venous insufficiency|venous insufficiency
340870|NCT02137486|stable angina|stable angina
340871|NCT02137486|high angulated bifurcation|high angulated bifurcation
340872|NCT02137486|SYNTAX|syntax
340873|NCT02137486|DES|des
340874|NCT02137486|BMS|bms
340875|NCT02137460|Alzheimer's disease|alzheimer's disease
340876|NCT02137460|Early diagnosis|early diagnosis
340877|NCT02137460|Prediction|prediction
340878|NCT02137460|Biomarker|biomarker
340879|NCT02137460|Imaging|imaging
340880|NCT02137447|Prevena|prevena
340881|NCT02137447|faster healing time|faster healing time
340882|NCT02137447|surgical site infection|surgical site infection
340883|NCT02137434|Acute calcium|acute calcium
340884|NCT02137434|Dietary calcium|dietary calcium
340885|NCT02137434|Supplementary calcium|supplementary calcium
340886|NCT02137434|Postprandial metabolism|postprandial metabolism
340887|NCT02137421|Coronary artery disease|coronary artery disease
340888|NCT02137421|Metabolic syndrome|metabolic syndrome
340889|NCT02137421|Resveratrol|resveratrol
340890|NCT02137421|β-catenin|β-catenin
340891|NCT02137421|Wnt signaling|wnt signaling
340892|NCT02137421|FOXO|foxo
340893|NCT02137421|MnSOD|mnsod
340894|NCT02137408|Chronic hypertension in pregnancy|chronic hypertension in pregnancy
340895|NCT02137408|Pre-term delivery|pre-term delivery
340896|NCT02137408|Preeclampsia|preeclampsia
340897|NCT02137408|Endothelial Health|endothelial health
340898|NCT02137408|Docosahexaenoic acid (DHA)|docosahexaenoic acid (dha)
340899|NCT02137395|Children, Dexamethasone, Sugammadex,|children, dexamethasone, sugammadex,
340900|NCT02137382|maldigestion of dietary macronutrients (pancreas not producing enough enzymes for digestion of fat, sugars and proteins) in Cystic Fibrosis|maldigestion of dietary macronutrients (pancreas not producing enough enzymes for digestion of fat, sugars and proteins) in cystic fibrosis
340901|NCT02137369|MDD|mdd
340902|NCT02137369|Major Depressive Disorder|major depressive disorder
340903|NCT02137369|Treatment|treatment
340904|NCT02137369|Antidepressants|antidepressants
340905|NCT02137369|Lexapro|lexapro
340906|NCT02137369|Talk therapy|talk therapy
340907|NCT02137356|rectal cancer|rectal cancer
340908|NCT02137356|rectal adenocarcinoma|rectal adenocarcinoma
340909|NCT02137356|Selinexor|selinexor
340910|NCT02137356|capecitabine|capecitabine
340911|NCT02137356|chemoradiation|chemoradiation
340912|NCT02137356|radiation|radiation
340913|NCT02137356|radiotherapy|radiotherapy
340914|NCT02137356|neoadjuvant|neoadjuvant
340915|NCT02137356|locally advanced rectal cancer|locally advanced rectal cancer
340916|NCT02137343|Gastric Cancer|gastric cancer
340917|NCT02137343|First Line Treatment Gastroesophageal Junction (GEJ)|first line treatment gastroesophageal junction (gej)
340918|NCT02137343|Gastroesophageal Junction Cancer (GEJ)|gastroesophageal junction cancer (gej)
340919|NCT02137343|GEJ Cancer|gej cancer
340920|NCT02137330|Obalon swallowable intragastric balloons|obalon swallowable intragastric balloons
340921|NCT02137330|Severe obesity|severe obesity
340922|NCT02137330|Children|children
340923|NCT02137317|Pesticides|pesticides
340924|NCT02137317|Personal protective equipment|personal protective equipment
340925|NCT02137317|Developing countries|developing countries
340926|NCT02137317|Tropical Climate|tropical climate
340927|NCT02137304|cough help|cough help
340928|NCT02137304|in-exsufflation|in-exsufflation
340929|NCT02137304|neuromuscular disease|neuromuscular disease
340930|NCT02137304|cough assistance optimization|cough assistance optimization
340931|NCT02137304|efficient cough flow|efficient cough flow
340932|NCT02137291|Video-assisted thoracoscopic surgery (VATS)|video-assisted thoracoscopic surgery (vats)
340933|NCT02137291|Lung isolation device|lung isolation device
340934|NCT02137291|One-lung ventilation|one-lung ventilation
340935|NCT02137291|Double lumen endotracheal tube|double lumen endotracheal tube
340936|NCT02137291|Bronchial blocker|bronchial blocker
340937|NCT02137278|Syncope|syncope
340938|NCT02137278|Presyncope|presyncope
340939|NCT02137278|Vasoactive drugs|vasoactive drugs
340940|NCT02137278|Hypotension|hypotension
340941|NCT02137278|Carotid sinus massage|carotid sinus massage
340942|NCT02137278|Tilt table test|tilt table test
340943|NCT02137265|Azoospermia|azoospermia
340944|NCT02137265|Hypogonadism|hypogonadism
340945|NCT02137265|Clomiphene|clomiphene
340946|NCT02137252|Invasive Breast Cancer (Stage I-III)|invasive breast cancer (stage i-iii)
340947|NCT02137252|Ductal Carcinoma in Situ|ductal carcinoma in situ
340948|NCT02137252|Lobular Carcinoma in Situ|lobular carcinoma in situ
340949|NCT02137252|Lobular Carcinoma|lobular carcinoma
340950|NCT02137252|Fatigue Related to Cancer Treatment|fatigue related to cancer treatment
340951|NCT02137213|Opioid-induced constipation|opioid-induced constipation
340952|NCT02137213|Methadone|methadone
340953|NCT02137213|Naloxone|naloxone
340954|NCT02137187|Atrial fibrillation|atrial fibrillation
340955|NCT02137187|Heart failure|heart failure
340956|NCT02137187|Catheter ablation|catheter ablation
340957|NCT02137187|Cardiac resynchronization therapy|cardiac resynchronization therapy
340958|NCT02137187|Implantable defibrillator|implantable defibrillator
340959|NCT02137148|Vascular Access|vascular access
340960|NCT02137148|Sonic Window|sonic window
340961|NCT02137148|Ultrasound|ultrasound
340962|NCT02137135|chronic postoperative pain|chronic postoperative pain
340963|NCT02137135|menstrual cycle|menstrual cycle
340964|NCT02137122|Volunteers|volunteers
340965|NCT02137109|Pediatric|pediatric
340966|NCT02137096|Recurrent nasopharynx carcinoma|recurrent nasopharynx carcinoma
340967|NCT02137083|Chemotherapy|chemotherapy
340968|NCT02137083|Endocrine therapy|endocrine therapy
340969|NCT02137083|Docetaxel|docetaxel
340970|NCT02137083|Fulvestrant|fulvestrant
340971|NCT02137070|Weightloss and brain function|weightloss and brain function
340972|NCT02137070|Effects of bariatric surgery on brain function|effects of bariatric surgery on brain function
340973|NCT02137070|Reduced glucose insulin changes and brain function|reduced glucose insulin changes and brain function
340974|NCT02137057|Heart Rate Variability|heart rate variability
340975|NCT02137057|spinal anesthesia|spinal anesthesia
340977|NCT02137057|cardiac autonomic dysfunction|cardiac autonomic dysfunction
340978|NCT02137044|multiple sclerosis|multiple sclerosis
340979|NCT02137044|pain|pain
340980|NCT02137044|depression|depression
340981|NCT02137018|hernia|hernia
340982|NCT02137018|incisional hernia|incisional hernia
340983|NCT02137018|device|device
340984|NCT02137018|pig|pig
340985|NCT02137005|walking|walking
340986|NCT02137005|gait disorders, neurologic|gait disorders, neurologic
340987|NCT02137005|health status|health status
340988|NCT02137005|cognition|cognition
340989|NCT02137005|quality of life|quality of life
340990|NCT02137005|Transition to Adult Care|transition to adult care
340991|NCT02136953|Obsessive-Compulsive Disorder|obsessive-compulsive disorder
340992|NCT02136953|Exercise|exercise
340993|NCT02136953|Cognitive Behavior Therapy|cognitive behavior therapy
340994|NCT02136953|Cognitive Behavioral Therapy|cognitive behavioral therapy
340995|NCT02136953|Treatment Efficacy|treatment efficacy
340996|NCT02136953|Brain-Derived Neurotrophic Factor|brain-derived neurotrophic factor
340997|NCT02136914|Levodopa Induced Dyskinesia|levodopa induced dyskinesia
340998|NCT02136914|LID|lid
340999|NCT02136914|Parkinsonism|parkinsonism
341000|NCT02136901|NuSurface|nusurface
341001|NCT02136901|Meniscus|meniscus
341002|NCT02136901|Prosthesis|prosthesis
341003|NCT02136901|KOOS|koos
341004|NCT02136888|Ponesimod|ponesimod
341005|NCT02136888|Safety|safety
341006|NCT02136875|COPD|copd
341007|NCT02136875|COPD exacerbation|copd exacerbation
341008|NCT02136862|Alport syndrome|alport syndrome
341009|NCT02136862|kidney disease|kidney disease
341010|NCT02136849|severe intellectual disability, genetic, de novo exome|severe intellectual disability, genetic, de novo exome
341011|NCT02136836|Genes, erbB-2|genes, erbb-2
341012|NCT02136836|Prognosis|prognosis
341013|NCT02136823|Spinal Cord Injury|spinal cord injury
341014|NCT02136810|Hypertension|hypertension
341015|NCT02136810|Perioperative Care|perioperative care
341016|NCT02136797|CMVpp65 Specific T-cells|cmvpp65 specific t-cells
341017|NCT02136797|Allogeneic Hematopoietic Stem Cell Transplantation|allogeneic hematopoietic stem cell transplantation
341018|NCT02136797|14-070|14-070
341019|NCT02136784|pain|pain
341020|NCT02136784|cold presser test|cold presser test
341021|NCT02136784|buprenorphine|buprenorphine
341022|NCT02136784|opioids|opioids
341023|NCT02136758|lifestyle modification|lifestyle modification
341024|NCT02136758|diet|diet
341025|NCT02136758|exercise|exercise
341026|NCT02136758|cardiovascular disease|cardiovascular disease
341027|NCT02136758|gene expression|gene expression
341028|NCT02136758|obesity|obesity
341029|NCT02136745|Irritable Bowel Syndrome|irritable bowel syndrome
341030|NCT02136745|Inflammatory Bowel Disease|inflammatory bowel disease
341031|NCT02136745|mind body|mind body
341032|NCT02136745|intervention|intervention
341033|NCT02136745|group|group
341034|NCT02136745|Relaxation Response|relaxation response
341035|NCT02136745|genomic effects|genomic effects
341036|NCT02136732|chronic conditions|chronic conditions
341037|NCT02136732|multimorbid|multimorbid
341038|NCT02136719|Uterine massage|uterine massage
341039|NCT02136719|vaginal birth|vaginal birth
341040|NCT02136719|postpartum haemorrhage|postpartum haemorrhage
341041|NCT02136706|Stable coronary artery disease|stable coronary artery disease
341042|NCT02136693|obstructed defecation|obstructed defecation
341043|NCT02136693|STARR|starr
341044|NCT02136693|constipation|constipation
341045|NCT02136693|incontinence|incontinence
341046|NCT02136693|psyllium|psyllium
341047|NCT02136680|HIV disease|hiv disease
341048|NCT02136680|palliative care|palliative care
341049|NCT02136680|educational intervention|educational intervention
341050|NCT02136667|Preeclampsia|preeclampsia
341051|NCT02136667|Cardiovascular disease (CVD) risk|cardiovascular disease (cvd) risk
341052|NCT02136654|diabetes|diabetes
341053|NCT02136654|ethnicity|ethnicity
341054|NCT02136654|South Asian|south asian
341055|NCT02136654|diabetes management|diabetes management
341056|NCT02136641|Anesthesia|anesthesia
341057|NCT02136641|Spinal Anesthesia|spinal anesthesia
341058|NCT02136641|Conscious Sedation|conscious sedation
341059|NCT02136641|Operating Rooms.|operating rooms.
341060|NCT02136628|RTL Technique|rtl technique
341061|NCT02136615|hyperbaric oxygenation|hyperbaric oxygenation
341062|NCT02136615|insulin sensitivity|insulin sensitivity
341063|NCT02136615|human|human
341064|NCT02136615|inflammation|inflammation
341065|NCT02136615|adipose tissue|adipose tissue
341066|NCT02136563|Chronic kidney disease|chronic kidney disease
341067|NCT02136563|Erythropoiesis stimulating agent response index|erythropoiesis stimulating agent response index
341068|NCT02136563|Hyporesponsive anemia to erythropoiesis stimulating agent|hyporesponsive anemia to erythropoiesis stimulating agent
341069|NCT02136563|Observational study|observational study
341070|NCT02136550|smoking|smoking
341071|NCT02136550|smoking cessation|smoking cessation
341072|NCT02136550|mucociliary clearance|mucociliary clearance
341073|NCT02136550|proteomics|proteomics
341074|NCT02136550|miRNA|mirna
341075|NCT02136498|smoking cessation|smoking cessation
341076|NCT02136498|varenicline|varenicline
341077|NCT02136498|adherence|adherence
341078|NCT02136472|Subfertility|subfertility
341079|NCT02136472|Metabolic syndrome|metabolic syndrome
341080|NCT02136472|Plasma volume|plasma volume
341081|NCT02136472|Intima media thickness|intima media thickness
341082|NCT02136472|Flow mediated dilatation|flow mediated dilatation
341083|NCT02136459|Thyroidectomy|thyroidectomy
341084|NCT02136459|Endotracheal tube|endotracheal tube
341085|NCT02136459|Voice|voice
341086|NCT02136459|Complications|complications
341087|NCT02136459|Patients undergoing elective thyroidectomy|patients undergoing elective thyroidectomy
341088|NCT02136446|Paravertebral block|paravertebral block
341089|NCT02136446|Mastectomy|mastectomy
341090|NCT02136446|Post-operative pain|post-operative pain
341091|NCT02136446|Echogenic|echogenic
341092|NCT02136446|Peripheral nerve block catheter|peripheral nerve block catheter
341093|NCT02136433|Hand|hand
341094|NCT02136433|Rehabilitation|rehabilitation
341095|NCT02136433|Stroke|stroke
341096|NCT02136433|Brain-injury|brain-injury
341097|NCT02136433|Tablet|tablet
341098|NCT02136407|Vitamin D|vitamin d
341099|NCT02136407|vitamin D deficiency|vitamin d deficiency
341100|NCT02136407|parathyroid hormone|parathyroid hormone
341101|NCT02136381|Lifestyle, interventions, retirement|lifestyle, interventions, retirement
341102|NCT02136368|older adults|older adults
341103|NCT02136368|multiple-modality exercise|multiple-modality exercise
341104|NCT02136368|mind-motor exercise|mind-motor exercise
341105|NCT02136368|self-reported cognitive complaints|self-reported cognitive complaints
341106|NCT02136368|global cognitive functioning|global cognitive functioning
341107|NCT02136368|mobility|mobility
341108|NCT02136368|vascular function|vascular function
341109|NCT02136368|sensorimotor function|sensorimotor function
341110|NCT02136368|brain imaging|brain imaging
341111|NCT02136368|community-based research|community-based research
341112|NCT02136368|subjective cognitive complaints|subjective cognitive complaints
341113|NCT02136342|no available effective treatment|no available effective treatment
341114|NCT02136316|Healthy volunteers|healthy volunteers
341115|NCT02136316|ASP7962|asp7962
341116|NCT02136316|pharmacokinetics|pharmacokinetics
341117|NCT02136290|Weight loss|weight loss
341118|NCT02136277|colorectal surgery|colorectal surgery
341119|NCT02136277|cardiac output|cardiac output
341120|NCT02136264|hypertension|hypertension
341121|NCT02136264|dietary intervention|dietary intervention
341122|NCT02136264|personalized nutrition|personalized nutrition
341123|NCT02136264|randomized controlled trial|randomized controlled trial
341124|NCT02136251|Total Shoulder Arthroplasty|total shoulder arthroplasty
341125|NCT02136251|Glenoid anchor peg component fixation|glenoid anchor peg component fixation
341126|NCT02136251|Autologous bone grafting|autologous bone grafting
341127|NCT02136238|amputation|amputation
341128|NCT02136238|transradial|transradial
341129|NCT02136238|prosthesis|prosthesis
341130|NCT02136238|terminal device|terminal device
341131|NCT02136225|youth|youth
341132|NCT02136225|gun|gun
341133|NCT02136225|access|access
341134|NCT02136225|home|home
341135|NCT02136186|home telemonitoring|home telemonitoring
341136|NCT02136186|readmission|readmission
341137|NCT02136186|high risk|high risk
341138|NCT02136160|elementary school|elementary school
341139|NCT02136160|children|children
341140|NCT02136160|health promotion|health promotion
341141|NCT02136160|teachers|teachers
341142|NCT02136160|prevention|prevention
341143|NCT02136147|Attention Deficit Disorder with Hyperactivity|attention deficit disorder with hyperactivity
341144|NCT02136147|Neuropsychiatry|neuropsychiatry
341145|NCT02136147|Drug therapy|drug therapy
341146|NCT02136147|Pharmacogenetics|pharmacogenetics
341147|NCT02136147|Child Psychiatry|child psychiatry
341148|NCT02136134|Multiple Myeloma|multiple myeloma
341149|NCT02136134|Plasmacytoma|plasmacytoma
341150|NCT02136134|Refractory Multiple Myeloma|refractory multiple myeloma
341151|NCT02136134|Relapsed Multiple Myeloma|relapsed multiple myeloma
341152|NCT02136134|Daratumumab|daratumumab
341153|NCT02136134|VELCADE|velcade
341154|NCT02136108|Chronic pain|chronic pain
712556|NCT00579709|Athymia|athymia
341155|NCT02136108|Complementary and alternative therapies|complementary and alternative therapies
341156|NCT02136108|Mobile health|mobile health
341157|NCT02136108|Medicaid|medicaid
341158|NCT02136108|Patient navigation|patient navigation
341159|NCT02136095|Fluorescent cholangiography|fluorescent cholangiography
341160|NCT02136095|Laparoscopic cholecystectomy|laparoscopic cholecystectomy
341161|NCT02136082|HIV|hiv
341162|NCT02136082|Women|women
341163|NCT02136082|Children|children
341164|NCT02136082|Nutrition|nutrition
341165|NCT02136056|Sick-leave|sick-leave
341166|NCT02136056|Return to work|return to work
341167|NCT02136056|Self-management|self-management
341168|NCT02136056|Self-efficacy|self-efficacy
341169|NCT02136056|Quality of Life and Well-being|quality of life and well-being
341170|NCT02136056|Motivation|motivation
341171|NCT02136030|Cryptococcal meningitis|cryptococcal meningitis
341172|NCT02136017|AEFI|aefi
341173|NCT02136017|influenza vaccine|influenza vaccine
341174|NCT02136004|arteriotomy|arteriotomy
341175|NCT02136004|vessel closure|vessel closure
341176|NCT02136004|femoral access site|femoral access site
341177|NCT02135978|Spinal Cord Injury|spinal cord injury
341178|NCT02135978|Shoulder Pain|shoulder pain
341179|NCT02135978|Exercise|exercise
341180|NCT02135952|Periodontitis|periodontitis
341181|NCT02135952|Diabetes|diabetes
341182|NCT02135926|Cerebral Stroke, Stroke, Acute, Brain Infarction|cerebral stroke, stroke, acute, brain infarction
341183|NCT02135913|Obese|obese
341184|NCT02135913|Children|children
341185|NCT02135913|Vitamin D deficiency|vitamin d deficiency
341186|NCT02135913|Low HDL|low hdl
341187|NCT02135900|Heliox|heliox
341188|NCT02135900|Obstructive Sleep Apnea|obstructive sleep apnea
341189|NCT02135887|Stage III Colorectal Cancer|stage iii colorectal cancer
341190|NCT02135887|Grade 4 Neutropenia|grade 4 neutropenia
341191|NCT02135887|MB-6|mb-6
341192|NCT02135861|Acute decompensated heart failure|acute decompensated heart failure
341193|NCT02135861|heart failure|heart failure
341194|NCT02135861|MRI|mri
341195|NCT02135861|trpV4 channel inhibitors|trpv4 channel inhibitors
341196|NCT02135861|pulmonary oedema|pulmonary oedema
341197|NCT02135822|nanoparticle albumin-bound paclitaxel|nanoparticle albumin-bound paclitaxel
341198|NCT02135822|gemcitabine|gemcitabine
341199|NCT02135822|advanced pancreatic cancer|advanced pancreatic cancer
341200|NCT02135796|Septic Shock|septic shock
341201|NCT02135796|Severe Sepsis|severe sepsis
341202|NCT02135796|ICU|icu
341203|NCT02135770|heparin|heparin
341204|NCT02135770|sepsis|sepsis
341205|NCT02135770|inflammation|inflammation
341206|NCT02135744|Chronic Obstructive Pulmonary Disease|chronic obstructive pulmonary disease
341207|NCT02135744|COPD|copd
341208|NCT02135744|Readmissions|readmissions
341209|NCT02135718|ELLIPTA|ellipta
341210|NCT02135718|Asthma|asthma
341211|NCT02135718|Inhaler preference|inhaler preference
341212|NCT02135718|Fluticasone furoate|fluticasone furoate
341213|NCT02135718|ELLIPTA inhaler|ellipta inhaler
341214|NCT02135718|Dry Powder Inhaler|dry powder inhaler
341215|NCT02135692|Severe eosinophilic asthma|severe eosinophilic asthma
341216|NCT02135692|Extension study|extension study
341217|NCT02135692|Expanded access|expanded access
341218|NCT02135692|Safety|safety
341219|NCT02135692|Mepolizumab|mepolizumab
341220|NCT02135692|Eosinophils|eosinophils
341221|NCT02135666|Twinrix|twinrix
341222|NCT02135666|Long-term follow-up|long-term follow-up
341223|NCT02135666|Persistence|persistence
341224|NCT02135666|Hepatitis A|hepatitis a
341225|NCT02135666|Antibody|antibody
341226|NCT02135666|Immunity|immunity
341227|NCT02135666|Hepatitis B|hepatitis b
341228|NCT02135666|Combination vaccine|combination vaccine
341229|NCT02135666|Adult|adult
341230|NCT02135601|colonoscopy|colonoscopy
341231|NCT02135601|water|water
341232|NCT02135601|adenoma|adenoma
341233|NCT02135601|pain|pain
341234|NCT02135575|premenopausal|premenopausal
341235|NCT02135575|postmenopausal|postmenopausal
341236|NCT02135575|cardiovascular|cardiovascular
341237|NCT02135575|exercise training|exercise training
341238|NCT02135575|vascular function|vascular function
341239|NCT02135575|cardiac function|cardiac function
341240|NCT02135575|cardiac morphology|cardiac morphology
341241|NCT02135575|health|health
341242|NCT02135562|endometrial cancer|endometrial cancer
341243|NCT02135562|survivor|survivor
341244|NCT02135562|obesity|obesity
341245|NCT02135562|diet|diet
341246|NCT02135562|high protein|high protein
341247|NCT02135562|protein-sparing modified fast intervention|protein-sparing modified fast intervention
341248|NCT02135562|PSMF|psmf
341249|NCT02135523|ovarian cancer|ovarian cancer
341250|NCT02135523|involved-field radiation therapy|involved-field radiation therapy
341251|NCT02135523|progression free survival|progression free survival
341252|NCT02135484|Prostate Cancer|prostate cancer
341253|NCT02135484|Adenocarcinoma of the prostate|adenocarcinoma of the prostate
341254|NCT02135484|Castrate resistant prostate cancer|castrate resistant prostate cancer
341255|NCT02135484|CRPC|crpc
341256|NCT02135484|Skeletal metastases|skeletal metastases
341257|NCT02135484|Alpharadin|alpharadin
341258|NCT02135484|Xofigo|xofigo
341259|NCT02135484|Radium-223 chloride|radium-223 chloride
341260|NCT02135484|Radium-223 dichloride|radium-223 dichloride
341261|NCT02135471|gingival recession|gingival recession
341262|NCT02135471|dental enamel proteins|dental enamel proteins
341263|NCT02135471|acellular dermal matrix graft|acellular dermal matrix graft
341264|NCT02135471|tobacco|tobacco
341265|NCT02135458|Heart failure|heart failure
341266|NCT02135458|Telemonitoring|telemonitoring
341267|NCT02135458|therapeutic education|therapeutic education
341268|NCT02135458|care network|care network
341269|NCT02135458|hospitalization|hospitalization
341270|NCT02135445|Drug therapy|drug therapy
341271|NCT02135432|Chronic Obstructive pulmonary disease, Ivacaftor|chronic obstructive pulmonary disease, ivacaftor
341272|NCT02135406|Adult|adult
341273|NCT02135406|18 years or older|18 years or older
341274|NCT02135406|multiple myeloma|multiple myeloma
341275|NCT02135406|poor prognosis|poor prognosis
341276|NCT02135406|relapsed/progressive disease|relapsed/progressive disease
341277|NCT02135406|within one year of first autologous stem cell transplantation|within one year of first autologous stem cell transplantation
341278|NCT02135367|PRP|prp
341279|NCT02135367|growth factors|growth factors
341280|NCT02135367|Viscosupplementation|viscosupplementation
341281|NCT02135367|injections|injections
341282|NCT02135367|chondropathy|chondropathy
341283|NCT02135367|randomized controlled trial|randomized controlled trial
341284|NCT02135354|AECOPD|aecopd
341285|NCT02135354|Chronic Obstructive Pulmonary Disease|chronic obstructive pulmonary disease
341286|NCT02135354|Acute exacerbation|acute exacerbation
341287|NCT02135354|Hospitalization|hospitalization
341288|NCT02135354|Azithromycin|azithromycin
341289|NCT02135354|Macrolides|macrolides
341290|NCT02135354|Randomized Controlled Trial|randomized controlled trial
341291|NCT02135354|Placebo|placebo
341292|NCT02135341|Detrusor Overactivity|detrusor overactivity
341293|NCT02135341|Impaired Contractility|impaired contractility
341294|NCT02135341|Botulinum Toxin A (BoNT-A)|botulinum toxin a (bont-a)
341295|NCT02135328|Type 2 diabetes|type 2 diabetes
341296|NCT02135328|Dietary behaviors|dietary behaviors
341297|NCT02135328|Physical activity behaviors|physical activity behaviors
341298|NCT02135328|Radio story, entertainment health education|radio story, entertainment health education
341299|NCT02135328|Immigrants|immigrants
341300|NCT02135328|Somali, Latino, Hmong|somali, latino, hmong
341301|NCT02135328|Families with 3-18 year old children|families with 3-18 year old children
341302|NCT02135315|Acute Coronary Syndrome, arterial pressure|acute coronary syndrome, arterial pressure
341303|NCT02135302|hepatic|hepatic
341304|NCT02135250|Traditional Chinese Medicine|traditional chinese medicine
341305|NCT02135211|non-small cell lung cancer (NSCLC)|non-small cell lung cancer (nsclc)
341306|NCT02135211|multiple risk factor|multiple risk factor
341307|NCT02135211|lifestyle intervention|lifestyle intervention
341308|NCT02135211|health behavior|health behavior
341309|NCT02135211|lifestyle risk reduction|lifestyle risk reduction
341310|NCT02135211|health related quality of life|health related quality of life
341311|NCT02135198|GABA modulator|gaba modulator
341312|NCT02135198|AZD7325|azd7325
341410|NCT02134678|psychotherapy|psychotherapy
341313|NCT02135198|Short interval intracortical inhibition|short interval intracortical inhibition
341314|NCT02135198|volunteers|volunteers
341315|NCT02135146|Hypotension|hypotension
341316|NCT02135146|Kidney injury|kidney injury
341317|NCT02135133|Chronic Lymphocytic Leukemia|chronic lymphocytic leukemia
341318|NCT02135133|Small Lymphocytic Lymphoma|small lymphocytic lymphoma
341319|NCT02135107|Gastroesophageal reflux disease|gastroesophageal reflux disease
341320|NCT02135094|trapezius|trapezius
341321|NCT02135094|upper back|upper back
341322|NCT02135094|muscle pain|muscle pain
341323|NCT02135094|pain relief|pain relief
341324|NCT02135094|ultrasound|ultrasound
341325|NCT02135094|double blind|double blind
341326|NCT02135094|Sam|sam
341327|NCT02135094|ZetrOZ|zetroz
341328|NCT02135094|muscle|muscle
341329|NCT02135094|LITUS|litus
341330|NCT02135094|low intensity therapeutic ultrasound|low intensity therapeutic ultrasound
341331|NCT02135081|Single ventricle|single ventricle
341332|NCT02135081|Hypoplastic Left Heart Syndrome|hypoplastic left heart syndrome
341333|NCT02135081|Congenital heart lesion|congenital heart lesion
341334|NCT02135081|Right or left ventricle|right or left ventricle
341335|NCT02135081|Cerebral blood flow|cerebral blood flow
341336|NCT02135081|Pulmonary blood flow|pulmonary blood flow
341337|NCT02135081|Staged Fontan reconstruction|staged fontan reconstruction
341338|NCT02135081|hemi Fontan/bidirectional Glenn stages|hemi fontan/bidirectional glenn stages
341339|NCT02135068|type 1 diabetes|type 1 diabetes
341340|NCT02135068|closed loop insulin delivery systems|closed loop insulin delivery systems
341341|NCT02135068|exercise|exercise
341342|NCT02135068|hypoglycemia|hypoglycemia
341343|NCT02135055|organ function|organ function
341344|NCT02135055|sedation|sedation
341345|NCT02135029|Hyperlipidemia|hyperlipidemia
341346|NCT02135029|statin intolerance|statin intolerance
341347|NCT02135016|effect-site concentration|effect-site concentration
341348|NCT02135016|propofol|propofol
341349|NCT02135016|thoracic epidural anesthesia|thoracic epidural anesthesia
341350|NCT02134990|Carcinoma, Non-Small-Cell Lung|carcinoma, non-small-cell lung
341351|NCT02134990|Docetaxel|docetaxel
341352|NCT02134977|Pharmacological therapy|pharmacological therapy
341353|NCT02134964|Safety|safety
341354|NCT02134964|Tolerability|tolerability
341355|NCT02134964|Pharmacokinetics|pharmacokinetics
341356|NCT02134964|Dose escalation|dose escalation
341357|NCT02134964|Randomized|randomized
341358|NCT02134964|Healthy volunteers|healthy volunteers
341359|NCT02134964|OLT1177|olt1177
341360|NCT02134964|Olatec|olatec
341361|NCT02134899|Autosomal dominant polycystic kidney disease|autosomal dominant polycystic kidney disease
341362|NCT02134899|cyst|cyst
341363|NCT02134899|kidney|kidney
341364|NCT02134899|liver|liver
341365|NCT02134899|kidney transplantation|kidney transplantation
341366|NCT02134899|IF/TA|if/ta
341367|NCT02134899|fibrosis|fibrosis
341368|NCT02134899|DSA|dsa
341369|NCT02134899|mTOR inhibitors|mtor inhibitors
341370|NCT02134899|calcineurin inhibitors|calcineurin inhibitors
341371|NCT02134873|Pain|pain
341372|NCT02134873|Pain management|pain management
341373|NCT02134873|Hospitalized|hospitalized
341374|NCT02134873|Infants|infants
341375|NCT02134873|Sucrose|sucrose
341376|NCT02134847|Resident|resident
341377|NCT02134847|Fatigue|fatigue
341378|NCT02134847|Sleep deprivation|sleep deprivation
341379|NCT02134847|medical errors|medical errors
341504|NCT02134314|Kidney Transplant|kidney transplant
341380|NCT02134808|Major Depressive Disorder|major depressive disorder
341381|NCT02134808|Creatine|creatine
341382|NCT02134808|Brain Chemistry|brain chemistry
341383|NCT02134808|Magnetic Resonance Spectroscopy|magnetic resonance spectroscopy
341384|NCT02134808|Treatment Resistance|treatment resistance
341385|NCT02134808|Selective Serotonin Reuptake Inhibitor (SSRI) Resistance|selective serotonin reuptake inhibitor (ssri) resistance
341386|NCT02134795|Parkinson's disease|parkinson's disease
341387|NCT02134782|Randomized Controlled Trial, yoga, children, chemotherapy, haematopoietic stem cell transplantation, fatigue, quality of life|randomized controlled trial, yoga, children, chemotherapy, haematopoietic stem cell transplantation, fatigue, quality of life
341388|NCT02134769|catheter-related bloodstream infections|catheter-related bloodstream infections
341389|NCT02134756|Supplement impact|supplement impact
341390|NCT02134756|Performance|performance
341391|NCT02134756|Fatigue|fatigue
341392|NCT02134743|dental implant|dental implant
341393|NCT02134743|Surface energy|surface energy
341394|NCT02134743|Hydrophilicity|hydrophilicity
341395|NCT02134743|Contact angle|contact angle
341396|NCT02134743|Titanium implant roughness|titanium implant roughness
341397|NCT02134743|Surface conditioning|surface conditioning
341398|NCT02134730|FRIENDS for life|friends for life
341399|NCT02134730|universal prevention|universal prevention
341400|NCT02134730|school children|school children
341401|NCT02134730|anxiety|anxiety
341402|NCT02134717|sarcoidosis|sarcoidosis
341403|NCT02134717|CCR5 inhibition|ccr5 inhibition
341404|NCT02134717|maraviroc|maraviroc
341405|NCT02134691|Posttraumatic Stress Disorder (PTSD)|posttraumatic stress disorder (ptsd)
341406|NCT02134691|Prolonged Exposure (PE)|prolonged exposure (pe)
341407|NCT02134678|self-system therapy|self-system therapy
341408|NCT02134678|cognitive therapy|cognitive therapy
341411|NCT02134678|mechanisms of action|mechanisms of action
341412|NCT02134665|Vancomycin|vancomycin
341413|NCT02134665|severe acute pancreatitis|severe acute pancreatitis
341414|NCT02134665|Creatinine clearance|creatinine clearance
341415|NCT02134652|Ultrasonography|ultrasonography
341416|NCT02134652|World Health|world health
341417|NCT02134626|Portal Hypertension|portal hypertension
341418|NCT02134626|Hepatic Venous Pressure Gradient|hepatic venous pressure gradient
341419|NCT02134626|Esophageal Varices|esophageal varices
341420|NCT02134626|Liver Cirrhosis|liver cirrhosis
341421|NCT02134626|Simvastatin|simvastatin
341422|NCT02134626|Nitric oxide|nitric oxide
341423|NCT02134626|HVPG|hvpg
341424|NCT02134613|99mTc-anti-TNF|99mtc-anti-tnf
341425|NCT02134613|Inflammation|inflammation
341426|NCT02134613|Psoriatic arthritis|psoriatic arthritis
341427|NCT02134613|Rheumatoid arthritis|rheumatoid arthritis
341428|NCT02134600|Omega-3 fatty acids|omega-3 fatty acids
341429|NCT02134600|DHA|dha
341430|NCT02134600|EPA|epa
341431|NCT02134600|Docosahexaenoic acid|docosahexaenoic acid
341432|NCT02134600|Eicosapentaenoic acid|eicosapentaenoic acid
341433|NCT02134600|Childhood cancer|childhood cancer
341434|NCT02134600|Body composition|body composition
341435|NCT02134600|Inflammation|inflammation
341436|NCT02134600|Neuropsychiatric symptoms|neuropsychiatric symptoms
341437|NCT02134587|Health knowledge, attitudes, practices.|health knowledge, attitudes, practices.
341438|NCT02134587|Adverse drug reaction reporting systems.|adverse drug reaction reporting systems.
341439|NCT02134587|Pharmacovigilance. Product Surveillance, Postmarketing.|pharmacovigilance. product surveillance, postmarketing.
341440|NCT02134587|Drug-related side effects and adverse reactions.|drug-related side effects and adverse reactions.
341441|NCT02134574|Lymphoma,|lymphoma,
341442|NCT02134574|leukemia,|leukemia,
775055|NCT00349024|mucositis|mucositis
341443|NCT02134574|multiple myeloma,|multiple myeloma,
341444|NCT02134574|hodgkin disease|hodgkin disease
341445|NCT02134522|non alcoholic fatty liver|non alcoholic fatty liver
341446|NCT02134522|childhood obesity|childhood obesity
341447|NCT02134522|Sleep Apnea|sleep apnea
341448|NCT02134509|Cigarette smoking|cigarette smoking
341449|NCT02134496|hip|hip
341450|NCT02134496|knee|knee
341451|NCT02134496|arthroplasty|arthroplasty
341452|NCT02134496|spinal|spinal
341453|NCT02134496|anesthesia|anesthesia
341454|NCT02134483|Parathyroid|parathyroid
341455|NCT02134483|Permanent hypocalcemia|permanent hypocalcemia
341456|NCT02134483|Transplantation|transplantation
341457|NCT02134470|saliva|saliva
341458|NCT02134470|blood|blood
341459|NCT02134470|urine|urine
341460|NCT02134444|Dizziness|dizziness
341461|NCT02134444|Vertigo|vertigo
341462|NCT02134444|Vestibular Diseases|vestibular diseases
341463|NCT02134444|Vestibular Neuritis|vestibular neuritis
341464|NCT02134444|Labyrinth Diseases|labyrinth diseases
341465|NCT02134444|Ear Diseases|ear diseases
341466|NCT02134444|Vestibular rehabilitation|vestibular rehabilitation
341467|NCT02134444|Telerehabilitation|telerehabilitation
341468|NCT02134444|Gaze control|gaze control
341469|NCT02134444|Balance|balance
341470|NCT02134431|HIV|hiv
341471|NCT02134431|tenofovir|tenofovir
341472|NCT02134431|miocrobicide|miocrobicide
341473|NCT02134431|endoscopy (colonoscopy, sigmoidoscopy)|endoscopy (colonoscopy, sigmoidoscopy)
341474|NCT02134431|adolescents|adolescents
341475|NCT02134431|pediatrics|pediatrics
341476|NCT02134418|Schizophrenia|schizophrenia
341477|NCT02134418|Irony|irony
341478|NCT02134418|Hemispheric processing|hemispheric processing
341479|NCT02134418|Theory of mind|theory of mind
341480|NCT02134405|functional dyspepsia|functional dyspepsia
341481|NCT02134405|symptoms|symptoms
341482|NCT02134405|proton pump inhibitor|proton pump inhibitor
341483|NCT02134405|gastritis|gastritis
341484|NCT02134392|C-diff|c-diff
341485|NCT02134392|Clostridium difficile|clostridium difficile
341486|NCT02134392|Fecal Transplant|fecal transplant
341487|NCT02134392|FMT|fmt
341488|NCT02134392|Fecal Microbiota Transplant|fecal microbiota transplant
341489|NCT02134379|Thoracic Impedance|thoracic impedance
341490|NCT02134379|Diagnostic Marker|diagnostic marker
341491|NCT02134379|Bed Rest Test|bed rest test
341492|NCT02134379|Transthoracic Impedance|transthoracic impedance
341493|NCT02134379|Heart Failure|heart failure
341494|NCT02134379|HF|hf
341495|NCT02134366|Epilepsia Partialis Continua|epilepsia partialis continua
341496|NCT02134366|Kojewnikov's Epilepsy|kojewnikov's epilepsy
341497|NCT02134366|Epilepsy|epilepsy
341498|NCT02134366|Clobazam|clobazam
341499|NCT02134366|Focal Motor Epilepsy|focal motor epilepsy
341500|NCT02134366|Partial Motor Seizure|partial motor seizure
341501|NCT02134340|IGF1R|igf1r
341502|NCT02134314|ESRD (End Stage Renal Disease)|esrd (end stage renal disease)
341503|NCT02134314|CKD (Chronic Kidney Disease)|ckd (chronic kidney disease)
341505|NCT02134314|ECD|ecd
341506|NCT02134314|delayed graft function|delayed graft function
341507|NCT02134314|chronic kidney disease|chronic kidney disease
341508|NCT02134314|expanded-criteria donor|expanded-criteria donor
341509|NCT02134314|end stage renal disease|end stage renal disease
341510|NCT02134301|oritavancin|oritavancin
341511|NCT02134301|pediatrics|pediatrics
342307|NCT02130752|Morbidity|morbidity
341512|NCT02134301|gram positive|gram positive
341513|NCT02134301|bacterial infection|bacterial infection
341514|NCT02134301|Confirmed|confirmed
341515|NCT02134301|Suspected|suspected
341516|NCT02134288|Dialysis|dialysis
341517|NCT02134288|Kidney Transplant|kidney transplant
341518|NCT02134288|immunosuppressive therapy|immunosuppressive therapy
341519|NCT02134288|Delayed Graft Function|delayed graft function
341520|NCT02134288|Belatacept|belatacept
341521|NCT02134275|whole body vibration training|whole body vibration training
341522|NCT02134275|young adult|young adult
341523|NCT02134275|weight gain|weight gain
341525|NCT02134275|randomized clinical trial|randomized clinical trial
341526|NCT02134262|Anti-CD19 CAR Expressing T cells Therapy|anti-cd19 car expressing t cells therapy
341527|NCT02134262|CD19 CAR Gene-Transduced Lymphocyte|cd19 car gene-transduced lymphocyte
341528|NCT02134262|Adoptive Immunotherapy|adoptive immunotherapy
341529|NCT02134262|Genetically Engineered Lymphocyte Therapy|genetically engineered lymphocyte therapy
341530|NCT02134262|Retroviral Vector|retroviral vector
341531|NCT02134262|Burkitt Lymphoma|burkitt lymphoma
341532|NCT02134262|Lymphoma|lymphoma
341533|NCT02134262|Lymphoma, Follicular|lymphoma, follicular
341534|NCT02134262|Lymphoma, Non-Hodgkin|lymphoma, non-hodgkin
341535|NCT02134262|Lymphomatoid Granulomatosis|lymphomatoid granulomatosis
341536|NCT02134262|Lymphoma, B-Cell|lymphoma, b-cell
341537|NCT02134262|Lymphoma, Large B-Cell, Diffuse|lymphoma, large b-cell, diffuse
341538|NCT02134262|Lymphoma, Large-Cell, Immunoblastic|lymphoma, large-cell, immunoblastic
341539|NCT02134262|Lymphoma, B-Cell, Marginal Zone|lymphoma, b-cell, marginal zone
341540|NCT02134262|Lymphoma, Extranodal NK-T-Cell|lymphoma, extranodal nk-t-cell
341541|NCT02134262|Lymphoma, Mantle-Cell|lymphoma, mantle-cell
341542|NCT02134262|Neoplasms by Histologic Type|neoplasms by histologic type
341543|NCT02134262|Neoplasms|neoplasms
341544|NCT02134262|Neoplasms, Experimental|neoplasms, experimental
341545|NCT02134262|Immune System Diseases|immune system diseases
341546|NCT02134249|infertility|infertility
341547|NCT02134249|ICSI|icsi
341548|NCT02134249|OHSS|ohss
341549|NCT02134249|Diosmin|diosmin
341550|NCT02134249|Cabergoline|cabergoline
341551|NCT02134210|PsO|pso
341552|NCT02134197|Oncology|oncology
341553|NCT02134197|Solid tumors|solid tumors
341554|NCT02134197|Antibody drug conjugate|antibody drug conjugate
341555|NCT02134197|Maximum tolerated dose|maximum tolerated dose
341556|NCT02134171|Thrombotic microangiopathy,|thrombotic microangiopathy,
341557|NCT02134171|haemolytic uremic syndrome,|haemolytic uremic syndrome,
341558|NCT02134171|thrombotic thrombocytopenic purpura,|thrombotic thrombocytopenic purpura,
341559|NCT02134171|ADAMTS13,|adamts13,
341560|NCT02134171|troponin,|troponin,
341561|NCT02134171|plasma exchange.|plasma exchange.
341562|NCT02134158|tDCS, gait disorders, equilibrium, hemiplegic, stroke|tdcs, gait disorders, equilibrium, hemiplegic, stroke
341563|NCT02134145|Mobile Health|mobile health
341564|NCT02134145|mHealth|mhealth
341565|NCT02134145|Technology|technology
341566|NCT02134132|Platelet gel|platelet gel
341567|NCT02134132|diabetic foot ulcer|diabetic foot ulcer
341568|NCT02134132|umbilical cord blood|umbilical cord blood
341569|NCT02134119|dietary supplement|dietary supplement
341570|NCT02134119|endurance athletes|endurance athletes
341571|NCT02134119|VO2max|vo2max
341572|NCT02134119|red blood cells|red blood cells
341573|NCT02134106|Multicenter|multicenter
341574|NCT02134106|Open-label|open-label
341575|NCT02134106|Randomized|randomized
341576|NCT02134106|Controlled|controlled
341577|NCT02134106|RCT|rct
341578|NCT02134106|antibiotic|antibiotic
341579|NCT02134106|drug-resistant|drug-resistant
341580|NCT02134106|Gram-negative|gram-negative
341581|NCT02134106|bacteria|bacteria
341582|NCT02134080|Tourette Syndrome|tourette syndrome
341583|NCT02134080|FAAH-Inhibitor|faah-inhibitor
341584|NCT02134080|Tics|tics
341585|NCT02134080|Tic Disorders|tic disorders
341586|NCT02134067|advanced solid tumors|advanced solid tumors
341587|NCT02134067|tumor|tumor
341588|NCT02134067|Dose Escalation|dose escalation
341589|NCT02134067|TAS-119|tas-119
341590|NCT02134067|Taxane|taxane
341591|NCT02134067|Paclitaxel|paclitaxel
341592|NCT02134067|Aurora A kinase inhibitor|aurora a kinase inhibitor
341593|NCT02134067|AurA|aura
341594|NCT02134054|Therapeutic drug monitoring|therapeutic drug monitoring
341595|NCT02134054|Biological treatment|biological treatment
341596|NCT02134054|IBD|ibd
341597|NCT02134041|traumatic brain injury|traumatic brain injury
341598|NCT02134041|Alzheimer disease|alzheimer disease
341599|NCT02134015|Carcinoma|carcinoma
341600|NCT02134015|Non-Small-Cell Lung|non-small-cell lung
341601|NCT02134015|Lung Neoplasms|lung neoplasms
341602|NCT02134015|Bronchogenic|bronchogenic
341603|NCT02134015|Bronchial Neoplasms|bronchial neoplasms
341604|NCT02134015|Respiratory Tract Neoplasms|respiratory tract neoplasms
341605|NCT02134015|Thoracic Neoplasms|thoracic neoplasms
341606|NCT02134015|Neoplasms by Site|neoplasms by site
341607|NCT02134015|Neoplasms|neoplasms
341608|NCT02134015|Lung Diseases|lung diseases
341609|NCT02134015|Respiratory Tract Diseases|respiratory tract diseases
341610|NCT02134015|Erlotinib|erlotinib
341611|NCT02134015|Therapeutic Uses|therapeutic uses
341612|NCT02134015|Pharmacologic Actions|pharmacologic actions
341613|NCT02134015|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action
341615|NCT02134002|disulfiram|disulfiram
341616|NCT02134002|beta-dopamine hydroxylase|beta-dopamine hydroxylase
341617|NCT02133989|Carotid stenosis|carotid stenosis
341618|NCT02133989|Stenting|stenting
341619|NCT02133989|Clopidogrel resistance|clopidogrel resistance
341620|NCT02133989|Stroke, ischemic|stroke, ischemic
341621|NCT02133976|chronic low back pain|chronic low back pain
341622|NCT02133976|psychosocial interventions|psychosocial interventions
341623|NCT02133976|mechanisms|mechanisms
341624|NCT02133963|depression|depression
341625|NCT02133963|postpartum depression|postpartum depression
341626|NCT02133963|pregnancy|pregnancy
341627|NCT02133963|perinatal depression|perinatal depression
341628|NCT02133963|sleep|sleep
341629|NCT02133963|life stress|life stress
341630|NCT02133950|preimplantation genetic diagnosis|preimplantation genetic diagnosis
341631|NCT02133950|cryopreservation|cryopreservation
341632|NCT02133950|pregnancy|pregnancy
341633|NCT02133924|Graft vs Host Disease|graft vs host disease
341634|NCT02133924|Graft vs Host Reaction|graft vs host reaction
341635|NCT02133924|allogeneic bone marrow transplantation|allogeneic bone marrow transplantation
341636|NCT02133924|allogeneic hematopoietic stem cell transplantation|allogeneic hematopoietic stem cell transplantation
341637|NCT02133924|adverse effects|adverse effects
341638|NCT02133898|Depression|depression
341639|NCT02133898|MTHFR|mthfr
341640|NCT02133898|L-methylfolate|l-methylfolate
341641|NCT02133885|Resistent Hypertension|resistent hypertension
436739|NCT01703585|DNA|dna
341642|NCT02133885|Systolic Blood Pressure|systolic blood pressure
341643|NCT02133872|Resistent Hypertension|resistent hypertension
341644|NCT02133846|4RT, CBS, PSP, CBD, TPI-287|4rt, cbs, psp, cbd, tpi-287
341645|NCT02133820|Healthy Volunteer|healthy volunteer
341646|NCT02133820|Pharmacokinetics|pharmacokinetics
341647|NCT02133807|Lipoprotein(a);|lipoprotein(a);
341648|NCT02133807|Lp(a) immunoadsorption;|lp(a) immunoadsorption;
341649|NCT02133807|Apheresis;|apheresis;
341650|NCT02133807|Coronary atherosclerosis;|coronary atherosclerosis;
341651|NCT02133807|Carotid Atherosclerosis;|carotid atherosclerosis;
341652|NCT02133807|Intima-media thickness;|intima-media thickness;
341653|NCT02133807|Regression;|regression;
341654|NCT02133807|Quantitative Coronary Angiography;|quantitative coronary angiography;
341655|NCT02133807|Intravascular Ultrasound;|intravascular ultrasound;
341656|NCT02133807|Virtual Histology;|virtual histology;
341657|NCT02133807|Plaque;|plaque;
341658|NCT02133807|Atorvastatin;|atorvastatin;
341659|NCT02133794|Hip fracture|hip fracture
341660|NCT02133794|Tomosynthesis|tomosynthesis
341661|NCT02133794|X-ray|x-ray
341662|NCT02133794|Emergency room|emergency room
341663|NCT02133781|Inactivated influenza vaccine|inactivated influenza vaccine
341664|NCT02133781|Live, attenuated influenza vaccine|live, attenuated influenza vaccine
341665|NCT02133781|Child identical twins|child identical twins
341666|NCT02133781|Young and elderly adults|young and elderly adults
341667|NCT02133742|Axitinib and MK-3475|axitinib and mk-3475
341668|NCT02133742|patients with advanced Renal Cell Cancer.|patients with advanced renal cell cancer.
341669|NCT02133716|pain|pain
341670|NCT02133716|premature infant|premature infant
341671|NCT02133716|sucrose|sucrose
341672|NCT02133716|breastfeeding|breastfeeding
341673|NCT02133716|expressed breast milk|expressed breast milk
341674|NCT02133716|PIPP|pipp
341675|NCT02133703|Genetic counseling|genetic counseling
341676|NCT02133703|genetic testing|genetic testing
341677|NCT02133703|BRCA1|brca1
341678|NCT02133703|BRCA2|brca2
341679|NCT02133703|Hereditary breast cancer|hereditary breast cancer
341680|NCT02133703|Hereditary ovarian cancer|hereditary ovarian cancer
341681|NCT02133690|rotavirus|rotavirus
341682|NCT02133690|rotavirus vaccine|rotavirus vaccine
341683|NCT02133690|BRV-PV|brv-pv
341684|NCT02133677|lung cancer and breast cancer patients with brain metastases|lung cancer and breast cancer patients with brain metastases
341685|NCT02133664|multiple sclerosis|multiple sclerosis
341686|NCT02133664|cognition|cognition
341687|NCT02133664|clinical trial|clinical trial
341688|NCT02133664|thiotic acid|thiotic acid
341689|NCT02133664|Omega-3 fatty acids|omega-3 fatty acids
341690|NCT02133651|Clostridium difficile|clostridium difficile
341691|NCT02133651|Intestinal Microbiota Transplantation|intestinal microbiota transplantation
341692|NCT02133651|Diarrhea|diarrhea
341693|NCT02133651|Fecal Microbiota Transplant|fecal microbiota transplant
341694|NCT02133638|Delirium|delirium
341695|NCT02133638|Hypoxic Brain Damage|hypoxic brain damage
341696|NCT02133638|Propofol|propofol
341697|NCT02133638|S100b protein|s100b protein
341698|NCT02133638|Sevoflurane|sevoflurane
341699|NCT02133625|Advanced solid tumor|advanced solid tumor
341700|NCT02133625|Metastatic solid tumor|metastatic solid tumor
341701|NCT02133612|esophageal cancer|esophageal cancer
341702|NCT02133612|adjuvant chemotherapy|adjuvant chemotherapy
341703|NCT02133612|esophageal surgery|esophageal surgery
341704|NCT02133612|paclitaxel|paclitaxel
341705|NCT02133612|cisplatin|cisplatin
341706|NCT02133586|Air pollution|air pollution
341708|NCT02133586|Nitrogen dioxide|nitrogen dioxide
341709|NCT02133586|Lung function|lung function
341710|NCT02133586|Cytokines|cytokines
341711|NCT02133573|progesterone|progesterone
341712|NCT02133573|congenital heart disease|congenital heart disease
341713|NCT02133573|periventricular leucomalacia|periventricular leucomalacia
341714|NCT02133573|brain development|brain development
341715|NCT02133573|cardiac surgery|cardiac surgery
341716|NCT02133573|neurodevelopmental disability|neurodevelopmental disability
341717|NCT02133573|fetus|fetus
341718|NCT02133573|fetal neuroprotection|fetal neuroprotection
341719|NCT02133560|Sickle cell|sickle cell
341720|NCT02133560|Thalassemia|thalassemia
341721|NCT02133560|Adherence|adherence
341722|NCT02133547|Nitric Oxide|nitric oxide
341723|NCT02133547|Nose|nose
341724|NCT02133547|Healthy Volunteers|healthy volunteers
341725|NCT02133547|Kartagener Syndrome|kartagener syndrome
341726|NCT02133547|Primary Ciliary Dyskinesia|primary ciliary dyskinesia
341727|NCT02133534|Chronic kidney disease|chronic kidney disease
341728|NCT02133534|High cholesterol|high cholesterol
341729|NCT02133521|DLBS1033|dlbs1033
341730|NCT02133521|Acute ischemic stroke|acute ischemic stroke
341731|NCT02133521|NIHSS|nihss
341732|NCT02133521|Barthel Index|barthel index
341733|NCT02133495|lower eyelid|lower eyelid
341734|NCT02133495|retraction|retraction
341735|NCT02133469|Effectiveness|effectiveness
341736|NCT02133469|Prevenar|prevenar
341737|NCT02133469|nasopharyngeal carriage|nasopharyngeal carriage
341738|NCT02133469|vaccine serotype|vaccine serotype
341739|NCT02133456|safety|safety
341740|NCT02133456|influenza vaccine|influenza vaccine
341741|NCT02133456|post-marketing|post-marketing
341742|NCT02133443|Mechanical ventilation|mechanical ventilation
341743|NCT02133443|Acute respiratory failure|acute respiratory failure
341744|NCT02133443|Weaning|weaning
341745|NCT02133443|Pressure support ventilation|pressure support ventilation
341746|NCT02133443|Neurally adjusted ventilatory assist|neurally adjusted ventilatory assist
341747|NCT02133430|Postoperative delirium|postoperative delirium
341748|NCT02133417|Quantitative Transmission Ultrasound|quantitative transmission ultrasound
341749|NCT02133417|QTUS|qtus
341750|NCT02133404|Mineral bone disease(MBD)|mineral bone disease(mbd)
341751|NCT02133404|Chronic kidney disease(CKD)|chronic kidney disease(ckd)
341752|NCT02133404|secondary hyperparathyroidism(SHPT)|secondary hyperparathyroidism(shpt)
341753|NCT02133391|Accountable Care Organization|accountable care organization
341754|NCT02133391|Comparative Effectiveness Research|comparative effectiveness research
341755|NCT02133391|Immunization/statistics & numerical data|immunization/statistics & numerical data
341756|NCT02133391|Medicaid|medicaid
341757|NCT02133391|Reminder Systems/economics|reminder systems/economics
341758|NCT02133391|Reminder Systems/statistics & numerical data|reminder systems/statistics & numerical data
341759|NCT02133378|Bleeding|bleeding
341760|NCT02133378|Hemostatic|hemostatic
341761|NCT02133352|pulmonary hypertension|pulmonary hypertension
341762|NCT02133352|diastolic dyfunction|diastolic dyfunction
341763|NCT02133326|Analgesia|analgesia
341764|NCT02133326|Third Molar Extraction|third molar extraction
341765|NCT02133326|Ibuprofen|ibuprofen
341766|NCT02133326|Acetaminophen|acetaminophen
341767|NCT02133326|Pain Medicine|pain medicine
341768|NCT02133326|Nonsteroidal|nonsteroidal
341769|NCT02133326|Anti-inflammatory|anti-inflammatory
341770|NCT02133313|Peritoneal Dialysis|peritoneal dialysis
341771|NCT02133313|Peritoneal Fibrosis|peritoneal fibrosis
341772|NCT02133313|Glucose Transporters|glucose transporters
341773|NCT02133274|Neoplasms|neoplasms
341774|NCT02133274|Early Palliative Care|early palliative care
341775|NCT02133274|Psychosocial Intervention|psychosocial intervention
341776|NCT02133274|Symptoms|symptoms
341777|NCT02133274|Quality of life|quality of life
341778|NCT02133274|Depression|depression
341779|NCT02133248|donor specific antibodies|donor specific antibodies
341780|NCT02133248|B cells|b cells
341781|NCT02133248|antibody mediated rejection|antibody mediated rejection
341782|NCT02133248|kidney transplant|kidney transplant
341783|NCT02133248|desensitization|desensitization
341784|NCT02133235|endobronchial blocker|endobronchial blocker
341785|NCT02133235|lung separation|lung separation
341786|NCT02133235|vedio-assisted thoracic operation|vedio-assisted thoracic operation
341787|NCT02133209|migraine|migraine
341788|NCT02133209|headache|headache
341789|NCT02133209|meditation|meditation
341790|NCT02133209|mindfulness based stress reduction|mindfulness based stress reduction
341791|NCT02133209|MBSR|mbsr
341792|NCT02133196|Metastatic|metastatic
341793|NCT02133196|Non-Small Cell Lung Cancer|non-small cell lung cancer
341794|NCT02133196|NSCLC|nsclc
341795|NCT02133196|Lung Cancer|lung cancer
341796|NCT02133170|BIPOLAR DISORDER|bipolar disorder
341797|NCT02133170|DEPRESSIVE SYMPTOMS|depressive symptoms
341798|NCT02133170|MINDFULNESS|mindfulness
341799|NCT02133170|PSYCHOEDUCATION|psychoeducation
341800|NCT02133170|BIPOLAR PATIENTS WITH DEPRESSIVE SYMPTOMS|bipolar patients with depressive symptoms
341801|NCT02133157|tumor|tumor
341802|NCT02133144|NAFLD|nafld
341803|NCT02133144|insulin resistance|insulin resistance
341804|NCT02133144|metabolic syndrome|metabolic syndrome
341805|NCT02133144|de novo lipogenesis|de novo lipogenesis
341806|NCT02133144|overfeeding|overfeeding
341807|NCT02133118|Type 2 diabetes|type 2 diabetes
341808|NCT02133118|New-user design|new-user design
341809|NCT02133118|Weight trajectory|weight trajectory
341810|NCT02133118|Add-on therapy|add-on therapy
341811|NCT02133118|Sulphonylureas.|sulphonylureas.
341812|NCT02133105|Heart failure|heart failure
341813|NCT02133105|Renal failure|renal failure
341814|NCT02133105|Inotropic drugs|inotropic drugs
341815|NCT02133105|Levosimendan|levosimendan
341816|NCT02133105|Dobutamine|dobutamine
341817|NCT02133092|Respiratory syncytial virus|respiratory syncytial virus
341818|NCT02133092|RSV|rsv
341819|NCT02133092|Lower respiratory tract infection|lower respiratory tract infection
341820|NCT02133092|LRTI|lrti
341821|NCT02133092|Acute respiratory infection|acute respiratory infection
341822|NCT02133092|Belgian children|belgian children
341823|NCT02133066|Ultrasound|ultrasound
341824|NCT02133066|Lumbar Puncture|lumbar puncture
341825|NCT02133066|Spinal Tap|spinal tap
341826|NCT02133066|Pediatric|pediatric
341827|NCT02133066|Infant|infant
341828|NCT02133066|Bedside Ultrasonography|bedside ultrasonography
341829|NCT02133053|Allergic Rhinitis|allergic rhinitis
341830|NCT02133053|Ectoine|ectoine
341831|NCT02133053|bitop|bitop
341832|NCT02133053|Ectoin|ectoin
341833|NCT02133040|Brown Adipose Tissue|brown adipose tissue
775149|NCT00348647|Prospective|prospective
341834|NCT02133027|Laparoscopic cholecystectomy|laparoscopic cholecystectomy
341835|NCT02133014|pancreatitis|pancreatitis
341836|NCT02133014|laparoscopic|laparoscopic
341837|NCT02133014|drainage|drainage
341838|NCT02133014|surgery|surgery
341839|NCT02133001|Major Depressive Disorder|major depressive disorder
341840|NCT02133001|Esketamine|esketamine
341841|NCT02133001|Intranasal esketamine|intranasal esketamine
341842|NCT02133001|Placebo|placebo
341843|NCT02132975|prostate|prostate
341844|NCT02132975|cancer|cancer
341845|NCT02132923|Respiratory syncytial virus|respiratory syncytial virus
341846|NCT02132923|RSV|rsv
341847|NCT02132923|Lower respiratory tract infection|lower respiratory tract infection
341848|NCT02132923|LRTI|lrti
341849|NCT02132923|Acute respiratory infection|acute respiratory infection
341850|NCT02132923|Japanese children|japanese children
341851|NCT02132897|Antiepileptic|antiepileptic
341852|NCT02132897|Carbamazepine|carbamazepine
341853|NCT02132897|Bio-equivalence|bio-equivalence
341854|NCT02132897|Fed|fed
341855|NCT02132897|Crossover|crossover
341856|NCT02132832|marijuana|marijuana
341857|NCT02132832|attentional bias|attentional bias
341858|NCT02132832|stress|stress
341859|NCT02132832|buspirone|buspirone
341860|NCT02132819|transfusion|transfusion
341861|NCT02132819|feeding|feeding
341862|NCT02132819|TRAGI|tragi
341863|NCT02132819|NEC|nec
341864|NCT02132806|class II furcation involvement|class ii furcation involvement
341865|NCT02132806|piezoelectric surgery|piezoelectric surgery
341866|NCT02132806|regeneration|regeneration
341867|NCT02132806|biomaterial|biomaterial
341868|NCT02132793|technology|technology
341869|NCT02132793|mobile|mobile
341870|NCT02132793|anger management|anger management
341871|NCT02132793|anger|anger
341872|NCT02132793|PTSD|ptsd
341873|NCT02132793|veterans|veterans
341874|NCT02132767|Heart surgery|heart surgery
341875|NCT02132767|Cardiac surgery|cardiac surgery
341876|NCT02132767|Coronary artery bypass|coronary artery bypass
341877|NCT02132767|Mitral valve surgery|mitral valve surgery
341878|NCT02132767|Aortic valve surgery|aortic valve surgery
341879|NCT02132767|Atrial fibrillation|atrial fibrillation
341880|NCT02132767|Atrial flutter|atrial flutter
341881|NCT02132767|Cardiac arrhythmia|cardiac arrhythmia
341882|NCT02132767|Valve surgery|valve surgery
341883|NCT02132741|OCT; hypertension; CKD|oct; hypertension; ckd
341884|NCT02132728|flaxseed|flaxseed
341885|NCT02132728|lignans|lignans
341886|NCT02132728|inflammation|inflammation
341887|NCT02132728|Nutrition|nutrition
341888|NCT02132728|enterolactone|enterolactone
341889|NCT02132728|enterodiol|enterodiol
341890|NCT02132689|Moderate Risk Acute Pulmonary Embolism|moderate risk acute pulmonary embolism
341891|NCT02132676|Self-Management|self-management
341892|NCT02132676|Patient Care Management|patient care management
341893|NCT02132676|Peer Group|peer group
341894|NCT02132676|Disease Management|disease management
341895|NCT02132676|Health Plan Implementation|health plan implementation
341896|NCT02132676|Diabetes Mellitus|diabetes mellitus
341897|NCT02132650|Rehabilitation|rehabilitation
341898|NCT02132650|Walking|walking
341899|NCT02132650|Motor skills disorders|motor skills disorders
341900|NCT02132650|Electromyography|electromyography
341901|NCT02132598|Lung Cancer|lung cancer
341902|NCT02132598|Non Small Cell|non small cell
341903|NCT02132598|Brain metastases|brain metastases
341904|NCT02132598|c-MET|c-met
341905|NCT02132520|Hemiparesis|hemiparesis
341906|NCT02132520|Stroke|stroke
341907|NCT02132520|Rehabilitation|rehabilitation
341908|NCT02132520|Transcranial Magnetic Stimulation, Repetitive|transcranial magnetic stimulation, repetitive
341909|NCT02132520|Electroencephalography|electroencephalography
341910|NCT02132520|Functional Neuroimaging|functional neuroimaging
341911|NCT02132520|Brain-Computer Interface|brain-computer interface
341912|NCT02132507|epilepsy|epilepsy
341913|NCT02132507|fMRI|fmri
341914|NCT02132507|EEG|eeg
341915|NCT02132507|ICA|ica
341916|NCT02132481|Smartphones|smartphones
341917|NCT02132481|Mobile phones|mobile phones
341918|NCT02132481|Substance use disorder|substance use disorder
341919|NCT02132481|Recovery Support Services|recovery support services
341920|NCT02132481|Ecological Momentary Assessment (EMA)|ecological momentary assessment (ema)
341921|NCT02132481|Ecological Momentary Intervention (EMI)|ecological momentary intervention (emi)
341922|NCT02132481|Randomized field experiment|randomized field experiment
341923|NCT02132481|Effectiveness|effectiveness
341924|NCT02132481|Post-Discharge|post-discharge
341925|NCT02132468|PNET|pnet
341926|NCT02132468|GI-NET|gi-net
341927|NCT02132468|neuroendocrine|neuroendocrine
341928|NCT02132468|carcinoid|carcinoid
341929|NCT02132455|Screening colonoscopy|screening colonoscopy
341930|NCT02132455|Surveillance colonoscopy|surveillance colonoscopy
341931|NCT02132442|Children|children
341932|NCT02132442|Adolescents|adolescents
341933|NCT02132442|Adults|adults
341934|NCT02132442|Type 2 diabetes|type 2 diabetes
341935|NCT02132442|Nonalcoholic fatty liver disease|nonalcoholic fatty liver disease
775449|NCT00347139|Efficacy|efficacy
341936|NCT02132442|Vitamin D deficiency|vitamin d deficiency
341937|NCT02132429|Migraine|migraine
341938|NCT02132416|Prospective study|prospective study
341939|NCT02132416|Surgical management|surgical management
341940|NCT02132416|Unstable thoracic cage injuries|unstable thoracic cage injuries
341941|NCT02132416|Trauma|trauma
341942|NCT02132416|Ventilator support|ventilator support
341943|NCT02132403|pancreatic cancer|pancreatic cancer
341944|NCT02132403|adenocarcinoma of the pancreas (PDAC)|adenocarcinoma of the pancreas (pdac)
341945|NCT02132403|mixed adenocarcinoma of the pancreas|mixed adenocarcinoma of the pancreas
341946|NCT02132403|locally advanced|locally advanced
341947|NCT02132403|recurrent|recurrent
341948|NCT02132403|metastatic|metastatic
341949|NCT02132390|Breast cancer|breast cancer
341950|NCT02132390|Chemotherapy induced amenorrhea|chemotherapy induced amenorrhea
341951|NCT02132390|Goserelin|goserelin
341952|NCT02132364|stroke|stroke
341953|NCT02132364|hypertension|hypertension
341954|NCT02132364|secondary prevention|secondary prevention
341955|NCT02132364|educational program|educational program
341956|NCT02132338|Type 2 Diabetes Mellitus|type 2 diabetes mellitus
341957|NCT02132338|Prevention|prevention
341958|NCT02132338|Health Education|health education
341959|NCT02132325|Pancreatic Cancer|pancreatic cancer
341960|NCT02132325|Dignity Therapy|dignity therapy
341961|NCT02132325|Palliative Care|palliative care
341962|NCT02132325|Advanced Lung Cancer|advanced lung cancer
341963|NCT02132325|Non-Small-Cell Lung Cancer|non-small-cell lung cancer
341964|NCT02132312|Cataract|cataract
341965|NCT02132312|Lens replacement|lens replacement
341966|NCT02132312|pediatric|pediatric
341967|NCT02132299|Malaria|malaria
341968|NCT02132299|Plasmodium falciparum malaria|plasmodium falciparum malaria
341969|NCT02132299|PfSPZ Vaccine|pfspz vaccine
341970|NCT02132299|PfSPZ Challenge|pfspz challenge
341971|NCT02132299|Controlled human malaria infection (CHMI)|controlled human malaria infection (chmi)
341972|NCT02132286|Functional magnetic resonance neuroimaging|functional magnetic resonance neuroimaging
341973|NCT02132286|Serotonin transporter gene polymorphism|serotonin transporter gene polymorphism
341974|NCT02132286|Amygdala|amygdala
341975|NCT02132286|Antidepressant|antidepressant
341976|NCT02132286|Quetiapine|quetiapine
341977|NCT02132286|Citalopram|citalopram
341978|NCT02132286|imaging biomarker|imaging biomarker
341979|NCT02132260|Naftifine|naftifine
341980|NCT02132260|Naftin®|naftin®
341981|NCT02132260|Tinea pedis|tinea pedis
341982|NCT02132247|Minor athletic injuries|minor athletic injuries
341983|NCT02132247|Pain|pain
341984|NCT02132247|Diclofenac|diclofenac
341985|NCT02132247|Topical|topical
341986|NCT02132221|Chronic non cancer pain|chronic non cancer pain
341987|NCT02132221|Long term opioid therapy|long term opioid therapy
341988|NCT02132221|Side effects|side effects
341989|NCT02132221|risks|risks
341990|NCT02132221|function|function
341991|NCT02132221|negative benefit/risk ratio|negative benefit/risk ratio
341992|NCT02132143|Lung adenocarcinoma|lung adenocarcinoma
341993|NCT02132143|Concurrent chemoradiotherapy|concurrent chemoradiotherapy
341994|NCT02132143|Sequential chemoradiotherapy|sequential chemoradiotherapy
341995|NCT02132143|Progression-free survival|progression-free survival
341996|NCT02132130|gene therapy|gene therapy
341997|NCT02132130|unilateral hearing loss|unilateral hearing loss
341998|NCT02132130|bilateral hearing loss|bilateral hearing loss
341999|NCT02132130|balance|balance
342000|NCT02132130|vestibular|vestibular
342001|NCT02132130|cochlear implant|cochlear implant
342002|NCT02132130|hearing restoration|hearing restoration
342003|NCT02132104|Intrauterine adhesions|intrauterine adhesions
342004|NCT02132104|Asherman Syndrome|asherman syndrome
342005|NCT02132104|Amnion graft|amnion graft
342006|NCT02132091|Sirtuins|sirtuins
342007|NCT02132091|Calorie Restriction|calorie restriction
342008|NCT02132091|Intermittent Fasting|intermittent fasting
342009|NCT02132091|Antioxidant|antioxidant
342010|NCT02132091|Aging|aging
342011|NCT02132091|Metabolism|metabolism
342012|NCT02132091|Mitochondria|mitochondria
342013|NCT02132091|Oxidative Stress|oxidative stress
342014|NCT02132078|Lung transplant recipients|lung transplant recipients
342015|NCT02132078|diverticulitis|diverticulitis
342016|NCT02132078|immunosuppression|immunosuppression
342017|NCT02132052|Essential Tremor|essential tremor
342018|NCT02132052|Multiple System Atrophy|multiple system atrophy
342019|NCT02132052|Corticobasal Degeneration|corticobasal degeneration
342020|NCT02132052|Supranuclear Palsy, Progressive|supranuclear palsy, progressive
342021|NCT02132052|Parkinson's Disease|parkinson's disease
342022|NCT02132052|PD|pd
342023|NCT02132039|Tai Chi, dementia, caregivers|tai chi, dementia, caregivers
342024|NCT02132026|Aortic Stenosis|aortic stenosis
342025|NCT02132026|Denosumab|denosumab
342026|NCT02132026|Alendronic Acid|alendronic acid
342027|NCT02132026|Osteoporosis|osteoporosis
342028|NCT02131987|Dislocation|dislocation
342029|NCT02131987|Hemiarthroplasty|hemiarthroplasty
342030|NCT02131987|Femoral neck fracture|femoral neck fracture
342031|NCT02131987|Femoral offset|femoral offset
775450|NCT00347126|Glaucoma|glaucoma
342032|NCT02131987|Leg length difference|leg length difference
342033|NCT02131987|Wiberg angle|wiberg angle
342034|NCT02131974|intubation, pediatric, endotracheal, cuffed ETT|intubation, pediatric, endotracheal, cuffed ett
342035|NCT02131961|diabetic foot|diabetic foot
342036|NCT02131961|foot ulcer|foot ulcer
342037|NCT02131961|foot wound|foot wound
342038|NCT02131961|plantar ulcer|plantar ulcer
342039|NCT02131961|plantar wound|plantar wound
342040|NCT02131961|contact cast|contact cast
342041|NCT02131961|collagenase|collagenase
342042|NCT02131948|Insulin resistance|insulin resistance
342043|NCT02131948|Brain insulin action|brain insulin action
342044|NCT02131948|Type 2 Diabetes|type 2 diabetes
342045|NCT02131909|unilateral cerebral palsy|unilateral cerebral palsy
342046|NCT02131909|children|children
342047|NCT02131909|upper-limb|upper-limb
342048|NCT02131909|mirror therapy|mirror therapy
342049|NCT02131909|bimanual coordination|bimanual coordination
342050|NCT02131909|kinematics analysis|kinematics analysis
342051|NCT02131896|Type 1 Diabetes|type 1 diabetes
342052|NCT02131896|Newly diagnosed|newly diagnosed
342053|NCT02131896|Lipid profile|lipid profile
342054|NCT02131896|Mediterranean diet|mediterranean diet
342055|NCT02131883|Health Anxiety|health anxiety
342056|NCT02131883|Hypochondriasis|hypochondriasis
342057|NCT02131883|Illness Anxiety Disorder|illness anxiety disorder
342058|NCT02131883|Somatic Symptom Disorder|somatic symptom disorder
342059|NCT02131883|Personality Disorders|personality disorders
342060|NCT02131883|Cognitive Behavioral Therapy|cognitive behavioral therapy
342061|NCT02131883|Group-CBT|group-cbt
342062|NCT02131883|Illness Perception|illness perception
342063|NCT02131883|Cost-effectiveness|cost-effectiveness
342064|NCT02131870|iron absorption|iron absorption
342065|NCT02131870|healthy females|healthy females
342066|NCT02131870|child bearing age|child bearing age
342067|NCT02131857|Mindfulness|mindfulness
342068|NCT02131857|stress reduction|stress reduction
342069|NCT02131844|colorectal surgery|colorectal surgery
342070|NCT02131844|postoperative recovery|postoperative recovery
342071|NCT02131844|early mobilization|early mobilization
342072|NCT02131831|telomere|telomere
342073|NCT02131831|telomerase|telomerase
342074|NCT02131831|cirrhosis|cirrhosis
342075|NCT02131818|amoxicillin|amoxicillin
342076|NCT02131818|postpartum infections|postpartum infections
342077|NCT02131818|puerperal infection|puerperal infection
342078|NCT02131805|skin|skin
342079|NCT02131805|Brachytherapy|brachytherapy
342080|NCT02131805|14-001|14-001
342081|NCT02131779|prostate cancer disparities|prostate cancer disparities
342082|NCT02131779|African American|african american
342083|NCT02131779|Spiritually based intervention|spiritually based intervention
342084|NCT02131779|Men's Health|men's health
342085|NCT02131779|Informed Decision Making|informed decision making
342086|NCT02131779|Community Based Participatory Research|community based participatory research
342087|NCT02131779|Health Communication|health communication
342088|NCT02131779|Health Information Technology|health information technology
342089|NCT02131779|Community Health Advisors|community health advisors
342090|NCT02131766|Diabetes Mellitus, Type 1|diabetes mellitus, type 1
342091|NCT02131766|Artificial Pancreas Project (APP)|artificial pancreas project (app)
342092|NCT02131766|Diabetes Assistant (DiAs)|diabetes assistant (dias)
342093|NCT02131766|Closed-Loop Control (CLC)|closed-loop control (clc)
342094|NCT02131753|hairy cell leukemia|hairy cell leukemia
342095|NCT02131753|untreated|untreated
342096|NCT02131753|cladribine subcutaneous|cladribine subcutaneous
342097|NCT02131740|corneal|corneal
342098|NCT02131740|eye rubbing|eye rubbing
342099|NCT02131727|hand hygiene|hand hygiene
342100|NCT02131727|communicable diseases|communicable diseases
342101|NCT02131727|respiratory tract infections|respiratory tract infections
342102|NCT02131727|primary prevention|primary prevention
342103|NCT02131727|employees|employees
342308|NCT02130739|Anesthesia|anesthesia
342104|NCT02131714|pressure pain threshold|pressure pain threshold
342105|NCT02131714|temporomandibular disorder syndrome|temporomandibular disorder syndrome
342106|NCT02131714|therapeutic exercise|therapeutic exercise
342107|NCT02131714|conservative treatment|conservative treatment
342108|NCT02131714|facial pain|facial pain
342109|NCT02131701|Physical fitness|physical fitness
342110|NCT02131701|Family history of type 2 diabetes|family history of type 2 diabetes
342111|NCT02131701|Prescription of exercise|prescription of exercise
342112|NCT02131688|safety;malignant lymphoma;|safety;malignant lymphoma;
342113|NCT02131675|C-peptide|c-peptide
342114|NCT02131675|type 1 diabetes|type 1 diabetes
342115|NCT02131662|Uterine fibroids|uterine fibroids
342116|NCT02131649|Prostate Cancer|prostate cancer
342117|NCT02131649|PET|pet
342118|NCT02131649|MRI|mri
342119|NCT02131649|Fluorocholine|fluorocholine
342120|NCT02131649|Radiotherapy|radiotherapy
342121|NCT02131649|Prostatectomy|prostatectomy
342122|NCT02131610|Sleep apnea|sleep apnea
342123|NCT02131610|Obstructive sleep apnea|obstructive sleep apnea
342124|NCT02131610|Subclinical atherosclerosis|subclinical atherosclerosis
342125|NCT02131610|Epigenetics|epigenetics
342126|NCT02131610|T cells|t cells
342127|NCT02131571|HIV|hiv
342128|NCT02131571|bone|bone
342129|NCT02131571|fractures|fractures
342130|NCT02131571|vitamin D|vitamin d
342131|NCT02131571|biomarkers|biomarkers
342132|NCT02131558|Endometrial cancer|endometrial cancer
342133|NCT02131558|Sentinel lymph node|sentinel lymph node
342134|NCT02131558|Indocyanine green|indocyanine green
342135|NCT02131558|Near infrared imaging|near infrared imaging
342136|NCT02131545|quetiapine|quetiapine
342137|NCT02131545|pharmacokinetics|pharmacokinetics
342138|NCT02131545|dementia|dementia
342139|NCT02131545|delirium|delirium
342140|NCT02131545|palliative care|palliative care
342141|NCT02131532|Post-stroke fatigue|post-stroke fatigue
342142|NCT02131532|Psychological intervention|psychological intervention
342143|NCT02131532|Feasibility|feasibility
342144|NCT02131506|Advanced HER2 positive Breast Cancer|advanced her2 positive breast cancer
342145|NCT02131506|pretreated breast cancer|pretreated breast cancer
342146|NCT02131506|advanced disease|advanced disease
342147|NCT02131454|asthma and COPD treatment|asthma and copd treatment
342148|NCT02131454|inhalation techniques|inhalation techniques
342149|NCT02131454|training of inhalation|training of inhalation
342150|NCT02131428|Heart Failure|heart failure
342151|NCT02131428|Depression|depression
342152|NCT02131428|BNP|bnp
342153|NCT02131415|schizophrenia|schizophrenia
342154|NCT02131415|real-life|real-life
342155|NCT02131415|long-acting injectable|long-acting injectable
342156|NCT02131415|Reliam|reliam
342157|NCT02131389|Hip|hip
342158|NCT02131389|Arthroplasty|arthroplasty
342159|NCT02131389|Arthroplasties|arthroplasties
342160|NCT02131389|Prosthesis|prosthesis
342161|NCT02131389|Iconacy|iconacy
342162|NCT02131389|Osteoarthritis|osteoarthritis
342163|NCT02131389|Arthritis|arthritis
342164|NCT02131389|THA|tha
342165|NCT02131389|THR|thr
342166|NCT02131389|DJD|djd
342167|NCT02131376|carcinoma, renal cell|carcinoma, renal cell
342168|NCT02131376|partial nephrectomy|partial nephrectomy
342169|NCT02131376|kidney function test|kidney function test
342170|NCT02131376|robotics|robotics
342171|NCT02131324|Psoriasis|psoriasis
342172|NCT02131311|single use|single use
342173|NCT02131311|disposable|disposable
342174|NCT02131311|pessary|pessary
342175|NCT02131311|stress urinary incontinence|stress urinary incontinence
342176|NCT02131311|sui|sui
342177|NCT02131298|Palbociclib|palbociclib
342178|NCT02131298|Itraconazole|itraconazole
342179|NCT02131298|Pharmacokinetics|pharmacokinetics
342180|NCT02131298|Drug-Drug Interaction Study|drug-drug interaction study
342181|NCT02131298|Healthy Volunteers|healthy volunteers
342182|NCT02131285|Rehabilitation,|rehabilitation,
342183|NCT02131285|Balance,|balance,
342184|NCT02131285|Sensory strategies,|sensory strategies,
342185|NCT02131285|Multiple Sclerosis,|multiple sclerosis,
342186|NCT02131285|Postural control|postural control
342187|NCT02131220|No-Reflow Phenomenon|no-reflow phenomenon
342188|NCT02131194|Cataract|cataract
342189|NCT02131194|Nutritional Supplement|nutritional supplement
342190|NCT02131181|Delirium, postoperative delirium, elderly|delirium, postoperative delirium, elderly
342191|NCT02131142|ischemic heart disease|ischemic heart disease
342192|NCT02131142|CAD|cad
342193|NCT02131129|schizophrenia|schizophrenia
342194|NCT02131129|schizophreniform disorder|schizophreniform disorder
342195|NCT02131129|schizoaffective disorder|schizoaffective disorder
342196|NCT02131129|first episode|first episode
342197|NCT02131129|psychosis|psychosis
342198|NCT02131129|cognition|cognition
342199|NCT02131116|schizophrenia|schizophrenia
342200|NCT02131116|schizophreniform disorder|schizophreniform disorder
342201|NCT02131116|schizoaffective disorder|schizoaffective disorder
342202|NCT02131116|cognition|cognition
342203|NCT02131116|metacognition|metacognition
342204|NCT02131116|insight|insight
342205|NCT02131116|first episode psychosis|first episode psychosis
342206|NCT02131116|psychosis|psychosis
342309|NCT02130739|Epidural|epidural
342207|NCT02131103|Pharmacoinvasive strategy|pharmacoinvasive strategy
342208|NCT02131090|Epidural|epidural
342209|NCT02131090|Catheter|catheter
342210|NCT02131090|Fixation|fixation
342211|NCT02131090|Device|device
342212|NCT02131090|Intrapartum|intrapartum
342213|NCT02131077|Lateral Epicondylitis|lateral epicondylitis
342214|NCT02131051|ectoine|ectoine
342215|NCT02131051|allergic rhinitis|allergic rhinitis
342216|NCT02131051|bitop|bitop
342217|NCT02131038|Ectoine|ectoine
342218|NCT02131038|bitop|bitop
342219|NCT02131038|Allergic Rhinitis|allergic rhinitis
342220|NCT02131012|Macular edema|macular edema
342221|NCT02130999|Non-24|non-24
342222|NCT02130999|absolute bioavailability|absolute bioavailability
342223|NCT02130999|tasimelteon|tasimelteon
342224|NCT02130999|Hetlioz™|hetlioz™
342225|NCT02130986|procalcitonin (PCT)|procalcitonin (pct)
342226|NCT02130986|lower respiratory tract infection (LRTI)|lower respiratory tract infection (lrti)
342227|NCT02130986|antibiotic exposure|antibiotic exposure
342228|NCT02130986|antibiotic decision making|antibiotic decision making
775451|NCT00347126|Latanoprost|latanoprost
342229|NCT02130986|community acquired pneumonia (CAP)|community acquired pneumonia (cap)
342230|NCT02130986|chronic obstructive pulmonary disease (COPD) exacerbation|chronic obstructive pulmonary disease (copd) exacerbation
342231|NCT02130986|acute asthma exacerbation|acute asthma exacerbation
342232|NCT02130986|acute bronchitis|acute bronchitis
342233|NCT02130986|procalcitonin guideline|procalcitonin guideline
342234|NCT02130973|teriparatide|teriparatide
342235|NCT02130973|Forteo|forteo
342236|NCT02130973|Denosumab|denosumab
342237|NCT02130973|Prolia|prolia
342238|NCT02130973|bone density|bone density
342239|NCT02130973|treatment|treatment
342241|NCT02130960|Reliability|reliability
342242|NCT02130960|Obese|obese
342243|NCT02130960|Energy Expenditure|energy expenditure
342244|NCT02130960|Resting Energy Expenditure|resting energy expenditure
342245|NCT02130960|Resting Metabolic Rate|resting metabolic rate
342246|NCT02130947|Metastatic Castration Resistant Prostate Cancer|metastatic castration resistant prostate cancer
342247|NCT02130947|Prostate Cancer|prostate cancer
342248|NCT02130947|mCRPC|mcrpc
342249|NCT02130947|Pilot Study|pilot study
342250|NCT02130947|UNC Lineberger|unc lineberger
342251|NCT02130947|Exercise|exercise
342252|NCT02130934|Childhood cancer|childhood cancer
342253|NCT02130934|anthracyclines|anthracyclines
342254|NCT02130934|cardiotoxicity|cardiotoxicity
342255|NCT02130934|cardiac MRI|cardiac mri
342256|NCT02130934|cumulative does of at least 150 mg/m2 of anthracyclines|cumulative does of at least 150 mg/m2 of anthracyclines
342257|NCT02130934|Ventricular function|ventricular function
342258|NCT02130921|Stigma|stigma
342259|NCT02130921|HIV|hiv
342260|NCT02130921|CHWs|chws
342261|NCT02130921|PLH|plh
342262|NCT02130921|Injecting Drug Users|injecting drug users
342263|NCT02130921|FM|fm
342264|NCT02130895|prescribing|prescribing
342265|NCT02130895|STOPP Criteria|stopp criteria
342266|NCT02130895|potentially inappropriate prescribing|potentially inappropriate prescribing
342267|NCT02130895|clinical decision support|clinical decision support
342268|NCT02130895|Electronic Medical Records|electronic medical records
342269|NCT02130895|primary care|primary care
342270|NCT02130882|Interleukin-5|interleukin-5
342271|NCT02130882|Monoclonal Antibody|monoclonal antibody
342272|NCT02130882|Treatment|treatment
342273|NCT02130869|Autologous stem cell transplantation|autologous stem cell transplantation
342274|NCT02130869|Natural killer cells|natural killer cells
342275|NCT02130856|Neonatal mortality|neonatal mortality
342276|NCT02130856|Neonatal kit|neonatal kit
342277|NCT02130856|Pakistan|pakistan
342278|NCT02130856|Randomized Control Trial|randomized control trial
342279|NCT02130856|Chlorhexidine|chlorhexidine
342280|NCT02130856|ThermoSpot|thermospot
342281|NCT02130856|Birth|birth
342282|NCT02130843|URINARY INCONTINENCE|urinary incontinence
342283|NCT02130843|URODYNAMICS|urodynamics
342284|NCT02130843|URINARY RETENTION|urinary retention
342285|NCT02130843|URINARY CATHETERIZATION|urinary catheterization
342286|NCT02130830|hemorrhoids|hemorrhoids
342287|NCT02130830|Rubber band ligation|rubber band ligation
342288|NCT02130830|pain|pain
342289|NCT02130817|Renal Transplant|renal transplant
342290|NCT02130817|Kidney Transplant|kidney transplant
342291|NCT02130817|Mean flourescent Intensity|mean flourescent intensity
342292|NCT02130817|Delayed Graft Function|delayed graft function
342293|NCT02130817|Antagonist of Thymocyte Cell Activation|antagonist of thymocyte cell activation
342294|NCT02130804|Obesity|obesity
342295|NCT02130804|Adipose tissue inflammation|adipose tissue inflammation
342296|NCT02130804|Salsalate|salsalate
342297|NCT02130804|Hispanics|hispanics
342298|NCT02130765|Monomorphic Ventricular Tachycardia|monomorphic ventricular tachycardia
342299|NCT02130765|Ischemic|ischemic
342300|NCT02130765|Non-ischemic|non-ischemic
342301|NCT02130765|Catheter Ablation|catheter ablation
342302|NCT02130752|Stomach Neoplasms|stomach neoplasms
342303|NCT02130752|Operative Time|operative time
342304|NCT02130752|Gastrectomy|gastrectomy
342305|NCT02130752|Surgical Hemorrhage|surgical hemorrhage
342306|NCT02130752|Mortality|mortality
342310|NCT02130739|Thoracic Nerves|thoracic nerves
342311|NCT02130739|Horner syndrome|horner syndrome
342312|NCT02130726|Gastric cancer|gastric cancer
342313|NCT02130726|Minimally-invasive|minimally-invasive
342314|NCT02130726|Oncological quality of resection|oncological quality of resection
342315|NCT02130700|mCRPC|mcrpc
342316|NCT02130700|metastatic|metastatic
342317|NCT02130700|castration-resistant prostate cancer|castration-resistant prostate cancer
342318|NCT02130687|Type 2 Diabetes Mellitus|type 2 diabetes mellitus
342319|NCT02130687|Hypertension|hypertension
342320|NCT02130687|Angiotensin Converting Enzyme Inhibitors|angiotensin converting enzyme inhibitors
342321|NCT02130687|Dipeptidyl Peptidase IV Inhibitors|dipeptidyl peptidase iv inhibitors
342322|NCT02130687|Sitagliptin|sitagliptin
342323|NCT02130687|Aprepitant|aprepitant
342324|NCT02130687|Ramipril|ramipril
342325|NCT02130674|traumatic brain injury|traumatic brain injury
342326|NCT02130674|glutamine|glutamine
342327|NCT02130674|microdialysis|microdialysis
342328|NCT02130674|metabolism|metabolism
342329|NCT02130661|drug interaction|drug interaction
342330|NCT02130661|healthy volunteer|healthy volunteer
342331|NCT02130661|rilapladib|rilapladib
342332|NCT02130661|SB-659032|sb-659032
342333|NCT02130661|Alzheimer's disease|alzheimer's disease
342334|NCT02130661|itraconazole|itraconazole
342335|NCT02130648|Non-invasive Prenatal Diagnosis (NIPD)|non-invasive prenatal diagnosis (nipd)
342336|NCT02130648|Cystic Fibrosis|cystic fibrosis
342337|NCT02130648|Quantitative real time MEMO-PCR|quantitative real time memo-pcr
342338|NCT02130635|PI3Kd|pi3kd
342339|NCT02130635|Pharmacodynamics|pharmacodynamics
342340|NCT02130635|dry powder inhaler|dry powder inhaler
342341|NCT02130635|GSK2269557|gsk2269557
342342|NCT02130635|safety|safety
342343|NCT02130635|COPD subjects|copd subjects
342344|NCT02130622|Diabetic Gastroparesis|diabetic gastroparesis
342345|NCT02130622|Promethazine|promethazine
342346|NCT02130570|Adverse events|adverse events
342347|NCT02130570|Readmissions|readmissions
342348|NCT02130570|Patient Centered Medical Home (PCMH)|patient centered medical home (pcmh)
342349|NCT02130570|Accountable Care Organizations (ACO)|accountable care organizations (aco)
342350|NCT02130570|Medication reconciliation|medication reconciliation
342351|NCT02130570|Discharge Advocate|discharge advocate
342352|NCT02130570|Patient engagement|patient engagement
342353|NCT02130570|Transitions of care|transitions of care
342354|NCT02130570|Transitions coach|transitions coach
342355|NCT02130570|Pharmacist intervention|pharmacist intervention
342356|NCT02130557|Leukemia|leukemia
342357|NCT02130557|Myelogenous|myelogenous
342358|NCT02130557|Chronic|chronic
342359|NCT02130557|BCR-ABL Positive|bcr-abl positive
342360|NCT02130557|Bosutinib|bosutinib
342361|NCT02130557|Leukemia, Myeloid|leukemia, myeloid
342362|NCT02130557|Leukemia, Myelogenous, Chronic, BCR-ABL Positive|leukemia, myelogenous, chronic, bcr-abl positive
342363|NCT02130557|Philadelphia Chromosome|philadelphia chromosome
342364|NCT02130557|Neoplasms by Histologic Type|neoplasms by histologic type
342365|NCT02130557|Bone Marrow Diseases|bone marrow diseases
342366|NCT02130557|Hematologic Diseases|hematologic diseases
342367|NCT02130557|Translocation, Genetic|translocation, genetic
342368|NCT02130557|Pathologic Processes|pathologic processes
342369|NCT02130557|Imatinib|imatinib
342370|NCT02130557|Therapeutic Uses|therapeutic uses
342371|NCT02130557|Pharmacologic Actions|pharmacologic actions
342372|NCT02130557|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action
342373|NCT02130466|PD1|pd1
342374|NCT02130466|PD-1|pd-1
342375|NCT02130466|PDL1|pdl1
342376|NCT02130466|PD-L1|pd-l1
342377|NCT02130453|Ischemia|ischemia
342378|NCT02130453|Coronary artery disease|coronary artery disease
342379|NCT02130453|Nuclear stress test|nuclear stress test
342380|NCT02130453|Stress Echocardiogram|stress echocardiogram
342381|NCT02130453|Echocardiography strain measurement|echocardiography strain measurement
342382|NCT02130453|Ultrasound cardiac imaging|ultrasound cardiac imaging
342383|NCT02130453|ReSTE|reste
342384|NCT02130453|SPECT|spect
342385|NCT02130453|Regadenoson|regadenoson
342386|NCT02130440|nasal obstruction|nasal obstruction
342387|NCT02130440|sneezing|sneezing
342388|NCT02130440|itching|itching
342389|NCT02130440|rhinorrhea|rhinorrhea
342390|NCT02130440|respiratory infections|respiratory infections
342391|NCT02130440|wheezing|wheezing
342392|NCT02130427|Adult subjects|adult subjects
342393|NCT02130427|NSCLC|nsclc
342394|NCT02130414|Cyclosporine|cyclosporine
342395|NCT02130414|Healthy Volunteers|healthy volunteers
342396|NCT02130414|Immunosuppressive Agents|immunosuppressive agents
342397|NCT02130414|CyCol|cycol
342398|NCT02130414|Pharmacokinetics|pharmacokinetics
342399|NCT02130401|neuromodulation|neuromodulation
342400|NCT02130401|caloric vestibular stimulation|caloric vestibular stimulation
342401|NCT02130401|Type 2 Diabetes|type 2 diabetes
342402|NCT02130362|Crohn's Disease|crohn's disease
342403|NCT02130362|Registry|registry
342404|NCT02130362|Adalimumab|adalimumab
342405|NCT02130362|Crohn's|crohn's
342406|NCT02130362|Inflammatory Bowel Diseases|inflammatory bowel diseases
342407|NCT02130362|Gastrointestinal Diseases|gastrointestinal diseases
342408|NCT02130349|IBD|ibd
342409|NCT02130349|Crohns Disease|crohns disease
342410|NCT02130349|Ulcerative Colitis|ulcerative colitis
342411|NCT02130349|Cohort|cohort
342412|NCT02130349|Biobank|biobank
342413|NCT02130349|Population based|population based
342414|NCT02130349|IBDSL|ibdsl
342415|NCT02130336|Metabolic syndrome|metabolic syndrome
342416|NCT02130336|Metabolic risk factors|metabolic risk factors
342417|NCT02130336|High-intensity interval training|high-intensity interval training
342418|NCT02130336|Moderate-intensity exercise|moderate-intensity exercise
342419|NCT02130323|Cervical intraepithelial neoplasia, Imiquimod|cervical intraepithelial neoplasia, imiquimod
342420|NCT02130310|Chronic ulcers|chronic ulcers
342421|NCT02130310|Venous ulcers|venous ulcers
342422|NCT02130297|Mohs|mohs
342423|NCT02130297|scar|scar
342424|NCT02130297|post excision|post excision
342425|NCT02130297|CO2 laser|co2 laser
342426|NCT02130297|laser|laser
342427|NCT02130297|skin cancer|skin cancer
342428|NCT02130297|resurfacing|resurfacing
342429|NCT02130271|Sciatica|sciatica
342430|NCT02130271|PET scan|pet scan
342431|NCT02130271|MRI|mri
342432|NCT02130271|Inflammation|inflammation
342433|NCT02130271|Epidural Steroid Injection (ESI)|epidural steroid injection (esi)
342434|NCT02130258|Radicular|radicular
342435|NCT02130258|Pain|pain
342436|NCT02130258|Epidural Steroid Injection|epidural steroid injection
342437|NCT02130245|Laparoscopic cholecystectomy|laparoscopic cholecystectomy
342438|NCT02130245|Acute cholecystitis|acute cholecystitis
342439|NCT02130245|Early|early
342440|NCT02130245|Delayed|delayed
342441|NCT02130232|Gestational weight gain|gestational weight gain
342442|NCT02130232|Lifestyle|lifestyle
342443|NCT02130232|Intervention|intervention
342444|NCT02130219|ICP, intracranial hypertension, Vittamed 205|icp, intracranial hypertension, vittamed 205
342445|NCT02130206|Plaque, Saliva, Cavities|plaque, saliva, cavities
342446|NCT02130193|Efficacy|efficacy
342447|NCT02130193|Danirixin|danirixin
342448|NCT02130193|EXACT-PRO|exact-pro
342449|NCT02130193|COPD|copd
342450|NCT02130193|Safety|safety
342451|NCT02130193|RD|rd
342452|NCT02130193|CXCR2 inhibitor|cxcr2 inhibitor
342453|NCT02130193|EXACT-RS|exact-rs
342454|NCT02130193|PK|pk
342455|NCT02130193|HCRU exacerbations|hcru exacerbations
342456|NCT02130193|PD|pd
342457|NCT02130167|Myopia progression|myopia progression
342458|NCT02130167|Low concentration atropine|low concentration atropine
342459|NCT02130154|Brown adipose Tissue|brown adipose tissue
342460|NCT02130154|Ageing|ageing
342461|NCT02130154|Sympathetic Nervous Stimulation|sympathetic nervous stimulation
342462|NCT02130154|Obesity|obesity
342463|NCT02130141|cocoa|cocoa
342464|NCT02130141|dark chocolate|dark chocolate
342465|NCT02130141|hypertension|hypertension
342466|NCT02130141|blood pressure monitoring, ambulatory|blood pressure monitoring, ambulatory
342467|NCT02130141|flavanols|flavanols
342468|NCT02130102|technology acceptance|technology acceptance
342469|NCT02130102|ambient assisted living|ambient assisted living
342470|NCT02130102|independent living|independent living
342471|NCT02130102|quality of life|quality of life
342472|NCT02130102|socioeconomic impact|socioeconomic impact
342473|NCT02130102|usability of information and communication technologies|usability of information and communication technologies
342474|NCT02130063|IDA|ida
342475|NCT02130063|Iron deficiency|iron deficiency
342476|NCT02130063|iron deficiency anaemia and who are intolerant or unresponsive to oral iron therapy|iron deficiency anaemia and who are intolerant or unresponsive to oral iron therapy
342477|NCT02130050|Obstructive Sleep Apnea|obstructive sleep apnea
342478|NCT02130050|Continuous Positive Airway Pressure|continuous positive airway pressure
342479|NCT02130050|Cardiovascular disease|cardiovascular disease
342480|NCT02130050|Polysomnography|polysomnography
342481|NCT02130050|Metabolomic|metabolomic
342482|NCT02130037|APPLICATION|application
342483|NCT02130037|SMARTPHONE|smartphone
342484|NCT02130037|BULIMIA|bulimia
342485|NCT02130037|B.E.D|b.e.d
342486|NCT02130037|BINGE EATING DISORDER|binge eating disorder
342487|NCT02130024|Age-related macular degeneration|age-related macular degeneration
342488|NCT02130024|AMD|amd
342489|NCT02130024|wet AMD|wet amd
342490|NCT02130024|ranibizumab|ranibizumab
342491|NCT02130024|aflibercept|aflibercept
342492|NCT02130024|geographic atrophy|geographic atrophy
342493|NCT02130024|inject and extend|inject and extend
342494|NCT02129998|Infertility|infertility
342495|NCT02129998|IVF/ICSI|ivf/icsi
342496|NCT02129998|Progesterone|progesterone
342497|NCT02129998|Preimplantation Factor (PIF)|preimplantation factor (pif)
342498|NCT02129985|the newly onset type 2 diabetes|the newly onset type 2 diabetes
342499|NCT02129985|short-term insulin treatment|short-term insulin treatment
342500|NCT02129985|exenatide sequential therapy|exenatide sequential therapy
342501|NCT02129985|beta cell function|beta cell function
342502|NCT02129985|glycaemic remission|glycaemic remission
342503|NCT02129972|Inflammatory Bowel Disease, colon lesions, colon capsule endoscopy|inflammatory bowel disease, colon lesions, colon capsule endoscopy
342504|NCT02129959|laparoscopic cholecystectomy, laparoscopic gastrectomy, laparoscopic colectomy, laparoscopic appendectomy, laparoscopic|laparoscopic cholecystectomy, laparoscopic gastrectomy, laparoscopic colectomy, laparoscopic appendectomy, laparoscopic
342505|NCT02129959|assisted vaginal hysterectomy, robot-assisted laparoscopic radical prostatectomy|assisted vaginal hysterectomy, robot-assisted laparoscopic radical prostatectomy
342506|NCT02129946|Type 2 Diabetes|type 2 diabetes
342507|NCT02129946|Resistant Starch|resistant starch
342508|NCT02129946|Postprandial Glucose|postprandial glucose
342509|NCT02129946|Postprandial Insulin|postprandial insulin
342510|NCT02129946|Satiety|satiety
342511|NCT02129933|EAC|eac
342512|NCT02129933|HGD|hgd
342513|NCT02129933|Esophagus|esophagus
342514|NCT02129920|Stroke|stroke
342515|NCT02129920|Cerebral Infarction|cerebral infarction
342516|NCT02129920|Atrial Fibrillation|atrial fibrillation
342517|NCT02129920|Arrhythmias, Cardiac|arrhythmias, cardiac
342518|NCT02129920|Heart Diseases|heart diseases
342519|NCT02129920|Cardiovascular Diseases|cardiovascular diseases
342520|NCT02129920|Cerebrovascular Disorders|cerebrovascular disorders
342521|NCT02129920|Brain Diseases|brain diseases
342522|NCT02129920|Central Nervous System Diseases|central nervous system diseases
342523|NCT02129920|Nervous System Diseases|nervous system diseases
342524|NCT02129920|Vascular Diseases|vascular diseases
342525|NCT02129920|Brain Infarction|brain infarction
342526|NCT02129920|Brain Ischemia|brain ischemia
342527|NCT02129920|Anticoagulants|anticoagulants
342528|NCT02129920|Hematologic Agents|hematologic agents
342529|NCT02129920|Therapeutic Uses|therapeutic uses
342530|NCT02129907|Anemias|anemias
342531|NCT02129907|Iron-Deficiency|iron-deficiency
342532|NCT02129907|thrombin|thrombin
342533|NCT02129894|cesarean section|cesarean section
342534|NCT02129894|postoperative pain|postoperative pain
342535|NCT02129894|pregnancy|pregnancy
342536|NCT02129894|abdominal binder|abdominal binder
342537|NCT02129868|Type 1 diabetes|type 1 diabetes
342538|NCT02129868|Closed-loop glucose control|closed-loop glucose control
342539|NCT02129868|Artificial Pancreas|artificial pancreas
342540|NCT02129868|Continuous subcutaneous insulin infusion|continuous subcutaneous insulin infusion
342541|NCT02129868|Continuous glucose monitoring|continuous glucose monitoring
342542|NCT02129842|AFib|afib
342543|NCT02129842|AF|af
342544|NCT02129842|ablation|ablation
342545|NCT02129842|EndoPAT|endopat
342546|NCT02129842|Endothelial dysfunction|endothelial dysfunction
342547|NCT02129842|PAT|pat
342548|NCT02129829|Cirrhosis|cirrhosis
342549|NCT02129829|HBV|hbv
342550|NCT02129829|HIV|hiv
342551|NCT02129829|HCV|hcv
342552|NCT02129816|Female|female
342553|NCT02129816|Postmenopause|postmenopause
342554|NCT02129803|Cystic Fibrosis, high flow 20 liters per minute (LPM) humidification therapy|cystic fibrosis, high flow 20 liters per minute (lpm) humidification therapy
342555|NCT02129790|Bipolar Disorder|bipolar disorder
342556|NCT02129790|Suicidal|suicidal
342557|NCT02129790|Depression|depression
342558|NCT02129790|Self-harm|self-harm
342559|NCT02129790|Psychosocial intervention|psychosocial intervention
342560|NCT02129777|Drug therapy|drug therapy
342561|NCT02129751|able to swallow medications without difficulty|able to swallow medications without difficulty
342562|NCT02129751|bupropion hydrobromide|bupropion hydrobromide
342563|NCT02129699|NSCLC|nsclc
342564|NCT02129699|stage IV|stage iv
342565|NCT02129686|Chemotherapy-induced peripheral neuropathy (CIPN)|chemotherapy-induced peripheral neuropathy (cipn)
342566|NCT02129686|Acupuncture|acupuncture
342567|NCT02129686|Early-Stage Breast Carcinoma|early-stage breast carcinoma
342568|NCT02129686|Stage I Breast Cancer|stage i breast cancer
342569|NCT02129686|Stage II Breast Cancer|stage ii breast cancer
342570|NCT02129686|Stage III Breast Cancer|stage iii breast cancer
342571|NCT02129673|Glaucoma|glaucoma
342572|NCT02129673|Intra-ocular pressure|intra-ocular pressure
342573|NCT02129673|Slow Release|slow release
342574|NCT02129673|Controlled release|controlled release
342575|NCT02129647|Neurofibromatosis Type 2|neurofibromatosis type 2
342576|NCT02129647|Vestibular Schwannomas|vestibular schwannomas
342577|NCT02129647|Axitinib|axitinib
342578|NCT02129634|Percutaneous Transluminal Angioplasty|percutaneous transluminal angioplasty
342579|NCT02129634|Limb-salvage|limb-salvage
342580|NCT02129634|Randomized Controlled Trial|randomized controlled trial
342581|NCT02129634|Paclitaxel|paclitaxel
342582|NCT02129621|Lipocalin|lipocalin
342583|NCT02129621|mineralocorticoid receptor|mineralocorticoid receptor
342584|NCT02129608|overweight|overweight
342585|NCT02129608|obese|obese
342586|NCT02129608|central adiposity|central adiposity
342587|NCT02129608|Laser|laser
342588|NCT02129608|lorcaserin|lorcaserin
342589|NCT02129608|low level laser therapy|low level laser therapy
342590|NCT02129608|belviq|belviq
342591|NCT02129595|Resveratrol|resveratrol
342592|NCT02129595|Diabetes Mellitus|diabetes mellitus
342593|NCT02129595|Diabetes Mellitus, Type 2|diabetes mellitus, type 2
342594|NCT02129595|Insulin Resistance|insulin resistance
342595|NCT02129595|Glucose Metabolism Disorders|glucose metabolism disorders
342596|NCT02129595|Metabolic Diseases|metabolic diseases
342597|NCT02129595|Endocrine System Diseases|endocrine system diseases
342598|NCT02129595|Hyperinsulinism|hyperinsulinism
342599|NCT02129595|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal
342600|NCT02129595|Analgesics, Non-Narcotic|analgesics, non-narcotic
342601|NCT02129595|Analgesics|analgesics
342602|NCT02129595|Sensory System Agents|sensory system agents
342603|NCT02129595|Peripheral Nervous System Agents|peripheral nervous system agents
342604|NCT02129595|Physiological Effects of Drugs|physiological effects of drugs
342605|NCT02129595|Pharmacologic Actions|pharmacologic actions
342606|NCT02129595|Anti-Inflammatory Agents|anti-inflammatory agents
342607|NCT02129595|Therapeutic Uses|therapeutic uses
342608|NCT02129595|Antirheumatic Agents|antirheumatic agents
342609|NCT02129595|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic
342610|NCT02129595|Antineoplastic Agents|antineoplastic agents
342611|NCT02129595|Antioxidants|antioxidants
342612|NCT02129595|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action
342613|NCT02129595|Protective Agents|protective agents
342614|NCT02129595|Enzyme Inhibitors|enzyme inhibitors
342615|NCT02129595|Platelet Aggregation Inhibitors|platelet aggregation inhibitors
342616|NCT02129595|Hematologic Agents|hematologic agents
342617|NCT02129595|Antimutagenic Agents|antimutagenic agents
342618|NCT02129595|Anticarcinogenic Agents|anticarcinogenic agents
342619|NCT02129595|Central Nervous System Agents|central nervous system agents
342620|NCT02129595|Brown Adipose Tissue|brown adipose tissue
342621|NCT02129556|Metastatic|metastatic
342622|NCT02129556|Breast|breast
342623|NCT02129556|trastuzumab-resistant|trastuzumab-resistant
342624|NCT02129556|PD-L1 expressing|pd-l1 expressing
342625|NCT02129556|HER2-positive|her2-positive
342627|NCT02129543|Stem Cell Transplantation|stem cell transplantation
342628|NCT02129543|Stem Cell Transplant|stem cell transplant
342629|NCT02129530|Community Mobilization|community mobilization
342630|NCT02129530|HIV|hiv
342631|NCT02129530|Intimate Partner Violence|intimate partner violence
342632|NCT02129530|Gender Norms|gender norms
342633|NCT02129504|root coverage|root coverage
342634|NCT02129504|gingival recession|gingival recession
342635|NCT02129504|periodontal surgery|periodontal surgery
342636|NCT02129491|stroke|stroke
342637|NCT02129491|Congenital stroke|congenital stroke
342638|NCT02129491|neonatal|neonatal
342639|NCT02129491|hemiplegia|hemiplegia
342640|NCT02129478|olanzapine|olanzapine
342641|NCT02129478|pediatrics|pediatrics
342642|NCT02129478|chemotherapy-induced nausea|chemotherapy-induced nausea
342643|NCT02129478|chemotherapy-induced vomiting|chemotherapy-induced vomiting
342644|NCT02129465|Cytomegalovirus|cytomegalovirus
342645|NCT02129465|CMV|cmv
342646|NCT02129465|pregnancy|pregnancy
342647|NCT02129465|transmission|transmission
342648|NCT02129452|Alzheimer disease|alzheimer disease
342649|NCT02129452|Dementia|dementia
342650|NCT02129452|Neurodegenerative Diseases|neurodegenerative diseases
342651|NCT02129452|Tauopathies|tauopathies
342652|NCT02129452|Amyloid beta Peptides|amyloid beta peptides
342653|NCT02129452|Amyloid Plaque|amyloid plaque
342654|NCT02129452|MicroRNAs|micrornas
342655|NCT02129452|Early Diagnosis|early diagnosis
342656|NCT02129439|Antisense oligonucleotide|antisense oligonucleotide
342657|NCT02129439|Colitis Ulcerosa|colitis ulcerosa
342658|NCT02129439|Ulcerative colitis|ulcerative colitis
342659|NCT02129439|Phase II|phase ii
342660|NCT02129439|Transcription factor GATA-3|transcription factor gata-3
342661|NCT02129439|intrarectal application|intrarectal application
342662|NCT02129439|proof-of-concept|proof-of-concept
342663|NCT02129426|Sedation|sedation
342664|NCT02129426|MRI|mri
342665|NCT02129413|Aneurysmal subarachnoid hemorrhage|aneurysmal subarachnoid hemorrhage
342666|NCT02129413|Subarachnoid hemorrhage|subarachnoid hemorrhage
342667|NCT02129413|Cerebral vasospasm|cerebral vasospasm
342668|NCT02129413|Ruptured aneurysm|ruptured aneurysm
342669|NCT02129413|Delayed Cerebral Ischemia|delayed cerebral ischemia
342670|NCT02129413|Delayed Ischemic Deficit|delayed ischemic deficit
342671|NCT02129413|Delayed ischemic neurological deficit|delayed ischemic neurological deficit
342672|NCT02129413|Neurostimulation|neurostimulation
342673|NCT02129413|Carotid body|carotid body
342674|NCT02129400|Xenon-inhalation|xenon-inhalation
342675|NCT02129400|Erythropoetin|erythropoetin
342676|NCT02129400|Pharmakokinetic|pharmakokinetic
342677|NCT02129400|Pharmacodynamic|pharmacodynamic
342678|NCT02129400|Hemodynamic parameters|hemodynamic parameters
342679|NCT02129400|Inflammatory parameters|inflammatory parameters
342680|NCT02129400|Growth factors|growth factors
342681|NCT02129400|Oxidative stress parameters|oxidative stress parameters
342682|NCT02129387|Nicotine|nicotine
342683|NCT02129387|Smoking Progression|smoking progression
342684|NCT02129387|EEG|eeg
342685|NCT02129387|Young adults|young adults
342686|NCT02129387|Light smokers|light smokers
342687|NCT02129387|rs1051730 genotype|rs1051730 genotype
342688|NCT02129374|Spondylolysis|spondylolysis
342689|NCT02129374|Lumbar spine|lumbar spine
342690|NCT02129374|Young population|young population
342691|NCT02129374|Direct repair|direct repair
342692|NCT02129374|Union rate|union rate
342693|NCT02129374|Functional outcome|functional outcome
342694|NCT02129361|traumatic brain injury|traumatic brain injury
342695|NCT02129348|Alzheimer's disease|alzheimer's disease
342696|NCT02129348|psychosis|psychosis
342697|NCT02129348|agitation|agitation
342698|NCT02129348|aggression|aggression
342699|NCT02129348|Lithium|lithium
342700|NCT02129348|delusions|delusions
342701|NCT02129348|hallucinations|hallucinations
342702|NCT02129335|glioblastoma|glioblastoma
342703|NCT02129335|partner|partner
342704|NCT02129335|stress|stress
342705|NCT02129335|exercise|exercise
342706|NCT02129335|outcome|outcome
342707|NCT02129309|COPD|copd
342708|NCT02129309|Apelin|apelin
342709|NCT02129309|agonist|agonist
342710|NCT02129309|antagonist|antagonist
342711|NCT02129296|Morbid obesity|morbid obesity
342712|NCT02129296|Gastric balloon|gastric balloon
342713|NCT02129296|Weight loss|weight loss
342714|NCT02129296|Tolerance|tolerance
342715|NCT02129296|Safety|safety
400528|NCT01866475|Intraosseous vascular access|intraosseous vascular access
342716|NCT02129283|physicians, nurses, ICU, end-of-life, simulation training|physicians, nurses, icu, end-of-life, simulation training
342717|NCT02129270|Fractures of the distal radius|fractures of the distal radius
342718|NCT02129270|Hematoma block|hematoma block
342719|NCT02129270|Lidocaine|lidocaine
342720|NCT02129244|MDR-TB|mdr-tb
342721|NCT02129244|HIV|hiv
342722|NCT02129244|Nurse Case Management (NCM)|nurse case management (ncm)
342723|NCT02129231|ezetimibe/simvastatin|ezetimibe/simvastatin
342724|NCT02129231|rosuvastatin|rosuvastatin
342725|NCT02129231|diabetic polyneuropathy|diabetic polyneuropathy
342726|NCT02129231|oxidative stress|oxidative stress
342727|NCT02129231|mitochondrial dysfunction|mitochondrial dysfunction
342728|NCT02129205|solid tumors|solid tumors
342729|NCT02129205|triple negative breast cancer|triple negative breast cancer
342730|NCT02129205|PF-06650808|pf-06650808
342731|NCT02129205|Phase 1|phase 1
342732|NCT02129153|Randomized controlled trial|randomized controlled trial
342733|NCT02129153|Population, School Age|population, school age
342734|NCT02129140|hernia repair|hernia repair
342735|NCT02129140|ventral incisional hernia|ventral incisional hernia
342736|NCT02129140|biologic mesh|biologic mesh
342737|NCT02129140|hernia graft|hernia graft
342738|NCT02129088|Healthy|healthy
342739|NCT02129088|Esketamine|esketamine
342740|NCT02129088|Phase 1|phase 1
342741|NCT02129088|Placebo|placebo
342742|NCT02129088|Elderly|elderly
342743|NCT02129088|Adult|adult
342744|NCT02129036|Ovarian cancer|ovarian cancer
342745|NCT02129036|Clear cell carcinoma|clear cell carcinoma
342746|NCT02129036|Paclitaxel-platinum|paclitaxel-platinum
342747|NCT02129036|Chemotherapy|chemotherapy
342748|NCT02129036|response to chemotherapy|response to chemotherapy
342749|NCT02129036|survival of clear cell ovarian carcinoma|survival of clear cell ovarian carcinoma
342750|NCT02129036|Prognostic factors|prognostic factors
342751|NCT02129023|Exergame|exergame
342752|NCT02129023|user health|user health
342753|NCT02129023|exercise|exercise
342754|NCT02129010|subarachnoid hemorrhage|subarachnoid hemorrhage
342755|NCT02129010|terson syndrome|terson syndrome
342756|NCT02129010|CSF-proteines|csf-proteines
342757|NCT02129010|phospho-tau|phospho-tau
342758|NCT02129010|beta-amyloid|beta-amyloid
342759|NCT02128997|obesity, cesarean section, wound complication|obesity, cesarean section, wound complication
342760|NCT02128984|Malnutrition|malnutrition
342761|NCT02128984|Dietary supplement|dietary supplement
342762|NCT02128984|Nutritional supplement|nutritional supplement
342763|NCT02128984|Symbiotic formula|symbiotic formula
342764|NCT02128984|DHA|dha
342765|NCT02128984|Cystic Fibrosis|cystic fibrosis
342766|NCT02128984|Failure to Thrive|failure to thrive
342767|NCT02128971|Iron supplement study|iron supplement study
342768|NCT02128958|Hepatocellular Carcinoma|hepatocellular carcinoma
342769|NCT02128958|Child-Pugh Class B Cirrhosis|child-pugh class b cirrhosis
342770|NCT02128945|PET|pet
342771|NCT02128945|Chronic lymphocytic Leukemia (CLL)|chronic lymphocytic leukemia (cll)
342772|NCT02128945|Diffuse Large B Cells Lymphoma (DLBCL)|diffuse large b cells lymphoma (dlbcl)
342773|NCT02128945|Fludarabine|fludarabine
342774|NCT02128919|Schizophrenia|schizophrenia
342775|NCT02128919|Cigarette smoking|cigarette smoking
342776|NCT02128919|Cognition|cognition
342777|NCT02128919|Craving|craving
342778|NCT02128919|MATRICS|matrics
342779|NCT02128906|ERCC1|ercc1
342780|NCT02128906|squamous cell carcinoma|squamous cell carcinoma
342781|NCT02128906|oropharynx|oropharynx
342782|NCT02128906|larynx|larynx
342783|NCT02128906|hypopharynx|hypopharynx
342784|NCT02128906|p16|p16
342785|NCT02128906|radiotherapy|radiotherapy
342786|NCT02128906|docetaxel|docetaxel
342787|NCT02128906|cetuximab|cetuximab
342788|NCT02128906|cisplatin|cisplatin
342789|NCT02128906|EGFR|egfr
342790|NCT02128906|Biomarker|biomarker
342791|NCT02128906|efficacy|efficacy
342792|NCT02128906|head and neck|head and neck
342793|NCT02128906|tongue|tongue
342794|NCT02128906|throat|throat
342795|NCT02128893|Isavuconazole|isavuconazole
342796|NCT02128893|Esomeprazole|esomeprazole
342797|NCT02128893|BAL4815|bal4815
342798|NCT02128893|BAL8728|bal8728
342799|NCT02128893|Healthy Subjects|healthy subjects
342800|NCT02128880|AEP, drinking, contraception, FASD, Internet interventions|aep, drinking, contraception, fasd, internet interventions
342801|NCT02128867|gastro-esophageal reflux|gastro-esophageal reflux
342802|NCT02128867|GOR|gor
342803|NCT02128867|GER|ger
342804|NCT02128867|airway clearance techniques|airway clearance techniques
342805|NCT02128854|Diabetes Mellitus, Type 2|diabetes mellitus, type 2
342806|NCT02128854|Diabetes Mellitus, Adult-Onset|diabetes mellitus, adult-onset
342807|NCT02128854|Diabetes Mellitus, Non-Insulin-Dependent|diabetes mellitus, non-insulin-dependent
342808|NCT02128854|Diabetes Mellitus, Noninsulin Dependent|diabetes mellitus, noninsulin dependent
342809|NCT02128854|Diabetes Mellitus, Type II|diabetes mellitus, type ii
342810|NCT02128854|African Americans|african americans
342811|NCT02128854|Blacks|blacks
342812|NCT02128854|Non-Hispanic Blacks|non-hispanic blacks
342813|NCT02128854|Randomized Control Trial|randomized control trial
438244|NCT01696604|safety|safety
342814|NCT02128854|Controlled Clinical Trial|controlled clinical trial
342815|NCT02128854|Behavioral Research|behavioral research
342816|NCT02128854|Behavioral Medicine|behavioral medicine
342817|NCT02128841|rivaroxaban|rivaroxaban
342818|NCT02128841|Heart Valve Prosthesis Implantation|heart valve prosthesis implantation
342819|NCT02128841|anticoagulants|anticoagulants
342820|NCT02128841|Factor Xa/antagonists & inhibitors|factor xa/antagonists & inhibitors
342821|NCT02128828|AIDS Dementia Complex|aids dementia complex
342822|NCT02128828|HIV-1-Associated Cognitive Motor Complex|hiv-1-associated cognitive motor complex
342823|NCT02128828|Human Immunodeficiency Virus|human immunodeficiency virus
342824|NCT02128815|adults|adults
342825|NCT02128815|coaching|coaching
342826|NCT02128815|type 2 diabetes|type 2 diabetes
342827|NCT02128802|Obesity|obesity
342828|NCT02128802|Renal failure|renal failure
342829|NCT02128802|Gastric bypass|gastric bypass
342830|NCT02128789|Older Adults|older adults
342831|NCT02128789|Caregivers|caregivers
342832|NCT02128789|Aging|aging
342833|NCT02128789|Support|support
342834|NCT02128776|Children|children
342835|NCT02128776|Chronic illnesses|chronic illnesses
342836|NCT02128724|Lung cancer|lung cancer
342837|NCT02128724|BKM120|bkm120
342838|NCT02128724|Hypoxia|hypoxia
342839|NCT02128724|Misonidazole|misonidazole
342840|NCT02128724|Radiotherapy|radiotherapy
342841|NCT02128724|Buparlisib|buparlisib
342842|NCT02128711|lung|lung
342843|NCT02128711|cystic fibrosis|cystic fibrosis
342844|NCT02128711|bacteria|bacteria
342845|NCT02128711|positive diagnosis of CF,|positive diagnosis of cf,
342846|NCT02128698|Bariatric surgery|bariatric surgery
342847|NCT02128698|Protein supplementation|protein supplementation
342848|NCT02128698|Physical activity|physical activity
342849|NCT02128698|Muscle mass|muscle mass
342850|NCT02128698|Weight loss|weight loss
342851|NCT02128698|Physical fitness|physical fitness
342852|NCT02128698|Muscle strength|muscle strength
342853|NCT02128685|Threatened miscarriage|threatened miscarriage
342854|NCT02128685|Dydrogesterone|dydrogesterone
342855|NCT02128685|Randomized controlled trial|randomized controlled trial
342856|NCT02128646|Pain Management|pain management
342857|NCT02128646|Exparel|exparel
342858|NCT02128646|Abdominal Hernia Repair|abdominal hernia repair
342859|NCT02128646|Laparoscopic Surgery|laparoscopic surgery
342860|NCT02128633|Dentin hypersensitivity|dentin hypersensitivity
342861|NCT02128633|Dentin Sensitivities|dentin sensitivities
342862|NCT02128620|Sexually transmitted diseases|sexually transmitted diseases
342863|NCT02128620|Internet|internet
342864|NCT02128620|Education|education
342865|NCT02128620|Appointments and Schedules|appointments and schedules
342866|NCT02128607|low back pain|low back pain
342867|NCT02128607|manual therapy|manual therapy
342868|NCT02128607|Mulligan|mulligan
342869|NCT02128607|sustained natural apophyseal glide (SNAG)|sustained natural apophyseal glide (snag)
342870|NCT02128607|Kinematic spine model|kinematic spine model
342871|NCT02128568|Depression/therapy;|depression/therapy;
342872|NCT02128568|Developing Countries;|developing countries;
342873|NCT02128568|Interpersonal Relations;|interpersonal relations;
342874|NCT02128568|Life Change Events;|life change events;
342875|NCT02128568|Psychotherapy, Group;|psychotherapy, group;
342876|NCT02128568|Resilience, Psychological;|resilience, psychological;
342877|NCT02128568|Sierra Leone;|sierra leone;
342878|NCT02128568|Survivors/psychology;|survivors/psychology;
342879|NCT02128568|Social Adjustment;|social adjustment;
342880|NCT02128568|Social Behavior;|social behavior;
342881|NCT02128568|War|war
342882|NCT02128555|ankle arthritis|ankle arthritis
342883|NCT02128555|osteoarthritis|osteoarthritis
342884|NCT02128555|total ankle replacement|total ankle replacement
342885|NCT02128555|arthrodesis|arthrodesis
342886|NCT02128555|quality of life|quality of life
342887|NCT02128555|musculoskeletal|musculoskeletal
342888|NCT02128542|Veterans HCV|veterans hcv
342889|NCT02128529|COPD|copd
342890|NCT02128490|Drug therapy|drug therapy
342891|NCT02128477|Myocardial infarction|myocardial infarction
342892|NCT02128477|Repolarization instability|repolarization instability
342893|NCT02128477|Ventricular fibrillation|ventricular fibrillation
342894|NCT02128464|Knee Osteoarthritis|knee osteoarthritis
342895|NCT02128464|Total Knee Arthroplasty|total knee arthroplasty
342896|NCT02128464|Customized Cutting Block|customized cutting block
342897|NCT02128464|Conventional Intramedullary Cutting Guide|conventional intramedullary cutting guide
342898|NCT02128451|meperdine ,fentanyl, clonidine, orthopedic surgery .|meperdine ,fentanyl, clonidine, orthopedic surgery .
343093|NCT02127541|exendin-4|exendin-4
342899|NCT02128425|Colorectal cancer|colorectal cancer
342900|NCT02128425|Metastatic colorectal cancer|metastatic colorectal cancer
342901|NCT02128425|FOLFOXIRI|folfoxiri
342902|NCT02128425|FOLFOX|folfox
342903|NCT02128425|Oxaliplatin|oxaliplatin
342904|NCT02128425|irinotecan|irinotecan
342905|NCT02128425|Leucovorin|leucovorin
342906|NCT02128425|5-FU|5-fu
400529|NCT01866475|EZ-IO|ez-io
400530|NCT01866436|Cognitive skills|cognitive skills
342907|NCT02128412|Patients scheduled to undergo coronary angioplasty and stenting because of symptoms related to a single de novo coronary artery stenoses|patients scheduled to undergo coronary angioplasty and stenting because of symptoms related to a single de novo coronary artery stenoses
342908|NCT02128399|antimicrobial stewardship|antimicrobial stewardship
342909|NCT02128360|Low ovarian reserve|low ovarian reserve
342910|NCT02128360|Poor responder|poor responder
342911|NCT02128360|Infertility|infertility
342912|NCT02128347|Hemodialysis, Home|hemodialysis, home
342913|NCT02128347|Peritoneal Dialysis|peritoneal dialysis
342914|NCT02128347|Telemedicine|telemedicine
342915|NCT02128334|Uro-Oncologists|uro-oncologists
342916|NCT02128334|PSA|psa
342917|NCT02128334|Eligard|eligard
342918|NCT02128334|prostate carcinoma|prostate carcinoma
342919|NCT02128321|Isavuconazole|isavuconazole
342920|NCT02128321|Repaglinide|repaglinide
342921|NCT02128321|Caffeine|caffeine
342922|NCT02128321|BAL4815|bal4815
342923|NCT02128321|BAL8728|bal8728
342924|NCT02128321|Healthy Subjects|healthy subjects
342925|NCT02128308|Antituberculosis agents|antituberculosis agents
342926|NCT02128308|Pharmacokinetics|pharmacokinetics
342927|NCT02128295|Breast pumps, breast milk, expression, term infants|breast pumps, breast milk, expression, term infants
342928|NCT02128282|Cholangiocarcinoma|cholangiocarcinoma
342929|NCT02128282|Bile duct cancer|bile duct cancer
342930|NCT02128282|Biliary tract cancer|biliary tract cancer
342931|NCT02128269|Antiphospholipid (aPL)-positive|antiphospholipid (apl)-positive
342932|NCT02128269|Antiphospholid syndrome (APS)|antiphospholid syndrome (aps)
342933|NCT02128256|Osteomyelitis|osteomyelitis
342934|NCT02128256|Bone substitute|bone substitute
342935|NCT02128256|Ceramic|ceramic
342936|NCT02128256|Gentamicin|gentamicin
342937|NCT02128230|High risk|high risk
342938|NCT02128230|Carfilzomib|carfilzomib
342939|NCT02128191|Patent ductus arteriosus|patent ductus arteriosus
342940|NCT02128191|Ibuprofen|ibuprofen
342941|NCT02128191|Bronchopulmonary dysplasia|bronchopulmonary dysplasia
342942|NCT02128178|Morbid obesity|morbid obesity
342943|NCT02128178|Laparoscopic surgery|laparoscopic surgery
342944|NCT02128178|Compression ultrasonography|compression ultrasonography
342945|NCT02128178|Pulmonary embolism|pulmonary embolism
342946|NCT02128178|Bleeding|bleeding
342947|NCT02128165|gastric balloon|gastric balloon
342948|NCT02128165|morbid obesity|morbid obesity
342949|NCT02128152|stroke|stroke
342950|NCT02128152|exoskeleton|exoskeleton
342951|NCT02128152|Ekso|ekso
342952|NCT02128152|ambulation|ambulation
342953|NCT02128152|robotics|robotics
342954|NCT02128139|Infective endocarditis|infective endocarditis
342955|NCT02128139|Developing country|developing country
342956|NCT02128139|Global health|global health
342957|NCT02128139|Cardiac surgery|cardiac surgery
342958|NCT02128139|Heart valve disease|heart valve disease
342959|NCT02128139|Bacteremia|bacteremia
342960|NCT02128126|Advanced or recurrent cervical cancer|advanced or recurrent cervical cancer
342961|NCT02128126|HPV16 positive|hpv16 positive
342962|NCT02128126|No curative treatment options|no curative treatment options
342963|NCT02128113|RTA 408|rta 408
342964|NCT02128113|Cataract surgery|cataract surgery
342965|NCT02128113|Corneal Endothelial Cells|corneal endothelial cells
342966|NCT02128113|omaveloxolone|omaveloxolone
342967|NCT02128100|Pancreatic Cancer|pancreatic cancer
342968|NCT02128087|HIV|hiv
342969|NCT02128087|Antiretroviral (ARV)|antiretroviral (arv)
342970|NCT02128087|co-trimoxazole|co-trimoxazole
342971|NCT02128087|SMS|sms
342972|NCT02128087|mobile Health (mHealth)|mobile health (mhealth)
342973|NCT02128087|Adolescents|adolescents
342974|NCT02128087|Uganda|uganda
342975|NCT02128087|Adherence|adherence
342976|NCT02128035|radiation protection|radiation protection
342977|NCT02128035|interventional cardiologist|interventional cardiologist
342978|NCT02128035|percutaneous coronary intervention (PCI)|percutaneous coronary intervention (pci)
342979|NCT02128035|angiography|angiography
342980|NCT02128035|lead shield|lead shield
342981|NCT02128022|Glucagon-Like Peptide 1|glucagon-like peptide 1
342982|NCT02128022|Angina Pectoris|angina pectoris
342983|NCT02128022|Percutaneous Coronary Intervention|percutaneous coronary intervention
342984|NCT02128022|Ischemic Preconditioning|ischemic preconditioning
342985|NCT02128022|Myocardial Reperfusion Injury|myocardial reperfusion injury
342986|NCT02127996|Angina Pectoris|angina pectoris
342987|NCT02127996|Percutaneous Coronary Intervention|percutaneous coronary intervention
342988|NCT02127996|Myocardial Infarction|myocardial infarction
342989|NCT02127996|Glucagon-Like Peptide 1|glucagon-like peptide 1
342990|NCT02127996|Reperfusion Injury|reperfusion injury
342991|NCT02127983|TB, HIV, case finding, access, informal providers|tb, hiv, case finding, access, informal providers
342992|NCT02127957|cystic fibrosis|cystic fibrosis
342993|NCT02127957|exercise|exercise
342994|NCT02127957|Cystic fibrosis related diabetes|cystic fibrosis related diabetes
342995|NCT02127918|Electrical status epilepticus in sleep|electrical status epilepticus in sleep
342996|NCT02127918|Continuous spikes and waves during sleep|continuous spikes and waves during sleep
342997|NCT02127918|Children|children
342998|NCT02127918|Electroencephalogram|electroencephalogram
342999|NCT02127918|Neuropsychology|neuropsychology
343000|NCT02127918|Development|development
343001|NCT02127918|Antiepileptic drugs|antiepileptic drugs
343002|NCT02127918|Clobazam|clobazam
343003|NCT02127918|Seizures|seizures
343004|NCT02127905|Fanconi Anemia|fanconi anemia
343005|NCT02127905|compassionate treatment|compassionate treatment
343006|NCT02127905|BMT|bmt
343007|NCT02127905|HSCT|hsct
343008|NCT02127905|unrelated|unrelated
343009|NCT02127905|bone marrow transplantation|bone marrow transplantation
343010|NCT02127905|PBSC|pbsc
343011|NCT02127905|peripheral blood|peripheral blood
343012|NCT02127905|CD34+|cd34+
343013|NCT02127892|Severe Combined Immune Deficiency|severe combined immune deficiency
343014|NCT02127892|SCID|scid
343015|NCT02127892|HLA-matched unrelated donor|hla-matched unrelated donor
343016|NCT02127892|unrelated|unrelated
343017|NCT02127892|MUD|mud
343018|NCT02127892|bone marrow|bone marrow
343019|NCT02127892|cord blood|cord blood
343020|NCT02127892|haplo-identical|haplo-identical
343021|NCT02127892|peripheral blood|peripheral blood
343022|NCT02127892|CD34+ selection|cd34+ selection
343023|NCT02127892|T cell depletion|t cell depletion
343024|NCT02127892|HSCT|hsct
343025|NCT02127892|BMT|bmt
343026|NCT02127892|CliniMACS|clinimacs
343027|NCT02127879|Repetitive Transcranial Magnetic Stimulation|repetitive transcranial magnetic stimulation
343028|NCT02127879|Schizophrenia|schizophrenia
343029|NCT02127879|Negative symptoms|negative symptoms
343030|NCT02127879|Intensive|intensive
343031|NCT02127879|Transcranial Magnetic Stimulation, Repetitive|transcranial magnetic stimulation, repetitive
343032|NCT02127866|Asthma, anticholinergics|asthma, anticholinergics
343033|NCT02127853|serial cataract surgery|serial cataract surgery
343034|NCT02127853|hyperalgesia|hyperalgesia
343035|NCT02127853|gabapentin|gabapentin
343036|NCT02127853|central sensitization|central sensitization
343037|NCT02127840|primary aldosteronism|primary aldosteronism
343038|NCT02127840|adrenal adenoma|adrenal adenoma
343039|NCT02127840|arterial hypertension|arterial hypertension
343040|NCT02127814|induced diarrhea|induced diarrhea
343041|NCT02127814|Clostridium difficile toxicity|clostridium difficile toxicity
343042|NCT02127788|Haematology|haematology
343043|NCT02127788|Micafungin|micafungin
343044|NCT02127788|Observational study|observational study
343045|NCT02127788|Prophylaxis|prophylaxis
343046|NCT02127788|Invasive Fungal Infection|invasive fungal infection
343047|NCT02127788|France|france
343048|NCT02127762|Pain|pain
343049|NCT02127762|Quality of Life|quality of life
343050|NCT02127762|Glycemic Control|glycemic control
343051|NCT02127762|diabetic neuropathy|diabetic neuropathy
343052|NCT02127762|mindfulness|mindfulness
343053|NCT02127762|stress reduction|stress reduction
343054|NCT02127762|adult|adult
343055|NCT02127762|chronic pain|chronic pain
343056|NCT02127762|depression|depression
343057|NCT02127762|cortisol|cortisol
343058|NCT02127749|antibiotics|antibiotics
343059|NCT02127749|gut microbiota|gut microbiota
343060|NCT02127749|endotoxemia|endotoxemia
343061|NCT02127749|innate immunity|innate immunity
343062|NCT02127723|cellulite|cellulite
343063|NCT02127710|AZD6094|azd6094
343064|NCT02127710|Savolitinib|savolitinib
343065|NCT02127710|Papillary Renal Cell Cancer|papillary renal cell cancer
343066|NCT02127697|Asthma, poorly controlled asthma, LAMA, Long-Acting Muscarinic Antagonist, Glycopyrronium, Glycopyrronium bromide, Anticholinergic|asthma, poorly controlled asthma, lama, long-acting muscarinic antagonist, glycopyrronium, glycopyrronium bromide, anticholinergic
343067|NCT02127684|diabetic macular edema|diabetic macular edema
343068|NCT02127645|RADIOTHERAPY|radiotherapy
343069|NCT02127645|TRANSANAL ENDOSCOPIC MICROSURGERY|transanal endoscopic microsurgery
343070|NCT02127645|LOCAL EXCISION|local excision
343071|NCT02127632|laryngeal mask Supreme|laryngeal mask supreme
343072|NCT02127632|laparoscopic gynecologic surgery|laparoscopic gynecologic surgery
343073|NCT02127632|Laryngeal mask during surgery|laryngeal mask during surgery
343074|NCT02127619|knee prosthesis|knee prosthesis
343075|NCT02127619|total knee replacement|total knee replacement
343076|NCT02127619|total knee arthroplasty|total knee arthroplasty
343077|NCT02127619|prospective study|prospective study
343078|NCT02127619|Therapeutic level IV|therapeutic level iv
343079|NCT02127593|Norgestimate|norgestimate
343080|NCT02127593|Ethinyl estradiol|ethinyl estradiol
343081|NCT02127593|Norgestrel|norgestrel
343082|NCT02127593|Norelgestromin|norelgestromin
343083|NCT02127593|Ortho cyclen|ortho cyclen
343084|NCT02127593|Phase 1|phase 1
343085|NCT02127593|Healthy Women|healthy women
343086|NCT02127580|THV|thv
343087|NCT02127580|BAV|bav
343088|NCT02127580|pre-dilation|pre-dilation
343089|NCT02127580|Aortic valve stenosis|aortic valve stenosis
343090|NCT02127567|medical writing, reporting, randomized controlled trial|medical writing, reporting, randomized controlled trial
343091|NCT02127541|Localisation of Insulinoma|localisation of insulinoma
343092|NCT02127541|beta-cell imaging|beta-cell imaging
343094|NCT02127541|68Ga-DOTA-exendin-4 PET/CT|68ga-dota-exendin-4 pet/ct
343095|NCT02127541|111In-DOTA-exendin-4 SPECT/CT|111in-dota-exendin-4 spect/ct
343096|NCT02127515|Down, trisomy 21|down, trisomy 21
343098|NCT02127515|Amniocentesis|amniocentesis
343099|NCT02127515|miscarriage|miscarriage
343100|NCT02127515|invasive|invasive
343101|NCT02127515|prenatal|prenatal
343102|NCT02127515|screening.|screening.
343103|NCT02127489|Bupivacaine, caudal, rectal midazolam, children|bupivacaine, caudal, rectal midazolam, children
343104|NCT02127463|AMD|amd
343105|NCT02127463|Dry AMD|dry amd
343106|NCT02127463|Non-Exudative AMD|non-exudative amd
343107|NCT02127463|MC-1101|mc-1101
343108|NCT02127450|Enterobacteriaceae|enterobacteriaceae
343109|NCT02127450|non-susceptible to carbapenem|non-susceptible to carbapenem
343110|NCT02127450|carbapenemases|carbapenemases
343111|NCT02127450|prevalence|prevalence
343112|NCT02127450|screening algorithm|screening algorithm
343113|NCT02127437|Autosomal dominant polycystic kidney disease,|autosomal dominant polycystic kidney disease,
343114|NCT02127437|Glomerular filtration rate,|glomerular filtration rate,
343115|NCT02127437|Somatostatin,|somatostatin,
343116|NCT02127437|lanreotide|lanreotide
343117|NCT02127424|Nurse|nurse
343118|NCT02127424|Nursing|nursing
343119|NCT02127424|Screening|screening
343120|NCT02127424|HIV|hiv
343121|NCT02127424|Emergency Service Hospital|emergency service hospital
343122|NCT02127411|Mindfulness|mindfulness
343123|NCT02127411|Benzodiazepines|benzodiazepines
343124|NCT02127411|Sleep|sleep
343125|NCT02127411|Dependence|dependence
343126|NCT02127411|Relapse Prevention|relapse prevention
343127|NCT02127398|C. difficile colitis|c. difficile colitis
343128|NCT02127398|fecal microbiota transplantation|fecal microbiota transplantation
343129|NCT02127372|non-small cell|non-small cell
343130|NCT02127372|lung cancer|lung cancer
343131|NCT02127359|Metastatic|metastatic
343132|NCT02127346|Chronic Periodontitis|chronic periodontitis
343133|NCT02127346|Vitamin D concentration|vitamin d concentration
343134|NCT02127346|Calcium concentration|calcium concentration
343135|NCT02127333|chronic obstructive pulmonary disease|chronic obstructive pulmonary disease
343136|NCT02127333|Coronary artery disease|coronary artery disease
343137|NCT02127333|Endothelial function|endothelial function
343138|NCT02127307|Myocardial sympathetic innervation|myocardial sympathetic innervation
343139|NCT02127307|Heart failure (HF)|heart failure (hf)
343140|NCT02127307|Nuclear imaging|nuclear imaging
343141|NCT02127307|Radiopharmaceutical|radiopharmaceutical
343142|NCT02127294|Foramen Ovale, Patent|foramen ovale, patent
343143|NCT02127294|migraine|migraine
343144|NCT02127294|transcatheter patent foramen ovale closure|transcatheter patent foramen ovale closure
343145|NCT02127294|contrast-enhanced transcranial Doppler|contrast-enhanced transcranial doppler
343146|NCT02127294|Transthoracic Echocardiography|transthoracic echocardiography
343147|NCT02127281|Revision total knee arthroplasty|revision total knee arthroplasty
343148|NCT02127281|Revision total hip arthroplasty|revision total hip arthroplasty
343149|NCT02127281|Negative pressure wound therapy system (NPWT)|negative pressure wound therapy system (npwt)
343150|NCT02127281|Drainage|drainage
343151|NCT02127255|chemotherapy|chemotherapy
343152|NCT02127255|nausea|nausea
343153|NCT02127255|vomiting|vomiting
343154|NCT02127255|cancer|cancer
343155|NCT02127242|hepatolithiasis|hepatolithiasis
343156|NCT02127242|ureteroscope|ureteroscope
343157|NCT02127242|air-pressure ballistic lithotripsy|air-pressure ballistic lithotripsy
343158|NCT02127242|hepatectomy|hepatectomy
343159|NCT02127229|endoscopic retrograde cholangiopancreatography|endoscopic retrograde cholangiopancreatography
343160|NCT02127229|disposable accessory cost|disposable accessory cost
343161|NCT02127229|endoscopy cost analysis|endoscopy cost analysis
343162|NCT02127216|Mobile Health|mobile health
343163|NCT02127216|Diabetes|diabetes
343164|NCT02127216|Self-Care of Diabetes|self-care of diabetes
343165|NCT02127203|oxidative stress|oxidative stress
343166|NCT02127203|periodontal disease|periodontal disease
343167|NCT02127203|nitric oxide|nitric oxide
343168|NCT02127190|nitro-fatty acids|nitro-fatty acids
343169|NCT02127190|anti-inflammatory|anti-inflammatory
343170|NCT02127190|Nrf2 activation|nrf2 activation
343171|NCT02127190|contrast induced AKI|contrast induced aki
343172|NCT02127177|obstructive sleep apnea|obstructive sleep apnea
343173|NCT02127177|coronary heart disease|coronary heart disease
343174|NCT02127177|continuous positive airway pressure|continuous positive airway pressure
343175|NCT02127177|lipid profiles|lipid profiles
343176|NCT02127177|high-sensitivity C-reactive protein|high-sensitivity c-reactive protein
343177|NCT02127138|unprotected distal left main bifurcation lesion|unprotected distal left main bifurcation lesion
343178|NCT02127138|Percutaneous coronary intervention|percutaneous coronary intervention
343179|NCT02127138|clinical study|clinical study
343180|NCT02127138|Active Transfer of Plaque （ATP）|active transfer of plaque （atp）
343181|NCT02127138|Provisional T Stenting|provisional t stenting
343182|NCT02127112|Ridge Augmentation|ridge augmentation
343183|NCT02127112|Bone regeneration|bone regeneration
343184|NCT02127112|Guided Bone Regeneration|guided bone regeneration
343185|NCT02127112|Partially Edentulous|partially edentulous
343186|NCT02127099|OSA|osa
343187|NCT02127099|obstructive|obstructive
343188|NCT02127099|sleep|sleep
343189|NCT02127099|apnea|apnea
343190|NCT02127099|operation|operation
343191|NCT02127086|Acute pain severity|acute pain severity
343192|NCT02127086|Non-communicative patients|non-communicative patients
343193|NCT02127086|PAIN algorithm|pain algorithm
343194|NCT02127086|Multi-dimensional Pain Assessment Tool (MOPAT)|multi-dimensional pain assessment tool (mopat)
343195|NCT02127073|Breast cancer|breast cancer
343196|NCT02127073|Ductal carcinoma in situ (DCIS)|ductal carcinoma in situ (dcis)
343197|NCT02127073|Oxytocin|oxytocin
343198|NCT02127060|vitamin C|vitamin c
343199|NCT02127060|effectiveness|effectiveness
343200|NCT02127060|pain management|pain management
343201|NCT02127060|posterior lumbar interbody fusion|posterior lumbar interbody fusion
343202|NCT02127034|Healthy subjects|healthy subjects
343203|NCT02127034|Mirabegron|mirabegron
343204|NCT02127034|Solifenacin|solifenacin
343205|NCT02127034|Digoxin|digoxin
343206|NCT02127021|Pancreaticoduodenectomy|pancreaticoduodenectomy
343207|NCT02127021|Nutritional Status|nutritional status
343208|NCT02127021|Quality of Life|quality of life
343209|NCT02127021|Biochemical Marker|biochemical marker
343210|NCT02127008|epidural fat|epidural fat
343211|NCT02127008|resection|resection
343212|NCT02127008|spinal stenosis|spinal stenosis
343213|NCT02127008|lumbar spine|lumbar spine
343214|NCT02126995|Fragile X Syndrome, Fra(X) Syndrome, FRAXA Syndrome|fragile x syndrome, fra(x) syndrome, fraxa syndrome
343215|NCT02126982|clopidogrel besylate|clopidogrel besylate
343216|NCT02126982|clopidogrel hydrogen sulfate|clopidogrel hydrogen sulfate
343217|NCT02126982|Generic clopidogrel|generic clopidogrel
343218|NCT02126982|Coronary Artery Disease|coronary artery disease
343219|NCT02126969|Cancer|cancer
343220|NCT02126969|Low dose radiation|low dose radiation
343221|NCT02126956|ACT-128800|act-128800
343222|NCT02126943|PAH|pah
343223|NCT02126943|pulmonary arterial hypertension|pulmonary arterial hypertension
343224|NCT02126930|anti-infectious treatment|anti-infectious treatment
343225|NCT02126930|observance|observance
343226|NCT02126930|pharmaceutical consultation|pharmaceutical consultation
343227|NCT02126917|Phase 1|phase 1
343228|NCT02126917|Alcohol|alcohol
343229|NCT02126917|Hydrocodone Bitartrate|hydrocodone bitartrate
343230|NCT02126917|Pharmacokinetics|pharmacokinetics
343231|NCT02126891|Cardiac functions|cardiac functions
343232|NCT02126891|Endurance training|endurance training
343233|NCT02126891|Senior athletes|senior athletes
343234|NCT02126852|residual paralysis,neuromuscular blockade,acceleromyography,electromyography|residual paralysis,neuromuscular blockade,acceleromyography,electromyography
343235|NCT02126813|Postoperative urinary retention|postoperative urinary retention
343236|NCT02126813|Fast-track total hip (THA) and knee arthroplasty (TKA)|fast-track total hip (tha) and knee arthroplasty (tka)
343237|NCT02126813|Urinary bladder volume|urinary bladder volume
343238|NCT02126800|breast cancer|breast cancer
343239|NCT02126787|Anxiety disorders|anxiety disorders
343240|NCT02126787|Depressive disorders|depressive disorders
343241|NCT02126787|Personality disorders|personality disorders
343242|NCT02126787|Psychodynamic psychotherapy|psychodynamic psychotherapy
343243|NCT02126787|Cognitive-behavioral psychotherapy|cognitive-behavioral psychotherapy
343244|NCT02126787|Group psychotherapy|group psychotherapy
343245|NCT02126787|Day treatment|day treatment
343246|NCT02126774|epilepsy|epilepsy
343247|NCT02126774|focal epilepsy|focal epilepsy
343248|NCT02126761|Influenza|influenza
343249|NCT02126761|elderly|elderly
343250|NCT02126761|adjuvant|adjuvant
343251|NCT02126748|bronchiolitis|bronchiolitis
343252|NCT02126748|Wang score|wang score
343253|NCT02126748|Sa02|sa02
343254|NCT02126748|airway clearance techniques|airway clearance techniques
343255|NCT02126748|intrapulmonary percussive ventilation|intrapulmonary percussive ventilation
343256|NCT02126748|assisted autogenic drainage|assisted autogenic drainage
343257|NCT02126722|Helicobacter pylori|helicobacter pylori
343258|NCT02126722|Gastritis|gastritis
343259|NCT02126709|Povidone Iodine|povidone iodine
343260|NCT02126709|Safety|safety
343261|NCT02126709|Efficacy|efficacy
343262|NCT02126709|Acne treatment|acne treatment
343263|NCT02126696|Anti-retroviral Therapy|anti-retroviral therapy
343264|NCT02126696|Lesotho|lesotho
343265|NCT02126696|Southern Africa|southern africa
343266|NCT02126696|Comorbidity|comorbidity
343267|NCT02126696|Virologic failure|virologic failure
343268|NCT02126683|Hashimoto's thyroiditis|hashimoto's thyroiditis
343269|NCT02126683|Plaquenil|plaquenil
343270|NCT02126657|Acne scars|acne scars
343271|NCT02126657|70% Glycolic acid peel|70% glycolic acid peel
343272|NCT02126644|Photoaging|photoaging
343273|NCT02126644|70% glycolic acid peel|70% glycolic acid peel
343274|NCT02126618|Lower urinary tract symptoms|lower urinary tract symptoms
343275|NCT02126618|urodynamic studies|urodynamic studies
343276|NCT02126618|diuresis|diuresis
343277|NCT02126605|diabetes alert dogs|diabetes alert dogs
343278|NCT02126605|hypoglycemia|hypoglycemia
343279|NCT02126579|melanoma|melanoma
343280|NCT02126579|neoplasms|neoplasms
343281|NCT02126579|Poly ICLC|poly iclc
343282|NCT02126579|Freund's Adjuvant|freund's adjuvant
343283|NCT02126579|Metastatic melanoma|metastatic melanoma
343284|NCT02126579|resiquimod|resiquimod
343285|NCT02126579|adjuvants|adjuvants
343286|NCT02126579|peptide vaccine|peptide vaccine
400531|NCT01866436|Multimedia|multimedia
438947|NCT01693458|HIV|hiv
343287|NCT02126566|striae distensiae|striae distensiae
343288|NCT02126540|Peripheral Arterial Disease|peripheral arterial disease
343289|NCT02126540|Atherectomy|atherectomy
343290|NCT02126540|Optical Coherence Tomography|optical coherence tomography
343291|NCT02126514|Beta secretase inhibitor|beta secretase inhibitor
343292|NCT02126514|Alzheimer disease|alzheimer disease
343293|NCT02126501|weaning|weaning
343294|NCT02126501|NCPAP|ncpap
343295|NCT02126501|Preterm|preterm
343296|NCT02126501|sudden wean|sudden wean
343297|NCT02126501|gradual pressure off wean|gradual pressure off wean
343298|NCT02126488|treadmill training|treadmill training
343299|NCT02126488|generalization|generalization
343300|NCT02126488|retention|retention
343301|NCT02126475|"parkinson patients ON"|"parkinson patients on"
343302|NCT02126475|"parkinson patients OFF"|"parkinson patients off"
343303|NCT02126475|time estimation|time estimation
343304|NCT02126475|anticipation|anticipation
343305|NCT02126462|Human Hookworm|human hookworm
343306|NCT02126462|Necator americanus|necator americanus
343307|NCT02126462|Hookworm|hookworm
343308|NCT02126462|Hookworm Disease|hookworm disease
343309|NCT02126462|Iron-deficiency anemia|iron-deficiency anemia
343310|NCT02126462|Soil-transmitted helminth infection|soil-transmitted helminth infection
343311|NCT02126462|Neglected Tropical Disease|neglected tropical disease
343312|NCT02126462|Na-APR-1|na-apr-1
343313|NCT02126462|Na-GST-1|na-gst-1
343314|NCT02126436|phantom limb pain|phantom limb pain
343315|NCT02126436|phantom limb sensation|phantom limb sensation
343316|NCT02126436|acupuncture|acupuncture
343317|NCT02126436|randomised controlled trial|randomised controlled trial
343318|NCT02126423|Drug Resistance, Microbial|drug resistance, microbial
343319|NCT02126410|sarcopenia|sarcopenia
343320|NCT02126410|sleep duration|sleep duration
343321|NCT02126410|body composition|body composition
343322|NCT02126410|skeletal muscle|skeletal muscle
343323|NCT02126397|endometrial polyp|endometrial polyp
343324|NCT02126397|resection of endometrial polyps|resection of endometrial polyps
343325|NCT02126397|hysteroscopy|hysteroscopy
343326|NCT02126397|bipolar electrode Versapoint|bipolar electrode versapoint
343327|NCT02126397|Laser Diode|laser diode
343328|NCT02126384|Immunology|immunology
343329|NCT02126384|human|human
343330|NCT02126384|B-lymphocytes subsets|b-lymphocytes subsets
343331|NCT02126384|Antibody-Producing Cells|antibody-producing cells
343332|NCT02126384|23 valent pneumococcal capsular polysaccharide vaccine|23 valent pneumococcal capsular polysaccharide vaccine
343333|NCT02126332|Severe acute pancreatitis|severe acute pancreatitis
343334|NCT02126332|Epidural analgesia|epidural analgesia
343335|NCT02126332|Acute respiratory failure|acute respiratory failure
343336|NCT02126332|Mechanical ventilation|mechanical ventilation
343337|NCT02126332|Intensive Care Unit (ICU)|intensive care unit (icu)
343338|NCT02126319|Cognitive-affective preparation|cognitive-affective preparation
343339|NCT02126319|prostate cancer counseling|prostate cancer counseling
343340|NCT02126280|proinflammatory cytokines|proinflammatory cytokines
343341|NCT02126280|anti-inflammatory cytokines|anti-inflammatory cytokines
343342|NCT02126280|human monocytes|human monocytes
343343|NCT02126280|activation|activation
343344|NCT02126280|biomarkers|biomarkers
343345|NCT02126280|asymptomatic atherosclerosis|asymptomatic atherosclerosis
343346|NCT02126267|periodontal disease|periodontal disease
343347|NCT02126267|therapy|therapy
343348|NCT02126267|anti-bacterial agents|anti-bacterial agents
343349|NCT02126267|Randomized Controlled Trials|randomized controlled trials
343350|NCT02126241|Heart Failure|heart failure
343351|NCT02126241|Cardiac Resyncronization Therapy|cardiac resyncronization therapy
343352|NCT02126241|Optimization|optimization
343353|NCT02126241|Non-invasive cardiac system|non-invasive cardiac system
343354|NCT02126241|Impedance measured cardiac output|impedance measured cardiac output
343355|NCT02126228|antibiotics, cesarean|antibiotics, cesarean
343356|NCT02126215|magnetic resonance imaging|magnetic resonance imaging
343357|NCT02126215|carbon dioxide|carbon dioxide
343358|NCT02126215|abdominal aortic aneurysm|abdominal aortic aneurysm
343359|NCT02126215|post-op delirium|post-op delirium
343360|NCT02126202|Elderly|elderly
343361|NCT02126202|Octogenarians|octogenarians
343362|NCT02126202|PCI|pci
343363|NCT02126202|Myocardial infarction|myocardial infarction
343364|NCT02126202|NSTEMI|nstemi
343365|NCT02126202|Unstable angina pectoris|unstable angina pectoris
343366|NCT02126189|Head and Neck Squamous Cell Carcinoma|head and neck squamous cell carcinoma
343367|NCT02126189|Human Papillomavirus|human papillomavirus
343368|NCT02126189|Aetiology|aetiology
343369|NCT02126189|prevalence|prevalence
343370|NCT02126189|risk factors|risk factors
343371|NCT02126189|clinical outcome|clinical outcome
343372|NCT02126163|Excessive Drinking|excessive drinking
343373|NCT02126163|Hazardous Drinking|hazardous drinking
343374|NCT02126137|HCV|hcv
343375|NCT02126137|Ezetimibe|ezetimibe
343376|NCT02126137|Cholesterol|cholesterol
343377|NCT02126137|Host|host
400532|NCT01866436|Education|education
400533|NCT01866436|Colorectal surgery|colorectal surgery
343378|NCT02126124|Brainsway, dTMS, Deep Transcranial Magnetic Stimulation, Smoking Cessation|brainsway, dtms, deep transcranial magnetic stimulation, smoking cessation
343676|NCT02124668|Xtandi|xtandi
343379|NCT02126098|ANCA-associated vasculitis|anca-associated vasculitis
343380|NCT02126098|Granulomatosis with polyangiitis|granulomatosis with polyangiitis
343381|NCT02126098|Microscopic polyangiitis|microscopic polyangiitis
343382|NCT02126098|Wegner's granulomatosis|wegner's granulomatosis
343383|NCT02126098|Eosinphilic granulomatosis with polyangiitis|eosinphilic granulomatosis with polyangiitis
343384|NCT02126085|ischemic stroke|ischemic stroke
343385|NCT02126085|recanalisation|recanalisation
343386|NCT02126085|sedation|sedation
343387|NCT02126072|Ethanol|ethanol
343388|NCT02126072|Alcohol|alcohol
343389|NCT02126072|Consumption|consumption
343390|NCT02126072|Gut wall integrity|gut wall integrity
343391|NCT02126072|Endotoxemia|endotoxemia
343392|NCT02126059|dementia|dementia
343393|NCT02126059|behavioral and psychological symptoms|behavioral and psychological symptoms
343394|NCT02126059|quality of life|quality of life
343395|NCT02126046|Cord Blood Transplant|cord blood transplant
343396|NCT02126046|Haploidentical HSCT|haploidentical hsct
343397|NCT02126046|Thalassemia major|thalassemia major
343398|NCT02126033|celiac|celiac
343399|NCT02126033|telomere|telomere
343400|NCT02126033|telomerase|telomerase
343401|NCT02126020|Keratoprosthesis|keratoprosthesis
343402|NCT02126020|corneal melt|corneal melt
343403|NCT02126020|keratolysis|keratolysis
343404|NCT02126020|Tumor necrosis factor alpha|tumor necrosis factor alpha
343405|NCT02126020|infliximab|infliximab
343406|NCT02126020|matrix metalloproteinase|matrix metalloproteinase
343407|NCT02126007|fatigue|fatigue
343408|NCT02126007|HIV|hiv
343409|NCT02126007|behavioral intervention|behavioral intervention
343410|NCT02126007|sleep|sleep
343411|NCT02125981|limaprost alfadex|limaprost alfadex
343412|NCT02125981|cervical myelopathy|cervical myelopathy
343413|NCT02125981|surgery|surgery
343414|NCT02125968|chronic low back pain|chronic low back pain
343415|NCT02125968|video game|video game
343416|NCT02125968|therapeutic effects|therapeutic effects
343417|NCT02125955|Pediatric|pediatric
343418|NCT02125955|Overweight|overweight
343419|NCT02125955|Obesity|obesity
343420|NCT02125955|Gut microbiota|gut microbiota
343421|NCT02125955|Adiposity|adiposity
343422|NCT02125955|Prebiotic|prebiotic
343423|NCT02125955|Dietary fiber|dietary fiber
343424|NCT02125942|Borderline Personality Disorder|borderline personality disorder
343425|NCT02125877|Iron overload|iron overload
343426|NCT02125877|Chelation|chelation
343427|NCT02125877|Thalassemia|thalassemia
343428|NCT02125877|Myelodysplastic syndrome (MDS)|myelodysplastic syndrome (mds)
343429|NCT02125877|Transfusional hemisiderosis|transfusional hemisiderosis
343430|NCT02125877|Deferasirox|deferasirox
343431|NCT02125877|ICL670|icl670
343432|NCT02125877|Dispersible tablet|dispersible tablet
343433|NCT02125877|Film-coated tablet|film-coated tablet
343434|NCT02125864|AMD|amd
343435|NCT02125864|VEGF|vegf
343436|NCT02125864|Aflibercept|aflibercept
343437|NCT02125851|slurry|slurry
343438|NCT02125851|splenda|splenda
343439|NCT02125851|sucralose|sucralose
343440|NCT02125851|budesonide|budesonide
343441|NCT02125851|mucosal contact time|mucosal contact time
343442|NCT02125838|laryngeal mask Supreme|laryngeal mask supreme
343443|NCT02125838|laparoscopic gynecologic surgery|laparoscopic gynecologic surgery
343444|NCT02125838|Laryngeal mask during surgery|laryngeal mask during surgery
343445|NCT02125812|Aggressive Periodontitis|aggressive periodontitis
343446|NCT02125812|antimicrobial(s)|antimicrobial(s)
343447|NCT02125812|microbiology|microbiology
343448|NCT02125773|PrEP|prep
343449|NCT02125773|Risk score|risk score
343450|NCT02125773|Self-perception|self-perception
343451|NCT02125760|Respiratory muscle training|respiratory muscle training
343452|NCT02125760|stroke|stroke
343453|NCT02125760|rehabilitation|rehabilitation
343454|NCT02125747|Respiratory muscle training; high-intensity training|respiratory muscle training; high-intensity training
343455|NCT02125721|cystinuria|cystinuria
343456|NCT02125721|D-penicillamine (Cuprimine®)|d-penicillamine (cuprimine®)
343457|NCT02125721|tiopronin (Thiola®)|tiopronin (thiola®)
343458|NCT02125708|preterm prelabor rupture of membranes|preterm prelabor rupture of membranes
343459|NCT02125708|Ovula Ring|ovula ring
343460|NCT02125708|body-core-temperature|body-core-temperature
343461|NCT02125708|biomarkers|biomarkers
343462|NCT02125708|Single pregnancies|single pregnancies
343463|NCT02125708|PPROM|pprom
343464|NCT02125708|gestation week 22 and 27|gestation week 22 and 27
343465|NCT02125682|HDL|hdl
343466|NCT02125682|Hyperlipidemia|hyperlipidemia
343467|NCT02125682|Diabetes|diabetes
343468|NCT02125682|Inflammation|inflammation
343469|NCT02125669|basal cell carcinoma|basal cell carcinoma
343470|NCT02125669|laser surgery|laser surgery
343471|NCT02125669|pulsed dye laser|pulsed dye laser
343472|NCT02125669|randomized controlled trial|randomized controlled trial
343473|NCT02125643|Exercise-induced muscle damage|exercise-induced muscle damage
343474|NCT02125643|Caffeine|caffeine
400534|NCT01866397|cidofovir|cidofovir
343475|NCT02125643|Maximal voluntary strength|maximal voluntary strength
343476|NCT02125630|Metastatic breast carcer|metastatic breast carcer
343477|NCT02125630|Bone metastasis|bone metastasis
343478|NCT02125630|surgery|surgery
343677|NCT02124668|MDV3100|mdv3100
343479|NCT02125617|Castration-resistant prostate cancer|castration-resistant prostate cancer
343480|NCT02125617|Abiraterone|abiraterone
343481|NCT02125617|Biomarker|biomarker
343482|NCT02125617|Urokinase Plasminogen Activator Receptor|urokinase plasminogen activator receptor
343483|NCT02125617|Plasma|plasma
343484|NCT02125617|Predictive markers|predictive markers
343485|NCT02125604|Gastrointestinal event|gastrointestinal event
343486|NCT02125591|Mild Traumatic Brain Injury|mild traumatic brain injury
343487|NCT02125565|Arterial|arterial
343488|NCT02125565|Blood|blood
343489|NCT02125565|Gas|gas
343490|NCT02125565|Needle|needle
343491|NCT02125565|Pain|pain
343492|NCT02125565|Local|local
343493|NCT02125565|Anaesthesia|anaesthesia
343494|NCT02125565|Anaesthetic|anaesthetic
343495|NCT02125552|vascular access device|vascular access device
343496|NCT02125552|ultrasonography|ultrasonography
343497|NCT02125539|Online adolescent substance abuse relapse prevention program|online adolescent substance abuse relapse prevention program
343498|NCT02125526|Acute myocardial infarction|acute myocardial infarction
343499|NCT02125526|Persisting ischemia|persisting ischemia
343500|NCT02125526|No reflow|no reflow
343501|NCT02125526|Intra-aortic balloon pump|intra-aortic balloon pump
343502|NCT02125526|Exhausted autoregulation|exhausted autoregulation
343503|NCT02125513|neoadjuvant chemotherapy|neoadjuvant chemotherapy
343504|NCT02125513|ovarian cancer|ovarian cancer
343505|NCT02125513|fallopian tube carcinoma|fallopian tube carcinoma
343506|NCT02125513|peritoneal carcinoma|peritoneal carcinoma
343507|NCT02125513|randomized study|randomized study
343508|NCT02125500|HCV/HIV coinfection|hcv/hiv coinfection
343509|NCT02125500|HCV genotype 1|hcv genotype 1
343510|NCT02125487|Clinical Breast Examination|clinical breast examination
343511|NCT02125487|Breast Cancer detection|breast cancer detection
343512|NCT02125487|Breast Simulator|breast simulator
343513|NCT02125487|Hybrid Simulation|hybrid simulation
343514|NCT02125487|Patient Simulation|patient simulation
343515|NCT02125487|Standardized Patient|standardized patient
343516|NCT02125487|Medical student education|medical student education
343517|NCT02125487|Health Communication|health communication
343518|NCT02125487|Communication Barriers|communication barriers
343519|NCT02125487|Cultural competency|cultural competency
343520|NCT02125487|Cultural|cultural
343521|NCT02125487|Middle East|middle east
343522|NCT02125487|Lebanon|lebanon
343523|NCT02125474|Neuroendocrine Tumors|neuroendocrine tumors
343524|NCT02125474|Lutetium|lutetium
343525|NCT02125474|Treatment Outcome|treatment outcome
343526|NCT02125461|Locally advanced|locally advanced
343527|NCT02125461|Unresectable Non-Small Cell Lung Cancer|unresectable non-small cell lung cancer
343528|NCT02125461|MEDI4736|medi4736
343529|NCT02125461|PD-L1|pd-l1
343530|NCT02125461|Stage III Non-Small Cell Lung Cancer|stage iii non-small cell lung cancer
343531|NCT02125461|Chemoradiation|chemoradiation
343532|NCT02125461|Immune-mediated cancer therapy|immune-mediated cancer therapy
343533|NCT02125448|Esophageal cancer|esophageal cancer
343534|NCT02125448|MRI|mri
343535|NCT02125448|PET-CT|pet-ct
343536|NCT02125448|Response assessment|response assessment
343537|NCT02125435|Healthy subjects|healthy subjects
343538|NCT02125435|ASP2408|asp2408
343539|NCT02125435|pharmacokinetics|pharmacokinetics
343540|NCT02125396|hepatocellular carcinoma|hepatocellular carcinoma
343541|NCT02125396|liver cancer|liver cancer
343542|NCT02125396|transarterial chemoembolization|transarterial chemoembolization
343543|NCT02125396|radiotherapy|radiotherapy
343544|NCT02125396|adjuvant therapy|adjuvant therapy
343545|NCT02125383|Parkinson's disease|parkinson's disease
343546|NCT02125383|Transcranial direct current stimulation|transcranial direct current stimulation
343547|NCT02125357|sequencing|sequencing
343548|NCT02125357|abiraterone|abiraterone
343549|NCT02125357|enzalutamide|enzalutamide
343550|NCT02125357|metastatic castration-resistant prostate cancer|metastatic castration-resistant prostate cancer
343551|NCT02125357|randomized|randomized
343552|NCT02125331|Blood Pressure|blood pressure
343553|NCT02125318|myeloproliferative neoplasm|myeloproliferative neoplasm
343554|NCT02125318|chronic myelogenous leukemia|chronic myelogenous leukemia
343555|NCT02125318|polycythemia vera|polycythemia vera
343556|NCT02125318|primary myelofibrosis|primary myelofibrosis
343557|NCT02125318|essential thrombocythemia|essential thrombocythemia
343558|NCT02125318|anagrelide|anagrelide
343559|NCT02125318|thrombocytosis|thrombocytosis
343560|NCT02125318|GALE-401|gale-401
343561|NCT02125305|Metformin|metformin
343562|NCT02125305|Pharmacokinetics/ Pharmacodynamics|pharmacokinetics/ pharmacodynamics
343563|NCT02125214|consciousness, anesthesia, electroencephalogram, microstate, long-range dependency|consciousness, anesthesia, electroencephalogram, microstate, long-range dependency
343564|NCT02125201|intranasal fentanyl|intranasal fentanyl
343565|NCT02125201|newborn|newborn
343566|NCT02125162|BCX4161|bcx4161
343567|NCT02125162|BioCryst|biocryst
343568|NCT02125162|hereditary angioedema|hereditary angioedema
343569|NCT02125162|relative bioavailability|relative bioavailability
343570|NCT02125162|kallikrein inhibitor|kallikrein inhibitor
343571|NCT02125149|pregnancy|pregnancy
343572|NCT02125149|obese|obese
343573|NCT02125136|unresectable|unresectable
343574|NCT02125136|borderline resectable|borderline resectable
343575|NCT02125110|neurotoxicants|neurotoxicants
343576|NCT02125110|MRI|mri
343577|NCT02125110|developing brain|developing brain
343578|NCT02125097|Intracranial Aneurysm Treatment|intracranial aneurysm treatment
343579|NCT02125097|Endovascular Therapy|endovascular therapy
343580|NCT02125084|Metastatic Prostate Cancer|metastatic prostate cancer
343581|NCT02125084|Castrate-resistant|castrate-resistant
343582|NCT02125084|Enzalutamide|enzalutamide
343583|NCT02125084|Everolimus|everolimus
343584|NCT02125058|intracutaneous sutures|intracutaneous sutures
343585|NCT02125058|transcutaneous sutures|transcutaneous sutures
343586|NCT02125058|dermatological surgery|dermatological surgery
343587|NCT02125058|facial area|facial area
343588|NCT02125045|GSH|gsh
343589|NCT02125045|cardiovascular risk factors|cardiovascular risk factors
343590|NCT02125045|endothelial dysfunction|endothelial dysfunction
343591|NCT02125045|oxidative stress|oxidative stress
343592|NCT02125019|Breast Cancer|breast cancer
343593|NCT02125019|Taxane|taxane
343594|NCT02125019|Gait|gait
343595|NCT02125019|Men|men
343596|NCT02125019|Women|women
343597|NCT02125006|Mindfulness|mindfulness
343598|NCT02125006|Breast Cancer|breast cancer
343599|NCT02125006|Painful Neuropathy|painful neuropathy
343600|NCT02125006|Chronic Pain|chronic pain
343601|NCT02125006|fMRI|fmri
343602|NCT02125006|Disability|disability
343603|NCT02125006|Quality of Life|quality of life
343604|NCT02125006|Cytokines|cytokines
343605|NCT02125006|Cortisol|cortisol
343606|NCT02124993|Gastrectomy|gastrectomy
343607|NCT02124980|Opioid Substitution Treatment|opioid substitution treatment
343608|NCT02124980|Cognitive Behavioral Therapy|cognitive behavioral therapy
343609|NCT02124980|Mobile Health|mobile health
343610|NCT02124928|stroke|stroke
343611|NCT02124928|biomarkers|biomarkers
343612|NCT02124928|vulnerable plaque|vulnerable plaque
343613|NCT02124928|carotid endarterectomy|carotid endarterectomy
343614|NCT02124928|carotid artery disease|carotid artery disease
343615|NCT02124915|prosthetic socket|prosthetic socket
343616|NCT02124915|amputee|amputee
343617|NCT02124889|bariatric surgery|bariatric surgery
343618|NCT02124889|multivitamin|multivitamin
343619|NCT02124889|weight loss|weight loss
343620|NCT02124889|adherence|adherence
343621|NCT02124876|amputee|amputee
343622|NCT02124876|prosthetics|prosthetics
343623|NCT02124837|lunch breaks, recovery, nature, park walking, relaxation|lunch breaks, recovery, nature, park walking, relaxation
343624|NCT02124811|Schizophrenia|schizophrenia
343625|NCT02124811|Clozapine|clozapine
343626|NCT02124811|Minocycline|minocycline
343627|NCT02124798|Subcutaneous|subcutaneous
343628|NCT02124798|Autoinjector|autoinjector
343629|NCT02124798|Belimumab|belimumab
343630|NCT02124798|Real-Life Use Study|real-life use study
343631|NCT02124798|Reliability|reliability
343632|NCT02124785|Long-term persistence|long-term persistence
343634|NCT02124785|Hepatitis A|hepatitis a
343635|NCT02124772|v600-mutation|v600-mutation
343636|NCT02124772|neuroblastoma|neuroblastoma
343637|NCT02124772|Trametinib|trametinib
343638|NCT02124772|pediatrics|pediatrics
343639|NCT02124772|Langerhans Cell Histiocytosis|langerhans cell histiocytosis
343640|NCT02124772|low grade glioma plexiform neurofibromas|low grade glioma plexiform neurofibromas
343641|NCT02124746|Primary Myelofibrosis|primary myelofibrosis
343642|NCT02124746|Post Polycythemia Vera Myelofibrosis|post polycythemia vera myelofibrosis
343643|NCT02124746|Post Essential Thrombocythemia Myelofibrosis|post essential thrombocythemia myelofibrosis
343644|NCT02124746|Polycythemia Vera|polycythemia vera
343645|NCT02124746|Essential Thrombocythemia|essential thrombocythemia
343646|NCT02124746|blood disorders|blood disorders
343647|NCT02124733|Actinic Keratosis|actinic keratosis
343648|NCT02124733|Actinic Keratoses|actinic keratoses
343649|NCT02124733|AK|ak
343650|NCT02124733|PDT|pdt
343651|NCT02124733|Photodynamic Therapy|photodynamic therapy
343652|NCT02124733|Blue Light Therapy|blue light therapy
343653|NCT02124733|ALA|ala
343654|NCT02124733|aminolevulinic acid|aminolevulinic acid
343655|NCT02124733|Levulan|levulan
343656|NCT02124720|Autism spectrum disorders|autism spectrum disorders
343657|NCT02124720|Stereotypy|stereotypy
343658|NCT02124720|Repetitive behavior|repetitive behavior
343659|NCT02124707|Head and neck cancer|head and neck cancer
343660|NCT02124707|Squamous cell carcinoma|squamous cell carcinoma
343661|NCT02124707|Metastatic|metastatic
343662|NCT02124707|Recurrent|recurrent
343663|NCT02124707|Phase II|phase ii
343664|NCT02124707|Carboplatin|carboplatin
343665|NCT02124707|Paclitaxel|paclitaxel
343666|NCT02124707|Cetuximab|cetuximab
343667|NCT02124694|historical trauma and unresolved grief|historical trauma and unresolved grief
343668|NCT02124694|complicated grief|complicated grief
343669|NCT02124694|prolonged grief|prolonged grief
343670|NCT02124694|interpersonal conflicts|interpersonal conflicts
343671|NCT02124694|depression|depression
343672|NCT02124694|American Indians|american indians
343673|NCT02124694|interpersonal psychotherapy|interpersonal psychotherapy
343674|NCT02124694|traumatic grief|traumatic grief
343675|NCT02124694|posttraumatic stress disorder|posttraumatic stress disorder
343678|NCT02124668|Progressive Castration-Resistant Prostate Cancer|progressive castration-resistant prostate cancer
343679|NCT02124668|Enzalutamide|enzalutamide
343680|NCT02124655|Biofilms|biofilms
343681|NCT02124655|Chlorhexidine|chlorhexidine
343682|NCT02124655|Microscopy, confocal|microscopy, confocal
343683|NCT02124655|Dental plaque|dental plaque
343684|NCT02124655|Mouthwashes|mouthwashes
343685|NCT02124642|Folate requirements|folate requirements
343686|NCT02124642|Pregnancy|pregnancy
343687|NCT02124642|Folic acid|folic acid
343688|NCT02124642|DNA methylation|dna methylation
343689|NCT02124642|Folate biomarkers|folate biomarkers
343690|NCT02124616|spinal muscular atrophy|spinal muscular atrophy
343691|NCT02124616|Muscular dystrophy|muscular dystrophy
343692|NCT02124616|Muscle diseases|muscle diseases
343693|NCT02124616|myasthenic syndromes|myasthenic syndromes
343694|NCT02124616|Polyneuropathies|polyneuropathies
343695|NCT02124616|Myopathies|myopathies
343696|NCT02124603|cataract|cataract
343697|NCT02124603|prophylaxis|prophylaxis
343698|NCT02124603|susceptibility|susceptibility
343699|NCT02124590|Carnitine|carnitine
343700|NCT02124590|Acylcarnitine|acylcarnitine
343701|NCT02124590|Exercise|exercise
343702|NCT02124590|Exercise Intensity|exercise intensity
343703|NCT02124590|Insulin Sensitivity|insulin sensitivity
343704|NCT02124564|Lacosamide|lacosamide
343705|NCT02124564|Epilepsy|epilepsy
343706|NCT02124564|Focal, Partial-Onset Seizures with or without secondary generalization|focal, partial-onset seizures with or without secondary generalization
343707|NCT02124564|Monotherapy|monotherapy
343708|NCT02124551|Goal-directed fluid therapy|goal-directed fluid therapy
343709|NCT02124512|obese|obese
343710|NCT02124512|insulin resistance|insulin resistance
343711|NCT02124512|metabolic syndrome|metabolic syndrome
343712|NCT02124499|anesthesia recovery period|anesthesia recovery period
343713|NCT02124499|postoperative complications|postoperative complications
343714|NCT02124499|pain|pain
343715|NCT02124499|pain measurement|pain measurement
343716|NCT02124499|postoperative nausea and vomiting|postoperative nausea and vomiting
343717|NCT02124499|quality of life|quality of life
343718|NCT02124499|genetic association study|genetic association study
343719|NCT02124486|IIH|iih
343720|NCT02124486|Weight loss|weight loss
343721|NCT02124486|Bariatric surgery|bariatric surgery
343722|NCT02124473|Resistant hypertension|resistant hypertension
343723|NCT02124473|Homeopathy|homeopathy
343724|NCT02124473|Blood pressure|blood pressure
343725|NCT02124473|Ambulatory blood pressure monitoring|ambulatory blood pressure monitoring
343726|NCT02124460|Pediatric|pediatric
343727|NCT02124460|Obesity|obesity
343728|NCT02124460|Overweight|overweight
343729|NCT02124460|Intervention|intervention
343730|NCT02124434|Laparoscopic Sleeve Gastrectomy surgery|laparoscopic sleeve gastrectomy surgery
343731|NCT02124421|Ovarian cancer|ovarian cancer
343732|NCT02124421|Cytoreductive surgery|cytoreductive surgery
343733|NCT02124421|Hyperthermic Intraperitoneal chemotherapy|hyperthermic intraperitoneal chemotherapy
343734|NCT02124421|Systemic chemotherapy|systemic chemotherapy
343735|NCT02124421|Primary peritoneal carcinoma|primary peritoneal carcinoma
343736|NCT02124421|Fallopian Tube cancer|fallopian tube cancer
343737|NCT02124421|Intraperitoneal chemotherapy|intraperitoneal chemotherapy
343738|NCT02124421|IV/IP chemotherapy|iv/ip chemotherapy
343739|NCT02124421|IV chemotherapy|iv chemotherapy
343740|NCT02124382|liver failure|liver failure
343741|NCT02124382|liver malignancy|liver malignancy
343742|NCT02124382|metabolic diseases|metabolic diseases
343743|NCT02124382|Pediatric liver transplanted recipients and their healthy donors|pediatric liver transplanted recipients and their healthy donors
343744|NCT02124369|Pancreatic cancer|pancreatic cancer
343745|NCT02124369|locally advanced|locally advanced
343746|NCT02124369|unresectable|unresectable
343747|NCT02124343|Neutrophil|neutrophil
343748|NCT02124343|Exercise|exercise
343749|NCT02124343|COPD|copd
343750|NCT02124343|Pulmonary Rehabilitation|pulmonary rehabilitation
343751|NCT02124330|Montmorillonite, proteic diet, in vitro and in vivo models|montmorillonite, proteic diet, in vitro and in vivo models
343752|NCT02124317|nanoparticle albumin-bound paclitaxel|nanoparticle albumin-bound paclitaxel
343753|NCT02124317|S-1|s-1
343754|NCT02124317|advanced pancreatic cancer|advanced pancreatic cancer
343755|NCT02124317|objective response rate|objective response rate
343756|NCT02124304|Sternocleidomastoid|sternocleidomastoid
343757|NCT02124304|Neck pain|neck pain
343758|NCT02124304|EMG|emg
343759|NCT02124304|Perceived Exertion|perceived exertion
343760|NCT02124304|Thera-Band|thera-band
343761|NCT02124304|Cervical Paraspinals|cervical paraspinals
343762|NCT02124291|In Vitro Fertilization|in vitro fertilization
343763|NCT02124291|Vitrification|vitrification
343764|NCT02124291|Frozen Embryo|frozen embryo
343765|NCT02124291|Assisted Hatching|assisted hatching
343766|NCT02124291|Pregnancy Rate|pregnancy rate
343767|NCT02124278|Single ascending dose|single ascending dose
343768|NCT02124278|Safety and tolerability in healthy subjects|safety and tolerability in healthy subjects
343769|NCT02124265|Oral Rehydration Therapy|oral rehydration therapy
343770|NCT02124252|cervical cancer screening|cervical cancer screening
343771|NCT02124252|human papillomavirus testing|human papillomavirus testing
343772|NCT02124252|Kenya|kenya
343773|NCT02124252|implementation science|implementation science
343774|NCT02124226|Chronic severe asthma, immunomodulation, methotrexate, steroids, omalizumab|chronic severe asthma, immunomodulation, methotrexate, steroids, omalizumab
343775|NCT02124213|Receptor Occupancy|receptor occupancy
343777|NCT02124213|D1 Receptor Agonist|d1 receptor agonist
343778|NCT02124174|acute myelogenous leukemia (AML)|acute myelogenous leukemia (aml)
343779|NCT02124174|myelodysplastic syndrome (MDS)|myelodysplastic syndrome (mds)
343780|NCT02124161|Pneumococcal polysaccharide vaccine|pneumococcal polysaccharide vaccine
343781|NCT02124161|13-valent pneumococcal conjugate vaccine|13-valent pneumococcal conjugate vaccine
343782|NCT02124161|invasive pneumococcal disease|invasive pneumococcal disease
343783|NCT02124161|flu vaccine|flu vaccine
343784|NCT02124148|cancer|cancer
343785|NCT02124135|Nutrition|nutrition
343786|NCT02124122|Focus|focus
343787|NCT02124122|safety|safety
343788|NCT02124109|Rheumatic Heart Disease|rheumatic heart disease
343789|NCT02124096|Zoonotic|zoonotic
343790|NCT02124096|Influenza|influenza
343791|NCT02124096|Infections|infections
343792|NCT02124096|Ohio|ohio
343793|NCT02124096|Fairs|fairs
343794|NCT02124083|Niemann Pick Disease, Type C1|niemann pick disease, type c1
343795|NCT02124083|Phase I, Phase 2|phase i, phase 2
343796|NCT02124083|Vorinostat|vorinostat
343797|NCT02124070|Cystinosis|cystinosis
343798|NCT02124070|Myopathy|myopathy
343799|NCT02124070|Recombiant Growth Hormone|recombiant growth hormone
343800|NCT02124057|Liver|liver
343801|NCT02124057|Motor Neuron Disease|motor neuron disease
343802|NCT02124044|Coinfection|coinfection
343803|NCT02124044|HCV Genotype 1b|hcv genotype 1b
343804|NCT02124044|Interferon Free therapy|interferon free therapy
343805|NCT02124044|Liver Biopsy|liver biopsy
343806|NCT02124044|Virological Response|virological response
343807|NCT02124031|Osteoarthritis|osteoarthritis
343808|NCT02124031|Rheumatoid Arthritis|rheumatoid arthritis
343809|NCT02124031|Disability|disability
343810|NCT02124031|Joint function|joint function
343811|NCT02124018|Myocardial infarction|myocardial infarction
343812|NCT02124018|Risk stratification|risk stratification
343813|NCT02124018|Sudden cardiac death|sudden cardiac death
343814|NCT02124018|Preserved ejection fraction|preserved ejection fraction
343815|NCT02124018|Programmed ventricular stimulation|programmed ventricular stimulation
343816|NCT02124005|Knee surgery|knee surgery
343817|NCT02124005|Femoral block|femoral block
343818|NCT02124005|Bupivacaine|bupivacaine
343819|NCT02124005|Ultrasound|ultrasound
343820|NCT02123966|Chronic Graft-versus-Host-Disease|chronic graft-versus-host-disease
343821|NCT02123966|Oral mucosal disease|oral mucosal disease
343822|NCT02123953|Drug therapy|drug therapy
343823|NCT02123940|Weaning from mechanical ventilation|weaning from mechanical ventilation
343824|NCT02123940|Lung ultrasound|lung ultrasound
343825|NCT02123940|Nasal humidified high flow therapy|nasal humidified high flow therapy
343826|NCT02123940|Weaning failure|weaning failure
343827|NCT02123940|Postextubation distress|postextubation distress
343828|NCT02123927|Drug therapy|drug therapy
343829|NCT02123914|Exercise training|exercise training
343830|NCT02123914|Allergic rhinitis|allergic rhinitis
343831|NCT02123914|Vitamin C|vitamin c
343832|NCT02123914|Cytokine|cytokine
343833|NCT02123914|Rhinitis symptoms|rhinitis symptoms
343834|NCT02123901|Mind and body Exercise|mind and body exercise
343835|NCT02123901|Flow mediated dilation|flow mediated dilation
343836|NCT02123901|Diabetes|diabetes
343837|NCT02123888|Prostate|prostate
343838|NCT02123888|Lung|lung
343839|NCT02123862|Prostate Cancer|prostate cancer
343840|NCT02123862|Breast Cancer|breast cancer
343841|NCT02123862|Colorectal Cancer|colorectal cancer
343842|NCT02123862|Colon Cancer|colon cancer
343843|NCT02123862|Rectal Cancer|rectal cancer
343844|NCT02123862|Cancer|cancer
343845|NCT02123862|Solid Tumor|solid tumor
343846|NCT02123862|Metastatic|metastatic
343847|NCT02123862|Circulating Tumor Cells|circulating tumor cells
343848|NCT02123810|fatigue|fatigue
343849|NCT02123810|motor skills|motor skills
343850|NCT02123810|cardiopulmonary resuscitation|cardiopulmonary resuscitation
343851|NCT02123784|Rotator Cuff Tear|rotator cuff tear
343852|NCT02123784|Rotator Cuff Repair|rotator cuff repair
343853|NCT02123784|Biomarker|biomarker
343854|NCT02123784|Predictive factors|predictive factors
343855|NCT02123784|Skeletal Muscle|skeletal muscle
343856|NCT02123784|Tendon|tendon
343857|NCT02123784|Subacromial Bursa|subacromial bursa
343858|NCT02123771|Focus of Study : HELICOBACTER PYLORI INFECTIONS|focus of study : helicobacter pylori infections
343859|NCT02123758|Prostatic Neoplasms|prostatic neoplasms
400535|NCT01866397|cvvh|cvvh
343860|NCT02123758|Metastatic Castration-Resistant Prostate Cancer (mCRPC)|metastatic castration-resistant prostate cancer (mcrpc)
343861|NCT02123758|Prostate cancer|prostate cancer
343862|NCT02123758|Abiraterone Acetate (ZYTIGA)|abiraterone acetate (zytiga)
343863|NCT02123758|Prednisone|prednisone
343864|NCT02123758|JNJ-56021927|jnj-56021927
343865|NCT02123745|infiltration|infiltration
343866|NCT02123745|extravasation|extravasation
343867|NCT02123745|peripheral intravenous therapy|peripheral intravenous therapy
343868|NCT02123732|Diabetes|diabetes
343869|NCT02123732|Diabetes Mellitus|diabetes mellitus
343871|NCT02123732|food supplement|food supplement
343872|NCT02123693|Osteopathic manipulative treatment|osteopathic manipulative treatment
343873|NCT02123693|Low back pain|low back pain
343874|NCT02123693|Dynamic MRI|dynamic mri
343875|NCT02123680|expectation|expectation
343876|NCT02123680|chronic illness|chronic illness
343877|NCT02123680|trajectory|trajectory
343878|NCT02123628|diabetic foot osteomyelitis, antibiotic treatment duration|diabetic foot osteomyelitis, antibiotic treatment duration
343879|NCT02123615|Primary Immunodeficiency|primary immunodeficiency
343880|NCT02123615|Subdermal bloodless space|subdermal bloodless space
343881|NCT02123615|Subdermal injection|subdermal injection
343882|NCT02123615|Subcutaneous injection|subcutaneous injection
343883|NCT02123615|Injectable electromyography needle|injectable electromyography needle
343884|NCT02123615|Electrical stimulation|electrical stimulation
343885|NCT02123615|MRI with Gadolinium|mri with gadolinium
343886|NCT02123602|patellofemoral pain syndrome|patellofemoral pain syndrome
343887|NCT02123602|abdominal muscles|abdominal muscles
343888|NCT02123576|Hepatorenal syndrome|hepatorenal syndrome
343889|NCT02123576|Renal failure|renal failure
343890|NCT02123576|Pentoxyfylline|pentoxyfylline
343891|NCT02123576|Liver transplantation|liver transplantation
343892|NCT02123576|Cirrhosis|cirrhosis
343893|NCT02123550|deep|deep
343894|NCT02123550|venous|venous
343895|NCT02123550|thrombosis|thrombosis
343896|NCT02123550|Doppler|doppler
343897|NCT02123550|ultrasound|ultrasound
343898|NCT02123550|plastic|plastic
343899|NCT02123550|surgery|surgery
343900|NCT02123550|thromboembolism|thromboembolism
343901|NCT02123550|prevention|prevention
343902|NCT02123537|Bioness L300 Foot Drop System|bioness l300 foot drop system
343903|NCT02123537|Functional electrical stimulation|functional electrical stimulation
343904|NCT02123524|Superficial Vein Thrombosis|superficial vein thrombosis
343905|NCT02123498|ear pressure|ear pressure
343906|NCT02123498|ear fullness|ear fullness
343907|NCT02123498|ear pain|ear pain
343908|NCT02123498|ETD|etd
343909|NCT02123498|laryngopharyngeal reflux|laryngopharyngeal reflux
343910|NCT02123498|LPR|lpr
343911|NCT02123498|gastroesophageal reflux disease|gastroesophageal reflux disease
343912|NCT02123498|GERD|gerd
343913|NCT02123498|nasopharyngeal reflux|nasopharyngeal reflux
343914|NCT02123498|acid reflux|acid reflux
343915|NCT02123485|Depression,|depression,
343916|NCT02123485|ECT,|ect,
343917|NCT02123485|rTMS,|rtms,
343918|NCT02123485|Right prefrontal,|right prefrontal,
343919|NCT02123485|antidepressive efficacy|antidepressive efficacy
343920|NCT02123485|Inflammation markers|inflammation markers
343921|NCT02123433|HIV|hiv
343922|NCT02123433|Streptococcus pneumoniae|streptococcus pneumoniae
343923|NCT02123433|13-valent conjugate pneumococcal vaccine|13-valent conjugate pneumococcal vaccine
343924|NCT02123433|Vaccine|vaccine
343925|NCT02123433|Immunological Response|immunological response
343926|NCT02123433|Pneumococcal Carriage|pneumococcal carriage
343927|NCT02123420|Platform Switching vs Regular Platform|platform switching vs regular platform
343928|NCT02123407|Advanced Gastric Cancer|advanced gastric cancer
343929|NCT02123407|Carbon Nanoparticles|carbon nanoparticles
343930|NCT02123407|Lymph Nodes|lymph nodes
343931|NCT02123394|Low Back Pain|low back pain
343932|NCT02123394|Mechanical Low Back Pain|mechanical low back pain
343933|NCT02123394|Low Back Ache|low back ache
343934|NCT02123394|Low Backache|low backache
343935|NCT02123394|Lower Back Pain|lower back pain
343936|NCT02123394|Lumbago|lumbago
343937|NCT02123381|tumor tissue and serum biomarkers|tumor tissue and serum biomarkers
343938|NCT02123381|cetuximab|cetuximab
343939|NCT02123381|preoperative radiotherapy|preoperative radiotherapy
343940|NCT02123381|esophageal squamous cell carcinoma|esophageal squamous cell carcinoma
343941|NCT02123368|Osteoarthritis|osteoarthritis
343942|NCT02123368|Mesenchimal stem cell|mesenchimal stem cell
343943|NCT02123368|Knee|knee
343944|NCT02123342|health|health
343945|NCT02123342|older adults|older adults
343946|NCT02123342|mobile phone|mobile phone
343947|NCT02123329|Qatar|qatar
343948|NCT02123329|Pharmacy|pharmacy
343949|NCT02123329|Pharmacist|pharmacist
343950|NCT02123329|Smoking cessation|smoking cessation
343951|NCT02123316|local allergic rhinitis|local allergic rhinitis
343952|NCT02123316|subcutaneous immunotherapy|subcutaneous immunotherapy
343953|NCT02123316|house dust mite allergy|house dust mite allergy
343954|NCT02123316|Dermatophagoides pteronyssinus allergy|dermatophagoides pteronyssinus allergy
343955|NCT02123303|Hypotension, Orthostatic Hypotension|hypotension, orthostatic hypotension
343956|NCT02123290|Plasmodium|plasmodium
343957|NCT02123290|falciparum|falciparum
343958|NCT02123290|malaria|malaria
343959|NCT02123290|vivax|vivax
343960|NCT02123290|DSM265|dsm265
343961|NCT02123290|pharmacokinetics|pharmacokinetics
343962|NCT02123290|adult|adult
343963|NCT02123251|Incentives,|incentives,
343964|NCT02123251|Diabetes,|diabetes,
343965|NCT02123251|Medicaid,|medicaid,
343966|NCT02123251|Health behavior,|health behavior,
343967|NCT02123251|Cost effectiveness|cost effectiveness
343968|NCT02123225|STOP-BANG|stop-bang
344066|NCT02122913|TRKA|trka
343969|NCT02123225|Obstructive sleep apnea (OSA)|obstructive sleep apnea (osa)
343970|NCT02123225|total knee arthroplasty (TKA)|total knee arthroplasty (tka)
343971|NCT02123225|portable monitoring|portable monitoring
343972|NCT02123225|sleep medicine|sleep medicine
343973|NCT02123225|unattended sleep study|unattended sleep study
343974|NCT02123225|postoperative sleep study|postoperative sleep study
343975|NCT02123212|Hepatitis C|hepatitis c
343976|NCT02123212|Chronic Hepatitis C|chronic hepatitis c
343977|NCT02123212|Screening|screening
343978|NCT02123199|COPD|copd
343979|NCT02123186|Newborn Screening , spinal muscular atrophy|newborn screening , spinal muscular atrophy
343980|NCT02123173|one lung ventilation,|one lung ventilation,
343981|NCT02123173|cardiac output|cardiac output
343982|NCT02123173|fluid responsiveness|fluid responsiveness
343983|NCT02123160|Depression|depression
343984|NCT02123160|Dyadic therapy|dyadic therapy
343985|NCT02123160|Behavioral Problems|behavioral problems
343986|NCT02123160|Child parent therapy|child parent therapy
343987|NCT02123160|Affect regulation|affect regulation
343988|NCT02123160|Immune markers|immune markers
343989|NCT02123160|Cortisol|cortisol
343990|NCT02123121|Aging|aging
343991|NCT02123121|Biogenesis|biogenesis
343992|NCT02123121|Cell Respiration|cell respiration
343993|NCT02123121|Elderly|elderly
343994|NCT02123121|Enzymes|enzymes
343995|NCT02123121|Mitochondria|mitochondria
343996|NCT02123121|Mitochondrial DNA|mitochondrial dna
343997|NCT02123121|Muscle Fatigue|muscle fatigue
343998|NCT02123121|Physical Function|physical function
343999|NCT02123121|Resveratrol|resveratrol
344000|NCT02123108|Simulect, Myfortic, OLT, Renal Dysfunction, Liver Transplant, Orthotopic Liver Transplantation|simulect, myfortic, olt, renal dysfunction, liver transplant, orthotopic liver transplantation
344001|NCT02123082|Urolithiasis|urolithiasis
344002|NCT02123082|Kidney stones|kidney stones
344003|NCT02123082|Ureteral Obstruction|ureteral obstruction
344004|NCT02123082|Ureteroscopes|ureteroscopes
344005|NCT02123082|Ureteroscopies|ureteroscopies
344006|NCT02123069|Autonomic nervous system|autonomic nervous system
344007|NCT02123069|Blood pressure|blood pressure
344008|NCT02123069|Blood vessels|blood vessels
344009|NCT02123069|Physiological effects of drugs|physiological effects of drugs
344010|NCT02123069|Vascular stiffness|vascular stiffness
344011|NCT02123056|reflex fainting|reflex fainting
344012|NCT02123056|vasovagal syncope|vasovagal syncope
344013|NCT02123056|metoprolol|metoprolol
344014|NCT02123056|randomized clinical trial|randomized clinical trial
344015|NCT02123056|quality of life|quality of life
344016|NCT02123043|rehabilitation|rehabilitation
344017|NCT02123043|wheelchair|wheelchair
344018|NCT02123043|older adults|older adults
344019|NCT02123043|manual wheelchair|manual wheelchair
344020|NCT02123043|motor learning|motor learning
344021|NCT02123043|biomechanics|biomechanics
344022|NCT02123043|gross mechanical efficiency|gross mechanical efficiency
344023|NCT02123030|Lung cancer|lung cancer
344024|NCT02123030|pulmonary disease|pulmonary disease
344025|NCT02123017|Bowel Evacuation|bowel evacuation
344026|NCT02123017|Colonoscopy Preparation|colonoscopy preparation
344027|NCT02123004|ST-Segment Elevation Myocardial Infarction|st-segment elevation myocardial infarction
344028|NCT02123004|Percutaneous Coronary Intervention|percutaneous coronary intervention
344029|NCT02122991|spinal cord injury|spinal cord injury
344030|NCT02122991|autonomic dysreflexia|autonomic dysreflexia
344031|NCT02122991|baroreceptor integrity|baroreceptor integrity
344032|NCT02122991|sympathetic integrity|sympathetic integrity
344033|NCT02122991|vagal integrity|vagal integrity
344034|NCT02122991|autonomic integrity|autonomic integrity
344035|NCT02122991|arterial stiffness|arterial stiffness
344036|NCT02122991|cognitive function|cognitive function
344037|NCT02122991|traumatic brain injury|traumatic brain injury
344038|NCT02122991|cerebral blood flow|cerebral blood flow
344039|NCT02122978|psoriasis|psoriasis
344040|NCT02122978|dermatology|dermatology
344041|NCT02122978|mindfulness|mindfulness
344042|NCT02122978|self-compassion|self-compassion
344043|NCT02122952|Gene Transfer|gene transfer
344044|NCT02122952|Gene Therapy|gene therapy
344045|NCT02122952|Adeno-associated virus|adeno-associated virus
344046|NCT02122952|Survival Motor Neuron|survival motor neuron
344047|NCT02122952|SMN|smn
344048|NCT02122952|AAV9|aav9
344049|NCT02122926|Transitions in care|transitions in care
344050|NCT02122926|discharge intervention|discharge intervention
344051|NCT02122926|RCT|rct
344052|NCT02122926|readmission rates|readmission rates
344053|NCT02122926|medication adherence|medication adherence
344054|NCT02122926|glycemic control|glycemic control
344055|NCT02122926|ED visits|ed visits
344056|NCT02122926|medication reconciliation|medication reconciliation
344057|NCT02122926|Coleman Transitions Coach|coleman transitions coach
344058|NCT02122926|telemonitoring; hypoglycemic events|telemonitoring; hypoglycemic events
344059|NCT02122913|Advanced solid tumors|advanced solid tumors
344060|NCT02122913|Neurotrophic tyrosine receptor kinase (NTRK)|neurotrophic tyrosine receptor kinase (ntrk)
344061|NCT02122913|NTRK1|ntrk1
344062|NCT02122913|NTRK2|ntrk2
344063|NCT02122913|NTRK3|ntrk3
344064|NCT02122913|Fusion Positive|fusion positive
344065|NCT02122913|TRK fusion|trk fusion
344067|NCT02122913|TRKB|trkb
344068|NCT02122913|TRKC|trkc
344069|NCT02122913|ETV6|etv6
344070|NCT02122887|jewish, arab, israel, teenagers|jewish, arab, israel, teenagers
344071|NCT02122874|Percutaneous neurostimulation; dermatome T7, type 2 diabetes|percutaneous neurostimulation; dermatome t7, type 2 diabetes
344072|NCT02122861|Melanoma|melanoma
344073|NCT02122848|Heart failure|heart failure
344074|NCT02122848|Exercise tolerance|exercise tolerance
344075|NCT02122848|Noninvasive ventilation|noninvasive ventilation
344076|NCT02122835|exercise|exercise
344077|NCT02122835|aerobic exercise|aerobic exercise
344078|NCT02122822|supratentoria glioma|supratentoria glioma
344079|NCT02122809|Chiauranib, advanced solid tumors, phase 1 study|chiauranib, advanced solid tumors, phase 1 study
344080|NCT02122796|Breast Cancer|breast cancer
344081|NCT02122796|Mastectomy|mastectomy
344082|NCT02122796|Acupuncture|acupuncture
344083|NCT02122770|Drug Therapy|drug therapy
344084|NCT02122731|antihypertensive therapy|antihypertensive therapy
344085|NCT02122731|amiloride|amiloride
344086|NCT02122731|add-on|add-on
344087|NCT02122731|resistant hypertension|resistant hypertension
344088|NCT02122731|blood pressure control|blood pressure control
344089|NCT02122731|type 2 diabetes mellitus,|type 2 diabetes mellitus,
344090|NCT02122731|microalbuminuria.|microalbuminuria.
344091|NCT02122705|Remifentanil|remifentanil
344092|NCT02122705|Labour analgesia|labour analgesia
344093|NCT02122666|Metabolic Syndrome|metabolic syndrome
344094|NCT02122666|Pre-diabetes|pre-diabetes
344095|NCT02122666|impaired glucose tolerance|impaired glucose tolerance
344096|NCT02122666|Phospholipids|phospholipids
344097|NCT02122653|Fatigue|fatigue
344098|NCT02122653|aging|aging
344099|NCT02122653|transcranial magnetic stimulation|transcranial magnetic stimulation
344100|NCT02122653|interpolated|interpolated
344101|NCT02122653|twitch technique|twitch technique
344102|NCT02122627|Vitamin D, COPD, immunomodulation, pulmonary function|vitamin d, copd, immunomodulation, pulmonary function
344103|NCT02122614|Chronic obstructive pulmonary disease|chronic obstructive pulmonary disease
344104|NCT02122614|COPD|copd
344105|NCT02122614|Pulmonary rehabilitation|pulmonary rehabilitation
344106|NCT02122614|Physical activity|physical activity
344107|NCT02122614|Exercise|exercise
344108|NCT02122588|serous and endometrioid ovarian, peritoneal, fallopian tube cancer, hereditary ovarian cancer, BRCA (breast cancer gene) mutation, genetic testing|serous and endometrioid ovarian, peritoneal, fallopian tube cancer, hereditary ovarian cancer, brca (breast cancer gene) mutation, genetic testing
344109|NCT02122575|Inflammasome|inflammasome
344110|NCT02122575|Fasting|fasting
344111|NCT02122575|Sirt3|sirt3
344112|NCT02122562|Ketamine|ketamine
344113|NCT02122562|Major Depression|major depression
344114|NCT02122562|Alcohol|alcohol
344115|NCT02122562|Alcohol Clamp|alcohol clamp
344116|NCT02122562|NMDA Antagonist|nmda antagonist
344117|NCT02122549|In-Hospital Cardiac Arrest|in-hospital cardiac arrest
344118|NCT02122549|Telemetry|telemetry
344119|NCT02122523|Image guided surgery|image guided surgery
344120|NCT02122510|Analgesia, casarean section, TAP block|analgesia, casarean section, tap block
344121|NCT02122497|abdominal aortic aneurysm|abdominal aortic aneurysm
344122|NCT02122497|aortic occlusive disease|aortic occlusive disease
344123|NCT02122497|cardiovascular biomarkers|cardiovascular biomarkers
344124|NCT02122497|open surgical repair|open surgical repair
344125|NCT02122497|endovascular aortic repair|endovascular aortic repair
344126|NCT02122484|reperfusion damage|reperfusion damage
344127|NCT02122471|CIC|cic
344128|NCT02122471|Constipation|constipation
344129|NCT02122471|Chronic Constipation|chronic constipation
344130|NCT02122471|Synergy|synergy
344131|NCT02122471|Plecanatide|plecanatide
344132|NCT02122458|hearing impairment|hearing impairment
344133|NCT02122458|post-traumatic stress disorder|post-traumatic stress disorder
344134|NCT02122458|traumatic brain injury|traumatic brain injury
344135|NCT02122458|auditory processing disorder|auditory processing disorder
344136|NCT02122445|Gluteus Maximum|gluteus maximum
344137|NCT02122445|Gluteus Medius|gluteus medius
344138|NCT02122445|TFL|tfl
344139|NCT02122445|EMG|emg
344140|NCT02122445|Flexion-Response Phenomenon|flexion-response phenomenon
344141|NCT02122445|Thera-Band|thera-band
344142|NCT02122445|kinesiology tape|kinesiology tape
344143|NCT02122432|teledermatology|teledermatology
344144|NCT02122432|dermatology|dermatology
344145|NCT02122432|general practice|general practice
344146|NCT02122432|organization of care|organization of care
344147|NCT02122406|Rheumatoid Arthritis|rheumatoid arthritis
344148|NCT02122406|Depression|depression
344149|NCT02122406|Anxiety|anxiety
344150|NCT02122406|DAS28|das28
344151|NCT02122406|HADS|hads
344152|NCT02122380|Growth Hormone|growth hormone
344153|NCT02122380|Dipeptidyl Peptidase 4|dipeptidyl peptidase 4
344154|NCT02122380|Polycystic Ovary Syndrome|polycystic ovary syndrome
344155|NCT02122328|Twin twin transfusion syndrome|twin twin transfusion syndrome
344156|NCT02122328|Sequential laser photocoagulation of communicating vessels|sequential laser photocoagulation of communicating vessels
344157|NCT02122302|Altered gastrointestinal anatomy|altered gastrointestinal anatomy
344158|NCT02122302|Chronic pancreatic disease|chronic pancreatic disease
344159|NCT02122302|Chronic pancreatic pain|chronic pancreatic pain
344160|NCT02122302|Patient self-assessment|patient self-assessment
344161|NCT02122302|Online assessment|online assessment
344162|NCT02122289|Exacerbation, QoL|exacerbation, qol
344163|NCT02122276|Spinal cord injury|spinal cord injury
344164|NCT02122276|Passive motion|passive motion
344165|NCT02122276|Fatigue index|fatigue index
344166|NCT02122276|Hypertonia|hypertonia
344167|NCT02122250|Diabetes|diabetes
344168|NCT02122250|Health literacy|health literacy
344169|NCT02122250|web intervention|web intervention
344170|NCT02122224|satiety|satiety
344171|NCT02122224|satiation|satiation
344172|NCT02122224|diet quality|diet quality
344173|NCT02122224|memory|memory
344174|NCT02122224|obesity|obesity
344175|NCT02122224|protein|protein
344176|NCT02122224|fiber|fiber
344177|NCT02122211|Sperm motility|sperm motility
344178|NCT02122198|Cognitive impairment|cognitive impairment
344179|NCT02122198|Executive function|executive function
344180|NCT02122198|Arterial stiffness|arterial stiffness
344181|NCT02122198|Endothelial function|endothelial function
344182|NCT02122198|Menopause|menopause
344183|NCT02122198|Women's health|women's health
344184|NCT02122198|Hormone therapy|hormone therapy
344185|NCT02122198|functional MRI|functional mri
344186|NCT02122159|safety|safety
344187|NCT02122159|tolerability|tolerability
344188|NCT02122159|RPE cellular therapy|rpe cellular therapy
344189|NCT02122159|MMD|mmd
344190|NCT02122146|ADC|adc
344191|NCT02122146|PF-06664178|pf-06664178
344192|NCT02122146|solid tumors|solid tumors
344193|NCT02122146|tumors|tumors
344194|NCT02122146|neoplasm metastasis|neoplasm metastasis
344195|NCT02122146|NSCLC|nsclc
344196|NCT02122146|non small cell lung cancer|non small cell lung cancer
344197|NCT02122146|OVCA|ovca
344198|NCT02122146|ovarian cancer|ovarian cancer
344199|NCT02122146|Phase 1|phase 1
344200|NCT02122146|breast cancer|breast cancer
344201|NCT02122133|IC aneurysms, coil embolization, PC 400, radiation exposure,|ic aneurysms, coil embolization, pc 400, radiation exposure,
344202|NCT02122120|enteral nutrition, tube feeding, nutritional support|enteral nutrition, tube feeding, nutritional support
344203|NCT02122107|Treatment Exposure|treatment exposure
344204|NCT02122107|Smoking History|smoking history
344205|NCT02122107|14-071|14-071
344206|NCT02122068|Meditation|meditation
344207|NCT02122068|Mindfulness|mindfulness
344208|NCT02122068|Caregiver|caregiver
344209|NCT02122068|Dementia|dementia
344210|NCT02122068|Depression|depression
344211|NCT02122055|combined sedation|combined sedation
344212|NCT02122029|Lifestyle intervention|lifestyle intervention
344213|NCT02122029|Bariatric surgery|bariatric surgery
344214|NCT02122029|Weight management|weight management
344215|NCT02122029|Physical activity|physical activity
344216|NCT02122016|Ventilator weaning|ventilator weaning
344217|NCT02122016|Protocols|protocols
344218|NCT02122016|Computer driven weaning|computer driven weaning
344219|NCT02122016|Decision Making, Computer-Assisted|decision making, computer-assisted
344220|NCT02122016|Therapy, Computer-Assisted|therapy, computer-assisted
344221|NCT02122016|Respiration, Artificial|respiration, artificial
344222|NCT02122003|sorafenib|sorafenib
344223|NCT02122003|pazopanib|pazopanib
344224|NCT02122003|cross-resistance|cross-resistance
344225|NCT02122003|TKI|tki
344226|NCT02122003|mRCC|mrcc
344227|NCT02121990|(IP) Cisplatin|(ip) cisplatin
344228|NCT02121990|IV/IP Paclitaxel|iv/ip paclitaxel
344229|NCT02121990|IV Bevacizumab|iv bevacizumab
344230|NCT02121990|Oral Olaparib (AZD2281)|oral olaparib (azd2281)
344231|NCT02121990|Optimally Debulked|optimally debulked
344232|NCT02121990|Stage II/III|stage ii/iii
344233|NCT02121990|Ovary|ovary
344234|NCT02121990|Pertoneum|pertoneum
344235|NCT02121990|10-220|10-220
344236|NCT02121964|unilateral primary total hip arthroplasty|unilateral primary total hip arthroplasty
344237|NCT02121964|bilateral primary total hip arthroplasty|bilateral primary total hip arthroplasty
344238|NCT02121964|Arthritis|arthritis
344239|NCT02121964|Orthopedic Disorders|orthopedic disorders
344240|NCT02121964|Orthopedics|orthopedics
344241|NCT02121964|Surgery,|surgery,
344242|NCT02121964|Orthopedic|orthopedic
344243|NCT02121964|arthroplasty|arthroplasty
344244|NCT02121964|hip|hip
344245|NCT02121964|osteoarthritis|osteoarthritis
440137|NCT01688336|5FU|5fu
344246|NCT02121964|capsulectomy|capsulectomy
344247|NCT02121964|capsulotomy|capsulotomy
344248|NCT02121951|Percutaneous Nephrostomy|percutaneous nephrostomy
344249|NCT02121951|Quadtatus Lumborum Block|quadtatus lumborum block
344250|NCT02121951|Cancer|cancer
344251|NCT02121951|Monitored Anaesthesia Care|monitored anaesthesia care
344252|NCT02121938|Very Low Birth Weight (VLBW)|very low birth weight (vlbw)
344253|NCT02121938|Microbiome|microbiome
344254|NCT02121925|Registry|registry
344255|NCT02121899|Registry|registry
344256|NCT02121873|breast cancer, nipple aspirate, ductal lavage, hyperplasia|breast cancer, nipple aspirate, ductal lavage, hyperplasia
344257|NCT02121860|Hepatic Impairment|hepatic impairment
344258|NCT02121860|Pharmacokinetics|pharmacokinetics
344259|NCT02121860|Pharmacodynamics|pharmacodynamics
344260|NCT02121808|Morbid Obesity|morbid obesity
344261|NCT02121808|Bariatric Surgery Candidate|bariatric surgery candidate
344262|NCT02121808|Pre-Oxygenation|pre-oxygenation
344263|NCT02121808|Functional Residual Capacity|functional residual capacity
344264|NCT02121795|HIV|hiv
344265|NCT02121795|HIV-1 Positive|hiv-1 positive
344266|NCT02121795|Virologically-suppressed|virologically-suppressed
344267|NCT02121782|QIV|qiv
344268|NCT02121782|Quadrivalent Influenza Vaccine|quadrivalent influenza vaccine
344269|NCT02121782|Influenza vaccine|influenza vaccine
344270|NCT02121782|Vaccination|vaccination
344271|NCT02121769|cholestasis|cholestasis
344272|NCT02121769|short bowel syndrome|short bowel syndrome
344273|NCT02121756|Dipyridamole|dipyridamole
344274|NCT02121756|HIV|hiv
344275|NCT02121756|Immune Markers|immune markers
344276|NCT02121756|Immune Activation|immune activation
344277|NCT02121756|Inflammation|inflammation
344278|NCT02121743|strattice|strattice
344279|NCT02121743|colostomy|colostomy
344280|NCT02121743|parastomal hernia|parastomal hernia
344281|NCT02121730|grafting kidney|grafting kidney
344282|NCT02121730|Cancer|cancer
344283|NCT02121717|Chiglitazar,diabetes,type 2 diabetes|chiglitazar,diabetes,type 2 diabetes
344284|NCT02121704|Sedation|sedation
344285|NCT02121704|Colonoscopy|colonoscopy
344286|NCT02121704|Propofol|propofol
344287|NCT02121704|Scope guide|scope guide
344288|NCT02121691|Cancer|cancer
344289|NCT02121691|Obesity|obesity
344290|NCT02121691|Body Mass Index|body mass index
344291|NCT02121678|Resistance training|resistance training
344292|NCT02121678|Aerobic exercise|aerobic exercise
344293|NCT02121678|Isokinetic muscle strength|isokinetic muscle strength
344294|NCT02121678|Bicycle ergometry test|bicycle ergometry test
344295|NCT02121678|Subcutaneous immunoglobulin|subcutaneous immunoglobulin
344296|NCT02121652|lung cancer survivors|lung cancer survivors
344297|NCT02121652|insomnia treatment|insomnia treatment
344298|NCT02121652|cognitive behavioral therapy|cognitive behavioral therapy
344299|NCT02121639|Metastatic Castration Resistant Prostate Cancer|metastatic castration resistant prostate cancer
344300|NCT02121639|AZD5363|azd5363
344301|NCT02121639|Docetaxel|docetaxel
344302|NCT02121639|Prednisolone|prednisolone
344303|NCT02121626|Cancer|cancer
344304|NCT02121626|Chemotheraphy|chemotheraphy
344305|NCT02121626|Small Bowel Bacterial Overgrowth|small bowel bacterial overgrowth
344306|NCT02121626|Bile Acid Malabsorption|bile acid malabsorption
344307|NCT02121626|Pancreatic Insufficiency|pancreatic insufficiency
344308|NCT02121626|Carbohydrate Malabsorption|carbohydrate malabsorption
344309|NCT02121626|Anorexia|anorexia
344310|NCT02121626|Borborygmi|borborygmi
344311|NCT02121626|Bloating|bloating
344312|NCT02121626|Constipation|constipation
344313|NCT02121626|Diarrhoea|diarrhoea
344314|NCT02121626|Mucositis|mucositis
344315|NCT02121626|Dysphagia|dysphagia
344316|NCT02121626|Early satiety|early satiety
344317|NCT02121626|Frequency of defaecation|frequency of defaecation
344318|NCT02121626|Incontinence|incontinence
344319|NCT02121626|Mucus discharge|mucus discharge
344320|NCT02121626|Nausea|nausea
344321|NCT02121626|Nocturnal defaecation|nocturnal defaecation
344322|NCT02121626|Pain|pain
344323|NCT02121626|Reflux|reflux
344324|NCT02121626|Regurgitation|regurgitation
344325|NCT02121626|Steatorrhoea|steatorrhoea
344326|NCT02121626|Tenesmus|tenesmus
344327|NCT02121626|Urgency of defaecation|urgency of defaecation
344328|NCT02121626|Vomiting|vomiting
344329|NCT02121626|Weight loss|weight loss
344330|NCT02121626|Wind.|wind.
344331|NCT02121600|Fluorocholine (FCH)|fluorocholine (fch)
344332|NCT02121600|Positron Emission Tomography (PET)|positron emission tomography (pet)
344333|NCT02121600|Magnetic Resonance Imaging (MRI)|magnetic resonance imaging (mri)
344334|NCT02121587|Musculoskeletal Pain, Osteopathy, Mindfulness|musculoskeletal pain, osteopathy, mindfulness
344335|NCT02121574|Surgery|surgery
344336|NCT02121574|thermometers|thermometers
344337|NCT02121574|Hypothermia|hypothermia
344338|NCT02121574|anesthesia|anesthesia
344339|NCT02121574|temperature|temperature
344340|NCT02121561|Shame|shame
344341|NCT02121548|Screen|screen
344342|NCT02121548|cervical, cancer|cervical, cancer
344343|NCT02121548|HPV|hpv
344344|NCT02121548|women|women
344345|NCT02121548|community health workers|community health workers
344346|NCT02121548|Hispanic/ Latinas|hispanic/ latinas
344347|NCT02121548|Haitian|haitian
344348|NCT02121496|Depression|depression
344349|NCT02121496|Development|development
344350|NCT02121496|Infant sleep|infant sleep
344351|NCT02121470|AKI|aki
344352|NCT02121470|Acute Kidney Injury|acute kidney injury
344353|NCT02121470|Renal failure|renal failure
344354|NCT02121470|NGAL|ngal
344355|NCT02121470|neutrophil gelatinase-associated lipocalin|neutrophil gelatinase-associated lipocalin
344356|NCT02121470|lipocalin-2|lipocalin-2
344357|NCT02121470|siderocalin|siderocalin
344358|NCT02121470|Intensive care|intensive care
344359|NCT02121470|ICU|icu
344360|NCT02121470|Critical care|critical care
344361|NCT02121457|cognitive performance|cognitive performance
344362|NCT02121457|selenium|selenium
344363|NCT02121457|brazil nuts|brazil nuts
344364|NCT02121457|oxidative stress|oxidative stress
344365|NCT02121444|RRMS|rrms
344366|NCT02121444|CIS|cis
344367|NCT02121366|Endoscopic Ultrasound-Guided Fine Needle Aspiration|endoscopic ultrasound-guided fine needle aspiration
344368|NCT02121366|Insulinoma|insulinoma
344369|NCT02121366|Ethanol|ethanol
344370|NCT02121366|Ablation Techniques|ablation techniques
344371|NCT02121353|Age related macular degeneration|age related macular degeneration
344373|NCT02121353|Wet AMD|wet amd
344374|NCT02121353|Eye conditions|eye conditions
344375|NCT02121353|CFT|cft
344376|NCT02121353|OCT|oct
344377|NCT02121353|CNV|cnv
344378|NCT02121353|FA|fa
344379|NCT02121353|Ocular|ocular
344380|NCT02121353|Eye|eye
344381|NCT02121353|Disorder of the eye|disorder of the eye
344382|NCT02121340|Depression|depression
344383|NCT02121340|Health disparities|health disparities
344384|NCT02121340|African American|african american
344385|NCT02121340|Geriatric|geriatric
344386|NCT02121327|stroke, disease management programs, self-management|stroke, disease management programs, self-management
344387|NCT02121314|TB|tb
344388|NCT02121314|bioavailability|bioavailability
344389|NCT02121314|HRZE|hrze
344390|NCT02121314|fasting|fasting
344391|NCT02121314|fed|fed
344392|NCT02121301|Dry Eye|dry eye
344393|NCT02121301|Dry Eye Syndrome|dry eye syndrome
344394|NCT02121301|SkQ1|skq1
344395|NCT02121301|KCS|kcs
344396|NCT02121301|Keratoconjunctivitis|keratoconjunctivitis
344397|NCT02121288|Peripheral Artery Disease|peripheral artery disease
344398|NCT02121288|Myocardial Blood Flow|myocardial blood flow
344399|NCT02121288|Cardiac Blood Flow|cardiac blood flow
344400|NCT02121236|CBCT|cbct
344401|NCT02121236|Ultrasonic diagnosis|ultrasonic diagnosis
344402|NCT02121236|Benign radiolucent lesions|benign radiolucent lesions
344403|NCT02121236|Histopathology|histopathology
344404|NCT02121223|acute ST segment elevated myocardial infarction|acute st segment elevated myocardial infarction
344405|NCT02121223|primary percutaneous intervention|primary percutaneous intervention
344406|NCT02121223|Stent Incomplete Apposition|stent incomplete apposition
344407|NCT02121197|Macular Diabetic Edema|macular diabetic edema
344408|NCT02121197|Ozurdex|ozurdex
344409|NCT02121197|Retrospective|retrospective
344410|NCT02121197|European|european
344411|NCT02121197|Intra-vitreal injections|intra-vitreal injections
344412|NCT02121184|Oxytocin|oxytocin
344413|NCT02121184|Labor, Obstetric|labor, obstetric
344414|NCT02121184|Non-reassuring fetal heart rate|non-reassuring fetal heart rate
344415|NCT02121184|Epidural|epidural
344416|NCT02121158|CSP 592|csp 592
344417|NCT02121158|ICD|icd
344418|NCT02121158|cardiovascular|cardiovascular
344419|NCT02121158|heart|heart
344420|NCT02121158|aging|aging
344421|NCT02121158|chronic diseases|chronic diseases
344422|NCT02121158|multi-site trial|multi-site trial
344423|NCT02121158|investigational device|investigational device
344424|NCT02121158|cardiomyopathy|cardiomyopathy
344425|NCT02121158|coronary artery disease|coronary artery disease
344426|NCT02121158|congestive heart failure|congestive heart failure
344427|NCT02121158|myocardial infarction|myocardial infarction
344428|NCT02121158|I-70|i-70
344429|NCT02121158|I70|i70
344430|NCT02121158|elderly|elderly
344431|NCT02121158|defibrillator|defibrillator
344432|NCT02121145|Vivotif|vivotif
344433|NCT02121145|Typherix|typherix
344434|NCT02121145|Salmonella Typhi|salmonella typhi
344435|NCT02121145|non-typhoid Salmonella|non-typhoid salmonella
344436|NCT02121145|Salmonella Paratyphi|salmonella paratyphi
344437|NCT02121145|enzyme-linked immunospot assay|enzyme-linked immunospot assay
344438|NCT02121145|Plasmablast|plasmablast
344439|NCT02121132|Overweight|overweight
344440|NCT02121132|Obesity|obesity
344441|NCT02121119|Peripheral nerve block|peripheral nerve block
344442|NCT02121119|Lidocaine|lidocaine
344443|NCT02121119|Bupivacaine|bupivacaine
344444|NCT02121093|vibration|vibration
344445|NCT02121093|physiotherapy|physiotherapy
344446|NCT02121093|cortex|cortex
344447|NCT02121093|muscles|muscles
344448|NCT02121067|postpartum|postpartum
344449|NCT02121067|contraception|contraception
344450|NCT02121067|intrauterine device|intrauterine device
440381|NCT01687179|LAM|lam
344451|NCT02121067|intrauterine system|intrauterine system
344452|NCT02121067|mirena|mirena
344453|NCT02121067|uterine involution|uterine involution
344454|NCT02121054|Antiplatelet Agents|antiplatelet agents
344455|NCT02121054|Drug Resistance|drug resistance
344456|NCT02121041|Hypertension|hypertension
344457|NCT02121041|Blood Pressure|blood pressure
344458|NCT02121041|Ambulatory Blood Pressure Monitoring|ambulatory blood pressure monitoring
344459|NCT02121028|Intracranial Atherosclerotic Disease|intracranial atherosclerotic disease
344460|NCT02121028|Stroke|stroke
344461|NCT02121028|Transient Ischemic Attack|transient ischemic attack
344462|NCT02121028|Imaging|imaging
344463|NCT02121015|Postpartum Depression|postpartum depression
344464|NCT02121015|Depression Prevention|depression prevention
344465|NCT02121015|Supportive Accountability|supportive accountability
344466|NCT02121015|Individual Internet Interventions (IIIs)|individual internet interventions (iiis)
344467|NCT02121015|Internet Support Groups (ISGs)|internet support groups (isgs)
344468|NCT02121002|Knee|knee
344469|NCT02120989|insomnia|insomnia
344470|NCT02120989|cognitive behavioral therapy for insomnia (CBT-I)|cognitive behavioral therapy for insomnia (cbt-i)
344471|NCT02120989|partner-assisted|partner-assisted
344472|NCT02120976|Safety|safety
344473|NCT02120976|Tolerability|tolerability
344474|NCT02120976|Pharmacokinetics|pharmacokinetics
344475|NCT02120976|Food-effect|food-effect
344476|NCT02120976|Diabetes|diabetes
344477|NCT02120963|Fatigue|fatigue
344478|NCT02120963|Rheumatoid Arthritis|rheumatoid arthritis
344479|NCT02120963|Physical Therapy|physical therapy
344480|NCT02120963|Person-Centred Care|person-centred care
344481|NCT02120950|PCV|pcv
344482|NCT02120937|amygdala|amygdala
344483|NCT02120937|mindfulness|mindfulness
344484|NCT02120937|mood|mood
344485|NCT02120937|emotion|emotion
344486|NCT02120937|bipolar disorder|bipolar disorder
344487|NCT02120937|parental bipolar disorder|parental bipolar disorder
344488|NCT02120937|adolescence|adolescence
344489|NCT02120924|Moderate facial rosacea|moderate facial rosacea
344490|NCT02120924|Azelaic acid|azelaic acid
344491|NCT02120924|Rosacea|rosacea
344492|NCT02120911|Her2+|her2+
344493|NCT02120911|Resectable esophageal carcinoma|resectable esophageal carcinoma
344494|NCT02120911|Pertuzumab|pertuzumab
344495|NCT02120911|Trastuzumab|trastuzumab
344496|NCT02120898|Actinic Keratosis|actinic keratosis
344497|NCT02120898|Imiquimod|imiquimod
344498|NCT02120898|Zyclara|zyclara
344499|NCT02120885|Gastric cancer|gastric cancer
344500|NCT02120885|minimally invasive gastrectomy|minimally invasive gastrectomy
344501|NCT02120885|Physical activity intervention|physical activity intervention
344502|NCT02120859|PCI|pci
344503|NCT02120859|Drug-eluting balloon (DEB)|drug-eluting balloon (deb)
344504|NCT02120859|Fractional flow reserve (FFR)|fractional flow reserve (ffr)
344505|NCT02120846|Stroke|stroke
344506|NCT02120846|Flywheel resistance exercise|flywheel resistance exercise
344507|NCT02120846|Muscle function|muscle function
344508|NCT02120846|Cognitive function|cognitive function
344509|NCT02120833|Atopic Dermatitis|atopic dermatitis
344510|NCT02120820|massage|massage
344511|NCT02120820|multisensory environment|multisensory environment
344512|NCT02120820|challenging behaviours|challenging behaviours
344513|NCT02120820|relaxation|relaxation
344514|NCT02120807|Certolizumab|certolizumab
344515|NCT02120807|Cisplatin|cisplatin
344516|NCT02120807|Pemetrexed|pemetrexed
344517|NCT02120807|thoracic|thoracic
344518|NCT02120807|13-063|13-063
344519|NCT02120794|Type 1 diabetes|type 1 diabetes
344520|NCT02120794|Pediatric|pediatric
344521|NCT02120794|Threshold Suspend|threshold suspend
344522|NCT02120794|Sensor augmented pump|sensor augmented pump
344523|NCT02120768|Barrier resection|barrier resection
344524|NCT02120768|Local recurrence|local recurrence
344525|NCT02120768|Complication|complication
344526|NCT02120742|Road traffic injury prevention|road traffic injury prevention
344527|NCT02120742|Helmet use|helmet use
344528|NCT02120742|mHealth intervention|mhealth intervention
344529|NCT02120729|Pharmacogenetics|pharmacogenetics
344530|NCT02120729|CYP2D6 Mutations|cyp2d6 mutations
344531|NCT02120729|Major Depressive Disorder|major depressive disorder
344532|NCT02120729|Psychiatric Inpatients|psychiatric inpatients
344533|NCT02120729|Length of Stay|length of stay
344534|NCT02120729|30 Day Readmission Rate|30 day readmission rate
344535|NCT02120729|Psychiatric hospital inpatients|psychiatric hospital inpatients
344536|NCT02120716|HIV|hiv
344537|NCT02120716|STIs|stis
344538|NCT02120716|Health Check Up|health check up
344539|NCT02120716|Intervention|intervention
344540|NCT02120703|Pregabalin|pregabalin
344541|NCT02120703|gabapentin|gabapentin
344542|NCT02120703|microdiscectomy|microdiscectomy
344543|NCT02120703|pain|pain
344544|NCT02120690|pain|pain
344545|NCT02120690|fibromyagia|fibromyagia
344546|NCT02120690|TNS|tns
344547|NCT02120677|skin cancer|skin cancer
344548|NCT02120677|basal cell carcinoma|basal cell carcinoma
344549|NCT02120651|Fibrin monomer|fibrin monomer
344550|NCT02120651|Tympanoplasty|tympanoplasty
344551|NCT02120651|Hemostatic sponge|hemostatic sponge
344552|NCT02120638|Multidrug Resistant Tuberculosis|multidrug resistant tuberculosis
344553|NCT02120638|Pyrazinamide|pyrazinamide
344554|NCT02120625|radiofrequency ablation|radiofrequency ablation
344555|NCT02120625|neurotomy|neurotomy
344556|NCT02120625|facet joint|facet joint
344557|NCT02120625|medial branch|medial branch
344558|NCT02120625|low back pain|low back pain
344559|NCT02120612|Opioid Dependence|opioid dependence
344560|NCT02120612|Addiction|addiction
344561|NCT02120612|Naloxone|naloxone
344562|NCT02120612|Naloxone Education|naloxone education
344563|NCT02120612|Opiate Overdose Knowledge Scale|opiate overdose knowledge scale
344564|NCT02120612|OOKS|ooks
344565|NCT02120586|Elderly|elderly
344566|NCT02120586|Institutionalization|institutionalization
344567|NCT02120586|Sarcopenia|sarcopenia
344568|NCT02120586|Strength training|strength training
344569|NCT02120586|Muscle mass|muscle mass
344570|NCT02120586|Muscle strength|muscle strength
344571|NCT02120586|Physical performance|physical performance
344572|NCT02120573|Cardiac Arrest|cardiac arrest
344672|NCT02120183|Neoplasms|neoplasms
344573|NCT02120573|Cardiopulmonary Resuscitation|cardiopulmonary resuscitation
344574|NCT02120573|Training|training
344575|NCT02120560|Atrial Fibrillation Ablation|atrial fibrillation ablation
344576|NCT02120560|Cerebrothromboemboli|cerebrothromboemboli
344577|NCT02120560|Neurocognitive Function|neurocognitive function
344578|NCT02120547|Liver Insufficiency|liver insufficiency
344579|NCT02120547|Hepatic impairment|hepatic impairment
344580|NCT02120534|soluble CD14 ,serum CD88,sepsis , SIRS.|soluble cd14 ,serum cd88,sepsis , sirs.
344581|NCT02120521|Sepsis and SIRS, ICU|sepsis and sirs, icu
344582|NCT02120508|stroke|stroke
344583|NCT02120508|aphasia|aphasia
344584|NCT02120508|rTMS|rtms
344585|NCT02120508|Functional MRI|functional mri
344586|NCT02120508|Speech training|speech training
344587|NCT02120495|condylectomy|condylectomy
344588|NCT02120495|TMJ function|tmj function
344589|NCT02120495|intraoral approach|intraoral approach
344590|NCT02120482|ABO isoagglutinins|abo isoagglutinins
344591|NCT02120482|ABO incompatible transplantation|abo incompatible transplantation
344592|NCT02120482|immunoadsorption|immunoadsorption
344593|NCT02120482|membrane filtration|membrane filtration
344594|NCT02120482|plasmapheresis|plasmapheresis
344595|NCT02120443|infiltration|infiltration
344596|NCT02120443|extravasation|extravasation
344597|NCT02120443|peripheral intravenous therapy|peripheral intravenous therapy
344598|NCT02120430|Early childhood|early childhood
344599|NCT02120430|Audiovisual materials|audiovisual materials
344600|NCT02120430|Parent-child interaction|parent-child interaction
344601|NCT02120430|Parenting programs|parenting programs
344602|NCT02120430|Timing|timing
344603|NCT02120417|Breast Cancer|breast cancer
344604|NCT02120404|septic shock, hemodynamic tolerance, esmolol|septic shock, hemodynamic tolerance, esmolol
344605|NCT02120378|miscarriage|miscarriage
344606|NCT02120378|fetal viability|fetal viability
344607|NCT02120378|prematurity|prematurity
344608|NCT02120365|Alcoholism|alcoholism
344609|NCT02120365|Heavy Drinking|heavy drinking
344610|NCT02120365|Perampanel|perampanel
344611|NCT02120352|bi-monthly|bi-monthly
344612|NCT02120352|GSK744|gsk744
344613|NCT02120352|injectable|injectable
344614|NCT02120352|long acting|long acting
344615|NCT02120352|maintenance|maintenance
344616|NCT02120352|abacavir|abacavir
344617|NCT02120352|every other month|every other month
344618|NCT02120352|rilpivirine|rilpivirine
344619|NCT02120352|HIV-1 infection|hiv-1 infection
344620|NCT02120352|integrase inhibitor|integrase inhibitor
344621|NCT02120352|TMC278 LA|tmc278 la
344622|NCT02120352|RPV|rpv
344623|NCT02120352|non-nucleoside reverse transcriptase inhibitor|non-nucleoside reverse transcriptase inhibitor
344624|NCT02120352|LA|la
344625|NCT02120352|once monthly|once monthly
344626|NCT02120352|GSK1265744|gsk1265744
344627|NCT02120352|induction|induction
344628|NCT02120352|treatment satisfication|treatment satisfication
344629|NCT02120352|once daily|once daily
344630|NCT02120352|lamivudine|lamivudine
344631|NCT02120352|adherence|adherence
344632|NCT02120352|TMC278|tmc278
344633|NCT02120352|therapy-naive|therapy-naive
344634|NCT02120339|Hypertension|hypertension
344635|NCT02120339|PAH|pah
344636|NCT02120326|Chronic migraine, tDCS, Transcranial direct current stimulation|chronic migraine, tdcs, transcranial direct current stimulation
344637|NCT02120313|rehabilitation|rehabilitation
344638|NCT02120313|total knee arthroplasty|total knee arthroplasty
344639|NCT02120287|Border Zone Stereotactic Radiosurgery|border zone stereotactic radiosurgery
344640|NCT02120287|Bevacizumab|bevacizumab
344641|NCT02120287|Recurrent Glioblastoma Multiforme|recurrent glioblastoma multiforme
344642|NCT02120287|Progressive Glioblastoma Multiforme|progressive glioblastoma multiforme
344643|NCT02120287|Magnetic Resonance Spectroscopy|magnetic resonance spectroscopy
344644|NCT02120287|Glioblastoma|glioblastoma
344645|NCT02120287|Brain Cancer|brain cancer
344646|NCT02120287|Brain Tumor|brain tumor
344647|NCT02120287|Radiosurgery|radiosurgery
344648|NCT02120274|RNA Virus Infections|rna virus infections
344649|NCT02120274|Flaviviridae Infections|flaviviridae infections
344650|NCT02120274|Hepatitis C|hepatitis c
344651|NCT02120274|Hepatitis C, Chronic|hepatitis c, chronic
344652|NCT02120274|Vitamin D|vitamin d
344653|NCT02120274|Cholecalciferol|cholecalciferol
344654|NCT02120274|Vitamin B 12|vitamin b 12
344655|NCT02120261|Myofascial Pain Syndrome|myofascial pain syndrome
344656|NCT02120261|trigger point injection|trigger point injection
344657|NCT02120248|WIC|wic
344658|NCT02120248|Oregon|oregon
344659|NCT02120248|Breastfeeding|breastfeeding
344660|NCT02120248|Peer Counseling|peer counseling
344661|NCT02120248|Exclusive Breastfeeding|exclusive breastfeeding
344662|NCT02120235|Lysosomal storage disorders|lysosomal storage disorders
344663|NCT02120235|LSD|lsd
344664|NCT02120235|Gaucher disease|gaucher disease
344665|NCT02120235|Fabry disease|fabry disease
344666|NCT02120235|Pompe disease|pompe disease
344667|NCT02120235|Niemann-Pick disease|niemann-pick disease
344668|NCT02120222|melanoma|melanoma
344669|NCT02120209|assessment; falls; older adults; prediction scale; standardized declaration|assessment; falls; older adults; prediction scale; standardized declaration
344670|NCT02120183|Caregivers|caregivers
344671|NCT02120183|Quality of life|quality of life
344673|NCT02120183|Psychotherapy, group|psychotherapy, group
344674|NCT02120183|Family|family
344675|NCT02120183|Adaptation, psychological|adaptation, psychological
344676|NCT02120183|Psycho-educational support group therapy|psycho-educational support group therapy
344677|NCT02120183|Cancer patients|cancer patients
344678|NCT02120170|Hemoclip, Heparin bridging therapy, colon polypectomy, warfarin|hemoclip, heparin bridging therapy, colon polypectomy, warfarin
344679|NCT02120157|Acute lymphoblastic leukemia|acute lymphoblastic leukemia
344680|NCT02120157|Acute myeloid leukemia|acute myeloid leukemia
344681|NCT02120157|Juvenile myelomonocytic leukemia|juvenile myelomonocytic leukemia
344682|NCT02120157|Treatment related leukemia|treatment related leukemia
344683|NCT02120157|Biphenotypic leukemia|biphenotypic leukemia
344684|NCT02120131|third molar surgery, periodontal probing depth , flap design|third molar surgery, periodontal probing depth , flap design
344685|NCT02120118|Treatment failure|treatment failure
344686|NCT02120105|Renal aminoaciduria|renal aminoaciduria
344687|NCT02120105|cystinuria|cystinuria
344688|NCT02120105|D-penicillamine|d-penicillamine
344689|NCT02120105|renal tubular transport|renal tubular transport
344690|NCT02120105|inborn errors|inborn errors
344691|NCT02120105|tiopronin|tiopronin
344692|NCT02120105|urolithiasis|urolithiasis
344693|NCT02120092|ACS, Acute coronary syndrome|acs, acute coronary syndrome
344694|NCT02120079|Dry Eye|dry eye
344695|NCT02120066|Submacular hemorrhage|submacular hemorrhage
344696|NCT02120066|Vitrectomy|vitrectomy
344697|NCT02120066|tissue- plasminogen activator|tissue- plasminogen activator
344698|NCT02120053|Immediate complete denture|immediate complete denture
344699|NCT02120053|Alveolar ridge resorption|alveolar ridge resorption
344700|NCT02120053|Alveolar bone loss|alveolar bone loss
344701|NCT02120053|Bone substitute material|bone substitute material
344702|NCT02120053|Edentulism|edentulism
344703|NCT02120027|Irritable Bowel Syndrome|irritable bowel syndrome
344704|NCT02120027|Colon, irritable|colon, irritable
344705|NCT02120027|Bowel disease|bowel disease
344706|NCT02120027|Diarrhea|diarrhea
344707|NCT02120014|Heart Failure|heart failure
344708|NCT02120014|Heart Failure Reduced Ejection Fraction|heart failure reduced ejection fraction
344709|NCT02120014|Heart Failure Preserved Ejection Fraction|heart failure preserved ejection fraction
344710|NCT02120014|Venous Plethysmography|venous plethysmography
344711|NCT02120014|Blood Volume Study|blood volume study
344712|NCT02120001|Medical Devices|medical devices
344713|NCT02120001|Ventilator-Associated Pneumonia (VAP)|ventilator-associated pneumonia (vap)
344714|NCT02120001|Ventilator-Associated Events (VAE)|ventilator-associated events (vae)
344715|NCT02120001|Endotracheal Tube|endotracheal tube
344716|NCT02120001|Microbial Diversity|microbial diversity
344717|NCT02120001|Drug-Resistance|drug-resistance
344718|NCT02120001|biofilms|biofilms
344719|NCT02120001|endotracheal intubation|endotracheal intubation
344720|NCT02120001|mechanical ventilation|mechanical ventilation
344721|NCT02119988|TIPS|tips
344722|NCT02119988|Embolization|embolization
344723|NCT02119988|Variceal rebleeding|variceal rebleeding
344724|NCT02119975|Rumination|rumination
344725|NCT02119975|Working memory|working memory
344726|NCT02119975|Depression|depression
344727|NCT02119975|Anxiety|anxiety
344728|NCT02119975|Working memory training|working memory training
344729|NCT02119975|Overgeneral memories|overgeneral memories
344730|NCT02119962|burnout|burnout
344731|NCT02119962|working memory|working memory
344732|NCT02119962|working memory training|working memory training
344733|NCT02119962|cognitive behavioral therapy|cognitive behavioral therapy
344734|NCT02119962|executive control|executive control
344735|NCT02119949|Substance abuse|substance abuse
344736|NCT02119949|Addiction|addiction
344737|NCT02119949|Working memory|working memory
344738|NCT02119949|Craving|craving
344739|NCT02119949|Impulsivity|impulsivity
344740|NCT02119949|Attention control|attention control
344741|NCT02119936|Stress|stress
344742|NCT02119936|Anxiety|anxiety
344743|NCT02119936|Mental Health|mental health
344744|NCT02119936|Mental Health Services|mental health services
344745|NCT02119936|Maternal Mental Health|maternal mental health
344746|NCT02119923|Depression|depression
344747|NCT02119923|Anxiety|anxiety
344748|NCT02119923|Working memory|working memory
344749|NCT02119923|Rumination|rumination
344750|NCT02119923|Cognitive training|cognitive training
344751|NCT02119923|Executive functioning|executive functioning
344752|NCT02119910|pediatric feeding disorders|pediatric feeding disorders
344753|NCT02119910|behavioral intervention|behavioral intervention
344754|NCT02119910|treatment manual|treatment manual
344755|NCT02119910|feeding|feeding
344756|NCT02119910|food refusal|food refusal
344757|NCT02119910|diet|diet
344758|NCT02119897|Oropharyngeal Mucositis|oropharyngeal mucositis
344759|NCT02119897|Myeloablative Hematopoietic Cell Transplantation|myeloablative hematopoietic cell transplantation
344760|NCT02119897|Low Level Light Therapy|low level light therapy
344761|NCT02119884|Gastric and Esophageal Varices|gastric and esophageal varices
344762|NCT02119884|Hepatic Venous Pressure Gradient|hepatic venous pressure gradient
344763|NCT02119884|Terlipressin|terlipressin
344764|NCT02119884|Octreotide|octreotide
344765|NCT02119871|Cerebral air emboli, heart surgery|cerebral air emboli, heart surgery
344766|NCT02119845|Chronic kidney disease|chronic kidney disease
344767|NCT02119845|Arteriovenous fistula (AVF)|arteriovenous fistula (avf)
344768|NCT02119845|Hemodialysis|hemodialysis
344769|NCT02119845|Vascular access|vascular access
344770|NCT02119845|Endovascular AVF (EndoAVF)|endovascular avf (endoavf)
344771|NCT02119832|Chronic kidney disease|chronic kidney disease
344772|NCT02119832|Arteriovenous fistula|arteriovenous fistula
344773|NCT02119832|Hemodialysis|hemodialysis
344774|NCT02119832|Vascular access|vascular access
344775|NCT02119819|Weight loss|weight loss
344776|NCT02119806|cardiac surgery, benzodiazepines, delirium|cardiac surgery, benzodiazepines, delirium
344777|NCT02119767|Atherosclerosis|atherosclerosis
344778|NCT02119754|Wound|wound
344779|NCT02119754|Ulcer|ulcer
344780|NCT02119754|Infected|infected
344781|NCT02119754|Infection|infection
344782|NCT02119741|Interdental papilla|interdental papilla
344783|NCT02119741|hyaluronic acid|hyaluronic acid
344784|NCT02119741|esthetic zone|esthetic zone
344785|NCT02119741|black triangles|black triangles
344786|NCT02119715|Breast Cancer|breast cancer
344787|NCT02119715|Neutropenia|neutropenia
344788|NCT02119715|Febrile Neutropenia|febrile neutropenia
344789|NCT02119702|HIV/AIDS, perinatal HIV infection|hiv/aids, perinatal hiv infection
344790|NCT02119689|Diabetes|diabetes
344791|NCT02119689|Retinopathy|retinopathy
344792|NCT02119676|Metastatic Colorectal Cancer|metastatic colorectal cancer
344793|NCT02119676|Colon Cancer|colon cancer
344794|NCT02119676|Ruxolitinib|ruxolitinib
344795|NCT02119676|adenocarcinoma|adenocarcinoma
344796|NCT02119676|regorafenib|regorafenib
344797|NCT02119676|Jakavi ®|jakavi ®
344798|NCT02119676|Jakafi ®|jakafi ®
344799|NCT02119676|Stivarga ®|stivarga ®
344800|NCT02119663|Metastatic pancreatic cancer|metastatic pancreatic cancer
344801|NCT02119650|Non small cell lung cancer|non small cell lung cancer
344802|NCT02119637|Emotion|emotion
344803|NCT02119637|Tactile Discrimination|tactile discrimination
344804|NCT02119637|Transcranial Magnetic Stimulation (TMS)|transcranial magnetic stimulation (tms)
344805|NCT02119637|Somatosensory|somatosensory
344806|NCT02119637|Somatosensory Cortex|somatosensory cortex
344807|NCT02119624|Neural Networks|neural networks
344808|NCT02119624|Alcoholism|alcoholism
344809|NCT02119624|fMRI|fmri
344810|NCT02119624|Reward|reward
344811|NCT02119624|Addiction|addiction
344812|NCT02119611|Deep Brain Stimulation|deep brain stimulation
344813|NCT02119611|Movement Disorders|movement disorders
344814|NCT02119611|Parkinson's Disease|parkinson's disease
344815|NCT02119611|Dystonia|dystonia
344816|NCT02119611|Essential Tremor|essential tremor
344817|NCT02119598|Prehospital care|prehospital care
344818|NCT02119598|Telemedicine|telemedicine
344819|NCT02119598|Ambulance-based telemedicine|ambulance-based telemedicine
344820|NCT02119585|orthotopic liver transplantation|orthotopic liver transplantation
344821|NCT02119585|ischemia reperfusion syndrome|ischemia reperfusion syndrome
344822|NCT02119585|cytokines|cytokines
344823|NCT02119585|respiratory system elastance|respiratory system elastance
344824|NCT02119585|lung elastance|lung elastance
344825|NCT02119585|chest wall elastance|chest wall elastance
344826|NCT02119585|shunt|shunt
344827|NCT02119585|dead space|dead space
344828|NCT02119585|acute respiratory failure|acute respiratory failure
344829|NCT02119585|atelectasis|atelectasis
344830|NCT02119585|pleural effusion|pleural effusion
344831|NCT02119572|diabetes,peer support|diabetes,peer support
344832|NCT02119559|Circulating Tumor Cells|circulating tumor cells
344833|NCT02119559|Treatment Efficiency|treatment efficiency
344834|NCT02119559|Biomarker|biomarker
344835|NCT02119546|Mild CognitIve impairment|mild cognitive impairment
344836|NCT02119546|Alzheimer's disease|alzheimer's disease
344837|NCT02119546|Cognitive function|cognitive function
344838|NCT02119546|Exercise training|exercise training
344839|NCT02119533|brain injury|brain injury
344840|NCT02119533|concussion|concussion
344841|NCT02119533|post traumatic stress|post traumatic stress
344842|NCT02119520|Periodontitis|periodontitis
344843|NCT02119520|Surgery|surgery
344844|NCT02119520|Growth Factors|growth factors
344845|NCT02119520|Statins|statins
344846|NCT02119507|Dental caries|dental caries
344847|NCT02119507|Curodont Repair|curodont repair
344848|NCT02119507|P11-4|p11-4
344849|NCT02119494|chronic obstructive pulmonary disease|chronic obstructive pulmonary disease
344850|NCT02119494|phenotypes|phenotypes
344851|NCT02119494|categories|categories
344852|NCT02119494|stage|stage
344853|NCT02119494|GOLD|gold
344854|NCT02119494|treatment|treatment
344855|NCT02119481|Mindfulness stress reduction training|mindfulness stress reduction training
344856|NCT02119481|Expressive writing condition|expressive writing condition
344857|NCT02119481|Waiting list control condition|waiting list control condition
344858|NCT02119442|Eisenmenger Syndrome, Pulmonary Arterial Hyptertension|eisenmenger syndrome, pulmonary arterial hyptertension
344859|NCT02119429|Blood pressure|blood pressure
344860|NCT02119429|Pre-menopausal|pre-menopausal
344861|NCT02119429|Supplementation|supplementation
344862|NCT02119416|Cardiovascular influences|cardiovascular influences
344863|NCT02119416|caffeine|caffeine
344864|NCT02119416|healthy children|healthy children
344865|NCT02119403|Minimal Sedation nitrous oxide|minimal sedation nitrous oxide
344866|NCT02119390|adolescents|adolescents
344867|NCT02119390|young adults|young adults
344868|NCT02119390|medication adherence|medication adherence
344869|NCT02119377|trans|trans
344870|NCT02119377|transsexual|transsexual
344871|NCT02119377|transgender|transgender
344872|NCT02119377|sistergirl|sistergirl
344873|NCT02119377|brotherboy|brotherboy
344874|NCT02119377|androgynous|androgynous
344875|NCT02119377|genderqueer|genderqueer
344876|NCT02119364|cerebral palsy|cerebral palsy
344877|NCT02119364|working memory|working memory
344878|NCT02119364|cognitive training|cognitive training
344879|NCT02119351|peripheral intravenous catheters|peripheral intravenous catheters
344880|NCT02119351|blood exposure|blood exposure
344881|NCT02119351|blood control|blood control
344882|NCT02119351|IV catheter insertion|iv catheter insertion
344883|NCT02119338|5-ala|5-ala
344884|NCT02119338|5-aminolevulinic acid|5-aminolevulinic acid
344885|NCT02119338|fluorescence-guided surgery|fluorescence-guided surgery
344886|NCT02119338|glioma|glioma
344887|NCT02119338|astrocytoma|astrocytoma
344888|NCT02119338|glioblastoma|glioblastoma
344889|NCT02119338|oligodendroglioma|oligodendroglioma
344890|NCT02119338|recurrence of glioma|recurrence of glioma
344891|NCT02119325|fibre|fibre
344892|NCT02119325|overweight|overweight
344893|NCT02119325|impaired fasting glucose|impaired fasting glucose
344894|NCT02119312|Malaria|malaria
344895|NCT02119312|Plasmodium|plasmodium
344896|NCT02119312|Plasmodium falciparum|plasmodium falciparum
344897|NCT02119312|Clinical Trials|clinical trials
344898|NCT02119312|Vaccine Study|vaccine study
344899|NCT02119312|Drug Study|drug study
344900|NCT02119312|Malaria Clinical Trials Center|malaria clinical trials center
344901|NCT02119312|Seattle BioMed|seattle biomed
344902|NCT02119312|Center for Infectious Disease Research|center for infectious disease research
344903|NCT02119286|long acting beta2- receptor agonist|long acting beta2- receptor agonist
344904|NCT02119286|long acting muscarininc receptor antagonist|long acting muscarininc receptor antagonist
344905|NCT02119286|dry powder inhaler|dry powder inhaler
344906|NCT02119286|safety|safety
344907|NCT02119286|COPD|copd
344908|NCT02119286|inhaled corticosteroid|inhaled corticosteroid
344909|NCT02119286|efficacy|efficacy
344910|NCT02119286|fluticasone furoate/vilanterol|fluticasone furoate/vilanterol
344911|NCT02119286|umeclidinium bromide|umeclidinium bromide
344912|NCT02119273|CRSsNP|crssnp
344913|NCT02119273|Steroids|steroids
344914|NCT02119273|Corticosteroids|corticosteroids
344915|NCT02119273|Endoscopic|endoscopic
344916|NCT02119273|Surgery|surgery
344917|NCT02119273|Perioperative|perioperative
344918|NCT02119260|First Time in Human|first time in human
344919|NCT02119260|TRPV4 inhibitor|trpv4 inhibitor
344920|NCT02119260|Heart failure|heart failure
344921|NCT02119247|systemic availability , pharmacokinetics, COPD|systemic availability , pharmacokinetics, copd
344922|NCT02119195|composite|composite
344923|NCT02119195|sealant|sealant
344924|NCT02119195|longevity|longevity
344925|NCT02119182|Traumatic Brain Injury|traumatic brain injury
344926|NCT02119182|Biomarkers|biomarkers
344927|NCT02119182|Neuroimaging|neuroimaging
344928|NCT02119182|Psychological Health|psychological health
344929|NCT02119182|Comparative Effectiveness Research|comparative effectiveness research
344930|NCT02119156|treatment holiday|treatment holiday
344932|NCT02119156|belimumab|belimumab
344933|NCT02119156|Lymphostat-B|lymphostat-b
344934|NCT02119156|rebound|rebound
344935|NCT02119156|SELENA SLEDAI|selena sledai
344936|NCT02119156|Systemic Lupus Erythematosus|systemic lupus erythematosus
344937|NCT02119156|immunogenicity|immunogenicity
441019|NCT01684384|PRO|pro
344938|NCT02119143|common cold, immunity, oxidative stress|common cold, immunity, oxidative stress
344939|NCT02119130|cluster randomized trial|cluster randomized trial
344940|NCT02119130|interferon-gamma|interferon-gamma
344941|NCT02119130|tuberculin test|tuberculin test
344942|NCT02119130|operational comparison|operational comparison
344943|NCT02119130|cost effectiveness|cost effectiveness
344944|NCT02119130|qualitative evaluation|qualitative evaluation
344945|NCT02119117|mtDNA|mtdna
344946|NCT02119117|aneuploidy|aneuploidy
344947|NCT02119117|IVF|ivf
344948|NCT02119117|blastocyst|blastocyst
344949|NCT02119117|COQ10|coq10
344950|NCT02119091|QT prolongation|qt prolongation
344951|NCT02119091|Chinese|chinese
344952|NCT02119091|Caucasian|caucasian
344953|NCT02119091|Moxifloxacin|moxifloxacin
344954|NCT02119078|Geriatrics|geriatrics
344955|NCT02119078|Acute Care for Elders|acute care for elders
344956|NCT02119078|Geriatric syndromes|geriatric syndromes
344957|NCT02119078|Delirium|delirium
344958|NCT02119078|Falls|falls
344959|NCT02119078|Polypharmacy|polypharmacy
344960|NCT02119065|Yttrium-90 Radioembolization|yttrium-90 radioembolization
344961|NCT02119065|hepatic malignancy|hepatic malignancy
344962|NCT02119065|hepatic metastatic disease|hepatic metastatic disease
344963|NCT02119039|Cross-linking|cross-linking
344964|NCT02119039|RGTA OTR4120 (CACICOL20)|rgta otr4120 (cacicol20)
344965|NCT02119026|metastatic colorectal cancer|metastatic colorectal cancer
344966|NCT02119026|Patients with metastatic colorectal cancer who did not receive|patients with metastatic colorectal cancer who did not receive
344967|NCT02119026|systemic treatment for their metastatic disease|systemic treatment for their metastatic disease
344968|NCT02118987|Drug Desensitization|drug desensitization
344969|NCT02118987|Hypersensitivity reactions to chemotherapeutic agents|hypersensitivity reactions to chemotherapeutic agents
344970|NCT02118974|Hysterectomy|hysterectomy
344971|NCT02118974|Robot-assisted|robot-assisted
344972|NCT02118974|Laparoscopy|laparoscopy
344973|NCT02118961|Diphtheria|diphtheria
344974|NCT02118961|Tetanus|tetanus
344975|NCT02118961|Pertussis|pertussis
344976|NCT02118961|DTaP vaccine|dtap vaccine
344977|NCT02118961|Adolescents|adolescents
344978|NCT02118948|abuse|abuse
344979|NCT02118948|sexual behavior|sexual behavior
344980|NCT02118948|sexual risk reduction|sexual risk reduction
344981|NCT02118948|behavioral intervention|behavioral intervention
344982|NCT02118922|LASIK|lasik
344983|NCT02118896|FK506E|fk506e
344984|NCT02118896|Heart Transplantation|heart transplantation
344985|NCT02118896|MR4|mr4
344986|NCT02118896|Tacrolimus|tacrolimus
344987|NCT02118896|Advagraf|advagraf
344988|NCT02118896|Kidney Transplantation|kidney transplantation
344989|NCT02118896|Renal Transplantation|renal transplantation
344990|NCT02118883|exercise|exercise
344991|NCT02118883|hydration|hydration
344992|NCT02118883|dehydration|dehydration
344993|NCT02118883|rehydration|rehydration
344994|NCT02118883|alkaline water|alkaline water
344995|NCT02118883|blood viscosity|blood viscosity
344996|NCT02118883|plasma osmolality|plasma osmolality
344997|NCT02118883|bioimpedance|bioimpedance
344998|NCT02118870|ACS patients|acs patients
344999|NCT02118870|Older than 18 years|older than 18 years
345001|NCT02118870|Combo stent|combo stent
345002|NCT02118857|Microorganisms and foods|microorganisms and foods
345003|NCT02118857|Fecal microbiota|fecal microbiota
345004|NCT02118857|Salivary microbiota|salivary microbiota
345005|NCT02118844|bariatric surgery|bariatric surgery
345006|NCT02118844|surgical conditions|surgical conditions
345007|NCT02118844|deep neuromuscular blockade|deep neuromuscular blockade
345008|NCT02118831|macular degeneration|macular degeneration
345009|NCT02118831|diabetic macular edema|diabetic macular edema
345010|NCT02118831|vein occlusion|vein occlusion
345011|NCT02118831|vascular endothelial growth factor|vascular endothelial growth factor
345012|NCT02118805|ALS|als
345013|NCT02118805|Myasthenia Gravis|myasthenia gravis
345014|NCT02118805|Myopathy|myopathy
345015|NCT02118805|Stroke|stroke
345016|NCT02118805|Parkinson's Disease|parkinson's disease
345017|NCT02118805|Bulbar|bulbar
345018|NCT02118805|Orofacial|orofacial
345019|NCT02118805|Ultrasound|ultrasound
345020|NCT02118805|Electrical Impedance Myography|electrical impedance myography
345021|NCT02118792|atopic dermatitis|atopic dermatitis
345022|NCT02118779|Myotonic Dystrophy Type 1|myotonic dystrophy type 1
345023|NCT02118779|DM1|dm1
345024|NCT02118779|Physical Exercise|physical exercise
345025|NCT02118779|Cognitive Behavioural Therapy|cognitive behavioural therapy
345026|NCT02118779|Biomarkers|biomarkers
345027|NCT02118766|atopic dermatitis|atopic dermatitis
345028|NCT02118753|ischemia-reperfusion injury|ischemia-reperfusion injury
345029|NCT02118740|Autologous Stem Cells|autologous stem cells
345030|NCT02118740|Spinal Cord Injury|spinal cord injury
345031|NCT02118740|Preclinical|preclinical
345032|NCT02118727|ALS|als
345033|NCT02118727|FTD|ftd
345034|NCT02118727|Tau|tau
345035|NCT02118727|pNF-H/C3|pnf-h/c3
345036|NCT02118714|Diabetic Nephropathies|diabetic nephropathies
345037|NCT02118714|Kidney Diseases|kidney diseases
345038|NCT02118714|Urologic Diseases|urologic diseases
345039|NCT02118714|Diabetes Complications|diabetes complications
345040|NCT02118714|Diabetes Mellitus|diabetes mellitus
345041|NCT02118714|Endocrine System Diseases|endocrine system diseases
345042|NCT02118701|Shared decision making|shared decision making
345043|NCT02118701|Dementia|dementia
345044|NCT02118701|Long-term care|long-term care
345045|NCT02118701|Nursing home|nursing home
345046|NCT02118701|Care plan|care plan
345047|NCT02118636|Joint pain|joint pain
345048|NCT02118636|Hormone receptor positive breast cancer|hormone receptor positive breast cancer
345049|NCT02118636|Estrogen|estrogen
345050|NCT02118636|Androgen|androgen
345051|NCT02118623|Bipolar Disorder|bipolar disorder
345052|NCT02118623|Bipolar|bipolar
345053|NCT02118623|Online intervention|online intervention
345054|NCT02118623|Internet intervention|internet intervention
345055|NCT02118623|Self help|self help
345056|NCT02118545|vWF|vwf
345057|NCT02118545|Liver Resection|liver resection
345058|NCT02118545|Liver Dysfunction|liver dysfunction
345059|NCT02118545|Liver Regeneration|liver regeneration
345060|NCT02118545|Postoperative Outcome|postoperative outcome
345061|NCT02118532|Atherosclerosis|atherosclerosis
345062|NCT02118532|Superficial Femoral Artery|superficial femoral artery
345063|NCT02118532|Proximal Popliteal Artery|proximal popliteal artery
345064|NCT02118519|Bone marrow derived Mesenchymal Stem Cells|bone marrow derived mesenchymal stem cells
345065|NCT02118519|Knee articular cartilage injury|knee articular cartilage injury
345066|NCT02118519|Chondrogenesis|chondrogenesis
345067|NCT02118519|orthopedics|orthopedics
345068|NCT02118506|Primary Parkinsonism.|primary parkinsonism.
345069|NCT02118506|Rehabilitation.|rehabilitation.
345070|NCT02118506|Biomechanics.|biomechanics.
345071|NCT02118506|Neurological gait disorders.|neurological gait disorders.
345072|NCT02118493|Benign Biliary Stenosis|benign biliary stenosis
345073|NCT02118493|Laser Excision|laser excision
345074|NCT02118480|Parkinson disease, cognitive rehabilitation, REHACOP|parkinson disease, cognitive rehabilitation, rehacop
345075|NCT02118467|Shock|shock
345076|NCT02118467|Vasopressor agents|vasopressor agents
345077|NCT02118467|Norepinephrine|norepinephrine
345078|NCT02118467|Epinephrine|epinephrine
345079|NCT02118467|Phenylephrine|phenylephrine
345080|NCT02118467|Vasopressin|vasopressin
345081|NCT02118467|Atrial fibrillation|atrial fibrillation
345082|NCT02118467|Tachyarrhythmia|tachyarrhythmia
345083|NCT02118454|Medication adherence|medication adherence
345084|NCT02118454|Self-management|self-management
345085|NCT02118454|Depression|depression
345086|NCT02118454|Coping|coping
345087|NCT02118454|Social support|social support
345088|NCT02118454|Mobile health|mobile health
345089|NCT02118454|Antiretroviral treatment|antiretroviral treatment
345090|NCT02118428|whole blood|whole blood
345091|NCT02118428|transfusion|transfusion
345092|NCT02118428|Plasmodium|plasmodium
345093|NCT02118428|Malaria|malaria
345094|NCT02118428|Pathogen Reduction Technology|pathogen reduction technology
345095|NCT02118428|Whole blood transfusion|whole blood transfusion
345096|NCT02118415|not eligible for surgery|not eligible for surgery
345097|NCT02118415|efficacy of immunotherapy following RCTx|efficacy of immunotherapy following rctx
345098|NCT02118376|obesity; fat distribution; inflammation|obesity; fat distribution; inflammation
345099|NCT02118363|upper limb|upper limb
345100|NCT02118363|lower limb|lower limb
345101|NCT02118363|monitoring|monitoring
345102|NCT02118363|assessment|assessment
345103|NCT02118363|sensor|sensor
345104|NCT02118337|select advanced malignancies,|select advanced malignancies,
345105|NCT02118337|kidney cancer,|kidney cancer,
345106|NCT02118337|clear cell renal cell carcinoma|clear cell renal cell carcinoma
345107|NCT02118324|Acute Lymphoblastic Leukemia|acute lymphoblastic leukemia
345108|NCT02118324|ALL|all
345109|NCT02118324|fitness intervention|fitness intervention
345110|NCT02118311|Acute Leukemias|acute leukemias
345111|NCT02118311|Burkitt's Lymphoma|burkitt's lymphoma
345112|NCT02118311|Natural Killer Cell Malignancies|natural killer cell malignancies
345113|NCT02118311|Chronic Myelogenous Leukemia|chronic myelogenous leukemia
345114|NCT02118311|Myelodysplastic Syndrome|myelodysplastic syndrome
345115|NCT02118311|Large-Cell Lymphoma|large-cell lymphoma
345116|NCT02118311|Hodgkin Lymphoma|hodgkin lymphoma
345117|NCT02118311|Multiple Myeloma|multiple myeloma
345118|NCT02118311|Chronic Lymphocytic Leukemia|chronic lymphocytic leukemia
345119|NCT02118311|Small Lymphocytic Lymphoma|small lymphocytic lymphoma
345120|NCT02118311|Marginal Zone B-Cell Lymphoma|marginal zone b-cell lymphoma
345121|NCT02118311|Follicular Lymphoma:|follicular lymphoma:
345122|NCT02118311|Lymphoplasmacytic Lymphoma|lymphoplasmacytic lymphoma
345123|NCT02118311|Mantle-Cell Lymphoma|mantle-cell lymphoma
345124|NCT02118311|Prolymphocytic Leukemia|prolymphocytic leukemia
345125|NCT02118285|Ovarian cancer|ovarian cancer
345126|NCT02118285|Fallopian cancer|fallopian cancer
345127|NCT02118285|Primary peritoneal cancer|primary peritoneal cancer
345128|NCT02118259|Multidisciplinary review of drug prescriptions|multidisciplinary review of drug prescriptions
400536|NCT01866397|renal replacement therapy|renal replacement therapy
441304|NCT01683084|AAA|aaa
345129|NCT02118259|Adverse drug events geriatric risk score|adverse drug events geriatric risk score
345130|NCT02118259|Residence for dependent elderly|residence for dependent elderly
345131|NCT02118246|Knee pain,Dry Needling, kinesioTape,Trigger point|knee pain,dry needling, kinesiotape,trigger point
345132|NCT02118233|carotid|carotid
345133|NCT02118233|stenosis|stenosis
345134|NCT02118233|surgery|surgery
345135|NCT02118233|cognitive|cognitive
345136|NCT02118233|unilateral|unilateral
345137|NCT02118207|SCUBA diving|scuba diving
345138|NCT02118207|Exercise|exercise
345139|NCT02118207|Microparticles|microparticles
345140|NCT02118207|Repetitive diving|repetitive diving
345141|NCT02118207|Endothelial function|endothelial function
345142|NCT02118194|paraplegia|paraplegia
345143|NCT02118194|paralysis|paralysis
345144|NCT02118194|robotics|robotics
345145|NCT02118194|walking|walking
345146|NCT02118194|immobilization|immobilization
345147|NCT02118168|HIV|hiv
345148|NCT02118168|HAART|haart
345149|NCT02118168|Tat Protein|tat protein
345150|NCT02118129|Vitamin D|vitamin d
345151|NCT02118129|Intervention|intervention
345152|NCT02118129|Behaviour|behaviour
345153|NCT02118129|Mobile app|mobile app
345154|NCT02118116|ASIST, gatekeeper, suicide, intervention, First Nations, Aboriginal, educational, prevention, safety|asist, gatekeeper, suicide, intervention, first nations, aboriginal, educational, prevention, safety
345155|NCT02118103|Lumbosacral Region|lumbosacral region
345156|NCT02118103|Psychomotor Performance|psychomotor performance
345157|NCT02118103|Manipulation, Spinal|manipulation, spinal
345158|NCT02118090|malaria|malaria
345159|NCT02118090|Plasmodium vivax|plasmodium vivax
345160|NCT02118090|drug resistance|drug resistance
345161|NCT02118090|chloroquine|chloroquine
345162|NCT02118090|Cambodia|cambodia
345163|NCT02118064|G17DT|g17dt
345164|NCT02118064|irinotecan|irinotecan
345165|NCT02118064|Colorectal Cancer|colorectal cancer
345166|NCT02118051|Infertility|infertility
345168|NCT02118051|Corifollitropin Alfa treatment|corifollitropin alfa treatment
345169|NCT02118051|Ovarian stimulation|ovarian stimulation
345170|NCT02118038|Postpartum haemorrhage|postpartum haemorrhage
345171|NCT02118038|Sulprostone|sulprostone
345172|NCT02118038|Cardiac impact|cardiac impact
345173|NCT02118038|Emotional impact|emotional impact
345174|NCT02118038|Cardiac magnetic imaging resonance|cardiac magnetic imaging resonance
345175|NCT02118025|Off-pump bypass graft surgery|off-pump bypass graft surgery
345176|NCT02118025|Mini extracorporeal circulation bypass surgery|mini extracorporeal circulation bypass surgery
345177|NCT02118012|Chlorcyclizine HCL|chlorcyclizine hcl
345178|NCT02118012|Direct Acting Antivirals|direct acting antivirals
345179|NCT02118012|Ribavirin|ribavirin
345180|NCT02118012|Chronic Hepatitis C|chronic hepatitis c
345181|NCT02117999|corneal cross-linking|corneal cross-linking
345182|NCT02117999|transepithelial corneal cross-linking|transepithelial corneal cross-linking
345183|NCT02117999|iontophoresis|iontophoresis
345184|NCT02117999|progressive keratoconus|progressive keratoconus
345185|NCT02117986|critically ill patients|critically ill patients
345186|NCT02117986|colistin dosing|colistin dosing
345187|NCT02117986|multidrug resistant bacteria|multidrug resistant bacteria
345188|NCT02117960|atherosclerotic|atherosclerotic
345189|NCT02117960|BMP-4|bmp-4
345190|NCT02117960|YKL40|ykl40
345191|NCT02117960|HSP70|hsp70
345192|NCT02117960|HSP27|hsp27
345193|NCT02117947|child secondhand smoke|child secondhand smoke
345194|NCT02117947|maternal smoking|maternal smoking
345195|NCT02117947|tobacco|tobacco
345196|NCT02117947|nicotine|nicotine
345197|NCT02117947|behavioral counseling|behavioral counseling
345198|NCT02117947|low-income|low-income
345199|NCT02117947|underserved|underserved
345200|NCT02117934|HBV vaccine|hbv vaccine
345201|NCT02117934|HEPLISAV-B|heplisav-b
345202|NCT02117934|Hepatitis B vaccine|hepatitis b vaccine
345203|NCT02117934|Hepatitis B|hepatitis b
345204|NCT02117934|Hepatitis|hepatitis
345205|NCT02117934|Hepatitis B virus (HBV)|hepatitis b virus (hbv)
345206|NCT02117934|Prevention and Control|prevention and control
345207|NCT02117934|Healthy|healthy
345208|NCT02117934|Healthy volunteers|healthy volunteers
345209|NCT02117921|Mind Body Syndrome|mind body syndrome
345210|NCT02117921|MBS|mbs
345211|NCT02117921|Chronic Pain|chronic pain
345212|NCT02117908|prevention|prevention
345213|NCT02117908|radiofrequency treatment|radiofrequency treatment
345214|NCT02117908|lung cancer ablation|lung cancer ablation
345215|NCT02117895|Distal Pancreatectomy|distal pancreatectomy
345216|NCT02117895|Celiac Plexus|celiac plexus
345217|NCT02117895|Resection|resection
345218|NCT02117895|Pancreatic Cancer|pancreatic cancer
345219|NCT02117895|Body and Tail|body and tail
345220|NCT02117882|lateral approach, bone augmentation , sinus floor elevation|lateral approach, bone augmentation , sinus floor elevation
345221|NCT02117869|Grapefruit juice|grapefruit juice
345222|NCT02117856|Implant-Supported Denture|implant-supported denture
345223|NCT02117856|Single-Implant Denture|single-implant denture
345224|NCT02117856|Patient Satisfaction|patient satisfaction
345225|NCT02117856|Edentulous Mandible|edentulous mandible
345226|NCT02117856|Dental Implants|dental implants
345227|NCT02117856|Standard of Care|standard of care
345228|NCT02117856|Randomized Clinical Trial|randomized clinical trial
345229|NCT02117830|To determine|to determine
345230|NCT02117830|effects|effects
345231|NCT02117830|once|once
345232|NCT02117830|daily|daily
345233|NCT02117830|oral doses|oral doses
345234|NCT02117830|Androxal|androxal
345235|NCT02117804|Discharge Planning|discharge planning
345236|NCT02117804|Decision Support|decision support
345237|NCT02117791|Riociguat, Adempas, sGC stimulator, CTEPH, Japan, PMS|riociguat, adempas, sgc stimulator, cteph, japan, pms
345238|NCT02117765|T1D|t1d
345239|NCT02117765|ustekinumab|ustekinumab
345240|NCT02117765|new-onset|new-onset
345241|NCT02117765|diabetes|diabetes
345242|NCT02117726|Sedation;|sedation;
345243|NCT02117726|ARDS;|ards;
345244|NCT02117726|Mechanical ventilation|mechanical ventilation
345245|NCT02117726|Hypnotics|hypnotics
345246|NCT02117726|Antianxiety Drugs|antianxiety drugs
345247|NCT02117726|Causing|causing
345248|NCT02117726|Adverse Effects|adverse effects
345249|NCT02117726|Therapeutic Use|therapeutic use
345250|NCT02117700|fatty liver|fatty liver
345251|NCT02117700|obesity|obesity
345252|NCT02117700|children|children
345253|NCT02117700|oxidative stress|oxidative stress
345254|NCT02117700|antioxidants|antioxidants
345255|NCT02117674|colonoscopy|colonoscopy
345256|NCT02117674|adenoma detection rate|adenoma detection rate
345257|NCT02117674|full spectrum colonoscopy|full spectrum colonoscopy
345258|NCT02117674|right colon retroflexion|right colon retroflexion
345259|NCT02117674|feasibility|feasibility
345260|NCT02117661|L-carnitine|l-carnitine
345261|NCT02117661|Metabolic syndrome|metabolic syndrome
345262|NCT02117661|Atherosclerosis|atherosclerosis
345263|NCT02117661|Coronary artery disease|coronary artery disease
345264|NCT02117661|Carotid|carotid
345265|NCT02117661|Plaque|plaque
345266|NCT02117661|Cardiovascular disease|cardiovascular disease
345267|NCT02117661|Heart disease|heart disease
345268|NCT02117661|Vascular disease|vascular disease
345269|NCT02117648|advanced cancer|advanced cancer
345270|NCT02117648|metastatic cancer|metastatic cancer
345271|NCT02117635|Efficacy|efficacy
345272|NCT02117635|Non comparative|non comparative
345273|NCT02117635|Neural stem cells|neural stem cells
345274|NCT02117635|Intracranial administration|intracranial administration
345275|NCT02117609|Elderly|elderly
345276|NCT02117609|Nursing home|nursing home
345277|NCT02117609|Functional impairment|functional impairment
345278|NCT02117609|High-protein oral supplement|high-protein oral supplement
345279|NCT02117596|Pediatric|pediatric
345280|NCT02117596|Renal|renal
345281|NCT02117596|Transplant|transplant
345282|NCT02117583|pharmacokinetics|pharmacokinetics
345283|NCT02117583|relative bioavailability|relative bioavailability
345284|NCT02117583|food effects|food effects
345285|NCT02117583|oxycodone|oxycodone
345286|NCT02117570|Clostridium difficile|clostridium difficile
345287|NCT02117570|vaccine|vaccine
345288|NCT02117557|Single-incision|single-incision
345289|NCT02117557|Laparoscopy|laparoscopy
345290|NCT02117557|Colorectal Cancer|colorectal cancer
345291|NCT02117544|Contact lens|contact lens
345292|NCT02117544|Presbyopia|presbyopia
345293|NCT02117544|Multifocal|multifocal
345294|NCT02117518|type 1 diabetes|type 1 diabetes
345295|NCT02117518|autoreactive T cells|autoreactive t cells
345296|NCT02117518|beta cell peptides|beta cell peptides
345297|NCT02117518|genetically modified T cells|genetically modified t cells
345298|NCT02117518|mRNA electroporation|mrna electroporation
345299|NCT02117505|Biological Availability|biological availability
345300|NCT02117505|JNJ-39220675|jnj-39220675
345301|NCT02117505|Healthy|healthy
345302|NCT02117505|Phase 1|phase 1
345303|NCT02117492|hysterectomy|hysterectomy
345304|NCT02117492|vaginal cuff|vaginal cuff
345305|NCT02117479|Metastatic pancreatic cancer|metastatic pancreatic cancer
345306|NCT02117479|Metastatic pancreatic adenocarcinoma that is recurrent|metastatic pancreatic adenocarcinoma that is recurrent
345307|NCT02117466|cetuximab|cetuximab
345308|NCT02117466|PET-imaging|pet-imaging
345309|NCT02117453|ANCA vasculitis|anca vasculitis
345310|NCT02117453|Statin|statin
345311|NCT02117453|Subclinical markers of atherosclerosis|subclinical markers of atherosclerosis
345312|NCT02117453|Cardiovascular events|cardiovascular events
345313|NCT02117453|Myocardial infarction|myocardial infarction
345314|NCT02117453|Stroke|stroke
345315|NCT02117453|Arterial revascularization|arterial revascularization
345316|NCT02117453|Unstable angina|unstable angina
345317|NCT02117453|Death|death
345318|NCT02117440|Lung Cancer|lung cancer
345319|NCT02117440|Lung Neoplasms|lung neoplasms
345320|NCT02117414|Magnetic Resonance Imaging (MRI)|magnetic resonance imaging (mri)
345321|NCT02117388|Older adults|older adults
345322|NCT02117388|insomnia|insomnia
345323|NCT02117388|CBT-I (cognitive behavioral therapy-insomnia)|cbt-i (cognitive behavioral therapy-insomnia)
345324|NCT02117388|Behavioral Therapy|behavioral therapy
345325|NCT02117388|SRT (sleep restriction therapy)|srt (sleep restriction therapy)
400537|NCT01866397|HCMV|hcmv
345326|NCT02117388|Cognitive Therapy|cognitive therapy
345327|NCT02117375|multiple sclerosis|multiple sclerosis
345328|NCT02117375|spinal cord|spinal cord
345330|NCT02117375|longitudinal study|longitudinal study
345331|NCT02117375|disability|disability
345332|NCT02117362|Melanoma|melanoma
345333|NCT02117362|Ipilimumab|ipilimumab
345334|NCT02117362|Yervoy|yervoy
345335|NCT02117362|Galectin|galectin
345336|NCT02117362|GR-MD-02|gr-md-02
345337|NCT02117362|galactoarabino-rhamnogalacturonate|galactoarabino-rhamnogalacturonate
345338|NCT02117362|galectin-3 inhibitor|galectin-3 inhibitor
345339|NCT02117362|Providence Health & Services|providence health & services
345340|NCT02117362|Earle A. Chiles Research Institute|earle a. chiles research institute
345341|NCT02117362|Robert W. Franz Cancer Center|robert w. franz cancer center
345342|NCT02117362|Immunotherapy|immunotherapy
345343|NCT02117349|surgical hemostasis|surgical hemostasis
345344|NCT02117349|bleeding|bleeding
345345|NCT02117349|fibrin sealant|fibrin sealant
345346|NCT02117349|fibrinogen|fibrinogen
345347|NCT02117349|thrombin|thrombin
345348|NCT02117349|spray dried|spray dried
345349|NCT02117323|corneal opacities|corneal opacities
345350|NCT02117323|Optical coherence tomography|optical coherence tomography
345351|NCT02117284|positron emission tomography (PET)|positron emission tomography (pet)
345352|NCT02117284|Rubidium-82|rubidium-82
345353|NCT02117284|myocardial perfusion imaging|myocardial perfusion imaging
345354|NCT02117284|automated elution system|automated elution system
345355|NCT02117284|controlled radioactivity delivery|controlled radioactivity delivery
345356|NCT02117271|obstructive sleep apnea|obstructive sleep apnea
345357|NCT02117271|treatment|treatment
345358|NCT02117271|placebo|placebo
345359|NCT02117271|appearance|appearance
345360|NCT02117271|skin quality|skin quality
345465|NCT02116738|flap|flap
345361|NCT02117258|Z-360, Pancreatic cancer, Pancreatic Adenocarcinoma|z-360, pancreatic cancer, pancreatic adenocarcinoma
345362|NCT02117245|Food effect on MGCD265 bioavailability in healthy volunteers|food effect on mgcd265 bioavailability in healthy volunteers
345363|NCT02117232|colonoscopy|colonoscopy
345364|NCT02117232|cecal intubation|cecal intubation
345365|NCT02117232|carbon dioxide insufflation|carbon dioxide insufflation
345366|NCT02117219|Myelodysplastic syndrome|myelodysplastic syndrome
345367|NCT02117219|MDS|mds
345368|NCT02117206|L-arginine|l-arginine
345369|NCT02117180|functional gastrointestinal disorders|functional gastrointestinal disorders
345370|NCT02117180|FGID|fgid
345371|NCT02117180|children|children
345372|NCT02117180|FODMAP|fodmap
345373|NCT02117154|Continuous Glucose Monitoring System|continuous glucose monitoring system
345374|NCT02117154|HbA1c|hba1c
345375|NCT02117154|Diabetes Mellitus, Type 2|diabetes mellitus, type 2
345376|NCT02117141|Food Effect|food effect
345377|NCT02117141|Pharmacokinetics|pharmacokinetics
345378|NCT02117128|Tranexamic Acid|tranexamic acid
345379|NCT02117128|Antifibrinolytic|antifibrinolytic
345380|NCT02117128|Blood transfusion|blood transfusion
345381|NCT02117128|Total knee arthroplasty|total knee arthroplasty
345382|NCT02117076|Restless leg syndrome|restless leg syndrome
345383|NCT02117076|RLS|rls
345384|NCT02117076|gabapentin|gabapentin
345385|NCT02117076|gabapentin enacarbil|gabapentin enacarbil
345386|NCT02117076|Neurontin|neurontin
345387|NCT02117076|Horizant|horizant
345388|NCT02117050|Multiple Sclerosis|multiple sclerosis
345389|NCT02117050|Rebif ®|rebif ®
345390|NCT02117050|Tecfidera ™|tecfidera ™
345391|NCT02117050|treatment change|treatment change
345392|NCT02117024|lung|lung
345393|NCT02117024|cancer|cancer
345394|NCT02117024|gp96|gp96
345395|NCT02117024|vaccine|vaccine
345396|NCT02117024|immunotherapy|immunotherapy
345397|NCT02117024|Heat Biologics|heat biologics
345398|NCT02117024|cyclophosphamide|cyclophosphamide
345399|NCT02117024|vinorelbine|vinorelbine
345400|NCT02117024|erlotinib|erlotinib
345401|NCT02117024|gemcitabine|gemcitabine
345402|NCT02117024|paclitaxel|paclitaxel
345403|NCT02117024|docetaxel|docetaxel
345404|NCT02117024|pemetrexed|pemetrexed
345405|NCT02116998|GEN-004|gen-004
345406|NCT02116998|Aluminum hydroxide|aluminum hydroxide
345407|NCT02116998|Vaccine|vaccine
345408|NCT02116998|Streptococcus pneumoniae|streptococcus pneumoniae
345409|NCT02116998|Pneumococcal Infections|pneumococcal infections
345410|NCT02116998|Strep pneumoniae|strep pneumoniae
345411|NCT02116998|Pneumonia|pneumonia
345412|NCT02116985|Dual-Loop TCI|dual-loop tci
345413|NCT02116985|NI|ni
345414|NCT02116985|Laparoscopic Cholecystectomy|laparoscopic cholecystectomy
345415|NCT02116972|osteoarthritis|osteoarthritis
345416|NCT02116972|knee|knee
345417|NCT02116972|pain|pain
345418|NCT02116972|corticosteroid|corticosteroid
345419|NCT02116972|intra-articular|intra-articular
345420|NCT02116972|injection|injection
345421|NCT02116959|Systemic|systemic
345422|NCT02116959|Chemotherapy|chemotherapy
345423|NCT02116959|Melphalan|melphalan
345424|NCT02116933|Autologous Fat Grafting|autologous fat grafting
345425|NCT02116933|Breast Augmentation|breast augmentation
775452|NCT00347126|Travoprost|travoprost
441669|NCT01681589|TBI|tbi
345426|NCT02116933|Stromal Vascular Fraction|stromal vascular fraction
345427|NCT02116933|Adipose Derived Stem Cell|adipose derived stem cell
345428|NCT02116920|CIN|cin
345429|NCT02116920|HPV DNA|hpv dna
345430|NCT02116920|mRNA E6/E7|mrna e6/e7
345431|NCT02116920|CIN triage|cin triage
345432|NCT02116920|Cervix Biopsy|cervix biopsy
345433|NCT02116920|VIA|via
345434|NCT02116920|Cervix Cancer|cervix cancer
345435|NCT02116907|Healthy|healthy
345436|NCT02116907|Male Subjects|male subjects
345437|NCT02116894|Colorectal cancer|colorectal cancer
345438|NCT02116894|PF-03446962|pf-03446962
345439|NCT02116894|regorafenib|regorafenib
345440|NCT02116881|Incisional hernia|incisional hernia
345441|NCT02116881|colorectal surgery|colorectal surgery
345442|NCT02116881|bowel obstruction|bowel obstruction
345443|NCT02116868|Pupillometry|pupillometry
345444|NCT02116868|Pupillary reflex|pupillary reflex
345445|NCT02116868|Analgesia|analgesia
345446|NCT02116868|Laparoscopic surgery|laparoscopic surgery
345447|NCT02116868|Total intravenous anesthesia|total intravenous anesthesia
345448|NCT02116868|Target controlled infusion|target controlled infusion
345449|NCT02116803|solid tumors|solid tumors
345450|NCT02116803|TKI258|tki258
345451|NCT02116803|Dovitinib|dovitinib
345452|NCT02116803|fulvestrant|fulvestrant
345453|NCT02116803|cancers with a mass|cancers with a mass
345454|NCT02116803|bulky tumor|bulky tumor
345455|NCT02116803|nodule|nodule
345456|NCT02116803|lump|lump
345457|NCT02116803|cancer|cancer
345458|NCT02116803|solid malignancies|solid malignancies
345459|NCT02116790|acute|acute
345460|NCT02116790|pain|pain
345461|NCT02116764|Rare Diseases|rare diseases
345462|NCT02116764|Primary Immune Deficiency Consortium|primary immune deficiency consortium
345463|NCT02116764|Retrospective|retrospective
345464|NCT02116751|HIV, antiretroviral, toxicity, eGFR, tubular disease, BMD|hiv, antiretroviral, toxicity, egfr, tubular disease, bmd
345466|NCT02116738|pilonidal sinus|pilonidal sinus
345468|NCT02116738|recurrence|recurrence
345469|NCT02116712|LAM|lam
345470|NCT02116712|saracatinib|saracatinib
345471|NCT02116712|Lymphangioleiomyomatosis|lymphangioleiomyomatosis
345472|NCT02116699|oropharyngeal|oropharyngeal
345473|NCT02116699|colostrum|colostrum
345474|NCT02116699|mother's milk|mother's milk
345475|NCT02116699|premature|premature
345476|NCT02116699|neonate|neonate
345477|NCT02116699|infection|infection
345478|NCT02116699|necrotizing enterocolitis|necrotizing enterocolitis
345479|NCT02116699|ventilator-associated pneumonia|ventilator-associated pneumonia
345480|NCT02116699|breastmilk|breastmilk
345481|NCT02116699|human milk|human milk
345482|NCT02116699|late-onset sepsis|late-onset sepsis
345483|NCT02116699|microbiome|microbiome
345484|NCT02116699|antioxidant|antioxidant
345485|NCT02116699|enteral feeds|enteral feeds
345486|NCT02116686|chronic heart failure|chronic heart failure
345487|NCT02116686|Polysomnography|polysomnography
345488|NCT02116686|Sleep Apnea Syndromes|sleep apnea syndromes
345489|NCT02116686|Electrocardiogram|electrocardiogram
345490|NCT02116673|Head injury|head injury
345491|NCT02116673|Concussion|concussion
345492|NCT02116673|Cognitive rest|cognitive rest
345493|NCT02116673|Emergency department|emergency department
345494|NCT02116647|Gender discrimination|gender discrimination
345495|NCT02116647|Psychoanalysis|psychoanalysis
345496|NCT02116647|Randomized controlled trial|randomized controlled trial
345497|NCT02116621|Musculoskeletal pain|musculoskeletal pain
345498|NCT02116621|Chronic pain|chronic pain
345499|NCT02116621|Patient centered outcomes research|patient centered outcomes research
345500|NCT02116621|Physician patient relationship|physician patient relationship
345501|NCT02116621|Mobile applications|mobile applications
345502|NCT02116595|volunteers|volunteers
345503|NCT02116582|MDV3100|mdv3100
345504|NCT02116582|Xtandi|xtandi
345505|NCT02116582|Abiraterone|abiraterone
345506|NCT02116582|Metastatic Castration-Resistant Prostate Cancer|metastatic castration-resistant prostate cancer
345507|NCT02116582|Enzalutamide|enzalutamide
345508|NCT02116569|Multiple Myeloma|multiple myeloma
345509|NCT02116569|Daratumumab|daratumumab
345510|NCT02116569|JNJ-54767414|jnj-54767414
345511|NCT02116569|Phase 1|phase 1
345512|NCT02116569|Relapse|relapse
345513|NCT02116569|Refractory|refractory
345514|NCT02116556|Alcoholic Hepatitis|alcoholic hepatitis
345515|NCT02116556|Bacterial Infections|bacterial infections
345516|NCT02116556|Acute-on-Chronic Liver Failure|acute-on-chronic liver failure
345517|NCT02116543|Hepatitis C|hepatitis c
345518|NCT02116543|HCV|hcv
345519|NCT02116517|obese women|obese women
345520|NCT02116517|high LDL-C|high ldl-c
345521|NCT02116504|Rheumatoid arthritis|rheumatoid arthritis
345522|NCT02116504|Juvenile Idiopathic Arthritis|juvenile idiopathic arthritis
345523|NCT02116504|Biopharmaceutical|biopharmaceutical
345524|NCT02116504|Immunogenicity|immunogenicity
345525|NCT02116504|Anti-Drug Antibody|anti-drug antibody
345526|NCT02116504|Prediction|prediction
345527|NCT02116478|plantar fasciitis|plantar fasciitis
345528|NCT02116478|gastrocnemius recession|gastrocnemius recession
345529|NCT02116439|Violence|violence
345530|NCT02116426|copeptin|copeptin
345531|NCT02116426|troponin HS|troponin hs
345532|NCT02116413|fluid challenge|fluid challenge
345533|NCT02116413|fluid resuscitation|fluid resuscitation
345534|NCT02116400|Suicidal ideation|suicidal ideation
345535|NCT02116387|Proprioception|proprioception
345536|NCT02116348|Cerebral palsy children|cerebral palsy children
345537|NCT02116348|Cerebrolysin|cerebrolysin
345538|NCT02116348|Sleep questionnaire|sleep questionnaire
345539|NCT02116348|Quality of life|quality of life
345540|NCT02116348|Bayley III scale|bayley iii scale
345541|NCT02116335|arterial stiffness|arterial stiffness
345542|NCT02116335|flow-mediated dilation|flow-mediated dilation
345543|NCT02116335|endothelial function|endothelial function
345544|NCT02116335|pulse wave velocity|pulse wave velocity
345545|NCT02116335|inflammation|inflammation
345546|NCT02116335|oxidative stress|oxidative stress
345547|NCT02116335|Nitric Oxide|nitric oxide
345548|NCT02116335|Cold Pressor Test|cold pressor test
345549|NCT02116335|physio flow|physio flow
345550|NCT02116335|Bosentan|bosentan
345551|NCT02116335|Endothelin Receptor|endothelin receptor
345552|NCT02116335|Endothelin-1|endothelin-1
345553|NCT02116335|BMI|bmi
345554|NCT02116335|stress|stress
345555|NCT02116335|blood pressure|blood pressure
345556|NCT02116283|smoking|smoking
345557|NCT02116283|healthy|healthy
345558|NCT02116283|smartphone|smartphone
345559|NCT02116270|Renal Failure|renal failure
345560|NCT02116270|Dialysis|dialysis
345561|NCT02116270|Biological Aging|biological aging
345562|NCT02116257|Nausea|nausea
345563|NCT02116257|Vomiting|vomiting
345564|NCT02116244|Dry Eye|dry eye
345565|NCT02116244|Civamide|civamide
345566|NCT02116244|Zucapsaicin|zucapsaicin
345567|NCT02116244|Neuropeptides|neuropeptides
345568|NCT02116244|TRPV-1|trpv-1
345569|NCT02116231|Nasopharyngeal neoplasm;IMRT; Concurrent chemotherapy|nasopharyngeal neoplasm;imrt; concurrent chemotherapy
345570|NCT02116218|Traditional Chinese Medicine|traditional chinese medicine
345571|NCT02116218|acupuncture|acupuncture
345572|NCT02116218|complementary alternative medicine|complementary alternative medicine
345573|NCT02116218|cancer pain|cancer pain
345574|NCT02116218|emergency department|emergency department
345575|NCT02116205|Hantaan virus|hantaan virus
345576|NCT02116205|Puumala virus|puumala virus
345577|NCT02116205|HFRS|hfrs
345578|NCT02116192|Non-alcoholic Fatty Liver Disease|non-alcoholic fatty liver disease
345579|NCT02116192|Adolescent|adolescent
345580|NCT02116179|Human Immunodeficiency Virus|human immunodeficiency virus
345581|NCT02116179|Acquired Immunodeficiency Syndrome|acquired immunodeficiency syndrome
345582|NCT02116179|Hepatitis C|hepatitis c
345583|NCT02116179|Hispanic|hispanic
345584|NCT02116179|Criminal Justice|criminal justice
345585|NCT02116166|aging|aging
345586|NCT02116166|sarcopenia|sarcopenia
345587|NCT02116166|mitochondria|mitochondria
345588|NCT02116166|skeletal muscle|skeletal muscle
345589|NCT02116166|inflammation|inflammation
345590|NCT02116153|Cardiac Troponin T|cardiac troponin t
345591|NCT02116153|Micro-RNA|micro-rna
345592|NCT02116153|Sensitivity|sensitivity
345593|NCT02116153|Specificity|specificity
345594|NCT02116140|positron emission tomography|positron emission tomography
345595|NCT02116140|[11C]hydroxyephedrine (HED)|[11c]hydroxyephedrine (hed)
345596|NCT02116140|[11C]acetate|[11c]acetate
345597|NCT02116140|Adaptive Servoventilation (ASV)|adaptive servoventilation (asv)
345598|NCT02116140|Myocardial Energetics|myocardial energetics
345599|NCT02116140|work-metabolic index (WMI)|work-metabolic index (wmi)
345600|NCT02116140|Myocardial sympathetic neuron (SN) presynaptic function continuous positive airway pressure|myocardial sympathetic neuron (sn) presynaptic function continuous positive airway pressure
345601|NCT02116140|heart rate variability|heart rate variability
345602|NCT02116140|overnight polysomnogram|overnight polysomnogram
345603|NCT02116140|Plasma Norepinephrine|plasma norepinephrine
345604|NCT02116140|Urine Normetanephrine|urine normetanephrine
345605|NCT02116140|Quality of Life|quality of life
345606|NCT02116127|Depression|depression
345607|NCT02116127|Pregnancy|pregnancy
345608|NCT02116127|Transcranial Direct Current Stimulation|transcranial direct current stimulation
345609|NCT02116114|Pulmonary Disease, Chronic Obstructive|pulmonary disease, chronic obstructive
345610|NCT02116101|Intestinal Health|intestinal health
345611|NCT02116101|Prebiotics|prebiotics
345612|NCT02116101|Blood Lipid|blood lipid
345613|NCT02116088|Externalizing problem behavior, teacher training, teacher coaching, primary school, elementary school, continuing professional development, advanced training|externalizing problem behavior, teacher training, teacher coaching, primary school, elementary school, continuing professional development, advanced training
345614|NCT02116049|Disclosure, intervention|disclosure, intervention
345616|NCT02116049|prevention|prevention
345617|NCT02116049|Disclosure Intervention|disclosure intervention
345618|NCT02116049|Attention Control Case Management|attention control case management
345619|NCT02116036|Antiphospholipid Antibody Syndrome|antiphospholipid antibody syndrome
345620|NCT02116036|Rivaroxaban|rivaroxaban
345621|NCT02116036|Thromboembolism|thromboembolism
345622|NCT02116036|Bleeding|bleeding
345623|NCT02116036|Feasibility|feasibility
345624|NCT02116023|Satiety, beverage, crossover|satiety, beverage, crossover
345625|NCT02116010|Wound Infection in burned patient|wound infection in burned patient
345626|NCT02115971|chronic|chronic
345627|NCT02115971|functional|functional
345628|NCT02115971|instability|instability
345629|NCT02115971|ankle|ankle
345630|NCT02115945|chronic postoperative pain|chronic postoperative pain
345631|NCT02115945|total knee arthroplasty|total knee arthroplasty
345632|NCT02115945|femoral block|femoral block
345633|NCT02115945|We aimed to compare the effects of epidural and femoral block on acute and chronic postoperative pain.|we aimed to compare the effects of epidural and femoral block on acute and chronic postoperative pain.
345634|NCT02115932|Diabetes Mellitus|diabetes mellitus
345635|NCT02115932|Diabetes Mellitus, Type 2|diabetes mellitus, type 2
345636|NCT02115932|Diabetes Complications|diabetes complications
345637|NCT02115932|Diabetic Foot|diabetic foot
345638|NCT02115932|Diabetic Neuropathies|diabetic neuropathies
345639|NCT02115932|Gait|gait
345640|NCT02115932|Balance, Postural|balance, postural
345641|NCT02115932|Muscle Strength|muscle strength
345642|NCT02115932|Exercise Therapy|exercise therapy
345643|NCT02115932|Physical Therapy Modalities|physical therapy modalities
345644|NCT02115932|Endocrine System Diseases|endocrine system diseases
345645|NCT02115932|Peripheral Nervous System Diseases|peripheral nervous system diseases
345646|NCT02115932|Metabolic Diseases|metabolic diseases
345647|NCT02115932|Glucose Metabolism Diseases|glucose metabolism diseases
345648|NCT02115932|Quality of Life|quality of life
345649|NCT02115932|Training|training
345650|NCT02115919|condyloma|condyloma
345651|NCT02115919|HIV|hiv
345652|NCT02115893|Nitrate|nitrate
345653|NCT02115893|Performance|performance
345654|NCT02115893|Sports|sports
345655|NCT02115880|Depression|depression
345656|NCT02115880|Prevention|prevention
345657|NCT02115880|Adolescent|adolescent
345658|NCT02115880|Child|child
345659|NCT02115880|Randomised Controlled Trial|randomised controlled trial
345660|NCT02115880|Risk|risk
345661|NCT02115880|Cognitive behavioural therapy|cognitive behavioural therapy
345662|NCT02115880|Group-based therapy|group-based therapy
345663|NCT02115867|diverticular disease|diverticular disease
345664|NCT02115867|diverticulitis|diverticulitis
345665|NCT02115867|diverticulosis|diverticulosis
345666|NCT02115854|usefullness of labial biopsy to distinguish between tuberculosis and sarcoidosis|usefullness of labial biopsy to distinguish between tuberculosis and sarcoidosis
345667|NCT02115841|Transcutaneous Nerve Stimulation|transcutaneous nerve stimulation
345668|NCT02115841|serial reaction time task|serial reaction time task
345669|NCT02115841|functional near infrared spectroscopy|functional near infrared spectroscopy
345670|NCT02115841|transcranial magnetic stimulation|transcranial magnetic stimulation
345671|NCT02115828|Vismodegib|vismodegib
345672|NCT02115828|Metastatic Castration-Resistant Prostate Cancer|metastatic castration-resistant prostate cancer
345673|NCT02115828|Accessible Metastatic Lesions for Tumor Biopsy|accessible metastatic lesions for tumor biopsy
345674|NCT02115815|Respiratory Syncytial Virus (RSV)|respiratory syncytial virus (rsv)
345675|NCT02115815|MEDI7510|medi7510
345676|NCT02115789|cicatrix|cicatrix
345677|NCT02115789|Demonstrate|demonstrate
345678|NCT02115789|that there|that there
345679|NCT02115789|is no perception of superiority|is no perception of superiority
345680|NCT02115776|bacteremia|bacteremia
345681|NCT02115776|prophylaxis|prophylaxis
345682|NCT02115776|antibiotics|antibiotics
345683|NCT02115776|dentistry|dentistry
345684|NCT02115763|physically active,|physically active,
345685|NCT02115763|18-35 year old men|18-35 year old men
345686|NCT02115750|CHS-0214|chs-0214
345687|NCT02115750|Enbrel|enbrel
345688|NCT02115750|RA|ra
345689|NCT02115750|Biosimilar|biosimilar
345690|NCT02115750|Etanercept|etanercept
345691|NCT02115724|Low childhood SES|low childhood ses
345692|NCT02115724|Early Life Stress|early life stress
345693|NCT02115724|Endothelial function|endothelial function
345694|NCT02115724|Flow mediated dilation|flow mediated dilation
345695|NCT02115724|Cardiovascular disease|cardiovascular disease
345696|NCT02115724|Subcutaneous adipose arterioles|subcutaneous adipose arterioles
345697|NCT02115711|India|india
345698|NCT02115711|Cardiovascular risk factors|cardiovascular risk factors
345699|NCT02115711|Community health workers|community health workers
345700|NCT02115711|Hypertension|hypertension
345701|NCT02115711|Diabetes|diabetes
345702|NCT02115711|Smoking|smoking
345703|NCT02115698|Sarcopenia|sarcopenia
345704|NCT02115698|Frailty|frailty
345705|NCT02115698|Ageing|ageing
345706|NCT02115698|Protein supplementation|protein supplementation
345707|NCT02115698|Protein quality|protein quality
345708|NCT02115698|Exercise training|exercise training
345709|NCT02115698|Muscle protein turnover|muscle protein turnover
345710|NCT02115685|spinal cord injury|spinal cord injury
345711|NCT02115685|sympathetic nervous system|sympathetic nervous system
345712|NCT02115685|locomotor training|locomotor training
345713|NCT02115685|exercise|exercise
345714|NCT02115672|Chronic myeloid leukemia|chronic myeloid leukemia
345715|NCT02115672|imatinib|imatinib
345716|NCT02115672|CXCR4 antagonist|cxcr4 antagonist
442053|NCT01680042|VAS|vas
345717|NCT02115672|BL-8040|bl-8040
345718|NCT02115659|ADPKD|adpkd
345719|NCT02115659|triptolide|triptolide
345720|NCT02115646|burn|burn
345721|NCT02115646|scar|scar
345722|NCT02115620|Heart failure|heart failure
345723|NCT02115620|Cardiac failure|cardiac failure
345724|NCT02115620|Congestive Heart Failure|congestive heart failure
345725|NCT02115620|Cardiomyopathy|cardiomyopathy
345726|NCT02115620|Myocardial Failure|myocardial failure
345727|NCT02115620|Telemedicine|telemedicine
345728|NCT02115620|Telehealth|telehealth
345729|NCT02115620|Remote Consultation|remote consultation
345730|NCT02115607|Breast cancer|breast cancer
345731|NCT02115607|Interstitial fluid pressure|interstitial fluid pressure
345732|NCT02115607|Angiogenesis|angiogenesis
345733|NCT02115607|Contrast enhanced ultrasound imaging|contrast enhanced ultrasound imaging
345734|NCT02115607|Subharmonic imaging|subharmonic imaging
345735|NCT02115607|Subharmonic pressure estimation|subharmonic pressure estimation
345736|NCT02115594|metastatic breast cancer|metastatic breast cancer
345737|NCT02115594|estrogen receptor|estrogen receptor
345738|NCT02115594|Histone Deacetylase Inhibitors|histone deacetylase inhibitors
345739|NCT02115594|Histone Deacetylases|histone deacetylases
345740|NCT02115594|HDAC inhibitors|hdac inhibitors
345741|NCT02115594|selective estrogen receptor modulator|selective estrogen receptor modulator
345742|NCT02115594|estrogen receptor modulator, selective|estrogen receptor modulator, selective
345743|NCT02115594|Estrogen receptor modulators, selective|estrogen receptor modulators, selective
345744|NCT02115581|Coenzyme O10|coenzyme o10
345745|NCT02115581|Children|children
345746|NCT02115581|Idiopathic Dilated Cardiomyopathy|idiopathic dilated cardiomyopathy
345747|NCT02115555|type 1|type 1
345748|NCT02115555|diabetes|diabetes
345749|NCT02115555|adolescents|adolescents
345750|NCT02115555|heath information technology|heath information technology
345751|NCT02115542|biliary|biliary
345752|NCT02115542|liver|liver
345753|NCT02115542|Refractory Advanced Biliary Cancers|refractory advanced biliary cancers
345754|NCT02115542|gallbladder cancer|gallbladder cancer
345755|NCT02115542|carcinoma|carcinoma
345756|NCT02115542|intra-hepatic biliary system|intra-hepatic biliary system
345757|NCT02115542|extra-hepatic biliary system|extra-hepatic biliary system
345758|NCT02115542|gall bladder|gall bladder
345759|NCT02115542|unresectable|unresectable
345760|NCT02115542|locally advanced|locally advanced
345761|NCT02115542|metastatic disease|metastatic disease
345762|NCT02115542|Bile Duct Diseases|bile duct diseases
345763|NCT02115542|Gallbladder Diseases|gallbladder diseases
345764|NCT02115542|regorafenib|regorafenib
345765|NCT02115542|stivarga|stivarga
345766|NCT02115542|Bay 73-4506|bay 73-4506
345767|NCT02115542|multikinase inhibitor|multikinase inhibitor
345768|NCT02115516|Malaria|malaria
345769|NCT02115516|Plasmodium falciparum malaria|plasmodium falciparum malaria
345770|NCT02115516|Antimalarial chemoprophylaxis|antimalarial chemoprophylaxis
345771|NCT02115516|PfSPZ Challenge|pfspz challenge
345772|NCT02115516|Cryopreserved Plasmodium Falciparum Sporozoites|cryopreserved plasmodium falciparum sporozoites
345773|NCT02115516|PfSPZ-CVac|pfspz-cvac
345774|NCT02115490|Alveolar bone|alveolar bone
345775|NCT02115490|Bisphosphonates|bisphosphonates
345776|NCT02115490|Cone-beam CT|cone-beam ct
345777|NCT02115490|Osteoporosis|osteoporosis
345778|NCT02115477|Uterus cancer|uterus cancer
345779|NCT02115477|Hysterectomy|hysterectomy
345780|NCT02115477|Lymphadenectomy|lymphadenectomy
345781|NCT02115477|Lymphedema|lymphedema
345782|NCT02115464|Metformin|metformin
345783|NCT02115464|Non-small cell lung cancer|non-small cell lung cancer
345784|NCT02115464|Locally advanced|locally advanced
345785|NCT02115464|Chemo-radiotherapy|chemo-radiotherapy
345786|NCT02115464|Lung cancer treatment|lung cancer treatment
345787|NCT02115399|Dermatitis|dermatitis
345788|NCT02115399|Staphylococcus|staphylococcus
345789|NCT02115399|Staphylococcus aureus|staphylococcus aureus
345790|NCT02115399|Dermatitis, Atopic|dermatitis, atopic
345791|NCT02115399|Non-atopic controls|non-atopic controls
345792|NCT02115386|Ph+ CML, chronic myeloid leukemia|ph+ cml, chronic myeloid leukemia
345793|NCT02115373|Hepatocellular Carcinoma|hepatocellular carcinoma
345794|NCT02115373|c-Met inhibitor|c-met inhibitor
345795|NCT02115373|Phase 1b|phase 1b
345796|NCT02115373|Sorafenib|sorafenib
345797|NCT02115373|MSC2156119J|msc2156119j
345798|NCT02115360|epidural calcitonin|epidural calcitonin
345799|NCT02115360|amputation|amputation
345800|NCT02115360|postoperative pain|postoperative pain
345801|NCT02115360|Later Complication|later complication
345802|NCT02115334|Developmental delay|developmental delay
345803|NCT02115334|Early Intervention|early intervention
345804|NCT02115334|Home programs|home programs
345805|NCT02115334|Preschool activities|preschool activities
345806|NCT02115269|Indoprocaf|indoprocaf
345807|NCT02115269|Indomethacin|indomethacin
345808|NCT02115269|Caffeine|caffeine
345809|NCT02115269|Prochlorperazine|prochlorperazine
345810|NCT02115269|Migraine with Aura|migraine with aura
345811|NCT02115269|Migraine without Aura|migraine without aura
345812|NCT02115269|Tension-Type Headache|tension-type headache
345813|NCT02115256|External Cephalic Version|external cephalic version
345814|NCT02115256|breech|breech
345815|NCT02115230|Heart Failure|heart failure
345816|NCT02115230|Heart Failure, Diastolic|heart failure, diastolic
345817|NCT02115230|Hypertension|hypertension
345818|NCT02115230|Renal Denervation|renal denervation
345819|NCT02115230|Irrigated Radiofrequency Catheter|irrigated radiofrequency catheter
345820|NCT02115217|Kinestiotaping|kinestiotaping
345821|NCT02115217|Basketball players|basketball players
345822|NCT02115217|Effect of kinesiotaping|effect of kinesiotaping
345823|NCT02115217|on postural stability|on postural stability
345824|NCT02115191|2-octylcyanoacrylate|2-octylcyanoacrylate
345825|NCT02115191|Urethrocutaneous fistulas.|urethrocutaneous fistulas.
345826|NCT02115191|Closure.|closure.
345827|NCT02115191|Recurrence.|recurrence.
345828|NCT02115178|Hemodynamic changes|hemodynamic changes
345829|NCT02115178|Spinal anesthesia|spinal anesthesia
345830|NCT02115178|Patient position|patient position
345831|NCT02115178|Impedance cardiography|impedance cardiography
345832|NCT02115152|Capecitabine|capecitabine
345833|NCT02115152|Neoadjuvant therapy|neoadjuvant therapy
345834|NCT02115152|Early Breast Cancer|early breast cancer
345835|NCT02115139|melanoma|melanoma
345836|NCT02115139|brain|brain
345837|NCT02115139|metastases|metastases
345838|NCT02115139|Patients with melanoma and brain metastases|patients with melanoma and brain metastases
345839|NCT02115113|Liver transplantation, everolimus, CNI-minimization, CNI-elimination, renal function|liver transplantation, everolimus, cni-minimization, cni-elimination, renal function
345840|NCT02115100|Paroxysmal atrial fibrillation|paroxysmal atrial fibrillation
345841|NCT02115100|Persistent atrial fibrillation|persistent atrial fibrillation
345842|NCT02115100|Out of range hypertension|out of range hypertension
345843|NCT02115100|Signs of sympathetic overdrive|signs of sympathetic overdrive
345844|NCT02115087|laparotomy|laparotomy
345845|NCT02115087|levobupivacaine|levobupivacaine
345846|NCT02115087|patient controlled analgesia|patient controlled analgesia
345847|NCT02115074|Low-grade gliomas|low-grade gliomas
345848|NCT02115074|high-grade gliomas|high-grade gliomas
345849|NCT02115074|optico-chiasmatic|optico-chiasmatic
345850|NCT02115074|relapsed|relapsed
345851|NCT02115074|refractory|refractory
345852|NCT02115061|Gastric varices,coil,cyanoacrylate,treating gastric varices.|gastric varices,coil,cyanoacrylate,treating gastric varices.
345853|NCT02115035|Multiple Myeloma|multiple myeloma
345854|NCT02115022|pancreatic cancer|pancreatic cancer
345855|NCT02115022|resectability|resectability
345856|NCT02115022|endosonography (EUS)|endosonography (eus)
345857|NCT02115022|multidetection computer tomography (MDCT)|multidetection computer tomography (mdct)
345858|NCT02115022|staging|staging
345859|NCT02115009|sacroiliac joint lumbopelvic ,chronic low back pain|sacroiliac joint lumbopelvic ,chronic low back pain
345860|NCT02114996|mechanical ventilation|mechanical ventilation
345861|NCT02114996|ischemic stroke|ischemic stroke
345862|NCT02114983|deep vein thrombosis|deep vein thrombosis
345863|NCT02114983|diagnostic accuracy|diagnostic accuracy
345864|NCT02114983|general practitioner|general practitioner
345865|NCT02114983|test|test
345866|NCT02114983|compression ultrasonography|compression ultrasonography
345867|NCT02114983|ultrasound|ultrasound
345868|NCT02114970|Older Adults|older adults
345869|NCT02114970|Informed Consent|informed consent
345870|NCT02114970|Technology|technology
345871|NCT02114970|Tablet-delivered|tablet-delivered
345872|NCT02114957|bio-availability|bio-availability
345873|NCT02114957|decursin|decursin
345874|NCT02114957|decursinol angelate|decursinol angelate
345875|NCT02114957|decursinol|decursinol
345876|NCT02114957|subjects|subjects
345877|NCT02114944|Do-not-intubate|do-not-intubate
345878|NCT02114944|DNI|dni
345879|NCT02114944|Palliative treatment|palliative treatment
345880|NCT02114944|Acute respiratory failure|acute respiratory failure
345881|NCT02114944|Acute on chronic respiratory failure|acute on chronic respiratory failure
345882|NCT02114944|Hypoxia|hypoxia
345883|NCT02114944|Respiratory acidosis|respiratory acidosis
345884|NCT02114944|Hypercarbia|hypercarbia
345885|NCT02114944|Non invasive ventilation|non invasive ventilation
345886|NCT02114944|NIV|niv
345887|NCT02114944|CPAP|cpap
345888|NCT02114944|Oxygen-therapy|oxygen-therapy
345889|NCT02114944|High-flow oxygen therapy|high-flow oxygen therapy
345890|NCT02114931|arthritis|arthritis
345891|NCT02114931|rheumatoid|rheumatoid
345892|NCT02114918|obsessive compulsive disorder|obsessive compulsive disorder
345893|NCT02114918|children|children
345894|NCT02114918|adolescents|adolescents
345895|NCT02114918|attention bias modification|attention bias modification
345896|NCT02114905|Tourette's|tourette's
345897|NCT02114905|Tic Disorder|tic disorder
345898|NCT02114905|CBIT|cbit
345899|NCT02114905|Dissemination|dissemination
345900|NCT02114905|Occupational Therapist|occupational therapist
345901|NCT02114892|metabolic syndrome|metabolic syndrome
345902|NCT02114892|central obesity|central obesity
345903|NCT02114892|resveratrol|resveratrol
345904|NCT02114892|insulin secretion|insulin secretion
345905|NCT02114892|insulin sensitivity|insulin sensitivity
345906|NCT02114879|Physical Therapy|physical therapy
345907|NCT02114879|Occupational Therapy|occupational therapy
345908|NCT02114879|Rehabilitation|rehabilitation
345909|NCT02114879|Older adults|older adults
345910|NCT02114879|Depression|depression
345911|NCT02114879|Physical Functioning|physical functioning
345912|NCT02114827|Multiple Myeloma|multiple myeloma
345913|NCT02114814|Diabetes|diabetes
345914|NCT02114814|Hispanic|hispanic
345915|NCT02114814|Adult|adult
345916|NCT02114814|Family Member|family member
345917|NCT02114801|Cerebral Palsy;|cerebral palsy;
345918|NCT02114801|Toothbrushing;|toothbrushing;
345919|NCT02114801|Dental Plaque|dental plaque
345920|NCT02114775|mild traumatic brain injury|mild traumatic brain injury
345921|NCT02114775|growth hormone|growth hormone
345922|NCT02114775|fatigue|fatigue
345923|NCT02114775|sildenafil|sildenafil
345924|NCT02114775|neurology|neurology
345925|NCT02114762|otitis media|otitis media
345926|NCT02114762|eustachian tube|eustachian tube
345927|NCT02114762|eustachian tube dysfunction|eustachian tube dysfunction
345928|NCT02114762|eustachian tube function testing|eustachian tube function testing
345929|NCT02114749|Healthy volunteers|healthy volunteers
345930|NCT02114749|Physiological variables : respiration and circulation|physiological variables : respiration and circulation
345931|NCT02114736|Stroke|stroke
345932|NCT02114736|Muscle spasticity|muscle spasticity
345933|NCT02114736|Stiff knee gait|stiff knee gait
345934|NCT02114736|Botulinum toxin|botulinum toxin
345935|NCT02114736|Tenotomy|tenotomy
345936|NCT02114723|Mediacal Taping concept|mediacal taping concept
345937|NCT02114723|Neuromuscular bandage|neuromuscular bandage
345938|NCT02114723|Physiotherapy techniques|physiotherapy techniques
345939|NCT02114723|Kinesio Tape|kinesio tape
345940|NCT02114710|coagulopathy|coagulopathy
345941|NCT02114710|hydrocortisone|hydrocortisone
345942|NCT02114710|organ failure|organ failure
345943|NCT02114697|Cancer survivorship|cancer survivorship
345944|NCT02114697|Cardiovascular disease|cardiovascular disease
345945|NCT02114697|Stroke|stroke
345946|NCT02114697|Transient ischemic attack (TIA)|transient ischemic attack (tia)
345947|NCT02114658|Anaplastic and medullary thyroid carcinoma|anaplastic and medullary thyroid carcinoma
345948|NCT02114658|Thyroid Neoplasms|thyroid neoplasms
345949|NCT02114645|Luteal phase support,GnRH agonist,ART cycles|luteal phase support,gnrh agonist,art cycles
345950|NCT02114632|ADHD, attention deficit/hyperactivity disorder, attention deficit disorder, inattention, cognitive skills, children, polyunsaturated fatty acids, PUFA|adhd, attention deficit/hyperactivity disorder, attention deficit disorder, inattention, cognitive skills, children, polyunsaturated fatty acids, pufa
345951|NCT02114619|radioiodine therapy|radioiodine therapy
345952|NCT02114619|Graves' disease|graves' disease
345953|NCT02114619|Hyperthyroidism|hyperthyroidism
345954|NCT02114619|calculated dose|calculated dose
345955|NCT02114606|Eosinophilic Esophagitis|eosinophilic esophagitis
345956|NCT02114606|EoE|eoe
345957|NCT02114606|Cytosponge|cytosponge
345958|NCT02114593|Mental Health|mental health
345959|NCT02114593|Children|children
345960|NCT02114593|Parent support program|parent support program
345961|NCT02114593|Somali families|somali families
345962|NCT02114593|Sweden|sweden
345963|NCT02114580|mild cognitive impairment|mild cognitive impairment
345964|NCT02114580|exercise|exercise
345965|NCT02114580|brain plasticity|brain plasticity
345966|NCT02114580|FMRI|fmri
345967|NCT02114567|AECOPD|aecopd
345968|NCT02114567|work of breathing|work of breathing
345969|NCT02114567|patient-ventilator synchrony|patient-ventilator synchrony
345970|NCT02114554|MELAS|melas
345971|NCT02114554|MIDD|midd
345972|NCT02114554|Heteroplasmy|heteroplasmy
345973|NCT02114528|Ventricular Tachycardia|ventricular tachycardia
345974|NCT02114528|Ventricular Arrhythmia|ventricular arrhythmia
345975|NCT02114528|Anti-arrhythmic drugs|anti-arrhythmic drugs
345976|NCT02114528|Catheter Ablation|catheter ablation
345977|NCT02114528|ICD Shocks|icd shocks
345978|NCT02114515|Patient Navigators|patient navigators
345979|NCT02114515|Readmissions|readmissions
345980|NCT02114515|Peer Coaching|peer coaching
345981|NCT02114502|Myeloma|myeloma
345982|NCT02114502|Multiple myeloma|multiple myeloma
345983|NCT02114502|MM|mm
345984|NCT02114502|Refractory|refractory
345985|NCT02114502|Relapsed|relapsed
345986|NCT02114502|Stem Cell Transplant|stem cell transplant
345987|NCT02114502|SCT|sct
345988|NCT02114502|Carfilzomib|carfilzomib
345989|NCT02114502|SAHA|saha
345990|NCT02114502|Vorinostat|vorinostat
345991|NCT02114502|Suberoylanilide Hydroxamic Acid|suberoylanilide hydroxamic acid
345992|NCT02114502|MSK-390|msk-390
345993|NCT02114502|Zolinza|zolinza
345994|NCT02114502|Gemcitabine|gemcitabine
345995|NCT02114502|Gemcitabine Hydrochloride|gemcitabine hydrochloride
345996|NCT02114502|Gemzar|gemzar
345997|NCT02114502|Busulfan|busulfan
345998|NCT02114502|Busulfex|busulfex
345999|NCT02114502|Myleran|myleran
346000|NCT02114502|Palifermin|palifermin
346001|NCT02114502|Kepivance|kepivance
346002|NCT02114502|Dexamethasone|dexamethasone
346003|NCT02114502|Decadron|decadron
346004|NCT02114502|Melphalan|melphalan
346005|NCT02114502|Alkeran|alkeran
346006|NCT02114502|Caphosol|caphosol
346007|NCT02114502|Glutamine|glutamine
346008|NCT02114502|Enterex|enterex
346009|NCT02114502|Glutapak-10|glutapak-10
346010|NCT02114502|NutreStore|nutrestore
346011|NCT02114502|Resource|resource
346012|NCT02114502|GlutaSolve|glutasolve
346013|NCT02114502|Sympt-X G.I.|sympt-x g.i.
346014|NCT02114502|Sympt-X|sympt-x
346015|NCT02114502|Pyridoxine|pyridoxine
346016|NCT02114489|AOH|aoh
346017|NCT02114489|ibandronate|ibandronate
346018|NCT02114476|GDM|gdm
346019|NCT02114476|implant|implant
346020|NCT02114476|diabetes mellitus|diabetes mellitus
346021|NCT02114476|metabolic syndrome|metabolic syndrome
346022|NCT02114463|Local analgesia system|local analgesia system
346023|NCT02114463|Ropivacaine|ropivacaine
346024|NCT02114463|Analgesic efficacy after operation|analgesic efficacy after operation
346025|NCT02114463|Postoperative|postoperative
346026|NCT02114450|Stroke|stroke
346027|NCT02114450|Paresis|paresis
346028|NCT02114450|Gait rehabilitation|gait rehabilitation
346029|NCT02114450|Human-Machine Interaction|human-machine interaction
346030|NCT02114450|Wearable Robotic Devices|wearable robotic devices
346031|NCT02114437|Closed-Loop TCI|closed-loop tci
346032|NCT02114437|NI|ni
346033|NCT02114437|Laparoscopic Cholecystectomy|laparoscopic cholecystectomy
346034|NCT02114424|Positional Obstructive sleep apnea syndrome (POSAS)|positional obstructive sleep apnea syndrome (posas)
346035|NCT02114424|Obstructive sleep apnea syndrome (OSAS)|obstructive sleep apnea syndrome (osas)
346036|NCT02114424|Apnea-Hypnea Index (AHI)|apnea-hypnea index (ahi)
346037|NCT02114424|Sleep questionnaire|sleep questionnaire
346038|NCT02114424|Positional sleep apnea belt|positional sleep apnea belt
346039|NCT02114424|Adverse events|adverse events
346040|NCT02114424|Compliance|compliance
346041|NCT02114385|Prevention|prevention
346042|NCT02114372|Alzheimer's disease|alzheimer's disease
346043|NCT02114372|Asymptomatic at risk for Alzheimer's disease|asymptomatic at risk for alzheimer's disease
346044|NCT02114372|Retinal diagnosis for Alzheimer's disease|retinal diagnosis for alzheimer's disease
346045|NCT02114359|gastric cancer, elderly, chemotherapy|gastric cancer, elderly, chemotherapy
346046|NCT02114346|Computed Tomography Angiogram|computed tomography angiogram
346047|NCT02114346|Side Effects|side effects
346048|NCT02114346|Contrast-Induced Nephropathy|contrast-induced nephropathy
346049|NCT02114346|Prevention|prevention
346050|NCT02114333|Shingles vaccine|shingles vaccine
346051|NCT02114333|Immune response|immune response
346052|NCT02114333|Zoster vaccine|zoster vaccine
346053|NCT02114320|Endoscopic ultrasonography|endoscopic ultrasonography
346054|NCT02114320|Biliary drainage|biliary drainage
346055|NCT02114320|Metal stent|metal stent
346056|NCT02114307|electrical stimulation|electrical stimulation
346057|NCT02114307|venous insufficiency|venous insufficiency
346058|NCT02114307|post thrombotic syndrome|post thrombotic syndrome
346059|NCT02114307|varicose veins|varicose veins
346060|NCT02114294|Patellofemoral pain syndrome|patellofemoral pain syndrome
346061|NCT02114294|Anterior knee pain|anterior knee pain
346062|NCT02114294|Randomised controlled trial|randomised controlled trial
346063|NCT02114294|Exercise intervention|exercise intervention
346064|NCT02114294|Hip strengthening|hip strengthening
346065|NCT02114294|Quadriceps based training|quadriceps based training
346066|NCT02114294|Anterior knee pain score|anterior knee pain score
346067|NCT02114281|Oral Health|oral health
346068|NCT02114281|Periodontitis|periodontitis
346069|NCT02114281|Tooth cavities|tooth cavities
346070|NCT02114281|Saliva|saliva
346071|NCT02114281|Halitosis|halitosis
346072|NCT02114281|Mucosa|mucosa
346073|NCT02114281|Chronic kidney disease|chronic kidney disease
346074|NCT02114281|Inflammation|inflammation
346075|NCT02114281|Nutrition|nutrition
346076|NCT02114268|Respiratory Syncytial Virus, RSV|respiratory syncytial virus, rsv
346077|NCT02114255|Influenza|influenza
346078|NCT02114255|Trained immunity|trained immunity
346079|NCT02114255|BCG|bcg
346080|NCT02114242|Parkinson's disease|parkinson's disease
346081|NCT02114242|multiple system atrophy|multiple system atrophy
346082|NCT02114242|progressive supranuclear palsy|progressive supranuclear palsy
346083|NCT02114242|alpha-synuclein|alpha-synuclein
346084|NCT02114229|Alisertib|alisertib
346085|NCT02114229|MLN8237|mln8237
346086|NCT02114229|AT/RT|at/rt
346087|NCT02114229|MRT|mrt
346088|NCT02114190|Overweight Adolescents|overweight adolescents
346089|NCT02114190|Mindful Eating and Living|mindful eating and living
346090|NCT02114190|Family Systems|family systems
346091|NCT02114190|Body-Mass Index|body-mass index
346092|NCT02114190|Mindfulness|mindfulness
346093|NCT02114177|Hepatitis C Virus Infection|hepatitis c virus infection
346094|NCT02114177|Simeprevir|simeprevir
346095|NCT02114177|Sofosbuvir|sofosbuvir
346096|NCT02114177|HCV|hcv
346097|NCT02114177|Cirrhosis|cirrhosis
346098|NCT02114164|AirSeal|airseal
346099|NCT02114164|Trocar|trocar
346100|NCT02114164|Carbon Dioxide Exchange and Absorption|carbon dioxide exchange and absorption
346101|NCT02114151|Hepatitis C Virus Infection|hepatitis c virus infection
442513|NCT01678079|Iron|iron
346102|NCT02114151|Simeprevir|simeprevir
346103|NCT02114151|Sofosbuvir|sofosbuvir
346104|NCT02114151|HCV|hcv
346105|NCT02114151|Cirrhosis|cirrhosis
346106|NCT02114138|postoperative acute kidney injury|postoperative acute kidney injury
346107|NCT02114138|pAKI|paki
346108|NCT02114138|stress injury on the kidney|stress injury on the kidney
346109|NCT02114138|chronic kidney disease|chronic kidney disease
346110|NCT02114138|CKD|ckd
346111|NCT02114125|Physical activity|physical activity
346112|NCT02114125|Cognitive training|cognitive training
346113|NCT02114112|Bronchopulmonary dysplasia|bronchopulmonary dysplasia
346114|NCT02114112|Continuous positive airway pressure pressure|continuous positive airway pressure pressure
346115|NCT02114112|Preterms|preterms
346116|NCT02114099|Kawasaki Disease|kawasaki disease
346117|NCT02114099|Aneurysm, Coronary|aneurysm, coronary
346118|NCT02114086|Observational Study|observational study
346119|NCT02114086|intraoperative Radiation of Breast Cancer|intraoperative radiation of breast cancer
346120|NCT02114086|early and late effects of radiation|early and late effects of radiation
346121|NCT02114086|cosmesis and quality of life|cosmesis and quality of life
346122|NCT02114073|glaucoma|glaucoma
346123|NCT02114073|trabeculectomy|trabeculectomy
346124|NCT02114073|cyclosporine|cyclosporine
346125|NCT02114073|betamethasone|betamethasone
346126|NCT02114060|HSV|hsv
346127|NCT02114060|Herpes|herpes
346128|NCT02114060|genital infection|genital infection
346129|NCT02114060|vaccine|vaccine
346130|NCT02114034|Severe asthma,|severe asthma,
346131|NCT02114034|child,|child,
346132|NCT02114034|outcome,|outcome,
346133|NCT02114021|Syndrome incidence after intubation|syndrome incidence after intubation
346134|NCT02114021|Betamethasone gel|betamethasone gel
346135|NCT02114021|lidocaine jelly|lidocaine jelly
346136|NCT02114021|sore throat|sore throat
346137|NCT02114021|cough|cough
346138|NCT02114021|hoarseness of voice|hoarseness of voice
346139|NCT02114008|Gastric emptying.|gastric emptying.
346140|NCT02114008|Residual gastric volume.|residual gastric volume.
346141|NCT02114008|Preoperative fasting.|preoperative fasting.
346142|NCT02114008|Morbid Obesity.|morbid obesity.
346143|NCT02114008|Diabetes.|diabetes.
346144|NCT02113995|Obesity, Morbid|obesity, morbid
346145|NCT02113995|Insulin Resistance|insulin resistance
346146|NCT02113995|Acute-Phase Reaction|acute-phase reaction
346147|NCT02113995|Gastroplasty|gastroplasty
346148|NCT02113995|Length of Stay|length of stay
346149|NCT02113995|Protocols|protocols
346150|NCT02113995|Randomized Controlled Trial.|randomized controlled trial.
346151|NCT02113969|Pelvic Organ Prolapse|pelvic organ prolapse
346152|NCT02113969|Quality of Life|quality of life
346153|NCT02113969|Symptoms|symptoms
346154|NCT02113969|Pessary|pessary
346155|NCT02113969|Treatment|treatment
346156|NCT02113956|HIV Prevention|hiv prevention
346157|NCT02113956|Adolescent Men who Have Sex with Men (AMSM)|adolescent men who have sex with men (amsm)
346158|NCT02113956|Text-Messaging|text-messaging
346159|NCT02113956|Information-Motivation-Behavioral Skills(IMB)Model|information-motivation-behavioral skills(imb)model
346160|NCT02113917|infant, adolescent and adult Hemophagocytic Syndrome|infant, adolescent and adult hemophagocytic syndrome
346161|NCT02113917|Hemophagocytic lymphohistiocytosis|hemophagocytic lymphohistiocytosis
346162|NCT02113904|Netherton syndrome|netherton syndrome
346163|NCT02113904|Adalimumab|adalimumab
346164|NCT02113904|TNF-alpha|tnf-alpha
346165|NCT02113904|Orphan genetic syndrome|orphan genetic syndrome
346166|NCT02113891|Antibody-mediated rejection|antibody-mediated rejection
346167|NCT02113891|Complement blockade|complement blockade
346168|NCT02113891|Eculizumab|eculizumab
346169|NCT02113891|Kidney transplantation|kidney transplantation
346170|NCT02113878|Carcinoma, Squamous Cell of Head and Neck|carcinoma, squamous cell of head and neck
346171|NCT02113878|Human Papillomavirus Positive Oropharyngeal Carcinoma|human papillomavirus positive oropharyngeal carcinoma
346172|NCT02113878|Hypopharyngeal Cancer|hypopharyngeal cancer
346173|NCT02113878|Early Invasive Cervical Squamous Cell Carcinoma|early invasive cervical squamous cell carcinoma
346174|NCT02113878|Carcinoma of Larynx|carcinoma of larynx
346175|NCT02113878|Cancer of Nasopharynx|cancer of nasopharynx
346176|NCT02113852|Non small cell Lung Cancer|non small cell lung cancer
346177|NCT02113852|Heavy smokers|heavy smokers
346178|NCT02113852|Treatment naive patients|treatment naive patients
346179|NCT02113839|Dyspnea perception|dyspnea perception
346180|NCT02113839|COPD|copd
346181|NCT02113839|Exacerbations|exacerbations
346182|NCT02113839|CO2 rebreathing test|co2 rebreathing test
346183|NCT02113826|Pazopanib|pazopanib
346184|NCT02113826|Alveolar soft part sarcoma|alveolar soft part sarcoma
346185|NCT02113813|irreversible EGFR inhibitor|irreversible egfr inhibitor
346186|NCT02113813|Non-Small-Cell Lung Cancer|non-small-cell lung cancer
346187|NCT02113813|Midazolam|midazolam
346188|NCT02113813|T790M resistance mutation|t790m resistance mutation
346189|NCT02113813|EGFR|egfr
346190|NCT02113813|NSCLC|nsclc
346191|NCT02113813|naquotinib|naquotinib
346192|NCT02113813|Epidermal Growth Factor Receptor mutations|epidermal growth factor receptor mutations
346193|NCT02113813|ASP8273|asp8273
346194|NCT02113787|epilepsy|epilepsy
346195|NCT02113787|anticonvulsants|anticonvulsants
346196|NCT02113787|generic drugs|generic drugs
346197|NCT02113748|Pulmonary disease, chronic obstructive|pulmonary disease, chronic obstructive
346198|NCT02113748|Downhill walking|downhill walking
346199|NCT02113748|exercise|exercise
346200|NCT02113735|ARDS|ards
346201|NCT02113735|Acute Respiratory Distress Syndrome|acute respiratory distress syndrome
346202|NCT02113735|Acthar|acthar
346203|NCT02113735|ACTH|acth
346204|NCT02113735|H.P. Acthar Gel|h.p. acthar gel
346205|NCT02113722|Sudden cardiac death|sudden cardiac death
346206|NCT02113722|Ganglionectomy|ganglionectomy
346207|NCT02113722|Ventricular arrhythmia|ventricular arrhythmia
346208|NCT02113722|Cardiac surgery|cardiac surgery
346209|NCT02113722|Implanted cardiac defibrillator|implanted cardiac defibrillator
346210|NCT02113709|Amblyopia|amblyopia
346211|NCT02113709|Strabismus|strabismus
346212|NCT02113709|Occlusion therapy|occlusion therapy
346213|NCT02113709|Visual improvement|visual improvement
346214|NCT02113696|morbid obesity|morbid obesity
346215|NCT02113696|BMI at or above 4O kg/m2|bmi at or above 4o kg/m2
346216|NCT02113696|ingestion of omega 3|ingestion of omega 3
346217|NCT02113696|inflammatory cytokines|inflammatory cytokines
346218|NCT02113696|biochemical factors|biochemical factors
346219|NCT02113696|anthropometric factors|anthropometric factors
346220|NCT02113683|colo-rectal cancer|colo-rectal cancer
346221|NCT02113683|stomach cancer|stomach cancer
346222|NCT02113683|melanoma|melanoma
346223|NCT02113683|MMS test|mms test
346224|NCT02113683|therapy monitoring|therapy monitoring
346225|NCT02113683|Sarcoma|sarcoma
346226|NCT02113670|stress urinary incontinence|stress urinary incontinence
346227|NCT02113670|abdominal leak point pressure|abdominal leak point pressure
346228|NCT02113670|urodynamic study|urodynamic study
346229|NCT02113657|Prostate cancer|prostate cancer
346230|NCT02113657|Castration-resistant prostate cancer|castration-resistant prostate cancer
346231|NCT02113657|CRPC|crpc
346232|NCT02113657|Metastatic|metastatic
346233|NCT02113657|Hormone therapy treatment|hormone therapy treatment
346234|NCT02113657|Androgen deprivation therapy|androgen deprivation therapy
346235|NCT02113657|gonadotropin-releasing hormone|gonadotropin-releasing hormone
346236|NCT02113657|GnRH|gnrh
346237|NCT02113657|Ipilimumab|ipilimumab
346238|NCT02113657|Yervoy|yervoy
346239|NCT02113657|BMS-734016|bms-734016
346240|NCT02113657|MDX010|mdx010
346241|NCT02113631|Hepatitis C treatment,|hepatitis c treatment,
346242|NCT02113631|Boceprevir,|boceprevir,
346243|NCT02113631|Telaprevir,|telaprevir,
346244|NCT02113631|Safety|safety
346245|NCT02113631|Effectiveness|effectiveness
346246|NCT02113631|Head-to-head trial|head-to-head trial
346247|NCT02113618|Cognitive function, alcohol dependence, working memory|cognitive function, alcohol dependence, working memory
346248|NCT02113605|Functional gastrointestinal disorders|functional gastrointestinal disorders
346249|NCT02113605|FGID|fgid
346250|NCT02113605|Recurrent abdominal pain|recurrent abdominal pain
346251|NCT02113605|Abdominal pain|abdominal pain
346252|NCT02113605|pain-predominant functional gastrointestinal disorders|pain-predominant functional gastrointestinal disorders
346253|NCT02113605|Pediatric pain|pediatric pain
346254|NCT02113592|Pain management|pain management
346255|NCT02113592|Opioid use|opioid use
346256|NCT02113592|Pragmatic|pragmatic
346257|NCT02113592|Collaborative care|collaborative care
346258|NCT02113592|Primary care|primary care
346259|NCT02113579|Tooth Sensitivity|tooth sensitivity
346260|NCT02113566|Delayed onset muscle soreness|delayed onset muscle soreness
346261|NCT02113566|DOMS|doms
346262|NCT02113540|coronary angiography|coronary angiography
346263|NCT02113540|chronic stable angina|chronic stable angina
346264|NCT02113540|CIN|cin
346265|NCT02113527|Electrogastrography|electrogastrography
346266|NCT02113527|Functional dyspepsia|functional dyspepsia
346267|NCT02113527|Gastric emptying|gastric emptying
346268|NCT02113527|Gastrointestinal peptides|gastrointestinal peptides
346269|NCT02113527|Rome III criteria|rome iii criteria
346270|NCT02113514|Appalachian|appalachian
346271|NCT02113514|abnormal pap test|abnormal pap test
346272|NCT02113501|HGT1|hgt1
346273|NCT02113501|high risk bladder cancer|high risk bladder cancer
346274|NCT02113501|substaging|substaging
346275|NCT02113501|repeat transurethral resection (reTUR)|repeat transurethral resection (retur)
346276|NCT02113501|lamina propria|lamina propria
346277|NCT02113475|CDT|cdt
346278|NCT02113475|PCDT|pcdt
346279|NCT02113475|DVT|dvt
346280|NCT02113475|PTS|pts
346281|NCT02113475|Quality of Life|quality of life
346282|NCT02113462|Chronic kidney disease|chronic kidney disease
346283|NCT02113462|Endothelial dysfunction|endothelial dysfunction
346284|NCT02113462|Inflammation|inflammation
346285|NCT02113462|Insulin resistance|insulin resistance
346286|NCT02113462|Tg/hdl ratio|tg/hdl ratio
346287|NCT02113449|Carbon Dioxide, Allergy symptoms|carbon dioxide, allergy symptoms
346288|NCT02113436|FP/SLM|fp/slm
346289|NCT02113436|Asthma|asthma
346290|NCT02113436|Infant|infant
346291|NCT02113436|Efficacy|efficacy
346292|NCT02113436|Safety|safety
346293|NCT02113423|superiority, re-irradiation, IMRT, recurrent T1-2 NPC|superiority, re-irradiation, imrt, recurrent t1-2 npc
346294|NCT02113410|osteoarthritis|osteoarthritis
346295|NCT02113410|Older adults|older adults
346296|NCT02113410|Sit 'N' Chair Yoga|sit 'n' chair yoga
346297|NCT02113410|Pain|pain
346298|NCT02113410|Physical Function|physical function
346299|NCT02113410|Balance|balance
346300|NCT02113410|Fatigue|fatigue
346301|NCT02113410|Depression|depression
346302|NCT02113410|Life Satisfaction|life satisfaction
346303|NCT02113397|Cystic fibrosis|cystic fibrosis
346304|NCT02113397|Microbiome|microbiome
346305|NCT02113397|Sputum|sputum
346306|NCT02113397|Tobramycin|tobramycin
346307|NCT02113397|Colistimethate|colistimethate
346308|NCT02113384|Rectal cancer|rectal cancer
346309|NCT02113384|Locally advanced rectal cancer|locally advanced rectal cancer
346310|NCT02113384|Peritoneal carcinomatosis|peritoneal carcinomatosis
346311|NCT02113384|Exfoliated peritoneal cells|exfoliated peritoneal cells
346312|NCT02113384|Peritoneal lavage|peritoneal lavage
346313|NCT02113371|Injury Prevention|injury prevention
346314|NCT02113371|Health Promotion|health promotion
346315|NCT02113371|Well being|well being
346316|NCT02113371|Safety|safety
346317|NCT02113371|Nutrition|nutrition
346318|NCT02113371|Physical Activity|physical activity
346319|NCT02113371|Sleep|sleep
346320|NCT02113371|Stress|stress
346321|NCT02113358|fluid therapy|fluid therapy
346322|NCT02113358|neurosurgery|neurosurgery
346323|NCT02113345|metamemory|metamemory
346324|NCT02113345|memory|memory
346325|NCT02113345|mild cognitive impairment|mild cognitive impairment
346326|NCT02113332|Insulin injections|insulin injections
346327|NCT02113332|Overweight|overweight
346328|NCT02113332|Inadequate glycaemic control|inadequate glycaemic control
346329|NCT02113319|Core Binding Factors|core binding factors
346330|NCT02113319|Acute Myelogenous Leukemia refractory to conventional chemotherapy|acute myelogenous leukemia refractory to conventional chemotherapy
346331|NCT02113319|molecular relapse|molecular relapse
346332|NCT02113293|phase I study|phase i study
346333|NCT02113293|tolerability|tolerability
346334|NCT02113293|safety|safety
346335|NCT02113293|CyclASol®|cyclasol®
346336|NCT02113293|eye drops|eye drops
346337|NCT02113267|esophagitis|esophagitis
346338|NCT02113267|eosinophils|eosinophils
346339|NCT02113267|allergy|allergy
346340|NCT02113267|inflammation|inflammation
346341|NCT02113267|corticosteroids|corticosteroids
346342|NCT02113254|corn|corn
346343|NCT02113254|macular pigment|macular pigment
346344|NCT02113254|lutein|lutein
346345|NCT02113254|zeaxanthin|zeaxanthin
346636|NCT02112123|icariin|icariin
346346|NCT02113254|Age Macular Degeneration|age macular degeneration
346347|NCT02113254|AMD|amd
346348|NCT02113241|metabolic syndrome|metabolic syndrome
346349|NCT02113241|forxiga|forxiga
346350|NCT02113241|dapagliflozin|dapagliflozin
346351|NCT02113241|insulin secretion|insulin secretion
346352|NCT02113241|insulin sensitivity|insulin sensitivity
346353|NCT02113228|Energy metabolism|energy metabolism
346354|NCT02113228|Stable isotopes|stable isotopes
346355|NCT02113228|Short bowel syndrome|short bowel syndrome
346356|NCT02113228|Doubly labeled water|doubly labeled water
346357|NCT02113215|aging|aging
346358|NCT02113215|lipid metabolism|lipid metabolism
346359|NCT02113215|very low density lipoproteins|very low density lipoproteins
346360|NCT02113202|Optical imaging|optical imaging
346361|NCT02113202|Fluorescence endoscopy|fluorescence endoscopy
346362|NCT02113202|Near infrared fluorescence|near infrared fluorescence
346363|NCT02113202|Familial Adenomatous Polyposis|familial adenomatous polyposis
346364|NCT02113202|IRDye800CW|irdye800cw
346365|NCT02113202|Vascular Endothelial Growth Factor A|vascular endothelial growth factor a
346366|NCT02113202|Gastrointestinal endoscopy|gastrointestinal endoscopy
346367|NCT02113189|gait|gait
346368|NCT02113189|Parkinson's disease|parkinson's disease
346369|NCT02113176|SAH|sah
346370|NCT02113163|Type 2 diabetes|type 2 diabetes
346371|NCT02113163|T2DM|t2dm
346372|NCT02113163|hypertriglyceridemia|hypertriglyceridemia
346373|NCT02113163|severe hypertriglyceridemia|severe hypertriglyceridemia
346374|NCT02113163|dyslipidemia|dyslipidemia
346375|NCT02113163|triglycerides|triglycerides
346376|NCT02113163|lipids|lipids
346377|NCT02113163|omega-3 fatty acids|omega-3 fatty acids
346378|NCT02113163|EPA|epa
346379|NCT02113163|ethyl-EPA|ethyl-epa
346380|NCT02113163|Metformin|metformin
346381|NCT02113163|Glucophage|glucophage
346382|NCT02113163|Lovaza|lovaza
346383|NCT02113163|Vascepa|vascepa
346384|NCT02113163|Epanova|epanova
346385|NCT02113163|Astra Zeneca|astra zeneca
346386|NCT02113163|Amarin|amarin
346387|NCT02113163|GSK|gsk
346388|NCT02113150|troponin t,cystatin-c,ketamine,remifentanil|troponin t,cystatin-c,ketamine,remifentanil
346389|NCT02113137|halitosis|halitosis
346390|NCT02113137|chlorine dioxide|chlorine dioxide
346391|NCT02113137|tongue cleaning|tongue cleaning
346392|NCT02113124|Chronic Brain Injury|chronic brain injury
712557|NCT00579709|Low T cell numbers|low t cell numbers
346393|NCT02113124|Traumatic brain injury (TBI)|traumatic brain injury (tbi)
346394|NCT02113124|Amino Acids|amino acids
346395|NCT02113124|Microbiome|microbiome
346396|NCT02113098|Stroke|stroke
346397|NCT02113098|Gait|gait
346398|NCT02113098|Rehabilitation|rehabilitation
346399|NCT02113085|Adolescents, foster care, self-determination|adolescents, foster care, self-determination
346400|NCT02113072|wheezing, immune system, cytokines, probiotics, infants.|wheezing, immune system, cytokines, probiotics, infants.
346401|NCT02113059|Liver regeneration|liver regeneration
346402|NCT02113059|liver dysfunction|liver dysfunction
346403|NCT02113059|platelets|platelets
346404|NCT02113059|plasma|plasma
346405|NCT02113059|serum|serum
346406|NCT02113059|platelet activation|platelet activation
346407|NCT02113059|morbidity|morbidity
346408|NCT02113059|mortality|mortality
346409|NCT02113059|Growth factors|growth factors
346410|NCT02113059|Postoperative clinical outcome|postoperative clinical outcome
346411|NCT02113046|pancreas|pancreas
346412|NCT02113046|pancreatico-jejunal anastomosis|pancreatico-jejunal anastomosis
346413|NCT02113046|postoperative pancreatic fistulae|postoperative pancreatic fistulae
346414|NCT02113007|Lymphoma; CNS; rituximab; temozolomide|lymphoma; cns; rituximab; temozolomide
346415|NCT02112994|Enzyme Replacement Therapy (ERT)|enzyme replacement therapy (ert)
346416|NCT02112994|Lysosomal Storage Disease|lysosomal storage disease
346417|NCT02112994|Late Onset Lysosomal Acid Lipase (LAL) Deficiency|late onset lysosomal acid lipase (lal) deficiency
346418|NCT02112994|Acid cholesteryl ester hydrolase deficiency, type 2|acid cholesteryl ester hydrolase deficiency, type 2
346419|NCT02112994|Acid lipase disease|acid lipase disease
346420|NCT02112994|Cholesterol ester hydrolase deficiency|cholesterol ester hydrolase deficiency
346421|NCT02112994|LAL Deficiency|lal deficiency
346422|NCT02112994|LIPA Deficiency|lipa deficiency
346423|NCT02112994|Wolman disease|wolman disease
346424|NCT02112994|Additional relevant MeSH terms:|additional relevant mesh terms:
346425|NCT02112994|Cholesterol Ester Storage Disease|cholesterol ester storage disease
346426|NCT02112994|Metabolic Diseases|metabolic diseases
346427|NCT02112994|Lipidoses|lipidoses
346428|NCT02112994|Lipid Metabolism, Inborn Errors|lipid metabolism, inborn errors
346429|NCT02112994|Metabolism, Inborn Errors|metabolism, inborn errors
346430|NCT02112994|Genetic Diseases, Inborn|genetic diseases, inborn
346431|NCT02112994|Lysosomal Storage Diseases|lysosomal storage diseases
346432|NCT02112994|Lipid Metabolism Disorders|lipid metabolism disorders
346433|NCT02112994|Infant, Newborn, Diseases|infant, newborn, diseases
346434|NCT02112981|Coronary Arteriosclerosis|coronary arteriosclerosis
346435|NCT02112968|Myopia|myopia
346436|NCT02112968|Hyperopia|hyperopia
346437|NCT02112968|Presbyopia|presbyopia
346438|NCT02112968|Supracor|supracor
346439|NCT02112968|Zyoptix|zyoptix
346440|NCT02112968|Proscan|proscan
346441|NCT02112968|LASIK|lasik
346442|NCT02112955|Stroke|stroke
346443|NCT02112955|Disease management|disease management
346444|NCT02112955|Self efficacy|self efficacy
346445|NCT02112955|Quality of life|quality of life
346446|NCT02112955|Community integration|community integration
346447|NCT02112942|Hepatitis C virus|hepatitis c virus
346448|NCT02112942|HCV|hcv
346449|NCT02112929|Magnetic Resonance Imaging|magnetic resonance imaging
346450|NCT02112929|Lung Diseases|lung diseases
346451|NCT02112890|Mexico|mexico
346452|NCT02112890|Adolescents|adolescents
346453|NCT02112890|Hepatitis|hepatitis
346454|NCT02112890|Seroprevalence|seroprevalence
346455|NCT02112890|Pertussis|pertussis
346456|NCT02112890|Young adults|young adults
346457|NCT02112877|iliofemoral vein|iliofemoral vein
346458|NCT02112877|venous|venous
346459|NCT02112877|venous obstruction|venous obstruction
346460|NCT02112838|IGA Glomerulonephritis|iga glomerulonephritis
346461|NCT02112838|Nephritis, IGA Type|nephritis, iga type
346462|NCT02112825|Exercise|exercise
346463|NCT02112825|blood pressure|blood pressure
346464|NCT02112825|chronic kidney disease|chronic kidney disease
346465|NCT02112812|Parkinsons disease|parkinsons disease
346466|NCT02112812|Helicobacter pylori|helicobacter pylori
346467|NCT02112812|Eradication|eradication
346468|NCT02112812|Levodopa response|levodopa response
346469|NCT02112812|Motor outcomes|motor outcomes
346470|NCT02112812|Quality of Life|quality of life
346471|NCT02112812|Open label|open label
346472|NCT02112799|Hepatitis B|hepatitis b
346473|NCT02112786|Overactive Bladder|overactive bladder
346474|NCT02112773|Adenoviral conjunctivitis diagnosed with AdenoPlus™ Test|adenoviral conjunctivitis diagnosed with adenoplus™ test
346475|NCT02112760|specific stabilization exercise|specific stabilization exercise
346476|NCT02112760|ultrasound|ultrasound
346477|NCT02112760|low back pain|low back pain
346478|NCT02112747|Colorectal Cancer Prevention|colorectal cancer prevention
346479|NCT02112747|Colorectal Cancer Screening|colorectal cancer screening
346480|NCT02112747|ACCS|accs
346481|NCT02112747|Lynch Syndrome|lynch syndrome
346482|NCT02112747|LS|ls
346483|NCT02112734|vitamin D|vitamin d
346484|NCT02112734|food allergy|food allergy
346485|NCT02112734|eczema|eczema
346486|NCT02112708|Psychotherapy, Rational-Emotive|psychotherapy, rational-emotive
346487|NCT02112708|Depression|depression
346488|NCT02112708|Social Work|social work
346489|NCT02112708|Primary Health Care|primary health care
346490|NCT02112695|endurance sportswomen|endurance sportswomen
346491|NCT02112695|addiction|addiction
346492|NCT02112695|undernutrition|undernutrition
346493|NCT02112695|[11C]diprenorphine Pet|[11c]diprenorphine pet
346494|NCT02112695|pituitary region|pituitary region
346495|NCT02112682|Sentinel lymph node metastasis|sentinel lymph node metastasis
346496|NCT02112682|Completion axillary lymph node dissection|completion axillary lymph node dissection
346497|NCT02112682|Axillary radiotherapy|axillary radiotherapy
346498|NCT02112656|Carcinoma|carcinoma
346499|NCT02112656|Carcinoma, Hepatocellular|carcinoma, hepatocellular
346500|NCT02112656|Neoplasms, Glandular and Epithelial|neoplasms, glandular and epithelial
346501|NCT02112656|Neoplasms by Histologic Type|neoplasms by histologic type
346502|NCT02112656|Neoplasms|neoplasms
346503|NCT02112656|Adenocarcinoma|adenocarcinoma
346504|NCT02112656|Liver Neoplasms|liver neoplasms
346505|NCT02112656|Digestive System Neoplasms|digestive system neoplasms
346506|NCT02112656|Neoplasms by Site|neoplasms by site
346507|NCT02112656|Digestive System Diseases|digestive system diseases
346508|NCT02112656|Liver Diseases|liver diseases
346509|NCT02112656|Doxorubicin|doxorubicin
346510|NCT02112656|Antibiotics, Antineoplastic|antibiotics, antineoplastic
346511|NCT02112656|Antineoplastic Agents|antineoplastic agents
346512|NCT02112656|Therapeutic Uses|therapeutic uses
346513|NCT02112656|Pharmacologic Actions|pharmacologic actions
346514|NCT02112643|Thyroid eye disease|thyroid eye disease
346515|NCT02112643|Thyroid orbitopathy|thyroid orbitopathy
346516|NCT02112643|Graves' orbitopathy|graves' orbitopathy
346517|NCT02112643|Graves' ophthalmopathy|graves' ophthalmopathy
346518|NCT02112630|Hepatitis C Infection|hepatitis c infection
346519|NCT02112630|HCV, genotype 1|hcv, genotype 1
346520|NCT02112630|End Stage Renal Disease|end stage renal disease
346521|NCT02112630|ESRD|esrd
346522|NCT02112630|Boceprevir|boceprevir
346523|NCT02112630|Pegylated Interferon|pegylated interferon
346524|NCT02112630|Ribavirin|ribavirin
346525|NCT02112617|Neuroblastoma|neuroblastoma
346526|NCT02112617|Childhood neuroblastoma|childhood neuroblastoma
346527|NCT02112617|Ganglioneuroblastoma|ganglioneuroblastoma
346528|NCT02112617|Pediatric neuroblastoma|pediatric neuroblastoma
346529|NCT02112604|critically ill, OSA, mechanical ventilation|critically ill, osa, mechanical ventilation
346530|NCT02112591|Stress urinary incontinence|stress urinary incontinence
346531|NCT02112591|mesh|mesh
346532|NCT02112591|tape|tape
346533|NCT02112591|micturition dysfunction|micturition dysfunction
346534|NCT02112591|urinary obstruction|urinary obstruction
346535|NCT02112591|TOT|tot
346536|NCT02112578|Vertigo, Meclizine, dimenhydrinate, Peripheral Origin|vertigo, meclizine, dimenhydrinate, peripheral origin
346537|NCT02112526|de Novo Activated B-cell (ABC) Subtype of Diffuse Large B-Cell Lymphoma|de novo activated b-cell (abc) subtype of diffuse large b-cell lymphoma
346538|NCT02112526|Diffuse Large B-Cell Lymphoma|diffuse large b-cell lymphoma
346539|NCT02112526|de Novo Activated B-cell (ABC)|de novo activated b-cell (abc)
346540|NCT02112526|de Novo Activated B-cell|de novo activated b-cell
346541|NCT02112526|ABC DLBCL|abc dlbcl
346542|NCT02112526|DLBCL|dlbcl
346543|NCT02112526|Lymphoma|lymphoma
346544|NCT02112526|B-Cell|b-cell
346545|NCT02112526|Immunoproliferative Disorders|immunoproliferative disorders
346546|NCT02112526|Immune System Diseases|immune system diseases
346547|NCT02112526|Bruton's tyrosine kinase|bruton's tyrosine kinase
346548|NCT02112487|pulmonary arterial hypertension|pulmonary arterial hypertension
346549|NCT02112487|PAH-SYMPACT|pah-sympact
346550|NCT02112487|PAH|pah
346551|NCT02112487|psychometric instrument|psychometric instrument
346552|NCT02112474|Failed Back Surgery Syndrome|failed back surgery syndrome
346553|NCT02112474|Neuropathic pain|neuropathic pain
346554|NCT02112474|Leg Pain|leg pain
346555|NCT02112474|Chronic Pain|chronic pain
346556|NCT02112474|Spinal Cord Stimulation|spinal cord stimulation
346557|NCT02112474|Neurostimulation|neurostimulation
346558|NCT02112461|end of life care|end of life care
346559|NCT02112448|congenital heart disease, pediatric cardiothoracic surgery|congenital heart disease, pediatric cardiothoracic surgery
346560|NCT02112435|obstructive sleep apnea|obstructive sleep apnea
346561|NCT02112435|mandibular advancement splint|mandibular advancement splint
346562|NCT02112435|active mandibular advancement splint|active mandibular advancement splint
346563|NCT02112435|oral appliance|oral appliance
346564|NCT02112422|Parturients|parturients
346565|NCT02112409|Adolescent idiopathic scoliosis|adolescent idiopathic scoliosis
346566|NCT02112409|scoliosis corrective surgery|scoliosis corrective surgery
346567|NCT02112409|autologous blood transfusion|autologous blood transfusion
346568|NCT02112409|cell salvage|cell salvage
346569|NCT02112409|acute normovolemic hemodilution|acute normovolemic hemodilution
346570|NCT02112409|hemoglobin level|hemoglobin level
346571|NCT02112396|CRAFT|craft
346572|NCT02112396|Concerned Significant Others|concerned significant others
346573|NCT02112396|Contingency management|contingency management
346574|NCT02112396|Reinforcement|reinforcement
346575|NCT02112396|Family Intervention|family intervention
346576|NCT02112383|Procrastination|procrastination
346577|NCT02112383|Cognitive behavior therapy|cognitive behavior therapy
346578|NCT02112383|Internet interventions|internet interventions
346579|NCT02112383|Group intervention|group intervention
346580|NCT02112383|Students|students
346581|NCT02112383|Randomized controlled trial|randomized controlled trial
346582|NCT02112370|Ropivacaine|ropivacaine
346583|NCT02112370|Epinephrine|epinephrine
346584|NCT02112370|Endoscopy|endoscopy
346585|NCT02112370|Robotics|robotics
346586|NCT02112370|Thyroidectomy|thyroidectomy
346587|NCT02112357|molecular profiling|molecular profiling
346588|NCT02112357|genetic sequencing|genetic sequencing
346589|NCT02112357|personalised medicine|personalised medicine
346590|NCT02112357|gastrointestinal cancer|gastrointestinal cancer
346591|NCT02112331|Preterm newborns|preterm newborns
346592|NCT02112331|Gastric lipolysis|gastric lipolysis
346593|NCT02112331|Physical treatments|physical treatments
346594|NCT02112331|Human milk|human milk
346595|NCT02112305|Magnesium sulphate nebulized|magnesium sulphate nebulized
346596|NCT02112279|Microbiota|microbiota
346597|NCT02112279|c-difficile|c-difficile
346598|NCT02112279|colonoscopy|colonoscopy
346599|NCT02112279|stool transplant|stool transplant
346600|NCT02112266|depression|depression
346601|NCT02112266|online therapy|online therapy
346602|NCT02112266|cognitive behavioural therapy|cognitive behavioural therapy
346603|NCT02112266|quality of life|quality of life
346604|NCT02112266|alexithymia|alexithymia
346605|NCT02112266|therapy expectation and satisfaction|therapy expectation and satisfaction
346606|NCT02112253|Tourette's syndrome|tourette's syndrome
346607|NCT02112253|Deep brain stimulation|deep brain stimulation
346608|NCT02112253|Stereotactic surgery|stereotactic surgery
346609|NCT02112253|Globus pallidus interna|globus pallidus interna
346610|NCT02112253|Tics|tics
346611|NCT02112240|sentinel lymph node|sentinel lymph node
346612|NCT02112240|lymphatic mapping|lymphatic mapping
346613|NCT02112240|rectal tumor|rectal tumor
346614|NCT02112227|Heart Failure|heart failure
346615|NCT02112227|Transitional Care|transitional care
346616|NCT02112227|Knowledge Translation|knowledge translation
346617|NCT02112227|Outcomes|outcomes
346618|NCT02112214|Helicobacter pylori treatment|helicobacter pylori treatment
346619|NCT02112214|Gastric cancer|gastric cancer
346620|NCT02112214|Screening|screening
346621|NCT02112175|Multiple Myeloma|multiple myeloma
346622|NCT02112175|Lenalidomide|lenalidomide
346623|NCT02112175|Revlimid|revlimid
346624|NCT02112175|MPV|mpv
346625|NCT02112175|Melphalan|melphalan
346626|NCT02112175|Prednisone|prednisone
346627|NCT02112175|Velcade|velcade
346628|NCT02112175|Placebo|placebo
346629|NCT02112149|Body Composition|body composition
346630|NCT02112149|Exercise|exercise
346631|NCT02112149|Survivorship|survivorship
346632|NCT02112136|Autosomal Dominant Polycystic Kidney Disease (ADPKD)|autosomal dominant polycystic kidney disease (adpkd)
346633|NCT02112136|Renal cysts|renal cysts
346634|NCT02112136|Chronic Kidney Diseases|chronic kidney diseases
346635|NCT02112136|Genetic|genetic
346637|NCT02112123|pharmacokinetics|pharmacokinetics
346638|NCT02112123|healthy participants|healthy participants
346639|NCT02112097|Plaque Psoriasis.|plaque psoriasis.
346640|NCT02112097|Subdermal bloodless space|subdermal bloodless space
346641|NCT02112097|Subdermal injection|subdermal injection
346642|NCT02112097|Subcutaneous injection|subcutaneous injection
346643|NCT02112097|Injectable electromyography needle|injectable electromyography needle
346644|NCT02112097|Electrical stimulation|electrical stimulation
346645|NCT02112097|MRI with Gadolinium|mri with gadolinium
346646|NCT02112071|Exercise|exercise
346647|NCT02112071|Diabetic kidney disease|diabetic kidney disease
346648|NCT02112071|vascular function|vascular function
346649|NCT02112071|physical function|physical function
346650|NCT02112032|melanoma|melanoma
346651|NCT02112032|advanced|advanced
346652|NCT02112019|Sjögren's Syndrome|sjögren's syndrome
346653|NCT02112019|Sialoendoscopy|sialoendoscopy
346654|NCT02112019|Saliva|saliva
346655|NCT02112019|Dry Mouth|dry mouth
346656|NCT02112006|hand surgery|hand surgery
346657|NCT02112006|wrist surgery|wrist surgery
346658|NCT02112006|finger surgery|finger surgery
346659|NCT02112006|anesthesia|anesthesia
346660|NCT02112006|regional anesthesia|regional anesthesia
346661|NCT02112006|postoperative pain|postoperative pain
346662|NCT02111993|Defibrillation testing|defibrillation testing
346663|NCT02111993|Upper Limit of Vulnerability|upper limit of vulnerability
346664|NCT02111993|ULV|ulv
346665|NCT02111993|DFT|dft
346666|NCT02111993|ICD|icd
346667|NCT02111993|implantable cardioverter defibrillator|implantable cardioverter defibrillator
346668|NCT02111993|cardiomyopathy|cardiomyopathy
346669|NCT02111993|cardiac arrhythmia|cardiac arrhythmia
346670|NCT02111993|cardiac device testing|cardiac device testing
346671|NCT02111980|CIED|cied
346672|NCT02111980|pacemaker|pacemaker
346673|NCT02111980|implantable cardioverter defibrillator|implantable cardioverter defibrillator
346674|NCT02111980|ICD|icd
346675|NCT02111980|radiofrequency|radiofrequency
346676|NCT02111980|cardiac device programming|cardiac device programming
346677|NCT02111980|RF sponge detection|rf sponge detection
346678|NCT02111980|RF assure|rf assure
346679|NCT02111980|cardiac internal electronic devices|cardiac internal electronic devices
346680|NCT02111980|temporary pacing|temporary pacing
346681|NCT02111980|pulmonary thromboendarterectomy|pulmonary thromboendarterectomy
346682|NCT02111980|pacing interference|pacing interference
346683|NCT02111980|Arrhythmia|arrhythmia
346684|NCT02111954|prostate cancer|prostate cancer
346685|NCT02111954|primary|primary
346686|NCT02111954|recurrence|recurrence
346687|NCT02111954|F-18-FCH PET/CT|f-18-fch pet/ct
346688|NCT02111954|Ga-68-NODAGA-MJ9 PET/CT|ga-68-nodaga-mj9 pet/ct
346689|NCT02111915|Maternal depression|maternal depression
346690|NCT02111902|Cardiovascular Disease|cardiovascular disease
346691|NCT02111902|Obesity|obesity
346692|NCT02111902|Physical Activity|physical activity
346693|NCT02111902|Vitamin D deficiency|vitamin d deficiency
346694|NCT02111902|African Americans|african americans
346695|NCT02111876|ICU, COPD, OHS, OSA, heart failure|icu, copd, ohs, osa, heart failure
346696|NCT02111863|Skin Cancer|skin cancer
346697|NCT02111863|Metastatic Melanoma|metastatic melanoma
346698|NCT02111863|Adoptive Cell Therapy|adoptive cell therapy
346699|NCT02111863|Immunotherapy|immunotherapy
346700|NCT02111863|Clinical Response|clinical response
346701|NCT02111850|Gene Therapy|gene therapy
346702|NCT02111850|Tumor Regression|tumor regression
346703|NCT02111850|Immunotherapy|immunotherapy
346704|NCT02111850|Adoptive Cell Therapy|adoptive cell therapy
346705|NCT02111824|Lung Cancer|lung cancer
346706|NCT02111824|Peripheral lung lesions|peripheral lung lesions
346707|NCT02111824|Lung biopsy|lung biopsy
346708|NCT02111824|Minimally invasive|minimally invasive
346709|NCT02111824|multimodality image-guided intervention system|multimodality image-guided intervention system
346710|NCT02111824|MIMIG|mimig
346711|NCT02111824|Indocyanine green|indocyanine green
346712|NCT02111824|ICG|icg
346713|NCT02111811|Depression|depression
346714|NCT02111811|Treatment Outcome|treatment outcome
346715|NCT02111811|Delivery of Healthcare, Integrated|delivery of healthcare, integrated
346716|NCT02111811|Employment|employment
346717|NCT02111811|Rehabilitation|rehabilitation
346718|NCT02111798|substance abuse treatment|substance abuse treatment
346719|NCT02111798|cocaine dependence|cocaine dependence
346720|NCT02111798|contingency management; abstinence incentives|contingency management; abstinence incentives
346721|NCT02111798|medication-enhanced behavioral therapy|medication-enhanced behavioral therapy
346722|NCT02111785|Dexamethasone|dexamethasone
346723|NCT02111785|Burr hole craniostomy|burr hole craniostomy
346724|NCT02111785|Chronic subdural hematoma|chronic subdural hematoma
346725|NCT02111772|mild asthma, rhinovirus, young adults|mild asthma, rhinovirus, young adults
346726|NCT02111746|Postoperative pain|postoperative pain
346727|NCT02111746|sternotomy|sternotomy
346728|NCT02111746|laparotomy|laparotomy
346729|NCT02111746|thoracotomy|thoracotomy
346730|NCT02111746|mini-thoracotomy|mini-thoracotomy
346731|NCT02111746|truncal surgical incisions|truncal surgical incisions
346732|NCT02111746|local anaesthetics|local anaesthetics
346733|NCT02111746|bupivacaine|bupivacaine
346734|NCT02111720|HIV|hiv
346735|NCT02111720|Disclosure|disclosure
346736|NCT02111720|Family|family
346737|NCT02111720|Intervention|intervention
346738|NCT02111694|infant|infant
346739|NCT02111694|intake|intake
346740|NCT02111694|satiation|satiation
346741|NCT02111694|mother|mother
346742|NCT02111694|feeding practices|feeding practices
346743|NCT02111694|bottle feeding|bottle feeding
346744|NCT02111694|formula feeding|formula feeding
346745|NCT02111694|maternal responsiveness|maternal responsiveness
346746|NCT02111694|infant cues|infant cues
346747|NCT02111681|Calypso-based Deep Inspiration Breath Hold (DIBH)|calypso-based deep inspiration breath hold (dibh)
346748|NCT02111681|radiation treatments|radiation treatments
346749|NCT02111681|13-174|13-174
346750|NCT02111668|Aorta|aorta
346751|NCT02111668|Dilatation|dilatation
346752|NCT02111668|Marfan syndrome|marfan syndrome
346753|NCT02111668|Genetic|genetic
346754|NCT02111668|Fbn1|fbn1
346755|NCT02111655|Thrombosis|thrombosis
346756|NCT02111655|Arteriovenous fistulae|arteriovenous fistulae
346757|NCT02111655|Hemodialysis|hemodialysis
346758|NCT02111655|Doppler ultrasound|doppler ultrasound
346759|NCT02111655|Vascular access blood flow|vascular access blood flow
346760|NCT02111655|Surveillance|surveillance
346761|NCT02111642|Pelvic organ prolapse|pelvic organ prolapse
346762|NCT02111642|Stress urinary incontinence|stress urinary incontinence
346763|NCT02111642|Midurethral sling|midurethral sling
346764|NCT02111642|Patient satisfaction|patient satisfaction
346765|NCT02111629|Vaginosis, bacterial; Candidiasis, vulvovaginal|vaginosis, bacterial; candidiasis, vulvovaginal
346766|NCT02111616|cancer survivorship care|cancer survivorship care
346767|NCT02111616|provider communication|provider communication
346768|NCT02111616|provider care coordination|provider care coordination
346769|NCT02111590|Immunoglobulins, Intravenous|immunoglobulins, intravenous
346770|NCT02111590|Immunoglobulins, Subcutaneous|immunoglobulins, subcutaneous
346771|NCT02111577|Immunotherapy|immunotherapy
346772|NCT02111577|Metastatic|metastatic
346773|NCT02111577|Castrate Resistant|castrate resistant
346774|NCT02111577|Prostate Cancer|prostate cancer
346775|NCT02111577|Biological|biological
346776|NCT02111577|Vaccine|vaccine
346777|NCT02111564|Heart Failure|heart failure
346778|NCT02111564|Respiratory Insufficiency|respiratory insufficiency
346779|NCT02111564|Stroke Acute|stroke acute
346780|NCT02111564|Infectious Diseases|infectious diseases
346781|NCT02111564|Rheumatic Diseases|rheumatic diseases
346782|NCT02111564|Medically ill Patient|medically ill patient
346783|NCT02111564|Rivaroxaban|rivaroxaban
346784|NCT02111564|Thromboembolism|thromboembolism
346785|NCT02111564|Prophylactic Anti-Coagulation|prophylactic anti-coagulation
346786|NCT02111551|Autism|autism
346787|NCT02111551|Nicotinic agonist|nicotinic agonist
346788|NCT02111551|Cognition|cognition
346789|NCT02111551|P50|p50
346790|NCT02111551|Alpha 7|alpha 7
346791|NCT02111499|psoriasis plaque test|psoriasis plaque test
346792|NCT02111499|topical application|topical application
346793|NCT02111499|atrophy measure|atrophy measure
346794|NCT02111486|Breakfast|breakfast
346795|NCT02111486|Satiety|satiety
346796|NCT02111486|Fibre|fibre
346797|NCT02111486|Glucose|glucose
346798|NCT02111486|Gastric emptying|gastric emptying
346799|NCT02111473|endothelial dysfunction|endothelial dysfunction
346800|NCT02111473|bone mineral metabolism|bone mineral metabolism
346801|NCT02111473|testosteron replacement treatment|testosteron replacement treatment
346802|NCT02111460|Initially|initially
346803|NCT02111460|Untreated|untreated
346804|NCT02111460|Distant metastatic|distant metastatic
346805|NCT02111447|children|children
346806|NCT02111447|sevoflurane|sevoflurane
346807|NCT02111447|isoflurane|isoflurane
346808|NCT02111447|propofol|propofol
346809|NCT02111447|anesthesia|anesthesia
346810|NCT02111447|MRI|mri
346811|NCT02111447|delirium|delirium
346812|NCT02111434|visceral adiposity index|visceral adiposity index
346813|NCT02111434|triglycerides / hdl cholesterol ratio|triglycerides / hdl cholesterol ratio
346814|NCT02111434|testosterone|testosterone
346815|NCT02111421|dexmedetomidine|dexmedetomidine
346816|NCT02111421|parturient|parturient
346817|NCT02111421|nonpregnant women|nonpregnant women
346818|NCT02111421|sedation|sedation
346819|NCT02111408|Sleep apnea syndromes|sleep apnea syndromes
346820|NCT02111408|Autonomic nervous system +/- disease|autonomic nervous system +/- disease
346821|NCT02111408|Depression|depression
346822|NCT02111408|Peripheral arterial disease|peripheral arterial disease
346823|NCT02111382|Low back pain|low back pain
346824|NCT02111382|osteopathic manipulations|osteopathic manipulations
346825|NCT02111382|electroencephalography|electroencephalography
346826|NCT02111369|Essential Tremor|essential tremor
346827|NCT02111369|Essential Vocal Tremor|essential vocal tremor
346828|NCT02111369|Essential Voice Tremor|essential voice tremor
346829|NCT02111343|auditory processing disorder|auditory processing disorder
346830|NCT02111343|central auditory processing disorder|central auditory processing disorder
346831|NCT02111343|auditory processing|auditory processing
346832|NCT02111343|auditory training|auditory training
346833|NCT02111330|Adenosine A2a receptor antagonist|adenosine a2a receptor antagonist
347429|NCT02108652|MPDL3280A|mpdl3280a
346834|NCT02111330|adenosine receptor modulator|adenosine receptor modulator
346835|NCT02111330|Cancer|cancer
346836|NCT02111317|ASP015K|asp015k
346837|NCT02111317|Pharmacokinetics|pharmacokinetics
346838|NCT02111317|Healthy Subjects|healthy subjects
346839|NCT02111304|cholera|cholera
346840|NCT02111304|diarrhea|diarrhea
346841|NCT02111304|secretory diarrhea|secretory diarrhea
346842|NCT02111304|ORS|ors
346843|NCT02111304|V. cholerae O1|v. cholerae o1
346844|NCT02111304|iOWH032|iowh032
346845|NCT02111304|children|children
346846|NCT02111304|pharmacokinetic|pharmacokinetic
346847|NCT02111304|Bangladesh|bangladesh
346848|NCT02111291|Diabetic Foot Ulcers|diabetic foot ulcers
346849|NCT02111278|Manipulation|manipulation
346850|NCT02111278|Lumbar|lumbar
346851|NCT02111278|Low Back Pain|low back pain
346852|NCT02111278|Manual Therapy|manual therapy
346853|NCT02111278|Adolescents|adolescents
346854|NCT02111252|Drug Therapy|drug therapy
346855|NCT02111239|DIEP|diep
346856|NCT02111239|DIEP flap|diep flap
346857|NCT02111239|Breast reconstruction|breast reconstruction
346858|NCT02111239|Breast Cancer|breast cancer
346859|NCT02111239|CTA|cta
346860|NCT02111239|MRA|mra
346861|NCT02111226|hypertension|hypertension
346862|NCT02111226|cardiovascular disease|cardiovascular disease
346863|NCT02111226|diabetes|diabetes
346864|NCT02111226|chronic disease management|chronic disease management
346865|NCT02111213|physical activity|physical activity
346866|NCT02111213|Intervention|intervention
346867|NCT02111213|Attitude to Computers|attitude to computers
346868|NCT02111200|urea cycle disorders|urea cycle disorders
346869|NCT02111187|LDE225|lde225
346870|NCT02111187|High risk localized prostate cancer|high risk localized prostate cancer
346871|NCT02111187|Pre-surgical|pre-surgical
346872|NCT02111174|Neuropathy|neuropathy
346873|NCT02111174|Peripheral neuropathy|peripheral neuropathy
346874|NCT02111174|Chemotherapy-induced peripheral neuropathy|chemotherapy-induced peripheral neuropathy
346875|NCT02111161|Randomised controlled trial (RCT)|randomised controlled trial (rct)
346876|NCT02111161|Immunoglobulin|immunoglobulin
346877|NCT02111161|Patient Reported Outcome|patient reported outcome
346878|NCT02111161|Health-Related Quality of Life|health-related quality of life
346879|NCT02111161|Short Form-36 (SF-36)|short form-36 (sf-36)
346880|NCT02111148|rupture of membranes, nitrazine, urea, creatinine|rupture of membranes, nitrazine, urea, creatinine
346881|NCT02111122|excessive daytime sleepiness|excessive daytime sleepiness
346882|NCT02111122|Parkinson`s Disease|parkinson`s disease
346883|NCT02111122|sleep-wake disturbances|sleep-wake disturbances
346884|NCT02111122|Sodium Oxybate|sodium oxybate
346885|NCT02111109|Microcirculation|microcirculation
346886|NCT02111109|Trauma|trauma
346887|NCT02111109|Haemorrhage|haemorrhage
346888|NCT02111109|Shock|shock
346889|NCT02111070|Influenza|influenza
346890|NCT02111070|Influenza vaccine|influenza vaccine
346891|NCT02111070|Split influenza vaccine|split influenza vaccine
346892|NCT02111057|Rheumatoid Arthritis|rheumatoid arthritis
346893|NCT02111057|Total Hip Replacement|total hip replacement
346894|NCT02111057|Flare|flare
346895|NCT02111057|Perioperative Outcomes|perioperative outcomes
346896|NCT02111044|de novo or partial responder to somatostatin analogues|de novo or partial responder to somatostatin analogues
346897|NCT02111031|CELLSEARCH|cellsearch
346898|NCT02111031|CTC|ctc
346899|NCT02111031|metastatic breast cancer|metastatic breast cancer
346900|NCT02111031|Registry|registry
346901|NCT02111031|mBC|mbc
346902|NCT02111005|apoptosis|apoptosis
346903|NCT02111005|periodontal disease|periodontal disease
346904|NCT02111005|smoking|smoking
346905|NCT02110979|Patient Decision Aid|patient decision aid
346906|NCT02110979|Shared Decision Making|shared decision making
346907|NCT02110966|Anaesthetic effect|anaesthetic effect
346908|NCT02110966|Inferior alveolar nerve block|inferior alveolar nerve block
346909|NCT02110966|Local tramadol|local tramadol
346910|NCT02110966|Mepivacaine|mepivacaine
346911|NCT02110966|Symptomatic irreversible pulpitis.|symptomatic irreversible pulpitis.
346912|NCT02110927|Abdominal fat|abdominal fat
346913|NCT02110927|Metabolic syndrome|metabolic syndrome
346914|NCT02110927|Microcurrent|microcurrent
346915|NCT02110927|Aerobic exercise|aerobic exercise
346916|NCT02110927|Lipolysis|lipolysis
346917|NCT02110914|Feasibility study|feasibility study
346918|NCT02110914|Coaching|coaching
346919|NCT02110914|Health related quality of life|health related quality of life
346920|NCT02110914|Adherence|adherence
346921|NCT02110901|radiocephalic|radiocephalic
346922|NCT02110901|arteriovenous fistula|arteriovenous fistula
346923|NCT02110901|AVF|avf
346924|NCT02110901|hemodialysis|hemodialysis
346925|NCT02110901|PRT-201|prt-201
346926|NCT02110901|vascular access|vascular access
346927|NCT02110901|kidney|kidney
346928|NCT02110901|renal|renal
346929|NCT02110901|vonapanitase|vonapanitase
346930|NCT02110901|PATENCY-1|patency-1
346931|NCT02110875|Healthy Volunteers|healthy volunteers
346932|NCT02110849|Prostate|prostate
346933|NCT02110849|Proton Therapy|proton therapy
346934|NCT02110849|Cancer|cancer
346935|NCT02110810|post-ERCP Acute Pancreatitis|post-ercp acute pancreatitis
346936|NCT02110810|Indomethacin|indomethacin
346937|NCT02110810|NSAIDs|nsaids
346938|NCT02110797|RETT syndrome|rett syndrome
346939|NCT02110797|MECP2|mecp2
346940|NCT02110797|Osteoporosis|osteoporosis
346941|NCT02110797|RANK-ligand|rank-ligand
346942|NCT02110797|osteoprotegerin|osteoprotegerin
346943|NCT02110784|Artemisinin based Combination Therapies|artemisinin based combination therapies
346944|NCT02110784|eurartesim|eurartesim
346945|NCT02110784|Dihydroartemisinin/Piperaquine|dihydroartemisinin/piperaquine
346946|NCT02110771|schizophrenia|schizophrenia
346947|NCT02110771|social cognition|social cognition
346948|NCT02110771|facial affects recognition|facial affects recognition
346949|NCT02110771|cognitive remediation|cognitive remediation
346950|NCT02110758|Patient Care Management|patient care management
346951|NCT02110758|Patient Care Planning|patient care planning
346952|NCT02110758|Patient-Centered Care|patient-centered care
346953|NCT02110758|Patient Care Team|patient care team
346954|NCT02110758|Advance Care Planning|advance care planning
346955|NCT02110758|Delivery of Health Care|delivery of health care
346956|NCT02110758|Evidence-based Practice|evidence-based practice
346957|NCT02110758|Health Care Costs|health care costs
346958|NCT02110758|Health Care Quality, Access, and Evaluation|health care quality, access, and evaluation
346959|NCT02110758|Quality of Health Care|quality of health care
346960|NCT02110758|Neoplasms|neoplasms
346961|NCT02110758|Medical Oncology|medical oncology
346962|NCT02110719|narcotic use|narcotic use
346963|NCT02110719|pain|pain
346964|NCT02110719|constipation|constipation
346965|NCT02110719|nausea|nausea
346966|NCT02110706|Myasthenia Gravis|myasthenia gravis
346967|NCT02110706|Rituximab|rituximab
346968|NCT02110706|SNOMED code 31839002|snomed code 31839002
346969|NCT02110693|Substance Use|substance use
346970|NCT02110693|Substance Use Disorder|substance use disorder
443654|NCT01672879|MRE|mre
346971|NCT02110693|Screening|screening
346972|NCT02110693|Brief Assessment|brief assessment
346973|NCT02110680|overactive bladder|overactive bladder
346974|NCT02110680|transcutaneous electric stimulation|transcutaneous electric stimulation
346975|NCT02110680|posterior tibial nerve stimulation|posterior tibial nerve stimulation
346976|NCT02110667|Prostate cancer|prostate cancer
346977|NCT02110667|Prostatectomy|prostatectomy
346978|NCT02110667|Ultrasound|ultrasound
346979|NCT02110667|TPUS|tpus
346980|NCT02110654|chronic rhinosinusitis|chronic rhinosinusitis
346981|NCT02110654|asthma|asthma
346982|NCT02110654|montelukast|montelukast
346983|NCT02110654|surgery|surgery
346984|NCT02110654|treatment outcomes|treatment outcomes
346985|NCT02110641|Breast Cancer|breast cancer
346986|NCT02110641|Survivorship|survivorship
346987|NCT02110641|Weight Loss|weight loss
346988|NCT02110628|total gastrectomy|total gastrectomy
346989|NCT02110628|pouch|pouch
346990|NCT02110628|roux-en-y|roux-en-y
346991|NCT02110628|quality of life|quality of life
346992|NCT02110602|Nutrition|nutrition
346993|NCT02110589|seizures|seizures
346994|NCT02110550|endocrown|endocrown
346995|NCT02110550|marginal adaptation|marginal adaptation
346996|NCT02110550|anatomic form|anatomic form
346997|NCT02110550|retention loss|retention loss
346998|NCT02110550|IPS.emmax crowns|ips.emmax crowns
346999|NCT02110537|Atrial fibrillation|atrial fibrillation
347000|NCT02110537|Acupuncture|acupuncture
347001|NCT02110537|Recurrence|recurrence
347002|NCT02110537|Electrical cardioversion|electrical cardioversion
347003|NCT02110524|Peripheral Arterial Disease|peripheral arterial disease
347004|NCT02110498|Pancreatic cyst|pancreatic cyst
347005|NCT02110498|IPMN|ipmn
347006|NCT02110498|SCA|sca
347007|NCT02110498|SPN|spn
347008|NCT02110498|MCN|mcn
347009|NCT02110498|pancreatic cystic neoplasm|pancreatic cystic neoplasm
347010|NCT02110485|Appendicitis|appendicitis
347011|NCT02110485|Pediatric|pediatric
347012|NCT02110485|Children|children
347013|NCT02110485|Non-operative|non-operative
347014|NCT02110485|Antibiotics alone|antibiotics alone
347015|NCT02110472|Emmetropic presbyopes|emmetropic presbyopes
347016|NCT02110472|Presbyopic|presbyopic
347017|NCT02110459|POL7080|pol7080
347018|NCT02110459|Pharmacokinetics|pharmacokinetics
347019|NCT02110446|Sjögren's syndrome|sjögren's syndrome
347020|NCT02110446|SS-1|ss-1
347021|NCT02110446|Gan-Lu-Yin|gan-lu-yin
347022|NCT02110446|Sang-Ju-Yin|sang-ju-yin
347023|NCT02110446|Xuefu-Zhuyu-Decoction|xuefu-zhuyu-decoction
347024|NCT02110433|chronic heart failure|chronic heart failure
347025|NCT02110433|BNP|bnp
347026|NCT02110433|telemedicine|telemedicine
347027|NCT02110433|telemonitoring|telemonitoring
347028|NCT02110433|weight|weight
347029|NCT02110433|education|education
347030|NCT02110433|self management|self management
347031|NCT02110433|cost effectiveness|cost effectiveness
347032|NCT02110420|Safety|safety
347033|NCT02110420|Pharmacokinetics|pharmacokinetics
347034|NCT02110420|Healthy Subjects|healthy subjects
347035|NCT02110420|First-in-Human|first-in-human
347036|NCT02110407|healthy young adults|healthy young adults
347037|NCT02110407|tDCS|tdcs
347038|NCT02110407|LOCATO task|locato task
347039|NCT02110407|visual-spatial learning|visual-spatial learning
347040|NCT02110394|observational|observational
347041|NCT02110394|chronic lymphocytic leukemia|chronic lymphocytic leukemia
347042|NCT02110394|bendamustine|bendamustine
347043|NCT02110381|High blood pressure|high blood pressure
347044|NCT02110355|Metastatic melanoma|metastatic melanoma
347045|NCT02110342|PF-04449913|pf-04449913
347046|NCT02110342|[14C]PF-04449913|[14c]pf-04449913
347047|NCT02110342|Human ADME|human adme
347048|NCT02110342|Radiolabel|radiolabel
347049|NCT02110342|Mass Balance|mass balance
347050|NCT02110342|Pharmacokinetics|pharmacokinetics
347051|NCT02110329|colorectal cancer|colorectal cancer
347052|NCT02110329|stage II and III|stage ii and iii
347053|NCT02110329|somatic quantitative molecular alterations|somatic quantitative molecular alterations
347054|NCT02110329|Qantitative Multiplex Pcr of Short fluorescent Fragments method (QMPSF)|qantitative multiplex pcr of short fluorescent fragments method (qmpsf)
347055|NCT02110290|quality of life|quality of life
347056|NCT02110290|adaptive sports|adaptive sports
347057|NCT02110290|therapeutic recreation|therapeutic recreation
347058|NCT02110290|mental health|mental health
347059|NCT02110277|Ovarian Cancer|ovarian cancer
347060|NCT02110277|Epithelial ovarian cancer|epithelial ovarian cancer
347061|NCT02110264|Opioid Use|opioid use
347062|NCT02110264|Incarceration|incarceration
347063|NCT02110264|Vivitrol|vivitrol
347064|NCT02110264|Patient Navigator|patient navigator
347065|NCT02110264|Drug Education|drug education
347066|NCT02110238|osteoarthritis|osteoarthritis
347067|NCT02110238|knee pain|knee pain
347069|NCT02110238|Euflexxa|euflexxa
347070|NCT02110238|HA|ha
347071|NCT02110238|hyaluronic acid|hyaluronic acid
347072|NCT02110225|Cone-Rod Degenerations|cone-rod degenerations
776029|NCT00345046|Glaucoma|glaucoma
347073|NCT02110225|Cone-Rod Dystrophy|cone-rod dystrophy
347074|NCT02110225|Cone-Rod Dystrophy 2|cone-rod dystrophy 2
347075|NCT02110225|Cone-Rod Retinal Dystrophy|cone-rod retinal dystrophy
347076|NCT02110225|Pigmentary Retinopathy|pigmentary retinopathy
347077|NCT02110225|Retinal Cone-Rod Dystrophy|retinal cone-rod dystrophy
347078|NCT02110225|Rod Cone Dystrophies|rod cone dystrophies
347079|NCT02110225|Rod-Cone Dystrophy|rod-cone dystrophy
347080|NCT02110225|Tapetoretinal Degeneration|tapetoretinal degeneration
347081|NCT02110212|Cataract|cataract
347082|NCT02110212|Surgery, cataract extraction|surgery, cataract extraction
347083|NCT02110212|Optical devices, laser|optical devices, laser
347084|NCT02110186|lumbar disc herniation|lumbar disc herniation
347085|NCT02110186|dynamic stabilization|dynamic stabilization
347086|NCT02110186|discectomy with posterior dynamic stabilization|discectomy with posterior dynamic stabilization
347087|NCT02110186|discectomy alone|discectomy alone
347088|NCT02110186|discectomy with internal fixation and fusion|discectomy with internal fixation and fusion
347089|NCT02110069|KHE|khe
347090|NCT02110069|Vascular anomaly|vascular anomaly
347091|NCT02110069|Kasabach-Merritt Syndrome|kasabach-merritt syndrome
347092|NCT02110069|Tufted angioma|tufted angioma
347093|NCT02110069|hemangioendothelioma|hemangioendothelioma
347094|NCT02110056|healthy older adults|healthy older adults
347095|NCT02110056|tDCS|tdcs
347096|NCT02110056|LOCATO task|locato task
347097|NCT02110056|visual-spatial learning|visual-spatial learning
347098|NCT02110043|mild cognitive impairment (MCI)|mild cognitive impairment (mci)
347099|NCT02110043|tDCS|tdcs
347100|NCT02110043|LOCATO task|locato task
347101|NCT02110043|visual-spatial learning|visual-spatial learning
347102|NCT02110030|Transcutaneous electrical nerve stimulation (TENS)|transcutaneous electrical nerve stimulation (tens)
347103|NCT02110030|Ultrasound|ultrasound
347104|NCT02110030|Interferential current therapy|interferential current therapy
347105|NCT02110030|Rehabilitation|rehabilitation
347106|NCT02110030|Shoulder pain|shoulder pain
347107|NCT02110017|Ecological task|ecological task
347108|NCT02110017|fMRI|fmri
347109|NCT02110017|Schizophrenia|schizophrenia
347110|NCT02110017|Social Cognition|social cognition
347111|NCT02109978|Diabetes|diabetes
347112|NCT02109978|Type 2 diabetes|type 2 diabetes
347113|NCT02109978|Diabetes therapy response|diabetes therapy response
347114|NCT02109978|Diabetes progression|diabetes progression
347115|NCT02109939|MDD|mdd
347116|NCT02109939|Pharmacogenomic|pharmacogenomic
347117|NCT02109939|Pharmacogenomic Testing|pharmacogenomic testing
347118|NCT02109939|Pharmacogenomics|pharmacogenomics
347119|NCT02109939|Genetic Testing|genetic testing
347120|NCT02109939|Genetics|genetics
347121|NCT02109939|Major Depressive Disorder|major depressive disorder
347122|NCT02109939|GeneSight|genesight
347123|NCT02109939|Assurex|assurex
347124|NCT02109939|AssureRx|assurerx
347125|NCT02109939|Psychotropic|psychotropic
347126|NCT02109939|Randomized|randomized
347127|NCT02109939|Double Blind|double blind
347128|NCT02109939|Placebo Controlled|placebo controlled
347129|NCT02109913|Breast Cancer|breast cancer
347130|NCT02109913|metastatic|metastatic
347131|NCT02109913|hormone receptor positive|hormone receptor positive
347132|NCT02109913|everolimus|everolimus
347133|NCT02109913|biomarker|biomarker
347134|NCT02109887|Pneumocystis jiroveci, cytomegalovirus, co-infection|pneumocystis jiroveci, cytomegalovirus, co-infection
347135|NCT02109861|Multiple Myeloma|multiple myeloma
347136|NCT02109861|Phase 0 study|phase 0 study
347137|NCT02109861|Microdose study|microdose study
347138|NCT02109861|Micro array|micro array
347139|NCT02109861|Gene expression profiling|gene expression profiling
347140|NCT02109848|keratoconus|keratoconus
347141|NCT02109848|post-keratoplasty|post-keratoplasty
347142|NCT02109835|Diabetes|diabetes
347143|NCT02109835|coronary artery disease|coronary artery disease
347144|NCT02109835|Cardiac computed tomography|cardiac computed tomography
347145|NCT02109835|Computed tomographics coronary angiography|computed tomographics coronary angiography
347146|NCT02109835|Plaque progression|plaque progression
347147|NCT02109822|Cystic Fibrosis|cystic fibrosis
347148|NCT02109822|Pulmonary Exacerbation|pulmonary exacerbation
347149|NCT02109822|Lung Infection|lung infection
347150|NCT02109822|Cystic Fibrosis Foundation|cystic fibrosis foundation
347151|NCT02109822|Cystic Fibrosis Foundation National Patient Registry|cystic fibrosis foundation national patient registry
347152|NCT02109796|tDCS|tdcs
347153|NCT02109796|Stroke|stroke
347154|NCT02109796|Force|force
347155|NCT02109796|Spasticity|spasticity
347156|NCT02109796|Gait|gait
347157|NCT02109796|EMG|emg
347158|NCT02109796|Isokinetic|isokinetic
347159|NCT02109783|Athletes|athletes
347160|NCT02109783|Ergogenic aids|ergogenic aids
347161|NCT02109783|Caffeine|caffeine
347162|NCT02109783|Nutrigenomics|nutrigenomics
347163|NCT02109783|Genotype|genotype
347164|NCT02109770|22q|22q
347165|NCT02109770|DiGeorge|digeorge
347166|NCT02109770|Angelman|angelman
347167|NCT02109770|Cri du chat|cri du chat
347168|NCT02109770|Miller Dieker|miller dieker
347169|NCT02109770|1p36|1p36
347170|NCT02109770|Phelan McDermid|phelan mcdermid
347171|NCT02109770|Prader Willi|prader willi
347172|NCT02109770|Wolf Hirschorn|wolf hirschorn
347173|NCT02109770|Smith Magenis|smith magenis
347174|NCT02109770|Trisomy 21|trisomy 21
347175|NCT02109770|Down syndrome|down syndrome
347176|NCT02109770|Trisomy 18|trisomy 18
347177|NCT02109770|Edwards syndrome|edwards syndrome
347178|NCT02109770|Trisomy 13|trisomy 13
347179|NCT02109770|Patau syndrome|patau syndrome
347180|NCT02109770|Monosomy X|monosomy x
347181|NCT02109770|Turner syndrome|turner syndrome
347182|NCT02109770|XXY|xxy
347183|NCT02109770|Klinefelter syndrome|klinefelter syndrome
347184|NCT02109770|XXX|xxx
347185|NCT02109770|XYY|xyy
347186|NCT02109757|Hearing conservation|hearing conservation
347187|NCT02109757|Personal attenuation rating|personal attenuation rating
347188|NCT02109757|earplug|earplug
347189|NCT02109731|Obstructive Sleep Apnea Syndrome (OSAS)|obstructive sleep apnea syndrome (osas)
347190|NCT02109731|Sleep Apnea|sleep apnea
347191|NCT02109718|Burns|burns
347192|NCT02109718|Dressings|dressings
347193|NCT02109718|Outpatient Management|outpatient management
347194|NCT02109718|Petrolatum Jelly|petrolatum jelly
347195|NCT02109718|Superficial Partial Thickness Burns|superficial partial thickness burns
347196|NCT02109718|Less than or equal to 10% Total Body Surface Area|less than or equal to 10% total body surface area
347197|NCT02109692|muscle dystrophies|muscle dystrophies
347198|NCT02109692|dystromirs|dystromirs
347199|NCT02109692|longitudinal study|longitudinal study
347200|NCT02109692|miRNA|mirna
347201|NCT02109653|NSCLC,|nsclc,
347202|NCT02109653|Non-Small Cell Lung Cancer,|non-small cell lung cancer,
347203|NCT02109653|BRAF V600,|braf v600,
347204|NCT02109653|LGX818|lgx818
347205|NCT02109640|Colorectal|colorectal
347206|NCT02109640|Surgery|surgery
347207|NCT02109640|Laparoscopic|laparoscopic
347208|NCT02109640|Analgesia|analgesia
347209|NCT02109640|Enhanced Recovery|enhanced recovery
347210|NCT02109640|Targinact|targinact
347211|NCT02109627|Acute Myeloid Leukemia|acute myeloid leukemia
347212|NCT02109627|Ficlatuzumab|ficlatuzumab
347213|NCT02109627|High Dose Cytarabine|high dose cytarabine
347214|NCT02109627|antibody|antibody
347215|NCT02109614|lipoprotein(a)|lipoprotein(a)
347216|NCT02109614|aortic stenosis|aortic stenosis
347217|NCT02109601|Patient Portals|patient portals
347218|NCT02109601|Personal Health Records|personal health records
347219|NCT02109601|Patient Engagement|patient engagement
347220|NCT02109601|Mobile Health|mobile health
347221|NCT02109601|Tablet Computers|tablet computers
347222|NCT02109575|Acute Rejection|acute rejection
347223|NCT02109575|Cardiac Biomarkers|cardiac biomarkers
347224|NCT02109575|Cardiac Catheterization|cardiac catheterization
347225|NCT02109575|Cardiomyopathy|cardiomyopathy
347226|NCT02109575|Cell-Free DNA|cell-free dna
347227|NCT02109575|Congenital Heart Defect|congenital heart defect
347228|NCT02109575|Congenital Heart Disease|congenital heart disease
347229|NCT02109575|Coronary Angiogram|coronary angiogram
347230|NCT02109575|Donor Specific DNA|donor specific dna
347231|NCT02109575|Donor Specific Cell-Free DNA|donor specific cell-free dna
347232|NCT02109575|Endomyocardial Biopsy|endomyocardial biopsy
347233|NCT02109575|Heart Failure|heart failure
347234|NCT02109575|Heart Transplant Failure|heart transplant failure
347235|NCT02109575|Heart Transplant|heart transplant
347236|NCT02109575|Heart Transplant Rejection|heart transplant rejection
347237|NCT02109562|Schizophrenia|schizophrenia
347238|NCT02109562|Schizophrenic|schizophrenic
347239|NCT02109562|Schizophrenias|schizophrenias
347240|NCT02109562|Risperidone|risperidone
347241|NCT02109536|Colonoscopy|colonoscopy
347242|NCT02109536|Looping|looping
347243|NCT02109536|Loop recognition|loop recognition
347244|NCT02109536|magnetic endoscopic imager|magnetic endoscopic imager
347245|NCT02109471|corneal opacities|corneal opacities
347246|NCT02109471|Optical coherence tomography|optical coherence tomography
347247|NCT02109458|Lung nodule biopsy|lung nodule biopsy
347248|NCT02109432|Pedal Desk|pedal desk
347249|NCT02109432|Physical Activity|physical activity
347250|NCT02109432|Workplace|workplace
347251|NCT02109432|Energy Expenditure|energy expenditure
347252|NCT02109419|computerized assessments|computerized assessments
347253|NCT02109419|mood|mood
347254|NCT02109419|cognition|cognition
347255|NCT02109393|Rehabilitation|rehabilitation
347256|NCT02109393|Robot-assisted walking training|robot-assisted walking training
347257|NCT02109393|Treadmill|treadmill
347258|NCT02109393|Lokomat|lokomat
347259|NCT02109367|ovarian cancer|ovarian cancer
347260|NCT02109367|ovarian mass|ovarian mass
347261|NCT02109367|CA-125|ca-125
347263|NCT02109367|culdocentesis|culdocentesis
347264|NCT02109367|biomarker(s)|biomarker(s)
347265|NCT02109354|HIV infection|hiv infection
347266|NCT02109354|Vaccine|vaccine
347267|NCT02109341|mPC|mpc
347268|NCT02109328|Bladder cancer|bladder cancer
347269|NCT02109328|Urothelial cancer|urothelial cancer
347270|NCT02109328|Alisertib|alisertib
347271|NCT02109328|Phase 2|phase 2
347272|NCT02109328|Advanced disease|advanced disease
347273|NCT02109289|Anti-Tumor necrosis factor alpha|anti-tumor necrosis factor alpha
347274|NCT02109289|18-FluoroDeoxyGlucose Positron Emission Tomography|18-fluorodeoxyglucose positron emission tomography
347275|NCT02109289|High-sensitivity C- Reactive protein|high-sensitivity c- reactive protein
347276|NCT02109276|Fuch's endothelial dystrophy|fuch's endothelial dystrophy
347277|NCT02109276|Aspheric intraocular lens|aspheric intraocular lens
347278|NCT02109276|Higher Order Aberrations|higher order aberrations
347279|NCT02109276|Contrast Sensitivity|contrast sensitivity
347280|NCT02109263|Breast-feeding|breast-feeding
347281|NCT02109263|Saccharose|saccharose
347282|NCT02109263|Breast-feeding newborn|breast-feeding newborn
347283|NCT02109263|cortical pain responses|cortical pain responses
347284|NCT02109263|near infrared spectroscopy (NIRS)|near infrared spectroscopy (nirs)
347285|NCT02109263|Salivary rate cortisol|salivary rate cortisol
347286|NCT02109263|heel lance|heel lance
347287|NCT02109250|Medullary Thyroid Cancer (MTC) vandetanib caprelsa|medullary thyroid cancer (mtc) vandetanib caprelsa
347288|NCT02109237|Lung transplantation|lung transplantation
347289|NCT02109237|Bronchiolitis obliterans|bronchiolitis obliterans
347290|NCT02109198|Mild Traumatic Brain Injury|mild traumatic brain injury
347291|NCT02109185|seasonal allergic rhinitis|seasonal allergic rhinitis
347292|NCT02109185|grass/tree/ragweed allergies|grass/tree/ragweed allergies
347293|NCT02109185|nasal congestion/stuffiness|nasal congestion/stuffiness
347294|NCT02109185|rhinnorea|rhinnorea
347295|NCT02109185|nasal itching|nasal itching
347296|NCT02109185|sneezing|sneezing
347297|NCT02109172|Chronic Obstructive Pulmonary Disease|chronic obstructive pulmonary disease
347298|NCT02109172|COPD|copd
347299|NCT02109146|TACE|tace
347300|NCT02109146|Postoperation|postoperation
347301|NCT02109133|deep neuromuscular blockade|deep neuromuscular blockade
347302|NCT02109133|intraocular pressure|intraocular pressure
347303|NCT02109107|body contouring|body contouring
347304|NCT02109107|body shaping|body shaping
347305|NCT02109107|circumference reduction|circumference reduction
347306|NCT02109094|insulin|insulin
347307|NCT02109094|metabolomics|metabolomics
347308|NCT02109081|dexamethasone|dexamethasone
347309|NCT02109081|delirium|delirium
347310|NCT02109081|postoperative cognitive dysfunction|postoperative cognitive dysfunction
347311|NCT02109081|postoperative|postoperative
347312|NCT02109081|elderly|elderly
347313|NCT02109068|Breast Cancer|breast cancer
347314|NCT02109068|Survivorship|survivorship
347315|NCT02109068|Weight Loss|weight loss
347316|NCT02109055|Cardiovascular Diseases|cardiovascular diseases
347317|NCT02109055|Thoracic Surgery|thoracic surgery
347318|NCT02109055|Exercise Therapy|exercise therapy
347319|NCT02109016|FGFR1 amplification|fgfr1 amplification
347320|NCT02109016|FGF alteration|fgf alteration
347321|NCT02109016|VEGF alteration|vegf alteration
347322|NCT02109016|PDGF alteration|pdgf alteration
347323|NCT02109016|Tyrosine kinase inhibitor|tyrosine kinase inhibitor
347324|NCT02109016|VEGFR inhibitor|vegfr inhibitor
347325|NCT02109016|FGFR inhibitor|fgfr inhibitor
347326|NCT02109016|PDGFR inhibitor|pdgfr inhibitor
347327|NCT02109016|VEGFR-FGFR inhibitor|vegfr-fgfr inhibitor
347328|NCT02109003|tracheal cuff|tracheal cuff
347329|NCT02109003|cuff overinflation|cuff overinflation
347330|NCT02109003|cuff underinflation|cuff underinflation
347331|NCT02108990|borderline personality disorder|borderline personality disorder
347332|NCT02108990|rejection|rejection
347333|NCT02108990|social pain|social pain
347334|NCT02108977|Remote Consultation|remote consultation
347335|NCT02108977|Teleconsultation|teleconsultation
347336|NCT02108977|Videoconferencing|videoconferencing
347430|NCT02108652|PD-1|pd-1
347337|NCT02108977|Genetic Counseling|genetic counseling
347338|NCT02108977|Costs and Cost Analysis|costs and cost analysis
347339|NCT02108977|Comparative Effectiveness Research|comparative effectiveness research
347340|NCT02108977|Telehealth|telehealth
347341|NCT02108964|NSCLC|nsclc
347342|NCT02108964|Non-small Cell Lung Cancer EGFRmut|non-small cell lung cancer egfrmut
347343|NCT02108964|EGFR TKIs (EGF816)|egfr tkis (egf816)
347344|NCT02108964|acquired T790M mutation|acquired t790m mutation
347345|NCT02108964|de novo T790M mutation|de novo t790m mutation
347346|NCT02108964|EGFR TKI activating mutation (i.e. L858R or ex19del)|egfr tki activating mutation (i.e. l858r or ex19del)
347347|NCT02108964|Treatment naive advanced NSCLC with EGFR activating mutations|treatment naive advanced nsclc with egfr activating mutations
347348|NCT02108964|Locally advanced NSCLC (Stage IIIB NSCLC not amenable to definitive multi-modality therapy including surgery)|locally advanced nsclc (stage iiib nsclc not amenable to definitive multi-modality therapy including surgery)
347349|NCT02108964|Metastatic NSCLC refers to Stage IV NSCLC|metastatic nsclc refers to stage iv nsclc
347350|NCT02108964|1st line|1st line
347351|NCT02108951|CML|cml
347352|NCT02108951|Ph-CML|ph-cml
347353|NCT02108951|leukaemia|leukaemia
347354|NCT02108951|leukemia|leukemia
347355|NCT02108951|chronic myeloid leukemia|chronic myeloid leukemia
347356|NCT02108951|chronic myeloid leukaemia|chronic myeloid leukaemia
347357|NCT02108951|TKI intolerance|tki intolerance
347358|NCT02108951|tyrosine kinase inhibitor|tyrosine kinase inhibitor
712558|NCT00579709|Immunoreconstitution|immunoreconstitution
347359|NCT02108951|tyrosine kinase inhibitor intolerance|tyrosine kinase inhibitor intolerance
347360|NCT02108912|stroke|stroke
347361|NCT02108912|gait|gait
347362|NCT02108912|cardiovascular|cardiovascular
347363|NCT02108899|Schizophrenia|schizophrenia
347364|NCT02108899|Episodic memory deficits|episodic memory deficits
347365|NCT02108886|preterm labor|preterm labor
347366|NCT02108886|montelukast|montelukast
347367|NCT02108886|uterine contractions|uterine contractions
347368|NCT02108873|Appointments and Schedules|appointments and schedules
347369|NCT02108873|Outpatient Clinics, Hospital/economics|outpatient clinics, hospital/economics
347370|NCT02108860|Granulomatosis with polyangiitis (Wegener's)|granulomatosis with polyangiitis (wegener's)
347371|NCT02108860|Granulomatosis with polyangiitis|granulomatosis with polyangiitis
347372|NCT02108860|GPA|gpa
347373|NCT02108860|Wegener's granulomatosis|wegener's granulomatosis
347374|NCT02108860|Wegener granulomatosis|wegener granulomatosis
347375|NCT02108860|Anti Neutrophil Cytoplasmic Antibody Associated Vasculitis|anti neutrophil cytoplasmic antibody associated vasculitis
347376|NCT02108860|ANCA Associated Vasculitis|anca associated vasculitis
347377|NCT02108860|AAV|aav
347378|NCT02108860|Vasculitis|vasculitis
347379|NCT02108860|Systemic vasculitis|systemic vasculitis
347380|NCT02108860|Systemic inflammatory disease|systemic inflammatory disease
347381|NCT02108860|Lung Diseases|lung diseases
347382|NCT02108860|Respiratory Tract Diseases|respiratory tract diseases
347383|NCT02108860|Vascular Diseases|vascular diseases
347384|NCT02108860|Abatacept|abatacept
347385|NCT02108860|CTLA4-Ig|ctla4-ig
347386|NCT02108860|Immunosuppressive agent|immunosuppressive agent
347387|NCT02108860|Prednisone|prednisone
347388|NCT02108860|Glucocorticoids|glucocorticoids
347389|NCT02108860|Glucocorticoid|glucocorticoid
347390|NCT02108860|Corticosteroid|corticosteroid
347391|NCT02108860|Corticosteroids|corticosteroids
347392|NCT02108860|Treatment|treatment
347393|NCT02108860|Pharmacologic Actions|pharmacologic actions
347394|NCT02108860|Therapeutic Uses|therapeutic uses
347395|NCT02108860|Anti Inflammatory Agents|anti inflammatory agents
347396|NCT02108847|Arthroplasty, Replacement, Hip|arthroplasty, replacement, hip
347397|NCT02108847|Pain, Postoperative|pain, postoperative
347398|NCT02108847|Nerve Block|nerve block
347399|NCT02108847|Anesthesia, Regional|anesthesia, regional
347400|NCT02108847|Fascia Iliaca Block|fascia iliaca block
347401|NCT02108847|Ultrasound Guided|ultrasound guided
347402|NCT02108834|chronic postsurgery pain|chronic postsurgery pain
347403|NCT02108834|acute pain|acute pain
347404|NCT02108821|Inflammatory Bowel Diseases (IBD)|inflammatory bowel diseases (ibd)
347405|NCT02108821|Crohn's Disease (CD)|crohn's disease (cd)
347406|NCT02108821|Ulcerative Colitis (UC)|ulcerative colitis (uc)
347407|NCT02108808|FFR|ffr
347408|NCT02108808|adenosine|adenosine
347409|NCT02108808|Ticagrelor|ticagrelor
347410|NCT02108769|Yoga|yoga
347411|NCT02108769|Yogic breathing|yogic breathing
347412|NCT02108769|Saliva|saliva
347413|NCT02108769|Proteomics|proteomics
347414|NCT02108769|Lipdomics|lipdomics
347415|NCT02108769|Nerve growth factor|nerve growth factor
347416|NCT02108769|Thirumanthiram|thirumanthiram
347417|NCT02108717|Telemedicine|telemedicine
347418|NCT02108717|appendicitis|appendicitis
347419|NCT02108717|remote consultation|remote consultation
347420|NCT02108704|Parkinson's Disease|parkinson's disease
347421|NCT02108704|Helicobacter pylori infection|helicobacter pylori infection
347422|NCT02108678|Acceptance and Commitment Therapy (ACT)|acceptance and commitment therapy (act)
347423|NCT02108678|Depression|depression
347424|NCT02108678|Illness Management|illness management
347425|NCT02108678|Behavioral Treatment|behavioral treatment
347426|NCT02108678|Impairment|impairment
347427|NCT02108652|anti-PD-L1|anti-pd-l1
347428|NCT02108652|PD-L1|pd-l1
347431|NCT02108652|bladder cancer|bladder cancer
347432|NCT02108652|atezolizumab|atezolizumab
347433|NCT02108652|Tecentriq|tecentriq
347434|NCT02108626|Electronic Cigarettes|electronic cigarettes
347435|NCT02108626|Lozenge|lozenge
347436|NCT02108626|Nicotine|nicotine
347437|NCT02108626|Tobacco|tobacco
347438|NCT02108626|Dependence|dependence
347439|NCT02108626|Withdrawal|withdrawal
347440|NCT02108613|Androgen deprivation therapy|androgen deprivation therapy
347441|NCT02108613|Supportive care|supportive care
347442|NCT02108613|Quality of life|quality of life
347443|NCT02108600|Kidney transplantation|kidney transplantation
347444|NCT02108600|Inflammation|inflammation
347445|NCT02108561|Breast Cancer Heterogeneity Her2|breast cancer heterogeneity her2
347446|NCT02108548|ASP7657|asp7657
347447|NCT02108548|Pharmacokinetics|pharmacokinetics
347448|NCT02108548|Pharmacodynamics|pharmacodynamics
347449|NCT02108548|Healthy Subjects|healthy subjects
347450|NCT02108548|First in man|first in man
347451|NCT02108548|Safety|safety
347452|NCT02108535|burns|burns
347453|NCT02108535|dressings|dressings
347454|NCT02108535|silver sulfadiazine|silver sulfadiazine
347455|NCT02108535|silver compounds|silver compounds
347456|NCT02108535|cost|cost
347457|NCT02108522|CMV infection|cmv infection
347458|NCT02108522|EBV infection|ebv infection
347459|NCT02108522|HHV6 virus infection|hhv6 virus infection
347460|NCT02108522|BK virus infection|bk virus infection
347461|NCT02108522|Adenovirus infection|adenovirus infection
347462|NCT02108522|JC virus infection|jc virus infection
347463|NCT02108522|allogeneic stem cell transplant|allogeneic stem cell transplant
347464|NCT02108522|Virus Specific T cells|virus specific t cells
347465|NCT02108509|Chronic Pancreatitis|chronic pancreatitis
347466|NCT02108509|Osteopenia|osteopenia
347467|NCT02108509|Osteoporosis|osteoporosis
347468|NCT02108509|Hypogonadism|hypogonadism
347469|NCT02108509|Opioid medications|opioid medications
347470|NCT02108496|meniscectomy|meniscectomy
347471|NCT02108496|meniscus|meniscus
347472|NCT02108496|implant|implant
347473|NCT02108496|koos|koos
347474|NCT02108496|nusurface|nusurface
347475|NCT02108470|Oral Health Related Quality of Life (OHRQoL)|oral health related quality of life (ohrqol)
347476|NCT02108470|Oral Health Impact Profile (OHIP)|oral health impact profile (ohip)
347477|NCT02108470|Dentist-Patient Relations|dentist-patient relations
347478|NCT02108470|patients' participation.|patients' participation.
347479|NCT02108470|patients' satisfaction with the consultation.|patients' satisfaction with the consultation.
347480|NCT02108457|concurrent chemotherapy|concurrent chemotherapy
347481|NCT02108444|hepatitis|hepatitis
347482|NCT02108444|hepatitis B|hepatitis b
347483|NCT02108444|lymphoma|lymphoma
347484|NCT02108444|Hematologic Diseases|hematologic diseases
347485|NCT02108431|urinary diversion|urinary diversion
347486|NCT02108431|urethral catheter|urethral catheter
347487|NCT02108431|suprapubic tube|suprapubic tube
347488|NCT02108431|radical prostatectomy|radical prostatectomy
347489|NCT02108431|robotic surgery|robotic surgery
347490|NCT02108431|discomfort|discomfort
347491|NCT02108431|pain|pain
347492|NCT02108405|critically ill patient.|critically ill patient.
347494|NCT02108392|phenotype|phenotype
347495|NCT02108392|eye|eye
347496|NCT02108392|biomarkers|biomarkers
347497|NCT02108366|severe|severe
347498|NCT02108366|influenza A|influenza a
347499|NCT02108366|celecoxib|celecoxib
347500|NCT02108353|Type 2 Diabetes|type 2 diabetes
347501|NCT02108353|metabolic control|metabolic control
347502|NCT02108353|Metabolomics|metabolomics
347503|NCT02108353|Circadian Rhythm|circadian rhythm
347504|NCT02108353|Melatonin|melatonin
347505|NCT02108353|Biomarker|biomarker
347506|NCT02108353|Clock Gene|clock gene
347507|NCT02108353|PBMC|pbmc
347508|NCT02108353|Cardiovascular function|cardiovascular function
347509|NCT02108353|Epigenetic modification|epigenetic modification
347510|NCT02108353|Lifestyle Intervention|lifestyle intervention
347511|NCT02108340|Appendicitis|appendicitis
347512|NCT02108340|Diagnosis|diagnosis
347513|NCT02108340|Microwave radiometry|microwave radiometry
347514|NCT02108340|Ultrasonography|ultrasonography
347515|NCT02108327|Blood loss|blood loss
347516|NCT02108327|total knee arthroplasty|total knee arthroplasty
347517|NCT02108327|hot knife|hot knife
347518|NCT02108327|cold knife|cold knife
347519|NCT02108327|unipolar electrocautery|unipolar electrocautery
347520|NCT02108327|surgical blade|surgical blade
347521|NCT02108301|chronic hepatitis C-virus infection|chronic hepatitis c-virus infection
347522|NCT02108301|renal transplantation|renal transplantation
347523|NCT02108301|glucose tolerance|glucose tolerance
347524|NCT02108301|immunosuppression|immunosuppression
347525|NCT02108236|acupuncture|acupuncture
347526|NCT02108236|chinese traditional medicine|chinese traditional medicine
347527|NCT02108223|ICSI|icsi
347528|NCT02108223|Suboptimal Ovarian Response|suboptimal ovarian response
347529|NCT02108223|rLH|rlh
347530|NCT02108210|Chronic fatigue syndrome|chronic fatigue syndrome
347531|NCT02108210|Cytokines|cytokines
347532|NCT02108210|Interleukin-1|interleukin-1
347533|NCT02108210|Fatigue|fatigue
347534|NCT02108210|Anakinra|anakinra
347535|NCT02108184|helicobacter eradication rates|helicobacter eradication rates
347536|NCT02108171|intranasal|intranasal
347537|NCT02108171|dexmedetomidine|dexmedetomidine
347538|NCT02108171|early recovery|early recovery
347539|NCT02108171|suspension laryngoscopy|suspension laryngoscopy
347540|NCT02108145|cholangiocarcinoma|cholangiocarcinoma
347541|NCT02108145|jaundice|jaundice
347542|NCT02108145|metal stent|metal stent
347543|NCT02108145|PTBS|ptbs
347544|NCT02108132|hemophilia|hemophilia
347545|NCT02108132|mesenchymal stem cells|mesenchymal stem cells
347546|NCT02108132|in-vitro transdifferentiation|in-vitro transdifferentiation
347547|NCT02108106|safety and tolerability|safety and tolerability
347548|NCT02108106|pharmacokinetic study|pharmacokinetic study
347549|NCT02108080|Alcohol|alcohol
347550|NCT02108080|Biomarkers|biomarkers
347551|NCT02108080|Adults|adults
347552|NCT02108080|Phenotype|phenotype
347553|NCT02108080|Imaging|imaging
347554|NCT02108054|fMRI|fmri
347555|NCT02108054|Alcoholism|alcoholism
347556|NCT02108054|Phenotype|phenotype
347557|NCT02108054|Imaging|imaging
347558|NCT02108041|Physicians|physicians
347559|NCT02108041|Genomics|genomics
347560|NCT02108041|Internal Medicine|internal medicine
347561|NCT02108041|WARFARIN|warfarin
347562|NCT02108028|Advance Care Planning Guide|advance care planning guide
347563|NCT02108028|End-of-Life|end-of-life
347564|NCT02108015|Transmembrane AMPA Receptor Regulatory Protein|transmembrane ampa receptor regulatory protein
347565|NCT02108015|Glutamate Receptors|glutamate receptors
347566|NCT02108015|Healthy Volunteers|healthy volunteers
347567|NCT02108002|Missense Mutations|missense mutations
347568|NCT02108002|Hemangioblastoma|hemangioblastoma
347569|NCT02108002|Histone Deacytelase Inhibitors|histone deacytelase inhibitors
347570|NCT02108002|Von Hippel-Lindau Disease|von hippel-lindau disease
347571|NCT02107989|Epilepsy|epilepsy
347573|NCT02107989|fMRI|fmri
347574|NCT02107989|MEG|meg
347575|NCT02107976|Diabetes|diabetes
347576|NCT02107976|Red Blood Cells|red blood cells
347577|NCT02107976|Vitamin C|vitamin c
347578|NCT02107976|Plasma Vitamin C Levels|plasma vitamin c levels
347579|NCT02107963|GD2-Expressing Tumors|gd2-expressing tumors
347580|NCT02107963|Anti-GD2 Chimeric Antigen Receptor|anti-gd2 chimeric antigen receptor
347581|NCT02107963|Osteosarcoma|osteosarcoma
347582|NCT02107963|Adoptive Immunotherapy|adoptive immunotherapy
347583|NCT02107963|Sarcomas|sarcomas
347584|NCT02107950|Ovarian|ovarian
347585|NCT02107950|Platinum Sensitive|platinum sensitive
347586|NCT02107950|Epithelial|epithelial
347587|NCT02107937|serous|serous
347588|NCT02107937|endometrioid|endometrioid
347589|NCT02107937|mucinous|mucinous
347590|NCT02107937|epithelial ovarian cancer|epithelial ovarian cancer
347591|NCT02107924|Total|total
347592|NCT02107924|Knee|knee
347593|NCT02107924|Replacment|replacment
347594|NCT02107924|Infection|infection
347595|NCT02107924|Stimulan|stimulan
347596|NCT02107911|men who have sex with men|men who have sex with men
347597|NCT02107911|non-occupational post exposure prophylaxis|non-occupational post exposure prophylaxis
347598|NCT02107911|HIV infection|hiv infection
347599|NCT02107859|Cystic fibrosis|cystic fibrosis
347600|NCT02107859|Nonsense mutation|nonsense mutation
347601|NCT02107859|Premature stop codon|premature stop codon
347602|NCT02107859|PTC124|ptc124
347603|NCT02107859|Ataluren|ataluren
347604|NCT02107820|Bladder training|bladder training
347605|NCT02107820|Percutaneous Tibial nerve stimulation|percutaneous tibial nerve stimulation
347606|NCT02107820|Overactive bladder|overactive bladder
347607|NCT02107820|Randomised controlled study|randomised controlled study
347608|NCT02107807|Influenza,|influenza,
347609|NCT02107807|H5N1|h5n1
347610|NCT02107807|aH5N1|ah5n1
347611|NCT02107807|H5N1 vaccine|h5n1 vaccine
347612|NCT02107807|Pandemic Influenza vaccine|pandemic influenza vaccine
347613|NCT02107807|MF59|mf59
347614|NCT02107807|Adjuvant|adjuvant
347615|NCT02107807|Avian flu|avian flu
347616|NCT02107807|Underlying Immunosuppressive|underlying immunosuppressive
347617|NCT02107807|immunosuppressive conditions|immunosuppressive conditions
347618|NCT02107807|Pandemic vaccine|pandemic vaccine
347619|NCT02107807|Adjuvanted vaccine|adjuvanted vaccine
347620|NCT02107794|Grave's|grave's
347621|NCT02107794|Disease|disease
347622|NCT02107794|Thyroid|thyroid
347623|NCT02107794|Hyperthyroidism|hyperthyroidism
347624|NCT02107794|Thyroidectomy|thyroidectomy
347625|NCT02107794|Radioactive|radioactive
347626|NCT02107794|Iodine|iodine
347627|NCT02107794|Antithyroid|antithyroid
347628|NCT02107794|Shared|shared
347629|NCT02107794|Decision|decision
347630|NCT02107794|Making|making
347631|NCT02107794|Aid|aid
347632|NCT02107794|Evidence|evidence
347633|NCT02107794|Based|based
347634|NCT02107794|Endocrinology|endocrinology
347635|NCT02107794|Mayo|mayo
347636|NCT02107794|Clinic|clinic
347637|NCT02107781|Open abdomen|open abdomen
347638|NCT02107781|abdominal compartment pressure|abdominal compartment pressure
347639|NCT02107768|Stroke|stroke
347640|NCT02107768|Exercise|exercise
347641|NCT02107768|Randomized trial|randomized trial
347642|NCT02107768|Quality of Life|quality of life
347643|NCT02107755|oligometastatic melanoma|oligometastatic melanoma
347644|NCT02107755|melanoma|melanoma
347645|NCT02107742|Injections|injections
347646|NCT02107742|Time factors|time factors
347647|NCT02107742|Pain|pain
347648|NCT02107742|Healthy volunteers|healthy volunteers
347649|NCT02107742|Lidocaine|lidocaine
347650|NCT02107729|Injections|injections
347651|NCT02107729|Pain|pain
347652|NCT02107729|Healthy volunteers|healthy volunteers
347653|NCT02107729|Lidocaine|lidocaine
347654|NCT02107716|Pain|pain
347655|NCT02107716|Injections|injections
347656|NCT02107716|Lidocaine|lidocaine
347657|NCT02107716|Healthy volunteers|healthy volunteers
347658|NCT02107703|MONARCH 2|monarch 2
347659|NCT02107690|Injections|injections
347660|NCT02107690|Temperature|temperature
347661|NCT02107690|Pain|pain
347662|NCT02107690|Healthy volunteers|healthy volunteers
347663|NCT02107690|Lidocaine|lidocaine
347664|NCT02107664|Radiotherapy|radiotherapy
347665|NCT02107664|Cachexia|cachexia
347666|NCT02107664|Inflammation|inflammation
347667|NCT02107664|Depression|depression
444609|NCT01668693|ERA|era
347668|NCT02107651|Bleeding|bleeding
347669|NCT02107651|Anticoagulation|anticoagulation
347670|NCT02107638|Parkinson's Disease|parkinson's disease
347671|NCT02107638|Osteopathic Manipulative Medicine|osteopathic manipulative medicine
347672|NCT02107638|Falls|falls
347673|NCT02107638|Balance|balance
347674|NCT02107638|Motor function|motor function
347675|NCT02107625|Defecation|defecation
347676|NCT02107625|Abdominal pain|abdominal pain
347677|NCT02107612|Mini-Dental Implant|mini-dental implant
347678|NCT02107612|Implant-Supported Dental Prosthesis|implant-supported dental prosthesis
347679|NCT02107612|Minimally Invasive Surgical procedures|minimally invasive surgical procedures
347680|NCT02107612|Overdentures|overdentures
347681|NCT02107612|Aged|aged
347682|NCT02107586|biceps tenodesis|biceps tenodesis
347683|NCT02107586|biceps tenotomy|biceps tenotomy
347684|NCT02107586|biceps tendonitis|biceps tendonitis
347685|NCT02107586|biceps inflammation|biceps inflammation
347686|NCT02107586|shoulder surgery|shoulder surgery
347687|NCT02107573|Randomized Controlled Trial|randomized controlled trial
347688|NCT02107573|Rotator Cuff Tear|rotator cuff tear
347689|NCT02107573|Suprascapular Nerve|suprascapular nerve
347690|NCT02107573|Decompression|decompression
347691|NCT02107573|Shoulder Surgery|shoulder surgery
347692|NCT02107560|Cholangitis|cholangitis
347693|NCT02107560|Bacteremia|bacteremia
347694|NCT02107560|Endotoxemia|endotoxemia
347695|NCT02107560|Blood|blood
347696|NCT02107560|Bile|bile
347697|NCT02107547|Randomized Controlled Trial (RCT)|randomized controlled trial (rct)
347698|NCT02107547|Type 2 SLAP lesions|type 2 slap lesions
347699|NCT02107547|labral tear|labral tear
347700|NCT02107547|biceps tenodesis|biceps tenodesis
347701|NCT02107547|shoulder surgery|shoulder surgery
347702|NCT02107547|RCT|rct
347703|NCT02107547|Comparison between two alternative surgical procedures|comparison between two alternative surgical procedures
347704|NCT02107534|parent training|parent training
347705|NCT02107534|homework|homework
347706|NCT02107534|parenting stress|parenting stress
347707|NCT02107521|sperm morphology|sperm morphology
347708|NCT02107521|ICSI|icsi
347709|NCT02107521|IMSI|imsi
347710|NCT02107521|implantation|implantation
347711|NCT02107521|pregnancy|pregnancy
347712|NCT02107508|activity energy expenditure|activity energy expenditure
347713|NCT02107508|body composition|body composition
347714|NCT02107495|CHF|chf
347715|NCT02107469|Diabetic Polyneuropathy|diabetic polyneuropathy
347716|NCT02107469|Diabetic|diabetic
347717|NCT02107469|Polyneuropathy|polyneuropathy
347718|NCT02107469|Ayurvedic|ayurvedic
347719|NCT02107469|Ayurveda|ayurveda
347720|NCT02107469|Neuralgia|neuralgia
347721|NCT02107469|Diabetic Neuralgia|diabetic neuralgia
347722|NCT02107469|Sida cordifolia|sida cordifolia
347723|NCT02107469|Phyllanthus Niruri|phyllanthus niruri
347724|NCT02107469|Phyllanthus Amarus|phyllanthus amarus
347725|NCT02107469|Extracts|extracts
347726|NCT02107469|Extract|extract
347727|NCT02107469|Crude Herb|crude herb
347728|NCT02107469|Crude|crude
347729|NCT02107469|Herb|herb
347730|NCT02107469|Herbal|herbal
347731|NCT02107469|Herbal Extract|herbal extract
347732|NCT02107469|Decoction|decoction
347733|NCT02107469|Churna|churna
347734|NCT02107469|Powder|powder
347735|NCT02107469|Bala|bala
347736|NCT02107469|Bhumyamalaki|bhumyamalaki
347737|NCT02107469|Tamalaki|tamalaki
347738|NCT02107456|Dry Needling, Myofascial trigger point, Upper trapezius|dry needling, myofascial trigger point, upper trapezius
347739|NCT02107430|Immunotherapy|immunotherapy
347740|NCT02107430|Prostate Cancer|prostate cancer
347741|NCT02107430|Biological, Vaccine|biological, vaccine
347742|NCT02107417|chemotherapy|chemotherapy
347743|NCT02107417|pain|pain
347744|NCT02107417|paresthesia|paresthesia
347745|NCT02107417|Physiotherapy|physiotherapy
347746|NCT02107417|Transcutaneous Electrical Nerve Stimulation|transcutaneous electrical nerve stimulation
347747|NCT02107404|Immunotherapy|immunotherapy
347748|NCT02107404|Prostate Cancer|prostate cancer
347749|NCT02107404|Biological|biological
347750|NCT02107404|Vaccine|vaccine
347751|NCT02107391|Immunotherapy|immunotherapy
347752|NCT02107391|Prostate Cancer|prostate cancer
347753|NCT02107391|Biological|biological
347754|NCT02107391|Vaccine|vaccine
347755|NCT02107391|Androgen Deprivation Therapy|androgen deprivation therapy
347756|NCT02107378|Immunotherapy|immunotherapy
347757|NCT02107378|Serous|serous
347758|NCT02107378|Relapsed|relapsed
347759|NCT02107378|Platinum resistant (pt)|platinum resistant (pt)
347760|NCT02107378|Ovarian Cancer (OvCa)|ovarian cancer (ovca)
347761|NCT02107378|Biological|biological
347762|NCT02107378|Vaccine|vaccine
347763|NCT02107365|Hepatitis C|hepatitis c
347764|NCT02107365|HCV infection|hcv infection
347765|NCT02107365|HCV genotype 4|hcv genotype 4
347766|NCT02107365|Non-responders HCV infected patients|non-responders hcv infected patients
347767|NCT02107365|Asunaprevir|asunaprevir
347768|NCT02107365|Daclatasvir|daclatasvir
347769|NCT02107365|Pegylated Interferon|pegylated interferon
347770|NCT02107365|Ribavirin|ribavirin
347771|NCT02107352|Anti-craving medication|anti-craving medication
347772|NCT02107352|Inhibition|inhibition
347773|NCT02107352|Attentional Bias|attentional bias
347774|NCT02107352|Event-Related Potentials|event-related potentials
347775|NCT02107352|Relapse|relapse
347776|NCT02107339|methadone|methadone
347777|NCT02107339|hydromorphone|hydromorphone
347778|NCT02107339|acute postoperative pain|acute postoperative pain
347779|NCT02107339|chronic persistent surgical pain|chronic persistent surgical pain
347780|NCT02107326|Type 1 diabetes|type 1 diabetes
347781|NCT02107326|HbA1C|hba1c
347782|NCT02107326|Quality of Life|quality of life
347783|NCT02107326|Hypoglycaemia|hypoglycaemia
347784|NCT02107326|Self-management|self-management
347785|NCT02107326|Telemedicine|telemedicine
347786|NCT02107300|Obstructive Sleep Apnea Syndrome|obstructive sleep apnea syndrome
347787|NCT02107274|Azithromycin|azithromycin
347788|NCT02107274|Bronchiectasis|bronchiectasis
347789|NCT02107274|Macrolide|macrolide
347790|NCT02107274|Inflammation|inflammation
347791|NCT02107274|Pulmonary|pulmonary
347792|NCT02107261|Musician's Dystonia|musician's dystonia
347793|NCT02107248|Arthroplasty|arthroplasty
347794|NCT02107248|Replacement|replacement
347795|NCT02107248|Hip|hip
347796|NCT02107248|Posterolateral surgery|posterolateral surgery
347797|NCT02107248|Precautions|precautions
347798|NCT02107235|Chemoradiotherapy|chemoradiotherapy
347799|NCT02107235|cisplatin|cisplatin
347800|NCT02107222|COPD|copd
347801|NCT02107222|Exacerbation|exacerbation
347802|NCT02107222|invasive ventilation|invasive ventilation
347803|NCT02107222|CO2-Removal|co2-removal
347804|NCT02107196|Irritable Bowel Syndrome|irritable bowel syndrome
347805|NCT02107196|Colon, irritable|colon, irritable
347806|NCT02107196|Bowel disease|bowel disease
347807|NCT02107196|Diarrhea|diarrhea
347808|NCT02107183|Oxygen therapy|oxygen therapy
347809|NCT02107183|Extubation|extubation
347810|NCT02107183|Weaning|weaning
347811|NCT02107183|Reintubation|reintubation
347812|NCT02107183|Acute respiratory failure|acute respiratory failure
347813|NCT02107144|trimetazidine|trimetazidine
347814|NCT02107144|microcirculation|microcirculation
347815|NCT02107144|stenting|stenting
347816|NCT02107144|pressure wire|pressure wire
347817|NCT02107118|Stem cells|stem cells
347818|NCT02107118|cardiovascular disease|cardiovascular disease
347819|NCT02107118|erectile dysfunction|erectile dysfunction
347820|NCT02107105|Rectal cancer|rectal cancer
347821|NCT02107105|Adenocarcinoma of the rectum|adenocarcinoma of the rectum
347822|NCT02107105|Quality of Life|quality of life
347823|NCT02107105|QOL|qol
347824|NCT02107105|Post surgery|post surgery
347825|NCT02107105|Pre-surgery|pre-surgery
347826|NCT02107105|Questionnaires|questionnaires
347827|NCT02107105|Surveys|surveys
347828|NCT02107079|melatonin|melatonin
347829|NCT02107079|bioavailability|bioavailability
347830|NCT02107079|pharmacokinetics|pharmacokinetics
347831|NCT02107066|exercise|exercise
347832|NCT02107066|physical activity|physical activity
347833|NCT02107066|ovarian cancer|ovarian cancer
347834|NCT02107066|quality of life|quality of life
347835|NCT02107066|fatigue|fatigue
347836|NCT02107066|weight|weight
347837|NCT02107053|Oxidative stress,|oxidative stress,
347838|NCT02107053|hemodialysis,|hemodialysis,
347839|NCT02107053|pomegranate juice,|pomegranate juice,
347840|NCT02107053|dietary supplement|dietary supplement
347841|NCT02107053|patients|patients
347842|NCT02107001|Lung ultrasound|lung ultrasound
347843|NCT02107001|Community acquired p neumonia (CAP)|community acquired p neumonia (cap)
347844|NCT02107001|Pleuritis|pleuritis
347845|NCT02107001|Pulmonary embolism|pulmonary embolism
347846|NCT02107001|Lung Cancer|lung cancer
347847|NCT02106988|Lymphoma|lymphoma
347848|NCT02106988|NK cell lymphoma-nasal type|nk cell lymphoma-nasal type
347849|NCT02106988|Radiation therapy|radiation therapy
347850|NCT02106988|XRT|xrt
347851|NCT02106988|Dexamethasone|dexamethasone
347852|NCT02106988|Decadron|decadron
347853|NCT02106988|Etoposide|etoposide
347854|NCT02106988|VePesid|vepesid
347855|NCT02106988|Ifosfamide|ifosfamide
347856|NCT02106988|Ifex|ifex
347857|NCT02106988|Mesna|mesna
347858|NCT02106988|Mesnex|mesnex
347859|NCT02106988|Carboplatin|carboplatin
347860|NCT02106988|Paraplatin|paraplatin
347861|NCT02106962|hemodialysis|hemodialysis
347862|NCT02106962|fistula|fistula
347863|NCT02106962|clotting|clotting
347864|NCT02106962|tranexamic acid|tranexamic acid
347865|NCT02106962|bacitracin|bacitracin
347866|NCT02106949|suicide attempt, SMS monitoring, recurrence, phone, prevention control, tertiary healthcare|suicide attempt, sms monitoring, recurrence, phone, prevention control, tertiary healthcare
347867|NCT02106936|Focal Hand Dystonia|focal hand dystonia
347868|NCT02106936|Depotentiation|depotentiation
347869|NCT02106936|Transcranial Magnetic Stimulation (TMS)|transcranial magnetic stimulation (tms)
347870|NCT02106936|Rapid Paired Associative Stimulation|rapid paired associative stimulation
347871|NCT02106936|Healthy Volunteer|healthy volunteer
347872|NCT02106910|Barrett's Esophagus|barrett's esophagus
347873|NCT02106910|Radiofrequency Ablation|radiofrequency ablation
347874|NCT02106884|Pancreatic cancer|pancreatic cancer
347875|NCT02106884|Locally advanced|locally advanced
347876|NCT02106884|Metastatic|metastatic
347877|NCT02106871|cancer|cancer
347878|NCT02106871|pancreas|pancreas
347879|NCT02106871|cholangiocarcinoma|cholangiocarcinoma
347880|NCT02106871|fatigue|fatigue
347881|NCT02106871|sildenafil|sildenafil
347882|NCT02106871|lean mass|lean mass
347883|NCT02106871|muscle|muscle
347884|NCT02106858|Stivarga / Regorafenib / Metastatic Colorectal Cancer / Metastatic or unresectable locally advanced GIST (Gastrointestinal stromal tumors)|stivarga / regorafenib / metastatic colorectal cancer / metastatic or unresectable locally advanced gist (gastrointestinal stromal tumors)
347885|NCT02106845|Regorafenib|regorafenib
347886|NCT02106845|Probe substrates|probe substrates
347887|NCT02106845|Pharmacokinetics|pharmacokinetics
347888|NCT02106845|Cancer|cancer
347889|NCT02106845|Safety|safety
347890|NCT02106845|Advanced solid malignant tumors|advanced solid malignant tumors
347891|NCT02106832|Ciprofloxacin|ciprofloxacin
347892|NCT02106832|Dry Powder for Inhalation|dry powder for inhalation
347893|NCT02106832|Exacerbation|exacerbation
347894|NCT02106832|Bronchiectasis|bronchiectasis
347895|NCT02106819|Cerebellar Ataxia|cerebellar ataxia
347896|NCT02106819|Emotions|emotions
347897|NCT02106819|Affective Prosody|affective prosody
347898|NCT02106819|Facial Expression|facial expression
347899|NCT02106819|Magnetic Resonance Imaging|magnetic resonance imaging
347900|NCT02106806|Oxidative stress|oxidative stress
347901|NCT02106806|Zinc|zinc
347902|NCT02106806|Chemotherapy|chemotherapy
347903|NCT02106806|Colorectal cancer|colorectal cancer
347904|NCT02106793|Chronic Rhinosinusitis|chronic rhinosinusitis
347905|NCT02106793|Mitomicin C|mitomicin c
347906|NCT02106793|Postoperative nasal synerchia|postoperative nasal synerchia
347907|NCT02106780|Phase 1|phase 1
347908|NCT02106780|Healthy subjects|healthy subjects
347909|NCT02106780|Excretion|excretion
347910|NCT02106780|14C-labeled ASP1707|14c-labeled asp1707
347911|NCT02106767|rosuvastatin|rosuvastatin
347912|NCT02106767|rifampin|rifampin
347913|NCT02106767|pharmacokinetics|pharmacokinetics
347914|NCT02106767|drug interaction|drug interaction
347915|NCT02106767|healthy volunteer|healthy volunteer
347916|NCT02106767|drug transporter|drug transporter
347917|NCT02106767|Asian|asian
347918|NCT02106767|White|white
347919|NCT02106741|Pain|pain
347920|NCT02106741|Acupressure|acupressure
347921|NCT02106741|Symptoms|symptoms
347922|NCT02106741|Fatigue|fatigue
347923|NCT02106741|Self-administered|self-administered
347924|NCT02106728|Eating Disorders|eating disorders
347925|NCT02106728|Family Therapy|family therapy
347926|NCT02106728|Multi-Family Therapy|multi-family therapy
347927|NCT02106728|Bulimia Nervosa|bulimia nervosa
347928|NCT02106728|Eating Disorder Not Otherwise Specified|eating disorder not otherwise specified
347929|NCT02106702|HIV|hiv
347930|NCT02106702|detention|detention
347931|NCT02106702|substance abuse|substance abuse
347932|NCT02106689|infertility, superovulation, gonadotropins, needle free injection system|infertility, superovulation, gonadotropins, needle free injection system
347933|NCT02106676|polycystic ovary Syndrome|polycystic ovary syndrome
347934|NCT02106676|hyperandrogenism|hyperandrogenism
347935|NCT02106676|cordblood|cordblood
347936|NCT02106676|androgens|androgens
347937|NCT02106663|atrial fibrillation|atrial fibrillation
347938|NCT02106663|paroxysmal atrial fibrillation|paroxysmal atrial fibrillation
347939|NCT02106663|PAF|paf
347940|NCT02106663|arrhythmia|arrhythmia
347941|NCT02106663|atrial fibrillation ablation|atrial fibrillation ablation
347942|NCT02106663|circumferential ablation|circumferential ablation
347943|NCT02106663|CPVA|cpva
347944|NCT02106663|segmental ablation|segmental ablation
347945|NCT02106663|PVI|pvi
347946|NCT02106663|pulmonary vein isolation|pulmonary vein isolation
347947|NCT02106650|Relapsed PTCL|relapsed ptcl
347948|NCT02106650|Refractory PTCL|refractory ptcl
347949|NCT02106637|ACS|acs
347950|NCT02106637|Cessation|cessation
347951|NCT02106624|mechanical ventilation|mechanical ventilation
347953|NCT02106611|stress echo|stress echo
347954|NCT02106611|Clinical Assessment|clinical assessment
347955|NCT02106611|14-017|14-017
347956|NCT02106598|Sentinel Lymph Node Mapping|sentinel lymph node mapping
347957|NCT02106598|Intraoperative Sentinel|intraoperative sentinel
347958|NCT02106598|Head and Neck Melanoma|head and neck melanoma
347959|NCT02106598|Targeted Silica Nanoparticles|targeted silica nanoparticles
347960|NCT02106598|cRGDY-PEG-Cy5.5-C dots|crgdy-peg-cy5.5-c dots
347961|NCT02106598|13-249|13-249
347962|NCT02106585|Safety|safety
347963|NCT02106585|Tolerability|tolerability
347964|NCT02106585|Pharmacokinetics|pharmacokinetics
347965|NCT02106585|Food-effect|food-effect
347966|NCT02106585|Diabetes|diabetes
347967|NCT02106572|superficial bladder cancer|superficial bladder cancer
347968|NCT02106572|viscum album extract|viscum album extract
347969|NCT02106572|mistletoe extract|mistletoe extract
347970|NCT02106572|abnobaVISCUM|abnobaviscum
776030|NCT00345046|Cataract|cataract
347971|NCT02106572|recurrence rate|recurrence rate
347972|NCT02106559|Pleural Photodynamic Therapy|pleural photodynamic therapy
347973|NCT02106559|Pleural Malignancy|pleural malignancy
347974|NCT02106559|PDT|pdt
347975|NCT02106546|veliparib|veliparib
347976|NCT02106546|carboplatin|carboplatin
347977|NCT02106546|paclitaxel|paclitaxel
347978|NCT02106546|Poly Adenosine diphosphate (ADP)-ribose Polymerase (PARP)|poly adenosine diphosphate (adp)-ribose polymerase (parp)
347979|NCT02106546|Overall Survival|overall survival
347980|NCT02106546|Advanced|advanced
347981|NCT02106546|Metastatic|metastatic
347982|NCT02106546|ABT-888|abt-888
347983|NCT02106546|Squamous|squamous
347984|NCT02106546|Randomized|randomized
347985|NCT02106546|non-small cell lung cancer|non-small cell lung cancer
347986|NCT02106546|placebo controlled|placebo controlled
347987|NCT02106533|Coronary artery disease|coronary artery disease
347988|NCT02106533|Exercise|exercise
347989|NCT02106533|Ventilatory efficiency|ventilatory efficiency
347990|NCT02106520|Epistaxis|epistaxis
347991|NCT02106520|Bevacizumab|bevacizumab
347992|NCT02106507|Apalutamide|apalutamide
347993|NCT02106507|RAD001|rad001
347994|NCT02106507|Everolimus|everolimus
347995|NCT02106507|Castration-resistant|castration-resistant
347996|NCT02106507|13-025|13-025
347997|NCT02106507|ARN-509|arn-509
347998|NCT02106494|Highly emetogenic chemotherapy (HEC)|highly emetogenic chemotherapy (hec)
347999|NCT02106494|Chemotherapy-Induced Nausea and Vomiting (CINV)|chemotherapy-induced nausea and vomiting (cinv)
348000|NCT02106481|TKA|tka
348001|NCT02106481|TKR|tkr
348002|NCT02106481|Knee OA|knee oa
348003|NCT02106481|pain management|pain management
348004|NCT02106481|Femoral Nerve Catheter|femoral nerve catheter
348005|NCT02106481|Single Shot Femoral Nerve Blocks|single shot femoral nerve blocks
348006|NCT02106468|Oral Lichen Planus|oral lichen planus
348007|NCT02106468|Corticosteroid|corticosteroid
348008|NCT02106468|Omega -3|omega -3
348009|NCT02106455|Pharmacological theapy|pharmacological theapy
348010|NCT02106442|Pharmacological therapy|pharmacological therapy
348011|NCT02106429|Vascular Surgery|vascular surgery
348012|NCT02106416|prostate cancer|prostate cancer
348013|NCT02106416|bladder cancer|bladder cancer
348014|NCT02106416|MRI|mri
348015|NCT02106416|PET|pet
348016|NCT02106416|perfusion|perfusion
348017|NCT02106390|Central Nervous System Diseases|central nervous system diseases
348018|NCT02106390|Nervous System Diseases|nervous system diseases
348019|NCT02106390|Meningitis|meningitis
348020|NCT02106338|follow-up to 10-0008, Clostridium difficile, dose-escalating, CRS3123|follow-up to 10-0008, clostridium difficile, dose-escalating, crs3123
348021|NCT02106325|Ketamine|ketamine
348022|NCT02106325|Ketlar|ketlar
348023|NCT02106325|Depression|depression
348024|NCT02106325|Antidepressants|antidepressants
348025|NCT02106325|Treatment|treatment
348026|NCT02106325|Acute|acute
348027|NCT02106312|Radiotherapy|radiotherapy
348028|NCT02106312|Myxoid liposarcoma|myxoid liposarcoma
348029|NCT02106312|Soft tissue sarcoma|soft tissue sarcoma
348030|NCT02106286|Cardiopulmonary exercise test|cardiopulmonary exercise test
348031|NCT02106286|surgery|surgery
348032|NCT02106286|abdominal aortic aneurysm|abdominal aortic aneurysm
348033|NCT02106286|anaerobic threshold|anaerobic threshold
348034|NCT02106286|fitness|fitness
348035|NCT02106286|beta-blockers|beta-blockers
348036|NCT02106273|LMA|lma
348037|NCT02106273|Bronchial blocker|bronchial blocker
348038|NCT02106260|safety|safety
348039|NCT02106260|pharmacokinetics (PK)|pharmacokinetics (pk)
348040|NCT02106260|pharmacodynamics (PD)|pharmacodynamics (pd)
348041|NCT02106260|CLS003|cls003
348042|NCT02106234|contrast induced nephropathy|contrast induced nephropathy
348043|NCT02106234|prophylactic intravenous hydration|prophylactic intravenous hydration
348044|NCT02106234|intravenous normal saline|intravenous normal saline
348045|NCT02106234|acute kidney injury|acute kidney injury
348046|NCT02106221|Care coordination|care coordination
348047|NCT02106221|nurse care management|nurse care management
348048|NCT02106221|practice facilitation|practice facilitation
348049|NCT02106221|health information technology|health information technology
348050|NCT02106182|Benign prostatic hyperplasia|benign prostatic hyperplasia
348051|NCT02106182|Nocturia|nocturia
348052|NCT02106182|Silodosin|silodosin
348053|NCT02106182|Thrupas|thrupas
348054|NCT02106169|Food allergy|food allergy
348055|NCT02106169|Children and families|children and families
348056|NCT02106169|Therapeutic education|therapeutic education
348057|NCT02106169|Quality of life|quality of life
348058|NCT02106130|Mosapride citrate|mosapride citrate
348059|NCT02106130|Rebamipide|rebamipide
348060|NCT02106130|pharmacokinetic drug drug interaction|pharmacokinetic drug drug interaction
348061|NCT02106130|oral administration|oral administration
348062|NCT02106130|healthy male subjects|healthy male subjects
348063|NCT02106104|Type 2 diabetes mellitus|type 2 diabetes mellitus
348064|NCT02106104|Diabetic kidney disease|diabetic kidney disease
348065|NCT02106104|Diabetic nephropathy|diabetic nephropathy
348066|NCT02106104|Renoprotection|renoprotection
348067|NCT02106104|DPP-4 inhibitors|dpp-4 inhibitors
348068|NCT02106104|Linagliptin|linagliptin
445052|NCT01666990|HIV|hiv
348069|NCT02106104|SU derivatives|su derivatives
348070|NCT02106104|Glimepiride|glimepiride
348071|NCT02106078|Bipolar Disorder|bipolar disorder
348072|NCT02106078|Bipolar|bipolar
348073|NCT02106078|Online Intervention|online intervention
348074|NCT02106078|Internet intervention|internet intervention
348075|NCT02106078|Self-Help|self-help
348076|NCT02106065|Dementia|dementia
348077|NCT02106065|Caregivers|caregivers
348078|NCT02106065|Neurodegenerative Diseases|neurodegenerative diseases
348079|NCT02106065|Brain Diseases|brain diseases
348080|NCT02106065|Cost of Illness|cost of illness
348081|NCT02106065|Stress, Psychological|stress, psychological
348082|NCT02106065|Depression|depression
348083|NCT02106065|Vital Statistics|vital statistics
348084|NCT02106065|Mortality|mortality
348085|NCT02106065|Behavioral Symptoms|behavioral symptoms
348086|NCT02106065|Residential Facilities|residential facilities
348087|NCT02106065|Emergency Medical Services|emergency medical services
348088|NCT02106065|Long-Term Care|long-term care
348089|NCT02106052|cognitive function|cognitive function
348090|NCT02106052|cognitive impairment|cognitive impairment
348091|NCT02106052|cognitive intervention|cognitive intervention
348092|NCT02106052|cognitive improvement|cognitive improvement
348093|NCT02106052|information processing speed|information processing speed
348094|NCT02106052|exercise training program|exercise training program
348095|NCT02106052|aerobic exercise|aerobic exercise
348096|NCT02106052|stretching and toning|stretching and toning
348097|NCT02106052|Multiple sclerosis|multiple sclerosis
348098|NCT02106052|executive function|executive function
348099|NCT02106039|diabetes mellitus|diabetes mellitus
348100|NCT02106039|tuberculosis|tuberculosis
348101|NCT02106039|management|management
348102|NCT02106039|randomized controlled trial|randomized controlled trial
348103|NCT02106026|Breastfeeding|breastfeeding
348104|NCT02106026|Nursing|nursing
348105|NCT02106026|Patient Education as Topic|patient education as topic
348106|NCT02106026|Health Knowledge, Attitudes, Practice|health knowledge, attitudes, practice
348107|NCT02106026|Hispanic Americans.|hispanic americans.
348108|NCT02106013|HDL|hdl
348109|NCT02106013|Carotid artery intima-media thickness|carotid artery intima-media thickness
348110|NCT02106013|Cholesterol efflux capacity|cholesterol efflux capacity
348111|NCT02106013|Antioxidant effect of HDL|antioxidant effect of hdl
348112|NCT02106013|Susceptibility to oxidation of HDL|susceptibility to oxidation of hdl
348113|NCT02106013|Anti-inflammatory effect of HDL|anti-inflammatory effect of hdl
348114|NCT02106013|Platelet aggregation inhibition by HDL|platelet aggregation inhibition by hdl
348115|NCT02106000|Post Partum|post partum
348116|NCT02106000|Inhaled Oxytocin|inhaled oxytocin
348117|NCT02106000|Inhalation Profiles|inhalation profiles
348118|NCT02105987|Abacavir/dolutegravir/lamivudine|abacavir/dolutegravir/lamivudine
348119|NCT02105987|Fixed-dose combination|fixed-dose combination
348120|NCT02105987|Once daily|once daily
348121|NCT02105987|Trii|trii
348122|NCT02105987|Single-tablet regimen|single-tablet regimen
348123|NCT02105974|COPD|copd
348124|NCT02105974|Fluticasone Furoate (FF)|fluticasone furoate (ff)
348125|NCT02105974|Vilanterol (VI)|vilanterol (vi)
348126|NCT02105974|Dry Powder Inhaler|dry powder inhaler
348127|NCT02105961|Chronic Obstructive Pulmonary Disease|chronic obstructive pulmonary disease
348128|NCT02105961|exacerbations|exacerbations
348129|NCT02105961|SB240563|sb240563
348130|NCT02105961|mepolizumab|mepolizumab
348131|NCT02105961|eosinophils|eosinophils
348132|NCT02105948|eosinophils|eosinophils
348133|NCT02105948|SB240563|sb240563
348134|NCT02105948|exacerbations|exacerbations
348135|NCT02105948|Chronic Obstructive Pulmonary Disease|chronic obstructive pulmonary disease
348136|NCT02105948|mepolizumab|mepolizumab
348137|NCT02105922|Frailty|frailty
348138|NCT02105922|Ageing|ageing
348139|NCT02105922|Protein supplementation|protein supplementation
348140|NCT02105922|Protein quality|protein quality
348141|NCT02105922|Exercise training|exercise training
348142|NCT02105922|Sarcopenia|sarcopenia
348143|NCT02105896|dental bonding|dental bonding
348144|NCT02105857|knee mobilazation|knee mobilazation
348145|NCT02105857|TKA|tka
348146|NCT02105857|joint replacement|joint replacement
348147|NCT02105857|rehabilitation|rehabilitation
348148|NCT02105844|atrial fibrillation|atrial fibrillation
348149|NCT02105844|dementia|dementia
348150|NCT02105844|cognitive dysfunction|cognitive dysfunction
348151|NCT02105844|stroke|stroke
348152|NCT02105844|Magnetic resonance imaging|magnetic resonance imaging
348153|NCT02105831|left ventricular assist device|left ventricular assist device
348154|NCT02105831|contrast ultrasound|contrast ultrasound
348155|NCT02105831|perfusion imaging|perfusion imaging
348156|NCT02105818|Self-reported questionnaire|self-reported questionnaire
348157|NCT02105818|Swallowing disorders|swallowing disorders
348158|NCT02105818|Systemic sclerosis|systemic sclerosis
348159|NCT02105818|Drug therapy|drug therapy
348160|NCT02105818|Adherence to medication regime|adherence to medication regime
348161|NCT02105818|Coping strategy|coping strategy
348162|NCT02105818|Pharmaceutical care|pharmaceutical care
348163|NCT02105818|Patient safety|patient safety
348164|NCT02105818|Patient oriented care|patient oriented care
348165|NCT02105805|intention weight loss|intention weight loss
348166|NCT02105805|heart failure|heart failure
348167|NCT02105805|6-minute walk test|6-minute walk test
348168|NCT02105792|Diabetes|diabetes
348169|NCT02105792|Type 2 diabetes|type 2 diabetes
348170|NCT02105792|Diabetes therapy response|diabetes therapy response
348171|NCT02105792|Diabetes progression|diabetes progression
348172|NCT02105766|Sickle Cell Disease|sickle cell disease
348173|NCT02105766|Allogeneic Hematopoietic Stem Cell Transplant|allogeneic hematopoietic stem cell transplant
348174|NCT02105766|Pentostatin (Nipent)|pentostatin (nipent)
348175|NCT02105766|Cyclophosphamide|cyclophosphamide
348176|NCT02105766|Alemtuzumab (Campath)|alemtuzumab (campath)
348177|NCT02105740|BEHAVIORAL|behavioral
348178|NCT02105740|HYPNOSIS|hypnosis
348179|NCT02105740|ANXIETY|anxiety
348180|NCT02105740|DEPRESSION|depression
348181|NCT02105727|Dietary sodium|dietary sodium
348182|NCT02105727|Urinary sodium excretion|urinary sodium excretion
348183|NCT02105727|Urinary iodine excretion|urinary iodine excretion
348184|NCT02105714|Diarrhoea|diarrhoea
348185|NCT02105714|Abdominal pain|abdominal pain
348186|NCT02105714|Bacterial|bacterial
348187|NCT02105714|Protozoal|protozoal
348188|NCT02105714|Helminth|helminth
348189|NCT02105675|Immunotherapy|immunotherapy
348190|NCT02105675|Metastatic|metastatic
348191|NCT02105675|Castrate Resistant|castrate resistant
348192|NCT02105675|Prostate Cancer|prostate cancer
348193|NCT02105675|Biological|biological
348194|NCT02105675|Vaccine|vaccine
348195|NCT02105649|cerebral palsy|cerebral palsy
348196|NCT02105649|standing|standing
348197|NCT02105649|strengthening|strengthening
348198|NCT02105623|Coronary Arteriosclerosis|coronary arteriosclerosis
348199|NCT02105623|rosuvastatin|rosuvastatin
348200|NCT02105610|volatile anesthetics|volatile anesthetics
348201|NCT02105610|desflurane|desflurane
348202|NCT02105610|isoflurane|isoflurane
348203|NCT02105610|sevoflurane|sevoflurane
348204|NCT02105610|TIVA|tiva
348205|NCT02105610|cardiac surgery|cardiac surgery
348206|NCT02105610|mortality|mortality
348207|NCT02105610|anesthesia|anesthesia
348208|NCT02105610|intensive care|intensive care
348209|NCT02105597|Diabetes mellitus|diabetes mellitus
348210|NCT02105597|Medication adherence|medication adherence
348211|NCT02105597|Compliance|compliance
348212|NCT02105597|Mobile health|mobile health
348213|NCT02105571|Body Weight|body weight
348214|NCT02105571|Nutrition|nutrition
348215|NCT02105571|Physical Activity|physical activity
348216|NCT02105571|Sleep|sleep
348217|NCT02105571|Health Promotion|health promotion
348218|NCT02105571|Stress|stress
348219|NCT02105571|Safety|safety
348220|NCT02105558|trial of labor after cesarean|trial of labor after cesarean
348221|NCT02105558|vaginal birth after cesarean|vaginal birth after cesarean
348222|NCT02105558|epidural vs combined spinal epidural|epidural vs combined spinal epidural
348223|NCT02105545|cancer|cancer
348224|NCT02105545|oncology|oncology
348225|NCT02105545|malignant|malignant
348226|NCT02105545|malignancy|malignancy
348227|NCT02105545|genetics|genetics
348228|NCT02105545|genomics|genomics
348229|NCT02105545|exome|exome
348231|NCT02105545|RNA|rna
348232|NCT02105545|sequencing|sequencing
348233|NCT02105545|epigenetic|epigenetic
348234|NCT02105545|clinically actionable findings|clinically actionable findings
348235|NCT02105545|CAF|caf
348236|NCT02105545|secondary findings|secondary findings
348237|NCT02105545|SF|sf
348238|NCT02105545|single nucleotide variants|single nucleotide variants
348239|NCT02105545|SNV|snv
348240|NCT02105545|bioinformatics|bioinformatics
348241|NCT02105545|genotype|genotype
348242|NCT02105545|The American College of Medical Genetics and Genomics|the american college of medical genetics and genomics
348243|NCT02105545|ACMG|acmg
348244|NCT02105532|Transfusion in gastrointestinal bleeding|transfusion in gastrointestinal bleeding
348245|NCT02105519|trivalent influenza vaccine, chronic kidney disease|trivalent influenza vaccine, chronic kidney disease
348246|NCT02105506|Esophagus|esophagus
348247|NCT02105506|Stomach|stomach
348248|NCT02105506|Resection|resection
348249|NCT02105506|Esophageal disease requiring surgery|esophageal disease requiring surgery
348250|NCT02105506|Gastric disease requiring surgery|gastric disease requiring surgery
348251|NCT02105493|Nitroglycerin|nitroglycerin
348252|NCT02105493|Radial Artery Occlusion|radial artery occlusion
348253|NCT02105493|Transradial Catheterization|transradial catheterization
348254|NCT02105480|Computer aided auscultation (CAA)|computer aided auscultation (caa)
348255|NCT02105480|Phonocardiogram analysis|phonocardiogram analysis
348256|NCT02105480|Murmur detection|murmur detection
348257|NCT02105480|Heart auscultation|heart auscultation
348258|NCT02105441|cochlear implant|cochlear implant
348259|NCT02105428|Polycystic Ovarian Syndrome (PCOS)|polycystic ovarian syndrome (pcos)
348260|NCT02105428|Insulin Resistance|insulin resistance
348261|NCT02105428|Overweight, Obese Women|overweight, obese women
348262|NCT02105428|Protein Metabolism|protein metabolism
348263|NCT02105428|Post Translational Modifications|post translational modifications
348264|NCT02105415|Critical care|critical care
348265|NCT02105415|Emergent|emergent
348266|NCT02105415|Etomidate|etomidate
348267|NCT02105415|Hemodynamics|hemodynamics
348268|NCT02105415|Intensive care unit|intensive care unit
348269|NCT02105415|Intubation|intubation
348270|NCT02105415|Ketamine-Propofol admixture|ketamine-propofol admixture
348271|NCT02105402|Speech sound disorders|speech sound disorders
348272|NCT02105402|Randomized Controlled Trial|randomized controlled trial
348273|NCT02105402|Speech intelligibility|speech intelligibility
348274|NCT02105402|PROMPT treatment|prompt treatment
348275|NCT02105402|Developmental motor speech disorders|developmental motor speech disorders
348276|NCT02105402|Children|children
348277|NCT02105402|Functional outcomes|functional outcomes
348278|NCT02105402|Treatment efficacy|treatment efficacy
348279|NCT02105389|fatigue|fatigue
348280|NCT02105389|quality of life|quality of life
348281|NCT02105389|chemotherapy|chemotherapy
348282|NCT02105389|haematopoietic stem cell transplantation|haematopoietic stem cell transplantation
348283|NCT02105389|children|children
348284|NCT02105389|pilot|pilot
348285|NCT02105389|yoga|yoga
348286|NCT02105376|depression|depression
348287|NCT02105376|cranial nerve stimulation|cranial nerve stimulation
348288|NCT02105376|trigeminal stimulation|trigeminal stimulation
348289|NCT02105350|MEK162|mek162
348290|NCT02105350|Gemcitabine|gemcitabine
348291|NCT02105350|Oxaliplatin|oxaliplatin
348292|NCT02105350|Non-resectable|non-resectable
348293|NCT02105350|Recurrent or metastatic|recurrent or metastatic
348294|NCT02105324|bionic pancreas|bionic pancreas
348295|NCT02105324|artificial pancreas|artificial pancreas
348296|NCT02105324|insulin|insulin
348297|NCT02105324|glucagon|glucagon
348298|NCT02105324|continuous glucose monitoring (CGM)|continuous glucose monitoring (cgm)
348299|NCT02105324|outpatient|outpatient
348300|NCT02105324|insulin pump|insulin pump
348301|NCT02105324|pediatrics|pediatrics
348302|NCT02105324|children|children
348303|NCT02105324|camp|camp
348304|NCT02105324|summer camp|summer camp
348305|NCT02105311|Intraocular pressure|intraocular pressure
348306|NCT02105311|Selective laser trabeculoplasty|selective laser trabeculoplasty
348307|NCT02105311|Travoprost|travoprost
348308|NCT02105311|Ocular surface disease|ocular surface disease
348309|NCT02105311|Glaucoma symptom scale|glaucoma symptom scale
348310|NCT02105298|Fluids|fluids
348311|NCT02105298|Intraoperative|intraoperative
348312|NCT02105298|Respiratory|respiratory
348313|NCT02105298|Outcomes|outcomes
348314|NCT02105298|Surgery|surgery
348315|NCT02105298|Anesthesia|anesthesia
348316|NCT02105259|Test|test
348317|NCT02105259|psychodynamic|psychodynamic
348318|NCT02105259|Internet-delivered psychodynamic treatment|internet-delivered psychodynamic treatment
348319|NCT02105259|patients with social anxiety disorder|patients with social anxiety disorder
348320|NCT02105246|cardiovascular disease|cardiovascular disease
348321|NCT02105246|cardiac rehabilitation|cardiac rehabilitation
348322|NCT02105246|secondary prevention|secondary prevention
348323|NCT02105246|comparative effectiveness|comparative effectiveness
348324|NCT02105246|6 minute walk test|6 minute walk test
348325|NCT02105233|ultrasonography|ultrasonography
348326|NCT02105233|ultrasonics|ultrasonics
348327|NCT02105233|brain|brain
348328|NCT02105233|surgery|surgery
348329|NCT02105220|Respiratory mechanics|respiratory mechanics
348330|NCT02105220|Esophageal pressure|esophageal pressure
348331|NCT02105220|Functional residual capacity|functional residual capacity
348332|NCT02105220|positive end-expiratory pressure|positive end-expiratory pressure
348333|NCT02105194|cerebral decompression illness|cerebral decompression illness
348334|NCT02105181|benign biliary stricture|benign biliary stricture
348335|NCT02105181|anastomotic biliary stricture after liver transplantation|anastomotic biliary stricture after liver transplantation
348336|NCT02105181|chronic pancreatitis|chronic pancreatitis
348337|NCT02105181|biliary surgical procedure|biliary surgical procedure
348338|NCT02105181|fully covered metal stent|fully covered metal stent
348339|NCT02105155|Liver transplantation,|liver transplantation,
348340|NCT02105155|Conversion (Prograf® to Advagraf®),|conversion (prograf® to advagraf®),
348341|NCT02105155|Prograf® ,|prograf® ,
348342|NCT02105155|Advagraf® ,|advagraf® ,
348748|NCT02102997|Stent|stent
348343|NCT02105155|acute rejection,|acute rejection,
348344|NCT02105155|GFR|gfr
348345|NCT02105142|Attention deficit hyperactivity disorder|attention deficit hyperactivity disorder
348346|NCT02105142|Interventions|interventions
348347|NCT02105142|Primary care|primary care
348348|NCT02105142|Pediatric|pediatric
348349|NCT02105090|Upper gastrointestinal tract|upper gastrointestinal tract
348350|NCT02105090|Endoscopy|endoscopy
348351|NCT02105090|Lozenge|lozenge
348352|NCT02105090|Articaine|articaine
348353|NCT02105090|Dyspepsia|dyspepsia
348354|NCT02105090|Hematemesis|hematemesis
348355|NCT02105090|Abdominal pain|abdominal pain
348356|NCT02105090|Heartburn|heartburn
348357|NCT02105077|xenon|xenon
348358|NCT02105077|doping|doping
348359|NCT02105077|anesthesia|anesthesia
348360|NCT02105077|mass spectrometry|mass spectrometry
348361|NCT02105077|surgery|surgery
348362|NCT02105038|distal radius fracture|distal radius fracture
348363|NCT02105038|steering|steering
348364|NCT02105038|steering wheel spinner knob|steering wheel spinner knob
348365|NCT02105025|insertion time|insertion time
348366|NCT02105012|Mild|mild
348367|NCT02105012|moderate persistent|moderate persistent
348368|NCT02105012|Adult|adult
348369|NCT02104986|non seminomateous malignant germ cell tumour (NSMGCT)|non seminomateous malignant germ cell tumour (nsmgct)
348370|NCT02104986|Dose De-escalation|dose de-escalation
348371|NCT02104986|Chemotherapy|chemotherapy
348372|NCT02104960|Skin Surface Microscopy|skin surface microscopy
348373|NCT02104960|Skin Aging|skin aging
348374|NCT02104960|PROOF|proof
348375|NCT02104895|Breast cancer|breast cancer
348376|NCT02104895|Early breast cancer|early breast cancer
348377|NCT02104895|Adjuvant breast cancer|adjuvant breast cancer
348378|NCT02104895|Accelerated partial breast irradiation|accelerated partial breast irradiation
348379|NCT02104895|Intensity modulated radiotherapy|intensity modulated radiotherapy
348380|NCT02104882|Glioblastoma Multiforme|glioblastoma multiforme
348381|NCT02104882|High-Grade Glioma|high-grade glioma
348382|NCT02104882|Malignant Glioma|malignant glioma
348384|NCT02104869|Influenza vaccine|influenza vaccine
348385|NCT02104856|Asthma|asthma
348386|NCT02104856|Bronchial Thermoplasty|bronchial thermoplasty
348387|NCT02104856|Registry|registry
348388|NCT02104856|Device|device
348389|NCT02104856|Alair|alair
348390|NCT02104830|empegfilgrastim|empegfilgrastim
348391|NCT02104830|pegylated filgrastim|pegylated filgrastim
348392|NCT02104830|neutropenia|neutropenia
348393|NCT02104830|febrile neutropenia|febrile neutropenia
348394|NCT02104830|chemotherapy-associated neutropenia|chemotherapy-associated neutropenia
348395|NCT02104830|breast cancer|breast cancer
348396|NCT02104830|docetaxel|docetaxel
348397|NCT02104830|doxorubicin|doxorubicin
348398|NCT02104817|omega-3 carboxylic acid|omega-3 carboxylic acid
348399|NCT02104804|Type 2 Diabetes Mellitus, Insulin, Dipeptidyl-Peptidase 4 Inhibitors, Metformin,saxagliptin,Endocrine System Diseases|type 2 diabetes mellitus, insulin, dipeptidyl-peptidase 4 inhibitors, metformin,saxagliptin,endocrine system diseases
348400|NCT02104791|Procalcitonin|procalcitonin
348401|NCT02104791|intra-amniotic subclinical infection.|intra-amniotic subclinical infection.
348402|NCT02104752|Curcumin|curcumin
348403|NCT02104752|Turmeric|turmeric
348404|NCT02104752|Schizophrenia|schizophrenia
348405|NCT02104752|Cognition|cognition
348406|NCT02104752|Psychosis|psychosis
348407|NCT02104739|prediabetes|prediabetes
348408|NCT02104739|diabetes mellitus type 2|diabetes mellitus type 2
348409|NCT02104739|exenatide|exenatide
348410|NCT02104739|saxagliptin|saxagliptin
348411|NCT02104739|exenatide ER|exenatide er
348412|NCT02104713|Skin Burn Degree Second|skin burn degree second
348413|NCT02104713|Second degree Burn|second degree burn
348414|NCT02104713|Burn wound|burn wound
348415|NCT02104700|HIV|hiv
348416|NCT02104687|GTD, goal-directed haemodynamic therapy|gtd, goal-directed haemodynamic therapy
348417|NCT02104687|CI, cardiac index|ci, cardiac index
348418|NCT02104687|MAP, mean arterial pressure|map, mean arterial pressure
348419|NCT02104687|CVP, central venous pressure|cvp, central venous pressure
348420|NCT02104622|spinal cord injury|spinal cord injury
348421|NCT02104622|exoskeleton|exoskeleton
348422|NCT02104622|ambulation|ambulation
348423|NCT02104622|walking|walking
348424|NCT02104622|robotics|robotics
348425|NCT02104609|Obesity|obesity
348426|NCT02104609|Emergency contraception|emergency contraception
348427|NCT02104609|Levonorgestrel emergency contraception|levonorgestrel emergency contraception
348428|NCT02104583|VT|vt
348429|NCT02104583|VF|vf
348430|NCT02104583|Ventricular Tachycardia|ventricular tachycardia
348431|NCT02104583|Ventricular Fibrillation|ventricular fibrillation
348432|NCT02104583|shock|shock
348433|NCT02104583|ATP|atp
348434|NCT02104570|Fatigue|fatigue
348435|NCT02104570|Proprioception|proprioception
348436|NCT02104570|Shoulder|shoulder
348437|NCT02104557|Sayana|sayana
348438|NCT02104557|Pregnancy|pregnancy
348439|NCT02104557|Contraception|contraception
348440|NCT02104557|Endometriosis-associated pain|endometriosis-associated pain
348441|NCT02104557|PMS|pms
348442|NCT02104557|Post Marketing Surveillance|post marketing surveillance
348443|NCT02104544|DHA intake;|dha intake;
348444|NCT02104544|Plasma;|plasma;
348445|NCT02104544|Erythrocyte;|erythrocyte;
348446|NCT02104544|Breast milk.|breast milk.
348447|NCT02104518|glucose-6-phosphate dehydrogenase|glucose-6-phosphate dehydrogenase
348448|NCT02104518|point-of-care diagnostic testing|point-of-care diagnostic testing
348449|NCT02104492|multiple sclerosis|multiple sclerosis
348450|NCT02104492|respiratory muscle strength|respiratory muscle strength
348451|NCT02104492|maximal inspiratory pressure (MIP)|maximal inspiratory pressure (mip)
348452|NCT02104492|maximal expiratory pressure (MEP)|maximal expiratory pressure (mep)
348453|NCT02104492|respiratory muscle endurance|respiratory muscle endurance
348454|NCT02104492|quality of life|quality of life
348455|NCT02104492|qualitative research|qualitative research
348456|NCT02104466|acupuncture|acupuncture
348457|NCT02104466|pain|pain
348458|NCT02104466|neuropathy|neuropathy
348459|NCT02104453|airway maneuver|airway maneuver
348460|NCT02104440|Cytopenia|cytopenia
348461|NCT02104414|Liposomal Bupivacaine|liposomal bupivacaine
348462|NCT02104414|Exparel|exparel
348463|NCT02104375|wave reflection|wave reflection
348464|NCT02104375|augmentation Index|augmentation index
348465|NCT02104375|heart rate variability|heart rate variability
348466|NCT02104375|arterial stiffness|arterial stiffness
348467|NCT02104349|spine surgery|spine surgery
348468|NCT02104349|post op pain management|post op pain management
348469|NCT02104336|Pearson|pearson
348470|NCT02104336|EPI743|epi743
348471|NCT02104336|EPI-743|epi-743
348472|NCT02104336|Vincerinone|vincerinone
348473|NCT02104336|Mitochondrial disorder|mitochondrial disorder
348474|NCT02104336|Mitochondrial disease|mitochondrial disease
348475|NCT02104323|Neurofibromatosis Type 2|neurofibromatosis type 2
348476|NCT02104323|Vestibular Schwannoma|vestibular schwannoma
348477|NCT02104323|Other NF2-related tumors|other nf2-related tumors
348478|NCT02104310|malignant glioma|malignant glioma
348479|NCT02104310|FDOPA|fdopa
348480|NCT02104310|PET CT|pet ct
348481|NCT02104310|radiation therapy|radiation therapy
348482|NCT02104297|Nasal septum operation|nasal septum operation
348483|NCT02104297|agitation|agitation
348484|NCT02104284|Bronchial provocation test|bronchial provocation test
348485|NCT02104284|Mannitol|mannitol
348486|NCT02104284|Methacholine|methacholine
348487|NCT02104284|Bronchial hyperreactivity|bronchial hyperreactivity
348488|NCT02104284|Sensitivity and specificity|sensitivity and specificity
348489|NCT02104271|chronic radiation proctitis|chronic radiation proctitis
348490|NCT02104271|argon plasma coagulation|argon plasma coagulation
348491|NCT02104271|rectal bleeding|rectal bleeding
348492|NCT02104258|Hamstring|hamstring
348493|NCT02104258|Muscle|muscle
348494|NCT02104258|Injury|injury
348495|NCT02104258|Treatment|treatment
348496|NCT02104258|Rehabilitation|rehabilitation
348497|NCT02104245|Non Cystic Fibrosis Bronchiectasis, Pulmaquin, Ciprofloxacin, Pseudomonas aeruginosa|non cystic fibrosis bronchiectasis, pulmaquin, ciprofloxacin, pseudomonas aeruginosa
348498|NCT02104232|Maternal depression|maternal depression
348499|NCT02104219|Hypophosphatasia|hypophosphatasia
348500|NCT02104219|HPP|hpp
348501|NCT02104219|bone disease|bone disease
348502|NCT02104219|Soft Bones|soft bones
348503|NCT02104219|low Alkaline Phosphatase|low alkaline phosphatase
348504|NCT02104219|genetic metabolic disorder|genetic metabolic disorder
348505|NCT02104219|alkaline phosphatase|alkaline phosphatase
348506|NCT02104219|tissue non-specific alkaline phosphatase|tissue non-specific alkaline phosphatase
348507|NCT02104219|rickets|rickets
348508|NCT02104219|osteomalacia|osteomalacia
348509|NCT02104193|brain metastases|brain metastases
348510|NCT02104193|simvastatin|simvastatin
348511|NCT02104193|radiation therapy|radiation therapy
348512|NCT02104180|non-inferiority|non-inferiority
348513|NCT02104180|randomized|randomized
348514|NCT02104180|TulleGras|tullegras
348515|NCT02104180|Urgotul|urgotul
348516|NCT02104180|pain|pain
348517|NCT02104180|venous leg ulcer|venous leg ulcer
348518|NCT02104180|healing|healing
348519|NCT02104167|DDD|ddd
348520|NCT02104167|degenerative disc disease|degenerative disc disease
348521|NCT02104167|cervical spine|cervical spine
348522|NCT02104167|fusion rate|fusion rate
348523|NCT02104141|DDD|ddd
348524|NCT02104141|lumbar spine|lumbar spine
348525|NCT02104141|fusion rate|fusion rate
348526|NCT02104141|degenerative disc disease|degenerative disc disease
348527|NCT02104128|Anhedonia|anhedonia
348528|NCT02104128|Dopamine|dopamine
348529|NCT02104128|Bupropion|bupropion
348530|NCT02104128|fMRI|fmri
348531|NCT02104128|emotional processing|emotional processing
348532|NCT02104128|reward|reward
348533|NCT02104115|Stomach|stomach
348534|NCT02104115|Small bowel|small bowel
348535|NCT02104115|Colon|colon
348536|NCT02104115|MRI|mri
348537|NCT02104115|Function|function
348538|NCT02104115|Gastrointestinal volumes|gastrointestinal volumes
348539|NCT02104102|Elderly|elderly
348540|NCT02104102|mirror therapy|mirror therapy
348541|NCT02104102|hands|hands
348542|NCT02104089|Thoracoabdominal aortic aneurysm|thoracoabdominal aortic aneurysm
348543|NCT02104089|Endovascular|endovascular
348544|NCT02104089|Fenestration|fenestration
348545|NCT02104089|Branch|branch
348546|NCT02104089|Off-the-shelf|off-the-shelf
348547|NCT02104076|Bile Duct Obstructions|bile duct obstructions
348548|NCT02104076|Biliary Stases|biliary stases
348549|NCT02104076|Biliary Tract|biliary tract
348551|NCT02104024|Kidney|kidney
348552|NCT02104024|Pancreas|pancreas
348553|NCT02104024|Transplant|transplant
348554|NCT02104024|Contrast Enhanced Ultrasound|contrast enhanced ultrasound
348555|NCT02104011|Angiomyolipomas in tuberous sclerosis|angiomyolipomas in tuberous sclerosis
348556|NCT02104011|Beta-blockers|beta-blockers
348557|NCT02104011|Anti-angiogenic therapies|anti-angiogenic therapies
348558|NCT02103998|extremely low gestational age neonate|extremely low gestational age neonate
348559|NCT02103998|hypothyroxinemia of prematurity|hypothyroxinemia of prematurity
348560|NCT02103998|brain development|brain development
348561|NCT02103998|cerebral palsy|cerebral palsy
348562|NCT02103998|cognitive dealy|cognitive dealy
348563|NCT02103985|Healthy|healthy
348564|NCT02103985|JNJ-39823277|jnj-39823277
348565|NCT02103985|JNJ-40917006|jnj-40917006
348566|NCT02103985|Pharmacokinetics|pharmacokinetics
348567|NCT02103972|All subjects of any ethnicity aged from 4 to 30 months with atopic dermatitis skin symptoms with a SCORAD equal or above 20|all subjects of any ethnicity aged from 4 to 30 months with atopic dermatitis skin symptoms with a scorad equal or above 20
348568|NCT02103946|serratus|serratus
348569|NCT02103946|paravertebral|paravertebral
348570|NCT02103946|breast|breast
348571|NCT02103946|cancer|cancer
348572|NCT02103946|axilla|axilla
348573|NCT02103907|balance|balance
348574|NCT02103907|knee|knee
348575|NCT02103907|osteoarthritis|osteoarthritis
348576|NCT02103907|physical function|physical function
348577|NCT02103894|Alzheimer's disease (AD)|alzheimer's disease (ad)
348578|NCT02103894|Parkinson's disease (PD)|parkinson's disease (pd)
348579|NCT02103894|Progressive supranuclear palsy (PSP)|progressive supranuclear palsy (psp)
348580|NCT02103894|Chronic traumatic encephalopathy (CTE)|chronic traumatic encephalopathy (cte)
348581|NCT02103894|Frontal temporal dementia (FTD)|frontal temporal dementia (ftd)
348582|NCT02103894|Pick's disease|pick's disease
348583|NCT02103894|tauopathies|tauopathies
348584|NCT02103881|Agitation|agitation
348585|NCT02103881|Ketamine|ketamine
348586|NCT02103881|Haloperidol|haloperidol
348587|NCT02103881|Emergency Medical Services|emergency medical services
348588|NCT02103881|Feeling of restlessness|feeling of restlessness
348589|NCT02103881|Increased motor activity|increased motor activity
348590|NCT02103868|Tobacco cessation|tobacco cessation
348591|NCT02103868|Zari worker|zari worker
348592|NCT02103868|Behavior therapy|behavior therapy
348593|NCT02103868|Qualitative Research|qualitative research
348594|NCT02103868|Mumbai|mumbai
348595|NCT02103855|pancreas transplantation|pancreas transplantation
348596|NCT02103855|immunosuppression|immunosuppression
348597|NCT02103855|belatacept|belatacept
348598|NCT02103829|Cigarette smoking|cigarette smoking
348599|NCT02103829|Tobacco smoking|tobacco smoking
348600|NCT02103829|Smoking, Tobacco|smoking, tobacco
348601|NCT02103803|concussion|concussion
348602|NCT02103803|sports-related concussion|sports-related concussion
348603|NCT02103803|mild traumatic brain injury (mTBI)|mild traumatic brain injury (mtbi)
348604|NCT02103803|eye tracking|eye tracking
348605|NCT02103803|oculometrics|oculometrics
348606|NCT02103777|high dose of caffeine|high dose of caffeine
348607|NCT02103777|low dose of caffeine|low dose of caffeine
348608|NCT02103777|prevention|prevention
348609|NCT02103764|Anovulatory Dysfunctional Uterine Bleeding|anovulatory dysfunctional uterine bleeding
348610|NCT02103764|cyclic desogestrel|cyclic desogestrel
348611|NCT02103764|cyclic medroxyprogesterone acetate|cyclic medroxyprogesterone acetate
348612|NCT02103764|lipid metabolism|lipid metabolism
348613|NCT02103764|glucose metabolism|glucose metabolism
348614|NCT02103764|endometrial histology changing|endometrial histology changing
348615|NCT02103751|biomarkers|biomarkers
348616|NCT02103751|HPHCs|hphcs
348617|NCT02103751|CVD|cvd
348618|NCT02103751|smoking|smoking
348619|NCT02103751|Smokers|smokers
348620|NCT02103751|non-smokers|non-smokers
348621|NCT02103738|Lucentis|lucentis
348622|NCT02103738|Ranibizumab|ranibizumab
348623|NCT02103738|Treat and Extend|treat and extend
348624|NCT02103738|wetAMD|wetamd
348625|NCT02103738|Age related macular degeneration|age related macular degeneration
348626|NCT02103699|Hepatitis C virus|hepatitis c virus
348627|NCT02103699|Simeprevir|simeprevir
348628|NCT02103699|Ribonucleic acid|ribonucleic acid
348629|NCT02103699|Sustained virologic response|sustained virologic response
348630|NCT02103686|Neuropathic pain|neuropathic pain
348631|NCT02103686|pregabalin|pregabalin
348632|NCT02103660|contraceptive implant|contraceptive implant
348633|NCT02103660|Depo-Medroxyprogesterone Acetate|depo-medroxyprogesterone acetate
348634|NCT02103660|Hormonal Contraception|hormonal contraception
348635|NCT02103660|progestin|progestin
348636|NCT02103647|Neuropathic pain|neuropathic pain
348637|NCT02103647|pregabalin|pregabalin
348638|NCT02103634|breast cancer|breast cancer
348639|NCT02103634|FDG PET/CT|fdg pet/ct
348640|NCT02103634|MRI|mri
348641|NCT02103634|NaF PET/MRI|naf pet/mri
348642|NCT02103634|NaF PET/CT|naf pet/ct
348749|NCT02102997|DES|des
348643|NCT02103608|at Home Photo depilation device, Silk'n.|at home photo depilation device, silk'n.
348644|NCT02103556|Constipation|constipation
348645|NCT02103556|Rome III criteria|rome iii criteria
348646|NCT02103556|Hemodialysis|hemodialysis
348647|NCT02103491|Half-ironman|half-ironman
348648|NCT02103491|Triathlon|triathlon
348649|NCT02103491|Salt|salt
348650|NCT02103491|Exercise|exercise
348651|NCT02103491|Performance|performance
348652|NCT02103478|Myelodysplastic Syndrome|myelodysplastic syndrome
348653|NCT02103478|MDS|mds
348654|NCT02103465|Parkinson's Disease|parkinson's disease
348655|NCT02103465|treatment|treatment
348656|NCT02103465|old patients|old patients
348657|NCT02103465|Rotigotine|rotigotine
348658|NCT02103439|Hepatitis C|hepatitis c
348659|NCT02103439|Cepeginterferon alfa|cepeginterferon alfa
348660|NCT02103439|Peginterferon|peginterferon
348661|NCT02103439|Treatment|treatment
348662|NCT02103426|Cytomegalovirus|cytomegalovirus
348663|NCT02103426|ASP0113|asp0113
348664|NCT02103426|CMV-seropositive|cmv-seropositive
348665|NCT02103426|Healthy subjects|healthy subjects
348666|NCT02103426|CMV-seronegative|cmv-seronegative
348667|NCT02103426|Dialysis|dialysis
348668|NCT02103374|weaned tobacco|weaned tobacco
348669|NCT02103374|Has not submitted an exacerbation in the past 3 months|has not submitted an exacerbation in the past 3 months
348670|NCT02103361|autoimmune disease|autoimmune disease
348671|NCT02103361|pregnancy|pregnancy
348672|NCT02103361|psoriasis|psoriasis
348673|NCT02103361|Stelara|stelara
348674|NCT02103361|ustekinumab|ustekinumab
348675|NCT02103361|birth outcome|birth outcome
348676|NCT02103361|malformation|malformation
348677|NCT02103361|birth defect|birth defect
348678|NCT02103361|psoriatic arthritis|psoriatic arthritis
348679|NCT02103361|Crohn's Disease|crohn's disease
348680|NCT02103348|Severe asthma|severe asthma
348681|NCT02103348|Sputum|sputum
348682|NCT02103348|Mucolysis|mucolysis
348683|NCT02103335|Myeloma|myeloma
348684|NCT02103335|Multiple Myeloma|multiple myeloma
348685|NCT02103335|Pomalidomide|pomalidomide
348686|NCT02103335|Marizomib|marizomib
348687|NCT02103335|Low dose Dexamethasone|low dose dexamethasone
348688|NCT02103335|Relapsed|relapsed
348689|NCT02103335|Refractory|refractory
348690|NCT02103309|Soft contact lenses|soft contact lenses
348691|NCT02103309|DACP|dacp
348692|NCT02103283|Diabetic Macular Edema|diabetic macular edema
348693|NCT02103244|pharmacokinetics|pharmacokinetics
348694|NCT02103244|safety|safety
348695|NCT02103231|Preterm birth|preterm birth
348696|NCT02103231|Hypertension|hypertension
348697|NCT02103231|Exercise capacity|exercise capacity
348698|NCT02103231|Cardiovascular risk|cardiovascular risk
348699|NCT02103218|HIV|hiv
348700|NCT02103218|risky sex prevention|risky sex prevention
348701|NCT02103218|intervention|intervention
348702|NCT02103205|Lactoferrin|lactoferrin
348703|NCT02103205|Infant formula|infant formula
348704|NCT02103205|Iron|iron
348705|NCT02103179|Extrahepatic cholangiocarcinoma|extrahepatic cholangiocarcinoma
348706|NCT02103179|ECC|ecc
348707|NCT02103179|VEGF signaling|vegf signaling
348708|NCT02103140|Breast Cancer|breast cancer
348709|NCT02103140|Obesity|obesity
348710|NCT02103140|African American female|african american female
348711|NCT02103140|exergaming|exergaming
348712|NCT02103101|polymorphism|polymorphism
348713|NCT02103101|ABCB1|abcb1
348714|NCT02103101|P-glycoprotein|p-glycoprotein
348715|NCT02103101|oral anticoagulant|oral anticoagulant
348716|NCT02103101|dabigatran|dabigatran
348717|NCT02103101|apixaban|apixaban
348718|NCT02103101|rivaroxaban|rivaroxaban
348719|NCT02103101|hemorrhagic complication|hemorrhagic complication
348720|NCT02103101|thrombo-embolism|thrombo-embolism
348721|NCT02103101|serious adverse event|serious adverse event
348722|NCT02103088|Prostate cancer|prostate cancer
348723|NCT02103088|Intervention|intervention
348724|NCT02103088|Rehabilitation|rehabilitation
348725|NCT02103088|Couple|couple
348726|NCT02103088|Sexology|sexology
348727|NCT02103088|Urology|urology
348728|NCT02103088|Late effects|late effects
348729|NCT02103075|spinocerebellar ataxia (SCA)|spinocerebellar ataxia (sca)
348730|NCT02103075|motor evoked potential (MEP)|motor evoked potential (mep)
348731|NCT02103075|Neuromuscular electrical stimulation (NMES)|neuromuscular electrical stimulation (nmes)
348732|NCT02103075|silent period|silent period
348733|NCT02103075|cerebellum|cerebellum
348734|NCT02103062|Metastatic Colorectal Cancer|metastatic colorectal cancer
348735|NCT02103062|nab®Paclitaxel|nab®paclitaxel
348736|NCT02103062|Response Evaluation in Solid Tumors|response evaluation in solid tumors
348737|NCT02103062|Progression Free Survival|progression free survival
348738|NCT02103062|Overall Survival|overall survival
348739|NCT02103062|Duration of Response|duration of response
348740|NCT02103062|RAS|ras
348741|NCT02103036|Low Back Pain|low back pain
348742|NCT02103036|Core stability exercise|core stability exercise
348743|NCT02103036|Back school|back school
348744|NCT02103036|TENS|tens
348745|NCT02103036|Infra- red light|infra- red light
348746|NCT02102997|DTS|dts
348747|NCT02102997|Stents|stents
348750|NCT02102997|Drug eluting|drug eluting
348751|NCT02102997|Drug Eluting Stent (DES)|drug eluting stent (des)
348752|NCT02102997|Drug eluting stents|drug eluting stents
348753|NCT02102997|Endothelial Progenitor Cell (EPC)|endothelial progenitor cell (epc)
348754|NCT02102997|Endothelial progenitor cell capturing|endothelial progenitor cell capturing
348755|NCT02102997|Sirolimus|sirolimus
348756|NCT02102997|Sirolimus eluting|sirolimus eluting
348757|NCT02102997|Percutaneous Coronary Intervention (PCI)|percutaneous coronary intervention (pci)
348758|NCT02102997|PCI|pci
348759|NCT02102997|Registry|registry
348760|NCT02102997|Registries|registries
348761|NCT02102997|Multi center|multi center
348762|NCT02102997|Multi centre|multi centre
348763|NCT02102984|distal malignancy of the extra-hepatic biliary tract|distal malignancy of the extra-hepatic biliary tract
348764|NCT02102984|metallic biliary stents|metallic biliary stents
348765|NCT02102984|covered biliary stents|covered biliary stents
348766|NCT02102984|uncovered biliary stents|uncovered biliary stents
348767|NCT02102971|liver|liver
348768|NCT02102971|ischemia|ischemia
348769|NCT02102971|reperfusion|reperfusion
348770|NCT02102958|diabetes|diabetes
348771|NCT02102958|visual impairment|visual impairment
348772|NCT02102958|foot care|foot care
348773|NCT02102958|diabetes self-management education|diabetes self-management education
348774|NCT02102945|Computed tomography|computed tomography
348775|NCT02102945|Perfusion imaging|perfusion imaging
348776|NCT02102945|Coma|coma
348777|NCT02102945|Heart arrest|heart arrest
348778|NCT02102945|Brain death|brain death
348779|NCT02102906|Adult|adult
348780|NCT02102906|Humans|humans
348781|NCT02102906|Conversion disorder|conversion disorder
348782|NCT02102906|Somatoform Disorders/therapy|somatoform disorders/therapy
348783|NCT02102906|Nervous System Disorders/therapy|nervous system disorders/therapy
348784|NCT02102893|for Gastroentero-Pancreatic Neuroendocrine Tumors in Taiwan|for gastroentero-pancreatic neuroendocrine tumors in taiwan
348785|NCT02102880|Genetic Association Studies|genetic association studies
348786|NCT02102867|HIV|hiv
348787|NCT02102867|STI|sti
348788|NCT02102867|Primary Prevention|primary prevention
348789|NCT02102867|Topical Microbicides|topical microbicides
348790|NCT02102867|User Experience|user experience
348791|NCT02102867|Drug Delivery Systems|drug delivery systems
348792|NCT02102854|kidney transplantation|kidney transplantation
348793|NCT02102854|acute rejection|acute rejection
348794|NCT02102854|rabbit antithymocyte globulin|rabbit antithymocyte globulin
348795|NCT02102828|DVT|dvt
348796|NCT02102828|Total Knee Arthroplasty|total knee arthroplasty
348797|NCT02102815|total knee arthroplasty|total knee arthroplasty
348798|NCT02102815|pain control|pain control
348799|NCT02102815|dexamethasone|dexamethasone
348800|NCT02102815|steroids|steroids
348801|NCT02102802|PTSD|ptsd
348802|NCT02102802|MDMA|mdma
348803|NCT02102802|Brain activity|brain activity
348804|NCT02102802|fMRI|fmri
348805|NCT02102802|Heart rate variability|heart rate variability
348806|NCT02102802|Physiological correlate|physiological correlate
348807|NCT02102776|Primary Pterygium|primary pterygium
348808|NCT02102776|Mitomycin C|mitomycin c
348809|NCT02102776|Amniotic membrane transplantation|amniotic membrane transplantation
348810|NCT02102776|Conjunctival autograft|conjunctival autograft
348811|NCT02102776|Multi-center randomized clinical trial|multi-center randomized clinical trial
348812|NCT02102763|Overweight|overweight
348813|NCT02102763|Obesity|obesity
348814|NCT02102763|Dietary intake|dietary intake
348815|NCT02102763|Physical activity levels|physical activity levels
348816|NCT02102763|Blood pressure levels|blood pressure levels
348817|NCT02102763|Family perceptions|family perceptions
348818|NCT02102737|insulin resistance|insulin resistance
348819|NCT02102737|Scintigraphy|scintigraphy
348820|NCT02102737|Hyperinsulinemic euglycemic clamp|hyperinsulinemic euglycemic clamp
348821|NCT02102724|African Americans|african americans
348822|NCT02102724|Older Adults|older adults
348823|NCT02102711|VITAMIN A|vitamin a
348824|NCT02102711|BLOOD CONCENTRATION|blood concentration
348825|NCT02102711|retinopathy of prematurity|retinopathy of prematurity
348826|NCT02102698|Tourette's Syndrome|tourette's syndrome
348827|NCT02102698|Ecopipam|ecopipam
348828|NCT02102698|D1 Receptor|d1 receptor
348829|NCT02102698|Phase 2|phase 2
348830|NCT02102685|VAC Therapy|vac therapy
348831|NCT02102685|Neck Abscess|neck abscess
348832|NCT02102685|Traditional Therapy|traditional therapy
348833|NCT02102685|Wound Healing|wound healing
348834|NCT02102659|Nutritional Assessment|nutritional assessment
348835|NCT02102659|Oral Epithelial Cell|oral epithelial cell
348836|NCT02102659|Apoptosis|apoptosis
348837|NCT02102633|bosutinib|bosutinib
348838|NCT02102633|dabigatran|dabigatran
348839|NCT02102633|drug interaction|drug interaction
348840|NCT02102633|p-glycoprotein|p-glycoprotein
348841|NCT02102633|pharmacokinetics|pharmacokinetics
348842|NCT02102620|intra-articular injection|intra-articular injection
348843|NCT02102620|corticosteroid|corticosteroid
348844|NCT02102620|osteoarthritis|osteoarthritis
348845|NCT02102620|Interphalangeal joint|interphalangeal joint
348846|NCT02102607|intrathecal; ropivacaine; motor blockade; local anesthetics|intrathecal; ropivacaine; motor blockade; local anesthetics
348847|NCT02102594|Myasthenia Gravis|myasthenia gravis
348848|NCT02102594|Systemic Lupus Erythematosus|systemic lupus erythematosus
348849|NCT02102594|Rheumatoid Arthritis|rheumatoid arthritis
348850|NCT02102594|proteasome inhibitor|proteasome inhibitor
348851|NCT02102594|Bortezomib|bortezomib
348852|NCT02102594|Velcade|velcade
348853|NCT02102594|antibody-mediated autoimmune disease|antibody-mediated autoimmune disease
348854|NCT02102581|Tourniquet|tourniquet
446171|NCT01661439|aps|aps
348855|NCT02102581|Total knee arthroplasty|total knee arthroplasty
348856|NCT02102581|Blood loss|blood loss
348857|NCT02102581|Limb swelling|limb swelling
348858|NCT02102581|Limb circumference|limb circumference
348859|NCT02102568|breast cancer|breast cancer
348860|NCT02102568|Chemotherapy-induced menopause|chemotherapy-induced menopause
348861|NCT02102568|quality of life|quality of life
348862|NCT02102542|glycopyrrolate|glycopyrrolate
348863|NCT02102542|efficacy|efficacy
348864|NCT02102542|antisialagogue|antisialagogue
348865|NCT02102529|pain|pain
348866|NCT02102529|quality of life|quality of life
348867|NCT02102516|Post operative pain management|post operative pain management
348868|NCT02102490|Endocrine Therapy, Taxane, MONARCH 1|endocrine therapy, taxane, monarch 1
348869|NCT02102477|Prostatic neoplasms|prostatic neoplasms
348870|NCT02102477|Locally advanced|locally advanced
348871|NCT02102477|Radiotherapy|radiotherapy
348872|NCT02102477|Surgery|surgery
348873|NCT02102477|Mortality|mortality
348874|NCT02102451|Interferon-free|interferon-free
348875|NCT02102451|Direct acting antiviral (DAA)|direct acting antiviral (daa)
348876|NCT02102451|Treatment as prevention|treatment as prevention
348877|NCT02102451|Surveillance|surveillance
348878|NCT02102451|Feasibility|feasibility
348879|NCT02102438|Elderly patients|elderly patients
348880|NCT02102438|Localized HER2+ Breast Cancer|localized her2+ breast cancer
348881|NCT02102438|Omission of anthracyclines|omission of anthracyclines
348882|NCT02102438|Neoadjuvant chemotherapy|neoadjuvant chemotherapy
348883|NCT02102438|Adjuvant chemotherapy|adjuvant chemotherapy
348884|NCT02102438|Safety information|safety information
348885|NCT02102425|Peritoneal Dialysis|peritoneal dialysis
348886|NCT02102425|Exit site infection|exit site infection
348887|NCT02102425|Exit site care|exit site care
348888|NCT02102425|Bandage|bandage
348889|NCT02102425|Prevention|prevention
348890|NCT02102425|Guidelines|guidelines
348892|NCT02102412|colonoscopy|colonoscopy
348893|NCT02102412|colon cancer|colon cancer
348894|NCT02102399|Voice training|voice training
348895|NCT02102399|Education|education
348896|NCT02102399|Voice|voice
348897|NCT02102399|Faculty|faculty
348898|NCT02102386|elective|elective
348899|NCT02102386|carotid endarterectomy surgery|carotid endarterectomy surgery
348900|NCT02102373|colonoscopy, pediatric, preparation, diet|colonoscopy, pediatric, preparation, diet
348901|NCT02102360|microsurgery, furcation defects, periodontal disease, enamel matrix proteins, bone substitutes|microsurgery, furcation defects, periodontal disease, enamel matrix proteins, bone substitutes
348902|NCT02102347|Physical Therapy Modalities|physical therapy modalities
348903|NCT02102347|osteoarthritis|osteoarthritis
348904|NCT02102334|Osteoarthritis, hip,|osteoarthritis, hip,
348905|NCT02102334|radiograpghic measurements|radiograpghic measurements
348906|NCT02102334|femoral offset|femoral offset
348907|NCT02102334|leg length discrepancy|leg length discrepancy
348908|NCT02102334|cup anteversion|cup anteversion
348909|NCT02102334|cup inclination|cup inclination
348910|NCT02102321|hookworm|hookworm
348911|NCT02102321|albendazole|albendazole
348912|NCT02102321|iron supplementation|iron supplementation
348913|NCT02102321|democratic republic of congo|democratic republic of congo
348914|NCT02102321|subsistence farmers|subsistence farmers
348915|NCT02102321|randomized control trial|randomized control trial
348916|NCT02102321|neglected tropical disease|neglected tropical disease
348917|NCT02102321|helminths|helminths
348918|NCT02102295|Gingivitis|gingivitis
348919|NCT02102295|antioxidant|antioxidant
348920|NCT02102295|dentifrice|dentifrice
348921|NCT02102295|Ascorbic Acid Derivative|ascorbic acid derivative
348922|NCT02102295|L ascorbic acid 2 phosphate magnesium salt|l ascorbic acid 2 phosphate magnesium salt
348923|NCT02102282|Pregnancy|pregnancy
348924|NCT02102282|Breast Cancer|breast cancer
348925|NCT02102282|Chemotherapy|chemotherapy
348926|NCT02102282|Surgery|surgery
348927|NCT02102282|Obstetric managment|obstetric managment
348928|NCT02102256|deafness|deafness
348929|NCT02102256|congenital|congenital
348930|NCT02102256|pediatric|pediatric
348931|NCT02102256|device|device
348932|NCT02102243|hypertension|hypertension
348933|NCT02102243|blood pressure|blood pressure
348934|NCT02102243|sympathetic nerve activity|sympathetic nerve activity
348935|NCT02102243|vascular oxidative stress|vascular oxidative stress
348936|NCT02102243|nitric oxide|nitric oxide
348937|NCT02102243|nitric oxide synthase (eNOS)|nitric oxide synthase (enos)
348938|NCT02102243|endothelium|endothelium
348939|NCT02102243|endothelial dysfunction|endothelial dysfunction
348940|NCT02102243|endothelial cell protein expression|endothelial cell protein expression
348941|NCT02102243|microvascular blood flow|microvascular blood flow
348942|NCT02102243|flow mediated dilation|flow mediated dilation
348943|NCT02102243|endothelial cell collection|endothelial cell collection
348944|NCT02102243|microbubbles|microbubbles
348945|NCT02102243|Definity|definity
348946|NCT02102230|Sleep Initiation and Maintenance Disorders|sleep initiation and maintenance disorders
348947|NCT02102230|marijuana abuse|marijuana abuse
348948|NCT02102230|Veterans|veterans
348949|NCT02102217|Major Abdominal Surgery|major abdominal surgery
348950|NCT02102217|C-reactive protein|c-reactive protein
348951|NCT02102217|Computed Tomography|computed tomography
348952|NCT02102217|Quality Control|quality control
348953|NCT02102217|Postoperative complications|postoperative complications
348954|NCT02102204|Secondary Hyperparathyroidism (SHPT), chrominc kidney disease (CKD), hemodialysis|secondary hyperparathyroidism (shpt), chrominc kidney disease (ckd), hemodialysis
348955|NCT02102178|oncological pain|oncological pain
348956|NCT02102178|therapeutic activities|therapeutic activities
348957|NCT02102178|occupational therapy.|occupational therapy.
348958|NCT02102165|Aurora|aurora
348959|NCT02102165|breast cancer|breast cancer
348960|NCT02102165|metastatic|metastatic
348961|NCT02102165|molecular screening|molecular screening
348962|NCT02102165|targeted gene sequencing|targeted gene sequencing
348963|NCT02102165|molecular aberrations|molecular aberrations
348964|NCT02102165|exploratory|exploratory
348965|NCT02102165|biomarker|biomarker
348966|NCT02102152|Tobramycin Podhaler|tobramycin podhaler
348967|NCT02102152|bronchiectasis|bronchiectasis
348968|NCT02102152|chronic infection|chronic infection
348969|NCT02102152|Pseudomonas Aeruginosa|pseudomonas aeruginosa
348970|NCT02102126|Renal denervation therapy|renal denervation therapy
348971|NCT02102126|Aortic blood pressure|aortic blood pressure
348972|NCT02102126|Blood pressure variability|blood pressure variability
348973|NCT02102126|Arterial stiffness|arterial stiffness
348974|NCT02102126|Target organ damage|target organ damage
348975|NCT02102126|Biomarker|biomarker
348976|NCT02102100|menthol, electronic cigarette, nicotine, smoking, tobacco|menthol, electronic cigarette, nicotine, smoking, tobacco
348977|NCT02102074|colon and rectal tumors|colon and rectal tumors
348978|NCT02102074|colon cancer markers|colon cancer markers
348979|NCT02102061|overweight|overweight
348980|NCT02102061|exercise|exercise
348981|NCT02102061|nutrition|nutrition
348982|NCT02102061|philosophy|philosophy
348983|NCT02102048|HIV|hiv
348984|NCT02102048|diabetes|diabetes
348985|NCT02102048|glucose metabolism|glucose metabolism
348986|NCT02102048|antiretroviral therapy|antiretroviral therapy
348987|NCT02102048|ritonavir|ritonavir
348988|NCT02102048|atazanavir|atazanavir
348989|NCT02102035|defect|defect
348990|NCT02102035|dorsal branch of the proper digital nerve|dorsal branch of the proper digital nerve
348991|NCT02102035|dorsal digital island flap|dorsal digital island flap
348992|NCT02102035|sensory reconstruction.|sensory reconstruction.
348993|NCT02102022|argininosuccinate synthetase|argininosuccinate synthetase
348994|NCT02102022|arginine|arginine
348995|NCT02102022|arginine deiminase|arginine deiminase
348996|NCT02102009|Malnutrition|malnutrition
348997|NCT02102009|Dietary supplement|dietary supplement
348998|NCT02102009|Nutritional supplement|nutritional supplement
348999|NCT02102009|Complete enteral formula|complete enteral formula
349000|NCT02102009|COPD|copd
349001|NCT02101996|stable isotopes|stable isotopes
349002|NCT02101996|triacylglycerol|triacylglycerol
349003|NCT02101983|Acute myeloid leukemia|acute myeloid leukemia
349004|NCT02101983|outpatient consolidation treatment|outpatient consolidation treatment
349005|NCT02101970|Breast cancer risk|breast cancer risk
349006|NCT02101970|DHA|dha
349007|NCT02101970|Omega-3 Fatty Acids|omega-3 fatty acids
349008|NCT02101970|EPA|epa
349009|NCT02101970|Weight Loss|weight loss
349010|NCT02101931|Bladder Cancer|bladder cancer
349011|NCT02101931|Laser Diagnosis|laser diagnosis
349012|NCT02101931|Amino levulinic Acid|amino levulinic acid
349013|NCT02101931|Photodynamic Detection|photodynamic detection
349014|NCT02101931|spectra of urine|spectra of urine
349015|NCT02101892|migraine|migraine
349016|NCT02101892|Amitriptyline|amitriptyline
349017|NCT02101892|pain modulation|pain modulation
349018|NCT02101892|pain psychophysics|pain psychophysics
349019|NCT02101892|pain neurophysiology|pain neurophysiology
349020|NCT02101892|preventive treatment|preventive treatment
349021|NCT02101866|Bioavailability Study|bioavailability study
349022|NCT02101866|Aviragen Therapeutics, Inc.|aviragen therapeutics, inc.
349023|NCT02101866|Aviragen Therapeutics|aviragen therapeutics
349024|NCT02101866|Aviragen|aviragen
349025|NCT02101840|Substance-Related Disorders|substance-related disorders
349026|NCT02101840|Prescription Drug Misuse|prescription drug misuse
349027|NCT02101840|Analgesics, Opioid|analgesics, opioid
349028|NCT02101840|Oxycodone|oxycodone
349029|NCT02101840|Randomized Controlled Trial|randomized controlled trial
349030|NCT02101840|Cross-Over Studies|cross-over studies
349031|NCT02101840|Placebo|placebo
349032|NCT02101840|Healthy Volunteers|healthy volunteers
349033|NCT02101801|environment, recycled wastewater, carbamazepine|environment, recycled wastewater, carbamazepine
349034|NCT02101762|Foley|foley
349035|NCT02101762|Catheters|catheters
349036|NCT02101762|CAUTI|cauti
349037|NCT02101762|ERASE CAUTI|erase cauti
349142|NCT02101385|RNA Sequencing|rna sequencing
349038|NCT02101749|trivalent inactivated influenza vaccine|trivalent inactivated influenza vaccine
349039|NCT02101736|Ages 3 - 15 years|ages 3 - 15 years
349040|NCT02101736|Cabozantinib|cabozantinib
349041|NCT02101736|XL184|xl184
776121|NCT00344591|AIDS|aids
446303|NCT01660789|Obesity|obesity
349042|NCT02101736|Plexiform Neurofibromas|plexiform neurofibromas
349043|NCT02101736|Neurofibromatosis|neurofibromatosis
349044|NCT02101736|Pathogenetic NF1 Mutations|pathogenetic nf1 mutations
349045|NCT02101736|Cometriq|cometriq
349046|NCT02101736|NF1|nf1
349047|NCT02101723|Zinc absorption|zinc absorption
349048|NCT02101723|Micronutrient supplement|micronutrient supplement
349049|NCT02101723|Microbiome|microbiome
349050|NCT02101723|Kenya|kenya
349051|NCT02101723|Complementary foods|complementary foods
349052|NCT02101723|Home fortification|home fortification
349053|NCT02101710|Bioequivalence|bioequivalence
349054|NCT02101710|Isosorbide 5-mononitrate|isosorbide 5-mononitrate
349055|NCT02101710|Elantan|elantan
349056|NCT02101710|Imdur|imdur
349057|NCT02101710|Korean|korean
349058|NCT02101710|Healthy|healthy
349059|NCT02101697|reduce|reduce
349060|NCT02101697|Indian health providers|indian health providers
349061|NCT02101684|Orteronel, Granulosa Cell Tumour|orteronel, granulosa cell tumour
349062|NCT02101671|agitation|agitation
349063|NCT02101671|anaesthesia|anaesthesia
349064|NCT02101671|laparoscopy|laparoscopy
349065|NCT02101671|surgery|surgery
349066|NCT02101671|delirium|delirium
349067|NCT02101671|sedation|sedation
349068|NCT02101671|emergence|emergence
349069|NCT02101671|steep|steep
349070|NCT02101671|trendelemburg|trendelemburg
349071|NCT02101671|position|position
349072|NCT02101671|delayed|delayed
349073|NCT02101671|Confusion|confusion
349074|NCT02101671|Disorientation|disorientation
349075|NCT02101645|Bioimpedance|bioimpedance
349076|NCT02101645|Venous ulcer|venous ulcer
349077|NCT02101645|Edema|edema
349078|NCT02101645|LIDC|lidc
349079|NCT02101645|Electrical stimulation|electrical stimulation
349080|NCT02101632|TMD|tmd
349081|NCT02101632|bee venom|bee venom
349082|NCT02101632|muscle tension|muscle tension
349083|NCT02101632|muscle pain|muscle pain
349084|NCT02101619|aortic stenosis|aortic stenosis
349085|NCT02101619|myocardial tissue|myocardial tissue
349086|NCT02101619|echocardiography|echocardiography
349087|NCT02101619|MRI|mri
349088|NCT02101606|Acute Stroke|acute stroke
349089|NCT02101606|Cerebral Stroke|cerebral stroke
349090|NCT02101606|Brain Ischemia|brain ischemia
349091|NCT02101606|Perfusion Imaging|perfusion imaging
349092|NCT02101606|MRI, Diffusion Weighted|mri, diffusion weighted
349093|NCT02101606|MRI, Perfusion Weighted|mri, perfusion weighted
349094|NCT02101593|argininosuccinate synthetase|argininosuccinate synthetase
349095|NCT02101593|arginine|arginine
349096|NCT02101593|arginine deiminase|arginine deiminase
349097|NCT02101580|argininosuccinate synthetase|argininosuccinate synthetase
349098|NCT02101580|arginine|arginine
349099|NCT02101580|arginine deiminase|arginine deiminase
349100|NCT02101567|Postpartum hemorrhage, Cesarean section, Uterotonics|postpartum hemorrhage, cesarean section, uterotonics
349101|NCT02101554|Pediatric|pediatric
349102|NCT02101554|pain indication|pain indication
349103|NCT02101554|controlled release morphine|controlled release morphine
349104|NCT02101541|Atrial fibrillation|atrial fibrillation
349105|NCT02101541|Arrhythmias, Cardiac|arrhythmias, cardiac
349106|NCT02101541|Heart diseases|heart diseases
349107|NCT02101541|Cardiovascular diseases|cardiovascular diseases
349108|NCT02101541|Pathological processes|pathological processes
349109|NCT02101528|Strength in PD patients|strength in pd patients
349110|NCT02101528|Isokinetic muscle strength|isokinetic muscle strength
349111|NCT02101515|randomized controlled trial|randomized controlled trial
349112|NCT02101515|labor complications|labor complications
349113|NCT02101515|cesarean section|cesarean section
349114|NCT02101515|second stage|second stage
349115|NCT02101502|Healthcare,educational effectiveness, institutional capacity|healthcare,educational effectiveness, institutional capacity
349116|NCT02101489|TVT|tvt
349117|NCT02101489|Stress urinary incontinence|stress urinary incontinence
349118|NCT02101476|Pain|pain
349119|NCT02101463|aortic|aortic
349120|NCT02101463|sm-FBSG|sm-fbsg
349121|NCT02101463|aneurysms|aneurysms
349122|NCT02101463|fenestrated|fenestrated
349123|NCT02101463|stent-grafts|stent-grafts
349124|NCT02101463|Vascular|vascular
349125|NCT02101463|Endovascular|endovascular
349126|NCT02101450|extra-abdominal|extra-abdominal
349127|NCT02101450|intra-abdominal|intra-abdominal
349128|NCT02101450|removal of placenta|removal of placenta
349129|NCT02101450|cesarean section|cesarean section
349130|NCT02101450|bleeding|bleeding
349131|NCT02101424|Overdose|overdose
349132|NCT02101424|Emergency Department|emergency department
349133|NCT02101424|Supplemental Oxygen|supplemental oxygen
349134|NCT02101424|Pulse Oximeter|pulse oximeter
349135|NCT02101424|Capnography|capnography
349136|NCT02101398|tDCS|tdcs
349137|NCT02101398|Stroke|stroke
349138|NCT02101398|Aphasia|aphasia
349139|NCT02101398|Naming|naming
349140|NCT02101385|Genomically-Directed Therapy|genomically-directed therapy
349141|NCT02101385|DNA Sequencing|dna sequencing
349143|NCT02101372|first episode psychosis|first episode psychosis
349144|NCT02101372|psychoeducation|psychoeducation
349145|NCT02101372|group therapy|group therapy
349146|NCT02101333|TAKAYASU ARTERITIS|takayasu arteritis
349147|NCT02101333|STEROID SPARING|steroid sparing
349148|NCT02101333|TOCILIZUMAB|tocilizumab
349149|NCT02101333|EFFICACY|efficacy
349150|NCT02101333|SAFETY|safety
349151|NCT02101320|surgery|surgery
349152|NCT02101320|nuclear medicine|nuclear medicine
349153|NCT02101320|Lymphoscintigraphy|lymphoscintigraphy
349154|NCT02101320|Gamma Camera|gamma camera
349155|NCT02101320|SNOLL|snoll
349156|NCT02101320|breast cancer|breast cancer
349157|NCT02101294|carpal tunnel syndrome|carpal tunnel syndrome
349158|NCT02101294|repetitive stress disorder|repetitive stress disorder
349159|NCT02101281|Dry Eye|dry eye
349160|NCT02101255|Dental caries|dental caries
349161|NCT02101255|Curodont Repair|curodont repair
349162|NCT02101255|P11-4|p11-4
349163|NCT02101242|Near-infrared-Spectroscopy|near-infrared-spectroscopy
349164|NCT02101229|Glycemic control algorithm|glycemic control algorithm
349165|NCT02101229|closed loop|closed loop
349166|NCT02101229|artificial pancreas|artificial pancreas
349167|NCT02101216|bioequivalence|bioequivalence
349168|NCT02101216|pharmacokinetics|pharmacokinetics
349169|NCT02101216|psoriasis|psoriasis
349170|NCT02101203|HSDD|hsdd
349171|NCT02101190|BIA 9-1067|bia 9-1067
349172|NCT02101190|Opicapone|opicapone
349173|NCT02101190|catechol-O-methyltransferase (COMT)|catechol-o-methyltransferase (comt)
349174|NCT02101177|Viral Hepatitis C|viral hepatitis c
349175|NCT02101177|Genotype 4|genotype 4
349177|NCT02101177|Egyptian National Program|egyptian national program
349178|NCT02101151|Type 2 diabetes mellitus|type 2 diabetes mellitus
349179|NCT02101151|vitamin D|vitamin d
349180|NCT02101151|cholecalciferol|cholecalciferol
349181|NCT02101151|obesity|obesity
349182|NCT02101138|Corticosteroids|corticosteroids
349183|NCT02101138|Eosinophilia|eosinophilia
349184|NCT02101099|Colonoscopy|colonoscopy
349185|NCT02101099|Force|force
349186|NCT02101099|Monitor|monitor
349187|NCT02101099|Endoscopist|endoscopist
349188|NCT02101099|Conscious|conscious
349189|NCT02101099|Sedation|sedation
349190|NCT02101099|Propofol|propofol
349191|NCT02101086|umbilical cord blood|umbilical cord blood
349192|NCT02101086|premature|premature
349193|NCT02101086|autologous transfusion|autologous transfusion
349194|NCT02101086|allogeneic transfusion|allogeneic transfusion
349195|NCT02101060|exercise|exercise
349196|NCT02101060|aging|aging
349197|NCT02101060|aerobic capacity|aerobic capacity
349198|NCT02101060|cardiac function|cardiac function
349199|NCT02101060|inflammation|inflammation
349200|NCT02101047|cesarean section|cesarean section
349201|NCT02101047|hypotension|hypotension
349202|NCT02101047|phenylephrine|phenylephrine
349203|NCT02100982|Multimorbidity|multimorbidity
349204|NCT02100982|Communication|communication
349205|NCT02100982|Primary Care|primary care
349206|NCT02100982|Mental Health|mental health
349207|NCT02100969|MG|mg
349208|NCT02100969|Hizentra|hizentra
349209|NCT02100969|autoimmune neuromuscular disorder|autoimmune neuromuscular disorder
349210|NCT02100956|chronic pain|chronic pain
349211|NCT02100956|neuropathic pain|neuropathic pain
349212|NCT02100943|Obstructive Sleep Apnea|obstructive sleep apnea
349213|NCT02100930|Anti-GD2 3F8 Monoclonal Antibody|anti-gd2 3f8 monoclonal antibody
349214|NCT02100930|oral isotretinoin|oral isotretinoin
349215|NCT02100930|GM-CSF|gm-csf
349216|NCT02100930|Sargramostim|sargramostim
349217|NCT02100930|13-260|13-260
349218|NCT02100917|Bioequivalence|bioequivalence
349219|NCT02100917|Biosimilarity|biosimilarity
349220|NCT02100917|Similarity|similarity
349221|NCT02100917|Pharmacokinetics|pharmacokinetics
349222|NCT02100917|Phase I|phase i
349223|NCT02100917|Trastuzumab|trastuzumab
349224|NCT02100917|Healthy Male Volunteers|healthy male volunteers
349225|NCT02100917|Single-dose|single-dose
349226|NCT02100917|HER-2|her-2
349227|NCT02100917|Oncology|oncology
349228|NCT02100904|Fibroids|fibroids
349229|NCT02100904|Radiofrequency ablation|radiofrequency ablation
349230|NCT02100904|Myomectomy|myomectomy
349231|NCT02100891|Ewing Sarcoma|ewing sarcoma
349232|NCT02100891|Neuroblastoma|neuroblastoma
349233|NCT02100891|Rhabdomyosarcoma|rhabdomyosarcoma
349234|NCT02100891|Osteosarcoma|osteosarcoma
349235|NCT02100891|CNS tumors|cns tumors
349236|NCT02100891|Brain Tumors|brain tumors
349237|NCT02100839|hypercholesterolemia|hypercholesterolemia
349238|NCT02100839|apolipoprotein E|apolipoprotein e
349239|NCT02100839|First in Human|first in human
349240|NCT02100839|Apolipoprotein E (ApoE)|apolipoprotein e (apoe)
349241|NCT02100839|Apolipoprotein E Mimetic (AEM)|apolipoprotein e mimetic (aem)
349242|NCT02100800|COPD|copd
349243|NCT02100800|Emphysema|emphysema
349244|NCT02100800|MRI|mri
349245|NCT02100800|UTE|ute
349246|NCT02100800|Quantification|quantification
349247|NCT02100800|CT|ct
349248|NCT02100787|tear osmolarity|tear osmolarity
349249|NCT02100787|keratitis sicca|keratitis sicca
349250|NCT02100787|ocular surface disease|ocular surface disease
349251|NCT02100787|TheraTears|theratears
349252|NCT02100774|bioavailability|bioavailability
349253|NCT02100774|postprandial period|postprandial period
349254|NCT02100774|genetic variants|genetic variants
349255|NCT02100774|single nucleotide polymorphisms|single nucleotide polymorphisms
349256|NCT02100774|vitamin|vitamin
349257|NCT02100774|carotenoid|carotenoid
349258|NCT02100774|lutein|lutein
349259|NCT02100774|lycopene|lycopene
349260|NCT02100774|tocopherol|tocopherol
349261|NCT02100774|cholecalciferol|cholecalciferol
349262|NCT02100761|Voriconazole|voriconazole
349263|NCT02100761|Invasive pulmonary aspergillosis|invasive pulmonary aspergillosis
349516|NCT02099565|LDL-cholesterol|ldl-cholesterol
349264|NCT02100761|Therapeutic drug monitoring|therapeutic drug monitoring
349265|NCT02100761|CYP genetic polymorphism|cyp genetic polymorphism
349266|NCT02100761|Efficacy|efficacy
349267|NCT02100761|Safety|safety
349268|NCT02100748|moderate to severe acute pain|moderate to severe acute pain
349269|NCT02100748|bunionectomy|bunionectomy
349270|NCT02100735|sedatives|sedatives
349271|NCT02100735|analgesics|analgesics
349272|NCT02100735|protocol|protocol
349273|NCT02100735|mechanical ventilation|mechanical ventilation
349274|NCT02100735|analgosedation|analgosedation
349275|NCT02100683|Occluder|occluder
349276|NCT02100657|multiple myeloma|multiple myeloma
349277|NCT02100657|plitidepsin|plitidepsin
349278|NCT02100657|APLIDIN|aplidin
349279|NCT02100618|Adolescents|adolescents
349280|NCT02100618|Adults|adults
349281|NCT02100618|Immunogenicity|immunogenicity
349282|NCT02100618|6.5 years|6.5 years
349283|NCT02100618|Safety|safety
349284|NCT02100618|Antibody persistence|antibody persistence
349285|NCT02100618|Human Papillomavirus (HPV) vaccine|human papillomavirus (hpv) vaccine
349286|NCT02100605|Nasal|nasal
349287|NCT02100605|Congestion|congestion
349288|NCT02100605|Decongestion|decongestion
349289|NCT02100605|Hypertonic|hypertonic
349290|NCT02100605|Saline solution|saline solution
349291|NCT02100592|brain injury|brain injury
349292|NCT02100592|coma|coma
349293|NCT02100592|intensive care|intensive care
349294|NCT02100592|early rehabilitation|early rehabilitation
349295|NCT02100566|Advance Directive|advance directive
349296|NCT02100553|Postmenopausal Women|postmenopausal women
349297|NCT02100553|Obese|obese
349298|NCT02100553|Non-obese|non-obese
349299|NCT02100553|Drug Interaction with Itraconazole|drug interaction with itraconazole
349300|NCT02100553|Pharmacokinetic|pharmacokinetic
349301|NCT02100540|PMS|pms
349302|NCT02100540|hot flashes|hot flashes
349303|NCT02100527|safety|safety
349304|NCT02100527|tolerability|tolerability
349305|NCT02100527|pharmacokinetics|pharmacokinetics
349306|NCT02100527|oral dosing|oral dosing
349307|NCT02100527|moderate to severe acne vulgaris|moderate to severe acne vulgaris
349308|NCT02100514|Primary hyperlipidemia or mixed dyslipidemia|primary hyperlipidemia or mixed dyslipidemia
349309|NCT02100514|high risk of cardiovascular events|high risk of cardiovascular events
349310|NCT02100514|multiple cardiovascular disease risk factors.|multiple cardiovascular disease risk factors.
349311|NCT02100501|Seizure control through dietary therapy in pediatric intractable epilepsy patients.|seizure control through dietary therapy in pediatric intractable epilepsy patients.
349312|NCT02100488|Closed-loop insulin infusion|closed-loop insulin infusion
349313|NCT02100488|Postprandial glucose control|postprandial glucose control
349314|NCT02100488|Glucose variability|glucose variability
349315|NCT02100462|Hypertension|hypertension
349316|NCT02100462|Platelet activation|platelet activation
349317|NCT02100462|Platelet aggregation|platelet aggregation
349318|NCT02100462|Chlorthalidone|chlorthalidone
349319|NCT02100449|Atelectasis|atelectasis
349320|NCT02100449|Pneumonia|pneumonia
349321|NCT02100449|Lung ultrasound|lung ultrasound
349322|NCT02100449|Doppler|doppler
349323|NCT02100436|children|children
349324|NCT02100436|H3N2|h3n2
349325|NCT02100436|H3N2v|h3n2v
349326|NCT02100436|influenza|influenza
349327|NCT02100436|pediatric|pediatric
349328|NCT02100436|unadjuvanted|unadjuvanted
349329|NCT02100436|vaccine|vaccine
349330|NCT02100410|Contact Lens|contact lens
349331|NCT02100410|Toric|toric
349332|NCT02100397|Enteric fever|enteric fever
349333|NCT02100397|Paratyphoid|paratyphoid
349334|NCT02100397|Salmonella Paratyphi|salmonella paratyphi
349335|NCT02100397|Challenge study|challenge study
349336|NCT02100397|Human model of infection|human model of infection
349337|NCT02100384|peri implant|peri implant
349338|NCT02100384|Maintenance|maintenance
349339|NCT02100384|Ultrasonic|ultrasonic
349340|NCT02100384|Scalers|scalers
349341|NCT02100371|BMS-833923|bms-833923
349342|NCT02100371|CA194002|ca194002
349343|NCT02100358|acute cholecystitis|acute cholecystitis
349344|NCT02100332|Drug Therapy|drug therapy
349345|NCT02100319|Pharmacological therapy|pharmacological therapy
349346|NCT02100293|magnesium sulfate, rocuronium|magnesium sulfate, rocuronium
349347|NCT02100280|Neuromuscular blockade|neuromuscular blockade
349348|NCT02100280|Sugammadex|sugammadex
349349|NCT02100280|Laparoscopic surgery|laparoscopic surgery
349350|NCT02100280|IL-6|il-6
349351|NCT02100241|Young adult|young adult
446709|NCT01658618|vlu|vlu
349352|NCT02100241|Muscle Stretching Exercises|muscle stretching exercises
349353|NCT02100241|Range of Motion, Articular|range of motion, articular
349354|NCT02100228|apixaban|apixaban
349355|NCT02100228|oral anticoagulant|oral anticoagulant
349356|NCT02100228|non-valvular atrial fibrillation|non-valvular atrial fibrillation
349357|NCT02100228|cardioversion|cardioversion
349358|NCT02100215|simulation|simulation
349359|NCT02100215|competence|competence
349360|NCT02100215|self-efficacy|self-efficacy
349361|NCT02100215|novice nurses|novice nurses
349362|NCT02100202|Dietary supplements|dietary supplements
349363|NCT02100202|Cotinine level|cotinine level
349364|NCT02100202|Malondialdehyde|malondialdehyde
349365|NCT02100202|Chronic smokers|chronic smokers
349366|NCT02100202|Hyperlipidemia|hyperlipidemia
349367|NCT02100176|Rehabilitation treatment|rehabilitation treatment
349368|NCT02100163|Ortho trauma. Virtual Reality. Pain. Anxiety|ortho trauma. virtual reality. pain. anxiety
349369|NCT02100150|Concussion|concussion
349370|NCT02100124|reproductive life planning|reproductive life planning
349371|NCT02100124|action planning|action planning
349372|NCT02100124|contraceptive use|contraceptive use
349373|NCT02100124|unintended pregnancy|unintended pregnancy
349374|NCT02100098|Ankle fracture|ankle fracture
349375|NCT02100098|Nerve block|nerve block
349376|NCT02100098|Postoperative pain|postoperative pain
349377|NCT02100098|Pain profile|pain profile
349378|NCT02100098|Rebound pain|rebound pain
349379|NCT02100085|Phase 1 follow up|phase 1 follow up
349380|NCT02100085|Cervical Intraepithelial Neoplasia|cervical intraepithelial neoplasia
349381|NCT02100085|Adult|adult
349382|NCT02100085|Safety|safety
349383|NCT02100085|Efficacy|efficacy
349384|NCT02100059|meniscectomy|meniscectomy
349385|NCT02100059|arthroscopic partial meniscectomy|arthroscopic partial meniscectomy
349386|NCT02100059|meniscus|meniscus
349387|NCT02100046|Ethosuximide|ethosuximide
349388|NCT02100046|Neuropathic pain|neuropathic pain
349389|NCT02100046|Pain|pain
349390|NCT02100046|Quality of life|quality of life
349391|NCT02100046|Neuropathic Pain diagnostic questionnaire ≥ 4|neuropathic pain diagnostic questionnaire ≥ 4
349392|NCT02100046|Analgesic treatment failure for at least 3 months|analgesic treatment failure for at least 3 months
349393|NCT02100020|physical activity|physical activity
349394|NCT02100020|exercise guidelines|exercise guidelines
349395|NCT02100020|multiple sclerosis|multiple sclerosis
349396|NCT02100007|solid tumors|solid tumors
349397|NCT02100007|relapsed|relapsed
349398|NCT02100007|advanced|advanced
349399|NCT02100007|metastatic|metastatic
349400|NCT02100007|small cell lung cancer|small cell lung cancer
349401|NCT02100007|ovarian cancer|ovarian cancer
349402|NCT02100007|refractory|refractory
349403|NCT02099994|HIV|hiv
349404|NCT02099994|vaccine|vaccine
349405|NCT02099981|Diabetes|diabetes
349406|NCT02099981|Diabetic|diabetic
349407|NCT02099981|Retinopathy|retinopathy
349408|NCT02099981|Ophthalmology|ophthalmology
349409|NCT02099981|Eye|eye
349410|NCT02099981|Eyes|eyes
349411|NCT02099955|spinal cord injury|spinal cord injury
349412|NCT02099955|vitamin D deficiency|vitamin d deficiency
349413|NCT02099955|pulmonary function|pulmonary function
349414|NCT02099955|metabolic diseases|metabolic diseases
349415|NCT02099942|Balloon Aortic Valvuloplasty|balloon aortic valvuloplasty
349416|NCT02099942|Valvuloplasty|valvuloplasty
349417|NCT02099942|Transcatheter Aortic Valve Replacement|transcatheter aortic valve replacement
349418|NCT02099942|Surgical Aortic Valve Replacement|surgical aortic valve replacement
349419|NCT02099929|Coffee|coffee
349420|NCT02099929|Glucose|glucose
349421|NCT02099929|Insulin|insulin
349422|NCT02099929|Diabetes|diabetes
349423|NCT02099929|Type 2 Diabetes Mellitus|type 2 diabetes mellitus
349424|NCT02099916|DHEA, pregnancy, ovarian reserve, AMH|dhea, pregnancy, ovarian reserve, amh
349425|NCT02099903|Heart Failure|heart failure
349426|NCT02099903|Heart Failure, Systolic|heart failure, systolic
349427|NCT02099903|Chagas Disease|chagas disease
349428|NCT02099903|Chagas Cardiomyopathy|chagas cardiomyopathy
349429|NCT02099903|Renal Denervation|renal denervation
349430|NCT02099903|Irrigated Radiofrequency Catheter|irrigated radiofrequency catheter
349431|NCT02099890|Chronic Inflammation|chronic inflammation
349432|NCT02099890|Spinal Cord Injury|spinal cord injury
349433|NCT02099890|Anti-inflammatory Diet|anti-inflammatory diet
349434|NCT02099890|Neuropathic Pain|neuropathic pain
349435|NCT02099890|Depression|depression
349436|NCT02099890|Cognitive Impairment|cognitive impairment
349437|NCT02099890|Somatic Nerve Function|somatic nerve function
349438|NCT02099890|Autonomic Nerve Function|autonomic nerve function
349439|NCT02099877|µ-opioid receptor polymorphism|µ-opioid receptor polymorphism
349440|NCT02099877|Opioids|opioids
349441|NCT02099877|Opioid analgesia|opioid analgesia
349442|NCT02099877|Labor analgesia|labor analgesia
349443|NCT02099838|Pioglitazone|pioglitazone
349444|NCT02099838|Metformin|metformin
349445|NCT02099838|Type 2 Diabetes Mellitus|type 2 diabetes mellitus
349446|NCT02099825|adult male|adult male
349447|NCT02099825|anxiety|anxiety
349448|NCT02099825|public speaking|public speaking
349849|NCT02098096|Veterans|veterans
349449|NCT02099825|healthy controls|healthy controls
349450|NCT02099825|exposure therapy|exposure therapy
349451|NCT02099825|social anxiety|social anxiety
349452|NCT02099825|mifepristone|mifepristone
349453|NCT02099825|d-cycloserine|d-cycloserine
349454|NCT02099799|Physical Activity|physical activity
349455|NCT02099799|COPD Self-Management|copd self-management
349456|NCT02099799|Internet|internet
349457|NCT02099799|6-Minute Walk Test|6-minute walk test
349458|NCT02099799|COPD Exacerbation|copd exacerbation
349459|NCT02099799|Health-related Quality of Life|health-related quality of life
349460|NCT02099786|hearing|hearing
349461|NCT02099786|cisplatin|cisplatin
349462|NCT02099786|Ototoxicity|ototoxicity
349463|NCT02099786|Veterans|veterans
349464|NCT02099773|AAC|aac
349465|NCT02099773|support worker|support worker
349466|NCT02099773|direct care staff|direct care staff
349467|NCT02099773|intellectual disability|intellectual disability
349468|NCT02099773|learning disability|learning disability
349469|NCT02099773|communication|communication
349470|NCT02099773|adults|adults
349471|NCT02099760|gonorrhea|gonorrhea
349472|NCT02099760|chlamydia|chlamydia
349473|NCT02099760|trichomonas|trichomonas
349474|NCT02099747|Aplastic Anaemia|aplastic anaemia
349475|NCT02099747|Eltrombopag|eltrombopag
349476|NCT02099747|HATG|hatg
349477|NCT02099747|ATGAM|atgam
349478|NCT02099734|14-016|14-016
349479|NCT02099721|Sudden Cardiac Arrest (SCA)|sudden cardiac arrest (sca)
349480|NCT02099721|Syncope|syncope
349481|NCT02099721|Non Sustained Ventricular Tachycardia (NSVT)|non sustained ventricular tachycardia (nsvt)
349482|NCT02099721|Premature Ventricular Contractions (PVC)|premature ventricular contractions (pvc)
349483|NCT02099721|Left Ventricular Ejection Fraction (LVEF)|left ventricular ejection fraction (lvef)
349484|NCT02099721|Primary Prevention|primary prevention
349485|NCT02099721|Secondary Prevention|secondary prevention
349486|NCT02099721|Antitachycardia pacing (ATP)|antitachycardia pacing (atp)
349487|NCT02099721|shock|shock
349488|NCT02099721|appropriate therapy|appropriate therapy
349489|NCT02099708|Pharmacological therapy|pharmacological therapy
349490|NCT02099695|Hyperhidrosis|hyperhidrosis
349491|NCT02099695|Oxybutynin|oxybutynin
349492|NCT02099682|Pharmacological therapy|pharmacological therapy
349493|NCT02099604|Hepatitis C - Genotype 4|hepatitis c - genotype 4
349494|NCT02099604|SVR (Sustained Virological Response)|svr (sustained virological response)
349495|NCT02099604|Vitamin D|vitamin d
349496|NCT02099604|Treatment Naïve|treatment naïve
349497|NCT02099591|Constipation|constipation
349498|NCT02099591|Colonic Inertia|colonic inertia
349499|NCT02099591|Dyschezia|dyschezia
349500|NCT02099591|Pharmacokinetics|pharmacokinetics
349501|NCT02099591|Naloxegol|naloxegol
349502|NCT02099591|Paediatric|paediatric
349503|NCT02099591|Opioids|opioids
349504|NCT02099591|Opioid induced constipation|opioid induced constipation
349505|NCT02099591|OIC|oic
349506|NCT02099591|Phase 1|phase 1
349507|NCT02099578|Blood pressure|blood pressure
349508|NCT02099578|Arterial stiffness|arterial stiffness
349509|NCT02099578|Pulse wave velocity|pulse wave velocity
349510|NCT02099578|Strawberries|strawberries
349511|NCT02099578|Endothelial function|endothelial function
349512|NCT02099578|Oxidative stress|oxidative stress
349513|NCT02099578|Postmenopausal women|postmenopausal women
349514|NCT02099565|Major Adverse Cardiovascular and Cerebrovascular Events (MACCE)|major adverse cardiovascular and cerebrovascular events (macce)
349515|NCT02099565|Statins|statins
349517|NCT02099565|Inflammatory markers|inflammatory markers
349518|NCT02099565|Percutaneous Coronary Intervention (PCI)|percutaneous coronary intervention (pci)
349519|NCT02099552|X-Linked hypohidrotic ectodermal dysplasia|x-linked hypohidrotic ectodermal dysplasia
349520|NCT02099552|XLHED|xlhed
349521|NCT02099552|Hypohidrotic ectodermal dysplasia|hypohidrotic ectodermal dysplasia
349522|NCT02099552|HED|hed
349523|NCT02099552|Christ-Siemens-Touraine syndrome|christ-siemens-touraine syndrome
349524|NCT02099539|absolute lymphocyte count|absolute lymphocyte count
349525|NCT02099539|antitumor|antitumor
349526|NCT02099539|cancer|cancer
349527|NCT02099539|immunotherapy|immunotherapy
349528|NCT02099539|immunochemotherapy|immunochemotherapy
349529|NCT02099539|interleukin-15|interleukin-15
349530|NCT02099539|multiple myeloma|multiple myeloma
349531|NCT02099539|NK cell|nk cell
349532|NCT02099539|refractory|refractory
349533|NCT02099539|relapsed|relapsed
349534|NCT02099539|T cell|t cell
349535|NCT02099539|white blood cell count|white blood cell count
349536|NCT02099526|cancer|cancer
349537|NCT02099526|caregiver|caregiver
349538|NCT02099526|caregiving|caregiving
349539|NCT02099526|care give|care give
349540|NCT02099526|elderly|elderly
349541|NCT02099526|older adults|older adults
349542|NCT02099526|unmet needs|unmet needs
349543|NCT02099526|post-discharge|post-discharge
349544|NCT02099526|cancer symptoms|cancer symptoms
349545|NCT02099513|Mobile Technology|mobile technology
349546|NCT02099513|Chronic illness|chronic illness
349547|NCT02099513|Wireless blood pressure device|wireless blood pressure device
349548|NCT02099513|Wireless scale|wireless scale
349549|NCT02099513|Pedometer|pedometer
349850|NCT02098096|strength|strength
349550|NCT02099500|Critical Limb Ischemia|critical limb ischemia
349551|NCT02099500|Peripheral Vascular Disease|peripheral vascular disease
349552|NCT02099500|Lower Limb Ulcer|lower limb ulcer
349553|NCT02099500|Gangrene|gangrene
349554|NCT02099500|Amputation|amputation
349555|NCT02099500|Lower Limb Wound|lower limb wound
349557|NCT02099474|HIV-1|hiv-1
349558|NCT02099474|HIV mother to child prevention|hiv mother to child prevention
349559|NCT02099474|Raltegravir|raltegravir
349560|NCT02099474|Pharmacokinetic|pharmacokinetic
349561|NCT02099435|Gastriointestinal|gastriointestinal
349562|NCT02099435|Lower gastriointestinal|lower gastriointestinal
349563|NCT02099435|Digestive|digestive
349564|NCT02099435|Hemostasis|hemostasis
349565|NCT02099435|Recurrent bleeding|recurrent bleeding
349566|NCT02099435|Hemospray|hemospray
349567|NCT02099409|Type 1 diabetes mellitus|type 1 diabetes mellitus
349568|NCT02099409|children|children
349569|NCT02099409|closed loop|closed loop
349570|NCT02099409|cross over|cross over
349571|NCT02099409|overnight|overnight
349572|NCT02099409|FLORENCED2|florenced2
349573|NCT02099409|DANA Diabecare R pump|dana diabecare r pump
349574|NCT02099409|FreeStyle Navigator II|freestyle navigator ii
349575|NCT02099409|Dexcom G4|dexcom g4
349576|NCT02099396|PFS,efficacy and safety,lobaplatin and gemcitabine in combination, second-line treatments on advanced osteosarcoma|pfs,efficacy and safety,lobaplatin and gemcitabine in combination, second-line treatments on advanced osteosarcoma
349577|NCT02099383|Stroke|stroke
349578|NCT02099383|Dehydration|dehydration
349579|NCT02099383|Fluid Therapy|fluid therapy
349580|NCT02099370|Multiple Sclerosis|multiple sclerosis
349581|NCT02099370|Tecfidera(R)|tecfidera(r)
349582|NCT02099370|Oral medication|oral medication
349583|NCT02099370|Adherence|adherence
349584|NCT02099331|Atrial Fibrillation|atrial fibrillation
349585|NCT02099331|Reactive Oxygen Species|reactive oxygen species
349586|NCT02099331|Cardiac Surgery|cardiac surgery
349587|NCT02099318|Rehearsal Platform|rehearsal platform
349588|NCT02099305|Adolescent; Depression|adolescent; depression
349589|NCT02099305|Early intervention (education)|early intervention (education)
349590|NCT02099305|Randomized Controlled Trial|randomized controlled trial
349591|NCT02099305|Primary Prevention|primary prevention
349592|NCT02099305|schools|schools
349593|NCT02099305|Health Literacy|health literacy
349594|NCT02099305|Discrimination (Psychology)|discrimination (psychology)
349595|NCT02099305|Mental Health Services|mental health services
349596|NCT02099292|lymphoma|lymphoma
349597|NCT02099292|high dose therapy|high dose therapy
349598|NCT02099292|DexaBEAM|dexabeam
349599|NCT02099292|Rituximab|rituximab
349600|NCT02099292|role of alternative salvage treatment - dexaBEAM|role of alternative salvage treatment - dexabeam
349601|NCT02099266|Umbilical Cord Blood (UCB) Stem Cell Transplant|umbilical cord blood (ucb) stem cell transplant
349602|NCT02099266|Hyperbaric oxygen|hyperbaric oxygen
349603|NCT02099266|Leukemia|leukemia
349604|NCT02099266|Lymphoma|lymphoma
349605|NCT02099266|MDS|mds
349606|NCT02099253|Age|age
349607|NCT02099253|Pharmacodynamics|pharmacodynamics
349608|NCT02099253|dexmedetomidine|dexmedetomidine
349609|NCT02099240|Osteomyelitis|osteomyelitis
349610|NCT02099240|IV Antibiotics|iv antibiotics
349611|NCT02099240|Oral Antibiotics|oral antibiotics
349612|NCT02099227|pediatric|pediatric
349613|NCT02099227|soft tissue infections|soft tissue infections
349614|NCT02099227|ultrasonography|ultrasonography
349615|NCT02099227|effectiveness|effectiveness
349616|NCT02099214|myocardial iron overload|myocardial iron overload
349617|NCT02099214|HFE-Associated Hereditary Hemochromatosis|hfe-associated hereditary hemochromatosis
349618|NCT02099214|3 Tesla MRI|3 tesla mri
349619|NCT02099214|cardiological strategy in haemochromatosis|cardiological strategy in haemochromatosis
349620|NCT02099214|congestive heart failure|congestive heart failure
349621|NCT02099201|ACT-389949|act-389949
349622|NCT02099162|OCT|oct
349623|NCT02099162|Coronary|coronary
349624|NCT02099162|Stenting|stenting
349625|NCT02099149|Group B Streptococcus|group b streptococcus
349626|NCT02099149|early onset disease|early onset disease
349627|NCT02099149|late onset disease|late onset disease
349628|NCT02099149|anticapsular antibodies|anticapsular antibodies
349629|NCT02099149|serotype specific|serotype specific
349630|NCT02099123|Survival|survival
349631|NCT02099123|Functional Disability|functional disability
349632|NCT02099123|Cardiovascular Disease|cardiovascular disease
349633|NCT02099123|Diabetes|diabetes
349634|NCT02099123|Dementia|dementia
349635|NCT02099123|Cancer|cancer
349636|NCT02099097|3D Coping Skills Game|3d coping skills game
349637|NCT02099097|Quit smoking|quit smoking
349638|NCT02099097|14-062|14-062
349639|NCT02099071|ACT-389949|act-389949
349640|NCT02099058|Cancer|cancer
349641|NCT02099058|Advanced Solid Tumor|advanced solid tumor
349642|NCT02099058|Neoplasm|neoplasm
349643|NCT02099032|nutrition|nutrition
349644|NCT02099032|milk|milk
349645|NCT02099032|polar lipids|polar lipids
349646|NCT02099032|cardiometabolic risk|cardiometabolic risk
349647|NCT02099019|Coronary CT angiography; Revascularization; Decision-making|coronary ct angiography; revascularization; decision-making
349648|NCT02098993|Sickle cell disease|sickle cell disease
349649|NCT02098993|Acute chest syndrome|acute chest syndrome
349650|NCT02098993|Hemoglobinopathy|hemoglobinopathy
349651|NCT02098993|Hemolytic anemia|hemolytic anemia
349652|NCT02098993|Heparin|heparin
349653|NCT02098993|Anticoagulant|anticoagulant
349654|NCT02098954|TKI|tki
349655|NCT02098954|resistance|resistance
349656|NCT02098954|erlotinib|erlotinib
349657|NCT02098954|combined chemotherapy|combined chemotherapy
349658|NCT02098941|topiramate|topiramate
349659|NCT02098941|oxcarbazepine|oxcarbazepine
349660|NCT02098941|levetiracetam|levetiracetam
349661|NCT02098941|retention rate|retention rate
349662|NCT02098928|Acupuncture|acupuncture
349663|NCT02098928|Electro acupuncture|electro acupuncture
349664|NCT02098928|Menopause|menopause
349665|NCT02098915|gastroschisis|gastroschisis
349666|NCT02098915|intestinal motility|intestinal motility
349667|NCT02098915|prokinetic agents|prokinetic agents
349668|NCT02098915|intravenous metoclopramide|intravenous metoclopramide
349669|NCT02098915|time to full enteral feeding|time to full enteral feeding
349670|NCT02098902|Overweight|overweight
349671|NCT02098902|Obesity|obesity
349672|NCT02098902|Overnutrition|overnutrition
349673|NCT02098902|Weight Loss|weight loss
349674|NCT02098902|Body Weight|body weight
349675|NCT02098902|Nutrition Disorders|nutrition disorders
349676|NCT02098889|Cervix, active phase of labor, Hyoscine-N-Butylbromide (HBB)|cervix, active phase of labor, hyoscine-n-butylbromide (hbb)
349677|NCT02098876|neointimal tissue area|neointimal tissue area
349678|NCT02098876|angulated coronary vessels|angulated coronary vessels
349679|NCT02098876|wall shear stress|wall shear stress
349680|NCT02098876|zotarolimus eluting stent|zotarolimus eluting stent
349681|NCT02098876|everolimus eluting stent|everolimus eluting stent
349682|NCT02098863|Sickle Cell Anemia|sickle cell anemia
349683|NCT02098863|Sickle Cell Disease|sickle cell disease
349684|NCT02098863|Survival|survival
349685|NCT02098863|Mortality|mortality
349686|NCT02098863|End-Order Dysfunction|end-order dysfunction
349687|NCT02098850|Staphylococcus aureus|staphylococcus aureus
349688|NCT02098850|bloodstream infection|bloodstream infection
349689|NCT02098850|bacteremia|bacteremia
349690|NCT02098837|HIV|hiv
349691|NCT02098824|vascular cognitive impairment|vascular cognitive impairment
349692|NCT02098824|treatment|treatment
349693|NCT02098824|cerebrovascular lesions|cerebrovascular lesions
349694|NCT02098824|memory impairment|memory impairment
349695|NCT02098824|executive dysfunction|executive dysfunction
349696|NCT02098824|neuronal networks|neuronal networks
349697|NCT02098824|white matter tracts|white matter tracts
349698|NCT02098824|monoaminergic systems|monoaminergic systems
349699|NCT02098824|cholinergic systems|cholinergic systems
349700|NCT02098824|DTI|dti
349701|NCT02098824|rs-fMRI|rs-fmri
349702|NCT02098798|Dysplasia, Inflammatory Bowel Disease|dysplasia, inflammatory bowel disease
349703|NCT02098785|VAP|vap
349704|NCT02098785|liver|liver
349705|NCT02098785|hepatology|hepatology
349706|NCT02098785|caffeine|caffeine
349707|NCT02098772|aortic valve disease|aortic valve disease
349708|NCT02098772|coronary bypass surgery|coronary bypass surgery
349709|NCT02098772|cardioplegic solutions|cardioplegic solutions
349710|NCT02098759|TSC|tsc
349711|NCT02098759|tuberous sclerosis complex|tuberous sclerosis complex
349712|NCT02098759|epilepsy|epilepsy
349713|NCT02098746|Pharmacological therapy|pharmacological therapy
349714|NCT02098733|Pharmacological therapy|pharmacological therapy
349715|NCT02098707|Stabilometric Platform|stabilometric platform
349716|NCT02098707|Rehabilitation|rehabilitation
349717|NCT02098707|Balance Disorders|balance disorders
349718|NCT02098707|Falls|falls
349719|NCT02098694|Physiotherapy|physiotherapy
349720|NCT02098694|Outpatient clinic|outpatient clinic
349721|NCT02098681|Pectus Excavatum|pectus excavatum
349722|NCT02098668|menstrual cycle dynamics|menstrual cycle dynamics
349723|NCT02098668|PCOS|pcos
349724|NCT02098668|hyperprolactinemia|hyperprolactinemia
349725|NCT02098668|endometriosis|endometriosis
349726|NCT02098668|infertility|infertility
349727|NCT02098655|Stabilometric Platform|stabilometric platform
349728|NCT02098655|Postural instability|postural instability
349729|NCT02098642|Gait Disturbances|gait disturbances
349730|NCT02098642|Metatarsophalangeal joint|metatarsophalangeal joint
349731|NCT02098629|Myocardial infarction|myocardial infarction
349732|NCT02098629|myocardial ischemia|myocardial ischemia
349733|NCT02098629|reperfusion injury|reperfusion injury
349734|NCT02098616|Hepatitis|hepatitis
349735|NCT02098616|Hepatitis, Chronic|hepatitis, chronic
349736|NCT02098616|Hepatitis C|hepatitis c
349737|NCT02098616|Hepatitis C, Chronic|hepatitis c, chronic
349738|NCT02098616|Liver Diseases|liver diseases
349739|NCT02098616|Digestive System Diseases|digestive system diseases
349740|NCT02098616|Hepatitis, Viral, Human|hepatitis, viral, human
349741|NCT02098616|RNA Virus Infections|rna virus infections
349742|NCT02098616|Antiviral Agents|antiviral agents
349743|NCT02098616|Drug Resistance, Viral|drug resistance, viral
349744|NCT02098590|Malaria|malaria
349745|NCT02098590|Plasmodium falciparum|plasmodium falciparum
349746|NCT02098577|Balance|balance
349747|NCT02098564|hand therapy|hand therapy
349748|NCT02098564|activity-based training|activity-based training
349749|NCT02098564|hand related injuries|hand related injuries
349750|NCT02098564|sense of coherence|sense of coherence
349751|NCT02098551|atopic dermatitis|atopic dermatitis
349753|NCT02098551|bet v 1 fragments|bet v 1 fragments
349754|NCT02098551|allergy|allergy
349755|NCT02098538|Regorafenib|regorafenib
349756|NCT02098538|13-244|13-244
349757|NCT02098525|Cryptococcal meningitis|cryptococcal meningitis
349758|NCT02098525|HIV/AIDS|hiv/aids
349759|NCT02098525|Antiretroviral therapy|antiretroviral therapy
349760|NCT02098525|Prognosis|prognosis
349761|NCT02098525|Thailand|thailand
349762|NCT02098512|Brentuximab Vedotin|brentuximab vedotin
349763|NCT02098512|Immunotherapy|immunotherapy
349764|NCT02098512|Relapsed Hodgkin Lymphoma|relapsed hodgkin lymphoma
349765|NCT02098512|Refractory Hodgkin Lymphoma|refractory hodgkin lymphoma
349766|NCT02098512|Reduced Intensity Conditioning|reduced intensity conditioning
349767|NCT02098512|Allogeneic Stem Cell Transplantation|allogeneic stem cell transplantation
349768|NCT02098486|Bile duct obstruction|bile duct obstruction
349769|NCT02098486|Cholangitis|cholangitis
349770|NCT02098486|Moxifloxacin|moxifloxacin
349771|NCT02098486|Ceftriaxone|ceftriaxone
349772|NCT02098486|Sepsis|sepsis
349773|NCT02098460|the Achilles tendon|the achilles tendon
349774|NCT02098460|intima-media thickness|intima-media thickness
349775|NCT02098447|vagus nerve stimulation effects on heart rate variability and peripheral blood perfusion|vagus nerve stimulation effects on heart rate variability and peripheral blood perfusion
349776|NCT02098421|Induction of Labor|induction of labor
349777|NCT02098421|Pitocin|pitocin
349778|NCT02098421|Oxytocin|oxytocin
349779|NCT02098421|Foley bulb|foley bulb
349780|NCT02098408|Ultra-high risk psychosis|ultra-high risk psychosis
349781|NCT02098408|Schizophrenia prodrome|schizophrenia prodrome
349782|NCT02098408|Cognitive remediation|cognitive remediation
349783|NCT02098382|Cervical ripening|cervical ripening
349784|NCT02098369|Chronic obstructive pulmonary disease (COPD)|chronic obstructive pulmonary disease (copd)
349785|NCT02098369|Supplemental oxygen|supplemental oxygen
349786|NCT02098369|Adherence|adherence
349787|NCT02098369|Telephonic education|telephonic education
349788|NCT02098369|Peer coaching|peer coaching
349789|NCT02098356|hemodialysis|hemodialysis
349790|NCT02098356|dialysis|dialysis
349791|NCT02098356|acidosis|acidosis
349792|NCT02098356|bicarbonate|bicarbonate
349793|NCT02098343|Ovarian cancer|ovarian cancer
349794|NCT02098343|Ovarian carcinoma|ovarian carcinoma
349795|NCT02098343|High Grade Serous Ovarian Cancer|high grade serous ovarian cancer
349796|NCT02098343|Recurrent Cancer|recurrent cancer
349797|NCT02098343|Resistant Cancer|resistant cancer
349798|NCT02098330|Vestibular neuritis|vestibular neuritis
349799|NCT02098330|Vertigo|vertigo
349800|NCT02098330|Head impulse test|head impulse test
349801|NCT02098330|Steroid|steroid
349802|NCT02098317|NAFLD|nafld
349803|NCT02098317|NASH|nash
349804|NCT02098317|DHA|dha
349805|NCT02098317|VITAMIN D|vitamin d
349806|NCT02098317|OBESITY|obesity
349807|NCT02098317|CHILDREN|children
349808|NCT02098304|Caries|caries
349809|NCT02098304|ICDAS|icdas
349810|NCT02098304|Lesion activity|lesion activity
349811|NCT02098304|Demineralisation|demineralisation
349812|NCT02098304|Imaging|imaging
349813|NCT02098265|aneurysm|aneurysm
349814|NCT02098265|transient ischemic attack|transient ischemic attack
349815|NCT02098252|brain arteriovenous malformation|brain arteriovenous malformation
349816|NCT02098252|Arteriovenous Malformations|arteriovenous malformations
349817|NCT02098252|AVM|avm
349818|NCT02098252|BAVM|bavm
349819|NCT02098252|Stroke|stroke
349820|NCT02098252|Intracranial Hemorrhage|intracranial hemorrhage
349821|NCT02098252|Congenital Abnormalities|congenital abnormalities
349822|NCT02098252|Aneurysm|aneurysm
349823|NCT02098252|Vascular Malformations|vascular malformations
349824|NCT02098252|Cardiovascular Abnormalities|cardiovascular abnormalities
349825|NCT02098252|Cardiovascular Diseases|cardiovascular diseases
349826|NCT02098252|Vascular Diseases|vascular diseases
349827|NCT02098213|plaque psoriasis|plaque psoriasis
349828|NCT02098213|DLQI|dlqi
349829|NCT02098213|VQ Dermato|vq dermato
349830|NCT02098213|PASI|pasi
349831|NCT02098213|PASI change|pasi change
349832|NCT02098213|phototherapy|phototherapy
349833|NCT02098213|balneotherapy|balneotherapy
349834|NCT02098213|hydrotherapy|hydrotherapy
349835|NCT02098213|Euroquol EQ 5d scale|euroquol eq 5d scale
349836|NCT02098213|Visual analogic scale|visual analogic scale
349837|NCT02098213|SPA treatment Scale|spa treatment scale
349838|NCT02098213|PSS|pss
349839|NCT02098200|tricuspid|tricuspid
349840|NCT02098200|regurgitation|regurgitation
349841|NCT02098200|repair|repair
349842|NCT02098200|outcomes|outcomes
349843|NCT02098187|Glomerular Filtration Rate|glomerular filtration rate
349844|NCT02098187|Acute Kidney Injury|acute kidney injury
349845|NCT02098174|Glomerular Filtration Rate|glomerular filtration rate
349846|NCT02098174|Acute kidney injury|acute kidney injury
349847|NCT02098096|knee|knee
349848|NCT02098096|arthritis|arthritis
349851|NCT02098096|exercise|exercise
349852|NCT02098096|muscle|muscle
349853|NCT02098083|acute|acute
349854|NCT02098083|stroke|stroke
349855|NCT02098083|gait|gait
349856|NCT02098070|Knee Pain|knee pain
349857|NCT02098070|Community Study|community study
349858|NCT02098070|Knee Osteoarthritis|knee osteoarthritis
349859|NCT02098070|Risk Factors|risk factors
349860|NCT02098057|IBS-diarrhea|ibs-diarrhea
349861|NCT02098044|knee osteoarthritis|knee osteoarthritis
349862|NCT02098044|epidemiology|epidemiology
349863|NCT02098044|risk factors|risk factors
349864|NCT02098044|prevalence|prevalence
349865|NCT02098044|professional football|professional football
349866|NCT02098031|Child Nutrition Sciences|child nutrition sciences
349867|NCT02098031|Growth and Development|growth and development
349868|NCT02098031|Developing Countries|developing countries
349869|NCT02097992|COPD|copd
349870|NCT02097992|airway blood flow|airway blood flow
349871|NCT02097979|glaucoma|glaucoma
349872|NCT02097979|adherence|adherence
349873|NCT02097979|medication possession ratio|medication possession ratio
349874|NCT02097979|intervention|intervention
349875|NCT02097953|Daptomycin|daptomycin
349876|NCT02097953|Rifampin|rifampin
349877|NCT02097953|P-glycoprotein|p-glycoprotein
349878|NCT02097953|Pharmacokinetic|pharmacokinetic
349879|NCT02097940|Postural balance|postural balance
349880|NCT02097940|Athletes|athletes
349881|NCT02097940|Sports|sports
349882|NCT02097940|Soccer|soccer
349883|NCT02097940|Physiotherapy|physiotherapy
349884|NCT02097927|Appetite|appetite
349885|NCT02097927|Satiety|satiety
349886|NCT02097927|Energy intake|energy intake
349887|NCT02097927|Saliva|saliva
349888|NCT02097927|Biomarkers|biomarkers
349889|NCT02097914|Secondhand smoke exposure|secondhand smoke exposure
349890|NCT02097914|Secondhand smoke|secondhand smoke
349891|NCT02097914|Environmental Tobacco Smoke|environmental tobacco smoke
349892|NCT02097914|Smoke-free homes|smoke-free homes
349893|NCT02097914|Smoke-free homes ban|smoke-free homes ban
349894|NCT02097901|Rotator Cuff|rotator cuff
349895|NCT02097901|Injury|injury
349896|NCT02097901|Repair|repair
349897|NCT02097901|Microfracture|microfracture
349898|NCT02097901|Healing|healing
349899|NCT02097875|Skin cancer|skin cancer
349900|NCT02097875|Basal cell carcinoma|basal cell carcinoma
349901|NCT02097875|Squamous cell carcinoma|squamous cell carcinoma
349902|NCT02097875|Melanoma|melanoma
349903|NCT02097862|Degenerative Disc Disease|degenerative disc disease
349904|NCT02097862|Disc Disease|disc disease
349905|NCT02097862|Back pain|back pain
349906|NCT02097862|stem cells|stem cells
349907|NCT02097862|adipose stem cells|adipose stem cells
349908|NCT02097862|ADSCs|adscs
349909|NCT02097849|vaccine|vaccine
349910|NCT02097849|pneumococcal|pneumococcal
349911|NCT02097849|meningococcal|meningococcal
349912|NCT02097849|tetanus diphtheria|tetanus diphtheria
349913|NCT02097849|immune response|immune response
349914|NCT02097836|postural control|postural control
349915|NCT02097836|Targeted Training|targeted training
349916|NCT02097836|cerebral palsy|cerebral palsy
349917|NCT02097836|trunk segments|trunk segments
349918|NCT02097823|olanzapine|olanzapine
349919|NCT02097823|Nausea and vomiting|nausea and vomiting
349920|NCT02097823|aprepitant|aprepitant
349921|NCT02097823|pediatrics|pediatrics
349922|NCT02097797|Inflammatory bowel disease|inflammatory bowel disease
349923|NCT02097797|Crohn's disease|crohn's disease
349924|NCT02097797|microbiota|microbiota
349925|NCT02097797|fecal transplantation|fecal transplantation
349926|NCT02097784|cirrhosis|cirrhosis
349927|NCT02097784|hepatorenal syndrome|hepatorenal syndrome
349928|NCT02097784|acute kidney injury|acute kidney injury
349929|NCT02097784|diastolic function|diastolic function
349930|NCT02097771|laryngeal mask airway ventilation|laryngeal mask airway ventilation
349931|NCT02097732|Metastatic melanoma|metastatic melanoma
349932|NCT02097732|Brain metastases|brain metastases
349933|NCT02097732|Radiation therapy|radiation therapy
349934|NCT02097732|Immune therapy|immune therapy
349935|NCT02097706|Boderline Personality Disorder|boderline personality disorder
349936|NCT02097706|Mental Illness|mental illness
349937|NCT02097706|Cognition|cognition
349938|NCT02097693|DBS|dbs
349939|NCT02097693|quality of life|quality of life
349940|NCT02097693|dystonia|dystonia
349941|NCT02097693|dyskinetic cerebral palsy|dyskinetic cerebral palsy
349942|NCT02097680|with disturbed glucose metabolism|with disturbed glucose metabolism
349943|NCT02097680|without disturbed glucose metabolism|without disturbed glucose metabolism
349944|NCT02097667|Severe early onset Fetal Growth Restrictions|severe early onset fetal growth restrictions
349945|NCT02097654|Hospital acquired|hospital acquired
349946|NCT02097654|Elderly|elderly
776617|NCT00342654|Genetics|genetics
349947|NCT02097641|Allogeneic Bone Marrow-derived Human Mesenchymal Stromal Cells|allogeneic bone marrow-derived human mesenchymal stromal cells
349948|NCT02097641|Acute Respiratory Distress Syndrome|acute respiratory distress syndrome
349949|NCT02097628|volume controlled ventilation|volume controlled ventilation
349950|NCT02097628|pressure controlled ventilation|pressure controlled ventilation
349951|NCT02097615|soft|soft
349952|NCT02097615|tissue|tissue
349953|NCT02097615|infections|infections
349954|NCT02097602|Reticulated platelets|reticulated platelets
349955|NCT02097602|noncardiac surgery|noncardiac surgery
349957|NCT02097602|major adverse cardiac and cerebrovascular events|major adverse cardiac and cerebrovascular events
349958|NCT02097602|outcome|outcome
349959|NCT02097602|High-risk or intermediate-risk noncardiac surgery|high-risk or intermediate-risk noncardiac surgery
349960|NCT02097589|Health Controls|health controls
349961|NCT02097576|Chronic Rhinosinusitis|chronic rhinosinusitis
349962|NCT02097563|Mood Disorders|mood disorders
349963|NCT02097563|Psychosis|psychosis
349964|NCT02097563|Subthreshold|subthreshold
349965|NCT02097563|Bipolar Disorder|bipolar disorder
349966|NCT02097550|Renal Insufficiency, Chronic|renal insufficiency, chronic
349967|NCT02097550|Kidney Failure, Chronic|kidney failure, chronic
349968|NCT02097550|Self Care|self care
349969|NCT02097550|Consumer Participation|consumer participation
349970|NCT02097550|Patient Participation|patient participation
349971|NCT02097550|Marketing|marketing
349972|NCT02097550|Consumer Health Information|consumer health information
349973|NCT02097511|Drug-drug interaction|drug-drug interaction
349974|NCT02097511|Pharmacokinetics|pharmacokinetics
349975|NCT02097511|Pharmacodynamics|pharmacodynamics
349976|NCT02097498|Simulation|simulation
349977|NCT02097498|Enhance|enhance
349978|NCT02097498|Safety|safety
349979|NCT02097498|Proficiency|proficiency
349980|NCT02097498|Paramedics.|paramedics.
349981|NCT02097498|Airway Management|airway management
349982|NCT02097498|Intubation|intubation
349983|NCT02097459|Breast cancer|breast cancer
349984|NCT02097459|Endocrine therapy|endocrine therapy
349985|NCT02097459|Perimenopausal and recently postmenopausal patients|perimenopausal and recently postmenopausal patients
349986|NCT02097459|Early-stage hormone receptor-positive|early-stage hormone receptor-positive
349987|NCT02097446|cystectomy|cystectomy
349988|NCT02097433|Dacomitinib|dacomitinib
349989|NCT02097433|PF299804|pf299804
349990|NCT02097433|pharmacokinetics|pharmacokinetics
349991|NCT02097433|healthy|healthy
349992|NCT02097433|Chinese|chinese
349993|NCT02097420|Mitral valve|mitral valve
349994|NCT02097381|HIV infection|hiv infection
349995|NCT02097381|GUT|gut
349996|NCT02097381|microbial translocation|microbial translocation
349997|NCT02097381|chronic inflammation|chronic inflammation
349998|NCT02097381|antiretroviral therapy|antiretroviral therapy
349999|NCT02097381|cART|cart
350000|NCT02097381|HAART|haart
350001|NCT02097381|Th17|th17
350002|NCT02097381|Th1|th1
350003|NCT02097381|CD4+|cd4+
350004|NCT02097368|Tongue strength|tongue strength
350005|NCT02097368|neuromuscular|neuromuscular
350006|NCT02097368|swallowing|swallowing
350007|NCT02097355|chronic disease|chronic disease
350008|NCT02097355|patient portal|patient portal
350009|NCT02097355|health information technology|health information technology
350010|NCT02097355|patient provider communication|patient provider communication
350011|NCT02097355|quality improvement|quality improvement
350012|NCT02097342|Type 2 Diabetes Mellitus|type 2 diabetes mellitus
350013|NCT02097342|Insulin sensitivity- hyperinsulinemic euglycemic clamp|insulin sensitivity- hyperinsulinemic euglycemic clamp
350014|NCT02097342|Pancreatic beta cell function|pancreatic beta cell function
350015|NCT02097342|Linagliptin|linagliptin
350016|NCT02097342|Voglibose|voglibose
350017|NCT02097342|Mixed meal test|mixed meal test
350018|NCT02097342|GLP-1 response|glp-1 response
350019|NCT02097329|bioavailability|bioavailability
350020|NCT02097329|antacid|antacid
350021|NCT02097329|rabeprazole|rabeprazole
350022|NCT02097329|famotidine|famotidine
350023|NCT02097329|palbociclib|palbociclib
350024|NCT02097316|Glycemic control|glycemic control
350025|NCT02097316|JewelPump accuracy|jewelpump accuracy
350026|NCT02097303|Prostate Cancer|prostate cancer
350027|NCT02097303|Bone Metastasis|bone metastasis
350028|NCT02097303|Symptomatic|symptomatic
350029|NCT02097303|Androgen Independent|androgen independent
350030|NCT02097303|Hormone Refractory|hormone refractory
350031|NCT02097303|Castrate Resistant|castrate resistant
350032|NCT02097303|AIPC|aipc
350033|NCT02097303|pre-chemotherapy|pre-chemotherapy
350034|NCT02097303|Post-chemotherapy|post-chemotherapy
350035|NCT02097290|Threshold algorithms|threshold algorithms
350036|NCT02097290|CRT-D|crt-d
350037|NCT02097251|Mucopolysaccharidosis Type 7|mucopolysaccharidosis type 7
350038|NCT02097251|Sly syndrome|sly syndrome
350039|NCT02097251|UX003|ux003
350040|NCT02097251|Enzyme Replacement Therapy|enzyme replacement therapy
350041|NCT02097251|rare disease|rare disease
350042|NCT02097251|Lysosomal Storage Disease|lysosomal storage disease
350043|NCT02097251|metabolic disorder|metabolic disorder
776618|NCT00342654|Nutrition|nutrition
447552|NCT01654939|HIV|hiv
350044|NCT02097212|Tracheobronchomalacia|tracheobronchomalacia
350045|NCT02097212|TBM|tbm
350046|NCT02097212|HyperDynamic Airway Collapse|hyperdynamic airway collapse
350047|NCT02097212|HDAC|hdac
350048|NCT02097212|Obstructive Sleep Apnea|obstructive sleep apnea
350049|NCT02097212|OSA|osa
350050|NCT02097199|activity, osteoprotegerin, endocan, atherosclerosis, biomarker|activity, osteoprotegerin, endocan, atherosclerosis, biomarker
350051|NCT02097186|Vascular disease|vascular disease
350052|NCT02097186|Open aortic aneurysm repair|open aortic aneurysm repair
350053|NCT02097186|Endovascular aneurysm repair|endovascular aneurysm repair
350054|NCT02097186|Carotid endartrectomy|carotid endartrectomy
350055|NCT02097186|Lower limb surgical revascularisation|lower limb surgical revascularisation
350056|NCT02097186|Major lower limb amputation|major lower limb amputation
350057|NCT02097160|childhood|childhood
350058|NCT02097160|healthy|healthy
350059|NCT02097160|vitamin D|vitamin d
350060|NCT02097160|bone|bone
350061|NCT02097160|dairy products|dairy products
350062|NCT02097147|Viibryd|viibryd
350063|NCT02097108|HIV infection|hiv infection
350064|NCT02097108|Raltegravir|raltegravir
350065|NCT02097108|Switch|switch
350066|NCT02097108|Hyperlipidemia|hyperlipidemia
350067|NCT02097108|Women|women
350068|NCT02097095|Correlates of risk|correlates of risk
350069|NCT02097095|TB|tb
350070|NCT02097095|Tuberculosis|tuberculosis
350071|NCT02097095|Sub-study|sub-study
350072|NCT02097095|TB-018|tb-018
350073|NCT02097082|Peripheral Arterial Disease|peripheral arterial disease
350074|NCT02097082|Intermittent Claudication|intermittent claudication
350075|NCT02097082|Vascular Diseases|vascular diseases
350076|NCT02097082|Cardiovascular Diseases|cardiovascular diseases
350077|NCT02097082|Superficial Femoral Artery|superficial femoral artery
350078|NCT02097069|Gestational diabetes mellitus|gestational diabetes mellitus
350079|NCT02097069|Myo-inositol|myo-inositol
350080|NCT02097069|D-chiro-inositol|d-chiro-inositol
350081|NCT02097069|Insulin resistance|insulin resistance
350082|NCT02097056|Alzheimer's disease|alzheimer's disease
350083|NCT02097017|lidocaine|lidocaine
350084|NCT02097017|laminaria|laminaria
350085|NCT02097017|dilatation and evacuation|dilatation and evacuation
350086|NCT02097017|pain|pain
350087|NCT02097004|chronic hepatitis B|chronic hepatitis b
350088|NCT02097004|Pegasys|pegasys
350089|NCT02097004|Euvax B|euvax b
350090|NCT02097004|Baracrude|baracrude
350091|NCT02096978|Implant|implant
350092|NCT02096978|Stability|stability
350093|NCT02096978|placement|placement
350094|NCT02096978|Osteotome|osteotome
350095|NCT02096965|Calcium oxalate|calcium oxalate
350096|NCT02096965|Calcium phosphate|calcium phosphate
350097|NCT02096965|Kidney stone|kidney stone
350098|NCT02096952|Attention-deficit/hyperactivity disorder|attention-deficit/hyperactivity disorder
350099|NCT02096952|ADHD|adhd
350100|NCT02096952|Autism spectrum disorder|autism spectrum disorder
350101|NCT02096952|ASD|asd
350102|NCT02096952|High-functioning ASD|high-functioning asd
350103|NCT02096952|Asperger's disorder|asperger's disorder
350104|NCT02096952|Asperger's|asperger's
350105|NCT02096926|Third Molar Extraction|third molar extraction
350106|NCT02096913|Rho-Inhibition|rho-inhibition
350107|NCT02096913|Plasticity|plasticity
350108|NCT02096913|Neurological Function|neurological function
350109|NCT02096913|RhoA|rhoa
350110|NCT02096913|Ibuprofen|ibuprofen
350111|NCT02096913|NSAIDs|nsaids
350112|NCT02096900|Pre-medication|pre-medication
350113|NCT02096900|Pre-operative anxiety|pre-operative anxiety
350114|NCT02096887|education|education
350115|NCT02096887|compliance|compliance
350116|NCT02096887|risk factors|risk factors
350117|NCT02096874|Peripheral retinal ischemia|peripheral retinal ischemia
350118|NCT02096874|ultra wide field fluorescein angiography|ultra wide field fluorescein angiography
350119|NCT02096874|Bevacizumab|bevacizumab
350120|NCT02096848|otitis media|otitis media
350121|NCT02096848|microbiology|microbiology
350122|NCT02096848|vaccines|vaccines
350123|NCT02096835|Postoperative nausea and vomiting|postoperative nausea and vomiting
350124|NCT02096835|Transcutaneous electrical acupoint stimulation|transcutaneous electrical acupoint stimulation
350125|NCT02096835|Gynecological laparoscopic surgery|gynecological laparoscopic surgery
350126|NCT02096835|Tropisetron|tropisetron
350127|NCT02096835|Dexamethasone|dexamethasone
350128|NCT02096822|Facilitated tucking|facilitated tucking
350129|NCT02096822|Non nutritive sucking|non nutritive sucking
350130|NCT02096822|Preterm|preterm
350131|NCT02096822|Pain relief|pain relief
350132|NCT02096809|Bone Conduction|bone conduction
350133|NCT02096809|Hearing loss - conductive|hearing loss - conductive
350134|NCT02096809|Osseointegration|osseointegration
350135|NCT02096809|Prostheses and Implants|prostheses and implants
350136|NCT02096757|Claudication|claudication
350137|NCT02096757|Critical Limb Ischemia|critical limb ischemia
350138|NCT02096757|Endovascular procedure|endovascular procedure
350139|NCT02096757|Atherosclerosis|atherosclerosis
350140|NCT02096679|Phase I, healthy, pharmacokinetics, Mass balance|phase i, healthy, pharmacokinetics, mass balance
350141|NCT02096666|MET Amplified Gastric/ Gastroesophageal Junction/ Esophageal Adenocarcinomas, or other solid tumors|met amplified gastric/ gastroesophageal junction/ esophageal adenocarcinomas, or other solid tumors
350142|NCT02096653|sacroiliac joint|sacroiliac joint
350143|NCT02096653|low back pain|low back pain
350144|NCT02096653|steroid injection|steroid injection
350145|NCT02096627|Cataract, femtosecond laser, FLACS|cataract, femtosecond laser, flacs
350146|NCT02096614|Adoptive cell transfer|adoptive cell transfer
350147|NCT02096614|Cell therapy|cell therapy
350148|NCT02096614|Immunotherapy|immunotherapy
350149|NCT02096614|MAGE-A4|mage-a4
350150|NCT02096614|Esophageal cancer|esophageal cancer
350151|NCT02096614|Melanoma|melanoma
350152|NCT02096614|Head and neck cancer|head and neck cancer
350153|NCT02096614|Ovarian cancer|ovarian cancer
350154|NCT02096614|TCR gene therapy|tcr gene therapy
350155|NCT02096601|Motor fluctuations|motor fluctuations
350156|NCT02096601|levodopa pharmacokinetics|levodopa pharmacokinetics
350157|NCT02096601|levodopa and carbidopa solution|levodopa and carbidopa solution
350158|NCT02096601|continuous subcutaneous delivery|continuous subcutaneous delivery
350159|NCT02096588|Breast cancer|breast cancer
350160|NCT02096588|Adriamycin|adriamycin
350161|NCT02096588|Simvastatin|simvastatin
350162|NCT02096588|Statin|statin
350163|NCT02096588|Echocardiogram|echocardiogram
350164|NCT02096575|nitrous oxide|nitrous oxide
350165|NCT02096575|pain|pain
350166|NCT02096562|knee welling outpatient compression stockings|knee welling outpatient compression stockings
350167|NCT02096549|cerebral palsy|cerebral palsy
350168|NCT02096549|Botulinum toxin|botulinum toxin
350169|NCT02096549|Propofol|propofol
350170|NCT02096549|Deep sedation|deep sedation
350171|NCT02096549|Bispectral index monitor|bispectral index monitor
350172|NCT02096536|Neonate|neonate
350173|NCT02096536|Vancomycin|vancomycin
350174|NCT02096536|LC/MS-MS|lc/ms-ms
350175|NCT02096536|protein binding|protein binding
350176|NCT02096523|inherited platelet disorders|inherited platelet disorders
350177|NCT02096523|proteome|proteome
350178|NCT02096510|Addison Disease|addison disease
350179|NCT02096510|Adrenal Hyperplasia Congenital|adrenal hyperplasia congenital
350180|NCT02096484|Metacognitive therapy|metacognitive therapy
350181|NCT02096484|mindfulness meditation therapy|mindfulness meditation therapy
350182|NCT02096484|group therapy|group therapy
350183|NCT02096484|generalized anxiety disorder|generalized anxiety disorder
350184|NCT02096484|Group Based Metacognitive Therapy|group based metacognitive therapy
350185|NCT02096484|Group Based Mindfulness Meditation Therapy|group based mindfulness meditation therapy
350186|NCT02096471|Neurofibromatosis Type 1 (Neurofibromas)|neurofibromatosis type 1 (neurofibromas)
350187|NCT02096471|PD-0325901|pd-0325901
350188|NCT02096471|Radiographic Response|radiographic response
350189|NCT02096471|Inoperable Plexiform Neurofibromas|inoperable plexiform neurofibromas
350190|NCT02096458|Drug therapy|drug therapy
350191|NCT02096445|stroke|stroke
350192|NCT02096445|acute|acute
350193|NCT02096445|rehabilitation|rehabilitation
350194|NCT02096445|robot therapy|robot therapy
350195|NCT02096445|hand function|hand function
350196|NCT02096445|fine motor skills|fine motor skills
350197|NCT02096445|neurocognitive|neurocognitive
350198|NCT02096445|sensory|sensory
350199|NCT02096445|Perfetti|perfetti
350200|NCT02096445|haptics|haptics
350201|NCT02096419|clopidogrel|clopidogrel
350202|NCT02096419|platelet reactivity|platelet reactivity
350203|NCT02096419|acute coronary syndrome|acute coronary syndrome
350204|NCT02096419|tailoring therapy|tailoring therapy
350205|NCT02096419|outcome|outcome
350206|NCT02096406|Coronary artery disease|coronary artery disease
350207|NCT02096406|Coronary artery bypass grafting|coronary artery bypass grafting
350208|NCT02096406|angiotensin converting enzyme inhibitor|angiotensin converting enzyme inhibitor
350209|NCT02096406|angiotensin receptor blocker|angiotensin receptor blocker
350210|NCT02096406|Surgical valve repair|surgical valve repair
350211|NCT02096406|Valve Replacement|valve replacement
350212|NCT02096380|Nasopharyngeal Carcinoma|nasopharyngeal carcinoma
350213|NCT02096380|cycle|cycle
350214|NCT02096380|induction chemotherapy|induction chemotherapy
350215|NCT02096380|docetaxel|docetaxel
350216|NCT02096367|vibrations|vibrations
350217|NCT02096367|stroke|stroke
350218|NCT02096367|posture|posture
350219|NCT02096367|gait|gait
350220|NCT02096367|readaptation|readaptation
350221|NCT02096328|Ventilator Associated Pneumonia (VAP)|ventilator associated pneumonia (vap)
350222|NCT02096328|Lower respiratory infection|lower respiratory infection
350223|NCT02096328|POL7080|pol7080
350224|NCT02096328|Pseudomonas aeruginosa|pseudomonas aeruginosa
350225|NCT02096328|Nosocomial pneumonia|nosocomial pneumonia
350226|NCT02096315|POL7080|pol7080
350227|NCT02096315|Pseudomonas aeruginosa|pseudomonas aeruginosa
350228|NCT02096315|Non cystic fibrosis bronchiectasis|non cystic fibrosis bronchiectasis
350229|NCT02096315|Exacerbation|exacerbation
350230|NCT02096302|Probiotics|probiotics
350231|NCT02096302|Infant Formula|infant formula
350232|NCT02096302|Microbiota|microbiota
350233|NCT02096302|Bifidobacterium longum biovar infantis CECT7210|bifidobacterium longum biovar infantis cect7210
350234|NCT02096302|Growth|growth
350235|NCT02096289|Relapsed Acute Myeloid Leukemia|relapsed acute myeloid leukemia
350236|NCT02096289|Refractory Acute Myeloid Leukemia|refractory acute myeloid leukemia
350237|NCT02096289|Thioridazine|thioridazine
350238|NCT02096289|Phase I|phase i
350239|NCT02096289|Clinical Trial|clinical trial
350240|NCT02096276|Pregnancy Registry|pregnancy registry
350241|NCT02096276|Boostrix|boostrix
350242|NCT02096276|Women|women
350243|NCT02096276|Cohort|cohort
350244|NCT02096276|Prospective|prospective
350245|NCT02096276|Pregnancy outcome|pregnancy outcome
350246|NCT02096276|Exploratory|exploratory
350247|NCT02096263|Infants|infants
350248|NCT02096263|Safety|safety
350249|NCT02096263|Healthy|healthy
350250|NCT02096263|Infanrix Hexa|infanrix hexa
350251|NCT02096263|Immunogenicity|immunogenicity
350252|NCT02096237|asthma, bronchial|asthma, bronchial
350253|NCT02096237|immunoadsorbents|immunoadsorbents
350254|NCT02096237|apheresis|apheresis
350255|NCT02096237|immunoglobulin E|immunoglobulin e
350256|NCT02096211|Total hip replacement|total hip replacement
350257|NCT02096211|Total hip arthroplasty|total hip arthroplasty
350258|NCT02096211|Hip joint replacement|hip joint replacement
350259|NCT02096211|Hip prosthesis replacement|hip prosthesis replacement
350260|NCT02096198|Total Hip Replacement|total hip replacement
350261|NCT02096198|Total Hip Arthroplasty|total hip arthroplasty
350262|NCT02096198|Hip Joint Replacement|hip joint replacement
350263|NCT02096198|Hip Prosthesis Replacement|hip prosthesis replacement
350264|NCT02096185|Breast cancer|breast cancer
350265|NCT02096185|Surgery|surgery
350266|NCT02096185|Specimen imaging|specimen imaging
350267|NCT02096159|Hypospadias|hypospadias
350268|NCT02096159|Anti-Bacterial Agents|anti-bacterial agents
350269|NCT02096146|Plate|plate
350270|NCT02096146|Hallux valgus|hallux valgus
350271|NCT02096146|Foot deformity|foot deformity
350272|NCT02096146|Screw|screw
350273|NCT02096146|Tarsometatarsal angle|tarsometatarsal angle
350274|NCT02096146|Cost effectiveness|cost effectiveness
350275|NCT02096133|Multiple sclerosis, vitamin D, HPA-axis, cortisol|multiple sclerosis, vitamin d, hpa-axis, cortisol
350276|NCT02096120|Periodontitis|periodontitis
350277|NCT02096107|Everolimus|everolimus
350278|NCT02096107|Graft dysfunction|graft dysfunction
350279|NCT02096107|Interstitial fibrosis|interstitial fibrosis
350280|NCT02096094|Antiseptics|antiseptics
350281|NCT02096094|Administration cutaneously|administration cutaneously
350282|NCT02096094|Chlorine compounds|chlorine compounds
350283|NCT02096094|Infection control|infection control
350284|NCT02096094|Anti-infecting agents, local|anti-infecting agents, local
350285|NCT02096081|Glabellar Frown Lines|glabellar frown lines
350286|NCT02096081|Frown Lines|frown lines
350287|NCT02096081|Facial Wrinkles|facial wrinkles
350288|NCT02096068|Neuroprotection|neuroprotection
350289|NCT02096042|Leukemia|leukemia
350290|NCT02096042|Acute Myeloid Leukemia|acute myeloid leukemia
350292|NCT02096042|CD30-Positive|cd30-positive
350293|NCT02096042|Relapsed|relapsed
350294|NCT02096042|Refractory|refractory
350295|NCT02096042|Brentuximab Vedotin|brentuximab vedotin
350296|NCT02096042|SGN-35|sgn-35
350297|NCT02096042|Adcetris|adcetris
350298|NCT02096042|5-Azacytidine|5-azacytidine
350299|NCT02096042|Azacytidine|azacytidine
350300|NCT02096042|Azacitidine|azacitidine
350301|NCT02096042|5-aza|5-aza
350302|NCT02096042|Vidaza|vidaza
350303|NCT02096042|5-AZC|5-azc
350304|NCT02096042|AZA-CR|aza-cr
350305|NCT02096042|Ladakamycin|ladakamycin
350306|NCT02096042|NSC-102816|nsc-102816
350307|NCT02096029|smoking|smoking
350308|NCT02096029|smoking cessation|smoking cessation
350309|NCT02096029|nicotine replacement therapy|nicotine replacement therapy
350310|NCT02096029|primary care|primary care
350311|NCT02096029|comparative effectiveness|comparative effectiveness
350312|NCT02096016|Surveillance|surveillance
350313|NCT02096016|Follow up|follow up
350314|NCT02096003|Intrathecal hydromorphone|intrathecal hydromorphone
350315|NCT02096003|Intrathecal morphine|intrathecal morphine
350316|NCT02096003|Primary cesarean section|primary cesarean section
350317|NCT02096003|Analgesia|analgesia
350318|NCT02095990|Facial Melasma|facial melasma
350319|NCT02095977|St. Jude Riata lead failure|st. jude riata lead failure
350320|NCT02095977|implantable cardioverter-defibrillator (ICD)|implantable cardioverter-defibrillator (icd)
350321|NCT02095977|externalized conductors|externalized conductors
350322|NCT02095977|ventricular tachyarrythmia|ventricular tachyarrythmia
350323|NCT02095977|electrophysiology|electrophysiology
350324|NCT02095964|cardiac syndrome X|cardiac syndrome x
350325|NCT02095964|inflammation|inflammation
350326|NCT02095964|dyslipidemia|dyslipidemia
350327|NCT02095938|schizophrenia|schizophrenia
350328|NCT02095938|brain structure|brain structure
350329|NCT02095938|treatment response|treatment response
350330|NCT02095938|solian|solian
350331|NCT02095938|gene|gene
350333|NCT02095912|Squamous Cell Carcinoma|squamous cell carcinoma
350334|NCT02095899|Thoracic Surgical Procedures|thoracic surgical procedures
350335|NCT02095873|Oral glucose tolerance test|oral glucose tolerance test
350336|NCT02095873|Flow mediated dilatation|flow mediated dilatation
350337|NCT02095873|Aortal pulse wave velocity|aortal pulse wave velocity
350338|NCT02095873|Finger-fold capillary density by capillaroscopy|finger-fold capillary density by capillaroscopy
350339|NCT02095847|Uterine Cancer|uterine cancer
350340|NCT02095847|Endometrial cancer|endometrial cancer
350341|NCT02095847|Hysterectomy|hysterectomy
350342|NCT02095847|Hysteroscopy|hysteroscopy
350343|NCT02095847|High-resolution microendoscopy|high-resolution microendoscopy
350344|NCT02095847|HRME|hrme
350345|NCT02095847|Hysteroscopic-guided resection|hysteroscopic-guided resection
350346|NCT02095847|Proflavine|proflavine
350347|NCT02095795|Exercise Therapy|exercise therapy
350348|NCT02095782|non-small cell lung cancer|non-small cell lung cancer
350349|NCT02095782|erlotinib|erlotinib
350350|NCT02095782|chemotherapy|chemotherapy
350351|NCT02095769|Pharmacogenomics|pharmacogenomics
350352|NCT02095769|Adverse Drug Reactions|adverse drug reactions
350353|NCT02095743|Early breast cancer|early breast cancer
350354|NCT02095743|Chemotherapy|chemotherapy
350355|NCT02095743|PICC line|picc line
350356|NCT02095743|Implanted port|implanted port
350357|NCT02095730|crosslinking|crosslinking
350358|NCT02095730|cornea|cornea
350359|NCT02095730|keratoconus|keratoconus
350360|NCT02095730|ectasia|ectasia
350361|NCT02095730|irradiance|irradiance
350362|NCT02095730|riboflavin|riboflavin
350363|NCT02095691|Renal Sympathetic Denervation|renal sympathetic denervation
350364|NCT02095678|Hepatocellular Carcinoma|hepatocellular carcinoma
350365|NCT02095678|Hepatoma|hepatoma
350366|NCT02095678|Liver Cancer, Adult|liver cancer, adult
350367|NCT02095678|Liver Cell Carcinoma|liver cell carcinoma
350368|NCT02095678|Liver Cell Carcinoma, Adult|liver cell carcinoma, adult
350370|NCT02095665|ureteric stents|ureteric stents
350371|NCT02095665|LUTS|luts
350372|NCT02095665|lower urinary tract symptoms|lower urinary tract symptoms
350373|NCT02095626|Peptide|peptide
350374|NCT02095587|Phase 1|phase 1
350375|NCT02095587|hepatic impairment|hepatic impairment
350376|NCT02095574|GDC-0199|gdc-0199
350377|NCT02095574|ADME|adme
350378|NCT02095574|Relapsed|relapsed
350379|NCT02095574|Refractory|refractory
350380|NCT02095574|ABT-199|abt-199
350381|NCT02095574|Non-Hodgkin's Lymphoma|non-hodgkin's lymphoma
350382|NCT02095561|HPV self testing|hpv self testing
350383|NCT02095561|screening uptake|screening uptake
350384|NCT02095561|cervical cáncer|cervical cáncer
350385|NCT02095561|cervical intraepithelial neoplasia|cervical intraepithelial neoplasia
350386|NCT02095535|obstetric patients|obstetric patients
350387|NCT02095535|chloraprep|chloraprep
350388|NCT02095535|chlorhexidine|chlorhexidine
350389|NCT02095535|drying time|drying time
350390|NCT02095522|colchicine NSTEMI endothelial function inflammation|colchicine nstemi endothelial function inflammation
350391|NCT02095496|sleep|sleep
350392|NCT02095496|intensive care|intensive care
350393|NCT02095496|mechanical ventilation|mechanical ventilation
350394|NCT02095470|Laryngoscopy|laryngoscopy
350395|NCT02095470|Equipment|equipment
350396|NCT02095470|Video Laryngoscope|video laryngoscope
350397|NCT02095457|Routine Outcome Monitoring|routine outcome monitoring
350398|NCT02095457|Psychotherapy|psychotherapy
350399|NCT02095457|Alliance|alliance
350400|NCT02095457|Feedback Informed Treatment|feedback informed treatment
350401|NCT02095457|Mental Health Outpatients|mental health outpatients
350402|NCT02095431|patients undergoing the liver transplantation|patients undergoing the liver transplantation
350403|NCT02095431|acute kidney injury|acute kidney injury
350404|NCT02095418|New-onset diabetes after transplantation (NODAT)|new-onset diabetes after transplantation (nodat)
350405|NCT02095418|Liver transplantation|liver transplantation
350406|NCT02095405|Supraventricular Tachycardia|supraventricular tachycardia
350407|NCT02095405|Atrial Fibrillation|atrial fibrillation
350408|NCT02095405|Electrophysiology Study|electrophysiology study
350409|NCT02095405|Programmed Electrical Stimulation|programmed electrical stimulation
350410|NCT02095392|soluble phosphate|soluble phosphate
350411|NCT02095392|phosphorus metabolism|phosphorus metabolism
350412|NCT02095392|calcium metabolism|calcium metabolism
350413|NCT02095392|bone metabolism|bone metabolism
350414|NCT02095392|human study|human study
350415|NCT02095379|oligosecretary multiple myeloma|oligosecretary multiple myeloma
350416|NCT02095366|Acute Pain|acute pain
350417|NCT02095366|Traumatic Pain|traumatic pain
350418|NCT02095366|Emergency setting|emergency setting
350419|NCT02095366|Prehospital setting|prehospital setting
350420|NCT02095366|Analgesia|analgesia
350421|NCT02095366|Intranasal device|intranasal device
350422|NCT02095366|Intra veinous injection|intra veinous injection
350423|NCT02095366|Sufentanil citrate|sufentanil citrate
350424|NCT02095366|Morphine Sulfate|morphine sulfate
350425|NCT02095353|Brain tumor|brain tumor
350426|NCT02095353|extraaxial|extraaxial
350427|NCT02095353|metastasis|metastasis
350428|NCT02095353|glioma|glioma
350429|NCT02095353|primary brain tumor|primary brain tumor
350430|NCT02095353|secondary brain tumor|secondary brain tumor
350431|NCT02095353|MRI|mri
350432|NCT02095353|perfusion|perfusion
776619|NCT00342641|Lymphoma|lymphoma
350433|NCT02095353|dynamic contrast enhancement|dynamic contrast enhancement
350434|NCT02095353|CBV|cbv
350435|NCT02095353|CBF|cbf
350436|NCT02095353|ktrans|ktrans
350437|NCT02095314|DTP-HB-Hib|dtp-hb-hib
350438|NCT02095314|Pentavalen|pentavalen
350439|NCT02095314|Pentabio|pentabio
350440|NCT02095314|Booster|booster
350441|NCT02095288|lipidomics|lipidomics
350442|NCT02095288|in vitro human whole blood assay|in vitro human whole blood assay
350443|NCT02095288|anti-inflammatory drugs|anti-inflammatory drugs
350444|NCT02095288|Lipidomics screening of anti-inflammatory drugs|lipidomics screening of anti-inflammatory drugs
350445|NCT02095275|BNP, acute kidney injury, fluid status|bnp, acute kidney injury, fluid status
350446|NCT02095249|prostate cancer|prostate cancer
350447|NCT02095249|radical prostatectomy|radical prostatectomy
350448|NCT02095223|Knee injury|knee injury
350449|NCT02095223|Meniscus injury|meniscus injury
350450|NCT02095223|Anterior cruciate ligament injury|anterior cruciate ligament injury
350451|NCT02095223|Knee ligament injury|knee ligament injury
350452|NCT02095210|PET scan|pet scan
350453|NCT02095210|HER2|her2
350454|NCT02095210|breast cancer|breast cancer
350455|NCT02095184|Breast Cancer|breast cancer
350456|NCT02095184|Postmenopausal|postmenopausal
350457|NCT02095184|Hormone-Receptor Positive|hormone-receptor positive
350458|NCT02095119|Uterine cervical cancer|uterine cervical cancer
350459|NCT02095119|Palliative|palliative
350460|NCT02095119|Treatment|treatment
350461|NCT02095119|Monoclonal antibody|monoclonal antibody
350462|NCT02095119|Nimotuzumab|nimotuzumab
350463|NCT02095106|forearm fractures|forearm fractures
350464|NCT02095106|pediatric fractures|pediatric fractures
350465|NCT02095106|distal radius|distal radius
350466|NCT02095093|Total Hip Arthroplasty|total hip arthroplasty
350467|NCT02095093|Navigation|navigation
350468|NCT02095093|Imageless|imageless
350469|NCT02095093|THA|tha
350470|NCT02095093|Computer navigated|computer navigated
350471|NCT02095080|Leucine|leucine
350472|NCT02095080|Upper Intake Level (UL)|upper intake level (ul)
350473|NCT02095080|Elderly|elderly
350474|NCT02095080|Amino acids|amino acids
350475|NCT02095080|Protein|protein
350476|NCT02095067|Telemedicine|telemedicine
350477|NCT02095067|Emergency medical dispatch|emergency medical dispatch
350478|NCT02095067|Prehospital care|prehospital care
350479|NCT02095067|Video conference|video conference
350480|NCT02095054|Advanced Cancers|advanced cancers
350481|NCT02095054|Advanced malignancy|advanced malignancy
350482|NCT02095054|Metastatic cancer|metastatic cancer
350483|NCT02095054|Advanced solid tumor|advanced solid tumor
350484|NCT02095054|Regorafenib|regorafenib
350485|NCT02095054|Stivarga|stivarga
350486|NCT02095054|Cetuximab|cetuximab
350487|NCT02095054|C225|c225
350488|NCT02095054|Erbitux|erbitux
350489|NCT02095054|IMC-C225|imc-c225
350490|NCT02095054|MOAB C225|moab c225
350491|NCT02095054|Questionnaire|questionnaire
350492|NCT02095054|Survey|survey
350493|NCT02095041|Oxygen saturation.|oxygen saturation.
350494|NCT02095041|Term infants.|term infants.
350495|NCT02095041|Saturation trend.|saturation trend.
350496|NCT02095041|Histogram.|histogram.
350497|NCT02095041|Public health nurse.|public health nurse.
350498|NCT02095041|congenital heart disease screening.|congenital heart disease screening.
350499|NCT02095015|MPS II|mps ii
350500|NCT02095015|iduronate-2-sulfatase|iduronate-2-sulfatase
350501|NCT02095015|Mucopolysaccharidosis VI|mucopolysaccharidosis vi
350502|NCT02095015|MPS|mps
350503|NCT02095015|MPS VI|mps vi
350504|NCT02095015|ear, nose and throat|ear, nose and throat
350505|NCT02095015|Mucopolysaccharidosis II|mucopolysaccharidosis ii
350506|NCT02095015|Hunter syndrome|hunter syndrome
350507|NCT02095015|ENT|ent
350508|NCT02095015|Mucopolysaccharidosis I|mucopolysaccharidosis i
350509|NCT02095015|Hurler, Hurler-Scheie, or Scheie syndrome|hurler, hurler-scheie, or scheie syndrome
350510|NCT02095015|Mucopolysaccharidosis|mucopolysaccharidosis
350511|NCT02095015|MPS I|mps i
350512|NCT02095015|Maroteaux-Lamy syndrome|maroteaux-lamy syndrome
350513|NCT02095002|modified valsalva maneuver, internal jugular vein|modified valsalva maneuver, internal jugular vein
350514|NCT02094989|electrocardiogram|electrocardiogram
350515|NCT02094989|vectorcardiogram|vectorcardiogram
350516|NCT02094989|telecardiology|telecardiology
350517|NCT02094989|linear regression|linear regression
350518|NCT02094989|individual transformation matrix|individual transformation matrix
350519|NCT02094989|posture|posture
350520|NCT02094976|Prone position|prone position
350647|NCT02094352|Pain management|pain management
350521|NCT02094976|Intra-abdominal pressure|intra-abdominal pressure
350522|NCT02094976|Respiratory system compliance|respiratory system compliance
350523|NCT02094976|Jackson table|jackson table
350524|NCT02094976|Wilson frame|wilson frame
350525|NCT02094976|Chest roll|chest roll
350526|NCT02094963|acute coronary syndrome|acute coronary syndrome
350527|NCT02094963|coronary disease|coronary disease
350528|NCT02094963|coronary artery disease|coronary artery disease
350529|NCT02094950|concurrent chemotherapy|concurrent chemotherapy
350530|NCT02094950|concurrent radiation|concurrent radiation
350531|NCT02094937|fluticasone propionate|fluticasone propionate
350532|NCT02094937|step-down regimen|step-down regimen
350533|NCT02094937|well-controlled subjects|well-controlled subjects
350534|NCT02094937|adults|adults
350535|NCT02094937|switching regimen|switching regimen
350536|NCT02094937|asthma|asthma
350537|NCT02094937|fluticasone furoate|fluticasone furoate
350538|NCT02094937|fluticasone furoate/Vilanterol|fluticasone furoate/vilanterol
350539|NCT02094924|Candesartan cilexetil|candesartan cilexetil
350540|NCT02094924|Hypertension|hypertension
350541|NCT02094924|Hydrochlorothiazide|hydrochlorothiazide
350542|NCT02094924|Healthy adult human subjects|healthy adult human subjects
350543|NCT02094924|Bioequivalence|bioequivalence
350544|NCT02094911|Prevention|prevention
350545|NCT02094911|Combined lifestyle intervention|combined lifestyle intervention
350546|NCT02094911|Primary health care|primary health care
350547|NCT02094898|Depression|depression
350548|NCT02094898|Unipolar|unipolar
350549|NCT02094898|Bipolar|bipolar
350550|NCT02094898|Suicidal|suicidal
350551|NCT02094859|Glucose Monitoring|glucose monitoring
350552|NCT02094846|Cellular phones|cellular phones
350553|NCT02094846|Type 2 diabetes|type 2 diabetes
350554|NCT02094846|Glycated hemoglobin|glycated hemoglobin
350555|NCT02094846|glycemic control|glycemic control
350556|NCT02094833|Diphtheria|diphtheria
350557|NCT02094833|Tetanus|tetanus
350558|NCT02094833|Pertussis|pertussis
350559|NCT02094833|Haemophilus influenzae type b infection|haemophilus influenzae type b infection
350560|NCT02094833|Hepatitis B|hepatitis b
350561|NCT02094833|DTaP-IPV-Hep - PRP-T vaccine|dtap-ipv-hep - prp-t vaccine
350562|NCT02094807|prospective study|prospective study
350563|NCT02094807|surgical management|surgical management
350564|NCT02094807|rib fractures|rib fractures
350565|NCT02094807|trauma|trauma
350566|NCT02094755|ASA-PLAVIX Reactivity in CLI|asa-plavix reactivity in cli
350567|NCT02094742|screening program|screening program
350568|NCT02094742|metastatic breast cancer|metastatic breast cancer
350569|NCT02094742|molecular profile|molecular profile
350570|NCT02094742|gene sequencing|gene sequencing
350571|NCT02094729|mild cognitive impairment|mild cognitive impairment
350572|NCT02094729|Alzheimer's disease|alzheimer's disease
350573|NCT02094716|Sarcoptes|sarcoptes
350574|NCT02094716|Scabiei|scabiei
350575|NCT02094716|Scabies|scabies
350576|NCT02094716|ectoparasite|ectoparasite
350577|NCT02094716|parasite|parasite
350578|NCT02094716|infestation|infestation
350579|NCT02094716|Renaissance|renaissance
350580|NCT02094703|female|female
350581|NCT02094703|age 18-65 years|age 18-65 years
350582|NCT02094703|storage symptoms|storage symptoms
350583|NCT02094703|clinical urinary tract infection|clinical urinary tract infection
350584|NCT02094703|non complicated|non complicated
350585|NCT02094690|head and neck neoplasms|head and neck neoplasms
350586|NCT02094690|radiotherapy|radiotherapy
350587|NCT02094690|physical therapy|physical therapy
350588|NCT02094690|trismus|trismus
350589|NCT02094664|Heat|heat
350590|NCT02094664|Humidification|humidification
350591|NCT02094664|Oxygen|oxygen
350592|NCT02094651|Abnormal EEGs|abnormal eegs
350593|NCT02094638|Traditional Chinese Medicine Injection|traditional chinese medicine injection
350594|NCT02094625|Cisplatin|cisplatin
350595|NCT02094625|N-acetylcysteine|n-acetylcysteine
350596|NCT02094625|Hearing Loss|hearing loss
350597|NCT02094625|Otoprotection|otoprotection
350598|NCT02094612|Attention Deficit and Disruptive Behavior Disorders|attention deficit and disruptive behavior disorders
350599|NCT02094612|Attention Deficit Disorder with Hyperactivity|attention deficit disorder with hyperactivity
350600|NCT02094612|Pediatrics|pediatrics
350601|NCT02094612|Patient Outcome Assessment|patient outcome assessment
350602|NCT02094573|Drug Therapy|drug therapy
350603|NCT02094560|therapy refractory|therapy refractory
350604|NCT02094560|endstage|endstage
350605|NCT02094560|solid tumours|solid tumours
350606|NCT02094547|Infant Formula|infant formula
350607|NCT02094547|Cognition|cognition
350608|NCT02094547|Neurodevelopment|neurodevelopment
350609|NCT02094547|Immunity|immunity
350610|NCT02094547|Microbiota|microbiota
350611|NCT02094534|Diabetes type 1|diabetes type 1
350612|NCT02094534|Oral Insulin|oral insulin
350613|NCT02094534|Safety|safety
350614|NCT02094534|Tolerability|tolerability
350615|NCT02094534|Phase 2a|phase 2a
350616|NCT02094534|Randomized|randomized
350617|NCT02094534|Blinded|blinded
350618|NCT02094534|Parallel|parallel
350619|NCT02094508|Parasitemia|parasitemia
350620|NCT02094508|HIV-Exposed|hiv-exposed
350621|NCT02094508|HIV-Unexposed|hiv-unexposed
350622|NCT02094508|Liver Stage|liver stage
350623|NCT02094508|Randomized|randomized
350624|NCT02094495|Tamoxifen|tamoxifen
350625|NCT02094495|Breast cancer|breast cancer
350626|NCT02094495|Knowkedge|knowkedge
350627|NCT02094469|Treatment for vasospastic angina|treatment for vasospastic angina
350628|NCT02094456|diverticular disease|diverticular disease
350629|NCT02094456|diverticular bleeding|diverticular bleeding
350630|NCT02094456|endoscopic clipping|endoscopic clipping
350631|NCT02094456|endoscopy|endoscopy
350632|NCT02094456|lower gastrointestinal bleeding|lower gastrointestinal bleeding
350633|NCT02094443|Chronic hepatitis C genotype 2|chronic hepatitis c genotype 2
350634|NCT02094443|Chronic hepatitis C genotype 3|chronic hepatitis c genotype 3
350635|NCT02094443|Cyclophilin inhibitor|cyclophilin inhibitor
350636|NCT02094443|Interferon intolerant|interferon intolerant
350637|NCT02094417|Anemia, Aplastic|anemia, aplastic
350638|NCT02094417|Thrombopoietin|thrombopoietin
350639|NCT02094417|Thrombocytopenia|thrombocytopenia
350640|NCT02094404|Emergency Department|emergency department
350641|NCT02094404|Pediatric Early Warning Score|pediatric early warning score
350642|NCT02094404|Manchester Triage System|manchester triage system
350643|NCT02094378|Healthy|healthy
350644|NCT02094378|Esketamine|esketamine
350645|NCT02094378|Cognitive functioning|cognitive functioning
350646|NCT02094352|Complex Regional Pain Syndrome|complex regional pain syndrome
350648|NCT02094352|Ketamine infusion|ketamine infusion
350649|NCT02094339|Local analgesia system|local analgesia system
350650|NCT02094339|Ropivacaine|ropivacaine
350651|NCT02094339|Analgesic efficacy after operation|analgesic efficacy after operation
350652|NCT02094339|Postoperative|postoperative
350653|NCT02094313|Atorvastatin|atorvastatin
350654|NCT02094313|Human Spermatozoa|human spermatozoa
350655|NCT02094313|Seminal fluid|seminal fluid
350656|NCT02094313|Accessory Glands|accessory glands
350657|NCT02094313|Cholesterol|cholesterol
350658|NCT02094313|Gonadotropins,|gonadotropins,
350659|NCT02094313|Testosterone|testosterone
350660|NCT02094300|Aorta|aorta
350661|NCT02094300|Thoracic|thoracic
350662|NCT02094300|Aortic dissection|aortic dissection
350663|NCT02094300|Rupture|rupture
350664|NCT02094300|Type B|type b
350665|NCT02094300|DeBakey type III|debakey type iii
350666|NCT02094300|Endovascular|endovascular
350667|NCT02094261|Phase II, open label study; safety and efficacy of AZD9291; diagnosis of Epidermal Growth Factor Receptor mutation positive and T790M mutation positive NSCLC|phase ii, open label study; safety and efficacy of azd9291; diagnosis of epidermal growth factor receptor mutation positive and t790m mutation positive nsclc
350668|NCT02094235|Dermatitis|dermatitis
350669|NCT02094235|Atopic|atopic
350670|NCT02094235|Pediatric|pediatric
350671|NCT02094235|Adolescent|adolescent
350672|NCT02094235|Child|child
350673|NCT02094209|External Fixation|external fixation
350674|NCT02094209|Tibial fracture|tibial fracture
350675|NCT02094209|Fracture healing|fracture healing
350676|NCT02094196|Reward- based learning|reward- based learning
350677|NCT02094196|Pavlovian-to-instrumental transfer|pavlovian-to-instrumental transfer
350678|NCT02094196|Relapse Risk|relapse risk
350679|NCT02094196|Positron emission tomography (PET)|positron emission tomography (pet)
350680|NCT02094196|Magnetic resonance spectroscopy (MRS)|magnetic resonance spectroscopy (mrs)
350681|NCT02094196|Dopamine receptor availability|dopamine receptor availability
350682|NCT02094196|Glutamate|glutamate
350683|NCT02094157|Atrial fibrillation|atrial fibrillation
350684|NCT02094157|Mechanical heart valve|mechanical heart valve
350685|NCT02094157|Stroke|stroke
350686|NCT02094157|Venous thromboembolism|venous thromboembolism
350687|NCT02094157|Hemorrhage|hemorrhage
350688|NCT02094144|Sedentary|sedentary
350689|NCT02094144|Physical activity|physical activity
350690|NCT02094144|Brisk walking|brisk walking
350691|NCT02094144|Postmenopausal women|postmenopausal women
350692|NCT02094144|Body composition|body composition
350693|NCT02094144|Balance|balance
350694|NCT02094144|Muscle strength|muscle strength
350695|NCT02094144|Depression, bone density|depression, bone density
350696|NCT02094144|Nutrition|nutrition
350697|NCT02094144|Biological effects|biological effects
350698|NCT02094131|incentive spirometry|incentive spirometry
350699|NCT02094131|flow-oriented spirometer|flow-oriented spirometer
350700|NCT02094131|volume-oriented spirometer|volume-oriented spirometer
350701|NCT02094131|physical therapy|physical therapy
350702|NCT02094131|respiratory muscle training|respiratory muscle training
350703|NCT02094118|Transfusion|transfusion
350704|NCT02094118|RBC|rbc
350705|NCT02094118|cardiac|cardiac
350706|NCT02094118|surgery|surgery
350707|NCT02094118|transfusion related acute lung injury (TRALI)|transfusion related acute lung injury (trali)
350708|NCT02094118|transfusion associated circulatory overload (TACO)|transfusion associated circulatory overload (taco)
350709|NCT02094105|esophageal cancer|esophageal cancer
350710|NCT02094105|screening|screening
350711|NCT02094105|endoscopy|endoscopy
350712|NCT02094105|prevention|prevention
350713|NCT02094092|L.reuteri ProTectis DSM 17938|l.reuteri protectis dsm 17938
350714|NCT02094092|Infantile colic|infantile colic
350715|NCT02094092|Maternal mental health.|maternal mental health.
350716|NCT02094092|Infant crying/fussing|infant crying/fussing
350717|NCT02094092|Edinburgh Postnatal Depression Scale (EPDS)|edinburgh postnatal depression scale (epds)
350718|NCT02094079|hypothyroidism|hypothyroidism
350719|NCT02094079|pregnancy|pregnancy
350720|NCT02094066|tranexamic acid|tranexamic acid
350721|NCT02094066|total hip arthroplasty|total hip arthroplasty
350722|NCT02094053|Down syndrome|down syndrome
350723|NCT02094053|regression symptoms|regression symptoms
712559|NCT00579709|Immunodeficiency|immunodeficiency
448457|NCT01650649|ECG|ecg
350724|NCT02094053|disabled activities of daily living|disabled activities of daily living
350725|NCT02094040|frailty|frailty
350726|NCT02094040|readmission|readmission
350727|NCT02094040|transition|transition
350728|NCT02094040|discharge|discharge
350729|NCT02094040|primary care|primary care
350730|NCT02094027|Obesity|obesity
350731|NCT02094027|Bariatric surgery|bariatric surgery
350732|NCT02094027|Binge eating|binge eating
350733|NCT02094027|Self help|self help
350734|NCT02094014|Perceptual masking|perceptual masking
350735|NCT02094014|Auditory stimulation|auditory stimulation
350736|NCT02094014|Speech|speech
350737|NCT02094014|Language|language
350738|NCT02094014|Verbal Fluency Disorders|verbal fluency disorders
350739|NCT02093962|TH-302|th-302
350740|NCT02093962|TH-CR-415|th-cr-415
350741|NCT02093962|Pemetrexed|pemetrexed
350742|NCT02093962|Non-small cell lung cancer|non-small cell lung cancer
350743|NCT02093962|Lung cancer|lung cancer
350744|NCT02093962|Evofosfamide|evofosfamide
350745|NCT02093936|airway inflammation|airway inflammation
350746|NCT02093936|induced sputum|induced sputum
350747|NCT02093936|normal values|normal values
350748|NCT02093936|lymphocyte|lymphocyte
350749|NCT02093936|eosinophil|eosinophil
350750|NCT02093936|neutrophil|neutrophil
350751|NCT02093923|HAE|hae
350752|NCT02093910|multiple myeloma|multiple myeloma
350753|NCT02093910|peripheral neuropathy|peripheral neuropathy
350754|NCT02093910|prophylaxis|prophylaxis
350755|NCT02093884|Pregnancy|pregnancy
350756|NCT02093884|Pregnancy, unplanned|pregnancy, unplanned
350757|NCT02093884|Reproductive behavior|reproductive behavior
350758|NCT02093884|Pregnancy in Adolescence|pregnancy in adolescence
350759|NCT02093884|Text messaging|text messaging
350760|NCT02093871|Ovarian cancer|ovarian cancer
350761|NCT02093871|Therapeutic hyperthermia|therapeutic hyperthermia
350762|NCT02093871|HEATT|heatt
350763|NCT02093871|whole body hyperthermia|whole body hyperthermia
350764|NCT02093871|hyperthermia|hyperthermia
350765|NCT02093871|PISH|pish
350766|NCT02093871|Verthermia|verthermia
350767|NCT02093871|Phase 1 clinical trial|phase 1 clinical trial
350768|NCT02093871|stage 3 ovarian cancer|stage 3 ovarian cancer
350769|NCT02093871|stage 4 ovarian cancer|stage 4 ovarian cancer
350770|NCT02093871|stage III ovarian cancer|stage iii ovarian cancer
350771|NCT02093871|stage IV ovarian cancer|stage iv ovarian cancer
350772|NCT02093871|late stage ovarian cancer|late stage ovarian cancer
350773|NCT02093871|Core HFC|core hfc
350774|NCT02093871|Lilja|lilja
350775|NCT02093871|Vertrees|vertrees
350776|NCT02093871|Bastidas|bastidas
350777|NCT02093871|total body hyperthermia|total body hyperthermia
350778|NCT02093858|Metabolic Syndrome|metabolic syndrome
350779|NCT02093845|Percutaneous coronary intervention|percutaneous coronary intervention
350780|NCT02093845|DES|des
350781|NCT02093845|Angina pectoris|angina pectoris
350782|NCT02093845|Stent|stent
350783|NCT02093832|femoral head size|femoral head size
350784|NCT02093832|cup size|cup size
350785|NCT02093832|Total hip arthroplasty|total hip arthroplasty
350786|NCT02093767|prebiotics|prebiotics
350787|NCT02093767|Synergy1|synergy1
350788|NCT02093728|Phase I, healthy, pharmacokinetics|phase i, healthy, pharmacokinetics
350789|NCT02093715|Bronchiolitis|bronchiolitis
350790|NCT02093715|FeNO|feno
350791|NCT02093715|Asthma|asthma
350792|NCT02093715|wheezing, RSV|wheezing, rsv
350793|NCT02093676|diabetes|diabetes
350794|NCT02093676|type 1|type 1
350795|NCT02093676|adolescents|adolescents
350796|NCT02093676|parents counselling|parents counselling
350797|NCT02093663|Mild|mild
350798|NCT02093663|Moderate|moderate
350799|NCT02093650|Menopausal symptoms|menopausal symptoms
350800|NCT02093650|menopause related quality of life|menopause related quality of life
350801|NCT02093650|black cohosh|black cohosh
350802|NCT02093650|cimicifuga racemosa|cimicifuga racemosa
350803|NCT02093650|MENQOL|menqol
350804|NCT02093650|Kupperman index|kupperman index
350805|NCT02093650|KI|ki
350806|NCT02093650|liver function tests|liver function tests
350807|NCT02093598|pharmacokinetic|pharmacokinetic
350808|NCT02093598|pharmacodynamic|pharmacodynamic
350809|NCT02093598|Carcinoma, Endometrioid|carcinoma, endometrioid
350810|NCT02093598|mTOR protein|mtor protein
350811|NCT02093598|temsirolimus|temsirolimus
350812|NCT02093598|torisel|torisel
350813|NCT02093598|biological marker|biological marker
350814|NCT02093598|phase II|phase ii
350815|NCT02093585|HIV-1|hiv-1
350816|NCT02093585|Abacavir|abacavir
350817|NCT02093585|Platelet activation|platelet activation
350818|NCT02093585|Thromboelastography|thromboelastography
350819|NCT02093585|Coagulation|coagulation
350820|NCT02093572|Clock genes|clock genes
350821|NCT02093572|Metabolism|metabolism
350822|NCT02093572|Insulin sensitivity|insulin sensitivity
350823|NCT02093559|Clinical Trial|clinical trial
350824|NCT02093559|Naloxone|naloxone
350825|NCT02093559|Motivational Interviewing|motivational interviewing
712560|NCT00579709|Complete DiGeorge|complete digeorge
350826|NCT02093533|Membranoproliferative glomerulonephritis|membranoproliferative glomerulonephritis
350827|NCT02093533|Nephrotic syndrome|nephrotic syndrome
350828|NCT02093533|Proteinuria|proteinuria
350829|NCT02093533|Alternative complement pathway|alternative complement pathway
350830|NCT02093533|Complement inhibition|complement inhibition
350831|NCT02093533|Eculizumab|eculizumab
350832|NCT02093520|Lumbar Spinal Stenosis|lumbar spinal stenosis
350833|NCT02093520|Spinal Stenosis|spinal stenosis
350834|NCT02093520|Neurogenic Claudication|neurogenic claudication
350835|NCT02093507|newborn|newborn
350836|NCT02093507|foot deformity congenital|foot deformity congenital
350837|NCT02093494|Septicemia|septicemia
350838|NCT02093494|Blood culture|blood culture
350839|NCT02093494|Contamination|contamination
350840|NCT02093468|Acute limb ischemia|acute limb ischemia
350841|NCT02093468|ALI|ali
350842|NCT02093468|Acute lower extremity arterial occlusion|acute lower extremity arterial occlusion
350843|NCT02093455|Endothelial function|endothelial function
350844|NCT02093416|Obesity|obesity
350845|NCT02093416|Leptin|leptin
350846|NCT02093403|AML|aml
350847|NCT02093403|Acute Myeloid Leukemia|acute myeloid leukemia
351136|NCT02092038|surgery|surgery
350848|NCT02093403|Adult Acute Myeloid Leukemia with T(8;21)(Q22;Q22)|adult acute myeloid leukemia with t(8;21)(q22;q22)
350849|NCT02093403|adult Acute Myeloid Leukemia with 11q23 (MLL) abnormalities|adult acute myeloid leukemia with 11q23 (mll) abnormalities
350850|NCT02093403|adult Acute Myeloid Leukemia with del(5q)|adult acute myeloid leukemia with del(5q)
350851|NCT02093403|adult Acute Myeloid Leukemia with inv(16)(p13;q22)|adult acute myeloid leukemia with inv(16)(p13;q22)
350852|NCT02093377|acute myocardial infarction|acute myocardial infarction
350853|NCT02093377|sleep apnea|sleep apnea
350854|NCT02093377|adaptive servo-ventilation|adaptive servo-ventilation
350855|NCT02093351|oncology, cancer, tumour, neoplasm, anticancer drug, pharmacokinetics, olaparib, anastrozole, tamoxifen, letrozole,|oncology, cancer, tumour, neoplasm, anticancer drug, pharmacokinetics, olaparib, anastrozole, tamoxifen, letrozole,
350856|NCT02093338|breast pain|breast pain
350857|NCT02093338|probiotic|probiotic
350858|NCT02093338|mastitis|mastitis
350859|NCT02093338|lactobacillus fermentun|lactobacillus fermentun
350860|NCT02093338|Staphylococcus|staphylococcus
350861|NCT02093325|eltrombopag , thrombocytopenia, solid tumor|eltrombopag , thrombocytopenia, solid tumor
350862|NCT02093312|Cancer|cancer
350863|NCT02093312|Food-delivery|food-delivery
350864|NCT02093312|Nutritional Intervention|nutritional intervention
350865|NCT02093312|Quality of life|quality of life
350866|NCT02093312|Outpatients|outpatients
350867|NCT02093286|Pentabio Vaccine|pentabio vaccine
350868|NCT02093286|Safety|safety
350869|NCT02093286|Infants|infants
350870|NCT02093286|Booster Dose|booster dose
350871|NCT02093286|DTwP/HepB/Hib|dtwp/hepb/hib
350872|NCT02093273|tOPV|topv
350873|NCT02093273|Antibody response|antibody response
350874|NCT02093273|Safety|safety
350875|NCT02093260|Flubio Vaccine (Influenza HA)|flubio vaccine (influenza ha)
350876|NCT02093260|Infants|infants
350877|NCT02093260|Children|children
350878|NCT02093260|Safety|safety
350879|NCT02093260|Immunogenicity|immunogenicity
350880|NCT02093234|self care of diabetes type 2 patients|self care of diabetes type 2 patients
350881|NCT02093234|mobile health cell phone application impact on health|mobile health cell phone application impact on health
350882|NCT02093234|community health workers impact on health|community health workers impact on health
350883|NCT02093221|Type 1 Diabetes Mellitus|type 1 diabetes mellitus
350884|NCT02093221|Alpha1-Proteinase Inhibitor|alpha1-proteinase inhibitor
350885|NCT02093221|Beta Cell|beta cell
350886|NCT02093221|Alpha1-Antitrypsin|alpha1-antitrypsin
350887|NCT02093195|Treatment, COPD, bosentan|treatment, copd, bosentan
350888|NCT02093156|bowel preparation|bowel preparation
350889|NCT02093156|Ottawa Score|ottawa score
350890|NCT02093143|Diagnostic panendoscopy of the upper airway|diagnostic panendoscopy of the upper airway
350891|NCT02093143|Total intravenous general anesthesia|total intravenous general anesthesia
350892|NCT02093143|Remifentanil|remifentanil
350893|NCT02093143|Propofol|propofol
351019|NCT02092649|Omega-3|omega-3
350894|NCT02093143|Target controlled infusion|target controlled infusion
350895|NCT02093143|Direct laryngoscopy|direct laryngoscopy
350896|NCT02093143|Tracheoscopy|tracheoscopy
350897|NCT02093143|Oesophagoscopy|oesophagoscopy
350898|NCT02093143|Ear Nose and Throat (ENT) tumor|ear nose and throat (ent) tumor
350899|NCT02093143|Ear Nose and Throat (ENT) cancer|ear nose and throat (ent) cancer
350900|NCT02093130|Double-blind Trial|double-blind trial
350901|NCT02093130|Placebo-controlled|placebo-controlled
350902|NCT02093130|Pomegranate|pomegranate
350903|NCT02093130|Memory|memory
350904|NCT02093130|Memory Impairment|memory impairment
350905|NCT02093130|Cognition|cognition
350906|NCT02093130|Ages 50-75|ages 50-75
350907|NCT02093117|Supratentorial neurosurgery|supratentorial neurosurgery
350908|NCT02093117|Recruitment maneuver|recruitment maneuver
350909|NCT02093117|Subdural pressure|subdural pressure
350910|NCT02093117|Brain relaxation|brain relaxation
350911|NCT02093117|Cerebral perfusion pressure|cerebral perfusion pressure
350912|NCT02093104|unresectable hepatocellular carcinoma|unresectable hepatocellular carcinoma
448703|NCT01649427|GFR|gfr
350913|NCT02093104|(undergoing chemoembolization and radioembolization)|(undergoing chemoembolization and radioembolization)
350914|NCT02093091|nano-filled resin modified glass ionomer|nano-filled resin modified glass ionomer
350915|NCT02093091|clinical performance|clinical performance
350916|NCT02093091|class I|class i
350917|NCT02093091|primary teeth|primary teeth
350918|NCT02093091|dentin bond strength|dentin bond strength
350919|NCT02093091|Filling of class I|filling of class i
350920|NCT02093065|severe hemophilia A|severe hemophilia a
350921|NCT02093065|coated platelets|coated platelets
350922|NCT02093065|bleeding|bleeding
350923|NCT02093052|Parenting|parenting
350924|NCT02093052|Parent child relations|parent child relations
350925|NCT02093052|Middle childhood outcomes|middle childhood outcomes
350926|NCT02093039|breast cancer screening|breast cancer screening
350927|NCT02093039|patient decision aids|patient decision aids
350928|NCT02093039|informed decision|informed decision
350929|NCT02093039|empowerment|empowerment
350930|NCT02093039|randomized control trial|randomized control trial
350931|NCT02093039|From 50 to 74 years old|from 50 to 74 years old
350932|NCT02093039|invited to national breast cancer screening|invited to national breast cancer screening
350933|NCT02093013|asthma|asthma
350934|NCT02093013|intervention|intervention
351232|NCT02091648|Children|children
350935|NCT02093013|medication adherence|medication adherence
350936|NCT02093013|inhaled corticosteroids|inhaled corticosteroids
350937|NCT02093013|asthma control|asthma control
350938|NCT02093013|integrated care|integrated care
350939|NCT02092987|Hispanic|hispanic
350940|NCT02092987|Dementia|dementia
350941|NCT02092987|Caregivers|caregivers
350942|NCT02092987|Depressive symptoms|depressive symptoms
350943|NCT02092987|Burden|burden
350944|NCT02092987|Pragmatic randomized trial|pragmatic randomized trial
350945|NCT02092974|transcranial direct current stimulation (tDCS)|transcranial direct current stimulation (tdcs)
350946|NCT02092974|selective serotonin reuptake inhibitor (SSRI)|selective serotonin reuptake inhibitor (ssri)
350947|NCT02092974|young|young
350948|NCT02092974|older adults|older adults
350949|NCT02092961|Rheumatoid Arthritis|rheumatoid arthritis
350950|NCT02092961|OSKIRA|oskira
350951|NCT02092961|fostamatinib|fostamatinib
350952|NCT02092961|CE-MRI|ce-mri
350953|NCT02092961|DCE-MRI|dce-mri
350954|NCT02092948|metastatic|metastatic
350955|NCT02092948|PSCA|psca
350956|NCT02092948|minibody|minibody
350957|NCT02092948|PET/CT|pet/ct
350958|NCT02092935|CDAD|cdad
350959|NCT02092935|Clostridium Difficile|clostridium difficile
350960|NCT02092896|Diabetes Mellitus|diabetes mellitus
350961|NCT02092896|Diabetes Mellitus, Type 1|diabetes mellitus, type 1
350962|NCT02092896|Glucose Metabolism Disorders|glucose metabolism disorders
350963|NCT02092896|Metabolic Diseases|metabolic diseases
350964|NCT02092896|Cognitive performance|cognitive performance
350965|NCT02092896|Hypoglycemia|hypoglycemia
350966|NCT02092896|Insulin|insulin
350967|NCT02092896|Glucagon-Like Peptide 1|glucagon-like peptide 1
350968|NCT02092896|Hypoglycemic Agents|hypoglycemic agents
350969|NCT02092896|Physiological Effects of Drugs|physiological effects of drugs
350970|NCT02092896|Pharmacologic Actions|pharmacologic actions
350971|NCT02092896|Incretins|incretins
350972|NCT02092896|Hormones|hormones
350973|NCT02092883|Infantile Spasms|infantile spasms
350974|NCT02092883|Neuroinflammation|neuroinflammation
350975|NCT02092883|PK11195|pk11195
350976|NCT02092883|PET|pet
350977|NCT02092883|ACTH|acth
350978|NCT02092870|Chronic Wounds|chronic wounds
350979|NCT02092870|Diabetes|diabetes
350980|NCT02092870|Adipose Derived Stem Cells|adipose derived stem cells
350981|NCT02092870|Diabetic Foot|diabetic foot
350982|NCT02092857|nutrient|nutrient
350983|NCT02092857|nutrition|nutrition
350984|NCT02092857|arachidonic acid|arachidonic acid
350985|NCT02092857|essential fatty acids|essential fatty acids
350986|NCT02092844|Menopause|menopause
350987|NCT02092844|Insomnia|insomnia
350988|NCT02092844|Hot Flashes|hot flashes
350989|NCT02092805|VAS|vas
350990|NCT02092805|VDS|vds
350991|NCT02092805|HAM-D|ham-d
350992|NCT02092805|Visceral pain|visceral pain
350993|NCT02092805|Malignancy|malignancy
350994|NCT02092805|rTMS|rtms
350995|NCT02092805|Motor cortex|motor cortex
350996|NCT02092805|Analgesia|analgesia
350997|NCT02092805|Dynorphin|dynorphin
350998|NCT02092766|malaria|malaria
350999|NCT02092766|anaemia|anaemia
351000|NCT02092766|artesunate|artesunate
351001|NCT02092753|Ketogenic diet, logi diet, breast cancer, rehabilitation|ketogenic diet, logi diet, breast cancer, rehabilitation
351002|NCT02092740|Testicular cancer|testicular cancer
351003|NCT02092727|Dialysis facilities|dialysis facilities
351004|NCT02092727|African Americans|african americans
351005|NCT02092727|Racial disparity|racial disparity
351006|NCT02092727|Kidney Transplantation|kidney transplantation
351007|NCT02092727|Community-based Participatory Research|community-based participatory research
351008|NCT02092727|Coalition|coalition
351009|NCT02092727|Georgia|georgia
351010|NCT02092688|time to delivery|time to delivery
351011|NCT02092688|PROM|prom
351012|NCT02092688|PTL|ptl
351013|NCT02092688|positive predictive value|positive predictive value
351014|NCT02092675|Chronic obstructive pulmonary disease|chronic obstructive pulmonary disease
351015|NCT02092675|frequent exacerbator|frequent exacerbator
351016|NCT02092675|endothelial dysfunction|endothelial dysfunction
351017|NCT02092675|Flow mediated dilatation|flow mediated dilatation
351018|NCT02092675|Systemic inflammation|systemic inflammation
351020|NCT02092649|Resting metabolic rate|resting metabolic rate
351021|NCT02092649|Eicosapentaenoic acid|eicosapentaenoic acid
351022|NCT02092649|Docosahexaenoic acid|docosahexaenoic acid
351023|NCT02092636|Hybrid NIR/US imaging technique|hybrid nir/us imaging technique
351024|NCT02092636|NIR/US imaging|nir/us imaging
351025|NCT02092636|US imaging|us imaging
351026|NCT02092636|US imaging technique|us imaging technique
351027|NCT02092623|Female|female
351028|NCT02092623|Prolapse surgery with transvaginal mesh|prolapse surgery with transvaginal mesh
351029|NCT02092623|Subjective outcome|subjective outcome
351030|NCT02092584|atherosclerotic|atherosclerotic
351031|NCT02092584|IGF-1|igf-1
351032|NCT02092584|IGFBP-3|igfbp-3
351033|NCT02092558|metaplasia, dysfunction, urinary bladder, children|metaplasia, dysfunction, urinary bladder, children
351034|NCT02092545|Obesity|obesity
351035|NCT02092519|EUSFNA|eusfna
351036|NCT02092519|endoscopic ultrasound|endoscopic ultrasound
351337|NCT02091206|Epidiolex|epidiolex
351037|NCT02092519|pancreatic masses|pancreatic masses
351038|NCT02092506|H pylori|h pylori
351039|NCT02092506|therapy|therapy
351040|NCT02092493|ScopeGuide|scopeguide
351041|NCT02092493|Colonoscopy|colonoscopy
351042|NCT02092493|Mental workload|mental workload
351043|NCT02092480|Feasibility Trial|feasibility trial
351044|NCT02092480|Educational Intervention|educational intervention
351045|NCT02092480|Teenage Pregnancy|teenage pregnancy
351046|NCT02092480|Boys|boys
351047|NCT02092480|Gender sensitive interventions|gender sensitive interventions
351048|NCT02092480|Unintended pregnancy|unintended pregnancy
351049|NCT02092480|Parents|parents
351050|NCT02092480|Process evaluation|process evaluation
351051|NCT02092480|Economic costing|economic costing
351052|NCT02092467|Post-marketing|post-marketing
351053|NCT02092467|Phase 4|phase 4
351054|NCT02092467|Open-label|open-label
351055|NCT02092467|Safety Surveillance|safety surveillance
351056|NCT02092467|CP690550|cp690550
351057|NCT02092467|Xeljanz|xeljanz
351058|NCT02092467|oral treatment|oral treatment
351059|NCT02092441|Nausea|nausea
351060|NCT02092441|Vomiting|vomiting
351061|NCT02092441|Antiemetic|antiemetic
351062|NCT02092428|Coronary Magnetic Resonance Imaging|coronary magnetic resonance imaging
351063|NCT02092428|CAD|cad
351064|NCT02092428|Coronary Magnetic Resonance Angiography|coronary magnetic resonance angiography
351065|NCT02092428|MRA|mra
351066|NCT02092428|3 Tesla MRI|3 tesla mri
351067|NCT02092415|Tourniquet|tourniquet
351068|NCT02092415|Muscle perfusion|muscle perfusion
351069|NCT02092415|Contrast ultrasound|contrast ultrasound
351070|NCT02092402|Fecal transplantation|fecal transplantation
351071|NCT02092402|microbiota transplantation|microbiota transplantation
351072|NCT02092402|irritable bowel syndrome|irritable bowel syndrome
351073|NCT02092402|IBS|ibs
351074|NCT02092389|Ulcerative Colitis|ulcerative colitis
351075|NCT02092389|Inflammatory Bowel Syndrome|inflammatory bowel syndrome
351076|NCT02092389|Adalimumab|adalimumab
351077|NCT02092389|Tumor necrosis factor (TNF) alpha Antibody|tumor necrosis factor (tnf) alpha antibody
351078|NCT02092389|Calprotectin|calprotectin
351079|NCT02092376|Bariatric surgery|bariatric surgery
351080|NCT02092376|vitamin D|vitamin d
351081|NCT02092376|supplementation|supplementation
351082|NCT02092363|Platinum-Sensitive Ovarian Cancer|platinum-sensitive ovarian cancer
351083|NCT02092337|CAST, Hearing aids, Speech recognition, Cochlear implants|cast, hearing aids, speech recognition, cochlear implants
351084|NCT02092311|varicocele|varicocele
351085|NCT02092311|varicocelectomy|varicocelectomy
351086|NCT02092311|complications of varicocelectomy|complications of varicocelectomy
351087|NCT02092311|Recurrence of varicocele|recurrence of varicocele
351088|NCT02092311|Post-varicocelectomy testicular atrophy|post-varicocelectomy testicular atrophy
351089|NCT02092311|Post-varicocelectomy hydrocele|post-varicocelectomy hydrocele
351090|NCT02092298|Gastrointestinal cancer|gastrointestinal cancer
351091|NCT02092298|Hyperthermic Intraperitoneal Chemoperfusion|hyperthermic intraperitoneal chemoperfusion
351092|NCT02092298|HIPEC|hipec
351093|NCT02092298|Gastric carcinomatosis|gastric carcinomatosis
351094|NCT02092298|Gastroesophageal cancer|gastroesophageal cancer
351095|NCT02092298|Mitomycin C|mitomycin c
351096|NCT02092298|Mitomycin|mitomycin
351097|NCT02092298|Cisplatin|cisplatin
351098|NCT02092298|Platinol-AQ|platinol-aq
351099|NCT02092298|Platinol|platinol
351100|NCT02092298|CDDP|cddp
351101|NCT02092298|Sodium Thiosulfate|sodium thiosulfate
351102|NCT02092298|Tinver|tinver
351103|NCT02092233|ARIES HSV 1&2|aries hsv 1&2
351104|NCT02092220|Bionic Pancreas|bionic pancreas
351105|NCT02092220|Insulin|insulin
351106|NCT02092220|Glucagon|glucagon
351107|NCT02092220|Continuous Glucose Monitor|continuous glucose monitor
351108|NCT02092194|beta 2-Microglobulin|beta 2-microglobulin
351109|NCT02092194|Hemodiafiltration|hemodiafiltration
351110|NCT02092194|convective volume|convective volume
351111|NCT02092168|Opicapone|opicapone
351112|NCT02092168|BIAL|bial
351113|NCT02092142|Q fever|q fever
351114|NCT02092142|Coxiella burnetii|coxiella burnetii
351115|NCT02092129|Acromegaly, surgery, histopathology, hyperprolactinaemia,|acromegaly, surgery, histopathology, hyperprolactinaemia,
351116|NCT02092103|Premature Birth|premature birth
351117|NCT02092103|Umbilical Cord Clamping|umbilical cord clamping
351118|NCT02092090|salt substitute|salt substitute
351119|NCT02092090|sodium reduction|sodium reduction
351120|NCT02092090|stroke|stroke
351121|NCT02092090|cluster randomized trial|cluster randomized trial
351122|NCT02092090|China|china
351123|NCT02092077|Growth Hormone-Deficient|growth hormone-deficient
351124|NCT02092077|recombinant human growth hormone|recombinant human growth hormone
351125|NCT02092064|basal proteinuria|basal proteinuria
351126|NCT02092064|FMF|fmf
351127|NCT02092064|pregnancy|pregnancy
351128|NCT02092051|Continuous glucose monitoring|continuous glucose monitoring
351129|NCT02092051|Type 1 diabetes|type 1 diabetes
351130|NCT02092051|Insulin injections|insulin injections
351131|NCT02092051|Cross-over|cross-over
351132|NCT02092038|glioblastoma|glioblastoma
351133|NCT02092038|temozolomide|temozolomide
351134|NCT02092038|radiation therapy|radiation therapy
351135|NCT02092038|radiotherapy|radiotherapy
351137|NCT02092038|pre-operative|pre-operative
351138|NCT02092038|neoadjuvant|neoadjuvant
351139|NCT02092025|Pharmacological therapy|pharmacological therapy
351140|NCT02092012|postoperative pain|postoperative pain
351141|NCT02092012|dexketoprofen trometamol|dexketoprofen trometamol
351142|NCT02092012|dexmedetomidine|dexmedetomidine
351143|NCT02091999|enfortumab vedotin|enfortumab vedotin
351270|NCT02091544|lifestyle intervention|lifestyle intervention
351144|NCT02091999|Metastatic Urothelial Cancer|metastatic urothelial cancer
351145|NCT02091999|Safety|safety
351146|NCT02091999|AGS-22C3E|ags-22c3e
351147|NCT02091999|EV-101|ev-101
351148|NCT02091999|Nectin 4 protein, humans|nectin 4 protein, humans
351149|NCT02091999|Clinical Trial, Phase 1|clinical trial, phase 1
351150|NCT02091999|ASG-22CE|asg-22ce
351151|NCT02091999|ASG-22ME|asg-22me
351152|NCT02091999|Pharmacokinetics of ASG-22CE|pharmacokinetics of asg-22ce
351153|NCT02091986|asthma, children, budesonide pMDI|asthma, children, budesonide pmdi
351154|NCT02091973|everolimus|everolimus
351155|NCT02091973|tacrolimus|tacrolimus
351156|NCT02091973|kidney transplantation|kidney transplantation
351157|NCT02091973|microRNA|microrna
351158|NCT02091960|Enzalutamide|enzalutamide
351159|NCT02091960|Trastuzumab|trastuzumab
351160|NCT02091960|Breast cancer|breast cancer
351161|NCT02091960|HER2|her2
351162|NCT02091960|Androgen receptor positive|androgen receptor positive
351163|NCT02091960|Xtandi|xtandi
351164|NCT02091947|FMS|fms
351165|NCT02091947|Urine incontinence|urine incontinence
351166|NCT02091934|Alcon|alcon
351167|NCT02091934|Wavelight|wavelight
351168|NCT02091934|PRK|prk
351169|NCT02091934|Wavefront-guided|wavefront-guided
351170|NCT02091934|Wavefront-optimized|wavefront-optimized
351171|NCT02091934|Myopia|myopia
351172|NCT02091934|Astigmatism|astigmatism
351173|NCT02091921|Critical Limb Ischemia, ticagrelor, Brilinta|critical limb ischemia, ticagrelor, brilinta
351174|NCT02091908|Influenza|influenza
351175|NCT02091908|H5N1|h5n1
351176|NCT02091908|aH5N1|ah5n1
351177|NCT02091908|H5N1 vaccine|h5n1 vaccine
351178|NCT02091908|Pandemic Influenza vaccine|pandemic influenza vaccine
351179|NCT02091908|MF59, Adjuvant, Avian flu|mf59, adjuvant, avian flu
351180|NCT02091908|Underlying medical conditions|underlying medical conditions
351181|NCT02091908|Underlying cardiovascular medical condition|underlying cardiovascular medical condition
351182|NCT02091908|Pandemic vaccine|pandemic vaccine
351183|NCT02091908|Charlson Comorbidity Index (CCI)|charlson comorbidity index (cci)
351184|NCT02091908|Adjuvanted vaccine|adjuvanted vaccine
351185|NCT02091895|probe-based confocal laser endomicroscopy, lower gastrointestinal disorders|probe-based confocal laser endomicroscopy, lower gastrointestinal disorders
351186|NCT02091882|OPC-14597 Digital|opc-14597 digital
351187|NCT02091882|Aripiprazole|aripiprazole
351188|NCT02091882|Medical Information Device #1 System (MIND1)|medical information device #1 system (mind1)
351189|NCT02091882|Ingestible Event Marker|ingestible event marker
351190|NCT02091869|Adolescents|adolescents
351191|NCT02091869|Asthma|asthma
351192|NCT02091869|Asthma Symptoms|asthma symptoms
351193|NCT02091817|oxytocin|oxytocin
351194|NCT02091817|face|face
351195|NCT02091817|memory|memory
351196|NCT02091804|Attachment theory|attachment theory
351197|NCT02091804|Parent- child relationship|parent- child relationship
351198|NCT02091804|Child mental health|child mental health
351199|NCT02091804|Behavioral health|behavioral health
351200|NCT02091791|acute lumbar sciatica, lumbar traction, traction force, radicular pain, lumbar functional parameters, disc herniation|acute lumbar sciatica, lumbar traction, traction force, radicular pain, lumbar functional parameters, disc herniation
351201|NCT02091765|Sexual dysfunction|sexual dysfunction
351202|NCT02091765|Intimacy problems|intimacy problems
351203|NCT02091765|Breast cancer survivors|breast cancer survivors
351204|NCT02091765|Internet-based|internet-based
351205|NCT02091765|Cognitive behavioral therapy|cognitive behavioral therapy
351206|NCT02091752|Primary Myelofibrosis|primary myelofibrosis
351207|NCT02091752|Hematologic Diseases|hematologic diseases
351208|NCT02091752|Myeloproliferative Disorders|myeloproliferative disorders
351209|NCT02091752|INC424|inc424
351210|NCT02091752|Ruxolitinib|ruxolitinib
351211|NCT02091726|Circumcision|circumcision
351212|NCT02091726|HIV prevention|hiv prevention
351213|NCT02091726|Surgical device|surgical device
351214|NCT02091726|Cyanoacrylate|cyanoacrylate
351215|NCT02091726|Tissue Adhesive|tissue adhesive
351216|NCT02091726|voluntary|voluntary
351217|NCT02091713|FMS|fms
351218|NCT02091713|functional movement screen|functional movement screen
351219|NCT02091700|Normal|normal
351220|NCT02091700|Healthy|healthy
351221|NCT02091700|Normal healthy patient|normal healthy patient
351222|NCT02091674|ankle sprain|ankle sprain
351223|NCT02091674|hyaluronic acid|hyaluronic acid
351224|NCT02091661|Clinically localized prostate cancer|clinically localized prostate cancer
351225|NCT02091661|Radical retropubic prostatectomy|radical retropubic prostatectomy
351226|NCT02091661|External beam radiotherapy|external beam radiotherapy
351227|NCT02091661|Efficacy|efficacy
351228|NCT02091661|Quality of life|quality of life
351229|NCT02091661|adverse events|adverse events
351230|NCT02091648|Asthma|asthma
351231|NCT02091648|Stress|stress
351233|NCT02091648|Psychosocial Factors|psychosocial factors
351234|NCT02091648|Relaxation|relaxation
351235|NCT02091648|Stress management|stress management
351236|NCT02091635|accommodation, emptying, motilitone|accommodation, emptying, motilitone
351237|NCT02091609|plaque removal around dental implants|plaque removal around dental implants
351238|NCT02091596|Wound|wound
351239|NCT02091596|Ulcer|ulcer
351240|NCT02091596|Infected|infected
351241|NCT02091596|Infection|infection
351242|NCT02091583|Metabolic syndrome|metabolic syndrome
351243|NCT02091583|Cardiovascular disease|cardiovascular disease
351244|NCT02091583|High Oleic Canola Oil|high oleic canola oil
351245|NCT02091583|DHA|dha
351246|NCT02091583|β-glucan|β-glucan
351247|NCT02091583|Barley|barley
351248|NCT02091583|Cholesterol|cholesterol
351249|NCT02091583|Lipoproteins|lipoproteins
351250|NCT02091583|Lipids|lipids
351251|NCT02091583|Inflammation|inflammation
351252|NCT02091583|Glucose|glucose
351253|NCT02091583|Insulin|insulin
351254|NCT02091583|Satiety|satiety
351255|NCT02091583|Body composition|body composition
351256|NCT02091583|Blood pressure|blood pressure
351257|NCT02091570|Hunger|hunger
351258|NCT02091570|Fullness|fullness
351259|NCT02091570|Satiety|satiety
351260|NCT02091570|Nutrition bar|nutrition bar
351261|NCT02091570|Crossover|crossover
351262|NCT02091557|GnRH-a|gnrh-a
351263|NCT02091557|endometriosis|endometriosis
351264|NCT02091557|chronic pelvic pain|chronic pelvic pain
351265|NCT02091557|VAS score|vas score
351266|NCT02091557|diagnostic accuracy|diagnostic accuracy
351267|NCT02091544|overweight|overweight
351268|NCT02091544|obesity|obesity
351269|NCT02091544|children|children
351271|NCT02091531|mTOR Inhibitor MLN0128|mtor inhibitor mln0128
351272|NCT02091531|PSA|psa
351273|NCT02091531|13-143|13-143
351274|NCT02091518|MRI|mri
351275|NCT02091518|13-239|13-239
351276|NCT02091518|volunteers|volunteers
351277|NCT02091518|patients|patients
351278|NCT02091492|Proximal humerus fracture, teriparatide|proximal humerus fracture, teriparatide
351279|NCT02091479|hæmorrhage, thrombosis|hæmorrhage, thrombosis
351280|NCT02091466|Hypothermia|hypothermia
351281|NCT02091466|Perioperative Care|perioperative care
351282|NCT02091466|Anesthesia|anesthesia
351283|NCT02091466|Spinal|spinal
351284|NCT02091466|Rewarming|rewarming
351285|NCT02091453|Brain injury|brain injury
351286|NCT02091453|stroke|stroke
351287|NCT02091453|cognitive rehabilitation|cognitive rehabilitation
351288|NCT02091440|Medical Device|medical device
351289|NCT02091440|Thoracic Surgical Procedure|thoracic surgical procedure
351290|NCT02091440|Pumps Heart Assist|pumps heart assist
351291|NCT02091440|Ventricular Assist Device|ventricular assist device
351292|NCT02091401|magnesium sulfate|magnesium sulfate
351293|NCT02091375|Cannabidiol|cannabidiol
351294|NCT02091375|CBD|cbd
351295|NCT02091375|Epidiolex|epidiolex
351296|NCT02091375|GWP42003-P|gwp42003-p
351297|NCT02091336|gestational diabetes|gestational diabetes
351298|NCT02091336|metformin|metformin
351299|NCT02091336|glyburide|glyburide
351300|NCT02091336|fetal growth|fetal growth
351301|NCT02091336|capillar glucose|capillar glucose
351302|NCT02091323|T2DM, gastric bypass surgery, BMI<35, obesity|t2dm, gastric bypass surgery, bmi<35, obesity
351303|NCT02091310|GFT505|gft505
351304|NCT02091310|TQT|tqt
351305|NCT02091310|QT/QTc|qt/qtc
351306|NCT02091310|Pharmacokinetic|pharmacokinetic
351307|NCT02091310|Healthy subjects|healthy subjects
449194|NCT01646775|opioid|opioid
351308|NCT02091310|Moxifloxacin|moxifloxacin
351309|NCT02091297|Buprenorphine|buprenorphine
351310|NCT02091297|Suboxone|suboxone
351311|NCT02091297|Subutex|subutex
351312|NCT02091297|Buprenex|buprenex
351313|NCT02091297|Caesarean Delivery|caesarean delivery
351314|NCT02091284|alcoholism|alcoholism
351315|NCT02091284|tDCS|tdcs
351316|NCT02091284|dlPFC|dlpfc
351317|NCT02091284|craving|craving
351318|NCT02091284|cognition|cognition
351319|NCT02091271|Evaluation|evaluation
351320|NCT02091271|Research|research
351321|NCT02091271|Healthy Volunteers|healthy volunteers
351322|NCT02091245|Relapsed acute lymphoblastic leukemia (ALL)|relapsed acute lymphoblastic leukemia (all)
351323|NCT02091245|Refractory acute lymphoblastic leukemia (ALL)|refractory acute lymphoblastic leukemia (all)
351324|NCT02091245|Relapsed acute myelogenous leukemia (AML)|relapsed acute myelogenous leukemia (aml)
351325|NCT02091245|Refractory acute myelogenous leukemia (AML)|refractory acute myelogenous leukemia (aml)
351326|NCT02091245|Relapsed childhood leukemia|relapsed childhood leukemia
351327|NCT02091245|Relapsed mixed lineage leukemia|relapsed mixed lineage leukemia
351328|NCT02091245|Refractory mixed lineage leukemia|refractory mixed lineage leukemia
351329|NCT02091245|Relapsed biphenotypic leukemia|relapsed biphenotypic leukemia
351330|NCT02091245|Refractory biphenotypic leukemia|refractory biphenotypic leukemia
351331|NCT02091245|Chronic myelogenous leukemia (CML) in blast crisis|chronic myelogenous leukemia (cml) in blast crisis
351332|NCT02091219|Hypovitaminosis D|hypovitaminosis d
351333|NCT02091219|Free 25-hydroxyvitamin D|free 25-hydroxyvitamin d
351334|NCT02091219|Total 25-hydroxyvitamin D|total 25-hydroxyvitamin d
351335|NCT02091206|Cannabidiol|cannabidiol
351336|NCT02091206|CBD|cbd
351338|NCT02091206|GWP42003-P|gwp42003-p
351339|NCT02091193|Krill Oil|krill oil
351340|NCT02091193|Endothelial Function|endothelial function
351341|NCT02091193|Type II Diabetes Mellitus|type ii diabetes mellitus
351342|NCT02091180|Anesthesia|anesthesia
351343|NCT02091180|Recovery|recovery
351344|NCT02091180|laparoscopy|laparoscopy
351345|NCT02091180|cholecystectomy|cholecystectomy
351346|NCT02091167|crack-cocaine addiction|crack-cocaine addiction
351348|NCT02091167|dlPFC|dlpfc
351349|NCT02091167|craving|craving
351350|NCT02091167|cognition|cognition
351351|NCT02091154|Food Intake Regulation|food intake regulation
351352|NCT02091154|Fruit|fruit
351353|NCT02091154|Vegetable|vegetable
351354|NCT02091115|Constipation|constipation
351355|NCT02091115|ROMA III criteria|roma iii criteria
351356|NCT02091115|Scale Bristol|scale bristol
351357|NCT02091076|Silk fibroin with bioactive coating layer dressing|silk fibroin with bioactive coating layer dressing
351358|NCT02091076|Wound healing|wound healing
351359|NCT02091076|Skin graft donor|skin graft donor
351360|NCT02091063|hematologic malignancies|hematologic malignancies
351361|NCT02091063|hodgkin|hodgkin
351362|NCT02091063|hodgkins|hodgkins
351363|NCT02091063|non-hodgkin|non-hodgkin
351364|NCT02091063|non-hodgkins|non-hodgkins
351365|NCT02091063|mantle cell lymphoma|mantle cell lymphoma
351366|NCT02091063|follicular|follicular
351367|NCT02091063|lymphoma|lymphoma
351368|NCT02091063|lymphoid malignancies|lymphoid malignancies
351369|NCT02091050|3D Brachytherapy|3d brachytherapy
351370|NCT02091050|cervical cancer|cervical cancer
351371|NCT02091050|endometrial cancer|endometrial cancer
351372|NCT02091050|vaginal vault brachytherapy|vaginal vault brachytherapy
351373|NCT02091037|Atopic dermatitis|atopic dermatitis
351374|NCT02091037|Bacterial colonization|bacterial colonization
351375|NCT02091011|This study is designed to efficiently provide device and battery longevity data on market released|this study is designed to efficiently provide device and battery longevity data on market released
351376|NCT02091011|Boston Scientific ICD and CRT-D (Cardiac Resynchronization Therapy Defibrillator) devices. In addition, the data collected will allow for|boston scientific icd and crt-d (cardiac resynchronization therapy defibrillator) devices. in addition, the data collected will allow for
351377|NCT02091011|comparisons of device survival probability estimated in the Product Performance Report versus|comparisons of device survival probability estimated in the product performance report versus
351378|NCT02091011|those collected in the study. The data collected will also provide a better understanding on the|those collected in the study. the data collected will also provide a better understanding on the
351379|NCT02091011|potential predictors of pulse generator battery longevity.|potential predictors of pulse generator battery longevity.
351380|NCT02090998|Migraine Headache|migraine headache
351381|NCT02090998|Menstrual Migraine|menstrual migraine
351382|NCT02090998|Vascular Headache|vascular headache
351383|NCT02090998|Temporal Lobe Seizure|temporal lobe seizure
351384|NCT02090985|Stoma|stoma
351385|NCT02090985|Peri-stomal|peri-stomal
351386|NCT02090985|Lipomodelling|lipomodelling
351387|NCT02090959|Duchenne muscular dystrophy|duchenne muscular dystrophy
351388|NCT02090959|Dystrophinopathy|dystrophinopathy
351389|NCT02090959|Nonsense mutation|nonsense mutation
351390|NCT02090959|Premature stop codon|premature stop codon
351391|NCT02090959|Becker muscular dystrophy|becker muscular dystrophy
351392|NCT02090959|DMD/BMD|dmd/bmd
351393|NCT02090959|PTC124|ptc124
351394|NCT02090959|Ataluren|ataluren
351395|NCT02090946|children with physical disabilities|children with physical disabilities
351396|NCT02090946|home activity programs|home activity programs
351397|NCT02090946|home programmes|home programmes
351398|NCT02090946|learning|learning
351399|NCT02090946|therapeutic relationship|therapeutic relationship
351400|NCT02090946|phenomenology|phenomenology
351401|NCT02090946|physiotherapy|physiotherapy
351402|NCT02090946|clinicians who teach|clinicians who teach
351403|NCT02090946|parent perspective|parent perspective
351404|NCT02090946|parent-professional relationships|parent-professional relationships
351405|NCT02090946|Parents/carers|parents/carers
351406|NCT02090946|long term physiotherapy needs|long term physiotherapy needs
351407|NCT02090907|Subclinical hypothyroidism|subclinical hypothyroidism
351408|NCT02090907|Atherosclerosis|atherosclerosis
351409|NCT02090907|Cardiovascular disease|cardiovascular disease
351410|NCT02090907|Endothelial function|endothelial function
351411|NCT02090907|Prevention|prevention
351412|NCT02090868|Non-Invasive Ventilation|non-invasive ventilation
351413|NCT02090868|Bi-Level Positive Airway Pressure|bi-level positive airway pressure
351414|NCT02090868|Continuous Positive Airway Pressure|continuous positive airway pressure
351415|NCT02090868|Critical Care|critical care
351416|NCT02090868|Nutrition|nutrition
351417|NCT02090868|Malnutrition|malnutrition
351418|NCT02090868|Staff attitudes, knowledge and beliefs|staff attitudes, knowledge and beliefs
351419|NCT02090842|Milk proteins|milk proteins
351420|NCT02090842|Blood pressure|blood pressure
351421|NCT02090842|Vascular function|vascular function
351422|NCT02090829|Autism|autism
351423|NCT02090829|Oxytocin|oxytocin
351424|NCT02090829|Syntocinon|syntocinon
351425|NCT02090790|dexamethasone|dexamethasone
351426|NCT02090790|femoral block|femoral block
351427|NCT02090790|total knee arthroplasty|total knee arthroplasty
351428|NCT02090751|Retinal Rod Photoreceptor Cells|retinal rod photoreceptor cells
351429|NCT02090751|Dark Adaptation|dark adaptation
351430|NCT02090725|fluctuating muscle weakness|fluctuating muscle weakness
351431|NCT02090725|hyporeflexia|hyporeflexia
351432|NCT02090725|autonomic Dysfunction|autonomic dysfunction
351433|NCT02090712|myocardial infarction|myocardial infarction
351434|NCT02090712|acute coronary syndrome|acute coronary syndrome
351435|NCT02090712|coronary disease|coronary disease
351436|NCT02090699|thalassemia major|thalassemia major
351437|NCT02090699|chronic blood transfusion related iron overload|chronic blood transfusion related iron overload
351438|NCT02090699|magnetic resonance imaging|magnetic resonance imaging
351439|NCT02090699|myocardium|myocardium
351440|NCT02090699|fibrosis|fibrosis
351441|NCT02090647|dental implant, aesthetic, implant abutment|dental implant, aesthetic, implant abutment
351442|NCT02090634|HIV|hiv
351443|NCT02090634|Bipolar Disorder|bipolar disorder
351444|NCT02090634|Medication Adherence|medication adherence
351445|NCT02090621|Liver|liver
351446|NCT02090621|transplantation|transplantation
351447|NCT02090621|Immunosuppression|immunosuppression
351448|NCT02090621|photopheresis|photopheresis
351449|NCT02090621|extracorporeal|extracorporeal
351450|NCT02090595|bipolar disorder|bipolar disorder
351451|NCT02090595|anxiety|anxiety
351452|NCT02090595|mindfulness|mindfulness
351453|NCT02090595|high risk|high risk
351454|NCT02090595|cognitive behavioral|cognitive behavioral
351455|NCT02090569|Functional micro-Doppler Sonography, fmDS, dysplasia, epilepsy, neurosurgery, cerebral blood volume, echography, hemodynamics|functional micro-doppler sonography, fmds, dysplasia, epilepsy, neurosurgery, cerebral blood volume, echography, hemodynamics
351456|NCT02090530|Cancer Genomics|cancer genomics
351457|NCT02090530|Tumor Sequencing|tumor sequencing
351458|NCT02090517|Nasal telangiectasis|nasal telangiectasis
351459|NCT02090504|alcohol withdrawal syndrome|alcohol withdrawal syndrome
351460|NCT02090504|treatment|treatment
351461|NCT02090504|sodium oxybate|sodium oxybate
351462|NCT02090504|oxazepam|oxazepam
351463|NCT02090491|autism|autism
351464|NCT02090465|Actinic Keratosis|actinic keratosis
351465|NCT02090452|Telemedicine|telemedicine
351466|NCT02090452|Mobile|mobile
351467|NCT02090452|Vital signs|vital signs
351468|NCT02090452|Prehospital care|prehospital care
351469|NCT02090452|Emergency medicine|emergency medicine
351470|NCT02090413|multiple sclerosis|multiple sclerosis
351471|NCT02090413|flushing|flushing
351472|NCT02090413|aspirin|aspirin
351473|NCT02090400|Women|women
351474|NCT02090400|Osteoporosis, Postmenopausal|osteoporosis, postmenopausal
351475|NCT02090400|Bazedoxifene|bazedoxifene
351476|NCT02090400|BMD|bmd
351477|NCT02090374|Allergy|allergy
351478|NCT02090374|Asthma|asthma
351479|NCT02090374|Biomarkers|biomarkers
351480|NCT02090374|Chemokines|chemokines
351481|NCT02090374|Cytokines|cytokines
351482|NCT02090374|Eosinophil|eosinophil
351483|NCT02090374|Gene Expression|gene expression
351484|NCT02090374|Grass pollen|grass pollen
351485|NCT02090374|Hay Fever|hay fever
351486|NCT02090374|Human Challenge Study|human challenge study
351487|NCT02090374|Inflammation|inflammation
351488|NCT02090374|Innate Immune Response|innate immune response
776835|NCT00342030|Diet|diet
351489|NCT02090374|Lipopolysaccharide|lipopolysaccharide
351490|NCT02090374|Mucosal Lining Fluid|mucosal lining fluid
351491|NCT02090374|Nasal|nasal
351492|NCT02090374|Nasorption|nasorption
351493|NCT02090374|Respiratory|respiratory
351494|NCT02090374|Respiratory Tract Infection|respiratory tract infection
351495|NCT02090374|T cells|t cells
351496|NCT02090374|Tuberculosis|tuberculosis
351497|NCT02090374|Virus|virus
351498|NCT02090361|collagen -elastin matrix|collagen -elastin matrix
351499|NCT02090361|skin graft|skin graft
351500|NCT02090361|loss of cutaneous substance|loss of cutaneous substance
351501|NCT02090335|community mental health|community mental health
351502|NCT02090335|health coach|health coach
351503|NCT02090335|weight loss|weight loss
351504|NCT02090335|fitness|fitness
351505|NCT02090335|serious mental illness|serious mental illness
351506|NCT02090335|health promotion|health promotion
351507|NCT02090322|ROP|rop
351508|NCT02090322|Bevacizumab|bevacizumab
351509|NCT02090322|No inferiority|no inferiority
351510|NCT02090283|Amicus Therapeutics|amicus therapeutics
351511|NCT02090283|Scioderm, Inc.|scioderm, inc.
351512|NCT02090283|Recessive Dystrophic|recessive dystrophic
351513|NCT02090283|Junctional non-Herlitz|junctional non-herlitz
351514|NCT02090283|Epidermolysis Bullosa|epidermolysis bullosa
351515|NCT02090283|Simplex|simplex
351516|NCT02090283|SD-101 6%|sd-101 6%
351517|NCT02090283|SD-101-6.0|sd-101-6.0
351518|NCT02090283|Allantoin 6%|allantoin 6%
351519|NCT02090283|Zorblisa|zorblisa
351520|NCT02090270|hair cortisol|hair cortisol
351521|NCT02090270|stroke|stroke
351522|NCT02090257|Heart transplant recipients who are entering into adult care.|heart transplant recipients who are entering into adult care.
351523|NCT02090244|PTH|pth
351524|NCT02090244|Spinal stenosis|spinal stenosis
351525|NCT02090244|Teriparatide|teriparatide
351526|NCT02090231|stroke|stroke
351527|NCT02090231|dysphagia|dysphagia
351528|NCT02090231|rTMS|rtms
351529|NCT02090205|cardio-pulmonary bypass|cardio-pulmonary bypass
351530|NCT02090205|cardiac surgery|cardiac surgery
351531|NCT02090205|lung injury prevention|lung injury prevention
351532|NCT02090205|mechanical ventilation|mechanical ventilation
351533|NCT02090205|pulmonary insufficiency|pulmonary insufficiency
351534|NCT02090192|Whole-body vibration;|whole-body vibration;
351535|NCT02090192|Frail Elderly;|frail elderly;
351536|NCT02090192|Blood flow;|blood flow;
351537|NCT02090192|Bone density|bone density
351538|NCT02090192|Mobility;|mobility;
351539|NCT02090192|Balance;|balance;
351540|NCT02090192|Muscle strength;|muscle strength;
351541|NCT02090192|Lower Extremity;|lower extremity;
351542|NCT02090192|Musculoskeletal System;|musculoskeletal system;
351543|NCT02090192|Health Status;|health status;
351544|NCT02090192|Exercise;|exercise;
351545|NCT02090192|Mechanical Oscillation|mechanical oscillation
351546|NCT02090179|MPS IIIB|mps iiib
351547|NCT02090179|Mucopolysaccharidosis|mucopolysaccharidosis
351548|NCT02090179|Mucopolysaccharidosis type IIIB|mucopolysaccharidosis type iiib
351549|NCT02090179|Sanfilippo Syndrome|sanfilippo syndrome
351550|NCT02090179|Metabolism, Inborn Errors|metabolism, inborn errors
351551|NCT02090179|Metabolic Diseases|metabolic diseases
351552|NCT02090179|Genetic Diseases, Inborn|genetic diseases, inborn
351553|NCT02090153|Advance Gastric Cancer,|advance gastric cancer,
351554|NCT02090153|S-1 plus leucovorin,|s-1 plus leucovorin,
351555|NCT02090153|ORR,|orr,
351556|NCT02090153|OS,|os,
351557|NCT02090153|TTP,|ttp,
351558|NCT02090153|TTF,|ttf,
351559|NCT02090153|Adverse events,|adverse events,
351560|NCT02090153|Pharmacokinetics|pharmacokinetics
351561|NCT02090140|cartilage/transplantation|cartilage/transplantation
351562|NCT02090140|cartilage, articular/injuries|cartilage, articular/injuries
351563|NCT02090140|cartilage, articular/surgery|cartilage, articular/surgery
351564|NCT02090140|chondrocytes/cytology|chondrocytes/cytology
351565|NCT02090140|knee injuries/surgery|knee injuries/surgery
351566|NCT02090140|knee joint/surgery|knee joint/surgery
351567|NCT02090140|orthopedic procedures/methods|orthopedic procedures/methods
351568|NCT02090140|tissue engineering|tissue engineering
351569|NCT02090140|tissue scaffolds|tissue scaffolds
351570|NCT02090140|arthroscopy/methods|arthroscopy/methods
351571|NCT02090140|chondrocytes/transplantation|chondrocytes/transplantation
351572|NCT02090140|adipose tissue/cytology|adipose tissue/cytology
351573|NCT02090140|cartilage, articular/cytology|cartilage, articular/cytology
351574|NCT02090140|chondrogenesis/physiology|chondrogenesis/physiology
351575|NCT02090140|osteogenesis/physiology|osteogenesis/physiology
351576|NCT02090140|stem cell transplantation/methods|stem cell transplantation/methods
351577|NCT02090140|stem cells|stem cells
351578|NCT02090140|tissue engineering/methods|tissue engineering/methods
351579|NCT02090140|cartilage, articular/pathology|cartilage, articular/pathology
351580|NCT02090140|chondrocytes/pathology|chondrocytes/pathology
351581|NCT02090140|knee joint/pathology|knee joint/pathology
351582|NCT02090140|platelet-rich plasma|platelet-rich plasma
351583|NCT02090114|Bipolar Androgen Therapy|bipolar androgen therapy
351584|NCT02090114|Testosterone|testosterone
351585|NCT02090114|Enzalutamide|enzalutamide
351586|NCT02090114|Abiraterone|abiraterone
351587|NCT02090114|Androgen Ablative Therapies|androgen ablative therapies
351588|NCT02090075|cardiac Computed tomography|cardiac computed tomography
351589|NCT02090075|coronary calcification|coronary calcification
351590|NCT02090075|intervention|intervention
351591|NCT02090075|warfarin|warfarin
351592|NCT02090075|apixaban|apixaban
351593|NCT02090062|endoscopic resection|endoscopic resection
351594|NCT02090062|H. pylori infection|h. pylori infection
351595|NCT02090049|Appetite|appetite
351596|NCT02090049|Satiety|satiety
351597|NCT02090049|Bread|bread
351598|NCT02090049|Dietary fiber|dietary fiber
351599|NCT02090049|Gastrointestinal hormones|gastrointestinal hormones
351600|NCT02090049|Glycemia|glycemia
351601|NCT02090049|Insulinemia|insulinemia
351602|NCT02090036|Efficacy|efficacy
351603|NCT02090036|Safety|safety
351604|NCT02090036|Primaquine|primaquine
351605|NCT02090036|Artemether-lumefantrine|artemether-lumefantrine
351606|NCT02090036|Gametocytes|gametocytes
351607|NCT02090023|Obstructive sleep apnea|obstructive sleep apnea
351608|NCT02090023|National Health Insurance Research Database in Taiwan|national health insurance research database in taiwan
351609|NCT02090023|Survival Analysis|survival analysis
351610|NCT02090023|Validation Studies|validation studies
351611|NCT02090023|Cohort Studies|cohort studies
351612|NCT02089997|Pharmacological therapy|pharmacological therapy
351613|NCT02089984|Cognitive Behavior Therapy|cognitive behavior therapy
351614|NCT02089984|On-line training|on-line training
351615|NCT02089958|Lapraoscopy, incisional hernia repair, mesh|lapraoscopy, incisional hernia repair, mesh
351616|NCT02089945|transcatheter aortic valve implantation|transcatheter aortic valve implantation
351617|NCT02089945|severe aortic stenosis|severe aortic stenosis
351618|NCT02089945|cognition|cognition
351619|NCT02089945|functional capacity|functional capacity
351620|NCT02089945|quality of life|quality of life
351621|NCT02089932|femoral nerve block|femoral nerve block
351622|NCT02089932|peri-neural dexmedetomidine|peri-neural dexmedetomidine
351623|NCT02089867|Ezetimibe|ezetimibe
351624|NCT02089867|Plant sterol|plant sterol
351625|NCT02089867|Hydroxymethylglutaryl coenzyme A Reductase Inhibitors|hydroxymethylglutaryl coenzyme a reductase inhibitors
351626|NCT02089867|Coronary artery disease|coronary artery disease
351627|NCT02089867|LDL-cholesterol|ldl-cholesterol
351628|NCT02089854|triple negative breast cancer|triple negative breast cancer
351629|NCT02089854|estrogen receptor-beta|estrogen receptor-beta
351630|NCT02089854|endocrine therapy|endocrine therapy
351631|NCT02089841|Efficacy|efficacy
351632|NCT02089841|Artemether/lumefantrine|artemether/lumefantrine
351633|NCT02089841|Malaria|malaria
351634|NCT02089841|Children|children
351635|NCT02089802|RCC|rcc
351636|NCT02089789|Thrombosis|thrombosis
351637|NCT02089789|Intellectual Disability|intellectual disability
351638|NCT02089789|Hypotonia|hypotonia
351639|NCT02089789|Hypoglycemia|hypoglycemia
351640|NCT02089789|Hypothyroidism|hypothyroidism
351641|NCT02089776|Stroke|stroke
351642|NCT02089776|fMRI|fmri
351643|NCT02089776|Real Time fMRI Feedback|real time fmri feedback
351644|NCT02089763|Hepatocellular carcinoma|hepatocellular carcinoma
351645|NCT02089763|HCC|hcc
351646|NCT02089763|Pegylated recombinant human arginase|pegylated recombinant human arginase
351647|NCT02089763|PEG-BCT-100|peg-bct-100
351648|NCT02089763|ASS|ass
351649|NCT02089763|OTC|otc
351650|NCT02089750|Low Back Pain|low back pain
351651|NCT02089750|Chiropractic|chiropractic
351652|NCT02089750|Shoe Orthotics|shoe orthotics
351653|NCT02089711|Normal subjects|normal subjects
351654|NCT02089698|Kelman tip|kelman tip
351655|NCT02089698|Mini-flared|mini-flared
351656|NCT02089698|phacoemulsification|phacoemulsification
351657|NCT02089698|cataract|cataract
351658|NCT02089633|hepatocellular carcinoma|hepatocellular carcinoma
351659|NCT02089633|HCC|hcc
351660|NCT02089633|pegylated recombinant human arginase|pegylated recombinant human arginase
351661|NCT02089633|PEG-BCT-100|peg-bct-100
351662|NCT02089633|oxaliplatin|oxaliplatin
351663|NCT02089633|capecitabine|capecitabine
351664|NCT02089620|Premenstrual syndrome|premenstrual syndrome
351665|NCT02089620|Oral contraceptive pills|oral contraceptive pills
351666|NCT02089620|Calcium Supplements|calcium supplements
351667|NCT02089594|Hyperbaric Oxygen Treatment|hyperbaric oxygen treatment
351668|NCT02089594|Mild Traumatic Brain Injury|mild traumatic brain injury
351669|NCT02089594|Persistent Post-Concussion Syndrome|persistent post-concussion syndrome
351670|NCT02089581|Healthy Volunteer|healthy volunteer
351671|NCT02089581|Pharmacokinetics|pharmacokinetics
351672|NCT02089581|Bioequivalence|bioequivalence
351673|NCT02089568|Living donation|living donation
351674|NCT02089568|Antibiotics|antibiotics
351675|NCT02089568|Laparoscopic surgery|laparoscopic surgery
351676|NCT02089542|thyroidectomy|thyroidectomy
351677|NCT02089542|parathyroid surgery|parathyroid surgery
351678|NCT02089542|parathyroid identification|parathyroid identification
351679|NCT02089542|methylene blue|methylene blue
351680|NCT02089542|near infrared fluorescence|near infrared fluorescence
351681|NCT02089542|intraoperative imaging|intraoperative imaging
351682|NCT02089529|Axial Spondyloarthritis|axial spondyloarthritis
351683|NCT02089529|Pain|pain
351684|NCT02089529|NSAIDs|nsaids
351685|NCT02089529|Placebo|placebo
351686|NCT02089529|Placebo intervention|placebo intervention
351687|NCT02089529|Stress|stress
351688|NCT02089529|Conditioning|conditioning
351689|NCT02089516|Frailty|frailty
351690|NCT02089516|Accelerometry|accelerometry
351691|NCT02089516|Physical activity|physical activity
351692|NCT02089516|validity|validity
351693|NCT02089477|Type 2 diabetes, InterWalk, Individual Support, Motivation|type 2 diabetes, interwalk, individual support, motivation
351694|NCT02089412|Healthy Subjects|healthy subjects
351695|NCT02089412|Absorption|absorption
351696|NCT02089412|High-Fat Meal|high-fat meal
351697|NCT02089360|Advanced glycation end product|advanced glycation end product
351698|NCT02089360|coronary|coronary
351699|NCT02089360|atherosclerosis|atherosclerosis
351700|NCT02089360|inflammation|inflammation
351701|NCT02089360|outcome|outcome
351702|NCT02089347|Tetanus|tetanus
351703|NCT02089347|Diphtheria|diphtheria
351704|NCT02089347|Pertussis|pertussis
351705|NCT02089347|TdaP vaccine|tdap vaccine
351706|NCT02089347|DT vaccine|dt vaccine
351707|NCT02089334|renal cell carcinoma|renal cell carcinoma
351708|NCT02089334|clear cell|clear cell
351709|NCT02089334|renal cancer|renal cancer
351710|NCT02089334|metastatic renal cancer|metastatic renal cancer
351711|NCT02089334|Carcinoma, Renal Cell*/therapy|carcinoma, renal cell*/therapy
351712|NCT02089334|Humans|humans
351713|NCT02089334|Kidney Neoplasms*/therapy|kidney neoplasms*/therapy
351714|NCT02089321|low back pain|low back pain
351715|NCT02089321|lumbopelvic assessment|lumbopelvic assessment
351716|NCT02089321|active straight leg raise|active straight leg raise
351717|NCT02089321|active hip abduction|active hip abduction
351718|NCT02089308|Smoking cessation|smoking cessation
351719|NCT02089308|Nicotine|nicotine
351720|NCT02089308|Tobacco Use Disorder|tobacco use disorder
351721|NCT02089308|Central Nervous System Agents|central nervous system agents
351722|NCT02089295|dose proportionality|dose proportionality
351723|NCT02089295|oxycodone|oxycodone
351724|NCT02089269|pancreatic neoplasms|pancreatic neoplasms
351725|NCT02089269|neoplasms|neoplasms
351726|NCT02089269|registry|registry
351727|NCT02089269|advanced pancreatic cancer|advanced pancreatic cancer
351728|NCT02089269|health services research|health services research
351729|NCT02089269|epidemiology|epidemiology
351730|NCT02089269|Germany|germany
351731|NCT02089269|palliative treatment|palliative treatment
351732|NCT02089269|palliative care|palliative care
351733|NCT02089269|localized, resectable pancreatic cancer|localized, resectable pancreatic cancer
351734|NCT02089269|adjuvant treatment|adjuvant treatment
351735|NCT02089243|Epilepsy,Temporal Lobe|epilepsy,temporal lobe
351736|NCT02089243|Brain Diseases|brain diseases
351737|NCT02089230|Leukemia|leukemia
351738|NCT02089230|Acute Myeloid Leukemia|acute myeloid leukemia
351740|NCT02089230|Advanced leukemias|advanced leukemias
351741|NCT02089230|Myelodysplastic syndrome|myelodysplastic syndrome
351742|NCT02089230|MDS|mds
351743|NCT02089230|Acute lymphoblastic leukemia|acute lymphoblastic leukemia
351744|NCT02089230|ALL|all
351745|NCT02089230|Relapsed|relapsed
351746|NCT02089230|Refractory|refractory
351747|NCT02089230|MEK 162|mek 162
351748|NCT02089217|asymptomatic|asymptomatic
351749|NCT02089217|carotid|carotid
351750|NCT02089217|stent|stent
351751|NCT02089217|endarterectomy|endarterectomy
351752|NCT02089217|embolic protection|embolic protection
351753|NCT02089217|medical management|medical management
351754|NCT02089217|hypertension|hypertension
351755|NCT02089217|hyperlipidemia|hyperlipidemia
351756|NCT02089217|cognition|cognition
351757|NCT02089217|risk factor control|risk factor control
351758|NCT02089204|Hypoxia Imaging -Guided Radiotherapy|hypoxia imaging -guided radiotherapy
351759|NCT02089204|PET/CT|pet/ct
351760|NCT02089204|simultaneous modulated accelerated radiation therapy (SMART)|simultaneous modulated accelerated radiation therapy (smart)
351761|NCT02089191|DACP|dacp
351762|NCT02089191|DAILIES® AquaComfort Plus|dailies® aquacomfort plus
351763|NCT02089191|Tear film stability|tear film stability
351764|NCT02089191|NIK-BUT|nik-but
351765|NCT02089178|total intravenous anesthesia, inhalation anesthesia, cancer cell cytotoxicity, breast tumor|total intravenous anesthesia, inhalation anesthesia, cancer cell cytotoxicity, breast tumor
351766|NCT02089152|Diabetes|diabetes
351767|NCT02089152|Melioidosis|melioidosis
351768|NCT02089152|stepped wedge trial|stepped wedge trial
351769|NCT02089152|behaviour change|behaviour change
351770|NCT02089152|Education program|education program
351771|NCT02089139|Back pain|back pain
351772|NCT02089139|Discogel|discogel
351773|NCT02089087|Rheumatoid arthritis, RA, first-in-human, single ascending dose, safety, tolerability|rheumatoid arthritis, ra, first-in-human, single ascending dose, safety, tolerability
351774|NCT02089074|Secondary Prevention|secondary prevention
351775|NCT02089074|Pharmacists|pharmacists
351776|NCT02089074|Directive Counseling|directive counseling
351777|NCT02089074|Medication Adherence|medication adherence
351778|NCT02089074|Patient Compliance|patient compliance
351779|NCT02089048|Amebiasis|amebiasis
351780|NCT02089048|auranofin|auranofin
351781|NCT02089048|pharmacodynamics|pharmacodynamics
351782|NCT02089048|pharmokinetics|pharmokinetics
351783|NCT02089035|Milk fatty acids|milk fatty acids
351784|NCT02089035|Total cholesterol|total cholesterol
351785|NCT02089035|Vascular function|vascular function
351786|NCT02089035|Blood pressure|blood pressure
351787|NCT02089022|Ice|ice
351788|NCT02089022|Heat|heat
351789|NCT02089022|Ground reaction forces|ground reaction forces
351790|NCT02089022|Electromyography|electromyography
351791|NCT02089022|Lower Limb|lower limb
351792|NCT02089022|Center of pressure|center of pressure
351793|NCT02088970|Infectious keratitis|infectious keratitis
351794|NCT02088970|Corneal cross linking|corneal cross linking
351795|NCT02088970|Topical antibiotics|topical antibiotics
351796|NCT02088957|Brivaracetam|brivaracetam
351797|NCT02088957|Phenytoin|phenytoin
351798|NCT02088957|Nonconvulsive electrographic seizures|nonconvulsive electrographic seizures
351799|NCT02088931|Tregs|tregs
351800|NCT02088931|Kidney transplantation|kidney transplantation
351801|NCT02088905|PCIT, autism, parent training, noncompliance|pcit, autism, parent training, noncompliance
351802|NCT02088892|BCG challenge study|bcg challenge study
351803|NCT02088866|Tinnitus|tinnitus
351804|NCT02088866|Otolaryngology|otolaryngology
351805|NCT02088853|intestinal|intestinal
351806|NCT02088853|metabolic control|metabolic control
351807|NCT02088853|mucosa|mucosa
351808|NCT02088853|human|human
351809|NCT02088853|diet|diet
351810|NCT02088840|SIGNB|signb
351811|NCT02088840|severe infections gram negative bacteria|severe infections gram negative bacteria
351812|NCT02088840|stem cell transplant|stem cell transplant
351813|NCT02088827|Exercise|exercise
351814|NCT02088827|Sedentary Behaviour|sedentary behaviour
351815|NCT02088827|Type 2 Diabetes|type 2 diabetes
351816|NCT02088827|Older Adults|older adults
351817|NCT02088814|posttraumatic stress|posttraumatic stress
351818|NCT02088814|burns|burns
351819|NCT02088814|injuries|injuries
351820|NCT02088814|children|children
351821|NCT02088801|Intubation; Difficult|intubation; difficult
351822|NCT02088788|radiation|radiation
351823|NCT02088788|radiation injury|radiation injury
351824|NCT02088788|occupational risk|occupational risk
351825|NCT02088762|margin of safety|margin of safety
351827|NCT02088749|weight loss|weight loss
351828|NCT02088749|treatment|treatment
351829|NCT02088749|lifestyle|lifestyle
351830|NCT02088723|Sleep Apnea, Obstructive|sleep apnea, obstructive
351831|NCT02088723|Sleep Apnea Syndromes|sleep apnea syndromes
351832|NCT02088723|Polysomnography|polysomnography
351833|NCT02088723|Sleep|sleep
351834|NCT02088723|Patient Positioning|patient positioning
351835|NCT02088710|Patients´ Expectations|patients´ expectations
351836|NCT02088710|Breast Cancer|breast cancer
351837|NCT02088710|Adjuvant Endocrine Treatment|adjuvant endocrine treatment
351838|NCT02088710|Nocebo|nocebo
351839|NCT02088710|Psycho-oncology|psycho-oncology
351840|NCT02088710|Satisfaction with information|satisfaction with information
351841|NCT02088684|Hormone receptor positive, HER2 negative|hormone receptor positive, her2 negative
351842|NCT02088671|NeuroSENSE|neurosense
351843|NCT02088671|Anesthesia|anesthesia
351844|NCT02088671|Hypnosis|hypnosis
351845|NCT02088671|Desflurane|desflurane
351846|NCT02088671|Propofol|propofol
351847|NCT02088658|Diabetes Mellitus, Type 2|diabetes mellitus, type 2
351848|NCT02088658|Diabetes Mellitus, Adult-Onset|diabetes mellitus, adult-onset
351849|NCT02088658|Diabetes Mellitus, Non-Insulin-Dependent|diabetes mellitus, non-insulin-dependent
351850|NCT02088658|Diabetes Mellitus, Noninsulin Dependent|diabetes mellitus, noninsulin dependent
351851|NCT02088658|Diabetes Mellitus, Type II|diabetes mellitus, type ii
351852|NCT02088658|African Americans|african americans
351853|NCT02088658|Blacks|blacks
351854|NCT02088658|non-Hispanic Blacks|non-hispanic blacks
351855|NCT02088658|Randomized Control Trial|randomized control trial
351856|NCT02088658|Controlled Clinical Trial|controlled clinical trial
351857|NCT02088658|Behavioral Research|behavioral research
351858|NCT02088658|Behavioral Medicine|behavioral medicine
351859|NCT02088645|Calcitonin|calcitonin
351860|NCT02088645|Medullary thyroid carcinoma|medullary thyroid carcinoma
351861|NCT02088645|Peptide receptor radionuclide therapy|peptide receptor radionuclide therapy
351862|NCT02088645|Gastrin|gastrin
351863|NCT02088645|Cholecystokinin-2 receptor|cholecystokinin-2 receptor
351864|NCT02088619|psychological wellbeing|psychological wellbeing
351865|NCT02088619|anxiety|anxiety
351866|NCT02088619|depression|depression
351867|NCT02088619|autonomic functioning|autonomic functioning
351868|NCT02088593|Medical Students|medical students
351869|NCT02088541|Relapsed/Refractory Acute Myeloid Leukemia|relapsed/refractory acute myeloid leukemia
351870|NCT02088541|Acute Myeloid Leukemia|acute myeloid leukemia
351871|NCT02088541|AML|aml
351872|NCT02088541|Karyopharm|karyopharm
351873|NCT02088541|Selinexor|selinexor
351874|NCT02088541|KPT-330|kpt-330
351875|NCT02088515|Nedaplatin|nedaplatin
351876|NCT02088515|lung squamous cell carcinoma|lung squamous cell carcinoma
351877|NCT02088502|Coronary Angiography|coronary angiography
777054|NCT00341380|NSCLC|nsclc
351878|NCT02088502|Side Effects|side effects
351879|NCT02088502|Contrast-Induced Nephropathy|contrast-induced nephropathy
351880|NCT02088502|Prevention|prevention
351881|NCT02088489|Atrial flutter|atrial flutter
351882|NCT02088489|Thermocool catheter|thermocool catheter
351883|NCT02088489|Thermocool SF catheter|thermocool sf catheter
351884|NCT02088476|candidemia|candidemia
351885|NCT02088476|children|children
351886|NCT02088476|mortality|mortality
351887|NCT02088476|risk factors|risk factors
351888|NCT02088463|Mechanical LBP|mechanical lbp
351889|NCT02088463|Mobilization|mobilization
351890|NCT02088463|Postpartum|postpartum
351891|NCT02088450|Cardiovascular complications|cardiovascular complications
351892|NCT02088450|Clinical trial|clinical trial
351893|NCT02088450|Elderly|elderly
351894|NCT02088450|Isolated systolic hypertension|isolated systolic hypertension
351895|NCT02088450|Stroke|stroke
351896|NCT02088398|relative bioavailability|relative bioavailability
351897|NCT02088398|food-effect|food-effect
351898|NCT02088359|cycled light, near darkness, growth|cycled light, near darkness, growth
351899|NCT02088346|Stroke|stroke
351900|NCT02088346|Thrombolysis|thrombolysis
351901|NCT02088346|Tissue plasminogen activator|tissue plasminogen activator
351902|NCT02088346|Urokinase|urokinase
351903|NCT02088346|Telemedicine|telemedicine
351904|NCT02088333|colorectal cancer screening|colorectal cancer screening
351905|NCT02088333|computer-assisted instruction|computer-assisted instruction
351906|NCT02088333|mHealth|mhealth
351907|NCT02088333|text message|text message
351908|NCT02088307|cardiovascular supplement|cardiovascular supplement
351909|NCT02088307|cardiovascular disease|cardiovascular disease
351910|NCT02088307|coronary artery disease|coronary artery disease
351911|NCT02088294|obesity|obesity
351912|NCT02088294|stress|stress
351913|NCT02088294|intuitive eating|intuitive eating
351914|NCT02088294|guided imagery|guided imagery
351915|NCT02088294|adolescents|adolescents
351916|NCT02088294|insulin resistance|insulin resistance
351917|NCT02088294|latinos|latinos
351918|NCT02088294|minorities|minorities
351919|NCT02088281|Indigo naturalis, indirubin, Th1 cells, Th17 cells|indigo naturalis, indirubin, th1 cells, th17 cells
351920|NCT02088255|Rehabilitation|rehabilitation
351921|NCT02088255|Gait|gait
351922|NCT02088255|Stroke|stroke
351923|NCT02088255|Biomechanics|biomechanics
351924|NCT02088229|Diabetic Macular Edema|diabetic macular edema
351925|NCT02088216|N-acetylcysteine；|n-acetylcysteine；
351926|NCT02088216|Bronchiectasis；|bronchiectasis；
351927|NCT02088216|Acute exacerbations；|acute exacerbations；
351928|NCT02088216|Antioxidant；|antioxidant；
351929|NCT02088216|Anti-inflammatory|anti-inflammatory
351930|NCT02088177|Cannabis|cannabis
351931|NCT02088177|Cannabis Dependence|cannabis dependence
351932|NCT02088177|Cannabis Use Disorder|cannabis use disorder
351933|NCT02088177|Marijuana|marijuana
351934|NCT02088177|Naltrexone|naltrexone
351935|NCT02088177|Long Acting Injectable Naltrexone|long acting injectable naltrexone
351936|NCT02088177|Treatment|treatment
351937|NCT02088164|PSA,|psa,
351938|NCT02088164|asian men,|asian men,
351939|NCT02088164|survival|survival
351940|NCT02088151|selective laser therapy|selective laser therapy
351941|NCT02088151|retinal pigment epithelium|retinal pigment epithelium
351942|NCT02088151|macular edema|macular edema
351943|NCT02088151|diabetic retinopathy|diabetic retinopathy
351944|NCT02088151|central serous chorioretinopathy|central serous chorioretinopathy
351945|NCT02088151|age-related macular degeneration|age-related macular degeneration
351946|NCT02088151|retinal vein occlusion|retinal vein occlusion
351947|NCT02088138|Thoracic Surgery|thoracic surgery
351948|NCT02088138|Electrical Stimulation|electrical stimulation
351949|NCT02088138|Rehabilitation|rehabilitation
351950|NCT02088138|Quality of Life|quality of life
351951|NCT02088125|Stroke|stroke
351952|NCT02088125|Incentive Spirometry|incentive spirometry
351953|NCT02088125|Breath Stacking|breath stacking
351954|NCT02088125|Optoelectronic Plethysmography|optoelectronic plethysmography
351955|NCT02088112|NSCLC|nsclc
351956|NCT02088099|Traumatic brain injury|traumatic brain injury
351957|NCT02088099|Telehealth|telehealth
351958|NCT02088099|ehealth|ehealth
351959|NCT02088099|Mobile Health|mobile health
351960|NCT02088099|social participation|social participation
351961|NCT02088099|patient participation|patient participation
351962|NCT02088099|consumer participation|consumer participation
351963|NCT02088099|Patient Outcome Assessment|patient outcome assessment
351964|NCT02088086|Pediatric obesity|pediatric obesity
351965|NCT02088086|Overweight|overweight
351966|NCT02088086|Body mass index|body mass index
351967|NCT02088086|Primary schools|primary schools
351968|NCT02088086|Secondary schools|secondary schools
351969|NCT02088047|Autism|autism
351970|NCT02088047|Self-Stimulating behaviors|self-stimulating behaviors
351971|NCT02088047|Autism Spectrum Disorders|autism spectrum disorders
351972|NCT02087995|Diabetes Mellitus|diabetes mellitus
351973|NCT02087956|Women|women
351974|NCT02087956|Depression|depression
351975|NCT02087956|Socioeconomically Disadvantaged|socioeconomically disadvantaged
351976|NCT02087956|Navigation|navigation
351977|NCT02087943|Atopic Dermatitis|atopic dermatitis
351978|NCT02087943|Atopic Eczema|atopic eczema
351979|NCT02087917|hypercholesterolemia|hypercholesterolemia
351980|NCT02087917|cholesterol absorption inhibitor|cholesterol absorption inhibitor
351981|NCT02087917|placebo-controlled trial|placebo-controlled trial
351982|NCT02087904|Osteoarthritis|osteoarthritis
351983|NCT02087904|Synovitis|synovitis
351984|NCT02087904|Knee|knee
351985|NCT02087904|Pain|pain
351986|NCT02087878|Hepatosplenic T-Cell Lymphoma|hepatosplenic t-cell lymphoma
351987|NCT02087852|Questionnaire|questionnaire
351988|NCT02087852|DNA|dna
351989|NCT02087852|saliva|saliva
351990|NCT02087852|kidney cancer|kidney cancer
351991|NCT02087852|13-218|13-218
351992|NCT02087813|neuromyelitis optica|neuromyelitis optica
351993|NCT02087813|optic neuritis|optic neuritis
351994|NCT02087813|longitudinally extensive transverse myelitis|longitudinally extensive transverse myelitis
351995|NCT02087800|smoking cessation|smoking cessation
351996|NCT02087800|smoking abstinence|smoking abstinence
351997|NCT02087800|allopregnanolone|allopregnanolone
351998|NCT02087787|bone marrow transplant|bone marrow transplant
351999|NCT02087787|hematologic malignancies|hematologic malignancies
352000|NCT02087761|ARIES Flu|aries flu
352001|NCT02087748|DOMS|doms
352002|NCT02087735|Cranberry|cranberry
352003|NCT02087735|Proanthocyanidins|proanthocyanidins
352004|NCT02087735|Urinary catabolites|urinary catabolites
352005|NCT02087722|Primary Insomnia|primary insomnia
352006|NCT02087696|Arthritis, Rheumatoid|arthritis, rheumatoid
352007|NCT02087696|methotrexate|methotrexate
352008|NCT02087696|intolerance|intolerance
352009|NCT02087696|poor compliance|poor compliance
352010|NCT02087696|contraindication|contraindication
352011|NCT02087696|Tocilizumab|tocilizumab
352012|NCT02087696|monotherapy|monotherapy
352013|NCT02087683|heart failure|heart failure
352014|NCT02087683|vitamin D deficiency|vitamin d deficiency
352015|NCT02087683|ventricular function|ventricular function
352016|NCT02087683|cytokines|cytokines
352017|NCT02087670|chronic heart failure|chronic heart failure
352018|NCT02087670|cardiac rehabilitation|cardiac rehabilitation
352019|NCT02087670|exercise|exercise
352020|NCT02087670|Natriuretic Brain Pro-peptid|natriuretic brain pro-peptid
352021|NCT02087657|Peripheral Blood Stem Cell (PBSC) Transplant|peripheral blood stem cell (pbsc) transplant
352022|NCT02087657|Hyperbaric oxygen|hyperbaric oxygen
352023|NCT02087657|Lymphoma|lymphoma
352024|NCT02087657|Myeloma|myeloma
352025|NCT02087631|multiple sclerosis|multiple sclerosis
352026|NCT02087631|quetiapine|quetiapine
352027|NCT02087631|remyelination|remyelination
352028|NCT02087618|MCI|mci
352029|NCT02087618|Alzheimer's|alzheimer's
352030|NCT02087618|Dementia|dementia
352031|NCT02087618|Tablet|tablet
352032|NCT02087618|Non-Pharmacological Intervention|non-pharmacological intervention
352033|NCT02087618|Cognition|cognition
352034|NCT02087605|Vascular stiffness, retinal vessels, target organ damage|vascular stiffness, retinal vessels, target organ damage
352035|NCT02087592|hereditary breast and ovarian cancer (HBOC)|hereditary breast and ovarian cancer (hboc)
352036|NCT02087592|BRCA1/2 mutation carriers|brca1/2 mutation carriers
352037|NCT02087592|Mediterranean diet|mediterranean diet
352038|NCT02087592|Structured exercise training|structured exercise training
352039|NCT02087592|prevention|prevention
352040|NCT02087579|Psychotic Disorders|psychotic disorders
352041|NCT02087579|Schizophrenia|schizophrenia
352042|NCT02087579|Bipolar Disorder|bipolar disorder
352043|NCT02087579|Depressive Disorder|depressive disorder
352044|NCT02087579|Antipsychotics|antipsychotics
352045|NCT02087579|Aripiprazole|aripiprazole
352046|NCT02087579|Olanzapine|olanzapine
352047|NCT02087579|Paliperidone|paliperidone
352048|NCT02087579|Quetiapine|quetiapine
352049|NCT02087579|Risperidone|risperidone
352050|NCT02087579|Capillary Concentration|capillary concentration
352051|NCT02087566|Linezolid|linezolid
352052|NCT02087566|Pharmacokinetics|pharmacokinetics
352053|NCT02087566|Haemodialysis|haemodialysis
352054|NCT02087566|Dosing adjustment|dosing adjustment
352055|NCT02087566|Eligible subjects were classified into three groups depending on their 24-h urinary creatinine clearance (CLcr) values or HD status.|eligible subjects were classified into three groups depending on their 24-h urinary creatinine clearance (clcr) values or hd status.
352056|NCT02087566|Group 1, included 6 healthy subjects with normal renal function (CLcr ˃80 ml/min);|group 1, included 6 healthy subjects with normal renal function (clcr ˃80 ml/min);
352057|NCT02087566|Group 2, included 6 patients with acute renal failure (RF) (30˂CLcr˂80 ml/mine);|group 2, included 6 patients with acute renal failure (rf) (30˂clcr˂80 ml/mine);
352058|NCT02087566|Group 3, included 6 patients on long term haemodialysis (minimum period of dialysis was 40 month while maximum period were 130 month)|group 3, included 6 patients on long term haemodialysis (minimum period of dialysis was 40 month while maximum period were 130 month)
352059|NCT02087553|Blood Transfusion|blood transfusion
352060|NCT02087553|Iron|iron
352061|NCT02087553|Packed Red Blood Cells|packed red blood cells
352062|NCT02087553|PRBC|prbc
352063|NCT02087553|NTBI|ntbi
352064|NCT02087527|Cellulitis|cellulitis
352065|NCT02087527|Soft Tissue Infections|soft tissue infections
352066|NCT02087527|Skin Diseases, Infectious|skin diseases, infectious
352067|NCT02087527|Corticosteroids|corticosteroids
352068|NCT02087527|Glucocorticoids|glucocorticoids
352069|NCT02087527|Dexamethasone|dexamethasone
352070|NCT02087514|Blood Transfusion|blood transfusion
352071|NCT02087514|Iron|iron
352072|NCT02087514|Red Blood Cells|red blood cells
352073|NCT02087501|Abdominal Aortic Aneurysm|abdominal aortic aneurysm
352074|NCT02087501|AAA|aaa
352075|NCT02087501|Abdominal Aortoiliac Aneurysm|abdominal aortoiliac aneurysm
352076|NCT02087501|Endovascular Aortic Repair|endovascular aortic repair
352077|NCT02087501|EVAR|evar
352078|NCT02087488|primary insomnia|primary insomnia
352079|NCT02087488|auricular acupuncture|auricular acupuncture
352080|NCT02087462|Sciatica|sciatica
352081|NCT02087462|Electroacupuncture|electroacupuncture
352082|NCT02087462|Intervertebral disc displacement|intervertebral disc displacement
352083|NCT02087423|Locally advanced, metastatic, Non-Small Cell Lung Cancer, MEDI4736, Durvalumab, PD-L1|locally advanced, metastatic, non-small cell lung cancer, medi4736, durvalumab, pd-l1
352084|NCT02087397|Stem Cell|stem cell
352085|NCT02087397|Erectile Dysfunction|erectile dysfunction
352086|NCT02087384|Anal intraepithelial neoplasia|anal intraepithelial neoplasia
352087|NCT02087384|HIV|hiv
352088|NCT02087384|HPV|hpv
352089|NCT02087384|Vaccination|vaccination
352090|NCT02087384|Gardasil|gardasil
352091|NCT02087384|Prophylactic|prophylactic
352092|NCT02087358|alcohol dependence|alcohol dependence
352093|NCT02087358|Stress- correlation|stress- correlation
352094|NCT02087358|genetic|genetic
352095|NCT02087358|CRHR1|crhr1
352096|NCT02087332|Kidney damage hypertension cardiovascular diseases, congestive heart failure renal function natriuresis natriuresis monitoring|kidney damage hypertension cardiovascular diseases, congestive heart failure renal function natriuresis natriuresis monitoring
352097|NCT02087306|Adenovirus Infection|adenovirus infection
352098|NCT02087241|Stage IV Lung Cancer|stage iv lung cancer
352099|NCT02087228|Endometrial ablation, menorrhagia|endometrial ablation, menorrhagia
352100|NCT02087215|diabetes mellitus|diabetes mellitus
352101|NCT02087215|foot ulcer|foot ulcer
352102|NCT02087215|boron|boron
352103|NCT02087215|wound care|wound care
352104|NCT02087202|pain|pain
352105|NCT02087189|ICD, CRT-D, lead|icd, crt-d, lead
352106|NCT02087176|NSCLC|nsclc
352107|NCT02087137|aging|aging
352108|NCT02087137|memory|memory
352109|NCT02087137|memory training|memory training
352110|NCT02087124|Whey protein|whey protein
352111|NCT02087124|Postprandial lipaemia|postprandial lipaemia
352112|NCT02087124|Pre-meal|pre-meal
352113|NCT02087124|Metabolic syndrome|metabolic syndrome
352114|NCT02087111|Telaprevir|telaprevir
352115|NCT02087111|Genotype 3 HCV|genotype 3 hcv
352116|NCT02087098|overactive bladder|overactive bladder
352117|NCT02087098|solifenacin|solifenacin
352118|NCT02087098|quality of life|quality of life
352119|NCT02087072|home visits|home visits
352120|NCT02087072|transitions of care|transitions of care
352121|NCT02087072|pharmacist|pharmacist
352122|NCT02087059|Post-Polycythemia Vera (PV) MF|post-polycythemia vera (pv) mf
352123|NCT02087059|Post-Essential Thrombocythemia (ET) MF|post-essential thrombocythemia (et) mf
352124|NCT02087033|supraventricular ectopic beats|supraventricular ectopic beats
352125|NCT02087020|Joint Prosthesis|joint prosthesis
352126|NCT02087020|Prosthesis-Related Infections|prosthesis-related infections
352127|NCT02087020|Joint Diseases|joint diseases
352128|NCT02087020|Therapeutic Irrigation|therapeutic irrigation
352129|NCT02087020|Prostheses and Implants|prostheses and implants
352130|NCT02087020|Arthroplasty Replacement|arthroplasty replacement
352131|NCT02087007|Treatment for vasospastic angina|treatment for vasospastic angina
352132|NCT02086994|carbetocin, misoprostol, pre-eclampsia, pph|carbetocin, misoprostol, pre-eclampsia, pph
352133|NCT02086955|Diabetes|diabetes
352134|NCT02086955|Nursing counseling|nursing counseling
352135|NCT02086955|Foot ulceration|foot ulceration
352136|NCT02086955|Outpatient|outpatient
352137|NCT02086955|Advanced Practice Nurse|advanced practice nurse
352138|NCT02086929|Trazodone|trazodone
352139|NCT02086929|Venlafaxine|venlafaxine
352140|NCT02086929|Major depressive disorder|major depressive disorder
352141|NCT02086916|Clostridium difficile|clostridium difficile
352142|NCT02086916|Prediction|prediction
352143|NCT02086916|Treatment|treatment
352144|NCT02086916|Failure|failure
352145|NCT02086903|Ticagrelor|ticagrelor
352146|NCT02086903|Clopidogrel|clopidogrel
352147|NCT02086903|Platelet function test|platelet function test
352148|NCT02086890|retinitis pigmentosa|retinitis pigmentosa
352149|NCT02086890|acupuncture|acupuncture
352150|NCT02086890|electroacupuncture|electroacupuncture
352151|NCT02086890|transcorneal electrical stimulation|transcorneal electrical stimulation
352152|NCT02086890|microcurrent|microcurrent
352153|NCT02086864|Attention Deficit Hyperactivity Disorder|attention deficit hyperactivity disorder
352154|NCT02086864|ADHD|adhd
352155|NCT02086864|Homeopathy|homeopathy
352156|NCT02086851|pediatric obesity|pediatric obesity
352157|NCT02086851|motivational interviewing|motivational interviewing
352158|NCT02086851|lifestyle intervention|lifestyle intervention
352159|NCT02086838|Iron deficiency anemia|iron deficiency anemia
450292|NCT01641796|CL|cl
352160|NCT02086838|Pregnancy|pregnancy
352161|NCT02086838|Iron therapy|iron therapy
352162|NCT02086799|asthma|asthma
352163|NCT02086799|thyroid hormones|thyroid hormones
352164|NCT02086799|treatment|treatment
352165|NCT02086799|asthma exacerbation|asthma exacerbation
352166|NCT02086773|Acute Leukemia|acute leukemia
352167|NCT02086773|Red Cell Transfusion|red cell transfusion
352168|NCT02086760|hydronephrosis|hydronephrosis
352169|NCT02086747|Abdominal Hysterectomy, Acetaminophen, chronic pain|abdominal hysterectomy, acetaminophen, chronic pain
352170|NCT02086734|Perfusion-CT|perfusion-ct
352171|NCT02086734|mRCC|mrcc
352172|NCT02086734|antiangiogenic therapy|antiangiogenic therapy
352173|NCT02086734|response assessment|response assessment
352174|NCT02086708|Sonoelastography,|sonoelastography,
352175|NCT02086708|Diffuse liver disease,|diffuse liver disease,
352176|NCT02086708|chronic liver disease,|chronic liver disease,
352177|NCT02086708|NASH,|nash,
352178|NCT02086708|NAFLD,|nafld,
352179|NCT02086708|Elevated Transaminases,|elevated transaminases,
352180|NCT02086708|Liver Biopsy,|liver biopsy,
352181|NCT02086708|Fibrosis,|fibrosis,
352182|NCT02086708|METAVIR|metavir
352183|NCT02086695|Chemotherapy|chemotherapy
352184|NCT02086695|Cardiotoxicity|cardiotoxicity
352185|NCT02086682|hemodialysis|hemodialysis
352186|NCT02086682|dialysis|dialysis
352187|NCT02086682|renal dialysis|renal dialysis
352188|NCT02086682|clotting|clotting
352189|NCT02086682|coagulation|coagulation
352190|NCT02086682|blood lines|blood lines
352191|NCT02086656|liver metastases|liver metastases
352192|NCT02086656|colorectal cancer|colorectal cancer
352193|NCT02086656|perioperative treatment|perioperative treatment
352194|NCT02086643|Infraclavicular block|infraclavicular block
352195|NCT02086643|Brachial Plexus|brachial plexus
352196|NCT02086643|Retroclavicular Approach|retroclavicular approach
352197|NCT02086643|Complications of retroclavicular approach|complications of retroclavicular approach
352198|NCT02086643|Success of retroclavicular approach|success of retroclavicular approach
352199|NCT02086643|Obese Patients|obese patients
352200|NCT02086643|Obesity and Anesthesia|obesity and anesthesia
352201|NCT02086630|disparities|disparities
352202|NCT02086630|antiretroviral|antiretroviral
352203|NCT02086630|HIV|hiv
352204|NCT02086630|barriers|barriers
352205|NCT02086630|access|access
352206|NCT02086630|delay|delay
352207|NCT02086630|decline|decline
352208|NCT02086630|discontinue|discontinue
352209|NCT02086630|African American|african american
352210|NCT02086630|Black|black
352211|NCT02086630|Latino|latino
352212|NCT02086630|Hispanic|hispanic
352213|NCT02086630|care continuum|care continuum
352214|NCT02086630|Heart to Heart Behavioral intervention|heart to heart behavioral intervention
352215|NCT02086630|Treatment as Usual|treatment as usual
352216|NCT02086591|Non Hodgkin Lymphoma|non hodgkin lymphoma
352217|NCT02086591|Doxycycline|doxycycline
352218|NCT02086578|multi-beam Intensity-Modulated Radiation Therapy (IMRT)|multi-beam intensity-modulated radiation therapy (imrt)
352219|NCT02086578|14-028|14-028
352220|NCT02086565|asthma,|asthma,
352221|NCT02086565|asthma control,|asthma control,
352222|NCT02086565|asthma-related quality of life|asthma-related quality of life
352223|NCT02086565|electronic health record,|electronic health record,
352224|NCT02086565|portal,|portal,
352225|NCT02086565|health literacy|health literacy
352226|NCT02086513|Graft versus Host Disease|graft versus host disease
352227|NCT02086513|Allogeneic Stem Cell Transplantation|allogeneic stem cell transplantation
352228|NCT02086500|Tranexamic acid|tranexamic acid
352229|NCT02086500|randomized|randomized
352230|NCT02086500|hemorrhage|hemorrhage
352231|NCT02086500|blinded|blinded
352232|NCT02086487|NIlotinib , Suboptimal Response , Imatinib|nilotinib , suboptimal response , imatinib
352233|NCT02086435|Myomectomy|myomectomy
352234|NCT02086435|Laparoscopic myomectomy|laparoscopic myomectomy
352235|NCT02086435|Morcellation|morcellation
352236|NCT02086435|Risk of dissemination|risk of dissemination
352237|NCT02086435|Uterine Sarcoma|uterine sarcoma
352238|NCT02086435|Parasitic myoma|parasitic myoma
352239|NCT02086396|obesity|obesity
352240|NCT02086396|cardiovascular risk factors|cardiovascular risk factors
352241|NCT02086396|pumpkin seed|pumpkin seed
352242|NCT02086396|diet quality|diet quality
352243|NCT02086383|Pulmonary Rehabilitation|pulmonary rehabilitation
352244|NCT02086383|Self-Efficacy|self-efficacy
352245|NCT02086383|Physical Activity|physical activity
352246|NCT02086370|PBS|pbs
352247|NCT02086370|Prophylactic bilateral salpingectomy|prophylactic bilateral salpingectomy
352248|NCT02086370|Ovarian cancer prevention|ovarian cancer prevention
352249|NCT02086370|Ovarian reserve|ovarian reserve
352250|NCT02086370|Permanent contraception|permanent contraception
352251|NCT02086370|Surgical sterilization|surgical sterilization
352252|NCT02086344|Total Laparoscopic Hysterectomy|total laparoscopic hysterectomy
352253|NCT02086344|TLH|tlh
352254|NCT02086344|Ovarian reserve|ovarian reserve
352255|NCT02086344|Prophylactic bilateral salpingectomy|prophylactic bilateral salpingectomy
352256|NCT02086344|Ovarian cancer prevention|ovarian cancer prevention
352257|NCT02086344|Ovarian cancer|ovarian cancer
352258|NCT02086344|Fallopian Tubes|fallopian tubes
352259|NCT02086318|Ovarian reserve|ovarian reserve
352260|NCT02086318|Ovarian age|ovarian age
352261|NCT02086318|Fertility|fertility
352262|NCT02086318|Reproductive prognosis|reproductive prognosis
352263|NCT02086318|Distance to menopause|distance to menopause
352264|NCT02086305|Transitional care|transitional care
352265|NCT02086305|Supportive and palliative care|supportive and palliative care
352266|NCT02086292|Injections|injections
352267|NCT02086292|Lidocaine|lidocaine
352268|NCT02086292|Pain|pain
352269|NCT02086292|Healthy volunteers|healthy volunteers
352270|NCT02086279|AMH levels|amh levels
352271|NCT02086279|Ovarian reserve|ovarian reserve
352272|NCT02086279|GnRH analogue|gnrh analogue
352273|NCT02086279|Ovarian reserve after GnRH analogue|ovarian reserve after gnrh analogue
352274|NCT02086279|Ovarian reserve modification|ovarian reserve modification
352275|NCT02086279|Antral follicle count|antral follicle count
352276|NCT02086279|Antral follicle count after GnRH analogue|antral follicle count after gnrh analogue
352277|NCT02086266|Prostatectomy|prostatectomy
352278|NCT02086266|Urinary Continence|urinary continence
352279|NCT02086266|Physical Therapy Modalities|physical therapy modalities
352280|NCT02086266|Pelvic Floor|pelvic floor
352281|NCT02086266|Randomized Trial.|randomized trial.
352282|NCT02086253|Endothelin, endothelium, flow-mediated dilatation|endothelin, endothelium, flow-mediated dilatation
352283|NCT02086227|Bioequivalence|bioequivalence
352284|NCT02086214|Upper limb|upper limb
352285|NCT02086214|Proprioceptive pressure therapy|proprioceptive pressure therapy
352286|NCT02086214|Children|children
352287|NCT02086214|Assisting Hand Assessment performance|assisting hand assessment performance
352288|NCT02086201|major depression|major depression
352289|NCT02086201|depression|depression
352290|NCT02086201|depressive disorder|depressive disorder
352291|NCT02086201|mental health|mental health
352292|NCT02086201|mental disorder|mental disorder
352293|NCT02086188|Multiple Sclerosis|multiple sclerosis
352294|NCT02086188|Overactive Bladder|overactive bladder
352295|NCT02086188|Incontinence|incontinence
352296|NCT02086188|Voiding|voiding
352297|NCT02086188|Bladder Urgency|bladder urgency
352298|NCT02086188|Pelvic Floor Exercises|pelvic floor exercises
352299|NCT02086175|relapsed/refractory indolent B cell non-Hodgkin lymphomas|relapsed/refractory indolent b cell non-hodgkin lymphomas
352300|NCT02086162|Schizophrenia|schizophrenia
352301|NCT02086162|Smoking|smoking
352302|NCT02086162|Tobacco|tobacco
352303|NCT02086162|Motivation|motivation
352304|NCT02086162|Cessation Treatment|cessation treatment
352305|NCT02086149|Quit smoking|quit smoking
352306|NCT02086149|Exercise|exercise
352307|NCT02086149|Tobacco|tobacco
352308|NCT02086149|Smoking|smoking
352309|NCT02086136|aortic dissection|aortic dissection
352310|NCT02086136|diagnosis|diagnosis
352311|NCT02086136|emergency medicine|emergency medicine
352312|NCT02086136|d-dimer|d-dimer
352313|NCT02086123|Analgesia|analgesia
352314|NCT02086123|Epidural Analgesia|epidural analgesia
352315|NCT02086123|Narcotic Analgesia|narcotic analgesia
352316|NCT02086123|Patient Controlled Analgesia|patient controlled analgesia
352317|NCT02086123|Anesthesia and Analgesia|anesthesia and analgesia
352318|NCT02086123|Anti inflammatory Analgesics|anti inflammatory analgesics
352319|NCT02086123|NSAIDS|nsaids
352320|NCT02086110|probiotic|probiotic
352321|NCT02086110|prebiotic|prebiotic
352322|NCT02086110|autism|autism
352323|NCT02086110|oligosaccharides|oligosaccharides
352324|NCT02086110|Bifidobacterium infantis|bifidobacterium infantis
352325|NCT02086097|pain|pain
352326|NCT02086097|symptomatic irreversible pulpitis|symptomatic irreversible pulpitis
352327|NCT02086097|postoperative dental pain|postoperative dental pain
352328|NCT02086084|Acute Exacerbation Chronic Obstructive Pulmonary Disease|acute exacerbation chronic obstructive pulmonary disease
352329|NCT02086084|AECOPD|aecopd
352330|NCT02086084|Non invasive ventilation|non invasive ventilation
352332|NCT02086084|Extracorporeal carbon dioxide removal|extracorporeal carbon dioxide removal
352333|NCT02086084|ECCO2R|ecco2r
352334|NCT02086071|REBIOP re-biopsies advanced or metastatic NSCLC|rebiop re-biopsies advanced or metastatic nsclc
352335|NCT02086058|overactive bladder|overactive bladder
352336|NCT02086058|daytime urinary incontinence|daytime urinary incontinence
352337|NCT02086058|children|children
352338|NCT02086058|gene expression|gene expression
352339|NCT02086045|Coronary artery disease|coronary artery disease
352340|NCT02086032|Sleeping quality|sleeping quality
352341|NCT02086032|menopause|menopause
352342|NCT02086032|climacteric|climacteric
352343|NCT02086032|progestin|progestin
352344|NCT02086032|dydrogesterone|dydrogesterone
352345|NCT02086032|micronized progesterone|micronized progesterone
352346|NCT02086019|Revascularisation, octogenarian,acute coronary syndromes|revascularisation, octogenarian,acute coronary syndromes
352347|NCT02086006|Coronary artery disease|coronary artery disease
352348|NCT02085993|romiplostim,|romiplostim,
352349|NCT02085993|Nplate,|nplate,
352350|NCT02085993|immune thrombocytopenic purpura|immune thrombocytopenic purpura
352351|NCT02085967|Healthy|healthy
352352|NCT02085967|Metabolism|metabolism
352353|NCT02085967|Drug-Drug Interactions|drug-drug interactions
352354|NCT02085941|Head and Neck Neoplasms|head and neck neoplasms
352355|NCT02085941|Malignant Neoplasm of Vertebral Column|malignant neoplasm of vertebral column
352356|NCT02085928|Tennis elbow|tennis elbow
352357|NCT02085928|Lateral epicondylitis|lateral epicondylitis
352358|NCT02085928|Intratissue percutaneous electrolysis|intratissue percutaneous electrolysis
352359|NCT02085928|Eccentric exercise|eccentric exercise
352360|NCT02085928|Ultrasonography|ultrasonography
352361|NCT02085876|patients|patients
352362|NCT02085876|present|present
352363|NCT02085876|undergo bariatric surgery|undergo bariatric surgery
352364|NCT02085811|Kyphoplasty|kyphoplasty
352365|NCT02085811|at a single level|at a single level
352366|NCT02085811|(between T11 and L5)|(between t11 and l5)
352367|NCT02085811|associated surgery|associated surgery
352368|NCT02085798|Leukemia, Myelomonocytic, Chronic, myelodysplastic syndrome, Prospective, Treatment strategy, epidemiologic data|leukemia, myelomonocytic, chronic, myelodysplastic syndrome, prospective, treatment strategy, epidemiologic data
352369|NCT02085785|weight loss|weight loss
352370|NCT02085785|exercise|exercise
352371|NCT02085785|home-based|home-based
352372|NCT02085785|lower extremity amputation|lower extremity amputation
352373|NCT02085785|pilot study|pilot study
352374|NCT02085759|Healthy|healthy
352375|NCT02085733|Arthritis, Septic|arthritis, septic
352376|NCT02085681|Diabetic Retinopathy|diabetic retinopathy
352377|NCT02085681|Screening|screening
352378|NCT02085681|Tele-medicine|tele-medicine
352379|NCT02085681|Retinal Imaging|retinal imaging
352380|NCT02085681|Remote diagnosis|remote diagnosis
352381|NCT02085668|Chronic Heart Failure|chronic heart failure
352382|NCT02085668|Cardio-Renal Syndrome|cardio-renal syndrome
352383|NCT02085668|Renal Denervation|renal denervation
352384|NCT02085668|Symplicity|symplicity
352385|NCT02085668|Sympathetic activation|sympathetic activation
352386|NCT02085655|Extranodal NK/T-cell lymphoma|extranodal nk/t-cell lymphoma
352387|NCT02085655|PA-Gemox regimen|pa-gemox regimen
352388|NCT02085655|thalidomide|thalidomide
352389|NCT02085642|Stroke|stroke
352390|NCT02085642|Acupuncture|acupuncture
352391|NCT02085642|Gait|gait
352392|NCT02085642|Spasticity|spasticity
352393|NCT02085629|renal failure, end stage|renal failure, end stage
352394|NCT02085629|renal transplantation|renal transplantation
352395|NCT02085629|cell therapy|cell therapy
352396|NCT02085629|macrophages, monocyte derived|macrophages, monocyte derived
352397|NCT02085629|immune tolerance|immune tolerance
352398|NCT02085629|ONE Study|one study
352399|NCT02085629|immunotherapy|immunotherapy
352400|NCT02085616|Smoking cessation|smoking cessation
352401|NCT02085616|Tobacco cessation|tobacco cessation
352402|NCT02085616|Quitline|quitline
352403|NCT02085616|Telephone counselling|telephone counselling
352404|NCT02085616|Intensity|intensity
352405|NCT02085603|advanced solid malignancies|advanced solid malignancies
352406|NCT02085590|BCG vaccine|bcg vaccine
352408|NCT02085590|Immunity|immunity
352409|NCT02085577|Morphine consumption|morphine consumption
352410|NCT02085577|Postoperative pain|postoperative pain
352411|NCT02085577|Ketamine|ketamine
352412|NCT02085577|Side effects|side effects
352413|NCT02085577|Spine surgery|spine surgery
352414|NCT02085577|Chronic pain|chronic pain
352415|NCT02085564|Gastroesophageal-junction cancer|gastroesophageal-junction cancer
352416|NCT02085564|neoadjuvant chemotherapy|neoadjuvant chemotherapy
352417|NCT02085551|peripheral arterial occlusion|peripheral arterial occlusion
352418|NCT02085551|visceral emboli|visceral emboli
352419|NCT02085551|limb ischemia|limb ischemia
352420|NCT02085551|adverse events|adverse events
352421|NCT02085551|Indigo System|indigo system
352422|NCT02085551|aspiration|aspiration
352423|NCT02085551|mechanical thrombectomy|mechanical thrombectomy
352424|NCT02085538|renal impairment|renal impairment
352425|NCT02085538|AUC|auc
352426|NCT02085538|Cmax|cmax
352427|NCT02085538|palbociclib|palbociclib
352428|NCT02085538|normal matched subjects|normal matched subjects
352429|NCT02085512|Post Traumatic Stress Disorder (PTSD)|post traumatic stress disorder (ptsd)
352430|NCT02085512|Major Depression|major depression
352431|NCT02085512|Secondary Prevention|secondary prevention
352432|NCT02085512|Neurocognitive Retraining|neurocognitive retraining
352433|NCT02085512|Randomized Controlled Trial|randomized controlled trial
352434|NCT02085499|nasal ventilation|nasal ventilation
352435|NCT02085499|premature infants|premature infants
352436|NCT02085499|synchronized ventilation|synchronized ventilation
352437|NCT02085486|dialysis|dialysis
352438|NCT02085486|av shunt|av shunt
352439|NCT02085486|cannulation|cannulation
352440|NCT02085486|ultrasound|ultrasound
352441|NCT02085486|outcome|outcome
352442|NCT02085473|Asthma|asthma
352443|NCT02085473|Healthy Subjects or Volunteers|healthy subjects or volunteers
352444|NCT02085473|Tralokinumab|tralokinumab
352445|NCT02085473|CAT-354|cat-354
352446|NCT02085447|Homelessness|homelessness
352447|NCT02085447|Antipsychotic Drugs|antipsychotic drugs
352448|NCT02085447|Antipsychotics|antipsychotics
352449|NCT02085447|Injectables|injectables
352450|NCT02085447|Long Acting Injectable Antipsychotic|long acting injectable antipsychotic
352451|NCT02085447|Psychotic Disorders|psychotic disorders
352452|NCT02085447|Schizophrenia|schizophrenia
352453|NCT02085447|Schizoaffective Disorder|schizoaffective disorder
352454|NCT02085447|Medication Adherence|medication adherence
352455|NCT02085447|Medication Non-Adherence|medication non-adherence
352456|NCT02085447|Community Mental Health Centers|community mental health centers
352457|NCT02085421|tdcs, neuromodulation, CRT, psychosis, schizophrenia|tdcs, neuromodulation, crt, psychosis, schizophrenia
352458|NCT02085395|Actinic Keratosis, AK, Bowen's Disease, Bowen|actinic keratosis, ak, bowen's disease, bowen
352459|NCT02085382|Kangaroo Mother Care(KMC), Low-birth weight, neonates|kangaroo mother care(kmc), low-birth weight, neonates
352460|NCT02085369|bariatric surgery|bariatric surgery
352461|NCT02085369|cognitive function|cognitive function
352462|NCT02085369|gene expression|gene expression
352463|NCT02085356|HIV|hiv
352464|NCT02085356|PMTCT|pmtct
352465|NCT02085356|South Africa|south africa
352466|NCT02085356|Couples|couples
352467|NCT02085356|Male involvement|male involvement
352468|NCT02085343|Exposure therapy|exposure therapy
352469|NCT02085343|Specific phobia|specific phobia
352470|NCT02085343|Fear of heights|fear of heights
352471|NCT02085343|Acrophobia|acrophobia
352472|NCT02085343|Safety behavior fading|safety behavior fading
352473|NCT02085343|Anti-phobic Actions|anti-phobic actions
352474|NCT02085317|Microcirculation|microcirculation
352475|NCT02085317|Leprosy|leprosy
352476|NCT02085317|Nervous system|nervous system
352477|NCT02085317|Orthogonal polarization spectral (OPS) imaging|orthogonal polarization spectral (ops) imaging
352478|NCT02085317|Laser Doppler flowmetry|laser doppler flowmetry
352479|NCT02085317|Iontophoresis.|iontophoresis.
352480|NCT02085304|Glioblastoma|glioblastoma
352481|NCT02085304|GBM|gbm
352482|NCT02085304|Radiation|radiation
352483|NCT02085304|GammaKnife(R)|gammaknife(r)
352484|NCT02085304|Radiosurgery|radiosurgery
352485|NCT02085304|Gliadel(R)|gliadel(r)
352486|NCT02085304|Temozolomide|temozolomide
352487|NCT02085304|Temodar(R)|temodar(r)
352488|NCT02085291|septic shock; microcirculation; norepinephrine|septic shock; microcirculation; norepinephrine
352489|NCT02085278|arteriovenous malformation|arteriovenous malformation
352490|NCT02085278|Brain|brain
352491|NCT02085278|AVM|avm
352492|NCT02085278|Onyx|onyx
352493|NCT02085278|Micro catheter|micro catheter
352494|NCT02085278|catheter entrapment,|catheter entrapment,
352495|NCT02085278|Embolization|embolization
352496|NCT02085278|Vein Of Galen|vein of galen
352497|NCT02085265|Alzheimer's Disease|alzheimer's disease
352498|NCT02085265|Hypertension|hypertension
352499|NCT02085265|Perindopril|perindopril
352500|NCT02085265|Telmisartan|telmisartan
352501|NCT02085265|Brain atrophy|brain atrophy
352502|NCT02085252|Drug Therapy|drug therapy
352503|NCT02085239|Breast Biopsy|breast biopsy
352504|NCT02085239|Ultrasound|ultrasound
352505|NCT02085239|Lidocaine|lidocaine
352506|NCT02085239|Ropivacaine|ropivacaine
352507|NCT02085239|Breast Lesion|breast lesion
352508|NCT02085226|Stroke|stroke
352509|NCT02085226|Rehabilitation|rehabilitation
352510|NCT02085226|Creative Engagement|creative engagement
352511|NCT02085226|Psychosocial|psychosocial
352512|NCT02085226|Art|art
352513|NCT02085213|Retained placenta|retained placenta
352514|NCT02085213|Manual Removal of Placenta|manual removal of placenta
352515|NCT02085213|Glyceryl Trinitrate|glyceryl trinitrate
352516|NCT02085200|glenohumeral internal rotation deficit|glenohumeral internal rotation deficit
352517|NCT02085200|overhead athlete|overhead athlete
352518|NCT02085200|shoulder exercise|shoulder exercise
352519|NCT02085200|posterior glenohumeral capsule|posterior glenohumeral capsule
352520|NCT02085200|posteroinferior glenohumeral ligament|posteroinferior glenohumeral ligament
352521|NCT02085200|posterior rotator cuff|posterior rotator cuff
352522|NCT02085187|Pulmonary rehabilitation|pulmonary rehabilitation
352523|NCT02085187|Training|training
352524|NCT02085187|Counselling|counselling
352525|NCT02085187|Telemedicine|telemedicine
352526|NCT02085187|Videoconference|videoconference
352527|NCT02085187|COPD|copd
352528|NCT02085187|Chronic disease|chronic disease
352529|NCT02085187|Internet.|internet.
352530|NCT02085148|Pediatric cancer|pediatric cancer
352531|NCT02085148|Rhabdomyosarcoma,|rhabdomyosarcoma,
352532|NCT02085148|Ewing sarcoma|ewing sarcoma
352533|NCT02085148|Hepatoblastoma|hepatoblastoma
352534|NCT02085148|Neuroblastoma|neuroblastoma
352535|NCT02085148|Wilm's tumor|wilm's tumor
352536|NCT02085135|depression|depression
352537|NCT02085135|major depressive disorder|major depressive disorder
352538|NCT02085135|Alkermes|alkermes
352539|NCT02085135|ALKS 5461|alks 5461
352540|NCT02085135|samidorphan|samidorphan
352541|NCT02085135|buprenorphine|buprenorphine
352542|NCT02085109|Cardiovascular Diseases|cardiovascular diseases
352543|NCT02085109|HDL metabolism|hdl metabolism
352544|NCT02085109|ApoA-I|apoa-i
352545|NCT02085109|High fat|high fat
352546|NCT02085109|Theobromine|theobromine
450805|NCT01639768|Safety|safety
352547|NCT02085096|Caregivers|caregivers
352548|NCT02085096|Coping Skills|coping skills
352549|NCT02085083|Inflammatory Bowel Disease|inflammatory bowel disease
352550|NCT02085083|Transition|transition
352551|NCT02085083|Adolescent|adolescent
352552|NCT02085083|Chronic Disease|chronic disease
352553|NCT02085083|Colitis, Ulcerative|colitis, ulcerative
352554|NCT02085044|malnutrition|malnutrition
352555|NCT02085044|children's health|children's health
352556|NCT02085044|prevention|prevention
352557|NCT02085044|ready-to-use supplementary food|ready-to-use supplementary food
352558|NCT02085044|lipid based nutrient supplement|lipid based nutrient supplement
352559|NCT02085044|chad|chad
352560|NCT02085044|children|children
352561|NCT02085031|Roux-en-Y Anastomosis|roux-en-y anastomosis
352562|NCT02085031|laparoscopic surgery|laparoscopic surgery
352563|NCT02085031|minilaparotomy|minilaparotomy
352564|NCT02085031|stomach neoplasms|stomach neoplasms
352565|NCT02085018|omeprazole, idiopathic pulmonary fibrosis|omeprazole, idiopathic pulmonary fibrosis
352566|NCT02084992|Congestive Heart Failure|congestive heart failure
352567|NCT02084992|Disease management|disease management
352568|NCT02084992|Hospitalization|hospitalization
352569|NCT02084979|Primary care mental health consultation|primary care mental health consultation
352570|NCT02084979|Telepsychiatry|telepsychiatry
352571|NCT02084979|Asynchronous telepsychiatry|asynchronous telepsychiatry
352572|NCT02084966|Kidney|kidney
352573|NCT02084966|Transplantation|transplantation
352574|NCT02084966|Imaging|imaging
352575|NCT02084966|Renal function|renal function
352576|NCT02084966|Optical Coherence Tomography|optical coherence tomography
352577|NCT02084940|PCOS|pcos
352578|NCT02084940|OHSS|ohss
352579|NCT02084940|GnRH antagonist|gnrh antagonist
352580|NCT02084940|IVF|ivf
352581|NCT02084940|COH|coh
352582|NCT02084914|endometrial scratching|endometrial scratching
352583|NCT02084914|pipelle|pipelle
352584|NCT02084914|pregnancy rate|pregnancy rate
352585|NCT02084914|unexplained infertility|unexplained infertility
352586|NCT02084901|Biodegradable stents|biodegradable stents
352587|NCT02084901|converage|converage
352588|NCT02084901|OCT|oct
352589|NCT02084875|Food effect|food effect
352590|NCT02084875|pharmacokinetic|pharmacokinetic
352591|NCT02084875|healthy volunteer|healthy volunteer
352592|NCT02084862|Tracheostomy|tracheostomy
352593|NCT02084862|Ultrasound|ultrasound
352594|NCT02084836|fMRI obesity adolescents|fmri obesity adolescents
352595|NCT02084797|arginine vasopressin|arginine vasopressin
352596|NCT02084797|sweat sodium|sweat sodium
352597|NCT02084797|V2 antagonist|v2 antagonist
352598|NCT02084797|running|running
352599|NCT02084784|Near-infrared fluorescence|near-infrared fluorescence
352600|NCT02084784|Image guided surgery|image guided surgery
352601|NCT02084784|Breast cancer;|breast cancer;
352602|NCT02084784|Sentinel lymph node biopsy|sentinel lymph node biopsy
352603|NCT02084784|Indocyanine green|indocyanine green
352604|NCT02084784|Methylene blue|methylene blue
352605|NCT02084771|contrast nephropathy|contrast nephropathy
352606|NCT02084771|contrast induced acute kidney injury|contrast induced acute kidney injury
352607|NCT02084771|acute kidney injury|acute kidney injury
352608|NCT02084771|prophylaxis|prophylaxis
352609|NCT02084771|randomized trial|randomized trial
352610|NCT02084758|COPD|copd
352611|NCT02084758|nitrate supplementation|nitrate supplementation
352612|NCT02084758|metabolic efficiency|metabolic efficiency
352613|NCT02084745|Boston keratoprosthesis|boston keratoprosthesis
352614|NCT02084745|Glaucoma drainage device|glaucoma drainage device
352615|NCT02084745|Ahmed tube shunt|ahmed tube shunt
352616|NCT02084732|Sorafenib, thyroid neoplasms, salicylic acid|sorafenib, thyroid neoplasms, salicylic acid
352617|NCT02084680|Prenatal|prenatal
352618|NCT02084680|Newborn care|newborn care
352619|NCT02084680|mobile phones|mobile phones
352620|NCT02084654|prediabetes|prediabetes
352621|NCT02084654|exenatide|exenatide
352622|NCT02084654|weight loss|weight loss
352623|NCT02084654|insulin resistance|insulin resistance
352624|NCT02084654|acute insulin response|acute insulin response
352625|NCT02084654|insulin secretion|insulin secretion
352626|NCT02084641|ectopic fat|ectopic fat
352627|NCT02084641|obesity|obesity
352628|NCT02084641|triglyceride storage|triglyceride storage
352629|NCT02084641|adipocyte|adipocyte
352630|NCT02084641|overfeeding|overfeeding
352631|NCT02084641|intrahepatic fat|intrahepatic fat
352632|NCT02084641|adipocyte proliferation|adipocyte proliferation
352633|NCT02084641|inflammation|inflammation
352634|NCT02084641|macrophage|macrophage
352635|NCT02084615|Aspirin|aspirin
352636|NCT02084615|Postoperative hemorrhage|postoperative hemorrhage
352637|NCT02084615|Inguinal hernia|inguinal hernia
352638|NCT02084602|artesunate|artesunate
352639|NCT02084602|mefloquine|mefloquine
352640|NCT02084602|falciparum|falciparum
352641|NCT02084602|peruvian amazon|peruvian amazon
352642|NCT02084589|PCEA, labor analgesia, background infusion, ropivacaine|pcea, labor analgesia, background infusion, ropivacaine
352643|NCT02084576|Cystoid macular edema|cystoid macular edema
450947|NCT01639001|ALK|alk
352644|NCT02084576|nonsteroidal anti-inflammatory drug|nonsteroidal anti-inflammatory drug
352645|NCT02084576|OCT|oct
352646|NCT02084576|phacoemulsification.|phacoemulsification.
352647|NCT02084563|Acute Myeloid Leukemia|acute myeloid leukemia
352648|NCT02084563|Myeloproliferative Neoplasms|myeloproliferative neoplasms
352649|NCT02084563|Myelodysplastic Syndromes|myelodysplastic syndromes
352650|NCT02084563|Myeloproliferative/Myelodysplastic Neoplasm|myeloproliferative/myelodysplastic neoplasm
352651|NCT02084563|Leukemia|leukemia
352652|NCT02084563|MDS|mds
352653|NCT02084563|MPN|mpn
352654|NCT02084563|AML|aml
352655|NCT02084563|Chronic myelomonocytic leukemia (CMML)|chronic myelomonocytic leukemia (cmml)
352656|NCT02084563|Polycythemia Vera (PV)|polycythemia vera (pv)
352657|NCT02084563|Essential Thrombocythemia (ET)|essential thrombocythemia (et)
352658|NCT02084563|Myelofibrosis (MF)|myelofibrosis (mf)
352659|NCT02084537|symptomatic|symptomatic
352660|NCT02084537|infected|infected
352661|NCT02084537|necrotic collection|necrotic collection
352662|NCT02084524|vulnerable|vulnerable
352663|NCT02084524|nutrition|nutrition
352664|NCT02084524|cancer|cancer
352665|NCT02084524|colorectal|colorectal
352666|NCT02084524|tumor|tumor
352667|NCT02084498|Automated bolus calculator (ABC)|automated bolus calculator (abc)
352668|NCT02084498|Advanced carbohydrate counting (ACC)|advanced carbohydrate counting (acc)
352669|NCT02084498|Patient empowerment|patient empowerment
352670|NCT02084485|COPD|copd
352671|NCT02084485|LPS|lps
352672|NCT02084472|atopic eczema|atopic eczema
352673|NCT02084472|moisturisers|moisturisers
352674|NCT02084472|alternatives|alternatives
352675|NCT02084472|affordable|affordable
352676|NCT02084459|Chronic pain|chronic pain
352677|NCT02084459|Supportive care|supportive care
352678|NCT02084459|Psychosocial Circumstances|psychosocial circumstances
352679|NCT02084459|Autonomy support|autonomy support
352680|NCT02084459|Nursing intervention|nursing intervention
352681|NCT02084446|Everolimus|everolimus
352682|NCT02084446|Tacrolimus|tacrolimus
352683|NCT02084446|Sodium Mycophenolate|sodium mycophenolate
352684|NCT02084446|CMV|cmv
352685|NCT02084446|Graft function|graft function
352686|NCT02084446|Acute rejection|acute rejection
352687|NCT02084433|MIH of the first permanent molar|mih of the first permanent molar
352688|NCT02084407|DM1|dm1
352689|NCT02084407|Cardiopathy|cardiopathy
352690|NCT02084407|Adult|adult
352691|NCT02084394|CBF autoregulation, rSO2,doppler, TCD, delirium,|cbf autoregulation, rso2,doppler, tcd, delirium,
352692|NCT02084381|CKD5, dialysis, high porous membranes|ckd5, dialysis, high porous membranes
352693|NCT02084368|combined lumbar plexus and sciatic nerve block，|combined lumbar plexus and sciatic nerve block，
352694|NCT02084368|combined spinal and epidural anesthesia|combined spinal and epidural anesthesia
352695|NCT02084355|Significant cancer pain|significant cancer pain
352696|NCT02084355|at least numeric rating scale 4|at least numeric rating scale 4
352697|NCT02084342|desmopressin|desmopressin
352698|NCT02084342|tranexamic acid|tranexamic acid
352699|NCT02084342|blood loss|blood loss
352700|NCT02084342|transfusion need|transfusion need
352701|NCT02084342|posterior scoliosis orthopedics|posterior scoliosis orthopedics
352702|NCT02084329|Physiotherapy|physiotherapy
352703|NCT02084329|Physical therapy|physical therapy
352704|NCT02084329|neurotrauma rehabilitation|neurotrauma rehabilitation
352705|NCT02084329|Rehabilitation|rehabilitation
352706|NCT02084329|Balance|balance
352707|NCT02084329|Balance Confidence|balance confidence
352708|NCT02084329|concussion|concussion
352709|NCT02084329|Post-Concussion|post-concussion
352710|NCT02084329|Mild Traumatic Brain Injury|mild traumatic brain injury
352711|NCT02084316|China CDC|china cdc
352712|NCT02084316|One4All testing algorithm|one4all testing algorithm
352713|NCT02084316|Guangxi Autonomous Region|guangxi autonomous region
352714|NCT02084316|Testing and Linkage to HIV Care in China|testing and linkage to hiv care in china
352715|NCT02084290|Crohn's disease|crohn's disease
352716|NCT02084290|Shared Decision Making|shared decision making
352717|NCT02084290|Decision Aid|decision aid
352718|NCT02084277|Oral health-related quality of life (OHRQoL)|oral health-related quality of life (ohrqol)
352719|NCT02084277|Self-ligating brackets (SLB)|self-ligating brackets (slb)
352720|NCT02084277|Conventional brackets (CB)|conventional brackets (cb)
352721|NCT02084277|Oral Health Impact Profile-14 (OHIP-14)|oral health impact profile-14 (ohip-14)
352722|NCT02084277|Short Form-36 (SF-36)|short form-36 (sf-36)
352723|NCT02084264|Adolescent Idiopathic Scoliosis|adolescent idiopathic scoliosis
352724|NCT02084264|Pediatric Scoliosis|pediatric scoliosis
352725|NCT02084251|safety,|safety,
352726|NCT02084251|pharmacokinetics,|pharmacokinetics,
352727|NCT02084251|Long acting GLP-1 analogue|long acting glp-1 analogue
352728|NCT02084238|SLE, IL-2|sle, il-2
352729|NCT02084225|low resource|low resource
352730|NCT02084225|conflict setting|conflict setting
352731|NCT02084225|ultrasound guided regional anesthesia|ultrasound guided regional anesthesia
352732|NCT02084225|acute injuries|acute injuries
352733|NCT02084225|pain management|pain management
352734|NCT02084225|education|education
352735|NCT02084225|ultrasound|ultrasound
352736|NCT02084225|trauma|trauma
352737|NCT02084225|emergency department|emergency department
352738|NCT02084173|alcohol|alcohol
352739|NCT02084173|60+ years|60+ years
352740|NCT02084173|treatment|treatment
352741|NCT02084173|met|met
352742|NCT02084173|cra|cra
352743|NCT02084173|multi site|multi site
352744|NCT02084173|multi country|multi country
352745|NCT02084173|questionnaire|questionnaire
352746|NCT02084173|random|random
352747|NCT02084134|pituitary adenoma|pituitary adenoma
352748|NCT02084134|Pituitary Tumor|pituitary tumor
352749|NCT02084134|transsphenoidal resection|transsphenoidal resection
352750|NCT02084134|pituitary cyst|pituitary cyst
352751|NCT02084121|metachromatic leukodystrophy|metachromatic leukodystrophy
352752|NCT02084108|Frail and dependent older adults|frail and dependent older adults
352753|NCT02084108|Integrated care|integrated care
352754|NCT02084108|Home care|home care
352755|NCT02084108|Multidimensional geriatric assessment|multidimensional geriatric assessment
352756|NCT02084108|RAI-HC (resident assessment instrument- Home care)|rai-hc (resident assessment instrument- home care)
352757|NCT02084108|Palliative care.|palliative care.
352758|NCT02084043|aerosol delivery|aerosol delivery
352759|NCT02084043|vibrating mesh nebulizer|vibrating mesh nebulizer
352760|NCT02084043|breath-actuated nebulizer|breath-actuated nebulizer
352761|NCT02084043|non invasive ventilation|non invasive ventilation
352762|NCT02084043|bilevel ventilator|bilevel ventilator
352763|NCT02084043|single limb circuit ventilator|single limb circuit ventilator
352764|NCT02084043|Amikacin|amikacin
352765|NCT02084030|cardiac surgery|cardiac surgery
352766|NCT02084030|POCD|pocd
352767|NCT02084030|GWAS|gwas
352768|NCT02084030|Susceptibility gene|susceptibility gene
352769|NCT02084017|Surgical Site Infection|surgical site infection
352770|NCT02084017|Vascular Surgery|vascular surgery
352771|NCT02084017|Negative Pressure Wound Therapy|negative pressure wound therapy
352772|NCT02084004|Type 2 diabetes mellitus|type 2 diabetes mellitus
352773|NCT02084004|Berberine Hydrochloride|berberine hydrochloride
352774|NCT02084004|Bifidobacterium|bifidobacterium
352775|NCT02083991|NODAT|nodat
352776|NCT02083991|Renal transplantation|renal transplantation
352777|NCT02083991|Corticosteroids avoidance|corticosteroids avoidance
352778|NCT02083991|CNI minimization|cni minimization
352779|NCT02083978|Bipolar Disorder|bipolar disorder
352780|NCT02083978|Magnetic Resonance Imaging (MRI) scanning|magnetic resonance imaging (mri) scanning
352781|NCT02083939|Inguinal hernia|inguinal hernia
352782|NCT02083939|Mesh repair|mesh repair
352783|NCT02083939|Prophylactic Antibiotics|prophylactic antibiotics
352784|NCT02083939|Herniorrhaphy|herniorrhaphy
352785|NCT02083939|Laparoscopic Inguinal Hernia Repair|laparoscopic inguinal hernia repair
352786|NCT02083926|Social Anxiety Disorder|social anxiety disorder
352787|NCT02083926|SAD|sad
352788|NCT02083926|Ketamine|ketamine
352789|NCT02083913|Severely obese|severely obese
352790|NCT02083913|Bariatric surgery|bariatric surgery
352791|NCT02083913|Physical activity|physical activity
352792|NCT02083913|Physical fitness|physical fitness
352793|NCT02083913|Telehealth|telehealth
352794|NCT02083913|Quality of life|quality of life
352795|NCT02083887|Immune response|immune response
352796|NCT02083887|Vaccine|vaccine
352797|NCT02083887|Malaria|malaria
352798|NCT02083874|cannabidiol|cannabidiol
352799|NCT02083874|CBD|cbd
352800|NCT02083874|marijuana|marijuana
352801|NCT02083874|withdrawal|withdrawal
352802|NCT02083874|treatment|treatment
352803|NCT02083861|osteoarthritis|osteoarthritis
352804|NCT02083861|arthritis|arthritis
352805|NCT02083861|musculoskeletal|musculoskeletal
352806|NCT02083861|connective tissue disease|connective tissue disease
352807|NCT02083861|ultrasound|ultrasound
352808|NCT02083861|pain|pain
352809|NCT02083861|mobility|mobility
352810|NCT02083861|heat|heat
352811|NCT02083861|strength|strength
352812|NCT02083861|ZetrOZ|zetroz
352813|NCT02083861|LITUS|litus
352814|NCT02083861|Sam|sam
352815|NCT02083861|grade 1|grade 1
352816|NCT02083861|grade 2|grade 2
352817|NCT02083848|Locoregional invasion|locoregional invasion
352818|NCT02083848|Stage IB1, IB2, IIA or IIB|stage ib1, ib2, iia or iib
352819|NCT02083835|post-operative pain|post-operative pain
352820|NCT02083835|paitent reported outcomes|paitent reported outcomes
352821|NCT02083835|quality improvement|quality improvement
352822|NCT02083822|premature baby|premature baby
352823|NCT02083822|MRI : conventional and advanced images|mri : conventional and advanced images
352824|NCT02083822|Executive function testing at 5 years of age|executive function testing at 5 years of age
352825|NCT02083796|manual therapy|manual therapy
352826|NCT02083796|rehabilitation|rehabilitation
352827|NCT02083796|shoulder|shoulder
352828|NCT02083796|spine|spine
352829|NCT02083770|Hispanics|hispanics
352830|NCT02083770|Patient Participation|patient participation
352831|NCT02083770|Refusal to Participate|refusal to participate
352832|NCT02083770|Education|education
352833|NCT02083770|Clinical Trials|clinical trials
352834|NCT02083757|Fluid responsiveness; Passive leg raising|fluid responsiveness; passive leg raising
352835|NCT02083744|Congestive Heart Failure|congestive heart failure
352836|NCT02083744|Self-care|self-care
352837|NCT02083744|Spanish|spanish
352838|NCT02083731|CMV infection|cmv infection
352839|NCT02083731|Mesenchymal Stem Cells|mesenchymal stem cells
352840|NCT02083731|Allogeneic hematopoietic stem cell transplantation|allogeneic hematopoietic stem cell transplantation
352841|NCT02083718|Poor Graft Function|poor graft function
352842|NCT02083718|Peripheral Blood Stem Cell|peripheral blood stem cell
352843|NCT02083718|Mesenchymal Stem Cells|mesenchymal stem cells
352844|NCT02083718|Allogeneic hematopoietic stem cell transplantation|allogeneic hematopoietic stem cell transplantation
352845|NCT02083705|Chest compression, Delivery Room, NICU,|chest compression, delivery room, nicu,
352846|NCT02083679|Carcinoma, Non-Small-Cell Lung|carcinoma, non-small-cell lung
352847|NCT02083679|Sym004|sym004
352848|NCT02083666|Phase I|phase i
352849|NCT02083666|Dose cohorts|dose cohorts
352850|NCT02083666|Escalating dose|escalating dose
352851|NCT02083666|Single dose|single dose
352852|NCT02083666|Multiple dose|multiple dose
352853|NCT02083666|Safety|safety
352854|NCT02083666|Tolerability|tolerability
352855|NCT02083666|Pharmacokinetics|pharmacokinetics
352856|NCT02083666|Pharmacodynamics|pharmacodynamics
352857|NCT02083666|volunteers|volunteers
352858|NCT02083653|Metastatic Colorectal Cancer|metastatic colorectal cancer
352859|NCT02083653|Best Supportive Care|best supportive care
352860|NCT02083653|Capecitabine|capecitabine
352861|NCT02083653|Fluorouracil (5-FU)|fluorouracil (5-fu)
352862|NCT02083653|Sym004|sym004
352863|NCT02083640|healthy volunteer|healthy volunteer
352864|NCT02083640|bioavailability|bioavailability
352865|NCT02083640|palbociclib|palbociclib
352866|NCT02083640|formulation|formulation
352867|NCT02083627|Pharmacokinetics|pharmacokinetics
352868|NCT02083627|Drug-Drug Interaction|drug-drug interaction
352869|NCT02083627|Intestinal Absorption|intestinal absorption
352870|NCT02083627|Fidaxomicin|fidaxomicin
352871|NCT02083627|Rosuvastatin|rosuvastatin
352872|NCT02083627|Multiple Doses|multiple doses
352873|NCT02083627|Single Doses|single doses
352874|NCT02083601|Caregivers|caregivers
352875|NCT02083601|Spinal Cord Injuries|spinal cord injuries
352876|NCT02083601|Psychology, Educational|psychology, educational
352877|NCT02083601|Counseling|counseling
352878|NCT02083601|Outcome Assessment (Health Care)|outcome assessment (health care)
352879|NCT02083588|Fibromyalgia|fibromyalgia
352881|NCT02083588|pain|pain
352882|NCT02083588|PFC|pfc
352883|NCT02083588|Subjects with Fibromyalgia|subjects with fibromyalgia
352884|NCT02083575|vitamin c|vitamin c
352885|NCT02083575|thalassemia major|thalassemia major
352886|NCT02083575|iron chelation|iron chelation
352887|NCT02083562|Bronchopulmonary dysplasia, preterm infant|bronchopulmonary dysplasia, preterm infant
352888|NCT02083549|Massive Transfusion Protocol|massive transfusion protocol
352889|NCT02083536|Low Dose Fractionated Whole Abdominal Radiation Therapy|low dose fractionated whole abdominal radiation therapy
352890|NCT02083536|LDFWART|ldfwart
352891|NCT02083536|Docetaxel|docetaxel
352892|NCT02083536|Ovarian Cancer|ovarian cancer
352893|NCT02083536|Ovarian Carcinoma|ovarian carcinoma
352894|NCT02083536|Platinum-Resistant|platinum-resistant
352895|NCT02083523|Motivational Interview, normative feedback, adolescents|motivational interview, normative feedback, adolescents
352896|NCT02083510|Colchicine|colchicine
352897|NCT02083510|Hypertriglyceridemia|hypertriglyceridemia
352898|NCT02083510|Apolipoprotein CIII|apolipoprotein ciii
352899|NCT02083497|kick|kick
352900|NCT02083497|taping|taping
352901|NCT02083497|dynamic equilibrium|dynamic equilibrium
352902|NCT02083458|critical care|critical care
352903|NCT02083458|catheterization|catheterization
352904|NCT02083458|axillary vein|axillary vein
352905|NCT02083445|Traumatic brain injury|traumatic brain injury
352906|NCT02083445|Exercise|exercise
352907|NCT02083445|Psychology|psychology
352908|NCT02083445|Physiology|physiology
352909|NCT02083445|Progenitor cells|progenitor cells
352910|NCT02083445|Hypoxia|hypoxia
352911|NCT02083432|intra-oral injections|intra-oral injections
352912|NCT02083432|CBT|cbt
352913|NCT02083432|Blood-Injury-Injection-phobia|blood-injury-injection-phobia
352914|NCT02083432|DSM-IV. 300.29|dsm-iv. 300.29
352915|NCT02083419|Left Ventricular Assist Devices (LVAD)|left ventricular assist devices (lvad)
352916|NCT02083419|Cardiac Resynchronization Devices (CRT)|cardiac resynchronization devices (crt)
352917|NCT02083406|Malaria|malaria
352918|NCT02083406|Bio-availability|bio-availability
352919|NCT02083393|dendritic cell|dendritic cell
352920|NCT02083380|Plasmodium falciparum malaria|plasmodium falciparum malaria
352921|NCT02083380|malaria|malaria
352922|NCT02083380|OZ439|oz439
352923|NCT02083380|piperaquine|piperaquine
352924|NCT02083380|PQP|pqp
352925|NCT02083354|melanoma|melanoma
352926|NCT02083354|dabrafenib|dabrafenib
352927|NCT02083354|trametinib|trametinib
352928|NCT02083328|heart rate variability|heart rate variability
352929|NCT02083328|exercise performance|exercise performance
352930|NCT02083315|acute pain, analgesia, respiratory drive, ventilator response to hypercapnia, pupillometry|acute pain, analgesia, respiratory drive, ventilator response to hypercapnia, pupillometry
451277|NCT01637259|HIV|hiv
352931|NCT02083302|campus sexual assault|campus sexual assault
352932|NCT02083302|bystander intervention|bystander intervention
352933|NCT02083289|ONO-9054|ono-9054
352934|NCT02083289|ocular hypertension (OHT)|ocular hypertension (oht)
352935|NCT02083289|Open angle-glaucoma (OAG)|open angle-glaucoma (oag)
352936|NCT02083289|Glaucoma|glaucoma
352937|NCT02083289|Eye Diseases|eye diseases
352938|NCT02083289|Mild to moderate|mild to moderate
352939|NCT02083276|Chlamydia trachomatis|chlamydia trachomatis
352940|NCT02083276|Urethritis|urethritis
352941|NCT02083276|Genital Diseases, Male|genital diseases, male
352942|NCT02083263|Lung function|lung function
352943|NCT02083237|mild cognitive impairment|mild cognitive impairment
352944|NCT02083237|memory training|memory training
352945|NCT02083237|healthy lifestyle|healthy lifestyle
352946|NCT02083237|psychosocial support|psychosocial support
352947|NCT02083211|Cervical cancer|cervical cancer
352948|NCT02083211|Recurrent or persistent tumor|recurrent or persistent tumor
352949|NCT02083211|Monoclonal antibody|monoclonal antibody
352950|NCT02083198|hyperchloremic acidosis|hyperchloremic acidosis
352951|NCT02083198|balanced fluids|balanced fluids
352952|NCT02083198|plasmalyte|plasmalyte
352953|NCT02083185|Drug therapy|drug therapy
352954|NCT02083172|USCOM (UltraSound Cardiac Output Monitor)|uscom (ultrasound cardiac output monitor)
352955|NCT02083172|2D echocardiography|2d echocardiography
352956|NCT02083172|agreement|agreement
352957|NCT02083172|pediatrics|pediatrics
352958|NCT02083133|Diabetes|diabetes
352959|NCT02083133|Renal Failure|renal failure
352960|NCT02083133|Dialysis|dialysis
352961|NCT02083133|End Stage Renal Disease|end stage renal disease
352962|NCT02083133|Hypoglycemia|hypoglycemia
352963|NCT02083120|high flow|high flow
352964|NCT02083120|COPD|copd
352965|NCT02083120|AIRVO|airvo
352966|NCT02083107|Postpartum hemorrhage|postpartum hemorrhage
352967|NCT02083107|Intrapartum blood loss|intrapartum blood loss
352968|NCT02083107|Misoprostol|misoprostol
352969|NCT02083081|tobacco|tobacco
352970|NCT02083081|smoking|smoking
352971|NCT02083068|Malaria, vaccine, P. vivax|malaria, vaccine, p. vivax
352972|NCT02083055|dexmedetomidine|dexmedetomidine
352973|NCT02083055|controlled hypotensive anesthesia|controlled hypotensive anesthesia
352974|NCT02083042|CMV|cmv
352975|NCT02083042|T-Track CMV|t-track cmv
352976|NCT02083042|kidney transplantation|kidney transplantation
352977|NCT02083029|Asthma|asthma
352978|NCT02083029|Death|death
352979|NCT02083029|Mechanism|mechanism
352980|NCT02083029|Syncope|syncope
352981|NCT02083029|Dive reflex|dive reflex
352982|NCT02083003|Pain|pain
352983|NCT02083003|Polyamine|polyamine
352984|NCT02083003|Cholecystectomy|cholecystectomy
352985|NCT02082990|Alcohol-related disorders|alcohol-related disorders
352986|NCT02082990|Alcohol Drinking|alcohol drinking
352987|NCT02082990|e-health|e-health
352988|NCT02082990|Alcohol Use Disorder Test|alcohol use disorder test
352989|NCT02082990|Quality of Life|quality of life
352990|NCT02082977|Refractory|refractory
353088|NCT02082652|Nevirapine|nevirapine
352991|NCT02082977|Phase I study, dose escalation study|phase i study, dose escalation study
352992|NCT02082977|diffuse large B cell lymphoma|diffuse large b cell lymphoma
352993|NCT02082977|Relapsed|relapsed
352994|NCT02082977|Solid tumors|solid tumors
352995|NCT02082977|transformed follicular lymphoma|transformed follicular lymphoma
352996|NCT02082977|Multiple myeloma|multiple myeloma
352997|NCT02082977|GSK2816126|gsk2816126
352998|NCT02082977|Non-Hodgkin's lymphoma|non-hodgkin's lymphoma
352999|NCT02082938|stroke,|stroke,
353000|NCT02082938|rehabilitation,|rehabilitation,
353001|NCT02082938|hemiparesis,|hemiparesis,
353002|NCT02082938|gait training|gait training
353003|NCT02082925|Exercise training|exercise training
353004|NCT02082925|Dyspnea threshold|dyspnea threshold
353005|NCT02082925|6MWT|6mwt
353006|NCT02082899|Allergic Conjunctivitis|allergic conjunctivitis
353007|NCT02082899|Interleukin 1 Receptor Inhibitor|interleukin 1 receptor inhibitor
353008|NCT02082899|Environmental Exposure Chamber|environmental exposure chamber
353009|NCT02082899|Conjunctival Allergen Provocation Test|conjunctival allergen provocation test
353010|NCT02082886|Metastasis|metastasis
353011|NCT02082886|Carcinomatosis|carcinomatosis
353012|NCT02082886|Carcinosis|carcinosis
353013|NCT02082886|Sarcomatosis|sarcomatosis
353014|NCT02082886|CRS|crs
353015|NCT02082886|Cytoreductive surgery|cytoreductive surgery
353016|NCT02082886|HIPEC|hipec
353017|NCT02082886|Heated Intraperitoneal Chemotherapy|heated intraperitoneal chemotherapy
353018|NCT02082886|Intra-abdominal|intra-abdominal
353019|NCT02082886|Sugarbaker technique|sugarbaker technique
353020|NCT02082886|Mitomycin C|mitomycin c
353021|NCT02082886|Cisplatin|cisplatin
353022|NCT02082886|Doxorubicin|doxorubicin
353023|NCT02082886|Oxaliplatin|oxaliplatin
353024|NCT02082886|Melphalan|melphalan
353025|NCT02082873|Quantitative EEG|quantitative eeg
353026|NCT02082873|Nonconvulsive seizures|nonconvulsive seizures
353027|NCT02082873|ICU EEG monitoring|icu eeg monitoring
353028|NCT02082860|Porphyria|porphyria
353029|NCT02082860|Gene therapy|gene therapy
353030|NCT02082860|AAV|aav
353031|NCT02082860|Liver gene transfer|liver gene transfer
353032|NCT02082834|Endovascular aneurysm repair EVAR|endovascular aneurysm repair evar
353033|NCT02082834|Endoleak/diagnosis|endoleak/diagnosis
353034|NCT02082834|VEOTM|veotm
353035|NCT02082834|Model-based iterative reconstruction (MBIR)|model-based iterative reconstruction (mbir)
353036|NCT02082834|Adaptive statistical iterative reconstruction (ASIR)|adaptive statistical iterative reconstruction (asir)
353037|NCT02082834|Aortic Aneurysm|aortic aneurysm
353038|NCT02082834|Low dose|low dose
353039|NCT02082834|Prospective|prospective
353040|NCT02082834|CTA|cta
353041|NCT02082808|Dolutegravir|dolutegravir
353042|NCT02082808|healthy volunteer|healthy volunteer
353043|NCT02082808|pharmacokinetics|pharmacokinetics
353044|NCT02082808|daclatasvir|daclatasvir
353045|NCT02082808|drug interaction|drug interaction
353046|NCT02082795|Breech presentation|breech presentation
353047|NCT02082795|External cephalic version|external cephalic version
353048|NCT02082795|Anaesthesia|anaesthesia
353049|NCT02082795|Qualitative|qualitative
353050|NCT02082795|Pregnancy|pregnancy
353051|NCT02082782|Colorectal liver metastases (CRLM)|colorectal liver metastases (crlm)
353052|NCT02082782|Tumor ablation|tumor ablation
353053|NCT02082782|Irreversible electroporation (IRE)|irreversible electroporation (ire)
353054|NCT02082782|Interventional oncology|interventional oncology
353055|NCT02082782|NanoKnife|nanoknife
353056|NCT02082782|Colorectal liver metastasis, unresectable and not-thermally ablative due to location near vulnerable structures like vessels or bile ducts|colorectal liver metastasis, unresectable and not-thermally ablative due to location near vulnerable structures like vessels or bile ducts
353057|NCT02082769|Gout|gout
353058|NCT02082769|Uric Acid|uric acid
353059|NCT02082769|Xanthine oxidase|xanthine oxidase
353060|NCT02082769|Febuxostat|febuxostat
353061|NCT02082756|Prediabetes|prediabetes
353062|NCT02082756|Berberine Hydrochloride|berberine hydrochloride
353063|NCT02082756|Bifidobacterium|bifidobacterium
353064|NCT02082743|Myopia|myopia
353065|NCT02082743|Outdoor activity|outdoor activity
353066|NCT02082743|Recess outside classroom|recess outside classroom
353067|NCT02082730|CFS/ME, Chronic fatigue syndrome, Pediatric, remote mobile technology|cfs/me, chronic fatigue syndrome, pediatric, remote mobile technology
353068|NCT02082704|Diabetes|diabetes
353069|NCT02082704|Education, Patient|education, patient
353070|NCT02082704|Educational Technology|educational technology
353071|NCT02082691|G-202|g-202
353072|NCT02082691|Hepatocellular|hepatocellular
353073|NCT02082678|Bipolar Disorder|bipolar disorder
353074|NCT02082678|BPD|bpd
353075|NCT02082678|Alcohol Use Disorder|alcohol use disorder
353076|NCT02082678|Alcohol Abuse|alcohol abuse
353077|NCT02082678|Alcohol Dependence|alcohol dependence
353078|NCT02082678|Ondansetron|ondansetron
353079|NCT02082678|Cognition|cognition
353080|NCT02082678|Mood|mood
353081|NCT02082665|rosuvastatin|rosuvastatin
353082|NCT02082665|BRAF V600|braf v600
353083|NCT02082665|Melanoma|melanoma
353084|NCT02082665|dabrafenib|dabrafenib
353085|NCT02082665|midazolam|midazolam
353086|NCT02082652|Etonogestrel|etonogestrel
353087|NCT02082652|Efavirenz|efavirenz
353089|NCT02082652|Pharmacokinetics|pharmacokinetics
353090|NCT02082639|Adolescents|adolescents
353091|NCT02082639|Havrix|havrix
353092|NCT02082639|Immunogenicity|immunogenicity
353093|NCT02082639|Cervarix|cervarix
353094|NCT02082639|Safety|safety
353095|NCT02082626|Phase I|phase i
353096|NCT02082626|Pediatric|pediatric
353097|NCT02082626|Cancer|cancer
353098|NCT02082626|Lymphoma|lymphoma
353099|NCT02082626|Eribulin|eribulin
353100|NCT02082613|Testicular hydrocele|testicular hydrocele
353101|NCT02082613|Hydrocele|hydrocele
353102|NCT02082613|Sclerotherapy|sclerotherapy
353103|NCT02082613|Surgery|surgery
353104|NCT02082613|Complications|complications
353105|NCT02082587|brain metastases|brain metastases
353106|NCT02082587|brain mets|brain mets
353107|NCT02082587|WBRT|wbrt
353108|NCT02082561|transdiagnostic treatment|transdiagnostic treatment
353109|NCT02082561|cognitive behavior therapy|cognitive behavior therapy
353110|NCT02082561|anxiety|anxiety
353111|NCT02082561|panic disorder|panic disorder
353112|NCT02082561|generalized anxiety disorder|generalized anxiety disorder
353113|NCT02082561|social anxiety disorder|social anxiety disorder
353114|NCT02082548|atrial fibrillation|atrial fibrillation
353115|NCT02082548|anticoagulation|anticoagulation
353116|NCT02082548|education|education
353117|NCT02082548|educational intervention|educational intervention
353118|NCT02082535|Premature Birth|premature birth
353119|NCT02082535|Brain Injuries|brain injuries
353120|NCT02082535|Leukomalacia Periventricular|leukomalacia periventricular
353121|NCT02082535|S100B protein human|s100b protein human
353122|NCT02082535|Glial Fibrillary Acidic Protein|glial fibrillary acidic protein
353123|NCT02082535|Magnetic Resonance Imaging|magnetic resonance imaging
353124|NCT02082535|Developmental Disabilities|developmental disabilities
353125|NCT02082522|Cholangiocarcinoma|cholangiocarcinoma
777055|NCT00341367|Analgesic|analgesic
353126|NCT02082522|Unresectable perihilar cholangiocarcinoma|unresectable perihilar cholangiocarcinoma
353127|NCT02082522|Klatskin tumor|klatskin tumor
353128|NCT02082522|Photodynamic therapy|photodynamic therapy
353129|NCT02082522|Porfimer sodium|porfimer sodium
353130|NCT02082522|Photofrin|photofrin
353131|NCT02082522|Gemcitabine|gemcitabine
353132|NCT02082522|Cisplatin|cisplatin
353133|NCT02082522|Stents|stents
353134|NCT02082522|CCA|cca
353135|NCT02082522|PDT|pdt
353136|NCT02082522|Bile duct cancer|bile duct cancer
353137|NCT02082522|Bile duct tumor|bile duct tumor
353138|NCT02082522|Bile duct adenocarcinoma|bile duct adenocarcinoma
353139|NCT02082522|Chemotherapy|chemotherapy
353140|NCT02082509|Traumatic Brain Injury|traumatic brain injury
353141|NCT02082509|Post-Concussive Symptoms|post-concussive symptoms
353142|NCT02082509|Brain Imaging|brain imaging
353143|NCT02082509|Cognition|cognition
353144|NCT02082496|Obesity|obesity
353145|NCT02082496|Obesity Genetics|obesity genetics
353146|NCT02082496|GLP-1|glp-1
353147|NCT02082496|GLP-1 Receptor Agonists|glp-1 receptor agonists
353148|NCT02082483|Kidney Transplant|kidney transplant
353149|NCT02082483|Screening|screening
353150|NCT02082457|Irritable Bowel Syndrome|irritable bowel syndrome
353151|NCT02082457|Constipation|constipation
353152|NCT02082457|C-IBS|c-ibs
353153|NCT02082431|Sensorineural hearing loss|sensorineural hearing loss
353154|NCT02082431|Long QT Syndrome|long qt syndrome
353155|NCT02082418|Mild cognitive impairment|mild cognitive impairment
353156|NCT02082418|Protein digestion|protein digestion
353157|NCT02082418|Tryptophan digestion|tryptophan digestion
353158|NCT02082418|Cognitive function|cognitive function
353159|NCT02082418|Mood|mood
353160|NCT02082418|Muscle function|muscle function
353161|NCT02082418|Alpha-lactalbumin|alpha-lactalbumin
353162|NCT02082379|Interface, aerosol, child, acceptance|interface, aerosol, child, acceptance
353163|NCT02082366|Atrial fibrillation|atrial fibrillation
353164|NCT02082366|CPVI|cpvi
353165|NCT02082366|TCD|tcd
353166|NCT02082366|nMARQ|nmarq
353167|NCT02082366|MES|mes
353168|NCT02082366|microembolic signals|microembolic signals
353169|NCT02082353|Granulomatous Disease, Chronic|granulomatous disease, chronic
353170|NCT02082353|Hematopoietic Stem Cell Transplantation (HSCT)|hematopoietic stem cell transplantation (hsct)
353171|NCT02082353|bone marrow transplant (BMT)|bone marrow transplant (bmt)
353172|NCT02082353|non-transplant|non-transplant
353173|NCT02082353|factors associated with best outcomes of transplant in CGD|factors associated with best outcomes of transplant in cgd
353174|NCT02082340|Tuberculosis|tuberculosis
353175|NCT02082340|Armenia|armenia
353176|NCT02082340|Clinical trial|clinical trial
353177|NCT02082340|Directly Observed Therapy (DOT)|directly observed therapy (dot)
353178|NCT02082340|Self-administered drug intake|self-administered drug intake
353179|NCT02082327|Fabry Disease|fabry disease
353180|NCT02082327|Fabry|fabry
353181|NCT02082327|Lysosomal storage disorders|lysosomal storage disorders
353182|NCT02082327|LSD|lsd
353183|NCT02082327|Amicus|amicus
353184|NCT02082327|migalastat HCl|migalastat hcl
353185|NCT02082327|migalastat|migalastat
353186|NCT02082327|AT1001|at1001
353187|NCT02082314|radiofrequency ablation|radiofrequency ablation
353188|NCT02082314|bone metastases|bone metastases
353189|NCT02082288|ICSI outcome|icsi outcome
353190|NCT02082275|Prenatal Care|prenatal care
353191|NCT02082275|Obstetrics|obstetrics
353192|NCT02082249|Safety|safety
353193|NCT02082249|Tolerability|tolerability
353194|NCT02082249|Efficacy|efficacy
353195|NCT02082249|levodopa-carbidopa intestinal gel|levodopa-carbidopa intestinal gel
353196|NCT02082249|levodopa|levodopa
353197|NCT02082249|carbidopa|carbidopa
353198|NCT02082249|Advanced Parkinson's Disease|advanced parkinson's disease
353199|NCT02082236|Plasma concentrations|plasma concentrations
353200|NCT02082223|Quality of life|quality of life
353201|NCT02082223|Deficits|deficits
353202|NCT02082223|Complex gastrointestinal surgery|complex gastrointestinal surgery
353203|NCT02082197|low testosterone|low testosterone
353204|NCT02082184|Sensing Technology|sensing technology
353205|NCT02082184|Type 2 Diabetes,|type 2 diabetes,
353206|NCT02082171|older adults|older adults
353207|NCT02082171|physical disability|physical disability
353208|NCT02082171|multidomain intervention|multidomain intervention
353209|NCT02082171|prevention|prevention
353210|NCT02082171|pilot study|pilot study
353211|NCT02082171|frailty|frailty
353212|NCT02082171|mobility|mobility
353213|NCT02082171|comprehensive geriatric assessment|comprehensive geriatric assessment
353214|NCT02082145|NMES|nmes
353215|NCT02082145|diabetic peripheral neuropathy|diabetic peripheral neuropathy
353216|NCT02082106|alpine skiing|alpine skiing
353217|NCT02082106|cross country skiing|cross country skiing
353218|NCT02082106|indoor cycling|indoor cycling
353219|NCT02082106|physical fitness|physical fitness
353220|NCT02082106|training status|training status
353221|NCT02082106|metabolic equivalent|metabolic equivalent
353222|NCT02082093|Chronic Kidney Disease|chronic kidney disease
353223|NCT02082093|telemedicine|telemedicine
353224|NCT02082054|rhinitis|rhinitis
353225|NCT02082054|seasonal|seasonal
353226|NCT02082054|allergic|allergic
353227|NCT02082015|Neuronal plasticity|neuronal plasticity
353228|NCT02082015|Transcranial magnetic stimulation|transcranial magnetic stimulation
353229|NCT02082015|Stroke|stroke
353230|NCT02082015|Upper extremity|upper extremity
353231|NCT02082015|Function|function
353232|NCT02082015|Recovery|recovery
353233|NCT02082002|Multiple scerlosis|multiple scerlosis
353234|NCT02082002|Fatigue|fatigue
353235|NCT02082002|Sleep|sleep
353236|NCT02082002|Somnolence|somnolence
353237|NCT02082002|Depression|depression
353238|NCT02082002|Cognitive disorders|cognitive disorders
353239|NCT02081989|Diabetes|diabetes
353240|NCT02081989|Renal denervation|renal denervation
353241|NCT02081963|Nebulized amikacin;|nebulized amikacin;
353242|NCT02081963|Non-Cystic Fibrosis Bronchiectasis;|non-cystic fibrosis bronchiectasis;
353243|NCT02081963|Bacterial clearance rate of sputum；|bacterial clearance rate of sputum；
353244|NCT02081963|Acute exacerbation.|acute exacerbation.
353245|NCT02081937|chimeric antigen receptor|chimeric antigen receptor
353246|NCT02081937|immunotherapy|immunotherapy
353247|NCT02081937|T lymphocyte|t lymphocyte
353248|NCT02081937|mantle cell lymphoma|mantle cell lymphoma
353249|NCT02081924|Infertility|infertility
353250|NCT02081924|Kisspeptin|kisspeptin
353251|NCT02081924|Reproductive hormones|reproductive hormones
353252|NCT02081911|adductor canal|adductor canal
353253|NCT02081911|femoral|femoral
353254|NCT02081911|quadriceps|quadriceps
353255|NCT02081898|low calorie diet|low calorie diet
353256|NCT02081898|BMI|bmi
353257|NCT02081898|sphingomyelin|sphingomyelin
353258|NCT02081898|L-leucine|l-leucine
353259|NCT02081898|L-phenylalanine|l-phenylalanine
353260|NCT02081885|Tricalcium phosphate|tricalcium phosphate
353261|NCT02081885|Chitosan|chitosan
353262|NCT02081885|Grafting, Bone|grafting, bone
353263|NCT02081885|Mandibular Fractures|mandibular fractures
353264|NCT02081872|Pharmacogenomics|pharmacogenomics
353265|NCT02081872|Target Drug Related Adverse Events (TDAE)|target drug related adverse events (tdae)
353266|NCT02081846|transitions of care|transitions of care
353267|NCT02081846|reutilization|reutilization
353268|NCT02081846|home nurse visit|home nurse visit
353269|NCT02081846|focus groups|focus groups
353270|NCT02081846|quality improvement|quality improvement
353271|NCT02081833|acute respiratory infections|acute respiratory infections
353272|NCT02081833|acute gastrointestinal infections|acute gastrointestinal infections
353273|NCT02081833|children|children
353274|NCT02081833|child|child
353275|NCT02081833|symptom diary|symptom diary
353276|NCT02081833|nasal swabs|nasal swabs
353277|NCT02081833|stool samples|stool samples
353278|NCT02081820|hyperglycemia|hyperglycemia
353279|NCT02081820|aneurysmal subarachnoid hemorrhage|aneurysmal subarachnoid hemorrhage
353280|NCT02081820|glycated hemoglobin|glycated hemoglobin
353281|NCT02081820|outcome|outcome
353282|NCT02081820|DCI|dci
353283|NCT02081768|Rathke's cleft cyst|rathke's cleft cyst
353284|NCT02081768|cystic craniopharyngiomas|cystic craniopharyngiomas
353285|NCT02081755|Immunosuppressive Agents|immunosuppressive agents
353286|NCT02081755|Liver Transplantation|liver transplantation
353287|NCT02081742|Colonoscopy, CT colonography, Colon capsule|colonoscopy, ct colonography, colon capsule
353288|NCT02081703|Postsurgical pain|postsurgical pain
353289|NCT02081703|Total knee arthroplasty|total knee arthroplasty
353290|NCT02081703|Total knee replacement|total knee replacement
353291|NCT02081690|PAH-SYMPACT|pah-sympact
353292|NCT02081690|psychometric instrument|psychometric instrument
353293|NCT02081664|Amalgam attributed health complaints|amalgam attributed health complaints
353294|NCT02081664|feasibility pilot study|feasibility pilot study
353295|NCT02081664|integrated medical care program|integrated medical care program
353296|NCT02081664|lifestyle|lifestyle
353297|NCT02081638|Treated Progressors|treated progressors
353298|NCT02081638|Immune Activation|immune activation
353299|NCT02081625|Duchenne muscular dystrophy|duchenne muscular dystrophy
353300|NCT02081625|NS-065/NCNP-01|ns-065/ncnp-01
353301|NCT02081625|exon 53 skipping|exon 53 skipping
353302|NCT02081625|morpholino|morpholino
353303|NCT02081599|insulin resistance|insulin resistance
353304|NCT02081586|CBT|cbt
353305|NCT02081586|Type 2 Diabetes|type 2 diabetes
353306|NCT02081586|Diabetes Distress|diabetes distress
353307|NCT02081586|Adherence|adherence
353308|NCT02081586|Smartphone App|smartphone app
353309|NCT02081586|Self-management|self-management
353310|NCT02081573|Brief CBT|brief cbt
353311|NCT02081573|smartphone app|smartphone app
353312|NCT02081573|mHealth|mhealth
353313|NCT02081573|diabetes distress|diabetes distress
353314|NCT02081573|adherence|adherence
353315|NCT02081573|cognitive behavioral therapy|cognitive behavioral therapy
353316|NCT02081560|pharmacokinetics|pharmacokinetics
353317|NCT02081560|antibiotic|antibiotic
353318|NCT02081560|Gram negative|gram negative
353319|NCT02081560|continuous renal replacement therapy|continuous renal replacement therapy
353320|NCT02081547|rectal carcinoma|rectal carcinoma
353321|NCT02081547|recurrence|recurrence
353322|NCT02081547|pathology|pathology
353323|NCT02081547|cytology|cytology
353324|NCT02081547|free cancer cells|free cancer cells
353325|NCT02081547|survival|survival
353326|NCT02081534|S-phosphate, hyperphosphatemia, hemodialysis, ESRD|s-phosphate, hyperphosphatemia, hemodialysis, esrd
353327|NCT02081521|behaviour change|behaviour change
353328|NCT02081521|diarrhoeal disease|diarrhoeal disease
353329|NCT02081521|handwashing|handwashing
353330|NCT02081521|breastfeeding|breastfeeding
353331|NCT02081521|diarrhoea management|diarrhoea management
353332|NCT02081508|Memory|memory
353333|NCT02081495|Neoplasms|neoplasms
353334|NCT02081495|Neoplasms, Ovarian|neoplasms, ovarian
353335|NCT02081495|Ovarian Cancer|ovarian cancer
353336|NCT02081495|Advanced or Refractory Solid Malignancies|advanced or refractory solid malignancies
353337|NCT02081495|Doxorubicin|doxorubicin
353338|NCT02081495|DOXIL|doxil
353339|NCT02081495|CAELYX|caelyx
353340|NCT02081469|Chronic hepatitis B|chronic hepatitis b
353341|NCT02081469|HBV|hbv
353342|NCT02081469|Chemotherapy|chemotherapy
353343|NCT02081469|Reactivation|reactivation
353344|NCT02081469|Prophylaxis|prophylaxis
353345|NCT02081443|coronary artery disease|coronary artery disease
353346|NCT02081443|platelet function|platelet function
353347|NCT02081443|ticagrelor|ticagrelor
353348|NCT02081443|cangrelor|cangrelor
353349|NCT02081417|Trauma|trauma
353350|NCT02081417|Post traumatic stress disorder|post traumatic stress disorder
353351|NCT02081417|substance use disorders|substance use disorders
353352|NCT02081417|peer-delivered trauma treatment|peer-delivered trauma treatment
353353|NCT02081404|Non-erosive Reflux Disease|non-erosive reflux disease
353354|NCT02081391|Acute Pain|acute pain
353355|NCT02081391|Post-operative|post-operative
353356|NCT02081391|Tapentadol|tapentadol
353357|NCT02081391|Opioid Treatment|opioid treatment
353358|NCT02081391|Pediatric Participants|pediatric participants
353359|NCT02081378|CML|cml
353360|NCT02081378|Ph+ ALL|ph+ all
353361|NCT02081352|Dermis|dermis
353362|NCT02081352|Diabetic foot ulcers|diabetic foot ulcers
353363|NCT02081352|Skin substitutes|skin substitutes
353364|NCT02081352|Decellularized|decellularized
353365|NCT02081326|Diabetes Mellitus, Type One|diabetes mellitus, type one
353366|NCT02081326|Diabetes Mellitus, Type I|diabetes mellitus, type i
353367|NCT02081326|Autoimmune Diabetes|autoimmune diabetes
353368|NCT02081326|Insulin Dependent Diabetes Mellitus 1|insulin dependent diabetes mellitus 1
353369|NCT02081326|IDDM|iddm
353370|NCT02081313|Netherton syndrome|netherton syndrome
353371|NCT02081313|Immune system|immune system
353372|NCT02081313|Skin barrier|skin barrier
353373|NCT02081300|Testosterone|testosterone
353374|NCT02081300|Male hypogonadism|male hypogonadism
353375|NCT02081300|Low testosterone|low testosterone
353376|NCT02081300|LPCN 1021|lpcn 1021
353377|NCT02081300|Androgel|androgel
353378|NCT02081300|Testim|testim
353379|NCT02081300|Testopel|testopel
353380|NCT02081300|Fortesta|fortesta
353381|NCT02081300|Axiron.|axiron.
353382|NCT02081300|Hypogonadism|hypogonadism
353383|NCT02081300|Eunuchism|eunuchism
353384|NCT02081300|Gonadal Disorders|gonadal disorders
353385|NCT02081300|Endocrine System Diseases|endocrine system diseases
353386|NCT02081300|Testosterone enanthate|testosterone enanthate
353387|NCT02081300|Testosterone undecanoate|testosterone undecanoate
353388|NCT02081300|Testosterone 17 beta-cypionate|testosterone 17 beta-cypionate
353389|NCT02081300|Methyltestosterone|methyltestosterone
353390|NCT02081300|Androgens|androgens
353391|NCT02081300|Hormones|hormones
353392|NCT02081300|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists
353393|NCT02081300|Physiological Effects of Drugs|physiological effects of drugs
353394|NCT02081300|Pharmacologic Actions|pharmacologic actions
353395|NCT02081300|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal
353396|NCT02081300|Antineoplastic Agents|antineoplastic agents
353397|NCT02081300|Anabolic Agents|anabolic agents
353398|NCT02081287|Bipolar Disorder|bipolar disorder
353399|NCT02081287|Depression|depression
353400|NCT02081287|Inositol|inositol
353401|NCT02081287|Inositol Hexaphosphate|inositol hexaphosphate
353402|NCT02081287|Phytic Acid|phytic acid
353403|NCT02081287|IP6|ip6
353404|NCT02081287|Lithium|lithium
353405|NCT02081287|Lamotrigine|lamotrigine
353406|NCT02081274|tidal volume|tidal volume
353407|NCT02081274|congenital heart disease|congenital heart disease
353408|NCT02081274|mortality|mortality
353409|NCT02081261|coronary artery bypass surgery|coronary artery bypass surgery
353410|NCT02081261|acute kidney injury|acute kidney injury
353411|NCT02081261|creatinine|creatinine
353412|NCT02081261|mortality|mortality
353413|NCT02081235|congenital heart disease|congenital heart disease
353414|NCT02081235|acute kidney injury|acute kidney injury
353415|NCT02081235|risk factor|risk factor
353416|NCT02081235|anesthesia|anesthesia
353417|NCT02081222|congenital heart disease|congenital heart disease
353418|NCT02081222|rotational thromboelastometry|rotational thromboelastometry
353419|NCT02081222|blood loss|blood loss
353420|NCT02081222|transfusion requirements|transfusion requirements
353421|NCT02081209|Lipolysis|lipolysis
353422|NCT02081209|Cryolipolysis|cryolipolysis
353423|NCT02081209|Fat Reduction|fat reduction
353424|NCT02081196|Lipolysis|lipolysis
353425|NCT02081196|Cryolipolysis|cryolipolysis
353426|NCT02081196|Fat Reduction|fat reduction
353427|NCT02081144|Standard Care Condition|standard care condition
353428|NCT02081144|Texting + NRT Condition|texting + nrt condition
353429|NCT02081131|periampullary cancer|periampullary cancer
353430|NCT02081131|pancreatic cancer|pancreatic cancer
353431|NCT02081131|randomized controlled trial|randomized controlled trial
353432|NCT02081131|Whipple's operation|whipple's operation
353433|NCT02081131|laparoscopy|laparoscopy
353434|NCT02081105|ARDS,|ards,
353435|NCT02081105|PEEP,|peep,
353436|NCT02081105|lung recruitment,|lung recruitment,
353437|NCT02081105|lung recruitability,|lung recruitability,
353438|NCT02081105|Chest-X-Ray,|chest-x-ray,
353439|NCT02081105|lung imaging,|lung imaging,
353440|NCT02081105|Pressure/Volume (PV) curve,|pressure/volume (pv) curve,
353441|NCT02081105|compliance,|compliance,
353442|NCT02081105|respiratory mechanics|respiratory mechanics
353443|NCT02081092|PAP|pap
353444|NCT02081092|Pulmonary Alveolar Proteinosis|pulmonary alveolar proteinosis
353445|NCT02081092|Pulmonary|pulmonary
353446|NCT02081092|Patients|patients
353447|NCT02081079|HCV GT 4|hcv gt 4
353448|NCT02081079|HCV GT 5|hcv gt 5
353449|NCT02081053|metastatic lesions|metastatic lesions
353450|NCT02081053|vertebral body|vertebral body
353451|NCT02081053|ablation|ablation
353452|NCT02081053|targeted radio-frequency ablation|targeted radio-frequency ablation
353453|NCT02081053|radio-frequency targeted vertebral augmentation|radio-frequency targeted vertebral augmentation
353454|NCT02081053|radiofrequency kyphoplasty|radiofrequency kyphoplasty
353455|NCT02081053|spine|spine
353456|NCT02081053|vertebral augmentation|vertebral augmentation
353457|NCT02081053|kyphoplasty|kyphoplasty
353458|NCT02081053|spinal ablation|spinal ablation
353459|NCT02081053|pain|pain
353460|NCT02081053|quality of life|quality of life
353461|NCT02081040|brainstem|brainstem
353462|NCT02081040|diaphragm|diaphragm
353463|NCT02081040|deglutition disorder|deglutition disorder
353464|NCT02081040|sonography|sonography
353465|NCT02081014|Hypoglycemia|hypoglycemia
353466|NCT02081014|Glucagon|glucagon
353467|NCT02081014|Diabetes|diabetes
353468|NCT02081001|Hypoglycemia|hypoglycemia
353469|NCT02081001|Glucagon|glucagon
353470|NCT02081001|Artificial Pancreas|artificial pancreas
353471|NCT02080988|stroke|stroke
353472|NCT02080988|deglutition disorders|deglutition disorders
353473|NCT02080988|cough|cough
353474|NCT02080988|aspiration pneumonia|aspiration pneumonia
353475|NCT02080988|diaphragm|diaphragm
353476|NCT02080988|respiratory function|respiratory function
353477|NCT02080962|non-melanoma skin cancer, radiotherapy, orthovoltage|non-melanoma skin cancer, radiotherapy, orthovoltage
353478|NCT02080949|brain metastases, hypofractionated stereotactic radiotherapy|brain metastases, hypofractionated stereotactic radiotherapy
353479|NCT02080936|Experimental approaches|experimental approaches
353480|NCT02080936|Peripheral muscle Keyword|peripheral muscle keyword
353481|NCT02080936|Rehabilitation|rehabilitation
353482|NCT02080923|Adolescent|adolescent
353483|NCT02080923|Adolescent Behavior|adolescent behavior
353484|NCT02080923|Age Factors|age factors
353485|NCT02080923|Courtship|courtship
353486|NCT02080923|Randomized Control Trial|randomized control trial
353487|NCT02080923|Female|female
353488|NCT02080923|Male|male
353593|NCT02080403|Periodontal Diseases|periodontal diseases
353489|NCT02080923|Minority Groups/statistics & numerical data|minority groups/statistics & numerical data
353490|NCT02080923|Risk-Taking|risk-taking
353491|NCT02080923|Sex Factors|sex factors
353492|NCT02080923|Sexual Behavior/statistics & numerical data|sexual behavior/statistics & numerical data
353493|NCT02080923|Substance-Related Disorders/epidemiology|substance-related disorders/epidemiology
353494|NCT02080923|Urban Population/statistics & numerical data|urban population/statistics & numerical data
353495|NCT02080923|Violence/statistics & numerical data|violence/statistics & numerical data
353496|NCT02080923|Dating Violence|dating violence
353497|NCT02080923|Dating Aggression|dating aggression
353498|NCT02080923|Perpetration|perpetration
353499|NCT02080910|Caregiver|caregiver
353500|NCT02080910|stroke|stroke
353501|NCT02080910|psychoeducation|psychoeducation
353502|NCT02080910|problem-solving|problem-solving
353503|NCT02080897|non-surgical|non-surgical
353504|NCT02080897|palliative surgery|palliative surgery
353505|NCT02080871|PAD|pad
353506|NCT02080871|Stent|stent
353507|NCT02080871|Claudication|claudication
353508|NCT02080871|Viabahn|viabahn
353509|NCT02080871|Gore|gore
353510|NCT02080871|Endoprosthesis|endoprosthesis
353511|NCT02080871|Vascular Diseases|vascular diseases
353512|NCT02080871|Cardiovascular Diseases|cardiovascular diseases
353513|NCT02080871|Iliac Occlusive Disease|iliac occlusive disease
353514|NCT02080871|Balloon Expandable|balloon expandable
353515|NCT02080871|Stent-graft|stent-graft
353516|NCT02080871|VBX|vbx
353517|NCT02080858|Apixaban|apixaban
353518|NCT02080858|Ticagrelor|ticagrelor
353519|NCT02080858|ASA|asa
353520|NCT02080858|shed blood|shed blood
353521|NCT02080858|perfusion chamber|perfusion chamber
353522|NCT02080845|Caffeine|caffeine
353523|NCT02080845|MRI|mri
353524|NCT02080845|Brain blood flow|brain blood flow
353525|NCT02080845|Cognition|cognition
353526|NCT02080845|Perfusion|perfusion
353527|NCT02080845|Resting functional magnetic resonance imaging (fMRI)|resting functional magnetic resonance imaging (fmri)
353528|NCT02080832|substance abuse|substance abuse
353529|NCT02080832|cocaine|cocaine
353530|NCT02080832|impulsivity|impulsivity
353531|NCT02080832|serotonin|serotonin
353532|NCT02080832|MRI|mri
353533|NCT02080819|drug abuse|drug abuse
353534|NCT02080819|cocaine|cocaine
353535|NCT02080819|impulsivity|impulsivity
353536|NCT02080819|dopamine|dopamine
353537|NCT02080806|stroke, dysphagia, cough, mechanical insufflation exsufflation|stroke, dysphagia, cough, mechanical insufflation exsufflation
353538|NCT02080754|Crush induction|crush induction
353539|NCT02080754|Cricoid pressure|cricoid pressure
353540|NCT02080754|Sellick maneuver|sellick maneuver
353541|NCT02080754|Lung aspiration|lung aspiration
353542|NCT02080754|Aspiration pneumonia|aspiration pneumonia
353543|NCT02080715|Sleep-wake|sleep-wake
353544|NCT02080715|regulation|regulation
353545|NCT02080715|volunteers|volunteers
353546|NCT02080702|GIT, Monosyn, anastomoses leakage|git, monosyn, anastomoses leakage
353547|NCT02080676|Cannabis|cannabis
353548|NCT02080676|Intra ocular pressure|intra ocular pressure
353549|NCT02080676|Ocular perfusion|ocular perfusion
353550|NCT02080676|Blood pressure|blood pressure
353551|NCT02080663|carpectomy, proximal row, long-term, wrist, arthritis|carpectomy, proximal row, long-term, wrist, arthritis
353552|NCT02080637|Single ventricle|single ventricle
353553|NCT02080585|Inactivity|inactivity
353554|NCT02080546|Vaginal cuff dehiscence|vaginal cuff dehiscence
353555|NCT02080546|Thermal Injury|thermal injury
353556|NCT02080546|Total laparoscopic hysterectomy|total laparoscopic hysterectomy
353557|NCT02080533|pulmonary arterial hypertension|pulmonary arterial hypertension
353558|NCT02080533|symptoms|symptoms
353559|NCT02080533|dyspnea|dyspnea
353560|NCT02080533|fatigue|fatigue
353561|NCT02080533|sleep|sleep
353562|NCT02080520|Prevention|prevention
353563|NCT02080520|Soy|soy
353564|NCT02080520|Fermented soy|fermented soy
353565|NCT02080520|Nattokinase|nattokinase
353566|NCT02080520|Randomized controlled trial|randomized controlled trial
353567|NCT02080520|Carotid artery|carotid artery
353568|NCT02080520|Cognition|cognition
353569|NCT02080520|Atherothrombosis|atherothrombosis
353570|NCT02080507|rTMS|rtms
353571|NCT02080507|depression|depression
353572|NCT02080507|ECT|ect
353573|NCT02080494|tranexamic acid|tranexamic acid
353574|NCT02080494|orthopaedic trauma|orthopaedic trauma
353575|NCT02080494|pelvic fracture|pelvic fracture
353576|NCT02080494|hip fracture|hip fracture
353577|NCT02080494|femur fracture|femur fracture
353578|NCT02080494|blood loss|blood loss
353579|NCT02080468|Effect|effect
353580|NCT02080468|Ethinyl Estradiol/Norgestimate|ethinyl estradiol/norgestimate
353581|NCT02080468|Pharmacokinetics|pharmacokinetics
353582|NCT02080468|Lomitapide.|lomitapide.
353583|NCT02080442|COPD|copd
353584|NCT02080442|Balance|balance
353585|NCT02080442|Pulmonary Rehabilitation|pulmonary rehabilitation
353586|NCT02080416|EBV|ebv
353587|NCT02080416|KSHV|kshv
353588|NCT02080416|malignancy|malignancy
353589|NCT02080416|lymphoma|lymphoma
353590|NCT02080416|sarcoma|sarcoma
353591|NCT02080416|virus-associated|virus-associated
353592|NCT02080403|Peri-Implantitis|peri-implantitis
353594|NCT02080403|Chlorhexidine gluconate|chlorhexidine gluconate
353595|NCT02080403|PerioChip|periochip
353596|NCT02080403|Anti-Infective Agents|anti-infective agents
353597|NCT02080403|Mouth Diseases|mouth diseases
353598|NCT02080403|Antiseptics|antiseptics
353599|NCT02080390|Her 2 Positive Breast Cancer|her 2 positive breast cancer
353600|NCT02080390|Trastuzumab|trastuzumab
353601|NCT02080390|Herceptin|herceptin
353602|NCT02080390|Heart Failure|heart failure
353603|NCT02080390|Echocardiography|echocardiography
353604|NCT02080377|Pregnancy|pregnancy
353605|NCT02080377|Gestational diabetes|gestational diabetes
353606|NCT02080377|Glycaemic control|glycaemic control
353607|NCT02080377|Metformin|metformin
353608|NCT02080364|Alzheimer's disease|alzheimer's disease
353609|NCT02080364|RAGE|rage
353610|NCT02080364|ADAS-cog|adas-cog
353611|NCT02080364|CDR-sb|cdr-sb
353612|NCT02080338|Orthodontic, Bracket slot, Effective, Randomized, Duration|orthodontic, bracket slot, effective, randomized, duration
353613|NCT02080325|weight loss|weight loss
353614|NCT02080325|high protein diet|high protein diet
353615|NCT02080325|plant protein|plant protein
353616|NCT02080325|satiety|satiety
353617|NCT02080325|soy|soy
353618|NCT02080312|Meniere's disease|meniere's disease
353619|NCT02080312|endolymphatic hydrops|endolymphatic hydrops
353620|NCT02080286|spatial neglect|spatial neglect
353621|NCT02080286|rehabilitation|rehabilitation
353622|NCT02080286|brain stimulation|brain stimulation
353623|NCT02080286|tDCS|tdcs
353624|NCT02080286|prism adaptation|prism adaptation
353625|NCT02080234|Lymphoma, Extranodal NK-T-Cell|lymphoma, extranodal nk-t-cell
353626|NCT02080234|asparaginase|asparaginase
353627|NCT02080234|GELOX|gelox
353628|NCT02080234|concurrent chemoradiotherapy|concurrent chemoradiotherapy
353629|NCT02080234|sIL-2R|sil-2r
353630|NCT02080221|metastatic pancreatic cancer|metastatic pancreatic cancer
353631|NCT02080221|pancreatic cancer|pancreatic cancer
353632|NCT02080221|metastatic|metastatic
353633|NCT02080208|hypoxemia|hypoxemia
353634|NCT02080208|high flow oxygen therapy|high flow oxygen therapy
353635|NCT02080208|respiratory failure|respiratory failure
353636|NCT02080182|Acute Pyelonephritis|acute pyelonephritis
353637|NCT02080182|Acetylcysteine|acetylcysteine
353638|NCT02080182|Pediatric|pediatric
353639|NCT02080169|Intensive care unit|intensive care unit
353640|NCT02080169|Mechanical ventilation|mechanical ventilation
353641|NCT02080169|Combined sedation|combined sedation
353642|NCT02080156|Obstructive Sleep Apnea|obstructive sleep apnea
353643|NCT02080156|Percutaneous Coronary Intervention|percutaneous coronary intervention
353644|NCT02080156|Coronary Artery Bypass Graft|coronary artery bypass graft
353645|NCT02080156|Mortality|mortality
353646|NCT02080156|Questionnaire|questionnaire
353647|NCT02080156|Biomarker|biomarker
353648|NCT02080143|Skin temperature measurements|skin temperature measurements
353649|NCT02080143|Heat patch adhesion|heat patch adhesion
353650|NCT02080143|Dermal irritation|dermal irritation
353651|NCT02080130|Gastroenteritis|gastroenteritis
353652|NCT02080130|diarrhea|diarrhea
353653|NCT02080117|kidney transplantation|kidney transplantation
353654|NCT02080117|delayed graft function|delayed graft function
353655|NCT02080117|creatinine|creatinine
353656|NCT02080117|graft survival|graft survival
353657|NCT02080104|postpartum hemorrhage|postpartum hemorrhage
353658|NCT02080104|oxytocin|oxytocin
353659|NCT02080104|vaginal delivery|vaginal delivery
353660|NCT02080104|prophylactic|prophylactic
353661|NCT02080078|Erlotinib|erlotinib
353662|NCT02080078|Theophylline|theophylline
353663|NCT02080078|Diarrhea|diarrhea
353664|NCT02080065|risk factor|risk factor
353665|NCT02080065|acute kidney injury|acute kidney injury
353666|NCT02080065|liver transplantation|liver transplantation
353667|NCT02080065|postoperative renal function|postoperative renal function
353668|NCT02080039|Spinal Cord Injury|spinal cord injury
353669|NCT02080039|Denervation|denervation
353670|NCT02080039|Electrical Stimulation|electrical stimulation
353671|NCT02080026|malaria|malaria
353672|NCT02080026|Plasmodium falciparum|plasmodium falciparum
353673|NCT02080000|Heart Failure|heart failure
353674|NCT02080000|Cardiac Resynchronisation Therapy|cardiac resynchronisation therapy
353675|NCT02080000|Biventricular Pacemaker|biventricular pacemaker
353676|NCT02080000|Optimisation|optimisation
353677|NCT02079987|Healthcare Coach|healthcare coach
353678|NCT02079987|Care Transition Intervention|care transition intervention
353679|NCT02079987|Emergency Department Population|emergency department population
353680|NCT02079987|Access to Care|access to care
353681|NCT02079974|endometriosis|endometriosis
353682|NCT02079974|pain|pain
353683|NCT02079974|fertility|fertility
353684|NCT02079961|anemia|anemia
353685|NCT02079961|children|children
353686|NCT02079961|iron-fortified product|iron-fortified product
353687|NCT02079961|value chain|value chain
353688|NCT02079948|Aging|aging
353689|NCT02079948|Cognitive Function|cognitive function
353690|NCT02079948|Physical Function|physical function
353691|NCT02079948|Systematic Inflammation|systematic inflammation
353692|NCT02079948|Methotrexate|methotrexate
353693|NCT02079948|Pain Symptoms|pain symptoms
353695|NCT02079935|Binge|binge
353696|NCT02079935|overconsumption of food|overconsumption of food
353697|NCT02079935|purging|purging
353698|NCT02079935|purge|purge
353699|NCT02079922|Multiple Ascending Dose|multiple ascending dose
353700|NCT02079922|healthy subjects|healthy subjects
353701|NCT02079922|Hypercholesterolemia|hypercholesterolemia
353702|NCT02079922|Hyperlipidemias|hyperlipidemias
353703|NCT02079922|Dyslipidemias|dyslipidemias
353704|NCT02079922|Lipid Metabolism Disorders|lipid metabolism disorders
353705|NCT02079922|Metabolic Diseases|metabolic diseases
353706|NCT02079909|Alzheimer's Disease|alzheimer's disease
353707|NCT02079909|Alzheimer's|alzheimer's
353708|NCT02079896|Dialysis|dialysis
353709|NCT02079844|Drug therapy|drug therapy
353710|NCT02079831|Adolescent obesity|adolescent obesity
353711|NCT02079831|childhood obesity|childhood obesity
353712|NCT02079831|anthropometry|anthropometry
353713|NCT02079831|body weights and measures|body weights and measures
353714|NCT02079818|visceral artery aneurysms|visceral artery aneurysms
353715|NCT02079818|arteriovenous malformations|arteriovenous malformations
353716|NCT02079818|Penumbra Ruby Coil System|penumbra ruby coil system
353717|NCT02079792|Budesonide|budesonide
353718|NCT02079792|Mucosal Atomization Device|mucosal atomization device
353719|NCT02079792|Head Position|head position
353720|NCT02079779|Robotic-assisted therapy|robotic-assisted therapy
353721|NCT02079779|Acute Stroke|acute stroke
777056|NCT00341367|Back Pain|back pain
353722|NCT02079779|International Classification of Functioning, Disability and Health|international classification of functioning, disability and health
353723|NCT02079753|COPD, portable concentrator, oxygen sources|copd, portable concentrator, oxygen sources
353724|NCT02079727|Condrosulf|condrosulf
353725|NCT02079727|Chondroitin sulfate|chondroitin sulfate
353726|NCT02079727|Celebrex|celebrex
353727|NCT02079727|Knee OA|knee oa
353728|NCT02079727|Knee osteoarthritis|knee osteoarthritis
353729|NCT02079714|Orthopaedic Trauma|orthopaedic trauma
353730|NCT02079714|Injury|injury
353731|NCT02079701|pneumonia|pneumonia
353732|NCT02079701|pneumococcus|pneumococcus
353733|NCT02079701|vaccine|vaccine
353734|NCT02079701|23-valent pneumococcal vaccine|23-valent pneumococcal vaccine
353735|NCT02079701|military recruits|military recruits
353736|NCT02079688|Antisense oligonucleotide|antisense oligonucleotide
353737|NCT02079688|atopic eczema|atopic eczema
353738|NCT02079688|atopic dermatitis|atopic dermatitis
353739|NCT02079688|Phase II|phase ii
353740|NCT02079688|Transcription factor GATA-3|transcription factor gata-3
353741|NCT02079688|dermal application|dermal application
353742|NCT02079688|Proof-of-Concept|proof-of-concept
353743|NCT02079649|Allergic conjunctivitis|allergic conjunctivitis
353744|NCT02079649|Red eyes|red eyes
353745|NCT02079649|Eyelid swelling|eyelid swelling
353746|NCT02079649|Ragweed|ragweed
353747|NCT02079649|Allergies|allergies
353748|NCT02079649|Itchy eyes|itchy eyes
353749|NCT02079649|Ocular redness|ocular redness
353750|NCT02079649|Chemosis|chemosis
353751|NCT02079649|Tearing|tearing
353752|NCT02079649|Watery eyes|watery eyes
353753|NCT02079623|Pancreatic cancer|pancreatic cancer
353754|NCT02079623|Electroporation|electroporation
353755|NCT02079623|Nano knife treatment|nano knife treatment
353756|NCT02079610|Depression|depression
353757|NCT02079610|Neurofeedback|neurofeedback
353758|NCT02079610|Amygdala|amygdala
353759|NCT02079597|SIRS|sirs
353760|NCT02079597|Ninj1|ninj1
353761|NCT02079597|Sepsis|sepsis
353762|NCT02079597|Healthy|healthy
353763|NCT02079584|Patient Compliance|patient compliance
353764|NCT02079584|Target Specific Anticoagulant|target specific anticoagulant
353765|NCT02079584|Quality of Life|quality of life
353766|NCT02079558|prevention|prevention
353767|NCT02079558|cesarean section|cesarean section
353768|NCT02079545|Healthy|healthy
353769|NCT02079545|Bioavailability|bioavailability
353770|NCT02079545|Pharmacokinetics|pharmacokinetics
353771|NCT02079545|Sirukumab|sirukumab
353772|NCT02079545|Subcutaneous|subcutaneous
353773|NCT02079545|Male|male
353774|NCT02079493|osteoarthritis|osteoarthritis
353775|NCT02079493|knee replacement|knee replacement
353776|NCT02079493|functional testing|functional testing
353777|NCT02079467|Arthroplasty, Hip|arthroplasty, hip
353778|NCT02079467|Replacement, Hip|replacement, hip
353779|NCT02079467|Postoperative Care|postoperative care
353780|NCT02079467|Rehabilitation|rehabilitation
353781|NCT02079441|Anti- TNF|anti- tnf
353782|NCT02079441|inflammatory bowel disease|inflammatory bowel disease
353783|NCT02079441|pregnancy|pregnancy
353784|NCT02079441|infant|infant
353785|NCT02079441|immunity|immunity
353786|NCT02079441|Immune function|immune function
353787|NCT02079428|Heart Failure|heart failure
353788|NCT02079428|Registry|registry
353789|NCT02079428|China|china
353790|NCT02079415|NICU|nicu
353791|NCT02079402|sepsis|sepsis
353792|NCT02079402|septic|septic
353793|NCT02079402|shock|shock
353794|NCT02079402|ICU|icu
353795|NCT02079402|intensive|intensive
353796|NCT02079402|critical|critical
353797|NCT02079402|resuscitation|resuscitation
353798|NCT02079402|fluid|fluid
353799|NCT02079402|IV|iv
353800|NCT02079402|crystalloid|crystalloid
353801|NCT02079402|balance|balance
353802|NCT02079389|colon cancer|colon cancer
353803|NCT02079389|rectum cancer|rectum cancer
353804|NCT02079389|laparoscopic ultrasound|laparoscopic ultrasound
353806|NCT02079389|Contrast enhanced ultrasound|contrast enhanced ultrasound
353807|NCT02079389|CEUS|ceus
353808|NCT02079389|Peroperative TNM staging|peroperative tnm staging
353809|NCT02079389|screening for liver metastases|screening for liver metastases
353810|NCT02079376|diabetes|diabetes
353811|NCT02079363|Pancreatic Diseases|pancreatic diseases
353812|NCT02079363|Pancreatic Neoplasms|pancreatic neoplasms
353813|NCT02079363|Pancreatitis|pancreatitis
353814|NCT02079363|DNA promoter hypermethylation|dna promoter hypermethylation
353815|NCT02079363|DNA methylation|dna methylation
353816|NCT02079363|Cell-free DNA|cell-free dna
353817|NCT02079363|Plasma|plasma
353818|NCT02079324|head and neck cancer|head and neck cancer
353819|NCT02079324|gene therapy|gene therapy
353820|NCT02079324|stem cell therapy|stem cell therapy
353821|NCT02079324|immunotherappy|immunotherappy
353822|NCT02079311|Patient warming|patient warming
353823|NCT02079311|Active warming|active warming
353824|NCT02079311|Forced Air Warming|forced air warming
353825|NCT02079311|Warming blanket|warming blanket
353826|NCT02079272|Tomotherapy|tomotherapy
353827|NCT02079272|Breast Cancer|breast cancer
353828|NCT02079272|Heart|heart
353829|NCT02079272|Subclinical cardiac lesions|subclinical cardiac lesions
353830|NCT02079272|Myocardial lesions|myocardial lesions
353831|NCT02079272|Coronary lesions|coronary lesions
353832|NCT02079272|Circulating biomarkers|circulating biomarkers
353833|NCT02079272|Ionizing radiation|ionizing radiation
353834|NCT02079272|Heart absorbed doses|heart absorbed doses
353835|NCT02079233|Basic Science|basic science
353836|NCT02079233|Safety|safety
353837|NCT02079233|Tolerability|tolerability
353838|NCT02079233|Efficacy of CLP|efficacy of clp
353839|NCT02079220|Colorectal Cancer|colorectal cancer
353840|NCT02079220|Metastatic Colorectal Cancer|metastatic colorectal cancer
353841|NCT02079194|Drug-eluting stents|drug-eluting stents
353842|NCT02079194|aspirin|aspirin
353843|NCT02079194|P2Y12 antagonist monotherapy|p2y12 antagonist monotherapy
353844|NCT02079168|Keloid|keloid
353845|NCT02079168|Cicatrix|cicatrix
353846|NCT02079168|Keloid prevention|keloid prevention
353847|NCT02079168|Keloid revision/excision|keloid revision/excision
353848|NCT02079168|Keloidectomy|keloidectomy
353849|NCT02079129|agreement between cMRI PVL grading and TTE PVL grading|agreement between cmri pvl grading and tte pvl grading
353850|NCT02079129|Edwards Sapien TAVR|edwards sapien tavr
353851|NCT02079116|Obesity|obesity
353852|NCT02079116|Lipids|lipids
353853|NCT02079116|Single Photon Emission Computed Tomography|single photon emission computed tomography
353854|NCT02079116|Functional Neuroimaging|functional neuroimaging
353855|NCT02079103|Virtual reality|virtual reality
353856|NCT02079103|Stroke|stroke
353857|NCT02079103|Arm motor function|arm motor function
353858|NCT02079103|Neurorehabilitation|neurorehabilitation
353859|NCT02079090|Propofol|propofol
353860|NCT02079090|Ketamine|ketamine
353861|NCT02079090|Fentanyl|fentanyl
353862|NCT02079090|Procedural sedation|procedural sedation
353863|NCT02079090|children|children
353864|NCT02079090|Emergency Department|emergency department
353865|NCT02079077|HIV, Immune quiescence, ASA, Hydroxychloroquin|hiv, immune quiescence, asa, hydroxychloroquin
353866|NCT02079064|Splenectomy|splenectomy
353867|NCT02079064|Desflurane|desflurane
353868|NCT02079064|Propofol|propofol
353869|NCT02079064|TCI|tci
353870|NCT02079064|ROTEM|rotem
353871|NCT02079051|Obesity Physical Performance Weight loss Optifast|obesity physical performance weight loss optifast
353872|NCT02079025|Prostate Biopsy|prostate biopsy
353873|NCT02079025|Ultrasound guided biopsy of the prostate|ultrasound guided biopsy of the prostate
353874|NCT02079025|High-resolution ultrasound|high-resolution ultrasound
353875|NCT02079012|Walking Program|walking program
353876|NCT02079012|Mental Disorders|mental disorders
353877|NCT02079012|Physical Activity|physical activity
353878|NCT02079012|Physical Fitness|physical fitness
353879|NCT02079012|Anxiety|anxiety
353880|NCT02079012|Depression|depression
353881|NCT02079012|Self Determination|self determination
353882|NCT02078999|Mechanical ventilation, procalcitonin, c-reactive protein|mechanical ventilation, procalcitonin, c-reactive protein
353883|NCT02078986|Whole-Body-Electromyostimulation|whole-body-electromyostimulation
353884|NCT02078986|High Intensity Resistance Exercise Training (HIT)|high intensity resistance exercise training (hit)
353885|NCT02078986|Lean Body Mass|lean body mass
353886|NCT02078986|Muscle Strength|muscle strength
353887|NCT02078973|Tolvaptan|tolvaptan
353888|NCT02078973|L-NMMA|l-nmma
353889|NCT02078973|Healthy subjects|healthy subjects
353890|NCT02078973|Nephrology|nephrology
353891|NCT02078960|Chronic Phase|chronic phase
353892|NCT02078960|Accelerated Phase|accelerated phase
353893|NCT02078960|CML|cml
353894|NCT02078960|Chronic Myeloid Leukemia|chronic myeloid leukemia
353895|NCT02078947|Diastolic heart failure, Heart failure with preserved ejection fraction, exercise|diastolic heart failure, heart failure with preserved ejection fraction, exercise
353896|NCT02078934|Surgical Endoscopy|surgical endoscopy
353897|NCT02078934|Morbid Obesity|morbid obesity
353898|NCT02078934|Weight Loss|weight loss
353899|NCT02078934|Bariatrics|bariatrics
353900|NCT02078934|Complex incisional hernia with mesh|complex incisional hernia with mesh
353901|NCT02078908|Central blood pressure|central blood pressure
353902|NCT02078908|Peripheral (brachial) blood pressure|peripheral (brachial) blood pressure
353903|NCT02078908|Renal variables|renal variables
353904|NCT02078908|Vasoactive hormones|vasoactive hormones
353905|NCT02078908|Pharmacology|pharmacology
353906|NCT02078908|Pharmacokinetics|pharmacokinetics
353907|NCT02078895|Lower Urinary tract discomfort , ureteral stent pain|lower urinary tract discomfort , ureteral stent pain
353908|NCT02078882|Primary Biliary Cirrhosis|primary biliary cirrhosis
353909|NCT02078882|Ursodeoxycholic acid|ursodeoxycholic acid
353910|NCT02078882|Abatacept|abatacept
353911|NCT02078882|Cytotoxic T-Lymphocyte Antigen 4 (CTLA-4)|cytotoxic t-lymphocyte antigen 4 (ctla-4)
353912|NCT02078843|NET|net
353913|NCT02078843|Gallium-68-DOTATATE|gallium-68-dotatate
353914|NCT02078843|PET/CT|pet/ct
353915|NCT02078843|Indium-111-pentetreotide scintigraphy|indium-111-pentetreotide scintigraphy
353916|NCT02078843|octreoscan|octreoscan
353917|NCT02078843|GEP-NET|gep-net
353918|NCT02078843|gastroenteropancreatic neuroendocrine tumors|gastroenteropancreatic neuroendocrine tumors
777057|NCT00341367|Lumbar Disc|lumbar disc
353919|NCT02078830|Wound Contamination|wound contamination
353920|NCT02078817|Treatment-resistant|treatment-resistant
353921|NCT02078804|Colorectal cancer|colorectal cancer
353922|NCT02078804|Mortality|mortality
353923|NCT02078804|Incidence|incidence
353924|NCT02078804|Screening|screening
353925|NCT02078804|Health-economy|health-economy
353926|NCT02078791|Fibromyalgia|fibromyalgia
353927|NCT02078791|Group Problem Solving Technique|group problem solving technique
353928|NCT02078791|infiltration|infiltration
353929|NCT02078778|Continuous airway pressure|continuous airway pressure
353930|NCT02078778|Hypertension|hypertension
353931|NCT02078778|Obstructive sleep apnea|obstructive sleep apnea
353932|NCT02078765|hypertension|hypertension
353933|NCT02078765|chronic kidneys disease|chronic kidneys disease
353934|NCT02078765|obstructive sleep apnea|obstructive sleep apnea
353935|NCT02078765|24-h blood pressure|24-h blood pressure
353936|NCT02078765|central blood pressure|central blood pressure
353937|NCT02078765|peripheral blood pressure|peripheral blood pressure
353938|NCT02078752|ADC|adc
353939|NCT02078752|PF-06647263|pf-06647263
353940|NCT02078752|solid tumors|solid tumors
353941|NCT02078752|tumors|tumors
353942|NCT02078752|neoplasm metastasis|neoplasm metastasis
353943|NCT02078752|TNBC|tnbc
353944|NCT02078752|Triple negative breast cancer|triple negative breast cancer
353945|NCT02078739|Yoga|yoga
353946|NCT02078739|COPD|copd
353947|NCT02078739|Congestive Heart Failure|congestive heart failure
353948|NCT02078726|glucagon, screening colonoscopy|glucagon, screening colonoscopy
353949|NCT02078713|contraception|contraception
353950|NCT02078713|patient decision support|patient decision support
353951|NCT02078713|patient decision aid|patient decision aid
353952|NCT02078713|shared decision making|shared decision making
353953|NCT02078713|Decision Making, Shared|decision making, shared
353954|NCT02078713|Patient-Centered Outcomes Research|patient-centered outcomes research
353955|NCT02078700|cancer|cancer
353956|NCT02078700|early palliative care|early palliative care
353957|NCT02078700|feasibility|feasibility
353958|NCT02078687|very preterm|very preterm
353959|NCT02078687|nutrition|nutrition
353960|NCT02078687|6 year follow-up|6 year follow-up
353961|NCT02078687|growth|growth
353962|NCT02078687|metabolic syndrome|metabolic syndrome
353963|NCT02078687|allergy|allergy
353964|NCT02078687|dexa|dexa
353965|NCT02078674|H7N9|h7n9
353966|NCT02078661|Keratoconjunctivitis sicca|keratoconjunctivitis sicca
353967|NCT02078661|Dry eye|dry eye
353968|NCT02078648|Glioma Associated Antigen|glioma associated antigen
353969|NCT02078648|Vaccine|vaccine
353970|NCT02078648|Adult|adult
353971|NCT02078648|Recurrent Glioblastoma|recurrent glioblastoma
353972|NCT02078648|Immunotherapy|immunotherapy
353973|NCT02078635|Arterial plaque|arterial plaque
353974|NCT02078635|portfolio diet|portfolio diet
353975|NCT02078635|dietary modification|dietary modification
353976|NCT02078635|dietary trials|dietary trials
353977|NCT02078635|Canadian Network|canadian network
353978|NCT02078635|knowledge synthesis and translation|knowledge synthesis and translation
353979|NCT02078635|Magnetic resonance imaging|magnetic resonance imaging
353980|NCT02078622|COPD|copd
353981|NCT02078622|Respiratory Therapist|respiratory therapist
353982|NCT02078622|Case Management|case management
353983|NCT02078622|Education|education
353984|NCT02078609|AML,|aml,
353985|NCT02078609|MDS,|mds,
353986|NCT02078609|PIM,|pim,
353987|NCT02078609|LGH447,|lgh447,
353988|NCT02078609|acute myelod leukemia,|acute myelod leukemia,
353989|NCT02078609|myelodysplastic syndrome,|myelodysplastic syndrome,
353990|NCT02078609|midostaurin,|midostaurin,
353991|NCT02078609|PKC412|pkc412
353992|NCT02078596|temper outbursts|temper outbursts
353993|NCT02078596|pediatric aggression|pediatric aggression
353994|NCT02078596|irritability|irritability
353995|NCT02078544|Cancer in Gynaecologic Oncology|cancer in gynaecologic oncology
353996|NCT02078505|Change in gut microbial population|change in gut microbial population
353997|NCT02078505|polycystic ovary syndrome|polycystic ovary syndrome
353998|NCT02078505|gut microbiome|gut microbiome
353999|NCT02078505|diet|diet
354000|NCT02078479|Malignancy|malignancy
354001|NCT02078479|VAS|vas
354002|NCT02078479|LANSS|lanss
354003|NCT02078479|VDS|vds
354004|NCT02078479|Neuropathic pain|neuropathic pain
354005|NCT02078479|rTMS|rtms
354006|NCT02078479|motor cortex|motor cortex
354007|NCT02078479|analgesia|analgesia
354008|NCT02078466|Functional assessment|functional assessment
354009|NCT02078466|readmission|readmission
354010|NCT02078466|acute care|acute care
354011|NCT02078466|older medical patients|older medical patients
354012|NCT02078453|Dental caries|dental caries
354013|NCT02078453|Diagnosis|diagnosis
354014|NCT02078453|Visual inspection|visual inspection
354015|NCT02078453|Radiographic examination|radiographic examination
354016|NCT02078440|Type 2 Diabetes|type 2 diabetes
354017|NCT02078440|Children|children
354018|NCT02078440|Adolescents|adolescents
354019|NCT02078440|Bioavailability|bioavailability
354020|NCT02078440|Cycloset|cycloset
354021|NCT02078440|Bromocriptine Mesylate|bromocriptine mesylate
354022|NCT02078401|Optic pathway glioma|optic pathway glioma
354023|NCT02078401|Ophthalmological screening|ophthalmological screening
354024|NCT02078375|Rheumatoid Arthritis|rheumatoid arthritis
354025|NCT02078323|Irritable Bowel Syndrome with Constipation (IBS-C)|irritable bowel syndrome with constipation (ibs-c)
354026|NCT02078323|Linaclotide|linaclotide
354027|NCT02078310|Dementia,|dementia,
354028|NCT02078310|Healthy|healthy
354029|NCT02078310|geriatric|geriatric
354030|NCT02078310|volunteers|volunteers
354031|NCT02078310|patients|patients
354032|NCT02078297|IL-23|il-23
354033|NCT02078297|IL-17A|il-17a
354034|NCT02078297|Skin biopsies|skin biopsies
354035|NCT02078284|platelet transfusion|platelet transfusion
354036|NCT02078258|depression，adolescent，attention bias，modification|depression，adolescent，attention bias，modification
354037|NCT02078245|Familial pancreatic cancer|familial pancreatic cancer
354038|NCT02078245|Surveillance|surveillance
354039|NCT02078245|Screening|screening
354040|NCT02078232|fine needle aspiration under ultrasound endoscopy|fine needle aspiration under ultrasound endoscopy
354041|NCT02078232|solid pancreatic tumors|solid pancreatic tumors
354042|NCT02078232|head of pancreas|head of pancreas
354043|NCT02078232|19G Flex needle|19g flex needle
354044|NCT02078232|22G standard needle|22g standard needle
354045|NCT02078206|Critical illness|critical illness
354046|NCT02078206|Neurocognition|neurocognition
354047|NCT02078206|Neurocognitive stimulation|neurocognitive stimulation
354048|NCT02078206|Delirium|delirium
354049|NCT02078206|Virtual Reality|virtual reality
354050|NCT02078206|cognitive|cognitive
354051|NCT02078206|rehabilitation|rehabilitation
354052|NCT02078206|ICU|icu
354053|NCT02078167|ipercholesterolemia not familiarity|ipercholesterolemia not familiarity
354054|NCT02078154|D-Dimer|d-dimer
354055|NCT02078154|DVT|dvt
354056|NCT02078154|Wells score|wells score
354057|NCT02078141|18F-deoxyglucose (FDG) PET, idiopathic Dilated Cardiomyopathy|18f-deoxyglucose (fdg) pet, idiopathic dilated cardiomyopathy
354058|NCT02078128|burn, wound healing, skin graft|burn, wound healing, skin graft
354059|NCT02078089|Refractory cancer pain|refractory cancer pain
354060|NCT02078076|MRI|mri
354061|NCT02078076|free-breathing acquisitions|free-breathing acquisitions
354062|NCT02078076|myopathy|myopathy
354063|NCT02078076|fibrosis assessment|fibrosis assessment
354064|NCT02078076|function|function
354065|NCT02078037|Intracerebral hemorrhage|intracerebral hemorrhage
354066|NCT02078037|Perihematomal edema|perihematomal edema
354067|NCT02078037|hemorrhage|hemorrhage
354068|NCT02078037|normothermia|normothermia
354069|NCT02078024|Onchocerciasis|onchocerciasis
354070|NCT02077985|autism|autism
354071|NCT02077985|electrodermal activity|electrodermal activity
354072|NCT02077985|cooperation|cooperation
354073|NCT02077985|anxiety|anxiety
354074|NCT02077985|distress|distress
354075|NCT02077985|stress|stress
354076|NCT02077985|oral care|oral care
354077|NCT02077985|sensory processing|sensory processing
354078|NCT02077985|behavior|behavior
354079|NCT02077985|occupational therapy|occupational therapy
354080|NCT02077972|PTSD|ptsd
354081|NCT02077972|Military service|military service
354082|NCT02077972|depression|depression
354083|NCT02077972|Whole Body Hyperthermia (WBH)|whole body hyperthermia (wbh)
354084|NCT02077959|Relapsed Multiple Myeloma|relapsed multiple myeloma
354085|NCT02077959|Refractory Multiple Myeloma|refractory multiple myeloma
354086|NCT02077933|Solid tumors|solid tumors
354087|NCT02077933|renal cell carcinoma|renal cell carcinoma
354088|NCT02077933|pancreatic neuroendocrine tumors|pancreatic neuroendocrine tumors
354089|NCT02077933|breast cancer|breast cancer
354090|NCT02077933|PI3K inhibitor|pi3k inhibitor
354091|NCT02077933|BYL719|byl719
354092|NCT02077933|alpelisib|alpelisib
354093|NCT02077933|everolimus|everolimus
354094|NCT02077933|exemestane|exemestane
354282|NCT02077075|overweight|overweight
354095|NCT02077920|Ventilator-associated pneumonia VAP|ventilator-associated pneumonia vap
354096|NCT02077920|Chlorhexidine|chlorhexidine
354097|NCT02077920|Oropharyngeal decontamination|oropharyngeal decontamination
354098|NCT02077920|Subglottic secretion drainage|subglottic secretion drainage
354099|NCT02077894|Whole Genome Sequencing|whole genome sequencing
354100|NCT02077894|Genetic Eye Disease|genetic eye disease
354101|NCT02077881|metastatic|metastatic
354102|NCT02077881|metastasis|metastasis
354103|NCT02077881|Pancreatic|pancreatic
354104|NCT02077881|Pancreas|pancreas
354105|NCT02077881|Cancer|cancer
354106|NCT02077881|adenocarcinoma|adenocarcinoma
354107|NCT02077868|CRC|crc
354108|NCT02077868|mCRC|mcrc
354109|NCT02077868|maintenance treatment|maintenance treatment
354110|NCT02077868|immune modulation|immune modulation
354111|NCT02077868|colorectal cancer|colorectal cancer
354112|NCT02077868|immunotherapy|immunotherapy
354113|NCT02077868|metastatic|metastatic
354114|NCT02077855|Sensitivity and Sensitivity|sensitivity and sensitivity
354115|NCT02077829|Implementation process|implementation process
354116|NCT02077829|implementation strategy|implementation strategy
354117|NCT02077829|Implementation research|implementation research
354118|NCT02077829|evidence based practice|evidence based practice
354119|NCT02077829|recovery|recovery
354120|NCT02077829|Illness management and recovery|illness management and recovery
354121|NCT02077816|body temperature|body temperature
354122|NCT02077816|Thermometry|thermometry
354123|NCT02077816|Infrared Rays|infrared rays
354124|NCT02077816|catheter related infection|catheter related infection
354125|NCT02077803|Healthy|healthy
354126|NCT02077803|Canagliflozin|canagliflozin
354127|NCT02077803|Metformin|metformin
354128|NCT02077803|Type 2 diabetes mellitus|type 2 diabetes mellitus
354129|NCT02077803|Bioequivalence|bioequivalence
354130|NCT02077803|GLUMETZA®|glumetza®
354131|NCT02077777|mesalazine|mesalazine
354132|NCT02077777|colon|colon
354133|NCT02077777|cancer|cancer
354134|NCT02077764|heart transplantation,|heart transplantation,
354135|NCT02077764|rejection|rejection
354136|NCT02077764|cardiac vasculopathy|cardiac vasculopathy
354137|NCT02077764|optical coherence tomography|optical coherence tomography
354138|NCT02077764|speckle tracking|speckle tracking
354139|NCT02077764|Positron Emission Tomography .|positron emission tomography .
354140|NCT02077764|exercise capacity|exercise capacity
354141|NCT02077738|effectiveness|effectiveness
354143|NCT02077738|high frequency chest wall oscillation|high frequency chest wall oscillation
354144|NCT02077738|mechanical ventilation|mechanical ventilation
354145|NCT02077738|pneumonia|pneumonia
354146|NCT02077738|randomized controlled trial|randomized controlled trial
354147|NCT02077725|drug related problems|drug related problems
354148|NCT02077725|comprehensive medication review|comprehensive medication review
354149|NCT02077725|quality of life|quality of life
354150|NCT02077699|Lactobacillus casei DG|lactobacillus casei dg
354151|NCT02077699|Irritable Bowel Syndrome|irritable bowel syndrome
354152|NCT02077686|diabetes|diabetes
354153|NCT02077686|education|education
354154|NCT02077686|randomized|randomized
354155|NCT02077686|prospective|prospective
354156|NCT02077673|GEJ-cancer|gej-cancer
354157|NCT02077673|surgery|surgery
354158|NCT02077673|gastroesophageal resection|gastroesophageal resection
354159|NCT02077673|gastroesophageal anastomosis|gastroesophageal anastomosis
354160|NCT02077673|anastomotic leakage|anastomotic leakage
354161|NCT02077660|Green tea, aging, oxidation, anthropometrics.|green tea, aging, oxidation, anthropometrics.
354162|NCT02077647|Knee osteoarthritis|knee osteoarthritis
354163|NCT02077647|knee osteonecrosis|knee osteonecrosis
354164|NCT02077647|osteotomy|osteotomy
354165|NCT02077621|cancer-related fatigue|cancer-related fatigue
354166|NCT02077621|Palliative Abdominal Surgery|palliative abdominal surgery
354167|NCT02077621|HRQL|hrql
354168|NCT02077608|In vitro fertilization|in vitro fertilization
354169|NCT02077608|Embryotransfer|embryotransfer
354170|NCT02077608|Hyaluronan|hyaluronan
354171|NCT02077608|Pregnancy rate|pregnancy rate
354172|NCT02077608|Implantation rate|implantation rate
354173|NCT02077595|transcutaneous electrical nerve stimulation|transcutaneous electrical nerve stimulation
354174|NCT02077595|transcranial magnetic stimulation|transcranial magnetic stimulation
354175|NCT02077582|acute ischemic stroke|acute ischemic stroke
354176|NCT02077569|AKT inhibitor|akt inhibitor
354177|NCT02077569|AZD5363|azd5363
354178|NCT02077569|Anti-tumour activity|anti-tumour activity
354179|NCT02077569|Breast cancer|breast cancer
354180|NCT02077569|ER positive|er positive
354181|NCT02077569|Oestrogen positive|oestrogen positive
354182|NCT02077569|post menopausal|post menopausal
354183|NCT02077569|chemotherapy required|chemotherapy required
354184|NCT02077569|no prior cancer treatment|no prior cancer treatment
354185|NCT02077556|tacrolimus, everolimus, pharmacokinetics, drug interaction|tacrolimus, everolimus, pharmacokinetics, drug interaction
354186|NCT02077530|Patients with metabolic syndrome age between 30 to 64: Central obesity (Men ≥ 90 cm Women ≥ 85 cm), Plasma triglycerides ≥ 150 mg/dL|patients with metabolic syndrome age between 30 to 64: central obesity (men ≥ 90 cm women ≥ 85 cm), plasma triglycerides ≥ 150 mg/dl
354283|NCT02077075|body mass index greater that 25 kg/m2|body mass index greater that 25 kg/m2
354284|NCT02077062|hepatectomy,|hepatectomy,
354187|NCT02077530|HDL cholesterol Men < 40 mg/dL, Women < 50 mg/dL, Blood pressure ≥130/85 mm Hg (or treatment for hypertension),|hdl cholesterol men < 40 mg/dl, women < 50 mg/dl, blood pressure ≥130/85 mm hg (or treatment for hypertension),
354188|NCT02077530|Fasting plasma glucose ≥ 100 mg/dL|fasting plasma glucose ≥ 100 mg/dl
354189|NCT02077517|Roux en Y Gastric Bypass|roux en y gastric bypass
354190|NCT02077517|Postoperative complications|postoperative complications
354191|NCT02077517|Hand sewn anastomosis|hand sewn anastomosis
354192|NCT02077517|Stapled anastomosis|stapled anastomosis
354193|NCT02077491|Aged|aged
354194|NCT02077491|Systemic Inflammatory Response Syndrome|systemic inflammatory response syndrome
354195|NCT02077491|Body Composition|body composition
354196|NCT02077491|Dietary Protein|dietary protein
354197|NCT02077465|COPD, chronic obstructive pulmonary disease; Phase 1b, Safety, Pharmacokinetics|copd, chronic obstructive pulmonary disease; phase 1b, safety, pharmacokinetics
354198|NCT02077452|Glucokinase activator|glucokinase activator
354199|NCT02077452|Phase I|phase i
354200|NCT02077452|Type 2 diabetes mellitus|type 2 diabetes mellitus
354201|NCT02077439|Stroke|stroke
354202|NCT02077439|Hand|hand
354203|NCT02077439|Upper Extremity|upper extremity
354204|NCT02077439|Robotics|robotics
354205|NCT02077426|Functional Capacity|functional capacity
354206|NCT02077426|Exercise Independence|exercise independence
354207|NCT02077426|Peripheral|peripheral
354208|NCT02077426|Strength|strength
354209|NCT02077413|muscle|muscle
354210|NCT02077413|eccentric exercise|eccentric exercise
354211|NCT02077413|T2 MRI|t2 mri
354212|NCT02077387|Inhibitory control|inhibitory control
354213|NCT02077387|executive functioning|executive functioning
354214|NCT02077387|childhood obesity|childhood obesity
354215|NCT02077387|preschool|preschool
354216|NCT02077387|snack foods|snack foods
354217|NCT02077387|caloric intake|caloric intake
354218|NCT02077374|NAFLD|nafld
354219|NCT02077374|NASH|nash
354220|NCT02077361|choroideremia|choroideremia
354221|NCT02077361|gene therapy|gene therapy
354222|NCT02077361|gene transfer|gene transfer
354223|NCT02077348|Diabetes Mellitus type I|diabetes mellitus type i
354224|NCT02077348|Ketoacidosis|ketoacidosis
354225|NCT02077348|Insulin withdrawal|insulin withdrawal
354226|NCT02077348|Growth hormone injection|growth hormone injection
354227|NCT02077348|Lipolysis and ATGL|lipolysis and atgl
354228|NCT02077335|Brachytherapy|brachytherapy
354229|NCT02077335|Monotherapy|monotherapy
354230|NCT02077335|HDR|hdr
354231|NCT02077322|Merocel Middle Meatus Spacers|merocel middle meatus spacers
354232|NCT02077322|Silastic Middle Meatus Spacers|silastic middle meatus spacers
354233|NCT02077322|Functional Endoscopic Sinus Surgery|functional endoscopic sinus surgery
354234|NCT02077309|T2DM,|t2dm,
354235|NCT02077309|vascular inflammation,|vascular inflammation,
354236|NCT02077309|18-FDG-PET,|18-fdg-pet,
354237|NCT02077309|plaque morphology,|plaque morphology,
354238|NCT02077309|MRI,|mri,
354239|NCT02077309|DPP-4 Inhibition|dpp-4 inhibition
354240|NCT02077296|cytokines|cytokines
354241|NCT02077296|predictive value|predictive value
354242|NCT02077296|preoperative chemoradiotherapy|preoperative chemoradiotherapy
354243|NCT02077296|rectal cancer|rectal cancer
354244|NCT02077283|NAFLD (non-alcoholic fatty liver disease, NAFLD)|nafld (non-alcoholic fatty liver disease, nafld)
354245|NCT02077283|urinary metabonomics|urinary metabonomics
354246|NCT02077283|TCM pattern|tcm pattern
354247|NCT02077283|"liver depression and spleen deficiency pattern,"|"liver depression and spleen deficiency pattern,"
354248|NCT02077283|"damp-heat in the interior pattern"|"damp-heat in the interior pattern"
354249|NCT02077270|colonoscopy|colonoscopy
354250|NCT02077270|acupuncture|acupuncture
354251|NCT02077270|pain|pain
354252|NCT02077244|patient|patient
354253|NCT02077244|intensive care|intensive care
354254|NCT02077244|follow up|follow up
354255|NCT02077244|post traumatic stress symptoms|post traumatic stress symptoms
354256|NCT02077244|randomized controlled trial|randomized controlled trial
354257|NCT02077205|Diagnostic and Statistical Manual of Mental Disorders-IV/-5: Anxiety Disorders in children|diagnostic and statistical manual of mental disorders-iv/-5: anxiety disorders in children
354258|NCT02077179|Postpartum|postpartum
354259|NCT02077179|Preeclampsia|preeclampsia
354260|NCT02077179|Gestational Hypertension|gestational hypertension
354261|NCT02077179|Gestational Diabetes|gestational diabetes
354262|NCT02077179|Exercise Intervention|exercise intervention
354263|NCT02077179|Dietary Intervention|dietary intervention
354264|NCT02077179|Behavioral Intervention|behavioral intervention
354265|NCT02077179|Mobile Website|mobile website
354266|NCT02077179|Mobile Application|mobile application
354267|NCT02077166|DLBCL|dlbcl
354268|NCT02077101|HIV|hiv
354269|NCT02077101|Therapeutic vaccine|therapeutic vaccine
354270|NCT02077101|acceptability|acceptability
354271|NCT02077101|representations|representations
354272|NCT02077088|interventional|interventional
354273|NCT02077088|doubleblind|doubleblind
354274|NCT02077088|randomised|randomised
354275|NCT02077088|pediatric|pediatric
354276|NCT02077088|prebiotic|prebiotic
354277|NCT02077088|atopic|atopic
354278|NCT02077088|dermatitis|dermatitis
354279|NCT02077088|infant|infant
354280|NCT02077075|weight loss|weight loss
354281|NCT02077075|healthy weight|healthy weight
354285|NCT02077062|liver regeneration|liver regeneration
354286|NCT02077062|mediators|mediators
354287|NCT02077049|elderly|elderly
354288|NCT02077049|exercise program|exercise program
354289|NCT02077049|self-training|self-training
354290|NCT02077049|mobility|mobility
354291|NCT02077049|computer-based learning games|computer-based learning games
354292|NCT02077049|serious game|serious game
354293|NCT02077049|balance|balance
354294|NCT02077049|training adherence|training adherence
354295|NCT02077049|training compliance|training compliance
354296|NCT02077049|Kinect ®|kinect ®
354297|NCT02077049|Fit Bit ®|fit bit ®
354298|NCT02077023|Stroke|stroke
354299|NCT02077023|Heart Attack|heart attack
354300|NCT02077023|Asymptomatic Carotid Artery Disease|asymptomatic carotid artery disease
354301|NCT02077023|Atrial Fibrillation|atrial fibrillation
354302|NCT02077010|milrinone|milrinone
354303|NCT02077010|heart failure|heart failure
354304|NCT02077010|cardiomyopathy|cardiomyopathy
354305|NCT02077010|inhaled|inhaled
453009|NCT01628861|sitting|sitting
354306|NCT02076997|Cancer|cancer
354307|NCT02076997|High Dose Methotrexate|high dose methotrexate
354308|NCT02076984|Ventral hernia|ventral hernia
354309|NCT02076984|Incisional hernia|incisional hernia
354310|NCT02076984|Patient affected by ventral or incisional hernias|patient affected by ventral or incisional hernias
354311|NCT02076971|Lung transplant|lung transplant
354312|NCT02076971|Quantiferon|quantiferon
354313|NCT02076971|Immuknow|immuknow
354314|NCT02076958|Implementation|implementation
354315|NCT02076958|Cancer|cancer
354316|NCT02076958|Early detection|early detection
354317|NCT02076958|Faith-based|faith-based
354318|NCT02076958|Community health advisor|community health advisor
354319|NCT02076945|Regional anesthesia|regional anesthesia
354320|NCT02076945|Diabetic neuropathy|diabetic neuropathy
354321|NCT02076945|Ultrasound|ultrasound
354322|NCT02076919|LHA510|lha510
354323|NCT02076919|First in human|first in human
354324|NCT02076919|Safety|safety
354325|NCT02076919|Tolerability|tolerability
354326|NCT02076919|Pharmacokinetics|pharmacokinetics
354327|NCT02076919|Elderly|elderly
354328|NCT02076919|Age-Related Macular Degeneration|age-related macular degeneration
354329|NCT02076919|AMD|amd
354330|NCT02076919|Ocular|ocular
354331|NCT02076919|Eye drop|eye drop
354332|NCT02076906|relapsed pediatric solid tumors|relapsed pediatric solid tumors
354333|NCT02076906|refractory pediatric solid tumors|refractory pediatric solid tumors
354334|NCT02076906|high intensity focused ultrasound|high intensity focused ultrasound
354335|NCT02076906|rhabdomyosarcoma|rhabdomyosarcoma
354336|NCT02076906|Ewing's sarcoma|ewing's sarcoma
354337|NCT02076906|osteosarcoma|osteosarcoma
354338|NCT02076906|neuroblastoma|neuroblastoma
354339|NCT02076906|Wilms' tumor|wilms' tumor
354340|NCT02076906|hepatic tumors|hepatic tumors
354341|NCT02076906|germ cell tumors|germ cell tumors
354342|NCT02076906|desmoid tumor|desmoid tumor
354343|NCT02076893|Tonsillectomy|tonsillectomy
354344|NCT02076893|Pain management|pain management
354345|NCT02076893|Pediatrics|pediatrics
354346|NCT02076880|Type 2 diabetes|type 2 diabetes
354347|NCT02076880|Obesity|obesity
354348|NCT02076880|Sleeve gastrectomy|sleeve gastrectomy
354349|NCT02076880|Insulin|insulin
354350|NCT02076880|GLP-1|glp-1
354351|NCT02076867|somatic symptoms and related disorders|somatic symptoms and related disorders
354352|NCT02076867|somatic symptoms|somatic symptoms
354353|NCT02076867|psychodynamic psychotherapy|psychodynamic psychotherapy
354354|NCT02076854|eating disorders|eating disorders
354355|NCT02076854|anorexia nervosa|anorexia nervosa
354356|NCT02076854|treatment|treatment
354357|NCT02076854|technology|technology
354358|NCT02076828|anemia|anemia
354359|NCT02076828|iron polymaltose complexes|iron polymaltose complexes
354360|NCT02076828|iron zinc|iron zinc
354361|NCT02076815|myeloproliferative neoplasm|myeloproliferative neoplasm
354362|NCT02076815|essential thrombocythemia|essential thrombocythemia
354363|NCT02076815|high risk patients|high risk patients
354364|NCT02076815|anagrelide|anagrelide
354365|NCT02076802|prehypertension|prehypertension
354366|NCT02076802|coronary atherosclerosis|coronary atherosclerosis
354367|NCT02076802|cardiovascular disease|cardiovascular disease
354368|NCT02076789|Device Replacement|device replacement
354369|NCT02076789|Device Upgrade|device upgrade
354370|NCT02076789|Long-term Postoperative Complications|long-term postoperative complications
354371|NCT02076789|Resource consumption and associated costs after device replacement/upgrade|resource consumption and associated costs after device replacement/upgrade
354372|NCT02076776|Stroke|stroke
354373|NCT02076776|Exercise|exercise
354374|NCT02076776|Rehabilitation|rehabilitation
354375|NCT02076776|Neuroplasticity|neuroplasticity
354376|NCT02076776|Task Practice|task practice
354377|NCT02076763|Observational|observational
354378|NCT02076763|Porphyria|porphyria
354379|NCT02076750|Inflammatory Bowel Diseases|inflammatory bowel diseases
354380|NCT02076750|Vitamin D|vitamin d
354381|NCT02076750|Cholecalciferol|cholecalciferol
354382|NCT02076750|Skin Pigmentation|skin pigmentation
354383|NCT02076737|Model-based iterative reconstruction MB-IR|model-based iterative reconstruction mb-ir
354384|NCT02076737|VEOTM|veotm
354385|NCT02076737|Ultra low-dose|ultra low-dose
354386|NCT02076737|Abdominal CT|abdominal ct
354387|NCT02076737|Dose reduction|dose reduction
354388|NCT02076737|Adaptative statistical iterative reconstruction ASIR|adaptative statistical iterative reconstruction asir
354389|NCT02076737|Acute renal colic|acute renal colic
354390|NCT02076724|Abdominal donor-site|abdominal donor-site
354391|NCT02076724|Breast reconstruction|breast reconstruction
354392|NCT02076724|Synthetic mesh|synthetic mesh
354393|NCT02076724|Biological mesh|biological mesh
354394|NCT02076711|Aortic Stenosis|aortic stenosis
354395|NCT02076711|Myocardial efficiency|myocardial efficiency
354396|NCT02076698|Deep Brain Stimulation|deep brain stimulation
354397|NCT02076698|Anterior Nucleus of thalamus|anterior nucleus of thalamus
354398|NCT02076698|Treatment refractory|treatment refractory
354399|NCT02076698|Pharmacoresistant partial epilepsy|pharmacoresistant partial epilepsy
354400|NCT02076698|vagus nerve stimulation therapy|vagus nerve stimulation therapy
354401|NCT02076685|pharmacogenetics|pharmacogenetics
354402|NCT02076685|anti-tuberculosis drug|anti-tuberculosis drug
354403|NCT02076685|genetic polymorphism|genetic polymorphism
354404|NCT02076685|isoniazid|isoniazid
354405|NCT02076672|prevention|prevention
354406|NCT02076672|non-malignant asbestos-related disease|non-malignant asbestos-related disease
354407|NCT02076672|benign pleural disease|benign pleural disease
354408|NCT02076672|asbestosis|asbestosis
354410|NCT02076659|IL10|il10
354411|NCT02076659|Interleukin|interleukin
354412|NCT02076659|monoclonal|monoclonal
354413|NCT02076659|antibody|antibody
354414|NCT02076659|Rheumatoid Arthritis|rheumatoid arthritis
354415|NCT02076646|Interleukin|interleukin
354416|NCT02076646|IL2|il2
354417|NCT02076646|monoclonal|monoclonal
354418|NCT02076646|antibody|antibody
354419|NCT02076646|cytokine|cytokine
354420|NCT02076646|Dacarbazine|dacarbazine
354421|NCT02076646|metastatic|metastatic
354422|NCT02076646|melanoma|melanoma
354423|NCT02076646|tumor targeting|tumor targeting
354424|NCT02076646|Dose definition|dose definition
354425|NCT02076646|L19|l19
354426|NCT02076633|L19|l19
354427|NCT02076633|monoclonal|monoclonal
354428|NCT02076633|antibody|antibody
354429|NCT02076633|IL-2|il-2
354430|NCT02076633|TNFα|tnfα
354431|NCT02076633|Interleukin|interleukin
354432|NCT02076633|Phase II|phase ii
354433|NCT02076633|metastatic melanoma|metastatic melanoma
354434|NCT02076633|clinical stage III|clinical stage iii
354435|NCT02076633|Clinical stage IV M1a|clinical stage iv m1a
354436|NCT02076620|L19|l19
354437|NCT02076620|monoclonal|monoclonal
354438|NCT02076620|antibody|antibody
354439|NCT02076620|doxorubicin|doxorubicin
354440|NCT02076620|TNFα|tnfα
354441|NCT02076620|solid tumour|solid tumour
354442|NCT02076620|sarcoma, breast cancer, lung carcinomas, gynecological cancer|sarcoma, breast cancer, lung carcinomas, gynecological cancer
354443|NCT02076620|anthracycline|anthracycline
354444|NCT02076607|vertebra|vertebra
354445|NCT02076607|column|column
354446|NCT02076607|lumbar|lumbar
354447|NCT02076607|toracica|toracica
354448|NCT02076607|fracture|fracture
354449|NCT02076607|burst|burst
354450|NCT02076568|diabetes|diabetes
354451|NCT02076568|education|education
354452|NCT02076568|randomized|randomized
354453|NCT02076568|prospective|prospective
354454|NCT02076555|diabetes|diabetes
354455|NCT02076555|education|education
354456|NCT02076555|randomized|randomized
354457|NCT02076555|prospective|prospective
354458|NCT02076542|diabetes|diabetes
354459|NCT02076542|education|education
354460|NCT02076542|randomized|randomized
354461|NCT02076542|prospective|prospective
354462|NCT02076529|chemotherapy induced nausea vomiting|chemotherapy induced nausea vomiting
354463|NCT02076516|Drug-eluting Stent,Coronary Artery Disease|drug-eluting stent,coronary artery disease
354464|NCT02076503|Neoplasm Staging|neoplasm staging
354465|NCT02076503|Positron-Emission Tomography|positron-emission tomography
354466|NCT02076503|Magnetic Resonance Imaging|magnetic resonance imaging
354467|NCT02076503|1-amino-3-fluorocyclobutane-1-carboxylic acid|1-amino-3-fluorocyclobutane-1-carboxylic acid
354468|NCT02076490|Telerehabilitation, mirror therapy, phantom limb pain|telerehabilitation, mirror therapy, phantom limb pain
354469|NCT02076477|intervention time|intervention time
354470|NCT02076477|radiotherapy|radiotherapy
354471|NCT02076477|oligometastatic|oligometastatic
354472|NCT02076477|non-small cell lung cancer|non-small cell lung cancer
354473|NCT02076438|antibiotics|antibiotics
354474|NCT02076438|diarrhea|diarrhea
354475|NCT02076438|c diff|c diff
354476|NCT02076438|Hospitalized patients|hospitalized patients
354477|NCT02076425|Depressive Disorder, Major|depressive disorder, major
354478|NCT02076425|Child Psychiatry|child psychiatry
354479|NCT02076425|Parent-Child Relationship|parent-child relationship
354480|NCT02076425|Therapy|therapy
354481|NCT02076399|Persistent Immune Thrombocytopenic Purpura|persistent immune thrombocytopenic purpura
354482|NCT02076399|Chronic Immune Thrombocytopenic Purpura|chronic immune thrombocytopenic purpura
354483|NCT02076360|Preoperative counseling|preoperative counseling
354484|NCT02076360|Patient satisfaction|patient satisfaction
354485|NCT02076360|Prolapse|prolapse
354486|NCT02076360|Sacrocolpopexy|sacrocolpopexy
354487|NCT02076347|Metformin|metformin
354488|NCT02076347|Vitamin B12 Deficiency|vitamin b12 deficiency
354489|NCT02076347|Population Management|population management
354490|NCT02076347|Pharmacist|pharmacist
354491|NCT02076334|compression, isokinetic, far-infrared|compression, isokinetic, far-infrared
354492|NCT02076308|Acupuncture, ultrasound|acupuncture, ultrasound
354493|NCT02076295|Cognition|cognition
354494|NCT02076295|Cholinergic nicotinic receptors|cholinergic nicotinic receptors
354495|NCT02076295|Positron Emission Tomography|positron emission tomography
354496|NCT02076282|Stage III non-small cell lung cancer|stage iii non-small cell lung cancer
354497|NCT02076282|Optimization|optimization
354498|NCT02076282|MRI|mri
354499|NCT02076282|Radiotherapy|radiotherapy
354500|NCT02076269|HRCT|hrct
354501|NCT02076269|Dry Powder Inhaler|dry powder inhaler
354502|NCT02076269|COPD|copd
354503|NCT02076269|Pharyngometry|pharyngometry
354504|NCT02076269|Inhalation Profiles|inhalation profiles
354505|NCT02076256|helping relationships, healthy lifestyle, quality of life|helping relationships, healthy lifestyle, quality of life
354632|NCT02075697|cyclosporine|cyclosporine
354506|NCT02076243|cutaneous squamous cell carcinoma|cutaneous squamous cell carcinoma
354507|NCT02076243|SCC|scc
354508|NCT02076243|abraxane|abraxane
354509|NCT02076243|nab-paclitaxel|nab-paclitaxel
354510|NCT02076243|unresectable|unresectable
354511|NCT02076243|metastatic|metastatic
354512|NCT02076230|14C-TH-302|14c-th-302
354513|NCT02076230|Advanced or Metastatic Solid Tumors|advanced or metastatic solid tumors
354514|NCT02076230|Evofosfamide|evofosfamide
354515|NCT02076217|Highly Effective Contraception|highly effective contraception
354516|NCT02076217|Emergency Contraception|emergency contraception
354517|NCT02076217|Birth Control|birth control
354518|NCT02076217|LARC (Long Acting Reversible Contraception)|larc (long acting reversible contraception)
354519|NCT02076217|HERC (Highly Effective Contraception)|herc (highly effective contraception)
354520|NCT02076204|Pregnancy|pregnancy
354521|NCT02076204|Postpartum programs|postpartum programs
354522|NCT02076204|Infant health services|infant health services
354523|NCT02076191|Ruxolitinib|ruxolitinib
354524|NCT02076191|Decitabine|decitabine
354525|NCT02076191|Myeloproliferative Neoplasms|myeloproliferative neoplasms
354526|NCT02076191|Combination Therapy|combination therapy
354527|NCT02076178|Pre-Exposure Prophylaxis|pre-exposure prophylaxis
354528|NCT02076178|HIV integrase|hiv integrase
354529|NCT02076178|Intramuscular Injection|intramuscular injection
354530|NCT02076178|GSK1265744|gsk1265744
354531|NCT02076165|insomnia|insomnia
354532|NCT02076165|women|women
354533|NCT02076152|Recurrent Glioblastoma|recurrent glioblastoma
354534|NCT02076139|tuberculosis|tuberculosis
354535|NCT02076139|treg|treg
354536|NCT02076139|tolerance|tolerance
354537|NCT02076139|probiotic|probiotic
354538|NCT02076139|mycobacteria|mycobacteria
354539|NCT02076126|Lung maturity|lung maturity
354540|NCT02076126|RDS|rds
354541|NCT02076126|Prematurity|prematurity
354542|NCT02076126|Lecithin-sphingomyelin ratio|lecithin-sphingomyelin ratio
354543|NCT02076126|Spectroscopy|spectroscopy
354544|NCT02076126|Chemometrics|chemometrics
354545|NCT02076113|cervical spondylotic myelopathy|cervical spondylotic myelopathy
354546|NCT02076113|degenerative cervical spondylosis|degenerative cervical spondylosis
354547|NCT02076113|spinal fusion|spinal fusion
354548|NCT02076087|Subcutaneous adipose tissue|subcutaneous adipose tissue
354549|NCT02076087|Lipectomy|lipectomy
354550|NCT02076061|COPD|copd
354551|NCT02076061|Primary Care|primary care
354552|NCT02076061|Smoking|smoking
354553|NCT02076061|Smokers|smokers
354554|NCT02076061|ex-Smokers|ex-smokers
354555|NCT02076061|Lung Cancer|lung cancer
354556|NCT02076061|Cardiovascular Disease|cardiovascular disease
354557|NCT02076061|Proteomics|proteomics
354558|NCT02076061|Biomarkers|biomarkers
354559|NCT02076061|Biobank|biobank
354560|NCT02076061|Disease Staging|disease staging
354561|NCT02076061|Gold Stage|gold stage
354562|NCT02076048|LCPUFA supplementation|lcpufa supplementation
354563|NCT02076048|Brain Imaging|brain imaging
354564|NCT02076048|MRI|mri
354565|NCT02076048|MEG|meg
354566|NCT02076035|low back pain|low back pain
354567|NCT02076035|periduroscopy|periduroscopy
354568|NCT02076035|genetic|genetic
354569|NCT02076035|genomic|genomic
354570|NCT02076035|inflammation|inflammation
354571|NCT02076022|Fat Grafting|fat grafting
354572|NCT02076022|Pain at amputation site|pain at amputation site
354573|NCT02076022|prosthetic|prosthetic
354574|NCT02076009|Multiple Myeloma|multiple myeloma
354575|NCT02076009|Relapsed Multiple Myeloma|relapsed multiple myeloma
354576|NCT02076009|Refractory Multiple Myeloma|refractory multiple myeloma
354577|NCT02076009|Daratumumab|daratumumab
354578|NCT02076009|Lenalidomide|lenalidomide
354579|NCT02076009|Dexamethasone|dexamethasone
354580|NCT02075996|pomalidomide, Imnovid, dexamethasone, Poseidon, multiple myeloma, daily routine, secondary malignancies, Germany, non-interventional study, safety,|pomalidomide, imnovid, dexamethasone, poseidon, multiple myeloma, daily routine, secondary malignancies, germany, non-interventional study, safety,
354581|NCT02075983|HIV|hiv
354582|NCT02075983|Vaccine|vaccine
354583|NCT02075983|Immunisation|immunisation
354585|NCT02075983|Adverse events|adverse events
354586|NCT02075983|Electroporation|electroporation
354587|NCT02075983|Transcutaneous|transcutaneous
354588|NCT02075983|GTU MultiHIV B Clade|gtu multihiv b clade
354589|NCT02075983|Antibody|antibody
354590|NCT02075983|Intramuscular|intramuscular
354591|NCT02075983|Immunogenicity|immunogenicity
354592|NCT02075970|Neonatal|neonatal
354593|NCT02075970|Anemia|anemia
354594|NCT02075970|Transfusion|transfusion
354595|NCT02075970|Erythropoetin|erythropoetin
354596|NCT02075970|Epoetin Alpha|epoetin alpha
354597|NCT02075970|Red Blood Cell|red blood cell
354598|NCT02075970|Survival|survival
354599|NCT02075970|Pharmacodynamics|pharmacodynamics
354600|NCT02075970|Model|model
354601|NCT02075957|Non-small cell lung cancer, adjuvant chemo-therapy, DNA chip|non-small cell lung cancer, adjuvant chemo-therapy, dna chip
354602|NCT02075944|Aerobic exercise|aerobic exercise
354603|NCT02075944|Cognitive function|cognitive function
354604|NCT02075944|Executive function|executive function
354605|NCT02075944|Brain-derived neurotrophic factor|brain-derived neurotrophic factor
354606|NCT02075905|Barrett's Esophagus|barrett's esophagus
354607|NCT02075905|Esophageal Adenocarcinoma|esophageal adenocarcinoma
354608|NCT02075892|cordyceps, aerobic capacity, exercise performance, fatigue|cordyceps, aerobic capacity, exercise performance, fatigue
354609|NCT02075853|Cerebral palsy|cerebral palsy
354610|NCT02075853|Pes planus|pes planus
354611|NCT02075853|Calcaneal lengthening|calcaneal lengthening
354612|NCT02075827|Appetite, metabolism, sedentary behaviour, stress response|appetite, metabolism, sedentary behaviour, stress response
354613|NCT02075801|Sealant, Margins Defect, Amalgam|sealant, margins defect, amalgam
354614|NCT02075775|instability|instability
354615|NCT02075749|irradiation|irradiation
354616|NCT02075749|mucositis|mucositis
354617|NCT02075749|triamcinolone acetonide|triamcinolone acetonide
354618|NCT02075749|licorice|licorice
354619|NCT02075749|mucoadhesive film|mucoadhesive film
354620|NCT02075710|Diet|diet
354621|NCT02075710|Sugar|sugar
354622|NCT02075710|Cardiovascular|cardiovascular
354623|NCT02075710|Lipid|lipid
354624|NCT02075697|psoriasis|psoriasis
354625|NCT02075697|biologic therapy|biologic therapy
354626|NCT02075697|infliximab|infliximab
354627|NCT02075697|etanercept|etanercept
354628|NCT02075697|efalizumab|efalizumab
354629|NCT02075697|adalimumab|adalimumab
354630|NCT02075697|ustekinumab|ustekinumab
354631|NCT02075697|methotrexate|methotrexate
354633|NCT02075697|acitretin|acitretin
354634|NCT02075671|Rosacea|rosacea
354635|NCT02075671|Photodynamic Therapy|photodynamic therapy
354636|NCT02075671|Aminolevulinic Acid|aminolevulinic acid
354637|NCT02075671|Papulopustular Rosacea|papulopustular rosacea
354638|NCT02075671|Blue Light|blue light
354639|NCT02075658|renal cell carcinoma|renal cell carcinoma
354640|NCT02075658|minimally invasive procedures|minimally invasive procedures
354641|NCT02075658|robotic nephrectomy|robotic nephrectomy
354642|NCT02075658|laparoscopic nephrectomy|laparoscopic nephrectomy
354643|NCT02075658|pneumoperitoneum|pneumoperitoneum
354644|NCT02075658|trocars|trocars
354645|NCT02075658|AirSeal® IFS|airseal® ifs
354646|NCT02075632|Alclometasone dipropionate|alclometasone dipropionate
354647|NCT02075632|Eczema|eczema
354648|NCT02075632|Psoriasis|psoriasis
354649|NCT02075632|Itch|itch
354650|NCT02075619|Amlodipine|amlodipine
354651|NCT02075619|Healthy volunteers|healthy volunteers
354652|NCT02075619|Rosuvastatin|rosuvastatin
354653|NCT02075619|Dyslipidaemia|dyslipidaemia
354654|NCT02075619|Pharmacokinetics|pharmacokinetics
354655|NCT02075619|Hypertension|hypertension
354656|NCT02075606|NET|net
354657|NCT02075606|Symptomatic response|symptomatic response
354658|NCT02075606|Functioning NeuroEndocrine Tumours|functioning neuroendocrine tumours
354659|NCT02075606|midgut region|midgut region
354660|NCT02075593|dolutegravir/abacavir/lamivudine fixed dose combination|dolutegravir/abacavir/lamivudine fixed dose combination
354661|NCT02075593|pregnant women|pregnant women
354662|NCT02075593|once daily|once daily
354663|NCT02075593|antiretroviral therapy-naive|antiretroviral therapy-naive
354664|NCT02075593|HIV-1 Infection|hiv-1 infection
354665|NCT02075593|integrase inhibitor|integrase inhibitor
354666|NCT02075580|cancer, quality of life, body-image, subcutaneous-implant|cancer, quality of life, body-image, subcutaneous-implant
354667|NCT02075567|Diabetes Mellitus Type 1|diabetes mellitus type 1
354668|NCT02075567|Exercise|exercise
354669|NCT02075567|Insulin Reduction|insulin reduction
354670|NCT02075567|Glucose|glucose
354671|NCT02075567|Hypoglycemia|hypoglycemia
354672|NCT02075567|Continuous Glucose Monitoring System|continuous glucose monitoring system
354673|NCT02075541|Immunogenicity|immunogenicity
354674|NCT02075541|Observer-blind|observer-blind
354675|NCT02075541|Reactogenicity|reactogenicity
354676|NCT02075541|Chronic Obstructive Pulmonary Disease|chronic obstructive pulmonary disease
354677|NCT02075541|Safety|safety
354678|NCT02075528|Paliperidone|paliperidone
354679|NCT02075528|Treatment response|treatment response
354680|NCT02075528|Schizophrenia|schizophrenia
354681|NCT02075528|Early prediction|early prediction
354682|NCT02075528|Pharmacokinetics|pharmacokinetics
354684|NCT02075515|Zoster|zoster
354685|NCT02075515|Immunogenicity|immunogenicity
354686|NCT02075515|Adults|adults
354687|NCT02075515|Consistency|consistency
354688|NCT02075502|claudication|claudication
354689|NCT02075502|community walking exercise|community walking exercise
354690|NCT02075502|community-based participatory research|community-based participatory research
354691|NCT02075502|exercise adherence|exercise adherence
354692|NCT02075502|endovascular therapy|endovascular therapy
354693|NCT02075489|Acupressure|acupressure
354694|NCT02075489|Reiki|reiki
354695|NCT02075489|EEG|eeg
354696|NCT02075489|EMG|emg
354697|NCT02075489|fatigue relief|fatigue relief
354698|NCT02075489|veterans|veterans
354699|NCT02075476|Fracture-luxation|fracture-luxation
354700|NCT02075476|humeral proximal extremity|humeral proximal extremity
354701|NCT02075476|Hemiarthroplasty|hemiarthroplasty
354702|NCT02075476|reverse Arthroplasty|reverse arthroplasty
354703|NCT02075463|recombinant human erythropoietin|recombinant human erythropoietin
354704|NCT02075463|GSK1278863|gsk1278863
354705|NCT02075463|hemodialysis|hemodialysis
354706|NCT02075463|anemia|anemia
354707|NCT02075463|Hemoglobin|hemoglobin
354708|NCT02075463|chronic rhEPO hyporesponsiveness|chronic rhepo hyporesponsiveness
354709|NCT02075463|chronic kidney disease|chronic kidney disease
354710|NCT02075463|erythropoiesis stimulating agents|erythropoiesis stimulating agents
354711|NCT02075463|pharmacokinetics|pharmacokinetics
354712|NCT02075450|Cardiac|cardiac
354713|NCT02075450|Arrest|arrest
354714|NCT02075450|Simulation|simulation
354715|NCT02075450|Feedback|feedback
354716|NCT02075437|Functional Abdominal Pain, Children|functional abdominal pain, children
354717|NCT02075437|Finding a treatment or intervention for children|finding a treatment or intervention for children
354718|NCT02075424|stress|stress
354719|NCT02075424|cortisol|cortisol
354720|NCT02075424|emergency call center|emergency call center
354721|NCT02075424|hospital staff|hospital staff
354722|NCT02075411|anterior cruciate ligament reconstruction|anterior cruciate ligament reconstruction
354723|NCT02075411|transplantation allografts|transplantation allografts
354724|NCT02075411|adolescent|adolescent
354725|NCT02075411|nerve block|nerve block
354726|NCT02075411|pain|pain
354727|NCT02075398|Portable pulse oximeter|portable pulse oximeter
354728|NCT02075385|Dysphagia|dysphagia
354729|NCT02075385|speech language therapy|speech language therapy
354730|NCT02075385|quality of life|quality of life
354731|NCT02075385|induction chemotherapy|induction chemotherapy
354732|NCT02075385|concurrent chemoradiotherapy|concurrent chemoradiotherapy
354733|NCT02075372|Chronic Total Occlusion of Coronary Artery|chronic total occlusion of coronary artery
354734|NCT02075372|Percutaneous Coronary Intervention|percutaneous coronary intervention
354735|NCT02075372|Hybrid|hybrid
354736|NCT02075372|Angioplasty|angioplasty
354737|NCT02075359|Total Energy Expenditure|total energy expenditure
354738|NCT02075359|Physical Activity Levels|physical activity levels
354739|NCT02075359|Body Mass Index|body mass index
354740|NCT02075359|Children|children
354741|NCT02075346|Patient safety monitors|patient safety monitors
354742|NCT02075320|CT|ct
354743|NCT02075320|Chest|chest
354744|NCT02075320|Lung|lung
354745|NCT02075307|insulin|insulin
354746|NCT02075307|diabetes|diabetes
354747|NCT02075307|obesity|obesity
354748|NCT02075307|DNA damage|dna damage
354749|NCT02075307|metabolic syndrome|metabolic syndrome
354750|NCT02075294|Aged|aged
354751|NCT02075294|Hepatitis B, Chronic|hepatitis b, chronic
354752|NCT02075294|Antiviral Agents|antiviral agents
354753|NCT02075268|Korean|korean
354754|NCT02075268|Healthy|healthy
354755|NCT02075268|Male|male
354756|NCT02075255|Asthma, Bronchial Diseases, Respiratory Tract Diseases, Lung Diseases, Obstructive Lung Diseases, OCS, Oral Corticosteroids|asthma, bronchial diseases, respiratory tract diseases, lung diseases, obstructive lung diseases, ocs, oral corticosteroids
354758|NCT02075229|Cochlear Implant|cochlear implant
354759|NCT02075229|Post-lingual onset hearing loss|post-lingual onset hearing loss
354760|NCT02075229|Profound hearing loss|profound hearing loss
354761|NCT02075229|Low Frequency hearing loss|low frequency hearing loss
354762|NCT02075229|Profound sensorineural hearing loss|profound sensorineural hearing loss
354763|NCT02075229|High frequency hearing loss|high frequency hearing loss
354764|NCT02075229|CMS-eligible patients|cms-eligible patients
354765|NCT02075216|Urinary Incontinence|urinary incontinence
354766|NCT02075216|Children|children
354767|NCT02075216|Bladder Exstrophy|bladder exstrophy
354768|NCT02075216|Extrophy -Epispadias complex,|extrophy -epispadias complex,
354769|NCT02075216|Modern staged repair,|modern staged repair,
354770|NCT02075216|Bladder neck reconstruction|bladder neck reconstruction
354771|NCT02075203|BCG Vaccinated|bcg vaccinated
354772|NCT02075177|neuroblastoma|neuroblastoma
354773|NCT02075164|Non-alcoholic Fatty Liver Disease|non-alcoholic fatty liver disease
354774|NCT02075164|Non-alcoholic steatohepatitis|non-alcoholic steatohepatitis
354775|NCT02075164|NAFLD|nafld
354776|NCT02075164|NASH|nash
354777|NCT02075151|Bronchial Thermoplasty|bronchial thermoplasty
354778|NCT02075125|Korea|korea
354779|NCT02075125|Platelet inhibition|platelet inhibition
354780|NCT02075125|Prasugrel|prasugrel
354781|NCT02075125|Ticagrelor|ticagrelor
354782|NCT02075125|ST-segment elevation myocardial infarction|st-segment elevation myocardial infarction
354784|NCT02075112|Isoflavone|isoflavone
354785|NCT02075112|Radiation Therapy|radiation therapy
354786|NCT02075112|Cisplatin|cisplatin
354787|NCT02075099|whole blood donation|whole blood donation
354788|NCT02075099|donation water drink|donation water drink
354789|NCT02075099|isotonic drink|isotonic drink
354790|NCT02075099|presyncopal and syncopal reactions|presyncopal and syncopal reactions
354791|NCT02075086|angiogenic switch|angiogenic switch
354792|NCT02075086|plasma cytokines|plasma cytokines
354793|NCT02075086|Colon cancer|colon cancer
354794|NCT02075073|Pharmacokinetics|pharmacokinetics
354795|NCT02075060|low-grade|low-grade
354796|NCT02075060|NMIBC|nmibc
354797|NCT02075047|Bipolar I Disorder (current or most recent episode manic). Children and adolescents aged 10 to 17 years.|bipolar i disorder (current or most recent episode manic). children and adolescents aged 10 to 17 years.
354798|NCT02075034|Myelodysplastic syndrome|myelodysplastic syndrome
354799|NCT02075034|MDS|mds
354800|NCT02075034|Low risk|low risk
354801|NCT02075034|Intermediate-1 risk|intermediate-1 risk
354802|NCT02075034|Intermediate-2 risk|intermediate-2 risk
354803|NCT02075034|International Prognostic Scoring System|international prognostic scoring system
354804|NCT02075034|IPSS|ipss
354805|NCT02075021|relapsed|relapsed
354806|NCT02075021|refractory|refractory
354807|NCT02075021|multiple myeloma|multiple myeloma
354808|NCT02075021|revlimid|revlimid
354809|NCT02075021|lenalidomide|lenalidomide
354810|NCT02075021|abraxane|abraxane
354811|NCT02075021|n-paclitaxel|n-paclitaxel
354812|NCT02075008|asthma|asthma
354813|NCT02075008|allergic asthma|allergic asthma
354814|NCT02075008|QGE031|qge031
354815|NCT02075008|open-label|open-label
354816|NCT02075008|IgE|ige
354817|NCT02075008|long-term safety|long-term safety
354818|NCT02074995|Burn, Severe burn, Lean body mass, Cachexia, Hypermetabolism, Catabolism, Wound healing|burn, severe burn, lean body mass, cachexia, hypermetabolism, catabolism, wound healing
354819|NCT02074982|chronic plaque type psoriasis, secukinumab, ustekinumab, inflammatory skin disease, scaling|chronic plaque type psoriasis, secukinumab, ustekinumab, inflammatory skin disease, scaling
354820|NCT02074969|re-operation rate|re-operation rate
354821|NCT02074969|pertrochanteric fractures|pertrochanteric fractures
354822|NCT02074969|GammaNail|gammanail
354823|NCT02074969|PFNA|pfna
354824|NCT02074969|Tip-Apex-Distance|tip-apex-distance
354825|NCT02074969|Parkers-Ratio|parkers-ratio
354826|NCT02074956|BCG Vaccinated|bcg vaccinated
354827|NCT02074956|HIV Negative|hiv negative
354828|NCT02074943|Androgenetic Alopecia|androgenetic alopecia
354829|NCT02074917|anterior cruciate ligament|anterior cruciate ligament
354830|NCT02074917|ACL|acl
354831|NCT02074917|anterior cruciate ligament reconstruction|anterior cruciate ligament reconstruction
354832|NCT02074917|outcome assessment|outcome assessment
354833|NCT02074917|outcome assessment, patient|outcome assessment, patient
354834|NCT02074917|treatment outcome|treatment outcome
354835|NCT02074917|exercise test|exercise test
354836|NCT02074917|anatomic|anatomic
354837|NCT02074917|anatomical|anatomical
354838|NCT02074917|single-bundle|single-bundle
354839|NCT02074917|force platform|force platform
354840|NCT02074917|postural balance|postural balance
354841|NCT02074917|biomechanics|biomechanics
354842|NCT02074917|CT scan|ct scan
354843|NCT02074917|X-ray computed tomography|x-ray computed tomography
354844|NCT02074917|tomography|tomography
354845|NCT02074917|diagnostic imaging|diagnostic imaging
354846|NCT02074917|knee|knee
354847|NCT02074917|knee injuries|knee injuries
354848|NCT02074917|joint instability|joint instability
354849|NCT02074917|reconstructive surgical procedures|reconstructive surgical procedures
354850|NCT02074917|knee surgery|knee surgery
354851|NCT02074917|arthroscopy|arthroscopy
354852|NCT02074917|athletes|athletes
354853|NCT02074917|sports medicine|sports medicine
354854|NCT02074917|humans|humans
354855|NCT02074917|prospective studies|prospective studies
354856|NCT02074917|Randomized Controlled Trial|randomized controlled trial
354857|NCT02074891|preexposure prophylaxis|preexposure prophylaxis
354858|NCT02074891|PrEP|prep
354859|NCT02074891|HIV|hiv
354860|NCT02074878|Breast Cancer|breast cancer
354861|NCT02074878|Metastatic|metastatic
354862|NCT02074878|Crizotinib|crizotinib
354863|NCT02074878|Sunitinib|sunitinib
354864|NCT02074878|Xalcori|xalcori
354865|NCT02074878|Sutent|sutent
354866|NCT02074839|acute myeloid leukemia|acute myeloid leukemia
354867|NCT02074839|AML|aml
354868|NCT02074839|myelodysplastic syndrome|myelodysplastic syndrome
354869|NCT02074839|MDS|mds
354870|NCT02074839|hematologic malignancies|hematologic malignancies
354871|NCT02074839|IDH|idh
354872|NCT02074839|Untreated AML|untreated aml
354873|NCT02074839|IDH1|idh1
354874|NCT02074839|relapsed AML|relapsed aml
354875|NCT02074839|refractory AML|refractory aml
354876|NCT02074813|Inspiratory muscle training|inspiratory muscle training
354877|NCT02074813|COPD|copd
354878|NCT02074813|dyspnea|dyspnea
354879|NCT02074813|Multidimensional Dyspnea Profile questionnaire (MDP).|multidimensional dyspnea profile questionnaire (mdp).
354880|NCT02074813|pulmonary rehabilitation|pulmonary rehabilitation
354881|NCT02074800|Healthy|healthy
354882|NCT02074800|CNTO 328|cnto 328
354883|NCT02074800|Sp2/0-derived CNTO 328|sp2/0-derived cnto 328
354884|NCT02074800|CHO-derived CNTO 328|cho-derived cnto 328
354885|NCT02074800|Safety|safety
354886|NCT02074800|Pharmacokinetics|pharmacokinetics
354887|NCT02074774|nasal cannula, high flow oxygen therapy, pulse oximetry|nasal cannula, high flow oxygen therapy, pulse oximetry
354888|NCT02074761|sacroiliac joint fusion|sacroiliac joint fusion
354889|NCT02074761|SIJ fusion|sij fusion
453765|NCT01625416|Suicide|suicide
354890|NCT02074761|SI joint|si joint
354891|NCT02074761|SIJ|sij
354892|NCT02074748|Bunion|bunion
354893|NCT02074748|Foot Arch|foot arch
354894|NCT02074748|Instability|instability
354895|NCT02074735|alcohol dependence|alcohol dependence
354896|NCT02074735|alcohol abuse|alcohol abuse
354897|NCT02074709|Pain, Liposomal bupivacaine, Wound infiltration|pain, liposomal bupivacaine, wound infiltration
354898|NCT02074696|brain derived neurotrophic factor|brain derived neurotrophic factor
354899|NCT02074657|Immunotherapy|immunotherapy
354900|NCT02074657|NKAEs|nkaes
354901|NCT02074657|Expanded haploidentical natural killer cells|expanded haploidentical natural killer cells
354902|NCT02074657|Activated natural killer cells|activated natural killer cells
354903|NCT02074644|Prostatism|prostatism
354904|NCT02074644|Randomized Controlled Trial|randomized controlled trial
354905|NCT02074644|Embolization, Therapeutic|embolization, therapeutic
354906|NCT02074644|Hyperplasia|hyperplasia
354907|NCT02074644|Prostatic Diseases|prostatic diseases
354908|NCT02074644|Genital Diseases, Male|genital diseases, male
354909|NCT02074631|bone mineral content|bone mineral content
354910|NCT02074631|bone mineral density|bone mineral density
354911|NCT02074631|bone formation|bone formation
354912|NCT02074631|bone resorption|bone resorption
354913|NCT02074631|pamidronate|pamidronate
354914|NCT02074631|children|children
354915|NCT02074631|DXA|dxa
354916|NCT02074631|bone marrow transplant|bone marrow transplant
354917|NCT02074618|Physical Therapy.|physical therapy.
354918|NCT02074618|Exercise.|exercise.
354919|NCT02074618|Rehabilitation.|rehabilitation.
354920|NCT02074618|Renal Insufficiency.|renal insufficiency.
354921|NCT02074618|Quality of life.|quality of life.
354922|NCT02074605|Melanoma|melanoma
354923|NCT02074605|Interferon|interferon
354924|NCT02074605|Cognition|cognition
354925|NCT02074592|Self assessment|self assessment
354926|NCT02074592|Audit|audit
354927|NCT02074592|Feedback|feedback
354928|NCT02074592|Quality|quality
354929|NCT02074592|Ultrasound|ultrasound
354930|NCT02074592|Fetal|fetal
354931|NCT02074592|Biometry|biometry
354932|NCT02074579|Irritable Bowel Syndrome|irritable bowel syndrome
354933|NCT02074579|Rome III criteria|rome iii criteria
354934|NCT02074579|abdominal bloating|abdominal bloating
354935|NCT02074579|natural|natural
354936|NCT02074579|herbal|herbal
354937|NCT02074579|Kampo|kampo
354938|NCT02074579|Adult ages 18 to 65|adult ages 18 to 65
354939|NCT02074579|Female subjects|female subjects
354940|NCT02074566|Pulmonary Vein Isolation|pulmonary vein isolation
354941|NCT02074566|Atrial fibrillation|atrial fibrillation
354942|NCT02074566|Cryoballoon therapy|cryoballoon therapy
354943|NCT02074566|Duration|duration
354944|NCT02074527|congenital heart disease|congenital heart disease
354945|NCT02074527|cardiac catheterization|cardiac catheterization
354946|NCT02074527|brazilian electronic registration|brazilian electronic registration
354947|NCT02074501|stroke|stroke
354948|NCT02074501|elderly|elderly
354949|NCT02074501|caregivers|caregivers
354950|NCT02074501|empowerment|empowerment
354951|NCT02074501|self-care|self-care
354952|NCT02074501|pilot study|pilot study
354953|NCT02074488|balance|balance
354954|NCT02074488|gait|gait
354955|NCT02074462|Voriconazole|voriconazole
354956|NCT02074462|CRP|crp
354957|NCT02074462|Inflammation|inflammation
354958|NCT02074462|Pharmacokinetics|pharmacokinetics
354959|NCT02074449|Pulmonary Arterial Hypertension|pulmonary arterial hypertension
354960|NCT02074449|Right Ventricular Performance|right ventricular performance
354961|NCT02074449|Treprostinil|treprostinil
354962|NCT02074449|Remodulin|remodulin
354963|NCT02074436|hematological malignancies|hematological malignancies
354964|NCT02074436|thrombocytopenia|thrombocytopenia
354965|NCT02074436|aminocaproic acid|aminocaproic acid
354966|NCT02074423|Cinnamon extract|cinnamon extract
354967|NCT02074423|Postprandial glycemia|postprandial glycemia
354968|NCT02074423|Glycemic index|glycemic index
354969|NCT02074423|Pre-diabetes|pre-diabetes
354970|NCT02074423|Metabolic syndrome|metabolic syndrome
354971|NCT02074371|coronary artery bypass surgery|coronary artery bypass surgery
354972|NCT02074371|cardiopulmonary bypass|cardiopulmonary bypass
354973|NCT02074371|ICU|icu
354974|NCT02074371|postoperative respiratory depression|postoperative respiratory depression
354975|NCT02074345|Drug therapy|drug therapy
354976|NCT02074345|Safety and immunogenicity of Hib vaccine|safety and immunogenicity of hib vaccine
354977|NCT02074332|Obesity|obesity
354978|NCT02074332|Physical activity|physical activity
354979|NCT02074332|Schoolchildren|schoolchildren
354980|NCT02074332|Intervention Studies|intervention studies
354981|NCT02074319|Schizophrenia|schizophrenia
354982|NCT02074319|Anti-Inflammatory|anti-inflammatory
354983|NCT02074319|Methotrexate|methotrexate
354984|NCT02074319|Psychosis Not Otherwise Specified|psychosis not otherwise specified
354985|NCT02074306|endotracheal intubation|endotracheal intubation
354986|NCT02074306|low energy ultrasound|low energy ultrasound
354987|NCT02074306|sputum culture|sputum culture
354988|NCT02074293|Subdermal bloodless space|subdermal bloodless space
354989|NCT02074293|Subdermal injection|subdermal injection
354990|NCT02074293|injectable EMG needle|injectable emg needle
354991|NCT02074293|electrical stimulation|electrical stimulation
354992|NCT02074293|MRI with Gadolinium|mri with gadolinium
354993|NCT02074293|Cervical Dystonia|cervical dystonia
354994|NCT02074293|intramuscular injection|intramuscular injection
354995|NCT02074293|cervical dystonia,|cervical dystonia,
354996|NCT02074280|rifaximin|rifaximin
354997|NCT02074280|endotoxemia|endotoxemia
354998|NCT02074280|cirrhosis|cirrhosis
354999|NCT02074280|advanced cirrhosis|advanced cirrhosis
355000|NCT02074228|Attention-deficit/hyperactivity disorder,|attention-deficit/hyperactivity disorder,
355001|NCT02074228|symptomatology,|symptomatology,
355002|NCT02074228|neurocognitive endophenotype,|neurocognitive endophenotype,
355003|NCT02074228|medication response|medication response
355004|NCT02074215|Mild Cognitive Impairment|mild cognitive impairment
355005|NCT02074215|Alzheimer's disease|alzheimer's disease
355006|NCT02074215|Aerobic exercise|aerobic exercise
355007|NCT02074202|18F fluorocholine|18f fluorocholine
355008|NCT02074202|18F fluorodeoxyglucose|18f fluorodeoxyglucose
355009|NCT02074202|hepatocellular carcinoma|hepatocellular carcinoma
355010|NCT02074202|PET CT scan|pet ct scan
355011|NCT02074176|Attention-deficit/hyperactivity disorder|attention-deficit/hyperactivity disorder
355012|NCT02074176|orexin A|orexin a
355013|NCT02074176|mRNA|mrna
355014|NCT02074163|Subdermal bloodless space|subdermal bloodless space
355015|NCT02074163|Subdermal injection|subdermal injection
355016|NCT02074163|injectable EMG needle|injectable emg needle
355017|NCT02074163|electrical stimulation|electrical stimulation
355018|NCT02074163|MRI with Gadolinium|mri with gadolinium
355019|NCT02074163|Chronic Migraine|chronic migraine
355020|NCT02074163|intramuscular injection|intramuscular injection
355021|NCT02074150|Subdermal bloodless space|subdermal bloodless space
355022|NCT02074150|Subdermal injection|subdermal injection
355023|NCT02074150|injectable EMG needle|injectable emg needle
355024|NCT02074150|electrical stimulation|electrical stimulation
355025|NCT02074150|MRI with Gadolinium|mri with gadolinium
355026|NCT02074150|Upper Limb Spasticity|upper limb spasticity
355027|NCT02074150|intramuscular injection|intramuscular injection
355028|NCT02074111|Moyamoya disease|moyamoya disease
355029|NCT02074111|Intracranial atherosclerotic stroke|intracranial atherosclerotic stroke
355030|NCT02074111|Intracranial steno-occlusive disease|intracranial steno-occlusive disease
355031|NCT02074111|ring finger 213 (RNF213) gene mutation|ring finger 213 (rnf213) gene mutation
355032|NCT02074111|high-resolution MRI|high-resolution mri
355033|NCT02074098|intubation|intubation
355034|NCT02074098|Cardiopulmonary resuscitation|cardiopulmonary resuscitation
355035|NCT02074098|Manikin study|manikin study
355036|NCT02074072|Endotracheal intubation|endotracheal intubation
355037|NCT02074072|Left lateral tilt wedge|left lateral tilt wedge
355038|NCT02074072|Maternal Cardiopulmonary Resuscitation|maternal cardiopulmonary resuscitation
355039|NCT02074072|Manikin Study|manikin study
355040|NCT02074020|SLE|sle
355041|NCT02074020|Lupus|lupus
355042|NCT02074020|Lupus Erythematosus, Systemic|lupus erythematosus, systemic
355043|NCT02074020|Autoimmune Diseases|autoimmune diseases
355044|NCT02074020|A-623|a-623
355045|NCT02074020|Blisibimod|blisibimod
355046|NCT02074020|Nephritis|nephritis
355047|NCT02074007|Acute Otitis Media|acute otitis media
355048|NCT02074007|Pain|pain
355049|NCT02074007|Ear Pain|ear pain
355050|NCT02074007|Ear Ache|ear ache
355051|NCT02074007|Ear infection|ear infection
355052|NCT02074007|middle ear infection|middle ear infection
355053|NCT02073994|chondrosarcoma|chondrosarcoma
355054|NCT02073994|cholangiocarcinoma|cholangiocarcinoma
355055|NCT02073994|glioma|glioma
355056|NCT02073994|advanced solid tumors|advanced solid tumors
355057|NCT02073994|IDH1|idh1
355058|NCT02073994|AG-120|ag-120
355059|NCT02073981|Parkinson Disease|parkinson disease
355060|NCT02073955|Stroke|stroke
355061|NCT02073955|Validation|validation
355062|NCT02073955|Community Health workers|community health workers
355063|NCT02073955|stroke symptom questionnaire|stroke symptom questionnaire
355064|NCT02073916|Breast Cancer|breast cancer
355065|NCT02073916|HER2 positive Breast Cancer|her2 positive breast cancer
355066|NCT02073903|dual handset interpreter phones|dual handset interpreter phones
355067|NCT02073903|communication|communication
355068|NCT02073903|14-042|14-042
355069|NCT02073890|traumatic Subarachnoid Haemorrhage|traumatic subarachnoid haemorrhage
355070|NCT02073890|Head Trauma|head trauma
355071|NCT02073890|Computed Tomography|computed tomography
355072|NCT02073877|Peri-implant dermatitis|peri-implant dermatitis
355073|NCT02073864|Aortic valve stenosis, stenosis, intervention|aortic valve stenosis, stenosis, intervention
355074|NCT02073851|TAVR|tavr
355075|NCT02073825|Computer-assisted interventions|computer-assisted interventions
355076|NCT02073825|Alcohol use disorders|alcohol use disorders
355077|NCT02073825|At-risk drinking|at-risk drinking
355078|NCT02073825|Spouses|spouses
355079|NCT02073825|Military|military
355080|NCT02073825|Brief Intervention|brief intervention
355081|NCT02073773|stroke, virtual reality based therapy|stroke, virtual reality based therapy
355082|NCT02073760|Healthcare acquired infections|healthcare acquired infections
355083|NCT02073760|Cardiac Surgery|cardiac surgery
355084|NCT02073760|Sternal Superficial Wound Infection|sternal superficial wound infection
355085|NCT02073760|Deep Sternal Infection|deep sternal infection
355086|NCT02073760|Mediastinitis|mediastinitis
355087|NCT02073760|Thoracotomy|thoracotomy
355088|NCT02073760|Conduit harvest or cannulation site|conduit harvest or cannulation site
355089|NCT02073760|Sepsis|sepsis
355090|NCT02073760|Pneumonia|pneumonia
355091|NCT02073747|Albuterol|albuterol
355092|NCT02073747|Serum Lactate|serum lactate
355093|NCT02073747|Lactic Acidosis|lactic acidosis
355094|NCT02073747|Asthma|asthma
355095|NCT02073734|pelvic organ prolapse surgery|pelvic organ prolapse surgery
355096|NCT02073734|dexamethasone|dexamethasone
355097|NCT02073734|postoperative nausea and vomiting|postoperative nausea and vomiting
355098|NCT02073734|peroperative administration|peroperative administration
355099|NCT02073695|Proximal humeral fracture|proximal humeral fracture
355100|NCT02073695|Shoulder|shoulder
355101|NCT02073695|Orthopaedics|orthopaedics
355102|NCT02073695|Neutral rotation brace|neutral rotation brace
355103|NCT02073695|Polysling|polysling
355104|NCT02073682|Active Cancer with Metastasis|active cancer with metastasis
355105|NCT02073669|latent tuberculosis|latent tuberculosis
355106|NCT02073669|tuberculin skin test|tuberculin skin test
355107|NCT02073669|Interferon gamma release assay|interferon gamma release assay
355108|NCT02073669|immigration|immigration
355109|NCT02073656|genotype 1|genotype 1
355110|NCT02073656|genotype 4|genotype 4
355111|NCT02073656|HIV|hiv
355112|NCT02073630|magnetoencephalography|magnetoencephalography
355113|NCT02073630|non invasive brain stimulation|non invasive brain stimulation
355114|NCT02073630|cerebellum|cerebellum
355115|NCT02073630|gamma rhythms|gamma rhythms
355116|NCT02073617|DynaCT|dynact
355117|NCT02073617|Aortic valve and root measurements|aortic valve and root measurements
355118|NCT02073617|TAVR|tavr
355119|NCT02073604|Congenital mirror movements|congenital mirror movements
355120|NCT02073604|SMA|sma
355121|NCT02073604|Movement preparation|movement preparation
355122|NCT02073604|Movement lateralization|movement lateralization
355123|NCT02073604|MRI|mri
355124|NCT02073604|Transcranial magnetic stimulation|transcranial magnetic stimulation
355125|NCT02073591|Children|children
355126|NCT02073591|Atopic Dermatitis|atopic dermatitis
355127|NCT02073591|Ceradan|ceradan
355129|NCT02073591|SCORAD|scorad
355130|NCT02073578|achalasia|achalasia
355131|NCT02073578|POEM|poem
355132|NCT02073578|peroral endoscopic myotomy|peroral endoscopic myotomy
355133|NCT02073578|myotomy|myotomy
355134|NCT02073578|Heller myotomy|heller myotomy
355135|NCT02073565|intracoronary stent|intracoronary stent
355136|NCT02073565|drug eluting stent|drug eluting stent
355137|NCT02073565|sirolimus|sirolimus
355138|NCT02073565|endothelial progenitor cells|endothelial progenitor cells
355139|NCT02073552|colon cleansing, bowel preparations; polyethyleneglycol|colon cleansing, bowel preparations; polyethyleneglycol
355140|NCT02073539|Chest compression|chest compression
355141|NCT02073539|One accelerometer|one accelerometer
355142|NCT02073539|Manikin Study|manikin study
355143|NCT02073526|Antibodies, Monoclonal|antibodies, monoclonal
355144|NCT02073526|Anti-TNF|anti-tnf
355145|NCT02073526|TNF-alpha|tnf-alpha
355146|NCT02073526|Trough level|trough level
355147|NCT02073526|Drug concentration|drug concentration
355148|NCT02073526|ELISA|elisa
355149|NCT02073513|Spasticity, Hand Function, Cerebral Palsy, Kinesiotape|spasticity, hand function, cerebral palsy, kinesiotape
355150|NCT02073500|Peritoneal carcinomatosis|peritoneal carcinomatosis
355151|NCT02073500|Peritoneal surface malignancy|peritoneal surface malignancy
355152|NCT02073500|Cytoreductive surgery|cytoreductive surgery
355153|NCT02073500|Hyperthermic intraperitoneal chemotherapy|hyperthermic intraperitoneal chemotherapy
355154|NCT02073500|CRS|crs
355155|NCT02073500|HIPEC|hipec
355156|NCT02073500|Prognostic biomarker|prognostic biomarker
355157|NCT02073500|Predictive biomarker|predictive biomarker
355158|NCT02073487|Neoadjuvant Breast Cancer|neoadjuvant breast cancer
355159|NCT02073487|HER2 positive Breast Cancer|her2 positive breast cancer
355160|NCT02073474|cannabinoids|cannabinoids
355161|NCT02073474|Sativex|sativex
355162|NCT02073474|THC|thc
355163|NCT02073474|delta-9-tetrahydrocannabinol|delta-9-tetrahydrocannabinol
355164|NCT02073474|cannabidiol|cannabidiol
355165|NCT02073474|CBD|cbd
355166|NCT02073474|Registry|registry
355167|NCT02073474|Safety|safety
355168|NCT02073474|MS|ms
355169|NCT02073461|Acne Vulgaris|acne vulgaris
355170|NCT02073448|Acne Vulgaris|acne vulgaris
355171|NCT02073435|liver transplantation|liver transplantation
355172|NCT02073435|living donor|living donor
355173|NCT02073435|Safety|safety
355174|NCT02073422|Magnetic resonance imaging|magnetic resonance imaging
355175|NCT02073422|Myocardial stress perfusion magnetic resonance imaging|myocardial stress perfusion magnetic resonance imaging
355176|NCT02073422|Fractional flow reserve|fractional flow reserve
355177|NCT02073422|Relaxometry|relaxometry
355178|NCT02073422|Coronary artery disease|coronary artery disease
355179|NCT02073409|Nontuberculous Mycobacteria|nontuberculous mycobacteria
355180|NCT02073383|Axillary brachial plexus block|axillary brachial plexus block
355181|NCT02073383|Ultrasound|ultrasound
355182|NCT02073383|Bupivacaine|bupivacaine
355183|NCT02073344|obstructive sleep apnea|obstructive sleep apnea
355184|NCT02073344|overhydration|overhydration
355185|NCT02073344|end stage renal disease|end stage renal disease
355186|NCT02073344|renal transplantation|renal transplantation
355187|NCT02073344|polysomnography|polysomnography
355188|NCT02073344|bioimpedance|bioimpedance
355189|NCT02073344|leg fluid shift|leg fluid shift
355190|NCT02073344|neck circumference|neck circumference
355191|NCT02073331|Open heart surgery, cardiac repair|open heart surgery, cardiac repair
355192|NCT02073305|obstructive sleep apnea|obstructive sleep apnea
355193|NCT02073305|end stage renal disease|end stage renal disease
355194|NCT02073305|cardiovascular events|cardiovascular events
355195|NCT02073240|Tuberculosis|tuberculosis
355196|NCT02073240|Infection Control|infection control
355197|NCT02073227|Healthy Volunteers|healthy volunteers
355198|NCT02073227|Canagliflozin|canagliflozin
355199|NCT02073227|Metformin|metformin
355200|NCT02073227|Type 2 diabetes mellitus|type 2 diabetes mellitus
355201|NCT02073175|Postpartum|postpartum
355202|NCT02073175|Dietary Supplements|dietary supplements
355203|NCT02073175|Mood Symptoms|mood symptoms
355204|NCT02073149|Iron|iron
355205|NCT02073149|Anemia|anemia
355206|NCT02073149|Sodium Fe(III)-ethylenediaminetetraacetic acid (NaFeEDTA)|sodium fe(iii)-ethylenediaminetetraacetic acid (nafeedta)
355207|NCT02073149|Ferrous compounds|ferrous compounds
355208|NCT02073149|Child, preschool|child, preschool
355209|NCT02073149|Kenya|kenya
355210|NCT02073123|Metastatic melanoma|metastatic melanoma
355211|NCT02073123|Stage III melanoma|stage iii melanoma
355212|NCT02073123|Stage IV melanoma|stage iv melanoma
355213|NCT02073123|unresectable|unresectable
355214|NCT02073110|Kidney cancer|kidney cancer
355215|NCT02073110|Renal mass|renal mass
355216|NCT02073110|Small renal mass|small renal mass
355217|NCT02073110|Optical Coherence Tomography|optical coherence tomography
355218|NCT02073110|OCT|oct
355219|NCT02073110|Diffuse Reflectance Spectroscopy|diffuse reflectance spectroscopy
355220|NCT02073110|DRS|drs
355221|NCT02073110|Optical Biopsy|optical biopsy
355222|NCT02073110|OB|ob
355223|NCT02073058|Subjects with Type 1 or Type 2 Diabetes Requiring Multiple daily Insulin Injection (MDI) or Continuous Subcutaneous Insulin Infusion (CSII)|subjects with type 1 or type 2 diabetes requiring multiple daily insulin injection (mdi) or continuous subcutaneous insulin infusion (csii)
355224|NCT02073032|Refeeding syndrome, risk factors, head and neck cancer|refeeding syndrome, risk factors, head and neck cancer
355225|NCT02073006|Chronic|chronic
355226|NCT02073006|Functional|functional
355227|NCT02073006|Constipation|constipation
355228|NCT02073006|less than 3 bowel movements per week|less than 3 bowel movements per week
355229|NCT02072993|Phase I, healthy, pharmacokinetics|phase i, healthy, pharmacokinetics
355230|NCT02072980|DT1|dt1
355231|NCT02072980|DAILIES TOTAL1®|dailies total1®
355232|NCT02072980|Lubricity|lubricity
355233|NCT02072967|Relapsed|relapsed
355234|NCT02072967|Refractory|refractory
355235|NCT02072967|Non-Hodgkin Lymphoma|non-hodgkin lymphoma
355236|NCT02072967|Bendamustine|bendamustine
355237|NCT02072941|Advance care planning|advance care planning
355238|NCT02072941|Latino Health|latino health
355239|NCT02072941|Medical decision making|medical decision making
355240|NCT02072941|Health Literacy|health literacy
355241|NCT02072941|Limited English proficiency|limited english proficiency
355242|NCT02072941|Aging|aging
355243|NCT02072902|Cohort|cohort
355244|NCT02072902|Historical|historical
355245|NCT02072902|Prospective|prospective
355246|NCT02072902|Medications|medications
355247|NCT02072902|Observational|observational
355248|NCT02072902|Glucose|glucose
355249|NCT02072902|Control|control
355250|NCT02072889|Cardiac Surgery|cardiac surgery
355251|NCT02072889|Internal Jugular Cannulation|internal jugular cannulation
355252|NCT02072889|Optimal Neck Angle|optimal neck angle
355253|NCT02072876|Stroke|stroke
355254|NCT02072876|Asymptomatic Intracranial Atherosclerotic Disease|asymptomatic intracranial atherosclerotic disease
355255|NCT02072876|Lifestyle and socio-economic risk factors|lifestyle and socio-economic risk factors
355256|NCT02072876|Clinical predictors|clinical predictors
355257|NCT02072850|Myocardial infarction|myocardial infarction
355258|NCT02072850|Primary percutaneous coronary intervention (PCI)|primary percutaneous coronary intervention (pci)
355259|NCT02072850|Thrombolysis|thrombolysis
355260|NCT02072850|Rescue PCI|rescue pci
355261|NCT02072850|Electrocardiogram|electrocardiogram
355262|NCT02072850|Magnetic resonance imaging|magnetic resonance imaging
355263|NCT02072850|Area-at-risk|area-at-risk
355264|NCT02072850|Myocardial salvage|myocardial salvage
355667|NCT02070913|Hypothermia|hypothermia
355265|NCT02072850|Infarct size|infarct size
355266|NCT02072850|Pressure wire|pressure wire
355267|NCT02072850|Coronary thermodilution|coronary thermodilution
355268|NCT02072850|Coronary microvascular function|coronary microvascular function
355269|NCT02072850|Index of microvascular resistance|index of microvascular resistance
355270|NCT02072850|Heart failure|heart failure
355271|NCT02072850|Prognosis|prognosis
355272|NCT02072837|hemodialysis, dyslipidemia, cardiovascular disease|hemodialysis, dyslipidemia, cardiovascular disease
355273|NCT02072824|Partial Onset Seizures|partial onset seizures
355274|NCT02072824|Epilepsy|epilepsy
355275|NCT02072824|Safety|safety
355276|NCT02072824|Efficacy|efficacy
355277|NCT02072824|Tolerability|tolerability
355278|NCT02072824|Pregabalin|pregabalin
355279|NCT02072824|Lyrica|lyrica
355280|NCT02072824|Adjunctive treatment|adjunctive treatment
355281|NCT02072824|Placebo controlled|placebo controlled
355282|NCT02072824|blinded|blinded
355283|NCT02072824|Eligibility Criteria|eligibility criteria
355284|NCT02072811|AML|aml
355285|NCT02072798|Randomized Controlled Trial|randomized controlled trial
355286|NCT02072798|Caesarean Section|caesarean section
355287|NCT02072798|Surgical Site Infections|surgical site infections
355288|NCT02072798|Wound Infections|wound infections
355289|NCT02072798|Infectious Morbidity|infectious morbidity
355290|NCT02072785|Adult Acute Lymphoblastic Leukemia|adult acute lymphoblastic leukemia
355291|NCT02072785|Vincristine Sulfate Liposome|vincristine sulfate liposome
355292|NCT02072785|Vincristine Sulfate|vincristine sulfate
355293|NCT02072759|Insulin sensitivity|insulin sensitivity
355294|NCT02072759|Metabolic flexibility|metabolic flexibility
355295|NCT02072746|cirrhosis|cirrhosis
355296|NCT02072746|alcohol|alcohol
355297|NCT02072733|frailty|frailty
355298|NCT02072733|oncogeriatrics|oncogeriatrics
355299|NCT02072733|Multidisciplinary intervention|multidisciplinary intervention
355300|NCT02072733|multimorbidity|multimorbidity
355301|NCT02072733|Comprehensive geriatric assessment|comprehensive geriatric assessment
355302|NCT02072733|patients|patients
355303|NCT02072720|Radiotherapy|radiotherapy
355304|NCT02072720|VEGF|vegf
355305|NCT02072720|esophagus carcinoma|esophagus carcinoma
355306|NCT02072720|bevacizumab|bevacizumab
355307|NCT02072707|Ventricular Tachycardia|ventricular tachycardia
355308|NCT02072707|RF ablation|rf ablation
355309|NCT02072707|Epicardial Access|epicardial access
355310|NCT02072707|Contact Sensor Irrigated tip catheter|contact sensor irrigated tip catheter
355311|NCT02072694|Obesity|obesity
355312|NCT02072694|Single Photon Emission Computed Tomography|single photon emission computed tomography
355313|NCT02072694|Functional Neuroimaging|functional neuroimaging
355314|NCT02072668|sickle cell anemia|sickle cell anemia
355315|NCT02072668|sickle cell disease|sickle cell disease
355316|NCT02072668|rivaroxaban|rivaroxaban
355317|NCT02072668|direct Xa inhibition|direct xa inhibition
355318|NCT02072668|coagulation|coagulation
355319|NCT02072668|anticoagulation|anticoagulation
355320|NCT02072629|Antimalarials|antimalarials
355321|NCT02072629|Antibiotics|antibiotics
355322|NCT02072629|ORS Zn|ors zn
355323|NCT02072629|Village Health Volunteers|village health volunteers
355324|NCT02072629|Integrated Community Case Management|integrated community case management
355325|NCT02072616|Circulating Tumor Cells|circulating tumor cells
355326|NCT02072616|pancreatic adenocarcinoma|pancreatic adenocarcinoma
355327|NCT02072616|circulating tumor DNA (KRAS)|circulating tumor dna (kras)
355328|NCT02072616|CA 19.9|ca 19.9
355329|NCT02072603|Infant HIV|infant hiv
355330|NCT02072603|Kenya|kenya
355331|NCT02072603|HITSystem|hitsystem
355332|NCT02072603|EID care|eid care
355333|NCT02072603|Early Infant Diagnosis|early infant diagnosis
355334|NCT02072590|Celiac disease|celiac disease
355335|NCT02072590|Eosinophilic esophagitis|eosinophilic esophagitis
355336|NCT02072590|Endomysial antibodies|endomysial antibodies
355337|NCT02072590|Transglutaminase antibodies|transglutaminase antibodies
355338|NCT02072590|Small-bowel|small-bowel
355339|NCT02072577|Nursing care, oral health, educational video, oral hygiene.|nursing care, oral health, educational video, oral hygiene.
355340|NCT02072538|Stress testing|stress testing
355341|NCT02072538|Troponin T|troponin t
355342|NCT02072538|GRACE score|grace score
355343|NCT02072538|Outcome|outcome
355344|NCT02072525|Pertussis|pertussis
355345|NCT02072525|Healthy adults|healthy adults
355346|NCT02072525|Tetanus|tetanus
355347|NCT02072525|Human serum samples|human serum samples
355348|NCT02072525|Streptococcus|streptococcus
355349|NCT02072525|Diphtheria|diphtheria
355350|NCT02072525|Plasma|plasma
355351|NCT02072525|Meningococcus|meningococcus
355352|NCT02072512|pre- and perimenopausal HR+ advanced breast cancer|pre- and perimenopausal hr+ advanced breast cancer
355353|NCT02072473|Re-entrant Atrioventricular Node Tachycardia|re-entrant atrioventricular node tachycardia
355354|NCT02072473|Unsuccessful right-sided slow pathway ablation|unsuccessful right-sided slow pathway ablation
355355|NCT02072473|Coronary sinus / left-sided slow pathway ablation|coronary sinus / left-sided slow pathway ablation
355356|NCT02072447|absolute bioavailability,|absolute bioavailability,
355357|NCT02072447|microdose,|microdose,
355358|NCT02072447|AMS|ams
355359|NCT02072434|Nonvalvular atrial fibrillation (NVAF)|nonvalvular atrial fibrillation (nvaf)
355360|NCT02072434|anti-coagulant|anti-coagulant
355361|NCT02072434|warfarin|warfarin
355362|NCT02072434|edoxaban|edoxaban
355363|NCT02072434|electrical cardioversion|electrical cardioversion
355364|NCT02072395|morbid obesity|morbid obesity
355365|NCT02072395|bariatric surgery|bariatric surgery
355366|NCT02072395|gastric banding|gastric banding
355367|NCT02072395|gastric plication|gastric plication
355368|NCT02072382|Hypertension|hypertension
355369|NCT02072382|Metformin|metformin
355370|NCT02072382|Ambulatory blood pressure monitor|ambulatory blood pressure monitor
355371|NCT02072369|stroke|stroke
355372|NCT02072369|hand|hand
355373|NCT02072369|fingers|fingers
355374|NCT02072369|rehabilitation|rehabilitation
355375|NCT02072369|training|training
355376|NCT02072356|Humanitarian Device|humanitarian device
355377|NCT02072356|Carcinoma|carcinoma
355378|NCT02072356|Hepatocellular Carcinoma|hepatocellular carcinoma
355379|NCT02072356|TheraSphere®|therasphere®
355381|NCT02072343|Capnography|capnography
355382|NCT02072343|Catheters|catheters
355383|NCT02072343|Intubation|intubation
355384|NCT02072330|Hypertension, Drug therapy|hypertension, drug therapy
355385|NCT02072317|PFS|pfs
355386|NCT02072304|mood disorder|mood disorder
355387|NCT02072304|depressive disorder|depressive disorder
355388|NCT02072304|mental disorders|mental disorders
355389|NCT02072304|program acceptability|program acceptability
355390|NCT02072304|behavioral symptoms|behavioral symptoms
355391|NCT02072304|suicidal ideation|suicidal ideation
355392|NCT02072304|patient adherence|patient adherence
355393|NCT02072265|infrared thermal image|infrared thermal image
355394|NCT02072265|wound healing|wound healing
355395|NCT02072265|wound infection|wound infection
355396|NCT02072252|Depression|depression
355397|NCT02072252|Anxiety|anxiety
355398|NCT02072252|Mobile Phone|mobile phone
355399|NCT02072252|Cellular Phone|cellular phone
355400|NCT02072252|Mobile Application|mobile application
355401|NCT02072252|Mobile Intervention|mobile intervention
355402|NCT02072252|App|app
355403|NCT02072252|mHealth|mhealth
355404|NCT02072252|eHealth|ehealth
355405|NCT02072252|Technology Assisted|technology assisted
355406|NCT02072252|Internet|internet
355407|NCT02072252|Cognitive Behavioral Therapy|cognitive behavioral therapy
355408|NCT02072252|LGBT|lgbt
355409|NCT02072252|Sexual Minorities|sexual minorities
355410|NCT02072252|Gay|gay
355411|NCT02072252|Bisexual|bisexual
355412|NCT02072252|Same Sex Attraction|same sex attraction
355413|NCT02072252|Males|males
355414|NCT02072252|Men|men
355415|NCT02072252|Youth|youth
355416|NCT02072252|Adolescents|adolescents
355417|NCT02072252|Young Adults|young adults
355418|NCT02072239|CABG|cabg
355419|NCT02072239|Intimal Hyperplasia|intimal hyperplasia
355420|NCT02072239|Atherosclerosis|atherosclerosis
355421|NCT02072239|Myocardial Infarction|myocardial infarction
355422|NCT02072213|Tamsulosin,controlled release formulation|tamsulosin,controlled release formulation
355423|NCT02072200|RA, MS, Safety, Efficacy, MR prednisone|ra, ms, safety, efficacy, mr prednisone
355424|NCT02072187|Depression|depression
355425|NCT02072187|Vitamin D|vitamin d
355426|NCT02072187|Complementary and Alternative Medicine|complementary and alternative medicine
355427|NCT02072187|Supplements|supplements
355428|NCT02072187|Non Remitted Depression|non remitted depression
355429|NCT02072161|Statin|statin
355430|NCT02072161|LDL|ldl
355431|NCT02072161|Cholesterol|cholesterol
355432|NCT02072148|Human Papilloma Virus|human papilloma virus
355433|NCT02072148|Oropharyngeal Squamous Cell Carcinoma|oropharyngeal squamous cell carcinoma
355434|NCT02072148|Transoral Robotic Surgery|transoral robotic surgery
355435|NCT02072122|dry eye|dry eye
355436|NCT02072122|fertility treatment|fertility treatment
355437|NCT02072122|Meibomian gland dysfunction|meibomian gland dysfunction
355438|NCT02072122|supra physiologic estrogen level|supra physiologic estrogen level
355439|NCT02072109|Near infrared spectroscopy|near infrared spectroscopy
355440|NCT02072109|Bolus nutrition|bolus nutrition
355441|NCT02072109|Continuous nutrition|continuous nutrition
355442|NCT02072109|Mesenteric circulation|mesenteric circulation
355443|NCT02072083|dexmedetomidine|dexmedetomidine
355444|NCT02072083|intranasal|intranasal
355445|NCT02072083|strabismus surgery|strabismus surgery
355446|NCT02072083|premedication|premedication
355447|NCT02072083|oculocardiac reflex|oculocardiac reflex
355448|NCT02072070|chondrocyte cells, Osteoarthritis, gene therapy|chondrocyte cells, osteoarthritis, gene therapy
355449|NCT02072044|Renal Cell Carcinoma（RCC）|renal cell carcinoma（rcc）
355450|NCT02072044|Anlotinib|anlotinib
355451|NCT02072031|Anlotinib|anlotinib
355452|NCT02072031|Sunitinib|sunitinib
355453|NCT02072031|Renal Cell Carcinoma（RCC）|renal cell carcinoma（rcc）
355454|NCT02072018|Peyronie's|peyronie's
355455|NCT02072018|Peyronie's disease|peyronie's disease
355456|NCT02072018|Treatment|treatment
355457|NCT02072018|Clinical Study|clinical study
355458|NCT02071979|Chronic|chronic
355459|NCT02071979|Non-healing|non-healing
355460|NCT02071979|Wounds|wounds
355461|NCT02071966|Micro-RNA, Microparticles, Ticagrelor, NSTE-ACS|micro-rna, microparticles, ticagrelor, nste-acs
355462|NCT02071940|Acral Melanoma subtypes|acral melanoma subtypes
355463|NCT02071940|Mucosal Melanoma subtypes|mucosal melanoma subtypes
355464|NCT02071927|leukemia|leukemia
355465|NCT02071927|glutaminase|glutaminase
355466|NCT02071927|glutamine|glutamine
355467|NCT02071888|Non-Hodgkin's lymphoma|non-hodgkin's lymphoma
355468|NCT02071888|Waldenstrom's macroglobulinemia|waldenstrom's macroglobulinemia
355469|NCT02071888|Multiple myeloma|multiple myeloma
355470|NCT02071888|glutaminase|glutaminase
355471|NCT02071888|glutamine|glutamine
355472|NCT02071875|Vasospasm|vasospasm
355473|NCT02071875|Aneurysm|aneurysm
355474|NCT02071875|SAH|sah
355475|NCT02071875|Nautilus NeuroWave|nautilus neurowave
355476|NCT02071862|Tumor metabolism|tumor metabolism
355477|NCT02071862|Glutaminase|glutaminase
355478|NCT02071862|Glutamine|glutamine
355479|NCT02071862|Tricarboxylic acid (TCA) cycle|tricarboxylic acid (tca) cycle
355480|NCT02071849|Aortic Insufficiency|aortic insufficiency
355481|NCT02071849|Aortic Regurgitation|aortic regurgitation
355482|NCT02071836|web application|web application
355483|NCT02071836|DWI intervention|dwi intervention
355484|NCT02071836|DUI intervention|dui intervention
355485|NCT02071836|Experimental group: Right Turns + treatment as usual|experimental group: right turns + treatment as usual
355486|NCT02071836|Control group: Treatment as usual|control group: treatment as usual
355487|NCT02071823|Opicapone,|opicapone,
355488|NCT02071823|Parkinson,|parkinson,
355489|NCT02071823|Bial,|bial,
355490|NCT02071823|BIA 9-1067|bia 9-1067
355491|NCT02071810|Parkinson's disease (PD)|parkinson's disease (pd)
355492|NCT02071810|Opicapone|opicapone
355493|NCT02071810|Bial|bial
355494|NCT02071810|BIA 9-1067|bia 9-1067
355495|NCT02071797|Therapeutic Hypothermia|therapeutic hypothermia
355496|NCT02071797|Cardiac Arrest|cardiac arrest
355497|NCT02071797|Randomised Controlled trial|randomised controlled trial
355498|NCT02071797|Pilot study|pilot study
355499|NCT02071771|DACP Toric|dacp toric
355500|NCT02071771|DAILIES® AquaComfort Plus®|dailies® aquacomfort plus®
355501|NCT02071771|Astigmatism|astigmatism
355502|NCT02071771|Toric|toric
355503|NCT02071758|Leishmaniasis|leishmaniasis
355504|NCT02071758|Visceral leishmaniasis|visceral leishmaniasis
355505|NCT02071758|Vaccine|vaccine
355506|NCT02071758|Adjuvant|adjuvant
355507|NCT02071758|GLA|gla
355508|NCT02071758|SLA|sla
355509|NCT02071693|subthalamic nucleus|subthalamic nucleus
355510|NCT02071693|deep brain stimulation|deep brain stimulation
355511|NCT02071693|cognition|cognition
355512|NCT02071693|white matter hyperintensities|white matter hyperintensities
355513|NCT02071680|atrial fibrillation|atrial fibrillation
355514|NCT02071680|atrial cardiac innervation|atrial cardiac innervation
355515|NCT02071680|catheter ablation of atrial fibrillation|catheter ablation of atrial fibrillation
355516|NCT02071680|High Frequency Stimulation|high frequency stimulation
355517|NCT02071680|ganglionated plexuses|ganglionated plexuses
355518|NCT02071680|123I-mIBG|123i-mibg
355519|NCT02071680|nuclear imaging|nuclear imaging
355520|NCT02071667|Chronic sinusitis|chronic sinusitis
355521|NCT02071667|Nasal Polyps|nasal polyps
355522|NCT02071654|Venus P-valve|venus p-valve
355523|NCT02071615|Brain Activity|brain activity
355524|NCT02071602|Heart attack|heart attack
355525|NCT02071602|Myocardial Infarction|myocardial infarction
355526|NCT02071602|STEMI|stemi
355527|NCT02071576|Myopia|myopia
355528|NCT02071576|Hyperopia|hyperopia
355529|NCT02071576|Proscan|proscan
355530|NCT02071576|LASIK|lasik
355531|NCT02071576|TENEO|teneo
355532|NCT02071576|Excimer|excimer
355533|NCT02071550|laparoscopic cholecystectomy, near infrared spectroscopy, positive end expiratory pressure|laparoscopic cholecystectomy, near infrared spectroscopy, positive end expiratory pressure
355534|NCT02071498|Pillbox|pillbox
355535|NCT02071498|Non-adherence|non-adherence
355536|NCT02071498|Applications|applications
355537|NCT02071498|Patient safety|patient safety
355538|NCT02071498|Elderly|elderly
355539|NCT02071459|L-threo DOPS (DroxiDopa)|l-threo dops (droxidopa)
355540|NCT02071459|Orthostatic Hypotension|orthostatic hypotension
355541|NCT02071459|Multiple system atrophy|multiple system atrophy
355542|NCT02071446|Deep Brain Stimulation|deep brain stimulation
355543|NCT02071446|Local Field Potential|local field potential
355544|NCT02071446|Subthalamic Nucleus|subthalamic nucleus
355545|NCT02071433|Saphenous nerve block|saphenous nerve block
355546|NCT02071433|Adductor canal block|adductor canal block
355547|NCT02071433|Anterior cruciate ligament|anterior cruciate ligament
355548|NCT02071433|Pain management|pain management
355549|NCT02071433|Day care|day care
355550|NCT02071407|traumatic brain injury|traumatic brain injury
355551|NCT02071407|sedation|sedation
355552|NCT02071407|midazolam|midazolam
355553|NCT02071394|Xenon|xenon
355554|NCT02071394|Hypothermia|hypothermia
355555|NCT02071394|Hypoxic Ischemic Encephalopathy|hypoxic ischemic encephalopathy
355556|NCT02071394|Newborn|newborn
355557|NCT02071394|Neonate|neonate
355558|NCT02071394|Term|term
355559|NCT02071394|Neuroprotection|neuroprotection
355560|NCT02071394|Cooling|cooling
355561|NCT02071394|HIE|hie
355562|NCT02071368|Healthy|healthy
355563|NCT02071368|Canagliflozin|canagliflozin
355564|NCT02071368|Metformin|metformin
355565|NCT02071368|JNJ-28431754|jnj-28431754
355566|NCT02071368|GLUMETZA®|glumetza®
355567|NCT02071368|Bioequivalence|bioequivalence
355568|NCT02071368|Fixed Dose Combination|fixed dose combination
355569|NCT02071355|Healthy|healthy
355570|NCT02071355|Chinese participants|chinese participants
355571|NCT02071355|TMC435|tmc435
355572|NCT02071355|Multiple oral doses|multiple oral doses
355573|NCT02071355|Pharmacokinetics|pharmacokinetics
355574|NCT02071355|Safety|safety
355575|NCT02071355|Tolerability|tolerability
355576|NCT02071342|acute myocardial infarction|acute myocardial infarction
355577|NCT02071342|bioresorbable vascular scaffold|bioresorbable vascular scaffold
355578|NCT02071342|percutaneous coronary intervention|percutaneous coronary intervention
355579|NCT02071329|FP-01.1|fp-01.1
355580|NCT02071329|Influenza A|influenza a
355581|NCT02071329|Flu|flu
355582|NCT02071329|Vaccine|vaccine
355583|NCT02071329|Virus|virus
355584|NCT02071329|H1N1|h1n1
355585|NCT02071329|Challenge|challenge
355586|NCT02071316|upper gastrointestinal bleeding|upper gastrointestinal bleeding
355587|NCT02071316|Hexacapron|hexacapron
355588|NCT02071316|hemostasis|hemostasis
355589|NCT02071303|Pain|pain
355590|NCT02071303|Hysteroscopy|hysteroscopy
355591|NCT02071303|Tramadol|tramadol
355592|NCT02071303|Celecoxib|celecoxib
355593|NCT02071290|Hemorrhagic Shock|hemorrhagic shock
355594|NCT02071290|Remote Ischemic Conditioning|remote ischemic conditioning
355595|NCT02071277|Mechanical ventilation|mechanical ventilation
355596|NCT02071277|Airway pressure release ventilation|airway pressure release ventilation
355597|NCT02071277|Biphasic intermittent positive airway pressure|biphasic intermittent positive airway pressure
355598|NCT02071277|Pressure-controlled ventilation|pressure-controlled ventilation
355599|NCT02071277|Lung protective ventilation|lung protective ventilation
355600|NCT02071277|Spontaneous breathing|spontaneous breathing
355601|NCT02071264|HIV/AIDS|hiv/aids
355602|NCT02071264|sex work|sex work
355603|NCT02071264|reproductive health|reproductive health
355604|NCT02071264|human rights|human rights
355605|NCT02071264|ethics|ethics
355606|NCT02071251|Wound complications|wound complications
355607|NCT02071251|Wound infection|wound infection
355608|NCT02071251|Wound separation|wound separation
355609|NCT02071238|Carpal tunnel|carpal tunnel
355610|NCT02071238|Carpal tunnel release|carpal tunnel release
355611|NCT02071238|Risk Recall|risk recall
355612|NCT02071238|Patient satisfaction|patient satisfaction
355613|NCT02071238|Pamphlet|pamphlet
355614|NCT02071238|Brochure|brochure
355615|NCT02071199|Gingivitis|gingivitis
355616|NCT02071199|Periodontitis|periodontitis
355617|NCT02071199|ACCS|accs
355618|NCT02071160|HIE|hie
355619|NCT02071160|hypothermia|hypothermia
355620|NCT02071160|encephalopathy|encephalopathy
355621|NCT02071160|anti oxidants|anti oxidants
355622|NCT02071160|MRI|mri
355623|NCT02071147|Follow-up|follow-up
355624|NCT02071147|No follow-up|no follow-up
355625|NCT02071147|removal|removal
355626|NCT02071147|Randomised Controlled Trial|randomised controlled trial
355627|NCT02071147|6 Weeks|6 weeks
355628|NCT02071134|Deep brain stimulation|deep brain stimulation
355629|NCT02071134|Parkinson's disease|parkinson's disease
355630|NCT02071134|Vercise|vercise
355631|NCT02071121|BIIB061|biib061
355632|NCT02071121|Healthy|healthy
355633|NCT02071095|Human immunodeficiency virus 1|human immunodeficiency virus 1
355634|NCT02071095|Combined Antiretroviral Therapy|combined antiretroviral therapy
355635|NCT02071095|Poly-ICLC|poly-iclc
355636|NCT02071095|Adjuvant|adjuvant
355637|NCT02071082|HIV|hiv
355638|NCT02071082|HBV|hbv
355639|NCT02071082|Coinfection|coinfection
355640|NCT02071069|Incurable colorectal cancer|incurable colorectal cancer
355641|NCT02071069|maintenance therapy|maintenance therapy
355642|NCT02071069|Cetuximab|cetuximab
355643|NCT02071043|neo-adjuvant chemotherapy|neo-adjuvant chemotherapy
355644|NCT02071043|advanced gastric cancer patients|advanced gastric cancer patients
355645|NCT02071043|para-aortic lymph node metastasis|para-aortic lymph node metastasis
355646|NCT02071030|CBCT|cbct
355647|NCT02071030|Third molar removal|third molar removal
355648|NCT02071030|Inferior alveolar nerve injury|inferior alveolar nerve injury
355649|NCT02071004|acute ischemic stroke|acute ischemic stroke
355650|NCT02070991|pre- and post-capillary pulmonary hypertension|pre- and post-capillary pulmonary hypertension
355651|NCT02070991|CpcPH|cpcph
355652|NCT02070978|Lupus Erythematosus, Systemic|lupus erythematosus, systemic
355653|NCT02070978|Atacicept 75 and 150 mg|atacicept 75 and 150 mg
355654|NCT02070978|LTE|lte
355655|NCT02070952|CyberKnife|cyberknife
355656|NCT02070952|Stereotactic Body Radiation Therapy|stereotactic body radiation therapy
355657|NCT02070952|Low and Intermediate Risk Prostate Cancer|low and intermediate risk prostate cancer
355658|NCT02070939|Phase 1|phase 1
355659|NCT02070939|Randomized|randomized
355660|NCT02070939|Double Blind|double blind
355661|NCT02070939|Placebo-Controlled|placebo-controlled
355662|NCT02070939|Single and Multiple Dose Escalation|single and multiple dose escalation
355663|NCT02070939|Safety Tolerability|safety tolerability
355664|NCT02070939|PK|pk
355665|NCT02070939|PD|pd
355666|NCT02070939|PF-06460414|pf-06460414
355668|NCT02070913|Acute Myocardial Infarction|acute myocardial infarction
355669|NCT02070913|Percutaneous Coronary Intervention|percutaneous coronary intervention
355670|NCT02070913|AMI|ami
355671|NCT02070913|PCI|pci
355672|NCT02070913|Therapeutic Hypothermia|therapeutic hypothermia
355673|NCT02070900|Prevention of Mother to Child Transmission|prevention of mother to child transmission
355674|NCT02070900|PMTCT|pmtct
355675|NCT02070900|Option B+|option b+
355676|NCT02070900|ART|art
355677|NCT02070900|Retention|retention
355678|NCT02070900|Loss to Follow Up|loss to follow up
355679|NCT02070900|Time to initiation|time to initiation
355680|NCT02070900|POC CD4|poc cd4
355681|NCT02070900|Clinical mentoring|clinical mentoring
355682|NCT02070900|Costing|costing
355683|NCT02070900|HIV|hiv
355684|NCT02070900|AIDS|aids
355685|NCT02070900|Zimbabwe|zimbabwe
355686|NCT02070874|pain and symptom management|pain and symptom management
355687|NCT02070861|Cardiac output|cardiac output
355688|NCT02070861|Exhaled CO2|exhaled co2
355689|NCT02070861|Nexfin|nexfin
355690|NCT02070861|Esophageal Doppler|esophageal doppler
355691|NCT02070848|red blood cell|red blood cell
355692|NCT02070848|knee extension exercise|knee extension exercise
355693|NCT02070835|Diabetic Foot Ulcer|diabetic foot ulcer
355694|NCT02070835|ReCell|recell
355695|NCT02070822|Hepatocellular carcinoma|hepatocellular carcinoma
355696|NCT02070822|Transarterial chemoembolization|transarterial chemoembolization
355697|NCT02070822|Magnetic resonance imaging|magnetic resonance imaging
355698|NCT02070809|wound|wound
355699|NCT02070809|tissue-engineered skin|tissue-engineered skin
355700|NCT02070796|Rotigotine|rotigotine
355701|NCT02070796|Transdermal Patch|transdermal patch
355702|NCT02070796|Bioequivalence|bioequivalence
355703|NCT02070783|depression|depression
355704|NCT02070783|cognition|cognition
355705|NCT02070783|emotion perception|emotion perception
355706|NCT02070783|information processing|information processing
355707|NCT02070744|CF|cf
355708|NCT02070731|TAVR|tavr
355709|NCT02070731|TAVI|tavi
355710|NCT02070731|Aortic Valve Stenosis|aortic valve stenosis
355711|NCT02070718|hot flashes|hot flashes
355712|NCT02070718|menopause|menopause
355713|NCT02070718|kappa agonist|kappa agonist
355714|NCT02070692|Contraceptive implant|contraceptive implant
355715|NCT02070692|Irregular vaginal bleeding|irregular vaginal bleeding
355716|NCT02070692|Etonogestrel implant|etonogestrel implant
355717|NCT02070679|Alpha-tocopherol|alpha-tocopherol
355718|NCT02070679|Vitamin E|vitamin e
355719|NCT02070679|Contrast-Induced Acute Kidney Injury|contrast-induced acute kidney injury
355720|NCT02070679|Coronary angiography|coronary angiography
355721|NCT02070666|ARDS|ards
355722|NCT02070666|Prevention|prevention
355723|NCT02070666|Protective mechanical ventilation|protective mechanical ventilation
355724|NCT02070666|low tidal volumes|low tidal volumes
355725|NCT02070653|Aorta|aorta
355726|NCT02070653|Aneurysm|aneurysm
355727|NCT02070653|Antiplatelet|antiplatelet
355728|NCT02070640|cholecystectomy|cholecystectomy
355729|NCT02070640|cholecystitis|cholecystitis
355730|NCT02070627|acute cholecystitis|acute cholecystitis
355731|NCT02070627|acute cholangitis|acute cholangitis
355732|NCT02070627|cholecystectomy|cholecystectomy
355733|NCT02070614|sufentanil|sufentanil
355734|NCT02070614|metabolism|metabolism
355735|NCT02070614|cytochrome P450 3A4|cytochrome p450 3a4
355736|NCT02070614|gene polymorphism|gene polymorphism
355737|NCT02070588|TBI|tbi
355738|NCT02070588|mTBI|mtbi
355739|NCT02070588|MR|mr
355740|NCT02070588|MRI|mri
355741|NCT02070588|Pulse Sequences|pulse sequences
355742|NCT02070588|NFL|nfl
355743|NCT02070575|PSA|psa
355744|NCT02070575|Human Kallikrein 2|human kallikrein 2
355745|NCT02070575|locally resected prostate cancer|locally resected prostate cancer
355746|NCT02070575|biochemical recurrence|biochemical recurrence
355747|NCT02070575|14-041|14-041
355748|NCT02070562|breast milk, dietary survey|breast milk, dietary survey
355749|NCT02070536|Acute Respiratory Distress Syndrome (ARDS)|acute respiratory distress syndrome (ards)
355750|NCT02070536|Receptor for advanced glycation end products (RAGE)|receptor for advanced glycation end products (rage)
355751|NCT02070536|Soluble RAGE (sRAGE)|soluble rage (srage)
355752|NCT02070536|Gene polymorphisms|gene polymorphisms
355753|NCT02070536|Biomarker|biomarker
355755|NCT02070484|Lumbar Spine|lumbar spine
355756|NCT02070484|Degenerative Disease|degenerative disease
355757|NCT02070484|Efficacy|efficacy
355758|NCT02070484|Fusion|fusion
355759|NCT02070445|CABG|cabg
355760|NCT02070445|pilot|pilot
355761|NCT02070445|ultrasound|ultrasound
355762|NCT02070445|perioperative|perioperative
355763|NCT02070445|low tidal volume ventilation|low tidal volume ventilation
355764|NCT02070432|LUZ11|luz11
355765|NCT02070432|head and neck cancer|head and neck cancer
355766|NCT02070432|photodynamic therapy|photodynamic therapy
355767|NCT02070432|Redaporfin|redaporfin
355768|NCT02070393|Hodgkins Disease in Young Females|hodgkins disease in young females
355769|NCT02070393|Breast Sparing Radiation Treatments|breast sparing radiation treatments
355770|NCT02070380|confirmed brain disease|confirmed brain disease
356069|NCT02069028|mortality|mortality
355771|NCT02070380|highly suspected brain disease|highly suspected brain disease
355772|NCT02070367|allodynia|allodynia
355773|NCT02070367|complex regional pain syndrome|complex regional pain syndrome
355774|NCT02070367|peripheral nerve injuries|peripheral nerve injuries
355775|NCT02070367|clinical measurement properties|clinical measurement properties
355776|NCT02070354|Obesity|obesity
355777|NCT02070354|Bariatric surgery|bariatric surgery
355778|NCT02070354|Physical Activity|physical activity
355779|NCT02070354|Nutrition|nutrition
355780|NCT02070354|Weight Loss|weight loss
355781|NCT02070341|patient tolerability|patient tolerability
355782|NCT02070341|quality|quality
355783|NCT02070328|Proton Therapy|proton therapy
355784|NCT02070328|Registry|registry
355785|NCT02070315|heart failure|heart failure
355786|NCT02070315|liver failure|liver failure
355787|NCT02070315|post liver transplant|post liver transplant
355788|NCT02070289|Multiple dose|multiple dose
355789|NCT02070289|safety|safety
355790|NCT02070289|tolerability|tolerability
355791|NCT02070289|PK|pk
355792|NCT02070276|Spinal anesthesia|spinal anesthesia
355793|NCT02070276|Systemic hypotension|systemic hypotension
355794|NCT02070276|Total fluid amount|total fluid amount
355795|NCT02070276|Non-invasive fluid responsiveness|non-invasive fluid responsiveness
355796|NCT02070276|Passive Leg Raising Test|passive leg raising test
355797|NCT02070263|Food allergy|food allergy
355798|NCT02070263|Tree nuts|tree nuts
355799|NCT02070250|Stress management|stress management
355800|NCT02070250|Coping skills|coping skills
355801|NCT02070250|Recently diagnosed cancer patients|recently diagnosed cancer patients
355802|NCT02070250|Intervention, Psychological|intervention, psychological
355803|NCT02070237|Obesity|obesity
355804|NCT02070237|Obesity, Morbid|obesity, morbid
355805|NCT02070237|Pregnancy|pregnancy
355806|NCT02070237|Cesarean|cesarean
355807|NCT02070237|Venous thromboembolism|venous thromboembolism
355808|NCT02070237|Deep venous thrombosis|deep venous thrombosis
355809|NCT02070237|Pulmonary embolism|pulmonary embolism
355810|NCT02070211|Psychotic Disorder|psychotic disorder
355811|NCT02070211|22q11 Deletion Syndrome|22q11 deletion syndrome
355812|NCT02070211|Fatty Acids, Omega-3|fatty acids, omega-3
355813|NCT02070198|Poor responders, IVF, GnRH agonist, GnRH antagonist, recombinant FSH|poor responders, ivf, gnrh agonist, gnrh antagonist, recombinant fsh
355814|NCT02070185|caloric adjustment,liking, flavour nutrient learning, children|caloric adjustment,liking, flavour nutrient learning, children
355815|NCT02070172|headache diagnosis|headache diagnosis
355816|NCT02070172|flexion rotation test|flexion rotation test
355817|NCT02070172|range of motion|range of motion
355818|NCT02070172|upper cervical|upper cervical
355819|NCT02070159|coronary artery disease|coronary artery disease
355820|NCT02070159|prasugrel|prasugrel
355821|NCT02070159|platelet function tests|platelet function tests
355822|NCT02070133|Chronic Bronchitis|chronic bronchitis
355823|NCT02070133|Statins|statins
355824|NCT02070133|Endothelial dysfunction|endothelial dysfunction
355825|NCT02070133|Systemic inflammation|systemic inflammation
355826|NCT02070133|BODE index|bode index
355827|NCT02070133|Uric acid|uric acid
355828|NCT02070133|Vascular growth factors|vascular growth factors
355829|NCT02070120|Nonmuscle invasive bladder cancer (NMIBC)|nonmuscle invasive bladder cancer (nmibc)
355830|NCT02070120|Mitomycin C|mitomycin c
355831|NCT02070120|Chemoresection|chemoresection
355832|NCT02070081|Obesity|obesity
355833|NCT02070081|Bariatric surgery|bariatric surgery
355834|NCT02070055|Maximal Rate of Fat Oxidation|maximal rate of fat oxidation
355835|NCT02070055|Substrate Oxidation|substrate oxidation
355836|NCT02070055|Fat oxidation|fat oxidation
355837|NCT02070055|Respiratory Exchange Ratio (RER)|respiratory exchange ratio (rer)
355838|NCT02070055|Exercise|exercise
355839|NCT02070055|indirect calorimetry|indirect calorimetry
355840|NCT02070055|substrate crossover|substrate crossover
355841|NCT02070042|Overactive Bladder|overactive bladder
355842|NCT02070042|Oxybutynin|oxybutynin
355843|NCT02070042|Omega -3 Fatty Acid|omega -3 fatty acid
355844|NCT02070029|Female Sexual Dysfunction (FSD)|female sexual dysfunction (fsd)
355845|NCT02070029|Hypoactive Sexual Desire Disorder (HSDD)|hypoactive sexual desire disorder (hsdd)
355846|NCT02070029|Low libido|low libido
355847|NCT02070029|Acupuncture|acupuncture
355848|NCT02069977|Autism|autism
355849|NCT02069977|Aripiprazole|aripiprazole
355850|NCT02069977|Abilify|abilify
355851|NCT02069951|Laparoscopy|laparoscopy
355852|NCT02069951|Training|training
355853|NCT02069951|Simulator|simulator
355854|NCT02069938|Subjects|subjects
355855|NCT02069912|Major Depression|major depression
355856|NCT02069912|Heart Disease|heart disease
355857|NCT02069912|Hispanics|hispanics
355858|NCT02069912|Collaborative Depression Care Management|collaborative depression care management
355859|NCT02069899|Hemophagocytic lymphohistiocytosis (HLH) previously treated with NI-0501|hemophagocytic lymphohistiocytosis (hlh) previously treated with ni-0501
355860|NCT02069899|Emapalumab|emapalumab
355861|NCT02069886|Endocrine complications|endocrine complications
355862|NCT02069886|transfusion dependent thalassemia|transfusion dependent thalassemia
355863|NCT02069873|Post Traumatic Stress Disorder|post traumatic stress disorder
355864|NCT02069873|Group|group
355865|NCT02069873|Treatment|treatment
355866|NCT02069873|Cognitive, Exposure, Skills|cognitive, exposure, skills
355867|NCT02069873|Women|women
355868|NCT02069873|Veterans|veterans
355869|NCT02069860|Bone Anchored Port|bone anchored port
355870|NCT02069860|Haemodialysis|haemodialysis
355871|NCT02069860|Mastoid bone|mastoid bone
355872|NCT02069860|Nephrology|nephrology
355873|NCT02069860|Retroauricular anchored devices|retroauricular anchored devices
355874|NCT02069860|Permanent central venous vascular access|permanent central venous vascular access
355875|NCT02069860|Hemodialysis|hemodialysis
355876|NCT02069860|Vascular Access for Haemodialysis|vascular access for haemodialysis
355877|NCT02069847|Esophageal stricture formation|esophageal stricture formation
355878|NCT02069847|Endoscopic mucosal resection|endoscopic mucosal resection
355879|NCT02069847|Endoscopic submucosal dissection|endoscopic submucosal dissection
355880|NCT02069847|Budesonide|budesonide
355881|NCT02069847|Radical endoscopic mucosal resection|radical endoscopic mucosal resection
355882|NCT02069847|EMR|emr
355883|NCT02069847|ESD|esd
355884|NCT02069834|Dolutegravir|dolutegravir
355885|NCT02069834|Rilpivirine|rilpivirine
355886|NCT02069834|PI- and NRTI- sparing ART regimen|pi- and nrti- sparing art regimen
355887|NCT02069834|switch study|switch study
355888|NCT02069795|concussion, athlete, speech analysis|concussion, athlete, speech analysis
355889|NCT02069782|Pregnancy|pregnancy
355890|NCT02069782|postpartum programs|postpartum programs
355891|NCT02069782|infant health services|infant health services
355892|NCT02069769|Hospice Care|hospice care
355893|NCT02069769|Head and Neck cancer|head and neck cancer
355894|NCT02069769|Gynecological Oncology|gynecological oncology
355895|NCT02069769|Sarcoma|sarcoma
355896|NCT02069769|Melanoma|melanoma
355897|NCT02069756|Duchenne|duchenne
355898|NCT02069756|Becker|becker
355899|NCT02069756|Muscular Dystrophy|muscular dystrophy
355900|NCT02069743|cancer pain|cancer pain
355901|NCT02069730|molecular profiling|molecular profiling
355902|NCT02069730|selinexor|selinexor
355903|NCT02069730|tumor tissue|tumor tissue
355904|NCT02069704|colorectal cancer|colorectal cancer
355905|NCT02069704|metastatic|metastatic
355906|NCT02069704|first-line treatment|first-line treatment
355907|NCT02069704|comparability|comparability
355908|NCT02069691|stroke,|stroke,
355909|NCT02069691|rehabilitation,|rehabilitation,
355910|NCT02069691|leg cycling,|leg cycling,
355911|NCT02069691|feedback,|feedback,
355912|NCT02069691|virtual reality|virtual reality
355913|NCT02069665|pneumonia|pneumonia
355914|NCT02069665|pediatrics|pediatrics
355915|NCT02069665|viral|viral
355916|NCT02069613|Mild traumatic injury to extremity (for controls)|mild traumatic injury to extremity (for controls)
355917|NCT02069613|mTBI|mtbi
355918|NCT02069613|concussion|concussion
355919|NCT02069613|MEG|meg
355920|NCT02069613|EEG|eeg
355921|NCT02069613|Blood|blood
355922|NCT02069613|MRI|mri
355923|NCT02069613|DTI|dti
355924|NCT02069613|biomarkers|biomarkers
355925|NCT02069600|Elderly|elderly
355926|NCT02069600|CPAP|cpap
355927|NCT02069600|clinical trial|clinical trial
355928|NCT02069600|obstructive sleep apnea|obstructive sleep apnea
355929|NCT02069587|PPROM|pprom
355930|NCT02069587|PREGNANCY|pregnancy
355931|NCT02069587|POMEGRANATE|pomegranate
355932|NCT02069587|OXIDATIVE STRESS|oxidative stress
355933|NCT02069535|Cupressus arizonica|cupressus arizonica
355934|NCT02069509|Friedreich's Ataxia|friedreich's ataxia
355935|NCT02069509|EFACTS|efacts
355936|NCT02069509|FRDA|frda
355937|NCT02069483|smoking|smoking
355938|NCT02069483|smoker|smoker
355939|NCT02069483|text|text
355940|NCT02069483|smartphone|smartphone
355941|NCT02069483|motivation|motivation
355942|NCT02069483|quitting|quitting
355943|NCT02069483|cessation|cessation
355944|NCT02069483|feedback|feedback
355945|NCT02069483|messages|messages
355946|NCT02069470|Stepped wedged design|stepped wedged design
355947|NCT02069470|Early cancer diagnosis|early cancer diagnosis
355948|NCT02069470|Continuing medical education|continuing medical education
355949|NCT02069431|inflammation|inflammation
355950|NCT02069431|physical function|physical function
355951|NCT02069431|cognitive function|cognitive function
355952|NCT02069392|schizophrenia|schizophrenia
355953|NCT02069392|cognition|cognition
355954|NCT02069392|cognitive remediation|cognitive remediation
355955|NCT02069392|nicotine|nicotine
355956|NCT02069379|Metabolic syndrome|metabolic syndrome
355957|NCT02069379|Insulin resistance|insulin resistance
355958|NCT02069379|Mu-opioid system|mu-opioid system
355959|NCT02069379|Depression|depression
355960|NCT02069379|Emotion regulation|emotion regulation
355961|NCT02069366|Post-Traumatic Stress Disorders|post-traumatic stress disorders
355962|NCT02069366|Dronabinol|dronabinol
355963|NCT02069366|Extinction|extinction
355964|NCT02069366|fMRI|fmri
355965|NCT02069353|Cardiac arrest|cardiac arrest
455221|NCT01618994|EBL|ebl
355966|NCT02069353|Neurological injury|neurological injury
355967|NCT02069353|Seizures|seizures
355968|NCT02069353|Spreading depolarizations|spreading depolarizations
355969|NCT02069353|Cerebral hypoperfusion|cerebral hypoperfusion
356070|NCT02069028|compliance|compliance
355970|NCT02069353|Brain tissue hypoxia|brain tissue hypoxia
355971|NCT02069327|Femur|femur
355972|NCT02069327|Fat|fat
355973|NCT02069327|Emboli|emboli
355974|NCT02069327|Bone|bone
355975|NCT02069327|Marrow|marrow
355976|NCT02069327|proteomic|proteomic
355977|NCT02069327|proteomics|proteomics
355978|NCT02069327|metabolomics|metabolomics
355979|NCT02069327|metabolomic|metabolomic
355980|NCT02069327|inflammatory|inflammatory
355981|NCT02069327|cytokine|cytokine
355982|NCT02069327|chemokine|chemokine
355983|NCT02069327|anaphlylatoxin|anaphlylatoxin
355984|NCT02069327|Thromboelastography|thromboelastography
355985|NCT02069327|Medical Center of the Rockies|medical center of the rockies
355986|NCT02069327|Fat Embolism Syndrome|fat embolism syndrome
355987|NCT02069327|Injury|injury
355988|NCT02069327|Fracture|fracture
355989|NCT02069327|Metabolite|metabolite
355990|NCT02069327|MCR|mcr
355991|NCT02069327|TEG|teg
355992|NCT02069327|FES|fes
355993|NCT02069301|Behavior Activation|behavior activation
355994|NCT02069301|Problem solving therapy|problem solving therapy
355995|NCT02069301|Depression Treatment|depression treatment
355996|NCT02069301|depression care integration|depression care integration
355997|NCT02069301|microfinance|microfinance
355998|NCT02069301|livelihood|livelihood
355999|NCT02069288|fludrocortisone|fludrocortisone
356000|NCT02069288|pharmacology|pharmacology
356001|NCT02069288|septic shock|septic shock
356002|NCT02069275|Immediate mobilization|immediate mobilization
356003|NCT02069275|Bedrest|bedrest
356004|NCT02069275|Coronary angiography|coronary angiography
356005|NCT02069275|Coronary percutaneous intervention|coronary percutaneous intervention
356130|NCT02068755|Coronary bypass|coronary bypass
356006|NCT02069275|Vascular access complications|vascular access complications
356007|NCT02069275|Patients comfort|patients comfort
356008|NCT02069262|obscure gastrointestinal bleeding|obscure gastrointestinal bleeding
356009|NCT02069262|laparoscopy|laparoscopy
356010|NCT02069262|angiography|angiography
356011|NCT02069249|Preschool children|preschool children
356012|NCT02069249|Sleep problems|sleep problems
356013|NCT02069249|Nutrition problems|nutrition problems
356014|NCT02069249|Online intervention|online intervention
356015|NCT02069249|Psychological functioning|psychological functioning
356016|NCT02069236|Glucose-6 phosphate dehydrogenase deficiency|glucose-6 phosphate dehydrogenase deficiency
356017|NCT02069236|capillary|capillary
356018|NCT02069236|venous|venous
356019|NCT02069236|genotype phenotype correlation|genotype phenotype correlation
356020|NCT02069223|Biliopancreatic Diversion with Duodenal Switch|biliopancreatic diversion with duodenal switch
356021|NCT02069223|Gastrectomy|gastrectomy
356022|NCT02069197|ketogenic diet|ketogenic diet
356023|NCT02069197|obesity|obesity
356024|NCT02069197|diabetes|diabetes
356025|NCT02069197|obstructive sleep apnea|obstructive sleep apnea
356026|NCT02069184|opioid usage requirements|opioid usage requirements
356027|NCT02069184|pain|pain
356028|NCT02069184|IV acetaminophen|iv acetaminophen
356029|NCT02069184|opioid usage|opioid usage
356030|NCT02069184|c-section|c-section
356031|NCT02069171|Lower extremity edema|lower extremity edema
356032|NCT02069171|Lower leg lymphedema|lower leg lymphedema
356033|NCT02069171|Lower leg edema|lower leg edema
356034|NCT02069171|Lymphedema|lymphedema
356035|NCT02069171|Pelvic lymph node dissection|pelvic lymph node dissection
356036|NCT02069171|Gynecologic Cancer Lymphedema Questionnaire|gynecologic cancer lymphedema questionnaire
356037|NCT02069158|Advanced solid tumor|advanced solid tumor
356038|NCT02069145|Hepatocellular Cancer|hepatocellular cancer
356039|NCT02069145|Liver Cancer|liver cancer
356040|NCT02069132|Warfarin|warfarin
356041|NCT02069132|International Warfarin Pharmacogenetics Consortium algorithm|international warfarin pharmacogenetics consortium algorithm
356042|NCT02069132|Atrial Fibrillation|atrial fibrillation
356043|NCT02069132|Heart Valve Prosthesis Implantation|heart valve prosthesis implantation
356044|NCT02069132|elderly|elderly
356045|NCT02069132|comorbidity|comorbidity
356046|NCT02069106|low density lipoprotein cholesterol|low density lipoprotein cholesterol
356047|NCT02069106|triglycerides|triglycerides
356048|NCT02069106|mixed hyperlipoproteinemia|mixed hyperlipoproteinemia
356049|NCT02069106|Dehydroascorbic Acid|dehydroascorbic acid
356050|NCT02069106|Eicosapentaenoic Acid|eicosapentaenoic acid
356051|NCT02069106|Fish oil|fish oil
356052|NCT02069080|Positron Emission Tomograhy|positron emission tomograhy
356053|NCT02069080|Metastasis|metastasis
356054|NCT02069067|breakthrough cancer pain|breakthrough cancer pain
356055|NCT02069067|pain|pain
356056|NCT02069067|neuropathic pain|neuropathic pain
356057|NCT02069067|intractable pain|intractable pain
356058|NCT02069067|cancer|cancer
356059|NCT02069054|asthma|asthma
356060|NCT02069054|COPD|copd
356061|NCT02069054|airway inflammation|airway inflammation
356062|NCT02069054|remodeling|remodeling
356063|NCT02069054|cytokines|cytokines
356064|NCT02069054|airway wall thickness|airway wall thickness
356065|NCT02069028|surviving sepsis campaign|surviving sepsis campaign
356066|NCT02069028|sepsis|sepsis
356067|NCT02069028|septic|septic
356068|NCT02069028|septicemia|septicemia
356071|NCT02069015|Patient education|patient education
356072|NCT02069015|Hypertension|hypertension
356073|NCT02069015|Patient activation|patient activation
356074|NCT02069002|Indoor Air|indoor air
356075|NCT02069002|Medically unexplained symptoms|medically unexplained symptoms
356076|NCT02069002|Randomized controlled trial|randomized controlled trial
356077|NCT02069002|Cognitive-Behavioral Therapy|cognitive-behavioral therapy
356078|NCT02069002|Applied relaxation|applied relaxation
356079|NCT02068950|Head and neck cancer|head and neck cancer
356080|NCT02068950|Concurrent chemoradiotherapy|concurrent chemoradiotherapy
356081|NCT02068950|Progressive resistance training|progressive resistance training
356082|NCT02068950|Exercise|exercise
356083|NCT02068950|Feasibility|feasibility
356084|NCT02068950|Weight loss|weight loss
356085|NCT02068950|LBM|lbm
356086|NCT02068950|Body composition|body composition
356087|NCT02068937|Heart Failure|heart failure
356088|NCT02068937|Therapy|therapy
356089|NCT02068937|Diuretics|diuretics
356090|NCT02068937|Algorithms|algorithms
356091|NCT02068924|Slow freezing|slow freezing
356092|NCT02068924|Vitrification|vitrification
356093|NCT02068924|Single embryo transfer|single embryo transfer
356094|NCT02068911|Neuromuscular disease|neuromuscular disease
356095|NCT02068911|Home ventilation|home ventilation
356096|NCT02068911|End tidal CO2|end tidal co2
356097|NCT02068911|Transcutaneous CO2|transcutaneous co2
356098|NCT02068911|Monitoring|monitoring
356099|NCT02068885|Low carbohydrate diet|low carbohydrate diet
356100|NCT02068885|Low fat diet|low fat diet
356101|NCT02068885|Glycemic index|glycemic index
356102|NCT02068885|Weight loss maintenance|weight loss maintenance
356103|NCT02068872|Obesity|obesity
356104|NCT02068872|Transplant|transplant
356105|NCT02068872|Sleeve Gastrectomy|sleeve gastrectomy
356106|NCT02068872|Liver Transplantation|liver transplantation
356107|NCT02068872|Weight Loss|weight loss
356108|NCT02068846|HIV|hiv
356109|NCT02068846|Salivary Gland Disease|salivary gland disease
356110|NCT02068846|Benign Lymphoepithelial Lesion|benign lymphoepithelial lesion
356111|NCT02068846|BK Polyomavirus|bk polyomavirus
356112|NCT02068833|Microalbuminuria|microalbuminuria
356113|NCT02068833|Gastrectomy|gastrectomy
356114|NCT02068833|Biliopancreatic Diversion With Duodenal Switch|biliopancreatic diversion with duodenal switch
356115|NCT02068820|Sentinel lymph nodes|sentinel lymph nodes
356116|NCT02068820|da Vinci|da vinci
356117|NCT02068820|Firefly|firefly
356118|NCT02068820|Sentinel lymph node mapping|sentinel lymph node mapping
356119|NCT02068820|Fluorescence Imaging|fluorescence imaging
356120|NCT02068820|SLN|sln
356121|NCT02068820|SLN mapping|sln mapping
356122|NCT02068768|fusion|fusion
356123|NCT02068768|lateral interbody fusion system|lateral interbody fusion system
356124|NCT02068768|lumbar spine|lumbar spine
356125|NCT02068768|degenerative disc disease|degenerative disc disease
356126|NCT02068755|anemia|anemia
356127|NCT02068755|renal impairment|renal impairment
356128|NCT02068755|thrombocytopenia|thrombocytopenia
356129|NCT02068755|anticoagulation|anticoagulation
356131|NCT02068755|Aortic valve surgery|aortic valve surgery
356132|NCT02068755|Mitral valve surgery|mitral valve surgery
356133|NCT02068755|red blood cell|red blood cell
356134|NCT02068755|platelet|platelet
356135|NCT02068755|fresh frozen plasma|fresh frozen plasma
356136|NCT02068755|octaplas|octaplas
356137|NCT02068742|post-operative cognitive dysfunction|post-operative cognitive dysfunction
356138|NCT02068742|elderly|elderly
356139|NCT02068742|Mini Mental State Examination|mini mental state examination
356140|NCT02068742|Geriatric Index of Comorbidity|geriatric index of comorbidity
356141|NCT02068742|Geriatric Depression Scale|geriatric depression scale
356142|NCT02068742|Trail Making Test B-A|trail making test b-a
356143|NCT02068742|Digit Span|digit span
356144|NCT02068742|Digit Symbol Substitution Test|digit symbol substitution test
356145|NCT02068729|degenerative disc disease|degenerative disc disease
356146|NCT02068729|DDD|ddd
356147|NCT02068729|Grade 1 spondylolisthesis|grade 1 spondylolisthesis
356148|NCT02068729|spondylolisthesis|spondylolisthesis
356149|NCT02068729|L2-S1|l2-s1
356150|NCT02068716|Healthcare acquired infections|healthcare acquired infections
356151|NCT02068716|Cardiovascular Surgery|cardiovascular surgery
356152|NCT02068716|Mediastinitis|mediastinitis
356153|NCT02068716|Thoracotomy|thoracotomy
356154|NCT02068716|Conduit harvest or cannulation site|conduit harvest or cannulation site
356155|NCT02068703|survey|survey
356156|NCT02068664|spatial neglect|spatial neglect
356157|NCT02068664|aphasia|aphasia
356158|NCT02068651|End-of-life care|end-of-life care
356159|NCT02068651|Treatment decision making|treatment decision making
356160|NCT02068651|Advance care planning|advance care planning
356161|NCT02068638|exercise|exercise
356162|NCT02068638|isotope labeling, stable|isotope labeling, stable
356163|NCT02068638|spectroscopy, magnetic resonance|spectroscopy, magnetic resonance
356164|NCT02068638|monitoring, home blood glucose|monitoring, home blood glucose
356165|NCT02068638|hormones|hormones
356166|NCT02068625|retinal detachment|retinal detachment
356167|NCT02068625|rasagiline|rasagiline
356168|NCT02068625|optical coherence tomography|optical coherence tomography
356169|NCT02068625|visual acuity|visual acuity
356170|NCT02068625|neuroprotection|neuroprotection
356172|NCT02068612|Executive function,|executive function,
356173|NCT02068612|cardiovascular fitness,|cardiovascular fitness,
356174|NCT02068612|cognitive function|cognitive function
356175|NCT02068599|Osteoarthritis|osteoarthritis
356176|NCT02068599|OA|oa
356177|NCT02068599|Arthritis pain|arthritis pain
356178|NCT02068573|Childhood Asthma|childhood asthma
356179|NCT02068573|Allergy|allergy
356180|NCT02068573|House dust mites|house dust mites
356181|NCT02068573|Indoor air quality|indoor air quality
356182|NCT02068547|posterior cervical fusion|posterior cervical fusion
356183|NCT02068547|posterior cervical decompression|posterior cervical decompression
356184|NCT02068534|in-depth individual interview|in-depth individual interview
356185|NCT02068534|charcoal-burning suicide|charcoal-burning suicide
356186|NCT02068521|Growth Hormone Deficiency|growth hormone deficiency
356187|NCT02068521|Pediatric Growth Hormone Deficiency|pediatric growth hormone deficiency
356188|NCT02068521|GHD|ghd
356189|NCT02068521|PGHD|pghd
356190|NCT02068521|VRS-317|vrs-317
356191|NCT02068521|Versartis|versartis
356192|NCT02068521|Growth disorder|growth disorder
356193|NCT02068521|Long acting growth hormone|long acting growth hormone
356194|NCT02068521|Growth hormone|growth hormone
356195|NCT02068521|Weekly growth hormone dosing|weekly growth hormone dosing
356196|NCT02068521|Semi-monthly growth hormone dosing|semi-monthly growth hormone dosing
356197|NCT02068521|Monthly growth hormone dosing|monthly growth hormone dosing
356198|NCT02068521|IGF-I|igf-i
356199|NCT02068521|Short stature|short stature
356200|NCT02068521|Height velocity|height velocity
356201|NCT02068521|Annual height velocity|annual height velocity
356202|NCT02068521|Growth rate|growth rate
356203|NCT02068521|Somavaratan|somavaratan
356204|NCT02068508|Drug therapy|drug therapy
356205|NCT02068495|Drug therapy|drug therapy
356206|NCT02068482|Uncomplicated|uncomplicated
356207|NCT02068482|Symptomatic|symptomatic
356208|NCT02068456|Drug therapy|drug therapy
356209|NCT02068443|Drug therapy|drug therapy
356210|NCT02068430|Corneal Ulcers|corneal ulcers
356211|NCT02068430|cross-linking|cross-linking
356212|NCT02068430|UVA|uva
356213|NCT02068430|Riboflavin|riboflavin
356214|NCT02068417|IIEF score|iief score
356215|NCT02068417|ED|ed
356216|NCT02068404|Tocolysis|tocolysis
356217|NCT02068404|Preterm labor|preterm labor
356218|NCT02068404|Nifedipine|nifedipine
356219|NCT02068404|Pharmacokinetics|pharmacokinetics
356220|NCT02068391|covert stroke|covert stroke
356221|NCT02068391|cerebral blood flow|cerebral blood flow
356222|NCT02068391|grey matter|grey matter
356223|NCT02068391|attention|attention
356224|NCT02068391|executive function|executive function
356225|NCT02068391|aerobic exercise|aerobic exercise
356226|NCT02068352|Atopic Dermatitis, Eczema|atopic dermatitis, eczema
356227|NCT02068326|Mentalization-based Treatment|mentalization-based treatment
356228|NCT02068326|Adolescence|adolescence
356229|NCT02068326|Borderline Personality Disorder|borderline personality disorder
356230|NCT02068300|1,5-anhydro-D-glucitol, hypoglycemia, surrogate marker|1,5-anhydro-d-glucitol, hypoglycemia, surrogate marker
356231|NCT02068287|Septic Shock|septic shock
356232|NCT02068287|Hemodynamic|hemodynamic
356233|NCT02068287|Inflammatory status|inflammatory status
356234|NCT02068287|Beta adrenergic modulation|beta adrenergic modulation
356235|NCT02068287|Esmolol|esmolol
356236|NCT02068235|Ponesimod|ponesimod
356237|NCT02068235|Bioavailability|bioavailability
356238|NCT02068235|Pharmacokinetics|pharmacokinetics
356239|NCT02068235|Safety|safety
356240|NCT02068222|Hepatitis C|hepatitis c
356241|NCT02068222|HCV|hcv
356242|NCT02068222|Interferon Free|interferon free
356243|NCT02068222|Chronic Hepatitis C|chronic hepatitis c
356244|NCT02068222|Hepatitis C virus|hepatitis c virus
356245|NCT02068222|Hepatitis C Genotype 3|hepatitis c genotype 3
356246|NCT02068209|Outpatient hysteroscopy|outpatient hysteroscopy
356247|NCT02068209|Tramadol|tramadol
356248|NCT02068196|Cancer|cancer
356249|NCT02068196|Malignant Melanoma|malignant melanoma
356250|NCT02068196|Ipilimumab|ipilimumab
356251|NCT02068183|World Trade Center exposure|world trade center exposure
356252|NCT02068183|cardiovascular risk|cardiovascular risk
356253|NCT02068183|insulin resistance|insulin resistance
356254|NCT02068183|post-traumatic stress|post-traumatic stress
356255|NCT02068183|pulmonary disease|pulmonary disease
356256|NCT02068170|QT-prolongation|qt-prolongation
356257|NCT02068170|Torsade de Pointes|torsade de pointes
356258|NCT02068170|QT-prolonging drugs|qt-prolonging drugs
356259|NCT02068144|Cranberry Extract|cranberry extract
356260|NCT02068131|Metastatic Colorectal Cancer|metastatic colorectal cancer
356261|NCT02068131|Novaferon|novaferon
356262|NCT02068131|Recombinant anti-tumor and anti-virus protein for injection|recombinant anti-tumor and anti-virus protein for injection
356263|NCT02068131|xeloda|xeloda
356264|NCT02068118|E health|e health
356265|NCT02068118|Telecardiology program|telecardiology program
356266|NCT02068118|Heart failure|heart failure
356267|NCT02068105|ALKS 5461|alks 5461
356268|NCT02068105|samidorphan|samidorphan
356269|NCT02068066|Physical work requirements|physical work requirements
356270|NCT02068066|Energy expenditure|energy expenditure
356271|NCT02068066|Physical activity|physical activity
356272|NCT02068066|Different occupational categories|different occupational categories
356273|NCT02068066|Aerobic capacity|aerobic capacity
356274|NCT02068040|with preserved ejection fraction of >55%|with preserved ejection fraction of >55%
356275|NCT02068027|Diabetes Mellitus|diabetes mellitus
356276|NCT02068027|Pain|pain
356277|NCT02068027|Foot pain|foot pain
356278|NCT02068027|Neuropathy|neuropathy
356279|NCT02068014|stapplers- obesity- stomach|stapplers- obesity- stomach
356280|NCT02067988|Radioembolization|radioembolization
356281|NCT02067988|Somatostatin receptor treatment|somatostatin receptor treatment
356282|NCT02067988|Neuroendocrine tumors|neuroendocrine tumors
356283|NCT02067988|Liver metastases|liver metastases
356284|NCT02067975|tryptophan|tryptophan
356285|NCT02067975|kynurenic acid|kynurenic acid
356286|NCT02067975|schizophrenia|schizophrenia
356287|NCT02067962|Juvenile idiopathic arhtritis|juvenile idiopathic arhtritis
356288|NCT02067962|JIA|jia
356289|NCT02067962|Gene identification|gene identification
356290|NCT02067962|Whole exome sequencing|whole exome sequencing
356291|NCT02067962|Next generation sequencing|next generation sequencing
356292|NCT02067962|Identification of molecular basis|identification of molecular basis
356293|NCT02067962|Acceptation of both parents to participate to the study|acceptation of both parents to participate to the study
356294|NCT02067923|T1D|t1d
356295|NCT02067923|type 1 diabetes|type 1 diabetes
356296|NCT02067923|type 1 diabetes mellitus|type 1 diabetes mellitus
356297|NCT02067923|juvenile diabetes|juvenile diabetes
356298|NCT02067923|autoimmune diabetes|autoimmune diabetes
356299|NCT02067923|autoimmune|autoimmune
356300|NCT02067923|anti-CD3 mAb|anti-cd3 mab
356301|NCT02067923|mAb hOKT3g1(Ala-Ala)|mab hokt3g1(ala-ala)
356302|NCT02067923|teplizumab|teplizumab
356303|NCT02067910|Abatacept|abatacept
356304|NCT02067910|Subcutaneous|subcutaneous
356305|NCT02067910|Sjögren's syndrome|sjögren's syndrome
356306|NCT02067910|Treatment|treatment
356307|NCT02067910|Safety|safety
356308|NCT02067910|Efficacy|efficacy
356309|NCT02067897|Nails, Ingrown|nails, ingrown
356310|NCT02067897|Children|children
356311|NCT02067897|Ambulatory Surgical Procedures|ambulatory surgical procedures
356312|NCT02067871|neuromuscular electrical stimulation|neuromuscular electrical stimulation
356313|NCT02067871|low-level laser therapy|low-level laser therapy
356314|NCT02067871|knee osteoarthritis|knee osteoarthritis
356315|NCT02067871|muscle architecture|muscle architecture
356316|NCT02067871|functionality|functionality
356317|NCT02067871|neuromuscular parameters|neuromuscular parameters
356318|NCT02067845|Lesbian, queer, bisexual women|lesbian, queer, bisexual women
356319|NCT02067845|HIV and STI prevention|hiv and sti prevention
356320|NCT02067845|Resilient coping|resilient coping
356321|NCT02067845|Sexual stigma|sexual stigma
356322|NCT02067845|Depression|depression
356323|NCT02067845|Safer-sex practices|safer-sex practices
356324|NCT02067845|Safer sex self-efficacy|safer sex self-efficacy
356325|NCT02067845|HIV/STI knowledge and testing|hiv/sti knowledge and testing
356326|NCT02067845|Pilot-testing|pilot-testing
356327|NCT02067819|Tourette's|tourette's
356328|NCT02067819|Tic Disorder|tic disorder
356329|NCT02067819|Dental Appliance|dental appliance
356330|NCT02067819|Oral Orthotic|oral orthotic
356331|NCT02067819|Mouthguard|mouthguard
356332|NCT02067806|PASS|pass
356333|NCT02067806|TNS|tns
356334|NCT02067806|CES|ces
356335|NCT02067806|CHLOROPROCAINE|chloroprocaine
356336|NCT02067793|NRX-1074|nrx-1074
356337|NCT02067793|NMDA Receptor Modulator|nmda receptor modulator
356338|NCT02067793|Major Depressive Disorder|major depressive disorder
356339|NCT02067793|Glycine site modulator|glycine site modulator
356340|NCT02067767|HIV-1 infection|hiv-1 infection
356341|NCT02067767|Nevirapine|nevirapine
356342|NCT02067767|Dolutegravir|dolutegravir
356343|NCT02067767|Anti-retroviral agents|anti-retroviral agents
356344|NCT02067754|The mutation profiling of circulating free DNA|the mutation profiling of circulating free dna
356345|NCT02067741|Post-menopausal women|post-menopausal women
356346|NCT02067741|topical application CR1447|topical application cr1447
356347|NCT02067741|endocrine responsive-HER2neg breast cancer|endocrine responsive-her2neg breast cancer
356348|NCT02067741|triple negative-androgen receptor positive breast cancer|triple negative-androgen receptor positive breast cancer
356349|NCT02067728|obesity prevention|obesity prevention
356350|NCT02067715|Tooth Discoloration|tooth discoloration
356351|NCT02067715|Bleaching Agents|bleaching agents
356352|NCT02067715|Tooth Bleaching|tooth bleaching
356353|NCT02067689|Normal cognition in healthy adults|normal cognition in healthy adults
356354|NCT02067689|Cognitive function|cognitive function
356355|NCT02067689|Transcranial direct current stimulation|transcranial direct current stimulation
356356|NCT02067689|Structural Magnetic Resonance Imaging|structural magnetic resonance imaging
356357|NCT02067689|Functional Magnetic Resonance Imaging|functional magnetic resonance imaging
356358|NCT02067676|Campylobacter jejuni|campylobacter jejuni
356359|NCT02067663|Postplacental IUD placement|postplacental iud placement
356360|NCT02067663|LNG-IUS|lng-ius
356361|NCT02067637|cancer therapy, cancer treatment|cancer therapy, cancer treatment
356460|NCT02067039|HIV testing|hiv testing
356362|NCT02067611|Phase 2, Efficacy, Safety, Osteoarthritis|phase 2, efficacy, safety, osteoarthritis
356363|NCT02067598|Scapular exercises|scapular exercises
356364|NCT02067572|oral health|oral health
356365|NCT02067572|mouthwash|mouthwash
356366|NCT02067572|salvia|salvia
356367|NCT02067572|hospice|hospice
356368|NCT02067572|xerostomia|xerostomia
356369|NCT02067572|mouth sores|mouth sores
356370|NCT02067559|Post Traumatic Stress Disorder|post traumatic stress disorder
356371|NCT02067559|PTSD|ptsd
356372|NCT02067559|Intensive Care Unit|intensive care unit
356373|NCT02067559|ICU|icu
356374|NCT02067546|constipation|constipation
356375|NCT02067520|Post C/S pain relief|post c/s pain relief
356376|NCT02067507|Human Papillomavirus|human papillomavirus
356377|NCT02067507|Immunization|immunization
356378|NCT02067507|Oncogenic viruses|oncogenic viruses
356379|NCT02067507|Cervical Cancer|cervical cancer
356380|NCT02067507|Health Disparities|health disparities
356381|NCT02067494|Low Back Pain|low back pain
356382|NCT02067494|Chronic Pain|chronic pain
356383|NCT02067494|Manual Therapy|manual therapy
356384|NCT02067494|Randomized Clinical Trial|randomized clinical trial
356385|NCT02067494|Bandages|bandages
356386|NCT02067481|Breast cancer|breast cancer
356387|NCT02067481|Survivors|survivors
356388|NCT02067481|Weight loss|weight loss
356389|NCT02067481|Diet|diet
356390|NCT02067481|Physical activity|physical activity
356391|NCT02067468|Human Papillomavirus|human papillomavirus
356392|NCT02067468|cervical cancer|cervical cancer
356393|NCT02067468|health services research|health services research
356394|NCT02067468|Colombia|colombia
356395|NCT02067468|Cervical Intraepithelial Neoplasia|cervical intraepithelial neoplasia
356396|NCT02067455|Right ventricular function|right ventricular function
356397|NCT02067455|echocardiography|echocardiography
356398|NCT02067455|left ventricular assist device|left ventricular assist device
356399|NCT02067455|exercise|exercise
356400|NCT02067442|acetaminophen intravenous oral pain scores opioids|acetaminophen intravenous oral pain scores opioids
356401|NCT02067416|neoadjuvant|neoadjuvant
356402|NCT02067416|mammostrat|mammostrat
356403|NCT02067416|TLE3|tle3
356404|NCT02067416|DDR|ddr
356405|NCT02067416|breast cancer|breast cancer
356406|NCT02067403|Pressure-support|pressure-support
356407|NCT02067403|Asynchrony|asynchrony
356408|NCT02067377|GOLD, COPD, cachexia, BMI|gold, copd, cachexia, bmi
356409|NCT02067364|hydrocephalus|hydrocephalus
356410|NCT02067364|CSF shunt|csf shunt
356411|NCT02067299|Depressive Disorder, Major|depressive disorder, major
356412|NCT02067299|Major Depressive Disorder|major depressive disorder
356413|NCT02067299|Insomnia|insomnia
356414|NCT02067299|JNJ-42847922|jnj-42847922
356415|NCT02067299|Placebo|placebo
356416|NCT02067221|percutaneous nephrolithotomy|percutaneous nephrolithotomy
356417|NCT02067221|renal calculi|renal calculi
356418|NCT02067221|ureteroscopy|ureteroscopy
356419|NCT02067208|Osteoarthritis|osteoarthritis
356420|NCT02067208|Cartilage|cartilage
356421|NCT02067208|Musculoskeletal|musculoskeletal
356422|NCT02067208|Biomechanics|biomechanics
356423|NCT02067208|Subtype|subtype
356424|NCT02067208|Footwear|footwear
356425|NCT02067208|Orthotics|orthotics
356426|NCT02067208|Joint Loading|joint loading
356427|NCT02067195|acute myocardial infarction,contrast,coronary intervention|acute myocardial infarction,contrast,coronary intervention
356428|NCT02067169|Transplantation|transplantation
356429|NCT02067169|CMV infection|cmv infection
356430|NCT02067169|antiviral resistance|antiviral resistance
356431|NCT02067156|glioblastoma|glioblastoma
356432|NCT02067143|Untreated philadelphia positive acute lymphoblastic leukemia|untreated philadelphia positive acute lymphoblastic leukemia
356433|NCT02067143|De novo|de novo
356434|NCT02067143|Secondary|secondary
356435|NCT02067143|Low-dose corticosteroids pretreatment|low-dose corticosteroids pretreatment
356436|NCT02067143|Pegylated asparaginase|pegylated asparaginase
356437|NCT02067143|Lineage-targeted risk and minimal residual disease|lineage-targeted risk and minimal residual disease
356438|NCT02067130|Beta Thalassemia Major|beta thalassemia major
356439|NCT02067117|influenza|influenza
356440|NCT02067091|STEMI|stemi
356441|NCT02067091|Coronary|coronary
356442|NCT02067091|Bioresorbable scaffold|bioresorbable scaffold
356443|NCT02067091|Drug eluting stent|drug eluting stent
356444|NCT02067091|Optical coherence tomography|optical coherence tomography
356445|NCT02067091|Multislice computed tomography|multislice computed tomography
356446|NCT02067078|nerve block|nerve block
356447|NCT02067078|total knee arthroplasty|total knee arthroplasty
356448|NCT02067078|saphenous nerve block|saphenous nerve block
356449|NCT02067078|obturator nerve block|obturator nerve block
356450|NCT02067078|pain|pain
356451|NCT02067078|opioid consumption|opioid consumption
356452|NCT02067065|Colonoscopy|colonoscopy
356453|NCT02067065|Sedation|sedation
356454|NCT02067065|Propofol|propofol
356455|NCT02067065|Non-anesthesiologist propofol administration|non-anesthesiologist propofol administration
356456|NCT02067052|Vulvar neoplasm|vulvar neoplasm
356457|NCT02067052|sentinel nodes|sentinel nodes
356458|NCT02067052|chemotherapy|chemotherapy
356459|NCT02067052|radiotherapy|radiotherapy
356461|NCT02067039|Rapid HIV test|rapid hiv test
356462|NCT02067039|HIV self-testing|hiv self-testing
356463|NCT02067039|Men who have sex with men (MSM)|men who have sex with men (msm)
356464|NCT02067039|HIV diagnosis|hiv diagnosis
356465|NCT02067039|Sexual behavior|sexual behavior
356466|NCT02067026|overweight|overweight
356467|NCT02067013|Tractional retinal detachment|tractional retinal detachment
356468|NCT02067013|Exudative retinal detachment|exudative retinal detachment
356469|NCT02067013|Macular hole|macular hole
356470|NCT02067013|Neovascular glaucoma|neovascular glaucoma
356471|NCT02066987|Action planning, Implementation intention|action planning, implementation intention
356472|NCT02066974|hepatocellular carcinoma|hepatocellular carcinoma
356473|NCT02066974|genomic expression|genomic expression
356474|NCT02066974|radiotherapy|radiotherapy
356475|NCT02066961|metastatic prostate cancer|metastatic prostate cancer
356476|NCT02066961|castration-resistant prostate cancer|castration-resistant prostate cancer
356477|NCT02066961|prostate cancer|prostate cancer
356478|NCT02066948|DXA|dxa
356479|NCT02066948|MRI|mri
356480|NCT02066948|Fitness assessment|fitness assessment
356481|NCT02066948|Meal tolerance test|meal tolerance test
356482|NCT02066935|immunosuppression|immunosuppression
356483|NCT02066935|medication nonadherence|medication nonadherence
356484|NCT02066935|kidney transplantation|kidney transplantation
356485|NCT02066922|Contact lenses|contact lenses
356486|NCT02066922|Nearsightedness|nearsightedness
356487|NCT02066922|Corneal curvature|corneal curvature
356488|NCT02066922|K-reading|k-reading
356489|NCT02066922|High minus|high minus
356490|NCT02066922|Spectacle refraction|spectacle refraction
356491|NCT02066909|pharmacokinetics|pharmacokinetics
356492|NCT02066909|safety|safety
356493|NCT02066909|tolerability|tolerability
356494|NCT02066909|healthy volunteers|healthy volunteers
356495|NCT02066909|steady state|steady state
356496|NCT02066909|multiple doses|multiple doses
356497|NCT02066909|Japanese subjects|japanese subjects
356498|NCT02066896|Sjogrens Syndrome|sjogrens syndrome
356499|NCT02066896|Syndrome, Sjogren's|syndrome, sjogren's
356500|NCT02066896|Sjogren Syndrome|sjogren syndrome
356501|NCT02066896|Sicca Syndrome|sicca syndrome
356502|NCT02066896|Syndrome, Sicca|syndrome, sicca
356503|NCT02066870|Icotinib|icotinib
356504|NCT02066870|Arsenic Trioxide|arsenic trioxide
356505|NCT02066870|Resistance|resistance
356506|NCT02066870|Non-small cell lung cancer|non-small cell lung cancer
356507|NCT02066857|Wrist fracture|wrist fracture
356508|NCT02066857|Radius fracture|radius fracture
356509|NCT02066857|Elderly|elderly
356510|NCT02066857|Splint|splint
356511|NCT02066857|Cast|cast
356512|NCT02066844|Hip Pain|hip pain
356513|NCT02066844|Hip Injection|hip injection
356514|NCT02066844|Hip Fracture|hip fracture
356515|NCT02066844|Hip Bursitis|hip bursitis
356516|NCT02066844|Hip Arthritis|hip arthritis
356517|NCT02066844|Hip Sciatica|hip sciatica
356518|NCT02066818|local anesthetic|local anesthetic
356519|NCT02066818|incision and drainage|incision and drainage
356520|NCT02066818|pain|pain
356521|NCT02066818|cutaneous abscess|cutaneous abscess
356522|NCT02066792|Social Phobia|social phobia
356523|NCT02066753|Cardiac arrest|cardiac arrest
356524|NCT02066753|Therapeutic Hypothermia|therapeutic hypothermia
356525|NCT02066753|Cardioprotectiveness|cardioprotectiveness
356526|NCT02066753|Hemodynamics|hemodynamics
356527|NCT02066740|Superficial Femoral Artery|superficial femoral artery
356528|NCT02066740|Proximal Popliteal Artery|proximal popliteal artery
356529|NCT02066740|Everflex|everflex
356530|NCT02066740|Entrust|entrust
356531|NCT02066740|stent|stent
356532|NCT02066727|Dexmedetomidine|dexmedetomidine
356533|NCT02066727|obturator nerve block|obturator nerve block
356534|NCT02066727|lidocaine|lidocaine
356535|NCT02066727|EC50|ec50
356536|NCT02066714|Enterovirus Infections|enterovirus infections
356537|NCT02066714|Hand, Foot and Mouth Disease|hand, foot and mouth disease
356538|NCT02066714|Coxsackievirus Infections|coxsackievirus infections
356539|NCT02066714|Herpangina|herpangina
356540|NCT02066714|Cognition|cognition
356541|NCT02066714|Neurocognitive|neurocognitive
356542|NCT02066714|Sequelae|sequelae
356543|NCT02066714|Outcomes|outcomes
356544|NCT02066701|Barrett's esophagus|barrett's esophagus
356545|NCT02066675|Metastatic|metastatic
356546|NCT02066675|Locally advanced|locally advanced
356547|NCT02066675|Soft tissue tumors|soft tissue tumors
777058|NCT00341367|Nerve|nerve
356548|NCT02066662|Coronary or Valvular Calcification|coronary or valvular calcification
356549|NCT02066662|Agatston Score|agatston score
356550|NCT02066662|Rivaroxaban|rivaroxaban
356551|NCT02066662|Coumarin|coumarin
356552|NCT02066662|Oral Anticoagulation Therapy (OAT)|oral anticoagulation therapy (oat)
356553|NCT02066662|Atrial Fibrillation|atrial fibrillation
356554|NCT02066662|Pulmonary Embolism|pulmonary embolism
356555|NCT02066649|portal hypertension|portal hypertension
356556|NCT02066649|esophageal varices|esophageal varices
356557|NCT02066649|variceal bleed|variceal bleed
356558|NCT02066649|carvedilol|carvedilol
356559|NCT02066649|variceal band ligation|variceal band ligation
356560|NCT02066623|coronary artery stenosis, vascular scaffold, ABSORB|coronary artery stenosis, vascular scaffold, absorb
356561|NCT02066597|Deep vein thrombosis|deep vein thrombosis
356562|NCT02066597|thrombectomy|thrombectomy
356563|NCT02066597|percutaneuos|percutaneuos
356564|NCT02066584|sibling oocytes|sibling oocytes
356565|NCT02066584|glucose|glucose
356566|NCT02066584|culture media|culture media
356567|NCT02066571|Parkinson's disease|parkinson's disease
356568|NCT02066571|Freezing of gait|freezing of gait
356569|NCT02066571|Gait|gait
356570|NCT02066558|Carbon monoxide|carbon monoxide
356571|NCT02066558|Headache|headache
356572|NCT02066558|Migraine|migraine
356573|NCT02066532|Breast Neoplasms|breast neoplasms
356574|NCT02066532|Breast Cancer|breast cancer
356575|NCT02066532|Breast Carcinoma|breast carcinoma
356576|NCT02066532|Breast tumors|breast tumors
356577|NCT02066532|Cancer of the Breast|cancer of the breast
356578|NCT02066532|Malignant tumor of the breast|malignant tumor of the breast
356579|NCT02066532|HER2 positive|her2 positive
356580|NCT02066532|erythroblastosis virus oncogene B-2 (erbB-2)|erythroblastosis virus oncogene b-2 (erbb-2)
356581|NCT02066532|Metastatic Breast Cancer|metastatic breast cancer
356582|NCT02066532|Secondary Breast Cancer|secondary breast cancer
356583|NCT02066519|Myasthenia gravis|myasthenia gravis
356584|NCT02066519|physical exercise|physical exercise
356585|NCT02066519|quality of life|quality of life
356586|NCT02066519|muscular performance|muscular performance
356587|NCT02066519|fatigability|fatigability
356588|NCT02066506|systemic right ventricle|systemic right ventricle
356589|NCT02066506|cardiac magnetic resonance imaging|cardiac magnetic resonance imaging
356590|NCT02066506|congenital heart disease|congenital heart disease
356591|NCT02066493|giant intracranial aneurysm|giant intracranial aneurysm
356592|NCT02066467|Phrenic Nerve Stimulation|phrenic nerve stimulation
356593|NCT02066467|Heartfailure treatment|heartfailure treatment
356594|NCT02066467|CRT-D therapy|crt-d therapy
356595|NCT02066467|Quadripolar lead|quadripolar lead
356596|NCT02066467|Lead related complication free rate|lead related complication free rate
356597|NCT02066454|myeloma|myeloma
356598|NCT02066454|antiXa anticoagulant|antixa anticoagulant
356599|NCT02066454|venous thromboembolic disease|venous thromboembolic disease
356600|NCT02066454|iMiDs|imids
356601|NCT02066441|Vitamin D|vitamin d
356602|NCT02066441|bone formation|bone formation
356603|NCT02066441|resorption|resorption
356604|NCT02066441|mineral density|mineral density
356605|NCT02066441|inflammation|inflammation
356606|NCT02066441|flexibility|flexibility
356607|NCT02066441|balance|balance
356608|NCT02066441|elderly|elderly
356609|NCT02066428|BCG Vaccinated|bcg vaccinated
356610|NCT02066428|HIV Negative|hiv negative
356611|NCT02066415|Chronic Migraine|chronic migraine
356612|NCT02066389|Musculoskeletal Disease|musculoskeletal disease
356613|NCT02066389|Arthritis|arthritis
356614|NCT02066389|Joint Diseases|joint diseases
356615|NCT02066389|anti-inflammatory agents|anti-inflammatory agents
356616|NCT02066389|antirheumatic agents|antirheumatic agents
356617|NCT02066363|Bioelectrical impedance|bioelectrical impedance
356618|NCT02066363|Parenteral nutrition|parenteral nutrition
356619|NCT02066363|Malnutrition|malnutrition
356620|NCT02066363|Quality of life.|quality of life.
356621|NCT02066363|Cancer cachexia|cancer cachexia
356622|NCT02066363|Body composition|body composition
356623|NCT02066350|Diabetes type 1|diabetes type 1
356624|NCT02066350|Endothelial dysfunction|endothelial dysfunction
356625|NCT02066350|Pancreas transplantation|pancreas transplantation
356626|NCT02066337|Ozone gel|ozone gel
356627|NCT02066337|Antioxidants|antioxidants
356628|NCT02066337|Chronic periodontitis|chronic periodontitis
356629|NCT02066337|Superoxide dismutase|superoxide dismutase
356630|NCT02066311|lupus|lupus
356631|NCT02066311|SLE|sle
356632|NCT02066298|Asthma|asthma
356633|NCT02066298|Mometasone|mometasone
356634|NCT02066298|Tiotropium|tiotropium
356635|NCT02066285|Solitary fibrous tumor|solitary fibrous tumor
356636|NCT02066285|Extraskeletal myxoid chondrosarcoma|extraskeletal myxoid chondrosarcoma
356637|NCT02066285|Unresectable|unresectable
356638|NCT02066285|Locally advanced|locally advanced
356639|NCT02066285|Metastatic disease|metastatic disease
356640|NCT02066272|IBD|ibd
356641|NCT02066272|anti-TNF|anti-tnf
356642|NCT02066272|biosimilars|biosimilars
356643|NCT02066272|safety|safety
356644|NCT02066259|colon cancer|colon cancer
356645|NCT02066259|cancer associated auto antibodies|cancer associated auto antibodies
356646|NCT02066259|colon cancer blood test|colon cancer blood test
356647|NCT02066246|laparoscopic robot-assisted surgery|laparoscopic robot-assisted surgery
356648|NCT02066246|in steep trendelenburg position|in steep trendelenburg position
356649|NCT02066233|Barrett's|barrett's
356650|NCT02066233|esophagus|esophagus
356651|NCT02066233|reflux|reflux
356652|NCT02066233|heartburn|heartburn
356653|NCT02066233|screening|screening
356654|NCT02066220|pediatric brain tumor|pediatric brain tumor
356655|NCT02066220|medulloblastoma|medulloblastoma
356656|NCT02066220|event-free survival (EFS)|event-free survival (efs)
356657|NCT02066220|progression-free survival (PFS)|progression-free survival (pfs)
356658|NCT02066220|overall survival (OS)|overall survival (os)
356659|NCT02066220|PNET|pnet
356660|NCT02066220|posterior fossa|posterior fossa
356661|NCT02066220|chemotherapy|chemotherapy
356662|NCT02066220|radiotherapy|radiotherapy
356663|NCT02066220|biological profile|biological profile
356664|NCT02066220|ß-catenin|ß-catenin
356665|NCT02066155|diabetes self-management support|diabetes self-management support
356666|NCT02066155|diabetes-related distress|diabetes-related distress
356667|NCT02066155|parish nurses|parish nurses
356668|NCT02066155|peer support|peer support
356669|NCT02066129|Asthma|asthma
356670|NCT02066129|Fluticasone|fluticasone
356671|NCT02066090|acupuncture|acupuncture
356672|NCT02066090|obesity|obesity
356673|NCT02066090|metabolomics|metabolomics
356674|NCT02066077|Major Depressive Disorder|major depressive disorder
356675|NCT02066077|Modified Electroconvulsive Therapy|modified electroconvulsive therapy
356676|NCT02066077|Cognition|cognition
356677|NCT02066077|Memory|memory
356678|NCT02066064|Colorectal Cancer|colorectal cancer
356679|NCT02066064|Adenoma|adenoma
356680|NCT02066064|Standard Colonoscopy|standard colonoscopy
356681|NCT02066064|G-EYE(TM) Colonoscopy|g-eye(tm) colonoscopy
356682|NCT02066038|chemotherapy|chemotherapy
356683|NCT02066038|maintenance therapy|maintenance therapy
356684|NCT02066038|erlotinib|erlotinib
356685|NCT02066025|breast cancer|breast cancer
356686|NCT02066025|cancer associated auto antibodies|cancer associated auto antibodies
356687|NCT02066025|breast cancer blood test|breast cancer blood test
356688|NCT02066012|Dysmetabolic Iron Overload Syndrome|dysmetabolic iron overload syndrome
356689|NCT02066012|Metabolic Syndrome X|metabolic syndrome x
356690|NCT02066012|Iron|iron
356691|NCT02066012|Monocyte|monocyte
356692|NCT02066012|Macrophage|macrophage
356693|NCT02066012|Polarization|polarization
356694|NCT02065999|Hepatitis C, chronic|hepatitis c, chronic
356695|NCT02065986|HIV|hiv
356696|NCT02065986|Prevention|prevention
356697|NCT02065986|Truvada|truvada
356698|NCT02065960|Feasibility study|feasibility study
356699|NCT02065960|Early breast cancer|early breast cancer
356700|NCT02065960|Stereotactic body radiotherapy|stereotactic body radiotherapy
356701|NCT02065960|Cyberknife|cyberknife
356702|NCT02065960|Pre-operative radiotherapy|pre-operative radiotherapy
356703|NCT02065947|paravertebral block, mastectomy, efficiency|paravertebral block, mastectomy, efficiency
356704|NCT02065934|in hospital cardiac arrest|in hospital cardiac arrest
356705|NCT02065934|in situ simulation|in situ simulation
356706|NCT02065934|clinical audit|clinical audit
356707|NCT02065934|education|education
356708|NCT02065921|COPD cohort|copd cohort
356709|NCT02065921|COPD management|copd management
356710|NCT02065921|exacerbation|exacerbation
356711|NCT02065908|breast cancer|breast cancer
356712|NCT02065908|anthracyclines|anthracyclines
356713|NCT02065908|cardiotoxicity|cardiotoxicity
356714|NCT02065908|circulating microRNA|circulating microrna
356715|NCT02065908|biomarker|biomarker
356716|NCT02065908|serum|serum
356717|NCT02065908|anthracyclines based chemotherapy|anthracyclines based chemotherapy
356718|NCT02065895|Physiologic Insulin Delivery (PID)|physiologic insulin delivery (pid)
356719|NCT02065895|Closed Loop|closed loop
356720|NCT02065895|Sensor|sensor
356721|NCT02065895|Insulin sensitivity|insulin sensitivity
356722|NCT02065882|fibrinogen, bleeding,|fibrinogen, bleeding,
356723|NCT02065869|ALL|all
356724|NCT02065869|AML|aml
356725|NCT02065869|hematologic neoplasms|hematologic neoplasms
356726|NCT02065869|hematologic malignancies|hematologic malignancies
356727|NCT02065869|primary immune deficiences|primary immune deficiences
356728|NCT02065869|hemoglobinopathy|hemoglobinopathy
356729|NCT02065869|congenital cytopenia|congenital cytopenia
356730|NCT02065869|anemia|anemia
356731|NCT02065843|Anxiety|anxiety
356732|NCT02065843|Third molar surgery|third molar surgery
356733|NCT02065843|Blood pressure|blood pressure
356734|NCT02065843|Heart rate|heart rate
356735|NCT02065843|Oxygen saturation|oxygen saturation
356736|NCT02065830|Robot|robot
356737|NCT02065830|Spinal Cord Injury|spinal cord injury
356738|NCT02065830|Gait|gait
356739|NCT02065830|Quality of life|quality of life
356740|NCT02065830|Rehabilitation|rehabilitation
356741|NCT02065830|Lower Limb|lower limb
356742|NCT02065817|Lipid|lipid
356743|NCT02065817|Apolipoproteins|apolipoproteins
777488|NCT00340210|Biomarkers|biomarkers
456198|NCT01614730|EMS|ems
356744|NCT02065817|Cardiovascular disease risks|cardiovascular disease risks
356745|NCT02065804|Herniorrhaphy|herniorrhaphy
356746|NCT02065804|Surgical Equipment|surgical equipment
356747|NCT02065804|Chronic Pain|chronic pain
356748|NCT02065804|Inguinal Herniorrhaphy|inguinal herniorrhaphy
356749|NCT02065804|Laparoscopy|laparoscopy
356750|NCT02065804|Surgical Outcome|surgical outcome
356751|NCT02065791|Diabetes Mellitus, Type 2|diabetes mellitus, type 2
356752|NCT02065791|Diabetic Nephropathies|diabetic nephropathies
356753|NCT02065791|Canagliflozin|canagliflozin
356754|NCT02065791|JNJ-28431754|jnj-28431754
356755|NCT02065791|End-Stage Kidney Disease|end-stage kidney disease
356756|NCT02065791|Chronic Kidney Disease|chronic kidney disease
356757|NCT02065791|Macroalbuminuria|macroalbuminuria
356758|NCT02065752|Healthy Volunteers|healthy volunteers
356759|NCT02065752|Canagliflozin|canagliflozin
356760|NCT02065752|Metformin|metformin
356761|NCT02065752|Type 2 diabetes mellitus|type 2 diabetes mellitus
356762|NCT02065739|Healthy|healthy
356763|NCT02065739|JNJ-42165279|jnj-42165279
356764|NCT02065739|Itraconazole|itraconazole
356765|NCT02065739|Pharmacokinetics|pharmacokinetics
356766|NCT02065713|Psoriatic arthritis, dactylitis, enthesitis|psoriatic arthritis, dactylitis, enthesitis
356767|NCT02065700|Methotrexate|methotrexate
356768|NCT02065700|insufficient responders|insufficient responders
356769|NCT02065674|type II Diabetes mellitus|type ii diabetes mellitus
356771|NCT02065674|PPBS|ppbs
356772|NCT02065674|HbA1c%|hba1c%
356773|NCT02065648|MRA|mra
356774|NCT02065648|Syngo Native|syngo native
356775|NCT02065648|Gadolinium|gadolinium
356776|NCT02065648|Non contrast|non contrast
356777|NCT02065622|Ulcerative Colitis|ulcerative colitis
356778|NCT02065609|Trastuzumab|trastuzumab
356779|NCT02065596|Sickle Cell Disease|sickle cell disease
356780|NCT02065596|Sickle Cell Anemia|sickle cell anemia
356781|NCT02065596|GvHD|gvhd
356782|NCT02065596|fludarabine|fludarabine
356783|NCT02065583|Ileus|ileus
356784|NCT02065583|Equipment and Supplies|equipment and supplies
356785|NCT02065583|Technology|technology
356786|NCT02065583|Acoustics|acoustics
356787|NCT02065570|Crohn's Disease|crohn's disease
356788|NCT02065557|Ulcerative Colitis|ulcerative colitis
356789|NCT02065557|adalimumab|adalimumab
356790|NCT02065544|Type 2 diabetes mellitus|type 2 diabetes mellitus
356791|NCT02065544|behavioral weight loss|behavioral weight loss
356792|NCT02065544|exercise training|exercise training
356793|NCT02065544|hemoglobin A1c|hemoglobin a1c
356794|NCT02065531|Low Back Pain|low back pain
356795|NCT02065531|Chronic Pain|chronic pain
356796|NCT02065531|Manipulation|manipulation
356797|NCT02065531|Manual Therapy|manual therapy
356798|NCT02065531|Randomized Controlled Trial|randomized controlled trial
356799|NCT02065518|Muscle strength|muscle strength
356800|NCT02065518|Electrical muscle stimulation|electrical muscle stimulation
356801|NCT02065518|Strength training|strength training
356802|NCT02065505|Spastic hemiparesis|spastic hemiparesis
356803|NCT02065505|Posture|posture
356804|NCT02065505|Pilates|pilates
356805|NCT02065505|Respiratory Capacity|respiratory capacity
356806|NCT02065492|Thalassemia|thalassemia
356807|NCT02065492|Amlodipine|amlodipine
356808|NCT02065492|Chelation|chelation
356809|NCT02065492|T2*|t2*
356810|NCT02065492|MRI|mri
356811|NCT02065492|Myocardial Iron|myocardial iron
356812|NCT02065479|Coronary Artery Disease|coronary artery disease
356813|NCT02065479|Percutaneous Coronary Intervention|percutaneous coronary intervention
356814|NCT02065479|Genetic Polymorphism|genetic polymorphism
356815|NCT02065479|Pharmacodynamic|pharmacodynamic
356816|NCT02065453|lap hysterectomy|lap hysterectomy
356817|NCT02065453|Women in need of a lap hysterectomy for benign disease.|women in need of a lap hysterectomy for benign disease.
356818|NCT02065440|Ebastine/Pseudoephedrine|ebastine/pseudoephedrine
356819|NCT02065440|subacute cough|subacute cough
356820|NCT02065440|upper airway cough syndrome|upper airway cough syndrome
356821|NCT02065427|Caregiver|caregiver
356822|NCT02065427|Burden|burden
356823|NCT02065427|Social support|social support
356824|NCT02065427|Primary health Care|primary health care
356825|NCT02065427|Home Care|home care
356826|NCT02065427|Intervention|intervention
356827|NCT02065414|Gums|gums
356828|NCT02065414|Gingiva|gingiva
356829|NCT02065414|Gingival Inflammation|gingival inflammation
356830|NCT02065414|Gingival Bleeding|gingival bleeding
356831|NCT02065375|RTA 408|rta 408
356832|NCT02065375|Ocular surgery|ocular surgery
356833|NCT02065375|Cataract surgery|cataract surgery
356834|NCT02065375|Ocular inflammation|ocular inflammation
356835|NCT02065375|Ocular pain|ocular pain
356836|NCT02065375|Eye inflammation|eye inflammation
356837|NCT02065362|EBV positive|ebv positive
356838|NCT02065362|TGFbeta|tgfbeta
356839|NCT02065362|Nasopharyngeal carcinoma|nasopharyngeal carcinoma
356840|NCT02065362|cytotoxic T lymphocytes|cytotoxic t lymphocytes
356841|NCT02065349|peripheral neuropathy|peripheral neuropathy
356842|NCT02065349|PHN|phn
356843|NCT02065349|pain|pain
356844|NCT02065349|PDPN|pdpn
356845|NCT02065336|HBV|hbv
356846|NCT02065336|Hepatitis|hepatitis
356847|NCT02065323|Prostate Cancer|prostate cancer
356848|NCT02065323|Metastatic|metastatic
356849|NCT02065323|Hormone-sensitive|hormone-sensitive
356850|NCT02065323|Androgen Deprivation Therapy (ADT)|androgen deprivation therapy (adt)
356851|NCT02065323|Castration-Resistant Prostate Cancer (CRPC)|castration-resistant prostate cancer (crpc)
356852|NCT02065323|Dovitinib|dovitinib
356853|NCT02065323|TKI258|tki258
356854|NCT02065323|Circulating Tumor Cells|circulating tumor cells
356855|NCT02065310|AGE|age
356856|NCT02065310|Diabetes Biomarkers|diabetes biomarkers
356857|NCT02065310|CEdG|cedg
356858|NCT02065284|MS|ms
356859|NCT02065284|Ambulation|ambulation
356860|NCT02065258|Asthma, Clinical control, Exercise|asthma, clinical control, exercise
356861|NCT02065245|Aging Frailty, Frailty, Cardiovascular, stem cells|aging frailty, frailty, cardiovascular, stem cells
356862|NCT02065219|Chronic Pain|chronic pain
356863|NCT02065219|Inguinal Hernia|inguinal hernia
356864|NCT02065219|Outcome|outcome
356865|NCT02065219|Surgical Procedure, Operative|surgical procedure, operative
356866|NCT02065206|Focus groups|focus groups
356867|NCT02065206|Underrepresented Minorities|underrepresented minorities
356868|NCT02065206|Social Media|social media
356869|NCT02065206|Clinical Research Careers|clinical research careers
356870|NCT02065167|avascular necrosis of femoral head|avascular necrosis of femoral head
356871|NCT02065167|cell therapy|cell therapy
356872|NCT02065167|Mesenchymal stem cells|mesenchymal stem cells
356873|NCT02065154|acute myeloid leukemia|acute myeloid leukemia
356874|NCT02065154|AML|aml
356875|NCT02065154|acute lymphoblastic leukemia|acute lymphoblastic leukemia
356876|NCT02065154|ALL|all
356877|NCT02065154|chronic myeloid leukemia|chronic myeloid leukemia
356878|NCT02065154|CML|cml
356879|NCT02065154|chronic lymphocytic leukemia|chronic lymphocytic leukemia
356880|NCT02065154|CLL|cll
356881|NCT02065154|non-Hodgkin lymphoma|non-hodgkin lymphoma
356882|NCT02065154|NHL|nhl
356883|NCT02065154|Hodgkin lymphoma|hodgkin lymphoma
356884|NCT02065154|HL|hl
356885|NCT02065154|myelodysplastic syndrome|myelodysplastic syndrome
356886|NCT02065154|MDS|mds
356887|NCT02065154|myelofibrosis|myelofibrosis
356888|NCT02065154|severe aplastic anemia|severe aplastic anemia
356889|NCT02065141|digestion|digestion
356890|NCT02065141|absorption|absorption
356891|NCT02065141|protein|protein
356892|NCT02065141|amino acids|amino acids
356893|NCT02065141|heart failure|heart failure
356894|NCT02065141|COPD|copd
356895|NCT02065115|ice|ice
356896|NCT02065115|cryotherapy|cryotherapy
356897|NCT02065115|puncture|puncture
356898|NCT02065115|pain|pain
356899|NCT02065102|Rotational atherectomy|rotational atherectomy
356900|NCT02065102|Angina|angina
356901|NCT02065102|Optical coherence tomography|optical coherence tomography
356902|NCT02065102|Intravascular ultrasound|intravascular ultrasound
356903|NCT02065102|Coronary stent|coronary stent
356904|NCT02065076|Sodium Polystyrene Sulfonate|sodium polystyrene sulfonate
356905|NCT02065076|Kayexalate|kayexalate
356906|NCT02065076|Pre-dialysis|pre-dialysis
356907|NCT02065076|Outpatients|outpatients
356908|NCT02065076|Hyperkalemia|hyperkalemia
356909|NCT02065076|Chronic kidney failure|chronic kidney failure
356910|NCT02065076|Potassium|potassium
356911|NCT02065063|MEK inhibitor|mek inhibitor
356912|NCT02065063|PD-0332991|pd-0332991
356913|NCT02065063|CDK4/6 inhibitor|cdk4/6 inhibitor
356914|NCT02065063|palbociclib|palbociclib
356915|NCT02065063|NRAS wild type|nras wild type
356916|NCT02065063|cutaneous melanoma|cutaneous melanoma
356917|NCT02065063|GSK1120212|gsk1120212
356918|NCT02065063|trametinib|trametinib
356919|NCT02065063|NRAS mutant|nras mutant
356920|NCT02065063|BRAFV600 wild type|brafv600 wild type
356921|NCT02065050|Diabetes mellitus|diabetes mellitus
356922|NCT02065050|Team approach|team approach
356923|NCT02065037|Insufflation|insufflation
356924|NCT02065037|Carbon Dioxide|carbon dioxide
356925|NCT02065037|Colonic Polyps|colonic polyps
356926|NCT02065037|Colonoscopy|colonoscopy
356927|NCT02065037|Randomized Controlled Trial|randomized controlled trial
356928|NCT02065024|b-cryptoxanthin|b-cryptoxanthin
356929|NCT02065024|plant sterols|plant sterols
356930|NCT02065024|serum Cholesterol|serum cholesterol
356931|NCT02065024|bone turnover markers|bone turnover markers
356932|NCT02064998|Randomized Controlled Trial|randomized controlled trial
356933|NCT02064998|Alcohol|alcohol
356934|NCT02064998|Internet|internet
356935|NCT02064998|Mobile phone|mobile phone
356936|NCT02064998|Screening|screening
356937|NCT02064998|Brief intervention|brief intervention
356938|NCT02064972|Graft vs Host Disease|graft vs host disease
356939|NCT02064972|Hematopoietic Stem Cell Transplant|hematopoietic stem cell transplant
356940|NCT02064972|Biological Marker|biological marker
356941|NCT02064972|Circulating Endothelial Cells|circulating endothelial cells
356942|NCT02064972|Endothelial Dysfunction|endothelial dysfunction
356943|NCT02064959|Subdural Hematoma|subdural hematoma
356944|NCT02064959|Traumatic Brain Injury|traumatic brain injury
356945|NCT02064959|Hypothermia|hypothermia
356946|NCT02064946|prostate cancer|prostate cancer
356947|NCT02064946|bone density|bone density
356948|NCT02064946|vitamin D|vitamin d
356949|NCT02064946|micronutrients|micronutrients
356950|NCT02064946|pharmacologic actions|pharmacologic actions
356951|NCT02064933|Wiskott-Aldrich Syndrome|wiskott-aldrich syndrome
356952|NCT02064933|Hematopoietic Stem Cell Transplantation|hematopoietic stem cell transplantation
356953|NCT02064933|Genetic Therapy|genetic therapy
356954|NCT02064907|Drug therapy|drug therapy
356955|NCT02064894|children|children
356956|NCT02064894|analgesia|analgesia
356957|NCT02064894|musculoskeletal injury|musculoskeletal injury
356958|NCT02064894|emergency|emergency
356959|NCT02064894|opioids|opioids
356960|NCT02064881|Postprandial lipemia|postprandial lipemia
356961|NCT02064881|Diabetes|diabetes
356962|NCT02064881|Metformin glycinate|metformin glycinate
356963|NCT02064881|oxidized LDL|oxidized ldl
356964|NCT02064868|AHF,|ahf,
356965|NCT02064868|RLX030,|rlx030,
356966|NCT02064868|SOC,|soc,
356967|NCT02064868|WHF,|whf,
357067|NCT02064452|children|children
356968|NCT02064868|RELAX-AHF-EU|relax-ahf-eu
356969|NCT02064868|Renal Impairment|renal impairment
356970|NCT02064855|Spinal stenosis|spinal stenosis
356971|NCT02064855|Spondylolisthesis|spondylolisthesis
356972|NCT02064855|Degenerative disc disease|degenerative disc disease
356973|NCT02064855|Spinal fusion|spinal fusion
356974|NCT02064855|Allograft|allograft
356975|NCT02064855|Interbody fusion|interbody fusion
356976|NCT02064842|Healthy|healthy
356977|NCT02064842|TMC647055|tmc647055
356978|NCT02064842|TMC435|tmc435
356979|NCT02064842|Simeprevir|simeprevir
356980|NCT02064842|Sovriad|sovriad
356981|NCT02064842|Ritonavir (RTV)|ritonavir (rtv)
356982|NCT02064829|Metastatic breast cancer|metastatic breast cancer
356983|NCT02064829|Locally recurrent breast cancer|locally recurrent breast cancer
356984|NCT02064829|Bioequivalence|bioequivalence
356985|NCT02064829|IG-001|ig-001
356986|NCT02064829|nab-paclitaxel|nab-paclitaxel
356987|NCT02064829|Paclitaxel|paclitaxel
356988|NCT02064829|Pharmacokinetics|pharmacokinetics
356989|NCT02064816|Multiple Sclerosis, Relapsing-Remitting|multiple sclerosis, relapsing-remitting
356990|NCT02064816|Interferon beta 1a|interferon beta 1a
356991|NCT02064816|Rebif®|rebif®
356992|NCT02064790|Gabapentin|gabapentin
356993|NCT02064790|Pregabalin|pregabalin
356994|NCT02064790|Lyrica|lyrica
356995|NCT02064790|Neurontin|neurontin
356996|NCT02064790|lumbar|lumbar
356997|NCT02064790|cervical|cervical
356998|NCT02064738|Omega-3 fatty acids|omega-3 fatty acids
356999|NCT02064738|Omega-6 fatty acids|omega-6 fatty acids
357000|NCT02064738|aspirin exacerbated respiratory disease|aspirin exacerbated respiratory disease
357001|NCT02064738|AERD|aerd
357002|NCT02064738|Samter's Triad|samter's triad
357003|NCT02064738|nasal polyp|nasal polyp
357004|NCT02064738|aspirin|aspirin
357005|NCT02064738|diet|diet
357006|NCT02064738|leukotriene|leukotriene
357007|NCT02064725|Endometrial cancer|endometrial cancer
357008|NCT02064725|Recurrent or persistent endometrial carcinoma|recurrent or persistent endometrial carcinoma
357009|NCT02064725|Progesterone Receptor Negative|progesterone receptor negative
357010|NCT02064725|Sodium cridanimod|sodium cridanimod
357011|NCT02064725|Virexxa|virexxa
357012|NCT02064712|Continuous Positive Airway Pressure|continuous positive airway pressure
357013|NCT02064699|Renal transplant|renal transplant
357014|NCT02064699|CMV|cmv
357015|NCT02064699|Test QuantiFERON-CMV|test quantiferon-cmv
357016|NCT02064673|prostate cancer|prostate cancer
357017|NCT02064673|radical prostatectomy|radical prostatectomy
357018|NCT02064660|Myopia|myopia
357019|NCT02064660|Children|children
357020|NCT02064660|Acupressure|acupressure
357021|NCT02064660|Refractive error|refractive error
357022|NCT02064660|Axial length|axial length
357023|NCT02064660|Korean medicine|korean medicine
357024|NCT02064647|Insulin Infusion Systems|insulin infusion systems
357025|NCT02064647|Blood Glucose|blood glucose
357026|NCT02064634|Shinbaro Capsule|shinbaro capsule
357027|NCT02064634|Celecoxib|celecoxib
357028|NCT02064634|Osteoarthritis|osteoarthritis
357029|NCT02064634|GCSB-5|gcsb-5
357030|NCT02064634|Discontinuation rate|discontinuation rate
357031|NCT02064634|Gastrointestinal adverse event|gastrointestinal adverse event
357032|NCT02064634|NSAIDs|nsaids
357033|NCT02064634|OASIS|oasis
357034|NCT02064608|Prostate|prostate
357035|NCT02064608|Cancer|cancer
357036|NCT02064608|Prostate Cancer|prostate cancer
357037|NCT02064608|High Risk|high risk
357038|NCT02064608|Intermediate Risk|intermediate risk
357039|NCT02064608|Early disease|early disease
357040|NCT02064608|Neoadjuvant treatment|neoadjuvant treatment
357041|NCT02064608|Radical Prostatectomy|radical prostatectomy
357042|NCT02064595|Tibial fractures.|tibial fractures.
357043|NCT02064595|Fracture fixation.|fracture fixation.
357044|NCT02064595|External fixators.|external fixators.
357045|NCT02064595|Intramedullary.|intramedullary.
357046|NCT02064595|Quality of life.|quality of life.
400538|NCT01866397|Pharmacokinetics of cidofovir during CVVH|pharmacokinetics of cidofovir during cvvh
357047|NCT02064582|prostate cancer, enzalutamide, radiation, hormone therapy|prostate cancer, enzalutamide, radiation, hormone therapy
357048|NCT02064543|Parkinson's disease|parkinson's disease
357049|NCT02064543|gait|gait
357050|NCT02064530|TAP block|tap block
357051|NCT02064530|dexmedetomidine|dexmedetomidine
357052|NCT02064530|bupivacaine|bupivacaine
357053|NCT02064530|postoperative analgesia|postoperative analgesia
357054|NCT02064517|Necrosed Immature monoradicular Teeth , Revascularisation pulpar, MTA apical barrier, Clinical and radiographic success|necrosed immature monoradicular teeth , revascularisation pulpar, mta apical barrier, clinical and radiographic success
357055|NCT02064504|Respiratory|respiratory
357056|NCT02064504|GSK961081 (MABA)|gsk961081 (maba)
357057|NCT02064504|healthy subjects|healthy subjects
357058|NCT02064504|pharmacokinetics|pharmacokinetics
357059|NCT02064504|GW685698 (fluticasone furoate)|gw685698 (fluticasone furoate)
357060|NCT02064491|Non-small cell lung cancer|non-small cell lung cancer
357061|NCT02064491|EGFR mutant|egfr mutant
357062|NCT02064491|Erlotinib|erlotinib
357063|NCT02064491|Treatment Beyond Progression|treatment beyond progression
357064|NCT02064478|Bone anchored hearing implant|bone anchored hearing implant
357065|NCT02064478|Bone anchored hearing device|bone anchored hearing device
357066|NCT02064452|behavior problems|behavior problems
357068|NCT02064452|prevention|prevention
357069|NCT02064452|parenting|parenting
357070|NCT02064452|online|online
357071|NCT02064452|pediatric|pediatric
357072|NCT02064439|deep vein thrombosis|deep vein thrombosis
357073|NCT02064439|pulmonary embolism|pulmonary embolism
357074|NCT02064439|long-term prevention of recurrent symptomatic VTE|long-term prevention of recurrent symptomatic vte
357075|NCT02064426|Anemia of CKD on dialysis|anemia of ckd on dialysis
357076|NCT02064413|Birth control|birth control
357077|NCT02064400|Rheumatoid arthritis|rheumatoid arthritis
357078|NCT02064400|Ultrasound|ultrasound
357079|NCT02064400|Remission|remission
357080|NCT02064400|Qualitative|qualitative
357081|NCT02064387|Multiple Myeloma|multiple myeloma
357082|NCT02064387|BCMA expressing Lymphomas|bcma expressing lymphomas
357083|NCT02064374|Dolutegravir|dolutegravir
357084|NCT02064374|drug interaction|drug interaction
357085|NCT02064374|metformin|metformin
357086|NCT02064374|pharmacokinetics|pharmacokinetics
357087|NCT02064374|healthy volunteers|healthy volunteers
357088|NCT02064361|SCUBA diving|scuba diving
357089|NCT02064361|exercise,|exercise,
357090|NCT02064361|microparticles|microparticles
357091|NCT02064361|neutrophil activation,|neutrophil activation,
357092|NCT02064361|high intensity exercise|high intensity exercise
357093|NCT02064335|physical activity coach, diabetic persons, health, behaviour|physical activity coach, diabetic persons, health, behaviour
357094|NCT02064322|sacroiliac joint fusion|sacroiliac joint fusion
357095|NCT02064322|SIJ fusion|sij fusion
357096|NCT02064322|SI joint|si joint
357097|NCT02064296|Fibromyalgia Chronic Pain|fibromyalgia chronic pain
357098|NCT02064270|incision care|incision care
357099|NCT02064270|Total Hip Arthroplasty|total hip arthroplasty
357100|NCT02064270|Total Knee Arthroplasty|total knee arthroplasty
357101|NCT02064270|Knee surgery|knee surgery
357102|NCT02064270|Hip surgery|hip surgery
357103|NCT02064257|autonomic nervous system|autonomic nervous system
357104|NCT02064257|auditory processing disorder|auditory processing disorder
357105|NCT02064257|social behavior|social behavior
357106|NCT02064244|renal|renal
357107|NCT02064244|kidney|kidney
357108|NCT02064244|creatinine|creatinine
357109|NCT02064244|Inferior Vena Cava (IVC)|inferior vena cava (ivc)
357110|NCT02064244|Acute Renal Failure (ARF)|acute renal failure (arf)
357111|NCT02064244|Acute Kidney Injury (AKI)|acute kidney injury (aki)
357112|NCT02064205|pre-load|pre-load
357113|NCT02064205|satiety|satiety
357114|NCT02064205|energy intake|energy intake
357115|NCT02064205|appetite|appetite
357116|NCT02064192|defibrillator, implantable cardioverter|defibrillator, implantable cardioverter
357117|NCT02064192|sudden cardiac death|sudden cardiac death
357118|NCT02064192|primary prophylaxis|primary prophylaxis
357119|NCT02064192|risk stratification|risk stratification
357120|NCT02064179|Congenital heart disease|congenital heart disease
357121|NCT02064179|Antiplatelet therapy|antiplatelet therapy
357122|NCT02064179|Aspirin|aspirin
357123|NCT02064166|Parkinson disease|parkinson disease
357124|NCT02064166|Multiple system atrophy|multiple system atrophy
357125|NCT02064166|Intranasal|intranasal
357126|NCT02064166|Insulin|insulin
357127|NCT02064153|Dialysate temperature|dialysate temperature
357128|NCT02064153|Spent dialysate|spent dialysate
357129|NCT02064153|Toxin removal|toxin removal
357130|NCT02064153|Intra-dialytic hypotension|intra-dialytic hypotension
357131|NCT02064153|Inter-compartmental resistance|inter-compartmental resistance
357132|NCT02064140|ARDS|ards
357133|NCT02064140|Mechanical Ventilation|mechanical ventilation
357134|NCT02064140|Tidal volume|tidal volume
357135|NCT02064140|NMBA|nmba
357136|NCT02064114|BMI >40|bmi >40
357137|NCT02064101|Scoliosis|scoliosis
357138|NCT02064101|EMG|emg
357139|NCT02064101|Pedicle screw|pedicle screw
357140|NCT02064101|Neuromonitoring|neuromonitoring
357141|NCT02064088|Regional anesthesia|regional anesthesia
357142|NCT02064088|TAP block|tap block
357143|NCT02064088|Pediatric anesthesia|pediatric anesthesia
357144|NCT02064088|analgesic effects|analgesic effects
357145|NCT02064088|pharmacokinetics|pharmacokinetics
357146|NCT02064075|Subarachnoid hemorrhage|subarachnoid hemorrhage
357147|NCT02064075|vasospasm|vasospasm
357148|NCT02064075|Lactated Ringer's solution|lactated ringer's solution
357149|NCT02064075|Hydroxyethyl starch solution|hydroxyethyl starch solution
357150|NCT02064062|Achilles Tendinopathy|achilles tendinopathy
357151|NCT02064062|Autologous Stem Cells|autologous stem cells
357152|NCT02064062|Musculoskeletal|musculoskeletal
357153|NCT02064049|Hepatitis C virus|hepatitis c virus
357154|NCT02064049|People who inject drugs|people who inject drugs
357155|NCT02064049|Drug users|drug users
357156|NCT02064049|Direct acting antiviral (DAA)|direct acting antiviral (daa)
357157|NCT02064049|Infectious diseases|infectious diseases
357158|NCT02064049|Prisoners|prisoners
357159|NCT02064036|Prostate Cancer|prostate cancer
357160|NCT02064036|Radiotherapy|radiotherapy
357161|NCT02064036|Androgen Deprivation|androgen deprivation
357162|NCT02064023|insulin pump|insulin pump
357163|NCT02064023|CSII|csii
357164|NCT02064023|multiple daily injections|multiple daily injections
357165|NCT02064023|MDI|mdi
357166|NCT02064023|type 1 diabetes|type 1 diabetes
357167|NCT02064023|type 2 diabetes|type 2 diabetes
357168|NCT02064023|pregnancy|pregnancy
357169|NCT02063971|Skin aging|skin aging
357170|NCT02063971|Soothing activity|soothing activity
357171|NCT02063971|Hyaluronic acid injections|hyaluronic acid injections
357172|NCT02063958|Neuroendocrine tumor|neuroendocrine tumor
357173|NCT02063958|Hsp90|hsp90
357174|NCT02063945|ADHA|adha
357175|NCT02063945|ODD|odd
357176|NCT02063945|Conduct disorder|conduct disorder
357177|NCT02063945|Aggression|aggression
357178|NCT02063945|Treatment|treatment
357179|NCT02063945|Methylphenidate|methylphenidate
357180|NCT02063945|Risperidone|risperidone
357181|NCT02063932|mucosal microbiome|mucosal microbiome
357182|NCT02063932|H.pylori|h.pylori
357183|NCT02063932|intestinal metaplasia|intestinal metaplasia
357184|NCT02063932|gastric neoplasia|gastric neoplasia
357185|NCT02063932|endomicroscopy|endomicroscopy
357186|NCT02063880|HIV-1|hiv-1
357187|NCT02063880|IRIS|iris
357188|NCT02063867|HAI|hai
357189|NCT02063867|MRSA|mrsa
357190|NCT02063867|VRE|vre
357191|NCT02063854|Drug Therapy|drug therapy
357192|NCT02063828|anxiety|anxiety
357193|NCT02063828|Dyspnea|dyspnea
357194|NCT02063828|respiratory functioning|respiratory functioning
357195|NCT02063802|pediatric obesity|pediatric obesity
357196|NCT02063802|conjugated linoleic acid|conjugated linoleic acid
357197|NCT02063802|CLA|cla
357198|NCT02063802|metformin|metformin
357199|NCT02063789|Immune Thrombocytopenia|immune thrombocytopenia
357200|NCT02063789|Immune Thrombocytopenic Purpura|immune thrombocytopenic purpura
357201|NCT02063789|Idiopathic Thrombocytopenic Purpura|idiopathic thrombocytopenic purpura
357202|NCT02063789|Human Immunoglobulin|human immunoglobulin
357203|NCT02063789|ITP|itp
357204|NCT02063789|IVIg|ivig
357205|NCT02063789|IgIV|igiv
357206|NCT02063789|IV-Globulin SN Inj.|iv-globulin sn inj.
357207|NCT02063776|Haemodiafiltration (HDF)|haemodiafiltration (hdf)
357208|NCT02063776|Haemodialysis (HD)|haemodialysis (hd)
357209|NCT02063776|Children|children
357210|NCT02063776|Carotid intima media thickness|carotid intima media thickness
357211|NCT02063776|Pulse wave velocity|pulse wave velocity
357212|NCT02063776|Height standard deviation score|height standard deviation score
357213|NCT02063763|Adult patients|adult patients
357214|NCT02063763|Immune primary thrombocytopenia|immune primary thrombocytopenia
357215|NCT02063763|Splenectomy|splenectomy
357216|NCT02063763|TPO-mimetics|tpo-mimetics
357217|NCT02063763|Eltrombopag|eltrombopag
357218|NCT02063763|Romiplostim|romiplostim
357219|NCT02063750|Fibromyalgia|fibromyalgia
357220|NCT02063750|Muscle strength exercises|muscle strength exercises
357221|NCT02063750|Pain|pain
357222|NCT02063750|Quality of life|quality of life
357223|NCT02063737|Shift work|shift work
357224|NCT02063737|Fatigue|fatigue
357225|NCT02063737|Sleepiness|sleepiness
357226|NCT02063737|Injury|injury
357227|NCT02063724|Invasive Breast Cancer|invasive breast cancer
357228|NCT02063724|Breast Cancer|breast cancer
357229|NCT02063724|Immunotherapy|immunotherapy
357230|NCT02063724|Vaccine|vaccine
357231|NCT02063724|Dendritic Cell|dendritic cell
357232|NCT02063711|Prenatal Yoga|prenatal yoga
357233|NCT02063711|Yoga, Pregnancy|yoga, pregnancy
357234|NCT02063711|Yoga, Fetal Response|yoga, fetal response
357235|NCT02063646|polyphenols|polyphenols
357236|NCT02063646|memory|memory
357237|NCT02063646|elderly|elderly
357238|NCT02063633|Thoracic malignancy, irradiation, respiratory gating system PET|thoracic malignancy, irradiation, respiratory gating system pet
357239|NCT02063620|IVRA, ketamine, lidocaine, ECG|ivra, ketamine, lidocaine, ecg
357240|NCT02063607|Hepatitis C naive|hepatitis c naive
357241|NCT02063594|Iodixanol|iodixanol
357242|NCT02063594|Iodinated Contrast|iodinated contrast
357243|NCT02063594|Liposome|liposome
357244|NCT02063594|Computed Tomography|computed tomography
357245|NCT02063594|X-ray Imaging|x-ray imaging
357246|NCT02063594|Blood pool agent|blood pool agent
357247|NCT02063594|Biomarker|biomarker
357248|NCT02063555|Tuberculosis|tuberculosis
357249|NCT02063555|BCG|bcg
357250|NCT02063555|HIV|hiv
357251|NCT02063555|TB Vaccines|tb vaccines
357252|NCT02063542|Postoperative cognitive changes|postoperative cognitive changes
357253|NCT02063542|Acetylcholine in CSF|acetylcholine in csf
357254|NCT02063542|Surgery|surgery
357255|NCT02063529|Colorectal cancer|colorectal cancer
357256|NCT02063529|Metastatic colorectal cancer|metastatic colorectal cancer
357257|NCT02063529|Liver metastases|liver metastases
357258|NCT02063529|Liver resection|liver resection
357259|NCT02063529|Liver ablation|liver ablation
357260|NCT02063529|Conversion therapy|conversion therapy
357261|NCT02063529|FOLFOXIRI|folfoxiri
357262|NCT02063529|Cetuximab|cetuximab
357263|NCT02063529|Oxaliplatin|oxaliplatin
357264|NCT02063529|Irinotecan|irinotecan
357265|NCT02063529|Leucovorin|leucovorin
357266|NCT02063516|Airway Cuff|airway cuff
357267|NCT02063516|Guardian|guardian
357268|NCT02063516|Proseal|proseal
357269|NCT02063516|Cuff Pressure|cuff pressure
357270|NCT02063516|laryngeal Mask Airway|laryngeal mask airway
357271|NCT02063503|prognostic indicator|prognostic indicator
357272|NCT02063503|nonspecific|nonspecific
357273|NCT02063503|chronic|chronic
357274|NCT02063503|low back pain|low back pain
357275|NCT02063503|Non specific chronic low back pain|non specific chronic low back pain
357276|NCT02063490|Adherence|adherence
357277|NCT02063490|dialysis|dialysis
357278|NCT02063490|intervention|intervention
357279|NCT02063490|nurse-led|nurse-led
357280|NCT02063490|phosphate binders|phosphate binders
357281|NCT02063490|trial|trial
357282|NCT02063464|Tumorcidal|tumorcidal
357283|NCT02063464|Monocytes|monocytes
357284|NCT02063464|Interferons Alpha and Gamma|interferons alpha and gamma
357285|NCT02063451|Obesity [C18.654.726.500]|obesity [c18.654.726.500]
357286|NCT02063451|Receptor, Opioid, mu [D12.776.543.750.100.620.550]|receptor, opioid, mu [d12.776.543.750.100.620.550]
357287|NCT02063451|Brain [A08.186.211]|brain [a08.186.211]
357288|NCT02063451|Affect [F01.470.047]|affect [f01.470.047]
357289|NCT02063438|Thoracotomy|thoracotomy
357290|NCT02063438|Pain|pain
357291|NCT02063438|Intracostal Suture|intracostal suture
357292|NCT02063438|Pericostal Suture|pericostal suture
357293|NCT02063425|Motor recovery|motor recovery
357294|NCT02063425|Fluoxetine|fluoxetine
357295|NCT02063425|Transcranial magnetic stimulation|transcranial magnetic stimulation
357296|NCT02063425|stroke|stroke
357297|NCT02063399|NPC|npc
357298|NCT02063399|Cancer screening|cancer screening
357299|NCT02063399|Plasma EBV DNA|plasma ebv dna
357300|NCT02063347|innate collateral supply|innate collateral supply
357301|NCT02063347|collateral|collateral
357302|NCT02063347|coronary collateral|coronary collateral
357303|NCT02063347|renal collateral|renal collateral
357304|NCT02063347|peripheral collateral|peripheral collateral
357305|NCT02063347|coronary artery disease|coronary artery disease
357306|NCT02063334|vitamin D3|vitamin d3
357307|NCT02063334|cholecalciferol|cholecalciferol
357308|NCT02063334|calcidiol|calcidiol
357309|NCT02063334|25-hydroxyvitamin D|25-hydroxyvitamin d
357310|NCT02063334|gene expression|gene expression
357311|NCT02063334|vitamin D receptor|vitamin d receptor
357312|NCT02063334|randomized controlled trial|randomized controlled trial
357313|NCT02063334|men|men
357314|NCT02063334|adults|adults
357315|NCT02063321|DME, diabetic retinopathy, diabetes mellitus, epidemiology|dme, diabetic retinopathy, diabetes mellitus, epidemiology
357316|NCT02063308|Oxaloacetate|oxaloacetate
357317|NCT02063308|OAA|oaa
357318|NCT02063308|AD|ad
357319|NCT02063308|Alzheimer's Disease|alzheimer's disease
357320|NCT02063295|Beloranib|beloranib
357321|NCT02063295|ZGN-440|zgn-440
357322|NCT02063295|ZGN-440 for injectable suspension|zgn-440 for injectable suspension
357323|NCT02063295|ZGN-433|zgn-433
357324|NCT02063282|Asymptomatic|asymptomatic
357325|NCT02063282|Carriage|carriage
357326|NCT02063282|Colonization|colonization
357327|NCT02063282|Clostridium difficile|clostridium difficile
357328|NCT02063282|Colitis|colitis
357329|NCT02063282|Rectal swab|rectal swab
357330|NCT02063269|rivastigmine, butyrylcholinesterase, MRI, PET|rivastigmine, butyrylcholinesterase, mri, pet
357331|NCT02063256|sperm count|sperm count
357332|NCT02063256|sperm concentration|sperm concentration
357333|NCT02063256|mobility|mobility
357334|NCT02063256|diet|diet
357335|NCT02063256|PUFA (polyunsaturated fatty acids)|pufa (polyunsaturated fatty acids)
357336|NCT02063243|Keloid, hypertrophic scar|keloid, hypertrophic scar
357337|NCT02063230|Phase I, healthy, pharmacokinetic, hepatic impairment|phase i, healthy, pharmacokinetic, hepatic impairment
357338|NCT02063204|Phase I, healthy, pharmacokinetics, renal impairment|phase i, healthy, pharmacokinetics, renal impairment
357339|NCT02063191|Atrial Fibrillation|atrial fibrillation
357340|NCT02063191|Bundle Branch Block|bundle branch block
357341|NCT02063165|Safflower Oil|safflower oil
357342|NCT02063165|Linoleic Acid|linoleic acid
357343|NCT02063165|Dyslipidemia|dyslipidemia
357344|NCT02063165|Hypertension|hypertension
357345|NCT02063139|Knemometry|knemometry
357346|NCT02063126|Coenzyme Q10 plus NADH|coenzyme q10 plus nadh
357347|NCT02063126|maximum Heart Rate|maximum heart rate
357348|NCT02063126|Fatigue|fatigue
357349|NCT02063126|Pain|pain
357350|NCT02063126|Sleep|sleep
357351|NCT02063113|Multiple myeloma,|multiple myeloma,
357352|NCT02063113|Older patient,|older patient,
357353|NCT02063113|Treatment,|treatment,
357354|NCT02063113|Geriatric assessment|geriatric assessment
357355|NCT02063100|Glomerulonephritis|glomerulonephritis
357356|NCT02063100|proteinuria|proteinuria
357357|NCT02063100|shenyankangfu tablets|shenyankangfu tablets
357358|NCT02063100|Losartan Potassium|losartan potassium
357359|NCT02063100|efficacy|efficacy
357360|NCT02063100|safety|safety
357361|NCT02063087|Head CT|head ct
357362|NCT02063087|Head Injury|head injury
357363|NCT02063087|Pediatric|pediatric
357364|NCT02063087|Emergency Department|emergency department
357365|NCT02063087|Decision Aids|decision aids
357366|NCT02063087|Shared Decision Making|shared decision making
357367|NCT02063061|extracorporeal shock wave therapy ESWT|extracorporeal shock wave therapy eswt
357368|NCT02063061|erectile dysfunction|erectile dysfunction
357369|NCT02063048|weight loss|weight loss
357370|NCT02063048|Text Messaging|text messaging
357371|NCT02063048|Short Message Service|short message service
357372|NCT02063048|Text Messages|text messages
357373|NCT02063035|lumbar spine surgery|lumbar spine surgery
357374|NCT02063035|thoracic spine surgery|thoracic spine surgery
357375|NCT02063022|Non metastatic Ewing's Sarcoma|non metastatic ewing's sarcoma
357376|NCT02062944|Liver Transplant|liver transplant
357377|NCT02062944|Sirolimus|sirolimus
357378|NCT02062944|Rapamune|rapamune
357379|NCT02062944|Immunosuppressant Therapy|immunosuppressant therapy
357380|NCT02062944|Withdrawal|withdrawal
357381|NCT02062931|Primary Infertility|primary infertility
357382|NCT02062931|Primary Amenorrhea|primary amenorrhea
357383|NCT02062931|Sex Steroid Deficiency|sex steroid deficiency
357384|NCT02062931|Premature Ovarian Failure (POF)|premature ovarian failure (pof)
357385|NCT02062918|Abdominal belt|abdominal belt
357386|NCT02062918|Chronic low back pain|chronic low back pain
357387|NCT02062918|Pain|pain
357388|NCT02062918|Functional capacity|functional capacity
357389|NCT02062892|everolimus|everolimus
357390|NCT02062892|sirolimus|sirolimus
357391|NCT02062892|tacrolimus|tacrolimus
357392|NCT02062892|vascular endothelial function|vascular endothelial function
357393|NCT02062892|kidney|kidney
357394|NCT02062892|Transplantation|transplantation
357395|NCT02062892|biomarkers|biomarkers
357396|NCT02062879|pain|pain
357397|NCT02062879|trauma|trauma
357398|NCT02062840|Whole Body Hyperthermia|whole body hyperthermia
357399|NCT02062840|Functional Magnetic Resonance Imaging|functional magnetic resonance imaging
357401|NCT02062827|Glioma|glioma
357402|NCT02062827|Virus|virus
357403|NCT02062827|Oncolytic virus|oncolytic virus
357404|NCT02062827|Gene therapy|gene therapy
357405|NCT02062827|Immunotherapy|immunotherapy
357406|NCT02062801|Combined spinal epidural analgesia, labor, fetal bradycardia|combined spinal epidural analgesia, labor, fetal bradycardia
357407|NCT02062788|Early Recovery After Surgery|early recovery after surgery
357408|NCT02062788|Oral rehydration solution|oral rehydration solution
357409|NCT02062788|Insulin resistance|insulin resistance
357410|NCT02062788|Postoperative complication|postoperative complication
357411|NCT02062749|Colorectal cancer|colorectal cancer
357412|NCT02062749|Colon Cancer|colon cancer
357413|NCT02062749|Pediatric|pediatric
357414|NCT02062749|Adolescent|adolescent
357415|NCT02062749|Hyperthermic Intraperitoneal Chemotherapy|hyperthermic intraperitoneal chemotherapy
357416|NCT02062749|HIPEC|hipec
357417|NCT02062749|Oxaliplatin|oxaliplatin
357418|NCT02062749|Eloxatin|eloxatin
357419|NCT02062736|methadone|methadone
357420|NCT02062736|heroin addiction|heroin addiction
357421|NCT02062736|methadone maintenance treatment|methadone maintenance treatment
357422|NCT02062736|adequate dosage of methadone|adequate dosage of methadone
357423|NCT02062723|methadone|methadone
357424|NCT02062723|heroin addiction|heroin addiction
357425|NCT02062723|methadone maintenance treatment|methadone maintenance treatment
357426|NCT02062723|adequate dosage of methadone|adequate dosage of methadone
357427|NCT02062710|cough|cough
357428|NCT02062710|cough reflex|cough reflex
357429|NCT02062710|capsaicin|capsaicin
357430|NCT02062710|diphenhydramine|diphenhydramine
357431|NCT02062710|phenylephrine|phenylephrine
357432|NCT02062710|dextromethorphan|dextromethorphan
357433|NCT02062710|placebo|placebo
357434|NCT02062697|Neoplasms|neoplasms
357435|NCT02062697|Glandular and Epithelial|glandular and epithelial
357436|NCT02062697|Ovarian Neoplasms|ovarian neoplasms
357437|NCT02062697|Ovarian cancer|ovarian cancer
357438|NCT02062684|IgAN|igan
357439|NCT02062684|IgA Nephropathy|iga nephropathy
357440|NCT02062684|A-623|a-623
357441|NCT02062684|Blisibimod|blisibimod
357442|NCT02062684|Kidney Disease|kidney disease
357443|NCT02062684|Persistent proteinuria|persistent proteinuria
357444|NCT02062671|ADPKD|adpkd
357445|NCT02062671|denervation|denervation
357446|NCT02062671|renal denervation|renal denervation
357448|NCT02062645|essential hypertension|essential hypertension
357449|NCT02062619|Stroke|stroke
357450|NCT02062619|Aphasia|aphasia
357451|NCT02062619|Acquired reading disorders|acquired reading disorders
357452|NCT02062619|Central alexia|central alexia
357453|NCT02062619|Computer based rehabilitation|computer based rehabilitation
357454|NCT02062619|Transcranial direct current stimulation|transcranial direct current stimulation
357455|NCT02062619|tDCS|tdcs
357456|NCT02062619|Magnetoencephalography|magnetoencephalography
357457|NCT02062619|MEG|meg
357458|NCT02062619|Magnetic Resonance Imaging|magnetic resonance imaging
357459|NCT02062619|MRI|mri
357460|NCT02062606|Scoliosis|scoliosis
357461|NCT02062606|Spinal Curvatures|spinal curvatures
357462|NCT02062606|Spinal Diseases|spinal diseases
357463|NCT02062606|Adolescent Idiopathic Scoliosis|adolescent idiopathic scoliosis
357464|NCT02062606|Spinal Deformity|spinal deformity
357465|NCT02062593|Stable angina|stable angina
357466|NCT02062593|Percutaneous coronary intervention|percutaneous coronary intervention
357467|NCT02062593|Optimal medical therapy|optimal medical therapy
357468|NCT02062593|Sham-control|sham-control
357469|NCT02062580|Vaccine immunogenicity|vaccine immunogenicity
357470|NCT02062580|Immune activation|immune activation
357471|NCT02062554|Myocardial infarction|myocardial infarction
357472|NCT02062554|Clinical outcome|clinical outcome
357473|NCT02062554|Flow-mediated dilation|flow-mediated dilation
357474|NCT02062554|Inflammation|inflammation
357475|NCT02062541|functional assessment|functional assessment
357476|NCT02062541|rehabilitation|rehabilitation
357477|NCT02062541|cross-sectorial cooperation|cross-sectorial cooperation
357478|NCT02062528|EPA|epa
357479|NCT02062489|breast cancer,|breast cancer,
357480|NCT02062489|tamoxifen,|tamoxifen,
357481|NCT02062489|ER/PR negative, ER-beta positive|er/pr negative, er-beta positive
357482|NCT02062463|Asthma|asthma
357483|NCT02062450|Arthroplasty|arthroplasty
357484|NCT02062450|Hip Replacement|hip replacement
357485|NCT02062450|Acetabular cup|acetabular cup
357486|NCT02062450|Dual mobility|dual mobility
357487|NCT02062450|Hip revision surgery|hip revision surgery
357488|NCT02062437|Arthroplasty|arthroplasty
357489|NCT02062437|Hip Replacement|hip replacement
357490|NCT02062437|Ceramic|ceramic
357491|NCT02062437|Acetabular cup|acetabular cup
357492|NCT02062437|Femoral stem|femoral stem
357493|NCT02062424|ischemic heart disease, dietary guidelines|ischemic heart disease, dietary guidelines
357494|NCT02062411|attention deficit disorder (ADHD)|attention deficit disorder (adhd)
357495|NCT02062411|cognitive behavioral therapy (CBT)|cognitive behavioral therapy (cbt)
357496|NCT02062411|adult|adult
357497|NCT02062398|PNP|pnp
357498|NCT02062398|Stimulation|stimulation
357499|NCT02062398|Peripheral neurostimulation|peripheral neurostimulation
357500|NCT02062372|7 T MRI|7 t mri
357501|NCT02062372|Radiotherapy|radiotherapy
357502|NCT02062372|Glioblastoma|glioblastoma
357503|NCT02062372|Biopsy|biopsy
357504|NCT02062359|Malignant Melanoma|malignant melanoma
357505|NCT02062359|Metastatic Cancer|metastatic cancer
357506|NCT02062359|Gene Therapy|gene therapy
357507|NCT02062359|Immunotherapy|immunotherapy
357508|NCT02062359|Tumor Regression|tumor regression
357509|NCT02062346|endothelin;|endothelin;
357510|NCT02062346|blood pressure;|blood pressure;
357511|NCT02062346|vasculitis|vasculitis
357512|NCT02062333|dexmedetomidine|dexmedetomidine
357513|NCT02062333|esmolol|esmolol
357514|NCT02062333|stapes reflex|stapes reflex
357515|NCT02062320|Acute Pain Service|acute pain service
357516|NCT02062320|postoperative analgesia|postoperative analgesia
357517|NCT02062320|Caesarean Section|caesarean section
357518|NCT02062320|non-opioid analgesia|non-opioid analgesia
357519|NCT02062320|opioid analgesia|opioid analgesia
357520|NCT02062320|epidural analgesia|epidural analgesia
357521|NCT02062307|Hypogonadism|hypogonadism
357522|NCT02062307|Asymmetric Dimethyl Arginine|asymmetric dimethyl arginine
357523|NCT02062307|Osteoprotegerin|osteoprotegerin
357524|NCT02062307|Fibroblast Growth Factor|fibroblast growth factor
357525|NCT02062307|Vitamin D|vitamin d
357526|NCT02062281|Safety|safety
357527|NCT02062281|Immunogenicity|immunogenicity
357528|NCT02062281|vaccine|vaccine
357529|NCT02062281|pneumococcal|pneumococcal
357530|NCT02062281|influenza|influenza
357531|NCT02062268|KAP|kap
357532|NCT02062268|drink driving|drink driving
357533|NCT02062268|public|public
357534|NCT02062268|Jiangsu province|jiangsu province
357535|NCT02062268|China|china
357536|NCT02062255|Asprin|asprin
357537|NCT02062255|Omega-3 Free Fatty Acids|omega-3 free fatty acids
357538|NCT02062255|Obesity|obesity
357539|NCT02062255|COX-2 inhibitor|cox-2 inhibitor
357540|NCT02062242|Pelvic Floor|pelvic floor
357541|NCT02062242|Physical Therapy Specialty|physical therapy specialty
357542|NCT02062242|Awareness|awareness
357543|NCT02062242|Electric Stimulation|electric stimulation
357544|NCT02062242|Palpation|palpation
457171|NCT01610310|SC|sc
357545|NCT02062229|oxidative stress|oxidative stress
357546|NCT02062229|oxysterols|oxysterols
357547|NCT02062229|fatty acids|fatty acids
357548|NCT02062229|seminal fluid|seminal fluid
357549|NCT02062216|Coronary artery disease|coronary artery disease
357550|NCT02062216|Percutaneous coronary intervention|percutaneous coronary intervention
357551|NCT02062216|Inflammatory receptors|inflammatory receptors
357552|NCT02062203|Akebia|akebia
357553|NCT02062203|QT interval|qt interval
357554|NCT02062203|TQT|tqt
357555|NCT02062203|pharmacokinetic|pharmacokinetic
357556|NCT02062203|anemia|anemia
357557|NCT02062203|chronic kidney disease|chronic kidney disease
357558|NCT02062203|CKD|ckd
357559|NCT02062203|chronic renal insufficiency|chronic renal insufficiency
357560|NCT02062203|renal impairment|renal impairment
357561|NCT02062203|safety|safety
357562|NCT02062164|psychosocial, healthcare, co-morbidities, extremely obese adolescents|psychosocial, healthcare, co-morbidities, extremely obese adolescents
357563|NCT02062151|Acupuncture|acupuncture
357564|NCT02062138|rehabilitation|rehabilitation
357565|NCT02062138|total knee arthroplasty|total knee arthroplasty
357566|NCT02062138|range of motion|range of motion
357567|NCT02062138|continuous passive motion|continuous passive motion
357568|NCT02062138|controlled active motion|controlled active motion
357569|NCT02062138|postoperative physical therapy|postoperative physical therapy
357570|NCT02062125|scleroderma|scleroderma
357571|NCT02062125|calcinosis|calcinosis
357572|NCT02062112|Bowel preparation solutions|bowel preparation solutions
357573|NCT02062112|Colonoscopy|colonoscopy
357574|NCT02062112|Polyethylene glycol|polyethylene glycol
357575|NCT02062086|Sarcopenia|sarcopenia
357576|NCT02062086|Mass muscle|mass muscle
357577|NCT02062086|Quality of life|quality of life
357578|NCT02062073|head lice|head lice
357579|NCT02062073|Hatchtech|hatchtech
357580|NCT02062060|Head Lice|head lice
357581|NCT02062060|Hatchtech|hatchtech
357582|NCT02062047|Diabetes Mellitus|diabetes mellitus
357583|NCT02062047|Chronic Periodontitis|chronic periodontitis
357584|NCT02062047|Root Planing|root planing
357585|NCT02062047|Cytokines|cytokines
357586|NCT02062047|microbiology|microbiology
357587|NCT02062047|Glycated hemoglobin|glycated hemoglobin
357588|NCT02062047|diabetic subjects|diabetic subjects
357589|NCT02062034|Oxidative stress|oxidative stress
357590|NCT02062034|Mitochondrial dysfunction|mitochondrial dysfunction
357591|NCT02062034|Ubiquinone|ubiquinone
357592|NCT02062034|Antioxidant combined therapy|antioxidant combined therapy
357593|NCT02062034|Diabetic retinopathy|diabetic retinopathy
357594|NCT02062008|Positron Emission Tomography-Magnetic Resonance Imaging|positron emission tomography-magnetic resonance imaging
357595|NCT02062008|Cardiac Disease|cardiac disease
357596|NCT02061995|Bone Diseases|bone diseases
357597|NCT02061995|Metabolic Bone Diseases|metabolic bone diseases
357598|NCT02061995|Osteoporosis|osteoporosis
357599|NCT02061995|Bone Fractures|bone fractures
357600|NCT02061995|Osteoporotic Fractures|osteoporotic fractures
357601|NCT02061995|Musculoskeletal Diseases|musculoskeletal diseases
357602|NCT02061982|Do It Yourself (DIY)|do it yourself (diy)
357603|NCT02061982|Caffeine|caffeine
357604|NCT02061982|Cognition|cognition
357605|NCT02061969|nursing home facility|nursing home facility
357606|NCT02061969|long-term care facility|long-term care facility
357607|NCT02061969|older patients|older patients
357608|NCT02061969|elderly patients|elderly patients
357609|NCT02061969|hyperglycemia|hyperglycemia
357610|NCT02061969|type 2 diabetes|type 2 diabetes
357611|NCT02061943|Spasmodic dysphonia|spasmodic dysphonia
357612|NCT02061943|Laryngeal dystonia|laryngeal dystonia
357613|NCT02061943|Dystonia|dystonia
357614|NCT02061943|Severity|severity
357615|NCT02061930|single tooth|single tooth
357616|NCT02061930|dental implant|dental implant
357617|NCT02061930|aesthetics outcome|aesthetics outcome
357618|NCT02061930|long term|long term
357619|NCT02061930|soft tissue recession|soft tissue recession
357620|NCT02061930|pink esthetic score|pink esthetic score
357621|NCT02061930|white esthetic score|white esthetic score
357622|NCT02061917|Biomarkers|biomarkers
357623|NCT02061917|Tobacco|tobacco
357624|NCT02061917|Tobacco-heating|tobacco-heating
357625|NCT02061917|Smokeless Tobacco|smokeless tobacco
357626|NCT02061917|Snus|snus
357627|NCT02061917|Smoking|smoking
357628|NCT02061917|Exposure|exposure
357629|NCT02061917|Quality of Life|quality of life
357630|NCT02061891|Coronary Stenosis|coronary stenosis
357631|NCT02061891|Coronary Artery Disease|coronary artery disease
357632|NCT02061891|Acute coronary syndrome|acute coronary syndrome
357633|NCT02061891|Percutaneous Coronary Intervention|percutaneous coronary intervention
357634|NCT02061891|Multidetector Computed Tomography|multidetector computed tomography
357635|NCT02061878|ApoE|apoe
357636|NCT02061878|beta-amyloid|beta-amyloid
357637|NCT02061813|Hatchtech|hatchtech
357638|NCT02061800|Unrelated donor transplant|unrelated donor transplant
357639|NCT02061800|Allogenic Stem Cell Transplant|allogenic stem cell transplant
357640|NCT02061800|Adult Bone Marrow Transplant|adult bone marrow transplant
357641|NCT02061800|Pediatric Bone Marrow Transplant|pediatric bone marrow transplant
357642|NCT02061800|Related donor transplant|related donor transplant
357643|NCT02061800|Haploidentical donor transplant|haploidentical donor transplant
357644|NCT02061800|Peripheral blood stem cell transplantation|peripheral blood stem cell transplantation
357645|NCT02061800|Non-malignant disease|non-malignant disease
357646|NCT02061800|Malignant disease|malignant disease
357647|NCT02061800|Bone marrow failure syndrome|bone marrow failure syndrome
357648|NCT02061800|Severe Aplastic Anemia|severe aplastic anemia
357649|NCT02061800|Severe Congenital Neutropenia|severe congenital neutropenia
357650|NCT02061800|Amegakaryocytic Thrombocytopenia|amegakaryocytic thrombocytopenia
357651|NCT02061800|Diamond-Blackfan Anemia|diamond-blackfan anemia
357652|NCT02061800|Schwachman Diamond Syndrome|schwachman diamond syndrome
357653|NCT02061800|Primary Immunodeficiency Syndrome|primary immunodeficiency syndrome
357654|NCT02061800|Acquired Immunodeficiency Syndrome|acquired immunodeficiency syndrome
357655|NCT02061800|Histiocytic Syndrome|histiocytic syndrome
357656|NCT02061800|Familial Hemophagocytic Lymphocytosis|familial hemophagocytic lymphocytosis
357657|NCT02061800|Lymphohistiocytosis|lymphohistiocytosis
357658|NCT02061800|Macrophage Activation Syndrome|macrophage activation syndrome
357659|NCT02061800|Langerhans Cell Histiocytosis (LCH)|langerhans cell histiocytosis (lch)
357660|NCT02061800|Hemoglobinopathies|hemoglobinopathies
357661|NCT02061800|Reduced-Intensity Conditioning|reduced-intensity conditioning
357662|NCT02061800|Sickle Cell Disease|sickle cell disease
357663|NCT02061800|Sickle Cell-beta-thalassemia|sickle cell-beta-thalassemia
357664|NCT02061774|acetaminophen in transforaminal lumbar interbody fusion|acetaminophen in transforaminal lumbar interbody fusion
357665|NCT02061735|skin imaging|skin imaging
357666|NCT02061735|image analysis|image analysis
357667|NCT02061735|infrared thermography|infrared thermography
357668|NCT02061735|infantile hemangioma|infantile hemangioma
357669|NCT02061735|three dimensional imaging|three dimensional imaging
357670|NCT02061735|color imaging and analysis|color imaging and analysis
357671|NCT02061735|propranolol|propranolol
357672|NCT02061735|timolol|timolol
357673|NCT02061735|ontogeny|ontogeny
357674|NCT02061709|Rhinoconjunctivitis|rhinoconjunctivitis
357675|NCT02061709|Rhinitis|rhinitis
357676|NCT02061709|Seasonal|seasonal
357677|NCT02061709|Ragweed|ragweed
357678|NCT02061709|Allergy|allergy
357679|NCT02061696|Coronary Artery Disease|coronary artery disease
357680|NCT02061696|Coronary Disease|coronary disease
357681|NCT02061696|Heart disease|heart disease
357682|NCT02061696|Cardiovascular Diseases|cardiovascular diseases
357683|NCT02061696|Arteriosclerosis|arteriosclerosis
357684|NCT02061696|Atherosclerosis|atherosclerosis
357685|NCT02061696|Manual Compression|manual compression
357686|NCT02061670|Ragweed|ragweed
357687|NCT02061670|Allergy|allergy
357688|NCT02061670|rhinoconjunctivitis|rhinoconjunctivitis
357689|NCT02061670|rhinitis|rhinitis
357690|NCT02061670|asthma|asthma
357691|NCT02061618|South Asian|south asian
357692|NCT02061605|Laparoscopic partial nephrectomy|laparoscopic partial nephrectomy
357693|NCT02061605|Surgical hemostasis|surgical hemostasis
357694|NCT02061605|Laser tissue welding|laser tissue welding
357695|NCT02061605|Tissue sealant|tissue sealant
357696|NCT02061579|Physical Activity|physical activity
357697|NCT02061566|Acute kidney injury|acute kidney injury
357698|NCT02061553|traumatic brain injury|traumatic brain injury
357699|NCT02061553|TBI|tbi
357700|NCT02061553|head injury|head injury
357701|NCT02061553|brain injury|brain injury
357702|NCT02061553|depression|depression
357703|NCT02061553|anxiety|anxiety
357704|NCT02061527|ADM|adm
357705|NCT02061527|Strattice|strattice
357706|NCT02061527|Breast reconstruction|breast reconstruction
357707|NCT02061527|Immediate breast reconstruction|immediate breast reconstruction
357708|NCT02061527|IBR|ibr
357709|NCT02061527|Acellular dermal matrix|acellular dermal matrix
357710|NCT02061527|Biological mesh|biological mesh
357711|NCT02061527|Randomized controlled trial|randomized controlled trial
357712|NCT02061527|RCT|rct
357713|NCT02061527|Breast cancer|breast cancer
357714|NCT02061527|Implants|implants
357715|NCT02061527|Mastectomy|mastectomy
357716|NCT02061527|Direct-to-implant|direct-to-implant
357717|NCT02061501|visual cognitive deficits|visual cognitive deficits
357718|NCT02061488|Artificial pancreas, closed loop glucose control, model predictive control|artificial pancreas, closed loop glucose control, model predictive control
357719|NCT02061475|Lidocaine patches|lidocaine patches
357720|NCT02061475|Pain|pain
357721|NCT02061475|Intravenous cannulation|intravenous cannulation
357722|NCT02061449|Toll-like receptor agonist|toll-like receptor agonist
357723|NCT02061449|immunostimulation|immunostimulation
357724|NCT02061436|chronic total occlusion, percutaneous coronary intervention|chronic total occlusion, percutaneous coronary intervention
357725|NCT02061423|Invasive Breast Cancer|invasive breast cancer
357726|NCT02061423|Breast Cancer|breast cancer
357727|NCT02061423|Immunotherapy|immunotherapy
357728|NCT02061423|Vaccine|vaccine
357729|NCT02061423|Dendritic Cell|dendritic cell
357730|NCT02061423|Neoadjuvant|neoadjuvant
357731|NCT02061410|Elderly|elderly
357732|NCT02061397|lymphangioleiomyomatosis (LAM)|lymphangioleiomyomatosis (lam)
357733|NCT02061397|tuberous sclerosis complex (TSC)|tuberous sclerosis complex (tsc)
457481|NCT01609465|CAD|cad
357734|NCT02061397|simvastatin|simvastatin
357735|NCT02061397|sirolimus|sirolimus
357736|NCT02061397|everolimus|everolimus
357737|NCT02061384|Infertility|infertility
357738|NCT02061371|stroke|stroke
357739|NCT02061371|spasticity|spasticity
357740|NCT02061371|physiotherapy|physiotherapy
357741|NCT02061371|virtual reality|virtual reality
357742|NCT02061358|Dengue|dengue
357743|NCT02061358|Arbovirus Infections|arbovirus infections
357744|NCT02061358|Flaviviridae Infections|flaviviridae infections
357745|NCT02061358|Flavivirus Infections|flavivirus infections
357746|NCT02061358|Hemorrhagic Fevers, Viral|hemorrhagic fevers, viral
357747|NCT02061358|RNA Virus Infections|rna virus infections
357748|NCT02061358|Virus Diseases|virus diseases
357749|NCT02061358|Pharmaceutical Solutions|pharmaceutical solutions
357750|NCT02061358|Pharmacologic Actions|pharmacologic actions
357751|NCT02061358|Therapeutic Uses|therapeutic uses
357752|NCT02061345|Prostate cancer|prostate cancer
357753|NCT02061345|Androgen Deprivation Therapy|androgen deprivation therapy
357754|NCT02061345|Mild Cognitive Impairment|mild cognitive impairment
357755|NCT02061332|Breast Cancer|breast cancer
357756|NCT02061332|DCIS|dcis
357757|NCT02061332|Immunotherapy|immunotherapy
357758|NCT02061332|Vaccine|vaccine
357759|NCT02061332|Dendritic Cell|dendritic cell
357760|NCT02061306|Celiac disease|celiac disease
357761|NCT02061306|coeliac disease|coeliac disease
357762|NCT02061306|microbiome|microbiome
357763|NCT02061306|gluten|gluten
357764|NCT02061306|infants|infants
357765|NCT02061306|pregnancy|pregnancy
357766|NCT02061306|genetic|genetic
357767|NCT02061280|Asthma|asthma
357768|NCT02061280|Clinical Trial Design|clinical trial design
357769|NCT02061280|Electronic Data Entry|electronic data entry
357770|NCT02061280|Mobile Devices|mobile devices
357771|NCT02061280|Home Spirometry|home spirometry
357772|NCT02061267|Metabolic Syndrome|metabolic syndrome
357773|NCT02061267|Olive Oil|olive oil
357774|NCT02061267|Niacin|niacin
357775|NCT02061254|Venous insufficiency|venous insufficiency
357776|NCT02061254|Lymphedema|lymphedema
357777|NCT02061254|Elastograph|elastograph
357778|NCT02061254|Ultrasonography|ultrasonography
357779|NCT02061254|Fibrosis|fibrosis
357780|NCT02061254|Dermis|dermis
357781|NCT02061254|Hypodermis|hypodermis
357782|NCT02061254|Skin|skin
357783|NCT02061241|Cardiac resynchronisation therapy|cardiac resynchronisation therapy
357784|NCT02061241|Pacing|pacing
357785|NCT02061215|CYTOF|cytof
357786|NCT02061215|CMV|cmv
357787|NCT02061215|PCR|pcr
357788|NCT02061215|HLA|hla
357789|NCT02061202|Sickle Cell Disease|sickle cell disease
357790|NCT02061202|Pain Crisis|pain crisis
357791|NCT02061202|Painful Crisis|painful crisis
357792|NCT02061202|Sickle Pain|sickle pain
357793|NCT02061189|neuromuscular disease, Spinal Muscular Atrophy, Infantile,|neuromuscular disease, spinal muscular atrophy, infantile,
357794|NCT02061189|motor function measure, Hammersmith scale,|motor function measure, hammersmith scale,
357795|NCT02061189|rehabilitation program, physical exercise|rehabilitation program, physical exercise
357796|NCT02061176|Hemorrhoids|hemorrhoids
357797|NCT02061176|Haemorrhoids|haemorrhoids
357798|NCT02061176|Transanal Haemorrhoidal Dearterialization|transanal haemorrhoidal dearterialization
357799|NCT02061176|Transanal Hemorrhoidal Dearterialisation|transanal hemorrhoidal dearterialisation
357800|NCT02061176|Open Haemorrhoidectomy|open haemorrhoidectomy
357801|NCT02061176|Open Hemorrhoidectomy|open hemorrhoidectomy
357802|NCT02061150|Early onset GBS sepsis|early onset gbs sepsis
357803|NCT02061150|Prevention|prevention
357804|NCT02061150|Maternal risk factors|maternal risk factors
357805|NCT02061137|Rett Syndrome (Mecp2 positive)|rett syndrome (mecp2 positive)
357806|NCT02061137|Fingolimod (FTY 720)|fingolimod (fty 720)
357807|NCT02061137|BDNF|bdnf
357808|NCT02061137|Brain Atrophy|brain atrophy
357809|NCT02061111|Mitochondria Function|mitochondria function
357810|NCT02061111|TPO-antibodies|tpo-antibodies
357811|NCT02061111|Subclinical Thyroid Disease|subclinical thyroid disease
357812|NCT02061111|Thyroid Disease In Pregnancy|thyroid disease in pregnancy
357813|NCT02061111|Children´s Development|children´s development
357814|NCT02061098|Pomegranate|pomegranate
357815|NCT02061098|Cardiovascular|cardiovascular
357816|NCT02061098|Urolithins|urolithins
357817|NCT02061098|Microbiota|microbiota
357818|NCT02061098|Polyphenols|polyphenols
357819|NCT02061098|Nutraceutical|nutraceutical
357820|NCT02061098|Dietary supplement|dietary supplement
357821|NCT02061085|Breast Neoplasm Metastasis|breast neoplasm metastasis
357822|NCT02061085|Receptor,HER-2|receptor,her-2
357823|NCT02061085|Eribulin|eribulin
357824|NCT02061085|Furans, quetones|furans, quetones
357825|NCT02061085|Antimitotic agent|antimitotic agent
357826|NCT02061072|pharmacokinetics|pharmacokinetics
357827|NCT02061072|population pharmacokinetics|population pharmacokinetics
357828|NCT02061072|hemophilia|hemophilia
357829|NCT02061072|factor VIII|factor viii
357830|NCT02061072|factor IX|factor ix
357831|NCT02061046|Gait|gait
357832|NCT02061046|Dual task|dual task
357833|NCT02061033|Hemophilia A|hemophilia a
357834|NCT02061033|Hemophilia B|hemophilia b
357835|NCT02061033|Von Willebrand's Disease|von willebrand's disease
357836|NCT02061033|Endogen thrombin potential|endogen thrombin potential
357837|NCT02061033|Overall hemostatic potential|overall hemostatic potential
357838|NCT02061033|Microparticles|microparticles
357839|NCT02061033|Fibrin clot|fibrin clot
357840|NCT02061020|delta-9-tetrahydrocannabinol, volunteers, cannabis users|delta-9-tetrahydrocannabinol, volunteers, cannabis users
357841|NCT02061007|skin cancer|skin cancer
357842|NCT02060981|Randomized controlled trial|randomized controlled trial
357843|NCT02060981|Primary medication adherence|primary medication adherence
357844|NCT02060981|Decision-support tool|decision-support tool
357845|NCT02060981|Patient-centered outcomes research|patient-centered outcomes research
357846|NCT02060981|Antihypertensive medications|antihypertensive medications
357847|NCT02060981|One-on-one patient interviews|one-on-one patient interviews
357848|NCT02060968|Promus PREMIER|promus premier
357849|NCT02060968|Routine Clinical Practice|routine clinical practice
357850|NCT02060955|Glioblastoma multiforme|glioblastoma multiforme
357851|NCT02060955|Immunotherapy|immunotherapy
357852|NCT02060955|Bevacizumab/Irinotecan|bevacizumab/irinotecan
357853|NCT02060955|ALECSAT|alecsat
357854|NCT02060955|recurrent|recurrent
357855|NCT02060942|Volume responsiveness mean systemic filling pressure|volume responsiveness mean systemic filling pressure
357856|NCT02060929|Healthy|healthy
357857|NCT02060929|Esketamine|esketamine
357858|NCT02060929|Intranasal|intranasal
357859|NCT02060929|Nasal Guide|nasal guide
357860|NCT02060929|Pharmacokinetics|pharmacokinetics
357861|NCT02060903|Head Lice|head lice
357862|NCT02060903|Hatchtech|hatchtech
357863|NCT02060890|Glioblastoma|glioblastoma
357864|NCT02060877|suspected lung cancer|suspected lung cancer
357865|NCT02060877|diagnostic work-up|diagnostic work-up
357866|NCT02060864|enzyme|enzyme
357867|NCT02060864|gluten|gluten
357868|NCT02060864|food intolerance|food intolerance
357869|NCT02060851|EPO|epo
357870|NCT02060851|Intravenous iron|intravenous iron
357871|NCT02060851|iron storage|iron storage
357872|NCT02060851|preterm anemia|preterm anemia
357873|NCT02060812|ultrasound guided axillary nerve block|ultrasound guided axillary nerve block
357874|NCT02060812|arthroscopic rotator cuff repair|arthroscopic rotator cuff repair
357875|NCT02060812|ultrasound guided suprascapular nerve block|ultrasound guided suprascapular nerve block
357876|NCT02060812|rebound phenomenon of pain|rebound phenomenon of pain
357877|NCT02060799|Dyspnea|dyspnea
357878|NCT02060799|Emergency Service, Hospital|emergency service, hospital
357879|NCT02060799|prognosis|prognosis
357880|NCT02060799|Fatal Outcome|fatal outcome
357881|NCT02060799|Epidemiology|epidemiology
357882|NCT02060786|Antiplatelet; clopidogrel; acute coronary syndrome|antiplatelet; clopidogrel; acute coronary syndrome
357883|NCT02060773|Septic shock|septic shock
357884|NCT02060773|Early goal directed therapy|early goal directed therapy
357885|NCT02060773|Fluid resuscitation|fluid resuscitation
357886|NCT02060773|Hepatic perfusion|hepatic perfusion
357887|NCT02060773|Indocyanine Green|indocyanine green
357888|NCT02060760|Prospective cohort study|prospective cohort study
357889|NCT02060760|Diagnostic accuracy|diagnostic accuracy
357890|NCT02060760|High sensitivity versus contemporary troponin I assay|high sensitivity versus contemporary troponin i assay
357891|NCT02060760|Gender|gender
357892|NCT02060760|Renal Function|renal function
357893|NCT02060734|Whiplash,|whiplash,
357894|NCT02060734|injection,|injection,
357895|NCT02060734|lidocaine,|lidocaine,
357896|NCT02060734|sham needling|sham needling
357897|NCT02060721|Chronic thromboembolic pulmonary hypertension (CTEPH)|chronic thromboembolic pulmonary hypertension (cteph)
357898|NCT02060695|Parkinson disease|parkinson disease
357899|NCT02060682|Fractional Flow Reserve|fractional flow reserve
357900|NCT02060682|Rapid Exchange|rapid exchange
357901|NCT02060682|Catheter|catheter
357902|NCT02060656|Relapsed or refractory Diffuse Large B-Cell Lymphoma after R-CHOP chemotherapy|relapsed or refractory diffuse large b-cell lymphoma after r-chop chemotherapy
357903|NCT02060630|Surgical revascularization|surgical revascularization
357904|NCT02060630|Endovascular revascularization|endovascular revascularization
357905|NCT02060630|Amputation|amputation
357906|NCT02060630|Peripheral artery disease|peripheral artery disease
357907|NCT02060630|Critical limb ischemia|critical limb ischemia
357908|NCT02060630|claudication|claudication
357909|NCT02060630|leg pain|leg pain
357910|NCT02060630|leg ulcer|leg ulcer
357911|NCT02060630|gangrene|gangrene
357912|NCT02060617|low back pain|low back pain
357913|NCT02060617|physical therapy|physical therapy
357914|NCT02060617|manual therapy|manual therapy
357915|NCT02060617|manipulation|manipulation
357916|NCT02060617|exercise|exercise
357917|NCT02060617|motor control|motor control
357918|NCT02060617|regional interdependence|regional interdependence
357919|NCT02060604|ketorolac|ketorolac
357920|NCT02060604|NSAIDs|nsaids
357921|NCT02060604|wet macular degeneration|wet macular degeneration
357922|NCT02060604|choroidal neovascularization|choroidal neovascularization
357923|NCT02060578|Cancer palliative care|cancer palliative care
357924|NCT02060578|Dead child|dead child
357925|NCT02060565|diagnosis|diagnosis
357926|NCT02060565|survival|survival
357927|NCT02060565|non-invasive method|non-invasive method
357928|NCT02060565|cirrhosis|cirrhosis
357929|NCT02060565|FibroScan|fibroscan
357930|NCT02060526|sulfoglucosamine sulfohydrolase (SGSH)|sulfoglucosamine sulfohydrolase (sgsh)
357931|NCT02060526|recombinant human heparan N-sulfatase (rhHNS)|recombinant human heparan n-sulfatase (rhhns)
357932|NCT02060526|Hunter's Syndrome|hunter's syndrome
357933|NCT02060526|Shire HGT|shire hgt
357934|NCT02060526|Lysosomal Storage Disease (LSD)|lysosomal storage disease (lsd)
357935|NCT02060526|Sanfilippo Syndrome Type A (Sanfilippo A)|sanfilippo syndrome type a (sanfilippo a)
357936|NCT02060526|enzyme replacement therapy (ERT)|enzyme replacement therapy (ert)
357937|NCT02060513|Wounded warriors|wounded warriors
357938|NCT02060513|Battlefield infection|battlefield infection
357939|NCT02060513|Acinetobacter|acinetobacter
357940|NCT02060513|ESBL|esbl
357941|NCT02060513|MRSA|mrsa
357942|NCT02060513|KPC|kpc
357943|NCT02060500|GERD|gerd
357944|NCT02060500|fundoplication|fundoplication
357945|NCT02060500|cardiaplication|cardiaplication
357946|NCT02060500|reflux|reflux
357947|NCT02060487|pulmonary arterial hypertension|pulmonary arterial hypertension
357948|NCT02060487|pulmonary hypertension|pulmonary hypertension
357949|NCT02060487|PAH|pah
357950|NCT02060487|sildenafil|sildenafil
357951|NCT02060487|revatio|revatio
357952|NCT02060474|Allan-Herndon-Dudley Syndrome|allan-herndon-dudley syndrome
357953|NCT02060474|MCT8|mct8
357954|NCT02060474|Triac|triac
357955|NCT02060474|Therapeutic Trial|therapeutic trial
357956|NCT02060448|Non-suicidal self-injury|non-suicidal self-injury
357957|NCT02060448|Self-injurious behavior|self-injurious behavior
357958|NCT02060448|NSSI|nssi
357959|NCT02060448|Anxiety|anxiety
357960|NCT02060448|Depression|depression
357961|NCT02060448|Transdiagnostic|transdiagnostic
357963|NCT02060448|Unified Protocol|unified protocol
357964|NCT02060435|diffuse large B-cell lymphoma|diffuse large b-cell lymphoma
357965|NCT02060435|Ebstein-Barr Virus|ebstein-barr virus
357966|NCT02060422|Epilepsy|epilepsy
357967|NCT02060422|Drug-resistant epilepsy|drug-resistant epilepsy
357968|NCT02060422|Seizure|seizure
357969|NCT02060422|Mindfulness|mindfulness
357970|NCT02060422|Stress|stress
357971|NCT02060422|Psychotherapy|psychotherapy
357972|NCT02060409|myelodysplastic syndrome|myelodysplastic syndrome
357973|NCT02060409|decitabine|decitabine
357974|NCT02060409|spliceosome mutation|spliceosome mutation
357975|NCT02060383|Cushing's disease|cushing's disease
357976|NCT02060383|acromegaly|acromegaly
357977|NCT02060383|pasireotide|pasireotide
357978|NCT02060383|hyperglycemia|hyperglycemia
357979|NCT02060370|Genitourinary Cancer|genitourinary cancer
357980|NCT02060370|Kidney Cancer|kidney cancer
357981|NCT02060370|Metastatic Renal Cell Carcinoma|metastatic renal cell carcinoma
357982|NCT02060370|mRCC|mrcc
357983|NCT02060370|Sunitinib|sunitinib
357984|NCT02060370|Sunitinib malate|sunitinib malate
357985|NCT02060370|SUO11248|suo11248
357986|NCT02060370|Sutent|sutent
357987|NCT02060370|Questionnaire|questionnaire
357988|NCT02060370|Survey|survey
357989|NCT02060357|Diabetes Mellitus|diabetes mellitus
357990|NCT02060357|PCI|pci
357991|NCT02060357|Drug eluting stent|drug eluting stent
357992|NCT02060357|OCT|oct
357993|NCT02060344|Cardiovascular Disease|cardiovascular disease
357994|NCT02060344|Hispanic|hispanic
357995|NCT02060344|Latinos|latinos
357996|NCT02060331|Nocturia|nocturia
357997|NCT02060331|Pelvic Organ Prolapse|pelvic organ prolapse
357998|NCT02060331|Nocturnal Polyuria|nocturnal polyuria
357999|NCT02060331|Post-obstructive Diuresis|post-obstructive diuresis
358000|NCT02060318|Crohn Disease|crohn disease
358001|NCT02060318|Regulatory T-cells|regulatory t-cells
358002|NCT02060318|Infliximab|infliximab
358003|NCT02060292|COPD|copd
358004|NCT02060292|Cognitive Function|cognitive function
358005|NCT02060292|MRI Brain|mri brain
358006|NCT02060292|Aortic Stiffness|aortic stiffness
358007|NCT02060292|Cerebrovascular disease|cerebrovascular disease
358008|NCT02060279|Obesity|obesity
358009|NCT02060279|Diabetes Mellitus|diabetes mellitus
358010|NCT02060279|Diabetes Mellitus, Type 2|diabetes mellitus, type 2
358011|NCT02060279|Prevention|prevention
358012|NCT02060279|Behavioral research|behavioral research
358013|NCT02060279|Metabolic Syndrome|metabolic syndrome
358014|NCT02060279|Metabolic Disease|metabolic disease
358015|NCT02060279|Overnutrition|overnutrition
358016|NCT02060279|Nutrition Disorders|nutrition disorders
358017|NCT02060279|Overweight|overweight
358018|NCT02060279|Body weight|body weight
358019|NCT02060279|Insulin resistance|insulin resistance
358020|NCT02060279|Carotenoids|carotenoids
358021|NCT02060279|Dietary Supplement|dietary supplement
358022|NCT02060279|Physical fitness|physical fitness
358023|NCT02060279|Sedentary lifestyle|sedentary lifestyle
358024|NCT02060240|Obesity|obesity
358025|NCT02060240|Prediabetic State|prediabetic state
358026|NCT02060240|Sedentary Lifestyle|sedentary lifestyle
358027|NCT02060240|Insulin Resistance|insulin resistance
358028|NCT02060240|Endothelium|endothelium
358029|NCT02060240|Eicosanoids|eicosanoids
358030|NCT02060240|Nitric Oxide|nitric oxide
358031|NCT02060240|Regional Blood Flow|regional blood flow
358032|NCT02060175|Optical coherence tomography, Drug-eluting stent, Strut coverage|optical coherence tomography, drug-eluting stent, strut coverage
358033|NCT02060162|antiretroviral therapy|antiretroviral therapy
358034|NCT02060162|Hepatitis C virus|hepatitis c virus
358035|NCT02060149|Extensively Drug Resistant A. Baumannii|extensively drug resistant a. baumannii
358036|NCT02060136|Electronic micturition chart, validation|electronic micturition chart, validation
358037|NCT02060123|Qigong|qigong
358038|NCT02060123|Telomerase|telomerase
358039|NCT02060123|Perceived stress|perceived stress
358040|NCT02060123|RCT|rct
358041|NCT02060123|Chinese|chinese
358042|NCT02060123|Abused women|abused women
358043|NCT02060123|intervention|intervention
358044|NCT02060123|Depression|depression
358045|NCT02060110|CRT|crt
358046|NCT02060110|HEART FAILURE|heart failure
358047|NCT02060097|Anti-aging|anti-aging
358048|NCT02060097|High-flavanol cocoa|high-flavanol cocoa
358049|NCT02060084|preterm;|preterm;
358050|NCT02060084|Intestinal flora;|intestinal flora;
358051|NCT02060084|early Micro-feeding|early micro-feeding
358052|NCT02060084|Feeding intolerance|feeding intolerance
358053|NCT02060071|aortic stenosis|aortic stenosis
358054|NCT02060058|hepatitis C virus|hepatitis c virus
358055|NCT02060058|hepatitis B virus|hepatitis b virus
358056|NCT02060058|boceprevir|boceprevir
358057|NCT02060058|null responder|null responder
358058|NCT02060058|partial responder|partial responder
358059|NCT02060058|relapser|relapser
358060|NCT02060045|bundle|bundle
358061|NCT02060045|prevention|prevention
358062|NCT02060045|Disturbance; Heart, Functional, Postoperative, Cardiac Surgery|disturbance; heart, functional, postoperative, cardiac surgery
358063|NCT02060032|Chronic periodontitis, Local drug delivery,|chronic periodontitis, local drug delivery,
358064|NCT02060019|Pharmacokinetics|pharmacokinetics
358065|NCT02060019|Pharmacodynamics|pharmacodynamics
358066|NCT02060019|Safety|safety
358067|NCT02060019|Tolerability|tolerability
358068|NCT02060006|TB|tb
358069|NCT02060006|IRIS|iris
358070|NCT02059993|continuous positive airway pressure|continuous positive airway pressure
358071|NCT02059993|hypertension|hypertension
358072|NCT02059993|coronary heart disease|coronary heart disease
358073|NCT02059993|metabolic disorder|metabolic disorder
358074|NCT02059993|obstructive sleep apnea|obstructive sleep apnea
358075|NCT02059980|OCD|ocd
358076|NCT02059980|Trichotillomania|trichotillomania
358077|NCT02059980|Response inhibition|response inhibition
358078|NCT02059980|Cognitive training|cognitive training
358079|NCT02059967|Lung|lung
358080|NCT02059954|Hysterectomy|hysterectomy
358081|NCT02059941|Severe traumatic brain injury, ICP, Latin America, outcomes|severe traumatic brain injury, icp, latin america, outcomes
358082|NCT02059928|fluid resuscitation|fluid resuscitation
358083|NCT02059928|invasive pressure monitoring|invasive pressure monitoring
358084|NCT02059915|pharmacokinetics|pharmacokinetics
358085|NCT02059915|bioequivalence|bioequivalence
358086|NCT02059915|bioavailability|bioavailability
358087|NCT02059915|oxycodone|oxycodone
358088|NCT02059902|Pain management|pain management
358089|NCT02059902|Narcotic consumption|narcotic consumption
358090|NCT02059902|Skin graft|skin graft
358091|NCT02059889|Lung|lung
358092|NCT02059876|breast cancer|breast cancer
358093|NCT02059876|dose dense|dose dense
358094|NCT02059876|neoadjuvant treatment|neoadjuvant treatment
358095|NCT02059876|pathologic complete response|pathologic complete response
358096|NCT02059863|cluster randomised trial|cluster randomised trial
358097|NCT02059863|low and middle income countries|low and middle income countries
358098|NCT02059863|community based intervention|community based intervention
358099|NCT02059863|complex intervention|complex intervention
358100|NCT02059824|Eyelid sensation, aesthesiometer|eyelid sensation, aesthesiometer
358101|NCT02059811|Kidney Diseases|kidney diseases
358102|NCT02059811|Renal Insufficiency, Chronic|renal insufficiency, chronic
358103|NCT02059811|Diet|diet
358104|NCT02059811|DASH diet|dash diet
358105|NCT02059811|Hypertension|hypertension
358106|NCT02059811|Vascular diseases|vascular diseases
358107|NCT02059811|Cardiovascular Diseases|cardiovascular diseases
358108|NCT02059811|Blood pressure|blood pressure
358109|NCT02059798|Myelopathy|myelopathy
358110|NCT02059785|Pinocembrin for Injection|pinocembrin for injection
358111|NCT02059785|Placebo|placebo
358112|NCT02059785|mRS|mrs
358113|NCT02059759|low-dose interleukin 2|low-dose interleukin 2
358114|NCT02059746|cesarean section|cesarean section
358115|NCT02059746|vaginal birth|vaginal birth
358116|NCT02059746|twins|twins
358117|NCT02059746|urinary incontinence|urinary incontinence
358118|NCT02059746|sexuality|sexuality
358119|NCT02059746|quality of life|quality of life
358120|NCT02059733|18F-DTBZ|18f-dtbz
358121|NCT02059720|acute myeloid leukemia|acute myeloid leukemia
358122|NCT02059720|allogeneic hematopoietic stem cell transplantation|allogeneic hematopoietic stem cell transplantation
358123|NCT02059720|autologous hematopoietic stem cell transplantation|autologous hematopoietic stem cell transplantation
358124|NCT02059720|maintenance treatment|maintenance treatment
358125|NCT02059720|hematopoietic stem cell transplantation|hematopoietic stem cell transplantation
358126|NCT02059694|Eyelid surgery|eyelid surgery
358127|NCT02059694|local block/anesthesia|local block/anesthesia
358128|NCT02059694|hyaluronidase|hyaluronidase
358129|NCT02059694|Bilateral upper eyelid surgery|bilateral upper eyelid surgery
358130|NCT02059694|Duke Eye Centre|duke eye centre
358131|NCT02059694|Duke Aesthetic Center|duke aesthetic center
358132|NCT02059668|locally advanced head and neck cancer|locally advanced head and neck cancer
358133|NCT02059668|biomarkers|biomarkers
358134|NCT02059668|definitive treatment|definitive treatment
358135|NCT02059668|adjuvant treatment|adjuvant treatment
358136|NCT02059668|radiochemotherapy|radiochemotherapy
358137|NCT02059655|Graves' disease|graves' disease
358138|NCT02059629|Heart failure|heart failure
358139|NCT02059629|Eluna pacemaker family|eluna pacemaker family
358140|NCT02059629|Sentus OTW BP L left ventricular lead|sentus otw bp l left ventricular lead
358141|NCT02059629|Bradycardia|bradycardia
358142|NCT02059629|SADE-free rate|sade-free rate
358143|NCT02059603|Electroacupuncture|electroacupuncture
358144|NCT02059603|Fast track program|fast track program
358145|NCT02059603|Postoperative ileus|postoperative ileus
358146|NCT02059603|Laparoscopic surgery|laparoscopic surgery
358147|NCT02059603|Colorectal surgery|colorectal surgery
358148|NCT02059603|Randomized controlled trial|randomized controlled trial
358149|NCT02059603|Hospital stay|hospital stay
358150|NCT02059590|14C-labeled isavuconazonium sulfate|14c-labeled isavuconazonium sulfate
358151|NCT02059590|Pyridinylmethyl-14C-labeled isavuconazonium sulfate|pyridinylmethyl-14c-labeled isavuconazonium sulfate
358152|NCT02059590|Healthy Subjects|healthy subjects
358153|NCT02059590|BAL8728|bal8728
358154|NCT02059590|BAL4815|bal4815
358155|NCT02059577|vitamins|vitamins
358156|NCT02059577|minerals|minerals
358157|NCT02059577|essential fatty acids|essential fatty acids
358158|NCT02059577|Epsom salts|epsom salts
358159|NCT02059577|carnitine|carnitine
358160|NCT02059577|digestive enzymes|digestive enzymes
358161|NCT02059577|gluten-free casein-free diet|gluten-free casein-free diet
358162|NCT02059564|Diabetes Mellitus|diabetes mellitus
358163|NCT02059564|Diabetes Mellitus, Type 2|diabetes mellitus, type 2
358164|NCT02059564|Glucose Metabolism Disorders|glucose metabolism disorders
358165|NCT02059564|Metabolic Diseases|metabolic diseases
358166|NCT02059564|Endocrine System Diseases|endocrine system diseases
358167|NCT02059564|Exendin-4|exendin-4
358168|NCT02059551|pulmonary embolism|pulmonary embolism
358169|NCT02059551|magnetic resonance imaging|magnetic resonance imaging
358170|NCT02059551|venous ultrasonography of the legs|venous ultrasonography of the legs
358171|NCT02059551|diagnostic performances|diagnostic performances
358172|NCT02059538|Obesity|obesity
358173|NCT02059538|Type 2 diabetes|type 2 diabetes
358174|NCT02059538|Coronary artery diseases|coronary artery diseases
358175|NCT02059538|Microbiota|microbiota
358176|NCT02059538|Omics (ie transcriptomics, metabolomics, metagenomics, lipidomics)|omics (ie transcriptomics, metabolomics, metagenomics, lipidomics)
358177|NCT02059525|observational|observational
358178|NCT02059525|Belgium|belgium
358179|NCT02059512|ischemic heart disease,|ischemic heart disease,
358180|NCT02059512|autologous bone marrow mononuclear cells|autologous bone marrow mononuclear cells
358181|NCT02059512|coronary artery bypass grafting|coronary artery bypass grafting
358182|NCT02059460|Terlipressin|terlipressin
358183|NCT02059460|Acute kidney injury|acute kidney injury
358184|NCT02059460|Liver transplantation|liver transplantation
358185|NCT02059460|NGAL|ngal
358186|NCT02059447|Controlled trial|controlled trial
358187|NCT02059447|Active control|active control
358188|NCT02059447|Waiting, non treatment, period|waiting, non treatment, period
358189|NCT02059447|Mindfulness Based Cognitive Therapy|mindfulness based cognitive therapy
358190|NCT02059447|Relaxation Therapy|relaxation therapy
358191|NCT02059421|Johrei therapy|johrei therapy
358192|NCT02059421|Sleep|sleep
358193|NCT02059421|CBT-I|cbt-i
358194|NCT02059421|Critical illness|critical illness
358195|NCT02059382|daily physical activity|daily physical activity
358196|NCT02059382|exercise|exercise
358197|NCT02059382|social support|social support
358198|NCT02059382|online social network|online social network
358199|NCT02059369|Atrial fibrillation|atrial fibrillation
358200|NCT02059369|Recurrence|recurrence
358201|NCT02059369|CFAE|cfae
358202|NCT02059369|linear ablation|linear ablation
358203|NCT02059356|Dementia|dementia
358204|NCT02059356|Alzheimer's|alzheimer's
358205|NCT02059356|Alzheimers|alzheimers
358206|NCT02059356|Cognitive decline|cognitive decline
358207|NCT02059356|Cognitive impairment|cognitive impairment
358208|NCT02059356|Memory loss|memory loss
358209|NCT02059356|Memory disorder|memory disorder
358210|NCT02059356|Forgetfulness|forgetfulness
358211|NCT02059356|Confusion|confusion
358212|NCT02059356|Senile|senile
358213|NCT02059356|Demented|demented
358214|NCT02059356|Developmental delay|developmental delay
358215|NCT02059356|Portal systemic shunting|portal systemic shunting
358216|NCT02059356|High ammonia level|high ammonia level
777704|NCT00339495|Lung|lung
458125|NCT01606696|CAD|cad
358217|NCT02059356|Elevated ammonia level|elevated ammonia level
358218|NCT02059343|pharmacokinetics|pharmacokinetics
358219|NCT02059343|pharmacodynamics|pharmacodynamics
358220|NCT02059343|safety|safety
358221|NCT02059343|dexmedetomidine|dexmedetomidine
358222|NCT02059343|cardiopulmonary bypass|cardiopulmonary bypass
358223|NCT02059343|children|children
358224|NCT02059330|Japanese PK-Bridging Study|japanese pk-bridging study
358225|NCT02059330|dose-proportionality study|dose-proportionality study
358226|NCT02059330|Palbociclib|palbociclib
358227|NCT02059330|PD-0332991|pd-0332991
358228|NCT02059330|healthy volunteers|healthy volunteers
358229|NCT02059304|cervical length|cervical length
358230|NCT02059304|prediction of preterm delivery|prediction of preterm delivery
358231|NCT02059291|Canakinumab, interleukin-1, Hereditary Periodic Fevers, auto-inflammatory diseases|canakinumab, interleukin-1, hereditary periodic fevers, auto-inflammatory diseases
358232|NCT02059278|Primary open angle glaucoma|primary open angle glaucoma
358233|NCT02059278|Ocular hypertension|ocular hypertension
358234|NCT02059239|Non-Hodgkin's Lymphoma|non-hodgkin's lymphoma
358235|NCT02059239|Hodgkin's Lymphoma|hodgkin's lymphoma
358236|NCT02059239|Lymphoma|lymphoma
358237|NCT02059239|Transplant|transplant
358238|NCT02059200|Randomised controlled trial|randomised controlled trial
358239|NCT02059200|Recurrent depression|recurrent depression
358240|NCT02059200|Mindfulness training|mindfulness training
358241|NCT02059200|Compassion training (MBCL)|compassion training (mbcl)
358242|NCT02059200|Fear of Compassion|fear of compassion
358243|NCT02059200|Added value Compassion|added value compassion
358244|NCT02059135|Preeclampsia|preeclampsia
358245|NCT02059135|Preterm preeclampsia|preterm preeclampsia
358246|NCT02059135|Pregnancy|pregnancy
358247|NCT02059109|Belmont|belmont
358248|NCT02059109|Rapid|rapid
358249|NCT02059109|Infuser|infuser
358250|NCT02059109|proficiency|proficiency
358251|NCT02059109|proficient|proficient
358252|NCT02059109|training|training
358253|NCT02059096|Multiple Sclerosis|multiple sclerosis
358254|NCT02059096|Repetitive transcranial magnetic stimulation (rTMS)|repetitive transcranial magnetic stimulation (rtms)
358255|NCT02059096|Chronic neuropathic pain|chronic neuropathic pain
358256|NCT02059096|Cortical excitability|cortical excitability
358257|NCT02059083|adolescent|adolescent
358258|NCT02059083|cannabis|cannabis
358259|NCT02059083|biofeedback|biofeedback
358260|NCT02059070|Nerve Block/adverse effects|nerve block/adverse effects
358261|NCT02059070|Phrenic Nerve|phrenic nerve
358262|NCT02059070|Respiratory function|respiratory function
358263|NCT02059070|Pain measurement|pain measurement
358264|NCT02059044|patient safety|patient safety
358265|NCT02059044|pharmacoepidemiology|pharmacoepidemiology
358266|NCT02059044|health services research|health services research
358267|NCT02059044|adherence|adherence
358268|NCT02059044|information technology|information technology
358269|NCT02059031|integrase inhibitor|integrase inhibitor
358270|NCT02059031|pharmacokinetics|pharmacokinetics
358271|NCT02059031|HIV|hiv
358272|NCT02059031|relative bioavailability|relative bioavailability
358273|NCT02059031|food|food
358274|NCT02059031|GSK1265744|gsk1265744
358275|NCT02059005|Addiction|addiction
358276|NCT02059005|Substance Use Disorder|substance use disorder
358277|NCT02059005|Rehospitalization|rehospitalization
358278|NCT02059005|Community Disease Management|community disease management
358279|NCT02059005|Behavioral Health|behavioral health
358280|NCT02059005|Community Health Worker|community health worker
358281|NCT02058992|Drug therapy|drug therapy
358282|NCT02058966|Entacapone|entacapone
358283|NCT02058966|COMT val158met|comt val158met
358284|NCT02058966|Methamphetamine|methamphetamine
358285|NCT02058953|Melanoma|melanoma
358286|NCT02058953|skin cancer|skin cancer
358287|NCT02058953|brain metastases|brain metastases
358288|NCT02058953|craniotomy|craniotomy
358289|NCT02058927|HIV|hiv
358290|NCT02058927|ART|art
358291|NCT02058927|children|children
358292|NCT02058914|Sugar sweetened beverages|sugar sweetened beverages
358293|NCT02058914|metabolism|metabolism
358294|NCT02058914|endocrine|endocrine
358295|NCT02058914|lipids|lipids
358296|NCT02058914|blood glucose|blood glucose
358297|NCT02058901|sunitinib|sunitinib
358298|NCT02058901|solid tumors|solid tumors
358299|NCT02058888|metagenomics|metagenomics
358300|NCT02058888|antimicrobial resistance|antimicrobial resistance
358301|NCT02058888|multidrug resistance|multidrug resistance
358302|NCT02058849|Mucositis|mucositis
358303|NCT02058849|Beetroot|beetroot
358304|NCT02058849|Head and neck cancer|head and neck cancer
358305|NCT02058836|Chronic testicular pain|chronic testicular pain
358306|NCT02058836|Orchialgia|orchialgia
358307|NCT02058836|Botulinum toxin|botulinum toxin
358308|NCT02058836|Botox|botox
358309|NCT02058836|Urology|urology
358310|NCT02058823|Hypoxia|hypoxia
358311|NCT02058823|Sleep apnea|sleep apnea
358312|NCT02058823|Valsartan|valsartan
358313|NCT02058823|Amlodipine|amlodipine
358314|NCT02058823|Healthy subjects|healthy subjects
358315|NCT02058823|Randomized|randomized
358316|NCT02058823|Cross-over|cross-over
358317|NCT02058823|International|international
358318|NCT02058823|Sympathetic nervous system|sympathetic nervous system
358319|NCT02058810|nasal high flow oxygen|nasal high flow oxygen
358320|NCT02058810|cardio-renal syndrom|cardio-renal syndrom
358321|NCT02058810|heartfailure|heartfailure
358322|NCT02058797|Procrastination|procrastination
358323|NCT02058797|Coherence Therapy|coherence therapy
358324|NCT02058797|Cognitive Behavioral Therapy|cognitive behavioral therapy
358325|NCT02058797|Repertory Grid Technique|repertory grid technique
358326|NCT02058797|Cognitive Conflicts|cognitive conflicts
358327|NCT02058797|Personal Dilemmas|personal dilemmas
358328|NCT02058771|Action potential duration restitution|action potential duration restitution
358329|NCT02058771|Ventricular arrhythmia|ventricular arrhythmia
358330|NCT02058771|Sudden cardiac death|sudden cardiac death
358331|NCT02058771|Body-surface potential mapping|body-surface potential mapping
358332|NCT02058771|Electrocardiogram|electrocardiogram
358333|NCT02058758|Breast cancer|breast cancer
358334|NCT02058758|Magnetic resonance spectroscopy|magnetic resonance spectroscopy
358335|NCT02058758|Diffusion weighted imaging|diffusion weighted imaging
358336|NCT02058745|Neuro-oncology|neuro-oncology
358337|NCT02058745|Caregivers|caregivers
358338|NCT02058745|Intervention Research|intervention research
358339|NCT02058745|Representational Approach|representational approach
358340|NCT02058745|Cognitive Behavioral Therapy|cognitive behavioral therapy
358341|NCT02058745|Family|family
358342|NCT02058745|Internet|internet
358343|NCT02058680|prostate specific antigen (PSA)|prostate specific antigen (psa)
358344|NCT02058667|Breast Cancer|breast cancer
358345|NCT02058667|Paclitaxel|paclitaxel
358346|NCT02058667|Helical Tomotherapy|helical tomotherapy
358347|NCT02058667|Chest wall|chest wall
358348|NCT02058654|Creatine|creatine
358349|NCT02058654|Functional magnetic resonance imaging (fMRI)|functional magnetic resonance imaging (fmri)
358350|NCT02058654|Phosphorus-31 magnetic resonance spectroscopy (31P-MRS)|phosphorus-31 magnetic resonance spectroscopy (31p-mrs)
358351|NCT02058641|cellular accumulation|cellular accumulation
358352|NCT02058641|macrophage phenotype|macrophage phenotype
358353|NCT02058641|cantharidin blister|cantharidin blister
358354|NCT02058641|M1/M2|m1/m2
358355|NCT02058641|inflammatory mediators|inflammatory mediators
358356|NCT02058641|Type 2 diabetes mellitus|type 2 diabetes mellitus
358357|NCT02058641|darapladib|darapladib
358358|NCT02058641|cytokines|cytokines
358359|NCT02058628|azelaic acid|azelaic acid
358360|NCT02058628|Clindamycin|clindamycin
358361|NCT02058628|Benzoyl peroxide|benzoyl peroxide
358362|NCT02058628|Acne vulgaris|acne vulgaris
358363|NCT02058615|Male caregivers|male caregivers
358364|NCT02058615|Breast cancer|breast cancer
358365|NCT02058615|Intervention|intervention
358366|NCT02058615|Online toolkit|online toolkit
358367|NCT02058602|HRCT|hrct
358368|NCT02058602|Airway morphometry|airway morphometry
358369|NCT02058602|Resistivity|resistivity
358370|NCT02058602|Inhalation Profiles|inhalation profiles
358371|NCT02058602|Inhaler|inhaler
358372|NCT02058602|Pharyngometry|pharyngometry
358373|NCT02058602|Idiopathic Pulmonary Fibrosis (IPF)|idiopathic pulmonary fibrosis (ipf)
358374|NCT02058589|Immunocompromised|immunocompromised
358375|NCT02058589|Safety|safety
358376|NCT02058589|≥ 18 years of age|≥ 18 years of age
358377|NCT02058589|Renal transplant|renal transplant
358378|NCT02058589|Adults|adults
358379|NCT02058589|Immunosuppressed|immunosuppressed
358380|NCT02058589|Immunogenicity|immunogenicity
358381|NCT02058589|Herpes zoster|herpes zoster
358382|NCT02058576|combination of dutasteride 0.5 mg and tamsulosin HCL 0.4 mg|combination of dutasteride 0.5 mg and tamsulosin hcl 0.4 mg
358383|NCT02058576|Tamsulosin|tamsulosin
358384|NCT02058576|healthy subject|healthy subject
358385|NCT02058576|bioequivalence|bioequivalence
358386|NCT02058576|GI198745|gi198745
358387|NCT02058576|dutasteride|dutasteride
358388|NCT02058576|tamsulosin hydrochloride|tamsulosin hydrochloride
358389|NCT02058563|Measles, mumps and rubella diseases|measles, mumps and rubella diseases
358390|NCT02058563|Safety|safety
358391|NCT02058563|Immunogenicity|immunogenicity
358392|NCT02058524|Ulcerative Colitis|ulcerative colitis
358393|NCT02058524|Fecal Microbiota Transplantation|fecal microbiota transplantation
358394|NCT02058498|Liver transplant|liver transplant
358395|NCT02058498|Physical Activity|physical activity
358396|NCT02058498|Quality of Life|quality of life
358397|NCT02058485|hypertension|hypertension
358398|NCT02058485|dexmedetomidine|dexmedetomidine
358399|NCT02058485|midazolam|midazolam
358400|NCT02058485|premedication|premedication
358401|NCT02058459|Chronic obstructive pulmonary disease, targeted lung denervation, intervention, device, safety, lung function, Holaira|chronic obstructive pulmonary disease, targeted lung denervation, intervention, device, safety, lung function, holaira
358402|NCT02058433|Chemotherapy|chemotherapy
358403|NCT02058433|Individual Paclitaxel dose|individual paclitaxel dose
358404|NCT02058433|pharmacokinetics|pharmacokinetics
358405|NCT02058420|bone health|bone health
358406|NCT02058407|food effect|food effect
777705|NCT00339495|Colorectal|colorectal
358407|NCT02058407|pharmacokinetics|pharmacokinetics
358408|NCT02058407|GSK2793660|gsk2793660
358409|NCT02058407|FTIH|ftih
358410|NCT02058407|pharmacodynamics|pharmacodynamics
358411|NCT02058407|safety|safety
358412|NCT02058394|Retained nuclear lens fragments|retained nuclear lens fragments
358413|NCT02058394|Phacoemulsification|phacoemulsification
358414|NCT02058394|Cataract Surgery|cataract surgery
358415|NCT02058368|Benign Prostatic Hyperplasia|benign prostatic hyperplasia
358416|NCT02058368|Quality of Life|quality of life
358417|NCT02058342|Prader Willi syndrome|prader willi syndrome
358418|NCT02058342|Obesity|obesity
358419|NCT02058342|Childhood|childhood
358420|NCT02058342|Family|family
358421|NCT02058342|Interactive games|interactive games
358422|NCT02058342|Playground games|playground games
358423|NCT02058342|Exercise routine|exercise routine
358424|NCT02058329|Hip fracture|hip fracture
358425|NCT02058329|postoperative complications|postoperative complications
358426|NCT02058329|Depression|depression
358427|NCT02058329|Environmental Hazards|environmental hazards
358428|NCT02058329|FIM scores|fim scores
358429|NCT02058329|Falls|falls
358430|NCT02058303|hand surgery|hand surgery
358431|NCT02058303|wrist surgery|wrist surgery
358432|NCT02058303|finger surgery|finger surgery
358433|NCT02058303|anesthesia|anesthesia
358434|NCT02058303|regional anesthesia|regional anesthesia
358435|NCT02058303|postoperative pain|postoperative pain
358436|NCT02058290|laparoscopic colectomy|laparoscopic colectomy
358437|NCT02058277|bosutinib|bosutinib
358438|NCT02058277|aprepitant|aprepitant
358439|NCT02058277|drug interaction|drug interaction
358440|NCT02058277|healthy volunteers|healthy volunteers
358441|NCT02058277|pharmacokinetics|pharmacokinetics
358442|NCT02058277|chronic myelogenous leukemia|chronic myelogenous leukemia
358443|NCT02058251|Alcohol|alcohol
358444|NCT02058251|Oxytocin|oxytocin
358445|NCT02058251|Stress reactivity|stress reactivity
358446|NCT02058238|Robotic-guided spinal fusions|robotic-guided spinal fusions
358447|NCT02058238|Scoliosis|scoliosis
358448|NCT02058238|Kyphoscoliosis|kyphoscoliosis
358449|NCT02058238|Spinal deformity|spinal deformity
358450|NCT02058238|Spondylosis|spondylosis
358451|NCT02058225|Infant Nutrition|infant nutrition
358452|NCT02058225|Magnetic resonance spectroscopy|magnetic resonance spectroscopy
358453|NCT02058225|Infant Brain Development|infant brain development
358454|NCT02058225|Diffusion weighted Imaging|diffusion weighted imaging
358455|NCT02058225|Diffusion tensor tractography|diffusion tensor tractography
358456|NCT02058212|ICSI|icsi
358457|NCT02058212|antioxidants|antioxidants
358459|NCT02058212|endometriosis|endometriosis
358460|NCT02058199|gastric bypass|gastric bypass
358461|NCT02058199|rivaroxaban|rivaroxaban
358462|NCT02058199|pharmacodynamics|pharmacodynamics
358463|NCT02058186|Atopic dermatitis, vitamin D supplementation, cathelicidin, Staphylococcus aureus colonization, SCORAD score|atopic dermatitis, vitamin d supplementation, cathelicidin, staphylococcus aureus colonization, scorad score
358464|NCT02058121|Eating disorders|eating disorders
358465|NCT02058121|Acceptance and Commitment Therapy|acceptance and commitment therapy
358466|NCT02058121|Body image|body image
358467|NCT02058108|Chronic hepatitis B, pediatrics, antiviral treatment, telbivudine|chronic hepatitis b, pediatrics, antiviral treatment, telbivudine
358468|NCT02058082|Failure to Conceive Due to Infertility of Male Partner|failure to conceive due to infertility of male partner
358469|NCT02058082|DNA Damage|dna damage
358470|NCT02058056|Early prophylactic|early prophylactic
358471|NCT02058056|cranial irradiation|cranial irradiation
358472|NCT02058056|hippocampal avoidance|hippocampal avoidance
358473|NCT02058056|limited disease small-cell lung cancer|limited disease small-cell lung cancer
358474|NCT02058030|ProSeal laryngeal mask airway|proseal laryngeal mask airway
358475|NCT02058030|Insertion success|insertion success
358476|NCT02058030|complication|complication
358477|NCT02058004|Microaspiration|microaspiration
358478|NCT02058004|ARDS|ards
358479|NCT02058004|Hospital acquired pneumonia|hospital acquired pneumonia
358480|NCT02058004|Cricoid pressure|cricoid pressure
358481|NCT02057978|Late Lumen Loss|late lumen loss
358482|NCT02057978|MACE|mace
358483|NCT02057978|Death|death
358485|NCT02057978|Thrombosis(definite or probable )|thrombosis(definite or probable )
358486|NCT02057965|Mesenchymal Stromal Cells|mesenchymal stromal cells
358487|NCT02057965|Allograft rejection|allograft rejection
358488|NCT02057965|Fibrosis|fibrosis
358489|NCT02057952|Weight Management|weight management
358490|NCT02057952|Diabetes|diabetes
358491|NCT02057952|Exercise|exercise
358492|NCT02057952|Portion Control|portion control
358493|NCT02057952|Multiple Chronic Conditions|multiple chronic conditions
358494|NCT02057939|Prostate cancer|prostate cancer
358495|NCT02057939|enzalutamide|enzalutamide
358496|NCT02057939|ADT|adt
358497|NCT02057939|radiation|radiation
358498|NCT02057926|Membrane degradation|membrane degradation
358499|NCT02057926|Collagen membrane bio-durability|collagen membrane bio-durability
358500|NCT02057913|Penile neoplasms|penile neoplasms
358501|NCT02057913|Chemotherapy|chemotherapy
358502|NCT02057913|Vinflunine|vinflunine
358503|NCT02057913|Phase II|phase ii
358504|NCT02057900|Postinfarction heart failure|postinfarction heart failure
358505|NCT02057900|Transplantation of human embryonic stem cell-derived cardiac progenitors|transplantation of human embryonic stem cell-derived cardiac progenitors
358506|NCT02057900|Tissue-engineered cellular graft|tissue-engineered cellular graft
358507|NCT02057900|Fibrin hydrogel|fibrin hydrogel
358508|NCT02057861|diabetes mellitus|diabetes mellitus
358509|NCT02057861|neuromuscular blockade|neuromuscular blockade
358510|NCT02057861|sugammadex|sugammadex
358511|NCT02057848|carbohydrate, hypoglycemia|carbohydrate, hypoglycemia
358512|NCT02057822|Vernal keratoconjunctivitis|vernal keratoconjunctivitis
358513|NCT02057822|Cytokines|cytokines
358514|NCT02057822|Mediators|mediators
358515|NCT02057822|Tears|tears
358516|NCT02057809|Developmental Disabilities|developmental disabilities
358517|NCT02057809|Family-centered services|family-centered services
358518|NCT02057809|Pediatric rehabilitation|pediatric rehabilitation
358519|NCT02057796|HIV-1|hiv-1
358520|NCT02057796|Tuberculosis|tuberculosis
358521|NCT02057796|Systematic empiric TB treatment|systematic empiric tb treatment
358522|NCT02057796|ART|art
358523|NCT02057796|TB diagnosis|tb diagnosis
358524|NCT02057796|Xpert MTB/RIF®|xpert mtb/rif®
358525|NCT02057796|Urine LAM|urine lam
358526|NCT02057744|Robotic-guided surgery|robotic-guided surgery
358527|NCT02057744|Minimally invasive spinal surgery|minimally invasive spinal surgery
358528|NCT02057744|Spinal fusion|spinal fusion
358529|NCT02057744|Pedicle screws|pedicle screws
358530|NCT02057718|Bile duct diseases|bile duct diseases
358531|NCT02057718|Intrahepatic Cholestasis|intrahepatic cholestasis
358532|NCT02057718|Cholestasis|cholestasis
358533|NCT02057718|PFIC|pfic
358534|NCT02057718|Pruritus|pruritus
358535|NCT02057718|Cholestatic Liver Disease|cholestatic liver disease
358536|NCT02057705|MTM|mtm
358537|NCT02057705|myotubular myopathy|myotubular myopathy
358538|NCT02057705|X-linked centronuclear myopathy|x-linked centronuclear myopathy
358539|NCT02057705|inherited myopathies|inherited myopathies
358540|NCT02057705|neuromuscular diseases|neuromuscular diseases
358541|NCT02057705|hypotonia|hypotonia
358542|NCT02057705|genetic mutation|genetic mutation
358543|NCT02057679|Acute cholecystitis.|acute cholecystitis.
358544|NCT02057679|Amoxicillin clavulanic|amoxicillin clavulanic
358545|NCT02057653|Goal-directed fluid management|goal-directed fluid management
358546|NCT02057601|Local anaesthetic infiltration|local anaesthetic infiltration
358547|NCT02057601|Fractured neck of femur|fractured neck of femur
358548|NCT02057601|Postoperative pain|postoperative pain
358549|NCT02057588|ablation|ablation
358550|NCT02057575|Open Angle Glaucoma|open angle glaucoma
358551|NCT02057575|Ocular Hypertension|ocular hypertension
358552|NCT02057575|Intraocular Pressure|intraocular pressure
358553|NCT02057575|AR13324|ar13324
358554|NCT02057575|PG324|pg324
358555|NCT02057562|Adenoma|adenoma
358556|NCT02057562|Diverticular disease|diverticular disease
358557|NCT02057562|Diverticulosis|diverticulosis
358558|NCT02057562|Colorectal carcinoma|colorectal carcinoma
358559|NCT02057562|Polyp|polyp
358560|NCT02057536|estrogen receptor positive, aromatase inhibitors, exercise,|estrogen receptor positive, aromatase inhibitors, exercise,
358561|NCT02057510|Head and Neck Cancer|head and neck cancer
358562|NCT02057510|Radiation Therapy|radiation therapy
358563|NCT02057484|long-term follow-up|long-term follow-up
358564|NCT02057484|liver transplant|liver transplant
358565|NCT02057484|kidney transplant|kidney transplant
358566|NCT02057484|Advagraf|advagraf
358567|NCT02057484|Tacrolimus|tacrolimus
358568|NCT02057471|Adenocarcinoma|adenocarcinoma
358569|NCT02057471|Anemia|anemia
358570|NCT02057471|Blood Transfusion|blood transfusion
358571|NCT02057471|Colorectal surgery|colorectal surgery
358572|NCT02057471|Preoperative care|preoperative care
358573|NCT02057471|Perioperative care|perioperative care
358574|NCT02057471|Postoperative care|postoperative care
358575|NCT02057471|Iron|iron
358576|NCT02057471|Hematinics|hematinics
358577|NCT02057471|Hepcidin|hepcidin
358578|NCT02057471|Quality of life|quality of life
358579|NCT02057471|Postoperative complications|postoperative complications
358580|NCT02057458|arterial stiffness|arterial stiffness
358581|NCT02057458|flow-mediated dilation|flow-mediated dilation
358582|NCT02057458|endothelial function|endothelial function
358583|NCT02057458|pulse wave velocity|pulse wave velocity
358584|NCT02057458|inflammation|inflammation
358585|NCT02057458|oxidative stress|oxidative stress
358586|NCT02057458|pulmonary function test|pulmonary function test
358587|NCT02057458|Cystic Fibrosis|cystic fibrosis
358588|NCT02057458|Lung Disease|lung disease
358589|NCT02057458|Nitric Oxide|nitric oxide
358590|NCT02057458|Exercise Capacity|exercise capacity
358591|NCT02057458|CF|cf
358592|NCT02057458|Muscle Function|muscle function
358593|NCT02057458|Sildenafil|sildenafil
358594|NCT02057458|Viagra|viagra
358595|NCT02057458|Revatio|revatio
358596|NCT02057445|cellular therapy|cellular therapy
358597|NCT02057445|lymphoma|lymphoma
358598|NCT02057445|lymphoproliferative disorder|lymphoproliferative disorder
458534|NCT01604850|HCV|hcv
358599|NCT02057432|I-II Breast Cancer|i-ii breast cancer
358600|NCT02057419|contraception|contraception
358601|NCT02057419|contraceptive methods|contraceptive methods
358602|NCT02057419|sexual lubricant|sexual lubricant
358603|NCT02057419|user experience|user experience
358604|NCT02057419|adherence|adherence
358605|NCT02057419|User experience: impact on use of contraceptive methods|user experience: impact on use of contraceptive methods
358606|NCT02057419|User experience: impact on use of sexual lubricants|user experience: impact on use of sexual lubricants
358607|NCT02057393|Melanoma|melanoma
358608|NCT02057393|Sentinel node biopsy|sentinel node biopsy
358609|NCT02057393|Indocyanine green|indocyanine green
358610|NCT02057393|Real time lymphangiography|real time lymphangiography
358611|NCT02057380|Paclitaxel|paclitaxel
358612|NCT02057380|Linsitinib|linsitinib
358613|NCT02057380|OSI-774|osi-774
358614|NCT02057380|Advanced Solid Tumor|advanced solid tumor
358615|NCT02057380|Tarceva|tarceva
358616|NCT02057380|Erlotinib|erlotinib
358617|NCT02057380|OSI-906|osi-906
358618|NCT02057367|supratentorial brain tumour|supratentorial brain tumour
358619|NCT02057367|craniotomy|craniotomy
358620|NCT02057354|Brain|brain
358621|NCT02057354|Brain-Derived Neurotrophic Factor|brain-derived neurotrophic factor
358622|NCT02057354|Brain Mapping|brain mapping
358623|NCT02057354|Cognition|cognition
358624|NCT02057354|Exercise|exercise
358625|NCT02057354|Hippocampus|hippocampus
358626|NCT02057354|Hydrocortisone|hydrocortisone
358627|NCT02057354|Learning|learning
358628|NCT02057354|Memory|memory
358629|NCT02057354|Magnetic Resonance Imaging|magnetic resonance imaging
358630|NCT02057354|Nerve Growth Factors|nerve growth factors
358631|NCT02057354|Neuroimaging|neuroimaging
358632|NCT02057354|Physical Endurance|physical endurance
358633|NCT02057354|Physical Fitness|physical fitness
358634|NCT02057354|Resistance Training|resistance training
358635|NCT02057354|Walking|walking
358636|NCT02057341|laminopathy|laminopathy
358637|NCT02057315|Migraine headache|migraine headache
358638|NCT02057315|Photophobia|photophobia
358639|NCT02057315|Phonophobia|phonophobia
358640|NCT02057315|Aura|aura
358641|NCT02057315|Topical treatment|topical treatment
358642|NCT02057302|Xuezhikang Dyslipidemia chinese medicine RCT|xuezhikang dyslipidemia chinese medicine rct
358643|NCT02057289|pediatric|pediatric
358644|NCT02057289|antifungal|antifungal
358645|NCT02057289|bone marrow|bone marrow
358646|NCT02057289|AML or relapsed ALL|aml or relapsed all
358647|NCT02057263|Vaccine|vaccine
358648|NCT02057263|Adjuvant|adjuvant
358649|NCT02057263|Bisphosphonates|bisphosphonates
358650|NCT02057263|Alendronate|alendronate
358651|NCT02057263|Hepatitis B vaccine|hepatitis b vaccine
358652|NCT02057224|Renal denervation|renal denervation
358653|NCT02057224|Hypertension|hypertension
358654|NCT02057224|Insulin resistance|insulin resistance
358655|NCT02057224|Adipose tissue function|adipose tissue function
358656|NCT02057185|Chronic Hematological Diseases|chronic hematological diseases
358657|NCT02057185|work|work
358658|NCT02057185|job|job
358659|NCT02057172|glycaemic control|glycaemic control
358660|NCT02057172|HM11260C|hm11260c
358661|NCT02057172|placebo|placebo
358662|NCT02057172|safety|safety
358663|NCT02057172|tolerability|tolerability
358664|NCT02057172|type 2 diabetes mellitus|type 2 diabetes mellitus
358665|NCT02057172|efficacy|efficacy
358666|NCT02057172|T2DM|t2dm
358667|NCT02057172|glycated haemoglobin (HbA1c)|glycated haemoglobin (hba1c)
358668|NCT02057172|glycosylated haemoglobin (HbA1c)|glycosylated haemoglobin (hba1c)
358669|NCT02057172|Glucagon-Like Peptide-1 (GLP-1) agonists|glucagon-like peptide-1 (glp-1) agonists
358670|NCT02057172|blood sugar levels|blood sugar levels
358671|NCT02057172|fasting plasma glucose (FPG)|fasting plasma glucose (fpg)
358672|NCT02057159|Secondary Progress Multiple Sclerosis|secondary progress multiple sclerosis
358673|NCT02057159|SPMS|spms
358674|NCT02057159|Multiple Sclerosis|multiple sclerosis
358675|NCT02057159|NeuroVax|neurovax
358676|NCT02057146|PSC|psc
358677|NCT02057146|mother-baby endoscopy|mother-baby endoscopy
358678|NCT02057146|ERCP|ercp
358679|NCT02057146|IPMN|ipmn
358680|NCT02057120|Kinesio Taping, Soccer, Hop Test, Electromyography, Athletic Performance, Muscle Strength Dynamometer|kinesio taping, soccer, hop test, electromyography, athletic performance, muscle strength dynamometer
358681|NCT02057081|Stress Disorders, Post-traumatic|stress disorders, post-traumatic
358682|NCT02057081|Mild Traumatic Brain Injury|mild traumatic brain injury
358683|NCT02057081|Veterans Health|veterans health
358684|NCT02057081|Veterans|veterans
358685|NCT02057081|Spouses|spouses
358686|NCT02057081|Couples|couples
358687|NCT02057081|Psychotherapy, Group|psychotherapy, group
358688|NCT02057081|Depression|depression
358689|NCT02057081|Couples Therapy|couples therapy
358690|NCT02057081|Family Therapy|family therapy
358691|NCT02057081|PTSD|ptsd
358692|NCT02057081|posttraumatic stress disorder|posttraumatic stress disorder
358693|NCT02057068|Caregivers|caregivers
358694|NCT02057068|Telemedicine|telemedicine
358695|NCT02057068|Sleep Disorders|sleep disorders
358696|NCT02057068|Meditation|meditation
358697|NCT02057068|Cognitive Behavioral Therapy|cognitive behavioral therapy
358698|NCT02057068|Activity Enhancement|activity enhancement
358699|NCT02057068|Technology|technology
358700|NCT02057068|Non-pharmacological sleep intervention|non-pharmacological sleep intervention
358701|NCT02057055|Antibacterial soaps|antibacterial soaps
358702|NCT02057055|Microbiome|microbiome
358703|NCT02057055|Commensal bacteria|commensal bacteria
358704|NCT02057055|Pyrosequencing|pyrosequencing
358705|NCT02057055|Innate immunity|innate immunity
358706|NCT02057042|Peer Support|peer support
358707|NCT02057042|cCBT|ccbt
358708|NCT02057042|primary care|primary care
358709|NCT02057029|Estrogen Receptor (ER) Positive|estrogen receptor (er) positive
358710|NCT02057029|Early Stage Breast Cancer|early stage breast cancer
358711|NCT02057029|Breast Cancer Index|breast cancer index
358712|NCT02057003|HIV|hiv
358713|NCT02057003|hepatitis C virus|hepatitis c virus
358714|NCT02057003|sustained virologic response|sustained virologic response
358715|NCT02057003|telaprevir|telaprevir
358716|NCT02057003|boceprevir|boceprevir
358717|NCT02057003|simeprevir|simeprevir
358718|NCT02057003|sofosbuvir|sofosbuvir
358719|NCT02057003|daclatasvir|daclatasvir
358720|NCT02057003|paritaprevir|paritaprevir
358721|NCT02057003|pegylated interferon|pegylated interferon
358722|NCT02057003|ribavirin|ribavirin
358723|NCT02057003|direct-acting antivirals|direct-acting antivirals
358724|NCT02057003|dasabuvir|dasabuvir
358725|NCT02057003|ombitasvir|ombitasvir
358726|NCT02057003|ledipasvir|ledipasvir
358727|NCT02057003|velpatasvir|velpatasvir
358728|NCT02057003|grazoprevir|grazoprevir
358729|NCT02057003|elbasvir|elbasvir
358730|NCT02056990|Athletes|athletes
358731|NCT02056977|Acute Respiratory Distress Syndrome|acute respiratory distress syndrome
358732|NCT02056977|Cardiac Surgical Procedure|cardiac surgical procedure
358733|NCT02056977|Mechanical Ventilation|mechanical ventilation
358734|NCT02056977|Postoperative Complications|postoperative complications
358735|NCT02056977|Positive End-Expiratory Pressure|positive end-expiratory pressure
358736|NCT02056977|Lung Collapse|lung collapse
358737|NCT02056977|Respiratory Failure|respiratory failure
358738|NCT02056977|Electrical Impedance Tomography|electrical impedance tomography
358739|NCT02056964|Acute Coronary Syndrome|acute coronary syndrome
358740|NCT02056964|Chest Pain|chest pain
358741|NCT02056964|Risk Stratification|risk stratification
358742|NCT02056964|Clinical Decision Aid|clinical decision aid
358743|NCT02056964|Emergency Department|emergency department
358744|NCT02056964|Low Risk Chest Pain|low risk chest pain
358745|NCT02056964|Non Cardiac Chest Pain|non cardiac chest pain
358746|NCT02056951|Rehabilitation|rehabilitation
358747|NCT02056951|Treatment Outcome|treatment outcome
358748|NCT02056951|Interprofessional Relations|interprofessional relations
358749|NCT02056951|Interdisciplinary Communication|interdisciplinary communication
358750|NCT02056951|Behavioural Exercise Therapy|behavioural exercise therapy
358751|NCT02056951|Cognitive Therapy|cognitive therapy
358752|NCT02056951|Health Education|health education
358753|NCT02056951|Workplace related information|workplace related information
358754|NCT02056951|Multicenter Study|multicenter study
358755|NCT02056938|Transplantation|transplantation
358756|NCT02056938|kidney|kidney
358757|NCT02056938|delayed graft function|delayed graft function
358758|NCT02056938|induction therapy|induction therapy
358759|NCT02056938|personalized medicine|personalized medicine
358760|NCT02056938|First kidney transplantation|first kidney transplantation
358761|NCT02056938|No anti HLA immunization prior transplantation|no anti hla immunization prior transplantation
358762|NCT02056938|Risk of DGF higher than 40% calculated byt he score DGFS|risk of dgf higher than 40% calculated byt he score dgfs
358763|NCT02056912|lipodystrophy|lipodystrophy
358764|NCT02056912|gene|gene
358765|NCT02056912|inborn error of metabolism|inborn error of metabolism
358766|NCT02056899|Preterm labor, premature birth, gabapentin|preterm labor, premature birth, gabapentin
358767|NCT02056886|breast cancer, sentinel lymph node, extemporaneous, OSNA|breast cancer, sentinel lymph node, extemporaneous, osna
358768|NCT02056873|deep brain stimulation|deep brain stimulation
358769|NCT02056873|DBS|dbs
358770|NCT02056873|tourette|tourette
358771|NCT02056873|tourette's|tourette's
358772|NCT02056873|tourette syndrome|tourette syndrome
358773|NCT02056873|TS|ts
358774|NCT02056860|cystic fibrosis|cystic fibrosis
358775|NCT02056847|Livalo, pitavastatin, hyperlipidemia, IFG|livalo, pitavastatin, hyperlipidemia, ifg
358776|NCT02056821|stroke|stroke
358777|NCT02056821|transcranial doppler|transcranial doppler
358778|NCT02056821|cerebral blood flow|cerebral blood flow
358779|NCT02056821|cardiac output|cardiac output
358780|NCT02056821|non-invasive hemodynamic monitoring|non-invasive hemodynamic monitoring
358781|NCT02056782|Acute Myeloid Leukemia|acute myeloid leukemia
358782|NCT02056782|AML|aml
358783|NCT02056782|ODSH|odsh
358784|NCT02056782|ODSH-AML|odsh-aml
358785|NCT02056782|Cantex|cantex
358786|NCT02056756|REFRACTORY OR RELAPSED|refractory or relapsed
358787|NCT02056756|CBD|cbd
358788|NCT02056730|chronic hemodialysis patients|chronic hemodialysis patients
779037|NCT00334126|Seroquel|seroquel
358789|NCT02056730|Hyperparathyroidism|hyperparathyroidism
358790|NCT02056730|Regpara|regpara
358791|NCT02056730|FGF 23|fgf 23
358792|NCT02056704|Dialysis Fistula|dialysis fistula
358793|NCT02056704|Dialysis Graft|dialysis graft
358794|NCT02056704|Stenosis|stenosis
358795|NCT02056704|Intravascular Ultrasound|intravascular ultrasound
358796|NCT02056704|Angiography|angiography
358797|NCT02056691|Resectable|resectable
358798|NCT02056691|non-metastatic|non-metastatic
358799|NCT02056691|colorectal|colorectal
358800|NCT02056691|carcinoma|carcinoma
358801|NCT02056691|cancer|cancer
358802|NCT02056691|neoplasm|neoplasm
358803|NCT02056691|exercise|exercise
358804|NCT02056691|effects|effects
358805|NCT02056691|program|program
358806|NCT02056691|pre-operative|pre-operative
358807|NCT02056691|proliferation|proliferation
358808|NCT02056691|diagnosed|diagnosed
358809|NCT02056691|surgery|surgery
358810|NCT02056691|biopsy|biopsy
358811|NCT02056691|muscle|muscle
358812|NCT02056691|signalling|signalling
358813|NCT02056691|IGF1|igf1
358814|NCT02056691|ki67|ki67
358815|NCT02056691|p53|p53
358816|NCT02056691|response|response
358817|NCT02056691|training|training
358818|NCT02056691|biochemical|biochemical
358819|NCT02056691|pathways|pathways
358820|NCT02056691|glucose|glucose
358821|NCT02056678|cholecystitis|cholecystitis
358822|NCT02056678|cholelithiasis|cholelithiasis
358823|NCT02056678|obstructive sleep apnea|obstructive sleep apnea
358824|NCT02056678|acetaminophen|acetaminophen
358825|NCT02056665|Angelman Syndrome|angelman syndrome
358826|NCT02056665|EFFICACY|efficacy
358827|NCT02056665|SAFETY|safety
358828|NCT02056665|MINOCYCLINE|minocycline
358829|NCT02056665|Pediatrics population|pediatrics population
358830|NCT02056665|Rare diseases|rare diseases
358831|NCT02056652|Preterm birth|preterm birth
358832|NCT02056652|Preterm delivery|preterm delivery
358833|NCT02056652|short cervix|short cervix
358834|NCT02056652|pessary|pessary
358835|NCT02056639|Premature birth|premature birth
358836|NCT02056639|Premature delivery|premature delivery
358837|NCT02056639|Short cervix|short cervix
358838|NCT02056639|Pessary|pessary
358839|NCT02056626|hypertension|hypertension
358840|NCT02056613|Blood Donation|blood donation
358841|NCT02056613|Tissue Procurement|tissue procurement
358842|NCT02056613|Cellular Therapies|cellular therapies
358843|NCT02056587|renal cell carcinoma|renal cell carcinoma
358844|NCT02056587|kidney cancer|kidney cancer
358845|NCT02056587|bevacizumab failure|bevacizumab failure
358846|NCT02056587|everolimus|everolimus
358847|NCT02056574|Endovascular repair|endovascular repair
358848|NCT02056574|Subarachnoid hemorrhage|subarachnoid hemorrhage
358849|NCT02056574|Ruptured intracranial aneurysm|ruptured intracranial aneurysm
358850|NCT02056574|Stroke|stroke
358851|NCT02056574|Coiling|coiling
358852|NCT02056574|NA-1|na-1
358853|NCT02056561|Anesthesia|anesthesia
358854|NCT02056561|Oxidants|oxidants
358855|NCT02056561|Antioxidants|antioxidants
358856|NCT02056548|preemptive antiviral treatment|preemptive antiviral treatment
358857|NCT02056548|lymphoma|lymphoma
358858|NCT02056548|chronic hepatitis B|chronic hepatitis b
358859|NCT02056535|Alcohol|alcohol
358860|NCT02056535|SBIRT (Screening, Brief Intervention, Referral to Treatment)|sbirt (screening, brief intervention, referral to treatment)
358861|NCT02056522|Melanoma|melanoma
358862|NCT02056522|Skin Cancer|skin cancer
358863|NCT02056509|cardiopulmonary resuscitation,Ventilation|cardiopulmonary resuscitation,ventilation
358864|NCT02056496|Pomegranate|pomegranate
358865|NCT02056496|Ellagic acid|ellagic acid
358866|NCT02056496|Pharmacokinetics|pharmacokinetics
358867|NCT02056496|Urolithins|urolithins
358868|NCT02056496|Bioavailability|bioavailability
358869|NCT02056483|neoplasms|neoplasms
358870|NCT02056483|rehabilitation|rehabilitation
358871|NCT02056483|anxiety|anxiety
358872|NCT02056483|depression|depression
358873|NCT02056483|adverse effects|adverse effects
358874|NCT02056483|health behavior|health behavior
358875|NCT02056457|Responsible fatherhood|responsible fatherhood
358876|NCT02056457|Healthy marriage|healthy marriage
358877|NCT02056457|Healthy relationships|healthy relationships
358878|NCT02056457|Parenting|parenting
358879|NCT02056457|Economic self-sufficiency|economic self-sufficiency
358880|NCT02056444|Blood conservation|blood conservation
358881|NCT02056444|Tranexamic acid|tranexamic acid
358882|NCT02056444|Total hip arthroplasty|total hip arthroplasty
358883|NCT02056431|Diabetes|diabetes
358884|NCT02056431|Neuropathy|neuropathy
358885|NCT02056431|Patient-Reported Outcomes|patient-reported outcomes
358886|NCT02056405|Postoperative Ileus|postoperative ileus
358887|NCT02056405|Mosapride|mosapride
358888|NCT02056405|Colorectal laparoscopic surgery|colorectal laparoscopic surgery
358889|NCT02056405|Prolonged postoperative ileus|prolonged postoperative ileus
358890|NCT02056392|Phase I, healthy, pharmacokinetics|phase i, healthy, pharmacokinetics
358891|NCT02056379|stridor|stridor
358892|NCT02056379|laryngitis|laryngitis
358893|NCT02056379|budesonide|budesonide
779038|NCT00334126|placebo|placebo
358894|NCT02056379|dexamethasone|dexamethasone
358895|NCT02056379|children|children
358896|NCT02056366|Cardiac Autonomic Neuropathy|cardiac autonomic neuropathy
358897|NCT02056353|Software|software
358898|NCT02056353|Algorithm|algorithm
358899|NCT02056353|Cardiac surgery|cardiac surgery
358900|NCT02056327|Oral Appliance|oral appliance
358901|NCT02056262|Bacteria|bacteria
358902|NCT02056262|microbial community|microbial community
358903|NCT02056262|hygiene|hygiene
358904|NCT02056249|hypoglycemia|hypoglycemia
358905|NCT02056249|Positron Emission Tomography|positron emission tomography
358906|NCT02056249|norepinephrine transporter|norepinephrine transporter
358907|NCT02056236|Cardiac arrest|cardiac arrest
358908|NCT02056236|Postanoxic encephalopathy|postanoxic encephalopathy
358909|NCT02056236|Electroencephalographic status epilepticus|electroencephalographic status epilepticus
358910|NCT02056236|EEG monitoring|eeg monitoring
358911|NCT02056236|Anti-epileptic drugs|anti-epileptic drugs
358912|NCT02056223|Patent ductus arteriosus|patent ductus arteriosus
358913|NCT02056223|Preterm infant|preterm infant
358914|NCT02056223|Paracetamol|paracetamol
358915|NCT02056223|Ibuprofen|ibuprofen
358916|NCT02056210|Stem cells|stem cells
358917|NCT02056210|Bone marrow|bone marrow
358918|NCT02056171|delirium|delirium
358919|NCT02056171|pediatrics|pediatrics
358920|NCT02056171|critical care|critical care
358921|NCT02056171|quetiapine|quetiapine
358922|NCT02056158|HIV|hiv
358923|NCT02056158|COPD|copd
358924|NCT02056158|Emphysema|emphysema
358925|NCT02056158|Smoking|smoking
358926|NCT02056119|Ventilators, mechanical|ventilators, mechanical
358927|NCT02056119|Aerosol Drug Therapy|aerosol drug therapy
358928|NCT02056119|Nebulizers|nebulizers
358929|NCT02056119|Equipment Contamination|equipment contamination
358930|NCT02056119|vibrating mesh nebulizer|vibrating mesh nebulizer
358931|NCT02056119|jet nebulizer|jet nebulizer
358932|NCT02056119|mechanical ventilation|mechanical ventilation
358933|NCT02056119|ventilator associated event|ventilator associated event
358934|NCT02056119|ventilator associated tracheobronchitis|ventilator associated tracheobronchitis
358935|NCT02056106|depression, Uganda, HIV, task-shifting, condom use, adherence|depression, uganda, hiv, task-shifting, condom use, adherence
358936|NCT02056093|NAVA - PAV- Breathing Variability - Asynchrony|nava - pav- breathing variability - asynchrony
358937|NCT02056080|Breast Neoplasm|breast neoplasm
358938|NCT02056080|Receptor,HER2|receptor,her2
358939|NCT02056080|Antineoplastic agent|antineoplastic agent
358940|NCT02056080|Antibodies, monoclonal|antibodies, monoclonal
358941|NCT02056080|Trastuzumab, Lapatinib|trastuzumab, lapatinib
358942|NCT02056080|Protein kinase inhibitors|protein kinase inhibitors
358943|NCT02056080|quinazolines|quinazolines
358944|NCT02056054|Autoimmune hepatitis|autoimmune hepatitis
358945|NCT02056054|Liver transplantation|liver transplantation
358946|NCT02056054|Hepatitis C|hepatitis c
358947|NCT02056002|Peer-driven intervention|peer-driven intervention
358948|NCT02056002|Interactive voice response system|interactive voice response system
358949|NCT02056002|Continuous Positive Airway Pressure therapy and adherence|continuous positive airway pressure therapy and adherence
358950|NCT02055976|PF-04950615|pf-04950615
358951|NCT02055976|Japan|japan
358952|NCT02055963|Head And Neck Cancer|head and neck cancer
358953|NCT02055963|Postsurgical symptom reduction|postsurgical symptom reduction
358954|NCT02055963|Minocycline|minocycline
358955|NCT02055963|Dynacin|dynacin
358956|NCT02055963|Minocin|minocin
358957|NCT02055963|Minocin PAC|minocin pac
358958|NCT02055963|Myrac|myrac
358959|NCT02055963|Solodyn|solodyn
358960|NCT02055963|Placebo|placebo
358961|NCT02055963|Sugar pill|sugar pill
358962|NCT02055963|Questionnaires|questionnaires
358963|NCT02055963|Surveys|surveys
358964|NCT02055950|Kidney transplant|kidney transplant
358965|NCT02055950|Marginal donors|marginal donors
358966|NCT02055950|Pulse perfusion|pulse perfusion
358967|NCT02055950|Graft function|graft function
358968|NCT02055937|mastectomy, reconstruction|mastectomy, reconstruction
358969|NCT02055924|Bruton's tyrosine kinase (BTK) Inhibition in B-cell Lymphomas|bruton's tyrosine kinase (btk) inhibition in b-cell lymphomas
358970|NCT02055911|diabetic macular edema|diabetic macular edema
358971|NCT02055911|intravitreal ranibizumab|intravitreal ranibizumab
358972|NCT02055911|f retinal ganglion cell|f retinal ganglion cell
358973|NCT02055872|Edema|edema
358974|NCT02055872|Hypoproteinemia|hypoproteinemia
358975|NCT02055872|Albumin|albumin
358976|NCT02055872|Diuresis|diuresis
358977|NCT02055872|Critical illness|critical illness
358978|NCT02055859|acoustic neuromas|acoustic neuromas
358979|NCT02055859|radiosurgery|radiosurgery
358980|NCT02055859|hearing preservation|hearing preservation
358981|NCT02055846|Androgen-independent prostate cancer|androgen-independent prostate cancer
358982|NCT02055807|Atelectasis|atelectasis
358983|NCT02055807|Ultrasound|ultrasound
358984|NCT02055807|Recruitment maneuver|recruitment maneuver
358985|NCT02055807|Positive end-expiratory pressure|positive end-expiratory pressure
358986|NCT02055794|perineal wound|perineal wound
358987|NCT02055794|perineal tear|perineal tear
358988|NCT02055794|perineum|perineum
358989|NCT02055794|pain|pain
358990|NCT02055794|childbirth|childbirth
358991|NCT02055781|Myelofibrosis|myelofibrosis
358992|NCT02055781|Post-Polycythemia Vera Myelofibrosis|post-polycythemia vera myelofibrosis
358993|NCT02055781|Post-Essential Thrombocythemia Myelofibrosis|post-essential thrombocythemia myelofibrosis
358994|NCT02055781|Primary Myelofibrosis|primary myelofibrosis
358995|NCT02055781|Polycythemia|polycythemia
358996|NCT02055781|Polycythemia Vera|polycythemia vera
358997|NCT02055781|Thrombocythemia, Essential|thrombocythemia, essential
358998|NCT02055781|Thrombocythemia|thrombocythemia
358999|NCT02055781|Myeloproliferative Disorders|myeloproliferative disorders
359000|NCT02055781|Bone Marrow Disease|bone marrow disease
359001|NCT02055781|Hematologic Diseases|hematologic diseases
359002|NCT02055781|Blood Platelet Disorders|blood platelet disorders
359003|NCT02055781|Hemorrhagic Disorders|hemorrhagic disorders
359004|NCT02055781|Splenomegaly|splenomegaly
359005|NCT02055781|Pacritinib|pacritinib
359006|NCT02055781|MPN-SAF|mpn-saf
359007|NCT02055781|MPN-SAF TSS|mpn-saf tss
359008|NCT02055781|Anemia|anemia
359009|NCT02055781|Myeloproliferative|myeloproliferative
359010|NCT02055781|Myeloproliferative Neoplasm|myeloproliferative neoplasm
359011|NCT02055781|Spleen|spleen
359012|NCT02055781|Spleen volume|spleen volume
359013|NCT02055781|Thrombocytopenia|thrombocytopenia
359014|NCT02055781|SB1518|sb1518
359015|NCT02055755|Diabetes|diabetes
359016|NCT02055755|Wounds|wounds
359017|NCT02055755|Wound Healing|wound healing
359018|NCT02055755|Diabetic Foot Ulcer|diabetic foot ulcer
359019|NCT02055755|DFU|dfu
359020|NCT02055755|Clinical Decision Support|clinical decision support
359021|NCT02055729|bedsore|bedsore
359022|NCT02055729|bacteria|bacteria
359023|NCT02055729|colonization|colonization
359024|NCT02055729|ecology|ecology
359025|NCT02055703|Healthy Subjects|healthy subjects
359026|NCT02055690|Advanced Recurrent Ovarian Cancer|advanced recurrent ovarian cancer
359027|NCT02055690|Pazopanib|pazopanib
359028|NCT02055690|Votrient|votrient
359029|NCT02055690|Fosbretabulin|fosbretabulin
359030|NCT02055677|personality profiles|personality profiles
359031|NCT02055677|values|values
359032|NCT02055677|empathy|empathy
359033|NCT02055677|quality of life|quality of life
359034|NCT02055677|vegetarians|vegetarians
359035|NCT02055677|vegans|vegans
359036|NCT02055651|Worksite|worksite
359037|NCT02055651|Cardiovascular|cardiovascular
359038|NCT02055651|Epidemiology|epidemiology
359039|NCT02055651|Risk factors|risk factors
359040|NCT02055638|Intermittent Explosive Disorder|intermittent explosive disorder
359041|NCT02055638|IED|ied
359042|NCT02055638|Aggression|aggression
359043|NCT02055638|SRX246|srx246
359044|NCT02055638|Vasopressin 1a Receptor Antagonist|vasopressin 1a receptor antagonist
359045|NCT02055638|V1a|v1a
359046|NCT02055625|Graft-versus-host-disease|graft-versus-host-disease
359047|NCT02055625|Immune system diseases|immune system diseases
359048|NCT02055625|Oral|oral
359049|NCT02055612|wet AMD|wet amd
359050|NCT02055612|epidemiology|epidemiology
359051|NCT02055599|Wound|wound
359052|NCT02055599|Wound Healing|wound healing
359053|NCT02055599|Pressure Ulcers|pressure ulcers
359054|NCT02055599|Chronic Wounds|chronic wounds
359055|NCT02055599|Clinical Decision Support|clinical decision support
359056|NCT02055573|Abusive Head Trauma|abusive head trauma
359057|NCT02055573|Early Literacy|early literacy
359058|NCT02055573|Parental Education|parental education
359059|NCT02055573|Low Income|low income
359060|NCT02055560|colorectal|colorectal
359061|NCT02055560|OnDose|ondose
359062|NCT02055560|MyCare|mycare
359063|NCT02055560|5-FU|5-fu
359064|NCT02055560|pharmacokinetics|pharmacokinetics
359065|NCT02055560|exposure|exposure
359066|NCT02055560|optimization|optimization
359067|NCT02055560|dose adjustment|dose adjustment
359068|NCT02055521|Composite tissue allograft|composite tissue allograft
359069|NCT02055521|operational tolerance|operational tolerance
359070|NCT02055521|skin rejection|skin rejection
359071|NCT02055521|Hand and Face allotransplantation|hand and face allotransplantation
359072|NCT02055508|Exercise|exercise
359073|NCT02055508|Physical Activity|physical activity
359074|NCT02055508|Palliative Care|palliative care
359075|NCT02055508|Lung Cancer|lung cancer
359076|NCT02055508|NSCLC|nsclc
359077|NCT02055495|Painful flatfeet|painful flatfeet
359078|NCT02055495|Planovagus feet|planovagus feet
359079|NCT02055495|Subtalar arthroeresis|subtalar arthroeresis
359080|NCT02055495|Lateral column lengthening|lateral column lengthening
359081|NCT02055495|Kinematic motion analysis|kinematic motion analysis
359082|NCT02055482|Anemia on CKD|anemia on ckd
359083|NCT02055469|Achalasia|achalasia
359084|NCT02055456|Hormones|hormones
359085|NCT02055456|Androgens|androgens
359086|NCT02055456|Aplastic Anemia|aplastic anemia
359087|NCT02055456|Bone Marrow Failure Syndromes|bone marrow failure syndromes
359088|NCT02055456|Idiopathic Pulmonary Fibrosis|idiopathic pulmonary fibrosis
359089|NCT02055456|Telomere|telomere
359090|NCT02055456|Telomere Shortening|telomere shortening
359091|NCT02055443|nuclear cardiology|nuclear cardiology
359092|NCT02055443|chest pain|chest pain
359093|NCT02055443|cardiac ischemia|cardiac ischemia
359094|NCT02055443|shortness of breath|shortness of breath
359095|NCT02055443|ECG|ecg
359096|NCT02055443|EKG|ekg
359097|NCT02055443|electrocardiogram|electrocardiogram
359098|NCT02055430|anuria|anuria
359099|NCT02055430|children|children
359100|NCT02055430|nephrostomy|nephrostomy
359101|NCT02055430|stents|stents
359102|NCT02055430|urinary calculi|urinary calculi
359103|NCT02055404|astigmatism|astigmatism
359104|NCT02055404|toric|toric
359105|NCT02055404|contact lenses|contact lenses
359106|NCT02055404|daily disposable contact lenses|daily disposable contact lenses
359107|NCT02055404|molded mark|molded mark
359108|NCT02055404|rotation mark|rotation mark
359109|NCT02055378|myopia|myopia
359110|NCT02055378|atropine|atropine
359111|NCT02055378|anterior chamber depth|anterior chamber depth
359112|NCT02055378|auricular acupoint|auricular acupoint
359113|NCT02055378|axial length|axial length
359114|NCT02055365|Hepatitis B vaccine|hepatitis b vaccine
359115|NCT02055326|Smoking|smoking
359116|NCT02055326|yoga|yoga
359117|NCT02055326|men|men
359118|NCT02055326|intervention|intervention
359119|NCT02055313|Exceptional patient|exceptional patient
359120|NCT02055313|Cancer care|cancer care
359121|NCT02055313|Lung cancer|lung cancer
359122|NCT02055313|Pancreatic cancer|pancreatic cancer
359123|NCT02055313|Stomach cancer|stomach cancer
359124|NCT02055313|Unexplained survival|unexplained survival
359125|NCT02055313|still alive from 2001-2008|still alive from 2001-2008
359126|NCT02055287|schizophrenia|schizophrenia
359127|NCT02055287|schizoaffective disorder|schizoaffective disorder
359128|NCT02055274|Parkinsons|parkinsons
359129|NCT02055248|Genetic Counseling|genetic counseling
359130|NCT02055248|Mobius Syndrome|mobius syndrome
359131|NCT02055248|Birth Defects|birth defects
359132|NCT02055248|Congenital Malformations|congenital malformations
359133|NCT02055248|Gene Identification|gene identification
359134|NCT02055235|Brain|brain
359135|NCT02055235|Pain|pain
359136|NCT02055235|Yoga|yoga
359137|NCT02055222|COPD|copd
359138|NCT02055222|Smoking|smoking
359139|NCT02055222|Idiopathic Pulmonary Fibrosis|idiopathic pulmonary fibrosis
359140|NCT02055209|African American|african american
359141|NCT02055183|Registry|registry
359142|NCT02055183|Botulinum toxin|botulinum toxin
359143|NCT02055183|Botulism Antitoxin Heptavalent- (Equine)|botulism antitoxin heptavalent- (equine)
359144|NCT02055183|BAT®|bat®
359145|NCT02055157|Achondroplasia|achondroplasia
359146|NCT02055157|Dwarfism|dwarfism
359147|NCT02055157|Bone Diseases, Developmental|bone diseases, developmental
359148|NCT02055157|Bone Diseases|bone diseases
359149|NCT02055144|NSCLC|nsclc
359150|NCT02055144|VeriStrat|veristrat
359151|NCT02055144|chemotherapy|chemotherapy
359152|NCT02055144|circulating tumor cells|circulating tumor cells
359153|NCT02055131|vascular access|vascular access
359154|NCT02055131|hemodialysis|hemodialysis
359155|NCT02055131|aspirin resistance|aspirin resistance
359156|NCT02055131|PFA-100|pfa-100
359157|NCT02055118|hunters disease|hunters disease
359158|NCT02055118|MPS II|mps ii
359159|NCT02055118|lysosomal storage disorder|lysosomal storage disorder
359160|NCT02055118|hunters syndrome|hunters syndrome
359161|NCT02055118|ert treatment|ert treatment
359162|NCT02055118|hunter's disease|hunter's disease
359163|NCT02055118|iduronate sulfatase|iduronate sulfatase
359164|NCT02055118|MPS society|mps society
359165|NCT02055118|mps 2|mps 2
359166|NCT02055118|enlarged adenoids|enlarged adenoids
359167|NCT02055118|hunter's syndrome|hunter's syndrome
359168|NCT02055118|iduronate 2 sulfatase|iduronate 2 sulfatase
359169|NCT02055118|chronic ear infection|chronic ear infection
359170|NCT02055118|mucopolysaccharides|mucopolysaccharides
359171|NCT02055118|hunter syndrome therapy|hunter syndrome therapy
359172|NCT02055118|hunter's syndrome treatment|hunter's syndrome treatment
359173|NCT02055118|enzyme replacement therapy|enzyme replacement therapy
359174|NCT02055118|hunter syndrome treatment|hunter syndrome treatment
359175|NCT02055118|elaprase|elaprase
359176|NCT02055118|MPSII|mpsii
359177|NCT02055118|lysosomal storage disease|lysosomal storage disease
359178|NCT02055118|mps diagnosis|mps diagnosis
359179|NCT02055118|mps symptoms|mps symptoms
359180|NCT02055118|idursulfase|idursulfase
359181|NCT02055118|hunter disease|hunter disease
359182|NCT02055118|hunter's disease treatment|hunter's disease treatment
359183|NCT02055118|MPS2|mps2
359184|NCT02055105|Pediatric Sepsis|pediatric sepsis
359185|NCT02055092|Young onset dementia|young onset dementia
359186|NCT02055092|Quality of life|quality of life
359187|NCT02055092|Specific needs|specific needs
359188|NCT02055092|Healthcare resources in dementia|healthcare resources in dementia
359189|NCT02055092|Frontotemporal dementia|frontotemporal dementia
359190|NCT02055092|Alzheimer's disease|alzheimer's disease
359191|NCT02055092|Healthcare services|healthcare services
359192|NCT02055079|ADPKD|adpkd
359194|NCT02055079|Polycystic kidney disease|polycystic kidney disease
359195|NCT02055079|Mammalian target of rapamycin|mammalian target of rapamycin
359196|NCT02055079|mTOR-I|mtor-i
359197|NCT02055079|Sirolimus|sirolimus
359198|NCT02055066|cancer|cancer
359199|NCT02055066|c-MET|c-met
359200|NCT02055053|Post Operative Pain|post operative pain
359201|NCT02055053|hernia repair|hernia repair
359202|NCT02055027|Sleep Apnea, Obstructive|sleep apnea, obstructive
359203|NCT02055027|Continuous Positive Airway Pressure|continuous positive airway pressure
359204|NCT02055027|Perioperative Period|perioperative period
359205|NCT02055014|Endobarrier|endobarrier
359206|NCT02055014|Duodenal-jejunal bypass liner|duodenal-jejunal bypass liner
359207|NCT02055014|Glucagon-like peptide-1 receptor agonist|glucagon-like peptide-1 receptor agonist
359208|NCT02055014|Liraglutide|liraglutide
359209|NCT02055014|Diabesity|diabesity
359210|NCT02055014|Type 2 diabetes|type 2 diabetes
359211|NCT02055014|Obesity|obesity
359212|NCT02055001|gender medicine|gender medicine
359213|NCT02055001|platelet function|platelet function
359214|NCT02055001|sex hormones|sex hormones
359215|NCT02055001|antiplatelet drugs|antiplatelet drugs
359216|NCT02055001|haemostasis|haemostasis
359217|NCT02054975|asthma, children, vitamin D deficiency, clinical trial|asthma, children, vitamin d deficiency, clinical trial
359218|NCT02054962|Pain|pain
359219|NCT02054949|N-acetyl cysteine|n-acetyl cysteine
359220|NCT02054949|Refractory Seizures|refractory seizures
359221|NCT02054923|colonoscopy|colonoscopy
359222|NCT02054923|videorecording|videorecording
359223|NCT02054923|quality indicators|quality indicators
359224|NCT02054923|screening|screening
359225|NCT02054923|colorectal cancer|colorectal cancer
359226|NCT02054884|Interleukin, IL2, F16, monoclonal, antibody, cytokine Paclitaxel, Merkel cell carcinoma|interleukin, il2, f16, monoclonal, antibody, cytokine paclitaxel, merkel cell carcinoma
359227|NCT02054871|Peripheral Angioplasty|peripheral angioplasty
359228|NCT02054871|Remote Ischaemic Preconditioning|remote ischaemic preconditioning
359229|NCT02054871|Contrast Induced Nephropathy|contrast induced nephropathy
359230|NCT02054858|Computerized Tomography|computerized tomography
359231|NCT02054858|Contrast enhanced|contrast enhanced
359232|NCT02054858|Acute Kidney Injury|acute kidney injury
359233|NCT02054858|Remote ischaemic preconditioning|remote ischaemic preconditioning
359234|NCT02054858|RIPC|ripc
359235|NCT02054845|Body awareness therapy|body awareness therapy
359236|NCT02054845|Physical therapy|physical therapy
359237|NCT02054819|lung cancer|lung cancer
359238|NCT02054819|NSCLC|nsclc
359240|NCT02054806|PD-1|pd-1
359241|NCT02054806|PDL1|pdl1
359242|NCT02054806|PD-L1|pd-l1
359243|NCT02054793|metastatic disease|metastatic disease
359244|NCT02054793|non-metastatic disease|non-metastatic disease
359245|NCT02054793|prostate cancer|prostate cancer
359246|NCT02054793|castration-resistant prostate cancer|castration-resistant prostate cancer
359247|NCT02054767|articaine|articaine
359248|NCT02054767|lidocaine|lidocaine
359249|NCT02054767|mepivacaine|mepivacaine
359250|NCT02054767|inferior alveolar nerve block|inferior alveolar nerve block
359251|NCT02054767|irreversible pulpitis|irreversible pulpitis
359252|NCT02054754|Dexanabinol|dexanabinol
359253|NCT02054754|Oral|oral
359254|NCT02054754|Safety|safety
359255|NCT02054754|Tolerability|tolerability
359256|NCT02054754|Pharmacokinetics|pharmacokinetics
359257|NCT02054728|right-heart catheterization|right-heart catheterization
359258|NCT02054728|respiratory muscle training|respiratory muscle training
359259|NCT02054728|inspiratory resistance|inspiratory resistance
359260|NCT02054728|hemodynamics|hemodynamics
359261|NCT02054702|Schizophrenia|schizophrenia
359262|NCT02054702|Mental Disorders|mental disorders
359263|NCT02054702|Psychotic Disorders|psychotic disorders
359264|NCT02054702|Antipsychotic|antipsychotic
359265|NCT02054702|Cognitive testing|cognitive testing
359266|NCT02054676|mandible|mandible
359267|NCT02054676|alveolar nerve inferior|alveolar nerve inferior
359268|NCT02054676|anatomy|anatomy
359269|NCT02054676|cross-sectional|cross-sectional
359270|NCT02054676|dental implants|dental implants
359271|NCT02054676|classification|classification
359272|NCT02054676|reliability|reliability
359273|NCT02054676|validity|validity
359274|NCT02054663|Acute coronary syndrome|acute coronary syndrome
359275|NCT02054663|Coronary artery disease|coronary artery disease
359276|NCT02054663|Antiplatelet therapy|antiplatelet therapy
359277|NCT02054663|Ticagrelor|ticagrelor
359278|NCT02054663|Clopidogrel|clopidogrel
359279|NCT02054650|Chronic low back pain|chronic low back pain
359280|NCT02054650|Type 2 diabetes mellitus|type 2 diabetes mellitus
359281|NCT02054650|Back pain|back pain
359282|NCT02054650|Diabetes|diabetes
359283|NCT02054650|Osteopathic manual treatment|osteopathic manual treatment
359284|NCT02054650|Osteopathic manipulative treatment|osteopathic manipulative treatment
359286|NCT02054650|Biomarkers|biomarkers
359287|NCT02054650|Glycemic control|glycemic control
359288|NCT02054650|Kidney function|kidney function
359289|NCT02054637|Bile reflux|bile reflux
359290|NCT02054637|Reflux esophagitis|reflux esophagitis
359291|NCT02054637|Lanreotide autogel|lanreotide autogel
359292|NCT02054637|Somatuline|somatuline
359293|NCT02054637|Endoscopy|endoscopy
359294|NCT02054637|Impedancemetry|impedancemetry
359295|NCT02054624|Obesity|obesity
359296|NCT02054624|Rural Health|rural health
359297|NCT02054624|Exercise|exercise
359298|NCT02054624|Weight loss|weight loss
359299|NCT02054624|Behavior change|behavior change
359300|NCT02054611|ARDS|ards
359301|NCT02054611|Chest radiographs|chest radiographs
359302|NCT02054611|Vignettes|vignettes
359303|NCT02054611|Online educational video|online educational video
359304|NCT02054585|dehydration|dehydration
359305|NCT02054585|pediatric|pediatric
359306|NCT02054585|glucose|glucose
359307|NCT02054585|IV fluid|iv fluid
359308|NCT02054572|AMG 416, ESRD, hemodialysis|amg 416, esrd, hemodialysis
359309|NCT02054559|localized|localized
359310|NCT02054559|diffuse large B-cell lymphoma|diffuse large b-cell lymphoma
359311|NCT02054559|R-CHOP chemotherapy|r-chop chemotherapy
359312|NCT02054559|radiotherapy|radiotherapy
359313|NCT02054533|Crohn's disease|crohn's disease
359314|NCT02054533|Ulcerative colitis|ulcerative colitis
359315|NCT02054533|Inflammatory bowel disease|inflammatory bowel disease
359316|NCT02054533|Surgery|surgery
359317|NCT02054533|Anti-Tumor Necrosis Factor|anti-tumor necrosis factor
359318|NCT02054533|Infection|infection
359319|NCT02054520|Stage IV|stage iv
359320|NCT02054520|metastatic melanoma|metastatic melanoma
359321|NCT02054507|Children|children
359322|NCT02054507|Cognitive outcome|cognitive outcome
359323|NCT02054507|Prematurity|prematurity
359324|NCT02054507|Care Network|care network
359325|NCT02054507|Outpatient follow-up of cognitive development|outpatient follow-up of cognitive development
359326|NCT02054507|Care resources|care resources
359327|NCT02054468|Muscle relaxant, Rocuronium, TIVA, Propofol|muscle relaxant, rocuronium, tiva, propofol
359329|NCT02054455|SIBO|sibo
359330|NCT02054455|LP-F19|lp-f19
359331|NCT02054442|cetuximab|cetuximab
359332|NCT02054442|methotrexate|methotrexate
359333|NCT02054442|squamous cell carcinoma head neck|squamous cell carcinoma head neck
359334|NCT02054442|palliative chemotherapy|palliative chemotherapy
359335|NCT02054416|non-traumatic lower limb amputation|non-traumatic lower limb amputation
359336|NCT02054416|AKA|aka
359337|NCT02054416|BKA|bka
359338|NCT02054390|Angiotensin converting enzyme inhibitor|angiotensin converting enzyme inhibitor
359339|NCT02054390|inflammation|inflammation
359340|NCT02054390|metabolic syndrome|metabolic syndrome
359341|NCT02054390|myonecrosis|myonecrosis
359342|NCT02054390|percutaneous coronary intervention|percutaneous coronary intervention
359343|NCT02054390|periprocedural myocardial injury|periprocedural myocardial injury
359344|NCT02054377|cystic fibrosis|cystic fibrosis
359345|NCT02054377|tai chi|tai chi
359346|NCT02054364|Eating Disorder|eating disorder
359347|NCT02054364|Anorexia Nervosa|anorexia nervosa
359348|NCT02054364|Eating Disorder Not Otherwise Specified|eating disorder not otherwise specified
359349|NCT02054364|Maudsley|maudsley
359350|NCT02054364|Family-Based Therapy|family-based therapy
359351|NCT02054364|FBT|fbt
359352|NCT02054364|Family Therapy|family therapy
359353|NCT02054364|Cognitive Remediation Therapy|cognitive remediation therapy
359354|NCT02054364|CRT|crt
359355|NCT02054351|Advanced ovarian cancer|advanced ovarian cancer
359356|NCT02054351|CLDN6 positive|cldn6 positive
359357|NCT02054325|Sclerotherapy|sclerotherapy
359358|NCT02054325|varicose veins|varicose veins
359359|NCT02054325|veins|veins
359360|NCT02054273|Adenoviral conjunctivitis diagnosed with AdenoPlus™ Test|adenoviral conjunctivitis diagnosed with adenoplus™ test
359361|NCT02054247|Carpal tunnel syndrome,ultrasound,pulsed ultrasound|carpal tunnel syndrome,ultrasound,pulsed ultrasound
359362|NCT02054234|Adenoviral conjunctivitis diagnosed with AdenoPlus™ Test|adenoviral conjunctivitis diagnosed with adenoplus™ test
359363|NCT02054221|hypertrophic cardiomyopathy|hypertrophic cardiomyopathy
359364|NCT02054221|mitral valve|mitral valve
359365|NCT02054208|human umbilical cord blood derived mesenchymal stem cells|human umbilical cord blood derived mesenchymal stem cells
359366|NCT02054208|stem cells|stem cells
359367|NCT02054208|alzheimer's disease|alzheimer's disease
359368|NCT02054208|cognitive ability|cognitive ability
359369|NCT02054208|mesenchymal stem cells|mesenchymal stem cells
359370|NCT02054208|cord blood|cord blood
359371|NCT02054182|vitamin D supplementation, pneumonia, bronchiolitis|vitamin d supplementation, pneumonia, bronchiolitis
359372|NCT02054156|Cystic fibrosis (CF)|cystic fibrosis (cf)
359373|NCT02054156|Azithromycin|azithromycin
359374|NCT02054156|Tobramycin solution for inhalation (TIS)|tobramycin solution for inhalation (tis)
359375|NCT02054156|Pseudomonas aeruginosa (Pa)|pseudomonas aeruginosa (pa)
359376|NCT02054156|Early Pseudomonas aeruginosa infection|early pseudomonas aeruginosa infection
359377|NCT02054156|Pulmonary exacerbation|pulmonary exacerbation
359378|NCT02054156|Standardized anti-pseudomonal therapy|standardized anti-pseudomonal therapy
359379|NCT02054143|sevoflurane|sevoflurane
359380|NCT02054143|cerebral vasoreactivity|cerebral vasoreactivity
359381|NCT02054143|arterial stiffness|arterial stiffness
359382|NCT02054143|Transcranial Doppler|transcranial doppler
359383|NCT02054143|SphygmoCor|sphygmocor
359384|NCT02054130|Asthma|asthma
359385|NCT02054117|Hemorrhage|hemorrhage
359386|NCT02054117|Intracerebral hemorrhage (ICH)|intracerebral hemorrhage (ich)
359387|NCT02054104|Minimal Residual Disease|minimal residual disease
359388|NCT02054104|Cancer Vaccine|cancer vaccine
359389|NCT02054104|Immunotherapy|immunotherapy
359390|NCT02054104|No Clinical Evidence of Active Disease|no clinical evidence of active disease
359391|NCT02054091|Preterm infants|preterm infants
359392|NCT02054091|Bovine colostrum|bovine colostrum
359393|NCT02054091|Feeding intolerance|feeding intolerance
359394|NCT02054091|Postnatal growth|postnatal growth
359395|NCT02054091|Intestinal maturation|intestinal maturation
359396|NCT02054091|Necrotizing enterocolitis|necrotizing enterocolitis
359397|NCT02054065|Urinary Catheter|urinary catheter
359398|NCT02054065|urinary tract infection|urinary tract infection
359399|NCT02054052|non-small cell lung cancer|non-small cell lung cancer
359400|NCT02054052|malignant pleural effusion|malignant pleural effusion
359401|NCT02054052|bevacizumab|bevacizumab
359402|NCT02054052|intrapleural injection|intrapleural injection
359403|NCT02054052|pericardial effusion|pericardial effusion
359404|NCT02054039|Cardiac surgery|cardiac surgery
359405|NCT02054039|Spirometry|spirometry
359406|NCT02054039|Physical Therapy Modalities|physical therapy modalities
359407|NCT02054039|Postoperative Complications|postoperative complications
359408|NCT02054000|No-reflow phenomenon, tirofiban, intracoronary|no-reflow phenomenon, tirofiban, intracoronary
359409|NCT02053974|Anthracycline|anthracycline
359410|NCT02053974|spironolactone|spironolactone
359411|NCT02053974|cardiotoxicity|cardiotoxicity
359412|NCT02053948|Reversal|reversal
359413|NCT02053948|Surgical technique|surgical technique
359414|NCT02053948|Pursestring Wound Closure|pursestring wound closure
359415|NCT02053948|Gunsight Skin Incision and Closure Technique|gunsight skin incision and closure technique
359416|NCT02053935|Dopamine|dopamine
359417|NCT02053935|hyperglycemic clamp|hyperglycemic clamp
359418|NCT02053935|sepsis|sepsis
359419|NCT02053935|hyperglycemia|hyperglycemia
359420|NCT02053935|insulin secretion|insulin secretion
359421|NCT02053922|caesarean section, ecbolics, postpartum hemorrhage|caesarean section, ecbolics, postpartum hemorrhage
359422|NCT02053909|Saphenous vein graft disease|saphenous vein graft disease
359423|NCT02053909|Coronary artery bypass graft surgery|coronary artery bypass graft surgery
359424|NCT02053909|Antiplatelet therapy|antiplatelet therapy
359425|NCT02053909|Coronary artery disease|coronary artery disease
359426|NCT02053909|Secondary prevention|secondary prevention
359427|NCT02053909|Graft patency|graft patency
359428|NCT02053896|Type I Gaucher|type i gaucher
359429|NCT02053896|ISU302|isu302
359430|NCT02053896|Imiglucerase|imiglucerase
359431|NCT02053883|SCI|sci
359432|NCT02053883|spinal cord injury|spinal cord injury
359433|NCT02053883|biologic drug|biologic drug
359434|NCT02053883|rho|rho
359435|NCT02053883|paralysis|paralysis
359436|NCT02053883|paraplegia|paraplegia
359437|NCT02053883|tetraplegia|tetraplegia
359438|NCT02053883|quadriplegia|quadriplegia
359439|NCT02053883|trauma|trauma
359440|NCT02053883|central nervous system|central nervous system
359441|NCT02053883|fibrin sealant|fibrin sealant
359442|NCT02053883|neurosurgery|neurosurgery
359443|NCT02053883|cervical|cervical
359444|NCT02053883|regeneration|regeneration
359445|NCT02053883|neurotrauma|neurotrauma
359446|NCT02053870|Adventitious lung sounds|adventitious lung sounds
359447|NCT02053870|Crackles|crackles
359448|NCT02053870|Wheezes|wheezes
359449|NCT02053870|Sputum location|sputum location
359450|NCT02053857|severe acute malnutrition|severe acute malnutrition
359451|NCT02053857|polyunsaturated fatty acids|polyunsaturated fatty acids
359452|NCT02053857|ready-to-use therapeutic food|ready-to-use therapeutic food
359453|NCT02053844|health care costs|health care costs
359454|NCT02053844|quality of health care|quality of health care
359455|NCT02053831|plastic surgery|plastic surgery
359456|NCT02053818|Cognitive dysfunction|cognitive dysfunction
359457|NCT02053818|Cardioprotection|cardioprotection
359458|NCT02053818|Recovery|recovery
359459|NCT02053818|Renal function|renal function
359460|NCT02053818|ICU discharge|icu discharge
359461|NCT02053805|prostate cancer|prostate cancer
359462|NCT02053805|BRCA1 Syndrome|brca1 syndrome
359463|NCT02053805|BRCA germ-line mutation|brca germ-line mutation
359464|NCT02053805|Lynch syndrome|lynch syndrome
359465|NCT02053805|BRCA2 Syndrome|brca2 syndrome
359466|NCT02053779|GnRH agonist|gnrh agonist
359467|NCT02053779|GnRH antagonist|gnrh antagonist
359468|NCT02053779|Luteal phase|luteal phase
359469|NCT02053766|Mitochondrial Diseases|mitochondrial diseases
359470|NCT02053766|Sevoflurane|sevoflurane
359471|NCT02053766|Dexmedetomidine (Precedex®)|dexmedetomidine (precedex®)
359472|NCT02053766|Propofol|propofol
359473|NCT02053753|denosumab, bioequivalence|denosumab, bioequivalence
359474|NCT02053727|Rheumatoid Arthritis|rheumatoid arthritis
359475|NCT02053727|Hepatitis B|hepatitis b
359476|NCT02053727|Abatacept|abatacept
359477|NCT02053727|Orencia|orencia
359478|NCT02053727|entecavir|entecavir
359479|NCT02053701|magnetic resonance spectroscopy|magnetic resonance spectroscopy
359480|NCT02053701|quantification precision|quantification precision
359481|NCT02053701|brain|brain
359482|NCT02053701|brain metabolites|brain metabolites
459682|NCT01599897|TB|tb
359483|NCT02053675|septic shock|septic shock
359484|NCT02053675|vasopressin|vasopressin
359485|NCT02053675|microcirculation|microcirculation
359486|NCT02053675|tissue oxygenation|tissue oxygenation
359487|NCT02053675|vasopressors|vasopressors
359488|NCT02053675|hemodynamics|hemodynamics
359489|NCT02053662|Bladder Cancer|bladder cancer
359490|NCT02053649|depression|depression
359491|NCT02053649|major depressive disorder|major depressive disorder
359492|NCT02053649|postpartum depression|postpartum depression
359493|NCT02053649|antenatal depression|antenatal depression
359494|NCT02053649|sleep|sleep
359495|NCT02053649|circadian|circadian
359496|NCT02053649|bright light|bright light
359497|NCT02053597|Primary breast cancer|primary breast cancer
359498|NCT02053597|Young women|young women
359499|NCT02053597|Ovarian function|ovarian function
359500|NCT02053597|Sexual function|sexual function
359501|NCT02053597|Eligible for adjuvant or neoadjuvant chemotherapy|eligible for adjuvant or neoadjuvant chemotherapy
359502|NCT02053597|Negative hormone-receptor status|negative hormone-receptor status
359503|NCT02053558|Anesthesiology|anesthesiology
359504|NCT02053558|Pain|pain
359505|NCT02053558|TAP block|tap block
359506|NCT02053558|Gynecology|gynecology
359507|NCT02053558|Postoperative|postoperative
359508|NCT02053558|Analgesia|analgesia
359509|NCT02053532|Trauma|trauma
359510|NCT02053532|Post-traumatic stress disorder (PTSD)|post-traumatic stress disorder (ptsd)
359511|NCT02053532|Imaging|imaging
359512|NCT02053532|Neuroimaging|neuroimaging
359513|NCT02053532|F-18-fluorodeoxyglucose (FDG)|f-18-fluorodeoxyglucose (fdg)
359514|NCT02053493|Heart Failure|heart failure
359515|NCT02053493|Preserved Ejection Fraction|preserved ejection fraction
359516|NCT02053480|pyruvate kinase deficiency|pyruvate kinase deficiency
359517|NCT02053480|hemolytic anemia|hemolytic anemia
359518|NCT02053480|anemia|anemia
359519|NCT02053480|enzymopathy|enzymopathy
359520|NCT02053480|jaundice|jaundice
359521|NCT02053480|splenectomy|splenectomy
359522|NCT02053480|health-related quality of life|health-related quality of life
359523|NCT02053480|Hematologic diseases|hematologic diseases
359524|NCT02053467|eConsultation|econsultation
359525|NCT02053467|Specialist care|specialist care
359526|NCT02053467|Primary health care|primary health care
359527|NCT02053467|Reducing wait times for specialist care|reducing wait times for specialist care
359528|NCT02053467|Reducing referral rates|reducing referral rates
359529|NCT02053454|RNAi therapeutic|rnai therapeutic
359530|NCT02053441|Muscle Protein Synthesis|muscle protein synthesis
359531|NCT02053441|Muscle Protein Breakdown|muscle protein breakdown
359532|NCT02053428|Head and neck cancer|head and neck cancer
359533|NCT02053428|Percutaneous image-guided gastrostomy|percutaneous image-guided gastrostomy
359534|NCT02053428|Pain|pain
359535|NCT02053428|Quality of life|quality of life
359536|NCT02053428|Complication|complication
359537|NCT02053415|krill oil|krill oil
359538|NCT02053415|omega-3 index|omega-3 index
359539|NCT02053415|plasma lipid profile|plasma lipid profile
359540|NCT02053415|tolerance|tolerance
359541|NCT02053415|young adults|young adults
359636|NCT02052934|Escherichia coli Infections|escherichia coli infections
359542|NCT02053402|vitamin D supplementation, persistent asthma, control|vitamin d supplementation, persistent asthma, control
359543|NCT02053389|Patient-Physician communication|patient-physician communication
359544|NCT02053389|Decision Support Techniques|decision support techniques
359545|NCT02053389|Health Communication|health communication
359546|NCT02053389|Physician-Patient Relationship|physician-patient relationship
359547|NCT02053389|Decision Making|decision making
359548|NCT02053376|gallbladder cancer, biliary cancer, bile duct cancer, hepatobiliary cancer, Biliary Tract Carcinoma|gallbladder cancer, biliary cancer, bile duct cancer, hepatobiliary cancer, biliary tract carcinoma
359549|NCT02053376|Cholangiocarcinoma|cholangiocarcinoma
359550|NCT02053363|tranexamic acid, reconstructive spine surgery|tranexamic acid, reconstructive spine surgery
359551|NCT02053350|Clostridium difficile|clostridium difficile
359552|NCT02053350|glutamine|glutamine
359553|NCT02053350|diarrhea|diarrhea
359554|NCT02053350|alanyl-glutamine|alanyl-glutamine
359555|NCT02053324|AvidinOX|avidinox
359556|NCT02053311|adenocarcinoma of the prostate|adenocarcinoma of the prostate
359557|NCT02053311|metastatic castration-resistant prostate cancer|metastatic castration-resistant prostate cancer
359558|NCT02053311|maintenance therapy|maintenance therapy
359559|NCT02053311|orteronel|orteronel
359560|NCT02053311|TAK-700|tak-700
359561|NCT02053298|Glaucoma|glaucoma
359562|NCT02053272|Diabetes|diabetes
359563|NCT02053272|Glycaemic control|glycaemic control
359564|NCT02053272|Delta-9-tetrahydrocannabivarin|delta-9-tetrahydrocannabivarin
359565|NCT02053272|Cannabinoids|cannabinoids
359566|NCT02053233|stroke|stroke
359567|NCT02053233|robot-assisted therapy|robot-assisted therapy
359568|NCT02053233|conventional therapy|conventional therapy
359569|NCT02053233|motor function|motor function
359570|NCT02053207|Cognitive training|cognitive training
359571|NCT02053207|Brain training|brain training
359572|NCT02053207|Plasticity-based training|plasticity-based training
359573|NCT02053207|Cardiac surgery|cardiac surgery
359574|NCT02053207|Preoperative|preoperative
359575|NCT02053207|Cognitive function|cognitive function
359576|NCT02053194|Inappropriate prescribing|inappropriate prescribing
359577|NCT02053194|Health Education|health education
359578|NCT02053194|Community Pharmacy Services|community pharmacy services
359579|NCT02053194|Medication Therapy Management|medication therapy management
359580|NCT02053194|Preventive Health Services|preventive health services
359581|NCT02053194|Polypharmacy|polypharmacy
359582|NCT02053194|Inappropriate prescriptions|inappropriate prescriptions
359583|NCT02053194|Aged|aged
359584|NCT02053181|Cadazolid|cadazolid
359585|NCT02053181|ACT-179811|act-179811
359586|NCT02053181|Pharmacokinetics|pharmacokinetics
359587|NCT02053181|Safety|safety
359588|NCT02053181|Tolerability|tolerability
359589|NCT02053155|Smoking cessation|smoking cessation
359590|NCT02053155|perioperative complication|perioperative complication
359591|NCT02053155|Smokerlyzer|smokerlyzer
359592|NCT02053155|smokers help line|smokers help line
359593|NCT02053142|Pharmacokinetics|pharmacokinetics
359594|NCT02053142|Herpes simplex virus|herpes simplex virus
359595|NCT02053142|Genital herpes ulcers|genital herpes ulcers
359596|NCT02053129|tuberculosis|tuberculosis
359597|NCT02053129|HIV|hiv
359598|NCT02053129|pregnancy|pregnancy
359599|NCT02053090|Fibromyalgia|fibromyalgia
359600|NCT02053090|Group Acupuncture|group acupuncture
359601|NCT02053090|Group Education with Stretching|group education with stretching
359602|NCT02053090|Nociceptive Reflex Testing|nociceptive reflex testing
359603|NCT02053090|Pain|pain
359604|NCT02053090|Sleep|sleep
359605|NCT02053090|Fatigue|fatigue
359606|NCT02053064|Neurodegenerative diseases|neurodegenerative diseases
359607|NCT02053064|Nervous systems diseases|nervous systems diseases
359608|NCT02053064|Genetic diseases, Inborn|genetic diseases, inborn
359609|NCT02053064|Metabolic diseases|metabolic diseases
359610|NCT02053064|Gene therapy|gene therapy
359611|NCT02053064|Adeno Associated Virus (AAV)|adeno associated virus (aav)
359612|NCT02053025|appetite|appetite
359613|NCT02053025|overweight|overweight
359614|NCT02053025|energy intake|energy intake
359615|NCT02053025|obesity|obesity
359616|NCT02053025|gut hormones|gut hormones
359617|NCT02052986|Fatty Acids, Omega-3|fatty acids, omega-3
359618|NCT02052986|Omega-3 fatty acids|omega-3 fatty acids
359619|NCT02052986|Docosahexaenoic acid (DHA)|docosahexaenoic acid (dha)
359620|NCT02052986|Eicosapentaenoic acid (EPA)|eicosapentaenoic acid (epa)
359621|NCT02052986|Docosapentaenoic acid (DPA)|docosapentaenoic acid (dpa)
359622|NCT02052986|Omega Index|omega index
359623|NCT02052986|Omega Score|omega score
359624|NCT02052986|Cardiac Rehab|cardiac rehab
359625|NCT02052973|Streptococcus mutans|streptococcus mutans
359626|NCT02052973|Natural products|natural products
359627|NCT02052947|Alzheimer's disease|alzheimer's disease
359628|NCT02052947|cerebrovascular disease|cerebrovascular disease
359629|NCT02052947|Lewy body disease|lewy body disease
359630|NCT02052947|MRI|mri
359631|NCT02052947|SPECT|spect
359632|NCT02052947|CSF|csf
359633|NCT02052947|biomarkers|biomarkers
359634|NCT02052947|disability|disability
359635|NCT02052947|Multicenter and prospective cohort study|multicenter and prospective cohort study
359738|NCT02052453|Surgery|surgery
359637|NCT02052934|ETEC Candidate Vaccine|etec candidate vaccine
359638|NCT02052934|Immunogenicity|immunogenicity
359639|NCT02052921|Observation|observation
359640|NCT02052921|Rectal Resection|rectal resection
359641|NCT02052921|complete clinical response|complete clinical response
359642|NCT02052921|neoadjuvant chemoradiotherapy.|neoadjuvant chemoradiotherapy.
359643|NCT02052895|Presepsin|presepsin
359644|NCT02052895|Sepsis|sepsis
359645|NCT02052895|SIRS|sirs
359646|NCT02052882|Romiplostim|romiplostim
359647|NCT02052882|Thrombocytopenia|thrombocytopenia
359648|NCT02052882|13-132|13-132
359649|NCT02052869|endotracheal intubation|endotracheal intubation
359650|NCT02052869|esophageal intubation|esophageal intubation
359651|NCT02052856|Tunnel Widening|tunnel widening
359652|NCT02052856|All-Inside Suspensory Method|all-inside suspensory method
359653|NCT02052856|Biointerference Screw Fixation|biointerference screw fixation
359654|NCT02052791|Spinal Muscular Atrophy|spinal muscular atrophy
359655|NCT02052791|SMA|sma
359656|NCT02052791|SMN|smn
359657|NCT02052791|SMNRx|smnrx
359658|NCT02052791|ISIS-SMNRx|isis-smnrx
359659|NCT02052791|ISIS 396443|isis 396443
359660|NCT02052791|IONIS-SMNRx|ionis-smnrx
359661|NCT02052791|IONIS-SMN Rx|ionis-smn rx
359662|NCT02052791|Spinraza|spinraza
359663|NCT02052778|Breast Cancer|breast cancer
359664|NCT02052778|Non Small Cell Lung Cancer|non small cell lung cancer
359665|NCT02052778|Gastric Cancer|gastric cancer
359666|NCT02052778|FGF|fgf
359667|NCT02052778|FGFR|fgfr
359668|NCT02052778|FGFR abnormality|fgfr abnormality
359669|NCT02052778|TAS-120|tas-120
359670|NCT02052778|Dose Escalation|dose escalation
359671|NCT02052739|Status Epilepticus|status epilepticus
359672|NCT02052739|Refractory status epilepticus|refractory status epilepticus
779137|NCT00333723|Glyburide|glyburide
359673|NCT02052739|Super-refractory status epilepticus|super-refractory status epilepticus
359674|NCT02052739|SAGE-547|sage-547
359675|NCT02052739|SAGE|sage
359676|NCT02052739|Sage Therapeutics|sage therapeutics
359677|NCT02052713|dutasteride|dutasteride
359678|NCT02052713|tamsulosin|tamsulosin
359679|NCT02052713|healthy subject|healthy subject
359680|NCT02052713|dutasteride and tamsulosin combination|dutasteride and tamsulosin combination
359681|NCT02052713|combination capsule of dutasteride 0.5 mg and tamsulosin HCL 0.4 mg|combination capsule of dutasteride 0.5 mg and tamsulosin hcl 0.4 mg
359682|NCT02052687|Healthy volunteer|healthy volunteer
359683|NCT02052674|Precursor to CAUTI|precursor to cauti
359684|NCT02052661|Infanrix™ hexa|infanrix™ hexa
359685|NCT02052661|Hepatitis B antibodies|hepatitis b antibodies
359686|NCT02052661|Immunogenicity|immunogenicity
359687|NCT02052661|Hepatitis B|hepatitis b
359688|NCT02052661|Adolescents|adolescents
359689|NCT02052661|Infancy|infancy
359690|NCT02052661|Engerix™-B Kinder|engerix™-b kinder
359691|NCT02052661|Safety|safety
359692|NCT02052648|glioblastoma multiforme|glioblastoma multiforme
359693|NCT02052648|glioma|glioma
359694|NCT02052648|gliosarcoma|gliosarcoma
359695|NCT02052648|malignant brain tumor|malignant brain tumor
359696|NCT02052635|Percutaneous Coronary Intervention|percutaneous coronary intervention
359697|NCT02052596|Boostrix|boostrix
359698|NCT02052596|Herpes zoster|herpes zoster
359699|NCT02052596|Immunogenicity|immunogenicity
359700|NCT02052596|Co-administration|co-administration
359701|NCT02052596|Adults|adults
359702|NCT02052596|Safety|safety
359703|NCT02052583|Cardiac arrest|cardiac arrest
359704|NCT02052583|Oxymetry|oxymetry
359705|NCT02052583|Hypothermia|hypothermia
359706|NCT02052570|School Reentry after pediatric HSCT|school reentry after pediatric hsct
359707|NCT02052557|Exparel|exparel
359708|NCT02052557|liposomal bupivicaine|liposomal bupivicaine
359709|NCT02052557|post operative pain control|post operative pain control
359710|NCT02052557|local anesthetic after surgery|local anesthetic after surgery
359711|NCT02052557|colorectal surgery|colorectal surgery
359712|NCT02052557|marcaine|marcaine
359713|NCT02052557|long acting local anesthetic|long acting local anesthetic
359714|NCT02052557|pain medication use after surgery|pain medication use after surgery
359715|NCT02052544|determination of heparin levels|determination of heparin levels
359716|NCT02052544|Patients|patients
359717|NCT02052544|requiring|requiring
359718|NCT02052544|unfractionated|unfractionated
359719|NCT02052518|Childhood obesity|childhood obesity
359720|NCT02052518|Breastfeeding|breastfeeding
359721|NCT02052518|Introduction of solids|introduction of solids
359722|NCT02052518|Introduction of juice|introduction of juice
359723|NCT02052505|inappropriate prescribing|inappropriate prescribing
359724|NCT02052505|psychiatry|psychiatry
359725|NCT02052505|medication quality|medication quality
359726|NCT02052505|patient safety|patient safety
359727|NCT02052505|medication errors|medication errors
359728|NCT02052479|Polycystic Ovary Syndrome|polycystic ovary syndrome
359729|NCT02052479|PCOS|pcos
359730|NCT02052479|Secondary Amenorrhea|secondary amenorrhea
359731|NCT02052479|Hirsutism|hirsutism
359732|NCT02052479|Hyperandrogenism|hyperandrogenism
359733|NCT02052479|Insulin Resistance|insulin resistance
359734|NCT02052466|Shoulder Joint|shoulder joint
359735|NCT02052466|Computed tomography|computed tomography
359736|NCT02052453|Pacemaker|pacemaker
359737|NCT02052453|ICD|icd
359739|NCT02052453|Electrocautery|electrocautery
359740|NCT02052453|Electromagnetic interference|electromagnetic interference
359741|NCT02052427|Ischemic heart disease|ischemic heart disease
359742|NCT02052427|Coronary artery disease|coronary artery disease
359743|NCT02052427|Chronic Heart Failure|chronic heart failure
359744|NCT02052427|Cardiovascular disease|cardiovascular disease
359745|NCT02052427|adult stem cells|adult stem cells
359746|NCT02052427|adipose derived regenerative cells|adipose derived regenerative cells
359747|NCT02052414|side effects|side effects
359748|NCT02052414|safety|safety
359749|NCT02052414|efficacy|efficacy
359750|NCT02052414|Gralise|gralise
359751|NCT02052414|Fibromyalgia|fibromyalgia
359752|NCT02052414|gabapentin|gabapentin
359753|NCT02052401|OLD AGE|old age
359754|NCT02052401|Elderly|elderly
359755|NCT02052401|Domiciliary Intervention|domiciliary intervention
359756|NCT02052401|Occupational Therapy|occupational therapy
359757|NCT02052401|Rehospitalization|rehospitalization
359758|NCT02052388|Skin Infection|skin infection
359759|NCT02052388|Staph aureus|staph aureus
359760|NCT02052388|MRSA|mrsa
359761|NCT02052388|MSSA|mssa
359762|NCT02052388|Cellulitis/Erysipelas|cellulitis/erysipelas
359763|NCT02052388|Wound Infection|wound infection
359764|NCT02052388|Abscess|abscess
359765|NCT02052375|Rheumatoid Arthritis|rheumatoid arthritis
359766|NCT02052375|ASP2408|asp2408
359767|NCT02052375|methotrexate|methotrexate
359768|NCT02052362|absolute bioavailability|absolute bioavailability
359769|NCT02052362|healthy volunteers|healthy volunteers
359770|NCT02052349|relative bioavailability|relative bioavailability
359771|NCT02052349|healthy volunteers|healthy volunteers
779822|NCT00330512|hypotention|hypotention
460041|NCT01598584|RCT|rct
359772|NCT02052336|Drug-Drug interaction|drug-drug interaction
359773|NCT02052336|Pharmacokinetics|pharmacokinetics
359774|NCT02052323|P.f Malaria, Artemisinin resistance, ACT treatment failure|p.f malaria, artemisinin resistance, act treatment failure
359775|NCT02052310|Anemia|anemia
359776|NCT02052310|Chronic Kidney Disease|chronic kidney disease
359777|NCT02052310|Hemoglobin|hemoglobin
359778|NCT02052310|End-Stage Renal Disease|end-stage renal disease
359779|NCT02052310|Incident-Dialysis|incident-dialysis
359780|NCT02052310|Erythropoieitin|erythropoieitin
359781|NCT02052310|Erythropoieisis stimulating-agent|erythropoieisis stimulating-agent
359782|NCT02052310|Roxadustat|roxadustat
359783|NCT02052310|AZD9941|azd9941
359784|NCT02052310|ASP1517|asp1517
359785|NCT02052297|Idiopathic Pulmonary Fibrosis (IPF)|idiopathic pulmonary fibrosis (ipf)
359786|NCT02052297|dosimetry|dosimetry
359787|NCT02052297|Positron Emission Tomograph (PET)|positron emission tomograph (pet)
359788|NCT02052284|ELBW|elbw
359789|NCT02052284|premature|premature
359790|NCT02052284|neonate|neonate
359791|NCT02052284|skin|skin
359792|NCT02052284|water loss|water loss
359793|NCT02052271|essential tremor|essential tremor
359794|NCT02052271|cerebellum|cerebellum
359795|NCT02052271|transcranial direct current stimulation|transcranial direct current stimulation
359796|NCT02052271|electrophysiology|electrophysiology
359797|NCT02052258|oxytocin|oxytocin
359798|NCT02052219|Blisibimod|blisibimod
359799|NCT02052219|IgA nephropathy|iga nephropathy
359800|NCT02052219|BAFF|baff
359801|NCT02052219|BLyS|blys
359802|NCT02052206|osteoarthritis|osteoarthritis
359803|NCT02052206|complexe proximal humeral fracture|complexe proximal humeral fracture
359804|NCT02052206|shoulder|shoulder
359805|NCT02052206|shoulder replacement|shoulder replacement
359806|NCT02052206|accuracy|accuracy
359807|NCT02052206|computer-assisted|computer-assisted
359808|NCT02052206|3D|3d
359809|NCT02052180|Carpalmetacarpal arthroplasty|carpalmetacarpal arthroplasty
359810|NCT02052180|Proximal row carpectomy|proximal row carpectomy
359811|NCT02052180|Post-operative pain control|post-operative pain control
359812|NCT02052180|Exparel|exparel
359813|NCT02052180|Marcaine|marcaine
359814|NCT02052154|Pneumococcal infection|pneumococcal infection
359815|NCT02052154|Splenectomized|splenectomized
359816|NCT02052154|vaccination|vaccination
359817|NCT02052141|Pediatric|pediatric
359818|NCT02052141|C1 inhibitor|c1 inhibitor
359819|NCT02052141|HAE|hae
359820|NCT02052141|Cinryze|cinryze
359821|NCT02052141|C1 INH|c1 inh
359822|NCT02052141|Prevention|prevention
359823|NCT02052128|endometrial cancer|endometrial cancer
359824|NCT02052128|ovarian cancer|ovarian cancer
359825|NCT02052128|breast cancer|breast cancer
359826|NCT02052128|uterine sarcoma|uterine sarcoma
359827|NCT02052128|uterine endometrioid adenocarcinoma|uterine endometrioid adenocarcinoma
359828|NCT02052115|breast cancer|breast cancer
359829|NCT02052115|exercise|exercise
359830|NCT02052115|weight loss|weight loss
359831|NCT02052115|executive function|executive function
359832|NCT02052115|breast cancer survivor|breast cancer survivor
359833|NCT02052102|Deep inspiration breath hold|deep inspiration breath hold
359834|NCT02052102|radiation therapy|radiation therapy
359835|NCT02052102|Cardiac toxicity|cardiac toxicity
359836|NCT02052102|Left-sided breast cancer|left-sided breast cancer
359837|NCT02052089|Tennis Elbow|tennis elbow
359838|NCT02052089|lateral epicondylosis|lateral epicondylosis
359839|NCT02052089|lateral epicondylitis|lateral epicondylitis
359840|NCT02052089|Platelet-Rich Plasma|platelet-rich plasma
359841|NCT02052089|Extracorporeal Shockwave Therapy|extracorporeal shockwave therapy
359842|NCT02052089|Prolotherapy|prolotherapy
359843|NCT02052089|Physiotherapy|physiotherapy
359844|NCT02052076|Energy balance|energy balance
359845|NCT02052076|meal pattern|meal pattern
359846|NCT02052076|metabolic syndrome|metabolic syndrome
359847|NCT02052063|rectocele|rectocele
359848|NCT02052063|intussusception|intussusception
359849|NCT02052063|surgery|surgery
359850|NCT02052050|colorectal-neoplasms,deep-muscles of the back,rehabilitation|colorectal-neoplasms,deep-muscles of the back,rehabilitation
359851|NCT02052037|Type 2 Diabetes|type 2 diabetes
359852|NCT02052037|Egg|egg
359853|NCT02052037|Glycemic Control|glycemic control
359854|NCT02052037|Insulin sensitivity|insulin sensitivity
359855|NCT02052037|Diet quality|diet quality
359856|NCT02052024|Spasticity|spasticity
359857|NCT02052024|Modified Ashworth Scale|modified ashworth scale
359858|NCT02052024|MYOBLOC|myobloc
359859|NCT02052024|Botox|botox
359860|NCT02052024|Muscle Atrophy|muscle atrophy
359861|NCT02052011|Chest Pain|chest pain
359862|NCT02052011|Microvascular Angina|microvascular angina
359863|NCT02052011|Ranolazine|ranolazine
359864|NCT02052011|Emergency department|emergency department
359865|NCT02052011|PET|pet
359866|NCT02051998|Geographic atrophy|geographic atrophy
359867|NCT02051998|Age-related macular degeneration|age-related macular degeneration
359868|NCT02051998|Retina|retina
359869|NCT02051998|Retinal pigment epithelium|retinal pigment epithelium
359870|NCT02051998|Optical coherence tomography|optical coherence tomography
359871|NCT02051998|Scanning laser ophthalmoscopy|scanning laser ophthalmoscopy
359872|NCT02051985|Chronic heart failure|chronic heart failure
359873|NCT02051985|Heart decompensation|heart decompensation
359874|NCT02051985|Aerobic exercise training|aerobic exercise training
359875|NCT02051985|Functional capacity|functional capacity
359876|NCT02051985|Dyspnea|dyspnea
359877|NCT02051985|Beta-adrenergic receptor signaling|beta-adrenergic receptor signaling
359878|NCT02051959|Phantom Limb Pain|phantom limb pain
359879|NCT02051959|Transcranial Direct Current Stimulation|transcranial direct current stimulation
359880|NCT02051959|Amputation|amputation
359881|NCT02051959|Diabetes Mellitus|diabetes mellitus
359882|NCT02051946|novel drug delivery technique for glaucoma patients|novel drug delivery technique for glaucoma patients
359883|NCT02051933|pilon|pilon
359884|NCT02051933|tibial plafond|tibial plafond
359885|NCT02051933|botox|botox
359886|NCT02051933|ankle dorsiflexion|ankle dorsiflexion
359887|NCT02051933|ankle functionality|ankle functionality
359888|NCT02051933|ankle range of motion|ankle range of motion
359889|NCT02051920|Elastography|elastography
359890|NCT02051894|Neonates|neonates
359891|NCT02051894|Dobutamine|dobutamine
359892|NCT02051894|Superior Vena Cana Flow|superior vena cana flow
359893|NCT02051894|Hypoxic Ischemic Encephalopathy|hypoxic ischemic encephalopathy
359894|NCT02051894|Pleth Variability Index|pleth variability index
359895|NCT02051868|Squamous cell carcinoma of the anus|squamous cell carcinoma of the anus
359896|NCT02051868|Anal cancer|anal cancer
359897|NCT02051868|Cancer of the anus|cancer of the anus
359898|NCT02051868|SCCA|scca
359899|NCT02051868|Cisplatin-5FU|cisplatin-5fu
359900|NCT02051868|Carboplatin-Paclitaxel|carboplatin-paclitaxel
359901|NCT02051868|inoperable|inoperable
359902|NCT02051868|locally recurrent|locally recurrent
359903|NCT02051868|metastatic|metastatic
359904|NCT02051855|Neonates|neonates
359905|NCT02051855|Superior Vena Cava Flow|superior vena cava flow
359906|NCT02051855|Pleth Variability Index|pleth variability index
359907|NCT02051855|Dobutamine|dobutamine
359908|NCT02051855|Intensive Care|intensive care
359909|NCT02051842|NAFLD|nafld
359910|NCT02051842|oxidative stress|oxidative stress
359911|NCT02051842|malondialdehyde|malondialdehyde
359912|NCT02051816|Endotracheal Intubation|endotracheal intubation
359913|NCT02051816|Apneic Oxygenation|apneic oxygenation
359914|NCT02051816|Respiratory failure|respiratory failure
359915|NCT02051803|smoking cessation|smoking cessation
359916|NCT02051803|women|women
359917|NCT02051751|Solid tumors, Head and neck non squamous cell carcinoma, breast cancer, PI3K inhibitor, BYL719, paclitaxel|solid tumors, head and neck non squamous cell carcinoma, breast cancer, pi3k inhibitor, byl719, paclitaxel
359918|NCT02051738|Healthy|healthy
359919|NCT02051738|Mebendazole|mebendazole
359920|NCT02051738|Fast-Disintegrating Chewable Formulation|fast-disintegrating chewable formulation
359921|NCT02051738|Bioavailability|bioavailability
359922|NCT02051712|chronic heart failure|chronic heart failure
359923|NCT02051712|exercise training|exercise training
359924|NCT02051712|preferred training|preferred training
359925|NCT02051712|prevention|prevention
359926|NCT02051699|Osteoarthritis of the knee|osteoarthritis of the knee
359927|NCT02051699|Weight bearing radiograph|weight bearing radiograph
359928|NCT02051699|Kellgren-Lawrence classification|kellgren-lawrence classification
359929|NCT02051699|Joint space width|joint space width
359930|NCT02051699|One-leg standing view|one-leg standing view
359931|NCT02051686|Acetabulum Fractures|acetabulum fractures
359932|NCT02051686|Pelvic Ring Injuries|pelvic ring injuries
359933|NCT02051686|Tranexamic Acid|tranexamic acid
359934|NCT02051673|Kidney Transplantation|kidney transplantation
359935|NCT02051647|medical students|medical students
359936|NCT02051647|Basel University|basel university
359937|NCT02051634|Aging|aging
359938|NCT02051634|Papaya|papaya
359939|NCT02051634|Fermented Papaya|fermented papaya
359940|NCT02051634|Inflammation|inflammation
359941|NCT02051634|Phytochemicals|phytochemicals
359942|NCT02051634|Physical function|physical function
359943|NCT02051634|Quality of life|quality of life
359944|NCT02051634|Fatigue|fatigue
359945|NCT02051634|Health|health
359946|NCT02051621|pulmonary vein isolation|pulmonary vein isolation
359947|NCT02051621|isthmus ablation|isthmus ablation
359948|NCT02051621|recurrence|recurrence
359949|NCT02051595|heart lung machine|heart lung machine
359950|NCT02051595|blood pump|blood pump
359951|NCT02051595|cardiac surgery|cardiac surgery
359952|NCT02051595|cardiopulmonary bypass|cardiopulmonary bypass
359953|NCT02051595|circulation|circulation
359954|NCT02051556|Parkinson's disease|parkinson's disease
359955|NCT02051556|Freezing of gait|freezing of gait
359956|NCT02051556|Asymmetry|asymmetry
359957|NCT02051556|Rehabilitation|rehabilitation
359958|NCT02051556|Physical therapy|physical therapy
359959|NCT02051530|mood|mood
359960|NCT02051530|empathy|empathy
359961|NCT02051530|mimicry|mimicry
359962|NCT02051530|emotional reactivity|emotional reactivity
359963|NCT02051530|prosody|prosody
359964|NCT02051517|Virectomy|virectomy
359965|NCT02051504|Type 1 diabetes|type 1 diabetes
359966|NCT02051504|Glycated hemoglobin|glycated hemoglobin
359967|NCT02051504|Muscle Oxygenation|muscle oxygenation
359968|NCT02051504|Exercise|exercise
359969|NCT02051504|Maximal Oxygen uptake|maximal oxygen uptake
359970|NCT02051504|Mitochondrial respiration|mitochondrial respiration
359971|NCT02051504|Endocannabinoid system|endocannabinoid system
359972|NCT02051504|Oxidative stress|oxidative stress
359973|NCT02051478|manipulation|manipulation
359974|NCT02051478|mobilization|mobilization
359975|NCT02051478|spine|spine
359976|NCT02051478|pressure pain|pressure pain
359977|NCT02051439|Varicose Veins|varicose veins
359978|NCT02051439|Venous Insufficiency|venous insufficiency
359979|NCT02051439|Doppler|doppler
359980|NCT02051439|Duplex|duplex
359981|NCT02051439|Valsava|valsava
359982|NCT02051426|neuropsychiatric effects|neuropsychiatric effects
359983|NCT02051413|Major depression|major depression
359984|NCT02051413|Antidepressant drug|antidepressant drug
359985|NCT02051413|Beta-arrestin|beta-arrestin
359986|NCT02051413|Biomarker|biomarker
359987|NCT02051413|Predictive factor|predictive factor
359988|NCT02051400|Intubation|intubation
359989|NCT02051400|Laryngoscopes|laryngoscopes
359990|NCT02051361|DAT = Dual Antiplatelet Treatment|dat = dual antiplatelet treatment
359991|NCT02051361|Major Cardiac Adverse Events|major cardiac adverse events
359992|NCT02051348|Helicobacter pylori|helicobacter pylori
359993|NCT02051348|Mild Indigestion|mild indigestion
359994|NCT02051335|Drug therapy|drug therapy
359995|NCT02051309|Smokers|smokers
359996|NCT02051309|Quit Smoking|quit smoking
359997|NCT02051309|Treatment|treatment
359998|NCT02051309|Guanfacine|guanfacine
359999|NCT02051283|Hepatocellular carcinoma|hepatocellular carcinoma
360000|NCT02051283|RFA|rfa
360001|NCT02051283|MRI|mri
360002|NCT02051270|Elderly|elderly
360003|NCT02051270|Nursing homes|nursing homes
360004|NCT02051270|Mild cognitive impairment|mild cognitive impairment
360005|NCT02051244|Alzheimer's Disease|alzheimer's disease
360006|NCT02051244|Retinal Nerve Fiber Layer|retinal nerve fiber layer
360007|NCT02051244|Ocular Computerized Tomography|ocular computerized tomography
360008|NCT02051244|Minimal Cognitive Impairment|minimal cognitive impairment
360009|NCT02051244|Subjective Memory Loss|subjective memory loss
360010|NCT02051244|Asymptomatic Preclinical Alzheimer's Disease|asymptomatic preclinical alzheimer's disease
360011|NCT02051231|Uterine contraction|uterine contraction
360012|NCT02051231|Oxytocin receptors|oxytocin receptors
360013|NCT02051231|Oxytocin desensitization|oxytocin desensitization
360014|NCT02051218|metastatic breast cancer|metastatic breast cancer
360015|NCT02051218|castration resistant metastatic prostate cancer|castration resistant metastatic prostate cancer
360016|NCT02051218|bone metastases|bone metastases
360017|NCT02051218|Denosumab|denosumab
360018|NCT02051218|XGEVA|xgeva
360019|NCT02051218|de-escalation|de-escalation
360020|NCT02051205|Parkinson's disease, risk factors, epidemiology|parkinson's disease, risk factors, epidemiology
360021|NCT02051192|obsessive-compulsive disorder|obsessive-compulsive disorder
360022|NCT02051192|Social phobia|social phobia
360023|NCT02051192|Generalized anxiety disorder|generalized anxiety disorder
360024|NCT02051192|Specific phobia|specific phobia
360025|NCT02051192|Separation anxiety disorder|separation anxiety disorder
360026|NCT02051192|Selective Mutism|selective mutism
360027|NCT02051192|Anxiety Disorder, Not Otherwise Specified|anxiety disorder, not otherwise specified
360028|NCT02051192|Counseling|counseling
360029|NCT02051192|Behavioral therapy|behavioral therapy
360030|NCT02051192|Psychotherapy|psychotherapy
360031|NCT02051192|Exposure|exposure
360032|NCT02051192|Young Children|young children
360033|NCT02051179|Repair|repair
360034|NCT02051179|Replacement|replacement
360035|NCT02051179|Dental Amalgam|dental amalgam
360036|NCT02051153|Modafinil|modafinil
360037|NCT02051153|Cognitive|cognitive
360038|NCT02051153|Performance|performance
360039|NCT02051140|Postural Balance|postural balance
360040|NCT02051140|Walking|walking
360041|NCT02051140|Giat|giat
360042|NCT02051140|Cognition|cognition
360043|NCT02051140|Learning|learning
360044|NCT02051140|Memory|memory
360045|NCT02051140|Antioxidants|antioxidants
360046|NCT02051140|Anti-Inflammatory Agents|anti-inflammatory agents
360047|NCT02051140|Brain|brain
360048|NCT02051140|Strawberry|strawberry
360049|NCT02051127|Exercise|exercise
360050|NCT02051127|Physical Fitness|physical fitness
360051|NCT02051127|Stress, Psychological|stress, psychological
360052|NCT02051127|Cognition|cognition
360053|NCT02051127|Psychophysiology|psychophysiology
360054|NCT02051127|Ergometry|ergometry
360055|NCT02051127|Exercise Test|exercise test
360056|NCT02051127|Sedentary Lifestyle|sedentary lifestyle
360057|NCT02051114|Rheumatoid arthritis|rheumatoid arthritis
360058|NCT02051088|Critical limb ischemia|critical limb ischemia
360059|NCT02051088|Intermittent claudication|intermittent claudication
360060|NCT02051088|endovascular treatment|endovascular treatment
360061|NCT02051088|drug-elution|drug-elution
360062|NCT02051075|IVF|ivf
360063|NCT02051075|ICSI|icsi
360064|NCT02051075|Asthenospermia|asthenospermia
360065|NCT02051075|pentoxyphylline|pentoxyphylline
360066|NCT02051075|Spermatozoa|spermatozoa
360067|NCT02051062|Pharmacokinetics|pharmacokinetics
360068|NCT02051062|BAT|bat
360069|NCT02051062|Pediatric|pediatric
360070|NCT02051049|CN|cn
360071|NCT02051049|UCD|ucd
360072|NCT02051036|moxibustion|moxibustion
360073|NCT02051023|keratoconjunctivitis sicca|keratoconjunctivitis sicca
360074|NCT02051023|dry eye|dry eye
360075|NCT02051023|dry eye syndrome|dry eye syndrome
360076|NCT02051023|dry eye disease|dry eye disease
360077|NCT02051023|steroids|steroids
360078|NCT02050984|Obesity|obesity
360079|NCT02050984|Hypertension|hypertension
360080|NCT02050984|Bariatric Surgery|bariatric surgery
360081|NCT02050984|Diabetes|diabetes
360082|NCT02050971|Umbilical Cord Blood|umbilical cord blood
360083|NCT02050971|Autologous Umbilical Cord Blood Transfusion|autologous umbilical cord blood transfusion
360084|NCT02050971|Prematurity Complications|prematurity complications
360085|NCT02050971|Infant, Premature, Diseases|infant, premature, diseases
360086|NCT02050971|Infant, Newborn, Diseases|infant, newborn, diseases
360087|NCT02050971|Hematologic Diseases|hematologic diseases
360088|NCT02050971|Lung Diseases|lung diseases
360089|NCT02050971|Central Nervous System Diseases|central nervous system diseases
360090|NCT02050971|Gastrointestinal Tract Diseases|gastrointestinal tract diseases
360091|NCT02050971|Vascular Diseases|vascular diseases
360092|NCT02050971|Retinopathies, Neonates|retinopathies, neonates
360093|NCT02050971|Prevention,Treatment|prevention,treatment
360094|NCT02050932|hepcidin|hepcidin
360095|NCT02050932|iron bioavailability|iron bioavailability
360096|NCT02050932|iron supplementation|iron supplementation
360097|NCT02050906|IDEA-P|idea-p
360098|NCT02050906|Androgen Deprivation Therapy|androgen deprivation therapy
360099|NCT02050893|septic shock|septic shock
360100|NCT02050893|sepsis|sepsis
360101|NCT02050893|fluid responsiveness|fluid responsiveness
360102|NCT02050893|Midazolam|midazolam
360103|NCT02050893|Propofol|propofol
360104|NCT02050893|haemodynamics|haemodynamics
360105|NCT02050880|Normal Eyes|normal eyes
360106|NCT02050880|Eye; Disorder with Glaucoma|eye; disorder with glaucoma
360107|NCT02050880|Eye; Disorder with Retinal Disease|eye; disorder with retinal disease
360108|NCT02050880|Eye; Disorder Corneal Disease incl kerato-refractive group|eye; disorder corneal disease incl kerato-refractive group
360109|NCT02050867|Youth Suicide|youth suicide
360110|NCT02050867|Suicide|suicide
360111|NCT02050854|Aripiprazole|aripiprazole
360112|NCT02050854|Treatment Adherence|treatment adherence
360113|NCT02050841|Pediatric|pediatric
360114|NCT02050841|patients|patients
360115|NCT02050841|replacement|replacement
360116|NCT02050841|coagulation factors|coagulation factors
360117|NCT02050841|plasma|plasma
360118|NCT02050841|s/d plasma|s/d plasma
360119|NCT02050841|Octaplas|octaplas
360120|NCT02050841|plasma replacement|plasma replacement
360121|NCT02050815|MEK162|mek162
360122|NCT02050815|Hepatic impairment|hepatic impairment
360123|NCT02050815|Healthy subjects|healthy subjects
360124|NCT02050802|Macitentan|macitentan
360125|NCT02050802|Pharmacokinetics|pharmacokinetics
360126|NCT02050802|Pharmacodynamics|pharmacodynamics
360127|NCT02050763|HIV|hiv
360128|NCT02050763|Intimate partner violence|intimate partner violence
360129|NCT02050763|Community based prevention intervention|community based prevention intervention
360130|NCT02050763|Uganda|uganda
360131|NCT02050763|Cluster randomized trial|cluster randomized trial
360132|NCT02050750|Must have registered with the ICORG 06-31 TAILORx trial|must have registered with the icorg 06-31 tailorx trial
360133|NCT02050737|Curative resection|curative resection
360134|NCT02050737|Adjuvant chemotherapy|adjuvant chemotherapy
360135|NCT02050724|Solitary Pulmonary Nodule|solitary pulmonary nodule
360136|NCT02050724|Thoracoscopy|thoracoscopy
360137|NCT02050724|Thoracic Surgery|thoracic surgery
360138|NCT02050724|Video-Assisted|video-assisted
360139|NCT02050724|Radioactive Tracers|radioactive tracers
360140|NCT02050724|Radioguided surgery|radioguided surgery
360141|NCT02050724|Handheld-SPECT|handheld-spect
360142|NCT02050711|Chronic obstructive pulmonary disease (COPD)|chronic obstructive pulmonary disease (copd)
360143|NCT02050711|Pulmonary rehabilitation|pulmonary rehabilitation
360144|NCT02050711|Computerized respiratory sounds|computerized respiratory sounds
360145|NCT02050698|fift metatarsal avulsion fracture|fift metatarsal avulsion fracture
360146|NCT02050698|hard-soled shoe|hard-soled shoe
360147|NCT02050698|short leg walking cast|short leg walking cast
360148|NCT02050698|protected weightbearing|protected weightbearing
360149|NCT02050672|Myoinositol|myoinositol
360150|NCT02050672|ART|art
360151|NCT02050672|EMBRYO QUALITY|embryo quality
360152|NCT02050646|Autoimmune hepatitis|autoimmune hepatitis
360153|NCT02050646|Liver dysfunction|liver dysfunction
360154|NCT02050646|Elevated serum auto antibodies|elevated serum auto antibodies
360155|NCT02050633|Craniocerebral Trauma|craniocerebral trauma
360156|NCT02050633|Long term outcome|long term outcome
360157|NCT02050633|Activities of Daily Living|activities of daily living
360158|NCT02050633|Cognitive Deficiency|cognitive deficiency
779823|NCT00330512|newborn|newborn
360159|NCT02050633|Health Care Quality, Access, and Evaluation|health care quality, access, and evaluation
360160|NCT02050633|Burden of care|burden of care
360161|NCT02050620|Breast cancer, exercise and quality of life|breast cancer, exercise and quality of life
360162|NCT02050581|Platelets are a part of the blood hat helps with clotting|platelets are a part of the blood hat helps with clotting
360163|NCT02050581|ITP idiopathic thrombocytopenia purpura low platelet count|itp idiopathic thrombocytopenia purpura low platelet count
360164|NCT02050568|Genital prolapse|genital prolapse
360165|NCT02050568|Genital prolapse surgery|genital prolapse surgery
360166|NCT02050568|Stress urinary incontinence|stress urinary incontinence
360167|NCT02050568|Urethral Pressure Reflectometry|urethral pressure reflectometry
360168|NCT02050542|cancer|cancer
360169|NCT02050542|prostate|prostate
360170|NCT02050542|PSA|psa
360171|NCT02050542|biopsies|biopsies
360172|NCT02050542|ultrasound|ultrasound
360173|NCT02050542|MRI|mri
360174|NCT02050542|fusion of images|fusion of images
360175|NCT02050529|Hypertension, Pregnancy induced|hypertension, pregnancy induced
360176|NCT02050529|Pre-eclampsia|pre-eclampsia
360177|NCT02050529|Eclampsia|eclampsia
360178|NCT02050529|Labetalol|labetalol
360179|NCT02050529|Hydralazine|hydralazine
360180|NCT02050516|Blastocyst, micro-well group culture dish|blastocyst, micro-well group culture dish
360181|NCT02050503|Mucositis|mucositis
360182|NCT02050503|Breakthrough pain|breakthrough pain
360183|NCT02050503|Head Nad neck cancer|head nad neck cancer
360184|NCT02050503|Intranasal transmucosal fentanyl in pectin|intranasal transmucosal fentanyl in pectin
360185|NCT02050477|Obesity|obesity
360186|NCT02050477|Bariatric|bariatric
360187|NCT02050477|Surgery|surgery
360188|NCT02050477|Sleeve|sleeve
360189|NCT02050477|Gastroplasty|gastroplasty
360190|NCT02050477|Laparoscopy|laparoscopy
360191|NCT02050464|Alzheimer Disease|alzheimer disease
360192|NCT02050464|Frontotemporal Dementia|frontotemporal dementia
360193|NCT02050464|Dementia, Vascular|dementia, vascular
360194|NCT02050464|Mild Cognitive Impairment|mild cognitive impairment
360195|NCT02050464|Diagnosis|diagnosis
360196|NCT02050464|Risk factors|risk factors
360197|NCT02050464|Biomarkers|biomarkers
360198|NCT02050464|AD|ad
360199|NCT02050464|FTD|ftd
360200|NCT02050464|VAD|vad
360201|NCT02050464|MCI|mci
360202|NCT02050451|radical cystectomy|radical cystectomy
360203|NCT02050451|urinary diversion|urinary diversion
360204|NCT02050451|nutrition|nutrition
360205|NCT02050451|oral supplementation|oral supplementation
360206|NCT02050451|enteral nutrition|enteral nutrition
360207|NCT02050438|Osteoarthritis Knee|osteoarthritis knee
360208|NCT02050438|Total Knee Arthroplasty|total knee arthroplasty
360209|NCT02050438|Quality of Life|quality of life
360210|NCT02050425|OSA|osa
360211|NCT02050425|CPAP|cpap
360212|NCT02050425|exhaled breath|exhaled breath
360213|NCT02050399|Isometric Exercise|isometric exercise
360214|NCT02050399|Arterial Pressure|arterial pressure
360215|NCT02050399|Autonomic Nervous System|autonomic nervous system
360216|NCT02050399|Cardiovascular system|cardiovascular system
360217|NCT02050399|Posture|posture
360218|NCT02050386|Brain arousal systems|brain arousal systems
360219|NCT02050386|Aging|aging
360220|NCT02050386|MRI|mri
360221|NCT02050386|fMRI|fmri
360222|NCT02050386|Cognition|cognition
360223|NCT02050373|Mucositis|mucositis
360224|NCT02050373|Stomatitis|stomatitis
360225|NCT02050373|Chemotherapy|chemotherapy
360226|NCT02050373|Hematopoietic stem cell transplant|hematopoietic stem cell transplant
360227|NCT02050373|Laser therapy|laser therapy
360228|NCT02050373|Inflammatory cytokines|inflammatory cytokines
360229|NCT02050360|Raynaud's phenomenon|raynaud's phenomenon
360230|NCT02050360|Sildenafil|sildenafil
360231|NCT02050360|Systemic Sclerosis|systemic sclerosis
360232|NCT02050360|Local cooling|local cooling
360233|NCT02050360|Microcirculation|microcirculation
360234|NCT02050347|CD19.CAR-CD28zeta|cd19.car-cd28zeta
360235|NCT02050347|chimeric antigen receptor|chimeric antigen receptor
360236|NCT02050347|hematopoietic stem cell transplant|hematopoietic stem cell transplant
360237|NCT02050334|Phase 1|phase 1
360238|NCT02050334|Healthy Volunteer|healthy volunteer
360239|NCT02050334|Safety|safety
360240|NCT02050334|Healthy Volunteer Safety Study|healthy volunteer safety study
360241|NCT02050282|Dyspnea|dyspnea
360242|NCT02050282|Prehospital|prehospital
360243|NCT02050282|Biomarker|biomarker
360244|NCT02050282|Heart failure|heart failure
360245|NCT02050282|Triage|triage
360246|NCT02050282|Randomized, controlled study|randomized, controlled study
360247|NCT02050256|Palliative care|palliative care
360248|NCT02050256|Continuing medical education|continuing medical education
360249|NCT02050256|General practitioner|general practitioner
360250|NCT02050256|Electronic decision support|electronic decision support
360251|NCT02050243|pediatrics|pediatrics
360252|NCT02050243|brain tumor|brain tumor
360253|NCT02050243|CNS|cns
360254|NCT02050243|fluorescence|fluorescence
360255|NCT02050243|5ALA|5ala
360256|NCT02050230|transfusion|transfusion
360257|NCT02050230|pulmonary hypertension|pulmonary hypertension
780037|NCT00329680|EPA|epa
360258|NCT02050230|intensive care medicine|intensive care medicine
360259|NCT02050217|Helmet|helmet
360260|NCT02050217|Neurally Adjusted Ventilatory Assist|neurally adjusted ventilatory assist
360261|NCT02050217|Children|children
360262|NCT02050217|Respiratory Failure|respiratory failure
360263|NCT02050204|work to family conflict|work to family conflict
360264|NCT02050204|supervisor support|supervisor support
360265|NCT02050204|long work hours|long work hours
360266|NCT02050204|cardiometabolic risk|cardiometabolic risk
360267|NCT02050204|sleep duration|sleep duration
360268|NCT02050204|insomnia symptoms|insomnia symptoms
360269|NCT02050178|Pancreatic Cancer|pancreatic cancer
360270|NCT02050178|Stage IV Pancreatic Cancer|stage iv pancreatic cancer
360271|NCT02050165|obesity|obesity
360272|NCT02050165|snacks|snacks
360273|NCT02050165|satiety|satiety
360274|NCT02050165|hunger|hunger
360275|NCT02050152|Amnesia|amnesia
360276|NCT02050152|Memory|memory
360277|NCT02050152|Implicit|implicit
360278|NCT02050152|Explicit|explicit
360279|NCT02050152|Nitrous Oxide|nitrous oxide
360280|NCT02050139|L-Cysteine|l-cysteine
360281|NCT02050139|Peritoneal dialysis|peritoneal dialysis
360282|NCT02050139|Diuresis|diuresis
360283|NCT02050139|Glomerular filtration rate|glomerular filtration rate
360284|NCT02050139|Peritoneal function|peritoneal function
360285|NCT02050139|Inflammation|inflammation
360286|NCT02050113|Complex Aortic Aneurysms|complex aortic aneurysms
360287|NCT02050113|Thoracoabdominal Aneurysms|thoracoabdominal aneurysms
360288|NCT02050113|Pararenal Aortic Aneurysms|pararenal aortic aneurysms
360289|NCT02050113|Juxtarenal Renal Aneurysms|juxtarenal renal aneurysms
360290|NCT02050113|Endovascular Branch Graft|endovascular branch graft
360291|NCT02050113|Fenestrated Stent Graft|fenestrated stent graft
360292|NCT02050113|Abdominal Aortic Aneurysm|abdominal aortic aneurysm
360293|NCT02050113|Endovascular|endovascular
360294|NCT02050100|primary lung adenocarcinoma Stages I, II, IIIA, IIIB|primary lung adenocarcinoma stages i, ii, iiia, iiib
360295|NCT02050100|squamous cell carcinoma Stages I, II, IIIA, IIIB|squamous cell carcinoma stages i, ii, iiia, iiib
360296|NCT02050100|benign non-calcified pulmonary nodules|benign non-calcified pulmonary nodules
360297|NCT02050100|early detection|early detection
360298|NCT02050087|Rotator cuff|rotator cuff
360299|NCT02050087|Rehabilitation|rehabilitation
360300|NCT02050048|Pancreatitis|pancreatitis
360301|NCT02050048|Endoscopic retrograde cholangiopancreatography|endoscopic retrograde cholangiopancreatography
360302|NCT02050048|Cholangiopancreatography, Endoscopic Retrograde|cholangiopancreatography, endoscopic retrograde
360303|NCT02050048|ERCP|ercp
360304|NCT02050048|High Volume|high volume
360305|NCT02050048|Lactated Ringer|lactated ringer
360306|NCT02050048|Intravenous Administration|intravenous administration
360307|NCT02050048|Sphincterotomy, Endoscopic|sphincterotomy, endoscopic
360308|NCT02050048|Pancreas|pancreas
360309|NCT02050035|Exercise Therapy|exercise therapy
360310|NCT02050035|Endothelium, vascular|endothelium, vascular
360311|NCT02050035|Blood Vessels|blood vessels
360312|NCT02050022|Biomarkers|biomarkers
360313|NCT02050022|Genomics|genomics
360314|NCT02050022|Proteomics|proteomics
360315|NCT02050022|Diagnostics|diagnostics
360316|NCT02050022|Prognostics|prognostics
360317|NCT02049996|Quality of life|quality of life
360318|NCT02049996|Robotic surgery|robotic surgery
360319|NCT02049996|Vaginal surgery|vaginal surgery
360320|NCT02049996|Prolapse repair|prolapse repair
360321|NCT02049996|Vaginal hysterectomy|vaginal hysterectomy
360322|NCT02049970|Supraclavicular block|supraclavicular block
360323|NCT02049957|MLN0128|mln0128
360324|NCT02049944|Antibiotic Prophylaxis|antibiotic prophylaxis
360325|NCT02049944|Obesity|obesity
360326|NCT02049944|Obesity, Morbid|obesity, morbid
360327|NCT02049944|Pregnancy|pregnancy
360328|NCT02049944|Infection; Cesarean Section|infection; cesarean section
360329|NCT02049931|osteoporosis, compression fracture, brace|osteoporosis, compression fracture, brace
360330|NCT02049918|Respiratory viruses|respiratory viruses
360331|NCT02049905|soft tissue sarcoma|soft tissue sarcoma
360332|NCT02049905|unresectable|unresectable
360333|NCT02049905|metastatic|metastatic
360334|NCT02049905|locally advanced|locally advanced
360336|NCT02049892|Total Hip Replacement|total hip replacement
360337|NCT02049892|Metal Ion|metal ion
360338|NCT02049892|2-5 years after surgery|2-5 years after surgery
360339|NCT02049892|Asymptomatic|asymptomatic
360340|NCT02049866|osteoporosis|osteoporosis
360341|NCT02049866|premenopausal|premenopausal
360342|NCT02049866|denosumab|denosumab
360343|NCT02049866|idiopathic|idiopathic
360344|NCT02049866|Idiopathic Osteoporosis in Premenopausal Women|idiopathic osteoporosis in premenopausal women
360345|NCT02049853|acute dyspnea|acute dyspnea
360346|NCT02049853|heart failure|heart failure
360347|NCT02049853|diagnostics|diagnostics
360348|NCT02049853|POCT analysis|poct analysis
360349|NCT02049853|preclinical area|preclinical area
360350|NCT02049840|Female sling|female sling
360351|NCT02049840|Stress Urinary Incontinence|stress urinary incontinence
360352|NCT02049840|Urination Disorders|urination disorders
360353|NCT02049840|Urologic Diseases|urologic diseases
780038|NCT00329680|GLA|gla
360354|NCT02049827|Renal transplant, BK virus|renal transplant, bk virus
360355|NCT02049814|Drug therapy|drug therapy
360356|NCT02049762|novel P2Y12 inhibitors|novel p2y12 inhibitors
360357|NCT02049762|aspirin|aspirin
360358|NCT02049762|platelet reactivity|platelet reactivity
360359|NCT02049762|acute coronary syndrome|acute coronary syndrome
360360|NCT02049749|Child Behavior Problems|child behavior problems
360361|NCT02049749|Parent Training Program|parent training program
360362|NCT02049723|Gastroesophageal reflux disease|gastroesophageal reflux disease
360363|NCT02049723|Knowledge|knowledge
360364|NCT02049697|Healthy|healthy
360365|NCT02049697|Healthy male participants|healthy male participants
360366|NCT02049697|14C-JNJ -39823277|14c-jnj -39823277
360367|NCT02049697|TPI 1062|tpi 1062
360368|NCT02049697|Tianeptine|tianeptine
360369|NCT02049697|Absorption|absorption
360370|NCT02049697|Metabolism|metabolism
360371|NCT02049697|Excretion|excretion
360372|NCT02049697|Pharmacokinetics|pharmacokinetics
360373|NCT02049658|tumor|tumor
360374|NCT02049658|cancer|cancer
360375|NCT02049645|lung cancer|lung cancer
360376|NCT02049645|breast cancer|breast cancer
360377|NCT02049632|Breast cancer|breast cancer
360378|NCT02049632|Sentinel Node Biopsy|sentinel node biopsy
360379|NCT02049632|Micrometastasis|micrometastasis
360380|NCT02049632|Axillary lymph node dissection|axillary lymph node dissection
360381|NCT02049619|Pharyngeal pack|pharyngeal pack
360382|NCT02049619|Nausea|nausea
360383|NCT02049619|Vomiting|vomiting
360384|NCT02049619|orthognathic surgery|orthognathic surgery
360385|NCT02049619|maxillary osteotomy|maxillary osteotomy
360386|NCT02049606|LAYLA|layla
360387|NCT02049606|Non-inferiority|non-inferiority
360388|NCT02049606|100mm pain VAS|100mm pain vas
360389|NCT02049593|protocol specific|protocol specific
360390|NCT02049580|lymphoma|lymphoma
360391|NCT02049567|cataract, presbyopia|cataract, presbyopia
360392|NCT02049554|preconception care|preconception care
360393|NCT02049554|women's health|women's health
360394|NCT02049541|BKM120|bkm120
360395|NCT02049541|B-Cell Lymphoma|b-cell lymphoma
360396|NCT02049541|PI3K inhibitor|pi3k inhibitor
360397|NCT02049528|Food Effect|food effect
360398|NCT02049528|Pharmacokinetic|pharmacokinetic
360399|NCT02049528|Healthy|healthy
360400|NCT02049528|Male|male
360401|NCT02049515|Phase 3|phase 3
360402|NCT02049515|CLL/SLL|cll/sll
360403|NCT02049515|PI3K|pi3k
360404|NCT02049502|ulcerative colitis|ulcerative colitis
360405|NCT02049502|fecal microbiota transplantation|fecal microbiota transplantation
360406|NCT02049489|ICT-121|ict-121
360407|NCT02049489|glioblastoma|glioblastoma
360408|NCT02049489|immunotherapy|immunotherapy
360409|NCT02049489|dendritic cell vaccine|dendritic cell vaccine
360410|NCT02049489|CD133|cd133
360411|NCT02049476|Uveitis, Intermediate|uveitis, intermediate
360412|NCT02049476|Uveitis, Posterior|uveitis, posterior
360413|NCT02049476|Dexamethasone|dexamethasone
360414|NCT02049476|Immunosuppressive Agents|immunosuppressive agents
360415|NCT02049476|Eye Abnormalities|eye abnormalities
360416|NCT02049476|Eye Diseases|eye diseases
360417|NCT02049476|Ophthalmology|ophthalmology
360418|NCT02049476|Ophthalmologic Surgical Procedures|ophthalmologic surgical procedures
360419|NCT02049476|Vision Disorders|vision disorders
360420|NCT02049476|Inflammation|inflammation
360421|NCT02049463|carotid artery|carotid artery
360422|NCT02049463|sound|sound
360423|NCT02049463|stenosis|stenosis
360424|NCT02049463|wall|wall
360425|NCT02049463|stroke|stroke
360426|NCT02049450|thalassemia|thalassemia
360427|NCT02049450|thalassemia major|thalassemia major
360428|NCT02049450|spleen enlargement|spleen enlargement
360429|NCT02049450|INC424|inc424
360430|NCT02049450|ruxolitinib|ruxolitinib
360432|NCT02049437|Immune failure|immune failure
360433|NCT02049437|Tocilizumab|tocilizumab
360434|NCT02049437|ACTEMRA|actemra
360435|NCT02049437|Antiretroviral therapy|antiretroviral therapy
360436|NCT02049437|HAART|haart
360437|NCT02049411|Ketamine|ketamine
360438|NCT02049411|acute cognitive dysfunction|acute cognitive dysfunction
360439|NCT02049411|geriatric patients|geriatric patients
360440|NCT02049398|Microbiome|microbiome
360441|NCT02049398|Saliva|saliva
360442|NCT02049398|Reliability|reliability
360443|NCT02049398|Oral Cavity|oral cavity
360444|NCT02049385|Glutamate|glutamate
360445|NCT02049385|Pathophysiology|pathophysiology
360446|NCT02049385|Depression|depression
360447|NCT02049385|Treatment|treatment
360448|NCT02049372|complications|complications
360449|NCT02049372|tonsillectomy|tonsillectomy
360450|NCT02049372|tonsillotomy|tonsillotomy
360451|NCT02049359|Diabetes|diabetes
360452|NCT02049346|Anemia|anemia
360453|NCT02049346|Hemodialysis|hemodialysis
360454|NCT02049346|Erythropoetin Stimulating Agents|erythropoetin stimulating agents
360455|NCT02049346|Comparison|comparison
360456|NCT02049294|Prednisone|prednisone
360457|NCT02049294|Eosinophils|eosinophils
360458|NCT02049294|Immunoglobin E (IgE)|immunoglobin e (ige)
360459|NCT02049294|Asthma|asthma
360460|NCT02049294|Bronchitis|bronchitis
360461|NCT02049294|Inflammation|inflammation
360462|NCT02049294|Allergy|allergy
360463|NCT02049268|alcohol|alcohol
360464|NCT02049268|nicotine|nicotine
360465|NCT02049268|addiction|addiction
360466|NCT02049268|functional MRI|functional mri
360467|NCT02049268|functional connectivity|functional connectivity
360468|NCT02049268|brain circuits|brain circuits
360469|NCT02049255|All|all
360470|NCT02049242|Hemorrhage|hemorrhage
360471|NCT02049242|Leiomyoma|leiomyoma
360472|NCT02049242|Myofibroma|myofibroma
360473|NCT02049242|Uterine Myomectomy|uterine myomectomy
360474|NCT02049242|Tourniquet|tourniquet
360475|NCT02049229|Stent|stent
360476|NCT02049229|Titanium|titanium
360477|NCT02049229|drug eluting stent|drug eluting stent
360478|NCT02049229|myocardial infarction|myocardial infarction
360479|NCT02049229|stent thrombosis|stent thrombosis
360480|NCT02049216|knee|knee
360481|NCT02049216|osteoarthritis|osteoarthritis
360482|NCT02049216|tape|tape
360483|NCT02049216|exercise|exercise
360484|NCT02049216|rocktape|rocktape
360485|NCT02049190|Advanced Prostate Cancer|advanced prostate cancer
360486|NCT02049190|Castration-resistant Prostate Cancer|castration-resistant prostate cancer
360487|NCT02049190|Prostatic Neoplasms|prostatic neoplasms
360488|NCT02049190|Genital Neoplasms, Male|genital neoplasms, male
360489|NCT02049190|Urogenital Neoplasms|urogenital neoplasms
360490|NCT02049190|Neoplasms by Site|neoplasms by site
360491|NCT02049190|Neoplasms|neoplasms
360492|NCT02049190|Genital Diseases, Male|genital diseases, male
360493|NCT02049190|Prostatic Diseases|prostatic diseases
360494|NCT02049190|onapristone|onapristone
360495|NCT02049177|Cancer|cancer
360496|NCT02049177|Epidemiology|epidemiology
360497|NCT02049177|Head and Neck|head and neck
360498|NCT02049177|HPV|hpv
360499|NCT02049164|AR08, Vasomotor Symptoms|ar08, vasomotor symptoms
360500|NCT02049151|Carcinoma, Non-Small-Cell Lung|carcinoma, non-small-cell lung
360501|NCT02049151|Tecemotide|tecemotide
360502|NCT02049151|Placebo|placebo
360503|NCT02049151|NSCLC|nsclc
360504|NCT02049151|L-BLP25|l-blp25
360505|NCT02049138|Musculoskeletal Disease|musculoskeletal disease
360506|NCT02049138|Arthritis|arthritis
360507|NCT02049138|Joint Diseases|joint diseases
360508|NCT02049138|Anti-inflammatory Agents|anti-inflammatory agents
360509|NCT02049138|Antirheumatic agents|antirheumatic agents
360510|NCT02049125|NGAL|ngal
360511|NCT02049125|Acute kidney injury|acute kidney injury
360512|NCT02049125|Cirrhosis|cirrhosis
360513|NCT02049125|Hepatorenal syndrome|hepatorenal syndrome
360514|NCT02049112|Cross-over|cross-over
360515|NCT02049112|Salivary equivalent|salivary equivalent
360516|NCT02049112|Dry mouth|dry mouth
360517|NCT02049112|Medical device|medical device
360518|NCT02049086|SBIRT|sbirt
360519|NCT02049086|Screening|screening
360520|NCT02049086|Brief Intervention|brief intervention
360521|NCT02049086|Referral to Treatment|referral to treatment
360522|NCT02049086|Pain-Management|pain-management
360523|NCT02049086|Veterans|veterans
360524|NCT02049073|hearing loss|hearing loss
360525|NCT02049073|noise induced hearing loss|noise induced hearing loss
360526|NCT02049073|zonisamide|zonisamide
360527|NCT02049060|MPM|mpm
360528|NCT02049060|NSCLC|nsclc
360529|NCT02049047|thymoma thymic carcinoma|thymoma thymic carcinoma
360530|NCT02049034|GLP-1 agonist|glp-1 agonist
360531|NCT02049034|Lixisenatide|lixisenatide
360532|NCT02049034|Postprandial glucose metabolism|postprandial glucose metabolism
360533|NCT02049034|Postprandial lipid metabolism|postprandial lipid metabolism
360534|NCT02049034|Gastric emptying|gastric emptying
360535|NCT02049034|Lipoprotein lipase activity|lipoprotein lipase activity
360536|NCT02049021|schizophrenia|schizophrenia
360537|NCT02049021|electroconvulsive therapy|electroconvulsive therapy
360538|NCT02049021|refractory Schizophrenia|refractory schizophrenia
360539|NCT02049021|super refractory schizophrenia|super refractory schizophrenia
360540|NCT02049021|clozapine|clozapine
360541|NCT02048995|Bipolar Disorder|bipolar disorder
360542|NCT02048995|Depression|depression
361134|NCT02046447|Benzhexol|benzhexol
360543|NCT02048995|Light Therapy|light therapy
360544|NCT02048995|Contrast Sensitivity|contrast sensitivity
360545|NCT02048995|Visual Evoked Potential|visual evoked potential
360546|NCT02048995|Visual or Neural Responses|visual or neural responses
360547|NCT02048995|Biomarker|biomarker
360548|NCT02048982|physician prescribing|physician prescribing
360549|NCT02048982|behavioral economics|behavioral economics
360550|NCT02048982|primary care practice|primary care practice
360551|NCT02048969|hepatic encephalopathy|hepatic encephalopathy
360552|NCT02048969|flumazenil|flumazenil
360553|NCT02048969|liver cirrhosis|liver cirrhosis
360554|NCT02048956|knee osteoarthritis|knee osteoarthritis
360555|NCT02048956|hydrotherapy|hydrotherapy
360557|NCT02048930|effectiveness|effectiveness
360558|NCT02048930|cost-effectiveness|cost-effectiveness
360559|NCT02048930|Easyhaler|easyhaler
360560|NCT02048930|Primary care|primary care
360561|NCT02048930|DPI|dpi
360562|NCT02048917|Smoking|smoking
360563|NCT02048917|Cessation|cessation
360564|NCT02048917|Bupropion|bupropion
360565|NCT02048917|Varenicline|varenicline
360566|NCT02048917|Nicotine|nicotine
360567|NCT02048917|Counseling|counseling
360568|NCT02048917|Tobacco|tobacco
360569|NCT02048904|microalbuminuria|microalbuminuria
360570|NCT02048904|type 2 diabetes|type 2 diabetes
360571|NCT02048878|Insomnia|insomnia
360572|NCT02048865|VTE Cancer|vte cancer
360573|NCT02048852|menthol|menthol
360574|NCT02048852|nicotine|nicotine
360575|NCT02048826|stroke|stroke
360576|NCT02048800|Treosulfan pharmacokinetics|treosulfan pharmacokinetics
360577|NCT02048800|Children|children
360578|NCT02048800|Any condition that requires an allogeneic HSCT|any condition that requires an allogeneic hsct
360579|NCT02048787|Renal impairment|renal impairment
360580|NCT02048787|Healthy volunteers|healthy volunteers
360581|NCT02048787|Clinical pharmacology study|clinical pharmacology study
360582|NCT02048748|Home Care Services|home care services
360583|NCT02048748|Telemedicine|telemedicine
360584|NCT02048696|Exercise training|exercise training
360585|NCT02048696|High intensity interval training|high intensity interval training
360586|NCT02048696|left ventricular systolic function|left ventricular systolic function
360587|NCT02048696|G-protein related kinase 2|g-protein related kinase 2
360588|NCT02048696|heart failure|heart failure
360589|NCT02048696|myocardial infarction|myocardial infarction
360590|NCT02048696|coronary artery disease|coronary artery disease
360591|NCT02048696|beta adrenergic receptor|beta adrenergic receptor
360592|NCT02048683|Pharmacokinetics|pharmacokinetics
360593|NCT02048683|Sevoflurane|sevoflurane
360594|NCT02048683|Burn|burn
360595|NCT02048683|Sedation|sedation
360596|NCT02048670|Pilot study|pilot study
360597|NCT02048670|Assessment of sway phase|assessment of sway phase
360598|NCT02048670|Therapy trial phase|therapy trial phase
360599|NCT02048657|LMA, Foley Airway Stylet Tool (FAST), introducer-tool (I-Tool)|lma, foley airway stylet tool (fast), introducer-tool (i-tool)
360600|NCT02048644|Platelets adhesion|platelets adhesion
360601|NCT02048631|oral cancer,Quality of life,Sensory|oral cancer,quality of life,sensory
360602|NCT02048618|Active Crohn's Disease|active crohn's disease
360603|NCT02048618|GLPG0634|glpg0634
360604|NCT02048592|cystic fibrosis, immunonutrition, oxidative stress|cystic fibrosis, immunonutrition, oxidative stress
360605|NCT02048566|Echocardiography, Transesophageal|echocardiography, transesophageal
360606|NCT02048566|Monitoring, Physiologic|monitoring, physiologic
360607|NCT02048566|Shock|shock
360608|NCT02048553|ventriculostomy; complications in neurosurgery;catheter accuracy;|ventriculostomy; complications in neurosurgery;catheter accuracy;
360609|NCT02048514|Aortic Aneurysm, Abdominal|aortic aneurysm, abdominal
360610|NCT02048514|Endovascular Procedures|endovascular procedures
360611|NCT02048501|Weight regain|weight regain
360612|NCT02048501|Sustain weight loss|sustain weight loss
360613|NCT02048501|Weight loss|weight loss
360614|NCT02048501|Gut hormones|gut hormones
360615|NCT02048488|non small cell lung cancer|non small cell lung cancer
360616|NCT02048488|NSCLC|nsclc
360617|NCT02048488|Anaplastic lymphoma kinase|anaplastic lymphoma kinase
360618|NCT02048488|ALK tyrosine kinase receptor|alk tyrosine kinase receptor
360619|NCT02048488|ALK+|alk+
360620|NCT02048488|TRK+|trk+
360621|NCT02048488|ALK inhibitor|alk inhibitor
360622|NCT02048488|TRK inhibitor|trk inhibitor
360623|NCT02048488|tropomyosin receptor kinase|tropomyosin receptor kinase
360624|NCT02048488|TRKA|trka
360625|NCT02048488|TRKB|trkb
360626|NCT02048488|TRKC|trkc
360627|NCT02048488|advanced malignancy|advanced malignancy
360628|NCT02048475|desflurane|desflurane
360629|NCT02048475|electroencephalogram|electroencephalogram
360630|NCT02048449|Reflux finding score, interrater reliability|reflux finding score, interrater reliability
360631|NCT02048436|Respiratory Rate|respiratory rate
360632|NCT02048423|suicidal|suicidal
360633|NCT02048397|Bronchiectasis.|bronchiectasis.
360634|NCT02048384|rapamycin|rapamycin
360635|NCT02048384|metformin|metformin
360636|NCT02048384|pancreatic cancer|pancreatic cancer
360637|NCT02048384|adenocarcinoma|adenocarcinoma
360638|NCT02048384|metastatic|metastatic
360639|NCT02048358|Healthy volunteers|healthy volunteers
360640|NCT02048358|first in human|first in human
360641|NCT02048358|2B3-201|2b3-201
360642|NCT02048358|methylprednisolone|methylprednisolone
360643|NCT02048358|CNS-targeting|cns-targeting
360644|NCT02048358|liposomal|liposomal
360645|NCT02048358|crossover|crossover
360646|NCT02048358|placebo controlled|placebo controlled
360647|NCT02048358|active controlled|active controlled
360648|NCT02048358|multiple sclerosis|multiple sclerosis
360649|NCT02048358|multiple sclerosis relapse|multiple sclerosis relapse
360650|NCT02048345|ten mL suspension of posaconazol (Noxafil) together with 240mL water will be taken by the volunteer in a fasted state|ten ml suspension of posaconazol (noxafil) together with 240ml water will be taken by the volunteer in a fasted state
360651|NCT02048345|ten mL suspension of posaconazol (Noxafil) together with 240mL water will be taken by the volunteer in a fed state|ten ml suspension of posaconazol (noxafil) together with 240ml water will be taken by the volunteer in a fed state
400539|NCT01866397|continuous venovenous hemofiltration|continuous venovenous hemofiltration
400540|NCT01866371|Retina|retina
360652|NCT02048345|two point six mL of suspension that is dissolved in 247mL water will be administered to the volunteer by the stomach catheter in a fasted state|two point six ml of suspension that is dissolved in 247ml water will be administered to the volunteer by the stomach catheter in a fasted state
360653|NCT02048345|two point six mL of suspension that is dissolved in 247mL water will be administered to the volunteer by the stomach catheter in a fed state|two point six ml of suspension that is dissolved in 247ml water will be administered to the volunteer by the stomach catheter in a fed state
360654|NCT02048332|Epstein-Barr Virus (EBV)|epstein-barr virus (ebv)
360655|NCT02048332|Adenovirus (ADV)|adenovirus (adv)
360656|NCT02048332|t-cells|t-cells
360657|NCT02048332|donor|donor
360658|NCT02048332|transplant|transplant
360659|NCT02048332|children|children
360660|NCT02048332|cytomegalovirus (CMV)|cytomegalovirus (cmv)
360661|NCT02048332|BK virus (BKV)|bk virus (bkv)
360662|NCT02048319|Liver cyst|liver cyst
360663|NCT02048319|Hepatic cyst|hepatic cyst
360664|NCT02048319|Symptomatic|symptomatic
360665|NCT02048319|Aspiration sclerotherapy|aspiration sclerotherapy
360666|NCT02048306|Chronic obstructive pulmonary disease (COPD)|chronic obstructive pulmonary disease (copd)
360667|NCT02048306|Pulmonary rehabilitation|pulmonary rehabilitation
360668|NCT02048306|Family|family
360669|NCT02048306|Integrated care|integrated care
360670|NCT02048306|Mixed methods|mixed methods
360671|NCT02048293|remifentanil|remifentanil
360672|NCT02048293|propofol|propofol
360673|NCT02048293|pharmacodynamic|pharmacodynamic
360674|NCT02048293|total intravenous anesthesia|total intravenous anesthesia
360675|NCT02048293|orotracheal intubation|orotracheal intubation
360676|NCT02048293|heart rate|heart rate
360677|NCT02048293|mean arterial pressure|mean arterial pressure
360678|NCT02048293|Cooper intubation condition score|cooper intubation condition score
360679|NCT02048267|Alcoholic|alcoholic
360680|NCT02048267|Non alcoholic|non alcoholic
360681|NCT02048267|Idiopathic|idiopathic
360682|NCT02048267|Tropical|tropical
360683|NCT02048267|Exocrine dysfunction|exocrine dysfunction
360684|NCT02048267|Endocrine dysfunction|endocrine dysfunction
360685|NCT02048267|Pain control|pain control
360686|NCT02048267|Frey's procedure|frey's procedure
360687|NCT02048267|Duodenum preserving pancreatic head resection|duodenum preserving pancreatic head resection
360688|NCT02048254|inoperable salivary gland cancer|inoperable salivary gland cancer
360689|NCT02048254|brachytherapy|brachytherapy
360690|NCT02048254|intensity-modulated radiation therapy|intensity-modulated radiation therapy
360691|NCT02048241|childhood|childhood
360692|NCT02048241|temper|temper
360693|NCT02048241|explosive|explosive
360694|NCT02048241|aggression|aggression
360695|NCT02048241|tantrums|tantrums
360696|NCT02048241|oppositional|oppositional
360697|NCT02048241|defiant|defiant
360698|NCT02048241|conduct|conduct
360699|NCT02048241|disruptive|disruptive
360700|NCT02048241|emotional dysregulation|emotional dysregulation
360701|NCT02048241|special education|special education
360702|NCT02048228|Clopidogrel,|clopidogrel,
360703|NCT02048228|Pharmacogenetics,|pharmacogenetics,
360704|NCT02048228|Platelet reactivity,|platelet reactivity,
360705|NCT02048228|CYP2C19,|cyp2c19,
360706|NCT02048228|point-of-care|point-of-care
360707|NCT02048215|thermogenesis|thermogenesis
360708|NCT02048215|low-calorie diet|low-calorie diet
360709|NCT02048215|uncoupling-protein 3|uncoupling-protein 3
360710|NCT02048215|beta-3 adrenoceptors|beta-3 adrenoceptors
360711|NCT02048215|thermogenic drugs|thermogenic drugs
360712|NCT02048202|clown|clown
360713|NCT02048202|neonate|neonate
360714|NCT02048202|premature|premature
360715|NCT02048176|Mutism|mutism
360716|NCT02048163|Meropenem|meropenem
360717|NCT02048163|Nausea|nausea
360718|NCT02048163|Pharmacokinetics|pharmacokinetics
360719|NCT02048124|25d ProCor needle|25d procor needle
360720|NCT02048124|22 gauge|22 gauge
360721|NCT02048124|endoscopic ultrasonography|endoscopic ultrasonography
360722|NCT02048124|fine needle biopsies|fine needle biopsies
360723|NCT02048124|Patients|patients
360724|NCT02048124|presenting|presenting
360725|NCT02048111|Hemophilia B|hemophilia b
360726|NCT02048111|Hemophilia A|hemophilia a
360727|NCT02048111|Blood Coagulation Disorders, Inherited|blood coagulation disorders, inherited
360728|NCT02048111|Blood Coagulation Disorders|blood coagulation disorders
360729|NCT02048111|Hematologic Diseases|hematologic diseases
360730|NCT02048111|Coagulation Protein Disorders|coagulation protein disorders
360731|NCT02048111|Hemorrhagic Disorders|hemorrhagic disorders
360732|NCT02048111|Genetic Diseases, Inborn|genetic diseases, inborn
360733|NCT02048111|Genetic Diseases, X-Linked|genetic diseases, x-linked
360734|NCT02048098|misoprostol|misoprostol
360735|NCT02048098|Labor, Induced|labor, induced
360736|NCT02048098|Pregnancy Trimester, Second|pregnancy trimester, second
360737|NCT02048098|Abortion, Induced|abortion, induced
360738|NCT02048085|ACS|acs
360739|NCT02048085|STEMI|stemi
360740|NCT02048085|Fibrinolysis|fibrinolysis
360741|NCT02048085|Pharmacodynamics|pharmacodynamics
360742|NCT02048085|Pharmacokinetics|pharmacokinetics
360743|NCT02048085|Plavix|plavix
360744|NCT02048085|Brilinta|brilinta
360745|NCT02048085|Ticagrelor|ticagrelor
360746|NCT02048085|Clopidogrel|clopidogrel
360747|NCT02048072|relapsing remitting|relapsing remitting
360748|NCT02048072|multiple sclerosis|multiple sclerosis
360749|NCT02048072|fingolimod|fingolimod
360750|NCT02048072|Gilenya|gilenya
360751|NCT02048072|autonomic nervous system|autonomic nervous system
360752|NCT02048059|ANG1005|ang1005
360753|NCT02048059|GRN1005|grn1005
360754|NCT02048059|Low-density lipoprotein receptor-related protein (LRP-1)|low-density lipoprotein receptor-related protein (lrp-1)
360755|NCT02048059|Targeted therapy|targeted therapy
360756|NCT02048059|Breast cancer|breast cancer
360757|NCT02048059|Brain metastases|brain metastases
360758|NCT02048059|Brain tumor|brain tumor
360759|NCT02048059|Blood-brain barrier|blood-brain barrier
360760|NCT02048059|Trastuzumab|trastuzumab
360761|NCT02048059|Herceptin|herceptin
360762|NCT02048059|Paclitaxel|paclitaxel
360763|NCT02048059|Taxol|taxol
360764|NCT02048059|Breast cancer with brain metastases|breast cancer with brain metastases
360765|NCT02048059|Triple Negative|triple negative
360766|NCT02048059|Triple negative breast cancer (TNBC)|triple negative breast cancer (tnbc)
360767|NCT02048059|Herceptin 2 (HER2)-positive|herceptin 2 (her2)-positive
360768|NCT02048059|HER2-negative|her2-negative
360769|NCT02048059|Metastatic brain tumors|metastatic brain tumors
360770|NCT02048046|ECMO|ecmo
360771|NCT02048046|Nutrition therapy|nutrition therapy
360772|NCT02048033|Obesity|obesity
360773|NCT02048033|Endogastric suturing|endogastric suturing
360774|NCT02048033|Jujenal anastomosis|jujenal anastomosis
360775|NCT02048033|weight regain|weight regain
360776|NCT02048007|Childhood mortality|childhood mortality
360777|NCT02048007|Azithromycin|azithromycin
360778|NCT02048007|Mass treatment|mass treatment
360779|NCT02048007|Infection|infection
360780|NCT02048007|Bacterial infections|bacterial infections
360781|NCT02048007|Trachoma|trachoma
360782|NCT02048007|Chlamydia infections|chlamydia infections
360783|NCT02048007|Malaria|malaria
360784|NCT02048007|Diarrhea|diarrhea
360785|NCT02048007|Respiratory Infections|respiratory infections
360786|NCT02048007|Antibiotic resistance|antibiotic resistance
360787|NCT02048007|Verbal Autopsy|verbal autopsy
360788|NCT02048007|Microbiome|microbiome
360789|NCT02047994|Gastric cancer|gastric cancer
360790|NCT02047994|Gastric cancer mortality|gastric cancer mortality
360791|NCT02047994|Helicobacter pylori treatment|helicobacter pylori treatment
360792|NCT02047994|Pepsinogen testing|pepsinogen testing
360793|NCT02047994|Endoscopy|endoscopy
360794|NCT02047994|Volatile marker|volatile marker
360795|NCT02047981|Childhood mortality|childhood mortality
360796|NCT02047981|Azithromycin|azithromycin
360797|NCT02047981|Mass treatment|mass treatment
360798|NCT02047981|Infection|infection
360799|NCT02047981|Verbal Autopsy|verbal autopsy
360800|NCT02047968|Wake therapy|wake therapy
360801|NCT02047968|Sleep deprivation|sleep deprivation
360802|NCT02047968|Light therapy|light therapy
360803|NCT02047968|Bipolar depression|bipolar depression
360804|NCT02047968|Sleep-wake cycle|sleep-wake cycle
360805|NCT02047968|Major depression|major depression
360806|NCT02047968|Depression|depression
360807|NCT02047968|Depressive Disorder|depressive disorder
360808|NCT02047968|Major Behavioural Symptoms|major behavioural symptoms
360809|NCT02047968|Mood Disorders|mood disorders
360810|NCT02047968|Mental Disorders|mental disorders
360811|NCT02047968|Dyssomnias|dyssomnias
360812|NCT02047968|Sleep Disorders|sleep disorders
360813|NCT02047968|Affective Disorders|affective disorders
360814|NCT02047929|Asthma|asthma
360815|NCT02047929|Shared decision making|shared decision making
360816|NCT02047929|Participatory methods|participatory methods
360817|NCT02047929|Practice facilitator|practice facilitator
360818|NCT02047929|Health coach|health coach
360819|NCT02047916|Neonates|neonates
360820|NCT02047916|Superior Vena Cava Flow|superior vena cava flow
360821|NCT02047916|Pleth variabilty index|pleth variabilty index
360822|NCT02047890|CDK inhibitor|cdk inhibitor
360823|NCT02047890|BAY1000394|bay1000394
360824|NCT02047890|Advanced malignancies|advanced malignancies
360825|NCT02047890|Japanese|japanese
360826|NCT02047877|Respiratory Secretions|respiratory secretions
360827|NCT02047877|Tracheal Secretions|tracheal secretions
360828|NCT02047877|Bronchial Secretions|bronchial secretions
360829|NCT02047877|NonBronchoscopic BAL|nonbronchoscopic bal
360830|NCT02047877|Interleukin 10|interleukin 10
360831|NCT02047877|Interleukin 12p70|interleukin 12p70
360832|NCT02047864|Osteoporosis|osteoporosis
360833|NCT02047864|Sarcopenia|sarcopenia
360834|NCT02047864|Strength|strength
360835|NCT02047864|Bone|bone
360836|NCT02047864|Muscle|muscle
360837|NCT02047864|Creatine|creatine
360838|NCT02047825|Multiple sclerosis|multiple sclerosis
360839|NCT02047825|Dexterity|dexterity
360840|NCT02047825|Upper limbs|upper limbs
360841|NCT02047812|Laparotomy|laparotomy
360842|NCT02047812|General Surgery|general surgery
360843|NCT02047812|Hospitals,General|hospitals,general
360844|NCT02047812|Hospitals,High-Volume|hospitals,high-volume
360845|NCT02047812|Hospitals,Low-Volume|hospitals,low-volume
360846|NCT02047812|Outcome Assessment (Health Care)|outcome assessment (health care)
360847|NCT02047799|elderly people, high blood pressure, vitamin D.|elderly people, high blood pressure, vitamin d.
360848|NCT02047786|Outcome Assessment (Health Care)|outcome assessment (health care)
360849|NCT02047786|Appendectomy|appendectomy
360850|NCT02047786|Child|child
360851|NCT02047786|Hospitals, Pediatric|hospitals, pediatric
360852|NCT02047786|Hospitals, General|hospitals, general
360853|NCT02047773|bronchiectasis|bronchiectasis
360854|NCT02047773|intravenous antibiotics|intravenous antibiotics
360855|NCT02047773|duration of antibiotic course|duration of antibiotic course
360856|NCT02047773|side effects|side effects
360857|NCT02047773|bacterial load|bacterial load
360858|NCT02047747|Brain|brain
360859|NCT02047747|Metastasis|metastasis
360860|NCT02047747|human epidermal receptor (HER)|human epidermal receptor (her)
360861|NCT02047695|migraine with aura|migraine with aura
360862|NCT02047695|migraine|migraine
360863|NCT02047695|case-control study|case-control study
360864|NCT02047695|magnetic resonance imaging|magnetic resonance imaging
360865|NCT02047695|brain diseases|brain diseases
360866|NCT02047656|Healthy volunteers, hypertension|healthy volunteers, hypertension
360867|NCT02047643|Type 1 diabetes|type 1 diabetes
360868|NCT02047643|Hypoglycemia|hypoglycemia
360869|NCT02047643|Accelerometer|accelerometer
360870|NCT02047630|Primary open angle glaucoma|primary open angle glaucoma
360871|NCT02047630|Ocular hypertension|ocular hypertension
360872|NCT02047630|latanoprost|latanoprost
360873|NCT02047630|generic|generic
360874|NCT02047630|intraocular pressure|intraocular pressure
360875|NCT02047617|Muscle Weakness|muscle weakness
360876|NCT02047617|Exercise therapy|exercise therapy
360877|NCT02047617|Physiotherapy|physiotherapy
360878|NCT02047617|Critical illness|critical illness
360879|NCT02047617|Intensive care|intensive care
360880|NCT02047617|Mechanical ventilation|mechanical ventilation
360881|NCT02047617|Rehabilitation|rehabilitation
360882|NCT02047604|Phase 2a multiple ascending dose, Anti-Very Late Antigen-1|phase 2a multiple ascending dose, anti-very late antigen-1
361267|NCT02045940|safety|safety
360883|NCT02047578|hematopoietic stem cell transplantation|hematopoietic stem cell transplantation
360884|NCT02047565|punch biopsy|punch biopsy
360886|NCT02047552|iron|iron
360887|NCT02047552|anemia|anemia
360888|NCT02047552|red blood cell transfusion|red blood cell transfusion
360889|NCT02047526|Heart Failure|heart failure
360890|NCT02047526|Cardiovascular disease|cardiovascular disease
360891|NCT02047526|Congestive Heart Failure|congestive heart failure
360892|NCT02047500|TH-302|th-302
360893|NCT02047500|Nab-paclitaxel|nab-paclitaxel
360894|NCT02047500|Gemcitabine|gemcitabine
360895|NCT02047500|Evofosfamide|evofosfamide
360896|NCT02047461|Molybdenum cofactor deficiency (MoCD)|molybdenum cofactor deficiency (mocd)
360897|NCT02047461|molybdenum cofactor (MoCo) biosynthesis|molybdenum cofactor (moco) biosynthesis
360898|NCT02047461|sulfite oxidase (SO)|sulfite oxidase (so)
360899|NCT02047461|xanthine dehydrogenase|xanthine dehydrogenase
360900|NCT02047461|aldehyde oxidase|aldehyde oxidase
360901|NCT02047461|S sulfocysteine (SSC)|s sulfocysteine (ssc)
360902|NCT02047448|transition of care|transition of care
360903|NCT02047448|care transitions|care transitions
360904|NCT02047448|readmission|readmission
360905|NCT02047448|medication|medication
360906|NCT02047448|adherence|adherence
360907|NCT02047448|medication management|medication management
360908|NCT02047448|medication reconciliation|medication reconciliation
360909|NCT02047448|patient counseling|patient counseling
360910|NCT02047448|pharmacist|pharmacist
360911|NCT02047435|Social participation|social participation
360912|NCT02047435|Loneliness|loneliness
360913|NCT02047435|General practice|general practice
360914|NCT02047435|Cultural institutions|cultural institutions
360915|NCT02047422|Heart failure, diuretics, kidney, glomerular filtration rate|heart failure, diuretics, kidney, glomerular filtration rate
360916|NCT02047383|respiratory infection|respiratory infection
360917|NCT02047383|physical variables|physical variables
360918|NCT02047370|stretching, diaphragm, asthma, manual therapy|stretching, diaphragm, asthma, manual therapy
360919|NCT02047357|Maternal depression|maternal depression
360920|NCT02047357|Mother|mother
360921|NCT02047357|Child|child
360922|NCT02047357|LTP|ltp
360923|NCT02047357|Learning Through Play|learning through play
360924|NCT02047357|Healthy thinking|healthy thinking
360925|NCT02047344|NSCLC|nsclc
360926|NCT02047331|periarticular drug injection|periarticular drug injection
360927|NCT02047331|fascia iliaca block|fascia iliaca block
360928|NCT02047331|knee arthroplasty|knee arthroplasty
360929|NCT02047305|ESCN|escn
360930|NCT02047305|RFA|rfa
360931|NCT02047292|Gait analysis|gait analysis
360932|NCT02047292|3D videofluoroscopy|3d videofluoroscopy
360933|NCT02047292|Femoroacetabular impingement|femoroacetabular impingement
360934|NCT02047292|Neck-cup impingement|neck-cup impingement
360935|NCT02047292|Head-neck ratio|head-neck ratio
360936|NCT02047292|Hip scores|hip scores
360937|NCT02047292|Functional assessment|functional assessment
360938|NCT02047292|Cup size|cup size
360939|NCT02047292|Range of motion|range of motion
360940|NCT02047292|Unilateral Primary|unilateral primary
360941|NCT02047292|Secondary|secondary
360942|NCT02047279|Atrial fibrillation|atrial fibrillation
360943|NCT02047279|Mitral valve|mitral valve
360944|NCT02047266|MICS CABG OPCABG ONCABG CAD|mics cabg opcabg oncabg cad
360945|NCT02047253|carfilzomib|carfilzomib
360946|NCT02047253|prostate cancer|prostate cancer
360947|NCT02047253|PSA (prostate-specific antigen)|psa (prostate-specific antigen)
360948|NCT02047253|CRPC (castration-resistant prostate cancer)|crpc (castration-resistant prostate cancer)
360949|NCT02047240|liver cirrhosis|liver cirrhosis
360950|NCT02047240|glomerular filtration|glomerular filtration
360951|NCT02047240|cystatin C|cystatin c
360952|NCT02047227|ESPART|espart
360953|NCT02047227|Reproductive Techniques, Assisted|reproductive techniques, assisted
360954|NCT02047227|Infertility|infertility
360955|NCT02047227|Pergoveris®|pergoveris®
360956|NCT02047227|GONAL-f®|gonal-f®
360957|NCT02047214|Glioblastoma multiforme|glioblastoma multiforme
360958|NCT02047214|Glioblastoma|glioblastoma
360959|NCT02047214|Radiotherapy|radiotherapy
360960|NCT02047214|Temozolomide|temozolomide
360961|NCT02047214|TPI 287|tpi 287
360962|NCT02047214|Taxoid|taxoid
360963|NCT02047214|Avastin|avastin
360964|NCT02047214|Bevacizumab|bevacizumab
360965|NCT02047201|Head and neck cancer|head and neck cancer
360966|NCT02047201|PET/CT|pet/ct
360967|NCT02047201|induction chemotherapy|induction chemotherapy
360968|NCT02047201|IMRT|imrt
360969|NCT02047188|narrow band imaging,microvessels,matrix metalloproteinase-7|narrow band imaging,microvessels,matrix metalloproteinase-7
360970|NCT02047162|diarrhea|diarrhea
360971|NCT02047162|gastroenteritis|gastroenteritis
360972|NCT02047162|antimicrobial drug resistance|antimicrobial drug resistance
360973|NCT02047162|antimicrobial agents|antimicrobial agents
360974|NCT02047162|Pakistan|pakistan
360975|NCT02047162|ambulatory care|ambulatory care
360976|NCT02047162|bismuth|bismuth
360977|NCT02047149|Myelogenous Leukemia|myelogenous leukemia
360978|NCT02047123|commercial flaxseed|commercial flaxseed
360979|NCT02047123|cholesterol|cholesterol
360980|NCT02047123|lipidic profile|lipidic profile
360981|NCT02047123|yoghurt|yoghurt
360982|NCT02047123|consumption|consumption
360983|NCT02047071|Obstructive sleep apnea|obstructive sleep apnea
360984|NCT02047071|Female gender|female gender
360985|NCT02047071|Continuous Positive Airway Pressure|continuous positive airway pressure
360986|NCT02047058|biomarker|biomarker
360987|NCT02047058|Q cell|q cell
360988|NCT02047058|Overall survival|overall survival
360989|NCT02047058|Progression-free survival|progression-free survival
360990|NCT02047045|severe chronic constipation|severe chronic constipation
360991|NCT02047045|randomized controlled|randomized controlled
360992|NCT02047045|electro-acupuncture|electro-acupuncture
360993|NCT02047045|prucalopride|prucalopride
360994|NCT02047032|electroacupuncture|electroacupuncture
360995|NCT02047032|urinary incontinence|urinary incontinence
360996|NCT02047032|PFMT|pfmt
360997|NCT02047032|Solifenacin|solifenacin
360998|NCT02047019|Drug combination|drug combination
360999|NCT02047019|Nifedipine GITS|nifedipine gits
361000|NCT02047019|Candesartan Cilexetil|candesartan cilexetil
361001|NCT02047019|Hypertension|hypertension
361002|NCT02047019|Combination therapy|combination therapy
361003|NCT02047006|Hemodialysis|hemodialysis
361004|NCT02047006|Rivaroxaban|rivaroxaban
361005|NCT02047006|AUC|auc
361006|NCT02046993|Hypertension|hypertension
361007|NCT02046993|self blood pressure monitoring|self blood pressure monitoring
361008|NCT02046993|smartphone based telemonitoring|smartphone based telemonitoring
361009|NCT02046993|primary care|primary care
361010|NCT02046967|endovenous laser ablation|endovenous laser ablation
361011|NCT02046967|endovenous steam ablation|endovenous steam ablation
361012|NCT02046967|great saphenous veins|great saphenous veins
361013|NCT02046967|quality of life|quality of life
361014|NCT02046954|transesophageal echocardiography|transesophageal echocardiography
361015|NCT02046954|tee|tee
361016|NCT02046954|toe|toe
361017|NCT02046954|cardiac surgery|cardiac surgery
361018|NCT02046941|aphasia|aphasia
361019|NCT02046941|stroke|stroke
361020|NCT02046941|Magnetic Resonance Imaging|magnetic resonance imaging
361021|NCT02046941|Diffusion Magnetic Resonance Imaging|diffusion magnetic resonance imaging
361022|NCT02046928|Leukemia|leukemia
361023|NCT02046928|Lymphoma|lymphoma
361024|NCT02046902|coronary artery disease|coronary artery disease
361025|NCT02046902|cardiac stent|cardiac stent
361026|NCT02046902|PCI procedure|pci procedure
361135|NCT02046447|Trihex|trihex
361027|NCT02046902|Patient preference|patient preference
361028|NCT02046876|neck pain|neck pain
361029|NCT02046876|physiotherapy|physiotherapy
361030|NCT02046876|adapted swimming|adapted swimming
361031|NCT02046876|therapeutic exercises|therapeutic exercises
361032|NCT02046876|health education|health education
361033|NCT02046863|Parkinson's disease|parkinson's disease
361034|NCT02046863|Tremor|tremor
361035|NCT02046863|Bradykinesia|bradykinesia
400541|NCT01866371|imaging|imaging
361036|NCT02046863|Deep brain stimulation|deep brain stimulation
361037|NCT02046863|Kinesia|kinesia
361038|NCT02046850|Phase I, healthy, pharmacokinetics,|phase i, healthy, pharmacokinetics,
361039|NCT02046837|Prostate cancer|prostate cancer
361040|NCT02046837|Exercise|exercise
361041|NCT02046837|Elderly|elderly
361042|NCT02046837|Quality of life|quality of life
361043|NCT02046837|Fatigue|fatigue
361044|NCT02046837|Physical fitness|physical fitness
361045|NCT02046837|Adherence|adherence
361046|NCT02046837|Cost-effectiveness|cost-effectiveness
361047|NCT02046811|Skin neoplasms|skin neoplasms
361048|NCT02046811|Radiation|radiation
361049|NCT02046811|Screening|screening
361050|NCT02046811|Self-examination|self-examination
361051|NCT02046811|Comparative effectiveness research|comparative effectiveness research
361052|NCT02046811|Dermoscopy|dermoscopy
361053|NCT02046798|Pharmacokinetics|pharmacokinetics
361054|NCT02046798|ASP3652|asp3652
361055|NCT02046798|14C radio-labeled|14c radio-labeled
361056|NCT02046798|Phase 1|phase 1
361057|NCT02046785|Fluid administration|fluid administration
361058|NCT02046785|Cardiac output|cardiac output
361059|NCT02046785|Right atrial pressure|right atrial pressure
361060|NCT02046785|Resuscitation|resuscitation
361061|NCT02046772|hemorrhoidectomy|hemorrhoidectomy
361062|NCT02046772|analgesia|analgesia
361063|NCT02046772|anaesthetic|anaesthetic
361064|NCT02046772|bupivacaine|bupivacaine
361065|NCT02046772|morphine chloride|morphine chloride
361066|NCT02046733|SCLC|sclc
361067|NCT02046733|CTLA-4|ctla-4
361068|NCT02046694|acute lymphoblastic leukemia|acute lymphoblastic leukemia
361069|NCT02046694|ALL|all
361070|NCT02046694|pediatric|pediatric
361071|NCT02046694|maintenance|maintenance
361072|NCT02046694|allopurinol|allopurinol
361073|NCT02046694|6-MP|6-mp
361074|NCT02046694|6-mercaptopurine|6-mercaptopurine
361075|NCT02046681|Medication Adherence|medication adherence
361076|NCT02046681|Medication Compliance|medication compliance
361077|NCT02046681|Medication Therapy Management|medication therapy management
361078|NCT02046681|Side effects|side effects
361079|NCT02046681|Analgesics|analgesics
361080|NCT02046681|Emergency Medicine|emergency medicine
361081|NCT02046681|Home care|home care
361082|NCT02046681|Aged|aged
361083|NCT02046681|Acetaminophen|acetaminophen
361084|NCT02046681|codeine|codeine
361085|NCT02046681|ibuprofen|ibuprofen
361086|NCT02046681|Oxycodone|oxycodone
361087|NCT02046668|Osteoarthritis of knee|osteoarthritis of knee
361088|NCT02046642|Amniotic fluid index;|amniotic fluid index;
361089|NCT02046642|amniotic fluid volume;|amniotic fluid volume;
361090|NCT02046642|intervention studies;|intervention studies;
361091|NCT02046642|maternal care patterns;|maternal care patterns;
361092|NCT02046642|mother-fetus relationships;|mother-fetus relationships;
361093|NCT02046642|rest;|rest;
361094|NCT02046642|sonography;|sonography;
361095|NCT02046642|transplacental exposure|transplacental exposure
361096|NCT02046590|Propofol|propofol
361097|NCT02046590|remifentanil|remifentanil
361098|NCT02046590|safety|safety
361099|NCT02046590|gastro-intestinal|gastro-intestinal
361100|NCT02046590|ERCP|ercp
361101|NCT02046590|minimally invasive|minimally invasive
361102|NCT02046590|intubation|intubation
361103|NCT02046590|ventilation|ventilation
361104|NCT02046577|Acute respiratory tract infections|acute respiratory tract infections
361105|NCT02046577|vitamin D|vitamin d
361106|NCT02046577|cholecalciferol|cholecalciferol
361107|NCT02046577|children|children
361108|NCT02046577|bronchiolitis|bronchiolitis
361109|NCT02046577|pneumonia|pneumonia
361110|NCT02046577|prevention|prevention
361111|NCT02046551|nicotine|nicotine
361112|NCT02046551|smoking|smoking
361113|NCT02046551|atomoxetine|atomoxetine
361114|NCT02046551|stress|stress
361115|NCT02046525|Fecal microbiota therapy|fecal microbiota therapy
361116|NCT02046512|Probiotics|probiotics
361117|NCT02046499|Prevention, post partum haemorrhage|prevention, post partum haemorrhage
361118|NCT02046486|ticagrelor|ticagrelor
361119|NCT02046486|ST elevation myocardial infarction|st elevation myocardial infarction
361120|NCT02046486|liquid formulation|liquid formulation
361121|NCT02046447|dystonia|dystonia
361122|NCT02046447|cervical dystonia|cervical dystonia
361123|NCT02046447|DYT1|dyt1
361124|NCT02046447|DYT 1|dyt 1
361125|NCT02046447|DYT-1|dyt-1
361126|NCT02046447|Dystonia 1|dystonia 1
361127|NCT02046447|fMRI|fmri
361128|NCT02046447|healthy|healthy
361129|NCT02046447|trihexyphenidyl|trihexyphenidyl
361130|NCT02046447|Artane|artane
361131|NCT02046447|Apo-Trihex|apo-trihex
361132|NCT02046447|Parkin|parkin
361133|NCT02046447|Pacitane|pacitane
361136|NCT02046408|Smoking|smoking
361137|NCT02046408|5A's for smoking cessation|5a's for smoking cessation
361138|NCT02046408|tailored health messages|tailored health messages
361139|NCT02046408|Patient-facing information technology|patient-facing information technology
361140|NCT02046408|Mobile health|mobile health
361141|NCT02046408|behavioral health|behavioral health
361142|NCT02046395|Type 2 Diabetes|type 2 diabetes
461775|NCT01591590|ADC|adc
361143|NCT02046395|Hypertension|hypertension
361144|NCT02046382|IV Acetaminophen|iv acetaminophen
361145|NCT02046382|Cesarean Section|cesarean section
361146|NCT02046382|Pain, Postoperative|pain, postoperative
361147|NCT02046369|Lurasidone, Latuda, Bipolar Depression|lurasidone, latuda, bipolar depression
361148|NCT02046356|hepatocellular carcinoma|hepatocellular carcinoma
361149|NCT02046356|radiofrequency ablation|radiofrequency ablation
361150|NCT02046356|Milan Criteria|milan criteria
361151|NCT02046356|recurrence|recurrence
361152|NCT02046356|risk factor|risk factor
361153|NCT02046343|physical activity|physical activity
361154|NCT02046343|prevention|prevention
361155|NCT02046343|health disparities|health disparities
361156|NCT02046343|behavior|behavior
361157|NCT02046343|community based intervention|community based intervention
361158|NCT02046330|Deep Brain Stimulation|deep brain stimulation
361159|NCT02046330|Treatment Resistant Depression|treatment resistant depression
361160|NCT02046330|Major Depressive Disorder|major depressive disorder
361161|NCT02046330|Depression|depression
361162|NCT02046330|ECT|ect
361163|NCT02046330|TNS|tns
361164|NCT02046304|Sarcoma|sarcoma
361165|NCT02046304|Soft Tissue Sarcomas|soft tissue sarcomas
361166|NCT02046304|STS|sts
361167|NCT02046304|Extremity and Trunk|extremity and trunk
361168|NCT02046304|Gemcitabine|gemcitabine
361169|NCT02046304|Gemcitabine Hydrochloride|gemcitabine hydrochloride
361170|NCT02046304|Gemzar|gemzar
361171|NCT02046304|External beam radiation therapy|external beam radiation therapy
361172|NCT02046304|EBRT|ebrt
361173|NCT02046304|Radiotherapy|radiotherapy
361174|NCT02046304|XRT|xrt
361175|NCT02046291|umbilical cord transplant|umbilical cord transplant
361176|NCT02046291|acute leukemia|acute leukemia
361177|NCT02046291|UCBT|ucbt
361178|NCT02046291|Hodgkin's Lymphoma|hodgkin's lymphoma
361179|NCT02046291|Lymphoid Leukemia|lymphoid leukemia
361180|NCT02046291|Multiple Myeloma|multiple myeloma
361181|NCT02046291|Myeloid and Monocytic Leukemia|myeloid and monocytic leukemia
361182|NCT02046291|Non-Hodgkin's Lymphoma|non-hodgkin's lymphoma
361183|NCT02046291|Hematopoietic malignancies|hematopoietic malignancies
361184|NCT02046265|Cervical cancer prevention|cervical cancer prevention
361185|NCT02046226|Critical Limb Ischemia|critical limb ischemia
361186|NCT02046226|Non Healing Wounds|non healing wounds
361187|NCT02046226|Diabetic Wounds|diabetic wounds
361188|NCT02046226|Foot Ulcers|foot ulcers
361189|NCT02046213|Metabolism and Excretion|metabolism and excretion
361190|NCT02046200|ivermectin, alcoholism, alcohol use disorder, treatment|ivermectin, alcoholism, alcohol use disorder, treatment
361191|NCT02046187|Ketogenic Diet|ketogenic diet
361192|NCT02046187|Brain tumor|brain tumor
361193|NCT02046187|Glioma|glioma
361194|NCT02046187|Glioblastoma|glioblastoma
361195|NCT02046187|Radiation|radiation
361196|NCT02046187|Chemotherapy|chemotherapy
361197|NCT02046187|temozolomide|temozolomide
361198|NCT02046174|colon|colon
361199|NCT02046174|colorectal|colorectal
361200|NCT02046174|rectal|rectal
361201|NCT02046174|cancer|cancer
361202|NCT02046174|macrobead|macrobead
361203|NCT02046174|stage IV|stage iv
361204|NCT02046174|metastatic|metastatic
361205|NCT02046174|biological|biological
361206|NCT02046174|mouse cells|mouse cells
361207|NCT02046174|new york|new york
361208|NCT02046174|new jersey|new jersey
361209|NCT02046174|clinical research|clinical research
361210|NCT02046161|colon preparation|colon preparation
361211|NCT02046148|Maternal vaccine|maternal vaccine
361212|NCT02046148|IgG|igg
361213|NCT02046148|IgA|iga
361214|NCT02046148|GBS|gbs
361215|NCT02046148|pregnant women|pregnant women
361216|NCT02046135|Pediatric|pediatric
361217|NCT02046135|Sodium bicarbonate|sodium bicarbonate
361218|NCT02046135|Acute kidney injury|acute kidney injury
361219|NCT02046135|Cardiac surgery|cardiac surgery
361220|NCT02046109|Repair|repair
361221|NCT02046109|Replace|replace
361222|NCT02046109|Composite|composite
361223|NCT02046109|restoration|restoration
361224|NCT02046109|failing dental restoration|failing dental restoration
361225|NCT02046109|filling|filling
361226|NCT02046109|dental|dental
361227|NCT02046109|dentistry|dentistry
361228|NCT02046096|Venous thrombosis|venous thrombosis
361229|NCT02046096|pulmonary embolism|pulmonary embolism
361230|NCT02046096|vena cava, inferior|vena cava, inferior
361231|NCT02046096|vena cava filters|vena cava filters
361232|NCT02046096|venous thromboembolism|venous thromboembolism
361233|NCT02046083|Teenager|teenager
361234|NCT02046083|Peanut|peanut
361235|NCT02046083|OIT (Oral Induction Tolerance)|oit (oral induction tolerance)
361236|NCT02046070|MLN9708|mln9708
361237|NCT02046070|Newly diagnosed|newly diagnosed
361238|NCT02046070|NDMM|ndmm
361239|NCT02046070|IXAZOMIB|ixazomib
361240|NCT02046070|RRMM|rrmm
361241|NCT02046057|Sentinel Lymph Node|sentinel lymph node
361242|NCT02046057|Ultrasound Guided Needle Core Biopsy|ultrasound guided needle core biopsy
361243|NCT02046044|Heart failure|heart failure
361244|NCT02046044|Digoxin|digoxin
361245|NCT02046044|Ivabradine|ivabradine
361246|NCT02046031|Ischemic stroke|ischemic stroke
361247|NCT02046031|safety|safety
361248|NCT02046031|Pharmacokinetics|pharmacokinetics
361249|NCT02046031|Ginkgolides Meglumine Injection|ginkgolides meglumine injection
361250|NCT02046018|Maternal and Child Health|maternal and child health
361251|NCT02046018|Rural Uganda|rural uganda
361252|NCT02046005|Family History|family history
361253|NCT02046005|RA|ra
361254|NCT02046005|Rheumatoid Arthritis|rheumatoid arthritis
361255|NCT02046005|Genetics|genetics
361256|NCT02046005|Rheumatoid Factor|rheumatoid factor
361257|NCT02046005|Shared Epitope|shared epitope
361258|NCT02046005|Anti-CCP|anti-ccp
361259|NCT02045953|Healthy Subjects|healthy subjects
361260|NCT02045953|SERETIDE|seretide
361261|NCT02045953|Pharmocokinetics|pharmocokinetics
361262|NCT02045953|FLIXOTIDE|flixotide
361263|NCT02045953|VENTOLIN Mini-Spacer|ventolin mini-spacer
361264|NCT02045940|FTIH|ftih
361265|NCT02045940|pharmacokinetics|pharmacokinetics
361266|NCT02045940|SARM|sarm
361268|NCT02045927|sedation|sedation
361269|NCT02045927|BIS|bis
361270|NCT02045927|monitoring|monitoring
361271|NCT02045914|calcium ionophore|calcium ionophore
361272|NCT02045914|fertilization rate|fertilization rate
361273|NCT02045914|poor ovarian reserve|poor ovarian reserve
361274|NCT02045901|Nausea|nausea
361275|NCT02045901|Vomiting|vomiting
361276|NCT02045901|Pregnancy|pregnancy
361277|NCT02045901|Adolescent|adolescent
361278|NCT02045901|Diclegis|diclegis
361279|NCT02045901|Morning|morning
361280|NCT02045901|Sickness|sickness
361281|NCT02045888|Hamstring|hamstring
361282|NCT02045888|Tear|tear
361283|NCT02045888|Muscle|muscle
361284|NCT02045888|Grade|grade
361285|NCT02045888|adipose|adipose
361286|NCT02045888|cells|cells
361287|NCT02045888|regenerative|regenerative
361288|NCT02045888|Celution|celution
361289|NCT02045888|stem|stem
361290|NCT02045888|cell|cell
361291|NCT02045888|liposuction|liposuction
361292|NCT02045888|fat|fat
361293|NCT02045875|Adherence monitoring|adherence monitoring
361294|NCT02045875|Motivational Interviewing Adherence strategies|motivational interviewing adherence strategies
361295|NCT02045862|Solifenacin Succinate|solifenacin succinate
361296|NCT02045862|Mirabegron|mirabegron
361297|NCT02045862|Urinary Incontinence|urinary incontinence
361298|NCT02045862|Combination Therapy|combination therapy
361299|NCT02045862|Urgency|urgency
361300|NCT02045862|Nocturia|nocturia
361301|NCT02045862|Overactive Bladder|overactive bladder
361302|NCT02045849|pharmacokinetics|pharmacokinetics
361303|NCT02045849|GSK2140944|gsk2140944
361304|NCT02045849|tolerability|tolerability
361305|NCT02045849|drug interaction|drug interaction
361306|NCT02045849|safety|safety
361307|NCT02045849|itraconazole|itraconazole
361308|NCT02045849|elderly healthy subjects|elderly healthy subjects
361309|NCT02045849|food effect|food effect
361310|NCT02045849|relative bioavailability|relative bioavailability
361311|NCT02045836|Pneumovax 23|pneumovax 23
361312|NCT02045836|Co-administration|co-administration
361313|NCT02045836|Herpes zoster|herpes zoster
361314|NCT02045836|Immunogenicity|immunogenicity
361315|NCT02045836|Safety|safety
361316|NCT02045836|Adults|adults
361317|NCT02045810|Measurement|measurement
361318|NCT02045810|nosiseption|nosiseption
361319|NCT02045797|Dose ranging|dose ranging
361320|NCT02045797|Intravenous|intravenous
361321|NCT02045797|Adaptive design|adaptive design
361322|NCT02045797|suspected or confirmed gram-positive acute bacterial skin and skin structure infection|suspected or confirmed gram-positive acute bacterial skin and skin structure infection
361323|NCT02045797|Subjects|subjects
361324|NCT02045797|infection|infection
361325|NCT02045797|Oral|oral
361326|NCT02045797|GSK2140944|gsk2140944
361327|NCT02045771|Depression|depression
361328|NCT02045771|Behavioral Activation|behavioral activation
361329|NCT02045745|Postoperative air leaks in risk patients.|postoperative air leaks in risk patients.
361330|NCT02045732|Multiple Sclerosis|multiple sclerosis
361331|NCT02045732|MRI|mri
361332|NCT02045719|cat´s claw|cat´s claw
361333|NCT02045719|uncaria tomentosa|uncaria tomentosa
361334|NCT02045719|quality of life|quality of life
361335|NCT02045719|no further therapeutic options|no further therapeutic options
361336|NCT02045706|Community Health Workers|community health workers
361337|NCT02045706|Service|service
361338|NCT02045706|Volunteerism|volunteerism
361339|NCT02045706|Health Behaviors|health behaviors
361340|NCT02045680|colorectal cancer|colorectal cancer
361341|NCT02045680|laparoscopy|laparoscopy
361342|NCT02045680|neuromuscular block|neuromuscular block
361343|NCT02045680|oxygen delivery|oxygen delivery
361344|NCT02045667|Becker's myotonia congenita (BMC)|becker's myotonia congenita (bmc)
361345|NCT02045667|Thomson's myotonia congenita (TMC)|thomson's myotonia congenita (tmc)
361346|NCT02045667|Paramyotonia Congenita (PMC)|paramyotonia congenita (pmc)
361347|NCT02045667|Sodium Channel Myotonia (SCM)|sodium channel myotonia (scm)
361348|NCT02045641|cardiac surgery|cardiac surgery
361349|NCT02045641|postoperative treatment|postoperative treatment
462098|NCT01589978|DES|des
361350|NCT02045641|pleural effusion|pleural effusion
361351|NCT02045641|physical performance|physical performance
361352|NCT02045628|Bariatric Surgery|bariatric surgery
361353|NCT02045628|Health Psychology|health psychology
361354|NCT02045602|Cancer|cancer
361355|NCT02045602|Solid Tumors|solid tumors
361356|NCT02045602|Gemcitabine|gemcitabine
361357|NCT02045602|Oncolytic virus|oncolytic virus
361358|NCT02045602|Metastatic|metastatic
361359|NCT02045602|Pancreatic cancer|pancreatic cancer
361360|NCT02045589|Cancer|cancer
361361|NCT02045589|Pancreatic adenocarcinoma|pancreatic adenocarcinoma
361362|NCT02045589|Locally advanced|locally advanced
361363|NCT02045589|Metastatic|metastatic
361364|NCT02045589|Gemcitabine|gemcitabine
361365|NCT02045589|Oncolytic virus|oncolytic virus
361366|NCT02045589|Abraxane®|abraxane®
361367|NCT02045576|Obstructive Sleep Apnea|obstructive sleep apnea
361368|NCT02045576|sleep position trainer|sleep position trainer
361369|NCT02045576|oral appliance therapy|oral appliance therapy
361370|NCT02045576|mandibular advancement device or splint|mandibular advancement device or splint
361371|NCT02045537|HIV|hiv
361372|NCT02045498|cpr|cpr
361373|NCT02045498|feedback|feedback
361374|NCT02045498|capnography|capnography
361375|NCT02045498|outcome|outcome
361376|NCT02045498|quality|quality
361377|NCT02045498|resuscitation|resuscitation
361378|NCT02045472|Influenza|influenza
361379|NCT02045472|Monoclonal antibody|monoclonal antibody
361380|NCT02045459|Microvascular Disease|microvascular disease
361381|NCT02045459|Exercise|exercise
361382|NCT02045459|Angina|angina
361383|NCT02045459|Chest pain|chest pain
361384|NCT02045420|Idiopathic Parkinson's Disease|idiopathic parkinson's disease
361385|NCT02045420|Magnetic Resonance Imaging|magnetic resonance imaging
361386|NCT02045420|MR Venography|mr venography
361387|NCT02045420|Flow Quantification|flow quantification
361388|NCT02045420|Susceptibility Weighted Imaging|susceptibility weighted imaging
361389|NCT02045407|Brain Death|brain death
361390|NCT02045407|Neurological Death|neurological death
361391|NCT02045407|Cerebral circulatory arrest|cerebral circulatory arrest
361392|NCT02045407|Computed Tomography Angiography|computed tomography angiography
361393|NCT02045394|haemoptysis|haemoptysis
361394|NCT02045394|hemoptysis|hemoptysis
361395|NCT02045394|airway bleeding|airway bleeding
361396|NCT02045381|Cancer|cancer
361397|NCT02045381|MRI|mri
361398|NCT02045368|refractory|refractory
361399|NCT02045368|intolerant|intolerant
361400|NCT02045368|solid tumors|solid tumors
361401|NCT02045329|Staphylococcus aureus, mupirocin, decolonization|staphylococcus aureus, mupirocin, decolonization
361402|NCT02045316|Preeclampsia|preeclampsia
361403|NCT02045316|Aquaporins|aquaporins
361404|NCT02045316|Placenta|placenta
361405|NCT02045303|Sub-acute wound|sub-acute wound
361406|NCT02045303|Chronic wound|chronic wound
361407|NCT02045303|wound|wound
361408|NCT02045303|MIST|mist
361409|NCT02045303|Soring|soring
361410|NCT02045303|Contact Ultrasound|contact ultrasound
361411|NCT02045303|Noncontact ultrasound|noncontact ultrasound
361412|NCT02045303|Wound Care|wound care
361413|NCT02045303|VIP Ultrasound Protocol|vip ultrasound protocol
361414|NCT02045303|Ultrasound|ultrasound
361415|NCT02045264|Firazyr|firazyr
361416|NCT02045264|Angioedema|angioedema
361417|NCT02045264|Angioedemas, Hereditary|angioedemas, hereditary
361418|NCT02045264|Vascular Diseases|vascular diseases
361419|NCT02045264|Cardiovascular Diseases|cardiovascular diseases
361420|NCT02045264|Urticaria|urticaria
361421|NCT02045264|Skin Diseases, Vascular|skin diseases, vascular
361422|NCT02045264|Skin Diseases|skin diseases
361423|NCT02045264|Hypersensitivity, Immediate|hypersensitivity, immediate
361424|NCT02045264|Hypersensitivity|hypersensitivity
361425|NCT02045264|Immune System Diseases|immune system diseases
361426|NCT02045264|Genetic Diseases, Inborn|genetic diseases, inborn
361427|NCT02045264|Icatibant|icatibant
361428|NCT02045264|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal
361429|NCT02045264|Analgesics, Non-Narcotic|analgesics, non-narcotic
361430|NCT02045264|Analgesics|analgesics
361431|NCT02045264|Sensory System Agents|sensory system agents
361432|NCT02045264|Peripheral Nervous System Agents|peripheral nervous system agents
361433|NCT02045264|Physiological Effects of Drugs|physiological effects of drugs
361434|NCT02045264|Pharmacologic Actions|pharmacologic actions
361435|NCT02045264|Anti-Inflammatory Agents|anti-inflammatory agents
361436|NCT02045264|Therapeutic Uses|therapeutic uses
361437|NCT02045264|Antirheumatic Agents|antirheumatic agents
361438|NCT02045264|Adrenergic beta-Antagonists|adrenergic beta-antagonists
361439|NCT02045264|Adrenergic Antagonists|adrenergic antagonists
361440|NCT02045264|Adrenergic Agents|adrenergic agents
361441|NCT02045264|Neurotransmitter Agents|neurotransmitter agents
361442|NCT02045264|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action
361443|NCT02045264|Central Nervous System Agents|central nervous system agents
362034|NCT02042781|PG545|pg545
361444|NCT02045251|Helicobacter pylori|helicobacter pylori
361445|NCT02045251|H. pylori|h. pylori
462160|NCT01589692|DRF|drf
361446|NCT02045251|Pylera|pylera
361447|NCT02045238|Bronchiolitis|bronchiolitis
361448|NCT02045238|Therapeutics|therapeutics
361449|NCT02045238|Saline Solution, Hypertonic|saline solution, hypertonic
361450|NCT02045225|social anxiety in sexual situations|social anxiety in sexual situations
361451|NCT02045212|Ischemic Optic Neuropathy|ischemic optic neuropathy
361452|NCT02045212|Traumatic Neuropathy|traumatic neuropathy
361453|NCT02045212|Non Arteritic Ischemic Neuropathy (NAION)|non arteritic ischemic neuropathy (naion)
361454|NCT02045199|Diabetic Neuropathies|diabetic neuropathies
361455|NCT02045199|Diabetes Mellitus|diabetes mellitus
361456|NCT02045199|Diabetic Foot|diabetic foot
361457|NCT02045199|Diabetes Complications|diabetes complications
361458|NCT02045186|Human Papilloma Virus|human papilloma virus
361459|NCT02045186|Oropharynx|oropharynx
361460|NCT02045186|Oropharyngeal Squamous Cell Carcinoma|oropharyngeal squamous cell carcinoma
361461|NCT02045186|Squamous Cell Carcinoma|squamous cell carcinoma
361462|NCT02045186|Radiation Therapy|radiation therapy
361463|NCT02045186|Chemotherapy|chemotherapy
361464|NCT02045173|Sleep apnea, Arrhythmias, Heart Failure, ICD, CRT-D, Apneascan|sleep apnea, arrhythmias, heart failure, icd, crt-d, apneascan
361465|NCT02045147|Home Bound Care Transitions|home bound care transitions
361466|NCT02045134|Post Operative Atrial Fibrillation after a cardiac surgery|post operative atrial fibrillation after a cardiac surgery
361467|NCT02045095|Drug therapy|drug therapy
361468|NCT02045082|Flocked swab|flocked swab
361469|NCT02045082|Traditional fiber swab|traditional fiber swab
361470|NCT02045082|Herpes simplex epithelial keratitis|herpes simplex epithelial keratitis
361471|NCT02045082|Quantitative PCR|quantitative pcr
361472|NCT02045056|Alzheimer disease|alzheimer disease
361473|NCT02045056|mild cognitive impairment|mild cognitive impairment
361474|NCT02045056|normal cognition|normal cognition
361475|NCT02045043|Sudden Cardiac Death|sudden cardiac death
361476|NCT02045043|Arrhythmias|arrhythmias
361477|NCT02045043|Congestive Heart Failure|congestive heart failure
361478|NCT02045043|Cardiomyopathy|cardiomyopathy
361479|NCT02045043|Single Nucleotide Polymorphisms|single nucleotide polymorphisms
361480|NCT02045043|Genomics|genomics
361481|NCT02045030|metastatic|metastatic
361482|NCT02045030|colorectal|colorectal
361483|NCT02045030|cancer|cancer
361484|NCT02045030|aflibercept|aflibercept
361485|NCT02045030|FOLFIRI|folfiri
361486|NCT02045017|Multiple Myeloma|multiple myeloma
361487|NCT02045017|Relapsed Multiple Myeloma|relapsed multiple myeloma
361488|NCT02045017|Refactory Multiple Myeloma|refactory multiple myeloma
361489|NCT02045017|Renal Insufficiency|renal insufficiency
361490|NCT02045017|Pomalidomide|pomalidomide
361491|NCT02045017|Dexamethasone|dexamethasone
361492|NCT02045004|Anesthesia|anesthesia
361493|NCT02045004|Surgery|surgery
361494|NCT02045004|Geriatrics|geriatrics
361495|NCT02045004|Postoperative cognitive dysfunction|postoperative cognitive dysfunction
361496|NCT02045004|Postoperative delirium|postoperative delirium
361497|NCT02045004|Dementia|dementia
361498|NCT02045004|Postoperative complications|postoperative complications
361499|NCT02045004|Neurological complications|neurological complications
361500|NCT02045004|Psychological complications|psychological complications
361501|NCT02044991|Sciatica|sciatica
361502|NCT02044991|Pelvic girdle pain|pelvic girdle pain
361503|NCT02044965|urinary tract infection|urinary tract infection
361504|NCT02044965|antibiotic prophylaxis|antibiotic prophylaxis
361505|NCT02044965|probiotics|probiotics
361506|NCT02044965|neurogenic bladder|neurogenic bladder
361507|NCT02044965|clean intermittent catheterization|clean intermittent catheterization
361508|NCT02044952|Crohn's Disease|crohn's disease
361509|NCT02044952|mesalazine|mesalazine
361510|NCT02044952|Tripterygium Glycosides|tripterygium glycosides
361511|NCT02044952|induction remission|induction remission
361512|NCT02044939|Sarcoidosis, pulmonary rehabilitation|sarcoidosis, pulmonary rehabilitation
361513|NCT02044900|obstructive sleep apnea|obstructive sleep apnea
361514|NCT02044900|polysomnography|polysomnography
361515|NCT02044900|heart rate variability|heart rate variability
361516|NCT02044900|mathematical biomarker|mathematical biomarker
361517|NCT02044887|Physical activity|physical activity
361518|NCT02044887|dementia|dementia
361519|NCT02044887|relative caregivers|relative caregivers
361520|NCT02044887|podometer|podometer
361521|NCT02044887|cardiovascular risk|cardiovascular risk
361522|NCT02044848|type 1 diabetes mellitus|type 1 diabetes mellitus
361523|NCT02044835|atherosclerotic renal artery stenosis, herbal medicine|atherosclerotic renal artery stenosis, herbal medicine
361524|NCT02044822|Chronic Lymphocytic Leukemia|chronic lymphocytic leukemia
361525|NCT02044822|CLL|cll
361526|NCT02044783|Adults|adults
361527|NCT02044783|Elderly|elderly
361528|NCT02044770|laparoscopic|laparoscopic
361529|NCT02044770|colectomy|colectomy
361530|NCT02044770|ENSEAL|enseal
361531|NCT02044757|Caffeine|caffeine
361532|NCT02044757|Addiction|addiction
361533|NCT02044757|Withdrawal symptoms|withdrawal symptoms
361534|NCT02044757|Pediatric|pediatric
361535|NCT02044757|Adolescent|adolescent
361536|NCT02044757|Overweight|overweight
361537|NCT02044744|Obesity|obesity
361538|NCT02044744|Pediatric Obesity|pediatric obesity
361539|NCT02044744|Physical Activity|physical activity
361540|NCT02044744|Physical Fitness|physical fitness
361541|NCT02044744|Primary Health Care|primary health care
361542|NCT02044744|Referral and Consultation|referral and consultation
361544|NCT02044731|Pediatrics|pediatrics
361545|NCT02044731|Obesity|obesity
361546|NCT02044731|Overweight|overweight
361547|NCT02044731|Intervention Studies|intervention studies
361548|NCT02044731|African Americans|african americans
361549|NCT02044731|Family|family
361550|NCT02044731|Body mass index|body mass index
361551|NCT02044718|adverse events|adverse events
361552|NCT02044718|unplanned admission intensive care|unplanned admission intensive care
361553|NCT02044718|chart review|chart review
361554|NCT02044705|Primary Health Care|primary health care
361555|NCT02044705|Pediatrics|pediatrics
361556|NCT02044705|Obesity|obesity
361557|NCT02044705|Overweight|overweight
361558|NCT02044705|Clinical trial|clinical trial
361559|NCT02044705|Hispanic Americans|hispanic americans
361560|NCT02044705|Family|family
361561|NCT02044705|Body mass index|body mass index
361562|NCT02044692|Hunter syndrome|hunter syndrome
361563|NCT02044692|Mucopolysaccharidosis II|mucopolysaccharidosis ii
361564|NCT02044692|Hunterase|hunterase
361565|NCT02044666|Critical Limb Ischemia|critical limb ischemia
361566|NCT02044666|Amputation|amputation
361567|NCT02044653|Phase 2|phase 2
361568|NCT02044614|Hemodialysis/Peritoneal Dialysis|hemodialysis/peritoneal dialysis
361569|NCT02044614|functionally anuric|functionally anuric
361570|NCT02044614|Icodextrin|icodextrin
361571|NCT02044614|Kidney Disease Quality of Life|kidney disease quality of life
361572|NCT02044601|Lung Cancer|lung cancer
361573|NCT02044601|Non-small cell lung cancer|non-small cell lung cancer
361574|NCT02044601|NSCLC|nsclc
361575|NCT02044601|Squamous cell carcinoma of the lung|squamous cell carcinoma of the lung
361576|NCT02044601|Adenocarcinoma of the lung|adenocarcinoma of the lung
361577|NCT02044601|Radiation therapy|radiation therapy
361578|NCT02044601|Proton therapy|proton therapy
361579|NCT02044601|XRT|xrt
361580|NCT02044601|Carboplatin|carboplatin
361581|NCT02044601|Paraplatin|paraplatin
361582|NCT02044601|Paclitaxel|paclitaxel
361583|NCT02044601|Taxol|taxol
361584|NCT02044601|Onartuzumab|onartuzumab
361585|NCT02044601|Erlotinib|erlotinib
361586|NCT02044601|Erlotinib hydrochloride|erlotinib hydrochloride
361587|NCT02044601|OSI-774|osi-774
361588|NCT02044601|CP358774|cp358774
361589|NCT02044601|Tarceva|tarceva
361590|NCT02044588|HBsAg(+) donor|hbsag(+) donor
361591|NCT02044588|HBsAg(-) donor|hbsag(-) donor
361592|NCT02044588|Anti-hepatitis B antibody|anti-hepatitis b antibody
361593|NCT02044588|Kidney allograft|kidney allograft
361594|NCT02044575|Clock genes, circadian regulation|clock genes, circadian regulation
361595|NCT02044562|dietary nitrate|dietary nitrate
361596|NCT02044562|radiotherapy|radiotherapy
361597|NCT02044562|nasopharyngeal carcinoma|nasopharyngeal carcinoma
361598|NCT02044549|Carbetocin|carbetocin
361599|NCT02044549|syntometrine|syntometrine
361600|NCT02044549|postpartum hemorrhage|postpartum hemorrhage
361601|NCT02044549|cesarean section|cesarean section
361602|NCT02044536|biopsy|biopsy
361603|NCT02044536|endoscopy|endoscopy
361604|NCT02044536|neoplasms|neoplasms
361605|NCT02044523|Chronic liver disease|chronic liver disease
361606|NCT02044523|Fibrosis|fibrosis
361607|NCT02044523|Elastography|elastography
361608|NCT02044523|Ultrasound|ultrasound
361609|NCT02044523|Magnetic resonance elastography|magnetic resonance elastography
361610|NCT02044523|Diagnostic performance|diagnostic performance
361611|NCT02044523|Sensitivity and specificity|sensitivity and specificity
361612|NCT02044510|Multiple Sclerosis|multiple sclerosis
361613|NCT02044510|Spinal Cord Injuries|spinal cord injuries
361614|NCT02044510|mirabegron|mirabegron
361615|NCT02044510|Urodynamics|urodynamics
361616|NCT02044497|pharmacokinetics|pharmacokinetics
361617|NCT02044497|pharmacogenomics|pharmacogenomics
361618|NCT02044497|oral oxycodone|oral oxycodone
361619|NCT02044497|pediatric surgical patients|pediatric surgical patients
361620|NCT02044484|HIV|hiv
361621|NCT02044484|AIDS|aids
361622|NCT02044484|Viral load|viral load
361623|NCT02044484|Primary care|primary care
361624|NCT02044471|left ventricular assist device|left ventricular assist device
361625|NCT02044471|continuous flow|continuous flow
361626|NCT02044471|remote ischemic conditioning|remote ischemic conditioning
361627|NCT02044471|hypertension|hypertension
361628|NCT02044471|sympathetic tone|sympathetic tone
361629|NCT02044471|endothelial dysfunction|endothelial dysfunction
361630|NCT02044458|Foley Catheterization|foley catheterization
361631|NCT02044458|Induction of Labor|induction of labor
361632|NCT02044458|5 French Stylette|5 french stylette
361633|NCT02044445|IVF, hCG, oocyte retrieval, time interval|ivf, hcg, oocyte retrieval, time interval
361634|NCT02044419|Comparative|comparative
361635|NCT02044419|Bioavailability|bioavailability
361636|NCT02044419|lomitapide|lomitapide
361637|NCT02044341|Acute Otitis Media|acute otitis media
361638|NCT02044341|Pain|pain
361639|NCT02044341|Ear Pain|ear pain
361640|NCT02044341|Ear Ache|ear ache
361641|NCT02044341|Ear infection|ear infection
361642|NCT02044341|middle ear infection|middle ear infection
361643|NCT02044302|pain|pain
361644|NCT02044302|breast cancer|breast cancer
361645|NCT02044302|breast implant|breast implant
361646|NCT02044302|breast reconstruction|breast reconstruction
361647|NCT02044289|depression|depression
361648|NCT02044289|electroconvulsive therapy (ECT)|electroconvulsive therapy (ect)
361649|NCT02044289|magnetic resonance imaging (MRI)|magnetic resonance imaging (mri)
361650|NCT02044276|Neutropenia|neutropenia
361651|NCT02044276|NHL|nhl
361652|NCT02044276|Non-Hodgkin lymphomas|non-hodgkin lymphomas
361653|NCT02044276|R-CHOP-21|r-chop-21
361654|NCT02044263|Cognitive therapy|cognitive therapy
361655|NCT02044263|Behavior therapy|behavior therapy
361656|NCT02044263|Waiting lists|waiting lists
361657|NCT02044263|Therapy, computer-assisted|therapy, computer-assisted
361658|NCT02044263|Internet|internet
361659|NCT02044250|Aspirin|aspirin
361660|NCT02044250|Clopidogrel|clopidogrel
361661|NCT02044250|Antiplatelet monotherapy|antiplatelet monotherapy
361662|NCT02044250|Drug-eluting stent|drug-eluting stent
361663|NCT02044237|trichotillomania|trichotillomania
361664|NCT02044237|online therapy|online therapy
361665|NCT02044211|Heart Failure, Systolic|heart failure, systolic
361666|NCT02044211|Depressive Disorder|depressive disorder
361667|NCT02044211|Depressive Disorder, Major|depressive disorder, major
361668|NCT02044211|Mood Disorder|mood disorder
361669|NCT02044198|Plasmodium Falciparum|plasmodium falciparum
361670|NCT02044198|Malaria|malaria
361671|NCT02044198|Vaccine|vaccine
361672|NCT02044198|Plasmodium|plasmodium
361673|NCT02044198|Falciparum|falciparum
361674|NCT02044185|HMGB1 Protein|hmgb1 protein
361675|NCT02044185|Graft versus Host Disease|graft versus host disease
361676|NCT02044185|Immunosuppressive Agents|immunosuppressive agents
361677|NCT02044185|oral mucositis|oral mucositis
361678|NCT02044172|Prostate cancer|prostate cancer
361679|NCT02044172|Treatment|treatment
361680|NCT02044172|Screening|screening
361681|NCT02044172|Surgery|surgery
361682|NCT02044172|Radiotherapy|radiotherapy
361683|NCT02044172|Active monitoring|active monitoring
361684|NCT02044159|Hydrocortisone|hydrocortisone
361685|NCT02044159|Pediatrics|pediatrics
361686|NCT02044159|Adrenal Insufficiency|adrenal insufficiency
361687|NCT02044107|Diarrhea,|diarrhea,
361688|NCT02044107|Pneumonia,|pneumonia,
361689|NCT02044107|Zinc treatment,|zinc treatment,
361690|NCT02044107|Patient Compliance.|patient compliance.
361691|NCT02044094|Opioid dependent|opioid dependent
361692|NCT02044094|Buprenorphine|buprenorphine
361693|NCT02044094|Suboxone Film|suboxone film
361694|NCT02044094|Opioid blockade|opioid blockade
361695|NCT02044094|Hydromorphone challenge|hydromorphone challenge
361696|NCT02044016|Achilles tendon rupture, lengthening, validity, goniometer.|achilles tendon rupture, lengthening, validity, goniometer.
361697|NCT02044003|angioplasty|angioplasty
361698|NCT02044003|dissections|dissections
361699|NCT02043990|NAVA|nava
361700|NCT02043990|noninvasive ventilation|noninvasive ventilation
361701|NCT02043990|infants|infants
361702|NCT02043977|Propofol|propofol
361703|NCT02043977|Insomnia|insomnia
361704|NCT02043977|Sleep disorder|sleep disorder
361705|NCT02043977|Sleep deprivation|sleep deprivation
361706|NCT02043977|Chronic insomnia|chronic insomnia
361707|NCT02043977|Refractory insomnia|refractory insomnia
361708|NCT02043977|Primary insomnia|primary insomnia
361709|NCT02043964|Multiple Sclerosis|multiple sclerosis
361710|NCT02043964|Clinically Isolated Syndrome|clinically isolated syndrome
361711|NCT02043964|Tears|tears
361712|NCT02043964|Isoelectric focusing|isoelectric focusing
361713|NCT02043964|Oligoclonal profile|oligoclonal profile
361714|NCT02043938|Electroencephalography|electroencephalography
361715|NCT02043938|pharmacological|pharmacological
361716|NCT02043925|QT-prolongation|qt-prolongation
361717|NCT02043925|Torsade de Pointes|torsade de pointes
361718|NCT02043925|drug interactions|drug interactions
361719|NCT02043925|psychiatry|psychiatry
361720|NCT02043912|QT-prolongation|qt-prolongation
361721|NCT02043912|Torsade de Pointes|torsade de pointes
361722|NCT02043912|Haloperidol|haloperidol
361723|NCT02043912|Drug interactions|drug interactions
361724|NCT02043899|Neuroblastoma|neuroblastoma
361725|NCT02043899|Positron emission tomography|positron emission tomography
361726|NCT02043899|124-iodine|124-iodine
361727|NCT02043899|Meta-Iodobenzylguanidine|meta-iodobenzylguanidine
361728|NCT02043886|Type 2 Diabetes, Postprandial Hypotension, Acarbose|type 2 diabetes, postprandial hypotension, acarbose
361729|NCT02043873|Clinical Trial|clinical trial
361730|NCT02043873|Composite Restorations|composite restorations
361731|NCT02043873|Restorations Repair|restorations repair
361732|NCT02043873|Replacement Restorations|replacement restorations
361733|NCT02043873|Operative Dentistry.|operative dentistry.
361734|NCT02043860|Multiple Myeloma|multiple myeloma
361735|NCT02043860|High Risk|high risk
361736|NCT02043860|Intermediate Risk|intermediate risk
361737|NCT02043860|Symptomatic|symptomatic
361738|NCT02043847|Multiple Myeloma|multiple myeloma
361739|NCT02043847|Relapsed|relapsed
361740|NCT02043847|Refractory|refractory
362035|NCT02042781|Phase I|phase i
361741|NCT02043847|Progressive Disease|progressive disease
361742|NCT02043847|Symptomatic|symptomatic
361743|NCT02043795|Bioresorbable Vascular Scaffold System|bioresorbable vascular scaffold system
361744|NCT02043795|Percutaneous Transluminal Angioplasty|percutaneous transluminal angioplasty
361745|NCT02043795|Stent|stent
361746|NCT02043769|South Africa|south africa
361747|NCT02043769|Eastern Cape|eastern cape
361748|NCT02043769|Child ARV|child arv
361749|NCT02043769|CLWHIV|clwhiv
361750|NCT02043756|Mitoxantrone Hydrochloride Liposome Injection|mitoxantrone hydrochloride liposome injection
361751|NCT02043730|pancreatic cancer|pancreatic cancer
361752|NCT02043730|locally advanced|locally advanced
361753|NCT02043730|unresectable cancer|unresectable cancer
361754|NCT02043717|Cystic Fibrosis|cystic fibrosis
361755|NCT02043717|Vitamin D|vitamin d
361756|NCT02043717|Lung function|lung function
361757|NCT02043704|IV Acetaminophen|iv acetaminophen
361758|NCT02043704|Vaginal Reconstruction|vaginal reconstruction
361759|NCT02043704|Pain, Postoperative|pain, postoperative
361760|NCT02043691|Endovascular|endovascular
361761|NCT02043691|Aortic|aortic
361762|NCT02043691|Aneurysm|aneurysm
361763|NCT02043691|Thoracoabdominal|thoracoabdominal
361764|NCT02043691|Juxtarenal|juxtarenal
361765|NCT02043691|Suprarenal|suprarenal
361766|NCT02043691|Endograft|endograft
361767|NCT02043691|Fenestrated|fenestrated
361768|NCT02043691|Branched|branched
361769|NCT02043691|Complex|complex
361770|NCT02043691|Abdominal|abdominal
361771|NCT02043691|Thoracic|thoracic
361773|NCT02043691|Stentgraft|stentgraft
361774|NCT02043678|Phase III|phase iii
361775|NCT02043678|Radium-223 dichloride|radium-223 dichloride
361776|NCT02043678|Abiraterone acetate|abiraterone acetate
361777|NCT02043678|Combination therapy|combination therapy
361778|NCT02043678|Chemotherapy-naive|chemotherapy-naive
361779|NCT02043678|Bone metastasis|bone metastasis
361780|NCT02043678|Castration-resistant prostate cancer (CRPC)|castration-resistant prostate cancer (crpc)
361781|NCT02043665|CAVATAK|cavatak
361782|NCT02043665|KEYNOTE-200|keynote-200
361783|NCT02043665|pembrolizumab|pembrolizumab
361784|NCT02043665|lung cancer|lung cancer
361785|NCT02043665|bladder cancer|bladder cancer
361786|NCT02043639|rotation|rotation
361787|NCT02043639|shoulder|shoulder
361788|NCT02043639|joint|joint
361789|NCT02043639|ROM|rom
361790|NCT02043639|abduction,|abduction,
361791|NCT02043639|internal rotation,|internal rotation,
361792|NCT02043639|external rotation,|external rotation,
361793|NCT02043639|flexion|flexion
361794|NCT02043639|normal|normal
361795|NCT02043639|joint movement|joint movement
361796|NCT02043639|physical examination|physical examination
361797|NCT02043626|childhood nutrition|childhood nutrition
361798|NCT02043626|physical activity|physical activity
361799|NCT02043626|school wellness|school wellness
361800|NCT02043626|school health|school health
361801|NCT02043626|nutritional policies|nutritional policies
361802|NCT02043626|childhood obesity|childhood obesity
361803|NCT02043613|Joint pain|joint pain
361804|NCT02043613|Context effects|context effects
361805|NCT02043613|Placebo effect|placebo effect
361806|NCT02043613|Exercise treatment|exercise treatment
361807|NCT02043600|Colitis, ulcerative|colitis, ulcerative
361808|NCT02043600|Yoga|yoga
361809|NCT02043587|Acute lymphoblastic leukemia|acute lymphoblastic leukemia
361810|NCT02043587|Lymphoblastic leukemia|lymphoblastic leukemia
361811|NCT02043587|Lymphoblastic lymphoma|lymphoblastic lymphoma
361812|NCT02043574|Aerobic Exercise|aerobic exercise
361813|NCT02043574|Treadmill Test|treadmill test
361814|NCT02043574|Sedentary Lifestyle|sedentary lifestyle
361815|NCT02043548|dermatomyositis|dermatomyositis
361816|NCT02043548|polymyositis|polymyositis
361817|NCT02043548|tocilizumab|tocilizumab
361818|NCT02043548|Actemra|actemra
361819|NCT02043535|myocardial perfusion imaging|myocardial perfusion imaging
361820|NCT02043535|myocardial blood flow|myocardial blood flow
361821|NCT02043535|pharmacologic stress agents|pharmacologic stress agents
361822|NCT02043535|carbon dioxide|carbon dioxide
361823|NCT02043535|rubidium 82 radioisotope|rubidium 82 radioisotope
361824|NCT02043535|positron emission tomography|positron emission tomography
361825|NCT02043522|123I-mIBG|123i-mibg
361826|NCT02043522|SPECT Imaging|spect imaging
361827|NCT02043522|Phantom imaging|phantom imaging
361828|NCT02043522|Heart failure|heart failure
361829|NCT02043522|Coronary artery disease|coronary artery disease
361830|NCT02043522|Heart to mediastinum ratios|heart to mediastinum ratios
361831|NCT02043522|heart to calibration ratios|heart to calibration ratios
361832|NCT02043522|Myocardial blood flow|myocardial blood flow
361833|NCT02043522|Myocardial blood flow researve|myocardial blood flow researve
361834|NCT02043509|smoking cessation|smoking cessation
361835|NCT02043509|pregnancy|pregnancy
361836|NCT02043509|cessation support|cessation support
361837|NCT02043509|tailored text messages|tailored text messages
361838|NCT02043509|self-help|self-help
361839|NCT02043509|MiQuit|miquit
361840|NCT02043496|Binge Eating Disorder|binge eating disorder
361841|NCT02043496|Binge Eating|binge eating
361842|NCT02043496|Eating Disorders|eating disorders
361843|NCT02043496|Obesity|obesity
361844|NCT02043496|Psychotherapy|psychotherapy
361845|NCT02043496|Cognitive Behavioral Therapy|cognitive behavioral therapy
361846|NCT02043483|CPAP|cpap
361847|NCT02043483|OSAS|osas
361848|NCT02043483|CEDOC (Centro de Estudos de Doenças Crónicas)|cedoc (centro de estudos de doenças crónicas)
361849|NCT02043483|FCM (Faculdade de Ciências Médicas)|fcm (faculdade de ciências médicas)
361850|NCT02043483|UNL (Universidade Nova de Lisboa|unl (universidade nova de lisboa
361851|NCT02043483|NOVA MEDICAL SCHOOL|nova medical school
361852|NCT02043483|FCT (Fundação para a Ciência e Tecnologia)|fct (fundação para a ciência e tecnologia)
361853|NCT02043470|Sinus/nasal cancer|sinus/nasal cancer
361854|NCT02043431|Heart failure|heart failure
361855|NCT02043431|Electronic medical records|electronic medical records
361856|NCT02043431|Genomics|genomics
361857|NCT02043431|Biobank|biobank
361858|NCT02043418|HIV|hiv
361859|NCT02043418|ARV|arv
361860|NCT02043418|Pediatric|pediatric
361861|NCT02043418|Cameroon|cameroon
361862|NCT02043392|intestinal anastomosis|intestinal anastomosis
361863|NCT02043392|non-emergent|non-emergent
361864|NCT02043392|intestinal revision|intestinal revision
361865|NCT02043392|magnetic compression|magnetic compression
361866|NCT02043392|anastomotic leak|anastomotic leak
361867|NCT02043379|congenital heart disease|congenital heart disease
361868|NCT02043379|Cardiopulmonary Bypass|cardiopulmonary bypass
361869|NCT02043379|Hypogammaglobulinemia|hypogammaglobulinemia
361870|NCT02043366|Remifentanil|remifentanil
361871|NCT02043366|Opioid-induced hyperalgesia|opioid-induced hyperalgesia
361872|NCT02043366|Postoperative pain|postoperative pain
361873|NCT02043366|Pain Intensity|pain intensity
361874|NCT02043340|Periodontitis|periodontitis
361875|NCT02043340|Bacterial viability|bacterial viability
361876|NCT02043340|Lactate dehydrogenase levels|lactate dehydrogenase levels
361877|NCT02043340|Indocyanine green|indocyanine green
361878|NCT02043340|Scaling and root planing|scaling and root planing
361879|NCT02043340|Antimicrobial photodynamic therapy.|antimicrobial photodynamic therapy.
361880|NCT02043327|Colonoscopy|colonoscopy
361881|NCT02043327|assessment|assessment
361882|NCT02043327|certification,|certification,
361883|NCT02043327|simulation,|simulation,
361884|NCT02043327|standard setting|standard setting
361885|NCT02043301|pharmacokinetics|pharmacokinetics
361886|NCT02043301|bioavailability|bioavailability
361887|NCT02043301|PF-04950615|pf-04950615
361888|NCT02043288|Pancreatic cancer|pancreatic cancer
361889|NCT02043288|Platinum|platinum
361890|NCT02043288|Micelle|micelle
361891|NCT02043275|resistance training|resistance training
361892|NCT02043262|Elderly|elderly
361893|NCT02043262|Home-based rehabilitation|home-based rehabilitation
361894|NCT02043262|Activities of daily living|activities of daily living
361895|NCT02043262|Restorative care|restorative care
361896|NCT02043262|Reablement|reablement
361897|NCT02043262|Everyday rehabilitation|everyday rehabilitation
361898|NCT02043249|DELAYED CORD CLAMPING|delayed cord clamping
361899|NCT02043249|MILKING OF CORD|milking of cord
361900|NCT02043249|PREMATURE INFANTS|premature infants
361901|NCT02043249|LEVEL OF IgG IN NEONATES|level of igg in neonates
361902|NCT02043236|Prostate cancer|prostate cancer
361903|NCT02043236|Androgen deprivation therapy|androgen deprivation therapy
361904|NCT02043236|Bone health|bone health
361905|NCT02043236|Bone mineral density|bone mineral density
361906|NCT02043223|Vitamin A|vitamin a
361907|NCT02043223|Breast milk|breast milk
361908|NCT02043223|Postpartum vitamin A supplementation|postpartum vitamin a supplementation
361909|NCT02043223|Infant vaccine response|infant vaccine response
361910|NCT02043210|substance use, Spanish speaking, CBT4CBT|substance use, spanish speaking, cbt4cbt
361911|NCT02043197|Depression,|depression,
361912|NCT02043197|depressive symptoms,|depressive symptoms,
361913|NCT02043197|major depressive disorder,|major depressive disorder,
361914|NCT02043197|Fevarine,|fevarine,
361915|NCT02043197|fluvoxamine,|fluvoxamine,
361916|NCT02043197|cognitive function,|cognitive function,
361917|NCT02043197|neurological disorders,|neurological disorders,
361918|NCT02043197|sleep state|sleep state
361919|NCT02043184|Neoplasms|neoplasms
361920|NCT02043184|Medication Adherence|medication adherence
361921|NCT02043184|Administration, Oral|administration, oral
361922|NCT02043184|Symptom Assessment|symptom assessment
361923|NCT02043184|Neurobehavioral Manifestations|neurobehavioral manifestations
361924|NCT02043184|Depression|depression
361925|NCT02043184|Behavioral Symptoms|behavioral symptoms
361926|NCT02043184|Utilization|utilization
361927|NCT02043158|Ovarian Cancer|ovarian cancer
361928|NCT02043158|Short term survivors|short term survivors
361929|NCT02043158|Long term survivors|long term survivors
361930|NCT02043158|Biobehavioral characteristics|biobehavioral characteristics
361931|NCT02043158|Sociodemographic characteristics|sociodemographic characteristics
361932|NCT02043158|Questionnaire|questionnaire
361933|NCT02043158|Survey|survey
361934|NCT02043158|Interview|interview
361935|NCT02043132|reverse shoulder arthroplasty|reverse shoulder arthroplasty
361936|NCT02043132|Rotator cuff|rotator cuff
361937|NCT02043132|Orthopedic joint surgery|orthopedic joint surgery
361938|NCT02043132|Total shoulder|total shoulder
361939|NCT02043132|Perioperative bleeding|perioperative bleeding
361940|NCT02043132|Tranexamic acid|tranexamic acid
361941|NCT02043132|Orthopedic complications|orthopedic complications
361942|NCT02043132|Hemorrhage|hemorrhage
361943|NCT02043132|Postoperative Hemorrhage|postoperative hemorrhage
361944|NCT02043132|Pathologic Processes|pathologic processes
361945|NCT02043132|Arthritis|arthritis
361946|NCT02043132|Joint Diseases|joint diseases
361947|NCT02043132|Musculoskeletal Diseases|musculoskeletal diseases
361948|NCT02043132|Postoperative Complications|postoperative complications
361949|NCT02043132|Antifibrinolytic Agents|antifibrinolytic agents
361950|NCT02043132|Fibrin Modulating Agents|fibrin modulating agents
361951|NCT02043132|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action
361952|NCT02043132|Pharmacologic Actions|pharmacologic actions
361953|NCT02043132|Hemostatics|hemostatics
361954|NCT02043132|Coagulants|coagulants
361955|NCT02043132|Hematologic Agents|hematologic agents
361956|NCT02043132|Therapeutic Uses|therapeutic uses
361957|NCT02043093|Adolescent suicide prevention|adolescent suicide prevention
361958|NCT02043093|Peer Leader prevention model|peer leader prevention model
361959|NCT02043093|Universal school-based prevention|universal school-based prevention
361960|NCT02043080|Tuberculosis|tuberculosis
361962|NCT02043080|Xpert MTB/RIF|xpert mtb/rif
361963|NCT02043080|Determine TB-LAM|determine tb-lam
361964|NCT02043080|UNC|unc
361965|NCT02043080|Zambia|zambia
361966|NCT02043080|Cost Effectiveness Analysis Curve|cost effectiveness analysis curve
361967|NCT02043080|Centre for Infectious Disease Research in Zambia|centre for infectious disease research in zambia
361968|NCT02043067|TB|tb
361969|NCT02043067|HIV|hiv
361970|NCT02043067|Extensively resistant TB|extensively resistant tb
361971|NCT02043067|Extra pulmonary TB|extra pulmonary tb
361972|NCT02043054|Type 2 Diabetes Mellitus (T2DM)|type 2 diabetes mellitus (t2dm)
361973|NCT02043054|Young Adults|young adults
361974|NCT02043054|Cardiovascular Disease (CVD)|cardiovascular disease (cvd)
361975|NCT02043054|GLP1 Analogue|glp1 analogue
361976|NCT02043054|DPP IV Inhibitor|dpp iv inhibitor
361977|NCT02043054|Obesity|obesity
361978|NCT02043054|Cardiometabolic Effects|cardiometabolic effects
361979|NCT02043054|Cardiac MRI|cardiac mri
361980|NCT02043028|Cardiopulmonary resuscitation|cardiopulmonary resuscitation
361981|NCT02043028|Chest compression|chest compression
361982|NCT02043028|Advanced cardiac life support|advanced cardiac life support
361983|NCT02043028|Posture|posture
361984|NCT02043015|voluntary counseling and testing (VCT)|voluntary counseling and testing (vct)
361985|NCT02043015|couples voluntary counseling and testing (CVCT)|couples voluntary counseling and testing (cvct)
361986|NCT02043015|pre-exposure prophylaxis (PrEP)|pre-exposure prophylaxis (prep)
361987|NCT02043015|homosexuality|homosexuality
361988|NCT02043015|male|male
361989|NCT02043015|South Africa|south africa
361990|NCT02042989|Advanced Cancers|advanced cancers
361991|NCT02042989|Advanced solid tumor|advanced solid tumor
361992|NCT02042989|Advanced p53 Mutant Malignancies|advanced p53 mutant malignancies
361993|NCT02042989|MLN9708|mln9708
361994|NCT02042989|Vorinostat|vorinostat
361995|NCT02042989|SAHA|saha
361996|NCT02042989|Suberoylanilide Hydroxamic Acid|suberoylanilide hydroxamic acid
361997|NCT02042989|MSK-390|msk-390
361998|NCT02042989|Zolinza|zolinza
361999|NCT02042976|Chronic obstructive pulmonary disease (COPD)|chronic obstructive pulmonary disease (copd)
362000|NCT02042976|Mindfulness-based cognitive therapy (MBCT)|mindfulness-based cognitive therapy (mbct)
362001|NCT02042976|Behavioural intervention|behavioural intervention
362002|NCT02042976|Quality-of-life|quality-of-life
362003|NCT02042976|Anxiety|anxiety
362004|NCT02042976|Depression|depression
362005|NCT02042976|Physical health status|physical health status
362006|NCT02042963|The cohort of Asian kidney transplant recipients|the cohort of asian kidney transplant recipients
362007|NCT02042963|The cohort of metabolic complication after kidney transplant|the cohort of metabolic complication after kidney transplant
362008|NCT02042963|The biorepository of Asian kidney transplant recipients|the biorepository of asian kidney transplant recipients
362009|NCT02042950|Lymphoma|lymphoma
362010|NCT02042950|Mantle Cell Lymphoma|mantle cell lymphoma
362011|NCT02042950|MCL|mcl
362012|NCT02042950|Relapsed|relapsed
362013|NCT02042950|Refractory|refractory
362014|NCT02042950|Carfilzomib|carfilzomib
362015|NCT02042937|Knee|knee
362016|NCT02042937|Hip|hip
362017|NCT02042937|Muscle Strength|muscle strength
362018|NCT02042937|Electromyography|electromyography
362019|NCT02042937|Biomechanical Phenomena|biomechanical phenomena
362020|NCT02042924|Leukemia|leukemia
362021|NCT02042924|Lymphoma|lymphoma
362022|NCT02042924|Myeloma|myeloma
362023|NCT02042924|Myelodysplastic Syndrome|myelodysplastic syndrome
362024|NCT02042898|Cardiac Surgery|cardiac surgery
362025|NCT02042898|Transfusion|transfusion
362026|NCT02042885|Prostate cancer|prostate cancer
362027|NCT02042872|Spinal Cord Injury|spinal cord injury
362028|NCT02042872|Disuse Osteoporosis|disuse osteoporosis
362029|NCT02042872|Zoledronic acid|zoledronic acid
362030|NCT02042872|Bisphosphonates|bisphosphonates
362031|NCT02042872|Dual Energy X-ray Absorptiometry|dual energy x-ray absorptiometry
362032|NCT02042859|EndoHPB|endohpb
362033|NCT02042820|Dry Eye|dry eye
362036|NCT02042781|Progen|progen
362037|NCT02042781|antimetastatic|antimetastatic
362038|NCT02042781|antiangiogenic|antiangiogenic
362039|NCT02042781|advanced cancer patients|advanced cancer patients
362040|NCT02042781|solid tumors|solid tumors
362041|NCT02042781|solid tumours|solid tumours
362042|NCT02042781|tumor microenvironment|tumor microenvironment
362043|NCT02042768|Glucose|glucose
362044|NCT02042768|Dialysate|dialysate
362045|NCT02042768|Peritoneal Dialysis|peritoneal dialysis
362046|NCT02042768|patients|patients
362047|NCT02042768|non-diabetic|non-diabetic
362048|NCT02042755|cataract|cataract
362049|NCT02042755|IOL|iol
362050|NCT02042755|trifocal|trifocal
362051|NCT02042755|FineVision|finevision
362052|NCT02042742|Cross-over studies|cross-over studies
362053|NCT02042742|Antioxidants|antioxidants
362054|NCT02042742|Hydroxytyrosol|hydroxytyrosol
362055|NCT02042742|Punicalagin|punicalagin
362056|NCT02042742|Treatment outcome|treatment outcome
362057|NCT02042742|Inflammatory markers|inflammatory markers
362058|NCT02042742|Endothelial function|endothelial function
362059|NCT02042742|Humans|humans
362060|NCT02042742|Adults|adults
362061|NCT02042742|volunteers|volunteers
362062|NCT02042729|volunteer|volunteer
362063|NCT02042716|preterm and term newborns|preterm and term newborns
362064|NCT02042716|diagnosis of cerebral white matter damage|diagnosis of cerebral white matter damage
362065|NCT02042716|quantitative brain elasticity|quantitative brain elasticity
362066|NCT02042716|Transfontanel ultrafast doppler|transfontanel ultrafast doppler
362067|NCT02042690|Acute Lymphoblastic Leukemia|acute lymphoblastic leukemia
362068|NCT02042690|hematopoietic stem cell transplantation|hematopoietic stem cell transplantation
362069|NCT02042690|chemotherapy|chemotherapy
362070|NCT02042677|ileostomy|ileostomy
362071|NCT02042677|1-piece|1-piece
362072|NCT02042677|assessment|assessment
362073|NCT02042677|Nova|nova
362074|NCT02042677|NovaLife|novalife
362075|NCT02042677|Dansac|dansac
362076|NCT02042651|ESWT|eswt
362077|NCT02042651|Chronic pelvic pain|chronic pelvic pain
362078|NCT02042651|randomized|randomized
362079|NCT02042651|sham controlled|sham controlled
362080|NCT02042612|Pharmacokinetics|pharmacokinetics
362081|NCT02042612|Sevoflurane|sevoflurane
362082|NCT02042612|Obesity|obesity
362083|NCT02042612|Sedation|sedation
362084|NCT02042612|ICU patients|icu patients
362085|NCT02042599|Pharmacokinetics|pharmacokinetics
362086|NCT02042599|Sevoflurane|sevoflurane
362087|NCT02042599|Acute kidney injury|acute kidney injury
362088|NCT02042599|Sedation|sedation
362089|NCT02042599|ICU patients|icu patients
362090|NCT02042534|stroke|stroke
362091|NCT02042534|TIA|tia
362092|NCT02042521|Cigarette|cigarette
362093|NCT02042521|Withdrawal|withdrawal
362094|NCT02042521|Nicotine|nicotine
362095|NCT02042482|Ultra coenzyme Q10|ultra coenzyme q10
362096|NCT02042482|L-carnitine|l-carnitine
362097|NCT02042469|awareness, clinical research, Saudi arabia|awareness, clinical research, saudi arabia
362098|NCT02042456|breast cancer|breast cancer
362099|NCT02042456|dense breasts|dense breasts
362100|NCT02042456|mammography screening|mammography screening
362101|NCT02042456|Screening techniques|screening techniques
362102|NCT02042456|women|women
362103|NCT02042404|Hearing impairment|hearing impairment
362104|NCT02042404|Hearing loss|hearing loss
362105|NCT02042391|PTLD|ptld
362106|NCT02042391|CD20-positive|cd20-positive
362107|NCT02042391|solid organ transplantation|solid organ transplantation
362108|NCT02042378|BRCA|brca
362109|NCT02042378|BRCA mutation|brca mutation
362110|NCT02042378|germline BRCA|germline brca
362111|NCT02042378|somatic BRCA|somatic brca
362112|NCT02042378|PARP inhibitor|parp inhibitor
362113|NCT02042378|rucaparib|rucaparib
362114|NCT02042378|CO-338|co-338
362115|NCT02042378|PF 01367338|pf 01367338
362116|NCT02042378|AG 14699|ag 14699
362117|NCT02042378|Clovis|clovis
362118|NCT02042378|Clovis Oncology|clovis oncology
362119|NCT02042378|RucaPanc|rucapanc
362120|NCT02042365|Enhanced recovery,|enhanced recovery,
362121|NCT02042365|sleeve gastrectomy,|sleeve gastrectomy,
362122|NCT02042339|Hyperbaric Oxygen|hyperbaric oxygen
362123|NCT02042339|Diabetic ulcer|diabetic ulcer
362124|NCT02042339|Wound healing|wound healing
362125|NCT02042339|3-D life-viz- system|3-d life-viz- system
362126|NCT02042339|Indocyanine green video angiography|indocyanine green video angiography
362127|NCT02042339|Transcutaneous oxygen pressure|transcutaneous oxygen pressure
362128|NCT02042339|Endothelial progenitor cells|endothelial progenitor cells
362129|NCT02042326|Arteriovenous Malformations|arteriovenous malformations
362130|NCT02042326|Sirolimus|sirolimus
362131|NCT02042326|Maxillofacial Surgery|maxillofacial surgery
362132|NCT02042300|XIENCE Xpedition|xience xpedition
362133|NCT02042300|Routine Clinical Practice|routine clinical practice
362134|NCT02042300|Alpine|alpine
362135|NCT02042300|Sierra|sierra
362136|NCT02042287|Bacterial Infections and Mycoses|bacterial infections and mycoses
362137|NCT02042287|Pharmaceutical Preparations|pharmaceutical preparations
362138|NCT02042287|Health Occupations|health occupations
362139|NCT02042274|Fish oil|fish oil
362140|NCT02042274|EPA|epa
362141|NCT02042274|DHA|dha
362142|NCT02042274|fatty acids|fatty acids
362143|NCT02042274|genetic variation|genetic variation
362144|NCT02042274|gene expression|gene expression
362145|NCT02042248|HIV|hiv
362146|NCT02042248|Acute HIV Infection|acute hiv infection
362147|NCT02042248|Chronic HIV Infection|chronic hiv infection
362148|NCT02042248|AGS-004|ags-004
362149|NCT02042248|Phase 1|phase 1
362150|NCT02042248|Antiretroviral Therapy|antiretroviral therapy
362151|NCT02042248|ART|art
362152|NCT02042248|UNC|unc
362153|NCT02042248|Argos Therapeutics|argos therapeutics
362154|NCT02042248|The CARE Collaboratory of AIDS|the care collaboratory of aids
362155|NCT02042248|Immunization|immunization
362156|NCT02042248|vaccination|vaccination
362157|NCT02042235|prematurity|prematurity
362158|NCT02042235|language|language
362159|NCT02042235|parent-implemented intervention|parent-implemented intervention
362160|NCT02042235|speech therapy|speech therapy
362161|NCT02042235|neurodevelopment|neurodevelopment
362162|NCT02042222|Sickle cell|sickle cell
362163|NCT02042222|Hydroxyurea|hydroxyurea
362164|NCT02042222|Dose prediction|dose prediction
362165|NCT02042222|Maximum tolerated dose|maximum tolerated dose
362166|NCT02042209|acute coronary syndrome|acute coronary syndrome
362167|NCT02042209|thoracic pain|thoracic pain
362168|NCT02042209|prehospital|prehospital
362169|NCT02042209|diagnostic score|diagnostic score
362170|NCT02042196|endothelial function|endothelial function
362171|NCT02042196|women|women
362172|NCT02042196|estrogen deficiency|estrogen deficiency
362173|NCT02042196|sex hormones|sex hormones
362174|NCT02042196|adiposity|adiposity
362175|NCT02042196|oxidative stress|oxidative stress
362176|NCT02042196|antioxidants|antioxidants
362177|NCT02042157|Quality of Life|quality of life
362178|NCT02042157|Caregivers|caregivers
362179|NCT02042157|Caregiver burden|caregiver burden
362180|NCT02042157|Urinary Tract Infections|urinary tract infections
362181|NCT02042157|Bidet|bidet
362182|NCT02042157|Women's health|women's health
362183|NCT02042157|Toileting|toileting
362184|NCT02042157|Hygiene|hygiene
362185|NCT02042157|Activities of Daily Living|activities of daily living
362186|NCT02042157|Functional impairment|functional impairment
362187|NCT02042157|Geriatrics|geriatrics
362188|NCT02042144|Neoplasms, Colorectal|neoplasms, colorectal
362189|NCT02042131|suicide|suicide
362190|NCT02042131|suicidal ideation|suicidal ideation
362191|NCT02042131|ambivalence|ambivalence
362192|NCT02042131|suicide ambivalence|suicide ambivalence
362193|NCT02042131|reasons for living|reasons for living
362194|NCT02042131|reasons for dying|reasons for dying
362195|NCT02042131|military|military
362196|NCT02042131|veteran|veteran
362197|NCT02042131|clinical trial|clinical trial
362198|NCT02042131|cognitive behavioral therapy|cognitive behavioral therapy
362199|NCT02042131|psychotherapy|psychotherapy
362200|NCT02042131|crisis|crisis
362201|NCT02042131|Treatment As Usual (TAU)|treatment as usual (tau)
362202|NCT02042131|Crisis Response Plan (CRP)|crisis response plan (crp)
362203|NCT02042131|Enhanced Crisis Response Plan (E-CRP)|enhanced crisis response plan (e-crp)
362204|NCT02042118|Neonatal resuscitation|neonatal resuscitation
362205|NCT02042118|Laryngeal Mask Airway (LMA)|laryngeal mask airway (lma)
362206|NCT02042118|Face mask ventilation (FMV)|face mask ventilation (fmv)
362207|NCT02042118|Uganda|uganda
362208|NCT02042118|Africa|africa
362209|NCT02042105|non-small-cell lung cancer|non-small-cell lung cancer
362210|NCT02042105|anaplastic lymphoma kinase|anaplastic lymphoma kinase
362211|NCT02042105|immunohistochemistry|immunohistochemistry
362212|NCT02042092|Ultrasound|ultrasound
362213|NCT02042092|MRA|mra
362214|NCT02042092|Large Vessel Vasculitis|large vessel vasculitis
362215|NCT02042092|Giant Cell Arteritis|giant cell arteritis
362216|NCT02042092|Takayasu Arteritis|takayasu arteritis
362217|NCT02042092|Immunological abnormalities|immunological abnormalities
362218|NCT02042079|Endoscopic full-thickness resection|endoscopic full-thickness resection
362219|NCT02042079|gastric subepithelial tumor|gastric subepithelial tumor
362220|NCT02042079|hybrid-NOTES|hybrid-notes
362221|NCT02042066|Resistant Hypertension|resistant hypertension
362222|NCT02042066|RH|rh
362223|NCT02042066|RHT|rht
362224|NCT02042066|Blood Pressure|blood pressure
362225|NCT02042066|Kidney|kidney
362226|NCT02042066|Shockwave|shockwave
362227|NCT02042053|imaging|imaging
362228|NCT02042053|diagnostic|diagnostic
362229|NCT02042053|castration resistant|castration resistant
362230|NCT02042053|metastatic prostate cancer|metastatic prostate cancer
362231|NCT02042053|immunotherapy|immunotherapy
362232|NCT02042027|corneal neovascularization|corneal neovascularization
362233|NCT02042027|Gamunex-C|gamunex-c
362234|NCT02042027|IVI-g|ivi-g
362235|NCT02042027|anterior segment inflammation|anterior segment inflammation
362236|NCT02042014|Pulmonary arterial hypertension, QTI571, open label study|pulmonary arterial hypertension, qti571, open label study
362237|NCT02041988|premedication|premedication
362238|NCT02041988|oral morphine|oral morphine
362239|NCT02041988|preemptive analgesia|preemptive analgesia
362240|NCT02041975|Prebiotics|prebiotics
362241|NCT02041975|Gut health|gut health
362242|NCT02041975|Satisfaction|satisfaction
362243|NCT02041962|Care Management|care management
362244|NCT02041962|Chronic Care Model|chronic care model
362245|NCT02041962|Mood Disorders|mood disorders
362246|NCT02041936|irreversible electroporation|irreversible electroporation
362247|NCT02041936|Nanoknife|nanoknife
362248|NCT02041936|pancreatic cancer|pancreatic cancer
362249|NCT02041923|preterm infant|preterm infant
362250|NCT02041923|stable infant|stable infant
362251|NCT02041923|mother-infant interaction|mother-infant interaction
362252|NCT02041923|health care cost|health care cost
362253|NCT02041923|H-HOPE intervention|h-hope intervention
362254|NCT02041923|mother outcomes|mother outcomes
362255|NCT02041923|infant behavioral organization|infant behavioral organization
362256|NCT02041923|infant growth|infant growth
362257|NCT02041897|EUS-FNA|eus-fna
362258|NCT02041897|Pancreatic cystic lesion|pancreatic cystic lesion
362259|NCT02041897|Diagnosis|diagnosis
362260|NCT02041884|Cognitive Behavioral Therapy|cognitive behavioral therapy
362261|NCT02041884|Dialectical Behavioral Therapy|dialectical behavioral therapy
362262|NCT02041884|Applied Relaxation|applied relaxation
362263|NCT02041884|Stress-reduction|stress-reduction
362264|NCT02041884|Smartphone application|smartphone application
362265|NCT02041884|ADHD|adhd
362266|NCT02041884|Randomized controlled trial|randomized controlled trial
362267|NCT02041884|Psychological treatment|psychological treatment
362268|NCT02041884|Efficacy|efficacy
362269|NCT02041871|Liver Surgery|liver surgery
362270|NCT02041871|Hepatectomy|hepatectomy
362271|NCT02041871|Immunonutrition|immunonutrition
362272|NCT02041871|Cancer|cancer
362273|NCT02041871|Morbidity|morbidity
362274|NCT02041871|Postoperative complication|postoperative complication
362275|NCT02041858|Alarms|alarms
362276|NCT02041858|Physiologic Monitoring|physiologic monitoring
362277|NCT02041858|Critical Care|critical care
362278|NCT02041858|Alarm fatigue|alarm fatigue
362279|NCT02041858|Adverse Events|adverse events
362280|NCT02041845|Radiotherapy|radiotherapy
362281|NCT02041845|Radiotherapy dosage|radiotherapy dosage
362282|NCT02041845|Dose fractionation|dose fractionation
362283|NCT02041845|Radiotherapy, image-guided|radiotherapy, image-guided
362284|NCT02041845|Thorax|thorax
362285|NCT02041819|Neoadjuvant chemotherapy|neoadjuvant chemotherapy
362286|NCT02041819|Nimotuzumab|nimotuzumab
362287|NCT02041819|Nab-Paclitaxel|nab-paclitaxel
362288|NCT02041819|Carcinoma of Esophagus|carcinoma of esophagus
362289|NCT02041793|Acute pancreatitis|acute pancreatitis
362290|NCT02041793|Pseudocyst|pseudocyst
362291|NCT02041780|Diagnostic|diagnostic
362292|NCT02041780|Liver fibrosis|liver fibrosis
362293|NCT02041780|Ishak score|ishak score
362294|NCT02041780|Fibrotest|fibrotest
362295|NCT02041780|ShearWave elastography|shearwave elastography
362296|NCT02041780|Liver biopsies|liver biopsies
362297|NCT02041767|Ertapenem; prostatic diffusion; antibioprophylaxy; pharmacokinetics; benign prostatic hyperplasia|ertapenem; prostatic diffusion; antibioprophylaxy; pharmacokinetics; benign prostatic hyperplasia
362298|NCT02041741|happiness|happiness
362299|NCT02041741|well-being|well-being
362300|NCT02041741|distress|distress
362301|NCT02041741|positive psychology|positive psychology
362302|NCT02041715|Virus Diseases|virus diseases
362303|NCT02041715|Hemorrhagic Fever, Ebola|hemorrhagic fever, ebola
362304|NCT02041715|Hemorrhagic Fevers, Viral|hemorrhagic fevers, viral
362305|NCT02041715|RNA Virus Infections|rna virus infections
362306|NCT02041715|Filoviridae Infections|filoviridae infections
362307|NCT02041715|Mononegavirales Infections|mononegavirales infections
362308|NCT02041702|Bradycardia|bradycardia
362309|NCT02041702|MRI Conditional Pacemaker|mri conditional pacemaker
362310|NCT02041702|St Jude Medical|st jude medical
362311|NCT02041702|Accent MRI Pacemaker|accent mri pacemaker
362312|NCT02041702|Tendril MRI Lead|tendril mri lead
362313|NCT02041689|Children|children
362314|NCT02041689|Cancer|cancer
362315|NCT02041689|Learning|learning
362316|NCT02041689|Education|education
362317|NCT02041689|Qualitative|qualitative
362318|NCT02041676|Chest|chest
362319|NCT02041676|Physiotherapy|physiotherapy
362320|NCT02041676|Increased Inspiratory Flow Technique|increased inspiratory flow technique
362321|NCT02041676|Prematurity|prematurity
362322|NCT02041676|Non Invasive Ventilation|non invasive ventilation
362323|NCT02041663|brain natriuretic peptide|brain natriuretic peptide
362324|NCT02041663|cardiac function|cardiac function
362325|NCT02041663|meningococcal infections|meningococcal infections
362326|NCT02041663|septic shock|septic shock
362327|NCT02041663|severe sepsis|severe sepsis
362328|NCT02041637|liver failure|liver failure
362329|NCT02041637|etiology|etiology
362330|NCT02041637|liver transplantation|liver transplantation
362331|NCT02041624|allergic|allergic
362332|NCT02041624|rhinitis|rhinitis
362333|NCT02041624|conjunctivitis|conjunctivitis
362334|NCT02041624|grass pollen|grass pollen
362335|NCT02041624|Allergen ImmunoTherapy (AIT)|allergen immunotherapy (ait)
362336|NCT02041624|grass mix|grass mix
362337|NCT02041611|WHO grade III and IV|who grade iii and iv
362338|NCT02041585|Hospital Readmission|hospital readmission
362339|NCT02041585|Social Isolation and Hospital Readmission|social isolation and hospital readmission
362340|NCT02041585|Age and Hospital Readmission|age and hospital readmission
362341|NCT02041585|Functional Status and Hospital Readmission|functional status and hospital readmission
362342|NCT02041585|Charlson Score and Hospital Readmission|charlson score and hospital readmission
362343|NCT02041585|Length of Stay and Hospital Readmission|length of stay and hospital readmission
362344|NCT02041546|Lung lavage,|lung lavage,
362345|NCT02041546|Surfactant,|surfactant,
362346|NCT02041546|Duration of mechanical|duration of mechanical
362347|NCT02041546|ventilation|ventilation
362348|NCT02041520|Seropositive HIV|seropositive hiv
362349|NCT02041520|Omega 3 fatty acids|omega 3 fatty acids
362350|NCT02041520|Oxidative stress|oxidative stress
362351|NCT02041507|Water-aided colonoscopy|water-aided colonoscopy
362352|NCT02041507|Water Immersion|water immersion
362353|NCT02041507|Water Exchange|water exchange
362354|NCT02041507|On-demand sedation|on-demand sedation
362355|NCT02041507|Unsedated colonoscopy|unsedated colonoscopy
362356|NCT02041507|Adenoma detection rate|adenoma detection rate
362357|NCT02041507|Mean adenomas per procedure|mean adenomas per procedure
362358|NCT02041494|Hernia|hernia
362359|NCT02041494|Ventral|ventral
362360|NCT02041494|Incisional|incisional
362361|NCT02041494|Abdominal|abdominal
362362|NCT02041494|Herniorrhaphy|herniorrhaphy
362363|NCT02041494|Recurrence|recurrence
362364|NCT02041494|Infection|infection
362365|NCT02041494|Mesh|mesh
362366|NCT02041494|Biologic|biologic
362367|NCT02041494|Synthetic|synthetic
362368|NCT02041468|ALK-positive|alk-positive
362369|NCT02041455|Fibromyalgia|fibromyalgia
362370|NCT02041455|Melatonin|melatonin
362371|NCT02041455|Amitriptylin|amitriptylin
362372|NCT02041455|Imune-pineal axis|imune-pineal axis
362373|NCT02041442|overactive bladder|overactive bladder
362374|NCT02041442|cystoscopy|cystoscopy
362375|NCT02041429|Recurrent Breast Cancer|recurrent breast cancer
362376|NCT02041429|Advanced Breast Cancer|advanced breast cancer
362377|NCT02041429|Metastatic Breast Cancer|metastatic breast cancer
362378|NCT02041416|Geriatric assessment|geriatric assessment
362379|NCT02041416|REDCap|redcap
362380|NCT02041416|touchscreen|touchscreen
362381|NCT02041416|age 65|age 65
362382|NCT02041364|Fatigue|fatigue
362383|NCT02041364|Biomarkers|biomarkers
362384|NCT02041364|Breast Cancer|breast cancer
362385|NCT02041351|metastatic breast cancer|metastatic breast cancer
362386|NCT02041351|taxanes|taxanes
362387|NCT02041351|heavily pretreated|heavily pretreated
362388|NCT02041312|Cholesterol|cholesterol
362389|NCT02041312|Gastric cancer|gastric cancer
362390|NCT02041312|Stage|stage
362391|NCT02041299|sickle cell disease|sickle cell disease
362392|NCT02041299|Iron overload|iron overload
362393|NCT02041299|Deferiprone|deferiprone
362394|NCT02041299|Ferriprox|ferriprox
362395|NCT02041299|deferoxamine|deferoxamine
362396|NCT02041299|Chelation|chelation
362397|NCT02041273|bioavailability|bioavailability
362398|NCT02041273|bioequivalence|bioequivalence
362399|NCT02041273|AUC|auc
362400|NCT02041273|Cmax|cmax
362401|NCT02041260|Adult|adult
362402|NCT02041260|differentiated thyroid cancer (DTC),|differentiated thyroid cancer (dtc),
362403|NCT02041260|poorly differentiated thyroid cancer|poorly differentiated thyroid cancer
362404|NCT02041260|not anaplastic thyroid cancer|not anaplastic thyroid cancer
362405|NCT02041234|Diabetes|diabetes
362406|NCT02041234|surgical treatment|surgical treatment
362407|NCT02041234|medical treatment|medical treatment
362408|NCT02041221|pharmacokinetics, pharmacodynamics, asthma|pharmacokinetics, pharmacodynamics, asthma
362409|NCT02041208|Chronic renal anemia|chronic renal anemia
362410|NCT02041208|Hemoglobin|hemoglobin
362411|NCT02041208|Kidney transplant|kidney transplant
362412|NCT02041195|Overweight|overweight
362413|NCT02041182|youth violence|youth violence
362414|NCT02041182|doctor-patient communication|doctor-patient communication
362415|NCT02041182|health risk behaviors|health risk behaviors
362416|NCT02041182|pre-visit questionnaires|pre-visit questionnaires
362417|NCT02041130|Heart Failure|heart failure
362418|NCT02041130|Heart Failure with Preserved Ejection Fraction|heart failure with preserved ejection fraction
362419|NCT02041104|Metabolic syndrome|metabolic syndrome
362420|NCT02041104|4 -week intervention|4 -week intervention
362421|NCT02041104|Randomised placebo controlled parallel study|randomised placebo controlled parallel study
362422|NCT02041104|Beta-glucans|beta-glucans
362423|NCT02041104|Abdominal fat|abdominal fat
362424|NCT02041104|Dyslipidemia|dyslipidemia
362425|NCT02041104|Insulin resistance|insulin resistance
362426|NCT02041104|Hypertension|hypertension
362427|NCT02041104|Gut Microbiota Composition|gut microbiota composition
362428|NCT02041104|Oral Glucose Tolerance Test|oral glucose tolerance test
362429|NCT02041104|Lipid Profile|lipid profile
362430|NCT02041104|Real-Time Polymerase Chain Reaction|real-time polymerase chain reaction
362431|NCT02041104|Denaturating Gradient Gel Electrophoresis|denaturating gradient gel electrophoresis
362432|NCT02041078|Liver surgery|liver surgery
362433|NCT02041078|Blood loss|blood loss
362434|NCT02041078|CUSA|cusa
362435|NCT02041078|Hepatic transection|hepatic transection
362436|NCT02041065|Liver transection|liver transection
362437|NCT02041065|Bloodloss|bloodloss
362438|NCT02041065|Operation time|operation time
362439|NCT02041065|Safety|safety
362440|NCT02041065|feasibility|feasibility
362441|NCT02041026|probiotic|probiotic
362442|NCT02041026|Yoghurt|yoghurt
362443|NCT02041026|NN20|nn20
362444|NCT02041013|Asthma|asthma
362445|NCT02041013|Health Literacy|health literacy
362446|NCT02041000|COPD|copd
362447|NCT02041000|pulmonary|pulmonary
362448|NCT02041000|stem cells|stem cells
362449|NCT02041000|emphysema|emphysema
362450|NCT02041000|lungs|lungs
362451|NCT02040987|Thorough QT study|thorough qt study
362452|NCT02040974|immunotherapy, house dust mites, pollens, allergic rhinitis|immunotherapy, house dust mites, pollens, allergic rhinitis
362453|NCT02040961|Patients|patients
362454|NCT02040961|Undergoing|undergoing
362455|NCT02040961|Elective|elective
362456|NCT02040961|Thoracic|thoracic
362457|NCT02040961|Surgery|surgery
362458|NCT02040922|Antibiotics|antibiotics
362459|NCT02040922|Campylobacter|campylobacter
362460|NCT02040922|Diarrhoea|diarrhoea
362461|NCT02040922|Enteritis|enteritis
362462|NCT02040922|Microbiota|microbiota
362463|NCT02040922|Calprotectin|calprotectin
362464|NCT02040909|sedation|sedation
362465|NCT02040909|quality of intubation|quality of intubation
362466|NCT02040909|hypotension|hypotension
362467|NCT02040909|pharmacodynamics|pharmacodynamics
362468|NCT02040909|pharmacokinetics|pharmacokinetics
362469|NCT02040896|computed tomography|computed tomography
362470|NCT02040896|emergency|emergency
362471|NCT02040896|CT scan|ct scan
362472|NCT02040896|ordering behavior|ordering behavior
362473|NCT02040896|diagnosis|diagnosis
362474|NCT02040896|radiation|radiation
362475|NCT02040883|Schizophrenia|schizophrenia
362476|NCT02040883|Tandospirone|tandospirone
362477|NCT02040883|Cognitive Therapy|cognitive therapy
362478|NCT02040870|Non-Small Cell lung Cancer|non-small cell lung cancer
362479|NCT02040870|NSCLC|nsclc
362480|NCT02040870|ALK|alk
362481|NCT02040870|LDK378|ldk378
362482|NCT02040870|ALK-rearranged|alk-rearranged
362483|NCT02040870|ALK-positive|alk-positive
362484|NCT02040870|advanced non-small cell lung cancer|advanced non-small cell lung cancer
362485|NCT02040857|Breast Cancer|breast cancer
362486|NCT02040805|compulsive hoarding|compulsive hoarding
362487|NCT02040805|clutter|clutter
362488|NCT02040805|hoarding disorder|hoarding disorder
362489|NCT02040792|COPD|copd
362490|NCT02040792|Chronic Obstructive Pulmonary Disease|chronic obstructive pulmonary disease
362491|NCT02040779|asthma|asthma
362492|NCT02040779|breath-actuated inhaler|breath-actuated inhaler
362493|NCT02040779|beclomethasone|beclomethasone
362494|NCT02040766|asthma|asthma
362495|NCT02040766|breath-actuated inhaler|breath-actuated inhaler
362496|NCT02040766|metered dose inhaler|metered dose inhaler
362497|NCT02040753|Lifestyle intervention|lifestyle intervention
362498|NCT02040753|Change of body composition|change of body composition
362499|NCT02040753|Physical activity|physical activity
362500|NCT02040753|Weight loss maintenance|weight loss maintenance
362501|NCT02040727|Myokines|myokines
362502|NCT02040727|Osteokines|osteokines
362503|NCT02040727|Glucose homeostasis|glucose homeostasis
362504|NCT02040727|Puberty|puberty
362505|NCT02040714|femur head necrosis|femur head necrosis
362506|NCT02040714|hip|hip
362507|NCT02040714|pediatric orthopedics|pediatric orthopedics
362508|NCT02040714|MRI|mri
362509|NCT02040714|Osteonecrosis|osteonecrosis
362510|NCT02040714|Bone diseases|bone diseases
362511|NCT02040714|Legg Calve Perthes Syndrome|legg calve perthes syndrome
362512|NCT02040662|paravertebral block|paravertebral block
362513|NCT02040662|thoracic epidural analgesia|thoracic epidural analgesia
362514|NCT02040662|videothoracoscopic surgery|videothoracoscopic surgery
362515|NCT02040662|lung lobectomy|lung lobectomy
362516|NCT02040649|Critical care|critical care
362517|NCT02040649|Respiration, artificial|respiration, artificial
362518|NCT02040636|Pertussis|pertussis
362519|NCT02040636|Tetanus|tetanus
362520|NCT02040636|Diphtheria|diphtheria
362521|NCT02040636|Poliomyelitis|poliomyelitis
362522|NCT02040636|Hepatitis B|hepatitis b
362523|NCT02040636|Acellular Pertussis Vaccines|acellular pertussis vaccines
362524|NCT02040623|Chronic Graft versus Host Disease|chronic graft versus host disease
362525|NCT02040623|Keratoconjunctivitis Sicca|keratoconjunctivitis sicca
362526|NCT02040610|Low Risk Prostate Cancer|low risk prostate cancer
362527|NCT02040610|Intermediate Risk Prostate Cancer|intermediate risk prostate cancer
362528|NCT02040610|Hypofractionated|hypofractionated
362529|NCT02040610|Image Guided Proton Therapy|image guided proton therapy
362530|NCT02040584|De Novo Liver Transplant, Tacrolimus Minimisation, Everolimus, Renal Function, Liver transplant, allograft rejection, xenograft rejection, host vs graft disease|de novo liver transplant, tacrolimus minimisation, everolimus, renal function, liver transplant, allograft rejection, xenograft rejection, host vs graft disease
362531|NCT02040545|Infertility|infertility
362532|NCT02040545|In Vitro Fertilization (IVF)|in vitro fertilization (ivf)
362533|NCT02040545|Venopuncture-free treatment|venopuncture-free treatment
362534|NCT02040545|Needle-free treatment|needle-free treatment
362535|NCT02040519|Overactive bladder|overactive bladder
362536|NCT02040519|Non obstructive urinary retention|non obstructive urinary retention
362537|NCT02040519|Sacral neuromodulation|sacral neuromodulation
362538|NCT02040506|Acute Myelogenous Leukemia|acute myelogenous leukemia
362539|NCT02040506|Acute Myeloid Leukemia|acute myeloid leukemia
362540|NCT02040506|Drug therapy|drug therapy
362541|NCT02040506|CD98|cd98
362542|NCT02040506|Relapsed|relapsed
362543|NCT02040506|Refractory|refractory
362544|NCT02040506|Monoclonal antibody|monoclonal antibody
362545|NCT02040493|breast cancer|breast cancer
362546|NCT02040493|IORT|iort
362547|NCT02040493|brachytherapy|brachytherapy
362548|NCT02040480|bioavailability|bioavailability
362549|NCT02040480|food effect|food effect
362550|NCT02040480|formulation|formulation
362551|NCT02040480|GSK2110183|gsk2110183
362552|NCT02040480|afuresertib|afuresertib
362553|NCT02040480|AKT inhibitor|akt inhibitor
362554|NCT02040441|Proteomics|proteomics
362555|NCT02040441|Diabetes|diabetes
362556|NCT02040441|Chronic kidney disease|chronic kidney disease
362557|NCT02040441|Diabetic nephropathy|diabetic nephropathy
362558|NCT02040441|Diabetic retinopathy|diabetic retinopathy
362559|NCT02040441|Mineralocorticoid receptor antagonists|mineralocorticoid receptor antagonists
362560|NCT02040441|Spironolactone|spironolactone
362561|NCT02040441|Microalbuminuria|microalbuminuria
362562|NCT02040428|Cardiovascular Diseases|cardiovascular diseases
362563|NCT02040428|Fibrin Sealant|fibrin sealant
362564|NCT02040428|Hemostatics|hemostatics
362565|NCT02040428|Coagulants|coagulants
362566|NCT02040402|Comparison of pneumococcal conjugated vaccine regimes|comparison of pneumococcal conjugated vaccine regimes
362567|NCT02040389|children|children
362568|NCT02040389|penile|penile
362569|NCT02040389|inguinal|inguinal
362570|NCT02040389|kidney parents|kidney parents
362571|NCT02040389|anxiety|anxiety
362572|NCT02040376|Paediatrics|paediatrics
362573|NCT02040376|Medulloblastoma|medulloblastoma
362574|NCT02040376|Metformin|metformin
362575|NCT02040363|COPD|copd
362576|NCT02040363|skeletal muscle|skeletal muscle
362577|NCT02040363|angiogenesis|angiogenesis
362578|NCT02040363|exercise training|exercise training
362579|NCT02040363|intensity|intensity
362580|NCT02040350|Pralidoxime, atropine, organophosphorous poisoning.|pralidoxime, atropine, organophosphorous poisoning.
362581|NCT02040285|CT colonography|ct colonography
362582|NCT02040259|ischemic stroke|ischemic stroke
362583|NCT02040259|mechanical thrombectomy device|mechanical thrombectomy device
362584|NCT02040259|Retriever|retriever
362585|NCT02040220|CRVO, Macular edema, Aflibercept, anti-VEGF|crvo, macular edema, aflibercept, anti-vegf
362586|NCT02040181|renal function, creatinine clearance|renal function, creatinine clearance
362587|NCT02040168|Ventilation|ventilation
362588|NCT02040168|PTSD|ptsd
362589|NCT02040168|sedation|sedation
362590|NCT02040142|Hyperthermic Intraperitoneal Mitomycin c|hyperthermic intraperitoneal mitomycin c
362591|NCT02040142|HIPEC|hipec
362592|NCT02040142|Cytoreduction|cytoreduction
362593|NCT02040116|Rapid Infusion Rituximab|rapid infusion rituximab
362594|NCT02040103|Deep Vein Thrombosis|deep vein thrombosis
362595|NCT02040103|Pulmonary Embolism|pulmonary embolism
362596|NCT02040103|Intermittent Pneumatic Compression|intermittent pneumatic compression
362597|NCT02040103|Pharmacologic DVT|pharmacologic dvt
362598|NCT02040103|Prophylaxis|prophylaxis
362599|NCT02040103|Critically Ill Patients.|critically ill patients.
362600|NCT02040077|opioid|opioid
362601|NCT02040077|overdose|overdose
362602|NCT02040077|OD|od
362603|NCT02040077|opiate|opiate
362604|NCT02040077|prescription opioids|prescription opioids
362605|NCT02040077|prescription pain medication|prescription pain medication
362606|NCT02040077|heroin|heroin
362607|NCT02040077|detoxification|detoxification
362608|NCT02040077|prevention|prevention
362609|NCT02040051|intensive care units|intensive care units
362610|NCT02040051|mechanical ventilation|mechanical ventilation
362611|NCT02040051|music therapy|music therapy
362612|NCT02040038|Diabetes|diabetes
362613|NCT02040038|Virtual Environment|virtual environment
362614|NCT02040038|Self-Management|self-management
362615|NCT02040025|hypertension|hypertension
362616|NCT02040025|diabetes mellitus|diabetes mellitus
362617|NCT02040025|hemoglobin A1C|hemoglobin a1c
362618|NCT02040025|peripheral vascular resistance|peripheral vascular resistance
362619|NCT02040025|EECP|eecp
362620|NCT02040025|Blood pressure|blood pressure
362621|NCT02040025|angiogenesis|angiogenesis
362622|NCT02040025|Coronary Artery Disease|coronary artery disease
362623|NCT02040025|Coronary Disease|coronary disease
362624|NCT02040025|Heart Diseases|heart diseases
362625|NCT02040025|Cardiovascular Diseases|cardiovascular diseases
362626|NCT02040012|Type 2 Diabetes Mellitus|type 2 diabetes mellitus
362627|NCT02039999|chronic|chronic
362628|NCT02039999|cough|cough
362629|NCT02039999|challenge|challenge
362630|NCT02039999|ATP|atp
362631|NCT02039999|hypersensitivity|hypersensitivity
362632|NCT02039999|TRPA1|trpa1
362633|NCT02039986|cystic fibrosis|cystic fibrosis
362634|NCT02039986|CF|cf
362635|NCT02039986|cystic fibrosis related diabetes|cystic fibrosis related diabetes
362636|NCT02039986|CFRD|cfrd
362637|NCT02039986|kalydeco|kalydeco
362638|NCT02039986|ivacaftor|ivacaftor
362639|NCT02039973|HIV|hiv
362640|NCT02039973|AIDS|aids
362641|NCT02039973|Tanzania|tanzania
362642|NCT02039973|depression|depression
362643|NCT02039973|perinatal|perinatal
362644|NCT02039973|psychotherapy|psychotherapy
362645|NCT02039973|task-sharing|task-sharing
362646|NCT02039973|problem-solving|problem-solving
362647|NCT02039960|Epidemiology|epidemiology
362648|NCT02039960|Drug Abuse Warning Network (DAWN)|drug abuse warning network (dawn)
362649|NCT02039960|bupropion|bupropion
362650|NCT02039960|abuse|abuse
362651|NCT02039947|BRAF V600K mutation|braf v600k mutation
362652|NCT02039947|Metastatic Melanoma|metastatic melanoma
362653|NCT02039947|BRAF V600R mutation|braf v600r mutation
362654|NCT02039947|BRAF V600D mutation|braf v600d mutation
362655|NCT02039947|BRAF V600E mutation|braf v600e mutation
362656|NCT02039947|Brain metastases BRAF inhibitor|brain metastases braf inhibitor
362657|NCT02039947|Intracranial|intracranial
362658|NCT02039934|type 2 diabetes|type 2 diabetes
362659|NCT02039934|exercise intervention|exercise intervention
362660|NCT02039934|high intensity interval training|high intensity interval training
362661|NCT02039908|Tolerance to stimulant medication|tolerance to stimulant medication
362662|NCT02039895|Cutaneous T-cell lymphoma|cutaneous t-cell lymphoma
362663|NCT02039895|Helical irradiation of the total skin|helical irradiation of the total skin
362664|NCT02039895|Refractory|refractory
362665|NCT02039895|Total skin electron beam therapy|total skin electron beam therapy
362666|NCT02039882|Acute Coronary Syndrome (ACS)|acute coronary syndrome (acs)
362667|NCT02039882|Percutaneous Coronary Intervention PCI|percutaneous coronary intervention pci
362668|NCT02039882|Normals|normals
362669|NCT02039882|Myocardial Infarction MI|myocardial infarction mi
362670|NCT02039882|Point of Care POC|point of care poc
362671|NCT02039882|Hypoxanthine|hypoxanthine
362672|NCT02039882|Inosine|inosine
362673|NCT02039882|HPLC High Pressure Liquid Chromatography|hplc high pressure liquid chromatography
362674|NCT02039869|NERD|nerd
362675|NCT02039869|Non erosive reflux disease|non erosive reflux disease
362676|NCT02039869|functional dyspepsia|functional dyspepsia
362677|NCT02039869|erosive esophagitis|erosive esophagitis
362678|NCT02039869|confocal endomicroscopy|confocal endomicroscopy
362679|NCT02039869|cell visio|cell visio
362680|NCT02039869|proton pump inhibitor|proton pump inhibitor
362681|NCT02039869|sucralfate|sucralfate
362682|NCT02039856|Patient-centered medical homes|patient-centered medical homes
362683|NCT02039856|Primary care|primary care
362684|NCT02039856|Women's health|women's health
362685|NCT02039856|Veterans|veterans
362686|NCT02039830|female|female
362687|NCT02039830|aging|aging
362688|NCT02039830|physiotherapy|physiotherapy
362689|NCT02039830|pelvic floor|pelvic floor
362690|NCT02039830|rehabilitation|rehabilitation
362691|NCT02039817|pharmacokinetics|pharmacokinetics
362692|NCT02039817|pharmacodynamics|pharmacodynamics
362693|NCT02039817|renal impairment|renal impairment
362694|NCT02039778|Glioblastoma|glioblastoma
362695|NCT02039778|High-grade Glioma|high-grade glioma
362696|NCT02039778|Brain Tums|brain tums
362697|NCT02039778|Temozolomide|temozolomide
362698|NCT02039778|Stem cell radiation therapy|stem cell radiation therapy
362699|NCT02039778|IMRT|imrt
362700|NCT02039778|Proton beam radiotherapy|proton beam radiotherapy
362701|NCT02039778|Conventional external beam radiotherapy|conventional external beam radiotherapy
362702|NCT02039778|Quality of Life|quality of life
362703|NCT02039778|Neurocognition|neurocognition
362704|NCT02039765|Ocular Redness|ocular redness
362705|NCT02039752|Multivessel|multivessel
362706|NCT02039739|Orsiro|orsiro
362707|NCT02039739|Drug Eluting Stent|drug eluting stent
362708|NCT02039739|Routine Clinical Practice|routine clinical practice
362709|NCT02039739|Angioplasty, Transluminal, Percutaneous Coronary|angioplasty, transluminal, percutaneous coronary
362710|NCT02039739|Coronary Artery Disease|coronary artery disease
362711|NCT02039726|Acute Myeloid Leukemia|acute myeloid leukemia
362712|NCT02039726|AML|aml
362713|NCT02039726|FMS-like tyrosine kinase 3|fms-like tyrosine kinase 3
362714|NCT02039726|FLT3-ITD|flt3-itd
362715|NCT02039726|Quizartinib|quizartinib
362716|NCT02039726|Leukemia|leukemia
362717|NCT02039726|Tablets|tablets
362718|NCT02039713|DeSyne|desyne
362719|NCT02039713|Angioplasty, Transluminal, Percutaneous Coronary|angioplasty, transluminal, percutaneous coronary
362720|NCT02039713|Coronary Artery Disease|coronary artery disease
362721|NCT02039687|neuropathy|neuropathy
463784|NCT01582581|CBT|cbt
362722|NCT02039687|sarcoidosis|sarcoidosis
362723|NCT02039674|PD-1|pd-1
362724|NCT02039674|PD1|pd1
362725|NCT02039674|Programmed Cell Death-1|programmed cell death-1
362726|NCT02039674|Programmed Cell Death 1|programmed cell death 1
362727|NCT02039674|Chemotherapy|chemotherapy
362728|NCT02039674|Pemetrexed|pemetrexed
362729|NCT02039674|Paclitaxel|paclitaxel
362730|NCT02039674|Bevacizumab|bevacizumab
362731|NCT02039674|Erlotinib|erlotinib
362732|NCT02039674|Gefitinib|gefitinib
362733|NCT02039674|Ipilimumab|ipilimumab
362734|NCT02039674|Carboplatin|carboplatin
362735|NCT02039661|Curettage;|curettage;
362736|NCT02039661|Pain Score|pain score
362737|NCT02039648|Periodontitis|periodontitis
363448|NCT02036502|PD-L1|pd-l1
362738|NCT02039648|Porphyromonas gingivalis|porphyromonas gingivalis
362739|NCT02039648|Rumex acetosa L.|rumex acetosa l.
362740|NCT02039648|Proanthocyanidins|proanthocyanidins
362741|NCT02039635|cancer|cancer
362742|NCT02039635|cancer related fatigue|cancer related fatigue
362743|NCT02039635|Korean red ginseng|korean red ginseng
362744|NCT02039635|chemotherapy|chemotherapy
362745|NCT02039609|vegetarian|vegetarian
362746|NCT02039609|vegan|vegan
362747|NCT02039609|omnivore|omnivore
362748|NCT02039609|Habitual diet|habitual diet
362749|NCT02039583|live birth|live birth
362750|NCT02039583|infant|infant
362751|NCT02039583|infant, newborn|infant, newborn
362752|NCT02039583|second-hand smoke|second-hand smoke
362753|NCT02039583|tobacco smoke pollution|tobacco smoke pollution
362754|NCT02039583|smoke-free|smoke-free
362755|NCT02039583|smoke-free policy|smoke-free policy
362756|NCT02039570|haemorrhoids|haemorrhoids
362757|NCT02039570|pelvic reflux|pelvic reflux
362758|NCT02039531|Knee|knee
362759|NCT02039531|osteoarthritis|osteoarthritis
362760|NCT02039531|plasma rich in growth factors|plasma rich in growth factors
362761|NCT02039531|platelet rich plasma|platelet rich plasma
362762|NCT02039531|hyaluronic acid|hyaluronic acid
362763|NCT02039518|Progression free Survival|progression free survival
362764|NCT02039505|Drug therapy|drug therapy
362765|NCT02039479|anti-suicide|anti-suicide
362766|NCT02039479|Lithium|lithium
362767|NCT02039479|Depression|depression
362768|NCT02039479|suicidal Ideation/behavior|suicidal ideation/behavior
362769|NCT02039453|Colonoscopy|colonoscopy
362770|NCT02039453|sedation|sedation
362771|NCT02039453|propofol|propofol
362772|NCT02039453|fentanyl|fentanyl
362773|NCT02039453|pethidine|pethidine
362774|NCT02039427|Sore throat|sore throat
362775|NCT02039427|Hoarseness|hoarseness
362776|NCT02039427|Intubation|intubation
362777|NCT02039427|Thyroidectomy|thyroidectomy
362778|NCT02039427|Ketorolac|ketorolac
362779|NCT02039427|Dexamethasone|dexamethasone
362780|NCT02039414|Obesity|obesity
362781|NCT02039414|Physical Inactivity|physical inactivity
362782|NCT02039414|Lipid Oxidation|lipid oxidation
362783|NCT02039414|Oxidative stress|oxidative stress
362784|NCT02039414|pregnancy|pregnancy
362785|NCT02039414|neonatal adiposity|neonatal adiposity
362786|NCT02039414|neonatal insulin sensitivity|neonatal insulin sensitivity
362788|NCT02039401|Lou Gehrig's disease|lou gehrig's disease
362789|NCT02039401|neurodegenerative disease|neurodegenerative disease
362790|NCT02039388|Ovarian Epithelial Cancer|ovarian epithelial cancer
362791|NCT02039388|Serous Intraepithelial Carcinoma (STIC)|serous intraepithelial carcinoma (stic)
362792|NCT02039388|BRCA1 gene|brca1 gene
362793|NCT02039388|BRCA2 gene|brca2 gene
362794|NCT02039388|Mutation|mutation
362795|NCT02039388|Neoplasms|neoplasms
362796|NCT02039388|Glandular and Epithelial|glandular and epithelial
362797|NCT02039388|Ovarian Neoplasms|ovarian neoplasms
362798|NCT02039388|Ovarian cancer|ovarian cancer
362799|NCT02039388|Carcinoma in situ|carcinoma in situ
362800|NCT02039388|family history breast cancer|family history breast cancer
362801|NCT02039388|family history ovarian cancer|family history ovarian cancer
362802|NCT02039375|IV tPA|iv tpa
362803|NCT02039375|Thrombolysis|thrombolysis
362804|NCT02039375|Stroke|stroke
362805|NCT02039375|Ischemic|ischemic
362806|NCT02039375|Monitoring|monitoring
362807|NCT02039349|Alcoholism|alcoholism
362808|NCT02039349|Ghrelin|ghrelin
362809|NCT02039349|Ghrelin Antagonism|ghrelin antagonism
362810|NCT02039323|Tenofovir|tenofovir
362811|NCT02039323|Tenofovir disoproxil|tenofovir disoproxil
362812|NCT02039323|Maraviroc|maraviroc
362813|NCT02039323|Pharmacologic Actions|pharmacologic actions
362814|NCT02039323|Anti-HIV agents|anti-hiv agents
362815|NCT02039323|Pharmacodynamics|pharmacodynamics
362816|NCT02039297|AWARE, Checklist, ICU, Outcome, Adults|aware, checklist, icu, outcome, adults
362817|NCT02039284|Cerebral palsy|cerebral palsy
362818|NCT02039284|novel intervention|novel intervention
362819|NCT02039284|sensory electrical stimulation|sensory electrical stimulation
362820|NCT02039284|virtual reality|virtual reality
362821|NCT02039284|cycling training|cycling training
362822|NCT02039284|constraint-induced therapy|constraint-induced therapy
362823|NCT02039284|biomechanical|biomechanical
362824|NCT02039284|physiology|physiology
362825|NCT02039284|outcome|outcome
362826|NCT02039271|music|music
362827|NCT02039271|total knee replacement|total knee replacement
362828|NCT02039271|Pain management|pain management
362829|NCT02039258|Healthy Volunteers|healthy volunteers
362830|NCT02039258|Canagliflozin|canagliflozin
362831|NCT02039258|Metformin|metformin
362832|NCT02039258|INVOKANA®|invokana®
362833|NCT02039258|Type 2 diabetes mellitus|type 2 diabetes mellitus
362834|NCT02039245|Healthy Volunteers|healthy volunteers
362835|NCT02039245|Canagliflozin|canagliflozin
362836|NCT02039245|Metformin|metformin
362837|NCT02039245|INVOKANA®|invokana®
362838|NCT02039245|Type 2 Diabetes Mellitus|type 2 diabetes mellitus
362839|NCT02039206|Machado Joseph disease|machado joseph disease
362840|NCT02039206|Deep TMS|deep tms
362842|NCT02039206|Transcranial Magnetic Stimulation|transcranial magnetic stimulation
362843|NCT02039206|SCA3|sca3
362844|NCT02039206|Magnetic Stimulation|magnetic stimulation
362845|NCT02039206|Brainsway|brainsway
362846|NCT02039193|Generalized anxiety disorder|generalized anxiety disorder
362847|NCT02039193|cognitive behavior therapy|cognitive behavior therapy
362848|NCT02039193|adherence|adherence
362849|NCT02039180|phase I|phase i
362850|NCT02039180|healthy volunteers|healthy volunteers
362851|NCT02039180|AZD3293|azd3293
362852|NCT02039180|bioavailability|bioavailability
362853|NCT02039180|Pharmacokinetics|pharmacokinetics
362854|NCT02039154|Exercise|exercise
362855|NCT02039154|Exercise tolerance|exercise tolerance
362856|NCT02039154|Aging|aging
362857|NCT02039154|Physical activity|physical activity
362858|NCT02039141|diabetes prevention program|diabetes prevention program
362859|NCT02039141|community based interventions|community based interventions
362860|NCT02039141|childhood obesity|childhood obesity
362861|NCT02039141|insulin resistance|insulin resistance
362862|NCT02039141|glucose tolerance|glucose tolerance
362863|NCT02039141|quality of life|quality of life
362864|NCT02039141|Latino youth|latino youth
362865|NCT02039141|physical activity|physical activity
362866|NCT02039141|nutrition|nutrition
362867|NCT02039102|hormonal contraceptives|hormonal contraceptives
362868|NCT02039102|combined pills|combined pills
362869|NCT02039102|progesterone-only contraceptives|progesterone-only contraceptives
362870|NCT02039102|body mass index|body mass index
362871|NCT02039102|asthma|asthma
362872|NCT02039102|Scotland|scotland
362873|NCT02039102|women|women
362874|NCT02039076|Healthy|healthy
362875|NCT02039063|Crohn's Disease|crohn's disease
362876|NCT02039050|Pulmonary Disease, Chronic Obstructive|pulmonary disease, chronic obstructive
362877|NCT02039050|Long-acting muscarinic antagonists|long-acting muscarinic antagonists
362878|NCT02039050|Impulse oscillometry|impulse oscillometry
362879|NCT02039024|18F-DTBZ|18f-dtbz
362880|NCT02039011|Asthma|asthma
362881|NCT02039011|Long acting beta-agonists|long acting beta-agonists
362882|NCT02039011|Long acting muscarinic antagonists|long acting muscarinic antagonists
362883|NCT02039011|Mannitol challenge|mannitol challenge
362884|NCT02038998|stroke|stroke
362885|NCT02038998|periodic acceleration|periodic acceleration
362886|NCT02038998|endothelium release|endothelium release
362887|NCT02038998|ischemic penumbra|ischemic penumbra
362888|NCT02038998|shear stress|shear stress
362889|NCT02038998|adrenomedullin|adrenomedullin
362890|NCT02038985|Endometriosis|endometriosis
362891|NCT02038985|Robotic Surgery|robotic surgery
362892|NCT02038985|Diagnostic Imaging|diagnostic imaging
362893|NCT02038959|Parkinson disease|parkinson disease
362894|NCT02038959|Parkinson's|parkinson's
362895|NCT02038959|Parkinson's disease|parkinson's disease
362896|NCT02038959|telemedicine|telemedicine
362897|NCT02038959|virtual visits|virtual visits
362898|NCT02038959|video calls|video calls
362899|NCT02038959|video conferencing|video conferencing
362900|NCT02038959|virtual house calls|virtual house calls
362901|NCT02038920|Drug Therapy|drug therapy
362902|NCT02038907|Norovirus, vaccination|norovirus, vaccination
362903|NCT02038894|Anesthetic|anesthetic
362904|NCT02038894|Pediatric|pediatric
362905|NCT02038894|Esophagogastroduodenoscopies|esophagogastroduodenoscopies
362906|NCT02038894|Eosinophilic esophagitis|eosinophilic esophagitis
362907|NCT02038894|Gastroesophageal reflux disease (GERD)|gastroesophageal reflux disease (gerd)
362908|NCT02038894|Abdominal Pain|abdominal pain
362909|NCT02038894|Vomiting|vomiting
362910|NCT02038894|Sevofluorane|sevofluorane
362911|NCT02038894|Propofol|propofol
362912|NCT02038894|Nasal cannula|nasal cannula
362913|NCT02038894|Intubation|intubation
362914|NCT02038894|Endotracheal tube|endotracheal tube
362915|NCT02038868|ASP4901|asp4901
362916|NCT02038868|BPH|bph
362917|NCT02038855|Dual-diagnosis|dual-diagnosis
362918|NCT02038855|Latino|latino
362919|NCT02038855|Mental health|mental health
362920|NCT02038855|Substance use|substance use
362921|NCT02038855|HIV risk|hiv risk
362922|NCT02038829|COPD|copd
362923|NCT02038803|Cystic Fibrosis Medication Adherence|cystic fibrosis medication adherence
362924|NCT02038790|opioid dependence|opioid dependence
464035|NCT01581359|IVF|ivf
362925|NCT02038790|buprenorphine/naloxone|buprenorphine/naloxone
362926|NCT02038790|Opioid-Related Disorders|opioid-related disorders
362927|NCT02038777|Hematologic Malignancies|hematologic malignancies
362928|NCT02038764|Phase 1|phase 1
362929|NCT02038764|RN168|rn168
362930|NCT02038764|Adults|adults
362931|NCT02038764|Type 1 Diabetes|type 1 diabetes
362932|NCT02038764|T1D|t1d
362933|NCT02038751|Genotyping|genotyping
362934|NCT02038751|Phenotyping|phenotyping
362935|NCT02038751|Sleep Apnea|sleep apnea
362936|NCT02038751|Genetic Association Studies|genetic association studies
362937|NCT02038751|Phenotype|phenotype
362938|NCT02038738|gallium|gallium
362939|NCT02038738|Ga|ga
362940|NCT02038738|PET Scan|pet scan
362941|NCT02038725|Risks|risks
362942|NCT02038725|Risk Factors|risk factors
362943|NCT02038725|ABCD2 score|abcd2 score
362944|NCT02038725|Predictive Value of Tests|predictive value of tests
362945|NCT02038725|Risk Assessment|risk assessment
362946|NCT02038725|Severity of Illness Index|severity of illness index
362947|NCT02038725|Decision Support Techniques|decision support techniques
362948|NCT02038712|Obesity|obesity
362949|NCT02038712|Binge eating disorder|binge eating disorder
362950|NCT02038712|fMRI|fmri
362951|NCT02038712|gut hormones|gut hormones
362952|NCT02038686|Hip fracture|hip fracture
362953|NCT02038686|Unstable (31A2 and 31A3)|unstable (31a2 and 31a3)
362954|NCT02038686|Proximal femoral nail|proximal femoral nail
362955|NCT02038673|ASP5878|asp5878
362956|NCT02038673|FGFR 1,2,3 and 4 inhibitor|fgfr 1,2,3 and 4 inhibitor
362957|NCT02038660|Coronary Artery Disease|coronary artery disease
362958|NCT02038660|Angioplasty, Balloon|angioplasty, balloon
362959|NCT02038647|Drug therapy|drug therapy
362960|NCT02038634|wrist|wrist
362961|NCT02038634|tendonitis|tendonitis
362962|NCT02038634|dequervain's|dequervain's
362963|NCT02038634|tenosynovitis|tenosynovitis
362964|NCT02038608|Parkinson|parkinson
362965|NCT02038608|serotonin|serotonin
362966|NCT02038608|dopamine|dopamine
362967|NCT02038608|non motor|non motor
362968|NCT02038608|progression|progression
362969|NCT02038608|PET|pet
362970|NCT02038595|brown adipose tissue|brown adipose tissue
362971|NCT02038582|HIV|hiv
362972|NCT02038582|HIV Counseling and Testing|hiv counseling and testing
362973|NCT02038582|Linkages to Care|linkages to care
362974|NCT02038582|Point of Care CD4|point of care cd4
362975|NCT02038582|Point of Care Viral Load|point of care viral load
362976|NCT02038543|Hyperoxaluria|hyperoxaluria
362977|NCT02038543|Oxalate|oxalate
362978|NCT02038543|Primary Hyperoxaluria|primary hyperoxaluria
362979|NCT02038530|Deep Vein Thrombosis|deep vein thrombosis
362980|NCT02038517|Insulin secretion|insulin secretion
362981|NCT02038517|Insulin sensitivity|insulin sensitivity
362982|NCT02038517|Orthotopic liver transplantation|orthotopic liver transplantation
362983|NCT02038517|Type 2 diabetes|type 2 diabetes
362984|NCT02038517|Metabolic syndrome|metabolic syndrome
362985|NCT02038517|Cardiovascular disease|cardiovascular disease
362986|NCT02038504|gastrointestinal fistula|gastrointestinal fistula
362987|NCT02038504|enteral nutrition|enteral nutrition
362988|NCT02038504|thyroid function|thyroid function
362989|NCT02038491|Epidural anesthesia|epidural anesthesia
362990|NCT02038491|Spinal anesthesia|spinal anesthesia
362991|NCT02038491|nerve blocks|nerve blocks
362992|NCT02038491|complications|complications
362993|NCT02038478|Sickle Cell Disease|sickle cell disease
362994|NCT02038478|Thalassemia|thalassemia
362995|NCT02038452|hand|hand
362996|NCT02038452|wrist|wrist
362997|NCT02038452|carpal|carpal
362998|NCT02038452|tunnel|tunnel
362999|NCT02038452|syndrome|syndrome
363000|NCT02038452|pragmatic|pragmatic
363001|NCT02038452|randomised|randomised
363002|NCT02038452|steroid|steroid
363003|NCT02038452|splint|splint
363004|NCT02038439|Evidence-Based Medicine|evidence-based medicine
363005|NCT02038439|Evidence Retrieval|evidence retrieval
363006|NCT02038439|Knowledge Translation|knowledge translation
363007|NCT02038439|Medical Education|medical education
363008|NCT02038413|NSCLC|nsclc
363009|NCT02038413|cT1/cT2aN0M0|ct1/ct2an0m0
363010|NCT02038413|Stereotactic lung treatment|stereotactic lung treatment
363011|NCT02038413|MAASTRO|maastro
363012|NCT02038413|age >18 years|age >18 years
363013|NCT02038335|immune cells|immune cells
363014|NCT02038335|contraception|contraception
363015|NCT02038335|intrauterine device|intrauterine device
363016|NCT02038335|IUD|iud
363017|NCT02038335|copper|copper
363018|NCT02038335|microbiota|microbiota
363019|NCT02038335|DMPA|dmpa
363020|NCT02038335|etonogestrel|etonogestrel
363021|NCT02038335|subdermal implant|subdermal implant
363022|NCT02038335|NET-EN|net-en
363023|NCT02038335|Jadelle|jadelle
363024|NCT02038335|Implanon|implanon
363025|NCT02038335|Cyclofem|cyclofem
363026|NCT02038322|OTC Home Use Conception Aid Cervical Cap Insemination|otc home use conception aid cervical cap insemination
363027|NCT02038309|Acute coronary syndrome|acute coronary syndrome
363028|NCT02038309|persistent platelet reactivity|persistent platelet reactivity
363029|NCT02038296|Hepatocellular carcinoma|hepatocellular carcinoma
363030|NCT02038296|Transarterial chemoembolization|transarterial chemoembolization
363031|NCT02038296|Gemcitabine|gemcitabine
363032|NCT02038283|Colorectal Neoplasms|colorectal neoplasms
363033|NCT02038283|Early Detection of Cancer|early detection of cancer
363034|NCT02038283|Quality of Life|quality of life
363035|NCT02038283|Quality-Adjusted Life Years|quality-adjusted life years
363036|NCT02038283|Direct Service Costs|direct service costs
363037|NCT02038283|Cost-Benefit Analysis|cost-benefit analysis
363038|NCT02038231|Adolescence|adolescence
363039|NCT02038231|Substance abuse|substance abuse
363040|NCT02038231|Mindfulness|mindfulness
363041|NCT02038218|DM-CHOC-PEN|dm-choc-pen
363042|NCT02038218|CNS|cns
363043|NCT02038218|brain|brain
363044|NCT02038218|melanoma|melanoma
363045|NCT02038218|lung cancer|lung cancer
363046|NCT02038218|breast cancer|breast cancer
363047|NCT02038218|glioblastoma multiforme|glioblastoma multiforme
363638|NCT02035488|Tobramycin|tobramycin
363048|NCT02038218|primary brain tumors|primary brain tumors
363049|NCT02038192|Caregiver|caregiver
363050|NCT02038192|Dementia|dementia
363051|NCT02038192|Long Term Care|long term care
363053|NCT02038192|Quality of Life|quality of life
363054|NCT02038192|Intervention|intervention
363055|NCT02038179|Pre-hypertension|pre-hypertension
363056|NCT02038179|JNC 7 stage I hypertension|jnc 7 stage i hypertension
363057|NCT02038140|Primary Ankle Replacement|primary ankle replacement
363058|NCT02038140|Total Ankle Arthroplasty|total ankle arthroplasty
363059|NCT02038140|Total Ankle Replacement|total ankle replacement
363060|NCT02038140|Trabecular Metal Total Ankle|trabecular metal total ankle
363061|NCT02038114|Odette Cancer Centre at Sunnybrook Health Sciences Centre|odette cancer centre at sunnybrook health sciences centre
363062|NCT02038114|Toronto|toronto
363063|NCT02038114|Ontario|ontario
363064|NCT02038088|Need general anesthesia|need general anesthesia
363065|NCT02038075|suicide|suicide
363066|NCT02038075|suicidal ideation|suicidal ideation
363067|NCT02038075|military|military
363068|NCT02038075|veteran|veteran
363069|NCT02038075|cognitive behavioral therapy|cognitive behavioral therapy
363070|NCT02038075|behavioral therapy|behavioral therapy
363071|NCT02038075|psychotherapy|psychotherapy
363072|NCT02038075|Brief Cognitive Behavioral Therapy (BCBT)|brief cognitive behavioral therapy (bcbt)
363073|NCT02038075|Treatement As Usual (TAU)|treatement as usual (tau)
363074|NCT02038049|Multiple Sclerosis|multiple sclerosis
363075|NCT02038049|Relapsing-Remitting Multiple Sclerosis|relapsing-remitting multiple sclerosis
363076|NCT02038049|Magnetic Resonance Imaging|magnetic resonance imaging
363077|NCT02038049|VAY736|vay736
363078|NCT02038049|Lanalumab|lanalumab
363079|NCT02038049|monoclonal antibody|monoclonal antibody
363080|NCT02038049|gadolinium [Gd]-enhancing lesions|gadolinium [gd]-enhancing lesions
363081|NCT02038049|B-Cell|b-cell
363082|NCT02038036|Polycythemia Vera|polycythemia vera
363083|NCT02038036|Hematologic Diseases|hematologic diseases
363084|NCT02038036|Myeloproliferative Disorders|myeloproliferative disorders
363085|NCT02038036|Bone Marrow Diseases|bone marrow diseases
363086|NCT02038036|Hydroxyurea|hydroxyurea
363087|NCT02038036|INC424|inc424
363088|NCT02038036|Ruxolitinib|ruxolitinib
363089|NCT02038023|Iv iron in pregnant women|iv iron in pregnant women
363090|NCT02038023|second and third trimester|second and third trimester
363091|NCT02037997|PFS|pfs
363092|NCT02037971|Systemic Lupus Erythematosus|systemic lupus erythematosus
363093|NCT02037971|Lupus|lupus
363094|NCT02037971|Sleep disorders|sleep disorders
363095|NCT02037971|Sleep disturbed|sleep disturbed
363096|NCT02037971|Physical exercise|physical exercise
363097|NCT02037971|Aerobic exercise|aerobic exercise
363098|NCT02037945|18F-Fluorocholine (18F-FCho)|18f-fluorocholine (18f-fcho)
363099|NCT02037945|Pet Scan|pet scan
363100|NCT02037945|MRI|mri
363101|NCT02037945|13-199|13-199
363102|NCT02037932|Aneurysm|aneurysm
363103|NCT02037932|Brain Aneurysm|brain aneurysm
363104|NCT02037906|Renal stones|renal stones
363105|NCT02037906|SWL|swl
363106|NCT02037880|Mucopolysaccharidosis|mucopolysaccharidosis
363107|NCT02037880|MPS|mps
363108|NCT02037880|Sanfilippo|sanfilippo
363109|NCT02037867|alcohol|alcohol
363110|NCT02037867|type 2 diabetes|type 2 diabetes
363111|NCT02037867|ALT|alt
363112|NCT02037867|abnormal liver enzymes|abnormal liver enzymes
363113|NCT02037867|hepatic fibrosis|hepatic fibrosis
363114|NCT02037867|cirrhosis|cirrhosis
363115|NCT02037841|Asthma|asthma
363116|NCT02037841|Nursing|nursing
363117|NCT02037841|Protocol|protocol
363118|NCT02037841|PRAM|pram
363119|NCT02037841|Length of Stay|length of stay
363120|NCT02037841|Weaning|weaning
363121|NCT02037841|Clinical pathway|clinical pathway
363122|NCT02037841|Asthma exacerbation|asthma exacerbation
363123|NCT02037828|COPD|copd
363124|NCT02037828|biomarker|biomarker
363125|NCT02037828|EBC|ebc
363126|NCT02037828|FEV1|fev1
363127|NCT02037815|hyperosmolar drugs|hyperosmolar drugs
363128|NCT02037815|mannitol|mannitol
363129|NCT02037815|hypertonic saline|hypertonic saline
363130|NCT02037815|serum osmolality|serum osmolality
363131|NCT02037815|correlation|correlation
363132|NCT02037802|caudal|caudal
363133|NCT02037802|epidural|epidural
363134|NCT02037802|pediatric|pediatric
363135|NCT02037802|renal|renal
363136|NCT02037802|transplant|transplant
363137|NCT02037802|hemodynamics|hemodynamics
363138|NCT02037789|pain|pain
363139|NCT02037789|low back pain|low back pain
363140|NCT02037789|GWAS|gwas
363141|NCT02037789|glycomics|glycomics
363142|NCT02037789|activomics|activomics
363143|NCT02037776|Rikkunshito|rikkunshito
363144|NCT02037776|Double blind|double blind
363145|NCT02037776|Functional dyspepsia (FD)|functional dyspepsia (fd)
363146|NCT02037763|Low back pain|low back pain
363147|NCT02037763|GWAS|gwas
363148|NCT02037763|Glycomics|glycomics
363149|NCT02037763|Activomics|activomics
363150|NCT02037763|Epigenetics|epigenetics
363151|NCT02037750|foster care|foster care
363152|NCT02037750|school adjustment|school adjustment
363153|NCT02037711|Laparoscopic|laparoscopic
363154|NCT02037711|Levobupivacaine|levobupivacaine
363155|NCT02037711|Pediatric|pediatric
363156|NCT02037711|Anesthesia|anesthesia
363157|NCT02037711|Instillation|instillation
363158|NCT02037711|surgeries|surgeries
363160|NCT02037698|CT|ct
363161|NCT02037698|Revascularization|revascularization
363162|NCT02037685|Statins|statins
363163|NCT02037685|Cholesterol lowering medications|cholesterol lowering medications
363164|NCT02037685|Adherence|adherence
363165|NCT02037685|Motivational interviewing|motivational interviewing
363166|NCT02037685|Minority populations|minority populations
363167|NCT02037672|PCOS|pcos
363168|NCT02037672|PDE-4 inhibitor|pde-4 inhibitor
363169|NCT02037672|roflumilast|roflumilast
363170|NCT02037672|metformin|metformin
363171|NCT02037672|obesity|obesity
363172|NCT02037646|Colorectal cancer|colorectal cancer
363173|NCT02037646|Screening|screening
363174|NCT02037646|Fecal occult blood|fecal occult blood
363175|NCT02037646|Fecal immunochemical test|fecal immunochemical test
363176|NCT02037646|Qualitative|qualitative
363177|NCT02037646|Quantitative|quantitative
363178|NCT02037620|Epidural Stimulation|epidural stimulation
363179|NCT02037607|Deep vein thrombosis|deep vein thrombosis
363180|NCT02037607|Children|children
363181|NCT02037607|Pediatric|pediatric
363182|NCT02037607|Anti-coagulant|anti-coagulant
363183|NCT02037607|Neurosurgical procedures|neurosurgical procedures
363184|NCT02037607|Blood Clot|blood clot
363185|NCT02037594|HIV|hiv
363186|NCT02037594|Pre-exposure prophylaxis|pre-exposure prophylaxis
363187|NCT02037594|PrEP|prep
363188|NCT02037594|MSM|msm
363189|NCT02037594|Demonstration Project|demonstration project
363190|NCT02037581|integrated care|integrated care
363191|NCT02037581|hometreatment|hometreatment
363192|NCT02037581|assertive community treatment (ACT)|assertive community treatment (act)
363193|NCT02037581|psychosis|psychosis
363194|NCT02037581|schizophrenia|schizophrenia
363195|NCT02037581|bipolar disorder|bipolar disorder
363196|NCT02037581|first episode|first episode
363197|NCT02037568|depression|depression
363198|NCT02037568|stress|stress
363199|NCT02037568|caregiving|caregiving
363200|NCT02037568|anxiety|anxiety
363201|NCT02037568|psychoeducation intervention|psychoeducation intervention
363202|NCT02037568|psycho-oncology|psycho-oncology
363203|NCT02037568|allogeneic hematopoietic stem cell transplant|allogeneic hematopoietic stem cell transplant
363204|NCT02037555|Antithrombin|antithrombin
363205|NCT02037555|Cardiopulmonary bypass|cardiopulmonary bypass
363206|NCT02037542|BMI, Lipid profile|bmi, lipid profile
363207|NCT02037516|residual muscle weakness, respiratory events|residual muscle weakness, respiratory events
363208|NCT02037490|Infants|infants
363209|NCT02037490|Mothers|mothers
363210|NCT02037490|Social media|social media
363211|NCT02037490|Obesity prevention|obesity prevention
363212|NCT02037464|Prostate Cancer|prostate cancer
363213|NCT02037464|Active Surveillance|active surveillance
363214|NCT02037464|Radical Prostatectomy|radical prostatectomy
363215|NCT02037451|Parkinson's disease|parkinson's disease
363216|NCT02037451|Auditory Cueing|auditory cueing
363217|NCT02037438|Clinical sleep medicine|clinical sleep medicine
363218|NCT02037438|New methodology for healthcare delivery|new methodology for healthcare delivery
363219|NCT02037438|Diagnosis and treatment of sleep disorders|diagnosis and treatment of sleep disorders
363220|NCT02037438|Electronic health records|electronic health records
363221|NCT02037438|Clinical informatics|clinical informatics
363222|NCT02037438|Evidence-based comparative effectiveness research|evidence-based comparative effectiveness research
363223|NCT02037438|Sleep specialists|sleep specialists
363224|NCT02037438|Primary care providers|primary care providers
363225|NCT02037438|Allied health professionals|allied health professionals
363226|NCT02037438|Patient-centered care|patient-centered care
363227|NCT02037425|Chronic Migraine|chronic migraine
363228|NCT02037425|onabotulinumtoxinA|onabotulinumtoxina
363229|NCT02037425|Headache|headache
363230|NCT02037425|Migraine|migraine
464446|NCT01579682|FBT|fbt
363231|NCT02037425|Neuronal regrowth|neuronal regrowth
363232|NCT02037425|Botox|botox
363233|NCT02037412|Ticagrelor|ticagrelor
363234|NCT02037412|strut coverage|strut coverage
363235|NCT02037412|DES|des
363236|NCT02037412|ACS|acs
363237|NCT02037412|OCT|oct
363238|NCT02037399|Endoscopic submucosal dissection|endoscopic submucosal dissection
363239|NCT02037399|early gastric cancer|early gastric cancer
363240|NCT02037399|pain relief|pain relief
363241|NCT02037399|intravenous dexamethasone|intravenous dexamethasone
363242|NCT02037399|present pain intensity|present pain intensity
363243|NCT02037386|Side branch stent|side branch stent
363244|NCT02037386|Coronary bifurcation lesion|coronary bifurcation lesion
363245|NCT02037373|intra and post-op coagulopathy in patients undergoing OLT|intra and post-op coagulopathy in patients undergoing olt
363246|NCT02037360|Smoking|smoking
363247|NCT02037360|Cessation|cessation
363248|NCT02037334|Preterm delivery|preterm delivery
363249|NCT02037334|Diagnostics|diagnostics
363250|NCT02037334|Biomechanics|biomechanics
363251|NCT02037321|Systematic review and meta-analysis|systematic review and meta-analysis
363252|NCT02037308|Glu298Asp polymorphism|glu298asp polymorphism
363253|NCT02037308|Blood pressure|blood pressure
363254|NCT02037308|Plasma NOx|plasma nox
363255|NCT02037308|Beetroot|beetroot
363256|NCT02037295|Gut Microbiota|gut microbiota
363257|NCT02037295|Obesity|obesity
363258|NCT02037295|Absorption|absorption
363259|NCT02037295|Overfeeding|overfeeding
363260|NCT02037282|HAI Titer|hai titer
363261|NCT02037282|Hemagglutination Inhibition Assays|hemagglutination inhibition assays
363262|NCT02037282|Immunogenicity|immunogenicity
363263|NCT02037282|Serum Antibody Response|serum antibody response
363264|NCT02037269|Cerenkov Luminescence Imaging, CLI, margin status|cerenkov luminescence imaging, cli, margin status
363265|NCT02037243|behavior change|behavior change
363266|NCT02037243|handwashing|handwashing
363267|NCT02037243|water treatment|water treatment
363268|NCT02037243|disgust|disgust
363269|NCT02037243|shame|shame
363270|NCT02037243|neighbour|neighbour
363271|NCT02037243|willingness to pay|willingness to pay
363272|NCT02037204|IMPACT|impact
363273|NCT02037204|Chondrons|chondrons
363274|NCT02037204|Mesenchymal stem cells|mesenchymal stem cells
363275|NCT02037204|Allogeneic MSCs|allogeneic mscs
363276|NCT02037204|single-stage|single-stage
363277|NCT02037204|Cartilage repair|cartilage repair
363278|NCT02037204|Safety|safety
363279|NCT02037204|Efficacy|efficacy
363280|NCT02037191|ALOPECIA AREATA|alopecia areata
363281|NCT02037191|TREATMENT METHOTREXATE|treatment methotrexate
363282|NCT02037178|Peripheral Obliterative Arteriopathy of the legs|peripheral obliterative arteriopathy of the legs
363283|NCT02037178|Screening by generalists|screening by generalists
363284|NCT02037178|Ultrasound|ultrasound
363285|NCT02037152|Chronic pain|chronic pain
363286|NCT02037152|Mobile applications|mobile applications
363287|NCT02037152|Mindfulness|mindfulness
363288|NCT02037152|Meditation|meditation
363289|NCT02037152|Telemedicine|telemedicine
363290|NCT02037152|Cellular phone|cellular phone
363291|NCT02037152|Pain Management|pain management
363292|NCT02037152|Therapy, computer-assisted|therapy, computer-assisted
363293|NCT02037139|Hearing loss|hearing loss
363294|NCT02037139|Screening|screening
363295|NCT02037139|Primary Care|primary care
363296|NCT02037113|IVUS|ivus
363298|NCT02037113|Femoro-popliteal disease|femoro-popliteal disease
363299|NCT02037113|Intravascular ultrasound|intravascular ultrasound
363300|NCT02037087|Short Message Service|short message service
363301|NCT02037087|newborn health|newborn health
363302|NCT02037087|maternal behavior|maternal behavior
363303|NCT02037087|good household pregnancy practice|good household pregnancy practice
363304|NCT02037087|care seeking|care seeking
363305|NCT02037074|Phosphodiesterase 10 inhibitor|phosphodiesterase 10 inhibitor
363306|NCT02037022|Autism Spectrum Disorder (ASD)|autism spectrum disorder (asd)
363307|NCT02037022|Autism|autism
363308|NCT02036983|Ultrasound guided|ultrasound guided
363309|NCT02036983|Bilateral Transversus abdominis Plane Block|bilateral transversus abdominis plane block
363310|NCT02036983|Dexamethasone|dexamethasone
363311|NCT02036983|Preperitoneal Instillation|preperitoneal instillation
363312|NCT02036983|Local Analgesic|local analgesic
363313|NCT02036983|Efficacy|efficacy
363314|NCT02036983|Total Extraperitoneal Bilateral Inguinal hernia repair|total extraperitoneal bilateral inguinal hernia repair
363315|NCT02036970|Pulmonary Arterial Hypertension|pulmonary arterial hypertension
363316|NCT02036970|PAH|pah
363317|NCT02036970|Bardoxolone methyl|bardoxolone methyl
363318|NCT02036970|6-minute walk distance|6-minute walk distance
363319|NCT02036970|CDDO-me|cddo-me
363320|NCT02036970|RTA 402|rta 402
363321|NCT02036970|Pulmonary Hypertension|pulmonary hypertension
363322|NCT02036970|Interstitial Lung Disease|interstitial lung disease
363323|NCT02036970|Idiopathic Interstitial Pneumonia|idiopathic interstitial pneumonia
363324|NCT02036970|Idiopathic Pulmonary Fibrosis|idiopathic pulmonary fibrosis
363325|NCT02036970|Sarcoidosis|sarcoidosis
363326|NCT02036970|Respiratory Bronchiolitis Associated ILD|respiratory bronchiolitis associated ild
464540|NCT01579357|CCB|ccb
363327|NCT02036970|Desquamative Interstitial Pneumonia|desquamative interstitial pneumonia
363328|NCT02036970|Cryptogenic Organizing Pneumonia|cryptogenic organizing pneumonia
363329|NCT02036970|Acute Interstitial Pneumonitis|acute interstitial pneumonitis
363330|NCT02036970|Idiopathic Lymphoid Interstitial Pneumonia|idiopathic lymphoid interstitial pneumonia
363331|NCT02036970|Idiopathic Pleuroparenchymal Fibroelastosis|idiopathic pleuroparenchymal fibroelastosis
363332|NCT02036957|capecitabine|capecitabine
363333|NCT02036957|dermatologic toxicity|dermatologic toxicity
363334|NCT02036944|Celiac Disease|celiac disease
363335|NCT02036944|Celiac Sprue|celiac sprue
363336|NCT02036944|Iron-Deficiency Anemia|iron-deficiency anemia
363337|NCT02036931|Joint|joint
363338|NCT02036931|Osteoarthritis|osteoarthritis
363339|NCT02036931|Avascular Necrosis|avascular necrosis
363340|NCT02036918|castrate resistant prostate cancer|castrate resistant prostate cancer
363341|NCT02036918|metastatic|metastatic
363342|NCT02036918|sipuleucel-T|sipuleucel-t
363343|NCT02036918|lymphadenectomy|lymphadenectomy
363344|NCT02036918|Excisional lymph node biopsy|excisional lymph node biopsy
363345|NCT02036905|neck pain, orthopedic manual therapy|neck pain, orthopedic manual therapy
363346|NCT02036892|Diabetes|diabetes
363639|NCT02035475|Prevention|prevention
363347|NCT02036879|Cystic Fibrosis|cystic fibrosis
363348|NCT02036879|Loestrin|loestrin
363349|NCT02036879|Hormone|hormone
363350|NCT02036866|knee osteoarthritis|knee osteoarthritis
363351|NCT02036866|grade I and II knee osteoarthritis|grade i and ii knee osteoarthritis
363352|NCT02036866|arthritis|arthritis
363353|NCT02036853|Triheptanoin|triheptanoin
363354|NCT02036853|Glut1 DS|glut1 ds
363355|NCT02036853|Epilepsy|epilepsy
363356|NCT02036853|Seizures|seizures
363357|NCT02036827|Pain, Postoperative|pain, postoperative
363358|NCT02036827|Neuromuscular Blocking Agents|neuromuscular blocking agents
363359|NCT02036827|Laparoscopy|laparoscopy
363360|NCT02036814|Hypertension|hypertension
363361|NCT02036814|Nursing|nursing
363362|NCT02036814|Therapeutic compliance|therapeutic compliance
363363|NCT02036814|Quality of life|quality of life
363364|NCT02036814|Health education|health education
363365|NCT02036801|ARDS|ards
363366|NCT02036801|Lung|lung
363367|NCT02036801|Specific Elastance|specific elastance
363368|NCT02036801|Pediatric patients|pediatric patients
363369|NCT02036788|Esophageal pressure, Mechanical ventilation|esophageal pressure, mechanical ventilation
363370|NCT02036762|Chronic Obstructive Pulmonary Disease|chronic obstructive pulmonary disease
363371|NCT02036762|Thoracoabdominal Mechanics|thoracoabdominal mechanics
363372|NCT02036762|Functional capacity|functional capacity
363373|NCT02036762|Quality of life|quality of life
363374|NCT02036736|Orthopedic Surgery|orthopedic surgery
363375|NCT02036736|Total hip prosthesis|total hip prosthesis
363376|NCT02036736|Total knee replacement|total knee replacement
363377|NCT02036736|Intraoperative anesthetic strategy|intraoperative anesthetic strategy
363378|NCT02036736|Propofol|propofol
363379|NCT02036736|Desflurane|desflurane
363380|NCT02036723|Macular Degeneration|macular degeneration
363381|NCT02036723|Eye Diseases|eye diseases
363382|NCT02036723|Neovascular Macular Degeneration|neovascular macular degeneration
363383|NCT02036723|Choroidal Neovascularization|choroidal neovascularization
363384|NCT02036723|Geographic Atrophy|geographic atrophy
363385|NCT02036710|GLP-1|glp-1
363386|NCT02036710|PYY|pyy
363387|NCT02036710|Leptin|leptin
363388|NCT02036710|Duodenal Switch|duodenal switch
363389|NCT02036697|Cesarean section|cesarean section
363390|NCT02036697|spinal anesthesia|spinal anesthesia
363391|NCT02036697|low dose spinal|low dose spinal
363392|NCT02036697|bupivacaine|bupivacaine
363393|NCT02036697|hemodynamics|hemodynamics
363394|NCT02036697|blood pressure|blood pressure
363395|NCT02036697|cardiac output|cardiac output
363396|NCT02036684|Prostate cancer|prostate cancer
363397|NCT02036684|Radical prostatectomy|radical prostatectomy
363398|NCT02036684|Prehabilitation|prehabilitation
363399|NCT02036684|Pelvic floor muscle exercises|pelvic floor muscle exercises
363400|NCT02036671|Arteriovenous fistula|arteriovenous fistula
363401|NCT02036671|Fistula|fistula
363402|NCT02036671|Chronic kidney disease|chronic kidney disease
363403|NCT02036671|Percutaneous|percutaneous
363404|NCT02036671|Kidney Disease|kidney disease
363405|NCT02036671|Kidney Failure, Chronic|kidney failure, chronic
363406|NCT02036671|Urologic Diseases|urologic diseases
363407|NCT02036671|Renal Insufficiency, Chronic|renal insufficiency, chronic
363408|NCT02036671|Renal Insufficiency|renal insufficiency
363409|NCT02036671|CKD|ckd
363410|NCT02036671|hemodialysis|hemodialysis
363411|NCT02036658|social anxiety|social anxiety
363412|NCT02036658|treatment|treatment
363413|NCT02036658|cognitive-behavioral therapy|cognitive-behavioral therapy
363414|NCT02036658|mindfulness-based stress reduction|mindfulness-based stress reduction
363415|NCT02036658|emotion regulation|emotion regulation
363416|NCT02036658|randomized controlled trial|randomized controlled trial
363417|NCT02036658|neuroimaging|neuroimaging
363418|NCT02036658|functional magnetic resonance imaging|functional magnetic resonance imaging
363419|NCT02036658|mediators|mediators
363420|NCT02036658|mechanisms|mechanisms
363421|NCT02036619|gestational diabetes|gestational diabetes
363422|NCT02036619|pregestational diabetes|pregestational diabetes
363423|NCT02036619|screening|screening
363424|NCT02036619|diagnostic criteria|diagnostic criteria
363425|NCT02036619|IADPSG|iadpsg
363426|NCT02036593|Cardiovascular Risk Factors|cardiovascular risk factors
363427|NCT02036580|Japan|japan
363428|NCT02036580|Phase2|phase2
363429|NCT02036580|Safety|safety
363430|NCT02036580|Tolerability|tolerability
363431|NCT02036580|Idiopathic Pulmonary Fibrosis|idiopathic pulmonary fibrosis
363432|NCT02036580|IPF|ipf
363433|NCT02036580|CAT-354|cat-354
363434|NCT02036580|Tralokinumab|tralokinumab
363435|NCT02036541|Glaucoma Implant|glaucoma implant
363436|NCT02036541|Trabeculectomy|trabeculectomy
363437|NCT02036541|POAG|poag
363438|NCT02036541|Primary Open Angle Glaucoma|primary open angle glaucoma
363439|NCT02036541|Pseudoexfoliation Glaucoma|pseudoexfoliation glaucoma
363440|NCT02036541|Pigmentary Glaucoma|pigmentary glaucoma
363441|NCT02036528|Foot Ulcer|foot ulcer
363442|NCT02036528|Diabetic Foot|diabetic foot
363443|NCT02036528|Gentamicins|gentamicins
363444|NCT02036528|infection|infection
363445|NCT02036502|PD1|pd1
363446|NCT02036502|PD-1|pd-1
363447|NCT02036502|PDL1|pdl1
363449|NCT02036476|Merkel Cell Carcinoma|merkel cell carcinoma
363450|NCT02036476|Skin Cancer|skin cancer
363451|NCT02036463|Duchenne Muscular Dystrophy|duchenne muscular dystrophy
363452|NCT02036463|Corticosteroids|corticosteroids
363453|NCT02036450|atrial fibrillation|atrial fibrillation
363454|NCT02036450|cardiac arrhythmia|cardiac arrhythmia
363456|NCT02036450|implantable loop recorder|implantable loop recorder
363457|NCT02036450|bleeding|bleeding
363458|NCT02036450|anticoagulation|anticoagulation
363459|NCT02036450|hypertension|hypertension
363460|NCT02036450|diabetes|diabetes
363461|NCT02036450|heart failure|heart failure
363462|NCT02036450|mortality|mortality
363463|NCT02036437|Induction of Labor|induction of labor
363464|NCT02036437|Misoprostol|misoprostol
363465|NCT02036411|clomiphene citrate|clomiphene citrate
363466|NCT02036411|amh|amh
363467|NCT02036411|inhibin b|inhibin b
363468|NCT02036398|Percutaneous Nephrolithotomy (PCNL)|percutaneous nephrolithotomy (pcnl)
363469|NCT02036398|Nephrostomy|nephrostomy
363470|NCT02036398|Double J stent|double j stent
363471|NCT02036398|PleuraL Effusion|pleural effusion
363472|NCT02036372|glucose|glucose
363473|NCT02036372|diabetes mellitus|diabetes mellitus
363474|NCT02036372|perioperative|perioperative
363475|NCT02036359|Non-small Cell Lung Cancer(NSCLC)|non-small cell lung cancer(nsclc)
363476|NCT02036346|ileostomy|ileostomy
363477|NCT02036346|colorectal resection|colorectal resection
363478|NCT02036346|dehydration|dehydration
363479|NCT02036346|nutritional status|nutritional status
363480|NCT02036333|near infrared spectroscopy|near infrared spectroscopy
363481|NCT02036333|pediatrics|pediatrics
363482|NCT02036307|Fish oils|fish oils
363483|NCT02036307|Triglycerides|triglycerides
363484|NCT02036307|Blood pressure|blood pressure
363485|NCT02036294|Patient self-care behaviors|patient self-care behaviors
363486|NCT02036294|Patient activation|patient activation
363487|NCT02036294|Family caregiver support|family caregiver support
363488|NCT02036294|Patient-centered care|patient-centered care
363489|NCT02036281|Terminally ill , histologically-confirmed advanced cancer|terminally ill , histologically-confirmed advanced cancer
363490|NCT02036281|Pain unrelieved by opioids|pain unrelieved by opioids
363491|NCT02036268|Ostomy education|ostomy education
363492|NCT02036268|Education|education
363493|NCT02036268|care of ostomy site|care of ostomy site
363494|NCT02036255|Prevention, Thrombosis, Hemodialysis, Vascular access device|prevention, thrombosis, hemodialysis, vascular access device
363495|NCT02036242|Opioid|opioid
363496|NCT02036242|Local anesthetic|local anesthetic
363497|NCT02036242|Labor delivery|labor delivery
363498|NCT02036242|Safety|safety
363499|NCT02036229|demodex|demodex
363500|NCT02036229|demodicidosis|demodicidosis
363501|NCT02036229|rosacea|rosacea
363502|NCT02036229|ivermectin|ivermectin
363503|NCT02036216|Hepatocellular Carcinoma；cell free tumor DNA; Mutation;|hepatocellular carcinoma；cell free tumor dna; mutation;
363504|NCT02036190|COPD, chronic obstructive pulmonary disease, emphysema|copd, chronic obstructive pulmonary disease, emphysema
363505|NCT02036177|IUB|iub
363506|NCT02036164|Locally advanced cervical cancer|locally advanced cervical cancer
363507|NCT02036164|Concurrent chemoradiation|concurrent chemoradiation
363508|NCT02036164|Adjuvant chemotherapy|adjuvant chemotherapy
363509|NCT02036151|Xylitol|xylitol
363510|NCT02036151|prevention|prevention
363511|NCT02036151|Mutans streptococci|mutans streptococci
363512|NCT02036151|caries|caries
363513|NCT02036151|plaque|plaque
363514|NCT02036151|children|children
363515|NCT02036125|Corticosteroid|corticosteroid
363516|NCT02036125|Ultrasound|ultrasound
363517|NCT02036125|Guided injection|guided injection
363518|NCT02036112|Advanced Lower rectal cancer|advanced lower rectal cancer
363519|NCT02036112|Extralevator abdominoperineal excision|extralevator abdominoperineal excision
363520|NCT02036112|Circumferential resection margin|circumferential resection margin
363521|NCT02036112|Morbidity|morbidity
363522|NCT02036112|Survival|survival
363523|NCT02036099|Dementia|dementia
363524|NCT02036099|Automobile driving|automobile driving
363525|NCT02036099|Accidents, traffic|accidents, traffic
363526|NCT02036086|Melanoma stage IIIB or C with BRAF mutation|melanoma stage iiib or c with braf mutation
363527|NCT02036086|Recurrent regional lymphadenopathy not suitable for surgery|recurrent regional lymphadenopathy not suitable for surgery
363528|NCT02036086|Eligible for neoadjuvant vemurafenib and cobimetinib|eligible for neoadjuvant vemurafenib and cobimetinib
363529|NCT02036073|erythropoietin|erythropoietin
363530|NCT02036073|preterm|preterm
363531|NCT02036073|brain injury|brain injury
363532|NCT02036073|cerebral palsy|cerebral palsy
363533|NCT02036073|PVL|pvl
363534|NCT02036060|Metastatic prostate cancer|metastatic prostate cancer
363535|NCT02036060|Abiraterone acetate|abiraterone acetate
363536|NCT02036021|pediatric anesthesia|pediatric anesthesia
363537|NCT02036021|perioperative respiratory events|perioperative respiratory events
363538|NCT02036021|days of hospitalization|days of hospitalization
363539|NCT02036021|cost of hospitalization|cost of hospitalization
363540|NCT02036008|Liver metastases|liver metastases
363541|NCT02036008|MRI|mri
363542|NCT02036008|Contrast Agents|contrast agents
363637|NCT02035488|Bronchiectasis|bronchiectasis
363543|NCT02035995|gestational diabetes mellitus; optical coherence tomography; pregnancy; retinal nerve fiber layer.|gestational diabetes mellitus; optical coherence tomography; pregnancy; retinal nerve fiber layer.
363544|NCT02035956|IVAC MUTANOME|ivac mutanome
363545|NCT02035956|IVAC|ivac
363546|NCT02035956|personalized therapy|personalized therapy
363547|NCT02035956|personalized immuno therapy|personalized immuno therapy
363548|NCT02035956|RB_0004-01|rb_0004-01
363549|NCT02035956|Ribological|ribological
363550|NCT02035956|Melanoma|melanoma
363551|NCT02035956|cancer vaccine|cancer vaccine
363552|NCT02035930|Bispectral Index Monitor, Menstrual Cycle, Dexmedetomidine|bispectral index monitor, menstrual cycle, dexmedetomidine
363553|NCT02035891|colchicine|colchicine
363554|NCT02035891|urinary albumin-to-creatinine ratio|urinary albumin-to-creatinine ratio
363555|NCT02035891|carotid Intima-Media Thickness|carotid intima-media thickness
363556|NCT02035891|overt nephropathy|overt nephropathy
363557|NCT02035891|Type 2 diabetes|type 2 diabetes
363558|NCT02035878|anxiety|anxiety
363559|NCT02035878|depression|depression
363560|NCT02035878|probiotics|probiotics
363561|NCT02035878|adult|adult
363562|NCT02035878|human|human
363563|NCT02035878|depression anxiety stress scale|depression anxiety stress scale
363564|NCT02035878|anxiety sensitivity index|anxiety sensitivity index
363565|NCT02035865|Psychiatric morbidity|psychiatric morbidity
363566|NCT02035865|Cognitive function|cognitive function
363567|NCT02035865|Heart transplantation|heart transplantation
363568|NCT02035865|Mortality|mortality
363569|NCT02035865|Cardiac allograft vasculopathy|cardiac allograft vasculopathy
363570|NCT02035839|Target Temperature Management|target temperature management
363571|NCT02035839|Cooling comatose survivors from OHCA|cooling comatose survivors from ohca
363572|NCT02035839|Good neurological outcome at modified Rankin Score (mRS) ≤ 3|good neurological outcome at modified rankin score (mrs) ≤ 3
363573|NCT02035813|metastatic breast cancer|metastatic breast cancer
363574|NCT02035813|circulating tumor cells|circulating tumor cells
363575|NCT02035813|eribulin|eribulin
363576|NCT02035813|ribociclib|ribociclib
363577|NCT02035800|Rheumatoid Arthritis|rheumatoid arthritis
363578|NCT02035800|Adalimumab|adalimumab
363579|NCT02035800|Humira|humira
363580|NCT02035787|metformin|metformin
363581|NCT02035787|endometrial cancer|endometrial cancer
363582|NCT02035787|Lineberger Comprehensive Cancer Center|lineberger comprehensive cancer center
363583|NCT02035787|complex atypical hyperplasia|complex atypical hyperplasia
363584|NCT02035774|Brachial plexus block|brachial plexus block
363585|NCT02035774|Suprascapular nerve block|suprascapular nerve block
363586|NCT02035761|MSA|msa
363587|NCT02035761|Shy-Dragers Syndrome|shy-dragers syndrome
363588|NCT02035761|Possible or Probable|possible or probable
363589|NCT02035748|Vitreomacular traction|vitreomacular traction
363590|NCT02035748|Symptomatic vitreomacular adhesion|symptomatic vitreomacular adhesion
363591|NCT02035748|Ocriplasmin|ocriplasmin
363592|NCT02035748|JETREA|jetrea
363593|NCT02035735|NBI,|nbi,
363594|NCT02035735|squamous cell carcinoma,|squamous cell carcinoma,
363595|NCT02035735|pharynx, larynx, surgical margins.|pharynx, larynx, surgical margins.
363596|NCT02035709|Therapy|therapy
363597|NCT02035696|influenza|influenza
363598|NCT02035696|children|children
363599|NCT02035696|safety|safety
363600|NCT02035696|tolerability|tolerability
363601|NCT02035696|immunogenicity|immunogenicity
363602|NCT02035683|metabolic response|metabolic response
363603|NCT02035683|chemotherapy|chemotherapy
363604|NCT02035670|diagnostic strategy|diagnostic strategy
363605|NCT02035670|effectiveness|effectiveness
363606|NCT02035670|fever of unknown origin|fever of unknown origin
363607|NCT02035657|Merkel cell carcinoma|merkel cell carcinoma
363608|NCT02035657|MCC|mcc
363609|NCT02035631|Breast Neoplasms|breast neoplasms
363610|NCT02035631|Recurrence|recurrence
363611|NCT02035631|Motor Activity|motor activity
363612|NCT02035631|Diet|diet
363613|NCT02035631|Quality of Life|quality of life
363614|NCT02035579|concussion|concussion
363615|NCT02035579|mild traumatic brain injury|mild traumatic brain injury
363616|NCT02035579|post-concussion syndrome|post-concussion syndrome
363617|NCT02035579|adolescents|adolescents
363618|NCT02035579|sports injury|sports injury
363619|NCT02035579|aerobic training|aerobic training
363620|NCT02035579|stretching training|stretching training
363621|NCT02035566|Minority Health|minority health
363622|NCT02035566|Health Status Disparities|health status disparities
363623|NCT02035566|Health Care Disparities|health care disparities
363624|NCT02035566|Rural Health|rural health
363625|NCT02035566|Telemedicine|telemedicine
363626|NCT02035566|Health Services Research|health services research
363627|NCT02035566|Social Determinants of Health|social determinants of health
363628|NCT02035566|Ecological Theory of Health|ecological theory of health
363629|NCT02035527|squamous cell carcinoma|squamous cell carcinoma
363630|NCT02035527|head and neck|head and neck
363631|NCT02035514|multiple sclerosis|multiple sclerosis
363632|NCT02035514|mesenchymal stem cells|mesenchymal stem cells
363633|NCT02035514|autologous transplantation|autologous transplantation
363634|NCT02035514|MRI efficacy|mri efficacy
363635|NCT02035514|clinical safety|clinical safety
363636|NCT02035488|Dry powder inhalation|dry powder inhalation
363640|NCT02035475|Pelvic Lymph Node Dissection|pelvic lymph node dissection
363641|NCT02035475|Lymphoceles|lymphoceles
363642|NCT02035475|Prostate Malignancies|prostate malignancies
363643|NCT02035475|daVinci|davinci
363644|NCT02035475|Vessel Sealer|vessel sealer
363645|NCT02035475|EndoWrist One|endowrist one
363646|NCT02035449|Video laryngoscope|video laryngoscope
363647|NCT02035449|Pre-hospital|pre-hospital
363648|NCT02035449|Endotracheal intubation|endotracheal intubation
363649|NCT02035449|Difficult endotracheal intubation|difficult endotracheal intubation
363650|NCT02035449|Pre hospital Critical care|pre hospital critical care
363651|NCT02035449|McGrath MAC|mcgrath mac
363652|NCT02035449|Airway device|airway device
363653|NCT02035436|Respiration, artificial|respiration, artificial
363654|NCT02035436|Critcal care|critcal care
363655|NCT02035423|Vitamin D Deficiency|vitamin d deficiency
363656|NCT02035423|Compliance|compliance
363657|NCT02035423|Milk|milk
363658|NCT02035410|cardiac devices|cardiac devices
363659|NCT02035410|prevention|prevention
363660|NCT02035410|infection|infection
363661|NCT02035397|botulinum toxin|botulinum toxin
363662|NCT02035397|Endoscopy|endoscopy
363663|NCT02035397|Satiation|satiation
363664|NCT02035397|Diet|diet
363665|NCT02035397|Weight Loss|weight loss
363666|NCT02035358|Metastatic|metastatic
363667|NCT02035358|Recurrent|recurrent
363668|NCT02035358|Refractory|refractory
363669|NCT02035358|Renal Cell Carcinoma|renal cell carcinoma
363670|NCT02035358|Kidney|kidney
363671|NCT02035358|clear-cell renal cancer|clear-cell renal cancer
363672|NCT02035358|Cancer|cancer
363673|NCT02035345|Recurrent Ovarian Cancer|recurrent ovarian cancer
363674|NCT02035345|Platinum Sensitive Ovarian Cancer|platinum sensitive ovarian cancer
363675|NCT02035332|Excessive Uterine Bleeding|excessive uterine bleeding
363676|NCT02035332|Menorrhagia|menorrhagia
363677|NCT02035332|Endometrial Ablation|endometrial ablation
363678|NCT02035293|COPD Exacerbation|copd exacerbation
363679|NCT02035293|Pulmonary embolism|pulmonary embolism
363680|NCT02035293|Standardized and consensus diagnostic strategy|standardized and consensus diagnostic strategy
363681|NCT02035280|Spine|spine
363682|NCT02035280|Deformity|deformity
363683|NCT02035280|Fusion|fusion
363684|NCT02035280|Elderly|elderly
363685|NCT02035280|SRS-22r|srs-22r
363686|NCT02035241|Spices|spices
363687|NCT02035241|Herbs|herbs
363688|NCT02035241|Functional food|functional food
363689|NCT02035241|Cardiometabolic risk|cardiometabolic risk
363690|NCT02035241|Metabolic syndrome|metabolic syndrome
363691|NCT02035241|Inflammation|inflammation
363692|NCT02035241|Appetite|appetite
363693|NCT02035241|Gut hormone|gut hormone
363694|NCT02035228|Chronic Obstructive Pulmonary Disease|chronic obstructive pulmonary disease
363695|NCT02035228|Lung Hyperinflation|lung hyperinflation
363696|NCT02035228|Abdominal Muscle|abdominal muscle
363697|NCT02035228|Functional Electrical Stimulation|functional electrical stimulation
363698|NCT02035215|Hyperlipidemia, Familial Combined|hyperlipidemia, familial combined
363699|NCT02035215|Omega 3 acids ethylesters 90|omega 3 acids ethylesters 90
363700|NCT02035215|Atorvastatin|atorvastatin
363701|NCT02035176|autism|autism
363702|NCT02035176|ADHD|adhd
363703|NCT02035176|attention deficit hyperactivity disorder|attention deficit hyperactivity disorder
363704|NCT02035176|behavioral assessment|behavioral assessment
363705|NCT02035176|behavior|behavior
363706|NCT02035163|Atrial fibrillation|atrial fibrillation
363707|NCT02035163|coronary artery bypass graft|coronary artery bypass graft
363708|NCT02035163|cryoablation|cryoablation
363709|NCT02035163|ganglionic plexi|ganglionic plexi
363710|NCT02035150|breakfast|breakfast
363711|NCT02035150|oatmeal|oatmeal
363712|NCT02035150|appetite|appetite
363713|NCT02035150|cholesterol|cholesterol
363714|NCT02035124|Prostate|prostate
363715|NCT02035124|Metastatic|metastatic
363716|NCT02035124|Refractory|refractory
363717|NCT02035124|mCRPC|mcrpc
363718|NCT02035111|Migraine|migraine
363719|NCT02035111|Tianshu capsule|tianshu capsule
363720|NCT02035098|cancer, pain, cluster trial, quality improvement|cancer, pain, cluster trial, quality improvement
363721|NCT02035085|19F MRI|19f mri
363722|NCT02035059|Oral Glucose Tolerance Test|oral glucose tolerance test
363723|NCT02035059|Fibronectin|fibronectin
363724|NCT02035059|Adiponectin|adiponectin
363725|NCT02035059|Copeptin|copeptin
363726|NCT02035059|Cortisol|cortisol
363727|NCT02035046|Gitelman|gitelman
363728|NCT02035046|Heterozygous SLC12A3 mutation|heterozygous slc12a3 mutation
363729|NCT02035046|Blood pressure|blood pressure
363730|NCT02035046|Hypokalemia|hypokalemia
363731|NCT02035020|frataxin, gamma interferon, Friedreich ataxia|frataxin, gamma interferon, friedreich ataxia
363732|NCT02034994|school-based intervention|school-based intervention
363733|NCT02034994|after school physical activity|after school physical activity
363734|NCT02034994|sugar sweetened beverages|sugar sweetened beverages
363735|NCT02034994|sedentary behavior|sedentary behavior
363736|NCT02034994|schoolchildren|schoolchildren
363737|NCT02034981|metastatic or unresectable locally advanced malignancies.|metastatic or unresectable locally advanced malignancies.
363738|NCT02034981|genomic alterations.|genomic alterations.
363739|NCT02034981|biological crizotinib targets (ALK, MET, ROS1, RON, AXL).|biological crizotinib targets (alk, met, ros1, ron, axl).
363740|NCT02034968|Nimotuzumab|nimotuzumab
363741|NCT02034968|Nab-Paclitaxel|nab-paclitaxel
363742|NCT02034968|Carcinoma of Esophagus|carcinoma of esophagus
363743|NCT02034955|Prostate Cancer|prostate cancer
363744|NCT02034955|Adaptive Radiotherapy|adaptive radiotherapy
363745|NCT02034955|Prostatectomy|prostatectomy
363746|NCT02034955|Patients who had a prostatectomy|patients who had a prostatectomy
363747|NCT02034942|non-sedation|non-sedation
363748|NCT02034929|colon cancer|colon cancer
363749|NCT02034929|adenoma|adenoma
363750|NCT02034929|colon polyps|colon polyps
363751|NCT02034916|Breast cancer|breast cancer
363752|NCT02034916|BRCA mutation|brca mutation
363753|NCT02034916|PARP inhibitor|parp inhibitor
363754|NCT02034916|BRCA 1|brca 1
363755|NCT02034916|BRCA 2|brca 2
363756|NCT02034903|Enteral Feeding|enteral feeding
363757|NCT02034903|Infant, Premature|infant, premature
363758|NCT02034890|orthotopic neobladder|orthotopic neobladder
363759|NCT02034890|urinary tract infection|urinary tract infection
363760|NCT02034890|intravesical instillation|intravesical instillation
363761|NCT02034890|hyaluronic acid|hyaluronic acid
363762|NCT02034877|13-valent pneunococcal conjugate vaccine|13-valent pneunococcal conjugate vaccine
363763|NCT02034877|pneumococcal disease prevention; safety and immunogenicity study|pneumococcal disease prevention; safety and immunogenicity study
363764|NCT02034864|low back pain|low back pain
363765|NCT02034864|manual therapy|manual therapy
363766|NCT02034864|randomized controlled trial|randomized controlled trial
363767|NCT02034851|Acute pyelonephritis|acute pyelonephritis
363768|NCT02034851|Renal scarring|renal scarring
363769|NCT02034851|Dexamethasone|dexamethasone
363770|NCT02034851|Children|children
363771|NCT02034851|Corticoids|corticoids
363772|NCT02034851|Complementary treatment|complementary treatment
363773|NCT02034851|Prevention strategy|prevention strategy
363774|NCT02034838|PK|pk
363775|NCT02034838|pharmacokinetic|pharmacokinetic
363776|NCT02034838|HIV-infected|hiv-infected
363777|NCT02034838|atazanavir|atazanavir
363778|NCT02034838|ritonavir|ritonavir
363779|NCT02034786|Mesenchymal stem cell|mesenchymal stem cell
363780|NCT02034786|Hyaluronic acid|hyaluronic acid
363781|NCT02034786|Adipose Tissue|adipose tissue
363782|NCT02034786|Filler Agent|filler agent
363783|NCT02034773|Safety, Pharmacokinetics, Pharmacodynamics, Healthy Subjects|safety, pharmacokinetics, pharmacodynamics, healthy subjects
363784|NCT02034760|Frailty|frailty
363785|NCT02034760|Ageing|ageing
363786|NCT02034760|Protein supplementation|protein supplementation
363787|NCT02034760|Protein quality|protein quality
363788|NCT02034760|Gut microbiota|gut microbiota
363789|NCT02034760|Metabolome|metabolome
363790|NCT02034760|Exercise training|exercise training
363791|NCT02034760|Sarcopenia|sarcopenia
363792|NCT02034747|Immunosuppressive regimen|immunosuppressive regimen
363793|NCT02034747|Advagraf|advagraf
363794|NCT02034747|kidney transplant|kidney transplant
363795|NCT02034747|Corticosteroid|corticosteroid
363796|NCT02034734|Phase 1|phase 1
363797|NCT02034734|ASP3652|asp3652
363798|NCT02034734|Cerebrospinal fluid (CSF)|cerebrospinal fluid (csf)
363799|NCT02034734|Multiple doses|multiple doses
363800|NCT02034721|Muscle damage|muscle damage
363801|NCT02034721|Muscle soreness|muscle soreness
363802|NCT02034721|Muscle function|muscle function
363803|NCT02034721|Innate immune function|innate immune function
363804|NCT02034721|Inflammation|inflammation
363805|NCT02034708|Primary brain tumor|primary brain tumor
363806|NCT02034695|Diabetes mellitus|diabetes mellitus
363807|NCT02034669|Acute Spinal cord Injury, Adipose derived stem cells|acute spinal cord injury, adipose derived stem cells
363808|NCT02034656|imatinib resistance|imatinib resistance
363809|NCT02034656|mutation|mutation
363810|NCT02034630|hematopoietic stem cell transplantation|hematopoietic stem cell transplantation
363811|NCT02034617|Cognition|cognition
363812|NCT02034617|Family nursing|family nursing
363813|NCT02034617|Infant, premature|infant, premature
363814|NCT02034617|Object attachment|object attachment
363815|NCT02034617|Stress, physiological|stress, physiological
363816|NCT02034617|Stress, psychological|stress, psychological
363817|NCT02034604|Naftopidil|naftopidil
363818|NCT02034604|safety|safety
363819|NCT02034539|peripheral artery disease|peripheral artery disease
363820|NCT02034539|critical limb ischemia|critical limb ischemia
363821|NCT02034539|VADOplex|vadoplex
363822|NCT02034539|intermittent foot compression|intermittent foot compression
363823|NCT02034526|Sinus node disease|sinus node disease
363824|NCT02034526|Atrial fibrillation|atrial fibrillation
363825|NCT02034526|Pacing|pacing
363826|NCT02034500|prevention|prevention
363827|NCT02034500|Shigella sonnei|shigella sonnei
363828|NCT02034487|Delayed Puberty|delayed puberty
363829|NCT02034487|Boys|boys
363830|NCT02034487|Hormones|hormones
363831|NCT02034487|Polymorphism, Genetic|polymorphism, genetic
363832|NCT02034461|Micro-Electrodes|micro-electrodes
363833|NCT02034461|Peripheral Nerve Injury|peripheral nerve injury
363834|NCT02034461|Amputation|amputation
363835|NCT02034461|Spinal Cord Injury|spinal cord injury
363836|NCT02034448|CRRT|crrt
363837|NCT02034448|Renal|renal
363838|NCT02034448|Kidney|kidney
363839|NCT02034448|adults|adults
363840|NCT02034448|registry|registry
363841|NCT02034448|AKI|aki
363842|NCT02034422|Exercise|exercise
363843|NCT02034409|Knee Osteoarthritis|knee osteoarthritis
363844|NCT02034409|Pulsed Low Intensity Ultrasound|pulsed low intensity ultrasound
363845|NCT02034396|Ulcers, venous, unna's boot|ulcers, venous, unna's boot
363846|NCT02034370|Interscalene nerve block|interscalene nerve block
363847|NCT02034370|Shoulder surgery|shoulder surgery
363848|NCT02034370|Obstructive Sleep Apnea|obstructive sleep apnea
363849|NCT02034370|Sleep Disordered Breathing|sleep disordered breathing
363850|NCT02034357|Parkinson Disease|parkinson disease
363851|NCT02034357|Sleep Disordered Breathing|sleep disordered breathing
363852|NCT02034357|Sleep Obstructive Apnea|sleep obstructive apnea
363853|NCT02034357|Polysomnography|polysomnography
363854|NCT02034357|CPAP (continuous positive airway pressure) titration|cpap (continuous positive airway pressure) titration
363855|NCT02034357|CPAP (continuous positive airway pressure) treatment|cpap (continuous positive airway pressure) treatment
363856|NCT02034344|Lupus Erythematosus, Cutaneous|lupus erythematosus, cutaneous
363857|NCT02034344|Lupus Erythematosus, Systemic|lupus erythematosus, systemic
363858|NCT02034344|Lupus Erythematosus, Discoid|lupus erythematosus, discoid
363859|NCT02034344|Healthy|healthy
363860|NCT02034344|Active Cutaneous Lupus Erythematosus|active cutaneous lupus erythematosus
363861|NCT02034344|Longitudinal Study|longitudinal study
363862|NCT02034344|Biomarkers|biomarkers
363863|NCT02034344|Subacute Cutaneous Lupus Erythematosus|subacute cutaneous lupus erythematosus
363864|NCT02034344|Skin Biopsy|skin biopsy
363865|NCT02034331|Insulin Sensitivity|insulin sensitivity
363866|NCT02034331|Microvascular permeability|microvascular permeability
363867|NCT02034331|Sympathetic nervous system|sympathetic nervous system
363868|NCT02034318|Fatigue|fatigue
363869|NCT02034318|Cardiac Sympathetic Denervation|cardiac sympathetic denervation
363870|NCT02034318|Parkinson Disease|parkinson disease
363871|NCT02034305|Airway Clearance|airway clearance
363872|NCT02034305|Duchenne Muscular Dystrophy|duchenne muscular dystrophy
363873|NCT02034305|Peak Cough Flow|peak cough flow
363874|NCT02034279|cirrhosis|cirrhosis
363875|NCT02034266|Type one diabetes|type one diabetes
363876|NCT02034266|nerve damage|nerve damage
363877|NCT02034266|neuropathy|neuropathy
363878|NCT02034266|omega-3 fatty acid|omega-3 fatty acid
363879|NCT02034266|supplementation|supplementation
363880|NCT02034266|nutrition|nutrition
363881|NCT02034253|duration of untreated psychosis|duration of untreated psychosis
363882|NCT02034253|glutamate|glutamate
363883|NCT02034253|functional connectivity|functional connectivity
363884|NCT02034253|structural connectivity|structural connectivity
363885|NCT02034253|schizophrenia|schizophrenia
363886|NCT02034253|psychosis|psychosis
363887|NCT02034227|leukemia|leukemia
363888|NCT02034214|HIV|hiv
363889|NCT02034214|adolescents|adolescents
363890|NCT02034188|multiple sclerosis|multiple sclerosis
363891|NCT02034188|umbilical cord|umbilical cord
363892|NCT02034188|mesenchymal|mesenchymal
363893|NCT02034188|stem cells|stem cells
363894|NCT02034175|apnea|apnea
363895|NCT02034175|hypopnea|hypopnea
363896|NCT02034175|polysomnography|polysomnography
363897|NCT02034175|respiratory|respiratory
363898|NCT02034175|cheyne|cheyne
363899|NCT02034162|Helminth infections|helminth infections
363900|NCT02034162|Helminths|helminths
363901|NCT02034162|Pediatric|pediatric
363902|NCT02034162|Preschool aged|preschool aged
363903|NCT02034162|School aged|school aged
363904|NCT02034162|Mebendazole|mebendazole
363905|NCT02034162|Vermox|vermox
363906|NCT02034162|Placebo|placebo
363907|NCT02034149|chronic kidney disease|chronic kidney disease
363908|NCT02034149|high risk|high risk
363909|NCT02034149|intervention|intervention
363910|NCT02034149|hypertension|hypertension
363911|NCT02034149|hyperglycemia|hyperglycemia
363912|NCT02034149|hyperlipidemia|hyperlipidemia
363913|NCT02034123|First time in humans|first time in humans
363914|NCT02034123|Small cell lung carcinoma|small cell lung carcinoma
363915|NCT02034123|Oncology|oncology
363916|NCT02034123|GSK2879552|gsk2879552
363917|NCT02034123|LSD1 inhibitor|lsd1 inhibitor
363918|NCT02034110|solid tumors|solid tumors
363919|NCT02034110|efficacy|efficacy
363920|NCT02034110|BRAF V600E mutation|braf v600e mutation
363921|NCT02034110|trametinib|trametinib
363922|NCT02034110|safety|safety
363923|NCT02034110|Dabrafenib|dabrafenib
363924|NCT02034097|ROS1|ros1
363925|NCT02034097|erlotinib|erlotinib
363926|NCT02034097|EGFR|egfr
363927|NCT02034097|non-small cell lung cancer|non-small cell lung cancer
363928|NCT02034097|foretinib|foretinib
363929|NCT02034084|Transradial approach,|transradial approach,
363930|NCT02034084|Coronary angiography|coronary angiography
363931|NCT02034071|Prader-Willi syndrome|prader-willi syndrome
363932|NCT02034058|Wingspan Stent System|wingspan stent system
363933|NCT02034058|Wingspan Stent|wingspan stent
363934|NCT02034058|Intracranial Stent|intracranial stent
363935|NCT02034058|Ischemic Stroke|ischemic stroke
363936|NCT02034058|Intracranial Atherosclerotic Disease|intracranial atherosclerotic disease
363937|NCT02034058|Intracranial Stenosis|intracranial stenosis
363938|NCT02034032|Osteoarthritis|osteoarthritis
363939|NCT02034032|Knee|knee
363940|NCT02034032|Arthritis|arthritis
363941|NCT02034032|TKA|tka
363942|NCT02034032|Total Knee Arthroplasty|total knee arthroplasty
363943|NCT02034006|pathological myopia|pathological myopia
363944|NCT02034006|choroidal neovascularization|choroidal neovascularization
363945|NCT02034006|ranibizumab|ranibizumab
363946|NCT02034006|mono-bilateral|mono-bilateral
363947|NCT02034006|poor visual acuity|poor visual acuity
363948|NCT02034006|retinal disease|retinal disease
363949|NCT02034006|eye disease|eye disease
363950|NCT02034006|Angiogenesis Inhibitors|angiogenesis inhibitors
363951|NCT02034006|Angiogenesis Modulating Agents|angiogenesis modulating agents
363952|NCT02033980|narrow band imaging(NBI)|narrow band imaging(nbi)
363953|NCT02033980|NICE classification|nice classification
363954|NCT02033980|colorectal lesions|colorectal lesions
363955|NCT02033980|predicting histology|predicting histology
363956|NCT02033967|liver donor|liver donor
363957|NCT02033967|hepatectomy|hepatectomy
363958|NCT02033967|vasodilator|vasodilator
363959|NCT02033967|central venous pressure|central venous pressure
363960|NCT02033967|stroke volume variation|stroke volume variation
363961|NCT02033954|Embolization|embolization
363962|NCT02033954|Hemorrhage|hemorrhage
363963|NCT02033954|TIPS|tips
363964|NCT02033954|GI Bleeding|gi bleeding
363965|NCT02033954|AV Fistula|av fistula
363966|NCT02033954|AV Malformation|av malformation
363967|NCT02033954|Traumatic Vascular Injury|traumatic vascular injury
363968|NCT02033941|Alzheimer's Disease|alzheimer's disease
363969|NCT02033941|Grapeseed Extract|grapeseed extract
363970|NCT02033941|Clinical Trial|clinical trial
363971|NCT02033941|Meganatural-AZ|meganatural-az
363972|NCT02033941|anti-oligomerization|anti-oligomerization
363973|NCT02033941|Phase 2|phase 2
363974|NCT02033941|Dietary Supplement|dietary supplement
363975|NCT02033941|Nutraceutical|nutraceutical
363976|NCT02033928|Myeloma|myeloma
363977|NCT02033928|MGUS (monoclonal gammopathy of undetermined significance)|mgus (monoclonal gammopathy of undetermined significance)
363978|NCT02033928|amyloidosis|amyloidosis
363979|NCT02033928|stem cell transplant|stem cell transplant
363980|NCT02033915|Suicide risk assessment|suicide risk assessment
363981|NCT02033915|interactive discussion group|interactive discussion group
363982|NCT02033915|suicide attempt|suicide attempt
363983|NCT02033915|self-harm|self-harm
363984|NCT02033915|randomized control study|randomized control study
363985|NCT02033915|identifying high risk group for suicide|identifying high risk group for suicide
363986|NCT02033902|Epilepsy|epilepsy
363987|NCT02033863|Varicocele|varicocele
363988|NCT02033863|Pelvic Congestion Syndrome|pelvic congestion syndrome
363989|NCT02033863|Pelvic Venous Incompetence|pelvic venous incompetence
363990|NCT02033863|Ovarian Varices|ovarian varices
363991|NCT02033850|small vessel disease|small vessel disease
363992|NCT02033850|cognition|cognition
363993|NCT02033850|treatment|treatment
363994|NCT02033850|rehabilitation|rehabilitation
363995|NCT02033850|attention|attention
363996|NCT02033850|fMRI|fmri
363997|NCT02033850|vascular dementia|vascular dementia
363998|NCT02033837|Coronary artery disease|coronary artery disease
363999|NCT02033837|Cardiac CT|cardiac ct
364000|NCT02033837|Appropriate Use Criteria (AUC)|appropriate use criteria (auc)
364001|NCT02033811|mitral regurgitation|mitral regurgitation
364002|NCT02033811|MitraClip system|mitraclip system
400542|NCT01866371|retinal degeneration|retinal degeneration
364003|NCT02033811|percutaneous mitral valve repair|percutaneous mitral valve repair
364004|NCT02033798|Urodynamics|urodynamics
364005|NCT02033798|Glomerular Filtration Rate|glomerular filtration rate
364006|NCT02033785|Prostatic hyperplasia|prostatic hyperplasia
364007|NCT02033759|Lymphedema|lymphedema
364008|NCT02033733|Post cardiac arrest|post cardiac arrest
364009|NCT02033733|Postcardiac arrest therapeutic hypothermia|postcardiac arrest therapeutic hypothermia
364010|NCT02033733|Therapeutic hypothermia protocol|therapeutic hypothermia protocol
364011|NCT02033733|Neuromuscular blocking agents|neuromuscular blocking agents
364012|NCT02033733|Muscle relaxants|muscle relaxants
364013|NCT02033733|Hypothermia-induced increased muscle tone|hypothermia-induced increased muscle tone
364014|NCT02033733|Microshivering|microshivering
364015|NCT02033720|postcardiac arrest|postcardiac arrest
364016|NCT02033720|post cardiac arrest syndrome|post cardiac arrest syndrome
364017|NCT02033720|post cardiac arrest hypothermia|post cardiac arrest hypothermia
364018|NCT02033720|pulseless electrical activity|pulseless electrical activity
364019|NCT02033720|asystole|asystole
364020|NCT02033720|therapeutic hypothermia|therapeutic hypothermia
364021|NCT02033720|therapeutic hypothermia after cardiac arrest|therapeutic hypothermia after cardiac arrest
364022|NCT02033720|therapeutic hypothermia neurologic outcome|therapeutic hypothermia neurologic outcome
364023|NCT02033707|Hallucinogen|hallucinogen
364024|NCT02033707|Cognitive effects|cognitive effects
364025|NCT02033707|Subjective effects|subjective effects
364026|NCT02033694|Lipid|lipid
364027|NCT02033694|Vulnerable Plaque|vulnerable plaque
364028|NCT02033694|Plaque|plaque
364029|NCT02033694|Cholesterol|cholesterol
364030|NCT02033694|Near Infrared Spectroscopy|near infrared spectroscopy
364031|NCT02033694|NIRS-IVUS|nirs-ivus
364032|NCT02033694|Intravascular Ultrasound|intravascular ultrasound
364033|NCT02033694|Angiography|angiography
364034|NCT02033694|Coronary Imaging|coronary imaging
364035|NCT02033681|epinephrine|epinephrine
364036|NCT02033681|hand|hand
364037|NCT02033681|ischemia|ischemia
364038|NCT02033681|lidocaine|lidocaine
364039|NCT02033681|upper extremity|upper extremity
364040|NCT02033668|bioavailability|bioavailability
364041|NCT02033668|Pharmacokinetics|pharmacokinetics
364042|NCT02033668|intravenous|intravenous
364043|NCT02033668|subcutaneous and intramuscular administration|subcutaneous and intramuscular administration
364044|NCT02033668|amyloid beta|amyloid beta
364045|NCT02033668|monoclonal antibody|monoclonal antibody
364046|NCT02033655|weight loss|weight loss
364047|NCT02033655|older adults|older adults
364048|NCT02033655|obesity|obesity
364049|NCT02033629|Anesthesia|anesthesia
364050|NCT02033629|remifentanil|remifentanil
364051|NCT02033629|propofol|propofol
364052|NCT02033629|target-controlled infusion|target-controlled infusion
364053|NCT02033629|cardiac surgery|cardiac surgery
364054|NCT02033603|Total knee arthroplasty|total knee arthroplasty
364055|NCT02033603|Total knee replacement|total knee replacement
364056|NCT02033603|Femoral Nerve Block|femoral nerve block
364057|NCT02033603|Adductor Canal Block|adductor canal block
364058|NCT02033564|Sore Throat|sore throat
364059|NCT02033564|Intubation|intubation
364060|NCT02033564|Laryngoscopy|laryngoscopy
364061|NCT02033564|Anesthesiology|anesthesiology
364062|NCT02033564|Perioperative|perioperative
364063|NCT02033564|Airway Management|airway management
364064|NCT02033551|Gastric Cancer|gastric cancer
364065|NCT02033551|Lung Cancer|lung cancer
364066|NCT02033551|PARP Inhibitor|parp inhibitor
364067|NCT02033551|Ovarian Cancer|ovarian cancer
364068|NCT02033551|Solid Tumors|solid tumors
364069|NCT02033551|Breast Cancer|breast cancer
364070|NCT02033551|Colon Cancer|colon cancer
364071|NCT02033538|Neoadjuvant chemotherapy|neoadjuvant chemotherapy
364072|NCT02033538|Nab-Paclitaxel|nab-paclitaxel
364073|NCT02033538|Carcinoma of Esophagus|carcinoma of esophagus
364074|NCT02033525|Chronic Meniscal Injury|chronic meniscal injury
364075|NCT02033525|Degenerative meniscus|degenerative meniscus
364076|NCT02033525|Meniscus injury|meniscus injury
364077|NCT02033525|Meniscal injury|meniscal injury
364078|NCT02033525|Mesenchymal stromal cells|mesenchymal stromal cells
364079|NCT02033525|Mesenchymal stem cells|mesenchymal stem cells
364080|NCT02033525|Advanced Therapy|advanced therapy
364081|NCT02033525|Bone marrow|bone marrow
364082|NCT02033512|Post-menopause|post-menopause
364083|NCT02033512|Hormone Replacement Therapy|hormone replacement therapy
364084|NCT02033512|Nanotechnology|nanotechnology
364085|NCT02033512|Biolipid B2|biolipid b2
364086|NCT02033499|Blood Glucose Self-Monitoring|blood glucose self-monitoring
364087|NCT02033499|Self-Monitoring, Blood Glucose|self-monitoring, blood glucose
364088|NCT02033499|Diabetes Mellitus, Type 2|diabetes mellitus, type 2
364089|NCT02033499|Quality of Life|quality of life
364090|NCT02033486|diffuse optical tomography|diffuse optical tomography
364091|NCT02033486|digital breast tomosynthesis|digital breast tomosynthesis
364092|NCT02033486|breast cancer|breast cancer
364093|NCT02033486|solid benign lesions|solid benign lesions
364094|NCT02033486|cysts|cysts
364095|NCT02033486|malignant lesions|malignant lesions
364096|NCT02033473|Apelin|apelin
364097|NCT02033473|insulin|insulin
364098|NCT02033473|volunteers|volunteers
364099|NCT02033460|Manual therapy|manual therapy
364100|NCT02033460|Exercise|exercise
364101|NCT02033460|Education|education
364102|NCT02033447|Prostate Cancer|prostate cancer
364103|NCT02033434|intranasal|intranasal
364104|NCT02033434|ketamine|ketamine
364105|NCT02033434|analgesia|analgesia
364106|NCT02033434|mountain medicine|mountain medicine
364107|NCT02033434|pre-hospital care|pre-hospital care
364108|NCT02033434|patient transport|patient transport
364109|NCT02033434|pilot study|pilot study
364110|NCT02033434|mountain environment|mountain environment
364111|NCT02033421|Infective endocarditis|infective endocarditis
364112|NCT02033421|Therapeutic drug monitoring|therapeutic drug monitoring
364113|NCT02033408|IBD: Inflammatory Bowel Diseases|ibd: inflammatory bowel diseases
364114|NCT02033408|CD: Crohn's Disease|cd: crohn's disease
364115|NCT02033408|UC: Ulcerative Colitis|uc: ulcerative colitis
364116|NCT02033408|ASC: Acute Severe Colitis|asc: acute severe colitis
364117|NCT02033408|FMT: Fecal Microbiota Transplantation|fmt: fecal microbiota transplantation
364118|NCT02033408|PUCAI: Pediatric Ulcerative Colitis Activity Index|pucai: pediatric ulcerative colitis activity index
364119|NCT02033408|Ciprofloxacin, Doxycycline, Gentamycin, amoxicillin, vancomycin, metronidazole,ciprofloxacin|ciprofloxacin, doxycycline, gentamycin, amoxicillin, vancomycin, metronidazole,ciprofloxacin
364120|NCT02033369|Major depressive disorder|major depressive disorder
364121|NCT02033369|MDD|mdd
364122|NCT02033369|depression|depression
364123|NCT02033369|pramipexole|pramipexole
364124|NCT02033356|adductor canal block|adductor canal block
364125|NCT02033356|volunteers|volunteers
364126|NCT02033356|US-guided peripheral nerve block|us-guided peripheral nerve block
364127|NCT02033356|lower limb|lower limb
364128|NCT02033356|MRI|mri
364129|NCT02033343|Prostate Cancer|prostate cancer
364130|NCT02033343|Real-time tracking|real-time tracking
364131|NCT02033343|Radiotherapy|radiotherapy
364132|NCT02033343|Dynamic Multileaf Collimator|dynamic multileaf collimator
364133|NCT02033330|phenolics|phenolics
364134|NCT02033330|orange peel|orange peel
364135|NCT02033330|bioavailability|bioavailability
364136|NCT02033304|Cesarean section|cesarean section
364137|NCT02033304|Pain|pain
364138|NCT02033304|Wound hyperalgesia|wound hyperalgesia
364139|NCT02033291|Cerebral Small Vessel Disease|cerebral small vessel disease
364140|NCT02033291|Blood-Brain Barrier permeability|blood-brain barrier permeability
364141|NCT02033291|Dynamic contrast enhanced Magnetic Resonance Imaging|dynamic contrast enhanced magnetic resonance imaging
364142|NCT02033291|Pharmacokinetic modeling|pharmacokinetic modeling
364143|NCT02033291|Reproducibility|reproducibility
364144|NCT02033265|Ultrasound-guided Axillary Brachial Plexus Block|ultrasound-guided axillary brachial plexus block
364145|NCT02033265|Obesity|obesity
364146|NCT02033265|Performance time|performance time
364147|NCT02033265|Failure rate|failure rate
364148|NCT02033265|Acute complications|acute complications
364149|NCT02033226|Periodontitis|periodontitis
364150|NCT02033226|Periodontal Regeneration|periodontal regeneration
364151|NCT02033226|Amniotic membrane|amniotic membrane
364152|NCT02033226|Guided tissue regeneration|guided tissue regeneration
364153|NCT02033226|Anti-inflammatory|anti-inflammatory
364154|NCT02033226|Periodontal Therapy.|periodontal therapy.
364155|NCT02033213|intraoperative|intraoperative
364156|NCT02033213|fluid management|fluid management
364157|NCT02033213|esophageal carcinoma|esophageal carcinoma
364158|NCT02033213|surgery|surgery
364159|NCT02033213|gas exchange|gas exchange
364160|NCT02033213|tissue perfusion|tissue perfusion
364161|NCT02033200|vision|vision
364162|NCT02033200|Stendra|stendra
364163|NCT02033200|avanafil|avanafil
364164|NCT02033200|PDE5 inhibitor|pde5 inhibitor
364165|NCT02033200|visual acuity|visual acuity
364166|NCT02033200|intraocular pressure|intraocular pressure
364167|NCT02033200|pupillometry|pupillometry
364168|NCT02033200|color vision discrimination|color vision discrimination
364169|NCT02033200|healthy males|healthy males
364170|NCT02033174|alcohol, inflammation, oxidation.|alcohol, inflammation, oxidation.
364171|NCT02033161|Functional gastrointestinal disorders|functional gastrointestinal disorders
364172|NCT02033161|FGID|fgid
364173|NCT02033161|Recurrent abdominal pain|recurrent abdominal pain
364174|NCT02033161|Abdominal pain|abdominal pain
364175|NCT02033161|pain-related functional gastrointestinal disorders|pain-related functional gastrointestinal disorders
364176|NCT02033135|Atherosclerosis|atherosclerosis
364177|NCT02033135|Intermittent claudication|intermittent claudication
364178|NCT02033135|Angioplasty|angioplasty
364179|NCT02033122|exercise, bronchial hyperresponsiveness, inflammation|exercise, bronchial hyperresponsiveness, inflammation
364180|NCT02033096|stannsoporfin|stannsoporfin
364181|NCT02033096|hyperbilirubinemia|hyperbilirubinemia
364182|NCT02033096|heme oxygenase|heme oxygenase
364183|NCT02033083|abortion|abortion
364184|NCT02033083|cervical dilation|cervical dilation
364185|NCT02033070|RFA|rfa
364186|NCT02033057|Muscular electrostimulation, mechanically ventilated, critically ill patients, muscular weakness.|muscular electrostimulation, mechanically ventilated, critically ill patients, muscular weakness.
780039|NCT00329680|Nutrition|nutrition
465655|NCT01574352|Obesity|obesity
364187|NCT02033044|borderline personality disorder|borderline personality disorder
364188|NCT02033044|cognitive rehabilitation|cognitive rehabilitation
364189|NCT02033044|psychoeducation|psychoeducation
364190|NCT02033044|psychosocial functioning|psychosocial functioning
364191|NCT02033031|branch retinal vein occlusion|branch retinal vein occlusion
364192|NCT02033031|central retinal thickness|central retinal thickness
364193|NCT02033031|visual acuity|visual acuity
364194|NCT02033031|central reintal sensitivity|central reintal sensitivity
364195|NCT02033018|Aflibercept|aflibercept
364196|NCT02033018|Myopia|myopia
364197|NCT02033018|Complications|complications
364198|NCT02033018|Neovascularization|neovascularization
364199|NCT02033018|OCT|oct
364200|NCT02033005|Body Composition|body composition
364201|NCT02033005|Adipose Tissue|adipose tissue
364202|NCT02033005|Intrahepatocellular Lipid|intrahepatocellular lipid
364203|NCT02033005|Infant|infant
364204|NCT02033005|Magnetic Resonance Imaging|magnetic resonance imaging
364205|NCT02033005|Magnetic Resonance Spectroscopy|magnetic resonance spectroscopy
364206|NCT02032966|outcomes|outcomes
364207|NCT02032966|surgical|surgical
364208|NCT02032966|non-surgical|non-surgical
364209|NCT02032966|ankle|ankle
364210|NCT02032966|malleolus|malleolus
364211|NCT02032966|fracture|fracture
364212|NCT02032966|tibia|tibia
364213|NCT02032966|fibula|fibula
364214|NCT02032966|bimalleolar|bimalleolar
364215|NCT02032966|trimalleolar|trimalleolar
364216|NCT02032953|colorectal cancer|colorectal cancer
364217|NCT02032953|protein recovery|protein recovery
364218|NCT02032953|perioperative nutrition|perioperative nutrition
364219|NCT02032953|hyperinsulinemia|hyperinsulinemia
364220|NCT02032953|normoglycemia|normoglycemia
364221|NCT02032953|hyperinsulinemic-normoglycemic clamp|hyperinsulinemic-normoglycemic clamp
364222|NCT02032953|anabolism|anabolism
364223|NCT02032940|MRI, Angiography, Pulse Sequence|mri, angiography, pulse sequence
364224|NCT02032927|osteoarthritis|osteoarthritis
364225|NCT02032927|pain|pain
364226|NCT02032927|opioids|opioids
364227|NCT02032914|pyogenic liver abscess|pyogenic liver abscess
364228|NCT02032914|colon cancer|colon cancer
364229|NCT02032862|menopause, hot flushes, hot flashes, salvia, sage, sweating|menopause, hot flushes, hot flashes, salvia, sage, sweating
364230|NCT02032849|ventilator associated pneumonia|ventilator associated pneumonia
364231|NCT02032849|subglottic secretion drainage|subglottic secretion drainage
364232|NCT02032849|manual air-impingement operation|manual air-impingement operation
364233|NCT02032849|prolonged intubation|prolonged intubation
364234|NCT02032823|Breast Cancer|breast cancer
364235|NCT02032823|Adjuvant|adjuvant
364236|NCT02032823|Olaparib|olaparib
364237|NCT02032823|BRCA 1/2|brca 1/2
364238|NCT02032823|HER2|her2
364239|NCT02032810|Stage III Melanoma|stage iii melanoma
364240|NCT02032810|Stage IV Melanoma|stage iv melanoma
364241|NCT02032810|HDAC Inhibitor|hdac inhibitor
364242|NCT02032758|Occupational; Cramp(s)|occupational; cramp(s)
364243|NCT02032719|Hypertension, Systolic, Uncontrolled|hypertension, systolic, uncontrolled
364244|NCT02032706|obstructive sleep apnea|obstructive sleep apnea
364245|NCT02032706|position therapy|position therapy
364246|NCT02032706|snoring|snoring
364247|NCT02032706|positional|positional
364248|NCT02032693|Everycell|everycell
364249|NCT02032693|DNA damage|dna damage
364250|NCT02032693|DNA inflammation|dna inflammation
364251|NCT02032693|DNA stress|dna stress
364252|NCT02032667|physical activity|physical activity
364253|NCT02032667|exergames|exergames
364254|NCT02032654|antibiotics|antibiotics
364255|NCT02032654|flucloxacillin|flucloxacillin
364256|NCT02032654|therapy duration|therapy duration
364257|NCT02032654|cellulitis|cellulitis
364258|NCT02032654|erysipelas|erysipelas
364259|NCT02032654|skin infections|skin infections
364260|NCT02032654|hospital|hospital
364261|NCT02032641|Non-ablative laser|non-ablative laser
364262|NCT02032641|Scar revision|scar revision
364263|NCT02032641|direct brow lift|direct brow lift
364264|NCT02032628|epigenetics|epigenetics
364265|NCT02032628|cancer|cancer
364266|NCT02032628|exercise|exercise
364267|NCT02032628|intensity|intensity
364268|NCT02032628|duration|duration
364269|NCT02032615|anemia|anemia
364270|NCT02032602|Myofascial Pain Syndromes|myofascial pain syndromes
364271|NCT02032602|Trigger Point|trigger point
364272|NCT02032602|Shoulder Pain|shoulder pain
364273|NCT02032602|Aged|aged
364274|NCT02032576|major depressive episode, electroconvulsive therapy|major depressive episode, electroconvulsive therapy
364275|NCT02032563|neoadjuvant therapy|neoadjuvant therapy
364276|NCT02032550|Localized prostate cancer|localized prostate cancer
364277|NCT02032550|Patient preference|patient preference
364278|NCT02032550|Treatment choice|treatment choice
364279|NCT02032550|Decision making|decision making
364280|NCT02032550|Patient centered outcomes|patient centered outcomes
364281|NCT02032537|callmax cream|callmax cream
364282|NCT02032537|uremic pruritus|uremic pruritus
364283|NCT02032498|sentinel lymph nodes|sentinel lymph nodes
364284|NCT02032498|radiocolloids|radiocolloids
364285|NCT02032498|Indocyanine Green|indocyanine green
364286|NCT02032498|complementarity|complementarity
364287|NCT02032498|axillary lymph node dissection|axillary lymph node dissection
364288|NCT02032485|colorectal cancer|colorectal cancer
364289|NCT02032485|Indocyanine Green|indocyanine green
364290|NCT02032485|visualization of peritoneal metastases|visualization of peritoneal metastases
364291|NCT02032472|Blood Pressure Monitoring, Ambulatory|blood pressure monitoring, ambulatory
364292|NCT02032472|Arterial Pressure|arterial pressure
364293|NCT02032472|Hypertension Controlled|hypertension controlled
364294|NCT02032472|Pharmacies|pharmacies
364295|NCT02032459|Pregnancy|pregnancy
364296|NCT02032459|Minority Women|minority women
364297|NCT02032459|Preterm delivery|preterm delivery
364298|NCT02032459|Fetal growth restriction|fetal growth restriction
364299|NCT02032459|Preeclampsia|preeclampsia
364300|NCT02032459|Gestational Diabetes|gestational diabetes
364301|NCT02032459|Vitamin D|vitamin d
364302|NCT02032433|extended-release naltrexone (Vivitrol)|extended-release naltrexone (vivitrol)
364303|NCT02032433|buprenorphine-naloxone (Suboxone)|buprenorphine-naloxone (suboxone)
364304|NCT02032433|comparative effective|comparative effective
364305|NCT02032433|relapse prevention|relapse prevention
364306|NCT02032394|Chlorhexidine|chlorhexidine
364307|NCT02032394|Povidone-iodine|povidone-iodine
364308|NCT02032394|bacteriuria|bacteriuria
364309|NCT02032394|Urinary Catheterization|urinary catheterization
364310|NCT02032394|Urinary tract infection|urinary tract infection
364311|NCT02032381|non infectious pulmonary complications after hematopoietic cell transplant|non infectious pulmonary complications after hematopoietic cell transplant
364312|NCT02032381|functional respiratory test and exercise test|functional respiratory test and exercise test
364313|NCT02032381|thoracic tomodensitometry|thoracic tomodensitometry
364314|NCT02032368|circulating tumour cell;|circulating tumour cell;
364315|NCT02032368|transarterial chemoembolization;|transarterial chemoembolization;
364316|NCT02032368|hepatocellular carcinoma;|hepatocellular carcinoma;
364317|NCT02032368|recurrence|recurrence
364414|NCT02031913|Steatosis|steatosis
364318|NCT02032329|Functional Electrical Stimulation (FES)|functional electrical stimulation (fes)
364319|NCT02032316|Renal Stone|renal stone
364320|NCT02032316|Ureteroscopy|ureteroscopy
364321|NCT02032316|Ureteral Stent|ureteral stent
364322|NCT02032316|post-uncomplicated ureteroscopy|post-uncomplicated ureteroscopy
364323|NCT02032316|UURS|uurs
364324|NCT02032277|Oncology|oncology
364325|NCT02032277|Triple negative breast cancer|triple negative breast cancer
364326|NCT02032277|German Breast Group - GBG 81|german breast group - gbg 81
364327|NCT02032277|United States Oncology - 12152|united states oncology - 12152
364328|NCT02032277|National Surgical Adjuvant Breast and Bowel Project - B-56-I|national surgical adjuvant breast and bowel project - b-56-i
364329|NCT02032277|Alliance - AFT-04|alliance - aft-04
364330|NCT02032277|Grupo Español de Investigación en Cáncer de Mama - GEICAM/2014-02|grupo español de investigación en cáncer de mama - geicam/2014-02
364331|NCT02032264|Next generation sequencing|next generation sequencing
364332|NCT02032264|Embryonic aneuploidy|embryonic aneuploidy
364333|NCT02032251|Sperm DNA damage ejaculated spermatozoa Ginger Herbal Drug Herbal medicine|sperm dna damage ejaculated spermatozoa ginger herbal drug herbal medicine
364334|NCT02032199|Gastric bypass|gastric bypass
364335|NCT02032199|Health-related quality of life|health-related quality of life
364336|NCT02032199|SF-36|sf-36
364337|NCT02032199|Questionnaire|questionnaire
364338|NCT02032199|Treatment guidelines|treatment guidelines
364339|NCT02032186|magnesium|magnesium
364340|NCT02032186|prematurity|prematurity
364341|NCT02032173|Ranibizumab|ranibizumab
364342|NCT02032173|Diabetic Macular Edema|diabetic macular edema
364343|NCT02032160|ADITEC|aditec
364344|NCT02032160|Immunology|immunology
364345|NCT02032160|Vaccines|vaccines
364346|NCT02032160|Hepatitis B|hepatitis b
364347|NCT02032160|Investigational study|investigational study
364348|NCT02032160|innate and adaptive immune responses|innate and adaptive immune responses
364349|NCT02032160|Hepatitis B vaccinations|hepatitis b vaccinations
364350|NCT02032134|Cryopreserved platelets, thrombocytopenia, DMSO|cryopreserved platelets, thrombocytopenia, dmso
364351|NCT02032121|Cancer survivors|cancer survivors
364352|NCT02032121|Long-term cancer survivor|long-term cancer survivor
364353|NCT02032108|Diabetes lifestyle intervention Rwanda|diabetes lifestyle intervention rwanda
364354|NCT02032095|IVIG|ivig
364355|NCT02032095|Renal transplantation|renal transplantation
364356|NCT02032095|desensitization|desensitization
364357|NCT02032056|Infections|infections
364358|NCT02032056|Allergy|allergy
364359|NCT02032056|Immune function|immune function
364360|NCT02032056|Microbiota|microbiota
364361|NCT02032056|infant|infant
364362|NCT02032043|Filariasis|filariasis
364363|NCT02032043|Onchocerciasis|onchocerciasis
364364|NCT02032043|Albendazole|albendazole
364365|NCT02032043|Ivermectin|ivermectin
364366|NCT02032043|STH Soil Transmitted Helminth infections|sth soil transmitted helminth infections
364367|NCT02032043|MDA Mass Drug Administration|mda mass drug administration
364368|NCT02032030|quality of Life|quality of life
364369|NCT02032030|pain|pain
364370|NCT02032030|nausea|nausea
364371|NCT02032030|falls|falls
364372|NCT02032030|intraoperative awareness|intraoperative awareness
364373|NCT02032030|anesthesia awareness|anesthesia awareness
364374|NCT02032030|cognition|cognition
364375|NCT02032030|activities of daily living|activities of daily living
364376|NCT02032030|major morbidity|major morbidity
364377|NCT02032030|all-cause mortality|all-cause mortality
364378|NCT02032017|Total Hip Arthroplasty|total hip arthroplasty
364379|NCT02032017|Gluteus medius|gluteus medius
364380|NCT02032017|Approach|approach
364381|NCT02032017|Rehabilitation|rehabilitation
364382|NCT02032017|Functional outcome|functional outcome
364383|NCT02032004|Chronic Heart Failure|chronic heart failure
364384|NCT02032004|CHF|chf
364385|NCT02032004|Left Ventricular Systolic Dysfunction|left ventricular systolic dysfunction
364386|NCT02032004|Ischemic Heart Failure|ischemic heart failure
364387|NCT02032004|Nonischemic Heart Failure|nonischemic heart failure
364388|NCT02032004|Stem Cells|stem cells
364389|NCT02032004|Allogeneic Mesenchymal Precursor Cells|allogeneic mesenchymal precursor cells
364390|NCT02031991|Bioequivalence|bioequivalence
364391|NCT02031991|Biosimilarity|biosimilarity
364392|NCT02031991|Similarity|similarity
364394|NCT02031991|Phase 1|phase 1
364395|NCT02031991|Bevacizumab|bevacizumab
364396|NCT02031991|Healthy Volunteers|healthy volunteers
364397|NCT02031991|Single-Dose|single-dose
364398|NCT02031991|Oncology|oncology
364399|NCT02031978|Breast Feeding|breast feeding
364400|NCT02031978|Infant Nutrition|infant nutrition
364401|NCT02031978|Childhood Obesity|childhood obesity
364402|NCT02031978|Infant feeding patterns|infant feeding patterns
364403|NCT02031978|WIC|wic
364404|NCT02031952|hepatocellular carcinoma|hepatocellular carcinoma
364405|NCT02031952|hepatectomy|hepatectomy
364406|NCT02031952|lymphadenectomy|lymphadenectomy
364407|NCT02031952|complication|complication
364408|NCT02031952|prognosis|prognosis
364409|NCT02031939|Rectal cancer|rectal cancer
364410|NCT02031939|neoadjuvant chemoradiotherapy|neoadjuvant chemoradiotherapy
364411|NCT02031939|optimization|optimization
364412|NCT02031913|Chronic hepatitis B|chronic hepatitis b
364413|NCT02031913|Hepatic fibrosis|hepatic fibrosis
364415|NCT02031887|starter formula|starter formula
364416|NCT02031887|stool microbiota|stool microbiota
364418|NCT02031887|caesarean section delivery|caesarean section delivery
364419|NCT02031874|H1N1|h1n1
364420|NCT02031874|HIV|hiv
364421|NCT02031874|Immunogenecity|immunogenecity
364422|NCT02031848|weight loss|weight loss
364423|NCT02031848|diet|diet
364424|NCT02031822|Primary Headache|primary headache
364425|NCT02031822|Greater Occipital Nerve|greater occipital nerve
364426|NCT02031822|Ultrasound|ultrasound
364427|NCT02031822|Chronic Pain|chronic pain
364428|NCT02031822|Cervicogenic|cervicogenic
364429|NCT02031822|Occipital Neuralgia|occipital neuralgia
364430|NCT02031822|Migraine|migraine
364431|NCT02031822|Tension type headache|tension type headache
364432|NCT02031822|Cluster headache|cluster headache
364433|NCT02031809|Thoracic Surgery, Video-Assisted|thoracic surgery, video-assisted
364434|NCT02031770|vascular endothelial cells|vascular endothelial cells
364435|NCT02031757|Balance control|balance control
364436|NCT02031757|Aging|aging
364437|NCT02031757|Balance reactions|balance reactions
364438|NCT02031757|Perturbation|perturbation
364439|NCT02031705|Fibrillation|fibrillation
364440|NCT02031705|Catheter ablation|catheter ablation
364441|NCT02031692|Benign paroxysmal positional vertigo|benign paroxysmal positional vertigo
364442|NCT02031692|Vitamin D|vitamin d
364443|NCT02031692|Calcium|calcium
364444|NCT02031692|Prevention|prevention
364445|NCT02031679|Chronic Idiopathic Urticaria|chronic idiopathic urticaria
364446|NCT02031666|Healthy|healthy
364447|NCT02031666|JNJ-56021927|jnj-56021927
364448|NCT02031666|ARN-509|arn-509
364449|NCT02031666|Bioavailability|bioavailability
364450|NCT02031653|Penile Cuff Test|penile cuff test
364451|NCT02031640|asthma|asthma
364452|NCT02031640|breath-actuated inhaler|breath-actuated inhaler
364453|NCT02031640|metered-dose inhaler|metered-dose inhaler
364454|NCT02031627|lymphedema|lymphedema
364455|NCT02031627|lymphoedema|lymphoedema
364456|NCT02031627|leg lymphoedema|leg lymphoedema
364457|NCT02031627|lower extremity lymphoedema|lower extremity lymphoedema
364458|NCT02031627|pneumatic compression device|pneumatic compression device
364459|NCT02031614|anemia|anemia
364460|NCT02031614|blood withdrawal|blood withdrawal
364461|NCT02031614|phlebotomy|phlebotomy
364462|NCT02031614|innate immunity|innate immunity
364463|NCT02031614|Immune reponse|immune reponse
364464|NCT02031588|Study of commensal flora|study of commensal flora
364465|NCT02031588|Fluoroquinolones|fluoroquinolones
364466|NCT02031575|Reproductive Health|reproductive health
364467|NCT02031575|Contraception|contraception
364468|NCT02031575|Public Health|public health
364469|NCT02031575|Sexual Health|sexual health
364470|NCT02031575|Adolescents|adolescents
364471|NCT02031575|Mobile Health|mobile health
364472|NCT02031562|Balance|balance
364473|NCT02031562|Falls|falls
364474|NCT02031562|Low back pain|low back pain
364475|NCT02031562|Geriatric|geriatric
364476|NCT02031523|endometriosis|endometriosis
364477|NCT02031523|dysmenorrhea|dysmenorrhea
364478|NCT02031523|Sanjie analgesic capsule|sanjie analgesic capsule
364479|NCT02031523|effect/safety|effect/safety
364480|NCT02031497|Sweetener, insulin, body mass index, physical activity|sweetener, insulin, body mass index, physical activity
364481|NCT02031432|cancer-related pain|cancer-related pain
364482|NCT02031432|cebranopadol|cebranopadol
364483|NCT02031419|CC-122|cc-122
364484|NCT02031419|CC-223|cc-223
364485|NCT02031419|CC-292|cc-292
364486|NCT02031419|Rituximab|rituximab
364487|NCT02031419|Lymphoma|lymphoma
364488|NCT02031419|Diffuse Large B-Cell Lymphoma|diffuse large b-cell lymphoma
364489|NCT02031419|Lenalidomide naïve Follicular Lymphoma|lenalidomide naïve follicular lymphoma
364490|NCT02031419|Lenalidomide exposed Follicular Lymphoma|lenalidomide exposed follicular lymphoma
364491|NCT02031380|Glaucoma|glaucoma
364492|NCT02031380|Open angle glaucoma|open angle glaucoma
364493|NCT02031380|ocular hypertension|ocular hypertension
364494|NCT02031380|compliance|compliance
364495|NCT02031354|Lysine Chloride|lysine chloride
364496|NCT02031328|prostate|prostate
364497|NCT02031328|radiation|radiation
364498|NCT02031328|stereotactic body radiation|stereotactic body radiation
364499|NCT02031315|sudden death|sudden death
364500|NCT02031315|sudden cardiac arrest|sudden cardiac arrest
364501|NCT02031302|Lotus|lotus
364502|NCT02031302|Valve|valve
364503|NCT02031302|Real world|real world
364504|NCT02031302|Aortic stenosis|aortic stenosis
364505|NCT02031302|High risk|high risk
364506|NCT02031289|Anemia|anemia
364507|NCT02031289|Iron deficiency|iron deficiency
364508|NCT02031289|Cardiac surgery|cardiac surgery
364509|NCT02031289|Perioperative Care|perioperative care
364510|NCT02031276|ABBV-066|abbv-066
364511|NCT02031276|BI 655066|bi 655066
364512|NCT02031276|risankizumab|risankizumab
364513|NCT02031224|Chronic Kidney Disease|chronic kidney disease
364514|NCT02031224|Restricted protein diets|restricted protein diets
364515|NCT02031224|Nutritional status|nutritional status
364516|NCT02031198|Alzheimer's disease|alzheimer's disease
364517|NCT02031198|tau|tau
364518|NCT02031198|dementia|dementia
364519|NCT02031198|elderly|elderly
364520|NCT02031198|cognitive|cognitive
364521|NCT02031198|disease modifying|disease modifying
364522|NCT02031198|treatment|treatment
364523|NCT02031198|immunization|immunization
364524|NCT02031198|vaccine|vaccine
364525|NCT02031172|Dry Eye Disease|dry eye disease
364526|NCT02031172|Sjogren's Syndrome|sjogren's syndrome
364527|NCT02031172|Tear Film|tear film
364528|NCT02031172|Ocular Surface|ocular surface
364529|NCT02031172|Aqueous Tear Deficiency|aqueous tear deficiency
364530|NCT02031159|perioperative hypothermia|perioperative hypothermia
364531|NCT02031159|zero heat flux|zero heat flux
364532|NCT02031159|non-invasive measurement of body core temperature|non-invasive measurement of body core temperature
364533|NCT02031107|stroke|stroke
364534|NCT02031107|brain stimulation|brain stimulation
364535|NCT02031107|electroencephalography|electroencephalography
364536|NCT02031107|functional magnetic resonance imaging|functional magnetic resonance imaging
364537|NCT02031107|functional connectivity|functional connectivity
364538|NCT02031068|active rehabilitation|active rehabilitation
364539|NCT02031068|exercise|exercise
364540|NCT02031068|concussion|concussion
364541|NCT02031055|Advanced solid tumors|advanced solid tumors
364542|NCT02031042|neoadjuvant chemotherapy|neoadjuvant chemotherapy
364543|NCT02031042|breast cancer|breast cancer
364544|NCT02031042|sentinel lymph node biopsy|sentinel lymph node biopsy
364545|NCT02031042|false negative rate|false negative rate
364546|NCT02031042|identification rate|identification rate
364547|NCT02031029|personality scores|personality scores
364548|NCT02031016|Chronic thoracic pain|chronic thoracic pain
364549|NCT02031016|Remifentanil|remifentanil
364550|NCT02031016|Fentanyl|fentanyl
364551|NCT02031016|sternotomy|sternotomy
364552|NCT02030990|photorefractive keratectomy|photorefractive keratectomy
364553|NCT02030990|corneal haze|corneal haze
364554|NCT02030990|mitomycin-C|mitomycin-c
364555|NCT02030990|postoperative steroids|postoperative steroids
364556|NCT02030951|preterm infant behavior|preterm infant behavior
364557|NCT02030951|tube feeding|tube feeding
364558|NCT02030951|feeding efficiency|feeding efficiency
364559|NCT02030938|breast implant|breast implant
364560|NCT02030938|revision augmentation|revision augmentation
364561|NCT02030938|stretch deformity|stretch deformity
364562|NCT02030938|fold malposition|fold malposition
364563|NCT02030938|bottoming out|bottoming out
364564|NCT02030912|The impact of a number of different types of antibiotics|the impact of a number of different types of antibiotics
364565|NCT02030912|The emergence and persistence of antibiotic resistance|the emergence and persistence of antibiotic resistance
364566|NCT02030899|Cervical vertebrae|cervical vertebrae
364567|NCT02030899|single|single
364568|NCT02030899|degenerative disease|degenerative disease
364569|NCT02030899|Fusion|fusion
364570|NCT02030899|Sagittal angle|sagittal angle
364571|NCT02030873|virtual simulation|virtual simulation
466154|NCT01572506|Anemia|anemia
364572|NCT02030873|temporal bone|temporal bone
364573|NCT02030873|surgical training|surgical training
364574|NCT02030873|medical education|medical education
364575|NCT02030873|self-directed learning|self-directed learning
364576|NCT02030873|final product assessment|final product assessment
364577|NCT02030873|cognitive load|cognitive load
364578|NCT02030873|reaction time|reaction time
364579|NCT02030873|skills training|skills training
364580|NCT02030873|simulator metrics|simulator metrics
364581|NCT02030808|Thoracic surgery|thoracic surgery
364582|NCT02030808|non-muscle relaxant|non-muscle relaxant
364583|NCT02030808|target-controlled infusion|target-controlled infusion
364584|NCT02030808|remifentanil|remifentanil
364585|NCT02030808|surgical conditions|surgical conditions
364586|NCT02030795|Thoracic surgery|thoracic surgery
364587|NCT02030795|Arndt® blocker|arndt® blocker
364588|NCT02030795|lung deflation|lung deflation
364589|NCT02030795|Disconnection technique|disconnection technique
364590|NCT02030795|Continuous suction|continuous suction
364591|NCT02030795|Elective video-assisted thoracoscopic|elective video-assisted thoracoscopic
364592|NCT02030782|depression|depression
364593|NCT02030782|quality improvement|quality improvement
364594|NCT02030782|treatment|treatment
364595|NCT02030782|adolescents|adolescents
364596|NCT02030769|Esophageal Neoplasms|esophageal neoplasms
364597|NCT02030769|Lugol's solution|lugol's solution
364598|NCT02030769|Pronase|pronase
364599|NCT02030769|Endoscopy, Digestive System|endoscopy, digestive system
364600|NCT02030769|Pretreatment method|pretreatment method
364601|NCT02030756|constipation|constipation
364602|NCT02030743|Falls|falls
364603|NCT02030743|Older adults|older adults
364604|NCT02030743|Balance|balance
364605|NCT02030743|Mobility|mobility
364606|NCT02030743|Visual attention|visual attention
364607|NCT02030730|Brief Parenting Training|brief parenting training
364608|NCT02030730|Early Intervention|early intervention
364609|NCT02030730|Child Behavior|child behavior
364610|NCT02030730|Greece|greece
364611|NCT02030717|Spinal anesthesia|spinal anesthesia
364612|NCT02030717|Epidural anesthesia|epidural anesthesia
364613|NCT02030717|Klonidin|klonidin
364614|NCT02030717|renal cell carcinoma|renal cell carcinoma
365011|NCT02029001|Durvalumab|durvalumab
364615|NCT02030691|Neonatal respiratory distress|neonatal respiratory distress
364616|NCT02030691|nHFPV|nhfpv
364617|NCT02030691|nCPAP|ncpap
364618|NCT02030691|cerebral tissue oxygenation|cerebral tissue oxygenation
364619|NCT02030691|NIRS|nirs
364620|NCT02030665|Marijuana Dependence|marijuana dependence
364621|NCT02030665|Individualized treatment|individualized treatment
364622|NCT02030665|Motivational Enhancement Treatment|motivational enhancement treatment
364623|NCT02030665|Cognitive-Behavioral Treatment|cognitive-behavioral treatment
364624|NCT02030665|Contingency Management|contingency management
364625|NCT02030652|premature newborn|premature newborn
364626|NCT02030652|nasal ventilation|nasal ventilation
364627|NCT02030652|noninvasive ventilation|noninvasive ventilation
364628|NCT02030652|continuous positive airway pressure|continuous positive airway pressure
364629|NCT02030626|Neuropathic pain|neuropathic pain
364630|NCT02030626|lumbar radiculopathy|lumbar radiculopathy
364631|NCT02030626|rTMS|rtms
364632|NCT02030626|tDCS|tdcs
364633|NCT02030626|placebo controlled study|placebo controlled study
364634|NCT02030613|juvenile idiopathic arthritis|juvenile idiopathic arthritis
364635|NCT02030613|etanercept|etanercept
364636|NCT02030587|Hyperaldosteronism|hyperaldosteronism
364637|NCT02030587|Adrenocortical adenoma|adrenocortical adenoma
364638|NCT02030587|Adrenalectomy|adrenalectomy
364639|NCT02030587|Catheter ablation|catheter ablation
364640|NCT02030561|NK cells|nk cells
364641|NCT02030561|trastuzumab|trastuzumab
364642|NCT02030561|immunotherapy|immunotherapy
364643|NCT02030548|CABG|cabg
364644|NCT02030548|dual antiplatelet therapy|dual antiplatelet therapy
364645|NCT02030548|aspirin|aspirin
364646|NCT02030548|clopidogrel|clopidogrel
364647|NCT02030548|prasugrel|prasugrel
364648|NCT02030548|ticagrelor|ticagrelor
364649|NCT02030522|Post-traumatic stress disorder|post-traumatic stress disorder
364650|NCT02030522|PTSD|ptsd
364651|NCT02030522|Accelerated Resolution Therapy|accelerated resolution therapy
364652|NCT02030522|Military|military
364653|NCT02030522|Veterans|veterans
364654|NCT02030522|Exposure therapy|exposure therapy
364655|NCT02030522|Eye movements|eye movements
364656|NCT02030509|cancer diagnosis|cancer diagnosis
364657|NCT02030496|distal radius fractures|distal radius fractures
364658|NCT02030496|Closed reduction|closed reduction
364659|NCT02030496|Open reduction internal fixation|open reduction internal fixation
364660|NCT02030496|Volar plate|volar plate
364661|NCT02030496|Redislocation|redislocation
364662|NCT02030496|Unstable fracture|unstable fracture
364663|NCT02030496|Extra-articular fracture|extra-articular fracture
364664|NCT02030496|Colles fracture|colles fracture
364665|NCT02030496|Barton fracture|barton fracture
400543|NCT01866345|orthodontics|orthodontics
364666|NCT02030470|Periodontitis, treatment, photodynamic, mid-term, bacteria|periodontitis, treatment, photodynamic, mid-term, bacteria
364667|NCT02030444|Neoplasms Staging|neoplasms staging
364668|NCT02030444|Bronchoscopy|bronchoscopy
364669|NCT02030444|Nuclear Medicine|nuclear medicine
364670|NCT02030444|Radiology|radiology
364671|NCT02030392|Functional abdominal pain|functional abdominal pain
364672|NCT02030392|psychological intervention|psychological intervention
364673|NCT02030392|quality of life|quality of life
364674|NCT02030392|Randomized controlled trial|randomized controlled trial
364675|NCT02030392|children|children
364676|NCT02030379|Cancer|cancer
364677|NCT02030353|Lifestyle intervention|lifestyle intervention
364678|NCT02030353|Internet intervention|internet intervention
364679|NCT02030353|Breast neoplasms|breast neoplasms
364680|NCT02030353|Body weight|body weight
364681|NCT02030353|Body weight changes|body weight changes
364682|NCT02030340|urodynamic investigation|urodynamic investigation
364683|NCT02030340|lower urinary tract dysfunction|lower urinary tract dysfunction
364684|NCT02030340|catheter|catheter
364685|NCT02030340|air-charged|air-charged
364686|NCT02030340|water filled|water filled
364687|NCT02030327|proteomics|proteomics
364688|NCT02030327|multiple trauma|multiple trauma
364689|NCT02030327|organ dysfunction|organ dysfunction
364690|NCT02030314|Chlorthalidone|chlorthalidone
364691|NCT02030314|Resistant Hypertension|resistant hypertension
364692|NCT02030314|Kidney Transplant Patients|kidney transplant patients
364693|NCT02030301|Herpes Simplex Virus, Type 2|herpes simplex virus, type 2
364694|NCT02030301|Herpes|herpes
364695|NCT02030301|HSV-2|hsv-2
364696|NCT02030288|alcohol|alcohol
364697|NCT02030288|substance use|substance use
364698|NCT02030288|eHealth|ehealth
364699|NCT02030275|Hypertrophic scar|hypertrophic scar
364700|NCT02030275|Cicatrix|cicatrix
364701|NCT02030275|Scar prevention|scar prevention
364702|NCT02030275|Scar revision|scar revision
364703|NCT02030249|Pre-diabetes|pre-diabetes
364704|NCT02030249|Obesity|obesity
364705|NCT02030249|Low calorie diet|low calorie diet
364706|NCT02030249|Diet - reducing|diet - reducing
364707|NCT02030249|Appetite|appetite
364708|NCT02030249|Visual analogue scale|visual analogue scale
364709|NCT02030249|Ghrelin|ghrelin
364710|NCT02030249|Peptide YY|peptide yy
364711|NCT02030249|Bone mass|bone mass
364712|NCT02030249|Bone turnover|bone turnover
364713|NCT02030249|Muscle strength|muscle strength
365304|NCT02027714|Lesotho|lesotho
364714|NCT02030236|hypothermia, induced|hypothermia, induced
364715|NCT02030236|rewarming|rewarming
364716|NCT02030236|therapeutic|therapeutic
364717|NCT02030236|heart arrest|heart arrest
364718|NCT02030236|asystole|asystole
364719|NCT02030236|frostbite|frostbite
364720|NCT02030223|transversus abdominis plane block|transversus abdominis plane block
364721|NCT02030223|inguinal hernia repair|inguinal hernia repair
364722|NCT02030223|acute postoperative pain|acute postoperative pain
364723|NCT02030223|neuropathic pain|neuropathic pain
364724|NCT02030210|Quality improvement|quality improvement
364725|NCT02030210|STEMI|stemi
364726|NCT02030210|Belgium|belgium
364727|NCT02030184|Lung cancer|lung cancer
364728|NCT02030184|Small cell lung cancer|small cell lung cancer
364729|NCT02030184|Neuroendocrine tumor|neuroendocrine tumor
364730|NCT02030184|Rhenium|rhenium
364731|NCT02030184|Re 188-P2045|re 188-p2045
364732|NCT02030171|Chronic low back pain|chronic low back pain
364733|NCT02030158|Severe sepsis|severe sepsis
364734|NCT02030158|Septic shock|septic shock
364735|NCT02030158|Early goal directed therapy|early goal directed therapy
364736|NCT02030158|Individual patient data meta-analysis|individual patient data meta-analysis
364737|NCT02030145|COPD|copd
364738|NCT02030145|Pulmonary|pulmonary
364739|NCT02030132|Physical activity|physical activity
364740|NCT02030132|Sedentary lifestyle|sedentary lifestyle
364741|NCT02030132|Pedometers|pedometers
364742|NCT02030132|Walking|walking
364743|NCT02030132|Financial Incentives|financial incentives
364744|NCT02030132|Behavioral Economics|behavioral economics
364745|NCT02030119|Sedentary lifestyle|sedentary lifestyle
364746|NCT02030119|Pedometers|pedometers
364747|NCT02030119|Obesity|obesity
364748|NCT02030119|Physical Activity|physical activity
364749|NCT02030119|Financial Incentives|financial incentives
364750|NCT02030119|Behavioral Economics|behavioral economics
364751|NCT02030106|Cervicovaginal microbiome|cervicovaginal microbiome
364752|NCT02030106|Microbiome|microbiome
364753|NCT02030106|Preterm Birth|preterm birth
364754|NCT02030106|Cervical Remodeling|cervical remodeling
364755|NCT02030106|Preterm delivery|preterm delivery
364756|NCT02030106|Microbiota|microbiota
364757|NCT02030093|Alcohol dependence|alcohol dependence
364758|NCT02030093|Telephone-based continuing care|telephone-based continuing care
364759|NCT02030093|Outcome monitoring|outcome monitoring
364760|NCT02030080|Pedometers|pedometers
364761|NCT02030080|Walking|walking
364762|NCT02030080|Financial incentives|financial incentives
364763|NCT02030080|Sedentary lifestyle|sedentary lifestyle
364764|NCT02030080|Behavioral economics|behavioral economics
364765|NCT02030067|oncology|oncology
364766|NCT02030067|tumor|tumor
364767|NCT02030067|metastatic|metastatic
364768|NCT02030067|bladder|bladder
364769|NCT02030041|simvastatin|simvastatin
364770|NCT02030041|cardiorespiratory fitness|cardiorespiratory fitness
364771|NCT02030041|vitamin D|vitamin d
364772|NCT02030041|exercise|exercise
364773|NCT02030041|mitochondria|mitochondria
364774|NCT02030028|Rheumatoid Arthritis|rheumatoid arthritis
364775|NCT02030028|ACTH gel|acth gel
364776|NCT02030015|infantile Tay-Sachs disease|infantile tay-sachs disease
364777|NCT02030015|juvenile Tay-Sachs disease|juvenile tay-sachs disease
364778|NCT02030015|infantile GM1 gangliosidosis|infantile gm1 gangliosidosis
364779|NCT02030015|juvenile GM1 gangliosidosis|juvenile gm1 gangliosidosis
364780|NCT02030015|infantile GM2 gangliosidosis|infantile gm2 gangliosidosis
364781|NCT02030015|juvenile GM2 gangliosidosis|juvenile gm2 gangliosidosis
364782|NCT02030015|Sandhoff disease|sandhoff disease
364783|NCT02030015|gangliosidoses|gangliosidoses
364784|NCT02030015|miglustat|miglustat
364785|NCT02030015|ketogenic diet|ketogenic diet
364786|NCT02030015|SYNER-G regimen|syner-g regimen
364787|NCT02030015|Syner-G|syner-g
364788|NCT02030015|Zavesca|zavesca
364789|NCT02030015|Tay-Sachs disease|tay-sachs disease
364790|NCT02030015|Tay Sachs disease|tay sachs disease
364791|NCT02029989|Metabolic Syndrome|metabolic syndrome
364792|NCT02029989|Antipsychotics|antipsychotics
364793|NCT02029989|Schizophrenia|schizophrenia
364794|NCT02029989|Bipolar Disorder|bipolar disorder
364795|NCT02029989|Diabetes|diabetes
364796|NCT02029989|Dyslipidemia|dyslipidemia
364797|NCT02029989|Hyperlipidemia|hyperlipidemia
364798|NCT02029989|Hypertension|hypertension
364799|NCT02029989|Obesity|obesity
364800|NCT02029989|Medication Therapy Management|medication therapy management
364801|NCT02029989|MTM|mtm
364802|NCT02029989|Pharmacist|pharmacist
364803|NCT02029989|Comprehensive Medication Management|comprehensive medication management
364804|NCT02029989|CMM|cmm
364805|NCT02029989|Health Disparity|health disparity
364806|NCT02029989|Monitoring|monitoring
364807|NCT02029989|Point of Care Testing|point of care testing
364808|NCT02029989|Chronic Persistent Mental Illness|chronic persistent mental illness
364809|NCT02029937|Squamous cell neoplasia|squamous cell neoplasia
364810|NCT02029937|Proflavine|proflavine
364811|NCT02029937|Lugol's chromoendoscopy|lugol's chromoendoscopy
364812|NCT02029911|Menorrhagia|menorrhagia
364813|NCT02029911|Excessive uterine bleeding|excessive uterine bleeding
364814|NCT02029911|Endometrial Ablation|endometrial ablation
364815|NCT02029898|cesarean section|cesarean section
364816|NCT02029898|anesthesia|anesthesia
364817|NCT02029898|children|children
364818|NCT02029885|Hypertension|hypertension
364819|NCT02029885|Renal Denervation|renal denervation
364820|NCT02029872|MRSA|mrsa
364821|NCT02029872|colonization|colonization
364822|NCT02029872|decolonization|decolonization
364823|NCT02029859|pregnancy (after 30 weeks of amenorhea)|pregnancy (after 30 weeks of amenorhea)
364824|NCT02029859|obesity (BMI>35)|obesity (bmi>35)
364825|NCT02029859|sleep apnea syndrom|sleep apnea syndrom
364826|NCT02029859|preeclampsy|preeclampsy
364827|NCT02029859|intrauterine growth restriction|intrauterine growth restriction
364828|NCT02029820|Contrast Nephropathy|contrast nephropathy
364829|NCT02029820|Prevention|prevention
364830|NCT02029820|Renalguard|renalguard
364831|NCT02029794|Cervical Cancer|cervical cancer
364832|NCT02029794|Cervical Cancer Screening|cervical cancer screening
364833|NCT02029794|Low Resource setting|low resource setting
364834|NCT02029794|HPV|hpv
364835|NCT02029794|Self-Collection|self-collection
364836|NCT02029794|VIA|via
364837|NCT02029781|Appendicitis|appendicitis
364838|NCT02029781|Laparoscopy|laparoscopy
364839|NCT02029781|Appendectomy|appendectomy
364840|NCT02029781|Negative appendectomy|negative appendectomy
364841|NCT02029781|Morbidity|morbidity
364842|NCT02029768|outcome|outcome
364843|NCT02029755|transversus abdominis plane block|transversus abdominis plane block
364844|NCT02029755|local infiltration|local infiltration
364845|NCT02029755|ropivacaine|ropivacaine
364846|NCT02029755|heart rate variability|heart rate variability
364847|NCT02029755|postoperative analgesia|postoperative analgesia
364848|NCT02029742|Sickle cell disease|sickle cell disease
364849|NCT02029742|Medication adherence|medication adherence
364850|NCT02029742|Hydroxyurea|hydroxyurea
364851|NCT02029742|Community health worker intervention|community health worker intervention
364852|NCT02029742|Sickle Cell Treatment|sickle cell treatment
364853|NCT02029729|RTA 408|rta 408
364854|NCT02029729|RTA 408 Capsules|rta 408 capsules
364855|NCT02029729|Non-small cell lung cancer|non-small cell lung cancer
364856|NCT02029729|Metastatic non-small cell lung cancer|metastatic non-small cell lung cancer
364857|NCT02029729|Incurable non-small cell lung cancer|incurable non-small cell lung cancer
364858|NCT02029729|Refractory melanoma|refractory melanoma
364859|NCT02029729|Relapsed melanoma|relapsed melanoma
364860|NCT02029716|RTA 408|rta 408
364861|NCT02029716|RTA 408 Lotion|rta 408 lotion
364862|NCT02029716|Oxidative stress|oxidative stress
364863|NCT02029716|Inflammation|inflammation
364864|NCT02029716|Volunteers|volunteers
364865|NCT02029703|Knee Osteoarthritis|knee osteoarthritis
364866|NCT02029703|Knee Pain|knee pain
364867|NCT02029703|Synvisc-One|synvisc-one
364868|NCT02029690|argininosuccinate synthetase|argininosuccinate synthetase
364869|NCT02029690|arginine|arginine
364870|NCT02029690|arginine deiminase|arginine deiminase
364871|NCT02029651|Stroke|stroke
364872|NCT02029651|Hand|hand
364873|NCT02029651|Rehabilitation|rehabilitation
364874|NCT02029651|Game|game
364875|NCT02029638|renal transplantation|renal transplantation
364876|NCT02029638|conditioning regimen|conditioning regimen
364877|NCT02029638|BMT|bmt
364878|NCT02029638|high dose post-transplant cyclophosphamide (PT/Cy)|high dose post-transplant cyclophosphamide (pt/cy)
364879|NCT02029638|renal allograft tolerance|renal allograft tolerance
364880|NCT02029638|immunosuppression withdrawal|immunosuppression withdrawal
364881|NCT02029612|Tobacco Use Cessation|tobacco use cessation
364882|NCT02029612|Cancer Prevention|cancer prevention
364883|NCT02029612|HIV/AIDS|hiv/aids
364884|NCT02029612|Questionnaires|questionnaires
364885|NCT02029612|Surveys|surveys
364886|NCT02029612|Nicotine patch|nicotine patch
364887|NCT02029612|Breath test|breath test
364888|NCT02029612|Cell Phone Calls for Smoking Cessation Counseling|cell phone calls for smoking cessation counseling
364889|NCT02029612|Text Message Smoking Cessation Support|text message smoking cessation support
364890|NCT02029573|Phase II|phase ii
364891|NCT02029573|Atorvastatin|atorvastatin
364892|NCT02029573|Temozolomide|temozolomide
364893|NCT02029573|Radiotherapy|radiotherapy
364894|NCT02029573|Glioblastoma Multiforme (GBM)|glioblastoma multiforme (gbm)
365019|NCT02028910|vomiting|vomiting
364895|NCT02029534|post-operative atrial fibrillation|post-operative atrial fibrillation
364896|NCT02029534|POAF|poaf
364897|NCT02029534|A-Fib|a-fib
364898|NCT02029521|cystic fibrosis|cystic fibrosis
364899|NCT02029521|growth Failure|growth failure
364900|NCT02029521|glutathione|glutathione
364901|NCT02029508|PSCC(Posterior semicircular canal)|pscc(posterior semicircular canal)
364902|NCT02029508|BPPV(Bening paroxysmal positional vertigo)|bppv(bening paroxysmal positional vertigo)
364903|NCT02029508|Vertigo|vertigo
364904|NCT02029508|Otorhinolaryngologic Diseases|otorhinolaryngologic diseases
364905|NCT02029495|Psoriatic Arthritis|psoriatic arthritis
364906|NCT02029495|Brodalumab|brodalumab
364907|NCT02029495|AMG 827|amg 827
364908|NCT02029482|ACT-128800|act-128800
364909|NCT02029469|Humeral Resurfacing|humeral resurfacing
364910|NCT02029469|Humeral Resurfacing Arthroplasty|humeral resurfacing arthroplasty
364911|NCT02029456|Massive Pulmonary embolism|massive pulmonary embolism
364912|NCT02029456|thrombolytic therapy|thrombolytic therapy
364913|NCT02029456|high risk|high risk
364914|NCT02029456|elderly|elderly
364915|NCT02029443|Bruton's tyrosine kinase inhibitor|bruton's tyrosine kinase inhibitor
364916|NCT02029430|HIV +|hiv +
364917|NCT02029430|HIV positive|hiv positive
364918|NCT02029430|AIDS|aids
364919|NCT02029430|Kaposi's sarcoma|kaposi's sarcoma
364920|NCT02029430|Sarcoma|sarcoma
364921|NCT02029430|tumor|tumor
364922|NCT02029430|cancer|cancer
364923|NCT02029391|Myofascial pain syndrome|myofascial pain syndrome
364924|NCT02029391|taping|taping
364925|NCT02029391|manual therapies|manual therapies
364926|NCT02029365|Infertility|infertility
364927|NCT02029365|desire for children|desire for children
364928|NCT02029365|eating disorder|eating disorder
364929|NCT02029365|anorexia nervosa|anorexia nervosa
364930|NCT02029365|bulimia nervosa|bulimia nervosa
364931|NCT02029365|eating disorders not otherwise specified|eating disorders not otherwise specified
364932|NCT02029352|Treatment|treatment
364933|NCT02029352|Sinecatechins|sinecatechins
364934|NCT02029339|Negative pressure wound therapy|negative pressure wound therapy
364935|NCT02029339|Acute wound infection|acute wound infection
364936|NCT02029339|complicated abdominal infection|complicated abdominal infection
364937|NCT02029339|Cytokines|cytokines
364938|NCT02029339|Matrix metalloproteinase|matrix metalloproteinase
364939|NCT02029326|colorectal cancer, cetuximab, biomarker, prometheus|colorectal cancer, cetuximab, biomarker, prometheus
364940|NCT02029300|pediatrics|pediatrics
364941|NCT02029300|fiberoptic intubation|fiberoptic intubation
364942|NCT02029300|oral intubation|oral intubation
364943|NCT02029300|nasal intubation|nasal intubation
364944|NCT02029300|children under the age of 2|children under the age of 2
364945|NCT02029287|Chronic heart failure|chronic heart failure
364946|NCT02029287|telemedicine|telemedicine
364947|NCT02029287|health service platform|health service platform
364948|NCT02029274|Dermatomyositis|dermatomyositis
364949|NCT02029261|Burn|burn
364950|NCT02029248|Anorectal malformation|anorectal malformation
364951|NCT02029248|fecal incontinence|fecal incontinence
364952|NCT02029248|quality of life|quality of life
364953|NCT02029248|child|child
364954|NCT02029235|Adult|adult
364955|NCT02029235|soft-tissue hand surgery|soft-tissue hand surgery
364956|NCT02029183|stroke, SAHS, BiPAP|stroke, sahs, bipap
364957|NCT02029170|ankle fracture|ankle fracture
364958|NCT02029170|weightbearing|weightbearing
364959|NCT02029170|cast|cast
364960|NCT02029118|Acupoint Application,Stable Angina Pectoris,herbal medicine|acupoint application,stable angina pectoris,herbal medicine
364961|NCT02029105|Mesothelioma,|mesothelioma,
364962|NCT02029105|Pleural diseases,|pleural diseases,
364963|NCT02029105|Mesothelin,|mesothelin,
364964|NCT02029105|Osteopontin,|osteopontin,
364965|NCT02029105|Hyaluronan,|hyaluronan,
364966|NCT02029105|Syndecan-1|syndecan-1
364967|NCT02029092|International|international
364968|NCT02029092|Multicenter|multicenter
364969|NCT02029092|Observational registry|observational registry
364970|NCT02029092|Orsiro Drug Eluting Stent (DES)|orsiro drug eluting stent (des)
364971|NCT02029092|Stenting|stenting
364972|NCT02029092|Treatment of coronary artery disease|treatment of coronary artery disease
364973|NCT02029092|Coronary revascularization|coronary revascularization
364974|NCT02029092|Percutaneous Coronary Intervention (PCI)|percutaneous coronary intervention (pci)
364975|NCT02029092|STEMI|stemi
364976|NCT02029092|NSTEMI|nstemi
364977|NCT02029092|Ischemia|ischemia
364978|NCT02029092|Angina|angina
364979|NCT02029092|Acute Myocardial Infarction (AMI)|acute myocardial infarction (ami)
364980|NCT02029092|Small Vessels|small vessels
364981|NCT02029092|Chronical Total Occlusion (CTO)|chronical total occlusion (cto)
364982|NCT02029079|Malnutrition|malnutrition
364983|NCT02029066|actinic keratosis|actinic keratosis
364984|NCT02029066|SR-T100|sr-t100
364985|NCT02029066|pharmacokinetics|pharmacokinetics
364986|NCT02029053|Vaginal dryness|vaginal dryness
364987|NCT02029053|Vaginal lubrication|vaginal lubrication
364988|NCT02029053|Post-menopausal symptoms|post-menopausal symptoms
364989|NCT02029053|Peri-menopausal symptoms|peri-menopausal symptoms
364990|NCT02029053|Urogenital atrophy|urogenital atrophy
364991|NCT02029053|Dyspareunia|dyspareunia
364992|NCT02029053|Painful intercourse|painful intercourse
364993|NCT02029040|Bronchiolitis|bronchiolitis
364994|NCT02029040|Hypertonic saline|hypertonic saline
364995|NCT02029040|Emergency Department|emergency department
364996|NCT02029027|Urinary Stress Incontinence|urinary stress incontinence
364997|NCT02029027|Urinary Mixed Incontinence|urinary mixed incontinence
364998|NCT02029014|LAmbre|lambre
364999|NCT02029001|Solid tumor|solid tumor
365000|NCT02029001|Recurrent/metastatic|recurrent/metastatic
365001|NCT02029001|Personalized medicine|personalized medicine
365002|NCT02029001|Genomic alteration|genomic alteration
365003|NCT02029001|Targeted therapy|targeted therapy
365004|NCT02029001|Nilotinib|nilotinib
365005|NCT02029001|Everolimus|everolimus
365006|NCT02029001|Sorafenib|sorafenib
365007|NCT02029001|Lapatinib|lapatinib
365008|NCT02029001|Pazopanib|pazopanib
365009|NCT02029001|Olaparib|olaparib
365010|NCT02029001|Immunotherapy|immunotherapy
365012|NCT02029001|Tremelimumab|tremelimumab
365013|NCT02028988|Intermediate Risk Prostate Cancer|intermediate risk prostate cancer
365014|NCT02028962|Smoking cessation|smoking cessation
365015|NCT02028962|Romanian adults|romanian adults
365016|NCT02028923|topical morphine|topical morphine
365017|NCT02028910|gastroenteritis|gastroenteritis
365018|NCT02028910|pediatrics|pediatrics
365020|NCT02028897|In vitro fertilization|in vitro fertilization
365022|NCT02028897|Embryo culture|embryo culture
365023|NCT02028897|Blastocyst transfer|blastocyst transfer
365024|NCT02028832|pain|pain
365025|NCT02028832|nausea/vomiting|nausea/vomiting
365026|NCT02028832|anxiety|anxiety
365027|NCT02028832|complementary and alternative medicine|complementary and alternative medicine
365028|NCT02028832|pediatric|pediatric
365029|NCT02028832|oncology|oncology
365030|NCT02028832|cost-effectiveness|cost-effectiveness
365031|NCT02028793|Pharmaceutical Care, Taiwan, pharmacist, Workload, pressure|pharmaceutical care, taiwan, pharmacist, workload, pressure
365032|NCT02028741|neck pain|neck pain
365033|NCT02028741|transverse vertebral pressures|transverse vertebral pressures
365034|NCT02028741|thoracic mobilization|thoracic mobilization
365035|NCT02028728|International|international
365036|NCT02028728|Multicenter|multicenter
365037|NCT02028728|Observational registry|observational registry
365038|NCT02028728|Orsiro Drug Eluting Stent (DES)|orsiro drug eluting stent (des)
365039|NCT02028728|Stenting|stenting
365040|NCT02028728|Treatment of coronary artery disease|treatment of coronary artery disease
365041|NCT02028728|Coronary revascularization|coronary revascularization
365042|NCT02028728|Percutaneous Coronary Intervention (PCI)|percutaneous coronary intervention (pci)
365043|NCT02028728|STEMI|stemi
365044|NCT02028728|NSTEMI|nstemi
365045|NCT02028728|Ischemia|ischemia
365046|NCT02028728|Angina|angina
365047|NCT02028728|Acute Myocardial Infarction (AMI)|acute myocardial infarction (ami)
365048|NCT02028728|Small Vessels|small vessels
365049|NCT02028728|Chronic Total Occlusion (CTO)|chronic total occlusion (cto)
365050|NCT02028715|IV Acetaminophen|iv acetaminophen
365051|NCT02028715|Ofirmev|ofirmev
365052|NCT02028715|Post-operative pain|post-operative pain
365053|NCT02028702|red clover|red clover
365054|NCT02028702|menopause|menopause
365055|NCT02028702|bioactive compounds|bioactive compounds
365056|NCT02028702|isoflavones|isoflavones
365057|NCT02028702|phytoestrogen|phytoestrogen
365058|NCT02028676|HIV|hiv
365059|NCT02028676|Africa|africa
365060|NCT02028676|children|children
365061|NCT02028676|antiretroviral therapy|antiretroviral therapy
365062|NCT02028676|laboratory monitoring|laboratory monitoring
365063|NCT02028676|toxicity|toxicity
365064|NCT02028676|CD4|cd4
365065|NCT02028676|induction maintenance|induction maintenance
365066|NCT02028676|cotrimoxazole|cotrimoxazole
365067|NCT02028676|prophylaxis|prophylaxis
365068|NCT02028676|abacavir|abacavir
365069|NCT02028676|lamivudine|lamivudine
365070|NCT02028676|once daily|once daily
365071|NCT02028663|P-CAB|p-cab
365072|NCT02028663|APA(Acid Pump Antagonist)|apa(acid pump antagonist)
365073|NCT02028650|relapse leukemia|relapse leukemia
365074|NCT02028650|DSI|dsi
365075|NCT02028637|asthma|asthma
365076|NCT02028637|toll like receptor|toll like receptor
365077|NCT02028637|innate immunity|innate immunity
365078|NCT02028624|Rheumatoid arthritis|rheumatoid arthritis
365079|NCT02028624|Mediterranean diet|mediterranean diet
365080|NCT02028624|Lifestyle intervention|lifestyle intervention
365081|NCT02028624|Adiponectin|adiponectin
365082|NCT02028624|Telephone counseling|telephone counseling
365083|NCT02028611|Rib fracture|rib fracture
365084|NCT02028611|Inverted grayscale|inverted grayscale
365085|NCT02028598|Clomipramine|clomipramine
365086|NCT02028598|Premature ejaculation|premature ejaculation
365087|NCT02028585|low-fat milk|low-fat milk
365088|NCT02028585|metabolic syndrome|metabolic syndrome
365089|NCT02028585|lipid profile|lipid profile
365090|NCT02028585|inflammation|inflammation
365091|NCT02028585|oxidative stress|oxidative stress
365092|NCT02028585|endothelial function|endothelial function
365093|NCT02028572|Structure function correlation|structure function correlation
365094|NCT02028572|Optical coherence tomography|optical coherence tomography
365095|NCT02028572|Retinal Nerve fibre layer thickness|retinal nerve fibre layer thickness
365096|NCT02028572|Visual fields|visual fields
365097|NCT02028572|Primary open angle glaucoma|primary open angle glaucoma
365098|NCT02028559|stones|stones
365099|NCT02028559|kidney|kidney
365100|NCT02028559|stone fragments|stone fragments
365101|NCT02028559|lithotripsy|lithotripsy
365102|NCT02028546|atopic dermatitis, skin cleansing, cleanser, moisturizer, skin hydration|atopic dermatitis, skin cleansing, cleanser, moisturizer, skin hydration
365103|NCT02028533|addiction|addiction
365104|NCT02028533|oxytocin|oxytocin
365105|NCT02028533|tolerability|tolerability
365106|NCT02028507|Palbociclib|palbociclib
365107|NCT02028507|Capecitabine|capecitabine
365108|NCT02028507|Hormonal Receptor positive|hormonal receptor positive
365109|NCT02028507|HER2 negative|her2 negative
365110|NCT02028507|Metastatic Breast Cancer|metastatic breast cancer
365305|NCT02027714|Couples|couples
365111|NCT02028507|Resistance to non-steroidal Aromatase inhibitors|resistance to non-steroidal aromatase inhibitors
365112|NCT02028507|Fulvestrant|fulvestrant
365113|NCT02028507|Exemestane|exemestane
365114|NCT02028507|Aromatase inhibitor|aromatase inhibitor
365115|NCT02028481|Macular hole|macular hole
365116|NCT02028481|Vitreoretinal surgery|vitreoretinal surgery
365117|NCT02028481|Macular surgery|macular surgery
365118|NCT02028481|Air tamponade|air tamponade
365119|NCT02028468|Femoral Neck Fracture|femoral neck fracture
365120|NCT02028468|Anterolateral approach|anterolateral approach
365121|NCT02028468|Trans-gluteal approach|trans-gluteal approach
365122|NCT02028468|Watson Jones approach|watson jones approach
365123|NCT02028468|Hardinge approach|hardinge approach
365124|NCT02028455|pediatric|pediatric
365125|NCT02028455|young adult|young adult
365126|NCT02028455|acute lymphoblastic leukemia|acute lymphoblastic leukemia
365127|NCT02028455|CD19|cd19
365128|NCT02028455|leukemia|leukemia
365129|NCT02028455|Chimeric Antigen Receptor|chimeric antigen receptor
365130|NCT02028455|T cell|t cell
365131|NCT02028429|Minimal Hepatic Encephalopathy (MHE)|minimal hepatic encephalopathy (mhe)
365132|NCT02028429|Psychometric Hepatic Encephalopathy Score (PHES)|psychometric hepatic encephalopathy score (phes)
365133|NCT02028429|Sickness Impact Profile (SIP)|sickness impact profile (sip)
365134|NCT02028429|Model for End-stage Liver Disease (MELD)|model for end-stage liver disease (meld)
365135|NCT02028429|Child-Turcotte-Pugh score (CTP)|child-turcotte-pugh score (ctp)
365136|NCT02028416|pancytopenia|pancytopenia
365137|NCT02028416|aplastic anemia|aplastic anemia
365138|NCT02028416|ATG|atg
365139|NCT02028416|Cyclosporin|cyclosporin
365140|NCT02028390|wounds|wounds
365141|NCT02028390|thermal|thermal
365142|NCT02028390|temperature|temperature
365143|NCT02028390|periwound|periwound
365144|NCT02028390|camera|camera
365145|NCT02028390|imaging|imaging
365146|NCT02028377|Adenocarcinoma|adenocarcinoma
365147|NCT02028377|imaging|imaging
365148|NCT02028377|PET|pet
365149|NCT02028377|MRI|mri
365150|NCT02028364|Locally advanced breast cancer|locally advanced breast cancer
365151|NCT02028364|HER2 negative|her2 negative
365152|NCT02028364|NSAI refractory|nsai refractory
365153|NCT02028364|Metastatic breast cancer|metastatic breast cancer
365154|NCT02028364|Estrogen-receptor positive (ER+)|estrogen-receptor positive (er+)
365155|NCT02028351|visual acuity|visual acuity
365156|NCT02028351|contrast sensitivity|contrast sensitivity
365157|NCT02028351|cataract|cataract
365158|NCT02028351|maculopathy|maculopathy
365159|NCT02028312|Dry Eye|dry eye
365160|NCT02028299|Pulmonary Arterial Hypertension|pulmonary arterial hypertension
365161|NCT02028299|Pulmonary Vascular Resistance|pulmonary vascular resistance
365162|NCT02028299|Right Heart Catheterization|right heart catheterization
365163|NCT02028286|Rosacea|rosacea
365164|NCT02028273|Neurogenesis|neurogenesis
365165|NCT02028273|Addiction|addiction
365166|NCT02028273|Cocaine|cocaine
365167|NCT02028273|MRI|mri
365168|NCT02028273|MRS|mrs
365169|NCT02028247|Autism spectrum disorders|autism spectrum disorders
365170|NCT02028247|Autism|autism
365171|NCT02028247|Asperger's syndrome|asperger's syndrome
365172|NCT02028247|Pervasive developmental disability - not otherwise specified|pervasive developmental disability - not otherwise specified
365173|NCT02028247|obsessive-compulsive disorder|obsessive-compulsive disorder
365174|NCT02028247|Social phobia|social phobia
365175|NCT02028247|Generalized anxiety disorder|generalized anxiety disorder
365176|NCT02028247|Specific phobia|specific phobia
365177|NCT02028247|Separation anxiety disorder|separation anxiety disorder
365178|NCT02028247|Counseling|counseling
365179|NCT02028247|Cognitive-behavioral therapy|cognitive-behavioral therapy
365180|NCT02028247|Psychotherapy|psychotherapy
365181|NCT02028221|Breast cancer prevention|breast cancer prevention
365182|NCT02028221|metformin|metformin
365183|NCT02028221|Breast cancer risk reduction|breast cancer risk reduction
365184|NCT02028208|Patch Test|patch test
365185|NCT02028208|Allergy Testing|allergy testing
365186|NCT02028208|Contact Dermatitis|contact dermatitis
365187|NCT02028208|Mercury, Aluminum or Palladium skin allergy|mercury, aluminum or palladium skin allergy
365188|NCT02028195|Health check|health check
365189|NCT02028195|Health promotion|health promotion
365190|NCT02028195|prevention diabetes|prevention diabetes
365191|NCT02028195|prevention cardiovascular disease|prevention cardiovascular disease
365192|NCT02028195|mental health|mental health
365193|NCT02028182|Patch Test|patch test
365194|NCT02028182|Allergy Testing|allergy testing
365195|NCT02028182|Contact dermatitis|contact dermatitis
365196|NCT02028182|Lyral allergen|lyral allergen
365197|NCT02028182|Fragrance Mix allergen|fragrance mix allergen
365198|NCT02028169|Work Productivity|work productivity
365199|NCT02028169|Anti-TNFs|anti-tnfs
365200|NCT02028169|Psoriatic Arthritis|psoriatic arthritis
365201|NCT02028143|Atrial Fibrillation|atrial fibrillation
365202|NCT02028130|Atrial fibrillation|atrial fibrillation
365203|NCT02028130|Ablation|ablation
365204|NCT02028130|Left atrial appendage occlusion|left atrial appendage occlusion
365205|NCT02028130|Stroke prevention|stroke prevention
365206|NCT02028091|Pulse walve arrival time differences|pulse walve arrival time differences
365415|NCT02027415|nitrates|nitrates
365207|NCT02028078|Endogenous glucose production|endogenous glucose production
365208|NCT02028078|Type 1 diabetes mellitus|type 1 diabetes mellitus
365209|NCT02028078|hypoglycaemic clamp|hypoglycaemic clamp
365210|NCT02028078|tracer to technique|tracer to technique
365211|NCT02028078|pharmacodynamics|pharmacodynamics
365212|NCT02028078|pharmacokinetics|pharmacokinetics
365213|NCT02028065|reversal of neuromuscular blockade|reversal of neuromuscular blockade
365214|NCT02028052|enlarged mediastinal nodes|enlarged mediastinal nodes
365215|NCT02028052|enlarged hilar lymph nodes|enlarged hilar lymph nodes
365216|NCT02028039|Leukemia|leukemia
365217|NCT02028039|Refractory Acute Lymphoblastic Leukemia|refractory acute lymphoblastic leukemia
365218|NCT02028039|ALL|all
365219|NCT02028039|Burkitt's lymphoma|burkitt's lymphoma
365220|NCT02028039|Lymphoblastic lymphoma|lymphoblastic lymphoma
365221|NCT02028039|IPI-145|ipi-145
365222|NCT02028026|Depressive Disorder|depressive disorder
365223|NCT02028026|Anxiety|anxiety
365224|NCT02028026|Comorbidity|comorbidity
365225|NCT02028026|Magnetic Resonance Imaging|magnetic resonance imaging
365226|NCT02028026|Magnetic Resonance Spectroscopy|magnetic resonance spectroscopy
365227|NCT02028026|Citalopram|citalopram
365228|NCT02028026|Vilazodone|vilazodone
365229|NCT02028026|Serotonin Uptake Inhibitors|serotonin uptake inhibitors
365230|NCT02028026|Receptor, Serotonin, 5-HT1A|receptor, serotonin, 5-ht1a
365231|NCT02028013|Erectile dysfunction, sexual dysfunction, bioresonance|erectile dysfunction, sexual dysfunction, bioresonance
365232|NCT02028000|Pregnancy|pregnancy
365233|NCT02028000|Pregnant|pregnant
365234|NCT02028000|Cesarean Section Delivery|cesarean section delivery
365235|NCT02027987|valproate acid|valproate acid
365236|NCT02027987|traumatic brain injury|traumatic brain injury
365237|NCT02027987|brain protection|brain protection
365238|NCT02027987|epilepsy|epilepsy
365239|NCT02027974|Hip|hip
365240|NCT02027974|Arthroplasty|arthroplasty
365241|NCT02027974|Arthroplasties|arthroplasties
365242|NCT02027974|Prosthesis|prosthesis
365243|NCT02027974|Iconacy|iconacy
365244|NCT02027974|Osteoarthritis|osteoarthritis
365245|NCT02027974|Arthritis|arthritis
365246|NCT02027974|THA|tha
365247|NCT02027974|THR|thr
365248|NCT02027974|DJD|djd
780644|NCT00327262|imatinib|imatinib
365249|NCT02027961|Metastatic or Unresectable Melanoma, durvalumab (MEDI4736), dafrafenib, trametinib, BRAF-mutation positive, wild-type BRAF, PD-L1, PD-1|metastatic or unresectable melanoma, durvalumab (medi4736), dafrafenib, trametinib, braf-mutation positive, wild-type braf, pd-l1, pd-1
365250|NCT02027948|nutritional management algorithm|nutritional management algorithm
365251|NCT02027948|nutritional and functional assessments|nutritional and functional assessments
365252|NCT02027948|13-264|13-264
365253|NCT02027935|Melanoma|melanoma
365254|NCT02027935|Metastatic|metastatic
365255|NCT02027935|CD8+ T cells|cd8+ t cells
365256|NCT02027935|White blood cell|white blood cell
365257|NCT02027935|Leukapheresis|leukapheresis
365258|NCT02027935|Cyclophosphamide|cyclophosphamide
365259|NCT02027935|Cytoxan|cytoxan
365260|NCT02027935|Neosar|neosar
365261|NCT02027935|Interleukin-2|interleukin-2
365262|NCT02027935|Aldesleukin|aldesleukin
365263|NCT02027935|IL-2|il-2
365264|NCT02027935|Proleukin|proleukin
365265|NCT02027935|Ipilimumab|ipilimumab
365266|NCT02027935|Yervoy|yervoy
365267|NCT02027935|BMS-734016|bms-734016
365268|NCT02027935|MDX010|mdx010
365269|NCT02027922|white spot lesion|white spot lesion
365270|NCT02027922|caries|caries
365271|NCT02027909|Sinus Node Dysfunction|sinus node dysfunction
365272|NCT02027896|Perioperative outcomes|perioperative outcomes
365273|NCT02027883|Defibrillators|defibrillators
365274|NCT02027883|Ventricular Fibrillation Induction Testing|ventricular fibrillation induction testing
365275|NCT02027870|DES|des
365276|NCT02027870|CAD|cad
365277|NCT02027870|EXCEL-II|excel-ii
365278|NCT02027870|JWMS|jwms
365279|NCT02027870|PCI|pci
365280|NCT02027857|brain electrical impedance;|brain electrical impedance;
365281|NCT02027857|traumatic brain injury;|traumatic brain injury;
365282|NCT02027857|brain edema;|brain edema;
365283|NCT02027857|intracranial pressure|intracranial pressure
365284|NCT02027831|lymph nodes|lymph nodes
365285|NCT02027818|margins|margins
365286|NCT02027818|tumorectomy|tumorectomy
365287|NCT02027805|Steroid-resistant|steroid-resistant
365288|NCT02027805|Graft vs Host Disease|graft vs host disease
365289|NCT02027805|Refractory acute Graft vs Host Disease|refractory acute graft vs host disease
365290|NCT02027805|Hematopoietic Stem Cell Transplantation|hematopoietic stem cell transplantation
365291|NCT02027805|Stem Cell Transplantation|stem cell transplantation
365292|NCT02027805|Allogeneic Stem Cell Transplantation|allogeneic stem cell transplantation
365293|NCT02027805|Immune System Diseases|immune system diseases
365294|NCT02027805|Antibodies, monoclonal|antibodies, monoclonal
365295|NCT02027805|Immunotoxins|immunotoxins
365296|NCT02027805|Immunosuppressive agents|immunosuppressive agents
365297|NCT02027779|GreenGene™ F, Previously Treated Patients|greengene™ f, previously treated patients
365298|NCT02027727|inflammatory bowel disease|inflammatory bowel disease
365299|NCT02027727|infliximab|infliximab
365300|NCT02027727|trough level|trough level
365301|NCT02027727|crohn's disease|crohn's disease
365302|NCT02027727|ulcerative colitis|ulcerative colitis
365303|NCT02027714|Discordant|discordant
365306|NCT02027714|Enhanced Prevention Package (EPP)|enhanced prevention package (epp)
365307|NCT02027714|ART|art
365308|NCT02027714|Counseling|counseling
365309|NCT02027714|Male Circumcision|male circumcision
365310|NCT02027688|Oral feeding|oral feeding
365311|NCT02027688|Premature|premature
365312|NCT02027688|Infants|infants
365313|NCT02027688|Neonatal Intensive Care Unit|neonatal intensive care unit
365314|NCT02027675|exercise|exercise
365315|NCT02027675|immune function|immune function
365316|NCT02027675|inflammation|inflammation
365317|NCT02027675|immunity|immunity
365318|NCT02027675|diet|diet
365319|NCT02027675|obesity|obesity
365320|NCT02027675|asthma|asthma
365321|NCT02027649|Bladder cancer|bladder cancer
365322|NCT02027649|Keratin 14|keratin 14
365323|NCT02027649|Pronostic marker|pronostic marker
365324|NCT02027649|Diagnostic marker|diagnostic marker
365325|NCT02027649|Noninvasive technique|noninvasive technique
365326|NCT02027636|Depression|depression
365327|NCT02027636|Latinos|latinos
365328|NCT02027636|Mental Health|mental health
365329|NCT02027636|Disparities|disparities
365330|NCT02027623|Mechanical low back pain|mechanical low back pain
365331|NCT02027623|Non-specific low back pain|non-specific low back pain
365332|NCT02027623|Exercise|exercise
365333|NCT02027623|Motor skill training|motor skill training
365334|NCT02027610|Infant|infant
365335|NCT02027610|Bangladesh|bangladesh
365336|NCT02027610|vitamin A|vitamin a
365337|NCT02027610|microbiota|microbiota
365338|NCT02027610|vaccine|vaccine
365339|NCT02027610|immunity|immunity
365340|NCT02027597|video games|video games
365341|NCT02027597|oral health|oral health
365342|NCT02027597|social cognitive theory|social cognitive theory
365343|NCT02027597|behavior change|behavior change
365344|NCT02027597|randomized trial|randomized trial
365345|NCT02027597|growth modeling|growth modeling
365346|NCT02027597|minority|minority
365347|NCT02027597|gender|gender
365348|NCT02027584|infant, premature|infant, premature
365349|NCT02027584|infant, newborn|infant, newborn
365350|NCT02027584|choline|choline
467141|NCT01568502|CAD|cad
365351|NCT02027571|Diabetes|diabetes
365352|NCT02027571|Race/Ethnicity|race/ethnicity
365353|NCT02027571|Offspring Cohort|offspring cohort
365354|NCT02027571|African Americans|african americans
365355|NCT02027571|Prediabetes Reversal|prediabetes reversal
365356|NCT02027571|Lifestyle Intervention|lifestyle intervention
365357|NCT02027571|Insulin Sensitivity|insulin sensitivity
365358|NCT02027571|Beta-cell Function|beta-cell function
365359|NCT02027571|Diabetes Prevention|diabetes prevention
365360|NCT02027558|cognitive behavioral therapy|cognitive behavioral therapy
365361|NCT02027558|insomnia|insomnia
365362|NCT02027558|apnea|apnea
365363|NCT02027545|cancer screening|cancer screening
365364|NCT02027545|decision making|decision making
365365|NCT02027519|Self-testing|self-testing
365366|NCT02027519|Home-based testing|home-based testing
365367|NCT02027519|Lesotho|lesotho
365368|NCT02027519|Discordant|discordant
365369|NCT02027506|ECG|ecg
365370|NCT02027506|aVL|avl
365371|NCT02027506|CHRONIC STABLE ANGINA|chronic stable angina
365372|NCT02027506|T WAVE|t wave
365373|NCT02027493|Children|children
365374|NCT02027493|Chronic hepatitis C|chronic hepatitis c
365375|NCT02027493|Hansenula polymorpha|hansenula polymorpha
365376|NCT02027493|Pegylated interferon|pegylated interferon
365377|NCT02027493|Response rate|response rate
365378|NCT02027493|Ribavirin|ribavirin
365379|NCT02027493|Treatment|treatment
365380|NCT02027480|Antiretroviral Therapy (ART)|antiretroviral therapy (art)
365381|NCT02027480|Biomarkers|biomarkers
365382|NCT02027480|Nyanza Province|nyanza province
365383|NCT02027480|Kenya|kenya
365384|NCT02027467|Hematopoietic stem cells|hematopoietic stem cells
365385|NCT02027467|Herbal|herbal
365386|NCT02027467|Dietary|dietary
365387|NCT02027467|CD cells|cd cells
365388|NCT02027467|Basic research|basic research
365389|NCT02027454|GSK1265744|gsk1265744
365390|NCT02027454|HIV|hiv
365391|NCT02027454|placebo|placebo
365392|NCT02027454|cardiac repolarization|cardiac repolarization
365393|NCT02027454|12-lead ECG|12-lead ecg
365394|NCT02027454|moxifloxacin|moxifloxacin
365395|NCT02027454|QTc|qtc
365396|NCT02027441|Serodiscordant|serodiscordant
365397|NCT02027441|Lesotho|lesotho
365398|NCT02027441|Home-based testing|home-based testing
365399|NCT02027428|Nab-paclitaxel|nab-paclitaxel
365400|NCT02027428|Albumin bound paclitaxel|albumin bound paclitaxel
365401|NCT02027428|Taxanes|taxanes
365402|NCT02027428|Maintenance trials|maintenance trials
365403|NCT02027428|Celgene|celgene
365404|NCT02027428|Abraxane|abraxane
365405|NCT02027428|ABI-007|abi-007
365406|NCT02027428|NSCLC|nsclc
365407|NCT02027428|Non-Small Cell Lung Cancer|non-small cell lung cancer
365408|NCT02027428|Cancer of the Lung|cancer of the lung
365409|NCT02027428|Carcinoma, Squamous Cell|carcinoma, squamous cell
365410|NCT02027428|Lung Neoplasms|lung neoplasms
365411|NCT02027428|Abound.sqm|abound.sqm
365412|NCT02027415|air pollution|air pollution
365413|NCT02027415|food|food
365414|NCT02027415|nitrites|nitrites
365416|NCT02027415|breath tests/methods|breath tests/methods
365417|NCT02027389|MSSA, MRSA|mssa, mrsa
365418|NCT02027376|Advanced Breast Cancer|advanced breast cancer
365419|NCT02027376|LDE225|lde225
365420|NCT02027376|Triple Negative|triple negative
365421|NCT02027376|Hormonal Receptor negative|hormonal receptor negative
365422|NCT02027376|Her2 negative|her2 negative
365423|NCT02027363|Metastasis colorectal cancer|metastasis colorectal cancer
365424|NCT02027363|Maintenance|maintenance
365425|NCT02027363|First-line treatment|first-line treatment
365426|NCT02027363|Capecitabine|capecitabine
365427|NCT02027337|combined oral contraceptives|combined oral contraceptives
365428|NCT02027337|drospirenone|drospirenone
365429|NCT02027337|cyproterone|cyproterone
365430|NCT02027337|hemostasis|hemostasis
365431|NCT02027337|antioxidants|antioxidants
365432|NCT02027324|Surgical site infection|surgical site infection
365433|NCT02027324|Cesarean delivery|cesarean delivery
365434|NCT02027324|Antisepsis|antisepsis
365435|NCT02027324|Povidone iodine|povidone iodine
365436|NCT02027324|Chlorhexidine alcohol|chlorhexidine alcohol
365437|NCT02027324|Endometritis|endometritis
365438|NCT02027311|Endoscopic Retrograde Cholangiopancreatography (ERCP)|endoscopic retrograde cholangiopancreatography (ercp)
365439|NCT02027311|Conscious Sedation|conscious sedation
365440|NCT02027311|etomidate|etomidate
365441|NCT02027311|midazolam|midazolam
365442|NCT02027298|Abatacept|abatacept
365443|NCT02027298|Sjogren's Syndrome|sjogren's syndrome
365444|NCT02027298|Rheumatoid Arthritis|rheumatoid arthritis
365445|NCT02027285|fortified milk, aging, health status|fortified milk, aging, health status
365446|NCT02027272|Eclampsia|eclampsia
365447|NCT02027259|Diabetes|diabetes
365448|NCT02027259|Depression|depression
365449|NCT02027259|Group|group
365450|NCT02027246|spinal cord injury|spinal cord injury
365451|NCT02027246|autologous bone marrow mononuclear cells|autologous bone marrow mononuclear cells
365452|NCT02027246|stem cell therapy|stem cell therapy
365453|NCT02027233|Prevention|prevention
365454|NCT02027233|Influenza|influenza
365455|NCT02027233|Adults hospitalized|adults hospitalized
365456|NCT02027233|Vaccines|vaccines
365457|NCT02027233|Effectiveness|effectiveness
365458|NCT02027207|Cholera|cholera
365459|NCT02027207|Oral cholera vaccine|oral cholera vaccine
365460|NCT02027207|Shanchol|shanchol
365461|NCT02027207|Protective efficacy|protective efficacy
365462|NCT02027207|Bangladesh|bangladesh
365463|NCT02027194|Allergic Rhinitis|allergic rhinitis
365464|NCT02027194|Chinese herbal medicine|chinese herbal medicine
365465|NCT02027194|Adolescents|adolescents
365466|NCT02027194|Double-blinded|double-blinded
365467|NCT02027194|Randomized controlled trial|randomized controlled trial
365468|NCT02027168|infertility|infertility
365469|NCT02027168|elevated FSH|elevated fsh
365470|NCT02027168|alternative treatment|alternative treatment
365471|NCT02027168|Clear Passage Approach|clear passage approach
365472|NCT02027168|Clear Passage Physical Therapy|clear passage physical therapy
365473|NCT02027155|healthy volunteers|healthy volunteers
365474|NCT02027129|Respiratory Distress Syndrome, Adult|respiratory distress syndrome, adult
365475|NCT02027129|Cor Pulmonale|cor pulmonale
365476|NCT02027129|High Frequency Ventilaiton|high frequency ventilaiton
365477|NCT02027116|chronic hepatitis C|chronic hepatitis c
365478|NCT02027116|DNA Vaccine|dna vaccine
365479|NCT02027116|Electroporation|electroporation
365480|NCT02027116|Intramuscular (IM) Injection|intramuscular (im) injection
365481|NCT02027103|Fetuin-A|fetuin-a
365482|NCT02027103|OPG|opg
365483|NCT02027103|Metformin|metformin
365484|NCT02027103|Pioglitazone|pioglitazone
365485|NCT02027077|physical activity|physical activity
365486|NCT02027077|diet|diet
365487|NCT02027077|small change|small change
365488|NCT02027077|behavior change|behavior change
365489|NCT02027051|population genetics|population genetics
365490|NCT02027025|Spasticity, Multiple sclerosis|spasticity, multiple sclerosis
365491|NCT02026934|Graft-Versus-Host Disease(GVHD)|graft-versus-host disease(gvhd)
365492|NCT02026934|Hematopoietic Stem Cell Transplantation.|hematopoietic stem cell transplantation.
365493|NCT02026934|Graft failure|graft failure
365494|NCT02026934|Graft exhaustion|graft exhaustion
365495|NCT02026921|Phase II study,|phase ii study,
365496|NCT02026921|Recurrent platinum-sensitive ovarian cancer|recurrent platinum-sensitive ovarian cancer
365497|NCT02026921|docetaxel|docetaxel
365498|NCT02026921|Carboplatin|carboplatin
365499|NCT02026921|Toxicity|toxicity
365500|NCT02026908|Prostate Artery Embolization|prostate artery embolization
365501|NCT02026908|PAE|pae
365502|NCT02026908|Benign Prostatic Hyperplasia|benign prostatic hyperplasia
365503|NCT02026908|BPH|bph
365504|NCT02026908|Lower Urinary Tract Symptoms|lower urinary tract symptoms
365505|NCT02026908|LUTS|luts
365506|NCT02026882|Airway, Caesarean|airway, caesarean
365507|NCT02026869|Vaginal administration, PCOS, Metformin|vaginal administration, pcos, metformin
365508|NCT02026856|oxidative stress, sepsis, selenium|oxidative stress, sepsis, selenium
365509|NCT02026830|Diabetic foot infections|diabetic foot infections
365510|NCT02026830|microorganisms|microorganisms
365511|NCT02026791|Supraglottic airway device|supraglottic airway device
365512|NCT02026791|I-gel|i-gel
365513|NCT02026791|SupremeLMA|supremelma
365514|NCT02026791|Elderly patient|elderly patient
365515|NCT02026739|minimally invasive esophagectomy; pulmonary function|minimally invasive esophagectomy; pulmonary function
365516|NCT02026674|urineflow|urineflow
365517|NCT02026674|luts|luts
365518|NCT02026674|urine flow|urine flow
365519|NCT02026674|uroflometry|uroflometry
365520|NCT02026674|bph|bph
365521|NCT02026635|heart failure|heart failure
365522|NCT02026635|Optivol® cardiac device|optivol® cardiac device
365523|NCT02026635|Medtronic CareLink|medtronic carelink
365524|NCT02026622|major depressive disorder|major depressive disorder
365525|NCT02026622|cerebrovascular reactivity|cerebrovascular reactivity
365526|NCT02026622|emotional reactivity|emotional reactivity
365527|NCT02026609|TIPS|tips
365528|NCT02026609|Hepatic encephalopathy|hepatic encephalopathy
365529|NCT02026609|Oral glutamine challenge|oral glutamine challenge
365530|NCT02026609|Psychometric tests|psychometric tests
365531|NCT02026609|Portal hypertension|portal hypertension
365532|NCT02026609|Cirrhosis|cirrhosis
365533|NCT02026596|subrachnoid hemorrhage|subrachnoid hemorrhage
365534|NCT02026596|secondary brain injury|secondary brain injury
365535|NCT02026570|Prosthesis|prosthesis
365536|NCT02026570|Falls|falls
365537|NCT02026570|Training|training
365538|NCT02026544|low frequency ultrasound|low frequency ultrasound
365539|NCT02026544|glomerular filtration rate|glomerular filtration rate
365540|NCT02026492|exercise-induced bronchoconstriction|exercise-induced bronchoconstriction
365541|NCT02026492|exercise-induced asthma|exercise-induced asthma
365542|NCT02026492|cold chamber|cold chamber
365543|NCT02026492|exercise challenge|exercise challenge
365544|NCT02026492|cold air challenge|cold air challenge
365545|NCT02026492|combined exercise- and cold-air challenge|combined exercise- and cold-air challenge
365546|NCT02026492|methacholine challenge|methacholine challenge
365547|NCT02026479|full-frequency sudden hearing loss|full-frequency sudden hearing loss
780837|NCT00326534|Sarcoidosis|sarcoidosis
365548|NCT02026479|post auricular injection|post auricular injection
365549|NCT02026479|glucocorticoid|glucocorticoid
365550|NCT02026479|multi-center|multi-center
365551|NCT02026466|Coronary Artery Disease|coronary artery disease
365552|NCT02026466|Chronic Total Occlusion|chronic total occlusion
365553|NCT02026453|Adverse drug events|adverse drug events
365554|NCT02026440|oral fluid collection device cotinine detection|oral fluid collection device cotinine detection
365555|NCT02026414|PrimaVie|primavie
365556|NCT02026414|Herbal Supplement|herbal supplement
365557|NCT02026414|Muscle biopsy|muscle biopsy
365558|NCT02026414|Energy|energy
365559|NCT02026414|Exercise|exercise
365560|NCT02026414|Human skeletal muscle adaptation|human skeletal muscle adaptation
365561|NCT02026414|Muscle function|muscle function
365562|NCT02026388|PH|ph
365563|NCT02026388|primary hyperoxaluria|primary hyperoxaluria
365564|NCT02026388|hyperoxaluria|hyperoxaluria
365565|NCT02026388|primary oxalosis|primary oxalosis
365566|NCT02026388|Primary Hyperoxaluria Type 1|primary hyperoxaluria type 1
365567|NCT02026388|Primary Hyperoxaluria Type 2|primary hyperoxaluria type 2
365568|NCT02026388|Primary Hyperoxaluria Type 3|primary hyperoxaluria type 3
365569|NCT02026388|Dent|dent
365570|NCT02026388|Dents|dents
365571|NCT02026388|Dent Disease|dent disease
365572|NCT02026388|Dent 1|dent 1
365573|NCT02026388|Dent 2|dent 2
365574|NCT02026388|Cystinuria|cystinuria
365575|NCT02026388|APRT|aprt
365576|NCT02026388|APRT deficiency|aprt deficiency
365577|NCT02026388|Biobank|biobank
365578|NCT02026362|HCC|hcc
365579|NCT02026362|DC|dc
365580|NCT02026362|CTL|ctl
365581|NCT02026349|influenza|influenza
365582|NCT02026349|flu|flu
365583|NCT02026349|fever|fever
365584|NCT02026349|cough|cough
365585|NCT02026349|body aches|body aches
365586|NCT02026349|headache|headache
365587|NCT02026349|nasal congestion|nasal congestion
365588|NCT02026349|body pains|body pains
365589|NCT02026349|sore throat|sore throat
365590|NCT02026349|fatigue|fatigue
365591|NCT02026349|T-705|t-705
365592|NCT02026349|favipiravir|favipiravir
365593|NCT02026349|favor|favor
365594|NCT02026349|flu symptoms|flu symptoms
365595|NCT02026336|asthma; inflammation; electronic nose|asthma; inflammation; electronic nose
365596|NCT02026310|glimepiride|glimepiride
365597|NCT02026310|metformin|metformin
365598|NCT02026310|basal insulin|basal insulin
365599|NCT02026310|Hemoglobin A, Glycosylated|hemoglobin a, glycosylated
365600|NCT02026310|glucose fluctuation|glucose fluctuation
365601|NCT02026310|hypoglycemia|hypoglycemia
365602|NCT02026297|postpartum hemorrhage|postpartum hemorrhage
365603|NCT02026297|estimated blood loss|estimated blood loss
365604|NCT02026297|coagulation|coagulation
365605|NCT02026297|thromboelastography|thromboelastography
365606|NCT02026297|tranexamic acid|tranexamic acid
365607|NCT02026284|Caesarean section|caesarean section
365608|NCT02026284|Anaesthesia|anaesthesia
365609|NCT02026284|Questionnaires|questionnaires
365610|NCT02026245|Arthritis|arthritis
365611|NCT02026245|rheumatoid|rheumatoid
365612|NCT02026245|joints|joints
365613|NCT02026245|swelling|swelling
365614|NCT02026245|measurement|measurement
365615|NCT02026245|movement|movement
365616|NCT02026245|electronic|electronic
365617|NCT02026245|data|data
365618|NCT02026245|glove|glove
365619|NCT02026245|goniometry|goniometry
365620|NCT02026245|outcome|outcome
365621|NCT02026245|stiffness|stiffness
365622|NCT02026232|Type 2 Diabetes|type 2 diabetes
365623|NCT02026232|Overweight|overweight
365624|NCT02026206|Primary Dysmenorrhea|primary dysmenorrhea
365625|NCT02026206|Pain|pain
365626|NCT02026167|Chronic Pain|chronic pain
365627|NCT02026167|Mood|mood
365628|NCT02026167|Physical Activity|physical activity
365629|NCT02026154|hypertension, biomarkers, echocardiography, heart failure|hypertension, biomarkers, echocardiography, heart failure
365630|NCT02026128|Uveitis|uveitis
365631|NCT02026128|Inflammation|inflammation
365632|NCT02026128|OCT|oct
365633|NCT02026128|Grading|grading
365634|NCT02026115|cancer|cancer
365635|NCT02026115|hospice|hospice
365636|NCT02026115|pain|pain
365637|NCT02026102|decision aid|decision aid
365638|NCT02026102|patient decision making|patient decision making
365639|NCT02026102|heart failure|heart failure
365640|NCT02026102|ejection fraction|ejection fraction
365641|NCT02026102|primary prevention|primary prevention
365642|NCT02026102|implantable cardioverter defibrillator|implantable cardioverter defibrillator
365643|NCT02026102|ICD|icd
365644|NCT02026102|pilot trial|pilot trial
365645|NCT02026102|patient centered health care|patient centered health care
365646|NCT02026076|low back pain|low back pain
365647|NCT02026076|traction|traction
365648|NCT02026076|unloading|unloading
365649|NCT02026050|dexamethasone|dexamethasone
365650|NCT02026050|intraarticular injection|intraarticular injection
365651|NCT02026050|interscalene brachial plexus block|interscalene brachial plexus block
365652|NCT02026037|Stress Disorders|stress disorders
365653|NCT02026037|Post-Traumatic|post-traumatic
467530|NCT01566682|CT|ct
365654|NCT02026037|Burns|burns
365655|NCT02026037|Brief Psychotherapy|brief psychotherapy
365656|NCT02026037|Cognitive Behavior Therapy|cognitive behavior therapy
365657|NCT02026011|alcohol use disorder|alcohol use disorder
365658|NCT02026011|naltrexone|naltrexone
365659|NCT02026011|Asian American|asian american
365660|NCT02026011|pharmacogenetics|pharmacogenetics
365661|NCT02026011|OPRM1 gene|oprm1 gene
365662|NCT02025998|ibudilast, alcoholism|ibudilast, alcoholism
365663|NCT02025985|Karyopharm|karyopharm
365664|NCT02025985|KPT-330|kpt-330
365665|NCT02025985|Selinexor|selinexor
365666|NCT02025985|SIGN|sign
365667|NCT02025985|ovarian cancer|ovarian cancer
365668|NCT02025985|endometrial cancer|endometrial cancer
365669|NCT02025985|cervical cancer|cervical cancer
365670|NCT02025985|SINE™|sine™
365671|NCT02025985|breast cancer|breast cancer
365672|NCT02025985|HER2 negative|her2 negative
365673|NCT02025972|Cerebral palsy|cerebral palsy
365674|NCT02025972|Umbilical cord blood|umbilical cord blood
365675|NCT02025972|Rehabilitation|rehabilitation
365676|NCT02025972|Cytokine|cytokine
365677|NCT02025972|Outcome|outcome
365678|NCT02025959|staff empowerment|staff empowerment
365679|NCT02025959|Sleep Apnea|sleep apnea
365680|NCT02025959|educational intervention|educational intervention
365681|NCT02025933|Children|children
365682|NCT02025933|Age 9-12 years|age 9-12 years
365683|NCT02025933|Overweight (iso-BMI > 25)|overweight (iso-bmi > 25)
365684|NCT02025907|Diabetes Mellitus, Type 2|diabetes mellitus, type 2
365685|NCT02025907|Canagliflozin|canagliflozin
365686|NCT02025907|Hemoglobin A1c|hemoglobin a1c
365687|NCT02025907|Metformin|metformin
365688|NCT02025907|Sitagliptin|sitagliptin
365689|NCT02025907|T2DM|t2dm
365690|NCT02025907|JNJ-28431754|jnj-28431754
365691|NCT02025894|neoplastic solid tumour|neoplastic solid tumour
365692|NCT02025894|PCVC|pcvc
365693|NCT02025894|thromboembolic complications|thromboembolic complications
365694|NCT02025894|infectious complications|infectious complications
365695|NCT02025894|risk factors|risk factors
365696|NCT02025868|Africa|africa
365697|NCT02025868|Antiretroviral Treatment|antiretroviral treatment
365698|NCT02025868|Adherence reinforcement|adherence reinforcement
365699|NCT02025868|Third line ART|third line art
365700|NCT02025868|Second line ART|second line art
365701|NCT02025868|Virologic failure|virologic failure
365702|NCT02025868|Adults|adults
365703|NCT02025855|Iatrogenic opioid abstinence syndrome|iatrogenic opioid abstinence syndrome
365704|NCT02025855|Methadone|methadone
365705|NCT02025855|Mechanical ventilation|mechanical ventilation
365706|NCT02025855|ICU delirium|icu delirium
365707|NCT02025855|Continuous sedation|continuous sedation
365708|NCT02025842|Hepatocellular carcinoma|hepatocellular carcinoma
365709|NCT02025842|Hepatitis B|hepatitis b
365710|NCT02025829|cystic fibrosis|cystic fibrosis
365711|NCT02025829|IL-17 neutrophils|il-17 neutrophils
365712|NCT02025803|Advanced solid tumors|advanced solid tumors
365713|NCT02025790|Achalasia|achalasia
365714|NCT02025790|POEM|poem
365715|NCT02025790|Pneumatic dilatation|pneumatic dilatation
365716|NCT02025790|Eckardt score|eckardt score
365717|NCT02025777|Ulcerative Colitis|ulcerative colitis
365718|NCT02025777|PillCam|pillcam
365719|NCT02025777|IBD|ibd
365720|NCT02025751|Diabetes|diabetes
365721|NCT02025751|Gastroparesis|gastroparesis
365722|NCT02025751|Delayed gastric emptying|delayed gastric emptying
365723|NCT02025751|Nausea|nausea
365724|NCT02025751|Vomiting|vomiting
365725|NCT02025751|Bloating|bloating
365726|NCT02025751|Abdominal pain|abdominal pain
365727|NCT02025751|Early Satiety|early satiety
365728|NCT02025751|Gastric stasis|gastric stasis
365729|NCT02025751|Gastropathy|gastropathy
365730|NCT02025725|Gastroparesis|gastroparesis
365731|NCT02025725|Diabetic|diabetic
365732|NCT02025725|Delayed gastric emptying|delayed gastric emptying
365733|NCT02025725|Gastric stasis|gastric stasis
365734|NCT02025725|Nausea|nausea
365735|NCT02025725|Vomiting|vomiting
365736|NCT02025725|Bloating|bloating
365737|NCT02025725|Abdominal pain|abdominal pain
365738|NCT02025725|Early satiety|early satiety
365739|NCT02025725|Gastropathy|gastropathy
365740|NCT02025686|Pain|pain
365741|NCT02025686|Inflammation|inflammation
365742|NCT02025686|Hyperalgesia|hyperalgesia
365743|NCT02025686|burn injury|burn injury
365744|NCT02025686|Hyperbaric Oxygen|hyperbaric oxygen
365745|NCT02025660|Mw|mw
365746|NCT02025660|Mycobacterium indicum prannii|mycobacterium indicum prannii
365747|NCT02025660|Mycobacterium w|mycobacterium w
365748|NCT02025660|Severe sepsis|severe sepsis
365749|NCT02025660|Septic shock|septic shock
365750|NCT02025647|Mood disorders|mood disorders
365751|NCT02025647|Anxiety disorders|anxiety disorders
365752|NCT02025647|Eating concerns|eating concerns
365753|NCT02025647|Pain concerns|pain concerns
365754|NCT02025647|Alcohol abuse|alcohol abuse
365755|NCT02025647|Self harm|self harm
365756|NCT02025647|Mental health|mental health
365757|NCT02025647|Clinical Decision Support|clinical decision support
365758|NCT02025634|Pain, Postoperative|pain, postoperative
365759|NCT02025634|Ofirmev|ofirmev
365760|NCT02025634|Acetaminophen|acetaminophen
365761|NCT02025634|Analgesics, Non-Narcotic|analgesics, non-narcotic
365762|NCT02025634|Arthroscopy|arthroscopy
365763|NCT02025621|coronary artery bypass grafting|coronary artery bypass grafting
365764|NCT02025621|CABG|cabg
365765|NCT02025621|mitral valve|mitral valve
365766|NCT02025621|LCOS|lcos
365767|NCT02025621|low cardiac output syndrome|low cardiac output syndrome
365768|NCT02025621|levosimendan|levosimendan
365769|NCT02025608|Restless legs syndrome|restless legs syndrome
365770|NCT02025595|Brain|brain
365771|NCT02025595|Genes|genes
365772|NCT02025595|Environment|environment
365773|NCT02025595|Etiology|etiology
365774|NCT02025595|Reward|reward
365775|NCT02025595|Satiety Response|satiety response
365776|NCT02025595|Central Nervous System|central nervous system
365777|NCT02025595|Magnetic Resonance Imaging|magnetic resonance imaging
365778|NCT02025595|Twins, Monozygotic|twins, monozygotic
365779|NCT02025595|Overweight|overweight
365780|NCT02025595|Obesity|obesity
365781|NCT02025582|idiopathic toe walking|idiopathic toe walking
365782|NCT02025582|gait disorder|gait disorder
365783|NCT02025582|gait analysis|gait analysis
365784|NCT02025582|kinesio taping|kinesio taping
365785|NCT02025582|ultrasound elastography|ultrasound elastography
365786|NCT02025582|pediatric|pediatric
365787|NCT02025582|children|children
365788|NCT02025582|muscle stiffness|muscle stiffness
365789|NCT02025582|muscle elasticity|muscle elasticity
365790|NCT02025569|chronic ankle instability|chronic ankle instability
365791|NCT02025569|lateral ankle sprain|lateral ankle sprain
365792|NCT02025569|manual therapy|manual therapy
365793|NCT02025569|star excursion balance test|star excursion balance test
365794|NCT02025569|strain and counterstrain|strain and counterstrain
365795|NCT02025556|High Frequency Episodic Migraine Headache|high frequency episodic migraine headache
365796|NCT02025556|Episodic Migraine Headache|episodic migraine headache
365797|NCT02025556|Migraine Headache|migraine headache
365798|NCT02025543|MRI|mri
365799|NCT02025543|Iron overload|iron overload
365800|NCT02025530|Stillbirth|stillbirth
365801|NCT02025530|Modifiable risk factors|modifiable risk factors
365802|NCT02025517|Parkinson's disease|parkinson's disease
365803|NCT02025517|rehabilitation|rehabilitation
365804|NCT02025517|kinematics|kinematics
365805|NCT02025517|cognition|cognition
365806|NCT02025504|Colonoscopy, Looping, Sigmoid Looping, ColoWrap, Binder, Patient Satisfaction|colonoscopy, looping, sigmoid looping, colowrap, binder, patient satisfaction
365807|NCT02025491|Disseminated leishmaniasis|disseminated leishmaniasis
365808|NCT02025491|Liposomal Amphotericin B|liposomal amphotericin b
365809|NCT02025491|Leishmania braziliensis|leishmania braziliensis
365810|NCT02025478|children|children
365811|NCT02025478|bone marrow transplant|bone marrow transplant
365812|NCT02025478|autologous|autologous
365813|NCT02025478|allogeneic|allogeneic
365814|NCT02025478|breastmilk|breastmilk
365815|NCT02025478|hematopoietic stem cell transplantation (HSCT)|hematopoietic stem cell transplantation (hsct)
365816|NCT02025465|Atrial Fibrillation|atrial fibrillation
365817|NCT02025465|Atrial Flutter|atrial flutter
365818|NCT02025465|Metoprolol|metoprolol
365819|NCT02025465|Diltiazem|diltiazem
365820|NCT02025452|diarrhoea|diarrhoea
365821|NCT02025452|gastroenteritis|gastroenteritis
365822|NCT02025452|rapid diagnostics|rapid diagnostics
365823|NCT02025452|probiotics|probiotics
365824|NCT02025452|sub-Saharan Africa|sub-saharan africa
365825|NCT02025439|Traumatic Brain Injury|traumatic brain injury
365826|NCT02025439|Transcranial Magnetic Stimulation|transcranial magnetic stimulation
365827|NCT02025439|Amantadine|amantadine
365828|NCT02025439|Vegetative State|vegetative state
365829|NCT02025439|Minimally Conscious State|minimally conscious state
365830|NCT02025426|Cesarean delivery|cesarean delivery
365831|NCT02025426|Spinal Anesthesia|spinal anesthesia
365832|NCT02025400|Rehabilitation|rehabilitation
365833|NCT02025400|eRehab|erehab
365834|NCT02025400|Physical Therapy|physical therapy
365835|NCT02025400|e-Health|e-health
365836|NCT02025400|Telemedicine|telemedicine
365837|NCT02025400|Telerehabilitation|telerehabilitation
365838|NCT02025400|Patient-Centered|patient-centered
365839|NCT02025374|spinal anesthesia|spinal anesthesia
365840|NCT02025374|cesarean section|cesarean section
365841|NCT02025374|hyperbaric levobupivacaine|hyperbaric levobupivacaine
365842|NCT02025361|prostate biopsy, local anesthesia, cancer detection rate.|prostate biopsy, local anesthesia, cancer detection rate.
365843|NCT02025322|HIV/AIDS|hiv/aids
365844|NCT02025322|Peer Mentoring|peer mentoring
365845|NCT02025322|Medication Adherence|medication adherence
365846|NCT02025322|Medication Non-adherent|medication non-adherent
365847|NCT02025322|Newly diagnosed|newly diagnosed
365848|NCT02025322|HIV-positive individuals|hiv-positive individuals
365849|NCT02025322|HIV viral load|hiv viral load
365850|NCT02025322|CD4 lymphocyte cell counts|cd4 lymphocyte cell counts
365851|NCT02025322|Treatment adherence|treatment adherence
780838|NCT00326534|Rickettsia|rickettsia
467758|NCT01565668|AC220|ac220
365852|NCT02025322|Health literacy|health literacy
365853|NCT02025322|Self-efficacy|self-efficacy
365854|NCT02025309|train of four|train of four
365855|NCT02025309|neuromuscular recovery|neuromuscular recovery
365856|NCT02025309|sugammadex|sugammadex
365857|NCT02025296|Telemedicine|telemedicine
365858|NCT02025296|Clinical decision support system|clinical decision support system
365859|NCT02025296|Ubiquitous healthcare|ubiquitous healthcare
365860|NCT02025296|Diabetes Care|diabetes care
365861|NCT02025296|Multifactorial Intervention|multifactorial intervention
365862|NCT02025283|Intervertebral disc disease|intervertebral disc disease
365863|NCT02025283|Radiculopathy|radiculopathy
365864|NCT02025283|Chronic pain|chronic pain
365865|NCT02025283|Thermocoagulation|thermocoagulation
365866|NCT02025270|Azoospermia, Spermatogonial Arrest, Maturation Arrest.|azoospermia, spermatogonial arrest, maturation arrest.
365867|NCT02025257|coronary artery disease|coronary artery disease
365868|NCT02025257|elderly|elderly
365869|NCT02025257|exercise|exercise
365870|NCT02025257|exercise-based cardiac rehabilitation|exercise-based cardiac rehabilitation
365871|NCT02025244|Key hole biopsy|key hole biopsy
365872|NCT02025244|Upper Gastrointestinal Submucosal Tumors|upper gastrointestinal submucosal tumors
365873|NCT02025244|EUS-FNA|eus-fna
365874|NCT02025244|Mitototic Activity|mitototic activity
365875|NCT02025244|GIST|gist
365876|NCT02025231|reirradiation|reirradiation
365877|NCT02025231|recurrent glioma|recurrent glioma
365878|NCT02025231|positron emission tomography|positron emission tomography
365879|NCT02025231|amino acid tracer|amino acid tracer
365880|NCT02025218|NSCLC|nsclc
365881|NCT02025218|EGFR|egfr
365882|NCT02025218|TKI|tki
365883|NCT02025218|Re-challenge|re-challenge
365884|NCT02025218|Lung Cancer|lung cancer
365885|NCT02025218|Resistance|resistance
365886|NCT02025192|ONT-380|ont-380
365887|NCT02025192|Capecitabine|capecitabine
365888|NCT02025192|Trastuzumab|trastuzumab
365889|NCT02025192|Xeloda|xeloda
365890|NCT02025192|Herceptin|herceptin
365891|NCT02025192|HER2 positive breast cancer|her2 positive breast cancer
365892|NCT02025192|Breast cancer|breast cancer
365893|NCT02025192|ARRY-380|arry-380
365894|NCT02025192|Tucatinib|tucatinib
365895|NCT02025179|Teriparatide|teriparatide
365896|NCT02025179|Osteoporosis|osteoporosis
365897|NCT02025179|Spinal Cord Injury|spinal cord injury
365898|NCT02025179|Bone Diseases|bone diseases
365899|NCT02025179|Metabolic Bone Diseases|metabolic bone diseases
365900|NCT02025179|Musculoskeletal Diseases|musculoskeletal diseases
365901|NCT02025179|Spinal Cord Diseases|spinal cord diseases
365902|NCT02025179|Central Nervous System Diseases|central nervous system diseases
365903|NCT02025179|Nervous System Diseases|nervous system diseases
365904|NCT02025179|Nervous System|nervous system
365905|NCT02025179|Wounds and Injuries|wounds and injuries
365906|NCT02025179|Bone Density Conservation Agents|bone density conservation agents
365907|NCT02025179|Physiological Effects of Drugs|physiological effects of drugs
365908|NCT02025179|Pharmacologic Actions|pharmacologic actions
365909|NCT02025179|Vibration|vibration
365910|NCT02025166|Pain|pain
365911|NCT02025166|abortion|abortion
365912|NCT02025166|paracetamol|paracetamol
365913|NCT02025166|lornoxicam|lornoxicam
365914|NCT02025140|Computer controlled anesthesia (CCLAD)|computer controlled anesthesia (cclad)
365915|NCT02025140|pain perception|pain perception
365916|NCT02025140|Effectiveness|effectiveness
365917|NCT02025140|primary molars|primary molars
365918|NCT02025140|Behavior|behavior
365919|NCT02025127|septic shock|septic shock
366613|NCT02021851|PONV|ponv
365920|NCT02025127|mechanical ventilation|mechanical ventilation
365921|NCT02025127|enteral nutrition|enteral nutrition
365922|NCT02025127|trophic feeding|trophic feeding
365923|NCT02025114|NSCLC, EGFR mutation|nsclc, egfr mutation
365924|NCT02025101|Slow Coronary Flow|slow coronary flow
365925|NCT02025075|Tomography|tomography
365926|NCT02025075|Oximetry|oximetry
365927|NCT02025075|Echocardiography|echocardiography
365928|NCT02025062|head and neck squamous cell carcinomas (HNSCCs)|head and neck squamous cell carcinomas (hnsccs)
365929|NCT02025062|elderly|elderly
365930|NCT02025062|cancer|cancer
365931|NCT02025062|comprehensive geriatric assessment|comprehensive geriatric assessment
365932|NCT02025062|functional status|functional status
365933|NCT02025062|malnutrition|malnutrition
365934|NCT02025062|survival|survival
365935|NCT02025049|pancreatitis|pancreatitis
365936|NCT02025036|Chemoradiotherapy， Esophageal Squamous Cancer|chemoradiotherapy， esophageal squamous cancer
365937|NCT02025023|Size|size
365938|NCT02025023|Pain|pain
365939|NCT02025023|Resolution|resolution
365940|NCT02025023|Complications|complications
365941|NCT02025023|Swelling|swelling
365942|NCT02025010|castration-resistant prostate cancer|castration-resistant prostate cancer
365943|NCT02024997|Pancreatic malignancy|pancreatic malignancy
365944|NCT02024997|Radiation Therapy|radiation therapy
365945|NCT02024984|LPFPCCPCOS|lpfpccpcos
365946|NCT02024971|Drug therapy|drug therapy
365947|NCT02024958|Adult ICU patients|adult icu patients
365948|NCT02024958|spontaneous breathing|spontaneous breathing
365949|NCT02024958|invasive ventilation|invasive ventilation
365950|NCT02024958|non-invasive ventilation|non-invasive ventilation
365951|NCT02024945|Drug therapy|drug therapy
365952|NCT02024906|isoflavone|isoflavone
365953|NCT02024906|CVD|cvd
365954|NCT02024906|soy intake|soy intake
365955|NCT02024906|subclinical hypothyroid|subclinical hypothyroid
365956|NCT02024893|Humeral retroversion|humeral retroversion
365957|NCT02024893|dynamic control ratio|dynamic control ratio
365958|NCT02024893|GIRD|gird
365959|NCT02024880|in vitro fertilization|in vitro fertilization
365960|NCT02024880|embryo transfer|embryo transfer
365961|NCT02024880|transfer catheter|transfer catheter
365962|NCT02024867|Methicillin resistent Staphylococcus aureus|methicillin resistent staphylococcus aureus
365963|NCT02024867|Staphylococcus aureus|staphylococcus aureus
365964|NCT02024854|Kangaroo-Mother Care Method|kangaroo-mother care method
365965|NCT02024854|Stress, Physiological|stress, physiological
365966|NCT02024841|Gastric cancer|gastric cancer
365967|NCT02024841|Peritoneal carcinomatosis|peritoneal carcinomatosis
365968|NCT02024841|Intraperitoneal docetaxel|intraperitoneal docetaxel
365969|NCT02024841|Cisplatin|cisplatin
365970|NCT02024841|TS-ONE|ts-one
365971|NCT02024828|Infant feeding|infant feeding
365972|NCT02024802|Pain|pain
365973|NCT02024802|Pain Cream|pain cream
365974|NCT02024802|Nociceptive pain|nociceptive pain
365975|NCT02024802|neurologic pain|neurologic pain
365976|NCT02024802|transdermal|transdermal
365977|NCT02024802|compounding|compounding
365978|NCT02024802|compound|compound
365979|NCT02024776|Training|training
365980|NCT02024776|Wellness|wellness
365981|NCT02024776|Aerobic capacity|aerobic capacity
365982|NCT02024776|Information and communication technology, surgical risk|information and communication technology, surgical risk
365983|NCT02024776|Abdominal surgery|abdominal surgery
365984|NCT02024763|Energy Expenditure|energy expenditure
365985|NCT02024763|Physical Education|physical education
365986|NCT02024763|Children|children
365987|NCT02024763|Randomized Controlled Trial|randomized controlled trial
365988|NCT02024750|Family centered care|family centered care
365989|NCT02024750|Patient centered care|patient centered care
365990|NCT02024750|Diabetes Mellitus, Type 1|diabetes mellitus, type 1
365991|NCT02024750|Problem Recognition in Illness Self-Management (PRISM)|problem recognition in illness self-management (prism)
365992|NCT02024711|Cataract|cataract
365993|NCT02024711|Intraocular Lens|intraocular lens
365994|NCT02024711|IOL|iol
365995|NCT02024711|Aphakia|aphakia
365996|NCT02024685|Prostate|prostate
365997|NCT02024685|Localized Prostate Cancer|localized prostate cancer
365998|NCT02024685|Decision making|decision making
365999|NCT02024672|Intrauterine devices|intrauterine devices
366000|NCT02024672|IUDs|iuds
366001|NCT02024672|postpartum|postpartum
366002|NCT02024672|contraception|contraception
366003|NCT02024659|nasal polyps|nasal polyps
366004|NCT02024659|remodeling|remodeling
366005|NCT02024659|inflammatory cells|inflammatory cells
366006|NCT02024659|budesonide|budesonide
366007|NCT02024646|Psoriatic Arthritis|psoriatic arthritis
366008|NCT02024646|Brodalumab|brodalumab
366009|NCT02024646|AMG 827|amg 827
366010|NCT02024620|depression|depression
366011|NCT02024620|technology|technology
366012|NCT02024620|psychotherapy|psychotherapy
366013|NCT02024620|behavioral activation|behavioral activation
366014|NCT02024594|Nitrous Oxide-Oxygen conscious sedation|nitrous oxide-oxygen conscious sedation
366015|NCT02024594|Cognitive Behavioral Therapy|cognitive behavioral therapy
366016|NCT02024594|Children, Preschool|children, preschool
366017|NCT02024594|dental anxiety|dental anxiety
366916|NCT02020174|Registry|registry
366018|NCT02024594|Patient Cooperation|patient cooperation
366019|NCT02024581|pediatric|pediatric
366020|NCT02024581|dermatology|dermatology
366021|NCT02024581|East Indian sandalwood oil|east indian sandalwood oil
366022|NCT02024581|pox virus|pox virus
366023|NCT02024568|Pregabalin|pregabalin
366024|NCT02024568|Arthralgia Myalgia Syndrome|arthralgia myalgia syndrome
366025|NCT02024568|Paclitaxel|paclitaxel
366026|NCT02024568|Pain management|pain management
366027|NCT02024568|Breast cancer|breast cancer
366028|NCT02024542|Bariatric Surgery|bariatric surgery
366029|NCT02024542|Obesity|obesity
366030|NCT02024542|Metabolic syndrome|metabolic syndrome
366031|NCT02024542|Diabetes|diabetes
366032|NCT02024516|Type 2 diabetes|type 2 diabetes
366033|NCT02024516|Pomegranate|pomegranate
366034|NCT02024516|Inflammation|inflammation
366035|NCT02024516|lipid profiles|lipid profiles
366036|NCT02024503|stroke|stroke
366037|NCT02024503|fMRI|fmri
366038|NCT02024503|DTI|dti
366039|NCT02024490|vitamin D, prematurity, RDS, BPD, maternal, neonatal|vitamin d, prematurity, rds, bpd, maternal, neonatal
366040|NCT02024477|endothelial cells|endothelial cells
366041|NCT02024477|cellular biomarker|cellular biomarker
366042|NCT02024477|endothelial dysfunction|endothelial dysfunction
366043|NCT02024464|Primary open angle glaucoma|primary open angle glaucoma
366044|NCT02024464|POAG|poag
366045|NCT02024464|Pseudoexfoliative glaucoma|pseudoexfoliative glaucoma
366046|NCT02024464|PXG|pxg
366047|NCT02024464|Pigmentary dispersion glaucoma|pigmentary dispersion glaucoma
366048|NCT02024464|PDG|pdg
366049|NCT02024464|Hydrus|hydrus
366050|NCT02024451|Radial shock wave|radial shock wave
366051|NCT02024451|Acupuncture|acupuncture
366052|NCT02024438|metastatic gastric cancer|metastatic gastric cancer
366053|NCT02024438|neurotoxicity|neurotoxicity
366054|NCT02024438|mFOLFOX6|mfolfox6
366055|NCT02024438|monosialotetrahexosylganglioside Sodium Injection|monosialotetrahexosylganglioside sodium injection
366056|NCT02024425|Clinical trials|clinical trials
366057|NCT02024425|Adult|adult
366058|NCT02024425|Women|women
366059|NCT02024425|Functional food|functional food
366060|NCT02024425|Dietary Supplements|dietary supplements
366061|NCT02024425|Overweight|overweight
366062|NCT02024425|Obese|obese
366063|NCT02024425|Absorptiometry, Dual X-Ray|absorptiometry, dual x-ray
366064|NCT02024425|Rosmarinus|rosmarinus
366065|NCT02024425|Oligosaccharides|oligosaccharides
366066|NCT02024425|Lactulose|lactulose
366067|NCT02024425|Bioactive peptide|bioactive peptide
366068|NCT02024412|metastatic colorectal cancer|metastatic colorectal cancer
366069|NCT02024412|neurotoxicity|neurotoxicity
366070|NCT02024412|mFOLFOX6|mfolfox6
366071|NCT02024412|monosialotetrahexosylganglioside Sodium Injection|monosialotetrahexosylganglioside sodium injection
366072|NCT02024399|Pediatric Overweight/Obesity, DEXA, Fitness|pediatric overweight/obesity, dexa, fitness
366073|NCT02024386|Guanylate Cyclase|guanylate cyclase
366074|NCT02024386|Pulmonary Edema of Mountaineers|pulmonary edema of mountaineers
366075|NCT02024386|Mountaineering|mountaineering
366076|NCT02024386|Performance-Enhancing Substances|performance-enhancing substances
366077|NCT02024386|Athletic Performance|athletic performance
366078|NCT02024373|chronic subdural hematoma|chronic subdural hematoma
366079|NCT02024373|Atorvastatin|atorvastatin
366080|NCT02024373|oral administration therapy|oral administration therapy
366081|NCT02024360|obesity|obesity
366082|NCT02024360|overweight|overweight
366083|NCT02024360|children|children
366084|NCT02024360|prevention|prevention
366085|NCT02024334|JIA|jia
366086|NCT02024334|LEFLUNOMIDE|leflunomide
366087|NCT02024334|EFFICACY|efficacy
366088|NCT02024321|abdominal surgery|abdominal surgery
366089|NCT02024321|TPN|tpn
366090|NCT02024321|blood glucose|blood glucose
366091|NCT02024308|acute myeloid leukemia,|acute myeloid leukemia,
366092|NCT02024308|AML1-ETO fusion protein,|aml1-eto fusion protein,
366093|NCT02024308|Fludarabine,|fludarabine,
366094|NCT02024308|recurrence|recurrence
366095|NCT02024269|macular degeneration|macular degeneration
366096|NCT02024269|stem cells|stem cells
366097|NCT02024269|adipose stem cells|adipose stem cells
366098|NCT02024256|Vaginal delivery|vaginal delivery
366099|NCT02024256|Perineal swelling|perineal swelling
366100|NCT02024256|Perineal pain|perineal pain
366101|NCT02024256|MgSo4|mgso4
366102|NCT02024256|Magnesium sulfate|magnesium sulfate
366103|NCT02024256|Cold water|cold water
366104|NCT02024243|Micro RNA|micro rna
366105|NCT02024243|Wound|wound
366106|NCT02024243|Chronic Venous Leg Ulcer|chronic venous leg ulcer
366107|NCT02024243|VLU|vlu
366108|NCT02024243|miR210|mir210
366109|NCT02024243|Indiana University Health Comprehensive Wound Center (CWC)|indiana university health comprehensive wound center (cwc)
366110|NCT02024204|World Trade Center Disaster|world trade center disaster
366111|NCT02024204|Environmental Exposure|environmental exposure
366112|NCT02024204|Respiratory Physiology|respiratory physiology
366113|NCT02024204|Inflammation|inflammation
366114|NCT02024204|Gastrointestinal Diseases|gastrointestinal diseases
366115|NCT02024204|Sinus Symptoms|sinus symptoms
366116|NCT02024204|PTSD|ptsd
366117|NCT02024204|Anxiety|anxiety
366118|NCT02024204|Depression|depression
366119|NCT02024204|Hypersensitivity|hypersensitivity
366120|NCT02024204|Spirometry|spirometry
366121|NCT02024204|Oscillometry|oscillometry
366122|NCT02024191|glutamine|glutamine
366123|NCT02024191|oxaliplatin|oxaliplatin
366124|NCT02024191|peripheral neuropathy|peripheral neuropathy
366125|NCT02024178|Prostate Cancer|prostate cancer
366126|NCT02024178|Radical Prostatectomy|radical prostatectomy
366127|NCT02024178|Ultrasound Imaging|ultrasound imaging
366128|NCT02024165|Ultrasound|ultrasound
366129|NCT02024165|FSE|fse
366130|NCT02024165|IUPC|iupc
366131|NCT02024139|Orthodontic pain|orthodontic pain
366132|NCT02024139|Chewing gum|chewing gum
366133|NCT02024126|Knee osteoarthritis|knee osteoarthritis
366134|NCT02024126|Exercise therapy|exercise therapy
366135|NCT02024126|RCT|rct
366136|NCT02024126|Intervention|intervention
366137|NCT02024126|Knee pain|knee pain
366138|NCT02024126|Muticenter|muticenter
366139|NCT02024126|Knee function|knee function
366140|NCT02024113|validation|validation
366141|NCT02024113|model|model
366142|NCT02024113|metabolic profile|metabolic profile
366143|NCT02024113|positron emission tomography|positron emission tomography
366144|NCT02024061|Adolescents|adolescents
366145|NCT02024061|Obesity|obesity
468152|NCT01563913|DHA|dha
366146|NCT02024061|Physical activity|physical activity
366147|NCT02024061|Sedentary behavior|sedentary behavior
366148|NCT02024061|Psychosocial health|psychosocial health
366149|NCT02024048|Pregnancy|pregnancy
366150|NCT02024048|OCT|oct
366151|NCT02024048|Enhanced depth imaging|enhanced depth imaging
366152|NCT02024048|Choroid|choroid
366153|NCT02024035|Tomotherapy|tomotherapy
366154|NCT02024035|Head and neck squamous celle carcinoma|head and neck squamous celle carcinoma
366155|NCT02024035|Health economic evaluation|health economic evaluation
366156|NCT02024022|colonoscopy|colonoscopy
366157|NCT02024022|bowel cleansing|bowel cleansing
366158|NCT02024022|polyethylene glycol|polyethylene glycol
366159|NCT02024022|sodium picosulphate / magnesium citrate|sodium picosulphate / magnesium citrate
366160|NCT02024009|chemoradiotherapy|chemoradiotherapy
366161|NCT02024009|nelfinavir|nelfinavir
366162|NCT02024009|abraxane|abraxane
366163|NCT02024009|gemcitabine|gemcitabine
366164|NCT02024009|radiotherapy|radiotherapy
366165|NCT02024009|capecitabine|capecitabine
366166|NCT02023996|HER2 positive|her2 positive
366167|NCT02023996|PET Imaging|pet imaging
366168|NCT02023996|89Zr-DFO-trastuzumab|89zr-dfo-trastuzumab
366169|NCT02023996|13-165|13-165
366170|NCT02023983|ST-segment elevation myocardial infarction|st-segment elevation myocardial infarction
366171|NCT02023983|Primary percutaneous coronary intervention|primary percutaneous coronary intervention
366172|NCT02023983|Low risk|low risk
366173|NCT02023983|Early discharge|early discharge
366174|NCT02023970|Bioprosthetic heart valves, immune response, structural valve deterioration, valvular disease.|bioprosthetic heart valves, immune response, structural valve deterioration, valvular disease.
366175|NCT02023957|Interactive Health-risk assessment|interactive health-risk assessment
366176|NCT02023957|Primary Care|primary care
366177|NCT02023957|Randomized|randomized
366178|NCT02023957|Open Label|open label
366179|NCT02023957|Efficacy Study|efficacy study
366180|NCT02023944|Memory|memory
366181|NCT02023944|Aging|aging
366182|NCT02023944|Healthy People|healthy people
366183|NCT02023944|Intervention|intervention
366184|NCT02023931|Oral mucosa|oral mucosa
366185|NCT02023931|Nrf2 pathway|nrf2 pathway
366186|NCT02023931|Broccoli Sprout Extract|broccoli sprout extract
366187|NCT02023931|Head and Neck Cancer|head and neck cancer
366188|NCT02023918|Growth hormone antagonism|growth hormone antagonism
366189|NCT02023866|Leigh Syndrome|leigh syndrome
366190|NCT02023866|Leber's hereditary optic neuropathy|leber's hereditary optic neuropathy
366191|NCT02023866|myoclonic epilepsy|myoclonic epilepsy
366192|NCT02023866|mitochondrial encephalomyopathy|mitochondrial encephalomyopathy
366193|NCT02023866|Kearn-Sayre syndrome|kearn-sayre syndrome
366194|NCT02023866|POLG-related disorders|polg-related disorders
366195|NCT02023866|Neurogastrointestinal encephalopathy|neurogastrointestinal encephalopathy
366196|NCT02023840|periodontitis|periodontitis
366197|NCT02023840|pockets|pockets
366198|NCT02023827|Transtheoretical Model|transtheoretical model
366199|NCT02023827|Stages of change|stages of change
366200|NCT02023827|Computer-tailored intervention|computer-tailored intervention
366201|NCT02023827|Delinquency|delinquency
366202|NCT02023827|Substance abuse|substance abuse
366203|NCT02023827|Juvenile offender|juvenile offender
366204|NCT02023827|Juvenile justice|juvenile justice
366205|NCT02023827|Rise Above Your Situation (RAYS) program|rise above your situation (rays) program
366206|NCT02023801|Menorrhagia|menorrhagia
366207|NCT02023801|Dysfunctional Uterine Bleeding|dysfunctional uterine bleeding
366208|NCT02023801|Endometrial Ablation|endometrial ablation
366209|NCT02023788|human umbilical cord blood-derived mesenchymal stem cells|human umbilical cord blood-derived mesenchymal stem cells
366210|NCT02023788|bronchopulmonary dysplasia|bronchopulmonary dysplasia
366211|NCT02023788|respiratory tract infection|respiratory tract infection
366212|NCT02023788|Premature infants|premature infants
366213|NCT02023762|mitral regurgitation|mitral regurgitation
366214|NCT02023762|local anaesthesia|local anaesthesia
367214|NCT02018718|MRI|mri
366215|NCT02023762|percutaneous repair|percutaneous repair
366216|NCT02023749|nuts|nuts
366217|NCT02023749|metabolic syndrome|metabolic syndrome
366218|NCT02023749|lipid profile|lipid profile
366219|NCT02023749|inflammation|inflammation
366220|NCT02023749|oxidative stress|oxidative stress
366221|NCT02023749|endothelial function|endothelial function
366222|NCT02023723|Energy Drink|energy drink
366223|NCT02023723|Electrocardiograph|electrocardiograph
366224|NCT02023723|Hemodynamic|hemodynamic
366225|NCT02023710|mucosal melanoma|mucosal melanoma
366226|NCT02023710|Bevacizumab|bevacizumab
366227|NCT02023710|Carboplatin|carboplatin
366228|NCT02023710|Paclitaxel|paclitaxel
366229|NCT02023684|Sleeve Gastrectomy|sleeve gastrectomy
366230|NCT02023684|Lidocaine|lidocaine
366231|NCT02023684|ropivacaine|ropivacaine
366233|NCT02023658|pMTCT|pmtct
366234|NCT02023645|lutein|lutein
366235|NCT02023645|cognition|cognition
366236|NCT02023645|neural efficiency|neural efficiency
366237|NCT02023645|aging|aging
366238|NCT02023632|older adults|older adults
781045|NCT00325793|nicardipine|nicardipine
366239|NCT02023632|physical activity|physical activity
366240|NCT02023632|self-categorization|self-categorization
366241|NCT02023632|group dynamics|group dynamics
366242|NCT02023632|self-identity|self-identity
366243|NCT02023619|Keratoconus|keratoconus
366244|NCT02023619|Astigmatism|astigmatism
366245|NCT02023619|Cornea|cornea
366246|NCT02023619|SD-OCT|sd-oct
366247|NCT02023606|Impulsive Aggression|impulsive aggression
366248|NCT02023606|ADHD|adhd
366249|NCT02023580|Viral suppression|viral suppression
366250|NCT02023580|Sexual risk|sexual risk
366251|NCT02023554|azithromycin|azithromycin
366252|NCT02023554|theophylline|theophylline
366253|NCT02023554|CYP3A4|cyp3a4
366254|NCT02023515|weight loss|weight loss
366255|NCT02023515|metabolic syndrome|metabolic syndrome
366256|NCT02023515|stress|stress
366257|NCT02023515|obesity|obesity
366258|NCT02023502|female stress urinary incontinence|female stress urinary incontinence
366259|NCT02023502|proteomics|proteomics
366260|NCT02023502|biomarker|biomarker
366261|NCT02023424|BDNF|bdnf
366262|NCT02023424|GLATIRAMER ACETATE|glatiramer acetate
366263|NCT02023424|RETT SYNDROME|rett syndrome
366264|NCT02023424|COPAXONE|copaxone
366265|NCT02023424|Bruria Ben-Zeev|bruria ben-zeev
366266|NCT02023411|Teriparatide|teriparatide
366267|NCT02023411|Inactive Charcot's neuroarthropathy|inactive charcot's neuroarthropathy
366268|NCT02023398|High Frequency|high frequency
366269|NCT02023398|Waist circumferential reduction|waist circumferential reduction
366270|NCT02023385|Low Level Laser Therapy|low level laser therapy
366271|NCT02023385|LLLT|lllt
366272|NCT02023385|Waist circumferential reduction|waist circumferential reduction
366273|NCT02023372|NuCel|nucel
366274|NCT02023372|Lumbar Spine|lumbar spine
366275|NCT02023372|Degenerative Disease|degenerative disease
366276|NCT02023372|Efficacy|efficacy
366277|NCT02023372|Fusion|fusion
366278|NCT02023359|Advanced breast cancer|advanced breast cancer
366279|NCT02023359|Everolimus|everolimus
366280|NCT02023346|Patient-Physician Communication|patient-physician communication
366281|NCT02023346|Brain cancer|brain cancer
366282|NCT02023346|13-253|13-253
366283|NCT02023333|Regorafenib|regorafenib
366284|NCT02023333|Performance Status|performance status
366285|NCT02023333|13-211|13-211
366286|NCT02023281|Depression|depression
366287|NCT02023281|Exercise|exercise
366288|NCT02023281|Neurotransmitters|neurotransmitters
366289|NCT02023281|Catecholimines|catecholimines
366290|NCT02023281|EEG|eeg
366291|NCT02023255|Healthy|healthy
366292|NCT02023255|JNJ-39393406|jnj-39393406
366293|NCT02023255|Safety|safety
366294|NCT02023255|Tolerability|tolerability
366295|NCT02023255|Pharmacokinetics|pharmacokinetics
366296|NCT02023242|Primary open angle glaucoma|primary open angle glaucoma
366297|NCT02023242|POAG|poag
366298|NCT02023242|Pseudoexfoliative glaucoma|pseudoexfoliative glaucoma
366299|NCT02023242|PXG|pxg
366300|NCT02023242|Pigmentary glaucoma|pigmentary glaucoma
366301|NCT02023242|PG|pg
366302|NCT02023242|Hydrus|hydrus
366303|NCT02023229|Branched chain aminoacids|branched chain aminoacids
366304|NCT02023229|Nutritional status|nutritional status
366305|NCT02023229|Hepatic encephalopathy|hepatic encephalopathy
366306|NCT02023216|Preterm infants|preterm infants
366307|NCT02023216|Non-nutritive sucking|non-nutritive sucking
366308|NCT02023216|Pacifier|pacifier
366309|NCT02023216|Gastro-esophageal reflux|gastro-esophageal reflux
366310|NCT02023216|pH-multiple intraluminal impedance|ph-multiple intraluminal impedance
366311|NCT02023216|Apneas|apneas
366312|NCT02023216|Bradycardias|bradycardias
366313|NCT02023216|Hypoxic episodes|hypoxic episodes
366314|NCT02023216|Polysomnographic monitoring|polysomnographic monitoring
366315|NCT02023190|liver cirrhosis|liver cirrhosis
366316|NCT02023190|liver transplant|liver transplant
366317|NCT02023190|nutritional status|nutritional status
366318|NCT02023190|bioelectrical impedance vector analysis|bioelectrical impedance vector analysis
366319|NCT02023177|phase angle|phase angle
366320|NCT02023177|liver cirrhosis|liver cirrhosis
366321|NCT02023177|mortality|mortality
366322|NCT02023177|malnutrition|malnutrition
366323|NCT02023138|Clinical practice guideline|clinical practice guideline
366324|NCT02023138|Brain injury|brain injury
366325|NCT02023138|Acceptability|acceptability
366326|NCT02023138|Feasibility|feasibility
366327|NCT02023138|Effectiveness|effectiveness
366328|NCT02023112|Japanese|japanese
366329|NCT02023112|Hepatitis C|hepatitis c
366330|NCT02023112|Treatment naive|treatment naive
366331|NCT02023112|Treatment experienced|treatment experienced
366332|NCT02023112|Genotype 2|genotype 2
366333|NCT02023112|Ombitasvir|ombitasvir
366334|NCT02023112|Paritaprevir|paritaprevir
366335|NCT02023112|Ritonavir|ritonavir
366336|NCT02023112|Ribavirin|ribavirin
366337|NCT02023112|VIEKIRAX Combination Tablets|viekirax combination tablets
366338|NCT02023099|Hepatitis C|hepatitis c
366339|NCT02023099|Genotype 1b|genotype 1b
366340|NCT02023099|Cirrhotic|cirrhotic
366341|NCT02023099|Treatment Experienced|treatment experienced
366342|NCT02023099|Treatment Naive|treatment naive
366343|NCT02023099|Japanese|japanese
366344|NCT02023099|ombitasvir|ombitasvir
366345|NCT02023099|paritaprevir|paritaprevir
366346|NCT02023099|ritonavir|ritonavir
366347|NCT02023099|VIEKIRAX Combination Tablets|viekirax combination tablets
366348|NCT02023086|Visual field defect|visual field defect
366349|NCT02023086|Blood oxygenation|blood oxygenation
366350|NCT02023086|Optic nerve Head|optic nerve head
366351|NCT02023047|Anal Fissure|anal fissure
366352|NCT02023047|Nifedipine|nifedipine
366353|NCT02023034|Parkinson disease, Physical Therapy, Fatigue, Quality of Life|parkinson disease, physical therapy, fatigue, quality of life
366354|NCT02023021|Pancreatic Cancer; Pancreatic Adenocarcinoma; Nab-paclitaxel; Gemcitabine; Adjuvant Therapy|pancreatic cancer; pancreatic adenocarcinoma; nab-paclitaxel; gemcitabine; adjuvant therapy
366355|NCT02022995|EGFR|egfr
366356|NCT02022995|cetuximab|cetuximab
366357|NCT02022995|colon cancer|colon cancer
366358|NCT02022982|KRAS mutant Non-Small Cell Lung Cancer|kras mutant non-small cell lung cancer
366359|NCT02022982|Solid Tumors|solid tumors
366360|NCT02022969|atelectasis|atelectasis
366361|NCT02022969|SPO2 - oscillations|spo2 - oscillations
366362|NCT02022943|Alzheimer's|alzheimer's
366363|NCT02022943|prevention|prevention
366364|NCT02022930|Osteoarthritis|osteoarthritis
366365|NCT02022930|Knee|knee
366366|NCT02022917|ovarian cancer.|ovarian cancer.
366367|NCT02022917|tubal cancer|tubal cancer
366368|NCT02022917|peritoneal cancer|peritoneal cancer
366369|NCT02022904|prostate cancer|prostate cancer
366370|NCT02022904|metastatic|metastatic
366371|NCT02022904|castrate resistant|castrate resistant
366372|NCT02022891|Sickle cell disease|sickle cell disease
366373|NCT02022891|psychological support|psychological support
366374|NCT02022891|quality of life|quality of life
366375|NCT02022878|Chronic total occlusion|chronic total occlusion
366376|NCT02022878|Percutaneous coronary intervention|percutaneous coronary intervention
366377|NCT02022878|Coronary computed tomography angiography|coronary computed tomography angiography
366378|NCT02022878|Coronary angiography|coronary angiography
366379|NCT02022865|periodontitis|periodontitis
366380|NCT02022865|cytokines|cytokines
366381|NCT02022865|adverse pregnancy outcome|adverse pregnancy outcome
366382|NCT02022852|Rectal Cancer|rectal cancer
366383|NCT02022852|Concurrent Chemoradiotherapy|concurrent chemoradiotherapy
366384|NCT02022852|Sequential Therapy|sequential therapy
366385|NCT02022839|mechanical ventilation, weaning|mechanical ventilation, weaning
366386|NCT02022839|ultrasonography|ultrasonography
366387|NCT02022826|Gastroparesis|gastroparesis
366388|NCT02022826|SmartPill Monitoring System (SPM)|smartpill monitoring system (spm)
366389|NCT02022826|Gastric Emptying Scintigraphy (GES)|gastric emptying scintigraphy (ges)
366390|NCT02022813|Energy requirements, Glucose turnover, Protein turnover|energy requirements, glucose turnover, protein turnover
366391|NCT02022787|RCC|rcc
366392|NCT02022787|Chemokines|chemokines
366393|NCT02022787|nephrectomy|nephrectomy
366394|NCT02022787|partial nephrectomy|partial nephrectomy
366395|NCT02022761|Mild or moderate asthmatics|mild or moderate asthmatics
366396|NCT02022761|Adults|adults
366397|NCT02022761|Laninamivir|laninamivir
366398|NCT02022735|Deep Brain Stimulation|deep brain stimulation
366399|NCT02022722|Pelvic Floor Myalgia|pelvic floor myalgia
366400|NCT02022722|Trigger Point Injections|trigger point injections
366401|NCT02022722|Pelvic Rehabilitation|pelvic rehabilitation
366402|NCT02022722|Dyspareunia|dyspareunia
366403|NCT02022709|Cognitive Behavior Therapy|cognitive behavior therapy
366404|NCT02022709|Exposure and Response/Ritual Prevention|exposure and response/ritual prevention
366405|NCT02022709|Selective Serotonin Reuptake Inhibitors|selective serotonin reuptake inhibitors
366406|NCT02022709|Psychotherapy|psychotherapy
366407|NCT02022709|Pharmacotherapy|pharmacotherapy
366408|NCT02022709|Citalopram|citalopram
366409|NCT02022709|Fluoxetine|fluoxetine
366410|NCT02022709|Paroxetine|paroxetine
366411|NCT02022709|Sertraline|sertraline
366412|NCT02022709|Fluvoxamine|fluvoxamine
366413|NCT02022709|fMRI|fmri
366414|NCT02022709|Stop Signal Task|stop signal task
366415|NCT02022696|Adenosine Deaminase Deficiency|adenosine deaminase deficiency
366416|NCT02022696|Gene Therapy|gene therapy
366417|NCT02022696|Lentiviral Vectors|lentiviral vectors
366418|NCT02022683|Endoscopic lung volume reduction|endoscopic lung volume reduction
366419|NCT02022683|Endobronchial valves|endobronchial valves
366420|NCT02022670|endothelial function|endothelial function
366421|NCT02022670|arterial stiffness|arterial stiffness
366422|NCT02022670|flow-mediated dilation|flow-mediated dilation
366423|NCT02022670|pulse wave velocity|pulse wave velocity
366424|NCT02022670|sodium nitrite|sodium nitrite
366425|NCT02022670|aging|aging
366426|NCT02022670|vascular diseases|vascular diseases
366427|NCT02022657|Pre exposure prophylaxis|pre exposure prophylaxis
366428|NCT02022657|Dried blood spots|dried blood spots
366429|NCT02022618|Hypertension|hypertension
366430|NCT02022618|Target organ damage|target organ damage
366431|NCT02022618|polymorphism|polymorphism
366432|NCT02022618|Hypertensive patients|hypertensive patients
366433|NCT02022605|ERCP, trainning, trainees, EMS|ercp, trainning, trainees, ems
366434|NCT02022579|Breast Cancer|breast cancer
366435|NCT02022579|Diagnosis|diagnosis
366436|NCT02022579|Malignant|malignant
366437|NCT02022579|Benign|benign
366438|NCT02022579|Biopsy|biopsy
366439|NCT02022566|Osteoarthritis knee|osteoarthritis knee
366440|NCT02022566|Osteoarthritis hip|osteoarthritis hip
366441|NCT02022566|Physical activity|physical activity
366442|NCT02022566|accelerometer|accelerometer
366443|NCT02022553|rectal cancer|rectal cancer
366444|NCT02022553|RACHEL|rachel
366445|NCT02022553|oil chemoembolization|oil chemoembolization
366446|NCT02022540|Neovascular Age-Related Macular Degeneration|neovascular age-related macular degeneration
366447|NCT02022540|AMD|amd
366448|NCT02022540|Macular Degeneration|macular degeneration
366449|NCT02022540|Age-Related Macular Degeneration|age-related macular degeneration
366450|NCT02022540|wet AMD|wet amd
366451|NCT02022540|neovascular AMD|neovascular amd
366452|NCT02022540|exudative AMD|exudative amd
366453|NCT02022527|Cost-Effectiveness,|cost-effectiveness,
366454|NCT02022527|Heart valve prosthesis|heart valve prosthesis
366455|NCT02022527|Warfarin,|warfarin,
366456|NCT02022527|Aspirin,|aspirin,
366457|NCT02022527|Egypt|egypt
366458|NCT02022501|Macular Degeneration|macular degeneration
366459|NCT02022488|Child|child
366460|NCT02022488|Sevoflurane|sevoflurane
366461|NCT02022488|Emergence delirium|emergence delirium
366462|NCT02022488|General anesthesia|general anesthesia
366463|NCT02022488|Premedication.|premedication.
366464|NCT02022475|vitamin D|vitamin d
366465|NCT02022475|fatigue|fatigue
366466|NCT02022462|Serious mental illnesses|serious mental illnesses
366467|NCT02022462|peer navigator|peer navigator
366468|NCT02022462|integrated health care|integrated health care
366469|NCT02022449|Maternal depression|maternal depression
366470|NCT02022449|Maternal psychosocial stress and distress|maternal psychosocial stress and distress
366471|NCT02022449|Maternal health outcomes|maternal health outcomes
366472|NCT02022449|Social support|social support
366473|NCT02022449|Pediatric cancer|pediatric cancer
366474|NCT02022410|CAS|cas
366475|NCT02022410|Length of stay|length of stay
366476|NCT02022410|Rehabilitation localisation|rehabilitation localisation
366477|NCT02022410|TKA|tka
366478|NCT02022397|tracheal intubation|tracheal intubation
366479|NCT02022397|predicting difficult intubation|predicting difficult intubation
366480|NCT02022397|general anesthesia|general anesthesia
366481|NCT02022397|difficult ventilation|difficult ventilation
366482|NCT02022384|Malignant glioma|malignant glioma
366483|NCT02022384|Anaplastic astrocytoma|anaplastic astrocytoma
366484|NCT02022384|Glioblastoma multiforme|glioblastoma multiforme
366485|NCT02022384|Immune|immune
366486|NCT02022384|Immunophenotyping|immunophenotyping
366487|NCT02022384|Immune cells|immune cells
366488|NCT02022384|activation state|activation state
366489|NCT02022384|Quality of live|quality of live
366490|NCT02022384|translational research|translational research
366491|NCT02022358|Osteosarcoma|osteosarcoma
366492|NCT02022358|Methotrexate|methotrexate
366493|NCT02022358|Glucarpidase|glucarpidase
366494|NCT02022358|Mucositis|mucositis
366495|NCT02022345|Percutaneous Coronary Intervention|percutaneous coronary intervention
366496|NCT02022345|Coronary Artery Disease|coronary artery disease
366497|NCT02022345|Angioplasty|angioplasty
366498|NCT02022345|Offsite cardiac surgery|offsite cardiac surgery
366499|NCT02022345|Heart disease|heart disease
366500|NCT02022345|Ischemic Heart Disease|ischemic heart disease
366501|NCT02022306|Hepatitis C|hepatitis c
366502|NCT02022293|Nasopharyngeal Carcinoma|nasopharyngeal carcinoma
366503|NCT02022293|Radiotherapy|radiotherapy
366504|NCT02022293|Carotid Stenosis|carotid stenosis
366505|NCT02022293|Atorvastatin|atorvastatin
366506|NCT02022267|clubfoot|clubfoot
366507|NCT02022267|gait analysis|gait analysis
366508|NCT02022267|outcome questionaire|outcome questionaire
366509|NCT02022267|Ponseti method|ponseti method
366510|NCT02022241|Ovarian Hyperstimulation Syndrome|ovarian hyperstimulation syndrome
366511|NCT02022241|Luteinizing Hormone|luteinizing hormone
366512|NCT02022241|Polycystic Ovarian Syndrome|polycystic ovarian syndrome
366513|NCT02022241|Ovarian Yield|ovarian yield
366514|NCT02022241|Ovarian Maturity|ovarian maturity
366515|NCT02022228|Ovarian Hyperstimulation Syndrome|ovarian hyperstimulation syndrome
366516|NCT02022228|Luteinizing Hormone|luteinizing hormone
366517|NCT02022228|Polycystic Ovarian Syndrome|polycystic ovarian syndrome
366518|NCT02022228|Ovarian Yield|ovarian yield
366519|NCT02022228|Ovarian Maturity|ovarian maturity
366520|NCT02022228|Gonadotropin Releasing Hormone Agonist|gonadotropin releasing hormone agonist
366521|NCT02022228|Human Chorionic Gonadotropin|human chorionic gonadotropin
366522|NCT02022189|Dent|dent
366523|NCT02022189|Dents|dents
366524|NCT02022189|Dent Disease|dent disease
366525|NCT02022189|Renal Biopsy|renal biopsy
366526|NCT02022189|Kidney Biopsy|kidney biopsy
366527|NCT02022189|Clinical Biopsy|clinical biopsy
366528|NCT02022176|Nitrate|nitrate
366529|NCT02022176|Nitrite|nitrite
366530|NCT02022176|Nitric oxide|nitric oxide
366531|NCT02022176|Resting metabolic rate|resting metabolic rate
366532|NCT02022176|Glucose uptake|glucose uptake
366533|NCT02022176|Insulin sensitivity|insulin sensitivity
366534|NCT02022176|Reactive oxygen species production|reactive oxygen species production
366535|NCT02022176|inorganic nitrate|inorganic nitrate
366536|NCT02022176|Sodium nitrite infusion|sodium nitrite infusion
366537|NCT02022163|Influenza, Human|influenza, human
366538|NCT02022163|RNA Virus Infections|rna virus infections
366539|NCT02022163|Respiratory Tract Diseases|respiratory tract diseases
366540|NCT02022163|Respiratory Tract Infections|respiratory tract infections
366541|NCT02022163|Aluminum Hydroxide|aluminum hydroxide
366542|NCT02022163|Adjuvants, Immunologic|adjuvants, immunologic
366543|NCT02022163|Immunogenic Factors|immunogenic factors
366544|NCT02022163|Physiological Effects of Drugs|physiological effects of drugs
366545|NCT02022163|Virus Diseases|virus diseases
366546|NCT02022163|Orthomyxoviridae Infections|orthomyxoviridae infections
366547|NCT02022163|Infection|infection
366548|NCT02022150|Paracentesis|paracentesis
366549|NCT02022150|Liver Cirrhosis|liver cirrhosis
366550|NCT02022150|ascites|ascites
366551|NCT02022150|body composition|body composition
366552|NCT02022137|Minimal hepatic encephalopathy|minimal hepatic encephalopathy
366553|NCT02022137|Hepatic encephalopathy|hepatic encephalopathy
366554|NCT02022124|chronic low back pain|chronic low back pain
366555|NCT02022124|open-label placebo|open-label placebo
366556|NCT02022046|chronic kidney disease|chronic kidney disease
366557|NCT02022046|cardiovascular disease|cardiovascular disease
366558|NCT02022046|nitric oxide|nitric oxide
366559|NCT02022046|homocysteine|homocysteine
366560|NCT02022046|asymmetric dimethylarginine|asymmetric dimethylarginine
366561|NCT02022046|methylation|methylation
366562|NCT02022033|Pancreatic Cancer|pancreatic cancer
366563|NCT02022033|Adjuvant|adjuvant
366564|NCT02022033|Pancreas|pancreas
366565|NCT02022033|Resected|resected
366566|NCT02022033|Invasive adenocarcinoma|invasive adenocarcinoma
366567|NCT02022033|adenosquamous cancer|adenosquamous cancer
366568|NCT02022033|Intraductal papillary mucinous neoplasm|intraductal papillary mucinous neoplasm
366569|NCT02022007|PCOS|pcos
366571|NCT02022007|DPP-4 inhibitor|dpp-4 inhibitor
366572|NCT02021981|Quality Improvement|quality improvement
366573|NCT02021981|Primary Care|primary care
366574|NCT02021981|Blood Pressure, High|blood pressure, high
366575|NCT02021981|Feedback|feedback
366576|NCT02021981|Knowledge|knowledge
366577|NCT02021955|randomized controlled trial|randomized controlled trial
366578|NCT02021955|quality of life|quality of life
366579|NCT02021955|patient readmission|patient readmission
366580|NCT02021955|mortality|mortality
366581|NCT02021955|patient satisfaction|patient satisfaction
366582|NCT02021955|intervention studies|intervention studies
366583|NCT02021955|multicenter study|multicenter study
366584|NCT02021942|primary inoperable thymoma|primary inoperable thymoma
366585|NCT02021942|local recurrent thymoma|local recurrent thymoma
366586|NCT02021942|reduction of tumor size|reduction of tumor size
366587|NCT02021942|SOM230 LAR|som230 lar
366588|NCT02021929|Randomized Controlled Trial|randomized controlled trial
366589|NCT02021929|Clinical Trial|clinical trial
366590|NCT02021929|sorafenib|sorafenib
366591|NCT02021929|Hepatopulmonary Syndrome|hepatopulmonary syndrome
366592|NCT02021903|arterial hypotension|arterial hypotension
366593|NCT02021903|postprandial sleepiness|postprandial sleepiness
366594|NCT02021903|orthostatic hypotension|orthostatic hypotension
366595|NCT02021903|synucleinopathies|synucleinopathies
366596|NCT02021903|hyperglycemia|hyperglycemia
366597|NCT02021890|Dance|dance
366598|NCT02021890|Physical activity|physical activity
366599|NCT02021890|Physical fitness|physical fitness
366600|NCT02021890|Weight loss|weight loss
366601|NCT02021877|Brain trauma|brain trauma
366602|NCT02021877|ICP measurement|icp measurement
366603|NCT02021877|cranial CT / MRI|cranial ct / mri
366604|NCT02021877|Glasgow Coma Score|glasgow coma score
366605|NCT02021877|acute TBI|acute tbi
366606|NCT02021877|EEG|eeg
366607|NCT02021877|metabolic, proteomic, and genetic biomarkers of TBIs|metabolic, proteomic, and genetic biomarkers of tbis
366608|NCT02021877|injury mechanism|injury mechanism
366609|NCT02021864|hypocalcemia, pregnancy, vitamin D|hypocalcemia, pregnancy, vitamin d
366610|NCT02021851|Dexamethasone,|dexamethasone,
366611|NCT02021851|Ondansetron|ondansetron
366612|NCT02021851|Aprepitant|aprepitant
366614|NCT02021851|Laparoscopic surgery|laparoscopic surgery
366615|NCT02021838|domestic violence homicide prevention|domestic violence homicide prevention
366616|NCT02021825|mitoxantrone|mitoxantrone
366617|NCT02021825|neuromyelitis optica|neuromyelitis optica
366619|NCT02021799|Gut microbiome|gut microbiome
366620|NCT02021799|Vaginal microbiome|vaginal microbiome
366621|NCT02021799|Oral microbiome|oral microbiome
366622|NCT02021799|Human milk microbiome|human milk microbiome
366623|NCT02021799|Nutritional Status|nutritional status
366624|NCT02021773|Headache|headache
366625|NCT02021773|Migraine|migraine
366626|NCT02021773|Chronic Migraine|chronic migraine
366627|NCT02021682|Aβ|aβ
366628|NCT02021682|ABeta|abeta
366629|NCT02021682|ABeta kinetics|abeta kinetics
366630|NCT02021682|Alzheimer's Disease|alzheimer's disease
366631|NCT02021682|Alzheimer's|alzheimer's
366632|NCT02021682|amyloid beta|amyloid beta
366633|NCT02021682|biomarker|biomarker
366634|NCT02021682|dementia|dementia
366635|NCT02021682|PET/PIB|pet/pib
366636|NCT02021669|Antidepressive agents|antidepressive agents
366637|NCT02021669|Coronary disease|coronary disease
366638|NCT02021669|Depression|depression
366639|NCT02021669|Depressive disorder|depressive disorder
366640|NCT02021669|Fatty Acids, Omega-3|fatty acids, omega-3
366641|NCT02021630|Obesity|obesity
366642|NCT02021630|Bariatric Surgery|bariatric surgery
366643|NCT02021630|Weight Loss|weight loss
366644|NCT02021630|Physical Activity|physical activity
366645|NCT02021630|Body Composition|body composition
366646|NCT02021617|Intraosseous Access|intraosseous access
366647|NCT02021617|EZ-IO|ez-io
366648|NCT02021604|Congenital Hyperinsulinism|congenital hyperinsulinism
366649|NCT02021604|HI|hi
366650|NCT02021604|Hypoglycemia|hypoglycemia
366651|NCT02021604|FDOPA|fdopa
366652|NCT02021604|18F-DOPA|18f-dopa
366653|NCT02021604|Hyperinsulinism|hyperinsulinism
366654|NCT02021604|Insulinoma|insulinoma
366655|NCT02021591|Diabetes|diabetes
366656|NCT02021591|Chronic disease|chronic disease
366657|NCT02021591|problem solving|problem solving
366658|NCT02021591|self management|self management
366659|NCT02021578|Depression|depression
366660|NCT02021578|Mood disorder|mood disorder
366661|NCT02021565|Caregivers|caregivers
366662|NCT02021565|Activities of Daily Living|activities of daily living
366663|NCT02021565|Dementia|dementia
366664|NCT02021565|Veterans|veterans
366665|NCT02021565|Self-Help Devices|self-help devices
366666|NCT02021565|Telemedicine|telemedicine
366667|NCT02021552|Trauma|trauma
366668|NCT02021552|Sepsis|sepsis
366669|NCT02021539|Elastography of the cervix|elastography of the cervix
366670|NCT02021539|Cervical elastography|cervical elastography
366671|NCT02021539|Predicting delivery|predicting delivery
366673|NCT02021526|Glut1 Deficiency|glut1 deficiency
366674|NCT02021526|Glucose Transporter Type 1 Deficiency|glucose transporter type 1 deficiency
366675|NCT02021526|Glucose Transporter Type I Deficiency|glucose transporter type i deficiency
366676|NCT02021513|SLE|sle
366677|NCT02021513|Fish Oil|fish oil
366678|NCT02021513|Omega-3|omega-3
366679|NCT02021448|OHS|ohs
366680|NCT02021422|metastatic pancreatic ductal adenocarcinoma (PDAC)|metastatic pancreatic ductal adenocarcinoma (pdac)
366681|NCT02021422|pancreatic cancer|pancreatic cancer
366682|NCT02021422|pancreas cancer|pancreas cancer
366683|NCT02021422|pancreatic adenocarcinoma|pancreatic adenocarcinoma
366684|NCT02021422|metastatic pancreas cancer|metastatic pancreas cancer
366685|NCT02021422|metastatic pancreatic cancer|metastatic pancreatic cancer
366686|NCT02021409|Anemia on CKD|anemia on ckd
366687|NCT02021396|splenic rescue; splenectomy|splenic rescue; splenectomy
366688|NCT02021383|Weight loss|weight loss
366689|NCT02021383|Weight maintenance|weight maintenance
366690|NCT02021383|Contingency Management|contingency management
366691|NCT02021383|College students|college students
366692|NCT02021383|Financial incentives|financial incentives
366693|NCT02021370|Anemia of CKD|anemia of ckd
366694|NCT02021357|Facial Pain|facial pain
366695|NCT02021357|Physical Therapy Modalities|physical therapy modalities
366696|NCT02021357|Temporomandibular Joint Disorders|temporomandibular joint disorders
366697|NCT02021357|Exercise Therapy|exercise therapy
366698|NCT02021331|jaw, edentulous, partially|jaw, edentulous, partially
366699|NCT02021318|Non-dialysis|non-dialysis
366700|NCT02021318|Roxadustat|roxadustat
366701|NCT02021318|ASP1517|asp1517
366702|NCT02021318|Chronic Kidney Disease (CKD)|chronic kidney disease (ckd)
366703|NCT02021318|Anemia|anemia
366704|NCT02021318|Hemoglobin|hemoglobin
366705|NCT02021305|Toll like Receptors|toll like receptors
366706|NCT02021305|TLR 4|tlr 4
366707|NCT02021305|Urinary track infections in children|urinary track infections in children
366708|NCT02021305|TLR 4 polymorphisms|tlr 4 polymorphisms
366709|NCT02021305|Innate immunity|innate immunity
366710|NCT02021305|Defence mechanisms|defence mechanisms
366711|NCT02021305|Immune responses|immune responses
366712|NCT02021292|Chronic thromboembolic pulmonary hypertension (CTEPH)|chronic thromboembolic pulmonary hypertension (cteph)
366713|NCT02021279|pelvic organ prolapse|pelvic organ prolapse
366714|NCT02021279|MatriStem|matristem
366715|NCT02021279|pelvic floor matrix|pelvic floor matrix
366716|NCT02021279|ACell|acell
366717|NCT02021279|native tissue repair|native tissue repair
366718|NCT02021253|Endotoxemia|endotoxemia
366719|NCT02021253|Probiotic|probiotic
366720|NCT02021253|Leaky gut|leaky gut
366721|NCT02021253|Gut permeability|gut permeability
366722|NCT02021253|Liver cirrhosis|liver cirrhosis
366723|NCT02021253|Liver fibrosis|liver fibrosis
366724|NCT02021253|Hepatocellular carcinoma|hepatocellular carcinoma
366725|NCT02021227|Acute respiratory failure|acute respiratory failure
366726|NCT02021227|Mechanical ventilation|mechanical ventilation
366727|NCT02021227|Rehabilitation|rehabilitation
366728|NCT02021227|Exercise chair sitting|exercise chair sitting
366729|NCT02021227|Weaning|weaning
366730|NCT02021227|Chronic respiratory failure|chronic respiratory failure
366731|NCT02021214|Methylphenidate|methylphenidate
366732|NCT02021214|Fear extinction|fear extinction
366733|NCT02021214|fMRI|fmri
366734|NCT02021214|mPFC|mpfc
366735|NCT02021188|Vascular inflammation|vascular inflammation
366736|NCT02021188|Atherosclerosis|atherosclerosis
366737|NCT02021188|Positron Emission Tomography|positron emission tomography
366738|NCT02021188|Molecular Imaging|molecular imaging
366739|NCT02021188|68Ga-DOTATATE|68ga-dotatate
366740|NCT02021175|Smoking Cessation|smoking cessation
366741|NCT02021175|Korean|korean
366742|NCT02021175|Youth|youth
366743|NCT02021175|Adolescent|adolescent
366744|NCT02021175|Dependence|dependence
366745|NCT02021175|Teen Smoking|teen smoking
366746|NCT02021175|Smoking and Youth|smoking and youth
366747|NCT02021175|Youth and Tobacco|youth and tobacco
366748|NCT02021175|Cognitive-Behavioral Motivational Enhancement|cognitive-behavioral motivational enhancement
366749|NCT02021175|Technology|technology
366750|NCT02021175|Nicotine Dependence|nicotine dependence
366751|NCT02021175|Cell Phone|cell phone
366752|NCT02021175|Smart Phone|smart phone
366753|NCT02021175|Internet|internet
366754|NCT02021175|Web|web
366755|NCT02021162|Multiple sclerosis|multiple sclerosis
366756|NCT02021162|Gilenya|gilenya
366757|NCT02021162|Healthy controls|healthy controls
366758|NCT02021162|Thalamic atrophy|thalamic atrophy
366759|NCT02021162|MRI|mri
366760|NCT02021149|Major Depressive Disorder|major depressive disorder
366761|NCT02021149|Whole Body Hyperthermia|whole body hyperthermia
366762|NCT02021149|Psychotherapy|psychotherapy
366763|NCT02021149|Therapist and patient alliance|therapist and patient alliance
366764|NCT02021123|Anidulafungin|anidulafungin
366765|NCT02021123|Gastric bypass|gastric bypass
366766|NCT02021123|Morbidly obese|morbidly obese
366767|NCT02021123|Pharmacokinetics|pharmacokinetics
366768|NCT02021123|Prophylaxis|prophylaxis
366769|NCT02021123|Yeast infection|yeast infection
366770|NCT02021097|Levonorgestrel；|levonorgestrel；
366771|NCT02021097|Ethinyl Estradiol；|ethinyl estradiol；
366772|NCT02021097|Oral Contraceptive|oral contraceptive
366773|NCT02021084|Familial Mediterranean Fever (FMF), probiotics|familial mediterranean fever (fmf), probiotics
366774|NCT02021032|BPH|bph
366775|NCT02021006|antibiotic prophylaxis|antibiotic prophylaxis
366776|NCT02021006|vesicoureteral reflux|vesicoureteral reflux
366777|NCT02021006|congenital abnormalities of kidney|congenital abnormalities of kidney
366778|NCT02021006|renal hypodysplasia|renal hypodysplasia
366779|NCT02021006|chronic kidney disease|chronic kidney disease
366780|NCT02020993|Nt-proBNP, newborn, preterm|nt-probnp, newborn, preterm
366781|NCT02020928|Oral Mucositis|oral mucositis
366782|NCT02020928|chemotherapy|chemotherapy
366783|NCT02020928|Bone Marrow Transplantation|bone marrow transplantation
366784|NCT02020889|eosinophils|eosinophils
366785|NCT02020889|SB 240563|sb 240563
366786|NCT02020889|Churg-Strauss Syndrome|churg-strauss syndrome
366787|NCT02020889|quality of life|quality of life
366788|NCT02020889|mepolizumab|mepolizumab
366789|NCT02020889|safety|safety
366790|NCT02020889|biomarkers|biomarkers
366791|NCT02020889|efficacy|efficacy
366792|NCT02020889|corticosteroids|corticosteroids
366793|NCT02020889|Eosinophilic granulomatosis with polyangiitis|eosinophilic granulomatosis with polyangiitis
366794|NCT02020850|Toe-Brachial Index|toe-brachial index
366795|NCT02020850|Ankle-Brachial Index|ankle-brachial index
366796|NCT02020850|Systolic blood pressure|systolic blood pressure
366797|NCT02020824|Acrophobia|acrophobia
366798|NCT02020785|proteinuria|proteinuria
366799|NCT02020772|primary health care|primary health care
366800|NCT02020772|Physical Therapy Specialty|physical therapy specialty
366801|NCT02020772|General Practitioners|general practitioners
366802|NCT02020772|General Practice|general practice
366803|NCT02020733|Hysterosalpingography|hysterosalpingography
366804|NCT02020733|balloon catheter|balloon catheter
366805|NCT02020733|metal cannula|metal cannula
366806|NCT02020733|pain assessment|pain assessment
366807|NCT02020694|Obesity|obesity
366808|NCT02020694|Insulin resistance|insulin resistance
366809|NCT02020694|Vitamin D|vitamin d
366810|NCT02020694|Cardiovascular risk factors|cardiovascular risk factors
366811|NCT02020681|Dental caries|dental caries
366812|NCT02020681|Curodont Repair|curodont repair
366813|NCT02020681|P11-4|p11-4
366814|NCT02020668|Pain|pain
366815|NCT02020668|Functional capacity|functional capacity
366816|NCT02020668|Quality of Life|quality of life
366817|NCT02020655|IL-1 alpha, Sebutape, shear- force|il-1 alpha, sebutape, shear- force
366818|NCT02020642|polysomnography|polysomnography
366819|NCT02020642|bioimpedance|bioimpedance
366820|NCT02020642|leg fluid shift|leg fluid shift
366821|NCT02020642|neck circumference|neck circumference
366822|NCT02020642|Sleep Apnea Syndromes|sleep apnea syndromes
366823|NCT02020642|Sleep Apnea, Obstructive|sleep apnea, obstructive
366824|NCT02020642|Sleep Disorders, Intrinsic|sleep disorders, intrinsic
366825|NCT02020642|Sleep Disorders|sleep disorders
366826|NCT02020642|Apnea|apnea
366827|NCT02020642|Kidney Diseases|kidney diseases
366828|NCT02020642|Kidney Failure, Chronic|kidney failure, chronic
781144|NCT00325273|Pregnancy|pregnancy
366829|NCT02020642|Renal Insufficiency, Chronic|renal insufficiency, chronic
366830|NCT02020642|Renal Insufficiency|renal insufficiency
366831|NCT02020642|Dyssomnias|dyssomnias
366832|NCT02020629|Glucagon|glucagon
366833|NCT02020629|Hypoglycemia|hypoglycemia
366834|NCT02020629|Counterregulation|counterregulation
366835|NCT02020603|peptic ulcer bleeding|peptic ulcer bleeding
366836|NCT02020603|hemostatic forceps|hemostatic forceps
366837|NCT02020603|soft coagulation|soft coagulation
366838|NCT02020603|argon plasma coagulation|argon plasma coagulation
366839|NCT02020590|Delayed-Union Fractures|delayed-union fractures
366840|NCT02020590|Impaired Healing|impaired healing
366841|NCT02020590|Fractures|fractures
366842|NCT02020590|Orthopedics|orthopedics
366843|NCT02020590|Bone|bone
366844|NCT02020590|Musculoskeletal Disorders|musculoskeletal disorders
366845|NCT02020564|Processing Speed|processing speed
366846|NCT02020564|Cognition|cognition
366847|NCT02020564|Intervention|intervention
366848|NCT02020564|Traumatic Brain Injury|traumatic brain injury
366849|NCT02020564|Mild Cognitive Impairment|mild cognitive impairment
366850|NCT02020551|Scores During IUD insertion.|scores during iud insertion.
366851|NCT02020538|Thoracic surgery|thoracic surgery
366852|NCT02020538|cardiac surgery|cardiac surgery
366853|NCT02020538|acute kidney injury|acute kidney injury
366854|NCT02020538|hyperchloremia|hyperchloremia
366855|NCT02020538|intravenous fluid|intravenous fluid
366856|NCT02020486|Healthy|healthy
366857|NCT02020473|Informed consents|informed consents
366858|NCT02020473|Withholding/withdrawing life support (WLS)|withholding/withdrawing life support (wls)
366859|NCT02020473|Intensive care unit (ICU)|intensive care unit (icu)
366860|NCT02020460|post-laminectomy pain syndrome,|post-laminectomy pain syndrome,
366861|NCT02020460|refractory,|refractory,
366862|NCT02020460|refractory chronic neuropathic pain,|refractory chronic neuropathic pain,
366863|NCT02020460|failed back surgery syndrome.|failed back surgery syndrome.
366864|NCT02020421|ischemic stroke|ischemic stroke
366865|NCT02020421|rehabilitation|rehabilitation
366866|NCT02020421|aphasia|aphasia
366867|NCT02020421|non-invasive brain stimulation|non-invasive brain stimulation
366868|NCT02020382|microRNAs|micrornas
366870|NCT02020382|Crohn's disease|crohn's disease
366871|NCT02020382|Ulcerative colitis|ulcerative colitis
366872|NCT02020382|colonic polyps screening|colonic polyps screening
366873|NCT02020382|controls|controls
366874|NCT02020356|Alzheimer's disease|alzheimer's disease
366875|NCT02020356|Neuroleptics|neuroleptics
366876|NCT02020356|Music therapy|music therapy
366877|NCT02020330|falciparum, malaria|falciparum, malaria
366878|NCT02020317|drug interactions|drug interactions
366879|NCT02020317|Drug Monitoring|drug monitoring
366880|NCT02020317|Potassium|potassium
366881|NCT02020317|Hyperkalemia|hyperkalemia
366882|NCT02020304|Combined spinal epidural duration|combined spinal epidural duration
366883|NCT02020304|labor pain|labor pain
366884|NCT02020291|Foxy-5|foxy-5
366885|NCT02020291|Wnt-5A|wnt-5a
366886|NCT02020278|Hyponatremia|hyponatremia
366887|NCT02020278|Euvolemic|euvolemic
366888|NCT02020278|Hypervolemic|hypervolemic
366889|NCT02020278|Serum sodium|serum sodium
366890|NCT02020278|Dilutional hyponatremia|dilutional hyponatremia
366891|NCT02020278|Electrolyte abnormality|electrolyte abnormality
366892|NCT02020278|Electrolyte imbalance|electrolyte imbalance
366893|NCT02020278|Metabolic disease|metabolic disease
366894|NCT02020278|Water-Electrolyte Imbalance|water-electrolyte imbalance
366895|NCT02020265|stress and depression related symptoms|stress and depression related symptoms
366896|NCT02020239|physical activity|physical activity
366897|NCT02020239|females|females
366898|NCT02020239|body composition|body composition
366899|NCT02020226|TH-302|th-302
366900|NCT02020226|Solid Tumors|solid tumors
366901|NCT02020226|QTc|qtc
366902|NCT02020226|Cardiac|cardiac
366903|NCT02020226|Evofosfamide|evofosfamide
366904|NCT02020213|successful percentage|successful percentage
366905|NCT02020200|Bipolar Disorder|bipolar disorder
366906|NCT02020200|Methylphenidate|methylphenidate
366907|NCT02020200|Cognitive Function|cognitive function
366908|NCT02020187|Congenital myopathy|congenital myopathy
366909|NCT02020187|Exercise|exercise
366910|NCT02020174|Preeclampsia|preeclampsia
366911|NCT02020174|Eclampsia|eclampsia
366912|NCT02020174|HELLP|hellp
366913|NCT02020174|HELLP Syndrome|hellp syndrome
366914|NCT02020174|Toxemia|toxemia
366915|NCT02020174|Hypertensive Disorder of Pregnancy|hypertensive disorder of pregnancy
366917|NCT02020174|Pregnancy Complication|pregnancy complication
366918|NCT02020174|Pregnancy|pregnancy
366919|NCT02020174|Maternal Death|maternal death
366920|NCT02020174|Premature|premature
366921|NCT02020174|High Blood Pressure|high blood pressure
366922|NCT02020174|Hypertension|hypertension
366923|NCT02020148|pregnancy|pregnancy
366924|NCT02020148|oxytocin|oxytocin
366925|NCT02020148|postpartum depression|postpartum depression
366926|NCT02020148|depression|depression
366927|NCT02020148|pregnant women|pregnant women
366928|NCT02020148|mood|mood
366929|NCT02020148|anxiety|anxiety
366930|NCT02020148|hormones|hormones
366931|NCT02020148|women's health|women's health
366932|NCT02020148|mental health|mental health
366933|NCT02020148|baby blues|baby blues
366934|NCT02020148|mood disorders|mood disorders
366935|NCT02020122|endogenous pain modulation|endogenous pain modulation
366936|NCT02020122|coronary artery bypass grafting|coronary artery bypass grafting
366937|NCT02020122|quantitative sensory testings|quantitative sensory testings
366938|NCT02020122|duloxetine|duloxetine
366939|NCT02020122|pregabalin|pregabalin
366940|NCT02020122|preemptive treatment|preemptive treatment
366941|NCT02020096|Lumbar plexus block|lumbar plexus block
366942|NCT02020096|Ultrasound guidance|ultrasound guidance
366943|NCT02020096|Nerve stimulator|nerve stimulator
366944|NCT02020083|VIH ; Placental transfer ; Tenofovir ; Emtricitabine ; Membrane transporter|vih ; placental transfer ; tenofovir ; emtricitabine ; membrane transporter
366945|NCT02020070|Ipilimumab|ipilimumab
366946|NCT02020070|Degarelix|degarelix
366947|NCT02020070|Radical Prostatectomy|radical prostatectomy
366948|NCT02020070|13-134|13-134
366949|NCT02020031|Revision knee joint|revision knee joint
366950|NCT02020005|menthol cigarettes|menthol cigarettes
366951|NCT02020005|smoking cessation|smoking cessation
366952|NCT02019992|sepsis|sepsis
366953|NCT02019992|mitochondrial DNA|mitochondrial dna
366954|NCT02019992|systemic inflammation|systemic inflammation
366955|NCT02019992|outcome|outcome
366956|NCT02019979|non squamous|non squamous
366957|NCT02019979|non small cell|non small cell
366958|NCT02019979|lung cancer|lung cancer
366959|NCT02019979|metformin|metformin
366960|NCT02019927|NAION|naion
366961|NCT02019927|Decreased vision|decreased vision
366962|NCT02019927|Eye trauma|eye trauma
366964|NCT02019927|Electrical stimulation|electrical stimulation
366965|NCT02019927|Multiple Sclerosis|multiple sclerosis
366966|NCT02019927|Optic Neuritis|optic neuritis
366967|NCT02019914|PTSD|ptsd
366968|NCT02019914|CPAP|cpap
366969|NCT02019914|OSA|osa
366970|NCT02019901|Rheumatoid arthritis|rheumatoid arthritis
366971|NCT02019901|Person-centered care|person-centered care
366972|NCT02019901|Tight control|tight control
366973|NCT02019888|Ear, Middle|ear, middle
366974|NCT02019888|Ear, Inner|ear, inner
366975|NCT02019888|Audiometry|audiometry
366976|NCT02019888|Acoustic impedance tests|acoustic impedance tests
366977|NCT02019875|Vitamin D|vitamin d
366978|NCT02019875|CYP3A4|cyp3a4
366979|NCT02019875|Calcium|calcium
366980|NCT02019862|Total hip arthroplasty|total hip arthroplasty
366981|NCT02019862|TRJ|trj
366982|NCT02019862|PMCF|pmcf
366983|NCT02019862|Hip stem|hip stem
366984|NCT02019849|THA, Plasmafit®|tha, plasmafit®
366985|NCT02019836|vit D; sepsis; newborn; maternal; neonatal|vit d; sepsis; newborn; maternal; neonatal
366986|NCT02019823|SMS-text|sms-text
366987|NCT02019823|mobile health|mobile health
366988|NCT02019823|mHealth|mhealth
366989|NCT02019823|treatment|treatment
366990|NCT02019823|adherence|adherence
366991|NCT02019797|aortic valve replacement|aortic valve replacement
366992|NCT02019784|Cirrhosis|cirrhosis
366993|NCT02019784|Hepatic encephalopathy|hepatic encephalopathy
366994|NCT02019771|HIV Infection|hiv infection
366995|NCT02019771|Men who have sex with men|men who have sex with men
366996|NCT02019771|Chlamydia|chlamydia
366997|NCT02019771|Gonorrhea|gonorrhea
366998|NCT02019745|Live attenuated influenza virus (LAIV)|live attenuated influenza virus (laiv)
366999|NCT02019745|Flu vaccine|flu vaccine
367000|NCT02019745|FluMist|flumist
367001|NCT02019745|Smokers|smokers
367002|NCT02019745|New and emerging tobacco products|new and emerging tobacco products
367003|NCT02019732|Mild outcomes|mild outcomes
367004|NCT02019732|Database|database
367005|NCT02019732|Influenza-attributable|influenza-attributable
367006|NCT02019732|Retrospective|retrospective
367007|NCT02019732|Influenza|influenza
367008|NCT02019732|United States of America (USA)|united states of america (usa)
367009|NCT02019719|Hemodialysis|hemodialysis
367010|NCT02019719|GSK1278863|gsk1278863
367011|NCT02019719|Pharmacokinetics|pharmacokinetics
367012|NCT02019719|Erythropoiesis Stimulating Agents|erythropoiesis stimulating agents
367013|NCT02019719|Chronic Kidney Disease|chronic kidney disease
367014|NCT02019719|Hemoglobin|hemoglobin
367015|NCT02019719|Recombinant Erythropoietin|recombinant erythropoietin
367016|NCT02019719|Prolyl Hydroxylase Inhibitor|prolyl hydroxylase inhibitor
367017|NCT02019719|Anemia|anemia
367018|NCT02019706|DOTATATE|dotatate
367019|NCT02019706|Cushing's Syndrome|cushing's syndrome
367020|NCT02019706|Hypercortisolism|hypercortisolism
367021|NCT02019693|Hereditary Papillary Renal Cell Carcinoma|hereditary papillary renal cell carcinoma
367022|NCT02019693|VEGF Pathway|vegf pathway
367023|NCT02019693|mTOR Inhibitor|mtor inhibitor
367024|NCT02019693|Kidney Cancer|kidney cancer
367025|NCT02019680|Endothelial Function|endothelial function
367026|NCT02019680|Biomarkers|biomarkers
367027|NCT02019680|Atherosclerosis|atherosclerosis
367028|NCT02019680|Blood Flow|blood flow
367029|NCT02019680|Blood Pressure|blood pressure
367030|NCT02019667|GABA|gaba
367031|NCT02019667|Seizures|seizures
367032|NCT02019667|Neurotransmitters|neurotransmitters
367033|NCT02019654|Post Traumatic Stress Disorder (PTSD)|post traumatic stress disorder (ptsd)
367034|NCT02019654|Traumatic Brain Injury|traumatic brain injury
367035|NCT02019654|Neuroendocrine|neuroendocrine
367036|NCT02019654|Epigenetics|epigenetics
367037|NCT02019641|Exercise|exercise
367038|NCT02019641|Interstitial Lung Disease|interstitial lung disease
367039|NCT02019641|Pulmonary Rehabilitation|pulmonary rehabilitation
367040|NCT02019628|NK cells cytotoxicity, dietary supplementation|nk cells cytotoxicity, dietary supplementation
367041|NCT02019615|disorders of consciousness|disorders of consciousness
367042|NCT02019615|minimally conscious state|minimally conscious state
367043|NCT02019615|traumatic brain injury|traumatic brain injury
367045|NCT02019615|transcranial direct current stimulation|transcranial direct current stimulation
367046|NCT02019602|Cimzia®|cimzia®
367048|NCT02019602|Placental transfer|placental transfer
367049|NCT02019602|Autoimmune diseases and pregnancy|autoimmune diseases and pregnancy
367050|NCT02019589|Secondary Amenorrhea|secondary amenorrhea
367051|NCT02019589|SPRY Trial|spry trial
367052|NCT02019576|Metastatic renal cell carcinoma|metastatic renal cell carcinoma
367053|NCT02019576|mRCC|mrcc
367054|NCT02019576|Clear cell|clear cell
367055|NCT02019563|pediatrics|pediatrics
367056|NCT02019563|dental caries|dental caries
367057|NCT02019563|dental pulp exposure|dental pulp exposure
367058|NCT02019563|incisor|incisor
367059|NCT02019550|Multiple Sclerosis, Relapsing-Remitting|multiple sclerosis, relapsing-remitting
367060|NCT02019550|Rebif®Rebidose®|rebif®rebidose®
367061|NCT02019550|Rebiject II®|rebiject ii®
367062|NCT02019524|Stage I breast cancer|stage i breast cancer
367063|NCT02019524|Stage II breast cancer|stage ii breast cancer
367064|NCT02019524|Stage IIIA, IIIB, and IIIC breast cancer|stage iiia, iiib, and iiic breast cancer
367065|NCT02019524|Male breast cancer|male breast cancer
367066|NCT02019524|Ovarian cancer|ovarian cancer
367067|NCT02019511|Orthopedic surgery|orthopedic surgery
367068|NCT02019511|Infections|infections
367069|NCT02019511|Steroid|steroid
367070|NCT02019511|Fast-track|fast-track
367071|NCT02019511|Total knee arthroplasty|total knee arthroplasty
367072|NCT02019511|Safety|safety
367073|NCT02019498|low back pain|low back pain
367074|NCT02019498|relaxation|relaxation
367075|NCT02019485|Healthy|healthy
367076|NCT02019485|Tapentadol|tapentadol
367077|NCT02019485|Tapentadol extended-release tamper-resistant formulation|tapentadol extended-release tamper-resistant formulation
367078|NCT02019485|Tapentadol extended-release prolonged-release formulation|tapentadol extended-release prolonged-release formulation
367079|NCT02019485|Bioequivalence|bioequivalence
367080|NCT02019485|Fasted Conditions|fasted conditions
367081|NCT02019472|Rheumatoid arthritis|rheumatoid arthritis
367082|NCT02019472|CNTO 136|cnto 136
367083|NCT02019472|Sirukumab|sirukumab
367084|NCT02019472|Adalimumab|adalimumab
367085|NCT02019472|HUMIRA®|humira®
367086|NCT02019446|type 2 diabetes mellitus|type 2 diabetes mellitus
367087|NCT02019446|onychomycosis|onychomycosis
367088|NCT02019446|laser treatment|laser treatment
367089|NCT02019446|antifungal|antifungal
367090|NCT02019433|THA, augment, revision, pelvis|tha, augment, revision, pelvis
367091|NCT02019407|atrial fibrillation|atrial fibrillation
367092|NCT02019407|atrial flutter|atrial flutter
367093|NCT02019407|catheter ablation|catheter ablation
367094|NCT02019407|cavo-tricuspid isthmus block|cavo-tricuspid isthmus block
367095|NCT02019342|blood pressure|blood pressure
367096|NCT02019342|mean arterial pressure|mean arterial pressure
367097|NCT02019342|MAP|map
367098|NCT02019342|intraoperative|intraoperative
367099|NCT02019342|postoperative|postoperative
367100|NCT02019342|anesthesia|anesthesia
367101|NCT02019316|Supplementation|supplementation
367102|NCT02019316|Performance|performance
367103|NCT02019316|Cognitive Function|cognitive function
367104|NCT02019316|Muscular Endurance|muscular endurance
367105|NCT02019316|BioSteel|biosteel
367106|NCT02019316|BCAA|bcaa
367107|NCT02019316|Branched Chain Amino Acids|branched chain amino acids
367108|NCT02019316|Sprint Interval Exercise|sprint interval exercise
367109|NCT02019264|Diabetes|diabetes
367110|NCT02019264|Cardiovascular Disease|cardiovascular disease
367111|NCT02019264|Multiple Cardiovascular Risk Factors|multiple cardiovascular risk factors
367112|NCT02019264|Obesity|obesity
367113|NCT02019264|Overweight|overweight
367114|NCT02019264|MACE|mace
367115|NCT02019264|Conversion to Diabetes|conversion to diabetes
367116|NCT02019225|dialysis|dialysis
367117|NCT02019225|hemodialysis|hemodialysis
367118|NCT02019225|pragmatic trial|pragmatic trial
367119|NCT02019225|end stage renal disease|end stage renal disease
367120|NCT02019225|randomized clinical trial|randomized clinical trial
367121|NCT02019212|99mTc-tetrofosmin|99mtc-tetrofosmin
367122|NCT02019212|myocardial perfusion imaging|myocardial perfusion imaging
367123|NCT02019212|SPECT|spect
367124|NCT02019212|radiation|radiation
367125|NCT02019186|type 1 diabetes|type 1 diabetes
367126|NCT02019186|endothelial function|endothelial function
367127|NCT02019186|adolescents|adolescents
367128|NCT02019186|vitamin C|vitamin c
367129|NCT02019186|vitamin E|vitamin e
367130|NCT02019173|exercise therapy|exercise therapy
367131|NCT02019173|brain injury|brain injury
367132|NCT02019173|postural balance|postural balance
367133|NCT02019160|silver nitrate|silver nitrate
367134|NCT02019160|sodium fluoride|sodium fluoride
367135|NCT02019160|silver diamine fluoride|silver diamine fluoride
367136|NCT02019160|caries|caries
367137|NCT02019160|non-inferiority trial|non-inferiority trial
367138|NCT02019147|HIE|hie
367139|NCT02019147|Biomarker|biomarker
367140|NCT02019134|chronic neck pain|chronic neck pain
367141|NCT02019134|relaxation technique|relaxation technique
367142|NCT02019134|comparative effectiveness research|comparative effectiveness research
367143|NCT02019108|osteoarthritis|osteoarthritis
367144|NCT02019108|knee|knee
367145|NCT02019108|walking|walking
367146|NCT02019108|toeout|toeout
367147|NCT02019108|gait modification|gait modification
367148|NCT02019095|Pneumonia, Ventilator-Associated|pneumonia, ventilator-associated
367149|NCT02019095|Respiratory Distress Syndrome, Adult|respiratory distress syndrome, adult
367150|NCT02019095|Pulmonary Surfactant-Associated Proteins|pulmonary surfactant-associated proteins
367151|NCT02019095|activin A|activin a
367152|NCT02019030|benign prostatic hyperplasia|benign prostatic hyperplasia
367153|NCT02019030|Transurethral vaporization of prostate|transurethral vaporization of prostate
367154|NCT02019017|Cluster Headache|cluster headache
367155|NCT02019017|Botulinum Toxin Type A|botulinum toxin type a
367156|NCT02019017|Sphenopalatine Ganglion Block|sphenopalatine ganglion block
367157|NCT02019017|Autonomic Nerve Block|autonomic nerve block
367158|NCT02018978|HIV prevention|hiv prevention
367159|NCT02018978|Behavioral intervention|behavioral intervention
367160|NCT02018978|Community-randomized trial|community-randomized trial
367161|NCT02018965|HIV|hiv
367162|NCT02018965|Extended-release Niacin|extended-release niacin
367163|NCT02018965|Immune activation|immune activation
367164|NCT02018952|Septic arthritis|septic arthritis
367165|NCT02018952|Ultrasonography|ultrasonography
367166|NCT02018952|Prognosis parameters|prognosis parameters
367167|NCT02018939|pharmacokinetics, doripenem, renal replacement therapy, MARS, organ replacement therapy|pharmacokinetics, doripenem, renal replacement therapy, mars, organ replacement therapy
367168|NCT02018926|Mocetinostat|mocetinostat
367169|NCT02018926|Azacitidine|azacitidine
367170|NCT02018926|Vidaza|vidaza
367171|NCT02018926|Myelodysplastic syndrome|myelodysplastic syndrome
367172|NCT02018926|HDAC|hdac
367173|NCT02018926|HMA|hma
367174|NCT02018926|MDS|mds
367175|NCT02018900|Synbiotics|synbiotics
367176|NCT02018900|Intestinal permeability|intestinal permeability
367177|NCT02018900|Microbiota|microbiota
367178|NCT02018900|Immune response|immune response
367179|NCT02018848|Obsessive-Compulsive Disorder|obsessive-compulsive disorder
367180|NCT02018848|Attention Training|attention training
367181|NCT02018848|Attention Bias Modification|attention bias modification
367182|NCT02018848|Dot-Probe Task|dot-probe task
367183|NCT02018848|Randomized Controlled Trial|randomized controlled trial
367184|NCT02018848|Online Treatment|online treatment
367185|NCT02018848|Washing|washing
367186|NCT02018848|Checking|checking
367187|NCT02018822|restorative material|restorative material
367188|NCT02018809|Medication Adherence|medication adherence
367189|NCT02018809|High Blood Pressure|high blood pressure
367190|NCT02018809|Diabetes|diabetes
367191|NCT02018809|Statins|statins
367192|NCT02018770|Temporomandibular Disorders, Electromyogram,|temporomandibular disorders, electromyogram,
367193|NCT02018770|Modalities of physiotherapy,|modalities of physiotherapy,
367194|NCT02018770|Temporomandibular dysfunction syndrome,|temporomandibular dysfunction syndrome,
367195|NCT02018770|Lasers.|lasers.
367196|NCT02018757|Carcinoma, Hepatocellular|carcinoma, hepatocellular
367197|NCT02018757|primary liver cancer|primary liver cancer
367198|NCT02018757|primary hepatocellular carcinoma|primary hepatocellular carcinoma
367199|NCT02018757|transarterial chemoembolization|transarterial chemoembolization
367200|NCT02018757|Chemoembolization, Therapeutic|chemoembolization, therapeutic
367201|NCT02018757|arsenic trioxide|arsenic trioxide
367202|NCT02018757|arsenous anhydride|arsenous anhydride
367203|NCT02018757|diarsenic trioxide|diarsenic trioxide
367204|NCT02018757|randomized controlled trial|randomized controlled trial
367205|NCT02018757|multicenter study|multicenter study
367206|NCT02018757|HCC|hcc
367207|NCT02018757|TACE|tace
367208|NCT02018731|Becker's Muscular dystrophy|becker's muscular dystrophy
367209|NCT02018731|BMD|bmd
367210|NCT02018731|Metformin|metformin
367211|NCT02018731|L-citrulline|l-citrulline
367212|NCT02018718|Skeletal muscle|skeletal muscle
367213|NCT02018718|Marathon|marathon
367215|NCT02018705|POEM|poem
367217|NCT02018705|Achalasia treatment|achalasia treatment
367218|NCT02018705|LES sphincter myotomy|les sphincter myotomy
367219|NCT02018679|Nodular basal cell carcinoma|nodular basal cell carcinoma
367220|NCT02018679|Er:YAG|er:yag
367221|NCT02018679|AFL-assisted|afl-assisted
367222|NCT02018679|MAL-PDT|mal-pdt
367223|NCT02018653|Cancer|cancer
367224|NCT02018653|Diarrhea|diarrhea
367225|NCT02018653|Calcium Alumina-Silicate|calcium alumina-silicate
367226|NCT02018653|CASAD|casad
367227|NCT02018653|Calcium Aluminosilicate anti-diarrheal|calcium aluminosilicate anti-diarrheal
367228|NCT02018653|Placebo|placebo
367229|NCT02018653|Sugar pill|sugar pill
367230|NCT02018653|Questionnaire|questionnaire
367231|NCT02018653|Survey|survey
367232|NCT02018640|cancer|cancer
367233|NCT02018640|tobacco use|tobacco use
367234|NCT02018640|pregnancy|pregnancy
367235|NCT02018627|bionic pancreas|bionic pancreas
367236|NCT02018627|artificial pancreas|artificial pancreas
367237|NCT02018627|insulin|insulin
367238|NCT02018627|glucagon|glucagon
367239|NCT02018627|clamp|clamp
367240|NCT02018614|Pain|pain
367241|NCT02018614|elderly|elderly
367242|NCT02018614|aged 65 or above 65|aged 65 or above 65
367243|NCT02018614|communication disorders|communication disorders
367244|NCT02018614|Algoplus® scale|algoplus® scale
367245|NCT02018588|requirements|requirements
367246|NCT02018588|amino acid|amino acid
367247|NCT02018588|tryptophan|tryptophan
367248|NCT02018575|lysine|lysine
367249|NCT02018575|bioavailability|bioavailability
367250|NCT02018575|amino acids|amino acids
367251|NCT02018575|corn|corn
367252|NCT02018562|Quality of Life|quality of life
367253|NCT02018562|Talking Tracheostomy Tube|talking tracheostomy tube
367254|NCT02018562|Speech|speech
367255|NCT02018562|Mechanically ventilated patients|mechanically ventilated patients
367256|NCT02018549|COPD|copd
367257|NCT02018549|placebo|placebo
367258|NCT02018549|inhalatory profile|inhalatory profile
367259|NCT02018536|Healthy|healthy
367260|NCT02018536|TMC435|tmc435
367261|NCT02018536|GSK2336805|gsk2336805
367262|NCT02018536|Pharmacokinetic|pharmacokinetic
367263|NCT02018536|Safety|safety
367264|NCT02018536|Tolerability|tolerability
367265|NCT02018523|Carcinoma, Non-Small-Cell Lung|carcinoma, non-small-cell lung
367266|NCT02018523|Stage 3B/4|stage 3b/4
367267|NCT02018523|Maintenance Therapy|maintenance therapy
367268|NCT02018523|Lenalidomide|lenalidomide
367269|NCT02018510|Healthy Volunteers|healthy volunteers
367270|NCT02018510|HIV|hiv
367271|NCT02018497|Essential arterial hypotension|essential arterial hypotension
367272|NCT02018497|Arterial hypotension|arterial hypotension
367273|NCT02018497|Low blood pressure|low blood pressure
367274|NCT02018497|Hypotension|hypotension
367275|NCT02018497|Essential arterial hypertension|essential arterial hypertension
367276|NCT02018497|Syncope|syncope
367277|NCT02018497|Dysautonomia|dysautonomia
367278|NCT02018497|Stress|stress
367279|NCT02018497|Adaptability|adaptability
367280|NCT02018497|Reactivity|reactivity
367281|NCT02018497|Homeostasis|homeostasis
367282|NCT02018497|Allostasis|allostasis
367283|NCT02018497|Allostatic load|allostatic load
367284|NCT02018497|Distress|distress
367285|NCT02018497|Epigenetic|epigenetic
367286|NCT02018497|Plasticity|plasticity
367407|NCT02017912|MSC-NTF|msc-ntf
367287|NCT02018484|Surgery / Knee / Replacement / MRI / Specific cutting guides|surgery / knee / replacement / mri / specific cutting guides
367288|NCT02018471|anxiety|anxiety
367289|NCT02018471|psychoeducational training|psychoeducational training
367290|NCT02018471|coping|coping
367291|NCT02018471|relaxation|relaxation
367292|NCT02018458|Dendritic cell vaccine|dendritic cell vaccine
367293|NCT02018458|Breast Cancer|breast cancer
367294|NCT02018458|Doxorubicin|doxorubicin
367295|NCT02018458|Paclitaxel|paclitaxel
367296|NCT02018458|Cyclophosphamide|cyclophosphamide
367297|NCT02018458|Carboplatin|carboplatin
367298|NCT02018406|Hematopoietic Growth Factors (EPO, G-CSF),|hematopoietic growth factors (epo, g-csf),
367299|NCT02018406|Neurological Diseases,|neurological diseases,
367300|NCT02018406|Neurorehabilitation,|neurorehabilitation,
367301|NCT02018406|Neurotrophic and Neuroprotective Effects|neurotrophic and neuroprotective effects
367302|NCT02018393|FEIBA®|feiba®
367303|NCT02018367|Barrett's esophagus|barrett's esophagus
367304|NCT02018367|proflavine|proflavine
367305|NCT02018367|Microscopic imaging|microscopic imaging
367306|NCT02018354|Orthopaedics|orthopaedics
367307|NCT02018354|Anterior cruciate ligament (ACL) reconstruction|anterior cruciate ligament (acl) reconstruction
367308|NCT02018354|Anterolateral ligament|anterolateral ligament
367309|NCT02018354|Lateral Extra-articular Tenodesis (LET)|lateral extra-articular tenodesis (let)
367310|NCT02018341|Assessment of biologic activity of a homeopathic remedy|assessment of biologic activity of a homeopathic remedy
367311|NCT02018315|G1D|g1d
367312|NCT02018315|Glut1 Disorder|glut1 disorder
367313|NCT02018315|Glucose Transporter Type 1 Disorder|glucose transporter type 1 disorder
367314|NCT02018315|Glucose Transporter Type I Disorder|glucose transporter type i disorder
367315|NCT02018302|G1D|g1d
367316|NCT02018302|Glut1 Deficiency|glut1 deficiency
367317|NCT02018302|Glucose Transporter Type 1 Deficiency|glucose transporter type 1 deficiency
367318|NCT02018302|Glucose Transporter Type I Deficiency|glucose transporter type i deficiency
367319|NCT02018289|Triclosan coated suture|triclosan coated suture
367320|NCT02018289|Surgical site infection|surgical site infection
367321|NCT02018289|Fecal peritonitis|fecal peritonitis
367322|NCT02018289|Superficial|superficial
367323|NCT02018289|incisional|incisional
367324|NCT02018276|Lidocaine|lidocaine
469670|NCT01557400|DMD|dmd
367325|NCT02018276|Magnesium|magnesium
367326|NCT02018276|Functional recovery|functional recovery
367328|NCT02018237|Nonalcoholic fatty liver disease|nonalcoholic fatty liver disease
367329|NCT02018237|High fructose corn syrup|high fructose corn syrup
367330|NCT02018224|Achilles tendon rupture, operative treatment, elongation, long-term follow up.|achilles tendon rupture, operative treatment, elongation, long-term follow up.
367331|NCT02018211|delayed onset muscle soreness|delayed onset muscle soreness
367332|NCT02018211|muscle damage|muscle damage
367333|NCT02018211|muscle function|muscle function
367334|NCT02018211|inflammation|inflammation
367335|NCT02018198|Host Immune Response|host immune response
367336|NCT02018198|Biomarker|biomarker
367337|NCT02018198|Point-of-Care|point-of-care
367338|NCT02018198|Myxovirus Resistance Protein A (MxA)|myxovirus resistance protein a (mxa)
367339|NCT02018198|C-reactive Protein (CRP)|c-reactive protein (crp)
367340|NCT02018146|Laryngeal Masks|laryngeal masks
367341|NCT02018146|Airway Management|airway management
367342|NCT02018133|CKD|ckd
367343|NCT02018133|chronic|chronic
367344|NCT02018133|kidney|kidney
367345|NCT02018133|vitamin D|vitamin d
367346|NCT02018120|multiple gingival recession|multiple gingival recession
367347|NCT02018120|platelet rich fibrin|platelet rich fibrin
367348|NCT02018120|connective tissue graft|connective tissue graft
367349|NCT02018120|microsurgery|microsurgery
367350|NCT02018120|periodontal diseases|periodontal diseases
367351|NCT02018120|gingival recession|gingival recession
367352|NCT02018107|Liver Tumor Ablation|liver tumor ablation
367353|NCT02018107|Liver Neoplasms|liver neoplasms
367354|NCT02018107|Positron Emission Tomography|positron emission tomography
367355|NCT02018107|Computed Tomography|computed tomography
367356|NCT02018094|Amputation|amputation
367357|NCT02018094|Infection|infection
367358|NCT02018094|Skin Preparation|skin preparation
367359|NCT02018094|SSI|ssi
367360|NCT02018094|Stump|stump
367361|NCT02018094|Wound|wound
367362|NCT02018081|pharmacokinetic study : open, prospective, monocentric|pharmacokinetic study : open, prospective, monocentric
367363|NCT02018068|Patient-controlled Perineural analgesia|patient-controlled perineural analgesia
367364|NCT02018068|Postoperative|postoperative
367365|NCT02018068|Orthopedic surgery|orthopedic surgery
367366|NCT02018068|"Remote Control versus at bedside care"|"remote control versus at bedside care"
367367|NCT02018068|Comparative medico-economic evaluation|comparative medico-economic evaluation
367368|NCT02018042|Alopecia Areata|alopecia areata
367369|NCT02018042|AA|aa
367370|NCT02018029|Heart failure|heart failure
367371|NCT02018029|Cardiac Resynchronisation Therapy|cardiac resynchronisation therapy
367372|NCT02018029|collagen peptides|collagen peptides
367373|NCT02018029|MIBG scintigraphy|mibg scintigraphy
367374|NCT02018016|Appendectomy|appendectomy
367375|NCT02018016|Hospitals,General|hospitals,general
367376|NCT02018016|Hospitals,High-Volume|hospitals,high-volume
367377|NCT02018016|Hospitals,Low-Volume|hospitals,low-volume
367378|NCT02018016|Outcome Assessment (Health Care)|outcome assessment (health care)
367379|NCT02017990|Renal transplantation|renal transplantation
367380|NCT02017990|n-3 polyunsaturated fatty acids|n-3 polyunsaturated fatty acids
367381|NCT02017990|Mortality|mortality
367382|NCT02017990|Graft loss|graft loss
367383|NCT02017990|Rejection|rejection
367384|NCT02017977|Laparotomy|laparotomy
367385|NCT02017977|General Surgery|general surgery
367386|NCT02017977|Hospitals,General|hospitals,general
367387|NCT02017977|Hospitals,Rural|hospitals,rural
367388|NCT02017977|Hospitals,Urban|hospitals,urban
367389|NCT02017977|Rural Health Services|rural health services
367390|NCT02017977|Geography, Medical|geography, medical
367391|NCT02017977|Outcome Assessment (Health Care)|outcome assessment (health care)
367392|NCT02017951|Appendectomy|appendectomy
367393|NCT02017951|Hospitals,General|hospitals,general
367394|NCT02017951|Hospitals,Rural|hospitals,rural
367395|NCT02017951|Hospitals,Urban|hospitals,urban
367396|NCT02017951|Rural Health Services|rural health services
367397|NCT02017951|Geography, Medical|geography, medical
367398|NCT02017951|Outcome Assessment (Health Care)|outcome assessment (health care)
367399|NCT02017938|Fatigue|fatigue
367400|NCT02017938|electromyography (EMG)|electromyography (emg)
367401|NCT02017938|central fatigue|central fatigue
367402|NCT02017938|cycling training|cycling training
367403|NCT02017925|Pulmonary Rehabilitation|pulmonary rehabilitation
367404|NCT02017925|Non-Small Cell Lung Cancer|non-small cell lung cancer
367405|NCT02017925|NSCLC|nsclc
367406|NCT02017912|Mesenchymal Stromal cells|mesenchymal stromal cells
367408|NCT02017912|Cell therapy|cell therapy
367409|NCT02017912|ALS|als
367410|NCT02017899|prevention|prevention
367411|NCT02017899|Shigella sonnei|shigella sonnei
367412|NCT02017886|Probiotics|probiotics
367413|NCT02017886|Oral health|oral health
367414|NCT02017886|Innate immunity|innate immunity
367415|NCT02017873|bleaching|bleaching
367416|NCT02017873|smokers|smokers
367417|NCT02017873|effectiveness|effectiveness
367418|NCT02017873|pain|pain
367419|NCT02017860|RAD001, everolimus, roll-over|rad001, everolimus, roll-over
367420|NCT02017847|oxygen consumption|oxygen consumption
367421|NCT02017847|activity monitors|activity monitors
367422|NCT02017847|METs|mets
367423|NCT02017847|intensity|intensity
367424|NCT02017834|oral cavity squamous cell carcinoma|oral cavity squamous cell carcinoma
367425|NCT02017834|head and neck cancer|head and neck cancer
367426|NCT02017834|oral cancer|oral cancer
367427|NCT02017821|Exercise|exercise
367428|NCT02017821|Oxygen Consumption|oxygen consumption
367429|NCT02017821|mental health|mental health
367430|NCT02017808|OCT|oct
367431|NCT02017808|Copaxone|copaxone
367432|NCT02017808|Multiple sclerosis|multiple sclerosis
367433|NCT02017808|relapsing-remitting|relapsing-remitting
367434|NCT02017795|asthma, mixed asthma, telehealth, action plan, exacerbation|asthma, mixed asthma, telehealth, action plan, exacerbation
367435|NCT02017782|Dust|dust
367436|NCT02017782|Ozone|ozone
367437|NCT02017782|Indoor air quality|indoor air quality
367438|NCT02017782|Indoor environment|indoor environment
367439|NCT02017782|Indoor climate|indoor climate
367440|NCT02017782|Cardiovascular diseases|cardiovascular diseases
367441|NCT02017782|Full body exposure|full body exposure
367442|NCT02017782|Exposure experiment with dust and ozone|exposure experiment with dust and ozone
367443|NCT02017782|Acute exposure to ozone and dust|acute exposure to ozone and dust
367444|NCT02017782|Respiratory outcomes|respiratory outcomes
367445|NCT02017782|Cardiovascular outcomes|cardiovascular outcomes
367446|NCT02017782|Acoustic rhinometry|acoustic rhinometry
367447|NCT02017782|Body inflammatory markers|body inflammatory markers
367448|NCT02017782|Cytokines|cytokines
367449|NCT02017782|Exhaled FeNO|exhaled feno
367450|NCT02017782|Nasal Lavage|nasal lavage
367451|NCT02017782|Heart rate variability|heart rate variability
367452|NCT02017782|Blood biomarkers|blood biomarkers
367453|NCT02017782|Subjective discomfort|subjective discomfort
367454|NCT02017782|General mucosal irritation|general mucosal irritation
367455|NCT02017769|Subcutaneous immunoglobulin|subcutaneous immunoglobulin
367456|NCT02017769|Magnetic resonance imaging|magnetic resonance imaging
367457|NCT02017756|Carotid artery|carotid artery
367458|NCT02017756|Atherosclerosis|atherosclerosis
367459|NCT02017756|Vulnerable plaque|vulnerable plaque
367460|NCT02017756|Magnetic resonance imaging|magnetic resonance imaging
367461|NCT02017756|Arterial wall|arterial wall
367462|NCT02017704|Endorectal Brachytherapy Radiation Therapy|endorectal brachytherapy radiation therapy
367463|NCT02017704|Intensity Modulated Radiation Therapy and Capecitabine|intensity modulated radiation therapy and capecitabine
367464|NCT02017678|JX-594|jx-594
367465|NCT02017678|Ovarian cancer|ovarian cancer
367466|NCT02017678|Peritoneal|peritoneal
367467|NCT02017678|Carcinomatosis|carcinomatosis
367468|NCT02017678|Vaccinia virus|vaccinia virus
367469|NCT02017678|Oncolytic virus|oncolytic virus
367470|NCT02017665|encephalitis|encephalitis
367471|NCT02017665|viral infections|viral infections
367472|NCT02017665|central nervous system|central nervous system
367473|NCT02017652|bowel motility|bowel motility
367474|NCT02017652|cerebral perfusion|cerebral perfusion
367475|NCT02017652|intestinal perfusion|intestinal perfusion
367476|NCT02017626|Fish allergy|fish allergy
367477|NCT02017626|immunotherapy|immunotherapy
367478|NCT02017626|hypoallergen|hypoallergen
367479|NCT02017613|CLL, SLL, NHL, SLL, PTCL, CTCL, MM, AML|cll, sll, nhl, sll, ptcl, ctcl, mm, aml
367480|NCT02017574|Stroke|stroke
367481|NCT02017574|Cerebral Infarction|cerebral infarction
367482|NCT02017561|Diastolic dysfunction|diastolic dysfunction
367483|NCT02017561|Metabolic syndrome|metabolic syndrome
367484|NCT02017561|Metformin|metformin
367485|NCT02017548|advance directives, advance care planning|advance directives, advance care planning
367486|NCT02017522|PET|pet
367487|NCT02017522|Cardiac sarcoidosis|cardiac sarcoidosis
367488|NCT02017522|FDG|fdg
367489|NCT02017522|Cardiac MRI|cardiac mri
367490|NCT02017509|Immunophenotype|immunophenotype
367491|NCT02017509|Immunoscore|immunoscore
367492|NCT02017509|MRI|mri
367493|NCT02017509|RNA Later|rna later
367494|NCT02017496|Breast cancer|breast cancer
367495|NCT02017496|locally advanced|locally advanced
367496|NCT02017496|neoadjuvant treatment|neoadjuvant treatment
367497|NCT02017496|breast conserving surgery|breast conserving surgery
367498|NCT02017483|ADHD,|adhd,
367499|NCT02017483|emotion recognition|emotion recognition
367500|NCT02017483|attention|attention
367501|NCT02017470|Women Heart Health|women heart health
367502|NCT02017470|Cardiovascular Disease|cardiovascular disease
367503|NCT02017470|focus group|focus group
367504|NCT02017470|advisory board|advisory board
367505|NCT02017470|one-on-one interview|one-on-one interview
367506|NCT02017457|Hematology|hematology
367507|NCT02017457|Acute Myelogenous Leukemia|acute myelogenous leukemia
367508|NCT02017457|Myelodysplasic syndrome|myelodysplasic syndrome
367509|NCT02017457|Allogeneic stem cell transplantation|allogeneic stem cell transplantation
367510|NCT02017457|Donor lymphocyte infusion|donor lymphocyte infusion
367511|NCT02017457|DLI|dli
367512|NCT02017457|Azacytidine|azacytidine
367513|NCT02017457|Vidaza|vidaza
367514|NCT02017457|Overall response rate|overall response rate
367515|NCT02017457|Relapse|relapse
367516|NCT02017444|Pseudotumor Cerebri|pseudotumor cerebri
367517|NCT02017444|Benign Intracranial Hypertension|benign intracranial hypertension
367518|NCT02017444|Headaches|headaches
367519|NCT02017444|Tinnitus|tinnitus
367520|NCT02017444|Papilledema|papilledema
367521|NCT02017444|Blindness|blindness
367522|NCT02017444|Optic Disk|optic disk
367523|NCT02017444|Intracranial Hypertension|intracranial hypertension
367524|NCT02017444|Clinical Trial, Phase 2|clinical trial, phase 2
367525|NCT02017444|11beta-Hydroxysteroid Dehydrogenase Type 1|11beta-hydroxysteroid dehydrogenase type 1
367526|NCT02017444|Obesity|obesity
367527|NCT02017431|Diesel exhaust|diesel exhaust
367528|NCT02017431|Particle depleted diesel exhaust|particle depleted diesel exhaust
367529|NCT02017431|Air pollution|air pollution
367530|NCT02017431|Airway responsiveness|airway responsiveness
367531|NCT02017431|Allergies|allergies
367532|NCT02017418|zeaxanthin|zeaxanthin
367533|NCT02017418|visual function|visual function
367534|NCT02017418|reaction time|reaction time
367535|NCT02017418|processing speed|processing speed
367536|NCT02017405|Digestibility|digestibility
367537|NCT02017405|Healthy volunteers|healthy volunteers
367538|NCT02017405|serum-derived bovine immunoglobulin protein isolate|serum-derived bovine immunoglobulin protein isolate
367539|NCT02017405|bovine IgG|bovine igg
367540|NCT02017405|adults|adults
367541|NCT02017392|postoperative agitation|postoperative agitation
367542|NCT02017392|endotracheal intubation|endotracheal intubation
367543|NCT02017392|general anesthesia|general anesthesia
367544|NCT02017379|upper gastrointestinal bleeding|upper gastrointestinal bleeding
367545|NCT02017379|melena|melena
367546|NCT02017379|hematemesis|hematemesis
367547|NCT02017366|Surgery|surgery
367548|NCT02017366|Malnutrition|malnutrition
367549|NCT02017366|Nutrition, Enteral|nutrition, enteral
367550|NCT02017340|Alzheimer's Disease|alzheimer's disease
367551|NCT02017340|Investigator-driven clinical trial|investigator-driven clinical trial
367552|NCT02017340|Nilvadipine|nilvadipine
367553|NCT02017340|Calcium Channel blocker|calcium channel blocker
367554|NCT02017340|Elderly|elderly
367555|NCT02017340|Therapeutic Intervention|therapeutic intervention
367556|NCT02017314|morbid obesity|morbid obesity
367557|NCT02017314|postoperative pain|postoperative pain
367558|NCT02017301|Liver Cirrhosis,Infection, Impedance, Body Composition|liver cirrhosis,infection, impedance, body composition
367559|NCT02017288|Head and Neck Cancers|head and neck cancers
367560|NCT02017288|Larynx|larynx
367561|NCT02017288|Oropharynx|oropharynx
367562|NCT02017288|Oral Cavity|oral cavity
367563|NCT02017262|Self-care|self-care
367564|NCT02017262|Patient education|patient education
367565|NCT02017236|Food Effect|food effect
367566|NCT02017236|Health subjects|health subjects
367567|NCT02017223|Physical activity|physical activity
367568|NCT02017197|Therapeutic Equivalency|therapeutic equivalency
367569|NCT02017197|Warfarin|warfarin
367570|NCT02017197|Drugs, Generic|drugs, generic
367571|NCT02017197|Anticoagulants|anticoagulants
367572|NCT02017197|Anticoagulants [Pharmacological Action]|anticoagulants [pharmacological action]
367573|NCT02017197|Coumarins|coumarins
367574|NCT02017184|Body Temperature Regulation Sensor Noninvasive|body temperature regulation sensor noninvasive
367575|NCT02017171|Kidney Diseases|kidney diseases
367576|NCT02017171|Diabetic Nephropathies|diabetic nephropathies
367577|NCT02017171|Diabetes Mellitus|diabetes mellitus
367578|NCT02017171|Diabetes Complications|diabetes complications
367579|NCT02017171|Uric acid|uric acid
367580|NCT02017171|Allopurinol|allopurinol
367581|NCT02017171|Glomerular filtration rate|glomerular filtration rate
367582|NCT02017171|Coronary artery disease|coronary artery disease
367583|NCT02017158|Obesity|obesity
367584|NCT02017158|Nutrition|nutrition
367585|NCT02017158|Children|children
367586|NCT02017145|infection|infection
367587|NCT02017145|chloraprep|chloraprep
367588|NCT02017145|chlorhexidine|chlorhexidine
367589|NCT02017145|lower extremity surgery|lower extremity surgery
367590|NCT02017145|antiseptic|antiseptic
367591|NCT02017145|bacterial colonization|bacterial colonization
367592|NCT02017132|Pomegranate|pomegranate
367593|NCT02017132|Blood pressure|blood pressure
367594|NCT02017132|Body composition|body composition
367595|NCT02017132|Weight-loss|weight-loss
367596|NCT02017132|Fat mass|fat mass
367597|NCT02017132|Polyphenols|polyphenols
367598|NCT02017132|Quality of Life|quality of life
367599|NCT02017106|Varicose Veins|varicose veins
367600|NCT02017093|CVA, rehabilitation|cva, rehabilitation
367601|NCT02017080|fetal thyroid ultrasound|fetal thyroid ultrasound
367602|NCT02017080|fetal fT4|fetal ft4
367603|NCT02017080|antithyroid antibodies|antithyroid antibodies
367604|NCT02017080|pregnancy|pregnancy
367605|NCT02017080|autoimmune thyroid disease|autoimmune thyroid disease
367606|NCT02017067|Resistance training|resistance training
367607|NCT02017067|musculoskeletal conditions|musculoskeletal conditions
367609|NCT02017041|opioid dependence, buprenorphine, smartphone, suboxone|opioid dependence, buprenorphine, smartphone, suboxone
367610|NCT02017015|Pancreatic cancer|pancreatic cancer
367611|NCT02017015|Metastatic pancreatic cancer|metastatic pancreatic cancer
367612|NCT02017015|treatment for pancreatic cancer|treatment for pancreatic cancer
367613|NCT02017015|Abraxane clinical research trials|abraxane clinical research trials
367614|NCT02017015|Celgene clinical research trials|celgene clinical research trials
367615|NCT02017002|Esophageal cancer|esophageal cancer
367616|NCT02017002|minimally invasive|minimally invasive
367617|NCT02017002|Surgical Procedures|surgical procedures
367618|NCT02017002|Esophagectomy|esophagectomy
367619|NCT02016989|Bacterial keratitis|bacterial keratitis
367620|NCT02016989|OTR4120|otr4120
367621|NCT02016989|Matrix therapy|matrix therapy
367622|NCT02016963|Monoclonal Antibody|monoclonal antibody
367623|NCT02016963|Safety|safety
367624|NCT02016963|Raxibacumab|raxibacumab
367625|NCT02016963|HGS1021|hgs1021
367626|NCT02016963|Immunogenicity|immunogenicity
367627|NCT02016937|Anesthesia , lactation, birth|anesthesia , lactation, birth
367628|NCT02016924|Pediatrics|pediatrics
367629|NCT02016924|Adolescents|adolescents
367631|NCT02016924|HIV-1|hiv-1
367632|NCT02016924|Treatment experienced|treatment experienced
367633|NCT02016898|Primary open angle glaucoma|primary open angle glaucoma
367634|NCT02016898|trabeculectomy|trabeculectomy
367635|NCT02016898|mitomycin-C|mitomycin-c
367636|NCT02016898|express mini-shunt|express mini-shunt
367637|NCT02016872|PET/CT|pet/ct
367638|NCT02016872|18F-FMISO|18f-fmiso
367639|NCT02016872|tumor hypoxia|tumor hypoxia
367640|NCT02016872|13-186|13-186
367641|NCT02016859|IPF Immature platelet fraction|ipf immature platelet fraction
367642|NCT02016859|ICU neutropenic fever|icu neutropenic fever
367643|NCT02016859|hip fracture|hip fracture
367644|NCT02016859|critically ill|critically ill
367645|NCT02016833|Ovarian Cancer|ovarian cancer
367646|NCT02016833|Cervical Cancer|cervical cancer
367647|NCT02016833|Leukemia|leukemia
367648|NCT02016833|Immunity|immunity
367649|NCT02016833|WT-1|wt-1
367650|NCT02016833|Survivin|survivin
367651|NCT02016833|HPV|hpv
367652|NCT02016820|Clostridium Difficile Infection|clostridium difficile infection
367653|NCT02016820|Proton Pump Inhibitors|proton pump inhibitors
367654|NCT02016820|Histamine-2 Receptor Antagonists|histamine-2 receptor antagonists
367655|NCT02016820|Gastroesophageal Reflux Disease|gastroesophageal reflux disease
367656|NCT02016807|Mucositis|mucositis
367657|NCT02016807|Sucralfate|sucralfate
367658|NCT02016807|Prothelial|prothelial
367659|NCT02016807|High potency sucralfate|high potency sucralfate
367660|NCT02016807|Ulcerations|ulcerations
367661|NCT02016807|Chemotherapy induced diarrhea|chemotherapy induced diarrhea
367662|NCT02016807|Radiation induced mucositis|radiation induced mucositis
367663|NCT02016807|Chemotherapy colitis|chemotherapy colitis
367664|NCT02016807|Radiation colitis|radiation colitis
367665|NCT02016807|Mucosal erosions|mucosal erosions
367666|NCT02016794|cervical|cervical
367667|NCT02016794|interbody|interbody
367668|NCT02016794|spacer|spacer
367669|NCT02016794|degenerative|degenerative
367670|NCT02016794|pain|pain
367671|NCT02016794|neck|neck
367672|NCT02016794|decompression|decompression
367673|NCT02016794|fusion|fusion
367674|NCT02016794|implant|implant
367675|NCT02016781|Myelodysplastic Syndrome|myelodysplastic syndrome
367676|NCT02016755|Peripheral Arterial Disease|peripheral arterial disease
367677|NCT02016755|Vascular Disease|vascular disease
367678|NCT02016755|CLI|cli
367679|NCT02016755|Critical Limb Ischemia|critical limb ischemia
367680|NCT02016755|PAD|pad
367681|NCT02016755|AnGes|anges
367682|NCT02016755|HGF Plasmid|hgf plasmid
367683|NCT02016755|HGF|hgf
367684|NCT02016755|Hepatocyte Growth Factor Plasmid|hepatocyte growth factor plasmid
367685|NCT02016755|gene therapy|gene therapy
367686|NCT02016742|Pharmacokinetics|pharmacokinetics
367687|NCT02016729|AML|aml
367688|NCT02016716|Postmenopausal Osteoporosis|postmenopausal osteoporosis
367689|NCT02016703|erythritol|erythritol
367690|NCT02016703|polyol|polyol
367691|NCT02016703|laxation|laxation
367692|NCT02016703|gastrointestinal|gastrointestinal
367693|NCT02016703|tolerance|tolerance
367694|NCT02016703|soft drinks|soft drinks
367695|NCT02016703|child|child
367696|NCT02016703|diarrhoea|diarrhoea
367697|NCT02016690|Prevention of severe RSV infection|prevention of severe rsv infection
367698|NCT02016690|Respiratory syncytial virus (RSV) infection|respiratory syncytial virus (rsv) infection
367699|NCT02016690|Down Syndrome|down syndrome
367700|NCT02016690|Immunocompromised|immunocompromised
367701|NCT02016690|Effectiveness of palivizumab|effectiveness of palivizumab
367702|NCT02016677|Breast reduction|breast reduction
367703|NCT02016677|Mastopexy|mastopexy
367704|NCT02016677|Sagging|sagging
367705|NCT02016664|Chronic Pain, Ketamine, Safety|chronic pain, ketamine, safety
367706|NCT02016638|Obstructive Sleep Apnea in pregnancy|obstructive sleep apnea in pregnancy
367707|NCT02016638|Pregnancy induced hypertension|pregnancy induced hypertension
367708|NCT02016638|Restless leg syndrome|restless leg syndrome
367709|NCT02016638|Sleep|sleep
367710|NCT02016612|Recurrent|recurrent
367711|NCT02016612|Ptosis|ptosis
367712|NCT02016612|Reduction|reduction
367713|NCT02016612|Mammoplasty|mammoplasty
367714|NCT02016612|Mastopexy|mastopexy
367715|NCT02016599|Hypotension|hypotension
367716|NCT02016599|Low blood pressure|low blood pressure
367717|NCT02016599|Neonate|neonate
367718|NCT02016599|Extremely Low Birth Weight Infant|extremely low birth weight infant
367719|NCT02016573|renal denervation|renal denervation
367720|NCT02016573|blood pressure|blood pressure
367721|NCT02016573|cardiovascular risk|cardiovascular risk
367722|NCT02016573|target organ damage|target organ damage
367723|NCT02016573|sympathetic activity|sympathetic activity
367724|NCT02016547|Stroke|stroke
367725|NCT02016547|Middle Cerebral Artery|middle cerebral artery
367726|NCT02016547|Thrombectomy|thrombectomy
367727|NCT02016547|Mechanical Thrombolysis|mechanical thrombolysis
367728|NCT02016547|Abciximab|abciximab
367729|NCT02016534|MET Amplified Gastric / Gastroesophageal Junction / Esophageal Adenocarcinoma, or other solid tumors.|met amplified gastric / gastroesophageal junction / esophageal adenocarcinoma, or other solid tumors.
367730|NCT02016521|Exercise|exercise
367731|NCT02016521|Clothing|clothing
367732|NCT02016521|Core body temperature|core body temperature
367733|NCT02016521|Skin Temperature|skin temperature
367734|NCT02016521|Performance|performance
367735|NCT02016508|Adult bone marrow stem cells|adult bone marrow stem cells
367736|NCT02016508|AMD|amd
367737|NCT02016482|Nail Psoriasis|nail psoriasis
367738|NCT02016482|Plaque Psoriasis|plaque psoriasis
367739|NCT02016456|Transcranial Magnetic Stimulation|transcranial magnetic stimulation
367740|NCT02016456|Neuronavigation|neuronavigation
367741|NCT02016456|Magnetic Resonance Imaging|magnetic resonance imaging
367742|NCT02016443|inguinal hernia|inguinal hernia
367743|NCT02016430|TMAO|tmao
367744|NCT02016430|Gut Flora|gut flora
367745|NCT02016430|Dietary Intervention|dietary intervention
367746|NCT02016430|Choline|choline
367747|NCT02016430|Carnitine|carnitine
367748|NCT02016417|Nasopharyngeal carcinoma|nasopharyngeal carcinoma
367749|NCT02016417|Induction chemotherapy|induction chemotherapy
367750|NCT02016417|Concurrent chemoradiotherapy|concurrent chemoradiotherapy
367751|NCT02016417|Gemcitabine|gemcitabine
367752|NCT02016417|Docetaxel|docetaxel
367753|NCT02016404|blood pressure|blood pressure
367754|NCT02016404|sodium|sodium
367755|NCT02016404|salt|salt
367756|NCT02016404|low sodium high potassium salt|low sodium high potassium salt
367757|NCT02016404|potassium|potassium
367758|NCT02016404|Vietnam|vietnam
367759|NCT02016404|randomized controlled trial|randomized controlled trial
367760|NCT02016365|Transthyretin amyloidosis|transthyretin amyloidosis
367761|NCT02016365|Cardiomyopathy|cardiomyopathy
367762|NCT02016365|ATTR|attr
367763|NCT02016365|neuropathy|neuropathy
367764|NCT02016352|hydrocephalus|hydrocephalus
367765|NCT02016352|proteomic|proteomic
367766|NCT02016352|cerebrospinal fluid|cerebrospinal fluid
367767|NCT02016326|Colonoscopy|colonoscopy
367768|NCT02016326|High Definition White Light|high definition white light
367769|NCT02016326|I-Scan|i-scan
367770|NCT02016326|Adenomas|adenomas
367771|NCT02016300|cartilage|cartilage
367772|NCT02016300|microfracture|microfracture
367773|NCT02016300|knee|knee
367774|NCT02016300|bracing|bracing
367775|NCT02016261|Cognitive function|cognitive function
367776|NCT02016248|CyberKnife|cyberknife
367777|NCT02016248|Prostate Cancer|prostate cancer
367778|NCT02016248|Stereotactic Body Radiation|stereotactic body radiation
367779|NCT02016248|SBRT|sbrt
367780|NCT02016248|Radiosurgery|radiosurgery
367781|NCT02016248|SABR|sabr
367782|NCT02016248|Stereotactic Ablative Body Radiotherapy|stereotactic ablative body radiotherapy
367783|NCT02016248|Boost|boost
367784|NCT02016235|Dent|dent
367785|NCT02016235|Dents|dents
367786|NCT02016235|Dent Disease|dent disease
367787|NCT02016235|Phosphorus Supplements|phosphorus supplements
367788|NCT02016235|FGF 23|fgf 23
367789|NCT02016222|primary progressive multiple sclerosis|primary progressive multiple sclerosis
367790|NCT02016222|diagnosis|diagnosis
367791|NCT02016222|tears|tears
367792|NCT02016222|isoelectric focusing|isoelectric focusing
367793|NCT02016222|oligoclonal bands|oligoclonal bands
367794|NCT02016196|TIPS|tips
367795|NCT02016196|portal pressure|portal pressure
367796|NCT02016196|rifaximin|rifaximin
367797|NCT02016196|overt hepatic encephalopathy|overt hepatic encephalopathy
367798|NCT02016196|microbiota|microbiota
367799|NCT02016183|Drug Therapy|drug therapy
367800|NCT02016170|platelet reactivity|platelet reactivity
367801|NCT02016170|ticagrelor|ticagrelor
367802|NCT02016170|prasugrel|prasugrel
367803|NCT02016157|Moxifloxacin|moxifloxacin
367804|NCT02016157|Chlorhexidine|chlorhexidine
367805|NCT02016157|In situ gel|in situ gel
367806|NCT02016157|Chronic periodontitis|chronic periodontitis
367807|NCT02016144|Airway management; Fiber optic technology; Intubation|airway management; fiber optic technology; intubation
367808|NCT02016131|endoleak|endoleak
367809|NCT02016131|EVAR|evar
367810|NCT02016131|AAA|aaa
367811|NCT02016131|CQDSA|cqdsa
367812|NCT02016118|RUTI|ruti
367813|NCT02016105|plaque type psoriasis|plaque type psoriasis
369496|NCT02008760|compliance|compliance
367814|NCT02016105|equivalent efficacy|equivalent efficacy
367815|NCT02016105|safety and immunogenicity|safety and immunogenicity
367816|NCT02016105|GP2017|gp2017
367817|NCT02016105|Humira®|humira®
367818|NCT02016092|Parkinson's disease|parkinson's disease
367819|NCT02016092|biomarkers|biomarkers
367820|NCT02016092|blood|blood
367821|NCT02016092|urine,|urine,
367822|NCT02016092|proteomics|proteomics
367823|NCT02016092|lipidomics|lipidomics
367824|NCT02016092|metabolomics|metabolomics
367825|NCT02016079|randomized controlled trial|randomized controlled trial
367826|NCT02016079|omega-3|omega-3
367827|NCT02016079|nutrition|nutrition
367828|NCT02016079|behavior problems|behavior problems
367829|NCT02016079|externalizing|externalizing
367830|NCT02016079|internalizing|internalizing
367831|NCT02016079|antisocial|antisocial
367832|NCT02016079|aggressive|aggressive
367833|NCT02016066|Healthy|healthy
367834|NCT02016066|CR6261|cr6261
367835|NCT02016066|Japanese|japanese
367836|NCT02016066|Safety|safety
367837|NCT02016066|Pharmacokinetics|pharmacokinetics
367838|NCT02016066|Immunogenicity|immunogenicity
367839|NCT02016040|Prostate cancer|prostate cancer
367840|NCT02016040|HIFU Hemi-ablation|hifu hemi-ablation
367841|NCT02016040|Prostate biopsies|prostate biopsies
367842|NCT02016014|Physical activity|physical activity
367843|NCT02016014|Alimentation|alimentation
367844|NCT02016014|Information and communication Technology|information and communication technology
367845|NCT02016014|Arterial aging|arterial aging
367846|NCT02016001|fluoride|fluoride
367847|NCT02016001|dental caries|dental caries
367848|NCT02016001|prevention|prevention
367849|NCT02015988|Acute coronary syndrome|acute coronary syndrome
367850|NCT02015988|Diabetes Mellitus, Type 2|diabetes mellitus, type 2
367851|NCT02015988|Hypertriglyceridemia|hypertriglyceridemia
367852|NCT02015988|Simvastatin|simvastatin
367853|NCT02015988|Fenofibrate|fenofibrate
367854|NCT02015975|patellar fracture|patellar fracture
367855|NCT02015975|fracture of patella|fracture of patella
367856|NCT02015975|patella|patella
367857|NCT02015975|locking plate osteosynthesis|locking plate osteosynthesis
367858|NCT02015975|osteosynthesis|osteosynthesis
367859|NCT02015975|star-plate|star-plate
367860|NCT02015975|arrow-plate|arrow-plate
367861|NCT02015962|Hypokalemia|hypokalemia
367862|NCT02015962|Intravenous|intravenous
367863|NCT02015962|Enteral|enteral
367864|NCT02015962|post-cardiac surgery|post-cardiac surgery
367865|NCT02015936|stage III cancer|stage iii cancer
367866|NCT02015936|stage IV cancer|stage iv cancer
367867|NCT02015936|cancer|cancer
367868|NCT02015936|advanced stage cancer|advanced stage cancer
367869|NCT02015936|Nintendo Wii training|nintendo wii training
367870|NCT02015936|exercise|exercise
367871|NCT02015936|physical training|physical training
367872|NCT02015936|physical function|physical function
367873|NCT02015936|physical fitness test|physical fitness test
367874|NCT02015923|Colonic cancer|colonic cancer
367875|NCT02015923|Metastasis|metastasis
367876|NCT02015884|Incivility|incivility
367877|NCT02015884|Rudeness|rudeness
367878|NCT02015884|Aggression|aggression
367879|NCT02015884|Violent act|violent act
367880|NCT02015884|Healthcare workers|healthcare workers
367881|NCT02015884|Emergency unit|emergency unit
367882|NCT02015832|SYNTAX II Score|syntax ii score
367883|NCT02015832|Pressure wires|pressure wires
367884|NCT02015832|instantaneous wave-free ratio|instantaneous wave-free ratio
367885|NCT02015832|fractional flow reserve|fractional flow reserve
367886|NCT02015832|intravascular ultrasound|intravascular ultrasound
367887|NCT02015832|Drug eluting stents|drug eluting stents
367888|NCT02015832|Stents|stents
367889|NCT02015832|Angioplasty|angioplasty
367890|NCT02015832|multi slice computed tomography|multi slice computed tomography
367891|NCT02015806|Quality improvement|quality improvement
367892|NCT02015806|Randomized controlled trial|randomized controlled trial
367893|NCT02015806|Medication adherence|medication adherence
367894|NCT02015806|RxTimer Cap|rxtimer cap
367895|NCT02015806|PillMinder|pillminder
367896|NCT02015806|Take-N-Slide|take-n-slide
367897|NCT02015806|Low-touch devices|low-touch devices
367898|NCT02015806|Medication management|medication management
367899|NCT02015793|Crohn's Disease|crohn's disease
367900|NCT02015793|Pharmacokinetics|pharmacokinetics
367901|NCT02015780|Drug therapy|drug therapy
367902|NCT02015767|Drug therapy|drug therapy
367903|NCT02015728|Refractory|refractory
367904|NCT02015728|Recurrent|recurrent
367905|NCT02015728|Brain|brain
367906|NCT02015728|Tumor|tumor
367907|NCT02015728|Pediatric|pediatric
367908|NCT02015728|Biologically Targeted Therapy|biologically targeted therapy
367909|NCT02015728|Sorafenib|sorafenib
367910|NCT02015728|Everolimus|everolimus
367911|NCT02015728|Erlotinib|erlotinib
367912|NCT02015728|Dasatinib|dasatinib
367913|NCT02015728|Temozolomide|temozolomide
367914|NCT02015728|Etoposide|etoposide
367915|NCT02015702|Physicians|physicians
367916|NCT02015702|Electronic Health Record|electronic health record
367917|NCT02015702|Education|education
367918|NCT02015663|Cystic Fibrosis|cystic fibrosis
367919|NCT02015663|CF|cf
781145|NCT00325260|influenza|influenza
470429|NCT01554319|Asthma|asthma
367920|NCT02015650|Locally advanced squamous cell carcinomas of head and neck|locally advanced squamous cell carcinomas of head and neck
367921|NCT02015637|Gonorrhea|gonorrhea
367922|NCT02015637|N. gonorrhoeae|n. gonorrhoeae
367923|NCT02015637|bacterial infection|bacterial infection
367924|NCT02015637|Anti-Infective Agents|anti-infective agents
367925|NCT02015637|Anti-Bacterial Agents|anti-bacterial agents
367926|NCT02015624|Acute coronary syndromes|acute coronary syndromes
367927|NCT02015624|Intensive Care Unit|intensive care unit
367928|NCT02015611|Vitamin D|vitamin d
367929|NCT02015611|Muscle power|muscle power
367930|NCT02015611|Muscle fiber|muscle fiber
367931|NCT02015611|Falls|falls
367932|NCT02015611|Aging|aging
367933|NCT02015598|Obstructive sleep apnoea|obstructive sleep apnoea
367934|NCT02015598|Antioxidant|antioxidant
367935|NCT02015598|drug treatment|drug treatment
367936|NCT02015598|oxidative stress|oxidative stress
367937|NCT02015598|Continuous Positive Airway Pressure|continuous positive airway pressure
367938|NCT02015572|Low back pain|low back pain
367939|NCT02015572|Return to work|return to work
367940|NCT02015572|Sickness absence|sickness absence
367941|NCT02015572|Rehabilitation|rehabilitation
367942|NCT02015572|Occupational intervention|occupational intervention
367943|NCT02015546|Major Depressive Disorder|major depressive disorder
367944|NCT02015546|Vilazodone|vilazodone
367945|NCT02015533|Healthy|healthy
367946|NCT02015533|CR8020|cr8020
367947|NCT02015533|Japanese|japanese
367948|NCT02015533|Safety|safety
367949|NCT02015533|Pharmacokinetics|pharmacokinetics
367950|NCT02015533|Immunogenicity|immunogenicity
367951|NCT02015494|Safety|safety
367952|NCT02015494|Immunogenicity|immunogenicity
367953|NCT02015481|Case control, safety, tolerability, efficacy.|case control, safety, tolerability, efficacy.
367954|NCT02015468|Distal radius fracture|distal radius fracture
367955|NCT02015468|Wrist fracture|wrist fracture
367956|NCT02015468|Physiotherapy|physiotherapy
367957|NCT02015468|Immobilization|immobilization
367958|NCT02015468|Volar locking plates|volar locking plates
367959|NCT02015468|Mobilization|mobilization
367960|NCT02015455|pragmatic trial|pragmatic trial
367961|NCT02015455|stepped-wedge design|stepped-wedge design
367962|NCT02015455|cluster-randomized trial|cluster-randomized trial
367963|NCT02015442|Sucrose in diet|sucrose in diet
367964|NCT02015429|Food intake|food intake
367965|NCT02015429|satiety|satiety
367966|NCT02015429|glycemia|glycemia
367967|NCT02015429|appetite|appetite
367968|NCT02015429|blood glucose|blood glucose
367969|NCT02015429|yellow peas|yellow peas
367970|NCT02015429|fibre|fibre
367971|NCT02015429|protein|protein
367972|NCT02015429|mixed meal|mixed meal
367973|NCT02015416|Melanoma|melanoma
367974|NCT02015416|Ovarian cancer|ovarian cancer
367975|NCT02015416|Sarcoma|sarcoma
367976|NCT02015416|Non-small cell lung cancer|non-small cell lung cancer
367977|NCT02015416|NSCLC|nsclc
367978|NCT02015416|Breast cancer|breast cancer
367979|NCT02015390|bone defects|bone defects
367980|NCT02015390|iatrogenic resection|iatrogenic resection
367981|NCT02015390|titanium mesh cage|titanium mesh cage
367982|NCT02015390|biomembrane|biomembrane
367983|NCT02015390|Masquelet technique|masquelet technique
367984|NCT02015364|Achilles tendon|achilles tendon
367985|NCT02015364|Rupture|rupture
367986|NCT02015364|Rehabilitation|rehabilitation
367987|NCT02015364|Dynamic rehabilitation|dynamic rehabilitation
367988|NCT02015351|Choroidal neovascularization|choroidal neovascularization
367989|NCT02015351|Vogt Koyanagi Harada Disease|vogt koyanagi harada disease
367990|NCT02015351|Inflammatory choroidal neovascularization|inflammatory choroidal neovascularization
367991|NCT02015351|Anti-VEGF|anti-vegf
367992|NCT02015338|Hemiparesis|hemiparesis
367993|NCT02015338|Cerebral Palsy|cerebral palsy
367994|NCT02015338|Congenital Stroke|congenital stroke
367995|NCT02015338|Congenital Infarct|congenital infarct
367996|NCT02015325|Water|water
367997|NCT02015325|Sanitation|sanitation
367998|NCT02015325|Hygiene|hygiene
367999|NCT02015325|Education|education
368000|NCT02015325|Evaluation|evaluation
368001|NCT02015312|Amyloidosis|amyloidosis
368002|NCT02015299|Diabetes|diabetes
368003|NCT02015299|Pulse Wave Velocity|pulse wave velocity
368004|NCT02015299|Dipeptidyl peptidase (DPP)-4 inhibitors|dipeptidyl peptidase (dpp)-4 inhibitors
368005|NCT02015299|Linagliptin|linagliptin
368006|NCT02015299|Arterial Stiffness|arterial stiffness
368007|NCT02015299|Subclinical arterial inflammation|subclinical arterial inflammation
368008|NCT02015286|Growth disorders|growth disorders
368009|NCT02015286|Saizen|saizen
368010|NCT02015286|Easypod|easypod
368011|NCT02015286|Growth hormone|growth hormone
368012|NCT02015286|Pediatric subject|pediatric subject
368013|NCT02015273|easypod™|easypod™
368014|NCT02015273|SAIZEN®|saizen®
368015|NCT02015260|human papilloma virus infection|human papilloma virus infection
368016|NCT02015260|Anogenital warts|anogenital warts
368017|NCT02015260|condylomata acuminata|condylomata acuminata
368018|NCT02015234|TNX-102 SL|tnx-102 sl
368019|NCT02015234|bedtime|bedtime
368020|NCT02015234|sublingual|sublingual
368021|NCT02015234|12-month|12-month
369497|NCT02008760|D3|d3
368022|NCT02015234|long term safety|long term safety
368023|NCT02015234|long term efficacy|long term efficacy
368024|NCT02015234|Fibromyalgia|fibromyalgia
368025|NCT02015221|chronic venous insufficiency|chronic venous insufficiency
368026|NCT02015221|venous leg ulcers|venous leg ulcers
368027|NCT02015221|pneumatic compression|pneumatic compression
368028|NCT02015208|CLL|cll
368029|NCT02015208|cytokine signaling|cytokine signaling
368030|NCT02015208|signal transduction inhibitors|signal transduction inhibitors
368031|NCT02015208|elderly|elderly
368032|NCT02015208|p53|p53
368033|NCT02015195|Jellyfish stings|jellyfish stings
368034|NCT02015195|Treatment|treatment
368035|NCT02015195|Humans|humans
368036|NCT02015195|Topical Treatments|topical treatments
368037|NCT02015195|Pain|pain
368038|NCT02015195|Erythema|erythema
368039|NCT02015182|Bupivacaine|bupivacaine
368040|NCT02015182|Sensorcaine|sensorcaine
368041|NCT02015182|Population pharmacokinetics|population pharmacokinetics
368042|NCT02015182|Children|children
368043|NCT02015182|Pediatrics|pediatrics
368044|NCT02015182|Transversus abdominis plane (TAP) block|transversus abdominis plane (tap) block
368045|NCT02015182|Regional Anesthesia|regional anesthesia
368046|NCT02015169|gastric cancer|gastric cancer
368047|NCT02015169|neoadjuvant chemotherapy|neoadjuvant chemotherapy
368048|NCT02015169|capecitabine|capecitabine
368049|NCT02015169|oxaliplatin|oxaliplatin
368050|NCT02015169|lapatinib|lapatinib
368051|NCT02015156|Trastuzumab|trastuzumab
368052|NCT02015156|Healthy Male Volunteers|healthy male volunteers
368053|NCT02015156|Single-Dose|single-dose
368054|NCT02015156|Phase 1|phase 1
368055|NCT02015156|Biosimilarity|biosimilarity
368056|NCT02015130|Type 2 diabetes|type 2 diabetes
368057|NCT02015130|hypertension|hypertension
368058|NCT02015130|individual|individual
368059|NCT02015104|Urothelial Cancinoma|urothelial cancinoma
368060|NCT02015104|Vaccines|vaccines
368061|NCT02015104|Immunotherapy|immunotherapy
368062|NCT02015104|TICE BCG|tice bcg
368063|NCT02015104|Intravesical Treatment|intravesical treatment
368064|NCT02015091|Healthy Subjects|healthy subjects
368065|NCT02015091|Vaccine-Mediated Protection|vaccine-mediated protection
368066|NCT02015091|Immunogenicity|immunogenicity
368067|NCT02015091|Sporozoites|sporozoites
368068|NCT02015091|Parasitemia|parasitemia
368069|NCT02015078|African American|african american
368070|NCT02015078|Eating Behavior Phenotypes|eating behavior phenotypes
368071|NCT02015078|Obesity|obesity
368072|NCT02015065|GIST|gist
368073|NCT02015065|Small Molecule|small molecule
368074|NCT02015065|Mesenchymal Tumor|mesenchymal tumor
368075|NCT02015065|Receptor Tyrosine Kinase|receptor tyrosine kinase
368076|NCT02015065|Survival|survival
368077|NCT02015039|Occupational Therapy|occupational therapy
368078|NCT02015039|Botulinum Toxin|botulinum toxin
368079|NCT02015039|Writer's Cramp|writer's cramp
368080|NCT02015026|Biospecimen Repository|biospecimen repository
368081|NCT02015026|Disease Progression Pattern|disease progression pattern
368082|NCT02015026|Specimen Analysis|specimen analysis
368083|NCT02015026|Genetic Analysis|genetic analysis
368084|NCT02015013|Leukapheresis|leukapheresis
368085|NCT02015013|Progenitor Cells|progenitor cells
368086|NCT02015000|Pterygium|pterygium
368087|NCT02015000|Recurrence|recurrence
368088|NCT02014987|Running related injury|running related injury
368089|NCT02014987|Overuse injury|overuse injury
368090|NCT02014987|Running pattern|running pattern
368091|NCT02014974|Fractures|fractures
368092|NCT02014974|burden of fractures|burden of fractures
368093|NCT02014974|orthopaedic fractures|orthopaedic fractures
368094|NCT02014974|orthopaedic injuries|orthopaedic injuries
368095|NCT02014974|orthopaedic trauma|orthopaedic trauma
368096|NCT02014974|fractures India|fractures india
368097|NCT02014974|observational study|observational study
368098|NCT02014974|outcomes of fracture care|outcomes of fracture care
368099|NCT02014974|wait times India|wait times india
368100|NCT02014974|epidemiology|epidemiology
368101|NCT02014948|Low Back Pain|low back pain
368102|NCT02014948|Physiotherapy|physiotherapy
368103|NCT02014935|Low-intensity Laser|low-intensity laser
368104|NCT02014935|Spasticity|spasticity
368105|NCT02014935|pain,|pain,
368106|NCT02014935|Fatigue|fatigue
368107|NCT02014909|KTN3379|ktn3379
368108|NCT02014909|Advanced cancer|advanced cancer
368109|NCT02014909|Phase 1|phase 1
368110|NCT02014909|Monoclonal antibody|monoclonal antibody
368111|NCT02014909|Safety and pharmacokinetics|safety and pharmacokinetics
368112|NCT02014909|CDX3379|cdx3379
368113|NCT02014896|Ischemic Stroke|ischemic stroke
368114|NCT02014896|Transient Ischemic Attack|transient ischemic attack
368115|NCT02014896|Transient Neurological Event|transient neurological event
368116|NCT02014896|Atrial Fibrillation|atrial fibrillation
368117|NCT02014896|Cryptogenic Stroke|cryptogenic stroke
368118|NCT02014896|Gene Expression|gene expression
368119|NCT02014896|RNA|rna
368120|NCT02014896|Anticoagulant|anticoagulant
368121|NCT02014896|NOAC|noac
368122|NCT02014896|Antiplatelet|antiplatelet
368123|NCT02014896|Cardiac monitoring|cardiac monitoring
368124|NCT02014896|Point of Care|point of care
368125|NCT02014896|tPA|tpa
368126|NCT02014896|Atheroembolic|atheroembolic
368127|NCT02014870|Influenza|influenza
368128|NCT02014870|Vaccine|vaccine
368129|NCT02014870|Virus|virus
368130|NCT02014870|H1N1|h1n1
368131|NCT02014870|Challenge|challenge
368132|NCT02014870|Vismederi|vismederi
368133|NCT02014857|Smoking, gingival crevicular fluid, matrix metalloproteinases, intercellular signaling peptides and proteins, healthy volunteers|smoking, gingival crevicular fluid, matrix metalloproteinases, intercellular signaling peptides and proteins, healthy volunteers
368134|NCT02014844|glioblastoma|glioblastoma
368135|NCT02014844|aldoxorubicin|aldoxorubicin
368136|NCT02014844|temozolomide|temozolomide
368137|NCT02014844|brain cancer|brain cancer
368138|NCT02014844|brain tumor|brain tumor
368139|NCT02014831|Squamous Cell Carcinoma of the penis|squamous cell carcinoma of the penis
368140|NCT02014831|Stage N3|stage n3
368141|NCT02014831|Metastasis|metastasis
368142|NCT02014831|TIP|tip
368143|NCT02014831|Cetuximab|cetuximab
368144|NCT02014831|Objective Response Rate|objective response rate
368145|NCT02014831|Safety profile|safety profile
368146|NCT02014831|Overall Survival|overall survival
368147|NCT02014831|Progression Free Survival|progression free survival
368148|NCT02014831|Quality of Life|quality of life
368149|NCT02014805|postoperative|postoperative
368150|NCT02014805|conformal|conformal
368151|NCT02014805|radiotherapy|radiotherapy
368152|NCT02014805|thymoma|thymoma
368153|NCT02014792|Haemodialysis|haemodialysis
368154|NCT02014792|Heart rate variability|heart rate variability
368155|NCT02014792|n-3 PUFA|n-3 pufa
368156|NCT02014779|Randomized Controlled Trial|randomized controlled trial
368157|NCT02014779|Alcohol|alcohol
368158|NCT02014779|Internet|internet
368159|NCT02014779|Internet based therapy|internet based therapy
368160|NCT02014779|Cognitive behavioral therapy|cognitive behavioral therapy
368161|NCT02014753|AMI|ami
368162|NCT02014753|STEMI|stemi
368163|NCT02014753|ACS|acs
368164|NCT02014740|Epicardial fat|epicardial fat
368165|NCT02014740|Type 2 diabetes|type 2 diabetes
368166|NCT02014740|Obesity|obesity
368167|NCT02014740|GLP-1 analogs|glp-1 analogs
368168|NCT02014727|Malaria vaccine|malaria vaccine
368169|NCT02014727|phase 1,|phase 1,
368170|NCT02014727|AMA1-DiCO|ama1-dico
368171|NCT02014701|echocardiogram|echocardiogram
368296|NCT02014285|Muscle Architecture|muscle architecture
368172|NCT02014701|regional wall motion abnormalities|regional wall motion abnormalities
368173|NCT02014701|myocardial contrast|myocardial contrast
368174|NCT02014688|Normal subjects|normal subjects
368176|NCT02014675|CRT-D|crt-d
368177|NCT02014675|Lead|lead
368178|NCT02014662|Muscle function, Muscle damage and recovery, Eccentric exercise, Muscle soreness, Protein synthesis|muscle function, muscle damage and recovery, eccentric exercise, muscle soreness, protein synthesis
368179|NCT02014649|Influenza treatment|influenza treatment
368180|NCT02014649|pediatric|pediatric
368181|NCT02014649|laninamivir|laninamivir
368182|NCT02014636|Pazopanib (GW786034)|pazopanib (gw786034)
368183|NCT02014636|MK 3475|mk 3475
368184|NCT02014636|Renal cell carcinoma|renal cell carcinoma
368185|NCT02014623|Allergic rhinitis|allergic rhinitis
368186|NCT02014623|Asthma|asthma
368187|NCT02014623|Regulatory T cells|regulatory t cells
368188|NCT02014623|IgE|ige
368189|NCT02014623|IgG4|igg4
368190|NCT02014610|Neutrophil|neutrophil
368191|NCT02014610|Lymphocyte|lymphocyte
368192|NCT02014610|Eosinophil|eosinophil
368193|NCT02014610|Leukocyte count|leukocyte count
368194|NCT02014610|Cardiovascular disease|cardiovascular disease
368195|NCT02014610|Atherosclerosis|atherosclerosis
368196|NCT02014610|Monocyte|monocyte
368197|NCT02014610|Basophil|basophil
368198|NCT02014597|Glaucoma|glaucoma
368199|NCT02014584|quality of life|quality of life
368200|NCT02014584|safety|safety
368201|NCT02014584|sexual function|sexual function
368202|NCT02014584|male pattern hair loss (MPHL)|male pattern hair loss (mphl)
368203|NCT02014584|Androgenic alopecia (AGA)|androgenic alopecia (aga)
368204|NCT02014584|dutasteride|dutasteride
368205|NCT02014584|satisfaction with hair growth|satisfaction with hair growth
368206|NCT02014571|NS5B|ns5b
368207|NCT02014571|chronic hepatitis C (CHC)|chronic hepatitis c (chc)
368208|NCT02014571|antiviral activity|antiviral activity
368209|NCT02014571|pharmacokinetics (PK)|pharmacokinetics (pk)
368210|NCT02014571|Safety|safety
368211|NCT02014571|hepatitis C virus (HCV)|hepatitis c virus (hcv)
368212|NCT02014571|GSK2878175|gsk2878175
368213|NCT02014558|Acute Myeloid Leukemia|acute myeloid leukemia
368214|NCT02014558|Gilteritinib|gilteritinib
368215|NCT02014558|ASP2215|asp2215
368216|NCT02014545|brain metastases|brain metastases
368217|NCT02014545|non-small cell lung cancer|non-small cell lung cancer
368218|NCT02014545|whole brain radiation therapy|whole brain radiation therapy
368219|NCT02014545|lucanthone|lucanthone
368220|NCT02014532|Leukotriene receptor antagonist|leukotriene receptor antagonist
368221|NCT02014532|Chronic periodontitis|chronic periodontitis
368222|NCT02014532|Scaling and root planing|scaling and root planing
368223|NCT02014532|C- reactive protein|c- reactive protein
368224|NCT02014519|Adults|adults
368225|NCT02014519|Hungary|hungary
368226|NCT02014519|Bordetella pertussis|bordetella pertussis
368227|NCT02014519|Seroprevalence|seroprevalence
368228|NCT02014519|Pertussis antibodies|pertussis antibodies
368229|NCT02014506|Children and adolescents|children and adolescents
368230|NCT02014506|Malignant disease|malignant disease
368231|NCT02014506|Non-malignant disease|non-malignant disease
368232|NCT02014506|TCRαβ depletion|tcrαβ depletion
368233|NCT02014506|Haploidentical hematopoietic stem cell transplantation|haploidentical hematopoietic stem cell transplantation
368234|NCT02014493|Respiration|respiration
368235|NCT02014493|Noninvasive Ventilation|noninvasive ventilation
368236|NCT02014493|Work of breathing|work of breathing
368237|NCT02014493|Infant, premature|infant, premature
368238|NCT02014493|Electromyography|electromyography
368239|NCT02014493|Diaphragm|diaphragm
368240|NCT02014480|Long-acting beta-agonist|long-acting beta-agonist
368241|NCT02014480|Chronic Obstructive Pulmonary Disease|chronic obstructive pulmonary disease
368242|NCT02014480|Umeclidinium|umeclidinium
368243|NCT02014480|Long-acting muscarinic antagonist|long-acting muscarinic antagonist
368244|NCT02014480|Vilanterol|vilanterol
368245|NCT02014454|Retinopathy of prematurity|retinopathy of prematurity
368246|NCT02014454|Propranolol|propranolol
368247|NCT02014454|Eye drops|eye drops
368248|NCT02014454|Newborns|newborns
368249|NCT02014454|Retinal angiogenesis|retinal angiogenesis
368250|NCT02014454|Retinal neovascularization|retinal neovascularization
368251|NCT02014415|Alpha-1|alpha-1
368252|NCT02014415|AAT Deficiency|aat deficiency
368253|NCT02014415|AATD|aatd
368254|NCT02014415|Liver|liver
368255|NCT02014415|Fibrosis|fibrosis
368256|NCT02014415|Liver Transplant|liver transplant
368257|NCT02014415|Cirrhosis|cirrhosis
368258|NCT02014402|Vascular surgery|vascular surgery
368259|NCT02014402|Hepatic surgery|hepatic surgery
368260|NCT02014402|Soft tissue surgery|soft tissue surgery
368261|NCT02014402|Spinal surgery|spinal surgery
368262|NCT02014389|Retinal Dystrophies|retinal dystrophies
368263|NCT02014389|Retinitis Pigmentosa|retinitis pigmentosa
368264|NCT02014389|Glaucoma|glaucoma
368265|NCT02014389|Visual Field|visual field
368266|NCT02014376|Epidermolysis Bullosa|epidermolysis bullosa
368267|NCT02014376|Simplex|simplex
368268|NCT02014376|Recessive Dystrophic|recessive dystrophic
368269|NCT02014376|Junctional non-Herlitz|junctional non-herlitz
368270|NCT02014337|Mifepristone|mifepristone
368271|NCT02014337|Eribulin Mesylate|eribulin mesylate
368272|NCT02014337|Breast Cancer|breast cancer
368273|NCT02014337|Ovarian Cancer|ovarian cancer
368274|NCT02014337|Sarcoma|sarcoma
368275|NCT02014337|Non-small cell lung cancer|non-small cell lung cancer
368276|NCT02014337|Carcinoma, transitional cell|carcinoma, transitional cell
368277|NCT02014337|Prostate cancer|prostate cancer
368278|NCT02014337|Prostatic neoplasms|prostatic neoplasms
368279|NCT02014311|Multidetector Computed Tomography|multidetector computed tomography
368280|NCT02014311|Myocardial Perfusion Imaging|myocardial perfusion imaging
368281|NCT02014311|Coronary Stenosis|coronary stenosis
368282|NCT02014311|Coronary Artery Disease|coronary artery disease
368283|NCT02014311|Angina Pectoris|angina pectoris
368284|NCT02014298|Burns|burns
368285|NCT02014298|Non-ablative fractional laser|non-ablative fractional laser
368286|NCT02014298|scar texture|scar texture
368287|NCT02014298|histology|histology
368288|NCT02014298|laser treatment|laser treatment
368289|NCT02014298|erbium:glass laser|erbium:glass laser
368290|NCT02014298|meshed skin-grafts|meshed skin-grafts
368291|NCT02014298|photothermolysis|photothermolysis
368292|NCT02014298|skin|skin
368293|NCT02014285|Acute Respiratory Failure|acute respiratory failure
368294|NCT02014285|Critical Illness|critical illness
368295|NCT02014285|Mechanical Ventilation|mechanical ventilation
368297|NCT02014285|Muscle Ultrasound|muscle ultrasound
368298|NCT02014272|Bioequivalence|bioequivalence
368299|NCT02014272|RIN 150|rin 150
368300|NCT02014272|Healthy volunteers|healthy volunteers
368301|NCT02014246|Movement Disorders|movement disorders
368302|NCT02014246|Polymorphisms|polymorphisms
368304|NCT02014246|Lymphoblast Cell Lines|lymphoblast cell lines
368305|NCT02014233|Randomized clinical trial|randomized clinical trial
368306|NCT02014233|Humans|humans
368307|NCT02014233|Omega-3 fatty acids|omega-3 fatty acids
368308|NCT02014233|Essential fatty acid|essential fatty acid
368309|NCT02014233|Neuromuscular function|neuromuscular function
368310|NCT02014233|Wingate|wingate
368311|NCT02014233|Maximum voluntary contraction|maximum voluntary contraction
368312|NCT02014233|Electromyography|electromyography
368313|NCT02014233|Seal oil|seal oil
368314|NCT02014233|Cycling time trial|cycling time trial
368315|NCT02014233|Placebo controlled|placebo controlled
368316|NCT02014194|Attentional Bias|attentional bias
368317|NCT02014194|Attentional Bias modification treatment|attentional bias modification treatment
368318|NCT02014181|cystic fibrosis|cystic fibrosis
368319|NCT02014181|isoprostanes|isoprostanes
368320|NCT02014181|8-oxo-dGuo|8-oxo-dguo
368321|NCT02014181|oxidative stress|oxidative stress
368322|NCT02014181|inflammation|inflammation
368323|NCT02014181|flaxseed|flaxseed
368324|NCT02014181|enterodiol|enterodiol
368325|NCT02014181|enterolactone|enterolactone
368613|NCT02012699|Plasma Cell Dyscrasia|plasma cell dyscrasia
368326|NCT02014155|Chronic Obstructive Pulmonary Disease,|chronic obstructive pulmonary disease,
368327|NCT02014103|bioequivalence|bioequivalence
368328|NCT02014103|tacrolimus|tacrolimus
368329|NCT02014103|transplant|transplant
368330|NCT02014103|CYP3A5 expressors/non expressors|cyp3a5 expressors/non expressors
368331|NCT02014090|ECP|ecp
368332|NCT02014090|Endurance exercise|endurance exercise
368333|NCT02014090|myocardial perfusion|myocardial perfusion
368334|NCT02014077|VATS( Video-Assisted Thoracoscopy )|vats( video-assisted thoracoscopy )
368335|NCT02014077|Thoracostomy Tube|thoracostomy tube
368336|NCT02014077|Empyema|empyema
368337|NCT02014077|Thoracotomy|thoracotomy
368338|NCT02014064|Methamphetamine, Atomoxetine, Clinical Pharmacology|methamphetamine, atomoxetine, clinical pharmacology
368339|NCT02014038|Ultrarunners|ultrarunners
368340|NCT02014038|ultramarathon runners|ultramarathon runners
368341|NCT02014038|ULTRA|ultra
368342|NCT02014038|Physical activity|physical activity
368343|NCT02014038|Health Risks|health risks
368344|NCT02014038|sedentary|sedentary
368345|NCT02014038|moderately active|moderately active
368346|NCT02014025|Laparoscope hepatectomy|laparoscope hepatectomy
368347|NCT02014025|Open hepatectomy|open hepatectomy
368348|NCT02014025|large PHC|large phc
368349|NCT02014025|safety and sensibility|safety and sensibility
368350|NCT02013986|salivary cortisol|salivary cortisol
368351|NCT02013986|circadian rhythm|circadian rhythm
368352|NCT02013986|children|children
368353|NCT02013986|etomidate|etomidate
368354|NCT02013973|Anti mullerian hormone|anti mullerian hormone
368355|NCT02013973|In vitro fertilization|in vitro fertilization
368356|NCT02013973|Optimal treatment|optimal treatment
368357|NCT02013973|Randomized controlled trial|randomized controlled trial
368358|NCT02013947|Exercise, moderate altitude, hypoxia, metabolic syndrome|exercise, moderate altitude, hypoxia, metabolic syndrome
368359|NCT02013921|Physical activity|physical activity
368360|NCT02013921|Cancer|cancer
368361|NCT02013908|acupuncture|acupuncture
368362|NCT02013908|emergency department|emergency department
368363|NCT02013908|acute pain|acute pain
368364|NCT02013908|ankle sprain|ankle sprain
368365|NCT02013908|neck pain|neck pain
368366|NCT02013908|primary headache|primary headache
368367|NCT02013895|liver|liver
368368|NCT02013895|surgery|surgery
368369|NCT02013895|liver function|liver function
368370|NCT02013895|GSA|gsa
368371|NCT02013895|ICG|icg
368372|NCT02013882|low flow anesthesia|low flow anesthesia
368373|NCT02013882|wash-in|wash-in
368374|NCT02013882|desflurane|desflurane
368375|NCT02013869|fresh gas flow|fresh gas flow
368376|NCT02013869|quality of anaesthesia|quality of anaesthesia
368377|NCT02013869|minimal alveolar concentration|minimal alveolar concentration
368378|NCT02013856|Blood pressure|blood pressure
368379|NCT02013856|Flavanols|flavanols
368380|NCT02013856|Cardiovascular disease|cardiovascular disease
368381|NCT02013843|Pediatric obesity|pediatric obesity
368382|NCT02013843|Community-based treatment|community-based treatment
368383|NCT02013843|dyslipidemia|dyslipidemia
368384|NCT02013843|hypertension|hypertension
368385|NCT02013843|diabetes|diabetes
368386|NCT02013778|outside of transplant criteria|outside of transplant criteria
368387|NCT02013752|Delivery tears|delivery tears
368388|NCT02013752|Birth injuries|birth injuries
368389|NCT02013752|Perineal protection device|perineal protection device
368390|NCT02013713|Cardiology|cardiology
368391|NCT02013713|Family Hypercholesterolemia|family hypercholesterolemia
368392|NCT02013700|IPF|ipf
368393|NCT02013700|Pulmonary fibrosis|pulmonary fibrosis
368394|NCT02013674|Cardiovascular, Chronic Ischemic Left Ventricular Dysfunction|cardiovascular, chronic ischemic left ventricular dysfunction
368395|NCT02013661|periodontal debridement|periodontal debridement
368396|NCT02013661|sutures|sutures
368397|NCT02013661|tissue reaction|tissue reaction
368398|NCT02013648|AML|aml
368399|NCT02013648|Dasatinib|dasatinib
368400|NCT02013648|Core Binding Factor (CBF)|core binding factor (cbf)
368401|NCT02013635|cerebral venous thrombosis|cerebral venous thrombosis
368402|NCT02013635|thrombin generation|thrombin generation
368403|NCT02013635|d-dimers|d-dimers
368404|NCT02013635|clinical evolution|clinical evolution
368405|NCT02013622|schizophrenia|schizophrenia
368406|NCT02013622|Mental Disorders|mental disorders
368407|NCT02013622|Psychotic Disorders|psychotic disorders
368408|NCT02013622|social avoidance|social avoidance
368409|NCT02013622|emotional withdrawal|emotional withdrawal
368410|NCT02013622|passive/apathetic|passive/apathetic
368411|NCT02013622|social withdrawal|social withdrawal
368412|NCT02013622|antipsychotic|antipsychotic
368413|NCT02013609|schizophrenia|schizophrenia
368414|NCT02013609|Major depressive disorder|major depressive disorder
368415|NCT02013609|Anxiety Symptoms|anxiety symptoms
368416|NCT02013609|School, Work environment|school, work environment
368417|NCT02013609|Mental Disorders|mental disorders
368418|NCT02013609|Psychotic Disorders|psychotic disorders
368419|NCT02013609|antipsychotic|antipsychotic
368420|NCT02013596|hepatic dysfunction|hepatic dysfunction
368421|NCT02013596|renal dysfunction|renal dysfunction
368422|NCT02013596|pneumoperitoneum|pneumoperitoneum
368423|NCT02013596|Transcutaneous electric stimulation|transcutaneous electric stimulation
368424|NCT02013583|Glucose Transporter Type I Deficiency|glucose transporter type i deficiency
368425|NCT02013583|Glucose Transporter Type 1 Deficiency|glucose transporter type 1 deficiency
368426|NCT02013583|G1D|g1d
368427|NCT02013583|Glut1 Deficiency|glut1 deficiency
368428|NCT02013570|postoperative pain; dexmedetomidine; adenotonsillectomy|postoperative pain; dexmedetomidine; adenotonsillectomy
368429|NCT02013557|Gestational Diabetes|gestational diabetes
368430|NCT02013557|Postpartum screening|postpartum screening
368431|NCT02013557|Text-messages|text-messages
368432|NCT02013557|75-g oral glucose tolerance test|75-g oral glucose tolerance test
368433|NCT02013544|Vulvovaginal atrophy (VVA)|vulvovaginal atrophy (vva)
368434|NCT02013544|Vaginal atrophy|vaginal atrophy
368435|NCT02013544|Atrophic vaginitis|atrophic vaginitis
368436|NCT02013544|prasterone|prasterone
368437|NCT02013544|DHEA|dhea
368438|NCT02013544|Intrarosa|intrarosa
368439|NCT02013531|schizophrenia|schizophrenia
368440|NCT02013531|Major depressive disorder|major depressive disorder
368441|NCT02013531|Anxiety Symptoms|anxiety symptoms
368442|NCT02013531|Mental Disorders|mental disorders
368443|NCT02013531|Psychotic Disorders|psychotic disorders
368444|NCT02013531|emotional withdrawal|emotional withdrawal
368445|NCT02013531|antipsychotic|antipsychotic
368446|NCT02013518|Alzheimers' disease|alzheimers' disease
368447|NCT02013518|Cognitive behavioral therapy|cognitive behavioral therapy
368448|NCT02013518|Depression|depression
368449|NCT02013518|Self-efficacy|self-efficacy
368450|NCT02013518|Quality of Life|quality of life
368451|NCT02013505|Colonoscopy|colonoscopy
368452|NCT02013492|Beta-Blocker|beta-blocker
368453|NCT02013492|metastatic melanoma|metastatic melanoma
368454|NCT02013492|hepatocellular carcinoma|hepatocellular carcinoma
368455|NCT02013466|Bioavailability|bioavailability
368456|NCT02013466|Amino Acids|amino acids
368457|NCT02013466|Elderly|elderly
368458|NCT02013466|Supplement|supplement
368459|NCT02013427|chronic|chronic
368460|NCT02013427|back|back
368461|NCT02013427|pain|pain
368462|NCT02013427|brain|brain
368463|NCT02013427|MRI|mri
368464|NCT02013401|mother-infant dyadic regulation|mother-infant dyadic regulation
368465|NCT02013401|stress|stress
368466|NCT02013401|psychophysiology|psychophysiology
368467|NCT02013401|emotion regulation|emotion regulation
368468|NCT02013388|N91115|n91115
368469|NCT02013388|GSNORi|gsnori
368470|NCT02013388|SNO|sno
368471|NCT02013388|Cavosonstat|cavosonstat
368472|NCT02013336|pediatric|pediatric
368473|NCT02013336|MM-398|mm-398
368474|NCT02013336|cyclophosphamide|cyclophosphamide
368475|NCT02013336|irinotecan|irinotecan
368476|NCT02013323|Septiline, chronic periodontitis, Immunomodulator, microbiology|septiline, chronic periodontitis, immunomodulator, microbiology
368477|NCT02013297|Pediatrics|pediatrics
368478|NCT02013297|SBRT|sbrt
368479|NCT02013297|Brain metastasis|brain metastasis
368480|NCT02013297|Pulmonary metastasis|pulmonary metastasis
368481|NCT02013297|Spinal metastasis|spinal metastasis
368482|NCT02013297|Pulmonary primary tumor|pulmonary primary tumor
368483|NCT02013297|Spinal primary tumor|spinal primary tumor
368484|NCT02013297|Relapsed ependymoma|relapsed ependymoma
368485|NCT02013297|Relapsed irradiated tumors|relapsed irradiated tumors
368486|NCT02013297|Local control rate|local control rate
368487|NCT02013297|Safety|safety
368488|NCT02013297|Overall survival|overall survival
368489|NCT02013297|Progression Free Survival|progression free survival
368490|NCT02013258|Prader Willi syndrome|prader willi syndrome
368491|NCT02013258|Oxytocin|oxytocin
368492|NCT02013232|Risperidone;|risperidone;
368493|NCT02013232|Aripiprazole;|aripiprazole;
368494|NCT02013232|Hyperprolactinemia;|hyperprolactinemia;
368495|NCT02013232|dose effects|dose effects
368496|NCT02013193|drug-coated balloon|drug-coated balloon
368497|NCT02013193|drug-eluting balloon|drug-eluting balloon
368498|NCT02013193|peripheral artery disease|peripheral artery disease
368499|NCT02013193|claudication|claudication
368500|NCT02013180|Prostate cancer, PSA, zinc, zinc/PSA|prostate cancer, psa, zinc, zinc/psa
368501|NCT02013167|Relapsed; Refractory; B-precursor; Acute Lymphoblastic Leukemia; Philadelphia Negative; ALL; Blinatumomab; Leukemia; Standard of Care; SOC|relapsed; refractory; b-precursor; acute lymphoblastic leukemia; philadelphia negative; all; blinatumomab; leukemia; standard of care; soc
368502|NCT02013141|Gram positive bacteria|gram positive bacteria
368503|NCT02013141|Telavancin|telavancin
368504|NCT02013141|VIBATIV|vibativ
368505|NCT02013141|Pediatric|pediatric
368506|NCT02013141|Pharmacokinetics|pharmacokinetics
368507|NCT02013115|infant|infant
368508|NCT02013115|respiratory distress syndrome|respiratory distress syndrome
400544|NCT01866345|Tooth Movement|tooth movement
368509|NCT02013089|genomic sequencing, Integrated genomic network analysis|genomic sequencing, integrated genomic network analysis
368510|NCT02013076|Asthma; Children; Cohort study; Corticosteroids|asthma; children; cohort study; corticosteroids
368511|NCT02013063|Single Pulmonary Nodule|single pulmonary nodule
368512|NCT02013063|SPN|spn
368513|NCT02013063|Lung cancer|lung cancer
368514|NCT02013063|Diagnostic|diagnostic
368515|NCT02013063|Computed Tomography|computed tomography
368516|NCT02013063|CT scan|ct scan
368517|NCT02013063|FDG-PET scan|fdg-pet scan
368518|NCT02013063|Dynamic CT scan|dynamic ct scan
368519|NCT02013063|DCE-CT scan|dce-ct scan
368520|NCT02013063|Dynamic contrast enhanced CT scan|dynamic contrast enhanced ct scan
368521|NCT02013063|soft tissue solitary dominant|soft tissue solitary dominant
368522|NCT02013063|≥ 8mm and ≤30mm|≥ 8mm and ≤30mm
368523|NCT02013037|cardiac transplantation|cardiac transplantation
368524|NCT02013037|immunosuppression|immunosuppression
368525|NCT02013037|acute cellular rejection|acute cellular rejection
368526|NCT02013037|antibody mediated rejection|antibody mediated rejection
368527|NCT02013037|sensitization|sensitization
368528|NCT02013037|antibody production in cardiac patients|antibody production in cardiac patients
368529|NCT02013037|panel reactive antibodies|panel reactive antibodies
368530|NCT02013037|desensitization strategies in heart transplant patients|desensitization strategies in heart transplant patients
368531|NCT02013037|complement activation|complement activation
368532|NCT02013037|complement c3d and c4d deposition|complement c3d and c4d deposition
368533|NCT02013037|terminal complement inhibition|terminal complement inhibition
368534|NCT02013037|complement C5 binding|complement c5 binding
368535|NCT02013037|Eculizumab|eculizumab
368536|NCT02013037|monoclonal antibody|monoclonal antibody
368537|NCT02013037|donor specific antibodies|donor specific antibodies
368538|NCT02012985|hyperoxaluria|hyperoxaluria
368539|NCT02012985|oxalate|oxalate
368540|NCT02012985|PH|ph
368541|NCT02012972|Antiretroviral therapy|antiretroviral therapy
368542|NCT02012972|HIV/AIDS|hiv/aids
368543|NCT02012972|Non-communicable diseases|non-communicable diseases
368544|NCT02012972|South Africa|south africa
368545|NCT02012959|Hyponatremia|hyponatremia
368546|NCT02012959|Euvolemic|euvolemic
368547|NCT02012959|Hypervolemic|hypervolemic
368548|NCT02012959|Serum sodium|serum sodium
368549|NCT02012959|Dilutional hyponatremia|dilutional hyponatremia
368550|NCT02012959|Electrolyte abnormality|electrolyte abnormality
368551|NCT02012959|Electrolyte imbalance|electrolyte imbalance
368552|NCT02012959|Metabolic disease|metabolic disease
368553|NCT02012933|3,4DAP, LEMS, CM|3,4dap, lems, cm
368554|NCT02012920|castration-resistant prostate cancer|castration-resistant prostate cancer
368555|NCT02012920|CYP17|cyp17
368556|NCT02012920|P450c17a|p450c17a
368557|NCT02012920|lyase|lyase
368558|NCT02012920|Prostate Cancer|prostate cancer
368559|NCT02012894|Obesity|obesity
368560|NCT02012894|Gastroesophageal reflux|gastroesophageal reflux
368561|NCT02012894|sleeve gastrectomy|sleeve gastrectomy
368562|NCT02012894|pH-monitoring|ph-monitoring
368563|NCT02012894|manometry|manometry
368564|NCT02012868|obstructive sleep apnoea|obstructive sleep apnoea
368565|NCT02012868|weight loss|weight loss
368566|NCT02012868|bariatric surgery|bariatric surgery
368567|NCT02012842|Metabolic Syndrome|metabolic syndrome
368568|NCT02012842|Periodontal Disease|periodontal disease
368569|NCT02012842|Periodontal therapy|periodontal therapy
368570|NCT02012842|inflammatory markers|inflammatory markers
368571|NCT02012842|C reactive protein|c reactive protein
368572|NCT02012842|serum fibrinogen|serum fibrinogen
368573|NCT02012842|glycated hemoglobin|glycated hemoglobin
368574|NCT02012829|cancer, CRC screening, communication|cancer, crc screening, communication
368575|NCT02012816|Uncircumcised men|uncircumcised men
368576|NCT02012816|Voluntary Medical Male circumcision|voluntary medical male circumcision
368577|NCT02012816|Peer-referral incentive|peer-referral incentive
368578|NCT02012803|Achilles tendon rupture|achilles tendon rupture
368579|NCT02012803|treatment, elongation|treatment, elongation
368580|NCT02012803|operative treatment of achilles tendon rupture|operative treatment of achilles tendon rupture
368581|NCT02012803|conservative treatment of achilles tendon rupture|conservative treatment of achilles tendon rupture
368582|NCT02012790|Migraine disorders|migraine disorders
368583|NCT02012777|sickle cell disease|sickle cell disease
368584|NCT02012777|propanolol|propanolol
368585|NCT02012777|red blood cell adhesion|red blood cell adhesion
368586|NCT02012764|Anti-CCP antibody|anti-ccp antibody
368587|NCT02012764|Inflammatory arthritis|inflammatory arthritis
368588|NCT02012764|Rheumatoid arthritis|rheumatoid arthritis
368589|NCT02012764|Musculoskeletal symptom|musculoskeletal symptom
368590|NCT02012751|Computer-assisted diagnosis|computer-assisted diagnosis
368591|NCT02012751|General practice|general practice
368592|NCT02012751|Dermatoscopy|dermatoscopy
368593|NCT02012751|Melanoma|melanoma
368594|NCT02012751|Nevus|nevus
368595|NCT02012725|Healthy|healthy
368596|NCT02012725|Myocardial fibrosis|myocardial fibrosis
368597|NCT02012725|Chronic kidney disease|chronic kidney disease
368598|NCT02012712|Personal health record|personal health record
368599|NCT02012712|medication management|medication management
368600|NCT02012712|patient safety|patient safety
368601|NCT02012699|Pancreatic Cancer|pancreatic cancer
368602|NCT02012699|Thyroid Cancer|thyroid cancer
368603|NCT02012699|Esophageal cancer|esophageal cancer
368604|NCT02012699|Thymus cancer|thymus cancer
368605|NCT02012699|Pancreatic tumor|pancreatic tumor
368606|NCT02012699|Esophageal tumor|esophageal tumor
368607|NCT02012699|Thymus tumor|thymus tumor
368608|NCT02012699|Thyroid Tumor|thyroid tumor
368609|NCT02012699|Thyroid Nodule|thyroid nodule
368610|NCT02012699|Lung Tumor|lung tumor
368611|NCT02012699|Breast Cancer|breast cancer
368612|NCT02012699|Neuroendocrine tumor|neuroendocrine tumor
369998|NCT02006771|Meal|meal
368614|NCT02012699|Healthy Control|healthy control
368615|NCT02012686|transcutaneous electric nerve stimulation|transcutaneous electric nerve stimulation
368616|NCT02012686|thyroidectomy|thyroidectomy
368617|NCT02012686|neck pain|neck pain
368618|NCT02012686|pain management|pain management
368619|NCT02012673|COPD|copd
368620|NCT02012673|Emphysema|emphysema
368621|NCT02012673|Bronchoscopy|bronchoscopy
368622|NCT02012673|Lung Volume Reduction|lung volume reduction
368623|NCT02012647|parkinson|parkinson
368624|NCT02012647|PD|pd
368625|NCT02012647|parkinson disease|parkinson disease
368626|NCT02012647|parkinson's|parkinson's
368627|NCT02012647|parkinson's disease|parkinson's disease
368628|NCT02012647|parkinsons|parkinsons
368629|NCT02012647|parkinsons disease|parkinsons disease
368630|NCT02012647|TMS|tms
368631|NCT02012647|DBS|dbs
368632|NCT02012647|transcranial magnetic stimulation|transcranial magnetic stimulation
368633|NCT02012647|deep brain stimulation|deep brain stimulation
368634|NCT02012634|Breast Cancer|breast cancer
368635|NCT02012634|Capecitabine|capecitabine
368636|NCT02012634|Triple Negative Breast CancerTNBC（TNBC）|triple negative breast cancertnbc（tnbc）
368637|NCT02012621|HIV/AIDS|hiv/aids
368638|NCT02012621|Adherence|adherence
368639|NCT02012621|Tenofovir|tenofovir
368640|NCT02012621|Dried Blood Spots|dried blood spots
368641|NCT02012608|breast|breast
368642|NCT02012569|skin grafting|skin grafting
368643|NCT02012569|elective treatment|elective treatment
368644|NCT02012543|constipation, agar|constipation, agar
368645|NCT02012530|Articular cartilage|articular cartilage
368646|NCT02012530|Hyaluronic Acid (HA)|hyaluronic acid (ha)
368647|NCT02012530|Platelet rich plasma (PRP)|platelet rich plasma (prp)
368648|NCT02012517|surgical site infection|surgical site infection
368649|NCT02012517|breast reconstruction|breast reconstruction
368650|NCT02012517|drains|drains
368651|NCT02012517|prophylaxis|prophylaxis
368652|NCT02012491|Spontaneous abortion|spontaneous abortion
368653|NCT02012491|Early Pregnancy Failure|early pregnancy failure
368654|NCT02012491|Mifepristone|mifepristone
368655|NCT02012491|Misoprostol|misoprostol
368656|NCT02012465|Steroid induced hyperglycemia|steroid induced hyperglycemia
368657|NCT02012465|Glucocorticoid induced hyperglycemia|glucocorticoid induced hyperglycemia
368658|NCT02012452|posttraumatic stress disorder|posttraumatic stress disorder
368659|NCT02012452|tobacco dependence|tobacco dependence
368660|NCT02012452|cognitive behavioral therapy|cognitive behavioral therapy
368661|NCT02012439|multiple sclerosis|multiple sclerosis
368662|NCT02012439|chronic pain|chronic pain
368663|NCT02012439|treatment|treatment
368664|NCT02012439|nonpharmacological|nonpharmacological
368665|NCT02012439|mindfulness|mindfulness
368666|NCT02012439|cognitive therapy|cognitive therapy
368667|NCT02012413|knee|knee
368668|NCT02012413|chondromalacia|chondromalacia
368669|NCT02012413|patella|patella
368670|NCT02012413|pulsed signal therapy|pulsed signal therapy
368672|NCT02012400|Asthma|asthma
368673|NCT02012400|Exercise|exercise
368674|NCT02012400|Asthma control|asthma control
368675|NCT02012400|Physical fitness|physical fitness
368676|NCT02012400|Quality of life|quality of life
368677|NCT02012387|Cholinergic urticaria|cholinergic urticaria
368678|NCT02012387|Omalizumab|omalizumab
368679|NCT02012374|aphasia|aphasia
368680|NCT02012374|anomia|anomia
368681|NCT02012374|speech therapy|speech therapy
368682|NCT02012374|rehabilitation|rehabilitation
368683|NCT02012374|neuroplasticity|neuroplasticity
368684|NCT02012374|fMRI|fmri
368685|NCT02012374|quality of life|quality of life
368686|NCT02012361|Ischemic preconditioning|ischemic preconditioning
368687|NCT02012361|Human limb ischemia|human limb ischemia
368688|NCT02012361|Total knee arthroplasty|total knee arthroplasty
368689|NCT02012361|Supplemental inspired helium|supplemental inspired helium
368690|NCT02012348|bacteria survival, surfactants|bacteria survival, surfactants
368691|NCT02012322|Aging|aging
368692|NCT02012322|Coenzyme Q10|coenzyme q10
368693|NCT02012322|Q10|q10
368694|NCT02012322|Quality of Life|quality of life
368695|NCT02012322|Oxidative Stress|oxidative stress
368696|NCT02012322|Mitochondrial Function|mitochondrial function
368697|NCT02012322|Cell Energetics|cell energetics
368698|NCT02012322|Fatigue|fatigue
368699|NCT02012322|Ubiquinone|ubiquinone
368700|NCT02012309|HIV|hiv
368701|NCT02012309|Streptococcus pneumoniae infection|streptococcus pneumoniae infection
368702|NCT02012309|Streptococcus pneumoniae colonization|streptococcus pneumoniae colonization
368703|NCT02012309|Pneumococcal vaccines|pneumococcal vaccines
368704|NCT02012309|Prevnar|prevnar
368705|NCT02012309|Pneumovax|pneumovax
368706|NCT02012309|Nasopharyngeal microbiome|nasopharyngeal microbiome
368707|NCT02012283|spices and vegetables|spices and vegetables
368708|NCT02012270|Aortic Aneurysm|aortic aneurysm
368709|NCT02012270|Hernia|hernia
368710|NCT02012270|Abdominal Wound Closure Techniques|abdominal wound closure techniques
368711|NCT02012257|anterior middle superior alveolar nerve|anterior middle superior alveolar nerve
368712|NCT02012257|electric pulp tester|electric pulp tester
368713|NCT02012257|local anesthesia|local anesthesia
368810|NCT02011789|inflammation|inflammation
370496|NCT02004379|Hepatitis C|hepatitis c
368714|NCT02012244|analgesia; colorectal surgery; immunity; local anesthetics; opioids|analgesia; colorectal surgery; immunity; local anesthetics; opioids
368715|NCT02012231|melanoma|melanoma
368716|NCT02012231|anaplastic thyroid cancer|anaplastic thyroid cancer
368717|NCT02012231|advanced papillary thyroid cancer|advanced papillary thyroid cancer
368718|NCT02012231|colorectal cancer|colorectal cancer
368719|NCT02012231|non-small cell lung cancer|non-small cell lung cancer
368720|NCT02012231|cholangiocarcinoma|cholangiocarcinoma
368721|NCT02012231|histiocytosis|histiocytosis
368722|NCT02012231|hairy cell leukemia|hairy cell leukemia
368723|NCT02012218|Major Depressive Disorder, Depression|major depressive disorder, depression
368724|NCT02012205|wet cupping - back pain - NSLBP - Saudi|wet cupping - back pain - nslbp - saudi
368725|NCT02012192|High-grade serous|high-grade serous
368726|NCT02012192|high-grade endometrioid|high-grade endometrioid
368727|NCT02012192|undifferentiated|undifferentiated
368728|NCT02012179|Diet|diet
368729|NCT02012179|Dietary sodium reduction|dietary sodium reduction
368730|NCT02012179|Salt restriction|salt restriction
368731|NCT02012179|Nutrition|nutrition
368732|NCT02012166|Diabetes Mellitus|diabetes mellitus
368733|NCT02012166|Diabetes Mellitus, Type 2|diabetes mellitus, type 2
368734|NCT02012166|Glucose Metabolism Disorders|glucose metabolism disorders
368735|NCT02012166|Metabolic Diseases|metabolic diseases
368736|NCT02012166|Endocrine System Diseases|endocrine system diseases
368737|NCT02012166|Therapeutic Uses|therapeutic uses
368738|NCT02012166|Pharmacologic Actions|pharmacologic actions
368739|NCT02012166|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action
368740|NCT02012166|Physiological Effects of Drugs|physiological effects of drugs
368741|NCT02012153|Mesenchymal stromal cells|mesenchymal stromal cells
368742|NCT02012153|Kidney transplantation|kidney transplantation
368743|NCT02012153|Tolerance|tolerance
368744|NCT02012114|Cystinosis, compliance, cysteamine, neurological assessments|cystinosis, compliance, cysteamine, neurological assessments
368745|NCT02012101|COPD|copd
368746|NCT02012101|dyspnea|dyspnea
368747|NCT02012101|exercise|exercise
368748|NCT02012101|Noninvasive Ventilation|noninvasive ventilation
368749|NCT02012088|Follicular lymphoma, large B-cell lymphoma|follicular lymphoma, large b-cell lymphoma
368750|NCT02012062|Nasopharyngeal carcinoma|nasopharyngeal carcinoma
368751|NCT02012062|Neoadjuvant chemotherapy|neoadjuvant chemotherapy
368752|NCT02012062|Concurrent chemotherapy|concurrent chemotherapy
368753|NCT02012062|Nimotuzumab|nimotuzumab
368754|NCT02012049|Healthy|healthy
368755|NCT02012049|Risperdal OD|risperdal od
368756|NCT02012049|Risperdal Quicklet|risperdal quicklet
368757|NCT02012049|Korea|korea
368758|NCT02012023|Low anterior resection|low anterior resection
368759|NCT02012023|Anastomotic leakage|anastomotic leakage
368760|NCT02012023|Defunctioning stoma|defunctioning stoma
368761|NCT02012023|Controllable tube ileostomy|controllable tube ileostomy
368762|NCT02012023|Loop ileostomy|loop ileostomy
368763|NCT02012010|hysteroscopy, water intoxication, hyponatremia|hysteroscopy, water intoxication, hyponatremia
368764|NCT02011971|epilepsy|epilepsy
368765|NCT02011971|cognition|cognition
368766|NCT02011971|memory|memory
368767|NCT02011958|Visceral Leishmaniasis|visceral leishmaniasis
368768|NCT02011958|HIV positive patients|hiv positive patients
368769|NCT02011958|Phase III trial|phase iii trial
368770|NCT02011958|Randomised|randomised
368771|NCT02011958|Liposomal amphotericin B|liposomal amphotericin b
368772|NCT02011958|Ambisome|ambisome
368773|NCT02011958|Miltefosine|miltefosine
368774|NCT02011958|Pentamidine|pentamidine
368775|NCT02011958|Efficacy|efficacy
368776|NCT02011958|Safety|safety
368777|NCT02011906|antioxidant enzymes|antioxidant enzymes
368778|NCT02011906|omega 3|omega 3
368779|NCT02011906|vitamin E|vitamin e
368780|NCT02011906|CAD|cad
368781|NCT02011906|Sirtuins|sirtuins
368782|NCT02011906|FOXOs|foxos
368783|NCT02011880|breast cancer|breast cancer
368784|NCT02011880|bone metastasis|bone metastasis
368785|NCT02011880|traditional Chinese medicine(TCM)|traditional chinese medicine(tcm)
368786|NCT02011867|Inner Ear Malformations|inner ear malformations
368787|NCT02011867|Gusher|gusher
368788|NCT02011867|Cochlear Implantation|cochlear implantation
368789|NCT02011854|acupuncture，rehabilitation,Shoulder-hand Syndrome|acupuncture，rehabilitation,shoulder-hand syndrome
368790|NCT02011841|liver cirrhosis|liver cirrhosis
471558|NCT01549548|CML|cml
368791|NCT02011841|ascites|ascites
368792|NCT02011841|spontaneous bacterial peritonitis|spontaneous bacterial peritonitis
368793|NCT02011841|recurrence|recurrence
368794|NCT02011828|Hemodialysis, paricalcitol|hemodialysis, paricalcitol
368795|NCT02011815|Breast neoplasms|breast neoplasms
368796|NCT02011815|Circadian rhythm|circadian rhythm
368797|NCT02011815|sleep|sleep
368798|NCT02011815|survival|survival
368799|NCT02011815|distress|distress
368800|NCT02011815|anxiety|anxiety
368801|NCT02011815|depression|depression
368802|NCT02011815|quality of life|quality of life
368803|NCT02011815|actigraph|actigraph
368804|NCT02011815|fatigue|fatigue
368805|NCT02011802|Sorbact TM|sorbact tm
368806|NCT02011802|Alginates|alginates
368807|NCT02011802|Dressing|dressing
368808|NCT02011802|Wound healing|wound healing
368809|NCT02011789|hypercholesterolemia|hypercholesterolemia
368811|NCT02011789|citrus limonoids|citrus limonoids
368812|NCT02011776|Corticosteroids Dry Eye Sjögren syndrome inflammation treatment|corticosteroids dry eye sjögren syndrome inflammation treatment
368813|NCT02011763|Hepatitis A|hepatitis a
368814|NCT02011763|hepatitis A virus|hepatitis a virus
368815|NCT02011763|Avaxim® 80U Pediatric|avaxim® 80u pediatric
368816|NCT02011750|schizophrenia|schizophrenia
368817|NCT02011750|toxoplasmosis|toxoplasmosis
368818|NCT02011737|Medical Expulsive therapy|medical expulsive therapy
368819|NCT02011698|Groin hernia|groin hernia
368820|NCT02011698|lichtenstein herniorrhaphy|lichtenstein herniorrhaphy
368821|NCT02011672|dairy|dairy
368822|NCT02011672|glucose|glucose
368823|NCT02011672|inflammation|inflammation
368824|NCT02011659|Ramosetron, postoperative nausea and vomiting, laparoscopy|ramosetron, postoperative nausea and vomiting, laparoscopy
368825|NCT02011646|diet|diet
368826|NCT02011646|body weight|body weight
368827|NCT02011646|eating|eating
368828|NCT02011646|eating disorder|eating disorder
368829|NCT02011646|exercise|exercise
368830|NCT02011581|Overweight|overweight
368831|NCT02011568|Therapeutic Hypothermia|therapeutic hypothermia
368832|NCT02011568|Out of hospital cardiac arrest|out of hospital cardiac arrest
368833|NCT02011568|Mild hypothermia|mild hypothermia
368834|NCT02011568|Moderate hypothermia|moderate hypothermia
368835|NCT02011542|Irritable Bowel Syndrome|irritable bowel syndrome
368836|NCT02011542|Gulf War Illness|gulf war illness
368837|NCT02011516|Marijuana|marijuana
368838|NCT02011516|Addiction|addiction
368839|NCT02011516|fMRI|fmri
368840|NCT02011516|Baclofen|baclofen
368841|NCT02011516|Treatment|treatment
368842|NCT02011477|Neural mobilization|neural mobilization
368843|NCT02011477|Physical therapy|physical therapy
368844|NCT02011477|Asymptomatic subjects|asymptomatic subjects
368845|NCT02011451|Multiple Sclerosis|multiple sclerosis
368846|NCT02011451|Green Tea|green tea
368847|NCT02011451|ECGC|ecgc
368848|NCT02011451|Theaphenon|theaphenon
368849|NCT02011451|Randomized placebo controlled trial|randomized placebo controlled trial
368850|NCT02011451|NAA|naa
368851|NCT02011451|Spectroscopy|spectroscopy
368852|NCT02011451|Brain Atrophy|brain atrophy
368853|NCT02011451|SIENA|siena
368854|NCT02011438|Social Anxiety|social anxiety
368855|NCT02011438|Prevention|prevention
368856|NCT02011438|Peer Relations|peer relations
368857|NCT02011438|Depression|depression
368858|NCT02011438|Adolescent|adolescent
368859|NCT02011438|High School|high school
368860|NCT02011438|Interpersonal|interpersonal
368861|NCT02011438|Peer Victimization|peer victimization
368862|NCT02011425|obstructive sleep apnea|obstructive sleep apnea
368863|NCT02011425|oral appliance|oral appliance
368864|NCT02011425|therapy|therapy
368865|NCT02011425|masseter muscle activity|masseter muscle activity
368866|NCT02011425|randomized controlled trial|randomized controlled trial
368867|NCT02011425|mandibular advancement device|mandibular advancement device
368868|NCT02011425|mandibular advancement appliance|mandibular advancement appliance
368869|NCT02011425|arousals|arousals
368870|NCT02011412|Trauma|trauma
368871|NCT02011412|Scoring Systems|scoring systems
368872|NCT02011412|Intermountain Risk Score|intermountain risk score
368873|NCT02011399|brain|brain
368874|NCT02011399|computer|computer
368875|NCT02011399|interfaces|interfaces
368876|NCT02011399|mobility impairments|mobility impairments
368877|NCT02011373|prolapse, laparoscopic sacrocolpopexy, IFABONDTM glue|prolapse, laparoscopic sacrocolpopexy, ifabondtm glue
368878|NCT02011360|Prader Willi syndrome|prader willi syndrome
368879|NCT02011360|childhood obesity|childhood obesity
368880|NCT02011360|ghrelin|ghrelin
368881|NCT02011360|appetite regulation|appetite regulation
368882|NCT02011321|subarachnoid hemorrhage|subarachnoid hemorrhage
368883|NCT02011321|aneurysm|aneurysm
368884|NCT02011321|vasospasm|vasospasm
368885|NCT02011321|clevidipine|clevidipine
368886|NCT02011321|transcranial dopplers|transcranial dopplers
368887|NCT02011295|OLT|olt
368888|NCT02011295|Surgical Intervention|surgical intervention
368889|NCT02011295|BMAC|bmac
368890|NCT02011282|ICU,|icu,
368891|NCT02011282|MYOPATHY,|myopathy,
368892|NCT02011282|NEUROPATHY,|neuropathy,
368893|NCT02011282|PNEUMONIA|pneumonia
368894|NCT02011269|TSO|tso
368895|NCT02011269|Ova|ova
368896|NCT02011269|Psoriasis|psoriasis
368897|NCT02011269|plaque psoriasis|plaque psoriasis
368898|NCT02011269|plaque-type|plaque-type
368899|NCT02011269|Coronado|coronado
368900|NCT02011269|Moderate to severe plaque psoriasis|moderate to severe plaque psoriasis
368901|NCT02011256|Transient Ischemic Attack|transient ischemic attack
368902|NCT02011256|Atrial Fibrillation|atrial fibrillation
368903|NCT02011256|NOTICE|notice
368904|NCT02011256|Implantable loop-recorder|implantable loop-recorder
368905|NCT02011256|Holter-monitoring|holter-monitoring
368906|NCT02011243|deficit|deficit
368907|NCT02011243|internal rotation|internal rotation
368908|NCT02011243|gleno humeral articulation|gleno humeral articulation
368909|NCT02011243|hand ball|hand ball
368910|NCT02011230|Dehydration|dehydration
368911|NCT02011230|Hoist|hoist
368912|NCT02011230|pain control|pain control
368913|NCT02011230|The intervention is to provide a commercially available isotonic hydration solution (Hoist®) to the patients.|the intervention is to provide a commercially available isotonic hydration solution (hoist®) to the patients.
369040|NCT02010671|Survey|survey
368914|NCT02011230|Patients will drink this solution post procedure as needed.|patients will drink this solution post procedure as needed.
368915|NCT02011230|Patients in the control group will use their discretion to drink any solution they feel suitable|patients in the control group will use their discretion to drink any solution they feel suitable
368916|NCT02011217|Rye|rye
368917|NCT02011217|Dietary Fibre|dietary fibre
368918|NCT02011217|Bread|bread
368919|NCT02011217|Crisp bread|crisp bread
368920|NCT02011217|Appetite|appetite
368921|NCT02011217|Satiety|satiety
368922|NCT02011217|Hunger|hunger
368923|NCT02011217|Desire to eat|desire to eat
368924|NCT02011217|Metabolism|metabolism
368925|NCT02011217|Glucose|glucose
368926|NCT02011217|Insulin|insulin
368927|NCT02011217|Gut hormones|gut hormones
368928|NCT02011217|Gastric emptying rate|gastric emptying rate
368929|NCT02011191|Biotin|biotin
368930|NCT02011191|Restless|restless
368931|NCT02011191|Kidney|kidney
368932|NCT02011191|Dialysis|dialysis
368933|NCT02011191|Renal|renal
368934|NCT02011165|Macular hole|macular hole
368935|NCT02011165|Vitrectomy|vitrectomy
368936|NCT02011165|Gas tamponade|gas tamponade
368937|NCT02011165|Vitreomacular traction in danger of macular hole formation|vitreomacular traction in danger of macular hole formation
368938|NCT02011165|Epiretinal membrane in danger of macular hole formation|epiretinal membrane in danger of macular hole formation
368939|NCT02011113|Pomalidomide,|pomalidomide,
368940|NCT02011113|CC-4047,|cc-4047,
368941|NCT02011113|Dexamethasone,|dexamethasone,
368942|NCT02011113|Relapsed and refractory multiple myeloma,|relapsed and refractory multiple myeloma,
368943|NCT02011113|phase 2|phase 2
368944|NCT02011061|Multidetector Computed Tomography|multidetector computed tomography
368945|NCT02011061|Coronary Stenosis|coronary stenosis
368946|NCT02011061|Coronary Artery Disease|coronary artery disease
368947|NCT02011061|Angina Pectoris|angina pectoris
368948|NCT02011035|Oral health|oral health
368949|NCT02011035|Mouth health|mouth health
368950|NCT02011035|Halitosis|halitosis
368951|NCT02011035|Oral bacteria|oral bacteria
368952|NCT02011035|Sore throat|sore throat
368953|NCT02011035|Colds|colds
368954|NCT02011022|Methotrexate,|methotrexate,
368955|NCT02011022|Pharmacokinetic|pharmacokinetic
368956|NCT02011022|Acute lymphoblastic leukemia|acute lymphoblastic leukemia
368957|NCT02011022|Model|model
368958|NCT02010970|phase I|phase i
368959|NCT02010970|healthy volunteers|healthy volunteers
368960|NCT02010970|AZD3293|azd3293
368961|NCT02010970|itraconazole|itraconazole
368962|NCT02010970|diltiazem|diltiazem
368963|NCT02010970|medazolam|medazolam
368964|NCT02010970|drug interactions|drug interactions
368965|NCT02010970|Pharmacokinetics|pharmacokinetics
368966|NCT02010957|123I Iodometomidate imaging|123i iodometomidate imaging
368967|NCT02010957|18F FDG positron emission tomography|18f fdg positron emission tomography
368968|NCT02010957|Adrenal tumour|adrenal tumour
368969|NCT02010944|Solifenacin|solifenacin
368970|NCT02010944|Mirabegron|mirabegron
368971|NCT02010944|Fixed-dose combination (FDC)|fixed-dose combination (fdc)
368972|NCT02010944|Single Entity Tablet (SET)|single entity tablet (set)
368973|NCT02010944|Pharmacokinetics|pharmacokinetics
368974|NCT02010944|Bioavailability|bioavailability
368975|NCT02010918|Knee Osteoarthritis;|knee osteoarthritis;
368976|NCT02010918|Glucosamine;|glucosamine;
368977|NCT02010918|Chondroitin.|chondroitin.
368978|NCT02010905|Losartan|losartan
368979|NCT02010879|patent ductus arterioses|patent ductus arterioses
368980|NCT02010879|ductal closure|ductal closure
368981|NCT02010879|thrombocyte|thrombocyte
368982|NCT02010866|internship and residency|internship and residency
368983|NCT02010866|physicians|physicians
368984|NCT02010866|prevention|prevention
368985|NCT02010866|counseling|counseling
368986|NCT02010866|suicide|suicide
368987|NCT02010866|depression|depression
368988|NCT02010866|burnout|burnout
782031|NCT00321997|AMD|amd
471806|NCT01548495|MDS|mds
368989|NCT02010853|Transient Global amnesia|transient global amnesia
368990|NCT02010853|fMRI|fmri
368991|NCT02010853|resting state|resting state
368992|NCT02010840|Depressive symptoms, marital relationship, quality of life|depressive symptoms, marital relationship, quality of life
368993|NCT02010827|Diabetes mellitus|diabetes mellitus
368994|NCT02010827|Glucagon|glucagon
368995|NCT02010827|Endogenous glucose production|endogenous glucose production
368996|NCT02010827|Incretin hormones|incretin hormones
368997|NCT02010814|PCOS|pcos
368998|NCT02010814|Inflammation|inflammation
368999|NCT02010814|Body Composition|body composition
369000|NCT02010801|hepatocellular carcinoma|hepatocellular carcinoma
369001|NCT02010801|irreversible electroporation|irreversible electroporation
369002|NCT02010801|liver cancer|liver cancer
369003|NCT02010762|Crohn's disease|crohn's disease
369004|NCT02010762|Vitamin D|vitamin d
369005|NCT02010762|Postoperative|postoperative
369006|NCT02010762|Recurrence|recurrence
369007|NCT02010762|Inflammatory bowel disease|inflammatory bowel disease
369008|NCT02010762|Gastroenteritis|gastroenteritis
369009|NCT02010762|Gastrointestinal Diseases|gastrointestinal diseases
369010|NCT02010762|Digestive System Diseases|digestive system diseases
369011|NCT02010762|Colonic Diseases|colonic diseases
369012|NCT02010762|Intestinal Diseases|intestinal diseases
369013|NCT02010762|Pathologic Processes|pathologic processes
369014|NCT02010736|Cerebral palsy|cerebral palsy
369015|NCT02010736|Gait|gait
369016|NCT02010736|Weight Bearing|weight bearing
369017|NCT02010736|Rehabilitation|rehabilitation
369018|NCT02010723|varicosis|varicosis
369019|NCT02010723|foam sclerotherapy|foam sclerotherapy
369020|NCT02010723|surgery|surgery
369021|NCT02010710|continuous electronic fetal monitoring|continuous electronic fetal monitoring
369022|NCT02010710|labour|labour
369023|NCT02010710|pregnancy|pregnancy
369024|NCT02010710|fetal distress|fetal distress
369025|NCT02010697|smoking cessation|smoking cessation
369026|NCT02010697|nonsmokers|nonsmokers
369027|NCT02010697|proxy|proxy
369028|NCT02010697|mail intervention|mail intervention
369029|NCT02010697|self-help|self-help
369030|NCT02010697|behavioral intervention|behavioral intervention
369031|NCT02010684|Diabetes|diabetes
369032|NCT02010684|Depression|depression
369033|NCT02010684|Self care|self care
369034|NCT02010684|Empowerment|empowerment
369035|NCT02010684|Behavioral intervention|behavioral intervention
369036|NCT02010684|Cognitive behavioral therapy|cognitive behavioral therapy
369037|NCT02010684|Diabetes Mellitus, Type 2|diabetes mellitus, type 2
369038|NCT02010671|Pregnancy|pregnancy
369039|NCT02010671|Cesarean Section|cesarean section
369041|NCT02010671|Delivery|delivery
369042|NCT02010645|Leukemia|leukemia
369043|NCT02010645|Advanced Myelodysplastic Syndrome|advanced myelodysplastic syndrome
369044|NCT02010645|MDS|mds
369045|NCT02010645|Intermediate-2 Myelodysplastic Syndrome|intermediate-2 myelodysplastic syndrome
369046|NCT02010645|High-Risk Myelodysplastic Syndrome|high-risk myelodysplastic syndrome
369047|NCT02010645|Chronic myelomonocytic leukemia|chronic myelomonocytic leukemia
369048|NCT02010645|CMML|cmml
369049|NCT02010645|Eltrombopag|eltrombopag
369050|NCT02010645|Promacta|promacta
369051|NCT02010645|Decitabine|decitabine
369052|NCT02010645|Dacogen|dacogen
369053|NCT02010632|Clopidogrel|clopidogrel
369054|NCT02010632|Platelet inhibition|platelet inhibition
369055|NCT02010632|Platelet aggregation|platelet aggregation
369056|NCT02010606|Newly diagnosed glioblastoma|newly diagnosed glioblastoma
369057|NCT02010606|Recurrent glioblastoma|recurrent glioblastoma
369058|NCT02010606|Dendritic cell vaccine|dendritic cell vaccine
369059|NCT02010606|Immunotherapy|immunotherapy
369060|NCT02010606|Cancer stem cells|cancer stem cells
369061|NCT02010606|Glioma stem cells|glioma stem cells
369062|NCT02010606|Glioma stem-like cells|glioma stem-like cells
369063|NCT02010606|Cancer stem-like cells|cancer stem-like cells
369064|NCT02010606|Neurosphere|neurosphere
369065|NCT02010606|Therapeutic Uses|therapeutic uses
369066|NCT02010606|Antineoplastic Agents|antineoplastic agents
369067|NCT02010606|Neoplasms|neoplasms
369068|NCT02010606|Immunologic Factors|immunologic factors
369069|NCT02010606|Interferon Inducers|interferon inducers
369070|NCT02010606|Physiological Effects of Drugs|physiological effects of drugs
369071|NCT02010606|Pharmacologic Actions|pharmacologic actions
369072|NCT02010567|rectal cancer|rectal cancer
369073|NCT02010567|colorectal cancer|colorectal cancer
369074|NCT02010567|locally advanced rectal cancer|locally advanced rectal cancer
369075|NCT02010567|locally advanced rectal cancer (resectable)|locally advanced rectal cancer (resectable)
369076|NCT02010567|locally advanced rectal cancer (non-resectable)|locally advanced rectal cancer (non-resectable)
369077|NCT02010567|chemoradiotherapy|chemoradiotherapy
369078|NCT02010567|nanopharmaceutical|nanopharmaceutical
369079|NCT02010567|CLRX101|clrx101
369080|NCT02010567|camptothecin|camptothecin
369081|NCT02010567|capecitabine|capecitabine
369082|NCT02010554|Multiple Sclerosis|multiple sclerosis
369083|NCT02010554|Disease modifying medication|disease modifying medication
369084|NCT02010554|Relapsing-Remitting MS|relapsing-remitting ms
369085|NCT02010554|Motivational Interviewing|motivational interviewing
369086|NCT02010554|Telephone Counseling|telephone counseling
369087|NCT02010541|type 1 diabetes among young children, sensor, insulin pump, education, psychological support|type 1 diabetes among young children, sensor, insulin pump, education, psychological support
369088|NCT02010528|Diabetes related distress, children, T1D, family hardiness, psychological well-being|diabetes related distress, children, t1d, family hardiness, psychological well-being
369089|NCT02010515|sudden cardiac death|sudden cardiac death
369090|NCT02010515|risk stratification|risk stratification
369091|NCT02010515|t-wave alternans|t-wave alternans
369092|NCT02010515|Holter electrocardiography|holter electrocardiography
369093|NCT02010515|heart rate turbulence|heart rate turbulence
369094|NCT02010502|Beet root|beet root
369095|NCT02010502|exercise performance|exercise performance
369096|NCT02010502|cyclists|cyclists
369097|NCT02010489|Bariatric Surgery|bariatric surgery
369098|NCT02010489|Exercise|exercise
369099|NCT02010489|Physical Fitness|physical fitness
369100|NCT02010476|Alzheimer's disease, CSF biomarkers, Insulin resistance|alzheimer's disease, csf biomarkers, insulin resistance
369101|NCT02010463|reward processing|reward processing
369298|NCT02009709|ectasia|ectasia
369102|NCT02010463|impulse control|impulse control
369103|NCT02010463|obese|obese
369104|NCT02010463|clinically obese|clinically obese
369105|NCT02010450|Sudden Infant Death Syndrome|sudden infant death syndrome
369106|NCT02010450|SIDS|sids
369107|NCT02010450|safe sleep|safe sleep
369108|NCT02010450|safe sleep message|safe sleep message
369109|NCT02010437|Superficial Venous Insufficiency|superficial venous insufficiency
369110|NCT02010424|reduced fertility|reduced fertility
369111|NCT02010398|Resistance training/methods|resistance training/methods
369112|NCT02010398|contralateral strength training|contralateral strength training
369113|NCT02010398|ipsilateral strength training|ipsilateral strength training
369114|NCT02010398|Isokinetic contraction|isokinetic contraction
369115|NCT02010398|Adaptation, Physiological/physiology|adaptation, physiological/physiology
369116|NCT02010398|Electromyography/methods|electromyography/methods
369117|NCT02010398|Transcranial Magnetic Stimulation/methods|transcranial magnetic stimulation/methods
369118|NCT02010398|Evoked Potentials, Motor|evoked potentials, motor
369119|NCT02010385|RYGB|rygb
369120|NCT02010385|Bariatric surgery|bariatric surgery
369121|NCT02010385|Taste|taste
369122|NCT02010385|Reward|reward
369123|NCT02010385|Food behaviour|food behaviour
369124|NCT02010385|Gut hormones|gut hormones
369125|NCT02010372|Immunization Registry|immunization registry
369126|NCT02010372|Human Papillomavirus|human papillomavirus
369127|NCT02010346|Early orthodontic treatment|early orthodontic treatment
369128|NCT02010346|Class II treatment|class ii treatment
369129|NCT02010346|Orthodontic treatment outcome|orthodontic treatment outcome
369130|NCT02010320|population model|population model
369131|NCT02010320|pharmacokinetic|pharmacokinetic
369132|NCT02010320|tacrolimus|tacrolimus
369133|NCT02010320|therapeutic drug monitoring|therapeutic drug monitoring
369134|NCT02010320|individualized dosing|individualized dosing
369135|NCT02010294|Invasive GAS infection|invasive gas infection
369136|NCT02010294|emm genotypes|emm genotypes
369137|NCT02010294|Bacterial virulence factors|bacterial virulence factors
369138|NCT02010294|Mendelian susceptibility to infections|mendelian susceptibility to infections
369139|NCT02010281|rTMS|rtms
369140|NCT02010281|peripheral neuropathic pain|peripheral neuropathic pain
369141|NCT02010281|randomized controlled trial|randomized controlled trial
369142|NCT02010268|Faecal calprotectin|faecal calprotectin
369143|NCT02010268|Feces|feces
369144|NCT02010268|Preterm neonates|preterm neonates
369145|NCT02010268|Enterocolitis|enterocolitis
369146|NCT02010268|Enteropathy|enteropathy
369147|NCT02010268|Necrotizing|necrotizing
369148|NCT02010242|Type 2 diabetes|type 2 diabetes
369149|NCT02010242|Proteinuria|proteinuria
369150|NCT02010242|Albuminuria|albuminuria
369151|NCT02010229|Placenta accreta|placenta accreta
369152|NCT02010229|previous caesarean|previous caesarean
369153|NCT02010229|placenta praevia|placenta praevia
369154|NCT02010229|severe obstetric haemorrhage|severe obstetric haemorrhage
369155|NCT02010229|population-based study|population-based study
369156|NCT02010203|TURBT|turbt
369157|NCT02010203|Bladder|bladder
369158|NCT02010203|Cancer|cancer
369159|NCT02010203|GP96|gp96
369160|NCT02010203|Vaccine|vaccine
369161|NCT02010203|Immunotherapy|immunotherapy
369162|NCT02010203|Heat Biologics|heat biologics
369164|NCT02010203|Bacillus Calmette-Guerin|bacillus calmette-guerin
369165|NCT02010203|Bacillus Calmette-Guérin|bacillus calmette-guérin
369166|NCT02010190|Pediatric malignancies|pediatric malignancies
369167|NCT02010190|Cancer survivors|cancer survivors
369168|NCT02010190|Coronary artery risk|coronary artery risk
369169|NCT02010190|Vascular function|vascular function
369170|NCT02010190|Cardiovascular risk in survivors of pediatric cancer|cardiovascular risk in survivors of pediatric cancer
369171|NCT02010164|Reproductive aging|reproductive aging
369172|NCT02010164|Mitochondria|mitochondria
782328|NCT00320931|Stress test|stress test
369173|NCT02010151|Out of Hospital Cardiac Arrest|out of hospital cardiac arrest
369174|NCT02010151|Cardiopulmonary Resuscitation|cardiopulmonary resuscitation
369175|NCT02010151|dispatch|dispatch
369176|NCT02010151|emergency medicine|emergency medicine
369177|NCT02010138|Internal Limiting Membrane|internal limiting membrane
369178|NCT02010138|Metamorphopsia|metamorphopsia
369179|NCT02010125|Anterior Cruciate Ligament (ACL)|anterior cruciate ligament (acl)
369180|NCT02010125|Magnetic Resonance Imaging (MRI)|magnetic resonance imaging (mri)
369181|NCT02010125|Osteoarthritis (OA)|osteoarthritis (oa)
369182|NCT02010125|Bio-specimens|bio-specimens
369183|NCT02010125|Acute ACL Injury|acute acl injury
369184|NCT02010125|Arthritis Foundation (AF)|arthritis foundation (af)
369185|NCT02010112|H.Pylori|h.pylori
369186|NCT02010086|Intervention|intervention
369187|NCT02010086|Autism|autism
369188|NCT02010086|Treatment sensitivity|treatment sensitivity
369189|NCT02010086|School aged|school aged
369190|NCT02010086|Cognitive behavioral therapy|cognitive behavioral therapy
369191|NCT02010086|Social Skills Intervention|social skills intervention
369192|NCT02010073|Lung|lung
369193|NCT02010073|ARDS|ards
369194|NCT02010073|acute|acute
369195|NCT02010073|respiratory|respiratory
369196|NCT02010073|syndrome|syndrome
369197|NCT02010073|prognosis|prognosis
369198|NCT02010073|outcome research|outcome research
369199|NCT02010073|respiratory infection|respiratory infection
369200|NCT02010073|sepsis|sepsis
369201|NCT02010073|organ failure|organ failure
369202|NCT02010073|hypoxaemia|hypoxaemia
369203|NCT02010060|Exercise training|exercise training
369204|NCT02010060|Non-exercise physical activity|non-exercise physical activity
369205|NCT02010060|pedometers|pedometers
369206|NCT02010047|Anaplastic lymphoma kinase gene|anaplastic lymphoma kinase gene
369207|NCT02010047|Polymerase chain reaction|polymerase chain reaction
369208|NCT02010047|Immunohistochemistry|immunohistochemistry
369209|NCT02010047|Fluorescence in situ hybridization|fluorescence in situ hybridization
369210|NCT02010034|TPN|tpn
369211|NCT02010034|Liver Function|liver function
369212|NCT02010034|parenteral nutritional fat emulsions|parenteral nutritional fat emulsions
369213|NCT02010021|breast cancer|breast cancer
369214|NCT02010021|postmenopausal|postmenopausal
369215|NCT02010021|letrozole|letrozole
369216|NCT02010021|RAD001|rad001
369217|NCT02010021|Everolimus|everolimus
369218|NCT02010008|breast cancer|breast cancer
369219|NCT02010008|cancer disparities|cancer disparities
369220|NCT02010008|Latino women|latino women
369221|NCT02010008|Hispanic women|hispanic women
369222|NCT02010008|mammography|mammography
369223|NCT02010008|multi-level intervention|multi-level intervention
369224|NCT02009995|Diabetes Mellitus|diabetes mellitus
369225|NCT02009995|Type 2 Diabetes Mellitus|type 2 diabetes mellitus
369226|NCT02009995|Resistance Training|resistance training
369227|NCT02009995|Resistance Exercise|resistance exercise
369228|NCT02009995|Resistance Band|resistance band
369229|NCT02009995|Thera-band|thera-band
369230|NCT02009995|elastic band|elastic band
369231|NCT02009995|exercise band|exercise band
369232|NCT02009982|Fainting|fainting
369233|NCT02009982|Ablation|ablation
369234|NCT02009982|Cardiology|cardiology
369235|NCT02009982|Cardiac Electrophysiology|cardiac electrophysiology
369236|NCT02009969|Psychosis|psychosis
369237|NCT02009969|Adverse effects|adverse effects
369238|NCT02009969|Symptom Severity|symptom severity
369239|NCT02009969|Magnetic Resonance Imaging|magnetic resonance imaging
369240|NCT02009943|critical illness|critical illness
369241|NCT02009943|iron supplementation|iron supplementation
369242|NCT02009943|functional iron deficiency|functional iron deficiency
369243|NCT02009943|ICU anemia|icu anemia
369244|NCT02009943|red blood cell transfusion|red blood cell transfusion
369245|NCT02009930|Enlisted military members|enlisted military members
369246|NCT02009930|CAC|cac
369247|NCT02009930|Coronary Artery Calcium|coronary artery calcium
369248|NCT02009930|Cardiovascular|cardiovascular
369249|NCT02009917|Indicator Amino Acid Oxidation|indicator amino acid oxidation
369250|NCT02009917|Non essential Amino acids|non essential amino acids
369251|NCT02009917|Protein|protein
369252|NCT02009917|Amino acid|amino acid
369253|NCT02009904|PKU|pku
369254|NCT02009904|Phenylketonuria|phenylketonuria
369255|NCT02009904|Phenylalanine|phenylalanine
369256|NCT02009904|Children|children
369257|NCT02009904|Stable isotopes|stable isotopes
369258|NCT02009904|Sapropterin dihydrochloride responsiveness|sapropterin dihydrochloride responsiveness
369259|NCT02009891|predictive model|predictive model
369260|NCT02009891|in vitro fertilization|in vitro fertilization
369261|NCT02009891|elective single embryo transfer|elective single embryo transfer
369262|NCT02009878|SIADH|siadh
369263|NCT02009865|Hypertriglyceridemia|hypertriglyceridemia
369264|NCT02009865|Dyslipidemia|dyslipidemia
369265|NCT02009865|Eicosapentaenoic acid|eicosapentaenoic acid
369266|NCT02009865|EPA|epa
369267|NCT02009865|Docosahexaenoic acid|docosahexaenoic acid
369268|NCT02009865|DHA|dha
369269|NCT02009852|microRNA-29b|microrna-29b
400545|NCT01866345|Bone Remodeling|bone remodeling
369270|NCT02009852|Oral squamous cell carcinoma|oral squamous cell carcinoma
369271|NCT02009852|migration|migration
369272|NCT02009852|prognosis|prognosis
369273|NCT02009839|anxiety|anxiety
369274|NCT02009839|frequency of speech|frequency of speech
369275|NCT02009839|selective mutism|selective mutism
369276|NCT02009826|Schizophrenia|schizophrenia
369277|NCT02009826|Psychosis|psychosis
369278|NCT02009826|Neuroinflammation|neuroinflammation
369279|NCT02009826|Microglial activation|microglial activation
369280|NCT02009813|Insulin resistance|insulin resistance
369281|NCT02009813|Inflammation|inflammation
369282|NCT02009813|Hypoxia|hypoxia
369283|NCT02009787|hypercholesterolemia; vitamin D; adjuvant therapy|hypercholesterolemia; vitamin d; adjuvant therapy
369284|NCT02009774|Colonoscopy|colonoscopy
369285|NCT02009774|Adenoma detection rate|adenoma detection rate
369286|NCT02009774|Narrow band imaging|narrow band imaging
369287|NCT02009774|Optical biopsy|optical biopsy
369288|NCT02009774|Accuracy|accuracy
369289|NCT02009735|Enterovirus 71 and Influenza Virus|enterovirus 71 and influenza virus
369290|NCT02009722|Cesarean Delivery|cesarean delivery
369291|NCT02009722|Intrathecal Morphine|intrathecal morphine
369292|NCT02009722|Intrathecal Hydromorphone|intrathecal hydromorphone
369293|NCT02009722|Obstetrical Analgesia|obstetrical analgesia
369294|NCT02009722|Spinal Anesthesia|spinal anesthesia
369295|NCT02009709|keratoconus|keratoconus
369296|NCT02009709|collagen crosslinking|collagen crosslinking
369297|NCT02009709|crosslinking|crosslinking
369299|NCT02009644|Abdominal Aortic Aneurysm|abdominal aortic aneurysm
369300|NCT02009644|AAA|aaa
369301|NCT02009644|Aneurysm|aneurysm
369302|NCT02009631|Solid Tumors|solid tumors
369303|NCT02009631|Ovarian Cancer|ovarian cancer
369304|NCT02009631|Colon Cancer|colon cancer
369305|NCT02009631|Lung Cancer|lung cancer
369306|NCT02009631|Breast Cancer|breast cancer
369307|NCT02009631|Gastric Cancer|gastric cancer
369308|NCT02009618|IBS|ibs
369309|NCT02009618|Rifaximin|rifaximin
369310|NCT02009605|icotinib, SCC|icotinib, scc
369311|NCT02009592|Hepatosteatosis|hepatosteatosis
369312|NCT02009592|Steatohepatitis|steatohepatitis
369313|NCT02009592|Rifaximin|rifaximin
369314|NCT02009592|Inflammatory cytokines|inflammatory cytokines
369315|NCT02009579|Uterine Cervical Cancer|uterine cervical cancer
369316|NCT02009579|Paclitaxel|paclitaxel
369317|NCT02009579|Carboplatin|carboplatin
369318|NCT02009579|Nintedanib|nintedanib
369319|NCT02009553|Anxiety|anxiety
369320|NCT02009553|Urodynamics|urodynamics
369321|NCT02009514|Hemodialysis|hemodialysis
369322|NCT02009514|Continuous glucose monitoring|continuous glucose monitoring
369323|NCT02009514|Hypoglycemia|hypoglycemia
369324|NCT02009514|Hyperglycemia|hyperglycemia
369325|NCT02009501|Infected wounds|infected wounds
369326|NCT02009501|NPWTi|npwti
369327|NCT02009501|VAC Instill|vac instill
369328|NCT02009501|Biofilm|biofilm
369329|NCT02009488|Diabetes Mellitus, Type 2|diabetes mellitus, type 2
369330|NCT02009488|Metformin|metformin
369331|NCT02009488|Canagliflozin|canagliflozin
369332|NCT02009488|INVOKANA®|invokana®
369333|NCT02009488|Insulin sensitivity|insulin sensitivity
369334|NCT02009488|DPP-4 inhibitor|dpp-4 inhibitor
369335|NCT02009488|dipeptidyl peptidase-4|dipeptidyl peptidase-4
369336|NCT02009475|Rehabilitation|rehabilitation
369337|NCT02009475|Exercise Training|exercise training
369338|NCT02009475|Interval training|interval training
369339|NCT02009462|HIV|hiv
369340|NCT02009462|Facial lipoatrophy|facial lipoatrophy
369341|NCT02009449|Phase 1/Phase 1b|phase 1/phase 1b
369342|NCT02009449|Oncology|oncology
369343|NCT02009449|Cancer|cancer
369344|NCT02009449|Solid Tumors|solid tumors
369345|NCT02009423|Gastro-Intestinal Stromal Tumour|gastro-intestinal stromal tumour
369346|NCT02009423|GIST|gist
369347|NCT02009423|Localized primary tumor|localized primary tumor
369348|NCT02009423|Adjuvant therapy.|adjuvant therapy.
369349|NCT02009410|Exocrine Pancreatic Insufficiency|exocrine pancreatic insufficiency
369350|NCT02009358|mental health promotion|mental health promotion
369351|NCT02009358|depression|depression
369352|NCT02009358|migrant workers|migrant workers
369353|NCT02009358|China|china
369354|NCT02009345|Familial hypercholesterolemia,|familial hypercholesterolemia,
369355|NCT02009345|High LDL-cholesterol|high ldl-cholesterol
369356|NCT02009345|Registry|registry
369357|NCT02009345|Coronary artery disease|coronary artery disease
369358|NCT02009319|endobronchial ultrasound|endobronchial ultrasound
369359|NCT02009319|EBUS - TBNA|ebus - tbna
369360|NCT02009319|elastography|elastography
369361|NCT02009319|strain ratio|strain ratio
369362|NCT02009319|lung cancer staging|lung cancer staging
369363|NCT02009306|Palliative|palliative
369364|NCT02009306|Symptom control|symptom control
369365|NCT02009306|Hospice|hospice
369366|NCT02009306|Opioid|opioid
369367|NCT02009306|Benzodiazepine|benzodiazepine
369368|NCT02009293|idiopathic pulmonary fibrosis|idiopathic pulmonary fibrosis
369369|NCT02009293|cough|cough
369370|NCT02009293|quality of life|quality of life
369371|NCT02009280|Propofol|propofol
369372|NCT02009280|Lung transplantation|lung transplantation
369373|NCT02009280|Extracorporeal membrane oxygenation|extracorporeal membrane oxygenation
369374|NCT02009280|Acute kidney injury|acute kidney injury
369375|NCT02009241|Lymphangioleiomyomatosis|lymphangioleiomyomatosis
369376|NCT02009241|Rehabilitation|rehabilitation
369377|NCT02009241|Exercise|exercise
369378|NCT02009228|Single-port laparoscopy|single-port laparoscopy
369379|NCT02009228|Abdominal pain|abdominal pain
369380|NCT02009228|Ovarian spillage|ovarian spillage
369381|NCT02009228|Endobag rupture|endobag rupture
369382|NCT02009228|Ovarian reserve|ovarian reserve
369383|NCT02009215|Uganda|uganda
369384|NCT02009215|intermittent preventive treatment|intermittent preventive treatment
369385|NCT02009215|dihydroartemisinin-piperaquine|dihydroartemisinin-piperaquine
369386|NCT02009215|schoolchildren|schoolchildren
369387|NCT02009215|malaria|malaria
369388|NCT02009202|Colon preparation|colon preparation
369389|NCT02009202|Child|child
369390|NCT02009189|home parenteral nutrition|home parenteral nutrition
369391|NCT02009189|central venous catheter|central venous catheter
369392|NCT02009176|Hepatocellular Carcinoma|hepatocellular carcinoma
369393|NCT02009176|Laparoscopic|laparoscopic
369394|NCT02009176|Aon-anatomical hepatectomy|aon-anatomical hepatectomy
369395|NCT02009176|Anatomical hepatectomy|anatomical hepatectomy
369396|NCT02009176|Micrometastases|micrometastases
369397|NCT02009137|small breast|small breast
369398|NCT02009137|augmentation|augmentation
369399|NCT02009137|breast volume|breast volume
369400|NCT02009137|External Soft Tissue Expansion System(ESTES)|external soft tissue expansion system(estes)
369401|NCT02009124|spinal cord injury|spinal cord injury
369402|NCT02009124|stem cell therapy|stem cell therapy
369403|NCT02009124|bone marrow|bone marrow
369404|NCT02009124|mononuclear cells|mononuclear cells
369405|NCT02009124|autologous|autologous
369406|NCT02009111|Transition to parenthood|transition to parenthood
369407|NCT02009111|Relationship intervention|relationship intervention
369408|NCT02009098|Randomized Controlled Trial|randomized controlled trial
369409|NCT02009098|Caesarean Section|caesarean section
369410|NCT02009098|preoperative|preoperative
369411|NCT02009098|intraoperative|intraoperative
369412|NCT02009098|prophylactic antibiotics|prophylactic antibiotics
369413|NCT02009098|antibiotics|antibiotics
369414|NCT02009098|timing|timing
369415|NCT02009098|surgical site infections|surgical site infections
369416|NCT02009098|endometritis|endometritis
369417|NCT02009098|wound infections|wound infections
369418|NCT02009098|urinary tract infections|urinary tract infections
369419|NCT02009098|infectious morbidity|infectious morbidity
369420|NCT02009098|neonatal antibiotics exposure|neonatal antibiotics exposure
369421|NCT02009098|Antibiotic Prophylaxis|antibiotic prophylaxis
369422|NCT02009072|Pterygium surgery|pterygium surgery
369423|NCT02009072|Sutureless glue free conjunctival autograft|sutureless glue free conjunctival autograft
369424|NCT02009072|Amniotic membrane graft.|amniotic membrane graft.
369425|NCT02009059|hypothermia|hypothermia
369426|NCT02009059|Temperature|temperature
369427|NCT02009059|epitympanic|epitympanic
369428|NCT02009059|pre-hospital|pre-hospital
369429|NCT02009046|Adolescent|adolescent
369430|NCT02009046|Sex education|sex education
369431|NCT02009046|Sexuality education|sexuality education
369432|NCT02009046|Sexually transmitted diseases|sexually transmitted diseases
369433|NCT02009046|Pregnancy|pregnancy
369434|NCT02009046|Sexual behavior|sexual behavior
369435|NCT02009046|Sexuality|sexuality
369436|NCT02009046|Relationship rights|relationship rights
369437|NCT02009046|Gender norms|gender norms
369438|NCT02009046|Human rights|human rights
369439|NCT02009046|Intervention studies|intervention studies
369440|NCT02009046|Parent intervention|parent intervention
369441|NCT02009046|Peer intervention|peer intervention
369442|NCT02009007|cerebral oximeter|cerebral oximeter
369443|NCT02009007|one lung ventilation|one lung ventilation
369444|NCT02009007|dopamine|dopamine
369445|NCT02009007|phenylephrine|phenylephrine
369446|NCT02008994|metastatic breast cancer|metastatic breast cancer
369447|NCT02008994|breast cancer|breast cancer
369448|NCT02008994|genomics|genomics
369449|NCT02008994|personalized medicine|personalized medicine
369450|NCT02008994|precision oncology|precision oncology
369451|NCT02008994|breast cancer treatment|breast cancer treatment
369452|NCT02008994|metastatic breast cancer treatment|metastatic breast cancer treatment
369453|NCT02008994|genetic testing and breast cancer treatment|genetic testing and breast cancer treatment
369454|NCT02008994|breast cancer trial|breast cancer trial
369455|NCT02008994|metastatic breast cancer trial|metastatic breast cancer trial
369456|NCT02008955|lysine, elderly, amino acid requirement, diet|lysine, elderly, amino acid requirement, diet
369457|NCT02008929|NKCELL|nkcell
369458|NCT02008916|AIN457, ankylosing spondylitis, chronic inflammatory disease, inflammatory back pain, secukinumab, self-injection|ain457, ankylosing spondylitis, chronic inflammatory disease, inflammatory back pain, secukinumab, self-injection
369459|NCT02008890|palmoplantar, pustular, psoriasis|palmoplantar, pustular, psoriasis
369460|NCT02008877|Malignant Peripheral Nerve Sheath Tumors|malignant peripheral nerve sheath tumors
369461|NCT02008877|MPNST|mpnst
369462|NCT02008877|Sarcoma|sarcoma
369463|NCT02008877|Ganetespib|ganetespib
369464|NCT02008877|Sirolimus|sirolimus
369465|NCT02008877|mTOR inhibitor|mtor inhibitor
369466|NCT02008877|Heat shock protein|heat shock protein
369467|NCT02008877|Hsp90|hsp90
369468|NCT02008864|End stage renal diseases|end stage renal diseases
369469|NCT02008864|Hemodialysis|hemodialysis
369470|NCT02008864|Uremic pruritus|uremic pruritus
369471|NCT02008864|Iranian traditional medicine|iranian traditional medicine
369472|NCT02008864|Cassia angustifolia|cassia angustifolia
369473|NCT02008851|Chronic kidney disease|chronic kidney disease
369474|NCT02008851|Type 2 Diabetes|type 2 diabetes
369475|NCT02008851|Neo-kidney augment|neo-kidney augment
369476|NCT02008851|Regenerative medicine|regenerative medicine
369477|NCT02008825|ViSiGi|visigi
369478|NCT02008825|Calibration tube|calibration tube
369479|NCT02008825|Sleeve gastrectomy|sleeve gastrectomy
369480|NCT02008812|Adenovirus|adenovirus
369481|NCT02008799|Stem cell, infertility, Azoospermia|stem cell, infertility, azoospermia
369482|NCT02008786|Coronary Artery Dissection, Spontaneous|coronary artery dissection, spontaneous
369483|NCT02008786|Angina|angina
369484|NCT02008773|schizophrenia|schizophrenia
369485|NCT02008773|schizoaffective|schizoaffective
369486|NCT02008773|schizophreniform|schizophreniform
369487|NCT02008773|inflammatory markers|inflammatory markers
369488|NCT02008773|HSV1|hsv1
369489|NCT02008773|cognition|cognition
369490|NCT02008773|early psychosis|early psychosis
369491|NCT02008773|valacyclovir|valacyclovir
369492|NCT02008760|pain|pain
369493|NCT02008760|quality of life|quality of life
369494|NCT02008760|ADL|adl
369495|NCT02008760|DOLO test|dolo test
369498|NCT02008747|Atrial fibrillation|atrial fibrillation
369499|NCT02008747|Neuropathic pain|neuropathic pain
369500|NCT02008747|Posterolateral thoracotomy|posterolateral thoracotomy
369501|NCT02008747|Lung resection|lung resection
369502|NCT02008721|Multiple System Atrophy|multiple system atrophy
369503|NCT02008721|epigallocatechin gallate|epigallocatechin gallate
369504|NCT02008708|Health|health
369505|NCT02008708|Microfinance|microfinance
369506|NCT02008695|Health|health
369507|NCT02008695|Youth|youth
369508|NCT02008695|Microfinance|microfinance
369509|NCT02008669|Multiple Sclerosis, Fatigue, Nutritional Status, Disability.|multiple sclerosis, fatigue, nutritional status, disability.
369510|NCT02008656|CAPECITABINE (ORAL)|capecitabine (oral)
369511|NCT02008656|FLUOROURACIL|fluorouracil
369512|NCT02008656|LEUCOVORIN|leucovorin
369513|NCT02008656|OXALIPLATIN|oxaliplatin
369514|NCT02008656|Total mesorectal excision|total mesorectal excision
369515|NCT02008656|Chemoradiation therapy|chemoradiation therapy
369516|NCT02008656|Total neoadjuvant therapy|total neoadjuvant therapy
369517|NCT02008656|13-213|13-213
369518|NCT02008643|Health related quality of life, food allergy, children, chronic diseases|health related quality of life, food allergy, children, chronic diseases
369519|NCT02008617|Anterior cruciate ligament reconstruction|anterior cruciate ligament reconstruction
369520|NCT02008604|ischemia|ischemia
369521|NCT02008604|stroke|stroke
369522|NCT02008604|transient ischemic attack (TIA)|transient ischemic attack (tia)
369523|NCT02008604|microbiome|microbiome
369524|NCT02008604|microbiota|microbiota
369525|NCT02008604|gut|gut
369526|NCT02008591|Neuraxial Technique|neuraxial technique
369527|NCT02008591|Epidural Technique|epidural technique
369528|NCT02008591|Dural Puncture Epidural Technique|dural puncture epidural technique
369529|NCT02008591|Combined Spinal Epidural Technique|combined spinal epidural technique
369530|NCT02008591|Labor Analgesia|labor analgesia
369531|NCT02008591|Obstetric|obstetric
369532|NCT02008578|Antiviral|antiviral
369533|NCT02008578|Adjunctive Therapy|adjunctive therapy
369534|NCT02008578|Antibody|antibody
369535|NCT02008565|Fecal incontinence|fecal incontinence
369536|NCT02008565|Loperamide|loperamide
369537|NCT02008565|anal exercises|anal exercises
369538|NCT02008565|biofeedback|biofeedback
369539|NCT02008552|Genetic factor|genetic factor
369540|NCT02008552|Valvulopathy|valvulopathy
369541|NCT02008552|Mediator|mediator
369542|NCT02008526|Text Messaging|text messaging
369543|NCT02008526|mHealth|mhealth
369544|NCT02008526|Methamphetamine|methamphetamine
369545|NCT02008526|HIV|hiv
369546|NCT02008526|AIDS|aids
369547|NCT02008513|AFFITOPE® AD02|affitope® ad02
369548|NCT02008513|Alzheimer Disease|alzheimer disease
369549|NCT02008513|Dementia|dementia
369550|NCT02008513|Brain Disease|brain disease
369551|NCT02008513|Nervous System Diseases|nervous system diseases
369552|NCT02008513|Tauopathies|tauopathies
369553|NCT02008513|Neurodegenerative Diseases|neurodegenerative diseases
369554|NCT02008513|Mental Disorders|mental disorders
369555|NCT02008500|Dentinal Hypersensitivity|dentinal hypersensitivity
369556|NCT02008500|Gingival Recession|gingival recession
369557|NCT02008500|Visual Analogue Score|visual analogue score
369558|NCT02008487|wound|wound
369559|NCT02008487|palliative care|palliative care
369560|NCT02008487|hospice|hospice
369561|NCT02008487|pressure ulcers|pressure ulcers
369562|NCT02008435|Group-delivered Diabetes Prevention Program|group-delivered diabetes prevention program
369563|NCT02008435|Obesity|obesity
369564|NCT02008435|Overweight|overweight
369565|NCT02008435|Lifestyle change|lifestyle change
369566|NCT02008435|Healthy eating|healthy eating
369567|NCT02008435|Weight loss|weight loss
369568|NCT02008435|Exercise|exercise
369569|NCT02008435|Cognitive-behavioral intervention|cognitive-behavioral intervention
369570|NCT02008435|Implementation intentions|implementation intentions
369571|NCT02008435|Mental imagery|mental imagery
369572|NCT02008435|Mental practice|mental practice
369573|NCT02008435|If-then plans|if-then plans
369574|NCT02008409|Minimally Invasive Surgery|minimally invasive surgery
369575|NCT02008409|EndoLift Liver Retractor|endolift liver retractor
369576|NCT02008396|MDMA|mdma
369577|NCT02008396|autism|autism
369578|NCT02008396|social anxiety|social anxiety
369579|NCT02008383|Colorectal cancer|colorectal cancer
369580|NCT02008383|Panitumumab|panitumumab
369581|NCT02008383|Cabozantinib|cabozantinib
369582|NCT02008370|minimally invasive cardiac surgery|minimally invasive cardiac surgery
369583|NCT02008370|Exparel|exparel
369584|NCT02008357|Cognition|cognition
369585|NCT02008357|Prevention|prevention
369586|NCT02008344|influenza|influenza
369587|NCT02008344|flu|flu
369588|NCT02008344|fever|fever
369589|NCT02008344|cough|cough
369590|NCT02008344|body aches|body aches
369591|NCT02008344|headache|headache
369592|NCT02008344|nasal congestion|nasal congestion
369593|NCT02008344|body pains|body pains
369594|NCT02008344|sore throat|sore throat
369595|NCT02008344|fatigue|fatigue
369596|NCT02008344|T-705|t-705
369597|NCT02008344|favipiravir|favipiravir
369598|NCT02008344|favor|favor
369599|NCT02008344|flu symptoms|flu symptoms
370497|NCT02004379|telaprevir|telaprevir
369600|NCT02008331|chronic kidney disease|chronic kidney disease
369601|NCT02008331|p-cresol|p-cresol
369602|NCT02008331|synbiotic|synbiotic
369603|NCT02008292|smoking|smoking
369604|NCT02008292|schizophrenia|schizophrenia
369605|NCT02008292|acetylcholine|acetylcholine
369606|NCT02008279|Healthy|healthy
369607|NCT02008279|CNTO 3157|cnto 3157
369608|NCT02008279|Pharmacokinetics|pharmacokinetics
369609|NCT02008253|INTRASTROMAL CORNEAL RING|intrastromal corneal ring
369610|NCT02008253|ASTIGMATISM|astigmatism
369611|NCT02008240|Infertility|infertility
369612|NCT02008240|Hydrosalpinx|hydrosalpinx
369613|NCT02008240|IVF-ET|ivf-et
369614|NCT02008240|Salpingectomy|salpingectomy
369615|NCT02008214|Pentoxifylline|pentoxifylline
369616|NCT02008214|Sustained virologic response|sustained virologic response
369617|NCT02008214|Hepatic fibrosis|hepatic fibrosis
369618|NCT02008201|dose-response study|dose-response study
369619|NCT02008188|Type 1 Diabetes Mellitus|type 1 diabetes mellitus
369620|NCT02008188|Artificial Pancreas|artificial pancreas
369621|NCT02008188|Closed Loop Control|closed loop control
369622|NCT02008188|Diabetes Assistant (DiAs)|diabetes assistant (dias)
369623|NCT02008188|Continuous Glucose Monitor (CGM)|continuous glucose monitor (cgm)
369624|NCT02008188|Insulin Pump|insulin pump
369625|NCT02008188|Metabolic Diseases|metabolic diseases
369626|NCT02008188|Endocrine System Diseases|endocrine system diseases
369627|NCT02008188|Autoimmune Diseases|autoimmune diseases
369628|NCT02008175|paediatric, keratoconus, collagen cross linking|paediatric, keratoconus, collagen cross linking
369629|NCT02008162|Emphysema, COPD, bronchoreversibility, ventilatory obstruction, lung volume reduction surgery, LVRS|emphysema, copd, bronchoreversibility, ventilatory obstruction, lung volume reduction surgery, lvrs
369630|NCT02008149|Osteoporosis|osteoporosis
369631|NCT02008136|myofascial pain|myofascial pain
369632|NCT02008136|muscle spasm|muscle spasm
369633|NCT02008136|botulinum toxin|botulinum toxin
369634|NCT02008136|cervicalgia|cervicalgia
369635|NCT02008136|lumbago|lumbago
369636|NCT02008136|low back pain|low back pain
369637|NCT02008123|Clopidogrel|clopidogrel
369638|NCT02008123|Clopidogrel Resistance|clopidogrel resistance
369639|NCT02008123|Primidone|primidone
369640|NCT02008123|Secondary Stroke Prevention|secondary stroke prevention
369641|NCT02008110|Heart failure|heart failure
369642|NCT02008110|Biomarker guided-therapy|biomarker guided-therapy
369643|NCT02008110|Carbohydrate antigen 125|carbohydrate antigen 125
369644|NCT02008110|Clinical outcomes.|clinical outcomes.
369645|NCT02008097|Ultrasound|ultrasound
369646|NCT02008097|Ultrasonography|ultrasonography
369647|NCT02008097|Liver transplantation|liver transplantation
369648|NCT02008097|Arterial Occlusive Diseases|arterial occlusive diseases
369649|NCT02008097|Hypertension|hypertension
369650|NCT02008097|Pregnancy, High Risk|pregnancy, high risk
369651|NCT02008097|Pregnancy|pregnancy
369652|NCT02008084|hypertriglyceridemia|hypertriglyceridemia
369653|NCT02008084|mixed hyperlipidemia|mixed hyperlipidemia
369654|NCT02008058|Metastatic Castrate-Resistant Prostate Cancer|metastatic castrate-resistant prostate cancer
369655|NCT02008058|LCCC 1231|lccc 1231
369656|NCT02008058|Lineberger Comprehensive Cancer Center|lineberger comprehensive cancer center
369657|NCT02008058|UNC Lineberger|unc lineberger
369658|NCT02008058|Prostate Cancer|prostate cancer
369659|NCT02008058|Pain|pain
369660|NCT02008045|MRI|mri
369661|NCT02008045|Imaging|imaging
369662|NCT02008045|Neurocognitive|neurocognitive
369663|NCT02008045|White matter injury|white matter injury
369664|NCT02008032|Mammography|mammography
369665|NCT02008032|Breast|breast
369666|NCT02008032|Implants|implants
369667|NCT02008019|Chondrosarcoma|chondrosarcoma
369668|NCT02008019|Neoadjuvant therapy|neoadjuvant therapy
369669|NCT02008019|Phase II|phase ii
369670|NCT02008019|Everolimus|everolimus
369671|NCT02008019|Success Rate|success rate
369672|NCT02008019|Progression Free Survival|progression free survival
369673|NCT02008019|Overall Survival|overall survival
369674|NCT02008019|Safety|safety
369675|NCT02008019|Quality of Life|quality of life
369676|NCT02008019|Molecular study (ancillary study)|molecular study (ancillary study)
369677|NCT02008006|Follicular Lymphoma|follicular lymphoma
369678|NCT02008006|Chemosensitive relapse|chemosensitive relapse
369679|NCT02008006|High Dose Chemotherapy|high dose chemotherapy
369680|NCT02008006|Bendamustine|bendamustine
369681|NCT02008006|BeEAM|beeam
369682|NCT02008006|Autologous Stem Cell Transplantation|autologous stem cell transplantation
369683|NCT02008006|Safety|safety
369684|NCT02008006|Event Free Survival|event free survival
369685|NCT02008006|Overall Response Rate|overall response rate
369686|NCT02008006|Progression Free Survival|progression free survival
369687|NCT02008006|Overall Survival|overall survival
369688|NCT02008006|Phase II|phase ii
369689|NCT02008006|World Health Organization (WHO) 1 grade|world health organization (who) 1 grade
369690|NCT02008006|WHO 2 grade|who 2 grade
369691|NCT02008006|WHO 3a grade|who 3a grade
369692|NCT02007993|Halitosis,|halitosis,
369693|NCT02007993|Photodynamic Therapy,|photodynamic therapy,
369694|NCT02007993|Adolescent|adolescent
369695|NCT02007980|urological problems|urological problems
369696|NCT02007980|indwelling urologic stent|indwelling urologic stent
369697|NCT02007980|kidney stone disease|kidney stone disease
369698|NCT02007980|urinary system obstruction|urinary system obstruction
369699|NCT02007980|hydronephrosis|hydronephrosis
369700|NCT02007980|ureteral damage|ureteral damage
369701|NCT02007954|HCC|hcc
369702|NCT02007915|Adolescent|adolescent
369703|NCT02007915|Avascular Necrosis|avascular necrosis
369704|NCT02007915|Bisphosphonates|bisphosphonates
369705|NCT02007915|Pamidronate|pamidronate
369706|NCT02007902|Preterm baby|preterm baby
369707|NCT02007902|Total plasma protein|total plasma protein
369708|NCT02007902|Albumin|albumin
369709|NCT02007902|Hemodynamic disturbances|hemodynamic disturbances
369710|NCT02007902|Perfusion|perfusion
369711|NCT02007902|Near Infra Red Spectroscopy (NIRS)|near infra red spectroscopy (nirs)
369712|NCT02007902|Ultrasound|ultrasound
369713|NCT02007876|Mobility|mobility
369714|NCT02007876|Activity|activity
369715|NCT02007876|Training|training
369716|NCT02007876|Abdominal|abdominal
369717|NCT02007876|Surgery|surgery
369718|NCT02007876|Adult|adult
369719|NCT02007863|Leukemia|leukemia
369720|NCT02007863|Myelodysplasia|myelodysplasia
369721|NCT02007863|Acute lymphocytic leukemia|acute lymphocytic leukemia
369722|NCT02007863|ALL|all
369723|NCT02007863|Acute myelogenous leukemia|acute myelogenous leukemia
369724|NCT02007863|AML|aml
369725|NCT02007863|Pediatric|pediatric
369726|NCT02007850|continuous femoral nerve block|continuous femoral nerve block
369727|NCT02007850|knee arthroplasty|knee arthroplasty
369728|NCT02007850|quadriceps muscle strength|quadriceps muscle strength
369729|NCT02007837|pregnancy induced hypertension|pregnancy induced hypertension
369730|NCT02007837|gestational hypertension|gestational hypertension
369731|NCT02007837|pre-eclampsia|pre-eclampsia
369732|NCT02007837|preeclampsia|preeclampsia
369733|NCT02007837|hypertensive disorders in pregnancy|hypertensive disorders in pregnancy
369734|NCT02007824|pressure ulcer|pressure ulcer
369735|NCT02007824|chronic wound|chronic wound
369736|NCT02007824|tissue necrosis|tissue necrosis
369737|NCT02007824|slough|slough
369738|NCT02007824|ultra sound|ultra sound
369739|NCT02007798|dexmedetomidine|dexmedetomidine
369740|NCT02007798|supratentorial tumors|supratentorial tumors
369741|NCT02007785|Cognitive Orientation to daily Occupational Performance|cognitive orientation to daily occupational performance
369742|NCT02007785|CO-OP|co-op
369743|NCT02007772|COPD, nHF, BiPAP|copd, nhf, bipap
369744|NCT02007759|Dysphagia|dysphagia
369745|NCT02007759|neuromuscular electrical stimulation|neuromuscular electrical stimulation
369746|NCT02007759|NMES|nmes
369747|NCT02007759|Neonates|neonates
369748|NCT02007759|Vitalstim|vitalstim
369749|NCT02007746|sickle cell disease|sickle cell disease
369750|NCT02007746|hemochromatosis|hemochromatosis
369751|NCT02007746|liver fibrosis|liver fibrosis
369752|NCT02007746|liver cirrhosis|liver cirrhosis
369753|NCT02007746|FibroScan|fibroscan
369754|NCT02007746|Ferriscan|ferriscan
369755|NCT02007746|liver iron|liver iron
369756|NCT02007733|Diarrhea|diarrhea
369757|NCT02007733|Dehydration|dehydration
369758|NCT02007733|Children|children
369759|NCT02007733|Resuscitation|resuscitation
369760|NCT02007733|Clinical Prediction Rule|clinical prediction rule
369761|NCT02007733|Low Income Country|low income country
369762|NCT02007733|Bangladesh|bangladesh
369763|NCT02007720|Serelaxin,|serelaxin,
369764|NCT02007720|WHF,|whf,
369765|NCT02007720|Likert Scale,|likert scale,
369766|NCT02007720|RELAX-AHF-ASIA,|relax-ahf-asia,
369767|NCT02007720|RLX030,|rlx030,
369768|NCT02007720|AHF,|ahf,
369769|NCT02007720|acute heart failure|acute heart failure
369770|NCT02007707|Asian American|asian american
369771|NCT02007707|Vietnamese American|vietnamese american
369772|NCT02007707|Smoking cessation|smoking cessation
369773|NCT02007707|Community Health Worker|community health worker
369774|NCT02007707|Lay Health Worker Outreach|lay health worker outreach
369775|NCT02007707|Family Intervention|family intervention
369776|NCT02007694|Phobic Disorders (Fear of Flying and acrophobia)|phobic disorders (fear of flying and acrophobia)
369777|NCT02007694|Virtual Reality Exposure Therapy|virtual reality exposure therapy
369778|NCT02007694|Fear extinction|fear extinction
369779|NCT02007694|propranolol|propranolol
369780|NCT02007694|Yohimbine|yohimbine
369781|NCT02007681|Sedentary Behavior; Breaks; Workplace; Energy Expenditure; Physical activity; doubly labeled water|sedentary behavior; breaks; workplace; energy expenditure; physical activity; doubly labeled water
369782|NCT02007668|low back pain|low back pain
369783|NCT02007668|kinesio taping|kinesio taping
369784|NCT02007655|Cardiovascular|cardiovascular
369785|NCT02007616|Cognitive aging|cognitive aging
369786|NCT02007616|Video games training|video games training
369787|NCT02007616|Attention|attention
369788|NCT02007616|Memory|memory
369789|NCT02007616|Wellbeing|wellbeing
369790|NCT02007616|Speed of processing|speed of processing
369791|NCT02007616|Executive functions|executive functions
369792|NCT02007603|chronic hemodialysis|chronic hemodialysis
369793|NCT02007603|ampicillin|ampicillin
369794|NCT02007603|sulbactam|sulbactam
369795|NCT02007603|amoxicillin|amoxicillin
369796|NCT02007603|clavulanic acid|clavulanic acid
369797|NCT02007603|pharmacokinetics|pharmacokinetics
369798|NCT02007577|insulin resistant|insulin resistant
369799|NCT02007564|Palliative care dyads|palliative care dyads
369800|NCT02007564|Volunteers|volunteers
369801|NCT02007564|Community-based|community-based
369802|NCT02007564|Mixed methods|mixed methods
369803|NCT02007551|Social Isolation|social isolation
369804|NCT02007551|Nutrition Assessments|nutrition assessments
369805|NCT02007551|Food Habits|food habits
369807|NCT02007551|Self Efficacy|self efficacy
369808|NCT02007551|Quality of Life|quality of life
369809|NCT02007551|Peer Group|peer group
369810|NCT02007538|Lung Cancer|lung cancer
369811|NCT02007538|Bronchoscopy|bronchoscopy
369812|NCT02007538|Fine Need Aspiration|fine need aspiration
369813|NCT02007538|Cytochemical Assays|cytochemical assays
369814|NCT02007512|advanced breast cancer|advanced breast cancer
369815|NCT02007512|enzalutamide|enzalutamide
369816|NCT02007512|MDV3100|mdv3100
369817|NCT02007512|Estrogen receptor positive (ER +)|estrogen receptor positive (er +)
369818|NCT02007512|Progesterone receptor positive (PgR +)|progesterone receptor positive (pgr +)
369819|NCT02007512|HER-2 normal|her-2 normal
369820|NCT02007499|Prehospital emergency care|prehospital emergency care
369821|NCT02007499|Out of hospital cardiac arrest|out of hospital cardiac arrest
369822|NCT02007499|Cardiopulmonary resuscitation|cardiopulmonary resuscitation
369823|NCT02007499|CPR|cpr
369824|NCT02007499|Heart arrest|heart arrest
369825|NCT02007499|Outcome|outcome
369826|NCT02007499|Bystander|bystander
369827|NCT02007486|Heart Failure|heart failure
369828|NCT02007486|Exercise|exercise
369829|NCT02007486|Dyspnea|dyspnea
369830|NCT02007486|Diaphragm electromyogram|diaphragm electromyogram
369831|NCT02007486|Respiratory mechanics|respiratory mechanics
369832|NCT02007473|Haemovigilance|haemovigilance
369833|NCT02007473|Plasma|plasma
369834|NCT02007473|Pathogen reduction|pathogen reduction
369835|NCT02007473|Methylene Blue|methylene blue
369836|NCT02007447|autism, oxytocin, autism spectrum disorder, social skills.|autism, oxytocin, autism spectrum disorder, social skills.
369837|NCT02007421|Human Papillomavirus,|human papillomavirus,
369838|NCT02007421|Anal High Grade Squamous intraepithelial lesions,|anal high grade squamous intraepithelial lesions,
369839|NCT02007421|Homosexual Men|homosexual men
369840|NCT02007421|High resolution anoscopy,|high resolution anoscopy,
369841|NCT02007421|Cancer Screening|cancer screening
369842|NCT02007421|HIV|hiv
369843|NCT02007408|abortion|abortion
369844|NCT02007408|analgesia|analgesia
369845|NCT02007408|paracervical block|paracervical block
369846|NCT02007408|lidocaine spray|lidocaine spray
369847|NCT02007343|Enterobacteriaceae|enterobacteriaceae
369848|NCT02007343|Pseudomonas|pseudomonas
369849|NCT02007343|Acinetobacter|acinetobacter
369850|NCT02007343|Stenotrophomonas|stenotrophomonas
369851|NCT02007343|Mortality|mortality
369852|NCT02007343|Morbidity|morbidity
369853|NCT02007343|Cost of Illness|cost of illness
369854|NCT02007343|Causality|causality
369855|NCT02007343|Multicenter Study|multicenter study
369856|NCT02007343|Cohort Studies|cohort studies
369857|NCT02007343|Case-Control Studies|case-control studies
369858|NCT02007343|Prospective Studies|prospective studies
369859|NCT02007343|Follow-up Studies|follow-up studies
369860|NCT02007330|systemic lidocaine|systemic lidocaine
369861|NCT02007330|postoperative pain|postoperative pain
369862|NCT02007330|recovery, pediatric|recovery, pediatric
369863|NCT02007330|inguinal hernia|inguinal hernia
369864|NCT02007330|laparoscopy|laparoscopy
369865|NCT02007317|BCC|bcc
369866|NCT02007291|Alzheimer, MMSE, response, colinesterase inhibitors (ChEI)|alzheimer, mmse, response, colinesterase inhibitors (chei)
369867|NCT02007278|diabetes|diabetes
369868|NCT02007278|hypoglycemia|hypoglycemia
369869|NCT02007278|glycemic variability|glycemic variability
369870|NCT02007278|vildagliptin|vildagliptin
369871|NCT02007278|glimepiride|glimepiride
369872|NCT02007252|Abdominal Aortic Aneurysm|abdominal aortic aneurysm
369873|NCT02007252|AAA|aaa
369874|NCT02007252|IL-1b|il-1b
369875|NCT02007252|Abdominal ultrasound|abdominal ultrasound
369876|NCT02007239|tocilizumab|tocilizumab
369877|NCT02007239|hemophagocytic lymphohistiocytosis (HLH)|hemophagocytic lymphohistiocytosis (hlh)
369878|NCT02007239|cytokine|cytokine
369879|NCT02007239|cytokine release syndrome|cytokine release syndrome
369880|NCT02007226|Coronary Heart Disease|coronary heart disease
369881|NCT02007226|spinal cord injury|spinal cord injury
369882|NCT02007226|risk factor|risk factor
369883|NCT02007226|postprandial lipemia|postprandial lipemia
369884|NCT02007213|Neuromuscular Disease|neuromuscular disease
369885|NCT02007213|Motor Function|motor function
369886|NCT02007213|Proxy Reported Outcome|proxy reported outcome
369887|NCT02007213|Young Children|young children
369888|NCT02007187|Unstable Angina Pectoris|unstable angina pectoris
369889|NCT02007187|Randomized Controlled Trial|randomized controlled trial
369890|NCT02007187|Traditional Chinese Medicine|traditional chinese medicine
369891|NCT02007174|recurrent pterygium|recurrent pterygium
369892|NCT02007174|bevacizumab|bevacizumab
369893|NCT02007174|triple dose|triple dose
369894|NCT02007148|gastric adenocarcinoma,|gastric adenocarcinoma,
369895|NCT02007148|capecitabine,|capecitabine,
369896|NCT02007148|second line treatment,|second line treatment,
369897|NCT02007148|recurrent or metastatic disease,|recurrent or metastatic disease,
369898|NCT02007148|overall survival,|overall survival,
369899|NCT02007148|tumor response,|tumor response,
369900|NCT02007148|quality of life|quality of life
369902|NCT02007122|CVVH|cvvh
369903|NCT02007122|renal replacement therapy|renal replacement therapy
369904|NCT02007122|ceftaroline|ceftaroline
369905|NCT02007122|pharmacokinetics|pharmacokinetics
369906|NCT02007096|Transabdominal plane block|transabdominal plane block
369907|NCT02007096|ventral hernia|ventral hernia
369908|NCT02007096|umbilical hernia|umbilical hernia
369909|NCT02007096|incisional hernia|incisional hernia
369910|NCT02007096|hernia repair|hernia repair
369911|NCT02007083|Lumbar Spinal stenosis|lumbar spinal stenosis
369912|NCT02007083|Surgical treatment of LSS.|surgical treatment of lss.
369914|NCT02007070|PD-1|pd-1
369915|NCT02007070|PDL1|pdl1
369916|NCT02007070|PD-L1|pd-l1
369917|NCT02007057|Suprascapular nerve block|suprascapular nerve block
369918|NCT02007057|Interscalene nerve block|interscalene nerve block
369919|NCT02007044|Leukemia|leukemia
369920|NCT02007044|Chronic lymphocytic leukemia|chronic lymphocytic leukemia
369921|NCT02007044|CLL|cll
369922|NCT02007044|Relapsed|relapsed
369923|NCT02007044|Ibrutinib|ibrutinib
369924|NCT02007044|PCI-32765|pci-32765
369925|NCT02007044|Rituximab|rituximab
369926|NCT02007044|Rituxan|rituxan
369927|NCT02007031|Hypertension|hypertension
369928|NCT02007031|Cold temperature|cold temperature
369929|NCT02007031|Blood pressure|blood pressure
369930|NCT02007031|Electrocardiography|electrocardiography
369931|NCT02007018|Surgical Site Infections|surgical site infections
369932|NCT02007018|Colorectal Resection|colorectal resection
369933|NCT02007018|Negative Pressure Wound Therapy|negative pressure wound therapy
369934|NCT02007005|superficial bladder cancer|superficial bladder cancer
369935|NCT02007005|mistletoe extract|mistletoe extract
369936|NCT02007005|maximum tolerated dose|maximum tolerated dose
369937|NCT02007005|marker tumor|marker tumor
369938|NCT02007005|remission|remission
369939|NCT02007005|recurrence rate|recurrence rate
369940|NCT02006979|cardiotoxicity|cardiotoxicity
369941|NCT02006979|Chemotherapy, Adjuvant|chemotherapy, adjuvant
369942|NCT02006979|Breast Neoplasms|breast neoplasms
369943|NCT02006979|Exercise|exercise
369944|NCT02006979|Cardiotoxins|cardiotoxins
369945|NCT02006979|Echocardiography|echocardiography
369946|NCT02006979|Speckle tracking|speckle tracking
369947|NCT02006979|Biological Markers|biological markers
369948|NCT02006979|Electrocardiography|electrocardiography
369949|NCT02006966|Systemic lidocaine|systemic lidocaine
369950|NCT02006966|postoperative pain|postoperative pain
369951|NCT02006966|Video-assisted thoracic surgery|video-assisted thoracic surgery
369952|NCT02006966|VATS|vats
369953|NCT02006953|gastrostomy|gastrostomy
369954|NCT02006953|enteral|enteral
369955|NCT02006940|alveoflex|alveoflex
369956|NCT02006940|probe-based confocal laser endomicroscopy|probe-based confocal laser endomicroscopy
369957|NCT02006940|pCLE|pcle
369958|NCT02006940|alveoscopy|alveoscopy
369959|NCT02006940|morphology|morphology
369960|NCT02006940|high resolution computed tomography|high resolution computed tomography
369961|NCT02006927|Prostate Cancer|prostate cancer
369962|NCT02006914|Insulin resistance|insulin resistance
369963|NCT02006914|HIV disease|hiv disease
369964|NCT02006914|chromium picolinate|chromium picolinate
369965|NCT02006901|surgical procedures, operative|surgical procedures, operative
369966|NCT02006901|lumbar vertebrae|lumbar vertebrae
369967|NCT02006901|decompression, surgical|decompression, surgical
369968|NCT02006901|microdecompression|microdecompression
369969|NCT02006901|laminectomy|laminectomy
369970|NCT02006901|registries|registries
369971|NCT02006888|Inflammation|inflammation
369972|NCT02006888|cataract surgery|cataract surgery
369973|NCT02006875|repetitive transcranial magnetic stimulation|repetitive transcranial magnetic stimulation
369974|NCT02006875|postural|postural
369975|NCT02006875|balance|balance
369976|NCT02006875|mobility|mobility
369977|NCT02006875|leg|leg
369978|NCT02006875|stroke|stroke
369979|NCT02006862|olanzapine|olanzapine
369980|NCT02006862|olanzapine treatment efficacy|olanzapine treatment efficacy
369981|NCT02006849|AfricanAmericans|africanamericans
369982|NCT02006849|Hypertension|hypertension
369983|NCT02006849|Proteinuria|proteinuria
369984|NCT02006849|ApoL1 gene|apol1 gene
369985|NCT02006836|glycemic index|glycemic index
369986|NCT02006836|glycemic response|glycemic response
369987|NCT02006836|diabetes|diabetes
369988|NCT02006836|pomelo|pomelo
369989|NCT02006823|Chronic Hepatitis C|chronic hepatitis c
369990|NCT02006810|Endothelium biomarkers|endothelium biomarkers
369991|NCT02006810|Atherosclerotic disease|atherosclerotic disease
369992|NCT02006810|Endothelial function|endothelial function
369993|NCT02006810|Nutritional stimuli|nutritional stimuli
369994|NCT02006797|reconciliation|reconciliation
369995|NCT02006797|discharge|discharge
369996|NCT02006797|pharmacist|pharmacist
369997|NCT02006797|drug related problems|drug related problems
369999|NCT02006771|Postprandial oxidative stress|postprandial oxidative stress
370000|NCT02006719|Adhesive Capsulitis|adhesive capsulitis
370001|NCT02006719|Frozen Shoulder|frozen shoulder
370002|NCT02006719|Shoulder Range of Motion limitation|shoulder range of motion limitation
370003|NCT02006719|Shoulder Pain|shoulder pain
370004|NCT02006693|XEN|xen
370005|NCT02006693|Primary Open Angle Glaucoma|primary open angle glaucoma
370006|NCT02006693|Filtration Device|filtration device
370007|NCT02006693|Ab interno|ab interno
370008|NCT02006680|Central Precocious Puberty|central precocious puberty
370009|NCT02006680|Suppression|suppression
370010|NCT02006680|Alpha Subunit|alpha subunit
370011|NCT02006680|Leuprolide Stimulation Test|leuprolide stimulation test
370012|NCT02006628|GWP42003|gwp42003
370013|NCT02006628|Cannabinoids|cannabinoids
370014|NCT02006628|Schizophrenia|schizophrenia
370015|NCT02006628|CBD|cbd
370016|NCT02006628|Cannabidiol|cannabidiol
370017|NCT02006602|Candesartan cilexetil|candesartan cilexetil
370018|NCT02006602|Healthy adult human subjects|healthy adult human subjects
370019|NCT02006602|Bioequivalence|bioequivalence
370020|NCT02006589|Bioequivalence|bioequivalence
370021|NCT02006589|Candesartan cilexetil|candesartan cilexetil
370022|NCT02006589|Healthy adult human subjects|healthy adult human subjects
370023|NCT02006576|Emphysema|emphysema
370024|NCT02006576|Prostaglandin E|prostaglandin e
370025|NCT02006576|Bronchoalveolar lavage|bronchoalveolar lavage
370026|NCT02006563|Brain Tumor|brain tumor
370027|NCT02006563|Glioblastoma multiforme|glioblastoma multiforme
370028|NCT02006563|GBM|gbm
370029|NCT02006563|Metabolic Tumor Volume|metabolic tumor volume
370030|NCT02006563|MTV|mtv
370031|NCT02006563|Clinical Tumor Volume|clinical tumor volume
370032|NCT02006563|CTV|ctv
370033|NCT02006550|Wnt|wnt
370034|NCT02006550|Notch|notch
370035|NCT02006550|Hedgehog|hedgehog
370036|NCT02006550|Tumor Sample|tumor sample
370037|NCT02006537|soluble epoxide hydrolase inhibitor|soluble epoxide hydrolase inhibitor
370038|NCT02006537|Entero-Test|entero-test
370039|NCT02006537|pharmacokinetics|pharmacokinetics
370040|NCT02006537|COPD|copd
370041|NCT02006537|safety|safety
370042|NCT02006524|Silent atrial fibrillation|silent atrial fibrillation
370043|NCT02006524|primary care|primary care
370044|NCT02006524|screening|screening
370045|NCT02006524|influenza vaccination|influenza vaccination
370046|NCT02006511|incisional negative pressure wound therapy|incisional negative pressure wound therapy
370047|NCT02006511|groin incision|groin incision
370048|NCT02006511|incisional VAC|incisional vac
370049|NCT02006511|Prevena|prevena
370050|NCT02006511|groin wound|groin wound
370051|NCT02006498|non-alcoholic fatty liver disease|non-alcoholic fatty liver disease
370052|NCT02006498|sillymarin|sillymarin
370053|NCT02006498|randomised trial|randomised trial
370054|NCT02006498|non-alcoholic steatohepatitis|non-alcoholic steatohepatitis
370055|NCT02006472|Huntington's Disease|huntington's disease
370056|NCT02006472|Pridopidine|pridopidine
370057|NCT02006472|Pride-HD|pride-hd
370058|NCT02006459|Gastrointestinal-mediated glucose disposal|gastrointestinal-mediated glucose disposal
370059|NCT02006459|Total pancreatectomy|total pancreatectomy
370060|NCT02006459|Incretin hormones|incretin hormones
370061|NCT02006459|Glucagon|glucagon
370062|NCT02006446|Male infertility|male infertility
370063|NCT02006446|sperm head vacuoles|sperm head vacuoles
370064|NCT02006446|sperm morphology|sperm morphology
370065|NCT02006446|aneuploidy|aneuploidy
370066|NCT02006446|DNA fragmentation|dna fragmentation
370067|NCT02006446|abnormal chromatin condensation|abnormal chromatin condensation
370068|NCT02006446|telomere abnormalities|telomere abnormalities
370069|NCT02006394|Inflammation|inflammation
370070|NCT02006394|Monocytes|monocytes
370071|NCT02006381|healthy boys|healthy boys
370072|NCT02006381|plasma oxytocin|plasma oxytocin
370073|NCT02006381|pediatric|pediatric
370074|NCT02006368|Volunteers|volunteers
370075|NCT02006368|Blood Platelets|blood platelets
370076|NCT02006368|Platelet Transfusion|platelet transfusion
370077|NCT02006342|Diabetes Mellitus|diabetes mellitus
370078|NCT02006342|Diabetic Ketoacidosis|diabetic ketoacidosis
370079|NCT02006342|Insulin Glargine|insulin glargine
370080|NCT02006342|Anion gap|anion gap
370081|NCT02006342|Metabolic acidosis|metabolic acidosis
370082|NCT02006303|Benign Prostate Hyperplasia|benign prostate hyperplasia
370083|NCT02006303|Green light|green light
370084|NCT02006303|Photoselective vaporization of the prostate|photoselective vaporization of the prostate
370085|NCT02006303|Prostatic artery embolization|prostatic artery embolization
370086|NCT02006303|Outcome|outcome
370087|NCT02006277|healthy volunteers|healthy volunteers
370088|NCT02006277|taste|taste
370089|NCT02006277|bioavailability|bioavailability
370090|NCT02006238|Hot flash|hot flash
370091|NCT02006238|Farabloc|farabloc
370092|NCT02006238|menopausal women|menopausal women
370093|NCT02006225|autologous|autologous
370094|NCT02006225|stem cell|stem cell
370095|NCT02006225|transplantation|transplantation
370096|NCT02006199|obsessive-compulsive disorder|obsessive-compulsive disorder
370097|NCT02006199|mindfulness|mindfulness
370098|NCT02006199|meditation|meditation
370099|NCT02006186|Bicycling|bicycling
370100|NCT02006173|Hya-Dermis mixed with lidocaine on reducing pain|hya-dermis mixed with lidocaine on reducing pain
370101|NCT02006147|Macular Edema|macular edema
370102|NCT02006147|RVO|rvo
370103|NCT02006134|Vasculitis|vasculitis
370104|NCT02006134|Primary CNS Vasculitis|primary cns vasculitis
370105|NCT02006134|Systemic vasculitis|systemic vasculitis
370106|NCT02006134|Churg-Strauss Syndrome|churg-strauss syndrome
370107|NCT02006134|Polyarteritis Nodosa|polyarteritis nodosa
370108|NCT02006134|Wegener Granulomatosis|wegener granulomatosis
370109|NCT02006134|Pediatric vasculitis|pediatric vasculitis
370110|NCT02006134|Childhood vasculitis|childhood vasculitis
370111|NCT02006134|Granulomatosis with polyangiitis|granulomatosis with polyangiitis
370112|NCT02006134|Microscopic Polyangiitis|microscopic polyangiitis
370113|NCT02006134|Takayasu Arteritis|takayasu arteritis
370114|NCT02006134|Autoimmune|autoimmune
370115|NCT02006134|ANCA-associated vasculitis|anca-associated vasculitis
370116|NCT02006121|Parkinson's disease|parkinson's disease
370117|NCT02006121|motor fluctuations|motor fluctuations
370118|NCT02006121|not well controlled|not well controlled
370119|NCT02006121|medical treatment|medical treatment
370120|NCT02006121|apomorphine|apomorphine
370121|NCT02006108|kidney|kidney
370122|NCT02006108|transplant|transplant
370123|NCT02006108|rejection|rejection
370124|NCT02006108|Feraheme|feraheme
370125|NCT02006108|ferumoxytol|ferumoxytol
370126|NCT02006095|carotid artery stenting|carotid artery stenting
370127|NCT02006095|carotid endarterectomy|carotid endarterectomy
370128|NCT02006095|magnetic resonance imaging (MRI)|magnetic resonance imaging (mri)
370129|NCT02006095|neuropsychological testing|neuropsychological testing
370130|NCT02006095|microemboli|microemboli
370131|NCT02006082|Telemedicine video-consultation (TVC)|telemedicine video-consultation (tvc)
370132|NCT02006082|Re-admission to hospital|re-admission to hospital
370133|NCT02006082|Time to re-admission|time to re-admission
370134|NCT02006082|Length if hospital stay|length if hospital stay
370135|NCT02006082|Patient satisfaction|patient satisfaction
370136|NCT02006082|Chronic obstructive pulmonary disease (COPD)|chronic obstructive pulmonary disease (copd)
370137|NCT02006069|CRT, non responders, MultiPoint Pacing (MPP)|crt, non responders, multipoint pacing (mpp)
370138|NCT02006030|Unresectable Hepatocellular Carcinoma|unresectable hepatocellular carcinoma
370139|NCT02006030|Liver Cancer|liver cancer
370140|NCT02006030|ADI|adi
370141|NCT02006030|ADI-PEG 20|adi-peg 20
370142|NCT02006004|AML|aml
370143|NCT02005991|PF-05212377|pf-05212377
370144|NCT02005991|phase 1|phase 1
370145|NCT02005991|open-label|open-label
370146|NCT02005991|5-HT2a receptor occupancy|5-ht2a receptor occupancy
370147|NCT02005991|positron emission tomography|positron emission tomography
370148|NCT02005991|healthy subjects|healthy subjects
370149|NCT02005991|brain|brain
370150|NCT02005991|cortex|cortex
370151|NCT02005991|alzheimers disease|alzheimers disease
370152|NCT02005965|Rectal Cancer|rectal cancer
370153|NCT02005965|Low Rectal Cancer|low rectal cancer
370154|NCT02005965|MERCURY|mercury
370155|NCT02005965|Cancer|cancer
370156|NCT02005965|CRM|crm
370157|NCT02005965|Circumferential Margin|circumferential margin
370158|NCT02005965|Quality of Life|quality of life
370159|NCT02005965|MRI|mri
370160|NCT02005965|Radiology|radiology
370161|NCT02005965|Abdominoperineal Excision|abdominoperineal excision
370162|NCT02005965|Anterior Resection|anterior resection
370163|NCT02005965|Surgery|surgery
370164|NCT02005965|Pathology|pathology
370165|NCT02005939|Pomegranate|pomegranate
370166|NCT02005939|Blood pressure|blood pressure
370167|NCT02005939|Insulin sensitivity|insulin sensitivity
370168|NCT02005939|Cortisol|cortisol
370169|NCT02005939|Quality of life|quality of life
370170|NCT02005939|Body composition|body composition
370171|NCT02005926|Breast cancer|breast cancer
370172|NCT02005926|Sentinel lymph node biopsy|sentinel lymph node biopsy
370173|NCT02005926|Ultrasonography|ultrasonography
370174|NCT02005926|Fine needle aspiration|fine needle aspiration
370175|NCT02005900|DHA|dha
370176|NCT02005900|Omega 3|omega 3
370177|NCT02005900|Polyunsaturated Fatty Acids|polyunsaturated fatty acids
370178|NCT02005900|Dyslipidemia induced by HAART|dyslipidemia induced by haart
370179|NCT02005900|Lipid metabolic alterations|lipid metabolic alterations
370180|NCT02005900|HIV|hiv
370181|NCT02005887|Premenopausal patients|premenopausal patients
370182|NCT02005887|ER-positive|er-positive
370183|NCT02005887|PgR+ (>50%)|pgr+ (>50%)
370184|NCT02005887|HER2-negative or not amplified|her2-negative or not amplified
370185|NCT02005861|osteochondral lesion|osteochondral lesion
370186|NCT02005861|talus|talus
370187|NCT02005861|ankle|ankle
370188|NCT02005861|cartilage repair|cartilage repair
370189|NCT02005848|Type-1 Diabetes|type-1 diabetes
370190|NCT02005848|T1D|t1d
370191|NCT02005848|Diabetes Mellitus|diabetes mellitus
370192|NCT02005835|HIV|hiv
370193|NCT02005835|Option B+|option b+
370194|NCT02005835|Prevention of Mother to Child Transmission|prevention of mother to child transmission
370195|NCT02005822|Cytomegalovirus|cytomegalovirus
370196|NCT02005822|Congenital infection|congenital infection
370197|NCT02005822|Sensorineural hearing loss|sensorineural hearing loss
370198|NCT02005822|Valganciclovir|valganciclovir
370199|NCT02005809|Endoscopic submucosal dissection|endoscopic submucosal dissection
370200|NCT02005809|gastric neoplasm|gastric neoplasm
370201|NCT02005809|second look endoscopy|second look endoscopy
370202|NCT02005783|incidence of grade 3/4 neutropenia|incidence of grade 3/4 neutropenia
370203|NCT02005783|incidence of febrile neutropenia|incidence of febrile neutropenia
370204|NCT02005783|time to neutropenia recovery|time to neutropenia recovery
370205|NCT02005783|safety|safety
370206|NCT02005757|rheumatoid arthritis|rheumatoid arthritis
370207|NCT02005757|RA|ra
370208|NCT02005757|Mizoribine|mizoribine
370209|NCT02005757|DAS28|das28
370210|NCT02005757|European League Against Rheumatism|european league against rheumatism
370211|NCT02005744|CKD-501|ckd-501
370212|NCT02005731|Low Intensity Shockwave|low intensity shockwave
370213|NCT02005731|Extracorporeal shockwave therapy|extracorporeal shockwave therapy
370214|NCT02005731|Erectile dysfunction|erectile dysfunction
370215|NCT02005692|pressure ulcers|pressure ulcers
370216|NCT02005692|bed sores|bed sores
370217|NCT02005692|patient turn protocol|patient turn protocol
370218|NCT02005692|patient movement|patient movement
370219|NCT02005692|patient monitoring|patient monitoring
370220|NCT02005679|Prelingual Deafness|prelingual deafness
370221|NCT02005679|Retention Disorders, Cognitive|retention disorders, cognitive
370222|NCT02005679|Sign language|sign language
370223|NCT02005679|Mini-Mental State|mini-mental state
370224|NCT02005666|Acne Vulgaris|acne vulgaris
370225|NCT02005666|DUAC|duac
370226|NCT02005666|CADILA|cadila
370227|NCT02005666|CLIANTHA|cliantha
370228|NCT02005653|Lymphatic filariasis|lymphatic filariasis
370229|NCT02005653|W. bancrofti|w. bancrofti
370230|NCT02005653|DEC|dec
370231|NCT02005653|Albendazole|albendazole
370232|NCT02005653|Doxycycline|doxycycline
370233|NCT02005627|grass pollen allergy|grass pollen allergy
370234|NCT02005627|hayfever|hayfever
370235|NCT02005627|atopy|atopy
370236|NCT02005627|allergic rhinitis|allergic rhinitis
370237|NCT02005627|sublingual immunotherapy tablets|sublingual immunotherapy tablets
370238|NCT02005614|Rational dose selection|rational dose selection
370239|NCT02005614|gamma knife radiosurgery|gamma knife radiosurgery
370240|NCT02005588|amino acid chelated iron|amino acid chelated iron
370241|NCT02005588|iron salt|iron salt
370242|NCT02005588|iron deficiency anemia|iron deficiency anemia
370243|NCT02005536|Poliomyelitis|poliomyelitis
370244|NCT02005536|Poliovirus|poliovirus
370245|NCT02005536|Polio|polio
370246|NCT02005536|IMOVAX POLIO®|imovax polio®
370247|NCT02005536|Inactivated polio vaccine|inactivated polio vaccine
370248|NCT02005510|cervical cancer|cervical cancer
370249|NCT02005510|screening|screening
370250|NCT02005510|human papillomavirus|human papillomavirus
370251|NCT02005510|cervical intraepithelial neoplasia|cervical intraepithelial neoplasia
370252|NCT02005497|Cancer prevention and control|cancer prevention and control
370253|NCT02005497|Health promotion|health promotion
370254|NCT02005497|Workplace|workplace
370255|NCT02005497|Dissemination|dissemination
370256|NCT02005497|Implementation|implementation
370257|NCT02005458|Neutropenia|neutropenia
370258|NCT02005458|Febrile neutropenia|febrile neutropenia
370259|NCT02005458|PEG-rhG-CSF|peg-rhg-csf
370260|NCT02005458|Myelosuppressive chemotherapy|myelosuppressive chemotherapy
370261|NCT02005445|Obstructive sleep apnea|obstructive sleep apnea
370262|NCT02005445|Coronary heart disease|coronary heart disease
370263|NCT02005445|Cardiac rehabilitation|cardiac rehabilitation
370264|NCT02005445|Cardiopulmonary exercise testing|cardiopulmonary exercise testing
370265|NCT02005432|Diabetis|diabetis
370266|NCT02005432|Retinal Neovascularization|retinal neovascularization
370267|NCT02005432|laser treatment|laser treatment
370268|NCT02005419|Pancreatic Cancer|pancreatic cancer
370269|NCT02005419|Pancreatic Adenocarcinoma|pancreatic adenocarcinoma
370270|NCT02005419|Metformin|metformin
370271|NCT02005419|Gemcitabine|gemcitabine
370272|NCT02005419|Adjuvant Therapy|adjuvant therapy
370273|NCT02005406|Wei JET|wei jet
370274|NCT02005393|FICE|fice
370275|NCT02005393|NBI|nbi
370276|NCT02005380|Alzheimer's Disease Rehabilitation|alzheimer's disease rehabilitation
370277|NCT02005367|substance use treatment|substance use treatment
370278|NCT02005367|person-centered treatment|person-centered treatment
370279|NCT02005367|residential treatment outcomes|residential treatment outcomes
370280|NCT02005367|dual diagnosis|dual diagnosis
370281|NCT02005367|recovery model|recovery model
370282|NCT02005367|psychosocial treatment|psychosocial treatment
370283|NCT02005354|Pain|pain
370284|NCT02005354|Bone marrow aspiration|bone marrow aspiration
370285|NCT02005354|trephine biopsy|trephine biopsy
370286|NCT02005341|Lumbar|lumbar
370287|NCT02005341|fusion|fusion
370288|NCT02005328|Xerostomia|xerostomia
370289|NCT02005328|hyposialia|hyposialia
370290|NCT02005328|hyposalivation|hyposalivation
370291|NCT02005328|saliva substitute|saliva substitute
370292|NCT02005328|Salivary Gland|salivary gland
370293|NCT02005328|Mouth Diseases|mouth diseases
370294|NCT02005328|Dry mouth|dry mouth
370295|NCT02005315|Pancreatic Cancer|pancreatic cancer
370296|NCT02005315|Stage IV Pancreatic Cancer|stage iv pancreatic cancer
370498|NCT02004379|boceprevir|boceprevir
370297|NCT02005302|chronic kidney disease|chronic kidney disease
370298|NCT02005302|mineral and bone disease|mineral and bone disease
370299|NCT02005302|Malnutrition|malnutrition
370300|NCT02005302|Vitamin D|vitamin d
370301|NCT02005302|low protein diet|low protein diet
370302|NCT02005289|CLL|cll
370303|NCT02005289|SLL|sll
370304|NCT02005289|PLL|pll
370305|NCT02005289|Chronic Lymphocytic Leukemia|chronic lymphocytic leukemia
370306|NCT02005289|Small Lymphocytic Lymphoma|small lymphocytic lymphoma
370307|NCT02005289|Prolymphocytic Leukemia|prolymphocytic leukemia
370308|NCT02005289|MOR00208|mor00208
370309|NCT02005289|MOR208|mor208
370310|NCT02005276|Sedentary|sedentary
370311|NCT02005276|Behavioral Economic Intervention|behavioral economic intervention
370312|NCT02005276|Team Studies|team studies
370313|NCT02005276|Financial Incentives|financial incentives
370314|NCT02005276|Workplace Wellness|workplace wellness
370315|NCT02005276|Team Incentives|team incentives
370316|NCT02005263|Hysteroscopy|hysteroscopy
370317|NCT02005250|osteoporosis|osteoporosis
370318|NCT02005250|hyperthyroidism|hyperthyroidism
370319|NCT02005250|hypothyroidism|hypothyroidism
370320|NCT02005237|Exercise|exercise
370321|NCT02005237|Cognition|cognition
370322|NCT02005237|Neuroimaging|neuroimaging
370323|NCT02005237|Rehabilitation|rehabilitation
370324|NCT02005237|Connectivity|connectivity
370325|NCT02005224|Insulin sensitivity|insulin sensitivity
370326|NCT02005224|Lipid profile|lipid profile
370327|NCT02005224|Body composition|body composition
370328|NCT02005224|Weight|weight
370329|NCT02005211|AZD3293|azd3293
370330|NCT02005211|Healthy volunteers|healthy volunteers
370331|NCT02005211|Young volunteers|young volunteers
370332|NCT02005211|Elderly volunteers|elderly volunteers
370333|NCT02005211|Japanese volunteers|japanese volunteers
370334|NCT02005211|Phase 1|phase 1
370335|NCT02005211|Single and multiple ascending dose study|single and multiple ascending dose study
370336|NCT02005172|arrhythmia, palpitations, lightheadedness|arrhythmia, palpitations, lightheadedness
370337|NCT02005159|Enterobacteria|enterobacteria
370338|NCT02005159|Bacteremia|bacteremia
370339|NCT02005159|Minimum inhibitory concentration|minimum inhibitory concentration
370340|NCT02005159|Susceptible|susceptible
370341|NCT02005159|Prognosis|prognosis
370342|NCT02005146|Hepatitis B|hepatitis b
370343|NCT02005146|Nucleoside/nucleotide|nucleoside/nucleotide
370344|NCT02005146|HBsAg loss|hbsag loss
370345|NCT02005133|Wet age-related macular degeneration|wet age-related macular degeneration
370346|NCT02005068|Osteoarticular infections|osteoarticular infections
370347|NCT02005068|Osteomyelitis|osteomyelitis
370348|NCT02005068|Joint infections|joint infections
370349|NCT02005068|MRSA (Methicillin- Resistant Staphylococcus Aureus)|mrsa (methicillin- resistant staphylococcus aureus)
370350|NCT02005068|MSSA (Methicillin- Susceptible Staphylococcus Aureus)|mssa (methicillin- susceptible staphylococcus aureus)
370351|NCT02005055|Brachytherapy|brachytherapy
370352|NCT02005055|Radiotherapy|radiotherapy
370353|NCT02005055|Scar treatment|scar treatment
400546|NCT01866345|Mandible|mandible
370354|NCT02005042|Physical activity|physical activity
370355|NCT02005042|Ecological Momentary Assessment|ecological momentary assessment
370356|NCT02005042|Ecological Momentary Intervention|ecological momentary intervention
370357|NCT02005042|Accelerometer|accelerometer
370358|NCT02005042|Smartphone|smartphone
370359|NCT02005029|Parkinson's Disease|parkinson's disease
370360|NCT02005029|Levodopa|levodopa
370361|NCT02005029|motor fluctuations|motor fluctuations
370362|NCT02005029|gastroparesis|gastroparesis
370363|NCT02005016|Aphasia|aphasia
370364|NCT02005016|Language Therapy|language therapy
370365|NCT02005016|Acquired Language Disorders|acquired language disorders
370366|NCT02005016|Semantics|semantics
370367|NCT02005016|Stroke|stroke
370368|NCT02004990|Children, Plaque|children, plaque
370369|NCT02004951|Superficial femoral artery|superficial femoral artery
370370|NCT02004951|paclitaxel|paclitaxel
370371|NCT02004951|stent|stent
370372|NCT02004951|self expandable|self expandable
370373|NCT02004951|restenosis|restenosis
370374|NCT02004951|endovascular|endovascular
370375|NCT02004951|above-the-knee intermediate length|above-the-knee intermediate length
370376|NCT02004938|measurements|measurements
370377|NCT02004938|jugular|jugular
370378|NCT02004938|ultrasound|ultrasound
370379|NCT02004938|pediatric|pediatric
370380|NCT02004938|respiratory|respiratory
370381|NCT02004938|diameter|diameter
370382|NCT02004925|pneumoperitoneum|pneumoperitoneum
370383|NCT02004925|free peritoneal air|free peritoneal air
370384|NCT02004925|ultrasonography|ultrasonography
370385|NCT02004912|maternal|maternal
370386|NCT02004912|neonatal|neonatal
370387|NCT02004912|child|child
370388|NCT02004912|health services|health services
370389|NCT02004912|health care|health care
370390|NCT02004912|Karnataka|karnataka
370391|NCT02004912|India|india
370392|NCT02004899|Labor epidural analgesia|labor epidural analgesia
370393|NCT02004899|Fentanyl|fentanyl
370394|NCT02004899|Bupivacaine|bupivacaine
370395|NCT02004899|Onset|onset
370396|NCT02004886|Diabetes Mellitus|diabetes mellitus
370397|NCT02004886|Diabetes Mellitus, Type 2|diabetes mellitus, type 2
370398|NCT02004886|Glucose Metabolism Disorders|glucose metabolism disorders
370399|NCT02004886|Metabolic Diseases|metabolic diseases
370400|NCT02004886|Endocrine System Diseases|endocrine system diseases
370401|NCT02004886|Therapeutic Uses|therapeutic uses
370402|NCT02004886|Pharmacologic Actions|pharmacologic actions
370403|NCT02004886|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action
370404|NCT02004886|Physiological Effects of Drugs|physiological effects of drugs
370405|NCT02004886|Metformin|metformin
370406|NCT02004873|pacemaker|pacemaker
370407|NCT02004873|leadless|leadless
370408|NCT02004873|single chamber|single chamber
370409|NCT02004860|local immunosuppressive|local immunosuppressive
370410|NCT02004860|Maintenance therapy|maintenance therapy
370539|NCT02004223|Hypofractionation|hypofractionation
370411|NCT02004795|Boron Neutron Capture Therapy|boron neutron capture therapy
370412|NCT02004795|Image-guided intensity modulation radiotherapy|image-guided intensity modulation radiotherapy
370413|NCT02004769|Metastatic gastric or gastro-esophageal junction cancer|metastatic gastric or gastro-esophageal junction cancer
370414|NCT02004769|Trastuzumab|trastuzumab
370415|NCT02004769|HER2-positive|her2-positive
370416|NCT02004769|Capecitabine|capecitabine
370417|NCT02004769|Docetaxel|docetaxel
370418|NCT02004769|First-line therapy|first-line therapy
370419|NCT02004756|pediatric|pediatric
370421|NCT02004756|congenital heart disease|congenital heart disease
370422|NCT02004756|cardiac and musculoskeletal funion|cardiac and musculoskeletal funion
370423|NCT02004756|cardiac and/or musculoskeletal metabolism|cardiac and/or musculoskeletal metabolism
370424|NCT02004756|exercise training intervention|exercise training intervention
370425|NCT02004743|Early Intervention|early intervention
370426|NCT02004743|Prevention|prevention
370427|NCT02004743|Risk Factors|risk factors
370428|NCT02004743|Exposure Therapy|exposure therapy
370429|NCT02004743|Psychoeducation|psychoeducation
370430|NCT02004717|advanced solid tumor|advanced solid tumor
370431|NCT02004717|Phase 1|phase 1
370432|NCT02004717|Oncology|oncology
370433|NCT02004652|Prucalopride|prucalopride
370434|NCT02004652|Gastrointestinal Diseases|gastrointestinal diseases
370435|NCT02004652|Postoperative ileus|postoperative ileus
370436|NCT02004652|Randomised trial|randomised trial
370437|NCT02004639|IMRT or HT with chemotherapy|imrt or ht with chemotherapy
370438|NCT02004626|Collagenase|collagenase
370439|NCT02004626|Phase III|phase iii
370440|NCT02004626|National|national
370441|NCT02004626|Noninferiority|noninferiority
370442|NCT02004626|Double-blind|double-blind
370443|NCT02004626|Multicenter|multicenter
370444|NCT02004626|Prospective.|prospective.
370445|NCT02004587|Hepatic impairment|hepatic impairment
370446|NCT02004587|Pharmacokinetics|pharmacokinetics
370447|NCT02004587|Pharmacodynamics|pharmacodynamics
370448|NCT02004587|Gemigliptin|gemigliptin
370449|NCT02004561|bariatric_surgery|bariatric_surgery
370450|NCT02004561|pediatric obesity|pediatric obesity
370451|NCT02004561|diabetes|diabetes
370452|NCT02004535|Hearing loss|hearing loss
370453|NCT02004535|Asymmetric hearing loss|asymmetric hearing loss
370454|NCT02004535|Cochlear implantation|cochlear implantation
370455|NCT02004522|Phase 3|phase 3
370456|NCT02004522|CLL/SLL|cll/sll
370457|NCT02004522|Pi3K|pi3k
370458|NCT02004509|atrial fibrillation|atrial fibrillation
370459|NCT02004509|stroke|stroke
370460|NCT02004509|pacemaker|pacemaker
370461|NCT02004509|anticoagulant|anticoagulant
370462|NCT02004483|percutaneous coronary intervention|percutaneous coronary intervention
370463|NCT02004483|ischemia|ischemia
370464|NCT02004483|strain|strain
370465|NCT02004483|coronary stenosis|coronary stenosis
370466|NCT02004470|post laparoscopic shoulder pain|post laparoscopic shoulder pain
370467|NCT02004470|active suction|active suction
370468|NCT02004470|lavage and suction|lavage and suction
370469|NCT02004470|right shoulder pain|right shoulder pain
370470|NCT02004470|post operative shoulder pain|post operative shoulder pain
370471|NCT02004457|HIV|hiv
370472|NCT02004457|Primary care|primary care
370473|NCT02004457|Engagement|engagement
370474|NCT02004457|Acceptance|acceptance
370475|NCT02004457|Disclosure|disclosure
370476|NCT02004457|Stigma|stigma
370477|NCT02004444|JC Virus|jc virus
370478|NCT02004444|Natalizumab|natalizumab
370479|NCT02004431|Chronic post surgical pain|chronic post surgical pain
370480|NCT02004431|Orthopaedic|orthopaedic
370481|NCT02004431|Anxiety|anxiety
370482|NCT02004431|depression|depression
370483|NCT02004418|C-Choline PET scans|c-choline pet scans
370484|NCT02004418|external beam radiotherapy|external beam radiotherapy
370485|NCT02004405|autonomic nervous system|autonomic nervous system
370486|NCT02004405|fibromyalgia|fibromyalgia
370487|NCT02004405|autonomic dysfunction|autonomic dysfunction
370488|NCT02004405|strengthening|strengthening
370489|NCT02004405|flexibility|flexibility
370490|NCT02004405|exercise|exercise
370491|NCT02004405|heart rate variability|heart rate variability
370492|NCT02004392|Alzheimer's disease|alzheimer's disease
370493|NCT02004392|Cognition|cognition
370494|NCT02004392|Alpha-7 nAChR|alpha-7 nachr
370495|NCT02004379|HCV|hcv
370499|NCT02004379|clinical practice|clinical practice
370500|NCT02004366|Diabetes|diabetes
370501|NCT02004366|Linagliptin|linagliptin
370502|NCT02004366|hospital hyperglycemia|hospital hyperglycemia
370503|NCT02004366|inpatient diabetes|inpatient diabetes
370504|NCT02004353|Cochlear® Hearing Implants|cochlear® hearing implants
370505|NCT02004340|pediatric epilepsy|pediatric epilepsy
370506|NCT02004340|transcutaneous vagus nerve stimulation|transcutaneous vagus nerve stimulation
370507|NCT02004314|Chloroquine|chloroquine
370508|NCT02004314|T cell immune activation|t cell immune activation
370509|NCT02004314|CD4 recovery|cd4 recovery
370510|NCT02004314|HIV|hiv
370511|NCT02004301|Formulation behaviour|formulation behaviour
370512|NCT02004301|Drug absorption profile|drug absorption profile
370513|NCT02004288|Probiotics|probiotics
370514|NCT02004288|Anorexia nervosa|anorexia nervosa
370515|NCT02004288|Constipation|constipation
370516|NCT02004288|Body weight|body weight
370517|NCT02004262|cancer|cancer
370518|NCT02004262|cancer vaccine|cancer vaccine
370519|NCT02004262|Listeria monocytogenes|listeria monocytogenes
370520|NCT02004262|Listeria-based vaccine|listeria-based vaccine
370521|NCT02004262|GVAX|gvax
370522|NCT02004262|cyclophosphamide|cyclophosphamide
370523|NCT02004262|Cytoxan|cytoxan
370524|NCT02004262|immunotherapy|immunotherapy
370525|NCT02004262|mesothelin|mesothelin
370526|NCT02004236|tRNS|trns
370527|NCT02004236|QEEG|qeeg
370528|NCT02004236|ERP|erp
370529|NCT02004236|ASD|asd
370530|NCT02004236|Autism|autism
370531|NCT02004236|verbal fluency|verbal fluency
370532|NCT02004236|empathy|empathy
370533|NCT02004236|noninvasive brain stimulation|noninvasive brain stimulation
370534|NCT02004236|tDCS|tdcs
370535|NCT02004223|Prostate Cancer|prostate cancer
370536|NCT02004223|Dose escalation|dose escalation
370537|NCT02004223|Stereotactic|stereotactic
370538|NCT02004223|SBRT|sbrt
370540|NCT02004210|transarterial chemoembolization|transarterial chemoembolization
370541|NCT02004210|transarterial radioembolization|transarterial radioembolization
370542|NCT02004210|advanced hepatocellular carcinoma|advanced hepatocellular carcinoma
370543|NCT02004184|Pemetrexed|pemetrexed
370544|NCT02004184|drug therapy|drug therapy
370545|NCT02004171|electronic cigarette|electronic cigarette
370546|NCT02004171|nicotine inhaler|nicotine inhaler
370547|NCT02004171|smoking cessation|smoking cessation
370548|NCT02004158|Acute coronary syndrome|acute coronary syndrome
370549|NCT02004158|Health behavior|health behavior
370550|NCT02004158|Mental health|mental health
370551|NCT02004145|MDD|mdd
370552|NCT02004145|Positive Psychology|positive psychology
370553|NCT02004145|Suicidality|suicidality
370554|NCT02004080|TBI|tbi
370555|NCT02004080|ICU|icu
370556|NCT02004080|Comparative Effectiveness Research|comparative effectiveness research
370557|NCT02004067|Evaporative|evaporative
370558|NCT02004067|Aqueous deficient|aqueous deficient
370559|NCT02004067|Dry eye disease|dry eye disease
370560|NCT02004054|multiple sclerosis|multiple sclerosis
370561|NCT02004054|diameter pupil|diameter pupil
370562|NCT02004041|pruritus|pruritus
370563|NCT02004041|atopic dermatitis|atopic dermatitis
370564|NCT02004041|VLY-686|vly-686
370565|NCT02004028|Mesothelioma|mesothelioma
370566|NCT02004028|adenoma|adenoma
370567|NCT02004028|Neoplasms, Mesothelial|neoplasms, mesothelial
370568|NCT02004028|Focal Adhesion Kinase Inhibitor|focal adhesion kinase inhibitor
370569|NCT02004015|Analytical|analytical
370570|NCT02004015|Diagnostic|diagnostic
370571|NCT02004015|Anesthesia|anesthesia
370572|NCT02004015|Analgesia|analgesia
370573|NCT02003976|knee osteoarthritis|knee osteoarthritis
370574|NCT02003976|high tibial osteotomy|high tibial osteotomy
370575|NCT02003976|gait analysis|gait analysis
370576|NCT02003976|muscular strength|muscular strength
370577|NCT02003976|body composition|body composition
370578|NCT02003976|magnetic resonance imaging|magnetic resonance imaging
370579|NCT02003976|biological markers|biological markers
370580|NCT02003963|Physical Activity|physical activity
370581|NCT02003963|Sedentary Behavior|sedentary behavior
370582|NCT02003963|Video Games|video games
370583|NCT02003963|Exergames|exergames
370584|NCT02003911|Asthma|asthma
370585|NCT02003911|Acute asthma exacerbation|acute asthma exacerbation
370586|NCT02003911|Pediatric|pediatric
370587|NCT02003911|Azithromycin|azithromycin
370588|NCT02003911|Macrolide|macrolide
370589|NCT02003911|Length of Stay|length of stay
370590|NCT02003911|Hospital Medicine|hospital medicine
370591|NCT02003898|Diabetes|diabetes
370592|NCT02003898|Insulin pump|insulin pump
370593|NCT02003898|Threshold Suspend|threshold suspend
370594|NCT02003885|Desflurane, mitral annular velocity, tissue Doppler imaging|desflurane, mitral annular velocity, tissue doppler imaging
370595|NCT02003859|IBD|ibd
370596|NCT02003859|Pediatrics|pediatrics
370597|NCT02003859|pCLE|pcle
370598|NCT02003833|Poly-L-lactic acid|poly-l-lactic acid
370599|NCT02003833|Sculptra Aesthetic|sculptra aesthetic
370600|NCT02003833|Skin Quality|skin quality
370601|NCT02003833|Wrinkles|wrinkles
370602|NCT02003833|Filler|filler
370603|NCT02003820|Autism|autism
370604|NCT02003820|Dental Caries|dental caries
370605|NCT02003820|Prevention|prevention
370606|NCT02003820|Oral Hygiene|oral hygiene
370607|NCT02003794|acute ischemic stroke|acute ischemic stroke
370608|NCT02003794|intravenous fluid|intravenous fluid
370609|NCT02003794|้hydration|้hydration
370610|NCT02003781|cardiovascular disease|cardiovascular disease
370611|NCT02003781|metabolic disease|metabolic disease
370612|NCT02003781|high risk|high risk
370613|NCT02003781|prospective cohort|prospective cohort
370614|NCT02003768|pneumoperitoneum|pneumoperitoneum
370615|NCT02003768|optic nerve sheath diameter|optic nerve sheath diameter
370616|NCT02003768|laparoscopy|laparoscopy
370617|NCT02003768|Patients|patients
370618|NCT02003768|general anesthesia|general anesthesia
370619|NCT02003768|diameter|diameter
370620|NCT02003755|Cerebral palsy|cerebral palsy
370621|NCT02003755|Continuous passive motion|continuous passive motion
370622|NCT02003755|Hypertonia|hypertonia
370623|NCT02003742|LUTS|luts
370624|NCT02003742|BPH|bph
370625|NCT02003729|obstructive sleep apnea|obstructive sleep apnea
370626|NCT02003729|Portable Monitor|portable monitor
370627|NCT02003729|AHI|ahi
370628|NCT02003729|ESS|ess
370629|NCT02003729|Cost effectiveness|cost effectiveness
370630|NCT02003703|Vaccine|vaccine
370631|NCT02003703|Primary Prevention|primary prevention
370632|NCT02003703|Immunogenicity|immunogenicity
370633|NCT02003690|Bipolar disorder|bipolar disorder
370634|NCT02003690|Adolescent suicidal behavior|adolescent suicidal behavior
370635|NCT02003690|Psychotherapy|psychotherapy
370636|NCT02003664|Cocaine|cocaine
370637|NCT02003664|Treatment|treatment
370638|NCT02003664|fMRI|fmri
370639|NCT02003664|Outcomes|outcomes
370640|NCT02003651|Common cold|common cold
370641|NCT02003625|Non-Hodgkin's lymphoma|non-hodgkin's lymphoma
370642|NCT02003625|Hodgkin's lymphoma|hodgkin's lymphoma
370643|NCT02003625|Multiple myeloma|multiple myeloma
370644|NCT02003625|Hematopoietic stem cells|hematopoietic stem cells
370645|NCT02003599|Radiodermatitis|radiodermatitis
370646|NCT02003599|Breast neoplasms|breast neoplasms
370647|NCT02003599|Laser Therapy, Low- Level|laser therapy, low- level
370648|NCT02003586|subjects|subjects
370649|NCT02003560|breast cancer|breast cancer
370650|NCT02003560|breast conserving therapy|breast conserving therapy
370651|NCT02003560|accelerated partial breast irradiation|accelerated partial breast irradiation
370652|NCT02003560|3D conformal radiotherapy|3d conformal radiotherapy
370653|NCT02003560|intensity modulated radiotherapy|intensity modulated radiotherapy
370654|NCT02003521|Lung Flute|lung flute
370655|NCT02003508|Prevalence|prevalence
370656|NCT02003508|HPV|hpv
370657|NCT02003508|Human papillomavirus|human papillomavirus
370658|NCT02003508|Vaccination|vaccination
370659|NCT02003495|Immunogenicity, Safety, Meningococcal Conjugate Vaccine|immunogenicity, safety, meningococcal conjugate vaccine
370660|NCT02003482|Head and Neck Cancer|head and neck cancer
370661|NCT02003482|Head and Neck Squamous Cell Carcinoma|head and neck squamous cell carcinoma
370662|NCT02003482|Intensity modulated radiation therapy|intensity modulated radiation therapy
370663|NCT02003482|IMRT|imrt
370664|NCT02003482|Anatomic Changes|anatomic changes
370665|NCT02003482|Postoperative|postoperative
370666|NCT02003482|Unresectable|unresectable
370667|NCT02003469|hypertension|hypertension
370668|NCT02003469|kidney disease|kidney disease
370669|NCT02003469|cardiovascular disease|cardiovascular disease
370670|NCT02003456|positron emission tomography|positron emission tomography
370671|NCT02003456|rubidium|rubidium
370672|NCT02003456|myocardial perfusion imaging|myocardial perfusion imaging
370673|NCT02003456|viability|viability
370674|NCT02003456|FDG|fdg
370675|NCT02003443|Acupressure|acupressure
370676|NCT02003443|Older Adults|older adults
370677|NCT02003443|Knee pain|knee pain
370678|NCT02003443|Pain Treatment|pain treatment
370679|NCT02003430|gynecologic malignancy|gynecologic malignancy
370680|NCT02003430|non-ovarian gynecological cancer|non-ovarian gynecological cancer
370681|NCT02003430|cervical cancer|cervical cancer
370682|NCT02003430|vaginal cancer|vaginal cancer
370683|NCT02003430|vulvar cancer|vulvar cancer
370684|NCT02003430|endometrial cancer|endometrial cancer
370685|NCT02003417|Prostate cancer|prostate cancer
370686|NCT02003417|External beam radiation treatment|external beam radiation treatment
370687|NCT02003417|Androgen deprivation therapy|androgen deprivation therapy
370688|NCT02003417|Definitive treatment|definitive treatment
370689|NCT02003417|Cardiovascular risk factors|cardiovascular risk factors
370690|NCT02003417|Quality of life|quality of life
370691|NCT02003404|ostomy appliance|ostomy appliance
370692|NCT02003391|Open Angle Glaucoma|open angle glaucoma
370693|NCT02003391|Ocular Hypertension|ocular hypertension
370694|NCT02003391|Intraocular Pressure|intraocular pressure
370695|NCT02003378|Chronotropic incompetence|chronotropic incompetence
370696|NCT02003365|osteoarthritis|osteoarthritis
370697|NCT02003365|knee|knee
370698|NCT02003365|corticosteroids|corticosteroids
370699|NCT02003365|triamcinolone acetonide|triamcinolone acetonide
370700|NCT02003365|synovial fluid|synovial fluid
370701|NCT02003352|TBI|tbi
370702|NCT02003352|PTSD|ptsd
370703|NCT02003352|Functional Neurology|functional neurology
370704|NCT02003352|Vestibular Rehabilitation|vestibular rehabilitation
370705|NCT02003352|Dynamic Computerized Posturography|dynamic computerized posturography
370706|NCT02003352|Saccadometry|saccadometry
370707|NCT02003313|safety, immunogenicity, Meningococcal Polysaccharide Vaccine|safety, immunogenicity, meningococcal polysaccharide vaccine
370708|NCT02003300|Oxygen uptake|oxygen uptake
370709|NCT02003300|Anesthetic gas uptake|anesthetic gas uptake
370710|NCT02003287|Deglutition Disorders|deglutition disorders
370711|NCT02003287|Intensive Care Units, Neonatal|intensive care units, neonatal
370712|NCT02003274|Mixed Meal Test|mixed meal test
370713|NCT02003274|Insulin Pump|insulin pump
370714|NCT02003274|Continuous Glucose Monitoring|continuous glucose monitoring
370715|NCT02003274|Metabolic Control Analysis|metabolic control analysis
370716|NCT02003274|Closed Loop Control|closed loop control
370717|NCT02003274|Artificial Pancreas|artificial pancreas
370718|NCT02003248|Parkinson's disease|parkinson's disease
370719|NCT02003248|ultrasound|ultrasound
370720|NCT02003248|dyskinesia|dyskinesia
370721|NCT02003248|magnetic resonance|magnetic resonance
370722|NCT02003235|Amblyopia|amblyopia
370723|NCT02003196|Brain injury|brain injury
370725|NCT02003196|immunosuppression|immunosuppression
370726|NCT02003196|mechanical ventilation|mechanical ventilation
370727|NCT02003183|Chronic Traumatic Encephalopathy|chronic traumatic encephalopathy
370728|NCT02003183|Traumatic Brain Injury|traumatic brain injury
370729|NCT02003183|Cognitive Impairment|cognitive impairment
370730|NCT02003183|Positron Emission Tomography|positron emission tomography
370731|NCT02003183|[F-18]FDDNP|[f-18]fddnp
370732|NCT02003170|Autism|autism
370733|NCT02003170|Autism Spectrum Disorder (ASD)|autism spectrum disorder (asd)
370734|NCT02003170|Pervasive Developmental Disorder (PDD)|pervasive developmental disorder (pdd)
370735|NCT02003170|Developmental delays|developmental delays
370736|NCT02003170|Genetic disorder|genetic disorder
370737|NCT02003170|Mitochondrial disorder|mitochondrial disorder
370738|NCT02003157|hypnosis embryo transfer IVF ICSI|hypnosis embryo transfer ivf icsi
370739|NCT02003144|Long-term safety study|long-term safety study
370740|NCT02003144|Extension trial|extension trial
370741|NCT02003144|Eculizumab|eculizumab
370742|NCT02003144|Neuromyelitis Optica Spectrum Disorder|neuromyelitis optica spectrum disorder
370743|NCT02003144|Devic's disease|devic's disease
370744|NCT02003144|Transverse Myelitis|transverse myelitis
370745|NCT02003144|Optic Neuritis|optic neuritis
370746|NCT02003144|Relapse|relapse
370747|NCT02003144|NMO-IgG|nmo-igg
370748|NCT02003144|CNS Autoimmune Disorders|cns autoimmune disorders
370749|NCT02003144|Demyelinating Disorders|demyelinating disorders
370750|NCT02003131|osteoarthritis|osteoarthritis
370751|NCT02003131|umbilical cord|umbilical cord
370752|NCT02003131|mesenchymal|mesenchymal
370753|NCT02003131|stem cells|stem cells
370754|NCT02003131|trophic factors|trophic factors
370755|NCT02003092|Metastatic|metastatic
370756|NCT02003092|Rexahn|rexahn
370757|NCT02003092|Phase 1|phase 1
370758|NCT02003092|Triple Negative Breast Cancer|triple negative breast cancer
370759|NCT02003092|Phase 2|phase 2
370760|NCT02003092|Relapsed|relapsed
370761|NCT02003066|Fluid Therapy|fluid therapy
370762|NCT02003066|Head and Neck Neoplasms|head and neck neoplasms
370763|NCT02003066|Surgical Flaps|surgical flaps
370764|NCT02003053|Critically ill|critically ill
370765|NCT02003053|intubated|intubated
370766|NCT02003053|safety|safety
370767|NCT02003053|feasibility|feasibility
370768|NCT02003053|inspiratory muscle training|inspiratory muscle training
370769|NCT02003014|Drug Therapy|drug therapy
370770|NCT02002975|Drug Therapy|drug therapy
370771|NCT02002949|Hemodialysis|hemodialysis
370772|NCT02002910|iFR|ifr
370773|NCT02002910|FFR|ffr
370774|NCT02002910|Medical Economy|medical economy
370775|NCT02002910|physiological assessment|physiological assessment
370776|NCT02002910|SYNTAX score|syntax score
370777|NCT02002897|Localized scleroderma UVA1 fractional carbon dioxide laser|localized scleroderma uva1 fractional carbon dioxide laser
370778|NCT02002884|Upper limb spasticity|upper limb spasticity
370779|NCT02002884|lower limb spasticity|lower limb spasticity
370780|NCT02002884|combined upper and lower limb spasticity|combined upper and lower limb spasticity
370781|NCT02002858|smoking|smoking
370782|NCT02002858|cessation|cessation
370783|NCT02002858|anxiety|anxiety
370784|NCT02002858|anxious|anxious
370785|NCT02002858|depression|depression
370786|NCT02002858|depressed|depressed
370787|NCT02002858|smoker|smoker
370788|NCT02002858|stress|stress
370789|NCT02002845|Tongue base resection, partial glossectomy|tongue base resection, partial glossectomy
370790|NCT02002832|schizophrenia|schizophrenia
370791|NCT02002832|Lurasidone|lurasidone
370792|NCT02002832|LATUDA|latuda
370793|NCT02002819|Alzheimer's disease|alzheimer's disease
370794|NCT02002819|AD|ad
370795|NCT02002819|Early-onset AD|early-onset ad
370796|NCT02002819|EOAD|eoad
370797|NCT02002819|Early-onset Alzheimer's|early-onset alzheimer's
370798|NCT02002819|Early-onset Alzheimer's disease|early-onset alzheimer's disease
370799|NCT02002806|Pancreatic cancer|pancreatic cancer
370800|NCT02002806|Pain|pain
370801|NCT02002793|pancreatitis|pancreatitis
370802|NCT02002793|early stage|early stage
370803|NCT02002793|mini-invasive abdominal drainage|mini-invasive abdominal drainage
370804|NCT02002780|pediatrics|pediatrics
370805|NCT02002780|stress|stress
370806|NCT02002780|cardiac surgery|cardiac surgery
370807|NCT02002754|eosinophilic bronchitis|eosinophilic bronchitis
370808|NCT02002754|cough variant asthma|cough variant asthma
370809|NCT02002754|bronchodilator|bronchodilator
370810|NCT02002741|patent ductus arteriosus|patent ductus arteriosus
370811|NCT02002741|PDA|pda
370812|NCT02002741|Preterm|preterm
370813|NCT02002741|Infant|infant
370814|NCT02002741|Electrocardiography|electrocardiography
370815|NCT02002741|Paracetamol|paracetamol
370816|NCT02002741|Acamol|acamol
370817|NCT02002741|ibuprofen|ibuprofen
370818|NCT02002741|Placebo|placebo
370819|NCT02002715|eosinophilic bronchitis|eosinophilic bronchitis
370820|NCT02002715|inhaled corticosteroids|inhaled corticosteroids
370821|NCT02002715|therapeutic effect|therapeutic effect
370822|NCT02002702|Acute heart failure (AHF),|acute heart failure (ahf),
370823|NCT02002702|Japanese,|japanese,
370824|NCT02002702|Safety and tolerability, Pharmacokinetics,|safety and tolerability, pharmacokinetics,
370825|NCT02002702|Renal Impairment|renal impairment
370826|NCT02002689|Solid tumor malignancy,|solid tumor malignancy,
370827|NCT02002689|hematologic malignancy,|hematologic malignancy,
370828|NCT02002689|mutation, translocations,|mutation, translocations,
370829|NCT02002689|signature,|signature,
370830|NCT02002689|PTCH1,|ptch1,
370831|NCT02002689|SMO,|smo,
370832|NCT02002689|LDE225,|lde225,
370833|NCT02002689|endometrial cancer,|endometrial cancer,
370834|NCT02002689|colon cancer,|colon cancer,
370835|NCT02002689|bladder,|bladder,
370836|NCT02002689|NSCLC|nsclc
370837|NCT02002676|rest energy expenditure,critical ill, outcome|rest energy expenditure,critical ill, outcome
370838|NCT02002650|Indomethacin, pancreatitis, ERCP|indomethacin, pancreatitis, ercp
370839|NCT02002611|Lobeglitazone|lobeglitazone
370840|NCT02002611|Warfarin|warfarin
370841|NCT02002611|Type 2 Diabetes Mellitus|type 2 diabetes mellitus
370842|NCT02002611|Drug-Drug interaction|drug-drug interaction
370843|NCT02002611|Phase 1|phase 1
370844|NCT02002598|Newly diagnosed|newly diagnosed
370845|NCT02002598|multiple myeloma|multiple myeloma
370846|NCT02002598|myeloma|myeloma
370847|NCT02002598|bendamustine|bendamustine
370848|NCT02002598|Treanda|treanda
370849|NCT02002598|carfilzomib|carfilzomib
370850|NCT02002598|dexamethasone|dexamethasone
370851|NCT02002598|phase I|phase i
370852|NCT02002598|phase II|phase ii
370853|NCT02002598|dose escalation|dose escalation
370854|NCT02002598|transplant|transplant
370855|NCT02002598|non-transplant|non-transplant
370856|NCT02002598|plasma cell|plasma cell
370857|NCT02002598|Kyprolis|kyprolis
370858|NCT02002585|Renal protection|renal protection
370859|NCT02002585|Renal sympathetic denervation|renal sympathetic denervation
370860|NCT02002572|Facial Mimic Muscle|facial mimic muscle
370861|NCT02002572|MRI|mri
370862|NCT02002572|Segmentation|segmentation
370863|NCT02002572|Three dimensional assessment|three dimensional assessment
370864|NCT02002572|Motion capture|motion capture
370865|NCT02002572|Movement analysis|movement analysis
370866|NCT02002572|Digital Image Correlation|digital image correlation
370867|NCT02002546|Heart Attack|heart attack
370868|NCT02002546|Myocardial Infarction|myocardial infarction
370869|NCT02002546|Angina|angina
370870|NCT02002546|Chest Pain|chest pain
370871|NCT02002520|Acute pain|acute pain
370872|NCT02002520|Epigenetic|epigenetic
370873|NCT02002520|Dental pain|dental pain
370874|NCT02002468|Risk Communication|risk communication
370875|NCT02002468|Follow-up|follow-up
370876|NCT02002468|Organisation of screening|organisation of screening
370877|NCT02002455|FACBC|facbc
370878|NCT02002455|PET/CT|pet/ct
370879|NCT02002455|PET/MRI|pet/mri
370880|NCT02002455|Radical prostatectomy|radical prostatectomy
370881|NCT02002455|Radiotherapy|radiotherapy
370882|NCT02002442|Mouthwash|mouthwash
370883|NCT02002442|Chlorhexidine|chlorhexidine
370884|NCT02002442|cetylpyridinium chloride|cetylpyridinium chloride
370885|NCT02002442|Saline|saline
370886|NCT02002442|Implants|implants
370887|NCT02002442|Saliva Collection|saliva collection
370888|NCT02002429|Facet joint|facet joint
370889|NCT02002429|Medial branch block|medial branch block
370890|NCT02002429|Radiofrequency denervation|radiofrequency denervation
370891|NCT02002429|Zygapophysial joint|zygapophysial joint
370892|NCT02002429|Low back pain|low back pain
370893|NCT02002416|C-met expression, gastric cancer, overall survival|c-met expression, gastric cancer, overall survival
370894|NCT02002403|Edema|edema
370895|NCT02002403|Macular Edema|macular edema
370896|NCT02002403|Retinal Diseases|retinal diseases
370897|NCT02002403|Eye Diseases|eye diseases
370898|NCT02002403|Danazol|danazol
370899|NCT02002403|Estrogen Antagonists|estrogen antagonists
370900|NCT02002403|Estrogen Receptor Modulators|estrogen receptor modulators
370901|NCT02002403|Hormone Antagonists|hormone antagonists
370902|NCT02002403|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists
370903|NCT02002403|Physiological Effects of Drugs|physiological effects of drugs
370904|NCT02002403|Pharmacologic Actions|pharmacologic actions
370905|NCT02002390|Stroke,Fingolimod(FTY 720), treatment|stroke,fingolimod(fty 720), treatment
370906|NCT02002377|Age Related Macular Degeneration, wet|age related macular degeneration, wet
370907|NCT02002377|aflibercept|aflibercept
370908|NCT02002364|tracheal intubation|tracheal intubation
370909|NCT02002338|pterygium surgery|pterygium surgery
370910|NCT02002338|refractive changes|refractive changes
370911|NCT02002338|surgical technique|surgical technique
370912|NCT02002312|Advanced Renal Cell Carcinoma|advanced renal cell carcinoma
370913|NCT02002312|Clear Cell Renal Cell Carcinoma (ccRCC)|clear cell renal cell carcinoma (ccrcc)
370914|NCT02002312|Lutetium-177|lutetium-177
370915|NCT02002312|Lu-177|lu-177
370916|NCT02002312|girentuximab|girentuximab
370917|NCT02002312|cG250|cg250
370918|NCT02002312|Monoclonal Antibody|monoclonal antibody
370919|NCT02002299|colorectal cancer|colorectal cancer
370920|NCT02002299|surface|surface
370921|NCT02002299|invasive front|invasive front
370922|NCT02002299|tumor budding|tumor budding
370923|NCT02002286|HIV-infected immunological non-responders|hiv-infected immunological non-responders
370924|NCT02002286|Tripterygium Wilfordii Hook F|tripterygium wilfordii hook f
370925|NCT02002286|Immune activation|immune activation
370926|NCT02002247|antioxidants|antioxidants
370927|NCT02002247|selenium|selenium
370928|NCT02002247|heart disease|heart disease
370929|NCT02002247|cardiac surgery|cardiac surgery
370930|NCT02002247|perioperative|perioperative
370931|NCT02002234|Hemicraniectomy, stroke, decompressive surgery, HeMMI|hemicraniectomy, stroke, decompressive surgery, hemmi
370932|NCT02002221|Diabetes Mellitus (DM) ,|diabetes mellitus (dm) ,
370933|NCT02002221|diabetes,|diabetes,
370934|NCT02002221|noninsulin-dependent diabetes mellitus (NIDDM),|noninsulin-dependent diabetes mellitus (niddm),
370935|NCT02002221|adult-onset diabetes,|adult-onset diabetes,
370936|NCT02002221|high blood sugar,|high blood sugar,
370937|NCT02002221|T2DM|t2dm
370938|NCT02002195|metastatic gastric cancer,|metastatic gastric cancer,
370939|NCT02002195|elderly,|elderly,
370940|NCT02002195|folinic acid,|folinic acid,
370941|NCT02002195|fluorouracil,|fluorouracil,
370942|NCT02002195|oxaliplatin,|oxaliplatin,
370943|NCT02002195|capecitabine,|capecitabine,
370944|NCT02002195|overall survival,|overall survival,
370945|NCT02002195|progression free survival|progression free survival
370946|NCT02002182|HPV|hpv
370947|NCT02002182|oropharynx|oropharynx
370948|NCT02002182|squamous cell carcinoma|squamous cell carcinoma
370949|NCT02002182|head and neck cancer|head and neck cancer
370950|NCT02002182|transoral robotic surgery|transoral robotic surgery
370951|NCT02002169|Catheter Related Bacteremia|catheter related bacteremia
370952|NCT02002143|Diabetes|diabetes
370953|NCT02002143|Older People|older people
370954|NCT02002143|Seniors|seniors
370955|NCT02002143|Group Appointments|group appointments
370956|NCT02002143|Group Medical Visits|group medical visits
370957|NCT02002143|Shared Appointments|shared appointments
370958|NCT02002143|Quality of Life|quality of life
370959|NCT02002143|Physical Activity|physical activity
370960|NCT02002143|Health care Utilization|health care utilization
370961|NCT02002143|Depression|depression
370962|NCT02002143|Anxiety|anxiety
370963|NCT02002130|Diabetes|diabetes
370964|NCT02002104|Expanded polytetrafluoroethylene( ePTFE)|expanded polytetrafluoroethylene( eptfe)
370965|NCT02002091|Type2 diabetes mellitus|type2 diabetes mellitus
370966|NCT02002091|Microangiopathy|microangiopathy
370967|NCT02002091|Chronic Kidney disease|chronic kidney disease
370968|NCT02002091|Cardiovascular disease|cardiovascular disease
370969|NCT02002078|caustic|caustic
370970|NCT02002078|corticosteroid therapy|corticosteroid therapy
370971|NCT02002078|stricture|stricture
370972|NCT02002078|children|children
370973|NCT02002065|hepatitis A|hepatitis a
370974|NCT02002065|inactivated hepatitis A vaccine|inactivated hepatitis a vaccine
370975|NCT02002065|attenuated alive hepatitis A vaccine|attenuated alive hepatitis a vaccine
370976|NCT02002065|immune persistence|immune persistence
370977|NCT02002052|non-small cell lung cancer, radiotherapy, chemotherapy, pneumonitis, functional lung avoidance|non-small cell lung cancer, radiotherapy, chemotherapy, pneumonitis, functional lung avoidance
370978|NCT02002039|Perinatal asphyxia|perinatal asphyxia
370979|NCT02002039|erythropoietin|erythropoietin
370980|NCT02002026|placenta previa, uterine artery ligation|placenta previa, uterine artery ligation
370981|NCT02002013|Adult|adult
370982|NCT02002013|ICU patient|icu patient
370983|NCT02002013|Fluid resuscitation|fluid resuscitation
370984|NCT02002013|observational study|observational study
370985|NCT02002000|Vitamin D deficiency|vitamin d deficiency
370986|NCT02002000|Musculoskeletal pain|musculoskeletal pain
370987|NCT02002000|Vitamin D supplementation|vitamin d supplementation
370988|NCT02001974|HER 2 negative|her 2 negative
370989|NCT02001974|metastatic breast cancer|metastatic breast cancer
370990|NCT02001974|Cancer Stem Cells|cancer stem cells
370991|NCT02001961|Fibrosis|fibrosis
370992|NCT02001961|collagen metabolism|collagen metabolism
370993|NCT02001961|paediatric, dilated cardiomyopathy|paediatric, dilated cardiomyopathy
370994|NCT02001961|biomarkers|biomarkers
370995|NCT02001961|T1 mapping|t1 mapping
370996|NCT02001961|MRI|mri
370997|NCT02001948|Spinal anaesthesia|spinal anaesthesia
370998|NCT02001948|morphine|morphine
370999|NCT02001948|postoperative analgesia|postoperative analgesia
371000|NCT02001948|vomiting|vomiting
371001|NCT02001935|COPD|copd
371002|NCT02001935|theophylline|theophylline
371003|NCT02001935|CYP1A2|cyp1a2
371004|NCT02001935|CYP2E1|cyp2e1
371005|NCT02001922|COPD|copd
371006|NCT02001922|Pulmonary disease, chronic obstructive|pulmonary disease, chronic obstructive
371007|NCT02001922|Integrated care|integrated care
371008|NCT02001922|Outcome and process assessment|outcome and process assessment
371009|NCT02001922|Quality indicators, Health care|quality indicators, health care
371010|NCT02001922|Self-management,|self-management,
371011|NCT02001922|Patient empowerment|patient empowerment
371012|NCT02001922|Quantitative and qualitative methods|quantitative and qualitative methods
371013|NCT02001909|Regorafenib|regorafenib
371014|NCT02001909|Neomycin|neomycin
371015|NCT02001909|Cancer|cancer
371016|NCT02001909|Pharmacokinetics|pharmacokinetics
371017|NCT02001909|Safety|safety
371018|NCT02001896|NSCLC|nsclc
371019|NCT02001896|EGFR-TKI|egfr-tki
371020|NCT02001883|Coronary artery disease, nutraceuticals, statins|coronary artery disease, nutraceuticals, statins
371021|NCT02001870|Infertility|infertility
371022|NCT02001870|female age|female age
371023|NCT02001870|intra-uterine insemination|intra-uterine insemination
371024|NCT02001870|in vitro fecundation|in vitro fecundation
371025|NCT02001870|assisted reproductive technology center|assisted reproductive technology center
371026|NCT02001857|patients,|patients,
371027|NCT02001857|undergoing|undergoing
371028|NCT02001857|pelvic|pelvic
371029|NCT02001857|lymph|lymph
371030|NCT02001857|node|node
371031|NCT02001857|dissection.|dissection.
371032|NCT02001831|Sarcopenia|sarcopenia
371033|NCT02001831|Frailty|frailty
371034|NCT02001831|Aging|aging
371035|NCT02001831|Skeletal muscle|skeletal muscle
371036|NCT02001831|Nutrition|nutrition
371037|NCT02001792|sedation|sedation
371038|NCT02001792|endoscopy|endoscopy
371039|NCT02001792|patient positioning|patient positioning
371040|NCT02001792|hypoxemia|hypoxemia
371041|NCT02001779|Malignant biliary obstruction|malignant biliary obstruction
371042|NCT02001779|Obstruction/stricture|obstruction/stricture
371043|NCT02001779|Stent|stent
371044|NCT02001779|Brachytherapy|brachytherapy
371045|NCT02001779|Bile duct|bile duct
371046|NCT02001766|High intensity exercise|high intensity exercise
371047|NCT02001766|Glycemic control|glycemic control
371048|NCT02001766|Exercise|exercise
371049|NCT02001740|shoulder|shoulder
371050|NCT02001701|vitreomacular adhesion|vitreomacular adhesion
371051|NCT02001701|vitreomacular traction|vitreomacular traction
371052|NCT02001701|macular hole|macular hole
371053|NCT02001701|epiretinal membrane|epiretinal membrane
371054|NCT02001701|intravitreal gas|intravitreal gas
371055|NCT02001701|sulfahexafluoride gas|sulfahexafluoride gas
371056|NCT02001701|perfluoropropane gas|perfluoropropane gas
371057|NCT02001701|ocriplasmin|ocriplasmin
371058|NCT02001701|vitrectomy|vitrectomy
371059|NCT02001675|Neuromuscular electrical stimulation (NMES)|neuromuscular electrical stimulation (nmes)
371060|NCT02001662|Minor arthroscopic knee surgery including ACL-reconstruction (hamstrins graft)|minor arthroscopic knee surgery including acl-reconstruction (hamstrins graft)
371061|NCT02001662|High pain responders|high pain responders
371062|NCT02001662|Adductore Canal Block|adductore canal block
371063|NCT02001662|Analgesics|analgesics
371064|NCT02001662|Ultrasound guided nerve block|ultrasound guided nerve block
371065|NCT02001649|suicide|suicide
371066|NCT02001649|adolescent|adolescent
371067|NCT02001649|genetic|genetic
371068|NCT02001649|SNP|snp
371069|NCT02001636|Bariatric surgery|bariatric surgery
371070|NCT02001636|Protein malnutrition|protein malnutrition
371071|NCT02001636|Protein supplementation|protein supplementation
371072|NCT02001636|Body composition|body composition
371073|NCT02001636|Body fat mass|body fat mass
371074|NCT02001636|Protein intake|protein intake
371075|NCT02001623|ovary cancer|ovary cancer
371076|NCT02001623|cervix cancer|cervix cancer
371077|NCT02001623|endometrium cancer|endometrium cancer
371078|NCT02001623|bladder cancer|bladder cancer
371079|NCT02001623|prostate cancer (CRPC)|prostate cancer (crpc)
371080|NCT02001623|esophagus cancer|esophagus cancer
371081|NCT02001623|lung cancer(NSCLC)|lung cancer(nsclc)
371082|NCT02001623|Squamous cell carcinoma of the head and neck (SCCHN)|squamous cell carcinoma of the head and neck (scchn)
371083|NCT02001610|microbiota|microbiota
371084|NCT02001610|probiotics|probiotics
371085|NCT02001610|fecal markers|fecal markers
371086|NCT02001597|surgery|surgery
371087|NCT02001597|robotic|robotic
371088|NCT02001597|ultrasound|ultrasound
371089|NCT02001597|guidance|guidance
371090|NCT02001597|endorectal|endorectal
371091|NCT02001571|Prostate Cancer|prostate cancer
371092|NCT02001571|Abiraterone acetate|abiraterone acetate
371093|NCT02001571|Pharmacokinetics|pharmacokinetics
371094|NCT02001558|Spinal cord injuries|spinal cord injuries
371095|NCT02001558|Pressure ulcer|pressure ulcer
371192|NCT02001090|Heart-Lung Machine|heart-lung machine
371193|NCT02001090|Coronary Artery Bypass|coronary artery bypass
371194|NCT02001090|Brachial Artery|brachial artery
371096|NCT02001545|acute coronary syndrome, antithrombotic management patterns,quality of life, acute clinical management strategies|acute coronary syndrome, antithrombotic management patterns,quality of life, acute clinical management strategies
371097|NCT02001532|Diabetes Mellitus, Type 2|diabetes mellitus, type 2
371098|NCT02001532|Diabetes Complications|diabetes complications
371099|NCT02001532|Diabetic Angiopathies|diabetic angiopathies
371100|NCT02001532|Diabetic Nephropathies|diabetic nephropathies
371101|NCT02001532|Myocardial Infarction|myocardial infarction
371102|NCT02001532|Stroke|stroke
371103|NCT02001532|Vascular Stiffness|vascular stiffness
371104|NCT02001532|Pulse Wave Analysis|pulse wave analysis
371105|NCT02001506|breast cancer|breast cancer
371106|NCT02001506|neoadjuvant|neoadjuvant
371107|NCT02001506|different number of chemotherapy cycles|different number of chemotherapy cycles
371108|NCT02001441|Physical Activity, Aging, Memory, Cognitive Impairment, MRI, Neuroscience|physical activity, aging, memory, cognitive impairment, mri, neuroscience
371109|NCT02001428|malaria|malaria
371110|NCT02001428|vivax|vivax
371111|NCT02001428|falciparum|falciparum
371112|NCT02001428|infants|infants
371113|NCT02001415|Progressive Myopia|progressive myopia
371114|NCT02001415|Contact Lenses|contact lenses
371115|NCT02001415|Spectacles|spectacles
371116|NCT02001402|climacteric symptoms ; nurse ;|climacteric symptoms ; nurse ;
371117|NCT02001402|intervention;follow-up|intervention;follow-up
371118|NCT02001389|Enzyme occupancy|enzyme occupancy
371119|NCT02001389|Positron emission tomography (PET)|positron emission tomography (pet)
371120|NCT02001389|Phosphodiesterase 10 inhibitor|phosphodiesterase 10 inhibitor
371121|NCT02001363|Reperfusion injury|reperfusion injury
371122|NCT02001363|Liraglutide|liraglutide
371123|NCT02001337|pancreatic cancer|pancreatic cancer
371124|NCT02001337|new-onset diabetic|new-onset diabetic
371125|NCT02001337|diabetes|diabetes
371126|NCT02001324|quality of life, heavy menstrual bleeding, electronic data collection|quality of life, heavy menstrual bleeding, electronic data collection
371127|NCT02001311|chlorhexidine gel|chlorhexidine gel
371128|NCT02001311|orthodontic brackets|orthodontic brackets
371129|NCT02001311|orthodontic patients|orthodontic patients
371130|NCT02001311|bacterial count|bacterial count
371131|NCT02001311|friction|friction
371132|NCT02001298|remifentanil|remifentanil
371133|NCT02001298|nitroprusside|nitroprusside
371134|NCT02001298|hypotension|hypotension
371135|NCT02001285|remifentanil|remifentanil
371136|NCT02001272|Elderly|elderly
371137|NCT02001272|Vulnerable|vulnerable
400547|NCT01866345|Osteotomy|osteotomy
371138|NCT02001272|Ovarian cancer|ovarian cancer
371139|NCT02001272|Chemotherapy|chemotherapy
371140|NCT02001259|post-operative pain control|post-operative pain control
371141|NCT02001259|total knee arthroplasty|total knee arthroplasty
371142|NCT02001259|epidural steroid injection|epidural steroid injection
371143|NCT02001246|mindfulness|mindfulness
371144|NCT02001246|cognitive behavior therapy|cognitive behavior therapy
371145|NCT02001246|awareness|awareness
371146|NCT02001246|anger|anger
371147|NCT02001246|aggression|aggression
371148|NCT02001233|EV71 vaccine|ev71 vaccine
371149|NCT02001233|EV71-associated HFMD|ev71-associated hfmd
371150|NCT02001233|efficacy|efficacy
371151|NCT02001233|safety|safety
371152|NCT02001233|immune persistence|immune persistence
371153|NCT02001220|screening|screening
371154|NCT02001220|invasive ventilation|invasive ventilation
371155|NCT02001220|mechanical ventilation|mechanical ventilation
371156|NCT02001220|weaning|weaning
371157|NCT02001220|spontaneous breathing trials|spontaneous breathing trials
371158|NCT02001194|Sedentary|sedentary
371159|NCT02001194|Behavioral Economic Intervention|behavioral economic intervention
371160|NCT02001194|Team Studies|team studies
371161|NCT02001194|Financial Incentives|financial incentives
371162|NCT02001194|Workplace Wellness|workplace wellness
371163|NCT02001194|Team Incentives|team incentives
371164|NCT02001181|Atopic Dermatitis|atopic dermatitis
371165|NCT02001181|Atopic Eczema|atopic eczema
371166|NCT02001181|Eczema|eczema
371167|NCT02001181|topical treatment|topical treatment
371168|NCT02001181|skin diseases|skin diseases
371169|NCT02001181|tofacitinib|tofacitinib
371170|NCT02001181|CP-690|cp-690
371171|NCT02001181|550|550
371172|NCT02001181|Janus Kinase inhibitor|janus kinase inhibitor
371173|NCT02001155|Water drinking test|water drinking test
371174|NCT02001155|trabeculectomy|trabeculectomy
371175|NCT02001155|tube shunt|tube shunt
371176|NCT02001142|Insulin Sensitivity|insulin sensitivity
371177|NCT02001142|Exercise|exercise
371178|NCT02001142|Metabolism|metabolism
371179|NCT02001129|Eye care adherence|eye care adherence
371180|NCT02001129|health care utilization|health care utilization
371181|NCT02001116|Quality of care|quality of care
371182|NCT02001116|Hospital|hospital
371183|NCT02001116|Children|children
371184|NCT02001116|WHO guideline|who guideline
371185|NCT02001103|adjuvant therapy|adjuvant therapy
371186|NCT02001103|cognitive deficits|cognitive deficits
371187|NCT02001103|first episode schizophrenia|first episode schizophrenia
371188|NCT02001103|glutamate hypothesis|glutamate hypothesis
371189|NCT02001103|memantine|memantine
371190|NCT02001103|negative symptoms|negative symptoms
371191|NCT02001090|Cardiac Surgical Procedures|cardiac surgical procedures
371195|NCT02001090|Vasodilation|vasodilation
371196|NCT02001090|Regional Blood Flow|regional blood flow
371197|NCT02001090|Ultrasonography|ultrasonography
371198|NCT02001064|interventions|interventions
371199|NCT02001064|technology|technology
371200|NCT02001064|adherence|adherence
371201|NCT02001064|ARV|arv
371202|NCT02001051|Diabetes, Hypertension, Hypercholesterolemia, Obesity, and Osteoporosis.|diabetes, hypertension, hypercholesterolemia, obesity, and osteoporosis.
371203|NCT02001051|Nonoperative and Operative Management|nonoperative and operative management
371204|NCT02001051|Adrenal Incidentalomas|adrenal incidentalomas
371205|NCT02001051|Excess of Cortisol|excess of cortisol
371206|NCT02001025|coronary vessels|coronary vessels
371207|NCT02001025|coronary stenosis|coronary stenosis
371208|NCT02001025|percutaneous transluminal angioplasty|percutaneous transluminal angioplasty
371209|NCT02001025|stents|stents
371210|NCT02001025|drug-eluting stents|drug-eluting stents
371211|NCT02001025|bioresorbable scaffolds|bioresorbable scaffolds
371212|NCT02001025|optical coherence tomography|optical coherence tomography
371213|NCT02001012|uncomplicated|uncomplicated
371214|NCT02001012|plasmodium|plasmodium
371215|NCT02001012|knowlesi|knowlesi
371216|NCT02001012|malaria|malaria
371217|NCT02001012|infection|infection
371218|NCT02000999|Bile duct stricture|bile duct stricture
371219|NCT02000999|Cholangiocarcinoma|cholangiocarcinoma
371220|NCT02000999|Pancreatic cancer|pancreatic cancer
371221|NCT02000999|Chronic pancreatitis|chronic pancreatitis
371222|NCT02000986|Hodgkin's Lymphoma|hodgkin's lymphoma
371223|NCT02000986|Brain and Nervous System|brain and nervous system
371224|NCT02000986|Non-Hodgkin's Lymphoma|non-hodgkin's lymphoma
371225|NCT02000986|Leukemia, not otherwise specified|leukemia, not otherwise specified
371226|NCT02000960|Glut1 DS|glut1 ds
371227|NCT02000947|anti-CTLA-4|anti-ctla-4
371228|NCT02000947|anti-PD-L1|anti-pd-l1
371229|NCT02000947|immunotherapy|immunotherapy
371230|NCT02000947|IMTC|imtc
371231|NCT02000934|TAK-659|tak-659
371232|NCT02000934|Solid Tumors|solid tumors
371233|NCT02000934|CLL|cll
371234|NCT02000934|DLBCL|dlbcl
371235|NCT02000921|Cigarette Smoking|cigarette smoking
371236|NCT02000921|Very Low Nicotine Content cigarettes (VLNC)|very low nicotine content cigarettes (vlnc)
371237|NCT02000921|Dual Tobacco Use|dual tobacco use
371238|NCT02000908|gynecological cancer|gynecological cancer
371239|NCT02000908|ovarian cancer|ovarian cancer
371240|NCT02000908|primary peritoneal cancer|primary peritoneal cancer
371241|NCT02000908|cervical caner|cervical caner
371242|NCT02000908|peripheral neuropathy|peripheral neuropathy
371243|NCT02000882|Breast Cancer|breast cancer
371244|NCT02000882|Triple Negative Breast Cancer|triple negative breast cancer
371245|NCT02000882|Brain Metastases|brain metastases
371246|NCT02000882|Capecitabine|capecitabine
371247|NCT02000882|Metastatic Breast Cancer|metastatic breast cancer
371248|NCT02000843|perforation|perforation
371249|NCT02000843|tympanoplasty|tympanoplasty
371250|NCT02000843|conchal cavum approach|conchal cavum approach
371251|NCT02000843|perichondrium/ cartilage|perichondrium/ cartilage
371252|NCT02000843|scar|scar
371253|NCT02000830|stannsoporfin|stannsoporfin
371254|NCT02000817|Beta Cell|beta cell
371255|NCT02000817|Monoclonal Antibody|monoclonal antibody
371256|NCT02000817|Otelixizumab|otelixizumab
371257|NCT02000817|Cytokine Release Syndrome|cytokine release syndrome
371258|NCT02000817|Epstein-Barr Virus|epstein-barr virus
371259|NCT02000817|Diabetes Mellitus|diabetes mellitus
371260|NCT02000804|Darapladib, Safety, Pharmacokinetics, Pharmacodynamics, Healthy Chinese Subjects|darapladib, safety, pharmacokinetics, pharmacodynamics, healthy chinese subjects
371261|NCT02000791|cLMA|clma
371262|NCT02000791|laryngoscopy|laryngoscopy
371263|NCT02000791|fiberoptic|fiberoptic
371264|NCT02000778|Occult Ovarian Carcinoma|occult ovarian carcinoma
371265|NCT02000765|oral|oral
371266|NCT02000765|ADME|adme
371267|NCT02000765|IV|iv
371268|NCT02000765|antibiotic|antibiotic
371269|NCT02000765|healthy volunteer|healthy volunteer
371270|NCT02000765|[14C]-GSK2140944|[14c]-gsk2140944
371271|NCT02000765|mass balance|mass balance
371272|NCT02000765|radiolabel|radiolabel
371273|NCT02000752|Labor|labor
371274|NCT02000752|Acupuncture|acupuncture
371275|NCT02000752|Placental expulsion time|placental expulsion time
371276|NCT02000752|Postpartum hemorrhage|postpartum hemorrhage
371277|NCT02000739|Breast cancer|breast cancer
371278|NCT02000739|melanoma|melanoma
371279|NCT02000739|GI cancer|gi cancer
371280|NCT02000739|ovarian cancer|ovarian cancer
371281|NCT02000739|lung cancer|lung cancer
371282|NCT02000739|metastatic cancer|metastatic cancer
371283|NCT02000739|brain cancer|brain cancer
371284|NCT02000739|head and neck cancer|head and neck cancer
371285|NCT02000700|Diabetes Mellitus, Type 2|diabetes mellitus, type 2
371286|NCT02000700|Canagliflozin|canagliflozin
371287|NCT02000700|JNJ-28431754|jnj-28431754
371288|NCT02000700|Pharmacokinetics|pharmacokinetics
371289|NCT02000700|Pharmacodynamics|pharmacodynamics
371290|NCT02000700|Children|children
371291|NCT02000700|Adolescents|adolescents
371292|NCT02000674|tracheal intubation|tracheal intubation
371484|NCT01999920|ASAD|asad
371293|NCT02000674|pre hospital emergency|pre hospital emergency
371294|NCT02000661|Fractional Flow Reserve (FFR)|fractional flow reserve (ffr)
371295|NCT02000661|FFR guided coronary interventions|ffr guided coronary interventions
371296|NCT02000661|Percutaneous Coronary Intervention|percutaneous coronary intervention
371297|NCT02000648|Allergic Rhinitis|allergic rhinitis
371298|NCT02000648|Non-allergic Rhinitis|non-allergic rhinitis
371299|NCT02000648|Chronic urticaria|chronic urticaria
371300|NCT02000622|Breast Cancer|breast cancer
371301|NCT02000622|Metastatic|metastatic
371302|NCT02000622|Olaparib|olaparib
371303|NCT02000622|BRCA|brca
371304|NCT02000622|PARP inhibitor|parp inhibitor
371305|NCT02000622|HER2|her2
371306|NCT02000622|chemotherapy|chemotherapy
371307|NCT02000609|pharmacodynamics COPD|pharmacodynamics copd
371308|NCT02000596|HER2 overexpressed|her2 overexpressed
371309|NCT02000596|Metastatic Breast Cancer|metastatic breast cancer
371310|NCT02000596|Elderly|elderly
371311|NCT02000583|Alzheimer's Disease|alzheimer's disease
371312|NCT02000583|AD|ad
371313|NCT02000583|Aerobic Exercise|aerobic exercise
371314|NCT02000583|Exercise|exercise
371315|NCT02000570|sitting position|sitting position
371316|NCT02000570|PPV|ppv
371317|NCT02000570|SVV|svv
371318|NCT02000570|PVI|pvi
371319|NCT02000570|fluid challenge|fluid challenge
371320|NCT02000570|preload indicators|preload indicators
371321|NCT02000557|Photographic analysis|photographic analysis
371322|NCT02000557|Cephalometric analysis|cephalometric analysis
371323|NCT02000557|Standardized photographs|standardized photographs
371324|NCT02000557|Angular measurements|angular measurements
371325|NCT02000557|Linear measurements|linear measurements
371326|NCT02000557|Malocclusion|malocclusion
371327|NCT02000557|Facial Profile|facial profile
371328|NCT02000544|Extracorporeal Circulation|extracorporeal circulation
371329|NCT02000544|Cardiopulmonary Bypass|cardiopulmonary bypass
371330|NCT02000544|Cardiac surgery|cardiac surgery
371331|NCT02000531|Non-small-cell lung cancer (NSCLC)|non-small-cell lung cancer (nsclc)
371332|NCT02000518|emergency radiotherapy|emergency radiotherapy
371333|NCT02000518|MSCC|mscc
371334|NCT02000518|spine|spine
371335|NCT02000518|neurological outcome|neurological outcome
371336|NCT02000466|Women|women
371337|NCT02000466|Pregnancy exposure|pregnancy exposure
371338|NCT02000466|FluLaval Quadrivalent|flulaval quadrivalent
371339|NCT02000466|Pregnancy outcome|pregnancy outcome
371340|NCT02000466|Pregnancy Registry|pregnancy registry
371341|NCT02000453|Quality of Life|quality of life
371342|NCT02000453|Infection|infection
371343|NCT02000453|GSK2586184|gsk2586184
371344|NCT02000453|ulcerative colitis|ulcerative colitis
371345|NCT02000440|GW856553|gw856553
371346|NCT02000440|Focal segmental glomerulosclerosis (FSGS)|focal segmental glomerulosclerosis (fsgs)
371347|NCT02000440|p38 mitogen-activated protein kinase (MAPK) inhibitor|p38 mitogen-activated protein kinase (mapk) inhibitor
371348|NCT02000440|losmapimod|losmapimod
371349|NCT02000440|nephrotic syndrome|nephrotic syndrome
371350|NCT02000427|Relapsed; Refractory; Philadelphia Positive; B-precursor; Acute Lymphoblastic Leukemia; ALL; Blinatumomab; Leukemia;|relapsed; refractory; philadelphia positive; b-precursor; acute lymphoblastic leukemia; all; blinatumomab; leukemia;
371351|NCT02000414|intraperitoneal|intraperitoneal
371352|NCT02000414|peritoneal dialysis|peritoneal dialysis
371353|NCT02000414|daptomycin|daptomycin
371354|NCT02000414|pharmacokinetics|pharmacokinetics
371355|NCT02000414|peritonitis|peritonitis
371356|NCT02000375|metastatic breastcancer|metastatic breastcancer
371357|NCT02000375|ER/PgR-negative/AR-positive|er/pgr-negative/ar-positive
371358|NCT02000375|ER and/or PgR-positive/AR-positive|er and/or pgr-positive/ar-positive
371359|NCT02000375|Androgen Receptor positve|androgen receptor positve
371360|NCT02000362|Crohn's Disease|crohn's disease
371361|NCT02000362|Stem cell|stem cell
371362|NCT02000362|Cell therapy|cell therapy
371363|NCT02000362|Auto-immune disease|auto-immune disease
371364|NCT02000362|furestem|furestem
371365|NCT02000362|CD|cd
371366|NCT02000362|inflammatory bowel disease|inflammatory bowel disease
371367|NCT02000362|MSCs|mscs
371368|NCT02000362|Mesenchymal Stem Cells|mesenchymal stem cells
371369|NCT02000362|hUCB-MSC|hucb-msc
371370|NCT02000362|UCB-MSC|ucb-msc
371371|NCT02000362|Umbilical cord Blood|umbilical cord blood
371372|NCT02000349|infertility|infertility
371373|NCT02000349|next generation sequencing|next generation sequencing
371374|NCT02000336|radiographic damage|radiographic damage
371375|NCT02000336|rheumatoid arthritis|rheumatoid arthritis
371376|NCT02000323|pancreatitis|pancreatitis
371377|NCT02000323|enteral nutrition|enteral nutrition
371378|NCT02000310|Gaucher disease|gaucher disease
371379|NCT02000310|Fabry disease|fabry disease
371380|NCT02000310|Pompe disease|pompe disease
371381|NCT02000310|Niemann-Pick disease|niemann-pick disease
371382|NCT02000297|Osteoarthritis|osteoarthritis
371383|NCT02000297|Knee|knee
371384|NCT02000297|High tibial osteotomy|high tibial osteotomy
371385|NCT02000297|Calcium phosphate|calcium phosphate
371386|NCT02000297|Calcium sulfate|calcium sulfate
371387|NCT02000284|Autism Spectrum Disorder|autism spectrum disorder
371388|NCT02000284|ASD|asd
371389|NCT02000284|Autism|autism
371485|NCT01999907|asthma|asthma
371390|NCT02000284|Pervasive developmental disorder - Not Otherwise Specified|pervasive developmental disorder - not otherwise specified
371391|NCT02000284|PDD-NOS|pdd-nos
371392|NCT02000284|Asperger's Syndrome|asperger's syndrome
371393|NCT02000284|Mitochondrial Disease|mitochondrial disease
371394|NCT02000284|Developmental Delay|developmental delay
371395|NCT02000284|Typical Development|typical development
371396|NCT02000258|Anterior cruciate ligament reconstruction|anterior cruciate ligament reconstruction
371397|NCT02000258|Double-bundle|double-bundle
371398|NCT02000258|MRI|mri
371399|NCT02000258|Graft location|graft location
371400|NCT02000245|bronchoscopy|bronchoscopy
371401|NCT02000245|anxiety|anxiety
371402|NCT02000245|touch|touch
371403|NCT02000245|sympathy|sympathy
371404|NCT02000232|gout|gout
371405|NCT02000232|colchicine|colchicine
371406|NCT02000219|hyperoxaluria|hyperoxaluria
371407|NCT02000219|oxalate|oxalate
371408|NCT02000219|PH|ph
371409|NCT02000219|dialysis|dialysis
371410|NCT02000206|Ketamine|ketamine
371411|NCT02000206|Alfentanil|alfentanil
371412|NCT02000206|Propofol|propofol
371413|NCT02000206|Oxygen saturation|oxygen saturation
371414|NCT02000206|Percutaneous carbon dioxide|percutaneous carbon dioxide
371415|NCT02000206|Bronchoscopy|bronchoscopy
371416|NCT02000167|Electron Transport Chain|electron transport chain
371417|NCT02000167|Mitochondrial Disease|mitochondrial disease
371418|NCT02000167|Chromosomal Deletion|chromosomal deletion
371419|NCT02000128|Peritoneal Dialysis|peritoneal dialysis
371420|NCT02000128|fluid overload|fluid overload
371421|NCT02000128|bioimpedance analysis|bioimpedance analysis
371422|NCT02000128|Randomized Controlled Trial|randomized controlled trial
371423|NCT02000089|familial pancreas cancer|familial pancreas cancer
371424|NCT02000089|(Peutz-Jeghers Syndrome) PJS|(peutz-jeghers syndrome) pjs
371425|NCT02000089|Breast cancer (BRCA) 2|breast cancer (brca) 2
371426|NCT02000089|Partner and Locator of BRCA2 (PALB2)|partner and locator of brca2 (palb2)
371427|NCT02000089|Familial Atypical Multiple Mole- Melanoma (FAMMM)|familial atypical multiple mole- melanoma (fammm)
371429|NCT02000089|Breast Cancer (BRCA)1|breast cancer (brca)1
371430|NCT02000089|(hereditary non-polyposis colorectal cancer or Lynch syndrome) HNPCC|(hereditary non-polyposis colorectal cancer or lynch syndrome) hnpcc
474915|NCT01535235|HIV|hiv
371431|NCT02000089|Lynch Syndrome|lynch syndrome
371432|NCT02000089|hereditary pancreatitis|hereditary pancreatitis
371433|NCT02000089|Protease Serine (PRSS)|protease serine (prss)
371434|NCT02000089|Chymotrypsin C (CTRC)|chymotrypsin c (ctrc)
371435|NCT02000089|Ataxia Telangiectasia Mutated(ATM)|ataxia telangiectasia mutated(atm)
371436|NCT02000076|Sleep|sleep
371437|NCT02000076|resting state|resting state
371438|NCT02000076|functional connectivity|functional connectivity
371439|NCT02000076|emotional contagion|emotional contagion
371440|NCT02000076|empathy|empathy
371441|NCT02000076|emotional regulation|emotional regulation
371442|NCT02000063|Hepatitis C|hepatitis c
371443|NCT02000063|acute|acute
371444|NCT02000063|early chronic|early chronic
371445|NCT02000050|resectable rectal cancer|resectable rectal cancer
371446|NCT02000050|up-front chemotherapy|up-front chemotherapy
371447|NCT02000050|neo-adjuvant short course radiotherapy|neo-adjuvant short course radiotherapy
371448|NCT02000050|short course radiotherapy|short course radiotherapy
371449|NCT02000011|patients|patients
371450|NCT02000011|aged 70 years old|aged 70 years old
371451|NCT02000011|thoracic,|thoracic,
371452|NCT02000011|digestive or|digestive or
371453|NCT02000011|urological|urological
371454|NCT02000011|resectable|resectable
371455|NCT01999985|Epidermal Growth Factor Receptor (EGFR)|epidermal growth factor receptor (egfr)
371456|NCT01999985|Tyrosine kinase inhibitors|tyrosine kinase inhibitors
371457|NCT01999985|Neoplasms|neoplasms
371458|NCT01999985|Lung Diseases|lung diseases
371459|NCT01999985|Respiratory Tract Diseases|respiratory tract diseases
371460|NCT01999985|Pleural Diseases|pleural diseases
371461|NCT01999985|Pleural Neoplasms|pleural neoplasms
371462|NCT01999985|Lung Neoplasms|lung neoplasms
371463|NCT01999985|Pleural Effusion|pleural effusion
371464|NCT01999985|Pleural Effusion, Malignant|pleural effusion, malignant
371465|NCT01999985|Respiratory Tract Neoplasms|respiratory tract neoplasms
371466|NCT01999985|Thoracic Neoplasms|thoracic neoplasms
371467|NCT01999985|Neoplasms by Site|neoplasms by site
371468|NCT01999985|EGFR mutation|egfr mutation
371469|NCT01999985|Afatinib|afatinib
371470|NCT01999985|Dasatinib|dasatinib
371471|NCT01999985|Carcinoma, Bronchogenic|carcinoma, bronchogenic
371472|NCT01999985|Gene Mutation|gene mutation
371473|NCT01999985|T790M mutation.|t790m mutation.
371474|NCT01999985|Non-small cell lung cancer|non-small cell lung cancer
371475|NCT01999972|Carcinoma|carcinoma
371476|NCT01999972|Renal Cell|renal cell
371477|NCT01999959|Unexplained Infertility, Pertubation, Gonadotrophin, Ovulation Induction, Intrauterine Insemination|unexplained infertility, pertubation, gonadotrophin, ovulation induction, intrauterine insemination
371478|NCT01999946|Heroin Dependence|heroin dependence
371479|NCT01999946|Opioid-Related Disorders|opioid-related disorders
371480|NCT01999933|Cervical cancer|cervical cancer
371481|NCT01999933|postoperative risk factor|postoperative risk factor
371482|NCT01999933|treatment|treatment
371483|NCT01999920|Adult separation anxiety disorder|adult separation anxiety disorder
371486|NCT01999907|virus diseases|virus diseases
371487|NCT01999907|pediatric|pediatric
371488|NCT01999907|RCT|rct
371489|NCT01999907|steroid|steroid
371490|NCT01999894|Namenda|namenda
371491|NCT01999894|Autism|autism
371492|NCT01999894|Memantine|memantine
371493|NCT01999894|Pediatric|pediatric
371494|NCT01999894|Forest Laboratories|forest laboratories
371495|NCT01999868|psoriasis vulgaris|psoriasis vulgaris
371496|NCT01999868|ustekinumab|ustekinumab
371497|NCT01999868|abatacept|abatacept
371498|NCT01999842|H7N9|h7n9
371499|NCT01999842|Influenza|influenza
371500|NCT01999842|Safety|safety
371501|NCT01999842|Adults|adults
371502|NCT01999842|Adjuvant|adjuvant
371503|NCT01999842|Immunogenicity|immunogenicity
371504|NCT01999816|pressure ulcer|pressure ulcer
371505|NCT01999816|lifestyle redesign|lifestyle redesign
371506|NCT01999816|spinal cord injury|spinal cord injury
371507|NCT01999790|upper lid|upper lid
371508|NCT01999790|exophthalmos|exophthalmos
371509|NCT01999790|grave's orbitopathy|grave's orbitopathy
371510|NCT01999777|Epilepsy|epilepsy
371511|NCT01999777|seizure clusters|seizure clusters
371512|NCT01999777|acute repetitive seizures|acute repetitive seizures
371513|NCT01999777|rescue treatment|rescue treatment
371514|NCT01999751|Magnetic Resonance Imaging|magnetic resonance imaging
371515|NCT01999751|Pacemaker, Artificial|pacemaker, artificial
371516|NCT01999751|Defibrillators, Implantable|defibrillators, implantable
371517|NCT01999725|Normal Volunteers, Safety, Pharmacokinetics|normal volunteers, safety, pharmacokinetics
371518|NCT01999712|heart failure|heart failure
371519|NCT01999712|left ventricular assist device|left ventricular assist device
371520|NCT01999712|right ventricular failure|right ventricular failure
371521|NCT01999699|Heplisav|heplisav
371522|NCT01999686|Polycystic ovarium syndrome|polycystic ovarium syndrome
371523|NCT01999686|DLBS3233|dlbs3233
371524|NCT01999686|metformin|metformin
371525|NCT01999686|insulin resistance|insulin resistance
371526|NCT01999686|Female|female
371527|NCT01999673|SUNRISE|sunrise
371528|NCT01999673|PPHM 1202|pphm 1202
371529|NCT01999673|Bavituximab|bavituximab
371530|NCT01999673|Peregrine|peregrine
371531|NCT01999660|Prostatic Neoplasms|prostatic neoplasms
371532|NCT01999660|Radiotherapy|radiotherapy
371533|NCT01999660|rectal toxicity|rectal toxicity
371534|NCT01999647|Lower Extremity|lower extremity
371535|NCT01999647|Sciatic Nerve|sciatic nerve
371536|NCT01999647|Anesthetics, Local|anesthetics, local
371537|NCT01999647|Ropivacaine|ropivacaine
371538|NCT01999647|Ultrasonography|ultrasonography
371539|NCT01999634|rectum|rectum
371540|NCT01999634|microdialysis|microdialysis
371541|NCT01999634|anastomotic leaks|anastomotic leaks
371542|NCT01999621|organ failure|organ failure
371543|NCT01999621|intensive care|intensive care
371544|NCT01999621|palliative care|palliative care
371545|NCT01999621|patient's wishes|patient's wishes
371546|NCT01999608|Infertility|infertility
371547|NCT01999595|transcutaneous electrical nerve stimulation|transcutaneous electrical nerve stimulation
371548|NCT01999595|pad size|pad size
371549|NCT01999595|pulse frequency|pulse frequency
371550|NCT01999595|blunt pressure pain|blunt pressure pain
371551|NCT01999595|healthy humans.|healthy humans.
371552|NCT01999582|Anemia|anemia
371553|NCT01999582|End Stage Kidney Disease|end stage kidney disease
371554|NCT01999582|Chronic Kidney Disease|chronic kidney disease
371555|NCT01999582|Dialysis|dialysis
371556|NCT01999582|Erythrpoietin Stimulating Agent (ESA)|erythrpoietin stimulating agent (esa)
371557|NCT01999543|Blood glucose|blood glucose
371558|NCT01999530|prazosin|prazosin
371559|NCT01999530|dopamine|dopamine
371560|NCT01999530|healthy|healthy
371561|NCT01999530|Positron Emission Tomography|positron emission tomography
371562|NCT01999530|PHNO|phno
371563|NCT01999530|scan|scan
371564|NCT01999530|effect|effect
371565|NCT01999504|Glucagon-like peptide-1|glucagon-like peptide-1
371566|NCT01999504|Glucose-dependent Insulinotropic Peptide|glucose-dependent insulinotropic peptide
371567|NCT01999504|Peptide YY|peptide yy
371568|NCT01999504|Glucagon|glucagon
371569|NCT01999504|Satiety|satiety
371570|NCT01999504|Meal|meal
371571|NCT01999504|palaeolithic|palaeolithic
371572|NCT01999465|Brachial plexus injury|brachial plexus injury
371573|NCT01999465|Brachial plexus palsy|brachial plexus palsy
371574|NCT01999465|Neonate|neonate
371575|NCT01999452|Paleolithic diet|paleolithic diet
371576|NCT01999426|Physical Therapy Modalities|physical therapy modalities
371577|NCT01999426|Pediatrics|pediatrics
371578|NCT01999426|Critical Care|critical care
371579|NCT01999426|Respiration, Artificial|respiration, artificial
371580|NCT01999413|AML|aml
371581|NCT01999413|high-risk cytogenetics|high-risk cytogenetics
371582|NCT01999413|younger patients|younger patients
371583|NCT01999413|Induction treatment|induction treatment
371584|NCT01999413|OMEGAVEN|omegaven
371585|NCT01999387|food|food
371586|NCT01999387|consumption|consumption
371587|NCT01999309|Schizophrenia spectrum disorders|schizophrenia spectrum disorders
371588|NCT01999283|Cervical pain|cervical pain
371589|NCT01999283|yoga|yoga
371590|NCT01999283|pilates|pilates
371591|NCT01999283|exercise|exercise
371592|NCT01999257|Genetic Counseling|genetic counseling
371593|NCT01999257|Technology|technology
371594|NCT01999257|Ashkenazi Jewish|ashkenazi jewish
371595|NCT01999257|Carrier screening|carrier screening
371596|NCT01999244|Overweight|overweight
371597|NCT01999244|Obesity|obesity
371598|NCT01999244|Weight Loss|weight loss
371599|NCT01999244|Self-monitoring|self-monitoring
371600|NCT01999244|Food Records|food records
371601|NCT01999244|Self-weighing|self-weighing
371602|NCT01999244|Technology|technology
371603|NCT01999231|Safety|safety
371604|NCT01999231|Tolerability|tolerability
371605|NCT01999231|ESAT6|esat6
371606|NCT01999231|CFP10|cfp10
371607|NCT01999231|skin test|skin test
371608|NCT01999231|diagnostic test|diagnostic test
371609|NCT01999205|workplace|workplace
371610|NCT01999205|intervention|intervention
371611|NCT01999205|physical activity|physical activity
371612|NCT01999205|sedentary behavior|sedentary behavior
371613|NCT01999205|evaluation|evaluation
371614|NCT01999192|inadequate response to MTX|inadequate response to mtx
371615|NCT01999192|Methotrexate|methotrexate
371616|NCT01999192|rheumatoid Arthritis|rheumatoid arthritis
371617|NCT01999192|Phase 2b|phase 2b
371618|NCT01999179|catheter related thrombosis|catheter related thrombosis
371619|NCT01999179|upper extremity deep venous thrombosis|upper extremity deep venous thrombosis
371620|NCT01999179|central venous catheters|central venous catheters
371621|NCT01999179|cancer|cancer
371622|NCT01999179|Catheters|catheters
371623|NCT01999153|skin graft|skin graft
371624|NCT01999153|donor site|donor site
371625|NCT01999114|Healthy subjects|healthy subjects
371626|NCT01999114|Opioid|opioid
371627|NCT01999114|Transdermal|transdermal
371628|NCT01999114|ECG|ecg
371629|NCT01999088|Fatty Acids, Omega-3|fatty acids, omega-3
371630|NCT01999088|Rosemary extract|rosemary extract
371631|NCT01999088|Functional meat|functional meat
371632|NCT01999088|Cardiovascular disease|cardiovascular disease
371633|NCT01999075|Duchenne Muscular Dystrophy|duchenne muscular dystrophy
371634|NCT01999075|Pulmonary complications|pulmonary complications
371635|NCT01999075|Lung volume recruitment,|lung volume recruitment,
371636|NCT01999075|Breath-stacking,|breath-stacking,
371637|NCT01999075|Cough efficacy,|cough efficacy,
371638|NCT01999075|Maximal insufflation capacity|maximal insufflation capacity
371639|NCT01999062|Breast RT|breast rt
371640|NCT01999062|Breast radiation therapy|breast radiation therapy
371641|NCT01999036|cardiac arrest, CPR, resuscitation|cardiac arrest, cpr, resuscitation
371642|NCT01999010|psychiatry|psychiatry
371643|NCT01999010|mental health|mental health
371644|NCT01999010|major depressive disorder|major depressive disorder
371645|NCT01999010|self-management|self-management
371646|NCT01999010|data visualization|data visualization
371647|NCT01999010|mood diaries|mood diaries
371648|NCT01999010|electronic diaries|electronic diaries
371649|NCT01999010|cell phones|cell phones
371650|NCT01999010|software|software
371651|NCT01999010|mental health telemetry|mental health telemetry
371652|NCT01999010|ecological momentary assessment|ecological momentary assessment
371653|NCT01998997|Delirium|delirium
371654|NCT01998997|Hospitalized elderly|hospitalized elderly
371655|NCT01998971|Multiple myeloma|multiple myeloma
371656|NCT01998971|Daratumumab|daratumumab
371657|NCT01998971|JNJ-54767414|jnj-54767414
371658|NCT01998971|Velcade-dexamethasone|velcade-dexamethasone
371659|NCT01998971|Velcade-melphalan-prednisone|velcade-melphalan-prednisone
371660|NCT01998971|Velcade-thalidomide-dexamethasone|velcade-thalidomide-dexamethasone
371661|NCT01998971|Pomalidomide-dexamethasone|pomalidomide-dexamethasone
371662|NCT01998971|Carfilzomib-dexamethasone|carfilzomib-dexamethasone
371663|NCT01998971|Carfilzomib-lenalidomide-dexamethasone|carfilzomib-lenalidomide-dexamethasone
371664|NCT01998971|Anti-CD38 Monoclonal Antibody|anti-cd38 monoclonal antibody
371665|NCT01998971|Immunomodulatory drug|immunomodulatory drug
371666|NCT01998971|IMiD|imid
371667|NCT01998958|Treatment resistant depressive disorder|treatment resistant depressive disorder
371668|NCT01998958|Intranasal esketamine|intranasal esketamine
371669|NCT01998958|Efficacy|efficacy
371670|NCT01998958|SYNAPSE|synapse
371671|NCT01998958|JNJ-54135419|jnj-54135419
371672|NCT01998945|Exposure therapy|exposure therapy
371673|NCT01998945|Cognitive behavioral therapy|cognitive behavioral therapy
371674|NCT01998945|Relaxation Training|relaxation training
371675|NCT01998945|Older Adults|older adults
371676|NCT01998945|Fall Injury|fall injury
371677|NCT01998945|Anxiety|anxiety
371678|NCT01998945|Posttraumatic Stress|posttraumatic stress
371679|NCT01998932|Venous Ulcer|venous ulcer
371680|NCT01998932|Leg Ulcer|leg ulcer
371681|NCT01998932|Metabonomics|metabonomics
371682|NCT01998932|Ulcer Fluid|ulcer fluid
371683|NCT01998854|Menorrhagia|menorrhagia
371684|NCT01998854|Leiomyoma|leiomyoma
371685|NCT01998854|Uterine Fibroids|uterine fibroids
371686|NCT01998828|Polycythemia|polycythemia
371687|NCT01998828|Polycythemia Vera|polycythemia vera
371688|NCT01998828|Essential Thrombocythemia|essential thrombocythemia
371689|NCT01998828|Thrombocytosis|thrombocytosis
371690|NCT01998828|Myeloproliferative Disorders|myeloproliferative disorders
371691|NCT01998828|Bone Marrow Diseases|bone marrow diseases
371692|NCT01998828|Hematologic Diseases|hematologic diseases
371693|NCT01998828|Blood Coagulation Disorders|blood coagulation disorders
371694|NCT01998828|Blood Platelet Disorders|blood platelet disorders
371695|NCT01998828|Hemorrhagic Disorders|hemorrhagic disorders
371696|NCT01998789|Liver Transplantation|liver transplantation
371697|NCT01998789|Everolimus|everolimus
371698|NCT01998789|Immunosuppression|immunosuppression
371699|NCT01998776|ulcer|ulcer
371700|NCT01998763|Vitamin D3 supplementation|vitamin d3 supplementation
371701|NCT01998763|metabolite profile|metabolite profile
371702|NCT01998763|SNPs|snps
371703|NCT01998763|bone-turnover marker|bone-turnover marker
371704|NCT01998750|obesity|obesity
371705|NCT01998750|genetics|genetics
371706|NCT01998750|early-onset|early-onset
371707|NCT01998750|childhood|childhood
371708|NCT01998737|Osteoporosis, diagnostics, ultrasound|osteoporosis, diagnostics, ultrasound
371709|NCT01998724|Chronic bronchitis|chronic bronchitis
371710|NCT01998724|Emphysema|emphysema
371711|NCT01998724|Pulmonary|pulmonary
371712|NCT01998724|COPD|copd
371713|NCT01998711|Alzheimer's disease|alzheimer's disease
371714|NCT01998711|Mild cognitive impairment|mild cognitive impairment
371715|NCT01998711|Memory intervention|memory intervention
371716|NCT01998711|Strategy use|strategy use
371717|NCT01998711|Memory group|memory group
371718|NCT01998698|cataract|cataract
371719|NCT01998698|phacoemulsification|phacoemulsification
371720|NCT01998698|monovision|monovision
371721|NCT01998698|multifocal lens|multifocal lens
371722|NCT01998685|Prostatectomy|prostatectomy
371723|NCT01998685|Coagulation Factor|coagulation factor
371724|NCT01998685|Balanced Anesthesia|balanced anesthesia
371725|NCT01998685|Intravenous Anesthesia,|intravenous anesthesia,
371726|NCT01998646|ASP4058|asp4058
371727|NCT01998646|healthy subjects|healthy subjects
400548|NCT01866332|back pain|back pain
371728|NCT01998633|Hemophagocytic lymphohistiocytosis|hemophagocytic lymphohistiocytosis
371729|NCT01998633|Chronic Active EBV|chronic active ebv
371730|NCT01998633|Chronic Granulomatous Disease|chronic granulomatous disease
371731|NCT01998633|Hyperimmunoglobulin M Syndrome (Hyper IGM)|hyperimmunoglobulin m syndrome (hyper igm)
371732|NCT01998633|Leukocyte Adhesion Deficiency|leukocyte adhesion deficiency
371733|NCT01998633|IPEX|ipex
371734|NCT01998633|Hematopoietic Stem Cell Transplant (HSCT)|hematopoietic stem cell transplant (hsct)
371735|NCT01998633|Non-Myeloablative Transplant (NST)|non-myeloablative transplant (nst)
371736|NCT01998633|Reduced-Intensity Conditioning (RIC)|reduced-intensity conditioning (ric)
371737|NCT01998620|Hepatitis B|hepatitis b
371738|NCT01998620|Cholestasis|cholestasis
371739|NCT01998607|Solid tumours|solid tumours
371740|NCT01998607|Bone Metastasis|bone metastasis
371741|NCT01998594|Thumb arthritis|thumb arthritis
371742|NCT01998594|CMC arthritis|cmc arthritis
371743|NCT01998594|Arthroplasty|arthroplasty
371744|NCT01998568|Intraocular pressure|intraocular pressure
371745|NCT01998568|Corneal edema|corneal edema
371746|NCT01998568|Tonometer|tonometer
371747|NCT01998568|Dynamic contour tonometer|dynamic contour tonometer
371748|NCT01998568|Tonopen|tonopen
371749|NCT01998568|iCare|icare
371750|NCT01998568|Goldmann applanation|goldmann applanation
371751|NCT01998542|Head and neck cancers|head and neck cancers
371752|NCT01998542|tumor vaccine|tumor vaccine
371753|NCT01998542|immunotherapy|immunotherapy
371754|NCT01998542|personalized anti-cancer vaccine|personalized anti-cancer vaccine
371755|NCT01998529|Lung Cancer|lung cancer
371756|NCT01998529|Unilateral Pleural Malignancy|unilateral pleural malignancy
371757|NCT01998529|Metastatic active pleural malignancy|metastatic active pleural malignancy
371758|NCT01998529|Lung tumors|lung tumors
371759|NCT01998529|Sarcomas|sarcomas
371760|NCT01998529|Cytoreductive Surgery|cytoreductive surgery
371761|NCT01998529|Hyperthermic Intrathoracic Pleural Chemotherapy|hyperthermic intrathoracic pleural chemotherapy
371762|NCT01998529|HITC|hitc
371763|NCT01998529|Cisplatin|cisplatin
371764|NCT01998529|Platinol-AQ|platinol-aq
371765|NCT01998529|Platinol|platinol
371766|NCT01998529|CDDP|cddp
371767|NCT01998529|Amifostine|amifostine
371768|NCT01998529|Ethyol|ethyol
371769|NCT01998529|Ethiofos|ethiofos
371770|NCT01998529|Gammaphos|gammaphos
371771|NCT01998516|Emotional Intelligence|emotional intelligence
371772|NCT01998503|AL amyloidosis|al amyloidosis
371773|NCT01998503|bortezomib|bortezomib
371774|NCT01998503|autologous stem cell transplantation|autologous stem cell transplantation
371775|NCT01998477|Influenza|influenza
371776|NCT01998477|Vaccine|vaccine
371777|NCT01998477|Flu|flu
371778|NCT01998477|Children|children
371779|NCT01998477|Adolescents|adolescents
371780|NCT01998464|Retinal Vasculitis|retinal vasculitis
371781|NCT01998464|Optical coherence tomography|optical coherence tomography
371782|NCT01998464|OCT|oct
371783|NCT01998464|Imaging|imaging
371784|NCT01998451|double sphincter in gallbladder|double sphincter in gallbladder
371785|NCT01998451|recurrence rate of gallstones|recurrence rate of gallstones
371786|NCT01998438|tranexamic acid|tranexamic acid
371787|NCT01998438|cardiac surgery|cardiac surgery
371788|NCT01998438|cardiopulmonary bypass|cardiopulmonary bypass
371884|NCT01998022|knowledge|knowledge
371789|NCT01998425|circulating fibrocytes|circulating fibrocytes
371790|NCT01998425|fibrocyte|fibrocyte
371791|NCT01998425|NSCLC|nsclc
371792|NCT01998425|treatment response|treatment response
371793|NCT01998425|survival|survival
371794|NCT01998425|stage|stage
371795|NCT01998399|CAP|cap
371796|NCT01998399|Pneumonia|pneumonia
371797|NCT01998399|Intensive Care Unit|intensive care unit
371798|NCT01998399|Mechanical Ventilation|mechanical ventilation
371799|NCT01998386|Tooth Whitening|tooth whitening
371800|NCT01998386|Adolescent|adolescent
371801|NCT01998386|Clinical Trial|clinical trial
371802|NCT01998373|Patient training|patient training
371803|NCT01998373|Rheumatoid arthritis|rheumatoid arthritis
371804|NCT01998373|Quality of life|quality of life
371805|NCT01998360|Circumcision|circumcision
371806|NCT01998360|Voluntary medical male circumcision|voluntary medical male circumcision
371807|NCT01998360|Minimally-invasive|minimally-invasive
371808|NCT01998360|HIV prevention|hiv prevention
371809|NCT01998334|Systemic Inflammatory Response Syndrome|systemic inflammatory response syndrome
371810|NCT01998334|Continuous Blood Purification|continuous blood purification
371811|NCT01998321|PSI: Patient Specific Instrument|psi: patient specific instrument
371812|NCT01998321|TKA: Total Knee Arthroplasty|tka: total knee arthroplasty
371813|NCT01998321|Articular Deformity|articular deformity
371814|NCT01998321|Varus|varus
371815|NCT01998295|Clearance time|clearance time
371816|NCT01998295|Recurrence time|recurrence time
371817|NCT01998295|Artemether/lumefantrine|artemether/lumefantrine
371818|NCT01998295|P. falciparum|p. falciparum
371819|NCT01998295|Uncomplicated malaria|uncomplicated malaria
371820|NCT01998295|Children|children
400549|NCT01866332|tape|tape
400550|NCT01866332|chronic|chronic
400551|NCT01866319|PD-1|pd-1
400552|NCT01866319|PD1|pd1
371821|NCT01998282|Focus of study is to assess filter/stove use and efficacy in reducing exposure to waterborne and airborne pathogens.|focus of study is to assess filter/stove use and efficacy in reducing exposure to waterborne and airborne pathogens.
371822|NCT01998256|AV optimization|av optimization
371823|NCT01998256|Interatrial conduction delay|interatrial conduction delay
371824|NCT01998243|morbid obesity|morbid obesity
371825|NCT01998243|bioenterics intragastric balloon|bioenterics intragastric balloon
371826|NCT01998243|bariatric surgery|bariatric surgery
371827|NCT01998230|esophageal cancer|esophageal cancer
371828|NCT01998230|esophagectomy|esophagectomy
371829|NCT01998230|oral feeding|oral feeding
371830|NCT01998217|extracorporeal shock wave lithotripsy|extracorporeal shock wave lithotripsy
371831|NCT01998217|remifentanil|remifentanil
371832|NCT01998217|flurbiprofen|flurbiprofen
371833|NCT01998217|pancreatic stone|pancreatic stone
371834|NCT01998204|Parkinson's disease|parkinson's disease
371835|NCT01998204|propofol|propofol
371836|NCT01998204|deep brain stimulator|deep brain stimulator
371837|NCT01998191|mortality|mortality
371838|NCT01998191|adverse events|adverse events
371839|NCT01998165|Anesthesia|anesthesia
371840|NCT01998165|Remifentanil|remifentanil
371841|NCT01998165|Ultiva|ultiva
371842|NCT01998113|gestational diabetes mellitus|gestational diabetes mellitus
371843|NCT01998113|glyburide|glyburide
371844|NCT01998113|metformin|metformin
371845|NCT01998113|oral agents|oral agents
371846|NCT01998113|insulin|insulin
371847|NCT01998113|outcomes|outcomes
371848|NCT01998100|PTSD|ptsd
371849|NCT01998100|Anxiety|anxiety
371850|NCT01998100|Behavior Therapy|behavior therapy
371851|NCT01998100|Prolonged Exposure|prolonged exposure
371852|NCT01998100|Exercise|exercise
371853|NCT01998100|Wellness|wellness
371854|NCT01998100|Post-traumatic|post-traumatic
371855|NCT01998100|Stress|stress
371856|NCT01998087|Exclusive breastfeeding|exclusive breastfeeding
371857|NCT01998087|Breastfeeding|breastfeeding
371858|NCT01998087|Proactive breastfeeding support|proactive breastfeeding support
371859|NCT01998087|Telephone breastfeeding support|telephone breastfeeding support
371860|NCT01998087|Infant feeding attitudes|infant feeding attitudes
371861|NCT01998087|Breastfeeding self-efficacy|breastfeeding self-efficacy
371862|NCT01998087|Breastfeeding difficulties|breastfeeding difficulties
371863|NCT01998074|Cow's Milk protein Allergy|cow's milk protein allergy
371864|NCT01998048|surgical treatment|surgical treatment
371865|NCT01998048|Bankart|bankart
371866|NCT01998048|Latarjet|latarjet
371867|NCT01998048|redislocation|redislocation
371868|NCT01998035|Lymphoid Malignancies|lymphoid malignancies
371869|NCT01998035|Lymphoma|lymphoma
371870|NCT01998035|Hodgkin Lymphoma|hodgkin lymphoma
371871|NCT01998035|Non-hodgkin Lymphoma|non-hodgkin lymphoma
371872|NCT01998035|Follicular Lymphoma|follicular lymphoma
371873|NCT01998035|Diffuse Large B-Cell Lymphoma|diffuse large b-cell lymphoma
371874|NCT01998035|Anaplastic Large Cell Lymphoma|anaplastic large cell lymphoma
371875|NCT01998035|Chronic Lymphocytic Leukemia|chronic lymphocytic leukemia
371876|NCT01998035|Small Lymphocytic Lymphoma|small lymphocytic lymphoma
371877|NCT01998035|Mantle Cell Lymphoma|mantle cell lymphoma
371878|NCT01998035|Marginal Zone Lymphoma|marginal zone lymphoma
371879|NCT01998035|Burkitt Lymphoma|burkitt lymphoma
371880|NCT01998035|Waldenstrom Macroglobulinemia|waldenstrom macroglobulinemia
371881|NCT01998035|Peripheral T-cell Lymphoma|peripheral t-cell lymphoma
371882|NCT01998035|Cutaneous T-cell Lymphoma|cutaneous t-cell lymphoma
371883|NCT01998022|hypertension|hypertension
371885|NCT01998022|blood pressure control|blood pressure control
371886|NCT01998009|colorectal cancer|colorectal cancer
371887|NCT01998009|mass screening|mass screening
371888|NCT01998009|fecal occult blood|fecal occult blood
371889|NCT01997996|Pelvic Organ Prolapse|pelvic organ prolapse
371890|NCT01997996|PROLIFT+M|prolift+m
371891|NCT01997996|Vita sexualis|vita sexualis
371892|NCT01997983|interstitial cystitis|interstitial cystitis
371893|NCT01997983|PBS/IC|pbs/ic
371894|NCT01997983|IC|ic
371895|NCT01997983|Botox|botox
371896|NCT01997983|Botulinum toxin|botulinum toxin
371897|NCT01997983|TC-3 Gel|tc-3 gel
371898|NCT01997983|TCGel|tcgel
371899|NCT01997983|TheraCoat|theracoat
371900|NCT01997970|NEAT|neat
371901|NCT01997970|Treadmill desk|treadmill desk
371902|NCT01997957|Hepatocellular Carcinoma|hepatocellular carcinoma
371903|NCT01997957|Transarterial Chemoembolization|transarterial chemoembolization
371904|NCT01997957|Hepatic Arterial Infusion Chemotherapy|hepatic arterial infusion chemotherapy
371905|NCT01997957|Efficacy|efficacy
371906|NCT01997931|bispectral index|bispectral index
371907|NCT01997931|sedation|sedation
371908|NCT01997931|intensive care|intensive care
371909|NCT01997931|mechanical ventilation|mechanical ventilation
371910|NCT01997918|Secondary allogeneic HSCT|secondary allogeneic hsct
371911|NCT01997918|Haploidentical HSCT|haploidentical hsct
371912|NCT01997905|Left Atrial Appendage|left atrial appendage
371913|NCT01997905|LAA|laa
371914|NCT01997905|Atrial Fibrillation|atrial fibrillation
371915|NCT01997905|AFib|afib
371916|NCT01997905|AF|af
371917|NCT01997905|IRB approved|irb approved
371918|NCT01997905|clinical|clinical
371919|NCT01997905|Stroke|stroke
371920|NCT01997905|TIA|tia
371921|NCT01997905|contraindication to oral anticoagulation therapy|contraindication to oral anticoagulation therapy
371922|NCT01997905|Arrhythmias, Cardiac|arrhythmias, cardiac
371923|NCT01997905|OAC|oac
371924|NCT01997905|trial|trial
371925|NCT01997905|study|study
371926|NCT01997905|LAA occlusion|laa occlusion
371927|NCT01997905|occluded|occluded
371928|NCT01997905|prevent|prevent
371929|NCT01997892|CKD|ckd
371930|NCT01997892|Darbepoetin Alfa|darbepoetin alfa
371931|NCT01997892|Dialysis|dialysis
371932|NCT01997892|Hemodialysis|hemodialysis
371933|NCT01997892|Anemia|anemia
371934|NCT01997892|Peg epoetin beta|peg epoetin beta
371935|NCT01997866|Obstructive Sleep Apnea|obstructive sleep apnea
371936|NCT01997866|Sleep Apnea|sleep apnea
371937|NCT01997866|Congestive Heart Failure|congestive heart failure
371938|NCT01997866|Heart Failure|heart failure
371939|NCT01997853|Omega 3 fatty acids|omega 3 fatty acids
371940|NCT01997853|C Reactive Protein|c reactive protein
371941|NCT01997853|Host Modulation|host modulation
371942|NCT01997853|Chronic Periodontitis|chronic periodontitis
371943|NCT01997840|Multiple Myeloma|multiple myeloma
371944|NCT01997840|Neoplasms, Plasma Cell|neoplasms, plasma cell
371945|NCT01997840|Neoplasms by Histologic Type|neoplasms by histologic type
371946|NCT01997840|Neoplasms|neoplasms
371947|NCT01997840|Blood Protein Disorders|blood protein disorders
371948|NCT01997840|Hematologic Diseases|hematologic diseases
371949|NCT01997840|Dexamethasone|dexamethasone
371950|NCT01997840|Dexamethasone acetate|dexamethasone acetate
371951|NCT01997840|Pomalidomide|pomalidomide
371952|NCT01997814|Herbal medicine,|herbal medicine,
371953|NCT01997814|Host modulation therapy,|host modulation therapy,
371954|NCT01997814|Periodontitis,|periodontitis,
371955|NCT01997814|Meta-analysis,|meta-analysis,
371956|NCT01997814|Scaling and root planing.|scaling and root planing.
371957|NCT01997801|Thyroidectomy|thyroidectomy
371958|NCT01997801|Endoscopy|endoscopy
371959|NCT01997801|Ketamine|ketamine
371960|NCT01997801|Acute Pain|acute pain
371961|NCT01997801|Chronic Pain|chronic pain
371962|NCT01997801|Postoperative period|postoperative period
371963|NCT01997788|Injection, Spinal|injection, spinal
371964|NCT01997788|Morphine|morphine
371965|NCT01997788|Analgesia|analgesia
371966|NCT01997788|Patient-Controlled|patient-controlled
371967|NCT01997788|Pain|pain
371968|NCT01997788|Postoperative|postoperative
371969|NCT01997788|Combined Modality Therapy|combined modality therapy
371970|NCT01997788|Nephrectomy|nephrectomy
371971|NCT01997775|IL-6|il-6
371972|NCT01997775|Metformin|metformin
371973|NCT01997775|Non-small cell lung cancer|non-small cell lung cancer
371974|NCT01997775|Lung adenocarcinoma|lung adenocarcinoma
371975|NCT01997762|resveratrol,|resveratrol,
371976|NCT01997762|gestational diabetes,|gestational diabetes,
371977|NCT01997762|beta cell function|beta cell function
371978|NCT01997762|history|history
371979|NCT01997749|stroke, ketogenic diet, ketosis, ischemia, brain, ketones, hyperglycemia, neuroprotection|stroke, ketogenic diet, ketosis, ischemia, brain, ketones, hyperglycemia, neuroprotection
371980|NCT01997736|Paroxysmal Atrial Fibrillation|paroxysmal atrial fibrillation
371981|NCT01997736|Catheter Ablation|catheter ablation
371982|NCT01997736|Ablation Techniques|ablation techniques
371983|NCT01997723|OSA, portable monitoring, home diagnosis|osa, portable monitoring, home diagnosis
371984|NCT01997684|Colorectal Cancer|colorectal cancer
371985|NCT01997684|Colonic Obstruction|colonic obstruction
371986|NCT01997671|Primary Care|primary care
371987|NCT01997671|Lipid-lowering therapy|lipid-lowering therapy
371988|NCT01997671|Prescription|prescription
371989|NCT01997671|Adequacy|adequacy
371990|NCT01997671|Primary prevention|primary prevention
371991|NCT01997671|Cardiovascular diseases|cardiovascular diseases
371992|NCT01997671|Electronic Medical records|electronic medical records
371993|NCT01997671|Clinical Practice Guideline|clinical practice guideline
371994|NCT01997658|Glucocorticoids|glucocorticoids
371995|NCT01997658|Total complication rate|total complication rate
371996|NCT01997658|Hepatectomy.|hepatectomy.
371997|NCT01997645|Anal fistula|anal fistula
371998|NCT01997645|Rectal fistula|rectal fistula
371999|NCT01997645|Intersphincteric fistula|intersphincteric fistula
372000|NCT01997645|Perianal fistula|perianal fistula
372001|NCT01997632|Poliomyelitis|poliomyelitis
372002|NCT01997632|Vaccine|vaccine
372003|NCT01997619|biological mesh|biological mesh
372004|NCT01997619|contaminated hernia|contaminated hernia
372005|NCT01997619|abdominal wall reconstruction|abdominal wall reconstruction
372006|NCT01997593|analgesia|analgesia
372007|NCT01997593|pediatric|pediatric
372008|NCT01997593|pain|pain
372009|NCT01997593|laparoscopy|laparoscopy
372010|NCT01997593|ropivacaine|ropivacaine
372011|NCT01997580|depression|depression
372012|NCT01997580|treatment|treatment
372013|NCT01997580|electrophysiology|electrophysiology
372014|NCT01997580|biomarker|biomarker
372015|NCT01997567|Hip Arthroscopy|hip arthroscopy
372016|NCT01997567|Regional Anesthesia|regional anesthesia
372017|NCT01997567|Peripheral Nerve block|peripheral nerve block
372018|NCT01997554|TSH Testing|tsh testing
372019|NCT01997554|sub-clinical hypothyroidism|sub-clinical hypothyroidism
372020|NCT01997515|Quality of Recovery 40 Questionaire|quality of recovery 40 questionaire
372021|NCT01997515|Pain|pain
372022|NCT01997515|Hypoxia|hypoxia
372023|NCT01997515|Gastric Surgery|gastric surgery
372024|NCT01997515|Obesity|obesity
372025|NCT01997515|Ketamine|ketamine
372026|NCT01997502|Hemoglobin|hemoglobin
372027|NCT01997502|Non-invasive|non-invasive
372028|NCT01997489|Eye|eye
372029|NCT01997489|Fabry|fabry
372030|NCT01997489|vessels|vessels
372031|NCT01997476|Combined Endoscopic Ultrasound Morphologic Evaluation.|combined endoscopic ultrasound morphologic evaluation.
372032|NCT01997450|Q/LAIV/FluMist® Quadrivalent Vaccine|q/laiv/flumist® quadrivalent vaccine
372033|NCT01997450|Inactivated Influenza Vaccine (IIV)|inactivated influenza vaccine (iiv)
372034|NCT01997450|Effectiveness|effectiveness
372035|NCT01997450|Influenza|influenza
372036|NCT01997437|Tissue-engineered tracheal transplantation|tissue-engineered tracheal transplantation
372162|NCT01996904|subscapularis tear|subscapularis tear
372037|NCT01997398|Deep brain stimulation surgery under general anesthesia|deep brain stimulation surgery under general anesthesia
372038|NCT01997398|Deep brain stimulation target accuracy|deep brain stimulation target accuracy
372039|NCT01997398|Deep brain stimulation for Parkinsons's disease|deep brain stimulation for parkinsons's disease
372040|NCT01997398|Deep brain stimulation functional outcomes|deep brain stimulation functional outcomes
372041|NCT01997398|Deep brain stimulation quality of life outcomes|deep brain stimulation quality of life outcomes
372042|NCT01997385|adapted APD|adapted apd
372043|NCT01997385|dwell time|dwell time
372044|NCT01997385|fill volume|fill volume
372045|NCT01997372|ATG|atg
372046|NCT01997372|SAA|saa
372047|NCT01997372|immunosuppressive treatment|immunosuppressive treatment
372048|NCT01997372|cyclosporine|cyclosporine
372049|NCT01997359|ART initiation|art initiation
372050|NCT01997359|HIV|hiv
372051|NCT01997359|AIDS|aids
372052|NCT01997359|Ethiopia|ethiopia
372053|NCT01997346|ART initiation|art initiation
372054|NCT01997346|Ethiopia|ethiopia
372055|NCT01997346|Clinic observation|clinic observation
372056|NCT01997346|VCT observation|vct observation
372057|NCT01997333|Metastatic Breast Cancer|metastatic breast cancer
372058|NCT01997333|Locally advanced breast cancer|locally advanced breast cancer
372059|NCT01997333|Breast cancer|breast cancer
372060|NCT01997333|Triple negative|triple negative
372061|NCT01997333|Estrogen|estrogen
372062|NCT01997333|Progesterone|progesterone
372063|NCT01997333|HER2 receptors|her2 receptors
372064|NCT01997333|Targeted treatment for breast cancer|targeted treatment for breast cancer
372065|NCT01997333|Antibody-drug-conjugate|antibody-drug-conjugate
372066|NCT01997333|Breast Neoplasms|breast neoplasms
372067|NCT01997333|CDX-011|cdx-011
372068|NCT01997333|gpNMB|gpnmb
372069|NCT01997333|METRIC|metric
372070|NCT01997333|Glembatumumab vedotin|glembatumumab vedotin
372071|NCT01997333|Triple Negative Breast Cancer|triple negative breast cancer
372072|NCT01997333|TNBC|tnbc
372073|NCT01997320|Sarcopenia|sarcopenia
372074|NCT01997320|Frailty|frailty
372075|NCT01997320|Strength|strength
372076|NCT01997320|Protein supplementation|protein supplementation
372077|NCT01997320|Ageing|ageing
372078|NCT01997307|acute coronary syndrome, coronary arteriography, menopause|acute coronary syndrome, coronary arteriography, menopause
372079|NCT01997294|sequential therapy|sequential therapy
372080|NCT01997294|atorvastatin|atorvastatin
372081|NCT01997294|acute myocardial infarction|acute myocardial infarction
372082|NCT01997281|dietary fiber|dietary fiber
372083|NCT01997281|diabetes mellitus|diabetes mellitus
372084|NCT01997281|gut hormone|gut hormone
372085|NCT01997268|Dyslipidemia|dyslipidemia
372086|NCT01997268|Hyperlipidemia|hyperlipidemia
372087|NCT01997268|Omega-3 Fatty Acids|omega-3 fatty acids
372088|NCT01997268|Metabolic Diseases|metabolic diseases
372089|NCT01997268|TG ≥500 mg/dL and ≤ 2,000 mg/dL|tg ≥500 mg/dl and ≤ 2,000 mg/dl
372090|NCT01997255|Everolimus|everolimus
372091|NCT01997255|Epilepsy|epilepsy
372092|NCT01997255|Sturge Weber Syndrome|sturge weber syndrome
372093|NCT01997255|Port wine stain|port wine stain
372094|NCT01997255|Glaucoma|glaucoma
372095|NCT01997242|CORONARY STENT|coronary stent
372096|NCT01997242|CARDIAC SURGERY|cardiac surgery
372097|NCT01997242|NON CARDIAC SURGEY|non cardiac surgey
372098|NCT01997229|Myasthenia Gravis|myasthenia gravis
372099|NCT01997229|Eculizumab|eculizumab
372100|NCT01997229|safety|safety
372101|NCT01997229|efficacy|efficacy
372102|NCT01997216|contact lenses|contact lenses
372103|NCT01997216|multifocal|multifocal
372104|NCT01997203|hepatitis C infection|hepatitis c infection
372105|NCT01997203|vitamin D|vitamin d
372106|NCT01997190|Immunotherapy|immunotherapy
372107|NCT01997190|Gene therapy|gene therapy
372108|NCT01997190|Tumor vaccine|tumor vaccine
372109|NCT01997177|simulation|simulation
372110|NCT01997177|training|training
372111|NCT01997177|colonoscopy|colonoscopy
400553|NCT01866319|PD-L1|pd-l1
372112|NCT01997177|standard setting|standard setting
372113|NCT01997138|pain, inflammation, surgery|pain, inflammation, surgery
372114|NCT01997112|Blood pressure|blood pressure
372115|NCT01997112|Hypertension|hypertension
372116|NCT01997112|Paracetamol|paracetamol
372117|NCT01997112|Acetaminophen|acetaminophen
372118|NCT01997099|Drug Library|drug library
372119|NCT01997099|Ambulatory Infusion Pump|ambulatory infusion pump
372120|NCT01997099|Medication Safety Software|medication safety software
372121|NCT01997099|CADD®-Solis VIP|cadd®-solis vip
372122|NCT01997099|Pump Programming|pump programming
372123|NCT01997099|Home Infusion Workflow|home infusion workflow
372124|NCT01997073|Respiratory enthalpy|respiratory enthalpy
372125|NCT01997073|One Lung Ventilation|one lung ventilation
372126|NCT01997060|Lifestyle intervention|lifestyle intervention
372127|NCT01997060|Body weight|body weight
372128|NCT01997060|Body composition|body composition
372129|NCT01997060|Weight loss maintenance|weight loss maintenance
372130|NCT01997060|Physical activity|physical activity
372131|NCT01997047|Pneumonia|pneumonia
372132|NCT01997047|bronchiolitis|bronchiolitis
372133|NCT01997047|asthma|asthma
372134|NCT01997047|children|children
372135|NCT01997047|tachypnea|tachypnea
372136|NCT01997047|developing countries|developing countries
372137|NCT01997047|diagnostic criteria|diagnostic criteria
372138|NCT01997034|Weight loss maintenance|weight loss maintenance
372139|NCT01997034|Body composition|body composition
372140|NCT01997034|Physical activity|physical activity
372141|NCT01997034|Lifestyle intervention|lifestyle intervention
372142|NCT01997021|Sedentary behavior|sedentary behavior
372143|NCT01997021|physical activity|physical activity
372144|NCT01997021|older adults|older adults
372145|NCT01996982|Induced therapeutic hypothermia|induced therapeutic hypothermia
372146|NCT01996969|metastatic colorectal cancer|metastatic colorectal cancer
372147|NCT01996969|refractory|refractory
372148|NCT01996969|regorafenib|regorafenib
372149|NCT01996969|biomarker|biomarker
372150|NCT01996969|gene sequencing|gene sequencing
372151|NCT01996956|stroke volume variation,|stroke volume variation,
372152|NCT01996956|cardiac output,|cardiac output,
372153|NCT01996956|fluid responsiveness,|fluid responsiveness,
372154|NCT01996956|noninvasive cardiac output monitor|noninvasive cardiac output monitor
372155|NCT01996943|Atrial Fibrillation|atrial fibrillation
372156|NCT01996943|Alcohol|alcohol
372157|NCT01996943|Electrophysiologic properties of the atria|electrophysiologic properties of the atria
372158|NCT01996943|Randomized Clinical Study|randomized clinical study
372159|NCT01996917|wound closure|wound closure
372160|NCT01996917|prineo|prineo
372161|NCT01996917|scar|scar
372163|NCT01996904|arthroscopic tendon repair|arthroscopic tendon repair
372164|NCT01996904|arthroscopic tendon debridement|arthroscopic tendon debridement
372165|NCT01996904|ASES|ases
372166|NCT01996891|Asthma|asthma
372167|NCT01996891|Nutrition|nutrition
372168|NCT01996891|Anti-inflammatory diet|anti-inflammatory diet
372169|NCT01996878|Parkinson's disease|parkinson's disease
372170|NCT01996878|Genetic Polymorphism|genetic polymorphism
372171|NCT01996865|Lymphoma, Mantle cell Lymphoma, Follicular Lymphoma, Marginal zone Lymphoma, Lenalidomide treatment, rituximab treatment, Non Hodgkins Lymphoma|lymphoma, mantle cell lymphoma, follicular lymphoma, marginal zone lymphoma, lenalidomide treatment, rituximab treatment, non hodgkins lymphoma
372172|NCT01996852|Erectile dysfunction|erectile dysfunction
372173|NCT01996852|ED|ed
372174|NCT01996852|Prostate|prostate
372175|NCT01996852|Prostatectomy|prostatectomy
372176|NCT01996826|Corneal Neovascularization|corneal neovascularization
372177|NCT01996826|Cornea Blood Vessels|cornea blood vessels
372178|NCT01996826|Corneal Graft Failure|corneal graft failure
372179|NCT01996826|High-Risk Penetrating Keratoplasty|high-risk penetrating keratoplasty
372577|NCT01995084|HX4|hx4
372180|NCT01996826|Corneal Transplant|corneal transplant
372181|NCT01996813|arthroscopy|arthroscopy
372182|NCT01996813|shoulder|shoulder
372183|NCT01996813|obesity|obesity
372184|NCT01996813|beach chair|beach chair
372185|NCT01996813|compression hose|compression hose
372186|NCT01996787|visibility tinted silicone hydrogel contact lenses for daily wear|visibility tinted silicone hydrogel contact lenses for daily wear
372187|NCT01996735|Endothelial function|endothelial function
372188|NCT01996735|Adenosine receptor stimulation|adenosine receptor stimulation
372189|NCT01996709|Silicone hydrogel contact lenses|silicone hydrogel contact lenses
372190|NCT01996709|Multi-purpose solution|multi-purpose solution
372191|NCT01996709|Lid Papillae|lid papillae
372192|NCT01996709|Palpebral Roughness|palpebral roughness
372193|NCT01996696|metformin|metformin
372194|NCT01996696|metabolic syndrome|metabolic syndrome
372195|NCT01996696|weight gain|weight gain
372196|NCT01996683|B-thalassemia|b-thalassemia
372197|NCT01996683|ferritin|ferritin
372198|NCT01996657|mechanical valves replacement|mechanical valves replacement
372199|NCT01996657|INR|inr
372200|NCT01996657|D-dimer|d-dimer
372201|NCT01996657|thromboembolic events|thromboembolic events
372202|NCT01996644|Anorexia, Bulimia, Anxiety, Exposure|anorexia, bulimia, anxiety, exposure
372203|NCT01996618|Premature Ventricular Beats|premature ventricular beats
372204|NCT01996618|Premature Heart Beats|premature heart beats
372205|NCT01996618|Ranolazine|ranolazine
372206|NCT01996592|chronic pain|chronic pain
372207|NCT01996592|cesarean section pain|cesarean section pain
372208|NCT01996579|Critically Ill|critically ill
372209|NCT01996579|Intensive care|intensive care
372210|NCT01996579|Nasogastric tube|nasogastric tube
372211|NCT01996579|Orogastric tube|orogastric tube
372212|NCT01996579|mechanically ventilated|mechanically ventilated
372213|NCT01996579|nosocomially acquired infections|nosocomially acquired infections
372214|NCT01996579|length of stay|length of stay
372215|NCT01996579|lactoferrin|lactoferrin
372216|NCT01996579|placebo controlled|placebo controlled
372217|NCT01996579|antibiotic free days|antibiotic free days
372218|NCT01996566|taste|taste
372219|NCT01996566|non-esterified fatty acids|non-esterified fatty acids
372220|NCT01996566|threshold|threshold
372221|NCT01996566|sensitivity|sensitivity
372222|NCT01996566|human|human
372223|NCT01996553|blood flow, regional|blood flow, regional
372224|NCT01996553|complications|complications
372225|NCT01996553|disease, arterial obstructive|disease, arterial obstructive
372226|NCT01996553|cardiac catheterization|cardiac catheterization
372227|NCT01996553|radial artery|radial artery
372228|NCT01996540|gastric neoplasm|gastric neoplasm
372229|NCT01996540|pancreatic neoplasm|pancreatic neoplasm
372230|NCT01996540|advanced|advanced
372231|NCT01996540|palliative care|palliative care
372232|NCT01996514|Children|children
372233|NCT01996514|Food advertisement|food advertisement
372234|NCT01996514|Obesity|obesity
372235|NCT01996514|Television viewing|television viewing
372236|NCT01996514|Food intake|food intake
372237|NCT01996449|Hypertension|hypertension
372238|NCT01996449|blood pressure|blood pressure
372239|NCT01996449|Aldosterone|aldosterone
372240|NCT01996449|Eplerenone|eplerenone
372241|NCT01996449|Amlodipine|amlodipine
372242|NCT01996449|Primary aldosteronism|primary aldosteronism
372243|NCT01996449|Exercise pressor reflex|exercise pressor reflex
372244|NCT01996449|handgrip exercise|handgrip exercise
372245|NCT01996449|passive arm cycling|passive arm cycling
372246|NCT01996449|active arm cycling|active arm cycling
372247|NCT01996436|cerebral vasospasm|cerebral vasospasm
372248|NCT01996436|aneurysmal subarachnoid hemorrhage|aneurysmal subarachnoid hemorrhage
372249|NCT01996436|intra arterial drug treatment for cerebral vasospasm|intra arterial drug treatment for cerebral vasospasm
372250|NCT01996436|nicardipine milrinone nitroglycerin verapamil|nicardipine milrinone nitroglycerin verapamil
372251|NCT01996423|Atopic dermatitis|atopic dermatitis
372252|NCT01996423|vitamin D|vitamin d
372253|NCT01996410|Breast Cancer|breast cancer
372254|NCT01996410|Acupuncture|acupuncture
372255|NCT01996410|Taxol|taxol
372256|NCT01996410|Cytoxan|cytoxan
372257|NCT01996410|Adriamycin|adriamycin
372258|NCT01996410|Taxotere|taxotere
372259|NCT01996410|Carboplatin|carboplatin
372260|NCT01996410|Perjeta|perjeta
372261|NCT01996410|Chemotherapy|chemotherapy
372262|NCT01996410|Chemotherapy-induced nausea, vomiting|chemotherapy-induced nausea, vomiting
372263|NCT01996410|Chemotherapy-induced peripheral neuropathy|chemotherapy-induced peripheral neuropathy
372264|NCT01996410|Adriamycin (60 mg/m2), Cytoxan (600 mg/m2), Taxol (175 mg/m2)|adriamycin (60 mg/m2), cytoxan (600 mg/m2), taxol (175 mg/m2)
372265|NCT01996410|Adriamycin (60 mg/m2), Cytoxan (600 mg/m2), Taxol (80 g/m2)|adriamycin (60 mg/m2), cytoxan (600 mg/m2), taxol (80 g/m2)
372266|NCT01996410|Taxotere (75mg/m2), Cytoxan (600 mg/m2)|taxotere (75mg/m2), cytoxan (600 mg/m2)
372267|NCT01996410|Taxotere (75 mg/m2), Carboplatin (AUC 6), Perjeta (840 mg loading fixed dose)|taxotere (75 mg/m2), carboplatin (auc 6), perjeta (840 mg loading fixed dose)
372268|NCT01996397|Heart failure|heart failure
372269|NCT01996397|Bundle branch block|bundle branch block
372270|NCT01996397|CRT response|crt response
372271|NCT01996384|Vulvodynia|vulvodynia
372272|NCT01996384|Provoked, localized vulvodynia|provoked, localized vulvodynia
372578|NCT01995084|PET|pet
372273|NCT01996384|vulvar vestibulitis|vulvar vestibulitis
372274|NCT01996384|provoked vestibulodynia|provoked vestibulodynia
372275|NCT01996384|vulvovaginal pain|vulvovaginal pain
372276|NCT01996384|vulvar pain|vulvar pain
372277|NCT01996384|vaginal pain|vaginal pain
372278|NCT01996384|chronic pain|chronic pain
372279|NCT01996384|lidocaine|lidocaine
372280|NCT01996384|numbing agent|numbing agent
372281|NCT01996384|anesthetic cream|anesthetic cream
372282|NCT01996384|acupuncture|acupuncture
372283|NCT01996384|electroacupuncture|electroacupuncture
372284|NCT01996384|electrical stimulated acupuncture|electrical stimulated acupuncture
372285|NCT01996384|manual acupuncture|manual acupuncture
372286|NCT01996384|classical acupuncture|classical acupuncture
372287|NCT01996384|non-classical acupuncture|non-classical acupuncture
372288|NCT01996384|Traditional Chinese Medicine|traditional chinese medicine
372289|NCT01996384|TCM|tcm
372290|NCT01996384|Chinese medicine|chinese medicine
372291|NCT01996384|Acupuncture and Oriental Medicine|acupuncture and oriental medicine
372292|NCT01996384|AOM|aom
372293|NCT01996384|treatment|treatment
372294|NCT01996384|feasibility|feasibility
372295|NCT01996384|pilot study|pilot study
400554|NCT01866319|PDL1|pdl1
372296|NCT01996384|Patient Reported Outcomes Measure Information System|patient reported outcomes measure information system
372297|NCT01996384|Tampon Test|tampon test
372298|NCT01996384|cotton swab test|cotton swab test
372299|NCT01996384|pain diary|pain diary
372300|NCT01996384|Research Electronic Data Capture|research electronic data capture
372301|NCT01996384|REDCap|redcap
372302|NCT01996358|Succinylcholine|succinylcholine
372303|NCT01996358|Rocuronium|rocuronium
372304|NCT01996358|Rigid Bronchoscopy|rigid bronchoscopy
372305|NCT01996345|Placenta Previa|placenta previa
372306|NCT01996345|Vaginal Pessary|vaginal pessary
372307|NCT01996345|Premature Birth|premature birth
372308|NCT01996319|Chronic obstructive pulmonary disease|chronic obstructive pulmonary disease
372309|NCT01996319|COPD|copd
372310|NCT01996306|AXEPT|axept
372311|NCT01996306|Fluorouracil|fluorouracil
372312|NCT01996306|CPT-11|cpt-11
372313|NCT01996306|XELIRI|xeliri
372314|NCT01996306|Bevacizumab|bevacizumab
372315|NCT01996306|FOLFIRI|folfiri
372316|NCT01996306|Capecitabine|capecitabine
372317|NCT01996306|2nd-line metastatic colorectal cancer|2nd-line metastatic colorectal cancer
372318|NCT01996293|pregnant|pregnant
372319|NCT01996293|bipolar|bipolar
372320|NCT01996293|lamotrigine|lamotrigine
372321|NCT01996293|lamictal|lamictal
372322|NCT01996293|women|women
372323|NCT01996293|female|female
372324|NCT01996267|neoadjuvant|neoadjuvant
372325|NCT01996267|breast cancer|breast cancer
372326|NCT01996267|HER2 positive|her2 positive
372327|NCT01996254|electrical stimulation|electrical stimulation
372328|NCT01996254|neurostimulation|neurostimulation
372329|NCT01996254|neuromodulation|neuromodulation
372330|NCT01996254|post-amputation pain|post-amputation pain
372331|NCT01996254|phantom limb pain|phantom limb pain
372332|NCT01996254|residual limb pain|residual limb pain
372333|NCT01996254|neuropathic pain|neuropathic pain
372334|NCT01996254|amputee pain|amputee pain
372335|NCT01996241|adolescent girls|adolescent girls
372336|NCT01996241|female sex work|female sex work
372337|NCT01996241|age at marriage|age at marriage
372338|NCT01996241|retention in school|retention in school
372339|NCT01996241|sexual debut|sexual debut
372340|NCT01996241|India|india
372341|NCT01996241|Karnataka|karnataka
372342|NCT01996228|Type 1 diabetes|type 1 diabetes
372343|NCT01996228|autoimmune|autoimmune
372344|NCT01996228|cord blood stem cell|cord blood stem cell
372345|NCT01996228|stem cell educator|stem cell educator
372346|NCT01996228|immune modulation|immune modulation
372347|NCT01996228|children|children
372348|NCT01996228|Control autoimmunity|control autoimmunity
372349|NCT01996228|stimulate the regeneration of islet beta cells|stimulate the regeneration of islet beta cells
372350|NCT01996202|Melanoma|melanoma
372351|NCT01996176|Sedentary Lifestyle|sedentary lifestyle
372352|NCT01996176|Sedentary work|sedentary work
372353|NCT01996176|Office workers|office workers
372354|NCT01996176|Work|work
372355|NCT01996176|Workplace intervention|workplace intervention
372356|NCT01996176|Sitting time|sitting time
372357|NCT01996150|atopic dermatitis|atopic dermatitis
372358|NCT01996150|eczema|eczema
372359|NCT01996150|bleach bath|bleach bath
372360|NCT01996150|itch|itch
372361|NCT01996150|skin barrier|skin barrier
372362|NCT01996150|staphylococcus aureus|staphylococcus aureus
372363|NCT01996137|Stroke|stroke
372364|NCT01996137|Treadmill|treadmill
372365|NCT01996137|Gait Speed|gait speed
372366|NCT01996124|COPD|copd
372367|NCT01996124|Pulmonary Hyperinflation|pulmonary hyperinflation
372368|NCT01996124|Ultra Long Acting Beta 2 Agonists|ultra long acting beta 2 agonists
372369|NCT01996124|Cor Pulmonale|cor pulmonale
372370|NCT01996124|Cardiac performance|cardiac performance
372371|NCT01996111|plantar fasciitis|plantar fasciitis
372372|NCT01996085|arterial hypertension|arterial hypertension
372373|NCT01996085|hemodynamics|hemodynamics
372374|NCT01996085|impedance cardiography|impedance cardiography
372579|NCT01995084|cancer|cancer
372375|NCT01996085|hypotensive therapy|hypotensive therapy
372376|NCT01996072|Primary hyperparathyroidism|primary hyperparathyroidism
372377|NCT01996072|Parathyroid|parathyroid
372378|NCT01996059|nutritional status|nutritional status
372379|NCT01996059|functional jejunal interposition|functional jejunal interposition
372380|NCT01996059|Roux-en-Y|roux-en-y
372381|NCT01996059|gastrectomy|gastrectomy
372382|NCT01996033|uncontrolled hypertension|uncontrolled hypertension
372383|NCT01996033|Renal Denervation|renal denervation
372384|NCT01996007|Pneumococcus|pneumococcus
372385|NCT01996007|Carriage|carriage
372386|NCT01996007|Children|children
372387|NCT01996007|Parents|parents
372388|NCT01996007|Immunogenicity|immunogenicity
372389|NCT01996007|PCV13|pcv13
372390|NCT01995981|Sarcoma, Soft Tissue|sarcoma, soft tissue
372391|NCT01995981|Pazopanib|pazopanib
372392|NCT01995981|Positron-Emission Tomography|positron-emission tomography
372393|NCT01995981|Pharmacokinetics|pharmacokinetics
372394|NCT01995981|Biomarker|biomarker
372395|NCT01995968|Stillbirth|stillbirth
372396|NCT01995968|Fetal growth restriction|fetal growth restriction
372397|NCT01995968|Small for gestational age|small for gestational age
372398|NCT01995968|Antenatal detection|antenatal detection
372399|NCT01995968|Prenatal Care|prenatal care
372400|NCT01995968|Mass Screening|mass screening
372401|NCT01995955|Coronary Microvascular Dysfunction|coronary microvascular dysfunction
372402|NCT01995955|coronary artery disease|coronary artery disease
372403|NCT01995955|index of myocardial resistance|index of myocardial resistance
372404|NCT01995942|Rectal Cancer|rectal cancer
372405|NCT01995942|EMVI|emvi
372406|NCT01995942|Extramural Venous Invasion|extramural venous invasion
372407|NCT01995942|Microarray|microarray
372408|NCT01995942|Biomarker|biomarker
372409|NCT01995942|mrEMVI|mremvi
372410|NCT01995942|Tumour Regression Grade|tumour regression grade
372411|NCT01995942|Cancer|cancer
372412|NCT01995942|Circumferential Resection Margin|circumferential resection margin
372415|NCT01995942|Radiology|radiology
372416|NCT01995942|Surgery|surgery
372417|NCT01995942|Pathology|pathology
372418|NCT01995929|neurogenic dysphagia|neurogenic dysphagia
372419|NCT01995929|transnasal endoscopy|transnasal endoscopy
372420|NCT01995929|functional endoscopy|functional endoscopy
372421|NCT01995890|nepafenac eye drops|nepafenac eye drops
372422|NCT01995890|intraocular pressure|intraocular pressure
372423|NCT01995864|Schizophrenia and Disorders with Psychotic Features|schizophrenia and disorders with psychotic features
372424|NCT01995864|Community Psychiatry|community psychiatry
372425|NCT01995851|Influenza|influenza
372426|NCT01995851|Vaccine|vaccine
372427|NCT01995838|Chronic Insomnia|chronic insomnia
372428|NCT01995838|Adults|adults
372429|NCT01995838|Elderly|elderly
372430|NCT01995825|bioequivalence|bioequivalence
372431|NCT01995825|lamotrigine|lamotrigine
372432|NCT01995825|epilepsy|epilepsy
372433|NCT01995799|Myocardial Infarction (and related inflammation)|myocardial infarction (and related inflammation)
372434|NCT01995786|Fluid Therapy|fluid therapy
372435|NCT01995786|Cost-Benefit Analysis|cost-benefit analysis
372436|NCT01995786|Hemodynamics|hemodynamics
372437|NCT01995786|Cost Control|cost control
372438|NCT01995773|Healthy women|healthy women
372439|NCT01995773|Quality of life|quality of life
372440|NCT01995773|Glucose metabolism|glucose metabolism
372441|NCT01995773|Adrenal reactivity|adrenal reactivity
372442|NCT01995773|Physical activity|physical activity
372443|NCT01995773|Body Composition|body composition
372444|NCT01995760|vancomycin|vancomycin
372445|NCT01995760|therapeutic response monitoring|therapeutic response monitoring
372446|NCT01995760|AUC/MIC|auc/mic
372447|NCT01995747|IgE|ige
372448|NCT01995747|Atopic Dermatitis|atopic dermatitis
372449|NCT01995747|antibody|antibody
372450|NCT01995747|allergy|allergy
372451|NCT01995734|Acromegaly, Pituitary diseases|acromegaly, pituitary diseases
372452|NCT01995721|recurrent respiratory papillomatosis|recurrent respiratory papillomatosis
372453|NCT01995721|human papillomavirus|human papillomavirus
372454|NCT01995721|vaccine|vaccine
372455|NCT01995721|treatment|treatment
372456|NCT01995721|immunology|immunology
372457|NCT01995721|relapse|relapse
372458|NCT01995708|CT7|ct7
372459|NCT01995708|MAGE-A3|mage-a3
372460|NCT01995708|WT1 mRNA-electroporated Autologous Langerhans|wt1 mrna-electroporated autologous langerhans
372461|NCT01995708|vaccine|vaccine
372462|NCT01995708|Autologous Stem Cell Transplantation|autologous stem cell transplantation
372463|NCT01995708|13-009|13-009
372464|NCT01995682|Independent living|independent living
372465|NCT01995682|walk with or without walking aids|walk with or without walking aids
372466|NCT01995643|Grape seed extract|grape seed extract
372467|NCT01995643|Polyphenols|polyphenols
372468|NCT01995643|Insulin|insulin
372469|NCT01995643|Oxidative stress Marker|oxidative stress marker
372470|NCT01995643|Inflammatory marker|inflammatory marker
372471|NCT01995643|Healthy human|healthy human
372472|NCT01995617|vaccine|vaccine
372473|NCT01995617|Streptococcus pneumoniae|streptococcus pneumoniae
372474|NCT01995617|Strep pneumo|strep pneumo
372475|NCT01995591|colon cancer|colon cancer
372476|NCT01995591|sentinel lymph node|sentinel lymph node
372477|NCT01995591|Indocyanine Green|indocyanine green
372478|NCT01995578|5'-Azacitidine|5'-azacitidine
372479|NCT01995578|Stem cell transplant|stem cell transplant
372480|NCT01995578|13-192|13-192
372481|NCT01995552|Post myocardial infarction patients with low EF.|post myocardial infarction patients with low ef.
372482|NCT01995539|Type 2|type 2
372483|NCT01995500|CAD|cad
372484|NCT01995500|PCI|pci
372485|NCT01995500|ACS|acs
372486|NCT01995500|non ACS|non acs
372487|NCT01995500|BioNIR|bionir
372488|NCT01995500|DES|des
372489|NCT01995487|more comers|more comers
372490|NCT01995487|DES|des
372491|NCT01995487|BioNIR|bionir
372492|NCT01995487|ACS|acs
372493|NCT01995487|non ACS|non acs
372494|NCT01995487|complex lesions|complex lesions
372495|NCT01995474|EUS|eus
372496|NCT01995474|pancreatic cancer|pancreatic cancer
372497|NCT01995474|cytology|cytology
372498|NCT01995474|fine needle aspiration|fine needle aspiration
372499|NCT01995448|The acute phase of Sepsis|the acute phase of sepsis
782329|NCT00320931|Rubudium|rubudium
372500|NCT01995448|multiparameter 8-color flow cytometry|multiparameter 8-color flow cytometry
372501|NCT01995422|Major depressive disorder|major depressive disorder
372502|NCT01995422|Follow-up study|follow-up study
372503|NCT01995422|Ecological momentary assessment|ecological momentary assessment
372504|NCT01995422|Physical activity|physical activity
372505|NCT01995422|Depression|depression
372506|NCT01995422|Self-esteem|self-esteem
372507|NCT01995422|Anxiety|anxiety
372508|NCT01995422|Rumination|rumination
372509|NCT01995422|Quality of life|quality of life
372510|NCT01995396|rectal cancer,|rectal cancer,
372511|NCT01995396|fecal incontinence,|fecal incontinence,
372512|NCT01995396|severe co-morbidity,|severe co-morbidity,
372513|NCT01995396|Hartmann´s procedure,|hartmann´s procedure,
372514|NCT01995396|abdominoperineal excision with intersphincteric dissection,|abdominoperineal excision with intersphincteric dissection,
372515|NCT01995396|postoperative complications,|postoperative complications,
372516|NCT01995396|pelvic abscess,|pelvic abscess,
372517|NCT01995396|perineal infections|perineal infections
372518|NCT01995370|Noncardioembolic cerebral infarction|noncardioembolic cerebral infarction
372519|NCT01995370|Dual antiplatelet therapy (DAPT)|dual antiplatelet therapy (dapt)
372520|NCT01995370|Cilostazol|cilostazol
372521|NCT01995370|Aspirin|aspirin
372522|NCT01995370|Clopidogrel|clopidogrel
372523|NCT01995331|aplastic anemia;|aplastic anemia;
372524|NCT01995331|cyclophosphamide;|cyclophosphamide;
372525|NCT01995331|immunosuppressive therapy;|immunosuppressive therapy;
372526|NCT01995331|cyclosporine A|cyclosporine a
372527|NCT01995318|Kinesiotaping|kinesiotaping
372528|NCT01995305|fanconi anemia|fanconi anemia
372529|NCT01995305|hematopoiesis maintainance|hematopoiesis maintainance
372530|NCT01995292|awake fiberoptic intubation|awake fiberoptic intubation
372531|NCT01995292|spray as you go technique|spray as you go technique
372532|NCT01995292|anesthesia|anesthesia
372533|NCT01995292|Enk Fiberoptic Atomizer Set|enk fiberoptic atomizer set
372534|NCT01995279|low back pain|low back pain
372535|NCT01995279|French Auriculotherapy|french auriculotherapy
372536|NCT01995279|postural control|postural control
372537|NCT01995279|balance|balance
372538|NCT01995279|posture|posture
372539|NCT01995240|pancreatic cancer|pancreatic cancer
372540|NCT01995240|MRI|mri
372541|NCT01995240|reproducibility|reproducibility
372542|NCT01995240|optimalization|optimalization
372543|NCT01995227|liver cancer|liver cancer
372544|NCT01995227|HCC|hcc
372545|NCT01995227|tumor vaccine|tumor vaccine
372546|NCT01995227|immunotherapy|immunotherapy
372547|NCT01995227|personalized anti-cancer vaccine|personalized anti-cancer vaccine
372548|NCT01995214|Postoperative delirium|postoperative delirium
372549|NCT01995214|Geriatric|geriatric
372550|NCT01995214|General anesthesia|general anesthesia
372551|NCT01995214|Propofol|propofol
372552|NCT01995214|Sevoflurane|sevoflurane
372553|NCT01995175|Asthma|asthma
372554|NCT01995175|Respiratory Syncytial virus|respiratory syncytial virus
372555|NCT01995175|Cohort study|cohort study
372556|NCT01995175|Quarterly phone contacts|quarterly phone contacts
372557|NCT01995175|Wheeze|wheeze
372558|NCT01995175|New born|new born
372559|NCT01995175|Lower Respiratory Tract Infection|lower respiratory tract infection
372560|NCT01995149|Familial Hypercholesterolemia|familial hypercholesterolemia
372561|NCT01995149|Familial Combined Hypercholesterolemia|familial combined hypercholesterolemia
372562|NCT01995149|Weight loss; Lipids; Phytosterols|weight loss; lipids; phytosterols
372563|NCT01995149|Obesity|obesity
372564|NCT01995149|Overweight.|overweight.
372565|NCT01995149|Lipids|lipids
372566|NCT01995136|Glaucoma|glaucoma
372567|NCT01995136|Ocular hypertension|ocular hypertension
372568|NCT01995123|Tobacco dependence|tobacco dependence
372569|NCT01995123|PTSD|ptsd
372570|NCT01995123|Behavioral Activation Therapy|behavioral activation therapy
372571|NCT01995097|smoking cessation|smoking cessation
372572|NCT01995097|smoking reduction|smoking reduction
372573|NCT01995097|scheduled gradual reduction|scheduled gradual reduction
372574|NCT01995097|pregnancy|pregnancy
372575|NCT01995097|text message intervention|text message intervention
372576|NCT01995084|hypoxia|hypoxia
372580|NCT01995071|Chronic Hepatitis C|chronic hepatitis c
372581|NCT01995071|Cirrhosis|cirrhosis
372582|NCT01995071|Child Pugh A|child pugh a
372583|NCT01995071|Hepatitis C virus|hepatitis c virus
372584|NCT01995071|Compensated Cirrhosis|compensated cirrhosis
372585|NCT01995071|Hepatitis C Genotype 1|hepatitis c genotype 1
372586|NCT01995071|Hepatitis C|hepatitis c
372587|NCT01995071|Interferon-Free|interferon-free
372588|NCT01995071|Cirrhotic|cirrhotic
372589|NCT01995058|CRPC|crpc
372590|NCT01995058|castration resistant prostate cancer|castration resistant prostate cancer
372591|NCT01995058|prostate cancer|prostate cancer
372592|NCT01995045|Retina|retina
372593|NCT01995045|Vitreoretinal|vitreoretinal
372594|NCT01995045|Surgery|surgery
372595|NCT01995032|Duchenne's muscular dystrophy|duchenne's muscular dystrophy
372596|NCT01995032|DMD|dmd
372597|NCT01995019|Arthralgia|arthralgia
372598|NCT01995019|Temporomandibular joint|temporomandibular joint
372599|NCT01995019|corticosteroids|corticosteroids
372600|NCT01995019|injection|injection
372601|NCT01995019|intra-articular|intra-articular
372602|NCT01995006|Effect|effect
372603|NCT01995006|metamizole|metamizole
372604|NCT01995006|salt-depleted|salt-depleted
372605|NCT01995006|subjects|subjects
372606|NCT01994993|Antibiotics|antibiotics
372607|NCT01994993|ampicillin|ampicillin
372608|NCT01994993|metronidazole|metronidazole
372609|NCT01994993|clindamycin|clindamycin
372610|NCT01994993|piperacillin-tazobactam|piperacillin-tazobactam
372611|NCT01994993|Safety|safety
372612|NCT01994993|Infants|infants
372613|NCT01994993|Intra abdominal infections|intra abdominal infections
372614|NCT01994967|Phase III|phase iii
372615|NCT01994967|Noninferiority|noninferiority
372616|NCT01994967|Controlled|controlled
372617|NCT01994967|Double-blind|double-blind
372618|NCT01994967|Randomized|randomized
372619|NCT01994967|Spinal|spinal
372620|NCT01994967|Anesthetic|anesthetic
372621|NCT01994967|Lower limb|lower limb
372622|NCT01994954|newborn intensive care unit|newborn intensive care unit
372623|NCT01994954|NICU|nicu
372624|NCT01994954|supplemental oxygen|supplemental oxygen
372625|NCT01994941|Acute Coronary Syndrome|acute coronary syndrome
372626|NCT01994941|Platelet Reactivity|platelet reactivity
372627|NCT01994941|P2Y12 Receptor Blocker|p2y12 receptor blocker
372628|NCT01994941|CYP2C19 Genotyping|cyp2c19 genotyping
372629|NCT01994915|exacerbation|exacerbation
372630|NCT01994915|functionality|functionality
372631|NCT01994915|occupational therapy|occupational therapy
372632|NCT01994915|chronic obstructive pulmonary disease|chronic obstructive pulmonary disease
372633|NCT01994889|amyloidosis|amyloidosis
372634|NCT01994889|amyloid|amyloid
372635|NCT01994889|transthyretin|transthyretin
372636|NCT01994889|TTR|ttr
372637|NCT01994837|GDC-0199|gdc-0199
372638|NCT01994837|Acute Myelogenous Leukemia|acute myelogenous leukemia
372639|NCT01994837|AML|aml
372640|NCT01994837|ABT-199|abt-199
372641|NCT01994837|Acute Myeloid Leukemia|acute myeloid leukemia
372642|NCT01994837|Myeloid Leukemia|myeloid leukemia
372643|NCT01994811|cancer|cancer
372644|NCT01994811|cardiovascular disease|cardiovascular disease
372645|NCT01994811|diabetes|diabetes
372646|NCT01994785|Sedation|sedation
372647|NCT01994785|Endoscopy|endoscopy
372648|NCT01994785|Capnography|capnography
372649|NCT01994772|Therapeutic hypothermia|therapeutic hypothermia
372650|NCT01994772|Targeted controlled temperature|targeted controlled temperature
372651|NCT01994772|Cardiac arrest|cardiac arrest
372652|NCT01994772|Non shockable rhythm|non shockable rhythm
372653|NCT01994772|successful resuscitation|successful resuscitation
372654|NCT01994759|Plantar fasciitis|plantar fasciitis
372655|NCT01994759|Treatment|treatment
372656|NCT01994759|Training|training
372657|NCT01994759|Glucocorticosteroid injection|glucocorticosteroid injection
372658|NCT01994733|end-stage renal disease|end-stage renal disease
372659|NCT01994733|hemodialysis|hemodialysis
372660|NCT01994733|mineral metabolism|mineral metabolism
372661|NCT01994733|serum phosphate|serum phosphate
372662|NCT01994733|phosphate binders|phosphate binders
372663|NCT01994720|Acute ischaemic stroke.|acute ischaemic stroke.
372664|NCT01994720|Transient ischaemic attack.|transient ischaemic attack.
372665|NCT01994707|Remote ischemic preconditioning|remote ischemic preconditioning
372666|NCT01994707|Coronary artery bypass graft surgery|coronary artery bypass graft surgery
372667|NCT01994707|Troponin T|troponin t
372668|NCT01994707|Apoptosis|apoptosis
372669|NCT01994707|Experimental|experimental
372670|NCT01994707|Cardioprotection|cardioprotection
372671|NCT01994668|lorazepam|lorazepam
372672|NCT01994668|intravenous|intravenous
372673|NCT01994668|pharmacolinetics|pharmacolinetics
372674|NCT01994668|healthy|healthy
372675|NCT01994668|Japanese|japanese
372676|NCT01994655|climacteric symptoms|climacteric symptoms
372677|NCT01994655|menopause|menopause
372678|NCT01994655|nurses|nurses
372679|NCT01994629|meningococcal disease|meningococcal disease
372680|NCT01994629|children|children
372681|NCT01994629|vaccination|vaccination
372682|NCT01994616|Keloid, hypertrophic scar|keloid, hypertrophic scar
372683|NCT01994603|Prevention|prevention
372684|NCT01994603|HIV|hiv
372685|NCT01994603|AIDS|aids
372686|NCT01994603|Fetal Alcohol Syndrome (FAS)|fetal alcohol syndrome (fas)
372687|NCT01994603|Alcohol Related Neurodevelopmental Disorder (ARND)|alcohol related neurodevelopmental disorder (arnd)
372688|NCT01994590|Prostate Cancer|prostate cancer
372689|NCT01994590|Metastatic Castrate-Resistant Prostate Cancer|metastatic castrate-resistant prostate cancer
372690|NCT01994590|mCRPC|mcrpc
372691|NCT01994590|Dovitinib|dovitinib
372692|NCT01994590|TKI258|tki258
372693|NCT01994590|Abiraterone Acetate|abiraterone acetate
372694|NCT01994590|Zytiga|zytiga
372695|NCT01994590|Prednisone|prednisone
372696|NCT01994577|Emergency Department|emergency department
372697|NCT01994577|Cardiac troponin|cardiac troponin
372698|NCT01994577|Myocardial infarction|myocardial infarction
372699|NCT01994564|OAG|oag
372700|NCT01994538|Urinary Tract Infections|urinary tract infections
372701|NCT01994538|Urinary antiinfective agents|urinary antiinfective agents
372702|NCT01994512|Spinal stenosis|spinal stenosis
372703|NCT01994512|Decompression|decompression
372704|NCT01994512|Fusion|fusion
372705|NCT01994512|Olisthesis|olisthesis
372706|NCT01994486|HCV Genotype 1|hcv genotype 1
372707|NCT01994486|Hepatitis C Virus Genotype 1|hepatitis c virus genotype 1
372708|NCT01994486|HCV|hcv
372709|NCT01994486|TVR|tvr
372710|NCT01994473|Schizophrenia|schizophrenia
372711|NCT01994460|Tuberculosis|tuberculosis
372712|NCT01994447|Informed Consent|informed consent
372713|NCT01994447|Instructional Films and Video|instructional films and video
372714|NCT01994447|Consent Comprehension|consent comprehension
372715|NCT01994447|Multimedia Consent|multimedia consent
372716|NCT01994447|Parent|parent
372717|NCT01994434|Deep branch of the ulnar nerve|deep branch of the ulnar nerve
372718|NCT01994434|Distal ulnar nerve compression|distal ulnar nerve compression
372719|NCT01994421|Facilitating kinesiotape|facilitating kinesiotape
372720|NCT01994421|Inhibiting kinesiotape|inhibiting kinesiotape
372721|NCT01994421|Classical tape|classical tape
372722|NCT01994421|No tape|no tape
372723|NCT01994408|physician inertia|physician inertia
372724|NCT01994408|hypertension|hypertension
372725|NCT01994408|telemedicine|telemedicine
372726|NCT01994408|mobile technology|mobile technology
372727|NCT01994395|Stroke|stroke
372728|NCT01994395|Gait|gait
372729|NCT01994395|Stride Management Assist|stride management assist
372730|NCT01994395|Mild-moderate Stroke, post 30 days or longer|mild-moderate stroke, post 30 days or longer
372731|NCT01994382|Leukemia|leukemia
372732|NCT01994382|Lymphocytic|lymphocytic
372733|NCT01994382|Chronic|chronic
372734|NCT01994382|B Cell|b cell
372735|NCT01994369|Breast Cancer|breast cancer
372736|NCT01994356|Contraceptive counseling|contraceptive counseling
372737|NCT01994356|Physician self disclosure|physician self disclosure
372738|NCT01994356|Satisfaction|satisfaction
372739|NCT01994356|Intrauterine contraceptive use|intrauterine contraceptive use
372740|NCT01994343|Chronic pelvic pain, women, pain, posture.|chronic pelvic pain, women, pain, posture.
372741|NCT01994330|acquired von Willebrand disease|acquired von willebrand disease
372742|NCT01994330|severe aortic stenosis|severe aortic stenosis
372743|NCT01994330|Heye´s syndrome|heye´s syndrome
372744|NCT01994330|desmopressin|desmopressin
372745|NCT01994330|von Willebrand multimers|von willebrand multimers
372746|NCT01994304|Safe Childbirth Checklist|safe childbirth checklist
372747|NCT01994304|Intrapartum mortality, Quality of Institutional delivery care|intrapartum mortality, quality of institutional delivery care
372748|NCT01994304|Maternal & newborn care practices|maternal & newborn care practices
372749|NCT01994291|Chemokine Antagonist|chemokine antagonist
372750|NCT01994291|Diabetic Macular Edema|diabetic macular edema
372751|NCT01994291|Diabetes|diabetes
372752|NCT01994291|Diabetes Mellitus|diabetes mellitus
372753|NCT01994291|Macular Edema|macular edema
372754|NCT01994291|Diabetic Retinopathy|diabetic retinopathy
372755|NCT01994291|Anti-VEGF|anti-vegf
372756|NCT01994265|Atrial fibrillation|atrial fibrillation
372757|NCT01994265|Cognition|cognition
372758|NCT01994265|Cognitive impairment|cognitive impairment
372759|NCT01994265|Anticoagulation|anticoagulation
372760|NCT01994265|Dabigatran|dabigatran
372761|NCT01994265|Warfarin|warfarin
372762|NCT01994265|Efficacy|efficacy
372763|NCT01994252|defibrillator|defibrillator
372764|NCT01994252|cardiac resynchronization|cardiac resynchronization
372765|NCT01994239|Prostate-Specific Antigen|prostate-specific antigen
372766|NCT01994239|LHRH antagonist|lhrh antagonist
372767|NCT01994239|Radiotherapy|radiotherapy
372768|NCT01994213|Famitinib|famitinib
372769|NCT01994213|Gastroenteropancreatic Neuroendocrine Tumor|gastroenteropancreatic neuroendocrine tumor
372770|NCT01994213|GEPNET|gepnet
372771|NCT01994200|Thyroid cancer|thyroid cancer
372772|NCT01994200|New diagnosis|new diagnosis
372773|NCT01994200|Dedicated Nurse|dedicated nurse
372774|NCT01994200|Interdisciplinary team|interdisciplinary team
372775|NCT01994200|Randomized Controlled Trial|randomized controlled trial
372776|NCT01994200|Intervention|intervention
372777|NCT01994200|Supportive care|supportive care
372778|NCT01994187|Carotid stenosis|carotid stenosis
372779|NCT01994187|Angioplasty|angioplasty
372780|NCT01994187|Carotid endarterectomy|carotid endarterectomy
372781|NCT01994187|Stroke|stroke
372782|NCT01994174|vascular|vascular
372783|NCT01994174|retina|retina
372784|NCT01994174|Anti-VEGF|anti-vegf
372785|NCT01994174|Aqueous humor dynamics|aqueous humor dynamics
372786|NCT01994161|ischemic stroke|ischemic stroke
372787|NCT01994161|intracranial stenting|intracranial stenting
372788|NCT01994161|vascular risk factor management|vascular risk factor management
372789|NCT01994148|Trauma|trauma
372790|NCT01994148|Gastrointestinal injury|gastrointestinal injury
372791|NCT01994148|Laparoscopy|laparoscopy
372792|NCT01994109|Sialorrhea|sialorrhea
372793|NCT01994109|Parkinson's disease|parkinson's disease
372794|NCT01994109|Amyotrophic lateral sclerosis (ALS)|amyotrophic lateral sclerosis (als)
372795|NCT01994109|stroke|stroke
372796|NCT01994109|neuroleptics|neuroleptics
372797|NCT01994057|Non-small cell lung cancer (NSCLC);|non-small cell lung cancer (nsclc);
372798|NCT01994057|EGFR-TKI;|egfr-tki;
372799|NCT01994057|Pharmacogenetics;|pharmacogenetics;
372800|NCT01994057|Precision medicine|precision medicine
372801|NCT01994057|somatic mutations ,germline mutations;|somatic mutations ,germline mutations;
372802|NCT01994044|Whiplash, surgery, multimodal rehabilitation, independent examiners|whiplash, surgery, multimodal rehabilitation, independent examiners
372803|NCT01994031|paclitaxel liposome injection|paclitaxel liposome injection
372804|NCT01994031|paclitaxel|paclitaxel
372805|NCT01994018|Vitamin D|vitamin d
372806|NCT01994018|Interferon Beta|interferon beta
372807|NCT01994018|Glatiramer Acetate|glatiramer acetate
372808|NCT01994018|Relapse rates|relapse rates
372809|NCT01993992|Anesthesia|anesthesia
372810|NCT01993979|Adjuvant chemotherapy|adjuvant chemotherapy
372811|NCT01993979|Surveillance|surveillance
372812|NCT01993979|Nephro-ureterectomy|nephro-ureterectomy
372813|NCT01993966|Urothelial carcinoma (UC),|urothelial carcinoma (uc),
372814|NCT01993966|(-)-epigallocatechin-3-gallate(EGCG),|(-)-epigallocatechin-3-gallate(egcg),
372815|NCT01993966|chemotherapy,|chemotherapy,
372816|NCT01993966|cytotoxicity,|cytotoxicity,
372817|NCT01993966|drug resistance,|drug resistance,
372818|NCT01993966|xenograft.|xenograft.
372819|NCT01993953|Muscle strength|muscle strength
372820|NCT01993953|Body composition|body composition
372821|NCT01993953|Body weight|body weight
372822|NCT01993953|Resistance training|resistance training
372823|NCT01993953|Personal training|personal training
372824|NCT01993953|BodyPump|bodypump
372825|NCT01993940|Opioid-induced Constipation|opioid-induced constipation
372826|NCT01993927|Drug Therapy|drug therapy
372827|NCT01993901|lung SBRT, ESAS, anxiety|lung sbrt, esas, anxiety
372828|NCT01993888|Hepatobiliary Surgery|hepatobiliary surgery
372829|NCT01993849|Anxiety|anxiety
372830|NCT01993849|Impulse control|impulse control
372831|NCT01993849|Depression|depression
372832|NCT01993849|ADHD|adhd
372833|NCT01993849|Fingernail Biting|fingernail biting
372834|NCT01993849|N-Acetylcysteine|n-acetylcysteine
372835|NCT01993849|NAC|nac
372836|NCT01993836|isoflurane|isoflurane
372837|NCT01993836|propofol|propofol
372838|NCT01993836|total intravenous anesthesia|total intravenous anesthesia
372839|NCT01993836|inhaled anesthetic|inhaled anesthetic
372840|NCT01993836|volatile anesthetic|volatile anesthetic
372841|NCT01993836|anesthesia|anesthesia
372842|NCT01993836|delirium|delirium
372843|NCT01993836|Post Operative Cognitive Dysfunction|post operative cognitive dysfunction
372844|NCT01993836|Alzheimer's Disease|alzheimer's disease
372845|NCT01993836|Mild Cognitive Impairment|mild cognitive impairment
372846|NCT01993797|Bronchiolitis|bronchiolitis
372847|NCT01993758|tourniquet pressure|tourniquet pressure
372848|NCT01993758|total knee arthroplasty|total knee arthroplasty
372849|NCT01993745|ECMO|ecmo
372850|NCT01993745|APACH II score|apach ii score
372851|NCT01993732|Cancer|cancer
372852|NCT01993732|Cryopreservation|cryopreservation
372853|NCT01993732|Ovarian Function|ovarian function
372854|NCT01993732|In Vitro|in vitro
372855|NCT01993719|Melanoma|melanoma
372856|NCT01993719|Adoptive Cell Therapy|adoptive cell therapy
372857|NCT01993706|Broadly HIV-1 Neutralizing Activity|broadly hiv-1 neutralizing activity
372858|NCT01993706|Healthy Adults|healthy adults
372859|NCT01993706|Placebo|placebo
372860|NCT01993706|HIV Prevention|hiv prevention
372861|NCT01993706|Monoclonal Antibodies|monoclonal antibodies
372862|NCT01993706|Antibodies|antibodies
372863|NCT01993693|knee|knee
372864|NCT01993693|pain|pain
372865|NCT01993693|osteoarthritis|osteoarthritis
372866|NCT01993693|ultrasound|ultrasound
372867|NCT01993654|Pigmented Lesions|pigmented lesions
372868|NCT01993654|PAM|pam
372869|NCT01993654|Ocular lesion|ocular lesion
372870|NCT01993641|Myelodysplastic Syndrome|myelodysplastic syndrome
372871|NCT01993641|MDS|mds
372872|NCT01993641|pracinostat|pracinostat
372873|NCT01993641|Hypomethylating Agent|hypomethylating agent
372874|NCT01993641|HMA|hma
372875|NCT01993641|azacitadine|azacitadine
372876|NCT01993641|Vidaza|vidaza
372877|NCT01993641|decitabine|decitabine
372878|NCT01993641|dacogen|dacogen
372879|NCT01993615|FAI|fai
372880|NCT01993615|femoroacetabular impingement|femoroacetabular impingement
372881|NCT01993615|hip pain|hip pain
372882|NCT01993615|hip arthroscopy|hip arthroscopy
372883|NCT01993615|physical therapy|physical therapy
372884|NCT01993602|general surgery|general surgery
372885|NCT01993602|postoperative care|postoperative care
372886|NCT01993602|breathing exercises|breathing exercises
372887|NCT01993602|respiratory muscle|respiratory muscle
372888|NCT01993602|postoperative complications|postoperative complications
372889|NCT01993602|lung volume measurements|lung volume measurements
372890|NCT01993602|pulmonary ventilations|pulmonary ventilations
372891|NCT01993602|thoracic wall|thoracic wall
372892|NCT01993589|Curettage; analgesia; paracetamol; lidocaine; Dexketoprofen trometamol; pethidine; diclofenac.|curettage; analgesia; paracetamol; lidocaine; dexketoprofen trometamol; pethidine; diclofenac.
372893|NCT01993563|Stroke|stroke
372894|NCT01993563|Rehabilitation|rehabilitation
372895|NCT01993563|Motor Imagery|motor imagery
476798|NCT01527188|HDM|hdm
372896|NCT01993563|Upper Extremity|upper extremity
372897|NCT01993563|Mirror Therapy|mirror therapy
372898|NCT01993550|lung cancer|lung cancer
372899|NCT01993550|family caregiving|family caregiving
372900|NCT01993550|behavioral intervention|behavioral intervention
372901|NCT01993550|counseling|counseling
372902|NCT01993550|symptom management|symptom management
372903|NCT01993498|cancer toxicities|cancer toxicities
372904|NCT01993498|cohort|cohort
372905|NCT01993498|breast cancer|breast cancer
372906|NCT01993485|transaortic valve replacement (TAVI)|transaortic valve replacement (tavi)
372907|NCT01993485|endothelial function|endothelial function
372908|NCT01993485|circulating microparticles|circulating microparticles
372909|NCT01993459|Quality of Recovery|quality of recovery
372910|NCT01993394|human centrifuge, oxygen, imaging, stroke volume, lung|human centrifuge, oxygen, imaging, stroke volume, lung
372911|NCT01993381|chemotherapy-induced nausea and vomiting|chemotherapy-induced nausea and vomiting
372912|NCT01993368|wisdom teeth extraction|wisdom teeth extraction
373037|NCT01992731|1 IVF/ICSI cycle|1 ivf/icsi cycle
372913|NCT01993355|non-specific chronic low back pain,|non-specific chronic low back pain,
372914|NCT01993355|health-related quality of life,|health-related quality of life,
372915|NCT01993355|physioterapy,|physioterapy,
372916|NCT01993355|sophrology,|sophrology,
372917|NCT01993355|cognitive-behavioral therapy,|cognitive-behavioral therapy,
372918|NCT01993355|motivational interviewing|motivational interviewing
372919|NCT01993342|adipocytokines|adipocytokines
372920|NCT01993342|osteoarthritis|osteoarthritis
372921|NCT01993342|inflammation|inflammation
372922|NCT01993342|ultrasonography|ultrasonography
372923|NCT01993316|neurofeedback|neurofeedback
372924|NCT01993316|EEG|eeg
372925|NCT01993316|transcranial magnetic stimulation|transcranial magnetic stimulation
372926|NCT01993303|Myocardial Perfusion Imaging|myocardial perfusion imaging
372927|NCT01993303|PET|pet
372928|NCT01993303|Rb-82|rb-82
372929|NCT01993264|Heart disease|heart disease
372930|NCT01993264|Echocardiogram|echocardiogram
372931|NCT01993264|Ultrasound|ultrasound
372932|NCT01993264|Heart defect|heart defect
372933|NCT01993264|Heart Dysfunction|heart dysfunction
372934|NCT01993264|Pediatric Cardiologists|pediatric cardiologists
372935|NCT01993264|Prenatal|prenatal
372936|NCT01993251|sleep,melatonin,autism,children|sleep,melatonin,autism,children
372937|NCT01993225|Low Testosterone|low testosterone
372938|NCT01993212|Low Testosterone|low testosterone
372939|NCT01993186|Glucose Transporter Type 1 Deficiency Syndrome Glut1|glucose transporter type 1 deficiency syndrome glut1
372940|NCT01993173|Diphtheria|diphtheria
372941|NCT01993173|Tetanus|tetanus
372942|NCT01993173|Pertussis|pertussis
372943|NCT01993173|ADACEL®|adacel®
372944|NCT01993173|Tdap vaccine|tdap vaccine
372945|NCT01993160|Fluorocholine (FCH)|fluorocholine (fch)
372946|NCT01993160|Positron emission tomography (PET)|positron emission tomography (pet)
372947|NCT01993160|Magnetic resonance imaging (MRI)|magnetic resonance imaging (mri)
372948|NCT01993147|Methylphenidate|methylphenidate
372949|NCT01993147|Placebo|placebo
372950|NCT01993147|functional Magnetic Resonance Imaging (fMRI)|functional magnetic resonance imaging (fmri)
372951|NCT01993147|Attention Control|attention control
372952|NCT01993134|Postoperative infection|postoperative infection
372953|NCT01993134|Antibiotic prophylaxis|antibiotic prophylaxis
372954|NCT01993134|Cefazolin|cefazolin
372955|NCT01993121|diabetes|diabetes
372956|NCT01993121|exercise|exercise
372957|NCT01993121|heart|heart
372958|NCT01993121|cardiovascular|cardiovascular
372959|NCT01993108|Methylphenidate|methylphenidate
372960|NCT01993108|Naltrexone|naltrexone
372961|NCT01993108|Placebo|placebo
372962|NCT01993108|Neuroimaging|neuroimaging
372963|NCT01993108|Prefrontal Control Circuits|prefrontal control circuits
372964|NCT01993108|Attention Control|attention control
372965|NCT01993108|Motor Control|motor control
372966|NCT01993108|Appetitive Control|appetitive control
372967|NCT01993095|Multiple Sclerosis|multiple sclerosis
372968|NCT01993095|Quality of Life|quality of life
372969|NCT01993095|Functional Fitness|functional fitness
372970|NCT01993082|Caregivers|caregivers
372971|NCT01993082|Telomerase|telomerase
372972|NCT01993082|Telomere Length|telomere length
372973|NCT01993082|Psychological Stress|psychological stress
372974|NCT01993082|Cardiovascular Risk|cardiovascular risk
372975|NCT01993082|Exercise|exercise
373076|NCT01992523|Acute Coronary Syndrome|acute coronary syndrome
372976|NCT01993056|injury incidence, male veteran soccer, 11+, Functional Movement Screen, FMS, warm-up|injury incidence, male veteran soccer, 11+, functional movement screen, fms, warm-up
372977|NCT01993043|ROP|rop
372978|NCT01993043|Bevacizumab|bevacizumab
372979|NCT01993043|Laser|laser
372980|NCT01993043|Development|development
372981|NCT01993017|Acute Coronary Syndrome|acute coronary syndrome
372982|NCT01993017|Depressive Symptoms|depressive symptoms
372983|NCT01992991|transcranial stimulation|transcranial stimulation
372984|NCT01992991|Intracranial hemorrhage|intracranial hemorrhage
372985|NCT01992991|Home training|home training
372986|NCT01992991|Occupational Therapy|occupational therapy
372987|NCT01992991|Jebsen Taylor Hand Function Test|jebsen taylor hand function test
372988|NCT01992978|radiofrequency-assisted（RF）|radiofrequency-assisted（rf）
372989|NCT01992978|hepatectomy|hepatectomy
372990|NCT01992978|postoperative liver injury|postoperative liver injury
372991|NCT01992965|continuous glucose monitoring；|continuous glucose monitoring；
372992|NCT01992965|critically ill;|critically ill;
372993|NCT01992939|pulse|pulse
372994|NCT01992939|heat|heat
372995|NCT01992939|blood circulation|blood circulation
372996|NCT01992926|health literacy|health literacy
372997|NCT01992926|health numeracy|health numeracy
372998|NCT01992913|Schizophrenia|schizophrenia
372999|NCT01992913|Cognitive Behavioral Therapy|cognitive behavioral therapy
373000|NCT01992913|Cognition|cognition
373001|NCT01992913|Vocational Rehabilitation|vocational rehabilitation
373002|NCT01992913|Supported Employment|supported employment
373003|NCT01992913|Schizoaffective Disorder|schizoaffective disorder
373004|NCT01992900|Plasmodium falciparum Malaria|plasmodium falciparum malaria
373005|NCT01992900|Eurartesim|eurartesim
373006|NCT01992900|ACT|act
373007|NCT01992887|HIV/AIDS|hiv/aids
373008|NCT01992887|Retention|retention
373009|NCT01992887|ART (anti-retroviral therapy) ineligible|art (anti-retroviral therapy) ineligible
373010|NCT01992874|Neoplasms|neoplasms
373011|NCT01992874|Pimasertib|pimasertib
373012|NCT01992874|Cancer|cancer
373013|NCT01992822|rTMS|rtms
373014|NCT01992822|fibromyalgia|fibromyalgia
373015|NCT01992822|experimental pain|experimental pain
373016|NCT01992809|Nonalcoholic fatty liver|nonalcoholic fatty liver
373017|NCT01992809|omega 3|omega 3
373018|NCT01992796|irbesartan, angiotensin, sepsis|irbesartan, angiotensin, sepsis
373019|NCT01992783|Resistant Starch|resistant starch
373020|NCT01992783|Antioxidant Status|antioxidant status
373021|NCT01992783|Insulin Resistance|insulin resistance
373022|NCT01992783|Overweight|overweight
373023|NCT01992783|Obesity|obesity
373024|NCT01992770|behavioural medicine|behavioural medicine
373025|NCT01992770|pain|pain
373026|NCT01992770|physical therapy|physical therapy
373027|NCT01992770|physical exercise|physical exercise
373028|NCT01992770|primary care|primary care
373029|NCT01992757|functional fibrinogen assay|functional fibrinogen assay
373030|NCT01992757|cardiac surgery|cardiac surgery
373031|NCT01992744|pregnancy|pregnancy
373032|NCT01992744|brain-derived neurotrophic factor|brain-derived neurotrophic factor
373033|NCT01992744|birth outcomes|birth outcomes
373034|NCT01992731|Age (38-42 years)|age (38-42 years)
373035|NCT01992731|pregnancy rates|pregnancy rates
373036|NCT01992731|3 IUI cycles|3 iui cycles
373038|NCT01992705|pancreatic cancer|pancreatic cancer
373039|NCT01992692|Parkinson's disease|parkinson's disease
373040|NCT01992692|remifentanil|remifentanil
373041|NCT01992692|deep brain stimulator|deep brain stimulator
373042|NCT01992692|cardiovascular response|cardiovascular response
373043|NCT01992666|Systemic lupus erythematosus|systemic lupus erythematosus
373044|NCT01992666|genetic|genetic
373045|NCT01992666|immunological|immunological
373046|NCT01992666|pediatric|pediatric
373047|NCT01992666|mutation|mutation
373048|NCT01992666|lupus|lupus
373049|NCT01992627|High Intensity Laser Therapy|high intensity laser therapy
373050|NCT01992627|elbow epicondylosis|elbow epicondylosis
373051|NCT01992614|Single Ascending Dose|single ascending dose
373052|NCT01992614|healthy subjects|healthy subjects
373053|NCT01992614|Hypercholesterolemia|hypercholesterolemia
373054|NCT01992614|Hyperlipidemias|hyperlipidemias
373055|NCT01992614|Dyslipidemias|dyslipidemias
373056|NCT01992614|Lipid Metabolism Disorders|lipid metabolism disorders
373057|NCT01992614|Metabolic Diseases|metabolic diseases
373058|NCT01992601|Drug interaction|drug interaction
373059|NCT01992601|Rosuvastatin|rosuvastatin
373060|NCT01992601|Telmisartan|telmisartan
373061|NCT01992601|Pharmacokinetic|pharmacokinetic
373062|NCT01992601|(Pharmacokinetics and Drug Interaction)|(pharmacokinetics and drug interaction)
373063|NCT01992575|Retinal vein occlusion|retinal vein occlusion
373064|NCT01992575|OCT|oct
373065|NCT01992575|Optical coherence tomography|optical coherence tomography
373066|NCT01992575|Imaging|imaging
373067|NCT01992536|Meningococcal|meningococcal
373068|NCT01992536|Booster|booster
373069|NCT01992536|MenABCWY|menabcwy
373070|NCT01992536|Menveo|menveo
373071|NCT01992536|Vaccine Adolescents|vaccine adolescents
373072|NCT01992536|Immune Response|immune response
373073|NCT01992536|N. Meningitidis|n. meningitidis
373074|NCT01992523|Ticagrelor|ticagrelor
373075|NCT01992523|antiplatelet|antiplatelet
373077|NCT01992497|Cesarean section, probiotic, formula fed, gut microbiota|cesarean section, probiotic, formula fed, gut microbiota
373078|NCT01992484|platelets, Acute coronary Syndrome (ACS), prasugrel, ticagrelor, aspirin|platelets, acute coronary syndrome (acs), prasugrel, ticagrelor, aspirin
373079|NCT01992471|BRCA1 testing|brca1 testing
373080|NCT01992471|BRCA2 testing|brca2 testing
373081|NCT01992471|13-215|13-215
373082|NCT01992458|implantable cardioverter defibrillator|implantable cardioverter defibrillator
373083|NCT01992458|death|death
373084|NCT01992458|shock|shock
373085|NCT01992458|mortality|mortality
373086|NCT01992458|complication|complication
373087|NCT01992458|sudden death|sudden death
373088|NCT01992445|suicide|suicide
373089|NCT01992445|suicidal intent|suicidal intent
373090|NCT01992445|thought markers|thought markers
373091|NCT01992432|Brain magnetic resonance imaging|brain magnetic resonance imaging
373092|NCT01992432|chemotherapy toxicity|chemotherapy toxicity
373093|NCT01992432|older woman|older woman
373094|NCT01992432|breast cancer|breast cancer
373095|NCT01992419|Out-of-hospital Cardiac arrest|out-of-hospital cardiac arrest
373096|NCT01992419|telephone dispatch assisted resuscitation|telephone dispatch assisted resuscitation
373097|NCT01992419|cardiac arrest phone detection|cardiac arrest phone detection
373098|NCT01992393|Epilepsy|epilepsy
373099|NCT01992393|Schizophrenia|schizophrenia
373100|NCT01992393|Schizoaffective Disorder|schizoaffective disorder
373101|NCT01992393|Bipolar Disorder|bipolar disorder
373102|NCT01992393|Depression|depression
373103|NCT01992393|Intervention|intervention
373104|NCT01992393|Treatment|treatment
373105|NCT01992393|Adherence|adherence
373106|NCT01992341|sarcomas|sarcomas
373107|NCT01992341|carcinomas|carcinomas
373108|NCT01992328|Immunoglobulin G Deficiency|immunoglobulin g deficiency
373109|NCT01992315|Scar|scar
373110|NCT01992315|Soft tissue defect|soft tissue defect
373111|NCT01992302|Rapid cycling|rapid cycling
373112|NCT01992289|XLHED|xlhed
373113|NCT01992289|HED|hed
373114|NCT01992289|Hypohidrotic ectodermal dysplasia|hypohidrotic ectodermal dysplasia
373115|NCT01992289|Christ-Siemens-Touraine Syndrome|christ-siemens-touraine syndrome
373116|NCT01992276|Influenza|influenza
373117|NCT01992276|Virus|virus
373118|NCT01992276|Monoclonal Antibody|monoclonal antibody
373119|NCT01992276|Immunization|immunization
373120|NCT01992276|Treatment|treatment
373121|NCT01992263|tuberculosis|tuberculosis
373122|NCT01992263|vitamin D|vitamin d
373123|NCT01992263|immunity|immunity
373124|NCT01992250|Cryoablation|cryoablation
373125|NCT01992237|ALI,|ali,
373126|NCT01992237|ARDS,|ards,
373127|NCT01992237|ECMO,|ecmo,
373128|NCT01992237|energy expenditure,|energy expenditure,
373129|NCT01992237|mechanical ventilation,|mechanical ventilation,
373130|NCT01992237|Extracorporeal Membrane Oxygenation|extracorporeal membrane oxygenation
373131|NCT01992237|Nutrition Assessment|nutrition assessment
373132|NCT01992237|Pulmonary Ventilation|pulmonary ventilation
373133|NCT01992224|severe acute pancreatitis|severe acute pancreatitis
373134|NCT01992224|mechanical ventilation|mechanical ventilation
373135|NCT01992198|antibiothearpy strategy|antibiothearpy strategy
373136|NCT01992198|cefoperazone|cefoperazone
373137|NCT01992198|metronidazole|metronidazole
373138|NCT01992198|meropenem|meropenem
373139|NCT01992159|Osteoporosis, Osteoporosis-Postmenopausal, Bone Diseases-Metabolic, Bone Diseases, Musculoskeletal Diseases|osteoporosis, osteoporosis-postmenopausal, bone diseases-metabolic, bone diseases, musculoskeletal diseases
373140|NCT01992146|central sensitization|central sensitization
373141|NCT01992146|endogenous opioids|endogenous opioids
373142|NCT01992146|humans|humans
373143|NCT01992146|latent sensitization|latent sensitization
373144|NCT01992146|naloxone|naloxone
373145|NCT01992146|open groin hernia repair|open groin hernia repair
373146|NCT01992146|pain|pain
373147|NCT01992146|randomized controlled trial|randomized controlled trial
373148|NCT01992146|secondary hyperalgesia|secondary hyperalgesia
373149|NCT01992146|target-controlled infusion|target-controlled infusion
373150|NCT01992133|Former gestational Diabetes|former gestational diabetes
373151|NCT01992133|Vitamin D deficiency|vitamin d deficiency
373152|NCT01992133|insulin resistance|insulin resistance
373153|NCT01992133|beta cell function|beta cell function
373154|NCT01992120|Simulation|simulation
373155|NCT01992120|Sepsis|sepsis
373156|NCT01992120|High-fidelity|high-fidelity
373157|NCT01992120|Severe Sepsis|severe sepsis
373158|NCT01992120|Septic Shock|septic shock
373159|NCT01992120|Education|education
373160|NCT01992107|Influenza|influenza
373161|NCT01992107|Influenza vaccine|influenza vaccine
373162|NCT01992107|Novartis|novartis
373163|NCT01992107|children|children
373164|NCT01992094|Influenza|influenza
373165|NCT01992094|Influenza vaccine|influenza vaccine
373166|NCT01992094|Novartis|novartis
373167|NCT01992094|Adults|adults
373168|NCT01992081|COPD, Physical Activity, Telecoaching, PROactive|copd, physical activity, telecoaching, proactive
373169|NCT01992068|lung cancer|lung cancer
373170|NCT01992055|Executive dysfunction|executive dysfunction
373171|NCT01992055|Neuropsychological rehabilitation|neuropsychological rehabilitation
373172|NCT01992055|Goal Management Training|goal management training
373174|NCT01992029|miRNA|mirna
373175|NCT01992029|biomarker|biomarker
373176|NCT01992029|monocentric observational study|monocentric observational study
373177|NCT01992016|Prostate cancer|prostate cancer
373178|NCT01992016|F18 FDG-PET|f18 fdg-pet
373179|NCT01992016|Imaging|imaging
373180|NCT01992016|Ranolazine|ranolazine
373181|NCT01992016|Bone metastases|bone metastases
373182|NCT01992016|Soft tissue metastases|soft tissue metastases
373183|NCT01991964|stridor|stridor
373184|NCT01991964|laryngomalacia|laryngomalacia
373185|NCT01991964|ultrasound|ultrasound
373186|NCT01991938|PI3K Inhibitor|pi3k inhibitor
373187|NCT01991938|mTOR Inhibitor|mtor inhibitor
373188|NCT01991938|Dual PI3K/mTOR Inhibitor|dual pi3k/mtor inhibitor
373189|NCT01991938|CSC|csc
373190|NCT01991938|Cancer Stem Cells|cancer stem cells
373191|NCT01991912|irrigation endoscopic decompression|irrigation endoscopic decompression
373192|NCT01991912|minimally invasive surgery|minimally invasive surgery
373193|NCT01991912|spinal stenosis|spinal stenosis
373194|NCT01991899|Measles, mumps and rubella vaccine|measles, mumps and rubella vaccine
373195|NCT01991899|Tetraviral vaccine|tetraviral vaccine
373196|NCT01991899|Immunogenicity, Reactogenicity and Safety|immunogenicity, reactogenicity and safety
373197|NCT01991899|Consistency of production|consistency of production
373198|NCT01991886|nasal High Flow|nasal high flow
373199|NCT01991886|premature baby|premature baby
373200|NCT01991886|CPAP (Continuous positive airways pressure)|cpap (continuous positive airways pressure)
373201|NCT01991873|metastatic colorectal cancer|metastatic colorectal cancer
373202|NCT01991873|maintenance therapy|maintenance therapy
373203|NCT01991873|Panitumumab|panitumumab
373204|NCT01991873|Vectibix®|vectibix®
373205|NCT01991847|colon|colon
373206|NCT01991847|cancer|cancer
373207|NCT01991847|prevention|prevention
373208|NCT01991847|exercise|exercise
373209|NCT01991847|physical activity|physical activity
373210|NCT01991847|rectal|rectal
373211|NCT01991834|laparoscopy|laparoscopy
373212|NCT01991834|surgical wound infection|surgical wound infection
373213|NCT01991834|antibiotic prophylaxis|antibiotic prophylaxis
373214|NCT01991834|gynecologic surgical procedures|gynecologic surgical procedures
373215|NCT01991795|Diabetes|diabetes
373216|NCT01991795|Coronary artery disease|coronary artery disease
373217|NCT01991795|Outcome|outcome
373218|NCT01991795|Prevention|prevention
373219|NCT01991795|Antiplatelet|antiplatelet
373220|NCT01991782|Telemedicine|telemedicine
373221|NCT01991782|Fracture|fracture
373222|NCT01991782|Orthopaedics|orthopaedics
373223|NCT01991769|exercise|exercise
373224|NCT01991769|endothelium|endothelium
373225|NCT01991769|postprandial period|postprandial period
373226|NCT01991756|Abdominal Aortic Aneurysms|abdominal aortic aneurysms
373227|NCT01991756|AAA|aaa
373228|NCT01991743|Version|version
373229|NCT01991743|Pregnancy|pregnancy
373230|NCT01991743|Vaginal Delivery|vaginal delivery
373231|NCT01991743|Pain Control|pain control
373232|NCT01991743|Combined Spinal Epidural|combined spinal epidural
373233|NCT01991717|Victus|victus
373234|NCT01991717|lensfragmentation|lensfragmentation
373235|NCT01991717|femtosecond laser assisted|femtosecond laser assisted
373236|NCT01991717|capsulotomy,|capsulotomy,
373237|NCT01991717|manual, continuous curvilinear capsulorhexis (CCC)|manual, continuous curvilinear capsulorhexis (ccc)
373238|NCT01991717|effective phaco time, phaco|effective phaco time, phaco
373239|NCT01991704|incubation|incubation
373240|NCT01991704|Craving|craving
373241|NCT01991704|alcohol dependence|alcohol dependence
373242|NCT01991691|Antineoplastic Agents|antineoplastic agents
373243|NCT01991665|Intrapartum Ultrasound|intrapartum ultrasound
373244|NCT01991665|Vacuum|vacuum
373245|NCT01991665|Occiput position|occiput position
373246|NCT01991652|Wilms tumour|wilms tumour
373247|NCT01991652|Childhood cancer|childhood cancer
373248|NCT01991652|Africa|africa
373249|NCT01991639|frailty|frailty
373250|NCT01991639|community-dwelling|community-dwelling
373251|NCT01991639|malnutrition|malnutrition
373252|NCT01991639|physical activity|physical activity
373253|NCT01991639|nutritional intervention|nutritional intervention
373254|NCT01991600|iron absorption|iron absorption
373255|NCT01991600|bioavailability|bioavailability
373256|NCT01991600|anaemia|anaemia
373257|NCT01991600|iron deficiency|iron deficiency
373258|NCT01991600|ferrous sulphate|ferrous sulphate
373259|NCT01991587|Influenza|influenza
373260|NCT01991587|Human|human
373261|NCT01991587|RNA Virus Infections|rna virus infections
373262|NCT01991587|Immunologic|immunologic
373263|NCT01991587|Immunogenic Factors|immunogenic factors
373264|NCT01991587|Physiological Effects of Drugs|physiological effects of drugs
373265|NCT01991587|Virus diseases|virus diseases
373266|NCT01991587|Orthomyxoviridae Infections|orthomyxoviridae infections
373267|NCT01991587|Infection|infection
373268|NCT01991574|urinary phosphate|urinary phosphate
373269|NCT01991574|iron hydroxide|iron hydroxide
373270|NCT01991574|hypophosphatemia|hypophosphatemia
373271|NCT01991574|phosphate binder|phosphate binder
373272|NCT01991574|ferric hydroxide adipate|ferric hydroxide adipate
373273|NCT01991561|Influenza, Human|influenza, human
373274|NCT01991561|RNA Virus Infections|rna virus infections
373275|NCT01991561|Respiratory Tract Diseases|respiratory tract diseases
373276|NCT01991561|Respiratory Tract Infections|respiratory tract infections
373277|NCT01991561|Aluminum Hydroxide|aluminum hydroxide
373278|NCT01991561|Adjuvants, Immunologic|adjuvants, immunologic
373279|NCT01991561|Immunogenic Factors|immunogenic factors
373280|NCT01991561|GLA-SE|gla-se
373281|NCT01991561|Physiological Effects of Drugs|physiological effects of drugs
373282|NCT01991561|Virus Diseases|virus diseases
373283|NCT01991561|Orthomyxoviridae Infections|orthomyxoviridae infections
373284|NCT01991561|Infection|infection
373285|NCT01991548|Insulin pump|insulin pump
373286|NCT01991470|Insulin requiring diabetes|insulin requiring diabetes
373287|NCT01991470|Children|children
373288|NCT01991470|Sensor|sensor
373289|NCT01991470|Accuracy|accuracy
373290|NCT01991457|ALL|all
373291|NCT01991418|non-small cell lung cancer|non-small cell lung cancer
373292|NCT01991418|thioredoxin reductase|thioredoxin reductase
373293|NCT01991418|carcina embryonic antigen|carcina embryonic antigen
373294|NCT01991405|Mild Cognitive Impairment|mild cognitive impairment
373295|NCT01991405|Working Memory Training|working memory training
373296|NCT01991405|Neuropsychological function in MCI|neuropsychological function in mci
373297|NCT01991392|Pancreaticoduodenectomy|pancreaticoduodenectomy
373298|NCT01991392|nasogastric tube|nasogastric tube
373299|NCT01991379|MEK162|mek162
373300|NCT01991379|Imatinib|imatinib
373301|NCT01991379|13-162|13-162
373302|NCT01991366|Major adverse microvascular integrity|major adverse microvascular integrity
373303|NCT01991366|all cause mortality|all cause mortality
373304|NCT01991366|Q Wave MI|q wave mi
373305|NCT01991353|Knee|knee
373306|NCT01991353|meniscus|meniscus
373307|NCT01991353|platelet rich plasma|platelet rich plasma
373308|NCT01991301|graft-versus-host disease|graft-versus-host disease
373309|NCT01991301|stem cell transplantation|stem cell transplantation
373310|NCT01991301|matched unrelated donors|matched unrelated donors
373311|NCT01991301|proteosmoe inhibitor|proteosmoe inhibitor
373312|NCT01991301|carfilzumib|carfilzumib
373313|NCT01991288|Total Knee Replacement|total knee replacement
373314|NCT01991288|Bupivacaine|bupivacaine
373315|NCT01991288|Levobupivacaine|levobupivacaine
373316|NCT01991288|Saphenous Nerve Block|saphenous nerve block
373317|NCT01991288|Local Infiltration Analgesia|local infiltration analgesia
373318|NCT01991275|Prostatic Neoplasms|prostatic neoplasms
373319|NCT01991275|Laparoscopy|laparoscopy
373320|NCT01991275|Injections, Spinal|injections, spinal
373321|NCT01991275|Morphine|morphine
373322|NCT01991249|pediatric acute leukemia|pediatric acute leukemia
373323|NCT01991249|Targeted high throughput sequencing|targeted high throughput sequencing
373324|NCT01991249|messenger RNA|messenger rna
373325|NCT01991197|Psoriasis|psoriasis
373326|NCT01991197|Type 2 Diabetes|type 2 diabetes
373327|NCT01991197|Dipeptidyl peptidase-4 inhibition|dipeptidyl peptidase-4 inhibition
373328|NCT01991197|Sitagliptin|sitagliptin
373329|NCT01991197|Gliclazide|gliclazide
373330|NCT01991197|Psoriasis area and severity index|psoriasis area and severity index
373331|NCT01991171|kinesio taping|kinesio taping
373332|NCT01991171|Muscle activation|muscle activation
373333|NCT01991171|Muscle inhibition|muscle inhibition
373334|NCT01991158|GAD-M regimen|gad-m regimen
373335|NCT01991158|first line chemotherapy|first line chemotherapy
373336|NCT01991158|NK/T-cell Lymphoma|nk/t-cell lymphoma
373337|NCT01991145|Cerebral Palsy|cerebral palsy
373338|NCT01991145|Umbilical Cord Blood|umbilical cord blood
373339|NCT01991145|Erythropoietin|erythropoietin
373340|NCT01991145|Rehabilitation|rehabilitation
373341|NCT01991132|Dry Eyes|dry eyes
373342|NCT01991132|Meibomian glands|meibomian glands
373343|NCT01991132|Algorithm|algorithm
373344|NCT01991132|MediView software|mediview software
373345|NCT01991119|Atrial fibrillation|atrial fibrillation
373346|NCT01991119|Propafenone|propafenone
373347|NCT01991119|Dronedarone|dronedarone
373348|NCT01991106|Exercise|exercise
373349|NCT01991106|Myocardial function|myocardial function
373350|NCT01991106|Vascular function|vascular function
373351|NCT01991106|Cardiovascular disease/prevention & control|cardiovascular disease/prevention & control
373352|NCT01991106|Paediatric obesity|paediatric obesity
373353|NCT01991106|Visceral adipose tissue|visceral adipose tissue
373354|NCT01991093|light transmittance aggregometry (LTA),multiple electrode aggregometry, clopidogrel-resistance|light transmittance aggregometry (lta),multiple electrode aggregometry, clopidogrel-resistance
373355|NCT01991080|biofeedback|biofeedback
373356|NCT01991080|relaxation|relaxation
373357|NCT01991080|Wheat germ juice|wheat germ juice
373358|NCT01991067|Marrow transplant recipients|marrow transplant recipients
373359|NCT01991054|Diabetes mellitus|diabetes mellitus
373360|NCT01991054|HgA1C|hga1c
373361|NCT01991054|25(OH) vitamin D|25(oh) vitamin d
373362|NCT01991054|HgA1C levels above 7.5%|hga1c levels above 7.5%
373363|NCT01991041|Lennox-Gastaut Syndrome|lennox-gastaut syndrome
373364|NCT01991002|14/21 diet|14/21 diet
373365|NCT01991002|BMI|bmi
373366|NCT01991002|biochemical blood markers|biochemical blood markers
373367|NCT01991002|quality of life|quality of life
373368|NCT01990989|clopidogrel|clopidogrel
373369|NCT01990989|pharmacogenomics|pharmacogenomics
373370|NCT01990989|CYP2C19|cyp2c19
373371|NCT01990989|platelet aggregation|platelet aggregation
373372|NCT01990989|score system|score system
373373|NCT01990989|ischemic cardiovascular outcomes|ischemic cardiovascular outcomes
373374|NCT01990989|hemorrhage complications|hemorrhage complications
373375|NCT01990976|Muscular Dystrophy|muscular dystrophy
373376|NCT01990976|Facioscapulohumeral|facioscapulohumeral
373377|NCT01990976|Physical training|physical training
373378|NCT01990976|Magnetic Resonance Imaging|magnetic resonance imaging
373379|NCT01990976|Muscle Biopsy|muscle biopsy
373380|NCT01990963|Brain trauma;|brain trauma;
373381|NCT01990963|MALUNA;|maluna;
373382|NCT01990963|densitometric data|densitometric data
373383|NCT01990963|CT|ct
373384|NCT01990950|Aneurysm|aneurysm
373385|NCT01990950|Aortic Aneurysm|aortic aneurysm
373386|NCT01990950|Iliac Aneurysm|iliac aneurysm
373387|NCT01990950|Aortic Aneurysm, Abdominal|aortic aneurysm, abdominal
373388|NCT01990950|Vascular Diseases|vascular diseases
373389|NCT01990950|Cardiovascular Diseases|cardiovascular diseases
373390|NCT01990950|Aortic Diseases|aortic diseases
373391|NCT01990937|oral midazolam|oral midazolam
373392|NCT01990937|sedation|sedation
373393|NCT01990937|premedication|premedication
373394|NCT01990937|upper gastrointestinal endoscopy|upper gastrointestinal endoscopy
373395|NCT01990937|EGD|egd
373396|NCT01990924|fluoroscopy|fluoroscopy
373397|NCT01990924|radiation|radiation
373398|NCT01990924|transradial|transradial
373399|NCT01990924|diagnostic|diagnostic
373400|NCT01990924|angiography|angiography
373401|NCT01990924|cardiac|cardiac
373402|NCT01990924|coronary|coronary
373403|NCT01990924|angioplasty|angioplasty
373404|NCT01990911|hypertension|hypertension
373405|NCT01990911|hypertensive heart disease|hypertensive heart disease
373406|NCT01990911|atrial fibrillation|atrial fibrillation
373407|NCT01990911|autonomic imbalance|autonomic imbalance
373408|NCT01990872|Vitamin D status|vitamin d status
373409|NCT01990872|25-hydroxyvitamin D|25-hydroxyvitamin d
373410|NCT01990872|Vitamin D3|vitamin d3
373411|NCT01990872|RCT|rct
373412|NCT01990872|Calcium intake|calcium intake
373413|NCT01990872|Dietary requirement|dietary requirement
373414|NCT01990846|antiviral, influenza|antiviral, influenza
373415|NCT01990820|Pediatric Chronic Rhinosinusitis|pediatric chronic rhinosinusitis
373416|NCT01990807|high risk|high risk
373417|NCT01990807|Philadelphia Chromosome absent|philadelphia chromosome absent
373418|NCT01990807|Childhood acute lymphoblastic leukemia|childhood acute lymphoblastic leukemia
373419|NCT01990794|Cobalt|cobalt
373420|NCT01990794|Dietary Supplements|dietary supplements
373421|NCT01990794|Hematological|hematological
373422|NCT01990794|Thyroid|thyroid
373423|NCT01990781|Lidocaine, Dexamethasone, Postoperative sore throat|lidocaine, dexamethasone, postoperative sore throat
373424|NCT01990768|tranexamic acid|tranexamic acid
373425|NCT01990768|traumatic brain injury|traumatic brain injury
373426|NCT01990768|intracranial hemorrhage|intracranial hemorrhage
373427|NCT01990768|prehospital|prehospital
373428|NCT01990768|neurologic outcome|neurologic outcome
373429|NCT01990768|glasgow outcome scale extended|glasgow outcome scale extended
373430|NCT01990768|disability rating scale|disability rating scale
373431|NCT01990716|Adult|adult
373432|NCT01990716|Colonoscopy|colonoscopy
373433|NCT01990703|Contraception|contraception
373434|NCT01990703|Birth Control|birth control
373435|NCT01990703|Levonorgestrel IUD|levonorgestrel iud
373436|NCT01990703|Mirena IUD|mirena iud
373437|NCT01990690|oligohydramnios,antioxidant,oxidative stress and pregnancy outcomes|oligohydramnios,antioxidant,oxidative stress and pregnancy outcomes
373438|NCT01990677|Central Serous Chorioretinopathy|central serous chorioretinopathy
373439|NCT01990677|csr|csr
373440|NCT01990677|cscr|cscr
373441|NCT01990677|eplerenone|eplerenone
373442|NCT01990677|vision|vision
373443|NCT01990677|choroid|choroid
373444|NCT01990677|retina|retina
373445|NCT01990677|acute|acute
373446|NCT01990677|chronic|chronic
373447|NCT01990638|coronary artery bypass graft|coronary artery bypass graft
373448|NCT01990638|Diabetes mellitus, type 2|diabetes mellitus, type 2
373449|NCT01990625|Maternal Near Miss Morbidity|maternal near miss morbidity
373450|NCT01990625|Maternal Mortality|maternal mortality
373451|NCT01990625|Neonatal Mortality|neonatal mortality
373452|NCT01990625|Gestational Age Dating|gestational age dating
373453|NCT01990625|Pregnancy Complications|pregnancy complications
373454|NCT01990625|Ultrasound|ultrasound
373455|NCT01990625|Stillbirth|stillbirth
373456|NCT01990612|Induction of labor|induction of labor
373457|NCT01990612|Expectant management of labor|expectant management of labor
373458|NCT01990612|39 weeks gestation|39 weeks gestation
373459|NCT01990599|nasopharyngeal tube|nasopharyngeal tube
373460|NCT01990599|airway management|airway management
373461|NCT01990599|thermal coagulation of the Gasserian ganglion|thermal coagulation of the gasserian ganglion
373462|NCT01990573|spinal surgery|spinal surgery
373463|NCT01990573|Methadone|methadone
373464|NCT01990560|mild hypercortisolism|mild hypercortisolism
373465|NCT01990560|Subclinical Cushing's Syndrome|subclinical cushing's syndrome
373466|NCT01990560|Preclinical Cushing's Syndrome|preclinical cushing's syndrome
373467|NCT01990547|Virtual Reality Exposure Therapy|virtual reality exposure therapy
373468|NCT01990547|functional Magnetic Resonance Imaging|functional magnetic resonance imaging
373469|NCT01990547|Traumatic Event|traumatic event
373470|NCT01990547|Trauma Survivor|trauma survivor
783380|NCT00316979|migraine|migraine
373471|NCT01990547|Combat-related PTSD|combat-related ptsd
373472|NCT01990547|mTBI|mtbi
373473|NCT01990547|mild TBI|mild tbi
373474|NCT01990547|PTSD|ptsd
373475|NCT01990547|Veteran|veteran
373476|NCT01990534|Lymphoma|lymphoma
373477|NCT01990534|Hodgkin|hodgkin
373478|NCT01990534|Relapsed|relapsed
373479|NCT01990534|Refractory|refractory
373480|NCT01990534|Antigens, CD30|antigens, cd30
373481|NCT01990534|Antibody-Drug Conjugate|antibody-drug conjugate
373482|NCT01990534|Antibodies, Monoclonal|antibodies, monoclonal
373483|NCT01990534|Monomethyl auristatin E|monomethyl auristatin e
373484|NCT01990534|Drug Therapy|drug therapy
373485|NCT01990534|Immunotherapy|immunotherapy
373486|NCT01990534|Hematologic Diseases|hematologic diseases
373487|NCT01990534|Additional Relevant MeSH terms:|additional relevant mesh terms:
373488|NCT01990534|Lymphoma, Large B-Cell, Diffuse|lymphoma, large b-cell, diffuse
373489|NCT01990534|Lymphoma, Hodgkin|lymphoma, hodgkin
373490|NCT01990534|Neoplasms by Histologic Type|neoplasms by histologic type
373491|NCT01990534|Neoplasms|neoplasms
373492|NCT01990534|Lymphoproliferative Disorders|lymphoproliferative disorders
373493|NCT01990534|Lymphatic Diseases|lymphatic diseases
373494|NCT01990534|Immunoproliferative Disorders|immunoproliferative disorders
373495|NCT01990534|Immune System Diseases|immune system diseases
373496|NCT01990534|Lymphoma, B-Cell|lymphoma, b-cell
373497|NCT01990534|Lymphoma, T-Cell|lymphoma, t-cell
373498|NCT01990534|Immunologic Factors|immunologic factors
373499|NCT01990534|Physiological Effects of Drugs|physiological effects of drugs
373500|NCT01990534|Pharmacologic Actions|pharmacologic actions
373501|NCT01990508|sugar-sweetened beverages|sugar-sweetened beverages
373502|NCT01990508|traffic-light labels|traffic-light labels
373503|NCT01990508|financial incentives|financial incentives
373504|NCT01990508|low-income community|low-income community
373505|NCT01990508|obesity prevention|obesity prevention
373506|NCT01990495|Renal failure|renal failure
373507|NCT01990495|Exercise testing|exercise testing
373508|NCT01990495|Exercise training|exercise training
373509|NCT01990495|Protein signaling|protein signaling
373510|NCT01990495|Skeletal muscle|skeletal muscle
373511|NCT01990469|Type 2 Diabetes Mellitus|type 2 diabetes mellitus
373512|NCT01990456|Extracorporeal Membrane Oxygenation|extracorporeal membrane oxygenation
373513|NCT01990456|Ventilator-Induced Lung Injury|ventilator-induced lung injury
373514|NCT01990456|Ventilators, Mechanical|ventilators, mechanical
373515|NCT01990456|Pulmonary Heart Disease|pulmonary heart disease
373516|NCT01990456|Ultrasonography|ultrasonography
373517|NCT01990443|Reslizumab|reslizumab
373518|NCT01990443|monoclonal antibody|monoclonal antibody
373519|NCT01990417|Muscle Stretching Exercises|muscle stretching exercises
373520|NCT01990417|Joint range of motion|joint range of motion
373521|NCT01990417|Resistance Training|resistance training
373522|NCT01990417|Physical Therapy|physical therapy
373523|NCT01990404|Premixed nitrous oxide and oxygen|premixed nitrous oxide and oxygen
373524|NCT01990404|Severe acute pain|severe acute pain
373525|NCT01990404|Prehospital setting|prehospital setting
373526|NCT01990365|Vertebral fracture, low back pain, gips, mobility|vertebral fracture, low back pain, gips, mobility
373527|NCT01990313|Parkinson's Disease|parkinson's disease
373528|NCT01990313|DBS|dbs
373529|NCT01990313|Deep Brain Stimulation|deep brain stimulation
373530|NCT01990313|Subthalamic Nucleus|subthalamic nucleus
373531|NCT01990300|Drug Therapy|drug therapy
373532|NCT01990287|Low Back Pain|low back pain
373533|NCT01990287|Failed Back surgery Syndrome|failed back surgery syndrome
373534|NCT01990287|Post-Laminectomy Syndrome|post-laminectomy syndrome
373535|NCT01990287|Spinal Cord Stimulation|spinal cord stimulation
373536|NCT01990287|Peripheral Nerve field Stimulation|peripheral nerve field stimulation
373537|NCT01990287|Pain|pain
373538|NCT01990274|Tuberculosis|tuberculosis
373539|NCT01990274|Diagnosis|diagnosis
373540|NCT01990274|GeneXpert MTB/RIF|genexpert mtb/rif
373541|NCT01990274|Point-of-treatment|point-of-treatment
373542|NCT01990274|Mobile unit|mobile unit
373543|NCT01990235|Advance care planning|advance care planning
373544|NCT01990235|Aging|aging
373545|NCT01990235|Health communication|health communication
373546|NCT01990235|Health literacy|health literacy
373547|NCT01990235|Medical decision making|medical decision making
373548|NCT01990235|primary care|primary care
373549|NCT01990235|vulnerable population|vulnerable population
373550|NCT01990235|chronic illness|chronic illness
373551|NCT01990222|ADHD|adhd
373552|NCT01990209|triple-negative breast cancer|triple-negative breast cancer
373553|NCT01990209|orteronel|orteronel
373554|NCT01990209|TAK-700|tak-700
373555|NCT01990209|metastatic breast cancer|metastatic breast cancer
373556|NCT01990196|prostate cancer|prostate cancer
373557|NCT01990196|hormone therapy|hormone therapy
373558|NCT01990196|radical prostatectomy|radical prostatectomy
373559|NCT01990183|preterm infants|preterm infants
373560|NCT01990183|early intervention|early intervention
373561|NCT01990183|enrichment|enrichment
373562|NCT01990183|cognitive, motor, visual development|cognitive, motor, visual development
373563|NCT01990183|tele-rehabilitation|tele-rehabilitation
783475|NCT00316563|cancer|cancer
373564|NCT01990131|computerized intervention|computerized intervention
373565|NCT01990131|cognitive bias modification|cognitive bias modification
373566|NCT01990131|anxiety|anxiety
373567|NCT01990131|suicide|suicide
373568|NCT01990118|Renal transplant|renal transplant
373569|NCT01990118|Renal allograft rejection|renal allograft rejection
373570|NCT01990118|Cyclosporine|cyclosporine
373571|NCT01990118|Gengraf|gengraf
373572|NCT01990105|atrial fibrillation|atrial fibrillation
373573|NCT01990105|anticoagulation|anticoagulation
373574|NCT01990105|antiarrhythmic medication|antiarrhythmic medication
373575|NCT01990105|CHA2DS2VASc score|cha2ds2vasc score
373576|NCT01990105|HAS-BLED score|has-bled score
373577|NCT01990105|CHADS2 score|chads2 score
373578|NCT01990092|Metanx|metanx
373579|NCT01990092|B vitamins|b vitamins
373580|NCT01990092|neuropathy|neuropathy
373581|NCT01990092|nutrition|nutrition
373582|NCT01990079|PTSD|ptsd
373583|NCT01990079|smoking|smoking
373584|NCT01990066|Quality of Life|quality of life
373585|NCT01990066|Physical Function|physical function
373586|NCT01990040|Short Bowel Syndrome|short bowel syndrome
373587|NCT01990040|SBS|sbs
373588|NCT01990040|teduglutide|teduglutide
373589|NCT01990040|Gattex|gattex
373590|NCT01990027|kidney stone|kidney stone
373591|NCT01990001|contraception, adherence, medication reminder|contraception, adherence, medication reminder
373592|NCT01989988|Type 2 Diabetes Mellitus (T2DM)|type 2 diabetes mellitus (t2dm)
373593|NCT01989988|Obesity|obesity
373594|NCT01989988|Laparoscopic gastric bypass|laparoscopic gastric bypass
373595|NCT01989988|Duodenum exclusion|duodenum exclusion
373596|NCT01989975|Sensor-Augmented Pump Therapy|sensor-augmented pump therapy
373597|NCT01989975|Connected Care|connected care
373598|NCT01989962|Aboriginal Health|aboriginal health
373599|NCT01989962|Diabetes Mellitus Type 2|diabetes mellitus type 2
373600|NCT01989962|Cultural Competency|cultural competency
373601|NCT01989962|Continuing Medical Education|continuing medical education
373602|NCT01989923|Smoking cessation|smoking cessation
373603|NCT01989923|Traditional nicotine replacement therapy|traditional nicotine replacement therapy
373604|NCT01989923|Electronic nicotine delivery devices|electronic nicotine delivery devices
373605|NCT01989923|electronic cigarettes|electronic cigarettes
373606|NCT01989923|cervical dysplasia|cervical dysplasia
373607|NCT01989910|Efavirenz|efavirenz
373608|NCT01989910|Raltegravir|raltegravir
373609|NCT01989910|Combination antiretroviral therapy|combination antiretroviral therapy
373610|NCT01989897|diluent|diluent
373611|NCT01989897|rhinitis|rhinitis
373612|NCT01989897|allergic|allergic
373613|NCT01989871|preterm|preterm
373614|NCT01989871|oral feeding|oral feeding
373615|NCT01989871|outcome|outcome
373616|NCT01989858|localized gastric adenocarcinoma, operable considered.|localized gastric adenocarcinoma, operable considered.
373617|NCT01989832|cohort|cohort
373618|NCT01989832|pharmaco-economic|pharmaco-economic
373619|NCT01989832|kidney|kidney
373620|NCT01989832|transplantation|transplantation
373621|NCT01989832|quality of life|quality of life
373622|NCT01989806|Spinal cord injury|spinal cord injury
373623|NCT01989806|robotic|robotic
373624|NCT01989806|locomotion|locomotion
373625|NCT01989793|sarcopenia|sarcopenia
373626|NCT01989793|frailty|frailty
373627|NCT01989793|losartan|losartan
373628|NCT01989767|sickness absence|sickness absence
373629|NCT01989767|rehabilitation|rehabilitation
373630|NCT01989767|mental disorders|mental disorders
373631|NCT01989767|screening|screening
373632|NCT01989754|Albuminuria|albuminuria
373633|NCT01989754|Canagliflozin|canagliflozin
373634|NCT01989754|Cardiovascular outcomes|cardiovascular outcomes
373635|NCT01989754|Type 2 Diabetes Mellitus|type 2 diabetes mellitus
373636|NCT01989754|T2DM|t2dm
373637|NCT01989754|JNJ-28431754|jnj-28431754
373638|NCT01989754|Antihyperglycemic Agent|antihyperglycemic agent
373639|NCT01989741|sleep restriction, decision making, wakefullness|sleep restriction, decision making, wakefullness
373640|NCT01989728|sickness absence, return to work, psychiatric examination, feedback, psychological distress, quality of life, attrition analysis, multiple imputation|sickness absence, return to work, psychiatric examination, feedback, psychological distress, quality of life, attrition analysis, multiple imputation
373641|NCT01989689|PSORIASIS|psoriasis
373642|NCT01989676|Phase 3|phase 3
373643|NCT01989676|trastuzumab|trastuzumab
373644|NCT01989676|Breast Neoplasms|breast neoplasms
373645|NCT01989663|Healthy Women|healthy women
373646|NCT01989624|Pancreatic adenocarcinoma|pancreatic adenocarcinoma
373647|NCT01989624|diagnosis|diagnosis
373648|NCT01989624|treatment|treatment
373649|NCT01989546|DNA Damage|dna damage
373650|NCT01989546|Advanced Solid Tumors|advanced solid tumors
373651|NCT01989546|BRCA Mutations|brca mutations
373652|NCT01989546|PARP Inhibitor|parp inhibitor
373653|NCT01989546|Pharmacodynamics|pharmacodynamics
373654|NCT01989533|HIV Vaccine|hiv vaccine
373655|NCT01989533|Healthy Volunteer|healthy volunteer
373656|NCT01989520|Relative bioavailability, Healthy volunteers, Neutrophils|relative bioavailability, healthy volunteers, neutrophils
373657|NCT01989507|tobacco smoking|tobacco smoking
373658|NCT01989507|smoking cessation|smoking cessation
373961|NCT01988233|Aging|aging
373659|NCT01989507|nicotine dependence|nicotine dependence
373660|NCT01989507|tobacco use disorder|tobacco use disorder
373661|NCT01989494|anesthesiologists|anesthesiologists
373662|NCT01989494|physical activity|physical activity
373663|NCT01989494|pedometer|pedometer
373664|NCT01989494|wellness|wellness
373665|NCT01989494|exercise|exercise
373666|NCT01989468|Psoriatic arthritis|psoriatic arthritis
373667|NCT01989468|AIN457|ain457
373668|NCT01989468|PsA|psa
373669|NCT01989468|ACR|acr
373670|NCT01989468|CASPAR|caspar
373671|NCT01989468|PASDAS|pasdas
373672|NCT01989468|secukinumab|secukinumab
373673|NCT01989468|autoinjector|autoinjector
373674|NCT01989455|Healthy|healthy
373675|NCT01989455|Deferiprone|deferiprone
373676|NCT01989455|DFP|dfp
373677|NCT01989455|L1|l1
373678|NCT01989442|cpap failure|cpap failure
373679|NCT01989442|bronchopulmonary dysplasia|bronchopulmonary dysplasia
373680|NCT01989442|nasal trauma|nasal trauma
373681|NCT01989442|ventilation duration|ventilation duration
373682|NCT01989442|non-invasive ventilation|non-invasive ventilation
373683|NCT01989429|psoriasis|psoriasis
373684|NCT01989429|Vitamin D3|vitamin d3
373685|NCT01989429|topical|topical
373686|NCT01989429|ointments|ointments
373687|NCT01989416|colonization|colonization
373688|NCT01989338|hallux valgus|hallux valgus
373689|NCT01989338|pain|pain
373690|NCT01989338|functional status|functional status
373691|NCT01989338|quality of life|quality of life
373692|NCT01989312|ultrasound|ultrasound
373693|NCT01989312|peripheral nerves|peripheral nerves
373694|NCT01989312|anesthetics|anesthetics
373695|NCT01989312|local|local
373696|NCT01989299|Heart failure with preserved ejection fraction (HFpEF)|heart failure with preserved ejection fraction (hfpef)
373697|NCT01989299|ILR|ilr
373698|NCT01989299|ventricular tachyarrhythmias|ventricular tachyarrhythmias
373699|NCT01989299|Safety|safety
373700|NCT01989286|Plagiocephaly|plagiocephaly
373701|NCT01989286|Posture|posture
373702|NCT01989286|Spine|spine
373703|NCT01989273|Trauma|trauma
373704|NCT01989273|Ultrasound|ultrasound
373705|NCT01989273|Shock|shock
373706|NCT01989273|Resuscitation|resuscitation
373707|NCT01989260|Endometriosis|endometriosis
373708|NCT01989247|Depression|depression
373709|NCT01989247|Anxiety|anxiety
373710|NCT01989247|Randomized Controlled Trial|randomized controlled trial
373711|NCT01989247|Self Care|self care
373712|NCT01989247|Intervention Studies|intervention studies
373713|NCT01989247|Health Education|health education
373714|NCT01989208|Heart Failure|heart failure
373715|NCT01989208|Congestive Heart Failure|congestive heart failure
373716|NCT01989208|Oxidative Stress|oxidative stress
373717|NCT01989208|Hydrogen Sulfide|hydrogen sulfide
373718|NCT01989195|ISCHEMIC OR CORONARY HEART DISEASE|ischemic or coronary heart disease
373719|NCT01989195|MYOCARDIAL INFARCTION|myocardial infarction
373720|NCT01989195|MAGNETIC RESONANCE IMAGING|magnetic resonance imaging
373721|NCT01989195|DELAYED GADOLINIUM ENHANCEMENT MRI|delayed gadolinium enhancement mri
373722|NCT01989195|MANGANESE-ENHANCED MRI|manganese-enhanced mri
373723|NCT01989195|INFARCT VOLUME/SIZE|infarct volume/size
373724|NCT01989195|ALL CAUSE MORTALITY|all cause mortality
373725|NCT01989195|VENTRICULAR ARRHYTHMIAS|ventricular arrhythmias
373726|NCT01989182|Endobronchial Valves|endobronchial valves
373727|NCT01989182|Intrabronchial Valves|intrabronchial valves
373728|NCT01989182|Bronchial Valve|bronchial valve
373729|NCT01989182|Chronic Obstructive Pulmonary Disease|chronic obstructive pulmonary disease
373730|NCT01989182|COPD|copd
373731|NCT01989182|Pulmonary Disease, Chronic Obstructive|pulmonary disease, chronic obstructive
373732|NCT01989182|Bronchoscopic Lung Volume Reduction|bronchoscopic lung volume reduction
373733|NCT01989182|BLVR|blvr
373734|NCT01989182|TLVR|tlvr
373735|NCT01989182|Emphysema|emphysema
373736|NCT01989182|Pulmonary Emphysema|pulmonary emphysema
373737|NCT01989182|Pathologic Process|pathologic process
373738|NCT01989182|Lung Diseases|lung diseases
373739|NCT01989182|Respiratory Tract Disease|respiratory tract disease
373740|NCT01989182|China|china
373741|NCT01989182|Spiration Valve System (SVS)|spiration valve system (svs)
373742|NCT01989156|Smoking|smoking
373743|NCT01989156|Candidate modified risk tobacco product|candidate modified risk tobacco product
373744|NCT01989156|Menthol conventional cigarettes|menthol conventional cigarettes
373745|NCT01989156|Reduced exposure|reduced exposure
373746|NCT01989156|HPHCs|hphcs
373747|NCT01989156|Ambulatory|ambulatory
373748|NCT01989143|Phase 1|phase 1
373749|NCT01989143|Randomized|randomized
373750|NCT01989143|Double-blind|double-blind
373751|NCT01989143|Placebo-controlled|placebo-controlled
373752|NCT01989143|Dose escalating|dose escalating
373753|NCT01989143|Single and Multiple doses|single and multiple doses
373754|NCT01989143|Safety|safety
373755|NCT01989143|Tolerability|tolerability
373756|NCT01989143|PK/PD|pk/pd
373757|NCT01989143|PF-06480605|pf-06480605
373758|NCT01989130|antimicrobial stewardship|antimicrobial stewardship
373759|NCT01989130|Cepheid Xpert CT/NG|cepheid xpert ct/ng
373760|NCT01989130|chlamydia|chlamydia
373761|NCT01989130|gonorrhea|gonorrhea
374067|NCT01987856|live birth|live birth
373762|NCT01989130|emergency department|emergency department
373763|NCT01989130|Diagnostic Techniques, Obstetrical and Gynecological|diagnostic techniques, obstetrical and gynecological
373764|NCT01989130|Diagnostic Techniques, Urological|diagnostic techniques, urological
373765|NCT01989104|Indirect calorimetry|indirect calorimetry
373766|NCT01989091|kidney dialysis|kidney dialysis
373767|NCT01989091|hemodialysis|hemodialysis
373768|NCT01989091|locking solution|locking solution
373769|NCT01989091|antimicrobial|antimicrobial
373770|NCT01989091|thrombolytic|thrombolytic
373771|NCT01989078|Kidney disorder|kidney disorder
373772|NCT01989078|Blood disorder|blood disorder
373773|NCT01989078|Pediatrics|pediatrics
373774|NCT01989065|Child obesity|child obesity
373775|NCT01989065|childhood obesity|childhood obesity
373776|NCT01989065|obesity treatment|obesity treatment
373777|NCT01989065|text messaging|text messaging
373778|NCT01989065|Lifestyle|lifestyle
373779|NCT01989052|Carboxyamidotriazole Orotate|carboxyamidotriazole orotate
373780|NCT01989052|CTO|cto
373781|NCT01989052|Lomustine|lomustine
373782|NCT01989052|N-(2-chloroethyl)-N'-cyclo-hexyl-N-nitrosourea (CCNU)|n-(2-chloroethyl)-n'-cyclo-hexyl-n-nitrosourea (ccnu)
373783|NCT01989052|CeeNU|ceenu
373784|NCT01989052|Malignant Glioma|malignant glioma
373785|NCT01989052|Pro00047969|pro00047969
373786|NCT01989052|Desjardins|desjardins
373787|NCT01989052|Duke|duke
373788|NCT01989052|The Preston Robert Tisch Brain Tumor Center|the preston robert tisch brain tumor center
373789|NCT01989026|BCG|bcg
373790|NCT01989026|non-specific effects|non-specific effects
373791|NCT01989026|neonatal mortality|neonatal mortality
373792|NCT01989026|vaccines|vaccines
373793|NCT01989013|Parkinson's disease|parkinson's disease
373794|NCT01989013|Craniosacral therapy|craniosacral therapy
373795|NCT01989013|cranial osteopathy|cranial osteopathy
373796|NCT01989000|Pancreatic cancer|pancreatic cancer
373797|NCT01989000|Hypoxia|hypoxia
373798|NCT01989000|Vasculature|vasculature
373799|NCT01989000|Stroma|stroma
373800|NCT01988987|Gestational diabetes|gestational diabetes
373801|NCT01988987|Postpartum glucose testing|postpartum glucose testing
373802|NCT01988987|Impaired glucose metabolism|impaired glucose metabolism
373803|NCT01988987|Diabetes mellitus|diabetes mellitus
373804|NCT01988961|Colitis, Ulcerative|colitis, ulcerative
373805|NCT01988961|Golimumab|golimumab
373806|NCT01988961|CNTO148|cnto148
373807|NCT01988961|SIMPONI|simponi
373808|NCT01988961|Length-109 Probe Set Panel|length-109 probe set panel
373809|NCT01988948|Human papilloma virus|human papilloma virus
373810|NCT01988948|Young women|young women
373811|NCT01988948|I-Share|i-share
373812|NCT01988922|ketamine polymorphisms|ketamine polymorphisms
373813|NCT01988909|Cutaneous leishmaniasis|cutaneous leishmaniasis
373814|NCT01988909|Paromomycin + Gentamicin Topical Cream|paromomycin + gentamicin topical cream
373815|NCT01988909|Safety|safety
373816|NCT01988909|Efficacy|efficacy
373817|NCT01988883|Postural Tachycardia Syndrome|postural tachycardia syndrome
373818|NCT01988883|Tachycardia|tachycardia
373819|NCT01988883|Orthostatic Intolerance|orthostatic intolerance
373820|NCT01988883|Autonomic Nervous System Diseases|autonomic nervous system diseases
373821|NCT01988883|Primary Dysautonomias|primary dysautonomias
373822|NCT01988883|Nervous System Diseases|nervous system diseases
373823|NCT01988883|Cardiovascular Diseases|cardiovascular diseases
373824|NCT01988883|Modafinil|modafinil
373825|NCT01988883|Propranolol|propranolol
373826|NCT01988883|Neurobehavioral Manifestations|neurobehavioral manifestations
373827|NCT01988883|Neurologic Manifestations|neurologic manifestations
373828|NCT01988883|Cognitive Symptoms|cognitive symptoms
373829|NCT01988883|Neuropsychological Tests|neuropsychological tests
373830|NCT01988857|Vietnam|vietnam
373831|NCT01988857|Children|children
373832|NCT01988857|Reactogenicity|reactogenicity
373833|NCT01988857|BoostrixTM|boostrixtm
373834|NCT01988857|Safety|safety
373835|NCT01988857|dTpa|dtpa
373836|NCT01988857|Booster|booster
373837|NCT01988857|Healthy|healthy
373838|NCT01988844|functionality|functionality
373839|NCT01988844|Cerebral palsy|cerebral palsy
373840|NCT01988844|Handwriting|handwriting
373841|NCT01988831|Malignant melanoma|malignant melanoma
373842|NCT01988831|betablocker|betablocker
373843|NCT01988831|propranolol|propranolol
373844|NCT01988831|interventional|interventional
373845|NCT01988831|prospective|prospective
373846|NCT01988831|adjuvant|adjuvant
373847|NCT01988831|recurrence|recurrence
373848|NCT01988818|wound dressing|wound dressing
373849|NCT01988818|silicone|silicone
373850|NCT01988818|standard wound dressing|standard wound dressing
373851|NCT01988766|Thrombosis|thrombosis
373852|NCT01988766|Central Venosis Catheter|central venosis catheter
373853|NCT01988766|Renal Disease|renal disease
373854|NCT01988766|Vascular Access|vascular access
373855|NCT01988753|Serum Biomarkers|serum biomarkers
373856|NCT01988753|Sheer-wave Elastography|sheer-wave elastography
373857|NCT01988753|Ultrasound imaging|ultrasound imaging
373858|NCT01988753|Viral hepatitis|viral hepatitis
373859|NCT01988753|Liver Fibrosis|liver fibrosis
373860|NCT01988753|Liver disease|liver disease
373861|NCT01988753|Hepatitis B|hepatitis b
373862|NCT01988753|Hepatitis C|hepatitis c
373863|NCT01988740|Ischemia-modified albumin|ischemia-modified albumin
373864|NCT01988740|Recurrent pregnancy loss|recurrent pregnancy loss
373865|NCT01988740|Abnormal placenta|abnormal placenta
373866|NCT01988714|Targeted cognitive training (TCT) plus evidence-based SE|targeted cognitive training (tct) plus evidence-based se
373867|NCT01988714|Computer games (CG) plus evidence-based SE|computer games (cg) plus evidence-based se
373868|NCT01988701|GVHD|gvhd
373869|NCT01988701|chronic Graft versus Host Disease|chronic graft versus host disease
373870|NCT01988688|deep brain stimulation|deep brain stimulation
373871|NCT01988662|nAMD, VEGF, VEGF agent, BCVA, CRT, Ranibizumab, Lucentis, Aflibercept, Eylea|namd, vegf, vegf agent, bcva, crt, ranibizumab, lucentis, aflibercept, eylea
373872|NCT01988649|Pain|pain
373873|NCT01988649|Oxytocin|oxytocin
373874|NCT01988636|Randomized|randomized
373875|NCT01988636|Double Blinded|double blinded
373876|NCT01988636|Mali|mali
373877|NCT01988636|Malaria|malaria
373878|NCT01988636|Transmission|transmission
373879|NCT01988623|Intellectual Disabilities|intellectual disabilities
373880|NCT01988623|Speech Delay|speech delay
373881|NCT01988623|Language Disorder|language disorder
373882|NCT01988610|cognition|cognition
373883|NCT01988610|prediabetes|prediabetes
373884|NCT01988610|mood|mood
373885|NCT01988597|Dry Eyes|dry eyes
373886|NCT01988597|Quality of life|quality of life
373887|NCT01988597|Utility assessment|utility assessment
373888|NCT01988584|Cerebral Palsy|cerebral palsy
373889|NCT01988584|Brain Injury|brain injury
373890|NCT01988584|Stem Cells|stem cells
373891|NCT01988584|Mononuclear Cells|mononuclear cells
373892|NCT01988584|Bone Marrow|bone marrow
373893|NCT01988584|Umbilical Cord Blood|umbilical cord blood
373894|NCT01988571|Stage I breast cancer|stage i breast cancer
373895|NCT01988571|Stage II breast cancer|stage ii breast cancer
373896|NCT01988571|Stage III breast cancer|stage iii breast cancer
373897|NCT01988558|Recurrent Tonsillitis|recurrent tonsillitis
373898|NCT01988558|Streptococcus A|streptococcus a
373899|NCT01988545|GLP-1|glp-1
373900|NCT01988545|blood flow|blood flow
373901|NCT01988545|cardiac out put|cardiac out put
373902|NCT01988545|stroke volume|stroke volume
373903|NCT01988545|beat to beat|beat to beat
373904|NCT01988545|effect of GLP-1 on cardiac parameters and blood flow|effect of glp-1 on cardiac parameters and blood flow
373905|NCT01988506|IL2,|il2,
373906|NCT01988506|Interleukin 2,|interleukin 2,
373907|NCT01988506|ILT101|ilt101
373908|NCT01988506|Proleukin®, RhIL-2|proleukin®, rhil-2
373909|NCT01988506|Auto-immune disease|auto-immune disease
373910|NCT01988506|Inflammatory disease|inflammatory disease
373911|NCT01988506|Inflammation|inflammation
373912|NCT01988506|Regulatory T cells,|regulatory t cells,
373913|NCT01988506|Treg|treg
373914|NCT01988506|Immunoregulation|immunoregulation
373915|NCT01988506|Immune tolerance|immune tolerance
373916|NCT01988493|Carcinoma, Hepatocellular|carcinoma, hepatocellular
373917|NCT01988493|MSC2156119J|msc2156119j
373918|NCT01988493|Sorafenib|sorafenib
373919|NCT01988493|Recommended Phase 2 dose|recommended phase 2 dose
373920|NCT01988480|Guided surgery|guided surgery
373921|NCT01988480|Sinus graft|sinus graft
373922|NCT01988467|nasal breathing, oral breathing, secondhand smoking,|nasal breathing, oral breathing, secondhand smoking,
373923|NCT01988441|autophagy|autophagy
373924|NCT01988441|children|children
373925|NCT01988441|polymorphism|polymorphism
373926|NCT01988428|sepsis|sepsis
373927|NCT01988428|severe sepsis|severe sepsis
373928|NCT01988428|septic shock|septic shock
373929|NCT01988402|gout|gout
373930|NCT01988402|allopurinol|allopurinol
373931|NCT01988363|greater occipital nerve|greater occipital nerve
373932|NCT01988363|occipital neuralgia|occipital neuralgia
373933|NCT01988363|cervicogenic headache|cervicogenic headache
373934|NCT01988350|pancreatic insufficiency|pancreatic insufficiency
373935|NCT01988350|pancreatic elastase|pancreatic elastase
373936|NCT01988350|fecal elastase|fecal elastase
373937|NCT01988350|smoking|smoking
373938|NCT01988350|tobacco|tobacco
373939|NCT01988337|Icon|icon
373940|NCT01988311|Psilocybin|psilocybin
373941|NCT01988311|Hallucinogens|hallucinogens
373942|NCT01988311|Pharmacologic Actions|pharmacologic actions
373943|NCT01988311|Central Nervous System Agents|central nervous system agents
373944|NCT01988311|Therapeutic Uses|therapeutic uses
373945|NCT01988311|Psychotropic Drugs|psychotropic drugs
373946|NCT01988285|Esophagitis|esophagitis
373947|NCT01988285|Eosinophilic Esophagitis|eosinophilic esophagitis
373948|NCT01988285|Esophageal Diseases|esophageal diseases
373949|NCT01988285|Gastrointestinal Diseases|gastrointestinal diseases
373950|NCT01988285|Digestive System Diseases|digestive system diseases
373951|NCT01988272|SPECT/CT|spect/ct
373952|NCT01988272|Dosimetry|dosimetry
373953|NCT01988272|Radiation absorbed dose|radiation absorbed dose
373954|NCT01988272|Non-Hodgkin's Lymphoma|non-hodgkin's lymphoma
400555|NCT01866293|Cabozantinib (XL184)|cabozantinib (xl184)
373955|NCT01988272|I-131 tositumomab radioimmunotherapy|i-131 tositumomab radioimmunotherapy
373956|NCT01988246|Diabetes|diabetes
373957|NCT01988246|Diabetic Retinopathy|diabetic retinopathy
373958|NCT01988233|Physical activity|physical activity
373959|NCT01988233|Dance|dance
373960|NCT01988233|Latinos|latinos
373962|NCT01988233|Older adults|older adults
373963|NCT01988233|Health disparities|health disparities
373965|NCT01988220|sensory deficit|sensory deficit
373966|NCT01988220|sensory retraining|sensory retraining
373967|NCT01988220|perceptual learning|perceptual learning
373968|NCT01988220|lower extremity|lower extremity
373969|NCT01988207|Muscle Tension Dysphonia|muscle tension dysphonia
373970|NCT01988207|Voice|voice
373971|NCT01988207|Hyperfunction|hyperfunction
373972|NCT01988194|acupuncture|acupuncture
373973|NCT01988194|postoperative pain|postoperative pain
373974|NCT01988194|nausea|nausea
373975|NCT01988194|vomiting|vomiting
373976|NCT01988194|anxiety|anxiety
373977|NCT01988194|depression|depression
373978|NCT01988194|hospitalization|hospitalization
373979|NCT01988194|inpatient|inpatient
373980|NCT01988181|Intradialytic Hypotension|intradialytic hypotension
373981|NCT01988181|Renal Dialysis|renal dialysis
373982|NCT01988181|Blood Volume Determination|blood volume determination
373983|NCT01988181|Clinical Trials, Randomized|clinical trials, randomized
373984|NCT01988181|Crossover Studies|crossover studies
373985|NCT01988168|Suture Techniques|suture techniques
373986|NCT01988168|Sutures|sutures
373987|NCT01988168|Surgical Staplers|surgical staplers
373988|NCT01988142|Spinal Cord Injury|spinal cord injury
373989|NCT01988142|Passive motion|passive motion
373990|NCT01988142|Fatigue index|fatigue index
373991|NCT01988142|Hypertonia|hypertonia
373992|NCT01988129|sleep|sleep
373993|NCT01988129|firefighter|firefighter
373994|NCT01988129|fire|fire
373995|NCT01988129|apnea|apnea
373996|NCT01988129|insomnia|insomnia
373997|NCT01988129|shift|shift
373998|NCT01988129|narcolepsy|narcolepsy
373999|NCT01988129|restless leg|restless leg
374000|NCT01988129|rls|rls
374001|NCT01988129|fatigue|fatigue
374002|NCT01988129|actigraph|actigraph
374003|NCT01988129|actigraphy|actigraphy
374004|NCT01988129|actiwatch|actiwatch
374005|NCT01988129|safety|safety
374006|NCT01988129|sleepiness|sleepiness
374007|NCT01988129|sleepy|sleepy
374008|NCT01988129|work|work
374009|NCT01988129|hours|hours
374010|NCT01988129|Federal Emergency Management Agency|federal emergency management agency
374011|NCT01988129|drowsy|drowsy
374012|NCT01988116|Chronic kidney disease|chronic kidney disease
374013|NCT01988116|Anemia of chronic disease|anemia of chronic disease
374014|NCT01988116|Iron Metabolism|iron metabolism
374015|NCT01988116|Iron Homeostasis|iron homeostasis
374016|NCT01988116|Vitamin D|vitamin d
374017|NCT01988116|Calcitriol|calcitriol
374018|NCT01988116|hemojuvelin|hemojuvelin
374019|NCT01988116|hepcidin|hepcidin
374020|NCT01988116|anemia|anemia
374021|NCT01988116|ferroportin|ferroportin
374022|NCT01988103|Psoriasis; Psoriatic Arthritis|psoriasis; psoriatic arthritis
374023|NCT01988090|Breast Cancer|breast cancer
374024|NCT01988090|Hormone Receptor Positive|hormone receptor positive
374025|NCT01988090|Vitamin D|vitamin d
374026|NCT01988064|pulse rate|pulse rate
374027|NCT01988064|patient education|patient education
374028|NCT01988064|training|training
374029|NCT01988038|Polycystic Kidney Disease|polycystic kidney disease
374030|NCT01988038|Autosomal Dominant Polycystic Kidney Disease|autosomal dominant polycystic kidney disease
374031|NCT01988038|Disease Progression|disease progression
374032|NCT01987986|cellulite|cellulite
374033|NCT01987986|dimple|dimple
374034|NCT01987986|orange peel|orange peel
374035|NCT01987986|cottage cheese|cottage cheese
374036|NCT01987986|mattress texture|mattress texture
374037|NCT01987947|MEMP1972A|memp1972a
374038|NCT01987934|Squamous Cell Carcinoma of the Head and Neck|squamous cell carcinoma of the head and neck
374039|NCT01987934|Methyl Green Pyronin Staining|methyl green pyronin staining
374040|NCT01987934|AgNORs|agnors
374041|NCT01987934|Morphometry|morphometry
374042|NCT01987921|Acute kidney injury|acute kidney injury
374043|NCT01987921|Pediatrics|pediatrics
374044|NCT01987921|Critical Care|critical care
374045|NCT01987908|Pain|pain
374046|NCT01987908|Biomarkers|biomarkers
374047|NCT01987908|6 minute walk test|6 minute walk test
374048|NCT01987908|5-HMF|5-hmf
374049|NCT01987908|Pharmacokinetics|pharmacokinetics
374050|NCT01987908|Analgesic use|analgesic use
374051|NCT01987908|Sickle cell disease|sickle cell disease
374052|NCT01987908|Aes-103|aes-103
374053|NCT01987908|SpO2|spo2
374054|NCT01987908|Anemia|anemia
374055|NCT01987908|Hemoglobin|hemoglobin
374056|NCT01987895|Post-antibiotic diarrhea|post-antibiotic diarrhea
374057|NCT01987895|Clostridium difficile infection|clostridium difficile infection
374058|NCT01987882|Outcomes research, treatment effectiveness, quality of life|outcomes research, treatment effectiveness, quality of life
374059|NCT01987869|hiperemesis gravidarum,vomiting,serotonin levels,ketonuria|hiperemesis gravidarum,vomiting,serotonin levels,ketonuria
374060|NCT01987856|aCGH|acgh
374061|NCT01987856|chromosome|chromosome
374062|NCT01987856|blastocyst|blastocyst
374063|NCT01987856|trophectoderm|trophectoderm
374064|NCT01987856|vitrification|vitrification
374065|NCT01987856|natural cycle|natural cycle
374066|NCT01987856|pregnancy|pregnancy
374068|NCT01987843|Psoriasis|psoriasis
374069|NCT01987843|Plaque Psoriasis|plaque psoriasis
374070|NCT01987830|Recurrent glioblastoma|recurrent glioblastoma
374071|NCT01987817|Characterized Peanut Allergen|characterized peanut allergen
374074|NCT01987817|Oral Desensitization|oral desensitization
374075|NCT01987817|Peanut Allergen|peanut allergen
374076|NCT01987817|Allergy|allergy
374077|NCT01987817|Peanut Allergy|peanut allergy
374078|NCT01987817|Peanut-Allergic Children|peanut-allergic children
374079|NCT01987817|Children|children
374080|NCT01987817|Peanut-Allergic Adults|peanut-allergic adults
374081|NCT01987778|Hot flashes|hot flashes
374082|NCT01987778|Menopause|menopause
374083|NCT01987778|HRQoL|hrqol
374084|NCT01987778|Resistance training|resistance training
374085|NCT01987778|Physical activity|physical activity
374086|NCT01987778|Adipose tissue|adipose tissue
374087|NCT01987739|Almorexant|almorexant
374088|NCT01987739|Zolpidem|zolpidem
374089|NCT01987726|Solid Tumor Malignancies|solid tumor malignancies
374090|NCT01987700|Abdominal Hernia Repair|abdominal hernia repair
374091|NCT01987700|Dermal Allograft|dermal allograft
374092|NCT01987700|Mesh|mesh
374093|NCT01987700|Component Separation|component separation
374094|NCT01987661|COPD|copd
374095|NCT01987661|NIV|niv
374096|NCT01987661|Airtrapping|airtrapping
374097|NCT01987661|Ventimotion2|ventimotion2
374098|NCT01987648|Craniotomy|craniotomy
374099|NCT01987648|Postoperative complications|postoperative complications
374100|NCT01987648|Perioperative care|perioperative care
374101|NCT01987648|Postoperative intracerebral hemorrhage|postoperative intracerebral hemorrhage
374102|NCT01987648|Postoperative seizure|postoperative seizure
374103|NCT01987635|Mitral valve disease|mitral valve disease
374104|NCT01987635|primarily regurgitation|primarily regurgitation
374105|NCT01987635|necessitating surgical repair|necessitating surgical repair
374106|NCT01987622|lumbar spinal stenosis|lumbar spinal stenosis
374107|NCT01987622|claudication|claudication
374108|NCT01987622|low back pain|low back pain
374109|NCT01987622|radiculopathy|radiculopathy
374110|NCT01987622|acupuncture|acupuncture
374111|NCT01987622|Korean medicine|korean medicine
374112|NCT01987622|randomized controlled trial|randomized controlled trial
374113|NCT01987609|Psoriasis|psoriasis
374114|NCT01987609|Dendritic cells|dendritic cells
374115|NCT01987609|Hyaluronidase|hyaluronidase
374116|NCT01987609|Hylenex|hylenex
374117|NCT01987570|Xanthine oxidase|xanthine oxidase
374118|NCT01987570|Magnetic resonance|magnetic resonance
374119|NCT01987570|Oxidative stress|oxidative stress
374120|NCT01987570|Inflammation|inflammation
374121|NCT01987557|treadmill|treadmill
374122|NCT01987557|parkinson's|parkinson's
374123|NCT01987557|proprioception|proprioception
374124|NCT01987557|cadence|cadence
374125|NCT01987557|step length|step length
374126|NCT01987557|intrinsic feedback|intrinsic feedback
374127|NCT01987544|COPD|copd
374128|NCT01987544|telemonitoring|telemonitoring
374129|NCT01987544|training|training
374130|NCT01987544|ergometer|ergometer
374131|NCT01987544|telemedicine|telemedicine
374132|NCT01987531|after open cardiac chamber cardiac surgery|after open cardiac chamber cardiac surgery
374133|NCT01987466|Neutrophil Gelatinase-associated Lipocalin(NGAL)|neutrophil gelatinase-associated lipocalin(ngal)
374134|NCT01987466|Acute renal failure|acute renal failure
374135|NCT01987466|Cardiac arrest|cardiac arrest
374136|NCT01987466|Hypothermia|hypothermia
374137|NCT01987453|genotype 1|genotype 1
374138|NCT01987427|Overweight|overweight
374139|NCT01987427|Obese|obese
374140|NCT01987427|Weight Management|weight management
374141|NCT01987414|Stroke|stroke
374142|NCT01987414|Cardiovascular Accident|cardiovascular accident
374143|NCT01987414|Task-oriented approach|task-oriented approach
374144|NCT01987414|Orthosis|orthosis
374145|NCT01987414|occupational therapy|occupational therapy
374146|NCT01987401|pulmonary|pulmonary
374147|NCT01987401|lung|lung
374148|NCT01987401|military and environmental exposures|military and environmental exposures
374149|NCT01987401|epidemiologic|epidemiologic
374150|NCT01987401|observational|observational
374151|NCT01987401|interview or questionnaire|interview or questionnaire
374152|NCT01987401|deployment related|deployment related
374153|NCT01987401|Enduring Freedom|enduring freedom
374154|NCT01987401|Iraqi Freedom|iraqi freedom
374155|NCT01987375|HNSCC|hnscc
374156|NCT01987375|Imaging|imaging
374157|NCT01987349|Influenza vaccines|influenza vaccines
374158|NCT01987349|healthy participants|healthy participants
374159|NCT01987349|immunity to influenza|immunity to influenza
374160|NCT01987349|identical twins|identical twins
374161|NCT01987349|fraternal twins|fraternal twins
374162|NCT01987349|non-twins|non-twins
374163|NCT01987336|Standard Foley Catheter|standard foley catheter
374164|NCT01987323|glaucoma|glaucoma
374165|NCT01987323|raised intraocular pressure|raised intraocular pressure
374166|NCT01987310|non alcoholic fatty liver disease|non alcoholic fatty liver disease
374167|NCT01987310|endothelial function|endothelial function
374168|NCT01987310|liver steatosis|liver steatosis
374169|NCT01987310|liver fibrosis|liver fibrosis
374170|NCT01987310|statin treatment|statin treatment
374171|NCT01987297|acute promyelocytic leukemia|acute promyelocytic leukemia
374172|NCT01987297|ATRA|atra
374173|NCT01987297|arsenic|arsenic
374174|NCT01987271|exercise tolerance|exercise tolerance
374175|NCT01987271|exercise test|exercise test
374176|NCT01987271|noninvasive ventilation|noninvasive ventilation
374177|NCT01987258|Glycemic control|glycemic control
374178|NCT01987258|excess post-exercise oxygen consumption|excess post-exercise oxygen consumption
374179|NCT01987219|familial dysautonomia|familial dysautonomia
374180|NCT01987206|artificial pancreas|artificial pancreas
374181|NCT01987193|Proton radiation|proton radiation
374182|NCT01987193|tumor blood flow|tumor blood flow
374183|NCT01987180|self-efficacy|self-efficacy
374184|NCT01987167|acute optic neuritis|acute optic neuritis
374185|NCT01987115|Trigger Finger|trigger finger
374186|NCT01987115|Physiotherapy|physiotherapy
374187|NCT01987115|Fascial Manipulation|fascial manipulation
374188|NCT01987102|Methotrexate|methotrexate
374189|NCT01987102|Rescue treatment|rescue treatment
374190|NCT01987089|Insomnia|insomnia
374191|NCT01987089|Sleep initiation and maintenance disorder|sleep initiation and maintenance disorder
374192|NCT01987089|Alcoholism|alcoholism
374193|NCT01987089|Cognitive behavioral therapy for insomnia|cognitive behavioral therapy for insomnia
374194|NCT01987076|DRESS|dress
374195|NCT01987076|Systemic steroid|systemic steroid
374196|NCT01987076|Topical steroid|topical steroid
374197|NCT01987076|Treatment|treatment
374198|NCT01987063|Twin delivery|twin delivery
374199|NCT01987063|Planned vaginal delivery|planned vaginal delivery
374200|NCT01987063|Planned cesarean delivery|planned cesarean delivery
374201|NCT01987063|Total breech extraction|total breech extraction
374202|NCT01987063|Internal cephalic version|internal cephalic version
374203|NCT01987063|External cephalic version|external cephalic version
374204|NCT01987037|autism spectrum disorder|autism spectrum disorder
374205|NCT01987037|neuropsychomotor assessment|neuropsychomotor assessment
374206|NCT01987037|NP-MOT|np-mot
374207|NCT01987037|motor skills|motor skills
374208|NCT01987037|gross motor|gross motor
374209|NCT01987011|Avian influenza|avian influenza
374210|NCT01986998|Multiple sclerosis relapse|multiple sclerosis relapse
374211|NCT01986998|oral methylprednisolone|oral methylprednisolone
374212|NCT01986998|EDSS|edss
374213|NCT01986998|gadolinium|gadolinium
374214|NCT01986972|Toothbrushing|toothbrushing
374215|NCT01986972|Dental plaque|dental plaque
374216|NCT01986972|Dentifrice|dentifrice
374217|NCT01986972|Oral hygiene|oral hygiene
374218|NCT01986959|Periodontal Dressings|periodontal dressings
374219|NCT01986959|Surgical crown lengthening|surgical crown lengthening
374220|NCT01986959|Periodontal surgery|periodontal surgery
374221|NCT01986920|SK|sk
374222|NCT01986920|Seborrheic Keratosis|seborrheic keratosis
374223|NCT01986907|wet AMD|wet amd
374224|NCT01986907|macular degeneration|macular degeneration
374225|NCT01986907|ranibizumab|ranibizumab
374226|NCT01986907|mono-bilateral|mono-bilateral
374227|NCT01986907|poor visual acuity|poor visual acuity
374228|NCT01986907|retinal disease|retinal disease
374229|NCT01986907|eye disease|eye disease
374230|NCT01986907|Angiogenesis Inhibitors|angiogenesis inhibitors
374231|NCT01986907|Angiogenesis Modulating Agents|angiogenesis modulating agents
374232|NCT01986894|TQT|tqt
374233|NCT01986894|Pharmacokinetic|pharmacokinetic
374234|NCT01986894|Healthy|healthy
374235|NCT01986868|Coronary Magnetic Resonance Angiography|coronary magnetic resonance angiography
374236|NCT01986868|CMRA|cmra
374237|NCT01986868|MRI with contrast|mri with contrast
374238|NCT01986868|MultiHance|multihance
374239|NCT01986868|Optimark|optimark
374240|NCT01986868|Gadolinium-based contrast|gadolinium-based contrast
374241|NCT01986868|MRA|mra
374242|NCT01986868|MR angiography|mr angiography
374243|NCT01986842|Muscle protein synthesis|muscle protein synthesis
374244|NCT01986842|Digestion and absorption kinetics|digestion and absorption kinetics
374245|NCT01986842|Leucine|leucine
374246|NCT01986842|Whey protein|whey protein
374247|NCT01986816|Obesity|obesity
374248|NCT01986816|Bariatric surgery|bariatric surgery
374249|NCT01986816|Laparoscopic gastric bypass|laparoscopic gastric bypass
374250|NCT01986816|Quality of life|quality of life
374251|NCT01986816|QALY|qaly
374252|NCT01986803|ST-elevation Myocardial Infarction (STEMI)|st-elevation myocardial infarction (stemi)
374253|NCT01986803|Primary Percutaneous Coronary Intervention within 24 hrs|primary percutaneous coronary intervention within 24 hrs
374254|NCT01986803|Healing score|healing score
374255|NCT01986803|OFDI|ofdi
374256|NCT01986790|Health insurance|health insurance
374257|NCT01986790|Health services accessibility|health services accessibility
374258|NCT01986790|Decision making|decision making
374259|NCT01986790|Health literacy|health literacy
374260|NCT01986777|cognitive complains|cognitive complains
374261|NCT01986777|RRSO|rrso
374262|NCT01986777|oophorectomy|oophorectomy
374263|NCT01986777|memory|memory
374264|NCT01986777|cognition|cognition
374265|NCT01986777|early menopause|early menopause
374266|NCT01986764|oophorectomy|oophorectomy
374267|NCT01986764|RRSO|rrso
374268|NCT01986764|menopause|menopause
374269|NCT01986764|early menopause|early menopause
374270|NCT01986764|cognition|cognition
374271|NCT01986764|memory|memory
374272|NCT01986764|brain-imaging|brain-imaging
374273|NCT01986751|nerve|nerve
374274|NCT01986751|block|block
374275|NCT01986751|motor blockade|motor blockade
374276|NCT01986751|lower extremity pain|lower extremity pain
374277|NCT01986751|nerve block|nerve block
374278|NCT01986725|vulvar neoplasia|vulvar neoplasia
374279|NCT01986725|vulvar cancer|vulvar cancer
374280|NCT01986725|vulvar intraepithelial neoplasia|vulvar intraepithelial neoplasia
374281|NCT01986725|self management|self management
374282|NCT01986725|symptom management|symptom management
374283|NCT01986712|Melanoma, Stage III, adjuvant, Quality of Life|melanoma, stage iii, adjuvant, quality of life
374284|NCT01986699|polypectomy|polypectomy
374285|NCT01986699|laparoscopic|laparoscopic
374286|NCT01986673|Pharmacokinetic Characterization|pharmacokinetic characterization
374287|NCT01986660|Pharmacokinetic Study|pharmacokinetic study
374288|NCT01986647|exercise|exercise
374289|NCT01986647|older adults|older adults
374290|NCT01986647|mobility disability|mobility disability
374291|NCT01986634|Laser Resurfacing|laser resurfacing
374292|NCT01986634|Rhytids|rhytids
374293|NCT01986634|Perioral|perioral
374294|NCT01986621|Percutaneous Coronary Intervention|percutaneous coronary intervention
374295|NCT01986621|Cardiac troponin|cardiac troponin
374296|NCT01986621|Antiplatelet therapy|antiplatelet therapy
374297|NCT01986608|Lacosamide|lacosamide
374298|NCT01986608|Vimpat|vimpat
374299|NCT01986608|Bioequivalence|bioequivalence
374300|NCT01986608|Bioavailability|bioavailability
374301|NCT01986608|Japanese|japanese
374302|NCT01986595|Neuroblastoma|neuroblastoma
374303|NCT01986595|anaplastic lymphoma kinase|anaplastic lymphoma kinase
374304|NCT01986595|cancer genetics|cancer genetics
374305|NCT01986595|target therapy|target therapy
374306|NCT01986595|RNA and genomic DNA extraction|rna and genomic dna extraction
374307|NCT01986595|complementary DNA(cDNA) preparation|complementary dna(cdna) preparation
374308|NCT01986595|Array-comparative genomic hybridization|array-comparative genomic hybridization
374309|NCT01986595|Multiplex ligation-dependent probe amplification (MLPA)|multiplex ligation-dependent probe amplification (mlpa)
374310|NCT01986595|Sequencing of cDNA prepared from NB|sequencing of cdna prepared from nb
374311|NCT01986595|Pyrosequencing|pyrosequencing
374312|NCT01986595|Quantitative real-time polymerase chain reaction(RT-PCR)|quantitative real-time polymerase chain reaction(rt-pcr)
374313|NCT01986595|Immunohistochemistry|immunohistochemistry
374314|NCT01986582|Allergic Rhinitis|allergic rhinitis
374315|NCT01986582|Congestion|congestion
374316|NCT01986582|Mucoadhesive Treatment|mucoadhesive treatment
374317|NCT01986582|Nasal Decongestant|nasal decongestant
374318|NCT01986569|Fluoroestradiol (FES)|fluoroestradiol (fes)
374319|NCT01986569|PET/CT scan|pet/ct scan
374320|NCT01986569|Estrogen Receptor|estrogen receptor
374321|NCT01986569|Recurrent breast cancer|recurrent breast cancer
374322|NCT01986569|Stage IV breast cancer|stage iv breast cancer
374323|NCT01986543|Pharmacokinetic|pharmacokinetic
374324|NCT01986530|irisin|irisin
374325|NCT01986530|adiponectin|adiponectin
374326|NCT01986530|leptin|leptin
374327|NCT01986530|lean body mass|lean body mass
374328|NCT01986530|fat mass|fat mass
374329|NCT01986517|Feedback|feedback
374330|NCT01986517|Therapeutic competencies|therapeutic competencies
374331|NCT01986517|Training|training
374332|NCT01986504|Infection|infection
374333|NCT01986504|Cohort|cohort
374334|NCT01986504|Prospective|prospective
374335|NCT01986504|Epidemiology|epidemiology
374336|NCT01986504|Outcome|outcome
374337|NCT01986491|Healthy|healthy
374338|NCT01986491|JNJ-39393406|jnj-39393406
374339|NCT01986491|Relative Bioavailability|relative bioavailability
374340|NCT01986491|Solid Formulation|solid formulation
374341|NCT01986465|lateral epicondylitis|lateral epicondylitis
374342|NCT01986465|treatment|treatment
374343|NCT01986465|steroid|steroid
374344|NCT01986465|immobilization|immobilization
374345|NCT01986452|OSA|osa
374346|NCT01986452|Apoplexy|apoplexy
374347|NCT01986452|CPAP|cpap
374348|NCT01986452|adherence|adherence
374349|NCT01986452|telemonitoring|telemonitoring
374350|NCT01986426|Transdermal accessible tumours|transdermal accessible tumours
374351|NCT01986413|COPD|copd
374352|NCT01986413|chronic hypercapnic respiratory failure|chronic hypercapnic respiratory failure
374353|NCT01986413|NIV|niv
374354|NCT01986413|respiratory events|respiratory events
374355|NCT01986413|IVAPS|ivaps
374356|NCT01986400|Adolescent|adolescent
374357|NCT01986400|Skype|skype
374358|NCT01986400|Peer Mentorship|peer mentorship
374359|NCT01986400|Internet Self-Management|internet self-management
478680|NCT01519011|MDS|mds
374360|NCT01986387|adolescent|adolescent
374361|NCT01986387|Skype|skype
374362|NCT01986387|peer mentorship|peer mentorship
374363|NCT01986387|internet self-management|internet self-management
374364|NCT01986374|IVF , embryo implantation, HCG|ivf , embryo implantation, hcg
374365|NCT01986361|Pharyngitis|pharyngitis
374366|NCT01986361|Sore Throat|sore throat
374367|NCT01986361|acute upper respiratory tract infection (URTI)|acute upper respiratory tract infection (urti)
374368|NCT01986348|GBM|gbm
374369|NCT01986348|Glioblastoma|glioblastoma
374370|NCT01986348|selinexor|selinexor
374371|NCT01986348|KPT-330|kpt-330
374372|NCT01986348|Karyopharm|karyopharm
374373|NCT01986348|brain tumor|brain tumor
374374|NCT01986348|brain cancer|brain cancer
374375|NCT01986348|Glioma|glioma
374376|NCT01986348|Astrocytoma|astrocytoma
374377|NCT01986348|Oligodendrogliomas|oligodendrogliomas
374378|NCT01986348|Oligo-astrocytomas|oligo-astrocytomas
374379|NCT01986335|Combined pentavalent DTP/HB/Hib vaccine|combined pentavalent dtp/hb/hib vaccine
374380|NCT01986335|Infants|infants
374381|NCT01986335|Primary vaccination|primary vaccination
374382|NCT01986322|DTP/HB/Hib vaccine|dtp/hb/hib vaccine
374383|NCT01986322|Immunogenicity|immunogenicity
374384|NCT01986322|Infants|infants
374385|NCT01986322|Safety|safety
374386|NCT01986309|Postoperative|postoperative
374387|NCT01986309|Nausea|nausea
374388|NCT01986309|Vomiting|vomiting
374389|NCT01986309|Pain|pain
374390|NCT01986309|Surgery|surgery
374391|NCT01986283|Abuse potential|abuse potential
374392|NCT01986283|PF-00345439|pf-00345439
374393|NCT01986283|drug abuse|drug abuse
374394|NCT01986244|Osteoarthritis|osteoarthritis
374395|NCT01986244|Arthritis|arthritis
374396|NCT01986244|Joint Diseases|joint diseases
374397|NCT01986231|diabetes|diabetes
374398|NCT01986231|insulin|insulin
374399|NCT01986231|glucagon|glucagon
374400|NCT01986231|glycogen|glycogen
374401|NCT01986231|MRS|mrs
374402|NCT01986205|Concussion|concussion
374403|NCT01986205|Traumatic brain injury|traumatic brain injury
374404|NCT01986205|Hyperbaric oxygenation|hyperbaric oxygenation
374405|NCT01986205|Post-concussion symptoms|post-concussion symptoms
374406|NCT01986205|Headache|headache
374407|NCT01986205|Carbon monoxide|carbon monoxide
374408|NCT01986192|anticoagulation|anticoagulation
374409|NCT01986192|pharmacomechanical thrombolysis|pharmacomechanical thrombolysis
374410|NCT01986192|aspiration thrombectomy|aspiration thrombectomy
374411|NCT01986153|Fatty acid, essential|fatty acid, essential
374412|NCT01986153|Immune system|immune system
374413|NCT01986153|Home parenteral nutrition|home parenteral nutrition
374414|NCT01986140|Breast Cancer|breast cancer
374415|NCT01986140|Alopecia|alopecia
374416|NCT01986140|Scalp|scalp
374417|NCT01986140|Cooling|cooling
374418|NCT01986127|Crohn disease|crohn disease
374419|NCT01986075|Cocaine Dependence Treatment|cocaine dependence treatment
374420|NCT01986075|Computer-assisted therapy|computer-assisted therapy
374421|NCT01986075|Pharmacotherapy|pharmacotherapy
374422|NCT01986062|ADHD|adhd
374423|NCT01986062|AR11|ar11
374424|NCT01986062|classroom design|classroom design
374425|NCT01986062|amphetamine sulfate|amphetamine sulfate
374426|NCT01986023|Stroke|stroke
374427|NCT01986023|Medication Adherence|medication adherence
374429|NCT01986023|Randomised|randomised
374430|NCT01985997|FluMist, Quadrivalent, Vaccine|flumist, quadrivalent, vaccine
374431|NCT01985984|Head and neck cancer|head and neck cancer
374432|NCT01985906|Aorta|aorta
374433|NCT01985906|Aneurysm|aneurysm
374434|NCT01985906|Stents|stents
374435|NCT01985906|Collateral Circulation|collateral circulation
374436|NCT01985893|Metastatic|metastatic
374437|NCT01985893|breast|breast
374438|NCT01985893|cancer|cancer
374439|NCT01985880|Biomarkers|biomarkers
374440|NCT01985854|Desflurane|desflurane
374441|NCT01985854|Propofol|propofol
374442|NCT01985854|Total intravenous anesthesia|total intravenous anesthesia
374443|NCT01985854|Neurosurgery|neurosurgery
374444|NCT01985841|Early breast cancer|early breast cancer
374445|NCT01985841|Primary operable breast cancer|primary operable breast cancer
374446|NCT01985841|HER2- negative|her2- negative
374447|NCT01985841|bevacizumab|bevacizumab
374448|NCT01985828|Prostate neoplasm|prostate neoplasm
374449|NCT01985828|Prostate Cancer|prostate cancer
374450|NCT01985815|obsessive-compulsive disorder|obsessive-compulsive disorder
374451|NCT01985815|Deep Brain Stimulation|deep brain stimulation
374452|NCT01985815|Psychosurgery|psychosurgery
374453|NCT01985789|airway hyperresponsiveness|airway hyperresponsiveness
374454|NCT01985776|Exercise|exercise
374455|NCT01985776|Electric Stimulation|electric stimulation
374456|NCT01985763|Genistein|genistein
374457|NCT01985763|soy supplements|soy supplements
374458|NCT01985763|phytoestrogens|phytoestrogens
374459|NCT01985763|colon cancer|colon cancer
374460|NCT01985763|rectal cancer|rectal cancer
374461|NCT01985763|colorectal cancer|colorectal cancer
374462|NCT01985763|metastatic|metastatic
374463|NCT01985763|stage IV|stage iv
478806|NCT01518517|relapse|relapse
374464|NCT01985763|FOLFOX|folfox
374465|NCT01985763|FOLFOX-Avastin|folfox-avastin
374466|NCT01985763|Chemotherapy|chemotherapy
374467|NCT01985750|dyspnea|dyspnea
374468|NCT01985750|fmri|fmri
374469|NCT01985750|d-cycloserine|d-cycloserine
374470|NCT01985737|Neonatal Intensive Care Units (NICUs)|neonatal intensive care units (nicus)
374471|NCT01985737|NICUs|nicus
374472|NCT01985737|Neonates|neonates
374473|NCT01985737|CLABSI|clabsi
374474|NCT01985737|Microbiome|microbiome
374475|NCT01985737|DNA signature|dna signature
374476|NCT01985737|Catheter infections|catheter infections
374477|NCT01985724|Early breast cancer|early breast cancer
374478|NCT01985724|Axillary node positive|axillary node positive
374479|NCT01985724|HER-2 negative|her-2 negative
374480|NCT01985724|Adjuvant chemotherapy|adjuvant chemotherapy
374481|NCT01985724|Dose dense|dose dense
374482|NCT01985724|Docetaxel|docetaxel
374483|NCT01985724|FEC|fec
374484|NCT01985711|Motivational Interviewing|motivational interviewing
374485|NCT01985711|Cognitive Behavioral Therapy|cognitive behavioral therapy
374486|NCT01985711|Transtheoretical Model of behavior change|transtheoretical model of behavior change
374487|NCT01985711|Questionnaires|questionnaires
374488|NCT01985711|Telemedicine/*methods|telemedicine/*methods
374489|NCT01985711|Comorbidity|comorbidity
374490|NCT01985711|Diabetes|diabetes
374491|NCT01985711|Glucose/metabolism|glucose/metabolism
374492|NCT01985711|Hemoglobin A, Glycosylated|hemoglobin a, glycosylated
374493|NCT01985711|Blood Pressure|blood pressure
374494|NCT01985711|Cholesterol, LDL/blood|cholesterol, ldl/blood
374495|NCT01985711|Quality of life|quality of life
374496|NCT01985711|Depressive Disorder/psychology/*therapy|depressive disorder/psychology/*therapy
374497|NCT01985711|Randomized Controlled Trials|randomized controlled trials
374498|NCT01985698|Low rectal cancer|low rectal cancer
374499|NCT01985698|Robotic|robotic
374500|NCT01985698|Laparoscopic|laparoscopic
374501|NCT01985698|Abdominoperineal resection|abdominoperineal resection
374502|NCT01985685|VO2, critically ill, oxygen consumption|vo2, critically ill, oxygen consumption
374503|NCT01985672|Infertility|infertility
374504|NCT01985659|Lymph Node Excision|lymph node excision
374505|NCT01985659|Thoracic Surgical Procedures|thoracic surgical procedures
374506|NCT01985659|Thoracic Surgery, Video-Assisted|thoracic surgery, video-assisted
374507|NCT01985659|Thoracotomy|thoracotomy
374508|NCT01985646|Hirschsprung disease|hirschsprung disease
374509|NCT01985646|conservative treatment|conservative treatment
374510|NCT01985646|surgery treatment|surgery treatment
374511|NCT01985646|infants|infants
374512|NCT01985633|Osteoarthritis|osteoarthritis
374513|NCT01985633|stem cells|stem cells
374514|NCT01985633|Platelet gel|platelet gel
374515|NCT01985633|Functional outcome|functional outcome
374516|NCT01985620|Vaccination|vaccination
374517|NCT01985620|RSV|rsv
374518|NCT01985620|Influenza|influenza
374519|NCT01985620|Prematurity|prematurity
374520|NCT01985594|preterm labor|preterm labor
374521|NCT01985581|Attention Deficit Hyperactivity Disorder|attention deficit hyperactivity disorder
374522|NCT01985581|Intuniv extended release|intuniv extended release
374523|NCT01985581|Executive Function|executive function
374524|NCT01985581|Quality of Life|quality of life
374525|NCT01985568|Obesity|obesity
374526|NCT01985568|weight-loss|weight-loss
374527|NCT01985568|Physical activity|physical activity
374528|NCT01985555|Phase I|phase i
374529|NCT01985555|Safety|safety
374530|NCT01985555|Pharmacokinetics|pharmacokinetics
374531|NCT01985516|Pain|pain
374532|NCT01985516|Urethra|urethra
374533|NCT01985516|Catheter|catheter
374534|NCT01985503|positron emission tomography|positron emission tomography
374535|NCT01985503|magnetic resonance imaging|magnetic resonance imaging
374536|NCT01985503|brown adipose tissue|brown adipose tissue
374537|NCT01985503|obesity|obesity
374538|NCT01985503|cardiovascular disease|cardiovascular disease
374539|NCT01985503|subclinical atherosclerosis|subclinical atherosclerosis
374540|NCT01985490|epiretinal membrane|epiretinal membrane
374541|NCT01985490|foveal avascular zone|foveal avascular zone
374542|NCT01985490|internal limiting membrane|internal limiting membrane
374543|NCT01985477|Myeloma|myeloma
374544|NCT01985477|Multiple myeloma|multiple myeloma
374545|NCT01985477|MM|mm
374546|NCT01985477|Relapsed/Refractory Multiple Myeloma|relapsed/refractory multiple myeloma
374547|NCT01985477|RR MM|rr mm
374548|NCT01985477|Lenalidomide|lenalidomide
374549|NCT01985477|CC-5013|cc-5013
374550|NCT01985477|Revlimid|revlimid
374551|NCT01985477|Dexamethasone|dexamethasone
374552|NCT01985477|Decadron|decadron
374553|NCT01985477|All-Trans Retinoic Acid|all-trans retinoic acid
374554|NCT01985477|ATRA|atra
374555|NCT01985477|Tretinoin (Oral)|tretinoin (oral)
374556|NCT01985477|Vesanoid|vesanoid
374557|NCT01985464|rheumatoid arthritis|rheumatoid arthritis
374558|NCT01985464|umbilical cord|umbilical cord
374559|NCT01985464|mesenchymal|mesenchymal
374560|NCT01985464|stem cells|stem cells
374561|NCT01985451|Lymphoma|lymphoma
400556|NCT01866293|12-240|12-240
374562|NCT01985438|Head and Neck Neoplasms|head and neck neoplasms
374563|NCT01985438|Nutritional Support|nutritional support
374564|NCT01985438|Randomized Controlled Trial|randomized controlled trial
374565|NCT01985438|Percutaneous Endoscopic Gastrostomy tube|percutaneous endoscopic gastrostomy tube
374566|NCT01985438|Nasogastric tube|nasogastric tube
374567|NCT01985438|Radiation Effects|radiation effects
374568|NCT01985438|Pakistan|pakistan
374569|NCT01985412|Rejection|rejection
374570|NCT01985412|Transplant|transplant
374571|NCT01985412|Cardiac|cardiac
374572|NCT01985412|Pulmonary|pulmonary
374573|NCT01985412|Heart|heart
374574|NCT01985412|Lung|lung
374575|NCT01985412|Cell-Free DNA|cell-free dna
374576|NCT01985412|cfDNA|cfdna
374577|NCT01985412|Cell|cell
374578|NCT01985412|Free|free
374579|NCT01985412|DNA|dna
374580|NCT01985412|Biopsy|biopsy
374581|NCT01985412|Non-Invasive|non-invasive
374582|NCT01985399|HIV|hiv
374583|NCT01985399|AIDS|aids
374584|NCT01985399|Aging|aging
374585|NCT01985386|Iron absorption|iron absorption
374586|NCT01985386|Slow release iron|slow release iron
374587|NCT01985386|Gastric delivery system|gastric delivery system
374588|NCT01985386|Iron deficiency|iron deficiency
374589|NCT01985373|intravenous immunoglobulin|intravenous immunoglobulin
374590|NCT01985373|pharmacokinetics|pharmacokinetics
374591|NCT01985373|10% IVIG|10% ivig
374592|NCT01985334|Moderate COPD, glycopyrronium bromide, indacaterol maleate and glycopyrronium bromide FDC, NVA237, QVA149|moderate copd, glycopyrronium bromide, indacaterol maleate and glycopyrronium bromide fdc, nva237, qva149
374593|NCT01985321|herpes labialis|herpes labialis
374594|NCT01985321|cold sore|cold sore
374595|NCT01985269|High risk|high risk
374596|NCT01985269|ART naive|art naive
374597|NCT01985256|glioma|glioma
374598|NCT01985256|glioblastoma|glioblastoma
374599|NCT01985256|glioblastoma multiforme|glioblastoma multiforme
374600|NCT01985256|Grade IV astrocytoma|grade iv astrocytoma
374601|NCT01985256|brain cancer|brain cancer
374602|NCT01985256|recurrent glioblastoma|recurrent glioblastoma
374603|NCT01985256|GBM|gbm
374604|NCT01985256|AA|aa
374605|NCT01985256|AOD|aod
374606|NCT01985256|anaplastic astrocytoma|anaplastic astrocytoma
374607|NCT01985256|anaplastic oligodendroglioma|anaplastic oligodendroglioma
374608|NCT01985256|anaplastic oligoastrocytoma|anaplastic oligoastrocytoma
374609|NCT01985256|malignant glioma|malignant glioma
374610|NCT01985256|high grade glioma|high grade glioma
374611|NCT01985243|Dietary diversity|dietary diversity
374612|NCT01985243|Infant and young child|infant and young child
374613|NCT01985243|Adolescents|adolescents
374614|NCT01985243|Anemia|anemia
374615|NCT01985243|Rural health|rural health
374616|NCT01985204|iodine|iodine
374617|NCT01985204|thyroid hormones|thyroid hormones
374618|NCT01985204|obesity|obesity
374619|NCT01985204|TSH|tsh
374620|NCT01985204|dyslipidemia|dyslipidemia
374621|NCT01985204|insulin resistance|insulin resistance
374622|NCT01985139|Obesity, food pleasure, behavioral tasks, endocannabinoids|obesity, food pleasure, behavioral tasks, endocannabinoids
374623|NCT01985126|Multiple myeloma|multiple myeloma
374624|NCT01985126|Daratumumab|daratumumab
374625|NCT01985126|Proteasome inhibitor|proteasome inhibitor
374626|NCT01985126|Immunomodulatory drug|immunomodulatory drug
374627|NCT01985126|IMiD|imid
374628|NCT01985113|thioredoxin reductase|thioredoxin reductase
374629|NCT01985113|non-small cell lung cancer|non-small cell lung cancer
374630|NCT01985074|case management, disease management, emergency|case management, disease management, emergency
374631|NCT01985074|department|department
374632|NCT01985061|Myelodysplasic syndrome|myelodysplasic syndrome
374633|NCT01985061|Acute Myeloid leukemia|acute myeloid leukemia
374634|NCT01985035|Obstructive sleep apnea|obstructive sleep apnea
374635|NCT01985035|obesity|obesity
374636|NCT01985035|diet|diet
374637|NCT01985035|energy expenditure|energy expenditure
374638|NCT01985022|autism|autism
374639|NCT01985022|autism spectrum disorders|autism spectrum disorders
374640|NCT01985022|pervasive developmental disorders|pervasive developmental disorders
374641|NCT01985022|toddlers|toddlers
374642|NCT01985022|intervention|intervention
374643|NCT01984983|Venezuelan equine encephalitis virus|venezuelan equine encephalitis virus
374644|NCT01984983|DNA vaccine|dna vaccine
374645|NCT01984983|electroporation|electroporation
374646|NCT01984983|intradermal|intradermal
374647|NCT01984983|intramuscular|intramuscular
374648|NCT01984970|McGrath Videolaryngoscope|mcgrath videolaryngoscope
374649|NCT01984970|double-lumen tube intubation|double-lumen tube intubation
374650|NCT01984970|Thoracic surgery|thoracic surgery
374651|NCT01984957|ALS|als
374652|NCT01984957|Motor neuron diseases|motor neuron diseases
374653|NCT01984957|Transcriptome|transcriptome
374654|NCT01984944|circadian rhythm|circadian rhythm
374655|NCT01984931|post operative nausea and vomiting|post operative nausea and vomiting
374656|NCT01984931|Trimebutine Maleate|trimebutine maleate
374657|NCT01984905|18 FDG PET-scan|18 fdg pet-scan
374658|NCT01984905|angioscan|angioscan
374659|NCT01984905|aortic dissection|aortic dissection
374660|NCT01984892|Autologous Vaccination|autologous vaccination
374661|NCT01984892|Intratumoral Injections|intratumoral injections
374662|NCT01984892|Intramuscular Injections|intramuscular injections
374663|NCT01984892|Advanced Accessible Solid Tumors|advanced accessible solid tumors
374664|NCT01984892|Poly-ICLC|poly-iclc
374665|NCT01984892|Phase II Clinical Trial|phase ii clinical trial
374666|NCT01984892|Safety|safety
374667|NCT01984892|Efficacy|efficacy
374668|NCT01984892|Autovaccination|autovaccination
374669|NCT01984892|In Situ|in situ
374670|NCT01984892|Host Targeted Strategy|host targeted strategy
374671|NCT01984892|Overall Survival|overall survival
374672|NCT01984892|Immunotherapy|immunotherapy
374673|NCT01984892|Adjuvant|adjuvant
374674|NCT01984866|CPR: Complete Pathological Response|cpr: complete pathological response
374675|NCT01984853|ACS|acs
374676|NCT01984853|repository|repository
374677|NCT01984853|Observational|observational
374678|NCT01984827|Hyperglycaemia|hyperglycaemia
374679|NCT01984827|Moxifloxacin|moxifloxacin
374680|NCT01984827|QTc prolongation|qtc prolongation
374681|NCT01984827|C-peptide|c-peptide
374682|NCT01984827|Dead in bed syndrome|dead in bed syndrome
374683|NCT01984801|SCD1|scd1
374684|NCT01984801|Gel|gel
374685|NCT01984801|Topical Administration|topical administration
374686|NCT01984801|Acne|acne
374687|NCT01984788|Oral Prophylaxis|oral prophylaxis
374688|NCT01984775|safety|safety
374689|NCT01984775|dermal|dermal
374690|NCT01984775|GSK2894512|gsk2894512
374691|NCT01984775|Cumulative irritation|cumulative irritation
374692|NCT01984736|Pharmacokinetic|pharmacokinetic
374693|NCT01984736|Safety|safety
374694|NCT01984723|Pharmacokinetic|pharmacokinetic
374695|NCT01984723|Safety|safety
374696|NCT01984710|Treatment Resistant Depression|treatment resistant depression
374697|NCT01984710|Deep Brain Stimulation|deep brain stimulation
374698|NCT01984710|Psychiatry|psychiatry
374699|NCT01984710|Neuro Surgery|neuro surgery
374700|NCT01984684|Bacterial skin infection|bacterial skin infection
374701|NCT01984684|infection|infection
374702|NCT01984684|skin|skin
374703|NCT01984684|delafloxacin|delafloxacin
374704|NCT01984684|vancomycin|vancomycin
374705|NCT01984684|aztreonam|aztreonam
374706|NCT01984684|methicillin-resistant Staphylococcus aureus (MRSA) bacteria|methicillin-resistant staphylococcus aureus (mrsa) bacteria
374707|NCT01984684|bacterial infection|bacterial infection
374708|NCT01984684|Anti-Infective Agents|anti-infective agents
374709|NCT01984658|pancreatic cancer|pancreatic cancer
374710|NCT01984645|Emergency Visit|emergency visit
374711|NCT01984645|Secure Health messaging|secure health messaging
374712|NCT01984645|Inpatient|inpatient
374713|NCT01984593|Yoga|yoga
374714|NCT01984593|Hypertension|hypertension
374715|NCT01984593|Quality of Life|quality of life
374716|NCT01984593|Primary Health Care|primary health care
374717|NCT01984593|Stress|stress
374718|NCT01984593|Anxiety|anxiety
374719|NCT01984593|Depression|depression
374720|NCT01984580|Barrett's esophagus|barrett's esophagus
374721|NCT01984580|Esophagus|esophagus
374722|NCT01984580|Adenocarcinoma|adenocarcinoma
374723|NCT01984567|Oxyphytosterols|oxyphytosterols
374724|NCT01984567|Oxidative stress|oxidative stress
374725|NCT01984567|Vitamin E|vitamin e
374726|NCT01984567|Lipoic acid|lipoic acid
374727|NCT01984541|Pollen|pollen
374728|NCT01984528|Immunotherapy|immunotherapy
374729|NCT01984528|Skin prick test|skin prick test
374730|NCT01984528|Standardization|standardization
374731|NCT01984528|Alternaria alternata|alternaria alternata
374732|NCT01984515|Post-traumatic Stress Disorder|post-traumatic stress disorder
374733|NCT01984515|Evidence-Based Psychotherapy|evidence-based psychotherapy
374734|NCT01984515|Treatment Engagement|treatment engagement
374735|NCT01984515|Cognitive Behavioral Therapy|cognitive behavioral therapy
374736|NCT01984515|Implementation Science|implementation science
374737|NCT01984502|Larynx Cancer|larynx cancer
374738|NCT01984489|SHR117887, Metformin,combination,PhaseII|shr117887, metformin,combination,phaseii
374739|NCT01984476|spinal cord injury|spinal cord injury
374740|NCT01984476|autonomic dysreflexia|autonomic dysreflexia
374741|NCT01984476|baroreceptor integrity|baroreceptor integrity
374742|NCT01984476|sympathetic integrity|sympathetic integrity
374743|NCT01984476|vagal integrity|vagal integrity
374744|NCT01984476|autonomic integrity|autonomic integrity
374745|NCT01984476|arterial stiffness|arterial stiffness
374746|NCT01984476|cognitive function|cognitive function
374747|NCT01984476|traumatic brain injury|traumatic brain injury
374748|NCT01984476|cerebral blood flow|cerebral blood flow
374749|NCT01984476|white matter hyperintensities|white matter hyperintensities
374750|NCT01984476|cerebral vascular resistance index|cerebral vascular resistance index
374751|NCT01984463|Postoperative pain|postoperative pain
374752|NCT01984463|Shoulder pain|shoulder pain
374753|NCT01984463|Thoracotomy|thoracotomy
374754|NCT01984450|Articular cartilage|articular cartilage
374755|NCT01984450|Autologous collagen|autologous collagen
374756|NCT01984450|BMAC|bmac
374757|NCT01984437|Vascular disease|vascular disease
374758|NCT01984437|Minimally invasive treatment|minimally invasive treatment
374759|NCT01984437|Endovascular treatment|endovascular treatment
374760|NCT01984437|Magellan|magellan
374761|NCT01984437|Robotic|robotic
374762|NCT01984424|High Cholesterol, Treatment for high cholesterol, Lowering cholesterol, Lowering high cholesterol, Hypercholesterolemia|high cholesterol, treatment for high cholesterol, lowering cholesterol, lowering high cholesterol, hypercholesterolemia
374763|NCT01984346|Atrial Fibrillation|atrial fibrillation
374764|NCT01984346|Convergent Procedure|convergent procedure
374765|NCT01984346|Combined Epicardial/ Endocardial Ablation|combined epicardial/ endocardial ablation
374766|NCT01984346|Hybrid Procedure|hybrid procedure
374767|NCT01984346|Radiofrequency Ablation|radiofrequency ablation
374768|NCT01984346|Arrhythmia|arrhythmia
374769|NCT01984346|RF Ablation|rf ablation
374770|NCT01984333|trichotillomania|trichotillomania
374771|NCT01984333|response inhibition|response inhibition
374772|NCT01984333|cognitive retraining|cognitive retraining
374773|NCT01984320|OHSS|ohss
374774|NCT01984320|ICSI|icsi
374775|NCT01984320|Coasting|coasting
374776|NCT01984320|Cabergoline|cabergoline
374777|NCT01984307|Acute coronary syndrome|acute coronary syndrome
374778|NCT01984307|Myocardial infarction|myocardial infarction
374779|NCT01984307|retrospective|retrospective
374780|NCT01984307|cohort study|cohort study
374781|NCT01984307|Healthcare resources utilization|healthcare resources utilization
374782|NCT01984294|HCV genotype 1|hcv genotype 1
374783|NCT01984294|HCV|hcv
374784|NCT01984294|Sustained Virologic Response|sustained virologic response
374785|NCT01984294|Direct-Acting Antiviral|direct-acting antiviral
374786|NCT01984294|Combination Therapy|combination therapy
374787|NCT01984294|GS-7977|gs-7977
374788|NCT01984294|GS-5885|gs-5885
374789|NCT01984294|Ribavirin|ribavirin
374790|NCT01984294|Open Label|open label
374791|NCT01984294|Sofosbuvir|sofosbuvir
374792|NCT01984294|Treatment-Naive|treatment-naive
374793|NCT01984294|Protease Inhibitors|protease inhibitors
374794|NCT01984294|PI|pi
374795|NCT01984294|Treatment experienced|treatment experienced
374796|NCT01984294|Cirrhotic|cirrhotic
374797|NCT01984281|Physical Activity|physical activity
374798|NCT01984281|Pedometers|pedometers
374799|NCT01984281|Quality of Life|quality of life
374800|NCT01984268|Rheumatoid arthritis|rheumatoid arthritis
374801|NCT01984268|ACTHAR|acthar
374802|NCT01984268|Methotrexate|methotrexate
374803|NCT01984268|Inadequate response|inadequate response
374804|NCT01984203|Shoulder|shoulder
374805|NCT01984203|Impingement|impingement
374806|NCT01984203|Rotator Cuff Syndrome|rotator cuff syndrome
374807|NCT01984203|Subacromial Impingement Syndrome|subacromial impingement syndrome
374808|NCT01984203|Exercise|exercise
374809|NCT01984203|Physiotherapy|physiotherapy
374810|NCT01984190|venous thromboembolism|venous thromboembolism
374811|NCT01984190|deep vein thrombosis|deep vein thrombosis
374812|NCT01984190|pulmonary emboli|pulmonary emboli
374813|NCT01984190|hip arthroplasty|hip arthroplasty
374814|NCT01984190|knee arthroplasty|knee arthroplasty
374815|NCT01984190|efficacy|efficacy
374816|NCT01984190|mobile compression device|mobile compression device
374817|NCT01984190|mechanical device|mechanical device
374818|NCT01984190|prophylaxis.|prophylaxis.
374819|NCT01984177|Cocaine|cocaine
374820|NCT01984177|Substance-Related Disorders|substance-related disorders
374821|NCT01984177|Drug Addiction|drug addiction
374822|NCT01984177|Substance Addiction|substance addiction
374823|NCT01984177|Dopamine|dopamine
374824|NCT01984177|Receptors, Dopamine D2|receptors, dopamine d2
374825|NCT01984177|Receptors, Dopamine D3|receptors, dopamine d3
374826|NCT01984177|Stress, Psychological|stress, psychological
374827|NCT01984177|Corticorelin|corticorelin
374828|NCT01984177|Neuroendocrine System|neuroendocrine system
374829|NCT01984177|Cortisol|cortisol
374830|NCT01984177|Adrenocorticotropic Hormone|adrenocorticotropic hormone
374831|NCT01984177|Positron-Emission Tomography|positron-emission tomography
374832|NCT01984177|11C-PHNO|11c-phno
374833|NCT01984164|cerebrovascular function|cerebrovascular function
374834|NCT01984138|estrogen receptor positive breast cancer|estrogen receptor positive breast cancer
374835|NCT01984138|breast cancer|breast cancer
374836|NCT01984125|Adolescent Immunization Rates|adolescent immunization rates
374837|NCT01984125|Provider prompts|provider prompts
374838|NCT01984112|Humerus|humerus
374839|NCT01984112|fracture|fracture
374840|NCT01984112|nail|nail
374841|NCT01984112|plate|plate
374842|NCT01984112|tuberosity|tuberosity
374843|NCT01984099|Postmolar Gestational Trophoblastic Disease, Hydatidiform Mole|postmolar gestational trophoblastic disease, hydatidiform mole
374844|NCT01984086|COPD|copd
374845|NCT01984086|Asthma|asthma
374846|NCT01984086|Respiratory|respiratory
374847|NCT01984073|Atherogenic dyslipidemia phenotype|atherogenic dyslipidemia phenotype
374848|NCT01984060|Aging|aging
374849|NCT01984060|Physical Activity|physical activity
374850|NCT01984060|Physical Function|physical function
374851|NCT01984060|HIV|hiv
374852|NCT01984060|Frailty|frailty
374853|NCT01984060|Autonomous Motivation|autonomous motivation
374854|NCT01984060|Depression|depression
374855|NCT01984047|safety|safety
374856|NCT01984047|GSK3050002|gsk3050002
374857|NCT01984047|CCR6 receptor|ccr6 receptor
374858|NCT01984047|single dose escalation|single dose escalation
374859|NCT01984047|Phase 1|phase 1
374860|NCT01984047|CCL20|ccl20
374861|NCT01984034|Educational outreach|educational outreach
374862|NCT01984034|Academic detailing|academic detailing
374863|NCT01984034|Guideline adherence|guideline adherence
374864|NCT01984034|Family Practice|family practice
374865|NCT01984034|Drug utilization|drug utilization
374866|NCT01984034|Program evaluation|program evaluation
374867|NCT01984034|Cost effectiveness|cost effectiveness
374868|NCT01984021|Physical Therapy Modalities|physical therapy modalities
374869|NCT01984021|Neck pain|neck pain
374870|NCT01984021|Acupuncture|acupuncture
374871|NCT01983995|Breast Cancer|breast cancer
374872|NCT01983995|Aromatase Inhibitors|aromatase inhibitors
374873|NCT01983995|Actigraphy|actigraphy
374874|NCT01983995|Pain|pain
374875|NCT01983995|Fatigue|fatigue
374876|NCT01983995|Sleep quality|sleep quality
374877|NCT01983982|Breast Cancer|breast cancer
374878|NCT01983982|Chemotherapy|chemotherapy
374879|NCT01983982|Chronic Pain|chronic pain
374880|NCT01983982|Survivorship|survivorship
374881|NCT01983969|Advanced Cancers|advanced cancers
374882|NCT01983969|Lymphoma|lymphoma
374883|NCT01983969|Recurrent Hodgkin's|recurrent hodgkin's
374884|NCT01983969|non-Hodgkin's lymphoma|non-hodgkin's lymphoma
374885|NCT01983969|Stem cell transplant|stem cell transplant
374886|NCT01983969|Azacitidine|azacitidine
374887|NCT01983969|5-azacytidine|5-azacytidine
374888|NCT01983969|5-aza|5-aza
374889|NCT01983969|Vidaza|vidaza
374890|NCT01983969|5-AZC|5-azc
374891|NCT01983969|AZA-CR|aza-cr
374892|NCT01983969|Ladakamycin|ladakamycin
374893|NCT01983969|NSC-102816|nsc-102816
374894|NCT01983969|Azacytidine|azacytidine
374895|NCT01983969|Vorinostat|vorinostat
374896|NCT01983969|SAHA|saha
374897|NCT01983969|Suberoylanilide Hydroxamic Acid|suberoylanilide hydroxamic acid
374898|NCT01983969|MSK-390|msk-390
374899|NCT01983969|Zolinza|zolinza
374900|NCT01983969|Gemcitabine|gemcitabine
374901|NCT01983969|Gemcitabine Hydrochloride|gemcitabine hydrochloride
374902|NCT01983969|Gemzar|gemzar
374903|NCT01983969|Busulfan|busulfan
374904|NCT01983969|Busulfex|busulfex
374905|NCT01983969|Myleran|myleran
374906|NCT01983969|Melphalan|melphalan
374907|NCT01983969|Alkeran|alkeran
374908|NCT01983969|Dexamethasone|dexamethasone
374909|NCT01983969|Decadron|decadron
374910|NCT01983969|Caphosol|caphosol
374911|NCT01983969|Glutamine|glutamine
374912|NCT01983969|Enterex|enterex
374913|NCT01983969|Glutapak-10|glutapak-10
374914|NCT01983969|NutreStore|nutrestore
374915|NCT01983969|Resource|resource
374916|NCT01983969|GlutaSolve|glutasolve
374917|NCT01983969|Sympt-X G.I.|sympt-x g.i.
374918|NCT01983969|Sympt-X|sympt-x
374919|NCT01983969|Pyridoxine|pyridoxine
374920|NCT01983969|Rituximab|rituximab
374921|NCT01983969|Rituxan|rituxan
374922|NCT01983956|early palliative care|early palliative care
374923|NCT01983956|patient empowerment|patient empowerment
374924|NCT01983956|cancer|cancer
374925|NCT01983956|assessment|assessment
374926|NCT01983956|end of life|end of life
374927|NCT01983930|Memory impairment|memory impairment
374928|NCT01983930|Meditation|meditation
374929|NCT01983930|Yoga|yoga
374930|NCT01983930|memory training|memory training
374931|NCT01983930|Mild cognitive impairment|mild cognitive impairment
374932|NCT01983930|MCI|mci
374933|NCT01983930|geriatric|geriatric
374934|NCT01983930|fMRI|fmri
374935|NCT01983917|diabetes|diabetes
374936|NCT01983917|mobile application|mobile application
374937|NCT01983917|diabetic retinopathy|diabetic retinopathy
374938|NCT01983904|Major depressive disorder (MDD)|major depressive disorder (mdd)
374939|NCT01983904|Bi-polar disorder (BP)|bi-polar disorder (bp)
374940|NCT01983891|food shelf|food shelf
374941|NCT01983891|nutrition education|nutrition education
374942|NCT01983891|cooking course|cooking course
374943|NCT01983852|End of Life Care|end of life care
374944|NCT01983852|Paediatric|paediatric
374945|NCT01983852|Experiences|experiences
374946|NCT01983852|Needs|needs
374947|NCT01983852|Current Practices|current practices
374948|NCT01983839|Moxifloxacin|moxifloxacin
374949|NCT01983839|Pneumonia|pneumonia
374950|NCT01983839|Pharmacokinetics|pharmacokinetics
374951|NCT01983826|nitrates|nitrates
374952|NCT01983826|blood flow|blood flow
374953|NCT01983826|vascular function|vascular function
374954|NCT01983826|exercise|exercise
374955|NCT01983813|Diabetes|diabetes
374956|NCT01983813|High Blood Pressure|high blood pressure
374957|NCT01983813|High Cholesterol|high cholesterol
374958|NCT01983813|Heart Irregularity|heart irregularity
374959|NCT01983813|Stroke|stroke
374960|NCT01983800|Mechanical Ventilation|mechanical ventilation
374961|NCT01983800|Volatile Sedation|volatile sedation
374962|NCT01983800|Intravenous Sedation|intravenous sedation
374963|NCT01983800|Delirium|delirium
374964|NCT01983787|Cystic Fibrosis|cystic fibrosis
374965|NCT01983787|Continuous infusion|continuous infusion
374966|NCT01983787|Pharmacokinetics|pharmacokinetics
374967|NCT01983774|CF|cf
374968|NCT01983748|Uveal Melanoma, Monosomy 3|uveal melanoma, monosomy 3
374969|NCT01983735|TELMINUVO Tab.|telminuvo tab.
374970|NCT01983735|CKD-828|ckd-828
374971|NCT01983735|Hypertension|hypertension
374972|NCT01983735|Stage 2 Hypertension|stage 2 hypertension
374973|NCT01983735|S-Amlodipine|s-amlodipine
374974|NCT01983735|Telmisartan|telmisartan
374975|NCT01983696|low oxygen tension|low oxygen tension
374976|NCT01983696|embryo quality|embryo quality
374977|NCT01983683|Clostridium difficile infection|clostridium difficile infection
374978|NCT01983683|Post-antibiotic diarrhea|post-antibiotic diarrhea
374979|NCT01983670|Pre-movement facilitation|pre-movement facilitation
374980|NCT01983670|Fast goal directed movement|fast goal directed movement
374981|NCT01983670|Triphasic EMG pattern|triphasic emg pattern
374982|NCT01983670|Temporal electrical stimulation,|temporal electrical stimulation,
374983|NCT01983670|Spinocerebellar Ataxia|spinocerebellar ataxia
374984|NCT01983657|Pulmonary|pulmonary
374985|NCT01983657|Pulmonary Alveolar Proteinosis|pulmonary alveolar proteinosis
374987|NCT01983644|acute ischemic stroke,endovascular recanalization|acute ischemic stroke,endovascular recanalization
374988|NCT01983644|mechanical thrombectomy|mechanical thrombectomy
374989|NCT01983631|Whole body vibration|whole body vibration
374990|NCT01983631|Reciprocal inhibition|reciprocal inhibition
374991|NCT01983631|Spinocerebellar ataxia|spinocerebellar ataxia
374992|NCT01983631|voluntary activation level|voluntary activation level
374993|NCT01983618|Cerebral ischemia|cerebral ischemia
374994|NCT01983618|Beachchair position|beachchair position
374995|NCT01983618|Interscalene nerve block|interscalene nerve block
374996|NCT01983592|Homeopathy|homeopathy
374997|NCT01983592|Fatigue|fatigue
374998|NCT01983592|Chemotherapy|chemotherapy
374999|NCT01983592|Cancer|cancer
375000|NCT01983553|Dengue Virus|dengue virus
375001|NCT01983553|Dengue Fever|dengue fever
375002|NCT01983553|Dengue Hemorrhagic Fever|dengue hemorrhagic fever
375003|NCT01983553|CYD Dengue Vaccine|cyd dengue vaccine
375004|NCT01983540|Diphtheria|diphtheria
375005|NCT01983540|Tetanus|tetanus
375006|NCT01983540|Whooping Cough|whooping cough
375007|NCT01983540|Hepatitis B|hepatitis b
375008|NCT01983540|Poliomyelitis|poliomyelitis
375009|NCT01983540|Pediatric combined vaccine|pediatric combined vaccine
375010|NCT01983527|Arthrographic distention|arthrographic distention
375011|NCT01983527|Hydrodilatation|hydrodilatation
375012|NCT01983527|Intra-articular corticosteroid injection|intra-articular corticosteroid injection
375013|NCT01983514|oxytocin|oxytocin
375014|NCT01983514|fMRI|fmri
375015|NCT01983514|social cognition|social cognition
375016|NCT01983514|heart rate variability|heart rate variability
375017|NCT01983514|pupillometry|pupillometry
375018|NCT01983514|eye tracking|eye tracking
375019|NCT01983501|ONT-380|ont-380
375020|NCT01983501|T-DM1|t-dm1
375021|NCT01983501|Kadcyla|kadcyla
375022|NCT01983501|Breast cancer|breast cancer
375023|NCT01983501|ARRY-380|arry-380
375024|NCT01983501|Tucatinib|tucatinib
375025|NCT01983488|Uveitis|uveitis
375026|NCT01983488|Vision Loss|vision loss
375027|NCT01983475|Spinal Cord Injury|spinal cord injury
375028|NCT01983475|Denosumab|denosumab
375029|NCT01983475|Osteoporosis|osteoporosis
375030|NCT01983475|Dual Energy X-ray Absorptiometry|dual energy x-ray absorptiometry
375031|NCT01983462|Prehypertension|prehypertension
375032|NCT01983462|Hypertension|hypertension
375033|NCT01983462|Obese|obese
375034|NCT01983462|Sympathetic Nervous System|sympathetic nervous system
375035|NCT01983462|renin-angiotensin system|renin-angiotensin system
375036|NCT01983462|Endothelial function|endothelial function
375037|NCT01983449|Adventitia|adventitia
375038|NCT01983449|Peripheral Artery Disease|peripheral artery disease
375039|NCT01983449|Restenosis|restenosis
375040|NCT01983449|Inflammation|inflammation
375041|NCT01983449|Anti-Inflammatory|anti-inflammatory
375042|NCT01983449|Dexamethasone|dexamethasone
375043|NCT01983436|Maxillofacial Orthognathic Surgery|maxillofacial orthognathic surgery
375044|NCT01983436|Manual lymphatic drainage|manual lymphatic drainage
375045|NCT01983423|Endometrial Biopsy|endometrial biopsy
375046|NCT01983423|Endometrial Sampling|endometrial sampling
375047|NCT01983423|In Vitro Fertilization|in vitro fertilization
375048|NCT01983423|Pregnancy|pregnancy
375049|NCT01983423|Implantation|implantation
375050|NCT01983410|BRCA Mutation Carriers|brca mutation carriers
375051|NCT01983410|PDAC carriers|pdac carriers
375052|NCT01983410|BRCAmut carriers|brcamut carriers
375053|NCT01983410|Registry|registry
375054|NCT01983410|13-217|13-217
375055|NCT01983397|aged, 80 and over|aged, 80 and over
375056|NCT01983397|Exercise|exercise
375057|NCT01983397|Cognition|cognition
375058|NCT01983397|Balance|balance
375059|NCT01983397|Randomized controlled trial|randomized controlled trial
375060|NCT01983384|Delirium|delirium
375061|NCT01983384|Cognition|cognition
375062|NCT01983384|Surgery|surgery
375063|NCT01983384|Anesthesia|anesthesia
375064|NCT01983384|Aging|aging
375065|NCT01983358|PARP-1 inhibitor|parp-1 inhibitor
400557|NCT01866280|Sleep|sleep
375066|NCT01983345|Myelomeningocele|myelomeningocele
375067|NCT01983345|Arnold Chiari malformation|arnold chiari malformation
375068|NCT01983345|Spina bifida|spina bifida
375069|NCT01983332|MDACC|mdacc
375070|NCT01983332|MOHO|moho
375071|NCT01983306|Constipation|constipation
375072|NCT01983306|Opioid|opioid
375073|NCT01983306|GC C Agonist|gc c agonist
375074|NCT01983306|Pain|pain
375075|NCT01983293|Non-left bundle branch block|non-left bundle branch block
375076|NCT01983293|QLV|qlv
375077|NCT01983293|LV lead pacing location|lv lead pacing location
375078|NCT01983293|CRT-D|crt-d
375079|NCT01983280|polysomnography|polysomnography
375080|NCT01983280|sleep|sleep
375081|NCT01983280|healing touch|healing touch
375082|NCT01983280|pediatric burn|pediatric burn
375083|NCT01983254|coping|coping
375084|NCT01983254|acute respiratory failure|acute respiratory failure
375085|NCT01983254|critical illness|critical illness
375086|NCT01983254|depression|depression
375087|NCT01983254|anxiety|anxiety
375088|NCT01983254|post-traumatic stress|post-traumatic stress
375089|NCT01983254|intensive care unit|intensive care unit
375090|NCT01983241|Pulmonary Emphysema|pulmonary emphysema
375091|NCT01983241|Alpha-1 Antitrypsin Deficiency|alpha-1 antitrypsin deficiency
375092|NCT01983241|AATD|aatd
375093|NCT01983241|Alpha-1 PI Deficiency|alpha-1 pi deficiency
375094|NCT01983241|Alpha-1 Protienase Inhibitor|alpha-1 protienase inhibitor
375095|NCT01983228|Musculoskeletal Pain|musculoskeletal pain
375096|NCT01983228|Walking|walking
375097|NCT01983228|African American|african american
375098|NCT01983228|Telephone Coaching|telephone coaching
375099|NCT01983228|Pedometer|pedometer
375100|NCT01983215|groin incisions|groin incisions
375101|NCT01983202|PCOS|pcos
375102|NCT01983202|Pregnancy|pregnancy
375103|NCT01983202|Obstetric|obstetric
375105|NCT01983189|transcranial magnetic stimulation|transcranial magnetic stimulation
375106|NCT01983189|rTMS|rtms
375107|NCT01983189|recurrent transcranial magnetic stimulation|recurrent transcranial magnetic stimulation
375108|NCT01983189|fMRI|fmri
375109|NCT01983189|functional magnetic resonance imaging.|functional magnetic resonance imaging.
375110|NCT01983176|Parotid tumor|parotid tumor
375111|NCT01983176|Partial superficial parotidectomy|partial superficial parotidectomy
375112|NCT01983176|Facial palsy|facial palsy
375113|NCT01983150|Population Health|population health
375114|NCT01983150|Smoking cessation|smoking cessation
375115|NCT01983150|Young adults|young adults
375116|NCT01983150|Cancer prevention|cancer prevention
375117|NCT01983150|Tobacco control strategies|tobacco control strategies
375118|NCT01983150|Behaviour modification|behaviour modification
375119|NCT01983150|Social Media|social media
375120|NCT01983150|Smartphone technology|smartphone technology
375121|NCT01983137|Chronic pain|chronic pain
375122|NCT01983137|Severe pain|severe pain
375123|NCT01983137|oxycodon|oxycodon
375124|NCT01983137|naloxon|naloxon
375125|NCT01983137|opioid-induced constipation|opioid-induced constipation
375126|NCT01983137|opioid|opioid
375127|NCT01983137|quality of life|quality of life
375128|NCT01983137|laxative|laxative
375129|NCT01983137|analgesic rescue medication|analgesic rescue medication
375130|NCT01983124|Advanced Melanoma|advanced melanoma
375131|NCT01983098|Colorectal cancer|colorectal cancer
375132|NCT01983098|Metastatic|metastatic
375133|NCT01983098|Circulating tumor DNA|circulating tumor dna
375134|NCT01983098|Biomaker|biomaker
375135|NCT01983085|Nitric Oxide Dressing|nitric oxide dressing
375136|NCT01983085|Nitric oxide|nitric oxide
375137|NCT01983085|Superficial partial thickness wound|superficial partial thickness wound
375138|NCT01983085|Burns|burns
375139|NCT01983085|Skin graft donor sites|skin graft donor sites
375140|NCT01983085|Improved healing|improved healing
375141|NCT01983085|Vasodilation|vasodilation
375142|NCT01983085|Angiogenesis|angiogenesis
375143|NCT01983085|Anti-microbial|anti-microbial
375144|NCT01983072|colonization of the gastrointestinal tract with bacteria|colonization of the gastrointestinal tract with bacteria
375145|NCT01983007|Diabetes Mellitus.|diabetes mellitus.
375146|NCT01982994|Physical Activity Education|physical activity education
375147|NCT01982994|Caregivers|caregivers
375148|NCT01982981|perception|perception
375149|NCT01982981|wellbeing|wellbeing
375150|NCT01982981|plain water|plain water
375151|NCT01982968|Idiopathic pulmonary fibrosis|idiopathic pulmonary fibrosis
375152|NCT01982968|IPF|ipf
375153|NCT01982968|Gastroesophageal reflux|gastroesophageal reflux
375154|NCT01982968|GER|ger
375155|NCT01982968|GERD|gerd
375156|NCT01982955|MSC2156119J|msc2156119j
375157|NCT01982955|Gefitinib|gefitinib
375158|NCT01982955|Pemetrexed|pemetrexed
375159|NCT01982955|Cisplatin|cisplatin
375160|NCT01982955|MET positive|met positive
375161|NCT01982955|Tepotinib|tepotinib
375162|NCT01982955|Carboplatin|carboplatin
375163|NCT01982955|INSIGHT|insight
375164|NCT01982916|Allergic Rhinitis|allergic rhinitis
375165|NCT01982916|Perennial Allergic Rhinitis|perennial allergic rhinitis
375166|NCT01982916|Non-seasonal Allergic Rhinitis|non-seasonal allergic rhinitis
375167|NCT01982916|PAR|par
375168|NCT01982903|kidney transplantation|kidney transplantation
375169|NCT01982903|connective tissue growth factor|connective tissue growth factor
375170|NCT01982903|fibrosis|fibrosis
375171|NCT01982890|Telomere length|telomere length
375172|NCT01982890|Longitudinal observation|longitudinal observation
375173|NCT01982877|decision making|decision making
375174|NCT01982877|values elicitation|values elicitation
375175|NCT01982877|patient centered care|patient centered care
375176|NCT01982877|Four Supports|four supports
375177|NCT01982877|Family Support|family support
375178|NCT01982864|Aminoglycosides|aminoglycosides
375179|NCT01982864|hemodialysis|hemodialysis
375180|NCT01982864|clinical pharmacokinetics|clinical pharmacokinetics
375181|NCT01982864|pharmacokinetic modelling|pharmacokinetic modelling
375182|NCT01982864|Bayesian estimation|bayesian estimation
375183|NCT01982864|Necessity|necessity
375184|NCT01982864|of the treatment|of the treatment
375185|NCT01982864|gentamicin|gentamicin
375186|NCT01982851|pain|pain
375187|NCT01982851|epidural|epidural
375188|NCT01982851|combined spinal epidural|combined spinal epidural
375189|NCT01982838|pain|pain
375190|NCT01982838|epidural|epidural
375191|NCT01982838|combined spinal epidural|combined spinal epidural
375192|NCT01982825|Tobacco use cessation|tobacco use cessation
375193|NCT01982825|Cigarette smoking|cigarette smoking
375194|NCT01982799|Endodontic treatment, analgesics, anesthesia, post-operative pain|endodontic treatment, analgesics, anesthesia, post-operative pain
375195|NCT01982773|Virtual Hope Box|virtual hope box
375196|NCT01982760|Rhinoplasty|rhinoplasty
375197|NCT01982760|Ecchymosis|ecchymosis
375198|NCT01982760|Edema|edema
375199|NCT01982747|Cardiac Safety|cardiac safety
375200|NCT01982747|General Safety|general safety
375201|NCT01982747|Pharmacokinetics|pharmacokinetics
375202|NCT01982734|bioavailability|bioavailability
375203|NCT01982734|curcumin|curcumin
375204|NCT01982734|pharmacokinetic|pharmacokinetic
375205|NCT01982734|curcuma longa|curcuma longa
375206|NCT01982734|age differences|age differences
375207|NCT01982734|sex differences|sex differences
375208|NCT01982708|Evaluation|evaluation
375209|NCT01982695|Duchenne muscular Dystrophy (DMD)|duchenne muscular dystrophy (dmd)
375210|NCT01982695|Cardiomyopathy|cardiomyopathy
375211|NCT01982695|Losartan|losartan
375212|NCT01982695|Lisinopril|lisinopril
375213|NCT01982669|Salty taste|salty taste
375214|NCT01982669|Urinary sodium excretion|urinary sodium excretion
375215|NCT01982669|Spicy hedonic|spicy hedonic
375216|NCT01982669|Blood pressure|blood pressure
375217|NCT01982617|Transtheoretical Model|transtheoretical model
375218|NCT01982617|Stages of Change|stages of change
375219|NCT01982617|Nicotine Dependence|nicotine dependence
375220|NCT01982617|Severe Mental Illness|severe mental illness
375221|NCT01982578|Treatment|treatment
375222|NCT01982578|Genistein|genistein
375223|NCT01982578|Alzheimer's disease|alzheimer's disease
375224|NCT01982578|Cerebrospinal fluid|cerebrospinal fluid
375225|NCT01982578|Amyloid beta|amyloid beta
375226|NCT01982565|Nitric oxide|nitric oxide
375227|NCT01982565|Nitric oxide dressing|nitric oxide dressing
375228|NCT01982565|NOx|nox
375229|NCT01982565|NOx dressing|nox dressing
375230|NCT01982565|Diabetic|diabetic
375231|NCT01982565|Foot|foot
375232|NCT01982565|Ulcers|ulcers
375233|NCT01982565|Chronic|chronic
375234|NCT01982552|Plaque psoriasis|plaque psoriasis
375235|NCT01982552|calcipotriene|calcipotriene
375236|NCT01982552|betamethasone dipropionate|betamethasone dipropionate
375237|NCT01982552|topical|topical
375238|NCT01982539|pain|pain
375239|NCT01982539|NSAID|nsaid
375240|NCT01982539|moderate pain|moderate pain
375241|NCT01982539|mild pain|mild pain
375242|NCT01982539|acute pain|acute pain
375243|NCT01982539|mild acute pain|mild acute pain
375244|NCT01982539|moderate acute pain|moderate acute pain
375245|NCT01982539|mild or moderate acute pain|mild or moderate acute pain
375246|NCT01982526|Ovarian reserve|ovarian reserve
375247|NCT01982526|Antimullerian hormone|antimullerian hormone
375248|NCT01982513|Cardiopulmonary Resuscitation|cardiopulmonary resuscitation
375249|NCT01982513|Pregnancy|pregnancy
375250|NCT01982513|Ultrasound|ultrasound
375251|NCT01982513|Inferior Vena Cava|inferior vena cava
375252|NCT01982500|Ovarian Cancer|ovarian cancer
375253|NCT01982500|Chemotherapy|chemotherapy
375254|NCT01982500|Anti-angiogenic agent|anti-angiogenic agent
375255|NCT01982500|Bevacizumab|bevacizumab
375256|NCT01982500|Front Line|front line
375257|NCT01982474|allergic rhinitis|allergic rhinitis
375258|NCT01982448|TRIPLE NEGATIVE BREAST CANCER WITHOUT GERMLINE BRCA MUTATIONS|triple negative breast cancer without germline brca mutations
375259|NCT01982448|CISPLATIN|cisplatin
375260|NCT01982448|PACLITAXEL|paclitaxel
375261|NCT01982435|Diabetes|diabetes
375262|NCT01982435|Macular Edema|macular edema
375263|NCT01982422|Attention Deficit and Hyperactivity Disorder|attention deficit and hyperactivity disorder
375264|NCT01982422|Nutrition|nutrition
375265|NCT01982422|Diet|diet
375266|NCT01982422|Developmental Origins of Disease|developmental origins of disease
375267|NCT01982396|HIV|hiv
375268|NCT01982396|paediatric|paediatric
375269|NCT01982396|Abacavir|abacavir
375270|NCT01982396|lamivudine|lamivudine
375271|NCT01982383|CSC|csc
375272|NCT01982383|Edema|edema
375273|NCT01982383|Retinopathy|retinopathy
375274|NCT01982344|mini-exchange-room|mini-exchange-room
375275|NCT01982344|physical activity|physical activity
375276|NCT01982344|quality of life|quality of life
375277|NCT01982344|peritoneal dialysis|peritoneal dialysis
375278|NCT01982331|H2N2|h2n2
375279|NCT01982331|vaccine|vaccine
375280|NCT01982318|Venous Leg Ulcer|venous leg ulcer
375281|NCT01982318|Leg Ulcer|leg ulcer
375282|NCT01982318|Venous Hypertension|venous hypertension
375283|NCT01982318|Venous Reflux|venous reflux
375284|NCT01982318|Deep Venous System|deep venous system
375285|NCT01982318|Chronic leg ulceration|chronic leg ulceration
375286|NCT01982318|Calf perforator|calf perforator
375287|NCT01982292|Chronic Heart Failure, CHF, Heart Failure, HF, Immunogenicity, Anti-bodies, Hypersensitivity, Serelaxin, RELAX-REPEAT|chronic heart failure, chf, heart failure, hf, immunogenicity, anti-bodies, hypersensitivity, serelaxin, relax-repeat
375391|NCT01981902|Dehydration|dehydration
375288|NCT01982279|Caloric compensation|caloric compensation
375289|NCT01982279|Eating in the absence of hunger|eating in the absence of hunger
375290|NCT01982279|Preschool children|preschool children
375291|NCT01982279|Maternal feeding practices|maternal feeding practices
375292|NCT01982279|Maternal eating behavior|maternal eating behavior
375293|NCT01982279|one year|one year
375294|NCT01982279|children|children
375295|NCT01982253|Drug therapy|drug therapy
375296|NCT01982240|CIC|cic
375297|NCT01982240|Constipation|constipation
375298|NCT01982240|Chronic Constipation|chronic constipation
375299|NCT01982240|Synergy|synergy
375300|NCT01982240|Plecanatide|plecanatide
375301|NCT01982227|colorectal cancer metastatic|colorectal cancer metastatic
375302|NCT01982227|indocyanine green|indocyanine green
375303|NCT01982214|osteopenia|osteopenia
375304|NCT01982214|whole body vibration|whole body vibration
375305|NCT01982214|women|women
375306|NCT01982214|bone microarchitecture|bone microarchitecture
375307|NCT01982214|bone density|bone density
375308|NCT01982188|single incision sling|single incision sling
375309|NCT01982188|cough stress test|cough stress test
375310|NCT01982188|MiniArc|miniarc
375311|NCT01982188|UDI-6|udi-6
375312|NCT01982188|UIQ-7|uiq-7
375313|NCT01982188|Sandvick Severity Index (SSI)|sandvick severity index (ssi)
375314|NCT01982175|Alemtuzumab|alemtuzumab
375315|NCT01982175|B-cell chronic lymphocytic leukemia|b-cell chronic lymphocytic leukemia
375316|NCT01982175|CD52|cd52
375317|NCT01982162|Sputum|sputum
375318|NCT01982162|Clinical cohorts|clinical cohorts
375319|NCT01982162|Smokers|smokers
375320|NCT01982162|Asthma|asthma
375321|NCT01982162|Biopsies|biopsies
375322|NCT01982162|Severe asthma|severe asthma
375323|NCT01982162|Collaborative research|collaborative research
375324|NCT01982162|Phenotyping|phenotyping
375325|NCT01982162|Lipidomics|lipidomics
375326|NCT01982162|Transcriptomics|transcriptomics
375327|NCT01982162|Proteomics|proteomics
375328|NCT01982162|Paediatric cohort|paediatric cohort
375329|NCT01982162|Systems Biology|systems biology
375330|NCT01982149|Chronic Obstructive Pulmonary Disease|chronic obstructive pulmonary disease
375331|NCT01982149|COPD|copd
375332|NCT01982149|Smokers|smokers
375333|NCT01982149|Nonsmokers|nonsmokers
375334|NCT01982110|smoking cessation|smoking cessation
375335|NCT01982110|mindfulness|mindfulness
375336|NCT01982110|behavioral intervention|behavioral intervention
375337|NCT01982097|Non-interventional|non-interventional
375338|NCT01982097|Nexavar|nexavar
375339|NCT01982097|Sorafenib|sorafenib
375340|NCT01982097|Carcinoma, renal cell|carcinoma, renal cell
375341|NCT01982097|Neoadjuvant|neoadjuvant
375342|NCT01982097|Nephrectomy|nephrectomy
375343|NCT01982097|Russian Federation|russian federation
375344|NCT01982084|Group B streptococcus|group b streptococcus
375345|NCT01982084|Immunisation|immunisation
375346|NCT01982084|Pregnancy|pregnancy
375347|NCT01982084|Attitudes|attitudes
375348|NCT01982071|Micafungin|micafungin
375349|NCT01982071|candidiasis|candidiasis
375350|NCT01982071|candidemia|candidemia
375351|NCT01982071|Open-label design|open-label design
375352|NCT01982045|Bone graft|bone graft
375353|NCT01982045|Ceramic|ceramic
375354|NCT01982045|Spinal fusion|spinal fusion
375355|NCT01982045|RCT|rct
375356|NCT01982045|Thoracolumbar region|thoracolumbar region
375357|NCT01982032|Periprosthetic aortic valve regurgitation|periprosthetic aortic valve regurgitation
375358|NCT01982032|3D transesophageal echocardiography|3d transesophageal echocardiography
375359|NCT01982032|Cardiac MRI|cardiac mri
375360|NCT01982019|26RFa|26rfa
375361|NCT01982019|sleeve gastrectomy|sleeve gastrectomy
375362|NCT01982019|diabetes|diabetes
375363|NCT01982019|obesity|obesity
375364|NCT01982006|cataract surgery|cataract surgery
375365|NCT01982006|femtosecond laser cataract surgery|femtosecond laser cataract surgery
375366|NCT01982006|phacoemulsification|phacoemulsification
375367|NCT01982006|Cost-Benefit Analysis|cost-benefit analysis
375368|NCT01982006|Cost Effectiveness|cost effectiveness
375369|NCT01982006|Hospital Costs|hospital costs
375370|NCT01981980|Carbon dioxide|carbon dioxide
375371|NCT01981980|Carboxytherapy|carboxytherapy
375372|NCT01981980|Radiofrequency|radiofrequency
375373|NCT01981967|Japanese encephalitis|japanese encephalitis
375374|NCT01981967|IMOJEV®|imojev®
375375|NCT01981967|Japanese encephalitis chimeric virus vaccine|japanese encephalitis chimeric virus vaccine
375376|NCT01981954|Solifenacin succinate suspension|solifenacin succinate suspension
375377|NCT01981954|Efficacy|efficacy
375378|NCT01981954|Safety|safety
375379|NCT01981941|Gabapentin|gabapentin
375380|NCT01981941|Restless legs syndrome (RLS)|restless legs syndrome (rls)
375381|NCT01981928|Phase 1|phase 1
375382|NCT01981928|Healthy Subjects|healthy subjects
375383|NCT01981928|Safety|safety
375384|NCT01981928|Tolerability|tolerability
375385|NCT01981928|Pharmacokinetics|pharmacokinetics
375386|NCT01981928|Single Ascending Oral Dose|single ascending oral dose
375387|NCT01981928|Food Effect|food effect
375388|NCT01981915|Cough augmentation|cough augmentation
375389|NCT01981915|Peak cough flow|peak cough flow
375390|NCT01981915|hyperinsufflation|hyperinsufflation
375392|NCT01981889|steroid, inflammatory bowel diseases|steroid, inflammatory bowel diseases
375393|NCT01981876|Dysplasia|dysplasia
375394|NCT01981876|Esophageal Squamous Cell Carcinoma|esophageal squamous cell carcinoma
375395|NCT01981863|cardiac surgery|cardiac surgery
375396|NCT01981863|cardiopulmonary bypass|cardiopulmonary bypass
375397|NCT01981863|fibrinolysis|fibrinolysis
375398|NCT01981863|thromboelastography|thromboelastography
375399|NCT01981863|D-Dimers|d-dimers
375400|NCT01981863|antifibrinolytic agents|antifibrinolytic agents
375401|NCT01981850|fibrosis|fibrosis
375402|NCT01981837|RNAi therapeutic|rnai therapeutic
375403|NCT01981824|prediction IUGR FL/MTC|prediction iugr fl/mtc
375404|NCT01981811|OPC-14597 Digital|opc-14597 digital
375405|NCT01981811|Aripiprazole|aripiprazole
375406|NCT01981811|Medical Information Device #1 System (MIND1)|medical information device #1 system (mind1)
375407|NCT01981811|Treatment Adherence|treatment adherence
375408|NCT01981811|Ingestible Event Marker|ingestible event marker
375409|NCT01981798|outpatient intervention program|outpatient intervention program
375410|NCT01981798|behavioral therapy approach|behavioral therapy approach
375411|NCT01981798|unspecific back pain|unspecific back pain
375412|NCT01981798|unspecific neck pain|unspecific neck pain
375413|NCT01981798|chronic pain|chronic pain
375414|NCT01981798|physiotherapy|physiotherapy
375415|NCT01981798|occupational therapy|occupational therapy
375416|NCT01981798|psychosocial aspects|psychosocial aspects
375417|NCT01981798|fear avoidance beliefs|fear avoidance beliefs
375418|NCT01981798|health-related quality of life|health-related quality of life
375419|NCT01981785|Primary immune deficiencies|primary immune deficiencies
375420|NCT01981785|Autoimmune diseases|autoimmune diseases
375421|NCT01981785|Inflammatory diseases|inflammatory diseases
375422|NCT01981785|Common variable immune deficiencies|common variable immune deficiencies
375423|NCT01981785|Primary Immunodeficiencies|primary immunodeficiencies
375424|NCT01981785|Immunoglobulin|immunoglobulin
375426|NCT01981785|IVIG|ivig
375427|NCT01981785|Recurrent Infections|recurrent infections
375428|NCT01981759|Schizophrenia|schizophrenia
375429|NCT01981759|Delusions|delusions
375430|NCT01981759|D-Cycloserine|d-cycloserine
375431|NCT01981759|CBT|cbt
375432|NCT01981746|adductor canal block|adductor canal block
375433|NCT01981746|healthy volunteers|healthy volunteers
375434|NCT01981746|US-guided peripheral nerve block|us-guided peripheral nerve block
375435|NCT01981746|lower limb|lower limb
375436|NCT01981733|Deep Vein Thrombosis|deep vein thrombosis
375437|NCT01981720|PRX-102|prx-102
375438|NCT01981720|pegunigalsidase alfa|pegunigalsidase alfa
375439|NCT01981720|Fabry Disease|fabry disease
375440|NCT01981707|castration-resistant prostate cancer|castration-resistant prostate cancer
375441|NCT01981707|abiraterone acetate|abiraterone acetate
375442|NCT01981707|enzalutamide|enzalutamide
375443|NCT01981707|choline pet|choline pet
375444|NCT01981694|Phase 1|phase 1
375445|NCT01981694|Randomized|randomized
375446|NCT01981694|Double Blind|double blind
375447|NCT01981694|Placebo-Controlled|placebo-controlled
375448|NCT01981694|Single-Dose Escalation|single-dose escalation
375449|NCT01981694|Safety|safety
375450|NCT01981694|Tolerability|tolerability
375451|NCT01981694|PK|pk
375452|NCT01981694|PD|pd
375453|NCT01981694|PF-06649751|pf-06649751
375454|NCT01981681|Phase 1|phase 1
375455|NCT01981681|Randomized|randomized
375456|NCT01981681|Placebo-Controlled|placebo-controlled
375457|NCT01981681|Multiple Dose Escalation|multiple dose escalation
375458|NCT01981681|Tolerability|tolerability
375459|NCT01981681|Safety|safety
375460|NCT01981681|PK|pk
375461|NCT01981681|Topical|topical
375462|NCT01981681|Healthy|healthy
375463|NCT01981681|PF-06263276|pf-06263276
375464|NCT01981655|Sodium Lactate|sodium lactate
375465|NCT01981655|Acute|acute
375466|NCT01981655|Heart|heart
375467|NCT01981655|Failure|failure
375468|NCT01981655|Perfusion|perfusion
375469|NCT01981629|Shock|shock
375470|NCT01981629|USCOM|uscom
375471|NCT01981629|Cardiac Ultrasound|cardiac ultrasound
375472|NCT01981629|Emergency Department|emergency department
375473|NCT01981616|Drug therapy|drug therapy
375474|NCT01981603|Navigators|navigators
375475|NCT01981603|Kidney Transplant|kidney transplant
375476|NCT01981603|Hemodialysis|hemodialysis
375477|NCT01981590|breathing, heart failure, sleep apnea|breathing, heart failure, sleep apnea
375478|NCT01981577|Parkinson Disease|parkinson disease
375479|NCT01981577|Subthalamic Nucleus|subthalamic nucleus
375480|NCT01981577|Ultrahigh field Magnetic Resonance imaging|ultrahigh field magnetic resonance imaging
375481|NCT01981577|Functional connectivity|functional connectivity
375482|NCT01981577|Structural connectivity|structural connectivity
375483|NCT01981564|Pediatric|pediatric
375484|NCT01981564|Emergency department visit|emergency department visit
375485|NCT01981551|Desmoid Tumor|desmoid tumor
375486|NCT01981551|Aggressive Fibromatosis|aggressive fibromatosis
375487|NCT01981551|Gamma-secretase Inhibitor|gamma-secretase inhibitor
375488|NCT01981551|Notch Pathway|notch pathway
375489|NCT01981538|Web-Based Survey|web-based survey
375490|NCT01981538|Cancer Caregivers|cancer caregivers
375491|NCT01981525|TP53 Mutation|tp53 mutation
375492|NCT01981525|Autosomal Dominant Hereditary Disorder|autosomal dominant hereditary disorder
375493|NCT01981525|Chemoprevention|chemoprevention
375494|NCT01981499|PF-05180999|pf-05180999
375495|NCT01981499|safety|safety
375496|NCT01981499|tolerability|tolerability
375497|NCT01981499|pharmacokinetics|pharmacokinetics
375498|NCT01981499|histamine|histamine
375499|NCT01981499|wheal|wheal
375500|NCT01981499|flare|flare
375501|NCT01981499|migraine|migraine
375502|NCT01981499|PDE2|pde2
375503|NCT01981486|PF-05180999|pf-05180999
375504|NCT01981486|safety|safety
375505|NCT01981486|tolerability|tolerability
375506|NCT01981486|pharmacokinetics|pharmacokinetics
375507|NCT01981486|migraine|migraine
375508|NCT01981486|PDE2|pde2
375509|NCT01981486|cAMP|camp
375510|NCT01981486|cGMP|cgmp
375511|NCT01981486|cantharidin|cantharidin
375512|NCT01981486|blister|blister
375513|NCT01981486|CYP3A induction|cyp3a induction
375514|NCT01981473|rheumatoid arthritis|rheumatoid arthritis
375515|NCT01981473|etanercept|etanercept
375516|NCT01981473|adalimumab|adalimumab
375517|NCT01981473|infliximab|infliximab
375518|NCT01981473|anti-drug antibody|anti-drug antibody
375519|NCT01981473|immunogenicity|immunogenicity
375520|NCT01981473|drug concentration|drug concentration
375521|NCT01981447|epilepsy|epilepsy
375522|NCT01981421|Liver fibrosis|liver fibrosis
375523|NCT01981421|Elastography|elastography
375524|NCT01981421|MR Elastography|mr elastography
375525|NCT01981421|Quantitative imaging|quantitative imaging
375526|NCT01981395|fenobam|fenobam
375527|NCT01981395|heat|heat
375528|NCT01981395|capsaicin|capsaicin
375529|NCT01981395|hyperalgesia|hyperalgesia
375530|NCT01981395|allodynia|allodynia
375531|NCT01981395|mood|mood
375532|NCT01981395|cognitive function|cognitive function
375533|NCT01981382|low back pain|low back pain
375534|NCT01981382|pain sensitivity|pain sensitivity
375535|NCT01981382|genes|genes
375536|NCT01981382|gene expression,|gene expression,
375537|NCT01981382|quantitative sensory testing|quantitative sensory testing
375538|NCT01981369|Dexmedetomidine sedation|dexmedetomidine sedation
375539|NCT01981369|Regional Anesthesia|regional anesthesia
375540|NCT01981369|Infraclavicular block|infraclavicular block
375541|NCT01981356|Psychotic Disorders|psychotic disorders
375542|NCT01981356|Acceptance and Commitment Therapy|acceptance and commitment therapy
375543|NCT01981356|Inpatient psychiatry|inpatient psychiatry
375544|NCT01981356|Schizophrenia|schizophrenia
375545|NCT01981356|Acute psychiatric disorder|acute psychiatric disorder
375546|NCT01981343|Gallbladder motility|gallbladder motility
375547|NCT01981343|A-F Betafood|a-f betafood
375548|NCT01981343|Betaine|betaine
375549|NCT01981343|Ejection fraction|ejection fraction
375550|NCT01981343|Ejection rate|ejection rate
375551|NCT01981343|Ultrasound|ultrasound
375552|NCT01981330|vocal fold scarring|vocal fold scarring
375553|NCT01981330|mesenchymal stem cells|mesenchymal stem cells
375554|NCT01981317|Obsessive Compulsive Disorder|obsessive compulsive disorder
375555|NCT01981317|Cognitive Behavioral Therapy|cognitive behavioral therapy
375556|NCT01981317|Stepped Care CBT|stepped care cbt
375557|NCT01981317|Exposure and Response Prevention|exposure and response prevention
375558|NCT01981317|Psychotherapy|psychotherapy
375559|NCT01981317|Counseling|counseling
375560|NCT01981304|Coronary artery disease|coronary artery disease
375561|NCT01981304|Percutaneous coronary intervention|percutaneous coronary intervention
375562|NCT01981291|Lower Extremity|lower extremity
375563|NCT01981291|Sciatic Nerve|sciatic nerve
375564|NCT01981291|Anesthesia, Regional|anesthesia, regional
375565|NCT01981291|Anesthetics, Local|anesthetics, local
375566|NCT01981291|Mepivacaine|mepivacaine
375567|NCT01981291|Ultrasonography|ultrasonography
375568|NCT01981278|Healthy|healthy
375569|NCT01981278|Tapentadol|tapentadol
375570|NCT01981278|Bioequivalence|bioequivalence
375571|NCT01981278|Fasted|fasted
375572|NCT01981252|Ulthera® System|ulthera® system
375573|NCT01981252|Ultherapy™ Treatment|ultherapy™ treatment
375574|NCT01981252|Ulthera, Inc.|ulthera, inc.
375575|NCT01981252|Micro-focused Ultrasound with Visualization (MFU-V)|micro-focused ultrasound with visualization (mfu-v)
375576|NCT01981239|voice analysis aspiration prediction|voice analysis aspiration prediction
375577|NCT01981213|Acetaminophen|acetaminophen
375578|NCT01981213|Suicide|suicide
375579|NCT01981213|Attempts|attempts
375580|NCT01981213|Early Predictors of Hepatic Injury|early predictors of hepatic injury
375581|NCT01981213|Childhood Suicidal Behaviour|childhood suicidal behaviour
375582|NCT01981200|COPD acute exacerbation|copd acute exacerbation
375583|NCT01981200|Physiotherapy|physiotherapy
375584|NCT01981200|Resistance training|resistance training
375585|NCT01981200|Muscle strength|muscle strength
375586|NCT01981200|Handheld dynamometer|handheld dynamometer
375587|NCT01981161|progressive multifocal leucoencephalopathy|progressive multifocal leucoencephalopathy
375588|NCT01981161|JC virus|jc virus
375589|NCT01981161|Zoster infection|zoster infection
375590|NCT01981135|Controlled Human exposure study|controlled human exposure study
375591|NCT01981135|Air Pollution|air pollution
375592|NCT01981135|Temperature|temperature
375593|NCT01981135|Lung Function|lung function
375594|NCT01981135|Cardiovascular|cardiovascular
375595|NCT01981096|juvenile fibromyalgia|juvenile fibromyalgia
375596|NCT01981096|pain in children|pain in children
375597|NCT01981096|musculoskeletal pain|musculoskeletal pain
375598|NCT01981096|cognitive behavioral therapy|cognitive behavioral therapy
375599|NCT01981096|coping skills training|coping skills training
375600|NCT01981083|Protein-Energy Malnutrition|protein-energy malnutrition
375601|NCT01981083|Chronic Kidney Disease|chronic kidney disease
375602|NCT01981083|Malnutrition-Inflammation Score|malnutrition-inflammation score
375603|NCT01981083|Subjective Global Assessment|subjective global assessment
375604|NCT01981083|Hemodialysis|hemodialysis
375605|NCT01981083|Egg albumin|egg albumin
375606|NCT01981070|parent support|parent support
375607|NCT01981070|mindfulness|mindfulness
375608|NCT01981070|intellectual disability|intellectual disability
375609|NCT01981070|developmental disability|developmental disability
375610|NCT01981070|empowerment|empowerment
375611|NCT01981070|psychological acceptance|psychological acceptance
375612|NCT01981070|parental stress|parental stress
375613|NCT01981070|parental depression|parental depression
375614|NCT01981057|parenteral nutrition|parenteral nutrition
375615|NCT01981057|Numeta|numeta
375616|NCT01981057|prescription software Cato Pan|prescription software cato pan
375617|NCT01981018|Mental imagery, CBT, anxiety, mood instability|mental imagery, cbt, anxiety, mood instability
375618|NCT01980992|Food Allergy|food allergy
375619|NCT01980992|Wheat Allergy|wheat allergy
375620|NCT01980992|Oral Immunotherapy|oral immunotherapy
375621|NCT01980979|congenital heart disease,pulmonary hypertension,prostacyclin|congenital heart disease,pulmonary hypertension,prostacyclin
375622|NCT01980927|Migraine|migraine
375623|NCT01980927|National Upper Cervical Chiropractic Association atlas correction|national upper cervical chiropractic association atlas correction
375624|NCT01980914|hypoglycemia|hypoglycemia
375625|NCT01980914|type 2 diabetes|type 2 diabetes
375626|NCT01980914|insulin glargine|insulin glargine
375627|NCT01980914|cardiac function|cardiac function
375628|NCT01980914|myocardial ischemia|myocardial ischemia
375629|NCT01980914|cardiac rhythm|cardiac rhythm
375630|NCT01980914|autonomic cardiovascular function|autonomic cardiovascular function
375631|NCT01980901|AAA|aaa
375632|NCT01980849|Nadroparin|nadroparin
375633|NCT01980849|venous thromboembolism prophylaxis|venous thromboembolism prophylaxis
375634|NCT01980836|Rheumatoid arthritis|rheumatoid arthritis
375635|NCT01980836|Tocilizumab|tocilizumab
375636|NCT01980836|Seasonal influenza vaccine|seasonal influenza vaccine
375637|NCT01980823|Breast Cancer|breast cancer
375638|NCT01980823|Metformin|metformin
375639|NCT01980823|Atorvastatin|atorvastatin
375640|NCT01980823|Ki-67|ki-67
375641|NCT01980797|Bicuspid aortic valve disease|bicuspid aortic valve disease
375642|NCT01980797|Thoracic aortic disease|thoracic aortic disease
375643|NCT01980797|Genetics|genetics
375644|NCT01980797|Echocardiography|echocardiography
375645|NCT01980797|Cardiac CT|cardiac ct
375646|NCT01980797|Cardiac MRI|cardiac mri
375647|NCT01980784|Spinal Cord Injury|spinal cord injury
375648|NCT01980771|HIV|hiv
375649|NCT01980771|prevention|prevention
375650|NCT01980771|men|men
375651|NCT01980771|African American|african american
375652|NCT01980758|obesity, pediatric obesity, bariatric, bariatric surgery|obesity, pediatric obesity, bariatric, bariatric surgery
375653|NCT01980745|autoimmune hepatitis|autoimmune hepatitis
375654|NCT01980745|recurrence|recurrence
375655|NCT01980745|treatment withdrawal|treatment withdrawal
375656|NCT01980745|chloroquine|chloroquine
375657|NCT01980745|maintenance of remission|maintenance of remission
375658|NCT01980706|Baclofen|baclofen
375659|NCT01980706|Alcohol Dependence|alcohol dependence
375660|NCT01980667|lurbinectedin|lurbinectedin
375661|NCT01980667|PM01183|pm01183
375662|NCT01980667|tumors|tumors
375663|NCT01980667|cancer|cancer
375664|NCT01980667|Pharma Mar|pharma mar
375665|NCT01980654|Pharmacyclics (PCYC)|pharmacyclics (pcyc)
375666|NCT01980654|PCYC|pcyc
375667|NCT01980654|Lymphoma|lymphoma
375668|NCT01980654|Follicular Lymphoma|follicular lymphoma
375669|NCT01980654|FL|fl
375670|NCT01980654|Rituximab|rituximab
375671|NCT01980654|Ibrutinib|ibrutinib
375672|NCT01980654|Rituxan|rituxan
375673|NCT01980654|Non-Hodgkin's Lymphoma (NHL)|non-hodgkin's lymphoma (nhl)
375674|NCT01980654|NHL|nhl
375675|NCT01980654|B-cell Lymphoma|b-cell lymphoma
375676|NCT01980641|Stroke|stroke
375677|NCT01980641|ADL|adl
375678|NCT01980641|mHealth|mhealth
375679|NCT01980641|App|app
375680|NCT01980641|Adherence|adherence
375681|NCT01980641|Home|home
375682|NCT01980641|Environment|environment
375683|NCT01980641|Tool|tool
375684|NCT01980641|Advice|advice
375685|NCT01980641|Smartphone|smartphone
375686|NCT01980628|MZL|mzl
375687|NCT01980628|NHL|nhl
375688|NCT01980628|SMZL|smzl
375689|NCT01980628|NMZL|nmzl
375690|NCT01980628|MALT|malt
375691|NCT01980602|Intermittent claudication|intermittent claudication
375692|NCT01980602|endothelial function|endothelial function
375795|NCT01980069|Neostigmine|neostigmine
375693|NCT01980602|cardiopulmonary testing|cardiopulmonary testing
375694|NCT01980602|inflammation|inflammation
375695|NCT01980602|muscle architecture|muscle architecture
375696|NCT01980589|multiple myeloma|multiple myeloma
375697|NCT01980576|Pain|pain
375698|NCT01980576|Sensitization|sensitization
375699|NCT01980576|Spondylitis|spondylitis
375700|NCT01980485|smoker|smoker
375701|NCT01980459|Hypomagnesemia, Cellular Mg, Inflammation, Diabetes Mellitus|hypomagnesemia, cellular mg, inflammation, diabetes mellitus
375702|NCT01980446|Coma|coma
375703|NCT01980446|Cardiac arrest|cardiac arrest
375704|NCT01980446|Neurophysiology|neurophysiology
375705|NCT01980446|Auditory evoked potential|auditory evoked potential
375706|NCT01980433|Wilson disease|wilson disease
375707|NCT01980433|Dystonia|dystonia
375708|NCT01980433|Movement Disorders|movement disorders
375709|NCT01980433|Handwriting|handwriting
375710|NCT01980433|Repetitive Transcranial Magnetic Stimulation|repetitive transcranial magnetic stimulation
375711|NCT01980420|Sleeve gastrectomy|sleeve gastrectomy
375712|NCT01980420|Oesogastric junction - GEJ|oesogastric junction - gej
375713|NCT01980420|Dynamic MRI Imaging|dynamic mri imaging
375714|NCT01980407|S-1|s-1
375715|NCT01980407|Oxaliplatin|oxaliplatin
375716|NCT01980407|Leucovorin|leucovorin
375717|NCT01980407|Gastric Cancer|gastric cancer
375718|NCT01980394|esophagus|esophagus
375719|NCT01980394|gastro-esophegeal junction|gastro-esophegeal junction
375720|NCT01980394|cancer|cancer
375721|NCT01980394|tumor seeding|tumor seeding
375722|NCT01980394|free viable tumor cells|free viable tumor cells
375723|NCT01980394|surgery|surgery
375724|NCT01980394|intraluminal tumor cells|intraluminal tumor cells
375725|NCT01980394|stump washout|stump washout
375726|NCT01980355|cancer|cancer
375727|NCT01980355|surgery|surgery
375728|NCT01980355|oncology|oncology
375729|NCT01980355|major|major
375730|NCT01980355|surgical oncology|surgical oncology
375731|NCT01980355|tranexamic acid|tranexamic acid
375732|NCT01980342|Long acting reversible contraception|long acting reversible contraception
375733|NCT01980342|HIV|hiv
375734|NCT01980329|CYP3A5|cyp3a5
375735|NCT01980329|maraviroc|maraviroc
375736|NCT01980329|polymorphism|polymorphism
375737|NCT01980316|Argatroban|argatroban
375738|NCT01980316|Extracranial vertebral Artery Stenting|extracranial vertebral artery stenting
375739|NCT01980316|restenosis|restenosis
375740|NCT01980303|Healthy|healthy
375741|NCT01980303|Japanese|japanese
375742|NCT01980303|Caucasian|caucasian
375743|NCT01980303|Anesthetics|anesthetics
375744|NCT01980303|Intranasal|intranasal
375745|NCT01980303|Esketamine|esketamine
375746|NCT01980303|Pharmacokinetics|pharmacokinetics
375747|NCT01980290|HCV genotype 1|hcv genotype 1
375748|NCT01980290|Liver Fibrosis|liver fibrosis
375749|NCT01980290|ex-People who INject Drugs (ex-PWIDs)|ex-people who inject drugs (ex-pwids)
375750|NCT01980264|Melanoma|melanoma
375751|NCT01980264|Basal Cell Carcinoma|basal cell carcinoma
375752|NCT01980264|Squamous Cell Carcinoma|squamous cell carcinoma
375753|NCT01980264|BD, AK|bd, ak
375754|NCT01980264|melanin|melanin
375755|NCT01980251|Delirium, electroencephalography, CSD|delirium, electroencephalography, csd
375756|NCT01980238|LAR|lar
375757|NCT01980238|anastomotic leakage|anastomotic leakage
375758|NCT01980238|Cannula ileostomy|cannula ileostomy
375759|NCT01980238|loop ileostomy|loop ileostomy
375760|NCT01980225|vitrification, blastocyst, artificial shrinkage, collapse|vitrification, blastocyst, artificial shrinkage, collapse
375761|NCT01980212|non-small cell lung cancer|non-small cell lung cancer
375762|NCT01980212|thioredoxin reductase|thioredoxin reductase
375763|NCT01980199|visceral leishmaniasis|visceral leishmaniasis
375764|NCT01980199|fexinidazole|fexinidazole
375765|NCT01980199|adults|adults
375766|NCT01980199|proof of concept|proof of concept
375767|NCT01980199|efficacy|efficacy
375768|NCT01980199|safety|safety
375769|NCT01980199|pharmacokinetic|pharmacokinetic
375770|NCT01980199|pharmacodynamic|pharmacodynamic
375771|NCT01980186|transcranial ultrasound|transcranial ultrasound
375772|NCT01980186|autism|autism
375773|NCT01980186|cortical dysplasia|cortical dysplasia
375774|NCT01980186|extra-axial fluid|extra-axial fluid
375775|NCT01980173|Bakri balloon|bakri balloon
375776|NCT01980147|Severe Mental Illness|severe mental illness
375777|NCT01980134|adenomatous colorectal lesions|adenomatous colorectal lesions
375778|NCT01980134|colorectal polyps|colorectal polyps
375779|NCT01980134|polyps|polyps
375780|NCT01980121|Respiratory Aspiration|respiratory aspiration
375781|NCT01980121|Pregnancy|pregnancy
375782|NCT01980121|Ultrasound|ultrasound
375783|NCT01980121|Gastric Contents|gastric contents
375784|NCT01980108|Pregnancy|pregnancy
375785|NCT01980108|Respiratory Aspiration|respiratory aspiration
375786|NCT01980108|Gastric Contents|gastric contents
375787|NCT01980108|Ultrasound|ultrasound
375788|NCT01980095|Helicobacter pylori|helicobacter pylori
375789|NCT01980095|H. pylori|h. pylori
375790|NCT01980095|Dyspepsia|dyspepsia
375791|NCT01980082|head and neck surgery|head and neck surgery
375792|NCT01980082|surgical wound infection|surgical wound infection
375793|NCT01980082|antibiotic prophylaxis|antibiotic prophylaxis
375794|NCT01980069|Sugammadex|sugammadex
375796|NCT01980069|Surgery|surgery
375797|NCT01980056|INT-2 or high-risk MDS|int-2 or high-risk mds
375798|NCT01980017|Diabetes Type 2 Mellitus|diabetes type 2 mellitus
375799|NCT01980017|Ottawa Model for Smoking Cessation|ottawa model for smoking cessation
375800|NCT01980017|Diabetes Education Programs|diabetes education programs
375801|NCT01979965|Mitral Regurgitation|mitral regurgitation
375802|NCT01979965|cardiac resynchronization therapy|cardiac resynchronization therapy
375803|NCT01979965|ranolazine|ranolazine
375804|NCT01979965|maximal medical therapy|maximal medical therapy
375805|NCT01979965|ischemic cardiomyopathy|ischemic cardiomyopathy
375806|NCT01979913|Primary Open Angle Glaucoma|primary open angle glaucoma
375807|NCT01979913|Ocular Hypertension|ocular hypertension
375808|NCT01979913|Tafluprost|tafluprost
375809|NCT01979913|Saflutan|saflutan
375810|NCT01979913|Intraocular pressure|intraocular pressure
375811|NCT01979913|Preservative free|preservative free
375812|NCT01979913|Single dose unit|single dose unit
375813|NCT01979900|TB Infection|tb infection
375814|NCT01979900|Lesion Degree|lesion degree
375815|NCT01979900|Bacteriology Indicators|bacteriology indicators
375816|NCT01979900|Cavity|cavity
375817|NCT01979900|Humoral Immunity|humoral immunity
375818|NCT01979900|Cellular Immunologic Response|cellular immunologic response
375819|NCT01979861|Endometrial ablation with vapor|endometrial ablation with vapor
375820|NCT01979848|continence outcomes|continence outcomes
375821|NCT01979848|sexual function|sexual function
375822|NCT01979848|Robotic Assisted Radical Prostatectomy|robotic assisted radical prostatectomy
375823|NCT01979848|thermal imaging|thermal imaging
375824|NCT01979848|localized hypothermia|localized hypothermia
375825|NCT01979835|intrauterine device, contraception|intrauterine device, contraception
375826|NCT01979822|medication pump, complications, safety observation|medication pump, complications, safety observation
375827|NCT01979809|Dietary change|dietary change
375828|NCT01979809|Young adult|young adult
375829|NCT01979809|Prevention|prevention
375830|NCT01979809|Web-based intervention|web-based intervention
375831|NCT01979809|eCoaching|ecoaching
375832|NCT01979796|Addiction, Schizophrenia, Electronic cigarettes|addiction, schizophrenia, electronic cigarettes
375833|NCT01979770|Adolescent|adolescent
375834|NCT01979770|Nutritional status|nutritional status
375835|NCT01979770|Body composition|body composition
375836|NCT01979770|Biochemical status|biochemical status
375837|NCT01979744|Intravenous ultrasound,|intravenous ultrasound,
375838|NCT01979744|third generation drug-eluting stent|third generation drug-eluting stent
375839|NCT01979731|Occupational health|occupational health
375840|NCT01979731|Ergonomics|ergonomics
375841|NCT01979731|Environments|environments
375842|NCT01979731|Prevention and Control|prevention and control
375843|NCT01979692|CLM|clm
375844|NCT01979692|The study will|the study will
375845|NCT01979692|focus on using|focus on using
375846|NCT01979692|CLM to|clm to
375847|NCT01979692|distinguish between|distinguish between
375848|NCT01979692|viable and|viable and
375849|NCT01979692|necrotic tissue|necrotic tissue
375850|NCT01979692|at TTNB in real time|at ttnb in real time
375851|NCT01979666|Knee AVN, Nitrates|knee avn, nitrates
375852|NCT01979640|bronchial cuff|bronchial cuff
375853|NCT01979640|double lumen tube|double lumen tube
375854|NCT01979640|blood tight seal|blood tight seal
375855|NCT01979627|transulnar approach|transulnar approach
375856|NCT01979627|transradial approach|transradial approach
375857|NCT01979627|angiography|angiography
375858|NCT01979627|angioplasty|angioplasty
375859|NCT01979614|coronary artery disease|coronary artery disease
375860|NCT01979601|hypercholesterolemia,|hypercholesterolemia,
375861|NCT01979601|LGT209,|lgt209,
375862|NCT01979601|PCSK9,|pcsk9,
375863|NCT01979601|LDL-C|ldl-c
375864|NCT01979575|Nexfin|nexfin
375865|NCT01979575|Flotrac|flotrac
375866|NCT01979575|Esophageal|esophageal
375867|NCT01979575|Cardiac output|cardiac output
375868|NCT01979562|Overuse injury|overuse injury
375869|NCT01979562|Femur|femur
375870|NCT01979562|Tibia|tibia
375871|NCT01979562|Running|running
375872|NCT01979562|Prevention|prevention
375873|NCT01979549|Adverse events|adverse events
375874|NCT01979549|Upper gastrointestinal endoscopy|upper gastrointestinal endoscopy
375875|NCT01979549|Sedation|sedation
375876|NCT01979484|bioavailability|bioavailability
375877|NCT01979471|Cardiovascular risk reduction|cardiovascular risk reduction
375878|NCT01979471|Diabetes|diabetes
375879|NCT01979471|Chronic Kidney Disease|chronic kidney disease
375880|NCT01979471|Atherosclerotic vascular disease|atherosclerotic vascular disease
375881|NCT01979471|Community Pharmacist|community pharmacist
375882|NCT01979471|Randomized controlled trial|randomized controlled trial
375883|NCT01979471|[eGFR <60 ml/min/1.73m2 and/or (ACR >= 30 mg/mmol or two consecutive ACR tests which are >= 3 mg/mmol)]|[egfr <60 ml/min/1.73m2 and/or (acr >= 30 mg/mmol or two consecutive acr tests which are >= 3 mg/mmol)]
375884|NCT01979458|Colonoscopy|colonoscopy
375885|NCT01979445|CAD|cad
375886|NCT01979432|Alzheimer, cognitive diseases, Ankle-to-brachial index|alzheimer, cognitive diseases, ankle-to-brachial index
375887|NCT01979419|mild cognitive impairment|mild cognitive impairment
375888|NCT01979419|Alzheimer's disease|alzheimer's disease
375889|NCT01979419|subcortical Vascular Dementia|subcortical vascular dementia
375890|NCT01979419|amyloid|amyloid
375891|NCT01979419|plaques|plaques
375892|NCT01979419|neuroimaging|neuroimaging
375893|NCT01979419|biomarkers|biomarkers
375894|NCT01979419|cognition disorder|cognition disorder
375895|NCT01979419|early detection|early detection
375896|NCT01979419|pre-dementia|pre-dementia
375897|NCT01979419|dementia|dementia
375898|NCT01979419|vascular MCI|vascular mci
375899|NCT01979406|Anthrax vaccine|anthrax vaccine
375900|NCT01979393|Locally advanced|locally advanced
375901|NCT01979393|stage III|stage iii
375902|NCT01979393|stage IV|stage iv
375903|NCT01979393|residual disease after primary surgery|residual disease after primary surgery
375904|NCT01979393|newly diagnosed HGUS|newly diagnosed hgus
375905|NCT01979393|Metastatic|metastatic
375906|NCT01979380|KD101|kd101
375907|NCT01979380|Anti-obesity Agents|anti-obesity agents
375908|NCT01979354|spinal morphine|spinal morphine
375909|NCT01979354|VATs lobectomy|vats lobectomy
375910|NCT01979341|dual trigger|dual trigger
375911|NCT01979341|hCG|hcg
375912|NCT01979341|GnRH agonist|gnrh agonist
375913|NCT01979341|ICSI|icsi
375914|NCT01979341|pregnancy|pregnancy
375915|NCT01979341|OHSS|ohss
375916|NCT01979328|Deep Vein Thrombosis|deep vein thrombosis
375917|NCT01979302|Geriatric Depression|geriatric depression
375918|NCT01979302|Depression Care Management|depression care management
375919|NCT01979302|home healthcare|home healthcare
375920|NCT01979302|nurse training intervention|nurse training intervention
375921|NCT01979289|Executive Dysfunction|executive dysfunction
375922|NCT01979289|Cognitive Remediation|cognitive remediation
375923|NCT01979289|Geriatric|geriatric
375924|NCT01979289|Depression|depression
375925|NCT01979250|endothelial keratoplasty|endothelial keratoplasty
375926|NCT01979250|Descemet's stripping automated endothelial keratoplasty|descemet's stripping automated endothelial keratoplasty
375927|NCT01979250|lamellar keratoplasty|lamellar keratoplasty
375928|NCT01979224|educational intervention, Asthma control, asthma knowledge|educational intervention, asthma control, asthma knowledge
375929|NCT01979211|head and neck cancer|head and neck cancer
375930|NCT01979198|burst fracture, kyphotic angle, surgical outcome|burst fracture, kyphotic angle, surgical outcome
375931|NCT01979172|LASIK|lasik
375932|NCT01979172|Intraocular lens|intraocular lens
375933|NCT01979172|Biometry|biometry
375934|NCT01979172|IOL master|iol master
375935|NCT01979159|aphasia|aphasia
375936|NCT01979159|apraxia of speech|apraxia of speech
375937|NCT01979159|outcomes|outcomes
375938|NCT01979146|Cancer|cancer
375939|NCT01979120|Sleep-disordered breathing|sleep-disordered breathing
375940|NCT01979120|Chronic heart failure|chronic heart failure
375941|NCT01979120|Implantable cardioverter-defibrillator|implantable cardioverter-defibrillator
375942|NCT01979120|Apnea-Hypopnea-Index|apnea-hypopnea-index
375943|NCT01979120|Portable Polygraphy Monitoring|portable polygraphy monitoring
375944|NCT01979120|Polysomnography|polysomnography
375945|NCT01979107|Health behavior|health behavior
375946|NCT01979107|Chronic disease|chronic disease
375947|NCT01979107|Proactive action|proactive action
375948|NCT01979107|General practitioner|general practitioner
375949|NCT01979107|Preventive health check|preventive health check
375950|NCT01979107|Social inequality in health|social inequality in health
375951|NCT01979107|Randomised controlled trial|randomised controlled trial
375952|NCT01979055|asthma|asthma
375953|NCT01979055|older adults|older adults
375954|NCT01979055|elderly|elderly
375955|NCT01979055|behavior|behavior
375956|NCT01979042|renal colic|renal colic
375957|NCT01979042|acute renal failure|acute renal failure
375958|NCT01979042|Neutrophil gelatinase associated lipocalin|neutrophil gelatinase associated lipocalin
375959|NCT01978977|mBC|mbc
375960|NCT01978977|HER2 negative|her2 negative
375961|NCT01978977|Chemotherapy|chemotherapy
375962|NCT01978977|Anti-angiogenic agent|anti-angiogenic agent
375963|NCT01978977|Bevacizumab|bevacizumab
375964|NCT01978977|1st Line|1st line
375965|NCT01978964|ONT-10|ont-10
375966|NCT01978964|MUC1|muc1
375967|NCT01978964|Vaccine|vaccine
375968|NCT01978964|Phase 1b|phase 1b
375969|NCT01978964|Solid tumors|solid tumors
375970|NCT01978964|Maintenance therapy|maintenance therapy
375971|NCT01978951|Chronic Kidney Disease|chronic kidney disease
375972|NCT01978951|Integrated Chronic Kidney Disease Care|integrated chronic kidney disease care
375973|NCT01978951|Village Health Volunteers|village health volunteers
375974|NCT01978925|Pharmaceutical care|pharmaceutical care
375975|NCT01978925|Medication Adherence|medication adherence
375976|NCT01978925|Blood Pressure|blood pressure
375977|NCT01978925|Diabetes|diabetes
375978|NCT01978925|Emergency|emergency
375979|NCT01978886|Diabetes Mellitus|diabetes mellitus
375980|NCT01978886|frozen shoulder|frozen shoulder
375981|NCT01978886|adhesive capsulitis|adhesive capsulitis
375982|NCT01978860|CABG Coronary artery bypass grafting|cabg coronary artery bypass grafting
375983|NCT01978860|CTO Chronic Total Occlusion|cto chronic total occlusion
375984|NCT01978860|PCI Percutaneous coronary intervention|pci percutaneous coronary intervention
375985|NCT01978860|MACE Major adverse cardiovascular event(s)|mace major adverse cardiovascular event(s)
375986|NCT01978860|MI Myocardial infarction|mi myocardial infarction
376088|NCT01978366|anti-fibrotic|anti-fibrotic
375987|NCT01978834|Osteoporosis, diagnosis, ultrasound|osteoporosis, diagnosis, ultrasound
375988|NCT01978821|Cerebral Palsy|cerebral palsy
375989|NCT01978821|autologous bone marrow mononuclear cells|autologous bone marrow mononuclear cells
375990|NCT01978821|stem cell therapy|stem cell therapy
375991|NCT01978795|concussion|concussion
375992|NCT01978795|high school|high school
375993|NCT01978795|web-based training|web-based training
375994|NCT01978795|school-based health care|school-based health care
375995|NCT01978782|raltegravir|raltegravir
375996|NCT01978782|citalopram|citalopram
375997|NCT01978782|pharmacokinetics|pharmacokinetics
375998|NCT01978782|drug-drug interaction|drug-drug interaction
375999|NCT01978756|Outpatient clinic|outpatient clinic
376000|NCT01978756|Breast cancer|breast cancer
376001|NCT01978756|Late toxicity|late toxicity
376002|NCT01978743|HIV|hiv
376003|NCT01978743|HIV-associated neurocognitive disorder|hiv-associated neurocognitive disorder
376004|NCT01978743|neurotoxicity|neurotoxicity
376005|NCT01978730|vascular dementia|vascular dementia
376006|NCT01978730|cognition|cognition
376007|NCT01978730|stroke|stroke
376008|NCT01978717|Anesthesia|anesthesia
376009|NCT01978717|T-helper|t-helper
376010|NCT01978717|MDSCs|mdscs
376011|NCT01978717|Colorectal cancer|colorectal cancer
376012|NCT01978717|Fast track|fast track
376013|NCT01978691|Obesity|obesity
376014|NCT01978691|Blood glucose|blood glucose
376015|NCT01978691|Waist circumference|waist circumference
376016|NCT01978691|Lipid metabolism|lipid metabolism
376017|NCT01978691|Probiotics|probiotics
376018|NCT01978691|Prebiotics|prebiotics
376019|NCT01978691|Dietary supplements|dietary supplements
376020|NCT01978691|Endotoxemia|endotoxemia
376021|NCT01978665|COPD exercise inflammation prednisone|copd exercise inflammation prednisone
376022|NCT01978626|Insomnia|insomnia
376023|NCT01978626|Comorbid insomnia|comorbid insomnia
376024|NCT01978626|Cognitive Behavioral Therapy|cognitive behavioral therapy
376025|NCT01978600|Open-Angle Glaucoma|open-angle glaucoma
376026|NCT01978600|Ocular Hypertension|ocular hypertension
376027|NCT01978600|Simbrinza™|simbrinza™
376028|NCT01978600|Intraocular Pressure|intraocular pressure
376029|NCT01978587|End-stage Renal Disease|end-stage renal disease
376030|NCT01978587|Hemodialysis|hemodialysis
376031|NCT01978587|Pharmacokinetics|pharmacokinetics
376032|NCT01978574|Cognitive reserve|cognitive reserve
376033|NCT01978574|intellectual enrichment|intellectual enrichment
376034|NCT01978548|Alzheimer Disease|alzheimer disease
376035|NCT01978548|Prodromal Alzheimer Disease|prodromal alzheimer disease
376036|NCT01978548|Safety|safety
376037|NCT01978548|Tolerability|tolerability
376038|NCT01978548|Pharmacokinetic|pharmacokinetic
376039|NCT01978548|Proof of Mechanism|proof of mechanism
376040|NCT01978548|JNJ-54861911|jnj-54861911
376041|NCT01978535|POTS|pots
376042|NCT01978522|Randomised trial|randomised trial
376043|NCT01978522|postal questionnaires|postal questionnaires
376044|NCT01978522|return rates|return rates
376045|NCT01978509|Colonoscopy|colonoscopy
376046|NCT01978483|Humans|humans
376047|NCT01978483|Adult|adult
376048|NCT01978483|skin|skin
376049|NCT01978483|metabolism|metabolism
376050|NCT01978483|radiation effects|radiation effects
376051|NCT01978483|Ultraviolet Rays|ultraviolet rays
376052|NCT01978483|RANKL|rankl
376053|NCT01978483|RANK Ligand|rank ligand
376054|NCT01978483|denosumab|denosumab
376055|NCT01978483|diphenylcyclopropenone|diphenylcyclopropenone
376056|NCT01978483|diphencyprone|diphencyprone
376057|NCT01978483|immunology|immunology
376058|NCT01978483|immunosuppression|immunosuppression
376059|NCT01978483|Antibodies, Monoclonal|antibodies, monoclonal
376060|NCT01978483|Dermatitis, Allergic Contact|dermatitis, allergic contact
376061|NCT01978483|Hypersensitivity, Delayed|hypersensitivity, delayed
376062|NCT01978470|epilepsy|epilepsy
376063|NCT01978470|drug resistent epilepsy|drug resistent epilepsy
376064|NCT01978470|partial onset seizures|partial onset seizures
376065|NCT01978470|trigeminal nerve stimulation|trigeminal nerve stimulation
376066|NCT01978470|neuromodulation|neuromodulation
376067|NCT01978444|D2 lymphadenectomy|d2 lymphadenectomy
376068|NCT01978444|Complete Mesogastrium Excision|complete mesogastrium excision
376069|NCT01978418|Lung fluid|lung fluid
376070|NCT01978418|Postnatal adaptation|postnatal adaptation
376071|NCT01978418|Salbutamol|salbutamol
376072|NCT01978418|Albuterol|albuterol
376073|NCT01978418|Epithelial Sodium Channel|epithelial sodium channel
376074|NCT01978405|Type 2 diabetes|type 2 diabetes
376075|NCT01978405|Nephropathy|nephropathy
376076|NCT01978405|Contrast medium|contrast medium
376077|NCT01978405|Alpha lipoic acid|alpha lipoic acid
376078|NCT01978392|disability|disability
376079|NCT01978392|self-management|self-management
376080|NCT01978392|chronic illness|chronic illness
376081|NCT01978392|chronic pain|chronic pain
376082|NCT01978392|occupation|occupation
376083|NCT01978392|> 6 months|> 6 months
376084|NCT01978379|General Anesthesia|general anesthesia
376085|NCT01978379|Nociception Level|nociception level
376086|NCT01978366|Duchenne muscular dystrophy|duchenne muscular dystrophy
376087|NCT01978366|halofuginone hydrobromide|halofuginone hydrobromide
376089|NCT01978366|anti-inflammatory|anti-inflammatory
376090|NCT01978366|muscle regeneration|muscle regeneration
376091|NCT01978366|protein synthesis inhibitor|protein synthesis inhibitor
376092|NCT01978353|Mild cognitive impairment|mild cognitive impairment
376093|NCT01978353|Dementia|dementia
376094|NCT01978353|Alzheimer's disease|alzheimer's disease
376095|NCT01978353|Memory Training|memory training
376096|NCT01978353|Cognitive Training|cognitive training
376097|NCT01978353|Cognitive Rehabilitation|cognitive rehabilitation
376098|NCT01978353|Neuropsychological Rehabilitation|neuropsychological rehabilitation
376099|NCT01978327|Alzheimer's disease|alzheimer's disease
376100|NCT01978327|GSK2647544|gsk2647544
376101|NCT01978327|drug-drug interaction|drug-drug interaction
376102|NCT01978327|healthy subjects|healthy subjects
376103|NCT01978327|Lp-PLA2|lp-pla2
376104|NCT01978327|simvastatin|simvastatin
376105|NCT01978314|Chronic Kidney Disease|chronic kidney disease
376106|NCT01978314|Acute Kidney Injury|acute kidney injury
376107|NCT01978314|AKI|aki
376108|NCT01978314|CKD|ckd
376109|NCT01978314|Plasma Volume|plasma volume
376110|NCT01978314|GFR|gfr
376111|NCT01978314|Glomerular Filtration Rate|glomerular filtration rate
376112|NCT01978314|Blood volume|blood volume
376113|NCT01978314|mGFR|mgfr
376114|NCT01978314|measured GFR|measured gfr
376115|NCT01978314|kidney biomarker|kidney biomarker
376116|NCT01978314|renal disease|renal disease
376117|NCT01978314|renal biomarker|renal biomarker
376118|NCT01978314|Renal function|renal function
376119|NCT01978314|kidney function|kidney function
376120|NCT01978314|organ function|organ function
376121|NCT01978314|kidney monitor|kidney monitor
376122|NCT01978314|kidney device|kidney device
376123|NCT01978301|triamcinolone acetonide (TAC)|triamcinolone acetonide (tac)
376124|NCT01978301|heavy water|heavy water
376125|NCT01978301|fibrosis|fibrosis
376126|NCT01978301|deuterium|deuterium
376127|NCT01978301|collagen degradation|collagen degradation
376128|NCT01978301|collagen synthesis|collagen synthesis
376129|NCT01978301|Keloid|keloid
376130|NCT01978301|patient|patient
376131|NCT01978275|total knee arthroplasty|total knee arthroplasty
376132|NCT01978275|lumbar plexus block|lumbar plexus block
376133|NCT01978275|stimulating catheters|stimulating catheters
376134|NCT01978275|peripheral nerve blocks|peripheral nerve blocks
376135|NCT01978262|influenza vaccine|influenza vaccine
376136|NCT01978262|cytokines|cytokines
376137|NCT01978262|hormones|hormones
376138|NCT01978262|progesterone|progesterone
376139|NCT01978249|Colorectal cancer|colorectal cancer
376140|NCT01978249|Primary tumor resection|primary tumor resection
376141|NCT01978249|Chemotherapy|chemotherapy
376142|NCT01978249|Overall survival|overall survival
376143|NCT01978249|Quality of life|quality of life
376144|NCT01978236|BRAF V600E mutation|braf v600e mutation
376145|NCT01978236|brain metastases|brain metastases
376146|NCT01978236|BRAF V600K mutation|braf v600k mutation
376147|NCT01978236|Metastatic melanoma|metastatic melanoma
376148|NCT01978236|BRAF inhibitor|braf inhibitor
376149|NCT01978236|brain neoplasms|brain neoplasms
376150|NCT01978236|GSK2118436|gsk2118436
376151|NCT01978223|Rotarix™|rotarix™
376152|NCT01978223|Case-control|case-control
376153|NCT01978223|Venezuela|venezuela
376154|NCT01978223|Vaccine effectiveness|vaccine effectiveness
376155|NCT01978223|Rotavirus Severe Gastroenteritis|rotavirus severe gastroenteritis
376156|NCT01978223|Children|children
376157|NCT01978223|Hospitalised|hospitalised
376158|NCT01978210|autism|autism
376159|NCT01978210|enuresis|enuresis
376160|NCT01978210|toilet-training|toilet-training
376161|NCT01978184|Pancreatic Cancer, resectable adenocarcinoma of the pancreas|pancreatic cancer, resectable adenocarcinoma of the pancreas
376162|NCT01978171|breast neoplasms|breast neoplasms
376163|NCT01978171|everolimus|everolimus
376164|NCT01978171|interstitial lung disease|interstitial lung disease
376165|NCT01978171|pneumonitis|pneumonitis
376166|NCT01978158|Oxygen|oxygen
376167|NCT01978158|Hypoxia|hypoxia
376168|NCT01978158|Hyperoxia|hyperoxia
376169|NCT01978158|Inflammation|inflammation
376170|NCT01978158|Innate immunity|innate immunity
376171|NCT01978145|efficacy|efficacy
376172|NCT01978145|tolerability|tolerability
376173|NCT01978145|capsule-based inhaler|capsule-based inhaler
376174|NCT01978145|quality of life|quality of life
376175|NCT01978145|safety|safety
376176|NCT01978145|multi-dose inhaler|multi-dose inhaler
376177|NCT01978145|fluticasone propionate/salmeterol (FSC) 250/50 mcg|fluticasone propionate/salmeterol (fsc) 250/50 mcg
376178|NCT01978145|Chronic obstructive pulmonary disease|chronic obstructive pulmonary disease
376179|NCT01978132|primary hyperaldosteronism|primary hyperaldosteronism
376180|NCT01978132|primary hypertension|primary hypertension
376181|NCT01978132|forearm ischemia-reperfusion|forearm ischemia-reperfusion
376182|NCT01978132|(reduction) in brachial artery FMD|(reduction) in brachial artery fmd
376183|NCT01978132|endothelial ischemia-reperfusion injury|endothelial ischemia-reperfusion injury
376184|NCT01978119|Multi-Dose Inhaler|multi-dose inhaler
376185|NCT01978119|safety|safety
376186|NCT01978119|Asthma|asthma
376187|NCT01978119|efficacy|efficacy
376188|NCT01978119|pharmacodynamics|pharmacodynamics
376189|NCT01978119|fluticasone propionate/salmeterol (FSC) 250/50 mcg|fluticasone propionate/salmeterol (fsc) 250/50 mcg
376190|NCT01978119|tolerability|tolerability
376191|NCT01978119|Capsule-Based Inhaler|capsule-based inhaler
376192|NCT01978106|toric calculator|toric calculator
376193|NCT01978106|toric intraocular lens power|toric intraocular lens power
376194|NCT01978106|Acrysof|acrysof
376195|NCT01978106|Tecnis|tecnis
376196|NCT01978106|iTrace|itrace
376197|NCT01978093|Conjugate|conjugate
376198|NCT01978093|Immunogenicity|immunogenicity
376199|NCT01978093|Hib-MenCY-TT vaccine|hib-mency-tt vaccine
376200|NCT01978093|Haemophilus type b|haemophilus type b
376201|NCT01978093|Safety|safety
376202|NCT01978093|Reactogenicity|reactogenicity
376203|NCT01978067|Uterine Scar From Previous Cesarean Delivery|uterine scar from previous cesarean delivery
376204|NCT01978067|previous caesarean scar deficiency|previous caesarean scar deficiency
376205|NCT01978067|transvaginal resection|transvaginal resection
376206|NCT01978067|quality of life|quality of life
376207|NCT01978067|sexual activity|sexual activity
376208|NCT01978054|Information Dissemination|information dissemination
376209|NCT01978054|Information Sharing|information sharing
376210|NCT01978054|Innovation Diffusion|innovation diffusion
376211|NCT01978054|Public Health Practice|public health practice
376212|NCT01978054|Evidence-Based Public Health|evidence-based public health
376213|NCT01978054|Chronic Disease Prevention|chronic disease prevention
376214|NCT01978054|Cancer Prevention and Control|cancer prevention and control
376215|NCT01978041|pharmacokinetics, saliva, plasma, fluoride, dental fluorosis, dental caries|pharmacokinetics, saliva, plasma, fluoride, dental fluorosis, dental caries
376216|NCT01978028|heart failure|heart failure
376217|NCT01978015|primary open angle glaucoma|primary open angle glaucoma
376218|NCT01978015|timolol|timolol
376219|NCT01978015|prostaglandin analogues|prostaglandin analogues
376220|NCT01977976|Endometrial injury|endometrial injury
376221|NCT01977976|Pipelle|pipelle
376222|NCT01977976|Implantation|implantation
376223|NCT01977976|Ongoing pregnancy rate|ongoing pregnancy rate
376224|NCT01977976|IVF|ivf
376225|NCT01977950|Undernutrition, Nutritional risk, NRS2002, nutritional care practices, hospital, elderly patients, nursing students|undernutrition, nutritional risk, nrs2002, nutritional care practices, hospital, elderly patients, nursing students
376226|NCT01977937|gabapentin|gabapentin
376227|NCT01977937|Analgesic Drugs|analgesic drugs
376228|NCT01977937|Analgesics, Nonopioid|analgesics, nonopioid
376229|NCT01977924|sleep apnea|sleep apnea
376230|NCT01977924|polyphenols|polyphenols
376231|NCT01977924|endothelial function|endothelial function
376232|NCT01977911|Airway reconstruction|airway reconstruction
376233|NCT01977911|Regenerative medicine|regenerative medicine
376234|NCT01977898|Postdural puncture headache|postdural puncture headache
376235|NCT01977898|Intrathecal morphine|intrathecal morphine
376236|NCT01977898|Intrathecal catheter|intrathecal catheter
376237|NCT01977898|Headache|headache
376238|NCT01977898|Labor and delivery|labor and delivery
376239|NCT01977898|Unintentional dural puncture|unintentional dural puncture
376240|NCT01977885|epigenetics|epigenetics
376241|NCT01977885|obesity|obesity
376242|NCT01977885|overweight|overweight
376243|NCT01977885|high protein diet|high protein diet
376244|NCT01977885|exercise|exercise
376245|NCT01977885|post menopausal women|post menopausal women
376246|NCT01977872|Arthritis|arthritis
376247|NCT01977872|Physical Activity|physical activity
376248|NCT01977872|Diet|diet
783884|NCT00315042|pharyngitis|pharyngitis
376249|NCT01977859|B-type Natriuretic Peptide|b-type natriuretic peptide
376250|NCT01977859|Metabolism|metabolism
376251|NCT01977859|Insulin infusion|insulin infusion
376252|NCT01977846|genetic testing|genetic testing
376253|NCT01977846|ABCA4|abca4
376254|NCT01977846|Stargardt|stargardt
376255|NCT01977846|retina|retina
376256|NCT01977846|retinal degeneration|retinal degeneration
376257|NCT01977833|BTdiet|btdiet
376258|NCT01977833|Dtdiet|dtdiet
376259|NCT01977833|High Calorie Breakfast diet (BTdiet)|high calorie breakfast diet (btdiet)
376260|NCT01977833|High Calorie Dinner diet (DTdiet)|high calorie dinner diet (dtdiet)
376261|NCT01977820|Phenylketonuria|phenylketonuria
376262|NCT01977820|Sapropterin|sapropterin
376263|NCT01977820|Placebo|placebo
376264|NCT01977820|Cognitive Abilities|cognitive abilities
376265|NCT01977820|Kuvan®|kuvan®
376266|NCT01977807|Myopia|myopia
376267|NCT01977807|Hyperopia|hyperopia
376268|NCT01977807|Presbyopia|presbyopia
376269|NCT01977807|Supracor|supracor
376270|NCT01977807|Zyoptix|zyoptix
376271|NCT01977807|Proscan|proscan
376272|NCT01977807|LASIK|lasik
376273|NCT01977794|Bisoprolol|bisoprolol
376274|NCT01977794|Amlodipine|amlodipine
376275|NCT01977794|Fixed dose combination (FDC)|fixed dose combination (fdc)
376276|NCT01977794|Systolic Blood Pressure (SBP)|systolic blood pressure (sbp)
376277|NCT01977794|Diastolic Blood Pressure (DBP)|diastolic blood pressure (dbp)
376278|NCT01977781|GVHD|gvhd
376279|NCT01977781|Ocular GVHD|ocular gvhd
376280|NCT01977781|Tacrolimus|tacrolimus
376281|NCT01977781|Methylprednisolone|methylprednisolone
376282|NCT01977768|M. vaccae|m. vaccae
376283|NCT01977768|TB|tb
376284|NCT01977768|MDR-TB|mdr-tb
376285|NCT01977768|V7-immunitor|v7-immunitor
376286|NCT01977729|anxiety|anxiety
376287|NCT01977716|Peritonitis|peritonitis
376288|NCT01977716|loss of residual renal function|loss of residual renal function
376289|NCT01977716|technique survival|technique survival
376290|NCT01977703|Heart Failure|heart failure
376291|NCT01977703|Advanced Heart Failure|advanced heart failure
376292|NCT01977703|LVAD|lvad
376293|NCT01977703|Left Ventricular Assist Device|left ventricular assist device
376294|NCT01977703|Heart-Assist Devices|heart-assist devices
376295|NCT01977664|oocyte maturation failure|oocyte maturation failure
376296|NCT01977664|Maturation induction in vitro|maturation induction in vitro
376297|NCT01977651|enzalutamide|enzalutamide
376298|NCT01977651|Xtandi|xtandi
376299|NCT01977651|seizure|seizure
376300|NCT01977651|Central Nervous System|central nervous system
376301|NCT01977651|MDV3100|mdv3100
376302|NCT01977651|metastatic castration-resistant prostate cancer (mCRPC)|metastatic castration-resistant prostate cancer (mcrpc)
376303|NCT01977638|Advanced solid tumours|advanced solid tumours
376304|NCT01977638|Lymphoma|lymphoma
376305|NCT01977638|Myeloma|myeloma
376306|NCT01977625|Menopause|menopause
376307|NCT01977625|fMRI|fmri
376308|NCT01977625|Vyvanse|vyvanse
376309|NCT01977612|Wound infection|wound infection
376310|NCT01977612|Wound separation|wound separation
376311|NCT01977612|Skin staples|skin staples
376312|NCT01977612|Subcuticular suture|subcuticular suture
376313|NCT01977599|Text message reminders|text message reminders
376314|NCT01977599|Short Message Service (SMS) Reminders|short message service (sms) reminders
376315|NCT01977599|Social Health Inequalities|social health inequalities
376316|NCT01977599|Breast Screening|breast screening
376317|NCT01977599|Screening|screening
376318|NCT01977599|Public Health Intervention|public health intervention
376319|NCT01977599|Missed Appointments|missed appointments
376320|NCT01977599|Non-attendance|non-attendance
376321|NCT01977586|Clear cell renal cell carcinoma|clear cell renal cell carcinoma
376322|NCT01977586|Stage IV renal cell carcinoma|stage iv renal cell carcinoma
376323|NCT01977586|Anti-angiogenic therapy|anti-angiogenic therapy
376324|NCT01977586|Response assessment|response assessment
376325|NCT01977586|Magnetic resonance imaging|magnetic resonance imaging
376326|NCT01977573|Prolyl hydroxylase inhibitor|prolyl hydroxylase inhibitor
376327|NCT01977573|pharmacokinetics|pharmacokinetics
376328|NCT01977573|GSK1278863|gsk1278863
376329|NCT01977573|Anemia|anemia
376330|NCT01977573|hemoglobin|hemoglobin
376331|NCT01977573|erythropoiesis stimulating agents|erythropoiesis stimulating agents
376332|NCT01977573|Chronic kidney disease|chronic kidney disease
376333|NCT01977560|Type 2 diabetes|type 2 diabetes
376334|NCT01977560|Exercise|exercise
376335|NCT01977560|High protein|high protein
376336|NCT01977547|Red blood cell transfusions|red blood cell transfusions
376337|NCT01977547|Red blood cell storage age|red blood cell storage age
376338|NCT01977547|Pediatrics|pediatrics
376339|NCT01977547|Critical Care|critical care
376340|NCT01977534|Bioabsorbable|bioabsorbable
376341|NCT01977534|Coronary Stent|coronary stent
376342|NCT01977534|Everolimus|everolimus
376343|NCT01977534|drug eluting stents|drug eluting stents
376344|NCT01977534|stents|stents
376345|NCT01977534|angioplasty|angioplasty
376346|NCT01977534|coronary artery disease|coronary artery disease
376347|NCT01977534|total coronary occlusion|total coronary occlusion
376348|NCT01977534|coronary artery restenosis|coronary artery restenosis
376349|NCT01977534|stent thrombosis|stent thrombosis
376350|NCT01977534|vascular disease|vascular disease
376351|NCT01977534|myocardial ischemia|myocardial ischemia
376352|NCT01977534|coronary artery stenosis|coronary artery stenosis
376353|NCT01977534|CAD|cad
376354|NCT01977534|CAOD|caod
376355|NCT01977508|Vascular access grafts|vascular access grafts
376356|NCT01977508|Haemodialysis|haemodialysis
376357|NCT01977495|Diabetes|diabetes
376358|NCT01977495|Enrollment methods|enrollment methods
376359|NCT01977495|Behavioral Economic Intervention|behavioral economic intervention
376360|NCT01977495|Opt-in Enrollment|opt-in enrollment
376361|NCT01977495|Opt-out Enrollment|opt-out enrollment
376362|NCT01977495|lottery|lottery
376363|NCT01977495|financial incentives|financial incentives
376364|NCT01977482|hemoglobin|hemoglobin
376365|NCT01977482|recombinant human erythropoietin|recombinant human erythropoietin
376366|NCT01977482|Chronic kidney disease|chronic kidney disease
376367|NCT01977482|hemodialysis|hemodialysis
376368|NCT01977482|pharmacokinetics|pharmacokinetics
376369|NCT01977482|erythropoiesis stimulating agents|erythropoiesis stimulating agents
376370|NCT01977482|Anemia|anemia
376371|NCT01977482|GSK1278863|gsk1278863
376372|NCT01977469|Chronic Obstructive Pulmonary Disease|chronic obstructive pulmonary disease
376373|NCT01977469|Activities of Daily Living|activities of daily living
376374|NCT01977469|Mortality|mortality
376375|NCT01977469|Strength Training|strength training
376376|NCT01977456|acute ischemic stroke|acute ischemic stroke
376377|NCT01977456|stroke|stroke
376378|NCT01977456|rt-PA, thrombolytic|rt-pa, thrombolytic
376379|NCT01977456|t-PA|t-pa
376380|NCT01977456|recombinant tissue plasminogen activator|recombinant tissue plasminogen activator
376381|NCT01977456|Activase|activase
376382|NCT01977456|eptifibatide|eptifibatide
376383|NCT01977456|Integrilin|integrilin
376384|NCT01977456|fibrinolytic agents|fibrinolytic agents
376385|NCT01977456|clot dissolving|clot dissolving
376386|NCT01977456|blood clot|blood clot
376387|NCT01977430|Residual renal function|residual renal function
376388|NCT01977430|Combined thiazide-furosemide therapy|combined thiazide-furosemide therapy
376389|NCT01977430|Haemodialysis|haemodialysis
376390|NCT01977417|Endothelial Function|endothelial function
376391|NCT01977417|Arterial Stiffness|arterial stiffness
376392|NCT01977417|Inflammation|inflammation
376393|NCT01977417|Muscle Sympathetic Nervous System|muscle sympathetic nervous system
376394|NCT01977417|Prediabetes|prediabetes
376395|NCT01977417|Autonomic function|autonomic function
376396|NCT01977404|Congestive heart failure|congestive heart failure
376397|NCT01977404|Energy expenditure|energy expenditure
376398|NCT01977404|Body composition|body composition
376399|NCT01977404|Caloric intake|caloric intake
376400|NCT01977365|Cluster Randomized Trial,|cluster randomized trial,
376401|NCT01977365|Nutrition counseling,|nutrition counseling,
376402|NCT01977365|Caretaker's knowledge|caretaker's knowledge
376403|NCT01977365|Child growth,|child growth,
376404|NCT01977365|Prevention,|prevention,
376405|NCT01977365|Acute malnutrition|acute malnutrition
376406|NCT01977352|Exparel|exparel
376407|NCT01977352|Liposomal Bupivacaine|liposomal bupivacaine
376408|NCT01977352|Arthroscopic Shoulder Surgery|arthroscopic shoulder surgery
376409|NCT01977339|Femoral Nerve Block|femoral nerve block
376410|NCT01977339|Liposomal Bupivacaine|liposomal bupivacaine
376411|NCT01977326|task sharing|task sharing
376412|NCT01977326|task shifting|task shifting
376413|NCT01977326|prenatal depression|prenatal depression
376414|NCT01977326|counselling|counselling
376415|NCT01977326|lay health workers|lay health workers
376416|NCT01977287|Multiple Sclerosis|multiple sclerosis
376417|NCT01977287|Functional Electrical Stimulation|functional electrical stimulation
376418|NCT01977287|Ankle Foot Orthosis|ankle foot orthosis
376419|NCT01977287|Walking performance|walking performance
376420|NCT01977287|gait analysis|gait analysis
376421|NCT01977287|fatigue|fatigue
376422|NCT01977287|activity monitoring|activity monitoring
376423|NCT01977274|ovarian, endometrium, cervix cancer|ovarian, endometrium, cervix cancer
376424|NCT01977235|Irinotecan; Cisplatin; Small-cell lung cancer; UGT1A1|irinotecan; cisplatin; small-cell lung cancer; ugt1a1
376425|NCT01977209|NSCLC; Gossypol; APE1; Chemotherapy|nsclc; gossypol; ape1; chemotherapy
376426|NCT01977196|DTB/HB/Hib vaccine|dtb/hb/hib vaccine
376427|NCT01977196|Infants|infants
376428|NCT01977196|Phase I|phase i
376429|NCT01977183|gastrointestinal|gastrointestinal
376430|NCT01977183|microbiome|microbiome
376431|NCT01977183|prebiotic|prebiotic
376432|NCT01977183|starch|starch
376433|NCT01977170|Adults|adults
376434|NCT01977170|Hib vaccines|hib vaccines
376435|NCT01977170|Immunogenicity|immunogenicity
376436|NCT01977170|Safety|safety
376437|NCT01977157|Impedance cardiography|impedance cardiography
376438|NCT01977157|bioimpedance|bioimpedance
376439|NCT01977157|spectroscopy|spectroscopy
376440|NCT01977157|extracellular resistance|extracellular resistance
376441|NCT01977157|body composition|body composition
376442|NCT01977157|hemodynamics|hemodynamics
376443|NCT01977157|alcohol|alcohol
376444|NCT01977144|Single Embryo Transfer|single embryo transfer
481313|NCT01507883|embryos|embryos
376445|NCT01977144|Double Embryo Transfer|double embryo transfer
376446|NCT01977144|CCS (Comprehensive Chromosome Screening)|ccs (comprehensive chromosome screening)
376447|NCT01977144|Aneuploidy|aneuploidy
376448|NCT01977144|Low Responders|low responders
376449|NCT01977118|Streptokinase|streptokinase
376450|NCT01977118|Percutaneous catheter drainage|percutaneous catheter drainage
376451|NCT01977118|Pancreatic necrosis|pancreatic necrosis
376452|NCT01977118|peripancreatic necrosis|peripancreatic necrosis
376453|NCT01977105|Infants|infants
376454|NCT01977105|Mothers|mothers
376455|NCT01977105|Social media|social media
376456|NCT01977105|Obesity prevention|obesity prevention
376457|NCT01977092|sober living houses|sober living houses
376458|NCT01977092|HIV|hiv
376459|NCT01977092|alcohol and drugs|alcohol and drugs
376460|NCT01977079|pregnancy|pregnancy
376461|NCT01977079|premature birth|premature birth
376462|NCT01977079|procalcitonin|procalcitonin
376463|NCT01977066|pancreatic cancer|pancreatic cancer
376464|NCT01977066|exercise training|exercise training
376465|NCT01977066|quality of life|quality of life
376466|NCT01977066|physical functioning|physical functioning
376467|NCT01977053|breast cancer|breast cancer
376468|NCT01977053|colon cancer|colon cancer
376469|NCT01977053|rectal cancer|rectal cancer
376470|NCT01977053|adjuvant chemotherapy|adjuvant chemotherapy
376471|NCT01977053|phone calls|phone calls
376472|NCT01977053|emotional states|emotional states
376473|NCT01977053|quality of life|quality of life
376474|NCT01977040|Vasa Previa|vasa previa
376475|NCT01977027|Rehabilitation|rehabilitation
376476|NCT01977027|Fingers|fingers
376477|NCT01977027|Grasp|grasp
376478|NCT01977027|Strength|strength
376479|NCT01977027|Hand Function|hand function
376480|NCT01977027|Motor Function|motor function
376481|NCT01977027|Post Stroke|post stroke
376482|NCT01977027|Brain Infraction|brain infraction
376483|NCT01977027|Biomechanis|biomechanis
376484|NCT01977027|Neuronal Plasticity|neuronal plasticity
376485|NCT01977027|Weight-Bearing|weight-bearing
376486|NCT01977001|Primary headache|primary headache
376487|NCT01977001|Headache|headache
376488|NCT01977001|MigraineBox|migrainebox
376489|NCT01976975|Depression|depression
376490|NCT01976975|Major Depressive Disorder|major depressive disorder
376491|NCT01976975|Bipolar Disorder|bipolar disorder
376492|NCT01976975|Mania|mania
376493|NCT01976975|Hypomania|hypomania
376494|NCT01976975|EEG|eeg
376495|NCT01976975|MRI|mri
376496|NCT01976975|Reward|reward
376497|NCT01976962|Prostatic neoplasms|prostatic neoplasms
376498|NCT01976962|Radiotherapy|radiotherapy
376499|NCT01976962|Dose fractionation|dose fractionation
376500|NCT01976962|Magnetic resonance imaging|magnetic resonance imaging
376501|NCT01976949|Cancer, social-networking intervention, cancer-related distress, internet health services, intervention delivery|cancer, social-networking intervention, cancer-related distress, internet health services, intervention delivery
376502|NCT01976936|Stroke|stroke
376503|NCT01976936|Rhabdomyolysis|rhabdomyolysis
376504|NCT01976936|Jaundice|jaundice
376505|NCT01976923|Intravitreal Bevacizumab|intravitreal bevacizumab
376506|NCT01976923|Tractional Retinal Detachment|tractional retinal detachment
376507|NCT01976923|Proliferative Diabetic Retinopathy|proliferative diabetic retinopathy
376508|NCT01976923|Small gauge pars plana vitrectomy|small gauge pars plana vitrectomy
376509|NCT01976923|Intraoperative bleeding|intraoperative bleeding
376510|NCT01976923|Post-operative vitreous hemorrhage|post-operative vitreous hemorrhage
376511|NCT01976923|Visual acuity|visual acuity
376512|NCT01976910|Glioblastoma multiforme|glioblastoma multiforme
376513|NCT01976910|Advanced cancers|advanced cancers
376514|NCT01976910|Brain Neoplasms, Malignant, Primary|brain neoplasms, malignant, primary
376515|NCT01976910|Brain Tumor, Recurrent|brain tumor, recurrent
376516|NCT01976910|Advanced cancer|advanced cancer
376517|NCT01976897|heel - mattress pressure interface|heel - mattress pressure interface
376518|NCT01976897|flexion|flexion
376519|NCT01976897|knee angular position|knee angular position
376520|NCT01976884|sepsis|sepsis
376521|NCT01976884|immunosuppression|immunosuppression
376522|NCT01976884|PD-L1|pd-l1
376523|NCT01976871|Restless Legs Syndrome|restless legs syndrome
376524|NCT01976871|Ekbom Syndrome|ekbom syndrome
376525|NCT01976871|Willis-Ekbom Disease|willis-ekbom disease
376526|NCT01976871|Rotigotine|rotigotine
376527|NCT01976871|Neupro|neupro
376528|NCT01976871|Dopamine Agonist|dopamine agonist
376529|NCT01976858|PEX168, diabetes, phase I|pex168, diabetes, phase i
376530|NCT01976845|propofol|propofol
376531|NCT01976845|midazolam|midazolam
376532|NCT01976845|sedative|sedative
376533|NCT01976845|anxiolytic|anxiolytic
376534|NCT01976845|amnesic|amnesic
376535|NCT01976845|recall|recall
376536|NCT01976845|Memory|memory
376537|NCT01976845|Perioperative outcomes|perioperative outcomes
376538|NCT01976819|Tracheotomy|tracheotomy
376539|NCT01976819|Tracheostomy|tracheostomy
376540|NCT01976819|Speaking valve|speaking valve
376541|NCT01976819|HME|hme
376542|NCT01976819|patients|patients
376543|NCT01976806|Docosahexaenoic acid|docosahexaenoic acid
376544|NCT01976806|DHA|dha
376545|NCT01976806|Periodontitis|periodontitis
376546|NCT01976806|Gingivitis|gingivitis
376547|NCT01976806|Omega-3 fatty acid|omega-3 fatty acid
376548|NCT01976806|Fish oil|fish oil
376549|NCT01976793|Recurrent depressive disorder|recurrent depressive disorder
376550|NCT01976793|Depression|depression
376551|NCT01976793|Depressive episode|depressive episode
376552|NCT01976793|Atypical antipsychotics|atypical antipsychotics
376553|NCT01976780|Malaria|malaria
376554|NCT01976780|P. falciparum mono infection|p. falciparum mono infection
376555|NCT01976780|Early Treatment Failure|early treatment failure
376556|NCT01976780|Late Treatment Failure|late treatment failure
376557|NCT01976767|Sputum|sputum
376558|NCT01976767|Clinical cohorts|clinical cohorts
376559|NCT01976767|Smokers|smokers
376560|NCT01976767|Asthma|asthma
376561|NCT01976767|Biopsies|biopsies
376562|NCT01976767|Severe asthma|severe asthma
376563|NCT01976767|Collaborative research|collaborative research
376564|NCT01976767|Phenotyping|phenotyping
376565|NCT01976767|Lipidomics|lipidomics
376566|NCT01976767|Transcriptomics|transcriptomics
376567|NCT01976767|Proteomics|proteomics
376568|NCT01976767|Paediatric cohort|paediatric cohort
376569|NCT01976767|Systems Biology|systems biology
376570|NCT01976741|Phase I|phase i
376571|NCT01976741|Dose escalation|dose escalation
376572|NCT01976741|refractory, locally advanced or metastatic solid tumor|refractory, locally advanced or metastatic solid tumor
376573|NCT01976741|Bladder cancer|bladder cancer
376574|NCT01976741|squamous non-small cell lung cancer|squamous non-small cell lung cancer
376575|NCT01976741|pan-FGFR inhibitor|pan-fgfr inhibitor
376576|NCT01976741|lung adenocarcinoma|lung adenocarcinoma
376577|NCT01976741|head and neck cancer|head and neck cancer
376578|NCT01976715|HIV|hiv
376579|NCT01976715|Treatment Failure|treatment failure
376580|NCT01976715|Drug Resistance|drug resistance
376581|NCT01976702|HIV risk behaviors|hiv risk behaviors
376582|NCT01976702|Pregnant drug abusers|pregnant drug abusers
376583|NCT01976689|Glucose Regulation|glucose regulation
376584|NCT01976689|Left Ventricular Hypertrophy|left ventricular hypertrophy
376585|NCT01976689|New-onset Diabetes|new-onset diabetes
376586|NCT01976689|Renal Transplantation|renal transplantation
376587|NCT01976598|chronic|chronic
376588|NCT01976598|back|back
376589|NCT01976598|leg|leg
376590|NCT01976598|pain|pain
376591|NCT01976598|sub-sensory|sub-sensory
376592|NCT01976598|stimulation|stimulation
376593|NCT01976598|Neuromodulation|neuromodulation
376594|NCT01976598|Yearwood|yearwood
376595|NCT01976585|Intratumoral injections|intratumoral injections
376596|NCT01976585|rhuFlt3L|rhuflt3l
376597|NCT01976585|Flt3L|flt3l
376598|NCT01976585|CDX-301|cdx-301
376599|NCT01976585|Vaccine|vaccine
376600|NCT01976585|Poly-ICLC|poly-iclc
376601|NCT01976585|iNHL|inhl
376602|NCT01976585|TLR3|tlr3
376603|NCT01976585|Low-Grade B-cell Lymphoma|low-grade b-cell lymphoma
376604|NCT01976585|Follicular|follicular
376605|NCT01976585|Marginal Zone|marginal zone
376606|NCT01976585|SLL|sll
376607|NCT01976585|Small lymphocytic|small lymphocytic
376608|NCT01976572|CKD Stage V|ckd stage v
376609|NCT01976572|dialysis|dialysis
376610|NCT01976559|ICP|icp
376611|NCT01976559|Intracranial pressure|intracranial pressure
376612|NCT01976559|Hydrocephalus|hydrocephalus
376613|NCT01976559|Idiopathic normal pressure hydrocephalus|idiopathic normal pressure hydrocephalus
376614|NCT01976559|CSF|csf
376615|NCT01976559|Cerebrospinal fluid|cerebrospinal fluid
376616|NCT01976559|Noninvasive ICP|noninvasive icp
376617|NCT01976520|Cancer vaccine|cancer vaccine
376618|NCT01976520|Chronic lymphocytic leukemia|chronic lymphocytic leukemia
376619|NCT01976520|CLL|cll
376620|NCT01976520|Autologous vaccine|autologous vaccine
376621|NCT01976520|B cell leukemia|b cell leukemia
376622|NCT01976494|Patient controlled analgesia equipment|patient controlled analgesia equipment
376623|NCT01976494|efficacy|efficacy
376624|NCT01976494|safety|safety
376625|NCT01976494|Accufuser Omnibus®|accufuser omnibus®
376626|NCT01976494|Upper abdominal surgery|upper abdominal surgery
376627|NCT01976494|laparotomy|laparotomy
376628|NCT01976455|obesity|obesity
376629|NCT01976455|carbon13|carbon13
376630|NCT01976455|over-eating|over-eating
376631|NCT01976455|metabolic chamber|metabolic chamber
376632|NCT01976455|room calorimeter|room calorimeter
376633|NCT01976442|Leukemia|leukemia
376634|NCT01976442|Transfusion|transfusion
376635|NCT01976429|barotrauma|barotrauma
376636|NCT01976429|barotitis|barotitis
376637|NCT01976429|middle ear|middle ear
376638|NCT01976429|flying|flying
376639|NCT01976429|diving|diving
376640|NCT01976429|Eustachian tube|eustachian tube
376641|NCT01976416|Hydroxyurea|hydroxyurea
376642|NCT01976390|Kidney|kidney
376643|NCT01976390|Kidney transplant|kidney transplant
376644|NCT01976390|Renal failure|renal failure
376645|NCT01976390|End Stage Renal Disease|end stage renal disease
376646|NCT01976390|kidney transplant recipient|kidney transplant recipient
376647|NCT01976364|Tofacitinib|tofacitinib
376648|NCT01976364|Psoriatic Arthritis|psoriatic arthritis
376649|NCT01976364|Xeljanz|xeljanz
376650|NCT01976364|CP-690550|cp-690550
376651|NCT01976364|Jak-inhibitor|jak-inhibitor
376652|NCT01976364|oral treatment|oral treatment
376653|NCT01976364|psoriasis|psoriasis
376654|NCT01976364|OPAL BALANCE|opal balance
376655|NCT01976364|methotrexate|methotrexate
376656|NCT01976364|pruritus|pruritus
376657|NCT01976364|itch|itch
376658|NCT01976364|DLQI|dlqi
376659|NCT01976351|Barrett's esophagus|barrett's esophagus
376660|NCT01976351|image-enhanced endoscopy|image-enhanced endoscopy
376661|NCT01976338|BRVO|brvo
376662|NCT01976338|macular edema|macular edema
376663|NCT01976338|vision impairment|vision impairment
376664|NCT01976338|retinal vein occlusion|retinal vein occlusion
376665|NCT01976338|ranibizumab|ranibizumab
376666|NCT01976338|branch retinal vein occlusion|branch retinal vein occlusion
376667|NCT01976338|anti-VEGF therapy|anti-vegf therapy
376668|NCT01976338|RFB002|rfb002
376669|NCT01976325|decision aid|decision aid
376670|NCT01976325|imported malaria|imported malaria
376671|NCT01976325|malaria prevention and control|malaria prevention and control
376672|NCT01976325|malaria chemoprophylaxis|malaria chemoprophylaxis
376673|NCT01976325|mefloquine|mefloquine
376674|NCT01976325|lariam|lariam
376675|NCT01976325|atovaquone-proguanil|atovaquone-proguanil
376676|NCT01976325|malarone|malarone
376677|NCT01976325|doxycycline|doxycycline
376678|NCT01976325|vibramycin|vibramycin
376679|NCT01976312|CRVO, macular edema, vision impairment, retinal vein occlusion, ranibizumab|crvo, macular edema, vision impairment, retinal vein occlusion, ranibizumab
376680|NCT01976221|Comprehensive referrals|comprehensive referrals
376681|NCT01976221|Appropriate referring|appropriate referring
376682|NCT01976221|Priority setting|priority setting
376683|NCT01976221|Waiting time in hospital|waiting time in hospital
376684|NCT01976208|Omalizumab|omalizumab
376685|NCT01976208|IgE|ige
376686|NCT01976208|Asthma|asthma
376687|NCT01976195|Thalidomide|thalidomide
376688|NCT01976195|Dexamethasone|dexamethasone
376689|NCT01976195|ITP|itp
376790|NCT01975701|BGJ398,|bgj398,
376690|NCT01976182|large granular lymphocytes leukemia|large granular lymphocytes leukemia
376691|NCT01976182|immunosuppressive drugs|immunosuppressive drugs
376692|NCT01976182|methotrexate|methotrexate
376693|NCT01976182|cyclophosphamide|cyclophosphamide
376694|NCT01976182|efficiency|efficiency
376695|NCT01976182|phase II randomized controlled trial|phase ii randomized controlled trial
376696|NCT01976169|Breast Cancer|breast cancer
376697|NCT01976169|Advanced Breast Cancer|advanced breast cancer
376698|NCT01976104|Thrombocytopenia|thrombocytopenia
376699|NCT01976104|Chronic Liver Disease|chronic liver disease
376700|NCT01976091|limb girdle muscular dystrophy|limb girdle muscular dystrophy
376701|NCT01976091|LGMD2D|lgmd2d
376702|NCT01976091|alpha-sarcoglycan|alpha-sarcoglycan
376703|NCT01976091|gene transfer|gene transfer
376704|NCT01976091|adeno-associated virus|adeno-associated virus
376705|NCT01976078|Voriconazole|voriconazole
376706|NCT01976078|Pharmacokinetics|pharmacokinetics
376707|NCT01976078|Ontogeny|ontogeny
376708|NCT01976078|Modeling|modeling
376709|NCT01976078|Bayesian|bayesian
376710|NCT01976065|Necrotic tooth pulp|necrotic tooth pulp
376711|NCT01976065|Immature permanent teeth|immature permanent teeth
376712|NCT01976065|Regeneration|regeneration
376713|NCT01976052|Biomarkers|biomarkers
376714|NCT01976052|Genomics|genomics
376715|NCT01976039|motorcyclist|motorcyclist
376716|NCT01976039|nasal mucociliary clearance|nasal mucociliary clearance
376717|NCT01976039|physical therapy|physical therapy
376718|NCT01976026|Flow Diversion|flow diversion
376719|NCT01976026|Aneurysm|aneurysm
376720|NCT01976026|Intracranial|intracranial
376721|NCT01976026|Cerebral|cerebral
376722|NCT01976026|Vertebral|vertebral
376723|NCT01976026|blood blister-like|blood blister-like
376724|NCT01976026|ruptured aneurysm|ruptured aneurysm
376725|NCT01976026|Pipeline Flow Diversion|pipeline flow diversion
376726|NCT01976026|Pipeline Flow Diverter|pipeline flow diverter
376727|NCT01976026|Best-Standard Treatment|best-standard treatment
376728|NCT01976013|PT|pt
376729|NCT01976013|INR|inr
376730|NCT01976013|intraventricular haemorrhage|intraventricular haemorrhage
376731|NCT01976013|pulmonary haemorrhage|pulmonary haemorrhage
376732|NCT01976013|ELBW infants|elbw infants
376733|NCT01975987|Intubation|intubation
376734|NCT01975987|Bonfils fiberscope|bonfils fiberscope
376735|NCT01975974|vascular|vascular
376736|NCT01975974|access|access
376737|NCT01975974|ultrasound|ultrasound
376738|NCT01975948|Mental Health|mental health
376739|NCT01975948|Education and Practice Support Program|education and practice support program
376740|NCT01975948|Depression|depression
376741|NCT01975948|Primary Care|primary care
376742|NCT01975948|Skill-based training|skill-based training
376743|NCT01975948|Patient centered outcomes|patient centered outcomes
376744|NCT01975935|diabetes mellitus type 2|diabetes mellitus type 2
376745|NCT01975935|non-alcoholic fatt liver disease|non-alcoholic fatt liver disease
376746|NCT01975935|obesity|obesity
376747|NCT01975922|language impairment|language impairment
376748|NCT01975922|language disorder|language disorder
376749|NCT01975922|language delay|language delay
376750|NCT01975922|late talkers|late talkers
376751|NCT01975922|late talking|late talking
376752|NCT01975909|Spinocerebellar Ataxia|spinocerebellar ataxia
376753|NCT01975909|SCA|sca
376754|NCT01975909|Ataxia|ataxia
376755|NCT01975909|Transcranial Magnetic Stimulation|transcranial magnetic stimulation
376756|NCT01975909|TMS|tms
376757|NCT01975883|Blood Glucose|blood glucose
376758|NCT01975883|Postoperative Complications|postoperative complications
376759|NCT01975883|Spine|spine
376760|NCT01975883|Orthopedic surgery|orthopedic surgery
376761|NCT01975870|Sedentary behavior, smartphone, application|sedentary behavior, smartphone, application
376762|NCT01975857|mild traumatic brain injury|mild traumatic brain injury
376763|NCT01975857|sleep|sleep
376764|NCT01975857|mind body intervention|mind body intervention
376765|NCT01975857|mind body bridging|mind body bridging
376766|NCT01975844|Anemia|anemia
376767|NCT01975844|End Stage Renal Disease|end stage renal disease
376768|NCT01975831|Non Triple Negative Breast Cancer|non triple negative breast cancer
376769|NCT01975818|Anemia of CKD on dialysis|anemia of ckd on dialysis
376770|NCT01975805|cesarean delivery|cesarean delivery
376771|NCT01975805|chlorhexidine|chlorhexidine
376772|NCT01975805|iodine|iodine
376773|NCT01975805|skin disinfectant|skin disinfectant
376774|NCT01975792|PPROM|pprom
376775|NCT01975792|Pregnant|pregnant
376776|NCT01975792|Preterm|preterm
376777|NCT01975792|Premature, labor|premature, labor
376778|NCT01975766|Carcinoma, squamous cell of head and neck|carcinoma, squamous cell of head and neck
376779|NCT01975766|Head and neck cancer|head and neck cancer
376780|NCT01975766|ketogenic diet|ketogenic diet
376781|NCT01975766|radiotherapy|radiotherapy
376782|NCT01975766|cisplatin|cisplatin
376783|NCT01975753|pain|pain
376784|NCT01975727|PONV|ponv
376785|NCT01975727|Dexamethasone|dexamethasone
376786|NCT01975727|Treatment|treatment
376787|NCT01975714|Glaucoma|glaucoma
376788|NCT01975714|Ocular hypertension|ocular hypertension
376789|NCT01975714|Preservative-free prostaglandins|preservative-free prostaglandins
376791|NCT01975701|recurrent glioblastoma'|recurrent glioblastoma'
376792|NCT01975701|recurrent GBM,|recurrent gbm,
376793|NCT01975701|FGFR,|fgfr,
376794|NCT01975662|MRSA|mrsa
376795|NCT01975662|bacteremia|bacteremia
376796|NCT01975662|vancomycin|vancomycin
376797|NCT01975662|daptomycin|daptomycin
376798|NCT01975649|postmenopausal|postmenopausal
376799|NCT01975649|hypoactive|hypoactive
376800|NCT01975649|sexual disorder|sexual disorder
376801|NCT01975649|androgen|androgen
376802|NCT01975636|Metabolism and Elimination|metabolism and elimination
376803|NCT01975623|Video assisted thoracoscopic surgery (VATS)|video assisted thoracoscopic surgery (vats)
376804|NCT01975610|Arthritis, Rheumatoid, Autoimmune, Inflammatory, Synovial, Bruton's tyrosine kinase (Btk), CC-292, Joint Disease|arthritis, rheumatoid, autoimmune, inflammatory, synovial, bruton's tyrosine kinase (btk), cc-292, joint disease
376805|NCT01975571|residual hearing|residual hearing
376806|NCT01975571|hybrid|hybrid
376807|NCT01975571|hearing preservation|hearing preservation
376808|NCT01975545|Down syndrome|down syndrome
376809|NCT01975545|Caries|caries
376810|NCT01975545|Dental varnish|dental varnish
376811|NCT01975519|TRC105|trc105
376812|NCT01975519|CD105|cd105
376813|NCT01975519|Endoglin|endoglin
376814|NCT01975519|Angiogenesis Inhibitor|angiogenesis inhibitor
376815|NCT01975519|STS|sts
376816|NCT01975519|Soft Tissue Sarcoma|soft tissue sarcoma
376817|NCT01975519|TKI|tki
376818|NCT01975519|Tyrosine Kinase Inhibitor|tyrosine kinase inhibitor
376819|NCT01975519|Pazopanib|pazopanib
376820|NCT01975519|Votrient|votrient
376821|NCT01975519|Advanced Soft Tissue Sarcoma|advanced soft tissue sarcoma
376822|NCT01975519|Angiosarcoma|angiosarcoma
376823|NCT01975506|Head Start|head start
376824|NCT01975506|Occupational Therapy|occupational therapy
376825|NCT01975493|Infectious Diseases|infectious diseases
376826|NCT01975493|Paediatrics|paediatrics
376827|NCT01975493|Neonatology|neonatology
376828|NCT01975493|Pharmacokinetics|pharmacokinetics
376829|NCT01975493|Antimicrobials|antimicrobials
376830|NCT01975467|midshaft clavicle fracture|midshaft clavicle fracture
376831|NCT01975467|intramedullary nail|intramedullary nail
376832|NCT01975467|sling|sling
376833|NCT01975454|Metastatic colorectal cancer|metastatic colorectal cancer
376834|NCT01975454|Chemotherapy|chemotherapy
376835|NCT01975454|Traditional Chinese Medicine (TCM)|traditional chinese medicine (tcm)
376836|NCT01975454|Teng-Long-Bu-Zhong-Tang|teng-long-bu-zhong-tang
376837|NCT01975441|Diethycarbamazine|diethycarbamazine
376838|NCT01975441|Albendazole|albendazole
376839|NCT01975441|Ivermectin|ivermectin
376840|NCT01975441|Lymphatic filariasis|lymphatic filariasis
376841|NCT01975415|Meditation|meditation
376842|NCT01975415|Sensors|sensors
376843|NCT01975415|Digital medicine|digital medicine
376844|NCT01975402|Congestive Heart Failure|congestive heart failure
376845|NCT01975389|myocardial infarction|myocardial infarction
376846|NCT01975389|stroke|stroke
376847|NCT01975389|hyperlipidemia|hyperlipidemia
376848|NCT01975376|myocardial infarction|myocardial infarction
376849|NCT01975376|stroke|stroke
376850|NCT01975376|hyperlipidemia|hyperlipidemia
376851|NCT01975363|Breast Cancer|breast cancer
376852|NCT01975350|Colistimethate sodium inhalation|colistimethate sodium inhalation
376853|NCT01975324|Ampyra|ampyra
376854|NCT01975324|NAION|naion
376855|NCT01975324|Dalfampridine|dalfampridine
376856|NCT01975298|RRMS|rrms
376857|NCT01975285|Pain management|pain management
376858|NCT01975285|Postoperative opioid requirements|postoperative opioid requirements
376859|NCT01975285|Perioperative outcomes|perioperative outcomes
376860|NCT01975285|Dexamethasone|dexamethasone
376861|NCT01975285|Anesthetic adjuvant|anesthetic adjuvant
376862|NCT01975285|Analgesic adjuvant|analgesic adjuvant
376863|NCT01975272|postoperative|postoperative
376864|NCT01975272|anemia|anemia
376865|NCT01975272|gynaecologic|gynaecologic
376866|NCT01975272|surgery|surgery
376867|NCT01975233|Endovascular|endovascular
376868|NCT01975233|Brain Aneurysm|brain aneurysm
376869|NCT01975181|cardiovascular health|cardiovascular health
376870|NCT01975181|lifestyle modification|lifestyle modification
376871|NCT01975181|patient reported outcomes|patient reported outcomes
376872|NCT01975181|risk assessment|risk assessment
376873|NCT01975168|laser acupuncture|laser acupuncture
376874|NCT01975168|obesity|obesity
376875|NCT01975155|Celiac disease|celiac disease
376876|NCT01975155|Gluten free diet nutrient content|gluten free diet nutrient content
376877|NCT01975155|mycotoxins|mycotoxins
376878|NCT01975155|Gluten free diet|gluten free diet
376879|NCT01975142|Metastatic breast cancer|metastatic breast cancer
376880|NCT01975142|HER2 negative primary tumor|her2 negative primary tumor
376881|NCT01975142|CTC HER2 positive|ctc her2 positive
376882|NCT01975077|patients with mCRC who failed 2nd therapy or more|patients with mcrc who failed 2nd therapy or more
376883|NCT01975064|Breast neoplasms|breast neoplasms
376884|NCT01975064|Colonic neoplasms|colonic neoplasms
376885|NCT01975064|Rectal neoplasms|rectal neoplasms
376886|NCT01975051|Kala- azar|kala- azar
376887|NCT01975051|PKDL|pkdl
376888|NCT01975051|Treatment|treatment
376889|NCT01975051|Pathogenesis|pathogenesis
376890|NCT01975051|Bangladesh|bangladesh
376891|NCT01975038|Melanin Index|melanin index
376892|NCT01975038|Fitzpatrick Skin Phototype|fitzpatrick skin phototype
376893|NCT01975038|Spectrophotometry|spectrophotometry
376894|NCT01975038|Skin Diseases|skin diseases
376895|NCT01975025|Renal Dialysis|renal dialysis
376896|NCT01974999|Kidney|kidney
376897|NCT01974999|Transplant|transplant
376898|NCT01974999|Rejection|rejection
376899|NCT01974986|dehydration|dehydration
376900|NCT01974986|exercise|exercise
376901|NCT01974986|rehydration|rehydration
376902|NCT01974986|sodium|sodium
376903|NCT01974986|water|water
376904|NCT01974986|carbohydrate|carbohydrate
376905|NCT01974973|autism spectrum disorders|autism spectrum disorders
376906|NCT01974973|stem cells|stem cells
376907|NCT01974947|Metabolic syndrome|metabolic syndrome
376908|NCT01974947|Epigenetic|epigenetic
376909|NCT01974947|Male infertility|male infertility
376910|NCT01974947|Sperm parameters|sperm parameters
376911|NCT01974947|Biomarkers|biomarkers
376912|NCT01974921|Asthma|asthma
376913|NCT01974921|Bronchial Thermoplasty|bronchial thermoplasty
376914|NCT01974921|Bronchial smooth muscle|bronchial smooth muscle
376915|NCT01974908|Ventricular Tachycardia|ventricular tachycardia
376916|NCT01974895|Children|children
376917|NCT01974895|Immunogenicity|immunogenicity
376918|NCT01974895|Fluzone®|fluzone®
376919|NCT01974895|6 to 35 months of age|6 to 35 months of age
376920|NCT01974895|Seasonal influenza|seasonal influenza
376921|NCT01974895|Safety|safety
376922|NCT01974882|abdominal surgery|abdominal surgery
376923|NCT01974882|cryotherapy|cryotherapy
376924|NCT01974882|pain score|pain score
376925|NCT01974882|narcotic utilization|narcotic utilization
376926|NCT01974869|Surgery,Crohn's disease,Ulcerative colitis|surgery,crohn's disease,ulcerative colitis
376927|NCT01974830|alpha-1|alpha-1
376928|NCT01974830|anti-trypsin|anti-trypsin
376929|NCT01974830|pulmonary function|pulmonary function
376930|NCT01974830|augmentation therayp|augmentation therayp
376931|NCT01974830|home care|home care
376932|NCT01974817|pneumococcal vaccine|pneumococcal vaccine
376933|NCT01974817|end stage renal disease|end stage renal disease
376934|NCT01974817|dialysis|dialysis
376935|NCT01974804|MRI|mri
376936|NCT01974804|Brain metastases|brain metastases
376937|NCT01974804|13-094|13-094
376938|NCT01974765|Enzalutamide|enzalutamide
376939|NCT01974765|Androgen Receptor Positive (AR+)|androgen receptor positive (ar+)
376940|NCT01974765|13-119|13-119
376941|NCT01974752|uveal melanoma|uveal melanoma
376942|NCT01974739|intensive care|intensive care
376943|NCT01974739|diuretics|diuretics
376944|NCT01974726|ear|ear
376945|NCT01974726|middle ear|middle ear
376946|NCT01974726|Eustachian tube|eustachian tube
376947|NCT01974726|Eustachian tube dysfunction|eustachian tube dysfunction
783885|NCT00315042|penicillin|penicillin
481962|NCT01505231|Shock|shock
377197|NCT01973569|joint damage|joint damage
376948|NCT01974726|Eustachian tube function|eustachian tube function
376949|NCT01974713|CKD progression|ckd progression
376950|NCT01974713|Inflammation|inflammation
376951|NCT01974713|FGF23|fgf23
376952|NCT01974713|Genetic biomarkers|genetic biomarkers
376953|NCT01974687|Hepatitis C virus|hepatitis c virus
376954|NCT01974687|HCV|hcv
376955|NCT01974674|diabetes|diabetes
376956|NCT01974674|transplantation|transplantation
376957|NCT01974648|Laryngeal Mask Airway Supreme|laryngeal mask airway supreme
376958|NCT01974648|propofol|propofol
376959|NCT01974648|remifentanil|remifentanil
376960|NCT01974648|effective dose of intravenous propofol|effective dose of intravenous propofol
376961|NCT01974648|ED50|ed50
376962|NCT01974635|Spinal Cord Injury|spinal cord injury
376963|NCT01974635|Robotic therapy|robotic therapy
376964|NCT01974635|Rehabilitation|rehabilitation
376965|NCT01974635|Sensation|sensation
376966|NCT01974635|Movement|movement
376967|NCT01974635|Proprioception|proprioception
376968|NCT01974635|Stroke|stroke
376969|NCT01974635|Acquired Brain Injury|acquired brain injury
376970|NCT01974609|pain relief|pain relief
376971|NCT01974609|narcotic pain relief|narcotic pain relief
376972|NCT01974609|non-narcotic pain relief|non-narcotic pain relief
376973|NCT01974609|post-operative pain relief|post-operative pain relief
376974|NCT01974609|carpal tunnel|carpal tunnel
376975|NCT01974596|Dental implants|dental implants
376976|NCT01974596|Probiotics|probiotics
376977|NCT01974596|Lactobacillus reuteri|lactobacillus reuteri
376978|NCT01974596|Periimplant mucositis|periimplant mucositis
376979|NCT01974596|Cytokines|cytokines
376980|NCT01974596|Bacterial load|bacterial load
376981|NCT01974583|the split-thickness skin graft （STSG） donor site|the split-thickness skin graft （stsg） donor site
376982|NCT01974583|regraft|regraft
376983|NCT01974583|wound healing|wound healing
376984|NCT01974570|Prehypertension|prehypertension
376985|NCT01974570|Hypertension|hypertension
376986|NCT01974570|Shrimp protein hydrolysate|shrimp protein hydrolysate
376987|NCT01974570|Marine protein hydrolysate|marine protein hydrolysate
376988|NCT01974570|Ambulatory blood pressure|ambulatory blood pressure
376989|NCT01974570|Blood pressure|blood pressure
376990|NCT01974557|Cardiac physiology|cardiac physiology
376991|NCT01974557|ageing|ageing
376992|NCT01974557|gender differences|gender differences
376993|NCT01974557|diastole|diastole
376994|NCT01974557|fluid challenge|fluid challenge
376995|NCT01974544|diabetes complications|diabetes complications
376996|NCT01974544|metabolic surgery|metabolic surgery
376997|NCT01974544|Intensive medicines|intensive medicines
376998|NCT01974518|Pemphigus|pemphigus
376999|NCT01974518|Rituximab|rituximab
377000|NCT01974518|Rituximab and IV cyclophosphamide combination|rituximab and iv cyclophosphamide combination
377001|NCT01974518|B cell re-population characteristics following Rituximab|b cell re-population characteristics following rituximab
377002|NCT01974492|saphenous vein graft|saphenous vein graft
377003|NCT01974492|composite graft|composite graft
377004|NCT01974492|coronary artery bypass grafting|coronary artery bypass grafting
377005|NCT01974492|graft remodeling|graft remodeling
377006|NCT01974479|Redirected Natural Killer Cells|redirected natural killer cells
377007|NCT01974479|Haploidentical Cell Therapy|haploidentical cell therapy
377008|NCT01974466|pancreatitis|pancreatitis
377009|NCT01974466|resuscitation goal|resuscitation goal
377010|NCT01974453|Radiation dose, transradial approach, percutaneous coronary interventions, coronary angiography|radiation dose, transradial approach, percutaneous coronary interventions, coronary angiography
377011|NCT01974440|Lymphoma|lymphoma
377012|NCT01974440|Follicular lymphoma|follicular lymphoma
377013|NCT01974440|Marginal zone lymphoma|marginal zone lymphoma
377014|NCT01974440|Indolent Non-Hodgkin lymphoma|indolent non-hodgkin lymphoma
377015|NCT01974440|PCI-32765|pci-32765
377016|NCT01974440|Ibrutinib|ibrutinib
377017|NCT01974440|Bendamustine|bendamustine
377018|NCT01974440|Rituximab|rituximab
377019|NCT01974440|Cyclophosphamide|cyclophosphamide
377020|NCT01974440|Doxorubicin|doxorubicin
377021|NCT01974440|Vincristine|vincristine
377022|NCT01974440|Prednisone|prednisone
377023|NCT01974440|R-CHOP|r-chop
377024|NCT01974427|Magnetic Resonance Imaging (MRI)|magnetic resonance imaging (mri)
377025|NCT01974427|Functional Imaging|functional imaging
377026|NCT01974427|BOLD Effect|bold effect
377027|NCT01974427|EEG|eeg
377028|NCT01974427|MEG|meg
377029|NCT01974414|oral lichen planus|oral lichen planus
377030|NCT01974414|cedar honey|cedar honey
377031|NCT01974414|atrophic|atrophic
377032|NCT01974414|erosive|erosive
377033|NCT01974414|pain|pain
377034|NCT01974414|treatment|treatment
377035|NCT01974414|clinical trial|clinical trial
377036|NCT01974401|oral irrigator|oral irrigator
377037|NCT01974401|leukemia|leukemia
377038|NCT01974401|blood dyscrasia|blood dyscrasia
377039|NCT01974401|Oral Health Index Simplified (OHI-S)|oral health index simplified (ohi-s)
377040|NCT01974401|supra gingival irrigator|supra gingival irrigator
400558|NCT01866280|Sleep duration|sleep duration
377041|NCT01974388|Bariatric surgery, sleeve gastrectomy, gastric leak|bariatric surgery, sleeve gastrectomy, gastric leak
377042|NCT01974375|Living donor|living donor
377043|NCT01974375|Liver transplant|liver transplant
377044|NCT01974375|antifungal prevention|antifungal prevention
377045|NCT01974362|Monolithic Zirconia|monolithic zirconia
377046|NCT01974362|Zirconia-Feldspathic zirconia|zirconia-feldspathic zirconia
377047|NCT01974362|Dental Implants|dental implants
377048|NCT01974362|Fracture|fracture
377049|NCT01974362|Chipping|chipping
377050|NCT01974349|Phase I, healthy, pharmacokinetics, food effect.|phase i, healthy, pharmacokinetics, food effect.
377051|NCT01974310|Macular Holes|macular holes
377052|NCT01974310|Non face down positioning|non face down positioning
377053|NCT01974310|Face down positioning|face down positioning
377054|NCT01974297|Hyperlipidemia|hyperlipidemia
377055|NCT01974297|Atorvastatin|atorvastatin
377056|NCT01974297|Fenofibric acid|fenofibric acid
377057|NCT01974297|combination|combination
377058|NCT01974297|monotherapy|monotherapy
377059|NCT01974245|Cholecalciferol|cholecalciferol
377060|NCT01974245|Kidney diseases|kidney diseases
377061|NCT01974232|Immune Thrombocytopenia (ITP), Thrombopoietin (TPO) agents, children, romiplostim and eltrombopag|immune thrombocytopenia (itp), thrombopoietin (tpo) agents, children, romiplostim and eltrombopag
377062|NCT01974219|HIV|hiv
377063|NCT01974219|COPD|copd
377064|NCT01974219|Chronic Obstructive Pulmonary Disease|chronic obstructive pulmonary disease
377065|NCT01974219|Smoking|smoking
377066|NCT01974206|ASP0113|asp0113
377067|NCT01974206|Cytomegalovirus (CMV)|cytomegalovirus (cmv)
377068|NCT01974206|Kidney Transplantation|kidney transplantation
377069|NCT01974180|Smoking|smoking
377070|NCT01974180|COPD|copd
377071|NCT01974180|Chronic Obstructive Pulmonary Disease|chronic obstructive pulmonary disease
377072|NCT01974180|Healthy Smoker|healthy smoker
377073|NCT01974180|Non-smoker|non-smoker
377074|NCT01974167|glucocorticoid-induced osteoporosis|glucocorticoid-induced osteoporosis
377075|NCT01974154|COPD|copd
377076|NCT01974154|Smoking|smoking
377077|NCT01974154|Non-smoker|non-smoker
377079|NCT01974115|Cellulite|cellulite
377080|NCT01974115|Extracorporeal shock wave therapy|extracorporeal shock wave therapy
377081|NCT01974115|ESWT|eswt
377082|NCT01974115|Radial shock wave therapy|radial shock wave therapy
377083|NCT01974115|RSWT|rswt
377084|NCT01974089|Dysphagia|dysphagia
377085|NCT01974089|Community acquired pneumonia|community acquired pneumonia
377086|NCT01974089|Mortality|mortality
377087|NCT01974089|Rehospitalization|rehospitalization
377088|NCT01974063|Smoking|smoking
377290|NCT01973335|natriuresis|natriuresis
377089|NCT01974063|Smoking Cessation|smoking cessation
377090|NCT01974063|Healthy Smoker|healthy smoker
377091|NCT01974063|Shisha Smoker|shisha smoker
377092|NCT01974063|Non-smoker|non-smoker
377093|NCT01974050|Influenza vaccination|influenza vaccination
377094|NCT01974024|Dexamethasone|dexamethasone
377095|NCT01974024|Hiccup|hiccup
377096|NCT01974024|Chemotherapy|chemotherapy
377097|NCT01974024|Methylprednisolone|methylprednisolone
377098|NCT01973998|COPD|copd
377099|NCT01973998|Emphysema|emphysema
377100|NCT01973998|Roflumilast|roflumilast
377101|NCT01973998|readmission|readmission
377102|NCT01973985|Pleural Effusion|pleural effusion
377103|NCT01973972|Diabetes|diabetes
377104|NCT01973972|Obesity|obesity
377105|NCT01973972|Complex Care|complex care
377106|NCT01973972|Primary Care|primary care
377107|NCT01973972|Chronic Disease|chronic disease
377108|NCT01973946|Cancer|cancer
377109|NCT01973933|Metformin|metformin
377110|NCT01973933|Pyrimethamine|pyrimethamine
377111|NCT01973933|Drug interaction|drug interaction
377112|NCT01973920|Diabetes Mellitus|diabetes mellitus
377113|NCT01973920|Oral Insulin|oral insulin
377114|NCT01973907|Sepsis|sepsis
377115|NCT01973907|Septic Shock|septic shock
377116|NCT01973907|Fluid Therapy|fluid therapy
377117|NCT01973907|Pediatrics|pediatrics
377118|NCT01973907|Resuscitation|resuscitation
377119|NCT01973907|Emergency Medicine|emergency medicine
377120|NCT01973907|Critical Care|critical care
377121|NCT01973894|PBPK|pbpk
377122|NCT01973894|Midazolam|midazolam
377123|NCT01973894|Pharmacokinetics|pharmacokinetics
377124|NCT01973894|Critically ill patients|critically ill patients
377125|NCT01973868|Regorafenib|regorafenib
377126|NCT01973868|Cetuximab|cetuximab
377127|NCT01973868|Solid tumors|solid tumors
377128|NCT01973868|Cancer|cancer
377129|NCT01973868|Safety|safety
377130|NCT01973868|Tolerability|tolerability
377131|NCT01973868|Pharmacokinetics|pharmacokinetics
377132|NCT01973842|GnRH agonist|gnrh agonist
377133|NCT01973842|OHSS|ohss
377134|NCT01973842|Triggering final oocyte maturation|triggering final oocyte maturation
377135|NCT01973829|CERTAIN, Checklist, ICU, Outcome, Adults|certain, checklist, icu, outcome, adults
377136|NCT01973816|deep endometriosis;|deep endometriosis;
377137|NCT01973816|rectal endometriosis;|rectal endometriosis;
377138|NCT01973816|rectal shaving;|rectal shaving;
377139|NCT01973816|colorectal resection;|colorectal resection;
377140|NCT01973816|bowel endometriosis|bowel endometriosis
377141|NCT01973803|Carpometacarpal joint|carpometacarpal joint
377142|NCT01973803|Osteoarthritis of CMC-1 joint|osteoarthritis of cmc-1 joint
377143|NCT01973790|Z-338|z-338
377144|NCT01973790|Functional Dyspepsia|functional dyspepsia
377145|NCT01973790|Postprandial Distress Syndrome|postprandial distress syndrome
377146|NCT01973777|intrauterine device, contraception|intrauterine device, contraception
377147|NCT01973764|Intraoperative ultrasound|intraoperative ultrasound
377148|NCT01973764|Ventricular System|ventricular system
377149|NCT01973764|Puncture|puncture
377150|NCT01973764|Ventricular catheter|ventricular catheter
377151|NCT01973764|Ventriculostomy|ventriculostomy
377152|NCT01973764|Hydrocephalus|hydrocephalus
377153|NCT01973764|Excessive accumulation of cerebrospinal fluids within the cranium. Often associated with dilatation of cerebral ventricles|excessive accumulation of cerebrospinal fluids within the cranium. often associated with dilatation of cerebral ventricles
377154|NCT01973764|Intracranial Hypertension|intracranial hypertension
377155|NCT01973764|increased pressure within the cranial vault. This may result from several conditions, including hydrocephalus, brain edema.|increased pressure within the cranial vault. this may result from several conditions, including hydrocephalus, brain edema.
377156|NCT01973738|raloxifene|raloxifene
377157|NCT01973738|bazedoxifene|bazedoxifene
377158|NCT01973738|bone mineral density|bone mineral density
377159|NCT01973738|bone turnover markers|bone turnover markers
377160|NCT01973738|bone quality|bone quality
377161|NCT01973699|shoulder arthroscopy, epinephrine, visualization|shoulder arthroscopy, epinephrine, visualization
377162|NCT01973673|prostate cancer|prostate cancer
377163|NCT01973673|ADT|adt
377164|NCT01973673|bone health|bone health
377165|NCT01973660|Human Epidermal Growth Factor Receptor 2|human epidermal growth factor receptor 2
377166|NCT01973660|HER2|her2
377167|NCT01973660|HER2 positive|her2 positive
377168|NCT01973660|PAM50|pam50
377169|NCT01973660|lapatinib|lapatinib
377170|NCT01973660|trastuzumab|trastuzumab
377171|NCT01973660|dual HER2 blockade|dual her2 blockade
377172|NCT01973660|neoadjuvant|neoadjuvant
377173|NCT01973647|insomnia|insomnia
377174|NCT01973647|cognitive behavioral therapy|cognitive behavioral therapy
377175|NCT01973647|COPD|copd
377176|NCT01973647|fatigue|fatigue
377177|NCT01973634|Radiotherapy|radiotherapy
377178|NCT01973608|Melanoma|melanoma
377179|NCT01973608|MSB0010445|msb0010445
377180|NCT01973608|Dose limiting toxicity|dose limiting toxicity
377181|NCT01973608|Stereotactic body radiation therapy|stereotactic body radiation therapy
377182|NCT01973595|almonds|almonds
377183|NCT01973595|inflammation|inflammation
377184|NCT01973595|immunity|immunity
377185|NCT01973595|gut microbiota|gut microbiota
377186|NCT01973595|stress|stress
377187|NCT01973595|diet quality|diet quality
377188|NCT01973582|Hepatitis B|hepatitis b
377189|NCT01973582|epidemiology|epidemiology
377190|NCT01973582|youth|youth
377191|NCT01973582|vaccine|vaccine
377192|NCT01973569|Rheumatoid Arthritis|rheumatoid arthritis
377193|NCT01973569|Denosumab|denosumab
377194|NCT01973569|RANKL|rankl
377195|NCT01973569|RANK|rank
377196|NCT01973569|AMG 162|amg 162
377198|NCT01973569|Developmental Phase III|developmental phase iii
377199|NCT01973543|PD|pd
377200|NCT01973543|Parkinson's disease|parkinson's disease
377201|NCT01973543|Aromatic Amino Acid Decarboxylase|aromatic amino acid decarboxylase
377202|NCT01973543|AADC|aadc
377203|NCT01973543|AAV2-AADC|aav2-aadc
377204|NCT01973543|AAV2|aav2
377205|NCT01973543|Viral Vector|viral vector
377206|NCT01973543|Gene Therapy|gene therapy
377207|NCT01973543|Gene Transfer|gene transfer
377208|NCT01973543|MRI|mri
377209|NCT01973543|PET|pet
377210|NCT01973543|VY-AADC01|vy-aadc01
377211|NCT01973530|femoral nerve block|femoral nerve block
377212|NCT01973530|adductor canal block|adductor canal block
377213|NCT01973530|steroid|steroid
377214|NCT01973530|total knee replacement|total knee replacement
377215|NCT01973517|Multiple sclerosis|multiple sclerosis
377216|NCT01973517|MRI|mri
377217|NCT01973517|USPIO|uspio
377218|NCT01973517|Ferumoxytol|ferumoxytol
377219|NCT01973517|Feraheme|feraheme
377220|NCT01973504|Trauma|trauma
377221|NCT01973504|Hemorrhagic shock|hemorrhagic shock
377222|NCT01973504|Hemorrhage|hemorrhage
377223|NCT01973504|Lactic acidosis|lactic acidosis
377224|NCT01973504|Oxygen therapeutics|oxygen therapeutics
377225|NCT01973504|Oxygen carriers|oxygen carriers
377226|NCT01973504|Ischemic rescue therapy|ischemic rescue therapy
377227|NCT01973504|Hemoglobin solutions|hemoglobin solutions
377228|NCT01973504|PEGylated hemoglobin|pegylated hemoglobin
377229|NCT01973491|ATX-MS-1467 (MSC2358825A)|atx-ms-1467 (msc2358825a)
377230|NCT01973491|Relapsing Multiple Sclerosis|relapsing multiple sclerosis
377231|NCT01973491|Magnetic resonance imaging (MRI)|magnetic resonance imaging (mri)
377232|NCT01973491|M2736|m2736
377233|NCT01973478|Major depressive disorder|major depressive disorder
377234|NCT01973478|Recurrent depressive disorder|recurrent depressive disorder
377235|NCT01973478|Bipolar disorder|bipolar disorder
377236|NCT01973478|Deep brain stimulation|deep brain stimulation
377237|NCT01973478|Accumbens|accumbens
377238|NCT01973465|C-Diff|c-diff
482323|NCT01503879|SPB|spb
377239|NCT01973465|Diarrhea|diarrhea
377240|NCT01973452|Dexmedetomidine|dexmedetomidine
377241|NCT01973452|Opioid|opioid
377242|NCT01973452|Thoracic Surgery|thoracic surgery
377243|NCT01973439|HIV|hiv
377244|NCT01973439|Abacavir|abacavir
377245|NCT01973439|Lamivudine|lamivudine
377246|NCT01973439|Pharmacokinetics|pharmacokinetics
377247|NCT01973426|Robot|robot
377248|NCT01973426|Thumb|thumb
377249|NCT01973426|Orthosis|orthosis
377250|NCT01973426|Hemiplegia|hemiplegia
377251|NCT01973426|Hemiplegic Stroke|hemiplegic stroke
377252|NCT01973426|Hemiplegic Cerebral Palsy|hemiplegic cerebral palsy
377253|NCT01973426|Stroke|stroke
377254|NCT01973426|Cerebral Palsy|cerebral palsy
377255|NCT01973426|Grasp assistance|grasp assistance
377256|NCT01973413|Artificial Pancreas Project|artificial pancreas project
377257|NCT01973413|Diabetes Mellitus, Type 1|diabetes mellitus, type 1
377258|NCT01973413|Insulin pump therapy|insulin pump therapy
377259|NCT01973413|Continuous Glucose Monitors (CGM)|continuous glucose monitors (cgm)
377260|NCT01973413|Juvenile-Onset Diabetes|juvenile-onset diabetes
377261|NCT01973413|Autoimmune Diabetes|autoimmune diabetes
377262|NCT01973413|Closed-to-Range|closed-to-range
377263|NCT01973413|Diabetes Assistant (DiAs)|diabetes assistant (dias)
377264|NCT01973387|Chronic lymphocytic leukemia|chronic lymphocytic leukemia
377265|NCT01973387|Small lymphocytic lymphoma|small lymphocytic lymphoma
377266|NCT01973387|Relapsed or refractory chronic lymphocytic leukemia|relapsed or refractory chronic lymphocytic leukemia
377267|NCT01973387|Relapsed or refractory small lymphocytic lymphoma|relapsed or refractory small lymphocytic lymphoma
377268|NCT01973387|Ibrutinib|ibrutinib
377269|NCT01973387|PCI-32765|pci-32765
377270|NCT01973387|Bruton's tyrosine kinase inhibitor|bruton's tyrosine kinase inhibitor
377271|NCT01973387|Rituximab|rituximab
377272|NCT01973387|Asia Pacific region participants|asia pacific region participants
377273|NCT01973361|Wounds|wounds
377274|NCT01973361|Lower extremity|lower extremity
377275|NCT01973361|Diabetes|diabetes
377276|NCT01973361|Arterial Insufficiency|arterial insufficiency
377277|NCT01973361|Debridement|debridement
377278|NCT01973361|Low frequency ultrasound|low frequency ultrasound
377279|NCT01973361|Contact ultrasound|contact ultrasound
377280|NCT01973361|Wound clinic|wound clinic
377281|NCT01973361|Wound bed preparation|wound bed preparation
377282|NCT01973361|Wound infection|wound infection
377283|NCT01973361|Chronic wound inflammation|chronic wound inflammation
377284|NCT01973348|amblyopia|amblyopia
377285|NCT01973335|acetazolamide|acetazolamide
377286|NCT01973335|bumetanide|bumetanide
377287|NCT01973335|cardio-renal syndrome|cardio-renal syndrome
377288|NCT01973335|diuretics|diuretics
377289|NCT01973335|heart failure|heart failure
377291|NCT01973335|spironolactone|spironolactone
377292|NCT01973322|Malignant melanoma stage III or IV|malignant melanoma stage iii or iv
377293|NCT01973322|pretreated melanoma|pretreated melanoma
377294|NCT01973322|vaccination|vaccination
377295|NCT01973322|autologous dendritic cells|autologous dendritic cells
377296|NCT01973322|autologous tumor lysate or homogenate|autologous tumor lysate or homogenate
377297|NCT01973322|immunomodulating radiotherapy|immunomodulating radiotherapy
377298|NCT01973309|Locally Recurrent|locally recurrent
377299|NCT01973309|Metastatic Breast Cancer|metastatic breast cancer
377300|NCT01973296|Health Literacy|health literacy
377301|NCT01973296|Care Transition Intervention|care transition intervention
377302|NCT01973296|Emergency Department Population|emergency department population
377303|NCT01973296|Access to Care|access to care
377304|NCT01973218|Meningitis, adolescents, Meningococcal B|meningitis, adolescents, meningococcal b
377305|NCT01973205|Migraine|migraine
377306|NCT01973205|acetaminophen|acetaminophen
377307|NCT01973205|aspirin|aspirin
377308|NCT01973166|Tattoo Removal|tattoo removal
377309|NCT01973166|Q-switched laser|q-switched laser
377310|NCT01973166|Nd:YAG laser|nd:yag laser
377311|NCT01973166|Nanosecond laser|nanosecond laser
377312|NCT01973166|Picosecond laser|picosecond laser
377313|NCT01973166|Laser therapy|laser therapy
377314|NCT01973166|Tattoo|tattoo
377315|NCT01973166|pulsed-laser|pulsed-laser
377316|NCT01973166|laser treatment|laser treatment
377317|NCT01973166|remove tattoo|remove tattoo
377318|NCT01973166|tattoo clearing|tattoo clearing
377319|NCT01973166|tattoo lightening|tattoo lightening
377320|NCT01973166|tattoo lighten|tattoo lighten
377321|NCT01973153|Obesity prevention|obesity prevention
377322|NCT01973153|Weight management|weight management
377323|NCT01973153|Motivational Interviewing|motivational interviewing
377324|NCT01973140|Tolvaptan|tolvaptan
377325|NCT01973140|Aquaretic Efficacy|aquaretic efficacy
377326|NCT01973127|alcohol|alcohol
377327|NCT01973127|addiction|addiction
377328|NCT01973127|TMS|tms
377329|NCT01973127|craving|craving
377330|NCT01973127|use|use
377331|NCT01973127|rTMS|rtms
377332|NCT01973127|EEG|eeg
377333|NCT01973127|LPP|lpp
377334|NCT01973127|p300|p300
377335|NCT01973127|ERN|ern
377336|NCT01973127|SST|sst
377337|NCT01973127|CCT|cct
377338|NCT01973127|AAAT|aaat
377339|NCT01973114|Menière's disease|menière's disease
377340|NCT01973114|Vertigo|vertigo
377341|NCT01973114|Hearing loss|hearing loss
377342|NCT01973114|Tinnitus|tinnitus
377343|NCT01973101|Advanced carcinomas of uterine cervix|advanced carcinomas of uterine cervix
377344|NCT01973101|Chemoradiation|chemoradiation
377345|NCT01973101|Chemo-induction|chemo-induction
377346|NCT01973101|Cisplatin|cisplatin
377347|NCT01973101|Gemcitabine|gemcitabine
377348|NCT01973075|Premature Ovarian Insufficiency (POI)|premature ovarian insufficiency (poi)
377349|NCT01973036|foley catheter|foley catheter
377350|NCT01973036|foley bulb|foley bulb
377351|NCT01973036|oxytocin|oxytocin
377352|NCT01973023|botulinum toxin injection|botulinum toxin injection
377353|NCT01973023|stroke|stroke
377354|NCT01973023|3D motion analysis|3d motion analysis
377355|NCT01973023|gait pattern|gait pattern
377356|NCT01973010|massage|massage
377357|NCT01973010|low back pain|low back pain
377358|NCT01972984|Estrogen receptor positive|estrogen receptor positive
377359|NCT01972971|warfarin|warfarin
377360|NCT01972971|pharmacist|pharmacist
377361|NCT01972971|anticoagulation|anticoagulation
377362|NCT01972945|vaginoscopy|vaginoscopy
377363|NCT01972945|hysteroscopy|hysteroscopy
377364|NCT01972945|office hysteroscopy|office hysteroscopy
377365|NCT01972945|outpatient hysteroscopy|outpatient hysteroscopy
377366|NCT01972932|Bio-K+®|bio-k+®
377367|NCT01972932|Placebo|placebo
377368|NCT01972932|AAD|aad
377369|NCT01972932|CDI|cdi
377370|NCT01972932|hospitalized subjects|hospitalized subjects
377371|NCT01972906|moxibustion|moxibustion
377372|NCT01972906|primary dysmenorrhea|primary dysmenorrhea
377373|NCT01972893|Selective GLP-1 agonist|selective glp-1 agonist
377374|NCT01972880|Open-label design|open-label design
377375|NCT01972880|Bioequivalence|bioequivalence
377376|NCT01972880|ASP1941|asp1941
377377|NCT01972867|Focal|focal
377378|NCT01972867|Prostate|prostate
377379|NCT01972867|Cancer|cancer
377380|NCT01972867|Irreversible|irreversible
377381|NCT01972867|Electroporation|electroporation
377382|NCT01972867|NanoKnife|nanoknife
377383|NCT01972854|keratoconus|keratoconus
377384|NCT01972854|cross-linking|cross-linking
377385|NCT01972854|KXL|kxl
377386|NCT01972841|Combination Therapy|combination therapy
377387|NCT01972841|Mirabegron|mirabegron
377388|NCT01972841|Overactive Bladder|overactive bladder
377389|NCT01972841|Urgency|urgency
377390|NCT01972841|Urinary Incontinence|urinary incontinence
377391|NCT01972841|Nocturia|nocturia
377392|NCT01972841|Solifenacin Succinate|solifenacin succinate
377393|NCT01972828|Septic shock|septic shock
377394|NCT01972828|Randomized controlled trial|randomized controlled trial
377395|NCT01972828|Preload dependence|preload dependence
377396|NCT01972828|Pulmonary thermodilution|pulmonary thermodilution
377397|NCT01972802|HEAD AND NECK|head and neck
377398|NCT01972789|Subfoveal choroidal neovascularization (CNV)|subfoveal choroidal neovascularization (cnv)
377399|NCT01972789|wet age-related macular degeneration(AMD)|wet age-related macular degeneration(amd)
377400|NCT01972789|inject and extend|inject and extend
377401|NCT01972789|retinal fluid|retinal fluid
377402|NCT01972776|COPD, inflammation, small airways, LCI, PFTs, lung heterogeneity|copd, inflammation, small airways, lci, pfts, lung heterogeneity
377403|NCT01972750|glioblastoma|glioblastoma
377404|NCT01972750|recurrence|recurrence
377405|NCT01972737|Vaccine|vaccine
377406|NCT01972737|Colon cancer|colon cancer
377407|NCT01972737|safety|safety
377408|NCT01972737|tolerability|tolerability
377409|NCT01972737|antibody responses|antibody responses
377410|NCT01972737|T cell responses|t cell responses
377411|NCT01972724|Drug therapy|drug therapy
377412|NCT01972711|Schizophrenia|schizophrenia
377413|NCT01972698|Focused Cardiac Ultrasound|focused cardiac ultrasound
377414|NCT01972698|Lung Ultrasound|lung ultrasound
377415|NCT01972698|Simulation|simulation
377416|NCT01972698|Education|education
377417|NCT01972698|Web-based learning|web-based learning
377418|NCT01972685|ILD, transbronchial, cryoprobe, VATS|ild, transbronchial, cryoprobe, vats
377419|NCT01972659|sugammadex|sugammadex
377420|NCT01972659|rocuronium|rocuronium
377421|NCT01972659|magnesium|magnesium
377422|NCT01972659|female|female
377423|NCT01972646|Cellulitis, treatment failure, skin and soft tissue infections, risk factors.|cellulitis, treatment failure, skin and soft tissue infections, risk factors.
377424|NCT01972633|endovenous treatment|endovenous treatment
377425|NCT01972633|Laser, Vnus Closure Fast|laser, vnus closure fast
377426|NCT01972633|Varicosis|varicosis
377427|NCT01972633|great saphenous vein|great saphenous vein
377428|NCT01972633|small saphenous vein|small saphenous vein
377429|NCT01972633|Venous Insufficiency|venous insufficiency
377430|NCT01972620|gallstones|gallstones
377431|NCT01972620|cholelithiasis|cholelithiasis
377432|NCT01972620|cholecystectomy, laparoscopic|cholecystectomy, laparoscopic
377433|NCT01972620|pain|pain
377434|NCT01972607|Migraine, aerobic exercise, prevention|migraine, aerobic exercise, prevention
377435|NCT01972581|neurocognitive visual reaction training|neurocognitive visual reaction training
377436|NCT01972581|baseball|baseball
377437|NCT01972568|Atacicept|atacicept
377438|NCT01972568|Placebo|placebo
377439|NCT01972542|Postprandial period|postprandial period
377440|NCT01972542|triglyceride|triglyceride
377441|NCT01972542|Diabetes mellitus, type 2|diabetes mellitus, type 2
377442|NCT01972542|Prediabetic state|prediabetic state
377443|NCT01972529|Thrombocytopenia|thrombocytopenia
377444|NCT01972529|Chronic Liver Disease|chronic liver disease
377445|NCT01972516|Platinum-Sensitive|platinum-sensitive
377446|NCT01972516|Ovarian Cancer|ovarian cancer
377447|NCT01972516|Fallopian Tube Cancer|fallopian tube cancer
377448|NCT01972516|Primary Peritoneal Cancer|primary peritoneal cancer
377449|NCT01972516|High-grade Serous|high-grade serous
377450|NCT01972503|Colorectal Neoplasms|colorectal neoplasms
377451|NCT01972503|Liver|liver
377452|NCT01972503|Neoplasm Metastasis|neoplasm metastasis
377453|NCT01972503|Tegafur|tegafur
377454|NCT01972503|oxaliplatin|oxaliplatin
377455|NCT01972490|colorectal neoplasms|colorectal neoplasms
377456|NCT01972490|liver metastasis|liver metastasis
377457|NCT01972490|chemotherapy|chemotherapy
377458|NCT01972490|avastin|avastin
377459|NCT01972477|DLBS1449|dlbs1449
377460|NCT01972477|diabetes mellitus|diabetes mellitus
377461|NCT01972477|HDL-cholesterol|hdl-cholesterol
377462|NCT01972464|Progesterone|progesterone
377463|NCT01972464|Placebo|placebo
377464|NCT01972464|Postpartum|postpartum
377465|NCT01972464|Tobacco|tobacco
377466|NCT01972464|Pregnancy|pregnancy
377467|NCT01972438|Graft Versus Host Disease|graft versus host disease
377468|NCT01972438|Hematopoietic Stem Cell Transplant|hematopoietic stem cell transplant
377469|NCT01972412|nursing care|nursing care
377470|NCT01972412|diabetes mellitus|diabetes mellitus
377471|NCT01972412|phone support|phone support
377472|NCT01972412|chronic care model|chronic care model
377473|NCT01972373|VEGF|vegf
377474|NCT01972373|Fluorescence|fluorescence
377475|NCT01972373|Endoscopy|endoscopy
377476|NCT01972373|Rectal cancer|rectal cancer
377477|NCT01972360|SPECT|spect
377478|NCT01972360|CMR|cmr
377479|NCT01972360|High risk for ischemic cardiovascular events|high risk for ischemic cardiovascular events
377480|NCT01972347|Melanoma|melanoma
377481|NCT01972347|Cutaneous melanoma|cutaneous melanoma
377482|NCT01972347|Malignant melanoma|malignant melanoma
377483|NCT01972347|Stage III B / C melanoma|stage iii b / c melanoma
377484|NCT01972347|Neoadjuvant treatment|neoadjuvant treatment
377485|NCT01972347|Pyrexia|pyrexia
377486|NCT01972347|Biomarkers|biomarkers
377487|NCT01972347|Dabrafenib|dabrafenib
377488|NCT01972347|Trametinib|trametinib
377489|NCT01972334|clostridium difficile|clostridium difficile
377490|NCT01972334|children|children
377491|NCT01972334|fecal transplant|fecal transplant
377492|NCT01972321|Community health worker|community health worker
377493|NCT01972321|Motivation|motivation
377494|NCT01972321|Performance|performance
377495|NCT01972321|Quality of care|quality of care
377496|NCT01972321|Africa|africa
377497|NCT01972308|asthma|asthma
377498|NCT01972308|patient advocate|patient advocate
377499|NCT01972308|health disparity|health disparity
377500|NCT01972308|patient-provider communication|patient-provider communication
377501|NCT01972282|Atrial fibrillation|atrial fibrillation
377502|NCT01972282|Stroke|stroke
377503|NCT01972282|Thrombus|thrombus
377504|NCT01972282|Thromboembolism|thromboembolism
377505|NCT01972282|Left atrial appendage|left atrial appendage
377506|NCT01972269|Epidural|epidural
377507|NCT01972269|Labor Analgesia|labor analgesia
377508|NCT01972269|Bupivacaine|bupivacaine
377509|NCT01972269|Minimum effective volume|minimum effective volume
377510|NCT01972243|risk of recurrent|risk of recurrent
377511|NCT01972217|Olaparib|olaparib
377512|NCT01972217|castration-resistant, metastatic prostate cancer|castration-resistant, metastatic prostate cancer
377513|NCT01972217|Prior Docetaxel Chemotherapy|prior docetaxel chemotherapy
377514|NCT01972191|Toric marking, Corneal horizontal marking|toric marking, corneal horizontal marking
377515|NCT01972165|Carpal tunnel syndrome|carpal tunnel syndrome
377516|NCT01972152|Hypoglycemia|hypoglycemia
377517|NCT01972152|Glucagon|glucagon
377518|NCT01972139|Uncontrolled hypertension|uncontrolled hypertension
377519|NCT01972139|blood pressure|blood pressure
377520|NCT01972139|renal denervation|renal denervation
377521|NCT01972139|HTN-4|htn-4
377522|NCT01972139|SYMPLICITY|symplicity
377523|NCT01972113|Vitamin K|vitamin k
377524|NCT01972113|Vitamin K2|vitamin k2
377525|NCT01972113|Menaquinone-7|menaquinone-7
377526|NCT01972113|Osteocalcin|osteocalcin
377527|NCT01972113|Children|children
377528|NCT01972113|Obesity|obesity
377529|NCT01972113|Insulin resistance|insulin resistance
377530|NCT01972113|Insulin sensitivity|insulin sensitivity
377531|NCT01972113|Beta-cell function|beta-cell function
377532|NCT01972113|Prediabetes|prediabetes
377533|NCT01972113|Matrix Gla protein|matrix gla protein
377534|NCT01972113|Arterial stiffness|arterial stiffness
377535|NCT01972113|Endothelial function|endothelial function
377536|NCT01972100|Low-level laser therapy|low-level laser therapy
377537|NCT01972100|Muscle fatigue resistance|muscle fatigue resistance
400559|NCT01866280|Meals|meals
377538|NCT01972074|Autism spectrum disorder|autism spectrum disorder
377539|NCT01972074|Treatment|treatment
377540|NCT01972074|Adolescents|adolescents
377541|NCT01972074|Memantine|memantine
377542|NCT01972074|functional Magnetic Resonance Imaging|functional magnetic resonance imaging
377543|NCT01972074|MRS|mrs
377544|NCT01972074|Neuroimaging|neuroimaging
377545|NCT01972048|breast cancer|breast cancer
377546|NCT01972048|breast cancer screening|breast cancer screening
377547|NCT01972048|mammogram|mammogram
377548|NCT01972035|EBV|ebv
377549|NCT01972035|CMV|cmv
377550|NCT01972035|Kidney transplant|kidney transplant
377551|NCT01972035|valganciclovir|valganciclovir
377552|NCT01972035|valacyclovir|valacyclovir
377553|NCT01972022|Drug Eluting Stents|drug eluting stents
377554|NCT01972022|Bioabsorbale Polymer Coating|bioabsorbale polymer coating
377555|NCT01972022|Neoatherosclerosis|neoatherosclerosis
377556|NCT01972022|Stent Coverage|stent coverage
377557|NCT01972022|Stent Failure|stent failure
377558|NCT01971996|Near infrared Spectroscopy|near infrared spectroscopy
377559|NCT01971983|Low back pain|low back pain
377560|NCT01971983|Spinal manipulation|spinal manipulation
377561|NCT01971983|Osteopathy|osteopathy
377562|NCT01971983|Muscle energy technique|muscle energy technique
377563|NCT01971983|Muscle thickness|muscle thickness
377564|NCT01971970|Inflammatory bowel disease|inflammatory bowel disease
377565|NCT01971970|Pediatric|pediatric
377566|NCT01971970|Adult|adult
377567|NCT01971970|Biomarker|biomarker
377568|NCT01971970|Anti-TNF response|anti-tnf response
377569|NCT01971970|Infliximab|infliximab
377570|NCT01971970|Adalimumab|adalimumab
377571|NCT01971957|ichthyosis|ichthyosis
377572|NCT01971957|spasticity|spasticity
377573|NCT01971957|spastic diplegia|spastic diplegia
377574|NCT01971957|intellectual disability|intellectual disability
377575|NCT01971944|Beta Blocker|beta blocker
377576|NCT01971944|Inotrope|inotrope
377577|NCT01971918|spondyloarthritis|spondyloarthritis
377699|NCT01971450|Russian Federation|russian federation
377578|NCT01971918|monoclonal antibodies anti-TNF|monoclonal antibodies anti-tnf
377579|NCT01971918|secondary treatment failure|secondary treatment failure
377580|NCT01971892|Abdominal surgery;|abdominal surgery;
377581|NCT01971892|Postoperative complication;|postoperative complication;
377582|NCT01971892|Acute respiratory failure;|acute respiratory failure;
377583|NCT01971892|Hypoxemia;|hypoxemia;
377584|NCT01971892|Intubation;|intubation;
377585|NCT01971892|Non-invasive ventilation|non-invasive ventilation
377586|NCT01971879|Remote ischemic preconditioning|remote ischemic preconditioning
377587|NCT01971879|Obliterating Arteriopathy of the Lower Limbs|obliterating arteriopathy of the lower limbs
377588|NCT01971866|Proton radiation|proton radiation
377589|NCT01971866|AlignRT|alignrt
377590|NCT01971853|Analgesia|analgesia
377591|NCT01971840|Physical activity|physical activity
377592|NCT01971840|Physical fitness|physical fitness
377593|NCT01971840|Obesity|obesity
377594|NCT01971840|Adiposity|adiposity
377595|NCT01971840|Adiposity rebound period|adiposity rebound period
377596|NCT01971840|Children|children
377597|NCT01971840|Blood pressure|blood pressure
377598|NCT01971840|Randomized controlled trials|randomized controlled trials
377599|NCT01971840|Barriers and facilitators of the environment|barriers and facilitators of the environment
377600|NCT01971827|Physical activity|physical activity
377601|NCT01971827|Obesity|obesity
377602|NCT01971827|Adiposity rebound period|adiposity rebound period
377603|NCT01971827|Children with ADHD|children with adhd
377604|NCT01971827|Children without ADHD|children without adhd
377605|NCT01971827|Academic performance|academic performance
377606|NCT01971827|Motor skills|motor skills
377607|NCT01971827|Health related-quality of life|health related-quality of life
377608|NCT01971827|Sleep|sleep
377609|NCT01971801|urinary incontinence|urinary incontinence
377610|NCT01971801|bowel incontinence|bowel incontinence
377611|NCT01971801|vitamin D|vitamin d
377612|NCT01971801|overactive bladder|overactive bladder
377613|NCT01971801|lower urinary tract symptoms|lower urinary tract symptoms
377614|NCT01971801|quality of life|quality of life
377615|NCT01971775|Ultrasonically Activated Shear|ultrasonically activated shear
377616|NCT01971775|Conventional Monopolar Electrocautery|conventional monopolar electrocautery
377617|NCT01971775|Gastric Cancer|gastric cancer
377618|NCT01971762|multiresistant bacteremia|multiresistant bacteremia
377619|NCT01971762|bacteremia management|bacteremia management
377620|NCT01971762|blood culture|blood culture
377621|NCT01971749|Coronary stent procedure (CSP|coronary stent procedure (csp
377622|NCT01971749|Coronary-artery bypass grafting (CABG)|coronary-artery bypass grafting (cabg)
377623|NCT01971736|1064nm YAG laser|1064nm yag laser
377624|NCT01971736|laxity|laxity
377625|NCT01971736|rhytides|rhytides
377626|NCT01971736|asian|asian
377627|NCT01971723|Testosterone|testosterone
377628|NCT01971723|Estrogen|estrogen
377629|NCT01971723|Insulin|insulin
377630|NCT01971723|Blood Lipid|blood lipid
377631|NCT01971723|Glucose|glucose
377632|NCT01971723|Creatine Kinase|creatine kinase
377633|NCT01971723|Strength|strength
377634|NCT01971723|Power Athlete|power athlete
377635|NCT01971710|HIV|hiv
377636|NCT01971710|AIDS|aids
377637|NCT01971710|PMTCT|pmtct
377638|NCT01971684|ITP|itp
377639|NCT01971684|idiopathic thrombocytopenic purpura|idiopathic thrombocytopenic purpura
377640|NCT01971684|bleeding score|bleeding score
377641|NCT01971684|platelet count|platelet count
377642|NCT01971684|health-related quality of life|health-related quality of life
377643|NCT01971684|HRQL|hrql
377644|NCT01971684|Purpura|purpura
377645|NCT01971684|Purpura, Thrombocytopenic|purpura, thrombocytopenic
377646|NCT01971684|Purpura, Thrombocytopenic, Idiopathic|purpura, thrombocytopenic, idiopathic
377647|NCT01971684|Blood Coagulation Disorders|blood coagulation disorders
377648|NCT01971684|Hematologic Diseases|hematologic diseases
377649|NCT01971684|Hemorrhage|hemorrhage
377650|NCT01971684|Skin Manifestations|skin manifestations
377651|NCT01971684|Thrombocytopenia|thrombocytopenia
377652|NCT01971684|Blood Platelet Disorders|blood platelet disorders
377653|NCT01971684|Immune System Diseases|immune system diseases
377654|NCT01971684|Hemorrhagic Disorders|hemorrhagic disorders
377655|NCT01971684|Autoimmune Diseases|autoimmune diseases
377656|NCT01971684|Therapeutic Uses|therapeutic uses
377657|NCT01971658|Multiple myeloma|multiple myeloma
377658|NCT01971658|Newly Diagnosed|newly diagnosed
377659|NCT01971645|Dexamethasone|dexamethasone
377660|NCT01971645|Ropivacaine|ropivacaine
377661|NCT01971645|Knee arthroscopy|knee arthroscopy
377662|NCT01971645|Femoral nerve blocks|femoral nerve blocks
377663|NCT01971645|Peripheral nerve blocks|peripheral nerve blocks
377664|NCT01971645|Adjuvant|adjuvant
377665|NCT01971645|Pediatrics|pediatrics
377666|NCT01971606|Statin, coronary artery bypass grafting, off-pump surgery, acute coronary syndrome|statin, coronary artery bypass grafting, off-pump surgery, acute coronary syndrome
377667|NCT01971567|Insomnia|insomnia
377668|NCT01971567|Electroencephalic|electroencephalic
377669|NCT01971567|Biofeedback|biofeedback
377670|NCT01971567|Neural oscillations|neural oscillations
377671|NCT01971567|Auto calibration|auto calibration
377672|NCT01971567|Relaxation|relaxation
377673|NCT01971541|mindfulness|mindfulness
377674|NCT01971541|behavior therapies, cognitive|behavior therapies, cognitive
377675|NCT01971541|posttraumatic stress disorder|posttraumatic stress disorder
377676|NCT01971541|group therapy|group therapy
377677|NCT01971528|Muscle strength, fatigue, electromyography (EMG), central fatigue, strength straining|muscle strength, fatigue, electromyography (emg), central fatigue, strength straining
377678|NCT01971515|MSC2363318A|msc2363318a
377679|NCT01971515|Maximum tolerated dose|maximum tolerated dose
377680|NCT01971515|Dose limiting toxicities|dose limiting toxicities
377681|NCT01971515|Recommended phase 2 dose|recommended phase 2 dose
377682|NCT01971515|M2698|m2698
377683|NCT01971515|Metastatic Breast Cancer|metastatic breast cancer
377684|NCT01971515|HER2+ Metastatic Breast Cancer|her2+ metastatic breast cancer
377685|NCT01971515|Hormone refractory ER/PR+ breast cancer|hormone refractory er/pr+ breast cancer
377686|NCT01971515|Tamoxifen|tamoxifen
377687|NCT01971515|PAM Pathway Alteration(s)|pam pathway alteration(s)
377688|NCT01971515|PAM Pathway|pam pathway
377689|NCT01971515|Targeted Therapy|targeted therapy
377690|NCT01971515|P70S6K|p70s6k
377691|NCT01971515|AKT Inhibition|akt inhibition
377692|NCT01971515|PI3K Pathway|pi3k pathway
377693|NCT01971515|HER2+ Trastuzumab Resistance|her2+ trastuzumab resistance
377694|NCT01971450|Non-interventional|non-interventional
377695|NCT01971450|Ventavis|ventavis
377696|NCT01971450|Iloprost|iloprost
377697|NCT01971450|Pulmonary hypertension|pulmonary hypertension
377698|NCT01971450|Compliance|compliance
377700|NCT01971437|Overactive Bladder|overactive bladder
377701|NCT01971437|OAB|oab
377702|NCT01971437|Cystoscopy|cystoscopy
377703|NCT01971437|Cystodistension|cystodistension
377704|NCT01971437|UTI|uti
377705|NCT01971437|Cytokines|cytokines
377706|NCT01971424|magnesium|magnesium
377707|NCT01971424|SPPB|sppb
377708|NCT01971424|strength|strength
377709|NCT01971424|physical performance|physical performance
377710|NCT01971424|24 hour magnesuria|24 hour magnesuria
377711|NCT01971411|Hyperparathyroidism|hyperparathyroidism
377712|NCT01971411|Hypoparathyroidism|hypoparathyroidism
377713|NCT01971411|Calcium|calcium
377714|NCT01971411|Vitamin D|vitamin d
377715|NCT01971411|Bone mineral density|bone mineral density
377716|NCT01971411|African American|african american
377717|NCT01971411|Female|female
377718|NCT01971411|Elderly|elderly
377719|NCT01971398|Fetal Alcohol Spectrum Disorders (FASD)|fetal alcohol spectrum disorders (fasd)
377720|NCT01971398|Prevention|prevention
377721|NCT01971398|Alcohol-Exposed Pregnancy|alcohol-exposed pregnancy
377722|NCT01971398|Knowledge|knowledge
377723|NCT01971398|Attitudes|attitudes
377724|NCT01971359|Stroke, Intracerebral Hemorrhage, ICH|stroke, intracerebral hemorrhage, ich
377725|NCT01971346|Psoriasis|psoriasis
377726|NCT01971346|ENBREL|enbrel
377727|NCT01971346|etanercept|etanercept
377728|NCT01971346|anti-TNF|anti-tnf
377729|NCT01971333|pulse pressure variation|pulse pressure variation
377730|NCT01971333|stroke volume variation|stroke volume variation
482917|NCT01501357|caries|caries
377731|NCT01971333|plethysmographic variation index|plethysmographic variation index
377732|NCT01971333|fluid responsiveness|fluid responsiveness
377733|NCT01971294|Urinary symptoms|urinary symptoms
377734|NCT01971294|Systemic sclerosis|systemic sclerosis
377735|NCT01971294|Severity index|severity index
377736|NCT01971294|Urinary tract infection|urinary tract infection
377737|NCT01971294|mortality|mortality
377738|NCT01971294|Quality of life|quality of life
377739|NCT01971281|Pancreatic adenocarcinoma|pancreatic adenocarcinoma
377740|NCT01971281|Pancreas tumor|pancreas tumor
377741|NCT01971281|Treatment|treatment
377742|NCT01971281|Minimal toxicity|minimal toxicity
377743|NCT01971281|TTFields|ttfields
377744|NCT01971281|Tumor Treating Fields|tumor treating fields
377745|NCT01971281|Novocure|novocure
377746|NCT01971268|T3 dental implants|t3 dental implants
377747|NCT01971268|Marginal bone loss|marginal bone loss
377748|NCT01971268|Survival rate|survival rate
377749|NCT01971255|Influenza A|influenza a
377750|NCT01971255|HAI|hai
377751|NCT01971255|H1N1|h1n1
377752|NCT01971255|Challenge Study|challenge study
377753|NCT01971255|Correlates of Protection|correlates of protection
377754|NCT01971242|Parkinson's|parkinson's
377755|NCT01971242|Parkinson's Disease|parkinson's disease
377756|NCT01971242|Exenatide|exenatide
377757|NCT01971242|Bydureon|bydureon
377758|NCT01971216|Breastfeeding, relaxation, anxiety, infant growth|breastfeeding, relaxation, anxiety, infant growth
377759|NCT01971203|seroquel XR|seroquel xr
377760|NCT01971203|quetiapine XR|quetiapine xr
377761|NCT01971203|major depression|major depression
377762|NCT01971203|generalized anxiety disorder|generalized anxiety disorder
377763|NCT01971203|CBT|cbt
377764|NCT01971203|co-morbid MDD|co-morbid mdd
377765|NCT01971164|anemia|anemia
377766|NCT01971164|chronic kidney disease|chronic kidney disease
377767|NCT01971164|hemodialysis|hemodialysis
377768|NCT01971151|Chronic|chronic
377769|NCT01971151|Back pain|back pain
377770|NCT01971151|Low back|low back
377771|NCT01971125|Diabetes Mellitus, Type 2|diabetes mellitus, type 2
377772|NCT01971125|Heart Diseases|heart diseases
377773|NCT01971125|Left Ventricular Dysfunction|left ventricular dysfunction
377774|NCT01971112|Multi-vitamins|multi-vitamins
377775|NCT01971112|Minerals|minerals
377776|NCT01971112|Respiratory infections|respiratory infections
377777|NCT01971112|DTH|dth
377778|NCT01971112|CRP|crp
377779|NCT01971112|Cathelicidin|cathelicidin
377780|NCT01971099|sexual function|sexual function
377781|NCT01971099|hypoactive|hypoactive
377782|NCT01971099|desire|desire
377783|NCT01971099|androgens|androgens
377784|NCT01971073|schizophrenic patients|schizophrenic patients
377785|NCT01971073|tDCS|tdcs
377786|NCT01971073|Executive functions|executive functions
377787|NCT01971073|Dorsolateral prefrontal cortex|dorsolateral prefrontal cortex
377788|NCT01971060|uterine fibroids|uterine fibroids
377789|NCT01971060|barbed suture|barbed suture
377790|NCT01971060|infertility|infertility
377791|NCT01971060|adhesions|adhesions
377792|NCT01971047|Diabetes|diabetes
377793|NCT01971047|Surgery|surgery
377794|NCT01971047|anesthesiology|anesthesiology
377795|NCT01971047|endocrinology|endocrinology
377796|NCT01970995|Candidate modified risk tobacco product|candidate modified risk tobacco product
377797|NCT01970995|Conventional cigarettes|conventional cigarettes
377798|NCT01970995|Reduced exposure|reduced exposure
377799|NCT01970995|HPHCs|hphcs
377800|NCT01970995|Ambulatory|ambulatory
377801|NCT01970982|Candidate modified risk tobacco product|candidate modified risk tobacco product
377802|NCT01970982|Conventional cigarette|conventional cigarette
377803|NCT01970982|Reduced exposure|reduced exposure
377804|NCT01970982|HPHCs|hphcs
377805|NCT01970982|Confinement|confinement
377806|NCT01970969|Atrial Fibrillation|atrial fibrillation
377807|NCT01970969|Cardiac monitoring|cardiac monitoring
377808|NCT01970969|Genomics|genomics
377809|NCT01970943|migraine, headache, episodic, chronic, pain|migraine, headache, episodic, chronic, pain
377810|NCT01970930|Tissue banking|tissue banking
377811|NCT01970917|tear film thickness|tear film thickness
377812|NCT01970917|optical coherence tomography|optical coherence tomography
377813|NCT01970917|topical lubricants|topical lubricants
377814|NCT01970917|tear film thickness in healthy subjects|tear film thickness in healthy subjects
377815|NCT01970904|Chronic hepatitis C|chronic hepatitis c
377816|NCT01970904|DEB025|deb025
377817|NCT01970904|Alisporivir|alisporivir
377818|NCT01970904|ribavirin therapy|ribavirin therapy
377819|NCT01970904|genotype 2/3 treatment naive patients|genotype 2/3 treatment naive patients
377820|NCT01970891|Freezing of Gait|freezing of gait
377821|NCT01970891|Gait|gait
377822|NCT01970891|Comfort|comfort
377823|NCT01970891|Pain tolerance|pain tolerance
377824|NCT01970891|Pain|pain
377825|NCT01970891|Sensory threshold|sensory threshold
377826|NCT01970891|Motor threshold|motor threshold
377827|NCT01970891|Pain threshold|pain threshold
377828|NCT01970865|Phase 1|phase 1
377829|NCT01970865|Phase 2|phase 2
377830|NCT01970865|safety|safety
377831|NCT01970865|pharmacokinetic|pharmacokinetic
377832|NCT01970865|pharmacodynamic|pharmacodynamic
377833|NCT01970865|efficacy|efficacy
377834|NCT01970852|Inpatient|inpatient
377835|NCT01970852|PHR Portal|phr portal
377836|NCT01970852|Information Technology|information technology
377837|NCT01970839|Tourniquet|tourniquet
377838|NCT01970839|Endoneural|endoneural
377839|NCT01970839|Ischemia|ischemia
377840|NCT01970826|aseptic sterilized field|aseptic sterilized field
377841|NCT01970826|clean sterilized field|clean sterilized field
377842|NCT01970826|dental implants|dental implants
377843|NCT01970826|Surgery|surgery
377844|NCT01970813|Parkinson's disease|parkinson's disease
377845|NCT01970813|Idiopathic Parkinson's disease|idiopathic parkinson's disease
377846|NCT01970813|acupuncture|acupuncture
377847|NCT01970813|bee venom acupuncture|bee venom acupuncture
377848|NCT01970800|IGF-1|igf-1
377849|NCT01970800|Short Stature|short stature
377850|NCT01970800|GH|gh
377851|NCT01970748|Variceal bleeding|variceal bleeding
377852|NCT01970748|Portal hypertension|portal hypertension
377853|NCT01970748|Hepatocellular carcinoma|hepatocellular carcinoma
377854|NCT01970748|Endoscopic variceal ligation|endoscopic variceal ligation
377855|NCT01970748|Non-selective beta-blocker|non-selective beta-blocker
377856|NCT01970709|Adverse Drug Reactions|adverse drug reactions
377857|NCT01970709|Emergency Department Visits|emergency department visits
377858|NCT01970709|Hospitalizations|hospitalizations
377859|NCT01970709|Pharmacogenomic|pharmacogenomic
377860|NCT01970696|ovarian|ovarian
377861|NCT01970696|testicular|testicular
377862|NCT01970696|stromal|stromal
377863|NCT01970696|Sertoli|sertoli
377864|NCT01970696|Leydig|leydig
377865|NCT01970696|gynandroblastoma|gynandroblastoma
377866|NCT01970696|juvenile granulosa cell tumor|juvenile granulosa cell tumor
377867|NCT01970696|DICER1|dicer1
377868|NCT01970657|Venous Stasis Ulcer|venous stasis ulcer
377869|NCT01970657|VLU|vlu
377870|NCT01970644|Neoplasm metastasis|neoplasm metastasis
377871|NCT01970644|Brain neoplasms|brain neoplasms
377872|NCT01970644|Radiosurgery|radiosurgery
377873|NCT01970644|Cognition disorders|cognition disorders
377874|NCT01970644|Cranial irradiation|cranial irradiation
377875|NCT01970631|Osteoarthritis|osteoarthritis
377876|NCT01970631|Total Knee Replacement|total knee replacement
377877|NCT01970631|total Knee Arthroplasty|total knee arthroplasty
377878|NCT01970631|Post-operative recovery TKR|post-operative recovery tkr
377879|NCT01970631|Physical Activity|physical activity
377880|NCT01970631|Motivational Interviewing|motivational interviewing
377881|NCT01970631|Financial Incentives|financial incentives
377882|NCT01970592|exercise|exercise
377883|NCT01970592|rehabilitation|rehabilitation
377884|NCT01970592|walking|walking
377885|NCT01970566|Intense Exercise/Moderate Calorie Restriction|intense exercise/moderate calorie restriction
377886|NCT01970566|Topiramate-Phentermine|topiramate-phentermine
377887|NCT01970553|lurbinectedin|lurbinectedin
377888|NCT01970553|PM01183|pm01183
377889|NCT01970553|tumors|tumors
377890|NCT01970553|cancer|cancer
377891|NCT01970553|Pharma Mar|pharma mar
377892|NCT01970540|lurbinectedin|lurbinectedin
377893|NCT01970540|PM01183|pm01183
377894|NCT01970540|tumors|tumors
377895|NCT01970540|cancer|cancer
377896|NCT01970540|Pharma Mar|pharma mar
377897|NCT01970501|atrial fibrillation|atrial fibrillation
377898|NCT01970501|atrial flutter|atrial flutter
377899|NCT01970501|heart failure|heart failure
377900|NCT01970501|reduced left ventricle ejection fraction|reduced left ventricle ejection fraction
377901|NCT01970501|electrical cardioversion|electrical cardioversion
377902|NCT01970501|GENETIC-AF|genetic-af
377903|NCT01970501|Medtronic|medtronic
377904|NCT01970501|bucindolol|bucindolol
377905|NCT01970501|pharmacogenetic|pharmacogenetic
377906|NCT01970501|ARCA|arca
377907|NCT01970501|Toprol|toprol
377908|NCT01970501|Toprol-XL|toprol-xl
377909|NCT01970501|Metoprolol|metoprolol
377910|NCT01970501|Metoprolol succinate|metoprolol succinate
377911|NCT01970488|Plaque Psoriasis|plaque psoriasis
377912|NCT01970475|Arthritis|arthritis
377913|NCT01970475|Rheumatoid|rheumatoid
377914|NCT01970436|Prenatal care|prenatal care
377915|NCT01970436|Pregnancy|pregnancy
377916|NCT01970436|Obstetrics|obstetrics
377917|NCT01970436|Telemedicine|telemedicine
377918|NCT01970423|Patients with pacemaker or ICD therapy|patients with pacemaker or icd therapy
377919|NCT01970410|teriflunomide|teriflunomide
377920|NCT01970410|natalizumab|natalizumab
377921|NCT01970410|relapsing multiple sclerosis|relapsing multiple sclerosis
377922|NCT01970384|transcranial direct current stimulation|transcranial direct current stimulation
377923|NCT01970384|stroke-related dysphagia|stroke-related dysphagia
377924|NCT01970384|cortical plasticity|cortical plasticity
377925|NCT01970371|Gram-negative|gram-negative
377926|NCT01970371|bacterial infection|bacterial infection
377927|NCT01970371|antibacterial|antibacterial
377928|NCT01970371|antimicrobial|antimicrobial
377929|NCT01970371|CRE|cre
377930|NCT01970371|CPE|cpe
377931|NCT01970371|BSI|bsi
377932|NCT01970371|pneumonia|pneumonia
377933|NCT01970371|HABP|habp
377934|NCT01970371|VABP|vabp
377935|NCT01970371|AP|ap
377936|NCT01970371|cUTI|cuti
377937|NCT01970371|UTI|uti
377938|NCT01970358|melanoma|melanoma
377939|NCT01970358|melanoma vaccine|melanoma vaccine
377940|NCT01970358|adjuvant therapy|adjuvant therapy
377941|NCT01970345|Autism Spectrum Disorder|autism spectrum disorder
377942|NCT01970345|IGF-1|igf-1
377943|NCT01970332|Peripheral Arterial Disease|peripheral arterial disease
377944|NCT01970332|Peripheral Vascular Disease|peripheral vascular disease
377945|NCT01970332|Claudication|claudication
377946|NCT01970332|Myopathy|myopathy
377947|NCT01970332|Oxidative stress|oxidative stress
377948|NCT01970332|Mitochondrial dysfunction|mitochondrial dysfunction
377949|NCT01970332|Biomechanics|biomechanics
377950|NCT01970332|Inflammation|inflammation
377951|NCT01970306|Esophageal Reinforcement|esophageal reinforcement
377952|NCT01970306|ACell MatriStem|acell matristem
377953|NCT01970306|13-178|13-178
377954|NCT01970293|Alcohol use|alcohol use
377955|NCT01970293|STI|sti
377956|NCT01970293|Incarcerated women|incarcerated women
377957|NCT01970293|AA|aa
377958|NCT01970254|hepatitis B virus infection|hepatitis b virus infection
377959|NCT01970254|HBV|hbv
377960|NCT01970254|Cancer Patients|cancer patients
377961|NCT01970254|chemotherapy|chemotherapy
377962|NCT01970254|HBV screening strategy|hbv screening strategy
377963|NCT01970254|HBV care|hbv care
377964|NCT01970254|chronic HBV|chronic hbv
377965|NCT01970254|concomitant HBV infection|concomitant hbv infection
377966|NCT01970254|viral infections|viral infections
377967|NCT01970241|corticosteroid|corticosteroid
377968|NCT01970241|diabetes|diabetes
377969|NCT01970241|insulin|insulin
377970|NCT01970202|obesity|obesity
377971|NCT01970202|overweight|overweight
377972|NCT01970202|sleeve gastrectomy|sleeve gastrectomy
377973|NCT01970189|Immune Thrombocytopenia|immune thrombocytopenia
377974|NCT01970189|Primary Immune Thrombocytopenia|primary immune thrombocytopenia
377975|NCT01970189|Purpura, Thrombocytopenic, Idiopathic|purpura, thrombocytopenic, idiopathic
377976|NCT01970189|Autoimmune Thrombocytopenia|autoimmune thrombocytopenia
377977|NCT01970189|Thrombocytopenia|thrombocytopenia
377978|NCT01970163|Diabetic foot ulcer|diabetic foot ulcer
377979|NCT01970163|Venous stasis ulcer|venous stasis ulcer
377980|NCT01970163|Wound of the lower extremity|wound of the lower extremity
377981|NCT01970163|Skin substitute|skin substitute
377982|NCT01970163|Acellular Dermal Matrix|acellular dermal matrix
377983|NCT01970150|rTMS|rtms
377984|NCT01970150|Alzheimer Disease|alzheimer disease
377985|NCT01970150|Memory|memory
377986|NCT01970150|attention|attention
377987|NCT01970150|EEG|eeg
377988|NCT01970137|Spinocerebellar degeneration (SCD)|spinocerebellar degeneration (scd)
377989|NCT01970137|Thyrotropin-Releasing Hormone (TRH)|thyrotropin-releasing hormone (trh)
377990|NCT01970137|Spinocerebellar Ataxia (SCA)|spinocerebellar ataxia (sca)
377991|NCT01970124|Spinocerebellar degeneration (SCD)|spinocerebellar degeneration (scd)
377992|NCT01970124|Thyrotropin-Releasing Hormone (TRH)|thyrotropin-releasing hormone (trh)
377993|NCT01970124|Spinocerebellar Ataxia (SCA)|spinocerebellar ataxia (sca)
377994|NCT01970111|Spinocerebellar degeneration (SCD)|spinocerebellar degeneration (scd)
377995|NCT01970111|Thyrotropin-Releasing Hormone (TRH)|thyrotropin-releasing hormone (trh)
378096|NCT01969682|Relapsed|relapsed
377996|NCT01970111|Spinocerebellar Ataxia (SCA)|spinocerebellar ataxia (sca)
377997|NCT01970111|Cortical Cerebellar Atrophy (CCA)|cortical cerebellar atrophy (cca)
377998|NCT01970098|Spinocerebellar degeneration (SCD)|spinocerebellar degeneration (scd)
377999|NCT01970098|Thyrotropin-Releasing Hormone (TRH)|thyrotropin-releasing hormone (trh)
378000|NCT01970098|Spinocerebellar Ataxia (SCA)|spinocerebellar ataxia (sca)
378001|NCT01970098|Cortical Cerebellar Atrophy (CCA)|cortical cerebellar atrophy (cca)
378002|NCT01970072|Remimazolam Tosylate|remimazolam tosylate
378003|NCT01970072|Phase Ⅰ study|phase ⅰ study
378004|NCT01970072|Health|health
378005|NCT01970059|Hypertension|hypertension
378006|NCT01970046|SP2086|sp2086
378007|NCT01970046|Phase III|phase iii
378008|NCT01970046|combination therapy|combination therapy
378009|NCT01970033|SP2086|sp2086
378010|NCT01970033|Phase III|phase iii
378011|NCT01970033|Monotherapy|monotherapy
378012|NCT01970020|Healthy|healthy
378013|NCT01970020|JNJ-38518168|jnj-38518168
378014|NCT01970020|14C-JNJ-38518168|14c-jnj-38518168
378015|NCT01970020|Absorption|absorption
378016|NCT01970020|Metabolism|metabolism
378017|NCT01970020|Excretion|excretion
378018|NCT01970007|venous|venous
378019|NCT01970007|outflow obstruction|outflow obstruction
378020|NCT01970007|iliofemoral vein|iliofemoral vein
378021|NCT01969994|Epicatechin|epicatechin
378022|NCT01969994|Flavanols|flavanols
378023|NCT01969994|Procyanidins|procyanidins
378024|NCT01969994|Polyphenols|polyphenols
378025|NCT01969994|Phytonutrients|phytonutrients
378026|NCT01969994|AMDE|amde
378027|NCT01969994|Antioxidants|antioxidants
378028|NCT01969981|Peripheral Inserted Central Catheter|peripheral inserted central catheter
378029|NCT01969955|nanoparticle albumin-bound paclitaxel|nanoparticle albumin-bound paclitaxel
400560|NCT01866280|Food intake|food intake
378030|NCT01969955|Squamous Cell Carcinoma of Lung|squamous cell carcinoma of lung
378031|NCT01969942|Ewings sarcoma|ewings sarcoma
378032|NCT01969916|Cardiac CT imaging|cardiac ct imaging
378033|NCT01969916|Myocardial ischemia|myocardial ischemia
378034|NCT01969916|Myocardial perfusion|myocardial perfusion
378035|NCT01969916|Vasodilator stress testing|vasodilator stress testing
378036|NCT01969916|Regadenoson|regadenoson
378037|NCT01969903|brachial plexus block|brachial plexus block
378038|NCT01969903|lidocaine|lidocaine
378039|NCT01969903|dexmedetomidine|dexmedetomidine
378040|NCT01969903|bradycardia|bradycardia
378041|NCT01969903|hypotension|hypotension
378042|NCT01969877|Head and neck cancer|head and neck cancer
378043|NCT01969877|Cetuximab|cetuximab
378044|NCT01969877|Cisplatin|cisplatin
378045|NCT01969877|Radiotherapy|radiotherapy
378046|NCT01969877|Quality of life|quality of life
378047|NCT01969877|Human papilloma virus|human papilloma virus
378048|NCT01969877|Health economy|health economy
378049|NCT01969877|Biomarker investigations|biomarker investigations
378050|NCT01969864|Randomized Controlled Trial|randomized controlled trial
378051|NCT01969864|Healthcare Disparities|healthcare disparities
378052|NCT01969851|Lacosamide|lacosamide
378053|NCT01969851|Vimpat|vimpat
378054|NCT01969851|Epilepsy|epilepsy
378055|NCT01969851|Children|children
378056|NCT01969825|Infertility|infertility
378057|NCT01969825|Intrauterine insemination|intrauterine insemination
378058|NCT01969825|Male factor infertility|male factor infertility
378059|NCT01969825|Massage|massage
378060|NCT01969825|Total motile sperm count|total motile sperm count
378061|NCT01969812|Infertility|infertility
378062|NCT01969812|Intrauterine Insemination|intrauterine insemination
378063|NCT01969812|Slow-release Insemination|slow-release insemination
378064|NCT01969812|Evie|evie
378065|NCT01969799|Gram-negative pneumonia|gram-negative pneumonia
378066|NCT01969799|Aerosol antibiotics|aerosol antibiotics
378067|NCT01969799|Mechanical ventilation|mechanical ventilation
378068|NCT01969799|Amikacin|amikacin
378069|NCT01969799|Fosfomycin|fosfomycin
378070|NCT01969799|Pneumonia, Bacterial|pneumonia, bacterial
378071|NCT01969799|Pneumonia|pneumonia
378072|NCT01969799|Bacterial Infections|bacterial infections
378073|NCT01969799|Lung Diseases|lung diseases
378074|NCT01969799|Respiratory Tract Diseases|respiratory tract diseases
378075|NCT01969799|Respiratory Tract Infections|respiratory tract infections
378076|NCT01969799|Anti-Bacterial Agents|anti-bacterial agents
378077|NCT01969799|Anti-Infective Agents|anti-infective agents
378078|NCT01969799|Therapeutic Uses|therapeutic uses
378079|NCT01969799|Pharmacologic Actions|pharmacologic actions
378080|NCT01969773|Botulinum Toxin A (BoNT-A)|botulinum toxin a (bont-a)
378081|NCT01969773|Interstitial Cystitis|interstitial cystitis
378082|NCT01969734|Emphysema|emphysema
378083|NCT01969734|Moderate COPD|moderate copd
378084|NCT01969734|Hyperinflation|hyperinflation
378085|NCT01969734|Endobronchial valves|endobronchial valves
378086|NCT01969695|ABT-199|abt-199
378087|NCT01969695|Cancer|cancer
378088|NCT01969695|GDC-0199|gdc-0199
378089|NCT01969695|non-Hodgkin's lymphoma|non-hodgkin's lymphoma
378090|NCT01969695|Relapsed|relapsed
378091|NCT01969695|Refractory|refractory
378092|NCT01969695|Safety|safety
378093|NCT01969682|non-Hodgkin's lymphoma|non-hodgkin's lymphoma
378094|NCT01969682|GDC-0199|gdc-0199
378095|NCT01969682|Safety|safety
378097|NCT01969682|Refractory|refractory
378098|NCT01969682|ABT-199|abt-199
378099|NCT01969682|Pharmacokinetics|pharmacokinetics
378100|NCT01969682|Cancer|cancer
378101|NCT01969669|non-Hodgkin's lymphoma|non-hodgkin's lymphoma
378102|NCT01969669|GDC-0199|gdc-0199
378103|NCT01969669|Safety|safety
378104|NCT01969669|Relapsed|relapsed
378105|NCT01969669|Refractory|refractory
378106|NCT01969669|ABT-199|abt-199
378107|NCT01969669|Pharmacokinetics|pharmacokinetics
378108|NCT01969669|Cancer|cancer
378109|NCT01969656|vitamin D analog|vitamin d analog
378110|NCT01969643|Breast cancer|breast cancer
378111|NCT01969643|Monomethyl auristatin E|monomethyl auristatin e
378112|NCT01969643|Antibody-drug conjugate|antibody-drug conjugate
378113|NCT01969643|Drug therapy|drug therapy
378114|NCT01969643|Metastatic|metastatic
378115|NCT01969643|LIV-1 protein, human|liv-1 protein, human
378116|NCT01969643|Trastuzumab|trastuzumab
378117|NCT01969643|Ladiratuzumab vedotin|ladiratuzumab vedotin
378118|NCT01969643|hLIV22-vcMMAE|hliv22-vcmmae
378119|NCT01969630|femoropopliteal lesions|femoropopliteal lesions
378120|NCT01969604|Rheumatoid Arthritis|rheumatoid arthritis
378121|NCT01969604|Sedentary Behaviour|sedentary behaviour
378122|NCT01969604|Motivational Counselling|motivational counselling
378123|NCT01969604|Short Text Message Service|short text message service
378124|NCT01969604|Fatigue|fatigue
378125|NCT01969604|Pain|pain
378126|NCT01969604|Self-efficacy|self-efficacy
378127|NCT01969604|ActivPAL|activpal
378128|NCT01969591|Fast track surgery, Laparoscopic surgery, colorectal cancer|fast track surgery, laparoscopic surgery, colorectal cancer
378129|NCT01969578|salivary duct cancer|salivary duct cancer
378130|NCT01969578|adenocarcinoma, NOS|adenocarcinoma, nos
378131|NCT01969578|androgen deprivation|androgen deprivation
378132|NCT01969578|androgen receptor|androgen receptor
378133|NCT01969552|TSH, thyroid hormones, thyroid tresting, levothyroxine|tsh, thyroid hormones, thyroid tresting, levothyroxine
378134|NCT01969526|Frail elderly|frail elderly
378135|NCT01969513|Vestibular Diseases|vestibular diseases
378136|NCT01969513|Vertigo|vertigo
378137|NCT01969513|Primary care|primary care
378138|NCT01969513|Epley maneuver|epley maneuver
378139|NCT01969500|Schizophrenia|schizophrenia
378140|NCT01969500|Schizoaffective Disorder|schizoaffective disorder
378141|NCT01969500|Self Management of Schizophrenia|self management of schizophrenia
378142|NCT01969500|SOS|sos
378143|NCT01969500|Serious Mental Illness|serious mental illness
378144|NCT01969500|Psychosis|psychosis
378145|NCT01969500|Social Dysfunction|social dysfunction
378146|NCT01969500|Medication Adherence|medication adherence
378147|NCT01969500|Mobile Application|mobile application
378148|NCT01969500|EHealth|ehealth
378149|NCT01969500|E-Health|e-health
378150|NCT01969500|Health Technology|health technology
378151|NCT01969500|mobile health|mobile health
378152|NCT01969500|m-Health|m-health
378153|NCT01969500|electronic health|electronic health
378154|NCT01969474|Tinnitus Cannabis|tinnitus cannabis
378155|NCT01969461|HIV positive|hiv positive
378156|NCT01969461|Adolescents|adolescents
378157|NCT01969461|Adolescent Trials Network|adolescent trials network
378158|NCT01969461|Comparative Effectiveness Trial|comparative effectiveness trial
378159|NCT01969461|Implementation|implementation
378160|NCT01969461|Adherence Intervention|adherence intervention
378161|NCT01969461|Alcohol Intervention|alcohol intervention
378162|NCT01969448|Nipple-areola skin sparing mastectomy|nipple-areola skin sparing mastectomy
378163|NCT01969448|Immediate reconstruction|immediate reconstruction
378164|NCT01969448|Prophylactic Mastectomy|prophylactic mastectomy
378165|NCT01969448|Breast-Q|breast-q
378166|NCT01969448|Breast Cancer|breast cancer
378167|NCT01969448|Ductal Carcinoma in Situ - Category|ductal carcinoma in situ - category
378168|NCT01969409|Lung|lung
378169|NCT01969409|Fibrosis|fibrosis
378170|NCT01969396|Biopsy|biopsy
378171|NCT01969396|Endometrial biopsy|endometrial biopsy
378172|NCT01969396|Endometrial sampling|endometrial sampling
378173|NCT01969396|sonohysterography|sonohysterography
378174|NCT01969383|healthy|healthy
378175|NCT01969370|Cancer|cancer
378176|NCT01969370|Cardiovascular disease|cardiovascular disease
378177|NCT01969370|Neurodegenerative disease|neurodegenerative disease
378178|NCT01969370|Neurodevelopmental disease|neurodevelopmental disease
378179|NCT01969370|Dysmorphology|dysmorphology
378180|NCT01969370|Hearing loss|hearing loss
378181|NCT01969370|Other conditions, including ophthalmic conditions|other conditions, including ophthalmic conditions
378182|NCT01969357|Sp2086|sp2086
378183|NCT01969357|Phase II|phase ii
378184|NCT01969357|monotherapy|monotherapy
378185|NCT01969331|Gastritis|gastritis
378186|NCT01969331|Helicobacter pylori|helicobacter pylori
378187|NCT01969318|SP2086|sp2086
378188|NCT01969318|Phase II|phase ii
378189|NCT01969318|combination therapy|combination therapy
378190|NCT01969305|Kazakhstan|kazakhstan
378191|NCT01969305|Central Asia|central asia
378192|NCT01969305|HIV prevention|hiv prevention
378193|NCT01969305|Adolescents|adolescents
378194|NCT01969305|Sexual risk behaviors|sexual risk behaviors
378195|NCT01969305|Drug abuse prevention|drug abuse prevention
378388|NCT01968356|CHG|chg
378196|NCT01969305|Multi-media intervention|multi-media intervention
378197|NCT01969305|Drug use|drug use
378198|NCT01969292|colonoscopy|colonoscopy
378199|NCT01969292|quality assurance|quality assurance
378200|NCT01969279|Osteoporosis|osteoporosis
378201|NCT01969279|Bisphosphonate|bisphosphonate
378202|NCT01969279|Atypical femoral fracture|atypical femoral fracture
378203|NCT01969279|Side effect|side effect
378204|NCT01969266|Healthy volunteer|healthy volunteer
378205|NCT01969266|PCI-32765|pci-32765
378206|NCT01969266|PCI 45227|pci 45227
378207|NCT01969266|JNJ-54179060|jnj-54179060
378208|NCT01969266|Pharmacokinetic|pharmacokinetic
378209|NCT01969253|Breast Cancer, Axillary Lymph Node Dissection, Lymphedema|breast cancer, axillary lymph node dissection, lymphedema
378210|NCT01969240|Chest Pain|chest pain
378211|NCT01969240|Decision Aid|decision aid
378212|NCT01969240|Acute Coronary Syndrome|acute coronary syndrome
378213|NCT01969240|Cardiac|cardiac
378214|NCT01969240|Emergency Department|emergency department
378215|NCT01969240|Cardiac Testing|cardiac testing
378216|NCT01969240|Healthcare Utilization|healthcare utilization
378217|NCT01969240|Patient Centered Outcomes|patient centered outcomes
378218|NCT01969240|Shared Decision Making|shared decision making
378219|NCT01969240|Unnecessary hospital admissions|unnecessary hospital admissions
378220|NCT01969227|Subanesthetic ketamine|subanesthetic ketamine
378221|NCT01969227|Mechanical ventilation|mechanical ventilation
378222|NCT01969227|Transpulmonary pressure|transpulmonary pressure
378223|NCT01969227|Spontaneous breathing trial|spontaneous breathing trial
378224|NCT01969227|Extubation|extubation
378225|NCT01969201|In vitro fertilization (IVF)|in vitro fertilization (ivf)
483547|NCT01498601|coma|coma
378226|NCT01969201|Assisted reproduction technologies (ART)|assisted reproduction technologies (art)
378227|NCT01969201|GnRH-antagonist|gnrh-antagonist
378228|NCT01969201|Follicle stimulating hormone (FSH)|follicle stimulating hormone (fsh)
378229|NCT01969188|spondyloarthritis|spondyloarthritis
378230|NCT01969188|ankylosing spondylitis|ankylosing spondylitis
378231|NCT01969188|psoriatic arthritis|psoriatic arthritis
378232|NCT01969149|Stress Hyperglycemia|stress hyperglycemia
378233|NCT01969149|Perioperative glycemic control|perioperative glycemic control
378234|NCT01969149|Cardiac surgery|cardiac surgery
378235|NCT01969149|Coronary artery bypass surgery|coronary artery bypass surgery
378236|NCT01969136|Alzheimer's disease|alzheimer's disease
378237|NCT01969136|Cognition|cognition
378238|NCT01969136|Alpha-7 nAChR|alpha-7 nachr
378239|NCT01969123|Alzheimer's disease|alzheimer's disease
378240|NCT01969123|Cognition|cognition
378241|NCT01969123|Alpha-7 nAChR|alpha-7 nachr
378242|NCT01969110|Immunonutrition|immunonutrition
378243|NCT01969097|Stroke|stroke
378244|NCT01969097|Hemiparesis|hemiparesis
378245|NCT01969097|tDCS|tdcs
378246|NCT01969097|Motor cortex|motor cortex
378247|NCT01969084|Type II Diabetes Mellitus|type ii diabetes mellitus
378248|NCT01969084|Diabetes|diabetes
378249|NCT01969084|Metabolism|metabolism
378250|NCT01969084|Linagliptin|linagliptin
378251|NCT01969084|Tradjenta|tradjenta
378252|NCT01969084|Glucose|glucose
378253|NCT01969071|levosimendan|levosimendan
378254|NCT01969071|mitral valve surgery|mitral valve surgery
378255|NCT01969071|cardiopulmonary bypass|cardiopulmonary bypass
378256|NCT01969071|serum creatinine|serum creatinine
378257|NCT01969071|estimated glomerular filtration rate|estimated glomerular filtration rate
378258|NCT01969071|ejection fraction|ejection fraction
378259|NCT01969058|Isotretinoin|isotretinoin
378260|NCT01969058|HIV-1|hiv-1
378261|NCT01969058|immunology markers|immunology markers
378262|NCT01969058|immune activation|immune activation
378263|NCT01969058|viral suppression|viral suppression
378264|NCT01969045|felxible bronchoscopy|felxible bronchoscopy
378265|NCT01969045|anaesthetics|anaesthetics
378266|NCT01969045|transcutaneous pCO2|transcutaneous pco2
378267|NCT01969045|capillary pCO2|capillary pco2
378268|NCT01969006|inguinal hernia, postoperative pain, localanesthesia, nerve blockage|inguinal hernia, postoperative pain, localanesthesia, nerve blockage
378269|NCT01968993|Degenerative Disc Disease|degenerative disc disease
378270|NCT01968980|High Risk of cardiovascular events|high risk of cardiovascular events
378271|NCT01968980|Heterozygous familial hypercholesterolemia|heterozygous familial hypercholesterolemia
378272|NCT01968967|mixed dyslipidemia|mixed dyslipidemia
378273|NCT01968967|high risk of cardiovascular events|high risk of cardiovascular events
378274|NCT01968967|multiple cardiovascular disease risk factors|multiple cardiovascular disease risk factors
378275|NCT01968954|mixed dyslipidemia|mixed dyslipidemia
378276|NCT01968954|high risk of cardiovascular events|high risk of cardiovascular events
378277|NCT01968941|stereotactic body radiotherapy|stereotactic body radiotherapy
378278|NCT01968941|conventional radiotherapy|conventional radiotherapy
378279|NCT01968941|inoperable patients|inoperable patients
378280|NCT01968941|local control|local control
378281|NCT01968941|cancer recurrence|cancer recurrence
378282|NCT01968941|toxicity|toxicity
378283|NCT01968941|survival|survival
378284|NCT01968928|Bladder urothelial carcinoma (UC)|bladder urothelial carcinoma (uc)
378285|NCT01968928|pyruvate kinase|pyruvate kinase
378286|NCT01968928|drug resistance|drug resistance
378287|NCT01968928|shikonin|shikonin
378389|NCT01968356|IPA|ipa
378588|NCT01967485|ADHD|adhd
378288|NCT01968915|LCL161, Paclitaxel, Japanese patient, Neoplasms|lcl161, paclitaxel, japanese patient, neoplasms
378289|NCT01968902|spasticity|spasticity
378290|NCT01968902|lower limb|lower limb
378291|NCT01968902|multiple sclerosis|multiple sclerosis
378292|NCT01968902|toxin|toxin
378293|NCT01968889|Critical illness neuromyopathy|critical illness neuromyopathy
378294|NCT01968889|Diaphragm dysfunction|diaphragm dysfunction
378295|NCT01968889|Mechanical ventilation|mechanical ventilation
378296|NCT01968889|Weaning|weaning
378297|NCT01968889|Ultrasound|ultrasound
378298|NCT01968850|osteoporosis|osteoporosis
378299|NCT01968850|HIV|hiv
378300|NCT01968850|bone Mineral Density|bone mineral density
378301|NCT01968850|alendronate|alendronate
378302|NCT01968850|vitamin D|vitamin d
378303|NCT01968824|pain|pain
378304|NCT01968798|ACES|aces
378305|NCT01968798|ASPREE Cancer Endpoints Study|aspree cancer endpoints study
378306|NCT01968798|Cancer|cancer
378307|NCT01968798|Aspirin|aspirin
378308|NCT01968798|Tumor|tumor
378309|NCT01968772|Fibromyalgia|fibromyalgia
378310|NCT01968772|Fibromyalgia Syndrome|fibromyalgia syndrome
378311|NCT01968772|Magnesium Chloride|magnesium chloride
378312|NCT01968772|Transdermal Magnesium Chloride|transdermal magnesium chloride
378313|NCT01968759|Chronic kidney disease|chronic kidney disease
378314|NCT01968759|Sevelamer carbonate|sevelamer carbonate
378315|NCT01968759|Proteinuria|proteinuria
378316|NCT01968759|Phosphate binders|phosphate binders
378317|NCT01968746|Sepsis|sepsis
378318|NCT01968746|Shock|shock
378319|NCT01968733|Pneumonia|pneumonia
378320|NCT01968733|CABP|cabp
378321|NCT01968733|CAP|cap
378322|NCT01968733|Macrolide|macrolide
378323|NCT01968707|surgical prep|surgical prep
378324|NCT01968707|CHG|chg
378325|NCT01968707|IPA|ipa
378326|NCT01968694|endometriosis|endometriosis
378327|NCT01968694|chronic pain|chronic pain
378328|NCT01968694|intravenous lidocaine|intravenous lidocaine
378329|NCT01968668|BAY94-8862|bay94-8862
378330|NCT01968668|MR antagonist|mr antagonist
378331|NCT01968668|Diabetic nephropathy|diabetic nephropathy
378332|NCT01968668|Japanese patients|japanese patients
378333|NCT01968655|Factor VIII Inhibitory Auto-antibodies|factor viii inhibitory auto-antibodies
378334|NCT01968642|Transthoracic echocardiograms|transthoracic echocardiograms
378335|NCT01968642|Appropriate Use Criteria|appropriate use criteria
378336|NCT01968642|Medical Education|medical education
378337|NCT01968629|Hepatocellular Carcinoma|hepatocellular carcinoma
378338|NCT01968590|Vitamin D|vitamin d
378339|NCT01968590|Cholecalciferol|cholecalciferol
378340|NCT01968590|Bone density|bone density
378341|NCT01968577|Coronary angioplasty|coronary angioplasty
378342|NCT01968577|Myocardial infarction|myocardial infarction
378343|NCT01968551|HIV-1|hiv-1
378345|NCT01968551|Treatment-Experienced|treatment-experienced
378346|NCT01968525|anemia|anemia
378347|NCT01968525|non-hypoxic apnoea|non-hypoxic apnoea
378348|NCT01968525|tracheal intubation|tracheal intubation
378349|NCT01968525|anesthesia|anesthesia
378350|NCT01968512|Attention Deficit Hyperactivity Disorder (ADHD);|attention deficit hyperactivity disorder (adhd);
378351|NCT01968512|Transcranial Direct Current Stimulation (tDCS);|transcranial direct current stimulation (tdcs);
378352|NCT01968512|Control Inhibitory;|control inhibitory;
378353|NCT01968512|Quantitative electroencephalography;|quantitative electroencephalography;
378354|NCT01968512|Functional Brain Network;|functional brain network;
378355|NCT01968512|Go/No Go test.|go/no go test.
378356|NCT01968499|coronary stent implantation; clopidogrel low response|coronary stent implantation; clopidogrel low response
378357|NCT01968473|Parkinson's disease|parkinson's disease
378358|NCT01968473|Freezing of Gait|freezing of gait
378359|NCT01968473|Neuromuscular Electrical Stimulation|neuromuscular electrical stimulation
378360|NCT01968473|Comfort|comfort
378361|NCT01968473|Pain tolerance|pain tolerance
378362|NCT01968473|Pain|pain
378363|NCT01968473|Sensory threshold|sensory threshold
378364|NCT01968473|Motor threshold|motor threshold
378365|NCT01968473|Pain threshold|pain threshold
378366|NCT01968460|Parkinson's Disease, Rasagiline, Pramipexole|parkinson's disease, rasagiline, pramipexole
378367|NCT01968434|cough|cough
378368|NCT01968434|common cold|common cold
378369|NCT01968434|antitussive agents|antitussive agents
378370|NCT01968434|mucosal protection|mucosal protection
378371|NCT01968434|medical device|medical device
378372|NCT01968421|OM-85, bronchiectasis, placebo, acute exacerbation|om-85, bronchiectasis, placebo, acute exacerbation
378373|NCT01968408|nosocomial diarrhea|nosocomial diarrhea
378374|NCT01968408|Lactobacillus reuteri DSM 17938|lactobacillus reuteri dsm 17938
378375|NCT01968408|rotavirus diarrhea|rotavirus diarrhea
378376|NCT01968408|probiotics|probiotics
378377|NCT01968382|IMM 124-E|imm 124-e
378378|NCT01968382|Bovine Colostrum|bovine colostrum
378379|NCT01968382|Alcoholic|alcoholic
378380|NCT01968382|Hepatitis|hepatitis
378381|NCT01968382|LPS|lps
378382|NCT01968382|Hyper-immune|hyper-immune
378383|NCT01968369|flow mediated vasodilatation|flow mediated vasodilatation
378384|NCT01968369|tomato|tomato
378385|NCT01968369|arterial stiffness|arterial stiffness
378386|NCT01968369|lycopene|lycopene
378387|NCT01968356|surgical skin prep|surgical skin prep
378390|NCT01968317|Endometrial Atypical Hyperplasia|endometrial atypical hyperplasia
378391|NCT01968317|Endometrial Adenocarcinoma|endometrial adenocarcinoma
378392|NCT01968317|Conservative Medication|conservative medication
378393|NCT01968304|Iron Status, Cancer|iron status, cancer
378394|NCT01968291|Health Literacy|health literacy
378395|NCT01968291|Teach-back|teach-back
378396|NCT01968291|Emergency|emergency
378397|NCT01968265|Type 2 Diabetes Mellitus|type 2 diabetes mellitus
378399|NCT01968252|Speckle-tracking echocardiography|speckle-tracking echocardiography
378400|NCT01968252|Transthoracic echocardiography|transthoracic echocardiography
378401|NCT01968252|Transesophageal echocardiography|transesophageal echocardiography
378402|NCT01968239|BRVO|brvo
378403|NCT01968239|Macular edema|macular edema
378404|NCT01968239|Ranibizumab|ranibizumab
378405|NCT01968239|re-treatment|re-treatment
378406|NCT01968226|carotid artery disease|carotid artery disease
378407|NCT01968226|carotid stenosis|carotid stenosis
378408|NCT01968226|carotid endarterectomy|carotid endarterectomy
378409|NCT01968226|RDG-K5|rdg-k5
378410|NCT01968226|PET imaging|pet imaging
378411|NCT01968213|ARIEL3|ariel3
378412|NCT01968213|ARIEL 3|ariel 3
378413|NCT01968213|platinum sensitive|platinum sensitive
378414|NCT01968213|PARP Inhibitor|parp inhibitor
378415|NCT01968213|rucaparib|rucaparib
378416|NCT01968213|homologous recombination|homologous recombination
483796|NCT01497639|GPi|gpi
378417|NCT01968213|homologous recombination deficiency|homologous recombination deficiency
378418|NCT01968213|CO-338|co-338
378419|NCT01968213|PF 01367338|pf 01367338
378420|NCT01968213|AG 14699|ag 14699
378421|NCT01968213|platinum sensitive ovarian cancer|platinum sensitive ovarian cancer
378422|NCT01968213|platinum sensitive fallopian tube cancer|platinum sensitive fallopian tube cancer
378423|NCT01968213|platinum sensitive primary peritoneal cancer|platinum sensitive primary peritoneal cancer
378424|NCT01968213|platinum sensitive peritoneal cancer|platinum sensitive peritoneal cancer
378425|NCT01968213|gynecological cancer|gynecological cancer
378426|NCT01968213|Clovis|clovis
378427|NCT01968213|Clovis Oncology|clovis oncology
378428|NCT01968200|cancer|cancer
378429|NCT01968200|chemotherapy|chemotherapy
378430|NCT01968200|anthracyclines|anthracyclines
378431|NCT01968174|astigmatism|astigmatism
378432|NCT01968174|lid surgery|lid surgery
378433|NCT01968174|older than 40 years|older than 40 years
378434|NCT01968174|can sign an acceptance form|can sign an acceptance form
378435|NCT01968174|uper lid surgery|uper lid surgery
378436|NCT01968148|glucose|glucose
378437|NCT01968148|cardiac arrest|cardiac arrest
378438|NCT01968148|resuscitation|resuscitation
378439|NCT01968148|insulin|insulin
378440|NCT01968148|GLP-1|glp-1
378441|NCT01968122|symptomatic Intracranial artery stenosis|symptomatic intracranial artery stenosis
378442|NCT01968122|conventional treatment|conventional treatment
378443|NCT01968122|stenting|stenting
378444|NCT01968122|stroke prevention|stroke prevention
378445|NCT01968122|medical treatment|medical treatment
378446|NCT01968122|endovascular treatment|endovascular treatment
378447|NCT01968096|Reflex|reflex
378448|NCT01968096|Post activation|post activation
378449|NCT01968096|Spinal cord injury|spinal cord injury
378450|NCT01968096|Pre-synaptic inhibition|pre-synaptic inhibition
378451|NCT01968096|Machine driven passive strech|machine driven passive strech
378452|NCT01968044|renal impairment|renal impairment
378453|NCT01968031|Parkinson's disease|parkinson's disease
378454|NCT01968031|Moderate to Severe Parkinson's Disease|moderate to severe parkinson's disease
378456|NCT01968018|Chronic Cancer Pain|chronic cancer pain
378457|NCT01968018|Tramadol HCI|tramadol hci
378458|NCT01968018|Acetaminophen|acetaminophen
378459|NCT01968018|Analgesics|analgesics
378460|NCT01968018|Pain assessment|pain assessment
378461|NCT01967992|diabetes|diabetes
378462|NCT01967992|obesity|obesity
378463|NCT01967992|mindful eating|mindful eating
378464|NCT01967992|positive affect|positive affect
378465|NCT01967992|low carbohydrate|low carbohydrate
378466|NCT01967992|ketogenic|ketogenic
378467|NCT01967992|diet|diet
378468|NCT01967940|HIV-1|hiv-1
378469|NCT01967940|HIV|hiv
378470|NCT01967940|Treatment-Experienced|treatment-experienced
378471|NCT01967927|carcinoma|carcinoma
378472|NCT01967927|cancer|cancer
378473|NCT01967927|head|head
378474|NCT01967927|neck|neck
378475|NCT01967927|otolaryngology|otolaryngology
378476|NCT01967901|Diabetic nephropathies|diabetic nephropathies
378477|NCT01967901|Nursing|nursing
378478|NCT01967901|Multidisciplinary|multidisciplinary
378479|NCT01967901|Self-care|self-care
378480|NCT01967901|Quality of Life|quality of life
378481|NCT01967888|Pancreatic islet auto-transplantation|pancreatic islet auto-transplantation
378482|NCT01967875|Gastric Cancer|gastric cancer
378483|NCT01967875|ERCC1|ercc1
378484|NCT01967875|Platinum|platinum
378485|NCT01967875|Chemotherapy|chemotherapy
378486|NCT01967849|obesity|obesity
378487|NCT01967849|type 2 diabetes|type 2 diabetes
378488|NCT01967836|Invasive Line|invasive line
378489|NCT01967836|IV Dressing protection|iv dressing protection
378490|NCT01967836|Hygiene|hygiene
378491|NCT01967836|Oncology|oncology
378492|NCT01967836|Ambulatory Care|ambulatory care
378493|NCT01967823|Metastatic Cancer|metastatic cancer
378494|NCT01967823|Gene Therapy|gene therapy
378495|NCT01967823|Immunotherapy|immunotherapy
378496|NCT01967823|Tumor Regression|tumor regression
378497|NCT01967823|Melanoma|melanoma
378498|NCT01967810|glioma|glioma
378499|NCT01967810|glioblastoma|glioblastoma
378500|NCT01967810|brain cancer|brain cancer
378501|NCT01967810|brain tumor|brain tumor
378502|NCT01967810|recurrent|recurrent
378503|NCT01967797|Obesity|obesity
378504|NCT01967784|Influenza|influenza
378505|NCT01967784|Quadrivalent Inactivated Influenza Vaccine|quadrivalent inactivated influenza vaccine
378506|NCT01967771|healthy volunteers|healthy volunteers
378507|NCT01967771|drug interaction|drug interaction
378508|NCT01967771|carbamazepine|carbamazepine
378509|NCT01967771|Dolutegravir|dolutegravir
378510|NCT01967771|pharmacokinetics|pharmacokinetics
378511|NCT01967758|Astrocytic Tumors|astrocytic tumors
378512|NCT01967758|Glioblastoma Multiforme|glioblastoma multiforme
378513|NCT01967758|Anaplastic Astrocytoma|anaplastic astrocytoma
378514|NCT01967758|Brain Tumor|brain tumor
378515|NCT01967758|Brain Cancer|brain cancer
378516|NCT01967758|Immunotherapy|immunotherapy
378517|NCT01967745|open appendectomy|open appendectomy
378518|NCT01967745|laparoscopic appendectomy|laparoscopic appendectomy
378519|NCT01967745|appendicitis|appendicitis
378520|NCT01967732|Smoking|smoking
378521|NCT01967732|Nicotine absorption|nicotine absorption
378522|NCT01967732|Modified risk tobacco product|modified risk tobacco product
378523|NCT01967732|Conventional cigarette|conventional cigarette
378524|NCT01967732|Nicotine replacement therapy|nicotine replacement therapy
378525|NCT01967732|Nicotine nasal spray|nicotine nasal spray
378526|NCT01967719|Smoking|smoking
378527|NCT01967719|Nicotine absorption|nicotine absorption
378528|NCT01967719|Candidate modified risk tobacco product|candidate modified risk tobacco product
378529|NCT01967719|Conventional cigarette|conventional cigarette
378530|NCT01967719|Nicotine replacement therapy: nasal spray|nicotine replacement therapy: nasal spray
378531|NCT01967706|Smoking|smoking
378532|NCT01967706|Nicotine absorption|nicotine absorption
378533|NCT01967706|Candidate modified risk tobacco product|candidate modified risk tobacco product
378534|NCT01967706|Cigarette|cigarette
378535|NCT01967706|Nicotine replacement therapy|nicotine replacement therapy
378536|NCT01967706|Nicotine gum|nicotine gum
378537|NCT01967693|Laryngeal contact granuloma|laryngeal contact granuloma
378538|NCT01967693|Treatment type|treatment type
378539|NCT01967693|Outcome|outcome
378540|NCT01967641|opioid dependence|opioid dependence
378541|NCT01967641|opioid abuse|opioid abuse
378542|NCT01967641|suboxone|suboxone
378543|NCT01967641|prescription pain medications|prescription pain medications
378544|NCT01967628|Vitamin D|vitamin d
378545|NCT01967628|Respiratory infection|respiratory infection
378546|NCT01967628|Innate immunity|innate immunity
378547|NCT01967615|PCI,|pci,
378548|NCT01967615|CTO,|cto,
378549|NCT01967615|bifurcation,|bifurcation,
378550|NCT01967615|clopidogrel,|clopidogrel,
378551|NCT01967615|prasugrel,|prasugrel,
378552|NCT01967615|ticagrelor|ticagrelor
378553|NCT01967602|Acute respiratory distress syndrome (ARDS)|acute respiratory distress syndrome (ards)
378554|NCT01967602|Extracorporeal membrane oxygenation (ECMO)|extracorporeal membrane oxygenation (ecmo)
378555|NCT01967602|biomarker|biomarker
378556|NCT01967576|Mutation in SDHB gene|mutation in sdhb gene
378557|NCT01967576|Mutation in SDHV gene|mutation in sdhv gene
378558|NCT01967576|Mutation in VHL gene|mutation in vhl gene
378559|NCT01967576|Pharmacogenomics analyses|pharmacogenomics analyses
378560|NCT01967576|Germline DNA examination|germline dna examination
378561|NCT01967563|Energy Expenditure|energy expenditure
378562|NCT01967563|Obesity|obesity
378563|NCT01967563|Carbohydrate|carbohydrate
378564|NCT01967563|Fat|fat
378565|NCT01967563|Ketones|ketones
378566|NCT01967550|Symptomatic knee OA Kellgren-Lawrence grade 1-3|symptomatic knee oa kellgren-lawrence grade 1-3
378567|NCT01967537|NET|net
378568|NCT01967537|MEN1|men1
378569|NCT01967537|Von Hippel Lindau (VHL)|von hippel lindau (vhl)
378570|NCT01967537|Surgical Resection|surgical resection
378571|NCT01967537|Somatostatin Receptor Status|somatostatin receptor status
378572|NCT01967524|Myofascial pain|myofascial pain
378573|NCT01967524|Perineal pain|perineal pain
378574|NCT01967524|Chronic pelvic pain|chronic pelvic pain
378575|NCT01967524|Botulinum toxin type A|botulinum toxin type a
378576|NCT01967524|Ropivacaïne|ropivacaïne
378577|NCT01967511|Cross-sectional study|cross-sectional study
378578|NCT01967511|Fibromuscular dysplasia|fibromuscular dysplasia
378579|NCT01967511|Fibroblast|fibroblast
378580|NCT01967511|Spontaneous Coronary Artery Dissection|spontaneous coronary artery dissection
378581|NCT01967511|Cervical Artery Dissection|cervical artery dissection
378582|NCT01967498|chronic otitis media with effusion|chronic otitis media with effusion
378583|NCT01967498|conductive hearing loss|conductive hearing loss
378584|NCT01967485|Attention Deficit Hyperactivity Disorder|attention deficit hyperactivity disorder
378585|NCT01967485|Medication adherence|medication adherence
378586|NCT01967485|Disease management|disease management
378587|NCT01967485|Text message|text message
378589|NCT01967485|Children|children
378590|NCT01967485|Reminder systems|reminder systems
378591|NCT01967485|Text Messaging|text messaging
378592|NCT01967485|Telemedicine|telemedicine
378593|NCT01967433|Fentanyl|fentanyl
378594|NCT01967433|Midazolam|midazolam
378595|NCT01967433|Sedation|sedation
378596|NCT01967433|Patient tolerance|patient tolerance
378597|NCT01967433|Duration of colonoscopy|duration of colonoscopy
378598|NCT01967420|Cognitive remediation|cognitive remediation
378599|NCT01967420|Social cognition training|social cognition training
378600|NCT01967420|First episode psychosis|first episode psychosis
378601|NCT01967420|Schizophrenia|schizophrenia
378602|NCT01967407|kidney tumor|kidney tumor
378603|NCT01967407|renal cell cancer|renal cell cancer
378605|NCT01967407|irreversible electroporation|irreversible electroporation
378606|NCT01967407|IRE|ire
378607|NCT01967407|partial kidney resection|partial kidney resection
378608|NCT01967407|percutaneous|percutaneous
378609|NCT01967407|ablation|ablation
378610|NCT01967407|IRENE|irene
378611|NCT01967394|Health Care Quality|health care quality
378612|NCT01967394|Access|access
378613|NCT01967394|Evaluation|evaluation
378614|NCT01967368|Influenza vaccine|influenza vaccine
378615|NCT01967368|intradermal|intradermal
378616|NCT01967368|intramuscular|intramuscular
378617|NCT01967368|efficacy|efficacy
378618|NCT01967368|safety|safety
378619|NCT01967355|preeclampsia|preeclampsia
378620|NCT01967355|lipid apheresis|lipid apheresis
378621|NCT01967355|apheresis|apheresis
378622|NCT01967342|chronic pain|chronic pain
378623|NCT01967342|pain|pain
378624|NCT01967342|chronic pain syndrome|chronic pain syndrome
378625|NCT01967342|widespread chronic pain|widespread chronic pain
378626|NCT01967342|back pain|back pain
378627|NCT01967342|literacy|literacy
378628|NCT01967342|health literacy|health literacy
378629|NCT01967342|group therapy|group therapy
378630|NCT01967342|psychosocial treatment|psychosocial treatment
378631|NCT01967342|cognitive-behavioral therapy|cognitive-behavioral therapy
378632|NCT01967342|pain education|pain education
378633|NCT01967342|health disparities|health disparities
378634|NCT01967342|patient-centered outcomes|patient-centered outcomes
378635|NCT01967303|Restless legs syndrome|restless legs syndrome
378636|NCT01967303|Stroke|stroke
378637|NCT01967303|Transient ischemic attack|transient ischemic attack
378638|NCT01967303|Cerebrovascular risk factors|cerebrovascular risk factors
378639|NCT01967290|stroke|stroke
378640|NCT01967290|motor deficits|motor deficits
378641|NCT01967290|motor rehabilitation|motor rehabilitation
378642|NCT01967290|neurorehabilitation|neurorehabilitation
378643|NCT01967290|medical devices|medical devices
378644|NCT01967290|wearable devices|wearable devices
378645|NCT01967290|e-health systems|e-health systems
378646|NCT01967264|Drug therapy|drug therapy
378647|NCT01967251|Prostatic Hyperplasia|prostatic hyperplasia
378648|NCT01967251|Phosphodiesterase 5 inhibitors|phosphodiesterase 5 inhibitors
378649|NCT01967251|Erectile DysfunctionDrug Therapy|erectile dysfunctiondrug therapy
378650|NCT01967238|immune response|immune response
378651|NCT01967225|Methicillin Resistant Staphylococcus Aureus,|methicillin resistant staphylococcus aureus,
378652|NCT01967225|Skin and soft tissue infection,|skin and soft tissue infection,
378653|NCT01967225|Bacteremia,|bacteremia,
378654|NCT01967225|Tedizolid|tedizolid
378655|NCT01967212|stroke|stroke
378656|NCT01967212|swallowing training|swallowing training
378657|NCT01967212|game-based|game-based
378658|NCT01967212|biofeedback|biofeedback
378659|NCT01967199|drug-eluting stent|drug-eluting stent
378660|NCT01967199|drug-coated Balloon|drug-coated balloon
378661|NCT01967199|recurrent In-Stent restenosis|recurrent in-stent restenosis
378662|NCT01967186|Type 1 diabetes|type 1 diabetes
378663|NCT01967186|islets|islets
378664|NCT01967186|transplantation|transplantation
378665|NCT01967186|nephropathy|nephropathy
378666|NCT01967186|intramuscular|intramuscular
378667|NCT01967173|Asthma|asthma
378668|NCT01967173|Fluticasone|fluticasone
378669|NCT01967173|Salmeterol|salmeterol
378670|NCT01967147|Dry eye|dry eye
378671|NCT01967147|Lipid deficiency|lipid deficiency
378672|NCT01967147|Tear film break-up time|tear film break-up time
378673|NCT01967134|HIV Negative|hiv negative
378674|NCT01967121|Compex, ice|compex, ice
378675|NCT01967095|Erlotinib|erlotinib
378676|NCT01967095|12-278|12-278
378677|NCT01967095|CNS involvement|cns involvement
378678|NCT01967056|Muscle strength|muscle strength
378679|NCT01967056|respiratory failure|respiratory failure
378680|NCT01967056|extubation failure|extubation failure
378681|NCT01967056|intensive care unit|intensive care unit
378682|NCT01967056|outcome prediction|outcome prediction
378683|NCT01967030|gestational diabetes mellitus|gestational diabetes mellitus
378684|NCT01967030|breastfeeding|breastfeeding
378685|NCT01967030|obesity|obesity
378686|NCT01967030|type 2 diabetes|type 2 diabetes
378687|NCT01967030|lactation|lactation
378688|NCT01967030|prospective|prospective
378689|NCT01967030|women|women
378690|NCT01967030|postpartum|postpartum
378691|NCT01967030|incident diabetes|incident diabetes
378692|NCT01967030|epidemiology|epidemiology
378693|NCT01967030|metabolomics|metabolomics
378694|NCT01967017|Intrauterine device|intrauterine device
378695|NCT01967017|Paracervical block|paracervical block
378696|NCT01966991|Down syndrome|down syndrome
378697|NCT01966991|prenatal screening|prenatal screening
378698|NCT01966991|trisomy 21|trisomy 21
378699|NCT01966991|patient satisfaction|patient satisfaction
378700|NCT01966978|Diabetes Mellitus, Type 2|diabetes mellitus, type 2
378701|NCT01966978|Insulin|insulin
378702|NCT01966978|Insulin, Long-Acting|insulin, long-acting
378703|NCT01966978|Insulin, Short Acting|insulin, short acting
378704|NCT01966978|Detemir|detemir
378705|NCT01966978|Liraglutide|liraglutide
378706|NCT01966978|GLP-1|glp-1
378707|NCT01966978|Glucagon Like Peptide|glucagon like peptide
378708|NCT01966978|Metformin|metformin
378709|NCT01966978|Uncontrolled Diabetes|uncontrolled diabetes
378710|NCT01966978|Elevated A1c|elevated a1c
378711|NCT01966978|Incretins|incretins
378712|NCT01966965|PIOLIN®, PEDICULOSIS, EFFICACY, SAFETY, PHYTOMEDICINE,|piolin®, pediculosis, efficacy, safety, phytomedicine,
378713|NCT01966965|ARRUDA, RUTA|arruda, ruta
378714|NCT01966952|Hypertension|hypertension
378715|NCT01966939|craniotomy|craniotomy
378716|NCT01966939|craniectomy|craniectomy
378717|NCT01966939|temporalis|temporalis
378718|NCT01966939|TMJ|tmj
378719|NCT01966939|mastication|mastication
378720|NCT01966939|QoL|qol
378721|NCT01966926|self monitoring|self monitoring
378722|NCT01966926|self weighing|self weighing
378723|NCT01966926|weight tracking|weight tracking
378724|NCT01966926|psychosocial outcomes|psychosocial outcomes
378725|NCT01966926|feasibility|feasibility
378726|NCT01966913|Germ Cell Tumors|germ cell tumors
378727|NCT01966913|Bevacizumab|bevacizumab
378728|NCT01966913|salvage therapy|salvage therapy
378729|NCT01966900|Human immunodeficiency disease|human immunodeficiency disease
378730|NCT01966900|HIV|hiv
378731|NCT01966900|Vaccine|vaccine
378732|NCT01966900|CN54gp140|cn54gp140
378733|NCT01966900|Glucopyranosyl lipid adjuvant|glucopyranosyl lipid adjuvant
378734|NCT01966900|GLA|gla
378735|NCT01966900|GLA-AF|gla-af
378736|NCT01966887|Heart failure|heart failure
378737|NCT01966887|Gene therapy|gene therapy
378738|NCT01966887|Serca2a|serca2a
378739|NCT01966887|Cardiomyopathy|cardiomyopathy
378740|NCT01966874|Medical abortion|medical abortion
378741|NCT01966874|Mifepristone|mifepristone
378742|NCT01966874|Misoprostol|misoprostol
378743|NCT01966874|Zacafemyl|zacafemyl
378744|NCT01966874|Mexico|mexico
378745|NCT01966861|mechanical ventilation|mechanical ventilation
378746|NCT01966861|weaning|weaning
378747|NCT01966861|acute respiratory failure|acute respiratory failure
378748|NCT01966861|weaning failure|weaning failure
378749|NCT01966861|lung ultrasound|lung ultrasound
378750|NCT01966848|Knee|knee
378751|NCT01966848|osteoarthritis|osteoarthritis
378752|NCT01966848|arthroplasty|arthroplasty
378753|NCT01966848|tka|tka
378754|NCT01966848|rsa|rsa
378755|NCT01966835|sleep quality|sleep quality
378756|NCT01966835|sleep disturbances|sleep disturbances
378757|NCT01966835|high intensity aerobic interval training|high intensity aerobic interval training
378758|NCT01966835|rheumatoid arthritis|rheumatoid arthritis
378759|NCT01966835|fatigue|fatigue
378760|NCT01966835|pain|pain
378761|NCT01966835|polysomnography|polysomnography
378762|NCT01966835|watt max|watt max
378763|NCT01966822|Osteoporosis|osteoporosis
378764|NCT01966822|Bone mineral density|bone mineral density
378765|NCT01966822|Dual-energy X-ray absorptiometry|dual-energy x-ray absorptiometry
378766|NCT01966822|HIV infection|hiv infection
378767|NCT01966822|Dolutegravir|dolutegravir
378768|NCT01966822|Integrase inhibitor|integrase inhibitor
378769|NCT01966809|Brain Tumor|brain tumor
378770|NCT01966809|Photodynamic Therapy|photodynamic therapy
378771|NCT01966809|Photochemotherapy|photochemotherapy
378772|NCT01966809|Astrocytoma|astrocytoma
378773|NCT01966809|Pilocytic Astrocytoma|pilocytic astrocytoma
378774|NCT01966809|Low grade Astrocytoma|low grade astrocytoma
378775|NCT01966809|Anaplastic Astrocytoma|anaplastic astrocytoma
378776|NCT01966809|Glioblastoma|glioblastoma
378777|NCT01966809|GBM|gbm
378778|NCT01966809|Chordoma|chordoma
378779|NCT01966809|Germinoma|germinoma
378780|NCT01966809|Germ Cell Tumor|germ cell tumor
378781|NCT01966809|Non-germinoma|non-germinoma
378782|NCT01966809|CNS Lymphoma|cns lymphoma
378783|NCT01966809|Craniopharyngioma|craniopharyngioma
378784|NCT01966809|Mixed Glioma|mixed glioma
378785|NCT01966809|Optic Nerve Glioma|optic nerve glioma
378786|NCT01966809|Meningioma|meningioma
378787|NCT01966809|Oligodendroglioma|oligodendroglioma
378788|NCT01966809|Pituitary Tumors|pituitary tumors
378789|NCT01966809|Desmoplastic Neuroepithelial Tumor|desmoplastic neuroepithelial tumor
378790|NCT01966809|DNET|dnet
378791|NCT01966809|glioblastoma multiforme|glioblastoma multiforme
378792|NCT01966809|glioma|glioma
378793|NCT01966809|glioblastoma survivors|glioblastoma survivors
378794|NCT01966809|what is glioblastoma|what is glioblastoma
378795|NCT01966809|gbm cancer|gbm cancer
378796|NCT01966809|oligoastrocytoma|oligoastrocytoma
378797|NCT01966809|gbm tumor|gbm tumor
378798|NCT01966809|anaplastic oligodendroglioma|anaplastic oligodendroglioma
378799|NCT01966809|High-Grade Glioma|high-grade glioma
378800|NCT01966809|high grade glioma|high grade glioma
378801|NCT01966809|glioblastomas|glioblastomas
378802|NCT01966809|glioblastoma cancer|glioblastoma cancer
378803|NCT01966809|anaplastic oligoastrocytoma|anaplastic oligoastrocytoma
378804|NCT01966809|astrocytoma glioma|astrocytoma glioma
378805|NCT01966809|glioblastoma clinical trials|glioblastoma clinical trials
378806|NCT01966809|photodynamic therapy for cancer|photodynamic therapy for cancer
378807|NCT01966809|glioblastoma multiforme clinical trials|glioblastoma multiforme clinical trials
378808|NCT01966809|astrocytoma glioblastoma|astrocytoma glioblastoma
378809|NCT01966809|gbm grade 4|gbm grade 4
378810|NCT01966809|clinical trials for glioblastoma|clinical trials for glioblastoma
378811|NCT01966809|photodynamic therapy cancer|photodynamic therapy cancer
378812|NCT01966809|clinical trials glioblastoma|clinical trials glioblastoma
378813|NCT01966809|glioblastoma clinical trials 2015|glioblastoma clinical trials 2015
378814|NCT01966809|glioblastoma clinical trials 2014 not open in 2014|glioblastoma clinical trials 2014 not open in 2014
378815|NCT01966809|glioblastoma trials|glioblastoma trials
378816|NCT01966809|gbm clinical trials|gbm clinical trials
378817|NCT01966809|glioblastoma immunotherapy|glioblastoma immunotherapy
378818|NCT01966809|malignant gliomas|malignant gliomas
378819|NCT01966809|anaplastic astrocytomas|anaplastic astrocytomas
378820|NCT01966809|immunotherapy for glioblastoma|immunotherapy for glioblastoma
378821|NCT01966809|immunotherapy glioblastoma|immunotherapy glioblastoma
378822|NCT01966809|High Grade Glioblastoma Multiforme|high grade glioblastoma multiforme
378823|NCT01966809|clinical trial glioblastoma|clinical trial glioblastoma
378824|NCT01966809|glioblastoma clinical trial|glioblastoma clinical trial
378825|NCT01966809|glioblastoma trial|glioblastoma trial
378826|NCT01966809|brain tumors|brain tumors
378827|NCT01966809|recurrent brain tumors|recurrent brain tumors
378828|NCT01966809|glioma grade 3|glioma grade 3
378829|NCT01966809|grade 3 brain tumor|grade 3 brain tumor
378830|NCT01966809|grade 4 brain tumor|grade 4 brain tumor
378831|NCT01966796|healthcare associated pneumonia|healthcare associated pneumonia
378832|NCT01966796|drug-resistant bacteria|drug-resistant bacteria
379073|NCT01965600|Endotoxin challenge|endotoxin challenge
378833|NCT01966796|pneumonia severity index|pneumonia severity index
378834|NCT01966757|Neuronal Ceroid Lipofuscinosis|neuronal ceroid lipofuscinosis
378836|NCT01966757|Batten's Disease|batten's disease
378837|NCT01966757|Children's Sleep Habits Questionnaire|children's sleep habits questionnaire
378838|NCT01966757|Restless Leg Syndrome|restless leg syndrome
378839|NCT01966731|Africa|africa
378840|NCT01966718|Rheumatoid arthritis|rheumatoid arthritis
378841|NCT01966718|Joint pain|joint pain
378842|NCT01966718|Repository corticotropin injection|repository corticotropin injection
378843|NCT01966705|severe health anxiety|severe health anxiety
378844|NCT01966705|somatic symptom disorder|somatic symptom disorder
378845|NCT01966705|illness anxiety disorder|illness anxiety disorder
378846|NCT01966705|cognitive behavior therapy|cognitive behavior therapy
378847|NCT01966705|bibliotherapy|bibliotherapy
378848|NCT01966705|internet|internet
378849|NCT01966705|exposure|exposure
378850|NCT01966692|Bioequivalence|bioequivalence
378851|NCT01966692|Fluticasone Propionate|fluticasone propionate
378852|NCT01966666|Alzheimer's disease|alzheimer's disease
378853|NCT01966666|mild to moderate|mild to moderate
378854|NCT01966653|nitrofurantoin|nitrofurantoin
378855|NCT01966653|fosfomycin|fosfomycin
378856|NCT01966653|urinary tract infection|urinary tract infection
378857|NCT01966653|clinical efficacy|clinical efficacy
378858|NCT01966653|bacteriologic response|bacteriologic response
378859|NCT01966640|diagnosis of allergy|diagnosis of allergy
378860|NCT01966640|Basophil Activation Test|basophil activation test
378861|NCT01966627|non alcoholic fatty liver|non alcoholic fatty liver
378862|NCT01966627|childhood obesity|childhood obesity
378863|NCT01966627|genetic variants|genetic variants
378864|NCT01966614|Benign prostatic hyperplasia|benign prostatic hyperplasia
378865|NCT01966614|BPH|bph
378866|NCT01966614|Enlarged prostate|enlarged prostate
378867|NCT01966614|Lower urinary tract symptoms (LUTS)|lower urinary tract symptoms (luts)
378868|NCT01966588|Antipsychotic agents|antipsychotic agents
378869|NCT01966588|Adverse effects|adverse effects
378870|NCT01966588|Genomics|genomics
378871|NCT01966588|Transcriptome|transcriptome
378872|NCT01966575|Polycystic ovary syndrome|polycystic ovary syndrome
378873|NCT01966575|Progestin|progestin
378874|NCT01966575|Endometrial shedding|endometrial shedding
378875|NCT01966575|Ovulation induction cycles|ovulation induction cycles
378876|NCT01966575|Clomiphene citrate|clomiphene citrate
378877|NCT01966575|Clinical pregnancy rate|clinical pregnancy rate
378878|NCT01966549|Pulmonary Disease, Chronic Obstructive|pulmonary disease, chronic obstructive
378879|NCT01966549|Moderate to Severe Chronic Obstructive Pulmonary Disease|moderate to severe chronic obstructive pulmonary disease
378880|NCT01966549|CNTO 6785|cnto 6785
378881|NCT01966549|Placebo|placebo
378882|NCT01966510|cord blood transplant|cord blood transplant
378883|NCT01966510|advanced lymphoid malignancies|advanced lymphoid malignancies
378884|NCT01966497|AML|aml
378885|NCT01966484|Succinylcholine|succinylcholine
378886|NCT01966484|Mivacurium|mivacurium
378887|NCT01966484|Rigid Bronchoscopy|rigid bronchoscopy
378888|NCT01966484|Intubating conditions|intubating conditions
378889|NCT01966484|Short Procedure|short procedure
378890|NCT01966445|GSK2849330|gsk2849330
378891|NCT01966445|Oncology|oncology
378892|NCT01966445|First Time in Human|first time in human
378893|NCT01966445|HER3|her3
378894|NCT01966432|Substance abuse|substance abuse
378895|NCT01966432|Alcohol use|alcohol use
378896|NCT01966432|Tobacco use|tobacco use
378897|NCT01966432|Brief intervention|brief intervention
378898|NCT01966432|Referral to treatment|referral to treatment
378899|NCT01966419|hepatic encephalopathy|hepatic encephalopathy
378900|NCT01966419|hyperammonemia|hyperammonemia
378901|NCT01966419|cirrhosis|cirrhosis
378902|NCT01966419|ornithine phenylacetate|ornithine phenylacetate
378903|NCT01966419|OCR-002|ocr-002
378904|NCT01966406|Pancreaticoduodenectomy|pancreaticoduodenectomy
378905|NCT01966406|nasogastric tube|nasogastric tube
378906|NCT01966393|Type 1 diabetes|type 1 diabetes
378907|NCT01966393|Hypoglycemia|hypoglycemia
378908|NCT01966393|Insulin|insulin
378909|NCT01966393|Glucagon|glucagon
378910|NCT01966393|Closed-loop strategy|closed-loop strategy
378911|NCT01966393|Artificial pancreas|artificial pancreas
378912|NCT01966367|Unrelated donor transplant|unrelated donor transplant
378913|NCT01966367|Haploidentical donor transplant|haploidentical donor transplant
378914|NCT01966367|Peripheral blood stem cell transplantation|peripheral blood stem cell transplantation
378915|NCT01966367|CD34+ selection|cd34+ selection
378916|NCT01966367|Non-malignant disease|non-malignant disease
378917|NCT01966367|Bone marrow failure syndrome|bone marrow failure syndrome
378918|NCT01966367|Severe Aplastic Anemia|severe aplastic anemia
378919|NCT01966367|Severe Congenital Neutropenia|severe congenital neutropenia
378920|NCT01966367|Amegakaryocytic Thrombocytopenia|amegakaryocytic thrombocytopenia
378921|NCT01966367|Diamond-Blackfan Anemia|diamond-blackfan anemia
378922|NCT01966367|Schwachman Diamond Syndrome|schwachman diamond syndrome
378923|NCT01966367|Primary Immunodeficiency Syndrome|primary immunodeficiency syndrome
378924|NCT01966367|Acquired Immunodeficiency Syndrome|acquired immunodeficiency syndrome
378925|NCT01966367|Histiocytic Syndrome|histiocytic syndrome
378926|NCT01966367|Familial Hemophagocytic Lymphocytosis|familial hemophagocytic lymphocytosis
378927|NCT01966367|Lymphohistiocytosis|lymphohistiocytosis
378928|NCT01966367|Macrophage Activation Syndrome|macrophage activation syndrome
378929|NCT01966367|Langerhans Cell Histiocytosis (LCH)|langerhans cell histiocytosis (lch)
378930|NCT01966367|Hemoglobinopathies|hemoglobinopathies
378931|NCT01966367|Sickle Cell Disease|sickle cell disease
378932|NCT01966367|Sickle Cell-beta-thalassemia|sickle cell-beta-thalassemia
378933|NCT01966354|adult|adult
378934|NCT01966354|catheterization, central venous|catheterization, central venous
378935|NCT01966354|ultrasonography, interventional|ultrasonography, interventional
378936|NCT01966354|evidence-based medicine|evidence-based medicine
378937|NCT01966354|cost-benefit analysis|cost-benefit analysis
378938|NCT01966302|Pulmonary Arterial Hypertension|pulmonary arterial hypertension
378939|NCT01966302|prostacyclin|prostacyclin
378940|NCT01966302|oral|oral
378941|NCT01966289|Colorectal Neoplasms|colorectal neoplasms
378942|NCT01966289|Intestinal Neoplasms|intestinal neoplasms
378943|NCT01966289|Gastrointestinal Neoplasms|gastrointestinal neoplasms
378944|NCT01966289|Digestive System Neoplasms|digestive system neoplasms
378945|NCT01966289|Neoplasms by Site|neoplasms by site
378946|NCT01966289|Neoplasms|neoplasms
378947|NCT01966289|Digestive System Diseases|digestive system diseases
378948|NCT01966289|Gastrointestinal Diseases|gastrointestinal diseases
378949|NCT01966289|Colonic Diseases|colonic diseases
378950|NCT01966289|Intestinal Diseases|intestinal diseases
378951|NCT01966289|Rectal Diseases|rectal diseases
378952|NCT01966276|Chronic Fatigue Syndrome (CFS)|chronic fatigue syndrome (cfs)
378953|NCT01966276|Myalgic Encephalomyelitis (ME)|myalgic encephalomyelitis (me)
378954|NCT01966276|central nervous system (CNS)|central nervous system (cns)
378956|NCT01966276|alertness|alertness
378957|NCT01966276|brain fog|brain fog
378958|NCT01966276|mitochondria|mitochondria
378959|NCT01966276|methylphenidate|methylphenidate
378960|NCT01966276|Ritalin|ritalin
378961|NCT01966276|stimulant|stimulant
378962|NCT01966276|multivitamin|multivitamin
378963|NCT01966276|multimineral|multimineral
378964|NCT01966276|micronutrients|micronutrients
378965|NCT01966276|supplements|supplements
378966|NCT01966263|total knee arthroplasty|total knee arthroplasty
378967|NCT01966263|femoral nerve block|femoral nerve block
378968|NCT01966263|local infiltration analgesia|local infiltration analgesia
378969|NCT01966263|fast track|fast track
378970|NCT01966198|pulse plethysmography, autonomic nervous system, heart rate variability, baro-reflex|pulse plethysmography, autonomic nervous system, heart rate variability, baro-reflex
378971|NCT01966185|virtual simulation|virtual simulation
378972|NCT01966185|temporal bone|temporal bone
378973|NCT01966185|surgical training|surgical training
378974|NCT01966185|medical education|medical education
378975|NCT01966185|self-directed learning|self-directed learning
378976|NCT01966185|final product assessment|final product assessment
378977|NCT01966185|cognitive load|cognitive load
378978|NCT01966185|reaction time|reaction time
378979|NCT01966185|skills training|skills training
378980|NCT01966185|simulator metrics|simulator metrics
378981|NCT01966172|NSAID, gabapentin, multimodal, morphine, dexamethasone, cardiac surgery, postoperative pain, analgesia.|nsaid, gabapentin, multimodal, morphine, dexamethasone, cardiac surgery, postoperative pain, analgesia.
378983|NCT01966133|Randomised controlled trial|randomised controlled trial
378984|NCT01966133|TACE|tace
378985|NCT01966133|Resection|resection
378986|NCT01966120|Photodynamic Therapy|photodynamic therapy
378987|NCT01966120|Field-directed Treatment|field-directed treatment
378988|NCT01966068|Asthma|asthma
378989|NCT01966068|Pediatrics|pediatrics
378990|NCT01966068|Health Technology|health technology
378991|NCT01966068|Meaningful Use Stage-3|meaningful use stage-3
378992|NCT01966068|Web Portal|web portal
378993|NCT01966042|Refractory angina|refractory angina
378994|NCT01966042|Cell Therapy|cell therapy
378995|NCT01966042|Bone Marrow|bone marrow
378996|NCT01966042|Mononuclear Cells|mononuclear cells
378997|NCT01966016|LV- Left Ventricular|lv- left ventricular
378998|NCT01966016|CRT- Cardiac resynchronization therapy|crt- cardiac resynchronization therapy
378999|NCT01966016|MSCRT- Multisite Cardiac resynchronization therapy (P-pacemaker; D-defibrillator)|mscrt- multisite cardiac resynchronization therapy (p-pacemaker; d-defibrillator)
379000|NCT01966016|BBB -bundle branch block|bbb -bundle branch block
379001|NCT01965990|Enteral nutrition|enteral nutrition
379002|NCT01965990|very low-calorie diet|very low-calorie diet
379003|NCT01965990|severe obesity|severe obesity
379004|NCT01965990|weight loss|weight loss
379005|NCT01965990|ketosis|ketosis
379006|NCT01965964|Dysphagia, Swallowing functions, Questionnaire in German|dysphagia, swallowing functions, questionnaire in german
379007|NCT01965925|Cognition|cognition
379008|NCT01965925|Sleep problems|sleep problems
379009|NCT01965925|Bipolar Disorder|bipolar disorder
379010|NCT01965912|Phenylketonuria|phenylketonuria
379011|NCT01965912|Kuvan|kuvan
379012|NCT01965912|Sapropterin dihydrochloride|sapropterin dihydrochloride
379013|NCT01965886|osteoarthritis|osteoarthritis
379014|NCT01965886|knee|knee
379015|NCT01965886|arthroplasty|arthroplasty
379016|NCT01965886|replacement|replacement
379017|NCT01965873|Pancreatitis, Acute necrotizing|pancreatitis, acute necrotizing
379018|NCT01965873|Enteral nutrition|enteral nutrition
379019|NCT01965873|Fasting|fasting
379020|NCT01965873|Complications|complications
379021|NCT01965873|Mortality|mortality
379022|NCT01965834|Multiple Myeloma|multiple myeloma
379023|NCT01965834|Fenofibrate|fenofibrate
379024|NCT01965821|tracheal cuff pressure|tracheal cuff pressure
379025|NCT01965821|continuous control|continuous control
379026|NCT01965821|microaspiration|microaspiration
379027|NCT01965795|Brain-derived neurotrophic factor|brain-derived neurotrophic factor
379028|NCT01965795|Cognitive function|cognitive function
379029|NCT01965795|Dietary supplement|dietary supplement
379030|NCT01965795|Coffee plant extract|coffee plant extract
379031|NCT01965769|Very low birth weight infants|very low birth weight infants
379032|NCT01965769|premature|premature
379033|NCT01965769|nutrition|nutrition
379034|NCT01965769|gastric residual|gastric residual
379035|NCT01965756|Alzheimer's Disease|alzheimer's disease
379036|NCT01965756|Vascular Dementia|vascular dementia
379037|NCT01965756|Dementia|dementia
379038|NCT01965756|Memory Impairment|memory impairment
379039|NCT01965743|intrauterine contraception (IUC)|intrauterine contraception (iuc)
379040|NCT01965743|social networks|social networks
379041|NCT01965743|social influence|social influence
379042|NCT01965743|diffusion of innovation|diffusion of innovation
379043|NCT01965743|intrauterine device (IUD)|intrauterine device (iud)
379044|NCT01965743|LARC|larc
379045|NCT01965730|dilated ascending aorta|dilated ascending aorta
379046|NCT01965717|endoleak|endoleak
379047|NCT01965717|MMP- 9|mmp- 9
379048|NCT01965717|biomarker|biomarker
379049|NCT01965704|Narcotic addiction during pregnancy|narcotic addiction during pregnancy
379050|NCT01965704|Neonatal abstinence syndrome|neonatal abstinence syndrome
379051|NCT01965704|NAS|nas
379052|NCT01965691|Phenylketonuria|phenylketonuria
379053|NCT01965691|PKU|pku
379054|NCT01965691|Phenylalanine metabolism|phenylalanine metabolism
379055|NCT01965691|Protein requirements|protein requirements
379056|NCT01965691|Indicator Amino acid Oxidation|indicator amino acid oxidation
379057|NCT01965691|Stable isotopes|stable isotopes
379058|NCT01965678|Osteopathic manipulative treatment|osteopathic manipulative treatment
379059|NCT01965678|muscle-skeletal disorder|muscle-skeletal disorder
379060|NCT01965678|quality of life|quality of life
379061|NCT01965665|Diabetes|diabetes
379062|NCT01965665|Surgical Intervention|surgical intervention
379063|NCT01965665|Honey|honey
379064|NCT01965652|Opioid Induced Constipation|opioid induced constipation
379065|NCT01965639|Diabetes Mellitus Type 2|diabetes mellitus type 2
379066|NCT01965639|Standard of care|standard of care
379067|NCT01965639|Quality of life|quality of life
379068|NCT01965639|Disease management|disease management
379069|NCT01965626|Oseltamivir|oseltamivir
379070|NCT01965626|Dexamethasone|dexamethasone
379071|NCT01965626|ITP|itp
379072|NCT01965613|Pyoderma Gangrenosum|pyoderma gangrenosum
379074|NCT01965587|novasure|novasure
379075|NCT01965587|Mirena IUS|mirena ius
379076|NCT01965587|menorrhagia|menorrhagia
379077|NCT01965587|pelvic pain|pelvic pain
379078|NCT01965587|ashermanns|ashermanns
379079|NCT01965574|ARDS - FLUID LOADING - PRELOAD DEPENDENCE|ards - fluid loading - preload dependence
379080|NCT01965548|spleen|spleen
379081|NCT01965548|injury|injury
379082|NCT01965548|patient transfer|patient transfer
379083|NCT01965548|splenectomy|splenectomy
379084|NCT01965548|embolization, theurapeutic|embolization, theurapeutic
379085|NCT01965535|Hepatitis C|hepatitis c
379087|NCT01965535|Cirrhosis|cirrhosis
379088|NCT01965522|Breast cancer|breast cancer
379089|NCT01965522|melatonin|melatonin
379090|NCT01965522|vitamin d|vitamin d
379091|NCT01965522|ki67|ki67
379092|NCT01965509|PEX168|pex168
379093|NCT01965509|Phase I/II|phase i/ii
379094|NCT01965509|add on to metformin|add on to metformin
379095|NCT01965496|PEX168|pex168
484684|NCT01493804|EEG|eeg
379096|NCT01965496|Phase I|phase i
379097|NCT01965496|titration|titration
379098|NCT01965483|radiotherapy|radiotherapy
379099|NCT01965483|adjuvant|adjuvant
379100|NCT01965483|weekly hypofractionation|weekly hypofractionation
379101|NCT01965457|obstructive sleep apnea|obstructive sleep apnea
379102|NCT01965457|pediatric|pediatric
379103|NCT01965457|adenoid hypertrophy|adenoid hypertrophy
379104|NCT01965444|Sub-epidermal moisture|sub-epidermal moisture
379105|NCT01965444|Pressure Ulcers|pressure ulcers
379106|NCT01965405|HIV|hiv
379107|NCT01965405|AIDS|aids
379108|NCT01965405|Nicotine Dependence|nicotine dependence
379109|NCT01965405|Smoking|smoking
379110|NCT01965405|Smoking cessation|smoking cessation
379111|NCT01965405|Contingency Management|contingency management
379112|NCT01965379|Dialysis|dialysis
379113|NCT01965379|Phosphorus|phosphorus
379114|NCT01965379|Diet|diet
379115|NCT01965366|Dexamethasone|dexamethasone
379116|NCT01965366|Virtual Reality|virtual reality
379117|NCT01965366|Military|military
379118|NCT01965366|PTSD|ptsd
379119|NCT01965353|Relapsed Multiple Myeloma|relapsed multiple myeloma
379120|NCT01965353|Relapse-Refractory Multiple Myeloma|relapse-refractory multiple myeloma
379121|NCT01965340|patients|patients
379122|NCT01965327|Friedreich ataxia|friedreich ataxia
379123|NCT01965327|Interferon gamma-1b|interferon gamma-1b
379124|NCT01965327|FRDA|frda
379125|NCT01965314|ultrasound guided regional anaesthesia|ultrasound guided regional anaesthesia
379126|NCT01965314|upper limb surgery|upper limb surgery
379127|NCT01965314|ultrasound guided axillary brachial plexus blockade|ultrasound guided axillary brachial plexus blockade
379128|NCT01965275|Advanced non-small cell lung cancer|advanced non-small cell lung cancer
379129|NCT01965275|High-dose|high-dose
379130|NCT01965275|Pulsatile|pulsatile
379131|NCT01965275|EGFR-TKIs|egfr-tkis
379132|NCT01965249|Laparotomy|laparotomy
379133|NCT01965249|short stitch|short stitch
379134|NCT01965249|long stitch|long stitch
379135|NCT01965249|MonoMax|monomax
379136|NCT01965236|hypertension, sodium intake, left ventricular function|hypertension, sodium intake, left ventricular function
379137|NCT01965223|Oligometastatic|oligometastatic
379138|NCT01965223|Neoplasia|neoplasia
379139|NCT01965223|Radiosurgery|radiosurgery
379140|NCT01965223|Stereotactic Ablative Body Radiotherapy|stereotactic ablative body radiotherapy
379141|NCT01965223|SABR|sabr
379142|NCT01965223|Metastases to the Lung|metastases to the lung
379143|NCT01965223|Non Haematological|non haematological
379144|NCT01965210|Rye|rye
379145|NCT01965210|Fermentable dietary fibre|fermentable dietary fibre
379146|NCT01965210|Inulin|inulin
379147|NCT01965210|Plant protein|plant protein
379148|NCT01965210|Gluten|gluten
379149|NCT01965210|Porridge|porridge
379150|NCT01965210|Bread|bread
379151|NCT01965210|Appetite|appetite
379152|NCT01965210|Satiety|satiety
379153|NCT01965210|Hunger|hunger
379154|NCT01965210|Desire to eat|desire to eat
379155|NCT01965210|Metabolism|metabolism
379156|NCT01965210|Glucose|glucose
379157|NCT01965210|Insulin|insulin
379158|NCT01965210|Gut hormones|gut hormones
379159|NCT01965210|Metabolomics|metabolomics
379160|NCT01965210|Gastric emptying rate|gastric emptying rate
379161|NCT01965210|Breath hydrogen and methane excretion|breath hydrogen and methane excretion
379162|NCT01965184|child|child
379163|NCT01965184|cognitive behavioral therapy|cognitive behavioral therapy
379164|NCT01965184|CBT|cbt
379165|NCT01965184|aggression|aggression
379166|NCT01965184|disruptive behavior|disruptive behavior
379167|NCT01965184|treatment|treatment
379168|NCT01965184|frustrative non-reward|frustrative non-reward
379169|NCT01965171|hematologic malignancy|hematologic malignancy
379170|NCT01965171|iron overload|iron overload
379171|NCT01965171|magnetic resonance imaging|magnetic resonance imaging
379172|NCT01965171|childhood cancer survivors|childhood cancer survivors
379173|NCT01965158|Opioid-induced Constipation|opioid-induced constipation
379174|NCT01965132|Rheumatiod Arhthritis|rheumatiod arhthritis
379175|NCT01965132|Ankylosing spondylitis|ankylosing spondylitis
379176|NCT01965132|Psoriatic arthritis|psoriatic arthritis
379177|NCT01965132|Biologic agents|biologic agents
379178|NCT01965132|Cohort studies|cohort studies
379179|NCT01965106|Glaucoma, Angle-Closure|glaucoma, angle-closure
379180|NCT01965106|Glaucoma, Closed-Angle|glaucoma, closed-angle
379181|NCT01965106|Primary angle closure|primary angle closure
379182|NCT01965106|Acute angle closure|acute angle closure
379183|NCT01965106|Acute angle-closure glaucoma|acute angle-closure glaucoma
379184|NCT01965093|perioperative|perioperative
379185|NCT01965093|desaturation|desaturation
379186|NCT01965093|growth development|growth development
379187|NCT01965093|intelligence outcome|intelligence outcome
379188|NCT01965080|Endometrial cancer|endometrial cancer
379189|NCT01965054|Intrahepatic cholestasis of pregnancy|intrahepatic cholestasis of pregnancy
379190|NCT01965054|fish oil|fish oil
379191|NCT01965054|omega-3|omega-3
379192|NCT01965054|Docosahexaenoic acid,|docosahexaenoic acid,
379193|NCT01965054|eicosapentaenoic acid|eicosapentaenoic acid
484796|NCT01493154|HPV|hpv
379194|NCT01965041|AVA Study|ava study
379195|NCT01965028|tinnitus|tinnitus
379196|NCT01965028|transcranial random noise stimulation|transcranial random noise stimulation
379197|NCT01965028|tRNS|trns
379198|NCT01965028|auditory cortex|auditory cortex
379199|NCT01965028|non-invasive brain stimulation|non-invasive brain stimulation
379200|NCT01965015|Heart Failure (HF)|heart failure (hf)
379201|NCT01965015|Left Atrial Pressure|left atrial pressure
379202|NCT01964989|Influenza|influenza
379203|NCT01964989|children|children
379204|NCT01964950|drug therapy|drug therapy
379205|NCT01964911|Martorell ulcer|martorell ulcer
379206|NCT01964911|Hypertensive leg ulcer|hypertensive leg ulcer
379207|NCT01964911|Pain|pain
379208|NCT01964911|Continuous nerve block|continuous nerve block
379209|NCT01964911|Ropivacaïne|ropivacaïne
379210|NCT01964911|Local anesthesic|local anesthesic
379211|NCT01964898|Smoking|smoking
379212|NCT01964898|Mood Management|mood management
379213|NCT01964898|Depression|depression
379214|NCT01964898|Behavioral Activation|behavioral activation
379215|NCT01964898|Acute Coronary Syndrome|acute coronary syndrome
379216|NCT01964898|Myocardial Infarction|myocardial infarction
379217|NCT01964872|Healthy volunteers|healthy volunteers
379218|NCT01964872|JNJ-38877618|jnj-38877618
379219|NCT01964872|Pharmacokinetic|pharmacokinetic
379220|NCT01964872|Safety|safety
379221|NCT01964872|Single-ascending dose|single-ascending dose
379222|NCT01964872|Multiple-ascending dose|multiple-ascending dose
379223|NCT01964859|healthy skin|healthy skin
379224|NCT01964859|wounds and injuries|wounds and injuries
379225|NCT01964859|prosthetics|prosthetics
379226|NCT01964859|amputations|amputations
379227|NCT01964859|dermal fibroblasts|dermal fibroblasts
379228|NCT01964846|inflammation|inflammation
379229|NCT01964846|high fat meal|high fat meal
379230|NCT01964846|resveratrol|resveratrol
379231|NCT01964846|curcumin|curcumin
379232|NCT01964846|gene expression|gene expression
379233|NCT01964833|clinical trial|clinical trial
379234|NCT01964833|DMT2|dmt2
379235|NCT01964833|periodontitis|periodontitis
379236|NCT01964833|PDT|pdt
379237|NCT01964807|Cardiovascular|cardiovascular
379238|NCT01964807|tobacco|tobacco
379239|NCT01964807|cigarettes|cigarettes
379240|NCT01964807|secondhand cigarette smoke|secondhand cigarette smoke
379241|NCT01964807|SHS|shs
379242|NCT01964807|smokeless tobacco|smokeless tobacco
379243|NCT01964807|chewing tobacco|chewing tobacco
379244|NCT01964807|snus|snus
379245|NCT01964807|electronic cigarettes|electronic cigarettes
379246|NCT01964807|vapor|vapor
379247|NCT01964807|particles|particles
379248|NCT01964807|oxidative stress|oxidative stress
379249|NCT01964807|flow-mediated dilation|flow-mediated dilation
379250|NCT01964807|FMD|fmd
379251|NCT01964794|Warfarin|warfarin
379252|NCT01964781|Administration, topical|administration, topical
379253|NCT01964781|tranexamic acid|tranexamic acid
379254|NCT01964781|adrenaline|adrenaline
379255|NCT01964781|bupivacaine|bupivacaine
379256|NCT01964781|surgery|surgery
379257|NCT01964755|EBV+|ebv+
379258|NCT01964755|NHL|nhl
379259|NCT01964755|HL|hl
379260|NCT01964755|Non Hodgkin's Lymphoma|non hodgkin's lymphoma
379261|NCT01964755|Hodgkin's Lymphoma|hodgkin's lymphoma
379262|NCT01964755|Epstein Barr Virus|epstein barr virus
379263|NCT01964755|Epstein Barr Virus Associated Non Hodgkin's Lymphoma|epstein barr virus associated non hodgkin's lymphoma
379264|NCT01964755|Epstein Barr Virus Associated Hodgkin's Lymphoma|epstein barr virus associated hodgkin's lymphoma
379265|NCT01964755|Post-Transplant Lymphoproliferative Disease|post-transplant lymphoproliferative disease
379266|NCT01964729|rTMS|rtms
379267|NCT01964729|Pain threshold|pain threshold
379268|NCT01964729|Neuromodulation|neuromodulation
379269|NCT01964729|Myofascial|myofascial
379270|NCT01964716|Prevenar 13|prevenar 13
379271|NCT01964716|13vPnC|13vpnc
379272|NCT01964716|Healthy Subjects|healthy subjects
379273|NCT01964690|Lactate|lactate
379274|NCT01964690|Sepsis|sepsis
379275|NCT01964690|Capillary lactate|capillary lactate
379276|NCT01964690|Venous lactate|venous lactate
379277|NCT01964690|Quick test|quick test
379278|NCT01964677|Magnetic Resonance Imaging (MRI)|magnetic resonance imaging (mri)
379279|NCT01964677|High Intensity Focused Ultrasound (HIFU)|high intensity focused ultrasound (hifu)
379280|NCT01964664|Mindfulness|mindfulness
379281|NCT01964664|Meditation|meditation
379282|NCT01964664|acute lateral sclerosis|acute lateral sclerosis
379283|NCT01964664|Cerebral Palsy|cerebral palsy
379284|NCT01964664|Cerebral Ataxia|cerebral ataxia
379285|NCT01964664|Locked-in Syndrome|locked-in syndrome
379286|NCT01964651|Healthy|healthy
379287|NCT01964651|JNJ-42165279|jnj-42165279
379288|NCT01964651|Pharmacokinetics|pharmacokinetics
379289|NCT01964651|Elderly|elderly
379290|NCT01964651|Young|young
379291|NCT01964638|Prostate Cancer|prostate cancer
379292|NCT01964638|Prostate Biopsy|prostate biopsy
379293|NCT01964638|Targeted Biopsy|targeted biopsy
379294|NCT01964625|Chronic GvHD|chronic gvhd
379295|NCT01964599|Fiber|fiber
379296|NCT01964599|Gastrointestinal|gastrointestinal
379297|NCT01964586|Septoplasty, Dexmedetomidine, Surgical Conditions|septoplasty, dexmedetomidine, surgical conditions
379298|NCT01964573|Parkinson's Disease|parkinson's disease
379299|NCT01964573|Rotigotine|rotigotine
379300|NCT01964573|Pharmacokinetics|pharmacokinetics
379301|NCT01964573|Healthy subjects|healthy subjects
379302|NCT01964560|Lacosamide|lacosamide
379303|NCT01964560|Vimpat|vimpat
379304|NCT01964560|UCB|ucb
379305|NCT01964560|Epilepsy|epilepsy
379306|NCT01964560|Partial Onset Seizures|partial onset seizures
379307|NCT01964560|Pediatric|pediatric
379308|NCT01964547|Cognition|cognition
379309|NCT01964547|Mood|mood
379310|NCT01964534|Metastatic|metastatic
379311|NCT01964534|Pancreatic|pancreatic
379312|NCT01964534|Cancer|cancer
379313|NCT01964534|Pancreas|pancreas
379314|NCT01964534|GERCOR|gercor
379315|NCT01964534|Gemcitabine|gemcitabine
379316|NCT01964534|LV5FU2|lv5fu2
379317|NCT01964534|ABI-007|abi-007
379318|NCT01964534|PACLITAXEL ALBUMIN-BOUND PARTICLES|paclitaxel albumin-bound particles
379319|NCT01964482|Hospitalization|hospitalization
379320|NCT01964482|Older|older
379321|NCT01964482|Medical patient|medical patient
379322|NCT01964482|Strength training|strength training
379323|NCT01964456|Bodily self-consciousness|bodily self-consciousness
379324|NCT01964456|intersubjective body|intersubjective body
379325|NCT01964456|Anorexia Nervosa|anorexia nervosa
379326|NCT01964456|Joint perception task|joint perception task
379327|NCT01964456|Interoceptive awareness|interoceptive awareness
379328|NCT01964443|Plaque Psoriasis|plaque psoriasis
379329|NCT01964443|Alexithymia|alexithymia
379330|NCT01964443|Quality of life|quality of life
379331|NCT01964430|Resectable pancreatic cancer|resectable pancreatic cancer
379332|NCT01964430|resected|resected
379333|NCT01964430|resectable PDA|resectable pda
379334|NCT01964430|adenocarcinoma|adenocarcinoma
379335|NCT01964430|surgically resected|surgically resected
379336|NCT01964430|adjuvant|adjuvant
379337|NCT01964430|Abraxane|abraxane
379338|NCT01964430|nab-paclitaxel|nab-paclitaxel
379339|NCT01964430|ABI-007|abi-007
379340|NCT01964430|gemcitabine|gemcitabine
379341|NCT01964430|Gemzar|gemzar
379342|NCT01964430|Phase 3|phase 3
379343|NCT01964417|BOWEL PREPARATION|bowel preparation
379344|NCT01964417|PEG|peg
379345|NCT01964417|Low-volume PEG Plus Ascorbic Acid|low-volume peg plus ascorbic acid
379346|NCT01964404|Dronabinol|dronabinol
379347|NCT01964404|Schizophrenia|schizophrenia
379348|NCT01964404|Dual Diagnosis|dual diagnosis
379349|NCT01964404|Substance Abuse|substance abuse
379350|NCT01964404|Cannabis Use Disorder|cannabis use disorder
379351|NCT01964378|cancer-related pain|cancer-related pain
379352|NCT01964378|neuropathic related cancer pain|neuropathic related cancer pain
379353|NCT01964378|morphine|morphine
379354|NCT01964378|cebranopadol (GRT6005)|cebranopadol (grt6005)
379355|NCT01964378|Numerical Rating Scale|numerical rating scale
379356|NCT01964326|atorvastatin|atorvastatin
379357|NCT01964326|Hypercholesterolemia|hypercholesterolemia
379358|NCT01964313|Acute coronary syndrome|acute coronary syndrome
379359|NCT01964313|treatment strategy|treatment strategy
379360|NCT01964313|genetics|genetics
379361|NCT01964274|Nursing Delirium Screening Scale,|nursing delirium screening scale,
379362|NCT01964274|Acetylcholinesterase Activity|acetylcholinesterase activity
379363|NCT01964261|Neural|neural
379364|NCT01964261|Prosthetic|prosthetic
379365|NCT01964261|Brain machine interface|brain machine interface
379366|NCT01964261|brain computer interface|brain computer interface
379367|NCT01964261|brain control|brain control
379368|NCT01964261|paralysis|paralysis
379369|NCT01964261|tetraplegia|tetraplegia
379370|NCT01964261|quadriplegia|quadriplegia
379371|NCT01964261|spinal cord injury|spinal cord injury
379372|NCT01964261|stimulation|stimulation
379373|NCT01964261|sensory feedback|sensory feedback
379374|NCT01964248|Blood gas analysis|blood gas analysis
379375|NCT01964248|Arterial puncture|arterial puncture
379376|NCT01964248|Local anesthesia|local anesthesia
379377|NCT01964248|Eutectic mixture|eutectic mixture
379378|NCT01964248|Lidocaïne/prilocaïne cream (5%)|lidocaïne/prilocaïne cream (5%)
379379|NCT01964248|Placebo|placebo
379380|NCT01964248|Pain Intensity Scale|pain intensity scale
379381|NCT01964248|Numerical Rating Scale|numerical rating scale
379382|NCT01964235|INC280, advanced hepatocellular carcinoma, c-MET pathway dysregulation.|inc280, advanced hepatocellular carcinoma, c-met pathway dysregulation.
379383|NCT01964222|Cancer|cancer
379384|NCT01964222|Clinical trials|clinical trials
379385|NCT01964222|Informed consent|informed consent
379386|NCT01964222|Health literacy|health literacy
379387|NCT01964209|ADHD|adhd
379388|NCT01964209|Validation|validation
379389|NCT01964209|Quality Improvement|quality improvement
379390|NCT01964209|Vanderbilt|vanderbilt
379391|NCT01964209|Conners 3rd Edition|conners 3rd edition
379392|NCT01964209|ADHD Measures|adhd measures
379393|NCT01964209|ADHD Adolescent|adhd adolescent
379394|NCT01964209|ADHD Questionnaire|adhd questionnaire
379395|NCT01964209|ICISS|iciss
400561|NCT01866280|Obesity|obesity
379396|NCT01964209|Integrated Clinical Information Sharing System|integrated clinical information sharing system
379397|NCT01964196|Chronic Renal Failure|chronic renal failure
379398|NCT01964196|Renal anemia|renal anemia
379399|NCT01964196|ASP1517|asp1517
379400|NCT01964183|Open-label design|open-label design
379401|NCT01964183|Pharmacokinetics|pharmacokinetics
379402|NCT01964183|Drug-Drug Interaction|drug-drug interaction
379403|NCT01964183|Mirabegron|mirabegron
379404|NCT01964170|ASP3550|asp3550
379405|NCT01964170|Prostate cancer|prostate cancer
379406|NCT01964157|non-small cell lung cancer (NSCLC)|non-small cell lung cancer (nsclc)
379407|NCT01964144|thyroid cancer, dovitinib|thyroid cancer, dovitinib
379408|NCT01964131|Bioequivalence|bioequivalence
379409|NCT01964131|pharmacodynamics|pharmacodynamics
379410|NCT01964131|pharmacokinetics|pharmacokinetics
379411|NCT01964131|safety|safety
379412|NCT01964131|tolerability|tolerability
379413|NCT01964131|D961H|d961h
379414|NCT01964131|Japanese|japanese
379415|NCT01964118|intermittent fasting|intermittent fasting
379416|NCT01964118|obesity|obesity
379417|NCT01964118|calorie restriction|calorie restriction
379418|NCT01964105|Hypomastia|hypomastia
379419|NCT01964105|Augmentation|augmentation
379420|NCT01964105|Breast|breast
379421|NCT01964105|3D|3d
379422|NCT01964105|Breast Q|breast q
379423|NCT01964092|Disability|disability
379424|NCT01964092|Individual placement and support|individual placement and support
379425|NCT01964092|Mental health|mental health
379426|NCT01964092|Quality of life|quality of life
379427|NCT01964092|Randomized controlled trial|randomized controlled trial
379428|NCT01964092|Rehabilitation|rehabilitation
379429|NCT01964092|Return to work|return to work
379430|NCT01964092|Supported employment|supported employment
379431|NCT01964066|therapeutic ERCP|therapeutic ercp
379432|NCT01964066|prevention of post-ERCP pancreatitis|prevention of post-ercp pancreatitis
379433|NCT01964066|thoracic epidural analgesia|thoracic epidural analgesia
379434|NCT01964053|Self-management adherence|self-management adherence
379435|NCT01964053|post acute care|post acute care
379436|NCT01964053|critical access hospitals|critical access hospitals
379437|NCT01964053|patient activation|patient activation
379438|NCT01964053|hospital readmission|hospital readmission
379439|NCT01964040|femoral nerve block|femoral nerve block
379440|NCT01964040|peri-neural dexmedetomidine|peri-neural dexmedetomidine
379441|NCT01964027|second line chemoregime|second line chemoregime
379442|NCT01964027|gastric cancer|gastric cancer
379443|NCT01964014|once|once
379444|NCT01963988|Bladder Pain Syndrome|bladder pain syndrome
379445|NCT01963988|Transurethral Resection of Ulcer|transurethral resection of ulcer
379446|NCT01963988|Transurethral Coagulation of Ulcer|transurethral coagulation of ulcer
379447|NCT01963962|Emergency contraception|emergency contraception
379448|NCT01963962|Levonorgestrel IUD|levonorgestrel iud
379449|NCT01963962|Copper IUD|copper iud
379450|NCT01963962|Oral Levonorgestrel|oral levonorgestrel
379451|NCT01963936|Infant newborn|infant newborn
379452|NCT01963936|Laryngeal mask airway|laryngeal mask airway
379453|NCT01963936|Positive pressure ventilation|positive pressure ventilation
379454|NCT01963936|Resuscitation|resuscitation
379455|NCT01963923|Pulmonary Rehabilitation|pulmonary rehabilitation
379456|NCT01963923|Lung Cancer Resection|lung cancer resection
379457|NCT01963923|Video-assisted thoracic surgery|video-assisted thoracic surgery
379458|NCT01963923|Exercise tolerance|exercise tolerance
379459|NCT01963923|Quality of life|quality of life
379460|NCT01963910|Mannitol|mannitol
379461|NCT01963910|TRPV1 receptor|trpv1 receptor
379462|NCT01963910|Pain|pain
379463|NCT01963910|Burning pain|burning pain
379464|NCT01963910|neuropathy|neuropathy
379465|NCT01963910|neuropathic pain|neuropathic pain
379466|NCT01963897|Genotype/phenotype correlations|genotype/phenotype correlations
379467|NCT01963897|Growth|growth
379468|NCT01963897|Bone health|bone health
379469|NCT01963897|Puberty|puberty
379470|NCT01963897|Quality of life|quality of life
379471|NCT01963884|Extraction Sockets|extraction sockets
379472|NCT01963884|Ridge dimensions|ridge dimensions
379473|NCT01963884|Dental Alveolar Anatomy|dental alveolar anatomy
379474|NCT01963884|Dental Implants|dental implants
379475|NCT01963884|Bone Physiology|bone physiology
379476|NCT01963871|chronic low back pain|chronic low back pain
379477|NCT01963871|low back pain|low back pain
379478|NCT01963871|yoga|yoga
379479|NCT01963832|stroke|stroke
379480|NCT01963832|Fluoxetine (FLX)|fluoxetine (flx)
379481|NCT01963832|eCIMT|ecimt
379482|NCT01963832|Central Nervous System|central nervous system
379483|NCT01963793|Pruritus|pruritus
379484|NCT01963780|lung transplantation|lung transplantation
379485|NCT01963780|lung preservation|lung preservation
379486|NCT01963780|breathing lung transplant|breathing lung transplant
379487|NCT01963767|memory|memory
379488|NCT01963767|cognition|cognition
379489|NCT01963767|dietary supplements|dietary supplements
379490|NCT01963754|Articaine 1:100.000|articaine 1:100.000
379491|NCT01963754|Dental Implants|dental implants
379492|NCT01963754|Posterior mandible|posterior mandible
784093|NCT00314340|Opioids|opioids
379493|NCT01963754|Loco-regional Anesthesia|loco-regional anesthesia
379494|NCT01963754|Subperiosteal Anesthesia|subperiosteal anesthesia
379495|NCT01963741|Leukotriene D4|leukotriene d4
379496|NCT01963741|allergic rhinitis|allergic rhinitis
379497|NCT01963741|nasal airway resistance|nasal airway resistance
379498|NCT01963741|nasal provocation test|nasal provocation test
379499|NCT01963741|nasal hyperreactivity|nasal hyperreactivity
379500|NCT01963741|airway inflammation|airway inflammation
379501|NCT01963741|asthma|asthma
379502|NCT01963728|post-transplant|post-transplant
379503|NCT01963728|diabetes mellitus|diabetes mellitus
379504|NCT01963728|renal transplant|renal transplant
379505|NCT01963728|kidney transplant|kidney transplant
379506|NCT01963728|lung transplant|lung transplant
379507|NCT01963728|heart transplant|heart transplant
379508|NCT01963728|insulin|insulin
379509|NCT01963715|IMGN289|imgn289
379510|NCT01963715|Antibody Drug Conjugate|antibody drug conjugate
379511|NCT01963715|antibody|antibody
379512|NCT01963715|EGFR|egfr
379513|NCT01963715|NSCLC|nsclc
379514|NCT01963715|SCCHN|scchn
379515|NCT01963715|Head and neck|head and neck
379516|NCT01963715|Squamous cell carcinoma|squamous cell carcinoma
379517|NCT01963715|Solid tumor|solid tumor
379518|NCT01963715|Immunogen|immunogen
379519|NCT01963715|Lung|lung
379520|NCT01963715|Phase 1|phase 1
379521|NCT01963702|predictive factor|predictive factor
379522|NCT01963702|response|response
379523|NCT01963702|gastric neoplasm|gastric neoplasm
379524|NCT01963702|oxaliplatin|oxaliplatin
379525|NCT01963702|docetaxol|docetaxol
379526|NCT01963702|capecitabine|capecitabine
379527|NCT01963689|Anxiety|anxiety
379528|NCT01963689|Self-Esteem|self-esteem
379529|NCT01963676|schizophrenia|schizophrenia
379530|NCT01963676|auditory hallucinations|auditory hallucinations
379531|NCT01963676|transcranial stimulation|transcranial stimulation
379532|NCT01963676|tDCS|tdcs
379533|NCT01963676|tACS|tacs
379534|NCT01963663|YKL-40|ykl-40
379535|NCT01963663|Chronic low grade inflammation|chronic low grade inflammation
379536|NCT01963663|type 2 diabetes mellitus|type 2 diabetes mellitus
379537|NCT01963663|metformin|metformin
379538|NCT01963663|pioglitazone|pioglitazone
379539|NCT01963637|obesity, sleeve gastrectomy, gastric bypass, gastric tomodensitometry, gastric pouch size, weight regain|obesity, sleeve gastrectomy, gastric bypass, gastric tomodensitometry, gastric pouch size, weight regain
379540|NCT01963624|Breast|breast
379541|NCT01963624|Screening|screening
379542|NCT01963624|Ultrasound|ultrasound
379543|NCT01963624|Elastography|elastography
379544|NCT01963624|Doppler ultrasonography|doppler ultrasonography
379545|NCT01963611|Multiple Sclerosis|multiple sclerosis
379546|NCT01963611|Relapsing Remitting|relapsing remitting
379547|NCT01963611|Plovamer acetate|plovamer acetate
379548|NCT01963611|Copaxone|copaxone
379549|NCT01963585|C reactive protein|c reactive protein
379550|NCT01963585|Airway hyperreactivity|airway hyperreactivity
379551|NCT01963585|Body mass index|body mass index
379552|NCT01963572|Breast cancer|breast cancer
379553|NCT01963572|Care model|care model
379554|NCT01963572|Physical Therapy|physical therapy
379555|NCT01963546|diabetic|diabetic
379556|NCT01963546|laparoscopic gastric bypass surgery|laparoscopic gastric bypass surgery
379557|NCT01963546|stress response|stress response
379558|NCT01963546|anesthesia|anesthesia
379559|NCT01963546|dexmedetomidine|dexmedetomidine
379560|NCT01963533|lung cancer|lung cancer
379561|NCT01963533|telomere length|telomere length
379562|NCT01963533|comorbidity|comorbidity
379563|NCT01963533|Eastern Cooperation Oncology Group (ECOG)|eastern cooperation oncology group (ecog)
379564|NCT01963533|chemotherapy|chemotherapy
379565|NCT01963520|Hip prosthesis infection|hip prosthesis infection
379566|NCT01963520|Reinfection|reinfection
379567|NCT01963520|Excision-synovectomy|excision-synovectomy
379568|NCT01963520|One stage/two stage revision|one stage/two stage revision
379569|NCT01963520|Antibiotherapy|antibiotherapy
379570|NCT01963494|Physical activity|physical activity
379571|NCT01963494|Health-behavior-change|health-behavior-change
379572|NCT01963494|Dyadic Planning|dyadic planning
379573|NCT01963494|Individual Planning|individual planning
379574|NCT01963481|hormonal therapy|hormonal therapy
379575|NCT01963481|immunotherapy|immunotherapy
379576|NCT01963468|Hearing Loss|hearing loss
379577|NCT01963468|Cochlear Implant|cochlear implant
379578|NCT01963468|Deaf|deaf
379579|NCT01963468|Hearing Impairment|hearing impairment
379580|NCT01963468|Hard of Hearing|hard of hearing
379581|NCT01963455|transplantation autologous stress urinary incontinence|transplantation autologous stress urinary incontinence
379582|NCT01963455|muscle derived cells|muscle derived cells
379583|NCT01963429|hepatocellular|hepatocellular
379584|NCT01963429|Proton|proton
379585|NCT01963429|RFA|rfa
379586|NCT01963403|etonogestrel implant|etonogestrel implant
379587|NCT01963403|birth control|birth control
379588|NCT01963403|irregular bleeding|irregular bleeding
379589|NCT01963403|heavy bleeding|heavy bleeding
379590|NCT01963390|Hypogonadism|hypogonadism
379591|NCT01963390|Testosterone Deficiency|testosterone deficiency
379592|NCT01963377|bronchoscopy|bronchoscopy
379593|NCT01963377|O2-supplementation|o2-supplementation
379594|NCT01963364|fructans|fructans
379595|NCT01963364|inulin|inulin
379596|NCT01963364|oligofructose|oligofructose
379597|NCT01963364|colonic fermentation|colonic fermentation
379598|NCT01963364|microbiota|microbiota
379599|NCT01963364|whoe gut transit|whoe gut transit
379600|NCT01963351|NSCLC|nsclc
379601|NCT01963351|Non-squamous|non-squamous
379602|NCT01963286|ICD|icd
379603|NCT01963286|CRT-D|crt-d
379604|NCT01963286|Sudden cardiac death|sudden cardiac death
379605|NCT01963286|Device settings|device settings
379606|NCT01963286|Optimized programming strategy|optimized programming strategy
379607|NCT01963221|elderly|elderly
379608|NCT01963221|aorta|aorta
379609|NCT01963221|inflammation|inflammation
379610|NCT01963221|arterial stiffness|arterial stiffness
379611|NCT01963221|PET/CT Imaging|pet/ct imaging
379612|NCT01963221|hypertension|hypertension
379613|NCT01963221|MRI|mri
379614|NCT01963208|partial onset seizures|partial onset seizures
379615|NCT01963208|complex partial seizures|complex partial seizures
379616|NCT01963208|simple partial seizures|simple partial seizures
379617|NCT01963208|anticonvulsant|anticonvulsant
379618|NCT01963208|ganaxolone|ganaxolone
379619|NCT01963208|neurosteroid|neurosteroid
379620|NCT01963208|Marinus|marinus
379621|NCT01963208|epilepsy|epilepsy
379622|NCT01963195|Adverse Reaction to Drug|adverse reaction to drug
379623|NCT01963195|Self Efficacy|self efficacy
379624|NCT01963169|Bone Health|bone health
379625|NCT01963169|Online intervention|online intervention
379626|NCT01963169|Dissemination|dissemination
379627|NCT01963169|Theory-based intervention|theory-based intervention
379628|NCT01963156|Prescription synchronization|prescription synchronization
379629|NCT01963156|Cardiovascular disease|cardiovascular disease
379630|NCT01963156|Medication adherence|medication adherence
379631|NCT01963156|Randomized controlled trial|randomized controlled trial
379632|NCT01963156|Chronic disease|chronic disease
379633|NCT01963156|Pharmacy benefit design|pharmacy benefit design
379634|NCT01963156|Quality improvement|quality improvement
379635|NCT01963130|Vildagliptin|vildagliptin
379636|NCT01963130|Portal Vein Pressure|portal vein pressure
379637|NCT01963130|Hepatosteatosis|hepatosteatosis
379638|NCT01963104|hearing test, audiology, healthcare utilization,|hearing test, audiology, healthcare utilization,
379639|NCT01963104|patient education, hearing screening|patient education, hearing screening
379640|NCT01963065|Children's environmental health|children's environmental health
379641|NCT01963065|Preterm birth|preterm birth
379642|NCT01963065|Newborns|newborns
379643|NCT01963065|Bisphenol A|bisphenol a
379644|NCT01963065|BPA|bpa
379645|NCT01963065|Phthalates|phthalates
379646|NCT01963065|Metals exposure|metals exposure
379647|NCT01963065|Very low birth weight|very low birth weight
379648|NCT01963065|NICU|nicu
379649|NCT01963065|Stress|stress
379650|NCT01963052|Metastatic Urothelial Cancer|metastatic urothelial cancer
379651|NCT01963052|AGS15E|ags15e
379652|NCT01963052|AGS15E-13-1|ags15e-13-1
379653|NCT01963052|ASG-15ME|asg-15me
379654|NCT01963052|Pharmacokinetics of AGS15E|pharmacokinetics of ags15e
379655|NCT01963026|spinal cord injury|spinal cord injury
379656|NCT01963026|upper extremity|upper extremity
379657|NCT01963026|skill performance|skill performance
379658|NCT01963026|motor learning|motor learning
379659|NCT01963013|Non-returning catheter valve|non-returning catheter valve
379660|NCT01963013|Catheter associated urinary tract infection|catheter associated urinary tract infection
379661|NCT01963013|Critically ill patients|critically ill patients
379662|NCT01963013|Prevention|prevention
379663|NCT01963000|Community Acquired Pneumonia|community acquired pneumonia
379664|NCT01963000|Emergency Department|emergency department
379665|NCT01963000|Standardized Care|standardized care
379666|NCT01963000|Reduced Mortality|reduced mortality
379667|NCT01963000|CRB-65 Risk Classes|crb-65 risk classes
379668|NCT01963000|Antibiotic Therapy|antibiotic therapy
379669|NCT01962974|Arthritis, Rheumatoid|arthritis, rheumatoid
379670|NCT01962961|HIV|hiv
379671|NCT01962961|Endothelial function|endothelial function
379672|NCT01962961|Oxidative stress|oxidative stress
379673|NCT01962961|Cardiovascular disease|cardiovascular disease
379674|NCT01962961|N-acetylcysteine|n-acetylcysteine
379675|NCT01962935|Healthy volunteer|healthy volunteer
379676|NCT01962935|Multiple ascending dose|multiple ascending dose
379677|NCT01962909|Pancreatic Resection|pancreatic resection
379678|NCT01962883|Post Concussion Syndrome|post concussion syndrome
379679|NCT01962883|Vestibular disturbance|vestibular disturbance
379680|NCT01962883|Balance|balance
379681|NCT01962883|Dizziness|dizziness
379772|NCT01962571|Multiple Sclerosis|multiple sclerosis
379682|NCT01962883|Dizziness handicap inventory|dizziness handicap inventory
379683|NCT01962883|Balance Error Scoring System|balance error scoring system
379684|NCT01962857|Physical activity|physical activity
379685|NCT01962857|Exercise|exercise
379686|NCT01962857|Insulin resistance|insulin resistance
379687|NCT01962857|High intensity interval training|high intensity interval training
379688|NCT01962857|Fat oxidation|fat oxidation
379690|NCT01962857|Lipids|lipids
379691|NCT01962857|Blood pressure|blood pressure
379692|NCT01962844|chronic coronary artery disease|chronic coronary artery disease
379693|NCT01962844|coconut oil extra virgin|coconut oil extra virgin
379694|NCT01962844|index of diet quality|index of diet quality
379695|NCT01962844|nutritional treatment|nutritional treatment
379696|NCT01962831|obesity|obesity
379697|NCT01962831|labor, induced|labor, induced
379698|NCT01962831|pregnancy|pregnancy
379699|NCT01962831|cervical ripening|cervical ripening
379700|NCT01962831|dinoprostone|dinoprostone
379701|NCT01962818|Respiratory Distress Syndrome In Premature Infants|respiratory distress syndrome in premature infants
379702|NCT01962818|Bronchopulmonary Dysplasia|bronchopulmonary dysplasia
379703|NCT01962818|Ventilator-Induced Lung Injury|ventilator-induced lung injury
379704|NCT01962818|Functional Residual Capacity|functional residual capacity
379705|NCT01962818|Electric impedance tomography|electric impedance tomography
379706|NCT01962792|PCI-32765|pci-32765
379707|NCT01962792|Multiple Myeloma|multiple myeloma
379948|NCT01962025|Renal failure|renal failure
379708|NCT01962792|Relapsed Refractory Multiple Myeloma|relapsed refractory multiple myeloma
379709|NCT01962792|Bruton's Tyrosine Kinase|bruton's tyrosine kinase
379710|NCT01962792|Carfilzomib|carfilzomib
379711|NCT01962792|Dexamethasone|dexamethasone
379712|NCT01962792|Ibrutinib|ibrutinib
379713|NCT01962779|Sleep Disordered Breathing|sleep disordered breathing
379714|NCT01962779|Cognitively normal elderly|cognitively normal elderly
379715|NCT01962779|Alzheimer's disease|alzheimer's disease
379716|NCT01962779|Prevention|prevention
379717|NCT01962779|Continuous positive airway pressure (CPAP)|continuous positive airway pressure (cpap)
379718|NCT01962753|Affective symptoms as prodromal stage of Alzheimer|affective symptoms as prodromal stage of alzheimer
379719|NCT01962727|scapular dyskinesis, kinematics, muscular activities|scapular dyskinesis, kinematics, muscular activities
379720|NCT01962714|Behavior therapies, cognitive|behavior therapies, cognitive
379721|NCT01962714|Mindfulness|mindfulness
379722|NCT01962714|Emotion|emotion
379723|NCT01962714|Group therapy|group therapy
379724|NCT01962701|C-section|c-section
379725|NCT01962688|Heart Failure|heart failure
379726|NCT01962688|Handheld ultrasound|handheld ultrasound
379727|NCT01962688|Inferior Vena Cava|inferior vena cava
379728|NCT01962675|tDCS|tdcs
379729|NCT01962675|motor training|motor training
379730|NCT01962675|SCI|sci
379731|NCT01962662|stroke|stroke
379732|NCT01962662|transcranial magnetic stimulation|transcranial magnetic stimulation
379733|NCT01962662|EMG biofeedback|emg biofeedback
379734|NCT01962662|motor function|motor function
379735|NCT01962662|neural plasticity|neural plasticity
379736|NCT01962662|force|force
379737|NCT01962649|Hepatocellular carcinoma|hepatocellular carcinoma
379738|NCT01962636|Umbilical Cord Transplant|umbilical cord transplant
379739|NCT01962636|Acute Myeloid Leukemia (AML)|acute myeloid leukemia (aml)
379740|NCT01962636|Acute Lymphocytic Leukemia (ALL)|acute lymphocytic leukemia (all)
379741|NCT01962636|Chronic Myelogenous Leukemia|chronic myelogenous leukemia
379742|NCT01962636|Plasma Cell Leukemia|plasma cell leukemia
379743|NCT01962636|Myelofibrosis|myelofibrosis
379744|NCT01962636|Myelodysplasia|myelodysplasia
379745|NCT01962636|Chronic Lymphocytic Leukemia|chronic lymphocytic leukemia
379746|NCT01962636|Small Lymphocytic Lymphoma|small lymphocytic lymphoma
379747|NCT01962636|Marginal Zone B-Cell Lymphoma|marginal zone b-cell lymphoma
379748|NCT01962636|Follicular Lymphoma|follicular lymphoma
379749|NCT01962636|Lymphoplasmacytic Lymphoma|lymphoplasmacytic lymphoma
379750|NCT01962636|Mantle-Cell Lymphoma|mantle-cell lymphoma
379751|NCT01962636|Prolymphocytic Leukemia|prolymphocytic leukemia
379752|NCT01962636|Large Cell Non-Hodgkin Lymphoma|large cell non-hodgkin lymphoma
379753|NCT01962636|Lymphoblastic Lymphoma|lymphoblastic lymphoma
379754|NCT01962636|Burkitt's Lymphoma|burkitt's lymphoma
379755|NCT01962636|Non-Hodgkin Lymphoma|non-hodgkin lymphoma
379756|NCT01962636|Multiple Myeloma|multiple myeloma
379757|NCT01962623|Severe Mood Dysregulation|severe mood dysregulation
379758|NCT01962623|Mood Disorders|mood disorders
379759|NCT01962623|Irritability|irritability
379760|NCT01962623|Disruptive Mood Dysregulation Disorder|disruptive mood dysregulation disorder
379761|NCT01962623|Interpersonal Psychotherapy|interpersonal psychotherapy
379762|NCT01962610|Pain care|pain care
379763|NCT01962610|emergency|emergency
379764|NCT01962610|clinical decision support|clinical decision support
379765|NCT01962610|abdominal pain|abdominal pain
379766|NCT01962597|hemodialysis|hemodialysis
379767|NCT01962597|aerobic exercise|aerobic exercise
379768|NCT01962597|resistance training|resistance training
379769|NCT01962597|walking speed|walking speed
379770|NCT01962597|randomized controlled trial|randomized controlled trial
379771|NCT01962571|Optic neuritis|optic neuritis
379773|NCT01962571|Clinically isolated syndrome|clinically isolated syndrome
379774|NCT01962571|Erythropoietin|erythropoietin
379775|NCT01962558|Tinnitus|tinnitus
379776|NCT01962558|Medical Device|medical device
379777|NCT01962558|Randomized|randomized
379778|NCT01962558|Vagus Nerve Stimulation|vagus nerve stimulation
379779|NCT01962545|Atrial Fibrillation|atrial fibrillation
379780|NCT01962545|Percutaneous coronary intervention|percutaneous coronary intervention
379781|NCT01962545|Stent|stent
379782|NCT01962545|Anticoagulant therapy|anticoagulant therapy
379783|NCT01962545|Antiplatelet therapy|antiplatelet therapy
379784|NCT01962545|Warfarin|warfarin
379785|NCT01962545|NOAC|noac
379786|NCT01962545|Aspirin|aspirin
379787|NCT01962545|Clopidogrel|clopidogrel
379788|NCT01962532|Neoplasms|neoplasms
379789|NCT01962532|Lymphoma|lymphoma
379790|NCT01962532|Advanced or refractory solid tumors|advanced or refractory solid tumors
379791|NCT01962532|Advanced or refractory lymphoma|advanced or refractory lymphoma
379792|NCT01962532|Gastric adenocarcinoma|gastric adenocarcinoma
379793|NCT01962532|Gastroesophageal junctions|gastroesophageal junctions
379794|NCT01962532|JNJ-42756493|jnj-42756493
379795|NCT01962532|Pharmacokinetics|pharmacokinetics
379796|NCT01962532|Japanese|japanese
379797|NCT01962532|Asian|asian
379798|NCT01962532|Pharmacodynamics|pharmacodynamics
379799|NCT01962519|gastrectomy|gastrectomy
379800|NCT01962519|gastric cancer|gastric cancer
379801|NCT01962519|oral feeding|oral feeding
379802|NCT01962519|complications|complications
379803|NCT01962506|Chest pain|chest pain
379804|NCT01962506|Copeptin|copeptin
379805|NCT01962506|High-sensitivity cardiac troponin|high-sensitivity cardiac troponin
379806|NCT01962506|Non-ST-Elevation (NSTE) - ACS|non-st-elevation (nste) - acs
379807|NCT01962467|Allergic rhinitis|allergic rhinitis
379808|NCT01962467|healthy volunteers|healthy volunteers
379809|NCT01962467|fluticasone furoate|fluticasone furoate
379810|NCT01962467|levocabastine|levocabastine
379811|NCT01962467|fixed dose combination|fixed dose combination
379812|NCT01962467|pharmacokinetics|pharmacokinetics
379813|NCT01962454|muscle mass|muscle mass
379814|NCT01962454|dynamic proteomics|dynamic proteomics
379815|NCT01962454|Duke University|duke university
379816|NCT01962454|Microbiopsy|microbiopsy
379817|NCT01962454|D2O|d2o
379818|NCT01962454|testosterone|testosterone
379819|NCT01962454|skeletal muscle|skeletal muscle
379820|NCT01962441|7977|7977
379821|NCT01962441|GS-7977|gs-7977
379822|NCT01962441|PSI-7977|psi-7977
379823|NCT01962441|Sofosbuvir (SOF)|sofosbuvir (sof)
379824|NCT01962441|Pegylated Interferon (Peg-IFN)|pegylated interferon (peg-ifn)
379825|NCT01962441|Ribavirin (RBV)|ribavirin (rbv)
379826|NCT01962428|ticagrelor|ticagrelor
379827|NCT01962428|loading dose|loading dose
379828|NCT01962428|non-ST-segment elevation acute coronary syndromes|non-st-segment elevation acute coronary syndromes
379829|NCT01962428|percutaneous coronary intervention|percutaneous coronary intervention
379830|NCT01962428|the antiplatelet effects|the antiplatelet effects
379831|NCT01962428|bleeding events|bleeding events
379832|NCT01962428|major adverse cardiac events|major adverse cardiac events
379833|NCT01962415|Severe Combined Immune Deficiency (SCID)|severe combined immune deficiency (scid)
379834|NCT01962415|Omenn Syndrome|omenn syndrome
379835|NCT01962415|Bare Lymphocyte Syndrome (BLS)|bare lymphocyte syndrome (bls)
379836|NCT01962415|Combined Immune Deficiency (CID) syndromes|combined immune deficiency (cid) syndromes
379837|NCT01962415|Combined Variable Immune Deficiency (CVID) syndrome|combined variable immune deficiency (cvid) syndrome
379838|NCT01962415|Wiskott-Aldrich Syndrome|wiskott-aldrich syndrome
379839|NCT01962415|Leukocyte adhesion deficiency|leukocyte adhesion deficiency
379840|NCT01962415|Chronic granulomatous disease (CGD)|chronic granulomatous disease (cgd)
379841|NCT01962415|X-linked Hyper IgM (XHIM) syndrome|x-linked hyper igm (xhim) syndrome
379842|NCT01962415|IPEX syndrome|ipex syndrome
379843|NCT01962415|Chediak - Higashi Syndrome|chediak - higashi syndrome
379844|NCT01962415|Autoimmune Lymphoproliferative Syndrome (ALPS)|autoimmune lymphoproliferative syndrome (alps)
379845|NCT01962415|Hemophagocytic Lymphohistiocytosis (HLH) syndromes|hemophagocytic lymphohistiocytosis (hlh) syndromes
379846|NCT01962415|Lymphocyte Signaling defects|lymphocyte signaling defects
379847|NCT01962415|Dyskeratosis Congenita (DC)|dyskeratosis congenita (dc)
379848|NCT01962415|Congenital Amegakaryocytic Thrombocytopenia (CAMT)|congenital amegakaryocytic thrombocytopenia (camt)
379849|NCT01962415|Osteopetrosis|osteopetrosis
379850|NCT01962415|Mucopolysaccharidoses|mucopolysaccharidoses
379851|NCT01962415|Hurler syndrome (MPS I)|hurler syndrome (mps i)
379852|NCT01962415|Hunter syndrome (MPS II)|hunter syndrome (mps ii)
379853|NCT01962415|Sanfilippo syndrome (MPS II)|sanfilippo syndrome (mps ii)
379854|NCT01962415|Leukodystrophies|leukodystrophies
379855|NCT01962415|Krabbe Disease|krabbe disease
379856|NCT01962415|Metachromatic leukodystrophy (MLD)|metachromatic leukodystrophy (mld)
379857|NCT01962415|X-linked adrenoleukodystrophy (ALD)|x-linked adrenoleukodystrophy (ald)
379858|NCT01962415|Alpha mannosidosis|alpha mannosidosis
379859|NCT01962415|Gaucher Disease|gaucher disease
379860|NCT01962415|Thalassemia major|thalassemia major
379861|NCT01962415|Sickle cell disease (SCD)|sickle cell disease (scd)
379862|NCT01962415|Diamond Blackfan Anemia (DBA)|diamond blackfan anemia (dba)
379863|NCT01962415|Crohn's Disease|crohn's disease
379864|NCT01962415|Inflammatory Bowel Disease|inflammatory bowel disease
379865|NCT01962415|Hematopoietic Stem Cell Transplant (HSCT)|hematopoietic stem cell transplant (hsct)
784378|NCT00313196|ASSET|asset
379866|NCT01962415|Congenital transfusion dependent anemias|congenital transfusion dependent anemias
379867|NCT01962415|Globoid cell leukodystrophy|globoid cell leukodystrophy
379868|NCT01962415|Hereditary diffuse leukoencephalopathy with spheroids (HDLS)|hereditary diffuse leukoencephalopathy with spheroids (hdls)
379869|NCT01962389|ISR, Laser, SFA, PAD|isr, laser, sfa, pad
379870|NCT01962376|Capecitabine|capecitabine
379871|NCT01962376|Oxaliplatin|oxaliplatin
379872|NCT01962376|Bevacizumab|bevacizumab
379873|NCT01962376|Potentially Resectable Gastric Cancer Liver Metastasis|potentially resectable gastric cancer liver metastasis
379874|NCT01962363|Friedreich's ataxia point mutation|friedreich's ataxia point mutation
379875|NCT01962350|Deep Brain Transcranial Magnetic Stimulation;|deep brain transcranial magnetic stimulation;
379876|NCT01962350|H1-Coil deep brain rTMS;|h1-coil deep brain rtms;
379877|NCT01962350|H1-Coil;|h1-coil;
379878|NCT01962350|Bipolar Depression;|bipolar depression;
379879|NCT01962350|Cognition.|cognition.
379880|NCT01962324|Quality of Life|quality of life
379881|NCT01962324|Radiotherapy|radiotherapy
379882|NCT01962324|Radiotherapy, dose-escalation|radiotherapy, dose-escalation
379883|NCT01962311|ALS|als
379884|NCT01962311|Spinal Cerebrospinal Fluid|spinal cerebrospinal fluid
379885|NCT01962311|Urine|urine
379886|NCT01962311|SERUM|serum
379887|NCT01962311|Diagnosis|diagnosis
379888|NCT01962285|neuronal inertia|neuronal inertia
379889|NCT01962285|loss of consciousness|loss of consciousness
379890|NCT01962285|propofol pharmacodynamics|propofol pharmacodynamics
379891|NCT01962285|Bispectral index|bispectral index
379892|NCT01962285|anesthesia, general/pharmacology|anesthesia, general/pharmacology
379893|NCT01962272|cancer|cancer
379894|NCT01962272|radiotherapy|radiotherapy
379895|NCT01962272|chemotherapy|chemotherapy
379896|NCT01962272|nutrition|nutrition
379897|NCT01962272|dietary counseling|dietary counseling
379898|NCT01962272|quality of life|quality of life
379899|NCT01962246|Capecitabine|capecitabine
379900|NCT01962246|Oxaliplatin|oxaliplatin
379901|NCT01962246|Preoperative Concurrent Chemoradiotherapy|preoperative concurrent chemoradiotherapy
379902|NCT01962246|Gastroesophageal Junction Adenocarcinoma|gastroesophageal junction adenocarcinoma
379903|NCT01962220|HIV/AIDS|hiv/aids
379904|NCT01962220|PMTCT|pmtct
379905|NCT01962220|Pregnant Women|pregnant women
379906|NCT01962220|Kenya|kenya
379907|NCT01962220|Maternal Health|maternal health
379908|NCT01962207|10 years Meningitec|10 years meningitec
379909|NCT01962207|Safety|safety
379910|NCT01962207|booster response|booster response
379911|NCT01962207|Adolescents|adolescents
379912|NCT01962207|Adults|adults
379913|NCT01962207|Immunogenicity|immunogenicity
379914|NCT01962207|Mencevax ACWY|mencevax acwy
379915|NCT01962181|EEG Attention Deficit / Hyperactivity Disorder (ADHD) Ritalin machine learning|eeg attention deficit / hyperactivity disorder (adhd) ritalin machine learning
379916|NCT01962168|Biliary Tract Neoplasms|biliary tract neoplasms
379917|NCT01962168|Neoplasms|neoplasms
379918|NCT01962168|Gastrointestinal Diseases|gastrointestinal diseases
379919|NCT01962168|Digestive System Diseases|digestive system diseases
379920|NCT01962168|Biliary Tract|biliary tract
379921|NCT01962168|Stents|stents
379922|NCT01962155|Fibrosis|fibrosis
379923|NCT01962155|Liver Cirrhosis|liver cirrhosis
379924|NCT01962155|non-invasive|non-invasive
379925|NCT01962155|biopsy|biopsy
379926|NCT01962155|hepatitis B virus|hepatitis b virus
379927|NCT01962103|Neuroblastoma|neuroblastoma
379928|NCT01962103|Rhabdomyosarcoma|rhabdomyosarcoma
379929|NCT01962103|Soft Tissue|soft tissue
379930|NCT01962103|Pediatric Oncology|pediatric oncology
379931|NCT01962103|Abraxane|abraxane
379932|NCT01962103|albumin-bound paclitaxel|albumin-bound paclitaxel
379933|NCT01962103|nab-paclitaxel|nab-paclitaxel
379934|NCT01962103|ABI-007|abi-007
379935|NCT01962103|taxane|taxane
379936|NCT01962103|solid tumors|solid tumors
379937|NCT01962090|Neck Pain|neck pain
379938|NCT01962090|Thoracic spine thrust manipulation|thoracic spine thrust manipulation
379939|NCT01962090|Osteopathic Manipulation|osteopathic manipulation
379940|NCT01962090|Dentistry|dentistry
379941|NCT01962090|Range of Motion|range of motion
379942|NCT01962077|pulpotomy|pulpotomy
379943|NCT01962077|MTA|mta
379944|NCT01962077|primary teeth|primary teeth
379945|NCT01962077|formocresol|formocresol
379946|NCT01962038|Mild Cognitive Impairment|mild cognitive impairment
379947|NCT01962038|Aging|aging
379949|NCT01962025|Hemodialysis|hemodialysis
379950|NCT01962025|Canulation technique|canulation technique
379951|NCT01962025|Training time|training time
379953|NCT01962025|Patient discomfort with cannulation technique|patient discomfort with cannulation technique
379954|NCT01962012|Orthodontic|orthodontic
379955|NCT01962012|Orthodontic Treatment|orthodontic treatment
379956|NCT01962012|Accelerated Tooth Movement|accelerated tooth movement
379957|NCT01962012|Malocclusion|malocclusion
379958|NCT01962012|Device|device
379959|NCT01962012|AcceleDent Aura|acceledent aura
379960|NCT01962012|Clear Aligners|clear aligners
379961|NCT01961999|Acute kidney injury|acute kidney injury
379962|NCT01961999|Cardiac surgery|cardiac surgery
784379|NCT00313196|ASSET-2|asset-2
379963|NCT01961999|Renal replacement therapy|renal replacement therapy
379964|NCT01961986|Rotator Cuff|rotator cuff
379965|NCT01961986|Rotator Cuff Sparing|rotator cuff sparing
379966|NCT01961986|Shoulder Replacement|shoulder replacement
379967|NCT01961986|Total Shoulder Replacement|total shoulder replacement
379968|NCT01961986|Total Shoulder Arthroplasty|total shoulder arthroplasty
379969|NCT01961986|Arthritis|arthritis
379970|NCT01961973|Articular cartilage|articular cartilage
379971|NCT01961973|Chondrocytes|chondrocytes
379972|NCT01961973|BMAC|bmac
379973|NCT01961960|ASP7374|asp7374
379974|NCT01961960|Prevention of seasonal influenza|prevention of seasonal influenza
379975|NCT01961947|ASP7374|asp7374
379976|NCT01961947|Approved egg-derived vaccine|approved egg-derived vaccine
379977|NCT01961947|Prevention of seasonal influenza|prevention of seasonal influenza
379978|NCT01961934|glioblastoma|glioblastoma
379979|NCT01961934|high grade brain tumors|high grade brain tumors
379980|NCT01961934|recurrent|recurrent
379981|NCT01961934|pseudo-progression|pseudo-progression
379982|NCT01961934|radionecrosis|radionecrosis
379983|NCT01961934|carbon acetate|carbon acetate
379984|NCT01961934|C11 aceate|c11 aceate
379985|NCT01961934|PET|pet
379986|NCT01961934|positron emission tomography|positron emission tomography
379987|NCT01961921|RNAi therapeutic|rnai therapeutic
379988|NCT01961895|Continuous lumbar plexus (LP) block analgesia|continuous lumbar plexus (lp) block analgesia
379989|NCT01961882|OCV-501|ocv-501
379990|NCT01961882|Acute Myeloid Leukemia|acute myeloid leukemia
379991|NCT01961882|Antigen specific cancer immunotherapeutic|antigen specific cancer immunotherapeutic
379992|NCT01961869|black raspberry|black raspberry
379993|NCT01961869|chemoprevention|chemoprevention
379994|NCT01961869|oral delivery|oral delivery
379995|NCT01961856|platelet reactivity|platelet reactivity
379996|NCT01961856|ticagrelor loading dose|ticagrelor loading dose
379997|NCT01961856|clopidogrel loading dose|clopidogrel loading dose
379998|NCT01961843|Castration Resistant|castration resistant
379999|NCT01961817|Retromolar|retromolar
380000|NCT01961817|Difficult Intubation|difficult intubation
380001|NCT01961791|gastric cancer, staging system, prognosis|gastric cancer, staging system, prognosis
380002|NCT01961765|Relapsed acute myeloid leukemia|relapsed acute myeloid leukemia
380003|NCT01961765|Refractory acute myeloid leukemia|refractory acute myeloid leukemia
380004|NCT01961752|bupivacaine,|bupivacaine,
380005|NCT01961752|triamcinolone acetonide,|triamcinolone acetonide,
380006|NCT01961752|endoscopic|endoscopic
380007|NCT01961752|submucosal|submucosal
380008|NCT01961752|dissection|dissection
380009|NCT01961752|Patients|patients
380010|NCT01961739|Hemorrhoids|hemorrhoids
380011|NCT01961739|Lidocaine|lidocaine
380012|NCT01961713|circulating tumor cells|circulating tumor cells
380013|NCT01961713|CTC-Chip|ctc-chip
380014|NCT01961661|intestinal inflammation|intestinal inflammation
380015|NCT01961661|intestinal microflora|intestinal microflora
380016|NCT01961661|children|children
380017|NCT01961648|Apnea|apnea
380018|NCT01961648|Sleep Apnea Disorder|sleep apnea disorder
380019|NCT01961648|Respiratory chemical drive|respiratory chemical drive
380020|NCT01961648|CO2|co2
380021|NCT01961635|Dental Implants|dental implants
380022|NCT01961635|Zirconia Abutments|zirconia abutments
380023|NCT01961635|Titanium abutments|titanium abutments
380024|NCT01961635|Acrylic abutments|acrylic abutments
380025|NCT01961635|Gingival Healing|gingival healing
380026|NCT01961635|Inflammation|inflammation
380027|NCT01961635|Bone loss|bone loss
380028|NCT01961622|Type 1 diabetes|type 1 diabetes
380029|NCT01961622|Closed loop insulin delivery|closed loop insulin delivery
380030|NCT01961622|Continuous subcutaneous glucose monitoring|continuous subcutaneous glucose monitoring
380031|NCT01961622|Continuous subcutaneous insulin infusion|continuous subcutaneous insulin infusion
380032|NCT01961609|Chronic plaque psoriasis|chronic plaque psoriasis
380033|NCT01961596|Cooling ice spray|cooling ice spray
380034|NCT01961596|Time to stability|time to stability
380035|NCT01961596|Jump|jump
380036|NCT01961570|Early stage hand osteoarthritis|early stage hand osteoarthritis
380037|NCT01961570|Carpometacarpal osteoarthritis|carpometacarpal osteoarthritis
380038|NCT01961557|incomplete spinal cord injury|incomplete spinal cord injury
380039|NCT01961557|EEG|eeg
380040|NCT01961557|Cerebral Palsy|cerebral palsy
380041|NCT01961557|Knee|knee
380042|NCT01961557|Muscular Dystrophies|muscular dystrophies
380043|NCT01961544|Breast Cancer|breast cancer
380044|NCT01961544|Metastatic|metastatic
380045|NCT01961531|DCIS|dcis
380046|NCT01961531|IDC|idc
380047|NCT01961531|Invasive breast carcinoma|invasive breast carcinoma
380048|NCT01961479|Premenstrual syndrome (PMS)|premenstrual syndrome (pms)
380049|NCT01961479|Premenstrual Dysphoric Disorder (PMDD)|premenstrual dysphoric disorder (pmdd)
380050|NCT01961479|Internet-based Therapy|internet-based therapy
380051|NCT01961479|Cognitive Behavioural Therapy (CBT)|cognitive behavioural therapy (cbt)
380052|NCT01961453|Hypertension|hypertension
380053|NCT01961453|Isosorbide Mononitrate|isosorbide mononitrate
380054|NCT01961453|Myocardial fibrosis|myocardial fibrosis
380055|NCT01961427|dietary nitrate|dietary nitrate
380056|NCT01961427|beetroot juice|beetroot juice
380057|NCT01961427|exercise performance|exercise performance
380058|NCT01961427|oxygen consumption|oxygen consumption
380059|NCT01961414|Exudative|exudative
380061|NCT01961414|Macular|macular
380062|NCT01961414|Degeneration|degeneration
380063|NCT01961414|Aflibercept|aflibercept
380064|NCT01961414|Eylea|eylea
380065|NCT01961414|Intravitreal|intravitreal
380066|NCT01961401|exercise|exercise
380067|NCT01961401|exercise therapy|exercise therapy
380068|NCT01961401|insulin resistance|insulin resistance
380069|NCT01961388|Type 2 Diabetes|type 2 diabetes
380070|NCT01961362|Pulmonary fibrosis|pulmonary fibrosis
380071|NCT01961362|Interstitial lung disease|interstitial lung disease
380072|NCT01961362|Connective tissue disease|connective tissue disease
380073|NCT01961362|Chronic hypersensitivity pneumonitis|chronic hypersensitivity pneumonitis
380074|NCT01961362|Idiopathic pulmonary fibrosis|idiopathic pulmonary fibrosis
380075|NCT01961362|Pulmonary fibrosis of any cause|pulmonary fibrosis of any cause
380076|NCT01961362|Primary supporters/caregivers|primary supporters/caregivers
380077|NCT01961349|sedation, propofol, gastrointestinal endoscopy|sedation, propofol, gastrointestinal endoscopy
380078|NCT01961336|IVF, poor responder, testosterone|ivf, poor responder, testosterone
380079|NCT01961323|Hypertension|hypertension
380080|NCT01961323|high blood pressure|high blood pressure
380081|NCT01961323|stress echocardiogram|stress echocardiogram
380082|NCT01961323|nebivolol|nebivolol
380083|NCT01961323|left ventricular diastolic dysfunction|left ventricular diastolic dysfunction
380084|NCT01961310|bacterial translocation|bacterial translocation
380085|NCT01961310|intestinal microbiota|intestinal microbiota
380086|NCT01961297|dystonia|dystonia
380087|NCT01961297|tremor|tremor
380088|NCT01961297|treatment|treatment
380089|NCT01961297|sodium oxybate|sodium oxybate
380090|NCT01961297|brain activity|brain activity
380091|NCT01961271|Norspan|norspan
380092|NCT01961271|buprenorphine|buprenorphine
380093|NCT01961271|transdermal|transdermal
380094|NCT01961271|patch|patch
380095|NCT01961271|chronic pain|chronic pain
380096|NCT01961271|non-malignant|non-malignant
380097|NCT01961271|osteoarthritis|osteoarthritis
380098|NCT01961271|rheumatoid arthritis|rheumatoid arthritis
380099|NCT01961271|lower back pain|lower back pain
380100|NCT01961271|joint pain|joint pain
380101|NCT01961271|muscle pain|muscle pain
380102|NCT01961271|opioid|opioid
380103|NCT01961271|analgesic|analgesic
380104|NCT01961271|painkiller|painkiller
380105|NCT01961271|Mundipharma|mundipharma
380106|NCT01961258|Severe Asthma, Community, comorbidities, patient compliance,PFT, anti-IgE therapy|severe asthma, community, comorbidities, patient compliance,pft, anti-ige therapy
380107|NCT01961232|Pulmonary Hypertension|pulmonary hypertension
380108|NCT01961232|biomarker|biomarker
380109|NCT01961232|cardiac|cardiac
380110|NCT01961232|circulation|circulation
380111|NCT01961232|heart disease|heart disease
380112|NCT01961232|lung disease|lung disease
380113|NCT01961193|critically ill patients|critically ill patients
380114|NCT01961193|punctal plug|punctal plug
380115|NCT01961193|corneal injuries|corneal injuries
380116|NCT01961180|Quality of Life|quality of life
380117|NCT01961180|Adrenal hyper activity|adrenal hyper activity
380118|NCT01961180|Glucose metabolism|glucose metabolism
380119|NCT01961167|PAD|pad
380120|NCT01961167|Stent|stent
380121|NCT01961167|Claudication|claudication
380122|NCT01961167|VIABAHN|viabahn
380123|NCT01961167|Gore|gore
380124|NCT01961167|Endoprosthesis|endoprosthesis
380125|NCT01961167|Vascular Diseases|vascular diseases
380126|NCT01961167|Cardiovascular Diseases|cardiovascular diseases
380127|NCT01961167|Iliac Occlusive Disease|iliac occlusive disease
380128|NCT01961167|Balloon Expandable|balloon expandable
380129|NCT01961167|Stent Graft|stent graft
380130|NCT01961167|VBX|vbx
380131|NCT01961154|Asthma|asthma
380132|NCT01961154|medication reduction|medication reduction
380133|NCT01961154|asthma exacerbation|asthma exacerbation
380134|NCT01961141|Ultrasound Doppler|ultrasound doppler
380135|NCT01961141|Pulmonary diseases|pulmonary diseases
380136|NCT01961141|Cardiopulmonary conditions|cardiopulmonary conditions
380137|NCT01961128|High risk|high risk
380138|NCT01961102|postmenopausal bleeding|postmenopausal bleeding
380139|NCT01961102|postmenopausal hyperplasia|postmenopausal hyperplasia
380140|NCT01961102|endometrial cancer|endometrial cancer
380141|NCT01961102|atypical hyperplasia|atypical hyperplasia
380142|NCT01961102|curettage|curettage
380143|NCT01961102|intraoperative rapid section|intraoperative rapid section
380144|NCT01961050|alcohol|alcohol
380145|NCT01961050|pregnancy|pregnancy
380146|NCT01961050|fetal exposure|fetal exposure
380147|NCT01961050|prevention|prevention
380148|NCT01961050|FAS|fas
380149|NCT01961050|Alcohol-Related Neurodevelopmental Disorder (ARND)|alcohol-related neurodevelopmental disorder (arnd)
380150|NCT01961037|Accidental Falls|accidental falls
380151|NCT01961037|Tai Chi|tai chi
380152|NCT01961037|Older Adults|older adults
380153|NCT01961037|Balance|balance
380154|NCT01961037|Moving for Better Balance|moving for better balance
380155|NCT01961037|Church|church
380156|NCT01961037|Congregational Intervention|congregational intervention
380157|NCT01961037|Rural|rural
380158|NCT01961037|West Virginia|west virginia
380159|NCT01961024|VLDL-TG kinetics|vldl-tg kinetics
380160|NCT01961024|Postprandial state|postprandial state
380161|NCT01961024|Obesity|obesity
380162|NCT01961011|nerve compression, carpal tunnel, clinical decision making|nerve compression, carpal tunnel, clinical decision making
380163|NCT01960998|radical prostatectomy|radical prostatectomy
380164|NCT01960998|urinary incontinence|urinary incontinence
380165|NCT01960998|prostate cancer|prostate cancer
380166|NCT01960998|telehealth|telehealth
380167|NCT01960998|pelvic floor muscle training|pelvic floor muscle training
380168|NCT01960985|Balance, Postural|balance, postural
380169|NCT01960985|Parkinson´s Disease|parkinson´s disease
380170|NCT01960985|H&Y 1-3|h&y 1-3
380171|NCT01960985|Exrecice|exrecice
380172|NCT01960985|Postural adjustments|postural adjustments
380173|NCT01960985|antecipatory postural|antecipatory postural
380174|NCT01960985|compensatory postural adjustments|compensatory postural adjustments
380175|NCT01960972|Blood pressure|blood pressure
380176|NCT01960972|Hypertension|hypertension
380177|NCT01960972|Stepped wedge trial design|stepped wedge trial design
380178|NCT01960946|Hypertension|hypertension
380179|NCT01960946|Galectin 3|galectin 3
380180|NCT01960946|Fibrosis|fibrosis
380181|NCT01960946|Vascular Stiffness|vascular stiffness
380182|NCT01960946|Echocardiography|echocardiography
380183|NCT01960933|STEMI|stemi
380184|NCT01960933|MVD|mvd
380185|NCT01960933|Full revascularization|full revascularization
380186|NCT01960933|Culprit lesion revascularization only|culprit lesion revascularization only
380187|NCT01960933|Primary PCI|primary pci
380188|NCT01960920|Air Pollution|air pollution
380189|NCT01960920|Heart Failure|heart failure
380190|NCT01960920|Endothelium|endothelium
380191|NCT01960920|Autonomic Dysfunction|autonomic dysfunction
380192|NCT01960920|Cardiopulmonary Exercise Test|cardiopulmonary exercise test
380193|NCT01960907|COPD|copd
380194|NCT01960907|CHF|chf
380195|NCT01960907|SDB|sdb
380196|NCT01960881|Prostate cancer|prostate cancer
380197|NCT01960855|anti-inflammatory agents|anti-inflammatory agents
380198|NCT01960855|Joint Diseases|joint diseases
380199|NCT01960855|Arthritis|arthritis
380200|NCT01960855|Musculoskeletal Disease|musculoskeletal disease
380201|NCT01960855|antirheumatic agents|antirheumatic agents
380202|NCT01960842|levodopa|levodopa
380203|NCT01960842|Advanced Parkinson's Disease|advanced parkinson's disease
380204|NCT01960842|carbidopa|carbidopa
380205|NCT01960842|levodopa-carbidopa intestinal gel|levodopa-carbidopa intestinal gel
380206|NCT01960842|Safety and Efficacy|safety and efficacy
380207|NCT01960829|melanoma|melanoma
380208|NCT01960829|TOR Serine-Threonine Kinases|tor serine-threonine kinases
380209|NCT01960816|nasal obstruction|nasal obstruction
380210|NCT01960803|Stage I Breast Carcinoma|stage i breast carcinoma
380211|NCT01960790|Humira®|humira®
380212|NCT01960790|Behcet's Disease|behcet's disease
380213|NCT01960790|Adalimumab|adalimumab
380214|NCT01960777|Hernia, Inguinal|hernia, inguinal
380215|NCT01960777|Laparoscopy|laparoscopy
380216|NCT01960777|Onstep|onstep
380217|NCT01960764|Autologous microbiome transplant|autologous microbiome transplant
380218|NCT01960764|Bacteria transplant|bacteria transplant
380219|NCT01960764|Treatment for atopic dermatitis|treatment for atopic dermatitis
380220|NCT01960738|Diving|diving
380221|NCT01960738|Water|water
380222|NCT01960738|Recreation|recreation
380223|NCT01960738|Precursor|precursor
380224|NCT01960725|Gastroenteritis|gastroenteritis
380225|NCT01960725|Diarrhea|diarrhea
380226|NCT01960725|Rotavirus|rotavirus
380227|NCT01960725|Vaccine|vaccine
380228|NCT01960725|Dehydration|dehydration
380229|NCT01960699|Prognosis|prognosis
380230|NCT01960699|Neurological outcome|neurological outcome
380231|NCT01960699|Resuscitation|resuscitation
380232|NCT01960699|Biomarker|biomarker
380233|NCT01960673|supraglottic airway,igel-LMA, ambu-LMA, changing position, head and neck position, oropharyngeal leak pressure,degree of rotation|supraglottic airway,igel-lma, ambu-lma, changing position, head and neck position, oropharyngeal leak pressure,degree of rotation
380234|NCT01960660|Fish Oil|fish oil
380235|NCT01960660|EPA|epa
380236|NCT01960660|DHA|dha
380237|NCT01960660|Omega-Score|omega-score
380238|NCT01960660|Lipemic Index|lipemic index
380239|NCT01960660|ethyl esters|ethyl esters
380240|NCT01960660|triglycerides|triglycerides
380241|NCT01960660|phospholipids|phospholipids
380242|NCT01960595|PCA,Nerve block,Hullax Valgus|pca,nerve block,hullax valgus
380243|NCT01960582|Housing adaptation|housing adaptation
380244|NCT01960582|Independence|independence
380245|NCT01960582|Costs|costs
380246|NCT01960569|Thrombexx|thrombexx
380247|NCT01960569|Topical r-Hirudin|topical r-hirudin
380248|NCT01960569|Efficacy|efficacy
380249|NCT01960569|haematoma|haematoma
380250|NCT01960556|simulation|simulation
380251|NCT01960543|Intrathecal anesthesia|intrathecal anesthesia
380252|NCT01960543|Levobupivacaine|levobupivacaine
380253|NCT01960543|Bupivacaine|bupivacaine
380254|NCT01960543|Hip fracture|hip fracture
380255|NCT01960517|Urinary|urinary
380256|NCT01960517|Incontinence|incontinence
380257|NCT01960517|Catheter|catheter
380258|NCT01960504|DREAMS|dreams
380259|NCT01960504|Drug Eluting Absorbable Metal Scaffold|drug eluting absorbable metal scaffold
380260|NCT01960504|Scaffold|scaffold
380261|NCT01960504|Coronary Artery Disease|coronary artery disease
380262|NCT01960504|Myocardial Ischemia|myocardial ischemia
380263|NCT01960504|Atherosclerosis|atherosclerosis
380264|NCT01960465|CPAP treatment|cpap treatment
380265|NCT01960465|hypertension|hypertension
380266|NCT01960452|Insomnia|insomnia
380267|NCT01960452|Primary insomnia|primary insomnia
380268|NCT01960452|High density EEG|high density eeg
380269|NCT01960452|Polysomnography|polysomnography
380270|NCT01960452|Healthy sleeping controls|healthy sleeping controls
380271|NCT01960439|disease activity|disease activity
380272|NCT01960439|central reader|central reader
380273|NCT01960439|endoscopic indices|endoscopic indices
380274|NCT01960426|Harvey Bradshaw score|harvey bradshaw score
380275|NCT01960426|Partial Mayo Clinical Score|partial mayo clinical score
380276|NCT01960426|Infliximab|infliximab
380277|NCT01960426|Adalimumab|adalimumab
380278|NCT01960400|Complex regional pain syndrome type 1 (CRPS)|complex regional pain syndrome type 1 (crps)
380279|NCT01960400|Transcranial direct current stimulation (tDCS)|transcranial direct current stimulation (tdcs)
380280|NCT01960400|Graded motor imagery (GMI)|graded motor imagery (gmi)
380281|NCT01960400|Magnetic resonance imaging (MRI)|magnetic resonance imaging (mri)
380282|NCT01960400|Functional magnetic resonance imaging (fMRI)|functional magnetic resonance imaging (fmri)
380283|NCT01960387|AML|aml
380284|NCT01960387|clofarabine|clofarabine
380285|NCT01960387|cytarabine|cytarabine
380286|NCT01960387|persistent AML|persistent aml
380287|NCT01960387|induction therapy|induction therapy
380288|NCT01960374|RAS or RAF oncogenes, Inhibition of MEK pathway, inhibition cancer cell proliferation promising anti-cancer therapeutic strategy.|ras or raf oncogenes, inhibition of mek pathway, inhibition cancer cell proliferation promising anti-cancer therapeutic strategy.
380289|NCT01960348|RNAi therapeutic|rnai therapeutic
380290|NCT01960348|FAP|fap
380291|NCT01960348|Familial Amyloid Polyneuropathy|familial amyloid polyneuropathy
380292|NCT01960348|TTR|ttr
380293|NCT01960348|Transthyretin|transthyretin
380294|NCT01960348|Amyloidosis|amyloidosis
380295|NCT01960335|whey protein intake|whey protein intake
380296|NCT01960335|obesity|obesity
380297|NCT01960335|visceral fat|visceral fat
380298|NCT01960335|resistance exercise training|resistance exercise training
380299|NCT01960335|sprint interval training|sprint interval training
380300|NCT01960335|endurance exercise training|endurance exercise training
380301|NCT01960335|yoga training|yoga training
380302|NCT01960335|healthy eating|healthy eating
380303|NCT01960335|healthy lifestyle strategies|healthy lifestyle strategies
380304|NCT01960335|leptin|leptin
380305|NCT01960335|hunger|hunger
380306|NCT01960322|adherence|adherence
380307|NCT01960322|nonadherence|nonadherence
380308|NCT01960322|compliance|compliance
380309|NCT01960322|noncompliance|noncompliance
380310|NCT01960322|liver transplantation|liver transplantation
380311|NCT01960296|clopidogrel|clopidogrel
380312|NCT01960296|general surgery|general surgery
380313|NCT01960270|relapse after an initial clinical response|relapse after an initial clinical response
380314|NCT01960257|tuberculosis|tuberculosis
380315|NCT01960257|tuberculosis treatment|tuberculosis treatment
380316|NCT01960257|wirelessly observed therapy|wirelessly observed therapy
380317|NCT01960257|proteus digital health|proteus digital health
380318|NCT01960257|digital health feedback system|digital health feedback system
380319|NCT01960244|familial|familial
380320|NCT01960244|hypercholesterolemia|hypercholesterolemia
380321|NCT01960244|FH|fh
380322|NCT01960218|acute decompensated heart failure|acute decompensated heart failure
380323|NCT01960218|gas exchange|gas exchange
380324|NCT01960218|cardiopulmonary|cardiopulmonary
380325|NCT01960218|dyspnea|dyspnea
380326|NCT01960218|cardiopulmonary analyzer|cardiopulmonary analyzer
380327|NCT01960218|heart disease|heart disease
380328|NCT01960218|cardiovascular disease|cardiovascular disease
380329|NCT01960218|cardiopulmonary exercise|cardiopulmonary exercise
380330|NCT01960205|Saxagliptin, prediabetes, glucose intolerance,obesity|saxagliptin, prediabetes, glucose intolerance,obesity
380331|NCT01960192|primary CNS lymphoma;chemotherapy;|primary cns lymphoma;chemotherapy;
380332|NCT01960192|RR;PFS;OS|rr;pfs;os
380333|NCT01960153|Heart failure|heart failure
380334|NCT01960153|Pulmonary hypertension|pulmonary hypertension
380335|NCT01960153|tadalafil|tadalafil
380336|NCT01960153|Phosphodiesterase Type 5 Inhibition|phosphodiesterase type 5 inhibition
380337|NCT01960114|Acetaminophen|acetaminophen
380338|NCT01960114|Paracetamol Analgesics|paracetamol analgesics
380339|NCT01960114|Analgesics|analgesics
380340|NCT01960114|Non-Narcotic Pain|non-narcotic pain
380341|NCT01960114|Postoperative Pain|postoperative pain
380342|NCT01960114|Antipyretics Dental Surgery|antipyretics dental surgery
380343|NCT01960114|Third molar extraction|third molar extraction
380344|NCT01960101|xerostomia|xerostomia
380345|NCT01960101|Saliva|saliva
380346|NCT01960101|iatrogenic oral dryness|iatrogenic oral dryness
380347|NCT01960101|antidepressants|antidepressants
380348|NCT01960101|mouth dryness|mouth dryness
380349|NCT01960101|milk product|milk product
380350|NCT01960088|Adolescent vaccines|adolescent vaccines
380351|NCT01960088|HPV vaccine|hpv vaccine
380352|NCT01960088|Pharmacies|pharmacies
380353|NCT01960075|status epilepticus, refractory, benzodiazepine, fosphenytoin, levetiracetam, valproic acid|status epilepticus, refractory, benzodiazepine, fosphenytoin, levetiracetam, valproic acid
380354|NCT01960062|diabetes|diabetes
380355|NCT01960062|web-based|web-based
380356|NCT01960062|software|software
380357|NCT01960062|device|device
380358|NCT01960049|Postoperative pain|postoperative pain
380359|NCT01960049|Liver resection|liver resection
380360|NCT01960049|Medial Open Transversus Abdominis Plane catheter|medial open transversus abdominis plane catheter
380361|NCT01960036|Substance Use Disorders|substance use disorders
380362|NCT01960036|Complementary Therapies|complementary therapies
380363|NCT01960036|Women|women
380364|NCT01960036|Mind-Body Therapies|mind-body therapies
380365|NCT01960036|Behavior and Behavior Mechanisms|behavior and behavior mechanisms
380366|NCT01960023|Colorectal cancer|colorectal cancer
380367|NCT01960023|KRAS|kras
380368|NCT01960023|BRAF|braf
380369|NCT01960023|NRAS|nras
380370|NCT01960023|PIK3CA|pik3ca
380371|NCT01960023|NSABP|nsabp
380372|NCT01959958|Nocturnal enuresis|nocturnal enuresis
380373|NCT01959958|Barriers to treatment|barriers to treatment
380374|NCT01959945|Prevention|prevention
380375|NCT01959932|Smoking|smoking
380376|NCT01959932|Candidate Modified Risk Tobacco Product|candidate modified risk tobacco product
380377|NCT01959932|Conventional cigarettes|conventional cigarettes
380378|NCT01959932|Reduced exposure|reduced exposure
380379|NCT01959932|Confinement|confinement
380380|NCT01959906|Esophagectomy|esophagectomy
380381|NCT01959880|Breast Augmentation|breast augmentation
380382|NCT01959880|Breast Reconstruction|breast reconstruction
380383|NCT01959880|Breast Revision|breast revision
380384|NCT01959880|Silicone Gel|silicone gel
380385|NCT01959880|Contour Profile Gel|contour profile gel
380386|NCT01959880|Siltex|siltex
380387|NCT01959880|CPG Styles|cpg styles
380388|NCT01959867|mastectomy|mastectomy
380389|NCT01959867|breast reconstruction|breast reconstruction
380390|NCT01959867|bovine|bovine
380391|NCT01959867|ADM|adm
380392|NCT01959867|breast cancer|breast cancer
380393|NCT01959867|breast implants|breast implants
380394|NCT01959867|breast expanders|breast expanders
380395|NCT01959867|radiation therapy|radiation therapy
380396|NCT01959828|pulmonary hypertension|pulmonary hypertension
380397|NCT01959828|cardiac surgery|cardiac surgery
380398|NCT01959828|Glenn surgery|glenn surgery
380399|NCT01959828|fontan surgery|fontan surgery
380400|NCT01959828|left ventricular assist device|left ventricular assist device
380401|NCT01959828|LVAD|lvad
380402|NCT01959802|Macular pseudohole|macular pseudohole
380403|NCT01959802|Cone outer segment tips line|cone outer segment tips line
380404|NCT01959789|Randomized Controlled Clinical Trial|randomized controlled clinical trial
380405|NCT01959789|Tooth Bleaching|tooth bleaching
380406|NCT01959776|cone outer segment tips line, foveal displacement|cone outer segment tips line, foveal displacement
380407|NCT01959763|Metabolic syndrome|metabolic syndrome
380408|NCT01959763|obesity|obesity
380409|NCT01959763|overweight|overweight
380410|NCT01959763|weight loss intervention|weight loss intervention
380411|NCT01959763|cognitive behavioral therapy|cognitive behavioral therapy
380412|NCT01959763|ICT intervention|ict intervention
380413|NCT01959763|cardiovascular disease|cardiovascular disease
380414|NCT01959763|persuasive systems design|persuasive systems design
380415|NCT01959737|reactivity of HPA axis|reactivity of hpa axis
380416|NCT01959724|Macular detachment|macular detachment
380417|NCT01959724|Macular retinoschisis|macular retinoschisis
380418|NCT01959724|Vitrectomy|vitrectomy
380419|NCT01959711|Lateral transperitoneal laparoscopic adrenalectomy|lateral transperitoneal laparoscopic adrenalectomy
380420|NCT01959711|Posterior retroperitoneoscopic adrenalectomy|posterior retroperitoneoscopic adrenalectomy
380421|NCT01959646|Immune Function|immune function
380422|NCT01959646|Aged Garlic Extract|aged garlic extract
380423|NCT01959646|Supplementation|supplementation
380424|NCT01959646|Inflammation|inflammation
380425|NCT01959620|PTSD|ptsd
380426|NCT01959607|Smoking|smoking
380427|NCT01959607|Nicotine absorption|nicotine absorption
380428|NCT01959607|Candidate modified risk tobacco product|candidate modified risk tobacco product
380429|NCT01959607|Cigarettes|cigarettes
380430|NCT01959607|Nicotine Replacement Therapy gum (NRT gum)|nicotine replacement therapy gum (nrt gum)
380431|NCT01959594|multiple doses|multiple doses
380432|NCT01959594|pharmacokinetics|pharmacokinetics
380433|NCT01959594|safety|safety
380434|NCT01959594|tolerability|tolerability
380435|NCT01959594|healthy volunteers|healthy volunteers
380436|NCT01959594|steady state|steady state
380437|NCT01959594|cognitive impairment associated with schizophrenia|cognitive impairment associated with schizophrenia
380438|NCT01959581|Wilmington Robotic Exoskeleton|wilmington robotic exoskeleton
380439|NCT01959581|Reaching|reaching
380440|NCT01959581|Upper extremity function|upper extremity function
380441|NCT01959581|Preterm Infants|preterm infants
380442|NCT01959581|Brain injury|brain injury
380443|NCT01959581|Pediatrics|pediatrics
380444|NCT01959581|Early Intervention|early intervention
380735|NCT01958021|Letrozole|letrozole
380445|NCT01959581|Arthrogryposis|arthrogryposis
380446|NCT01959568|Retinal Detachment|retinal detachment
380447|NCT01959568|Double Tamponade|double tamponade
380448|NCT01959568|Perfluorocarbon liquids|perfluorocarbon liquids
380449|NCT01959568|Vitrectomy|vitrectomy
380450|NCT01959542|Prostate Cancer|prostate cancer
380451|NCT01959516|COPD, early morning symptoms|copd, early morning symptoms
380452|NCT01959503|Aorta|aorta
380453|NCT01959503|Aortic|aortic
380454|NCT01959503|Reconstruction|reconstruction
380455|NCT01959503|CABG|cabg
380456|NCT01959503|Bypass|bypass
380457|NCT01959464|Assisted reproductive technology|assisted reproductive technology
380458|NCT01959464|Infertility|infertility
380459|NCT01959464|Progesterone|progesterone
380460|NCT01959464|Vaginal gel|vaginal gel
380461|NCT01959464|Luteal-phase support|luteal-phase support
380462|NCT01959451|Prasugrel|prasugrel
380463|NCT01959451|Clopidogrel|clopidogrel
380464|NCT01959438|Phase I study for safety|phase i study for safety
380465|NCT01959438|Later Phase II study for responses|later phase ii study for responses
380466|NCT01959425|Anticoagulation|anticoagulation
380467|NCT01959425|Oral|oral
380468|NCT01959425|Paroxysmal atrial fibrillation|paroxysmal atrial fibrillation
380469|NCT01959425|Patients post successful cardiac ablation|patients post successful cardiac ablation
380470|NCT01959425|Symptomatic high-burden paroxysmal AF|symptomatic high-burden paroxysmal af
380471|NCT01959425|3 months post procedure|3 months post procedure
380472|NCT01959425|Remain free from AF recurrence|remain free from af recurrence
380473|NCT01959412|wheezing, short of breath, laba, inhaler|wheezing, short of breath, laba, inhaler
380474|NCT01959399|ASP015K|asp015k
380475|NCT01959399|healthy subjects|healthy subjects
380476|NCT01959360|Arthroplasty, Total Hip Replacement, Hip|arthroplasty, total hip replacement, hip
380477|NCT01959360|Surgical Procedures, Operative|surgical procedures, operative
380478|NCT01959360|Surgical Procedures, Minimally Invasive|surgical procedures, minimally invasive
380479|NCT01959347|urinary incontinence|urinary incontinence
380480|NCT01959347|midurethral sling|midurethral sling
380481|NCT01959347|pelvic floor therapy|pelvic floor therapy
380482|NCT01959334|Diabetes Mellitus|diabetes mellitus
380483|NCT01959334|Hypoglycemia|hypoglycemia
380484|NCT01959334|Glucagon|glucagon
380485|NCT01959334|Anti-glucagon Antibody|anti-glucagon antibody
380486|NCT01959334|Immunogenicity|immunogenicity
380487|NCT01959308|Adherence|adherence
380488|NCT01959308|Compliance|compliance
380489|NCT01959308|Immunosuppressive Therapy|immunosuppressive therapy
380490|NCT01959308|Liver Transplant|liver transplant
380491|NCT01959308|Liver Recipients|liver recipients
380492|NCT01959308|Adult|adult
380493|NCT01959308|Adolescent|adolescent
380494|NCT01959282|Colitis, Ulcerative|colitis, ulcerative
380495|NCT01959282|JNJ-54781532|jnj-54781532
380496|NCT01959282|Moderate|moderate
380497|NCT01959282|Severe|severe
380498|NCT01959282|Active|active
380499|NCT01959256|Stroke|stroke
380500|NCT01959256|Visual Field Defect|visual field defect
380501|NCT01959256|Visual perceptual learning|visual perceptual learning
380502|NCT01959256|Brain connectivity|brain connectivity
380503|NCT01959243|Ocular redness|ocular redness
380504|NCT01959230|Ocular redness|ocular redness
380505|NCT01959217|HIV|hiv
380506|NCT01959217|Substance Abuse|substance abuse
380507|NCT01959217|Prospective Memory|prospective memory
380508|NCT01959204|pharmacokinetics|pharmacokinetics
380509|NCT01959204|safety|safety
380510|NCT01959191|Platelet activity, CABG, off-pump surgery|platelet activity, cabg, off-pump surgery
380511|NCT01959165|Ulcerative Colitis, Japanese, subcutaneously|ulcerative colitis, japanese, subcutaneously
380512|NCT01959152|Cochlear Implant|cochlear implant
380513|NCT01959152|HiRes™ 90K Advantage implant|hires™ 90k advantage implant
380514|NCT01959152|Cochlear Implantation|cochlear implantation
380515|NCT01959152|HiFocus™ Mid-Scala electrode|hifocus™ mid-scala electrode
380516|NCT01959152|Listening Benefits|listening benefits
380517|NCT01959152|Adults|adults
380518|NCT01959152|Cochlear Implant Benefit|cochlear implant benefit
380519|NCT01959152|HiRes Fidelity 120™|hires fidelity 120™
380520|NCT01959152|Electrical Stimulation|electrical stimulation
380521|NCT01959126|Telomerase|telomerase
380522|NCT01959126|Telomere length|telomere length
380523|NCT01959126|Psychological Sress|psychological sress
380524|NCT01959126|Mindfulness|mindfulness
380525|NCT01959113|Microbiome|microbiome
380526|NCT01959113|Bacteria transplant|bacteria transplant
380527|NCT01959113|Atopic dermatitis treatments|atopic dermatitis treatments
380528|NCT01959100|hematopoietic stem cell transplantation|hematopoietic stem cell transplantation
380529|NCT01959100|pulmonary non-infectious complications|pulmonary non-infectious complications
380530|NCT01959100|bronchiolitis obliterans syndrome|bronchiolitis obliterans syndrome
380531|NCT01959087|Single port surgery|single port surgery
380532|NCT01959087|Colonic surgery|colonic surgery
380533|NCT01959087|Postoperative morbidity|postoperative morbidity
486560|NCT01486056|ECG|ecg
380534|NCT01959087|Postoperative outcomes|postoperative outcomes
380535|NCT01959061|Advanced colorectal cancer of liver metastatic|advanced colorectal cancer of liver metastatic
380536|NCT01959048|Clostridium difficile associated disease|clostridium difficile associated disease
380537|NCT01959048|fecal microbiota transplantation|fecal microbiota transplantation
380538|NCT01959022|Posttramatic Stress Disorder|posttramatic stress disorder
380539|NCT01959022|Post-traumatic Stress Disorder|post-traumatic stress disorder
380540|NCT01959022|PTSD|ptsd
380541|NCT01959022|Doxazosin|doxazosin
380542|NCT01959022|Nightmares|nightmares
380543|NCT01959022|Sleep Disturbance|sleep disturbance
380544|NCT01959009|newborn, lung disease, mechanical ventilation, lung recruitment, high frequency ventilation|newborn, lung disease, mechanical ventilation, lung recruitment, high frequency ventilation
380545|NCT01958983|dementia|dementia
380546|NCT01958983|drumming|drumming
380547|NCT01958983|emotion|emotion
380548|NCT01958983|cognition|cognition
380549|NCT01958983|functional MRI|functional mri
380550|NCT01958970|End Stage Renal Disease|end stage renal disease
380551|NCT01958970|ESRD|esrd
380552|NCT01958970|Maintenance Hemodialysis|maintenance hemodialysis
380553|NCT01958970|Hemodialysis|hemodialysis
380554|NCT01958970|Dialysis|dialysis
380556|NCT01958970|Protein Energy Wasting|protein energy wasting
380557|NCT01958970|PEW|pew
380558|NCT01958957|ischemic stroke|ischemic stroke
380559|NCT01958957|safety|safety
380560|NCT01958957|Ginkgolides Meglumine Injection|ginkgolides meglumine injection
380561|NCT01958944|CF|cf
380562|NCT01958944|Cystic Fibrosis|cystic fibrosis
380563|NCT01958944|NO|no
380564|NCT01958944|nitric oxide|nitric oxide
380565|NCT01958944|inhalation|inhalation
380566|NCT01958918|wet age-related macular degeneration (AMD)|wet age-related macular degeneration (amd)
380567|NCT01958918|ranibizumab|ranibizumab
380568|NCT01958918|aflibercept|aflibercept
380569|NCT01958918|Best Corrected Visual Acuity (BCVA)|best corrected visual acuity (bcva)
380570|NCT01958918|Spectral Domain Optical Coherence Tomography (SD-OCT)|spectral domain optical coherence tomography (sd-oct)
380571|NCT01958892|BPH|bph
380572|NCT01958879|internal derangement,arthrocentesis,corticosteroid|internal derangement,arthrocentesis,corticosteroid
380573|NCT01958866|Fever|fever
380574|NCT01958866|Body temperature|body temperature
380575|NCT01958853|Pain|pain
380576|NCT01958840|Behavioral|behavioral
380577|NCT01958840|Activation|activation
380578|NCT01958840|Treatment|treatment
380579|NCT01958827|Dose Escalation|dose escalation
380580|NCT01958827|Crohn's Disease|crohn's disease
380581|NCT01958801|Supraclavicular brachial plexus block|supraclavicular brachial plexus block
380582|NCT01958801|Interscalene brachial plexus block|interscalene brachial plexus block
380583|NCT01958801|Arthroscopic shoulder surgery|arthroscopic shoulder surgery
380584|NCT01958788|Cognitive-behavioral treatment|cognitive-behavioral treatment
380585|NCT01958788|Generalized anxiety disorder|generalized anxiety disorder
380586|NCT01958788|Worry|worry
380587|NCT01958788|Behavioral experiments|behavioral experiments
380588|NCT01958788|Safety behaviors|safety behaviors
380589|NCT01958788|Anxiety|anxiety
380590|NCT01958775|Lipoproteins, apoB, GLP-2|lipoproteins, apob, glp-2
380591|NCT01958762|Screening|screening
380592|NCT01958762|Cancer|cancer
380593|NCT01958762|Tobacco|tobacco
380594|NCT01958762|General Practitioner|general practitioner
380595|NCT01958762|Precancerous Lesion|precancerous lesion
380596|NCT01958762|Dysplasia|dysplasia
380597|NCT01958762|Tobacco vendor|tobacco vendor
380598|NCT01958723|Problem Specific Template|problem specific template
380599|NCT01958723|Physician Documentation|physician documentation
380600|NCT01958723|Electronic Medical Record Documentation|electronic medical record documentation
380601|NCT01958710|Catheterization, Bronchial|catheterization, bronchial
380602|NCT01958710|Pneumonectomy|pneumonectomy
380603|NCT01958710|Lobectomy|lobectomy
380604|NCT01958710|Thoracoplasty|thoracoplasty
380605|NCT01958697|Nutritional Disorders|nutritional disorders
380606|NCT01958697|Feeding Behavior|feeding behavior
380607|NCT01958684|Bleeding pattern|bleeding pattern
380608|NCT01958684|LNG-IUS|lng-ius
380609|NCT01958684|Cu-IUD|cu-iud
380610|NCT01958684|postabortion|postabortion
380611|NCT01958645|Phase 1, healthy male subjects, safety and tolerability, pharmacodynamic, pharmacokinetic|phase 1, healthy male subjects, safety and tolerability, pharmacodynamic, pharmacokinetic
380612|NCT01958619|open label|open label
380613|NCT01958619|healthy volunteers|healthy volunteers
380614|NCT01958619|pharmacokinetic|pharmacokinetic
380615|NCT01958619|parallel group|parallel group
380616|NCT01958606|Stroke|stroke
380617|NCT01958606|Rehabilitation|rehabilitation
380618|NCT01958606|Exercise|exercise
380619|NCT01958606|Intensity|intensity
380620|NCT01958606|Gait|gait
380621|NCT01958593|PTSD|ptsd
380622|NCT01958593|Posttraumatic stress disorder|posttraumatic stress disorder
380623|NCT01958593|MDMA|mdma
380624|NCT01958593|psychotherapy|psychotherapy
380625|NCT01958567|Scleritis|scleritis
380626|NCT01958567|Episcleritis|episcleritis
712561|NCT00579709|Typical DiGeorge|typical digeorge
380627|NCT01958567|Optical coherence Tomography|optical coherence tomography
380628|NCT01958541|Sleep|sleep
380629|NCT01958541|Insomnia|insomnia
380630|NCT01958541|Suicidal Symptoms|suicidal symptoms
380631|NCT01958541|Suicidal Ideation|suicidal ideation
380632|NCT01958541|Military Veteran|military veteran
380633|NCT01958541|Service Member|service member
380634|NCT01958541|Depression|depression
380635|NCT01958515|Radiation Therapy|radiation therapy
380636|NCT01958515|Chemotherapy|chemotherapy
380637|NCT01958515|Chemoradiation Therapy|chemoradiation therapy
380638|NCT01958502|nonunion|nonunion
380639|NCT01958502|mesenchymal stem cell|mesenchymal stem cell
380640|NCT01958502|scaffold|scaffold
380642|NCT01958502|long bone|long bone
380643|NCT01958476|Neonatal Abstinence Syndrome|neonatal abstinence syndrome
380644|NCT01958476|Opioids|opioids
380645|NCT01958463|Clostridium Difficile Infection|clostridium difficile infection
380646|NCT01958463|Fecal Microbiota Transplantation|fecal microbiota transplantation
380647|NCT01958450|acne scar|acne scar
380648|NCT01958450|Laser therapy|laser therapy
380649|NCT01958450|wound healing|wound healing
380650|NCT01958437|Aging|aging
380651|NCT01958437|Alzheimer's Disease/Dementia|alzheimer's disease/dementia
380652|NCT01958437|Cognitive Disorders|cognitive disorders
380653|NCT01958437|Imaging|imaging
380654|NCT01958437|Magnetic Resonance Imaging (MRI)|magnetic resonance imaging (mri)
380655|NCT01958437|Neurology|neurology
380656|NCT01958437|Physical Medicine & Rehabilitation|physical medicine & rehabilitation
380657|NCT01958437|transcranial direct current stimulation|transcranial direct current stimulation
380658|NCT01958424|metabolic syndrome|metabolic syndrome
380659|NCT01958424|in vitro fertilization|in vitro fertilization
380660|NCT01958424|c reactive protein|c reactive protein
380661|NCT01958424|over-weight women|over-weight women
380662|NCT01958424|ovarian stimulation|ovarian stimulation
380663|NCT01958398|Randomized Controlled Trial|randomized controlled trial
380664|NCT01958398|Alcohol|alcohol
380665|NCT01958398|Internet|internet
380666|NCT01958398|Mobile phone|mobile phone
380667|NCT01958398|Screening|screening
380668|NCT01958398|Brief intervention|brief intervention
380669|NCT01958385|Total Body Weight Loss|total body weight loss
380670|NCT01958359|Randomized Controlled Trial|randomized controlled trial
380671|NCT01958359|Alcohol|alcohol
380672|NCT01958359|Telephone|telephone
380673|NCT01958359|Mobile phone|mobile phone
380674|NCT01958359|Screening|screening
380675|NCT01958359|Brief intervention|brief intervention
380676|NCT01958359|IVR-based conversation menu with exercises and vignettes|ivr-based conversation menu with exercises and vignettes
380677|NCT01958333|Health-Related Physical Fitness|health-related physical fitness
380678|NCT01958333|Aerobic Endurance|aerobic endurance
380679|NCT01958333|Muscular Endurance|muscular endurance
380680|NCT01958333|Flexibility|flexibility
380681|NCT01958320|patent ductus arteriosus|patent ductus arteriosus
380682|NCT01958320|patent ductus arteriosus ligation|patent ductus arteriosus ligation
380683|NCT01958320|necrotizing enterocolitis|necrotizing enterocolitis
380684|NCT01958320|spontaneous intestinal perforation|spontaneous intestinal perforation
380685|NCT01958255|tobacco quit rates|tobacco quit rates
380686|NCT01958242|Cardiopulmonary bypass|cardiopulmonary bypass
380687|NCT01958242|pediatric|pediatric
380688|NCT01958242|blood products|blood products
380689|NCT01958242|conservation|conservation
380690|NCT01958216|TICE-human-stable isotopes|tice-human-stable isotopes
380691|NCT01958190|Liver transplantation long term renal function|liver transplantation long term renal function
380692|NCT01958190|tacrolimus sirolimus|tacrolimus sirolimus
380693|NCT01958177|stem cell|stem cell
380694|NCT01958177|cerebellar ataxia|cerebellar ataxia
380695|NCT01958177|BMMNC|bmmnc
380696|NCT01958151|colonoscopy|colonoscopy
380697|NCT01958151|deep sedation|deep sedation
380698|NCT01958151|anxiety|anxiety
380699|NCT01958138|Laryngeal Mask Airway|laryngeal mask airway
380700|NCT01958138|Propofol|propofol
380701|NCT01958138|Isoflurane|isoflurane
380702|NCT01958138|Pediatric patients|pediatric patients
380703|NCT01958138|Emergence|emergence
380704|NCT01958125|vagus nerve stimulation|vagus nerve stimulation
380705|NCT01958125|vagal nerve stimulation|vagal nerve stimulation
380706|NCT01958125|nVNS|nvns
380707|NCT01958125|VNS|vns
380708|NCT01958125|cluster headache|cluster headache
380709|NCT01958125|non invasive|non invasive
380710|NCT01958125|gammacore|gammacore
380711|NCT01958112|Cervical Cancer|cervical cancer
380712|NCT01958112|Cervical|cervical
380713|NCT01958112|Cervix|cervix
380714|NCT01958099|Injury Prevention|injury prevention
380715|NCT01958086|Neural|neural
380716|NCT01958086|Prosthetic|prosthetic
380717|NCT01958086|brain machine interface|brain machine interface
380718|NCT01958086|brain computer interface|brain computer interface
380719|NCT01958086|brain control|brain control
380720|NCT01958086|paralysis|paralysis
380721|NCT01958086|tetraplegia|tetraplegia
380722|NCT01958086|quadriplegia|quadriplegia
380723|NCT01958086|spinal cord injury|spinal cord injury
380724|NCT01958073|Recurrent Urinary Tract Infection|recurrent urinary tract infection
486801|NCT01485159|burden|burden
380725|NCT01958073|Postmenopausal|postmenopausal
380726|NCT01958073|Vaginal Estrogen|vaginal estrogen
380727|NCT01958047|Phase I|phase i
380728|NCT01958047|ASP3652|asp3652
380729|NCT01958047|Single dose|single dose
380730|NCT01958047|Dietary intake|dietary intake
380731|NCT01958021|HR-positive|hr-positive
380732|NCT01958021|HER2-negative|her2-negative
380733|NCT01958021|Advanced breast cancer|advanced breast cancer
380734|NCT01958021|LEE011|lee011
380736|NCT01958021|CDK|cdk
380737|NCT01958021|CDK4|cdk4
380738|NCT01958021|CDK6|cdk6
380739|NCT01958021|CDK4/6|cdk4/6
380740|NCT01958021|Phase III|phase iii
380741|NCT01958021|ER-positive|er-positive
380742|NCT01958021|PR-positive|pr-positive
380743|NCT01958021|Postmenopausal|postmenopausal
380744|NCT01957943|Omega 3 lipid emulsions|omega 3 lipid emulsions
380745|NCT01957943|Liver transplantation|liver transplantation
380746|NCT01957943|Ischemia reperfusion injury|ischemia reperfusion injury
380747|NCT01957943|graft function|graft function
380748|NCT01957930|HbA1c|hba1c
380749|NCT01957930|Iontophoresis|iontophoresis
380750|NCT01957930|Intensified insulin treatment|intensified insulin treatment
380751|NCT01957930|Ischemic foot ulcer|ischemic foot ulcer
380752|NCT01957930|Type 1 diabetes|type 1 diabetes
380753|NCT01957917|HIV|hiv
380754|NCT01957917|Food Insecurity|food insecurity
380755|NCT01957917|Antiretroviral Therapy|antiretroviral therapy
380756|NCT01957904|ArterX, surgical sealant|arterx, surgical sealant
380757|NCT01957891|Hypoxia|hypoxia
380758|NCT01957891|Multiple wavelengths|multiple wavelengths
380759|NCT01957865|HIV/AIDS|hiv/aids
380760|NCT01957865|adherence|adherence
380761|NCT01957865|real time monitoring|real time monitoring
380762|NCT01957865|SMS|sms
380763|NCT01957865|mHealth|mhealth
380764|NCT01957865|social support|social support
380765|NCT01957826|mesenchymal|mesenchymal
380766|NCT01957826|stem cells|stem cells
380767|NCT01957826|transendocardial injection|transendocardial injection
380768|NCT01957826|dilated idiopathic cardiomyopathy|dilated idiopathic cardiomyopathy
380769|NCT01957826|idiopathic cardiomyopathy|idiopathic cardiomyopathy
380770|NCT01957813|APHIA AIDS, Population and Health Integrated Assistance|aphia aids, population and health integrated assistance
380771|NCT01957813|DIC Drop-in center|dic drop-in center
380772|NCT01957813|DMPA depot medroxyprogesterone acetate|dmpa depot medroxyprogesterone acetate
380773|NCT01957813|DRH Division of Reproductive Health|drh division of reproductive health
380774|NCT01957813|FAIR Family AIDS Initiative Response|fair family aids initiative response
380775|NCT01957813|FHOK Family Health Options Kenya|fhok family health options kenya
380776|NCT01957813|FP Family planning|fp family planning
380777|NCT01957813|FGD Focus group discussion|fgd focus group discussion
380778|NCT01957813|FSW Female sex worker|fsw female sex worker
380779|NCT01957813|GSKenya Gold Star Kenya|gskenya gold star kenya
380780|NCT01957813|HTC HIV testing and counseling|htc hiv testing and counseling
380781|NCT01957813|HIV Human Immunodeficiency Virus|hiv human immunodeficiency virus
380782|NCT01957813|KNASP Kenya National AIDS Strategic Plan|knasp kenya national aids strategic plan
380783|NCT01957813|MARPS Most at-risk populations|marps most at-risk populations
380784|NCT01957813|MoPHS Ministry of Public Health and Sanitation|mophs ministry of public health and sanitation
380785|NCT01957813|MMS Ministry of Medical Services|mms ministry of medical services
380786|NCT01957813|NASCOP National AIDS and STI Control Program|nascop national aids and sti control program
380787|NCT01957813|RH Reproductive health|rh reproductive health
380788|NCT01957813|SRH Sexual and reproductive health|srh sexual and reproductive health
380789|NCT01957813|STI Sexually transmitted infection|sti sexually transmitted infection
380790|NCT01957813|USAID United States Agency for International Development|usaid united states agency for international development
380791|NCT01957800|weight loss|weight loss
380792|NCT01957800|healthy diet|healthy diet
380793|NCT01957800|website|website
380794|NCT01957800|action planning|action planning
380795|NCT01957800|phone|phone
380796|NCT01957800|social|social
380797|NCT01957787|Metastatic lung tumors|metastatic lung tumors
380798|NCT01957787|Pulmonary metastatic disease|pulmonary metastatic disease
380799|NCT01957748|Retention|retention
380800|NCT01957748|Care|care
380801|NCT01957748|Engagement|engagement
380802|NCT01957735|metastatic cancer|metastatic cancer
380803|NCT01957735|solid tumor|solid tumor
380804|NCT01957735|unresectable tumor|unresectable tumor
380805|NCT01957735|brain cancer|brain cancer
380806|NCT01957735|lymphoma|lymphoma
380807|NCT01957696|Diabetes mellitus|diabetes mellitus
380808|NCT01957696|Pancreas transplantation|pancreas transplantation
380809|NCT01957696|Rejection|rejection
380810|NCT01957696|Surgical complications|surgical complications
380811|NCT01957696|Allograft biopsies|allograft biopsies
380812|NCT01957696|Immunological analyses|immunological analyses
380813|NCT01957696|Pancreas graft survival|pancreas graft survival
380814|NCT01957683|intracranial aneurysm|intracranial aneurysm
380815|NCT01957683|bifurcation|bifurcation
380816|NCT01957683|wide-neck|wide-neck
380817|NCT01957683|saccular|saccular
380818|NCT01957683|endovascular treatment|endovascular treatment
380819|NCT01957683|coil embolization|coil embolization
380820|NCT01957683|stent|stent
380821|NCT01957683|bare platinum|bare platinum
380822|NCT01957670|Keratoconjunctivitis Sicca|keratoconjunctivitis sicca
380823|NCT01957670|Dry Eye Syndromes|dry eye syndromes
380824|NCT01957631|Plantar Fasciitis|plantar fasciitis
380825|NCT01957631|Steroid|steroid
380826|NCT01957631|Platelet rich plasma|platelet rich plasma
380827|NCT01957631|Injection|injection
380828|NCT01957631|Ultrasound|ultrasound
380829|NCT01957605|prone position|prone position
380928|NCT01957033|whiplash|whiplash
380830|NCT01957605|hemodynamic variation|hemodynamic variation
380831|NCT01957605|mean systemic pressure|mean systemic pressure
380832|NCT01957579|Phase I|phase i
380833|NCT01957579|advanced|advanced
380834|NCT01957579|B cell malignancies|b cell malignancies
380835|NCT01957579|dose escalation|dose escalation
380836|NCT01957579|CD19|cd19
380837|NCT01957579|Japanese|japanese
380838|NCT01957566|propofol sedation|propofol sedation
380839|NCT01957566|children|children
380840|NCT01957566|procedure sedation|procedure sedation
380841|NCT01957540|ticagrelor|ticagrelor
380842|NCT01957540|prasugrel|prasugrel
380843|NCT01957540|endothelial function|endothelial function
380844|NCT01957527|ticagrelor|ticagrelor
380845|NCT01957527|endothelial function|endothelial function
380846|NCT01957527|peripheral arterial tonometry|peripheral arterial tonometry
380847|NCT01957501|Major Depressive Disorder|major depressive disorder
380848|NCT01957501|Bipolar Disorder|bipolar disorder
380849|NCT01957501|Adolescents|adolescents
380850|NCT01957501|Biomarker|biomarker
380851|NCT01957436|prostate|prostate
380852|NCT01957436|cancer|cancer
380853|NCT01957436|metastatic hormone-naive|metastatic hormone-naive
380854|NCT01957436|radiotherapy|radiotherapy
380855|NCT01957436|abiraterone acetate|abiraterone acetate
380856|NCT01957436|docetaxel|docetaxel
380857|NCT01957423|Crohn's disease|crohn's disease
380858|NCT01957423|whey protein|whey protein
380859|NCT01957423|soy protein|soy protein
380860|NCT01957423|nutritional status|nutritional status
380861|NCT01957423|activity of disease|activity of disease
380862|NCT01957410|Major Depressive Disorder|major depressive disorder
380863|NCT01957410|Ketamine|ketamine
380864|NCT01957410|Evoked potentials|evoked potentials
380865|NCT01957410|Somatosensory evoked potentials|somatosensory evoked potentials
380866|NCT01957410|Motor evoked potentials|motor evoked potentials
380867|NCT01957410|Cortical plasticity|cortical plasticity
380868|NCT01957371|PTSD|ptsd
380869|NCT01957371|Yoga|yoga
380870|NCT01957371|Complementary and Alternative Medicine (CAM)|complementary and alternative medicine (cam)
380871|NCT01957371|Chronic Pain|chronic pain
380872|NCT01957345|constitutional functional disorders of platelets|constitutional functional disorders of platelets
380873|NCT01957345|platelet signalling defects|platelet signalling defects
380874|NCT01957332|molecular imaging|molecular imaging
380875|NCT01957332|HER2-PET|her2-pet
380876|NCT01957332|89Zr-trastuzumab|89zr-trastuzumab
380877|NCT01957332|FES-PET|fes-pet
380878|NCT01957332|metastatic breast cancer|metastatic breast cancer
380879|NCT01957332|clinical utility|clinical utility
380880|NCT01957306|hot flashes, night sweats|hot flashes, night sweats
380881|NCT01957280|HER3|her3
380882|NCT01957267|Glaucoma|glaucoma
380883|NCT01957267|Optical Coherence Tomography|optical coherence tomography
380884|NCT01957267|Intraocular pressure|intraocular pressure
380885|NCT01957267|Optic nervehead|optic nervehead
380886|NCT01957267|Nerve fiber layer|nerve fiber layer
380887|NCT01957202|levocabastine fixed dose combination, Rhinitis, Allergic, Perennial and Seasonal, Allergic Rhinitis, fluticasone furoate|levocabastine fixed dose combination, rhinitis, allergic, perennial and seasonal, allergic rhinitis, fluticasone furoate
380888|NCT01957189|pharmacokinetics, Chinese|pharmacokinetics, chinese
380889|NCT01957189|Avodart, Duodart, dutasteride, tamsulosin, drug-drug interaction,|avodart, duodart, dutasteride, tamsulosin, drug-drug interaction,
380890|NCT01957176|myelodysplastic syndromes|myelodysplastic syndromes
380891|NCT01957176|thrombocytopenia|thrombocytopenia
380892|NCT01957176|acute myeloid leukemia|acute myeloid leukemia
380893|NCT01957176|, idiopathic thrombocytopenic purpura|, idiopathic thrombocytopenic purpura
380894|NCT01957176|Eltrombopag|eltrombopag
380895|NCT01957176|pediatrics|pediatrics
380896|NCT01957163|dry powder inhaler|dry powder inhaler
380897|NCT01957163|fluticasone furoate/vilanterol|fluticasone furoate/vilanterol
380898|NCT01957163|umeclidinium bromide|umeclidinium bromide
380899|NCT01957163|safety|safety
380900|NCT01957163|long acting beta2- receptor agonist|long acting beta2- receptor agonist
380901|NCT01957163|long acting muscarininc receptor antagonist|long acting muscarininc receptor antagonist
380902|NCT01957163|efficacy|efficacy
380903|NCT01957163|COPD|copd
380904|NCT01957163|inhaled corticosteroid|inhaled corticosteroid
380905|NCT01957137|Urinary|urinary
380906|NCT01957137|Urge|urge
380907|NCT01957137|Incontinence|incontinence
380908|NCT01957098|L-arabinose|l-arabinose
380909|NCT01957098|D-xylose|d-xylose
380910|NCT01957098|sucrose|sucrose
380911|NCT01957098|glucose|glucose
380912|NCT01957098|insulin|insulin
380913|NCT01957098|C-peptide|c-peptide
380914|NCT01957098|GLP-1|glp-1
380915|NCT01957085|Hepatitis C|hepatitis c
380916|NCT01957072|Cystic fibrosis|cystic fibrosis
380917|NCT01957072|Nutrition|nutrition
380918|NCT01957072|Weight|weight
380919|NCT01957072|BMI|bmi
380920|NCT01957072|Behaviour change|behaviour change
380921|NCT01957059|DMD|dmd
380922|NCT01957059|Duchenne muscular dystrophy|duchenne muscular dystrophy
380923|NCT01957059|Duchenne|duchenne
380924|NCT01957059|BMN053|bmn053
380925|NCT01957059|BioMarin|biomarin
380926|NCT01957046|Opioid induced constipation|opioid induced constipation
380927|NCT01957046|Laxatives|laxatives
380929|NCT01957033|neck pain|neck pain
380930|NCT01957033|manual therapy|manual therapy
380931|NCT01957033|exercise|exercise
380932|NCT01957033|dosage|dosage
380933|NCT01957007|Phase 1|phase 1
380934|NCT01957007|dose escalation|dose escalation
380935|NCT01957007|histologically confirmed|histologically confirmed
380936|NCT01957007|malignancy metastatic|malignancy metastatic
380937|NCT01956994|Whey Protein|whey protein
380938|NCT01956994|Arterial Stiffness|arterial stiffness
380939|NCT01956994|Neurovascular Coupling|neurovascular coupling
380940|NCT01956994|Cerebrovascular Reactivity|cerebrovascular reactivity
380941|NCT01956994|Hemodynamics|hemodynamics
380942|NCT01956994|Blood Flow|blood flow
380943|NCT01956994|Pulsatility|pulsatility
380944|NCT01956981|controlled hypotension, dexmedetomidine, magnesium sulfate.|controlled hypotension, dexmedetomidine, magnesium sulfate.
380945|NCT01956968|Shoulder pain, Scapular dyskinesia, Physical examination|shoulder pain, scapular dyskinesia, physical examination
380946|NCT01956942|GLAUCOMA|glaucoma
380947|NCT01956942|MICROPULSE|micropulse
380948|NCT01956942|LASER|laser
380949|NCT01956942|TRABECULOPLASTY|trabeculoplasty
380950|NCT01956942|OPEN ANGLE|open angle
380951|NCT01956942|INTRAOCULAR PRESSURE|intraocular pressure
380952|NCT01956929|Insulin Resistance|insulin resistance
380953|NCT01956929|Prediabetic State|prediabetic state
380954|NCT01956929|Metformin|metformin
380955|NCT01956916|Pulmonary exacerbation|pulmonary exacerbation
380956|NCT01956916|Inflammation|inflammation
380957|NCT01956916|Intestinal microbiota|intestinal microbiota
380958|NCT01956903|mesenchymal stem cell transplantation|mesenchymal stem cell transplantation
380959|NCT01956890|Breast neoplasms|breast neoplasms
380960|NCT01956890|PET|pet
380961|NCT01956890|MRI|mri
380962|NCT01956864|Vitamin D|vitamin d
380963|NCT01956851|insulin, kisspeptin, GLP 1|insulin, kisspeptin, glp 1
380964|NCT01956838|food intake|food intake
380965|NCT01956838|tastants|tastants
380966|NCT01956838|obesity|obesity
380967|NCT01956825|non alcoholic fatty liver disease|non alcoholic fatty liver disease
380968|NCT01956825|LCARNITINE amino acid|lcarnitine amino acid
380969|NCT01956825|magnesium|magnesium
380970|NCT01956825|fat content|fat content
380971|NCT01956812|clivatuzumab tetraxetan|clivatuzumab tetraxetan
380972|NCT01956812|90Y-clivatuzumab tetraxetan|90y-clivatuzumab tetraxetan
380973|NCT01956812|IMMU-107|immu-107
380974|NCT01956799|MDS|mds
380975|NCT01956799|PMF|pmf
380976|NCT01956799|CMML|cmml
380977|NCT01956799|AA|aa
380978|NCT01956786|Amlodipine|amlodipine
380979|NCT01956786|Folic Acid|folic acid
380980|NCT01956786|Homocysteine|homocysteine
380981|NCT01956786|Blood Pressure|blood pressure
380982|NCT01956773|family health history|family health history
380983|NCT01956773|prevention|prevention
380984|NCT01956773|genetic risk|genetic risk
380985|NCT01956773|clinical decision support|clinical decision support
380986|NCT01956760|Insomnia|insomnia
380987|NCT01956734|glioblastoma|glioblastoma
380988|NCT01956734|first recurrence|first recurrence
380989|NCT01956734|temozolomide|temozolomide
380990|NCT01956721|Heart Failure , Skeletal muscle,Calcium,Ryanodine Receptor, Mitochondria, Exercise training, Muscle biopsy, Healthy volunteers|heart failure , skeletal muscle,calcium,ryanodine receptor, mitochondria, exercise training, muscle biopsy, healthy volunteers
380991|NCT01956669|VEGF|vegf
380992|NCT01956669|Pazopanib|pazopanib
380993|NCT01956669|Sarcoma|sarcoma
380994|NCT01956669|GW786034|gw786034
380995|NCT01956669|Refractory Solid Tumors|refractory solid tumors
380996|NCT01956656|lotus leaf, mouthwash, gingivitis|lotus leaf, mouthwash, gingivitis
380997|NCT01956643|sham feeding|sham feeding
380998|NCT01956643|postoperative ileus|postoperative ileus
380999|NCT01956643|liver transplantation|liver transplantation
381000|NCT01956591|Treatment efficacy|treatment efficacy
381001|NCT01956591|Long-term effects|long-term effects
381002|NCT01956591|Tachyphylaxis|tachyphylaxis
381003|NCT01956591|Undesirable effects|undesirable effects
381004|NCT01956591|Side effects|side effects
381005|NCT01956591|Self-assessment|self-assessment
381006|NCT01956591|Hyperhidrosis|hyperhidrosis
381007|NCT01956591|Quality of life|quality of life
381008|NCT01956565|Pulmonary Disease, Chronic Obstructive|pulmonary disease, chronic obstructive
381009|NCT01956565|Rehabilitation|rehabilitation
381010|NCT01956565|Physiotherapy|physiotherapy
381011|NCT01956565|Patient Compliance|patient compliance
381012|NCT01956565|Inspiratory Muscle Training|inspiratory muscle training
381013|NCT01956565|Respiratory Muscle Training|respiratory muscle training
381014|NCT01956552|Metastatic breast cancer|metastatic breast cancer
381015|NCT01956552|Tumor biopsy|tumor biopsy
381016|NCT01956552|Phenotype and genotype characterization|phenotype and genotype characterization
381017|NCT01956526|Heart Failure with Preserved Ejection Fraction (HFpEF)|heart failure with preserved ejection fraction (hfpef)
381018|NCT01956526|Diastolic Heart Failure (DHF)|diastolic heart failure (dhf)
381019|NCT01956526|Diastolic Dysfunction (DD)|diastolic dysfunction (dd)
381020|NCT01956513|ADC|adc
381021|NCT01956513|breast cancer|breast cancer
381022|NCT01956513|complete pathological response|complete pathological response
381023|NCT01956500|glucosamine|glucosamine
381024|NCT01956500|inflammation|inflammation
381128|NCT01955941|choroid|choroid
381025|NCT01956500|quality of life|quality of life
381026|NCT01956500|physical function|physical function
381027|NCT01956487|Bioequivalence|bioequivalence
381028|NCT01956487|RYTHMOL SR®|rythmol sr®
381029|NCT01956487|Atrial fibrillation|atrial fibrillation
381030|NCT01956487|Propafenone|propafenone
381031|NCT01956487|Pharmavokinetics|pharmavokinetics
381032|NCT01956474|keratoconus|keratoconus
381033|NCT01956474|cross-linking|cross-linking
381034|NCT01956474|Post-LASIK ectasia|post-lasik ectasia
381035|NCT01956474|Pellucid marginal degeneration|pellucid marginal degeneration
381036|NCT01956474|Forme fruste pellucid marginal degeneration|forme fruste pellucid marginal degeneration
381037|NCT01956474|FFKC|ffkc
381038|NCT01956474|Radial Keratotomy|radial keratotomy
381039|NCT01956474|Terrien's Marginal Degeneration|terrien's marginal degeneration
381040|NCT01956461|osteoporosis|osteoporosis
381041|NCT01956461|BMD|bmd
381042|NCT01956461|teriparatide|teriparatide
381043|NCT01956461|nursing home|nursing home
381044|NCT01956448|Percutaneous coronary intervention|percutaneous coronary intervention
381045|NCT01956448|DES|des
381046|NCT01956448|Angina pectoris|angina pectoris
381047|NCT01956448|Stent|stent
381048|NCT01956409|breast neoplasms|breast neoplasms
381049|NCT01956409|18F-FCH PET|18f-fch pet
381050|NCT01956409|MRI|mri
381051|NCT01956396|male circumcision|male circumcision
381052|NCT01956396|HIV|hiv
381053|NCT01956396|Zimbabwe|zimbabwe
381054|NCT01956383|male circumcision|male circumcision
381055|NCT01956383|HIV|hiv
381056|NCT01956383|Zimbabwe|zimbabwe
381057|NCT01956370|Male Circumcision|male circumcision
381058|NCT01956370|HIV Prevention|hiv prevention
381059|NCT01956370|Medical Device|medical device
381060|NCT01956357|aquatic exercises;|aquatic exercises;
381061|NCT01956357|deep water running;|deep water running;
381062|NCT01956357|diabetes;|diabetes;
381063|NCT01956357|blood glucose;|blood glucose;
381064|NCT01956357|inflammation.|inflammation.
381065|NCT01956344|Hoarding Disorder|hoarding disorder
381066|NCT01956344|Clutter|clutter
381067|NCT01956344|CBT|cbt
381068|NCT01956344|Cognitive behavior therapy|cognitive behavior therapy
381069|NCT01956344|fMRI|fmri
381070|NCT01956344|Obsessive compulsive disorder (OCD)|obsessive compulsive disorder (ocd)
381071|NCT01956344|Healthy control|healthy control
381072|NCT01956331|NSC lung Cancer,Elderly patients,post operative,|nsc lung cancer,elderly patients,post operative,
381073|NCT01956318|Chronic venous insufficiency|chronic venous insufficiency
381074|NCT01956318|Varicose vein|varicose vein
381075|NCT01956318|Crenobalneotherapy|crenobalneotherapy
381076|NCT01956318|Balneotherapy|balneotherapy
381077|NCT01956318|Spa therapy|spa therapy
381078|NCT01956279|Pregnenolone|pregnenolone
381079|NCT01956279|Gulf War Veteran|gulf war veteran
381080|NCT01956279|Fatigue|fatigue
381081|NCT01956279|Musculoskeletal Pain|musculoskeletal pain
381082|NCT01956279|Cognitive Decline|cognitive decline
381083|NCT01956279|Placebo Control|placebo control
381084|NCT01956266|Prosody|prosody
381085|NCT01956266|Communication|communication
381086|NCT01956266|Dysarthria|dysarthria
381087|NCT01956253|Bladder Cancer|bladder cancer
381088|NCT01956253|Neratinib|neratinib
381089|NCT01956253|13-2526|13-2526
381090|NCT01956240|shoulder|shoulder
381091|NCT01956240|pectoralis minor|pectoralis minor
381092|NCT01956240|stretching|stretching
381093|NCT01956240|scapular kinematics|scapular kinematics
381094|NCT01956214|hemodialysis|hemodialysis
381095|NCT01956214|exercise|exercise
381096|NCT01956214|electrical stimulation|electrical stimulation
381097|NCT01956175|electrical pharyngeal stimulation|electrical pharyngeal stimulation
381098|NCT01956175|stroke-related dysphagia|stroke-related dysphagia
381099|NCT01956175|tracheostomy|tracheostomy
381100|NCT01956175|decannulation|decannulation
381101|NCT01956149|gastric cancer|gastric cancer
381102|NCT01956149|second-line treatment|second-line treatment
381103|NCT01956149|Cabazitaxel|cabazitaxel
381104|NCT01956149|response|response
381105|NCT01956045|Intensive Care Units|intensive care units
381106|NCT01956045|Judgment|judgment
381107|NCT01956045|Disability Evaluation|disability evaluation
381108|NCT01956045|Autonomy|autonomy
381109|NCT01956032|LCIG|lcig
381110|NCT01956032|Parkinson's disease|parkinson's disease
381111|NCT01956032|levodopa carbidopa intestinal gel|levodopa carbidopa intestinal gel
381112|NCT01956032|Telemedicine|telemedicine
381113|NCT01955993|Obesity, adolescence,pharmacokinetics,fentanyl|obesity, adolescence,pharmacokinetics,fentanyl
381114|NCT01955980|CRS|crs
381115|NCT01955980|without polyposis|without polyposis
381116|NCT01955967|Effect|effect
381117|NCT01955967|Lidocaine|lidocaine
381118|NCT01955954|carbon dioxide monitoring|carbon dioxide monitoring
381119|NCT01955954|panic disorder|panic disorder
381120|NCT01955954|biofeedback|biofeedback
381121|NCT01955954|breathing training|breathing training
381122|NCT01955954|Primary diagnosis|primary diagnosis
381123|NCT01955954|panic attacks|panic attacks
381124|NCT01955941|Uveal melanoma|uveal melanoma
381125|NCT01955941|brachytherapy|brachytherapy
381126|NCT01955941|radiation|radiation
381127|NCT01955941|ciliary body|ciliary body
381129|NCT01955941|I-125 plaque brachytherapy|i-125 plaque brachytherapy
381130|NCT01955915|choroid|choroid
381131|NCT01955915|tumor|tumor
381133|NCT01955915|malignant melanoma|malignant melanoma
381134|NCT01955902|Opioid dependence|opioid dependence
381135|NCT01955902|Buprenorphine|buprenorphine
381136|NCT01955902|Adherence|adherence
381137|NCT01955902|Substance use|substance use
381138|NCT01955902|Suboxone|suboxone
381139|NCT01955889|Exercise|exercise
381140|NCT01955889|Rehabilitation|rehabilitation
381141|NCT01955889|Telemedicine|telemedicine
381142|NCT01955876|Fosrenol|fosrenol
381143|NCT01955876|hyperphosphatemia|hyperphosphatemia
381144|NCT01955876|chronic kidney disease not on dialysis|chronic kidney disease not on dialysis
381145|NCT01955863|Prostatic Neoplasms|prostatic neoplasms
381146|NCT01955863|Prostatectomy, Retropubic|prostatectomy, retropubic
381147|NCT01955863|Patient Discharge|patient discharge
381148|NCT01955824|bronchoscopy|bronchoscopy
381149|NCT01955824|lignocaine|lignocaine
381150|NCT01955824|cough|cough
381151|NCT01955811|platelet transfusion|platelet transfusion
381152|NCT01955811|Fibrinogen|fibrinogen
381153|NCT01955811|blood coagulation|blood coagulation
381154|NCT01955811|Thrombocytopenia|thrombocytopenia
381155|NCT01955811|in-vitro experiments|in-vitro experiments
381156|NCT01955811|FGTW|fgtw
381157|NCT01955811|Fit2012|fit2012
381158|NCT01955811|factor I|factor i
381159|NCT01955811|Fibrin|fibrin
381160|NCT01955798|Laparoscopy|laparoscopy
381161|NCT01955798|Gyneacological|gyneacological
381162|NCT01955798|Entry techniques|entry techniques
381163|NCT01955785|Traumatic brain injury|traumatic brain injury
381164|NCT01955785|Intracranial pressure|intracranial pressure
381165|NCT01955785|Ventilation|ventilation
381166|NCT01955785|Respiratory therapy|respiratory therapy
381167|NCT01955772|Haematopoietic stem cell transplantation|haematopoietic stem cell transplantation
381168|NCT01955772|Malignant hemopathy|malignant hemopathy
381169|NCT01955772|Artificial nutrition|artificial nutrition
381170|NCT01955694|BAY94-8862|bay94-8862
381171|NCT01955694|MR antagonist|mr antagonist
381172|NCT01955694|Heart failure|heart failure
381173|NCT01955694|Japanese patients|japanese patients
381174|NCT01955681|Epidermal Growth Factor Receptor Tyrosine Kinase Inhibitor retrement.|epidermal growth factor receptor tyrosine kinase inhibitor retrement.
381175|NCT01955668|11q-deleted relapsed/refractory chronic lymphocytic leukaemia|11q-deleted relapsed/refractory chronic lymphocytic leukaemia
381176|NCT01955668|Prolymphocytic leukaemia|prolymphocytic leukaemia
381177|NCT01955668|B cell lymphomas|b cell lymphomas
381178|NCT01955655|Baclofen|baclofen
381179|NCT01955655|cerebral palsy|cerebral palsy
381180|NCT01955655|colic|colic
381181|NCT01955655|crying infant|crying infant
381182|NCT01955655|recurrent crying spells|recurrent crying spells
381183|NCT01955655|spasticity|spasticity
381184|NCT01955655|therapy|therapy
381185|NCT01955642|Clopidogrel|clopidogrel
381186|NCT01955642|Brain Ischemia|brain ischemia
381187|NCT01955642|Ischemic attack|ischemic attack
381188|NCT01955642|Biological response to clopidogrel|biological response to clopidogrel
381189|NCT01955616|Parkinson's disease, chronic constipation|parkinson's disease, chronic constipation
381190|NCT01955590|Metacognitive therapy|metacognitive therapy
381191|NCT01955590|Eye Movement Desensitization Reprocessing (EMDR)|eye movement desensitization reprocessing (emdr)
381192|NCT01955590|Cognitive therapy|cognitive therapy
381193|NCT01955577|Vitamin D deficiency|vitamin d deficiency
381194|NCT01955577|Ring fixator|ring fixator
381195|NCT01955577|Tibial fracture|tibial fracture
381196|NCT01955525|Acute coronary syndrome|acute coronary syndrome
381197|NCT01955525|health related quality of life|health related quality of life
381198|NCT01955525|mortality|mortality
381199|NCT01955486|flight simulation|flight simulation
381200|NCT01955486|middle ear|middle ear
381201|NCT01955486|Eustachian tube function|eustachian tube function
381202|NCT01955473|Solid tumors|solid tumors
381203|NCT01955473|Sym004|sym004
381204|NCT01955473|Phase 1|phase 1
381205|NCT01955447|Blood glucose|blood glucose
381206|NCT01955421|NSCLC|nsclc
381207|NCT01955421|stage IIIB|stage iiib
381208|NCT01955421|stage IV)|stage iv)
712562|NCT00579709|Atypical DiGeorge|atypical digeorge
381209|NCT01955421|confirmed by histology or cytology methods|confirmed by histology or cytology methods
381210|NCT01955421|Harboring a PCR-confirmed activating mutation of EGFR, including an exon 19 deletion or an exon 21 L858R point mutation|harboring a pcr-confirmed activating mutation of egfr, including an exon 19 deletion or an exon 21 l858r point mutation
381211|NCT01955408|overactive bladder|overactive bladder
381212|NCT01955408|bladder cancer|bladder cancer
381213|NCT01955408|Synergo|synergo
381214|NCT01955408|urodynamic study|urodynamic study
381215|NCT01955395|Relaxation Response Resiliency Program (3RP)|relaxation response resiliency program (3rp)
381216|NCT01955395|monoclonal gammopathy of undetermined significance|monoclonal gammopathy of undetermined significance
381217|NCT01955395|smoldering multiple myeloma|smoldering multiple myeloma
381218|NCT01955382|Parasite Clearance Rate|parasite clearance rate
381219|NCT01955382|Parasite Half Life|parasite half life
381220|NCT01955382|Actidose Aqua|actidose aqua
381221|NCT01955382|Severe Malaria|severe malaria
381222|NCT01955369|incidence|incidence
381223|NCT01955369|phenotype|phenotype
381224|NCT01955369|mortality|mortality
381225|NCT01955356|Scratching|scratching
381226|NCT01955356|Endometrial biopsy|endometrial biopsy
381227|NCT01955356|Ongoing embryo implantation|ongoing embryo implantation
381228|NCT01955356|Assisted reproductive techniques|assisted reproductive techniques
381229|NCT01955343|Immune response|immune response
381230|NCT01955343|Cancer|cancer
381231|NCT01955330|CABG, Hybrid, Robotic surgery|cabg, hybrid, robotic surgery
381232|NCT01955317|Neonate|neonate
381233|NCT01955317|Bangladesh|bangladesh
381234|NCT01955317|Health behavior|health behavior
381235|NCT01955317|Handwashing|handwashing
381236|NCT01955317|Developing countries|developing countries
381237|NCT01955317|Infectious disease|infectious disease
381238|NCT01955291|Virtual Reality, Motor Learning, Rehabilitation, Upper Limb|virtual reality, motor learning, rehabilitation, upper limb
381239|NCT01955278|Laparoscopic colorectal surgery|laparoscopic colorectal surgery
381240|NCT01955278|Parastomal hernia|parastomal hernia
381241|NCT01955278|Prophylactic|prophylactic
381242|NCT01955278|Mesh|mesh
381243|NCT01955265|Positive youth development|positive youth development
381244|NCT01955265|Sports / physical activity|sports / physical activity
381245|NCT01955252|Endemic treponematoses|endemic treponematoses
381246|NCT01955252|Azithromycin|azithromycin
381247|NCT01955252|Mass drug administration|mass drug administration
381248|NCT01955252|Eradication|eradication
381249|NCT01955239|Head and Neck Cancer|head and neck cancer
381250|NCT01955239|Radiotherapy|radiotherapy
381251|NCT01955239|IMRT|imrt
381252|NCT01955239|Stem cell|stem cell
381253|NCT01955239|Parotid gland|parotid gland
381254|NCT01955213|constipation, methylnaltrexone, opoid|constipation, methylnaltrexone, opoid
381255|NCT01955200|Stent implantation|stent implantation
381256|NCT01955200|Clopidogrel low response|clopidogrel low response
381257|NCT01955200|Ticagrelor|ticagrelor
381258|NCT01955200|Cilostazol|cilostazol
381259|NCT01955200|Clopidogrel|clopidogrel
381260|NCT01955187|SEQUENTIAL THERAPY|sequential therapy
381261|NCT01955187|PRIMARY MEMBRANOUS NEPHROPATHY|primary membranous nephropathy
381262|NCT01955187|TACROLIMUS|tacrolimus
381263|NCT01955187|RITUXIMAB|rituximab
381264|NCT01955174|Botulinum toxin|botulinum toxin
381265|NCT01955174|Esophageal motility disorder|esophageal motility disorder
381266|NCT01955174|Distal esophageal spasm|distal esophageal spasm
381267|NCT01955148|PTB|ptb
381268|NCT01955148|sPTB|sptb
381269|NCT01955148|cervical cerclage|cervical cerclage
381270|NCT01955148|LEEP|leep
381271|NCT01955148|PROM|prom
381272|NCT01955148|short cervix|short cervix
381273|NCT01955135|Prematurity, Retinopathy, propofol, ketamine, sedation|prematurity, retinopathy, propofol, ketamine, sedation
381274|NCT01955122|polyp/adenoma miss rate|polyp/adenoma miss rate
381275|NCT01955122|colonoscopy add-on device|colonoscopy add-on device
381276|NCT01955122|enhanced screening|enhanced screening
381277|NCT01955109|Food allergy|food allergy
381278|NCT01955109|Immediate hypersensitivity|immediate hypersensitivity
381279|NCT01955109|Whole peanut extract|whole peanut extract
381280|NCT01955109|Allergenic product|allergenic product
381281|NCT01955109|Specific Immunotherapy|specific immunotherapy
381282|NCT01955109|Epicutaneous Immunotherapy (EPIT)|epicutaneous immunotherapy (epit)
381283|NCT01955096|fast-track surgery, laparoscopic gastrectomy|fast-track surgery, laparoscopic gastrectomy
381284|NCT01955083|Obstructive sleep apnea|obstructive sleep apnea
381285|NCT01955083|snoring|snoring
381286|NCT01955083|radiofrequency|radiofrequency
381287|NCT01955083|pillar implant|pillar implant
381288|NCT01955083|snore sound analysis|snore sound analysis
381289|NCT01955070|Informed consent|informed consent
381290|NCT01955070|Ethics|ethics
381291|NCT01955044|neonatal prematurity|neonatal prematurity
381292|NCT01955044|infant, extremely low birth weight|infant, extremely low birth weight
381293|NCT01955044|fatty acids, polyunsaturated|fatty acids, polyunsaturated
381294|NCT01955031|Telemedicine|telemedicine
381295|NCT01955031|Telemonitoring|telemonitoring
381296|NCT01955031|Education|education
381297|NCT01955031|Nutrition|nutrition
381298|NCT01955031|Food behaviour|food behaviour
381299|NCT01955031|Weight|weight
381300|NCT01955031|Physical activity|physical activity
381301|NCT01955031|Glycaemia|glycaemia
381302|NCT01955031|Self-monitoring blood glucose|self-monitoring blood glucose
381303|NCT01955018|computed tomography|computed tomography
381304|NCT01955018|radiation|radiation
381305|NCT01955018|screening|screening
381306|NCT01955018|asbestos|asbestos
381307|NCT01955018|workers|workers
381308|NCT01955018|cancer|cancer
381309|NCT01955005|Health Records, Personal|health records, personal
381310|NCT01955005|Delivery of healthcare|delivery of healthcare
381311|NCT01955005|Consumer Participation|consumer participation
381312|NCT01955005|Internet|internet
381313|NCT01954992|glufosfamide|glufosfamide
381314|NCT01954992|5-FU|5-fu
381315|NCT01954992|metastatic pancreatic adenocarcinoma|metastatic pancreatic adenocarcinoma
381316|NCT01954979|Graft versus Host Disease|graft versus host disease
381317|NCT01954979|ABATACEPT|abatacept
381318|NCT01954966|Nicotine|nicotine
381319|NCT01954966|Smoking|smoking
381515|NCT01954186|Oxytocin|oxytocin
381320|NCT01954953|Retinitis Pigmentosa Syndromic|retinitis pigmentosa syndromic
381321|NCT01954953|Congenital Deafness|congenital deafness
381322|NCT01954953|Usher Syndrome Retinitis Pigmentosa and Deafness|usher syndrome retinitis pigmentosa and deafness
381323|NCT01954953|Progressive Hearing Loss|progressive hearing loss
381324|NCT01954953|Retinitis Pigmentosa|retinitis pigmentosa
381325|NCT01954940|Whole body vibration therapy, muscle strength testing, bone health, ambulatory, endurance.|whole body vibration therapy, muscle strength testing, bone health, ambulatory, endurance.
381326|NCT01954927|Pain control|pain control
381327|NCT01954914|Plerixafor|plerixafor
381328|NCT01954914|donor|donor
381329|NCT01954914|allogeneic peripheral stam cell donation|allogeneic peripheral stam cell donation
381330|NCT01954914|PBSC|pbsc
381331|NCT01954914|poor donors|poor donors
381332|NCT01954875|neurodegenerative diseases|neurodegenerative diseases
381333|NCT01954875|amyotrophic lateral sclerosis|amyotrophic lateral sclerosis
381334|NCT01954875|multiple sclerosis|multiple sclerosis
381335|NCT01954875|Parkinson's Disease|parkinson's disease
381336|NCT01954862|Water-aided colonoscopy|water-aided colonoscopy
381337|NCT01954862|Water Immersion colonoscopy|water immersion colonoscopy
381338|NCT01954862|Water Exchange colonoscopy|water exchange colonoscopy
381339|NCT01954862|Carbon-dioxide colonoscopy|carbon-dioxide colonoscopy
381340|NCT01954862|Painless unsedated colonoscopy|painless unsedated colonoscopy
381341|NCT01954862|Adenoma detection rate|adenoma detection rate
381342|NCT01954862|Mean Adenomas per Procedure|mean adenomas per procedure
381343|NCT01954849|gingivitis|gingivitis
381344|NCT01954849|inflammation|inflammation
381345|NCT01954849|plaque|plaque
381346|NCT01954849|orthodontics|orthodontics
381347|NCT01954836|short-term fasting|short-term fasting
381348|NCT01954836|adjuvant chemotherapy|adjuvant chemotherapy
381349|NCT01954836|toxicity|toxicity
381350|NCT01954836|side-effects|side-effects
381351|NCT01954836|ovarial carinoma|ovarial carinoma
381352|NCT01954836|breast cancer|breast cancer
381353|NCT01954823|Multiple sclerosis, Patient-reported outcomes, patient diary|multiple sclerosis, patient-reported outcomes, patient diary
381354|NCT01954810|JECV|jecv
381355|NCT01954810|IMOJEV|imojev
381356|NCT01954810|Booster response|booster response
381357|NCT01954810|Children|children
381358|NCT01954810|antibody response|antibody response
381359|NCT01954810|Duration|duration
381360|NCT01954797|Physical fitness|physical fitness
381361|NCT01954797|relaxation|relaxation
381362|NCT01954797|stroke|stroke
381363|NCT01954797|cerebral ischemia|cerebral ischemia
381364|NCT01954797|cerebral perfusion|cerebral perfusion
381365|NCT01954797|biomarkers|biomarkers
381366|NCT01954797|MRI|mri
381367|NCT01954771|Diabetes mellitus|diabetes mellitus
381368|NCT01954771|Coronary artery disease|coronary artery disease
381369|NCT01954771|SMBG|smbg
381370|NCT01954771|Elderly|elderly
381371|NCT01954758|Window of implantation|window of implantation
381372|NCT01954758|Personalized embryo transfer|personalized embryo transfer
381373|NCT01954758|Fresh embryo transfer|fresh embryo transfer
381374|NCT01954758|Delayed embryo transfer|delayed embryo transfer
381375|NCT01954758|Elective deferred embryo transfer|elective deferred embryo transfer
381376|NCT01954758|Endometrial receptivity array|endometrial receptivity array
381377|NCT01954758|Endometrial receptivity analysis|endometrial receptivity analysis
381378|NCT01954758|Endometrial receptivity test|endometrial receptivity test
381379|NCT01954758|Frozen embryo transfer|frozen embryo transfer
381380|NCT01954745|Bile Duct Cancer|bile duct cancer
381381|NCT01954745|intrahepatic cholangiocarcinoma|intrahepatic cholangiocarcinoma
381382|NCT01954745|extrahepatic cholangiocarcinoma|extrahepatic cholangiocarcinoma
381383|NCT01954745|Cabozantinib|cabozantinib
381384|NCT01954719|Cervix Uteri, Cesarean Section, Infection, Dilatation|cervix uteri, cesarean section, infection, dilatation
381385|NCT01954693|Tuberous Sclerosis|tuberous sclerosis
381386|NCT01954693|Everolimus|everolimus
381387|NCT01954693|Neurocognitive functioning|neurocognitive functioning
381388|NCT01954680|bipolar disorder|bipolar disorder
381389|NCT01954680|child|child
381390|NCT01954680|adolescent|adolescent
381391|NCT01954667|Gastroesophageal Reflux Disease; Anthropometric Measures; Leptin|gastroesophageal reflux disease; anthropometric measures; leptin
381392|NCT01954641|breast cancer|breast cancer
381393|NCT01954641|lung cancer|lung cancer
381394|NCT01954641|cancer treatments|cancer treatments
381395|NCT01954641|racial inequity|racial inequity
381396|NCT01954641|health systems change|health systems change
381397|NCT01954641|transparency|transparency
381398|NCT01954641|accountability|accountability
381399|NCT01954628|Exacerbation of COPD|exacerbation of copd
381400|NCT01954628|Unstable COPD|unstable copd
381401|NCT01954615|ACT-281959|act-281959
381402|NCT01954615|ACT-246475|act-246475
381403|NCT01954602|Biliary cannulation|biliary cannulation
381404|NCT01954602|Endoscopic retrograde cholangiopancreatography|endoscopic retrograde cholangiopancreatography
381405|NCT01954602|Touch guide-wire techniques|touch guide-wire techniques
381406|NCT01954602|No touch guide-wire techniques|no touch guide-wire techniques
381407|NCT01954589|ACT-462206|act-462206
381408|NCT01954589|Selective dual orexin receptor antagonist|selective dual orexin receptor antagonist
381409|NCT01954576|bevacizumab-naïve recurrent GBM|bevacizumab-naïve recurrent gbm
381410|NCT01954576|bevacizumab-refractory GBM|bevacizumab-refractory gbm
381411|NCT01954563|Tuberculosis|tuberculosis
381412|NCT01954563|Vaccine|vaccine
381413|NCT01954563|Immunogenicity|immunogenicity
381414|NCT01954550|Exercise|exercise
381415|NCT01954550|Dementia|dementia
381416|NCT01954550|Cognition|cognition
381417|NCT01954550|Brain Volume|brain volume
381418|NCT01954550|Aging|aging
381419|NCT01954537|Exertional heat illness|exertional heat illness
381420|NCT01954537|Hydration Status|hydration status
381421|NCT01954537|Preseason football|preseason football
381422|NCT01954537|heat stroke|heat stroke
381423|NCT01954511|Stomatognathic diseases;|stomatognathic diseases;
381424|NCT01954511|Temporomandibular Joint Dysfunction Syndrome|temporomandibular joint dysfunction syndrome
381425|NCT01954498|Randomized controlled trial|randomized controlled trial
381426|NCT01954498|Spermatozoa|spermatozoa
381427|NCT01954498|Sperm|sperm
381428|NCT01954498|Male Infertility|male infertility
381429|NCT01954498|Walnuts|walnuts
381430|NCT01954498|Nutrition|nutrition
381431|NCT01954498|Male Reproduction|male reproduction
381432|NCT01954485|LaserLok, connective tissue, adhesion|laserlok, connective tissue, adhesion
381433|NCT01954472|Portfolio diet|portfolio diet
381434|NCT01954472|dietary modification|dietary modification
381435|NCT01954472|hypercholesterolemia|hypercholesterolemia
381436|NCT01954472|diabetes|diabetes
381437|NCT01954472|Exercise|exercise
381438|NCT01954472|CVD risk|cvd risk
381439|NCT01954472|glycemic index|glycemic index
381440|NCT01954472|inflammatory biomarkers|inflammatory biomarkers
381441|NCT01954472|monounsaturated fat|monounsaturated fat
381442|NCT01954472|saturated fat|saturated fat
381443|NCT01954472|nuts|nuts
381444|NCT01954472|plant sterols|plant sterols
381445|NCT01954472|vegetable protein|vegetable protein
381446|NCT01954472|viscous fiber|viscous fiber
381447|NCT01954472|soy|soy
381448|NCT01954459|Type 1 diabetes|type 1 diabetes
381449|NCT01954459|Continuous glucose sensor|continuous glucose sensor
381450|NCT01954459|Insupatch|insupatch
381451|NCT01954433|Cost-effectiveness analyses|cost-effectiveness analyses
381452|NCT01954433|Cost-utility analyses|cost-utility analyses
381453|NCT01954433|Upper extremity|upper extremity
381454|NCT01954433|Orthopedic|orthopedic
381455|NCT01954433|Shoulder arthroplasty|shoulder arthroplasty
381456|NCT01954433|Rotator cuff tear repair|rotator cuff tear repair
381457|NCT01954433|Resection interposition suspension arthroplasty|resection interposition suspension arthroplasty
381458|NCT01954420|Pain|pain
381459|NCT01954420|Fatigue|fatigue
381460|NCT01954420|Sleep|sleep
381461|NCT01954420|Cancer|cancer
381462|NCT01954420|Relaxation|relaxation
381463|NCT01954420|Distraction|distraction
381464|NCT01954420|Symptoms|symptoms
381465|NCT01954407|smoking-related messages|smoking-related messages
381466|NCT01954407|anti-smoking messages|anti-smoking messages
381467|NCT01954407|smoking-related beliefs|smoking-related beliefs
381468|NCT01954407|anti-smoking intentions|anti-smoking intentions
381469|NCT01954355|advanced solid tumor|advanced solid tumor
381470|NCT01954355|ovarian cancer|ovarian cancer
381471|NCT01954355|LDE225|lde225
381472|NCT01954355|Paclitaxel|paclitaxel
381473|NCT01954355|Hedgehog inhibitor|hedgehog inhibitor
381474|NCT01954342|Pregnancy|pregnancy
381475|NCT01954342|Postpartum|postpartum
381476|NCT01954329|Biomarkers|biomarkers
381477|NCT01954329|TIA|tia
381478|NCT01954329|Diagnosis|diagnosis
381479|NCT01954316|advanced cancer|advanced cancer
381480|NCT01954316|CFI-400945 fumarate|cfi-400945 fumarate
381481|NCT01954316|polo-like kinase 4|polo-like kinase 4
381482|NCT01954316|PLK4|plk4
381483|NCT01954316|tablet|tablet
381484|NCT01954316|dose escalation|dose escalation
381485|NCT01954316|genetic testing|genetic testing
381486|NCT01954290|Stroke|stroke
381487|NCT01954290|Brain Edema|brain edema
381488|NCT01954290|Brain Herniation|brain herniation
381489|NCT01954290|Conivaptan|conivaptan
381490|NCT01954277|Chronic Tension-Type Headache|chronic tension-type headache
381491|NCT01954277|Electroacupuncture|electroacupuncture
381492|NCT01954277|Headache Impact|headache impact
381493|NCT01954277|BDNF|bdnf
381494|NCT01954277|TNF|tnf
381495|NCT01954264|Saharan Western Africa|saharan western africa
381496|NCT01954264|Epidemiology|epidemiology
381497|NCT01954264|Post-Approval Programme study|post-approval programme study
381498|NCT01954264|Malaria|malaria
381499|NCT01954264|Burden of Disease Study|burden of disease study
381500|NCT01954251|FLU-D-QIV|flu-d-qiv
381501|NCT01954251|Adults|adults
381502|NCT01954251|Safety|safety
381503|NCT01954251|Immunogenicity|immunogenicity
381504|NCT01954251|co-administration|co-administration
381505|NCT01954251|Herpes zoster|herpes zoster
381506|NCT01954238|Anti-coagulant|anti-coagulant
381507|NCT01954238|Coagulation factor Xa inhibitor|coagulation factor xa inhibitor
381508|NCT01954225|Fistula in ano|fistula in ano
381509|NCT01954225|Bhagandara|bhagandara
381510|NCT01954225|Udumbara sutra|udumbara sutra
381511|NCT01954212|Oral health|oral health
381512|NCT01954199|Sciatica|sciatica
381513|NCT01954199|Nerve pain|nerve pain
381514|NCT01954199|Low back pain|low back pain
381516|NCT01954186|Active Management of Third Stage of Labour|active management of third stage of labour
381517|NCT01954134|Tumor Suppressor Protein p53,|tumor suppressor protein p53,
381518|NCT01954134|Iodine Radioisotopes|iodine radioisotopes
381519|NCT01954121|Levetiracetam|levetiracetam
381520|NCT01954121|Keppra|keppra
381521|NCT01954121|Monotherapy|monotherapy
381522|NCT01954121|China|china
381523|NCT01954121|Epilepsy|epilepsy
381524|NCT01954121|Partial-onset Seizures|partial-onset seizures
381525|NCT01954108|tendinopathy|tendinopathy
381526|NCT01954108|hyaluronan|hyaluronan
381527|NCT01954108|tendon|tendon
381528|NCT01954108|hyaluronic acid|hyaluronic acid
381529|NCT01954108|extracorporeal shock wave|extracorporeal shock wave
381530|NCT01954095|17-OHPC, Prometrium, Cerclage, Pre-term birth, Short cervix|17-ohpc, prometrium, cerclage, pre-term birth, short cervix
381531|NCT01954082|Retinopathy|retinopathy
381532|NCT01954082|Prematurity|prematurity
381533|NCT01954082|Infant, Newborn, Diseases|infant, newborn, diseases
381534|NCT01954056|NICHD Neonatal Research Network|nichd neonatal research network
381535|NCT01954056|Mechanical ventilation|mechanical ventilation
381536|NCT01954056|Intubation|intubation
381537|NCT01954056|Neurodevelopmental impairment|neurodevelopmental impairment
381538|NCT01954043|melanoma|melanoma
381539|NCT01954043|dabrafenib|dabrafenib
381540|NCT01954043|BRAF V600|braf v600
381541|NCT01954043|rabeprazole|rabeprazole
381542|NCT01954043|rifampin|rifampin
381543|NCT01954030|Carboxyamidotriazole Orotate|carboxyamidotriazole orotate
381544|NCT01954030|CTO|cto
381545|NCT01954030|Bevacizumab|bevacizumab
381546|NCT01954030|Avastin|avastin
381547|NCT01954030|Malignant Glioma|malignant glioma
381548|NCT01954030|Pro00044274|pro00044274
381549|NCT01954030|Desjardins|desjardins
381550|NCT01954030|Duke|duke
381551|NCT01954030|The Preston Robert Tisch Brain Tumor Center|the preston robert tisch brain tumor center
381552|NCT01953978|Pain|pain
381553|NCT01953978|Analgesia|analgesia
381554|NCT01953978|Postoperative|postoperative
381555|NCT01953978|Dexamethasone|dexamethasone
381556|NCT01953978|Spine surgery|spine surgery
381557|NCT01953926|Neratinib|neratinib
381558|NCT01953926|Nerlynx|nerlynx
381559|NCT01953926|Breast|breast
381560|NCT01953926|Gastroesophageal|gastroesophageal
381561|NCT01953926|Endometrial|endometrial
381562|NCT01953926|Ovarian|ovarian
381563|NCT01953926|Biliary Tract|biliary tract
381564|NCT01953926|Solid Tumors|solid tumors
381565|NCT01953926|Cancer|cancer
381566|NCT01953926|HER2|her2
381567|NCT01953926|HER4|her4
381568|NCT01953926|EGFR|egfr
381569|NCT01953926|Bladder/Urinary Tract|bladder/urinary tract
381570|NCT01953926|Paclitaxel|paclitaxel
381571|NCT01953926|Fulvestrant|fulvestrant
381572|NCT01953926|Trastuzumab|trastuzumab
381573|NCT01953926|Fibrolamellar Carcinoma|fibrolamellar carcinoma
381574|NCT01953900|Osteosarcoma|osteosarcoma
381575|NCT01953900|T-Cells|t-cells
381576|NCT01953900|varicella zoster virus (VZV)|varicella zoster virus (vzv)
381577|NCT01953900|GD2|gd2
381578|NCT01953900|Neuroblastoma|neuroblastoma
381579|NCT01953887|Phase I|phase i
381580|NCT01953887|Final formulation EC905|final formulation ec905
381581|NCT01953887|Solifenacin succinate|solifenacin succinate
381582|NCT01953887|Tamsulosin HCl|tamsulosin hcl
381583|NCT01953887|Marketed drugs|marketed drugs
381584|NCT01953874|heart failure|heart failure
381585|NCT01953874|congestive heart failure|congestive heart failure
381586|NCT01953874|acute decompensated heart failure|acute decompensated heart failure
381587|NCT01953874|chronic heart failure|chronic heart failure
381588|NCT01953874|left-sided heart failure|left-sided heart failure
381589|NCT01953874|heart failure decompensation|heart failure decompensation
381590|NCT01953874|sleep apnea|sleep apnea
381591|NCT01953874|sleep disordered breathing|sleep disordered breathing
381592|NCT01953874|central sleep apnea|central sleep apnea
784488|NCT00312767|Fabrazyme|fabrazyme
381593|NCT01953874|obstructive sleep apnea|obstructive sleep apnea
381594|NCT01953874|cheyne-stokes respiration|cheyne-stokes respiration
381595|NCT01953861|Phase I|phase i
381596|NCT01953861|Combination tablet EC905|combination tablet ec905
381597|NCT01953861|Omnic OCAS®|omnic ocas®
381598|NCT01953861|Vesicare®|vesicare®
381599|NCT01953861|Food effect|food effect
381600|NCT01953861|Vesomni|vesomni
381601|NCT01953861|VesiFlow|vesiflow
381602|NCT01953861|Urizia|urizia
381603|NCT01953848|Phase I|phase i
381604|NCT01953848|Combination tablet EC905|combination tablet ec905
381605|NCT01953848|Steady-state|steady-state
381606|NCT01953848|Vesomni|vesomni
381607|NCT01953848|VesiFlow|vesiflow
381608|NCT01953848|Urizia|urizia
381609|NCT01953835|Pharmacokinetics|pharmacokinetics
381610|NCT01953835|GSK2586184|gsk2586184
381611|NCT01953835|Simvastatin|simvastatin
381612|NCT01953835|Rosuvastatin|rosuvastatin
381613|NCT01953835|Poloxamer|poloxamer
381614|NCT01953822|Observational|observational
381615|NCT01953822|Cohort|cohort
381616|NCT01953822|Autoimmune disease|autoimmune disease
381617|NCT01953822|Cervarix®|cervarix®
381618|NCT01953822|Women aged 9 to 25 years|women aged 9 to 25 years
381619|NCT01953822|United Kingdom|united kingdom
381620|NCT01953809|oral|oral
381621|NCT01953809|oral contraceptive|oral contraceptive
381622|NCT01953809|pharmacokinetics|pharmacokinetics
381623|NCT01953809|drug interaction|drug interaction
381624|NCT01953809|pharmacodynamics|pharmacodynamics
381625|NCT01953809|GSK1322322|gsk1322322
381626|NCT01953809|antibiotic|antibiotic
381628|NCT01953796|Polycystic Ovarian Syndrome stair step traditional protocol|polycystic ovarian syndrome stair step traditional protocol
381629|NCT01953770|Acute lymphoblastic leukemia, children, adolescents, L-asparaginase, methotrexate|acute lymphoblastic leukemia, children, adolescents, l-asparaginase, methotrexate
381630|NCT01953757|diabetic neuropathy, diet, vegan, vegetarian|diabetic neuropathy, diet, vegan, vegetarian
381631|NCT01953744|Fluconazole; Meglumine antimoniate;L.Braziliensis;|fluconazole; meglumine antimoniate;l.braziliensis;
381632|NCT01953744|L.Guyanensis|l.guyanensis
381633|NCT01953731|palbociclib|palbociclib
381634|NCT01953731|PD-0332991|pd-0332991
381635|NCT01953731|rifampin|rifampin
381636|NCT01953731|drug-drug interaction study|drug-drug interaction study
381637|NCT01953705|omega 3 fatty acids|omega 3 fatty acids
381638|NCT01953705|cognitive decline|cognitive decline
381639|NCT01953705|MRI|mri
381640|NCT01953705|endothelial function|endothelial function
381641|NCT01953705|white matter|white matter
381642|NCT01953705|executive function|executive function
381643|NCT01953705|prevention|prevention
381644|NCT01953705|DTI|dti
381645|NCT01953705|ASL|asl
381646|NCT01953692|PD1|pd1
381647|NCT01953692|PD-1|pd-1
381648|NCT01953692|PDL1|pdl1
381649|NCT01953692|PD-L1|pd-l1
381650|NCT01953666|word prediction software, text input speed, copm, occupational therapist, rehabilitation, spinal cord injury|word prediction software, text input speed, copm, occupational therapist, rehabilitation, spinal cord injury
381651|NCT01953614|quantitative encephalography|quantitative encephalography
381652|NCT01953614|brain computer interface|brain computer interface
381653|NCT01953614|chiropractic|chiropractic
381654|NCT01953614|sacro-occipital technique|sacro-occipital technique
381655|NCT01953575|Mucosal Impedance|mucosal impedance
381656|NCT01953575|Eosinophilic Esophagitis|eosinophilic esophagitis
381657|NCT01953575|EoE|eoe
381658|NCT01953562|infants|infants
381659|NCT01953562|NICU|nicu
381660|NCT01953562|intubated|intubated
381661|NCT01953562|ventilator|ventilator
381662|NCT01953549|physical activity, relaxation, activities of daily living, motor functions, cognitive functions|physical activity, relaxation, activities of daily living, motor functions, cognitive functions
381663|NCT01953523|erectile dysfunction|erectile dysfunction
381664|NCT01953523|peyronies|peyronies
381665|NCT01953523|interstitial cystitis|interstitial cystitis
381666|NCT01953523|cardiomyopathy|cardiomyopathy
381667|NCT01953523|emphysema|emphysema
381668|NCT01953523|copd|copd
381669|NCT01953523|arthritis|arthritis
381670|NCT01953523|multiple sclerosis|multiple sclerosis
381671|NCT01953523|parkinson's|parkinson's
381672|NCT01953510|Pneumococcal vaccines|pneumococcal vaccines
381673|NCT01953510|10-valent pneumococcal vaccine|10-valent pneumococcal vaccine
381674|NCT01953510|13-valent pneumococcal vaccine|13-valent pneumococcal vaccine
381675|NCT01953510|Immunization Schedule|immunization schedule
381676|NCT01953510|Public Health|public health
381677|NCT01953458|Hepatitis B and C|hepatitis b and c
381678|NCT01953458|ANRS HEPATHER French Cohort|anrs hepather french cohort
381679|NCT01953432|Cocaine-Related Disorders|cocaine-related disorders
381680|NCT01953432|Cocaine|cocaine
381681|NCT01953432|Doxazosin|doxazosin
381682|NCT01953432|Cardiovascular Agents|cardiovascular agents
381683|NCT01953432|Antihypertensive Agents|antihypertensive agents
381684|NCT01953432|Adrenergic alpha-1 Receptor Antagonists|adrenergic alpha-1 receptor antagonists
381685|NCT01953432|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists
381686|NCT01953432|Adrenergic Antagonists|adrenergic antagonists
712563|NCT00579709|Complete DiGeorge Anomaly|complete digeorge anomaly
488095|NCT01479634|HIV|hiv
381687|NCT01953432|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action
381688|NCT01953432|Neurotransmitter Agents|neurotransmitter agents
381689|NCT01953432|Therapeutic Uses|therapeutic uses
381690|NCT01953432|Pharmacologic Actions|pharmacologic actions
381691|NCT01953432|Substance-Related Disorders|substance-related disorders
381692|NCT01953406|hepatocellular carcinoma|hepatocellular carcinoma
381693|NCT01953406|lung metastasis|lung metastasis
381694|NCT01953406|5-fluorouracil/mitomycin|5-fluorouracil/mitomycin
381695|NCT01953380|Intervention Studies|intervention studies
381696|NCT01953380|Eczema|eczema
381697|NCT01953380|Randomized Controlled Trial|randomized controlled trial
381698|NCT01953380|Knowledge|knowledge
381699|NCT01953380|Quality of Life|quality of life
381700|NCT01953367|Bioequivalence|bioequivalence
381701|NCT01953367|AUC|auc
381702|NCT01953367|Cmax|cmax
381703|NCT01953354|Ulcerative colitis (UC)|ulcerative colitis (uc)
381704|NCT01953354|Inflammatory Bowel Disease (IBD)|inflammatory bowel disease (ibd)
381705|NCT01953354|Trichuris suis ova (TSO)|trichuris suis ova (tso)
381706|NCT01953341|Migraine|migraine
381707|NCT01953328|Japanese, high cholesterol, LDL-C, High Cardiovascular Risk|japanese, high cholesterol, ldl-c, high cardiovascular risk
381708|NCT01953315|urinary incontinence, muscle progenitor cells, MPCs|urinary incontinence, muscle progenitor cells, mpcs
381709|NCT01953302|ventral hernia|ventral hernia
381710|NCT01953302|infection|infection
381711|NCT01953302|hematoma|hematoma
381712|NCT01953302|seroma|seroma
381713|NCT01953302|recurrence|recurrence
381714|NCT01953302|mesh technique|mesh technique
381715|NCT01953289|Appendicitis|appendicitis
381716|NCT01953289|Free fluid|free fluid
381717|NCT01953276|Acute Coronary Syndrome|acute coronary syndrome
381718|NCT01953276|Chest pain|chest pain
381719|NCT01953276|Electrocardiograms|electrocardiograms
381720|NCT01953276|Risk Stratification|risk stratification
381721|NCT01953276|Emergency Department|emergency department
381722|NCT01953263|urinary incontinence, muscle fibers|urinary incontinence, muscle fibers
381723|NCT01953250|Deep infiltrating endometriosis|deep infiltrating endometriosis
381724|NCT01953250|Laparoscopic sigmoid resection|laparoscopic sigmoid resection
381725|NCT01953250|laparoscopic rectum resection|laparoscopic rectum resection
381726|NCT01953250|Colorectal surgery|colorectal surgery
381727|NCT01953237|Schizophrenia|schizophrenia
381728|NCT01953237|antipsychotic medication adherence|antipsychotic medication adherence
381729|NCT01953237|mobile phones|mobile phones
381730|NCT01953224|Physical activity|physical activity
381731|NCT01953224|Video game|video game
381732|NCT01953224|Mobile|mobile
381733|NCT01953224|Technology|technology
381734|NCT01953224|Obesity|obesity
381735|NCT01953198|hypoxia hypobaric|hypoxia hypobaric
381736|NCT01953185|elderly|elderly
381737|NCT01953185|subjects|subjects
381738|NCT01953146|PCOS|pcos
381739|NCT01953107|Anemia|anemia
381740|NCT01953107|Ovarian cancer|ovarian cancer
381741|NCT01953107|Uterine cancer|uterine cancer
381742|NCT01953107|Cervical cancer|cervical cancer
381743|NCT01953107|Oral iron|oral iron
381744|NCT01953094|Cervical|cervical
381745|NCT01953081|Enteral feeding|enteral feeding
381746|NCT01953068|POCD|pocd
381747|NCT01953068|Executive Reaction Time Test|executive reaction time test
381748|NCT01953068|Aortic valve surgery|aortic valve surgery
381749|NCT01953068|Cognitive functions|cognitive functions
381750|NCT01953068|Transcatheter Aortic Valve Implantation|transcatheter aortic valve implantation
381751|NCT01953055|stereotactic ablative radiotherapy|stereotactic ablative radiotherapy
381752|NCT01953055|androgen deprivation therapy|androgen deprivation therapy
381753|NCT01953042|Obsessive-Compulsive Disorder|obsessive-compulsive disorder
381754|NCT01953042|Health Education|health education
381755|NCT01953016|Job Syndrome/HIES|job syndrome/hies
381756|NCT01953016|GATA2|gata2
381757|NCT01953016|Primary Immunodeficiencies|primary immunodeficiencies
381758|NCT01953016|SCID|scid
381759|NCT01953016|DOCK8|dock8
381760|NCT01952990|Pharmacokinetic|pharmacokinetic
381761|NCT01952964|exit site infection|exit site infection
381762|NCT01952964|skin allergy|skin allergy
381763|NCT01952964|physical damage|physical damage
381764|NCT01952951|rectal neoplasms|rectal neoplasms
381765|NCT01952951|radiotherapy|radiotherapy
381766|NCT01952951|Antineoplastic Agents|antineoplastic agents
381767|NCT01952938|knee revision surgery,|knee revision surgery,
381768|NCT01952938|rotating hinge prosthesis|rotating hinge prosthesis
381769|NCT01952899|Intensive Care Unit|intensive care unit
381770|NCT01952899|Delirium|delirium
381771|NCT01952899|Implementation|implementation
381772|NCT01952899|Guideline|guideline
381773|NCT01952886|malignant glioma|malignant glioma
381774|NCT01952886|antiemetic|antiemetic
381775|NCT01952886|ondansetron|ondansetron
381776|NCT01952886|granisetron|granisetron
381777|NCT01952886|Preston Robert Tisch Brain Tumor Center|preston robert tisch brain tumor center
381778|NCT01952886|Pro00041233|pro00041233
381779|NCT01952886|Duke|duke
381780|NCT01952873|stents|stents
784489|NCT00312767|dialysis|dialysis
381781|NCT01952873|angioplasty, balloon, coronary|angioplasty, balloon, coronary
381782|NCT01952873|coronary artery stenosis|coronary artery stenosis
381783|NCT01952873|optical coherence tomography|optical coherence tomography
381784|NCT01952860|Lung Cancer|lung cancer
381785|NCT01952860|Non-small cell lung cancer|non-small cell lung cancer
381786|NCT01952860|NSCLC|nsclc
381787|NCT01952860|Caregiving partner|caregiving partner
381788|NCT01952860|Hatha Yoga|hatha yoga
381789|NCT01952860|Radiation therapy|radiation therapy
381791|NCT01952860|Questionnaires|questionnaires
381792|NCT01952860|Surveys|surveys
381793|NCT01952847|Advanced Cancers|advanced cancers
381794|NCT01952847|Mucositis|mucositis
381795|NCT01952847|Esophagitis|esophagitis
381796|NCT01952847|mTOR Inhibitor-based Regimen|mtor inhibitor-based regimen
381797|NCT01952847|Radiation to the Esophagus|radiation to the esophagus
381798|NCT01952847|Thoracic malignancies|thoracic malignancies
381799|NCT01952847|Placebo|placebo
381800|NCT01952847|Glutamine|glutamine
381801|NCT01952847|Enterex|enterex
381802|NCT01952847|Glutapak-10|glutapak-10
381803|NCT01952847|NutreStore|nutrestore
381804|NCT01952847|Resource|resource
381805|NCT01952847|GlutaSolve|glutasolve
381806|NCT01952847|Sympt-X G.I.|sympt-x g.i.
381807|NCT01952847|Sympt-X|sympt-x
381808|NCT01952847|Questionnaires|questionnaires
381809|NCT01952847|Surveys|surveys
381810|NCT01952834|coronary artery disease|coronary artery disease
381811|NCT01952834|probiotic|probiotic
381812|NCT01952834|endothelial function|endothelial function
381813|NCT01952834|brachial artery|brachial artery
381814|NCT01952834|ntric oxide|ntric oxide
381815|NCT01952821|Head and Neck Cancer|head and neck cancer
381816|NCT01952821|Physical function|physical function
381817|NCT01952821|Cancer Related Fatigue|cancer related fatigue
381818|NCT01952821|Gait Speed|gait speed
381819|NCT01952821|6MWT|6mwt
381820|NCT01952821|10-Meter Walk Test|10-meter walk test
381821|NCT01952821|30-Second Chair Stand|30-second chair stand
381822|NCT01952821|Linear Analog Scale of Function|linear analog scale of function
381823|NCT01952821|Modified Brief Fatigue Inventory|modified brief fatigue inventory
381824|NCT01952769|anti PD1,diffuse pontine glioma|anti pd1,diffuse pontine glioma
381825|NCT01952756|cilostazol|cilostazol
381826|NCT01952756|endothelial progenitor cells|endothelial progenitor cells
381827|NCT01952756|vasculogenesis|vasculogenesis
381828|NCT01952756|angiogenesis|angiogenesis
381829|NCT01952756|peripheral arterial disease|peripheral arterial disease
381830|NCT01952756|biomarkers|biomarkers
381831|NCT01952743|Atrial Fibrillation|atrial fibrillation
381832|NCT01952743|Hypertension|hypertension
381833|NCT01952743|Renal Denervation|renal denervation
381834|NCT01952730|Stage IV|stage iv
381835|NCT01952730|Hepatic Lesions|hepatic lesions
381836|NCT01952691|hallux valgus|hallux valgus
381837|NCT01952691|pain|pain
381838|NCT01952691|conservative|conservative
381839|NCT01952691|treatment|treatment
381840|NCT01952678|DaTscan|datscan
381841|NCT01952678|Parkinson's Disease|parkinson's disease
381842|NCT01952652|Naproxen-codeine|naproxen-codeine
381843|NCT01952652|preemptive analgesia|preemptive analgesia
381844|NCT01952652|day case surgery|day case surgery
381845|NCT01952626|intrathecal|intrathecal
381846|NCT01952626|morphine|morphine
381847|NCT01952626|ondansetron|ondansetron
381848|NCT01952626|palonosetron|palonosetron
381849|NCT01952626|pruritus|pruritus
381850|NCT01952613|Foot drop|foot drop
381851|NCT01952613|Functional Electrical Stimulation|functional electrical stimulation
381852|NCT01952600|Chronic Kidney Disease|chronic kidney disease
381853|NCT01952600|Hemodialysis|hemodialysis
381854|NCT01952600|Peritoneal Dialysis|peritoneal dialysis
381855|NCT01952574|migraine, headache, prevention, prophylaxis|migraine, headache, prevention, prophylaxis
381856|NCT01952561|pharmacokinetics|pharmacokinetics
381857|NCT01952561|vaginal ring|vaginal ring
381858|NCT01952522|Resistance training|resistance training
381859|NCT01952522|Walking|walking
381860|NCT01952522|Weight bearing|weight bearing
381861|NCT01952496|Cerebral Palsy|cerebral palsy
381862|NCT01952496|Non ambulatory|non ambulatory
381863|NCT01952496|Neuromuscular disability|neuromuscular disability
381864|NCT01952496|Children|children
381865|NCT01952483|Multiple Sclerosis (MS)|multiple sclerosis (ms)
381866|NCT01952470|Lung transplantation|lung transplantation
381867|NCT01952470|Respiratory Tract Infections|respiratory tract infections
381868|NCT01952470|Respiratory Therapy|respiratory therapy
381869|NCT01952470|Isotonic Solutions|isotonic solutions
381870|NCT01952470|Sodium Chloride|sodium chloride
381871|NCT01952470|Postoperative complications|postoperative complications
381872|NCT01952470|Postoperative care|postoperative care
381873|NCT01952470|dornase alfa|dornase alfa
381874|NCT01952444|monoclonal antibody, ETI-204, ciprofloxacin, safety, PK|monoclonal antibody, eti-204, ciprofloxacin, safety, pk
381875|NCT01952431|Total Lung Capacity|total lung capacity
381876|NCT01952392|Effectiveness study|effectiveness study
381877|NCT01952392|Acute coronary Syndrome|acute coronary syndrome
381878|NCT01952392|Real-life|real-life
381879|NCT01952392|France|france
488309|NCT01478971|Hgb|hgb
381880|NCT01952379|Melasma|melasma
381881|NCT01952379|Lymphocytes|lymphocytes
381882|NCT01952379|Macrophages|macrophages
381883|NCT01952379|Mast cells|mast cells
381884|NCT01952379|Interleukin 17|interleukin 17
381885|NCT01952379|COX-2|cox-2
381886|NCT01952379|Inflammation|inflammation
381887|NCT01952366|Aged|aged
381888|NCT01952366|Depression|depression
381889|NCT01952366|Cognition|cognition
381890|NCT01952366|Longitudinal study|longitudinal study
381891|NCT01952353|Hepatocellular Carcinoma; Transarterial Chemoembolization; Hepatic Resection; Portal Vein Tumor Thrombosis|hepatocellular carcinoma; transarterial chemoembolization; hepatic resection; portal vein tumor thrombosis
381892|NCT01952301|Autologous; Collagen Matrix; Keratinized Tissue|autologous; collagen matrix; keratinized tissue
381893|NCT01952262|ultrasound|ultrasound
381894|NCT01952262|diaphragm|diaphragm
381895|NCT01952262|intensive care|intensive care
381896|NCT01952262|critical care|critical care
381897|NCT01952249|Ovarian|ovarian
381898|NCT01952249|Primary Peritoneal|primary peritoneal
381899|NCT01952249|Fallopian Tube Cancer|fallopian tube cancer
381900|NCT01952236|Smoking|smoking
381901|NCT01952236|Quit|quit
381902|NCT01952236|Tobacco|tobacco
381903|NCT01952236|Abstinence|abstinence
381904|NCT01952236|Adult|adult
381905|NCT01952236|Text Messaging|text messaging
381906|NCT01952236|Web-based|web-based
381907|NCT01952236|Mobile phone|mobile phone
381908|NCT01952236|smartphone|smartphone
381909|NCT01952236|internet|internet
381911|NCT01952223|adenocarcinome|adenocarcinome
381912|NCT01952223|prostate|prostate
381913|NCT01952223|relapse|relapse
381914|NCT01952223|Radiotherapy|radiotherapy
381915|NCT01952223|Androgen Deprivation Therapy|androgen deprivation therapy
381916|NCT01952223|Cabazitaxel|cabazitaxel
381917|NCT01952197|Passive Leg Raise|passive leg raise
381918|NCT01952197|Cardiac arrest|cardiac arrest
381919|NCT01952197|Survival after CPR|survival after cpr
381920|NCT01952184|vitrification|vitrification
381921|NCT01952184|oocyte|oocyte
381922|NCT01952184|donor|donor
381923|NCT01952184|open|open
381924|NCT01952184|closed|closed
381925|NCT01952171|Genomics|genomics
381926|NCT01952171|Birth Defects|birth defects
381927|NCT01952171|Congenital Heart Disease|congenital heart disease
381928|NCT01952158|Multidrug-Resistant Organisms|multidrug-resistant organisms
381929|NCT01952158|Hospital Infection|hospital infection
381930|NCT01952158|Colonization|colonization
381931|NCT01952158|Healthcare Personnel|healthcare personnel
381932|NCT01952132|Schizophrenia|schizophrenia
381933|NCT01952119|hypertension|hypertension
381934|NCT01952106|venepuncture|venepuncture
381935|NCT01952106|distraction|distraction
381936|NCT01952106|distress|distress
381937|NCT01952093|Early intervention|early intervention
381938|NCT01952093|Mother-child interaction|mother-child interaction
381939|NCT01952093|Neurodevelopment|neurodevelopment
381940|NCT01952093|Parenting|parenting
381941|NCT01952093|Prematurity|prematurity
381942|NCT01952093|School age|school age
381943|NCT01952080|SBS|sbs
381944|NCT01952080|Pediatric SBS|pediatric sbs
381945|NCT01952080|Short Bowel Syndrome|short bowel syndrome
381946|NCT01952067|Hip Prosthesis|hip prosthesis
381947|NCT01952067|surgery|surgery
381948|NCT01952067|cements|cements
381949|NCT01952067|Radiostereometric Analysis|radiostereometric analysis
381950|NCT01952054|Breast cancer|breast cancer
381951|NCT01952054|Breast carcinoma|breast carcinoma
381952|NCT01952054|Bone metastasis|bone metastasis
381953|NCT01952054|Cancer that has spread to the bone|cancer that has spread to the bone
381954|NCT01952054|Denosumab|denosumab
381955|NCT01952054|AMG 162|amg 162
381956|NCT01952054|Prolia|prolia
381957|NCT01952054|Hormonal agent|hormonal agent
381958|NCT01952041|Schizophrenia|schizophrenia
381959|NCT01952041|Schizoaffective Disorder|schizoaffective disorder
381960|NCT01952041|Mobile Application|mobile application
381961|NCT01952041|Relapse|relapse
381962|NCT01952041|SMI|smi
381963|NCT01952041|EHealth|ehealth
381964|NCT01952041|E-Health|e-health
381965|NCT01952041|Health Technology|health technology
381966|NCT01952041|mHealth|mhealth
381967|NCT01952041|m-Health|m-health
381968|NCT01952041|Mobile Health|mobile health
381969|NCT01952041|Serious Mental Illness|serious mental illness
381970|NCT01952041|Electronic Health|electronic health
381971|NCT01952028|MDC1A|mdc1a
381972|NCT01952028|Congenital Muscular Dystrophy|congenital muscular dystrophy
381973|NCT01952028|Merosin Deficient|merosin deficient
381974|NCT01952028|LAMA2|lama2
381975|NCT01952028|brain white matter abnormalities|brain white matter abnormalities
381976|NCT01952028|Seizure|seizure
381977|NCT01952015|generalized pustular psoriasis|generalized pustular psoriasis
381978|NCT01952015|skin condition|skin condition
381979|NCT01952015|skin disease,|skin disease,
381980|NCT01952002|Blood Pressure|blood pressure
381981|NCT01952002|heart rate|heart rate
381982|NCT01952002|electrocardiogram|electrocardiogram
381983|NCT01952002|Cardiac arrhythmias|cardiac arrhythmias
381984|NCT01952002|respiratory exercise|respiratory exercise
381985|NCT01951989|Gaucher disease|gaucher disease
381986|NCT01951989|Imiglucerase|imiglucerase
381987|NCT01951989|Pharmacokinetics|pharmacokinetics
381988|NCT01951976|breast|breast
381989|NCT01951976|carcinoma|carcinoma
381990|NCT01951976|stage 0-III breast cancer|stage 0-iii breast cancer
381991|NCT01951976|post-menopausal|post-menopausal
381992|NCT01951976|aromatase inhibitor (AI)|aromatase inhibitor (ai)
381993|NCT01951976|joint pain|joint pain
381994|NCT01951976|AI-associated joint pain|ai-associated joint pain
381995|NCT01951963|pain management|pain management
381996|NCT01951963|ketamine|ketamine
381997|NCT01951963|morphine|morphine
381998|NCT01951963|pediatrics|pediatrics
381999|NCT01951963|emergency medicine|emergency medicine
382000|NCT01951937|Cognitive Test|cognitive test
382001|NCT01951937|Omega-3 Fatty acids|omega-3 fatty acids
382002|NCT01951924|Multifocal Motor Neuropathy|multifocal motor neuropathy
382003|NCT01951911|Pain Management|pain management
382004|NCT01951911|Ketamine|ketamine
382005|NCT01951911|Palliative care|palliative care
382006|NCT01951898|asthma|asthma
382007|NCT01951898|regulatory T cells|regulatory t cells
382008|NCT01951898|leukotriene antagonist|leukotriene antagonist
382009|NCT01951872|caffeine dependence|caffeine dependence
382010|NCT01951872|caffeine withdrawal|caffeine withdrawal
382011|NCT01951872|caffeine use disorder|caffeine use disorder
382012|NCT01951833|Lung clearance index (LCI)|lung clearance index (lci)
382013|NCT01951807|Psychosocial Effects of Cancer and Treatment|psychosocial effects of cancer and treatment
382014|NCT01951807|Coping|coping
382015|NCT01951794|HIV infected|hiv infected
382016|NCT01951794|HIV exposed|hiv exposed
382017|NCT01951794|HIV-free|hiv-free
382018|NCT01951781|marker CD64|marker cd64
382019|NCT01951781|blood sample|blood sample
382020|NCT01951781|nosocomial infection|nosocomial infection
382021|NCT01951781|preterm newborn|preterm newborn
382022|NCT01951755|Inoperable NSCLC|inoperable nsclc
382023|NCT01951755|TKIs|tkis
382024|NCT01951742|wrinkles|wrinkles
382025|NCT01951729|Blood sugar|blood sugar
382026|NCT01951729|GIP|gip
382027|NCT01951729|Xenin-25|xenin-25
382028|NCT01951729|Cholinergic Signaling|cholinergic signaling
382029|NCT01951729|Atropine|atropine
382030|NCT01951729|Insulin|insulin
382031|NCT01951729|Glucagon|glucagon
382032|NCT01951729|Pancreatic polypeptide|pancreatic polypeptide
382033|NCT01951716|Vagotomy|vagotomy
382034|NCT01951716|Vagus Nerve|vagus nerve
382035|NCT01951716|Xenin-25|xenin-25
382036|NCT01951716|GIP|gip
382037|NCT01951716|Insulin Secretion|insulin secretion
382038|NCT01951716|Glucagon Secretion|glucagon secretion
382039|NCT01951716|Gastric Emptying|gastric emptying
382040|NCT01951690|Focal Adhesion Kinase inhibitor|focal adhesion kinase inhibitor
382041|NCT01951690|FAK inhibitor|fak inhibitor
382042|NCT01951690|Cancer Stem Cells|cancer stem cells
382043|NCT01951690|CSC|csc
382044|NCT01951690|KRAS mutation|kras mutation
382045|NCT01951677|hepatitis B virus|hepatitis b virus
382046|NCT01951677|vaccine|vaccine
382047|NCT01951677|adjuvant|adjuvant
382048|NCT01951677|prophylaxis|prophylaxis
382049|NCT01951651|Diabetes|diabetes
382050|NCT01951638|Worsening Heart Failure|worsening heart failure
382051|NCT01951638|Heart Failure with Preserved Ejection Fraction|heart failure with preserved ejection fraction
382052|NCT01951625|Worsening Heart Failure|worsening heart failure
382053|NCT01951625|Heart Failure with Reduced Ejection Fraction|heart failure with reduced ejection fraction
382054|NCT01951612|cognitive impairment|cognitive impairment
382055|NCT01951612|ischemic white matter disease|ischemic white matter disease
382056|NCT01951612|small vessel disease|small vessel disease
382057|NCT01951612|transient ischemic attack|transient ischemic attack
382058|NCT01951612|mild stroke|mild stroke
382059|NCT01951612|stroke risk|stroke risk
382190|NCT01951001|Acute Coronary Syndrome, Asians, platelet, prasugrel|acute coronary syndrome, asians, platelet, prasugrel
382060|NCT01951599|Phase I, healthy, bioavailability, pharmacokinetics, safety, tolerability.|phase i, healthy, bioavailability, pharmacokinetics, safety, tolerability.
382061|NCT01951573|contact lenses|contact lenses
382062|NCT01951573|multifocal|multifocal
382063|NCT01951573|daily disposable|daily disposable
382064|NCT01951573|silicone hydrogel|silicone hydrogel
382065|NCT01951573|presbyopia|presbyopia
382066|NCT01951547|HbA1c|hba1c
382067|NCT01951547|hs-CRP|hs-crp
382068|NCT01951547|non-surgical periodontal therapy|non-surgical periodontal therapy
382069|NCT01951547|oral health education|oral health education
382070|NCT01951547|probing pocket depth|probing pocket depth
382071|NCT01951547|plaque index|plaque index
382072|NCT01951547|gingival bleeding index.|gingival bleeding index.
382073|NCT01951534|breast reconstruction|breast reconstruction
382074|NCT01951521|Rectal cancer|rectal cancer
382075|NCT01951521|Locally advanced rectal cancer|locally advanced rectal cancer
382076|NCT01951521|Radiotherapy|radiotherapy
382077|NCT01951521|Boost|boost
382078|NCT01951521|Dose-escalation|dose-escalation
382079|NCT01951521|Pathological complete response|pathological complete response
382080|NCT01951521|Response|response
382081|NCT01951508|Methylphenidate|methylphenidate
382082|NCT01951508|Modafinil|modafinil
382083|NCT01951508|MDMA|mdma
382084|NCT01951508|fMRI|fmri
382085|NCT01951508|emotion-processing|emotion-processing
382086|NCT01951508|social cognition|social cognition
382087|NCT01951456|Smoking cessation|smoking cessation
382088|NCT01951456|resistance training|resistance training
382089|NCT01951443|ginseng|ginseng
382090|NCT01951443|clinical trial|clinical trial
382091|NCT01951443|vascular|vascular
382092|NCT01951443|ginsenosides|ginsenosides
382093|NCT01951443|blood pressure|blood pressure
382094|NCT01951430|Adult patients|adult patients
382095|NCT01951430|Infective events|infective events
382096|NCT01951430|Antibiotic|antibiotic
382097|NCT01951430|Antifungal|antifungal
382098|NCT01951430|Myelodysplastic syndrome|myelodysplastic syndrome
382099|NCT01951404|Left Ventricular Hypertrophy|left ventricular hypertrophy
382100|NCT01951404|Allopurinol|allopurinol
382101|NCT01951404|End Stage Renal Disease|end stage renal disease
382102|NCT01951404|Haemodialysis|haemodialysis
382103|NCT01951404|Renal Replacement Therapy|renal replacement therapy
382104|NCT01951404|MRI|mri
382105|NCT01951391|study|study
382106|NCT01951391|subjects|subjects
382107|NCT01951378|Asthma|asthma
382108|NCT01951378|Asthma exacerbation|asthma exacerbation
382109|NCT01951365|Schwannoma|schwannoma
382110|NCT01951365|Growth|growth
382111|NCT01951365|intradural|intradural
382112|NCT01951365|natural history|natural history
382113|NCT01951352|study|study
382114|NCT01951352|meant|meant
382115|NCT01951352|individuals|individuals
382116|NCT01951339|diabetes|diabetes
382117|NCT01951339|type 2 diabetes|type 2 diabetes
382118|NCT01951339|exercise|exercise
382119|NCT01951339|echo|echo
382120|NCT01951339|heart|heart
382121|NCT01951339|sitagliptin|sitagliptin
382122|NCT01951339|glimepiride|glimepiride
382123|NCT01951339|cardiovascular|cardiovascular
382124|NCT01951326|Crohn's Disease|crohn's disease
382125|NCT01951326|moderate to severe|moderate to severe
382126|NCT01951326|remission|remission
382127|NCT01951326|MAP|map
382128|NCT01951326|antibiotic|antibiotic
382129|NCT01951313|Meal tolerance test focusing on carotenoids absorption|meal tolerance test focusing on carotenoids absorption
382130|NCT01951261|Telemonitoring|telemonitoring
382131|NCT01951261|COPD|copd
382132|NCT01951261|Home care|home care
382133|NCT01951248|chronic kidney disease|chronic kidney disease
382134|NCT01951248|obstructive sleep apnea|obstructive sleep apnea
382135|NCT01951248|24-h blood pressure|24-h blood pressure
382136|NCT01951248|central blood pressure|central blood pressure
382137|NCT01951248|peripheral blood pressure|peripheral blood pressure
382138|NCT01951222|Asthma, COPD, broncodilator, airway, lung, inhalation, antimuscarinic|asthma, copd, broncodilator, airway, lung, inhalation, antimuscarinic
382139|NCT01951209|Human|human
382140|NCT01951209|Hepatitis C|hepatitis c
382141|NCT01951209|Cirrhosis|cirrhosis
382142|NCT01951209|B-cell|b-cell
382143|NCT01951209|Rifaximin|rifaximin
382144|NCT01951196|Chronic kidney disease|chronic kidney disease
382145|NCT01951196|24 hour blood pressure|24 hour blood pressure
382146|NCT01951196|central blood pressure|central blood pressure
382147|NCT01951196|peripheral blood pressure|peripheral blood pressure
382148|NCT01951196|obstructive sleep apnea|obstructive sleep apnea
382149|NCT01951144|Phase 1|phase 1
382150|NCT01951144|Single Dose|single dose
382151|NCT01951144|Pharmacokinetics|pharmacokinetics
382152|NCT01951144|Safety|safety
382153|NCT01951144|Toleration|toleration
382154|NCT01951144|Pharmacodynamics|pharmacodynamics
382155|NCT01951118|Smell|smell
382156|NCT01951118|Olfaction Disorders|olfaction disorders
382157|NCT01951118|Atropine|atropine
382158|NCT01951118|Donepezil|donepezil
382159|NCT01951118|Cholinesterase Inhibitors|cholinesterase inhibitors
382160|NCT01951118|Cognition Disorders|cognition disorders
382161|NCT01951105|Subacute|subacute
382162|NCT01951105|Back|back
382163|NCT01951105|Pain|pain
382164|NCT01951105|Brain|brain
382165|NCT01951105|MRI|mri
382166|NCT01951092|HIV|hiv
382167|NCT01951092|adherence|adherence
382168|NCT01951092|retention|retention
382169|NCT01951092|texting|texting
382170|NCT01951079|Digoxin|digoxin
382171|NCT01951079|Intra-amniotic injection|intra-amniotic injection
382172|NCT01951079|feticide|feticide
382173|NCT01951079|second trimester abortion|second trimester abortion
382174|NCT01951053|Healthy|healthy
382175|NCT01951053|Safety|safety
382176|NCT01951053|Tolerability|tolerability
382177|NCT01951053|Pharmacokinetics|pharmacokinetics
382178|NCT01951053|Pharmacodynamics|pharmacodynamics
382179|NCT01951053|JNJ-40411813|jnj-40411813
382180|NCT01951053|Positive allosteric modulator|positive allosteric modulator
382181|NCT01951040|Oxytocin, breastfeeding|oxytocin, breastfeeding
382182|NCT01951027|Safety|safety
382183|NCT01951027|Pharmacokinetics|pharmacokinetics
382184|NCT01951027|Pharmacodynamics|pharmacodynamics
382185|NCT01951027|DLT|dlt
382186|NCT01951027|Immunogenecity|immunogenecity
382187|NCT01951014|Adolescence|adolescence
382188|NCT01951014|Pregnancy|pregnancy
382189|NCT01951014|Telemedicine|telemedicine
382191|NCT01950936|Infection|infection
382192|NCT01950936|Antibiotics|antibiotics
382193|NCT01950936|COLD|cold
382194|NCT01950910|Amyotrophic lateral sclerosis|amyotrophic lateral sclerosis
382195|NCT01950910|motor neuron disease|motor neuron disease
382196|NCT01950910|biological markers|biological markers
382197|NCT01950910|biomarkers|biomarkers
382198|NCT01950897|muscular dystrophies|muscular dystrophies
382199|NCT01950897|muscular dystrophy|muscular dystrophy
382200|NCT01950884|•Non-alcoholic Steatohepatitis (NASH)|•non-alcoholic steatohepatitis (nash)
382201|NCT01950871|HistoScanning|histoscanning
382202|NCT01950871|TRUS|trus
382203|NCT01950871|Prostate cancer|prostate cancer
382204|NCT01950871|Biopsy guidance|biopsy guidance
382205|NCT01950845|anesthesiology, Closed-Loop system, automated fluid management, cardiac output optimization, high risk surgical patient, major abdominal surgery|anesthesiology, closed-loop system, automated fluid management, cardiac output optimization, high risk surgical patient, major abdominal surgery
382206|NCT01950832|Structure of Retina|structure of retina
382207|NCT01950832|Macular Thickness|macular thickness
382208|NCT01950832|Retinal Nerve Fiber Layer|retinal nerve fiber layer
382209|NCT01950832|Choroidal Thickness|choroidal thickness
382210|NCT01950832|PCOS|pcos
382211|NCT01950832|Optical Coherence Tomography|optical coherence tomography
382212|NCT01950819|kidney failure|kidney failure
382213|NCT01950819|dialysis|dialysis
382214|NCT01950819|renal failure|renal failure
382215|NCT01950819|transplantation|transplantation
382216|NCT01950793|Hyaluronic acid, trigger finger|hyaluronic acid, trigger finger
382217|NCT01950780|Alopecia Areata|alopecia areata
382218|NCT01950780|Ruxolitinib|ruxolitinib
382219|NCT01950728|volunteers|volunteers
382220|NCT01950728|18 to 65 years|18 to 65 years
382221|NCT01950728|Males and Females|males and females
382222|NCT01950715|Irritable Bowel Syndrome|irritable bowel syndrome
382223|NCT01950715|Sacral Nerve Stimulation|sacral nerve stimulation
382224|NCT01950715|Gastro-colic response|gastro-colic response
382225|NCT01950715|Multimodal Stimulation|multimodal stimulation
382226|NCT01950663|Diagnostic Equipment|diagnostic equipment
382227|NCT01950663|Validation Studies|validation studies
382228|NCT01950624|Patient Registry|patient registry
382229|NCT01950624|Down Syndrome|down syndrome
382230|NCT01950611|acute promyelocytic leukemia|acute promyelocytic leukemia
382231|NCT01950611|arsenic trioxide|arsenic trioxide
382232|NCT01950611|proteasome inhibition|proteasome inhibition
382233|NCT01950611|bortezomib|bortezomib
382234|NCT01950598|Boston Keratoprosthesis type I surgery, frozen corneal graft|boston keratoprosthesis type i surgery, frozen corneal graft
382235|NCT01950585|Hydroxyurea|hydroxyurea
382236|NCT01950585|Pulmonary Hypertension|pulmonary hypertension
382237|NCT01950585|Idiopathic Pulmonary Arterial Hypertension|idiopathic pulmonary arterial hypertension
382238|NCT01950585|Familial Pulmonary Arterial Hypertension|familial pulmonary arterial hypertension
382239|NCT01950585|CD34 + Cells|cd34 + cells
382240|NCT01950572|Samples|samples
382241|NCT01950572|Biobank|biobank
382242|NCT01950572|Lung Neoplasms|lung neoplasms
382243|NCT01950572|Ovarian Neoplasms|ovarian neoplasms
382244|NCT01950559|soy allergy|soy allergy
382245|NCT01950559|food allergy|food allergy
382246|NCT01950559|pediatric|pediatric
382247|NCT01950559|adult|adult
382248|NCT01950546|silver nanoparticles|silver nanoparticles
382249|NCT01950546|antimicrobial activity|antimicrobial activity
382250|NCT01950546|toxicity|toxicity
382251|NCT01950546|biofilm|biofilm
382252|NCT01950546|cariostatic agents|cariostatic agents
382253|NCT01950533|Peanut allergy|peanut allergy
382254|NCT01950533|Milk allergy|milk allergy
382255|NCT01950533|Egg allergy|egg allergy
382256|NCT01950533|Pediatric|pediatric
382257|NCT01950533|Adult|adult
382258|NCT01950533|Food allergy|food allergy
382259|NCT01950520|Adipose Tissue|adipose tissue
382260|NCT01950520|Adult|adult
382261|NCT01950520|Resting Energy Expenditure|resting energy expenditure
382262|NCT01950520|RESPIRATORY QUOTIENT|respiratory quotient
382263|NCT01950520|BASAL METABOLIC RATE|basal metabolic rate
382264|NCT01950507|Fluconazole|fluconazole
382265|NCT01950507|Graft Versus Host Disease|graft versus host disease
382266|NCT01950507|Voriconazole|voriconazole
382267|NCT01950507|Azoles|azoles
382268|NCT01950494|hand dermatitis|hand dermatitis
382269|NCT01950494|health care workers|health care workers
382270|NCT01950494|hand sanitizer|hand sanitizer
382271|NCT01950481|LDK378|ldk378
382272|NCT01950481|pharmacokinetics|pharmacokinetics
382273|NCT01950481|hepatic impairment|hepatic impairment
382274|NCT01950468|Parkinson's Disease|parkinson's disease
382275|NCT01950455|Parkinson's Disease|parkinson's disease
382276|NCT01950442|malignant strictures|malignant strictures
382277|NCT01950442|esophageal staging|esophageal staging
382278|NCT01950429|Microbiome|microbiome
382279|NCT01950429|Sickle Cell Disease|sickle cell disease
382280|NCT01950429|Bone Marrow Transplant|bone marrow transplant
784901|NCT00311025|stroke|stroke
488819|NCT01476930|cupping|cupping
382281|NCT01950416|ST elevation myocardial infarction|st elevation myocardial infarction
382282|NCT01950416|Fibrinolysis|fibrinolysis
382283|NCT01950416|Ticagrelor|ticagrelor
382284|NCT01950416|Clopidogrel|clopidogrel
382285|NCT01950416|Platelet reactivity|platelet reactivity
382286|NCT01950377|Dopamine Transporter|dopamine transporter
382287|NCT01950377|D2 Dopamine Receptor Subtype|d2 dopamine receptor subtype
382288|NCT01950377|Dopamine|dopamine
382289|NCT01950377|Dopamine Genes|dopamine genes
382290|NCT01950377|Dopaminergic Mechanisms|dopaminergic mechanisms
382291|NCT01950364|Lymphoma|lymphoma
382292|NCT01950364|Hodgkin|hodgkin
382293|NCT01950364|Anaplastic Large-cell|anaplastic large-cell
382294|NCT01950364|Relapsed|relapsed
382295|NCT01950364|Refractory|refractory
382296|NCT01950364|Antigens, CD30|antigens, cd30
382297|NCT01950364|Antibody-Drug Conjugate|antibody-drug conjugate
382298|NCT01950364|Antibodies, Monoclonal|antibodies, monoclonal
382299|NCT01950364|Lymphoma, Non-Hodgkin|lymphoma, non-hodgkin
382300|NCT01950364|Lymphoma, Large-Cell, Anaplastic|lymphoma, large-cell, anaplastic
382301|NCT01950364|Monomethyl auristatin E|monomethyl auristatin e
382302|NCT01950364|Drug Therapy|drug therapy
382303|NCT01950364|Immunotherapy|immunotherapy
382304|NCT01950364|Hematologic Diseases|hematologic diseases
382305|NCT01950325|HIV-1 Viral Load|hiv-1 viral load
382306|NCT01950325|CD4 Count|cd4 count
382307|NCT01950325|Antiviral|antiviral
382308|NCT01950325|HIV-1 Infection|hiv-1 infection
382309|NCT01950325|Broadly Neutralizing Antibody|broadly neutralizing antibody
382310|NCT01950312|Autoimmune Inner Ear Disease|autoimmune inner ear disease
382311|NCT01950312|Inner Ear Disease|inner ear disease
382312|NCT01950312|Meniere's Disease|meniere's disease
382313|NCT01950312|Sudden Sensorineural Hearing Loss|sudden sensorineural hearing loss
382314|NCT01950286|T-cell Acute Lymphoblastic Leukemia|t-cell acute lymphoblastic leukemia
382315|NCT01950286|chemotherapy|chemotherapy
382316|NCT01950286|allogeneic stem cell transplantation|allogeneic stem cell transplantation
382520|NCT01949324|MacTel|mactel
382317|NCT01950260|Graves' disease|graves' disease
382318|NCT01950260|Radioactive iodine|radioactive iodine
382319|NCT01950260|Hypothyroidism|hypothyroidism
382320|NCT01950221|Double-blind Trial|double-blind trial
382321|NCT01950221|Placebo-controlled|placebo-controlled
382322|NCT01950221|Pomegranate|pomegranate
382323|NCT01950221|Memory|memory
382324|NCT01950221|Memory Impairment|memory impairment
382325|NCT01950221|Cognition|cognition
382326|NCT01950221|Ages 50-75|ages 50-75
382327|NCT01950208|Assessment|assessment
382328|NCT01950195|Melanoma|melanoma
382329|NCT01950195|Metastases|metastases
382330|NCT01950195|Brain|brain
382331|NCT01950195|Spine|spine
382332|NCT01950195|SRS(Stereotactic Radiosurgery))|srs(stereotactic radiosurgery))
382333|NCT01950195|Ipilimumab|ipilimumab
382334|NCT01950182|Luminal B2 subtype|luminal b2 subtype
382335|NCT01950182|First line treatment|first line treatment
382336|NCT01950169|Hip fracture|hip fracture
382337|NCT01950169|Nutritional supplement|nutritional supplement
382338|NCT01950169|Bisphosphonates|bisphosphonates
382339|NCT01950169|Bone mineral density|bone mineral density
382340|NCT01950169|Body composition|body composition
382341|NCT01950143|prostate cancer prevention|prostate cancer prevention
382342|NCT01950143|diet|diet
382343|NCT01950143|global gene expression|global gene expression
382344|NCT01950143|metabolic changes|metabolic changes
382345|NCT01950130|IABP|iabp
382346|NCT01950130|IABC|iabc
382347|NCT01950130|coronary artery disease|coronary artery disease
382348|NCT01950130|prophylactic|prophylactic
382349|NCT01950130|cardiac assist|cardiac assist
382350|NCT01950117|nonpedunculated|nonpedunculated
382351|NCT01950117|neoplastic|neoplastic
382352|NCT01950117|colorectal|colorectal
382353|NCT01950117|polyps|polyps
382354|NCT01950104|Embryo biopsy|embryo biopsy
382355|NCT01950104|Blastocyst stage|blastocyst stage
382356|NCT01950104|Day 3|day 3
382357|NCT01950104|Preimplantation genetic screening|preimplantation genetic screening
382358|NCT01950091|low back pain|low back pain
382359|NCT01950091|internet|internet
382360|NCT01950091|app|app
382361|NCT01950091|prevention|prevention
382362|NCT01950091|treatment|treatment
382363|NCT01950078|gene polymorphism|gene polymorphism
382364|NCT01950078|pain perception|pain perception
382365|NCT01950078|postoperative pain|postoperative pain
382366|NCT01950052|VLCD|vlcd
382367|NCT01950052|Low calorie diet|low calorie diet
382368|NCT01950052|very low calorie diet|very low calorie diet
382369|NCT01950052|pre-operative diet|pre-operative diet
382370|NCT01950052|liver shrinking diet|liver shrinking diet
382371|NCT01950052|bariatric surgery|bariatric surgery
382372|NCT01950052|gastric bypass|gastric bypass
382373|NCT01950039|Obesity|obesity
382374|NCT01950039|Glucose Intolerance|glucose intolerance
382375|NCT01950026|skin temperature|skin temperature
382376|NCT01950026|ethnic groups|ethnic groups
382377|NCT01950026|cryotherapy|cryotherapy
382378|NCT01950013|Presbycusis|presbycusis
382379|NCT01950013|Aging|aging
382380|NCT01950013|hearing aids|hearing aids
382381|NCT01950013|hearing training|hearing training
382382|NCT01950000|Pain. Analgesia. Prevention|pain. analgesia. prevention
382383|NCT01949974|Palliative Chemotherapy|palliative chemotherapy
382384|NCT01949974|Integral Attention Program|integral attention program
382385|NCT01949974|Advanced cancer|advanced cancer
382386|NCT01949974|Randomized Clinical Trial|randomized clinical trial
382387|NCT01949961|intervention|intervention
382388|NCT01949961|sonothrombolysis|sonothrombolysis
382389|NCT01949961|Ultrasound treatment|ultrasound treatment
382390|NCT01949948|treatment, intervention, thrombolysis|treatment, intervention, thrombolysis
382391|NCT01949935|Mupirocin|mupirocin
382392|NCT01949935|Surgical Site Infections|surgical site infections
382393|NCT01949935|Coronary Artery Bypass Grafting|coronary artery bypass grafting
382394|NCT01949922|regenerative medicine|regenerative medicine
382395|NCT01949922|fecal incontinence|fecal incontinence
382396|NCT01949922|muscle fiber injection|muscle fiber injection
382397|NCT01949909|plasmodium falciparum|plasmodium falciparum
382398|NCT01949909|long synthetic peptide|long synthetic peptide
382399|NCT01949909|antibody|antibody
382400|NCT01949909|T cell|t cell
382401|NCT01949909|cytokine|cytokine
382402|NCT01949909|vaccine|vaccine
382403|NCT01949909|safety|safety
382404|NCT01949909|phase 1|phase 1
382405|NCT01949896|Pro inflammatory cytokine|pro inflammatory cytokine
382406|NCT01949896|Necrotizing enterocolitis|necrotizing enterocolitis
382407|NCT01949896|Packed red blood cell transfusion|packed red blood cell transfusion
382408|NCT01949883|Phase 1|phase 1
382409|NCT01949883|Oncology|oncology
382410|NCT01949883|BET Inhibitor|bet inhibitor
382411|NCT01949857|Hepatitis A|hepatitis a
382412|NCT01949857|Vaccine|vaccine
382413|NCT01949857|Safety|safety
382414|NCT01949857|efficacy|efficacy
382415|NCT01949844|MRI|mri
382416|NCT01949844|Magnetic Resonance Imaging|magnetic resonance imaging
382417|NCT01949844|myocardial perfusion|myocardial perfusion
382418|NCT01949844|myocardial perfusion imaging|myocardial perfusion imaging
382419|NCT01949844|Novel MRI Techniques|novel mri techniques
382420|NCT01949831|functional assessment|functional assessment
382421|NCT01949831|acute care|acute care
382422|NCT01949831|older medical patients|older medical patients
382423|NCT01949779|Coil embolization|coil embolization
382424|NCT01949779|TransForm™ Occlusion Balloon Catheter|transform™ occlusion balloon catheter
382425|NCT01949779|Registry|registry
382426|NCT01949779|Neurointerventional procedures|neurointerventional procedures
382427|NCT01949753|Obsessive-compulsive disorder (OCD)|obsessive-compulsive disorder (ocd)
382428|NCT01949753|Exposure therapy|exposure therapy
382429|NCT01949753|Extinction learning|extinction learning
382430|NCT01949753|Pregnenolone|pregnenolone
382431|NCT01949727|AECOPD|aecopd
382432|NCT01949727|COPD|copd
382433|NCT01949727|Emphysema|emphysema
382434|NCT01949727|Chronic bronchitis|chronic bronchitis
382435|NCT01949675|Cholera|cholera
382436|NCT01949675|Shanchol™|shanchol™
382437|NCT01949675|Cholera Vaccine|cholera vaccine
382438|NCT01949662|Advanced Cancers|advanced cancers
382439|NCT01949662|Locally advanced cancer|locally advanced cancer
382440|NCT01949662|Metastatic cancer|metastatic cancer
382441|NCT01949662|Recurrent cancer|recurrent cancer
382442|NCT01949662|Incurable cancer|incurable cancer
382443|NCT01949662|Delirium|delirium
382444|NCT01949662|Agitation|agitation
382445|NCT01949662|Lorazepam|lorazepam
382446|NCT01949662|Haloperidol|haloperidol
382447|NCT01949662|Placebo|placebo
382448|NCT01949662|Questionnaires|questionnaires
382449|NCT01949662|Surveys|surveys
382450|NCT01949662|Acute palliative care unit|acute palliative care unit
382451|NCT01949649|body image|body image
382452|NCT01949649|body dissatisfaction|body dissatisfaction
382453|NCT01949623|RP|rp
382454|NCT01949610|Healthy Participants|healthy participants
382455|NCT01949610|JNJ26489112|jnj26489112
382456|NCT01949610|14C-JNJ26489112|14c-jnj26489112
382457|NCT01949610|Absorption|absorption
382458|NCT01949610|Metabolism|metabolism
382459|NCT01949610|Excretion|excretion
382460|NCT01949571|Mirtazapine.|mirtazapine.
382461|NCT01949571|Addiction.|addiction.
382462|NCT01949571|Cocaine.|cocaine.
382463|NCT01949571|Cocaine-craving.|cocaine-craving.
382464|NCT01949571|Cocaine-withdrawal|cocaine-withdrawal
382465|NCT01949558|diet|diet
382466|NCT01949558|lifestyle|lifestyle
382467|NCT01949519|prostate cancer|prostate cancer
382468|NCT01949519|lycopene|lycopene
382469|NCT01949519|docetaxel|docetaxel
382470|NCT01949519|metastatic|metastatic
382471|NCT01949519|castration resistant|castration resistant
382472|NCT01949506|Lung metastases|lung metastases
382473|NCT01949506|Radiation Therapy|radiation therapy
382474|NCT01949506|Stereotactic Body Radiation Therapy|stereotactic body radiation therapy
382475|NCT01949493|carpal tunnel syndrome|carpal tunnel syndrome
382476|NCT01949493|traction|traction
382477|NCT01949493|mechanical traction|mechanical traction
382478|NCT01949493|Phystrac|phystrac
785430|NCT00309062|Allergy|allergy
382479|NCT01949480|Peripheral nerve block|peripheral nerve block
382480|NCT01949480|Ultrasound guidance|ultrasound guidance
382481|NCT01949480|Postoperative pain management post status thoracotomy|postoperative pain management post status thoracotomy
382482|NCT01949480|Postoperative pain management post status VATS|postoperative pain management post status vats
382483|NCT01949467|ferroportin disease|ferroportin disease
382484|NCT01949467|dysmetabolic hepatosiderosis|dysmetabolic hepatosiderosis
382485|NCT01949467|genetic hemochromatosis|genetic hemochromatosis
382486|NCT01949467|hyperferritinemia|hyperferritinemia
382487|NCT01949467|hepcidin|hepcidin
382488|NCT01949467|iron fumarate|iron fumarate
382489|NCT01949467|physiopathological study|physiopathological study
382490|NCT01949467|diagnosis|diagnosis
382491|NCT01949467|HFE gene|hfe gene
382492|NCT01949467|TRF2 gene|trf2 gene
382493|NCT01949467|iron parameters|iron parameters
382494|NCT01949467|divalent cations|divalent cations
382495|NCT01949454|trachoma|trachoma
382496|NCT01949454|trichiasis|trichiasis
382497|NCT01949454|trachomatous trichiasis|trachomatous trichiasis
382498|NCT01949454|bilamellar tarsal rotation|bilamellar tarsal rotation
382499|NCT01949454|fluorometholone|fluorometholone
382500|NCT01949454|placebo controlled|placebo controlled
382501|NCT01949441|HDM Allergy|hdm allergy
382502|NCT01949441|Rhinoconjunctivitis|rhinoconjunctivitis
382503|NCT01949441|Immunotherapy|immunotherapy
382504|NCT01949441|ToleroMune HDM|toleromune hdm
382505|NCT01949428|HDM Allergy|hdm allergy
382506|NCT01949428|Rhinoconjunctivitis|rhinoconjunctivitis
382507|NCT01949415|House Dust Mite|house dust mite
382508|NCT01949415|Rhinoconjunctivitis|rhinoconjunctivitis
382509|NCT01949415|ToleroMune|toleromune
382510|NCT01949376|breast cancer|breast cancer
382511|NCT01949376|invasive ductal carcinoma|invasive ductal carcinoma
382512|NCT01949376|cognitive impairment|cognitive impairment
382513|NCT01949376|adjuvant therapy|adjuvant therapy
382514|NCT01949376|hormone therapy|hormone therapy
382515|NCT01949376|hormonal therapy|hormonal therapy
382516|NCT01949376|chemotherapy|chemotherapy
382517|NCT01949376|chemo brain|chemo brain
382518|NCT01949376|MRI|mri
382519|NCT01949363|Gonococcal Infections, Cefixime, Neisseria gonorrhoeae, Azithromycin, antibiotic, cephalosporin|gonococcal infections, cefixime, neisseria gonorrhoeae, azithromycin, antibiotic, cephalosporin
382521|NCT01949298|immediate loading of dental implant|immediate loading of dental implant
382522|NCT01949298|implant supported over denture|implant supported over denture
382523|NCT01949285|Spinal cord injury|spinal cord injury
382524|NCT01949285|Paralysis|paralysis
382525|NCT01949285|Rehabilitation|rehabilitation
382526|NCT01949285|Assessment|assessment
382527|NCT01949285|Theranostics|theranostics
382529|NCT01949259|Retrospective|retrospective
382530|NCT01949259|Lung cancer|lung cancer
382531|NCT01949246|Biomarkers|biomarkers
382532|NCT01949220|Inherited|inherited
382533|NCT01949220|Von Willebrand disease|von willebrand disease
382534|NCT01949220|Von Willebrand factor|von willebrand factor
382535|NCT01949220|Deficiency|deficiency
382536|NCT01949220|safety|safety
382537|NCT01949207|Incompetent perforating veins|incompetent perforating veins
382538|NCT01949207|EVLA|evla
382539|NCT01949207|Phlebectomies|phlebectomies
382540|NCT01949207|TRansluminal Occlusion of Perforators (TRLOP) closure of incompetent perforators.|transluminal occlusion of perforators (trlop) closure of incompetent perforators.
382541|NCT01949194|liver metastases|liver metastases
382542|NCT01949181|Metals|metals
382543|NCT01949181|Metalloids|metalloids
382544|NCT01949181|Blood|blood
382545|NCT01949181|Hair|hair
382546|NCT01949181|Lung|lung
382547|NCT01949181|Lung cancer|lung cancer
382548|NCT01949181|Chronic obstructive pulmonary disease|chronic obstructive pulmonary disease
382549|NCT01949155|otitis media|otitis media
382550|NCT01949155|otorrhea|otorrhea
382551|NCT01949155|middle ear effusion|middle ear effusion
382552|NCT01949155|tympanostomy tubes|tympanostomy tubes
382553|NCT01949142|otitis media|otitis media
382554|NCT01949142|otorrhea|otorrhea
382555|NCT01949142|middle ear effusion|middle ear effusion
382556|NCT01949142|tympanostomy tubes|tympanostomy tubes
382557|NCT01949129|stem cell transplantation|stem cell transplantation
382558|NCT01949129|children and adolescents|children and adolescents
382559|NCT01949129|high risk acute lymphoblastic leukaemia|high risk acute lymphoblastic leukaemia
382560|NCT01949103|Gram-positive|gram-positive
382561|NCT01949090|H7N1|h7n1
382562|NCT01949090|AS03 adjuvant|as03 adjuvant
382563|NCT01949090|Safety|safety
382564|NCT01949090|Immunogenicity|immunogenicity
382565|NCT01949090|Influenza|influenza
382566|NCT01949090|Adults|adults
382567|NCT01949090|Elderly adults|elderly adults
382568|NCT01949077|Hepatitis|hepatitis
382569|NCT01949077|Hepatitis C|hepatitis c
382570|NCT01949077|Observational study|observational study
382571|NCT01949077|Biomarkers of treatment response|biomarkers of treatment response
382572|NCT01949051|Allergic rhinitis|allergic rhinitis
382573|NCT01949051|levocabastine|levocabastine
382574|NCT01949051|allergen challenge|allergen challenge
382575|NCT01949038|Pain|pain
382576|NCT01949038|Discomfort|discomfort
382577|NCT01949038|Anxiety|anxiety
382578|NCT01949038|Satisfaction|satisfaction
382579|NCT01949038|Compliance|compliance
382580|NCT01949012|Midazolam|midazolam
382581|NCT01949012|Endtidal carbon dioxide|endtidal carbon dioxide
382582|NCT01949012|Desaturation|desaturation
382583|NCT01948999|electroconvulsive therapy|electroconvulsive therapy
382584|NCT01948999|treatment-refractory schizophrenia|treatment-refractory schizophrenia
382585|NCT01948973|Irritable Bowel Syndrome|irritable bowel syndrome
382586|NCT01948973|Sacral Nerve Stimulation|sacral nerve stimulation
382587|NCT01948973|Symptoms|symptoms
382588|NCT01948973|Quality of Life|quality of life
382589|NCT01948973|Bowel habits|bowel habits
382590|NCT01948960|Breast Neoplasms|breast neoplasms
382591|NCT01948960|everolimus|everolimus
382592|NCT01948960|pharmacokinetics|pharmacokinetics
382593|NCT01948960|elderly patients|elderly patients
382594|NCT01948960|obese patients|obese patients
382595|NCT01948934|Skin|skin
382596|NCT01948934|Injury|injury
382597|NCT01948934|Membrane amniotic|membrane amniotic
382598|NCT01948934|Wound|wound
382600|NCT01948921|tolerance|tolerance
382601|NCT01948921|discomfort|discomfort
382602|NCT01948908|Sedation|sedation
382603|NCT01948908|Laceration repair|laceration repair
382604|NCT01948908|Children|children
382605|NCT01948908|Intranasal|intranasal
382606|NCT01948908|Midazolam|midazolam
382607|NCT01948895|Desvenlafaxine|desvenlafaxine
382608|NCT01948895|Open-label|open-label
382609|NCT01948895|Flexible-dose|flexible-dose
382610|NCT01948895|Dysthymic disorder|dysthymic disorder
382611|NCT01948895|Anxiety disorders|anxiety disorders
382612|NCT01948895|Generalized anxiety disorder|generalized anxiety disorder
382613|NCT01948895|Social anxiety disorder|social anxiety disorder
382614|NCT01948895|Post-traumatic stress disorder|post-traumatic stress disorder
382615|NCT01948882|Birth control|birth control
382616|NCT01948869|Phoenix|phoenix
382617|NCT01948869|Mild atopic dermatitis|mild atopic dermatitis
382618|NCT01948869|efficacy|efficacy
382619|NCT01948869|safety|safety
382620|NCT01948856|Recurrent common cold|recurrent common cold
382621|NCT01948856|laryngitis|laryngitis
382622|NCT01948856|pharyngitis/tonsillitis|pharyngitis/tonsillitis
382623|NCT01948856|acute rhinitis|acute rhinitis
382624|NCT01948856|acute rhinosinusitis|acute rhinosinusitis
382625|NCT01948856|acute otitis media|acute otitis media
382626|NCT01948843|HER2 Negative Metastatic Breast Cancer|her2 negative metastatic breast cancer
382627|NCT01948830|Ranibizumab, Lucentis, choroidal neovascularization, age-related macular degeneration, treat and extend regimen|ranibizumab, lucentis, choroidal neovascularization, age-related macular degeneration, treat and extend regimen
382628|NCT01948817|Thalassemia|thalassemia
382629|NCT01948791|Alzheimer's disease|alzheimer's disease
382630|NCT01948791|ENA713|ena713
382631|NCT01948791|Chinese patients|chinese patients
382632|NCT01948791|INSTINCT|instinct
382633|NCT01948765|xenon anesthesia|xenon anesthesia
382634|NCT01948765|Off-pump coronary artery bypass graft surgery|off-pump coronary artery bypass graft surgery
382635|NCT01948752|Nutrition policy|nutrition policy
382636|NCT01948752|food labelling|food labelling
382637|NCT01948752|diet|diet
382638|NCT01948752|obesity|obesity
382639|NCT01948752|health behavior|health behavior
382640|NCT01948739|Brain machine interface|brain machine interface
382641|NCT01948739|Rehabilitation robotics|rehabilitation robotics
382642|NCT01948739|Stroke|stroke
382643|NCT01948739|Hemiparesis|hemiparesis
382644|NCT01948726|Breast cancer|breast cancer
382645|NCT01948726|Hypofractionation|hypofractionation
382646|NCT01948726|Simultaneous integrated boost|simultaneous integrated boost
382647|NCT01948726|Toxicity|toxicity
382648|NCT01948700|Motivational Interviewing|motivational interviewing
382649|NCT01948700|Problem Drinking|problem drinking
382650|NCT01948700|Adolescents|adolescents
382651|NCT01948700|Minority Health|minority health
382652|NCT01948687|real time elastography|real time elastography
382653|NCT01948687|hepatitis|hepatitis
382654|NCT01948648|plant sterols|plant sterols
382655|NCT01948648|cholesterol|cholesterol
382656|NCT01948648|colesevelam|colesevelam
382657|NCT01948648|phytosterolemia|phytosterolemia
382658|NCT01948648|fish oil|fish oil
382659|NCT01948635|tracheal cuff shape|tracheal cuff shape
382660|NCT01948635|microaspiration|microaspiration
382661|NCT01948635|pepsin|pepsin
382662|NCT01948635|ventilator-associated pneumonia|ventilator-associated pneumonia
382663|NCT01948622|Anxiety|anxiety
382664|NCT01948622|Third molar surgery|third molar surgery
382665|NCT01948622|Blood pressure|blood pressure
382666|NCT01948622|Heart rate|heart rate
382667|NCT01948622|Oxygen saturation|oxygen saturation
382668|NCT01948596|pregnant women|pregnant women
382669|NCT01948596|depression|depression
382670|NCT01948596|depressive symptoms|depressive symptoms
382671|NCT01948596|omega-3 fatty acids|omega-3 fatty acids
382672|NCT01948583|vaginal dryness|vaginal dryness
382673|NCT01948583|hyaluronic acid|hyaluronic acid
382674|NCT01948583|menopause|menopause
382675|NCT01948570|acne,comedones, oily skin|acne,comedones, oily skin
382676|NCT01948557|Breastfeeding|breastfeeding
382677|NCT01948557|Infants|infants
382678|NCT01948557|Mother to child transmission of HIV|mother to child transmission of hiv
382679|NCT01948557|Survival|survival
382680|NCT01948544|COPD|copd
382681|NCT01948544|LTOT|ltot
382682|NCT01948544|Long-Term Oxygen Therapy|long-term oxygen therapy
382683|NCT01948544|Portable Oxygen Concentrator|portable oxygen concentrator
382684|NCT01948544|Quality of Life|quality of life
382685|NCT01948544|Six Minute Walk Distance Test|six minute walk distance test
382686|NCT01948531|Antiage|antiage
382687|NCT01948518|Pulmonary hypertension|pulmonary hypertension
382688|NCT01948518|Parenchymal Lung Disease|parenchymal lung disease
382689|NCT01948518|Diffusion Capacity|diffusion capacity
382690|NCT01948505|Craniotomy|craniotomy
382691|NCT01948466|Nutrition|nutrition
382692|NCT01948466|Commercials|commercials
382693|NCT01948466|Elementary|elementary
382694|NCT01948466|Lunchroom|lunchroom
382695|NCT01948466|Fruits|fruits
382696|NCT01948466|Vegetables|vegetables
382697|NCT01948453|CAD|cad
382698|NCT01948453|CIMT|cimt
382699|NCT01948453|FMD|fmd
382700|NCT01948440|Substance abuse, early recovery, relapse prevention|substance abuse, early recovery, relapse prevention
382701|NCT01948427|UCD|ucd
382702|NCT01948427|BUPHENYL|buphenyl
382703|NCT01948427|RAVICTI|ravicti
382704|NCT01948427|Urea|urea
382705|NCT01948427|Urea cycle disorder|urea cycle disorder
382706|NCT01948427|Glycerol phenylbutyrate|glycerol phenylbutyrate
382707|NCT01948427|Benzoate|benzoate
382708|NCT01948427|Sodium phenylbutyrate|sodium phenylbutyrate
382709|NCT01948427|Ornithine transcarbamylase (OTC)|ornithine transcarbamylase (otc)
382710|NCT01948427|Argininosuccinate synthetase (ASS)|argininosuccinate synthetase (ass)
382711|NCT01948427|Argininosuccinate lyase (ASL)|argininosuccinate lyase (asl)
382712|NCT01948427|Carbamyl phosphate synthetase (CPS)|carbamyl phosphate synthetase (cps)
382713|NCT01948427|Arginine|arginine
382714|NCT01948427|Citrulline|citrulline
382715|NCT01948427|Ammonia|ammonia
382716|NCT01948414|Obesity|obesity
382717|NCT01948414|Hyperalimentation|hyperalimentation
382718|NCT01948414|Event-Related Potential|event-related potential
382719|NCT01948414|P300|p300
382720|NCT01948388|Rheumatoid arthritis|rheumatoid arthritis
382721|NCT01948375|subject blinding|subject blinding
382722|NCT01948375|placebo needle|placebo needle
382916|NCT01947413|randomized controlled trial|randomized controlled trial
382723|NCT01948336|Contrast-induced nephropathy, Dexmedetomidine, Endothelin-1|contrast-induced nephropathy, dexmedetomidine, endothelin-1
382724|NCT01948323|Pregnancy|pregnancy
382725|NCT01948323|Maternal health|maternal health
382726|NCT01948323|Newborn health|newborn health
382727|NCT01948323|Information technology|information technology
382728|NCT01948323|Health education|health education
382729|NCT01948323|Cellphone|cellphone
382730|NCT01948323|Touch screen technology|touch screen technology
382731|NCT01948323|Pregnancy outcome|pregnancy outcome
382732|NCT01948323|Low-Middle income|low-middle income
382733|NCT01948323|Nurse-led|nurse-led
382734|NCT01948323|Nutrition|nutrition
382735|NCT01948323|Exercise|exercise
382736|NCT01948284|cecal intubation time|cecal intubation time
382737|NCT01948284|water exchange|water exchange
382738|NCT01948284|pain|pain
382739|NCT01948271|Psoriasis|psoriasis
382740|NCT01948271|Trichuris suis ova|trichuris suis ova
382741|NCT01948271|T-lymphocytes|t-lymphocytes
382742|NCT01948258|Pregnancy|pregnancy
382743|NCT01948245|Catheter Related Blood Stream Infection|catheter related blood stream infection
382744|NCT01948245|Long-term intestinal Failure|long-term intestinal failure
382745|NCT01948245|Taurolidine|taurolidine
382746|NCT01948245|Catheter lock solution|catheter lock solution
382747|NCT01948245|Antimicrobial agent|antimicrobial agent
382748|NCT01948245|Home Parenteral Nutrition|home parenteral nutrition
382749|NCT01948245|Anti-infective agents|anti-infective agents
382750|NCT01948206|Sudden Cardiac Death|sudden cardiac death
382751|NCT01948206|Implantable Cardioverter-Defibrillator|implantable cardioverter-defibrillator
382752|NCT01948206|Cardiomyopathy|cardiomyopathy
382753|NCT01948206|Prolonged Paced QRS Duration|prolonged paced qrs duration
382754|NCT01948193|Diphtheria|diphtheria
382755|NCT01948193|Tetanus|tetanus
382756|NCT01948193|Whooping Cough|whooping cough
382757|NCT01948193|Hepatitis B|hepatitis b
382758|NCT01948193|Poliomyelitis|poliomyelitis
382759|NCT01948193|DTaP IPV-Hep B-PRP~T combined vaccine (Hexaxim™)|dtap ipv-hep b-prp~t combined vaccine (hexaxim™)
382760|NCT01948180|NKTCL|nktcl
382761|NCT01948180|T cell|t cell
382762|NCT01948180|CITADEL|citadel
382763|NCT01948180|Epstein-Barr Virus|epstein-barr virus
382764|NCT01948180|Natural Killer|natural killer
382765|NCT01948167|Depression|depression
382766|NCT01948167|Prevention|prevention
382767|NCT01948167|Adolescents|adolescents
382768|NCT01948154|Cerebral Palsy|cerebral palsy
382769|NCT01948154|Early Intervention|early intervention
382770|NCT01948154|Speech Function|speech function
382771|NCT01948154|Quality of Life|quality of life
382772|NCT01948128|Breast|breast
382773|NCT01948115|Breech presentation|breech presentation
382774|NCT01948115|equimolar mixture of oxygen and nitrous oxide|equimolar mixture of oxygen and nitrous oxide
382775|NCT01948115|external cephalic version|external cephalic version
382776|NCT01948102|Amyotrophic Lateral Sclerosis|amyotrophic lateral sclerosis
382777|NCT01948102|motor neuron disease|motor neuron disease
382778|NCT01948102|biological markers|biological markers
382779|NCT01948102|biomarkers|biomarkers
382780|NCT01948089|Chronic Stroke|chronic stroke
382781|NCT01948089|near transfer|near transfer
382782|NCT01948089|far transfer|far transfer
382783|NCT01948089|working memory|working memory
382784|NCT01948089|fluid intelligence|fluid intelligence
382785|NCT01948089|cognitive training|cognitive training
382786|NCT01948089|dual n-back|dual n-back
382787|NCT01948076|splenomegaly|splenomegaly
382788|NCT01948076|pleural effusion|pleural effusion
382789|NCT01948037|hydrotherapy|hydrotherapy
382790|NCT01948037|randomized controlled trial|randomized controlled trial
382791|NCT01948037|lower extremity arterial disease|lower extremity arterial disease
382792|NCT01948037|diabetes|diabetes
382793|NCT01947998|Rivaroxaban|rivaroxaban
382794|NCT01947998|Stroke Prevention in Atrial Fibrillation|stroke prevention in atrial fibrillation
382795|NCT01947998|Anticoagulants|anticoagulants
382796|NCT01947998|Hematologic Agents|hematologic agents
382797|NCT01947998|Therapeutic Uses|therapeutic uses
382798|NCT01947998|Observational|observational
382799|NCT01947998|Venous Thromboembolism|venous thromboembolism
382800|NCT01947998|Secondary Prevention of Acute Coronary Syndrome|secondary prevention of acute coronary syndrome
382801|NCT01947998|Intracranial Hemorrhages|intracranial hemorrhages
382802|NCT01947998|Gastrointestinal Hemorrhage|gastrointestinal hemorrhage
382803|NCT01947985|Rivaroxaban|rivaroxaban
382804|NCT01947985|Stroke Prevention in Atrial Fibrillation|stroke prevention in atrial fibrillation
382805|NCT01947985|Anticoagulants|anticoagulants
382806|NCT01947985|Hematologic Agents|hematologic agents
382807|NCT01947985|Therapeutic Uses|therapeutic uses
382808|NCT01947985|Observational|observational
382809|NCT01947985|Venous Thromboembolism|venous thromboembolism
382810|NCT01947985|Secondary Prevention of Acute Coronary Syndrome|secondary prevention of acute coronary syndrome
382811|NCT01947985|Intracranial Hemorrhages|intracranial hemorrhages
382812|NCT01947985|Gastrointestinal Hemorrhage|gastrointestinal hemorrhage
382813|NCT01947972|preterm neonate|preterm neonate
382814|NCT01947972|tailored fortification|tailored fortification
382815|NCT01947972|nutrition|nutrition
382816|NCT01947972|maternal breast milk composition|maternal breast milk composition
382817|NCT01947959|Rivaroxaban|rivaroxaban
382818|NCT01947959|Stroke Prevention in Atrial Fibrillation|stroke prevention in atrial fibrillation
382819|NCT01947959|Anticoagulants|anticoagulants
382820|NCT01947959|Hematologic Agents|hematologic agents
382821|NCT01947959|Therapeutic Uses|therapeutic uses
382822|NCT01947959|Observational|observational
382823|NCT01947959|Venous Thromboembolism|venous thromboembolism
382824|NCT01947959|Secondary Prevention of Acute Coronary Syndrome|secondary prevention of acute coronary syndrome
382825|NCT01947959|Intracranial Hemorrhages|intracranial hemorrhages
382826|NCT01947959|Gastrointestinal Hemorrhage|gastrointestinal hemorrhage
382827|NCT01947946|Asthma, Bronchial Diseases, Respiratory Tract Diseases, Lung Diseases, Obstructive Lung Diseases|asthma, bronchial diseases, respiratory tract diseases, lung diseases, obstructive lung diseases
382828|NCT01947920|Healthy|healthy
382829|NCT01947920|Pain|pain
382830|NCT01947920|Tramadol hydrochloride|tramadol hydrochloride
382831|NCT01947920|Tramadol HCl|tramadol hcl
382832|NCT01947920|Analgesic|analgesic
382833|NCT01947920|QT prolongation|qt prolongation
382834|NCT01947920|RWJ-26898-002|rwj-26898-002
382835|NCT01947907|Human Growth Hormone|human growth hormone
382836|NCT01947907|rhGH|rhgh
382838|NCT01947907|GHD|ghd
382839|NCT01947881|Diabetic Macular Edema|diabetic macular edema
382840|NCT01947881|anti-VEGF|anti-vegf
382841|NCT01947881|Treatment Response|treatment response
382842|NCT01947842|Smartphone|smartphone
382843|NCT01947842|adherence|adherence
382844|NCT01947842|contraceptives|contraceptives
382845|NCT01947842|college|college
382846|NCT01947842|females|females
382847|NCT01947829|hemodialysis|hemodialysis
382848|NCT01947829|dialysis dose|dialysis dose
382849|NCT01947816|Ulcerative Colitis|ulcerative colitis
382850|NCT01947803|Schizophrenia|schizophrenia
382851|NCT01947803|Paliperidone|paliperidone
382852|NCT01947803|Safety|safety
382853|NCT01947803|Effectiveness|effectiveness
382854|NCT01947803|Chinese|chinese
382855|NCT01947790|Type 2 diabetes|type 2 diabetes
382856|NCT01947790|left ventricular mass|left ventricular mass
382857|NCT01947790|pioglitazone|pioglitazone
382858|NCT01947777|Phase 1|phase 1
382859|NCT01947777|Healthy subjects|healthy subjects
382860|NCT01947777|DDI|ddi
382861|NCT01947777|CYP3A|cyp3a
382862|NCT01947764|HIV|hiv
382863|NCT01947764|Disclosure|disclosure
382864|NCT01947764|Pediatrics|pediatrics
382865|NCT01947751|Catheter related infection|catheter related infection
382866|NCT01947751|Central venous catheter|central venous catheter
382867|NCT01947751|CVC infection|cvc infection
382868|NCT01947738|Healthy|healthy
382869|NCT01947738|Subjects|subjects
382870|NCT01947738|Safety|safety
382871|NCT01947738|Tolerability|tolerability
382872|NCT01947738|VBY891|vby891
382873|NCT01947738|Maximum|maximum
382874|NCT01947738|Pharmacodynamic|pharmacodynamic
382875|NCT01947738|Pharmacokinetic|pharmacokinetic
382876|NCT01947712|Peripheral arterial disease|peripheral arterial disease
382877|NCT01947712|Oxidative stress|oxidative stress
382878|NCT01947712|Cocoa|cocoa
382879|NCT01947712|polyphenols|polyphenols
382880|NCT01947712|NADPH oxidase|nadph oxidase
382881|NCT01947686|osteoarthritis, patellofemoral|osteoarthritis, patellofemoral
382882|NCT01947647|behavior therapy|behavior therapy
382883|NCT01947647|Randomized Controlled Trials|randomized controlled trials
382884|NCT01947647|Depressive Disorder|depressive disorder
382885|NCT01947647|Anxiety Disorders|anxiety disorders
382886|NCT01947647|comorbidity|comorbidity
382887|NCT01947621|Broken heart syndrome, stress cardiomyopathy|broken heart syndrome, stress cardiomyopathy
382888|NCT01947595|diabetes mellitus type 2|diabetes mellitus type 2
382889|NCT01947595|impaired glucose tolerance|impaired glucose tolerance
382890|NCT01947595|lifestyle intervention|lifestyle intervention
382891|NCT01947595|body fat distribution|body fat distribution
382892|NCT01947595|prevention|prevention
382893|NCT01947582|multiple sclerosis|multiple sclerosis
382894|NCT01947582|gait|gait
382895|NCT01947582|ankle foot orthosis (AFO)|ankle foot orthosis (afo)
382896|NCT01947556|diabetes|diabetes
382897|NCT01947556|insulin administration|insulin administration
382898|NCT01947556|hyperglycaemia|hyperglycaemia
382899|NCT01947556|insulin aspart|insulin aspart
382900|NCT01947478|Drug-Eluting Angioplasty Balloon|drug-eluting angioplasty balloon
382901|NCT01947478|Drug Coated Angioplasty Balloon|drug coated angioplasty balloon
382902|NCT01947478|Peripheral Artery Disease|peripheral artery disease
382903|NCT01947478|Experimental|experimental
382904|NCT01947478|Percutaneous Transluminal Angioplasty (PTA)|percutaneous transluminal angioplasty (pta)
382905|NCT01947452|Youth violence reduction|youth violence reduction
382906|NCT01947452|Youth crime reduction|youth crime reduction
382907|NCT01947452|School engagement|school engagement
382908|NCT01947452|Employment|employment
382909|NCT01947452|Social-emotional learning|social-emotional learning
382910|NCT01947439|multivessel stenting|multivessel stenting
382911|NCT01947426|DHA, term neonates, mother milk|dha, term neonates, mother milk
382912|NCT01947413|repetitive transcranial magnetic stimulation|repetitive transcranial magnetic stimulation
382913|NCT01947413|BoNTA|bonta
382914|NCT01947413|stroke|stroke
382915|NCT01947413|optimal treatment protocol|optimal treatment protocol
383204|NCT01946178|Leiomyomas|leiomyomas
382917|NCT01947413|motor control|motor control
382918|NCT01947413|clinical predictors|clinical predictors
382919|NCT01947400|Physician and Patient Communication|physician and patient communication
382920|NCT01947400|Acknowledge Introduce Duration Explanation Thank|acknowledge introduce duration explanation thank
382921|NCT01947400|Hospital Consumer Assessment of Health Plans Survey|hospital consumer assessment of health plans survey
382922|NCT01947374|Cartilage|cartilage
382923|NCT01947374|Articular|articular
382924|NCT01947335|Coronary|coronary
382925|NCT01947335|Angioplasty|angioplasty
382926|NCT01947335|Percutaneous coronary intervention|percutaneous coronary intervention
382928|NCT01947335|Contrast|contrast
382929|NCT01947335|Acute Renal failure|acute renal failure
382930|NCT01947335|Intravascular ultrasound|intravascular ultrasound
382931|NCT01947335|Prevention|prevention
382932|NCT01947322|Natural killer cell|natural killer cell
382933|NCT01947322|Haploidentical|haploidentical
382934|NCT01947322|Acute myeloid leukemia|acute myeloid leukemia
382935|NCT01947322|Chemotherapy|chemotherapy
382936|NCT01947309|Revlimid, lenalidomide, multiple myeloma, PFS, Response Rates|revlimid, lenalidomide, multiple myeloma, pfs, response rates
382937|NCT01947296|Oral antineoplastic agent|oral antineoplastic agent
382938|NCT01947296|Adverse Effects|adverse effects
382939|NCT01947296|Cancer Networks|cancer networks
382940|NCT01947296|Continuity of care|continuity of care
382941|NCT01947296|Coordination of patient's care|coordination of patient's care
382942|NCT01947283|Patient-Provider Relationship|patient-provider relationship
382943|NCT01947283|Shared Decision Making|shared decision making
382944|NCT01947283|Therapeutic Alliance|therapeutic alliance
382945|NCT01947283|Mental Health|mental health
382946|NCT01947283|Minority Health|minority health
382947|NCT01947283|Patient Activation|patient activation
382948|NCT01947283|Communication|communication
382949|NCT01947270|Potentially inappropriate medications|potentially inappropriate medications
382950|NCT01947270|Elderly|elderly
382951|NCT01947270|Prevention|prevention
382952|NCT01947270|Multidisciplinary program|multidisciplinary program
382953|NCT01947270|Checklist|checklist
382954|NCT01947270|Stepped wedge design|stepped wedge design
382955|NCT01947270|AGED, 75 AND OVER|aged, 75 and over
382956|NCT01947244|Doulas|doulas
382957|NCT01947244|Parenting|parenting
382958|NCT01947244|Breast Feeding|breast feeding
382959|NCT01947244|Pregnancy in Adolescence|pregnancy in adolescence
382960|NCT01947244|Child Development|child development
382961|NCT01947231|neck pain|neck pain
382962|NCT01947231|chronic|chronic
382963|NCT01947231|Global Postural Re-education|global postural re-education
489699|NCT01473095|AKT|akt
382964|NCT01947231|manual therapy|manual therapy
382965|NCT01947231|physical therapy|physical therapy
382966|NCT01947205|Curettage|curettage
382967|NCT01947205|analgesia|analgesia
382968|NCT01947205|paracervical block|paracervical block
382969|NCT01947205|paracetamol|paracetamol
382970|NCT01947205|lidocaine|lidocaine
382971|NCT01947205|Dexketoprofen trometamol|dexketoprofen trometamol
382972|NCT01947192|Chlorhexidine|chlorhexidine
382973|NCT01947192|Matrix metalloproteinases (MMP) inhibitor|matrix metalloproteinases (mmp) inhibitor
382974|NCT01947192|Adhesive system|adhesive system
382975|NCT01947192|Controlled clinical trial|controlled clinical trial
382976|NCT01947192|Dental restoration|dental restoration
382977|NCT01947192|Noncarious cervical lesions|noncarious cervical lesions
382978|NCT01947192|Dental restoration failure|dental restoration failure
382979|NCT01947166|Whipple|whipple
382980|NCT01947140|Lymphoid Malignancies|lymphoid malignancies
382981|NCT01947140|Multiple Myeloma|multiple myeloma
382982|NCT01947140|Lymphoma|lymphoma
382983|NCT01947140|Hodgkin Lymphoma|hodgkin lymphoma
382984|NCT01947140|Non-hodgkin Lymphoma|non-hodgkin lymphoma
382985|NCT01947140|Follicular Lymphoma|follicular lymphoma
382986|NCT01947140|Diffuse Large B-Cell Lymphoma|diffuse large b-cell lymphoma
382987|NCT01947140|Anaplastic Large Cell Lymphoma|anaplastic large cell lymphoma
382988|NCT01947140|Chronic Lymphocytic Leukemia|chronic lymphocytic leukemia
382989|NCT01947140|Small Lymphocytic Lymphoma|small lymphocytic lymphoma
382990|NCT01947140|Mantle Cell Lymphoma|mantle cell lymphoma
382991|NCT01947140|Marginal Zone Lymphoma|marginal zone lymphoma
382992|NCT01947140|Burkitt Lymphoma|burkitt lymphoma
382993|NCT01947140|Waldenstrom Macroglobulinemia|waldenstrom macroglobulinemia
382994|NCT01947140|Peripheral T-cell Lymphoma|peripheral t-cell lymphoma
382995|NCT01947140|Cutaneous T-cell Lymphoma|cutaneous t-cell lymphoma
382996|NCT01947127|Lactate|lactate
382997|NCT01947127|Sepsis|sepsis
382998|NCT01947127|Septic shock|septic shock
382999|NCT01947127|Disease progression|disease progression
383000|NCT01947127|Prognosis|prognosis
383001|NCT01947114|General anesthesia,|general anesthesia,
383002|NCT01947114|Children,|children,
383003|NCT01947114|Rigid Bronchoscopy,|rigid bronchoscopy,
383004|NCT01947114|Remifentanil,|remifentanil,
383005|NCT01947114|Propofol,|propofol,
383006|NCT01947114|Ketamine.|ketamine.
383007|NCT01947101|Stool transplant|stool transplant
383008|NCT01947101|Ulcerative Colitis|ulcerative colitis
383009|NCT01947101|Fecal transplant|fecal transplant
383010|NCT01947101|Inflammatory Bowel Disease|inflammatory bowel disease
383011|NCT01947088|Epilepsy, seizure disorder|epilepsy, seizure disorder
383012|NCT01947075|Fever|fever
383013|NCT01947075|Tanzania|tanzania
383014|NCT01947075|Pneumonia|pneumonia
383015|NCT01947075|HIV|hiv
383016|NCT01947075|Diabetes|diabetes
383017|NCT01947075|Indoor Air Pollution|indoor air pollution
383018|NCT01947062|NSCLC|nsclc
383019|NCT01947062|Metronomic chemotherapy|metronomic chemotherapy
383020|NCT01947062|Metronomic cyclophosphamide|metronomic cyclophosphamide
383021|NCT01947049|Influenza|influenza
383022|NCT01947049|diagnostic testing|diagnostic testing
383023|NCT01947049|antiviral treatment|antiviral treatment
383024|NCT01947049|rapid influenza testing|rapid influenza testing
383025|NCT01947036|autoimmune disease|autoimmune disease
383026|NCT01947036|immune-mediated disease|immune-mediated disease
383027|NCT01947036|T and B cells immunophenotype|t and b cells immunophenotype
383028|NCT01947036|IL23 signaling|il23 signaling
383029|NCT01947036|genetic risk variants|genetic risk variants
383030|NCT01947010|antibodies|antibodies
383031|NCT01946984|diclofenac, ERCP and pancreatitis|diclofenac, ercp and pancreatitis
383032|NCT01946958|Triple P|triple p
383033|NCT01946945|infertility|infertility
383034|NCT01946945|recurrent pregnancy loss|recurrent pregnancy loss
383035|NCT01946945|miscarriage|miscarriage
383036|NCT01946945|Next Generation Sequencing|next generation sequencing
383037|NCT01946932|Induced hypothermia|induced hypothermia
383038|NCT01946932|Mild induced hypothermia|mild induced hypothermia
383039|NCT01946932|Resuscitation|resuscitation
383040|NCT01946932|Therapeutic hypothermia|therapeutic hypothermia
383041|NCT01946932|Neurological function|neurological function
383042|NCT01946932|Cardiovascular diseases|cardiovascular diseases
383043|NCT01946932|Rehabilitation|rehabilitation
383044|NCT01946932|Quality of life|quality of life
383045|NCT01946932|Cognition|cognition
383046|NCT01946919|Cinepazide|cinepazide
383047|NCT01946919|Adverse Drug Reaction|adverse drug reaction
383048|NCT01946919|Safety|safety
383049|NCT01946919|Real World Study|real world study
383050|NCT01946893|meditation|meditation
383051|NCT01946893|education|education
383052|NCT01946893|stress, psychological|stress, psychological
383053|NCT01946893|aged|aged
383054|NCT01946880|Systemic Lupus Erythematosus|systemic lupus erythematosus
383055|NCT01946880|Mycophenolate Mofetil (MMF)|mycophenolate mofetil (mmf)
383056|NCT01946867|Oral cavity Cancer|oral cavity cancer
383057|NCT01946867|Oropharynx Cancer|oropharynx cancer
785830|NCT00307320|stress|stress
383058|NCT01946854|Gastrointestinal|gastrointestinal
383059|NCT01946854|Metastatic Well-differentiated Mucinous Appendiceal Adenocarcinomas with Pseudomyxoma Peritonea|metastatic well-differentiated mucinous appendiceal adenocarcinomas with pseudomyxoma peritonea
383060|NCT01946854|Appendiceal cancer|appendiceal cancer
383061|NCT01946854|Surgically unresectable|surgically unresectable
383062|NCT01946854|Chemotherapy|chemotherapy
383063|NCT01946854|Observation|observation
383064|NCT01946854|Questionnaires|questionnaires
383065|NCT01946841|Chronic kidney disease|chronic kidney disease
383066|NCT01946841|Hemodialysis|hemodialysis
383067|NCT01946841|Severe malnutrition|severe malnutrition
383068|NCT01946841|Enteral nutrition|enteral nutrition
383069|NCT01946828|Field Induced Mydriasis|field induced mydriasis
383070|NCT01946828|FIM|fim
383071|NCT01946828|ATI|ati
383072|NCT01946802|Heart arrest|heart arrest
383073|NCT01946802|Cardiopulmonary resuscitation|cardiopulmonary resuscitation
383074|NCT01946802|Hypothermia induced|hypothermia induced
383075|NCT01946802|Seizures|seizures
383076|NCT01946802|Electroencephalography|electroencephalography
383077|NCT01946789|cancer|cancer
383078|NCT01946789|IL-15|il-15
383079|NCT01946789|melanoma|melanoma
383080|NCT01946789|metastatic|metastatic
383081|NCT01946789|unresectable|unresectable
383082|NCT01946789|solid tumors|solid tumors
383083|NCT01946789|renal cell|renal cell
383084|NCT01946789|non-small cell lung|non-small cell lung
383085|NCT01946789|squamous cell head and neck|squamous cell head and neck
383086|NCT01946737|Coronary|coronary
383087|NCT01946737|Artery|artery
383088|NCT01946737|Disease|disease
383089|NCT01946737|Diagnostic|diagnostic
383090|NCT01946737|Performance|performance
383091|NCT01946737|Angiography|angiography
383092|NCT01946711|CRS|crs
383093|NCT01946711|polyposis|polyposis
383094|NCT01946672|gynaecological malignancy|gynaecological malignancy
383095|NCT01946672|pelvic lymphadenectomy|pelvic lymphadenectomy
383096|NCT01946672|lymphedema|lymphedema
383097|NCT01946672|sentinel node|sentinel node
383098|NCT01946672|reverse mapping|reverse mapping
383099|NCT01946659|Tailored Telephone Intervention|tailored telephone intervention
383100|NCT01946620|Chronic Obstructive Pulmonary Disease|chronic obstructive pulmonary disease
383101|NCT01946620|Exacerbations|exacerbations
383102|NCT01946620|FEV1 ≤ 50%|fev1 ≤ 50%
383103|NCT01946607|Neuroticism|neuroticism
383104|NCT01946607|Emotion processing|emotion processing
383105|NCT01946607|Eye gaze movements|eye gaze movements
383106|NCT01946607|Heart Rate Variability|heart rate variability
383107|NCT01946594|fever|fever
383108|NCT01946594|antipyretics|antipyretics
383109|NCT01946594|acetaminophen|acetaminophen
383110|NCT01946594|influenza vaccine|influenza vaccine
383111|NCT01946594|influenza, human|influenza, human
383112|NCT01946594|body temperature changes|body temperature changes
383113|NCT01946594|Orthomyxoviridae Infections|orthomyxoviridae infections
383114|NCT01946594|RNA virus infections|rna virus infections
383115|NCT01946594|Virus Diseases|virus diseases
383116|NCT01946594|Respiratory Tract Infections|respiratory tract infections
383117|NCT01946594|Respiratory Tract Diseases|respiratory tract diseases
383118|NCT01946555|Breakthrough cancer pain|breakthrough cancer pain
383119|NCT01946555|Neuropathic pain|neuropathic pain
383120|NCT01946555|Major opioid|major opioid
383121|NCT01946555|Analgesics|analgesics
383122|NCT01946542|exercise|exercise
383123|NCT01946542|heart failure|heart failure
383124|NCT01946542|fatigue|fatigue
383125|NCT01946542|physical endurance|physical endurance
383126|NCT01946542|functional food|functional food
383127|NCT01946516|viral screening|viral screening
383128|NCT01946503|Short Gut|short gut
383129|NCT01946503|Short Bowel Syndrome|short bowel syndrome
383130|NCT01946503|Intestinal Failure|intestinal failure
383131|NCT01946503|Home parenteral nutrition|home parenteral nutrition
383132|NCT01946503|Feeding Behavior|feeding behavior
383133|NCT01946503|Enteral Nutrition|enteral nutrition
383134|NCT01946503|Parent-Child Relations|parent-child relations
383135|NCT01946503|Parenteral Nutrition|parenteral nutrition
383136|NCT01946503|Digestive System Diseases|digestive system diseases
383137|NCT01946477|Multiple Myeloma, MM, cancer, oncology, hematology, plasma, neoplasm, plasmacytoma|multiple myeloma, mm, cancer, oncology, hematology, plasma, neoplasm, plasmacytoma
383138|NCT01946464|edentulous|edentulous
383139|NCT01946464|bearded|bearded
383140|NCT01946464|patients|patients
383141|NCT01946464|requiring|requiring
383142|NCT01946464|general anesthesia|general anesthesia
383143|NCT01946464|Mallampati Class II or IV|mallampati class ii or iv
383144|NCT01946451|idiopathic epiretinal membranes|idiopathic epiretinal membranes
383145|NCT01946451|secondary epiretinal membranes|secondary epiretinal membranes
383146|NCT01946438|Influenza|influenza
383147|NCT01946438|Fluzone® Quadrivalent, Influenza Virus Vaccine (2013-2014 formulation),|fluzone® quadrivalent, influenza virus vaccine (2013-2014 formulation),
383148|NCT01946438|Fluzone® Intradermal, Influenza Virus Vaccine (2013-2014 formulation),|fluzone® intradermal, influenza virus vaccine (2013-2014 formulation),
383149|NCT01946438|Fluzone® High-Dose, Influenza Virus Vaccine (2013-2014 formulation)|fluzone® high-dose, influenza virus vaccine (2013-2014 formulation)
383150|NCT01946425|Influenza|influenza
383151|NCT01946425|Influenza virus vaccine|influenza virus vaccine
383152|NCT01946425|Fluzone® Quadrivalent Influenza Vaccine (No Preservative)|fluzone® quadrivalent influenza vaccine (no preservative)
383153|NCT01946412|Cystic Fibrosis|cystic fibrosis
383154|NCT01946373|Melanoma|melanoma
383155|NCT01946373|Dendritic cell vaccination|dendritic cell vaccination
383156|NCT01946373|Lymphodepletion|lymphodepletion
383157|NCT01946373|Adoptive cell transfer|adoptive cell transfer
383158|NCT01946373|T cells|t cells
383159|NCT01946373|Tumor infiltrating lymphocytes|tumor infiltrating lymphocytes
383160|NCT01946373|Fludarabine|fludarabine
383161|NCT01946373|IL-2|il-2
383162|NCT01946373|Interleukin-2|interleukin-2
383163|NCT01946373|Cyclophosphamide|cyclophosphamide
383164|NCT01946373|Phase I study|phase i study
383165|NCT01946373|Monocytes|monocytes
383166|NCT01946373|Autologous|autologous
383167|NCT01946373|NY-ESO-1|ny-eso-1
383168|NCT01946347|Insulin Resistance|insulin resistance
383169|NCT01946347|Hyperglycemia|hyperglycemia
383170|NCT01946347|Endothelial function|endothelial function
383171|NCT01946347|Oxidative stress|oxidative stress
383172|NCT01946308|sleep|sleep
383173|NCT01946308|sleep efficiency|sleep efficiency
383174|NCT01946308|active sleep|active sleep
383175|NCT01946308|quiet sleep|quiet sleep
383176|NCT01946308|arousals|arousals
383177|NCT01946308|premature infant|premature infant
383178|NCT01946308|conformational positioning|conformational positioning
383179|NCT01946308|mattress|mattress
383180|NCT01946308|feeding difficulty|feeding difficulty
383181|NCT01946308|neonatal intensive care unit|neonatal intensive care unit
383182|NCT01946308|sleep state|sleep state
383183|NCT01946308|behavioral observation|behavioral observation
383184|NCT01946308|stress behavior|stress behavior
383185|NCT01946308|self-regulatory behavior|self-regulatory behavior
383186|NCT01946308|surgery|surgery
383187|NCT01946308|gastrointestinal|gastrointestinal
383188|NCT01946282|neoplasm|neoplasm
383189|NCT01946282|colorectal|colorectal
383190|NCT01946282|cancer|cancer
383191|NCT01946282|uninsured|uninsured
383192|NCT01946282|FIT|fit
383193|NCT01946282|Fecal Immunochemical Test|fecal immunochemical test
383194|NCT01946204|Prostate neoplasms|prostate neoplasms
383195|NCT01946204|Prostate cancer|prostate cancer
383196|NCT01946204|Castration-resistant prostate cancer|castration-resistant prostate cancer
383197|NCT01946204|Non-metastatic castration-resistant prostate cancer|non-metastatic castration-resistant prostate cancer
383198|NCT01946204|ARN-509|arn-509
383199|NCT01946204|Apalutamide|apalutamide
383200|NCT01946191|Weight maintenance|weight maintenance
383201|NCT01946191|Electronic health record|electronic health record
383202|NCT01946191|Primary care|primary care
383203|NCT01946178|Uterine Fibroids|uterine fibroids
383205|NCT01946178|High-Intensity Focused Ultrasound Ablation|high-intensity focused ultrasound ablation
383206|NCT01946178|Ultrasonography|ultrasonography
383207|NCT01946165|Prostate Cancer|prostate cancer
383208|NCT01946165|High risk prostate cancer|high risk prostate cancer
383209|NCT01946165|Abiraterone acetate|abiraterone acetate
383211|NCT01946165|Prednisone|prednisone
383212|NCT01946165|Enzalutamide|enzalutamide
383213|NCT01946165|MDV3100|mdv3100
383214|NCT01946165|XTANDI|xtandi
383215|NCT01946165|Androgen ablation|androgen ablation
383216|NCT01946165|LHRHa|lhrha
383217|NCT01946165|Hormonal therapy|hormonal therapy
383218|NCT01946100|multifocal|multifocal
383219|NCT01946100|genetic|genetic
383220|NCT01946100|bronchoalveolar carcinoma|bronchoalveolar carcinoma
383221|NCT01946100|adenocarcinoma in situ|adenocarcinoma in situ
383222|NCT01946100|ground glass opacity|ground glass opacity
383223|NCT01946100|next generation sequencing|next generation sequencing
383224|NCT01946087|Remote ischemic preconditioning|remote ischemic preconditioning
383225|NCT01946087|cardiac surgery|cardiac surgery
383226|NCT01946087|left ventricular hypertrophy|left ventricular hypertrophy
383227|NCT01946087|reperfusion injury salvage kinase|reperfusion injury salvage kinase
383228|NCT01946074|ABBV-181|abbv-181
383229|NCT01946074|ABT-165|abt-165
383230|NCT01946074|cancer|cancer
383231|NCT01946074|neoplasm|neoplasm
383232|NCT01946074|advanced solid tumor|advanced solid tumor
383233|NCT01946074|colorectal cancer|colorectal cancer
383234|NCT01946061|Oxaliplatin, S-1, Gastric cancer, Adjuvant chemotherapy|oxaliplatin, s-1, gastric cancer, adjuvant chemotherapy
383235|NCT01946022|infertility|infertility
383236|NCT01946022|ovulation induction|ovulation induction
383237|NCT01946022|luteal phase|luteal phase
383238|NCT01946022|granulosa cells function|granulosa cells function
383239|NCT01946022|GnRH agonist and antagonist|gnrh agonist and antagonist
383240|NCT01946022|HMG|hmg
383241|NCT01946022|FSHr|fshr
383242|NCT01945996|Hispanic Americans|hispanic americans
383243|NCT01945996|Cellular Phone|cellular phone
383244|NCT01945996|Behavior|behavior
383245|NCT01945983|Septic shock|septic shock
383246|NCT01945983|Severe sepsis|severe sepsis
383247|NCT01945983|Norepinephrine|norepinephrine
383248|NCT01945970|Vascular function|vascular function
785831|NCT00307320|anxiety|anxiety
383249|NCT01945970|Flow mediated dilation|flow mediated dilation
383250|NCT01945970|Tea|tea
383251|NCT01945957|autism|autism
383252|NCT01945957|brain|brain
383253|NCT01945957|functional magnetic resonance imaging|functional magnetic resonance imaging
383254|NCT01945957|oxytocin|oxytocin
383255|NCT01945944|pediatric|pediatric
383256|NCT01945944|mucolytic|mucolytic
383257|NCT01945944|respiratory failure|respiratory failure
383258|NCT01945944|atelectasis|atelectasis
383259|NCT01945944|hypertonic saline|hypertonic saline
383260|NCT01945931|Maternal health|maternal health
383261|NCT01945931|perinatal health|perinatal health
383262|NCT01945931|mHealth|mhealth
383263|NCT01945931|smartphone|smartphone
383264|NCT01945931|mobile phone|mobile phone
383265|NCT01945931|Ethiopia|ethiopia
383266|NCT01945918|Diabetes Mellitus, Type 2|diabetes mellitus, type 2
383267|NCT01945918|Diabetes Mellitus|diabetes mellitus
383268|NCT01945918|Primary Health Care|primary health care
383269|NCT01945918|Self care|self care
383270|NCT01945905|Tuberculosis|tuberculosis
383271|NCT01945905|Adherence, medication|adherence, medication
383272|NCT01945905|Patient compliance|patient compliance
383273|NCT01945892|macular edema, irvine gass syndrome, ozurdex|macular edema, irvine gass syndrome, ozurdex
383274|NCT01945879|pancreatic cancer|pancreatic cancer
383275|NCT01945879|heparin|heparin
383276|NCT01945879|thromboembolic events|thromboembolic events
383277|NCT01945879|bleedings|bleedings
383278|NCT01945866|Diabetic Macular Edema|diabetic macular edema
383279|NCT01945866|Anti-vascular endothelial growth factor|anti-vascular endothelial growth factor
383280|NCT01945866|Dexamethasone Intravitreal implant|dexamethasone intravitreal implant
383281|NCT01945866|Ranibizumab intravitreal injection|ranibizumab intravitreal injection
383282|NCT01945801|Sleep apnea|sleep apnea
383283|NCT01945801|Treatment|treatment
383284|NCT01945801|Sodium-Restricted Diet|sodium-restricted diet
383285|NCT01945801|Diuretic|diuretic
383286|NCT01945801|Lasilactone|lasilactone
383287|NCT01945775|Breast cancer|breast cancer
383288|NCT01945775|BRCA mutation|brca mutation
383289|NCT01945775|PARP inhibitor|parp inhibitor
383290|NCT01945775|BRCA 1|brca 1
383291|NCT01945775|BRCA 2|brca 2
383292|NCT01945762|RET Mutation|ret mutation
383293|NCT01945762|DIagnostics|diagnostics
383294|NCT01945762|Medullary Thyroid Cancer|medullary thyroid cancer
383295|NCT01945762|MTC|mtc
383296|NCT01945736|Opiate withdrawal in children|opiate withdrawal in children
383297|NCT01945723|Endoscopy|endoscopy
383298|NCT01945723|Gastrointestinal tract|gastrointestinal tract
383299|NCT01945723|Bacterial markers|bacterial markers
383300|NCT01945723|volunteers|volunteers
383301|NCT01945710|Tumors|tumors
383302|NCT01945697|DNA methylation, biomarkers, oral cancer|dna methylation, biomarkers, oral cancer
383303|NCT01945645|Prevention|prevention
383304|NCT01945645|Screening|screening
383305|NCT01945645|Type 2 diabetes|type 2 diabetes
383306|NCT01945645|Action Competence|action competence
383307|NCT01945645|Family practice|family practice
383308|NCT01945645|Health Services Research|health services research
383310|NCT01945619|Adenovirus|adenovirus
383311|NCT01945619|EBV|ebv
383312|NCT01945619|Stem cell transplant|stem cell transplant
383313|NCT01945619|cytotoxic T-lymphocytes|cytotoxic t-lymphocytes
383314|NCT01945580|POP|pop
383315|NCT01945580|Transvaginal|transvaginal
383316|NCT01945580|Native Tissue Repair|native tissue repair
383317|NCT01945580|Repair Augmented with Mesh|repair augmented with mesh
383318|NCT01945580|Biologic Graft|biologic graft
383319|NCT01945580|Pelvic Organ Prolapse|pelvic organ prolapse
383320|NCT01945567|Parkinson's disease|parkinson's disease
383321|NCT01945567|Essential tremor|essential tremor
383322|NCT01945567|Tremor|tremor
383323|NCT01945567|Deep brain stimulation|deep brain stimulation
383324|NCT01945567|Posterior subthalamic area|posterior subthalamic area
383325|NCT01945567|Zona incerta|zona incerta
383326|NCT01945554|infiltrative therapy|infiltrative therapy
383327|NCT01945554|cervical disc herniation|cervical disc herniation
383328|NCT01945554|lumbar disc herniation|lumbar disc herniation
383329|NCT01945541|Intraoperative Fluid Administration|intraoperative fluid administration
383330|NCT01945541|Body Composition Measurement|body composition measurement
383331|NCT01945528|Platelet Rich Plasma|platelet rich plasma
383332|NCT01945528|tendinopathy|tendinopathy
383333|NCT01945528|epicondylitis|epicondylitis
383334|NCT01945528|ultrasound|ultrasound
383335|NCT01945528|injection therapy|injection therapy
383336|NCT01945528|needle tenotomy|needle tenotomy
383337|NCT01945515|Stroke|stroke
383338|NCT01945515|transcranial direct current stimulation|transcranial direct current stimulation
383339|NCT01945515|robotic rehabilitation|robotic rehabilitation
383340|NCT01945515|gait|gait
383341|NCT01945476|midazolam|midazolam
383342|NCT01945476|premedication|premedication
383343|NCT01945476|functional recovery|functional recovery
383344|NCT01945476|breast cancer|breast cancer
383345|NCT01945424|Quadrivalent Influenza Vaccine|quadrivalent influenza vaccine
383346|NCT01945424|Pregnancy Registry|pregnancy registry
383347|NCT01945424|Influenza|influenza
383348|NCT01945411|Airway Management|airway management
383349|NCT01945411|Ventilation|ventilation
383350|NCT01945398|Pulmonary Rehabilitation|pulmonary rehabilitation
383351|NCT01945398|Inspiratory Muscle Training|inspiratory muscle training
383352|NCT01945398|Inspiratory Muscle Strength|inspiratory muscle strength
383353|NCT01945398|Vascular Resistance|vascular resistance
383354|NCT01945398|Exercise|exercise
383355|NCT01945398|Chronic Obstructive Pulmonary Disease|chronic obstructive pulmonary disease
383356|NCT01945385|Abortion|abortion
383357|NCT01945385|LARC|larc
383358|NCT01945385|Contraception|contraception
383359|NCT01945385|IUD|iud
383360|NCT01945385|Contraceptive implant|contraceptive implant
383361|NCT01945385|behavioral change|behavioral change
383362|NCT01945385|video intervention|video intervention
383363|NCT01945359|Relapsing Multiple Sclerosis|relapsing multiple sclerosis
383364|NCT01945359|Dimethyl Fumarate|dimethyl fumarate
383365|NCT01945359|Natalizumab|natalizumab
383366|NCT01945346|PRX167700|prx167700
383367|NCT01945346|Osteoarthritis|osteoarthritis
383368|NCT01945333|Cognitive remediation|cognitive remediation
383369|NCT01945333|Schizophrenia|schizophrenia
383370|NCT01945333|Schizoaffective disorder|schizoaffective disorder
383371|NCT01945320|hemodialysis|hemodialysis
383372|NCT01945320|wasting and malnutrition|wasting and malnutrition
383373|NCT01945320|nutrition status|nutrition status
383374|NCT01945320|bioelectrical impedance analysis|bioelectrical impedance analysis
383375|NCT01945320|body composition|body composition
383376|NCT01945307|Complement|complement
383377|NCT01945307|Serum Bactericidal Assay|serum bactericidal assay
383378|NCT01945268|vascular, influenza, vaccine, heart failure|vascular, influenza, vaccine, heart failure
383379|NCT01945255|Calcification|calcification
383380|NCT01945255|aortic pulse wave velocity|aortic pulse wave velocity
383381|NCT01945255|peripheral artery occlusion disease|peripheral artery occlusion disease
383382|NCT01945255|hemodialysis|hemodialysis
383383|NCT01945255|metabolic syndrome|metabolic syndrome
383384|NCT01945242|Drug Therapy|drug therapy
383385|NCT01945216|Drug therapy|drug therapy
383386|NCT01945203|Calcification|calcification
383387|NCT01945203|aortic pulse wave velocity|aortic pulse wave velocity
383388|NCT01945203|peripheral artery occlusion disease|peripheral artery occlusion disease
383389|NCT01945203|peritoneal dialysis|peritoneal dialysis
383390|NCT01945203|metabolic syndrome|metabolic syndrome
383391|NCT01945177|endoscopy|endoscopy
383392|NCT01945177|gastric intestinal metaplasia|gastric intestinal metaplasia
383393|NCT01945177|gastric cancer|gastric cancer
383394|NCT01945164|XL999|xl999
383395|NCT01945164|Advanced Malignancy|advanced malignancy
383396|NCT01945151|spastic hemiparesis|spastic hemiparesis
383397|NCT01945138|Total Pancreatectomy|total pancreatectomy
383398|NCT01945138|Islet Auto-Transplantation|islet auto-transplantation
383399|NCT01945138|Closed Loop Insulin Pump|closed loop insulin pump
383499|NCT01944696|hyperbilirubinemia|hyperbilirubinemia
383500|NCT01944696|prematurity|prematurity
383400|NCT01945099|diabetes, insulin,post prandial, closed loop, artificial pancreas, hyperglycemia|diabetes, insulin,post prandial, closed loop, artificial pancreas, hyperglycemia
383401|NCT01945086|Dermatitis, Atopic|dermatitis, atopic
383402|NCT01945086|Eczema|eczema
383403|NCT01945086|Ustekinumab|ustekinumab
383404|NCT01945086|CNTO1275|cnto1275
383405|NCT01945086|STELARA|stelara
383406|NCT01945073|Educational intervention|educational intervention
383407|NCT01945073|Formal Counselling|formal counselling
383408|NCT01945073|Knowledge|knowledge
383409|NCT01945073|Illness Perception|illness perception
383410|NCT01945060|Artificial Pancreas Project|artificial pancreas project
383411|NCT01945060|Diabetes Assistant (DiAs) Medical Platform System|diabetes assistant (dias) medical platform system
383412|NCT01945060|Artificial Pancreas Platform|artificial pancreas platform
383413|NCT01945060|Insulin Pump|insulin pump
383414|NCT01945060|Continuous Glucose Monitor|continuous glucose monitor
383415|NCT01945060|Closed-Loop Control|closed-loop control
383416|NCT01945060|heart rate Control to Range System (hrCTR)|heart rate control to range system (hrctr)
383417|NCT01945047|depression|depression
383418|NCT01945047|treatment|treatment
383419|NCT01945047|ketamine|ketamine
383420|NCT01945047|ottawa|ottawa
383421|NCT01945047|treatment-resistant|treatment-resistant
383422|NCT01945047|infusion|infusion
383423|NCT01945034|topical ibuprofen|topical ibuprofen
383424|NCT01945034|ankle sprain|ankle sprain
383425|NCT01945021|Non small cell lung cancer|non small cell lung cancer
383426|NCT01945021|NSCLC|nsclc
383427|NCT01945021|ROS1|ros1
383428|NCT01945021|ROS1 positive|ros1 positive
383429|NCT01945021|ROS1 proto oncogene|ros1 proto oncogene
383430|NCT01945021|c ros tyrosine kinases|c ros tyrosine kinases
383431|NCT01945021|ROS1 positive NSCLC|ros1 positive nsclc
383432|NCT01945021|ROS1 lung cancer|ros1 lung cancer
383433|NCT01945021|ALK negative|alk negative
383434|NCT01945021|Lung Carcinoma|lung carcinoma
383435|NCT01945021|Neoplasm|neoplasm
383436|NCT01945021|Crizotinib|crizotinib
383437|NCT01945021|Xalkori|xalkori
383438|NCT01945021|Previously treated or untreated|previously treated or untreated
383439|NCT01945021|North East Asian|north east asian
383441|NCT01945008|observational study|observational study
383442|NCT01945008|HCV direct-acting antiviral agents|hcv direct-acting antiviral agents
383443|NCT01944982|Immunotherapy|immunotherapy
383444|NCT01944982|NKAEs|nkaes
383445|NCT01944982|Expanded haploidentical natural killer cells|expanded haploidentical natural killer cells
383446|NCT01944982|Activated natural killer cells|activated natural killer cells
383447|NCT01944956|Maturation|maturation
383448|NCT01944956|preterm infants|preterm infants
383449|NCT01944956|sucking and swallowing|sucking and swallowing
383450|NCT01944943|refractory/relapsed|refractory/relapsed
383451|NCT01944943|diffuse large B-cell lymphoma|diffuse large b-cell lymphoma
383452|NCT01944943|indolent non-hodgkin lymphoma|indolent non-hodgkin lymphoma
383453|NCT01944943|Primary central nervous system lymphoma|primary central nervous system lymphoma
383454|NCT01944943|chronic lymphocytic leukemia|chronic lymphocytic leukemia
383455|NCT01944917|Electromagnetic field|electromagnetic field
383456|NCT01944917|VAS score|vas score
383457|NCT01944917|Heart Rate Variability|heart rate variability
383458|NCT01944904|XOS|xos
383459|NCT01944904|pre-diabetic|pre-diabetic
383460|NCT01944904|abnormal glucose levels|abnormal glucose levels
383461|NCT01944891|Adolescent girls|adolescent girls
383462|NCT01944891|Mozambique|mozambique
383463|NCT01944891|Diet|diet
383464|NCT01944891|Anthropometrics|anthropometrics
383465|NCT01944891|Serum biomarkers|serum biomarkers
383466|NCT01944878|Peptic ulcer|peptic ulcer
383467|NCT01944878|Liver cirrhosis|liver cirrhosis
383468|NCT01944878|Portal hypertension|portal hypertension
383469|NCT01944865|Aerobic Interval Training|aerobic interval training
383470|NCT01944865|Supramaximal Training|supramaximal training
383471|NCT01944852|icodextrin|icodextrin
383472|NCT01944852|double dose|double dose
383473|NCT01944852|elderly incident CAPD patients|elderly incident capd patients
383474|NCT01944852|DIDo study|dido study
383475|NCT01944839|Wet AMD|wet amd
383476|NCT01944839|choroidal neovascularization|choroidal neovascularization
383477|NCT01944839|Fovista®|fovista®
383478|NCT01944839|E10030|e10030
383479|NCT01944839|Lucentis®|lucentis®
383480|NCT01944826|Dyspnea|dyspnea
383481|NCT01944826|Angina pectoris|angina pectoris
383482|NCT01944813|Advance Care planning|advance care planning
383483|NCT01944813|End-of-life Discussions|end-of-life discussions
383484|NCT01944813|Questionaires|questionaires
383485|NCT01944813|Palliative Care|palliative care
383486|NCT01944800|Ticagrelor|ticagrelor
383487|NCT01944800|Prasugrel|prasugrel
383488|NCT01944800|Acute coronary syndrome|acute coronary syndrome
383489|NCT01944800|Percutaneous coronary intervention|percutaneous coronary intervention
383490|NCT01944774|Moxifloxacin|moxifloxacin
383491|NCT01944761|pediatrics|pediatrics
383492|NCT01944761|Brain Tumor|brain tumor
383493|NCT01944761|Neuro-radiation|neuro-radiation
383494|NCT01944761|Exercise|exercise
383495|NCT01944709|melanoma|melanoma
383496|NCT01944709|dendritic cells|dendritic cells
383497|NCT01944709|peptide|peptide
383498|NCT01944709|Melan-A|melan-a
383501|NCT01944696|extremely low birth weight (ELBW)|extremely low birth weight (elbw)
383502|NCT01944696|phototherapy|phototherapy
383503|NCT01944696|cycled phototherapy|cycled phototherapy
383504|NCT01944696|intermittent phototherapy|intermittent phototherapy
383505|NCT01944657|Major Depressive Disorder Clinical Outcomes|major depressive disorder clinical outcomes
383506|NCT01944657|Transcranial Magnetic Stimulation|transcranial magnetic stimulation
383507|NCT01944657|Standard Medication Monotherapy|standard medication monotherapy
383508|NCT01944657|Exploratory Field Study|exploratory field study
383509|NCT01944605|Endotoxin|endotoxin
383510|NCT01944605|Cytokine|cytokine
383511|NCT01944605|Metabolism|metabolism
383512|NCT01944592|Gynaecology Teaching Associate|gynaecology teaching associate
383513|NCT01944592|Pelvic examination|pelvic examination
383514|NCT01944592|Students|students
383515|NCT01944553|Spine|spine
383516|NCT01944553|Accurancy|accurancy
383517|NCT01944553|Robotic|robotic
383518|NCT01944553|Screw placement|screw placement
383519|NCT01944553|Degenerative|degenerative
383520|NCT01944514|Action potential duration restitution|action potential duration restitution
383521|NCT01944514|Ventricular arrhythmia|ventricular arrhythmia
383522|NCT01944514|Sudden cardiac death|sudden cardiac death
383523|NCT01944514|Peri-infarct zone|peri-infarct zone
383524|NCT01944514|Electrocardiogram|electrocardiogram
383525|NCT01944501|tinnitus|tinnitus
383526|NCT01944501|hearing loss|hearing loss
383527|NCT01944501|Transcranial magnetic stimulation|transcranial magnetic stimulation
383528|NCT01944501|Transcranial direct current stimulation|transcranial direct current stimulation
383529|NCT01944488|Precocious puberty|precocious puberty
383530|NCT01944488|GnRH-test|gnrh-test
383531|NCT01944475|Precocious puberty|precocious puberty
383532|NCT01944475|Premature thelarche|premature thelarche
383533|NCT01944475|Tanner-stage|tanner-stage
383534|NCT01944475|GnRH-test|gnrh-test
383535|NCT01944462|pneumococcal vaccine|pneumococcal vaccine
383536|NCT01944462|pharmacist vaccination|pharmacist vaccination
383537|NCT01944462|Pneumovax 23|pneumovax 23
383538|NCT01944462|pneumococcal vaccine polyvalent|pneumococcal vaccine polyvalent
383539|NCT01944449|Type 2 diabetes (T2D)|type 2 diabetes (t2d)
383540|NCT01944449|Whey Protein Concentrate (WPC)|whey protein concentrate (wpc)
383541|NCT01944436|Pharmacogenomics|pharmacogenomics
383542|NCT01944436|Dementia with Lewy bodies|dementia with lewy bodies
383543|NCT01944436|Adverse events|adverse events
383544|NCT01944436|Polymorphisms|polymorphisms
383545|NCT01944436|Acetylcholinesterase|acetylcholinesterase
383546|NCT01944436|Parkinson's Disease Dementia|parkinson's disease dementia
383547|NCT01944436|Cognitive enhancers|cognitive enhancers
383548|NCT01944436|Clinical efficacy|clinical efficacy
383549|NCT01944436|Cytochrome P450|cytochrome p450
383550|NCT01944436|Butyrylcholinesterase|butyrylcholinesterase
383551|NCT01944410|PRP|prp
383552|NCT01944410|TBC|tbc
383553|NCT01944410|Treatment|treatment
383554|NCT01944397|Atrial fibrillation|atrial fibrillation
383555|NCT01944397|Heart failure|heart failure
383556|NCT01944397|Stroke|stroke
383557|NCT01944397|Myocardial infarction|myocardial infarction
383558|NCT01944371|Latent reservoir|latent reservoir
383559|NCT01944358|Syphilis; human immunodeficiency virus; penicillin|syphilis; human immunodeficiency virus; penicillin
383560|NCT01944332|gamete treatment|gamete treatment
383561|NCT01944332|ICSI|icsi
383562|NCT01944332|IVF|ivf
383563|NCT01944332|infertility|infertility
383564|NCT01944332|oocyte activation|oocyte activation
383565|NCT01944319|Infection; Meropenem; Pharmacokinetics; Pharmacodynamics|infection; meropenem; pharmacokinetics; pharmacodynamics
383566|NCT01944306|Pharmacokinetics|pharmacokinetics
383567|NCT01944306|Pharmacology, Clinical|pharmacology, clinical
383568|NCT01944306|Drug Efficacy|drug efficacy
383569|NCT01944306|Drug Failure|drug failure
383570|NCT01944306|Contraceptive Agents|contraceptive agents
383571|NCT01944293|Ketamine|ketamine
383572|NCT01944293|Midazolam|midazolam
383573|NCT01944293|Bipolar Disorder|bipolar disorder
383574|NCT01944293|Major Depressive Episode|major depressive episode
383575|NCT01944293|Suicidal Ideation|suicidal ideation
383576|NCT01944293|Suicide|suicide
383577|NCT01944293|Depression|depression
383578|NCT01944293|Treatment|treatment
383579|NCT01944293|Ketamine Treatment|ketamine treatment
383580|NCT01944254|Cardiac surgical procedures|cardiac surgical procedures
383581|NCT01944254|Pulmonary Artery Catheterizations|pulmonary artery catheterizations
383582|NCT01944254|Cardiac output|cardiac output
383583|NCT01944254|Swan Ganz Catheterization|swan ganz catheterization
383584|NCT01944241|cervical surgery|cervical surgery
383585|NCT01944241|LLETZ|lletz
383586|NCT01944241|LEEP|leep
383587|NCT01944241|Cone biopsy|cone biopsy
383588|NCT01944241|Fertility|fertility
383589|NCT01944228|inflammation|inflammation
383590|NCT01944228|vagus nerve stimulation|vagus nerve stimulation
383591|NCT01944228|chronic heart failure|chronic heart failure
383592|NCT01944228|Systemic Inflammatory Response Syndrome|systemic inflammatory response syndrome
383593|NCT01944228|sepsis|sepsis
383594|NCT01944228|auto-immune diseases|auto-immune diseases
383595|NCT01944215|Normal subjects|normal subjects
383596|NCT01944215|Female|female
383597|NCT01944215|Molecular Breast Imaging|molecular breast imaging
383598|NCT01944215|Fasting|fasting
383599|NCT01944215|Exercise|exercise
383600|NCT01944215|Tracer Uptake|tracer uptake
383601|NCT01944215|Tc-99m Sestamibi|tc-99m sestamibi
383602|NCT01944215|Prandial status|prandial status
383603|NCT01944215|metabolic status|metabolic status
383604|NCT01944215|negative mammogram|negative mammogram
383605|NCT01944215|Caffeine|caffeine
383606|NCT01944215|External Warming|external warming
383607|NCT01944202|Echocardiography|echocardiography
383608|NCT01944202|Appropriate Use Criteria|appropriate use criteria
383609|NCT01944202|Educational Intervention|educational intervention
383610|NCT01944189|lumefantrine pharmacokinetics & bioavailability|lumefantrine pharmacokinetics & bioavailability
383611|NCT01944176|COPD|copd
383612|NCT01944176|Statins|statins
383613|NCT01944176|Cytokines|cytokines
383614|NCT01944163|Low back pain|low back pain
383615|NCT01944163|Impact analysis|impact analysis
383616|NCT01944163|Cluster randomized trial|cluster randomized trial
383617|NCT01944163|Referral rule|referral rule
383618|NCT01944163|Axial spondyloarthritis|axial spondyloarthritis
383619|NCT01944150|Hypnosis|hypnosis
383620|NCT01944150|chronic pain|chronic pain
383621|NCT01944150|transcutaneous electrical nerve stimulation|transcutaneous electrical nerve stimulation
383622|NCT01944150|nociceptive pain|nociceptive pain
383623|NCT01944150|neuropathic pain|neuropathic pain
383624|NCT01944150|complementary therapies|complementary therapies
383625|NCT01944137|colonic neoplasms|colonic neoplasms
383626|NCT01944137|Lung neoplasms|lung neoplasms
383627|NCT01944137|patient-centered nursing|patient-centered nursing
383628|NCT01944137|breast neoplasms|breast neoplasms
383629|NCT01944124|Mobile health|mobile health
383630|NCT01944124|Metabolic syndrome|metabolic syndrome
383631|NCT01944124|Exercise prescription|exercise prescription
383632|NCT01944124|Exercise intervention|exercise intervention
383633|NCT01944124|Disease prevention|disease prevention
383634|NCT01944124|Rural health|rural health
383635|NCT01944111|Gastric plication|gastric plication
383636|NCT01944085|children|children
383637|NCT01944085|supracondylar fracture|supracondylar fracture
383638|NCT01944085|pin removal|pin removal
383639|NCT01944085|analgesia|analgesia
383640|NCT01944085|pain score|pain score
383641|NCT01944072|Chronic Obstructive Pulmonary Disease|chronic obstructive pulmonary disease
383642|NCT01944072|COPD|copd
383643|NCT01944072|Pulmonary rehabilitation|pulmonary rehabilitation
383644|NCT01944072|Aerobic exercise|aerobic exercise
383645|NCT01944072|CEDOC|cedoc
383646|NCT01944072|FCM|fcm
383647|NCT01944072|UNL|unl
383648|NCT01944072|NOVA MEDICAL SCHOOL|nova medical school
383649|NCT01944046|autism, ASD, autistic, Asperger's, PDD-NOS, oxytocin|autism, asd, autistic, asperger's, pdd-nos, oxytocin
383650|NCT01944033|β2-agonist|β2-agonist
383651|NCT01944033|Ipratropium Bromide|ipratropium bromide
383652|NCT01944033|Chronic Obstructive Pulmonary Disease Exacerbation|chronic obstructive pulmonary disease exacerbation
383653|NCT01944033|Emergency departement|emergency departement
383654|NCT01944020|Sleep Apnea, Obstructive|sleep apnea, obstructive
383655|NCT01944020|Energy Balance|energy balance
383656|NCT01944020|Food Intake|food intake
383657|NCT01944020|Energy Expenditure|energy expenditure
383658|NCT01944020|Sleep|sleep
383659|NCT01944020|Obesity|obesity
383660|NCT01944007|CLP|clp
383661|NCT01943994|Psilocybin|psilocybin
383662|NCT01943994|Smoking cessation|smoking cessation
383663|NCT01943955|dizziness|dizziness
383664|NCT01943955|vertigo|vertigo
383665|NCT01943955|unsteadiness|unsteadiness
383666|NCT01943955|unbalance|unbalance
383667|NCT01943955|falls|falls
383668|NCT01943942|Mexico|mexico
383669|NCT01943942|Montelukast|montelukast
383670|NCT01943942|Pharmacokinetics|pharmacokinetics
383671|NCT01943942|Bioequivalence|bioequivalence
383672|NCT01943929|Nasal septum|nasal septum
383673|NCT01943929|Headache|headache
383674|NCT01943929|Mucosa contact point headache|mucosa contact point headache
383675|NCT01943916|breast imaging diagnosis|breast imaging diagnosis
383676|NCT01943916|breast ultrasound|breast ultrasound
383677|NCT01943916|Imagio|imagio
383678|NCT01943916|Seno Medical Instruments, Inc.|seno medical instruments, inc.
383679|NCT01943916|Seno|seno
383680|NCT01943916|opto-acoustics|opto-acoustics
383681|NCT01943916|OA|oa
383682|NCT01943916|angiogenesis|angiogenesis
383683|NCT01943916|blood map|blood map
383684|NCT01943890|Hypertonic saline|hypertonic saline
383685|NCT01943890|Lung physiotherapy|lung physiotherapy
383686|NCT01943864|pharmacokinetics|pharmacokinetics
383687|NCT01943864|second line monotherapy|second line monotherapy
383688|NCT01943864|GSK1120212 (trametinib)|gsk1120212 (trametinib)
383689|NCT01943864|MEK inhibitor|mek inhibitor
383690|NCT01943864|locally advanced or metastatic biliary tract cancers|locally advanced or metastatic biliary tract cancers
383691|NCT01943851|leukemia|leukemia
383692|NCT01943851|Acute myeloid leukemia|acute myeloid leukemia
383693|NCT01943851|BET inhibitor|bet inhibitor
383694|NCT01943851|lymphoma|lymphoma
383695|NCT01943851|Myelodysplastic syndromes|myelodysplastic syndromes
383696|NCT01943851|Oncology|oncology
383697|NCT01943851|multiple myeloma|multiple myeloma
383698|NCT01943851|GSK525762|gsk525762
383699|NCT01943825|Dengue|dengue
383700|NCT01943825|Dengue fever|dengue fever
383701|NCT01943825|CYD dengue vaccine|cyd dengue vaccine
383702|NCT01943825|IXIARO JE vaccine|ixiaro je vaccine
383703|NCT01943825|Flavivirus|flavivirus
383704|NCT01943799|Hepatitis B (HBV)|hepatitis b (hbv)
383705|NCT01943799|Oral antiviral (OAV)|oral antiviral (oav)
383706|NCT01943799|GS-4774|gs-4774
383707|NCT01943786|Wild type KRAS|wild type kras
383708|NCT01943773|delirium|delirium
383709|NCT01943773|surgery|surgery
383710|NCT01943773|operation|operation
383711|NCT01943773|geriatric|geriatric
383712|NCT01943773|complication|complication
383713|NCT01943760|Tramadol|tramadol
383714|NCT01943760|Children|children
383715|NCT01943760|Hernioplasty|hernioplasty
383716|NCT01943760|Wound infiltration|wound infiltration
383717|NCT01943747|sepsis|sepsis
383718|NCT01943747|severe sepsis|severe sepsis
383719|NCT01943747|septic shock|septic shock
383720|NCT01943747|infection|infection
383721|NCT01943747|organ dysfunction|organ dysfunction
383722|NCT01943747|quality improvement|quality improvement
383723|NCT01943734|Information|information
383724|NCT01943734|Lifestyle|lifestyle
383725|NCT01943734|Occupational Health|occupational health
383726|NCT01943695|Breast Cancer|breast cancer
383727|NCT01943695|Exercise|exercise
383728|NCT01943695|Chemotherapy|chemotherapy
383729|NCT01943695|15-178|15-178
383730|NCT01943682|Relapsed acute myeloid leukemia|relapsed acute myeloid leukemia
383731|NCT01943682|non-therapy related acute myeloid leukemia|non-therapy related acute myeloid leukemia
383732|NCT01943682|Refractory acute myeloid leukemia|refractory acute myeloid leukemia
383733|NCT01943682|Untreated acute myeloid leukemia|untreated acute myeloid leukemia
383734|NCT01943682|Lymphoma|lymphoma
383735|NCT01943682|Leukemia|leukemia
383736|NCT01943669|Spinal Cord Injury|spinal cord injury
383737|NCT01943656|Spinal Cord Injury|spinal cord injury
383738|NCT01943643|angiography, bifurcation, stenting, CT|angiography, bifurcation, stenting, ct
383739|NCT01943630|HPV condyloma acuminata|hpv condyloma acuminata
383740|NCT01943617|Liver Cirrhosis|liver cirrhosis
383741|NCT01943617|Hepatitis B|hepatitis b
383742|NCT01943617|Compensation|compensation
383743|NCT01943617|Efficacy|efficacy
383744|NCT01943604|Neuropsychology|neuropsychology
383745|NCT01943604|Breakfast eating patters|breakfast eating patters
383746|NCT01943604|Glucose|glucose
383747|NCT01943604|Child Psychology|child psychology
383748|NCT01943591|treatment trial|treatment trial
383749|NCT01943591|cerebral aneurysm|cerebral aneurysm
383750|NCT01943591|randomized|randomized
383751|NCT01943591|coils|coils
383752|NCT01943591|endovascular|endovascular
383753|NCT01943591|Aneurysm|aneurysm
383754|NCT01943591|Intracranial Aneurysm|intracranial aneurysm
383755|NCT01943591|Vascular Diseases|vascular diseases
383756|NCT01943591|Cardiovascular Diseases|cardiovascular diseases
383757|NCT01943591|Intracranial Arterial Diseases|intracranial arterial diseases
383758|NCT01943591|Cerebrovascular Disorders|cerebrovascular disorders
383759|NCT01943591|Brain Diseases|brain diseases
383760|NCT01943591|Central Nervous System Diseases|central nervous system diseases
383761|NCT01943591|Nervous System Diseases|nervous system diseases
383762|NCT01943565|Pregnancy|pregnancy
383763|NCT01943565|Healthy|healthy
383764|NCT01943565|Intrathecal|intrathecal
383765|NCT01943565|Opioids|opioids
383766|NCT01943565|Spinal|spinal
383767|NCT01943565|Anesthesia|anesthesia
383768|NCT01943565|Pain|pain
383769|NCT01943565|Cesarean|cesarean
383770|NCT01943565|Delivery|delivery
383771|NCT01943565|Human|human
383772|NCT01943526|Ireland|ireland
383773|NCT01943526|Natalizumab|natalizumab
383774|NCT01943513|Muscle Disuse Atrophy|muscle disuse atrophy
383775|NCT01943500|Breast cancer|breast cancer
383776|NCT01943500|Prostate cancer|prostate cancer
383777|NCT01943500|Colorectal cancer|colorectal cancer
383778|NCT01943500|Circulating tumor cell (CTC)|circulating tumor cell (ctc)
383779|NCT01943487|Phase I|phase i
383780|NCT01943487|Verapamil|verapamil
383781|NCT01943487|Tamsulosin OCAS|tamsulosin ocas
383782|NCT01943487|Solifenacin|solifenacin
383783|NCT01943487|Pharmacokinetics|pharmacokinetics
383784|NCT01943487|EC905|ec905
383785|NCT01943474|IV Catheter comparison|iv catheter comparison
383786|NCT01943474|AccuCath versus Conventional IV Catheters|accucath versus conventional iv catheters
383787|NCT01943474|IV Catheter Study|iv catheter study
383788|NCT01943474|IV Catheter User Preference Comparison|iv catheter user preference comparison
383789|NCT01943474|First Attempt Success Rate for IV Catheters|first attempt success rate for iv catheters
383790|NCT01943474|AccuCath Device Performance|accucath device performance
383791|NCT01943474|Complication Rates for IV Catheters|complication rates for iv catheters
383792|NCT01943474|Average Dwell Time for IV Catheters|average dwell time for iv catheters
383793|NCT01943474|Patient Satisfaction with IV Catheters|patient satisfaction with iv catheters
383794|NCT01943474|Clinician Satisfaction with AccuCath Device Performance|clinician satisfaction with accucath device performance
383795|NCT01943461|Solid Tumors|solid tumors
383796|NCT01943461|MSB0010718C|msb0010718c
383797|NCT01943461|anti PD-L1|anti pd-l1
383798|NCT01943461|avelumab|avelumab
383800|NCT01943448|Macula Lutea Hemorrhage|macula lutea hemorrhage
383801|NCT01943448|High Myopia|high myopia
383802|NCT01943448|Optical Coherence Tomography|optical coherence tomography
383803|NCT01943435|Spinal Stenosis|spinal stenosis
383804|NCT01943435|Spinal manipulation|spinal manipulation
383805|NCT01943435|Exercise|exercise
383806|NCT01943435|Epidural injection|epidural injection
383807|NCT01943422|advanced|advanced
383808|NCT01943422|melanoma|melanoma
383809|NCT01943422|Vemurafenib|vemurafenib
383810|NCT01943422|High-dose Interferon alfa-2b|high-dose interferon alfa-2b
383811|NCT01943409|Parenteral nutrition|parenteral nutrition
383812|NCT01943409|lipid emulsion|lipid emulsion
383813|NCT01943409|Intralipid|intralipid
383814|NCT01943409|ClinOleic|clinoleic
383815|NCT01943409|Inflammation|inflammation
383816|NCT01943409|Infection|infection
383817|NCT01943409|Bloodstream Infection|bloodstream infection
383818|NCT01943409|length of stay|length of stay
383819|NCT01943409|mortality|mortality
383820|NCT01943396|age-related macular degeneration|age-related macular degeneration
383822|NCT01943396|rheohemapheresis|rheohemapheresis
383823|NCT01943396|plasma filtration|plasma filtration
383824|NCT01943396|electroretinography|electroretinography
383825|NCT01943396|ERG|erg
383826|NCT01943396|multifocal ERG|multifocal erg
383827|NCT01943396|double plasma filtration|double plasma filtration
383828|NCT01943383|Hypertension|hypertension
383829|NCT01943370|endoscopic sinus surgery|endoscopic sinus surgery
383830|NCT01943370|post-operative irrigation|post-operative irrigation
383831|NCT01943370|pain|pain
383832|NCT01943370|debridement|debridement
383833|NCT01943357|diabetes|diabetes
383834|NCT01943357|patient education|patient education
788658|NCT00297375|acute|acute
383835|NCT01943357|self management|self management
383836|NCT01943357|health improvement|health improvement
383837|NCT01943344|vascular large hole closure|vascular large hole closure
383838|NCT01943344|arteriotomy closure|arteriotomy closure
383839|NCT01943344|Large hole vascular closure device|large hole vascular closure device
383840|NCT01943344|vascular closure device|vascular closure device
383841|NCT01943344|percutaneous vascular closure device|percutaneous vascular closure device
383842|NCT01943318|Liver Cirrhosis|liver cirrhosis
383843|NCT01943318|Hepatocellular carcinoma|hepatocellular carcinoma
383844|NCT01943305|Yellow Fever|yellow fever
383845|NCT01943305|vaccination|vaccination
383846|NCT01943305|Japanese encephalitis|japanese encephalitis
383847|NCT01943305|antibodies|antibodies
383848|NCT01943292|Focal Adhesion Kinase inhibitor|focal adhesion kinase inhibitor
383849|NCT01943292|FAK inhibitor|fak inhibitor
383850|NCT01943292|Cancer Stem Cells|cancer stem cells
383851|NCT01943292|CSC|csc
383852|NCT01943279|medical abortion|medical abortion
383853|NCT01943279|telephone follow-up|telephone follow-up
383854|NCT01943279|ultrasound|ultrasound
383855|NCT01943279|serum hCG|serum hcg
383856|NCT01943279|methotrexate|methotrexate
383857|NCT01943279|misoprostol|misoprostol
383858|NCT01943253|Early gastric cancer,|early gastric cancer,
383859|NCT01943253|endoscopic submucosal dissection (ESD)|endoscopic submucosal dissection (esd)
383860|NCT01943253|water-jet assisted ESD|water-jet assisted esd
383861|NCT01943227|humidity|humidity
383862|NCT01943227|enthalpy|enthalpy
383863|NCT01943227|mechanical ventilation|mechanical ventilation
383864|NCT01943214|Diabetes Mellitus|diabetes mellitus
383865|NCT01943214|Body constitution|body constitution
383866|NCT01943175|schizophrenia|schizophrenia
383867|NCT01943175|stem cells|stem cells
383868|NCT01943175|neurons|neurons
383869|NCT01943175|genetic hish risk for schizophrenia|genetic hish risk for schizophrenia
383870|NCT01943136|impetigo|impetigo
383871|NCT01943136|papaya extract ointment|papaya extract ointment
383872|NCT01943123|probiotics,|probiotics,
383873|NCT01943123|streptococcus mutans,|streptococcus mutans,
383874|NCT01943123|lactobacilli,|lactobacilli,
383875|NCT01943123|plaque index,|plaque index,
383876|NCT01943123|gingival index|gingival index
383877|NCT01943110|Intradermal injections|intradermal injections
383878|NCT01943110|Vaccine delivery devices|vaccine delivery devices
383879|NCT01943071|dementia|dementia
383880|NCT01943071|day care centre programs|day care centre programs
383881|NCT01943071|patients|patients
383882|NCT01943071|family carers|family carers
383883|NCT01943071|cost-consequence analysis|cost-consequence analysis
383884|NCT01943006|Mucopolysaccaride polysulfate (MPS)|mucopolysaccaride polysulfate (mps)
383885|NCT01943006|MPS|mps
383886|NCT01943006|Heparinoide|heparinoide
383887|NCT01943006|Infusionphlebitis|infusionphlebitis
383888|NCT01943006|Prevention|prevention
383889|NCT01943006|Superficial thrombophlebitis|superficial thrombophlebitis
383890|NCT01943006|Treatment|treatment
383891|NCT01942993|melanoma|melanoma
383892|NCT01942993|unresectable|unresectable
383893|NCT01942993|mutation|mutation
383894|NCT01942993|BRAF protein|braf protein
383895|NCT01942980|Breast cancer|breast cancer
383896|NCT01942980|one brain metastasis|one brain metastasis
383897|NCT01942967|Neonate|neonate
383898|NCT01942967|Hemodynamic|hemodynamic
383899|NCT01942967|Tissue oxygenation|tissue oxygenation
383900|NCT01942967|Non invasive ventilation|non invasive ventilation
383901|NCT01942954|Alcohol Dependence|alcohol dependence
383902|NCT01942954|Cognitive Therapy|cognitive therapy
383903|NCT01942954|Executive Function|executive function
383904|NCT01942954|Mobile Health|mobile health
383905|NCT01942954|Recovery of Function|recovery of function
383906|NCT01942954|Rehabilitation|rehabilitation
383907|NCT01942889|COPD|copd
383908|NCT01942889|exercise training|exercise training
383909|NCT01942889|pulmonary rehabilitation|pulmonary rehabilitation
383910|NCT01942889|antioxidant|antioxidant
383911|NCT01942889|muscle|muscle
383912|NCT01942876|Drugs|drugs
383913|NCT01942876|at risk|at risk
383914|NCT01942876|community health center patients|community health center patients
383915|NCT01942837|Enzalutamid|enzalutamid
383916|NCT01942837|Prostate Cancer|prostate cancer
383917|NCT01942811|DRUG PREVENTION|drug prevention
383918|NCT01942811|BINATIONAL|binational
383919|NCT01942811|CASUAL USE OF ILLICIT DRUGS|casual use of illicit drugs
383920|NCT01942811|BRIEF INTERVENTION|brief intervention
383921|NCT01942811|SBIRT|sbirt
383922|NCT01942798|Rehabilitation|rehabilitation
383923|NCT01942798|Lower Limb Amputation|lower limb amputation
383924|NCT01942798|Prosthetic|prosthetic
383925|NCT01942798|Walking|walking
383926|NCT01942798|unilateral transtibial amputation|unilateral transtibial amputation
383927|NCT01942798|unilateral transfemoral amputation|unilateral transfemoral amputation
383928|NCT01942798|older adults|older adults
383929|NCT01942798|cognitive computer games|cognitive computer games
383930|NCT01942798|home-based training|home-based training
383931|NCT01942798|Nintendo Wii|nintendo wii
383932|NCT01942798|virtual reality|virtual reality
383933|NCT01942772|powered ankle-foot orthosis|powered ankle-foot orthosis
383934|NCT01942772|mechanical structure|mechanical structure
383935|NCT01942772|optimization|optimization
383936|NCT01942772|dorsiflexion|dorsiflexion
383937|NCT01942772|plantar flexion|plantar flexion
383938|NCT01942772|gait|gait
383939|NCT01942772|servomotor|servomotor
383940|NCT01942772|ankle rehabilitation|ankle rehabilitation
383941|NCT01942759|Breast Neoplasms|breast neoplasms
383942|NCT01942759|Positron-Emission Tomography|positron-emission tomography
383943|NCT01942759|Diffusion Magnetic Resonance Imaging|diffusion magnetic resonance imaging
383944|NCT01942746|blueberry|blueberry
383945|NCT01942746|anthocyanin|anthocyanin
383946|NCT01942746|dark vision|dark vision
383947|NCT01942746|photo bleaching|photo bleaching
383948|NCT01942746|Visual Perception|visual perception
383949|NCT01942746|Photic Stimulation|photic stimulation
383950|NCT01942707|Abdominoplasty,Seroma,Bariatric surgery|abdominoplasty,seroma,bariatric surgery
383951|NCT01942694|Prediabetes|prediabetes
383952|NCT01942694|Vitamin D|vitamin d
383953|NCT01942681|female|female
383954|NCT01942681|mixed urinary incontinence|mixed urinary incontinence
383955|NCT01942668|Vasomotor symptoms|vasomotor symptoms
383956|NCT01942668|Hot flashes|hot flashes
383957|NCT01942668|Endometrial protection|endometrial protection
383959|NCT01942655|Chronic inflammatory bowel disease|chronic inflammatory bowel disease
383960|NCT01942655|Reservoirs|reservoirs
383961|NCT01942655|IL-17|il-17
383962|NCT01942655|IL-23|il-23
383963|NCT01942655|Intestinal biopsies|intestinal biopsies
383964|NCT01942642|cataract surgery, meibomian gland dysfunction, meibum expressibility, meibography|cataract surgery, meibomian gland dysfunction, meibum expressibility, meibography
383965|NCT01942629|prognostic markers,Pancreatic ductal adenocarcinoma|prognostic markers,pancreatic ductal adenocarcinoma
383966|NCT01942616|IPV|ipv
383967|NCT01942603|Minimal (SN) tumor burden|minimal (sn) tumor burden
383968|NCT01942603|Stage III|stage iii
383969|NCT01942603|Patients|patients
383970|NCT01942603|Lymphnode Dissections|lymphnode dissections
383971|NCT01942590|Pompe disease|pompe disease
383972|NCT01942577|NoSting|nosting
383973|NCT01942577|Skin protectants|skin protectants
383974|NCT01942577|Emollients|emollients
383975|NCT01942577|Skin microbiome|skin microbiome
383976|NCT01942564|traumatic brain injury|traumatic brain injury
383977|NCT01942564|photophobia|photophobia
383978|NCT01942564|photosensitivity|photosensitivity
383979|NCT01942564|pupil|pupil
383980|NCT01942538|rTMS|rtms
383981|NCT01942538|fibromyalgia|fibromyalgia
383982|NCT01942538|sham|sham
383983|NCT01942538|maintenance session|maintenance session
383984|NCT01942538|pain|pain
383985|NCT01942525|IUGR|iugr
383986|NCT01942525|aEEG|aeeg
383987|NCT01942525|preterm infants|preterm infants
383988|NCT01942525|neurodevelopmental outcome|neurodevelopmental outcome
383989|NCT01942512|Intracranial Aneurysm - Endovascular treatment -|intracranial aneurysm - endovascular treatment -
383990|NCT01942512|Coiling - Stenting - Flow diversion - Flow disruption -|coiling - stenting - flow diversion - flow disruption -
383991|NCT01942512|Recanalization - Risk factors|recanalization - risk factors
383992|NCT01942499|COPD, exercise, community|copd, exercise, community
383993|NCT01942486|migraine|migraine
383994|NCT01942486|photophobia|photophobia
383995|NCT01942486|light sensitivity|light sensitivity
383996|NCT01942486|melanopsin cells|melanopsin cells
383997|NCT01942486|intrinsically photosensitive retinal ganglion cells|intrinsically photosensitive retinal ganglion cells
383998|NCT01942460|Iron|iron
383999|NCT01942460|Anemia|anemia
384000|NCT01942460|Chronic Kidney Disease|chronic kidney disease
384001|NCT01942460|Peritoneal Dialysis|peritoneal dialysis
384002|NCT01942460|Inflammation|inflammation
384003|NCT01942460|Oxidative stress|oxidative stress
384004|NCT01942447|Fecal microbiota transplantation|fecal microbiota transplantation
384005|NCT01942447|microbiota|microbiota
384006|NCT01942447|clostridium difficile|clostridium difficile
384007|NCT01942447|clostridium difficile infection|clostridium difficile infection
384008|NCT01942447|Efficacy of FMT|efficacy of fmt
384009|NCT01942434|Fatty acids|fatty acids
384010|NCT01942434|Breast milk nutrients|breast milk nutrients
384011|NCT01942434|Cognitive development|cognitive development
384012|NCT01942434|Electrophysiology|electrophysiology
384013|NCT01942434|Long-term assessment|long-term assessment
384014|NCT01942421|Limbal deficiency|limbal deficiency
384015|NCT01942421|Cultivated limbal transplantation|cultivated limbal transplantation
384016|NCT01942421|Ex vivo limbal transplantation|ex vivo limbal transplantation
384017|NCT01942421|Cultivated autologous mucosal epithelial transplantation|cultivated autologous mucosal epithelial transplantation
384018|NCT01942408|Atrial fibrillation|atrial fibrillation
384019|NCT01942408|Pulmonary vein isolation|pulmonary vein isolation
384020|NCT01942408|Pulmonary vein reconnection|pulmonary vein reconnection
384021|NCT01942395|Diet|diet
384022|NCT01942395|Sodium|sodium
384023|NCT01942395|Hypertension|hypertension
384024|NCT01942395|Potassium|potassium
384025|NCT01942395|Antioxidants|antioxidants
384026|NCT01942395|Congestive Heart Failure|congestive heart failure
491092|NCT01467310|TNBC|tnbc
384027|NCT01942395|Heart failure with normal ejection fraction|heart failure with normal ejection fraction
384028|NCT01942395|Heart failure with preserved ejection fraction|heart failure with preserved ejection fraction
384029|NCT01942382|Schizophrenia|schizophrenia
384030|NCT01942382|JNS010|jns010
384031|NCT01942382|Paliperidone Palmitate|paliperidone palmitate
384032|NCT01942382|Clinical Pharmacology|clinical pharmacology
384033|NCT01942369|Endometriosis|endometriosis
384034|NCT01942304|Sinus Floor Augmentation|sinus floor augmentation
384035|NCT01942304|Maxillary Sinus|maxillary sinus
384036|NCT01942304|Bone Substitutes|bone substitutes
384037|NCT01942304|Bone Regeneration|bone regeneration
384038|NCT01942291|Niacin|niacin
384039|NCT01942291|Endothelial function|endothelial function
384040|NCT01942291|Laropiprant|laropiprant
384041|NCT01942291|HDL|hdl
384042|NCT01942278|Healthcare|healthcare
384043|NCT01942278|Patients|patients
384044|NCT01942265|Influenza, Immunogenicity, Monovalent, A/H7N9, Vaccine, AS03, Adjuvant|influenza, immunogenicity, monovalent, a/h7n9, vaccine, as03, adjuvant
384045|NCT01942252|Secondhand smoking, pain, postoperative complications|secondhand smoking, pain, postoperative complications
384046|NCT01942239|hypoglycemia|hypoglycemia
384047|NCT01942239|very low birth weight neonate|very low birth weight neonate
384048|NCT01942239|continuous glucose monitoring|continuous glucose monitoring
384049|NCT01942226|Dry eye syndrome|dry eye syndrome
384050|NCT01942213|Macular|macular
384051|NCT01942213|Degeneration|degeneration
384052|NCT01942213|Age related|age related
384053|NCT01942213|Neovascular|neovascular
384054|NCT01942200|carcinoma|carcinoma
384055|NCT01942200|colon cancer|colon cancer
384056|NCT01942200|colorectal cancer|colorectal cancer
384057|NCT01942200|ambulant chemotherapy|ambulant chemotherapy
384058|NCT01942200|treatment cycles|treatment cycles
384059|NCT01942200|Oxaliplatin|oxaliplatin
384060|NCT01942200|Oxaliplatin onkovis|oxaliplatin onkovis
384061|NCT01942200|Quantity of Oxaliplatin|quantity of oxaliplatin
384062|NCT01942200|Packaging Sizes|packaging sizes
384063|NCT01942174|Antipneumococcal vaccination|antipneumococcal vaccination
384064|NCT01942174|Methotrexate treatment|methotrexate treatment
384065|NCT01942161|Schyzophrenia, pediatric patients|schyzophrenia, pediatric patients
384066|NCT01942148|Schizophrenia, Pediatric patients|schizophrenia, pediatric patients
384067|NCT01942135|Palbociclib (PD-0332991)|palbociclib (pd-0332991)
384068|NCT01942135|Fulvestrant|fulvestrant
384069|NCT01942135|Goserelin|goserelin
384070|NCT01942135|Hormone receptor-+|hormone receptor-+
384071|NCT01942135|HER2-negative|her2-negative
384072|NCT01942135|Prior Endocrine treatment|prior endocrine treatment
384073|NCT01942135|any menopausal status|any menopausal status
384074|NCT01942135|PALOMA-3|paloma-3
384075|NCT01942122|DLBS1442|dlbs1442
384076|NCT01942122|Endometriosis|endometriosis
384077|NCT01942122|Pain|pain
384078|NCT01942122|Visual Analogue Scale|visual analogue scale
384079|NCT01942122|Endometriosis Health Profile (EHP-30TM)|endometriosis health profile (ehp-30tm)
384080|NCT01942109|heart failure|heart failure
384081|NCT01942109|diuretics|diuretics
384082|NCT01942109|furosemide|furosemide
384083|NCT01942109|torasemide|torasemide
384084|NCT01942070|Cardiovascular Disease|cardiovascular disease
384085|NCT01942070|Myocardial Infarction|myocardial infarction
384086|NCT01942070|Bioresorbable vascular scaffold|bioresorbable vascular scaffold
384087|NCT01942070|Durable polymer everolimus-eluting stent|durable polymer everolimus-eluting stent
384088|NCT01942070|Primary angioplasty|primary angioplasty
384089|NCT01942070|Stent|stent
384090|NCT01942044|Shear stress|shear stress
384091|NCT01942044|Optical coherence tomography|optical coherence tomography
384092|NCT01942044|Drug-eluting stents|drug-eluting stents
384093|NCT01942031|Ischemic stroke|ischemic stroke
384094|NCT01942031|Hemorrhagic stroke|hemorrhagic stroke
384095|NCT01942031|TIA|tia
384096|NCT01942031|Atrial fibrillation|atrial fibrillation
384097|NCT01942031|prevention|prevention
384098|NCT01942031|primary care|primary care
384099|NCT01942018|esophagogastric junction outflow obstruction|esophagogastric junction outflow obstruction
384100|NCT01942018|EGOO|egoo
384101|NCT01942018|Per oral endoscopic myotomy|per oral endoscopic myotomy
384102|NCT01942018|POEM|poem
384103|NCT01942018|Gastroesophageal reflux disease|gastroesophageal reflux disease
384104|NCT01942018|GERD|gerd
384105|NCT01941992|head and neck|head and neck
384106|NCT01941992|Squamous Cell Carcinoma|squamous cell carcinoma
384107|NCT01941992|oral mucositis|oral mucositis
384108|NCT01941992|Chemo-radiotherapy|chemo-radiotherapy
384109|NCT01941966|Anal canal cancer;capecitabine; mitomycin; radiotherapy.|anal canal cancer;capecitabine; mitomycin; radiotherapy.
384110|NCT01941953|Metformin|metformin
384111|NCT01941953|Metastatic Colorectal Cancer|metastatic colorectal cancer
384112|NCT01941953|Fluorouracil|fluorouracil
384113|NCT01941927|Melanoma|melanoma
384114|NCT01941927|Wild-type|wild-type
384115|NCT01941927|BRAF|braf
384116|NCT01941914|Calcium electroporation|calcium electroporation
384117|NCT01941914|calcium|calcium
788659|NCT00297375|migraine|migraine
384118|NCT01941914|electroporation|electroporation
384119|NCT01941914|electrotransfer|electrotransfer
384120|NCT01941914|keloid|keloid
384121|NCT01941901|Cutaneous metastases|cutaneous metastases
384122|NCT01941875|controlled ovarian hyperstimulation|controlled ovarian hyperstimulation
384123|NCT01941875|gonadotropins|gonadotropins
384124|NCT01941875|intrauterine insemination|intrauterine insemination
384125|NCT01941875|infertility|infertility
384126|NCT01941875|luteal progesterone|luteal progesterone
384127|NCT01941862|computerized intervention|computerized intervention
384128|NCT01941862|cognitive bias modification|cognitive bias modification
384129|NCT01941862|anxiety|anxiety
384130|NCT01941862|mood|mood
384131|NCT01941862|perceived burdensomeness|perceived burdensomeness
384132|NCT01941862|thwarted belongingness|thwarted belongingness
384133|NCT01941862|suicide|suicide
384134|NCT01941862|post-traumatic stress disorder|post-traumatic stress disorder
384135|NCT01941849|Phaeochromocytoma|phaeochromocytoma
384136|NCT01941849|Paraganglioma|paraganglioma
384137|NCT01941849|Neuroendocrine Tumour|neuroendocrine tumour
384138|NCT01941849|Vandetanib|vandetanib
384139|NCT01941849|131I-mIBG|131i-mibg
384140|NCT01941849|Radionucleotide Therapy|radionucleotide therapy
384141|NCT01941849|Vascular Endothelial Growth Factor (VEGF)|vascular endothelial growth factor (vegf)
384142|NCT01941849|Epidermal Growth Factor Receptor (EGFR)|epidermal growth factor receptor (egfr)
384143|NCT01941849|RET|ret
384144|NCT01941849|Tyrosine Kinase|tyrosine kinase
384145|NCT01941836|Statin intolerant|statin intolerant
384146|NCT01941836|Statin tolerant|statin tolerant
384147|NCT01941836|LDL|ldl
384148|NCT01941836|Cholesterol|cholesterol
384149|NCT01941823|acute renal failure|acute renal failure
384150|NCT01941823|CRRT|crrt
384151|NCT01941823|continuous dialysis|continuous dialysis
384152|NCT01941823|carnitine|carnitine
384153|NCT01941823|cardiac strain|cardiac strain
384154|NCT01941771|Breast cancer|breast cancer
384155|NCT01941771|Metronomic chemotherapy|metronomic chemotherapy
384156|NCT01941771|Vinorelbine|vinorelbine
384157|NCT01941771|Navelbine|navelbine
384158|NCT01941771|Capecitabine|capecitabine
384159|NCT01941771|Xeloda|xeloda
384160|NCT01941771|Antineoplastic Agents|antineoplastic agents
384161|NCT01941719|Diabetes Mellitus|diabetes mellitus
384162|NCT01941719|Diabetic Foot|diabetic foot
384163|NCT01941719|Diabetic Peripheral Neuropathy|diabetic peripheral neuropathy
384164|NCT01941719|Diabetic Foot Education|diabetic foot education
384165|NCT01941706|Epilepsy|epilepsy
384166|NCT01941706|Seizure|seizure
384167|NCT01941706|Cognitive Behavioral Therapy|cognitive behavioral therapy
384168|NCT01941706|Mindfulness|mindfulness
384169|NCT01941706|Depression|depression
384170|NCT01941706|Depressive symptoms|depressive symptoms
384171|NCT01941706|prevention|prevention
384172|NCT01941706|Coping skills|coping skills
384173|NCT01941706|Quality of life|quality of life
384174|NCT01941706|Telehealth|telehealth
384175|NCT01941706|Phone intervention|phone intervention
384176|NCT01941706|Internet-based intervention|internet-based intervention
384177|NCT01941693|alcohol|alcohol
384178|NCT01941693|anxiety|anxiety
384179|NCT01941693|depression|depression
384180|NCT01941693|comorbidity|comorbidity
384181|NCT01941693|CBT|cbt
384182|NCT01941667|Congenital Heart Disease|congenital heart disease
384183|NCT01941667|Neonates and infants|neonates and infants
384184|NCT01941667|Telehealth|telehealth
384185|NCT01941667|Virtual Home Visits|virtual home visits
384186|NCT01941628|Cesarean section|cesarean section
384187|NCT01941628|General anesthesia|general anesthesia
384188|NCT01941628|neuromuscular blockade|neuromuscular blockade
384189|NCT01941628|Surgical conditions|surgical conditions
384190|NCT01941602|surgery|surgery
384191|NCT01941602|enoxaparin|enoxaparin
384192|NCT01941602|venous thromboembolism|venous thromboembolism
384193|NCT01941602|perioperative care|perioperative care
384194|NCT01941576|Heart defects, Congenital|heart defects, congenital
384195|NCT01941576|rhBNP|rhbnp
384196|NCT01941576|heart failure|heart failure
384197|NCT01941550|untreated, high risk prostate cancer|untreated, high risk prostate cancer
384198|NCT01941537|Atopic Dermatitis|atopic dermatitis
384199|NCT01941524|Brain oxygenation|brain oxygenation
384200|NCT01941524|NIRS|nirs
384201|NCT01941524|aEEG|aeeg
384202|NCT01941524|surfactant|surfactant
384203|NCT01941511|QTc|qtc
384204|NCT01941511|African-American|african-american
384205|NCT01941511|GMI-1070|gmi-1070
384206|NCT01941511|QT/QTc interval prolongation|qt/qtc interval prolongation
384207|NCT01941498|nearsighted|nearsighted
384208|NCT01941498|farsighted|farsighted
384209|NCT01941498|astigmatism|astigmatism
384210|NCT01941498|LASIK|lasik
384211|NCT01941498|refractive surgery|refractive surgery
384212|NCT01941498|WaveLight|wavelight
384213|NCT01941485|nearsighted|nearsighted
384214|NCT01941485|astigmatism|astigmatism
384215|NCT01941485|LASIK|lasik
384216|NCT01941485|refractive surgery|refractive surgery
384217|NCT01941485|WaveLight|wavelight
384218|NCT01941459|CK-MB|ck-mb
384219|NCT01941459|troponin-T|troponin-t
788660|NCT00297375|headache|headache
384220|NCT01941433|rheumatoid arthritis|rheumatoid arthritis
384221|NCT01941433|self-management|self-management
384222|NCT01941433|online|online
384223|NCT01941433|patient passport|patient passport
384224|NCT01941420|CK-MB|ck-mb
384225|NCT01941420|troponin-T|troponin-t
384226|NCT01941420|Cytokines under ischemia|cytokines under ischemia
384227|NCT01941394|GVHD|gvhd
384228|NCT01941394|Relapse|relapse
384229|NCT01941394|Overall Survival|overall survival
384230|NCT01941381|Otitis Media|otitis media
384231|NCT01941381|Tympanometry|tympanometry
384232|NCT01941368|Performance|performance
384233|NCT01941368|Aerobic Exercise|aerobic exercise
384234|NCT01941342|Obstructive Jaundice|obstructive jaundice
384235|NCT01941342|Preoperative Biliary Drainage|preoperative biliary drainage
384236|NCT01941342|Pancreatoduodenectomy|pancreatoduodenectomy
384237|NCT01941329|Diabetes|diabetes
384238|NCT01941329|Proliferative Retinopathy|proliferative retinopathy
384239|NCT01941329|Ranibizumab|ranibizumab
384240|NCT01941329|Panretinal Photocoagulation|panretinal photocoagulation
384241|NCT01941316|Carfilzomib|carfilzomib
384242|NCT01941316|Irinotecan|irinotecan
384243|NCT01941316|Small Cell Lung Cancer|small cell lung cancer
384244|NCT01941316|Non Small Cell Lung Cancer|non small cell lung cancer
384245|NCT01941316|Ovarian Cancer|ovarian cancer
384246|NCT01941316|Gastric Cancer|gastric cancer
384247|NCT01941316|Esophageal Cancer|esophageal cancer
384248|NCT01941316|Cervical Cancer|cervical cancer
384249|NCT01941303|Non-small cell lung cancer|non-small cell lung cancer
384250|NCT01941290|International|international
384251|NCT01941290|Multicenter|multicenter
384252|NCT01941290|Observational registry|observational registry
384253|NCT01941290|Orsiro Drug Eluting Stents (DES)|orsiro drug eluting stents (des)
384254|NCT01941290|Stenting|stenting
384255|NCT01941290|Treatment of Coronary Artery Disease|treatment of coronary artery disease
384256|NCT01941290|Coronary Revascularization|coronary revascularization
384257|NCT01941290|Percutaneous Coronary Intervention (PCI)|percutaneous coronary intervention (pci)
384258|NCT01941290|Diabetes Mellitus Type 1|diabetes mellitus type 1
384259|NCT01941290|Diabetes Mellitus Type 2|diabetes mellitus type 2
384260|NCT01941290|STEMI|stemi
384261|NCT01941290|NSTEMI|nstemi
384262|NCT01941290|Ischemia|ischemia
384263|NCT01941290|Angina|angina
384264|NCT01941290|Subgroups|subgroups
384265|NCT01941290|Acute Myocardial Infarction|acute myocardial infarction
384266|NCT01941290|Small Vessels|small vessels
384267|NCT01941290|Chronic Total Occlusion|chronic total occlusion
384268|NCT01941264|malaria|malaria
384269|NCT01941264|placenta|placenta
384270|NCT01941264|pregnancy|pregnancy
384271|NCT01941264|plasmodium falciparum|plasmodium falciparum
384272|NCT01941264|screening and treatment|screening and treatment
384273|NCT01941264|rapid diagnostic test|rapid diagnostic test
384274|NCT01941264|coartem|coartem
384275|NCT01941264|artemether-lumefantrine|artemether-lumefantrine
384276|NCT01941264|community health worker|community health worker
384277|NCT01941251|Transcranial Magnetic Stimulation|transcranial magnetic stimulation
384278|NCT01941251|Repetitive Transcranial Magnetic Stimulation|repetitive transcranial magnetic stimulation
384279|NCT01941251|Schizophrenia|schizophrenia
384280|NCT01941251|Schizoaffective Disorder|schizoaffective disorder
384281|NCT01941251|Treatment|treatment
384282|NCT01941251|Negative Symptoms|negative symptoms
384283|NCT01941251|Positive Symptoms|positive symptoms
384284|NCT01941251|TMS|tms
384285|NCT01941251|rTMS|rtms
384286|NCT01941238|Ramadan|ramadan
384287|NCT01941238|Fasting|fasting
384288|NCT01941238|Diabetes|diabetes
384289|NCT01941238|Type1|type1
384290|NCT01941238|Insulin|insulin
384291|NCT01941238|Pump|pump
384292|NCT01941225|Chronic obstructive pulmonary disease|chronic obstructive pulmonary disease
384293|NCT01941225|Pulmonary vasculature|pulmonary vasculature
384294|NCT01941225|Inhaled iloprost|inhaled iloprost
384295|NCT01941225|Inhaled prostacyclin|inhaled prostacyclin
384296|NCT01941225|Dynamic hyperinflation|dynamic hyperinflation
384297|NCT01941225|Oxidative stress|oxidative stress
384298|NCT01941225|Cardiopulmonary exercise testing|cardiopulmonary exercise testing
384299|NCT01941225|B-type natriuretic peptide|b-type natriuretic peptide
384300|NCT01941212|Music therapy|music therapy
384301|NCT01941212|pain|pain
384302|NCT01941212|gynecological surgeries|gynecological surgeries
384303|NCT01941186|Children|children
384304|NCT01941186|Developmental Delays|developmental delays
384305|NCT01941186|Early Intervention (EI)|early intervention (ei)
384306|NCT01941186|Patient Decision Aid (PDA)|patient decision aid (pda)
384307|NCT01941147|Acute Stroke|acute stroke
384308|NCT01941147|Brain Ischemia|brain ischemia
384309|NCT01941147|Extremely Low Frequency Magnetic Fields|extremely low frequency magnetic fields
384310|NCT01941121|HIV Screening|hiv screening
384311|NCT01941121|Linkage to PrEP|linkage to prep
384312|NCT01941121|Linkage to Care|linkage to care
384313|NCT01941121|CCTG|cctg
384314|NCT01941121|593|593
384315|NCT01941108|AIDS|aids
384316|NCT01941108|peer navigation|peer navigation
384317|NCT01941108|ecological momentary assessment|ecological momentary assessment
384318|NCT01941108|eMOCHA|emocha
491443|NCT01466114|RRMS|rrms
384319|NCT01941108|Baltimore|baltimore
384320|NCT01941108|IDU|idu
384321|NCT01941030|Peripheral Artery Disease|peripheral artery disease
384322|NCT01941030|Critical Limb Ischemia|critical limb ischemia
384323|NCT01941030|Orbital Atherectomy|orbital atherectomy
384324|NCT01941030|Balloon Angioplasty|balloon angioplasty
384325|NCT01941030|Intravascular Ultrasound (IVUS)|intravascular ultrasound (ivus)
384326|NCT01941030|Fractional Flow Reserve (FFR)|fractional flow reserve (ffr)
384327|NCT01941004|multiple sclerosis (MS)|multiple sclerosis (ms)
384328|NCT01941004|relapsing remitting multiple sclerosis (RRMS)|relapsing remitting multiple sclerosis (rrms)
384329|NCT01941004|fingolimod|fingolimod
384330|NCT01940978|Methamphetamine|methamphetamine
384331|NCT01940978|Methylphenidate|methylphenidate
384332|NCT01940978|ADHD|adhd
384333|NCT01940939|schizophrenia|schizophrenia
384334|NCT01940926|rheumatoid arthritis|rheumatoid arthritis
384335|NCT01940926|angiogenesis|angiogenesis
384336|NCT01940926|68Ga-PRGD2|68ga-prgd2
384337|NCT01940926|18F-FDG|18f-fdg
384338|NCT01940926|positron emission tomography/computed tomography|positron emission tomography/computed tomography
384339|NCT01940900|Wet AMD|wet amd
384340|NCT01940900|choroidal neovascularization|choroidal neovascularization
384341|NCT01940900|Fovista®|fovista®
384342|NCT01940900|E10030|e10030
384343|NCT01940900|Lucentis®|lucentis®
384344|NCT01940887|Wet AMD|wet amd
384345|NCT01940887|choroidal neovascularization|choroidal neovascularization
384346|NCT01940887|Fovista®|fovista®
384347|NCT01940887|E10030|e10030
384348|NCT01940887|Avastin®|avastin®
384349|NCT01940887|Eylea®|eylea®
384350|NCT01940874|Cerebral Oximetry.|cerebral oximetry.
384351|NCT01940874|Aortic valve stenosis.|aortic valve stenosis.
384352|NCT01940874|Aortic valve regurgitation.|aortic valve regurgitation.
384353|NCT01940874|Coronary artery disease.|coronary artery disease.
384354|NCT01940848|Iberogast|iberogast
384355|NCT01940848|efficacy|efficacy
384356|NCT01940848|safety|safety
384357|NCT01940796|Brentuximab Vedotin|brentuximab vedotin
384358|NCT01940796|GVHD|gvhd
384359|NCT01940796|Refractory Chronic Graft vs Host Disease|refractory chronic graft vs host disease
384360|NCT01940770|Diabetes Mellitus(DM)|diabetes mellitus(dm)
384361|NCT01940770|Bydureon|bydureon
384362|NCT01940770|Exenatide|exenatide
384363|NCT01940757|Necator americanus|necator americanus
384364|NCT01940757|Hookworm Infection|hookworm infection
384365|NCT01940757|Experimental challenge infection|experimental challenge infection
384366|NCT01940744|Low back pain|low back pain
384367|NCT01940744|Non-specific Low back pain|non-specific low back pain
384368|NCT01940718|Priapism|priapism
384369|NCT01940718|Sickle cell disease|sickle cell disease
384370|NCT01940718|Testosterone|testosterone
384371|NCT01940718|Androgen deficiency|androgen deficiency
384372|NCT01940705|hearing aids|hearing aids
384373|NCT01940705|counseling|counseling
384374|NCT01940705|outcomes assessment (health care)|outcomes assessment (health care)
384375|NCT01940705|rehabilitation|rehabilitation
384376|NCT01940666|Hyperandrogenism/|hyperandrogenism/
384377|NCT01940666|FAI/|fai/
384378|NCT01940666|Metabolic syndrome/|metabolic syndrome/
384379|NCT01940666|Adipocytokines/|adipocytokines/
384380|NCT01940666|Insulin resistance.|insulin resistance.
384381|NCT01940640|neonates, DHA|neonates, dha
384382|NCT01940627|Ubiquinol, exercise|ubiquinol, exercise
384383|NCT01940614|Copeptin|copeptin
384384|NCT01940614|differential diagnosis of polyuria polydipsia syndrome|differential diagnosis of polyuria polydipsia syndrome
384385|NCT01940614|diabetes insipidus|diabetes insipidus
384386|NCT01940614|compulsive water drinking|compulsive water drinking
384387|NCT01940614|water deprivation test|water deprivation test
384484|NCT01940198|sydney|sydney
384485|NCT01940159|Schizophrenia|schizophrenia
384388|NCT01940614|Diabetes insipidus (central and nephrogenic)|diabetes insipidus (central and nephrogenic)
384389|NCT01940601|solid tumors|solid tumors
384390|NCT01940601|balugrastim|balugrastim
384391|NCT01940575|Tissue restorative biomaterial|tissue restorative biomaterial
384392|NCT01940575|Hyaluronic acid|hyaluronic acid
384393|NCT01940575|Restylane®|restylane®
384394|NCT01940575|Wrinkle Severity Rating Scale (WSRS)|wrinkle severity rating scale (wsrs)
384395|NCT01940575|Global Aesthetic Improvement Scale (GAIS)|global aesthetic improvement scale (gais)
384396|NCT01940575|Nasolabial fold(NLF)|nasolabial fold(nlf)
384397|NCT01940562|cord blood transplantation|cord blood transplantation
384398|NCT01940562|platelets|platelets
384399|NCT01940562|eltrombopag|eltrombopag
384400|NCT01940549|PTSD|ptsd
384401|NCT01940549|tDCS|tdcs
384402|NCT01940549|Trauma|trauma
384403|NCT01940536|Hip Fracture|hip fracture
384404|NCT01940536|Blood Transfusion|blood transfusion
384405|NCT01940536|Blood Loss|blood loss
384406|NCT01940536|Tranexamic Acid|tranexamic acid
384407|NCT01940523|total knee arthroplasty|total knee arthroplasty
384408|NCT01940523|total knee replacement|total knee replacement
384409|NCT01940523|tranexamic acid|tranexamic acid
384410|NCT01940523|osteoarthritis|osteoarthritis
788872|NCT00296712|Bupropion|bupropion
384411|NCT01940523|degenerative joint disease|degenerative joint disease
384412|NCT01940471|Hepatitis|hepatitis
384413|NCT01940471|Tenofovir|tenofovir
384414|NCT01940471|Viread|viread
384415|NCT01940432|simple stress urinary incontinence|simple stress urinary incontinence
384416|NCT01940419|Reduction of blood loss|reduction of blood loss
384417|NCT01940419|Surgical complication|surgical complication
384418|NCT01940419|Hysterectomy|hysterectomy
384419|NCT01940419|Antifibrinolytic Agents|antifibrinolytic agents
384420|NCT01940419|Randomized Controlled Trials|randomized controlled trials
384421|NCT01940406|Essential Tremor|essential tremor
384422|NCT01940406|Parkinson Disease|parkinson disease
384423|NCT01940406|Electrical Stimulation|electrical stimulation
384424|NCT01940406|Tremor|tremor
384425|NCT01940393|urticaria|urticaria
384426|NCT01940393|bilastine|bilastine
384427|NCT01940393|fexofenadine|fexofenadine
384428|NCT01940393|cetirizine|cetirizine
384429|NCT01940393|ebastine|ebastine
384430|NCT01940393|desloratadine|desloratadine
384431|NCT01940367|Overactive Bladder|overactive bladder
384432|NCT01940367|TENS|tens
384433|NCT01940367|PTNS|ptns
384434|NCT01940367|Electrical Nerve Stimulation|electrical nerve stimulation
384435|NCT01940367|Urge Urinary Incontinence|urge urinary incontinence
384436|NCT01940354|IV Catheter comparison|iv catheter comparison
384437|NCT01940354|AccuCath versus Conventional IV Catheters|accucath versus conventional iv catheters
384438|NCT01940354|IV Catheter Study|iv catheter study
384439|NCT01940354|IV Catheter User Preference Comparison|iv catheter user preference comparison
384440|NCT01940354|First Attempt Success Rate for IV Catheters|first attempt success rate for iv catheters
384441|NCT01940354|AccuCath Device Performance|accucath device performance
384442|NCT01940354|Patient Satisfaction with IV Catheters|patient satisfaction with iv catheters
384443|NCT01940354|Clinician Satisfaction with AccuCath Device Performance|clinician satisfaction with accucath device performance
384444|NCT01940341|Hepatitis|hepatitis
384445|NCT01940341|Tenofovir|tenofovir
384446|NCT01940341|Viread|viread
384447|NCT01940328|Ultrasound Doppler|ultrasound doppler
384448|NCT01940328|Congestive heart failure|congestive heart failure
384449|NCT01940328|Pulmonary Edema|pulmonary edema
384450|NCT01940315|Defender Study|defender study
384451|NCT01940315|experimental vaccine|experimental vaccine
384452|NCT01940315|inhalational intoxication|inhalational intoxication
384453|NCT01940302|Malnutrition; Metabolic disorders|malnutrition; metabolic disorders
384454|NCT01940289|algometry|algometry
384455|NCT01940289|pain|pain
384457|NCT01940276|Prostate cancer|prostate cancer
384458|NCT01940276|metastatic|metastatic
384459|NCT01940276|castrate resistant|castrate resistant
384460|NCT01940276|abiraterone acetate|abiraterone acetate
384461|NCT01940276|prednisone|prednisone
384462|NCT01940276|metastatic prostate cancer|metastatic prostate cancer
384463|NCT01940263|oxidative stress|oxidative stress
384464|NCT01940263|dyslipidemia|dyslipidemia
384465|NCT01940263|inflammation|inflammation
384466|NCT01940263|apoptosis|apoptosis
384467|NCT01940250|Hand, foot and mouth disease|hand, foot and mouth disease
384468|NCT01940250|Autonomic nervous system dysregulation|autonomic nervous system dysregulation
384469|NCT01940250|Magnesium sulphate|magnesium sulphate
384470|NCT01940237|Depression|depression
384471|NCT01940237|Psychotherapy|psychotherapy
384472|NCT01940237|Cancer|cancer
384473|NCT01940237|Pancreatic Cancer|pancreatic cancer
384474|NCT01940237|Lung Cancer|lung cancer
384475|NCT01940237|Colon Cancer|colon cancer
384476|NCT01940237|Prostate Cancer|prostate cancer
384477|NCT01940224|Pregabalin|pregabalin
384478|NCT01940224|Laparoscopic colorectal surgery|laparoscopic colorectal surgery
384479|NCT01940224|Postoperative pain|postoperative pain
384480|NCT01940224|Opioid consumption|opioid consumption
384481|NCT01940198|Atazanavir|atazanavir
384482|NCT01940198|long-term|long-term
384483|NCT01940198|primary care setting|primary care setting
384486|NCT01940159|Schizoaffective disorders|schizoaffective disorders
384487|NCT01940120|Mitral Valve Insufficiency|mitral valve insufficiency
384488|NCT01940120|Mitral Valve Regurgitation|mitral valve regurgitation
384489|NCT01940120|Mitral Valve Incompetence|mitral valve incompetence
384490|NCT01940120|Mitral Regurgitation|mitral regurgitation
384491|NCT01940120|Mitral Insufficiency|mitral insufficiency
384492|NCT01940120|Mitral Valve|mitral valve
384493|NCT01940120|MR|mr
384494|NCT01940120|Mitral Valve Prolapse|mitral valve prolapse
384495|NCT01940120|Edge to Edge (E2E)|edge to edge (e2e)
384496|NCT01940120|Alfieri Technique|alfieri technique
384497|NCT01940120|MitraClip|mitraclip
384498|NCT01940120|Functional MR|functional mr
384499|NCT01940120|Degenerative MR|degenerative mr
384500|NCT01940120|Echocardiogram|echocardiogram
384501|NCT01940120|Coronary Artery Disease (CAD)|coronary artery disease (cad)
384502|NCT01940120|Heart Failure|heart failure
384503|NCT01940120|Heart Attack|heart attack
384504|NCT01940120|EVEREST|everest
384505|NCT01940120|EVEREST I|everest i
384506|NCT01940120|EVEREST II|everest ii
384507|NCT01940120|REALISM|realism
384508|NCT01940107|breast cancer,|breast cancer,
789524|NCT00295048|cognition|cognition
384509|NCT01940107|radiotherapy,|radiotherapy,
384510|NCT01940107|physical therapy,|physical therapy,
384511|NCT01940107|upper limb|upper limb
384512|NCT01940094|Granulomatosis with polyangiitis|granulomatosis with polyangiitis
384513|NCT01940094|Wegener's granulomatosis|wegener's granulomatosis
384514|NCT01940094|WG|wg
384515|NCT01940094|GPA|gpa
384516|NCT01940094|ANCA-Associated Vasculitis|anca-associated vasculitis
384517|NCT01940094|AAV|aav
384518|NCT01940094|Vasculitis|vasculitis
384519|NCT01940094|Prednisone|prednisone
384520|NCT01940094|Glucocorticoid|glucocorticoid
384521|NCT01940094|Taper|taper
384522|NCT01940081|Cardiomyopathy, Dilated|cardiomyopathy, dilated
384523|NCT01940081|Tachycardia, Ventricular|tachycardia, ventricular
384524|NCT01940081|Ventricular Fibrillation|ventricular fibrillation
384525|NCT01940081|Arrhythmias, Cardiac/etiology|arrhythmias, cardiac/etiology
384526|NCT01940081|Arrhythmias, Cardiac/physiopathology|arrhythmias, cardiac/physiopathology
384527|NCT01940081|Magnetic Resonance Imaging|magnetic resonance imaging
384528|NCT01940081|3-Iodobenzylguanidine/diagnostic use|3-iodobenzylguanidine/diagnostic use
384529|NCT01940081|Sympathetic Nervous System/radionuclide imaging|sympathetic nervous system/radionuclide imaging
384530|NCT01940081|Electrophysiologic Techniques, Cardiac|electrophysiologic techniques, cardiac
384531|NCT01940081|Biopsy|biopsy
384532|NCT01940081|Genetic Testing|genetic testing
384533|NCT01940081|Echocardiography|echocardiography
384534|NCT01940081|Electrocardiography, Ambulatory|electrocardiography, ambulatory
384535|NCT01940081|Exercise Test|exercise test
384536|NCT01940068|Hypersensitivity|hypersensitivity
384537|NCT01940068|Milk Hypersensitivity|milk hypersensitivity
384538|NCT01940068|Immune System Diseases|immune system diseases
384539|NCT01940068|Food Hypersensitivity|food hypersensitivity
384540|NCT01940055|Balance|balance
384541|NCT01940055|Gait|gait
384542|NCT01940055|Instrumented Treadmill|instrumented treadmill
384543|NCT01940055|Recumbent cycle|recumbent cycle
384544|NCT01940055|Cognitive games|cognitive games
384545|NCT01940029|vancomycin, neurosurgery, critical ill, pharmacokinetics|vancomycin, neurosurgery, critical ill, pharmacokinetics
384546|NCT01940016|Feasibility study|feasibility study
384547|NCT01940016|Interactive voice response system (IVR)|interactive voice response system (ivr)
384548|NCT01940016|health coach|health coach
384549|NCT01940016|no evidence of disease|no evidence of disease
384550|NCT01940003|Diabetes, Gestational|diabetes, gestational
384551|NCT01940003|Pregnancy Outcome|pregnancy outcome
384552|NCT01940003|Exercise|exercise
384553|NCT01940003|glycemic control|glycemic control
384554|NCT01939990|Chronic Obstructive Pulmonary Disease|chronic obstructive pulmonary disease
384555|NCT01939977|Hyperparathyroidism|hyperparathyroidism
384556|NCT01939977|Hyperparathyroidism Secondary|hyperparathyroidism secondary
384557|NCT01939977|Paricalcitol|paricalcitol
384558|NCT01939977|Calcifediol|calcifediol
384559|NCT01939977|Parathyroid hormone|parathyroid hormone
384560|NCT01939977|Renal transplantation|renal transplantation
384561|NCT01939964|Wrinkles|wrinkles
384562|NCT01939964|Activation Mist|activation mist
384563|NCT01939951|Asthma|asthma
384564|NCT01939951|Persistent|persistent
384565|NCT01939925|patient education|patient education
384566|NCT01939925|Health Knowledge, Attitudes, Practice|health knowledge, attitudes, practice
384567|NCT01939925|comprehension|comprehension
384568|NCT01939925|consumer health information|consumer health information
384569|NCT01939899|MLN9708|mln9708
384570|NCT01939899|Lymphoma|lymphoma
384571|NCT01939899|IXAZOMIB|ixazomib
384572|NCT01939886|Malaria treatment efficacy|malaria treatment efficacy
384573|NCT01939886|Malaria transmission|malaria transmission
384574|NCT01939873|Kristeller maneuver; Second stage of labor;|kristeller maneuver; second stage of labor;
384575|NCT01939873|Perineal laceration; Obstetrical outcome;|perineal laceration; obstetrical outcome;
384576|NCT01939873|Neonatal outcome|neonatal outcome
384577|NCT01939847|Metastatic breast cancer|metastatic breast cancer
384578|NCT01939847|Breast cancer|breast cancer
384579|NCT01939847|Molecular profiling|molecular profiling
384580|NCT01939847|Personalized medicine|personalized medicine
384581|NCT01939834|Type 1 Diabetes Mellitus|type 1 diabetes mellitus
384582|NCT01939834|Artificial Pancreas|artificial pancreas
384583|NCT01939834|Diabetes Assistant (DiAs)|diabetes assistant (dias)
384584|NCT01939834|Continuous Glucose Monitor|continuous glucose monitor
384585|NCT01939821|Fecal incontinence|fecal incontinence
384586|NCT01939821|attitudes|attitudes
384587|NCT01939821|knowledge|knowledge
384588|NCT01939821|quality of care|quality of care
384589|NCT01939795|cardiac resynchronization therapy (CRT)|cardiac resynchronization therapy (crt)
384590|NCT01939782|Metabolic CLock Genes (MCG)|metabolic clock genes (mcg)
384591|NCT01939782|Type 2 Diabetes (T2D)|type 2 diabetes (t2d)
384592|NCT01939769|fMRI|fmri
384593|NCT01939769|Catecholamines|catecholamines
384594|NCT01939769|Stress|stress
384595|NCT01939769|Exercise|exercise
384596|NCT01939769|Memory|memory
384597|NCT01939756|High risk non-muscle invasive urothelial bladder cancer|high risk non-muscle invasive urothelial bladder cancer
384598|NCT01939756|Intravesical BCG|intravesical bcg
384599|NCT01939756|Local toxicity|local toxicity
384600|NCT01939756|Natural baobab oil|natural baobab oil
384601|NCT01939730|Lymphoma|lymphoma
384602|NCT01939730|Follicular B-Cell Lymphoma|follicular b-cell lymphoma
384603|NCT01939730|Rituximab|rituximab
384604|NCT01939730|Rituxan|rituxan
384605|NCT01939730|GM-CSF|gm-csf
384606|NCT01939730|Sargramostim|sargramostim
384607|NCT01939730|Leukine|leukine
384608|NCT01939717|Parkinson's disease|parkinson's disease
384609|NCT01939717|Irish set dancing|irish set dancing
384610|NCT01939691|difluprednate|difluprednate
384611|NCT01939691|prednisolone acetate|prednisolone acetate
384612|NCT01939691|nepafenac|nepafenac
384613|NCT01939665|Locally advanced pancreatic carcinoma|locally advanced pancreatic carcinoma
384614|NCT01939665|LAPC|lapc
384615|NCT01939665|Irreversible electroporation|irreversible electroporation
384616|NCT01939665|NanoKnife|nanoknife
384617|NCT01939665|IRE|ire
384618|NCT01939665|Safety|safety
384619|NCT01939665|Efficacy|efficacy
384620|NCT01939665|Non-thermal ablation|non-thermal ablation
384621|NCT01939665|Percutaneous ablation|percutaneous ablation
384622|NCT01939665|Low Energy Direct Current|low energy direct current
384623|NCT01939652|minilaparotomy|minilaparotomy
384624|NCT01939652|AAA|aaa
384625|NCT01939652|fluid regime|fluid regime
384626|NCT01939639|Oxytocin|oxytocin
384627|NCT01939639|fMRI|fmri
384628|NCT01939626|embryo|embryo
384629|NCT01939626|culture|culture
384630|NCT01939613|fluid resuscitation|fluid resuscitation
384631|NCT01939613|burn|burn
384632|NCT01939613|colloid,|colloid,
384633|NCT01939613|multiple organ dysfunction|multiple organ dysfunction
384634|NCT01939613|intra-abdominal pressure|intra-abdominal pressure
384635|NCT01939600|Resistant starch|resistant starch
384636|NCT01939600|Ileostomy|ileostomy
384637|NCT01939600|In vivo|in vivo
384638|NCT01939600|Carbohydrate digestibility|carbohydrate digestibility
384639|NCT01939587|Adenosine A1 receptor antagonist|adenosine a1 receptor antagonist
384640|NCT01939587|Asthma|asthma
384641|NCT01939587|adenosine receptor modulator|adenosine receptor modulator
384642|NCT01939587|COPD|copd
384643|NCT01939574|Glioblastoma|glioblastoma
384644|NCT01939574|Potential Image Biomarkers|potential image biomarkers
384645|NCT01939574|PFS|pfs
384646|NCT01939574|Bevacizumab|bevacizumab
384647|NCT01939574|Conventional Therapy|conventional therapy
384648|NCT01939561|Myotonia|myotonia
384649|NCT01939561|Lamotrigine|lamotrigine
384650|NCT01939561|RCT|rct
384651|NCT01939561|treatment|treatment
384652|NCT01939548|PF-02545920|pf-02545920
384653|NCT01939548|schizophrenia|schizophrenia
384654|NCT01939548|outpatient|outpatient
384655|NCT01939548|safety|safety
384656|NCT01939548|efficacy|efficacy
384657|NCT01939548|suboptimal response|suboptimal response
384658|NCT01939535|Endometriosis|endometriosis
384659|NCT01939535|Magnetic resonance imaging|magnetic resonance imaging
384660|NCT01939522|diabetes|diabetes
384661|NCT01939522|pneumococcal|pneumococcal
384662|NCT01939496|Diabetes Mellitus, Type 2|diabetes mellitus, type 2
384663|NCT01939496|Hypertension|hypertension
384664|NCT01939496|Canagliflozin|canagliflozin
384665|NCT01939496|JNJ 28431754|jnj 28431754
384666|NCT01939496|Sodium-Glucose Transporter 2|sodium-glucose transporter 2
384667|NCT01939496|Blood Glucose|blood glucose
384668|NCT01939496|Type 2 Diabetes Mellitus|type 2 diabetes mellitus
384669|NCT01939483|Irinotecan hydrochloride|irinotecan hydrochloride
384670|NCT01939483|Irinotecan|irinotecan
384671|NCT01939483|CAMPTOSAR|camptosar
384672|NCT01939470|osteoporosis|osteoporosis
384673|NCT01939470|bone|bone
384674|NCT01939470|inflammation|inflammation
384675|NCT01939470|diabetes|diabetes
384676|NCT01939470|vitamin D|vitamin d
384677|NCT01939444|Antidotes|antidotes
384678|NCT01939444|naloxone|naloxone
384679|NCT01939444|administration, intravenous|administration, intravenous
384680|NCT01939444|administration, intranasal|administration, intranasal
384681|NCT01939444|pharmacology|pharmacology
384682|NCT01939431|Podoconiosis|podoconiosis
384683|NCT01939431|Ethiopian|ethiopian
384684|NCT01939418|metastatic breast cancer|metastatic breast cancer
384685|NCT01939418|triple negative breast cancer|triple negative breast cancer
384686|NCT01939418|gemcitabine|gemcitabine
384687|NCT01939418|RAD001|rad001
384688|NCT01939405|Obesity|obesity
384689|NCT01939405|Overweight|overweight
384690|NCT01939405|Physical Activity|physical activity
384691|NCT01939405|Built Environment|built environment
384692|NCT01939405|counseling|counseling
384693|NCT01939392|Resistant hypertension|resistant hypertension
384694|NCT01939392|Uncontrolled hypertension|uncontrolled hypertension
384695|NCT01939392|Renal artery ablation|renal artery ablation
384696|NCT01939379|Total knee arthroplasty|total knee arthroplasty
384697|NCT01939379|nerve block|nerve block
384698|NCT01939379|Pain control after surgery|pain control after surgery
384699|NCT01939366|Painful Diabetic Peripheral Neuropathy|painful diabetic peripheral neuropathy
384700|NCT01939353|Adult ADHD|adult adhd
384701|NCT01939327|diffuse large B cell|diffuse large b cell
789623|NCT00294632|Lymphoma|lymphoma
384702|NCT01939327|non-Hodgkin lymphoma|non-hodgkin lymphoma
384703|NCT01939314|Headache|headache
384704|NCT01939314|Migraine|migraine
384705|NCT01939301|Pulmonary embolism clot|pulmonary embolism clot
384706|NCT01939288|neuromuscular stimulation|neuromuscular stimulation
384707|NCT01939288|intermittent pneumatic compression|intermittent pneumatic compression
384708|NCT01939262|Arthritis|arthritis
384709|NCT01939262|Pain|pain
384710|NCT01939262|Function|function
384711|NCT01939262|Diet|diet
384712|NCT01939262|Vegan|vegan
384713|NCT01939262|Vegetarian|vegetarian
384714|NCT01939262|Restriction|restriction
384715|NCT01939236|chronic heart failure|chronic heart failure
384716|NCT01939236|traditional Chinese medicine|traditional chinese medicine
384717|NCT01939236|syndrome differentiation|syndrome differentiation
384718|NCT01939223|Stage IV colorectal cancer / Liver Metastasis|stage iv colorectal cancer / liver metastasis
384719|NCT01939197|HCV Genotype 4|hcv genotype 4
384720|NCT01939197|Interferon-Free|interferon-free
384721|NCT01939197|Hepatitis C Genotype 1|hepatitis c genotype 1
384722|NCT01939197|Compensated Cirrhosis|compensated cirrhosis
384723|NCT01939197|Hepatitis C Genotype 4|hepatitis c genotype 4
384724|NCT01939197|HCV / HIV coinfection|hcv / hiv coinfection
384725|NCT01939197|Cirrhotic|cirrhotic
384726|NCT01939197|Hepatitis C|hepatitis c
384727|NCT01939197|HIV-1|hiv-1
384728|NCT01939197|HCV Genotype 1|hcv genotype 1
384729|NCT01939171|Thymoglobulin|thymoglobulin
384730|NCT01939171|Cadaver donor|cadaver donor
384731|NCT01939171|Kidney injury brain death related|kidney injury brain death related
384732|NCT01939158|Co-administration|co-administration
384733|NCT01939158|Safety|safety
384734|NCT01939158|Persistence|persistence
384735|NCT01939158|Immunogenicity|immunogenicity
384736|NCT01939158|Prevenar 13|prevenar 13
384737|NCT01939158|Meningococcal vaccine|meningococcal vaccine
384738|NCT01939158|Toddlers|toddlers
384739|NCT01939158|5 years|5 years
384740|NCT01939145|hospital admission|hospital admission
384741|NCT01939132|Psoriatic Arthritis|psoriatic arthritis
384742|NCT01939132|ACTH|acth
384743|NCT01939132|Acthar|acthar
384744|NCT01939119|retinal vascular occlusion|retinal vascular occlusion
384745|NCT01939119|drinking habits|drinking habits
384746|NCT01939119|body hydration|body hydration
384747|NCT01939119|body-fluid balance|body-fluid balance
384748|NCT01939106|Stoma|stoma
384749|NCT01939106|Ileostomy|ileostomy
384750|NCT01939106|pouch|pouch
384751|NCT01939106|Drainable Pouch for collection of stool|drainable pouch for collection of stool
384752|NCT01939093|Quetiapine|quetiapine
384753|NCT01939093|Haloperidol|haloperidol
384754|NCT01939093|Methamphetamine|methamphetamine
384755|NCT01939093|Psychosis|psychosis
384756|NCT01939080|moderate risk|moderate risk
384757|NCT01939080|high risk|high risk
384758|NCT01939067|respiratory distress|respiratory distress
384759|NCT01939067|Heated Humidified High Flow Nasal Cannula (HHHFNC)|heated humidified high flow nasal cannula (hhhfnc)
384760|NCT01939067|HHHFNC|hhhfnc
384761|NCT01939067|noninvasive nasal continuous positive airway pressure (NCPAP)|noninvasive nasal continuous positive airway pressure (ncpap)
384762|NCT01939067|NCPAP|ncpap
384763|NCT01939041|Subacute Stroke|subacute stroke
384764|NCT01939041|Unilateral Robot-Assisted Training|unilateral robot-assisted training
384765|NCT01939041|Bilateral Robot-Assisted Training|bilateral robot-assisted training
384766|NCT01939041|Motor control|motor control
384767|NCT01939041|Physiological Response|physiological response
384768|NCT01939015|3D miniplate|3d miniplate
384769|NCT01939015|angle mandibular fracture|angle mandibular fracture
384770|NCT01939015|champy technique|champy technique
384771|NCT01939015|internal rigid fixation|internal rigid fixation
384772|NCT01939002|flu-like symptoms|flu-like symptoms
384773|NCT01938989|cataract|cataract
384774|NCT01938989|intraocular lens|intraocular lens
384775|NCT01938989|IOL|iol
384776|NCT01938989|blue light filter|blue light filter
384777|NCT01938976|Asthma|asthma
384778|NCT01938976|Tobacco|tobacco
384779|NCT01938976|Waterpipe|waterpipe
384780|NCT01938976|Cigarettes|cigarettes
384781|NCT01938976|Adolescents|adolescents
384782|NCT01938976|Peer education|peer education
384783|NCT01938976|Jordan|jordan
384784|NCT01938963|Depression|depression
384785|NCT01938963|Hypertension|hypertension
384786|NCT01938963|Older Adults|older adults
384787|NCT01938911|Trier social stress test|trier social stress test
384788|NCT01938911|Oxytocin|oxytocin
384789|NCT01938911|Hypertension|hypertension
384790|NCT01938898|Randomized trial|randomized trial
384791|NCT01938898|Invitation letter|invitation letter
384792|NCT01938898|Recruitment|recruitment
384793|NCT01938898|Retention|retention
384794|NCT01938872|critical limb ischemia|critical limb ischemia
384795|NCT01938872|drug-eluting balloon|drug-eluting balloon
384796|NCT01938872|restenosis|restenosis
384797|NCT01938859|bipolar disorder|bipolar disorder
384798|NCT01938859|lithium|lithium
384799|NCT01938859|quetiapine|quetiapine
384800|NCT01938859|Medicine, Chinese Traditional|medicine, chinese traditional
384801|NCT01938859|efficacy|efficacy
492178|NCT01463046|AML|aml
384802|NCT01938859|safety|safety
384803|NCT01938859|Recurrence|recurrence
384804|NCT01938820|Hepatitis B|hepatitis b
384805|NCT01938820|Liver Cirrhosis|liver cirrhosis
384806|NCT01938820|Regression|regression
384807|NCT01938820|Efficacy|efficacy
384808|NCT01938807|type 1 diabetes|type 1 diabetes
384809|NCT01938807|parents|parents
384810|NCT01938807|mobile application|mobile application
384811|NCT01938807|diabetes management|diabetes management
384812|NCT01938781|Hepatitis B|hepatitis b
384813|NCT01938781|Liver fibrosis|liver fibrosis
384814|NCT01938781|Regression|regression
384815|NCT01938781|Efficacy|efficacy
384816|NCT01938768|Multiple trauma|multiple trauma
384817|NCT01938768|Polytrauma|polytrauma
384818|NCT01938768|Hyperfibrinolysis|hyperfibrinolysis
384819|NCT01938768|Tranexamic acid|tranexamic acid
384820|NCT01938768|Thrombelastometry|thrombelastometry
384821|NCT01938742|A/H7N9,Adjuvant,Immunogenicity,Influenza,MF59,Monovalent,Vaccine|a/h7n9,adjuvant,immunogenicity,influenza,mf59,monovalent,vaccine
384822|NCT01938729|HEPATIC ARTERIAL INFUSION|hepatic arterial infusion
384823|NCT01938729|FLOXURIDINE|floxuridine
384824|NCT01938729|DEXAMETHASONE|dexamethasone
384825|NCT01938729|GEMCITABINE|gemcitabine
384826|NCT01938729|Pump|pump
384827|NCT01938729|13-148|13-148
384828|NCT01938716|Pancreatic Cancer|pancreatic cancer
384829|NCT01938716|Adenocarcinoma of the Pancreas|adenocarcinoma of the pancreas
384830|NCT01938716|Intratumoral gemcitabine levels|intratumoral gemcitabine levels
384831|NCT01938716|Pancreatic surgery|pancreatic surgery
384832|NCT01938716|Pharmacokinetic testing|pharmacokinetic testing
384833|NCT01938716|PK|pk
384834|NCT01938716|Gemcitabine|gemcitabine
384835|NCT01938716|Gemcitabine Hydrochloride|gemcitabine hydrochloride
384836|NCT01938716|Gemzar|gemzar
384837|NCT01938690|stroke, transcranial magnetic stimulation, rehabilitation|stroke, transcranial magnetic stimulation, rehabilitation
384838|NCT01938677|Vestibular schwannoma|vestibular schwannoma
384839|NCT01938677|Gamma knife radiosurgery|gamma knife radiosurgery
384840|NCT01938677|Hearing preservation|hearing preservation
384841|NCT01938664|cocaine|cocaine
384842|NCT01938664|dependence|dependence
384843|NCT01938664|pharmacotherapy|pharmacotherapy
384844|NCT01938638|Advanced malignancies|advanced malignancies
384845|NCT01938638|TNBC|tnbc
384846|NCT01938638|DLBCL|dlbcl
384847|NCT01938638|Gastric cancer|gastric cancer
384848|NCT01938625|Hepatitis C, Chronic|hepatitis c, chronic
384849|NCT01938625|Recurrent Chronic Hepatitis C|recurrent chronic hepatitis c
384850|NCT01938625|Pharmacokinetics|pharmacokinetics
384851|NCT01938625|Simeprevir|simeprevir
384852|NCT01938625|Daclatasvir|daclatasvir
384853|NCT01938625|Ribavirin|ribavirin
384854|NCT01938625|Orthotopic Liver Transplantation|orthotopic liver transplantation
384855|NCT01938625|TMC435|tmc435
384856|NCT01938625|BMS-790052|bms-790052
384857|NCT01938625|RBV|rbv
384858|NCT01938612|MEDI4736|medi4736
384859|NCT01938612|Advanced solid tumors|advanced solid tumors
384860|NCT01938612|squamous cell carcinoma of the head and Neck|squamous cell carcinoma of the head and neck
384861|NCT01938612|biliary tract cancer|biliary tract cancer
384862|NCT01938612|squamous cell carcinoma of esophagus cancer|squamous cell carcinoma of esophagus cancer
384863|NCT01938612|B7-H1|b7-h1
384864|NCT01938612|PD-L1|pd-l1
384865|NCT01938599|Plaque Psoriasis|plaque psoriasis
384866|NCT01938586|Scar|scar
384867|NCT01938586|Appearance|appearance
384868|NCT01938547|perioperative|perioperative
384869|NCT01938547|blood pressure|blood pressure
384870|NCT01938547|pediatrics|pediatrics
384871|NCT01938547|pediatric surgery|pediatric surgery
384872|NCT01938521|Red Grape Cells powder (RGC)|red grape cells powder (rgc)
384873|NCT01938521|Placebo (PLA)|placebo (pla)
384874|NCT01938508|dermatitis|dermatitis
384875|NCT01938508|Minocycline|minocycline
384876|NCT01938508|bioavailability|bioavailability
384877|NCT01938495|ALS|als
384878|NCT01938495|DPS|dps
384879|NCT01938495|Diaphragm Pacing|diaphragm pacing
384880|NCT01938482|SCD1|scd1
384881|NCT01938482|Topical Administration|topical administration
384882|NCT01938482|Acne|acne
384883|NCT01938482|Gel|gel
384884|NCT01938469|Bariatric|bariatric
384885|NCT01938469|Gastric Bypass|gastric bypass
384986|NCT01938079|ECMO|ecmo
384886|NCT01938469|Gastric Banding,|gastric banding,
384887|NCT01938469|Incretins|incretins
384888|NCT01938469|glucagon-like peptide-1(GLP-1)|glucagon-like peptide-1(glp-1)
384889|NCT01938469|gastric inhibitory peptide (GIP)|gastric inhibitory peptide (gip)
384890|NCT01938456|Non-small cell lung cancer|non-small cell lung cancer
384891|NCT01938456|GSK1120212 (trametinib)|gsk1120212 (trametinib)
384892|NCT01938456|Japanese|japanese
384893|NCT01938456|Phase Ib|phase ib
384894|NCT01938456|combination therapy|combination therapy
384895|NCT01938456|docetaxel|docetaxel
384896|NCT01938456|MEK inhibitor|mek inhibitor
384897|NCT01938443|pharmacodynamics|pharmacodynamics
384898|NCT01938443|MEK inhibitor|mek inhibitor
384899|NCT01938443|Focal adhesion kinase inhibitor|focal adhesion kinase inhibitor
384900|NCT01938443|cancer|cancer
492212|NCT01462903|TIL|til
384901|NCT01938443|pharmacokinetic|pharmacokinetic
384902|NCT01938443|mesothelioma|mesothelioma
384903|NCT01938443|Phase 1|phase 1
384904|NCT01938417|tobramycin|tobramycin
384905|NCT01938417|bone graft substitute|bone graft substitute
384906|NCT01938417|pharmacokinetics|pharmacokinetics
384907|NCT01938417|renal failure|renal failure
384908|NCT01938404|Plasma exchange|plasma exchange
384909|NCT01938404|Thrombotic Thrombocytopenic Purpura|thrombotic thrombocytopenic purpura
384910|NCT01938404|TTP|ttp
384911|NCT01938391|Peripheral Artery Disease|peripheral artery disease
384912|NCT01938391|PAD|pad
384913|NCT01938391|Claudication|claudication
384914|NCT01938391|Peripheral Vascular Disease|peripheral vascular disease
384915|NCT01938391|PVD|pvd
384916|NCT01938391|Orbital Atherectomy|orbital atherectomy
384917|NCT01938391|Balloon Angioplasty|balloon angioplasty
384918|NCT01938391|Intravascular Ultrasound (IVUS)|intravascular ultrasound (ivus)
384919|NCT01938378|Octaplas|octaplas
384920|NCT01938352|Influenza|influenza
384921|NCT01938352|Virus|virus
384922|NCT01938352|Monoclonal Antibody|monoclonal antibody
384923|NCT01938352|Immunization|immunization
384924|NCT01938352|Treatment|treatment
384925|NCT01938339|prostate cancer|prostate cancer
384926|NCT01938339|MRI|mri
384927|NCT01938339|PET|pet
384928|NCT01938326|Stomach neoplasm|stomach neoplasm
384929|NCT01938326|TLDG|tldg
384930|NCT01938326|SIDG|sidg
384931|NCT01938326|single-port|single-port
384932|NCT01938326|inflammatory response|inflammatory response
384933|NCT01938313|gastric cancer|gastric cancer
384934|NCT01938313|ERAS (early recovery after surgery)|eras (early recovery after surgery)
384935|NCT01938313|fast track|fast track
384936|NCT01938313|laparoscopic gastrectomy|laparoscopic gastrectomy
384938|NCT01938274|Knee|knee
384939|NCT01938274|Osteoarthritis|osteoarthritis
384940|NCT01938274|Arthroplasty|arthroplasty
384941|NCT01938274|Physical Activity|physical activity
384942|NCT01938274|Expectations|expectations
384943|NCT01938274|Leisure Activity|leisure activity
384944|NCT01938248|Pacemaker, Artificial|pacemaker, artificial
384945|NCT01938248|Defibrillators, Implantable|defibrillators, implantable
384946|NCT01938248|Atrial Fibrillation|atrial fibrillation
384947|NCT01938248|Stroke Risk|stroke risk
384948|NCT01938235|Myocardial infarction|myocardial infarction
384949|NCT01938235|Percutaneous coronary intervention|percutaneous coronary intervention
384950|NCT01938235|Reperfusion injury|reperfusion injury
384951|NCT01938235|Exenatide|exenatide
384952|NCT01938235|Magnetic resonance imaging|magnetic resonance imaging
384953|NCT01938222|abdominal wall closure|abdominal wall closure
384954|NCT01938222|short stitch technique|short stitch technique
384955|NCT01938196|Chronic Constipation|chronic constipation
384956|NCT01938196|Constipation|constipation
384957|NCT01938196|Functional gastrointestinal disorders|functional gastrointestinal disorders
384958|NCT01938183|chronic periodontitis|chronic periodontitis
384959|NCT01938183|metronidazole|metronidazole
384960|NCT01938157|High Risk of Breast Cancer|high risk of breast cancer
384961|NCT01938157|Diffusion Magnetic Resonance Imaging|diffusion magnetic resonance imaging
384962|NCT01938144|Common cold|common cold
384963|NCT01938144|efficacy|efficacy
384964|NCT01938144|symptoms|symptoms
384965|NCT01938144|Wisconsin Upper Respiratory Symptom Survey - 21|wisconsin upper respiratory symptom survey - 21
384966|NCT01938144|ibuprofen|ibuprofen
384967|NCT01938144|phenylephrine|phenylephrine
384968|NCT01938144|pseudoephedrine|pseudoephedrine
384969|NCT01938131|knee, osteoarthritis, muscle vibration|knee, osteoarthritis, muscle vibration
384970|NCT01938118|Infant diet|infant diet
384971|NCT01938118|Family diet|family diet
384972|NCT01938118|Responsive feeding|responsive feeding
384973|NCT01938118|Infant temperament|infant temperament
384974|NCT01938118|Physical activity|physical activity
384975|NCT01938118|Television|television
384976|NCT01938105|Cervical cancer|cervical cancer
384977|NCT01938105|Nimotuzumab|nimotuzumab
384978|NCT01938105|Intensity-modulated radiation therapy|intensity-modulated radiation therapy
384979|NCT01938105|Concurrent chemoradiotherapy|concurrent chemoradiotherapy
384980|NCT01938092|High-tone pelvic floor dysfunction|high-tone pelvic floor dysfunction
384981|NCT01938092|Spasm|spasm
384982|NCT01938092|Pelvic pain|pelvic pain
384983|NCT01938092|Diazepam|diazepam
384984|NCT01938092|Female|female
384985|NCT01938092|Randomized trial|randomized trial
384987|NCT01938079|Ketamine|ketamine
384988|NCT01938079|Opiates|opiates
384989|NCT01938079|Lung failure|lung failure
384990|NCT01938079|Extracorporeal membrane oxygenation|extracorporeal membrane oxygenation
384991|NCT01938079|Mechanical ventilation|mechanical ventilation
384992|NCT01938079|Sedation|sedation
384993|NCT01938066|procellera|procellera
384994|NCT01938053|STI, STD|sti, std
384995|NCT01938040|laparoscopic cholecystectomy|laparoscopic cholecystectomy
384996|NCT01938027|Rectal Neoplasms|rectal neoplasms
384997|NCT01938027|Colorectal Neoplasms|colorectal neoplasms
384998|NCT01938027|transanal surgery|transanal surgery
384999|NCT01938014|MPS I|mps i
385000|NCT01938014|MPS II|mps ii
385001|NCT01938014|MPS III|mps iii
385002|NCT01938014|MPS VI|mps vi
385003|NCT01938014|Krabbe disease|krabbe disease
385004|NCT01938014|globoid cell leukodystrophy|globoid cell leukodystrophy
385005|NCT01938014|galactosylceramide lipidosis|galactosylceramide lipidosis
385006|NCT01938014|mucopolysaccharidoses|mucopolysaccharidoses
385007|NCT01938014|mucopolysaccharidosis|mucopolysaccharidosis
385008|NCT01938014|Rare Diseases Clinical Research Network|rare diseases clinical research network
385009|NCT01938014|Lysosomal Disease Network|lysosomal disease network
385010|NCT01938014|enzyme replacement therapy|enzyme replacement therapy
385011|NCT01938014|hematopoietic stem cell transplant|hematopoietic stem cell transplant
385012|NCT01938014|telephone-based surveillance|telephone-based surveillance
385013|NCT01938014|Hurler syndrome|hurler syndrome
385014|NCT01938014|Hunter syndrome|hunter syndrome
385015|NCT01938014|Scheie syndrome|scheie syndrome
385016|NCT01938014|Hurler-Scheie syndrome|hurler-scheie syndrome
385017|NCT01938014|Sanfilippo syndrome|sanfilippo syndrome
385018|NCT01938014|Maroteaux-Lamy syndrome|maroteaux-lamy syndrome
385019|NCT01938001|Non-Hodgkins Follicular lymphoma, Non-Hodgkins Marginal zone lymphoma, treatment for follicular lymphoma, treatment for Marginal zone lymphoma|non-hodgkins follicular lymphoma, non-hodgkins marginal zone lymphoma, treatment for follicular lymphoma, treatment for marginal zone lymphoma
385020|NCT01937988|Doula|doula
385021|NCT01937988|Abortion|abortion
385022|NCT01937988|Pain|pain
385023|NCT01937988|support|support
385024|NCT01937949|Aortic aneurysm|aortic aneurysm
385025|NCT01937936|caregiver stress|caregiver stress
385026|NCT01937936|depression|depression
385027|NCT01937936|quality of life|quality of life
385028|NCT01937936|cognitive behavioral therapy|cognitive behavioral therapy
385029|NCT01937910|neuroplastic change|neuroplastic change
385030|NCT01937910|myelin|myelin
385031|NCT01937897|Unilateral Massage|unilateral massage
385032|NCT01937897|Depression|depression
385033|NCT01937858|HbA1c|hba1c
385034|NCT01937858|glycated hemoglobin|glycated hemoglobin
385035|NCT01937858|correlation|correlation
385036|NCT01937858|diabetes|diabetes
385037|NCT01937858|renal failure|renal failure
385038|NCT01937819|BOWEL PREPARATION|bowel preparation
385039|NCT01937819|SMARTPHONE APPLICATION|smartphone application
385040|NCT01937806|Chronic hepatitis B|chronic hepatitis b
385041|NCT01937793|radiation|radiation
385042|NCT01937793|speech-language pathology|speech-language pathology
385043|NCT01937754|Prehypertension|prehypertension
385044|NCT01937754|Nitric Oxide|nitric oxide
385045|NCT01937754|Blood Pressure|blood pressure
385046|NCT01937754|Functional Capacity|functional capacity
385047|NCT01937754|Quality of Life|quality of life
385048|NCT01937728|Hepatitis C|hepatitis c
385049|NCT01937728|Genotype 1|genotype 1
385050|NCT01937728|Peg interferon|peg interferon
385051|NCT01937728|alfa 1a|alfa 1a
385052|NCT01937728|Ribavirin|ribavirin
385053|NCT01937689|Breast cancer|breast cancer
385054|NCT01937689|advanced|advanced
385055|NCT01937689|Pyrotinib|pyrotinib
385056|NCT01937689|Phase I|phase i
385057|NCT01937689|HER2 positive advanced breast cancer|her2 positive advanced breast cancer
385058|NCT01937663|Chronic Constipation|chronic constipation
385059|NCT01937663|Constipation|constipation
385060|NCT01937663|Functional gastrointestinal disorders|functional gastrointestinal disorders
385061|NCT01937650|Radiotherapy, metronidazole, cervical cancer, Mulago|radiotherapy, metronidazole, cervical cancer, mulago
385062|NCT01937637|Cognitive Behavioral Intervention for Breathlessness|cognitive behavioral intervention for breathlessness
385063|NCT01937624|Diagnostic ultrasound|diagnostic ultrasound
385064|NCT01937611|dexmedetomidine|dexmedetomidine
385065|NCT01937611|intramuscular premedication|intramuscular premedication
385066|NCT01937611|bradycardiac|bradycardiac
385067|NCT01937598|Incretin, DPP-4 inhibitor|incretin, dpp-4 inhibitor
385068|NCT01937585|prostate cancer|prostate cancer
385069|NCT01937585|partner|partner
385070|NCT01937585|communication messages|communication messages
385071|NCT01937585|monitoring style|monitoring style
385072|NCT01937585|AA men|aa men
385073|NCT01937572|Total knee arthroplasty (TKA)|total knee arthroplasty (tka)
385074|NCT01937572|Computer aided systems|computer aided systems
385075|NCT01937559|tranexaminic acid (TXA)|tranexaminic acid (txa)
385076|NCT01937546|Anal Canal/injuries|anal canal/injuries
385077|NCT01937546|Delivery, Obstetric/methods|delivery, obstetric/methods
385078|NCT01937546|Labour Stage, Second|labour stage, second
385079|NCT01937546|Lacerations/prevention & control|lacerations/prevention & control
385173|NCT01937091|HIV|hiv
385376|NCT01935908|Seizures|seizures
385080|NCT01937546|Obstetric Labour Complications/prevention & control|obstetric labour complications/prevention & control
385081|NCT01937546|perineum/injuries|perineum/injuries
385082|NCT01937533|Magnetic Resonance Imaging|magnetic resonance imaging
385083|NCT01937520|acupuncture|acupuncture
385084|NCT01937520|inflammation|inflammation
385085|NCT01937520|thyroid|thyroid
385086|NCT01937520|parathyroid|parathyroid
385087|NCT01937494|asthma|asthma
385088|NCT01937494|bronchial hyperresponsiveness|bronchial hyperresponsiveness
385089|NCT01937494|histamine challenge test|histamine challenge test
385090|NCT01937494|spirometry|spirometry
385091|NCT01937481|Child, Preschool|child, preschool
385092|NCT01937481|Parents|parents
385093|NCT01937481|Family|family
385094|NCT01937481|Obesity|obesity
385095|NCT01937481|Overweight|overweight
385096|NCT01937481|Diet|diet
385097|NCT01937481|Overnutrition|overnutrition
385098|NCT01937481|Motor Activity|motor activity
385099|NCT01937481|Child Care|child care
385100|NCT01937481|Schools|schools
385101|NCT01937468|Chronic GVHD|chronic gvhd
385102|NCT01937468|Chronic graft versus host disease|chronic graft versus host disease
385103|NCT01937468|Allogeneic stem cell transplant|allogeneic stem cell transplant
385104|NCT01937455|HIV|hiv
385105|NCT01937455|AIDS|aids
385106|NCT01937455|HIV vaccine|hiv vaccine
385107|NCT01937455|HIV prevention|hiv prevention
385108|NCT01937455|AAV|aav
385109|NCT01937455|PG9|pg9
385110|NCT01937442|Multiple myeloma|multiple myeloma
385111|NCT01937442|Pharmacokinetics|pharmacokinetics
385112|NCT01937442|Thalidomide|thalidomide
385113|NCT01937429|Colonoscopy - Chromoendoscopy - Indigo Carmin® - Adenoma detection - Tepid water|colonoscopy - chromoendoscopy - indigo carmin® - adenoma detection - tepid water
385114|NCT01937403|Physical Therapy|physical therapy
385115|NCT01937403|Return to sport|return to sport
385116|NCT01937351|Atherectomy|atherectomy
385117|NCT01937351|Optical Coherence Tomography|optical coherence tomography
385118|NCT01937351|Lumivascular|lumivascular
385119|NCT01937338|Healthy volunteers, Phase 1|healthy volunteers, phase 1
385120|NCT01937325|Eligible CF patients with G551D gene mutation|eligible cf patients with g551d gene mutation
385121|NCT01937312|glaucoma|glaucoma
385122|NCT01937312|prostaglandin analogue|prostaglandin analogue
385123|NCT01937312|brinzolamide|brinzolamide
385124|NCT01937312|brimonidine|brimonidine
385125|NCT01937299|glaucoma|glaucoma
385126|NCT01937299|prostaglandin analogue|prostaglandin analogue
385127|NCT01937299|brinzolamide|brinzolamide
385128|NCT01937299|brimonidine|brimonidine
385129|NCT01937286|LDLT,HCC, Microvascular invasion|ldlt,hcc, microvascular invasion
385130|NCT01937273|Nutritional status, malnutrition, chemo-radiotherapy|nutritional status, malnutrition, chemo-radiotherapy
385131|NCT01937247|Operative Time|operative time
385132|NCT01937247|Operating Rooms|operating rooms
385133|NCT01937247|Efficiency|efficiency
385134|NCT01937221|mild cognitive impairment|mild cognitive impairment
385135|NCT01937221|mild to moderate cognitive impairment|mild to moderate cognitive impairment
385136|NCT01937208|Esophageal Carcinoma|esophageal carcinoma
385137|NCT01937208|chemoradiation|chemoradiation
385138|NCT01937208|radiation dose|radiation dose
385139|NCT01937195|IV Catheter comparison|iv catheter comparison
385140|NCT01937195|AccuCath versus Conventional IV Catheters|accucath versus conventional iv catheters
385141|NCT01937195|IV Catheter Study|iv catheter study
385142|NCT01937195|IV Catheter User Preference Comparison|iv catheter user preference comparison
385143|NCT01937195|First Attempt Success Rate for IV Catheters|first attempt success rate for iv catheters
385144|NCT01937195|AccuCath Device Performance|accucath device performance
385145|NCT01937195|Complication Rates for IV Catheters|complication rates for iv catheters
385146|NCT01937195|Average Dwell Time for IV Catheters|average dwell time for iv catheters
385147|NCT01937195|Patient Satisfaction with IV Catheters|patient satisfaction with iv catheters
385148|NCT01937195|Clinician Satisfaction with AccuCath Device Performance|clinician satisfaction with accucath device performance
385149|NCT01937182|Stroke|stroke
385150|NCT01937182|SSRI (Selective Serotonin Reuptake Inhibitors)|ssri (selective serotonin reuptake inhibitors)
385151|NCT01937182|Serotonin|serotonin
385152|NCT01937182|5-HT (5-Hydroxytryptamine)|5-ht (5-hydroxytryptamine)
385153|NCT01937182|Neuroprotection|neuroprotection
385154|NCT01937182|MRI (Magnetic Resonance Imaging)|mri (magnetic resonance imaging)
385155|NCT01937182|Platelet|platelet
385156|NCT01937182|CT (computerized tomography)|ct (computerized tomography)
385157|NCT01937182|Post Stroke Depression|post stroke depression
385158|NCT01937143|parent education|parent education
385159|NCT01937143|immunization|immunization
385160|NCT01937143|vaccination|vaccination
385161|NCT01937143|infant|infant
385162|NCT01937143|pain management|pain management
385163|NCT01937130|Liver Failure|liver failure
385164|NCT01937130|Cirrhosis|cirrhosis
385165|NCT01937130|Alcoholic Hepatitis|alcoholic hepatitis
385166|NCT01937117|Breast cancer|breast cancer
385167|NCT01937117|Preoperative treatment|preoperative treatment
385168|NCT01937117|Neoadjuvant treatment|neoadjuvant treatment
385169|NCT01937104|Intracranial pressure|intracranial pressure
385170|NCT01937104|Laparoscopy|laparoscopy
385171|NCT01937104|Optic nerve sheath diameter|optic nerve sheath diameter
385172|NCT01937104|Position|position
385174|NCT01937091|clinical trials|clinical trials
385175|NCT01937013|Frontotemporal Dementia|frontotemporal dementia
385177|NCT01937013|oxytocin|oxytocin
385178|NCT01937013|fMRI|fmri
385179|NCT01936961|Cancer|cancer
385180|NCT01936948|Large colon polyps|large colon polyps
385181|NCT01936948|Polyp resection|polyp resection
385182|NCT01936948|Colon cancer screening|colon cancer screening
385183|NCT01936948|Colonoscopy|colonoscopy
385184|NCT01936948|Endoscopic mucosal resection|endoscopic mucosal resection
385185|NCT01936935|Insulin sensitivity|insulin sensitivity
385186|NCT01936922|Fall accidents|fall accidents
385187|NCT01936922|Gait|gait
385188|NCT01936922|Balance|balance
385189|NCT01936922|Fear of falling|fear of falling
385190|NCT01936922|Virtual reality|virtual reality
385191|NCT01936896|Acute myocardial infarction|acute myocardial infarction
385192|NCT01936896|Heart Failure|heart failure
385193|NCT01936896|Inflammation|inflammation
385194|NCT01936883|prostatic neoplasm|prostatic neoplasm
385195|NCT01936883|brachytherapy|brachytherapy
385196|NCT01936883|quality of life|quality of life
385197|NCT01936883|high dose rate|high dose rate
385198|NCT01936883|low dose rate|low dose rate
385199|NCT01936870|Toviaz|toviaz
385200|NCT01936870|Fesoterodine|fesoterodine
385201|NCT01936870|Post marketing surveillance|post marketing surveillance
385202|NCT01936870|Japanese|japanese
385203|NCT01936870|Overactive Bladder|overactive bladder
385204|NCT01936870|OAB|oab
385205|NCT01936870|Good post marketing practice|good post marketing practice
385206|NCT01936870|Regulatory Post Marketing Commitment Plan|regulatory post marketing commitment plan
385207|NCT01936792|Concussion|concussion
385208|NCT01936792|Mild Traumatic Brain Injury|mild traumatic brain injury
385209|NCT01936792|Traumatic Brain Injury|traumatic brain injury
385210|NCT01936779|plasma triglycerides|plasma triglycerides
385211|NCT01936779|dietary fat|dietary fat
385212|NCT01936779|liver fat metabolism|liver fat metabolism
385213|NCT01936779|human|human
385214|NCT01936766|malaria, falciparum|malaria, falciparum
385215|NCT01936766|sepsis|sepsis
385216|NCT01936766|fluid therapy|fluid therapy
385217|NCT01936766|thermodilution|thermodilution
385218|NCT01936766|extravascular lung water|extravascular lung water
385219|NCT01936766|acute kidney injury|acute kidney injury
385220|NCT01936753|PMTCT|pmtct
385221|NCT01936753|HIV|hiv
385222|NCT01936753|Mentor Mothers|mentor mothers
385223|NCT01936753|Nigeria|nigeria
385224|NCT01936753|Retention|retention
385225|NCT01936753|Adherence|adherence
385226|NCT01936740|Efficacy and Safety|efficacy and safety
385227|NCT01936727|efficiency and safety|efficiency and safety
385228|NCT01936714|Efficacy and Safety|efficacy and safety
385229|NCT01936675|Coronary Artery Disease|coronary artery disease
385230|NCT01936675|Myocardial Infarction|myocardial infarction
385231|NCT01936675|Genomic Risk Communication|genomic risk communication
385232|NCT01936675|Risk Stratification|risk stratification
385233|NCT01936662|Airway management comparison|airway management comparison
385234|NCT01936649|Nuclear imaging|nuclear imaging
385235|NCT01936649|Radiopharmaceutical|radiopharmaceutical
385236|NCT01936649|Iobenguane|iobenguane
385237|NCT01936649|I-123|i-123
385238|NCT01936649|reproducibility|reproducibility
385239|NCT01936649|Quantitative measurements|quantitative measurements
385240|NCT01936649|myocardial uptake|myocardial uptake
385241|NCT01936649|SPECT imaging|spect imaging
385242|NCT01936649|planar imaging|planar imaging
385243|NCT01936649|AdreView™|adreview™
385244|NCT01936636|Breakthrough cancer pain|breakthrough cancer pain
385245|NCT01936636|diary|diary
385246|NCT01936636|quality of life|quality of life
385247|NCT01936636|Abstral|abstral
385248|NCT01936636|BTcP|btcp
385249|NCT01936623|brief intervention|brief intervention
385250|NCT01936623|computerized brief intervention|computerized brief intervention
385251|NCT01936610|Lecture|lecture
385252|NCT01936610|Role-playing|role-playing
385253|NCT01936610|Knowledge|knowledge
385254|NCT01936610|Attitude|attitude
385255|NCT01936610|Decision making|decision making
385256|NCT01936610|Type of delivery|type of delivery
385257|NCT01936597|external cardiac massage, medical hotline,|external cardiac massage, medical hotline,
385258|NCT01936545|Liver transplantation, reactive oxygen species, antioxidant|liver transplantation, reactive oxygen species, antioxidant
385259|NCT01936532|multiple myeloma|multiple myeloma
385260|NCT01936519|Everolimus|everolimus
385261|NCT01936519|Zortress|zortress
385262|NCT01936519|Renal Function|renal function
385263|NCT01936519|Tacrolimus|tacrolimus
385264|NCT01936519|Cyclosporine|cyclosporine
385265|NCT01936519|Myfortic|myfortic
385266|NCT01936519|Mycophenolic Acid|mycophenolic acid
385267|NCT01936519|Liver Transplantation|liver transplantation
385268|NCT01936506|Cognitive training|cognitive training
385269|NCT01936506|Depression|depression
385270|NCT01936493|Uterine leiomyomas (fibroids or myomas)|uterine leiomyomas (fibroids or myomas)
385271|NCT01936493|Uterine fibroids|uterine fibroids
385272|NCT01936493|Fibroids|fibroids
385273|NCT01936493|Uterine leiomyomas|uterine leiomyomas
385274|NCT01936467|Pancreatic solid lesions|pancreatic solid lesions
385275|NCT01936467|Pancreatic mass|pancreatic mass
385276|NCT01936467|Pancreatic cancer|pancreatic cancer
385277|NCT01936467|Endoscopic Ultrasound|endoscopic ultrasound
385278|NCT01936467|EUS|eus
385279|NCT01936467|Fine needle aspiration|fine needle aspiration
385280|NCT01936467|FNA|fna
385281|NCT01936467|EUS-FNA|eus-fna
385282|NCT01936441|Menopause|menopause
385283|NCT01936441|Vasomotor|vasomotor
385284|NCT01936441|Symptoms|symptoms
385285|NCT01936441|Sleep|sleep
492704|NCT01460758|rTMS|rtms
385286|NCT01936441|Cognitive Behavioral Therapy|cognitive behavioral therapy
385287|NCT01936415|Knee prosthesis|knee prosthesis
385288|NCT01936402|Cardiopulmonary Resuscitation|cardiopulmonary resuscitation
385289|NCT01936376|kidney safety|kidney safety
385290|NCT01936376|biomarkers|biomarkers
385291|NCT01936376|serum creatinine|serum creatinine
385292|NCT01936376|BUN|bun
385293|NCT01936376|cystic fibrosis|cystic fibrosis
385294|NCT01936376|head and neck cancer|head and neck cancer
385295|NCT01936376|renal injury|renal injury
385296|NCT01936376|drug induced acute kidney injury|drug induced acute kidney injury
385297|NCT01936376|aminoglycoside|aminoglycoside
385298|NCT01936376|cisplatin|cisplatin
385299|NCT01936376|nephrotoxicity|nephrotoxicity
385300|NCT01936376|biomarker qualification|biomarker qualification
385301|NCT01936363|Ovarian Cancer|ovarian cancer
385302|NCT01936363|Pimasertib|pimasertib
385303|NCT01936363|Placebo|placebo
385304|NCT01936363|SAR245409|sar245409
385305|NCT01936350|Heart failure|heart failure
385306|NCT01936324|acne vulgaris|acne vulgaris
385307|NCT01936311|Health Behavior|health behavior
385308|NCT01936311|Behavior change|behavior change
385309|NCT01936311|self-management goal|self-management goal
385310|NCT01936311|health goal|health goal
385311|NCT01936298|Hand Edema|hand edema
385312|NCT01936298|Exercise Therapy|exercise therapy
385313|NCT01936233|Hepatocellular Carcinoma|hepatocellular carcinoma
385314|NCT01936233|Aspirin|aspirin
385315|NCT01936233|antiviral treatment|antiviral treatment
385316|NCT01936233|recurrence free survival|recurrence free survival
385317|NCT01936233|radical therapy|radical therapy
385318|NCT01936220|Schizophrenia|schizophrenia
385319|NCT01936220|First-psychotic episode|first-psychotic episode
385320|NCT01936220|Initial phase|initial phase
385321|NCT01936220|Relapse prevention|relapse prevention
385322|NCT01936220|Specialized treatment|specialized treatment
385323|NCT01936220|Parent groups|parent groups
385324|NCT01936220|Social functioning|social functioning
385325|NCT01936207|acute|acute
385326|NCT01936207|respiratory|respiratory
385327|NCT01936207|syndrome|syndrome
385328|NCT01936207|prognosis|prognosis
385329|NCT01936207|outcome research|outcome research
385330|NCT01936207|respiratory infection|respiratory infection
385331|NCT01936207|sepsis|sepsis
385332|NCT01936207|organ failure|organ failure
385333|NCT01936181|Rheumatoid Arthritis|rheumatoid arthritis
385334|NCT01936181|Infliximab|infliximab
385335|NCT01936181|Biosimilar|biosimilar
385336|NCT01936168|GSV|gsv
385337|NCT01936168|Primary Varicose Veins|primary varicose veins
385338|NCT01936168|Great Saphenous Vein|great saphenous vein
385339|NCT01936168|Treatment|treatment
385340|NCT01936155|Joint Mobility|joint mobility
385341|NCT01936155|Skin Tissue Oxygenation|skin tissue oxygenation
385342|NCT01936155|Neuromuscular Electrical Stimulation|neuromuscular electrical stimulation
385343|NCT01936155|Goniometry|goniometry
385344|NCT01936155|Transcutaneous Oxygen Measurements (tcpO2)|transcutaneous oxygen measurements (tcpo2)
385345|NCT01936155|Water Displacement|water displacement
385346|NCT01936142|Resynchroniztion therapy|resynchroniztion therapy
385347|NCT01936142|Kidney|kidney
385348|NCT01936142|Contrast media|contrast media
385349|NCT01936142|Prevention|prevention
385350|NCT01936116|Sonohysterography|sonohysterography
385351|NCT01936116|catheter placement|catheter placement
385352|NCT01936116|pain magnitude|pain magnitude
385353|NCT01936116|vasovagal reaction|vasovagal reaction
385354|NCT01936103|Acute anterior myocardial infarction|acute anterior myocardial infarction
385355|NCT01936103|Percutaneous coronary stent implantation|percutaneous coronary stent implantation
385356|NCT01936103|Intensive statin therapy|intensive statin therapy
385357|NCT01936103|Left ventricular function|left ventricular function
385358|NCT01936077|Infertility, IVF, ovarian stimulation, rec LH, GnRH antagonist|infertility, ivf, ovarian stimulation, rec lh, gnrh antagonist
385359|NCT01936064|Breast Cancer|breast cancer
385360|NCT01936064|Jobelyn|jobelyn
385361|NCT01936064|Sorghum bicolor|sorghum bicolor
385362|NCT01936038|CPAP|cpap
385363|NCT01936038|Upper Airway Toning|upper airway toning
385364|NCT01936038|Obstructive Sleep Apnoea|obstructive sleep apnoea
385365|NCT01936025|Diabetes mellitus|diabetes mellitus
385366|NCT01936012|Lisinopril|lisinopril
385367|NCT01936012|Bioequivalence|bioequivalence
385368|NCT01936012|Bioavailability|bioavailability
385369|NCT01936012|Pharmacokinetic|pharmacokinetic
385370|NCT01936012|Angiotensin-converting enzyme inhibitor|angiotensin-converting enzyme inhibitor
385371|NCT01935999|Colostomy|colostomy
385372|NCT01935999|peristomal skin|peristomal skin
385373|NCT01935999|stoma|stoma
385374|NCT01935999|pouch|pouch
385375|NCT01935908|Subarachnoid Hemorrhage|subarachnoid hemorrhage
385377|NCT01935908|Prophylaxis|prophylaxis
385378|NCT01935908|Levetiracetam|levetiracetam
385379|NCT01935895|blood pressure reduction|blood pressure reduction
385380|NCT01935895|vascular reactivity|vascular reactivity
385381|NCT01935895|combined exercise session|combined exercise session
385382|NCT01935856|patients|patients
385383|NCT01935856|receiving|receiving
385384|NCT01935856|hemodialysis|hemodialysis
385385|NCT01935856|Secondary|secondary
385386|NCT01935843|CART-HER-2|cart-her-2
385387|NCT01935843|HER-2 positive|her-2 positive
385388|NCT01935843|Advanced|advanced
385389|NCT01935843|Refactory|refactory
385390|NCT01935843|Solid tumors|solid tumors
385391|NCT01935830|PET Imaging|pet imaging
385392|NCT01935830|Efavirenz|efavirenz
385393|NCT01935830|Ritonavior [11C] LAAM|ritonavior [11c] laam
385394|NCT01935830|Healthy volunteers|healthy volunteers
385395|NCT01935804|pioglitazone|pioglitazone
385396|NCT01935804|metformin|metformin
385397|NCT01935804|hyperglycemic agents|hyperglycemic agents
385398|NCT01935804|physiological effects of drugs|physiological effects of drugs
385399|NCT01935804|bone health|bone health
385400|NCT01935765|Type 1 diabetes, sleep apnea, polysomnography,|type 1 diabetes, sleep apnea, polysomnography,
385401|NCT01935765|autonomic neuropathy, intima media thickness|autonomic neuropathy, intima media thickness
385402|NCT01935752|fibromuscular|fibromuscular
385403|NCT01935752|dysplasia|dysplasia
385404|NCT01935752|endothelium|endothelium
385405|NCT01935752|microparticles|microparticles
385406|NCT01935752|microRNA|microrna
385407|NCT01935726|Pulmonary fibrosis|pulmonary fibrosis
385408|NCT01935726|Interstitial lung disease|interstitial lung disease
385409|NCT01935726|Connective tissue disease|connective tissue disease
385410|NCT01935726|Chronic hypersensitivity pneumonitis|chronic hypersensitivity pneumonitis
385411|NCT01935726|Idiopathic pulmonary fibrosis|idiopathic pulmonary fibrosis
385412|NCT01935700|hepatocellular carcinoma|hepatocellular carcinoma
385413|NCT01935700|colchicine|colchicine
385414|NCT01935687|Instrumented Wheel|instrumented wheel
385415|NCT01935687|Manual Wheelchair|manual wheelchair
385416|NCT01935687|Spinal Cord Injury (SCI)|spinal cord injury (sci)
385417|NCT01935687|Manual wheelchair Users|manual wheelchair users
385418|NCT01935687|Aged between 18-70 years|aged between 18-70 years
385419|NCT01935674|Hypercholesterolaemia|hypercholesterolaemia
385421|NCT01935674|Rosuvastatin|rosuvastatin
385422|NCT01935674|Protease inhibitor switching|protease inhibitor switching
385423|NCT01935661|Blood transfusion|blood transfusion
385424|NCT01935661|Hemosiderosis|hemosiderosis
385426|NCT01935648|Knee arthroplasty|knee arthroplasty
385427|NCT01935635|CHB|chb
385428|NCT01935635|Antiviral|antiviral
385429|NCT01935635|Dentritic cells|dentritic cells
385430|NCT01935635|Immune Therapy|immune therapy
385431|NCT01935622|heart failure|heart failure
385432|NCT01935622|non-ischemic cardiomyopathy|non-ischemic cardiomyopathy
385433|NCT01935609|traumatic brain injury|traumatic brain injury
385434|NCT01935609|acquired brain injury|acquired brain injury
385435|NCT01935596|Anesthesia|anesthesia
385436|NCT01935596|Randomized study|randomized study
385437|NCT01935596|Lower limbs surgery|lower limbs surgery
385438|NCT01935583|traumatic brain injury|traumatic brain injury
385439|NCT01935570|Bioavailability of magnesium|bioavailability of magnesium
385440|NCT01935570|Digestive and general tolerance|digestive and general tolerance
385441|NCT01935557|Continuous heparin infusion|continuous heparin infusion
385442|NCT01935557|Intermittent heparin infusion|intermittent heparin infusion
385443|NCT01935557|during catheter ablation|during catheter ablation
385444|NCT01935544|Botulinum Toxin|botulinum toxin
385445|NCT01935544|Ultrasound-guidance|ultrasound-guidance
385446|NCT01935544|Stroke|stroke
385447|NCT01935544|Spasticity|spasticity
385448|NCT01935544|Ultrasonography|ultrasonography
385449|NCT01935544|Hemiplegia|hemiplegia
385450|NCT01935531|actinic keratoses|actinic keratoses
385451|NCT01935531|tumor metabolism|tumor metabolism
385452|NCT01935531|glycolysis|glycolysis
385453|NCT01935531|diclofenac|diclofenac
385454|NCT01935531|warburg effect|warburg effect
385455|NCT01935505|smoking cessation|smoking cessation
385456|NCT01935505|intervention model|intervention model
385457|NCT01935505|Chinese|chinese
385458|NCT01935505|quitting rate|quitting rate
385459|NCT01935492|metastatic breast cancer|metastatic breast cancer
385460|NCT01935492|HER2/neu negative|her2/neu negative
385461|NCT01935492|paclitaxel|paclitaxel
385462|NCT01935492|bevacizumab|bevacizumab
385463|NCT01935492|liposomal doxorubicine|liposomal doxorubicine
385464|NCT01935492|capecitabine|capecitabine
385465|NCT01935479|AK159, teriparatide acetate|ak159, teriparatide acetate
385466|NCT01935466|Pioglitazone|pioglitazone
385467|NCT01935466|Bladder cancer|bladder cancer
385468|NCT01935466|Type 2 Diabetes|type 2 diabetes
385469|NCT01935440|HIV, drug use|hiv, drug use
385470|NCT01935427|Pulse Oximeter|pulse oximeter
385471|NCT01935427|Stroke Volume|stroke volume
385472|NCT01935427|Hemorrhagic shock|hemorrhagic shock
385473|NCT01935427|Compensatory Reserve Index|compensatory reserve index
385474|NCT01935401|Bulimia Nervosa|bulimia nervosa
385475|NCT01935401|Bulimia|bulimia
385476|NCT01935401|Response Inhibition|response inhibition
385477|NCT01935401|fNIR|fnir
385478|NCT01935401|Neuroimaging|neuroimaging
385479|NCT01935388|Mechanical ventilation|mechanical ventilation
385480|NCT01935388|chronic obstructive pulmonary disease|chronic obstructive pulmonary disease
385481|NCT01935388|asthma|asthma
385482|NCT01935388|common canister|common canister
385483|NCT01935388|MDI|mdi
385484|NCT01935388|ventilator associated pneumonia|ventilator associated pneumonia
385485|NCT01935375|Postpartum Depression|postpartum depression
385486|NCT01935375|Nurse Midwife|nurse midwife
385487|NCT01935375|Interpersonal Psychotherapy|interpersonal psychotherapy
385488|NCT01935362|Flavanones|flavanones
385489|NCT01935362|Bioavailability|bioavailability
385490|NCT01935362|Blood vessel health|blood vessel health
385491|NCT01935362|Blood glucose|blood glucose
385492|NCT01935349|Diabetes mellitus (DM)|diabetes mellitus (dm)
385493|NCT01935349|hypertension (HT)|hypertension (ht)
385494|NCT01935349|Hong Kong|hong kong
385495|NCT01935336|Lung Cancer|lung cancer
385496|NCT01935336|Malignancy|malignancy
385497|NCT01935336|Predictive biomarkers|predictive biomarkers
385498|NCT01935323|high intensity interval training|high intensity interval training
385499|NCT01935323|aerobic exercise|aerobic exercise
385500|NCT01935323|insulin sensitivity|insulin sensitivity
385501|NCT01935323|obesity|obesity
385502|NCT01935323|cardiovascular fitness|cardiovascular fitness
385503|NCT01935310|Photoaging|photoaging
385504|NCT01935310|imiquimod|imiquimod
385505|NCT01935310|wrinkles|wrinkles
385506|NCT01935310|elastosis|elastosis
385507|NCT01935271|immunosenescence|immunosenescence
385508|NCT01935271|sarcopenia|sarcopenia
385509|NCT01935258|Medically unexplained symptoms|medically unexplained symptoms
385510|NCT01935258|Somatization|somatization
385511|NCT01935258|Psychosomatic therapy|psychosomatic therapy
385512|NCT01935245|Coronary artery bypass grafting|coronary artery bypass grafting
385513|NCT01935245|Extracorporeal circulation|extracorporeal circulation
385514|NCT01935245|Minimal extracorporeal circulation|minimal extracorporeal circulation
385515|NCT01935245|Coagulopathy|coagulopathy
385516|NCT01935245|Thrombocytopathy|thrombocytopathy
385517|NCT01935245|Platelet dysfunction|platelet dysfunction
385518|NCT01935232|Osteoporosis, diagnostics, ultrasound|osteoporosis, diagnostics, ultrasound
385519|NCT01935219|mild cognitive impairment|mild cognitive impairment
385520|NCT01935219|seniors|seniors
385521|NCT01935219|cognitive training|cognitive training
385522|NCT01935219|driving|driving
385523|NCT01935219|driving simulation|driving simulation
385524|NCT01935219|intervention|intervention
385525|NCT01935219|goal management training|goal management training
385526|NCT01935219|process speed training|process speed training
385527|NCT01935206|secondary hyperalgesia|secondary hyperalgesia
385528|NCT01935206|allodynia|allodynia
385529|NCT01935206|mechanical pain threshold|mechanical pain threshold
385530|NCT01935206|naloxone|naloxone
385531|NCT01935206|endogenous opioids|endogenous opioids
385532|NCT01935206|pain|pain
385533|NCT01935193|platelets aggregation|platelets aggregation
385534|NCT01935193|asa resistance|asa resistance
385535|NCT01935180|colon polyps|colon polyps
385536|NCT01935180|adenoma resection|adenoma resection
385537|NCT01935180|colon cancer screening|colon cancer screening
385538|NCT01935180|colonoscopy|colonoscopy
385539|NCT01935180|polyp detection|polyp detection
385540|NCT01935167|Microalbuminuria|microalbuminuria
385541|NCT01935154|NSCLC|nsclc
385542|NCT01935154|Vaccine|vaccine
385543|NCT01935141|Pulmonary Embolus|pulmonary embolus
385544|NCT01935141|Radio Contrast Material|radio contrast material
385545|NCT01935141|Computed Tomography|computed tomography
385546|NCT01935128|Renal Transplant|renal transplant
385547|NCT01935128|Immunosuppression|immunosuppression
385548|NCT01935128|Steroid Avoidance|steroid avoidance
385549|NCT01935128|Calcineurin Avoidance|calcineurin avoidance
385550|NCT01935128|Mammalian Target of Rapamycin (mTOR)|mammalian target of rapamycin (mtor)
385551|NCT01935128|Kidney|kidney
385552|NCT01935115|Depression|depression
385553|NCT01935115|MDD|mdd
385554|NCT01935115|Treatment Resistant Depression|treatment resistant depression
385555|NCT01935115|Electroconvulsive Therapy|electroconvulsive therapy
385556|NCT01935115|ECT|ect
385557|NCT01935115|Ketamine|ketamine
385558|NCT01935115|Propofol|propofol
385559|NCT01935115|NMDA|nmda
385560|NCT01935102|metastatic breast cancer|metastatic breast cancer
385561|NCT01935102|bevacizumab|bevacizumab
385562|NCT01935102|single nucleotide polymorphism|single nucleotide polymorphism
385563|NCT01935102|VEGF-A|vegf-a
385564|NCT01935102|VEGFR-2|vegfr-2
385565|NCT01935102|IL-8|il-8
385566|NCT01935089|HIV-1|hiv-1
385567|NCT01935089|Interferon alpha|interferon alpha
385568|NCT01935089|Integrated DNA|integrated dna
385569|NCT01935089|Latent reservoir|latent reservoir
385570|NCT01935076|Maternal obesity|maternal obesity
385571|NCT01935076|Macrosomic|macrosomic
385572|NCT01935076|miRNA|mirna
385573|NCT01935076|Fetal overgrowth|fetal overgrowth
385574|NCT01935063|Vulvodynia|vulvodynia
385575|NCT01935063|Provoked vestibulodynia|provoked vestibulodynia
385576|NCT01935063|Vulvar pain|vulvar pain
385577|NCT01935063|Dyspareunia|dyspareunia
385578|NCT01935063|Couples therapy|couples therapy
385579|NCT01935063|Lidocaine|lidocaine
385580|NCT01935063|Cognitive behavioral couple therapy|cognitive behavioral couple therapy
789624|NCT00294632|MCL|mcl
385581|NCT01935063|Cognitive behavioral therapy|cognitive behavioral therapy
385582|NCT01935063|Pain|pain
385583|NCT01935063|Pain during sexual intercourse|pain during sexual intercourse
385584|NCT01935050|Depression|depression
385585|NCT01935050|Parkinson's disease|parkinson's disease
385586|NCT01935050|Cognitive-Behavioral Treatment|cognitive-behavioral treatment
385587|NCT01935024|Alzheimer's disease|alzheimer's disease
385588|NCT01935024|dementia|dementia
385589|NCT01935024|aerobic exercise|aerobic exercise
385590|NCT01934998|SCA6, parkinsonism, Datscan|sca6, parkinsonism, datscan
385591|NCT01934985|Single-Photon Emission-Computed Tomography|single-photon emission-computed tomography
385592|NCT01934985|Myocardial Perfusion Imaging|myocardial perfusion imaging
385593|NCT01934985|Ischemia|ischemia
385594|NCT01934985|Stress test|stress test
385595|NCT01934985|Coronary Artery Disease (CAD)|coronary artery disease (cad)
385596|NCT01934985|Coronary Flow Reserve (CFR)|coronary flow reserve (cfr)
385597|NCT01934985|Coronary Angiography|coronary angiography
385598|NCT01934972|Bipolar disorder|bipolar disorder
385599|NCT01934946|hip fracture|hip fracture
385600|NCT01934933|inflammation|inflammation
385601|NCT01934933|etanercept|etanercept
385602|NCT01934933|celecoxib|celecoxib
385603|NCT01934933|ankylsoing spondylitis|ankylsoing spondylitis
385604|NCT01934894|HER2-positive breast cancer|her2-positive breast cancer
385605|NCT01934894|intracranial metastases|intracranial metastases
385606|NCT01934894|lapatinib|lapatinib
385607|NCT01934894|cabazitaxel|cabazitaxel
385608|NCT01934868|low back pain|low back pain
385609|NCT01934868|sciatica|sciatica
385610|NCT01934868|spinal stenosis|spinal stenosis
385611|NCT01934868|epidural injections|epidural injections
385612|NCT01934868|prolotherapy|prolotherapy
385613|NCT01934868|sacroiliac pain or dysfunction.|sacroiliac pain or dysfunction.
385614|NCT01934855|cancer|cancer
385615|NCT01934855|radiotherapy|radiotherapy
385616|NCT01934855|4D-MRI|4d-mri
385617|NCT01934855|4D-CT|4d-ct
385619|NCT01934816|Incretins, KATP channels, intradermal injection|incretins, katp channels, intradermal injection
385620|NCT01934803|Alcohol Use|alcohol use
385621|NCT01934803|Microbial Translocation|microbial translocation
385622|NCT01934803|Inflammation|inflammation
385623|NCT01934803|Altered Coagulation|altered coagulation
385624|NCT01934803|Russia|russia
385625|NCT01934803|Zinc|zinc
385626|NCT01934803|AMI|ami
385627|NCT01934803|VACS index|vacs index
385628|NCT01934803|Reynolds risk score|reynolds risk score
385629|NCT01934777|NAFLD|nafld
385630|NCT01934777|NASH|nash
385631|NCT01934777|fibrosis|fibrosis
385632|NCT01934738|Multiple dose|multiple dose
385633|NCT01934738|safety|safety
385634|NCT01934738|tolerability|tolerability
385635|NCT01934738|PK|pk
385636|NCT01934725|Ischemic Stroke|ischemic stroke
385637|NCT01934725|Brain Infarction|brain infarction
385638|NCT01934725|Patent Foramen Ovale|patent foramen ovale
385639|NCT01934725|Stroke in the Young|stroke in the young
385640|NCT01934725|Myocardial Infarction|myocardial infarction
385641|NCT01934725|Cerebral Venous Thrombosis|cerebral venous thrombosis
385642|NCT01934725|Pulmonary Embolism|pulmonary embolism
385643|NCT01934725|Deep Vein Thrombosis|deep vein thrombosis
385644|NCT01934725|Subarachnoid Hemorrhage|subarachnoid hemorrhage
385645|NCT01934725|Prognosis|prognosis
385646|NCT01934725|Databases, Genetic|databases, genetic
385647|NCT01934699|Coronary stenosis|coronary stenosis
385648|NCT01934699|Angina pectoris|angina pectoris
385649|NCT01934699|Left ventricular wall motion abnormalities|left ventricular wall motion abnormalities
385650|NCT01934699|2D-Strain|2d-strain
385651|NCT01934660|Cardiovascular Disease|cardiovascular disease
385652|NCT01934660|Diabetes Mellitus|diabetes mellitus
385653|NCT01934660|Inflammation|inflammation
385654|NCT01934634|Pancreatic Cancer|pancreatic cancer
385655|NCT01934634|Stage IV Pancreatic Cancer|stage iv pancreatic cancer
385656|NCT01934634|Stage IV metastatic pancreatic ductal adenocarcinoma|stage iv metastatic pancreatic ductal adenocarcinoma
385657|NCT01934621|Stroke|stroke
385658|NCT01934621|Rehabilitation|rehabilitation
385659|NCT01934621|Cognition|cognition
385660|NCT01934621|Disability|disability
385661|NCT01934595|Critically ill|critically ill
385662|NCT01934595|Protein|protein
385663|NCT01934595|Supplement|supplement
385664|NCT01934595|ICU|icu
385665|NCT01934595|Protein synthesis|protein synthesis
385666|NCT01934530|implant complications|implant complications
385667|NCT01934530|esthetics|esthetics
385668|NCT01934530|soft tissue grafting|soft tissue grafting
385669|NCT01934504|clinical tolerance|clinical tolerance
385670|NCT01934504|biomarker(s) identification|biomarker(s) identification
385671|NCT01934491|Cognitive training|cognitive training
385672|NCT01934491|Depression|depression
385673|NCT01934478|Breast|breast
385674|NCT01934478|Cancer|cancer
385675|NCT01934478|Human Epidermal Growth Factor 2 (Her2)|human epidermal growth factor 2 (her2)
385676|NCT01934478|irradiation|irradiation
385677|NCT01934465|NSCLC|nsclc
385678|NCT01934465|Chemotherapy|chemotherapy
385679|NCT01934465|Anti-angiogenic agent|anti-angiogenic agent
385680|NCT01934465|Bevacizumab|bevacizumab
385681|NCT01934465|1st Line|1st line
385682|NCT01934452|complete remission|complete remission
385683|NCT01934439|Stroke|stroke
385684|NCT01934439|Rehabilitation|rehabilitation
385685|NCT01934439|Dyssynergia|dyssynergia
385686|NCT01934439|Robotics|robotics
385687|NCT01934439|AMES|ames
385688|NCT01934439|Cerebrovascular Accident|cerebrovascular accident
385689|NCT01934426|Admission High Risk Elderly|admission high risk elderly
385690|NCT01934413|Palliative Care|palliative care
385691|NCT01934413|Technology|technology
385692|NCT01934413|Rural|rural
385693|NCT01934413|Transitional Care|transitional care
385694|NCT01934400|Osteoporosis|osteoporosis
385695|NCT01934400|fall prevention|fall prevention
385696|NCT01934400|high risk population|high risk population
385697|NCT01934387|World Health Organization Fracture Risk Assessment Tool|world health organization fracture risk assessment tool
385698|NCT01934387|Osteoporosis|osteoporosis
385699|NCT01934387|Aged|aged
385700|NCT01934387|Prevention|prevention
385701|NCT01934387|Fracture|fracture
385702|NCT01934387|FRAX|frax
385703|NCT01934374|task-oriented training, long-term effects, plasticity|task-oriented training, long-term effects, plasticity
385704|NCT01934361|BKM120|bkm120
385705|NCT01934361|Recurrent glioblastoma multiforme|recurrent glioblastoma multiforme
385706|NCT01934361|rGBM|rgbm
385707|NCT01934361|buparlisib|buparlisib
385708|NCT01934335|breast cancer, TKI, tyrosine kinase inhibitor, vandetanib, Ki-67|breast cancer, tki, tyrosine kinase inhibitor, vandetanib, ki-67
385709|NCT01934322|frequent users of the emergency department|frequent users of the emergency department
385710|NCT01934322|vulnerable populations|vulnerable populations
385711|NCT01934322|case management|case management
385712|NCT01934322|cost savings intervention|cost savings intervention
385713|NCT01934322|quality of life|quality of life
385714|NCT01934322|number of emergency department visits|number of emergency department visits
385715|NCT01934309|tuberculosis|tuberculosis
385716|NCT01934309|isoniazid preventative therapy|isoniazid preventative therapy
385717|NCT01934309|clinical decision support|clinical decision support
385719|NCT01934309|Kenya|kenya
385720|NCT01934309|eHealth|ehealth
385721|NCT01934296|deep brain stimulation|deep brain stimulation
385722|NCT01934296|cortical recording|cortical recording
385723|NCT01934296|neuroprosthesis|neuroprosthesis
385724|NCT01934231|Acute bacterial rhinosinusitis|acute bacterial rhinosinusitis
385725|NCT01934231|Amoxicilin|amoxicilin
385726|NCT01934231|Infection|infection
385727|NCT01934231|Potassium clavulanate|potassium clavulanate
385728|NCT01934218|Knee|knee
385729|NCT01934218|Osteoarthritis|osteoarthritis
385730|NCT01934218|Intra-articular injection|intra-articular injection
385731|NCT01934205|GSK2140944|gsk2140944
385732|NCT01934205|pharmacokinetics|pharmacokinetics
385733|NCT01934205|bronchoalveolar lavage|bronchoalveolar lavage
385734|NCT01934205|pulmonary|pulmonary
385735|NCT01934205|antimicrobial|antimicrobial
385736|NCT01934205|healthy volunteer|healthy volunteer
385737|NCT01934192|tolerability|tolerability
385738|NCT01934192|camicinal|camicinal
385739|NCT01934192|single dose|single dose
385740|NCT01934192|acetaminophen|acetaminophen
385741|NCT01934192|gastric emptying|gastric emptying
385742|NCT01934192|critically ill|critically ill
385743|NCT01934192|GSK962040|gsk962040
385744|NCT01934192|pharmacokinetics|pharmacokinetics
385745|NCT01934192|pharmacodynamics|pharmacodynamics
385746|NCT01934192|gut motility|gut motility
385747|NCT01934153|hyperhidrosis|hyperhidrosis
385748|NCT01934153|topical|topical
385749|NCT01934153|[14C] radiolabel|[14c] radiolabel
385750|NCT01934153|palm|palm
385751|NCT01934153|GSK573719|gsk573719
385752|NCT01934153|axilla|axilla
385753|NCT01934153|Umeclidinium|umeclidinium
385754|NCT01934140|Healthy|healthy
385755|NCT01934140|Adults|adults
385756|NCT01934140|Safety|safety
385757|NCT01934140|Neisseria meningitidis|neisseria meningitidis
385758|NCT01934140|Booster response|booster response
385759|NCT01934140|Immunogenicity|immunogenicity
385760|NCT01934140|Adolescents|adolescents
385761|NCT01934140|Serogroups A, C, W-135, and Y|serogroups a, c, w-135, and y
385762|NCT01934140|long-term antibody persistence|long-term antibody persistence
385763|NCT01934127|Immunogenicity|immunogenicity
385764|NCT01934127|H7N1|h7n1
385765|NCT01934127|Influenza|influenza
385766|NCT01934127|Safety|safety
385767|NCT01934127|AS03 adjuvant|as03 adjuvant
385768|NCT01934127|Adults|adults
385769|NCT01934088|Inflammatory Bowel disease|inflammatory bowel disease
385770|NCT01934088|IBD|ibd
385771|NCT01934088|Sedation|sedation
385772|NCT01934088|NAPS|naps
385773|NCT01934088|Propofol|propofol
385774|NCT01934088|Midazolam|midazolam
385775|NCT01934088|Satisfaction|satisfaction
385776|NCT01934088|Feasibility|feasibility
385777|NCT01934075|Obstetric fistula|obstetric fistula
385778|NCT01934075|Mental health|mental health
385779|NCT01934075|Tanzania|tanzania
385780|NCT01934036|Weight loss|weight loss
385781|NCT01934036|Nutritional supplement|nutritional supplement
385782|NCT01934036|Waist|waist
385783|NCT01934036|Body composition|body composition
385784|NCT01934036|Skinfolds|skinfolds
385785|NCT01934023|plasticity, schizophrenia, varenicline, non smokers,|plasticity, schizophrenia, varenicline, non smokers,
385786|NCT01933997|pharmacokinetics|pharmacokinetics
385787|NCT01933997|metadoxine|metadoxine
385788|NCT01933984|Bronchodilator agents,|bronchodilator agents,
385789|NCT01933984|chronic obstructive pulmonary disease,|chronic obstructive pulmonary disease,
385790|NCT01933984|endotracheal intubation,|endotracheal intubation,
385791|NCT01933984|mechanical ventilator|mechanical ventilator
385792|NCT01933958|Regorafenib|regorafenib
385793|NCT01933958|Gastrointestinal stromal tumors|gastrointestinal stromal tumors
385794|NCT01933932|Mitogen-Activated Protein Kinase Kinase inhibitor; Non Small Cell Lung Cancer; metastatic; second line treatment for Non Small Cell Lung Cancer; KRAS mutation|mitogen-activated protein kinase kinase inhibitor; non small cell lung cancer; metastatic; second line treatment for non small cell lung cancer; kras mutation
385795|NCT01933919|Obsessive Compulsive Disorder|obsessive compulsive disorder
385796|NCT01933919|Adolescent Subjects|adolescent subjects
385797|NCT01933919|Pediatric Subjects|pediatric subjects
385798|NCT01933906|CML|cml
385799|NCT01933906|Chronic myeloid leukemia|chronic myeloid leukemia
385800|NCT01933906|Chronic myeloid leukaemia|chronic myeloid leukaemia
385801|NCT01933906|PEG-Proline-Interferon-alpha 2b|peg-proline-interferon-alpha 2b
385802|NCT01933906|Interferon|interferon
385803|NCT01933906|P1101|p1101
385804|NCT01933906|Imatinib|imatinib
385805|NCT01933893|Pipelle, luteal, follicular, implantation|pipelle, luteal, follicular, implantation
385806|NCT01933880|Attention Deficit Hyperactivity Disorder|attention deficit hyperactivity disorder
385807|NCT01933880|Methylphenidate Hydrochloride|methylphenidate hydrochloride
385808|NCT01933880|CONCERTA|concerta
385809|NCT01933867|water|water
385810|NCT01933867|colonoscopy|colonoscopy
385811|NCT01933867|Crohn´s disease|crohn´s disease
385812|NCT01933867|ulcerative colitis|ulcerative colitis
385813|NCT01933854|Urinary incontinence|urinary incontinence
385814|NCT01933854|riverside|riverside
385815|NCT01933854|women|women
385816|NCT01933854|Amapa|amapa
385817|NCT01933841|Post operative residual curarization|post operative residual curarization
385818|NCT01933841|Neuromuscular blocking drugs|neuromuscular blocking drugs
385819|NCT01933828|Lung cancer|lung cancer
385820|NCT01933828|surgery video-assisted|surgery video-assisted
385821|NCT01933828|robot|robot
385822|NCT01933828|surgical treatment|surgical treatment
385823|NCT01933815|Glioblastoma multiforme|glioblastoma multiforme
385824|NCT01933815|Glioblastoma|glioblastoma
385825|NCT01933815|Radiotherapy|radiotherapy
385826|NCT01933815|Temozolomide|temozolomide
385827|NCT01933815|TPI 287|tpi 287
385828|NCT01933815|Taxoid|taxoid
385829|NCT01933815|Avastin|avastin
385830|NCT01933815|Bevacizumab|bevacizumab
385831|NCT01933802|mesenchymal stem cells|mesenchymal stem cells
385832|NCT01933802|neural progenitors|neural progenitors
385833|NCT01933802|autologous|autologous
385834|NCT01933802|bone marrow|bone marrow
385835|NCT01933802|multiple sclerosis|multiple sclerosis
385836|NCT01933789|Palliative Care|palliative care
385837|NCT01933789|End-of-Life Issues|end-of-life issues
385838|NCT01933789|Patient/Clinician Communication|patient/clinician communication
385839|NCT01933789|Patient/Family Communication|patient/family communication
385840|NCT01933789|Concordance|concordance
385841|NCT01933789|Treatment Preferences|treatment preferences
385842|NCT01933789|Anxiety|anxiety
385843|NCT01933789|Depressive Symptoms|depressive symptoms
385844|NCT01933789|Talking with Your Doctor|talking with your doctor
385845|NCT01933789|Coping with Serious Illness|coping with serious illness
385846|NCT01933789|Outpatient Collaboration|outpatient collaboration
385847|NCT01933776|Diphtheria|diphtheria
385848|NCT01933776|Tetanus|tetanus
385849|NCT01933776|Pertussis|pertussis
385850|NCT01933776|ADACEL®|adacel®
385851|NCT01933776|Tdap vaccine|tdap vaccine
385852|NCT01933750|Presbyopia|presbyopia
385853|NCT01933750|Reading Glasses|reading glasses
385854|NCT01933750|Near Vision|near vision
385855|NCT01933737|postural balance;|postural balance;
385856|NCT01933737|elderly;|elderly;
385857|NCT01933737|proprioception;|proprioception;
385858|NCT01933737|prevention;|prevention;
385859|NCT01933737|fall|fall
385860|NCT01933724|granulomatosis with polyangiitis|granulomatosis with polyangiitis
385861|NCT01933724|GPA|gpa
385862|NCT01933724|Wegeners'|wegeners'
385863|NCT01933724|WG|wg
385864|NCT01933724|vasculitis|vasculitis
385865|NCT01933724|taper|taper
385866|NCT01933724|prednisone|prednisone
385867|NCT01933724|glucocorticoid|glucocorticoid
385868|NCT01933724|ANCA-associated vasculitis|anca-associated vasculitis
385869|NCT01933724|AAV|aav
385870|NCT01933724|Wegener Granulomatosis|wegener granulomatosis
385871|NCT01933724|Systemic Vasculitis|systemic vasculitis
385872|NCT01933724|Lung diseases, interstitial|lung diseases, interstitial
385873|NCT01933724|Lung diseases|lung diseases
385874|NCT01933724|Respiratory Tract Diseases|respiratory tract diseases
385875|NCT01933724|Anti-Neutrophil Cytoplasmic Antibody-Associated Vasculitis|anti-neutrophil cytoplasmic antibody-associated vasculitis
385876|NCT01933724|Vascular Diseases|vascular diseases
385877|NCT01933724|Cardiovascular Diseases|cardiovascular diseases
385878|NCT01933724|Glucocorticoids|glucocorticoids
385879|NCT01933724|Hormones|hormones
385880|NCT01933724|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists
385881|NCT01933724|Physiological Effects of Drugs|physiological effects of drugs
385882|NCT01933724|Pharmacologic Actions|pharmacologic actions
385883|NCT01933724|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal
385884|NCT01933724|Antineoplastic Agents|antineoplastic agents
385885|NCT01933724|Therapeutic Uses|therapeutic uses
385886|NCT01933724|Anti-Inflammatory Agents|anti-inflammatory agents
385887|NCT01933711|CD20+ aggressive lymphoma|cd20+ aggressive lymphoma
385888|NCT01933711|mantle cell lymphoma|mantle cell lymphoma
385889|NCT01933711|rituximab|rituximab
385890|NCT01933711|maintenance|maintenance
385891|NCT01933698|Bioequivalence|bioequivalence
385892|NCT01933698|Amoxicillin|amoxicillin
385894|NCT01933672|Phase 1b|phase 1b
385895|NCT01933672|type 2 diabetes|type 2 diabetes
385896|NCT01933672|metformin background|metformin background
385897|NCT01933672|PF-04937319|pf-04937319
385898|NCT01933659|Helicobacter pylori|helicobacter pylori
385899|NCT01933659|deep see water|deep see water
385900|NCT01933646|Group B streptococcus|group b streptococcus
385901|NCT01933646|Incidence|incidence
385902|NCT01933646|Case fatality rate|case fatality rate
385903|NCT01933646|Serotype distribution|serotype distribution
385904|NCT01933633|Pregnancy|pregnancy
385905|NCT01933633|Fertility|fertility
385906|NCT01933633|exercise|exercise
385907|NCT01933633|Fertilization in vitro|fertilization in vitro
385908|NCT01933620|Multidrug-Resistant Organism|multidrug-resistant organism
385909|NCT01933620|Nosocomial Infection|nosocomial infection
385910|NCT01933542|Chlorzoxazone|chlorzoxazone
385911|NCT01933542|Postoperative pain|postoperative pain
385912|NCT01933542|Spine surgery|spine surgery
385913|NCT01933542|Opioid consumption|opioid consumption
385914|NCT01933529|diabetes|diabetes
385915|NCT01933529|glucose tolerance|glucose tolerance
385916|NCT01933529|insulin secretion|insulin secretion
385917|NCT01933529|insulin sensitivity|insulin sensitivity
385918|NCT01933529|erythropoietin|erythropoietin
385919|NCT01933529|inflammation|inflammation
385920|NCT01933529|cytokines|cytokines
385921|NCT01933516|GP2013|gp2013
385922|NCT01933516|Japanese|japanese
385923|NCT01933516|indolent B-cell non-Hodgkin's lymphoma|indolent b-cell non-hodgkin's lymphoma
385924|NCT01933516|biosimilar|biosimilar
385925|NCT01933516|CD20|cd20
385926|NCT01933516|GP13-101|gp13-101
385927|NCT01933503|MAD|mad
385928|NCT01933503|SAD|sad
385929|NCT01933503|Obeticholic Acid (OCA)|obeticholic acid (oca)
385930|NCT01933490|hyperinsulinemic hypoglycemia|hyperinsulinemic hypoglycemia
385931|NCT01933477|Maternal Health|maternal health
385932|NCT01933477|Child Health|child health
385933|NCT01933477|HIV infection|hiv infection
385934|NCT01933477|Antenatal care|antenatal care
385935|NCT01933477|Postpartum care|postpartum care
385936|NCT01933477|Prevention of mother to child transmission (PMTCT)|prevention of mother to child transmission (pmtct)
385937|NCT01933477|Breast feeding|breast feeding
385938|NCT01933477|Antiretrovirals|antiretrovirals
385939|NCT01933464|Rosacea|rosacea
385940|NCT01933464|Cromolyn sodium|cromolyn sodium
385941|NCT01933451|fluid therapy|fluid therapy
385942|NCT01933451|Intraoperative care|intraoperative care
385943|NCT01933451|Patient Outcome Assessment|patient outcome assessment
385944|NCT01933451|pulse pressure variation|pulse pressure variation
385945|NCT01933451|restrictive fluid therapy|restrictive fluid therapy
385946|NCT01933451|goal-directed fluid therapy|goal-directed fluid therapy
385947|NCT01933451|esophagectomy|esophagectomy
385948|NCT01933438|birth related brachial plexus injury|birth related brachial plexus injury
385949|NCT01933438|brachial plexus|brachial plexus
385950|NCT01933438|splint|splint
385951|NCT01933425|surgical conditions|surgical conditions
385952|NCT01933425|laparoscopy|laparoscopy
385953|NCT01933412|Dialysis|dialysis
385954|NCT01933412|Hepatitis B|hepatitis b
385955|NCT01933399|Low back pain|low back pain
385956|NCT01933399|Back brace|back brace
385957|NCT01933399|Lumbar orthoses|lumbar orthoses
385958|NCT01933399|Lumbosacral orthoses|lumbosacral orthoses
385959|NCT01933399|Low back pain treatment|low back pain treatment
385960|NCT01933386|Single Sided Deafness|single sided deafness
385961|NCT01933386|SSD|ssd
385962|NCT01933386|Unilateral hearing loss|unilateral hearing loss
385963|NCT01933373|Randomized|randomized
385964|NCT01933373|Toupet|toupet
385965|NCT01933373|Dor|dor
385966|NCT01933373|Achalasia|achalasia
385967|NCT01933360|Misoprostol|misoprostol
385968|NCT01933360|First trimester pregnancy|first trimester pregnancy
385969|NCT01933360|Surgical abortion|surgical abortion
385970|NCT01933360|Cervical priming|cervical priming
385971|NCT01933334|pirfenidone|pirfenidone
385972|NCT01933334|SSc-ILD|ssc-ild
385973|NCT01933334|scleroderma|scleroderma
385974|NCT01933334|systemic sclerosis|systemic sclerosis
385975|NCT01933334|interstitial lung disease|interstitial lung disease
493680|NCT01456780|MGD|mgd
385976|NCT01933321|ALS, stem cells|als, stem cells
385977|NCT01933308|Pulmonary Rehabilitation|pulmonary rehabilitation
385978|NCT01933308|Comparison of exercise training protocol|comparison of exercise training protocol
385979|NCT01933308|Exercise tolerance|exercise tolerance
385980|NCT01933308|Functional and quality of life status|functional and quality of life status
385981|NCT01933308|Cognitive and psychological status|cognitive and psychological status
385982|NCT01933308|Compliance to exercise recommendations|compliance to exercise recommendations
385983|NCT01933308|Long term adherence to exercise recommendations|long term adherence to exercise recommendations
385984|NCT01933295|treatment|treatment
385985|NCT01933282|MESA, chemotherapy,NK/T cell lymphoma|mesa, chemotherapy,nk/t cell lymphoma
385986|NCT01933256|Type 2 Diabetes Mellitus|type 2 diabetes mellitus
385987|NCT01933256|HIP2B|hip2b
385988|NCT01933256|Placebo|placebo
385989|NCT01933256|islet β cell|islet β cell
385990|NCT01933243|Anxiety|anxiety
385991|NCT01933243|Anorexia nervosa|anorexia nervosa
385992|NCT01933243|Adolescents|adolescents
385993|NCT01933243|Fish oil|fish oil
385994|NCT01933217|TBI|tbi
385995|NCT01933217|traumatic brain injury|traumatic brain injury
385996|NCT01933217|ADHD|adhd
385997|NCT01933217|methylphenidate|methylphenidate
385998|NCT01933217|Concerta|concerta
385999|NCT01933217|attention problems|attention problems
386000|NCT01933204|perimenopause|perimenopause
386001|NCT01933204|hot flash|hot flash
386002|NCT01933204|palpitation|palpitation
386003|NCT01933191|Dental Anxiety, Physical Activity, Dental Phobia|dental anxiety, physical activity, dental phobia
386004|NCT01933191|Cortisol, Amylase|cortisol, amylase
386005|NCT01933178|Dry eyes|dry eyes
386006|NCT01933178|Cirrus AS-OCT|cirrus as-oct
386007|NCT01933178|Excess folds of the conjunctiva|excess folds of the conjunctiva
386008|NCT01933165|Dry Eyes|dry eyes
386009|NCT01933165|LipiView|lipiview
386010|NCT01933165|Lipid thickness|lipid thickness
386011|NCT01933152|wAMD|wamd
386012|NCT01933152|anti-VEGF|anti-vegf
386013|NCT01933139|Informed consent|informed consent
386014|NCT01933139|preoperative counseling|preoperative counseling
386015|NCT01933139|hysterectomy|hysterectomy
386016|NCT01933113|Obesity|obesity
386017|NCT01933113|Deep Brain Stimulation|deep brain stimulation
386018|NCT01933113|LHA|lha
386019|NCT01933100|Functional constipation|functional constipation
386020|NCT01933100|Brown rice based-meal|brown rice based-meal
386021|NCT01933100|Polished rice based-meal|polished rice based-meal
386022|NCT01933100|Wheat based-meal|wheat based-meal
386023|NCT01933087|Hand hygiene,|hand hygiene,
386024|NCT01933087|Randonmised Controlled Trials,|randonmised controlled trials,
386025|NCT01933087|Hospital|hospital
386026|NCT01933074|Urinary Urgency|urinary urgency
386027|NCT01933061|Skin cancer, Melanoma|skin cancer, melanoma
386028|NCT01933048|influenza|influenza
386029|NCT01933035|ITP|itp
386030|NCT01933035|Thrombocytopenia|thrombocytopenia
386031|NCT01933035|mean platelet mass|mean platelet mass
386032|NCT01933035|mean platelet component|mean platelet component
386033|NCT01933022|Exploratory|exploratory
386034|NCT01933022|Biomarkers|biomarkers
386035|NCT01933022|Eligard|eligard
386036|NCT01933022|Metastatic prostate cancer|metastatic prostate cancer
386037|NCT01932996|Smoking Cessation|smoking cessation
386038|NCT01932996|Smoking Cessation Products|smoking cessation products
386039|NCT01932996|Tobacco Use Cessation Products|tobacco use cessation products
386040|NCT01932983|Neuromuscular blockade|neuromuscular blockade
386041|NCT01932983|TOF test|tof test
386042|NCT01932983|Quantitative TOF method|quantitative tof method
386043|NCT01932983|Visual interpretation of TOF|visual interpretation of tof
386044|NCT01932970|Secondary Hyperparathyroidism (SHPT), chronic kidney disease (CKD), hemodialysis, parathyroid hormone (PTH), hypocalcemia, bone and mineral metabolism|secondary hyperparathyroidism (shpt), chronic kidney disease (ckd), hemodialysis, parathyroid hormone (pth), hypocalcemia, bone and mineral metabolism
386045|NCT01932957|Laparoscopy|laparoscopy
386046|NCT01932957|Ruptured ectopic pregnancy|ruptured ectopic pregnancy
386047|NCT01932931|Vitamin D|vitamin d
386048|NCT01932931|Major depression|major depression
386049|NCT01932931|SSRIs|ssris
386050|NCT01932931|Osteoporosis|osteoporosis
386051|NCT01932918|reactive oxygen species|reactive oxygen species
386052|NCT01932918|ischemia reperfusion injury|ischemia reperfusion injury
386053|NCT01932905|deep repetitive transcranial magnetic stimulation|deep repetitive transcranial magnetic stimulation
386054|NCT01932905|chronic pain|chronic pain
386055|NCT01932905|assessment|assessment
386056|NCT01932905|neuropathic pain|neuropathic pain
386057|NCT01932905|central pain|central pain
386058|NCT01932905|treatment|treatment
386059|NCT01932892|transhumeral|transhumeral
386060|NCT01932866|pre-diabetes|pre-diabetes
386061|NCT01932866|diabetes risk score|diabetes risk score
386062|NCT01932866|motivation|motivation
386063|NCT01932866|Air Force|air force
386064|NCT01932866|Military|military
386065|NCT01932866|Lifestyle change|lifestyle change
386066|NCT01932840|attitudes and understanding of plant sterol claims|attitudes and understanding of plant sterol claims
386067|NCT01932840|general Canadian population|general canadian population
386068|NCT01932827|Attitudes and understanding of oat fibre claims|attitudes and understanding of oat fibre claims
386069|NCT01932827|Food labels|food labels
386070|NCT01932827|General Canadian population|general canadian population
386071|NCT01932814|Aminoglycosides|aminoglycosides
386072|NCT01932814|Acute kidney injury|acute kidney injury
386073|NCT01932814|Severe sepsis|severe sepsis
386074|NCT01932814|Critically ill patient|critically ill patient
386075|NCT01932801|harm reduction, naltrexone, alcohol dependence, homelessness|harm reduction, naltrexone, alcohol dependence, homelessness
386076|NCT01932788|pregnancy|pregnancy
386077|NCT01932788|Vitamin D status|vitamin d status
386078|NCT01932736|middle ear|middle ear
386079|NCT01932736|Eustachian tube|eustachian tube
386080|NCT01932736|fMRI|fmri
386081|NCT01932723|Stabilization exercises, Pain, Disability, Menstruation|stabilization exercises, pain, disability, menstruation
386082|NCT01932710|Leukemia|leukemia
386083|NCT01932710|Acute myelogenous leukemia|acute myelogenous leukemia
386085|NCT01932710|High-risk myelodysplastic leukemia|high-risk myelodysplastic leukemia
386086|NCT01932710|MDS|mds
386087|NCT01932710|Infection risk|infection risk
386088|NCT01932710|White Blood Cell transfusion|white blood cell transfusion
386089|NCT01932710|Prophylactic therapy|prophylactic therapy
386090|NCT01932671|Cardiovascular diseases|cardiovascular diseases
386091|NCT01932671|Atherosclerosis|atherosclerosis
386092|NCT01932671|Multidetector Computed Tomography|multidetector computed tomography
386093|NCT01932671|Diabetes Mellitus, Type 2|diabetes mellitus, type 2
386094|NCT01932658|autologous|autologous
386095|NCT01932658|Lymphoablation|lymphoablation
386096|NCT01932658|hematopoietic|hematopoietic
386097|NCT01932658|immune system|immune system
386098|NCT01932645|prostatitis|prostatitis
386099|NCT01932645|pelvic pain|pelvic pain
386100|NCT01932645|urinary symptoms|urinary symptoms
386101|NCT01932645|sexual dysfunction|sexual dysfunction
386102|NCT01932632|Polypharmacy|polypharmacy
386103|NCT01932632|De-prescribing|de-prescribing
386104|NCT01932632|Frailty|frailty
386105|NCT01932593|multiple sclerosis|multiple sclerosis
386106|NCT01932593|bone marrow|bone marrow
386107|NCT01932593|stem cell therapy|stem cell therapy
386108|NCT01932580|gastric|gastric
386109|NCT01932580|esophageal|esophageal
386110|NCT01932580|adenocarcinoma|adenocarcinoma
386111|NCT01932554|Sickle Cell Pain Crisis|sickle cell pain crisis
386112|NCT01932554|Abciximab|abciximab
386113|NCT01932554|Integrins|integrins
386114|NCT01932554|Cell Adhesion Molecules|cell adhesion molecules
386115|NCT01932541|Bipolar Disorder|bipolar disorder
386116|NCT01932541|Mania|mania
386117|NCT01932541|Bipolar I|bipolar i
386118|NCT01932541|Bipolar II|bipolar ii
386119|NCT01932541|Bipolar Spectrum Disorder|bipolar spectrum disorder
386120|NCT01932541|Pediatric|pediatric
386121|NCT01932528|Absorption|absorption
386122|NCT01932528|Metabolism|metabolism
386123|NCT01932528|Excretion|excretion
386124|NCT01932502|epilepsy|epilepsy
386125|NCT01932502|Onfi|onfi
386126|NCT01932502|clonazepam|clonazepam
386127|NCT01932463|Tremor|tremor
386128|NCT01932463|Essential Tremor|essential tremor
386129|NCT01932463|Medication-refractory Essential Tremor|medication-refractory essential tremor
386130|NCT01932450|hypertension|hypertension
386131|NCT01932450|radiofrequency ablation|radiofrequency ablation
386132|NCT01932450|autosomal dominant polycystic kidney disease|autosomal dominant polycystic kidney disease
386133|NCT01932437|Monoclonal antibody, ETI-204, IM, safety, PK, immunogenicity|monoclonal antibody, eti-204, im, safety, pk, immunogenicity
386134|NCT01932424|Children|children
386135|NCT01932398|Alpha|alpha
386136|NCT01932398|Lateralization|lateralization
386137|NCT01932398|Attention|attention
386138|NCT01932398|ADHD|adhd
386139|NCT01932398|Oscillation|oscillation
386140|NCT01932385|Sorafenib|sorafenib
386141|NCT01932385|Hepatocellular carcinoma|hepatocellular carcinoma
386142|NCT01932385|Best supportive care|best supportive care
386143|NCT01932385|Survival|survival
386144|NCT01932372|Rheumatoid Arthritis|rheumatoid arthritis
386145|NCT01932372|Good Post Marketing Study Practice|good post marketing study practice
386146|NCT01932372|Tofacitinib|tofacitinib
386147|NCT01932372|Xeljanz|xeljanz
386148|NCT01932372|Regulatory Post Marketing Commitment Plan|regulatory post marketing commitment plan
386149|NCT01932359|Scar outcome|scar outcome
386150|NCT01932359|Mohs surgery|mohs surgery
386151|NCT01932359|face|face
386152|NCT01932346|near infra-red spectroscopy, coronary artery bypass grafting|near infra-red spectroscopy, coronary artery bypass grafting
386153|NCT01932333|Healthy|healthy
386154|NCT01932333|Safety|safety
386155|NCT01932333|Tolerability|tolerability
386156|NCT01932333|Pharmacokinetics|pharmacokinetics
386157|NCT01932333|Pharmacodynamics|pharmacodynamics
386158|NCT01932333|JNJ-40411813|jnj-40411813
386159|NCT01932333|Positive allosteric modulator|positive allosteric modulator
386160|NCT01932320|Healthy|healthy
386161|NCT01932320|Relative Bioavailability|relative bioavailability
386162|NCT01932320|Food effect|food effect
386163|NCT01932320|JNJ-40411813|jnj-40411813
386164|NCT01932320|Positive allosteric modulator|positive allosteric modulator
386165|NCT01932320|Solid Dosage Formulation of JNJ-40411813|solid dosage formulation of jnj-40411813
386166|NCT01932320|Ketoconazole|ketoconazole
386354|NCT01931644|HIV/AIDS|hiv/aids
386167|NCT01932307|Surgeon neck health|surgeon neck health
386168|NCT01932294|Advanced Heart Failure|advanced heart failure
386169|NCT01932294|Refractory Heart Failure|refractory heart failure
386170|NCT01932294|Mechanical Circulatory Support Device|mechanical circulatory support device
386171|NCT01932294|Ventricular Assist Device|ventricular assist device
386172|NCT01932294|Medamacs|medamacs
386173|NCT01932281|muscle power|muscle power
386174|NCT01932281|muscle fatigue|muscle fatigue
386175|NCT01932281|SierraSil|sierrasil
386176|NCT01932255|microvascular decompression surgery|microvascular decompression surgery
386177|NCT01932255|cerebrospinal fluid leakage|cerebrospinal fluid leakage
386178|NCT01932255|postoperative complications|postoperative complications
386179|NCT01932242|anthrax, monoclonal antibody, ETI-204, safety, PK|anthrax, monoclonal antibody, eti-204, safety, pk
386180|NCT01932229|Advanced NSCLC|advanced nsclc
386181|NCT01932229|EGFR mutation|egfr mutation
386182|NCT01932229|TKIs|tkis
386183|NCT01932229|Tyrosine Kinase Inhibitors|tyrosine kinase inhibitors
386184|NCT01932216|robotic single-site cholecystectomy|robotic single-site cholecystectomy
386185|NCT01932216|laparoscopic cholecystectomy|laparoscopic cholecystectomy
386186|NCT01932216|cosmesis|cosmesis
386187|NCT01932216|quality of life|quality of life
386188|NCT01932203|Cerebral small vessel disease|cerebral small vessel disease
386189|NCT01932203|Leukoaraiosis|leukoaraiosis
386190|NCT01932203|Magnetic Resonance Imaging|magnetic resonance imaging
386191|NCT01932203|Diffusion Tensor Imaging|diffusion tensor imaging
386192|NCT01932190|Acute Kidney Injury|acute kidney injury
386193|NCT01932190|Critical Care|critical care
386194|NCT01932190|Renal Replacement Therapy|renal replacement therapy
386195|NCT01932190|Treatment Outcome|treatment outcome
386196|NCT01932177|Everolimus ; Sorafenib ; Phase 1 trial ; Solid tumor|everolimus ; sorafenib ; phase 1 trial ; solid tumor
386197|NCT01932164|Cleft lip and palate|cleft lip and palate
386198|NCT01932164|Deciduous dental pulp stem cells|deciduous dental pulp stem cells
386199|NCT01932164|mesenchymal stem cells|mesenchymal stem cells
386200|NCT01932164|tissue engineering|tissue engineering
386201|NCT01932164|bone tissue engineering|bone tissue engineering
386202|NCT01932164|bioengineering|bioengineering
386203|NCT01932151|type-1 HRS|type-1 hrs
386204|NCT01932151|active bacterial infections|active bacterial infections
386205|NCT01932151|terlipressin and albumin|terlipressin and albumin
386206|NCT01932151|kidney function|kidney function
386207|NCT01932138|Community-based intervention|community-based intervention
386208|NCT01932138|Community health workers|community health workers
386209|NCT01932138|Antenatal care|antenatal care
386210|NCT01932138|HIV|hiv
386211|NCT01932138|PMTCT|pmtct
386212|NCT01932138|HIV vertical transmission|hiv vertical transmission
386213|NCT01932138|Public-sector health systems|public-sector health systems
386214|NCT01932112|Pulmonary Vein Isolation|pulmonary vein isolation
386215|NCT01932112|Adenosin effect|adenosin effect
386216|NCT01932112|Atrial fibrillation ablation|atrial fibrillation ablation
386217|NCT01932099|pathological constriction; restricted outflow, stenosis|pathological constriction; restricted outflow, stenosis
386218|NCT01932086|male|male
386219|NCT01932086|Glucose|glucose
386220|NCT01932086|Triglyceride|triglyceride
386221|NCT01932086|Glycemic index|glycemic index
386222|NCT01932086|White rice|white rice
386223|NCT01932086|Brown rice|brown rice
386224|NCT01932086|Black rice|black rice
386225|NCT01932086|Bread|bread
386226|NCT01932073|Radiation|radiation
386227|NCT01932073|dermatitis|dermatitis
386228|NCT01932073|radiodermatitis|radiodermatitis
386229|NCT01932073|radiotherapy induced|radiotherapy induced
386230|NCT01932073|skin reactions|skin reactions
386231|NCT01932073|low level laser therapy|low level laser therapy
386232|NCT01932073|breast cancer|breast cancer
386233|NCT01932060|Oxytocin|oxytocin
386234|NCT01932060|blood loss|blood loss
386235|NCT01932060|Cesarean delivery|cesarean delivery
386236|NCT01932034|Vancomycin|vancomycin
386237|NCT01932034|Pharmacokinetics|pharmacokinetics
386238|NCT01932034|Pharmacodynamics|pharmacodynamics
386239|NCT01932034|Decision support|decision support
386240|NCT01932021|necrotitis angiodermatitis|necrotitis angiodermatitis
386241|NCT01932021|autologous fat transplantation|autologous fat transplantation
386242|NCT01932021|mesenchymal stem cells|mesenchymal stem cells
386243|NCT01932008|Coronary artery bypass grafting|coronary artery bypass grafting
386244|NCT01932008|Chronic kidney disease|chronic kidney disease
386245|NCT01932008|Body composition|body composition
386246|NCT01932008|Physical activity|physical activity
386247|NCT01932008|Physical function|physical function
386248|NCT01931982|diabetes, GLP-1, Victoza, CFR, microvascular dysfunction|diabetes, glp-1, victoza, cfr, microvascular dysfunction
386249|NCT01931969|Vein catheterization; Ultrasound; Landmark; Complication|vein catheterization; ultrasound; landmark; complication
386250|NCT01931956|Mitral Valve Insufficiency|mitral valve insufficiency
789827|NCT00293839|bladder|bladder
386251|NCT01931956|Mitral Valve Regurgitation|mitral valve regurgitation
386252|NCT01931956|Mitral Valve Incompetence|mitral valve incompetence
386253|NCT01931956|Mitral Regurgitation|mitral regurgitation
386254|NCT01931956|Mitral Insufficiency|mitral insufficiency
386255|NCT01931956|Mitral Valve|mitral valve
386256|NCT01931956|Mitral Regurgitation (MR)|mitral regurgitation (mr)
386257|NCT01931956|Mitral Valve Prolapse|mitral valve prolapse
386258|NCT01931956|Edge to Edge (E2E)|edge to edge (e2e)
386259|NCT01931956|Alfieri Technique|alfieri technique
386260|NCT01931956|MitraClip|mitraclip
386261|NCT01931956|Functional MR|functional mr
386262|NCT01931956|Degenerative MR|degenerative mr
386263|NCT01931956|Echocardiogram|echocardiogram
386264|NCT01931956|Coronary Artery Disease (CAD)|coronary artery disease (cad)
386265|NCT01931956|Heart Failure|heart failure
386266|NCT01931956|Heart Attack|heart attack
386267|NCT01931956|EVEREST|everest
386268|NCT01931956|EVEREST I|everest i
386269|NCT01931956|EVEREST II|everest ii
386270|NCT01931956|REALISM|realism
386271|NCT01931930|Gastrointestinal discomfort|gastrointestinal discomfort
386272|NCT01931930|Perilla frutescens|perilla frutescens
386273|NCT01931930|bloating|bloating
386274|NCT01931930|abdominal discomfort|abdominal discomfort
386275|NCT01931930|human study|human study
386276|NCT01931930|healthy subjects|healthy subjects
386277|NCT01931917|Prevention|prevention
386278|NCT01931917|Parenting|parenting
386279|NCT01931917|Infants|infants
386280|NCT01931917|Family programs|family programs
386281|NCT01931917|Early intervention|early intervention
386282|NCT01931904|IOP|iop
386283|NCT01931904|Glaucoma|glaucoma
386284|NCT01931904|Trabeculectomy|trabeculectomy
386285|NCT01931891|preeclampsia, ADAMTS , wharton jelly, extracellüler matrix, placenta|preeclampsia, adamts , wharton jelly, extracellüler matrix, placenta
386286|NCT01931878|Restless Legs Syndrome|restless legs syndrome
386287|NCT01931878|Leg pain|leg pain
386288|NCT01931878|Sleep|sleep
386289|NCT01931878|Dysesthesias|dysesthesias
386290|NCT01931878|incobotulinumtoxin|incobotulinumtoxin
386291|NCT01931865|cancer pain, radiation therapy, surgery, incobotulinum toxin|cancer pain, radiation therapy, surgery, incobotulinum toxin
386292|NCT01931852|Acute Coronary Syndrome|acute coronary syndrome
386293|NCT01931852|Chest pain|chest pain
386294|NCT01931852|Cardiac MRI|cardiac mri
386295|NCT01931852|Risk Stratification|risk stratification
386296|NCT01931852|Emergency Department|emergency department
386297|NCT01931852|Elevated Troponin|elevated troponin
386298|NCT01931852|Troponin|troponin
386299|NCT01931852|Non-ST Elevation Myocardial Infarction|non-st elevation myocardial infarction
386300|NCT01931826|Schistosomiasis|schistosomiasis
386301|NCT01931826|Surgical treatment|surgical treatment
386302|NCT01931826|Endoscopic treatment|endoscopic treatment
386303|NCT01931774|acne vulgaris cognitive functions|acne vulgaris cognitive functions
386304|NCT01931761|Pharmacokinetics, mass balance, AZD6244|pharmacokinetics, mass balance, azd6244
386305|NCT01931735|menisci|menisci
386306|NCT01931735|tibial|tibial
386307|NCT01931722|branched chain amino acid requirement|branched chain amino acid requirement
386308|NCT01931722|older men|older men
386309|NCT01931722|strength training|strength training
386310|NCT01931722|sarcopenia|sarcopenia
386311|NCT01931696|Efficacy|efficacy
386312|NCT01931696|Acupuncture|acupuncture
386313|NCT01931696|Asthma|asthma
386314|NCT01931683|LMA removal|lma removal
386315|NCT01931683|remifentanil|remifentanil
386316|NCT01931683|propofol|propofol
386317|NCT01931670|Non-Menstrual Pelvic Pain (NMPP)|non-menstrual pelvic pain (nmpp)
386318|NCT01931670|Dysmenorrhea (DYS)|dysmenorrhea (dys)
386319|NCT01931670|Elagolix|elagolix
386320|NCT01931670|Endometriosis Associated Pain|endometriosis associated pain
386321|NCT01931670|Gonadotropin-Releasing Hormone Antagonist|gonadotropin-releasing hormone antagonist
386322|NCT01931657|LNG-IUS|lng-ius
386323|NCT01931657|Mirena|mirena
386324|NCT01931657|Contraception|contraception
386325|NCT01931657|Bleeding|bleeding
386326|NCT01931657|Hormonal effects in the breast|hormonal effects in the breast
386327|NCT01931644|ADD/ADHD|add/adhd
386328|NCT01931644|Alopecia Areata|alopecia areata
386329|NCT01931644|Ankylosing Spondylitis|ankylosing spondylitis
386330|NCT01931644|Asthma|asthma
386331|NCT01931644|Atopic Dermatitis Eczema|atopic dermatitis eczema
386332|NCT01931644|Beta Thalassemia|beta thalassemia
386333|NCT01931644|Bipolar Disorder|bipolar disorder
386334|NCT01931644|Breast Cancer|breast cancer
386335|NCT01931644|Celiac Disease|celiac disease
386336|NCT01931644|Cervical Cancer|cervical cancer
386337|NCT01931644|Chronic Inflammatory Demyelinating Polyneuropathy|chronic inflammatory demyelinating polyneuropathy
386338|NCT01931644|Chronic Kidney Diseases|chronic kidney diseases
386339|NCT01931644|Chronic Obstructive Pulmonary Disease|chronic obstructive pulmonary disease
386340|NCT01931644|Colon Cancer|colon cancer
386341|NCT01931644|Colorectal Cancer|colorectal cancer
386342|NCT01931644|Crohn's Disease|crohn's disease
386343|NCT01931644|Cystic Fibrosis|cystic fibrosis
386344|NCT01931644|Depression|depression
386345|NCT01931644|Diabete Mellitus|diabete mellitus
789828|NCT00293839|overactive|overactive
386346|NCT01931644|Duchenne Muscular Dystrophy|duchenne muscular dystrophy
386347|NCT01931644|Endometriosis|endometriosis
386348|NCT01931644|Epilepsy|epilepsy
386349|NCT01931644|Facioscapulohumeral Muscular Dystrophy|facioscapulohumeral muscular dystrophy
386350|NCT01931644|G6PD Deficiency|g6pd deficiency
386351|NCT01931644|General Anxiety Disorder|general anxiety disorder
386352|NCT01931644|Hepatitis B|hepatitis b
386353|NCT01931644|Hereditary Hemorrhagic Telangiectasia|hereditary hemorrhagic telangiectasia
386355|NCT01931644|Human Papilloma Virus|human papilloma virus
386356|NCT01931644|Huntington's Disease|huntington's disease
386357|NCT01931644|Idiopathic Thrombocytopenic Purpura|idiopathic thrombocytopenic purpura
386358|NCT01931644|Insomnia|insomnia
386359|NCT01931644|Kidney Cancer|kidney cancer
386360|NCT01931644|Leukemia|leukemia
386361|NCT01931644|Lung Cancer|lung cancer
386362|NCT01931644|Lupus Nephritis|lupus nephritis
386363|NCT01931644|Lymphoma|lymphoma
386364|NCT01931644|Melanoma|melanoma
386365|NCT01931644|Multiple Myeloma|multiple myeloma
386366|NCT01931644|Multiple Sclerosis|multiple sclerosis
386367|NCT01931644|Myositis|myositis
386368|NCT01931644|Myotonic Dystrophy|myotonic dystrophy
386369|NCT01931644|Ovarian Cancer|ovarian cancer
386370|NCT01931644|Pancreatic Cancer|pancreatic cancer
386371|NCT01931644|Parkinson's Disease|parkinson's disease
386372|NCT01931644|Polycystic Kidney Diseases|polycystic kidney diseases
386373|NCT01931644|Prostate Cancer|prostate cancer
386374|NCT01931644|Psoriasis|psoriasis
386375|NCT01931644|Psoriatic Arthritis|psoriatic arthritis
386376|NCT01931644|Rosacea|rosacea
386377|NCT01931644|Scleroderma|scleroderma
386378|NCT01931644|Sickle Cell Anemia|sickle cell anemia
386379|NCT01931644|Sickle Cell Disease|sickle cell disease
386380|NCT01931644|Sickle Cell Trait|sickle cell trait
386381|NCT01931644|Sjogren's Syndrome|sjogren's syndrome
386382|NCT01931644|Skin Cancer|skin cancer
386383|NCT01931644|Spinal Muscular Atrophy|spinal muscular atrophy
386384|NCT01931644|Systemic Lupus Erythematosus|systemic lupus erythematosus
386385|NCT01931644|Thrombotic Thrombocytopenic Purpura|thrombotic thrombocytopenic purpura
386386|NCT01931644|Trisomy 21|trisomy 21
386387|NCT01931644|Ulcerative Colitis|ulcerative colitis
386388|NCT01931631|Diabetes Mellitus, Type 2|diabetes mellitus, type 2
386389|NCT01931631|Diet, Vegetarian|diet, vegetarian
386390|NCT01931631|Diet, Fat-Restricted|diet, fat-restricted
386391|NCT01931631|Glycemic Index|glycemic index
386392|NCT01931618|alcohol|alcohol
386393|NCT01931618|online intervention|online intervention
386394|NCT01931618|hazardous drinking|hazardous drinking
386395|NCT01931618|harmful drinking|harmful drinking
386396|NCT01931618|early intervention|early intervention
386397|NCT01931618|behavior change intervention|behavior change intervention
386398|NCT01931592|ESBL|esbl
386399|NCT01931592|neutropenia|neutropenia
386400|NCT01931592|eradication|eradication
386401|NCT01931592|bloodstream infection|bloodstream infection
386402|NCT01931592|immunosuppression|immunosuppression
386403|NCT01931579|confocal endo-microscopy, lung nodule, respiratory neoplasms|confocal endo-microscopy, lung nodule, respiratory neoplasms
386404|NCT01931566|Drug therapy|drug therapy
386405|NCT01931540|Obesity|obesity
386406|NCT01931540|Epigenesis, Genetic|epigenesis, genetic
386407|NCT01931540|Exercise Therapy|exercise therapy
386408|NCT01931527|Obesity|obesity
386409|NCT01931527|Metabolic syndrome|metabolic syndrome
386410|NCT01931527|Hyperuricemia|hyperuricemia
386411|NCT01931462|Cancer of the Kidney|cancer of the kidney
386412|NCT01931462|Renal Cancer|renal cancer
386413|NCT01931462|Renal Neoplasms|renal neoplasms
386414|NCT01931462|Neoplasms, Kidney|neoplasms, kidney
386415|NCT01931449|Pancreatoduodenectomy|pancreatoduodenectomy
386416|NCT01931449|Digestive Tract Reconstruction|digestive tract reconstruction
386417|NCT01931449|Pancreas|pancreas
386418|NCT01931436|Menopause, pharmacokinetic|menopause, pharmacokinetic
386419|NCT01931397|Dried blood spots|dried blood spots
386420|NCT01931397|kidney transplant|kidney transplant
386421|NCT01931397|Children|children
386422|NCT01931384|Luteal phase support|luteal phase support
386423|NCT01931384|Human chorionic gonadotrophin|human chorionic gonadotrophin
386424|NCT01931384|frozen-thawed embryo transfer cycle|frozen-thawed embryo transfer cycle
386425|NCT01931371|fistula in ano|fistula in ano
386426|NCT01931371|anal fistula|anal fistula
386427|NCT01931371|recurrence|recurrence
386428|NCT01931371|costs|costs
386429|NCT01931345|Rapid HIV testing|rapid hiv testing
386430|NCT01931345|MSM|msm
386431|NCT01931345|Motivational Interviewing|motivational interviewing
386432|NCT01931345|HIV prevention|hiv prevention
386433|NCT01931345|HIV/AIDS|hiv/aids
386434|NCT01931345|At-risk anal intercourse|at-risk anal intercourse
386435|NCT01931345|Randomized trial|randomized trial
386436|NCT01931332|Arthroplasty|arthroplasty
386437|NCT01931332|Analgesia|analgesia
386438|NCT01931319|baclofen withdrawal|baclofen withdrawal
386439|NCT01931319|interruption|interruption
386440|NCT01931319|spasticity|spasticity
386441|NCT01931319|pharmacokinetics|pharmacokinetics
386442|NCT01931319|tolerability|tolerability
386443|NCT01931319|intravenous|intravenous
386444|NCT01931293|atrophic glossitis, burning mouth syndrome, gastric parietal cell antibody, thyroglobulin antibody, thyroid microsomal antibody, HLA-DR, HLA-DQ|atrophic glossitis, burning mouth syndrome, gastric parietal cell antibody, thyroglobulin antibody, thyroid microsomal antibody, hla-dr, hla-dq
386445|NCT01931280|Gestational diabetes|gestational diabetes
386446|NCT01931241|atherosclerosis|atherosclerosis
386447|NCT01931241|atherosclerotic heart disease|atherosclerotic heart disease
386448|NCT01931241|hypercholesteremia|hypercholesteremia
386449|NCT01931241|atherosclerotic plaque|atherosclerotic plaque
386450|NCT01931241|hyperlipidemia|hyperlipidemia
386451|NCT01931228|Intensive care unit|intensive care unit
386452|NCT01931228|acute respiratory insufficiency|acute respiratory insufficiency
386453|NCT01931228|Respiratory failure|respiratory failure
386454|NCT01931228|Mechanical Insufflation-Exsufflation|mechanical insufflation-exsufflation
386455|NCT01931150|Topical Dapsone 5% Gel|topical dapsone 5% gel
386456|NCT01931150|Moisturizer|moisturizer
386457|NCT01931150|rash|rash
386458|NCT01931150|13-012|13-012
386459|NCT01931124|maximal oxygen uptake, activity levels, elderly|maximal oxygen uptake, activity levels, elderly
386460|NCT01931111|physical activity|physical activity
386461|NCT01931111|maximal oxygen uptake|maximal oxygen uptake
386462|NCT01931098|Brain Tumors|brain tumors
386463|NCT01931072|Exercise|exercise
386464|NCT01931072|High-intensity interval training|high-intensity interval training
386465|NCT01931072|Moderate training|moderate training
386466|NCT01931072|Healthy elderly|healthy elderly
386467|NCT01931072|Skeletal muscle|skeletal muscle
386468|NCT01931072|DNA-methylation|dna-methylation
386469|NCT01931072|Gene expression|gene expression
386470|NCT01931072|subjects|subjects
386471|NCT01931059|Imaging|imaging
386472|NCT01931059|Risperidone|risperidone
386473|NCT01931059|Placebo|placebo
386474|NCT01931059|antipsychotic|antipsychotic
386475|NCT01931046|prostate cancer|prostate cancer
386476|NCT01931046|adenocarcinoma of the prostate|adenocarcinoma of the prostate
386477|NCT01931033|Autism Spectrum Disorders|autism spectrum disorders
386478|NCT01931033|Pervasive Developmental Disorders|pervasive developmental disorders
386479|NCT01931033|ASD|asd
386480|NCT01931033|PDD|pdd
386481|NCT01931033|Oxytocin|oxytocin
386482|NCT01931033|Syntocinon|syntocinon
386483|NCT01931033|treatment|treatment
386484|NCT01931020|Pain|pain
386485|NCT01931020|Preterm|preterm
386486|NCT01931020|Neonates|neonates
386487|NCT01931020|24% Sucrose|24% sucrose
386488|NCT01931020|25% Dextrose|25% dextrose
386489|NCT01931007|osteoarthritis|osteoarthritis
386490|NCT01930994|LNG: Levonorgestrel|lng: levonorgestrel
386491|NCT01930994|MSI: Marie Stopes International|msi: marie stopes international
386492|NCT01930994|MSK: Marie Stopes Kenya|msk: marie stopes kenya
386493|NCT01930994|PK: Pharmacokinetic|pk: pharmacokinetic
386494|NCT01930981|quality of life|quality of life
386495|NCT01930981|toxicities|toxicities
386496|NCT01930981|hematopoietic stem cell transplantation|hematopoietic stem cell transplantation
386497|NCT01930968|Uveal melanoma, ocular melanoma|uveal melanoma, ocular melanoma
386498|NCT01930955|Non-antibiotic prescribing|non-antibiotic prescribing
386499|NCT01930955|acute upper respiratory tract infection|acute upper respiratory tract infection
386500|NCT01930955|white cell count|white cell count
386501|NCT01930955|vomiting|vomiting
386502|NCT01930942|rectal carcinoma|rectal carcinoma
386503|NCT01930942|preoperative concurrent chemoradiotherapy|preoperative concurrent chemoradiotherapy
386504|NCT01930929|Bariatric surgery|bariatric surgery
386505|NCT01930929|Complications|complications
386506|NCT01930929|Drugs|drugs
386507|NCT01930916|Prothrombin Time/instrumentation|prothrombin time/instrumentation
386508|NCT01930916|Prothrombin Time/utilization|prothrombin time/utilization
386509|NCT01930916|Blood Coagulation Disorders/blood|blood coagulation disorders/blood
386510|NCT01930916|Blood Coagulation Disorders/complications|blood coagulation disorders/complications
386511|NCT01930916|Blood Coagulation Disorders/diagnosis|blood coagulation disorders/diagnosis
386512|NCT01930916|Prospective Studies|prospective studies
386513|NCT01930916|Adult|adult
386514|NCT01930916|Reproducibility of Results|reproducibility of results
386515|NCT01930916|Point-of-Care Systems/utilization|point-of-care systems/utilization
386516|NCT01930916|Aged|aged
386517|NCT01930916|Elderly|elderly
386518|NCT01930903|PRO-Kinetic Energy BMS + Pantera Lux DEB combination|pro-kinetic energy bms + pantera lux deb combination
386519|NCT01930877|quality of recovery|quality of recovery
386520|NCT01930877|spine surgery|spine surgery
386521|NCT01930877|intravenous lidocaine|intravenous lidocaine
386522|NCT01930864|metformin|metformin
386523|NCT01930864|colorectal cancer|colorectal cancer
386524|NCT01930864|chemotherapy|chemotherapy
386525|NCT01930851|Bariatric surgery|bariatric surgery
386526|NCT01930851|Quality of life|quality of life
386527|NCT01930851|Complications|complications
386528|NCT01930838|Bariatric surgery|bariatric surgery
386529|NCT01930838|Complications|complications
386530|NCT01930838|Osteoporosis|osteoporosis
386531|NCT01930838|Neuropathy|neuropathy
386532|NCT01930838|Vitamine deficiency|vitamine deficiency
386533|NCT01930812|18F-NaF PET/CT|18f-naf pet/ct
386534|NCT01930812|Bone imaging|bone imaging
386535|NCT01930773|clopidogrel|clopidogrel
386536|NCT01930773|prasugrel|prasugrel
386537|NCT01930773|platelet function testing|platelet function testing
386538|NCT01930773|genotyping|genotyping
386539|NCT01930773|peri-procedural MI|peri-procedural mi
386540|NCT01930760|pediatric|pediatric
386541|NCT01930760|Childhood Obesity|childhood obesity
386542|NCT01930760|motivational interviewing|motivational interviewing
386543|NCT01930760|pediatric primary care physicians|pediatric primary care physicians
386544|NCT01930747|pneumoperitoneum|pneumoperitoneum
386545|NCT01930747|laparoscopy|laparoscopy
386546|NCT01930734|Heart Failure|heart failure
386547|NCT01930734|Dobutamine|dobutamine
386548|NCT01930708|BG-12|bg-12
386549|NCT01930695|DX functionality|dx functionality
386550|NCT01930695|Atrial fibrillation|atrial fibrillation
386551|NCT01930695|CRT-D indication|crt-d indication
386552|NCT01930682|Myocardial Infarction|myocardial infarction
386553|NCT01930682|Catheterization|catheterization
386554|NCT01930682|Fibrinolysis|fibrinolysis
386555|NCT01930669|Heart Rate Variability|heart rate variability
386556|NCT01930669|Multiple Organ Dysfunction Syndrome|multiple organ dysfunction syndrome
386557|NCT01930669|Critically Ill|critically ill
386558|NCT01930656|osteoporisis|osteoporisis
386559|NCT01930656|fracture|fracture
386560|NCT01930656|risk|risk
386561|NCT01930656|cost effectiveness|cost effectiveness
386562|NCT01930656|FRAX|frax
386563|NCT01930656|mobile device|mobile device
386564|NCT01930643|Electric muscle stimulation|electric muscle stimulation
386565|NCT01930643|mechanical ventilation|mechanical ventilation
386566|NCT01930643|chronic respiratory failure|chronic respiratory failure
386567|NCT01930630|extraesophageal saline injection (ESI);|extraesophageal saline injection (esi);
386568|NCT01930630|esophageal squamous cell carcinoma (ESCC);|esophageal squamous cell carcinoma (escc);
386569|NCT01930630|esophageal cancer;|esophageal cancer;
386570|NCT01930630|endoscopic ultrasonography (EUS)|endoscopic ultrasonography (eus)
386571|NCT01930617|surgery|surgery
386572|NCT01930617|trephining|trephining
386573|NCT01930617|drainage|drainage
386574|NCT01930617|therapeutic irrigation|therapeutic irrigation
386575|NCT01930617|subdural space|subdural space
386576|NCT01930617|postoperative complications|postoperative complications
386577|NCT01930617|mortality|mortality
386578|NCT01930604|Palmar hyperhidrosis.|palmar hyperhidrosis.
386579|NCT01930604|Plantar hyperhidrosis.|plantar hyperhidrosis.
386580|NCT01930604|Inguinal (groins and buttocks) hyperhidrosis.|inguinal (groins and buttocks) hyperhidrosis.
386581|NCT01930604|Craniofacial hyperhidrosis.|craniofacial hyperhidrosis.
386582|NCT01930604|Truncal hyperhidrosis.|truncal hyperhidrosis.
386583|NCT01930591|fibrinolytic therapy|fibrinolytic therapy
386584|NCT01930591|stenting|stenting
386585|NCT01930591|platelet activity|platelet activity
386586|NCT01930578|bioimpedance analysis|bioimpedance analysis
386587|NCT01930578|spectroscopy|spectroscopy
386588|NCT01930578|electrolyte sodium bromide|electrolyte sodium bromide
386589|NCT01930578|extracellular water|extracellular water
386590|NCT01930565|acne|acne
386591|NCT01930565|therapeutics|therapeutics
386592|NCT01930565|clinical trial|clinical trial
386593|NCT01930565|natural compound|natural compound
386594|NCT01930565|Lactobacillus fermented Chamaecypris obtuse|lactobacillus fermented chamaecypris obtuse
386595|NCT01930565|tea tree oil|tea tree oil
386596|NCT01930526|COPD|copd
386597|NCT01930526|Exercise|exercise
386598|NCT01930526|Cycling|cycling
386599|NCT01930526|Single leg|single leg
386600|NCT01930526|Pulmonary Rehabilitation|pulmonary rehabilitation
386601|NCT01930513|Obesity|obesity
386602|NCT01930513|Obstructive Sleep Apnea|obstructive sleep apnea
386603|NCT01930513|Exercise|exercise
386604|NCT01930513|Walking tests|walking tests
386605|NCT01930513|Cardiopulmonary exercise tests|cardiopulmonary exercise tests
386606|NCT01930513|Physical activity|physical activity
386607|NCT01930487|Primary open angle glaucoma|primary open angle glaucoma
386608|NCT01930487|intraocular pressure|intraocular pressure
386609|NCT01930487|ocular perfusion pressure|ocular perfusion pressure
386610|NCT01930487|retrobulbar blood flow|retrobulbar blood flow
386611|NCT01930487|retinal capillary blood flow|retinal capillary blood flow
386612|NCT01930487|choroidal blood flow|choroidal blood flow
386613|NCT01930474|lung cancer, plasma DNA, free DNA, EGFR, ALK|lung cancer, plasma dna, free dna, egfr, alk
386614|NCT01930448|Bariatric|bariatric
386615|NCT01930448|Gastric Bypass|gastric bypass
386616|NCT01930448|Gastric Banding,|gastric banding,
386617|NCT01930448|Type 2 Diabetes|type 2 diabetes
386618|NCT01930448|Incretins|incretins
386619|NCT01930448|GLP-1|glp-1
386620|NCT01930448|GIP|gip
386621|NCT01930448|Insulin secretion|insulin secretion
386622|NCT01930448|insulin sensitivity|insulin sensitivity
386623|NCT01930435|Quality of Life|quality of life
386624|NCT01930422|Direct transcranial electrical stimulation (tDCS)|direct transcranial electrical stimulation (tdcs)
386625|NCT01930422|Sham procedure|sham procedure
386626|NCT01930422|Tobacco consumption|tobacco consumption
386627|NCT01930422|Craving|craving
386628|NCT01930409|Femoral Fractures|femoral fractures
386629|NCT01930409|Hip Fractures|hip fractures
386630|NCT01930409|Frail older adults|frail older adults
386631|NCT01930409|Quality of Life|quality of life
386632|NCT01930409|Feasibility Studies|feasibility studies
386633|NCT01930396|Hemodialysis|hemodialysis
386634|NCT01930396|Anticoagulation|anticoagulation
386635|NCT01930396|Tinzaparin|tinzaparin
386636|NCT01930396|Unfractionated Heparin|unfractionated heparin
386637|NCT01930396|Randomized Controlled Trial|randomized controlled trial
386638|NCT01930383|biomarkers|biomarkers
386639|NCT01930370|pediatrics|pediatrics
386640|NCT01930370|phosphate and postassium revmoval|phosphate and postassium revmoval
386641|NCT01930370|dialysate bicarbonate modeling|dialysate bicarbonate modeling
386642|NCT01930357|Rabies|rabies
386643|NCT01930357|Purified Vero Rabies Vaccine - Serum Free (VRVg)|purified vero rabies vaccine - serum free (vrvg)
386644|NCT01930357|Imovax® rabies|imovax® rabies
386645|NCT01930357|Human Diploid Cell Vaccine|human diploid cell vaccine
386646|NCT01930344|stereopsis|stereopsis
386647|NCT01930344|3D laparoscopy|3d laparoscopy
386648|NCT01930344|OCHRA|ochra
386649|NCT01930331|Uncomplicated Plasmodium falciparum Malaria|uncomplicated plasmodium falciparum malaria
386650|NCT01930305|Heating transfusion|heating transfusion
386651|NCT01930279|T cell markers|t cell markers
386652|NCT01930227|hypotension|hypotension
386653|NCT01930227|spinal anesthesia|spinal anesthesia
386654|NCT01930227|cesarean|cesarean
386655|NCT01930175|Pemphigus vulgaris|pemphigus vulgaris
386656|NCT01930175|pemphigus|pemphigus
386657|NCT01930175|blistering disease|blistering disease
386658|NCT01930162|HSC835|hsc835
386659|NCT01930162|single umbilical cord blood transplantation|single umbilical cord blood transplantation
386660|NCT01930162|non-myeloablative conditioning regimen|non-myeloablative conditioning regimen
386661|NCT01930162|Umbilical cord blood|umbilical cord blood
386662|NCT01930162|UCB transplantation|ucb transplantation
386663|NCT01930149|Cholesterol screening|cholesterol screening
386664|NCT01930149|High cholesterol|high cholesterol
386665|NCT01930149|Cardiovascular disease|cardiovascular disease
386666|NCT01930149|Statin treatment|statin treatment
386667|NCT01930136|Calorie restriction|calorie restriction
386668|NCT01930136|Type 2 diabetes|type 2 diabetes
386669|NCT01930136|Obesity|obesity
386670|NCT01930136|Diabetic nephropathy prevention|diabetic nephropathy prevention
386671|NCT01930123|Fructose|fructose
386672|NCT01930123|NASH|nash
386673|NCT01930123|advanced fibrosis|advanced fibrosis
386674|NCT01930123|biomarker|biomarker
386675|NCT01930123|magnetic resonance|magnetic resonance
386676|NCT01930110|Type 1 diabetes|type 1 diabetes
386677|NCT01930110|Hypoglycemia|hypoglycemia
386678|NCT01930110|Insulin|insulin
386679|NCT01930110|Glucagon|glucagon
386680|NCT01930110|Closed-loop system|closed-loop system
386681|NCT01930110|Artificial pancreas|artificial pancreas
386682|NCT01930097|Type 1 diabetes|type 1 diabetes
386683|NCT01930097|Hypoglycemia|hypoglycemia
386684|NCT01930097|Insulin|insulin
386685|NCT01930097|Glucagon|glucagon
386686|NCT01930097|Closed-loop system|closed-loop system
386687|NCT01930097|Artificial pancreas|artificial pancreas
386688|NCT01930097|Carbohydrate counting|carbohydrate counting
386689|NCT01930084|HIV|hiv
386690|NCT01930084|linkage|linkage
386691|NCT01930084|retention|retention
386692|NCT01930032|Clostridium difficile infection|clostridium difficile infection
386693|NCT01930019|etomidate,|etomidate,
386694|NCT01930019|thiopental,|thiopental,
386695|NCT01930019|serum cortisol concentration,|serum cortisol concentration,
386696|NCT01930006|c-Met|c-met
386697|NCT01930006|VEGFR|vegfr
386698|NCT01930006|Ron|ron
386699|NCT01930006|Cancer|cancer
386700|NCT01930006|Tumor|tumor
386701|NCT01930006|Safety|safety
386702|NCT01930006|Phase 1|phase 1
386703|NCT01929993|Conization|conization
386704|NCT01929993|Cervical Intraepithelial Neoplasia|cervical intraepithelial neoplasia
386705|NCT01929993|Cervix Dysplasia|cervix dysplasia
386706|NCT01929993|Therapy|therapy
386707|NCT01929993|Electrosurgery|electrosurgery
386708|NCT01929980|HSCT|hsct
386709|NCT01929980|cytopenia|cytopenia
386710|NCT01929980|immune suppression|immune suppression
386711|NCT01929980|proteasome inhibitor|proteasome inhibitor
386712|NCT01929967|Heterotaxy syndrome|heterotaxy syndrome
386713|NCT01929967|Asplenia|asplenia
386714|NCT01929967|Polysplenia|polysplenia
386715|NCT01929889|schizophrenia|schizophrenia
386716|NCT01929889|schizoaffective disorder|schizoaffective disorder
386717|NCT01929889|iloperidone|iloperidone
386718|NCT01929889|Fanapt|fanapt
386719|NCT01929889|social cognition|social cognition
386720|NCT01929889|cognition|cognition
386721|NCT01929863|Metformin|metformin
386722|NCT01929863|Diabetes|diabetes
386723|NCT01929837|Tinnitus|tinnitus
386724|NCT01929837|Transcranial magnetic stimulation|transcranial magnetic stimulation
386725|NCT01929824|dysphagia, trouble swallowing, chest pain|dysphagia, trouble swallowing, chest pain
386726|NCT01929798|artificial pancreas|artificial pancreas
386727|NCT01929785|post tranplant heart allograft|post tranplant heart allograft
386728|NCT01929759|HIV|hiv
386729|NCT01929759|neurocognitive symptoms|neurocognitive symptoms
386730|NCT01929759|efavirenz|efavirenz
386731|NCT01929759|elvitegravir|elvitegravir
386732|NCT01929759|neurometabolites|neurometabolites
386733|NCT01929733|Patent Ductus Arteriosus|patent ductus arteriosus
386734|NCT01929720|cancer|cancer
386735|NCT01929720|cancer survivors|cancer survivors
386736|NCT01929720|worry|worry
386737|NCT01929720|insomnia|insomnia
386738|NCT01929720|symptoms|symptoms
386739|NCT01929720|fatigue|fatigue
386740|NCT01929720|depression|depression
386741|NCT01929720|anxiety|anxiety
386742|NCT01929681|Low Field Magnetic Stimulation|low field magnetic stimulation
386743|NCT01929681|bipolar|bipolar
386744|NCT01929681|depression|depression
386745|NCT01929681|alternative treatment|alternative treatment
386946|NCT01928654|Diabetic|diabetic
386746|NCT01929668|ulcerative colitis|ulcerative colitis
386747|NCT01929668|bowel preparation|bowel preparation
386748|NCT01929655|Phase II|phase ii
386749|NCT01929655|symptomatic castration-resistant prostate cancer|symptomatic castration-resistant prostate cancer
386750|NCT01929655|bone metastases|bone metastases
386751|NCT01929642|Tuberous Sclerosis Complex (TSC)|tuberous sclerosis complex (tsc)
386752|NCT01929642|self-injury|self-injury
386753|NCT01929642|Autism|autism
386754|NCT01929629|Phase 1|phase 1
386755|NCT01929629|Healthy Volunteers|healthy volunteers
386756|NCT01929629|First Time in Man|first time in man
386757|NCT01929629|Pharmacokinetics|pharmacokinetics
386758|NCT01929616|adenocarcinoma, colorectal,regorafenib|adenocarcinoma, colorectal,regorafenib
386759|NCT01929603|oncology, cancer, tumour, anticancer drug, pharmacokinetics, olaparib, rifampicin, neoplasm, CYP P450 inducer|oncology, cancer, tumour, anticancer drug, pharmacokinetics, olaparib, rifampicin, neoplasm, cyp p450 inducer
386760|NCT01929590|Colonoscopy|colonoscopy
386761|NCT01929590|Preparation|preparation
386762|NCT01929590|Polyp|polyp
386763|NCT01929590|Polyethylene glycol|polyethylene glycol
386764|NCT01929577|ASP015K|asp015k
386765|NCT01929577|healthy subjects|healthy subjects
386766|NCT01929564|cardiovascular disease|cardiovascular disease
386767|NCT01929564|risk factor|risk factor
386768|NCT01929564|broccoli|broccoli
386769|NCT01929564|GST|gst
386770|NCT01929564|blood pressure|blood pressure
386771|NCT01929564|Total cholesterol|total cholesterol
386772|NCT01929551|glycemic index|glycemic index
386773|NCT01929538|Chronic pancreatitis|chronic pancreatitis
386774|NCT01929538|Biliary stricture|biliary stricture
386775|NCT01929538|Endoscopic treatment|endoscopic treatment
386776|NCT01929538|cSEMS|csems
386777|NCT01929499|Colon cancer|colon cancer
386778|NCT01929499|Cytokine-induced killer cells|cytokine-induced killer cells
386779|NCT01929499|Adjuvant immunotherapy|adjuvant immunotherapy
386780|NCT01929499|Adjuvant chemotherapy|adjuvant chemotherapy
386781|NCT01929473|Pertussis infection|pertussis infection
386782|NCT01929473|Risk factors|risk factors
386783|NCT01929447|sleep disorders|sleep disorders
386784|NCT01929447|sleep apnea|sleep apnea
386785|NCT01929447|ambulatory device|ambulatory device
386786|NCT01929447|WatchPAT|watchpat
386787|NCT01929434|cerebral palsy|cerebral palsy
386788|NCT01929434|cell transplantation|cell transplantation
386789|NCT01929434|rehabilitation|rehabilitation
386790|NCT01929421|colorectal cancer|colorectal cancer
386791|NCT01929421|gemcitabine|gemcitabine
386792|NCT01929421|S-1|s-1
386793|NCT01929395|Breast Cancer|breast cancer
386794|NCT01929395|Breast Conserving Surgery|breast conserving surgery
386795|NCT01929395|Breast diagnostics|breast diagnostics
386796|NCT01929395|Breast imaging|breast imaging
386797|NCT01929382|dose titration|dose titration
386798|NCT01929382|FLS|fls
386799|NCT01929382|flu like symptoms|flu like symptoms
386800|NCT01929382|Actimmune|actimmune
386801|NCT01929369|ESRD|esrd
386802|NCT01929369|CKD|ckd
386803|NCT01929369|AV GRAFTS|av grafts
386804|NCT01929369|THROMBOSED AV GRAFTS|thrombosed av grafts
386805|NCT01929356|lung function tests|lung function tests
386806|NCT01929356|chest physiotherapy|chest physiotherapy
386807|NCT01929343|cocaine|cocaine
386808|NCT01929343|addiction|addiction
386809|NCT01929343|lidocaine|lidocaine
386810|NCT01929343|memory|memory
386811|NCT01929343|drug abuse|drug abuse
386812|NCT01929330|Bioequivalence|bioequivalence
386813|NCT01929330|Healthy Male Volunteers|healthy male volunteers
386814|NCT01929330|Androgenetic Alopecia|androgenetic alopecia
386815|NCT01929330|Dutasteride|dutasteride
386816|NCT01929330|Safety|safety
386817|NCT01929330|Tolerability|tolerability
386818|NCT01929317|Ropinirole|ropinirole
386819|NCT01929317|Parkinson's disease|parkinson's disease
386820|NCT01929291|Korea|korea
386821|NCT01929291|Post-marketing surveillance|post-marketing surveillance
386822|NCT01929291|Boostrix|boostrix
386823|NCT01929291|Prescribing information|prescribing information
386824|NCT01929291|Safety|safety
386825|NCT01929265|INFL|infl
386826|NCT01929265|Indolent non-follicular|indolent non-follicular
386827|NCT01929265|untreated INFL|untreated infl
386828|NCT01929252|dexmedetomidine|dexmedetomidine
386829|NCT01929252|wound infiltration|wound infiltration
386830|NCT01929252|postoperative analgesia|postoperative analgesia
790192|NCT00292994|Obesity|obesity
386831|NCT01929226|anthrax, monoclonal antibody, ETI-204, safety, PK|anthrax, monoclonal antibody, eti-204, safety, pk
386832|NCT01929187|Onychomycosis, BioEqual carrier system, amorolfine.|onychomycosis, bioequal carrier system, amorolfine.
386833|NCT01929174|Congenital heart disease|congenital heart disease
386834|NCT01929174|Myocardial fibrosis|myocardial fibrosis
386835|NCT01929174|Diastolic dysfunction|diastolic dysfunction
386836|NCT01929161|positive emotions|positive emotions
386837|NCT01929161|meditation|meditation
386838|NCT01929161|oxytocin|oxytocin
386839|NCT01929148|risk-reducing salpingectomy|risk-reducing salpingectomy
386840|NCT01929148|prophylactic bilateral salpingectomy|prophylactic bilateral salpingectomy
386841|NCT01929148|ovarian cancer prevention|ovarian cancer prevention
386842|NCT01929148|ovarian reserve|ovarian reserve
386843|NCT01929135|Periodontal Disease|periodontal disease
386947|NCT01928654|Laser|laser
386844|NCT01929135|Chronic Periodontitis|chronic periodontitis
386845|NCT01929135|Atorvastatin|atorvastatin
386846|NCT01929135|Statins|statins
386847|NCT01929135|Hydroxymethylglutaryl-coenzyme A Reductase Inhibitors|hydroxymethylglutaryl-coenzyme a reductase inhibitors
386848|NCT01929135|Dentifrice|dentifrice
386849|NCT01929122|Prevention & control|prevention & control
386850|NCT01929122|Diet|diet
386851|NCT01929122|Functional food|functional food
386852|NCT01929122|Nutrition Assessment|nutrition assessment
386853|NCT01929122|Oryza sativa|oryza sativa
386854|NCT01929122|Rice Bran|rice bran
386855|NCT01929122|Phaseolus vulgaris L.|phaseolus vulgaris l.
386856|NCT01929122|Legumes|legumes
386857|NCT01929122|Microbiome|microbiome
386858|NCT01929122|Metabolomics|metabolomics
386859|NCT01929122|Prebiotics|prebiotics
386860|NCT01929083|Torsades de pointes|torsades de pointes
386861|NCT01929083|Progesterone|progesterone
386862|NCT01929083|Clinical trial|clinical trial
386863|NCT01929083|Risk reduction|risk reduction
386864|NCT01929083|Electrocardiography|electrocardiography
386865|NCT01929070|HCP1007|hcp1007
386866|NCT01929070|Rosuvastatin|rosuvastatin
386867|NCT01929070|Omega-3|omega-3
386868|NCT01929018|Amputation|amputation
386869|NCT01929018|Rehabilitation|rehabilitation
386870|NCT01929018|Exercise|exercise
386871|NCT01929018|Movement|movement
386872|NCT01929005|Comprehensive care|comprehensive care
386873|NCT01929005|Medicare|medicare
386874|NCT01929005|Cost-sharing|cost-sharing
386875|NCT01929005|Quality of care|quality of care
386876|NCT01928992|Mammography|mammography
386878|NCT01928992|Breast Cancer Detection|breast cancer detection
386879|NCT01928979|LA/LAA Thrombus|la/laa thrombus
386880|NCT01928979|Atrial Fibrillation|atrial fibrillation
386881|NCT01928979|Observation|observation
386882|NCT01928966|dietary fat|dietary fat
386883|NCT01928966|fat intake|fat intake
386884|NCT01928966|blood pressure|blood pressure
386885|NCT01928966|women|women
386886|NCT01928966|phytoestrogen|phytoestrogen
386887|NCT01928966|pumpkin seeds|pumpkin seeds
386888|NCT01928966|cardiovascular disease|cardiovascular disease
386889|NCT01928966|heart disease|heart disease
386890|NCT01928966|secoisolariciresinol|secoisolariciresinol
386891|NCT01928966|monounsaturated fat|monounsaturated fat
386892|NCT01928966|polyunsaturated fat|polyunsaturated fat
386893|NCT01928966|feeding study|feeding study
386894|NCT01928953|opioid induced constipation in patients without cancer and with cancer|opioid induced constipation in patients without cancer and with cancer
386895|NCT01928940|Advanced solid tumors|advanced solid tumors
386896|NCT01928940|BRAF|braf
386897|NCT01928940|Melanoma|melanoma
386898|NCT01928888|Acute heartburn episodes|acute heartburn episodes
386899|NCT01928849|Amputation|amputation
386900|NCT01928849|Post-amputation Pain|post-amputation pain
386901|NCT01928849|Neuropathic pain|neuropathic pain
386902|NCT01928849|Valproic Acid|valproic acid
386903|NCT01928849|Anesthesia, Conduction|anesthesia, conduction
386904|NCT01928849|Neuralgia, stump|neuralgia, stump
386905|NCT01928836|Carcinoma, Non-Small-Cell Lung|carcinoma, non-small-cell lung
386906|NCT01928836|Small Cell Lung Carcinoma|small cell lung carcinoma
386907|NCT01928836|Biological Markers|biological markers
386908|NCT01928836|ROC Curve|roc curve
386909|NCT01928836|Delayed Diagnosis|delayed diagnosis
386910|NCT01928823|agoraphobia|agoraphobia
386911|NCT01928823|panic disorder|panic disorder
386912|NCT01928823|D-Cycloserine|d-cycloserine
386913|NCT01928823|DCS|dcs
386914|NCT01928823|exposure|exposure
386915|NCT01928823|cognitive behavioral therapy|cognitive behavioral therapy
386916|NCT01928823|CBT|cbt
386917|NCT01928823|augmentation|augmentation
386918|NCT01928810|Panic Disorder|panic disorder
386919|NCT01928810|Agoraphobia|agoraphobia
386920|NCT01928810|Physical Activity|physical activity
386921|NCT01928797|cardiac output pregnancy spinal anesthesia|cardiac output pregnancy spinal anesthesia
386922|NCT01928784|Low back pain|low back pain
386923|NCT01928784|extracorporeal shock wave therapy|extracorporeal shock wave therapy
386924|NCT01928784|Trigger Points|trigger points
386925|NCT01928771|Asthma,|asthma,
386926|NCT01928771|Bronchial Diseases,|bronchial diseases,
386927|NCT01928771|Respiratory Tract Diseases,|respiratory tract diseases,
386928|NCT01928771|Lung Diseases,|lung diseases,
386929|NCT01928771|Obstructive Lung Diseases|obstructive lung diseases
386930|NCT01928758|Smoking|smoking
386931|NCT01928758|Nicotine|nicotine
386932|NCT01928745|Stewart approach|stewart approach
386933|NCT01928745|sepsis|sepsis
386934|NCT01928745|SIRS|sirs
386935|NCT01928745|cardiothoracic surgery|cardiothoracic surgery
386936|NCT01928745|CABG|cabg
386937|NCT01928719|Smoking|smoking
386938|NCT01928719|Nicotine|nicotine
386939|NCT01928706|edentulism|edentulism
386940|NCT01928706|denture liner|denture liner
386941|NCT01928706|prosthodontics|prosthodontics
386942|NCT01928706|OHIP EDENT|ohip edent
386943|NCT01928693|infectious corneal ulcers|infectious corneal ulcers
386944|NCT01928680|Triple Negative Breast Cancer, Cisplatin, Capecitabine|triple negative breast cancer, cisplatin, capecitabine
386945|NCT01928654|Edema|edema
386948|NCT01928654|Treatment|treatment
386949|NCT01928602|Crossover|crossover
386950|NCT01928602|Chronic stroke|chronic stroke
386951|NCT01928602|Stroke|stroke
386952|NCT01928602|Rehabilitation|rehabilitation
386953|NCT01928602|Language Therapy|language therapy
386954|NCT01928602|Aphasia|aphasia
386955|NCT01928602|Aphasia Therapy|aphasia therapy
386956|NCT01928602|Computerised Therapy|computerised therapy
386957|NCT01928602|Computerised Rehabilitation|computerised rehabilitation
386958|NCT01928602|Tablet|tablet
386959|NCT01928602|Apps|apps
386960|NCT01928602|Aphasia Rehabilitation|aphasia rehabilitation
386961|NCT01928602|Rehabilitation on Portable Tablets|rehabilitation on portable tablets
386962|NCT01928589|Cyclophosphamide|cyclophosphamide
386963|NCT01928589|Doxorubicin|doxorubicin
386964|NCT01928589|Docetaxel|docetaxel
386965|NCT01928589|Carboplatin|carboplatin
386966|NCT01928589|Herceptin|herceptin
386967|NCT01928589|Partial Breast Irradiation|partial breast irradiation
386968|NCT01928589|Concurrent Chemotherapy|concurrent chemotherapy
386969|NCT01928550|Diabetes|diabetes
386971|NCT01928550|PDR|pdr
386972|NCT01928537|International Working Group|international working group
386973|NCT01928537|azacitidine|azacitidine
386974|NCT01928537|decitabine|decitabine
386975|NCT01928524|Gastric cancer|gastric cancer
386976|NCT01928524|Cancer of the esophagus|cancer of the esophagus
386977|NCT01928524|Oxaliplatin|oxaliplatin
386978|NCT01928524|Docetaxel|docetaxel
386979|NCT01928524|S1|s1
386980|NCT01928511|Hepatitis B virus|hepatitis b virus
386981|NCT01928511|HBeAg positive|hbeag positive
386982|NCT01928511|HBeAg negative|hbeag negative
386983|NCT01928511|antiviral therapy|antiviral therapy
386984|NCT01928511|nucleoside analogues|nucleoside analogues
386985|NCT01928498|arteriovenous fistulae|arteriovenous fistulae
386986|NCT01928498|arteriovenous graft|arteriovenous graft
386987|NCT01928498|restenosis|restenosis
386988|NCT01928498|angioplasty|angioplasty
386989|NCT01928498|drug eluting balloon|drug eluting balloon
386990|NCT01928472|Influenza, H7N9, Vaccine|influenza, h7n9, vaccine
386991|NCT01928459|BGJ398|bgj398
386992|NCT01928459|BYL719|byl719
386993|NCT01928459|advanced solid tumor|advanced solid tumor
386994|NCT01928459|metastatic breast cancer|metastatic breast cancer
386995|NCT01928459|PK3CA|pk3ca
386996|NCT01928459|FGFR|fgfr
386997|NCT01928459|fibroblast growth factor receptor|fibroblast growth factor receptor
386998|NCT01928446|Lithium|lithium
386999|NCT01928446|Placebo|placebo
387000|NCT01928446|Double-blind methods|double-blind methods
387001|NCT01928446|Clinical Trials, Randomized|clinical trials, randomized
387002|NCT01928446|Veterans|veterans
387003|NCT01928433|Urinary Tract Infection|urinary tract infection
387004|NCT01928433|Pyelonephritis|pyelonephritis
387005|NCT01928420|Alzheimer Disease|alzheimer disease
387006|NCT01928420|Alzheimer Type Senile Dementia|alzheimer type senile dementia
387007|NCT01928420|Alzheimer's Disease|alzheimer's disease
387008|NCT01928420|clinical trial|clinical trial
387009|NCT01928420|dementia|dementia
387010|NCT01928420|diabetes|diabetes
387011|NCT01928420|dietary supplements|dietary supplements
387012|NCT01928420|Senile Dementia, Alzheimer|senile dementia, alzheimer
387013|NCT01928420|Therapeutics|therapeutics
387014|NCT01928420|Brain Diseases|brain diseases
387015|NCT01928420|Central Nervous System Diseases|central nervous system diseases
387016|NCT01928420|Nervous System Diseases|nervous system diseases
387017|NCT01928420|Neurodegenerative Diseases|neurodegenerative diseases
387018|NCT01928420|Delirium, Dementia, Amnestic, Cognitive|delirium, dementia, amnestic, cognitive
387019|NCT01928420|Disorders|disorders
387020|NCT01928420|Mental Disorders|mental disorders
387021|NCT01928407|naives, CD4 < 200 cell/mm3, Atazanavir, Darunavir|naives, cd4 < 200 cell/mm3, atazanavir, darunavir
387022|NCT01928368|Mild asthma|mild asthma
387023|NCT01928368|Atopic asthma|atopic asthma
387024|NCT01928368|Healthy volunteers|healthy volunteers
387025|NCT01928368|First-in-human|first-in-human
387026|NCT01928316|Healthy|healthy
387027|NCT01928316|Bioequivalence|bioequivalence
387028|NCT01928316|Mizolastine|mizolastine
387029|NCT01928316|Domestic|domestic
387030|NCT01928316|Imported|imported
387031|NCT01928303|opioids|opioids
494970|NCT01451281|DND|dnd
387032|NCT01928303|chronic pain|chronic pain
387033|NCT01928303|oxycodone|oxycodone
387034|NCT01928303|oxymorphone|oxymorphone
387035|NCT01928303|patients using opioid pain medication|patients using opioid pain medication
387036|NCT01928277|Symptom assessment agreement|symptom assessment agreement
387037|NCT01928277|Work of breathing|work of breathing
387038|NCT01928264|Mental disorders|mental disorders
387039|NCT01928264|Physical activity|physical activity
387040|NCT01928264|Disability pension|disability pension
387041|NCT01928264|Disability pension due to mental illness|disability pension due to mental illness
387042|NCT01928264|Ability to work|ability to work
387043|NCT01928264|Mental toughness|mental toughness
387044|NCT01928238|NIV|niv
387045|NCT01928238|NAVA|nava
387046|NCT01928238|noninvasive neurally adjusted ventilatory|noninvasive neurally adjusted ventilatory
387047|NCT01928238|noninvasive pressure support ventilation|noninvasive pressure support ventilation
387048|NCT01928225|HSIL|hsil
387049|NCT01928225|CIN|cin
387050|NCT01928225|HPV|hpv
387051|NCT01928225|HPV vaccination|hpv vaccination
387052|NCT01928225|gardasil|gardasil
387053|NCT01928225|HIV|hiv
387054|NCT01928225|cervical dysplasia|cervical dysplasia
387055|NCT01928225|LEEP|leep
387056|NCT01928225|cervical cancer|cervical cancer
387057|NCT01928212|retinal nerve fiber layer thickness|retinal nerve fiber layer thickness
387058|NCT01928212|optical coherence tomography|optical coherence tomography
387059|NCT01928212|Parkinson disease|parkinson disease
387060|NCT01928199|diabetes|diabetes
387061|NCT01928199|transplant|transplant
387062|NCT01928199|kidney|kidney
387063|NCT01928173|Sleep Initiation and Maintenance Disorders|sleep initiation and maintenance disorders
387064|NCT01928173|Cognitive Therapy|cognitive therapy
387065|NCT01928160|Non-small cell lung cancer, EGFR mutation, erlotinib acquired resistance|non-small cell lung cancer, egfr mutation, erlotinib acquired resistance
387066|NCT01928147|NS5B polymerase inhibitor|ns5b polymerase inhibitor
387067|NCT01928147|Phase 1|phase 1
387068|NCT01928147|Genotype 1|genotype 1
387069|NCT01928134|Vitamin K2|vitamin k2
387070|NCT01928134|Vitamin D3|vitamin d3
387071|NCT01928134|Bioavailability of calcium|bioavailability of calcium
387072|NCT01928134|volunteers|volunteers
387073|NCT01928134|Men|men
387074|NCT01928134|non-pregnant women|non-pregnant women
387075|NCT01928134|twenty years of age|twenty years of age
387076|NCT01928121|nurse|nurse
387077|NCT01928121|expert program|expert program
387078|NCT01928121|primary care|primary care
387079|NCT01928121|implementation|implementation
387080|NCT01928121|interdisciplinary|interdisciplinary
387081|NCT01928121|effectiveness|effectiveness
387082|NCT01928121|disease management system|disease management system
387083|NCT01928095|atherosclerosis|atherosclerosis
387084|NCT01928095|carotid endartherectomy|carotid endartherectomy
387085|NCT01928082|Hypercalciuria, Familial Idiopathic|hypercalciuria, familial idiopathic
387086|NCT01928082|Hypercalciuria|hypercalciuria
387087|NCT01928082|Osteopenia|osteopenia
387088|NCT01928082|Osteoporosis|osteoporosis
387089|NCT01928082|Postmenopausal women|postmenopausal women
387090|NCT01928004|edentulous|edentulous
387091|NCT01928004|complete denture|complete denture
387092|NCT01927991|tinnitus|tinnitus
387093|NCT01927991|cognitive behavioural therapy|cognitive behavioural therapy
387094|NCT01927991|internet treatment|internet treatment
387095|NCT01927978|Esophageal cancer|esophageal cancer
387096|NCT01927978|18F-FDG PET|18f-fdg pet
387097|NCT01927978|staging|staging
387098|NCT01927978|therapy planning|therapy planning
387099|NCT01927978|therapy response monitoring|therapy response monitoring
387100|NCT01927978|prognosis|prognosis
387101|NCT01927965|gastrointestinal tract|gastrointestinal tract
387102|NCT01927965|GI tract|gi tract
387103|NCT01927965|advanced gastrointestinal tumors|advanced gastrointestinal tumors
387104|NCT01927965|gastrointestinal tumors|gastrointestinal tumors
387105|NCT01927965|GI tumors|gi tumors
387106|NCT01927965|biliary|biliary
387107|NCT01927965|gallbladder,|gallbladder,
387108|NCT01927965|colorectal,|colorectal,
387109|NCT01927965|gastric,|gastric,
387110|NCT01927965|hepatocellular|hepatocellular
387111|NCT01927965|esophageal|esophageal
387112|NCT01927965|pancreatic|pancreatic
387113|NCT01927952|hammertoe|hammertoe
387114|NCT01927939|Breast cancer; bone metastases; 18F-FDG PET; 99mTc bone scintigraphy; therapy response monitoring; prognosis|breast cancer; bone metastases; 18f-fdg pet; 99mtc bone scintigraphy; therapy response monitoring; prognosis
387115|NCT01927926|Energy intake|energy intake
387116|NCT01927926|appetite|appetite
387117|NCT01927926|satiety|satiety
387118|NCT01927926|gut hormones|gut hormones
387119|NCT01927900|Human milk oligosaccharides|human milk oligosaccharides
387120|NCT01927900|Microbiota|microbiota
387121|NCT01927900|Prebiotics|prebiotics
387122|NCT01927887|Papillary Carcinoma of Thyroid|papillary carcinoma of thyroid
387123|NCT01927887|Follicular thyroid cancer lymph node metastasis|follicular thyroid cancer lymph node metastasis
387124|NCT01927887|Metastatic medullary thyroid cancer|metastatic medullary thyroid cancer
387125|NCT01927874|infiltration|infiltration
387126|NCT01927874|hemorrhoidectomy|hemorrhoidectomy
387127|NCT01927874|Postoperative pain|postoperative pain
387128|NCT01927822|termination of pregnancy, abortion|termination of pregnancy, abortion
387129|NCT01927809|Hereditary Diseases|hereditary diseases
387130|NCT01927809|Colon|colon
387131|NCT01927783|Cardiovascular Disease|cardiovascular disease
387132|NCT01927783|Obesity|obesity
387133|NCT01927770|WES|wes
387134|NCT01927770|Informed Consent|informed consent
387135|NCT01927770|WGS|wgs
387136|NCT01927757|rheumatoid arthritis|rheumatoid arthritis
387137|NCT01927757|etanercept|etanercept
387138|NCT01927757|arthritis|arthritis
387139|NCT01927757|adalimumab failure to respond|adalimumab failure to respond
387140|NCT01927757|loss of response to adalimumab|loss of response to adalimumab
387141|NCT01927757|ACR20|acr20
387142|NCT01927757|methotrexate|methotrexate
387143|NCT01927757|Swollen joints|swollen joints
387144|NCT01927757|tender joints|tender joints
387145|NCT01927744|Head and Neck Cancer|head and neck cancer
387245|NCT01927354|microRNA29|microrna29
387146|NCT01927744|Squamous cell carcinoma of the head and neck|squamous cell carcinoma of the head and neck
387147|NCT01927744|SCCHN|scchn
387148|NCT01927744|Oral cavity squamous cell carcinomas|oral cavity squamous cell carcinomas
387149|NCT01927744|Docetaxel|docetaxel
387150|NCT01927744|Taxotere|taxotere
387151|NCT01927744|Erlotinib|erlotinib
387152|NCT01927744|Erlotinib Hydrochloride|erlotinib hydrochloride
387153|NCT01927744|OSI-774|osi-774
387154|NCT01927744|CP358774|cp358774
387155|NCT01927744|Tarceva|tarceva
387156|NCT01927744|Questionnaire|questionnaire
387157|NCT01927744|Survey|survey
387158|NCT01927744|Phone call|phone call
387159|NCT01927718|Blood And Marrow Transplantation|blood and marrow transplantation
387160|NCT01927718|Myeloma|myeloma
387161|NCT01927718|Multiple myeloma|multiple myeloma
387163|NCT01927718|Autologous stem cell transplantation|autologous stem cell transplantation
387164|NCT01927718|ASCT|asct
387165|NCT01927718|Thalidomide|thalidomide
387166|NCT01927718|Thalomid|thalomid
387167|NCT01927718|Lenalidomide|lenalidomide
387168|NCT01927718|CC-5013|cc-5013
387169|NCT01927718|Revlimid|revlimid
387170|NCT01927718|Questionnaires|questionnaires
387171|NCT01927718|Surveys|surveys
387172|NCT01927705|Atopic dermatitis|atopic dermatitis
387173|NCT01927705|Stem cell|stem cell
387174|NCT01927705|Cell therapy|cell therapy
387175|NCT01927705|skin disease|skin disease
387176|NCT01927705|furestem|furestem
387177|NCT01927705|AD|ad
387178|NCT01927705|hUCB-MSC|hucb-msc
387179|NCT01927705|UCB-MSC|ucb-msc
387180|NCT01927705|Umbilical cord Blood|umbilical cord blood
387181|NCT01927692|MG|mg
387182|NCT01927666|glucoraphanin|glucoraphanin
387183|NCT01927666|broccoli|broccoli
387184|NCT01927666|gut microbiota|gut microbiota
387185|NCT01927653|Amnestic mild cognitive impairment|amnestic mild cognitive impairment
387186|NCT01927653|Dysexecutive mild cognitive impairment|dysexecutive mild cognitive impairment
387187|NCT01927653|Diffusion MRI|diffusion mri
387188|NCT01927640|Cocaine|cocaine
387189|NCT01927640|Dexmedetomidine|dexmedetomidine
387190|NCT01927640|Myocardial Contrast Echocardiography|myocardial contrast echocardiography
387191|NCT01927627|Prostate cancer|prostate cancer
387192|NCT01927627|adenocarcinoma of the prostate|adenocarcinoma of the prostate
387193|NCT01927627|Enzalutamide|enzalutamide
387194|NCT01927614|Cardiac Allograft Vasculopathy|cardiac allograft vasculopathy
387195|NCT01927614|Cardiac MRI|cardiac mri
387196|NCT01927614|Cardiac CT|cardiac ct
387197|NCT01927614|Observational study|observational study
387198|NCT01927601|TAVR|tavr
387199|NCT01927601|aortic disease|aortic disease
387200|NCT01927588|Certican|certican
387201|NCT01927588|Renal Transplant|renal transplant
387202|NCT01927588|Cytomegalovirus Infection|cytomegalovirus infection
387203|NCT01927575|TOMOSYNTHESIS|tomosynthesis
387204|NCT01927549|cardiogenic shock|cardiogenic shock
387205|NCT01927549|infarction|infarction
387206|NCT01927549|multivessel coronary artery disease|multivessel coronary artery disease
387207|NCT01927549|angioplasty|angioplasty
387208|NCT01927523|Youth violence|youth violence
387209|NCT01927523|Crime|crime
387210|NCT01927523|Educational achievement|educational achievement
387211|NCT01927510|Early mobilization, rehabilitation, intensive care|early mobilization, rehabilitation, intensive care
387212|NCT01927497|Rectal cancer|rectal cancer
387213|NCT01927497|Extralevator abdominoperineal resection|extralevator abdominoperineal resection
387214|NCT01927497|Biological Mesh|biological mesh
387215|NCT01927497|Primary closure|primary closure
387216|NCT01927484|methotrexate,|methotrexate,
387217|NCT01927484|osteoarthritis,|osteoarthritis,
387218|NCT01927484|pain,|pain,
387219|NCT01927484|function,|function,
387220|NCT01927484|synovitis|synovitis
387221|NCT01927471|Menstrual cycles|menstrual cycles
387222|NCT01927471|Ultrasound|ultrasound
387223|NCT01927471|Ovary|ovary
387224|NCT01927471|Polycystic Ovary Syndrome (PCOS)|polycystic ovary syndrome (pcos)
387225|NCT01927471|Physical activity|physical activity
387226|NCT01927471|Diet|diet
387227|NCT01927432|Polycystic Ovary Syndrome (PCOS)|polycystic ovary syndrome (pcos)
387228|NCT01927432|Nutrition|nutrition
387229|NCT01927432|Metabolism|metabolism
387230|NCT01927432|Antral follicle growth|antral follicle growth
387231|NCT01927432|Menstrual Cyclicity|menstrual cyclicity
387232|NCT01927406|Thyroid Eye Disease|thyroid eye disease
387233|NCT01927406|Graves' Disease|graves' disease
387234|NCT01927406|Prostaglandin Analogues|prostaglandin analogues
387235|NCT01927380|autonomic nervous system modulation|autonomic nervous system modulation
387236|NCT01927380|heart rate variability|heart rate variability
387237|NCT01927380|prostatectomy|prostatectomy
387238|NCT01927380|steep trendelenburg|steep trendelenburg
387239|NCT01927380|pneumoperitoneum|pneumoperitoneum
387240|NCT01927367|Clinical Decision Support System|clinical decision support system
387241|NCT01927367|Primary Health Care|primary health care
387242|NCT01927367|Clinical Practice Guidelines|clinical practice guidelines
387243|NCT01927354|Head-and-Neck squamous cell carcinoma (HNSCC)|head-and-neck squamous cell carcinoma (hnscc)
387244|NCT01927354|epithelial-mesenchymal transition (EMT)|epithelial-mesenchymal transition (emt)
387246|NCT01927354|Twist1|twist1
387247|NCT01927341|MEK162,|mek162,
387248|NCT01927341|panitumumab,|panitumumab,
387249|NCT01927341|mutant RAS,|mutant ras,
387250|NCT01927341|wild-type RAS,|wild-type ras,
387251|NCT01927341|metastatic colorectal cancer,|metastatic colorectal cancer,
387252|NCT01927341|adult mCRC patient|adult mcrc patient
387253|NCT01927328|Adenocarcinoma|adenocarcinoma
387254|NCT01927328|Anemia|anemia
387255|NCT01927328|Palliative therapy|palliative therapy
387256|NCT01927328|Palliative care|palliative care
387257|NCT01927328|Palliative treatments|palliative treatments
387258|NCT01927328|Chemotherapy|chemotherapy
387259|NCT01927328|Esophageal Cancer|esophageal cancer
387260|NCT01927328|Gastric Cancer|gastric cancer
387261|NCT01927315|Stem cells|stem cells
387262|NCT01927315|Regeneration|regeneration
387263|NCT01927315|Angiogenesis|angiogenesis
387264|NCT01927315|Prevention|prevention
387265|NCT01927302|Aphasia|aphasia
387266|NCT01927302|Dysgraphia|dysgraphia
387267|NCT01927302|Anomia|anomia
387268|NCT01927302|Agrammatism|agrammatism
387269|NCT01927302|Stroke|stroke
387270|NCT01927302|Language Recovery|language recovery
387271|NCT01927302|Treatment|treatment
387272|NCT01927302|Biomarkers of Recovery|biomarkers of recovery
387273|NCT01927289|Ultrasound|ultrasound
387274|NCT01927289|supraclavicular block|supraclavicular block
387275|NCT01927289|distal forearm block|distal forearm block
387276|NCT01927289|Grip Strength|grip strength
387277|NCT01927289|Satisfaction|satisfaction
387278|NCT01927276|Schizophrenia|schizophrenia
387279|NCT01927276|Gluten|gluten
387280|NCT01927250|cohort study|cohort study
387281|NCT01927250|diet program|diet program
387282|NCT01927250|art therapy|art therapy
387283|NCT01927250|laying-on-of-hands|laying-on-of-hands
387284|NCT01927250|quality of life|quality of life
387285|NCT01927237|pulmonary artery pressure|pulmonary artery pressure
387286|NCT01927237|ARDS|ards
387287|NCT01927237|alveolar hypoventilation|alveolar hypoventilation
387288|NCT01927237|hypercapnic acidosis|hypercapnic acidosis
387289|NCT01927237|permissive hypercapnia|permissive hypercapnia
387290|NCT01927237|myocardial strain|myocardial strain
387291|NCT01927185|central venous access|central venous access
387292|NCT01927185|ultrasonography|ultrasonography
387293|NCT01927185|subclavian vein|subclavian vein
387294|NCT01927185|pneumothorax|pneumothorax
387295|NCT01927185|vessel view|vessel view
387296|NCT01927159|Tuberculosis|tuberculosis
387297|NCT01927159|TB|tb
387298|NCT01927159|Pulmonary|pulmonary
387299|NCT01927159|Vaccine|vaccine
387300|NCT01927159|Adjuvant|adjuvant
387301|NCT01927146|Lauren classification|lauren classification
387302|NCT01927146|HER2 status|her2 status
387303|NCT01927146|Resectable gastric cancer|resectable gastric cancer
387304|NCT01927133|Fibrosis, HBV, HCV, ALD, NAFLD|fibrosis, hbv, hcv, ald, nafld
387305|NCT01927120|GVHD|gvhd
387306|NCT01927120|Allogeneic|allogeneic
387307|NCT01927120|Hematopoietic Cell Transplant|hematopoietic cell transplant
387308|NCT01927107|probiotics|probiotics
387309|NCT01927107|obesity|obesity
387310|NCT01927107|oxidative stress|oxidative stress
387311|NCT01927094|probiotics, diarrhea|probiotics, diarrhea
387312|NCT01927055|NOH|noh
387313|NCT01927055|OH|oh
387314|NCT01927055|PD|pd
387315|NCT01927055|MSA|msa
387316|NCT01927055|PAF|paf
387317|NCT01927055|DBH|dbh
387318|NCT01927042|Eating Disorders|eating disorders
387319|NCT01927042|Carers|carers
387320|NCT01927029|twin pregnancy|twin pregnancy
387321|NCT01927029|progesterone|progesterone
387322|NCT01927029|preterm delivery|preterm delivery
387323|NCT01927029|>14 years|>14 years
387324|NCT01927029|Abscense of cerclage,|abscense of cerclage,
387325|NCT01927029|TTTS, hemorrage,|ttts, hemorrage,
387326|NCT01927029|history of thrombosis.|history of thrombosis.
387327|NCT01927029|cervix >15mm|cervix >15mm
387328|NCT01927016|Esophageal Neoplasm|esophageal neoplasm
387329|NCT01927016|Esophagus|esophagus
387330|NCT01927016|Surgery|surgery
387331|NCT01927016|Outcome assessment|outcome assessment
387332|NCT01927003|defect,|defect,
387333|NCT01927003|dorsal branch of the digital artery,|dorsal branch of the digital artery,
387334|NCT01927003|dorsal digital flap,|dorsal digital flap,
387335|NCT01927003|dorsal metacarpal artery flap.|dorsal metacarpal artery flap.
387336|NCT01926964|Adjuvant treatment recommendation|adjuvant treatment recommendation
387337|NCT01926964|Early breast cancer|early breast cancer
387338|NCT01926964|Oncotype DX|oncotype dx
387339|NCT01926964|Genetic profiling|genetic profiling
387340|NCT01926951|hypertension|hypertension
387341|NCT01926925|Type 2 diabetes, Endothelium, children/adolescents|type 2 diabetes, endothelium, children/adolescents
387342|NCT01926912|Schizophrenia|schizophrenia
387343|NCT01926912|Paliperidone Palmitate|paliperidone palmitate
387344|NCT01926912|Hospital setting|hospital setting
387345|NCT01926912|Schizophrenic Disorders|schizophrenic disorders
387346|NCT01926860|Prevenar13|prevenar13
387347|NCT01926860|pneumococcal conjugate vaccine|pneumococcal conjugate vaccine
387348|NCT01926860|Epaxal|epaxal
387349|NCT01926860|hepatitis A vaccine|hepatitis a vaccine
387644|NCT01925482|otitis|otitis
387350|NCT01926847|Digital ischemia|digital ischemia
387351|NCT01926847|Raynaud's phenomenon|raynaud's phenomenon
387352|NCT01926834|promoting angiogenesis in multiple targets|promoting angiogenesis in multiple targets
387353|NCT01926834|herbal medicine|herbal medicine
387354|NCT01926834|traditional chinese medicine|traditional chinese medicine
387355|NCT01926834|random clinical trial|random clinical trial
387356|NCT01926795|toddler's fracture|toddler's fracture
387357|NCT01926795|tibial fracture|tibial fracture
387358|NCT01926795|children|children
387359|NCT01926769|Colorectal cancer|colorectal cancer
387360|NCT01926769|Metformin|metformin
387362|NCT01926769|FOFIRI|fofiri
387363|NCT01926769|5FU|5fu
387364|NCT01926769|irinotecan|irinotecan
387365|NCT01926769|oxaliplatin|oxaliplatin
387366|NCT01926756|bacteriuria|bacteriuria
387367|NCT01926756|straight catheterization|straight catheterization
387368|NCT01926756|urinary tract infections|urinary tract infections
387369|NCT01926756|iatrogenic|iatrogenic
387370|NCT01926743|near infrared|near infrared
387371|NCT01926743|fluorescence imaging|fluorescence imaging
387372|NCT01926743|indocyanine green|indocyanine green
387373|NCT01926743|gastrectomy|gastrectomy
387374|NCT01926717|Single Roux-y of Pancreaticojejunostomy-choledochojejunostomy|single roux-y of pancreaticojejunostomy-choledochojejunostomy
387375|NCT01926691|dementia|dementia
387376|NCT01926691|poststroke cognitive impairment|poststroke cognitive impairment
387377|NCT01926691|inflammation|inflammation
387378|NCT01926691|stress|stress
387379|NCT01926678|swedish massage|swedish massage
387380|NCT01926678|fatigue|fatigue
387381|NCT01926678|light touch|light touch
387382|NCT01926678|inflammation|inflammation
387383|NCT01926665|Blood And Marrow Transplantation|blood and marrow transplantation
387384|NCT01926665|Mantle cell lymphoma|mantle cell lymphoma
387385|NCT01926665|MCL|mcl
387386|NCT01926665|T-cell lymphoma|t-cell lymphoma
387387|NCT01926665|TCL|tcl
387388|NCT01926665|Diffuse large b-cell lymphoma|diffuse large b-cell lymphoma
387389|NCT01926665|DLBCL|dlbcl
387390|NCT01926665|Autologous stem cell transplantation|autologous stem cell transplantation
387391|NCT01926665|ASCT|asct
387392|NCT01926665|Carfilzomib|carfilzomib
387393|NCT01926665|CFZ|cfz
387394|NCT01926665|Dexamethasone|dexamethasone
387395|NCT01926665|Decadron|decadron
387396|NCT01926639|Follicular lymphoma|follicular lymphoma
387397|NCT01926639|Rituximab|rituximab
387398|NCT01926639|Autologous dendritic cells|autologous dendritic cells
387399|NCT01926639|Cancer vaccine|cancer vaccine
387400|NCT01926626|Nicotine addiction|nicotine addiction
387401|NCT01926626|Smoking Cessation|smoking cessation
387402|NCT01926626|Quit Smoking|quit smoking
387403|NCT01926626|moclobemide|moclobemide
387404|NCT01926626|Nicotine Patch|nicotine patch
387405|NCT01926613|Schizophrenia|schizophrenia
387406|NCT01926613|Chronic Mental Disorder|chronic mental disorder
387407|NCT01926613|Employment|employment
387408|NCT01926613|Cognitive remediation|cognitive remediation
387409|NCT01926613|Vocational rehabilitation|vocational rehabilitation
387410|NCT01926600|gastric ulcer|gastric ulcer
387411|NCT01926600|duodenal ulcer|duodenal ulcer
387412|NCT01926600|re-bleeding rate|re-bleeding rate
387413|NCT01926600|intragastric pH|intragastric ph
387414|NCT01926600|proton pump inhibitor|proton pump inhibitor
387415|NCT01926587|rigosertib|rigosertib
387416|NCT01926587|ON 01910.Na|on 01910.na
387417|NCT01926587|azacitidine|azacitidine
387418|NCT01926587|Vidaza|vidaza
387419|NCT01926574|absenteeism|absenteeism
387420|NCT01926574|rehabilitation|rehabilitation
387421|NCT01926574|return to work|return to work
387422|NCT01926561|Hypotensive bradycardic event|hypotensive bradycardic event
387423|NCT01926561|Interscalene brachial plexus block|interscalene brachial plexus block
387424|NCT01926561|Sitting position|sitting position
387425|NCT01926561|Shoulder arthroscopic surgery|shoulder arthroscopic surgery
387426|NCT01926548|Pharmacokinetics|pharmacokinetics
387427|NCT01926548|Safety|safety
387428|NCT01926535|amniotic membrane|amniotic membrane
387429|NCT01926535|contact lens|contact lens
387430|NCT01926535|bullous keratopathy|bullous keratopathy
387431|NCT01926522|Exercise Therapy|exercise therapy
387432|NCT01926483|Stage IIIA-N2 NSCLC|stage iiia-n2 nsclc
387433|NCT01926470|epidural injections, intravascular injection|epidural injections, intravascular injection
387434|NCT01926457|First trimester treatment of prediabetes|first trimester treatment of prediabetes
387435|NCT01926457|First trimester treatment of gestational diabetes|first trimester treatment of gestational diabetes
387436|NCT01926457|Umbilical cord C-Peptide|umbilical cord c-peptide
387437|NCT01926457|Neonatal fat mass|neonatal fat mass
387438|NCT01926457|Gestational weight gain|gestational weight gain
387439|NCT01926457|Infant obesity|infant obesity
387440|NCT01926444|colonoscopy|colonoscopy
387441|NCT01926444|sedation-free|sedation-free
387442|NCT01926444|colorectal cancer|colorectal cancer
387443|NCT01926444|CRC screening|crc screening
387444|NCT01926444|prevention|prevention
387445|NCT01926444|analgesia|analgesia
387446|NCT01926444|colonic|colonic
387447|NCT01926444|kappa|kappa
387448|NCT01926444|opioid agonist|opioid agonist
387449|NCT01926444|pain management|pain management
387450|NCT01926444|oral|oral
387451|NCT01926444|hydrogen sulfide|hydrogen sulfide
387452|NCT01926444|peripheral|peripheral
387453|NCT01926418|HIV|hiv
387454|NCT01926418|Condoms|condoms
387455|NCT01926418|Men who have sex with men|men who have sex with men
387456|NCT01926418|implementation intentions|implementation intentions
387457|NCT01926418|executive function|executive function
387458|NCT01926405|hypersomnia|hypersomnia
387459|NCT01926405|narcolepsy|narcolepsy
387460|NCT01926405|amylase|amylase
387461|NCT01926405|salivary sampling|salivary sampling
387462|NCT01926379|Ethiopia|ethiopia
387463|NCT01926379|TB|tb
387464|NCT01926379|tuberculosis|tuberculosis
387465|NCT01926379|HIV|hiv
387466|NCT01926379|IPT|ipt
387467|NCT01926379|isoniazid|isoniazid
387468|NCT01926379|adherence|adherence
387469|NCT01926379|combination intervention package|combination intervention package
387470|NCT01926379|retention|retention
387471|NCT01926353|Vesicoureteral Reflux (VUR)|vesicoureteral reflux (vur)
387472|NCT01926353|Complicated Urinary Tract Infection|complicated urinary tract infection
387473|NCT01926353|Vantris|vantris
387474|NCT01926353|Polyacrylate Polyalcohol Copolymer|polyacrylate polyalcohol copolymer
387475|NCT01926327|PRP PRGF Osteoarthritis|prp prgf osteoarthritis
387476|NCT01926301|sepsis|sepsis
387477|NCT01926301|cerebrovascular autoregulation|cerebrovascular autoregulation
387478|NCT01926301|delirium|delirium
387479|NCT01926275|COPD|copd
387480|NCT01926275|Noninvasive Positive Pressure Ventilation|noninvasive positive pressure ventilation
387481|NCT01926275|Respiratory Muscle Training|respiratory muscle training
387482|NCT01926262|Pain, Neck, Exercise, Pilots, Crewmembers,|pain, neck, exercise, pilots, crewmembers,
387483|NCT01926249|Alzheimer's disease|alzheimer's disease
387484|NCT01926249|Mild Cognitive Impairment|mild cognitive impairment
387485|NCT01926210|Poor ovarian response|poor ovarian response
387486|NCT01926210|in vitro fertilization|in vitro fertilization
387487|NCT01926210|mild ovarian stimulation|mild ovarian stimulation
387488|NCT01926210|controlled ovarian stimulation|controlled ovarian stimulation
387489|NCT01926184|HIV/AIDS|hiv/aids
387490|NCT01926184|Treatment as Prevention|treatment as prevention
387491|NCT01926184|Methamphetamine|methamphetamine
387492|NCT01926184|Cocaine|cocaine
387493|NCT01926184|HIV viral Load|hiv viral load
387494|NCT01926158|Denosumab|denosumab
387495|NCT01926158|Osteoporosis|osteoporosis
387496|NCT01926158|Hip replacement|hip replacement
387497|NCT01926158|Osteoarthritis|osteoarthritis
387498|NCT01926158|Radiostereometric analysis (RSA)|radiostereometric analysis (rsa)
387499|NCT01926158|Dual energy X-ray absorptiometry (DXA)|dual energy x-ray absorptiometry (dxa)
387500|NCT01926132|ascorbic acid|ascorbic acid
387501|NCT01926132|fatigue|fatigue
387502|NCT01926132|mitochondrial DNA|mitochondrial dna
387503|NCT01926132|patient for more than 6 months|patient for more than 6 months
387504|NCT01926106|Nasal Intermittent Positive-Pressure Ventilation|nasal intermittent positive-pressure ventilation
387505|NCT01926106|Nasal Continuous Positive Airway Pressure|nasal continuous positive airway pressure
387506|NCT01926106|twin|twin
387507|NCT01926106|respiratory distress syndrome|respiratory distress syndrome
387508|NCT01926093|Acute Respiratory Distress Syndrome (ARDS)|acute respiratory distress syndrome (ards)
387509|NCT01926080|Depression|depression
387510|NCT01926080|Spirituality|spirituality
387511|NCT01926080|Neonatal death|neonatal death
387512|NCT01926080|Bereavement|bereavement
387513|NCT01926080|Randomized controlled trial|randomized controlled trial
387514|NCT01926067|Accelerometer|accelerometer
387515|NCT01926067|Cardiopulmonary by pass|cardiopulmonary by pass
387516|NCT01926041|community|community
387517|NCT01926041|preventive medicine|preventive medicine
387518|NCT01926041|prediabetes|prediabetes
387519|NCT01926041|smoking cessation|smoking cessation
387520|NCT01926028|recurrent vulvovaginal candidiasis|recurrent vulvovaginal candidiasis
387521|NCT01926028|candida|candida
387522|NCT01926028|NDV3|ndv3
387523|NCT01926028|vaginal thrush|vaginal thrush
387524|NCT01926028|chronic yeast infection|chronic yeast infection
387525|NCT01925976|obesity|obesity
387526|NCT01925976|dietetic intervention|dietetic intervention
387527|NCT01925976|eating behaviors|eating behaviors
387528|NCT01925976|children|children
387529|NCT01925976|healthy eating|healthy eating
387530|NCT01925976|energy dense foods|energy dense foods
387531|NCT01925963|Normal|normal
387532|NCT01925963|Traumatic brain injury|traumatic brain injury
387533|NCT01925963|Neuroimaging|neuroimaging
387534|NCT01925963|Hyperbaric oxygen|hyperbaric oxygen
387535|NCT01925963|Neurobehavioral symptom inventory|neurobehavioral symptom inventory
387536|NCT01925950|BDP|bdp
387537|NCT01925950|orBec|orbec
387538|NCT01925950|GVHD|gvhd
387539|NCT01925950|beclomethasone dipropionate|beclomethasone dipropionate
387540|NCT01925950|bone marrow transplant|bone marrow transplant
387541|NCT01925950|hematopoietic cell transplant|hematopoietic cell transplant
387542|NCT01925950|HCT|hct
387543|NCT01925950|stem cell transplant|stem cell transplant
387544|NCT01925950|marrow transplant|marrow transplant
387545|NCT01925950|SCT|sct
387546|NCT01925950|beclomethasone 17,21-dipropionate|beclomethasone 17,21-dipropionate
387547|NCT01925937|Coenzyme Q10|coenzyme q10
387548|NCT01925937|Atorvastatin|atorvastatin
387549|NCT01925937|clinical trial|clinical trial
387550|NCT01925937|congestive heart failure|congestive heart failure
387551|NCT01925924|Dental cements|dental cements
387552|NCT01925924|Orthodontic adhesives|orthodontic adhesives
387553|NCT01925924|Glass ionomer cement|glass ionomer cement
387554|NCT01925924|Tooth demineralization|tooth demineralization
387555|NCT01925911|Phase 1|phase 1
387556|NCT01925911|Healthy subjects|healthy subjects
387557|NCT01925911|DDI|ddi
387558|NCT01925911|CYP3A|cyp3a
387559|NCT01925898|Laceration|laceration
387560|NCT01925898|Sedation|sedation
387561|NCT01925898|Pediatrics|pediatrics
387562|NCT01925885|Atrial Arrhythmia|atrial arrhythmia
387563|NCT01925872|ischemic cerebrovascular disease|ischemic cerebrovascular disease
387564|NCT01925872|Percutaneous transluminal angioplasty and stenting|percutaneous transluminal angioplasty and stenting
387565|NCT01925872|Clopidogrel resistance|clopidogrel resistance
387566|NCT01925859|Pharmacokinetic analysis|pharmacokinetic analysis
387567|NCT01925859|EryDex|erydex
387568|NCT01925846|Pseudomonas aeruginosa|pseudomonas aeruginosa
387569|NCT01925846|type three secretory system|type three secretory system
387570|NCT01925846|contact lens associated microbial keratitis|contact lens associated microbial keratitis
387571|NCT01925820|Hepatitis B,Entecavir,Pegylated IFN|hepatitis b,entecavir,pegylated ifn
387572|NCT01925807|Adolescent|adolescent
387573|NCT01925807|Suicidal Ideation|suicidal ideation
387574|NCT01925807|Emergency Department|emergency department
387575|NCT01925807|Crisis|crisis
387576|NCT01925807|Attachment|attachment
387577|NCT01925807|Coping|coping
387578|NCT01925794|Stent, Coronary Arteries for Early healing|stent, coronary arteries for early healing
387579|NCT01925781|Smoking Cessation|smoking cessation
387580|NCT01925781|Nicotine Addiction|nicotine addiction
387581|NCT01925781|e-Cigarette|e-cigarette
387582|NCT01925781|electronic nicotine delivery device|electronic nicotine delivery device
387583|NCT01925781|electronic cigarette|electronic cigarette
387584|NCT01925781|nicotine replacement therapy|nicotine replacement therapy
387585|NCT01925768|Apremilast, Psoriatic Arthritis, PDE4 inhibitor|apremilast, psoriatic arthritis, pde4 inhibitor
387586|NCT01925755|Non-interventional|non-interventional
387587|NCT01925755|Rivaroxaban|rivaroxaban
387588|NCT01925755|Prevention in prior stroke or TIA|prevention in prior stroke or tia
387589|NCT01925755|Russian Federation|russian federation
387590|NCT01925742|Fetal aneuploidy|fetal aneuploidy
387591|NCT01925729|middle ear|middle ear
387592|NCT01925729|allergy|allergy
387593|NCT01925729|nose|nose
387594|NCT01925716|cholesterol,LDL|cholesterol,ldl
387595|NCT01925716|vegetable oils|vegetable oils
387596|NCT01925716|heart diseases|heart diseases
387597|NCT01925690|Multiple Sclerosis|multiple sclerosis
387598|NCT01925690|Disease modifying medication|disease modifying medication
387599|NCT01925690|Relapsing-Remitting MS|relapsing-remitting ms
387600|NCT01925690|Motivational Interviewing|motivational interviewing
387601|NCT01925690|Telephone Counseling|telephone counseling
387602|NCT01925677|Transplant|transplant
387603|NCT01925677|donor|donor
387604|NCT01925677|nephrectomy|nephrectomy
387605|NCT01925677|robotic|robotic
387606|NCT01925677|laparoscopy|laparoscopy
387607|NCT01925677|single-port|single-port
387608|NCT01925664|Doulas|doulas
387609|NCT01925664|Parenting|parenting
387610|NCT01925664|Breastfeeding|breastfeeding
387611|NCT01925664|Pregnancy in Adolescence|pregnancy in adolescence
387612|NCT01925651|Post Mastectomy Radiotherapy|post mastectomy radiotherapy
387613|NCT01925651|Breast Cancer|breast cancer
387614|NCT01925651|Bolus|bolus
387615|NCT01925651|Radiodermatitis|radiodermatitis
387616|NCT01925638|Healthy Volunteers|healthy volunteers
387617|NCT01925638|Refametinib|refametinib
387618|NCT01925638|Ketoconazole|ketoconazole
387619|NCT01925638|Pharmacokinetics|pharmacokinetics
387620|NCT01925612|Antibodies, Monoclonal|antibodies, monoclonal
387621|NCT01925612|Antibody-Drug Conjugate|antibody-drug conjugate
387622|NCT01925612|Antigens, CD30|antigens, cd30
387623|NCT01925612|Drug Therapy|drug therapy
387624|NCT01925612|Hematologic Diseases|hematologic diseases
387625|NCT01925612|Lymphoma, B-cell|lymphoma, b-cell
387626|NCT01925612|Lymphoma, Large B-cell, Diffuse|lymphoma, large b-cell, diffuse
387627|NCT01925612|Monomethyl auristatin E|monomethyl auristatin e
387628|NCT01925599|Nevus|nevus
387629|NCT01925599|Choroidal Melanoma|choroidal melanoma
387630|NCT01925599|BAP1 mutation|bap1 mutation
387631|NCT01925573|RECURRENT GLIOBLASTOMA|recurrent glioblastoma
387632|NCT01925573|Brain Tumor|brain tumor
387633|NCT01925534|Optiflow|optiflow
387634|NCT01925534|Humidified high-flow oxygen therapy|humidified high-flow oxygen therapy
387635|NCT01925534|Noninvasive ventilation|noninvasive ventilation
387636|NCT01925534|Acute respiratory failure|acute respiratory failure
387637|NCT01925534|Standard oxygen therapy|standard oxygen therapy
387638|NCT01925521|Intestinal Infection|intestinal infection
387639|NCT01925495|otitis media|otitis media
387640|NCT01925495|middle ear|middle ear
387641|NCT01925495|feedback pathways|feedback pathways
387642|NCT01925495|middle-ear pressure|middle-ear pressure
387643|NCT01925482|middle ear|middle ear
387645|NCT01925482|gas exchange|gas exchange
387646|NCT01925469|Hysterosalpingogram|hysterosalpingogram
387647|NCT01925469|HSG|hsg
387648|NCT01925469|Pain relief|pain relief
387649|NCT01925469|Analgesia|analgesia
387650|NCT01925469|Benzocaine|benzocaine
387651|NCT01925456|urge urinary incontinence|urge urinary incontinence
387652|NCT01925443|diabetes mellitus non-insulin-dependent|diabetes mellitus non-insulin-dependent
387653|NCT01925443|low level laser therapy|low level laser therapy
387654|NCT01925430|Observational|observational
387655|NCT01925430|Sleep|sleep
387656|NCT01925430|Algorithm|algorithm
387657|NCT01925417|Clostridium difficile|clostridium difficile
387658|NCT01925417|C diff|c diff
387659|NCT01925417|Microbiota Restoration Therapy|microbiota restoration therapy
387660|NCT01925417|MRT|mrt
387661|NCT01925417|microbiota suspension|microbiota suspension
387662|NCT01925417|CDI|cdi
387663|NCT01925417|CDAD|cdad
387664|NCT01925417|Fecal transplant|fecal transplant
387665|NCT01925417|Fecal Microbiota Transplant|fecal microbiota transplant
387666|NCT01925417|FMT|fmt
387667|NCT01925417|Diarrhea|diarrhea
387668|NCT01925417|Fecal bacteriotherapy|fecal bacteriotherapy
387669|NCT01925404|Physical activity|physical activity
387670|NCT01925404|parks|parks
387671|NCT01925404|programming|programming
387672|NCT01925404|public health|public health
387673|NCT01925391|Pediatric glaucoma|pediatric glaucoma
387674|NCT01925391|Intraocular pressure|intraocular pressure
387675|NCT01925391|pediatric glaucoma diagnosis|pediatric glaucoma diagnosis
387676|NCT01925391|Volatiles and intraocular pressure|volatiles and intraocular pressure
387677|NCT01925391|nitrous oxide|nitrous oxide
387678|NCT01925391|Tetracaine|tetracaine
387679|NCT01925378|Cervical Dysplasia|cervical dysplasia
387680|NCT01925352|ischemic heart disease|ischemic heart disease
387681|NCT01925352|adenovirus|adenovirus
387682|NCT01925352|hepatocyte growth factor|hepatocyte growth factor
387683|NCT01925313|Safety|safety
387684|NCT01925313|Pharmacokinetics|pharmacokinetics
387685|NCT01925300|Pharmacokinetics|pharmacokinetics
387686|NCT01925300|Pharmacodynamics|pharmacodynamics
387687|NCT01925300|Safety|safety
387688|NCT01925300|Tolerability|tolerability
387689|NCT01925287|bioavailability|bioavailability
387690|NCT01925287|curcumin|curcumin
387691|NCT01925287|curcuma longa|curcuma longa
387692|NCT01925287|healthy humans|healthy humans
387693|NCT01925287|safety|safety
387694|NCT01925287|sex differences|sex differences
387695|NCT01925274|metastatic colorectal cancer|metastatic colorectal cancer
387696|NCT01925274|colorectal cancer|colorectal cancer
387697|NCT01925274|KRAS|kras
387698|NCT01925274|colon cancer|colon cancer
387699|NCT01925274|mCRC|mcrc
387700|NCT01925274|CRC|crc
387701|NCT01925274|PF-05212384|pf-05212384
387702|NCT01925274|KRAS wild type colorectal cancer|kras wild type colorectal cancer
387703|NCT01925274|irinotecan|irinotecan
387704|NCT01925274|cetuximab|cetuximab
387705|NCT01925274|NRAS|nras
387706|NCT01925261|knee osteoarthritis|knee osteoarthritis
387707|NCT01925261|bilateral|bilateral
387708|NCT01925261|osteoarthritis|osteoarthritis
387709|NCT01925248|Whey protein|whey protein
387710|NCT01925248|protein supplement|protein supplement
387711|NCT01925248|Diabetes|diabetes
387712|NCT01925248|Type 2 DM|type 2 dm
387713|NCT01925248|Hyperglycemia|hyperglycemia
387714|NCT01925248|Insulin secretagogue|insulin secretagogue
387715|NCT01925235|remote ischemic preconditioning|remote ischemic preconditioning
387716|NCT01925235|acute kidney injury|acute kidney injury
387717|NCT01925235|TAVI|tavi
387718|NCT01925235|RenPRO trial|renpro trial
387719|NCT01925235|parameters|parameters
387720|NCT01925209|sporadic inclusion body myositis,|sporadic inclusion body myositis,
387721|NCT01925209|myositis,|myositis,
387722|NCT01925209|muscle wasting,|muscle wasting,
387723|NCT01925209|controlled clinical trial,|controlled clinical trial,
387724|NCT01925209|randomized,|randomized,
387725|NCT01925209|body mass,|body mass,
387726|NCT01925209|muscle function,|muscle function,
387727|NCT01925209|strength,|strength,
387728|NCT01925209|performance,|performance,
387729|NCT01925209|physical function|physical function
387730|NCT01925196|Motor Neuron Disease|motor neuron disease
387731|NCT01925196|Frontotemporal Dementia|frontotemporal dementia
387732|NCT01925196|Cognitive Testing|cognitive testing
387733|NCT01925196|Magnetic Resonance Imaging (MRI)|magnetic resonance imaging (mri)
387734|NCT01925196|Transcranial Magnetic Stimulation (TMS)|transcranial magnetic stimulation (tms)
387735|NCT01925183|Boceprevir|boceprevir
387736|NCT01925183|HIV/HCV-coinfection|hiv/hcv-coinfection
387737|NCT01925183|HIV/HCV coinfection|hiv/hcv coinfection
387738|NCT01925183|HIV/HCV|hiv/hcv
387739|NCT01925183|Response-guided therapy|response-guided therapy
387740|NCT01925170|Dense breast tissue|dense breast tissue
387741|NCT01925170|Breast Cancer Screening|breast cancer screening
387742|NCT01925170|Molecular Breast Imaging|molecular breast imaging
387743|NCT01925170|Breast Cancer|breast cancer
387744|NCT01925170|Breast|breast
387745|NCT01925105|Polypharmacy|polypharmacy
387746|NCT01925092|Cushing's disease|cushing's disease
387747|NCT01925092|Mifepristone|mifepristone
387748|NCT01925092|Cushing's syndrome|cushing's syndrome
387749|NCT01925092|Pharmacokinetic-pharmacodynamic|pharmacokinetic-pharmacodynamic
387750|NCT01925092|Child/pediatric population|child/pediatric population
387751|NCT01925092|Safety-efficacy|safety-efficacy
387752|NCT01925079|acute coronary syndrome|acute coronary syndrome
387753|NCT01925079|statins|statins
387754|NCT01925079|LDL-C|ldl-c
387755|NCT01925079|intensive education|intensive education
387756|NCT01925027|Nano+ DES|nano+ des
387757|NCT01925027|OCT|oct
387758|NCT01925027|Neointimal hyperplasia|neointimal hyperplasia
387759|NCT01925027|DAPT|dapt
387760|NCT01925027|3 month|3 month
387761|NCT01925014|Appendectomy|appendectomy
387762|NCT01925014|Appendicitis|appendicitis
387763|NCT01925014|False Positive Reactions|false positive reactions
387764|NCT01925014|Humans|humans
387765|NCT01925014|Radiation Dosage|radiation dosage
387766|NCT01925014|Tomography, X-Ray Computed|tomography, x-ray computed
387767|NCT01925014|Young Adult|young adult
387768|NCT01925001|Sickle cell anemia|sickle cell anemia
387769|NCT01925001|Sickle cell disease|sickle cell disease
387770|NCT01925001|Sickling crisis|sickling crisis
387771|NCT01925001|Vaso-occlusive crisis|vaso-occlusive crisis
387772|NCT01925001|Carboxyhemoglobin|carboxyhemoglobin
387773|NCT01925001|Oxygen therapeutic|oxygen therapeutic
387774|NCT01925001|Ischemic rescue therapy|ischemic rescue therapy
387775|NCT01925001|Hemoglobin solution|hemoglobin solution
387776|NCT01925001|Pegylated hemoglobin|pegylated hemoglobin
387777|NCT01924988|BPH, benign prostatic hyperplasia|bph, benign prostatic hyperplasia
387778|NCT01924962|chronic occlusion of coronary artery|chronic occlusion of coronary artery
387779|NCT01924962|left ventricular function|left ventricular function
387780|NCT01924962|revascularisation|revascularisation
387781|NCT01924949|7977|7977
387782|NCT01924949|5885|5885
387783|NCT01924949|GS-7977|gs-7977
387784|NCT01924949|GS-5885|gs-5885
387785|NCT01924949|SOF|sof
387786|NCT01924949|LDV|ldv
387787|NCT01924949|Sofosbuvir|sofosbuvir
387788|NCT01924949|Ledipasvir|ledipasvir
387789|NCT01924949|FDC|fdc
387790|NCT01924923|uveal melanoma|uveal melanoma
387791|NCT01924923|biopsy|biopsy
387792|NCT01924923|enucleation|enucleation
387793|NCT01924923|ocular cancer|ocular cancer
387794|NCT01924910|Healthy, by self report|healthy, by self report
387795|NCT01924897|CPET test|cpet test
387796|NCT01924897|Exercise training|exercise training
387797|NCT01924897|Prehabilitation|prehabilitation
387798|NCT01924897|Exercise Test|exercise test
387799|NCT01924884|Vacuum-Assisted Closure|vacuum-assisted closure
387800|NCT01924884|Topical Negative-Pressure Therapy|topical negative-pressure therapy
387801|NCT01924884|Negative-Pressure Dressings|negative-pressure dressings
387802|NCT01924858|PET, healthy subjects|pet, healthy subjects
387803|NCT01924858|Lp-PLA2|lp-pla2
387804|NCT01924858|positron emission tomography|positron emission tomography
387805|NCT01924858|Alzheimer's disease|alzheimer's disease
387806|NCT01924858|brain exposure|brain exposure
387807|NCT01924858|GSK2647544|gsk2647544
387808|NCT01924819|Gastric cancer|gastric cancer
387809|NCT01924819|Stomach cancer|stomach cancer
387810|NCT01924819|Chemoradiotherapy|chemoradiotherapy
387811|NCT01924819|Surgery|surgery
387812|NCT01924819|Chemotherapy|chemotherapy
387813|NCT01924819|Neoadjuvant|neoadjuvant
387814|NCT01924806|debridement|debridement
387815|NCT01924806|post-debridement|post-debridement
387816|NCT01924806|infection|infection
387817|NCT01924806|prevention|prevention
387818|NCT01924806|wound|wound
387819|NCT01924806|wound tissue|wound tissue
387820|NCT01924806|wound management|wound management
387821|NCT01924806|WoundWand|woundwand
387822|NCT01924806|wound size reduction|wound size reduction
387823|NCT01924806|wound bed debridement|wound bed debridement
387824|NCT01924806|WoundWand Debridement Device|woundwand debridement device
387825|NCT01924806|chronic wound|chronic wound
387826|NCT01924806|delayed healing|delayed healing
387827|NCT01924806|cellular senescence|cellular senescence
387828|NCT01924806|acute wound|acute wound
387829|NCT01924806|diabetic foot ulcer|diabetic foot ulcer
387830|NCT01924806|venous leg ulcers|venous leg ulcers
387831|NCT01924806|radiofrequency debridement|radiofrequency debridement
387832|NCT01924806|necrotic tissue|necrotic tissue
387833|NCT01924806|wound healing|wound healing
387834|NCT01924806|skin|skin
387835|NCT01924780|Dose-Response Relationship, Immunologic|dose-response relationship, immunologic
387836|NCT01924754|HPV|hpv
387837|NCT01924754|Gardasil|gardasil
387838|NCT01924754|seroconversion|seroconversion
387839|NCT01924741|Liver neoplasms|liver neoplasms
387840|NCT01924741|Liver regeneration|liver regeneration
387841|NCT01924715|somatoform disorder|somatoform disorder
387842|NCT01924715|psychotherapy|psychotherapy
387843|NCT01924715|depression|depression
387844|NCT01924715|anxiety|anxiety
387845|NCT01924715|personality disorder|personality disorder
387846|NCT01924689|Phase 1|phase 1
387847|NCT01924689|Metastatic Disease|metastatic disease
387848|NCT01924689|Solid Tumor|solid tumor
387849|NCT01924689|Malignancy|malignancy
387850|NCT01924689|Metastases|metastases
387851|NCT01924689|Clinical Trial|clinical trial
387852|NCT01924689|Hypoxia|hypoxia
387853|NCT01924689|Necrosis|necrosis
387854|NCT01924689|Intratumoral|intratumoral
387855|NCT01924689|Locally advanced cancer|locally advanced cancer
387856|NCT01924689|Immunotherapy|immunotherapy
387857|NCT01924689|Sarcoma|sarcoma
387858|NCT01924689|Chordoma|chordoma
387859|NCT01924689|Bacteriolytic|bacteriolytic
387860|NCT01924676|food effect|food effect
387861|NCT01924676|pharmacokinetics|pharmacokinetics
387862|NCT01924676|bioavailability|bioavailability
387863|NCT01924676|oxycodone|oxycodone
387864|NCT01924676|management of moderate to severe pain|management of moderate to severe pain
387865|NCT01924663|Heart Failure|heart failure
387866|NCT01924663|Acute Kidney Injury|acute kidney injury
387867|NCT01924663|Myocardial Dysfunction|myocardial dysfunction
387868|NCT01924663|Pediatric Critical Care|pediatric critical care
387869|NCT01924663|Pediatric Intensive Care Units|pediatric intensive care units
387870|NCT01924663|Respiratory Virus|respiratory virus
387871|NCT01924611|Dental caries|dental caries
387872|NCT01924611|Atraumatic Restorative Technique|atraumatic restorative technique
387873|NCT01924598|Anorexia Nervosa|anorexia nervosa
387874|NCT01924598|Treatment Development|treatment development
387875|NCT01924598|Capacity|capacity
387876|NCT01924598|Neuroimaging|neuroimaging
387877|NCT01924598|Magnetoencephalography|magnetoencephalography
387878|NCT01924598|functional MRI|functional mri
387879|NCT01924598|Reward processing|reward processing
387880|NCT01924598|Habit formation|habit formation
387881|NCT01924585|Colorectal|colorectal
387882|NCT01924585|Surgery|surgery
387883|NCT01924585|Frailty|frailty
387884|NCT01924585|Elderly|elderly
387885|NCT01924585|Quality of Life|quality of life
387886|NCT01924572|umbilical cord clamping|umbilical cord clamping
387887|NCT01924572|Placental residual blood volume|placental residual blood volume
387888|NCT01924572|hematocrit|hematocrit
387889|NCT01924572|hemoglobin|hemoglobin
387890|NCT01924572|bilirubin|bilirubin
387891|NCT01924559|Airway|airway
387892|NCT01924546|cognition|cognition
387893|NCT01924546|hydration|hydration
387894|NCT01924546|schoolchildren|schoolchildren
387895|NCT01924520|Antipsychotic|antipsychotic
387896|NCT01924520|FK949E|fk949e
387897|NCT01924520|Quetiapine|quetiapine
387898|NCT01924507|Sleep medicine|sleep medicine
387899|NCT01924507|Sleep apnea|sleep apnea
387900|NCT01924507|Acute myocardial infarction|acute myocardial infarction
387901|NCT01924507|Heart failure|heart failure
387902|NCT01924507|CPAP|cpap
387903|NCT01924494|telemedicine, tele-endoscopy|telemedicine, tele-endoscopy
387904|NCT01924481|Caffeine|caffeine
387905|NCT01924481|Flavonoids|flavonoids
387906|NCT01924481|MRI|mri
387907|NCT01924481|Brain blood flow|brain blood flow
387908|NCT01924481|Cognition|cognition
387909|NCT01924481|Perfusion|perfusion
387910|NCT01924481|Resting functional magnetic resonance imaging (fMRI)|resting functional magnetic resonance imaging (fmri)
387911|NCT01924468|Cognitive Control|cognitive control
387912|NCT01924468|fMRI|fmri
387913|NCT01924468|Genetics|genetics
387914|NCT01924468|Dopamine|dopamine
387915|NCT01924455|HIV|hiv
387916|NCT01924455|HBV|hbv
387917|NCT01924442|Coronary Artery Disease|coronary artery disease
387918|NCT01924442|Off-Pump|off-pump
387919|NCT01924442|Myocardial Ischemia|myocardial ischemia
387920|NCT01924442|Heart Disease|heart disease
387921|NCT01924429|Attention Deficit Hyperactivity Disorder|attention deficit hyperactivity disorder
387922|NCT01924429|ADHD|adhd
387923|NCT01924429|fMRI|fmri
387924|NCT01924429|Imaging|imaging
387925|NCT01924429|Vyvanse|vyvanse
387926|NCT01924429|Stimulant Medication|stimulant medication
387927|NCT01924429|Treatment|treatment
387928|NCT01924429|Clinical Trial|clinical trial
387929|NCT01924429|Adult|adult
387930|NCT01924403|TKA|tka
387931|NCT01924403|Wound Closure|wound closure
387932|NCT01924403|Wound Perfusion|wound perfusion
387933|NCT01924390|Tooth extraction|tooth extraction
387934|NCT01924377|AF|af
387935|NCT01924364|Craniomaxillofacial (CMF) Battle-injured (BI)|craniomaxillofacial (cmf) battle-injured (bi)
387936|NCT01924364|Facial Trauma|facial trauma
387937|NCT01924364|Fat Grafts|fat grafts
387938|NCT01924364|Autogenous Fat Transfers (AFT)|autogenous fat transfers (aft)
387939|NCT01924364|Wounded warriors|wounded warriors
387940|NCT01924351|Breast Cancer with Brain Metastasis|breast cancer with brain metastasis
387941|NCT01924351|HER2-positive|her2-positive
387942|NCT01924351|HER-2 therapy|her-2 therapy
387943|NCT01924338|Patient|patient
387944|NCT01924338|localisation|localisation
387945|NCT01924338|in cranial|in cranial
387946|NCT01924338|radiation|radiation
387947|NCT01924338|therapy|therapy
387948|NCT01924338|thickness of|thickness of
387949|NCT01924325|apixaban|apixaban
387950|NCT01924325|clopidogrel|clopidogrel
387951|NCT01924325|aspirin|aspirin
387952|NCT01924325|new oral anticoagulant|new oral anticoagulant
387953|NCT01924325|TIA|tia
387954|NCT01924325|acute minor ischemic stroke|acute minor ischemic stroke
387955|NCT01924312|stroke, dementia, hypertension, diabetes, hyperlipidemia, smoking, obesity|stroke, dementia, hypertension, diabetes, hyperlipidemia, smoking, obesity
387956|NCT01924286|HIV|hiv
387957|NCT01924286|Tuberculosis|tuberculosis
387958|NCT01924286|Immune reconstitution inflammatory syndrome|immune reconstitution inflammatory syndrome
387959|NCT01924286|Highly active antiretroviral therapy|highly active antiretroviral therapy
387960|NCT01924286|Glucocorticoids|glucocorticoids
387961|NCT01924286|Prednisone|prednisone
387962|NCT01924286|Preventive therapy|preventive therapy
387963|NCT01924273|Port Wine Stain Birthmarks|port wine stain birthmarks
387964|NCT01924234|Remifentanil|remifentanil
387965|NCT01924234|Pharyngeal dysfunction|pharyngeal dysfunction
387966|NCT01924234|Subjective swallowing difficulties|subjective swallowing difficulties
387967|NCT01924234|Pulmonary aspiration|pulmonary aspiration
387968|NCT01924208|Timothy|timothy
387969|NCT01924208|Influenza|influenza
387970|NCT01924208|Interferon|interferon
387971|NCT01924208|T cell|t cell
387972|NCT01924208|Tonsil|tonsil
387973|NCT01924195|lung|lung
387974|NCT01924195|Anlotinib|anlotinib
387975|NCT01924195|AL3818|al3818
387976|NCT01924195|NSCLC|nsclc
387977|NCT01924195|Cancer|cancer
387978|NCT01924182|chronic pain|chronic pain
387979|NCT01924182|inadequate pain relief|inadequate pain relief
387980|NCT01924182|intolerable side effects|intolerable side effects
387981|NCT01924169|Hematologic Disorder|hematologic disorder
387982|NCT01924169|Chronic Lymphocytic Leukemia|chronic lymphocytic leukemia
387983|NCT01924169|CLL|cll
387984|NCT01924169|Hypogammaglobulinemia|hypogammaglobulinemia
387985|NCT01924169|Impaired Response to Vaccinations|impaired response to vaccinations
387986|NCT01924169|Immunoglobulins|immunoglobulins
387987|NCT01924169|Immune system's function|immune system's function
387988|NCT01924169|Lenalidomide|lenalidomide
387989|NCT01924169|CC-5013|cc-5013
387990|NCT01924169|Revlimid|revlimid
387991|NCT01924169|Flu vaccine|flu vaccine
387992|NCT01924169|TIV|tiv
387993|NCT01924169|Pneumonia vaccine|pneumonia vaccine
387994|NCT01924143|ADHD|adhd
387995|NCT01924143|Fibromyalgia|fibromyalgia
387996|NCT01924117|cervical intraepithelial neoplasia, HPV, Cancer|cervical intraepithelial neoplasia, hpv, cancer
387997|NCT01924104|IVF failure, implantation rate, heparin & aspirin|ivf failure, implantation rate, heparin & aspirin
387998|NCT01924078|breast cancer|breast cancer
387999|NCT01924078|metronomic chemotherapy|metronomic chemotherapy
388000|NCT01924078|aromatase inhibitors|aromatase inhibitors
388001|NCT01924065|Atrial fibrillation, conversion, stroke|atrial fibrillation, conversion, stroke
388002|NCT01924039|Psychosis|psychosis
388003|NCT01924039|Substance Use|substance use
388004|NCT01924039|Motivational Enhancement Therapy|motivational enhancement therapy
388005|NCT01924026|Phenylketonuria|phenylketonuria
388006|NCT01924026|Mild Hyperphenylalaninemia|mild hyperphenylalaninemia
388007|NCT01924026|PKU|pku
388008|NCT01924026|MHP|mhp
388009|NCT01924013|Pregnancy|pregnancy
388010|NCT01924013|Infant Growth|infant growth
388011|NCT01924013|Vitamin D|vitamin d
388012|NCT01924013|Bangladesh|bangladesh
388013|NCT01923987|Short course radiotherapy|short course radiotherapy
388014|NCT01923987|Modified FOLFOX6|modified folfox6
388015|NCT01923987|Delayed surgery|delayed surgery
388016|NCT01923987|Rectal cancer|rectal cancer
388017|NCT01923987|Synchronous metastasis|synchronous metastasis
388018|NCT01923987|Liver metastasis|liver metastasis
388019|NCT01923987|Lung metastasis|lung metastasis
388020|NCT01923961|Maintenance hemodialysis or hemodiafiltration|maintenance hemodialysis or hemodiafiltration
388021|NCT01923961|>18 years|>18 years
388022|NCT01923961|Stable condition|stable condition
388023|NCT01923948|Hepatocellular carcinoma|hepatocellular carcinoma
496219|NCT01446133|CLL|cll
388024|NCT01923948|Hepatectomy|hepatectomy
388025|NCT01923948|randomized controlled trials(RCTs)|randomized controlled trials(rcts)
388026|NCT01923948|Postoperative Pain|postoperative pain
388027|NCT01923935|Multiple myeloma, busulfan, melphalan,transplantation|multiple myeloma, busulfan, melphalan,transplantation
388028|NCT01923922|glioblastoma multiforme|glioblastoma multiforme
388029|NCT01923922|CT Perfusion|ct perfusion
388030|NCT01923922|Survival|survival
388031|NCT01923909|Knee|knee
388032|NCT01923909|Osteoarthritis|osteoarthritis
388033|NCT01923909|Bahrain|bahrain
388034|NCT01923909|PRP|prp
388035|NCT01923909|Steroid|steroid
388036|NCT01923909|WOMAC|womac
388037|NCT01923909|Oxford Knee Score|oxford knee score
388038|NCT01923909|Platelet-rich plasma|platelet-rich plasma
388039|NCT01923896|food refusal|food refusal
388040|NCT01923896|behavioral intervention|behavioral intervention
388041|NCT01923896|D-cycloserine|d-cycloserine
388042|NCT01923844|Newborn|newborn
388043|NCT01923844|perfusion index|perfusion index
388044|NCT01923844|pulsatility index|pulsatility index
388045|NCT01923844|respiratory distress syndrome|respiratory distress syndrome
388046|NCT01923844|surfactant|surfactant
388047|NCT01923844|transcutaneous carbon monoxide|transcutaneous carbon monoxide
388048|NCT01923831|Magnesium, Post operative sore throat, Prone position, Tracheal intubation|magnesium, post operative sore throat, prone position, tracheal intubation
388049|NCT01923818|rivaroxaban|rivaroxaban
388050|NCT01923818|aspirin|aspirin
388051|NCT01923818|new oral anticoagulant|new oral anticoagulant
388053|NCT01923818|acute minor ischemic stroke|acute minor ischemic stroke
388155|NCT01923376|cirrhosis|cirrhosis
388054|NCT01923792|House Dust Mite Allergy|house dust mite allergy
388055|NCT01923792|Rhinoconjunctivitis|rhinoconjunctivitis
388056|NCT01923792|Environmental Exposure Unit|environmental exposure unit
388057|NCT01923792|Immunotherapy|immunotherapy
388058|NCT01923792|ToleroMune HDM|toleromune hdm
388059|NCT01923779|Grass allergy|grass allergy
388060|NCT01923779|Rhinoconjunctivitis|rhinoconjunctivitis
388061|NCT01923779|Environmental Exposure Unit|environmental exposure unit
388062|NCT01923779|Immunotherapy|immunotherapy
388063|NCT01923779|ToleroMune Grass|toleromune grass
388064|NCT01923766|Transplantation|transplantation
388065|NCT01923753|Cystic Fibrosis|cystic fibrosis
388066|NCT01923753|Neural respiratory drive|neural respiratory drive
388067|NCT01923753|Airway clearance technique|airway clearance technique
388068|NCT01923753|Expectoration|expectoration
388069|NCT01923753|Positive expiratory pressure device|positive expiratory pressure device
388070|NCT01923740|Absorb™ BVS|absorb™ bvs
388071|NCT01923740|Angioplasty|angioplasty
388072|NCT01923740|Bioabsorbable|bioabsorbable
388073|NCT01923740|BVS|bvs
388074|NCT01923740|Bioresorbable|bioresorbable
388075|NCT01923740|Coronary Artery Disease|coronary artery disease
388076|NCT01923740|Coronary Artery Endothelial Responsiveness|coronary artery endothelial responsiveness
388077|NCT01923740|Coronary artery restenosis|coronary artery restenosis
388078|NCT01923740|Coronary artery stenosis|coronary artery stenosis
388079|NCT01923740|Coronary scaffold|coronary scaffold
388080|NCT01923740|Coronary Stent|coronary stent
388081|NCT01923740|Drug eluting stents|drug eluting stents
388082|NCT01923740|Everolimus|everolimus
388083|NCT01923740|Myocardial ischemia|myocardial ischemia
388084|NCT01923740|Stent thrombosis|stent thrombosis
388085|NCT01923740|Stents|stents
388086|NCT01923727|[89Zr]Df-IAB2M|[89zr]df-iab2m
388087|NCT01923727|Prostate|prostate
388088|NCT01923727|PET Scan|pet scan
388089|NCT01923714|Glaucoma|glaucoma
388090|NCT01923701|At Risk Mental State|at risk mental state
388091|NCT01923701|Attenuated Psychosis Syndrome|attenuated psychosis syndrome
388092|NCT01923701|Prodrom|prodrom
388093|NCT01923701|Paranoia|paranoia
388094|NCT01923701|Psychosis|psychosis
388095|NCT01923701|Cognitive Behavioral Therapy|cognitive behavioral therapy
388096|NCT01923701|Group|group
388097|NCT01923701|Family|family
388098|NCT01923701|ARMS|arms
388099|NCT01923688|Prediction Prevention Severe Hypoglycemia RealTime Alert|prediction prevention severe hypoglycemia realtime alert
388100|NCT01923675|myopia|myopia
388101|NCT01923675|nearsightedness|nearsightedness
388102|NCT01923675|axial elongation of the eye|axial elongation of the eye
388103|NCT01923675|refractive error|refractive error
388104|NCT01923662|Paraplegia|paraplegia
388105|NCT01923662|Tetraplegia|tetraplegia
388106|NCT01923662|Spinal Cord Injury|spinal cord injury
388107|NCT01923662|FES|fes
388108|NCT01923649|postoperative dumping|postoperative dumping
388109|NCT01923649|somatostatin analogues|somatostatin analogues
388110|NCT01923649|somatulin|somatulin
388111|NCT01923649|lanreotide|lanreotide
388112|NCT01923649|dumping syndrome|dumping syndrome
388113|NCT01923636|Cytomegalovirus, congenital, handicap|cytomegalovirus, congenital, handicap
388114|NCT01923610|Low risk HIV infection|low risk hiv infection
388115|NCT01923610|HIV Seronegativity|hiv seronegativity
388116|NCT01923610|HIV Preventive Vaccine|hiv preventive vaccine
388117|NCT01923597|Proteinuria|proteinuria
388118|NCT01923597|Oxidative stress|oxidative stress
388119|NCT01923597|Epigallocatechin gallate|epigallocatechin gallate
388120|NCT01923545|PEG-G-CSF|peg-g-csf
388121|NCT01923493|neck pain|neck pain
388122|NCT01923493|tuina|tuina
388123|NCT01923467|smoking|smoking
388124|NCT01923467|nicotine replacement|nicotine replacement
388125|NCT01923467|internet|internet
388126|NCT01923454|paracentesis|paracentesis
388127|NCT01923454|primary acute angle closure|primary acute angle closure
388128|NCT01923454|iridotomy|iridotomy
388129|NCT01923454|filtration|filtration
388130|NCT01923454|glaucoma|glaucoma
388131|NCT01923415|Lupus Erythematosus, Subacute, Cutaneous|lupus erythematosus, subacute, cutaneous
388132|NCT01923415|Lupus Erythematosus, Systemic|lupus erythematosus, systemic
388133|NCT01923415|Lupus Erythematosus, Discoid|lupus erythematosus, discoid
388134|NCT01923415|Active Cutaneous Lupus Erythematosus|active cutaneous lupus erythematosus
388135|NCT01923415|Systemic Cutaneous Lupus Erythematosus|systemic cutaneous lupus erythematosus
388136|NCT01923415|Skin Biopsy|skin biopsy
388137|NCT01923415|Lesions|lesions
388138|NCT01923402|Biomarkers|biomarkers
388139|NCT01923402|Metabolic Profiling|metabolic profiling
388140|NCT01923402|Metabolomics|metabolomics
388141|NCT01923402|Tobacco|tobacco
388142|NCT01923402|Smokeless Tobacco|smokeless tobacco
388143|NCT01923402|Moist Snuff|moist snuff
388144|NCT01923389|T2DM|t2dm
388145|NCT01923389|obesity|obesity
388146|NCT01923389|safety|safety
388147|NCT01923389|multiple dose|multiple dose
388148|NCT01923389|intravenous|intravenous
388149|NCT01923376|hepatic encephalopathy|hepatic encephalopathy
388150|NCT01923376|hepatic coma|hepatic coma
388151|NCT01923376|HE|he
388152|NCT01923376|PSE|pse
388153|NCT01923376|lactulose|lactulose
388154|NCT01923376|golytely|golytely
388156|NCT01923376|Hepatic Insufficiency|hepatic insufficiency
388157|NCT01923376|Liver Cirrhosis|liver cirrhosis
388158|NCT01923376|Fibrosis|fibrosis
388159|NCT01923376|Brain Damage, Chronic|brain damage, chronic
388160|NCT01923376|Delirium|delirium
388161|NCT01923376|Encephalitis|encephalitis
388162|NCT01923376|Neurotoxicity Syndromes|neurotoxicity syndromes
388163|NCT01923376|Liver Failure|liver failure
388164|NCT01923376|Liver Diseases|liver diseases
388165|NCT01923376|Digestive System Diseases|digestive system diseases
388166|NCT01923376|Brain Diseases, Metabolic|brain diseases, metabolic
388167|NCT01923376|Brain Diseases|brain diseases
388168|NCT01923376|Central Nervous System Diseases|central nervous system diseases
388169|NCT01923376|Nervous System Diseases|nervous system diseases
388170|NCT01923376|Metabolic Diseases|metabolic diseases
388171|NCT01923376|Pathologic Processes|pathologic processes
388172|NCT01923376|Confusion|confusion
388173|NCT01923376|Neurobehavioral Manifestations|neurobehavioral manifestations
388174|NCT01923376|Neurologic Manifestations|neurologic manifestations
388175|NCT01923376|Signs and Symptoms|signs and symptoms
388176|NCT01923376|Delirium, Dementia, Amnestic, Cognitive Disorders|delirium, dementia, amnestic, cognitive disorders
388177|NCT01923376|Mental Disorders|mental disorders
388178|NCT01923376|Central Nervous System Viral Diseases|central nervous system viral diseases
388179|NCT01923376|Virus Diseases|virus diseases
388180|NCT01923376|Central Nervous System Infections|central nervous system infections
388181|NCT01923376|Poisoning|poisoning
388182|NCT01923376|Substance-Related Disorders|substance-related disorders
388183|NCT01923376|Citric Acid|citric acid
388184|NCT01923363|pharmacokinetics|pharmacokinetics
388185|NCT01923363|obesity|obesity
388186|NCT01923363|piperacillin-tazobactam combination product|piperacillin-tazobactam combination product
388187|NCT01923363|pharmacodynamics|pharmacodynamics
388188|NCT01923363|piperacillin/tazobactam|piperacillin/tazobactam
388189|NCT01923350|Weight reduction|weight reduction
388190|NCT01923350|Behavioral intervention|behavioral intervention
388191|NCT01923350|Gestational diabetes mellitus|gestational diabetes mellitus
388192|NCT01923350|Type 2 diabetes|type 2 diabetes
388193|NCT01923350|Diabetes testing|diabetes testing
388194|NCT01923337|Colorectal cancer|colorectal cancer
388195|NCT01923311|Pediatrics|pediatrics
388196|NCT01923311|Adolescents|adolescents
388197|NCT01923311|HIV|hiv
388198|NCT01923311|HIV-1|hiv-1
388199|NCT01923311|Treatment-experienced|treatment-experienced
388200|NCT01923246|Alcohol consumption|alcohol consumption
388201|NCT01923246|Brief intervention|brief intervention
388202|NCT01923246|Automated techniques|automated techniques
388203|NCT01923233|liver cancer|liver cancer
388204|NCT01923233|HCC|hcc
388205|NCT01923233|tumor vaccine|tumor vaccine
388206|NCT01923233|immunotherapy|immunotherapy
388207|NCT01923220|Breast Cancer|breast cancer
388208|NCT01923220|Radiation Therapy|radiation therapy
388209|NCT01923220|Radiation Dermatitis|radiation dermatitis
388210|NCT01923168|BYL719|byl719
388211|NCT01923168|alpelisib|alpelisib
388212|NCT01923168|Breast Cancer|breast cancer
388213|NCT01923168|BKM120|bkm120
388214|NCT01923168|buparlisib|buparlisib
388215|NCT01923168|Pathological Complete Response|pathological complete response
388216|NCT01923168|neoadjuvant|neoadjuvant
388217|NCT01923168|hormone receptor-positive|hormone receptor-positive
388218|NCT01923168|HER2 negative|her2 negative
388219|NCT01923168|Objective Response Rate|objective response rate
388220|NCT01923142|Vitiligo|vitiligo
388221|NCT01923142|Outer-Root-Sheath|outer-root-sheath
388222|NCT01923142|Melanocytes|melanocytes
388223|NCT01923142|Hair Follicles|hair follicles
388224|NCT01923129|indwelling catheter|indwelling catheter
388225|NCT01923129|foley|foley
388226|NCT01923129|duration|duration
388227|NCT01923116|Anal intraepithelial neoplasia|anal intraepithelial neoplasia
388228|NCT01923116|HIV|hiv
388229|NCT01923116|HPV|hpv
388230|NCT01923116|Vaccination|vaccination
388231|NCT01923116|Treatment|treatment
388232|NCT01923077|acute myocardial infarction|acute myocardial infarction
388233|NCT01923077|Statin|statin
388234|NCT01923077|speckle tracking echocardiography|speckle tracking echocardiography
388235|NCT01923077|Strain|strain
388236|NCT01923077|MSCT|msct
388237|NCT01923077|plaque|plaque
388238|NCT01923077|vulnerable plaque|vulnerable plaque
388239|NCT01923051|chronic obstructive pulmonary disease|chronic obstructive pulmonary disease
388240|NCT01923051|COPD|copd
388241|NCT01923051|national database|national database
388242|NCT01923051|observational|observational
388243|NCT01923038|atelectasis|atelectasis
388244|NCT01923038|laparoscopic surgery|laparoscopic surgery
388245|NCT01923038|anesthesia|anesthesia
388246|NCT01923038|mechanical ventilation|mechanical ventilation
388247|NCT01923038|Prevent|prevent
388248|NCT01923038|shape of the airway|shape of the airway
388249|NCT01923038|pressure-time curve|pressure-time curve
388250|NCT01922986|stroke|stroke
388251|NCT01922986|rehabilitation|rehabilitation
388252|NCT01922986|hemiplegia|hemiplegia
388253|NCT01922986|repetitive transcranial magnetic stimulation|repetitive transcranial magnetic stimulation
388254|NCT01922973|ghrelin|ghrelin
388255|NCT01922973|growth hormone|growth hormone
388256|NCT01922973|aging|aging
388257|NCT01922973|normal volunteers|normal volunteers
388258|NCT01922960|trauma|trauma
388259|NCT01922960|multiple organ dysfunction syndrome|multiple organ dysfunction syndrome
388260|NCT01922908|Ischemic|ischemic
388261|NCT01922908|Stroke|stroke
388262|NCT01922908|Stem Cells|stem cells
388263|NCT01922908|MSC|msc
388264|NCT01922908|Allogeneic|allogeneic
388265|NCT01922908|Bone Marrow|bone marrow
388266|NCT01922895|Alcoholic Hepatitis|alcoholic hepatitis
388267|NCT01922895|MELD < 20|meld < 20
388268|NCT01922895|Probiotic|probiotic
388269|NCT01922895|Nutritional Supplement|nutritional supplement
388270|NCT01922895|Lactobacillus Rhamnosus GG|lactobacillus rhamnosus gg
388271|NCT01922882|HIV|hiv
388272|NCT01922882|Maternal disclosure|maternal disclosure
388273|NCT01922882|Health promotion|health promotion
388274|NCT01922882|Maternal mental health|maternal mental health
388275|NCT01922882|Child behavior|child behavior
388276|NCT01922869|Absorption|absorption
388277|NCT01922869|Metabolism|metabolism
388278|NCT01922869|Excretion|excretion
388279|NCT01922869|Flavonoids|flavonoids
388280|NCT01922869|Polyphenols|polyphenols
388281|NCT01922869|Genes|genes
388282|NCT01922869|Gut-microflora|gut-microflora
388283|NCT01922843|Hemodialysis|hemodialysis
388284|NCT01922830|Sleeve Gastrectomy|sleeve gastrectomy
388285|NCT01922830|NAFLD|nafld
388286|NCT01922830|gut microbiot|gut microbiot
388287|NCT01922830|Bariatric surgery|bariatric surgery
388288|NCT01922791|Nutrition|nutrition
388289|NCT01922791|Probiotics|probiotics
388290|NCT01922791|Fish oil|fish oil
388291|NCT01922765|Helicobacter|helicobacter
388292|NCT01922765|Eradication|eradication
388293|NCT01922752|CEP-37440|cep-37440
388294|NCT01922752|Advanced solid tumors|advanced solid tumors
388295|NCT01922752|Metastatic solid tumors|metastatic solid tumors
388296|NCT01922739|low back pain|low back pain
388297|NCT01922739|hydrocodone bitartrate|hydrocodone bitartrate
388298|NCT01922739|opioids|opioids
388299|NCT01922713|biofortification|biofortification
388300|NCT01922713|vitamin A|vitamin a
388301|NCT01922713|maize|maize
388302|NCT01922713|beta-carotene|beta-carotene
388303|NCT01922713|breastmilk|breastmilk
388304|NCT01922713|Zambia|zambia
388305|NCT01922700|Pepper spray|pepper spray
388306|NCT01922700|bronchospasm|bronchospasm
388307|NCT01922700|lacrimation|lacrimation
388309|NCT01922648|Immune response|immune response
388310|NCT01922648|Paediatric|paediatric
388311|NCT01922635|Primary lymphedema quality of life, genetic research|primary lymphedema quality of life, genetic research
388312|NCT01922622|minimum effective dose of local anaesthetic|minimum effective dose of local anaesthetic
388313|NCT01922622|spinal catheter|spinal catheter
388314|NCT01922622|fractured neck of femur|fractured neck of femur
388315|NCT01922622|a step up, step down methodology|a step up, step down methodology
388316|NCT01922609|Carotid stenting|carotid stenting
388317|NCT01922609|Proximal protection system|proximal protection system
388318|NCT01922609|Transcranial Doppler ultrasound|transcranial doppler ultrasound
388319|NCT01922609|Cerebrovascular reserve|cerebrovascular reserve
388320|NCT01922596|Total Knee Arthroplasty|total knee arthroplasty
388321|NCT01922596|Adductor Canal Blockade|adductor canal blockade
388322|NCT01922596|Us-guided nerve blockade|us-guided nerve blockade
388323|NCT01922583|NSCLC, EGFR mutation|nsclc, egfr mutation
388324|NCT01922570|Enteral nutrition|enteral nutrition
388325|NCT01922570|Supplemental parenteral nutrition|supplemental parenteral nutrition
388326|NCT01922570|Critical illness|critical illness
388327|NCT01922570|ICU patients|icu patients
388328|NCT01922570|diarrhea|diarrhea
388329|NCT01922544|heart failure|heart failure
388330|NCT01922544|cardiac resynchronization therapy|cardiac resynchronization therapy
388331|NCT01922544|coronary sinus lead|coronary sinus lead
388332|NCT01922531|mTBI|mtbi
388333|NCT01922531|Mild Traumatic Brain Injury|mild traumatic brain injury
388334|NCT01922531|Axonal Injury|axonal injury
388335|NCT01922518|atrioventricular block, cardiomyopathy|atrioventricular block, cardiomyopathy
388336|NCT01922492|autologous islet transplantation|autologous islet transplantation
388337|NCT01922492|partial pancreatectomy|partial pancreatectomy
388338|NCT01922492|pancreatogenic diabetes|pancreatogenic diabetes
388339|NCT01922479|Heart Failure|heart failure
388340|NCT01922479|Anemia|anemia
388341|NCT01922479|Iron Deficiency|iron deficiency
388342|NCT01922479|Ferric Carboxymaltose|ferric carboxymaltose
388343|NCT01922479|Asian|asian
388344|NCT01922466|chronic neck pain|chronic neck pain
388345|NCT01922466|combined treatment between conventional and complementary alternative medical treatment|combined treatment between conventional and complementary alternative medical treatment
388346|NCT01922466|bee venom acupuncture|bee venom acupuncture
388347|NCT01922466|NSAIDs|nsaids
388348|NCT01922453|breech presentation|breech presentation
388349|NCT01922453|vertex presentation|vertex presentation
388350|NCT01922440|Chronic Hypoparathyroidism|chronic hypoparathyroidism
388351|NCT01922440|rhPTH(1-84)|rhpth(1-84)
388352|NCT01922440|Observational study|observational study
388353|NCT01922440|parathyroid hormone (PTH)|parathyroid hormone (pth)
388354|NCT01922440|Drug registry|drug registry
388355|NCT01922414|Staghorn stones|staghorn stones
388356|NCT01922414|Percutaneous nephrolithotomy|percutaneous nephrolithotomy
388357|NCT01922414|Laser|laser
388358|NCT01922414|Randomized trial|randomized trial
388359|NCT01922414|Lithotripsy|lithotripsy
388360|NCT01922388|Parkinson disease|parkinson disease
388361|NCT01922388|deep brain stimulation|deep brain stimulation
388362|NCT01922388|subthalamic nucleus|subthalamic nucleus
388363|NCT01922388|motor complication|motor complication
388364|NCT01922388|quality of life|quality of life
388365|NCT01922362|STSG|stsg
388366|NCT01922362|wound healing|wound healing
388367|NCT01922336|Pharmacokinetics|pharmacokinetics
388368|NCT01922323|Living liver donor|living liver donor
388369|NCT01922297|Delinquency|delinquency
388370|NCT01922297|HIV Associated Risk Behavior|hiv associated risk behavior
388371|NCT01922297|Juveniles|juveniles
388372|NCT01922297|Family based treatment|family based treatment
388373|NCT01922297|Multidimensional Family Therapy|multidimensional family therapy
388374|NCT01922284|HIV|hiv
388375|NCT01922284|Vaccine|vaccine
388376|NCT01922284|Immunisation|immunisation
388377|NCT01922284|DNA|dna
388378|NCT01922284|Adverse events|adverse events
388379|NCT01922284|MVA-C|mva-c
388380|NCT01922284|GLA-AF|gla-af
388381|NCT01922284|Antibody|antibody
388382|NCT01922271|COPD|copd
388383|NCT01922258|OPC-34712|opc-34712
388384|NCT01922258|brexpiprazole|brexpiprazole
388385|NCT01922258|Dementia|dementia
388386|NCT01922258|Alzheimer's Disease|alzheimer's disease
388387|NCT01922258|Cognitive Disorders|cognitive disorders
388388|NCT01922258|Memory|memory
388389|NCT01922258|Agitation|agitation
388390|NCT01922245|aphasia|aphasia
388391|NCT01922245|therapy|therapy
388392|NCT01922245|stroke|stroke
388393|NCT01922245|language|language
388394|NCT01922245|naming|naming
388395|NCT01922245|quality of life|quality of life
388396|NCT01922245|tDCS|tdcs
388397|NCT01922245|treatment|treatment
388398|NCT01922219|depression|depression
388399|NCT01922219|cognitive therapy|cognitive therapy
388400|NCT01922219|cognitive behavioral therapy|cognitive behavioral therapy
388401|NCT01922219|CBT|cbt
388402|NCT01922219|psychotherapy|psychotherapy
388403|NCT01922219|MDD|mdd
388404|NCT01922219|major depressive disorder|major depressive disorder
388405|NCT01922219|MRI|mri
388406|NCT01922219|fMRI|fmri
388407|NCT01922206|HIV|hiv
388408|NCT01922206|Maternal Disclosure|maternal disclosure
388409|NCT01922180|Chest Computed Tomography|chest computed tomography
388410|NCT01922167|Aging|aging
388411|NCT01922167|Frailty|frailty
388412|NCT01922167|Leucine|leucine
388413|NCT01922167|Resistance Exercise|resistance exercise
388414|NCT01922154|Angiogenesis inhibitors|angiogenesis inhibitors
388415|NCT01922154|Neovascular|neovascular
388416|NCT01922154|Intraocular pressure|intraocular pressure
388417|NCT01922154|Retinal Vein Occlusion|retinal vein occlusion
388418|NCT01922154|Vascular Endothelial Growth Factor|vascular endothelial growth factor
388419|NCT01922141|High blood pressure, stage 1 and 2 hypertension|high blood pressure, stage 1 and 2 hypertension
388420|NCT01922128|Non-exudative, dry AMD|non-exudative, dry amd
388421|NCT01922115|COGNITIVE FUNCTION|cognitive function
388422|NCT01922115|OVERACTIVE BLADDER|overactive bladder
388423|NCT01922115|[C23.888.942.343.780]|[c23.888.942.343.780]
388424|NCT01922102|vision loss,PM,CNV,ranibizumab,verteporfinPDT,Brilliance|vision loss,pm,cnv,ranibizumab,verteporfinpdt,brilliance
388425|NCT01922089|Heart failure, reduced ejection fraction, LCZ696, titration, safety, tolerability|heart failure, reduced ejection fraction, lcz696, titration, safety, tolerability
388426|NCT01922063|disc herniation surgery|disc herniation surgery
388427|NCT01922063|physiotherapy, exercise therapy|physiotherapy, exercise therapy
388428|NCT01922063|randomized|randomized
388429|NCT01922063|long term|long term
388430|NCT01922063|follow up|follow up
388431|NCT01921972|AD, Dementia|ad, dementia
388432|NCT01921946|Fimasartan|fimasartan
388433|NCT01921933|End-stage renal disease|end-stage renal disease
388434|NCT01921933|ESRD|esrd
388435|NCT01921933|AVF|avf
388436|NCT01921933|Fistulas|fistulas
388437|NCT01921920|Omeprazole, Prilosec, Phase I, Healthy Subjects, Pharmacokinetics, Bioequivalence|omeprazole, prilosec, phase i, healthy subjects, pharmacokinetics, bioequivalence
388438|NCT01921907|Actinic keratosis|actinic keratosis
388439|NCT01921907|topical|topical
388440|NCT01921907|dermatology|dermatology
388441|NCT01921907|treatment|treatment
388442|NCT01921907|clinical study|clinical study
388443|NCT01921907|double blinded|double blinded
388444|NCT01921894|asthma|asthma
388445|NCT01921894|vitamin D|vitamin d
388446|NCT01921881|Glucose tolerance|glucose tolerance
388447|NCT01921829|Cardiorenal failure|cardiorenal failure
388448|NCT01921829|Cardiorenal syndrome|cardiorenal syndrome
388449|NCT01921829|Diuretic resistance|diuretic resistance
388450|NCT01921829|Volume overload|volume overload
388451|NCT01921829|Edema|edema
388452|NCT01921829|Health-related quality of life|health-related quality of life
388453|NCT01921829|Outcomes|outcomes
388454|NCT01921829|Treatment protocol|treatment protocol
388455|NCT01921790|Avastin+ GemAOD|avastin+ gemaod
388456|NCT01921790|first line chemotherapy|first line chemotherapy
388457|NCT01921790|NK/T-cell Lymphoma|nk/t-cell lymphoma
388458|NCT01921777|Muscle|muscle
388459|NCT01921777|exercise|exercise
388460|NCT01921777|soreness|soreness
388461|NCT01921777|Damage|damage
388462|NCT01921777|Traumeel|traumeel
388463|NCT01921777|homeopathy|homeopathy
388464|NCT01921751|SMAD4|smad4
388465|NCT01921751|IMRT|imrt
388466|NCT01921751|gemcitabine|gemcitabine
388467|NCT01921751|high-dose radiotherapy|high-dose radiotherapy
388468|NCT01921738|Chronic Periodontitis, Azithromycin, SRP|chronic periodontitis, azithromycin, srp
388469|NCT01921725|wound healing|wound healing
388470|NCT01921725|carbon|carbon
388471|NCT01921712|COPD|copd
388472|NCT01921712|Chronic Obstructive Pulmonary Disease|chronic obstructive pulmonary disease
388473|NCT01921699|macrophages|macrophages
388474|NCT01921699|adenocarcinoma|adenocarcinoma
388475|NCT01921699|chemoresistance|chemoresistance
388476|NCT01921686|Eosinophil|eosinophil
388477|NCT01921686|Reflux|reflux
388478|NCT01921686|Esophagus|esophagus
388479|NCT01921686|Food allergy|food allergy
388480|NCT01921686|Trouble Swallowing|trouble swallowing
388481|NCT01921686|Pediatrics|pediatrics
388482|NCT01921686|Healthy Volunteers|healthy volunteers
388483|NCT01921673|Gastric cancer|gastric cancer
388484|NCT01921673|Phase I/II|phase i/ii
388485|NCT01921673|Second-line chemotherapy|second-line chemotherapy
388486|NCT01921673|Dovitinib|dovitinib
388487|NCT01921673|Docetaxel|docetaxel
388488|NCT01921673|Refractory to first-line chemotherapy|refractory to first-line chemotherapy
388489|NCT01921647|safety/tolerability and pharmacokinetics/pharmacodynamics|safety/tolerability and pharmacokinetics/pharmacodynamics
388490|NCT01921621|proficiency based progression|proficiency based progression
388491|NCT01921621|surgical skill|surgical skill
388492|NCT01921621|metric validation|metric validation
388493|NCT01921621|formative feedback|formative feedback
388494|NCT01921621|simulator model|simulator model
388495|NCT01921608|Male Circumcision|male circumcision
388496|NCT01921608|HIV Prevention|hiv prevention
388497|NCT01921608|HIV Infections|hiv infections
388498|NCT01921595|balanced salt colloid, coagulation profiles, spinal cord tumor|balanced salt colloid, coagulation profiles, spinal cord tumor
388499|NCT01921543|Deep Brain Stimulation|deep brain stimulation
388500|NCT01921543|Major Depressive Disorder|major depressive disorder
388501|NCT01921543|Psychosurgery|psychosurgery
388502|NCT01921543|Electrical stimulation|electrical stimulation
388503|NCT01921530|Posterolateral Fusion|posterolateral fusion
388504|NCT01921530|Interbody Fusion|interbody fusion
388505|NCT01921530|Lumbar|lumbar
388506|NCT01921530|Spinal Stenosis|spinal stenosis
388507|NCT01921530|Degenerative Spondylolisthesis|degenerative spondylolisthesis
388508|NCT01921517|Biomechanics|biomechanics
388509|NCT01921517|Osteogenesis|osteogenesis
388510|NCT01921504|Functional Dyspepsia|functional dyspepsia
388511|NCT01921504|Acupuncture|acupuncture
388512|NCT01921504|Genotype|genotype
388513|NCT01921504|Ghrelin|ghrelin
388514|NCT01921465|outpatient care|outpatient care
388515|NCT01921465|videoconferencing|videoconferencing
388516|NCT01921465|elective cesarean section|elective cesarean section
790193|NCT00292994|Exercise|exercise
388517|NCT01921452|Hypothyroidism|hypothyroidism
388518|NCT01921452|Third generation TSH kit|third generation tsh kit
388519|NCT01921452|Quantitative POC TSH kit|quantitative poc tsh kit
388520|NCT01921452|Qualitative POC TSH kit|qualitative poc tsh kit
388521|NCT01921439|smoking|smoking
388522|NCT01921439|quit smoking|quit smoking
388523|NCT01921439|smoking cessation|smoking cessation
388524|NCT01921439|smoking study|smoking study
388525|NCT01921439|secondhand smoke|secondhand smoke
388526|NCT01921439|smokers|smokers
388527|NCT01921426|Squamous Cell Carcinoma of the Head and Neck|squamous cell carcinoma of the head and neck
388528|NCT01921426|Oral Cavity|oral cavity
388529|NCT01921426|Oropharynx|oropharynx
388530|NCT01921426|Radiation|radiation
388531|NCT01921426|Chemotherapy|chemotherapy
388532|NCT01921426|Cisplatin|cisplatin
388533|NCT01921426|Oral Mucositis|oral mucositis
388534|NCT01921426|Superoxide Dismutase|superoxide dismutase
388535|NCT01921413|Plasmodium falciparum|plasmodium falciparum
388536|NCT01921413|Clinical Malaria|clinical malaria
388537|NCT01921413|Fever|fever
388538|NCT01921413|Schistosoma hematobium|schistosoma hematobium
388539|NCT01921413|Rheumatoid arthritis|rheumatoid arthritis
388540|NCT01921400|Hepatitis C (HCV)|hepatitis c (hcv)
388541|NCT01921400|Infection Transmission, Maternal-Fetal|infection transmission, maternal-fetal
388542|NCT01921400|Placenta|placenta
388543|NCT01921400|Trophoblast|trophoblast
388544|NCT01921374|Duchenne;|duchenne;
388545|NCT01921374|mothers caregivers;|mothers caregivers;
388546|NCT01921374|sleep;|sleep;
388547|NCT01921374|hormonal profile;|hormonal profile;
388548|NCT01921374|cardiac profile;|cardiac profile;
388549|NCT01921374|biochemical profile;|biochemical profile;
388550|NCT01921374|inflammatory profile.|inflammatory profile.
388551|NCT01921361|Shivering|shivering
388552|NCT01921361|Dexmedetomidine|dexmedetomidine
388553|NCT01921361|Spinal anesthesia|spinal anesthesia
388554|NCT01921348|Hay Fever|hay fever
388555|NCT01921348|Hayfever|hayfever
388556|NCT01921348|Pollen Allergy|pollen allergy
388557|NCT01921348|Pollinosis|pollinosis
388558|NCT01921348|Seasonal Allergic Rhinitis|seasonal allergic rhinitis
388559|NCT01921335|ARRY-380|arry-380
388560|NCT01921335|Trastuzumab|trastuzumab
388561|NCT01921335|Advanced HER2-positive breast cancer|advanced her2-positive breast cancer
388562|NCT01921309|osteoarthritis|osteoarthritis
388563|NCT01921309|avascular necrosis|avascular necrosis
388564|NCT01921309|rheumatoid arthritis|rheumatoid arthritis
388565|NCT01921309|correction of functional deformity|correction of functional deformity
388566|NCT01921309|dysplasia of the hip|dysplasia of the hip
388567|NCT01921296|Breast cancer|breast cancer
388568|NCT01921296|Aromatase inhibitor|aromatase inhibitor
388569|NCT01921283|propofol, endoscopy, bispectral index|propofol, endoscopy, bispectral index
388570|NCT01921270|Oromandibular Dystonia|oromandibular dystonia
388571|NCT01921270|Oral Dystonia|oral dystonia
388572|NCT01921270|Tardive Dystonia|tardive dystonia
388573|NCT01921270|botulinum toxin|botulinum toxin
388574|NCT01921270|abobotulinumtoxinA|abobotulinumtoxina
388575|NCT01921257|Cat Allergy|cat allergy
388576|NCT01921257|Rhinoconjunctivitis|rhinoconjunctivitis
388577|NCT01921244|Autistic Disorder|autistic disorder
388578|NCT01921244|Decision Making|decision making
388579|NCT01921244|Medication Therapy Management|medication therapy management
388580|NCT01921218|Kidney transplant|kidney transplant
388581|NCT01921205|Lacosamide|lacosamide
388583|NCT01921205|UCB|ucb
388584|NCT01921205|Epilepsy|epilepsy
388585|NCT01921205|Partial Onset Seizures|partial onset seizures
388586|NCT01921205|Pediatric|pediatric
388587|NCT01921179|Post Traumatic Stress Disorder,|post traumatic stress disorder,
388588|NCT01921179|Mild Traumatic Brain Injury|mild traumatic brain injury
388589|NCT01921179|Concussion|concussion
388590|NCT01921179|Cognitive Rehabilitation|cognitive rehabilitation
388591|NCT01921166|infertility|infertility
388592|NCT01921166|diminished ovarian reserve|diminished ovarian reserve
388593|NCT01921166|fertilization in vitro|fertilization in vitro
388594|NCT01921166|ovulation inducion|ovulation inducion
388595|NCT01921166|vitrification|vitrification
388596|NCT01921140|Oncology, cancer, tumour, neoplasm, anticancer drug, food, area under the curve, pharmacokinetics, olaparib, neoplasm, metabolites, QT interval effects|oncology, cancer, tumour, neoplasm, anticancer drug, food, area under the curve, pharmacokinetics, olaparib, neoplasm, metabolites, qt interval effects
388597|NCT01921127|COPD, Comparative effectiveness, Symbicort|copd, comparative effectiveness, symbicort
388598|NCT01921101|nutrition|nutrition
388599|NCT01921101|enteral feeding|enteral feeding
388600|NCT01921101|parenteral feeding|parenteral feeding
388601|NCT01921101|hospital malnutrition|hospital malnutrition
388602|NCT01921088|fMRI|fmri
388603|NCT01921088|Neurofeedback|neurofeedback
388604|NCT01921088|Blood pressure|blood pressure
388605|NCT01921088|Psychophysiology|psychophysiology
388606|NCT01921075|physiology, normal function|physiology, normal function
388607|NCT01921062|Distal radius fracture|distal radius fracture
388608|NCT01921062|Motor imagery|motor imagery
388609|NCT01921062|Immobilisation|immobilisation
388610|NCT01921062|Effectivity|effectivity
388611|NCT01921023|Blood Gas analysis|blood gas analysis
388612|NCT01920997|Healthy|healthy
388613|NCT01920997|normal menstrual cycles|normal menstrual cycles
388614|NCT01920971|chronic low back pain|chronic low back pain
388615|NCT01920971|infrared energy|infrared energy
388616|NCT01920971|effects|effects
388617|NCT01920932|Pediatric cancer|pediatric cancer
388618|NCT01920932|Hodgkin lymphoma|hodgkin lymphoma
388619|NCT01920932|Targeted therapy|targeted therapy
388620|NCT01920932|Frontline therapy|frontline therapy
388621|NCT01920932|Brentuximab vedotin|brentuximab vedotin
388622|NCT01920932|Quality of Life|quality of life
388623|NCT01920932|OEPA/COPDac|oepa/copdac
388624|NCT01920906|Psoriasis|psoriasis
388625|NCT01920906|Korean|korean
388626|NCT01920906|Healthy Volunteers|healthy volunteers
388627|NCT01920880|Anterior cutaneous nerve entrapment syndrome|anterior cutaneous nerve entrapment syndrome
388628|NCT01920880|ACNES|acnes
388629|NCT01920880|chronic abdominal wall pain|chronic abdominal wall pain
388630|NCT01920880|CAWP|cawp
388631|NCT01920867|Stem Cells|stem cells
388632|NCT01920867|Bone Marrow Derived Stem Cells|bone marrow derived stem cells
388633|NCT01920867|BMSC|bmsc
388634|NCT01920867|BMC (Bone Marrow Cell)|bmc (bone marrow cell)
388635|NCT01920867|Mesenchymal Stem Cells|mesenchymal stem cells
388636|NCT01920867|MSC|msc
388637|NCT01920867|Eye Disease|eye disease
388638|NCT01920867|Eye Stem Cells|eye stem cells
388639|NCT01920867|Ophthalmology|ophthalmology
388640|NCT01920867|Ophthalmic Disease|ophthalmic disease
388641|NCT01920867|Retina|retina
388642|NCT01920867|Retinal Disease|retinal disease
388643|NCT01920867|Macular Degeneration|macular degeneration
388644|NCT01920867|Age Related Macular Degeneration|age related macular degeneration
388645|NCT01920867|Myopic Macular Degeneration|myopic macular degeneration
388646|NCT01920867|Geographic Atrophy|geographic atrophy
388647|NCT01920867|Dry Macular Degeneration|dry macular degeneration
388648|NCT01920867|Wet Macular Degeneration|wet macular degeneration
388649|NCT01920867|Retinal Atrophy|retinal atrophy
388650|NCT01920867|Retinal Dystrophy|retinal dystrophy
388651|NCT01920867|Hereditary Retinal Dystrophy|hereditary retinal dystrophy
388652|NCT01920867|Retinitis Pigmentosa|retinitis pigmentosa
388653|NCT01920867|Stargardt Disease|stargardt disease
388654|NCT01920867|Cone Dystrophy|cone dystrophy
388655|NCT01920867|Cone Rod Dystrophy|cone rod dystrophy
388656|NCT01920867|Maculopathy|maculopathy
388657|NCT01920867|Optic Nerve Disease|optic nerve disease
388658|NCT01920867|Optic Nerve Atrophy|optic nerve atrophy
388659|NCT01920867|Optic Atrophy|optic atrophy
388660|NCT01920867|Ischemic Optic Neuropathy|ischemic optic neuropathy
388661|NCT01920867|Optic Nerve Damage|optic nerve damage
388662|NCT01920867|Optic Nerve Compression|optic nerve compression
388663|NCT01920867|Compressive Optic Neuropathy|compressive optic neuropathy
388664|NCT01920867|Devics Syndrome|devics syndrome
388665|NCT01920854|Soluble Ferric Pyrophosphate, Pharmacokinetics, Iron, Hemodialysis|soluble ferric pyrophosphate, pharmacokinetics, iron, hemodialysis
388666|NCT01920841|lipolytic|lipolytic
388667|NCT01920841|herbal extracts|herbal extracts
388668|NCT01920841|thigh girth|thigh girth
388669|NCT01920841|thigh smoothness|thigh smoothness
388670|NCT01920789|Non-small call lung cancer|non-small call lung cancer
388671|NCT01920789|Medically inoperable|medically inoperable
388672|NCT01920789|Stage one|stage one
388673|NCT01920789|Radiotherapy|radiotherapy
388674|NCT01920789|SBRT|sbrt
388675|NCT01920789|Hypofractionation|hypofractionation
388676|NCT01920789|Conventional fractionation|conventional fractionation
388677|NCT01920776|critical ultrasound|critical ultrasound
388678|NCT01920763|Intracerebral hemorrhage|intracerebral hemorrhage
388679|NCT01920763|Surgical evacuation|surgical evacuation
388680|NCT01920763|Minimally-invasive surgery|minimally-invasive surgery
388681|NCT01920750|Leprosy, skin test, MLSA-LAM, MLCwA, diagnosis, Protocol 98-202|leprosy, skin test, mlsa-lam, mlcwa, diagnosis, protocol 98-202
388682|NCT01920737|ALL|all
388683|NCT01920737|Bone Marrow|bone marrow
388684|NCT01920737|Ph Negative|ph negative
388685|NCT01920737|Daunorubicin|daunorubicin
388686|NCT01920737|Vincristine|vincristine
388687|NCT01920737|Prednisone|prednisone
388688|NCT01920737|PEG-Asparaginase|peg-asparaginase
388689|NCT01920737|Methotrexate|methotrexate
388690|NCT01920737|16-MP (6-Mercaptopurine)|16-mp (6-mercaptopurine)
388691|NCT01920737|Cyclophosphamide|cyclophosphamide
388692|NCT01920737|Cytarabine|cytarabine
388693|NCT01920737|Leucovorin|leucovorin
388694|NCT01920737|Dexamethasone|dexamethasone
388695|NCT01920737|12-266|12-266
388696|NCT01920724|Preschool children|preschool children
388697|NCT01920724|Body composition|body composition
388698|NCT01920711|Heart failure|heart failure
388699|NCT01920711|preserved ejection fraction|preserved ejection fraction
388700|NCT01920711|diastolic heart failure|diastolic heart failure
388701|NCT01920698|Heart Valve Diseases|heart valve diseases
388702|NCT01920698|Heart failure|heart failure
388703|NCT01920698|Heart diseases|heart diseases
388704|NCT01920698|Mitral valve insufficiency|mitral valve insufficiency
388705|NCT01920685|Paranoia|paranoia
388706|NCT01920685|CBT|cbt
388707|NCT01920685|Reasoning|reasoning
388708|NCT01920685|Anxiety|anxiety
388709|NCT01920659|High Intensity Training|high intensity training
388710|NCT01920659|Insulin sensitivity|insulin sensitivity
388711|NCT01920659|Fitness|fitness
388712|NCT01920620|obesity, inpatient, intervention, weight loss|obesity, inpatient, intervention, weight loss
388713|NCT01920607|Fecal Incontinence.|fecal incontinence.
388714|NCT01920607|Anal Incontinence.|anal incontinence.
388715|NCT01920607|Functional Bowel Disorders.|functional bowel disorders.
388716|NCT01920607|SNS.|sns.
388717|NCT01920607|Artificial Sphincters.|artificial sphincters.
388718|NCT01920607|Magnetic Anal Sphincter.|magnetic anal sphincter.
388719|NCT01920594|GSK1278863|gsk1278863
388720|NCT01920594|Thoracic Aortic Aneurysm Repair|thoracic aortic aneurysm repair
388721|NCT01920581|CEIP|ceip
388722|NCT01920581|pharmacodependance|pharmacodependance
388723|NCT01920581|addictovigilance|addictovigilance
388724|NCT01920581|benzodiazepines and benzodiazepines related drugs|benzodiazepines and benzodiazepines related drugs
388725|NCT01920581|elderly|elderly
388726|NCT01920568|GSK2371746|gsk2371746
388727|NCT01920568|Denosumab|denosumab
388728|NCT01920568|China|china
388729|NCT01920568|skeletal-related events|skeletal-related events
388730|NCT01920568|bone metastases|bone metastases
388731|NCT01920568|bridging study|bridging study
388732|NCT01920568|solid tumors|solid tumors
388733|NCT01920555|Depression|depression
388734|NCT01920555|Treatment Resistant Depression|treatment resistant depression
388735|NCT01920555|Ketamine|ketamine
388736|NCT01920555|Antidepressant|antidepressant
388737|NCT01920555|MDD|mdd
388738|NCT01920555|Major Depression|major depression
388739|NCT01920529|asthma, aerobic exercise, child, cytokines|asthma, aerobic exercise, child, cytokines
388740|NCT01920516|Isolated limb infusion|isolated limb infusion
388741|NCT01920516|Melphalan|melphalan
388742|NCT01920516|Limb Melanoma|limb melanoma
388743|NCT01920516|Tumor response|tumor response
388744|NCT01920503|cholangiocarcinoma|cholangiocarcinoma
388745|NCT01920503|transarterial chemoembolization|transarterial chemoembolization
388746|NCT01920503|doxorubicin|doxorubicin
388747|NCT01920503|tumor response|tumor response
388748|NCT01920477|Pemphigus|pemphigus
388749|NCT01920477|MAB|mab
388750|NCT01920477|autoimmune disorder|autoimmune disorder
388751|NCT01920477|human CD20 antigen|human cd20 antigen
388752|NCT01920477|subcutaneous|subcutaneous
388753|NCT01920477|vulgaris|vulgaris
388754|NCT01920477|Phase 3|phase 3
388755|NCT01920477|monoclonal antibody|monoclonal antibody
388756|NCT01920477|ofatumumab|ofatumumab
388757|NCT01920477|PV|pv
388758|NCT01920477|rare disease|rare disease
388759|NCT01920477|OMB157|omb157
388760|NCT01920477|adult|adult
388761|NCT01920451|sleep|sleep
388762|NCT01920451|insomnia|insomnia
388763|NCT01920451|posttraumatic stress disorder|posttraumatic stress disorder
388764|NCT01920451|hypertension|hypertension
388765|NCT01920451|cardiovascular disease|cardiovascular disease
388766|NCT01920438|Percutaneous endoscopic gastrostomy,|percutaneous endoscopic gastrostomy,
388767|NCT01920438|Radiologically inserted gastrostomy,|radiologically inserted gastrostomy,
388768|NCT01920438|Complications|complications
388769|NCT01920425|Parkinson's disease|parkinson's disease
388770|NCT01920425|dyskinesia|dyskinesia
388771|NCT01920425|fluctuations|fluctuations
388772|NCT01920425|tremor|tremor
388773|NCT01920425|bradykinesia|bradykinesia
388774|NCT01920425|levodopa|levodopa
388775|NCT01920412|Atrial fibrillation|atrial fibrillation
388776|NCT01920412|Thrombosis|thrombosis
388777|NCT01920412|Ischemic stroke|ischemic stroke
388778|NCT01920412|Left atrial appendage occluder|left atrial appendage occluder
388779|NCT01920412|Intervention method|intervention method
388780|NCT01920399|CAZ-AVI China phase I PK study|caz-avi china phase i pk study
388781|NCT01920386|Acute Toothache|acute toothache
388782|NCT01920386|Wontran|wontran
388783|NCT01920386|Wontran SR Tab.|wontran sr tab.
388784|NCT01920386|Tramadol Hydrochloride/Acetaminophen|tramadol hydrochloride/acetaminophen
388785|NCT01920373|degenerative joint disease|degenerative joint disease
388786|NCT01920373|temporomandibular joint|temporomandibular joint
388787|NCT01920360|KNEE OSTEOARTHRITIS|knee osteoarthritis
388788|NCT01920360|BALNEOTHERAPY|balneotherapy
388789|NCT01920360|SULPHUROUS WATERS|sulphurous waters
388790|NCT01920360|WOMAC|womac
388791|NCT01920360|LEQUESNE|lequesne
388792|NCT01920360|HEALTH ASSESSMENT QUESTIONNAIRE|health assessment questionnaire
388793|NCT01920360|SHORT FORM - 36|short form - 36
388794|NCT01920360|VAS|vas
388795|NCT01920347|hypoxic encephalopathy|hypoxic encephalopathy
388796|NCT01920347|cardiac arrest|cardiac arrest
388797|NCT01920347|outcome|outcome
388798|NCT01920347|pupillary reflex|pupillary reflex
388799|NCT01920334|coronary disease|coronary disease
388800|NCT01920334|heart diseases|heart diseases
388801|NCT01920334|enzymes|enzymes
388802|NCT01920334|sleep|sleep
388803|NCT01920334|troponin|troponin
388804|NCT01920334|zolpidem|zolpidem
388805|NCT01920321|COPD|copd
388806|NCT01920321|Bronchoscopic LVR|bronchoscopic lvr
388807|NCT01920321|Emphysema|emphysema
388808|NCT01920321|Hot injury|hot injury
388809|NCT01920269|non-muscle invasive bladder cancer|non-muscle invasive bladder cancer
388810|NCT01920269|intravesical chemotherapy|intravesical chemotherapy
388811|NCT01920269|mitomycin|mitomycin
388812|NCT01920269|passive diffusion|passive diffusion
388813|NCT01920269|electromotive drug administration|electromotive drug administration
388814|NCT01920256|Insulin therapy|insulin therapy
388815|NCT01920256|Type 2 diabetes|type 2 diabetes
388816|NCT01920243|Telemedicine|telemedicine
388817|NCT01920243|self-management|self-management
388818|NCT01920243|Medical psychology|medical psychology
388819|NCT01920243|Health psychology|health psychology
388820|NCT01920243|Rehabilitation|rehabilitation
388821|NCT01920243|Education, Health|education, health
388822|NCT01920230|Burnout|burnout
388823|NCT01920230|Stress|stress
388824|NCT01920230|Mindfulness|mindfulness
388825|NCT01920230|Acceptance-commitment therapy (ACT)|acceptance-commitment therapy (act)
388826|NCT01920230|Intervention|intervention
388827|NCT01920230|Effectiveness|effectiveness
388828|NCT01920230|Working conditions|working conditions
388829|NCT01920230|Work engagement|work engagement
388830|NCT01920230|Psychological well-being|psychological well-being
388831|NCT01920230|Life situation|life situation
388832|NCT01920217|sepsis|sepsis
388833|NCT01920217|SNP|snp
388834|NCT01920217|mortality|mortality
388835|NCT01920204|Mastocytosis|mastocytosis
388836|NCT01920204|ISM|ism
388837|NCT01920204|SSM|ssm
388838|NCT01920191|Glioblastoma|glioblastoma
388839|NCT01920165|respiratory tract infections|respiratory tract infections
388840|NCT01920165|upper respiratory tract infections|upper respiratory tract infections
388841|NCT01920165|lower respiratory tract infections|lower respiratory tract infections
388842|NCT01920165|hospitalisation|hospitalisation
388843|NCT01920165|child|child
388844|NCT01920165|children|children
388845|NCT01920165|minors|minors
388846|NCT01920165|infants|infants
388847|NCT01920165|second-hand smoke|second-hand smoke
388848|NCT01920165|tobacco smoke pollution|tobacco smoke pollution
388849|NCT01920165|smoke-free|smoke-free
388850|NCT01920165|smoke-free policy|smoke-free policy
388851|NCT01920165|smoke-free legislation|smoke-free legislation
388852|NCT01920165|public places|public places
388853|NCT01920152|Hip, Chondropenia, Osteoarthritis.|hip, chondropenia, osteoarthritis.
388854|NCT01920126|sodium bicarbonate, renal function, infective endocarditis, open heart surgery|sodium bicarbonate, renal function, infective endocarditis, open heart surgery
388855|NCT01920113|Endoscopic submucosal dissection|endoscopic submucosal dissection
388856|NCT01920113|propofol|propofol
388857|NCT01920113|remifentanil|remifentanil
388858|NCT01920113|dexmedetomidine|dexmedetomidine
388859|NCT01920113|efficacy|efficacy
388860|NCT01920113|safeness|safeness
388861|NCT01920100|Health Care Costs|health care costs
388862|NCT01920100|Genetic Polymorphism|genetic polymorphism
388863|NCT01920087|Atypical Facial Pain|atypical facial pain
388864|NCT01920087|Persistent Idiopathic Facial Pain|persistent idiopathic facial pain
388865|NCT01920087|Atypical Trigeminal Neuralgia|atypical trigeminal neuralgia
388866|NCT01920087|Orofacial Pain|orofacial pain
388867|NCT01920087|Orofacial neuropathic pain|orofacial neuropathic pain
388868|NCT01920087|Fothergill Disease|fothergill disease
388869|NCT01920087|Tic Douloureux|tic douloureux
388870|NCT01920087|Prosopalgia|prosopalgia
388871|NCT01920074|Anal Fissure|anal fissure
388872|NCT01920074|Nitroglycerin|nitroglycerin
388873|NCT01920074|Pediatrics|pediatrics
388874|NCT01920074|RECTIV®|rectiv®
388875|NCT01920074|Pediatric Research Equity Act|pediatric research equity act
388876|NCT01920061|Advanced cancer|advanced cancer
388877|NCT01920061|solid tumors|solid tumors
388878|NCT01920061|PI3K|pi3k
388879|NCT01920061|mTOR|mtor
388880|NCT01920061|PI3K/mTOR|pi3k/mtor
388881|NCT01920061|metastatic|metastatic
388882|NCT01920061|Triple Negative Breast Cancer (TNBC)|triple negative breast cancer (tnbc)
388883|NCT01920048|Heart Failure|heart failure
388884|NCT01920048|Ventricular Dysfunction|ventricular dysfunction
388885|NCT01920048|Ischemic Cardiomyopathy|ischemic cardiomyopathy
388886|NCT01920048|Ischemic Heart Disease|ischemic heart disease
388887|NCT01920048|Revascularization|revascularization
388888|NCT01920048|Percutaneous Coronary Intervention|percutaneous coronary intervention
388889|NCT01920048|Randomized Control Trial|randomized control trial
388890|NCT01920048|Implantable Cardioverter Defibrillator|implantable cardioverter defibrillator
388891|NCT01920035|Incontinence post RARP|incontinence post rarp
388892|NCT01920035|Surgery induced incontinence|surgery induced incontinence
388893|NCT01920035|Incontinence after prostatectomy|incontinence after prostatectomy
388894|NCT01920035|Neuropathy-induced incontinence|neuropathy-induced incontinence
388895|NCT01920022|medical abortion|medical abortion
388896|NCT01920022|postabortion contraception|postabortion contraception
388897|NCT01920022|LARC|larc
388898|NCT01920022|Nexplanon|nexplanon
388899|NCT01920022|subdermal contraceptive implant|subdermal contraceptive implant
388900|NCT01920009|pharmacy care|pharmacy care
388901|NCT01920009|adherence|adherence
388902|NCT01920009|coronary heart disease|coronary heart disease
497346|NCT01441622|AL539|al539
388903|NCT01919996|Ocular safety|ocular safety
388904|NCT01919996|azithromycin|azithromycin
388905|NCT01919996|pharyngitis|pharyngitis
388906|NCT01919996|tonsillitis|tonsillitis
388907|NCT01919983|cardiac|cardiac
388908|NCT01919983|innervation|innervation
388909|NCT01919983|inflammation|inflammation
388910|NCT01919983|sudden|sudden
388911|NCT01919983|death|death
388912|NCT01919970|Autism|autism
388913|NCT01919970|Asperger's Syndrome|asperger's syndrome
388914|NCT01919970|Pervasive Developmental Disorder Not Otherwise Specified|pervasive developmental disorder not otherwise specified
388915|NCT01919970|Treatment|treatment
388916|NCT01919970|Cognitive-behavioral therapy|cognitive-behavioral therapy
388917|NCT01919970|Anxiety|anxiety
388918|NCT01919970|Children|children
388919|NCT01919970|Therapy|therapy
388920|NCT01919970|Generalized Anxiety Disorder|generalized anxiety disorder
388921|NCT01919970|Social Phobia|social phobia
388922|NCT01919970|Separation Anxiety Disorder|separation anxiety disorder
388923|NCT01919970|Obsessive-compulsive Disorder|obsessive-compulsive disorder
388924|NCT01919970|Specific Phobia|specific phobia
388925|NCT01919957|epilepsy|epilepsy
388926|NCT01919957|surgery|surgery
388927|NCT01919957|functional MRI|functional mri
388928|NCT01919957|memory outcome|memory outcome
388929|NCT01919944|itch|itch
388930|NCT01919931|Candida albicans|candida albicans
388931|NCT01919931|Candidiasis|candidiasis
388932|NCT01919931|Biofilm|biofilm
388933|NCT01919931|Flow cytometry|flow cytometry
388934|NCT01919931|Mannose Binding Lectin|mannose binding lectin
388935|NCT01919905|Mozzarella cheese fortification|mozzarella cheese fortification
388936|NCT01919905|Bioavailability of Vitamin D|bioavailability of vitamin d
388937|NCT01919892|predictors of response|predictors of response
388938|NCT01919892|bipolar disorder|bipolar disorder
388939|NCT01919892|depression|depression
388940|NCT01919892|lithium treatment|lithium treatment
388941|NCT01919892|biomarkers|biomarkers
388942|NCT01919879|Chemotherapy refractory|chemotherapy refractory
388943|NCT01919879|wtKRAS metastatic colorectal cancer|wtkras metastatic colorectal cancer
388944|NCT01919879|cross over|cross over
388945|NCT01919853|Cancer|cancer
388946|NCT01919853|Fatigue|fatigue
388947|NCT01919853|Mindfulness|mindfulness
388948|NCT01919853|Meditation|meditation
388949|NCT01919853|Neoplasms|neoplasms
388950|NCT01919853|Signs and symptoms|signs and symptoms
388951|NCT01919840|hemostatic disorders|hemostatic disorders
388952|NCT01919840|ardiac surgery|ardiac surgery
388953|NCT01919840|cardiopulmonary bypass|cardiopulmonary bypass
388954|NCT01919827|Idiopathic pulmonary fibrosis|idiopathic pulmonary fibrosis
388955|NCT01919827|Stem cells|stem cells
388956|NCT01919827|Mesenchymal stem cells|mesenchymal stem cells
388957|NCT01919801|icatibant|icatibant
388958|NCT01919801|Firazyr|firazyr
388959|NCT01919801|ACE-I|ace-i
388960|NCT01919788|Diabetes Mellitus Type I|diabetes mellitus type i
388961|NCT01919788|Hypoglycemia|hypoglycemia
388962|NCT01919788|Counter-regulatory mechanisms|counter-regulatory mechanisms
388963|NCT01919762|Bacteremia|bacteremia
388964|NCT01919762|Sepsis|sepsis
388965|NCT01919762|Acinetobacter baumannii|acinetobacter baumannii
388966|NCT01919762|Staphylococcus aureus|staphylococcus aureus
388967|NCT01919762|Klebsiella pneumonia|klebsiella pneumonia
388968|NCT01919762|Pseudomonas aeruginosa|pseudomonas aeruginosa
388969|NCT01919762|Enterococcus faecalis|enterococcus faecalis
388970|NCT01919762|Magnetic Relaxation Detection|magnetic relaxation detection
388971|NCT01919762|Nuclear Magnetic Resonance Detection|nuclear magnetic resonance detection
388972|NCT01919762|Blood culture|blood culture
388973|NCT01919749|breast cancer metastatic|breast cancer metastatic
388974|NCT01919749|molecular profiling|molecular profiling
388975|NCT01919749|sequencing|sequencing
388976|NCT01919749|profiling|profiling
388977|NCT01919749|breast cancer|breast cancer
388978|NCT01919736|knee OA|knee oa
388979|NCT01919723|PCI|pci
388980|NCT01919723|Ticagrelor|ticagrelor
388981|NCT01919723|Eptifibatide|eptifibatide
388982|NCT01919710|Neutropenia|neutropenia
388983|NCT01919710|chemotherapy|chemotherapy
388984|NCT01919710|rHSA/GCSF|rhsa/gcsf
388985|NCT01919697|Plecantaide|plecantaide
388986|NCT01919697|Chronic Idiopathic Constipation|chronic idiopathic constipation
388987|NCT01919697|Chronic|chronic
388988|NCT01919697|Idiopathic|idiopathic
388989|NCT01919697|Constipation|constipation
388990|NCT01919697|Synergy|synergy
388991|NCT01919697|CIC|cic
388992|NCT01919697|CIC study|cic study
388993|NCT01919697|CIC OLE|cic ole
388994|NCT01919697|CIC OLE study|cic ole study
388995|NCT01919697|OLE|ole
388996|NCT01919697|OLE CIC|ole cic
388997|NCT01919697|OLE CIC3|ole cic3
388998|NCT01919697|Open label|open label
388999|NCT01919697|Open label study|open label study
389000|NCT01919697|Long term|long term
389001|NCT01919697|Long term study|long term study
389002|NCT01919697|Extension|extension
389003|NCT01919697|Extension study|extension study
712564|NCT00579696|Multiple Diseases|multiple diseases
389004|NCT01919684|Glucagon receptor antagonist|glucagon receptor antagonist
389005|NCT01919671|Ischemic Stroke|ischemic stroke
389006|NCT01919671|Tongxinluo capsule|tongxinluo capsule
389007|NCT01919658|nerve blocks in Anterior cruciate ligament surgery|nerve blocks in anterior cruciate ligament surgery
389008|NCT01919645|Rheumatoid Arthritis|rheumatoid arthritis
389009|NCT01919645|Sleep Disorders|sleep disorders
389010|NCT01919645|Polysomnography|polysomnography
389011|NCT01919645|Sleep Stages|sleep stages
389012|NCT01919645|Physical Exercise|physical exercise
389013|NCT01919632|lifestyle|lifestyle
389014|NCT01919632|physical activity|physical activity
389015|NCT01919632|endothelial function|endothelial function
389016|NCT01919632|cardiovascular|cardiovascular
389017|NCT01919632|occupational|occupational
389018|NCT01919632|prevention|prevention
389019|NCT01919606|hysterectomy|hysterectomy
389020|NCT01919606|analgesia|analgesia
389021|NCT01919593|Blood culture|blood culture
389022|NCT01919593|Contamination|contamination
389023|NCT01919593|Chlorhexidine gluconate|chlorhexidine gluconate
389024|NCT01919593|Povidone iodine|povidone iodine
389025|NCT01919580|Gα12|gα12
389026|NCT01919580|Oral cancer|oral cancer
389027|NCT01919567|SOX-9|sox-9
389028|NCT01919567|Oral cancer|oral cancer
389029|NCT01919567|arecoline|arecoline
389030|NCT01919554|House Dust Mite Allergic Rhinitis|house dust mite allergic rhinitis
389031|NCT01919554|Phase I|phase i
389032|NCT01919554|House Dust Mite Allergen Extract|house dust mite allergen extract
389033|NCT01919541|Colorectal Surgery|colorectal surgery
389034|NCT01919528|ultrasonography|ultrasonography
389035|NCT01919528|catheterization|catheterization
389036|NCT01919528|central line|central line
389037|NCT01919528|mechanical ventilation|mechanical ventilation
389038|NCT01919528|intensive care|intensive care
389039|NCT01919528|axillary vein|axillary vein
389040|NCT01919515|pediatric|pediatric
389041|NCT01919515|primary molars|primary molars
389042|NCT01919515|stainless steel crowns|stainless steel crowns
389043|NCT01919489|Incretins|incretins
389044|NCT01919489|Liraglutide|liraglutide
389045|NCT01919489|Glargine|glargine
389046|NCT01919489|Randomized controlled trial|randomized controlled trial
389047|NCT01919489|basal insulin|basal insulin
389048|NCT01919489|hospital discharge|hospital discharge
389049|NCT01919489|inpatient diabetes|inpatient diabetes
389050|NCT01919476|Postprandial|postprandial
389051|NCT01919476|Insulin resistance|insulin resistance
389052|NCT01919476|Lipids|lipids
389053|NCT01919476|Satiety|satiety
389054|NCT01919476|Almonds|almonds
389055|NCT01919463|Colonoscopy|colonoscopy
389056|NCT01919463|Lower Gastrointestinal Tract|lower gastrointestinal tract
389057|NCT01919463|Magnetic Endoscopic Imaging|magnetic endoscopic imaging
389058|NCT01919463|Abdominal Compression|abdominal compression
389059|NCT01919450|PET|pet
389060|NCT01919450|Lexiscan|lexiscan
389061|NCT01919450|Regadenoson|regadenoson
389062|NCT01919450|Rubidium|rubidium
389063|NCT01919450|Blood Flow Reserve|blood flow reserve
389064|NCT01919450|Myocardial Perfusion|myocardial perfusion
389065|NCT01919450|Quantitated Myocardial Perfusion|quantitated myocardial perfusion
389066|NCT01919411|Chronic rhinosinusitis|chronic rhinosinusitis
389067|NCT01919411|Sinus surgery|sinus surgery
389068|NCT01919411|Antibiotics|antibiotics
389069|NCT01919385|Type 1 diabetes|type 1 diabetes
389070|NCT01919385|Insulin Pump|insulin pump
389071|NCT01919359|ablative laser|ablative laser
389072|NCT01919359|soft tissue filler|soft tissue filler
389073|NCT01919346|Kidney Transplantation|kidney transplantation
389074|NCT01919346|Delayed Graft Function|delayed graft function
389075|NCT01919320|SynCardia|syncardia
389076|NCT01919320|Total Artificial Heart|total artificial heart
389077|NCT01919320|TAH-t|tah-t
389078|NCT01919307|Seizures|seizures
389079|NCT01919307|Convulsions|convulsions
389080|NCT01919307|Anticonvulsants|anticonvulsants
389081|NCT01919307|Epilepsy|epilepsy
389082|NCT01919307|Neurologic|neurologic
389083|NCT01919294|nonalcoholic fatty liver disease|nonalcoholic fatty liver disease
389084|NCT01919294|nonalcoholic steatohepatitis|nonalcoholic steatohepatitis
389085|NCT01919294|hypogonadism|hypogonadism
389086|NCT01919294|testosterone replacement therapy|testosterone replacement therapy
389087|NCT01919281|exercise|exercise
389088|NCT01919281|resistance training|resistance training
389089|NCT01919281|insulin resistance|insulin resistance
389090|NCT01919281|high intensity interval training|high intensity interval training
389091|NCT01919268|Pilates-based exercises|pilates-based exercises
389092|NCT01919268|Electrotherapy|electrotherapy
389093|NCT01919268|Interferencial current|interferencial current
389094|NCT01919255|Colonoscopy|colonoscopy
389095|NCT01919255|Bowel preparation|bowel preparation
389096|NCT01919255|Picolight|picolight
389097|NCT01919255|Clicolon|clicolon
389098|NCT01919255|Coolprep|coolprep
389099|NCT01919229|HR-positive|hr-positive
389100|NCT01919229|HER2-negative|her2-negative
389101|NCT01919229|Breast cancer|breast cancer
389102|NCT01919229|LEE011|lee011
389103|NCT01919229|Letrozole|letrozole
389104|NCT01919229|CDK|cdk
389105|NCT01919229|CDK4|cdk4
389106|NCT01919229|CDK6|cdk6
389107|NCT01919229|CDK4/6|cdk4/6
389108|NCT01919229|Pharmacodynamics|pharmacodynamics
389109|NCT01919229|Pre-surgical|pre-surgical
389110|NCT01919229|Postmenopausal|postmenopausal
389111|NCT01919177|Heart Failure|heart failure
389112|NCT01919177|Arterial hemodynamics|arterial hemodynamics
389113|NCT01919177|Exercise capacity|exercise capacity
389114|NCT01919177|Mitochondrial oxidative capacity|mitochondrial oxidative capacity
389115|NCT01919164|Osteoarthritis of knee|osteoarthritis of knee
389116|NCT01919164|Recombinant Human Fibroblast Growth Factor-18 (rhFGF-18)|recombinant human fibroblast growth factor-18 (rhfgf-18)
389117|NCT01919164|Sprifermin|sprifermin
389118|NCT01919164|Placebo|placebo
389119|NCT01919151|survival|survival
389120|NCT01919125|Chronic hepatitis C|chronic hepatitis c
389121|NCT01919125|Hepatitis C virus|hepatitis c virus
389122|NCT01919125|HCV|hcv
389123|NCT01919112|Brain stimulation|brain stimulation
389124|NCT01919099|Post-Transplant Infection|post-transplant infection
389125|NCT01919099|Post-Transplant Bacteremia|post-transplant bacteremia
389126|NCT01919099|Post-Transplant Virus|post-transplant virus
389127|NCT01919086|Bortezomib|bortezomib
389128|NCT01919086|Dexamethasone|dexamethasone
389129|NCT01919086|Lenalidomide|lenalidomide
389130|NCT01919086|13-064|13-064
389131|NCT01919073|Attention Deficit, ADD, ADHD, ODD, Oppositional Behavior, Disruptive Behavior, Behavior Modification, Parent Management Training, Pre-School|attention deficit, add, adhd, odd, oppositional behavior, disruptive behavior, behavior modification, parent management training, pre-school
389132|NCT01919047|overactive bladder|overactive bladder
389133|NCT01919047|mirabegron|mirabegron
389134|NCT01919047|occurrence of adverse events|occurrence of adverse events
389135|NCT01919047|Overactive Bladder Symptom Score|overactive bladder symptom score
389136|NCT01919034|Interleukin-20, Thrombomodulin, Huntington disease, patient control analgesic|interleukin-20, thrombomodulin, huntington disease, patient control analgesic
389137|NCT01919008|FK949E|fk949e
389138|NCT01919008|Pharmacokinetics|pharmacokinetics
389139|NCT01919008|Major Depressive Disorder|major depressive disorder
389140|NCT01918995|CVT3146|cvt3146
389141|NCT01918995|Regadenoson|regadenoson
389142|NCT01918982|Aortic aneurysm|aortic aneurysm
389143|NCT01918982|circulating endothelial progenitor cells|circulating endothelial progenitor cells
389144|NCT01918969|Endothelial progenitor cells|endothelial progenitor cells
389145|NCT01918969|Healthy blood donors|healthy blood donors
389146|NCT01918956|immunotherapy|immunotherapy
389147|NCT01918956|birch pollen|birch pollen
389148|NCT01918956|seasonal allergy|seasonal allergy
389149|NCT01918956|up-dosing|up-dosing
389150|NCT01918943|Spine|spine
389151|NCT01918943|Aspen device|aspen device
389152|NCT01918943|PLIF|plif
389153|NCT01918943|Low back pain|low back pain
389154|NCT01918930|Melanoma|melanoma
389155|NCT01918930|Accessible tumors|accessible tumors
389156|NCT01918930|B7-H3 positive tumors|b7-h3 positive tumors
389157|NCT01918917|Arthroscopic knee surgery|arthroscopic knee surgery
389158|NCT01918917|Dexmedetomidine|dexmedetomidine
389159|NCT01918917|Analgesia|analgesia
389160|NCT01918904|calcinosis|calcinosis
389161|NCT01918904|sodium thiosulfate|sodium thiosulfate
389162|NCT01918904|topical treatment|topical treatment
389163|NCT01918904|connective tissue disease|connective tissue disease
389164|NCT01918891|stroke|stroke
389165|NCT01918891|transient ischemic attack|transient ischemic attack
389166|NCT01918891|High blood pressure|high blood pressure
389167|NCT01918891|Hypertension|hypertension
389168|NCT01918878|age-related macular degeneration|age-related macular degeneration
389169|NCT01918878|intravitreal injections|intravitreal injections
389170|NCT01918878|Aflibercept|aflibercept
389171|NCT01918878|EYLEA|eylea
389172|NCT01918865|Type 2 Diabetes Mellitus|type 2 diabetes mellitus
389173|NCT01918865|T2DM|t2dm
389174|NCT01918852|Hand-foot syndrome|hand-foot syndrome
389175|NCT01918852|Toxicity|toxicity
389176|NCT01918852|Fluoropyrimidine|fluoropyrimidine
389177|NCT01918852|Capecitabine|capecitabine
389178|NCT01918852|Teysuno|teysuno
389179|NCT01918852|S1|s1
389180|NCT01918839|Investigational Device (VINCI Plus)|investigational device (vinci plus)
389181|NCT01918839|Correction of nasolabial fold|correction of nasolabial fold
389182|NCT01918839|Wrinkle improvement|wrinkle improvement
389183|NCT01918839|Wrinkle correction|wrinkle correction
389184|NCT01918800|fatigue|fatigue
389185|NCT01918800|quality of life|quality of life
389186|NCT01918800|rehabilitation|rehabilitation
389187|NCT01918800|self management|self management
389188|NCT01918800|energy effectiveness|energy effectiveness
389189|NCT01918774|Unemployment|unemployment
389190|NCT01918774|Cognitive Behavioral Therapy|cognitive behavioral therapy
389191|NCT01918774|Mental Disorders|mental disorders
389192|NCT01918761|NSCLC|nsclc
389193|NCT01918761|Stage IV|stage iv
389194|NCT01918761|Pemetrexed|pemetrexed
389195|NCT01918761|Dacomitinib|dacomitinib
389196|NCT01918735|Safety|safety
389197|NCT01918735|Tolerability|tolerability
389198|NCT01918735|Assessment of potential adverse events|assessment of potential adverse events
389199|NCT01918735|Assessment of potential laboratory abnormalities|assessment of potential laboratory abnormalities
389200|NCT01918722|Activating blood stagnation and expelling blood stasis|activating blood stagnation and expelling blood stasis
389201|NCT01918722|Hematoma enlargement|hematoma enlargement
389202|NCT01918722|herbal medicine|herbal medicine
389203|NCT01918722|traditional chinese medicine|traditional chinese medicine
389204|NCT01918722|random clinical trial|random clinical trial
389205|NCT01918696|suicide|suicide
389206|NCT01918696|anger|anger
389207|NCT01918696|interpretation modification|interpretation modification
389208|NCT01918696|computerized treatment|computerized treatment
389209|NCT01918670|atrial fibrillation; catheter ablation; relapse; stroke; death|atrial fibrillation; catheter ablation; relapse; stroke; death
389210|NCT01918657|Interventional|interventional
389211|NCT01918657|Randomized|randomized
389212|NCT01918657|Double blind|double blind
389213|NCT01918657|Placebo controlled|placebo controlled
389214|NCT01918657|Pediatric|pediatric
389215|NCT01918618|levosimendan|levosimendan
389216|NCT01918618|renal effects|renal effects
389217|NCT01918618|cardiac surgery|cardiac surgery
389218|NCT01918618|left heart insufficiency|left heart insufficiency
389219|NCT01918605|prostate cancer|prostate cancer
389220|NCT01918605|brachytherapy|brachytherapy
389221|NCT01918605|spacer|spacer
389222|NCT01918605|side effect|side effect
389223|NCT01918592|bladder cancer|bladder cancer
389224|NCT01918592|neoadjuvant chemotherapy|neoadjuvant chemotherapy
389225|NCT01918592|radical cystectomy|radical cystectomy
389226|NCT01918592|lymphadenectomy|lymphadenectomy
389227|NCT01918592|biomarker|biomarker
389228|NCT01918553|AMD|amd
389229|NCT01918553|epidemiology|epidemiology
389230|NCT01918553|risk factors|risk factors
389231|NCT01918553|cohort study|cohort study
389232|NCT01918540|Radiostereometry|radiostereometry
389233|NCT01918540|Total Hip Arthroplasty|total hip arthroplasty
389234|NCT01918540|Stem design|stem design
389235|NCT01918527|Locally advanced colon cancer|locally advanced colon cancer
389236|NCT01918527|Neoadjuvant chemotherapy|neoadjuvant chemotherapy
389237|NCT01918514|Magnesium sulfate|magnesium sulfate
389238|NCT01918514|epidural|epidural
389239|NCT01918514|interscalene|interscalene
389240|NCT01918514|NMDA receptor|nmda receptor
389241|NCT01918501|multiple sclerosis|multiple sclerosis
389242|NCT01918501|Remyelination|remyelination
389243|NCT01918501|Mitochondria|mitochondria
389244|NCT01918501|fatty acids|fatty acids
389245|NCT01918488|Diabetic Nephropathies|diabetic nephropathies
389246|NCT01918488|Hypertension|hypertension
389247|NCT01918488|Proteinuria|proteinuria
389248|NCT01918488|Albuminuria|albuminuria
389249|NCT01918488|Epithelial Sodium Channels|epithelial sodium channels
389250|NCT01918488|Epithelial Sodium Channel Blockers|epithelial sodium channel blockers
389251|NCT01918488|Amiloride|amiloride
389252|NCT01918475|randomized controlled trial|randomized controlled trial
389253|NCT01918475|placebo controlled trial|placebo controlled trial
389254|NCT01918475|cross over trial|cross over trial
389255|NCT01918462|Alcoholic hepatitis|alcoholic hepatitis
389256|NCT01918462|IL-22|il-22
389257|NCT01918462|Kupffer cells|kupffer cells
389258|NCT01918449|OSA|osa
389259|NCT01918449|CPAP treatment|cpap treatment
389260|NCT01918449|primary care|primary care
389261|NCT01918449|efficacy|efficacy
389262|NCT01918436|Attention Deficit Hyperactivity Disorder|attention deficit hyperactivity disorder
389263|NCT01918436|Neurocognitive training for preschool children with ADHD|neurocognitive training for preschool children with adhd
389264|NCT01918436|Play intervention for children with ADHD|play intervention for children with adhd
389265|NCT01918423|Childhood adiposity|childhood adiposity
389266|NCT01918423|Metabolic risk factors|metabolic risk factors
389267|NCT01918423|Bone mineralization|bone mineralization
389268|NCT01918410|contact lens|contact lens
389269|NCT01918410|alginic|alginic
389270|NCT01918410|dry eyes|dry eyes
389271|NCT01918397|Levofloxacin|levofloxacin
389272|NCT01918397|Optimized background regimen|optimized background regimen
389273|NCT01918384|Duchenne muscular dystrophy|duchenne muscular dystrophy
389274|NCT01918384|NPC-14|npc-14
389275|NCT01918384|Arbekacin|arbekacin
389276|NCT01918384|nonsense|nonsense
389277|NCT01918384|readthrough|readthrough
389278|NCT01918345|Diabetes|diabetes
389279|NCT01918345|Diabetes Mellitus|diabetes mellitus
389280|NCT01918345|Diabetes Mellitus, Type 2|diabetes mellitus, type 2
389281|NCT01918345|Diabetes, gestational|diabetes, gestational
389282|NCT01918345|Prevention & control|prevention & control
389283|NCT01918345|Postpartum Period|postpartum period
389284|NCT01918345|Mothers|mothers
389285|NCT01918345|Diet|diet
389286|NCT01918345|Diabetic Diet|diabetic diet
389287|NCT01918345|Exercise|exercise
389288|NCT01918345|Life Style|life style
389289|NCT01918345|Motivation|motivation
389290|NCT01918345|Health Behavior|health behavior
389291|NCT01918345|Insulin-Secreting Cells|insulin-secreting cells
389292|NCT01918345|Randomized Controlled Trial|randomized controlled trial
389293|NCT01918345|Clinical Trial|clinical trial
389294|NCT01918345|Pilot Projects|pilot projects
389295|NCT01918345|Feasibility Studies|feasibility studies
389296|NCT01918306|Triple Negative Breast Cancer|triple negative breast cancer
389297|NCT01918306|Estrogen receptor negative breast cancer|estrogen receptor negative breast cancer
389298|NCT01918306|Metastatic breast cancer|metastatic breast cancer
389299|NCT01918306|Stage IV breast cancer|stage iv breast cancer
389300|NCT01918306|HER2 negative breast cancer|her2 negative breast cancer
389301|NCT01918293|ASTHMA|asthma
389302|NCT01918293|SMARTPHONE APPLICATION|smartphone application
389303|NCT01918280|Klinefelter Syndrome|klinefelter syndrome
389304|NCT01918280|Azoospermia|azoospermia
389305|NCT01918280|Seminal analyses|seminal analyses
389306|NCT01918280|Testicular biopsy|testicular biopsy
389307|NCT01918241|Pegylation|pegylation
389308|NCT01918241|G-CSF|g-csf
389309|NCT01918241|Efficacy|efficacy
389310|NCT01918241|Satety|satety
389311|NCT01918202|Enzyme occupancy|enzyme occupancy
389313|NCT01918202|Phosphodiesterase 10 inhibitor|phosphodiesterase 10 inhibitor
389314|NCT01918189|back pain|back pain
389315|NCT01918189|low back pain|low back pain
389316|NCT01918189|chronic pain|chronic pain
389317|NCT01918189|cognitive behavior therapy|cognitive behavior therapy
389318|NCT01918189|behavior therapy|behavior therapy
389319|NCT01918176|Palbociclib|palbociclib
389320|NCT01918176|PD-0332991|pd-0332991
389321|NCT01918176|Proton Pump Inhibitor|proton pump inhibitor
389322|NCT01918176|DDI|ddi
389323|NCT01918176|Healthy Volunteers|healthy volunteers
389324|NCT01918176|Pharmacokinetics|pharmacokinetics
389325|NCT01918176|Rabeprazole|rabeprazole
389326|NCT01918163|pomegranate pills, male infertility, pregnancy rate, semen analysis, ROS, oxidative stress|pomegranate pills, male infertility, pregnancy rate, semen analysis, ros, oxidative stress
389327|NCT01918124|disease free survival, overall survival|disease free survival, overall survival
389328|NCT01918111|Renal denervation, Exercise diastolic function, Atherosclerosis, New methods|renal denervation, exercise diastolic function, atherosclerosis, new methods
389329|NCT01918072|Women's Health|women's health
389330|NCT01918072|Hospitals, Veterans|hospitals, veterans
389331|NCT01918072|Education|education
389332|NCT01918072|Remote consultation|remote consultation
389333|NCT01918072|Videoconferencing|videoconferencing
389334|NCT01918059|Trauma|trauma
389335|NCT01918059|Eyelid|eyelid
389336|NCT01918059|Laceration|laceration
389337|NCT01918059|Tissue adhesive|tissue adhesive
389338|NCT01918059|suture|suture
389339|NCT01918059|cosmetic|cosmetic
389340|NCT01918059|octyl-2-cyanoacrylate|octyl-2-cyanoacrylate
389341|NCT01918046|biomarker|biomarker
389342|NCT01918046|MIOX|miox
389343|NCT01918033|Rhinitis|rhinitis
389344|NCT01918033|Allergic Rhinitis|allergic rhinitis
389345|NCT01918033|Nose Diseases|nose diseases
389346|NCT01918033|Respiratory Tract Diseases|respiratory tract diseases
389640|NCT01916824|melancholia|melancholia
389347|NCT01918033|Immune System Diseases|immune system diseases
389348|NCT01918033|Cholinergic Antagonists|cholinergic antagonists
389349|NCT01918033|Cholinergic Agents|cholinergic agents
389350|NCT01918033|Neurotransmitter Agents|neurotransmitter agents
389351|NCT01918033|Histamine H1 Antagonists, Non-Sedating|histamine h1 antagonists, non-sedating
389352|NCT01918033|Histamine H1 Antagonists|histamine h1 antagonists
389353|NCT01918033|Histamine Antagonists|histamine antagonists
389354|NCT01918033|Histamine Agents|histamine agents
389355|NCT01918020|Fruit|fruit
389356|NCT01918020|Vegetables|vegetables
389357|NCT01918020|Motor Activity|motor activity
389358|NCT01918007|Apnea|apnea
389359|NCT01918007|Sleep Apnea Syndromes|sleep apnea syndromes
389360|NCT01918007|Snoring|snoring
389361|NCT01918007|Sleep Apnea, Obstructive|sleep apnea, obstructive
389362|NCT01918007|Respiration Disorders|respiration disorders
389363|NCT01918007|Respiratory Tract Diseases|respiratory tract diseases
389364|NCT01918007|Signs and Symptoms, Respiratory Signs and Symptoms|signs and symptoms, respiratory signs and symptoms
389365|NCT01918007|Sleep Disorders, Intrinsic|sleep disorders, intrinsic
389366|NCT01918007|Dyssomnias|dyssomnias
389367|NCT01918007|Sleep Disorders|sleep disorders
389368|NCT01918007|Respiratory Sounds|respiratory sounds
389369|NCT01917981|Intermittent cardiac monitoring|intermittent cardiac monitoring
389370|NCT01917981|Implantable device|implantable device
389371|NCT01917968|POP|pop
389372|NCT01917968|Transvaginal|transvaginal
389373|NCT01917968|Native Tissue Repair|native tissue repair
389374|NCT01917968|Repair Augmented with Mesh|repair augmented with mesh
389375|NCT01917968|Pelvic Organ Prolapse|pelvic organ prolapse
389376|NCT01917955|MRI|mri
389377|NCT01917942|Radiotherapy|radiotherapy
389378|NCT01917942|Humidification|humidification
389379|NCT01917942|Mucositis|mucositis
389380|NCT01917929|[E04.555.110.110.110]|[e04.555.110.110.110]
389381|NCT01917903|walking|walking
389382|NCT01917903|Parkinson's disease|parkinson's disease
389383|NCT01917903|physical therapy|physical therapy
389384|NCT01917903|falls|falls
389385|NCT01917903|memory|memory
389386|NCT01917903|attention|attention
389387|NCT01917903|multitasking|multitasking
389388|NCT01917903|exercise|exercise
389389|NCT01917890|curcumin|curcumin
712565|NCT00579696|Queens|queens
389390|NCT01917890|radioprotective|radioprotective
389391|NCT01917890|radiosensitizer|radiosensitizer
389392|NCT01917877|Becacizumab|becacizumab
389393|NCT01917877|pulmonary fibrosis|pulmonary fibrosis
389394|NCT01917877|irradiation|irradiation
389395|NCT01917877|chemotherapy|chemotherapy
389396|NCT01917864|Autism|autism
389397|NCT01917864|Autism Spectrum Disorders|autism spectrum disorders
389398|NCT01917864|Prosody|prosody
389399|NCT01917864|Speech treatment|speech treatment
389400|NCT01917851|Accurate|accurate
389401|NCT01917851|Hb|hb
389402|NCT01917851|noninvasive measurement|noninvasive measurement
389403|NCT01917838|Mental Health Services|mental health services
389404|NCT01917825|radicular pain|radicular pain
389405|NCT01917812|physical activity|physical activity
389406|NCT01917812|exercise|exercise
389407|NCT01917812|mHealth|mhealth
389408|NCT01917812|smartphone|smartphone
389409|NCT01917812|activity tracker|activity tracker
389410|NCT01917812|pedometer|pedometer
389411|NCT01917812|text messaging|text messaging
389412|NCT01917812|SMS|sms
389413|NCT01917799|Aspirin|aspirin
389414|NCT01917799|Heparin|heparin
389415|NCT01917799|pregnancy|pregnancy
389416|NCT01917799|miscarriage|miscarriage
389417|NCT01917760|Gamma-aminobutyric acid|gamma-aminobutyric acid
389418|NCT01917760|Pharmacokinetics|pharmacokinetics
389419|NCT01917760|Pharmacodynamics|pharmacodynamics
389420|NCT01917760|Insulin|insulin
389421|NCT01917760|C-peptide|c-peptide
389422|NCT01917760|Glucagon|glucagon
389423|NCT01917747|Infant hearing screening|infant hearing screening
389424|NCT01917747|Patient Navigator|patient navigator
389425|NCT01917734|severe acute malnutrition|severe acute malnutrition
389426|NCT01917734|severe wasting|severe wasting
389427|NCT01917734|facility-based care|facility-based care
389428|NCT01917734|community-based care|community-based care
389429|NCT01917734|Madhya Pradesh|madhya pradesh
389430|NCT01917734|India|india
389431|NCT01917721|Kawasaki disease|kawasaki disease
389432|NCT01917721|doxycycline|doxycycline
389433|NCT01917721|coronary artery aneurysm|coronary artery aneurysm
389434|NCT01917708|non malignant conditions|non malignant conditions
389435|NCT01917708|blood and marrow transplant|blood and marrow transplant
389436|NCT01917695|Bulky cervical cancers|bulky cervical cancers
389437|NCT01917695|Neoadjuvant Chemotherapy|neoadjuvant chemotherapy
389438|NCT01917695|Neoadjuvant Chemoradiotherapy|neoadjuvant chemoradiotherapy
389439|NCT01917682|robotic-assisted PCI|robotic-assisted pci
389440|NCT01917682|coronary intervention|coronary intervention
389441|NCT01917682|CorPath PRECISION Registry|corpath precision registry
389442|NCT01917682|PCI|pci
389443|NCT01917682|angioplasty|angioplasty
389444|NCT01917643|COPD, Comparative Effectiveness, Symbicort|copd, comparative effectiveness, symbicort
389445|NCT01917630|Celiac disease|celiac disease
389446|NCT01917630|Gluten-free diet|gluten-free diet
389447|NCT01917630|Coeliac disease|coeliac disease
389448|NCT01917630|Celiac sprue|celiac sprue
389449|NCT01917604|open versus closed surgical technique|open versus closed surgical technique
389450|NCT01917604|impacted maxillary canine|impacted maxillary canine
389451|NCT01917604|orthodontic disimpaction|orthodontic disimpaction
389452|NCT01917591|Bandages|bandages
389453|NCT01917591|Biological Dressings|biological dressings
389454|NCT01917591|Chronic Disease|chronic disease
389455|NCT01917591|Collagen|collagen
389456|NCT01917591|Epithelium|epithelium
389457|NCT01917591|Extracellular Matrix|extracellular matrix
389458|NCT01917591|Extra Cellular Matrix|extra cellular matrix
389459|NCT01917591|Fibroblasts|fibroblasts
389460|NCT01917591|Granulation Tissue|granulation tissue
389461|NCT01917591|Leg Ulcer|leg ulcer
389462|NCT01917591|Middle Aged|middle aged
389463|NCT01917591|Prospective Studies|prospective studies
389464|NCT01917591|Soft Tissue Injuries|soft tissue injuries
389465|NCT01917591|Treatment Outcome|treatment outcome
389466|NCT01917591|Varicose Ulcer|varicose ulcer
389467|NCT01917591|Wound Healing|wound healing
389468|NCT01917591|Wounds and Injuries|wounds and injuries
389469|NCT01917591|biopsy|biopsy
389470|NCT01917591|autoimmunity|autoimmunity
389471|NCT01917578|Breast Cancer|breast cancer
389472|NCT01917578|shrinkage modes|shrinkage modes
389473|NCT01917578|three-dimensional reconstruction|three-dimensional reconstruction
389474|NCT01917578|neoadjuvant chemotherapy|neoadjuvant chemotherapy
389475|NCT01917578|Magnetic Resonance Imaging|magnetic resonance imaging
389476|NCT01917565|airway management|airway management
389477|NCT01917565|laryngoscope|laryngoscope
389478|NCT01917565|Airtraq|airtraq
389479|NCT01917565|Macintosh laryngoscope|macintosh laryngoscope
389480|NCT01917565|fiberoptic bronchoscope|fiberoptic bronchoscope
389481|NCT01917565|intubation|intubation
389482|NCT01917552|Gastric adenocarcinoma, gastroesophageal junction adenocarcinoma, adjuvant, capecitabine, gastric cancer, stage 1b|gastric adenocarcinoma, gastroesophageal junction adenocarcinoma, adjuvant, capecitabine, gastric cancer, stage 1b
389483|NCT01917526|Oxygen|oxygen
389484|NCT01917526|PACU|pacu
389485|NCT01917526|Hypoxemia|hypoxemia
389486|NCT01917513|Adenoma|adenoma
389487|NCT01917513|Polyps|polyps
498108|NCT01438775|BPO|bpo
389488|NCT01917513|CRC|crc
389489|NCT01917513|Colonoscopy|colonoscopy
389490|NCT01917513|Detection Yield|detection yield
389491|NCT01917500|Continues non-invasive Blood pressure measurement|continues non-invasive blood pressure measurement
389492|NCT01917500|Continues non-invasive Cardiac Output measurement|continues non-invasive cardiac output measurement
389493|NCT01917474|low-lipid diet|low-lipid diet
389494|NCT01917474|normal lipid intake|normal lipid intake
389495|NCT01917474|saturated fats reduction|saturated fats reduction
389496|NCT01917474|headache attacks|headache attacks
389497|NCT01917448|postoperative pain|postoperative pain
389498|NCT01917448|spinal morphine|spinal morphine
389499|NCT01917448|video-assisted thoracoscopic surgery|video-assisted thoracoscopic surgery
389500|NCT01917435|fiberoptic bronchoscopy,|fiberoptic bronchoscopy,
389501|NCT01917435|Video-stylet,|video-stylet,
389502|NCT01917435|Nasotracheal Intubation|nasotracheal intubation
389503|NCT01917409|Conventional Laryngoscopy ,|conventional laryngoscopy ,
389504|NCT01917409|Video-stylet ,|video-stylet ,
389505|NCT01917409|Nasotracheal Intubation|nasotracheal intubation
389506|NCT01917396|caesarean, bowel, gass|caesarean, bowel, gass
389507|NCT01917383|glaucoma|glaucoma
389508|NCT01917383|primary open angle glaucoma|primary open angle glaucoma
389509|NCT01917383|ocular hypertension|ocular hypertension
389510|NCT01917383|adenosine agonist|adenosine agonist
389511|NCT01917383|eye drop|eye drop
389512|NCT01917383|trabodenoson|trabodenoson
389513|NCT01917383|trabecular meshwork|trabecular meshwork
389514|NCT01917370|intrahepatic cholangiocarcinoma|intrahepatic cholangiocarcinoma
389515|NCT01917370|icc|icc
389516|NCT01917370|vegf signal pathway|vegf signal pathway
389517|NCT01917357|Vaccination|vaccination
389518|NCT01917357|Immunisation|immunisation
389519|NCT01917357|Virus|virus
389520|NCT01917357|Diphtheria|diphtheria
389521|NCT01917357|Pertussis|pertussis
389522|NCT01917357|Tetanus|tetanus
389523|NCT01917357|Hepatitis B|hepatitis b
389524|NCT01917357|Haemophilus Influenzae|haemophilus influenzae
389525|NCT01917357|Immunity|immunity
389526|NCT01917344|Phenylketonuria|phenylketonuria
389527|NCT01917344|MRI|mri
389528|NCT01917344|Neuropsychological functioning|neuropsychological functioning
389529|NCT01917344|Neurological functioning|neurological functioning
389530|NCT01917344|EEG|eeg
389531|NCT01917331|spirometry|spirometry
389532|NCT01917331|severe COPD|severe copd
389533|NCT01917331|lung disease|lung disease
389534|NCT01917331|fixed combination|fixed combination
389535|NCT01917318|Post traumatic stress disorder|post traumatic stress disorder
389536|NCT01917318|Treatment of post traumatic stress disorder|treatment of post traumatic stress disorder
389537|NCT01917318|Symptoms of arousal in post traumatic stress disorder|symptoms of arousal in post traumatic stress disorder
389538|NCT01917318|Iloperidone in post traumatic stress disorder|iloperidone in post traumatic stress disorder
389539|NCT01917305|Bacteria|bacteria
389540|NCT01917305|bone level|bone level
389541|NCT01917305|bone loss|bone loss
389542|NCT01917305|dental implants|dental implants
389543|NCT01917305|implant design|implant design
389544|NCT01917305|platform-shifting|platform-shifting
389545|NCT01917305|platform-matching|platform-matching
389546|NCT01917292|Periodontitis|periodontitis
389547|NCT01917292|Prehypertension|prehypertension
389548|NCT01917292|Periodontal Intervention|periodontal intervention
389549|NCT01917279|Metastatic Breast Cancer|metastatic breast cancer
389550|NCT01917279|Antineoplastic Agents|antineoplastic agents
389551|NCT01917279|Therapeutic Uses|therapeutic uses
389552|NCT01917279|Antimetabolites|antimetabolites
389553|NCT01917279|Tubulin Modulators|tubulin modulators
389554|NCT01917279|Maintenance chemotherapy|maintenance chemotherapy
389555|NCT01917279|Metronomic chemotherapy|metronomic chemotherapy
389556|NCT01917279|Capecitabine|capecitabine
389557|NCT01917279|Docetaxel|docetaxel
389558|NCT01917253|infiltration, phlebitis, occlusion, thrombosis|infiltration, phlebitis, occlusion, thrombosis
389559|NCT01917240|Monophasic|monophasic
389560|NCT01917240|Sequential|sequential
389561|NCT01917240|Media|media
389562|NCT01917201|Coronary Artery Disease|coronary artery disease
389563|NCT01917201|Drug Eluting Stents|drug eluting stents
389564|NCT01917201|Intravascular Ultrasound|intravascular ultrasound
389565|NCT01917201|Optical Coherence Tomography|optical coherence tomography
389566|NCT01917201|Intravascular Visualization|intravascular visualization
389567|NCT01917175|HIV|hiv
389568|NCT01917175|Cohort|cohort
389569|NCT01917175|Early HIV infection|early hiv infection
389570|NCT01917175|Côte d'Ivoire|côte d'ivoire
389571|NCT01917175|Disease progression|disease progression
389572|NCT01917162|contact lenses|contact lenses
389573|NCT01917162|daily disposable contact lenses|daily disposable contact lenses
389574|NCT01917162|silicone hydrogel|silicone hydrogel
389575|NCT01917162|contact lens comfort|contact lens comfort
389576|NCT01917162|near-sighted|near-sighted
389577|NCT01917149|Dilated cardiomyopathy|dilated cardiomyopathy
389578|NCT01917149|High dose ACEI/ARB|high dose acei/arb
389579|NCT01917136|pulmonary hypertension|pulmonary hypertension
389580|NCT01917136|right ventricular function|right ventricular function
389581|NCT01917136|11C acetate|11c acetate
389582|NCT01917136|FDG|fdg
389583|NCT01917136|ranolazine|ranolazine
389584|NCT01917123|L-Citrulline malate,Coronary Heart Disease, Brachial Index|l-citrulline malate,coronary heart disease, brachial index
389585|NCT01917084|Passive range of motion|passive range of motion
389586|NCT01917084|Single ventricle|single ventricle
389587|NCT01917084|Infants|infants
389588|NCT01917084|Congenital heart disease|congenital heart disease
389589|NCT01917058|Alopecia Areata|alopecia areata
389590|NCT01917058|Abatacept|abatacept
389591|NCT01917045|sufentanil|sufentanil
389592|NCT01917045|morphine|morphine
389593|NCT01917045|postoperative pain control|postoperative pain control
389594|NCT01917045|body fat percentage|body fat percentage
389595|NCT01917045|gynecology laparoscopic surgery|gynecology laparoscopic surgery
389596|NCT01917045|lipid solubility|lipid solubility
389597|NCT01917032|Trace Elements|trace elements
389598|NCT01917032|Preschool|preschool
389599|NCT01917032|Malnutrition|malnutrition
389600|NCT01917032|Fortified Food|fortified food
389601|NCT01917019|Japan|japan
389602|NCT01916980|Dermatitis|dermatitis
389603|NCT01916980|Dermatitis, Atopic|dermatitis, atopic
389604|NCT01916980|Skin Diseases|skin diseases
389605|NCT01916980|Skin Diseases, Genetic|skin diseases, genetic
389606|NCT01916980|Genetic Diseases, Inborn|genetic diseases, inborn
389607|NCT01916980|Skin Diseases, Eczematous|skin diseases, eczematous
389608|NCT01916980|Hypersensitivity, Immediate|hypersensitivity, immediate
389609|NCT01916980|Hypersensitivity|hypersensitivity
389610|NCT01916980|Immune System Diseases|immune system diseases
389611|NCT01916967|Urticaria|urticaria
389612|NCT01916967|Skin Diseases, Vascular|skin diseases, vascular
389613|NCT01916967|Skin Diseases|skin diseases
389614|NCT01916967|Hypersensitivity, Immediate|hypersensitivity, immediate
389615|NCT01916967|Hypersensitivity|hypersensitivity
389616|NCT01916967|Immune System Diseases|immune system diseases
389617|NCT01916967|Cholinergic Antagonists|cholinergic antagonists
389618|NCT01916967|Cholinergic Agents|cholinergic agents
389619|NCT01916967|Neurotransmitter Agents|neurotransmitter agents
389620|NCT01916967|Histamine H1 Antagonists, Non-Sedating|histamine h1 antagonists, non-sedating
389621|NCT01916967|Histamine H1 Antagonists|histamine h1 antagonists
389622|NCT01916967|Histamine Antagonists|histamine antagonists
389623|NCT01916967|Histamine Agents|histamine agents
389624|NCT01916954|Malaria|malaria
389625|NCT01916954|Pregnancy|pregnancy
389626|NCT01916954|Plasmodium falciparum|plasmodium falciparum
389627|NCT01916928|Circulating cell free fetal DNA|circulating cell free fetal dna
389628|NCT01916928|Intrauterine fetal demise|intrauterine fetal demise
389629|NCT01916928|Miscarriage|miscarriage
389630|NCT01916902|Optical Coherence Tomography|optical coherence tomography
389631|NCT01916902|Ticagrelor|ticagrelor
389632|NCT01916889|Delirium|delirium
389633|NCT01916876|medical in-patients|medical in-patients
389634|NCT01916876|follow-up care|follow-up care
389635|NCT01916876|developing country|developing country
389636|NCT01916837|Breast cancer|breast cancer
389637|NCT01916837|Feasibility|feasibility
389638|NCT01916837|Genomic grade index|genomic grade index
389639|NCT01916824|depression|depression
389641|NCT01916824|treatment|treatment
389642|NCT01916811|Low Back Pain|low back pain
389643|NCT01916811|Load quantitative MRI|load quantitative mri
389644|NCT01916798|Infertility|infertility
389645|NCT01916798|intralipid|intralipid
389646|NCT01916798|invitro fertilization|invitro fertilization
389647|NCT01916798|repeated implantation failure|repeated implantation failure
389648|NCT01916798|repeated miscarriage|repeated miscarriage
389649|NCT01916772|cherubism|cherubism
389650|NCT01916772|bone tumors|bone tumors
389651|NCT01916759|immunization|immunization
389652|NCT01916746|Caesarean Scar Pregnancy|caesarean scar pregnancy
389653|NCT01916746|Transvaginal Resection|transvaginal resection
389654|NCT01916746|treatment|treatment
389655|NCT01916707|trauma|trauma
389656|NCT01916707|enoxaparin|enoxaparin
389657|NCT01916707|weight based|weight based
389658|NCT01916707|prophylaxis|prophylaxis
389659|NCT01916694|Gestational diabetes mellitus|gestational diabetes mellitus
389660|NCT01916694|m Health|m health
389661|NCT01916694|Smartphone|smartphone
389662|NCT01916694|Blood glucose monitoring|blood glucose monitoring
389663|NCT01916681|Induction|induction
389664|NCT01916681|Labor|labor
389665|NCT01916681|Cervical foley|cervical foley
389666|NCT01916681|Misoprostol|misoprostol
389667|NCT01916681|Pitocin|pitocin
389668|NCT01916681|Oxytocin|oxytocin
389669|NCT01916681|Cytotec|cytotec
389670|NCT01916681|Delivery|delivery
389671|NCT01916681|IOL|iol
389672|NCT01916655|Obstructive Sleep Apnea|obstructive sleep apnea
389673|NCT01916655|Adherence|adherence
389674|NCT01916655|Chronic Disease|chronic disease
389675|NCT01916655|Telemedicine|telemedicine
389676|NCT01916655|Continuous Positive Airway Pressure|continuous positive airway pressure
389677|NCT01916655|Mobile Health|mobile health
389678|NCT01916642|iv lidocaine|iv lidocaine
389679|NCT01916642|inducing dose|inducing dose
389680|NCT01916642|etomidate|etomidate
389681|NCT01916642|dose response|dose response
389682|NCT01916616|paradoxical vocal fold motion|paradoxical vocal fold motion
389683|NCT01916616|cognitive-behavioral therapy|cognitive-behavioral therapy
389684|NCT01916590|Post-operative pain|post-operative pain
389685|NCT01916590|Anterior Cruciate Ligament repair|anterior cruciate ligament repair
389686|NCT01916577|Stem Cell Mobilization|stem cell mobilization
389687|NCT01916577|Stem Cells|stem cells
389688|NCT01916577|Transplantation|transplantation
389689|NCT01916577|Autologous|autologous
389690|NCT01916564|Bowel preparation|bowel preparation
389691|NCT01916564|Morning colonoscopy|morning colonoscopy
389692|NCT01916564|Split-dose|split-dose
389693|NCT01916564|Same-morning whole-dose|same-morning whole-dose
389694|NCT01916564|Reduced-volume PEG-ELS|reduced-volume peg-els
389695|NCT01916538|anorexia nervosa|anorexia nervosa
389696|NCT01916538|genetics|genetics
389697|NCT01916538|gene|gene
389698|NCT01916538|eating disorder|eating disorder
389699|NCT01916525|Acute coronary syndrome|acute coronary syndrome
389700|NCT01916525|Cost-effectiveness|cost-effectiveness
389701|NCT01916525|Cardiac rehabilitation|cardiac rehabilitation
389702|NCT01916525|Exercise|exercise
389703|NCT01916525|Physical activity|physical activity
389704|NCT01916525|Home monitoring|home monitoring
389705|NCT01916512|CETP, HDL, LDL, apoB-100, apoB-48, remnants|cetp, hdl, ldl, apob-100, apob-48, remnants
389706|NCT01916499|Child, adolescent|child, adolescent
389707|NCT01916499|Coronary artery disease|coronary artery disease
389708|NCT01916499|Magnetic resonance imaging|magnetic resonance imaging
389709|NCT01916473|Epidural analgesia|epidural analgesia
389710|NCT01916473|continuous wound infusion|continuous wound infusion
389711|NCT01916473|ropivacaine|ropivacaine
389712|NCT01916473|total abdominal hysterectomy|total abdominal hysterectomy
389713|NCT01916460|Gastroparesis|gastroparesis
389714|NCT01916460|Endoscopic ultrasound|endoscopic ultrasound
389715|NCT01916460|Interstitial cell of Cajal|interstitial cell of cajal
389716|NCT01916447|Angiogenesis Inhibitor|angiogenesis inhibitor
389717|NCT01916447|Monoclonal Antibody|monoclonal antibody
389718|NCT01916447|Vascular Endothelial Growth Factor A (VEGF-A)|vascular endothelial growth factor a (vegf-a)
389719|NCT01916434|Farmed fish|farmed fish
389720|NCT01916434|Dietary intervention|dietary intervention
389721|NCT01916434|Long-term intervention|long-term intervention
389722|NCT01916434|Omega-3 index|omega-3 index
389723|NCT01916434|Cardiovascular risk markers|cardiovascular risk markers
389724|NCT01916434|Coagulation and endothelial activation|coagulation and endothelial activation
389725|NCT01916434|Bleeding time|bleeding time
389726|NCT01916434|Inflammation|inflammation
389727|NCT01916434|Oxidative stress|oxidative stress
389728|NCT01916434|Gut health|gut health
389729|NCT01916434|Micronutrient availability|micronutrient availability
389730|NCT01916421|Pancreatic adenocarcinoma|pancreatic adenocarcinoma
389731|NCT01916421|lymphadenopathy|lymphadenopathy
389732|NCT01916421|Endoscopic ultrasound|endoscopic ultrasound
389733|NCT01916408|Exercise|exercise
389734|NCT01916408|Inflammation|inflammation
389735|NCT01916408|Upper Respiratory Tract Illness|upper respiratory tract illness
389736|NCT01916408|Oral Proteolytic and Hydrolytic Enzymes|oral proteolytic and hydrolytic enzymes
389737|NCT01916408|Flavinoids|flavinoids
389738|NCT01916395|Migraine|migraine
389739|NCT01916382|Alkaptonuria, nitisinone,Ochronosis, Homogentisic acid|alkaptonuria, nitisinone,ochronosis, homogentisic acid
389740|NCT01916369|Peripheral Arterial Disease|peripheral arterial disease
389741|NCT01916369|Fontaine Stage II, III or IV|fontaine stage ii, iii or iv
389742|NCT01916369|Vascular disease|vascular disease
389743|NCT01916369|Cardiovascular diseases|cardiovascular diseases
389744|NCT01916369|Neural stem cell|neural stem cell
389745|NCT01916356|Infertility|infertility
389746|NCT01916356|Education|education
389747|NCT01916356|Risk Factors|risk factors
389748|NCT01916356|Fertility knowledge|fertility knowledge
389749|NCT01916356|Fertility myths|fertility myths
389750|NCT01916343|Laparoscopy|laparoscopy
389751|NCT01916343|Surgical skills|surgical skills
389752|NCT01916343|Team training|team training
389753|NCT01916343|Obstetrics and Gynecology|obstetrics and gynecology
389754|NCT01916343|Curriculum|curriculum
389755|NCT01916304|Drug Therapy|drug therapy
389756|NCT01916252|Multiple Myeloma|multiple myeloma
389757|NCT01916252|MEL200|mel200
389758|NCT01916252|BUMEL|bumel
389759|NCT01916239|Pomegranate|pomegranate
389760|NCT01916239|Urolithins|urolithins
389761|NCT01916239|Colorectal cancer|colorectal cancer
389762|NCT01916239|Colon cancer|colon cancer
389763|NCT01916239|Metabolite|metabolite
389764|NCT01916239|Gene expression|gene expression
389765|NCT01916239|microRNA|microrna
389766|NCT01916239|Nutraceutical|nutraceutical
389767|NCT01916239|Food supplement|food supplement
389768|NCT01916239|Polyphenol|polyphenol
389769|NCT01916239|Gut microbiota|gut microbiota
389770|NCT01916226|cetirizine|cetirizine
389771|NCT01916226|seasonal allergic rhinitis|seasonal allergic rhinitis
389772|NCT01916226|Quality of Life|quality of life
389773|NCT01916226|fluticasone propionate nasal spray|fluticasone propionate nasal spray
389774|NCT01916161|Crohn's disease|crohn's disease
389775|NCT01916161|ulcerative colitis|ulcerative colitis
389776|NCT01916161|anxiety|anxiety
389777|NCT01916161|patient knowledge|patient knowledge
389778|NCT01916161|information sources|information sources
389779|NCT01916148|Hypoglycemia|hypoglycemia
389780|NCT01916148|Hyperinsulinism|hyperinsulinism
389781|NCT01916135|[18F]-SKI-249380|[18f]-ski-249380
389782|NCT01916135|PET Imaging|pet imaging
389783|NCT01916135|CT Imaging|ct imaging
389784|NCT01916135|12-182|12-182
389785|NCT01916122|Fluorestradiol (FES)|fluorestradiol (fes)
389786|NCT01916122|PET/CT scan|pet/ct scan
389787|NCT01916122|Estrogen Receptor|estrogen receptor
389788|NCT01916122|13-071|13-071
389789|NCT01916109|Gemcitabine|gemcitabine
389790|NCT01916109|Carboplatin|carboplatin
389791|NCT01916109|Panitumumab|panitumumab
389792|NCT01916109|(GCaP)|(gcap)
389793|NCT01916109|radical cystectomy|radical cystectomy
389794|NCT01916109|10-103|10-103
389795|NCT01916070|syncope|syncope
389796|NCT01916070|near syncope|near syncope
389797|NCT01916070|prognosis|prognosis
389798|NCT01916070|emergency department|emergency department
389799|NCT01916057|Positron-Emission Tomography Scan|positron-emission tomography scan
389800|NCT01916057|Fluorodeoxyglucose F18|fluorodeoxyglucose f18
389801|NCT01916057|Magnetic Resonance Imaging|magnetic resonance imaging
389802|NCT01916057|Enzyme-Linked Immunospot Assay|enzyme-linked immunospot assay
389803|NCT01916057|Immune Reconstitution Inflammatory Syndrome|immune reconstitution inflammatory syndrome
389804|NCT01916057|Real-Time Polymerase Chain Reaction|real-time polymerase chain reaction
389805|NCT01916057|beta-1,3-D-glucan|beta-1,3-d-glucan
389806|NCT01916057|Candida spp.|candida spp.
389807|NCT01916057|Genetic Susceptibility|genetic susceptibility
389808|NCT01916057|Genotype|genotype
389809|NCT01916044|caesarean,|caesarean,
389810|NCT01916044|trial of labor,|trial of labor,
389811|NCT01916044|ultrasound|ultrasound
389812|NCT01916018|Congenital hypothyroidism|congenital hypothyroidism
389813|NCT01916018|Thyroid dysgenesis|thyroid dysgenesis
389814|NCT01916018|Genetics|genetics
389815|NCT01916018|Associated malformations|associated malformations
389816|NCT01916018|Psychomotor delay|psychomotor delay
389817|NCT01916018|Mental retardation|mental retardation
389818|NCT01915979|plasma rich in growth factors, tendinopathy, traumatology|plasma rich in growth factors, tendinopathy, traumatology
389819|NCT01915979|,rotator cuff, effectiveness, plasma rich in platelets|,rotator cuff, effectiveness, plasma rich in platelets
389820|NCT01915953|Accurte Hb noninvasive measurement|accurte hb noninvasive measurement
389821|NCT01915940|Glaucoma|glaucoma
389822|NCT01915940|Primary Open-Angle Glaucoma|primary open-angle glaucoma
389823|NCT01915940|Ocular Hypertension|ocular hypertension
389824|NCT01915888|Clinical|clinical
389825|NCT01915888|Children|children
389826|NCT01915888|Rotavirus|rotavirus
389827|NCT01915888|Cost|cost
389828|NCT01915888|Rotarix vaccination|rotarix vaccination
389829|NCT01915875|Cystic fibrosis-pain-sophrology|cystic fibrosis-pain-sophrology
389830|NCT01915862|Acute ischemic stroke|acute ischemic stroke
389831|NCT01915862|Blood pressure variability|blood pressure variability
389832|NCT01915862|Ambulatory arterial stiffness index|ambulatory arterial stiffness index
389833|NCT01915862|Ambulatory blood pressure monitoring|ambulatory blood pressure monitoring
389834|NCT01915862|Outcome|outcome
389835|NCT01915836|11-043|11-043
389934|NCT01915420|Angioplasty|angioplasty
389836|NCT01915836|MSKCC Tobacco Cessation Program|mskcc tobacco cessation program
389837|NCT01915797|Pediatric patients, tumor, developmental abnormalities|pediatric patients, tumor, developmental abnormalities
389838|NCT01915745|Osteoporosis|osteoporosis
389839|NCT01915745|Bone densitometry|bone densitometry
389840|NCT01915745|Fracture|fracture
389841|NCT01915745|Anti-osteoporotic treatment|anti-osteoporotic treatment
389842|NCT01915745|Short message service|short message service
389843|NCT01915706|Glaucoma drainage device|glaucoma drainage device
389844|NCT01915706|Baerveldt 350|baerveldt 350
389845|NCT01915706|Ripcord|ripcord
389846|NCT01915706|Complications|complications
389847|NCT01915693|Radiotherapy|radiotherapy
389848|NCT01915693|stent|stent
389849|NCT01915693|quality of life|quality of life
389850|NCT01915654|Cardiac surgery|cardiac surgery
389851|NCT01915654|Transfusion|transfusion
389852|NCT01915641|walking capacity|walking capacity
389853|NCT01915641|COPD|copd
389854|NCT01915641|OSA|osa
389855|NCT01915641|CPAP|cpap
389856|NCT01915628|MACE|mace
389857|NCT01915628|Safety|safety
389858|NCT01915628|Efficacy|efficacy
389859|NCT01915628|On label|on label
389860|NCT01915628|Myocardial Infarction|myocardial infarction
389861|NCT01915628|Cardiac death|cardiac death
389862|NCT01915628|TVR|tvr
389863|NCT01915628|stent thrombosis|stent thrombosis
389864|NCT01915615|Hypertrophic cardiomyopathy|hypertrophic cardiomyopathy
389865|NCT01915615|Cardiac magnetic resonance imaging|cardiac magnetic resonance imaging
389866|NCT01915615|CMR|cmr
389867|NCT01915615|Genetics|genetics
389868|NCT01915615|Biomarkers|biomarkers
389869|NCT01915615|Late gadolinium enhancement|late gadolinium enhancement
389870|NCT01915615|T1 mapping|t1 mapping
790292|NCT00292370|Paroxetine|paroxetine
389871|NCT01915602|Hepatocellular Carcinoma|hepatocellular carcinoma
389872|NCT01915602|Mitogen-activated Extracellular-signal-regulated kinase (MEK) inhibitor|mitogen-activated extracellular-signal-regulated kinase (mek) inhibitor
389873|NCT01915602|Sorafenib|sorafenib
389874|NCT01915602|Objective tumor response rate (ORR)|objective tumor response rate (orr)
389875|NCT01915602|modified RECIST criteria|modified recist criteria
389876|NCT01915589|Hepatocellular Carcinoma|hepatocellular carcinoma
389877|NCT01915589|Mitogen-activated Extracellular-signal-regulated kinase (MEK) inhibitor|mitogen-activated extracellular-signal-regulated kinase (mek) inhibitor
389878|NCT01915589|Objective tumor response rate (ORR)|objective tumor response rate (orr)
389879|NCT01915589|modified RECIST criteria|modified recist criteria
389880|NCT01915563|Mechanical ventilation|mechanical ventilation
389881|NCT01915563|Weaning|weaning
389882|NCT01915563|Extubation failure|extubation failure
389883|NCT01915550|Diabetes mellitus|diabetes mellitus
389884|NCT01915550|Pregnancy|pregnancy
389885|NCT01915550|Insulin|insulin
389886|NCT01915550|Metformin|metformin
389887|NCT01915537|poor prognosis|poor prognosis
389888|NCT01915537|severe RA|severe ra
389889|NCT01915537|infliximab|infliximab
389890|NCT01915511|Idiopathic pulmonary fibrosis|idiopathic pulmonary fibrosis
389891|NCT01915511|Pulmonary fibrosis|pulmonary fibrosis
389892|NCT01915511|IPF|ipf
389893|NCT01915511|Registry|registry
389894|NCT01915511|1199.174|1199.174
389895|NCT01915511|Interstitial Lung Disease|interstitial lung disease
389896|NCT01915511|ILD|ild
389897|NCT01915511|Interstitial Lung Disease with Progressive Phenotype|interstitial lung disease with progressive phenotype
389898|NCT01915498|acute myeloid leukemia|acute myeloid leukemia
389899|NCT01915498|AML|aml
389900|NCT01915498|myelodysplastic syndrome|myelodysplastic syndrome
389901|NCT01915498|MDS|mds
389902|NCT01915498|hematologic malignancies|hematologic malignancies
389903|NCT01915498|IDH2|idh2
389904|NCT01915498|Phase I|phase i
389905|NCT01915498|Phase II|phase ii
389906|NCT01915498|AG-221|ag-221
389907|NCT01915498|relapse AML|relapse aml
389908|NCT01915498|refractory AML|refractory aml
389909|NCT01915472|Metastatic Colorectal Cancer|metastatic colorectal cancer
389910|NCT01915472|Colorectal Cancer|colorectal cancer
389911|NCT01915472|Rectal Cancer|rectal cancer
389912|NCT01915472|previously treated|previously treated
389913|NCT01915459|Stroke|stroke
389914|NCT01915459|Spasticity|spasticity
389915|NCT01915446|EVAR|evar
389916|NCT01915446|endovascular aortic repair|endovascular aortic repair
389917|NCT01915446|acute kidney failure|acute kidney failure
389918|NCT01915446|mesenteric ischemia|mesenteric ischemia
389919|NCT01915433|Secondary Progressive Multiple Sclerosis|secondary progressive multiple sclerosis
389920|NCT01915433|Primary Progressive Multiple Sclerosis|primary progressive multiple sclerosis
389921|NCT01915433|Relapsing progressive multiple sclerosis|relapsing progressive multiple sclerosis
389922|NCT01915433|relapsing remitting multiple sclerosis|relapsing remitting multiple sclerosis
389923|NCT01915433|Fatigue|fatigue
389924|NCT01915433|Quality of life|quality of life
389925|NCT01915433|Paleo|paleo
389926|NCT01915433|Nutrition|nutrition
389927|NCT01915433|Ketogenic|ketogenic
389928|NCT01915420|Drug eluting stent|drug eluting stent
389929|NCT01915420|Bioabsorbable|bioabsorbable
389930|NCT01915420|Bioresorbable|bioresorbable
389931|NCT01915420|Coronary Stent|coronary stent
389932|NCT01915420|Scaffold|scaffold
389933|NCT01915420|Stents|stents
389935|NCT01915420|Coronary Artery Disease|coronary artery disease
389936|NCT01915420|Stentthrombosis|stentthrombosis
389937|NCT01915420|Rotational atherectomy|rotational atherectomy
389938|NCT01915394|Respiratory Syncytial Virus Infections|respiratory syncytial virus infections
389939|NCT01915394|Epidemics|epidemics
389940|NCT01915394|Neonatal Intensive Care Unit|neonatal intensive care unit
389941|NCT01915394|Newborn infants|newborn infants
389942|NCT01915381|Intellectual disability|intellectual disability
389943|NCT01915381|mHealth|mhealth
389944|NCT01915381|App|app
389945|NCT01915381|Physical activity|physical activity
389946|NCT01915381|Adherence|adherence
389947|NCT01915368|Exercise|exercise
389948|NCT01915368|Rehabilitation|rehabilitation
389949|NCT01915368|Dose|dose
389950|NCT01915368|Randomized controlled trial|randomized controlled trial
389951|NCT01915368|Stroke|stroke
389952|NCT01915355|onychomycosis|onychomycosis
389953|NCT01915355|nail|nail
389954|NCT01915355|fungus|fungus
389955|NCT01915342|Monosynaptic reflex|monosynaptic reflex
389956|NCT01915342|H-reflex|h-reflex
389957|NCT01915329|CRPS|crps
389958|NCT01915329|repetitive sensory stimulation|repetitive sensory stimulation
389959|NCT01915329|cortical reorganization|cortical reorganization
389960|NCT01915329|2-point-discrimination|2-point-discrimination
389961|NCT01915303|Cushing's disease, pituitary tumors, pasireotide, cabergoline, combination treatment, UFC, hormone disorder, cortisol, adrenocorticotropic hormone|cushing's disease, pituitary tumors, pasireotide, cabergoline, combination treatment, ufc, hormone disorder, cortisol, adrenocorticotropic hormone
389962|NCT01915290|physical activity|physical activity
389963|NCT01915290|maximal oxygen uptake|maximal oxygen uptake
790293|NCT00292370|Quetiapine|quetiapine
389964|NCT01915277|Pediatric corrective cardiac surgery|pediatric corrective cardiac surgery
389965|NCT01915264|Diabetes Mellitus|diabetes mellitus
389966|NCT01915264|Type 2 Diabetes|type 2 diabetes
389967|NCT01915264|Acarbose (25/50mg) and Metformin (500mg) in fixed dose combination|acarbose (25/50mg) and metformin (500mg) in fixed dose combination
389968|NCT01915251|Vulvovaginal Candidiasis|vulvovaginal candidiasis
389969|NCT01915251|Amoxicilin|amoxicilin
389970|NCT01915251|Microbiome|microbiome
389971|NCT01915238|Age-Related Macular Degeneration (AMD)|age-related macular degeneration (amd)
389972|NCT01915238|AMD|amd
389973|NCT01915225|Tissue Procurement|tissue procurement
389974|NCT01915225|Surgery|surgery
389975|NCT01915225|Metastasectomy|metastasectomy
389976|NCT01915212|Vaccination|vaccination
389977|NCT01915212|Replication-Defective|replication-defective
389978|NCT01915212|Genital Herpes|genital herpes
389979|NCT01915212|Safety|safety
389980|NCT01915212|Immune Responses|immune responses
389981|NCT01915186|DHEA|dhea
389982|NCT01915186|Poor ovarian reserve|poor ovarian reserve
389983|NCT01915186|Normal ovarian reserve|normal ovarian reserve
389984|NCT01915186|In vitro fertilization treatment|in vitro fertilization treatment
389985|NCT01915186|Ovarian response|ovarian response
389986|NCT01915186|Pregnancy outcomes|pregnancy outcomes
389987|NCT01915173|Gastroesophageal reflux disease (GERD)|gastroesophageal reflux disease (gerd)
389988|NCT01915173|Heartburn|heartburn
389989|NCT01915173|Dyspepsia|dyspepsia
389990|NCT01915147|oxycodone naloxone combination|oxycodone naloxone combination
389991|NCT01915147|severe chronic pain|severe chronic pain
389992|NCT01915147|non-malignant pain|non-malignant pain
389993|NCT01915147|Non-malignant pain that requires around-the-clock opioid therapy|non-malignant pain that requires around-the-clock opioid therapy
389994|NCT01915134|nasopharyngeal carcinoma|nasopharyngeal carcinoma
389995|NCT01915134|Recombinant Human Endostatin|recombinant human endostatin
389996|NCT01915134|chemotherapy|chemotherapy
389997|NCT01915134|gemcitabine and cisplatin|gemcitabine and cisplatin
389998|NCT01915121|Bladder Cancer|bladder cancer
389999|NCT01915121|Intervention|intervention
390000|NCT01915121|Education|education
390001|NCT01915121|Randomized Controlled Trials|randomized controlled trials
390002|NCT01915095|spinal cord injury|spinal cord injury
390003|NCT01915095|neural control|neural control
390004|NCT01915095|motor function|motor function
390005|NCT01915095|hand movement|hand movement
390006|NCT01915082|Lung Function|lung function
390007|NCT01915082|Allograft Outcome|allograft outcome
390008|NCT01915069|contraception|contraception
390009|NCT01915069|Cilostazol|cilostazol
390010|NCT01915069|phosphodiesterase inhibitors|phosphodiesterase inhibitors
390011|NCT01915069|To assess the ability of Cilostazol to act as a contraceptive agent|to assess the ability of cilostazol to act as a contraceptive agent
390012|NCT01915056|Comprehensive Geriatric Assessment (CGA)|comprehensive geriatric assessment (cga)
390013|NCT01915056|GA-driven interventions|ga-driven interventions
390014|NCT01915056|Toxicity|toxicity
390015|NCT01915056|Outcomes|outcomes
390016|NCT01915056|providing information|providing information
390017|NCT01915056|older cancer patients|older cancer patients
390018|NCT01915056|first-line chemotherapy|first-line chemotherapy
390019|NCT01915056|second-line chemotherapy|second-line chemotherapy
390020|NCT01915043|lymphedema, prevention, ehealth, cancer|lymphedema, prevention, ehealth, cancer
390021|NCT01915030|Muscle|muscle
390022|NCT01915030|Physical performance|physical performance
390023|NCT01915030|Protein|protein
390024|NCT01915030|Diet|diet
390025|NCT01915030|Caloric restriction|caloric restriction
390026|NCT01915017|Cognitive Adaptation Training|cognitive adaptation training
390027|NCT01915017|Cognitive Behavior Therapy for Psychosis|cognitive behavior therapy for psychosis
390028|NCT01915017|Schizophrenia|schizophrenia
390029|NCT01915004|Pediatric Urology|pediatric urology
390030|NCT01915004|Urotherapy|urotherapy
390031|NCT01915004|Nonneurogenic Lower Urinary Tract Dysfunction|nonneurogenic lower urinary tract dysfunction
390032|NCT01915004|Dysfunctional Elimination Syndrome|dysfunctional elimination syndrome
390033|NCT01915004|Randomized Controlled Trial|randomized controlled trial
390034|NCT01914991|proximal interphalangeal joint|proximal interphalangeal joint
390035|NCT01914991|Orthoses|orthoses
390036|NCT01914965|Huntington's disease|huntington's disease
390037|NCT01914965|Apathy|apathy
390038|NCT01914965|Bupropion|bupropion
390039|NCT01914952|CaHMB|cahmb
390040|NCT01914952|HMB free acid|hmb free acid
390041|NCT01914952|HMB|hmb
390042|NCT01914939|autism spectrum disorder|autism spectrum disorder
390043|NCT01914939|social skills deficits|social skills deficits
390044|NCT01914939|cognitive behavioral therapy|cognitive behavioral therapy
390045|NCT01914939|oxytocin|oxytocin
390046|NCT01914939|young adult|young adult
390047|NCT01914926|metoprolol|metoprolol
390048|NCT01914926|diltiazem|diltiazem
390049|NCT01914926|heart rate|heart rate
390050|NCT01914913|retinitis pigmentosa|retinitis pigmentosa
390051|NCT01914913|Bone marrow|bone marrow
390052|NCT01914913|stem cell|stem cell
390053|NCT01914913|BMMNC|bmmnc
390054|NCT01914900|oral cavity cancer|oral cavity cancer
390055|NCT01914900|induction chemotherapy|induction chemotherapy
390056|NCT01914900|TP53|tp53
390057|NCT01914900|beta tubulin II|beta tubulin ii
390058|NCT01914887|Ulcerative Colitis|ulcerative colitis
390059|NCT01914887|Inflammatory Bowel Disease|inflammatory bowel disease
390060|NCT01914887|Mesenchymal stem cells|mesenchymal stem cells
390061|NCT01914874|Community Sample|community sample
390062|NCT01914835|cocaine dependence|cocaine dependence
390063|NCT01914835|neuropsychological rehabilitation|neuropsychological rehabilitation
390064|NCT01914835|executive functions|executive functions
390065|NCT01914822|Ritalin|ritalin
390066|NCT01914822|methylphenidate hydrochloride|methylphenidate hydrochloride
390067|NCT01914822|experimental pain|experimental pain
390068|NCT01914796|Phase 1|phase 1
390069|NCT01914796|Randomized|randomized
390070|NCT01914796|Double Blind|double blind
390071|NCT01914796|Placebo-Controlled|placebo-controlled
390072|NCT01914796|Single-Dose Escalation|single-dose escalation
390073|NCT01914796|Safety|safety
390074|NCT01914796|Tolerability|tolerability
390075|NCT01914796|PK|pk
390076|NCT01914796|PD|pd
390077|NCT01914796|PF-06412562|pf-06412562
390078|NCT01914783|air pollution|air pollution
390079|NCT01914783|ozone|ozone
390080|NCT01914783|fine particle|fine particle
390081|NCT01914783|cytokine|cytokine
390082|NCT01914783|chemokine|chemokine
390083|NCT01914783|oxidative stress|oxidative stress
390084|NCT01914783|inflammation|inflammation
390085|NCT01914783|heart rate variability|heart rate variability
390086|NCT01914783|autonomic nervous system|autonomic nervous system
390087|NCT01914783|sympathetic nerve activity|sympathetic nerve activity
390088|NCT01914783|plasma catecholamine|plasma catecholamine
390089|NCT01914770|pooled analyses|pooled analyses
390090|NCT01914770|quality of life|quality of life
390091|NCT01914770|SELENA SLEDAI|selena sledai
390092|NCT01914770|SLE|sle
390093|NCT01914770|steroid use|steroid use
390094|NCT01914770|responder rate|responder rate
390095|NCT01914770|flares|flares
390096|NCT01914770|belimumab|belimumab
390097|NCT01914770|BILAG|bilag
390098|NCT01914757|Asthma, Bronchial Diseases, Respiratory Tract Diseases, Lung Diseases, Obstructive Lung Diseases|asthma, bronchial diseases, respiratory tract diseases, lung diseases, obstructive lung diseases
390099|NCT01914744|NHL|nhl
390100|NCT01914744|HBV|hbv
390101|NCT01914744|entecavir|entecavir
390102|NCT01914744|lamivudine|lamivudine
390103|NCT01914731|Fecal Microbiota Transplant|fecal microbiota transplant
390104|NCT01914731|Clostridium difficile|clostridium difficile
390105|NCT01914731|Diarrhea|diarrhea
390106|NCT01914718|DLBCL|dlbcl
390107|NCT01914718|DA-EPOCH-R|da-epoch-r
390108|NCT01914705|Landmark|landmark
390109|NCT01914705|Ultrasound|ultrasound
390110|NCT01914705|central venous catheter|central venous catheter
390111|NCT01914679|Fibromyalgia|fibromyalgia
390112|NCT01914679|Pain|pain
390113|NCT01914679|Brain|brain
390114|NCT01914679|Stimulation|stimulation
390115|NCT01914679|Device|device
390116|NCT01914679|Treatment|treatment
390117|NCT01914666|Chronic Low Back Pain|chronic low back pain
390118|NCT01914666|CLBP|clbp
390119|NCT01914640|Waist circumference, Metabolic Syndrome, Cardiovascular risk|waist circumference, metabolic syndrome, cardiovascular risk
390120|NCT01914627|Psoriasis capitis|psoriasis capitis
390121|NCT01914627|Scaling|scaling
390122|NCT01914627|Salicylic acid|salicylic acid
390123|NCT01914627|Dimethicone|dimethicone
390124|NCT01914627|Plaque removal|plaque removal
390125|NCT01914614|Breast Cancer|breast cancer
390126|NCT01914614|Working Women|working women
390127|NCT01914601|Laryngoscope|laryngoscope
390128|NCT01914601|Macintosh|macintosh
390129|NCT01914601|King Vision|king vision
390130|NCT01914601|tracheal intubation|tracheal intubation
390131|NCT01914601|cervical spines|cervical spines
390132|NCT01914536|POMPE|pompe
390133|NCT01914536|Glycogenosis type II|glycogenosis type ii
390134|NCT01914536|Acid maltase deficiency|acid maltase deficiency
390135|NCT01914523|Laryngoscope|laryngoscope
390136|NCT01914523|Macintosh|macintosh
390137|NCT01914523|Glidescope|glidescope
390138|NCT01914523|King Vision|king vision
390139|NCT01914523|AirTraq|airtraq
390140|NCT01914523|tracheal intubation|tracheal intubation
390141|NCT01914510|ovarian|ovarian
390142|NCT01914510|cancer|cancer
390143|NCT01914510|clear cell|clear cell
390144|NCT01914510|ENMD-2076|enmd-2076
390145|NCT01914510|oral|oral
390146|NCT01914510|capsule|capsule
390147|NCT01914484|tyrosine kinase inhibitor resistance|tyrosine kinase inhibitor resistance
390148|NCT01914484|chronic myeloid leukemia|chronic myeloid leukemia
390149|NCT01914484|acute lymphoblastic leukemia|acute lymphoblastic leukemia
390150|NCT01914484|nilotinib|nilotinib
390151|NCT01914484|ruxolitinib|ruxolitinib
390152|NCT01914458|Lung cancer|lung cancer
390153|NCT01914458|Low-dose computed tomography scan|low-dose computed tomography scan
390154|NCT01914419|Postpartum hemorrhage|postpartum hemorrhage
390155|NCT01914419|Oxytocin|oxytocin
390156|NCT01914419|Prevention|prevention
390157|NCT01914419|Third stage of labor|third stage of labor
390158|NCT01914419|Hemoglobin|hemoglobin
390159|NCT01914419|Intravenous|intravenous
390160|NCT01914419|Intramuscular|intramuscular
390161|NCT01914419|Bolus|bolus
390162|NCT01914406|Heart transplant recipients|heart transplant recipients
390163|NCT01914406|Exercise capacity|exercise capacity
390164|NCT01914406|endothelial function|endothelial function
390165|NCT01914406|Quality of life|quality of life
390166|NCT01914393|Schizophrenia|schizophrenia
390167|NCT01914393|Autism|autism
390168|NCT01914393|Lurasidone|lurasidone
390169|NCT01914393|Latuda|latuda
390548|NCT01912261|Anemia|anemia
390170|NCT01914380|Wet age-related macular degeneration|wet age-related macular degeneration
390171|NCT01914380|Anti-VEGF-Therapy|anti-vegf-therapy
390172|NCT01914380|Observational study|observational study
390173|NCT01914354|T cells|t cells
390174|NCT01914354|Human Alloimmune Reactivity|human alloimmune reactivity
390175|NCT01914354|immunosuppression|immunosuppression
390176|NCT01914341|Infant|infant
390177|NCT01914341|Newborn|newborn
390178|NCT01914341|Music|music
390179|NCT01914328|Postoperative Pulmonary Complications|postoperative pulmonary complications
390180|NCT01914328|PORC|porc
390181|NCT01914328|Surgical Related Outcome|surgical related outcome
390182|NCT01914328|Surgical Related Mortality|surgical related mortality
390183|NCT01914328|Postoperative ICU length of stay|postoperative icu length of stay
390184|NCT01914315|Rehabilitation|rehabilitation
390185|NCT01914315|Heart failure|heart failure
390186|NCT01914315|HFPEF|hfpef
390187|NCT01914315|Exercise training|exercise training
390188|NCT01914289|Intrahepatic Cholangiocarcinoma|intrahepatic cholangiocarcinoma
390189|NCT01914289|Prognosis|prognosis
390190|NCT01914289|Resection|resection
390191|NCT01914289|Radiotherapy|radiotherapy
390192|NCT01914263|Cord blood-Derived cytokine induced killer cells,|cord blood-derived cytokine induced killer cells,
390193|NCT01914263|Radical resection|radical resection
390194|NCT01914250|Frenotomy|frenotomy
390195|NCT01914250|Pain|pain
390196|NCT01914237|Single-Branched Stent Graft System|single-branched stent graft system
390197|NCT01914237|Aortic Dissection|aortic dissection
390198|NCT01914237|Endovascular Repair|endovascular repair
390199|NCT01914224|Prehypertension|prehypertension
390200|NCT01914224|Hypertension|hypertension
390201|NCT01914224|Sodium|sodium
390202|NCT01914224|Potassium|potassium
390203|NCT01914224|renin|renin
390204|NCT01914224|aldosterone|aldosterone
390205|NCT01914198|sleep study|sleep study
390206|NCT01914198|NCH|nch
390207|NCT01914185|Childhood|childhood
390208|NCT01914185|Physical activity|physical activity
390209|NCT01914185|Nutrition|nutrition
390210|NCT01914185|Health Promotion|health promotion
390211|NCT01914172|rare disease|rare disease
390212|NCT01914172|community-based participatory research|community-based participatory research
390213|NCT01914172|health promotion|health promotion
390214|NCT01914172|quantitative research|quantitative research
390215|NCT01914172|qualitative research|qualitative research
390216|NCT01914172|focus group|focus group
390217|NCT01914146|Diabetes|diabetes
390218|NCT01914146|Insulin|insulin
390219|NCT01914146|Orthostatic Hypotension|orthostatic hypotension
390220|NCT01914146|Falls|falls
390221|NCT01914146|Syncope|syncope
390222|NCT01914133|Acarbose|acarbose
390223|NCT01914133|PPH (Post Prandial Hypotension)|pph (post prandial hypotension)
390224|NCT01914133|Falls|falls
390225|NCT01914133|Syncope|syncope
390226|NCT01914133|Elderly|elderly
390227|NCT01914120|lung cancer|lung cancer
390228|NCT01914120|quality of life|quality of life
390229|NCT01914120|FACT-L|fact-l
390230|NCT01914107|malignancy|malignancy
390231|NCT01914107|solid tumor|solid tumor
390232|NCT01914107|cancer pain|cancer pain
390233|NCT01914094|Preoperative care|preoperative care
390234|NCT01914094|Exercise therapy|exercise therapy
390235|NCT01914094|Cardiac surgery|cardiac surgery
390236|NCT01914081|dilated cardiomyopathy|dilated cardiomyopathy
390237|NCT01914081|Resveratrol|resveratrol
390238|NCT01914068|Neoadjuvant chemoradiotherapy (NACRT)|neoadjuvant chemoradiotherapy (nacrt)
390239|NCT01914068|Rectal cancer|rectal cancer
390240|NCT01914068|Physical fitness|physical fitness
390241|NCT01914068|Exercise programme|exercise programme
390243|NCT01914068|Stage III/IV|stage iii/iv
390244|NCT01914068|Locally advanced operable|locally advanced operable
390245|NCT01914068|patients|patients
390246|NCT01914042|Opioid induced hyperalgesia|opioid induced hyperalgesia
390247|NCT01914042|Neuropathic pain|neuropathic pain
390248|NCT01914042|Opioids|opioids
390249|NCT01914042|Sciatica|sciatica
390250|NCT01914042|Serotonin-norepinephrine reuptake inhibitor (SNRI)|serotonin-norepinephrine reuptake inhibitor (snri)
390251|NCT01913990|Nausea|nausea
390252|NCT01913990|Vomiting|vomiting
390253|NCT01913938|Hemophagocytosis, adults, rhG-CSF|hemophagocytosis, adults, rhg-csf
390254|NCT01913899|phantom limb pain|phantom limb pain
390255|NCT01913899|mirror therapy|mirror therapy
390256|NCT01913899|amputees|amputees
390257|NCT01913899|phantom limb|phantom limb
390258|NCT01913899|occupational therapy|occupational therapy
390259|NCT01913886|Cardiovascular Diseases|cardiovascular diseases
390260|NCT01913886|Myocardial Ischemia|myocardial ischemia
390261|NCT01913886|Coronary Artery Disease|coronary artery disease
390262|NCT01913886|Heart Diseases|heart diseases
390263|NCT01913886|Coronary Disease|coronary disease
390264|NCT01913886|Ventricular Dysfunction|ventricular dysfunction
390265|NCT01913886|Arteriosclerosis|arteriosclerosis
390266|NCT01913873|High-sensitivity Cardiac Troponin|high-sensitivity cardiac troponin
390267|NCT01913873|Creatinin Kinase MB|creatinin kinase mb
390268|NCT01913873|Cardiac Surgery|cardiac surgery
390269|NCT01913873|Myocardial injury|myocardial injury
390270|NCT01913873|Myocardial infarction|myocardial infarction
390271|NCT01913873|Concentration change|concentration change
390272|NCT01913860|UTI|uti
390273|NCT01913860|antibiotics|antibiotics
390274|NCT01913860|prescribing|prescribing
390275|NCT01913860|primary care|primary care
390276|NCT01913834|Parathyroid hormone 1-34|parathyroid hormone 1-34
390277|NCT01913808|Postoperative anemia|postoperative anemia
390278|NCT01913808|Total knee arthroplasty|total knee arthroplasty
390279|NCT01913808|Iron therapy|iron therapy
390280|NCT01913782|Chronic low back pain, CLBC, fMRI|chronic low back pain, clbc, fmri
390281|NCT01913769|post-RT|post-rt
390282|NCT01913769|myocardial perfusion images|myocardial perfusion images
390283|NCT01913743|fMRI|fmri
390284|NCT01913743|cognitive strategies|cognitive strategies
390285|NCT01913743|obesity|obesity
390286|NCT01913743|weight loss|weight loss
390287|NCT01913743|mindsets|mindsets
390288|NCT01913730|Multiple Myeloma|multiple myeloma
390289|NCT01913730|Refractory|refractory
390290|NCT01913730|Relapsed|relapsed
390291|NCT01913717|Prostate cancer|prostate cancer
390292|NCT01913717|Radiotherapy|radiotherapy
390293|NCT01913717|hypofractionated radiotherapy|hypofractionated radiotherapy
390294|NCT01913704|venous leg ulcer|venous leg ulcer
390295|NCT01913704|mixed aetiology leg ulcers|mixed aetiology leg ulcers
390296|NCT01913691|Neuroendocrine Skin Cancer|neuroendocrine skin cancer
390297|NCT01913691|Merkel Cell Polyomavirus|merkel cell polyomavirus
390298|NCT01913691|Immunotherapy|immunotherapy
390299|NCT01913652|dedifferentiated liposarcoma|dedifferentiated liposarcoma
390300|NCT01913652|cabazitaxel|cabazitaxel
390301|NCT01913639|BAY 73-4506 (REGORAFENIB)|bay 73-4506 (regorafenib)
390302|NCT01913639|FLUOROURACIL|fluorouracil
390303|NCT01913639|LEUCOVORIN|leucovorin
390304|NCT01913639|OXALIPLATIN|oxaliplatin
390305|NCT01913626|subjective memory complains|subjective memory complains
390306|NCT01913600|TARGET LESION REVASCULARIZATION (TLR)|target lesion revascularization (tlr)
390307|NCT01913600|TARGET VESSEL REVASCULARIZATION (TVR)|target vessel revascularization (tvr)
390308|NCT01913600|Coronary Artery Disease|coronary artery disease
390309|NCT01913600|MYOCARDIAL INFARCTION (MI)|myocardial infarction (mi)
390310|NCT01913600|PERCUTANEOUS CORONARY INTERVENTION (PCI)|percutaneous coronary intervention (pci)
390311|NCT01913600|STENT THROMBOSIS|stent thrombosis
390312|NCT01913600|TARGET LESION FAILURE (TLF)|target lesion failure (tlf)
390313|NCT01913561|Electrocardiogram|electrocardiogram
390314|NCT01913561|gel electrodes|gel electrodes
390315|NCT01913561|textile electrodes|textile electrodes
390316|NCT01913535|Depression|depression
390317|NCT01913535|Treatment Resistant Depression|treatment resistant depression
390318|NCT01913535|Antidepressant|antidepressant
390319|NCT01913535|Major Depression|major depression
390320|NCT01913535|MDD|mdd
390321|NCT01913509|hemiplegic shoulder pain|hemiplegic shoulder pain
390322|NCT01913509|poststroke fatigue|poststroke fatigue
390323|NCT01913509|functional electrical stimulation|functional electrical stimulation
390324|NCT01913509|stroke rehabilitation|stroke rehabilitation
390325|NCT01913496|web application|web application
390326|NCT01913496|nutrition knowledge|nutrition knowledge
390327|NCT01913496|physical activity|physical activity
390328|NCT01913470|NAFLD|nafld
390329|NCT01913470|Non-alcoholic Fatty Liver Disease|non-alcoholic fatty liver disease
390330|NCT01913470|Obesity|obesity
390331|NCT01913470|Pediatrics|pediatrics
390332|NCT01913470|Children|children
390333|NCT01913470|Losartan|losartan
390334|NCT01913470|Cozaar|cozaar
390335|NCT01913457|Ultrasound Doppler|ultrasound doppler
390336|NCT01913457|Lungs|lungs
390337|NCT01913457|Pulmonary artery hypertension|pulmonary artery hypertension
390338|NCT01913444|Recombinant Antithrombin|recombinant antithrombin
390339|NCT01913444|ATryn|atryn
390340|NCT01913444|Pharmacokinetics|pharmacokinetics
390341|NCT01913444|ECMO|ecmo
390342|NCT01913444|Neonates|neonates
390343|NCT01913418|Traditional Chinese Medicine|traditional chinese medicine
390344|NCT01913418|Suan-Zao-Ren Tang|suan-zao-ren tang
390345|NCT01913418|Methadone|methadone
390346|NCT01913418|Opiate dependence|opiate dependence
390347|NCT01913418|Sleep|sleep
390348|NCT01913379|Phase 1|phase 1
390349|NCT01913379|MDV3100|mdv3100
390350|NCT01913379|Gemfibrozil|gemfibrozil
390351|NCT01913379|Itraconazole|itraconazole
390352|NCT01913379|Xtandi|xtandi
390353|NCT01913379|enzalutamide|enzalutamide
390354|NCT01913340|erythropoietin|erythropoietin
390355|NCT01913340|therapeutic hypothermia|therapeutic hypothermia
390356|NCT01913327|cognition|cognition
390357|NCT01913327|executive function|executive function
390358|NCT01913327|prefrontal cortex|prefrontal cortex
390359|NCT01913327|locus coeruleus|locus coeruleus
390360|NCT01913288|neonatal care, preterm, maternal sounds, auditory stimulation|neonatal care, preterm, maternal sounds, auditory stimulation
390361|NCT01913275|cholecystojejunostomy|cholecystojejunostomy
390362|NCT01913275|whipple's pancreaticoduodenectomy|whipple's pancreaticoduodenectomy
390363|NCT01913275|endoscopic stenting|endoscopic stenting
390364|NCT01913275|hyperbilirubinemia|hyperbilirubinemia
390365|NCT01913262|depression|depression
390366|NCT01913262|phq9|phq9
390367|NCT01913262|phq-9|phq-9
390368|NCT01913262|standard treatment|standard treatment
390369|NCT01913249|Anorectal fistula|anorectal fistula
390370|NCT01913249|LIFT|lift
390371|NCT01913249|Seton|seton
390372|NCT01913236|Tailored implementation interventions|tailored implementation interventions
390373|NCT01913236|Primary care|primary care
390374|NCT01913236|Depression in the elderly|depression in the elderly
390375|NCT01913223|Endoscopic submucosal dissection|endoscopic submucosal dissection
390376|NCT01913223|jet injector|jet injector
390377|NCT01913223|saline solution|saline solution
390378|NCT01913223|safety|safety
390379|NCT01913223|effectiveness|effectiveness
390380|NCT01913197|Prostate Brachytherapy|prostate brachytherapy
390381|NCT01913132|NPWT; vascular surgery; inguinal incisions|npwt; vascular surgery; inguinal incisions
390382|NCT01913119|extranodal NKTcell lymphoma|extranodal nktcell lymphoma
390383|NCT01913093|Childhood leukemia survivors|childhood leukemia survivors
390384|NCT01913093|Acute lymphoblastic leukemia|acute lymphoblastic leukemia
390385|NCT01913093|Leukemia|leukemia
390386|NCT01913093|Late effects|late effects
390387|NCT01913093|Folate|folate
390388|NCT01913093|Blood folate|blood folate
390389|NCT01913093|Neurotoxicity|neurotoxicity
390390|NCT01913093|Methotrexate|methotrexate
390391|NCT01913093|Pharmacogenetics|pharmacogenetics
390392|NCT01913093|Cognitive|cognitive
390393|NCT01913093|Cognitive late effects|cognitive late effects
390394|NCT01913093|N-PhenoGENICS|n-phenogenics
390395|NCT01913080|health management|health management
390396|NCT01913067|brain metastasis|brain metastasis
390397|NCT01913067|breast cancer|breast cancer
390398|NCT01913067|HER2 negative|her2 negative
390399|NCT01913067|NSCLC|nsclc
390400|NCT01913054|Etomidate|etomidate
390401|NCT01913054|Propofol|propofol
390402|NCT01913054|Painless gastroscopy|painless gastroscopy
390403|NCT01913041|perioperative hypothermia|perioperative hypothermia
390404|NCT01913041|Epidemiology|epidemiology
390405|NCT01913041|Tympanic temperature|tympanic temperature
390406|NCT01913028|safety, tolerability, pharmacokinetics,immunogenicity, MEDI9929, Japanese|safety, tolerability, pharmacokinetics,immunogenicity, medi9929, japanese
390407|NCT01912989|motivational interviewing|motivational interviewing
390408|NCT01912989|obesity|obesity
390409|NCT01912989|parent|parent
390410|NCT01912976|Bowen's disease|bowen's disease
390411|NCT01912976|Er:YAG|er:yag
390412|NCT01912976|AFL-assisted|afl-assisted
390413|NCT01912976|MAL-PDT|mal-pdt
390414|NCT01912963|HER-2 Positive Breast Cancer|her-2 positive breast cancer
390415|NCT01912963|Metastatic Breast Cancer|metastatic breast cancer
390416|NCT01912950|intense pulsed light|intense pulsed light
390417|NCT01912950|IPL|ipl
390418|NCT01912950|healthy volunteer|healthy volunteer
390549|NCT01912261|Postoperative fatigue|postoperative fatigue
390419|NCT01912950|light-based hair removal|light-based hair removal
390420|NCT01912950|hair removal|hair removal
390421|NCT01912950|epilation|epilation
390422|NCT01912950|laser hair removal|laser hair removal
390423|NCT01912950|permanent hair reduction|permanent hair reduction
390424|NCT01912937|Paclitaxel|paclitaxel
390528|NCT01912352|Response|response
390425|NCT01912937|Percutaneous Transluminal Angioplasty|percutaneous transluminal angioplasty
390426|NCT01912937|Balloon Catheter|balloon catheter
390427|NCT01912937|Pharmacokinetic|pharmacokinetic
390428|NCT01912937|Peripheral Artery Disease|peripheral artery disease
390429|NCT01912937|PAD|pad
390430|NCT01912924|chronic pain from failed knee surgery|chronic pain from failed knee surgery
390431|NCT01912846|End-of-life care|end-of-life care
390432|NCT01912846|Preference of end-of-life care|preference of end-of-life care
390433|NCT01912846|RCT|rct
390434|NCT01912846|Terminally ill cancer patients|terminally ill cancer patients
390435|NCT01912833|postpartum depression|postpartum depression
390436|NCT01912807|Postoperative vomiting|postoperative vomiting
390437|NCT01912807|Children|children
390438|NCT01912794|Cerebrovascular Accident|cerebrovascular accident
390439|NCT01912794|Rehabilitation|rehabilitation
390440|NCT01912794|Sensory System|sensory system
390441|NCT01912781|contact lenses|contact lenses
390442|NCT01912781|contact lens solution|contact lens solution
390443|NCT01912781|gas permeable contact lenses|gas permeable contact lenses
390444|NCT01912768|contact lenses|contact lenses
390445|NCT01912768|contact lens solution|contact lens solution
390446|NCT01912768|soft contact lenses|soft contact lenses
390447|NCT01912755|Pulpitis|pulpitis
390448|NCT01912755|Hot tooth|hot tooth
390449|NCT01912755|Articaine|articaine
390450|NCT01912755|Lidocaine|lidocaine
390451|NCT01912755|Local anesthetics|local anesthetics
390452|NCT01912742|Weight loss|weight loss
390453|NCT01912742|Speed of weight loss|speed of weight loss
390454|NCT01912742|Metabolic compensation|metabolic compensation
390455|NCT01912742|Diet therapy|diet therapy
390456|NCT01912729|Depression prevention|depression prevention
390457|NCT01912729|Technology Assisted|technology assisted
390458|NCT01912729|Adolescents|adolescents
390459|NCT01912729|Peer networked|peer networked
390460|NCT01912716|pancreatitis|pancreatitis
390461|NCT01912716|ERCP|ercp
390462|NCT01912677|hypertension in pregnancy|hypertension in pregnancy
390463|NCT01912677|preeclampsia|preeclampsia
390464|NCT01912677|anti-hypertension|anti-hypertension
390465|NCT01912677|labetalol|labetalol
390466|NCT01912677|nifedipine|nifedipine
390467|NCT01912677|methyldopa|methyldopa
390468|NCT01912651|facial skin wound|facial skin wound
390469|NCT01912651|facial wound|facial wound
390470|NCT01912651|skin wound|skin wound
390471|NCT01912651|facial defect|facial defect
390472|NCT01912651|reconstructive skin graft|reconstructive skin graft
390473|NCT01912638|Trabeculectomy|trabeculectomy
390474|NCT01912638|Glaucoma|glaucoma
390475|NCT01912638|Steroids|steroids
390476|NCT01912638|Ologen|ologen
390477|NCT01912638|Viscoelastic|viscoelastic
390478|NCT01912612|Breast cancer|breast cancer
390479|NCT01912612|Pain sensitivity|pain sensitivity
390480|NCT01912599|Glaucoma|glaucoma
390481|NCT01912599|Intraocular Pressure|intraocular pressure
390482|NCT01912599|Blood Pressure|blood pressure
390483|NCT01912586|erectile dysfunction|erectile dysfunction
390484|NCT01912586|laparoscopic surgery|laparoscopic surgery
390485|NCT01912586|rectal cancer|rectal cancer
390486|NCT01912586|sildenafil|sildenafil
390487|NCT01912586|vacuum erection device|vacuum erection device
390488|NCT01912573|heroin|heroin
390489|NCT01912573|prescription pain killers|prescription pain killers
390490|NCT01912573|narcotics|narcotics
390491|NCT01912534|Sarcomere Mutations|sarcomere mutations
390492|NCT01912521|HIV|hiv
390493|NCT01912521|Stigma|stigma
390494|NCT01912521|Social support|social support
390495|NCT01912521|Social network|social network
390496|NCT01912521|Kenya|kenya
390497|NCT01912508|cervical length|cervical length
390498|NCT01912508|cervical curvature|cervical curvature
390499|NCT01912469|Muscle|muscle
390500|NCT01912469|exercise|exercise
390501|NCT01912469|soreness|soreness
390502|NCT01912469|Damage|damage
390503|NCT01912469|Traumeel|traumeel
390504|NCT01912456|Hereditary Angioedema|hereditary angioedema
390505|NCT01912430|Integrated Care Coaching|integrated care coaching
390506|NCT01912430|Chronic Care Coaching|chronic care coaching
390507|NCT01912430|Care Coaching|care coaching
390508|NCT01912417|HEMODIALYSIS|hemodialysis
390509|NCT01912417|Kidney Failure, Chronic|kidney failure, chronic
390510|NCT01912417|AEROBIC EXERCISE|aerobic exercise
390511|NCT01912404|alcoholic hepatitis|alcoholic hepatitis
390512|NCT01912391|Depression|depression
390513|NCT01912391|Anxiety|anxiety
390514|NCT01912391|Headaches|headaches
390515|NCT01912391|Migraines|migraines
390516|NCT01912391|Irritable Bowel Syndrome IBS|irritable bowel syndrome ibs
390517|NCT01912391|Neurodermatitis|neurodermatitis
390518|NCT01912391|Fibromyalgia|fibromyalgia
390519|NCT01912391|Premenstrual Syndrome PMS|premenstrual syndrome pms
390520|NCT01912391|Temporomandibular Joint Dysfunction TMJ|temporomandibular joint dysfunction tmj
390521|NCT01912365|Fracture|fracture
390522|NCT01912365|Supracondylar|supracondylar
390523|NCT01912365|Pediatric|pediatric
390524|NCT01912365|Orthopedic|orthopedic
390525|NCT01912352|ADHD|adhd
390526|NCT01912352|ADRA2A|adra2a
390527|NCT01912352|Methylphenidate|methylphenidate
390529|NCT01912339|Hyperlasia|hyperlasia
390530|NCT01912339|Retention|retention
390531|NCT01912339|Prostate|prostate
390532|NCT01912326|pacemaker|pacemaker
390533|NCT01912326|atrial fibrillation|atrial fibrillation
390534|NCT01912313|IBS patients|ibs patients
390535|NCT01912313|healthy subjects|healthy subjects
390536|NCT01912287|Generalized Anxiety Disorder|generalized anxiety disorder
390537|NCT01912287|GAD|gad
390538|NCT01912287|Yoga|yoga
390539|NCT01912287|CBT|cbt
390540|NCT01912274|AML|aml
390541|NCT01912274|open label|open label
390542|NCT01912274|nonrandomized|nonrandomized
390543|NCT01912274|single arm|single arm
390544|NCT01912274|elderly patients|elderly patients
390545|NCT01912274|HMA|hma
390546|NCT01912274|newly diagnosed|newly diagnosed
390547|NCT01912261|Coronary artery bypass grafting|coronary artery bypass grafting
390550|NCT01912261|Functional Capacity|functional capacity
390551|NCT01912261|Iron|iron
390552|NCT01912261|Adherence|adherence
390553|NCT01912261|Quality of Life|quality of life
390554|NCT01912248|acute rise of systolic and diastolic bloodpressure|acute rise of systolic and diastolic bloodpressure
390555|NCT01912235|Arginine synthesis|arginine synthesis
390556|NCT01912235|15N2 arginine, 1-13C Glutamine, 2-15N Glutamine, 15N Proline|15n2 arginine, 1-13c glutamine, 2-15n glutamine, 15n proline
390557|NCT01912209|employees|employees
390558|NCT01912209|metabolic syndrome|metabolic syndrome
390559|NCT01912209|obesity|obesity
390560|NCT01912209|sub-clinical cardiovascular disease|sub-clinical cardiovascular disease
390561|NCT01912209|weight loss|weight loss
390562|NCT01912209|diet|diet
390563|NCT01912196|Depressive Disorder|depressive disorder
390564|NCT01912183|pediatric obesity|pediatric obesity
390565|NCT01912183|e-learning|e-learning
390566|NCT01912183|personal health record|personal health record
390567|NCT01912183|personal electronic device|personal electronic device
390568|NCT01912183|pilot|pilot
390569|NCT01912170|omega-3 fatty acid|omega-3 fatty acid
390570|NCT01912170|gestational diabetes|gestational diabetes
390571|NCT01912170|insulin sensitivity|insulin sensitivity
390572|NCT01912131|13-120|13-120
390573|NCT01912118|Nociception|nociception
390574|NCT01912118|General anesthesia|general anesthesia
390575|NCT01912105|endotracheal tube|endotracheal tube
390576|NCT01912105|ct scan|ct scan
390577|NCT01912105|cleaning device|cleaning device
390578|NCT01912105|biofilm|biofilm
390579|NCT01912105|mechanical ventilation|mechanical ventilation
390580|NCT01912053|Intra-hepatic Cholangiocarcinoma treatment|intra-hepatic cholangiocarcinoma treatment
390581|NCT01912040|Safety profile|safety profile
390582|NCT01912040|locally produced 123 Iodine MIBG|locally produced 123 iodine mibg
390583|NCT01912014|stroke|stroke
390584|NCT01912014|psychosocial|psychosocial
390585|NCT01912014|intervention|intervention
390586|NCT01912014|quality of life|quality of life
390587|NCT01912001|end stage renal disease|end stage renal disease
390588|NCT01912001|kidney failure|kidney failure
390589|NCT01912001|home dialysis|home dialysis
390590|NCT01912001|hemodialysis|hemodialysis
390591|NCT01912001|peritoneal dialysis|peritoneal dialysis
390592|NCT01912001|gaps in care|gaps in care
390593|NCT01912001|co-morbidity|co-morbidity
390594|NCT01912001|transitions of care settings|transitions of care settings
390595|NCT01911988|Peripheral immune cells|peripheral immune cells
390596|NCT01911988|Colorectal Cancers|colorectal cancers
390597|NCT01911988|Stage II/ Stage III|stage ii/ stage iii
390598|NCT01911988|Recurrence|recurrence
390599|NCT01911988|Metastasis|metastasis
390600|NCT01911975|Small Fiber Neuropathy|small fiber neuropathy
390601|NCT01911975|Painful Neuropathy|painful neuropathy
390602|NCT01911975|NAV1.7 Voltage-Gated Sodium Channel|nav1.7 voltage-gated sodium channel
390603|NCT01911975|SCN9A|scn9a
390604|NCT01911949|femoral nerve block|femoral nerve block
390605|NCT01911949|ultrasound guided|ultrasound guided
390606|NCT01911949|total hip arthroplasty|total hip arthroplasty
390607|NCT01911936|CLJM716,|cljm716,
390608|NCT01911936|Japanese patients,|japanese patients,
390609|NCT01911936|Neoplasms|neoplasms
390610|NCT01911910|primary prevention|primary prevention
390611|NCT01911910|Cardiovascular disease|cardiovascular disease
390612|NCT01911910|Cardiovascular magnetic resonance (CMR)|cardiovascular magnetic resonance (cmr)
390613|NCT01911910|Electronic coaching (e-coaching)|electronic coaching (e-coaching)
390614|NCT01911897|Hypertension|hypertension
390615|NCT01911884|Rokitansky syndrome|rokitansky syndrome
390616|NCT01911884|surgical or vaginal dilatation of vaginal aplasia|surgical or vaginal dilatation of vaginal aplasia
390617|NCT01911884|quality of global and sexual life|quality of global and sexual life
390618|NCT01911871|Thalassemia|thalassemia
390619|NCT01911871|sickle cell disease|sickle cell disease
390620|NCT01911871|myelodysplasia|myelodysplasia
390621|NCT01911871|transfusion|transfusion
390622|NCT01911871|chelation|chelation
390623|NCT01911845|HCV Genotype 1|hcv genotype 1
390624|NCT01911845|Hepatitis Genotype 1|hepatitis genotype 1
390625|NCT01911845|Interferon Free|interferon free
390626|NCT01911845|methadone|methadone
390627|NCT01911845|HCV|hcv
390628|NCT01911845|Buprenorphine|buprenorphine
390629|NCT01911845|Hepatitis C|hepatitis c
390630|NCT01911845|Viekira Pak|viekira pak
390631|NCT01911845|paritaprevir|paritaprevir
390632|NCT01911845|Viekira|viekira
390633|NCT01911845|ombitasvir|ombitasvir
390634|NCT01911845|dasabuvir|dasabuvir
390635|NCT01911832|Cancer of the esophagogastric junction|cancer of the esophagogastric junction
390636|NCT01911832|Reconstruction of gastric tube|reconstruction of gastric tube
390637|NCT01911832|Quality of life|quality of life
390638|NCT01911832|Width|width
390639|NCT01911832|Regurgitation|regurgitation
390640|NCT01911819|Histomorphometric Analysis|histomorphometric analysis
390641|NCT01911819|New bone Formation|new bone formation
390642|NCT01911819|Sinus Augmentation|sinus augmentation
390643|NCT01911819|Bone Graft Materials|bone graft materials
390644|NCT01911806|Back care pillow|back care pillow
390645|NCT01911806|chronic non-specific low back pain|chronic non-specific low back pain
390646|NCT01911806|randomized controlled trial|randomized controlled trial
390647|NCT01911793|stoma|stoma
390648|NCT01911793|ileus|ileus
390649|NCT01911793|postoperative|postoperative
390650|NCT01911793|stoma tube|stoma tube
390651|NCT01911741|Phase I|phase i
390652|NCT01911741|Enzalutamide|enzalutamide
390653|NCT01911741|Relative bioavailability of MDV3100|relative bioavailability of mdv3100
390654|NCT01911741|Immediate release oral formulation|immediate release oral formulation
390655|NCT01911741|Xtandi|xtandi
390656|NCT01911728|Drug-Drug Interaction|drug-drug interaction
390657|NCT01911728|Phase 1|phase 1
390658|NCT01911728|MDV3100|mdv3100
390659|NCT01911728|Xtandi|xtandi
390660|NCT01911728|Enzalutamide|enzalutamide
390661|NCT01911715|Phase 1|phase 1
390662|NCT01911715|Mass Balance|mass balance
390663|NCT01911715|MDV3100|mdv3100
390664|NCT01911715|Xtandi|xtandi
390665|NCT01911715|Enzalutamide|enzalutamide
390666|NCT01911715|Metabolism|metabolism
390667|NCT01911715|Excretion|excretion
390668|NCT01911689|pancreatitis|pancreatitis
390669|NCT01911689|MRI|mri
390670|NCT01911689|APACHEⅡ|apacheⅱ
390671|NCT01911689|T2*|t2*
390672|NCT01911689|T2 star|t2 star
390673|NCT01911650|Achilles|achilles
390674|NCT01911650|tendinopathy|tendinopathy
390675|NCT01911637|Healthy|healthy
390676|NCT01911637|Subjects|subjects
390677|NCT01911637|Safety|safety
390678|NCT01911637|Tolerability|tolerability
390679|NCT01911637|VBY-036|vby-036
390680|NCT01911637|Maximum|maximum
390681|NCT01911637|Pharmacodynamic|pharmacodynamic
390682|NCT01911637|Pharmacokinetic|pharmacokinetic
390683|NCT01911585|Posttraumatic Stress Disorder|posttraumatic stress disorder
390684|NCT01911585|PTSD|ptsd
390685|NCT01911585|Prolonged Exposure Therapy|prolonged exposure therapy
390686|NCT01911585|Cognitive Behavioral Therapy|cognitive behavioral therapy
390687|NCT01911572|Streptococcus species|streptococcus species
390688|NCT01911572|Streptococcus pyogenes|streptococcus pyogenes
390689|NCT01911572|Streptococcus agalactiae|streptococcus agalactiae
390690|NCT01911572|Necrotising fasciitis|necrotising fasciitis
390691|NCT01911572|Sepsis|sepsis
390692|NCT01911559|Standing-frame|standing-frame
390693|NCT01911559|Chronic constipation|chronic constipation
390694|NCT01911559|Cerebral palsy|cerebral palsy
390695|NCT01911559|Quadriplegia|quadriplegia
390696|NCT01911559|Severe diplegia|severe diplegia
390697|NCT01911494|cluster randomized controlled trial|cluster randomized controlled trial
390698|NCT01911494|pre-eclampsia|pre-eclampsia
390699|NCT01911494|eclampsia|eclampsia
390700|NCT01911494|maternal mortality|maternal mortality
390701|NCT01911468|PCOS|pcos
390702|NCT01911468|obesity|obesity
390703|NCT01911468|GLP-1 receptor agonist|glp-1 receptor agonist
390704|NCT01911468|liraglutide|liraglutide
390705|NCT01911468|metformin|metformin
390706|NCT01911455|Fragile X Syndrome|fragile x syndrome
390707|NCT01911442|Autism, Lurasidone, Latuda|autism, lurasidone, latuda
390708|NCT01911429|schizophrenia|schizophrenia
390709|NCT01911429|Lurasidone|lurasidone
390710|NCT01911429|Latuda|latuda
390711|NCT01911403|Femoral Artery puncture|femoral artery puncture
390712|NCT01911390|High cholesterol.|high cholesterol.
390713|NCT01911364|Frequent exacerbators|frequent exacerbators
390714|NCT01911351|nitrous oxide|nitrous oxide
390715|NCT01911351|pediatric pain and anxiety|pediatric pain and anxiety
390716|NCT01911338|Spinal Manipulation|spinal manipulation
390717|NCT01911338|Teaching|teaching
390718|NCT01911338|Thoracic Vertebrae|thoracic vertebrae
390719|NCT01911338|Feedback|feedback
390720|NCT01911325|Squamous non-small cell lung cancer|squamous non-small cell lung cancer
390721|NCT01911325|NSCLC|nsclc
390722|NCT01911325|Docetaxel|docetaxel
390723|NCT01911325|Buparlisib|buparlisib
390724|NCT01911325|BKM120|bkm120
390725|NCT01911325|Metastatic|metastatic
390726|NCT01911325|Stage IIIb|stage iiib
390727|NCT01911325|Stage IV|stage iv
390728|NCT01911325|PI3K inhibitor|pi3k inhibitor
390729|NCT01911299|Choline|choline
390730|NCT01911299|Glycerophosphocholine|glycerophosphocholine
390731|NCT01911299|Choline alphoscerate|choline alphoscerate
390732|NCT01911299|Fetal alcohol spectrum disorders|fetal alcohol spectrum disorders
390733|NCT01911299|Fetal alcohol syndrome|fetal alcohol syndrome
390734|NCT01911299|Partial fetal alcohol syndrome|partial fetal alcohol syndrome
390735|NCT01911299|Alcohol-related neurodevelopmental disorder|alcohol-related neurodevelopmental disorder
390736|NCT01911299|Prenatal alcohol exposure|prenatal alcohol exposure
390737|NCT01911299|Fetal Alcohol Effects|fetal alcohol effects
390738|NCT01911299|Pregnancy Complications|pregnancy complications
390739|NCT01911299|Alcohol-Induced Disorders|alcohol-induced disorders
390740|NCT01911299|Alcohol-Related Disorders|alcohol-related disorders
390741|NCT01911299|Central Nervous System Agents|central nervous system agents
390742|NCT01911299|Therapeutic Uses|therapeutic uses
390743|NCT01911273|Hepatocellular carcinoma|hepatocellular carcinoma
390744|NCT01911273|monoclonal antibody|monoclonal antibody
390745|NCT01911273|ALK-1|alk-1
390746|NCT01911273|best supportive care|best supportive care
390747|NCT01911260|Zinc|zinc
390748|NCT01911260|Growth|growth
390749|NCT01911260|Child|child
390750|NCT01911260|Dietary Supplements|dietary supplements
390751|NCT01911260|Randomized Controlled Trial|randomized controlled trial
390752|NCT01911221|Meningococcal disease,|meningococcal disease,
390753|NCT01911221|Adults|adults
499779|NCT01432002|FDG|fdg
390754|NCT01911208|Minority|minority
390755|NCT01911208|Recruitment|recruitment
390756|NCT01911195|General anesthesia|general anesthesia
390757|NCT01911195|cognition|cognition
390758|NCT01911195|consciousness|consciousness
390759|NCT01911182|apnea of prematurity|apnea of prematurity
390760|NCT01911182|control of breathing|control of breathing
390761|NCT01911182|newborn|newborn
390762|NCT01911182|CO2 inhalation|co2 inhalation
390763|NCT01911169|atherosclerosis|atherosclerosis
390764|NCT01911169|systemic lupus erythematosus|systemic lupus erythematosus
390765|NCT01911169|flow mediated dilation|flow mediated dilation
390766|NCT01911169|interferon gene signature|interferon gene signature
390767|NCT01911156|Chronic Hepatitis B|chronic hepatitis b
390768|NCT01911130|outcomes measures|outcomes measures
390769|NCT01911130|strength measurement|strength measurement
390770|NCT01911130|disease progression|disease progression
390771|NCT01911104|muscle|muscle
390772|NCT01911104|mitochondrial function|mitochondrial function
390773|NCT01911104|exercise resistance|exercise resistance
390774|NCT01911104|human|human
390775|NCT01911104|myotubes|myotubes
390776|NCT01911104|epigenetics|epigenetics
390777|NCT01911091|skeletal muscle|skeletal muscle
390778|NCT01911091|adipose tissue|adipose tissue
390779|NCT01911091|metabolism|metabolism
390780|NCT01911091|oxidation|oxidation
390781|NCT01911091|mitochondrial capacity|mitochondrial capacity
390782|NCT01911078|Metabolic syndrome|metabolic syndrome
390783|NCT01911078|Renal denervation|renal denervation
390784|NCT01911078|Renal artery|renal artery
390785|NCT01911078|Muscle sympathetic nerve activity|muscle sympathetic nerve activity
390786|NCT01911065|Herpes zoster|herpes zoster
390787|NCT01911065|immune response|immune response
390788|NCT01911065|Zostavax|zostavax
390789|NCT01911065|twins|twins
390790|NCT01911065|non-twins|non-twins
390791|NCT01911052|Bowel preparation|bowel preparation
390792|NCT01911039|GVHD|gvhd
390793|NCT01911039|cGVHD|cgvhd
390794|NCT01911026|Bowel preparation|bowel preparation
390795|NCT01911013|degenerative cervical disease|degenerative cervical disease
390796|NCT01911013|anterior cervical discectomy and fusion|anterior cervical discectomy and fusion
390797|NCT01911013|plate and cage|plate and cage
390798|NCT01911013|cage alone|cage alone
390799|NCT01910987|Multiple Myeloma|multiple myeloma
390800|NCT01910987|bortezomib|bortezomib
390801|NCT01910987|Velcade|velcade
390802|NCT01910987|First or Second Relapse|first or second relapse
390803|NCT01910987|retreatment|retreatment
390804|NCT01910987|Prolonged therapy|prolonged therapy
390805|NCT01910974|oesophagus|oesophagus
390806|NCT01910974|stomach|stomach
390807|NCT01910974|intestine|intestine
390808|NCT01910974|rectum|rectum
390809|NCT01910948|omega-3 gastric cancer perioperation|omega-3 gastric cancer perioperation
390810|NCT01910935|Physical activity|physical activity
390811|NCT01910935|Hypertension|hypertension
390812|NCT01910935|Scheme reference|scheme reference
390813|NCT01910935|Primary care|primary care
390814|NCT01910922|vegetable acceptance|vegetable acceptance
390815|NCT01910922|vegetable intake|vegetable intake
390816|NCT01910922|vegetable liking|vegetable liking
390817|NCT01910922|learning mechanisms|learning mechanisms
390818|NCT01910922|repeated exposure to flavor|repeated exposure to flavor
390819|NCT01910922|flavor learning|flavor learning
390820|NCT01910922|replace salt with spice|replace salt with spice
390821|NCT01910909|Hepatocellular carcinoma|hepatocellular carcinoma
390822|NCT01910909|unresectable|unresectable
390823|NCT01910909|small size|small size
390824|NCT01910909|Stereotactic body radiotherapy|stereotactic body radiotherapy
390825|NCT01910883|Safety|safety
390826|NCT01910883|Tolerability|tolerability
390827|NCT01910883|Pharmacokinetic|pharmacokinetic
390828|NCT01910870|Early-relapse|early-relapse
390829|NCT01910844|triple negative breast cancer|triple negative breast cancer
390830|NCT01910844|late-relapse|late-relapse
390831|NCT01910831|bruising, reduction, older age, aging|bruising, reduction, older age, aging
390832|NCT01910818|radiation|radiation
390833|NCT01910818|dermatitis|dermatitis
390834|NCT01910818|laser|laser
390835|NCT01910818|fractional|fractional
390837|NCT01910818|chronic|chronic
390838|NCT01910818|fibrosis|fibrosis
390839|NCT01910818|scar|scar
390840|NCT01910805|Gestational diabetes|gestational diabetes
390841|NCT01910805|Diabetes mellitus|diabetes mellitus
390842|NCT01910805|diabetes in pregnancy|diabetes in pregnancy
390843|NCT01910805|diabetes risk|diabetes risk
390844|NCT01910805|diabetes risk awareness|diabetes risk awareness
390845|NCT01910805|African-American|african-american
390846|NCT01910805|Women|women
390847|NCT01910779|Atrial Fibrillation|atrial fibrillation
390848|NCT01910779|Cardioversion|cardioversion
390849|NCT01910779|Biphasic Shock|biphasic shock
390850|NCT01910766|pcos|pcos
390851|NCT01910766|coenzymeQ10|coenzymeq10
390852|NCT01910766|clomiphene citrate|clomiphene citrate
390853|NCT01910753|Head and neck cancer,|head and neck cancer,
793594|NCT00280241|Leukemia|leukemia
390854|NCT01910753|physical activity,|physical activity,
390855|NCT01910753|nutrition therapeutic education|nutrition therapeutic education
390856|NCT01910740|Randomized Controlled Trial|randomized controlled trial
390857|NCT01910740|Exercise Movement Techniques|exercise movement techniques
390858|NCT01910740|Frail Elderly|frail elderly
390859|NCT01910740|Gait|gait
390860|NCT01910727|American Indian|american indian
390861|NCT01910727|Diabetes|diabetes
390862|NCT01910727|Pre-diabetes|pre-diabetes
390863|NCT01910727|Family health Coach|family health coach
390864|NCT01910714|HIV/AIDS|hiv/aids
390865|NCT01910714|Prevention|prevention
390866|NCT01910714|American Indian|american indian
390867|NCT01910714|Substance use|substance use
390868|NCT01910714|CBPR|cbpr
390869|NCT01910701|Home visiting interventions|home visiting interventions
390870|NCT01910701|American Indian|american indian
390871|NCT01910701|Community based participatory research|community based participatory research
390872|NCT01910688|RGB Salvage, RFA|rgb salvage, rfa
390873|NCT01910662|Suction Skin Blister|suction skin blister
390874|NCT01910662|Induration|induration
390875|NCT01910662|Tuberculin Purified Protein Derivative|tuberculin purified protein derivative
390876|NCT01910662|Erythema|erythema
390877|NCT01910662|Biopsy|biopsy
390878|NCT01910662|Keyhole Limpet Hemocyanin|keyhole limpet hemocyanin
390879|NCT01910662|Delayed Type Hypersensitivity|delayed type hypersensitivity
390880|NCT01910649|drisapersen|drisapersen
390881|NCT01910636|HCV genotype 2 (GT-2)|hcv genotype 2 (gt-2)
390882|NCT01910623|Quality of life|quality of life
390883|NCT01910623|Health related quality of life outcomes|health related quality of life outcomes
390884|NCT01910623|Long-term|long-term
390885|NCT01910623|Aida 0493|aida 0493
390886|NCT01910623|AIDA 2000|aida 2000
390887|NCT01910610|wild-type RAS metastatic colorectal cancer|wild-type ras metastatic colorectal cancer
390888|NCT01910584|quality of life|quality of life
390889|NCT01910584|sexual activity|sexual activity
390890|NCT01910584|Novasure endometrial ablation|novasure endometrial ablation
390891|NCT01910584|menorrhagia|menorrhagia
390892|NCT01910558|Alpha-cyclodextrin|alpha-cyclodextrin
390893|NCT01910558|Dietary fiber|dietary fiber
390894|NCT01910558|Fecal fat|fecal fat
390895|NCT01910558|Saturated fat|saturated fat
390896|NCT01910519|influenza A (H5N1) virus|influenza a (h5n1) virus
390897|NCT01910519|H5N1 influenza|h5n1 influenza
390898|NCT01910519|influenza A/H5/N1|influenza a/h5/n1
390899|NCT01910519|monovalent H5N1 influenza vaccine|monovalent h5n1 influenza vaccine
390900|NCT01910519|systems biology|systems biology
390901|NCT01910519|AS03 adjuvant|as03 adjuvant
390902|NCT01910519|unadjuvanted|unadjuvanted
390903|NCT01910493|mhealth|mhealth
390904|NCT01910493|mobile health|mobile health
390905|NCT01910493|SMS|sms
390906|NCT01910493|SMS reminders|sms reminders
390907|NCT01910493|ART retention in care|art retention in care
390908|NCT01910493|PMTCT|pmtct
390909|NCT01910493|PMTCT cascade|pmtct cascade
390910|NCT01910493|retention in care|retention in care
390911|NCT01910454|Stroke|stroke
390912|NCT01910454|Occupational Therapy|occupational therapy
390913|NCT01910454|Cognition|cognition
390914|NCT01910441|Type 2 Diabetes Mellitus, Glycemic variability|type 2 diabetes mellitus, glycemic variability
390915|NCT01910428|L-asparaginase encapsulated in RBCs, leukemia, lymphoma|l-asparaginase encapsulated in rbcs, leukemia, lymphoma
390916|NCT01910402|antiretroviral therapy naïve|antiretroviral therapy naïve
390917|NCT01910402|women|women
390918|NCT01910402|once daily|once daily
390919|NCT01910402|HIV infection|hiv infection
390920|NCT01910402|atazanavir|atazanavir
390921|NCT01910402|tenofovir/emtricitabine|tenofovir/emtricitabine
390922|NCT01910402|dolutegravir/abacavir/lamivudine fixed dose combination|dolutegravir/abacavir/lamivudine fixed dose combination
390923|NCT01910402|integrase inhibitor|integrase inhibitor
390924|NCT01910402|ritonavir|ritonavir
390925|NCT01910389|Heart failure|heart failure
390926|NCT01910389|Pulmonary hypertension|pulmonary hypertension
390927|NCT01910389|tadalafil|tadalafil
390928|NCT01910389|Phosphodiesterase Type 5 Inhibition|phosphodiesterase type 5 inhibition
390929|NCT01910363|poststroke spasticity|poststroke spasticity
390930|NCT01910363|lower limb|lower limb
390931|NCT01910363|botulinum toxin|botulinum toxin
390932|NCT01910363|A2|a2
390933|NCT01910350|Breast & cervical cancer prevention & screening|breast & cervical cancer prevention & screening
390934|NCT01910337|ASA I patients|asa i patients
390935|NCT01910324|Juvenile Offenders|juvenile offenders
390936|NCT01910324|HIV/STD Prevention|hiv/std prevention
390937|NCT01910324|Adolescent Substance Abuse|adolescent substance abuse
390938|NCT01910324|Multidimensional Family Therapy|multidimensional family therapy
390939|NCT01910298|Breast reconstruction|breast reconstruction
390940|NCT01910298|Breast implant|breast implant
390941|NCT01910298|Breast cancer|breast cancer
390942|NCT01910298|Mastectomy|mastectomy
390943|NCT01910285|Anesthetic induction|anesthetic induction
390944|NCT01910285|Intubation conditions|intubation conditions
390945|NCT01910285|Tooth extraction|tooth extraction
390946|NCT01910285|Propofol|propofol
390947|NCT01910285|Sufentanil|sufentanil
390948|NCT01910285|Remifentanil|remifentanil
390949|NCT01910272|Radiation attenuation|radiation attenuation
390950|NCT01910272|Fluoroscopy|fluoroscopy
390951|NCT01910272|Invasive cardiac procedures|invasive cardiac procedures
390952|NCT01910272|Cardiac Catheterization|cardiac catheterization
390953|NCT01910259|Secondary Progressive Multiple Sclerosis|secondary progressive multiple sclerosis
390954|NCT01910259|Neuroprotective|neuroprotective
390955|NCT01910259|Repurposed drugs|repurposed drugs
390956|NCT01910259|Brain atrophy|brain atrophy
390957|NCT01910259|Percentage Brain Volume Change|percentage brain volume change
390958|NCT01910259|Magnetic Resonance Imaging|magnetic resonance imaging
390959|NCT01910259|Optical Coherence Tomography|optical coherence tomography
390960|NCT01910259|Cerebrospinal fluid|cerebrospinal fluid
390961|NCT01910259|Amiloride|amiloride
390962|NCT01910259|Riluzole|riluzole
390963|NCT01910259|Double blind|double blind
390964|NCT01910259|Placebo|placebo
390965|NCT01910259|Fluoxetine|fluoxetine
390966|NCT01910246|Metformin|metformin
390967|NCT01910246|Insulin Resistance|insulin resistance
390968|NCT01910246|Cardiac Function|cardiac function
390969|NCT01910233|dyspnea|dyspnea
390970|NCT01910233|registry|registry
390971|NCT01910233|baseline characteristics|baseline characteristics
390972|NCT01910233|mortality|mortality
390973|NCT01910233|risk assessment|risk assessment
390974|NCT01910233|emergency department|emergency department
390975|NCT01910142|bone metabolism|bone metabolism
390976|NCT01910129|vagus nerve stimulation|vagus nerve stimulation
390977|NCT01910129|vagal nerve stimulation|vagal nerve stimulation
390978|NCT01910129|nVNS|nvns
390980|NCT01910129|epilepsy|epilepsy
390981|NCT01910129|non invasive|non invasive
390982|NCT01910129|gammacore|gammacore
390983|NCT01910116|osteoarthritis|osteoarthritis
390984|NCT01910116|hand|hand
390985|NCT01910116|Shinbaro|shinbaro
390986|NCT01910116|GCSB-5|gcsb-5
390987|NCT01910103|Breast Neoplasms/radiography|breast neoplasms/radiography
390988|NCT01910103|Mammography/methods|mammography/methods
390989|NCT01910103|Mass Screening|mass screening
390990|NCT01910103|Tomography, X-Ray Computed/methods|tomography, x-ray computed/methods
390991|NCT01910103|Predictive Value of Tests|predictive value of tests
390992|NCT01910103|False Positive Reactions|false positive reactions
390993|NCT01910090|fasting condition|fasting condition
390994|NCT01910077|tacrolimus|tacrolimus
390995|NCT01910077|tacrobell capsule|tacrobell capsule
390996|NCT01910077|prograf capsule|prograf capsule
390997|NCT01910077|bioequivalence|bioequivalence
390998|NCT01910064|Acne Vulgaris|acne vulgaris
390999|NCT01910025|Argininosuccinate Synthetase|argininosuccinate synthetase
391000|NCT01910025|Arginine|arginine
391001|NCT01910025|Arginine deiminase|arginine deiminase
391002|NCT01910025|Failed prior systemic therapy|failed prior systemic therapy
391003|NCT01910012|Argininosuccinate Synthetase|argininosuccinate synthetase
391004|NCT01910012|Arginine|arginine
391005|NCT01910012|Arginine deiminase|arginine deiminase
391006|NCT01910012|Failed prior systemic therapy|failed prior systemic therapy
391007|NCT01909999|Dental Implants|dental implants
391008|NCT01909999|Osseointegration|osseointegration
391009|NCT01909999|Immediate Dental Implant Loading|immediate dental implant loading
391010|NCT01909999|Bone formation|bone formation
391011|NCT01909986|ONO-4053|ono-4053
391012|NCT01909986|Healthy adult male subjects|healthy adult male subjects
391013|NCT01909986|pharmacokinetics|pharmacokinetics
391014|NCT01909986|metabolism|metabolism
391015|NCT01909986|excretion|excretion
391016|NCT01909986|mass balance|mass balance
391017|NCT01909973|Depression|depression
391018|NCT01909973|Antidepressant Medication|antidepressant medication
391019|NCT01909973|Adherence|adherence
391020|NCT01909973|Mobile Smartphone Intervention|mobile smartphone intervention
391021|NCT01909973|Telemedicine|telemedicine
391022|NCT01909973|Primary Care|primary care
391023|NCT01909960|Normal pressure hydrocephalus|normal pressure hydrocephalus
391024|NCT01909960|Flow MRI|flow mri
391025|NCT01909960|Dementia|dementia
391026|NCT01909960|Cerebrospinal fluid|cerebrospinal fluid
391027|NCT01909960|Shunt|shunt
391028|NCT01909947|Respiratory rate variability|respiratory rate variability
391029|NCT01909947|Heart rate variability|heart rate variability
391030|NCT01909947|Extubation readiness|extubation readiness
391031|NCT01909947|Extubation failure|extubation failure
391032|NCT01909947|Clinical predictors|clinical predictors
391033|NCT01909934|Lymphoma|lymphoma
391034|NCT01909934|Anaplastic Large-cell|anaplastic large-cell
391035|NCT01909934|Relapsed|relapsed
391036|NCT01909934|Refractory|refractory
391037|NCT01909934|Antigens, CD30|antigens, cd30
391038|NCT01909934|Antibody-Drug Conjugate|antibody-drug conjugate
391039|NCT01909934|Antibodies, Monoclonal|antibodies, monoclonal
391040|NCT01909934|Lymphoma, Non-Hodgkin|lymphoma, non-hodgkin
391041|NCT01909934|Lymphoma, Large-Cell, Anaplastic|lymphoma, large-cell, anaplastic
391042|NCT01909934|monomethyl auristatin E|monomethyl auristatin e
391043|NCT01909934|Drug Therapy|drug therapy
391044|NCT01909934|Immunotherapy|immunotherapy
391045|NCT01909934|Hematologic Diseases|hematologic diseases
500131|NCT01430845|GDD|gdd
391046|NCT01909908|Wounds and injuries|wounds and injuries
391047|NCT01909908|Ulcer|ulcer
391048|NCT01909908|Diabetic angiopathies|diabetic angiopathies
391049|NCT01909908|Diabetic foot|diabetic foot
391050|NCT01909908|Venous insufficiency|venous insufficiency
391051|NCT01909908|Extracellular matrix|extracellular matrix
391052|NCT01909882|Family member's massage therapy|family member's massage therapy
391053|NCT01909882|Vital signs|vital signs
391054|NCT01909882|Glasgow coma scale|glasgow coma scale
391055|NCT01909882|Intensive care unit|intensive care unit
391056|NCT01909882|Randomized controlled Clinical Trial|randomized controlled clinical trial
391057|NCT01909882|Iran|iran
391058|NCT01909869|MACE|mace
391059|NCT01909869|TVR|tvr
391060|NCT01909869|MI|mi
391061|NCT01909869|TLF|tlf
391062|NCT01909869|Death|death
391063|NCT01909830|Colorectal Cancer Metastatic|colorectal cancer metastatic
391064|NCT01909830|pretreated|pretreated
391065|NCT01909804|Hepatitis|hepatitis
391066|NCT01909804|Genotype 1|genotype 1
391067|NCT01909804|Genotype 3|genotype 3
391068|NCT01909804|Treatment experienced|treatment experienced
391069|NCT01909791|Diabetic Macular Edema|diabetic macular edema
391070|NCT01909791|anti-vascular endothelial growth factor|anti-vascular endothelial growth factor
391071|NCT01909765|Circumcision|circumcision
391072|NCT01909765|postoperative pain|postoperative pain
391073|NCT01909752|Lung cancer|lung cancer
391074|NCT01909752|DRibble Vaccine|dribble vaccine
391075|NCT01909752|Imiquimod|imiquimod
391076|NCT01909752|GM-CSF|gm-csf
391077|NCT01909752|HPV vaccine (Ceravix)|hpv vaccine (ceravix)
391078|NCT01909752|Cyclophosphamide|cyclophosphamide
391079|NCT01909739|AKI, atrovastatin, Valvular heart surgery|aki, atrovastatin, valvular heart surgery
391080|NCT01909726|Hospital Design|hospital design
391081|NCT01909726|Technology|technology
391082|NCT01909726|Anxiety|anxiety
391083|NCT01909713|acne, pediatric|acne, pediatric
391084|NCT01909700|Single Incision, Mesh, Complications|single incision, mesh, complications
391085|NCT01909687|blood glucose monitoring systems|blood glucose monitoring systems
391086|NCT01909687|ISO 15197|iso 15197
391087|NCT01909687|system accuracy|system accuracy
391088|NCT01909661|allergy|allergy
391089|NCT01909661|Cow's milk protein|cow's milk protein
391090|NCT01909661|Tolerance|tolerance
391091|NCT01909661|Efficacy|efficacy
391092|NCT01909661|Infants' growth|infants' growth
391093|NCT01909622|Vitamin D|vitamin d
391094|NCT01909622|Milk fortification|milk fortification
391095|NCT01909622|Children|children
391096|NCT01909622|Colombia|colombia
391097|NCT01909609|male|male
391098|NCT01909583|congenital|congenital
391099|NCT01909583|surgery|surgery
391100|NCT01909583|peri-operative|peri-operative
391101|NCT01909583|counselling|counselling
391102|NCT01909557|Acetyl-L-carnitine|acetyl-l-carnitine
391103|NCT01909557|Interferons|interferons
391104|NCT01909557|Ribavirin|ribavirin
391105|NCT01909557|Hepatitis C|hepatitis c
391106|NCT01909557|Fatigue|fatigue
391107|NCT01909544|Pulmonary Disease, Chronic Obstructive|pulmonary disease, chronic obstructive
391108|NCT01909544|Muscle fatigue|muscle fatigue
391109|NCT01909544|Energy metabolism|energy metabolism
391110|NCT01909544|Muscle oxygenation|muscle oxygenation
391111|NCT01909531|Deep Brain Stimulation|deep brain stimulation
391112|NCT01909531|Parkinsons Disease|parkinsons disease
391113|NCT01909531|Essential Tremor|essential tremor
391114|NCT01909531|Asleep DBS|asleep dbs
391115|NCT01909518|Esophageal Squamous Intraepithelial Neoplasia|esophageal squamous intraepithelial neoplasia
391116|NCT01909518|surface maturation scoring|surface maturation scoring
391117|NCT01909518|probe-based confocal laser endomicroscopy|probe-based confocal laser endomicroscopy
391118|NCT01909518|virtual chromoendoscopy|virtual chromoendoscopy
391119|NCT01909492|Multiple Sclerosis|multiple sclerosis
391120|NCT01909492|MS|ms
391121|NCT01909492|Relaxin|relaxin
391122|NCT01909466|OPC-14597|opc-14597
391123|NCT01909466|Aripiprazole|aripiprazole
391124|NCT01909466|Schizophrenia|schizophrenia
391125|NCT01909453|Melanoma|melanoma
391126|NCT01909453|Cutaneous melanoma|cutaneous melanoma
391127|NCT01909453|Skin disease|skin disease
391128|NCT01909453|Skin cancer|skin cancer
391129|NCT01909453|Skin Neoplasms|skin neoplasms
391130|NCT01909453|Neoplasm Metastasis|neoplasm metastasis
391131|NCT01909453|BRAF mutant|braf mutant
391132|NCT01909453|BRAF V600E|braf v600e
391133|NCT01909453|BRAF V600K|braf v600k
391134|NCT01909453|Cancer|cancer
391135|NCT01909453|LGX818|lgx818
391136|NCT01909453|MEK162|mek162
391137|NCT01909453|vemurafenib|vemurafenib
391138|NCT01909453|combination|combination
391139|NCT01909453|BRAF inhibitor|braf inhibitor
391140|NCT01909453|resistance|resistance
391141|NCT01909453|The combination of a selective BRAF- and a MEK1/2-inhibitor|the combination of a selective braf- and a mek1/2-inhibitor
391142|NCT01909453|Prior immunotherapy|prior immunotherapy
391143|NCT01909453|MEK inhibitor|mek inhibitor
391144|NCT01909453|Phase III|phase iii
391145|NCT01909453|Combo 300, Combo 450|combo 300, combo 450
793595|NCT00280241|Fludarabine|fludarabine
391146|NCT01909427|Active rheumatoid arthritis despite methotrexate therapy|active rheumatoid arthritis despite methotrexate therapy
391147|NCT01909427|CNTO 6785|cnto 6785
391148|NCT01909427|Methotrexate|methotrexate
391149|NCT01909401|Liver Transplantation|liver transplantation
391150|NCT01909388|Cancer|cancer
391151|NCT01909388|Prostate Cancer|prostate cancer
391152|NCT01909388|Brachytherapy|brachytherapy
391153|NCT01909388|Dose escalation|dose escalation
391154|NCT01909388|High Dose Rate|high dose rate
391155|NCT01909388|MRI-TRUS fusion|mri-trus fusion
391156|NCT01909388|Detection of DILs by MRI|detection of dils by mri
391157|NCT01909362|advanced metastatic colorectal cancer|advanced metastatic colorectal cancer
391158|NCT01909362|mCRC|mcrc
391159|NCT01909362|Colorectal Cancer|colorectal cancer
391160|NCT01909362|Colorectal Carcinoma|colorectal carcinoma
391161|NCT01909362|Colorectal Tumors|colorectal tumors
391162|NCT01909362|Genetic mutation testing|genetic mutation testing
391163|NCT01909362|Tumor tissue sampling|tumor tissue sampling
391164|NCT01909349|medical rehabilitation|medical rehabilitation
391165|NCT01909349|aftercare|aftercare
391166|NCT01909349|multiple health behavior change|multiple health behavior change
391167|NCT01909349|diet|diet
391168|NCT01909349|physical activity|physical activity
391169|NCT01909349|computer|computer
391170|NCT01909349|international study|international study
391171|NCT01909349|ETHNOPSYCHOLOGY|ethnopsychology
391172|NCT01909349|HABIT|habit
391173|NCT01909349|HEALTH|health
391174|NCT01909349|eHealth|ehealth
391175|NCT01909349|eLearning|elearning
391176|NCT01909310|anesthesia, cardiac arrest, resuscitation, ventilation|anesthesia, cardiac arrest, resuscitation, ventilation
391177|NCT01909297|airway management|airway management
391178|NCT01909271|Stroke|stroke
391179|NCT01909271|Community Health Education|community health education
391180|NCT01909271|Minority Health|minority health
391181|NCT01909271|healthcare disparities|healthcare disparities
391182|NCT01909245|Islet cells|islet cells
391183|NCT01909245|hypoglycemia|hypoglycemia
391184|NCT01909245|hypoglycemia unawareness|hypoglycemia unawareness
391185|NCT01909245|islet after kidney transplantation|islet after kidney transplantation
391186|NCT01909245|islet transplant|islet transplant
391187|NCT01909245|insulin independence|insulin independence
391188|NCT01909245|insulin dependence|insulin dependence
391189|NCT01909245|labile diabetes|labile diabetes
391190|NCT01909232|Depression|depression
391191|NCT01909232|Depressive Disorder|depressive disorder
391192|NCT01909232|Major depression|major depression
391193|NCT01909232|Major depressive disorder|major depressive disorder
391194|NCT01909232|MDD|mdd
391195|NCT01909232|Treatment resistant depression|treatment resistant depression
391196|NCT01909232|Treatment intolerant depression|treatment intolerant depression
391197|NCT01909232|TRMD|trmd
391198|NCT01909232|TIMD|timd
391199|NCT01909232|Transcranial Magnetic Stimulation|transcranial magnetic stimulation
391200|NCT01909232|TMS|tms
391201|NCT01909219|preparation, cleansing, colon|preparation, cleansing, colon
391202|NCT01909167|Pregnancy|pregnancy
391203|NCT01909167|symptoms of depression|symptoms of depression
391204|NCT01909167|anxiety|anxiety
391205|NCT01909167|online CBT therapy|online cbt therapy
391206|NCT01909167|treatment as usual|treatment as usual
391207|NCT01909167|maternal bonding|maternal bonding
391208|NCT01909167|postnatal period|postnatal period
391209|NCT01909154|neurophysiological parameters improvement|neurophysiological parameters improvement
391210|NCT01909154|spinal cord injury|spinal cord injury
391211|NCT01909154|biology therapy|biology therapy
391212|NCT01909141|letrozole|letrozole
391213|NCT01909141|clomiphene citrate|clomiphene citrate
391214|NCT01909141|pioglitazone|pioglitazone
391215|NCT01909141|metformin|metformin
391216|NCT01909141|ovulation induction|ovulation induction
391217|NCT01909141|PCOS|pcos
391218|NCT01909128|children, fermented milk fermented rice, gastrointestinal infections, respiratory infections|children, fermented milk fermented rice, gastrointestinal infections, respiratory infections
391219|NCT01909102|Acceptance and Commitment Therapy|acceptance and commitment therapy
391220|NCT01909102|Cardiac rehabilitation|cardiac rehabilitation
391221|NCT01909050|celiac disease|celiac disease
391222|NCT01909050|refractory celiac disease|refractory celiac disease
391223|NCT01909050|gluten sensitivity|gluten sensitivity
391224|NCT01909037|osteoarthritis|osteoarthritis
391225|NCT01909037|curcumin|curcumin
391226|NCT01909037|biomarker|biomarker
391227|NCT01909037|pain|pain
391228|NCT01909024|Randomised controlled trial|randomised controlled trial
391229|NCT01909024|Endovenous laser treatment|endovenous laser treatment
391230|NCT01909024|Transjugular coil embolisation|transjugular coil embolisation
391231|NCT01908998|Y-Balance test|y-balance test
391232|NCT01908985|glaucoma|glaucoma
391233|NCT01908985|high intensity focused ultrasound|high intensity focused ultrasound
391234|NCT01908985|aqueous humor|aqueous humor
391235|NCT01908985|fluorophotometry|fluorophotometry
391236|NCT01908972|Hemangioma|hemangioma
391237|NCT01908972|Propranolol|propranolol
391238|NCT01908972|prednisolone|prednisolone
391239|NCT01908972|steroid|steroid
500357|NCT01429909|T2*|t2*
391240|NCT01908959|Hispanic Women|hispanic women
391241|NCT01908959|Postpartum|postpartum
391242|NCT01908959|Overweight Hispanic Women|overweight hispanic women
391243|NCT01908959|Low-income|low-income
391244|NCT01908959|Physical Activity|physical activity
391245|NCT01908959|Walking|walking
391246|NCT01908946|Polio|polio
391247|NCT01908933|Advanced Emphysema|advanced emphysema
391248|NCT01908933|Heterogeneous Lower Lobe Predominant Emphysema|heterogeneous lower lobe predominant emphysema
391249|NCT01908933|Heterogeneous Upper and Lower Lobe Predominant|heterogeneous upper and lower lobe predominant
391250|NCT01908907|Premature Infants|premature infants
391251|NCT01908907|DHA(docosahexaenoic acid)|dha(docosahexaenoic acid)
391252|NCT01908907|DHA deficit|dha deficit
391253|NCT01908881|Child Development|child development
391254|NCT01908881|Mother-Child relations|mother-child relations
391255|NCT01908881|Primary Health Care|primary health care
391256|NCT01908881|Public Policy|public policy
391257|NCT01908855|somatoform symptoms|somatoform symptoms
391258|NCT01908855|somatic symptoms|somatic symptoms
391259|NCT01908855|somatoform disorder|somatoform disorder
391260|NCT01908855|somatic symptom disorder|somatic symptom disorder
391261|NCT01908855|cognitive-behavioral therapy|cognitive-behavioral therapy
391262|NCT01908855|emotion regulation training|emotion regulation training
391263|NCT01908842|Opioid|opioid
391264|NCT01908842|Dependence|dependence
391265|NCT01908842|agonist|agonist
391266|NCT01908842|buprenorphine|buprenorphine
391267|NCT01908842|naloxone|naloxone
391268|NCT01908842|BUP/NAL|bup/nal
391269|NCT01908829|Vesitrim|vesitrim
391270|NCT01908829|Betanis|betanis
391271|NCT01908829|Urgency|urgency
391272|NCT01908829|Frequency|frequency
391273|NCT01908829|Mirabegron|mirabegron
391274|NCT01908829|YM178|ym178
391275|NCT01908829|Betmiga|betmiga
391276|NCT01908829|Vesicare|vesicare
391277|NCT01908829|Micturition|micturition
391278|NCT01908829|YM905|ym905
391279|NCT01908829|Solifenacin|solifenacin
391280|NCT01908829|Urinary incontinence|urinary incontinence
391281|NCT01908829|Overactive Bladder (OAB)|overactive bladder (oab)
391282|NCT01908829|Myrbetriq|myrbetriq
391283|NCT01908829|Vesikur|vesikur
391284|NCT01908829|Urgency incontinence|urgency incontinence
391285|NCT01908803|AOMT|aomt
391286|NCT01908803|tympanostomy tubes|tympanostomy tubes
391287|NCT01908803|Otorrhea|otorrhea
391288|NCT01908803|anti-infective|anti-infective
391289|NCT01908790|venous oximeter|venous oximeter
391290|NCT01908790|non-invasive monitor|non-invasive monitor
391291|NCT01908790|heart failure (HF)|heart failure (hf)
391292|NCT01908764|ear tubes|ear tubes
391293|NCT01908764|tympanostomy tubes|tympanostomy tubes
391294|NCT01908764|Otitis Media at the time of Tympanostomy Tube surgery|otitis media at the time of tympanostomy tube surgery
391295|NCT01908764|OMTT|omtt
391296|NCT01908738|Endometrial biopsy|endometrial biopsy
391297|NCT01908738|paracervical block|paracervical block
391298|NCT01908738|Lidocaine spray|lidocaine spray
391299|NCT01908738|women|women
391300|NCT01908738|abnormal uterine bleeding|abnormal uterine bleeding
391301|NCT01908686|ASD|asd
391302|NCT01908673|heart rate variability biofeedback|heart rate variability biofeedback
391303|NCT01908673|automatic self transcedental meditation|automatic self transcedental meditation
391304|NCT01908660|HIV|hiv
391305|NCT01908660|hepatitis C virus|hepatitis c virus
391306|NCT01908660|hepatitis B virus|hepatitis b virus
391307|NCT01908660|antiretroviral drugs|antiretroviral drugs
391308|NCT01908660|nucleos(t)ide reverse transcriptase inhibitors|nucleos(t)ide reverse transcriptase inhibitors
391309|NCT01908660|non-nucleos(t)ide reverse transcriptase inhibitors|non-nucleos(t)ide reverse transcriptase inhibitors
391310|NCT01908660|protease inhibitors|protease inhibitors
391311|NCT01908660|integrase inhibitors|integrase inhibitors
391312|NCT01908660|entry inhibitors|entry inhibitors
391313|NCT01908660|transaminase elevations|transaminase elevations
391314|NCT01908660|alanine aminotransferase|alanine aminotransferase
391315|NCT01908660|aspartate aminotransferase|aspartate aminotransferase
391316|NCT01908660|bilirubin elevations|bilirubin elevations
391317|NCT01908660|hepatic fibrosis|hepatic fibrosis
391318|NCT01908647|mTBI|mtbi
391319|NCT01908647|PTSD|ptsd
391320|NCT01908634|Bioavailability|bioavailability
391321|NCT01908634|Strawberry polyphenols|strawberry polyphenols
391322|NCT01908634|Fruit Beverage Matrix|fruit beverage matrix
391323|NCT01908621|multiple myeloma|multiple myeloma
391324|NCT01908621|mobilization|mobilization
391325|NCT01908621|G-CSF|g-csf
391326|NCT01908621|filgrastim|filgrastim
391327|NCT01908621|cytosine arabinoside|cytosine arabinoside
391328|NCT01908621|autologous stem cell transplantation|autologous stem cell transplantation
391329|NCT01908569|MACS, time-lapse, embryo, spermatozoid, sperm|macs, time-lapse, embryo, spermatozoid, sperm
391330|NCT01908543|Iron deficiency|iron deficiency
391331|NCT01908543|Nosebleeds|nosebleeds
391332|NCT01908530|Diabetes|diabetes
391333|NCT01908530|Continuous Glucose Monitoring|continuous glucose monitoring
391334|NCT01908530|Microprobes|microprobes
794191|NCT00277953|Pediatric|pediatric
391335|NCT01908517|HPV Vaccine Adherence|hpv vaccine adherence
391336|NCT01908517|Electronic Reminders|electronic reminders
391337|NCT01908491|patient controlled analgesia|patient controlled analgesia
391338|NCT01908491|wound catheter infusion|wound catheter infusion
391339|NCT01908491|postoperative pain control|postoperative pain control
391340|NCT01908491|pectus excavatum|pectus excavatum
391341|NCT01908491|pain score|pain score
391342|NCT01908478|locally advanced|locally advanced
391343|NCT01908478|unresectable|unresectable
391344|NCT01908478|pancreatic|pancreatic
391345|NCT01908478|pancreas|pancreas
391346|NCT01908478|pancreatic adenocarcinoma|pancreatic adenocarcinoma
391347|NCT01908452|Schizophrenia|schizophrenia
391348|NCT01908452|pyridoxal kinase activity|pyridoxal kinase activity
391349|NCT01908452|plasma pyridoxal level|plasma pyridoxal level
391350|NCT01908439|muscle electrical activity|muscle electrical activity
391351|NCT01908439|whole-body vibration|whole-body vibration
391352|NCT01908439|latency|latency
391353|NCT01908426|cabozantinib|cabozantinib
391354|NCT01908426|XL184|xl184
391355|NCT01908426|liver cancer|liver cancer
391356|NCT01908426|hepatocellular carcinoma|hepatocellular carcinoma
391357|NCT01908426|tyrosine kinase inhibitor|tyrosine kinase inhibitor
391358|NCT01908426|MET kinase|met kinase
391359|NCT01908426|vascular endothelial growth factor receptor 2 (VEGFR2)|vascular endothelial growth factor receptor 2 (vegfr2)
391360|NCT01908413|Advanced Solid Tumors|advanced solid tumors
391361|NCT01908413|Lymphoma|lymphoma
391362|NCT01908413|Open-Label|open-label
391363|NCT01908413|Dose-Escalation|dose-escalation
391364|NCT01908413|IAP|iap
391365|NCT01908400|Mental retardation , stem cell,BMMNC|mental retardation , stem cell,bmmnc
391366|NCT01908387|Oral azacitidine|oral azacitidine
391367|NCT01908387|CC-486|cc-486
391368|NCT01908387|Hematological neoplasms|hematological neoplasms
391369|NCT01908387|Phase 1|phase 1
391370|NCT01908374|Active-placebo controlled double blind cross over|active-placebo controlled double blind cross over
391371|NCT01908361|comparative efficacy research|comparative efficacy research
391372|NCT01908361|combination therapy|combination therapy
391373|NCT01908361|neurorehabilitation|neurorehabilitation
391374|NCT01908361|robotic rehabilitation|robotic rehabilitation
391375|NCT01908361|restraint therapy|restraint therapy
391376|NCT01908348|Erythritol|erythritol
391377|NCT01908348|Endothelial function|endothelial function
391378|NCT01908335|interferon|interferon
391379|NCT01908335|ribavirin|ribavirin
391380|NCT01908335|virological response|virological response
391381|NCT01908322|Hepatocellular carcinoma|hepatocellular carcinoma
391382|NCT01908322|Intermediate stage|intermediate stage
391383|NCT01908322|Observational study|observational study
391384|NCT01908309|acute kidney injury|acute kidney injury
391385|NCT01908309|contrast media|contrast media
391386|NCT01908309|cystatin-C|cystatin-c
391387|NCT01908296|FK949E|fk949e
391388|NCT01908296|fluvoxamine|fluvoxamine
391389|NCT01908296|Antipsychotic|antipsychotic
391390|NCT01908296|Quetiapine|quetiapine
391391|NCT01908244|Preterm infants, music, Neonatal Intensive Care Unit (NICU)|preterm infants, music, neonatal intensive care unit (nicu)
391392|NCT01908231|Pulmonary embolism, plasma lactate, right ventricular dysfunction|pulmonary embolism, plasma lactate, right ventricular dysfunction
391393|NCT01908218|ULBT, diffficult laryngoscopy, Predictive Value of Tests|ulbt, diffficult laryngoscopy, predictive value of tests
391394|NCT01908205|Autism|autism
391395|NCT01908205|Social|social
391396|NCT01908205|Functioning|functioning
391397|NCT01908205|Cognition|cognition
391398|NCT01908205|Repetitive Behaviors|repetitive behaviors
391399|NCT01908205|Anxiety|anxiety
391400|NCT01908205|Quality of Life|quality of life
391401|NCT01908192|Sodium Benzoate|sodium benzoate
391402|NCT01908192|Schizophrenia|schizophrenia
391403|NCT01908192|Adolescent|adolescent
391404|NCT01908192|Antipsychotic|antipsychotic
391405|NCT01908192|Anti-psychotic|anti-psychotic
391406|NCT01908192|NMDA|nmda
391407|NCT01908192|NaBen|naben
391408|NCT01908192|pediatric|pediatric
391409|NCT01908179|Sterotactic Radiosurgery|sterotactic radiosurgery
391410|NCT01908153|Picture food type|picture food type
391411|NCT01908153|Taste type|taste type
391412|NCT01908127|film modelling|film modelling
391413|NCT01908127|dental anxiety|dental anxiety
391414|NCT01908127|cooperative behaviour|cooperative behaviour
391415|NCT01908127|children|children
391416|NCT01908114|Polio disease|polio disease
391417|NCT01908114|Intervention Package|intervention package
391418|NCT01908114|Polio sero prevalence and sero conversion|polio sero prevalence and sero conversion
391419|NCT01908114|Polio high risk areas of Pakistan|polio high risk areas of pakistan
391420|NCT01908088|Epidermolysis Bullosa mitten hand deformity autologous cultured fibroblast|epidermolysis bullosa mitten hand deformity autologous cultured fibroblast
391421|NCT01908088|amniotic membrane|amniotic membrane
391422|NCT01908075|Primary care|primary care
391423|NCT01908075|Asthma management|asthma management
391424|NCT01908075|Real-world|real-world
391425|NCT01908075|Observational|observational
391426|NCT01908075|Fostair|fostair
391427|NCT01908075|Seretide|seretide
794192|NCT00277953|Cardiac|cardiac
391428|NCT01908062|Substance related disorders|substance related disorders
391429|NCT01908062|HIV|hiv
391430|NCT01908062|naltrexone|naltrexone
391431|NCT01908049|Probiotic|probiotic
391432|NCT01908049|HIV|hiv
391433|NCT01908049|Microbial translocation|microbial translocation
391434|NCT01908049|inflammation|inflammation
391435|NCT01908049|microbiota composition|microbiota composition
391436|NCT01908036|Chronic fatigue syndrome|chronic fatigue syndrome
391437|NCT01908036|CFS|cfs
391438|NCT01908036|myalgic encephalomyelitis|myalgic encephalomyelitis
391439|NCT01908036|M.E.|m.e.
391440|NCT01908036|activity monitor|activity monitor
391441|NCT01908023|exercise therapy|exercise therapy
391442|NCT01908023|oxygen consumption|oxygen consumption
391443|NCT01908010|Alzheimer's disease|alzheimer's disease
391444|NCT01907997|Systemic lidocaine, Intravenous lidocaine infusion, postoperative pain, quality of recovery, Robot-assisted thyroidectomy, thyroid cancer|systemic lidocaine, intravenous lidocaine infusion, postoperative pain, quality of recovery, robot-assisted thyroidectomy, thyroid cancer
391445|NCT01907984|premedication|premedication
391446|NCT01907984|diclofenac|diclofenac
391447|NCT01907984|postoperative headache|postoperative headache
391448|NCT01907984|Visual Analog Scale|visual analog scale
391449|NCT01907958|Microalbuminuria|microalbuminuria
391450|NCT01907958|Hypertensive|hypertensive
391451|NCT01907958|Diabetics|diabetics
391452|NCT01907958|urine albumin|urine albumin
391453|NCT01907945|Household water treatment|household water treatment
391454|NCT01907945|Waterborne illness|waterborne illness
391455|NCT01907945|ceramic filters|ceramic filters
391456|NCT01907945|social network|social network
391457|NCT01907932|splenomegaly|splenomegaly
391458|NCT01907932|ultrasound|ultrasound
391459|NCT01907932|VScan|vscan
391460|NCT01907919|Pulp capping, Diode laser 808 nm, Tertiary dentin, RM-GIC|pulp capping, diode laser 808 nm, tertiary dentin, rm-gic
391461|NCT01907906|Pathogen reduction technology|pathogen reduction technology
391462|NCT01907880|breast|breast
391463|NCT01907880|bone|bone
391464|NCT01907880|pain|pain
391465|NCT01907841|Investigate IPC on EIMD|investigate ipc on eimd
391466|NCT01907789|Ovarian Carcinoma|ovarian carcinoma
391467|NCT01907789|Ovary|ovary
391468|NCT01907789|BRCA Mutation Carriers|brca mutation carriers
391469|NCT01907789|BRCA1 or BRCA2 mutation|brca1 or brca2 mutation
391470|NCT01907789|High risk for developing ovarian cancer|high risk for developing ovarian cancer
391471|NCT01907789|Ovarian cancer screening|ovarian cancer screening
391472|NCT01907789|Risk-reducing salpingo-oophorectomy|risk-reducing salpingo-oophorectomy
391473|NCT01907789|RRSO|rrso
391474|NCT01907789|Prophylactic salpingectomy with delayed oophorectomy|prophylactic salpingectomy with delayed oophorectomy
391475|NCT01907789|PSDO|psdo
391476|NCT01907789|Questionnaire|questionnaire
391477|NCT01907789|Quality of life|quality of life
391478|NCT01907789|QOL|qol
391479|NCT01907789|Survey|survey
391480|NCT01907789|Transvaginal ultrasound|transvaginal ultrasound
391481|NCT01907789|Phone call|phone call
391482|NCT01907763|asthma|asthma
391483|NCT01907763|SOTB07|sotb07
391484|NCT01907750|biliary fistula|biliary fistula
391485|NCT01907750|biliary stricture|biliary stricture
391486|NCT01907750|biliary drainage tube|biliary drainage tube
391487|NCT01907724|Chronic hepatitis C|chronic hepatitis c
391488|NCT01907724|Hepatitis C virus|hepatitis c virus
391489|NCT01907724|HCV|hcv
391490|NCT01907711|Acupuncture.|acupuncture.
391491|NCT01907711|Fatigue syndrome chronic.|fatigue syndrome chronic.
391492|NCT01907711|Sleep disturbances.|sleep disturbances.
391493|NCT01907711|Pain.|pain.
391494|NCT01907711|Cognitive impairment.|cognitive impairment.
391495|NCT01907698|vaginal intercourse|vaginal intercourse
391496|NCT01907698|labour|labour
391497|NCT01907698|term pregnancy|term pregnancy
391498|NCT01907672|Malaria|malaria
391499|NCT01907672|Rapid Diagnostic Tests for Malaria|rapid diagnostic tests for malaria
391500|NCT01907672|Chemical Shops|chemical shops
391501|NCT01907672|Drug Shops|drug shops
391502|NCT01907672|Diagnostics|diagnostics
391503|NCT01907672|Testing for Malaria|testing for malaria
391504|NCT01907659|Respiratory|respiratory
391505|NCT01907659|Viruses|viruses
391506|NCT01907659|Bacterial|bacterial
391507|NCT01907659|Antibiotics|antibiotics
391508|NCT01907659|Procalcitonin|procalcitonin
391509|NCT01907646|bladder training, radical hysterectomy,gynaecologic cancer|bladder training, radical hysterectomy,gynaecologic cancer
391510|NCT01907633|Death, Sudden, Cardiac|death, sudden, cardiac
391511|NCT01907633|Risk of Sudden Cardiac Death|risk of sudden cardiac death
391512|NCT01907633|Domperidone|domperidone
391513|NCT01907633|Proton Pump Inhibitors (PPI)|proton pump inhibitors (ppi)
391514|NCT01907633|Metoclopramide|metoclopramide
391515|NCT01907633|Observational Study|observational study
391516|NCT01907607|Advanced Gastrointestinal Stromal Tumor Refractory to Imatinib and Sunitinib|advanced gastrointestinal stromal tumor refractory to imatinib and sunitinib
391517|NCT01907607|PD-0332991|pd-0332991
391518|NCT01907607|Orally|orally
391519|NCT01907607|Efficacy and safety|efficacy and safety
391520|NCT01907607|Adult patients|adult patients
391521|NCT01907607|Refractory|refractory
391522|NCT01907607|Imatinib|imatinib
391523|NCT01907607|Sunitinib|sunitinib
391524|NCT01907490|Topical treatment of Head Lice Infestation|topical treatment of head lice infestation
391525|NCT01907464|Anorexia nervosa|anorexia nervosa
391526|NCT01907464|Bone mineral density|bone mineral density
391527|NCT01907464|Teenagers or young women|teenagers or young women
391528|NCT01907464|Bone remodelling markers|bone remodelling markers
391529|NCT01907438|BRCA|brca
391530|NCT01907438|estrogen|estrogen
391531|NCT01907438|epithelial breast cells|epithelial breast cells
391532|NCT01907438|genome profile|genome profile
391533|NCT01907412|First time parents|first time parents
391534|NCT01907412|Coparenting|coparenting
391535|NCT01907412|Family Foundations|family foundations
391536|NCT01907399|obese patients|obese patients
391537|NCT01907399|obese patients with type 2 diabetes|obese patients with type 2 diabetes
391538|NCT01907399|healthy volunteers|healthy volunteers
391539|NCT01907386|Endoleaks|endoleaks
391540|NCT01907386|Non-invasive vascular elastography|non-invasive vascular elastography
391541|NCT01907373|olmesartan|olmesartan
391542|NCT01907373|probenecid|probenecid
391543|NCT01907373|pharmacokinetics|pharmacokinetics
391544|NCT01907373|tolerability|tolerability
391545|NCT01907347|intensive care unit (ICU)|intensive care unit (icu)
391546|NCT01907347|body composition|body composition
391547|NCT01907347|phase angle|phase angle
391548|NCT01907347|mortality|mortality
391549|NCT01907347|nosocomial infection|nosocomial infection
391550|NCT01907347|bioimpedance analysis|bioimpedance analysis
391551|NCT01907347|nutrition|nutrition
391552|NCT01907334|oscillometry|oscillometry
391554|NCT01907334|methacholine|methacholine
391555|NCT01907321|stroke|stroke
391556|NCT01907321|dysphagia|dysphagia
391557|NCT01907321|dystussia|dystussia
391558|NCT01907321|cough|cough
391559|NCT01907321|maximum expiratory pressure|maximum expiratory pressure
391560|NCT01907308|Bladder cancer|bladder cancer
391561|NCT01907308|Urothelial cancer|urothelial cancer
391562|NCT01907308|Urothelial carcinoma|urothelial carcinoma
391563|NCT01907295|idiopathic|idiopathic
391564|NCT01907295|heritable|heritable
391565|NCT01907295|anorexigen|anorexigen
391566|NCT01907282|Schizophrenia|schizophrenia
391567|NCT01907282|psychosis|psychosis
391568|NCT01907230|Rheumatoid arthritis|rheumatoid arthritis
391569|NCT01907230|Inactive HBV carrier|inactive hbv carrier
391570|NCT01907230|Resolved Hepatitis B|resolved hepatitis b
391571|NCT01907230|HBV reactivation|hbv reactivation
391572|NCT01907230|Anti-tumor necrotic factor-alfa|anti-tumor necrotic factor-alfa
391573|NCT01907217|Electroconvulsive therapy|electroconvulsive therapy
391574|NCT01907217|ECT|ect
391575|NCT01907217|electrode placement|electrode placement
391576|NCT01907217|effectiveness|effectiveness
391577|NCT01907217|cognition|cognition
391578|NCT01907217|autobiographical memory|autobiographical memory
391579|NCT01907191|Hip Arthroscopy|hip arthroscopy
391580|NCT01907191|Liposomal Bupivacaine|liposomal bupivacaine
391581|NCT01907191|Bupivacaine|bupivacaine
391582|NCT01907178|total knee arthroplasty|total knee arthroplasty
391583|NCT01907152|malnutrition|malnutrition
391584|NCT01907152|undernourishment|undernourishment
391585|NCT01907152|loss of muscle mass|loss of muscle mass
391586|NCT01907139|comparative efficacy research|comparative efficacy research
391587|NCT01907139|combination therapy|combination therapy
391588|NCT01907139|neurorehabilitation|neurorehabilitation
391589|NCT01907139|robot-assisted therapy|robot-assisted therapy
391590|NCT01907139|constraint-induced therapy|constraint-induced therapy
391591|NCT01907126|HIV|hiv
391592|NCT01907126|Sexually transmitted infections|sexually transmitted infections
391593|NCT01907126|Sexual abuse|sexual abuse
391594|NCT01907126|Physical abuse|physical abuse
391595|NCT01907126|Women|women
391596|NCT01907126|Prison|prison
391597|NCT01907087|Late infantile Neuronal Ceroid Lipofuscinosis Type 2|late infantile neuronal ceroid lipofuscinosis type 2
391598|NCT01907087|LINCL|lincl
391599|NCT01907087|NCL2|ncl2
391600|NCT01907087|CLN2|cln2
391601|NCT01907087|Jansky-Bielschowsky disease|jansky-bielschowsky disease
391602|NCT01907074|liver function tests|liver function tests
391603|NCT01907074|end stage liver disease|end stage liver disease
391604|NCT01907074|cirrhosis|cirrhosis
391605|NCT01907074|living liver donor|living liver donor
391606|NCT01907061|acute renal failure|acute renal failure
391607|NCT01907061|post liver transplant|post liver transplant
391608|NCT01907048|Survey|survey
391609|NCT01907048|Effectiveness of risk minimization measures|effectiveness of risk minimization measures
391610|NCT01907048|Rivaroxaban|rivaroxaban
391611|NCT01907048|Anticoagulants|anticoagulants
391612|NCT01907022|repetitive transcranial magnetic stimulation|repetitive transcranial magnetic stimulation
391613|NCT01907022|chronic tinnitus|chronic tinnitus
391614|NCT01907022|relaxation|relaxation
391615|NCT01906944|trigger point injection|trigger point injection
391616|NCT01906944|transversus abdominis plane|transversus abdominis plane
391617|NCT01906944|abdominal wall pain|abdominal wall pain
391618|NCT01906931|Interstitial lung disease|interstitial lung disease
391619|NCT01906931|Oxygen therapy|oxygen therapy
391620|NCT01906931|Walk|walk
391621|NCT01906918|ischemia|ischemia
391622|NCT01906918|reperfusion|reperfusion
391623|NCT01906918|myocardial ischemia|myocardial ischemia
391624|NCT01906918|myocardial reperfusion|myocardial reperfusion
391625|NCT01906866|Sleep disturbance|sleep disturbance
391626|NCT01906866|Circadian|circadian
391627|NCT01906866|Prolong release melatonin|prolong release melatonin
391628|NCT01906866|Autism Spectrum Disorder|autism spectrum disorder
391629|NCT01906866|Smith-Magenis Syndrome|smith-magenis syndrome
391630|NCT01906866|Angelman Syndrome|angelman syndrome
391631|NCT01906866|tuberous sclerosis|tuberous sclerosis
391632|NCT01906853|BCG|bcg
391633|NCT01906853|Bacille Calmette Guérin|bacille calmette guérin
391634|NCT01906853|Allergy|allergy
391635|NCT01906853|Immunity|immunity
391636|NCT01906853|Immune response|immune response
391637|NCT01906853|Vaccine|vaccine
391638|NCT01906853|Infants|infants
391639|NCT01906853|Children|children
391640|NCT01906853|Infection|infection
391641|NCT01906840|Chronic renal failure|chronic renal failure
391642|NCT01906840|Hemodialysis|hemodialysis
391643|NCT01906840|Oxidative stress|oxidative stress
391644|NCT01906840|Turmeric|turmeric
391645|NCT01906827|cholestasis|cholestasis
391646|NCT01906827|pregnancy|pregnancy
391647|NCT01906827|p wave dispersion|p wave dispersion
391648|NCT01906827|arrhythmia|arrhythmia
391649|NCT01906801|Osteoarthritis|osteoarthritis
391650|NCT01906801|Glucosamine sulfate|glucosamine sulfate
391651|NCT01906801|Diacerein|diacerein
391652|NCT01906801|Randomized controlled trial|randomized controlled trial
391653|NCT01906775|ICD|icd
391654|NCT01906775|ventricular tachyarrhythmia|ventricular tachyarrhythmia
391655|NCT01906775|shock|shock
391656|NCT01906775|sub-threshold pacing|sub-threshold pacing
391657|NCT01906762|Morphine, Acetaminophen, Renal colic, Emergency treatment|morphine, acetaminophen, renal colic, emergency treatment
391658|NCT01906749|Acute coronary syndrome|acute coronary syndrome
391659|NCT01906749|Colchicine|colchicine
391660|NCT01906710|Adverse Drug Events|adverse drug events
391661|NCT01906710|Drug related problems|drug related problems
391662|NCT01906710|Medication Reconciliation|medication reconciliation
391663|NCT01906710|Medication review|medication review
391664|NCT01906710|discharge counseling|discharge counseling
391665|NCT01906710|Hospital Pharmacy based|hospital pharmacy based
391666|NCT01906710|integrated medicines management|integrated medicines management
391667|NCT01906710|patient safety|patient safety
391668|NCT01906684|Acthar Gel|acthar gel
391669|NCT01906684|MS relapse|ms relapse
391670|NCT01906684|7T MRI imaging|7t mri imaging
391671|NCT01906684|Quality of Life|quality of life
391672|NCT01906671|6-mercaptopurine|6-mercaptopurine
391673|NCT01906671|Drug formulation|drug formulation
391674|NCT01906658|H.P. Acthar Gel|h.p. acthar gel
391675|NCT01906658|Acthar|acthar
391676|NCT01906658|amyotrophic lateral sclerosis|amyotrophic lateral sclerosis
391677|NCT01906658|ALS|als
391678|NCT01906645|Patient Readmission|patient readmission
391679|NCT01906645|Continuity of Patient Care|continuity of patient care
391680|NCT01906619|Febrile Seizure|febrile seizure
391681|NCT01906619|Respiratory physiology|respiratory physiology
391682|NCT01906619|Respiratory drive|respiratory drive
391683|NCT01906619|Respiratory alkalosis|respiratory alkalosis
391684|NCT01906606|child nutritional status|child nutritional status
391685|NCT01906606|child development|child development
391686|NCT01906606|maternal depression|maternal depression
391687|NCT01906593|safety|safety
391688|NCT01906593|influenza vaccine|influenza vaccine
391689|NCT01906593|post-marketing|post-marketing
391690|NCT01906580|HBV|hbv
391691|NCT01906580|entecavir|entecavir
391692|NCT01906580|peginterferon|peginterferon
391693|NCT01906567|cadmium|cadmium
391694|NCT01906567|lead|lead
391695|NCT01906567|mercury|mercury
391696|NCT01906567|preeclampsia|preeclampsia
391697|NCT01906567|pregnancy|pregnancy
391698|NCT01906541|X-CGD|x-cgd
391699|NCT01906541|chronic granulomatous disease|chronic granulomatous disease
391700|NCT01906541|gene-therapy|gene-therapy
391701|NCT01906528|Nondepolarizing neuromuscular blocking drug|nondepolarizing neuromuscular blocking drug
391702|NCT01906528|Mivacurium|mivacurium
391703|NCT01906528|Sensitivity|sensitivity
391704|NCT01906528|Sex|sex
391705|NCT01906515|Anemia|anemia
391706|NCT01906515|Blood transfusion|blood transfusion
391707|NCT01906515|non invasive hemoglobin monitoring|non invasive hemoglobin monitoring
391708|NCT01906515|patient safety|patient safety
391709|NCT01906489|anemia|anemia
391710|NCT01906489|chronic kidney disease|chronic kidney disease
391711|NCT01906489|CKD|ckd
391712|NCT01906489|chronic renal insufficiency|chronic renal insufficiency
391713|NCT01906489|renal impairment|renal impairment
391714|NCT01906489|erythropoietin|erythropoietin
391715|NCT01906489|kidney|kidney
391716|NCT01906489|oral anemia treatment|oral anemia treatment
391717|NCT01906489|hemoglobin|hemoglobin
391718|NCT01906489|hypoxia-inducible factor|hypoxia-inducible factor
391719|NCT01906489|HIF|hif
400562|NCT01866267|Human Immunodeficiency Virus|human immunodeficiency virus
391720|NCT01906489|hypoxia-inducible factor prolyl-hydroxylase inhibitor|hypoxia-inducible factor prolyl-hydroxylase inhibitor
391721|NCT01906489|HIF-PHI|hif-phi
391722|NCT01906489|efficacy|efficacy
391723|NCT01906489|safety|safety
391724|NCT01906489|pharmacokinetics|pharmacokinetics
391725|NCT01906476|Depression|depression
391726|NCT01906476|Telephone Cognitive Behavior Therapy|telephone cognitive behavior therapy
391727|NCT01906476|Internet Cognitive Behavioral Therapy|internet cognitive behavioral therapy
391728|NCT01906437|Cardiac fibrosis and Lymphoma|cardiac fibrosis and lymphoma
391729|NCT01906424|spinal cord injury|spinal cord injury
391730|NCT01906424|quadriplegia|quadriplegia
391731|NCT01906424|tetraplegia|tetraplegia
391732|NCT01906424|stimulation|stimulation
391733|NCT01906398|Refractory epilepsy|refractory epilepsy
391734|NCT01906398|ketogenic diet|ketogenic diet
391735|NCT01906398|efficacy|efficacy
391736|NCT01906385|Glioma|glioma
391737|NCT01906385|Brain Tumor|brain tumor
391738|NCT01906385|Radiotherapy|radiotherapy
391739|NCT01906372|dermatomyositis|dermatomyositis
391740|NCT01906372|polymyositis|polymyositis
391741|NCT01906359|Interesterified fat|interesterified fat
391742|NCT01906359|Stereospecific number 2|stereospecific number 2
391743|NCT01906359|Gut hormones|gut hormones
391744|NCT01906359|GIP|gip
391745|NCT01906359|Insulin sensitivity|insulin sensitivity
391746|NCT01906359|Postprandial lipaemia|postprandial lipaemia
391747|NCT01906359|Haemostatic markers|haemostatic markers
391748|NCT01906333|Exercise|exercise
391749|NCT01906333|Ectopic fat accumulation|ectopic fat accumulation
391750|NCT01906320|anorexia nervosa|anorexia nervosa
391751|NCT01906320|restricting type|restricting type
391752|NCT01906320|muscle strength|muscle strength
391753|NCT01906320|exercise|exercise
391754|NCT01906320|body composition|body composition
391755|NCT01906320|physical activity|physical activity
391756|NCT01906307|hepatorenal syndrome|hepatorenal syndrome
391757|NCT01906294|Type 2 Diabetes Mellitus|type 2 diabetes mellitus
391758|NCT01906281|adipocytokines|adipocytokines
391759|NCT01906281|osteoarthritis|osteoarthritis
391760|NCT01906281|cardiovascular risk|cardiovascular risk
391761|NCT01906268|Generalized Anxiety Disorder|generalized anxiety disorder
391762|NCT01906268|Social Anxiety Disorder|social anxiety disorder
391763|NCT01906268|Panic Disorder|panic disorder
391764|NCT01906268|Antidepressants Resistant|antidepressants resistant
391765|NCT01906268|Attentional Bias Modification Treatment (ABMT)|attentional bias modification treatment (abmt)
391766|NCT01906268|Attentional Retraining|attentional retraining
391767|NCT01906268|Adjuvant Therapy|adjuvant therapy
391768|NCT01906255|HIV-1|hiv-1
391769|NCT01906255|Truvada|truvada
391770|NCT01906255|FTC/TDF|ftc/tdf
391771|NCT01906255|Pre-exposure prophylaxis|pre-exposure prophylaxis
391772|NCT01906255|PrEP|prep
391773|NCT01906255|Adherence|adherence
391774|NCT01906255|Resistance|resistance
391775|NCT01906216|Hepatocellular carcinoma|hepatocellular carcinoma
391776|NCT01906216|sorafenib|sorafenib
391777|NCT01906216|transarterial chemoembolization|transarterial chemoembolization
391778|NCT01906203|Ultramarathon|ultramarathon
391779|NCT01906203|bioelectrical impedance|bioelectrical impedance
391780|NCT01906203|Phase-Angle|phase-angle
391781|NCT01906190|influenza vaccine|influenza vaccine
391782|NCT01906190|immune response|immune response
391783|NCT01906190|persistence|persistence
391784|NCT01906164|RSV|rsv
391785|NCT01906125|Bioequivalence|bioequivalence
391786|NCT01906125|Cmax|cmax
391787|NCT01906125|AUC|auc
391788|NCT01906073|fentanyl|fentanyl
391789|NCT01906073|administration, intranasal|administration, intranasal
391790|NCT01906073|morphine|morphine
391791|NCT01906073|patient satisfaction|patient satisfaction
391792|NCT01906073|patient preference|patient preference
391793|NCT01906047|Non-cystic fibrosis bronchiectasis|non-cystic fibrosis bronchiectasis
391794|NCT01906021|Thermomap|thermomap
391795|NCT01906021|Hepatic Lesions|hepatic lesions
391796|NCT01906021|Radiofrequency Ablation|radiofrequency ablation
391797|NCT01906021|Microwave|microwave
391798|NCT01906021|Non-Invasive Technique|non-invasive technique
391799|NCT01906008|Colorectal cancer|colorectal cancer
391800|NCT01906008|CRC|crc
391801|NCT01906008|Acute peripheral neuropathy|acute peripheral neuropathy
391802|NCT01906008|Numbness|numbness
391803|NCT01906008|Pain|pain
391804|NCT01906008|Loss of motor function|loss of motor function
391805|NCT01906008|Minocycline|minocycline
391806|NCT01906008|Dynacin|dynacin
391807|NCT01906008|Minocin|minocin
391808|NCT01906008|Minocin PAC|minocin pac
391809|NCT01906008|Myrac|myrac
391810|NCT01906008|Solodyn|solodyn
391811|NCT01906008|Placebo|placebo
391812|NCT01906008|Questionnaires|questionnaires
391813|NCT01906008|Surveys|surveys
391814|NCT01906008|Sensory tests|sensory tests
391815|NCT01905995|deep brain sitimulation|deep brain sitimulation
391816|NCT01905995|local field potentials|local field potentials
391817|NCT01905969|Gastric caner, adjuvant chemotherapy|gastric caner, adjuvant chemotherapy
391818|NCT01905917|Stroke|stroke
391819|NCT01905904|electroconvulsive therapy|electroconvulsive therapy
391820|NCT01905904|seizures|seizures
391821|NCT01905904|sevoflurane|sevoflurane
391822|NCT01905891|Non melanoma skin cancer|non melanoma skin cancer
392116|NCT01904461|children|children
391823|NCT01905891|Field of cancerization|field of cancerization
391824|NCT01905891|Skin carcinogenesis|skin carcinogenesis
391825|NCT01905865|Undiagnosed Medical Conditions|undiagnosed medical conditions
391826|NCT01905852|Transcatheter Aortic Valve Replacement|transcatheter aortic valve replacement
391827|NCT01905852|Ejection Fraction|ejection fraction
391828|NCT01905852|Fractional Flow Reserve|fractional flow reserve
391829|NCT01905852|Myocardial Fibrosis|myocardial fibrosis
391830|NCT01905839|Rigidity|rigidity
391831|NCT01905839|Assessment|assessment
391832|NCT01905839|Parkinson's Disease|parkinson's disease
391833|NCT01905839|Physiological Measures|physiological measures
391834|NCT01905826|Myelodysplastic Syndromes|myelodysplastic syndromes
391835|NCT01905826|Herpesvirus|herpesvirus
391836|NCT01905826|Disseminated nontuberculous Mycobacterial (NTM)|disseminated nontuberculous mycobacterial (ntm)
391837|NCT01905826|Human Papilloma Virus (HPV)|human papilloma virus (hpv)
391838|NCT01905826|Leukemia|leukemia
391839|NCT01905800|Vertigo and dizziness.|vertigo and dizziness.
391840|NCT01905800|semicircular canals|semicircular canals
391841|NCT01905774|Renal Function|renal function
391842|NCT01905761|obesity|obesity
391843|NCT01905748|Coagulation|coagulation
391844|NCT01905735|RA|ra
391845|NCT01905722|MRI|mri
391846|NCT01905722|metabolism|metabolism
391847|NCT01905722|healthy|healthy
391848|NCT01905722|7 Tesla|7 tesla
391849|NCT01905709|C diff|c diff
391850|NCT01905709|CDI|cdi
391851|NCT01905709|clostridium difficile associated diarrhea|clostridium difficile associated diarrhea
391852|NCT01905670|Cardiac Resynchronization Therapy|cardiac resynchronization therapy
391853|NCT01905670|cardiac pacing|cardiac pacing
391854|NCT01905670|electrical stimulation|electrical stimulation
391855|NCT01905670|bi-ventricular pacing|bi-ventricular pacing
391856|NCT01905657|PD1|pd1
391857|NCT01905657|PD-1|pd-1
391858|NCT01905657|PDL1|pdl1
391859|NCT01905657|PD-L1|pd-l1
391860|NCT01905644|Vaginal delivery|vaginal delivery
391861|NCT01905644|Perineal lesions|perineal lesions
391862|NCT01905644|Anal sphincter rupture|anal sphincter rupture
391863|NCT01905644|Ultrasound|ultrasound
391864|NCT01905631|Pruritus|pruritus
391865|NCT01905631|Atopic Dermatitis|atopic dermatitis
391866|NCT01905618|Medical Education|medical education
391867|NCT01905618|Tobacco Dependence Treatment|tobacco dependence treatment
391868|NCT01905618|Physician Delivered Intervention|physician delivered intervention
391869|NCT01905592|Human Epidermal Growth Factor 2 Negative Carcinoma of Breast|human epidermal growth factor 2 negative carcinoma of breast
391870|NCT01905592|BRCA1 Gene Mutation|brca1 gene mutation
391871|NCT01905592|BRCA2 Gene Mutation|brca2 gene mutation
391872|NCT01905592|Parp Inhibitor|parp inhibitor
391873|NCT01905592|BRCA|brca
391874|NCT01905579|flaremetry|flaremetry
391875|NCT01905579|aqueous proteins|aqueous proteins
391876|NCT01905579|clinical grading|clinical grading
391877|NCT01905579|Compare flaremetry readings with the protein content of the aqueous|compare flaremetry readings with the protein content of the aqueous
391878|NCT01905579|Compare flaremetry readings with clinical grading of flare|compare flaremetry readings with clinical grading of flare
391879|NCT01905566|Plaque, Atherosclerotic|plaque, atherosclerotic
391880|NCT01905566|clopidogrel|clopidogrel
391881|NCT01905566|ticagrelor|ticagrelor
391882|NCT01905566|Fluorodeoxyglucose F18|fluorodeoxyglucose f18
391883|NCT01905566|Positron-Emission Tomography and Computed Tomography|positron-emission tomography and computed tomography
391884|NCT01905527|Multiple Sclerosis|multiple sclerosis
391885|NCT01905527|Relapsing-Remitting|relapsing-remitting
391886|NCT01905527|Rebif|rebif
391887|NCT01905527|Quintiles Geographic Area Group|quintiles geographic area group
391888|NCT01905527|Standard Subgroup|standard subgroup
391889|NCT01905527|Custom Subgroup|custom subgroup
391890|NCT01905527|RxCrossroads Geographic Area Group|rxcrossroads geographic area group
391891|NCT01905501|Balanced anesthesia|balanced anesthesia
391892|NCT01905501|Inhalation anesthesia|inhalation anesthesia
391893|NCT01905501|Reperfusion injury|reperfusion injury
391894|NCT01905501|Microsurgical Free flap|microsurgical free flap
391895|NCT01905475|STEMI|stemi
391896|NCT01905475|AMI|ami
391897|NCT01905475|repair|repair
391898|NCT01905462|Cervarix|cervarix
391899|NCT01905462|Spontaneous abortion|spontaneous abortion
391900|NCT01905462|Vaccine|vaccine
391901|NCT01905462|Human Papillomavirus|human papillomavirus
391902|NCT01905436|Filariasis|filariasis
391903|NCT01905436|Onchocerciasis|onchocerciasis
391904|NCT01905436|Albendazole|albendazole
391905|NCT01905436|Ivermectin|ivermectin
391906|NCT01905436|STH Soil Transmitted Helminth infections|sth soil transmitted helminth infections
391907|NCT01905436|MDA Mass Drug Administration|mda mass drug administration
391908|NCT01905423|Filariasis|filariasis
391909|NCT01905423|Albendazole|albendazole
391910|NCT01905423|Diethylcarbamazine|diethylcarbamazine
391911|NCT01905423|STH Soil Transmitted Helminths|sth soil transmitted helminths
391912|NCT01905423|MDA Mass Drug Administration|mda mass drug administration
391913|NCT01905384|pancreatic cancer|pancreatic cancer
391914|NCT01905384|cholangiocarcinoma|cholangiocarcinoma
391915|NCT01905384|metastatic malignancy|metastatic malignancy
391916|NCT01905384|jaundice|jaundice
391917|NCT01905371|amphetamine|amphetamine
392117|NCT01904461|vacuum|vacuum
391918|NCT01905371|stroke recovery|stroke recovery
391919|NCT01905319|juvenile idiopathic arthritis|juvenile idiopathic arthritis
391920|NCT01905319|incidence rate|incidence rate
391921|NCT01905306|dental implants|dental implants
391922|NCT01905306|immediate loading|immediate loading
391923|NCT01905306|full-arch|full-arch
391924|NCT01905306|computer guided implant surgery|computer guided implant surgery
391925|NCT01905280|allograft|allograft
391926|NCT01905280|acellular dermal matrix|acellular dermal matrix
391927|NCT01905280|alveolar ridge|alveolar ridge
391928|NCT01905267|mindfulness|mindfulness
391929|NCT01905267|relapse prevention|relapse prevention
391930|NCT01905267|recovery|recovery
391931|NCT01905267|depression|depression
391932|NCT01905267|adolescents|adolescents
391933|NCT01905254|Transient elastography|transient elastography
391934|NCT01905254|mini-laparoscopy|mini-laparoscopy
391935|NCT01905254|liver biopsy|liver biopsy
391936|NCT01905254|liver cirrhosis|liver cirrhosis
391937|NCT01905254|autoimmune hepatitis|autoimmune hepatitis
391938|NCT01905228|Metastatic Advance Solid Neoplasms|metastatic advance solid neoplasms
391939|NCT01905228|Unresectable Advance Solid Neoplasms|unresectable advance solid neoplasms
391940|NCT01905215|Immunogenicity|immunogenicity
391941|NCT01905215|Respiratory Syncytial Virus|respiratory syncytial virus
391942|NCT01905215|Reactogenicity|reactogenicity
391943|NCT01905215|Vaccination|vaccination
391945|NCT01905202|Proton Pump Inhibitor|proton pump inhibitor
391946|NCT01905202|Safety|safety
391947|NCT01905202|Tolerability|tolerability
391948|NCT01905202|pH control|ph control
391949|NCT01905202|Bile Acid|bile acid
391950|NCT01905189|pulmonary arterial hypertension|pulmonary arterial hypertension
391951|NCT01905189|cardiac resynchronization therapy|cardiac resynchronization therapy
391952|NCT01905176|Heart Failure|heart failure
391953|NCT01905176|Randomized Control Trial|randomized control trial
391954|NCT01905176|Disease management|disease management
391955|NCT01905176|Self-care|self-care
391956|NCT01905176|Nursing|nursing
391957|NCT01905176|Patient education as topic|patient education as topic
391958|NCT01905163|Laparoscopy, interval debulking surgery|laparoscopy, interval debulking surgery
391959|NCT01905150|pancreatic Cancer|pancreatic cancer
391960|NCT01905150|G-FLIP, Gemcitabine 5FU Leucovorin Irinotecan Oxaliplatin|g-flip, gemcitabine 5fu leucovorin irinotecan oxaliplatin
391961|NCT01905150|G-FLIP-DM (G-FLIP + Low doses Docetaxel and Mitomycin C)|g-flip-dm (g-flip + low doses docetaxel and mitomycin c)
391962|NCT01905150|Vitamin C (ascorbic acid)|vitamin c (ascorbic acid)
391963|NCT01905137|Myofascial pelvic pain|myofascial pelvic pain
391964|NCT01905124|Uveitis|uveitis
391965|NCT01905124|Intermediate uveitis|intermediate uveitis
391966|NCT01905124|Posterior uveitis|posterior uveitis
391967|NCT01905098|Detoxification|detoxification
391968|NCT01905098|Sauna|sauna
391969|NCT01905098|Hyperthermia|hyperthermia
391970|NCT01905072|Obesity|obesity
391971|NCT01905072|Breastfeeding|breastfeeding
391972|NCT01905072|Educational Intervention|educational intervention
391973|NCT01905059|HIV infection|hiv infection
391974|NCT01905059|second line ART|second line art
391975|NCT01905059|maintenance strategies|maintenance strategies
391976|NCT01905059|Protease inhibitors|protease inhibitors
391977|NCT01905059|mono or bi-therapy|mono or bi-therapy
391978|NCT01905033|Sepsis|sepsis
391979|NCT01905033|Pneumonia|pneumonia
391980|NCT01905033|Peritonitis|peritonitis
391981|NCT01905033|Biomarkers|biomarkers
391982|NCT01905033|Transcriptomics|transcriptomics
391983|NCT01905033|Pathogen detection|pathogen detection
391984|NCT01905020|Type 1 diabetes|type 1 diabetes
391985|NCT01905020|Hypoglycemia|hypoglycemia
391986|NCT01905020|Insulin|insulin
391987|NCT01905020|Glucagon|glucagon
391988|NCT01905020|Closed-loop system|closed-loop system
391989|NCT01905020|Artificial pancreas|artificial pancreas
391990|NCT01905007|Implantable cardioverter defibrillator|implantable cardioverter defibrillator
391991|NCT01905007|Defibrillation threshold testing|defibrillation threshold testing
391992|NCT01904994|HIV (Human Immunodeficiency Virus)|hiv (human immunodeficiency virus)
391993|NCT01904994|ART (antiretroviral therapy)|art (antiretroviral therapy)
391994|NCT01904994|financial incentive|financial incentive
391995|NCT01904994|linkage|linkage
391996|NCT01904994|retention|retention
391997|NCT01904994|SMS (Short Message Service) appointment reminder|sms (short message service) appointment reminder
391998|NCT01904994|accelerated ART|accelerated art
391999|NCT01904994|CD4+ count|cd4+ count
392000|NCT01904903|Breast Cancer HER2 Positive|breast cancer her2 positive
392001|NCT01904903|Cardiac Safety|cardiac safety
392002|NCT01904890|Asian Americans|asian americans
392003|NCT01904890|colorectal cancer screening|colorectal cancer screening
392004|NCT01904890|cancer prevention|cancer prevention
392005|NCT01904890|Filipinos Americans|filipinos americans
392006|NCT01904890|Hmong Americans|hmong americans
392007|NCT01904890|Korean Americans|korean americans
501375|NCT01425684|MRI|mri
392008|NCT01904890|Randomized Controlled Trials|randomized controlled trials
392009|NCT01904877|HIV testing|hiv testing
392010|NCT01904877|linkage|linkage
392011|NCT01904877|care|care
392012|NCT01904864|randomized controlled trial|randomized controlled trial
392013|NCT01904864|iron medication|iron medication
392014|NCT01904864|Anemia|anemia
392015|NCT01904864|Hematologic Disease|hematologic disease
392016|NCT01904864|Anemia, Iron deficiency|anemia, iron deficiency
392017|NCT01904864|anemia, nutritional|anemia, nutritional
392018|NCT01904864|ferrous sulfate|ferrous sulfate
392019|NCT01904864|NovaFerrum®|novaferrum®
392020|NCT01904851|Peripheral Arterial Disease|peripheral arterial disease
392022|NCT01904851|Registry|registry
392023|NCT01904851|Angioplasty|angioplasty
392024|NCT01904851|Endovascular Procedures|endovascular procedures
392025|NCT01904786|Hypoxic Ischemic Encephalopathy|hypoxic ischemic encephalopathy
392026|NCT01904786|Newborn|newborn
392027|NCT01904786|Outcomes|outcomes
392028|NCT01904786|Melatonin|melatonin
392029|NCT01904773|Combined Multiple Motor and Vocal Tic Disorder; Tourette Disorder; Gilles de la Tourette Syndrome; Tourette Disease|combined multiple motor and vocal tic disorder; tourette disorder; gilles de la tourette syndrome; tourette disease
392030|NCT01904760|agitation|agitation
392031|NCT01904760|delirium|delirium
392032|NCT01904760|dexmedetomidine|dexmedetomidine
392033|NCT01904760|head and neck surgery|head and neck surgery
392034|NCT01904760|microvascular free tissue transfer|microvascular free tissue transfer
392035|NCT01904760|flap|flap
392036|NCT01904747|Food|food
392037|NCT01904747|Bioavailability|bioavailability
392038|NCT01904747|Fasted|fasted
392039|NCT01904747|Fed|fed
392040|NCT01904734|testosterone|testosterone
392041|NCT01904734|hypogonadism|hypogonadism
392042|NCT01904734|pituitary|pituitary
392043|NCT01904708|Phenylketonuria|phenylketonuria
392044|NCT01904708|PKU|pku
392045|NCT01904708|Exercise|exercise
392046|NCT01904708|Muscle Protein Synthesis|muscle protein synthesis
392047|NCT01904708|Plasma Phenylalanine concentration|plasma phenylalanine concentration
392048|NCT01904695|resistant hypertension|resistant hypertension
392049|NCT01904695|causal inference|causal inference
392050|NCT01904695|a chorot study|a chorot study
392051|NCT01904695|recipe of removing both phlegm and blood stasis|recipe of removing both phlegm and blood stasis
392052|NCT01904682|Erythrocyte transfusion|erythrocyte transfusion
392053|NCT01904682|Erythropoiesis-stimulating agent|erythropoiesis-stimulating agent
392054|NCT01904682|International Prognostic Scoring System|international prognostic scoring system
392055|NCT01904669|Fertility|fertility
392056|NCT01904669|Infertility|infertility
392057|NCT01904669|Pregnancy|pregnancy
392058|NCT01904669|Conception|conception
392059|NCT01904669|Behavioral|behavioral
392060|NCT01904669|Lifestyle|lifestyle
392061|NCT01904669|Preconception Care|preconception care
392062|NCT01904669|Women's Health|women's health
392063|NCT01904669|Abortion, Spontaneous|abortion, spontaneous
392064|NCT01904669|Cohort Studies|cohort studies
392065|NCT01904669|Epidemiology|epidemiology
392066|NCT01904669|Internet|internet
392067|NCT01904656|Colorectal Cancer Screening|colorectal cancer screening
392068|NCT01904656|Ohio Appalachia|ohio appalachia
392069|NCT01904630|gene sequencing|gene sequencing
392070|NCT01904630|familial|familial
392071|NCT01904630|risk factors|risk factors
392072|NCT01904617|Length of labor|length of labor
392073|NCT01904617|second stage of labor|second stage of labor
392074|NCT01904617|intravenous hydration of labor|intravenous hydration of labor
392075|NCT01904617|intravenous glucose|intravenous glucose
392076|NCT01904604|Peanut Allergy|peanut allergy
392077|NCT01904604|Food Allergy|food allergy
392078|NCT01904604|Viaskin peanut patch|viaskin peanut patch
392079|NCT01904604|Allergen Immunotherapy|allergen immunotherapy
392080|NCT01904604|Epicutaneous Immunotherapy|epicutaneous immunotherapy
392081|NCT01904604|Whole peanut extract|whole peanut extract
392082|NCT01904604|Allergenic product|allergenic product
392083|NCT01904604|Immediate hypersensitivity|immediate hypersensitivity
392084|NCT01904591|Spinal Cord Injury|spinal cord injury
392085|NCT01904591|Antioxidants|antioxidants
392086|NCT01904591|tractography|tractography
392087|NCT01904591|ASIA assessment|asia assessment
392088|NCT01904578|Menopause|menopause
392089|NCT01904578|Sleep quality|sleep quality
392090|NCT01904578|Acupressure|acupressure
392091|NCT01904565|Hyperthermia,|hyperthermia,
392092|NCT01904565|Proton beam therapy|proton beam therapy
392093|NCT01904565|Soft Tissue Sarcoma|soft tissue sarcoma
392094|NCT01904565|Radiotherapy|radiotherapy
392095|NCT01904565|Phase I/II trial|phase i/ii trial
392096|NCT01904552|Apical periodontitis|apical periodontitis
392097|NCT01904552|Dentaport ZX|dentaport zx
392098|NCT01904552|electronic apex locators|electronic apex locators
392100|NCT01904552|Raypex 5|raypex 5
392101|NCT01904552|working length|working length
392102|NCT01904526|Guanfacine|guanfacine
392103|NCT01904526|PK/PD|pk/pd
392104|NCT01904526|Smokers|smokers
392105|NCT01904513|Metals|metals
392106|NCT01904513|Pesticides|pesticides
501510|NCT01425086|PCM|pcm
392107|NCT01904513|Toxicity|toxicity
392108|NCT01904500|Cesarean delivery|cesarean delivery
392109|NCT01904474|obesity|obesity
392110|NCT01904474|overweight|overweight
392111|NCT01904474|technology|technology
392112|NCT01904474|internet|internet
392113|NCT01904474|intervention|intervention
392114|NCT01904474|adolescents|adolescents
392115|NCT01904461|tonsillectomy|tonsillectomy
392118|NCT01904461|medical device|medical device
392119|NCT01904461|pain|pain
392120|NCT01904461|hemorrhage|hemorrhage
392121|NCT01904461|post-surgical complications|post-surgical complications
392122|NCT01904448|pediatric|pediatric
392123|NCT01904448|profound hearing loss|profound hearing loss
392124|NCT01904448|auditory brainstem implant|auditory brainstem implant
392125|NCT01904448|cochlear implant|cochlear implant
392126|NCT01904448|developmental or acquired cochlear nerve deficiency (CND)|developmental or acquired cochlear nerve deficiency (cnd)
392127|NCT01904448|cochlear aplasia (Michel)|cochlear aplasia (michel)
392128|NCT01904448|post-meningitis cochlear ossification|post-meningitis cochlear ossification
392129|NCT01904448|cochlear malformation|cochlear malformation
392130|NCT01904448|CND|cnd
392131|NCT01904422|Diabetes mellitus.|diabetes mellitus.
392132|NCT01904422|Periodontitis|periodontitis
392133|NCT01904422|Periodontal treatment.|periodontal treatment.
392134|NCT01904357|Cefazolin, Pediatric|cefazolin, pediatric
392135|NCT01904344|Sleep|sleep
392136|NCT01904344|Sleep- related breathing disorders|sleep- related breathing disorders
392137|NCT01904344|Respiratory pathology|respiratory pathology
392138|NCT01904331|Cardiotoxicity|cardiotoxicity
392139|NCT01904331|long-term effects|long-term effects
392140|NCT01904331|chemotherapy|chemotherapy
392141|NCT01904331|radiotherapy|radiotherapy
392142|NCT01904318|male|male
392143|NCT01904318|Phase I|phase i
392144|NCT01904318|A dose block-randomized|a dose block-randomized
392145|NCT01904318|Double-blinded|double-blinded
392146|NCT01904318|Placebo controlled|placebo controlled
392147|NCT01904318|Single Dose|single dose
392148|NCT01904318|dose Escalation|dose escalation
392149|NCT01904318|IDP-73152 mesylate|idp-73152 mesylate
392150|NCT01904318|Food Effect|food effect
392151|NCT01904318|Pharmacokinetics|pharmacokinetics
392152|NCT01904318|health male volunteer|health male volunteer
392153|NCT01904318|PDF inhibitor|pdf inhibitor
392154|NCT01904305|Pneumonia|pneumonia
392155|NCT01904253|Second line Small Cell Lung Cancer, (SCLC), Refractory or Sensitive to First line Platinum based chemotherapy|second line small cell lung cancer, (sclc), refractory or sensitive to first line platinum based chemotherapy
392156|NCT01904240|Parkinson's disease|parkinson's disease
392157|NCT01904240|GI tract|gi tract
392158|NCT01904240|Lipopolysaccharide binding protein|lipopolysaccharide binding protein
392159|NCT01904227|Borderline Personality Disorder|borderline personality disorder
392160|NCT01904227|Dialectical Behavior Therapy|dialectical behavior therapy
392161|NCT01904214|renal impairement|renal impairement
392162|NCT01904214|pharmacokinetics|pharmacokinetics
392163|NCT01904201|Immune function|immune function
392164|NCT01904201|Interferon-gamma release assays|interferon-gamma release assays
392165|NCT01904201|Active HIV cell Reservoirs|active hiv cell reservoirs
392166|NCT01904188|microbial identification|microbial identification
392167|NCT01904188|antibiotic resistance|antibiotic resistance
392168|NCT01904188|GeneZ and other techniques as developed|genez and other techniques as developed
392169|NCT01904188|sepsis|sepsis
392170|NCT01904188|Systemic Inflammatory Response Syndrome|systemic inflammatory response syndrome
392171|NCT01904175|Stem cell transplantation, non-myeloablative|stem cell transplantation, non-myeloablative
392172|NCT01904149|Moderate to severe acute pain|moderate to severe acute pain
392173|NCT01904149|Postoperative pain|postoperative pain
392174|NCT01904149|Abdominal hysterectomy|abdominal hysterectomy
392175|NCT01904149|Analgesics|analgesics
392176|NCT01904149|Dexketoprofen|dexketoprofen
392177|NCT01904149|Tramadol|tramadol
392178|NCT01904110|Risedronate,cholecalciferol,BMD,montly,weekly,compliance|risedronate,cholecalciferol,bmd,montly,weekly,compliance
392179|NCT01904097|Fibromyalgia|fibromyalgia
392180|NCT01904097|Transcranial Direct Current Stimulation|transcranial direct current stimulation
392181|NCT01904097|tDCS|tdcs
392182|NCT01904097|Pregabalin|pregabalin
392183|NCT01904097|Functional Neuroimaging|functional neuroimaging
392184|NCT01904097|Near Infrared Spectroscopy|near infrared spectroscopy
392185|NCT01904097|NIRS|nirs
392186|NCT01904097|Chronic Pain|chronic pain
392187|NCT01904097|Transcranial Magnetic Stimulation|transcranial magnetic stimulation
392188|NCT01904097|TMS|tms
392189|NCT01904084|Distal radius fracture|distal radius fracture
392190|NCT01904071|Hip Fracture|hip fracture
392191|NCT01904071|Ultrasound|ultrasound
392192|NCT01904071|Nerve Block|nerve block
392193|NCT01904058|PBC|pbc
392194|NCT01904032|Vitamin D|vitamin d
392195|NCT01904032|Diabetes|diabetes
392196|NCT01904032|Self-Management|self-management
392197|NCT01904032|Depression|depression
392198|NCT01904032|Women|women
392199|NCT01904019|arthroplasty|arthroplasty
392200|NCT01904019|trapezio-metacarpial|trapezio-metacarpial
392201|NCT01904006|grouped embryo culture|grouped embryo culture
392202|NCT01904006|embryo density|embryo density
392203|NCT01904006|low oxygen|low oxygen
392204|NCT01904006|benchtop incubator|benchtop incubator
392205|NCT01904006|culture condition|culture condition
392206|NCT01903980|Epipericardial Fat Necrosis|epipericardial fat necrosis
392207|NCT01903980|Fat Necrosis|fat necrosis
392208|NCT01903980|Chest Pain|chest pain
392209|NCT01903980|Pericardial Necrosis|pericardial necrosis
392210|NCT01903980|Pleuritic pain|pleuritic pain
392211|NCT01903967|Pituitary|pituitary
392212|NCT01903967|CGH array|cgh array
392213|NCT01903967|Tumor|tumor
392214|NCT01903941|exercise|exercise
392215|NCT01903928|cytomegalovirus|cytomegalovirus
392216|NCT01903928|HCT|hct
392217|NCT01903928|DNA vaccine|dna vaccine
392218|NCT01903928|transplantation|transplantation
392219|NCT01903902|Coronary artery disease|coronary artery disease
392220|NCT01903902|Balloon angioplasty|balloon angioplasty
392221|NCT01903902|Drug-eluting balloon|drug-eluting balloon
392222|NCT01903889|AE adverse event|ae adverse event
392223|NCT01903889|AIDS acquired immunodeficiency syndrome|aids acquired immunodeficiency syndrome
392224|NCT01903889|ALT (SGPT) alanine aminotransferase|alt (sgpt) alanine aminotransferase
392225|NCT01903889|ART antiretroviral therapy|art antiretroviral therapy
392226|NCT01903889|AST (SGOT) aspartate aminotransferase|ast (sgot) aspartate aminotransferase
392227|NCT01903889|DCF data collection forms|dcf data collection forms
392228|NCT01903889|DMC Data Monitoring Committee|dmc data monitoring committee
392229|NCT01903889|FDA (U.S.) Food and Drug Administration|fda (u.s.) food and drug administration
392230|NCT01903889|GCP Good Clinical Practice guidelines|gcp good clinical practice guidelines
392231|NCT01903889|HB sAg Hepatitis B surface antigen|hb sag hepatitis b surface antigen
392232|NCT01903889|ICH International Conference of Harmonization|ich international conference of harmonization
392233|NCT01903889|IND Investigational New Drug Application|ind investigational new drug application
392234|NCT01903889|IRB Institutional Review Board|irb institutional review board
392235|NCT01903889|IU International units|iu international units
392236|NCT01903889|mg milligram(s)|mg milligram(s)
392237|NCT01903889|mm3 cubic millimeter(s)|mm3 cubic millimeter(s)
392238|NCT01903889|PCR polymerase chain reaction|pcr polymerase chain reaction
392239|NCT01903889|SAE serious adverse event|sae serious adverse event
392240|NCT01903889|µg microgram|µg microgram
392241|NCT01903889|ULN upper limit of the normal range|uln upper limit of the normal range
392242|NCT01903889|WB Western Blot|wb western blot
392243|NCT01903889|ANC Antenatal care|anc antenatal care
392244|NCT01903889|ARV Antiretroviral|arv antiretroviral
392245|NCT01903889|C&T Care and treatment|c&t care and treatment
392246|NCT01903889|CPR Contraceptive prevalence rate|cpr contraceptive prevalence rate
392247|NCT01903889|DHS Demographic and Health Survey|dhs demographic and health survey
392248|NCT01903889|EGPAF Elizabeth Glaser Pediatric AIDS Foundation|egpaf elizabeth glaser pediatric aids foundation
392249|NCT01903889|FP Family planning|fp family planning
392250|NCT01903889|HIV Human immunodeficiency virus|hiv human immunodeficiency virus
392251|NCT01903889|HTC HIV testing and counseling|htc hiv testing and counseling
392252|NCT01903889|IUCD Intrauterine contraceptive device|iucd intrauterine contraceptive device
392253|NCT01903889|MCH Maternal/child health|mch maternal/child health
392254|NCT01903889|PDA Personal digital assistant|pda personal digital assistant
392255|NCT01903889|PEPFAR President's Emergency Plan for AIDS Relief|pepfar president's emergency plan for aids relief
392256|NCT01903889|PHSC Protection of Human Subjects Committee|phsc protection of human subjects committee
392257|NCT01903889|PMTCT Prevention of maternal to child transmission|pmtct prevention of maternal to child transmission
392258|NCT01903889|STAR-SW Strengthening TB and HIV/AIDS Response in the South Western Region of Uganda|star-sw strengthening tb and hiv/aids response in the south western region of uganda
392259|NCT01903889|STI Sexually transmitted infection|sti sexually transmitted infection
392260|NCT01903889|TM Technical monitor|tm technical monitor
392261|NCT01903889|USAID United States Agency for International Development|usaid united states agency for international development
392262|NCT01903889|WHO World Health Organization|who world health organization
392263|NCT01903863|FFP|ffp
392264|NCT01903863|fresh frozen plasma|fresh frozen plasma
392265|NCT01903863|ECMO|ecmo
392266|NCT01903863|extracorporeal membrane oxygenation|extracorporeal membrane oxygenation
392267|NCT01903863|anticoagulation|anticoagulation
392268|NCT01903863|transfusion|transfusion
392269|NCT01903850|Benign central airway obstruction|benign central airway obstruction
392270|NCT01903850|Malignant central airway obstruction|malignant central airway obstruction
392271|NCT01903850|Spray cryotherapy|spray cryotherapy
392272|NCT01903850|Endoluminal tumors|endoluminal tumors
392273|NCT01903850|Airway granulation tissue|airway granulation tissue
392274|NCT01903837|Schizophrenia|schizophrenia
392275|NCT01903837|Olanzapine|olanzapine
392276|NCT01903837|Samidorphan|samidorphan
392277|NCT01903837|Alkermes|alkermes
392278|NCT01903824|Irdabisant|irdabisant
392279|NCT01903824|cognitive impairment|cognitive impairment
392280|NCT01903811|carfilzomib|carfilzomib
392281|NCT01903811|relapsed|relapsed
392282|NCT01903811|refractory|refractory
392283|NCT01903811|multiple myeloma|multiple myeloma
392284|NCT01903785|exercise-induced bronchoconstriction (EIB)|exercise-induced bronchoconstriction (eib)
392285|NCT01903785|inhaled salbutamol|inhaled salbutamol
392286|NCT01903785|performance enhancing|performance enhancing
392287|NCT01903785|cycling|cycling
392288|NCT01903733|Subjects|subjects
392289|NCT01903733|Chronic Myeloid Leukemia|chronic myeloid leukemia
392290|NCT01903733|CML|cml
392291|NCT01903733|Bosutinib|bosutinib
392292|NCT01903733|Extension|extension
392293|NCT01903707|Schizophrenia|schizophrenia
392294|NCT01903707|Psychosis|psychosis
392295|NCT01903707|Cognitive deficits|cognitive deficits
392393|NCT01903161|delayed remote ischemic preconditioning|delayed remote ischemic preconditioning
392296|NCT01903681|Sleep problems, autism spectrum disorder, prolonged-release melatonin, Circadin, endogenous saliva melatonin|sleep problems, autism spectrum disorder, prolonged-release melatonin, circadin, endogenous saliva melatonin
392297|NCT01903681|Smith-Magenis syndrome, Angelman syndrome, Tuberous Sclerosis|smith-magenis syndrome, angelman syndrome, tuberous sclerosis
392298|NCT01903603|cerebral palsy|cerebral palsy
392299|NCT01903603|multi-modal brain techniques|multi-modal brain techniques
392301|NCT01903603|Kinematic|kinematic
392302|NCT01903603|motor control|motor control
392303|NCT01903590|TVT,TOT,Randomized|tvt,tot,randomized
392304|NCT01903577|Ergonomics|ergonomics
392305|NCT01903577|Robotic Surgery|robotic surgery
392306|NCT01903577|Laparoscopic Surgery|laparoscopic surgery
392307|NCT01903564|fetus|fetus
392308|NCT01903564|fetal arrhythmia|fetal arrhythmia
392309|NCT01903564|fetal heart rate|fetal heart rate
392310|NCT01903564|long QT syndrome|long qt syndrome
392311|NCT01903551|post-operative pain|post-operative pain
392312|NCT01903551|loco-regional analgesia|loco-regional analgesia
392313|NCT01903551|minimally invasive surgery|minimally invasive surgery
392314|NCT01903512|TMJ arthrocentesis|tmj arthrocentesis
392315|NCT01903512|internal derangement|internal derangement
392316|NCT01903512|conservative treatment|conservative treatment
392317|NCT01903486|Trouble swallowing|trouble swallowing
392318|NCT01903486|dysphagia|dysphagia
392319|NCT01903486|disorder of the esophagus|disorder of the esophagus
392320|NCT01903473|Allogeneic hematopoietic cell transplantation|allogeneic hematopoietic cell transplantation
392321|NCT01903473|GVHD|gvhd
392322|NCT01903473|Regulatory T cells|regulatory t cells
392323|NCT01903473|Steroid refractory|steroid refractory
392324|NCT01903473|Rapamycin|rapamycin
392325|NCT01903473|Immune recovery|immune recovery
392326|NCT01903473|Infusion|infusion
392327|NCT01903473|HLA-identical sibling|hla-identical sibling
392328|NCT01903473|HLA-matched unrelated donor|hla-matched unrelated donor
392329|NCT01903473|IL-2|il-2
392330|NCT01903447|Internalizing psychopathologies|internalizing psychopathologies
392331|NCT01903447|Depression|depression
392332|NCT01903447|Anxiety|anxiety
392333|NCT01903447|MRI|mri
392334|NCT01903447|medication treatment|medication treatment
392335|NCT01903447|psychotherapy|psychotherapy
392336|NCT01903447|brain function|brain function
392337|NCT01903421|Elderly surgical patients|elderly surgical patients
392338|NCT01903421|Alzheimer's disease|alzheimer's disease
392339|NCT01903421|Dementia|dementia
392340|NCT01903421|Elderly|elderly
392341|NCT01903421|Surgery|surgery
392342|NCT01903395|Colorectal Neoplasms/*drug therapy/*secondary|colorectal neoplasms/*drug therapy/*secondary
392343|NCT01903395|Health Services Accessibility|health services accessibility
392344|NCT01903395|Humans|humans
392345|NCT01903395|Supportive Care Needs|supportive care needs
392346|NCT01903395|Psychooncology|psychooncology
392347|NCT01903395|Primary Health Care/*methods|primary health care/*methods
392348|NCT01903395|Treatment Outcome|treatment outcome
392349|NCT01903395|Socioeconomic Factors|socioeconomic factors
392350|NCT01903395|Quality Assurance, Health Care|quality assurance, health care
392351|NCT01903395|Adult|adult
392352|NCT01903395|Aged|aged
392353|NCT01903395|Aged, 80 and over|aged, 80 and over
392354|NCT01903369|Shear wave|shear wave
392355|NCT01903369|Elastography|elastography
392356|NCT01903369|Repeatability and Reproducibility|repeatability and reproducibility
392357|NCT01903343|Shear wave|shear wave
392358|NCT01903343|Elastography|elastography
392359|NCT01903343|Repeatability and Reproducibility|repeatability and reproducibility
392360|NCT01903330|ERC1671|erc1671
392361|NCT01903330|GM-CSF|gm-csf
392362|NCT01903330|Cyclophosphamide|cyclophosphamide
392363|NCT01903330|Bevacizumab|bevacizumab
392364|NCT01903304|Olive oil|olive oil
392365|NCT01903304|DTH|dth
392366|NCT01903304|elderly|elderly
392367|NCT01903278|interferon|interferon
392368|NCT01903278|ribavirin|ribavirin
392369|NCT01903278|sustained virological response|sustained virological response
392370|NCT01903265|pain|pain
392371|NCT01903265|sleep|sleep
392372|NCT01903252|UC|uc
392373|NCT01903226|spinal cord injury|spinal cord injury
392374|NCT01903226|physical capacity|physical capacity
392375|NCT01903226|energy expenditure|energy expenditure
392376|NCT01903226|training|training
392377|NCT01903213|Peritoneal dialysis|peritoneal dialysis
392378|NCT01903213|Bixalomer|bixalomer
400563|NCT01866267|AIDS|aids
392379|NCT01903213|Chronic renal failure patients with Hyperphosphatemia|chronic renal failure patients with hyperphosphatemia
392380|NCT01903213|Kiklin®|kiklin®
392381|NCT01903200|Antipsychotic|antipsychotic
392382|NCT01903200|FK949E|fk949e
392383|NCT01903200|Quetiapine|quetiapine
392384|NCT01903200|Elderly|elderly
392385|NCT01903187|hypertension|hypertension
392386|NCT01903187|resistant hypertension|resistant hypertension
392387|NCT01903187|renal denervation|renal denervation
392388|NCT01903174|Breast Cancer|breast cancer
392389|NCT01903174|Breast Reconstruction|breast reconstruction
392390|NCT01903174|Breast Tissue Expansion|breast tissue expansion
392391|NCT01903174|Breast Tissue Expander|breast tissue expander
392392|NCT01903174|Two Stage Breast Reconstruction|two stage breast reconstruction
392394|NCT01903161|troponin|troponin
392395|NCT01903161|valve replacement surgery|valve replacement surgery
392396|NCT01903148|ANEMIA IN CHRONIC KIDNEY DISEASE PATIENTS NOT ON DIALYSIS|anemia in chronic kidney disease patients not on dialysis
392397|NCT01903135|Obesity Hypoventilation Syndrome|obesity hypoventilation syndrome
392398|NCT01903135|Prevalence|prevalence
392399|NCT01903135|Bicarbonate|bicarbonate
392400|NCT01903096|Panic disorder|panic disorder
392401|NCT01903096|Generalized anxiety disorder|generalized anxiety disorder
392402|NCT01903096|Social phobia|social phobia
392403|NCT01903096|Specific phobia|specific phobia
392404|NCT01903096|Major depressive disorder|major depressive disorder
392405|NCT01903096|Dysthymia|dysthymia
392406|NCT01903096|Somatizations disorder|somatizations disorder
392407|NCT01903096|Pain disorder|pain disorder
392408|NCT01903083|Pancreas|pancreas
392409|NCT01903083|Pancreatic cancer|pancreatic cancer
392410|NCT01903083|Immunotherapy|immunotherapy
392411|NCT01903083|Chemotherapy|chemotherapy
392412|NCT01903083|Radiation|radiation
392413|NCT01903083|Surgery|surgery
392414|NCT01903083|Pancreaticoduodenectomy|pancreaticoduodenectomy
392415|NCT01903057|Mass Drug Administration|mass drug administration
392416|NCT01903057|Neglected Tropical Diseases|neglected tropical diseases
392417|NCT01903057|Preventive Chemotherapy and Transmission Control|preventive chemotherapy and transmission control
392418|NCT01903057|Preventive Chemotherapy|preventive chemotherapy
392419|NCT01903044|Lowe extremity ischemia|lowe extremity ischemia
392420|NCT01903044|Bone marrow|bone marrow
392421|NCT01903044|Neoangiogenesis|neoangiogenesis
392422|NCT01903005|Opioid, Dependence, agonist, Buprenorphine, Naloxone|opioid, dependence, agonist, buprenorphine, naloxone
392423|NCT01902966|Cervical Cancer|cervical cancer
392424|NCT01902966|Propranolol|propranolol
392425|NCT01902966|Betachron|betachron
392426|NCT01902966|Inderal|inderal
392427|NCT01902966|Beta blocker|beta blocker
392428|NCT01902966|Questionnaires|questionnaires
392429|NCT01902966|Surveys|surveys
392430|NCT01902966|Symptom inventory|symptom inventory
392431|NCT01902966|Anxiety and depression survey|anxiety and depression survey
392432|NCT01902966|Pain inventory|pain inventory
392433|NCT01902966|Quality of life survey|quality of life survey
392434|NCT01902966|Relaxation audio recording|relaxation audio recording
392435|NCT01902966|MP3 player|mp3 player
392436|NCT01902966|Diary|diary
392437|NCT01902953|Sentinel lymph nodes|sentinel lymph nodes
392438|NCT01902953|colon cancer|colon cancer
392439|NCT01902953|rectal cancer|rectal cancer
392440|NCT01902953|immunohistochemistry|immunohistochemistry
392441|NCT01902927|Exercise tolerance|exercise tolerance
392442|NCT01902927|Dyspnea|dyspnea
392443|NCT01902927|Affective distraction|affective distraction
392444|NCT01902914|hearing aids|hearing aids
392445|NCT01902914|hearing disability|hearing disability
392446|NCT01902914|community|community
392447|NCT01902914|hearing aids service|hearing aids service
392448|NCT01902901|Whole Genome Sequencing|whole genome sequencing
392449|NCT01902901|Carrier status|carrier status
392450|NCT01902901|Genetics|genetics
392451|NCT01902888|popliteal artery|popliteal artery
392452|NCT01902888|aneurysm|aneurysm
392453|NCT01902888|popliteal artery aneurysm|popliteal artery aneurysm
392454|NCT01902888|asymptomatic aneurysm|asymptomatic aneurysm
392455|NCT01902888|mural thrombus|mural thrombus
392456|NCT01902888|Viabahn|viabahn
392457|NCT01902888|Gore|gore
392458|NCT01902888|Endoprosthesis|endoprosthesis
392459|NCT01902862|Lymphoma, follicular|lymphoma, follicular
392460|NCT01902862|Bortezomib|bortezomib
392461|NCT01902862|Rituximab|rituximab
392462|NCT01902849|intravenous anesthesia|intravenous anesthesia
392463|NCT01902849|inhalational anesthesia|inhalational anesthesia
392464|NCT01902849|interleukins|interleukins
392465|NCT01902849|colorectal surgery|colorectal surgery
392466|NCT01902836|Dialyzable Leukocyte Extracts|dialyzable leukocyte extracts
392467|NCT01902836|Transferon|transferon
392468|NCT01902836|atopic dermatitis|atopic dermatitis
392469|NCT01902823|Nurse Navigator|nurse navigator
392470|NCT01902823|Satisfaction with Care|satisfaction with care
392471|NCT01902823|Quality of Life|quality of life
392472|NCT01902823|Symptom Distress|symptom distress
392473|NCT01902797|Refugee camps|refugee camps
392474|NCT01902797|Household residence|household residence
392475|NCT01902797|Treated bednets|treated bednets
392476|NCT01902797|PCR|pcr
392477|NCT01902784|Intensive Care Unit patients and families|intensive care unit patients and families
392478|NCT01902784|Surrogate decision making|surrogate decision making
392479|NCT01902784|Life Sustaining Treatments (LST)|life sustaining treatments (lst)
392480|NCT01902771|Dendritic Cell Vaccine|dendritic cell vaccine
392481|NCT01902771|DCV|dcv
392482|NCT01902771|Pediatric|pediatric
392483|NCT01902771|Brain Tumor|brain tumor
392484|NCT01902771|In Situ|in situ
392485|NCT01902771|Lysate|lysate
392486|NCT01902771|Tumor Lysate|tumor lysate
392487|NCT01902771|Glioblastoma Multiforme|glioblastoma multiforme
392488|NCT01902771|GBM|gbm
392489|NCT01902771|Pheresis|pheresis
392490|NCT01902771|Leukapheresis|leukapheresis
392491|NCT01902771|High Grade Glioma|high grade glioma
392492|NCT01902771|HGG|hgg
392493|NCT01902758|exercise performance|exercise performance
392494|NCT01902693|HIV|hiv
392495|NCT01902693|Chemotherapy|chemotherapy
392496|NCT01902693|Cohort|cohort
392497|NCT01902693|Cancer|cancer
392498|NCT01902693|HAART|haart
392499|NCT01902693|Malignancy|malignancy
392500|NCT01902680|Prostate cancer, permanent implant brachytherapy, image fusion, focal therapy, active surveillance|prostate cancer, permanent implant brachytherapy, image fusion, focal therapy, active surveillance
392501|NCT01902667|Retroperitoneal Sarcoma|retroperitoneal sarcoma
392502|NCT01902667|Magnetic Resonance Imaging|magnetic resonance imaging
392503|NCT01902654|Osteoarthritis|osteoarthritis
392504|NCT01902654|cardiovascular disease|cardiovascular disease
392505|NCT01902641|succinylcholine|succinylcholine
392506|NCT01902641|rocuronium|rocuronium
392507|NCT01902641|sugammadex|sugammadex
392508|NCT01902641|Intubating Conditions|intubating conditions
392509|NCT01902641|short Procedures|short procedures
392510|NCT01902563|osteopathic manipulative treatment|osteopathic manipulative treatment
392511|NCT01902563|newborns|newborns
392512|NCT01902563|preterm infants|preterm infants
392513|NCT01902563|procedures|procedures
392514|NCT01902550|Healthy|healthy
392515|NCT01902550|JNJ-54452840|jnj-54452840
392516|NCT01902550|Metoprolol Tartrate Immediate-Release|metoprolol tartrate immediate-release
392517|NCT01902550|Placebo|placebo
392518|NCT01902550|Male|male
392519|NCT01902537|Constipation|constipation
392520|NCT01902537|Prucalopride|prucalopride
392521|NCT01902524|Chronic Pain|chronic pain
392522|NCT01902524|Fentanyl-TTS|fentanyl-tts
392523|NCT01902524|Fentanyl Patch|fentanyl patch
392524|NCT01902524|Transdermal|transdermal
392525|NCT01902524|Non-cancer Pain|non-cancer pain
392526|NCT01902498|aspirin|aspirin
392527|NCT01902485|Contraception|contraception
392528|NCT01902485|Medical Abortion|medical abortion
392529|NCT01902485|Implant|implant
392530|NCT01902485|Injectable|injectable
392531|NCT01902485|Quickstart|quickstart
392532|NCT01902472|HIV-1|hiv-1
392533|NCT01902472|Truvada|truvada
392534|NCT01902472|FTC/TDF|ftc/tdf
392535|NCT01902472|Pre-exposure prophylaxis|pre-exposure prophylaxis
392536|NCT01902472|PrEP|prep
392537|NCT01902472|Resistance|resistance
392538|NCT01902459|Hemostasis|hemostasis
392539|NCT01902446|Chlorhexidine|chlorhexidine
392540|NCT01902446|Randomized Controlled Trial|randomized controlled trial
392541|NCT01902446|Emergency Medical Services|emergency medical services
392542|NCT01902446|Intubation, Endotracheal|intubation, endotracheal
392543|NCT01902407|Pcrit|pcrit
392544|NCT01902407|Critical closing pressure|critical closing pressure
392545|NCT01902407|Down syndrome|down syndrome
392546|NCT01902407|Obstructive Sleep Apnea|obstructive sleep apnea
392547|NCT01902407|Sleep MRI|sleep mri
392548|NCT01902394|digestive health and natural defenses|digestive health and natural defenses
392549|NCT01902368|Gluten free diet|gluten free diet
392550|NCT01902355|Central Venous Catheterization|central venous catheterization
392551|NCT01902329|Acute Myeloid Leukemia|acute myeloid leukemia
392552|NCT01902329|Antibody-Drug Conjugate|antibody-drug conjugate
392553|NCT01902329|CD33 Antigen|cd33 antigen
392554|NCT01902329|Immunotherapy|immunotherapy
392555|NCT01902329|Drug Therapy|drug therapy
392556|NCT01902329|Acute Myelogenous Leukemia|acute myelogenous leukemia
392557|NCT01902329|Acute Promyelocytic Leukemia|acute promyelocytic leukemia
392558|NCT01902329|APL|apl
392559|NCT01902316|Type 2 Diabetes Mellitus|type 2 diabetes mellitus
392560|NCT01902316|peptide biomarker|peptide biomarker
392561|NCT01902316|early diagnosis|early diagnosis
392562|NCT01902316|label free|label free
392563|NCT01902303|Herpes Labialis|herpes labialis
392564|NCT01902303|Herpes Simplex|herpes simplex
392565|NCT01902303|Herpes|herpes
392566|NCT01902303|Ultra Violet (UV) Induced|ultra violet (uv) induced
392567|NCT01902290|Inadequately controlled asthma, brodalumab, AMG 827|inadequately controlled asthma, brodalumab, amg 827
392568|NCT01902277|Delirium|delirium
392569|NCT01902277|Intensive Care Unit|intensive care unit
392570|NCT01902277|Critical illness|critical illness
392571|NCT01902264|Levomefolate calcium|levomefolate calcium
392572|NCT01902264|Contraceptives, oral, combined|contraceptives, oral, combined
392573|NCT01902264|Neural tube defects|neural tube defects
392574|NCT01902251|Phase 1|phase 1
392575|NCT01902251|Prostate cancer|prostate cancer
392576|NCT01902251|Bioavailability|bioavailability
392577|NCT01902251|Food effect|food effect
392578|NCT01902251|Pharmacokinetics|pharmacokinetics
392579|NCT01902251|Xtandi|xtandi
392580|NCT01902251|Enzalutamide|enzalutamide
392581|NCT01902251|MDV3100|mdv3100
392582|NCT01902238|neuroendocrine tumor|neuroendocrine tumor
392583|NCT01902238|ethanol|ethanol
392584|NCT01902238|endoscopic ultrasonography|endoscopic ultrasonography
392585|NCT01902225|Lymphoma|lymphoma
392586|NCT01902225|T-Cell|t-cell
392587|NCT01902225|Cutaneous|cutaneous
392588|NCT01902225|Doxil|doxil
392589|NCT01902225|romidepsin|romidepsin
392590|NCT01902225|skin|skin
392591|NCT01902186|HIV|hiv
392592|NCT01902186|osteopenia|osteopenia
392593|NCT01902186|t-score|t-score
392594|NCT01902186|DEXA|dexa
392595|NCT01902186|tenofovir|tenofovir
392596|NCT01902186|raltegravir|raltegravir
392597|NCT01902147|abdominal|abdominal
392598|NCT01902147|thoracic|thoracic
392599|NCT01902147|arthroplasty|arthroplasty
392600|NCT01902134|Moderate to severe acute pain|moderate to severe acute pain
392601|NCT01902134|Postoperative pain|postoperative pain
392602|NCT01902134|Hip arthroplasty|hip arthroplasty
392603|NCT01902134|Analgesics|analgesics
392604|NCT01902134|Dexketoprofen|dexketoprofen
392605|NCT01902134|Tramadol|tramadol
392606|NCT01902108|clonidine|clonidine
392607|NCT01902108|bupivacaine|bupivacaine
392608|NCT01902108|post-operative pain|post-operative pain
392609|NCT01902108|arthrodesis|arthrodesis
392610|NCT01902108|discectomy|discectomy
392611|NCT01902108|local infiltration|local infiltration
392612|NCT01902095|tooth pastes|tooth pastes
392613|NCT01902095|tooth powders|tooth powders
392614|NCT01902095|Stain Index|stain index
392615|NCT01902082|ARDS|ards
392616|NCT01902082|mesenchymal stem cells|mesenchymal stem cells
392617|NCT01902082|Safety|safety
392618|NCT01902082|Cytokines|cytokines
392619|NCT01902069|sweet and fat preference|sweet and fat preference
392620|NCT01902056|allograft|allograft
392621|NCT01902056|acellular dermal matrix|acellular dermal matrix
392622|NCT01902056|Alloderm|alloderm
392623|NCT01902043|diabetes mellitus|diabetes mellitus
392624|NCT01902043|cohort study|cohort study
392625|NCT01902043|quality of care|quality of care
392626|NCT01902043|quality indicators, Health care|quality indicators, health care
392627|NCT01902043|quality of Health Care|quality of health care
392628|NCT01902043|outcome and process assessment|outcome and process assessment
392629|NCT01902043|health services research|health services research
392630|NCT01902043|chronic diseases prevention and management|chronic diseases prevention and management
392631|NCT01902017|Joint|joint
392632|NCT01902017|Contracture|contracture
392633|NCT01902017|Elbow|elbow
392634|NCT01902017|Fracture|fracture
392635|NCT01902017|Dislocation|dislocation
392636|NCT01902004|Major Depression|major depression
392637|NCT01902004|Geriatric Major Depression|geriatric major depression
392638|NCT01902004|Executive Cognitive Dysfunction|executive cognitive dysfunction
392639|NCT01902004|Mild Cognitive Impairment|mild cognitive impairment
392640|NCT01902004|Older Adults|older adults
392641|NCT01902004|Geriatric|geriatric
392642|NCT01902004|Executive Cognitive Impairment|executive cognitive impairment
392643|NCT01902004|Quality of Life|quality of life
392644|NCT01902004|Disability|disability
392645|NCT01902004|Comorbidity|comorbidity
392646|NCT01902004|Medical Burden|medical burden
392647|NCT01902004|Safety|safety
392648|NCT01902004|Candidate Genes|candidate genes
392649|NCT01901991|Nonpalpable breast lesions|nonpalpable breast lesions
392650|NCT01901991|Breast Cancer and carcinoma in situ|breast cancer and carcinoma in situ
392651|NCT01901991|Radioactive seed localization|radioactive seed localization
392652|NCT01901991|Wire-guided localization|wire-guided localization
392653|NCT01901991|Randomized study|randomized study
392654|NCT01901978|Obesity|obesity
392655|NCT01901978|Insulin Resistance|insulin resistance
392656|NCT01901978|Weight loss|weight loss
392657|NCT01901978|Women|women
392658|NCT01901952|Self management diabetes intervention|self management diabetes intervention
392659|NCT01901939|exercise|exercise
392660|NCT01901939|elderly|elderly
392661|NCT01901939|activities of daily living|activities of daily living
392662|NCT01901939|disability|disability
392663|NCT01901913|Type 1 Diabetes|type 1 diabetes
392664|NCT01901913|Artificial pancreas|artificial pancreas
392665|NCT01901913|Closed loop|closed loop
392666|NCT01901887|Adults|adults
392667|NCT01901887|Suicidality|suicidality
392668|NCT01901874|Stroke|stroke
392669|NCT01901874|Carotid Artery Stenting (CAS)|carotid artery stenting (cas)
392670|NCT01901874|Embolic Protection Device (EPD)|embolic protection device (epd)
392671|NCT01901874|Stent|stent
392672|NCT01901874|Carotid Stenosis|carotid stenosis
392673|NCT01901874|Constriction, Pathologic|constriction, pathologic
392674|NCT01901874|Carotid Artery Diseases|carotid artery diseases
392675|NCT01901874|Cerebrovascular Disorders|cerebrovascular disorders
392676|NCT01901874|Brain Diseases|brain diseases
794289|NCT00277524|Arrhythmia|arrhythmia
392677|NCT01901874|Central Nervous System Diseases|central nervous system diseases
392678|NCT01901874|Nervous System Diseases|nervous system diseases
392679|NCT01901874|Arterial Occlusive Diseases|arterial occlusive diseases
392680|NCT01901874|Vascular Diseases|vascular diseases
392681|NCT01901874|Cardiovascular Diseases|cardiovascular diseases
392682|NCT01901874|Pathological Conditions, Anatomical|pathological conditions, anatomical
392683|NCT01901874|Angioplasty|angioplasty
392684|NCT01901861|GLP-1, GIP, DPP-4 inhibition, iset function|glp-1, gip, dpp-4 inhibition, iset function
392685|NCT01901848|Smoking Cessation|smoking cessation
392686|NCT01901848|Stress Disorders, Post-Traumatic|stress disorders, post-traumatic
392687|NCT01901848|Psychotherapy|psychotherapy
392688|NCT01901822|acellular dermal matrix|acellular dermal matrix
392689|NCT01901809|Heart failure, diastolic|heart failure, diastolic
392690|NCT01901809|HFpEF|hfpef
392691|NCT01901809|Diuretics|diuretics
392692|NCT01901809|Dopamine|dopamine
392693|NCT01901796|Anxiety|anxiety
392694|NCT01901796|Depression|depression
392695|NCT01901796|CBT|cbt
392696|NCT01901783|allograft|allograft
392697|NCT01901783|regeneration|regeneration
392698|NCT01901783|alveolar ridge|alveolar ridge
392699|NCT01901770|HPV|hpv
392700|NCT01901770|Ohio Appalachia|ohio appalachia
392701|NCT01901770|HPV vaccine|hpv vaccine
392702|NCT01901770|No evidence of disease|no evidence of disease
392703|NCT01901744|Contrast Sensitivity , Pediatric Cataract Surgery,|contrast sensitivity , pediatric cataract surgery,
392704|NCT01901731|transjugular coil embolisation|transjugular coil embolisation
392705|NCT01901731|endovenous treatment of varicose veins|endovenous treatment of varicose veins
392706|NCT01901731|pelvic venous reflux|pelvic venous reflux
392707|NCT01901731|recurrent varicose veins|recurrent varicose veins
392708|NCT01901718|Breakthrough Pain|breakthrough pain
392709|NCT01901718|Subsys|subsys
392710|NCT01901718|Fentanyl|fentanyl
392711|NCT01901718|Opioid|opioid
392712|NCT01901718|Persistent Pain|persistent pain
392713|NCT01901705|Psoriasis|psoriasis
392714|NCT01901705|Indigo Naturalis|indigo naturalis
392715|NCT01901705|chinese medicine|chinese medicine
392716|NCT01901692|liver cancer|liver cancer
392717|NCT01901692|first-line|first-line
392718|NCT01901692|tumor thrombus|tumor thrombus
392719|NCT01901692|vascular invasion|vascular invasion
392720|NCT01901679|Obesity|obesity
392721|NCT01901679|Post-menopausal|post-menopausal
392722|NCT01901666|growth hormone, Chronic Myelogenous Leukemia, Imatinib,serum IGF-1|growth hormone, chronic myelogenous leukemia, imatinib,serum igf-1
392723|NCT01901653|Small cell lung cancer|small cell lung cancer
392724|NCT01901627|Spondylitis, Ankylosing|spondylitis, ankylosing
392725|NCT01901627|adalimumab|adalimumab
392726|NCT01901627|Prospective Studies|prospective studies
392727|NCT01901614|Keratoconus|keratoconus
392728|NCT01901614|Corneal Opacity|corneal opacity
392729|NCT01901614|Keratoplasty|keratoplasty
392730|NCT01901601|KERATOPLASTY|keratoplasty
392731|NCT01901601|STROMAL OPACITIES|stromal opacities
392732|NCT01901588|strabismus|strabismus
392733|NCT01901588|pediatric|pediatric
392734|NCT01901588|emergence delirium|emergence delirium
392735|NCT01901588|precedex/dexmedetomidine|precedex/dexmedetomidine
392736|NCT01901575|idiopathic ventricular tachycardia|idiopathic ventricular tachycardia
392737|NCT01901562|ductoscopy|ductoscopy
392738|NCT01901562|nipple discharge|nipple discharge
392739|NCT01901562|breast|breast
392740|NCT01901562|papilloma|papilloma
392741|NCT01901536|First time parents|first time parents
392742|NCT01901536|Coparenting|coparenting
392743|NCT01901536|Family Foundations|family foundations
392744|NCT01901523|Discrepancy|discrepancy
392745|NCT01901523|Committee on Publication Ethics|committee on publication ethics
392746|NCT01901523|Correction|correction
392747|NCT01901523|Erratum|erratum
392748|NCT01901523|Retraction|retraction
392749|NCT01901510|polyp|polyp
392750|NCT01901497|non invasive ventilation|non invasive ventilation
392751|NCT01901497|single limb circuit ventilator|single limb circuit ventilator
392752|NCT01901497|bilevel|bilevel
392753|NCT01901497|nebulization|nebulization
392754|NCT01901497|nebulizer|nebulizer
392755|NCT01901497|vibrating mesh nebulizer|vibrating mesh nebulizer
392756|NCT01901497|amikacin|amikacin
392757|NCT01901484|Schistosoma mansoni|schistosoma mansoni
392758|NCT01901484|morbidity|morbidity
392759|NCT01901484|chemotherapy|chemotherapy
392760|NCT01901471|Cyclosporine, cardiogenic shock, SOFA score,|cyclosporine, cardiogenic shock, sofa score,
392761|NCT01901458|apheresis|apheresis
392762|NCT01901458|peripheral blood progenitor cells|peripheral blood progenitor cells
392763|NCT01901458|peripheral blood stem cells|peripheral blood stem cells
392764|NCT01901445|Quality of life|quality of life
392765|NCT01901445|Constipation|constipation
392766|NCT01901445|Focus groups|focus groups
392767|NCT01901445|Health education|health education
392768|NCT01901445|Problem-based learning|problem-based learning
392769|NCT01901432|chronic myeloproliferative neoplasms|chronic myeloproliferative neoplasms
392770|NCT01901432|Polycythemia Vera|polycythemia vera
392771|NCT01901432|Essential Thrombocythemia|essential thrombocythemia
392772|NCT01901432|Primary Myelofibrosis|primary myelofibrosis
392773|NCT01901432|Post-Polycythemia Vera Myelofibrosis|post-polycythemia vera myelofibrosis
392774|NCT01901432|Post-Essential Thrombocythemia Myelofibrosis|post-essential thrombocythemia myelofibrosis
392775|NCT01901432|Givinostat|givinostat
392776|NCT01901419|nitroglycerin|nitroglycerin
392777|NCT01901419|cardiopulmonary bypass|cardiopulmonary bypass
392778|NCT01901419|cardiac surgery|cardiac surgery
392779|NCT01901406|epiretinal membrane, stereopsis, aniseikonia|epiretinal membrane, stereopsis, aniseikonia
392780|NCT01901393|Post Operative Pain,|post operative pain,
392781|NCT01901393|Pail relief|pail relief
392782|NCT01901367|Adiponectin, Glucose, Insulin, Leptin|adiponectin, glucose, insulin, leptin
392783|NCT01901354|Acute lung injury (ALI)|acute lung injury (ali)
392784|NCT01901354|Adult respiratory distress syndrome (ARDS)|adult respiratory distress syndrome (ards)
392785|NCT01901354|Low-tidal-volume strategy|low-tidal-volume strategy
392786|NCT01901354|ARDSNet|ardsnet
392787|NCT01901354|airway pressure release ventilation (APRV)|airway pressure release ventilation (aprv)
392788|NCT01901354|biomarkers of lung injury|biomarkers of lung injury
392789|NCT01901341|Opioid|opioid
392790|NCT01901341|Constipation|constipation
392791|NCT01901341|Chronic|chronic
392792|NCT01901341|Pain|pain
392793|NCT01901328|Opioid|opioid
392794|NCT01901328|Constipation|constipation
392795|NCT01901328|Chronic|chronic
392796|NCT01901328|Pain|pain
392797|NCT01901315|telepsychiatry|telepsychiatry
392798|NCT01901315|telemental health|telemental health
392799|NCT01901315|teleassistance|teleassistance
392800|NCT01901315|health care delivery|health care delivery
392801|NCT01901315|depression|depression
392802|NCT01901315|Telemedicine|telemedicine
392803|NCT01901315|Remote Consultation|remote consultation
392804|NCT01901315|Videoconferencing|videoconferencing
392805|NCT01901315|Community Mental Health Services|community mental health services
392806|NCT01901302|Opioid|opioid
392807|NCT01901302|Constipation|constipation
392808|NCT01901302|Chronic|chronic
392809|NCT01901302|Pain|pain
392810|NCT01901289|Peripheral Vascular Disease|peripheral vascular disease
392811|NCT01901289|Femoral Artery|femoral artery
392812|NCT01901289|Popliteal Artery|popliteal artery
392813|NCT01901289|Drug-Eluting Stent|drug-eluting stent
392814|NCT01901276|Proton Pump Inhibitors|proton pump inhibitors
392815|NCT01901276|Microbiome|microbiome
392816|NCT01901276|Clostridium difficile|clostridium difficile
392817|NCT01901263|Cognitive and behavioral units|cognitive and behavioral units
392818|NCT01901263|Alzheimer Disease|alzheimer disease
392819|NCT01901263|Dementia|dementia
392820|NCT01901250|Dental Caries|dental caries
392821|NCT01901250|Xylitol|xylitol
392822|NCT01901250|Prevention|prevention
392823|NCT01901237|Cancer|cancer
392824|NCT01901237|Adolescent and Young Adult|adolescent and young adult
392825|NCT01901237|Exercise|exercise
392826|NCT01901237|Physical Activity|physical activity
392827|NCT01901237|Quality of Life|quality of life
392828|NCT01901237|End-of-Life|end-of-life
392829|NCT01901237|Palliative|palliative
392830|NCT01901237|Terminal|terminal
392831|NCT01901237|Yoga|yoga
392832|NCT01901237|Alternative Therapies|alternative therapies
392833|NCT01901237|Fitness|fitness
392834|NCT01901237|Fatigue|fatigue
392835|NCT01901211|Cerebral palsy|cerebral palsy
392836|NCT01901211|Interactive computer play|interactive computer play
392837|NCT01901211|Multi-player gaming|multi-player gaming
392838|NCT01901211|Exercise|exercise
392839|NCT01901146|Human Epidermal Growth Factor Receptor 2 (HER2)|human epidermal growth factor receptor 2 (her2)
392840|NCT01901146|Positive Early Breast Cancer|positive early breast cancer
392841|NCT01901133|Phase 1|phase 1
392842|NCT01901133|MDV3100|mdv3100
392843|NCT01901133|Hepatic Impairment|hepatic impairment
392844|NCT01901133|Kidney Diseases|kidney diseases
392845|NCT01901133|Xtandi|xtandi
392846|NCT01901133|enzalutamide|enzalutamide
392847|NCT01901120|Betanis®|betanis®
392848|NCT01901120|mirabegron|mirabegron
392849|NCT01901120|Overactive Bladder|overactive bladder
392850|NCT01901107|Hemodialysis|hemodialysis
392851|NCT01901107|CKD (chronic kidney disease)|ckd (chronic kidney disease)
392852|NCT01901107|ASP1585|asp1585
392853|NCT01901107|Hyperphosphatemia|hyperphosphatemia
392854|NCT01901081|Implantable Myoelectric Sensor|implantable myoelectric sensor
392855|NCT01901081|IMES|imes
392856|NCT01901081|transradial|transradial
392857|NCT01901081|amputation|amputation
392858|NCT01901081|myoelectric|myoelectric
392859|NCT01901081|prosthesis|prosthesis
392860|NCT01901081|prosthetic control|prosthetic control
392861|NCT01901068|Laparotomy|laparotomy
392862|NCT01901068|Surgical Procedures, Elective|surgical procedures, elective
392863|NCT01901068|Sutures|sutures
392864|NCT01901068|Abdominal Wound Closure Techniques|abdominal wound closure techniques
392865|NCT01901055|sleep apnea|sleep apnea
392866|NCT01901055|diabetes|diabetes
392867|NCT01901042|Quality of life|quality of life
392868|NCT01901042|Symbiotic|symbiotic
392869|NCT01901042|Proctitis/Radiotherapy|proctitis/radiotherapy
392870|NCT01901029|Male Reproductive Health|male reproductive health
392871|NCT01901029|Floating Population|floating population
502499|NCT01421251|Flu|flu
392872|NCT01901029|Sexual Behavior|sexual behavior
392873|NCT01901029|Erectile Dysfunction|erectile dysfunction
392874|NCT01901029|Premature Ejaculation|premature ejaculation
392876|NCT01901016|depressive symptoms|depressive symptoms
392877|NCT01901016|quality of life|quality of life
392878|NCT01901016|relaxation|relaxation
392879|NCT01901016|viral load|viral load
392880|NCT01901016|CD4+ T cell count|cd4+ t cell count
392881|NCT01900990|Noninvasive Positive Pressure Ventilation|noninvasive positive pressure ventilation
392882|NCT01900990|Invasive Positive Pressure Ventilation|invasive positive pressure ventilation
392883|NCT01900990|tracheotomy|tracheotomy
392884|NCT01900977|Universal Test and Treat (UTT)|universal test and treat (utt)
392885|NCT01900977|Combination Prevention|combination prevention
392886|NCT01900964|Regeneration|regeneration
392887|NCT01900964|Bone regeneration|bone regeneration
392888|NCT01900964|Grafting, Bone|grafting, bone
392889|NCT01900964|Allograft|allograft
392890|NCT01900964|Xenograft|xenograft
392891|NCT01900951|Small cell lung cancer|small cell lung cancer
392892|NCT01900951|temozolomide|temozolomide
392893|NCT01900951|Maintenance chemotherapy|maintenance chemotherapy
392894|NCT01900938|Cholangiopancreatography|cholangiopancreatography
392895|NCT01900938|Endoscopic Retrograde|endoscopic retrograde
392896|NCT01900925|Low back pain, non-specific low back pain|low back pain, non-specific low back pain
392897|NCT01900912|sanitation|sanitation
392898|NCT01900912|diarrhea prevalence|diarrhea prevalence
392899|NCT01900912|health|health
392900|NCT01900912|social networks|social networks
392901|NCT01900912|cooperation|cooperation
392902|NCT01900899|Healthy|healthy
392903|NCT01900899|Immunogenicity|immunogenicity
392904|NCT01900899|Children|children
392905|NCT01900899|Neisseria meningitidis|neisseria meningitidis
392906|NCT01900899|Long-term antibody persistence|long-term antibody persistence
392907|NCT01900899|Safety|safety
392908|NCT01900899|Serogroups A, C, W-135, and Y|serogroups a, c, w-135, and y
392909|NCT01900886|prison, disorder, hepatitis c|prison, disorder, hepatitis c
392910|NCT01900873|Inspiratory Muscle Training|inspiratory muscle training
392911|NCT01900873|COPD|copd
392912|NCT01900873|Inspiratory Muscle Function|inspiratory muscle function
392913|NCT01900873|Dyspnea|dyspnea
392914|NCT01900860|Vitamin D|vitamin d
392915|NCT01900860|Bone quality|bone quality
392916|NCT01900860|Bone density|bone density
392917|NCT01900860|calcium metabolism|calcium metabolism
392918|NCT01900860|High resolution peripheral quantitative computed tomography|high resolution peripheral quantitative computed tomography
392919|NCT01900860|Dual X-ray absorptiometry|dual x-ray absorptiometry
392920|NCT01900860|Quality of life|quality of life
392921|NCT01900847|Ketamine|ketamine
392922|NCT01900847|Acute Pain|acute pain
392923|NCT01900795|Postsurgical pain|postsurgical pain
392924|NCT01900743|Sarcoma|sarcoma
392925|NCT01900743|Metastatic|metastatic
392926|NCT01900743|Regorafenib|regorafenib
392927|NCT01900730|Breast cancer|breast cancer
392928|NCT01900730|Metastatic|metastatic
392929|NCT01900730|Indwelling pleural catheter|indwelling pleural catheter
392930|NCT01900730|Valproic acid|valproic acid
392931|NCT01900730|VPA|vpa
392932|NCT01900730|Depakene|depakene
392933|NCT01900730|Placebo|placebo
392934|NCT01900730|Pill diary|pill diary
392935|NCT01900730|Drainage diary|drainage diary
392936|NCT01900730|Questionnaires|questionnaires
392937|NCT01900730|Surveys|surveys
392938|NCT01900691|Esophageal Fistula|esophageal fistula
392939|NCT01900691|Esophageal Neoplasms|esophageal neoplasms
392940|NCT01900691|Esophageal Perforation|esophageal perforation
392941|NCT01900691|Esophageal Stenosis|esophageal stenosis
392942|NCT01900691|Stents|stents
392943|NCT01900639|aspirin|aspirin
392944|NCT01900639|circadian rhythm|circadian rhythm
392945|NCT01900639|platelet reactivity|platelet reactivity
392946|NCT01900639|platelet activation|platelet activation
392947|NCT01900639|time dependent|time dependent
392948|NCT01900613|child obesity|child obesity
392949|NCT01900613|Mexican-American|mexican-american
392950|NCT01900613|Nutrition education|nutrition education
392951|NCT01900613|Intervention|intervention
392952|NCT01900587|Healthy|healthy
392953|NCT01900587|Bio-equivalence|bio-equivalence
392954|NCT01900587|Tapentadol extended release|tapentadol extended release
392955|NCT01900587|Tamper-resistant formulation|tamper-resistant formulation
392956|NCT01900574|Colitis, Ulcerative|colitis, ulcerative
392957|NCT01900574|Ulcerative Colitis|ulcerative colitis
392958|NCT01900574|Moderately to Severely Active Ulcerative Colitis|moderately to severely active ulcerative colitis
392959|NCT01900574|Golimumab|golimumab
392960|NCT01900574|Simponi|simponi
392961|NCT01900574|Human anti-TNFα Antibody|human anti-tnfα antibody
392962|NCT01900574|Pediatric participants|pediatric participants
392963|NCT01900574|Safety and Pharmacokinetics|safety and pharmacokinetics
392964|NCT01900561|prostate cancer|prostate cancer
392965|NCT01900561|survivorship|survivorship
392966|NCT01900561|intervention|intervention
392967|NCT01900561|telemedicine|telemedicine
392968|NCT01900548|Osteopenia|osteopenia
392969|NCT01900548|Sarcopenia|sarcopenia
392970|NCT01900548|Osteoporosis|osteoporosis
392971|NCT01900548|Physical function|physical function
392972|NCT01900548|Body composition|body composition
392973|NCT01900548|Muscle protein|muscle protein
392974|NCT01900548|Leucine|leucine
392975|NCT01900548|Ketogenic amino acids|ketogenic amino acids
392976|NCT01900548|Resistance Training|resistance training
392977|NCT01900548|Whey protein|whey protein
392978|NCT01900548|Soy protein|soy protein
392979|NCT01900548|Bone turnover|bone turnover
392980|NCT01900535|chlorhexidine|chlorhexidine
392981|NCT01900535|gingivitis|gingivitis
392982|NCT01900535|periodontitis|periodontitis
392983|NCT01900522|Drug therapy|drug therapy
392984|NCT01900509|Childhood leukemia|childhood leukemia
392985|NCT01900509|Childhood lymphoma|childhood lymphoma
392986|NCT01900509|Bendamustine|bendamustine
392987|NCT01900496|cHL|chl
392988|NCT01900496|Hodgkin lymphoma|hodgkin lymphoma
392989|NCT01900496|Lymphoma|lymphoma
392990|NCT01900496|relapsed Lymphoma|relapsed lymphoma
392991|NCT01900496|SGN-35|sgn-35
392992|NCT01900496|Brentuximab Vedotin|brentuximab vedotin
392993|NCT01900496|Rituxan|rituxan
392994|NCT01900496|Rituximab|rituximab
392995|NCT01900470|Multiple chronic conditions|multiple chronic conditions
392996|NCT01900444|Japanese encephalitis|japanese encephalitis
392997|NCT01900444|Japanese encephalitis chimeric virus vaccine|japanese encephalitis chimeric virus vaccine
392998|NCT01900444|IMOJEV®|imojev®
392999|NCT01900418|breast cancer|breast cancer
393000|NCT01900418|aromatase inhibitors|aromatase inhibitors
393001|NCT01900418|physical activity|physical activity
393002|NCT01900418|joint pain|joint pain
393003|NCT01900405|Dexmedetomidine|dexmedetomidine
393004|NCT01900405|Administration, Intranasal|administration, intranasal
393005|NCT01900405|Children|children
393006|NCT01900405|Computerized Tomography|computerized tomography
393007|NCT01900379|Obstructive sleep apneas syndrome|obstructive sleep apneas syndrome
393008|NCT01900379|Continuous positive airway pressure treatment|continuous positive airway pressure treatment
393009|NCT01900379|Heart failure|heart failure
393010|NCT01900379|Coronary reperfusion surgery|coronary reperfusion surgery
393011|NCT01900366|Obesity|obesity
393012|NCT01900366|Healthy Volunteers|healthy volunteers
393013|NCT01900340|GLP-1|glp-1
393014|NCT01900340|satiation peptides|satiation peptides
393015|NCT01900340|food intake|food intake
393016|NCT01900327|pancreatic cancer|pancreatic cancer
393017|NCT01900327|surgery|surgery
393018|NCT01900327|chemoradiation|chemoradiation
393019|NCT01900327|neoadjuvant treatment|neoadjuvant treatment
393020|NCT01900327|overall survival|overall survival
393021|NCT01900314|Major Depression|major depression
393022|NCT01900314|Major Depressive Disorder|major depressive disorder
393024|NCT01900314|rTMS|rtms
393025|NCT01900301|exposure|exposure
393026|NCT01900301|scopolamine|scopolamine
393027|NCT01900301|extinction learning|extinction learning
393028|NCT01900301|social anxiety|social anxiety
393029|NCT01900288|short bowel disorder|short bowel disorder
393030|NCT01900288|short bowel syndrome|short bowel syndrome
393031|NCT01900288|home parenteral nutrition|home parenteral nutrition
393032|NCT01900288|HPN|hpn
393033|NCT01900288|total parenteral nutrition|total parenteral nutrition
393034|NCT01900288|TPN|tpn
393035|NCT01900288|telehealth|telehealth
393036|NCT01900288|telemedicine|telemedicine
393037|NCT01900275|Sepsis|sepsis
393038|NCT01900275|Trauma|trauma
393039|NCT01900275|Shock|shock
393040|NCT01900275|Acute kidney injury|acute kidney injury
393041|NCT01900275|Heparanase|heparanase
393042|NCT01900262|Biomechanics|biomechanics
393043|NCT01900262|Ankle Strength|ankle strength
393044|NCT01900262|Postural Control|postural control
393045|NCT01900262|Running Mechanics|running mechanics
393046|NCT01900236|Patients newly initiating outpatient HIV medical care|patients newly initiating outpatient hiv medical care
393047|NCT01900210|Criminal justice|criminal justice
393048|NCT01900210|substance abuse treatment|substance abuse treatment
393049|NCT01900210|HIV risk behaviors|hiv risk behaviors
393050|NCT01900158|Phase I|phase i
393051|NCT01900158|CCA|cca
393052|NCT01900158|Cholangiocarcinoma|cholangiocarcinoma
393053|NCT01900158|bile duct cancer|bile duct cancer
393054|NCT01900158|klatskin|klatskin
393055|NCT01900158|perihilar|perihilar
393056|NCT01900158|Amphinex|amphinex
393057|NCT01900158|Gemcitabine|gemcitabine
393058|NCT01900158|Photochemical internalisation|photochemical internalisation
393059|NCT01900158|Safety|safety
393060|NCT01900158|Tolerability|tolerability
393061|NCT01900158|Efficacy|efficacy
393062|NCT01900158|Cisplatin|cisplatin
393063|NCT01900158|PCI|pci
393064|NCT01900158|extrahepatic|extrahepatic
393065|NCT01900158|local control|local control
393066|NCT01900158|local tumour treatment|local tumour treatment
393067|NCT01900158|biliary|biliary
393068|NCT01900158|fimaporfin|fimaporfin
393069|NCT01900132|Electrophysiology|electrophysiology
393070|NCT01900132|Neuromuscular Disease|neuromuscular disease
393071|NCT01900119|Oral Microbiome|oral microbiome
393072|NCT01900119|Next Generation Sequencing|next generation sequencing
393073|NCT01900106|late presenter|late presenter
393074|NCT01900106|naïve|naïve
393075|NCT01900106|advanced HIV disease|advanced hiv disease
393076|NCT01900080|HIV|hiv
393077|NCT01900080|AIDS|aids
393078|NCT01900080|Antiretroviral therapy|antiretroviral therapy
393079|NCT01900080|Retention in care|retention in care
393080|NCT01900080|Adherence|adherence
393081|NCT01900080|Cost-effectiveness|cost-effectiveness
393082|NCT01900054|TAU-284|tau-284
393083|NCT01900054|Bepotastine besilate|bepotastine besilate
393084|NCT01900054|Histamine H1 receptor antagonists|histamine h1 receptor antagonists
393085|NCT01900054|children|children
393086|NCT01900028|oncology,|oncology,
393087|NCT01900028|cancer,|cancer,
393088|NCT01900028|tumour,|tumour,
393089|NCT01900028|anticancer drug,|anticancer drug,
393090|NCT01900028|pharmacokinetics,|pharmacokinetics,
393091|NCT01900028|olaparib,itraconazole,|olaparib,itraconazole,
393092|NCT01900028|neoplasm,|neoplasm,
393093|NCT01900028|QT interval|qt interval
393094|NCT01899989|Stereotactic Body Radiation Therapy (SBRT)|stereotactic body radiation therapy (sbrt)
393095|NCT01899989|Chemotherapy|chemotherapy
393096|NCT01899989|13-113|13-113
393097|NCT01899976|covered biliary stent|covered biliary stent
393098|NCT01899976|X-Suit NIR Covered Biliary Stent|x-suit nir covered biliary stent
393099|NCT01899976|malignant strictures in biliary tree|malignant strictures in biliary tree
393100|NCT01899963|wet Age Related Macular Degeneration|wet age related macular degeneration
393101|NCT01899963|Diabetic Macular Edema|diabetic macular edema
393102|NCT01899963|Telemedicine|telemedicine
393103|NCT01899963|Teleophthalmology|teleophthalmology
393104|NCT01899963|Time to Treatment|time to treatment
393105|NCT01899950|Niemann-Pick disease type C|niemann-pick disease type c
393106|NCT01899950|Lysosomal disease|lysosomal disease
393107|NCT01899937|Endothelial dysfunction|endothelial dysfunction
393108|NCT01899937|Flow mediated dilation|flow mediated dilation
393109|NCT01899937|Brachial artery flow mediated dilation|brachial artery flow mediated dilation
393111|NCT01899898|Refractory epilepsy|refractory epilepsy
393112|NCT01899898|Dietary therapy|dietary therapy
393113|NCT01899898|Non-Pharmacological therapy|non-pharmacological therapy
393114|NCT01899898|Simplified Modified Atkins Diet|simplified modified atkins diet
393115|NCT01899885|Emergency laparotomy|emergency laparotomy
393116|NCT01899885|Emergency laparoscopy|emergency laparoscopy
393117|NCT01899872|Type 1 Diabetes Mellitus|type 1 diabetes mellitus
393118|NCT01899872|Endothelial progenitor cell|endothelial progenitor cell
393119|NCT01899872|Endothelial function|endothelial function
393120|NCT01899872|Exercise|exercise
393121|NCT01899859|Non-Alcoholic Steatohepatitis (NASH)|non-alcoholic steatohepatitis (nash)
393122|NCT01899846|Makena|makena
393123|NCT01899846|Pharmacokinetics|pharmacokinetics
393124|NCT01899846|Prior preterm delivery|prior preterm delivery
393125|NCT01899846|Hydroxyprogesterone Caproate|hydroxyprogesterone caproate
393126|NCT01899846|17P|17p
393127|NCT01899833|Coronary Artery Disease|coronary artery disease
393128|NCT01899833|CAD|cad
393129|NCT01899781|Lacerations|lacerations
393130|NCT01899781|Tendons|tendons
393131|NCT01899781|Antobiotic|antobiotic
393132|NCT01899768|efficacy|efficacy
393133|NCT01899768|hypertussive challenge|hypertussive challenge
393134|NCT01899768|voltage gated sodium channels (VGSC)|voltage gated sodium channels (vgsc)
393135|NCT01899768|anaesthesia|anaesthesia
393136|NCT01899768|Safety and tolerability|safety and tolerability
393137|NCT01899768|capsaicin challenge|capsaicin challenge
393138|NCT01899768|cough|cough
393139|NCT01899768|citric acid challenge|citric acid challenge
393140|NCT01899768|pharmacokinetics|pharmacokinetics
393141|NCT01899755|monoclonal antibody|monoclonal antibody
393142|NCT01899755|healthy volunteer|healthy volunteer
393143|NCT01899755|TNF alpha|tnf alpha
393144|NCT01899729|plaque psoriasis|plaque psoriasis
393145|NCT01899729|autoimmune disease|autoimmune disease
393146|NCT01899729|Toll like receptor|toll like receptor
393147|NCT01899716|Severe Depression|severe depression
393148|NCT01899716|Quality of life|quality of life
393149|NCT01899716|Exercise|exercise
393150|NCT01899716|BDNF|bdnf
393151|NCT01899716|TBARS|tbars
393152|NCT01899703|Intestinal bile acid transport inhibitor|intestinal bile acid transport inhibitor
393153|NCT01899703|Pruritus|pruritus
393154|NCT01899703|Primary biliary cirrhosis|primary biliary cirrhosis
393155|NCT01899703|Ursodeoxycholic acid|ursodeoxycholic acid
393156|NCT01899703|GSK2330672|gsk2330672
393157|NCT01899703|Pharmacokinetics|pharmacokinetics
393158|NCT01899690|breast reconstruction|breast reconstruction
393159|NCT01899690|cancer|cancer
393160|NCT01899690|expander|expander
393161|NCT01899690|antibiotics|antibiotics
393162|NCT01899690|infection|infection
393163|NCT01899690|surgical site infection|surgical site infection
393164|NCT01899690|surgery|surgery
393165|NCT01899690|oncology|oncology
393166|NCT01899690|plastic surgery|plastic surgery
393167|NCT01899677|Symbiotic,cytokines, necrotising enterocolitis|symbiotic,cytokines, necrotising enterocolitis
393168|NCT01899664|peripheral nerves|peripheral nerves
502867|NCT01419860|ICG|icg
393169|NCT01899664|quadriplegia|quadriplegia
393170|NCT01899664|nerve transfer|nerve transfer
393171|NCT01899664|surgical procedures, operative|surgical procedures, operative
393172|NCT01899664|hand|hand
393173|NCT01899664|upper extremity|upper extremity
393174|NCT01899664|quality of life|quality of life
393175|NCT01899651|EEG|eeg
393176|NCT01899651|Brain|brain
393177|NCT01899651|Infants|infants
393178|NCT01899651|Preterm|preterm
393179|NCT01899651|Hemorrhage|hemorrhage
393180|NCT01899651|Bleeding|bleeding
393181|NCT01899625|Obesity|obesity
393182|NCT01899625|weight loss|weight loss
393183|NCT01899625|young adults|young adults
393184|NCT01899612|menopause|menopause
393185|NCT01899612|vaginal atrophy|vaginal atrophy
393186|NCT01899612|cytokine|cytokine
393187|NCT01899612|IL-1beta|il-1beta
393188|NCT01899612|IL-6|il-6
393189|NCT01899612|IL-8|il-8
393190|NCT01899612|TNF-alpha|tnf-alpha
393191|NCT01899586|Aging|aging
393192|NCT01899586|Functional Capacity|functional capacity
393193|NCT01899586|Exercise Independence|exercise independence
393194|NCT01899586|Peripheral Adaptations|peripheral adaptations
393195|NCT01899586|Vascular|vascular
393196|NCT01899573|Heart failure|heart failure
393197|NCT01899573|mitral regurgitation|mitral regurgitation
393198|NCT01899573|mitral valve|mitral valve
393199|NCT01899560|Acute respiratory distress syndrome (ARDS)|acute respiratory distress syndrome (ards)
393200|NCT01899560|positive end expiratory pressure (PEEP)|positive end expiratory pressure (peep)
393201|NCT01899560|Staircase recruitment maneuver (SRM)|staircase recruitment maneuver (srm)
393202|NCT01899560|Lung elastance|lung elastance
393203|NCT01899560|chest wall elastance|chest wall elastance
393204|NCT01899534|Pregnancy|pregnancy
393205|NCT01899534|Mental Health|mental health
393206|NCT01899534|Screening|screening
393207|NCT01899534|Computer|computer
393208|NCT01899534|Feasibility|feasibility
393209|NCT01899521|alcoholism|alcoholism
393210|NCT01899521|lung health|lung health
393211|NCT01899521|pulmonary|pulmonary
393212|NCT01899521|macrophage|macrophage
393213|NCT01899521|zinc|zinc
393214|NCT01899521|SAMe|same
393215|NCT01899521|S-adenosylmethionine|s-adenosylmethionine
393216|NCT01899521|alveolar|alveolar
393217|NCT01899495|blood pressure|blood pressure
393218|NCT01899495|hypertension|hypertension
393219|NCT01899495|salt sensitivity|salt sensitivity
393220|NCT01899482|Venous Insufficiency|venous insufficiency
393221|NCT01899482|Physical Therapy Techniques|physical therapy techniques
393222|NCT01899482|Manual Lymphatic Drainage|manual lymphatic drainage
393223|NCT01899443|total hip replacement|total hip replacement
393224|NCT01899443|total knee replacement|total knee replacement
393225|NCT01899443|patient outcomes|patient outcomes
393226|NCT01899443|health services research|health services research
393227|NCT01899430|PCOS|pcos
393228|NCT01899430|obesity|obesity
393229|NCT01899430|GLP-1 receptor agonist|glp-1 receptor agonist
393230|NCT01899430|liraglutide|liraglutide
393231|NCT01899430|metformin|metformin
393232|NCT01899417|osteoarthritis|osteoarthritis
393233|NCT01899417|knee replacement|knee replacement
393234|NCT01899417|patient-specific|patient-specific
393235|NCT01899417|economics|economics
393236|NCT01899404|Cervical Cancer|cervical cancer
393237|NCT01899404|PET Scan for cervix|pet scan for cervix
393238|NCT01899404|MRI for cervix|mri for cervix
393239|NCT01899391|Prostate cancer|prostate cancer
393240|NCT01899378|probiotics|probiotics
393241|NCT01899365|anti-pneumococcal vaccination|anti-pneumococcal vaccination
393242|NCT01899365|information|information
393243|NCT01899365|emergency department|emergency department
393244|NCT01899339|submassive pulmonary embolism|submassive pulmonary embolism
393245|NCT01899339|Ultrasonic energy|ultrasonic energy
393246|NCT01899339|Ekosonic Endovascular Device|ekosonic endovascular device
393247|NCT01899339|RV:LV function after Pulmonary Embolism|rv:lv function after pulmonary embolism
393248|NCT01899313|methamphetamine dependence|methamphetamine dependence
393249|NCT01899313|texting|texting
393250|NCT01899313|short message service|short message service
393251|NCT01899313|addiction|addiction
393252|NCT01899313|amphetamine|amphetamine
393253|NCT01899313|outpatient|outpatient
393254|NCT01899300|Refractory Benign Esophageal Strictures caused by Caustic Ingestion|refractory benign esophageal strictures caused by caustic ingestion
393255|NCT01899287|workers education|workers education
393256|NCT01899287|occupational|occupational
393257|NCT01899209|Obstructed Defecation|obstructed defecation
393258|NCT01899209|Rectal rectocele|rectal rectocele
393259|NCT01899209|Intussusception|intussusception
393260|NCT01899209|STARR|starr
393261|NCT01899209|Ventral Rectopexy|ventral rectopexy
393262|NCT01899196|Cardiac surgery|cardiac surgery
393263|NCT01899183|Chronic cough|chronic cough
393264|NCT01899183|Esophagus|esophagus
393265|NCT01899183|Gastro-esophageal reflux disease|gastro-esophageal reflux disease
393266|NCT01899183|Esophageal surgery|esophageal surgery
393267|NCT01899183|Minimally invasive surgery|minimally invasive surgery
393268|NCT01899183|Extra-esophageal reflux symptoms.|extra-esophageal reflux symptoms.
393269|NCT01899170|deep brain stimulation|deep brain stimulation
393270|NCT01899170|multi-coil transcranial magnetic stimulation|multi-coil transcranial magnetic stimulation
393271|NCT01899170|PET-imaging|pet-imaging
393272|NCT01899170|personalized treatment|personalized treatment
393273|NCT01899157|Nutritional status|nutritional status
393274|NCT01899157|Nutritional situation|nutritional situation
393275|NCT01899144|Albuterol Spiromax|albuterol spiromax
393276|NCT01899144|ProAir HFA|proair hfa
393277|NCT01899144|albuterol sulfate|albuterol sulfate
393278|NCT01899131|dental implants|dental implants
393279|NCT01899131|crestal bone|crestal bone
393280|NCT01899131|gingival margin|gingival margin
393281|NCT01899118|locally advanced rectal cancer|locally advanced rectal cancer
393282|NCT01899118|Neoadjuvant chemoradiotherapy|neoadjuvant chemoradiotherapy
393283|NCT01899118|Nimotuzumab|nimotuzumab
393284|NCT01899092|Genotype 1|genotype 1
393285|NCT01899092|Chronic Hepatitis C|chronic hepatitis c
393286|NCT01899092|CHC|chc
393287|NCT01899092|HCV|hcv
393288|NCT01899092|Hepatitis|hepatitis
393289|NCT01899092|RNAi|rnai
393290|NCT01899092|shRNA|shrna
393291|NCT01899092|ddRNAi|ddrnai
393292|NCT01899092|AAV8|aav8
393294|NCT01899092|Adeno-associated virus|adeno-associated virus
393295|NCT01899092|Adeno-associated viral vectors|adeno-associated viral vectors
393296|NCT01899079|Breast Cancer|breast cancer
393297|NCT01899079|Prosigna|prosigna
393298|NCT01899079|FFPE|ffpe
393299|NCT01899079|node negative|node negative
393300|NCT01899079|estrogen receptor positive|estrogen receptor positive
393301|NCT01899079|HER2 negative|her2 negative
393302|NCT01899066|Efficacy|efficacy
393303|NCT01899053|Drug Therapy|drug therapy
393304|NCT01899053|TAK-228|tak-228
393305|NCT01899053|TAK-117|tak-117
393306|NCT01899040|neuromodulation|neuromodulation
393307|NCT01899040|migraine headache|migraine headache
393308|NCT01899027|Arterial hypertension|arterial hypertension
393309|NCT01899027|Radiofrequency ablation|radiofrequency ablation
393310|NCT01899027|Renal function|renal function
393311|NCT01899001|Polycystic Ovary Syndrome|polycystic ovary syndrome
393312|NCT01899001|PCOS|pcos
393313|NCT01899001|Depression|depression
393314|NCT01899001|Anxiety|anxiety
393315|NCT01899001|Weight loss|weight loss
393316|NCT01899001|Exercise|exercise
393317|NCT01899001|Nutrition|nutrition
393318|NCT01899001|Therapy|therapy
393319|NCT01899001|Mood symptoms|mood symptoms
393320|NCT01899001|Stress|stress
393321|NCT01898975|Neurosurgical patients|neurosurgical patients
393322|NCT01898975|Fluid loading|fluid loading
393323|NCT01898975|Fluid responsiveness|fluid responsiveness
393324|NCT01898975|NICOM|nicom
393325|NCT01898975|Stroke volume variation|stroke volume variation
393326|NCT01898975|Pulse pressure variation|pulse pressure variation
393327|NCT01898975|Total peripheral resistance|total peripheral resistance
393328|NCT01898975|Gray zone approach|gray zone approach
393329|NCT01898962|Oligometastases|oligometastases
393330|NCT01898962|Metastatic cancer|metastatic cancer
393331|NCT01898962|Stereotactic radiosurgery|stereotactic radiosurgery
393332|NCT01898949|Diet-induced thermogenesis|diet-induced thermogenesis
393333|NCT01898949|Cold-induced thermogenesis|cold-induced thermogenesis
393334|NCT01898949|Brown adipose tissue|brown adipose tissue
393335|NCT01898949|Brown fat|brown fat
393336|NCT01898923|WH-1,Diabetic Foot,Ulcer|wh-1,diabetic foot,ulcer
393337|NCT01898845|Neoplasms|neoplasms
393338|NCT01898832|Cholestasis, pregnant, interleukin 17|cholestasis, pregnant, interleukin 17
393339|NCT01898819|DEXMEDETOMIDINE|dexmedetomidine
393340|NCT01898819|intraocular pressure|intraocular pressure
393341|NCT01898806|Alopecia Areata|alopecia areata
393342|NCT01898806|Kenalog|kenalog
393343|NCT01898806|Triamcinolone|triamcinolone
393344|NCT01898767|mild|mild
393345|NCT01898767|asthma|asthma
393346|NCT01898767|allergic|allergic
393347|NCT01898754|Transmitted Drug Resistance|transmitted drug resistance
393348|NCT01898741|Pancreatic cancer|pancreatic cancer
393349|NCT01898741|Radiotherapy|radiotherapy
393350|NCT01898741|SBRT|sbrt
393351|NCT01898715|Adrenocortical carcinoma|adrenocortical carcinoma
393352|NCT01898715|Adrenal cancer|adrenal cancer
393353|NCT01898715|ACC|acc
393354|NCT01898676|Extended-release divalproex sodium|extended-release divalproex sodium
393355|NCT01898676|Depakote ER|depakote er
393356|NCT01898650|craniosynostosis|craniosynostosis
393357|NCT01898650|sagittal synostosis|sagittal synostosis
393358|NCT01898650|metopic synostosis|metopic synostosis
393359|NCT01898650|coronal synostosis|coronal synostosis
393360|NCT01898650|lambdoid synostosis|lambdoid synostosis
393361|NCT01898637|pulmonary embolism|pulmonary embolism
393362|NCT01898637|pulse oximetry|pulse oximetry
393363|NCT01898637|change in oxygen saturation|change in oxygen saturation
393364|NCT01898637|hypoxemia|hypoxemia
393365|NCT01898637|emergency department|emergency department
393366|NCT01898637|deep inspiration|deep inspiration
393367|NCT01898637|vital capacity|vital capacity
393368|NCT01898637|clinical diagnosis|clinical diagnosis
393369|NCT01898624|mirabegron|mirabegron
393370|NCT01898624|Overactive Bladder|overactive bladder
393371|NCT01898624|Betanis®|betanis®
393372|NCT01898624|glaucoma|glaucoma
393373|NCT01898611|Frailty|frailty
393374|NCT01898611|Sarcopenia|sarcopenia
393375|NCT01898611|Weight Loss|weight loss
393376|NCT01898611|Exercise|exercise
393377|NCT01898611|Aging|aging
393378|NCT01898611|Ghrelin|ghrelin
393379|NCT01898611|Elderly|elderly
393380|NCT01898572|Newly Diagnosed Type II Diabetes Mellitus|newly diagnosed type ii diabetes mellitus
393381|NCT01898572|Carotid Intimae-media Thickness|carotid intimae-media thickness
393382|NCT01898572|Carotid Plaque|carotid plaque
393383|NCT01898572|Cardiovascular Disease|cardiovascular disease
393384|NCT01898559|little cigars|little cigars
393385|NCT01898559|cigarettes|cigarettes
393386|NCT01898559|smoking|smoking
393387|NCT01898546|Ischemic postconditioning|ischemic postconditioning
393388|NCT01898546|Myocardial Infarction|myocardial infarction
393389|NCT01898546|Microvascular Obstruction|microvascular obstruction
393390|NCT01898520|Spasticity|spasticity
393391|NCT01898507|low nicotine|low nicotine
393392|NCT01898507|cigarettes|cigarettes
393393|NCT01898507|NMR|nmr
393394|NCT01898481|Health care decision making|health care decision making
393395|NCT01898468|Neuropathic pain symptoms|neuropathic pain symptoms
393396|NCT01898468|Intracostal Closure Technique|intracostal closure technique
393397|NCT01898468|Pericostal Suture Closure Technique|pericostal suture closure technique
393398|NCT01898468|Post surgical pain|post surgical pain
393399|NCT01898468|Post thoracotomy pain|post thoracotomy pain
393400|NCT01898455|Migraine|migraine
393401|NCT01898455|Cluster headache|cluster headache
393402|NCT01898455|headache|headache
393403|NCT01898442|platelet function|platelet function
393404|NCT01898442|ticagrelor|ticagrelor
393405|NCT01898442|STEMI|stemi
393406|NCT01898429|Treatment Resistant Depression|treatment resistant depression
393407|NCT01898429|Treatment Refractory Depression|treatment refractory depression
393408|NCT01898429|Treatment Resistant Bipolar Disorder|treatment resistant bipolar disorder
393409|NCT01898429|Treatment Refractory Bipolar Disorder|treatment refractory bipolar disorder
393410|NCT01898429|Deep brain stimulation|deep brain stimulation
393412|NCT01898390|Parkinson's Disease|parkinson's disease
393413|NCT01898390|Allo-Transplantation|allo-transplantation
393414|NCT01898390|Fetal Ventral Mesencephalic Tissue|fetal ventral mesencephalic tissue
393415|NCT01898377|Children|children
393416|NCT01898377|Chronic graft-versus-host disease|chronic graft-versus-host disease
393417|NCT01898351|Alternative sources of plant proteins|alternative sources of plant proteins
393418|NCT01898351|High protein diets|high protein diets
393419|NCT01898351|Satiety|satiety
393420|NCT01898351|Postprandial effects|postprandial effects
393421|NCT01898351|Bioactive phytochemicals|bioactive phytochemicals
393422|NCT01898351|Phytochemicals bioactivity and metabolism|phytochemicals bioactivity and metabolism
393423|NCT01898351|Macronutrients metabolism|macronutrients metabolism
393424|NCT01898351|Health effects of plant proteins vs. meat proteins|health effects of plant proteins vs. meat proteins
393425|NCT01898351|Partial meat proteins replacement with plant proteins|partial meat proteins replacement with plant proteins
393426|NCT01898351|Satiety of meals rich in plant proteins|satiety of meals rich in plant proteins
393427|NCT01898351|Postprandial effects of meals rich in plant proteins|postprandial effects of meals rich in plant proteins
393428|NCT01898351|Plant phytochemicals and macronutrients bioavailability and metabolism|plant phytochemicals and macronutrients bioavailability and metabolism
393429|NCT01898338|MRSA|mrsa
393430|NCT01898338|bacteremia|bacteremia
393431|NCT01898338|therapy|therapy
393432|NCT01898325|Fibrosis|fibrosis
393433|NCT01898325|Gaucher disease|gaucher disease
393434|NCT01898299|Schizophrenia|schizophrenia
393435|NCT01898286|C peptide|c peptide
393436|NCT01898286|beta cell function|beta cell function
393437|NCT01898286|immune modulation of type 1 diabetes|immune modulation of type 1 diabetes
393438|NCT01898286|immune intervention in type 1 diabetes|immune intervention in type 1 diabetes
393439|NCT01898273|Glioma|glioma
393440|NCT01898273|Glioblastoma Multiforme|glioblastoma multiforme
393441|NCT01898273|PET|pet
393442|NCT01898273|Imaging|imaging
393443|NCT01898273|Radiopharmaceutical|radiopharmaceutical
393444|NCT01898273|Diagnostic|diagnostic
393445|NCT01898260|contact lenses|contact lenses
393446|NCT01898260|daily disposable contact lenses|daily disposable contact lenses
393447|NCT01898260|silicone hydrogel|silicone hydrogel
393448|NCT01898260|contact lens comfort|contact lens comfort
393449|NCT01898260|near-sighted|near-sighted
393450|NCT01898247|Thoracentesis|thoracentesis
393451|NCT01898247|Simulation Based Mastery Learning|simulation based mastery learning
393452|NCT01898247|Medical Education|medical education
393453|NCT01898247|Length of Stay|length of stay
393454|NCT01898247|Cost of Care|cost of care
393455|NCT01898234|Hemodynamics|hemodynamics
393456|NCT01898234|intradialytic hypotension|intradialytic hypotension
393457|NCT01898234|subjective tolerance|subjective tolerance
393458|NCT01898234|dialysis membranes|dialysis membranes
393459|NCT01898234|high flux|high flux
393460|NCT01898234|low flux|low flux
393461|NCT01898234|hemodialysis|hemodialysis
393462|NCT01898208|Bacteremia|bacteremia
393463|NCT01898208|Fungemia|fungemia
393464|NCT01898208|Bloodstream infection|bloodstream infection
393465|NCT01898208|susceptibility|susceptibility
393466|NCT01898208|MRSA|mrsa
393467|NCT01898208|VRE|vre
393468|NCT01898143|Whole body vibration, cardiorespiratory response|whole body vibration, cardiorespiratory response
393469|NCT01898117|Triple negative|triple negative
393470|NCT01898117|Metastatic|metastatic
393471|NCT01898104|rectal|rectal
393472|NCT01898104|low risk|low risk
393473|NCT01898104|moderate risk|moderate risk
393474|NCT01898091|Oral|oral
393475|NCT01898091|Mucositis|mucositis
393476|NCT01898091|Stomatitis|stomatitis
393477|NCT01898091|Radiotherapy|radiotherapy
393478|NCT01898078|MLN8237|mln8237
393479|NCT01898078|Alisertib|alisertib
393480|NCT01898078|Food effects|food effects
393481|NCT01898065|Hypoxia|hypoxia
393482|NCT01898065|radiotherapy|radiotherapy
393483|NCT01898065|PET with 18-F-MISO|pet with 18-f-miso
393484|NCT01898065|MRI|mri
393485|NCT01898052|pain control|pain control
393486|NCT01898052|periarticular injection|periarticular injection
393487|NCT01898052|Total knee arthroplasty|total knee arthroplasty
393488|NCT01898052|levobupivacaine|levobupivacaine
393489|NCT01898052|multimodal drug injection|multimodal drug injection
393490|NCT01898039|malignant melanoma|malignant melanoma
393491|NCT01898039|vaccine|vaccine
393492|NCT01898039|cell line|cell line
393493|NCT01898039|high risk|high risk
393494|NCT01898039|residual disease|residual disease
393495|NCT01898026|PGX|pgx
393496|NCT01898026|fibre|fibre
393497|NCT01898026|postprandial glycemia|postprandial glycemia
393498|NCT01898013|pain|pain
393499|NCT01898013|pregnenolone|pregnenolone
393500|NCT01898013|Veterans|veterans
393501|NCT01898013|clinical trial|clinical trial
393502|NCT01898013|neurosteroid|neurosteroid
393503|NCT01898013|allopregnanolone|allopregnanolone
393504|NCT01898013|low back|low back
393505|NCT01898013|placebo controlled|placebo controlled
393506|NCT01898013|randomized|randomized
393507|NCT01898013|musculoskeletal|musculoskeletal
393508|NCT01898000|Gingivitis|gingivitis
393509|NCT01898000|Herbal medicine|herbal medicine
393510|NCT01898000|Plaque control|plaque control
393511|NCT01897987|Human Umbilical Cord Blood Derived Mesenchymal Stem Cells|human umbilical cord blood derived mesenchymal stem cells
393512|NCT01897987|Bronchopulmonary dysplasia|bronchopulmonary dysplasia
393513|NCT01897987|Premature infants|premature infants
393514|NCT01897935|Uveitis|uveitis
393515|NCT01897896|Chorea|chorea
393516|NCT01897896|Huntington Disease|huntington disease
393517|NCT01897870|continuity of care|continuity of care
393518|NCT01897870|medicines management|medicines management
393519|NCT01897870|home visit|home visit
393520|NCT01897870|drug-related problems|drug-related problems
393521|NCT01897857|diabetes mellitus(DM)|diabetes mellitus(dm)
393522|NCT01897857|radial artery cannulation|radial artery cannulation
393523|NCT01897857|artery blood flow|artery blood flow
393524|NCT01897857|complication|complication
393525|NCT01897857|End stage renal disease undergoing kidney transplantation|end stage renal disease undergoing kidney transplantation
393526|NCT01897844|volunteers|volunteers
393527|NCT01897831|Piperacillin Sodium and sulbactam sodium|piperacillin sodium and sulbactam sodium
393528|NCT01897831|Phase IV clinical studies|phase iv clinical studies
393529|NCT01897831|Respiratory and urinary tract infections|respiratory and urinary tract infections
393530|NCT01897805|Coronary artery disease|coronary artery disease
393531|NCT01897766|Genotropin|genotropin
393532|NCT01897766|Somatropin|somatropin
393533|NCT01897766|Long Term Follow-Up|long term follow-up
393534|NCT01897766|Special Investigation|special investigation
393535|NCT01897766|Small for Gestational Age|small for gestational age
393536|NCT01897766|SGA|sga
393537|NCT01897753|SGA|sga
393538|NCT01897753|Growth hormone|growth hormone
393539|NCT01897740|sildenafil|sildenafil
393540|NCT01897740|pulmonary arterial hypertension|pulmonary arterial hypertension
393541|NCT01897740|PAH|pah
393542|NCT01897727|sleep apnea|sleep apnea
393543|NCT01897727|hypertension|hypertension
393544|NCT01897727|aldosterone|aldosterone
393545|NCT01897727|hyperaldosteronism|hyperaldosteronism
393546|NCT01897727|spironolactone|spironolactone
393547|NCT01897727|blood pressure|blood pressure
393548|NCT01897727|resistant|resistant
393549|NCT01897701|H7N9|h7n9
393550|NCT01897688|Diabetes|diabetes
393551|NCT01897688|Islet|islet
393552|NCT01897688|Pancreas|pancreas
393553|NCT01897688|Hypoglycemia|hypoglycemia
393554|NCT01897688|T1D|t1d
393555|NCT01897688|Transplant|transplant
393556|NCT01897675|Cutaneous Abscess|cutaneous abscess
393557|NCT01897675|Emergency Department|emergency department
393558|NCT01897662|overweight|overweight
393559|NCT01897662|satiety|satiety
393560|NCT01897662|functional food|functional food
393561|NCT01897662|food intake|food intake
393562|NCT01897662|digestive tolerance|digestive tolerance
393563|NCT01897649|functional food|functional food
393564|NCT01897649|digestive tolerance|digestive tolerance
393565|NCT01897649|microbiota|microbiota
393566|NCT01897649|bifidogenic effect|bifidogenic effect
393567|NCT01897636|endoscopic ultrasound-guided fine-needle injection|endoscopic ultrasound-guided fine-needle injection
393568|NCT01897636|dendritic cell|dendritic cell
393569|NCT01897636|vaccination|vaccination
393570|NCT01897610|Immuncell-LC, advanced hepatocellular carcinoma|immuncell-lc, advanced hepatocellular carcinoma
393571|NCT01897584|laparoscopy, Trendelenburg Position, ventilation|laparoscopy, trendelenburg position, ventilation
393572|NCT01897545|Arterial hypertension|arterial hypertension
393573|NCT01897545|Atrial Fibrillation|atrial fibrillation
393574|NCT01897545|Percutaneous renal denervation|percutaneous renal denervation
393575|NCT01897519|High risk surgery|high risk surgery
393576|NCT01897519|Acute Kidney Injury|acute kidney injury
393577|NCT01897506|Food insecurity|food insecurity
393578|NCT01897506|Health literacy|health literacy
393579|NCT01897506|Quality of life|quality of life
393580|NCT01897402|Central Nervous System Infections|central nervous system infections
393581|NCT01897402|Meningitis|meningitis
393582|NCT01897402|toxoid|toxoid
393583|NCT01897402|Meningococcal vaccine|meningococcal vaccine
393584|NCT01897402|conjugate vaccines|conjugate vaccines
393585|NCT01897389|Healthy volunteers|healthy volunteers
393586|NCT01897389|Bioavailability|bioavailability
393587|NCT01897389|Abiraterone acetate|abiraterone acetate
393588|NCT01897389|ZYTIGA|zytiga
393589|NCT01897376|wound|wound
393590|NCT01897376|infection|infection
393591|NCT01897376|cesarean delivery|cesarean delivery
393592|NCT01897376|obesity|obesity
393593|NCT01897363|Prader Willi Syndrome|prader willi syndrome
393594|NCT01897363|Hypoglycemia|hypoglycemia
393595|NCT01897363|Fasting study|fasting study
393596|NCT01897350|STEMI|stemi
393597|NCT01897350|Myocardial edema|myocardial edema
393598|NCT01897350|Cardiovascular magnetic resonance|cardiovascular magnetic resonance
393599|NCT01897324|Poor Ovarian Response|poor ovarian response
393600|NCT01897324|Poor Responders|poor responders
393601|NCT01897324|IVF/ICSI|ivf/icsi
393602|NCT01897324|Growth Hormone|growth hormone
393603|NCT01897311|cesarean section|cesarean section
393604|NCT01897311|pain|pain
393605|NCT01897311|transcutaneous electrical nerve stimulation|transcutaneous electrical nerve stimulation
393606|NCT01897311|postpartum period|postpartum period
393607|NCT01897298|chronic obstructive pulmonary disease (COPD)|chronic obstructive pulmonary disease (copd)
393608|NCT01897298|urban training|urban training
393609|NCT01897298|physical activity|physical activity
393610|NCT01897298|active aging|active aging
393611|NCT01897285|Performance and safety of the AQUACEL® foam adhesive dressing|performance and safety of the aquacel® foam adhesive dressing
393612|NCT01897272|carpal tunnel syndrome|carpal tunnel syndrome
393613|NCT01897272|splinting|splinting
393614|NCT01897272|nerve decompression|nerve decompression
393615|NCT01897259|tennis elbow|tennis elbow
393616|NCT01897259|lateral epicondylitis|lateral epicondylitis
393617|NCT01897246|distal radius malunion|distal radius malunion
393618|NCT01897246|extra-articular|extra-articular
393619|NCT01897220|Noncardiac surgery;|noncardiac surgery;
393620|NCT01897220|Perioperative ischemic complications;|perioperative ischemic complications;
393621|NCT01897220|Perioperative bleeding complications;|perioperative bleeding complications;
393622|NCT01897220|Antithrombotic therapy;|antithrombotic therapy;
393623|NCT01897220|Coronary artery disease;|coronary artery disease;
393624|NCT01897220|Stent thrombosis;|stent thrombosis;
393625|NCT01897220|Perioperative infarction.|perioperative infarction.
393626|NCT01897207|prostate cancer|prostate cancer
393627|NCT01897207|dendritic cells|dendritic cells
393628|NCT01897207|vaccination|vaccination
393629|NCT01897181|Central auditory processing|central auditory processing
393630|NCT01897181|Bilateral sensorineural hearing loss|bilateral sensorineural hearing loss
393631|NCT01897181|Hearing aids|hearing aids
393632|NCT01897155|analgesia, postoperative;|analgesia, postoperative;
393633|NCT01897155|analgesics opioid;|analgesics opioid;
393634|NCT01897155|hyperalgesia;|hyperalgesia;
393635|NCT01897155|remifentanil;|remifentanil;
393636|NCT01897155|hypertension.|hypertension.
393637|NCT01897103|Peripheral Artery Disease|peripheral artery disease
393638|NCT01897103|Endarterectomy (Carotid)|endarterectomy (carotid)
393639|NCT01897103|Aortic Aneurysm, Abdominal|aortic aneurysm, abdominal
393640|NCT01897103|Aortic Aneurysm, Thoracic|aortic aneurysm, thoracic
393641|NCT01897103|Amputation|amputation
393642|NCT01897103|Platelet Activity|platelet activity
393643|NCT01897103|Thrombin|thrombin
393644|NCT01897103|Transcriptomics|transcriptomics
393645|NCT01897090|Elimination Diet|elimination diet
393646|NCT01897090|Crohn's disease|crohn's disease
393647|NCT01897077|Food Allergy|food allergy
393648|NCT01897077|Peanut|peanut
393649|NCT01897077|Sublingual Immunotherapy|sublingual immunotherapy
393650|NCT01897064|Schizophrenia|schizophrenia
393651|NCT01897064|Cognition|cognition
393652|NCT01897064|Aerobic Exercise|aerobic exercise
393653|NCT01897051|Liver cirrhosis|liver cirrhosis
393654|NCT01897051|Portal hypertension|portal hypertension
393655|NCT01897051|Hepatic Venous Pressure Gradient|hepatic venous pressure gradient
393656|NCT01897051|Rifaximin|rifaximin
393657|NCT01897025|Stroke|stroke
393658|NCT01897025|Noninvasive brain stimulation|noninvasive brain stimulation
393659|NCT01897025|Brain-computer interface|brain-computer interface
393660|NCT01897025|Motor imagery|motor imagery
393661|NCT01897025|Rehabilitation|rehabilitation
393662|NCT01896986|Special risk patients|special risk patients
393663|NCT01896986|Immunosuppressive biologic treatments|immunosuppressive biologic treatments
393792|NCT01896245|hoarseness|hoarseness
393664|NCT01896986|PRD (Paediatric Rheumatological Disease)|prd (paediatric rheumatological disease)
393665|NCT01896986|IBD (Inflammatory Bowel Disease)|ibd (inflammatory bowel disease)
393666|NCT01896973|Benign Prostatic Hyperplasia|benign prostatic hyperplasia
393667|NCT01896973|BPH|bph
393668|NCT01896973|LUTS|luts
393669|NCT01896973|Vortx Rx|vortx rx
393670|NCT01896973|Histotripsy|histotripsy
393671|NCT01896960|Post spinal hypotension|post spinal hypotension
393672|NCT01896960|Cesarian Section|cesarian section
393673|NCT01896960|ET50|et50
393674|NCT01896960|Bupivacaine|bupivacaine
393675|NCT01896960|Fentanyl|fentanyl
393676|NCT01896934|Depression|depression
393677|NCT01896934|Antidepressants|antidepressants
393678|NCT01896934|Elderly|elderly
393679|NCT01896934|Geriatrics|geriatrics
393680|NCT01896921|HIV|hiv
393681|NCT01896908|diastolic dysfunction|diastolic dysfunction
393682|NCT01896908|Sodium restriction|sodium restriction
393683|NCT01896908|Randomized clinical trial|randomized clinical trial
393684|NCT01896882|Diet, Sodium-Restricted|diet, sodium-restricted
393685|NCT01896882|Food and Nutrition Education|food and nutrition education
393686|NCT01896882|Renal Dialyisis|renal dialyisis
393687|NCT01896869|Pancreatic Cancer|pancreatic cancer
393688|NCT01896869|Vaccine|vaccine
393689|NCT01896869|Immunotherapy|immunotherapy
393690|NCT01896869|Ipilimumab|ipilimumab
393691|NCT01896869|CTLA-4|ctla-4
393692|NCT01896869|antibody|antibody
393693|NCT01896869|FOLFIRINOX|folfirinox
393694|NCT01896856|SGI-110|sgi-110
393695|NCT01896856|irinotecan|irinotecan
393696|NCT01896856|regorafenib|regorafenib
393697|NCT01896856|methylation|methylation
393698|NCT01896856|colorectal|colorectal
393699|NCT01896856|metastatic|metastatic
393700|NCT01896856|TAS-102|tas-102
393701|NCT01896856|lonsurf|lonsurf
393702|NCT01896843|Positron Emission Tomography (PET)|positron emission tomography (pet)
393703|NCT01896843|Metabotropic Glutamate Receptors|metabotropic glutamate receptors
393704|NCT01896830|Clostridium difficile infection|clostridium difficile infection
393705|NCT01896830|Clostridium difficile Toxoid Vaccine|clostridium difficile toxoid vaccine
393706|NCT01896739|Healthy infants with over than 37 weeks gestation periods.|healthy infants with over than 37 weeks gestation periods.
393707|NCT01896739|over than 2.5Kg at at birth weight.|over than 2.5kg at at birth weight.
393708|NCT01896713|Prostate Cancer|prostate cancer
393709|NCT01896713|MRI|mri
393710|NCT01896713|TRUSBx|trusbx
393711|NCT01896700|Multiple sclerosis|multiple sclerosis
393712|NCT01896700|postural balance|postural balance
393713|NCT01896700|walking|walking
393714|NCT01896687|nonspecific low back pain|nonspecific low back pain
393715|NCT01896687|chronic low back pain|chronic low back pain
393716|NCT01896674|Computed tomography|computed tomography
393717|NCT01896661|Sleep apnea|sleep apnea
393718|NCT01896661|Hypertension|hypertension
393719|NCT01896661|Treatment|treatment
393720|NCT01896661|Diuretics|diuretics
393721|NCT01896661|Chlorthalidone|chlorthalidone
393722|NCT01896661|Amlodipine|amlodipine
393723|NCT01896635|Ulcerative Colitis|ulcerative colitis
393724|NCT01896635|Inflammatory Bowel Disease|inflammatory bowel disease
393725|NCT01896635|Fecal Transplantation|fecal transplantation
393726|NCT01896635|Fecal Microbiota Transplantation|fecal microbiota transplantation
393727|NCT01896622|Dabigatran Etexilate|dabigatran etexilate
393728|NCT01896622|Ritonavir|ritonavir
393729|NCT01896622|Cobicistat|cobicistat
393730|NCT01896622|P-Glycoprotein|p-glycoprotein
393731|NCT01896609|Chronic hepatitis c|chronic hepatitis c
393732|NCT01896609|Egyptian population|egyptian population
393733|NCT01896609|Reiferon Retard|reiferon retard
393734|NCT01896609|Ribavirin|ribavirin
393735|NCT01896609|Nitazoxanide|nitazoxanide
393736|NCT01896609|Bon one|bon one
393737|NCT01896596|vaccines|vaccines
393738|NCT01896596|immunogenicity|immunogenicity
393739|NCT01896596|adverse reactions|adverse reactions
393740|NCT01896570|atrial fibrillation|atrial fibrillation
393741|NCT01896570|catheter ablation|catheter ablation
393742|NCT01896570|subsequent atrial tachycardia|subsequent atrial tachycardia
393743|NCT01896570|mechanisms|mechanisms
393744|NCT01896557|clopidogrel|clopidogrel
393745|NCT01896557|omeprazole|omeprazole
393746|NCT01896557|ranitidin|ranitidin
393747|NCT01896557|interaction|interaction
393748|NCT01896557|aggregability|aggregability
393749|NCT01896544|cholecalciferol|cholecalciferol
393750|NCT01896544|vitamin D|vitamin d
393751|NCT01896544|sepsis|sepsis
393752|NCT01896544|infection|infection
393753|NCT01896518|second hand smoke exposure; children|second hand smoke exposure; children
393754|NCT01896505|bone|bone
393755|NCT01896505|soft-tissue|soft-tissue
393756|NCT01896505|sarcoma|sarcoma
503632|NCT01416558|GBG|gbg
393757|NCT01896505|KPT-330|kpt-330
393758|NCT01896505|food|food
393759|NCT01896505|effects|effects
393760|NCT01896505|Selinexor|selinexor
393761|NCT01896492|PCOS,|pcos,
393762|NCT01896492|NAC,|nac,
393763|NCT01896492|OVULATION INDUCTION,|ovulation induction,
393764|NCT01896492|CLOMOPHEN CITRATE|clomophen citrate
393765|NCT01896479|thyroid cancer|thyroid cancer
393766|NCT01896479|medullary thyroid cancer|medullary thyroid cancer
393767|NCT01896466|Fall Risk|fall risk
393768|NCT01896466|Gait|gait
393769|NCT01896466|Dynamic Balance|dynamic balance
393770|NCT01896466|Static Balance|static balance
393771|NCT01896466|Neuromodulation|neuromodulation
393772|NCT01896440|Pediatric|pediatric
393773|NCT01896440|Ondansetron|ondansetron
393774|NCT01896440|Cardiac repolarization|cardiac repolarization
393775|NCT01896440|QTc interval|qtc interval
393776|NCT01896427|Third Molar|third molar
393777|NCT01896427|Edema|edema
393778|NCT01896427|pain|pain
393779|NCT01896427|trismus|trismus
393780|NCT01896414|Metabolic Syndrome|metabolic syndrome
393781|NCT01896414|Omega 3 Fish Oil|omega 3 fish oil
393782|NCT01896401|large bore endovascular catheterization procedures|large bore endovascular catheterization procedures
393783|NCT01896401|Vascular Closure Device|vascular closure device
393784|NCT01896388|PTSD/ifenprodil|ptsd/ifenprodil
393785|NCT01896375|Gutkha|gutkha
393786|NCT01896375|Pan masala ban|pan masala ban
393787|NCT01896375|Legislation|legislation
393788|NCT01896375|Smokeless tobacco|smokeless tobacco
393789|NCT01896349|Psychotherapy, Treatment Resistant Depression, depression|psychotherapy, treatment resistant depression, depression
393790|NCT01896271|kidney cancer|kidney cancer
393791|NCT01896271|metastatic cancer|metastatic cancer
393793|NCT01896245|sore throat|sore throat
393794|NCT01896245|intubating conditions|intubating conditions
393795|NCT01896245|vocal cord injuries|vocal cord injuries
393796|NCT01896245|sevoflurane|sevoflurane
393797|NCT01896232|Secondary Hyperparathyroidism, renal, kidney, kidneys, dialysis, hemodialysis, chronic kidney disease, CKD, SHPT|secondary hyperparathyroidism, renal, kidney, kidneys, dialysis, hemodialysis, chronic kidney disease, ckd, shpt
393798|NCT01896219|Medical device|medical device
393800|NCT01896219|Needle|needle
393801|NCT01896219|Navigation|navigation
393802|NCT01896219|IMACTIS-CT®|imactis-ct®
393803|NCT01896219|Thoraco-abdominal level|thoraco-abdominal level
393804|NCT01896219|anesthesia needles|anesthesia needles
393805|NCT01896180|POAG|poag
393806|NCT01896180|OHT|oht
393807|NCT01896180|OHTN|ohtn
393808|NCT01896180|IOP|iop
393809|NCT01896167|Headache|headache
393810|NCT01896167|Migraine|migraine
393811|NCT01896167|Aura|aura
393812|NCT01896167|Cerebral hemodynamics|cerebral hemodynamics
393813|NCT01896154|dietary fibers, influenza vaccination, HI titres|dietary fibers, influenza vaccination, hi titres
393814|NCT01896128|stroke|stroke
393815|NCT01896128|CVA|cva
393816|NCT01896128|cerebrovascular accident|cerebrovascular accident
393817|NCT01896128|hemiparesis|hemiparesis
393818|NCT01896128|impairment|impairment
393819|NCT01896128|motor recovery|motor recovery
393820|NCT01896128|neuroplasticity|neuroplasticity
393821|NCT01896128|nuvigil|nuvigil
393822|NCT01896128|armodafinil|armodafinil
393823|NCT01896115|Stimulation, implantable pulse generator, deep brain stimulation|stimulation, implantable pulse generator, deep brain stimulation
393824|NCT01896102|Adrenoleukodystrophy|adrenoleukodystrophy
393825|NCT01896102|X-linked adrenoleukodystrophy|x-linked adrenoleukodystrophy
393826|NCT01896102|Gene therapy|gene therapy
393827|NCT01896102|Hematopoietic stem cell|hematopoietic stem cell
393828|NCT01896076|caudal space|caudal space
393829|NCT01896076|children|children
393830|NCT01896076|ultrasound evaluation|ultrasound evaluation
393831|NCT01896063|Electroacupuncture, Sedation|electroacupuncture, sedation
393832|NCT01896050|Joint pain|joint pain
393833|NCT01896050|Grip strength|grip strength
393834|NCT01896050|Hormone receptor positive breast cancer|hormone receptor positive breast cancer
393835|NCT01896037|Spinal cord injury|spinal cord injury
393836|NCT01896037|Tetraplegia|tetraplegia
393837|NCT01896037|Quadraplegia|quadraplegia
393838|NCT01896037|Cholesterol|cholesterol
393839|NCT01896037|HDL-c|hdl-c
393840|NCT01896037|LDL-c|ldl-c
393841|NCT01896037|Omega-3 fatty acids|omega-3 fatty acids
393842|NCT01895998|sickle cell disease|sickle cell disease
393843|NCT01895998|pulmonary hypertension|pulmonary hypertension
393844|NCT01895998|airway hyperreactivity|airway hyperreactivity
393845|NCT01895998|acute chest syndrome|acute chest syndrome
393846|NCT01895959|knee osteoarthritis (OA)|knee osteoarthritis (oa)
393847|NCT01895959|hyaluronic acid injection|hyaluronic acid injection
393848|NCT01895946|Advanced solid malignancy, AZD5363,|advanced solid malignancy, azd5363,
393849|NCT01895946|food effect,|food effect,
393850|NCT01895946|formulation comparison|formulation comparison
393851|NCT01895933|Investigational device (chitosan gel)|investigational device (chitosan gel)
393852|NCT01895933|Wound healing|wound healing
393853|NCT01895933|Endoscopic sinus surgery|endoscopic sinus surgery
393854|NCT01895933|SurgiShield|surgishield
393855|NCT01895920|HIV|hiv
393856|NCT01895920|Biofilm|biofilm
393857|NCT01895920|Transmission|transmission
393858|NCT01895907|Special Olympics|special olympics
393859|NCT01895907|occupational therapy|occupational therapy
393860|NCT01895907|SCOPE|scope
393861|NCT01895907|life participation improvement|life participation improvement
393862|NCT01895894|Mycophenolate mofetil|mycophenolate mofetil
393863|NCT01895894|Immunosuppressive Agents|immunosuppressive agents
393864|NCT01895894|Nephrosis|nephrosis
393865|NCT01895881|Intracranial Aneurysm|intracranial aneurysm
393866|NCT01895881|Estradiol|estradiol
393867|NCT01895868|Ultrasound training|ultrasound training
393868|NCT01895868|Ultrasound simulation|ultrasound simulation
393869|NCT01895868|Ultrasound assessment|ultrasound assessment
393870|NCT01895868|Technology-enhanced learning|technology-enhanced learning
393871|NCT01895868|virtual reality simulation|virtual reality simulation
393872|NCT01895842|Leukemia|leukemia
393873|NCT01895842|Myelodysplastic syndrome|myelodysplastic syndrome
393874|NCT01895842|MDS|mds
393875|NCT01895842|Low or intermediate-1 risk|low or intermediate-1 risk
393876|NCT01895842|Maximum tolerated dose|maximum tolerated dose
393877|NCT01895842|MTD|mtd
393878|NCT01895842|Ruxolitinib|ruxolitinib
393879|NCT01895842|Jakafi|jakafi
393880|NCT01895842|INCB018424|incb018424
393881|NCT01895842|INC424|inc424
393882|NCT01895829|Head and Neck Cancer|head and neck cancer
393883|NCT01895829|Squamous cell carcinomas of the head and neck|squamous cell carcinomas of the head and neck
393884|NCT01895829|HNSCC|hnscc
393885|NCT01895829|Magnetic resonance imaging|magnetic resonance imaging
393886|NCT01895829|MRI|mri
393887|NCT01895829|Ferumoxytol|ferumoxytol
393888|NCT01895829|Ultra-small superparamagnetic iron oxide nanoparticle|ultra-small superparamagnetic iron oxide nanoparticle
393889|NCT01895829|USPIO|uspio
393890|NCT01895829|Contrast agent|contrast agent
393891|NCT01895829|Dynamic contrast imaging|dynamic contrast imaging
393893|NCT01895816|male infertility,oligo spermia|male infertility,oligo spermia
393894|NCT01895803|smoking woman|smoking woman
393895|NCT01895790|Pancreatic Cancer|pancreatic cancer
393896|NCT01895790|Pancreatic Duct|pancreatic duct
393897|NCT01895790|Stent|stent
393898|NCT01895790|Pancreatic Duct Stent|pancreatic duct stent
393899|NCT01895790|Cancer|cancer
393900|NCT01895790|Pain|pain
393901|NCT01895790|Obstructive Pain|obstructive pain
393902|NCT01895790|Palliative|palliative
393903|NCT01895764|ankylosing spondylitis|ankylosing spondylitis
393904|NCT01895751|Non-ST elevation myocardial infarction (NSTEMI)|non-st elevation myocardial infarction (nstemi)
393905|NCT01895751|Non-ST elevation acute coronary syndrome (NSTE-ACS)|non-st elevation acute coronary syndrome (nste-acs)
393906|NCT01895751|Unstable Angina|unstable angina
393907|NCT01895751|Medical therapy|medical therapy
393908|NCT01895751|Coronary angiogram|coronary angiogram
393909|NCT01895751|Percutaneous coronary intervention|percutaneous coronary intervention
393910|NCT01895751|Coronary artery bypass surgery|coronary artery bypass surgery
393911|NCT01895751|Coronary revascularization|coronary revascularization
393912|NCT01895751|Health economics|health economics
393913|NCT01895738|Trauma|trauma
393914|NCT01895738|Injuries|injuries
393915|NCT01895738|Violence|violence
393916|NCT01895738|Adolescent|adolescent
393917|NCT01895738|WrapAround care|wraparound care
393918|NCT01895712|International|international
393919|NCT01895712|Multicenter|multicenter
393920|NCT01895712|Observational registry|observational registry
393921|NCT01895712|Orsiro Drug Eluting Stents (DES)|orsiro drug eluting stents (des)
393922|NCT01895712|Stenting|stenting
393923|NCT01895712|Treatment of Coronary Artery Disease|treatment of coronary artery disease
393924|NCT01895712|Coronary revascularization|coronary revascularization
393925|NCT01895712|Percutaneous Coronary Intervention (PCI)|percutaneous coronary intervention (pci)
393926|NCT01895712|Diabetes Mellitus Type 1|diabetes mellitus type 1
393927|NCT01895712|Diabetes Mellitus Type 2|diabetes mellitus type 2
393928|NCT01895712|STEMI|stemi
393929|NCT01895712|NSTEMI|nstemi
393930|NCT01895712|Ischemia|ischemia
393931|NCT01895712|Angina|angina
393932|NCT01895712|Subgroups|subgroups
393933|NCT01895712|Acute Myocardial Infarction|acute myocardial infarction
393934|NCT01895712|Small vessels|small vessels
393935|NCT01895712|Chronic Total Occlusion|chronic total occlusion
393936|NCT01895699|Contrast agent|contrast agent
393937|NCT01895699|endothelium|endothelium
393938|NCT01895699|Free radical|free radical
393939|NCT01895699|Alpha lipoic acid|alpha lipoic acid
393940|NCT01895686|open angle glaucoma|open angle glaucoma
393941|NCT01895686|narrow angles|narrow angles
393942|NCT01895686|angle closure glaucoma|angle closure glaucoma
393943|NCT01895686|gonioscopy|gonioscopy
393944|NCT01895686|anterior segment OCT|anterior segment oct
393945|NCT01895673|FDG-PET|fdg-pet
393946|NCT01895673|Radiofrequency Ablation|radiofrequency ablation
393947|NCT01895673|Magnetic Resonance Imaging|magnetic resonance imaging
393948|NCT01895660|P-CIMT|p-cimt
393949|NCT01895660|Pediatric Constraint Induced Movement Therapy|pediatric constraint induced movement therapy
393950|NCT01895660|Hemiparesis|hemiparesis
393951|NCT01895660|Cerebral Palsy|cerebral palsy
393952|NCT01895660|Children|children
393953|NCT01895647|electric muscle stimulation|electric muscle stimulation
393954|NCT01895647|respiratory failure|respiratory failure
393955|NCT01895647|sepsis|sepsis
393956|NCT01895647|interleukin 6|interleukin 6
393957|NCT01895647|interleukin 15|interleukin 15
393958|NCT01895634|Ischemia|ischemia
393959|NCT01895634|Stroke|stroke
393960|NCT01895634|Ischemic Stroke|ischemic stroke
393961|NCT01895634|Thrombectomy|thrombectomy
393962|NCT01895634|Brain clot|brain clot
393963|NCT01895634|Cerebrovascular disease|cerebrovascular disease
393964|NCT01895634|Recanalization|recanalization
393965|NCT01895634|Revascularization|revascularization
393966|NCT01895634|Clot Retriever|clot retriever
393967|NCT01895634|Neurovascular Intervention|neurovascular intervention
393968|NCT01895634|Interventional Neuroradiology|interventional neuroradiology
393969|NCT01895634|neurovascular clinical trial|neurovascular clinical trial
393970|NCT01895608|aged or aged 80 and over|aged or aged 80 and over
393971|NCT01895608|gait disorder|gait disorder
393972|NCT01895608|attention|attention
393973|NCT01895595|obesity|obesity
393974|NCT01895595|stress|stress
393975|NCT01895595|intuitive eating|intuitive eating
393976|NCT01895595|guided imagery|guided imagery
393977|NCT01895595|latinos|latinos
393978|NCT01895595|adolescents|adolescents
393979|NCT01895595|insulin resistance|insulin resistance
393980|NCT01895582|Ageing|ageing
393981|NCT01895582|Tuberculosis|tuberculosis
393982|NCT01895582|Interferon gamma releasing tests|interferon gamma releasing tests
393983|NCT01895556|Malawi|malawi
393984|NCT01895556|Risk Compensation|risk compensation
393985|NCT01895556|Male Circumcision|male circumcision
393986|NCT01895556|Demand|demand
393987|NCT01895530|Probiotics|probiotics
393988|NCT01895530|colorectal cancer|colorectal cancer
393989|NCT01895530|postoperative infection|postoperative infection
393990|NCT01895530|immune function|immune function
393991|NCT01895530|bacterial translocation|bacterial translocation
393992|NCT01895530|gastrointestinal surgery|gastrointestinal surgery
393993|NCT01895504|Colonoscopy|colonoscopy
393994|NCT01895504|Colorectal cancer|colorectal cancer
393995|NCT01895504|Adenoma|adenoma
393996|NCT01895478|asthma|asthma
393997|NCT01895478|pediatrics|pediatrics
393998|NCT01895478|control|control
393999|NCT01895478|medication adherence|medication adherence
394000|NCT01895465|urine collection, contamination|urine collection, contamination
394001|NCT01895452|Schizophrenia|schizophrenia
394002|NCT01895439|Bone marrow derived Mesenchymal Stem Cells|bone marrow derived mesenchymal stem cells
394003|NCT01895439|Multiple Sclerosis|multiple sclerosis
394004|NCT01895439|Oligodendrocytes|oligodendrocytes
394005|NCT01895439|Neuroimmunology|neuroimmunology
394006|NCT01895439|Autoimmune disease|autoimmune disease
394007|NCT01895413|Cartilage injury|cartilage injury
394008|NCT01895413|Osteoarthritis|osteoarthritis
394009|NCT01895413|Mesenchymal stem cells|mesenchymal stem cells
394010|NCT01895400|Renexin for Recurrent Vestibulopathy|renexin for recurrent vestibulopathy
394011|NCT01895374|Laser therapy|laser therapy
394012|NCT01895374|Biological dressing|biological dressing
394013|NCT01895374|Amniotic membrane|amniotic membrane
394014|NCT01895374|Hydrocolloid bandages|hydrocolloid bandages
394015|NCT01895374|wound healing|wound healing
394016|NCT01895361|SelG1|selg1
394017|NCT01895361|P-selectin|p-selectin
394018|NCT01895361|monoclonal antibody|monoclonal antibody
394019|NCT01895361|sickle cell disease|sickle cell disease
394020|NCT01895361|sickle cell anemia|sickle cell anemia
394021|NCT01895361|sickle cell|sickle cell
394022|NCT01895361|pain crisis|pain crisis
394023|NCT01895361|pain crises|pain crises
394024|NCT01895361|vasoocclusion|vasoocclusion
394025|NCT01895361|vaso-occlusion|vaso-occlusion
394026|NCT01895361|priapism|priapism
394027|NCT01895361|hepatic sequestration|hepatic sequestration
394028|NCT01895361|splenic sequestration|splenic sequestration
394029|NCT01895361|chest syndrome|chest syndrome
394030|NCT01895322|Tolvaptan|tolvaptan
394031|NCT01895322|dialysis|dialysis
394032|NCT01895309|Rheumatoid Arthritis|rheumatoid arthritis
394033|NCT01895309|Etanercept|etanercept
394034|NCT01895309|Biosimilar|biosimilar
394035|NCT01895296|dumping syndrome|dumping syndrome
394036|NCT01895296|OGTT|ogtt
394037|NCT01895296|hypoglycemia|hypoglycemia
394038|NCT01895283|Aerobic training|aerobic training
394039|NCT01895283|VO2max|vo2max
394040|NCT01895283|Bethlem myopathy|bethlem myopathy
394041|NCT01895270|opioid dependence|opioid dependence
394042|NCT01895270|buprenorphine|buprenorphine
394043|NCT01895270|isradipine|isradipine
394044|NCT01895270|opioid withdrawal|opioid withdrawal
394045|NCT01895270|opioid detoxification|opioid detoxification
394046|NCT01895257|TTP1|ttp1
394047|NCT01895257|TTP2|ttp2
394048|NCT01895257|PFS|pfs
394049|NCT01895257|Safety|safety
394050|NCT01895257|R0 resection rate|r0 resection rate
394051|NCT01895257|Quality of life|quality of life
394052|NCT01895257|Overall Survival|overall survival
394053|NCT01895244|scleroderma|scleroderma
794290|NCT00277524|Tachycardia|tachycardia
394054|NCT01895244|autologous stem cell transplantation|autologous stem cell transplantation
394055|NCT01895244|thiotepa|thiotepa
394056|NCT01895244|cluster of differentiation (CD) 34 selection|cluster of differentiation (cd) 34 selection
394057|NCT01895192|sperm morphology|sperm morphology
394058|NCT01895192|vacuoles|vacuoles
394059|NCT01895192|fertile|fertile
394060|NCT01895192|Motile Sperm Organellar Morphology Examination|motile sperm organellar morphology examination
394061|NCT01895192|high magnification|high magnification
394062|NCT01895192|reference values|reference values
394063|NCT01895179|Time-restricted feeding|time-restricted feeding
394064|NCT01895179|Intermittent fasting|intermittent fasting
394065|NCT01895179|Prediabetes|prediabetes
394066|NCT01895179|Insulin resistance|insulin resistance
394067|NCT01895179|Glucose tolerance|glucose tolerance
394068|NCT01895179|Insulin sensitivity|insulin sensitivity
394069|NCT01895179|Circadian rhythms|circadian rhythms
394070|NCT01895179|Diurnal|diurnal
394071|NCT01895166|Endobronchial ultrasonography with a guide sheath|endobronchial ultrasonography with a guide sheath
394072|NCT01895166|Peripheral pulmonary lesions|peripheral pulmonary lesions
394073|NCT01895166|Transbronchial biopsy|transbronchial biopsy
394074|NCT01895153|bladder pain syndrome|bladder pain syndrome
394075|NCT01895153|pentosan polysulfate|pentosan polysulfate
394076|NCT01895153|hydrodistension|hydrodistension
394077|NCT01895140|Treatment-resistant hypertension|treatment-resistant hypertension
394078|NCT01895140|Renal denervation|renal denervation
394079|NCT01895140|Ambulatory blood pressure|ambulatory blood pressure
394080|NCT01895127|Kidney Transplant|kidney transplant
394081|NCT01895127|Renal Transplant|renal transplant
394082|NCT01895127|Rejection|rejection
394083|NCT01895127|Antibody mediated|antibody mediated
394084|NCT01895127|Humoral|humoral
394085|NCT01895127|Eculizumab|eculizumab
394086|NCT01895114|Renal function|renal function
394087|NCT01895114|cirrhotic patients|cirrhotic patients
394088|NCT01895114|transplant evaluation|transplant evaluation
394089|NCT01895101|blood loss|blood loss
394090|NCT01895101|tranexamix acid|tranexamix acid
394091|NCT01895101|cardiac surgery|cardiac surgery
394092|NCT01895088|presbyopia|presbyopia
394093|NCT01895075|Budesonide|budesonide
394094|NCT01895075|Inhalation|inhalation
394095|NCT01895075|Premature infants|premature infants
394096|NCT01895062|colonoscopy|colonoscopy
394097|NCT01895062|oxygen desaturation|oxygen desaturation
394098|NCT01895049|Tacrolimus|tacrolimus
394099|NCT01895049|Everolimus|everolimus
394100|NCT01895049|Cytomegalovirus|cytomegalovirus
394101|NCT01895049|Thymoglobulin|thymoglobulin
394102|NCT01895049|Deceased donors|deceased donors
394103|NCT01895049|Expanded criteria|expanded criteria
394104|NCT01895036|maintained on 2 mg or less of buprenorphine, in which discontinuation of agonist treatment is clinically feasible but difficult|maintained on 2 mg or less of buprenorphine, in which discontinuation of agonist treatment is clinically feasible but difficult
394105|NCT01895010|prevention and treatment|prevention and treatment
394106|NCT01895010|improvement of the patient's appetite|improvement of the patient's appetite
394107|NCT01895010|TACE|tace
394108|NCT01894997|Deep Vein Thrombosis|deep vein thrombosis
394109|NCT01894997|Neuromuscular Electrical Stimulation|neuromuscular electrical stimulation
394110|NCT01894997|Intermittent Pneumatic Compression|intermittent pneumatic compression
394111|NCT01894997|Doppler Ultrasound|doppler ultrasound
394112|NCT01894984|Schizophrenia|schizophrenia
394113|NCT01894984|Risperidone|risperidone
394114|NCT01894984|Risperdal Consta|risperdal consta
394115|NCT01894984|Oral antipsychotic|oral antipsychotic
394116|NCT01894958|Fragile X disorder|fragile x disorder
394117|NCT01894958|Autism|autism
394118|NCT01894932|Psychotherapy, Group|psychotherapy, group
394119|NCT01894919|Meningococcal B disease,|meningococcal b disease,
394120|NCT01894919|Antibody persistence|antibody persistence
394121|NCT01894906|Soluble Ferric Pyrophosphate,|soluble ferric pyrophosphate,
394122|NCT01894906|Pharmacokinetics,|pharmacokinetics,
394123|NCT01894906|Iron, Mass Transfer,|iron, mass transfer,
394124|NCT01894906|Hemodialysis|hemodialysis
394125|NCT01894906|chronic therapy;|chronic therapy;
394126|NCT01894867|LIVER CIRRHOSIS|liver cirrhosis
394127|NCT01894867|MAGNESIUM|magnesium
394128|NCT01894867|MINIMAL ENCEPHALOPATHY|minimal encephalopathy
394129|NCT01894867|MUSCLE WEAKNESS|muscle weakness
394130|NCT01894854|Radiostereometry|radiostereometry
394131|NCT01894854|Total Hip Arthroplasty|total hip arthroplasty
394132|NCT01894854|Stem design|stem design
394133|NCT01894841|depression|depression
394134|NCT01894841|prevention|prevention
394135|NCT01894841|Veterans health|veterans health
394136|NCT01894828|Nutritional support|nutritional support
394137|NCT01894828|Gastrointestinal cancer|gastrointestinal cancer
394138|NCT01894828|Malnutrition|malnutrition
394139|NCT01894815|major depressive disorder|major depressive disorder
394140|NCT01894815|major depression|major depression
394141|NCT01894815|depressive disorder|depressive disorder
394142|NCT01894815|major depressive episode|major depressive episode
394143|NCT01894802|Tetraplegia|tetraplegia
394144|NCT01894802|Quadriplegia|quadriplegia
394145|NCT01894802|Spinal cord injury|spinal cord injury
394146|NCT01894802|Brainstem or spinal stroke|brainstem or spinal stroke
394147|NCT01894802|Neuroprosthetic|neuroprosthetic
394148|NCT01894802|Brain-machine interface|brain-machine interface
394149|NCT01894802|Brain-computer interface|brain-computer interface
394150|NCT01894802|Neural activity|neural activity
394151|NCT01894802|Sensory stimulation|sensory stimulation
394152|NCT01894802|Microstimulation|microstimulation
394153|NCT01894789|myocardial blood flow|myocardial blood flow
394154|NCT01894789|myocardial perfusion imaging|myocardial perfusion imaging
394155|NCT01894789|myocardial blood flow reserve|myocardial blood flow reserve
394156|NCT01894789|positron emission tomography|positron emission tomography
394157|NCT01894789|adenosine|adenosine
394158|NCT01894789|ticagrelor|ticagrelor
394159|NCT01894789|clopidogrel|clopidogrel
394160|NCT01894776|healthy volunteers|healthy volunteers
394161|NCT01894763|esophagus|esophagus
394162|NCT01894763|cancer|cancer
394163|NCT01894750|Heart Failure|heart failure
394164|NCT01894750|Self-Care|self-care
394165|NCT01894685|Colorectal|colorectal
394166|NCT01894685|Adenoma|adenoma
394167|NCT01894685|Recurrence|recurrence
394168|NCT01894685|Mesalazine|mesalazine
394169|NCT01894685|Chemoprevention|chemoprevention
394170|NCT01894672|LGX818|lgx818
394171|NCT01894672|BRAF Inhibitor|braf inhibitor
394172|NCT01894672|Stage IV melanoma|stage iv melanoma
394173|NCT01894672|unresectable stage III melanoma|unresectable stage iii melanoma
394174|NCT01894672|BRAFV600 mutation|brafv600 mutation
394175|NCT01894672|13-053|13-053
394176|NCT01894633|Prophylactic Cranial Irradiation|prophylactic cranial irradiation
394177|NCT01894633|Metastasis|metastasis
394178|NCT01894633|Cloroquine|cloroquine
394179|NCT01894620|Alzheimer's|alzheimer's
394180|NCT01894620|rTMS|rtms
394181|NCT01894620|sleep quality|sleep quality
394182|NCT01894620|dementia|dementia
394183|NCT01894620|memory|memory
394184|NCT01894607|Kidney Cancer|kidney cancer
394185|NCT01894607|Renal Mass|renal mass
394186|NCT01894607|Open partial nephrectomy|open partial nephrectomy
394187|NCT01894607|Ultrasound-guided surgery|ultrasound-guided surgery
394188|NCT01894607|DEFINITY|definity
394189|NCT01894607|Contrast agent|contrast agent
394190|NCT01894607|Phone call|phone call
394191|NCT01894594|Sickle cell disease|sickle cell disease
394192|NCT01894594|Chronic kidney disease|chronic kidney disease
394193|NCT01894594|Bicarbonate therapy|bicarbonate therapy
394194|NCT01894555|Platelet Transcriptome|platelet transcriptome
394195|NCT01894555|Coronary Artery Disease|coronary artery disease
394196|NCT01894555|Myocardial Ischemia|myocardial ischemia
394197|NCT01894555|Coronary Disease|coronary disease
394198|NCT01894555|Heart Diseases|heart diseases
394199|NCT01894555|Cardiovascular Diseases|cardiovascular diseases
394200|NCT01894555|Arteriosclerosis|arteriosclerosis
394201|NCT01894555|Arterial Occlusive Diseases|arterial occlusive diseases
394202|NCT01894555|Vascular Diseases|vascular diseases
394203|NCT01894555|Aspirin|aspirin
394204|NCT01894529|ischemic stroke|ischemic stroke
394205|NCT01894529|immune biomarkers|immune biomarkers
394206|NCT01894529|stroke-associated infection|stroke-associated infection
394207|NCT01894529|functional outcome|functional outcome
394208|NCT01894529|prediction|prediction
394209|NCT01894490|Gastrointestinal surgery, complications, length of hospital stay, mortality|gastrointestinal surgery, complications, length of hospital stay, mortality
394210|NCT01894464|truancy|truancy
394211|NCT01894464|attendance|attendance
394212|NCT01894464|education|education
394213|NCT01894464|primary school|primary school
394214|NCT01894464|elementary school|elementary school
394215|NCT01894451|Inflammatory Breast Carcinoma|inflammatory breast carcinoma
394216|NCT01894451|89Zr-bevacizumab|89zr-bevacizumab
394217|NCT01894438|NAFLD|nafld
394218|NCT01894438|NASH|nash
394219|NCT01894438|Mediterranean diet|mediterranean diet
394220|NCT01894438|Mediterranean lifestyle|mediterranean lifestyle
394221|NCT01894425|Medically assisted procreation|medically assisted procreation
394222|NCT01894425|Assisted reproductive technology|assisted reproductive technology
394223|NCT01894425|Human papilloma virus|human papilloma virus
394224|NCT01894399|HM61713|hm61713
394225|NCT01894399|pharmacokinetics|pharmacokinetics
394226|NCT01894399|Phase I|phase i
394227|NCT01894399|healthy|healthy
394228|NCT01894399|olmutinib|olmutinib
394229|NCT01894386|GW642444 (Vilanterol)|gw642444 (vilanterol)
394230|NCT01894386|GSK573719 (Umeclidinium)|gsk573719 (umeclidinium)
394231|NCT01894386|GW685698 (Fluticasone Furoate)|gw685698 (fluticasone furoate)
394232|NCT01894386|pharmacokinetics|pharmacokinetics
394233|NCT01894386|Healthy subjects|healthy subjects
394234|NCT01894360|Pharmacokinetics|pharmacokinetics
394235|NCT01894360|Phase 1|phase 1
394236|NCT01894360|Healthy Subjects|healthy subjects
394237|NCT01894360|Comparability|comparability
394238|NCT01894360|Belimumab|belimumab
394239|NCT01894347|Colistin, MDR, inhalative therapy|colistin, mdr, inhalative therapy
394240|NCT01894334|Aortic dissection|aortic dissection
394241|NCT01894334|acute lung injury|acute lung injury
394242|NCT01894334|injury mechanism|injury mechanism
794291|NCT00277524|Bradycardia|bradycardia
394243|NCT01894334|early intervention|early intervention
394244|NCT01894321|Acute cholecystitis|acute cholecystitis
394245|NCT01894321|Elderly|elderly
394246|NCT01894321|Critically ill patients|critically ill patients
394247|NCT01894321|Surgical high risk|surgical high risk
394248|NCT01894321|Percutaneous cholecystostomy|percutaneous cholecystostomy
394249|NCT01894321|Cholecystectomy|cholecystectomy
394250|NCT01894308|Male Hormone Replacement|male hormone replacement
394251|NCT01894308|Multiple Dose|multiple dose
394252|NCT01894308|Single Period|single period
394253|NCT01894308|Phase II|phase ii
394254|NCT01894308|Dose Ranging|dose ranging
394255|NCT01894308|Adult Male Subjects|adult male subjects
394256|NCT01894308|Testosterone Replacement|testosterone replacement
394257|NCT01894295|Vitamin D analogues|vitamin d analogues
394258|NCT01894295|Resting Metabolic rate|resting metabolic rate
394259|NCT01894295|obesity|obesity
394260|NCT01894282|Chronic Lower Back Pain|chronic lower back pain
394261|NCT01894282|Manual Therapy|manual therapy
394262|NCT01894282|Cognitive Behavioral Therapy|cognitive behavioral therapy
394263|NCT01894256|oncology,|oncology,
394264|NCT01894256|cancer,|cancer,
394265|NCT01894256|neoplasm,|neoplasm,
394266|NCT01894256|anticancer drug,|anticancer drug,
394267|NCT01894256|pharmacokinetics,|pharmacokinetics,
394268|NCT01894256|area under curve,|area under curve,
394269|NCT01894256|olaparib,|olaparib,
394270|NCT01894256|solid tumour,|solid tumour,
394271|NCT01894256|mild renal impairment,|mild renal impairment,
394272|NCT01894256|moderate renal impairment|moderate renal impairment
394273|NCT01894243|oncology,|oncology,
394274|NCT01894243|cancer,|cancer,
394275|NCT01894243|neoplasm,|neoplasm,
394276|NCT01894243|anticancer drug,|anticancer drug,
394277|NCT01894243|pharmacokinetics,|pharmacokinetics,
394278|NCT01894243|area under curve,|area under curve,
394279|NCT01894243|olaparib,|olaparib,
394280|NCT01894243|solid tumour,|solid tumour,
394281|NCT01894243|mild hepatic impairment,|mild hepatic impairment,
394282|NCT01894243|moderate hepatic impairment|moderate hepatic impairment
394283|NCT01894230|high cholesterol|high cholesterol
394284|NCT01894230|genetic testing|genetic testing
394285|NCT01894230|medication adherence|medication adherence
394286|NCT01894230|statins|statins
394287|NCT01894230|Adverse Effects|adverse effects
394288|NCT01894230|pharmacogenetics|pharmacogenetics
394289|NCT01894217|high cholesterol|high cholesterol
394290|NCT01894217|genetic testing|genetic testing
394291|NCT01894217|medication adherence|medication adherence
394292|NCT01894217|statins|statins
394293|NCT01894217|Adverse Effects|adverse effects
394294|NCT01894217|Pharmacogenetic|pharmacogenetic
394295|NCT01894204|HTTPE|httpe
394296|NCT01894204|Idiopathic Pulmonary embolism|idiopathic pulmonary embolism
394297|NCT01894191|adenoma detection rate|adenoma detection rate
394298|NCT01894191|colonoscopy|colonoscopy
394299|NCT01894191|water exchange|water exchange
394300|NCT01894165|molybdenum cofactor deficiency (MoCD)|molybdenum cofactor deficiency (mocd)
394301|NCT01894165|deficiency of activity of molybdenum-dependent enzymes|deficiency of activity of molybdenum-dependent enzymes
394302|NCT01894152|XIENCE PRIME EECSS|xience prime eecss
394303|NCT01894152|XIENCE V EECSS|xience v eecss
394304|NCT01894152|XIENCE PRIME|xience prime
394305|NCT01894152|SPIRIT PRIME|spirit prime
394306|NCT01894152|XIENCE PRIME SV (Small Vessel)|xience prime sv (small vessel)
394307|NCT01894152|XIENCE PRIME LL (Long Lesion)|xience prime ll (long lesion)
394308|NCT01894152|Coronary Artery Disease|coronary artery disease
394309|NCT01894152|Coronary Heart Disease|coronary heart disease
394310|NCT01894152|Cardiovascular Disease|cardiovascular disease
394311|NCT01894152|Myocardial Infarction|myocardial infarction
394312|NCT01894152|Stent Thrombosis|stent thrombosis
394313|NCT01894139|Gestational weight gain|gestational weight gain
394314|NCT01894139|Obese women|obese women
394315|NCT01894139|Fetal programming|fetal programming
394316|NCT01894139|Metabolic disorders|metabolic disorders
394317|NCT01894139|Development of obesity|development of obesity
394318|NCT01894139|Development og overweight|development og overweight
394319|NCT01894139|Complications during pregnancy and birth|complications during pregnancy and birth
394320|NCT01894113|interstitial lung disease|interstitial lung disease
394321|NCT01894113|transbronchial biopsy|transbronchial biopsy
394322|NCT01894113|cryobiopsy|cryobiopsy
394323|NCT01894074|Subfertility|subfertility
394324|NCT01894074|Anovulatory|anovulatory
394325|NCT01894074|Obese|obese
394326|NCT01894074|Women|women
394327|NCT01894061|adult giant cell glioblastoma|adult giant cell glioblastoma
394328|NCT01894061|adult glioblastoma|adult glioblastoma
394329|NCT01894061|adult gliosarcoma|adult gliosarcoma
394330|NCT01894061|recurrent adult brain tumor|recurrent adult brain tumor
394331|NCT01894061|Bevacizumab-naive|bevacizumab-naive
394332|NCT01894061|NovoTTF-100A|novottf-100a
394333|NCT01894048|asthma control|asthma control
394334|NCT01894048|small airways|small airways
394335|NCT01894048|extra-fine particle inhaled corticosteroids|extra-fine particle inhaled corticosteroids
394336|NCT01894035|Pulmonary Hypertension|pulmonary hypertension
394337|NCT01894035|Ventavis|ventavis
504390|NCT01413438|GBM|gbm
394338|NCT01894035|Patient compliance|patient compliance
394339|NCT01894022|Inoperable chronic thromboembolic pulmonary hypertension, endothelin receptor antagonist|inoperable chronic thromboembolic pulmonary hypertension, endothelin receptor antagonist
394340|NCT01894009|Osteopathic manipulation|osteopathic manipulation
394341|NCT01894009|Exercise therapy|exercise therapy
394342|NCT01894009|Pregnancy pelvic girdle pain|pregnancy pelvic girdle pain
394343|NCT01893996|rheumatoid|rheumatoid
394344|NCT01893996|arthritis|arthritis
394345|NCT01893996|cardiovascular|cardiovascular
394346|NCT01893996|adalimumab|adalimumab
394347|NCT01893996|tnf|tnf
394348|NCT01893996|biologic|biologic
394349|NCT01893983|Mental Health|mental health
394350|NCT01893983|Veterans Health|veterans health
394351|NCT01893983|Rural|rural
394352|NCT01893983|Motivational Interviewing|motivational interviewing
394353|NCT01893957|breast cancer|breast cancer
394354|NCT01893957|physical therapy|physical therapy
394355|NCT01893957|electrical stimulation|electrical stimulation
394356|NCT01893957|tactile sensitivity|tactile sensitivity
394357|NCT01893957|flow blood|flow blood
394358|NCT01893944|Breast cancer|breast cancer
394359|NCT01893944|vibratory therapy|vibratory therapy
394360|NCT01893944|virtual reality|virtual reality
394361|NCT01893931|Geriatrics|geriatrics
394362|NCT01893931|Emergency Medicine|emergency medicine
394363|NCT01893931|Care Transitions|care transitions
394364|NCT01893918|Smoking|smoking
394365|NCT01893918|Dyspnea|dyspnea
394366|NCT01893892|Basal Cell Carcinoma|basal cell carcinoma
394367|NCT01893892|Gorlin syndrome|gorlin syndrome
394368|NCT01893892|Erivedge|erivedge
394369|NCT01893892|Basal Cell Nevus Syndrome|basal cell nevus syndrome
394370|NCT01893853|dehydration|dehydration
394371|NCT01893853|fluid balance|fluid balance
394372|NCT01893853|exercise|exercise
394373|NCT01893853|heat|heat
394374|NCT01893853|body weight|body weight
394375|NCT01893853|performance|performance
394376|NCT01893827|Naltrexone|naltrexone
394377|NCT01893827|Extended-release naltrexone|extended-release naltrexone
394378|NCT01893827|Oral naltrexone|oral naltrexone
394379|NCT01893827|Vivitrol|vivitrol
394380|NCT01893827|XR-NTX|xr-ntx
394889|NCT01891682|Sepsis|sepsis
394381|NCT01893827|alcohol dependence|alcohol dependence
394382|NCT01893827|primary care|primary care
394383|NCT01893827|Medical Management|medical management
394384|NCT01893801|pancreatic cancer|pancreatic cancer
394385|NCT01893801|pancreatic adenocarcinoma|pancreatic adenocarcinoma
394386|NCT01893801|Stage IV pancreatic cancer|stage iv pancreatic cancer
394387|NCT01893801|pancreas|pancreas
394388|NCT01893801|pancreatic|pancreatic
394389|NCT01893788|hypertension|hypertension
394390|NCT01893788|left ventricular hypertrophy|left ventricular hypertrophy
394391|NCT01893788|renin angiotensin system|renin angiotensin system
394392|NCT01893788|aldosterone|aldosterone
394393|NCT01893788|aliskiren|aliskiren
394394|NCT01893788|eplerenone|eplerenone
394395|NCT01893788|P3NP|p3np
394396|NCT01893775|Anti CD 122|anti cd 122
394397|NCT01893775|Monoclonal Antibody Therapy|monoclonal antibody therapy
394398|NCT01893775|Autoimmune Inflammatory Enteropathy|autoimmune inflammatory enteropathy
394399|NCT01893762|neutrophil|neutrophil
394400|NCT01893762|exercise|exercise
394401|NCT01893762|URTI|urti
394402|NCT01893762|Innate|innate
394403|NCT01893762|Immune|immune
394404|NCT01893749|depression|depression
394405|NCT01893749|prevention|prevention
394406|NCT01893749|teen|teen
394407|NCT01893749|at risk|at risk
394408|NCT01893749|internet|internet
394409|NCT01893736|Breastfeeding|breastfeeding
394410|NCT01893736|professional support|professional support
394411|NCT01893736|postnatal|postnatal
394412|NCT01893736|interventions|interventions
394413|NCT01893736|exclusive breastfeeding|exclusive breastfeeding
394414|NCT01893736|randomized controlled trial|randomized controlled trial
394415|NCT01893723|autonomous nervous system monitoring|autonomous nervous system monitoring
394416|NCT01893723|analgesia nociception balance|analgesia nociception balance
394417|NCT01893723|remifentanil|remifentanil
394418|NCT01893723|analgesia nociception index|analgesia nociception index
394419|NCT01893723|hemodynamic reactivity|hemodynamic reactivity
394420|NCT01893710|peritoneal dialysis|peritoneal dialysis
394421|NCT01893710|parietal peritoneum|parietal peritoneum
394422|NCT01893710|omentum|omentum
394423|NCT01893710|chronic kidney disease|chronic kidney disease
394424|NCT01893710|vasculopathy|vasculopathy
394425|NCT01893684|protein|protein
394426|NCT01893684|physical function|physical function
394427|NCT01893684|muscle quality|muscle quality
394428|NCT01893684|fatigue|fatigue
394429|NCT01893684|weight loss|weight loss
394430|NCT01893671|LASIK|lasik
394431|NCT01893671|corneal power|corneal power
394432|NCT01893671|astigmatism|astigmatism
394433|NCT01893671|HOA|hoa
394434|NCT01893671|Optical Coherence Tomography|optical coherence tomography
394435|NCT01893658|Interstitial Nephritis|interstitial nephritis
394436|NCT01893658|Nephritis|nephritis
795631|NCT00271596|ADHD|adhd
394437|NCT01893658|Tubulointerstitial|tubulointerstitial
394438|NCT01893658|Renal disease|renal disease
394439|NCT01893658|Kidney|kidney
394440|NCT01893645|Pronto-7|pronto-7
394441|NCT01893645|SpHb|sphb
394442|NCT01893645|Obstetric patients|obstetric patients
394443|NCT01893632|Benzodiazepines|benzodiazepines
394444|NCT01893632|clonazepam|clonazepam
394445|NCT01893632|alprazolam|alprazolam
394446|NCT01893632|Klonopin|klonopin
394447|NCT01893632|Xanax|xanax
394448|NCT01893632|diazepam|diazepam
394449|NCT01893632|Valium|valium
394450|NCT01893632|lorazepam|lorazepam
394451|NCT01893632|Ativan|ativan
394452|NCT01893619|Chronic fatigue syndrome|chronic fatigue syndrome
394453|NCT01893619|Karnofsky score|karnofsky score
394454|NCT01893619|supplements|supplements
394455|NCT01893606|diarrhea|diarrhea
394456|NCT01893606|abdominal pain|abdominal pain
394457|NCT01893593|Cardiovascular risk|cardiovascular risk
394458|NCT01893593|lifestyle change|lifestyle change
394459|NCT01893593|blood pressure|blood pressure
394460|NCT01893593|body mass index|body mass index
394461|NCT01893593|tobacco|tobacco
394462|NCT01893580|Cancer|cancer
394463|NCT01893580|Rehabilitation|rehabilitation
394464|NCT01893580|Exercise|exercise
394465|NCT01893580|Lung cancer|lung cancer
394466|NCT01893580|NSCLC|nsclc
394467|NCT01893541|CIRRHOTIC|cirrhotic
394468|NCT01893541|VARICEAL BLEEDING|variceal bleeding
394469|NCT01893541|PRIMARY PROPHYLAXIS|primary prophylaxis
394470|NCT01893489|positron emission tomography|positron emission tomography
394471|NCT01893489|macrophage|macrophage
394472|NCT01893489|neomannosyl human serum albumin|neomannosyl human serum albumin
394473|NCT01893476|chronic obstructive pulmonary disease|chronic obstructive pulmonary disease
394474|NCT01893476|implementation|implementation
394475|NCT01893463|hemorrhage control|hemorrhage control
394476|NCT01893463|wound closure|wound closure
394477|NCT01893450|Graves ophthalmopathy|graves ophthalmopathy
394478|NCT01893450|Exophthalmos|exophthalmos
394479|NCT01893450|Proptosis|proptosis
394480|NCT01893450|Quality of life|quality of life
394481|NCT01893424|Biological Availability|biological availability
394482|NCT01893424|Pharmacokinetics|pharmacokinetics
394483|NCT01893385|vitamin D|vitamin d
394484|NCT01893385|supplementation|supplementation
394582|NCT01892917|Coronary revascularization|coronary revascularization
394485|NCT01893385|immunocompetente cells, immune system|immunocompetente cells, immune system
394486|NCT01893385|influenza vaccine|influenza vaccine
394487|NCT01893385|elderly|elderly
394488|NCT01893372|Leukemia|leukemia
394489|NCT01893372|Myelodysplastic syndrome|myelodysplastic syndrome
394490|NCT01893372|MDS|mds
394491|NCT01893372|Overall response rate|overall response rate
394492|NCT01893372|ORR|orr
394493|NCT01893372|Eltrombopag|eltrombopag
394494|NCT01893372|Promacta|promacta
394495|NCT01893372|Hypomethylating Agent|hypomethylating agent
394496|NCT01893359|hyperopia|hyperopia
394497|NCT01893359|hyperopic astigmatism|hyperopic astigmatism
394498|NCT01893359|cross-linking|cross-linking
394499|NCT01893346|Ceftazidime, Avibactam, Anti-Infectives|ceftazidime, avibactam, anti-infectives
394500|NCT01893333|cervical cancer|cervical cancer
394501|NCT01893333|nerve sparing radical hysterectomy|nerve sparing radical hysterectomy
394502|NCT01893320|Leukemia|leukemia
394503|NCT01893320|Acute Myeloid Leukemia|acute myeloid leukemia
394504|NCT01893320|AML|aml
394505|NCT01893320|High-risk Myelodysplastic Syndrome|high-risk myelodysplastic syndrome
394506|NCT01893320|MDS|mds
394507|NCT01893320|Chronic Myelomonocytic Leukemia|chronic myelomonocytic leukemia
394508|NCT01893320|CMM|cmm
394509|NCT01893320|Maximum tolerated dose|maximum tolerated dose
394510|NCT01893320|MTD|mtd
394511|NCT01893320|Vosaroxin|vosaroxin
394512|NCT01893320|Decitabine|decitabine
394513|NCT01893320|Dacogen|dacogen
394514|NCT01893307|Head And Neck Cancer|head and neck cancer
394515|NCT01893307|Oropharyngeal Cancer|oropharyngeal cancer
394516|NCT01893307|Squamous cell carcinoma of the oropharynx|squamous cell carcinoma of the oropharynx
394517|NCT01893307|Acute and late toxicity|acute and late toxicity
394518|NCT01893307|Intensity modulated photon therapy|intensity modulated photon therapy
394519|NCT01893307|IMRT|imrt
394520|NCT01893307|Intensity modulated proton therapy|intensity modulated proton therapy
394521|NCT01893307|IMPT|impt
394522|NCT01893307|Modified barium swallow|modified barium swallow
394523|NCT01893307|MBS|mbs
394524|NCT01893307|Questionnaires|questionnaires
394525|NCT01893307|Surveys|surveys
394526|NCT01893229|Bipolar disorder|bipolar disorder
394527|NCT01893229|Comparative Effectiveness Research|comparative effectiveness research
394528|NCT01893229|Therapeutics|therapeutics
394529|NCT01893229|Patient Dropouts|patient dropouts
394530|NCT01893216|anxiety|anxiety
394531|NCT01893216|depression|depression
394532|NCT01893216|sexual dysfunction|sexual dysfunction
394533|NCT01893216|infertility|infertility
394534|NCT01893190|Ruptured saccular aneurysm|ruptured saccular aneurysm
394535|NCT01893190|nimodipine|nimodipine
394536|NCT01893190|safety|safety
394537|NCT01893190|tolerability|tolerability
394538|NCT01893190|Subarachnoid hemorrhage|subarachnoid hemorrhage
394539|NCT01893177|Influenza|influenza
394540|NCT01893177|Virus|virus
394541|NCT01893177|Vaccination|vaccination
394542|NCT01893177|Inflexal V|inflexal v
394543|NCT01893164|cubital tunnel syndrome|cubital tunnel syndrome
394544|NCT01893164|simple decompression|simple decompression
394545|NCT01893164|anterior subcutaneous transposition of ulnar nerve|anterior subcutaneous transposition of ulnar nerve
394546|NCT01893164|anterior intramuscular transposition of ulnar nerve|anterior intramuscular transposition of ulnar nerve
394547|NCT01893164|severity scale|severity scale
394548|NCT01893151|Iguratimod|iguratimod
394549|NCT01893151|MRI|mri
394550|NCT01893151|Rheumatoid Arthritis|rheumatoid arthritis
394551|NCT01893138|Urinary Incontinence, Stress|urinary incontinence, stress
394552|NCT01893138|Tissue Therapy (Cell Therapy)|tissue therapy (cell therapy)
394553|NCT01893138|Transplantation, Autologous|transplantation, autologous
394554|NCT01893060|Prematurity|prematurity
394555|NCT01893060|Central line care|central line care
394556|NCT01893060|Umbilical line colonization|umbilical line colonization
394557|NCT01893060|Colonization|colonization
394558|NCT01893060|Newborn Intensive Care Unit|newborn intensive care unit
394559|NCT01893060|Neonatal Intensive Care Unit|neonatal intensive care unit
394560|NCT01893047|breast milk production|breast milk production
394561|NCT01893034|Femoroacetabular Impingement|femoroacetabular impingement
394562|NCT01893034|Arthroscopy|arthroscopy
394563|NCT01893034|Physiotherapy|physiotherapy
394564|NCT01893034|Randomised Controlled Trial|randomised controlled trial
394565|NCT01893008|Esophageal cancer|esophageal cancer
394566|NCT01893008|Surgery|surgery
394567|NCT01892995|suicide|suicide
394568|NCT01892995|ketamine|ketamine
394569|NCT01892995|low-dose ketamine|low-dose ketamine
394570|NCT01892995|suicidal ideations|suicidal ideations
394571|NCT01892995|emergency department|emergency department
394572|NCT01892982|Maternal Depression|maternal depression
394573|NCT01892982|Preterm Birth|preterm birth
394574|NCT01892982|Preterm Outcomes|preterm outcomes
394575|NCT01892982|Child Development|child development
394576|NCT01892917|International|international
394577|NCT01892917|Multicenter|multicenter
394578|NCT01892917|Observational registry|observational registry
394579|NCT01892917|Orsiro Drug Eluting Stent (DES)|orsiro drug eluting stent (des)
394580|NCT01892917|Stenting|stenting
394581|NCT01892917|Treatment of Coronary Artery Disease|treatment of coronary artery disease
394888|NCT01891682|Pediatrics|pediatrics
394583|NCT01892917|Percutaneous Coronary Intervention|percutaneous coronary intervention
394584|NCT01892917|STEMI|stemi
394585|NCT01892917|NSTEMI|nstemi
394586|NCT01892917|Ischemia|ischemia
394587|NCT01892917|Subgroups|subgroups
394588|NCT01892917|Acute Myocardial Infarction|acute myocardial infarction
394589|NCT01892917|Diabetes|diabetes
394590|NCT01892917|Small Vessels|small vessels
394591|NCT01892917|Chronic Total Occlusion (CTO)|chronic total occlusion (cto)
394592|NCT01892904|YAZ|yaz
394593|NCT01892904|Flexible regimen|flexible regimen
394594|NCT01892904|Drospirenone|drospirenone
394595|NCT01892904|Ethinylestradiol Betadex|ethinylestradiol betadex
394596|NCT01892904|Dysmenorrhea|dysmenorrhea
394597|NCT01892904|Japanese patients|japanese patients
394598|NCT01892891|Healthy|healthy
394599|NCT01892891|Subjects|subjects
394600|NCT01892891|Safety|safety
394601|NCT01892891|Tolerability|tolerability
394602|NCT01892891|VBY036|vby036
394603|NCT01892891|maximum|maximum
394604|NCT01892891|pharmacodynamic|pharmacodynamic
394605|NCT01892891|pharmacokinetic|pharmacokinetic
394606|NCT01892865|Operating room utilization|operating room utilization
394607|NCT01892852|Acupuncture|acupuncture
394608|NCT01892852|Traditional Korean Medicine|traditional korean medicine
394609|NCT01892826|FET|fet
394610|NCT01892826|Blastocyst|blastocyst
394611|NCT01892826|natural cycle|natural cycle
394612|NCT01892826|hCG|hcg
394613|NCT01892826|Spontaneous LH pic|spontaneous lh pic
394614|NCT01892813|Nicotine dependence|nicotine dependence
394615|NCT01892813|Smoking cessation|smoking cessation
394616|NCT01892813|Telehealth|telehealth
394617|NCT01892813|Alcohol use|alcohol use
394618|NCT01892813|Depression|depression
394619|NCT01892813|Body weight|body weight
394620|NCT01892800|Lung Cancer|lung cancer
394621|NCT01892800|Ventricular function, Right|ventricular function, right
394622|NCT01892787|Asthma|asthma
394623|NCT01892787|Small airways|small airways
394624|NCT01892787|Extra fine particle long-acting beta agonists|extra fine particle long-acting beta agonists
394625|NCT01892774|LSPAF|lspaf
394626|NCT01892774|asymptomatic|asymptomatic
394627|NCT01892774|exercise tolerance|exercise tolerance
394628|NCT01892761|mycophenolate mofetil|mycophenolate mofetil
394629|NCT01892761|mycophenolic acid|mycophenolic acid
394630|NCT01892761|MPA|mpa
394631|NCT01892761|MMF|mmf
394632|NCT01892761|Pharmacokinetics|pharmacokinetics
394633|NCT01892761|renal transplantation|renal transplantation
394634|NCT01892748|Lupus|lupus
394635|NCT01892748|Juvenile|juvenile
394636|NCT01892748|Cholecalciferol|cholecalciferol
795632|NCT00271596|HD|hd
394637|NCT01892748|Disease activity|disease activity
394638|NCT01892748|Bone Mass|bone mass
394639|NCT01892748|Fatigue|fatigue
394640|NCT01892748|Safety|safety
394641|NCT01892722|pediatric|pediatric
394642|NCT01892722|multiple sclerosis|multiple sclerosis
394643|NCT01892709|acute|acute
394644|NCT01892709|pain|pain
394645|NCT01892709|emergency department|emergency department
394646|NCT01892709|hydromorphone|hydromorphone
394647|NCT01892709|in ER|in er
394648|NCT01892696|inspiratory flow pattern|inspiratory flow pattern
394649|NCT01892696|mechanical ventilation|mechanical ventilation
394650|NCT01892696|cardiac preload|cardiac preload
394651|NCT01892696|arterial pulse pressure variation|arterial pulse pressure variation
394652|NCT01892696|inferior vena cava collapsibility|inferior vena cava collapsibility
394653|NCT01892683|propofol|propofol
394654|NCT01892683|exhaled|exhaled
394655|NCT01892683|monitoring|monitoring
394656|NCT01892683|anesthesia|anesthesia
394657|NCT01892670|Blood|blood
394658|NCT01892670|Whole blood|whole blood
394659|NCT01892670|Cold-storage|cold-storage
394660|NCT01892670|Filtration|filtration
394661|NCT01892670|Transfusion|transfusion
394662|NCT01892670|Platelet-function|platelet-function
394663|NCT01892657|Cetaphil Daily Facial Moisturizer with SPF 50+|cetaphil daily facial moisturizer with spf 50+
394664|NCT01892657|Hypoallergenicity|hypoallergenicity
394665|NCT01892657|Skin Irritation|skin irritation
394666|NCT01892644|Hemochromatosis|hemochromatosis
394667|NCT01892644|Myelodysplastic syndromes|myelodysplastic syndromes
394668|NCT01892644|Iron overload|iron overload
394669|NCT01892644|Deferasirox|deferasirox
394670|NCT01892644|Chelation therapy|chelation therapy
394671|NCT01892644|Venesection|venesection
394672|NCT01892644|Phlebotomy|phlebotomy
394673|NCT01892644|Ferritin|ferritin
394674|NCT01892644|Transfusional siderosis|transfusional siderosis
394675|NCT01892631|Text messaging|text messaging
394676|NCT01892605|Mozart K.448|mozart k.448
394677|NCT01892605|first unprovoked seizure|first unprovoked seizure
394678|NCT01892605|epileptiform discharges|epileptiform discharges
394679|NCT01892605|music therapy|music therapy
394680|NCT01892605|children|children
394681|NCT01892592|Hypertension|hypertension
394682|NCT01892592|African American|african american
394683|NCT01892592|Health Disparities|health disparities
394684|NCT01892592|Stroke|stroke
394685|NCT01892592|Cardiovascular Disease|cardiovascular disease
394686|NCT01892579|Agitation|agitation
394687|NCT01892579|Dementia|dementia
394688|NCT01892579|Alzheimer's Disease|alzheimer's disease
394689|NCT01892579|Neuropsychiatric Behaviors|neuropsychiatric behaviors
394691|NCT01892566|mobile health|mobile health
394692|NCT01892566|spirometry|spirometry
394693|NCT01892553|Dyspnea|dyspnea
394694|NCT01892553|Transcranial direct current stimulation (tDCS)|transcranial direct current stimulation (tdcs)
394695|NCT01892553|Perception|perception
394696|NCT01892527|Colorectal Cancer Metastatic|colorectal cancer metastatic
394697|NCT01892527|wild type KRAS|wild type kras
394698|NCT01892527|C-met overexpression|c-met overexpression
394699|NCT01892527|Tivantinib|tivantinib
394700|NCT01892527|Cetuximab|cetuximab
394701|NCT01892514|osteonecrosis|osteonecrosis
394702|NCT01892514|bone marrow concentrate|bone marrow concentrate
394703|NCT01892514|demineralized bone matrix|demineralized bone matrix
394704|NCT01892514|homologous lyophilized bone chips|homologous lyophilized bone chips
394705|NCT01892514|autologous platelet rich fibrin|autologous platelet rich fibrin
394706|NCT01892514|mesenchymal stromal cells|mesenchymal stromal cells
394707|NCT01892501|Mediastinal lymphadenopathy|mediastinal lymphadenopathy
394708|NCT01892501|PET CT to 18FDG|pet ct to 18fdg
394709|NCT01892501|EUS|eus
394710|NCT01892488|COPD|copd
394711|NCT01892488|AE-COPD|ae-copd
394712|NCT01892488|Chronic obstructive pulmonary disease|chronic obstructive pulmonary disease
394713|NCT01892488|acute exacerbations of Chronic obstructive pulmonary disease|acute exacerbations of chronic obstructive pulmonary disease
394714|NCT01892475|Physical Activity|physical activity
394715|NCT01892475|Incentives|incentives
394716|NCT01892475|Mental Accounting|mental accounting
394717|NCT01892475|Older adults|older adults
394718|NCT01892436|Extension study, psoriatic arthritis, pre-filled syringe|extension study, psoriatic arthritis, pre-filled syringe
394719|NCT01892397|intracranial supratentorial meningioma|intracranial supratentorial meningioma
394720|NCT01892397|Atypical and Anaplastic Meningioma|atypical and anaplastic meningioma
394721|NCT01892397|Optune (NovoTTF-100A)|optune (novottf-100a)
394722|NCT01892397|13-067|13-067
394723|NCT01892358|injection drug use|injection drug use
394724|NCT01892345|Neuromyelitis Optica|neuromyelitis optica
394725|NCT01892345|Neuromyelitis Optica Spectrum Disorder|neuromyelitis optica spectrum disorder
394726|NCT01892345|Devic's disease, Transverse Myelitis|devic's disease, transverse myelitis
394727|NCT01892345|Optic Neuritis|optic neuritis
394728|NCT01892345|relapse|relapse
394729|NCT01892345|eculizumab|eculizumab
394730|NCT01892345|soliris|soliris
394731|NCT01892345|NMO-IgG|nmo-igg
394732|NCT01892345|CNS Autoimmune Disorders|cns autoimmune disorders
394733|NCT01892345|Demyelinating Disorders|demyelinating disorders
394734|NCT01892345|NMO|nmo
394735|NCT01892345|NMOSD|nmosd
394736|NCT01892293|Multiple Myeloma|multiple myeloma
394737|NCT01892293|Autologous stem cell transplantation|autologous stem cell transplantation
394738|NCT01892293|Received initial treatment previously|received initial treatment previously
394739|NCT01892267|PEGJ|pegj
394740|NCT01892267|PEG-J|peg-j
394741|NCT01892267|Percutaneous Endoscopic Gastrostomy|percutaneous endoscopic gastrostomy
394742|NCT01892267|Feeding tube|feeding tube
394743|NCT01892267|Gastroparesis|gastroparesis
394744|NCT01892267|Acute pancreatitis|acute pancreatitis
394745|NCT01892267|Stroke|stroke
394746|NCT01892267|Respiratory failure|respiratory failure
394747|NCT01892267|GERD|gerd
394748|NCT01892267|Balloon|balloon
394749|NCT01892267|Self-propelled|self-propelled
394750|NCT01892254|incretin effect|incretin effect
394751|NCT01892254|PCOS|pcos
394752|NCT01892254|insulin resistance|insulin resistance
394753|NCT01892254|OGTT|ogtt
394754|NCT01892254|IIGI|iigi
394755|NCT01892241|Chronic hepatitis B,Spontaneous Decline of HBV DNA,Peginterferon a-2a, entecavir|chronic hepatitis b,spontaneous decline of hbv dna,peginterferon a-2a, entecavir
394756|NCT01892228|antiretroviral therapy|antiretroviral therapy
394757|NCT01892228|education|education
394758|NCT01892228|mortality|mortality
394759|NCT01892215|Uterine incision.|uterine incision.
394760|NCT01892215|Blunt transversal expansion.|blunt transversal expansion.
394761|NCT01892215|Blunt cephalad-caudad expansion.|blunt cephalad-caudad expansion.
394762|NCT01892189|Drug therapy|drug therapy
394763|NCT01892176|coenzyme Q10, Parkinson disease, oxidative damage|coenzyme q10, parkinson disease, oxidative damage
394764|NCT01892163|Diabetic macular edema, Ozurdex|diabetic macular edema, ozurdex
394765|NCT01892137|Actinic Keratosis|actinic keratosis
394766|NCT01892137|Histopathology|histopathology
394767|NCT01892137|Reflectance Confocal Microscopy|reflectance confocal microscopy
394768|NCT01892137|Local Skin Reaction|local skin reaction
394769|NCT01892124|Motivational Interviewing|motivational interviewing
394770|NCT01892124|Cognitive Therapy|cognitive therapy
394771|NCT01892124|Community-Based Participatory Research|community-based participatory research
394772|NCT01892124|Indians, North American|indians, north american
394773|NCT01892111|SET|set
394774|NCT01892111|infertility|infertility
394775|NCT01892111|IVF/ICSI|ivf/icsi
394776|NCT01892111|pregnancy|pregnancy
394777|NCT01892098|Zinc|zinc
394778|NCT01892098|Bone|bone
394779|NCT01892098|Adolescents|adolescents
394780|NCT01892098|Growth|growth
394781|NCT01892085|Breast milk|breast milk
394782|NCT01892085|lactogenesis stage two|lactogenesis stage two
394783|NCT01892085|premature infant|premature infant
394784|NCT01892085|insufficient milk supply|insufficient milk supply
394785|NCT01892085|breast milk expression|breast milk expression
394786|NCT01892072|hepatocellular carcinoma|hepatocellular carcinoma
394787|NCT01892072|HCC|hcc
394788|NCT01892072|VEGF signaling pathway|vegf signaling pathway
394789|NCT01892059|renal tumour|renal tumour
394790|NCT01892059|partial nephrectomy|partial nephrectomy
394791|NCT01892059|laparoscope|laparoscope
394792|NCT01892059|segmental renal artery clamping|segmental renal artery clamping
394793|NCT01892046|Small Cell Lung Cancer|small cell lung cancer
394794|NCT01892046|Non Small Cell Lung Cancer|non small cell lung cancer
394795|NCT01892046|Hsp90|hsp90
394796|NCT01892033|Posttraumatic Stress Disorder|posttraumatic stress disorder
394797|NCT01892033|PTSD|ptsd
394798|NCT01892033|Aerobic Exercise|aerobic exercise
394799|NCT01892033|Women|women
394800|NCT01892033|Veteran|veteran
394801|NCT01892007|Hearing loss|hearing loss
394802|NCT01892007|Hearing aid|hearing aid
394803|NCT01892007|Speech intelligibility|speech intelligibility
394804|NCT01892007|Speech perception|speech perception
394805|NCT01892007|Cognitive training|cognitive training
394806|NCT01892007|Working memory|working memory
394807|NCT01892007|Working memory training|working memory training
394808|NCT01891994|Cytokine|cytokine
394809|NCT01891994|Hematopoiesis|hematopoiesis
394810|NCT01891994|Autoimmunity|autoimmunity
394811|NCT01891994|Thrombocytopenia|thrombocytopenia
394812|NCT01891994|Neutropenia|neutropenia
394813|NCT01891981|Leukemia|leukemia
394814|NCT01891981|Acute Lymphoblastic Leukemia|acute lymphoblastic leukemia
394815|NCT01891981|ALL|all
394816|NCT01891981|Relapsed and/or refractory|relapsed and/or refractory
394817|NCT01891981|Moxetumomab Pasudotox|moxetumomab pasudotox
394818|NCT01891981|Maximum tolerated dose|maximum tolerated dose
394819|NCT01891981|MTD|mtd
394820|NCT01891968|Leukemia|leukemia
394821|NCT01891968|Myelodysplastic syndrome|myelodysplastic syndrome
394822|NCT01891968|MDS|mds
394823|NCT01891968|Low or intermediate-1|low or intermediate-1
394824|NCT01891968|Bortezomib|bortezomib
394825|NCT01891968|Velcade|velcade
394826|NCT01891968|LDP-341|ldp-341
394827|NCT01891968|MLN341|mln341
394828|NCT01891968|PS-341|ps-341
394829|NCT01891955|Diabetes mellitus type 2|diabetes mellitus type 2
394830|NCT01891955|Cereals|cereals
394831|NCT01891955|Dairy|dairy
394832|NCT01891955|Dietary carbohydrates|dietary carbohydrates
394833|NCT01891955|Dietary fiber|dietary fiber
394834|NCT01891955|Food|food
394835|NCT01891955|Metabolic syndrome|metabolic syndrome
394836|NCT01891955|Satiety|satiety
394837|NCT01891942|Normal|normal
394838|NCT01891942|subjects|subjects
394839|NCT01891929|Schizophrenia|schizophrenia
394840|NCT01891929|Cognitive Remediation|cognitive remediation
394841|NCT01891929|Working abilities and social functioning|working abilities and social functioning
394842|NCT01891890|Pediatrics|pediatrics
394843|NCT01891877|Sickle Cell Trait|sickle cell trait
394844|NCT01891877|Football|football
394845|NCT01891877|Sickling|sickling
394846|NCT01891877|Heat Illness|heat illness
394847|NCT01891877|SCT|sct
394848|NCT01891851|Healthy|healthy
394849|NCT01891851|Hepatitis C|hepatitis c
394850|NCT01891851|TMC435350|tmc435350
394851|NCT01891851|Ritonavir|ritonavir
394852|NCT01891851|Pharmacokinetics|pharmacokinetics
394853|NCT01891838|surgery|surgery
394854|NCT01891838|transsphenoidal surgery|transsphenoidal surgery
394855|NCT01891838|pituitary adenoma|pituitary adenoma
394856|NCT01891838|mechanical ventilation|mechanical ventilation
394857|NCT01891838|bleeding|bleeding
394858|NCT01891825|Atrial fibrillation|atrial fibrillation
394859|NCT01891825|Persistent atrial fibrillation|persistent atrial fibrillation
394860|NCT01891825|Atrial fibrillation ablation|atrial fibrillation ablation
394861|NCT01891812|Sickle cell disease|sickle cell disease
394862|NCT01891812|Vaso-occlusive crisis|vaso-occlusive crisis
394863|NCT01891812|Nitrous oxide|nitrous oxide
394864|NCT01891812|Emergency department|emergency department
394865|NCT01891799|HIV/AIDS|hiv/aids
394866|NCT01891799|PMTCT|pmtct
394867|NCT01891799|Option B+|option b+
394868|NCT01891799|Swaziland|swaziland
394869|NCT01891773|Asthma|asthma
394870|NCT01891773|Inhaled Corticosteroids|inhaled corticosteroids
394871|NCT01891773|School Nurses|school nurses
394872|NCT01891747|gliomas|gliomas
394873|NCT01891734|Veterans|veterans
394874|NCT01891734|Health Services|health services
394875|NCT01891734|Mental Health|mental health
394876|NCT01891734|Technology|technology
394877|NCT01891734|Primary Health Care|primary health care
394878|NCT01891734|Psychotherapy|psychotherapy
394879|NCT01891721|cognitive training|cognitive training
394880|NCT01891721|schizophrenia|schizophrenia
394881|NCT01891721|mismatch negativity|mismatch negativity
394882|NCT01891721|cognition|cognition
394883|NCT01891721|functional capacity|functional capacity
394884|NCT01891721|EEG|eeg
394885|NCT01891682|Methionine Metabolism|methionine metabolism
394886|NCT01891682|Parenteral Nutrition|parenteral nutrition
394887|NCT01891682|Pediatric|pediatric
394890|NCT01891682|Observational Study|observational study
394891|NCT01891669|ADC 5T4|adc 5t4
394892|NCT01891669|PF-06263507|pf-06263507
394893|NCT01891669|solid tumors|solid tumors
394894|NCT01891669|lung cancer|lung cancer
394895|NCT01891669|breast cancer|breast cancer
394896|NCT01891669|ovarian cancer|ovarian cancer
394897|NCT01891669|cancer|cancer
394898|NCT01891669|tumors|tumors
394899|NCT01891669|neoplasm metastasis|neoplasm metastasis
394900|NCT01891656|Motivational Interviewing|motivational interviewing
394901|NCT01891656|Internet|internet
394902|NCT01891656|Treatment|treatment
394903|NCT01891656|Substance-Related Disorders|substance-related disorders
394904|NCT01891656|Criminal Justice|criminal justice
394905|NCT01891630|African American|african american
394906|NCT01891630|Asthma|asthma
394907|NCT01891617|exercise|exercise
394908|NCT01891617|high carbohydrate and high fat diets|high carbohydrate and high fat diets
394909|NCT01891617|insulin|insulin
394910|NCT01891617|gut peptides|gut peptides
394911|NCT01891617|appetite|appetite
394912|NCT01891617|metabolism|metabolism
394913|NCT01891617|glucose|glucose
394914|NCT01891591|Obesity|obesity
394915|NCT01891591|Gastric bypass|gastric bypass
394916|NCT01891591|Energy balance|energy balance
394917|NCT01891591|Nutritional status|nutritional status
394918|NCT01891591|Protein balance|protein balance
394919|NCT01891552|Colon Cancer, Liver Metastasis, DEBIRI, cetuximab, efficacy|colon cancer, liver metastasis, debiri, cetuximab, efficacy
394920|NCT01891539|Hepatocellular carcinoma, doxorubicin, chemoembolization|hepatocellular carcinoma, doxorubicin, chemoembolization
394921|NCT01891526|Metabolisation of 9-cis-retinoic acid|metabolisation of 9-cis-retinoic acid
394922|NCT01891526|hepatic patients|hepatic patients
394923|NCT01891526|investigation of urine and blood samples|investigation of urine and blood samples
394924|NCT01891513|Physical activity|physical activity
394925|NCT01891513|Hypertension|hypertension
394926|NCT01891513|Physical function|physical function
394928|NCT01891500|Persistent Fetal Circulation Syndrome|persistent fetal circulation syndrome
394929|NCT01891500|Infant, Newborn|infant, newborn
394930|NCT01891500|Nitric Oxide|nitric oxide
394931|NCT01891500|Oxidative Stress|oxidative stress
394932|NCT01891500|Endothelin 1|endothelin 1
394933|NCT01891500|Vascular Endothelial Growth Factor|vascular endothelial growth factor
394934|NCT01891487|Eyebrow|eyebrow
394935|NCT01891487|Hypotrichosis|hypotrichosis
394936|NCT01891487|Thinning|thinning
394937|NCT01891487|Bimatoprost|bimatoprost
394938|NCT01891461|total knee arthroplasty|total knee arthroplasty
394939|NCT01891461|post-operative bleeding|post-operative bleeding
394940|NCT01891461|floseal|floseal
394941|NCT01891435|antipyretics|antipyretics
394942|NCT01891435|oral paracetamol|oral paracetamol
394943|NCT01891435|intravenous paracetamol|intravenous paracetamol
394944|NCT01891435|intramuscular diclofenac|intramuscular diclofenac
394945|NCT01891435|emergency department|emergency department
394946|NCT01891422|Glycoprotein Storage Disease|glycoprotein storage disease
394947|NCT01891422|Lysosomal Storage Disease|lysosomal storage disease
394948|NCT01891422|mannosidase deficiency disorders|mannosidase deficiency disorders
394949|NCT01891422|Neuraminidase deficiency with beta-galactosidase deficiency|neuraminidase deficiency with beta-galactosidase deficiency
394950|NCT01891422|mucolipidoses|mucolipidoses
394951|NCT01891422|Oligosaccharidoses|oligosaccharidoses
394952|NCT01891422|Lysosomal Disease|lysosomal disease
394953|NCT01891422|Metabolic Disease, Inborn|metabolic disease, inborn
394954|NCT01891422|aspartylglucosaminuria|aspartylglucosaminuria
394955|NCT01891422|fucosidosis|fucosidosis
394956|NCT01891422|galactosialidosis|galactosialidosis
394957|NCT01891422|alpha mannosidosis|alpha mannosidosis
394958|NCT01891422|beta mannosidosis|beta mannosidosis
394959|NCT01891422|mucolipidosis II|mucolipidosis ii
394960|NCT01891422|mucolipidosis III|mucolipidosis iii
394961|NCT01891422|Schindler disease|schindler disease
394962|NCT01891422|sialidosis|sialidosis
394963|NCT01891409|HIV prevention|hiv prevention
394964|NCT01891409|Male Circumcision|male circumcision
394965|NCT01891409|Children|children
394966|NCT01891409|Childhood|childhood
394967|NCT01891409|Shang Ring|shang ring
394968|NCT01891396|Knee osteoarthritis|knee osteoarthritis
394969|NCT01891396|Hyaluronic acid|hyaluronic acid
394970|NCT01891396|HA Injection|ha injection
394971|NCT01891396|Steroid Injection|steroid injection
394972|NCT01891396|Knee injection|knee injection
394973|NCT01891383|Dementia|dementia
394974|NCT01891383|Traumatic brain injury (TBI)|traumatic brain injury (tbi)
394975|NCT01891383|Mild cognitive impairment (MCI)|mild cognitive impairment (mci)
394976|NCT01891383|Chronic traumatic encephalopathy (CTE)|chronic traumatic encephalopathy (cte)
394977|NCT01891383|Remote effects of TBI|remote effects of tbi
394978|NCT01891383|Post-traumatic stress disorder (PTSD_|post-traumatic stress disorder (ptsd_
394979|NCT01891357|Unilateral primary invasive carcinoma of the breast|unilateral primary invasive carcinoma of the breast
394980|NCT01891344|ovarian cancer|ovarian cancer
394981|NCT01891344|fallopian tube cancer|fallopian tube cancer
394982|NCT01891344|primary peritoneal cancer|primary peritoneal cancer
394983|NCT01891344|peritoneal cancer|peritoneal cancer
394984|NCT01891344|platinum sensitive|platinum sensitive
394985|NCT01891344|relapsed disease|relapsed disease
394986|NCT01891344|PARP Inhibitor|parp inhibitor
394987|NCT01891344|rucaparib|rucaparib
394988|NCT01891344|homologous recombination|homologous recombination
394989|NCT01891344|homologous recombination deficiency|homologous recombination deficiency
394990|NCT01891344|genomic scarring|genomic scarring
394991|NCT01891344|loss of heterozygosity|loss of heterozygosity
394992|NCT01891344|CO-338|co-338
394993|NCT01891344|PF 01367338|pf 01367338
394994|NCT01891344|AG 14699|ag 14699
394995|NCT01891344|platinum sensitive ovarian cancer|platinum sensitive ovarian cancer
394996|NCT01891344|platinum sensitive fallopian tube cancer|platinum sensitive fallopian tube cancer
394997|NCT01891344|platinum sensitive primary peritoneal cancer|platinum sensitive primary peritoneal cancer
394998|NCT01891344|platinum sensitive peritoneal cancer|platinum sensitive peritoneal cancer
394999|NCT01891344|gynecological cancer|gynecological cancer
395000|NCT01891344|Clovis|clovis
395001|NCT01891344|Clovis Oncology|clovis oncology
395002|NCT01891344|ARIEL2|ariel2
395003|NCT01891344|ARIEL 2|ariel 2
395004|NCT01891344|ARIEL3|ariel3
395005|NCT01891344|ARIEL 3|ariel 3
395006|NCT01891279|short bowel syndrome|short bowel syndrome
395007|NCT01891279|Elemental formula|elemental formula
395008|NCT01891279|partially hydrolyzed formula|partially hydrolyzed formula
395009|NCT01891279|Enteral feeding|enteral feeding
395010|NCT01891279|TPN dependency|tpn dependency
395011|NCT01891279|Intestinal adaptation|intestinal adaptation
395012|NCT01891279|TPN cholestasis|tpn cholestasis
395013|NCT01891253|cardiac output|cardiac output
395014|NCT01891253|mechanical ventilation|mechanical ventilation
395015|NCT01891253|inert gas rebreathing|inert gas rebreathing
395016|NCT01891253|pulse contour analysis|pulse contour analysis
395017|NCT01891240|Diagnostic|diagnostic
395018|NCT01891240|Pre-eclampsia|pre-eclampsia
395019|NCT01891240|Pregnancy outcome|pregnancy outcome
395020|NCT01891240|Mass screening|mass screening
395021|NCT01891240|Diagnostic Techniques and Procedures|diagnostic techniques and procedures
395022|NCT01891227|Bendamustine|bendamustine
395023|NCT01891227|Capecitabine|capecitabine
395024|NCT01891227|Pretreated|pretreated
395025|NCT01891227|Her2 negative|her2 negative
395026|NCT01891227|Advanced breast cancer|advanced breast cancer
395027|NCT01891227|Metastatic breast cancer|metastatic breast cancer
395028|NCT01891227|Anthracycline pretreatment|anthracycline pretreatment
395029|NCT01891227|Taxane pretreatment|taxane pretreatment
395030|NCT01891214|Inflammatory bowel diseases|inflammatory bowel diseases
395031|NCT01891214|Inflammatory Bowel Disease Questionnaire (IBDQ)|inflammatory bowel disease questionnaire (ibdq)
395032|NCT01891201|Bonding|bonding
395033|NCT01891201|Oxytocin|oxytocin
395034|NCT01891201|Breastfeeding|breastfeeding
395035|NCT01891201|Newborn|newborn
395036|NCT01891201|Delivery|delivery
395037|NCT01891188|hepatic blood,|hepatic blood,
395038|NCT01891188|cardiac cath,|cardiac cath,
395039|NCT01891188|hepatic oxygenation,|hepatic oxygenation,
395040|NCT01891188|pediatrics|pediatrics
395041|NCT01891175|Caesarean|caesarean
395042|NCT01891175|hypotension|hypotension
395043|NCT01891175|Spinal Anaesthesia|spinal anaesthesia
395044|NCT01891175|intermittent pneumatic compression|intermittent pneumatic compression
395045|NCT01891175|lower extremities|lower extremities
395046|NCT01891162|quality of life, incontinence urinary, socioeconomic|quality of life, incontinence urinary, socioeconomic
395047|NCT01891136|Peanut allergy|peanut allergy
395048|NCT01891123|Non-small Cell Lung Cancer|non-small cell lung cancer
395049|NCT01891123|Breast cancer|breast cancer
395050|NCT01891123|plasma drug concentration|plasma drug concentration
395051|NCT01891123|Nasopharygeal carcinoma|nasopharygeal carcinoma
395052|NCT01891110|electric stimulation|electric stimulation
395053|NCT01891110|tilt-table|tilt-table
395054|NCT01891097|Insomnia|insomnia
395055|NCT01891097|Acupuncture|acupuncture
395056|NCT01891097|Electroacupuncture|electroacupuncture
395057|NCT01891097|Aricular acupuncture|aricular acupuncture
395058|NCT01891097|Randomized Clinical Trial|randomized clinical trial
395059|NCT01891097|Traditional Chinese Medicine|traditional chinese medicine
395060|NCT01891084|Influenza|influenza
395061|NCT01891084|Antipyretics|antipyretics
395062|NCT01891084|Fever|fever
395063|NCT01891071|Multiple sclerosis|multiple sclerosis
395064|NCT01891071|Lung volume recruitment|lung volume recruitment
395065|NCT01891071|Pulmonary function impairment|pulmonary function impairment
395066|NCT01891071|Cough impairment|cough impairment
395067|NCT01891045|Psychotherapy|psychotherapy
395068|NCT01891045|Drug addiction|drug addiction
395069|NCT01891045|Drop-out|drop-out
395070|NCT01891045|OQ-45.2|oq-45.2
395071|NCT01891045|Clinical trial|clinical trial
395072|NCT01891045|Randomized Controlled Trail|randomized controlled trail
395073|NCT01891032|acute kidney injury, partial nephrectomy, biomarker|acute kidney injury, partial nephrectomy, biomarker
395074|NCT01891006|Randomized Controlled Trial|randomized controlled trial
395075|NCT01891006|Economical Evaluation|economical evaluation
395076|NCT01891006|Caesarean Section|caesarean section
395077|NCT01891006|Cesarean Section|cesarean section
395078|NCT01891006|Postoperative Wound Treatment|postoperative wound treatment
395265|NCT01890200|TCM-700C|tcm-700c
395079|NCT01891006|Surgical Site Infections|surgical site infections
395080|NCT01891006|Wound Infections|wound infections
395081|NCT01891006|Infectious Morbidity|infectious morbidity
395082|NCT01891006|Negative Pressure Wound Therapy|negative pressure wound therapy
395083|NCT01890980|WT-1-vaccine Montanide|wt-1-vaccine montanide
395084|NCT01890980|GM-CSF|gm-csf
395085|NCT01890980|Wilms Tumor-1 vaccine|wilms tumor-1 vaccine
395086|NCT01890980|immunotherapy|immunotherapy
395087|NCT01890980|Montanide|montanide
395088|NCT01890980|Sargramostim|sargramostim
395089|NCT01890980|Granulocyte Macrophage Colony Stimulating Factor|granulocyte macrophage colony stimulating factor
395090|NCT01890980|Malignant Pleural Mesothelioma|malignant pleural mesothelioma
395092|NCT01890980|soluble mesothelin related protein|soluble mesothelin related protein
395093|NCT01890980|SMRP|smrp
395094|NCT01890967|low density lipoprotein, heterozygous familial hypercholesterolemia, polygenic hypercholesterolemia|low density lipoprotein, heterozygous familial hypercholesterolemia, polygenic hypercholesterolemia
395095|NCT01890954|Type 1 Diabetes Mellitus (T1DM)|type 1 diabetes mellitus (t1dm)
395096|NCT01890954|Closed Loop Control (CLC)|closed loop control (clc)
395097|NCT01890954|Diabetes Assistant (DiAs)|diabetes assistant (dias)
395098|NCT01890954|Continuous Glucose Monitor (CGM)|continuous glucose monitor (cgm)
395099|NCT01890941|Dry eye syndromes|dry eye syndromes
395100|NCT01890941|Corneal diseases|corneal diseases
395101|NCT01890941|Conjunctival diseases|conjunctival diseases
395102|NCT01890928|Gluconeogenesis|gluconeogenesis
395103|NCT01890928|Glycogenolysis|glycogenolysis
395104|NCT01890928|Pyruvate cycling|pyruvate cycling
395105|NCT01890928|Glucose production rates|glucose production rates
395106|NCT01890928|Mitochondria|mitochondria
395107|NCT01890928|Acylcarnitines|acylcarnitines
395108|NCT01890915|Spinal cord injury|spinal cord injury
395109|NCT01890915|Body temperature|body temperature
395110|NCT01890915|Executive function|executive function
395111|NCT01890915|Sweat|sweat
395112|NCT01890889|Total Cholesterol|total cholesterol
395113|NCT01890889|LDL|ldl
395114|NCT01890876|glucose tolerance, hypoxia, myokines, exercise|glucose tolerance, hypoxia, myokines, exercise
395115|NCT01890863|asthma|asthma
395116|NCT01890863|fluticasone propionate/salmeterol|fluticasone propionate/salmeterol
395117|NCT01890863|PK equivalence|pk equivalence
395118|NCT01890863|COPD|copd
395119|NCT01890863|pharmacokinetics|pharmacokinetics
395120|NCT01890863|fluticasone propionate/salmeterol in a capsule-based inhaler|fluticasone propionate/salmeterol in a capsule-based inhaler
395121|NCT01890863|fluticasone propionate/salmeterol in a multi-dose dry powder inhaler|fluticasone propionate/salmeterol in a multi-dose dry powder inhaler
395122|NCT01890863|Respiratory|respiratory
395123|NCT01890850|Risk factors|risk factors
395124|NCT01890850|U.S. commercially insured population|u.s. commercially insured population
395125|NCT01890850|Pertussis/whooping cough infection|pertussis/whooping cough infection
395126|NCT01890850|Retrospective database study|retrospective database study
395127|NCT01890837|Rectal Compliance|rectal compliance
395128|NCT01890837|Rectal Sensation|rectal sensation
395129|NCT01890837|Rectal Tone|rectal tone
395130|NCT01890824|Breast Cancer|breast cancer
395131|NCT01890824|Fat metabolism|fat metabolism
395132|NCT01890824|Fat digestion|fat digestion
395133|NCT01890824|physical activity|physical activity
395134|NCT01890824|muscle function|muscle function
395135|NCT01890811|CKD|ckd
395136|NCT01890811|Hemodialysis|hemodialysis
395137|NCT01890811|Protein Digestion|protein digestion
395138|NCT01890811|Fat Digestion|fat digestion
395139|NCT01890811|Gut Function|gut function
395140|NCT01890811|Glucose Absorption|glucose absorption
395141|NCT01890811|Muscle Function|muscle function
395142|NCT01890798|Duchenne Muscular Dystrophy|duchenne muscular dystrophy
395143|NCT01890798|GSK2402968|gsk2402968
395144|NCT01890798|drisapersen|drisapersen
395145|NCT01890772|Hepatitis C Genotype 1|hepatitis c genotype 1
395146|NCT01890772|Vitamin D|vitamin d
395147|NCT01890772|treatment-naive|treatment-naive
395148|NCT01890759|Meningitis|meningitis
395149|NCT01890759|Meningococcal Infection|meningococcal infection
395150|NCT01890759|Menactra®|menactra®
395151|NCT01890746|AML|aml
395152|NCT01890746|de novo AML|de novo aml
395153|NCT01890746|leukemia|leukemia
395154|NCT01890746|sAML/MDS|saml/mds
395155|NCT01890746|acute myeloid leukemia|acute myeloid leukemia
395156|NCT01890746|acute myelogenous leukemia (AML)|acute myelogenous leukemia (aml)
395157|NCT01890746|secondary acute myeloid leukemia|secondary acute myeloid leukemia
395158|NCT01890746|ETB115|etb115
395159|NCT01890746|Eltrombopag|eltrombopag
395160|NCT01890746|thrombocytopenia|thrombocytopenia
395161|NCT01890746|oral thrombopoietin receptor agonist|oral thrombopoietin receptor agonist
395410|NCT01889550|Downs syndrome|downs syndrome
395162|NCT01890733|Massive Rotator Cuff Tear, Sub-acromial spacer, Best repair of rotator cuff,|massive rotator cuff tear, sub-acromial spacer, best repair of rotator cuff,
395163|NCT01890720|Randomized Controlled Trial|randomized controlled trial
395164|NCT01890720|Economical Evaluation|economical evaluation
395165|NCT01890720|Caesarean Section|caesarean section
395166|NCT01890720|postoperative wound treatment|postoperative wound treatment
395167|NCT01890720|surgical site infections|surgical site infections
395168|NCT01890720|wound infections|wound infections
395169|NCT01890720|infectious morbidity|infectious morbidity
395170|NCT01890720|Negative Pressure Wound Therapy|negative pressure wound therapy
395171|NCT01890720|Incisional Negative Pressure Wound Therapy|incisional negative pressure wound therapy
395172|NCT01890720|Obesity|obesity
395173|NCT01890707|Gynecology|gynecology
395174|NCT01890707|Pain|pain
395175|NCT01890707|Anesthesia|anesthesia
395176|NCT01890707|Quality of Recovery 40|quality of recovery 40
395177|NCT01890694|Hyponatremia|hyponatremia
395178|NCT01890694|Dilutional Hyponatremia|dilutional hyponatremia
395179|NCT01890694|Euvolemic Hyponatremia|euvolemic hyponatremia
395180|NCT01890694|Hypervolemic Hyponatremia|hypervolemic hyponatremia
395181|NCT01890694|Fluid Restriction|fluid restriction
395182|NCT01890694|Tolvaptan|tolvaptan
395183|NCT01890681|childhood obesity|childhood obesity
395184|NCT01890681|child care|child care
395185|NCT01890681|infant|infant
395186|NCT01890681|toddler|toddler
395187|NCT01890668|Breastfeeding behaviour|breastfeeding behaviour
395188|NCT01890668|OMT (Osteopathic Manipulative Treatment)|omt (osteopathic manipulative treatment)
395189|NCT01890668|suboptimal infant breastfeeding behaviour|suboptimal infant breastfeeding behaviour
395190|NCT01890668|healthy newborns|healthy newborns
395191|NCT01890655|relapsing-remitting multiple sclerosis|relapsing-remitting multiple sclerosis
395192|NCT01890655|RRMS|rrms
395193|NCT01890642|Pain|pain
395194|NCT01890642|Children|children
395195|NCT01890642|Venipuncture|venipuncture
395196|NCT01890642|J tip|j tip
395197|NCT01890642|Lidocaine|lidocaine
395198|NCT01890642|video observation|video observation
395199|NCT01890629|diabetes mellitus|diabetes mellitus
395200|NCT01890603|Care coordination, primary care|care coordination, primary care
395201|NCT01890603|nurse care management|nurse care management
395202|NCT01890603|practice facilitation|practice facilitation
395203|NCT01890590|Renal Cell Carcinoma|renal cell carcinoma
395204|NCT01890590|Cyberknife|cyberknife
395205|NCT01890577|Chronic kidney disease|chronic kidney disease
395206|NCT01890577|Dialysis|dialysis
395207|NCT01890577|Erythropoiesis stimulating agent|erythropoiesis stimulating agent
395208|NCT01890577|South Africa|south africa
395209|NCT01890551|Adoloescent, patellofemoral, instability,biomechanics, magnetic resonance imaging|adoloescent, patellofemoral, instability,biomechanics, magnetic resonance imaging
395210|NCT01890538|vertigo|vertigo
395211|NCT01890538|dimenhydrinate|dimenhydrinate
395212|NCT01890538|piracetam|piracetam
395213|NCT01890525|radiation|radiation
395214|NCT01890499|tolerability|tolerability
395215|NCT01890499|diet after operation|diet after operation
395216|NCT01890447|Cocooning|cocooning
395217|NCT01890447|Web-based questionnaire|web-based questionnaire
395218|NCT01890447|Italy|italy
395219|NCT01890447|Pertussis|pertussis
395220|NCT01890447|Spain|spain
395221|NCT01890447|Survey|survey
395222|NCT01890434|Myocardial Perfusion Imaging|myocardial perfusion imaging
395223|NCT01890421|Myocardial Perfusion Imaging|myocardial perfusion imaging
395224|NCT01890408|Laparotomy|laparotomy
395225|NCT01890408|Hepatic resection|hepatic resection
395226|NCT01890408|continuous wound catheter analgesia|continuous wound catheter analgesia
395227|NCT01890408|morphine|morphine
395228|NCT01890408|post operative recovery|post operative recovery
395229|NCT01890395|mitochondrial DAMPS|mitochondrial damps
395230|NCT01890382|resistance exercise|resistance exercise
395231|NCT01890382|protein|protein
395232|NCT01890382|creatine|creatine
395233|NCT01890382|leucine|leucine
395234|NCT01890382|aging|aging
395235|NCT01890369|Old Age|old age
395236|NCT01890369|Sarcopenia|sarcopenia
395237|NCT01890369|Amino Acid|amino acid
395238|NCT01890369|Muscle|muscle
395239|NCT01890356|Depression|depression
395240|NCT01890356|Treatment|treatment
395241|NCT01890356|Transcranial electrical stimulation|transcranial electrical stimulation
395242|NCT01890356|Maintenance|maintenance
395243|NCT01890330|Canola Oil|canola oil
395244|NCT01890330|Metabolic Syndrome|metabolic syndrome
395245|NCT01890330|Serum LDL cholesterol|serum ldl cholesterol
395246|NCT01890317|Cardiogenic shock|cardiogenic shock
395247|NCT01890317|acute myocardial infarction|acute myocardial infarction
395248|NCT01890317|mild hypothermia|mild hypothermia
395249|NCT01890304|Traumatic Brain Injury|traumatic brain injury
395251|NCT01890304|Concussion|concussion
395252|NCT01890304|Sports related injury|sports related injury
395253|NCT01890291|Immuncell-LC, Hepatocellular carcinoma|immuncell-lc, hepatocellular carcinoma
395254|NCT01890278|Brain Cancer|brain cancer
395255|NCT01890278|Metastatic Brain Cancer|metastatic brain cancer
395256|NCT01890278|IMRT|imrt
395257|NCT01890265|Idiopathic Pulmonary Fibrosis, IPF, Idiopathic Interstitial Pneumonia, Interstitial Lung Disease, Lung Fibrosis|idiopathic pulmonary fibrosis, ipf, idiopathic interstitial pneumonia, interstitial lung disease, lung fibrosis
395258|NCT01890213|alphavirus|alphavirus
395259|NCT01890213|colon cancer|colon cancer
395260|NCT01890213|immune response|immune response
395261|NCT01890213|CEA|cea
395262|NCT01890200|add-on treatment|add-on treatment
395263|NCT01890200|botanical drug|botanical drug
395264|NCT01890200|HCV genotype 1|hcv genotype 1
395266|NCT01890161|asthma|asthma
395267|NCT01890148|Asthma|asthma
395268|NCT01890135|randomized|randomized
395269|NCT01890135|double blind|double blind
395270|NCT01890135|blood flow|blood flow
395271|NCT01890135|muscle perfusion|muscle perfusion
395272|NCT01890135|safety|safety
395273|NCT01890122|Drug therapy|drug therapy
395274|NCT01890109|Vasomotor symptoms; Hot Flashes; Menopause|vasomotor symptoms; hot flashes; menopause
395275|NCT01890096|HDR|hdr
395276|NCT01890096|monotherapy|monotherapy
395277|NCT01890096|low|low
395278|NCT01890096|intermediate|intermediate
395279|NCT01890096|prostate cancer|prostate cancer
395280|NCT01890083|Hepatitis C|hepatitis c
395281|NCT01890083|Interferon-alpha|interferon-alpha
395282|NCT01890083|Depression|depression
395283|NCT01890083|Major Depressive Disorder|major depressive disorder
395284|NCT01890083|Exercise|exercise
395285|NCT01890083|Physical Activity|physical activity
395286|NCT01890070|mediterranean diet, nutrigenomics, body composition, inflammation, oxidative stress|mediterranean diet, nutrigenomics, body composition, inflammation, oxidative stress
395287|NCT01890044|VTE|vte
395288|NCT01890044|DVT|dvt
395289|NCT01890044|Venous Thromboembolism|venous thromboembolism
395290|NCT01890044|Deep Vein Thrombosis|deep vein thrombosis
395291|NCT01890044|Pulmonary embolus|pulmonary embolus
395292|NCT01890044|Trauma|trauma
395293|NCT01890031|cardiovascular disease|cardiovascular disease
395294|NCT01890031|cholesterol|cholesterol
395295|NCT01890018|Acute Myocardial Infarction (AMI)|acute myocardial infarction (ami)
395296|NCT01890018|taking a statin medication|taking a statin medication
395297|NCT01890018|also have a medication adherence ratio (MPR)|also have a medication adherence ratio (mpr)
395298|NCT01890005|Preeclampsia|preeclampsia
395299|NCT01890005|Low dose aspirin|low dose aspirin
395300|NCT01890005|Fetal growth restriction|fetal growth restriction
395301|NCT01890005|Neonatal death|neonatal death
395302|NCT01890005|Stillbirth|stillbirth
395303|NCT01890005|Abruptio placenta|abruptio placenta
395304|NCT01889992|Heart transplantation|heart transplantation
395305|NCT01889992|Cardiac allograft remodeling|cardiac allograft remodeling
395306|NCT01889992|Immunosuppression|immunosuppression
505660|NCT01408563|NHL|nhl
395307|NCT01889992|Cardiac MRI|cardiac mri
395308|NCT01889992|M-TOR inhibitor|m-tor inhibitor
395309|NCT01889979|Pain during labour|pain during labour
395310|NCT01889979|Duration of labour|duration of labour
395311|NCT01889979|Apgar score|apgar score
395312|NCT01889979|Umbilical cord pH|umbilical cord ph
395313|NCT01889966|vasoreactivity testing|vasoreactivity testing
395314|NCT01889966|Sildenafil|sildenafil
395315|NCT01889966|precapillary pulmonary hypertension|precapillary pulmonary hypertension
395316|NCT01889966|connective tissue disease|connective tissue disease
395317|NCT01889966|mean pressure in the pulmonary artery 25 mmHg or more|mean pressure in the pulmonary artery 25 mmhg or more
395318|NCT01889966|mean pulmonary capillary wedge pressure below 16 mmHg|mean pulmonary capillary wedge pressure below 16 mmhg
395319|NCT01889953|EUS-Guided Biliary Drainage|eus-guided biliary drainage
395320|NCT01889953|Endoscopic retrograde cholangiopancreatography|endoscopic retrograde cholangiopancreatography
395321|NCT01889953|Malignant Biliary Obstruction|malignant biliary obstruction
395322|NCT01889940|Acute Spinal Cord Injury|acute spinal cord injury
395323|NCT01889940|Patient Satisfaction|patient satisfaction
395324|NCT01889940|Psychological Distress|psychological distress
395325|NCT01889940|Rehabilitation|rehabilitation
395326|NCT01889940|Training Professionals|training professionals
395327|NCT01889940|Burnout|burnout
395328|NCT01889940|Job Content|job content
395329|NCT01889927|exercise|exercise
395330|NCT01889927|physiotherapy|physiotherapy
395331|NCT01889927|lung function|lung function
395332|NCT01889927|quality of life|quality of life
395333|NCT01889888|Male urethral stricture|male urethral stricture
395334|NCT01889888|ADRC|adrc
395335|NCT01889888|Adipose-derived regenerative cells|adipose-derived regenerative cells
395336|NCT01889888|Fat tissue|fat tissue
395337|NCT01889888|Stem cells|stem cells
395338|NCT01889862|PKU|pku
395339|NCT01889862|PEG-PAL|peg-pal
395340|NCT01889862|Prism|prism
395341|NCT01889862|BioMarin|biomarin
395342|NCT01889862|rAvPAL-PEG|ravpal-peg
395343|NCT01889862|Pegvaliase|pegvaliase
395344|NCT01889836|meningococcal conjugate vaccine serogroup C|meningococcal conjugate vaccine serogroup c
395345|NCT01889836|Prevention|prevention
395346|NCT01889823|Oxygen|oxygen
395347|NCT01889823|Hypoxia|hypoxia
395348|NCT01889823|Hyperoxia|hyperoxia
395349|NCT01889823|Inflammation|inflammation
395350|NCT01889823|Innate immunity|innate immunity
395351|NCT01889810|Vitamin D, Pre-diabetes, Insulin Resistance|vitamin d, pre-diabetes, insulin resistance
395352|NCT01889797|Untreated Non-Hodgkin's Lymphoma|untreated non-hodgkin's lymphoma
395353|NCT01889797|Low Tumor Burden Non-Hodgkin's Lymphoma|low tumor burden non-hodgkin's lymphoma
395354|NCT01889797|NHL|nhl
395355|NCT01889797|Indolent|indolent
395356|NCT01889797|Rituximab|rituximab
395357|NCT01889797|Rituxan|rituxan
395358|NCT01889797|GA101|ga101
395359|NCT01889797|Obinutuzumab|obinutuzumab
395360|NCT01889784|diabetes mellitus, type 2|diabetes mellitus, type 2
395361|NCT01889784|phototherapy|phototherapy
395362|NCT01889784|physical exercise|physical exercise
395363|NCT01889784|oxygen consumption|oxygen consumption
395364|NCT01889784|arterial blood pressure|arterial blood pressure
395365|NCT01889784|heart rate|heart rate
395366|NCT01889784|baroreflex sensitivity|baroreflex sensitivity
395367|NCT01889784|cardiovascular autonomic control|cardiovascular autonomic control
395368|NCT01889758|bioequivalence|bioequivalence
395369|NCT01889758|tacrolimus|tacrolimus
395370|NCT01889758|kidney|kidney
395371|NCT01889758|liver|liver
395372|NCT01889758|transplant|transplant
395373|NCT01889719|HIV Prevention|hiv prevention
395374|NCT01889706|Type 1 diabetes mellitus,|type 1 diabetes mellitus,
395375|NCT01889706|metformin,|metformin,
395376|NCT01889706|insulin resistance,|insulin resistance,
395377|NCT01889706|obesity|obesity
395378|NCT01889693|positron emission tomography|positron emission tomography
395379|NCT01889693|macrophage|macrophage
395380|NCT01889693|neomannosyl human serum albumin|neomannosyl human serum albumin
395381|NCT01889680|colorectal cancer|colorectal cancer
395382|NCT01889680|metastatic colorectal cancer|metastatic colorectal cancer
395383|NCT01889680|ziv-aflibercept|ziv-aflibercept
395384|NCT01889680|NSABP|nsabp
395385|NCT01889667|Oral Insulin|oral insulin
395386|NCT01889667|Diabetes Mellitus Type 2|diabetes mellitus type 2
395387|NCT01889667|Safety|safety
395388|NCT01889667|Pharmacodynamics|pharmacodynamics
395389|NCT01889667|Pharmacokinetics|pharmacokinetics
395390|NCT01889628|Glycaemic response|glycaemic response
395391|NCT01889628|Glycaemic Index|glycaemic index
395392|NCT01889628|Nutritional formula|nutritional formula
395393|NCT01889628|Asia|asia
395394|NCT01889628|Ethnic differences|ethnic differences
395395|NCT01889628|Chinese|chinese
395396|NCT01889628|Malay|malay
395397|NCT01889628|Indian|indian
395398|NCT01889615|Ovarian cancer|ovarian cancer
395399|NCT01889615|PET/CT|pet/ct
395400|NCT01889615|glucose 6 phosphatase|glucose 6 phosphatase
395401|NCT01889602|Healthy volunteers|healthy volunteers
395402|NCT01889602|Topiramate|topiramate
395403|NCT01889602|Neurocognition|neurocognition
505765|NCT01408056|Timolol|timolol
395404|NCT01889602|Drug-induced cognitive deficits|drug-induced cognitive deficits
395405|NCT01889576|glucose|glucose
395406|NCT01889563|chronic obstructive pulmonary disease|chronic obstructive pulmonary disease
395407|NCT01889563|heart rate variability|heart rate variability
395408|NCT01889563|physical training|physical training
395409|NCT01889550|Screening|screening
395411|NCT01889550|Informed choice|informed choice
395412|NCT01889550|eHealth|ehealth
395413|NCT01889537|Virtual Reality Ketamine|virtual reality ketamine
395414|NCT01889511|Text Messaging|text messaging
395415|NCT01889511|Medication Adherence|medication adherence
395416|NCT01889511|Oral Agents|oral agents
395417|NCT01889498|Acetazolamide, intracranial/cerebrospinal fluid pressure, paraplegia, thoracoabdominal aortic surgery|acetazolamide, intracranial/cerebrospinal fluid pressure, paraplegia, thoracoabdominal aortic surgery
395418|NCT01889485|Aortic Aneurysm, Abdominal|aortic aneurysm, abdominal
395419|NCT01889485|Carotid Stenosis|carotid stenosis
395420|NCT01889485|Peripheral Arterial Disease|peripheral arterial disease
395421|NCT01889485|Health Services Accessibility|health services accessibility
395422|NCT01889472|CPAP compliance|cpap compliance
395423|NCT01889472|leaks|leaks
395424|NCT01889472|Respiratory disturbances index|respiratory disturbances index
395425|NCT01889472|quality of life|quality of life
395426|NCT01889446|Propionic acid|propionic acid
395427|NCT01889446|Food preservatives|food preservatives
395428|NCT01889433|Hepatitis C|hepatitis c
395429|NCT01889433|Cepeginterferon alfa|cepeginterferon alfa
395430|NCT01889433|Peginterferon|peginterferon
395431|NCT01889433|Treatment|treatment
395432|NCT01889420|myeloma|myeloma
395433|NCT01889420|relapse|relapse
395434|NCT01889420|refractory|refractory
395435|NCT01889420|relapsed|relapsed
395436|NCT01889420|pomalidomide|pomalidomide
395437|NCT01889420|pomalyst|pomalyst
395438|NCT01889420|everolimus|everolimus
395439|NCT01889420|afinitor|afinitor
395440|NCT01889420|dexamethasone|dexamethasone
395441|NCT01889407|Acute Myeloid Leukemia|acute myeloid leukemia
395442|NCT01889394|pilonidal sinus|pilonidal sinus
395443|NCT01889394|excision|excision
395444|NCT01889394|primary wound closure|primary wound closure
395445|NCT01889394|limberg flap|limberg flap
395446|NCT01889381|Facial Injuries|facial injuries
395447|NCT01889381|Face Transplant|face transplant
395448|NCT01889381|Facial Transplantation|facial transplantation
395449|NCT01889381|Facial Deformity|facial deformity
395450|NCT01889368|Insulin resistance|insulin resistance
395451|NCT01889368|Central adiposity|central adiposity
395452|NCT01889368|Elevated blood pressure|elevated blood pressure
395453|NCT01889368|Vascular reactivity|vascular reactivity
395454|NCT01889368|Elevated triglycerides|elevated triglycerides
395455|NCT01889368|Low high-density lipoprotein (HDL)|low high-density lipoprotein (hdl)
395456|NCT01889355|diabetes|diabetes
395457|NCT01889355|glucose|glucose
395458|NCT01889355|glucometer|glucometer
395459|NCT01889342|MCT|mct
395460|NCT01889342|Metacognitive therapy|metacognitive therapy
395461|NCT01889342|Anxiety disorders|anxiety disorders
395462|NCT01889342|Transdiagnostic|transdiagnostic
395463|NCT01889316|Fetal monitoring|fetal monitoring
395465|NCT01889303|concurrent chemoradiotherapy|concurrent chemoradiotherapy
395466|NCT01889303|FOLFOX6|folfox6
395467|NCT01889303|chemotherapy|chemotherapy
395468|NCT01889303|docetaxel|docetaxel
395469|NCT01889303|cisplatin|cisplatin
395470|NCT01889303|gastric cancer|gastric cancer
395471|NCT01889290|methylnaltrexone|methylnaltrexone
395472|NCT01889290|opioid-antagonist|opioid-antagonist
395473|NCT01889290|Obstipation|obstipation
395474|NCT01889290|pharmacokinetics|pharmacokinetics
395475|NCT01889277|Diabetic Nephropathy|diabetic nephropathy
395476|NCT01889264|Methionine Metabolism|methionine metabolism
395477|NCT01889264|Enteral Nutrition|enteral nutrition
395478|NCT01889264|Pediatric|pediatric
395479|NCT01889264|Pediatrics|pediatrics
395480|NCT01889264|Sepsis|sepsis
395481|NCT01889264|Observational Study|observational study
395482|NCT01889251|Vitreomacular Adhesion|vitreomacular adhesion
395483|NCT01889251|Vitreomacular Traction|vitreomacular traction
395484|NCT01889251|Vitreomacular Traction Syndrome|vitreomacular traction syndrome
395485|NCT01889251|Vitrectomy|vitrectomy
395486|NCT01889251|Central Visual Field Defect|central visual field defect
395487|NCT01889251|Blind Spot|blind spot
395488|NCT01889251|Intravitreal Injection|intravitreal injection
395489|NCT01889251|Macula|macula
395490|NCT01889251|Retina|retina
395491|NCT01889251|Decreased Visual Acuity|decreased visual acuity
395492|NCT01889251|Visual Complaint|visual complaint
395493|NCT01889251|SD-OCT|sd-oct
395494|NCT01889251|Macular Hole|macular hole
395495|NCT01889238|breast cancer|breast cancer
395496|NCT01889238|triple negative|triple negative
395497|NCT01889238|androgen receptor positive|androgen receptor positive
395498|NCT01889199|polycystic ovary syndrome|polycystic ovary syndrome
395499|NCT01889199|hirsutism|hirsutism
395500|NCT01889199|anovulation|anovulation
395501|NCT01889199|oligomenorrhea|oligomenorrhea
395502|NCT01889199|amenorrhea|amenorrhea
395503|NCT01889199|hyperandrogenism|hyperandrogenism
395504|NCT01889199|antiandrogen effect|antiandrogen effect
395505|NCT01889186|Chronic Lymphocytic Leukemia|chronic lymphocytic leukemia
395506|NCT01889186|17 p Deletion|17 p deletion
395507|NCT01889160|Healthy volunteers, Phase 1|healthy volunteers, phase 1
395508|NCT01889147|Peak plasma concentration|peak plasma concentration
395509|NCT01889147|safety and efficacy|safety and efficacy
395510|NCT01889147|therapeutic agent|therapeutic agent
395511|NCT01889147|LPS-mediated diseases|lps-mediated diseases
395512|NCT01889147|Pharmacokinetics of administered hRESCAP|pharmacokinetics of administered hrescap
395513|NCT01889147|Determine half-time|determine half-time
395514|NCT01889134|primary hyperparathyroidism|primary hyperparathyroidism
395515|NCT01889134|RANKL|rankl
395516|NCT01889134|osteoprotegerin|osteoprotegerin
395517|NCT01889134|bone mineral density|bone mineral density
395518|NCT01889134|alendronate|alendronate
395519|NCT01889134|parathyroidectomy|parathyroidectomy
395520|NCT01889108|Premature|premature
395521|NCT01889108|Development|development
395522|NCT01889108|Motor|motor
395523|NCT01889108|Cognitive|cognitive
395524|NCT01889108|Parent|parent
395525|NCT01889082|Obesity|obesity
395526|NCT01889082|weight loss|weight loss
395527|NCT01889082|young adults|young adults
395528|NCT01889056|Erythropoietin|erythropoietin
395529|NCT01889056|Cognition|cognition
395530|NCT01889056|Exercise|exercise
395531|NCT01889043|Amyotrophic Lateral Sclerosis|amyotrophic lateral sclerosis
395532|NCT01889043|Noninvasive Ventilation|noninvasive ventilation
395533|NCT01889043|Polysomnography|polysomnography
395534|NCT01889030|Cardiovascular primary prevention|cardiovascular primary prevention
395535|NCT01889030|Cardiovascular risk strtification|cardiovascular risk strtification
395663|NCT01888432|RAD001H|rad001h
395536|NCT01889017|generic immunosuppressive|generic immunosuppressive
395537|NCT01889004|Cerebral blood flow|cerebral blood flow
395538|NCT01889004|Consciousness|consciousness
395539|NCT01889004|Dexmedetomidine|dexmedetomidine
395540|NCT01889004|EEG|eeg
395541|NCT01889004|Event related potentials|event related potentials
395542|NCT01889004|Functional magnetic resonance imaging|functional magnetic resonance imaging
395543|NCT01889004|General anesthesia|general anesthesia
395544|NCT01889004|Positron emission tomography|positron emission tomography
395545|NCT01889004|Propofol|propofol
395546|NCT01888991|Glucose|glucose
395547|NCT01888991|Exercise|exercise
395548|NCT01888991|Metabolic flexibility|metabolic flexibility
395549|NCT01888991|Substrate Oxidation|substrate oxidation
395550|NCT01888991|Food intake|food intake
395551|NCT01888978|Pancreas|pancreas
395552|NCT01888978|cancer|cancer
395553|NCT01888978|metastatic|metastatic
395554|NCT01888978|chemotherapy|chemotherapy
395555|NCT01888965|Maintenance therapy|maintenance therapy
395556|NCT01888965|Adjuvant Therapy|adjuvant therapy
395557|NCT01888939|Executive Function|executive function
395558|NCT01888939|Child|child
395559|NCT01888939|Obesity|obesity
395560|NCT01888939|Exercise|exercise
395561|NCT01888939|Insulin Sensitivity|insulin sensitivity
395562|NCT01888926|rPAS|rpas
395563|NCT01888926|Dystonia|dystonia
395564|NCT01888913|Body Weight|body weight
395565|NCT01888913|Virtual Environment|virtual environment
395566|NCT01888900|Hepatitis C|hepatitis c
395567|NCT01888900|Non-Responders|non-responders
395568|NCT01888900|Direct Acting Antivirals|direct acting antivirals
395569|NCT01888900|Interferon Free|interferon free
395570|NCT01888900|Cirrhosis|cirrhosis
395571|NCT01888874|Methotrexate insufficient responders|methotrexate insufficient responders
395572|NCT01888861|length of stay in ICU|length of stay in icu
395573|NCT01888861|ventilator free days|ventilator free days
395574|NCT01888848|Postural Balance|postural balance
395575|NCT01888848|Walking|walking
395576|NCT01888848|Gait|gait
395577|NCT01888848|Cognition|cognition
395578|NCT01888848|Learning|learning
395579|NCT01888848|Memory|memory
395580|NCT01888848|Blueberry|blueberry
395581|NCT01888848|Antioxidants|antioxidants
395582|NCT01888848|Anti-Inflammatory Agents|anti-inflammatory agents
395583|NCT01888848|Brain|brain
395584|NCT01888835|HIV|hiv
395585|NCT01888835|sexual behavior|sexual behavior
395586|NCT01888822|Laparoscopic cholecystectomy|laparoscopic cholecystectomy
395587|NCT01888822|Prophylactic antibiotics|prophylactic antibiotics
395588|NCT01888809|teen parents|teen parents
395589|NCT01888809|early childhood development|early childhood development
395590|NCT01888809|home visitation|home visitation
395591|NCT01888809|evidence-based treatment|evidence-based treatment
395592|NCT01888796|T2DM|t2dm
395593|NCT01888796|diastolic dysfunction|diastolic dysfunction
395594|NCT01888783|CRPS Type I|crps type i
395595|NCT01888783|tactile acuity|tactile acuity
395596|NCT01888783|2-point-discrimination|2-point-discrimination
395597|NCT01888783|Grating Orientation Task|grating orientation task
395598|NCT01888783|sensory signs|sensory signs
395599|NCT01888757|Bioequivalence|bioequivalence
395600|NCT01888757|Lamotrigine Extended Release|lamotrigine extended release
395601|NCT01888757|crossover|crossover
395602|NCT01888744|Intracytoplasmic sperm injection (ICSI)|intracytoplasmic sperm injection (icsi)
395603|NCT01888744|PGD|pgd
395604|NCT01888744|GnrH agonist|gnrh agonist
395605|NCT01888744|GnRH antagonist|gnrh antagonist
395606|NCT01888731|Bioequivalence|bioequivalence
395607|NCT01888731|Lamotrigine Extended Release|lamotrigine extended release
395608|NCT01888731|crossover|crossover
395609|NCT01888705|COPD|copd
395610|NCT01888705|Complexity|complexity
395611|NCT01888705|Entropy Sampling|entropy sampling
395612|NCT01888705|Variability|variability
395613|NCT01888705|Respiratory Mechanics|respiratory mechanics
395614|NCT01888705|FOT|fot
395615|NCT01888692|PET/CT|pet/ct
395616|NCT01888692|Radiotherapy|radiotherapy
395617|NCT01888692|Lung Cancer|lung cancer
395618|NCT01888679|Airway|airway
395619|NCT01888679|Endotracheal intubation|endotracheal intubation
395620|NCT01888679|selective intubation|selective intubation
395621|NCT01888653|PTSD|ptsd
395622|NCT01888653|Attention Bias to threat|attention bias to threat
395623|NCT01888653|Attention Bias Modification Treatment|attention bias modification treatment
395624|NCT01888640|TENS|tens
395625|NCT01888640|Fibromyalgia|fibromyalgia
395626|NCT01888640|Accelerometer|accelerometer
395627|NCT01888627|Schizophrenia|schizophrenia
395628|NCT01888627|Bipolar disorder|bipolar disorder
395629|NCT01888627|Assertive community treatment|assertive community treatment
395630|NCT01888627|Integrated care|integrated care
395631|NCT01888627|Severe and persistent mental disorder|severe and persistent mental disorder
395632|NCT01888614|carbon mono oxide|carbon mono oxide
395633|NCT01888614|sickle cell|sickle cell
395634|NCT01888614|hemolysis|hemolysis
395635|NCT01888588|Uncomplicated peptic ulcer|uncomplicated peptic ulcer
395636|NCT01888588|Low dose aspirin (ASA)|low dose aspirin (asa)
395637|NCT01888588|Acid-suppressing drugs|acid-suppressing drugs
395638|NCT01888588|Epidemiology|epidemiology
395639|NCT01888575|Discontinuation of low dose ASA,|discontinuation of low dose asa,
395640|NCT01888575|Secondary cardiovascular prevention,|secondary cardiovascular prevention,
395641|NCT01888575|Acid-suppressing drugs,|acid-suppressing drugs,
395642|NCT01888575|Gastrointestinal risk,|gastrointestinal risk,
395643|NCT01888575|Epidemiology|epidemiology
395644|NCT01888549|Chronic cough, proton pump inhibitor, GERD, nonacid reflux,|chronic cough, proton pump inhibitor, gerd, nonacid reflux,
395645|NCT01888497|Sleeplessness|sleeplessness
395646|NCT01888484|PID|pid
395647|NCT01888471|Streptococcal disease|streptococcal disease
395648|NCT01888471|Feasibility|feasibility
395649|NCT01888471|Infants|infants
395650|NCT01888458|Adult|adult
395651|NCT01888458|allo-Stem Cell Transplantation|allo-stem cell transplantation
395652|NCT01888458|Cord Blood|cord blood
395653|NCT01888445|Renal anemia|renal anemia
395654|NCT01888445|Chronic Renal Failure|chronic renal failure
395655|NCT01888445|ASP1517|asp1517
395656|NCT01888432|liver transplantation|liver transplantation
395657|NCT01888432|everolimus|everolimus
395658|NCT01888432|tacrolimus|tacrolimus
395659|NCT01888432|reduced calcineuron inhibitor|reduced calcineuron inhibitor
395660|NCT01888432|renal function|renal function
395661|NCT01888432|living donor|living donor
395662|NCT01888432|RAD001H2307|rad001h2307
395664|NCT01888419|Post Breast Therapy Pain Syndrome|post breast therapy pain syndrome
395665|NCT01888419|Lipotransplantation|lipotransplantation
395666|NCT01888419|Breast Cancer|breast cancer
395668|NCT01888406|Obesity|obesity
395669|NCT01888406|Weight gain prevention|weight gain prevention
395670|NCT01888406|Eating disorder|eating disorder
395671|NCT01888406|Binge eating|binge eating
395672|NCT01888393|pharmacokinetics, hepatic impairment|pharmacokinetics, hepatic impairment
395673|NCT01888380|Autopsy|autopsy
395674|NCT01888380|Minimally invasive|minimally invasive
395675|NCT01888380|Foetuses|foetuses
395676|NCT01888380|Newborns|newborns
395677|NCT01888380|Children|children
395678|NCT01888380|Adolescents|adolescents
395680|NCT01888354|Multiple Sclerosis|multiple sclerosis
395681|NCT01888315|Hypertension|hypertension
395682|NCT01888315|Heart Failure|heart failure
395683|NCT01888315|Sympathetic activity|sympathetic activity
395684|NCT01888276|Words generation, compulsive gamblers|words generation, compulsive gamblers
395685|NCT01888263|Bioequivalence|bioequivalence
395686|NCT01888263|Lamotrigine Extended Release|lamotrigine extended release
395687|NCT01888263|crossover|crossover
395688|NCT01888250|Bioequivalence|bioequivalence
395689|NCT01888250|Lamotrigine Extended Release|lamotrigine extended release
395690|NCT01888250|crossover|crossover
395691|NCT01888237|Dyspepsia|dyspepsia
395692|NCT01888237|Helicobacter pylori|helicobacter pylori
395693|NCT01888237|Clarithromycin resistance|clarithromycin resistance
395694|NCT01888237|Other Specified Disorders of Function of Stomach|other specified disorders of function of stomach
395695|NCT01888198|ablation|ablation
395696|NCT01888198|quality of Life (QOL)|quality of life (qol)
395697|NCT01888198|kidney|kidney
395698|NCT01888198|registry|registry
395699|NCT01888198|Ablation of Renal Masses Outcomes Registry (ARMOR)|ablation of renal masses outcomes registry (armor)
395700|NCT01888198|13-116|13-116
395701|NCT01888185|Parkinson's|parkinson's
395702|NCT01888185|PD|pd
395703|NCT01888185|nigrostriatal|nigrostriatal
395704|NCT01888185|substantia nigra|substantia nigra
395705|NCT01888185|MRI|mri
395706|NCT01888185|DTI|dti
395707|NCT01888185|FA|fa
395708|NCT01888185|R2*|r2*
395709|NCT01888185|Parkinson's Disease Biomarkers Program|parkinson's disease biomarkers program
395710|NCT01888185|PDBP|pdbp
395711|NCT01888185|ferritin|ferritin
395712|NCT01888185|transferrin|transferrin
395713|NCT01888185|Fe|fe
395714|NCT01888185|iron protein|iron protein
395715|NCT01888185|PSP|psp
395716|NCT01888185|MSA|msa
395717|NCT01888146|Pain management|pain management
395718|NCT01888146|Opioid use|opioid use
395719|NCT01888146|Pragmatic|pragmatic
395720|NCT01888146|Collaborative care|collaborative care
395721|NCT01888146|Primary care|primary care
395722|NCT01888107|Schizophrenia|schizophrenia
395723|NCT01888107|Schizoaffective Disorder|schizoaffective disorder
395724|NCT01888107|Antipsychotics|antipsychotics
395725|NCT01888107|Risperidone|risperidone
395726|NCT01888107|Long-acting injectable|long-acting injectable
395727|NCT01888094|Central venous catheter|central venous catheter
395728|NCT01888094|Complications|complications
395729|NCT01888094|Ultrasound|ultrasound
395730|NCT01888094|Subclavian vein cannulation|subclavian vein cannulation
395731|NCT01888094|Critical care|critical care
395732|NCT01888094|Echocardiography|echocardiography
395733|NCT01888094|Chest radiographyiography|chest radiographyiography
395734|NCT01888055|Healthy older adults Cortical Plasticity|healthy older adults cortical plasticity
395735|NCT01888055|Transcranial Direct Current Stimulation|transcranial direct current stimulation
395736|NCT01888029|mild cognitive impairment|mild cognitive impairment
395737|NCT01888029|Transcranial Direct Current Stimulation|transcranial direct current stimulation
395738|NCT01888029|Cortical Plasticity|cortical plasticity
395739|NCT01888003|anemia|anemia
395740|NCT01887977|Orthognathic surgery|orthognathic surgery
395741|NCT01887977|Speech production|speech production
395742|NCT01887977|MRI|mri
395743|NCT01887964|Diabetes|diabetes
395744|NCT01887964|Obesity|obesity
395745|NCT01887964|Cardiovascular disease|cardiovascular disease
395746|NCT01887964|Metabolic syndrome|metabolic syndrome
395747|NCT01887925|breast neoplasms|breast neoplasms
395748|NCT01887925|sleep|sleep
395749|NCT01887925|anxiety|anxiety
395750|NCT01887925|depression|depression
395751|NCT01887925|life quality|life quality
395752|NCT01887912|Clostridium difficile Toxoid Vaccine|clostridium difficile toxoid vaccine
395753|NCT01887912|Clostridium difficile infection|clostridium difficile infection
395754|NCT01887912|Cdiffense|cdiffense
395755|NCT01887899|cortical plasticity|cortical plasticity
395756|NCT01887899|transcranial direct current stimulation|transcranial direct current stimulation
395757|NCT01887873|open angle glaucoma|open angle glaucoma
395758|NCT01887873|cataract|cataract
395759|NCT01887860|Cetaphil Daily Facial Moisturizer SPF 50|cetaphil daily facial moisturizer spf 50
395760|NCT01887847|nicotine|nicotine
395761|NCT01887847|pharmacokinetics|pharmacokinetics
395762|NCT01887834|bloating|bloating
395763|NCT01887834|constipation|constipation
395764|NCT01887834|diarrhea|diarrhea
395765|NCT01887834|gas|gas
395766|NCT01887834|mucous|mucous
395767|NCT01887834|cramping|cramping
395768|NCT01887808|Determine|determine
395769|NCT01887808|Hypoallergenicity|hypoallergenicity
395770|NCT01887808|Cetaphil DermaControl Oil Control Moisturizer SPF 30|cetaphil dermacontrol oil control moisturizer spf 30
395771|NCT01887795|Informed Consent;|informed consent;
395772|NCT01887795|Ethical Principles;|ethical principles;
395773|NCT01887795|Data collection|data collection
395774|NCT01887782|depression|depression
395775|NCT01887782|magnetic|magnetic
395776|NCT01887782|brain stimulation|brain stimulation
395777|NCT01887782|treatment-resistant|treatment-resistant
395778|NCT01887769|Lung cancer|lung cancer
395779|NCT01887769|Body composition analysis|body composition analysis
395780|NCT01887769|Ct-Scan|ct-scan
395781|NCT01887769|Muscle mass|muscle mass
395782|NCT01887769|Cachexia|cachexia
395783|NCT01887756|telerehabilitation stroke virtual reatlity|telerehabilitation stroke virtual reatlity
395784|NCT01887743|GERD|gerd
395785|NCT01887743|Obesity|obesity
395786|NCT01887743|Pediatric|pediatric
395787|NCT01887743|Pantoprazole|pantoprazole
395788|NCT01887743|CYP2C19|cyp2c19
395789|NCT01887743|Pharmacokinetic|pharmacokinetic
395790|NCT01887730|Hand Hygiene|hand hygiene
395791|NCT01887730|Communicable Diseases|communicable diseases
395792|NCT01887730|Prevention|prevention
395793|NCT01887717|hepatocellular carcinoma|hepatocellular carcinoma
395794|NCT01887717|portal vein thrombosis|portal vein thrombosis
395795|NCT01887691|Diabetes|diabetes
395796|NCT01887691|Prediabetic|prediabetic
395797|NCT01887691|Prediabetes|prediabetes
395798|NCT01887691|Glucose intolerance|glucose intolerance
395799|NCT01887691|Sleep quality|sleep quality
395800|NCT01887691|Continuous glucose monitoring|continuous glucose monitoring
395801|NCT01887691|Diabetes risk|diabetes risk
395802|NCT01887691|eszopiclone|eszopiclone
395803|NCT01887665|substance use disorders|substance use disorders
395804|NCT01887665|substance abuse|substance abuse
395805|NCT01887665|substance abuse treatment|substance abuse treatment
395806|NCT01887665|contingency management|contingency management
395807|NCT01887652|In Vitro Fertilization|in vitro fertilization
395808|NCT01887652|ovulation induction|ovulation induction
395809|NCT01887652|anti-mullerian hormone|anti-mullerian hormone
395810|NCT01887639|Non-psychotic unipolar major depression|non-psychotic unipolar major depression
395811|NCT01887639|Resistant depression|resistant depression
395812|NCT01887626|Phase 1, pharmacokinetic, safety, Ticagrelor|phase 1, pharmacokinetic, safety, ticagrelor
395813|NCT01887613|Gabapentin|gabapentin
395815|NCT01887600|chronic kidney disease (CKD)|chronic kidney disease (ckd)
395816|NCT01887600|Hemoglobin (Hb)|hemoglobin (hb)
395817|NCT01887600|non-dialysis|non-dialysis
395818|NCT01887548|Crohn's disease|crohn's disease
395819|NCT01887548|inflammatory bowel disease|inflammatory bowel disease
395820|NCT01887548|quality of life|quality of life
395821|NCT01887548|personality|personality
395822|NCT01887548|neuroticism|neuroticism
395823|NCT01887535|Healthy|healthy
395824|NCT01887535|Elderly|elderly
395825|NCT01887535|Safety|safety
395826|NCT01887535|Tolerability|tolerability
395827|NCT01887535|Pharmacokinetic|pharmacokinetic
395828|NCT01887535|Alzheimer's Disease|alzheimer's disease
395829|NCT01887535|JNJ-54861911|jnj-54861911
395830|NCT01887522|Children|children
395831|NCT01887522|Adolescents|adolescents
395832|NCT01887522|Young Adults|young adults
395833|NCT01887509|Rectal cancer|rectal cancer
395834|NCT01887509|Tumor margin|tumor margin
395835|NCT01887509|Confocal endomicroscopy|confocal endomicroscopy
395836|NCT01887509|Virtual biopsy|virtual biopsy
395837|NCT01887509|Fluorescein|fluorescein
395838|NCT01887496|Varicella|varicella
395839|NCT01887496|Turkey|turkey
395840|NCT01887496|hospitalization|hospitalization
395841|NCT01887496|varicella vaccine|varicella vaccine
395842|NCT01887483|IBS|ibs
395843|NCT01887483|bowel function|bowel function
395844|NCT01887483|probiotic|probiotic
395845|NCT01887470|Bowel Evacuation|bowel evacuation
395846|NCT01887470|Colonoscopy Preparation|colonoscopy preparation
395847|NCT01887457|voriconazole|voriconazole
395848|NCT01887457|VFEND|vfend
395849|NCT01887457|individualised|individualised
395850|NCT01887457|personalised|personalised
395851|NCT01887444|Pediatric Gastroenterology|pediatric gastroenterology
395852|NCT01887444|Probiotics|probiotics
395853|NCT01887444|Lactobacillus reuteri|lactobacillus reuteri
395854|NCT01887431|Diabetes Mellitus, Type 1|diabetes mellitus, type 1
395855|NCT01887431|Adult|adult
395856|NCT01887431|Insulin Infusion Systems|insulin infusion systems
395857|NCT01887431|Telecare|telecare
395858|NCT01887418|Hypogonadism|hypogonadism
395859|NCT01887418|Testosterone enanthate|testosterone enanthate
395860|NCT01887405|Adrenaline|adrenaline
395861|NCT01887405|Auto-injector|auto-injector
395862|NCT01887405|Jext|jext
395863|NCT01887405|Epipen|epipen
395864|NCT01887392|Long-term Care|long-term care
395865|NCT01887392|Knowledge Translation|knowledge translation
395866|NCT01887379|Gastroretentive drug formulation|gastroretentive drug formulation
395867|NCT01887379|Furosemide|furosemide
395868|NCT01887379|Magnetic Marker Monitoring|magnetic marker monitoring
395869|NCT01887379|Magnetic marker|magnetic marker
395870|NCT01887379|Oedema|oedema
395871|NCT01887366|Cocaine addiction|cocaine addiction
395872|NCT01887366|TV-1380|tv-1380
395873|NCT01887366|Recombinant human serum albumin (HSA) mutated butyrylcholinesterase (AlbuBChE)|recombinant human serum albumin (hsa) mutated butyrylcholinesterase (albubche)
395874|NCT01887353|atrial fibrillation|atrial fibrillation
395875|NCT01887353|heart failure|heart failure
395876|NCT01887353|ranolazine|ranolazine
395877|NCT01887353|cardioversion|cardioversion
395878|NCT01887353|persistent AF|persistent af
395879|NCT01887353|paroxysmal AF|paroxysmal af
395880|NCT01887327|G6PD deficiency|g6pd deficiency
395881|NCT01887327|Antibody (ABO) incompatibility|antibody (abo) incompatibility
395882|NCT01887327|Coombs positive ABO/ rhesus factor (RH) incompatibility|coombs positive abo/ rhesus factor (rh) incompatibility
395883|NCT01887327|Intensive phototherapy in neonates|intensive phototherapy in neonates
395884|NCT01887314|Cancer|cancer
395885|NCT01887314|Cisplatin|cisplatin
395886|NCT01887314|Nausea|nausea
395887|NCT01887314|Ginger|ginger
395888|NCT01887314|Zingiber officinale|zingiber officinale
395889|NCT01887314|5HT3|5ht3
395890|NCT01887314|Dexamethasone|dexamethasone
395891|NCT01887314|Neurokinin-1 (NK-1)|neurokinin-1 (nk-1)
395892|NCT01887314|Interleukin-6 (IL-6)|interleukin-6 (il-6)
395893|NCT01887314|Tumor necrosis factor-alpha (TNF-alpha)|tumor necrosis factor-alpha (tnf-alpha)
395894|NCT01887314|Insulin like growth factor-1 (IGF-1)|insulin like growth factor-1 (igf-1)
395895|NCT01887314|Placebo|placebo
395896|NCT01887314|FLIE|flie
395897|NCT01887314|BFI|bfi
395898|NCT01887275|Chronic hepatitis B|chronic hepatitis b
395899|NCT01887275|Medical Ozone|medical ozone
395900|NCT01887275|Interferon-α|interferon-α
395901|NCT01887275|Efficacy|efficacy
395902|NCT01887262|fluid|fluid
395903|NCT01887262|edema|edema
395904|NCT01887223|Encapsulated blebs|encapsulated blebs
395905|NCT01887223|trabeculectomy failure|trabeculectomy failure
395906|NCT01887223|glaucoma|glaucoma
395907|NCT01887210|HIV|hiv
395908|NCT01887210|youth|youth
395909|NCT01887210|medical adherence|medical adherence
395910|NCT01887197|cystic fibrosis|cystic fibrosis
395911|NCT01887197|mucociliary clearance|mucociliary clearance
395912|NCT01887197|airway surface liquid|airway surface liquid
395913|NCT01887197|nuclear medicine|nuclear medicine
395914|NCT01887197|mannitol|mannitol
395915|NCT01887171|Liver transplantation|liver transplantation
395916|NCT01887171|Early allograft dysfunction|early allograft dysfunction
395917|NCT01887171|Ischemic reperfusion injury|ischemic reperfusion injury
395918|NCT01887171|Portal and arterial ex vivo HTK flush|portal and arterial ex vivo htk flush
395919|NCT01887145|Carpal tunnel syndrome|carpal tunnel syndrome
395920|NCT01887145|Surgery|surgery
395921|NCT01887145|Outcomes|outcomes
395922|NCT01887132|Sleep Architecture|sleep architecture
395923|NCT01887132|Autism|autism
395924|NCT01887132|Language Development|language development
395925|NCT01887093|coronary artery disease|coronary artery disease
395926|NCT01887093|walking|walking
395927|NCT01887093|lipids|lipids
395928|NCT01887093|inflammatory markers|inflammatory markers
395929|NCT01887093|time of day|time of day
395930|NCT01887080|Cardiovascular rehabilitation home-based|cardiovascular rehabilitation home-based
395931|NCT01887080|Acute myocardial infarction|acute myocardial infarction
395932|NCT01887080|Obesity|obesity
395933|NCT01887080|Microcurrent|microcurrent
395934|NCT01887067|Hypertension|hypertension
395935|NCT01887067|Diabetes Mellitus|diabetes mellitus
395936|NCT01887041|Advanced, metastasising pancreatic head carcinoma|advanced, metastasising pancreatic head carcinoma
395937|NCT01887041|Jaundice|jaundice
395938|NCT01887041|Biliodigestive anastomosis|biliodigestive anastomosis
395939|NCT01887041|Endoscopically inserted biliary tract drainage|endoscopically inserted biliary tract drainage
395940|NCT01887041|Quality of Life|quality of life
395941|NCT01887028|Carbon deoxide pneumoperitoneum|carbon deoxide pneumoperitoneum
395942|NCT01887028|Intraperitoneal pressure|intraperitoneal pressure
395943|NCT01887028|Peritoneum|peritoneum
395944|NCT01887028|Gene expression|gene expression
395945|NCT01887028|Post-operative recovery|post-operative recovery
395946|NCT01887028|Laparoscopic Humidification System|laparoscopic humidification system
395947|NCT01887015|Postoperative pulmonary complications|postoperative pulmonary complications
395948|NCT01887015|Oxygen therapy|oxygen therapy
395949|NCT01887015|Nasal high flow oxygen therapy|nasal high flow oxygen therapy
395950|NCT01887015|Nasal high flow cannula|nasal high flow cannula
395951|NCT01887002|Irritable Bowel Syndrome|irritable bowel syndrome
395952|NCT01887002|IBS|ibs
395953|NCT01887002|ONO-2952|ono-2952
395954|NCT01886989|diabetes|diabetes
395955|NCT01886989|cocoa polyphenols|cocoa polyphenols
395956|NCT01886989|postprandial glycemia|postprandial glycemia
395957|NCT01886989|postprandial lipemia|postprandial lipemia
395958|NCT01886976|multiple myeloma|multiple myeloma
395959|NCT01886950|CKD stage 5|ckd stage 5
395960|NCT01886950|Bone histomorphometry|bone histomorphometry
395961|NCT01886950|Renal transplantation|renal transplantation
395962|NCT01886924|Tobacco|tobacco
395963|NCT01886924|Nicotine|nicotine
395964|NCT01886924|Dependence|dependence
395965|NCT01886924|Quitline|quitline
395966|NCT01886911|prosocial behavior|prosocial behavior
395967|NCT01886911|prosocial|prosocial
395968|NCT01886911|attention training|attention training
395969|NCT01886911|attention|attention
395970|NCT01886911|empathy|empathy
395971|NCT01886911|emotion recognition|emotion recognition
395972|NCT01886885|Mindfulness|mindfulness
395973|NCT01886885|Meditation|meditation
395974|NCT01886885|Chronic Pain|chronic pain
395975|NCT01886833|Rotavirus|rotavirus
395976|NCT01886833|Diarrhoea|diarrhoea
395977|NCT01886833|Immunisation|immunisation
395978|NCT01886833|Seroconversion|seroconversion
395979|NCT01886833|Breastmilk|breastmilk
395980|NCT01886833|HIV|hiv
395981|NCT01886833|Zinc|zinc
395982|NCT01886833|Vitamin A|vitamin a
395983|NCT01886833|Failure|failure
395984|NCT01886820|Dementia|dementia
395985|NCT01886820|Alzheimer's Disease|alzheimer's disease
395986|NCT01886820|Terminally Ill|terminally ill
395987|NCT01886794|pelvic floor dysfunction|pelvic floor dysfunction
395988|NCT01886794|pelvic organ prolapse|pelvic organ prolapse
395989|NCT01886794|vaginal estrogen effects|vaginal estrogen effects
395990|NCT01886781|only constipation and diarrhea predominant|only constipation and diarrhea predominant
395991|NCT01886781|no mixed or alternating types|no mixed or alternating types
395992|NCT01886768|Nasal anesthesia|nasal anesthesia
395993|NCT01886768|endoscopes|endoscopes
395994|NCT01886768|transnasal endoscopy|transnasal endoscopy
395995|NCT01886755|Acute gastroenteritis|acute gastroenteritis
395996|NCT01886755|Probiotics|probiotics
395997|NCT01886755|Lactobacillus reuteri|lactobacillus reuteri
395998|NCT01886755|Zinc supplementation|zinc supplementation
395999|NCT01886755|Infants|infants
396000|NCT01886755|Age 6 months to 36 months|age 6 months to 36 months
396001|NCT01886742|Perioperative antibiotic prophylaxis|perioperative antibiotic prophylaxis
396002|NCT01886742|Morbidly Obese|morbidly obese
396003|NCT01886729|transcranial direct current stimulation|transcranial direct current stimulation
396004|NCT01886729|time shift|time shift
396005|NCT01886716|Alcohol Abuse|alcohol abuse
396006|NCT01886716|Alcohol Dependence|alcohol dependence
396007|NCT01886716|Alcohol Drinking|alcohol drinking
396008|NCT01886716|Social Anxiety|social anxiety
396009|NCT01886716|Social Phobia|social phobia
396010|NCT01886716|Anxiety Disorders|anxiety disorders
396011|NCT01886703|Physical activity|physical activity
396012|NCT01886703|Exercise|exercise
396013|NCT01886703|Quality of Life|quality of life
396014|NCT01886703|Radiation Therapy|radiation therapy
396015|NCT01886703|Breast Cancer|breast cancer
396016|NCT01886703|Head and Neck Cancer|head and neck cancer
396017|NCT01886677|prostate cancer|prostate cancer
396018|NCT01886677|intervention|intervention
396019|NCT01886677|diet|diet
396020|NCT01886677|physical activity|physical activity
396021|NCT01886677|exercise|exercise
396022|NCT01886677|weight loss|weight loss
396023|NCT01886677|biomarkers|biomarkers
396024|NCT01886677|cancer progression|cancer progression
396025|NCT01886651|acute lymphoblastic leukemia|acute lymphoblastic leukemia
396026|NCT01886651|child|child
396027|NCT01886651|6-mercaptopurine|6-mercaptopurine
396028|NCT01886651|methotrexate|methotrexate
396029|NCT01886638|Platelets|platelets
396030|NCT01886638|HIV|hiv
396031|NCT01886638|Cardiovascular disease|cardiovascular disease
396032|NCT01886638|Acute myocardial infarction|acute myocardial infarction
396033|NCT01886638|Abacavir|abacavir
396034|NCT01886638|Antiretrovirals|antiretrovirals
396035|NCT01886612|Deep Vein Thrombosis|deep vein thrombosis
396036|NCT01886612|Neuromuscular Electrical Stimulation|neuromuscular electrical stimulation
396037|NCT01886612|Intermittent Pneumatic Compression|intermittent pneumatic compression
396038|NCT01886612|Doppler Ultrasound|doppler ultrasound
396039|NCT01886586|Mild Cognitive Impairment|mild cognitive impairment
396040|NCT01886586|memory impairment|memory impairment
396041|NCT01886586|problem-solving therapy|problem-solving therapy
396042|NCT01886586|depression prevention|depression prevention
396043|NCT01886586|caregiver stress|caregiver stress
396044|NCT01886586|exercise|exercise
396045|NCT01886534|Heart failure|heart failure
396046|NCT01886534|Heart diseases|heart diseases
396047|NCT01886534|Cardiovascular diseases|cardiovascular diseases
396048|NCT01886534|Health information technology|health information technology
396049|NCT01886534|Disease management|disease management
396050|NCT01886534|Patient care management|patient care management
396051|NCT01886534|Self care|self care
396052|NCT01886534|Informal caregiver|informal caregiver
396053|NCT01886534|Care partner|care partner
396054|NCT01886534|Peer support|peer support
396055|NCT01886534|Transitional care|transitional care
396056|NCT01886534|Patient education|patient education
396057|NCT01886534|Teach-back|teach-back
396058|NCT01886534|Clinical decision aid|clinical decision aid
396059|NCT01886443|Liver|liver
396060|NCT01886443|Transplantation|transplantation
396061|NCT01886443|Ischemia-reperfusion|ischemia-reperfusion
396062|NCT01886443|Safety|safety
396063|NCT01886404|HIV|hiv
396064|NCT01886404|efavirenz|efavirenz
396065|NCT01886404|Sustiva|sustiva
396066|NCT01886404|pharmacokinetics|pharmacokinetics
396067|NCT01886404|Pharmacogenomics|pharmacogenomics
396068|NCT01886391|Heart Failure|heart failure
396069|NCT01886391|Dyspnea|dyspnea
396070|NCT01886391|Diaphragmatic breathing retraining|diaphragmatic breathing retraining
396071|NCT01886391|Fatigue|fatigue
396072|NCT01886391|Health-related Outcomes|health-related outcomes
396073|NCT01886378|FAOD|faod
396074|NCT01886378|VLCAD|vlcad
396075|NCT01886378|CPT II|cpt ii
396076|NCT01886378|CPT2|cpt2
396077|NCT01886378|CPT 2|cpt 2
396078|NCT01886378|LCHAD|lchad
396079|NCT01886378|UX007|ux007
396080|NCT01886378|Triheptanoin|triheptanoin
396081|NCT01886378|TFP|tfp
396082|NCT01886378|C7|c7
396083|NCT01886365|Computer based glycemic control, insulin, blood glucose|computer based glycemic control, insulin, blood glucose
396084|NCT01886352|laparoscopic|laparoscopic
396085|NCT01886352|pain|pain
396086|NCT01886326|Obesity|obesity
396087|NCT01886326|energy balance|energy balance
396088|NCT01886326|variety|variety
396089|NCT01886326|nut intake|nut intake
396090|NCT01886313|Herpes Zoster|herpes zoster
396091|NCT01886313|Postherpetic Neuralgia|postherpetic neuralgia
396092|NCT01886313|Shingles|shingles
396093|NCT01886313|Civamide|civamide
396094|NCT01886313|Zucapsaicin|zucapsaicin
396095|NCT01886313|Neuropeptides|neuropeptides
396096|NCT01886313|TRPV-1|trpv-1
396097|NCT01886287|endocrine system|endocrine system
396098|NCT01886287|neuroendocrine tumors|neuroendocrine tumors
396099|NCT01886287|neuroendocrine cancer|neuroendocrine cancer
396100|NCT01886287|metastatic|metastatic
396101|NCT01886287|neuroendocrine|neuroendocrine
396102|NCT01886287|gastrointestinal (GI)|gastrointestinal (gi)
396103|NCT01886287|high-dose octreotide|high-dose octreotide
396104|NCT01886287|flushing|flushing
396105|NCT01886287|diarrhea|diarrhea
396106|NCT01886287|quality of life in patients|quality of life in patients
396107|NCT01886287|disease-related symptoms|disease-related symptoms
396108|NCT01886274|EEG|eeg
396109|NCT01886274|migraine|migraine
396110|NCT01886274|pain|pain
396111|NCT01886274|phosphene|phosphene
396112|NCT01886274|tDCs|tdcs
396113|NCT01886274|TMS|tms
396114|NCT01886261|validation|validation
396115|NCT01886261|physical activity|physical activity
396116|NCT01886261|place-based interventions|place-based interventions
396117|NCT01886261|construct validity|construct validity
396118|NCT01886261|divergent validity|divergent validity
396119|NCT01886261|usability|usability
396120|NCT01886261|gps|gps
396121|NCT01886261|PALMS|palms
396122|NCT01886248|hepatic veno-occlusive disease after hematopoietic stem cell transplantation|hepatic veno-occlusive disease after hematopoietic stem cell transplantation
396123|NCT01886222|Traumatic brain injury|traumatic brain injury
396124|NCT01886196|elderly|elderly
396125|NCT01886196|women|women
396126|NCT01886196|exercise|exercise
396127|NCT01886196|pQCT|pqct
396128|NCT01886196|ibuprofen|ibuprofen
396129|NCT01886183|Postural Balance|postural balance
396130|NCT01886183|Virtual Reality Exposure Therapy|virtual reality exposure therapy
396131|NCT01886183|Gait|gait
396132|NCT01886183|Stroke|stroke
396133|NCT01886170|Adults with self-reported diagnosis of diabetes recruited from waiting rooms at outpatient primary care sites at the University of Pennsylvania|adults with self-reported diagnosis of diabetes recruited from waiting rooms at outpatient primary care sites at the university of pennsylvania
396134|NCT01886157|trigger finger|trigger finger
396135|NCT01886157|orthotic intervention|orthotic intervention
396136|NCT01886144|OA|oa
396137|NCT01886144|arthritis|arthritis
396138|NCT01886144|knee OA|knee oa
396139|NCT01886131|REM behaviour disorder|rem behaviour disorder
396140|NCT01886131|Subthalamic nucleus|subthalamic nucleus
396141|NCT01886131|Local field potential|local field potential
396142|NCT01886131|Motor control|motor control
396143|NCT01886118|In vitro fertilization|in vitro fertilization
396144|NCT01886118|Autologous Endometrial Co-Culture|autologous endometrial co-culture
396145|NCT01886105|Osteosarcoma|osteosarcoma
396146|NCT01886105|Osteogenic Sarcoma|osteogenic sarcoma
396147|NCT01886105|Sarcoma|sarcoma
396148|NCT01886105|Bone Cancer|bone cancer
396149|NCT01886092|tinnitus|tinnitus
396150|NCT01886027|IBS|ibs
396151|NCT01886027|Relaxation|relaxation
396152|NCT01886027|Emotional exposure|emotional exposure
396153|NCT01886027|Emotional Processing|emotional processing
396154|NCT01886014|pain|pain
396155|NCT01886014|pain modulation|pain modulation
396156|NCT01886014|placebo analgesia|placebo analgesia
396157|NCT01886001|Newborn Intensive Care Unit|newborn intensive care unit
396158|NCT01886001|Neonatal Intensive Care Unit|neonatal intensive care unit
396159|NCT01886001|Colonization|colonization
396160|NCT01886001|Line Colonization|line colonization
396161|NCT01886001|Umbilical line|umbilical line
396162|NCT01886001|Umbilical Cord Care|umbilical cord care
396163|NCT01885988|Erectile dysfunction|erectile dysfunction
396164|NCT01885975|Apical Ballooning syndrome|apical ballooning syndrome
396165|NCT01885975|Personality|personality
396166|NCT01885962|pressure ulcer prevention|pressure ulcer prevention
396167|NCT01885962|spinal cord injury|spinal cord injury
396290|NCT01885377|Primary care|primary care
396264|NCT01885481|betamethasone|betamethasone
396168|NCT01885962|internet delivered pressure ulcer intervention|internet delivered pressure ulcer intervention
396169|NCT01885949|Metastatic|metastatic
396170|NCT01885936|LOPD|lopd
396171|NCT01885936|Pompe Disease|pompe disease
396172|NCT01885923|schizophrenia; relapse prevention; information technology|schizophrenia; relapse prevention; information technology
396173|NCT01885897|Acute myelogenous leukemia (AML)|acute myelogenous leukemia (aml)
396174|NCT01885897|Acute lymphoblastic leukemia (ALL)|acute lymphoblastic leukemia (all)
396175|NCT01885897|Myelodysplastic syndromes (MDS)|myelodysplastic syndromes (mds)
396176|NCT01885897|Lymphoma|lymphoma
396177|NCT01885897|Myeloma|myeloma
396178|NCT01885897|Chronic Lymphocytic Leukemia (CLL)|chronic lymphocytic leukemia (cll)
396179|NCT01885897|Chronic myelogenous leukemia (CML)|chronic myelogenous leukemia (cml)
396180|NCT01885884|Supportive Care|supportive care
396181|NCT01885884|Palliative Care|palliative care
396182|NCT01885884|Pancreatic Cancer|pancreatic cancer
396183|NCT01885884|Embedded, coordinated model of supportive care within oncology care|embedded, coordinated model of supportive care within oncology care
396184|NCT01885884|Patient and Caregiver support|patient and caregiver support
396185|NCT01885871|Sun|sun
396186|NCT01885871|Age|age
396187|NCT01885871|Spot|spot
396188|NCT01885858|health services research|health services research
396189|NCT01885858|family planning|family planning
396190|NCT01885858|ethnicity|ethnicity
396191|NCT01885858|healthcare disparities|healthcare disparities
396192|NCT01885845|postpartum blood loss measurement|postpartum blood loss measurement
506843|NCT01403766|GFR|gfr
396193|NCT01885845|BRASSS-V drape|brasss-v drape
396194|NCT01885832|autologous adipose stem cells|autologous adipose stem cells
396195|NCT01885832|stromal vascular fraction|stromal vascular fraction
396196|NCT01885832|osteoarthritis|osteoarthritis
396197|NCT01885819|Adipose stromal vascular fraction|adipose stromal vascular fraction
396198|NCT01885819|Rheumatoid arthritis|rheumatoid arthritis
396199|NCT01885819|adult stem cells|adult stem cells
396200|NCT01885806|Apathy; Alzheimer's disease; Cognition; Burden of Care|apathy; alzheimer's disease; cognition; burden of care
396201|NCT01885780|Astigmatism, arcuate incisions, astigmatic keratotomy|astigmatism, arcuate incisions, astigmatic keratotomy
396202|NCT01885767|Neurofibromatosis|neurofibromatosis
396203|NCT01885767|NF|nf
396204|NCT01885767|Neurofibromatosis 1|neurofibromatosis 1
396205|NCT01885767|NF1|nf1
396206|NCT01885767|Neurofibromatosis 2|neurofibromatosis 2
396207|NCT01885767|NF2|nf2
396208|NCT01885767|Schwannomatosis|schwannomatosis
396209|NCT01885754|Biopsy|biopsy
396210|NCT01885754|Maximal incremental cardiopulmonary test|maximal incremental cardiopulmonary test
396211|NCT01885754|Muscle strength test|muscle strength test
396212|NCT01885754|magnetic stimulation|magnetic stimulation
396213|NCT01885702|Dendritic cell vaccination|dendritic cell vaccination
396214|NCT01885702|MSI-high colorectal cancer (CRC)|msi-high colorectal cancer (crc)
396215|NCT01885702|Vaccines|vaccines
396216|NCT01885702|Immunotherapy|immunotherapy
396217|NCT01885702|CRC|crc
396218|NCT01885702|Germline MMR-gene mutation without disease criteria of CRC|germline mmr-gene mutation without disease criteria of crc
396219|NCT01885663|Umbilical cord blood|umbilical cord blood
396220|NCT01885663|Acquired brain injury|acquired brain injury
396221|NCT01885650|Non invasive ventilation|non invasive ventilation
396222|NCT01885650|Chest physiotherapy|chest physiotherapy
396223|NCT01885650|Airway clearance|airway clearance
396224|NCT01885637|Palliative|palliative
396225|NCT01885637|Palliation|palliation
396226|NCT01885637|Cancer|cancer
396227|NCT01885637|Care|care
396228|NCT01885637|SPC|spc
396229|NCT01885637|Caregivers|caregivers
396230|NCT01885637|Home Care Services, Hospital-Based|home care services, hospital-based
396231|NCT01885637|Psychological|psychological
396232|NCT01885637|From Oncological Treatment to Palliative Care at Home|from oncological treatment to palliative care at home
396233|NCT01885637|Place of death|place of death
396234|NCT01885624|TAB08|tab08
396235|NCT01885624|healthy volunteers|healthy volunteers
396236|NCT01885611|Leprosy|leprosy
396237|NCT01885572|breast reconstruction|breast reconstruction
396238|NCT01885572|mastectomy|mastectomy
396239|NCT01885572|mesh|mesh
396240|NCT01885572|breast cancer|breast cancer
396241|NCT01885559|polycystic kidney disease|polycystic kidney disease
396242|NCT01885559|polycystic|polycystic
396243|NCT01885559|kidney|kidney
396244|NCT01885559|disease|disease
396245|NCT01885559|adpkd|adpkd
396246|NCT01885559|halt|halt
396247|NCT01885559|pkd|pkd
396248|NCT01885559|blood pressure|blood pressure
396249|NCT01885559|bp|bp
396250|NCT01885559|hypertension|hypertension
396251|NCT01885559|renal|renal
396252|NCT01885559|renin-angiotensin-aldosterone-system|renin-angiotensin-aldosterone-system
396253|NCT01885559|RAAS|raas
396254|NCT01885546|diabetes|diabetes
396255|NCT01885546|glucose|glucose
396256|NCT01885546|glucometer|glucometer
396257|NCT01885533|Graves' disease|graves' disease
396258|NCT01885533|radioiodine|radioiodine
396259|NCT01885533|thyroid|thyroid
396260|NCT01885533|hypothyroidism|hypothyroidism
396261|NCT01885533|Graves' orbitopathy|graves' orbitopathy
396262|NCT01885520|low back pain|low back pain
396263|NCT01885481|dexamethasone|dexamethasone
396265|NCT01885481|epidural steroid injection|epidural steroid injection
396266|NCT01885481|comparative effectiveness research|comparative effectiveness research
396267|NCT01885468|Hydrocephalus shunt|hydrocephalus shunt
396268|NCT01885468|proGAV|progav
396269|NCT01885455|non-small cell lung cancer (NSCLC)|non-small cell lung cancer (nsclc)
396270|NCT01885442|mechanical ventilation|mechanical ventilation
396271|NCT01885442|cycle ergometry|cycle ergometry
396272|NCT01885442|intensive care unit|intensive care unit
396273|NCT01885442|rehabilitation|rehabilitation
396274|NCT01885429|Protein Turnover|protein turnover
396275|NCT01885429|Resistance Exercise|resistance exercise
396276|NCT01885429|Whey Protein|whey protein
396277|NCT01885429|Leucine|leucine
396278|NCT01885403|Acute Cardiogenic Pulmonary Edema,|acute cardiogenic pulmonary edema,
396279|NCT01885403|Acute Decompensated Heart Failure,|acute decompensated heart failure,
396280|NCT01885403|BiLevel Positive Airway Pressure,|bilevel positive airway pressure,
396281|NCT01885403|Continuous Positive Airway Pressure|continuous positive airway pressure
396282|NCT01885390|Hypertension|hypertension
396283|NCT01885390|High blood pressure|high blood pressure
396284|NCT01885390|Resistant blood pressure|resistant blood pressure
396285|NCT01885390|Uncontrolled blood pressure|uncontrolled blood pressure
396286|NCT01885377|Subacromial pain|subacromial pain
396287|NCT01885377|Impingement|impingement
396288|NCT01885377|Exercises|exercises
396289|NCT01885377|Physical therapy|physical therapy
396291|NCT01885364|esmolol|esmolol
396292|NCT01885364|pain|pain
396293|NCT01885364|propofol|propofol
396294|NCT01885364|remifentanil|remifentanil
396295|NCT01885351|Colorectal Cancer Screening|colorectal cancer screening
396296|NCT01885351|Ambulatory Care|ambulatory care
396297|NCT01885351|Patient-Centered Care|patient-centered care
396298|NCT01885351|Intervention Studies|intervention studies
396299|NCT01885351|Longitudinal Studies|longitudinal studies
396300|NCT01885338|Schizophrenia|schizophrenia
396301|NCT01885338|Cognition|cognition
396302|NCT01885338|Neurocognition|neurocognition
396303|NCT01885338|N-Acetylcysteine|n-acetylcysteine
396304|NCT01885338|NAC|nac
396305|NCT01885338|EEG|eeg
396306|NCT01885325|Physical Activity|physical activity
396307|NCT01885325|Sedentary Behavior|sedentary behavior
396308|NCT01885325|Preschool Children|preschool children
396309|NCT01885312|Drinking|drinking
396310|NCT01885312|Heavy Drinking|heavy drinking
396311|NCT01885312|Technology|technology
396312|NCT01885312|Mobile Phone|mobile phone
396313|NCT01885312|Text Message|text message
396314|NCT01885312|Problem Drinking|problem drinking
396315|NCT01885312|Alcohol Problems|alcohol problems
396316|NCT01885312|Alcoholism|alcoholism
396317|NCT01885312|Moderation-Oriented Treatment|moderation-oriented treatment
396318|NCT01885312|Controlled Drinking|controlled drinking
396319|NCT01885312|Reduced Drinking|reduced drinking
396320|NCT01885299|Radiosurgery|radiosurgery
396321|NCT01885299|CyberKnife|cyberknife
396322|NCT01885299|Benign tumors|benign tumors
396323|NCT01885299|Malignant tumors|malignant tumors
396324|NCT01885299|Cranial tumors|cranial tumors
396325|NCT01885299|Extracranial tumors|extracranial tumors
396326|NCT01885299|Lung|lung
396327|NCT01885299|Liver|liver
396328|NCT01885299|Pancreas|pancreas
396329|NCT01885299|Prostate|prostate
396330|NCT01885299|Stereotactic radiosurgery|stereotactic radiosurgery
396331|NCT01885299|Stereotactic body radiotherapy|stereotactic body radiotherapy
396332|NCT01885286|circumcision|circumcision
396333|NCT01885286|HIV prevention|hiv prevention
396334|NCT01885273|pressurized irrigation|pressurized irrigation
396335|NCT01885273|wound cleansing method|wound cleansing method
396336|NCT01885273|irrigation|irrigation
396337|NCT01885273|swabbing|swabbing
396338|NCT01885273|appropriate pressure for irrigation|appropriate pressure for irrigation
396339|NCT01885260|Type 2 Diabetes Mellitus|type 2 diabetes mellitus
396340|NCT01885260|T2DM|t2dm
396341|NCT01885234|Glycated hemoglobin|glycated hemoglobin
396342|NCT01885234|HOMA|homa
396343|NCT01885234|Pregnancy|pregnancy
396344|NCT01885234|aerobic exercise|aerobic exercise
396345|NCT01885221|smokeless tobacco cessation|smokeless tobacco cessation
396346|NCT01885221|social support|social support
396347|NCT01885221|partner support|partner support
396348|NCT01885195|RAS, RAF, MEK, NF1, MEK162, signature, papillary thyroid, small intestine, bladder, esophagus, lung cancer, NSCLC, acute myelogenous leukemia, AML|ras, raf, mek, nf1, mek162, signature, papillary thyroid, small intestine, bladder, esophagus, lung cancer, nsclc, acute myelogenous leukemia, aml
396349|NCT01885169|Cystic fibrosis|cystic fibrosis
396350|NCT01885169|Influenza|influenza
396351|NCT01885169|Vaccine|vaccine
396352|NCT01885143|Mammography|mammography
396353|NCT01885117|Influenza,|influenza,
396354|NCT01885117|Adults,|adults,
396355|NCT01885117|Elderly,|elderly,
396356|NCT01885117|Immunology,|immunology,
396357|NCT01885117|Safety|safety
396358|NCT01885052|Smoking Cessation Clinical Trial|smoking cessation clinical trial
396359|NCT01885052|Text Messaging Program|text messaging program
396360|NCT01885052|Smoking Cessation Aid|smoking cessation aid
396361|NCT01885039|Cancer|cancer
396362|NCT01885039|Breast Cancer|breast cancer
396463|NCT01884519|Influenza|influenza
396363|NCT01885039|Molecular Subtypes|molecular subtypes
396364|NCT01885039|Asian Breast Cancer|asian breast cancer
396365|NCT01885026|Randomized Controlled Trial|randomized controlled trial
396367|NCT01885026|Drugs|drugs
396368|NCT01885026|Internet|internet
396369|NCT01885026|Screening|screening
396370|NCT01885026|Brief intervention|brief intervention
396371|NCT01885013|HER2 negative|her2 negative
396372|NCT01885013|metastatic breast cancer|metastatic breast cancer
396373|NCT01885013|non endocrine responsive disease|non endocrine responsive disease
396374|NCT01884974|Myeloproliferative disease|myeloproliferative disease
396375|NCT01884974|Pulmonary Hypertension|pulmonary hypertension
396376|NCT01884948|at least 1 segment|at least 1 segment
396377|NCT01884948|multiple wedge resections (≥3)|multiple wedge resections (≥3)
396378|NCT01884935|Pediatric|pediatric
396379|NCT01884922|Children|children
396380|NCT01884922|adolescents|adolescents
396381|NCT01884922|young adults|young adults
396382|NCT01884870|Asymptomatic|asymptomatic
396383|NCT01884870|ureteral|ureteral
396384|NCT01884870|calculi|calculi
396385|NCT01884870|renal function|renal function
396386|NCT01884870|treatment|treatment
396387|NCT01884831|damage to the skin, the skin equivalent, cell therapy|damage to the skin, the skin equivalent, cell therapy
396388|NCT01884818|Thoracic spine, pain, manipulation|thoracic spine, pain, manipulation
396389|NCT01884805|Adaptive Optics Visual Simulator|adaptive optics visual simulator
396390|NCT01884805|Wavefront aberrometer|wavefront aberrometer
396391|NCT01884805|Optical Aberrations|optical aberrations
396392|NCT01884805|Hyperopia|hyperopia
396393|NCT01884792|prediabetes|prediabetes
396394|NCT01884792|physical inactivity|physical inactivity
396395|NCT01884792|sedentary|sedentary
396396|NCT01884792|standing|standing
396397|NCT01884779|HIV|hiv
396398|NCT01884779|Histoplasmosis|histoplasmosis
396399|NCT01884779|Histoplasma capsulatum var.capsulatum|histoplasma capsulatum var.capsulatum
396400|NCT01884779|ELISA test|elisa test
396401|NCT01884753|lower urinary tract symptoms|lower urinary tract symptoms
396402|NCT01884753|overactive bladder syndrome|overactive bladder syndrome
396403|NCT01884753|antimuscarinic drug|antimuscarinic drug
396404|NCT01884753|three-dimensional power Doppler ultrasound|three-dimensional power doppler ultrasound
396405|NCT01884753|sexual dysfunction|sexual dysfunction
396406|NCT01884740|GBM|gbm
396407|NCT01884740|AA|aa
396408|NCT01884740|FA|fa
396409|NCT01884740|PXA|pxa
396410|NCT01884740|AOA|aoa
396411|NCT01884740|High grade glioma|high grade glioma
396412|NCT01884727|Obesity|obesity
396413|NCT01884727|Overweight|overweight
396414|NCT01884727|Over nutrition|over nutrition
396415|NCT01884727|nutrition disorders|nutrition disorders
396416|NCT01884727|energy expenditure|energy expenditure
396417|NCT01884727|metabolic rate|metabolic rate
396418|NCT01884714|diabetes|diabetes
396419|NCT01884714|obesity|obesity
396420|NCT01884714|metabolism|metabolism
396421|NCT01884714|clinical study|clinical study
396422|NCT01884701|Chronic Total Occlusion CTO|chronic total occlusion cto
396423|NCT01884688|Asymptomatic Multiple Myeloma|asymptomatic multiple myeloma
396424|NCT01884688|Auto-ENK Cell Therapy|auto-enk cell therapy
396425|NCT01884688|Natural Killer Cells|natural killer cells
396426|NCT01884675|Endothelin Receptor Antagonist|endothelin receptor antagonist
396427|NCT01884675|Inoperable Chronic Thromboembolic Pulmonary Hypertension|inoperable chronic thromboembolic pulmonary hypertension
396428|NCT01884662|spinal cord injury|spinal cord injury
396429|NCT01884662|neuropathic pain|neuropathic pain
396430|NCT01884649|Acute phase reactant, fetuin A, Hashimoto thyroiditis|acute phase reactant, fetuin a, hashimoto thyroiditis
396431|NCT01884636|Isavuconazole|isavuconazole
396432|NCT01884636|Pharmacokinetics|pharmacokinetics
396433|NCT01884636|Healthy Subjects|healthy subjects
396434|NCT01884636|BAL8557|bal8557
396435|NCT01884636|BAL4815|bal4815
396436|NCT01884636|methotrexate|methotrexate
396437|NCT01884597|PEARL2|pearl2
396439|NCT01884597|Polypoidal Choroidal Vasculopathy|polypoidal choroidal vasculopathy
396440|NCT01884571|Immunosuppression|immunosuppression
396441|NCT01884571|ALS|als
396442|NCT01884571|Neuromuscular Disorders|neuromuscular disorders
396443|NCT01884558|Isavuconazole|isavuconazole
396444|NCT01884558|Pharmacokinetics|pharmacokinetics
396445|NCT01884558|Healthy Subjects|healthy subjects
396446|NCT01884558|BAL8557|bal8557
396447|NCT01884558|BAL4815|bal4815
396448|NCT01884558|metformin|metformin
396449|NCT01884545|heart disease|heart disease
396450|NCT01884545|type 2 diabetes|type 2 diabetes
396451|NCT01884545|genetic testing|genetic testing
396452|NCT01884545|health coaching|health coaching
396453|NCT01884545|risk assessment|risk assessment
396454|NCT01884532|Adverse Local Tissue Reaction|adverse local tissue reaction
396455|NCT01884532|Metal Ions|metal ions
396456|NCT01884532|Serum|serum
396457|NCT01884532|Whole Blood|whole blood
396458|NCT01884532|Metal-on-Metal|metal-on-metal
396459|NCT01884532|Total Hip Arthroplasty|total hip arthroplasty
396460|NCT01884532|ASR-XL Metal-on-Metal|asr-xl metal-on-metal
396461|NCT01884532|Revised ASR-XL Metal-on-Metal|revised asr-xl metal-on-metal
396462|NCT01884519|Elderly|elderly
396464|NCT01884519|Safety|safety
396465|NCT01884519|Adults|adults
396466|NCT01884519|Immunogenicity|immunogenicity
396467|NCT01884493|Parkinson's Disease|parkinson's disease
396468|NCT01884493|Freezing of Gait|freezing of gait
396469|NCT01884493|movement-related cortical potential|movement-related cortical potential
396470|NCT01884493|repetitive transcranial magnetic stimulation|repetitive transcranial magnetic stimulation
396471|NCT01884480|Advagraf, pharmacogenetics, Cyp3A5|advagraf, pharmacogenetics, cyp3a5
396472|NCT01884467|Urinary Tract Infections|urinary tract infections
396473|NCT01884467|Gentamicin|gentamicin
396474|NCT01884454|sleep|sleep
396475|NCT01884454|obstructive sleep apnea|obstructive sleep apnea
396476|NCT01884454|reproduction|reproduction
396477|NCT01884454|sperm|sperm
396478|NCT01884454|hormones|hormones
396479|NCT01884454|men|men
396480|NCT01884441|Hodgkin|hodgkin
396481|NCT01884441|Lymphoma|lymphoma
396482|NCT01884441|refractory|refractory
396483|NCT01884441|relapsed|relapsed
396484|NCT01884428|Hodgkin|hodgkin
396485|NCT01884428|Lymphoma|lymphoma
396486|NCT01884389|HIV|hiv
396487|NCT01884389|Chronic disease|chronic disease
396488|NCT01884389|Early palliative care|early palliative care
396489|NCT01884389|Patient navigation|patient navigation
396490|NCT01884376|nerve biopsy|nerve biopsy
396491|NCT01884376|nerve regeneration|nerve regeneration
396492|NCT01884376|neuroma pain|neuroma pain
396493|NCT01884376|loss of sensation|loss of sensation
396494|NCT01884363|Endothelial function|endothelial function
396495|NCT01884363|walnuts|walnuts
396496|NCT01884363|clinical trial|clinical trial
396497|NCT01884363|Nutrition|nutrition
396498|NCT01884363|cardiovascular disease|cardiovascular disease
396499|NCT01884324|Gastroschisis|gastroschisis
396500|NCT01884324|Cesarean delivery|cesarean delivery
396501|NCT01884324|Neonatal outcomes|neonatal outcomes
396502|NCT01884311|Primary Immune Deficiency Disorders|primary immune deficiency disorders
396503|NCT01884311|Common Variable Immunodeficiency|common variable immunodeficiency
396504|NCT01884311|X-linked agammaglobulinaemia|x-linked agammaglobulinaemia
396505|NCT01884311|Hyper-IgM Syndrome|hyper-igm syndrome
396506|NCT01884311|Subcutaneous|subcutaneous
396507|NCT01884311|Immunoglobulins|immunoglobulins
396508|NCT01884298|remifentanil|remifentanil
396509|NCT01884298|isolated systolic hypertension|isolated systolic hypertension
396510|NCT01884298|morbidity|morbidity
396511|NCT01884298|epidural combined general anesthesia|epidural combined general anesthesia
396512|NCT01884285|Advanced Castrate-resistant Prostate Cancer(CRPC)|advanced castrate-resistant prostate cancer(crpc)
396513|NCT01884285|Squamous Non-Small Cell Lung Cancer(sqNSCLC)|squamous non-small cell lung cancer(sqnsclc)
396514|NCT01884285|Triple Negative Breast Cancer(TNBC)|triple negative breast cancer(tnbc)
396515|NCT01884285|PTEN-deficient/mutated Advanced Solid Malignancies|pten-deficient/mutated advanced solid malignancies
396516|NCT01884285|PIK3CB mutated/amplified advanced solid malignancies|pik3cb mutated/amplified advanced solid malignancies
396517|NCT01884259|local advanced squamous cell carcinoma|local advanced squamous cell carcinoma
396518|NCT01884259|Larynx|larynx
396519|NCT01884259|Hypopharynx|hypopharynx
396520|NCT01884259|Oropharynx|oropharynx
396521|NCT01884259|Cavum oris|cavum oris
396522|NCT01884259|docetaxel|docetaxel
396523|NCT01884259|cisplatin|cisplatin
396524|NCT01884259|5-fluorouracil|5-fluorouracil
396525|NCT01884259|Cetuximab|cetuximab
396526|NCT01884246|lifestyle change|lifestyle change
396527|NCT01884246|behavior change|behavior change
396528|NCT01884246|obesity|obesity
396529|NCT01884246|hypertension|hypertension
396530|NCT01884246|hyperlipidemia|hyperlipidemia
396531|NCT01884246|physical inactivity|physical inactivity
396532|NCT01884246|depression|depression
396533|NCT01884233|HIV|hiv
396534|NCT01884233|Opioid Abuse|opioid abuse
396535|NCT01884233|Mobile technology|mobile technology
396536|NCT01884220|Wolman Disease|wolman disease
396537|NCT01884220|Cholesteryl Ester Storage Disease|cholesteryl ester storage disease
396538|NCT01884220|Enzyme deficiency|enzyme deficiency
396539|NCT01884220|Natural History|natural history
396540|NCT01884220|Medical Records Review|medical records review
396541|NCT01884194|retinoblastoma|retinoblastoma
396542|NCT01884194|pineoblastoma|pineoblastoma
396543|NCT01884181|Huntington Disease, diffusion MRI, diagnosis, fast imaging|huntington disease, diffusion mri, diagnosis, fast imaging
396544|NCT01884129|Circulating tumor cells|circulating tumor cells
396545|NCT01884129|Head and neck cancer|head and neck cancer
396546|NCT01884129|Squamous cell carcinoma|squamous cell carcinoma
396547|NCT01884129|Survival|survival
396548|NCT01884129|Prognosis|prognosis
396549|NCT01884116|Capsaicin|capsaicin
396550|NCT01884116|myofascial pain syndrome|myofascial pain syndrome
396551|NCT01884116|non-steroidal anti-inflammatory agents|non-steroidal anti-inflammatory agents
396552|NCT01884116|transcutaneous electric nerve stimulation|transcutaneous electric nerve stimulation
396553|NCT01884103|TBI|tbi
396554|NCT01884103|Trauma|trauma
396555|NCT01884103|Traumatic Brain Injury|traumatic brain injury
396556|NCT01884090|Empowerment|empowerment
396557|NCT01884090|Youth|youth
396558|NCT01884090|Violence|violence
396559|NCT01884090|Community|community
396560|NCT01884090|Prevention|prevention
396561|NCT01884077|patient outcomes two years after shoulder replacement|patient outcomes two years after shoulder replacement
396562|NCT01884077|seventy years of age and older|seventy years of age and older
396563|NCT01884064|focal hand dystonia|focal hand dystonia
396564|NCT01884064|rehabilitation|rehabilitation
396565|NCT01884064|rTMS|rtms
396566|NCT01884064|writer's cramp|writer's cramp
396567|NCT01884064|clinical|clinical
396568|NCT01884051|Pulmonary arterial hypertension|pulmonary arterial hypertension
396569|NCT01884038|Liver Transplant|liver transplant
396570|NCT01884038|Prostacyclin|prostacyclin
396571|NCT01884038|Treprostinil sodium|treprostinil sodium
396572|NCT01884038|Remodulin|remodulin
396573|NCT01884038|Reperfusion Injury|reperfusion injury
396574|NCT01884038|Primary Nonfunction|primary nonfunction
396575|NCT01884025|patient centered care|patient centered care
396576|NCT01884025|physical activity|physical activity
396577|NCT01884025|behavioral activation|behavioral activation
396578|NCT01884025|self efficacy|self efficacy
396579|NCT01884025|serious mental illness|serious mental illness
396580|NCT01883986|palliative care|palliative care
396582|NCT01883973|DBS|dbs
396583|NCT01883960|cerebral palsy|cerebral palsy
396584|NCT01883960|cerebral vascular accident|cerebral vascular accident
396585|NCT01883960|multi-modal brain techniques|multi-modal brain techniques
396586|NCT01883960|MRI|mri
396587|NCT01883960|motor control|motor control
396588|NCT01883947|Stroke|stroke
396589|NCT01883947|Massage|massage
396590|NCT01883947|General Health|general health
396591|NCT01883947|Independence|independence
396592|NCT01883934|In Vitro Fertilization (IVF)|in vitro fertilization (ivf)
396593|NCT01883934|Embryo donation|embryo donation
396594|NCT01883921|Primary Immunodeficiency|primary immunodeficiency
396595|NCT01883921|Immunodeficiencies|immunodeficiencies
396596|NCT01883921|Primary Immunodeficiency Diseases|primary immunodeficiency diseases
396597|NCT01883921|PIDD|pidd
396598|NCT01883921|CVID|cvid
396599|NCT01883921|PI|pi
396600|NCT01883921|Common Variable Immunodeficiency|common variable immunodeficiency
396601|NCT01883921|Hypogammaglobulinemia|hypogammaglobulinemia
396602|NCT01883921|Acquired Hypogammaglobulinemia|acquired hypogammaglobulinemia
396603|NCT01883921|Immunology|immunology
396604|NCT01883921|Autoimmune Deficiency|autoimmune deficiency
396605|NCT01883921|Intravenous Immunoglobulin|intravenous immunoglobulin
396606|NCT01883921|Subcutaneous Immunoglobulin|subcutaneous immunoglobulin
396607|NCT01883921|IVIg|ivig
396608|NCT01883921|SCIg|scig
396609|NCT01883921|Immune Globulin|immune globulin
396610|NCT01883921|Outcomes Research|outcomes research
396611|NCT01883921|Immunodeficiency|immunodeficiency
396612|NCT01883908|Acupuncture therapy|acupuncture therapy
396613|NCT01883908|Mucositis|mucositis
396614|NCT01883908|oropharyngeal cancer|oropharyngeal cancer
396615|NCT01883895|Pain|pain
396616|NCT01883895|exercise-induced hypoalgesia|exercise-induced hypoalgesia
396617|NCT01883882|chronic non-cancer pain|chronic non-cancer pain
396618|NCT01883882|opioid taper|opioid taper
396619|NCT01883882|chronic pain self-management|chronic pain self-management
396620|NCT01883882|motivational interviewing|motivational interviewing
396621|NCT01883869|Platelet inhibition|platelet inhibition
396622|NCT01883869|Platelet-leukocyte aggregates|platelet-leukocyte aggregates
396623|NCT01883869|Platelet-neutrophil aggregates|platelet-neutrophil aggregates
396624|NCT01883869|CAP|cap
396625|NCT01883869|HAP|hap
396626|NCT01883869|ALI|ali
396627|NCT01883869|Blood Platelets|blood platelets
396628|NCT01883856|Refractory Glaucoma|refractory glaucoma
396629|NCT01883856|Intractable Glaucoma|intractable glaucoma
396630|NCT01883856|Primary Open Angle Glaucoma|primary open angle glaucoma
396631|NCT01883856|Neovascular Glaucoma|neovascular glaucoma
396632|NCT01883843|Chronic Stroke|chronic stroke
396633|NCT01883843|tDCS|tdcs
396634|NCT01883843|transcranial direct current stimulation|transcranial direct current stimulation
396635|NCT01883843|task oriented circuit training|task oriented circuit training
396636|NCT01883843|TOCT|toct
396637|NCT01883843|gait training|gait training
396638|NCT01883830|traumatic brain injury (TBI)|traumatic brain injury (tbi)
396639|NCT01883830|balance disorders|balance disorders
396640|NCT01883830|attention deficits|attention deficits
396641|NCT01883830|x-box|x-box
396642|NCT01883830|gaming|gaming
396643|NCT01883830|virtual reality|virtual reality
396644|NCT01883817|ADHD|adhd
396645|NCT01883804|Diabetes|diabetes
396646|NCT01883804|Diabetes Mellitus|diabetes mellitus
396647|NCT01883804|Type 1 Diabetes|type 1 diabetes
396648|NCT01883791|substance abuse prevention and treatment|substance abuse prevention and treatment
396649|NCT01883791|comorbidity|comorbidity
396650|NCT01883791|SBIRT|sbirt
396651|NCT01883778|Attitudes of health personnel|attitudes of health personnel
396652|NCT01883778|Attitudes of patients|attitudes of patients
396653|NCT01883778|Medical compliance|medical compliance
396654|NCT01883778|Cost awareness|cost awareness
396655|NCT01883778|Cost analysis|cost analysis
396656|NCT01883778|Patient knowledge|patient knowledge
396657|NCT01883778|Physician knowledge|physician knowledge
396658|NCT01883778|Medical economics|medical economics
396659|NCT01883778|Policy|policy
396660|NCT01883778|Questionnaires|questionnaires
396661|NCT01883778|Health literacy|health literacy
396662|NCT01883765|ADHD, Neurofeedback, CBT|adhd, neurofeedback, cbt
396663|NCT01883752|Goal-directed fluid therapy|goal-directed fluid therapy
396664|NCT01883739|Parental anxiety|parental anxiety
396665|NCT01883739|Children's safety|children's safety
396666|NCT01883739|Family Centered Care|family centered care
396667|NCT01883739|Bedside Transfer Rounds|bedside transfer rounds
396668|NCT01883739|Pediatric Cardiac Intensive Care|pediatric cardiac intensive care
396669|NCT01883726|Unilateral complete cleft lip, Nasoalveolar molding|unilateral complete cleft lip, nasoalveolar molding
396670|NCT01883713|anemia|anemia
396671|NCT01883713|CPB|cpb
396672|NCT01883713|methemoglobin|methemoglobin
396673|NCT01883713|hypoxia|hypoxia
396674|NCT01883700|Healthy|healthy
396675|NCT01883700|Glycemic Index|glycemic index
396676|NCT01883700|Glycemic Load|glycemic load
396677|NCT01883700|Blood Glucose|blood glucose
396678|NCT01883700|Arterial Stiffness|arterial stiffness
396679|NCT01883674|Sarcopenia|sarcopenia
396680|NCT01883674|Physical capacity|physical capacity
396681|NCT01883674|Muscle force|muscle force
396682|NCT01883674|Muscle quality|muscle quality
396683|NCT01883674|Milk proteins|milk proteins
396684|NCT01883674|Essential amino acids|essential amino acids
396685|NCT01883674|Proteins|proteins
396686|NCT01883674|Resistance training|resistance training
396687|NCT01883674|Exercise|exercise
396688|NCT01883661|stem cell|stem cell
396689|NCT01883661|Multiple Sclerosis|multiple sclerosis
396690|NCT01883661|BMMNC|bmmnc
396691|NCT01883648|Mild to Moderate Alzheimer's disease|mild to moderate alzheimer's disease
396692|NCT01883622|diabetes|diabetes
396693|NCT01883622|pregnancy|pregnancy
396694|NCT01883622|glucose variability|glucose variability
396695|NCT01883622|continuous glucose monitoring (CGM)|continuous glucose monitoring (cgm)
396696|NCT01883622|gestational diabetes mellitus (GDM)|gestational diabetes mellitus (gdm)
396697|NCT01883609|Plasmodium Falciparum|plasmodium falciparum
396698|NCT01883609|Malaria|malaria
396699|NCT01883609|Vaccine|vaccine
396700|NCT01883609|Plasmodium|plasmodium
396701|NCT01883609|Falciparum|falciparum
396702|NCT01883583|Ultrasound|ultrasound
396703|NCT01883583|Perfusion Imaging|perfusion imaging
396704|NCT01883583|Elasticity Imaging Techniques|elasticity imaging techniques
396705|NCT01883583|Kidney Transplantation|kidney transplantation
396706|NCT01883583|Graft Rejection|graft rejection
396707|NCT01883583|Chronic allograft nephropathy|chronic allograft nephropathy
396708|NCT01883570|visual search strategy, training, chest x-ray|visual search strategy, training, chest x-ray
396709|NCT01883544|Safety|safety
396710|NCT01883544|Tolerability|tolerability
396711|NCT01883544|Pharmacokinetics|pharmacokinetics
396712|NCT01883544|Pharmacodynamics|pharmacodynamics
396713|NCT01883544|ALXN1007|alxn1007
396714|NCT01883544|Healthy Male and Female Subjects|healthy male and female subjects
396715|NCT01883531|improving lung function|improving lung function
396716|NCT01883531|paediatric and adolescent|paediatric and adolescent
396717|NCT01883531|FEV1|fev1
396718|NCT01883518|Fibrosarcoma|fibrosarcoma
396719|NCT01883518|Neurofibrosarcoma|neurofibrosarcoma
396720|NCT01883518|Histiocytoma|histiocytoma
396721|NCT01883518|Histiocytoma, Malignant Fibrous|histiocytoma, malignant fibrous
396722|NCT01883518|Chondrosarcoma|chondrosarcoma
396723|NCT01883518|Synovial Sarcoma|synovial sarcoma
396724|NCT01883518|Leiomyosarcoma|leiomyosarcoma
396725|NCT01883518|Liposarcoma|liposarcoma
396726|NCT01883518|Myosarcoma|myosarcoma
396727|NCT01883518|Rhabdomyosarcoma|rhabdomyosarcoma
396728|NCT01883518|Sarcoma, Alveolar Soft Part|sarcoma, alveolar soft part
396729|NCT01883518|NY-ESO-1|ny-eso-1
396730|NCT01883518|MAGE|mage
396731|NCT01883518|MAGE A3|mage a3
396732|NCT01883518|Vaccine|vaccine
396733|NCT01883518|Immunotherapy|immunotherapy
396734|NCT01883505|Motor fluctuations|motor fluctuations
396735|NCT01883505|levodopa pharmacokinetics|levodopa pharmacokinetics
396736|NCT01883505|levodopa and carbidopa solution|levodopa and carbidopa solution
396737|NCT01883505|continuous subcutaneous delivery|continuous subcutaneous delivery
396738|NCT01883505|Patch-pump|patch-pump
396739|NCT01883492|Only Female|only female
396740|NCT01883492|Age between 20 - 75 at the time of operation|age between 20 - 75 at the time of operation
396741|NCT01883466|Air Pollution|air pollution
396742|NCT01883466|Biodiesel exhaust|biodiesel exhaust
396743|NCT01883466|Diesel exhaust|diesel exhaust
396744|NCT01883466|Vascular function|vascular function
396745|NCT01883466|Fibrinolysis|fibrinolysis
396746|NCT01883466|Acute endothelial responses|acute endothelial responses
396747|NCT01883440|Duration|duration
396748|NCT01883427|Days with URTI symptoms|days with urti symptoms
396749|NCT01883414|Ulthera, Ultherapy, Surgical scar, scar,|ulthera, ultherapy, surgical scar, scar,
396750|NCT01883401|Strawberries|strawberries
396751|NCT01883401|Heart health|heart health
396752|NCT01883401|Anthocyanins|anthocyanins
396753|NCT01883388|Lung Cancer|lung cancer
396754|NCT01883388|blood sample|blood sample
396755|NCT01883375|Palliative Care|palliative care
396756|NCT01883375|Family|family
398952|NCT01874002|Sirolimus|sirolimus
396757|NCT01883375|adaptation, psychological|adaptation, psychological
396758|NCT01883362|acute myeloid leukemia|acute myeloid leukemia
396759|NCT01883362|AML|aml
396760|NCT01883362|FLT3-ITD|flt3-itd
396761|NCT01883362|midostaurin|midostaurin
396762|NCT01883362|PKC412|pkc412
396763|NCT01883362|allogeneic hematopoeitic stem cell tranplant|allogeneic hematopoeitic stem cell tranplant
396764|NCT01883362|SCT|sct
396765|NCT01883362|HSCT|hsct
396766|NCT01883362|CR1|cr1
396767|NCT01883362|adult|adult
396768|NCT01883336|Incidental pancreatic cysts|incidental pancreatic cysts
396769|NCT01883323|Measurable|measurable
396770|NCT01883323|Unresectable|unresectable
396771|NCT01883323|Stage III|stage iii
396772|NCT01883323|Stage IV|stage iv
396773|NCT01883323|Metastatic|metastatic
396774|NCT01883323|Melanoma|melanoma
396775|NCT01883323|Tumor-Infiltrating Lymphocytes|tumor-infiltrating lymphocytes
396776|NCT01883323|Low-Dose Interleukin-2|low-dose interleukin-2
396777|NCT01883323|Cyclophosphamide|cyclophosphamide
396778|NCT01883323|Fludarabine|fludarabine
507513|NCT01400958|TMZ|tmz
396779|NCT01883310|Multiple Sclerosis|multiple sclerosis
396780|NCT01883310|transcranial direct current stimulation|transcranial direct current stimulation
396781|NCT01883310|TOCT|toct
396782|NCT01883310|task-oriented circuit training|task-oriented circuit training
396783|NCT01883310|locomotor function|locomotor function
396784|NCT01883310|mobility|mobility
396785|NCT01883310|balance|balance
396786|NCT01883297|Measurable|measurable
396787|NCT01883297|Recurrent|recurrent
396788|NCT01883297|Platinum resistant|platinum resistant
396789|NCT01883297|Tumor-Infiltrating Lymphocytes|tumor-infiltrating lymphocytes
396790|NCT01883297|Low-Dose Interleukin-2|low-dose interleukin-2
396791|NCT01883297|Autologous dendritic cells|autologous dendritic cells
396792|NCT01883297|Anti-CD3 monoclonal antibody|anti-cd3 monoclonal antibody
396793|NCT01883297|High grade serous ovarian, fallopian tube, or primary peritoneal cancer|high grade serous ovarian, fallopian tube, or primary peritoneal cancer
396794|NCT01883297|Cyclophosphamide|cyclophosphamide
396795|NCT01883284|Cystic Fibrosis|cystic fibrosis
396796|NCT01883284|nasal epithelia|nasal epithelia
396797|NCT01883284|mucins|mucins
396798|NCT01883245|Orofacial chronic pain|orofacial chronic pain
396799|NCT01883245|tDCS|tdcs
396800|NCT01883245|Transcranial direct current stimulation|transcranial direct current stimulation
396801|NCT01883245|Brain stimulation|brain stimulation
396802|NCT01883219|Philadelphia chromosome|philadelphia chromosome
396803|NCT01883219|Acute lymphoblastic leukemia|acute lymphoblastic leukemia
396804|NCT01883219|Allogeneic hematopoietic cell transplantation|allogeneic hematopoietic cell transplantation
396805|NCT01883219|Minimal residual disease|minimal residual disease
396806|NCT01883219|Tyrosine kinase inhibitor|tyrosine kinase inhibitor
396807|NCT01883206|Cytomegalovirus|cytomegalovirus
396808|NCT01883193|preconception maternal nutrition|preconception maternal nutrition
396809|NCT01883193|LBW|lbw
396810|NCT01883193|Length-for-age|length-for-age
396811|NCT01883193|maternal nutrition supplement|maternal nutrition supplement
396812|NCT01883193|multi-micronutrient fortified lipid-based supplement|multi-micronutrient fortified lipid-based supplement
396813|NCT01883193|infant growth|infant growth
396814|NCT01883193|low-resource settings|low-resource settings
396815|NCT01883180|haploidentical hematopoietic Stem Cell Transplantation|haploidentical hematopoietic stem cell transplantation
396816|NCT01883180|Antithymocyte globulin|antithymocyte globulin
396817|NCT01883180|viral infection|viral infection
396818|NCT01883128|Biochemical Failure|biochemical failure
396819|NCT01883128|Radiotherapy|radiotherapy
396820|NCT01883128|Radiorecurrent Prostate Cancer|radiorecurrent prostate cancer
396821|NCT01883128|MRI Prostate|mri prostate
396822|NCT01883128|Whole Body MRI|whole body mri
396823|NCT01883128|Bone Scan|bone scan
396824|NCT01883128|Choline PET|choline pet
396825|NCT01883128|Focal Salvage Treatment|focal salvage treatment
396826|NCT01883128|HIFU|hifu
396827|NCT01883128|Cryotherapy|cryotherapy
396828|NCT01883115|Telescopic extraperitoneal dissection|telescopic extraperitoneal dissection
396829|NCT01883115|Single incision laparosocpic surgery|single incision laparosocpic surgery
396830|NCT01883115|Inguinal hernia|inguinal hernia
396831|NCT01883115|Triport system|triport system
396832|NCT01883076|Hypoplastic Left Heart Syndrome|hypoplastic left heart syndrome
396833|NCT01883076|HLHS|hlhs
396834|NCT01883076|Congenital Heart Disease|congenital heart disease
396835|NCT01883076|Umbilical cord blood|umbilical cord blood
396836|NCT01883076|UCB|ucb
396837|NCT01883076|Cord blood|cord blood
396838|NCT01883076|Stem cells|stem cells
396839|NCT01883076|Regenerative therapy|regenerative therapy
396840|NCT01883076|Stage II Glenn|stage ii glenn
396841|NCT01883076|Glenn Surgery|glenn surgery
396842|NCT01883050|Coronary artery disease|coronary artery disease
396843|NCT01883050|Percutaneous Intervention|percutaneous intervention
396844|NCT01883050|Stent|stent
396845|NCT01883050|Balloon angioplasty|balloon angioplasty
396846|NCT01883050|Angiogram|angiogram
396847|NCT01883050|Coronary angiogram|coronary angiogram
396848|NCT01883037|Cystic Fibrosis|cystic fibrosis
396849|NCT01883037|Cystic Fibrosis related diabetes|cystic fibrosis related diabetes
396850|NCT01883037|Oral glucose tolerance test|oral glucose tolerance test
399155|NCT01873118|readmission|readmission
396851|NCT01883024|Real time continuous glucose monitoring, decision support software, smartphone application.|real time continuous glucose monitoring, decision support software, smartphone application.
396852|NCT01883011|Piracetam|piracetam
396853|NCT01883011|Stroke|stroke
396854|NCT01883011|Aphasia|aphasia
396855|NCT01883011|Acute|acute
396856|NCT01883011|Cerebral|cerebral
396857|NCT01883011|Ischemic|ischemic
396858|NCT01883011|Nootropil|nootropil
396859|NCT01882998|HIV and pregnancy|hiv and pregnancy
396860|NCT01882998|HIV and breastfeeding|hiv and breastfeeding
396861|NCT01882998|Mother-to-child transmission of HIV|mother-to-child transmission of hiv
396862|NCT01882998|Africa|africa
396863|NCT01882998|Uganda|uganda
396864|NCT01882985|docetaxel|docetaxel
396865|NCT01882985|lycopene|lycopene
396866|NCT01882985|prostate cancer|prostate cancer
396867|NCT01882933|Gastric adenocarcinoma|gastric adenocarcinoma
396868|NCT01882933|HIPEC|hipec
396869|NCT01882933|Oxaliplatin|oxaliplatin
396870|NCT01882933|Signet ring cell|signet ring cell
396871|NCT01882920|Cytoreductive surgery|cytoreductive surgery
396872|NCT01882920|hyperthermic intraperitoneal chemotherapy|hyperthermic intraperitoneal chemotherapy
396873|NCT01882920|Goal directed fluid therapy|goal directed fluid therapy
396874|NCT01882907|vildagliptin|vildagliptin
396875|NCT01882907|metformin|metformin
396876|NCT01882894|Plantar fasciitis, orthotic, functional outcome|plantar fasciitis, orthotic, functional outcome
396877|NCT01882842|Infertility|infertility
396878|NCT01882842|Endometrium|endometrium
396879|NCT01882842|Live birth|live birth
396880|NCT01882829|depression|depression
396881|NCT01882829|major depressive disorder|major depressive disorder
396882|NCT01882829|treatment resistant|treatment resistant
396883|NCT01882829|Nuedexta|nuedexta
396884|NCT01882829|dextromethorphan|dextromethorphan
396885|NCT01882829|antidepressant|antidepressant
396886|NCT01882829|glutamate|glutamate
396887|NCT01882829|NMDA receptor|nmda receptor
396888|NCT01882816|non-anaplastic|non-anaplastic
396889|NCT01882816|non-medullary|non-medullary
396890|NCT01882816|radiation|radiation
396891|NCT01882816|IMRT|imrt
396892|NCT01882816|Doxorubicin|doxorubicin
396893|NCT01882816|13-070|13-070
396894|NCT01882803|PI3K Inhibitor|pi3k inhibitor
396895|NCT01882790|coronary artery spasm|coronary artery spasm
396896|NCT01882790|hypertension|hypertension
396897|NCT01882790|Pathophysiology|pathophysiology
396898|NCT01882790|atrioventricular block|atrioventricular block
396899|NCT01882790|blood pressure|blood pressure
396900|NCT01882790|autonomic nervous function|autonomic nervous function
396901|NCT01882751|kinematics|kinematics
396902|NCT01882751|knee joint|knee joint
396903|NCT01882738|Cervical length|cervical length
396904|NCT01882738|BMI|bmi
396905|NCT01882699|Insomnia|insomnia
396906|NCT01882686|Pain|pain
396907|NCT01882686|Back Pain|back pain
396908|NCT01882686|Low Back Pain|low back pain
396909|NCT01882686|Chronic Low Back Pain|chronic low back pain
396910|NCT01882686|Cognitive Functional Therapy|cognitive functional therapy
396911|NCT01882686|Intervention|intervention
396912|NCT01882686|Subclassification|subclassification
396913|NCT01882686|Multidimensional|multidimensional
396914|NCT01882673|Tobacco|tobacco
396915|NCT01882673|nicotine|nicotine
396916|NCT01882673|dependence|dependence
396917|NCT01882673|quitline|quitline
396918|NCT01882647|psoriasis|psoriasis
396919|NCT01882647|lotion|lotion
396920|NCT01882647|investigator's global assessment|investigator's global assessment
396921|NCT01882621|NSCLC|nsclc
396922|NCT01882621|Monosialoganglioside(GM1)|monosialoganglioside(gm1)
396923|NCT01882621|neurotoxicity|neurotoxicity
396924|NCT01882608|psychiatry|psychiatry
396925|NCT01882608|mental health|mental health
396926|NCT01882608|mood disorders|mood disorders
396927|NCT01882608|mood diaries|mood diaries
396928|NCT01882608|electronic diaries|electronic diaries
396929|NCT01882608|cell phones|cell phones
396930|NCT01882608|software|software
396931|NCT01882608|mental health telemetry|mental health telemetry
396932|NCT01882608|ecological momentary assessment|ecological momentary assessment
396933|NCT01882595|Nebulization aerosol nebulizer tracheostomy|nebulization aerosol nebulizer tracheostomy
396934|NCT01882556|Early treatment of spasticity.|early treatment of spasticity.
396935|NCT01882556|Post stroke spasticity.|post stroke spasticity.
396936|NCT01882543|Interstitial cystitis|interstitial cystitis
396937|NCT01882543|Bladder pain syndrome|bladder pain syndrome
396938|NCT01882543|IC/BPS|ic/bps
396939|NCT01882543|AQX-1125|aqx-1125
396940|NCT01882543|SHIP1|ship1
396941|NCT01882530|Post operative analgesia ;|post operative analgesia ;
396942|NCT01882530|Paracetamol ;|paracetamol ;
396943|NCT01882530|Ketoprofen ;|ketoprofen ;
396944|NCT01882530|Nefopam ;|nefopam ;
396945|NCT01882530|Morphine|morphine
396946|NCT01882504|Pyoderma Gangrenosum|pyoderma gangrenosum
396947|NCT01882504|Classic Pyoderma Gangrenosum|classic pyoderma gangrenosum
396948|NCT01882504|Atypical Pyoderma Gangrenosum|atypical pyoderma gangrenosum
396949|NCT01882504|Peristomal Pyoderma Gangrenosum|peristomal pyoderma gangrenosum
396950|NCT01882491|Erosive Osteoarthritis|erosive osteoarthritis
396951|NCT01882491|Osteoarthritis|osteoarthritis
396952|NCT01882491|Osteoarthritis of the Hand|osteoarthritis of the hand
396953|NCT01882478|Barrett's esophagus|barrett's esophagus
396954|NCT01882478|Early esophageal adenocarcinoma|early esophageal adenocarcinoma
396955|NCT01882478|Radio Frequency Ablation|radio frequency ablation
396956|NCT01882478|Cryotherapy|cryotherapy
396957|NCT01882452|Memory specificity training|memory specificity training
396958|NCT01882452|Autobiographical memory|autobiographical memory
396959|NCT01882452|Major depressive disorder|major depressive disorder
396960|NCT01882439|psoriatic arthritis|psoriatic arthritis
396961|NCT01882439|tofacitinib|tofacitinib
396962|NCT01882439|ACR20|acr20
396963|NCT01882439|HAQ-DI|haq-di
396964|NCT01882439|TNF inhibitor failure|tnf inhibitor failure
396965|NCT01882426|CONSTRUCT|construct
400564|NCT01866254|Hydromorphone|hydromorphone
396966|NCT01882426|Cluster randomization controlled trial|cluster randomization controlled trial
396967|NCT01882426|Gastroenterology practices in North America|gastroenterology practices in north america
396968|NCT01882400|Osteoporosis|osteoporosis
396969|NCT01882400|Severe muscular dystrophy|severe muscular dystrophy
396970|NCT01882400|Cystic fibrosis|cystic fibrosis
396971|NCT01882387|Allogeneic Peripheral Blood Stem Cell Transplantation|allogeneic peripheral blood stem cell transplantation
396972|NCT01882387|Graft-vs-Host Disease|graft-vs-host disease
396973|NCT01882387|Neutrophil Engraftment|neutrophil engraftment
396974|NCT01882387|Platelet Engraftment|platelet engraftment
396975|NCT01882387|Immune Reconstitution|immune reconstitution
396976|NCT01882387|Mucositis|mucositis
396977|NCT01882374|Double Umbilical Cord Blood Transplantation|double umbilical cord blood transplantation
396978|NCT01882374|Acute Graft versus Host Disease|acute graft versus host disease
396979|NCT01882374|Neutrophil Engraftment|neutrophil engraftment
396980|NCT01882374|Platelet Recovery|platelet recovery
396981|NCT01882374|Immune Reconstitution|immune reconstitution
396982|NCT01882374|Mucositis|mucositis
396983|NCT01882361|opioid addiction|opioid addiction
396984|NCT01882361|opioid treatment|opioid treatment
396985|NCT01882361|naloxone|naloxone
396986|NCT01882348|tobacco control, tobacco treatment, pediatrics, parents|tobacco control, tobacco treatment, pediatrics, parents
396987|NCT01882335|Human capital formation|human capital formation
396988|NCT01882322|FK506|fk506
396989|NCT01882322|tacrolimus|tacrolimus
396990|NCT01882322|immunosuppressant|immunosuppressant
396991|NCT01882283|serum lipids|serum lipids
396992|NCT01882283|cholesterol|cholesterol
396993|NCT01882283|serum cholesterol|serum cholesterol
396994|NCT01882283|black tea|black tea
396995|NCT01882283|flavonoids|flavonoids
396996|NCT01882283|crossover trial|crossover trial
396997|NCT01882283|randomized control trial|randomized control trial
396998|NCT01882283|diet controlled|diet controlled
396999|NCT01882270|pericoronitis|pericoronitis
397000|NCT01882270|periodontal|periodontal
397001|NCT01882257|obstructive sleep apnea|obstructive sleep apnea
397002|NCT01882257|sleep-disordered breathing|sleep-disordered breathing
397003|NCT01882257|hypercapnia|hypercapnia
397004|NCT01882257|spinal cord injury|spinal cord injury
397005|NCT01882244|traumatic brain injury|traumatic brain injury
397006|NCT01882244|cognition|cognition
397007|NCT01882244|rehabilitation|rehabilitation
397008|NCT01882244|attentional regulation|attentional regulation
397009|NCT01882244|working memory|working memory
397010|NCT01882231|Osteosarcoma|osteosarcoma
397011|NCT01882231|Ewing sarcoma|ewing sarcoma
397012|NCT01882231|Paget's disease|paget's disease
397013|NCT01882231|bone cancer|bone cancer
397014|NCT01882231|childhood cancers|childhood cancers
397015|NCT01882231|DCE MRI|dce mri
397016|NCT01882231|DW MRI|dw mri
397017|NCT01882231|CEST MRI|cest mri
397018|NCT01882231|MT MRI|mt mri
397019|NCT01882218|Liver cancer|liver cancer
397020|NCT01882205|Ulcerative colitis|ulcerative colitis
397021|NCT01882205|DALM|dalm
397022|NCT01882205|chromoendoscopy|chromoendoscopy
397023|NCT01882205|dysplasia|dysplasia
397024|NCT01882205|virtual chromoendoscopy|virtual chromoendoscopy
397025|NCT01882205|FICE|fice
397026|NCT01882205|NBI|nbi
397027|NCT01882205|I-scan|i-scan
397028|NCT01882192|family|family
397029|NCT01882192|physical activity|physical activity
397030|NCT01882192|planning|planning
397031|NCT01882179|Reperfusion injury|reperfusion injury
397032|NCT01882179|myocardial infarct size|myocardial infarct size
397033|NCT01882179|MRI|mri
397034|NCT01882179|spironolactone|spironolactone
397035|NCT01882166|Fertilization in Vitro|fertilization in vitro
397036|NCT01882166|Sperm Injections, Intracytoplasmic|sperm injections, intracytoplasmic
397037|NCT01882166|Follicle Stimulating Hormone|follicle stimulating hormone
397038|NCT01882166|Embryonic Development|embryonic development
397039|NCT01882140|burns|burns
397040|NCT01882140|wound healing|wound healing
397041|NCT01882140|magnetic field therapy|magnetic field therapy
397042|NCT01882127|Purpura|purpura
397043|NCT01882127|Idiopathic Thrombocytopenic Purpura|idiopathic thrombocytopenic purpura
397044|NCT01882114|atherosclerosis|atherosclerosis
397045|NCT01882114|cardiovascular events|cardiovascular events
397046|NCT01882114|ankle-brachial index|ankle-brachial index
397047|NCT01882114|carotid disease|carotid disease
397048|NCT01882114|echocardiography|echocardiography
397049|NCT01882114|mediterranean diet|mediterranean diet
397050|NCT01882114|platelet activation|platelet activation
397051|NCT01882101|Fecal incontinence|fecal incontinence
397052|NCT01882101|posterior tibial nerve stimulation|posterior tibial nerve stimulation
397053|NCT01882101|biofeedback|biofeedback
397054|NCT01882101|quality of life|quality of life
397056|NCT01882088|psyllium|psyllium
397057|NCT01882088|Lower esophageal sphincter|lower esophageal sphincter
397058|NCT01882088|Esophageal motility|esophageal motility
397059|NCT01882088|Dietary fiber|dietary fiber
397060|NCT01882088|Heartburn|heartburn
397061|NCT01882088|gastroesophageal reflux|gastroesophageal reflux
397062|NCT01882088|non-erosive gastroesophageal reflux disease|non-erosive gastroesophageal reflux disease
397063|NCT01882075|Anesthesia|anesthesia
397064|NCT01882075|Fluid administration|fluid administration
397065|NCT01882075|Closed-loop|closed-loop
397066|NCT01882023|EDNOS|ednos
397067|NCT01882023|adolescents|adolescents
397068|NCT01882010|Parkinson's disease|parkinson's disease
397069|NCT01882010|motor function|motor function
397070|NCT01882010|immune activation|immune activation
397071|NCT01882010|T cells|t cells
397073|NCT01882010|GMCSF|gmcsf
397074|NCT01882010|leukine|leukine
397075|NCT01882010|sargramostim|sargramostim
397076|NCT01882010|magnetoencephalography|magnetoencephalography
397077|NCT01881997|Procedure|procedure
397078|NCT01881997|Abscess|abscess
397079|NCT01881997|Emergency Department|emergency department
397080|NCT01881997|Opioid|opioid
397081|NCT01881997|Fentanyl|fentanyl
397082|NCT01881984|Medium-chain acyl-CoA dehydrogenase deficiency|medium-chain acyl-coa dehydrogenase deficiency
397083|NCT01881984|MCAD deficiency|mcad deficiency
397084|NCT01881984|MCADD|mcadd
397085|NCT01881984|ACADM deficiency|acadm deficiency
397086|NCT01881984|MCADH deficiency|mcadh deficiency
397087|NCT01881984|985A>G mutation|985a>g mutation
397088|NCT01881984|K304E mutation|k304e mutation
397089|NCT01881984|Ravicti|ravicti
397090|NCT01881984|glycerol phenylbutyrate|glycerol phenylbutyrate
397091|NCT01881971|HIV|hiv
397092|NCT01881971|lung|lung
397093|NCT01881971|lipids|lipids
397094|NCT01881971|no lipid lowering medication|no lipid lowering medication
397095|NCT01881971|normal liver and kidney function|normal liver and kidney function
397096|NCT01881971|on stable ART regimen|on stable art regimen
397097|NCT01881971|not pregnant|not pregnant
397098|NCT01881945|Swallowing|swallowing
397099|NCT01881945|Hyperventilation|hyperventilation
397100|NCT01881932|acupuncture therapy|acupuncture therapy
397101|NCT01881932|sham acupuncture therapy|sham acupuncture therapy
397102|NCT01881932|chemotherapy-induced peripheral neuropathy (CIPN)|chemotherapy-induced peripheral neuropathy (cipn)
397103|NCT01881919|Functional Food|functional food
397104|NCT01881906|aerobic exercise|aerobic exercise
397105|NCT01881906|Lung cancer|lung cancer
397106|NCT01881906|psyco-social|psyco-social
397107|NCT01881893|Quality of life|quality of life
397108|NCT01881893|Psychosocial Support Systems|psychosocial support systems
397109|NCT01881893|Randomized Controls as Topic|randomized controls as topic
397110|NCT01881893|Cognitive Therapy|cognitive therapy
397111|NCT01881893|Feasibility Studies|feasibility studies
397112|NCT01881880|Tomosynthesis|tomosynthesis
397113|NCT01881880|Mammography|mammography
397114|NCT01881880|Breast cancer|breast cancer
397115|NCT01881841|Alcohol abuse|alcohol abuse
397116|NCT01881841|Substance use|substance use
397117|NCT01881841|Tobacco use disorder|tobacco use disorder
397118|NCT01881841|Motivational Enhancement Therapy|motivational enhancement therapy
397119|NCT01881841|Adolescents|adolescents
397120|NCT01881815|Chronic wounds with different etiologies|chronic wounds with different etiologies
397121|NCT01881815|Diabetic foot ulcers|diabetic foot ulcers
397122|NCT01881815|venous leg ulcers|venous leg ulcers
397123|NCT01881815|pressure sores|pressure sores
397124|NCT01881815|acute wounds|acute wounds
397125|NCT01881802|Opioid drug Abuse|opioid drug abuse
397126|NCT01881802|Morphine|morphine
397127|NCT01881802|Immune Function|immune function
397128|NCT01881789|multiple myeloma|multiple myeloma
397129|NCT01881789|proteasome inhibitor|proteasome inhibitor
397130|NCT01881789|oprozomib|oprozomib
397131|NCT01881789|orpozomib tablets|orpozomib tablets
397132|NCT01881776|Single injection interscalene brachial plexus block|single injection interscalene brachial plexus block
397133|NCT01881776|Continuous interscalene brachial plexus block|continuous interscalene brachial plexus block
397134|NCT01881776|General anesthesia|general anesthesia
397135|NCT01881776|Postoperative pain|postoperative pain
397136|NCT01881776|Recovery profile|recovery profile
397137|NCT01881763|Electroconvulsive Therapy|electroconvulsive therapy
397138|NCT01881763|Ketamine|ketamine
397139|NCT01881763|anesthesia|anesthesia
397140|NCT01881763|depression|depression
397141|NCT01881763|unipolar|unipolar
397142|NCT01881763|bipolar|bipolar
397143|NCT01881750|Autism PRT|autism prt
397144|NCT01881737|autism|autism
397145|NCT01881711|hydrocephalus|hydrocephalus
397146|NCT01881711|CSF shunt|csf shunt
397147|NCT01881711|shunt malfunction|shunt malfunction
397148|NCT01881711|shunt obstruction|shunt obstruction
397149|NCT01881711|ShuntCheck|shuntcheck
397150|NCT01881711|ShuntCheck-Micro-Pumper|shuntcheck-micro-pumper
397151|NCT01881698|pregnancy|pregnancy
397152|NCT01881698|platelet function|platelet function
397153|NCT01881698|monitoring|monitoring
397154|NCT01881698|multiple electrode aggregometry|multiple electrode aggregometry
397155|NCT01881672|Aspiration pneumonia|aspiration pneumonia
397156|NCT01881672|Coma|coma
397157|NCT01881672|Mechanical ventilation|mechanical ventilation
397158|NCT01881659|cervical cancer|cervical cancer
397159|NCT01881659|cancer prevention|cancer prevention
397160|NCT01881659|cervical screening|cervical screening
397161|NCT01881659|HPV testing|hpv testing
400565|NCT01866254|Morphine|morphine
508046|NCT01398657|ADT|adt
397162|NCT01881659|triage techniques|triage techniques
397163|NCT01881646|Neuroinflammation|neuroinflammation
397164|NCT01881646|Postoperative cognitive dysfunction|postoperative cognitive dysfunction
397165|NCT01881633|gaucher disease, imiglucerase, ISU302|gaucher disease, imiglucerase, isu302
397166|NCT01881620|PET scan|pet scan
397167|NCT01881620|CT scan|ct scan
397168|NCT01881620|Diagnostic performance|diagnostic performance
397169|NCT01881607|tobacco smoke pollution|tobacco smoke pollution
397170|NCT01881607|Tobacco use|tobacco use
397171|NCT01881594|ileostomy closure,postoperative ileus,stimulation ileostomy|ileostomy closure,postoperative ileus,stimulation ileostomy
397172|NCT01881581|Therapeutic|therapeutic
397173|NCT01881581|Vaccine|vaccine
397174|NCT01881581|HIV|hiv
397175|NCT01881581|MVA|mva
397176|NCT01881581|DNA|dna
397177|NCT01881568|Total Knee Arthroplasty, TKA, blood loss|total knee arthroplasty, tka, blood loss
397178|NCT01881555|fractional flow reserve|fractional flow reserve
397179|NCT01881555|multivessel coronary artery disease|multivessel coronary artery disease
397180|NCT01881555|angiography|angiography
397181|NCT01881542|preeclampsia|preeclampsia
397182|NCT01881542|proteinuria|proteinuria
397183|NCT01881542|urine collection|urine collection
397184|NCT01881529|limited scleroderma|limited scleroderma
397185|NCT01881529|diffuse scleroderma|diffuse scleroderma
397186|NCT01881529|Sclerosis|sclerosis
397187|NCT01881529|Progressive|progressive
397188|NCT01881529|Limited|limited
397189|NCT01881503|life-threatening anemia|life-threatening anemia
397190|NCT01881503|blood alternative|blood alternative
397191|NCT01881503|HBOC|hboc
397192|NCT01881490|Crohn's Disease|crohn's disease
397193|NCT01881490|MRE|mre
397194|NCT01881490|Pelvic MRI|pelvic mri
397195|NCT01881490|P-MRI|p-mri
397196|NCT01881490|colonoscopy|colonoscopy
397197|NCT01881490|gastroscopy|gastroscopy
397198|NCT01881477|immobilization|immobilization
397199|NCT01881477|physical therapy|physical therapy
397200|NCT01881477|intensive care|intensive care
397201|NCT01881477|bed rest|bed rest
397202|NCT01881477|movement|movement
397203|NCT01881451|Tumour hypoxia|tumour hypoxia
397204|NCT01881451|Clear Cell Ovarian Cancer|clear cell ovarian cancer
397205|NCT01881451|Recurrent|recurrent
397206|NCT01881451|Metastatic|metastatic
397207|NCT01881438|Retinal Detachment|retinal detachment
397208|NCT01881438|Fluoroquinolones|fluoroquinolones
397209|NCT01881438|Ciprofloxacin|ciprofloxacin
397210|NCT01881438|Levofloxacin|levofloxacin
397211|NCT01881438|Gatifloxacin|gatifloxacin
397212|NCT01881438|Gemifloxacin|gemifloxacin
397213|NCT01881438|Moxifloxacin|moxifloxacin
397214|NCT01881438|Norfloxacin|norfloxacin
397215|NCT01881438|Ofloxacin|ofloxacin
397216|NCT01881438|Beta-Lactam|beta-lactam
397217|NCT01881425|POAG|poag
397218|NCT01881412|Asthma|asthma
397219|NCT01881412|Children|children
397220|NCT01881412|Inhaled Corticosteroids|inhaled corticosteroids
397221|NCT01881412|Emergency Department|emergency department
397222|NCT01881399|Cholelithiasis|cholelithiasis
397223|NCT01881399|Gallbladder polyps|gallbladder polyps
397224|NCT01881399|Fluorescence|fluorescence
397225|NCT01881399|Indocyanine green (ICG)|indocyanine green (icg)
397226|NCT01881399|Intraoperative cholangiography (IOC)|intraoperative cholangiography (ioc)
397227|NCT01881399|da Vinci surgical system|da vinci surgical system
397228|NCT01881386|Magnetic Resonance Spectroscopy|magnetic resonance spectroscopy
397229|NCT01881386|Lactate|lactate
397230|NCT01881373|Obesity|obesity
397231|NCT01881373|Child|child
397232|NCT01881373|Food|food
397233|NCT01881373|Physical Activity|physical activity
397234|NCT01881373|Pacific|pacific
397235|NCT01881360|fibromyalgia|fibromyalgia
397236|NCT01881360|celiac-type symptoms|celiac-type symptoms
397237|NCT01881360|gluten-free diet|gluten-free diet
397238|NCT01881360|hypocaloric diet|hypocaloric diet
397239|NCT01881347|endothelium|endothelium
397240|NCT01881347|mitochondria|mitochondria
397241|NCT01881347|reactive oxygen species|reactive oxygen species
397242|NCT01881347|vascular biology|vascular biology
397243|NCT01881347|arterial stiffness|arterial stiffness
397244|NCT01881347|nitric oxide|nitric oxide
397245|NCT01881334|Haploidentical Donor|haploidentical donor
397246|NCT01881334|T-cell depleted Stem Cells|t-cell depleted stem cells
397247|NCT01881334|Allogeneic Transplant|allogeneic transplant
397248|NCT01881334|Umbilical Cord Blood Donor|umbilical cord blood donor
397249|NCT01881334|High Risk Malignancies|high risk malignancies
397250|NCT01881334|Metabolic Disorders|metabolic disorders
397251|NCT01881334|Immune Deficiency|immune deficiency
397252|NCT01881334|Acute Lymphoblastic Leukemia|acute lymphoblastic leukemia
397253|NCT01881334|Acute Myelogenous Leukemia|acute myelogenous leukemia
397254|NCT01881334|Myelodysplastic Syndrome|myelodysplastic syndrome
397255|NCT01881334|ALL|all
397256|NCT01881334|AML|aml
397257|NCT01881334|MDS|mds
397258|NCT01881334|CGD|cgd
397259|NCT01881334|SCID|scid
397260|NCT01881334|Adrenoleukodystrophy|adrenoleukodystrophy
397261|NCT01881334|Metachromaticleukodystrophy|metachromaticleukodystrophy
397262|NCT01881334|Krabbe|krabbe
397263|NCT01881334|PMD|pmd
397264|NCT01881334|Hunter's|hunter's
397265|NCT01881334|Hurler's|hurler's
397266|NCT01881334|Severe Aplastic Anemia|severe aplastic anemia
397267|NCT01881334|Lymphoma|lymphoma
397268|NCT01881334|Sickle Cell Disease|sickle cell disease
397269|NCT01881334|Thalassemia|thalassemia
397270|NCT01881321|Contraception|contraception
397271|NCT01881321|Counseling|counseling
397272|NCT01881295|Potassium|potassium
397273|NCT01881295|Potato|potato
397274|NCT01881295|French Fries|french fries
397275|NCT01881295|Bioavailability|bioavailability
397276|NCT01881295|Blood Pressure|blood pressure
397277|NCT01881282|Hemorrhoids|hemorrhoids
397278|NCT01881282|Carraghenates|carraghenates
397279|NCT01881282|Mayinglong Musk|mayinglong musk
397280|NCT01881282|Titanoreine|titanoreine
397281|NCT01881256|Preterm birth|preterm birth
397282|NCT01881256|Parenteral and enteral nutrition|parenteral and enteral nutrition
397283|NCT01881256|Body composition in preterm infants|body composition in preterm infants
397284|NCT01881243|Cardiac Arrest, Hyperoxia, Ischemia-reperfusion Injury, Reactive Oxygen Species, Oxidative Stress, Neuropsychological Tests|cardiac arrest, hyperoxia, ischemia-reperfusion injury, reactive oxygen species, oxidative stress, neuropsychological tests
397285|NCT01881230|Breast Cancer|breast cancer
397286|NCT01881230|Cancer of the Breast|cancer of the breast
397287|NCT01881230|Metastatic Breast Cancer|metastatic breast cancer
397288|NCT01881230|Metastatic Triple Negative Breast Cancer|metastatic triple negative breast cancer
397289|NCT01881230|Triple Negative Breast Cancer|triple negative breast cancer
397290|NCT01881230|Triple Negative Metastatic Breast Cancer|triple negative metastatic breast cancer
397291|NCT01881230|Basal-like breast cancer|basal-like breast cancer
397292|NCT01881230|Hormone receptor negative breast cancer|hormone receptor negative breast cancer
397293|NCT01881230|Estrogen receptor negative breast cancer|estrogen receptor negative breast cancer
397294|NCT01881230|Progesterone negative receptor breast cancer|progesterone negative receptor breast cancer
397295|NCT01881230|HER2 Negative Breast Cancer|her2 negative breast cancer
397296|NCT01881230|Abraxane|abraxane
397297|NCT01881230|nab-Paclitaxel|nab-paclitaxel
397298|NCT01881230|ABI-007|abi-007
397299|NCT01881230|gemcitabine|gemcitabine
397300|NCT01881230|Gemzar|gemzar
397301|NCT01881230|carboplatin|carboplatin
397302|NCT01881230|Paraplatin|paraplatin
397303|NCT01881230|Paraplatin AQ|paraplatin aq
397304|NCT01881230|Phase 2|phase 2
397305|NCT01881230|Phase 3|phase 3
397306|NCT01881217|Phase I|phase i
397307|NCT01881217|Dose escalation|dose escalation
397308|NCT01881217|Advanced, refractory solid tumors|advanced, refractory solid tumors
397309|NCT01881217|FGFR2|fgfr2
397310|NCT01881204|Hesperidin|hesperidin
397311|NCT01881204|Osteoporosis|osteoporosis
397312|NCT01881204|Bone Loss|bone loss
397313|NCT01881191|multiple sclerosis|multiple sclerosis
397314|NCT01881191|relapsing remitting|relapsing remitting
397315|NCT01881191|MRI|mri
397316|NCT01881191|teriflunomide|teriflunomide
397317|NCT01881191|aubagio|aubagio
397318|NCT01881191|gray matter atrophy|gray matter atrophy
397319|NCT01881191|gray matter pathology|gray matter pathology
397320|NCT01881178|CRP|crp
397321|NCT01881178|Nopalea|nopalea
397322|NCT01881178|Fruit|fruit
397323|NCT01881178|Juice|juice
397324|NCT01881152|Stroke|stroke
397325|NCT01881152|Community education|community education
397326|NCT01881152|Awareness|awareness
397327|NCT01881152|Prehospital delay|prehospital delay
397328|NCT01881139|Exercise|exercise
397329|NCT01881139|Lipid|lipid
397330|NCT01881139|Left ventricular|left ventricular
397331|NCT01881139|heart function|heart function
397332|NCT01881100|resin infiltration|resin infiltration
397333|NCT01881100|randomized clinical trial|randomized clinical trial
397334|NCT01881100|fluoride varnish|fluoride varnish
397335|NCT01881100|caries lesion|caries lesion
397336|NCT01881100|deciduous teeth|deciduous teeth
397337|NCT01881087|Knee Arthroscopy|knee arthroscopy
397338|NCT01881087|Levobupivacaine|levobupivacaine
397339|NCT01881087|Spinal Anesthesia|spinal anesthesia
397340|NCT01881087|Motor Block|motor block
397341|NCT01881074|Type II Diabetes|type ii diabetes
397342|NCT01881074|Periodontal Disease|periodontal disease
397343|NCT01881074|Periodontitis|periodontitis
397344|NCT01881074|Gum Disease|gum disease
397345|NCT01881074|Gingivitis|gingivitis
397346|NCT01881074|Triclosan|triclosan
397347|NCT01881074|Inflammatory Markers|inflammatory markers
397348|NCT01881074|Immune Response|immune response
397349|NCT01881061|Sonography|sonography
397350|NCT01881061|ICU|icu
397351|NCT01881061|PEEP|peep
397352|NCT01881048|Breast cancer|breast cancer
399254|NCT01872715|Oracea|oracea
397353|NCT01881048|Omega-3 Fatty Acid|omega-3 fatty acid
397354|NCT01881048|Celecoxib|celecoxib
397355|NCT01881048|Celebrex|celebrex
397357|NCT01881035|Hypertension|hypertension
397358|NCT01881035|End stage renal disease|end stage renal disease
397359|NCT01881022|Breast Cancer|breast cancer
397360|NCT01881022|Couples|couples
397361|NCT01881022|Sexual Dysfunction|sexual dysfunction
795633|NCT00271596|SSRI|ssri
508264|NCT01397656|CPR|cpr
397362|NCT01881022|Psychosexual Intervention|psychosexual intervention
397363|NCT01881022|Sex Therapy|sex therapy
397364|NCT01881022|Online Support|online support
397365|NCT01881022|e-health|e-health
397366|NCT01881009|Diabetes|diabetes
397367|NCT01881009|Insulin|insulin
397368|NCT01881009|Closed loop|closed loop
397369|NCT01881009|Nocturnal glucose control|nocturnal glucose control
397370|NCT01880996|Ovarian Cancer|ovarian cancer
397371|NCT01880996|Gynecological Malignancies|gynecological malignancies
397372|NCT01880996|Chemotherapy|chemotherapy
397373|NCT01880996|Tai-chi|tai-chi
397374|NCT01880996|Qigong|qigong
397375|NCT01880996|Fatigue|fatigue
397376|NCT01880996|Quality of life|quality of life
397377|NCT01880996|Sleep disturbance|sleep disturbance
397378|NCT01880983|EPP|epp
397379|NCT01880983|Bloomer|bloomer
397380|NCT01880983|Porphyria|porphyria
397381|NCT01880957|bipolar disorder|bipolar disorder
397382|NCT01880957|bipolar depression|bipolar depression
397383|NCT01880957|serotonin transporter|serotonin transporter
397384|NCT01880957|serotonin receptors|serotonin receptors
397385|NCT01880957|binding potential|binding potential
397386|NCT01880957|brain imaging|brain imaging
397387|NCT01880957|unipolar depression|unipolar depression
397388|NCT01880944|spine|spine
397389|NCT01880944|trauma|trauma
397390|NCT01880944|MRI|mri
397391|NCT01880944|contrast|contrast
397392|NCT01880918|Compression Anastomosis|compression anastomosis
397393|NCT01880905|the length of uterine ovarian ligament|the length of uterine ovarian ligament
397394|NCT01880879|coronary artery disease|coronary artery disease
397395|NCT01880879|PCI|pci
397396|NCT01880879|stent|stent
397397|NCT01880866|PAH|pah
397398|NCT01880853|breast cancer|breast cancer
397399|NCT01880853|screening|screening
397400|NCT01880853|mammography|mammography
397401|NCT01880853|ultrasound|ultrasound
397402|NCT01880827|GIP|gip
397403|NCT01880827|GLP-1|glp-1
397404|NCT01880827|type 2 diabetes|type 2 diabetes
397405|NCT01880827|obesity|obesity
397406|NCT01880827|splanchnic blood flow|splanchnic blood flow
397407|NCT01880827|incretin hormones|incretin hormones
397408|NCT01880814|Depression, child, cognitive behavioral treatment, parent training, personalized treatment|depression, child, cognitive behavioral treatment, parent training, personalized treatment
397409|NCT01880801|ITP|itp
397410|NCT01880788|Age Related Macular Degeneration|age related macular degeneration
397411|NCT01880788|Choroidal Neovascularization|choroidal neovascularization
397412|NCT01880788|Central Serous Chorioretinopathy|central serous chorioretinopathy
397413|NCT01880762|PET MR development and validation|pet mr development and validation
397414|NCT01880723|exhaled breath condensate|exhaled breath condensate
397415|NCT01880723|diffusion capacity of the lungs for carbon monoxide and nitric oxide|diffusion capacity of the lungs for carbon monoxide and nitric oxide
397416|NCT01880723|albuterol|albuterol
397417|NCT01880723|peripheral oxygen saturation|peripheral oxygen saturation
397418|NCT01880723|ion regulation|ion regulation
397419|NCT01880710|long term follow-up|long term follow-up
397420|NCT01880710|urinary incontinence|urinary incontinence
397421|NCT01880710|pelvic organ prolapse|pelvic organ prolapse
397422|NCT01880710|total versus subtotal hysterectomy|total versus subtotal hysterectomy
397423|NCT01880697|Influenza|influenza
397424|NCT01880697|adults|adults
397425|NCT01880697|elderly|elderly
397426|NCT01880697|immunology|immunology
397427|NCT01880697|safety|safety
397428|NCT01880684|Thermodilution|thermodilution
397429|NCT01880684|Blood Volume|blood volume
397430|NCT01880684|Cardiac Output|cardiac output
397432|NCT01880684|Capnography|capnography
397433|NCT01880684|Blood Pressure|blood pressure
397434|NCT01880658|Maintenance therapy|maintenance therapy
397435|NCT01880658|Capecitabine|capecitabine
397436|NCT01880658|Adjuvant chemotherapy|adjuvant chemotherapy
397437|NCT01880658|Post-operation|post-operation
397438|NCT01880645|Breast Cancer|breast cancer
397439|NCT01880645|Invasive breast cancer|invasive breast cancer
397440|NCT01880645|Axillary lymph node metastases|axillary lymph node metastases
397441|NCT01880645|Ultrasound|ultrasound
397442|NCT01880645|Fine needle aspiration|fine needle aspiration
397443|NCT01880645|FNA|fna
397444|NCT01880645|Lymph node surgery|lymph node surgery
397445|NCT01880645|Partial mastectomy|partial mastectomy
397446|NCT01880645|Total mastectomy|total mastectomy
397447|NCT01880632|XELOX|xelox
397448|NCT01880632|perioperative treatment|perioperative treatment
397449|NCT01880632|locally advanced gastric adenocarcinoma|locally advanced gastric adenocarcinoma
397450|NCT01880632|D2 resection|d2 resection
397451|NCT01880619|Double J|double j
397452|NCT01880619|Ureteral stents|ureteral stents
397453|NCT01880619|Symptoms|symptoms
397454|NCT01880619|Alpha blockers|alpha blockers
397455|NCT01880619|Anticholinergic|anticholinergic
397456|NCT01880593|Ketamine|ketamine
397457|NCT01880593|glutamate|glutamate
397458|NCT01880593|N-methyl-D-aspartate|n-methyl-d-aspartate
397459|NCT01880593|depression|depression
397460|NCT01880593|major depressive disorder|major depressive disorder
397461|NCT01880593|treatment resistant|treatment resistant
397462|NCT01880593|antidepressant|antidepressant
397463|NCT01880593|lithium|lithium
397464|NCT01880554|Liver metastases|liver metastases
397465|NCT01880554|Colorectal primary cancer|colorectal primary cancer
397466|NCT01880554|Contrast-enhanced ultrasound|contrast-enhanced ultrasound
397467|NCT01880554|Sonovue®|sonovue®
397468|NCT01880541|Patients with breast cancer and breast surgery requiring|patients with breast cancer and breast surgery requiring
397469|NCT01880515|Lung cancer|lung cancer
397470|NCT01880515|BIBW 2992|bibw 2992
397471|NCT01880515|Skin Rash|skin rash
397472|NCT01880515|Tetracycline|tetracycline
397473|NCT01880515|Afatinib|afatinib
397474|NCT01880502|Healthy, Volunteers|healthy, volunteers
397475|NCT01880489|transgender women|transgender women
397476|NCT01880489|sexual risk|sexual risk
397477|NCT01880489|substance use|substance use
397478|NCT01880489|HIV prevention|hiv prevention
397479|NCT01880489|behavioral intervention|behavioral intervention
397480|NCT01880476|Diabetes Mellitus, Type 2|diabetes mellitus, type 2
397481|NCT01880476|Comorbidity|comorbidity
397482|NCT01880476|Aged|aged
397483|NCT01880476|Health Services|health services
397484|NCT01880463|Dry eye disease|dry eye disease
397485|NCT01880463|incidence|incidence
397486|NCT01880463|progression|progression
397487|NCT01880411|PEK fusion protein Healthbanks|pek fusion protein healthbanks
397488|NCT01880398|FIstula in ano; Bhagandar|fistula in ano; bhagandar
397489|NCT01880385|bevacizumab|bevacizumab
397490|NCT01880385|inflammatory breast cancer|inflammatory breast cancer
397491|NCT01880385|non metastatic|non metastatic
397492|NCT01880385|Avastin|avastin
397493|NCT01880372|Diabetes|diabetes
397494|NCT01880372|Diabetic Retinopathy|diabetic retinopathy
397495|NCT01880372|Retinopathy|retinopathy
397496|NCT01880372|Free radical|free radical
397497|NCT01880372|Retinal diseases|retinal diseases
397498|NCT01880372|Antioxidants|antioxidants
397499|NCT01880372|Protective agents|protective agents
397500|NCT01880372|Thioctic acid|thioctic acid
397501|NCT01880346|Cystic Fibrosis|cystic fibrosis
397502|NCT01880346|Vitamin D|vitamin d
397503|NCT01880346|absorption|absorption
397504|NCT01880346|vitamin Deficiency|vitamin deficiency
397505|NCT01880346|fat soluble|fat soluble
397506|NCT01880333|Refractory epilepsy|refractory epilepsy
397507|NCT01880333|dietary therapy|dietary therapy
397508|NCT01880333|non-pharmacological therapy|non-pharmacological therapy
397509|NCT01880333|Modified Atkin Diet|modified atkin diet
397510|NCT01880307|Crohn's disease|crohn's disease
397511|NCT01880307|pediatric|pediatric
397512|NCT01880307|infliximab|infliximab
397513|NCT01880307|top-down|top-down
397514|NCT01880307|ITSKids|itskids
397515|NCT01880294|Constipation|constipation
397516|NCT01880294|Chronic constipation|chronic constipation
397517|NCT01880294|Asia-Pacific|asia-pacific
397518|NCT01880294|Gastroentrology|gastroentrology
397519|NCT01880294|Asian participants|asian participants
397520|NCT01880281|G protein-coupled receptor 99|g protein-coupled receptor 99
397521|NCT01880281|2-oxoglutarate receptor 1|2-oxoglutarate receptor 1
397522|NCT01880281|alpha-ketoglutarate|alpha-ketoglutarate
397523|NCT01880281|urine|urine
397524|NCT01880281|pH|ph
397525|NCT01880281|acidosis|acidosis
397526|NCT01880281|alkalosis|alkalosis
397527|NCT01880281|Healthy volunteers|healthy volunteers
397528|NCT01880255|Repetitive Transcranial Magnetic Stimulation|repetitive transcranial magnetic stimulation
397529|NCT01880255|Schizophrenia|schizophrenia
397530|NCT01880255|Cognition|cognition
397531|NCT01880255|Working Memory|working memory
397532|NCT01880242|International|international
397533|NCT01880242|Multicenter|multicenter
397534|NCT01880242|Observational registry|observational registry
397535|NCT01880242|Orsiro Drug Eluting Stent (DES)|orsiro drug eluting stent (des)
397536|NCT01880242|Stenting|stenting
397537|NCT01880242|Treatment of Coronary Artery Disease|treatment of coronary artery disease
397538|NCT01880242|Coronary revascularization|coronary revascularization
397539|NCT01880242|Percutaneous Coronary Intervention (PCI)|percutaneous coronary intervention (pci)
397540|NCT01880242|STEMI|stemi
397541|NCT01880242|NSTEMI|nstemi
397542|NCT01880242|Ischemia|ischemia
397543|NCT01880242|Angina|angina
397544|NCT01880242|Subgroups|subgroups
397545|NCT01880242|Acute Myocardial Infarction|acute myocardial infarction
397546|NCT01880242|Diabetes|diabetes
397547|NCT01880242|Small Vessels|small vessels
397548|NCT01880242|Chronic Total Occlusion (CTO)|chronic total occlusion (cto)
397549|NCT01880216|Deep vein thrombosis|deep vein thrombosis
397550|NCT01880216|DVT|dvt
397551|NCT01880216|Treatment|treatment
397552|NCT01880216|Low molecular weight heparin|low molecular weight heparin
397553|NCT01880216|Bemiparin|bemiparin
397554|NCT01880216|Enoxaparin|enoxaparin
397555|NCT01880203|thyroid|thyroid
397556|NCT01880203|elastography SWE|elastography swe
397557|NCT01880203|indeterminate cytology|indeterminate cytology
397558|NCT01880164|Scoliosis|scoliosis
397559|NCT01880164|Kyphosis|kyphosis
397560|NCT01880164|Sagittal plane deformity|sagittal plane deformity
397561|NCT01880151|Alzheimer's disease|alzheimer's disease
397562|NCT01880151|Dementia|dementia
397563|NCT01880151|Prodromal|prodromal
397565|NCT01880151|ERP|erp
397566|NCT01880151|Biomarkers|biomarkers
397567|NCT01880138|Animated cartoon, Emergence agitation|animated cartoon, emergence agitation
397568|NCT01880125|Tramadol|tramadol
397569|NCT01880125|Acetaminophen|acetaminophen
397570|NCT01880125|Pharmacokinetics|pharmacokinetics
397571|NCT01880125|Sustained release|sustained release
397572|NCT01880125|Immediate release|immediate release
397573|NCT01880112|Infection|infection
397574|NCT01880112|Cesarean delivery|cesarean delivery
397575|NCT01880112|Antibiotic prophylaxis|antibiotic prophylaxis
397576|NCT01880112|Cefazolin dosing|cefazolin dosing
397577|NCT01880099|addiction|addiction
397578|NCT01880099|smoking|smoking
397579|NCT01880099|tobacco|tobacco
397580|NCT01880099|cigarettes|cigarettes
397581|NCT01880086|Chronic pain|chronic pain
397582|NCT01880086|Low testosterone|low testosterone
397583|NCT01880086|Hypogonadism|hypogonadism
397584|NCT01880086|Opioid analgesics|opioid analgesics
397585|NCT01880086|Narcotics|narcotics
397586|NCT01880086|Opioid-induced androgen deficiency|opioid-induced androgen deficiency
397587|NCT01880086|OPIAD|opiad
397588|NCT01880086|Male infertility|male infertility
397589|NCT01880086|Clomiphene citrate|clomiphene citrate
397590|NCT01880086|Selective Estrogen Receptor Modulators|selective estrogen receptor modulators
397591|NCT01880086|Testosterone replacement therapy|testosterone replacement therapy
397592|NCT01880060|Worksite|worksite
397593|NCT01880060|weight loss|weight loss
397594|NCT01880060|obesity|obesity
397595|NCT01880047|Immune Thrombocytopenia|immune thrombocytopenia
397596|NCT01880047|ITP|itp
397597|NCT01880047|Eltrombopag|eltrombopag
397598|NCT01880047|Promacta|promacta
397599|NCT01880008|positron emission tomography|positron emission tomography
397600|NCT01880008|magnetic resonance imaging|magnetic resonance imaging
397601|NCT01880008|diffusion magnetic resonance imaging|diffusion magnetic resonance imaging
397602|NCT01880008|radionuclide imaging|radionuclide imaging
397603|NCT01880008|disease management|disease management
397604|NCT01880008|radiation therapy|radiation therapy
397605|NCT01879982|Bipolar disorder|bipolar disorder
397606|NCT01879982|subtypes|subtypes
397607|NCT01879969|computer-assisted orthognathic surgery; facial asymmetry|computer-assisted orthognathic surgery; facial asymmetry
397608|NCT01879956|Executive Functions|executive functions
397609|NCT01879956|Schizophrenia|schizophrenia
397610|NCT01879956|Occupational Therapy|occupational therapy
397611|NCT01879943|Colorectal cancer|colorectal cancer
397612|NCT01879943|Follow up|follow up
397613|NCT01879943|Colonoscopy|colonoscopy
397614|NCT01879943|Videocapsule|videocapsule
397615|NCT01879930|randomized|randomized
397616|NCT01879930|placebo-controlled|placebo-controlled
397617|NCT01879930|double-blind study|double-blind study
397618|NCT01879930|doxycycline|doxycycline
397619|NCT01879917|c-peptide|c-peptide
397620|NCT01879917|insulin|insulin
397621|NCT01879917|hypoglycemia|hypoglycemia
397622|NCT01879917|Newly onset|newly onset
397623|NCT01879917|Diabetes|diabetes
397624|NCT01879917|Type 1|type 1
397625|NCT01879917|Beta cell|beta cell
397626|NCT01879917|Autoimmune|autoimmune
397627|NCT01879917|Glucagon|glucagon
397628|NCT01879917|Meal test|meal test
397629|NCT01879904|Colorectal Neoplasms|colorectal neoplasms
397630|NCT01879891|Exercise Intensity|exercise intensity
397631|NCT01879891|Metabolism|metabolism
397632|NCT01879891|Insulin|insulin
397633|NCT01879878|pancreatic adenocarcinoma|pancreatic adenocarcinoma
397634|NCT01879878|broccoli sprouts|broccoli sprouts
397635|NCT01879878|sulforaphane|sulforaphane
397636|NCT01879878|palliative chemotherapy|palliative chemotherapy
397637|NCT01879878|cancer stem cells|cancer stem cells
397638|NCT01879865|PKPD|pkpd
397639|NCT01879865|Dexmedetomidine|dexmedetomidine
397640|NCT01879865|Auditory Stimulation|auditory stimulation
397641|NCT01879865|Cardiac Output|cardiac output
397642|NCT01879852|Quadriceps strength|quadriceps strength
397643|NCT01879852|Knee|knee
397644|NCT01879852|Rehabilitation|rehabilitation
397645|NCT01879826|Aculaser|aculaser
397646|NCT01879826|Microlight ML830|microlight ml830
397647|NCT01879826|Kidney biopsy|kidney biopsy
397648|NCT01879826|Pain|pain
397649|NCT01879826|Anxiety|anxiety
397650|NCT01879826|Sedation|sedation
397651|NCT01879813|Memory|memory
397652|NCT01879813|Attention|attention
397653|NCT01879787|Stroke|stroke
397654|NCT01879787|transcranial direct current stimulation|transcranial direct current stimulation
397655|NCT01879787|constraint-induced movement therapy|constraint-induced movement therapy
397656|NCT01879787|mental practice|mental practice
397657|NCT01879774|Hyponatremia|hyponatremia
397658|NCT01879761|Immunosuppressed|immunosuppressed
397659|NCT01879761|Sepsis|sepsis
397660|NCT01879761|Staphylococcus Aureus|staphylococcus aureus
397661|NCT01879761|Bacteremia|bacteremia
397662|NCT01879761|HLA-DR|hla-dr
397663|NCT01879748|Parkinson's disease|parkinson's disease
397664|NCT01879748|Azilect|azilect
397665|NCT01879748|rasagiline mesylate|rasagiline mesylate
397666|NCT01879722|Drug therapy|drug therapy
397667|NCT01879709|schizophrenia|schizophrenia
397668|NCT01879709|Cognition|cognition
397669|NCT01879709|Independent living skills|independent living skills
397670|NCT01879683|Hunner's lesion|hunner's lesion
397671|NCT01879644|ADHD|adhd
397672|NCT01879644|Neurofeedback|neurofeedback
397673|NCT01879644|Self-Management|self-management
397674|NCT01879644|Parental Psychoeducation|parental psychoeducation
397675|NCT01879644|Social Support|social support
397676|NCT01879631|radial keratotomy; keratoconus; optical rehabilitation|radial keratotomy; keratoconus; optical rehabilitation
397677|NCT01879618|Fragmin|fragmin
397678|NCT01879618|dalteparin|dalteparin
397679|NCT01879618|hemodialysis|hemodialysis
397680|NCT01879618|anticoagulation|anticoagulation
397681|NCT01879618|Renal Failure|renal failure
397682|NCT01879605|Spinal surgery|spinal surgery
397683|NCT01879605|Bowel preparation|bowel preparation
397684|NCT01879605|Ileus|ileus
397685|NCT01879605|Constipation|constipation
397686|NCT01879605|Well-being|well-being
397687|NCT01879592|Sickle cell disease|sickle cell disease
397688|NCT01879592|Asthma|asthma
397689|NCT01879592|Metabolomics|metabolomics
397690|NCT01879592|Gene expression|gene expression
397691|NCT01879579|Insulin|insulin
397692|NCT01879579|Telemedicine|telemedicine
397693|NCT01879553|Influenza,|influenza,
397694|NCT01879553|Adults,|adults,
397695|NCT01879553|Elderly,|elderly,
397696|NCT01879553|Immunology,|immunology,
397697|NCT01879553|Safety|safety
397698|NCT01879540|Influenza,|influenza,
397699|NCT01879540|Elderly,|elderly,
397700|NCT01879540|Immunology,|immunology,
397701|NCT01879540|Safety|safety
397702|NCT01879514|IgA nephropathy|iga nephropathy
397703|NCT01879514|Therapy of Chinese medicine|therapy of chinese medicine
397704|NCT01879501|Low vision|low vision
397705|NCT01879501|Self management|self management
397706|NCT01879501|Randomized controlled trial|randomized controlled trial
397707|NCT01879501|Quality of life|quality of life
397708|NCT01879501|Self efficacy|self efficacy
397709|NCT01879501|Effectiveness|effectiveness
397710|NCT01879501|Chronic eye diseases management|chronic eye diseases management
397711|NCT01879488|Aerosol|aerosol
397712|NCT01879488|Lung deposition|lung deposition
397713|NCT01879488|Mechanical ventilation|mechanical ventilation
397714|NCT01879462|chronic hepatitis C (CHC)|chronic hepatitis c (chc)
397715|NCT01879462|Hepatitis C virus (HCV)|hepatitis c virus (hcv)
397716|NCT01879462|NS5B|ns5b
397717|NCT01879462|pharmacokinetics|pharmacokinetics
397718|NCT01879462|GSK2878175|gsk2878175
397719|NCT01879462|safety|safety
397720|NCT01879462|FTIH|ftih
397721|NCT01879462|healthy subjects|healthy subjects
397722|NCT01879449|Spasticity|spasticity
397723|NCT01879449|Veterans|veterans
397724|NCT01879449|Prevalence|prevalence
397725|NCT01879436|Pregnancy, Placenta, Cancer|pregnancy, placenta, cancer
397726|NCT01879410|GSK573719|gsk573719
397727|NCT01879410|lung function|lung function
397728|NCT01879410|salmeterol (SAL)|salmeterol (sal)
397729|NCT01879410|umeclidinium bromide (UMEC)|umeclidinium bromide (umec)
397730|NCT01879410|GW642444|gw642444
397731|NCT01879410|Chronic obstructive pulmonary disease|chronic obstructive pulmonary disease
397732|NCT01879410|Novel Dry Powder Inhaler (NDPI)|novel dry powder inhaler (ndpi)
397733|NCT01879410|fluticasone propionate (FP)|fluticasone propionate (fp)
397734|NCT01879410|vilanterol (VI)|vilanterol (vi)
397735|NCT01879397|atherosclerosis|atherosclerosis
397736|NCT01879397|arteriosclerosis|arteriosclerosis
397737|NCT01879397|carotid stenosis|carotid stenosis
397738|NCT01879397|carotid endarterectomy|carotid endarterectomy
397739|NCT01879397|Stroke|stroke
397740|NCT01879384|microdialysis|microdialysis
397741|NCT01879384|bone free flap|bone free flap
397742|NCT01879384|head and neck|head and neck
397743|NCT01879384|monitoring free flap|monitoring free flap
397744|NCT01879384|reconstructive surgery|reconstructive surgery
397745|NCT01879358|Drug-eluting stent|drug-eluting stent
397746|NCT01879358|Safety|safety
397747|NCT01879358|Efficacy|efficacy
397748|NCT01879345|Anticonvulsant|anticonvulsant
397749|NCT01879332|Anticonvulsant|anticonvulsant
397750|NCT01879319|LDL-C, triglycerides, high cholesterol|ldl-c, triglycerides, high cholesterol
397751|NCT01879293|Metformin|metformin
397752|NCT01879293|Left ventricular mass|left ventricular mass
397753|NCT01879293|Endothelial dysfunction|endothelial dysfunction
397754|NCT01879293|cardiac magnetic resonance|cardiac magnetic resonance
397755|NCT01879293|aortic pulse wave|aortic pulse wave
397756|NCT01879280|pterional craniotomy|pterional craniotomy
397757|NCT01879280|osteoplastic craniotomy|osteoplastic craniotomy
397758|NCT01879280|temporalis|temporalis
397759|NCT01879280|minimally-invasive|minimally-invasive
397760|NCT01879254|obsessive compulsive disorder (OCD)|obsessive compulsive disorder (ocd)
397761|NCT01879254|deep brain stimulation (DBS)|deep brain stimulation (dbs)
397762|NCT01879254|psychosurgery|psychosurgery
397763|NCT01879254|long-term follow-up|long-term follow-up
400566|NCT01866254|cesarean delivery|cesarean delivery
397764|NCT01879241|amyotrophic lateral sclerosis|amyotrophic lateral sclerosis
397765|NCT01879241|survival time|survival time
397766|NCT01879241|ALS functioning Rating Scale|als functioning rating scale
397767|NCT01879241|quality of life|quality of life
397768|NCT01879241|survival|survival
397769|NCT01879228|Cystic Fibrosis|cystic fibrosis
397770|NCT01879228|Diabetes|diabetes
397771|NCT01879228|Pancreatic Insufficiency|pancreatic insufficiency
397772|NCT01879202|multiple sclerosis|multiple sclerosis
397773|NCT01879202|fatigue|fatigue
397774|NCT01879202|fatigue severity scale|fatigue severity scale
397775|NCT01879202|fatigue impact scale|fatigue impact scale
397776|NCT01879202|quality of life|quality of life
397777|NCT01879163|Vaccine|vaccine
397778|NCT01879163|Immunogenicity|immunogenicity
397779|NCT01879137|Copeptin|copeptin
397780|NCT01879137|Arginin stimulation test|arginin stimulation test
397781|NCT01879111|Depressive episode|depressive episode
397782|NCT01879111|Chronic ischaemic heart disease|chronic ischaemic heart disease
397783|NCT01879111|Hypertension|hypertension
397784|NCT01879098|probiotics|probiotics
397785|NCT01879098|inflammation|inflammation
397786|NCT01879098|bile|bile
397787|NCT01879098|hunger|hunger
397788|NCT01879098|satiety|satiety
397789|NCT01879085|advanced|advanced
397790|NCT01879085|metastatic|metastatic
397791|NCT01879085|unresectable|unresectable
397792|NCT01879085|soft|soft
397793|NCT01879085|tissue|tissue
397794|NCT01879085|sarcomas|sarcomas
397795|NCT01879072|Biomarkers|biomarkers
397796|NCT01879072|Hematopoietic stem cell transplant|hematopoietic stem cell transplant
397797|NCT01879059|insulin resistance|insulin resistance
397798|NCT01879059|exercise|exercise
397799|NCT01879059|continuous glucose monitoring|continuous glucose monitoring
397800|NCT01879059|blood flow|blood flow
397801|NCT01879059|endothelial function|endothelial function
397802|NCT01879046|Mesenchymal stem cells|mesenchymal stem cells
397803|NCT01879046|articular cartilage|articular cartilage
397804|NCT01879046|tissue engineering|tissue engineering
397805|NCT01879046|immunomodulation|immunomodulation
397806|NCT01879046|osteo-arthritis|osteo-arthritis
397807|NCT01879033|Obesity|obesity
397808|NCT01879033|endothelial function|endothelial function
397809|NCT01879033|Rh-PAT|rh-pat
397810|NCT01879033|adipocytokines|adipocytokines
397811|NCT01879020|MT-8995|mt-8995
397812|NCT01879020|Dyslipidemia|dyslipidemia
397813|NCT01879020|Cholesteryl ester transfer proteins|cholesteryl ester transfer proteins
397814|NCT01878994|Overweight|overweight
397815|NCT01878994|Obesity|obesity
397816|NCT01878994|Children|children
397817|NCT01878994|Behaviour|behaviour
397818|NCT01878994|Physical Activity|physical activity
397819|NCT01878994|Nutrition|nutrition
397820|NCT01878981|Catheter Ablation versus Drug Therapy in AF in China|catheter ablation versus drug therapy in af in china
397821|NCT01878955|Antimullarian hormone(AMH)|antimullarian hormone(amh)
397822|NCT01878955|Polycystic Ovary|polycystic ovary
397823|NCT01878955|Multicystic Ovary|multicystic ovary
397825|NCT01878942|Pharmacology|pharmacology
397826|NCT01878942|Pharmacokinetics|pharmacokinetics
397827|NCT01878942|Pharmacodynamics|pharmacodynamics
397828|NCT01878942|Mechanism of action|mechanism of action
397829|NCT01878942|Psychedelic|psychedelic
397830|NCT01878942|Serotonin|serotonin
397831|NCT01878942|Prepulse inhibition|prepulse inhibition
397832|NCT01878942|LSD-induced neuroendocrine effects|lsd-induced neuroendocrine effects
397833|NCT01878942|Long-term psychological effects|long-term psychological effects
397834|NCT01878929|pollen|pollen
397835|NCT01878929|allergen immunotherapy|allergen immunotherapy
397836|NCT01878929|subcutaneous allergen immunotherapy|subcutaneous allergen immunotherapy
397837|NCT01878929|SCIT|scit
397838|NCT01878916|the incidence of thrombosis,|the incidence of thrombosis,
397839|NCT01878916|the effect of Hcy on thrombosis formation,|the effect of hcy on thrombosis formation,
397840|NCT01878916|the relation between Hcy and plasma vitamin levels,|the relation between hcy and plasma vitamin levels,
397841|NCT01878916|to compare these results with the control group|to compare these results with the control group
397842|NCT01878890|Solid tumors (other than pancreas)|solid tumors (other than pancreas)
397843|NCT01878877|Chronic pain|chronic pain
397844|NCT01878877|neuropathic pain|neuropathic pain
397845|NCT01878864|Pain, Discomfort, Periodontitis, Scaling and Root Planning, Visual Analogue Scale, McGills Pain Questionnaire|pain, discomfort, periodontitis, scaling and root planning, visual analogue scale, mcgills pain questionnaire
397846|NCT01878825|Immunogenicity|immunogenicity
397847|NCT01878825|Trivalent|trivalent
397848|NCT01878825|Safety|safety
397849|NCT01878825|Adults|adults
397850|NCT01878825|Elderly|elderly
397851|NCT01878825|Influenza|influenza
397852|NCT01878812|Immunogenicity|immunogenicity
397853|NCT01878812|Influenza|influenza
397854|NCT01878812|Adults|adults
397855|NCT01878812|Safety|safety
397856|NCT01878812|Elderly|elderly
397857|NCT01878799|Direct Acting Antiviral|direct acting antiviral
397858|NCT01878799|Treatment Naive|treatment naive
397859|NCT01878799|Interferon Sparing|interferon sparing
397860|NCT01878799|Ribavirin Sparing|ribavirin sparing
508880|NCT01394770|outcome|outcome
397861|NCT01878786|kidney failure|kidney failure
397862|NCT01878773|Prostate Cancer|prostate cancer
397863|NCT01878773|MRI scan|mri scan
397864|NCT01878773|External beam radiotherapy|external beam radiotherapy
397865|NCT01878760|APRICOT|apricot
397866|NCT01878760|Anaesthesia|anaesthesia
397867|NCT01878760|Children|children
397868|NCT01878760|kids|kids
397869|NCT01878760|Paediatric Anaesthesia|paediatric anaesthesia
397870|NCT01878760|Observational Trial|observational trial
397871|NCT01878760|epidemiology|epidemiology
397872|NCT01878760|severe critical events in|severe critical events in
397873|NCT01878760|European Society of Anaesthesiology|european society of anaesthesiology
397874|NCT01878760|Europe|europe
397875|NCT01878747|Pediatric|pediatric
397876|NCT01878747|Pain|pain
397877|NCT01878747|Postoperative|postoperative
397878|NCT01878747|General Anesthesia|general anesthesia
397879|NCT01878747|Anesthesia Recovery Period|anesthesia recovery period
397880|NCT01878747|Infant Behavior|infant behavior
397881|NCT01878747|Adolescent Behavior|adolescent behavior
397882|NCT01878747|Patient Satisfaction|patient satisfaction
397883|NCT01878721|PET/CT|pet/ct
397884|NCT01878721|infection|infection
397885|NCT01878721|vasculitis|vasculitis
397886|NCT01878708|T-Cell Lymphoma|t-cell lymphoma
397887|NCT01878708|Relapsed T-Cell Lymphoma|relapsed t-cell lymphoma
397888|NCT01878708|Refractory T-Cell Lymphoma|refractory t-cell lymphoma
397889|NCT01878708|Oncaspar®|oncaspar®
397890|NCT01878708|PEG-L-asparaginase and dexamethasone|peg-l-asparaginase and dexamethasone
397891|NCT01878695|Integrative Medicine|integrative medicine
397892|NCT01878695|Breast Cancer|breast cancer
397893|NCT01878695|Stage 0|stage 0
397894|NCT01878695|Stage 1|stage 1
397895|NCT01878669|n-acetyl cysteine|n-acetyl cysteine
397896|NCT01878669|percutaneous coronary intervention|percutaneous coronary intervention
397897|NCT01878643|aerosolized antibiotic|aerosolized antibiotic
397898|NCT01878643|ventilator-associated pneumonia|ventilator-associated pneumonia
397899|NCT01878643|bacterial resistance|bacterial resistance
397900|NCT01878643|ventilator -associated tracheobronchitis|ventilator -associated tracheobronchitis
397901|NCT01878643|clinical pulmonary infection score|clinical pulmonary infection score
397902|NCT01878630|Chronic Heart Failure|chronic heart failure
397904|NCT01878617|SJMB12|sjmb12
397905|NCT01878617|Brain Cancer|brain cancer
397906|NCT01878617|Brain Tumors in Children|brain tumors in children
397907|NCT01878617|Cisplatin|cisplatin
397908|NCT01878617|Cyclophosphamide|cyclophosphamide
397909|NCT01878617|Embryonal Tumors of CNS|embryonal tumors of cns
397910|NCT01878617|GDC-0449|gdc-0449
397911|NCT01878617|Gemcitabine|gemcitabine
397912|NCT01878617|Hedgehog Pathway Inhibitor|hedgehog pathway inhibitor
397913|NCT01878617|Infratentorial|infratentorial
397914|NCT01878617|Mass in Brain|mass in brain
397915|NCT01878617|Medulloblastoma|medulloblastoma
397916|NCT01878617|Medulloblastoma Brain Tumor|medulloblastoma brain tumor
397917|NCT01878617|Medulloblastoma Tumor|medulloblastoma tumor
397918|NCT01878617|Molecular|molecular
397919|NCT01878617|Neuroectodermal Tumor, Primitive|neuroectodermal tumor, primitive
397920|NCT01878617|Newly Diagnosed Childhood Medulloblastoma|newly diagnosed childhood medulloblastoma
397921|NCT01878617|Non-SHH Non-WNT|non-shh non-wnt
397922|NCT01878617|Pediatric Brain Tumor|pediatric brain tumor
397923|NCT01878617|Pemetrexed|pemetrexed
397924|NCT01878617|Posterior Fossa Tumor|posterior fossa tumor
397925|NCT01878617|Proton Beam Therapy|proton beam therapy
397926|NCT01878617|Radiation Therapy|radiation therapy
397927|NCT01878617|Rare Brain Tumor|rare brain tumor
397928|NCT01878617|Risk|risk
397929|NCT01878617|SHH|shh
397930|NCT01878617|Sonic Hedgehog Pathway|sonic hedgehog pathway
397931|NCT01878617|St Jude Medullo|st jude medullo
397932|NCT01878617|St. Jude Brain Tumor Studies|st. jude brain tumor studies
397933|NCT01878617|St. Jude Medullo|st. jude medullo
397934|NCT01878617|St. Jude Studies|st. jude studies
397935|NCT01878617|St. Jude Treatment|st. jude treatment
397936|NCT01878617|Treatment for Brain Tumors in Children|treatment for brain tumors in children
397937|NCT01878617|Untreated Childhood Medulloblastoma|untreated childhood medulloblastoma
397938|NCT01878617|Vincristine|vincristine
397939|NCT01878617|Vismodegib|vismodegib
397940|NCT01878617|WNT|wnt
397941|NCT01878591|labour|labour
397942|NCT01878591|dystocia|dystocia
397943|NCT01878591|operative delivery|operative delivery
397944|NCT01878591|vacuum|vacuum
397945|NCT01878591|ultrasound|ultrasound
397946|NCT01878578|Anticonvulsant, BIA 2-093|anticonvulsant, bia 2-093
397947|NCT01878565|HBIg|hbig
397948|NCT01878565|GM-CSF|gm-csf
397949|NCT01878565|HBV vaccine|hbv vaccine
397950|NCT01878565|immune regulatory therapy|immune regulatory therapy
397951|NCT01878526|gastroesophageal reflux disease|gastroesophageal reflux disease
397952|NCT01878526|heart burn|heart burn
397953|NCT01878526|regurgitation|regurgitation
397954|NCT01878526|systemic sclerosis|systemic sclerosis
397955|NCT01878526|scleroderma|scleroderma
397956|NCT01878526|proton pump inhibitor|proton pump inhibitor
397957|NCT01878526|alginic acid|alginic acid
397958|NCT01878526|omeprazole|omeprazole
397959|NCT01878526|prokinetic|prokinetic
397960|NCT01878500|Bladder exstrophy epispadias complex|bladder exstrophy epispadias complex
397961|NCT01878500|Pelvic floor musculature|pelvic floor musculature
397962|NCT01878500|Intraoperative stereotactic imaging|intraoperative stereotactic imaging
397963|NCT01878487|Acute MI|acute mi
397964|NCT01878487|Primary percutaneous coronary intervention|primary percutaneous coronary intervention
397965|NCT01878487|thrombus aspiration, IVUS|thrombus aspiration, ivus
397966|NCT01878474|MT-8995|mt-8995
397967|NCT01878474|Dyslipidemia|dyslipidemia
397968|NCT01878474|Cholesteryl ester transfer proteins|cholesteryl ester transfer proteins
397969|NCT01878435|Short Message System|short message system
397970|NCT01878435|SMS reminder|sms reminder
397971|NCT01878435|mobile phone|mobile phone
397972|NCT01878435|cell phone|cell phone
397973|NCT01878435|vaccination|vaccination
397974|NCT01878435|immunization|immunization
397975|NCT01878435|mHealth|mhealth
397976|NCT01878409|Sexuality|sexuality
397977|NCT01878409|Parkinson Disease|parkinson disease
397978|NCT01878409|BISF|bisf
397979|NCT01878409|IIEF|iief
397980|NCT01878409|FSFI|fsfi
397981|NCT01878396|Circulating Melanoma cells in metastatic melanoma|circulating melanoma cells in metastatic melanoma
397982|NCT01878383|(HSV)|(hsv)
397983|NCT01878357|MST|mst
397984|NCT01878357|Malaria|malaria
397985|NCT01878357|Indonesia|indonesia
397986|NCT01878357|Transmission|transmission
397987|NCT01878305|hepatic encephalopathy|hepatic encephalopathy
397988|NCT01878305|brain waves|brain waves
397989|NCT01878305|electroencephalogram|electroencephalogram
397990|NCT01878305|transcranial Doppler ultrasonography|transcranial doppler ultrasonography
397991|NCT01878305|physiological monitoring|physiological monitoring
397992|NCT01878305|intensive care|intensive care
397993|NCT01878266|Diffuse Intrinsic Pontine Glioma (DIPG)|diffuse intrinsic pontine glioma (dipg)
397994|NCT01878266|Hypofractionated Radiotherapy|hypofractionated radiotherapy
397995|NCT01878266|Radiotherapy|radiotherapy
397996|NCT01878266|Median survival|median survival
397997|NCT01878253|Total Shoulder Arthoplasty|total shoulder arthoplasty
397998|NCT01878240|Vascular surgery|vascular surgery
397999|NCT01878240|Abdominal Aortic aneurysm|abdominal aortic aneurysm
398000|NCT01878240|endovascular|endovascular
398001|NCT01878214|Health communication|health communication
398002|NCT01878214|Smoking cessation|smoking cessation
398003|NCT01878214|Health behavior|health behavior
398004|NCT01878214|Construction industry|construction industry
398005|NCT01878214|Audience segmentation|audience segmentation
398006|NCT01878201|Fimasartan|fimasartan
398007|NCT01878201|24 hours ABP monitoring(ABPM)|24 hours abp monitoring(abpm)
398008|NCT01878201|antihypertension|antihypertension
398009|NCT01878188|inodiftagene vixteplasmid|inodiftagene vixteplasmid
398010|NCT01878175|Arthroplasty, Replacement, Hip|arthroplasty, replacement, hip
398011|NCT01878175|Veterans|veterans
398012|NCT01878175|Exercise|exercise
398013|NCT01878162|Prevention|prevention
398014|NCT01878162|Wellness|wellness
398015|NCT01878162|Occupation|occupation
398016|NCT01878162|Work|work
398017|NCT01878162|Law Enforcement|law enforcement
398018|NCT01878162|Exercise|exercise
398019|NCT01878123|Arthritis|arthritis
398020|NCT01878123|Rheumatoid Arthritis|rheumatoid arthritis
398021|NCT01878123|Joint Diseases|joint diseases
398022|NCT01878123|Musculoskeletal Diseases|musculoskeletal diseases
398023|NCT01878123|Rheumatic Diseases|rheumatic diseases
398024|NCT01878123|Connective Tissue Diseases|connective tissue diseases
398025|NCT01878123|Autoimmune Diseases|autoimmune diseases
398026|NCT01878123|Immune System Diseases|immune system diseases
398027|NCT01878123|Antirheumatic agents|antirheumatic agents
398028|NCT01878110|Trichotillomania|trichotillomania
398029|NCT01878110|Hair pulling|hair pulling
398030|NCT01878110|Behavior therapy|behavior therapy
398031|NCT01878084|Tissue regeneration|tissue regeneration
398032|NCT01878084|sol gel bioglass|sol gel bioglass
398033|NCT01878084|alveolar ridge preservation|alveolar ridge preservation
398034|NCT01878084|children|children
398035|NCT01878084|Egyptian|egyptian
398036|NCT01878084|class II orthodontic cases|class ii orthodontic cases
398037|NCT01878058|Prostate cancer|prostate cancer
398038|NCT01878058|Brachytherapy|brachytherapy
398039|NCT01878058|Seed implant|seed implant
398040|NCT01878045|American Indians|american indians
398041|NCT01878045|Diabetic Nephropathy|diabetic nephropathy
398042|NCT01878045|Kidney Biopsy|kidney biopsy
398043|NCT01878045|Type 2 Diabetes Mellitus|type 2 diabetes mellitus
398044|NCT01878045|Retinopathy|retinopathy
398045|NCT01878032|Retinal Disease|retinal disease
398046|NCT01878032|Inherited Retinal Degeneration|inherited retinal degeneration
398047|NCT01878019|Pain|pain
398048|NCT01878019|Placebo|placebo
398049|NCT01878019|Opiate Antagonist|opiate antagonist
398050|NCT01878006|Opiate Receptor|opiate receptor
398051|NCT01878006|Genotype|genotype
398052|NCT01878006|PET Imaging|pet imaging
398053|NCT01877993|coronary artery spasm|coronary artery spasm
398054|NCT01877993|pathophysiology|pathophysiology
398055|NCT01877993|atrioventricular block|atrioventricular block
398056|NCT01877993|blood pressure|blood pressure
398057|NCT01877993|autonomic nervous function|autonomic nervous function
398058|NCT01877954|hydrofluoroalkane beclomethasone|hydrofluoroalkane beclomethasone
398059|NCT01877954|fluticasone|fluticasone
398060|NCT01877954|paediatrics|paediatrics
398061|NCT01877954|real-life|real-life
398062|NCT01877954|observational|observational
398063|NCT01877954|primary care|primary care
398064|NCT01877941|cardiac output|cardiac output
398065|NCT01877941|pulse oximetry|pulse oximetry
398066|NCT01877941|hemodynamics|hemodynamics
398067|NCT01877928|Obstructive sleep apnea, CPAP, Boussignac|obstructive sleep apnea, cpap, boussignac
398068|NCT01877915|Heart Failure|heart failure
398069|NCT01877915|Coronary Artery Disease|coronary artery disease
398070|NCT01877915|Stroke|stroke
398071|NCT01877915|Myocardial Infarction|myocardial infarction
398072|NCT01877915|Anticoagulation|anticoagulation
398073|NCT01877889|Healthy|healthy
398074|NCT01877889|Canagliflozin|canagliflozin
398075|NCT01877889|INVOKANA|invokana
398076|NCT01877889|Dapagliflozin|dapagliflozin
398077|NCT01877889|FORXIGA|forxiga
398078|NCT01877889|Pharmacodynamics|pharmacodynamics
398079|NCT01877863|intradialytic exercise|intradialytic exercise
398080|NCT01877863|hemodialysis|hemodialysis
398081|NCT01877837|Stem cell transplant|stem cell transplant
398082|NCT01877837|Sickle cell|sickle cell
398083|NCT01877837|Stem cell transplantation|stem cell transplantation
398084|NCT01877837|Related|related
398085|NCT01877837|Unrelated|unrelated
398086|NCT01877824|Surgery|surgery
398087|NCT01877824|Training|training
398088|NCT01877811|Lung Cancer|lung cancer
398089|NCT01877811|RET Inhibitor|ret inhibitor
398090|NCT01877811|Solid Tumors|solid tumors
398091|NCT01877811|RET mutations or rearrangements|ret mutations or rearrangements
398092|NCT01877811|BRAF mutations or rearrangements|braf mutations or rearrangements
398093|NCT01877811|Squamous NSCLC|squamous nsclc
398094|NCT01877811|KRAS mutation|kras mutation
398095|NCT01877811|Other Lung adenocarcinomas|other lung adenocarcinomas
398096|NCT01877772|cuff repair|cuff repair
398097|NCT01877772|arthroscopic|arthroscopic
398098|NCT01877772|Trephination|trephination
398099|NCT01877772|Bone|bone
398100|NCT01877772|cuff tear|cuff tear
398101|NCT01877759|Stem cell ,liver cirrhosis|stem cell ,liver cirrhosis
398102|NCT01877746|ICM|icm
398103|NCT01877746|myocarditis|myocarditis
398104|NCT01877746|cardiomyopathy|cardiomyopathy
398105|NCT01877746|endomyocardial biopsy|endomyocardial biopsy
398106|NCT01877746|immunosuppression|immunosuppression
398107|NCT01877733|Resistance training|resistance training
398108|NCT01877720|Preterm infant less than 32 weeks of gestation age|preterm infant less than 32 weeks of gestation age
398109|NCT01877720|intubated more than 48 hours after birth|intubated more than 48 hours after birth
398110|NCT01877720|postextubation|postextubation
398111|NCT01877694|pink eye|pink eye
398112|NCT01877668|psoriatic arthritis|psoriatic arthritis
398113|NCT01877668|radiographic changes|radiographic changes
398114|NCT01877668|active comparator|active comparator
398115|NCT01877668|tofacitinib|tofacitinib
398116|NCT01877655|ASP0113|asp0113
398117|NCT01877655|Cytomegalovirus (CMV)|cytomegalovirus (cmv)
398118|NCT01877655|Hematopoietic Cell Transplant (HCT)|hematopoietic cell transplant (hct)
398119|NCT01877642|ADASUVE|adasuve
398120|NCT01877642|inhaled loxapine|inhaled loxapine
398121|NCT01877642|drug drug interaction|drug drug interaction
398122|NCT01877642|lorazepam|lorazepam
398123|NCT01877642|acute treatment of agitation|acute treatment of agitation
398124|NCT01877629|Pharmacokinetics|pharmacokinetics
398125|NCT01877629|Tolerability|tolerability
398126|NCT01877629|Safety|safety
398127|NCT01877629|ACT-129968|act-129968
398128|NCT01877616|sleep disorders|sleep disorders
398129|NCT01877616|insomnia|insomnia
398130|NCT01877616|hypersomnia|hypersomnia
398131|NCT01877616|sleep-disordered breathing|sleep-disordered breathing
398132|NCT01877616|cardiovascular health|cardiovascular health
398133|NCT01877616|stroke|stroke
398134|NCT01877616|ischemic heart disease|ischemic heart disease
398135|NCT01877616|Atahualpa|atahualpa
398136|NCT01877551|HIV|hiv
398137|NCT01877551|Protease inhibitor|protease inhibitor
398138|NCT01877551|insulin resistance|insulin resistance
398139|NCT01877551|Tauroursodeoxycholic acid|tauroursodeoxycholic acid
398140|NCT01877525|colorectal polyps|colorectal polyps
398141|NCT01877525|resect and discard|resect and discard
398142|NCT01877525|endoscopic prediction|endoscopic prediction
398143|NCT01877525|histological diagnosis|histological diagnosis
398144|NCT01877525|narrow band imaging|narrow band imaging
398145|NCT01877499|Hemodiafiltration|hemodiafiltration
398146|NCT01877499|Convection volume|convection volume
398147|NCT01877499|Filtration fraction|filtration fraction
398148|NCT01877499|Blood flow|blood flow
398149|NCT01877499|Treatment time|treatment time
398150|NCT01877486|atrial fibrillation|atrial fibrillation
398151|NCT01877486|cryoballoon ablation|cryoballoon ablation
398152|NCT01877486|persistent AF|persistent af
398153|NCT01877486|paroxysmal AF|paroxysmal af
398154|NCT01877486|dofetilide|dofetilide
398155|NCT01877473|atrial fibrillation|atrial fibrillation
398156|NCT01877473|persistent AF|persistent af
398157|NCT01877473|catheter ablation|catheter ablation
400040|NCT01868906|FMISO PET|fmiso pet
398158|NCT01877473|duration of 7 days to one year|duration of 7 days to one year
398159|NCT01877473|with symptoms and failure of at least one antiarrhythmic drug|with symptoms and failure of at least one antiarrhythmic drug
398160|NCT01877460|sodium alginate|sodium alginate
398161|NCT01877460|chocolate milk|chocolate milk
398162|NCT01877460|satiety|satiety
398163|NCT01877460|energy intake|energy intake
398164|NCT01877460|glycemia|glycemia
398165|NCT01877460|insulinemia|insulinemia
398166|NCT01877447|tDCS|tdcs
398167|NCT01877447|Brain stimulation|brain stimulation
398168|NCT01877447|depressive disorder|depressive disorder
398169|NCT01877434|Reversed shoulder arthroplasty|reversed shoulder arthroplasty
398170|NCT01877434|Treatment|treatment
398171|NCT01877434|TESS|tess
398172|NCT01877421|Reducing plaque|reducing plaque
398173|NCT01877421|Reducing gingivitis|reducing gingivitis
398174|NCT01877421|safety|safety
398175|NCT01877421|proof of concept|proof of concept
398176|NCT01877421|antiplaque chewing gum|antiplaque chewing gum
398177|NCT01877408|disposable circumcision device|disposable circumcision device
398178|NCT01877408|Tissue adhesive|tissue adhesive
398179|NCT01877408|Open surgical circumcision|open surgical circumcision
398180|NCT01877408|Minimally-invasive circumcision|minimally-invasive circumcision
398181|NCT01877395|Rabies|rabies
398182|NCT01877395|Purified Vero Rabies Vaccine - Serum Free|purified vero rabies vaccine - serum free
398183|NCT01877395|Human Diploid Cell Vaccine|human diploid cell vaccine
398184|NCT01877395|Imovax® Rabies|imovax® rabies
398185|NCT01877356|ambulatory surgery|ambulatory surgery
398186|NCT01877356|spinal anesthesia|spinal anesthesia
398187|NCT01877356|micturition|micturition
398188|NCT01877356|bladder retention|bladder retention
398189|NCT01877356|unilateral block|unilateral block
398190|NCT01877356|prilocaine hyperbaric|prilocaine hyperbaric
398191|NCT01877356|prilocaine plain|prilocaine plain
398192|NCT01877356|local anaesthetic dose|local anaesthetic dose
398193|NCT01877343|cardiac functional health classification|cardiac functional health classification
398194|NCT01877343|Congenital heart failure|congenital heart failure
398195|NCT01877343|chronic heart failure|chronic heart failure
398196|NCT01877330|shoulder arthroscopy|shoulder arthroscopy
398197|NCT01877330|ultrasound guided nerve block|ultrasound guided nerve block
398198|NCT01877330|interscalene nerve block|interscalene nerve block
398199|NCT01877317|Audiology|audiology
398200|NCT01877317|hearing loss|hearing loss
398201|NCT01877317|hearing healthcare|hearing healthcare
398202|NCT01877317|mobile app|mobile app
398203|NCT01877317|hearing aid fitting|hearing aid fitting
398204|NCT01877317|audiometry|audiometry
398205|NCT01877317|audiogram|audiogram
398206|NCT01877291|smoking, nasal lavage, exhaled breath condensate, mucociliary transport|smoking, nasal lavage, exhaled breath condensate, mucociliary transport
398207|NCT01877278|Osteoarthritis|osteoarthritis
398208|NCT01877278|Pulsed electromagnetic fields|pulsed electromagnetic fields
398209|NCT01877278|Device|device
398210|NCT01877278|Pain|pain
398211|NCT01877278|Pressure algometry|pressure algometry
398212|NCT01877252|critical limb ischemia|critical limb ischemia
398213|NCT01877252|endovascular treatment|endovascular treatment
398214|NCT01877252|open surgical repair|open surgical repair
398215|NCT01877252|diabetic foot|diabetic foot
398216|NCT01877226|Healthy|healthy
398217|NCT01877226|Tapentadol|tapentadol
398218|NCT01877213|coaching|coaching
398219|NCT01877213|therapeutic education|therapeutic education
398220|NCT01877213|hospital admission|hospital admission
398221|NCT01877213|quality improvement strategies|quality improvement strategies
398222|NCT01877213|management program|management program
398223|NCT01877213|nurse follow up|nurse follow up
398224|NCT01877213|discharge planning|discharge planning
398225|NCT01877213|rehospitalization|rehospitalization
398226|NCT01877187|Primary liver cancer|primary liver cancer
398227|NCT01877187|Metastatic liver cancer|metastatic liver cancer
398228|NCT01877174|Internal Carotid Stenosis|internal carotid stenosis
398229|NCT01877174|Reverse Flow|reverse flow
398230|NCT01877174|Carotid stenting|carotid stenting
398231|NCT01877174|MICHI(TM) NPS+f|michi(tm) nps+f
398232|NCT01877148|Parkinson, rehabilitation, tDCS|parkinson, rehabilitation, tdcs
398233|NCT01877135|anal carcinoma|anal carcinoma
398234|NCT01877135|AIN3|ain3
398235|NCT01877135|cohort study|cohort study
398236|NCT01877109|Lymphoma|lymphoma
398237|NCT01877109|Prognosis|prognosis
398238|NCT01877109|Biomarker|biomarker
398239|NCT01877109|Quality of life|quality of life
398240|NCT01877096|Motivational Interviewing|motivational interviewing
398241|NCT01877096|Screening Colonoscopy|screening colonoscopy
398242|NCT01877096|Cancer Prevention|cancer prevention
398243|NCT01877083|KIF5B-RET-Positive Adenocarcinoma|kif5b-ret-positive adenocarcinoma
398244|NCT01877083|Lung Cancer|lung cancer
398245|NCT01877083|NSCLC|nsclc
398246|NCT01877083|Non-Small Cell Lung Cancer|non-small cell lung cancer
398247|NCT01877070|assessments|assessments
398248|NCT01877070|13-076|13-076
398249|NCT01877057|Pea protein|pea protein
398250|NCT01877057|Satiety hormone|satiety hormone
398251|NCT01877057|Ussing Chamber|ussing chamber
398252|NCT01877044|Prebiotics|prebiotics
398253|NCT01877044|Intestinal permeability|intestinal permeability
398254|NCT01877044|Gut barrier function|gut barrier function
398255|NCT01877044|Immunity|immunity
398256|NCT01877031|central line|central line
398257|NCT01877031|ultrasound guided central line insertion|ultrasound guided central line insertion
398258|NCT01877031|virtual reality|virtual reality
398259|NCT01877031|augmented reality|augmented reality
398260|NCT01877018|Comparative Effectiveness Research|comparative effectiveness research
398261|NCT01877018|Reminder Systems|reminder systems
398262|NCT01877018|Patient Participation|patient participation
398263|NCT01877018|Primary Health Care|primary health care
398264|NCT01877018|Early Detection of Cancer|early detection of cancer
398265|NCT01877018|Colorectal Neoplasms|colorectal neoplasms
398266|NCT01877005|Multicenter, single arm and opened label phase II study|multicenter, single arm and opened label phase ii study
398267|NCT01876992|diabetes|diabetes
398268|NCT01876992|pediatrics|pediatrics
398269|NCT01876992|obesity|obesity
398270|NCT01876992|healthy volunteers|healthy volunteers
398271|NCT01876992|metformin|metformin
398272|NCT01876992|nutrition|nutrition
398273|NCT01876992|healthy controls|healthy controls
398274|NCT01876992|bmi|bmi
398275|NCT01876966|HIV|hiv
398276|NCT01876966|pharmacokinetic interaction|pharmacokinetic interaction
398277|NCT01876966|healthy HIV-negative person|healthy hiv-negative person
398278|NCT01876940|supraglottic airway|supraglottic airway
398279|NCT01876940|children|children
398280|NCT01876940|tracheal intubation|tracheal intubation
398281|NCT01876940|fiberoptic bronchoscopy|fiberoptic bronchoscopy
398282|NCT01876927|Locally|locally
398283|NCT01876927|Advanced|advanced
398284|NCT01876927|Resectable|resectable
398285|NCT01876927|Gastric Cancer|gastric cancer
398286|NCT01876914|Diabetes|diabetes
398287|NCT01876914|Edema|edema
398288|NCT01876914|DME|dme
398289|NCT01876914|OCT|oct
398290|NCT01876901|Rectal cancer|rectal cancer
398291|NCT01876901|Coloanal anastomosis|coloanal anastomosis
398292|NCT01876901|Phase 2 clinical trial|phase 2 clinical trial
398293|NCT01876888|patient satisfaction|patient satisfaction
398294|NCT01876888|physical therapy|physical therapy
398295|NCT01876888|MedRisk instrument|medrisk instrument
398296|NCT01876875|psoriasis|psoriasis
398297|NCT01876875|obesity|obesity
398298|NCT01876862|HIV-1|hiv-1
398299|NCT01876862|chronic infection|chronic infection
398300|NCT01876862|cure|cure
398301|NCT01876862|remission|remission
398302|NCT01876849|diabetes|diabetes
398303|NCT01876849|exenatide|exenatide
398304|NCT01876849|Byetta|byetta
398305|NCT01876849|Amylin|amylin
398306|NCT01876849|Lilly|lilly
398307|NCT01876836|i-gel|i-gel
398308|NCT01876836|C-LMA|c-lma
398309|NCT01876836|gastroeosephageal reflux|gastroeosephageal reflux
398310|NCT01876836|sore troat|sore troat
398311|NCT01876823|Memory Decline|memory decline
398312|NCT01876823|Depression|depression
398313|NCT01876823|Elderly|elderly
398314|NCT01876823|Antidepressants|antidepressants
398315|NCT01876823|Treatment|treatment
398316|NCT01876823|memantine|memantine
398317|NCT01876810|Gemfibrozil|gemfibrozil
398318|NCT01876810|Nicotine Dependence|nicotine dependence
398319|NCT01876810|Smoking|smoking
398320|NCT01876810|Cigarettes|cigarettes
398321|NCT01876784|vandetanib, AZD 6474, Differentiated Thyroid Cancer|vandetanib, azd 6474, differentiated thyroid cancer
398322|NCT01876771|177lutetium-DOTA(O)Tyr3)octreotate|177lutetium-dota(o)tyr3)octreotate
398323|NCT01876758|ECT|ect
398324|NCT01876758|Memory Training|memory training
398325|NCT01876758|Cognitive Remediation|cognitive remediation
398326|NCT01876758|Electroconvulsive Therapy|electroconvulsive therapy
398327|NCT01876758|Treatment Resistant Depression|treatment resistant depression
398328|NCT01876758|Depression|depression
398329|NCT01876758|Geriatric Depression|geriatric depression
398330|NCT01876758|Memory Loss|memory loss
398331|NCT01876758|Cognitive Training|cognitive training
398332|NCT01876732|hemodialysis|hemodialysis
398333|NCT01876732|viatmin B12 deficiency|viatmin b12 deficiency
398334|NCT01876732|Epogen|epogen
398335|NCT01876719|ADHD|adhd
398336|NCT01876719|AR08|ar08
398337|NCT01876719|adrenergic receptor agonists|adrenergic receptor agonists
398338|NCT01876719|randomized, placebo-controlled clinical trial|randomized, placebo-controlled clinical trial
398339|NCT01876706|UroLift System|urolift system
398340|NCT01876680|chronic|chronic
398341|NCT01876680|neck|neck
398342|NCT01876680|shoulder|shoulder
398343|NCT01876680|exercise|exercise
398344|NCT01876654|Total Knee Replacement|total knee replacement
398345|NCT01876654|Patient specific instrumentation|patient specific instrumentation
398346|NCT01876641|Metastatic melanoma|metastatic melanoma
398347|NCT01876641|melanoma|melanoma
398348|NCT01876641|BRAF-mutated Metastatic Melanoma|braf-mutated metastatic melanoma
398349|NCT01876641|V600EBRAF-mutated metastatic melanoma|v600ebraf-mutated metastatic melanoma
398350|NCT01876641|Decitabine|decitabine
398351|NCT01876641|Vemurafenib|vemurafenib
398352|NCT01876628|Clindamycin|clindamycin
398353|NCT01876628|Cellulitis|cellulitis
398354|NCT01876628|Flucloxacillin|flucloxacillin
398355|NCT01876628|Group A streptococcus|group a streptococcus
400726|NCT01865565|neoadjuvant|neoadjuvant
398356|NCT01876628|Staphylococcus aureus|staphylococcus aureus
398357|NCT01876615|safety/tolerability and pharmacokinetics/pharmacodynamics|safety/tolerability and pharmacokinetics/pharmacodynamics
398358|NCT01876602|adolescents|adolescents
398359|NCT01876602|exercise|exercise
398360|NCT01876602|fitness|fitness
398361|NCT01876602|school-based|school-based
398362|NCT01876589|Coronary Artery Disease (CAD)|coronary artery disease (cad)
398363|NCT01876589|Invasive coronary angiography (ICA)|invasive coronary angiography (ica)
398364|NCT01876589|Positron Emission Tomography (PET)|positron emission tomography (pet)
398365|NCT01876576|colonoscopy|colonoscopy
398366|NCT01876563|thioredoxin|thioredoxin
398367|NCT01876563|TBP-2|tbp-2
398368|NCT01876563|thioredoxin reductase|thioredoxin reductase
398369|NCT01876563|vitamin D|vitamin d
398370|NCT01876563|DIABETES|diabetes
398371|NCT01876550|Mupirocin Calcium Cream 2%|mupirocin calcium cream 2%
398372|NCT01876550|Bactroban® Cream|bactroban® cream
398373|NCT01876550|Secondarily infected traumatic skin lesions|secondarily infected traumatic skin lesions
398374|NCT01876524|Substance Use Disorder|substance use disorder
398375|NCT01876524|Attention Deficit Disorder With Hyperactivity|attention deficit disorder with hyperactivity
398376|NCT01876524|Schizophrenia|schizophrenia
398377|NCT01876524|Bipolar disorder|bipolar disorder
398378|NCT01876524|Personality disorder|personality disorder
398379|NCT01876511|MSI|msi
398380|NCT01876511|MSS (microsatellite unstable)|mss (microsatellite unstable)
398381|NCT01876511|MLH 1|mlh 1
398382|NCT01876511|MSH 2|msh 2
398383|NCT01876511|MSH 6|msh 6
398384|NCT01876511|PMS2|pms2
398385|NCT01876511|BRAF pV600E|braf pv600e
398386|NCT01876511|TGFBR2|tgfbr2
398387|NCT01876511|Mutation load|mutation load
398388|NCT01876511|tumor mutation load|tumor mutation load
398389|NCT01876511|mutation burden|mutation burden
398390|NCT01876511|tumor mutation burden (TMB)|tumor mutation burden (tmb)
398391|NCT01876511|hypermutation|hypermutation
398392|NCT01876511|POLE|pole
398393|NCT01876511|MSI Negative with Mutator Phenotype (High Tumor Mutation Burden)|msi negative with mutator phenotype (high tumor mutation burden)
398394|NCT01876511|TMB|tmb
398395|NCT01876485|Diabetes Mellitus|diabetes mellitus
398396|NCT01876485|health literacy|health literacy
398397|NCT01876485|patient activation|patient activation
398398|NCT01876485|goals of care|goals of care
398399|NCT01876394|Healthy|healthy
398400|NCT01876394|Arterial Stiffness|arterial stiffness
398401|NCT01876394|Blood Pressure|blood pressure
398402|NCT01876394|Blood Glucose|blood glucose
398403|NCT01876394|Vascular Function|vascular function
398404|NCT01876368|hypertension,|hypertension,
398405|NCT01876368|LCZ696,|lcz696,
398406|NCT01876368|olmesartan|olmesartan
398407|NCT01876355|Delirium, clonidine, ICU, sedation|delirium, clonidine, icu, sedation
398408|NCT01876342|sports hernia|sports hernia
398409|NCT01876342|sportsman's hernia|sportsman's hernia
398410|NCT01876342|chronic groin pain|chronic groin pain
398411|NCT01876342|open minimal repair|open minimal repair
398412|NCT01876342|totally extraperitoneal endoscopic technique|totally extraperitoneal endoscopic technique
398413|NCT01876329|Rheumatoid Arthritis|rheumatoid arthritis
398414|NCT01876329|Vitamin B12 deficiency|vitamin b12 deficiency
398415|NCT01876329|Autoimmune Thyroid Disease|autoimmune thyroid disease
398416|NCT01876329|Autoantibodies|autoantibodies
398417|NCT01876316|Moxifloxacin|moxifloxacin
398418|NCT01876316|QT interval prolongation|qt interval prolongation
398419|NCT01876316|Korean|korean
398420|NCT01876316|Japanese|japanese
398421|NCT01876290|Anesthesiology|anesthesiology
398422|NCT01876290|Complications|complications
398423|NCT01876290|Closed-loop|closed-loop
398424|NCT01876277|Cancer|cancer
398425|NCT01876277|Body image|body image
398426|NCT01876277|Adolescent|adolescent
398427|NCT01876264|Colorectal surgery|colorectal surgery
398428|NCT01876264|Colonoscopy|colonoscopy
398429|NCT01876264|Randomized controlled trial|randomized controlled trial
398430|NCT01876251|Breast cancer metastatic|breast cancer metastatic
398431|NCT01876251|docetaxel|docetaxel
398432|NCT01876251|PF-03084014|pf-03084014
398433|NCT01876238|Breast Cancer|breast cancer
398434|NCT01876238|Patient-Doctor Communication|patient-doctor communication
398435|NCT01876238|Supportive Care|supportive care
398436|NCT01876225|cervical biopsy|cervical biopsy
398437|NCT01876225|forced cough|forced cough
398438|NCT01876225|pain|pain
398439|NCT01876225|VAS scale|vas scale
398440|NCT01876212|melanoma|melanoma
398441|NCT01876212|metastatic|metastatic
398442|NCT01876212|vaccine|vaccine
398443|NCT01876212|BRAF|braf
398444|NCT01876199|HIV-1|hiv-1
398445|NCT01876199|acute|acute
398446|NCT01876199|diagnosis|diagnosis
398447|NCT01876199|pharmacies|pharmacies
398448|NCT01876199|healthcare facilities|healthcare facilities
398449|NCT01876186|antimuscarinic treatment|antimuscarinic treatment
398450|NCT01876186|urodynamic studies|urodynamic studies
398451|NCT01876186|nerve growth factor|nerve growth factor
398452|NCT01876173|Sudden cardiac death|sudden cardiac death
398453|NCT01876173|implantable cardioverter defibrillator|implantable cardioverter defibrillator
398454|NCT01876173|decision aid|decision aid
398455|NCT01876147|Low vision|low vision
398456|NCT01876147|Vision testing|vision testing
398457|NCT01876147|Retinitis Pigmentosa|retinitis pigmentosa
398458|NCT01876147|AMD|amd
398459|NCT01876147|Visual acuity|visual acuity
398460|NCT01876147|Poor vision|poor vision
398461|NCT01876147|Quantification|quantification
398462|NCT01876134|Cardiac surgery|cardiac surgery
398463|NCT01876134|Acute kidney injury|acute kidney injury
398464|NCT01876134|Cyr-61|cyr-61
398465|NCT01876134|Pulse wave analysis|pulse wave analysis
398466|NCT01876121|NSAIDs|nsaids
398467|NCT01876121|Acute pain|acute pain
398468|NCT01876108|Steatohepatitis|steatohepatitis
398469|NCT01876108|Helicobacter pylori|helicobacter pylori
398470|NCT01876108|Alanine aminotransferase|alanine aminotransferase
398471|NCT01876108|Aspartate aminotransferase|aspartate aminotransferase
398472|NCT01876108|Fatty Liver|fatty liver
398473|NCT01876108|Liver Diseases|liver diseases
398474|NCT01876108|Digestive System Diseases|digestive system diseases
398475|NCT01876082|Desmoids tumors|desmoids tumors
398476|NCT01876082|Pazopanib|pazopanib
398477|NCT01876082|Phase 2 clinical trial|phase 2 clinical trial
398478|NCT01876082|Cross over|cross over
398479|NCT01876056|Psychosis|psychosis
398480|NCT01876056|Culture|culture
398481|NCT01876056|CBT|cbt
398482|NCT01876030|Functional electrical stimulation (FES)|functional electrical stimulation (fes)
398483|NCT01876030|Sub acute stroke|sub acute stroke
398484|NCT01876030|Gait analysis|gait analysis
398485|NCT01876017|CRF|crf
398486|NCT01876017|STEM CELL|stem cell
398487|NCT01876017|CKD|ckd
398488|NCT01876004|ectopic pregnancy|ectopic pregnancy
398489|NCT01876004|methotrexate|methotrexate
398490|NCT01876004|human chorionic gonadotropin beta subunit|human chorionic gonadotropin beta subunit
398491|NCT01876004|expectant management|expectant management
398492|NCT01875978|Phytosterols|phytosterols
398493|NCT01875978|Endothelial progenitor cells|endothelial progenitor cells
398494|NCT01875952|Latent tuberculosis infection|latent tuberculosis infection
398495|NCT01875952|Human immunodeficiency virus (HIV)|human immunodeficiency virus (hiv)
398496|NCT01875952|Treatment|treatment
398497|NCT01875952|Isoniazid|isoniazid
398498|NCT01875939|healthy volunteers|healthy volunteers
398499|NCT01875913|Curiosity|curiosity
398500|NCT01875913|Intention|intention
398501|NCT01875913|Follow Through|follow through
398502|NCT01875900|neonatal resuscitation|neonatal resuscitation
398503|NCT01875900|video-assisted learning|video-assisted learning
398504|NCT01875900|self-directed training|self-directed training
398505|NCT01875900|simulation|simulation
398506|NCT01875900|simulation-based training|simulation-based training
398507|NCT01875900|simulation-based medical education|simulation-based medical education
398508|NCT01875900|objective structured clinical examination|objective structured clinical examination
398509|NCT01875874|liver failure|liver failure
398510|NCT01875874|acute liver failure|acute liver failure
398511|NCT01875874|fulminant hepatic failure|fulminant hepatic failure
398512|NCT01875874|primary graft non-function|primary graft non-function
398513|NCT01875874|surgically-induced liver failure|surgically-induced liver failure
398514|NCT01875874|ELAD|elad
398515|NCT01875874|ALF|alf
398516|NCT01875874|FHF|fhf
398517|NCT01875874|PNF|pnf
398518|NCT01875861|Antipsychotic Agents|antipsychotic agents
398519|NCT01875861|Metabolic Syndrome|metabolic syndrome
398520|NCT01875861|Quality Improvement|quality improvement
398521|NCT01875848|pain management|pain management
398522|NCT01875835|Acute myocardiac infarction|acute myocardiac infarction
398523|NCT01875835|Bare-metal stent|bare-metal stent
398524|NCT01875835|Everolimus-eluting stent|everolimus-eluting stent
398525|NCT01875835|Optical coherence tomography|optical coherence tomography
398526|NCT01875822|Curcumin|curcumin
398527|NCT01875822|Epigenetics|epigenetics
398528|NCT01875822|Schizophrenia|schizophrenia
398529|NCT01875822|Nitric Oxide synthetase|nitric oxide synthetase
398530|NCT01875822|cognition|cognition
398531|NCT01875822|negative symptoms|negative symptoms
398532|NCT01875809|RDN|rdn
398533|NCT01875809|renal denervation|renal denervation
398534|NCT01875809|catecholamine|catecholamine
398535|NCT01875809|spill-over|spill-over
398536|NCT01875809|blood pressure|blood pressure
398537|NCT01875809|electrophysiology|electrophysiology
398538|NCT01875809|ablation|ablation
398539|NCT01875796|cannabis|cannabis
398540|NCT01875796|marijuana|marijuana
398541|NCT01875796|anxiety|anxiety
398542|NCT01875796|transdiagnostic|transdiagnostic
398543|NCT01875796|dual diagnosis|dual diagnosis
398544|NCT01875796|cannabis abuse|cannabis abuse
398545|NCT01875796|cannabis dependence|cannabis dependence
398546|NCT01875796|cannabis use disorder|cannabis use disorder
398547|NCT01875783|diabetes|diabetes
398548|NCT01875783|diabetic macular edema|diabetic macular edema
398549|NCT01875783|diabetic retinopathy|diabetic retinopathy
398550|NCT01875783|optical coherence tomography|optical coherence tomography
398551|NCT01875770|Retinal Vein Occlusion|retinal vein occlusion
398552|NCT01875757|Vitamin D|vitamin d
398553|NCT01875757|Acute bronchitis|acute bronchitis
398554|NCT01875757|Upper respiratory tract infection|upper respiratory tract infection
398555|NCT01875757|Recurrent bronchitis|recurrent bronchitis
398556|NCT01875757|Acute bronchiolitis|acute bronchiolitis
398557|NCT01875757|Infants|infants
398558|NCT01875744|constipation|constipation
398559|NCT01875744|children|children
398560|NCT01875744|polyethylene glycol|polyethylene glycol
398561|NCT01875731|Pneumonia|pneumonia
398562|NCT01875731|Acute respiratory infection|acute respiratory infection
398563|NCT01875731|Decision-support techniques|decision-support techniques
398564|NCT01875692|Metagenomic|metagenomic
398565|NCT01875692|Ventilator-Associated Pneumonia (VAP)|ventilator-associated pneumonia (vap)
398566|NCT01875679|Surgical education|surgical education
398567|NCT01875679|Deliberate practice|deliberate practice
398568|NCT01875679|Debriefing|debriefing
398569|NCT01875679|Behaviour modelling|behaviour modelling
398570|NCT01875666|breast cancer|breast cancer
398571|NCT01875666|Kinome|kinome
398572|NCT01875666|HER two positive|her two positive
398573|NCT01875653|metastatic melanoma|metastatic melanoma
398574|NCT01875653|dendritic cells|dendritic cells
398575|NCT01875653|immunotherapy|immunotherapy
398576|NCT01875653|Granulocyte-Macrophage Colony Stimulating Factor|granulocyte-macrophage colony stimulating factor
398577|NCT01875653|overall survival|overall survival
398578|NCT01875653|autologous|autologous
398579|NCT01875653|peripheral blood mononuclear cells|peripheral blood mononuclear cells
398580|NCT01875653|treatment|treatment
398581|NCT01875653|phase 3|phase 3
398582|NCT01875653|tumor cells|tumor cells
398583|NCT01875640|disorder of sex development|disorder of sex development
398584|NCT01875640|intersex|intersex
398585|NCT01875640|46,XX congenital adrenal hyperplasia|46,xx congenital adrenal hyperplasia
398586|NCT01875640|hypospadias|hypospadias
398587|NCT01875640|decision support tool|decision support tool
398588|NCT01875601|NK Cells|nk cells
398589|NCT01875601|Cytokine|cytokine
398590|NCT01875601|Lymphodepleting Chemotherapy|lymphodepleting chemotherapy
398591|NCT01875601|Immunotherapy|immunotherapy
398592|NCT01875601|Pediatric|pediatric
398593|NCT01875588|Healthy Controls|healthy controls
398594|NCT01875588|HIV-positive|hiv-positive
398595|NCT01875588|Neurophyschological Testing|neurophyschological testing
398596|NCT01875588|Thinking and Memory|thinking and memory
398597|NCT01875588|Lumbar Drain/Puncture|lumbar drain/puncture
398598|NCT01875575|glucagon-like peptide-1|glucagon-like peptide-1
398599|NCT01875575|peptide tyrosine tyrosine|peptide tyrosine tyrosine
398600|NCT01875575|ghrelin|ghrelin
398601|NCT01875575|stomach|stomach
398602|NCT01875575|small intestine|small intestine
398603|NCT01875575|gastric emptying|gastric emptying
398604|NCT01875562|Neck pain|neck pain
398605|NCT01875562|Cervical radiculopathy|cervical radiculopathy
398606|NCT01875562|Qishe Pill|qishe pill
398607|NCT01875562|Traditional Chinese Medicine|traditional chinese medicine
398608|NCT01875536|transcranial magnetic stimulation|transcranial magnetic stimulation
398609|NCT01875536|spasticity|spasticity
398610|NCT01875536|physiotherapy|physiotherapy
398611|NCT01875536|Rehabilitation|rehabilitation
398612|NCT01875523|Renal disease|renal disease
398613|NCT01875523|renal impairment|renal impairment
398614|NCT01875523|End stage renal disease|end stage renal disease
398615|NCT01875523|Healthy volunteer|healthy volunteer
398616|NCT01875523|Pharmacokinetics|pharmacokinetics
398617|NCT01875497|athletes, polyphenols, nutrition, oxidative stress|athletes, polyphenols, nutrition, oxidative stress
398618|NCT01875484|miR-126|mir-126
398619|NCT01875484|Left Ventricular Remodeling|left ventricular remodeling
398620|NCT01875484|Myocardial Infarction|myocardial infarction
398621|NCT01875484|primary percutaneous coronary intervention|primary percutaneous coronary intervention
398622|NCT01875484|left ventricular end diastolic volume|left ventricular end diastolic volume
398623|NCT01875484|left ventricular ejection fraction|left ventricular ejection fraction
398624|NCT01875484|major adverse cardiovascular events|major adverse cardiovascular events
398625|NCT01875458|Aclasta|aclasta
398626|NCT01875458|Actonel|actonel
398627|NCT01875458|alendronate|alendronate
398628|NCT01875458|alendronate/cholecalciferol|alendronate/cholecalciferol
398629|NCT01875458|Aredia|aredia
398630|NCT01875458|Atelvia|atelvia
398631|NCT01875458|Boniva|boniva
398632|NCT01875458|Didronel|didronel
398633|NCT01875458|etidronate|etidronate
398634|NCT01875458|Fosamax|fosamax
398635|NCT01875458|Fosamax Plus D|fosamax plus d
398636|NCT01875458|ibandronate|ibandronate
398637|NCT01875458|pamidronate|pamidronate
398638|NCT01875458|Reclast|reclast
398639|NCT01875458|risedronate|risedronate
398640|NCT01875458|Skelid|skelid
398641|NCT01875458|tiludronate|tiludronate
398642|NCT01875458|zoledronic acid|zoledronic acid
398643|NCT01875458|Zometa|zometa
398644|NCT01875458|Bisphosphonate|bisphosphonate
398645|NCT01875458|Atypical Femur Fracture (AFF)|atypical femur fracture (aff)
398646|NCT01875458|Osteoporosis|osteoporosis
398647|NCT01875458|Bisphosphonate Related Osteonecrosis of the Jaw (BRONJ)|bisphosphonate related osteonecrosis of the jaw (bronj)
398648|NCT01875445|Inositol|inositol
398649|NCT01875445|Trichotillomania|trichotillomania
398650|NCT01875445|Hair Pulling|hair pulling
398651|NCT01875445|Impulse Control Disorder|impulse control disorder
398652|NCT01875393|Prostatic Disease|prostatic disease
398653|NCT01875393|Genital Neoplasm,male|genital neoplasm,male
398654|NCT01875393|Urogenital neoplasm|urogenital neoplasm
398655|NCT01875393|Genital disease,male|genital disease,male
398656|NCT01875393|Male urogenital disease|male urogenital disease
398657|NCT01875393|Neoplasms|neoplasms
398658|NCT01875393|Neoplasms by site|neoplasms by site
398659|NCT01875393|Prostatic neoplasm|prostatic neoplasm
398660|NCT01875393|Carcinoma|carcinoma
398661|NCT01875380|metastatic colorectal cancer|metastatic colorectal cancer
398662|NCT01875380|frail and unfit patient|frail and unfit patient
398663|NCT01875380|regorafenib|regorafenib
398664|NCT01875367|Subcutaneous trastuzumab|subcutaneous trastuzumab
398665|NCT01875367|Intravenous trastuzumab|intravenous trastuzumab
398666|NCT01875367|HER2 positive|her2 positive
398667|NCT01875367|Advanced Breast Cancer|advanced breast cancer
398668|NCT01875341|type 2 diabetes|type 2 diabetes
398669|NCT01875341|diabetic nephropathy|diabetic nephropathy
398670|NCT01875341|hypertension|hypertension
398671|NCT01875341|sleep apnea|sleep apnea
398672|NCT01875341|sympathetic hyperactivity|sympathetic hyperactivity
398673|NCT01875328|stroke|stroke
398674|NCT01875328|blood pressure|blood pressure
398675|NCT01875328|telemedicine|telemedicine
398676|NCT01875302|COPD PRO Instraments equivalency|copd pro instraments equivalency
398677|NCT01875276|Rhinitis|rhinitis
398678|NCT01875276|Antihistamine|antihistamine
398679|NCT01875276|Nasal Steroid Therapy|nasal steroid therapy
398680|NCT01875263|catheter-related bacteremia, SAMS|catheter-related bacteremia, sams
398681|NCT01875263|catheter related bacteremia|catheter related bacteremia
398682|NCT01875263|susceptible|susceptible
398683|NCT01875263|aureus meticillin|aureus meticillin
398684|NCT01875250|Gene Transfer|gene transfer
398685|NCT01875250|Androgen Receptor Antagonist|androgen receptor antagonist
398687|NCT01875250|Immune Response|immune response
398688|NCT01875250|Immunotherapy|immunotherapy
398689|NCT01875237|Leukemia|leukemia
398690|NCT01875237|Myeloma|myeloma
398691|NCT01875237|Myeloproliferative Diseases|myeloproliferative diseases
398692|NCT01875237|Myelodysplastic syndrome|myelodysplastic syndrome
398693|NCT01875237|MDS|mds
398694|NCT01875237|Lymphoma|lymphoma
398695|NCT01875237|Hodgkin disease|hodgkin disease
398696|NCT01875237|Multiple myeloma|multiple myeloma
398697|NCT01875237|MM|mm
398698|NCT01875237|Transplant donor|transplant donor
398699|NCT01875237|T-cells|t-cells
398700|NCT01875237|G-versus-host disease|g-versus-host disease
398701|NCT01875237|GvHD|gvhd
398702|NCT01875237|G-CSF|g-csf
398703|NCT01875237|Filgrastim|filgrastim
398704|NCT01875237|Neupogen|neupogen
398705|NCT01875237|Fludarabine|fludarabine
398706|NCT01875237|Fludarabine phosphate|fludarabine phosphate
398707|NCT01875237|Fludara|fludara
398708|NCT01875237|Melphalan|melphalan
398709|NCT01875237|Alkeran|alkeran
398710|NCT01875237|Alemtuzumab|alemtuzumab
398711|NCT01875237|CAMPATH-1H|campath-1h
398712|NCT01875237|Campath|campath
398713|NCT01875237|Tacrolimus|tacrolimus
398714|NCT01875237|Prograf|prograf
398715|NCT01875237|Mini-methotrexate|mini-methotrexate
398716|NCT01875237|AP 1903|ap 1903
398717|NCT01875237|Methylprednisolone|methylprednisolone
398718|NCT01875237|Depo-Medrol|depo-medrol
398719|NCT01875237|Medrol|medrol
398720|NCT01875237|Solu-Medrol|solu-medrol
398721|NCT01875237|Stem cell infusion|stem cell infusion
398722|NCT01875237|Donor lymphocyte infusion|donor lymphocyte infusion
398723|NCT01875237|DLI|dli
398724|NCT01875237|Questionnaire|questionnaire
398725|NCT01875237|Survey|survey
398726|NCT01875224|kidney transplant|kidney transplant
398727|NCT01875224|diabetes after transplant|diabetes after transplant
398728|NCT01875224|belatacept|belatacept
398729|NCT01875198|Splenectomy;|splenectomy;
398730|NCT01875198|Spleen-preserving|spleen-preserving
398731|NCT01875185|acute coronary syndrome|acute coronary syndrome
398732|NCT01875185|clotting|clotting
398733|NCT01875185|hormones|hormones
398734|NCT01875185|women|women
398735|NCT01875172|bupropion SR|bupropion sr
398736|NCT01875172|randomized controlled trial|randomized controlled trial
398737|NCT01875172|pregnancy|pregnancy
398738|NCT01875159|Prematurity|prematurity
398739|NCT01875159|Apnea of prematurity|apnea of prematurity
398740|NCT01875159|Intermittent hypoxia|intermittent hypoxia
398741|NCT01875133|airway disease|airway disease
398742|NCT01875133|bronchitis|bronchitis
398743|NCT01875133|emphysema|emphysema
398744|NCT01875133|lung|lung
398745|NCT01875120|Anxiety|anxiety
398746|NCT01875120|Somatoform Disorders|somatoform disorders
398747|NCT01875068|referrals|referrals
398748|NCT01875068|nurse practitioners|nurse practitioners
398749|NCT01875068|physician assistants|physician assistants
398750|NCT01875068|consultative general internal medicine|consultative general internal medicine
398751|NCT01875055|Cerebral|cerebral
398752|NCT01875055|desaturation|desaturation
398753|NCT01875029|Low back pain|low back pain
398754|NCT01875029|chronic pain|chronic pain
398755|NCT01875029|tDCS|tdcs
398756|NCT01875029|transcranial direct current stimulation|transcranial direct current stimulation
398757|NCT01875016|Cryo ablation|cryo ablation
398758|NCT01875016|Cardiomyopathy|cardiomyopathy
398759|NCT01874977|rheumatoid arthritis|rheumatoid arthritis
398760|NCT01874977|fatigue|fatigue
398761|NCT01874977|physical activity|physical activity
398762|NCT01874964|HIV Prevention|hiv prevention
398763|NCT01874964|Opioid-Related Disorders|opioid-related disorders
398764|NCT01874964|Medication Assisted Treatment|medication assisted treatment
398765|NCT01874964|Methadone|methadone
398766|NCT01874951|Depression|depression
398767|NCT01874951|Recurrence|recurrence
398768|NCT01874951|Relapse|relapse
398769|NCT01874951|Antidepressants|antidepressants
398770|NCT01874951|Naltrexone|naltrexone
398771|NCT01874951|Drug augmentation|drug augmentation
398772|NCT01874886|Magnetic resonance imaging|magnetic resonance imaging
398773|NCT01874886|Diffusion tensor imaging|diffusion tensor imaging
398774|NCT01874886|Hippocampus|hippocampus
398775|NCT01874886|Cannabis|cannabis
398776|NCT01874886|Geriatrics|geriatrics
398777|NCT01874886|Neuropsychology|neuropsychology
398778|NCT01874886|Apolipoprotein E|apolipoprotein e
398779|NCT01874847|melatonin|melatonin
398780|NCT01874847|placebo|placebo
398781|NCT01874847|post-concussion syndrome|post-concussion syndrome
398782|NCT01874847|mild traumatic brain injury|mild traumatic brain injury
398783|NCT01874847|concussion|concussion
398784|NCT01874847|treatment|treatment
398785|NCT01874847|outcome|outcome
398786|NCT01874847|children|children
398787|NCT01874847|functional magnetic resonance imaging|functional magnetic resonance imaging
398788|NCT01874847|transcranial magnetic stimulation|transcranial magnetic stimulation
398789|NCT01874847|sleep|sleep
398790|NCT01874834|ozone|ozone
398791|NCT01874834|diesel|diesel
398792|NCT01874834|lung function|lung function
398793|NCT01874834|cardiac electrophysiology|cardiac electrophysiology
398794|NCT01874834|mediators of inflammation and clotting|mediators of inflammation and clotting
398795|NCT01874821|Frozen Shoulder|frozen shoulder
398796|NCT01874821|Adhesive Capsulitis|adhesive capsulitis
398797|NCT01874821|ROM|rom
398798|NCT01874821|Dynasplint|dynasplint
398799|NCT01874808|movement preparation|movement preparation
398800|NCT01874808|gait|gait
398801|NCT01874808|gait initiation|gait initiation
398802|NCT01874808|postural control|postural control
398803|NCT01874808|neuroimaging|neuroimaging
398804|NCT01874795|Autonomic Nervous System|autonomic nervous system
398805|NCT01874795|Neuromodulation|neuromodulation
398806|NCT01874795|Exercise|exercise
398807|NCT01874795|Pulmonary oxygen kinetics|pulmonary oxygen kinetics
398808|NCT01874795|Oxygen uptake|oxygen uptake
398809|NCT01874782|spinal cord injury|spinal cord injury
398810|NCT01874782|cardiovascular|cardiovascular
398811|NCT01874782|orthostatic hypotension|orthostatic hypotension
398812|NCT01874782|transcranial electrical stimulation|transcranial electrical stimulation
398813|NCT01874782|electrotherapy|electrotherapy
398814|NCT01874769|RDEB|rdeb
398815|NCT01874769|COL7A1|col7a1
398816|NCT01874769|Collagen VII|collagen vii
398817|NCT01874756|schizophrenia|schizophrenia
398818|NCT01874756|Estrogen receptor agonist|estrogen receptor agonist
398819|NCT01874756|cognitive impairment|cognitive impairment
398820|NCT01874756|negative symptoms|negative symptoms
398821|NCT01874743|HIV,|hiv,
398822|NCT01874743|Rosuvastatine,|rosuvastatine,
398823|NCT01874743|Antiretroviral therapy|antiretroviral therapy
398824|NCT01874730|colorectal surgery|colorectal surgery
398825|NCT01874730|fluid therapy|fluid therapy
398826|NCT01874717|Conscious sedation|conscious sedation
398827|NCT01874717|Dental anxiety|dental anxiety
398828|NCT01874717|Oral midazolam|oral midazolam
398829|NCT01874717|Intravenous midazolam|intravenous midazolam
398830|NCT01874717|Behaviour|behaviour
398831|NCT01874704|Stress, occupation, biomarkers, emergency, physicians|stress, occupation, biomarkers, emergency, physicians
398832|NCT01874691|acute myocardial infarction|acute myocardial infarction
398833|NCT01874691|China|china
398834|NCT01874691|Registry|registry
398835|NCT01874665|Gastrointestinal Neoplasms|gastrointestinal neoplasms
398836|NCT01874665|Gastrointestinal stromal tumor|gastrointestinal stromal tumor
398837|NCT01874665|mesenchymal tumor|mesenchymal tumor
398838|NCT01874639|Hepatectomy|hepatectomy
398839|NCT01874639|blood loss|blood loss
398840|NCT01874639|hemostasis|hemostasis
398841|NCT01874639|coagulation|coagulation
398842|NCT01874639|Liver surgery (benign or malign)|liver surgery (benign or malign)
398843|NCT01874639|Resection of 2 or more segments|resection of 2 or more segments
398844|NCT01874626|acute ankle sprain|acute ankle sprain
398845|NCT01874626|Grade I or Grade II|grade i or grade ii
398846|NCT01874613|Craniofacial bone reconstruction|craniofacial bone reconstruction
398847|NCT01874613|Fibre-reinforced composite|fibre-reinforced composite
398848|NCT01874613|Bioactive glass|bioactive glass
398849|NCT01874613|Craniotomy|craniotomy
398850|NCT01874613|Skull bone defect|skull bone defect
398851|NCT01874587|Adaptative radiotherapy|adaptative radiotherapy
398852|NCT01874587|oropharynx carcinoma|oropharynx carcinoma
398853|NCT01874587|xerostomia|xerostomia
398854|NCT01874574|Knee Osteoarthritis|knee osteoarthritis
398855|NCT01874574|Corticosteroid|corticosteroid
398856|NCT01874574|Hyaluronic acid|hyaluronic acid
398857|NCT01874574|Intra-articular injection|intra-articular injection
398858|NCT01874561|Custirsen sodium|custirsen sodium
398859|NCT01874561|TV1011|tv1011
398860|NCT01874561|OGX-011|ogx-011
398861|NCT01874561|Thorough QT study|thorough qt study
398862|NCT01874561|cancer|cancer
398863|NCT01874548|Autophagy|autophagy
398864|NCT01874548|Cancer metabolism|cancer metabolism
398865|NCT01874548|Cervical cancer|cervical cancer
398866|NCT01874548|Diffusion weighted imaging|diffusion weighted imaging
398867|NCT01874548|Human papillomavirus|human papillomavirus
398868|NCT01874548|Magnetic resonance spectroscopy.|magnetic resonance spectroscopy.
398869|NCT01874522|Advanced solid tumors (excluding breast cancer) for which no standard therapy exists|advanced solid tumors (excluding breast cancer) for which no standard therapy exists
398870|NCT01874405|Iron overload|iron overload
398871|NCT01874405|thalassaemia|thalassaemia
398872|NCT01874405|deferasirox|deferasirox
398873|NCT01874405|magnetic resonance|magnetic resonance
398874|NCT01874405|endocrine function|endocrine function
398875|NCT01874379|Joint Replacement|joint replacement
398876|NCT01874379|Hip Replacement|hip replacement
398877|NCT01874379|Knee Replacement|knee replacement
398878|NCT01874379|Complementary Medicine Intervention|complementary medicine intervention
398879|NCT01874353|BRCA|brca
398880|NCT01874353|Ovarian cancer|ovarian cancer
398881|NCT01874353|Chemotherapy|chemotherapy
398882|NCT01874353|PARP Inhibitor|parp inhibitor
398883|NCT01874353|Platinum sensitive|platinum sensitive
398884|NCT01874340|Multiple Sclerosis|multiple sclerosis
398885|NCT01874340|Relapsing Multiple Sclerosis|relapsing multiple sclerosis
398886|NCT01874340|AIN457|ain457
398887|NCT01874340|Secukinumab|secukinumab
398888|NCT01874340|Magnetic Resonance Imaging|magnetic resonance imaging
398889|NCT01874340|Relapsing Remitting Multiple Sclerosis|relapsing remitting multiple sclerosis
398890|NCT01874340|Autoimmune Diseases|autoimmune diseases
398891|NCT01874340|Nervous System Diseases|nervous system diseases
398892|NCT01874340|Immune System Diseases|immune system diseases
398893|NCT01874340|Demyelinating Diseases|demyelinating diseases
398894|NCT01874314|tuberculosis, SQ109, QTc, moxifloxacin, crossover, placebo, pharmacokinetic, randomized, single-center|tuberculosis, sq109, qtc, moxifloxacin, crossover, placebo, pharmacokinetic, randomized, single-center
398895|NCT01874288|NHL|nhl
398896|NCT01874288|Immunocytokine|immunocytokine
398897|NCT01874288|Lymphoma|lymphoma
398898|NCT01874288|Non-Hodgkin|non-hodgkin
398899|NCT01874288|B-cell|b-cell
398900|NCT01874288|IL (interleukin)|il (interleukin)
398901|NCT01874249|Hepatic fibrosis|hepatic fibrosis
398902|NCT01874249|Steatosis|steatosis
398903|NCT01874249|Noninvasive markers.|noninvasive markers.
398904|NCT01874236|SI joint pain, SI joint dysfunction, degenerative sacroiliitis, sacroiliac joint disruption|si joint pain, si joint dysfunction, degenerative sacroiliitis, sacroiliac joint disruption
398905|NCT01874223|Interstitial Lung Disease (ILD)|interstitial lung disease (ild)
398906|NCT01874223|Idiopathic Pulmonary Fibrosis (IPF)|idiopathic pulmonary fibrosis (ipf)
398907|NCT01874197|Thoracoabdominal Aortic Aneurysm|thoracoabdominal aortic aneurysm
398908|NCT01874197|Branched vessels|branched vessels
398909|NCT01874158|Trichomonas vaginalis|trichomonas vaginalis
398910|NCT01874145|Multiple Sclerosis|multiple sclerosis
398911|NCT01874145|Relapsing-Remitting Multiple Sclerosis|relapsing-remitting multiple sclerosis
398912|NCT01874145|Glatiramer Acetate|glatiramer acetate
398913|NCT01874145|Glatiramer|glatiramer
398914|NCT01874132|Exercise|exercise
398915|NCT01874132|Blood pressure|blood pressure
398916|NCT01874132|Lipids|lipids
398917|NCT01874132|Body composition|body composition
398918|NCT01874132|Fitness|fitness
398919|NCT01874132|Bone density|bone density
398920|NCT01874132|Quality of life|quality of life
398921|NCT01874119|melanoma|melanoma
398922|NCT01874119|renal cell carcinoma|renal cell carcinoma
398923|NCT01874119|interleukin-2|interleukin-2
398924|NCT01874106|Hemodialysis|hemodialysis
398925|NCT01874106|Diet|diet
398926|NCT01874106|Inflammation|inflammation
398927|NCT01874106|Malnutrition|malnutrition
398928|NCT01874054|Antibody-Drug Conjugate|antibody-drug conjugate
398929|NCT01874054|Antibodies, Monoclonal|antibodies, monoclonal
398930|NCT01874054|Hodgkin Disease|hodgkin disease
398931|NCT01874054|Hematologic Diseases|hematologic diseases
398932|NCT01874054|Drug Therapy|drug therapy
398933|NCT01874054|Immunotherapy|immunotherapy
398934|NCT01874054|Antigens, CD30|antigens, cd30
398935|NCT01874054|Lymphoma|lymphoma
398936|NCT01874054|monomethylauristatin E|monomethylauristatin e
398937|NCT01874041|Physical Therapy Modalities|physical therapy modalities
398938|NCT01874041|Facial Pain|facial pain
398939|NCT01874041|Orthodontic Appliances|orthodontic appliances
398940|NCT01874028|Trientine|trientine
398941|NCT01874028|Pharmacokinetics|pharmacokinetics
398942|NCT01874015|Crohn's disease|crohn's disease
398943|NCT01874015|mesenchymal stem cell|mesenchymal stem cell
398944|NCT01874015|fistula|fistula
398945|NCT01874002|Stents|stents
398946|NCT01874002|Stent|stent
398947|NCT01874002|Drug eluting|drug eluting
398948|NCT01874002|Drug eluting stent|drug eluting stent
398949|NCT01874002|Drug eluting stents|drug eluting stents
398950|NCT01874002|Endothelial progenitor cell|endothelial progenitor cell
398951|NCT01874002|Endothelial progenitor cell capturing|endothelial progenitor cell capturing
398953|NCT01874002|Sirolimus eluting|sirolimus eluting
398954|NCT01874002|Percutaneous Coronary Intervention|percutaneous coronary intervention
398955|NCT01874002|PCI|pci
398956|NCT01874002|Registry|registry
398957|NCT01874002|Registries|registries
398958|NCT01874002|Multi center|multi center
398959|NCT01874002|Multi centre|multi centre
398960|NCT01873989|Chronic pain|chronic pain
398961|NCT01873989|Opioid addiction|opioid addiction
398962|NCT01873989|Symptomatic hypogonadism|symptomatic hypogonadism
398963|NCT01873989|Testosterone replacement|testosterone replacement
398964|NCT01873989|Opioid agonist maintenance|opioid agonist maintenance
398965|NCT01873989|Methadone|methadone
398966|NCT01873989|Buprenorphine|buprenorphine
398967|NCT01873937|Lasertherapy|lasertherapy
398968|NCT01873937|Ledtherapy|ledtherapy
398969|NCT01873937|TMJs|tmjs
398970|NCT01873937|pain relief|pain relief
398971|NCT01873937|oral aperture|oral aperture
398972|NCT01873924|Batten disease|batten disease
398973|NCT01873924|NCL|ncl
398974|NCT01873924|Neuronal Ceroid Lipofuscinosis|neuronal ceroid lipofuscinosis
398975|NCT01873911|MPS IIIA|mps iiia
398976|NCT01873911|MPS IIIB|mps iiib
398977|NCT01873911|Sanfilippo syndrome type A|sanfilippo syndrome type a
398978|NCT01873911|Sanfilippo syndrome type B|sanfilippo syndrome type b
398979|NCT01873911|Hurler syndrome|hurler syndrome
398980|NCT01873911|cognitive decline|cognitive decline
398981|NCT01873911|MPS IH|mps ih
398982|NCT01873898|femoral artery|femoral artery
398983|NCT01873898|access site|access site
398984|NCT01873898|hemostasis|hemostasis
398985|NCT01873885|PB1046, VIP, Essential Hypertension, Vasomera|pb1046, vip, essential hypertension, vasomera
398986|NCT01873859|Lactic acidosis|lactic acidosis
398987|NCT01873859|Contrast media|contrast media
398988|NCT01873859|Angiography|angiography
398989|NCT01873859|Diabetic|diabetic
398990|NCT01873859|Metformin|metformin
398991|NCT01873820|Vitamin C|vitamin c
398992|NCT01873820|calcium ascorbate|calcium ascorbate
398993|NCT01873820|ascorbic acid|ascorbic acid
398994|NCT01873807|Idarubicin|idarubicin
398995|NCT01873807|Etoposide|etoposide
398996|NCT01873807|HSCT|hsct
398997|NCT01873807|Acute Lymphoblastic Leukemia|acute lymphoblastic leukemia
398998|NCT01873794|Fatigue|fatigue
398999|NCT01873794|Sleep|sleep
399000|NCT01873794|Quality of life|quality of life
399001|NCT01873794|Cancer|cancer
399002|NCT01873794|Light|light
399003|NCT01873768|Tranexamic acid|tranexamic acid
399004|NCT01873768|6-Aminocaproic Acid|6-aminocaproic acid
399005|NCT01873768|Arthroplasty|arthroplasty
399006|NCT01873768|Osteoarthritis|osteoarthritis
399007|NCT01873768|Arthritis|arthritis
399008|NCT01873768|Joint Diseases|joint diseases
399009|NCT01873768|Musculoskeletal Diseases|musculoskeletal diseases
399010|NCT01873768|Rheumatic Diseases|rheumatic diseases
399011|NCT01873768|Antifibrinolytic Agents|antifibrinolytic agents
399012|NCT01873768|Fibrin Modulating Agents|fibrin modulating agents
399013|NCT01873768|Pharmacologic Actions|pharmacologic actions
399014|NCT01873768|Coagulants|coagulants
399015|NCT01873768|Therapeutic Uses|therapeutic uses
399016|NCT01873755|asthma|asthma
399017|NCT01873755|children|children
399018|NCT01873755|physical activity|physical activity
399019|NCT01873755|school|school
399020|NCT01873742|Psychotherapy feedback|psychotherapy feedback
399021|NCT01873729|ADHD|adhd
399022|NCT01873729|Naltrexone|naltrexone
399023|NCT01873729|Adults|adults
399024|NCT01873716|Atherosclerosis|atherosclerosis
399025|NCT01873716|Molecular Imaging|molecular imaging
399026|NCT01873716|Vascular Biology|vascular biology
399027|NCT01873716|Inflammation|inflammation
399028|NCT01873716|Fluorescence|fluorescence
399029|NCT01873703|MDS|mds
399030|NCT01873703|High risk myelodysplastic syndrome|high risk myelodysplastic syndrome
399031|NCT01873703|Intermediate-2 Myelodysplastic syndrome|intermediate-2 myelodysplastic syndrome
399032|NCT01873703|Untreated|untreated
399033|NCT01873690|Antibiotics|antibiotics
399034|NCT01873690|Shock Wave Lithotripsy|shock wave lithotripsy
399035|NCT01873690|Urinary Tract Infection|urinary tract infection
399036|NCT01873664|fMRI|fmri
399037|NCT01873664|Jaw tapping|jaw tapping
399038|NCT01873664|Memory disorder|memory disorder
796041|NCT00270127|hemoglobin|hemoglobin
399039|NCT01873664|Mild cognitive impairment|mild cognitive impairment
399040|NCT01873664|MCI|mci
399041|NCT01873664|Working memory|working memory
399042|NCT01873638|5-year outcome after cholecystectomy|5-year outcome after cholecystectomy
399043|NCT01873625|mesenchymal stem cells|mesenchymal stem cells
399044|NCT01873625|osteoarthritis|osteoarthritis
399045|NCT01873625|arthritis rheumatoid|arthritis rheumatoid
399046|NCT01873612|Dexmedetomidine|dexmedetomidine
399047|NCT01873612|Propofol|propofol
399048|NCT01873612|Hypoxic ventilatory response|hypoxic ventilatory response
399049|NCT01873612|Hypercapnic ventilatory response|hypercapnic ventilatory response
399050|NCT01873573|radiation-induced stricture|radiation-induced stricture
399051|NCT01873573|anastomotic stricture|anastomotic stricture
399052|NCT01873573|esophagogastroduodenoscopy (EGD)|esophagogastroduodenoscopy (egd)
399053|NCT01873573|dilation|dilation
399054|NCT01873573|steroid injection|steroid injection
399055|NCT01873573|triamcinolone|triamcinolone
399056|NCT01873573|difficulty swallowing|difficulty swallowing
399057|NCT01873560|fractional flow reserve|fractional flow reserve
399058|NCT01873560|drug eluting stent|drug eluting stent
399059|NCT01873560|coronary atherosclerosis|coronary atherosclerosis
399060|NCT01873547|spinal cord injury|spinal cord injury
399061|NCT01873547|cell transplantation|cell transplantation
399062|NCT01873547|rehabilitation|rehabilitation
399064|NCT01873521|Positive Pressure Ventilation|positive pressure ventilation
399065|NCT01873521|Neurally Adjusted Ventilatory Assist|neurally adjusted ventilatory assist
399066|NCT01873521|Patient/ventilator Asynchrony|patient/ventilator asynchrony
399067|NCT01873521|Pediatric patient|pediatric patient
399068|NCT01873521|Infant|infant
399069|NCT01873469|glioblastoma multiforme|glioblastoma multiforme
399070|NCT01873469|radiotherapy|radiotherapy
399071|NCT01873430|Melatonin|melatonin
399072|NCT01873430|Sunburn|sunburn
399073|NCT01873430|Erythema|erythema
399074|NCT01873430|Sunlight|sunlight
399075|NCT01873430|Ultraviolet rays|ultraviolet rays
399076|NCT01873391|Diagnostic hysteroscopy|diagnostic hysteroscopy
399077|NCT01873391|Pain|pain
399078|NCT01873391|VAS|vas
399079|NCT01873391|Multivariate analysis|multivariate analysis
399080|NCT01873391|Normal saline|normal saline
399081|NCT01873391|Carbon dioxide|carbon dioxide
399082|NCT01873378|Uterine myoma|uterine myoma
399083|NCT01873378|GnRHa|gnrha
399084|NCT01873378|Hysteroscopy|hysteroscopy
399085|NCT01873378|Cold loop|cold loop
399086|NCT01873365|Quality of life|quality of life
399087|NCT01873365|Herpes zoster|herpes zoster
399088|NCT01873365|Postherpetic neuralgia|postherpetic neuralgia
399089|NCT01873365|Japan|japan
399090|NCT01873365|Physician-practice|physician-practice
399091|NCT01873365|Adults|adults
399092|NCT01873365|Health economics|health economics
399093|NCT01873339|Drug interaction, healthy volunteer, SB-480848, Lp-PLA2, darapladib, atherosclerosis, midazolam|drug interaction, healthy volunteer, sb-480848, lp-pla2, darapladib, atherosclerosis, midazolam
399094|NCT01873326|newly diagnosed GCT|newly diagnosed gct
399095|NCT01873326|Intermediate|intermediate
399096|NCT01873326|Poor-Risk|poor-risk
399097|NCT01873326|BLEOMYCIN|bleomycin
399098|NCT01873326|CISPLATIN|cisplatin
399099|NCT01873326|ETOPOSIDE (VP-16)|etoposide (vp-16)
399100|NCT01873326|IFOSFAMIDE|ifosfamide
399101|NCT01873326|TAXOL (PACLITAXEL)|taxol (paclitaxel)
399102|NCT01873326|13-074|13-074
399103|NCT01873300|Achalasia|achalasia
399104|NCT01873300|Dysphagia|dysphagia
399105|NCT01873300|Endoscopic|endoscopic
399106|NCT01873300|Myotomy|myotomy
399107|NCT01873300|Heller|heller
399108|NCT01873300|NOTES|notes
399109|NCT01873300|POEM|poem
399110|NCT01873287|Concussions|concussions
399111|NCT01873287|Persistent post-concussion symptoms|persistent post-concussion symptoms
399112|NCT01873287|PCS|pcs
399113|NCT01873287|Clinical Prediction Rule|clinical prediction rule
399114|NCT01873261|Neurally Adjusted Ventilatory Assist|neurally adjusted ventilatory assist
399115|NCT01873261|Pediatric Acute Respiratory Failure|pediatric acute respiratory failure
399116|NCT01873261|non-invasive ventilation|non-invasive ventilation
399117|NCT01873248|Neuroendocrine Carcinoma|neuroendocrine carcinoma
399118|NCT01873222|Coronary Artery Disease|coronary artery disease
399119|NCT01873222|Percutaneous Coronary Intervention|percutaneous coronary intervention
399120|NCT01873222|Optical Frequency Domain Imaging|optical frequency domain imaging
399121|NCT01873222|Intravascular Ultrasound|intravascular ultrasound
399122|NCT01873183|echocardiography|echocardiography
399123|NCT01873183|morbid obesity|morbid obesity
399124|NCT01873183|bariatric surgery|bariatric surgery
399125|NCT01873183|venous return|venous return
399126|NCT01873183|mean arterial blood pressure|mean arterial blood pressure
399127|NCT01873170|immune cells|immune cells
399128|NCT01873170|contraception|contraception
399129|NCT01873170|intrauterine device|intrauterine device
399130|NCT01873170|IUD|iud
399131|NCT01873170|copper|copper
399132|NCT01873170|microflora|microflora
399133|NCT01873170|DMPA|dmpa
399134|NCT01873170|etonogestrel|etonogestrel
399135|NCT01873170|subdermal implant|subdermal implant
399136|NCT01873157|Kidney transplantation|kidney transplantation
399137|NCT01873157|Antibody formation|antibody formation
399138|NCT01873157|Graft rejection|graft rejection
399139|NCT01873157|Proteasome inhibitors|proteasome inhibitors
399140|NCT01873157|Randomized controlled trial|randomized controlled trial
399141|NCT01873144|Bronchiolitis|bronchiolitis
399142|NCT01873144|Hypertonic saline solution|hypertonic saline solution
399143|NCT01873144|High-flow oxygen therapy|high-flow oxygen therapy
399144|NCT01873144|Respiratory distress|respiratory distress
399145|NCT01873144|Comfort|comfort
399146|NCT01873131|hemangioma|hemangioma
399147|NCT01873131|infantile hemangioma|infantile hemangioma
399148|NCT01873131|pulsed dye laser|pulsed dye laser
399149|NCT01873131|PDL|pdl
399150|NCT01873131|topical beta blocker|topical beta blocker
399151|NCT01873131|timolol maleate|timolol maleate
399152|NCT01873131|timolol|timolol
399153|NCT01873118|hospital discharge|hospital discharge
399154|NCT01873118|discharge readiness|discharge readiness
399156|NCT01873118|Emergency Department visits|emergency department visits
399157|NCT01873118|Nurse assessment|nurse assessment
399158|NCT01873092|Oximetry|oximetry
399159|NCT01873092|Physical Activity|physical activity
399160|NCT01873079|ERCP|ercp
399161|NCT01873079|sphincterotomy|sphincterotomy
399162|NCT01873079|proton pump inhibitor|proton pump inhibitor
399163|NCT01873066|Type 1 diabetes|type 1 diabetes
399164|NCT01873066|Closed-loop glucose control|closed-loop glucose control
399165|NCT01873066|Artificial Pancreas|artificial pancreas
399166|NCT01873066|Continuous subcutaneous insulin infusion|continuous subcutaneous insulin infusion
399167|NCT01873066|Continuous glucose monitoring|continuous glucose monitoring
399168|NCT01873053|Osteoarthritis, Knee|osteoarthritis, knee
399169|NCT01873053|WIN-34B|win-34b
399170|NCT01873040|Social Media|social media
399171|NCT01873040|Vaccine|vaccine
399172|NCT01873040|Immunization|immunization
399173|NCT01873027|Coronary Artery Disease|coronary artery disease
399174|NCT01873027|Percutaneous Coronary Intervention|percutaneous coronary intervention
399175|NCT01873027|Optical Frequency Domain Imaging|optical frequency domain imaging
399176|NCT01873027|Intravascular Ultrasound|intravascular ultrasound
399177|NCT01873001|Healthy volunteers|healthy volunteers
399178|NCT01873001|Drug-drug Interaction|drug-drug interaction
399179|NCT01873001|Pharmacokinetics|pharmacokinetics
399180|NCT01873001|Abiraterone|abiraterone
399181|NCT01873001|JNJ-589485|jnj-589485
399182|NCT01873001|Abiraterone acetate|abiraterone acetate
399183|NCT01873001|JNJ-212082|jnj-212082
399184|NCT01873001|Pioglitazone HCl|pioglitazone hcl
399185|NCT01872988|antiviral therapy|antiviral therapy
399186|NCT01872988|intermediate stage|intermediate stage
399187|NCT01872988|hepatitis B virus|hepatitis b virus
399188|NCT01872962|Nasopharyngeal carcinoma|nasopharyngeal carcinoma
399189|NCT01872962|Induction chemotherapy|induction chemotherapy
399190|NCT01872962|Concurrent chemoradiotherapy|concurrent chemoradiotherapy
399191|NCT01872962|Clinical trial|clinical trial
399192|NCT01872949|Heart Failure|heart failure
399193|NCT01872949|NYHA Class III|nyha class iii
399194|NCT01872949|NYHA Class IV|nyha class iv
399195|NCT01872923|Amphinex|amphinex
399196|NCT01872923|PCI|pci
399197|NCT01872923|Bleomycin|bleomycin
399198|NCT01872923|Cutaneous malignancies|cutaneous malignancies
399199|NCT01872923|Sub-cutaneous malignancies|sub-cutaneous malignancies
399200|NCT01872923|Safety|safety
399201|NCT01872923|Phase I|phase i
399202|NCT01872923|Photochemical Internalisation|photochemical internalisation
399203|NCT01872923|Squamous Cell Carcinoma|squamous cell carcinoma
399204|NCT01872923|Head and Neck cancer|head and neck cancer
399205|NCT01872923|Breast Cancer|breast cancer
399206|NCT01872923|HNSCC|hnscc
399207|NCT01872923|SCCHN|scchn
399208|NCT01872923|Advanced or metastatic cancer|advanced or metastatic cancer
399209|NCT01872923|Dose finding|dose finding
399210|NCT01872910|Wisdom tooth extraction|wisdom tooth extraction
399211|NCT01872897|Gastroesophageal Reflux Disease|gastroesophageal reflux disease
399212|NCT01872897|GERD|gerd
399213|NCT01872897|Acid reflux|acid reflux
399214|NCT01872897|Compound Sodium Alginate Double Action Chewable Tablet|compound sodium alginate double action chewable tablet
399215|NCT01872897|Gaviscon Double Action Tablets|gaviscon double action tablets
399216|NCT01872884|Stroke|stroke
399217|NCT01872884|Ischemic stroke|ischemic stroke
399218|NCT01872884|Acute stroke|acute stroke
399219|NCT01872884|Embolectomy|embolectomy
399220|NCT01872884|Endovascular therapy|endovascular therapy
399221|NCT01872884|Intra-arterial therapy|intra-arterial therapy
399222|NCT01872884|Sedation|sedation
399223|NCT01872884|Anesthesia|anesthesia
399224|NCT01872845|Statin|statin
399225|NCT01872845|CIMT|cimt
399226|NCT01872845|BES|bes
399227|NCT01872793|bioelectrical impedance vector analysis|bioelectrical impedance vector analysis
399228|NCT01872793|nutritional assessment|nutritional assessment
399229|NCT01872793|nutritional status|nutritional status
399230|NCT01872793|mortality|mortality
399231|NCT01872793|complications|complications
399232|NCT01872780|CYP2C8|cyp2c8
399233|NCT01872780|genetic polymorphism|genetic polymorphism
399234|NCT01872780|rosiglitazone|rosiglitazone
399235|NCT01872780|Korean|korean
399236|NCT01872767|Acute on Chronic Liver Failure (ACLF),Cirrhosis,|acute on chronic liver failure (aclf),cirrhosis,
399237|NCT01872767|Institute of Liver & Biliary Sciences (ILBS)|institute of liver & biliary sciences (ilbs)
399238|NCT01872754|Bronchial fibroscopy|bronchial fibroscopy
399239|NCT01872754|Remifentanil|remifentanil
399240|NCT01872754|Propofol|propofol
399241|NCT01872754|Sedation|sedation
399242|NCT01872754|Target Controlled Infusion|target controlled infusion
399243|NCT01872741|craniotomy,|craniotomy,
399244|NCT01872741|intracerebral aneurysms,|intracerebral aneurysms,
399245|NCT01872741|atrophy,|atrophy,
399246|NCT01872741|temporal muscle,|temporal muscle,
399247|NCT01872741|outcome|outcome
399248|NCT01872728|facial block|facial block
399249|NCT01872728|levobupivacaine|levobupivacaine
399250|NCT01872728|regional anesthesia|regional anesthesia
399251|NCT01872728|rhinoplasty|rhinoplasty
399252|NCT01872728|outpatient|outpatient
399253|NCT01872715|Papulopustular Rosacea|papulopustular rosacea
399255|NCT01872715|anti inflammatory doxycycline|anti inflammatory doxycycline
399256|NCT01872702|Malaria elimination|malaria elimination
399257|NCT01872702|Chemotherapy|chemotherapy
399258|NCT01872702|Epidemiology|epidemiology
399259|NCT01872702|South East Asia|south east asia
399260|NCT01872702|Artemisinin resistance|artemisinin resistance
399261|NCT01872702|Dihydroartemisinin piperaquine|dihydroartemisinin piperaquine
399262|NCT01872702|Primaquine|primaquine
399263|NCT01872676|Thermography|thermography
399264|NCT01872676|Skin Temperature|skin temperature
399265|NCT01872676|Manipulation, Spinal|manipulation, spinal
399266|NCT01872676|Physical Therapy Modalities|physical therapy modalities
399267|NCT01872663|Morbid obesity|morbid obesity
399268|NCT01872663|Bariatric surgery|bariatric surgery
399269|NCT01872663|Pulmonary atelectasis|pulmonary atelectasis
399270|NCT01872663|Spirometry|spirometry
399271|NCT01872663|Continuos Positive Airway Pressure|continuos positive airway pressure
399272|NCT01872663|Physical therapy speciality|physical therapy speciality
399273|NCT01872650|postoperative adhesions|postoperative adhesions
399274|NCT01872650|adhesion prevention|adhesion prevention
399275|NCT01872650|colorectal surgery|colorectal surgery
399276|NCT01872650|temporary ostomy|temporary ostomy
399277|NCT01872611|Diabetes Type I|diabetes type i
399278|NCT01872611|Diabetes Type II|diabetes type ii
399279|NCT01872611|Non-proliferative diabetic retinopathy|non-proliferative diabetic retinopathy
399280|NCT01872611|Macular edema|macular edema
399281|NCT01872611|Cataract|cataract
399282|NCT01872598|Alzheimer|alzheimer
399283|NCT01872598|dementia|dementia
399284|NCT01872598|cognitive disease|cognitive disease
399285|NCT01872598|memory loss|memory loss
399286|NCT01872598|cerebrovascular disease|cerebrovascular disease
399287|NCT01872598|tyrosine kinase inhibitor|tyrosine kinase inhibitor
399288|NCT01872585|Parenting|parenting
399289|NCT01872585|Mental Illness|mental illness
399290|NCT01872585|Maternal sensitivity|maternal sensitivity
399291|NCT01872585|Parent-child relationship|parent-child relationship
399292|NCT01872533|obesity|obesity
399293|NCT01872533|hypoxia|hypoxia
399294|NCT01872533|insulin sensitivity|insulin sensitivity
399295|NCT01872533|altitude|altitude
399296|NCT01872520|the Injection of DanShenDuoFenSuanYan|the injection of danshenduofensuanyan
399297|NCT01872520|Magnesium Lithospermate B|magnesium lithospermate b
399298|NCT01872520|Safety|safety
399299|NCT01872520|Real World Study|real world study
399300|NCT01872507|cerebral palsy|cerebral palsy
399301|NCT01872507|autonomic nerveus system|autonomic nerveus system
399302|NCT01872507|heart rate variability|heart rate variability
399303|NCT01872494|Local analgesia system|local analgesia system
399304|NCT01872494|Ropivacaine|ropivacaine
399305|NCT01872494|Analgesic efficacy after operation|analgesic efficacy after operation
399306|NCT01872494|Postoperative|postoperative
399307|NCT01872481|Phantom limb pain syndrome|phantom limb pain syndrome
399308|NCT01872481|Neuropathic pain|neuropathic pain
399309|NCT01872481|Antipersonnel landmines|antipersonnel landmines
399310|NCT01872481|Transcranial Magnetic Stimulation|transcranial magnetic stimulation
399311|NCT01872468|Glomerular filtration Rate.|glomerular filtration rate.
399312|NCT01872468|Primary Health Care.|primary health care.
399313|NCT01872468|Cluster Clinical Trial.|cluster clinical trial.
399314|NCT01872429|subtotal parathyroidectomy|subtotal parathyroidectomy
399315|NCT01872429|calcium|calcium
399316|NCT01872429|phosphorus|phosphorus
399317|NCT01872429|parathyroid hormone|parathyroid hormone
399318|NCT01872429|hyperparathyroidism|hyperparathyroidism
399319|NCT01872416|Refractory and relapsed small cell lung cancer|refractory and relapsed small cell lung cancer
399320|NCT01872416|Liposomal Doxorubicin|liposomal doxorubicin
399321|NCT01872416|ifosfamide|ifosfamide
399322|NCT01872403|Squamous Cell Carcinoma of the lung|squamous cell carcinoma of the lung
399323|NCT01872390|Lesotho|lesotho
399324|NCT01872390|TB|tb
399325|NCT01872390|tuberculosis|tuberculosis
399326|NCT01872390|HIV|hiv
399327|NCT01872390|antiretroviral therapy|antiretroviral therapy
399328|NCT01872390|ART|art
399329|NCT01872390|adherence|adherence
399330|NCT01872390|combination intervention package|combination intervention package
399331|NCT01872390|retention|retention
399332|NCT01872377|pancreas|pancreas
399333|NCT01872377|pancreatic|pancreatic
399334|NCT01872377|unresectable|unresectable
399335|NCT01872377|CyberKnife|cyberknife
399336|NCT01872377|SBRT|sbrt
399337|NCT01872364|Hernia repair|hernia repair
399338|NCT01872364|Hydrocelectomy|hydrocelectomy
399339|NCT01872364|Global Health|global health
399340|NCT01872364|Global Disease Burden|global disease burden
399341|NCT01872364|Surgical Mission|surgical mission
399342|NCT01872364|Dominican Republic|dominican republic
399343|NCT01872364|Cost-minimization|cost-minimization
399344|NCT01872364|Procedural cost|procedural cost
399345|NCT01872364|Material cost|material cost
399346|NCT01872364|Item utilization|item utilization
399347|NCT01872364|Excision of benign cutaneous mass|excision of benign cutaneous mass
399348|NCT01872364|Minor procedure|minor procedure
399349|NCT01872351|chronic fatigue syndrome|chronic fatigue syndrome
399350|NCT01872351|mitochondrial disorder|mitochondrial disorder
400727|NCT01865565|imatinib|imatinib
399351|NCT01872351|conditioning exercise|conditioning exercise
399352|NCT01872351|nutraceutical supplements|nutraceutical supplements
399353|NCT01872351|high protein diet|high protein diet
399354|NCT01872338|suicide prevention|suicide prevention
399355|NCT01872338|minfulness-based cognitive therapy|minfulness-based cognitive therapy
399356|NCT01872338|mindfulness meditation|mindfulness meditation
399357|NCT01872338|Veterans|veterans
399358|NCT01872338|safety planning|safety planning
399359|NCT01872325|cardiac arrest|cardiac arrest
399360|NCT01872325|bystander cardiopulmonary resuscitation CPR|bystander cardiopulmonary resuscitation cpr
399361|NCT01872325|dispatch-assisted CPR instructions|dispatch-assisted cpr instructions
399362|NCT01872325|agonal breathing|agonal breathing
399363|NCT01872312|BPF(Bronchopleural fistulae)|bpf(bronchopleural fistulae)
399364|NCT01872286|Capsule Endoscopy|capsule endoscopy
399365|NCT01872273|Metabolic Syndrome|metabolic syndrome
399366|NCT01872273|Obese|obese
399367|NCT01872273|Overweight|overweight
399368|NCT01872273|Hypertension|hypertension
399369|NCT01872273|Hyperlipidemia|hyperlipidemia
399370|NCT01872273|Glucose Intolerant|glucose intolerant
399371|NCT01872273|High blood sugar|high blood sugar
399372|NCT01872273|Exercise in obesity|exercise in obesity
399373|NCT01872273|Platelets|platelets
399374|NCT01872260|Hormone-receptor positive|hormone-receptor positive
399375|NCT01872234|Heart Failure|heart failure
399376|NCT01872234|Cardiac Resynchronization Therapy|cardiac resynchronization therapy
399377|NCT01872234|Mild systolic dysfunction|mild systolic dysfunction
399378|NCT01872234|Left Bundle Branch Block|left bundle branch block
399379|NCT01872221|Glioblastoma|glioblastoma
399380|NCT01872221|Spectroscopy|spectroscopy
399382|NCT01872221|Glioma stem cells|glioma stem cells
399383|NCT01872221|Surgery|surgery
399384|NCT01872221|Radioresistance|radioresistance
399385|NCT01872208|PAD|pad
399386|NCT01872208|Atherosclerosis|atherosclerosis
399387|NCT01872208|Peripheral circulation|peripheral circulation
399388|NCT01872208|Blood Vessel Prosthesis|blood vessel prosthesis
399389|NCT01872208|Tissue-Engineered Vascular Graft|tissue-engineered vascular graft
399390|NCT01872208|Vascular Prosthesis Implantation|vascular prosthesis implantation
399391|NCT01872208|Femoro-Popliteal Bypass|femoro-popliteal bypass
399392|NCT01872195|Checklist|checklist
399393|NCT01872195|In-Hospital Mortality|in-hospital mortality
399394|NCT01872195|In-Hospital Morbidity|in-hospital morbidity
399395|NCT01872156|Smoking|smoking
399396|NCT01872156|Primary care|primary care
399397|NCT01872130|Moh's Surgery|moh's surgery
399398|NCT01872130|mosaicing algorithm|mosaicing algorithm
399399|NCT01872130|intraoperative imaging|intraoperative imaging
399400|NCT01872130|12-239|12-239
399401|NCT01872104|rectal cancer|rectal cancer
399402|NCT01872104|rectal adenocarcinoma|rectal adenocarcinoma
399403|NCT01872104|photodynamic therapy|photodynamic therapy
399404|NCT01872104|chemothrapy|chemothrapy
399405|NCT01872078|Pharmacokinetics, Pharmacodynamics, endocrinopathies, PCOS, female, hormone, LH|pharmacokinetics, pharmacodynamics, endocrinopathies, pcos, female, hormone, lh
399406|NCT01872039|Nicardipine|nicardipine
399407|NCT01872039|Hypertension|hypertension
399408|NCT01872039|Calcium blocker|calcium blocker
399409|NCT01872026|ASP7991|asp7991
399410|NCT01872026|Plasma concentration|plasma concentration
399411|NCT01872026|Pharmacodynamics|pharmacodynamics
399412|NCT01872026|Pharmacokinetics|pharmacokinetics
399413|NCT01872013|Plasma concentration|plasma concentration
399414|NCT01872013|Urinary concentration|urinary concentration
399415|NCT01872013|ASP7991|asp7991
399416|NCT01872000|Intraocular lens|intraocular lens
399417|NCT01872000|Phacoemulsification|phacoemulsification
399418|NCT01871987|FK949E|fk949e
399419|NCT01871987|Quetiapine|quetiapine
399420|NCT01871987|Antipsychotic|antipsychotic
399421|NCT01871974|FK949E|fk949e
399422|NCT01871974|Antipsychotic|antipsychotic
399423|NCT01871974|Quetiapine|quetiapine
399424|NCT01871909|Physical trauma|physical trauma
399425|NCT01871896|Surgical Endoscopy|surgical endoscopy
399426|NCT01871896|Morbid Obesity|morbid obesity
399427|NCT01871896|Weight Loss|weight loss
399428|NCT01871896|Bariatrics|bariatrics
399429|NCT01871896|Surgical Revision|surgical revision
399430|NCT01871883|Sensitive skin|sensitive skin
399431|NCT01871883|Transient potential receptor vanilloid 1|transient potential receptor vanilloid 1
399432|NCT01871883|TRPV1|trpv1
399433|NCT01871883|Transepidermal water loss|transepidermal water loss
399434|NCT01871883|Skin Phototype|skin phototype
399435|NCT01871883|Lactic acid test|lactic acid test
399436|NCT01871883|Skin irritancy tests|skin irritancy tests
399437|NCT01871818|Multiple sclerosis|multiple sclerosis
399438|NCT01871818|Rehabilitation|rehabilitation
399439|NCT01871818|Chronic evolutive disease|chronic evolutive disease
399440|NCT01871818|Physiotherapy|physiotherapy
399441|NCT01871818|Resistance training|resistance training
399442|NCT01871818|Endurance training|endurance training
399443|NCT01871792|Contrast-induced nephropathy|contrast-induced nephropathy
399444|NCT01871792|Prevention|prevention
399445|NCT01871792|Statin|statin
399446|NCT01871792|Pitavastatin|pitavastatin
399447|NCT01871766|Rhabdomyosarcoma|rhabdomyosarcoma
399448|NCT01871766|Radiation therapy|radiation therapy
399449|NCT01871766|Proton beam|proton beam
399450|NCT01871740|Folic acid|folic acid
399451|NCT01871740|Renal function decline|renal function decline
399452|NCT01871740|Hypertension|hypertension
399453|NCT01871740|Hyperhomocysteinemia|hyperhomocysteinemia
399454|NCT01871740|Chronic kidney disease|chronic kidney disease
399455|NCT01871740|MTHFR C677T genotype|mthfr c677t genotype
399456|NCT01871740|Randomized controlled trial|randomized controlled trial
399457|NCT01871727|Persistent or Recurrent Cutaneous T-Cell Lymphoma|persistent or recurrent cutaneous t-cell lymphoma
399458|NCT01871727|E7777|e7777
399459|NCT01871714|XLHED|xlhed
399460|NCT01871714|HED|hed
399461|NCT01871714|Hypohidrotic Ectodermal Dysplasia|hypohidrotic ectodermal dysplasia
399462|NCT01871714|X Linked Hypohidrotic Ectodermal Dysplasia|x linked hypohidrotic ectodermal dysplasia
399463|NCT01871701|Corrected QT interval prolongation|corrected qt interval prolongation
399464|NCT01871701|Psychotropic drugs|psychotropic drugs
399465|NCT01871688|pelvic floor dysfunction|pelvic floor dysfunction
399466|NCT01871688|neuromodulation|neuromodulation
399467|NCT01871688|rehabilitation|rehabilitation
399468|NCT01871675|Lymphoma|lymphoma
399469|NCT01871675|Chronic Lymphocytic Leukemia|chronic lymphocytic leukemia
399470|NCT01871675|Non-Hodgkin Lymphoma|non-hodgkin lymphoma
399471|NCT01871675|T-cell Lymphoma|t-cell lymphoma
399472|NCT01871675|Rituxan|rituxan
399473|NCT01871675|Bendamustine|bendamustine
399474|NCT01871675|Hematologic Malignancy|hematologic malignancy
399475|NCT01871675|Relapsed|relapsed
399476|NCT01871675|Refractory|refractory
399477|NCT01871662|HCV|hcv
399478|NCT01871662|Hepatitis C|hepatitis c
399479|NCT01871649|psoriatic arthritis|psoriatic arthritis
399480|NCT01871649|golimumab|golimumab
399481|NCT01871649|methotrexate|methotrexate
399482|NCT01871649|minimal disease activity|minimal disease activity
399483|NCT01871649|safety|safety
399484|NCT01871649|withdrawal|withdrawal
399485|NCT01871636|endoscopy|endoscopy
399486|NCT01871636|WESD|wesd
399487|NCT01871636|EMR|emr
399488|NCT01871623|Cleft lip and palate|cleft lip and palate
399489|NCT01871623|Cone-Beam Computed Tomography|cone-beam computed tomography
399490|NCT01871623|Le Fort I Osteotomy|le fort i osteotomy
399491|NCT01871623|Segmental Osteotomy|segmental osteotomy
399492|NCT01871623|Stability|stability
399493|NCT01871610|Traumatic brain injury|traumatic brain injury
399494|NCT01871610|mild TBI|mild tbi
399495|NCT01871610|Alzheimer's disease|alzheimer's disease
399496|NCT01871610|[18F]AV-45 PET amyloid binding imaging|[18f]av-45 pet amyloid binding imaging
399497|NCT01871597|Lung cancer|lung cancer
399498|NCT01871597|VATS procedure|vats procedure
399499|NCT01871597|Pulmonary Artery Sealing|pulmonary artery sealing
399500|NCT01871584|A colon hydrotherapy system|a colon hydrotherapy system
399501|NCT01871584|Hydrocolonic preparation|hydrocolonic preparation
399502|NCT01871584|Preparation for colonoscopy|preparation for colonoscopy
399503|NCT01871558|type 2 diabetes|type 2 diabetes
399504|NCT01871558|basal insulin|basal insulin
399505|NCT01871558|vildagliptin|vildagliptin
399506|NCT01871545|hepatocellular carcinoma|hepatocellular carcinoma
399507|NCT01871545|HCC|hcc
399508|NCT01871545|liver cancer|liver cancer
399509|NCT01871545|liver disease|liver disease
399510|NCT01871545|magnetic resonance imaging|magnetic resonance imaging
399511|NCT01871545|MRI|mri
399512|NCT01871532|Monofollicular Development|monofollicular development
399513|NCT01871532|Gonal-f®|gonal-f®
399514|NCT01871532|Recombinant Follicle Stimulating Hormone|recombinant follicle stimulating hormone
399515|NCT01871532|Ovarian hyperstimulation syndrome (OHSS)|ovarian hyperstimulation syndrome (ohss)
399516|NCT01871519|vertebral body compression fracture|vertebral body compression fracture
399517|NCT01871480|NSCLC|nsclc
399518|NCT01871480|CIK|cik
399519|NCT01871480|Gefitinib|gefitinib
399520|NCT01871480|Adenocarcinoma|adenocarcinoma
399521|NCT01871402|psoriasis|psoriasis
399522|NCT01871402|lotion|lotion
399523|NCT01871402|investigator's global assessment|investigator's global assessment
399524|NCT01871376|PCV|pcv
399525|NCT01871363|Preoperative Chemoradiotherapy|preoperative chemoradiotherapy
399526|NCT01871363|Bevacizumab|bevacizumab
399527|NCT01871363|Locally Advanced Rectal Cancer|locally advanced rectal cancer
399528|NCT01871350|Cancer|cancer
399529|NCT01871350|Chemotherapy|chemotherapy
399530|NCT01871350|Chemo related toxicity|chemo related toxicity
399531|NCT01871350|Protein digestion|protein digestion
399532|NCT01871350|Fat digestion|fat digestion
399533|NCT01871350|Gut function|gut function
399534|NCT01871350|Glucose absorption|glucose absorption
399535|NCT01871350|Muscle function|muscle function
399536|NCT01871337|Multiple Sclerosis|multiple sclerosis
399537|NCT01871337|urinary incontinence|urinary incontinence
399538|NCT01871311|metastatic Kras wildtype|metastatic kras wildtype
399539|NCT01871311|squamous cell carcinoma|squamous cell carcinoma
399540|NCT01871311|cetuximab|cetuximab
399541|NCT01871311|nilotinib|nilotinib
399542|NCT01871298|internet and mobile technology use|internet and mobile technology use
399543|NCT01871298|history of drug use|history of drug use
399544|NCT01871298|injection drug user (IDU) syringe customers|injection drug user (idu) syringe customers
399545|NCT01871285|ATC, Opioid, withdrawal, switch|atc, opioid, withdrawal, switch
399546|NCT01871259|Sedation, sleep apnea, propofol|sedation, sleep apnea, propofol
399547|NCT01871233|anti-epileptic drug|anti-epileptic drug
399548|NCT01871233|Extended Access Program|extended access program
399549|NCT01871233|partial onset seizures|partial onset seizures
399550|NCT01871233|Perampanel|perampanel
399551|NCT01871220|Implant Abutments|implant abutments
399552|NCT01871220|Oral Mucosa Changes|oral mucosa changes
399553|NCT01871220|Implant Esthetics|implant esthetics
399554|NCT01871207|Erythropoietin (EPO)|erythropoietin (epo)
399555|NCT01871207|Diabetes|diabetes
399556|NCT01871207|Diabetic Retinopathy|diabetic retinopathy
399557|NCT01871207|Vascular Endothelial Growth Factor (VEGF)|vascular endothelial growth factor (vegf)
399558|NCT01871207|Erythropoiesis Stimulating Agents (ESA)|erythropoiesis stimulating agents (esa)
399559|NCT01871142|5 Hydroxymethyl 2 Furfural|5 hydroxymethyl 2 furfural
399560|NCT01871142|AES103|aes103
399561|NCT01871142|Exercise|exercise
399562|NCT01871129|Dexmedetomidine|dexmedetomidine
399563|NCT01871129|Postoperative Period|postoperative period
399564|NCT01871129|Airway extubation|airway extubation
399565|NCT01871129|Systolic Pressure|systolic pressure
399566|NCT01871116|breast cancer|breast cancer
399567|NCT01871116|early stage|early stage
399568|NCT01871116|weight loss|weight loss
399569|NCT01871103|Soft tissue defect|soft tissue defect
399570|NCT01871103|dorsal branch of the digital artery|dorsal branch of the digital artery
399571|NCT01871103|dorsal branch of the digital nerve|dorsal branch of the digital nerve
399572|NCT01871103|dorsal homodigital island flap|dorsal homodigital island flap
399573|NCT01871090|Remote Monitoring|remote monitoring
399574|NCT01871090|Remote Care|remote care
399575|NCT01871090|Cardiac Resynchronization Therapy|cardiac resynchronization therapy
399576|NCT01871090|Pacemaker|pacemaker
399577|NCT01871090|Implantable Cardioverter Defibrillator|implantable cardioverter defibrillator
399578|NCT01871064|Laparotomy|laparotomy
399579|NCT01871064|laparoscopic surgery|laparoscopic surgery
399580|NCT01871064|general anesthesia|general anesthesia
399581|NCT01871064|Neuromuscular Block|neuromuscular block
399582|NCT01871038|vaccine effectiveness|vaccine effectiveness
399583|NCT01871038|rotavirus|rotavirus
399584|NCT01871038|acute gastroenteritis|acute gastroenteritis
399585|NCT01871025|Chronic obstructive pulmonary disease|chronic obstructive pulmonary disease
399586|NCT01871012|Nerve Block|nerve block
399587|NCT01871012|Intraoperative Care|intraoperative care
399588|NCT01871012|Postoperative Recovery and Complications|postoperative recovery and complications
399589|NCT01871012|Stress and Inflammation|stress and inflammation
399590|NCT01870986|Healthy Volunteers|healthy volunteers
399591|NCT01870986|Phase 1|phase 1
399592|NCT01870986|PK|pk
399593|NCT01870986|adalimumab|adalimumab
399594|NCT01870986|Single-dose|single-dose
399595|NCT01870986|Immunology|immunology
399596|NCT01870986|Bioequivalence|bioequivalence
399597|NCT01870986|Biosimilarity|biosimilarity
399598|NCT01870986|Similarity.|similarity.
399599|NCT01870973|postoperative pain|postoperative pain
399600|NCT01870973|root canal treatment|root canal treatment
399601|NCT01870947|Stage I endometrial adenocarcinoma|stage i endometrial adenocarcinoma
399602|NCT01870947|Obesity|obesity
399603|NCT01870947|Exercise and Physical Fitness|exercise and physical fitness
399604|NCT01870947|Diet|diet
399605|NCT01870947|Cancer|cancer
399606|NCT01870934|Telemedicine|telemedicine
399607|NCT01870934|Diabetes|diabetes
399608|NCT01870934|Foot Ulcers|foot ulcers
399609|NCT01870895|YM060|ym060
399610|NCT01870895|Ramosetron|ramosetron
399611|NCT01870895|Diarrhea-predominant Irritable Bowel Syndrome|diarrhea-predominant irritable bowel syndrome
399612|NCT01870882|Opioid-Related Disorders|opioid-related disorders
399613|NCT01870882|Cocaine-Related Disorders|cocaine-related disorders
399614|NCT01870882|Substance-Related Disorders|substance-related disorders
399615|NCT01870882|Mental Disorders|mental disorders
511184|NCT01384981|NIV|niv
399616|NCT01870882|Cocaine|cocaine
399617|NCT01870882|Methadone|methadone
399618|NCT01870882|Therapeutic Uses|therapeutic uses
399619|NCT01870856|Ocular discomfort|ocular discomfort
399620|NCT01870856|Contact lenses|contact lenses
399621|NCT01870856|Myopia|myopia
399622|NCT01870843|Depressive Disorder, Major|depressive disorder, major
399623|NCT01870843|Depressive Disorder|depressive disorder
399624|NCT01870843|Depression|depression
399625|NCT01870843|Anxiety|anxiety
399626|NCT01870843|Escitalopram|escitalopram
399627|NCT01870843|Quality of life|quality of life
399628|NCT01870843|Social functionality|social functionality
399629|NCT01870817|Randomized|randomized
399630|NCT01870817|Jejunostomy|jejunostomy
399631|NCT01870817|Enteral|enteral
399632|NCT01870817|Nutrition|nutrition
399633|NCT01870817|Esophagectomy|esophagectomy
399634|NCT01870817|Gastrectomy|gastrectomy
399635|NCT01870804|Statins|statins
399636|NCT01870804|Contrast-Induced Acute Kidney Injury|contrast-induced acute kidney injury
399637|NCT01870804|Periprocedural Myocardial Damage|periprocedural myocardial damage
399638|NCT01870791|Esophageal adenocarcinoma|esophageal adenocarcinoma
399639|NCT01870791|Gastric adenocarcinoma|gastric adenocarcinoma
399640|NCT01870778|acute heart failure,|acute heart failure,
399641|NCT01870778|AHF,|ahf,
399642|NCT01870778|multi-center,|multi-center,
399643|NCT01870778|randomized,|randomized,
399644|NCT01870778|double-blind|double-blind
399645|NCT01870739|LCZ696,|lcz696,
399646|NCT01870739|Hypertension,|hypertension,
399647|NCT01870739|Aortic stiffness,|aortic stiffness,
399648|NCT01870739|Central blood pressure,|central blood pressure,
399649|NCT01870739|Cardiovascular MRI|cardiovascular mri
399650|NCT01870726|Glioblastoma multiforme (GBM), glioblastoma, Grade IV Astrocytoma, brain tumor, brain cancer, giant cell glioblastoma, gliosarcoma|glioblastoma multiforme (gbm), glioblastoma, grade iv astrocytoma, brain tumor, brain cancer, giant cell glioblastoma, gliosarcoma
399651|NCT01870713|gastric bypass surgery|gastric bypass surgery
399652|NCT01870713|proteomics|proteomics
399653|NCT01870687|vitex agnus castus|vitex agnus castus
399654|NCT01870687|clinical trial|clinical trial
399655|NCT01870687|cyclic mastodynia|cyclic mastodynia
399656|NCT01870687|PMS|pms
399657|NCT01870687|prospective|prospective
399658|NCT01870674|safety|safety
399659|NCT01870674|tolerability|tolerability
399660|NCT01870674|pharmacokinetics|pharmacokinetics
399661|NCT01870674|pharmacodynamics|pharmacodynamics
399662|NCT01870661|Intravenous placement|intravenous placement
399663|NCT01870661|Ultrasound|ultrasound
399664|NCT01870648|Low-middle income country|low-middle income country
399665|NCT01870648|Dehydration|dehydration
399666|NCT01870648|Intravenous Rehydration|intravenous rehydration
399667|NCT01870648|Pakistan|pakistan
399668|NCT01870635|Low-middle income country|low-middle income country
399669|NCT01870635|Dehydration|dehydration
399670|NCT01870635|Intravenous Rehydration|intravenous rehydration
399671|NCT01870635|Pakistan|pakistan
399672|NCT01870622|Newborn,|newborn,
399673|NCT01870622|Infant,|infant,
399674|NCT01870622|Endotracheal Intubation,|endotracheal intubation,
399675|NCT01870622|Carbon dioxide detector,|carbon dioxide detector,
399676|NCT01870622|Flow waves|flow waves
399677|NCT01870583|Cesarean delivery|cesarean delivery
399678|NCT01870583|Surgical site infection|surgical site infection
399679|NCT01870583|Pregnancy|pregnancy
399680|NCT01870583|Postpartum|postpartum
399681|NCT01870570|Glycaemia|glycaemia
399682|NCT01870570|Insulinemia|insulinemia
399683|NCT01870557|Diabetes Mellitus|diabetes mellitus
399684|NCT01870557|Bone|bone
399685|NCT01870557|Bone Status|bone status
399686|NCT01870557|Glycemic Markers|glycemic markers
399687|NCT01870557|Osteoporosis|osteoporosis
399688|NCT01870557|Osteopenia|osteopenia
399689|NCT01870544|gastric bypass|gastric bypass
399690|NCT01870544|microbiota|microbiota
399691|NCT01870544|probiotic|probiotic
399692|NCT01870531|Transient Ischemic Attack|transient ischemic attack
399693|NCT01870518|Parkinson's disease|parkinson's disease
399694|NCT01870518|Dementia|dementia
399695|NCT01870505|BYL719|byl719
399696|NCT01870505|Letrozole|letrozole
399697|NCT01870505|Exemestane|exemestane
399698|NCT01870505|13-027|13-027
399699|NCT01870492|IV-tPA|iv-tpa
399700|NCT01870492|Activase|activase
399701|NCT01870492|endovascular therapy|endovascular therapy
399702|NCT01870479|Malignant Lymphoma|malignant lymphoma
399703|NCT01870479|Chemotherapy|chemotherapy
399704|NCT01870479|Music therapy|music therapy
399705|NCT01870453|Alzheimer Disease|alzheimer disease
399706|NCT01870453|Dementia|dementia
399707|NCT01870453|Postoperative Care|postoperative care
399708|NCT01870453|Cognitive Reserve|cognitive reserve
399709|NCT01870440|Uveitis|uveitis
399710|NCT01870440|Macular Edema|macular edema
399711|NCT01870427|Macular Edema|macular edema
399712|NCT01870427|Central Retinal Vein Occlusion|central retinal vein occlusion
399713|NCT01870427|CRVO|crvo
399714|NCT01870427|Aflibercept|aflibercept
399715|NCT01870427|VEGF Trap-Eye|vegf trap-eye
399716|NCT01870427|Eylea|eylea
399717|NCT01870427|Ranibizumab|ranibizumab
399718|NCT01870427|Bevacizumab|bevacizumab
399719|NCT01870375|Mucopolysaccharidosis|mucopolysaccharidosis
399720|NCT01870375|Longitudinal|longitudinal
399721|NCT01870375|Brain|brain
399722|NCT01870375|Cognition|cognition
399723|NCT01870375|Quality-of-Life|quality-of-life
399724|NCT01870375|Hurler syndrome|hurler syndrome
399725|NCT01870375|Hunter syndrome|hunter syndrome
399726|NCT01870375|Hurler-Scheie syndrome|hurler-scheie syndrome
399727|NCT01870375|Scheie syndrome|scheie syndrome
399728|NCT01870375|Maroteaux-Lamy syndrome|maroteaux-lamy syndrome
399729|NCT01870375|MPS I|mps i
399730|NCT01870375|MPS II|mps ii
399731|NCT01870375|MPS VI|mps vi
399732|NCT01870375|Mucopolysaccharidosis type I|mucopolysaccharidosis type i
399733|NCT01870375|Mucopolysaccharidosis type II|mucopolysaccharidosis type ii
399734|NCT01870375|Mucopolysaccharidosis type VI|mucopolysaccharidosis type vi
399735|NCT01870375|MPS IV|mps iv
399736|NCT01870375|MPS VII|mps vii
399737|NCT01870375|Mucopolysaccharidosis type IV|mucopolysaccharidosis type iv
399738|NCT01870375|Mucopolysaccharidosis type VII|mucopolysaccharidosis type vii
399739|NCT01870375|Morquio syndrome|morquio syndrome
399740|NCT01870375|Sly syndrome|sly syndrome
399741|NCT01870349|cytokines|cytokines
399742|NCT01870349|dental implants|dental implants
399743|NCT01870349|peri-implantitis|peri-implantitis
399744|NCT01870310|Heart failure|heart failure
399745|NCT01870310|Renal denervation|renal denervation
399746|NCT01870271|PTSD|ptsd
399747|NCT01870271|childhood sexual abuse|childhood sexual abuse
399748|NCT01870271|physical abuse|physical abuse
399749|NCT01870271|developmentally adapted cognitive processing therapy|developmentally adapted cognitive processing therapy
399750|NCT01870258|Myocardial infarction|myocardial infarction
399751|NCT01870258|artificial neural networks|artificial neural networks
399752|NCT01870258|Electrocardiography|electrocardiography
399753|NCT01870232|Greater palatine nerve Block|greater palatine nerve block
399754|NCT01870232|Inferior Alveolar nerve block|inferior alveolar nerve block
399755|NCT01870232|dental anesthesia|dental anesthesia
399756|NCT01870232|Ultrasonography|ultrasonography
399757|NCT01870219|sevoflurane|sevoflurane
399758|NCT01870219|ketamine|ketamine
399759|NCT01870219|QT interval|qt interval
399760|NCT01870206|Immunogenicity|immunogenicity
399761|NCT01870206|Safety|safety
399762|NCT01870206|Efficacy|efficacy
399763|NCT01870206|Poliomyelitis|poliomyelitis
399764|NCT01870206|Newborn|newborn
399765|NCT01870193|Glutathione deficiency in aging|glutathione deficiency in aging
399766|NCT01870193|Impaired mitochondrial fatty-acid oxidation in aging|impaired mitochondrial fatty-acid oxidation in aging
399767|NCT01870180|Meibomian Glad Dysfunction|meibomian glad dysfunction
399768|NCT01870180|EyeBag|eyebag
399769|NCT01870180|Hot Compress|hot compress
399770|NCT01870180|Dry Eyes|dry eyes
399771|NCT01870167|PEG|peg
399772|NCT01870167|Percutaneous Endoscopic Gastrostomy|percutaneous endoscopic gastrostomy
399773|NCT01870167|antibiotic prophylaxis|antibiotic prophylaxis
399774|NCT01870154|Burnout syndrome|burnout syndrome
399775|NCT01870154|Job stressors|job stressors
399776|NCT01870154|Primary Health Care|primary health care
399777|NCT01870154|Health professional|health professional
399778|NCT01870141|Glucose Control|glucose control
399779|NCT01870141|Depression|depression
399780|NCT01870141|Self-Efficacy|self-efficacy
399781|NCT01870128|Rheumatoid arthritis|rheumatoid arthritis
399782|NCT01870128|Steroid|steroid
399783|NCT01870115|Melatonin|melatonin
399784|NCT01870115|Strontium Citrate|strontium citrate
399785|NCT01870115|Osteoporosis|osteoporosis
399786|NCT01870115|Osteopenia|osteopenia
399787|NCT01870089|Non invasive ventilation|non invasive ventilation
399788|NCT01870089|Computer-driven system|computer-driven system
399789|NCT01870089|Acute respiratory failure|acute respiratory failure
399790|NCT01870063|5 minute bleeding test|5 minute bleeding test
399791|NCT01870063|swamb|swamb
399792|NCT01870063|fibtem|fibtem
399793|NCT01870063|extem|extem
399794|NCT01870050|lichen simplex chronicus|lichen simplex chronicus
399795|NCT01870050|prurigo|prurigo
399796|NCT01870037|Overactive Bladder|overactive bladder
399797|NCT01870037|OAB|oab
399798|NCT01870037|gene therapy|gene therapy
399799|NCT01870024|status epilepticus|status epilepticus
399800|NCT01870024|epilepsy|epilepsy
399801|NCT01870024|seizures|seizures
399802|NCT01870024|convulsive seizures|convulsive seizures
399803|NCT01870024|convulsions|convulsions
399804|NCT01870024|benzodiazepines|benzodiazepines
399805|NCT01870024|anticonvulsants|anticonvulsants
399806|NCT01870011|Propofol, renal protection, kidney transplantation|propofol, renal protection, kidney transplantation
399807|NCT01869998|Vortex|vortex
399808|NCT01869998|Thrombus|thrombus
399809|NCT01869998|Contrast echocardiography|contrast echocardiography
399810|NCT01869998|Prediction and prevention of apical thrombus formation in acute myocardial infarction patient by using Vortex parameters.|prediction and prevention of apical thrombus formation in acute myocardial infarction patient by using vortex parameters.
399811|NCT01869985|HCP1104|hcp1104
399812|NCT01869985|Eperisone Hydrochloride|eperisone hydrochloride
399813|NCT01869985|Aceclofenac|aceclofenac
399814|NCT01869972|PKU|pku
399815|NCT01869972|phenylketonuria|phenylketonuria
399816|NCT01869972|hyperphenylalaninemia|hyperphenylalaninemia
399817|NCT01869972|Kuvan|kuvan
399818|NCT01869972|sapropterin|sapropterin
399819|NCT01869946|Hip arthroplasty|hip arthroplasty
399820|NCT01869933|Proliferative, Diabetic, Retinopathy|proliferative, diabetic, retinopathy
399821|NCT01869920|breastfeeding|breastfeeding
399822|NCT01869920|education|education
399823|NCT01869920|intervention|intervention
399824|NCT01869894|Malignant biliary obstruction|malignant biliary obstruction
399825|NCT01869894|metal stent|metal stent
399826|NCT01869894|patency|patency
399827|NCT01869855|chronic subdural hematoma|chronic subdural hematoma
399828|NCT01869855|traumatic brain injury|traumatic brain injury
399829|NCT01869855|burr hole trepanation|burr hole trepanation
399830|NCT01869855|drainage after evacuation of chronic subdural hematoma|drainage after evacuation of chronic subdural hematoma
399831|NCT01869855|intracranial bleed|intracranial bleed
399832|NCT01869842|Resolute zotarolumus-eluting stent|resolute zotarolumus-eluting stent
399833|NCT01869842|optical coherence tomography|optical coherence tomography
399834|NCT01869829|Candida|candida
399835|NCT01869829|Pediatric|pediatric
399836|NCT01869829|Antifungal|antifungal
399837|NCT01869738|heart attack|heart attack
399838|NCT01869725|Neuroendocrine Tumor|neuroendocrine tumor
399839|NCT01869725|Ga-DOTATOC PET|ga-dotatoc pet
399840|NCT01869725|Imaging|imaging
400930|NCT01864603|PrEP|prep
399841|NCT01869712|cupping therapy|cupping therapy
399842|NCT01869712|acupuncture|acupuncture
399843|NCT01869712|partially randomized|partially randomized
399844|NCT01869712|patient preference|patient preference
399845|NCT01869712|fibromyalgia|fibromyalgia
399846|NCT01869712|criteria formulated by American College Rheumatology 2002|criteria formulated by american college rheumatology 2002
399847|NCT01869699|Fever|fever
399848|NCT01869699|Acetaminophen|acetaminophen
399849|NCT01869699|Critical Care|critical care
399850|NCT01869699|ICU|icu
399851|NCT01869699|Febrile|febrile
399852|NCT01869673|Difficult mask ventilation|difficult mask ventilation
399853|NCT01869673|extubation|extubation
399854|NCT01869673|nasal surgery|nasal surgery
399855|NCT01869660|First hospitalization|first hospitalization
399856|NCT01869647|kidney stones|kidney stones
399857|NCT01869634|HIV|hiv
399858|NCT01869634|cardiovascular risk|cardiovascular risk
399859|NCT01869634|systemic immune activation|systemic immune activation
399860|NCT01869608|postpartum screening|postpartum screening
399861|NCT01869608|type 2 diabetes|type 2 diabetes
399862|NCT01869595|2000 MSM and TG sites in Bangkok,Lampang,Ubonratchathani|2000 msm and tg sites in bangkok,lampang,ubonratchathani
399863|NCT01869582|Fetal hypoxia|fetal hypoxia
399864|NCT01869582|Birth asphyxia|birth asphyxia
399865|NCT01869582|Neonatal resuscitation|neonatal resuscitation
399866|NCT01869569|Radiation|radiation
399867|NCT01869569|Neuropathic Pain|neuropathic pain
399868|NCT01869569|Pregabalin|pregabalin
399869|NCT01869556|pregnancy|pregnancy
399870|NCT01869556|postpartum hemorrhage|postpartum hemorrhage
399871|NCT01869556|Cesarean delivery|cesarean delivery
399872|NCT01869556|failure to progress in labor|failure to progress in labor
399873|NCT01869504|Ballooned intercostal drain|ballooned intercostal drain
399874|NCT01869504|Pleural effusion|pleural effusion
399875|NCT01869491|Gastroesophageal Reflux Disease|gastroesophageal reflux disease
399876|NCT01869491|GERD|gerd
399877|NCT01869491|Dyspepsia|dyspepsia
399878|NCT01869491|Indigestion|indigestion
399879|NCT01869491|Heartburn|heartburn
399880|NCT01869491|Acid reflux|acid reflux
399881|NCT01869491|Compound Sodium Alginate Double Action Chewable Tablets|compound sodium alginate double action chewable tablets
399882|NCT01869491|Gaviscon Double Action Tablets|gaviscon double action tablets
399883|NCT01869452|education|education
399884|NCT01869452|risk factors|risk factors
399885|NCT01869452|quality of life|quality of life
399886|NCT01869452|coronary disease|coronary disease
399887|NCT01869452|telephone follow up|telephone follow up
399888|NCT01869452|dedicated nurse|dedicated nurse
399889|NCT01869439|Pressure Ulcers|pressure ulcers
399890|NCT01869439|Bed Sores|bed sores
399891|NCT01869439|Measuring|measuring
399892|NCT01869439|Visual Images|visual images
399893|NCT01869439|Thermal Images|thermal images
399894|NCT01869439|External Wounds|external wounds
399895|NCT01869439|Area|area
399896|NCT01869439|Length|length
399897|NCT01869439|Width|width
399898|NCT01869439|Gradient|gradient
399899|NCT01869426|colics|colics
399900|NCT01869413|urothelial cell carcinoma|urothelial cell carcinoma
399901|NCT01869413|transition cell carcinoma|transition cell carcinoma
399902|NCT01869413|bladder cancer|bladder cancer
399903|NCT01869413|radical cystectomy|radical cystectomy
399904|NCT01869413|cystectomy|cystectomy
399905|NCT01869413|bladder removal|bladder removal
399906|NCT01869413|tranexamic acid|tranexamic acid
399907|NCT01869413|cyklokapron|cyklokapron
399908|NCT01869374|Depression|depression
399909|NCT01869374|Brain Stimulation|brain stimulation
399910|NCT01869374|Seizure therapy|seizure therapy
399911|NCT01869374|Convulsive Therapy|convulsive therapy
399912|NCT01869361|preterm labor|preterm labor
399913|NCT01869361|tocolysis|tocolysis
399914|NCT01869361|indomethacin|indomethacin
399915|NCT01869348|Physical activity|physical activity
399916|NCT01869348|Activity monitor|activity monitor
399917|NCT01869348|Technology|technology
399918|NCT01869348|Obesity|obesity
399919|NCT01869348|Aging muscle|aging muscle
399920|NCT01869335|breast cancer|breast cancer
399921|NCT01869335|MRI|mri
399922|NCT01869335|mammography|mammography
399923|NCT01869335|microcalcifications|microcalcifications
399924|NCT01869335|Local staging of breast microcalcifications|local staging of breast microcalcifications
399925|NCT01869335|Evaluation of ex vivo MRI for breast malignancies detected by MRI only|evaluation of ex vivo mri for breast malignancies detected by mri only
399926|NCT01869322|Humerus|humerus
399927|NCT01869322|Fracture|fracture
399928|NCT01869322|Sling|sling
399929|NCT01869322|Splint|splint
399930|NCT01869322|Coaptation|coaptation
399931|NCT01869309|Coronary artery disease|coronary artery disease
399932|NCT01869309|anti-platelet medications|anti-platelet medications
399933|NCT01869309|Platelet-aggregation Inhibitors|platelet-aggregation inhibitors
399934|NCT01869296|unsedated|unsedated
399935|NCT01869296|water immersion colonoscopy|water immersion colonoscopy
399936|NCT01869296|endoscope water pump flow rates|endoscope water pump flow rates
399937|NCT01869283|Physical Therapy Modalities|physical therapy modalities
399938|NCT01869283|Myofascial Pain Syndromes|myofascial pain syndromes
399939|NCT01869283|Skeletal Muscle|skeletal muscle
401226|NCT01863459|ADD|add
399940|NCT01869270|hexosaminidase deficiency|hexosaminidase deficiency
399941|NCT01869270|Tay-Sachs disease|tay-sachs disease
399942|NCT01869270|Sandhoff disease|sandhoff disease
399943|NCT01869270|late-onset Tay-Sachs disease|late-onset tay-sachs disease
399944|NCT01869270|adult-onset Tay-Sachs disease|adult-onset tay-sachs disease
399945|NCT01869270|late onset Tay Sachs disease|late onset tay sachs disease
399946|NCT01869270|adult onset Tay Sachs disease|adult onset tay sachs disease
399947|NCT01869270|retrospective|retrospective
399948|NCT01869270|hexosaminidase A activity|hexosaminidase a activity
399949|NCT01869270|GM2-ganglioside|gm2-ganglioside
399950|NCT01869270|gangliosidoses|gangliosidoses
399951|NCT01869270|natural history|natural history
399952|NCT01869270|hexosaminidase|hexosaminidase
399953|NCT01869257|triclosan|triclosan
399954|NCT01869257|colorectal|colorectal
399955|NCT01869257|surgery|surgery
399956|NCT01869257|surgical site infection|surgical site infection
399957|NCT01869218|Cancer|cancer
399958|NCT01869218|Advanced|advanced
399959|NCT01869218|Solid|solid
399960|NCT01869218|Hematological|hematological
399961|NCT01869218|Malignancy|malignancy
399962|NCT01869218|Tissue|tissue
399963|NCT01869218|Bank|bank
399964|NCT01869205|COPD|copd
399965|NCT01869205|Emphysema|emphysema
399966|NCT01869205|Bronchoscopic lung volume reduction|bronchoscopic lung volume reduction
399967|NCT01869205|Endobronchial valve|endobronchial valve
399968|NCT01869192|Malignant|malignant
399969|NCT01869192|Neoplasm|neoplasm
399970|NCT01869192|Cancer|cancer
399971|NCT01869192|Female|female
399972|NCT01869192|Breast|breast
399973|NCT01869192|Stage II|stage ii
399974|NCT01869192|Stage III|stage iii
399975|NCT01869179|Well being|well being
399976|NCT01869179|Low income|low income
399977|NCT01869179|Choir singing|choir singing
399978|NCT01869179|Spanish speaking|spanish speaking
399979|NCT01869179|Community based|community based
399980|NCT01869179|Seniors|seniors
399981|NCT01869179|60+ aged adults|60+ aged adults
399982|NCT01869166|chemotherapy and/or EGFR-antibody/kinase inhibitor therapy refractory solid tumors|chemotherapy and/or egfr-antibody/kinase inhibitor therapy refractory solid tumors
399983|NCT01869153|Growth, weight|growth, weight
399984|NCT01869127|hookworm|hookworm
399985|NCT01869127|necator americanus|necator americanus
399986|NCT01869127|ancyclostoma duodenale|ancyclostoma duodenale
399987|NCT01869127|shoes|shoes
399988|NCT01869127|anaemia|anaemia
399989|NCT01869127|children|children
399990|NCT01869101|Prediabetes|prediabetes
399991|NCT01869101|Diabetes prevention|diabetes prevention
399992|NCT01869088|TACE|tace
399993|NCT01869088|Carcinoma,Hepatocellular|carcinoma,hepatocellular
399994|NCT01869088|Liver Neoplasms|liver neoplasms
399995|NCT01869088|overall survival|overall survival
399996|NCT01869088|Recombinant Human Adenovirus Type 5 Injection|recombinant human adenovirus type 5 injection
399997|NCT01869075|Quality Improvement|quality improvement
399998|NCT01869075|Patient Safety|patient safety
399999|NCT01869075|Knowledge Translation|knowledge translation
400001|NCT01869049|Immune Thrombocytopenia|immune thrombocytopenia
400002|NCT01869049|macrophage|macrophage
400003|NCT01869049|spleen tissue|spleen tissue
400004|NCT01869036|Caudal|caudal
400005|NCT01869036|anesthesia|anesthesia
400006|NCT01869036|morphine|morphine
400007|NCT01869036|children|children
400008|NCT01869023|Advanced Malignant Pleural Mesothelioma|advanced malignant pleural mesothelioma
400009|NCT01869023|Gemcitabine and cisplatin|gemcitabine and cisplatin
796042|NCT00270127|transfusion|transfusion
400010|NCT01869023|Gemcitabine continuous infusion|gemcitabine continuous infusion
400011|NCT01869010|HIV infection|hiv infection
400012|NCT01869010|Antiretroviral treatment|antiretroviral treatment
400013|NCT01869010|Renal disease|renal disease
400014|NCT01869010|Renal tubular damage|renal tubular damage
400015|NCT01869010|Free-water clearance|free-water clearance
400016|NCT01868997|Thyroid Eye Disease, Graves Orbitopathy, Thyroid Associated|thyroid eye disease, graves orbitopathy, thyroid associated
400017|NCT01868997|Ophthalmopathy|ophthalmopathy
400018|NCT01868971|EndoRings|endorings
400019|NCT01868958|Magnetic resonance imaging (MRI)|magnetic resonance imaging (mri)
400020|NCT01868958|Diffusion tensor imaging|diffusion tensor imaging
400021|NCT01868958|Spine|spine
400022|NCT01868945|Vitamin D3|vitamin d3
400023|NCT01868945|Calcifediol 25|calcifediol 25
400024|NCT01868945|Frail|frail
400025|NCT01868945|Dose-response|dose-response
400026|NCT01868932|wheeze|wheeze
400027|NCT01868932|early childhood|early childhood
400028|NCT01868932|asthma|asthma
400029|NCT01868932|bronchiolitis|bronchiolitis
400030|NCT01868932|infection triggered|infection triggered
400031|NCT01868919|"Pilot Projects[Mesh]"|"pilot projects[mesh]"
400032|NCT01868919|"Parenting[Mesh]"|"parenting[mesh]"
400033|NCT01868919|"Child Behaviour[Mesh]"|"child behaviour[mesh]"
400034|NCT01868919|"Mental Health[Mesh]"|"mental health[mesh]"
400035|NCT01868919|"Family Practice[Mesh]"|"family practice[mesh]"
400036|NCT01868906|Anaplastic Astrocytoma|anaplastic astrocytoma
400037|NCT01868906|Brain Tumors|brain tumors
400038|NCT01868906|Cancer Imaging|cancer imaging
400039|NCT01868906|Fluoromisonidazole|fluoromisonidazole
400041|NCT01868906|Glioblastoma|glioblastoma
400042|NCT01868906|High Grade Glioma|high grade glioma
400043|NCT01868906|Hypoxia Modification|hypoxia modification
400044|NCT01868906|Positron Emission Tomography|positron emission tomography
400045|NCT01868906|Radiation-Sensitizing Agents|radiation-sensitizing agents
400046|NCT01868906|Spinal Cord Stimulation|spinal cord stimulation
400047|NCT01868906|Tumor Hypoxia Measurement|tumor hypoxia measurement
400048|NCT01868854|Tip catheter|tip catheter
400049|NCT01868854|Peritoneal Dialysis|peritoneal dialysis
400050|NCT01868854|Risk Factot|risk factot
400051|NCT01868854|Mecanical Function|mecanical function
400052|NCT01868841|123I-mIBG|123i-mibg
400053|NCT01868841|AdreView|adreview
400054|NCT01868841|SPECT|spect
400055|NCT01868841|Heart to Mediastinal Ratio|heart to mediastinal ratio
400056|NCT01868828|Multiple Myeloma|multiple myeloma
400057|NCT01868828|Combination Therapy|combination therapy
400058|NCT01868802|Ketamine|ketamine
400059|NCT01868802|Depression|depression
400060|NCT01868802|Depressive Disorder|depressive disorder
400061|NCT01868789|Adult-acquired flatfoot disorder (AAFD)|adult-acquired flatfoot disorder (aafd)
400062|NCT01868789|flexible flatfoot|flexible flatfoot
400063|NCT01868789|computed tomography (CT)|computed tomography (ct)
400064|NCT01868763|telemedicine|telemedicine
400065|NCT01868763|coaching|coaching
400066|NCT01868763|lifestyle change|lifestyle change
400067|NCT01868763|weight loss|weight loss
400068|NCT01868737|Human Immunodeficiency Virus|human immunodeficiency virus
400069|NCT01868737|Necrotizing Enterocolitis|necrotizing enterocolitis
400070|NCT01868737|Premature infant|premature infant
400071|NCT01868737|Probiotic|probiotic
400072|NCT01868737|Very Low Birth Weight|very low birth weight
400073|NCT01868724|Kidney Renal|kidney renal
400074|NCT01868711|Major Depressive Disorder|major depressive disorder
400075|NCT01868711|Cognitive Behavior Therapy|cognitive behavior therapy
400076|NCT01868711|Psychological Mindedness|psychological mindedness
400077|NCT01868698|Physical Therapy Modalities|physical therapy modalities
400078|NCT01868698|Electric Stimulation Therapy|electric stimulation therapy
400079|NCT01868698|Hyperthermia, Induced|hyperthermia, induced
400080|NCT01868698|Diabetes Mellitus|diabetes mellitus
400081|NCT01868685|Muscle, anabolism, cachexia, respiratory failure, diaphragm|muscle, anabolism, cachexia, respiratory failure, diaphragm
400082|NCT01868672|Secondhand smoke exposure|secondhand smoke exposure
400083|NCT01868672|Smoke-free homes|smoke-free homes
400084|NCT01868672|Smoke-free home bans|smoke-free home bans
400085|NCT01868646|Combined Treatment of Patients With Type II Diabetes Mellitus|combined treatment of patients with type ii diabetes mellitus
400086|NCT01868633|Cesarean delivery|cesarean delivery
400087|NCT01868633|Analgesia|analgesia
400088|NCT01868633|Pain|pain
400089|NCT01868633|Dexamethasone|dexamethasone
400090|NCT01868633|intrathecal morphine|intrathecal morphine
400091|NCT01868633|spinal anesthesia|spinal anesthesia
400092|NCT01868620|Progressive keratoconus|progressive keratoconus
400093|NCT01868620|standard CXL|standard cxl
400094|NCT01868620|iontophoretic CXL|iontophoretic cxl
400095|NCT01868620|keratometry|keratometry
400096|NCT01868607|Respiratory resistance|respiratory resistance
400097|NCT01868607|Respiratory reactance|respiratory reactance
400098|NCT01868607|Adult lung function|adult lung function
400099|NCT01868607|Forced oscillation technique|forced oscillation technique
400100|NCT01868607|subjects|subjects
400567|NCT01866254|pain management|pain management
400568|NCT01866254|respiratory depression|respiratory depression
400101|NCT01868594|Combined treatment of patients with type I diabetes mellitus|combined treatment of patients with type i diabetes mellitus
400102|NCT01868490|Cholangiocarcinoma|cholangiocarcinoma
400103|NCT01868490|Cytokine induced killer cells|cytokine induced killer cells
400104|NCT01868490|CIK|cik
400105|NCT01868490|Treg|treg
400106|NCT01868490|Th17|th17
400107|NCT01868477|myelodysplastic syndrome|myelodysplastic syndrome
400108|NCT01868477|MDS|mds
400109|NCT01868477|myelodysplasia|myelodysplasia
400110|NCT01868477|blood disorder|blood disorder
400111|NCT01868477|cytopenias|cytopenias
400112|NCT01868477|low blood counts|low blood counts
400113|NCT01868477|progressive bone marrow failure|progressive bone marrow failure
400114|NCT01868477|adult|adult
400115|NCT01868477|ICL570|icl570
400116|NCT01868477|deferasirox|deferasirox
400117|NCT01868477|erythropoietin|erythropoietin
400118|NCT01868477|erythropoiesis|erythropoiesis
400119|NCT01868477|NF-kB pathway|nf-kb pathway
400120|NCT01868477|hematopoiesis.|hematopoiesis.
400121|NCT01868464|challenge|challenge
400122|NCT01868464|Mycobacterium tuberculosis|mycobacterium tuberculosis
400123|NCT01868464|parent protocol|parent protocol
400124|NCT01868464|TB|tb
400125|NCT01868464|Tice BCG|tice bcg
400126|NCT01868464|tuberculosis|tuberculosis
400127|NCT01868451|DACARBAZINE|dacarbazine
400128|NCT01868451|DOXORUBICIN/ADRIAMYCIN|doxorubicin/adriamycin
400129|NCT01868451|SGN-35 (BRENTUXIMAB VEDOTIN)|sgn-35 (brentuximab vedotin)
400130|NCT01868451|VINBLASTINE|vinblastine
400131|NCT01868451|Involved-site radiation therapy (ISRT)|involved-site radiation therapy (isrt)
400132|NCT01868451|Early stage|early stage
400133|NCT01868451|13-034|13-034
400134|NCT01868438|Pyronaridine artesunate tablet|pyronaridine artesunate tablet
400135|NCT01868438|Pyronaridine artesunate granules|pyronaridine artesunate granules
400136|NCT01868438|Pyramax tablet|pyramax tablet
400137|NCT01868438|Pyramax granules|pyramax granules
400138|NCT01868438|Bioavailability|bioavailability
400139|NCT01868412|Wound healing|wound healing
400140|NCT01868412|Wound infection|wound infection
400141|NCT01868412|Resin salve|resin salve
400142|NCT01868412|Medical honey|medical honey
400143|NCT01868399|dengue virus|dengue virus
400144|NCT01868386|Radiotherapy, hypofractionated|radiotherapy, hypofractionated
400145|NCT01868386|Salvage therapy|salvage therapy
400146|NCT01868386|Radiotherapy, adjuvant|radiotherapy, adjuvant
400147|NCT01868373|commensal microbiota bacteroides colitis pseudomembranous|commensal microbiota bacteroides colitis pseudomembranous
400148|NCT01868360|cornea|cornea
400149|NCT01868360|transplant|transplant
400150|NCT01868360|graft|graft
400151|NCT01868360|neovascularization|neovascularization
400152|NCT01868347|obese patients|obese patients
400153|NCT01868347|specific elastance|specific elastance
400154|NCT01868347|Trendelenburg Position|trendelenburg position
400155|NCT01868347|Pneumoperitoneum|pneumoperitoneum
400156|NCT01868347|robotic surgery|robotic surgery
400157|NCT01868347|Prostatectomy|prostatectomy
400158|NCT01868334|influenza vaccine|influenza vaccine
400159|NCT01868334|PPSV|ppsv
400160|NCT01868334|Tdap|tdap
400161|NCT01868334|vaccination|vaccination
400162|NCT01868334|adult|adult
400163|NCT01868321|Mechanical ventilation|mechanical ventilation
400164|NCT01868321|Acute respiratory failure|acute respiratory failure
400165|NCT01868321|Acute respiratory distress syndrome|acute respiratory distress syndrome
400166|NCT01868282|anterior cruciate ligament repair, Obturator nerve block, Hamstrings graft, Ropivacaine,|anterior cruciate ligament repair, obturator nerve block, hamstrings graft, ropivacaine,
400167|NCT01868282|Postoperative pain|postoperative pain
400168|NCT01868256|myocardial infarction|myocardial infarction
400169|NCT01868256|primary percutaneous intervention|primary percutaneous intervention
400170|NCT01868256|prognosis|prognosis
400171|NCT01868256|early discharge|early discharge
400172|NCT01868243|Atrial Fibrillation|atrial fibrillation
400173|NCT01868243|Bioprosthesis|bioprosthesis
400174|NCT01868243|Stroke|stroke
400175|NCT01868243|Dabigatran|dabigatran
400176|NCT01868243|Warfarin|warfarin
400177|NCT01868204|Obesity|obesity
400178|NCT01868204|Binge eating disorder|binge eating disorder
400179|NCT01868204|Pharmacogenetic|pharmacogenetic
400180|NCT01868204|Food craving|food craving
400181|NCT01868204|Brain areas|brain areas
400182|NCT01868204|Topiramate|topiramate
400183|NCT01868191|Diabetes|diabetes
400184|NCT01868191|Neuropathy|neuropathy
400185|NCT01868178|awareness|awareness
400186|NCT01868165|Cognitive decline|cognitive decline
400187|NCT01868165|High blood pressure|high blood pressure
400188|NCT01868165|Hypertension|hypertension
400189|NCT01868165|Ageing|ageing
400190|NCT01868165|Dementia|dementia
400191|NCT01868165|Antihypertensives|antihypertensives
400192|NCT01868152|sufentanil|sufentanil
400193|NCT01868152|individual variation|individual variation
400194|NCT01868152|pain threshold|pain threshold
400195|NCT01868152|narcotrend index|narcotrend index
400196|NCT01868139|Cryotherapy|cryotherapy
400197|NCT01868139|Esophageal cancer|esophageal cancer
400198|NCT01868139|Esophageal carcinoma|esophageal carcinoma
400199|NCT01868139|Liquid nitrogen|liquid nitrogen
400200|NCT01868139|Esophageal adenocarcinoma|esophageal adenocarcinoma
400201|NCT01868139|Esophageal squamous cell carcinoma|esophageal squamous cell carcinoma
400202|NCT01868139|Endoscopy|endoscopy
400203|NCT01868139|Ablation|ablation
400204|NCT01868126|Santen|santen
400206|NCT01868126|Glaucoma|glaucoma
400207|NCT01868126|Ocular hypertension|ocular hypertension
400208|NCT01868113|Children U-5|children u-5
400209|NCT01868113|ALRI|alri
400210|NCT01868113|Inhaled Corticosteroids|inhaled corticosteroids
400211|NCT01868100|Cancer|cancer
400212|NCT01868100|quality of life|quality of life
400213|NCT01868100|palliative care|palliative care
400214|NCT01868100|supportive care|supportive care
400215|NCT01868100|Financial distress|financial distress
400216|NCT01868087|nutritional supplement|nutritional supplement
400217|NCT01868087|immune system|immune system
400218|NCT01868087|RC surgery|rc surgery
400219|NCT01868074|pregnancy, arch height, collapsed arch|pregnancy, arch height, collapsed arch
400220|NCT01868048|Spasticity|spasticity
400221|NCT01868048|Multiple Sclerosis|multiple sclerosis
400222|NCT01868035|radioimmunotherapy|radioimmunotherapy
400223|NCT01868035|Iodine 131 Tositumomab|iodine 131 tositumomab
400224|NCT01868022|FGFR1|fgfr1
400225|NCT01868022|FP1039|fp1039
400226|NCT01868022|GSK3052230|gsk3052230
400227|NCT01868022|docetaxel|docetaxel
400228|NCT01868022|FGFR|fgfr
400229|NCT01868022|carboplatin|carboplatin
400230|NCT01868022|HGS1036|hgs1036
400231|NCT01868022|squamous non-small cell lung cancer|squamous non-small cell lung cancer
400232|NCT01868022|paclitaxel|paclitaxel
400233|NCT01868009|fluticasone furoate|fluticasone furoate
400234|NCT01868009|COPD|copd
400235|NCT01868009|ELLIPTA|ellipta
400236|NCT01868009|fluticasone propionate|fluticasone propionate
400237|NCT01868009|DISKUS|diskus
400238|NCT01868009|Novel Dry Powder Inhaler (NDPI)|novel dry powder inhaler (ndpi)
400239|NCT01868009|device preference|device preference
400240|NCT01868009|salmeterol|salmeterol
400241|NCT01868009|vilanterol|vilanterol
400242|NCT01867996|Retosiban, Efavirenz, Induction|retosiban, efavirenz, induction
400243|NCT01867983|Tobacco cessation|tobacco cessation
400244|NCT01867983|Weight gain prevention|weight gain prevention
400245|NCT01867970|remote sensing technology|remote sensing technology
400246|NCT01867970|physical activity|physical activity
400247|NCT01867970|self-management support|self-management support
400248|NCT01867970|primary care nursing|primary care nursing
400249|NCT01867957|anthrax|anthrax
400250|NCT01867957|vaccine|vaccine
400251|NCT01867957|bioterrorism|bioterrorism
400252|NCT01867957|efficacy|efficacy
400253|NCT01867957|safety|safety
400254|NCT01867944|Chronic constipation|chronic constipation
400255|NCT01867944|Hemorrhoids|hemorrhoids
400256|NCT01867944|Acupressure|acupressure
400257|NCT01867905|Severe sepsis|severe sepsis
400258|NCT01867905|Septic shock|septic shock
400259|NCT01867905|Bacteremia|bacteremia
400260|NCT01867905|Antibiotics|antibiotics
400261|NCT01867905|Blood culture positivity|blood culture positivity
400262|NCT01867892|Locally Advanced Pancreatic Cancer|locally advanced pancreatic cancer
400263|NCT01867879|Advanced solid tumors (excluding breast cancer) for which no standard therapy exists|advanced solid tumors (excluding breast cancer) for which no standard therapy exists
400264|NCT01867866|Advanced solid tumors (excluding breast cancer) for which no standard therapy exists|advanced solid tumors (excluding breast cancer) for which no standard therapy exists
400265|NCT01867801|PCI|pci
400266|NCT01867801|Coronary disease|coronary disease
400267|NCT01867801|Ischemia|ischemia
400268|NCT01867775|Alzheimer's disease|alzheimer's disease
400269|NCT01867775|Sleep disorders|sleep disorders
400270|NCT01867775|Mirtazapine|mirtazapine
400271|NCT01867775|Treatment|treatment
400272|NCT01867775|Intervention|intervention
400273|NCT01867775|insomnia|insomnia
400274|NCT01867762|Chronic Obstructive Pulmonary Disease|chronic obstructive pulmonary disease
400275|NCT01867762|JNJ 49095397|jnj 49095397
400276|NCT01867762|RV568|rv568
400277|NCT01867762|Forced expiratory volume in one second|forced expiratory volume in one second
400278|NCT01867762|FEV1|fev1
400279|NCT01867749|Major Depressive Disorder (MDD)|major depressive disorder (mdd)
400280|NCT01867749|Miscarriage|miscarriage
400281|NCT01867749|Stillbirth|stillbirth
400282|NCT01867749|Neonatal death|neonatal death
400283|NCT01867749|Interpersonal psychotherapy|interpersonal psychotherapy
400284|NCT01867749|Group Therapy|group therapy
400285|NCT01867749|Coping with Depression (CWD)|coping with depression (cwd)
400286|NCT01867736|Stenosis|stenosis
400287|NCT01867736|Occlusions|occlusions
400288|NCT01867736|Infrapopliteal arteries|infrapopliteal arteries
400289|NCT01867736|Below the knee arteries|below the knee arteries
400290|NCT01867736|PTA|pta
400291|NCT01867736|POBA|poba
400292|NCT01867736|DRB|drb
400293|NCT01867723|Cancer internet support program|cancer internet support program
400294|NCT01867710|Mineralocorticoid Excess ; Chemotherapy-Naïve; Metastatic Castration-Resistant Prostate Cancer; Abiraterone Acetate; Zytiga; Prednisone; dexamethasone|mineralocorticoid excess ; chemotherapy-naïve; metastatic castration-resistant prostate cancer; abiraterone acetate; zytiga; prednisone; dexamethasone
400295|NCT01867684|Stroke|stroke
400296|NCT01867684|Acquired brain injury|acquired brain injury
400297|NCT01867671|Allergy, Peanut|allergy, peanut
400298|NCT01867671|Peanut allergy|peanut allergy
400299|NCT01867671|Hypersensitivity|hypersensitivity
400300|NCT01867671|Immunotherapy|immunotherapy
400301|NCT01867671|Desensitization, Immunologic|desensitization, immunologic
400302|NCT01867658|Pleural Air Leak|pleural air leak
400303|NCT01867658|Pulmonary resection|pulmonary resection
400304|NCT01867658|Video Assisted|video assisted
400305|NCT01867658|Robotic Assisted|robotic assisted
400306|NCT01867645|Critical illness|critical illness
400307|NCT01867645|Critical illness polyneuropathy and/or myopathy|critical illness polyneuropathy and/or myopathy
400308|NCT01867645|Intravenous immunoglobulins|intravenous immunoglobulins
400309|NCT01867645|Multiple organ failure|multiple organ failure
400310|NCT01867645|SIRS|sirs
400311|NCT01867645|Sepsis|sepsis
400312|NCT01867632|Palatoplasty|palatoplasty
400313|NCT01867632|Acellular Dermal Matrix|acellular dermal matrix
400314|NCT01867593|Newly diagnosed|newly diagnosed
400315|NCT01867567|cesarean|cesarean
400316|NCT01867567|bandage removal|bandage removal
400317|NCT01867567|infection|infection
400318|NCT01867567|disruption|disruption
400319|NCT01867567|satisfaction|satisfaction
400320|NCT01867567|patient satisfaction|patient satisfaction
400321|NCT01867554|Intellectual disability|intellectual disability
400322|NCT01867554|Autism spectrum disorders|autism spectrum disorders
400323|NCT01867554|gene|gene
400324|NCT01867554|Next generation sequencing|next generation sequencing
400325|NCT01867541|cataract surgery|cataract surgery
400326|NCT01867541|intraocular lens power calculation|intraocular lens power calculation
400327|NCT01867541|effective lens position|effective lens position
400328|NCT01867541|improving the refractive outcome after cataract surgery|improving the refractive outcome after cataract surgery
400329|NCT01867541|predicting the IOL position|predicting the iol position
400330|NCT01867515|Hearing|hearing
401227|NCT01863459|Anxiety|anxiety
400331|NCT01867515|Hearing Loss, sensorineural|hearing loss, sensorineural
400332|NCT01867515|Speech Perception|speech perception
400333|NCT01867463|Antigen|antigen
400334|NCT01867463|Ookinetes|ookinetes
400335|NCT01867463|Mosquito|mosquito
400336|NCT01867463|Membrane|membrane
400337|NCT01867463|Assay|assay
400338|NCT01867450|Biomarkers|biomarkers
400339|NCT01867450|Deisel Exhaust|deisel exhaust
400340|NCT01867450|Occupational Exposure|occupational exposure
400341|NCT01867450|Cross-Sectional Study|cross-sectional study
400342|NCT01867437|24 Hour Energy Expenditure|24 hour energy expenditure
400343|NCT01867437|Resting Energy Expenditure|resting energy expenditure
400344|NCT01867437|Obesity|obesity
400345|NCT01867437|Healthy Volunteers|healthy volunteers
400346|NCT01867424|Testosterone Membrane Transporter|testosterone membrane transporter
400347|NCT01867424|OATP1B3|oatp1b3
400348|NCT01867424|Castration Resistant Prostate Cancer|castration resistant prostate cancer
400349|NCT01867424|Prostatectomy|prostatectomy
400350|NCT01867424|Gadolinium-Based Contrast Agent|gadolinium-based contrast agent
400351|NCT01867411|Smoking Cessation|smoking cessation
400352|NCT01867411|fMRI|fmri
400353|NCT01867411|e-Cigarettes|e-cigarettes
400354|NCT01867398|Conduct Disorder|conduct disorder
400355|NCT01867398|Antipsychotic|antipsychotic
400356|NCT01867398|Treatment Study|treatment study
400357|NCT01867398|Functional Magnetic Resonance Imaging (fMRI)|functional magnetic resonance imaging (fmri)
400358|NCT01867398|Adolescents|adolescents
400359|NCT01867385|Fatigue|fatigue
400360|NCT01867385|Chronic Hepatitis|chronic hepatitis
400361|NCT01867385|Chronic Hepatitis B|chronic hepatitis b
400362|NCT01867385|Chronic Hepatitis C|chronic hepatitis c
400363|NCT01867385|Hepatitis|hepatitis
400364|NCT01867372|Alzheimer's Disease|alzheimer's disease
400365|NCT01867359|Alzheimer Disease|alzheimer disease
400366|NCT01867359|Molecular|molecular
400367|NCT01867359|Molecular Genetics|molecular genetics
400368|NCT01867359|DNA|dna
400369|NCT01867346|Cognition|cognition
400370|NCT01867346|Aging|aging
400371|NCT01867346|Cognitive Decline|cognitive decline
400372|NCT01867346|Dementia|dementia
400373|NCT01867346|Alzheimer's Disease|alzheimer's disease
400374|NCT01867333|Immunotherapy|immunotherapy
400375|NCT01867333|Gene Transfer|gene transfer
400376|NCT01867333|Androgen Receptor Antagonist|androgen receptor antagonist
400377|NCT01867333|PSA|psa
400378|NCT01867333|Immune Response|immune response
400379|NCT01867320|HTLV-1|htlv-1
400380|NCT01867320|HTLV-1 Associated Myelopathy|htlv-1 associated myelopathy
400381|NCT01867281|aspirin|aspirin
400382|NCT01867281|asthma|asthma
400383|NCT01867281|Aspirin desensitization|aspirin desensitization
400384|NCT01867281|Aspirin induced asthma|aspirin induced asthma
400385|NCT01867281|Immune System Diseases|immune system diseases
400386|NCT01867281|Respiratory Hypersensitivity|respiratory hypersensitivity
400387|NCT01867268|Acetazolamide administration|acetazolamide administration
400388|NCT01867268|prone positioning|prone positioning
400389|NCT01867268|Cerebrospinal fluid leakage|cerebrospinal fluid leakage
400390|NCT01867268|Cerebrospinal fluid collection|cerebrospinal fluid collection
400391|NCT01867268|wound dehiscence|wound dehiscence
400392|NCT01867255|venlafaxine|venlafaxine
400393|NCT01867255|Effexor|effexor
400394|NCT01867255|antidepressive agent|antidepressive agent
400395|NCT01867242|cigarette|cigarette
400396|NCT01867242|snus|snus
400397|NCT01867242|smoking|smoking
400398|NCT01867242|tobacco|tobacco
400399|NCT01867229|pre-menauposal|pre-menauposal
400400|NCT01867229|neo-adjuvant or adjuvant chemotherapy|neo-adjuvant or adjuvant chemotherapy
400401|NCT01867229|no metastases|no metastases
400402|NCT01867190|CLI|cli
400403|NCT01867177|HIV|hiv
400404|NCT01867177|health care utilization|health care utilization
400405|NCT01867177|HIV testing|hiv testing
400406|NCT01867177|access to care|access to care
400407|NCT01867164|Vaginitis|vaginitis
400408|NCT01867164|Infectious vaginosis|infectious vaginosis
400409|NCT01867164|Terconazole|terconazole
400410|NCT01867164|Clindamycin|clindamycin
400411|NCT01867164|Fluocinolone|fluocinolone
400412|NCT01867164|Metronidazole|metronidazole
400413|NCT01867164|Nystatin|nystatin
400414|NCT01867151|Burning Mouth Syndrome|burning mouth syndrome
400415|NCT01867151|Gluten|gluten
400416|NCT01867151|Gluten Free Diet|gluten free diet
400417|NCT01867138|Coagulase negative staphylococcus|coagulase negative staphylococcus
400418|NCT01867138|nosocomial neonatal sepsis|nosocomial neonatal sepsis
400419|NCT01867138|cefazolin|cefazolin
400420|NCT01867138|vancomycin|vancomycin
400421|NCT01867138|newborn|newborn
400422|NCT01867086|ovarian cancer|ovarian cancer
400423|NCT01867060|Cardiac monitoring|cardiac monitoring
400424|NCT01867060|Biomarkers|biomarkers
400425|NCT01867060|Transthoracic echocardiography|transthoracic echocardiography
400426|NCT01867034|non ST segment myocardial infarction|non st segment myocardial infarction
400427|NCT01867021|Trivalent inactivated subunit influenza vaccines|trivalent inactivated subunit influenza vaccines
400428|NCT01867021|50 years and above|50 years and above
400429|NCT01867021|healthy subjects|healthy subjects
400430|NCT01866995|Ginseng|ginseng
400431|NCT01866995|Prostatostasis|prostatostasis
400432|NCT01866995|Erectile Dysfunction|erectile dysfunction
400433|NCT01866982|umbilical cord milking|umbilical cord milking
400434|NCT01866982|delayed cord clamping|delayed cord clamping
400435|NCT01866943|Blood Loss|blood loss
400436|NCT01866943|Tranexamic Acid|tranexamic acid
400437|NCT01866943|Total Hip Arthroplasty|total hip arthroplasty
400438|NCT01866943|Post Op|post op
400439|NCT01866943|Post Operative|post operative
400440|NCT01866943|Prevent Post Operative Blood Loss|prevent post operative blood loss
400441|NCT01866917|Transversis Abdominis Plane Block|transversis abdominis plane block
400442|NCT01866917|obese|obese
400443|NCT01866917|robotic surgery|robotic surgery
400444|NCT01866917|laparoscopic surgery|laparoscopic surgery
400445|NCT01866904|Coronary artery disease, Myocardial infarction|coronary artery disease, myocardial infarction
400446|NCT01866891|hemodialysis|hemodialysis
400447|NCT01866891|microcirculation|microcirculation
400448|NCT01866891|physical perdialytic activity|physical perdialytic activity
400449|NCT01866891|cycling|cycling
400450|NCT01866878|transcutaneous electrical nerve stimulation, sensitivity, multiple sclerosis,Reeducation through labor tactile discrimination|transcutaneous electrical nerve stimulation, sensitivity, multiple sclerosis,reeducation through labor tactile discrimination
400451|NCT01866865|BRCA1|brca1
400452|NCT01866865|BRCA2|brca2
400453|NCT01866852|Longitudinal Study|longitudinal study
400454|NCT01866839|Acute Lymphoblastic Leukemia (ALL)|acute lymphoblastic leukemia (all)
400455|NCT01866839|Acute Myelogenous Leukemia (AML)|acute myelogenous leukemia (aml)
400456|NCT01866839|Chronic Lymphocytic Leukemia (CLL)|chronic lymphocytic leukemia (cll)
400457|NCT01866839|Chronic Myelogenous Leukemia (CML)|chronic myelogenous leukemia (cml)
400458|NCT01866839|Myelodyplastic Syndrome (MDS)|myelodyplastic syndrome (mds)
400459|NCT01866826|HIV|hiv
400460|NCT01866826|Eradication Strategies|eradication strategies
400461|NCT01866826|Immune Activation|immune activation
400462|NCT01866813|breast cancer|breast cancer
400463|NCT01866813|cancer survivors|cancer survivors
400464|NCT01866800|TAVI|tavi
400465|NCT01866800|TAVR|tavr
400466|NCT01866800|CIN|cin
400467|NCT01866800|AKI|aki
400468|NCT01866787|Postoperative orthostatic intolerance|postoperative orthostatic intolerance
400469|NCT01866787|Surgical inflammatory response|surgical inflammatory response
400470|NCT01866722|nicotine dependence|nicotine dependence
400471|NCT01866722|smoking cessation|smoking cessation
400472|NCT01866722|lapse|lapse
400473|NCT01866722|relapse|relapse
400474|NCT01866722|tobacco|tobacco
400475|NCT01866722|quit attempts|quit attempts
400476|NCT01866722|abstinence|abstinence
400477|NCT01866722|motivation|motivation
400478|NCT01866722|reduction|reduction
400479|NCT01866696|Computer assisted implant surgery,|computer assisted implant surgery,
400480|NCT01866696|Immediate loading,|immediate loading,
400481|NCT01866696|CAD/CAM|cad/cam
400482|NCT01866683|Yoga|yoga
400483|NCT01866683|Electroencephalography|electroencephalography
400484|NCT01866683|Heart rate variability|heart rate variability
400485|NCT01866683|Breathing Exercises|breathing exercises
400486|NCT01866683|Quality of life|quality of life
400632|NCT01865968|inactivated HAV vaccine; live attenuated HAV vaccine; immunogenicity; safety|inactivated hav vaccine; live attenuated hav vaccine; immunogenicity; safety
400633|NCT01865955|Ultrasound|ultrasound
400634|NCT01865955|Spinal anesthesia|spinal anesthesia
400635|NCT01865955|Cesarean section|cesarean section
400636|NCT01865942|spinal metastases|spinal metastases
400637|NCT01865942|spine surgery|spine surgery
400638|NCT01865942|metastatic spinal cord compression|metastatic spinal cord compression
400639|NCT01865942|EQ-5D|eq-5d
400640|NCT01865942|HRQOL|hrqol
400641|NCT01865903|NSCLC|nsclc
400642|NCT01865903|sarcopenia|sarcopenia
400643|NCT01865903|cachexia|cachexia
400644|NCT01865890|Plavix or clopidogrel resistance|plavix or clopidogrel resistance
400645|NCT01865877|Parkinson's disease|parkinson's disease
400646|NCT01865877|Motor|motor
400647|NCT01865877|Non-motor|non-motor
400648|NCT01865877|Progression|progression
400649|NCT01865877|Complications|complications
400650|NCT01865864|CPAP|cpap
400651|NCT01865864|diurnal blood pressure|diurnal blood pressure
400652|NCT01865864|obstructive sleep apnea|obstructive sleep apnea
400653|NCT01865864|24 hour blood pressure monitor|24 hour blood pressure monitor
400654|NCT01865851|Inspired oxygen|inspired oxygen
400655|NCT01865851|end-tidal oxygen|end-tidal oxygen
400656|NCT01865851|end-tidal carbon dioxide|end-tidal carbon dioxide
400657|NCT01865851|respiratory rate|respiratory rate
400658|NCT01865851|preoxygenation|preoxygenation
400659|NCT01865851|classic face mask|classic face mask
400660|NCT01865851|NuMask|numask
400661|NCT01865838|Total thyroidectomy|total thyroidectomy
400662|NCT01865838|Seprafilm|seprafilm
400663|NCT01865838|Swallowing difficulty post thyroidectomy|swallowing difficulty post thyroidectomy
400664|NCT01865825|Erosive Esophagitis|erosive esophagitis
400665|NCT01865825|Gastroesophageal reflux disease|gastroesophageal reflux disease
400666|NCT01865799|FTC/TDF|ftc/tdf
400667|NCT01865799|PrEP|prep
400668|NCT01865799|Truvada|truvada
400669|NCT01865799|Drug utilization|drug utilization
400670|NCT01865786|FTC/TDF|ftc/tdf
400671|NCT01865786|Truvada|truvada
400672|NCT01865786|PrEP|prep
400673|NCT01865786|Antiretroviral Pregnancy Registry|antiretroviral pregnancy registry
400674|NCT01865760|Glucagon like peptide 1|glucagon like peptide 1
400675|NCT01865760|Insulin secretion|insulin secretion
400676|NCT01865760|Hypoglycemia|hypoglycemia
400677|NCT01865747|renal cell cancer|renal cell cancer
400678|NCT01865747|kidney|kidney
400679|NCT01865747|vascular endothelial growth factor receptor 2 (VEGFR2)|vascular endothelial growth factor receptor 2 (vegfr2)
400680|NCT01865747|tyrosine kinase inhibitor|tyrosine kinase inhibitor
400681|NCT01865747|hepatocyte growth factor receptor protein (MET)|hepatocyte growth factor receptor protein (met)
400682|NCT01865747|von Hippel-Lindau gene|von hippel-lindau gene
400683|NCT01865734|Fasciitis, Plantar|fasciitis, plantar
400684|NCT01865734|Heel Pain|heel pain
400685|NCT01865734|Physical Therapy|physical therapy
400686|NCT01865734|Podiatry|podiatry
400687|NCT01865734|Musculoskeletal Manipulations|musculoskeletal manipulations
400688|NCT01865734|Exercise Therapy|exercise therapy
400689|NCT01865721|Bowel cancer screening|bowel cancer screening
400690|NCT01865721|Analgesia|analgesia
400691|NCT01865721|Entonox|entonox
400692|NCT01865721|Pain|pain
400693|NCT01865721|Side effects|side effects
400694|NCT01865721|Colonoscopy|colonoscopy
400695|NCT01865708|Ethanol Lock|ethanol lock
400696|NCT01865708|Alcohol lock|alcohol lock
400697|NCT01865708|Urinary catheter|urinary catheter
400698|NCT01865708|Safety|safety
400699|NCT01865695|pancreatic exocrine insufficiency|pancreatic exocrine insufficiency
400700|NCT01865695|faecal elastase|faecal elastase
400701|NCT01865695|diarrhoea|diarrhoea
400702|NCT01865695|coeliac|coeliac
400703|NCT01865695|creon|creon
400704|NCT01865695|gastrointestinal|gastrointestinal
400705|NCT01865682|Ankle|ankle
400706|NCT01865682|Knee|knee
400707|NCT01865682|Orthosis|orthosis
400708|NCT01865682|Kinematics|kinematics
400709|NCT01865682|Kinetics|kinetics
400710|NCT01865669|Uterine contraction|uterine contraction
400711|NCT01865669|Dose response|dose response
400712|NCT01865669|Oxytocin|oxytocin
400713|NCT01865656|provider skill and self-efficacy|provider skill and self-efficacy
400714|NCT01865656|Appropriate and timely referral for obstetric emergencies|appropriate and timely referral for obstetric emergencies
400715|NCT01865656|Intervention feasibility and acceptability|intervention feasibility and acceptability
400716|NCT01865643|Laryngoscopy|laryngoscopy
400717|NCT01865643|Intubation|intubation
400718|NCT01865643|Glidescope|glidescope
400719|NCT01865630|Prophylactic treatment with Etanercept in aSAH.|prophylactic treatment with etanercept in asah.
400720|NCT01865630|Safety of Etanercept in the prevention of DCI in aSAH.|safety of etanercept in the prevention of dci in asah.
400721|NCT01865591|hypertension|hypertension
400722|NCT01865591|uncontrolled hypertension|uncontrolled hypertension
400723|NCT01865591|resistant hypertension|resistant hypertension
400724|NCT01865565|gastrointestinal stromal tumor|gastrointestinal stromal tumor
400725|NCT01865565|GIST|gist
400728|NCT01865552|Pharmacokinetics|pharmacokinetics
400729|NCT01865539|Chronic lower back pain|chronic lower back pain
400730|NCT01865539|Custom foot orthotics|custom foot orthotics
400731|NCT01865539|Veterans|veterans
400732|NCT01865526|Chronic kidney disease|chronic kidney disease
400733|NCT01865526|Low protein diet|low protein diet
400734|NCT01865526|CKD stage 3b-5|ckd stage 3b-5
400735|NCT01865513|Anaesthesia|anaesthesia
400736|NCT01865513|Anaesthesiology|anaesthesiology
400737|NCT01865513|muscle Relaxants|muscle relaxants
400738|NCT01865513|POPULAR|popular
400739|NCT01865513|postoperative pulmonary complications|postoperative pulmonary complications
400740|NCT01865513|Respiratory failure|respiratory failure
400741|NCT01865513|Suspected pulmonary infection|suspected pulmonary infection
400742|NCT01865513|Pulmonary infiltrates|pulmonary infiltrates
400743|NCT01865513|Pleural effusion|pleural effusion
400744|NCT01865513|Atelectasis|atelectasis
400745|NCT01865513|Pneumothorax|pneumothorax
400746|NCT01865513|Bronchospasm|bronchospasm
400747|NCT01865513|Aspiration pneumonitis|aspiration pneumonitis
400748|NCT01865513|Cardiopulmonary oedema|cardiopulmonary oedema
400749|NCT01865513|European Society of Anaesthesiology|european society of anaesthesiology
400750|NCT01865513|neuromuscular blockade|neuromuscular blockade
400751|NCT01865513|europe|europe
400752|NCT01865500|COPD exacerbation|copd exacerbation
400753|NCT01865500|Nebulized budesonide|nebulized budesonide
400754|NCT01865500|Parenteral steroid|parenteral steroid
400755|NCT01865487|BCG Vaccinated|bcg vaccinated
400756|NCT01865487|HIV Negative|hiv negative
400757|NCT01865474|DLBS1033, Type 2 DM, fibrinolytic, hypercoagulation|dlbs1033, type 2 dm, fibrinolytic, hypercoagulation
400758|NCT01865461|Magnetic Resonance Imaging|magnetic resonance imaging
400759|NCT01865448|Docosahexaenoic Acids|docosahexaenoic acids
400760|NCT01865448|Fatty Acids, Omega-3|fatty acids, omega-3
400761|NCT01865448|Obesity|obesity
400762|NCT01865448|Inflammation|inflammation
400763|NCT01865409|Newborn|newborn
400764|NCT01865409|Prematures|prematures
400765|NCT01865409|Feeding difficulty|feeding difficulty
400766|NCT01865409|Kangaroo Care|kangaroo care
400767|NCT01865409|Heart rate variability|heart rate variability
400768|NCT01865266|ventilator-associated pneumonia|ventilator-associated pneumonia
400769|NCT01865266|mechanical ventilation|mechanical ventilation
400770|NCT01865266|ulinastatin for injection|ulinastatin for injection
400771|NCT01865266|bronchoalveolar lavage fluid|bronchoalveolar lavage fluid
400772|NCT01865266|inflammatory factors|inflammatory factors
400773|NCT01865253|renal denervation|renal denervation
400774|NCT01865253|blood pressure|blood pressure
400775|NCT01865253|cardiovascular risk|cardiovascular risk
400776|NCT01865253|target organ damage|target organ damage
400777|NCT01865253|sympathetic activity|sympathetic activity
400778|NCT01865253|chronic kidney disease|chronic kidney disease
400779|NCT01865253|non-compliance|non-compliance
400780|NCT01865240|renal denervation|renal denervation
400781|NCT01865240|blood pressure|blood pressure
400782|NCT01865240|cardiovascular risk|cardiovascular risk
400783|NCT01865240|target organ damage|target organ damage
400784|NCT01865240|sympathetic activity|sympathetic activity
400785|NCT01865227|Obesity|obesity
400786|NCT01865227|Bariatric surgery|bariatric surgery
400787|NCT01865227|Binge Eating Disorder|binge eating disorder
400788|NCT01865227|Psychological Health|psychological health
400789|NCT01865227|Counselling|counselling
400790|NCT01865201|Radiotherapy|radiotherapy
400791|NCT01865201|Radiation-induced brain necrosis|radiation-induced brain necrosis
400792|NCT01865201|Edaravone|edaravone
400793|NCT01865201|Effectiveness|effectiveness
400794|NCT01865201|Safety|safety
400795|NCT01865188|LCZ696,|lcz696,
400796|NCT01865188|amlodipine,|amlodipine,
400797|NCT01865188|hypertension,|hypertension,
400798|NCT01865188|ABPM|abpm
400799|NCT01865162|Glioblastoma multiforme, ketogenic diet, neoplasm|glioblastoma multiforme, ketogenic diet, neoplasm
400800|NCT01865149|Child|child
400801|NCT01865149|Optic nerve sheath diameter|optic nerve sheath diameter
400802|NCT01865149|Hydrocephalus|hydrocephalus
400803|NCT01865149|Intracranial hypertension|intracranial hypertension
400804|NCT01865123|post-traumatic stress disorder|post-traumatic stress disorder
400805|NCT01865123|transcendental meditation|transcendental meditation
400806|NCT01865123|cognitive behavioral therapy|cognitive behavioral therapy
400807|NCT01865123|prolonged exposure|prolonged exposure
400808|NCT01865110|Mantle Cell Lymphoma|mantle cell lymphoma
400809|NCT01865110|RCHOP|rchop
400810|NCT01865110|RHAD|rhad
400811|NCT01865110|rituximab|rituximab
400812|NCT01865110|lenalidomide|lenalidomide
400813|NCT01865097|Imagery|imagery
400814|NCT01865097|Pain|pain
400815|NCT01865097|Depression|depression
400816|NCT01865097|Non-Motor|non-motor
400817|NCT01865071|ileostomy|ileostomy
400818|NCT01865071|rectal resection|rectal resection
400819|NCT01865071|proctectomy|proctectomy
400820|NCT01865071|stoma closure|stoma closure
400821|NCT01865071|rectal cancer|rectal cancer
400822|NCT01864993|non celiac gluten sensitivity|non celiac gluten sensitivity
400823|NCT01864993|gluten|gluten
400824|NCT01864993|irritable bowel syndrome|irritable bowel syndrome
512515|NCT01379222|AAA|aaa
401434|NCT01862536|tadalafil|tadalafil
400825|NCT01864993|functional disorders|functional disorders
400826|NCT01864967|carbon dioxide infusion|carbon dioxide infusion
400827|NCT01864967|dilatation of peripheral blood vessels|dilatation of peripheral blood vessels
400828|NCT01864967|capillaries|capillaries
400829|NCT01864967|macrophags|macrophags
400830|NCT01864967|fibroblasts|fibroblasts
400831|NCT01864967|Improvement granulation tissue in chronic wounds|improvement granulation tissue in chronic wounds
400832|NCT01864954|Smoking|smoking
400833|NCT01864954|Postpartum|postpartum
400834|NCT01864954|Pregnancy|pregnancy
400835|NCT01864954|Quit|quit
400836|NCT01864954|Tobacco|tobacco
400837|NCT01864954|Abstinence|abstinence
400838|NCT01864954|Relapse|relapse
400839|NCT01864954|Relapse prevention|relapse prevention
400840|NCT01864941|Multiple Sclerosis|multiple sclerosis
400842|NCT01864941|CCSVI|ccsvi
400843|NCT01864941|Zamboni|zamboni
400844|NCT01864941|catheter venography|catheter venography
400845|NCT01864941|balloon angioplasty|balloon angioplasty
400846|NCT01864928|Acute Ischemic stroke|acute ischemic stroke
400847|NCT01864928|ePRISM|eprism
400848|NCT01864915|colon capsule|colon capsule
400849|NCT01864915|bowel preparation|bowel preparation
400850|NCT01864915|booster|booster
400851|NCT01864915|prucalopride|prucalopride
400852|NCT01864915|picosalax|picosalax
400853|NCT01864902|CD33 positive acute myeloid leukemia (AML)|cd33 positive acute myeloid leukemia (aml)
400854|NCT01864850|HNSCC|hnscc
400855|NCT01864850|Elderly|elderly
400856|NCT01864850|Geriatry|geriatry
400857|NCT01864837|tongue coating thickness|tongue coating thickness
400858|NCT01864837|tongue diagnosis system|tongue diagnosis system
400859|NCT01864837|tongue coating percentage|tongue coating percentage
400860|NCT01864837|availability|availability
400861|NCT01864837|diagnostic device|diagnostic device
400862|NCT01864824|air pollution|air pollution
400863|NCT01864824|particulate matter 2.5 (PM2.5)|particulate matter 2.5 (pm2.5)
400864|NCT01864824|methyl donor|methyl donor
400865|NCT01864824|DNA methylation|dna methylation
400866|NCT01864824|mRNA|mrna
400867|NCT01864824|epigenetics|epigenetics
400868|NCT01864824|controlled human exposures|controlled human exposures
400869|NCT01864824|cardiovascular responses|cardiovascular responses
400870|NCT01864811|infants|infants
400871|NCT01864811|unilateral cerebral pares|unilateral cerebral pares
400872|NCT01864811|hand function|hand function
400873|NCT01864811|early intervention|early intervention
400874|NCT01864811|constraint induced movement therapy|constraint induced movement therapy
400875|NCT01864798|Young|young
400876|NCT01864798|Breast Neoplasms|breast neoplasms
400877|NCT01864798|Denosumab|denosumab
400878|NCT01864798|RANKL|rankl
400879|NCT01864785|Operative treatment|operative treatment
400880|NCT01864785|internal fixation|internal fixation
400881|NCT01864785|posterior spinal fusion|posterior spinal fusion
400882|NCT01864772|HNSCC|hnscc
400883|NCT01864772|Metastatic|metastatic
400884|NCT01864772|Recurrent|recurrent
400885|NCT01864772|Elderly|elderly
400886|NCT01864772|Geriatry|geriatry
400887|NCT01864759|melanoma|melanoma
400888|NCT01864759|oncolytic|oncolytic
400889|NCT01864759|adenovirus|adenovirus
400890|NCT01864759|virotherapy|virotherapy
400891|NCT01864759|locally advanced|locally advanced
400892|NCT01864759|metastatic|metastatic
400893|NCT01864733|Chronic heart failure|chronic heart failure
400894|NCT01864733|Undernutrition|undernutrition
400895|NCT01864733|Rehabilitation|rehabilitation
400896|NCT01864733|Physical exercise|physical exercise
400897|NCT01864733|Nutrition|nutrition
400898|NCT01864733|n-3 fatty acids|n-3 fatty acids
400899|NCT01864733|Androgen|androgen
400900|NCT01864733|Testosterone|testosterone
400901|NCT01864720|stepped care model|stepped care model
400902|NCT01864720|insomnia|insomnia
400903|NCT01864720|cancer|cancer
400904|NCT01864720|cognitive-behavioural therapy|cognitive-behavioural therapy
400905|NCT01864720|self-help treatment|self-help treatment
400906|NCT01864720|Internet|internet
400907|NCT01864720|non-inferiority design|non-inferiority design
400908|NCT01864720|cost-effectiveness|cost-effectiveness
400909|NCT01864707|multiple sclerosis, fatigue|multiple sclerosis, fatigue
400910|NCT01864694|behavioral research|behavioral research
400911|NCT01864694|diet|diet
400912|NCT01864694|health information systems|health information systems
400913|NCT01864681|NSCLC|nsclc
400914|NCT01864681|TKIs|tkis
400915|NCT01864681|Metformin|metformin
400916|NCT01864681|PFS|pfs
400917|NCT01864681|overall survival|overall survival
400918|NCT01864681|IL-6|il-6
400919|NCT01864668|Acute respiratory distress syndrome|acute respiratory distress syndrome
400920|NCT01864668|lung strain|lung strain
400921|NCT01864668|small tidal volume|small tidal volume
400922|NCT01864616|Vitamin D|vitamin d
400923|NCT01864616|Crohn disease|crohn disease
400924|NCT01864616|Disease activity|disease activity
400925|NCT01864616|Inflammation|inflammation
400926|NCT01864616|prevention|prevention
400927|NCT01864603|HIV treatment and prevention|hiv treatment and prevention
400928|NCT01864603|Tuberculosis|tuberculosis
400929|NCT01864603|Community health campaign|community health campaign
400931|NCT01864590|Open Abdomen|open abdomen
400932|NCT01864590|Negative Pressure Wound Therapy|negative pressure wound therapy
400933|NCT01864590|Temporary Abdominal Closure|temporary abdominal closure
400934|NCT01864590|Mesh|mesh
400935|NCT01864590|Abdominal reconstruction|abdominal reconstruction
400936|NCT01864564|Gestational diabetes|gestational diabetes
400937|NCT01864564|Screening|screening
400938|NCT01864564|Obesity|obesity
400939|NCT01864564|Anhydroglucitol|anhydroglucitol
400940|NCT01864538|TH-302|th-302
400941|NCT01864538|Advanced Melanoma|advanced melanoma
400942|NCT01864538|Metastatic|metastatic
400943|NCT01864538|Biomarker|biomarker
400944|NCT01864538|Mucosal Melanoma|mucosal melanoma
400945|NCT01864538|Evofosfamide|evofosfamide
400946|NCT01864525|voice|voice
400947|NCT01864525|tremor|tremor
400948|NCT01864525|essential tremor|essential tremor
400949|NCT01864525|essential voice tremor|essential voice tremor
400950|NCT01864525|voice treatment|voice treatment
400951|NCT01864525|octanoic acid|octanoic acid
400952|NCT01864525|octanol|octanol
400953|NCT01864525|voice disorder|voice disorder
400954|NCT01864525|dysphonia|dysphonia
400955|NCT01864512|Immune Thrombocytopenia|immune thrombocytopenia
400956|NCT01864512|eltrombopag|eltrombopag
400957|NCT01864512|immune regulation|immune regulation
400958|NCT01864473|Fistula , Bhagandar|fistula , bhagandar
400959|NCT01864460|autonomic|autonomic
400960|NCT01864460|neuropathy|neuropathy
400961|NCT01864460|balance|balance
400962|NCT01864460|exercise|exercise
400963|NCT01864447|VTE|vte
400964|NCT01864447|Exercise|exercise
400965|NCT01864447|Diet|diet
400966|NCT01864447|Weight loss|weight loss
400967|NCT01864447|DVT|dvt
400968|NCT01864447|PE|pe
400969|NCT01864434|Knee Prosthesis|knee prosthesis
400970|NCT01864434|Total Knee Arthroplasty|total knee arthroplasty
400971|NCT01864434|Cruciate Retaining|cruciate retaining
400972|NCT01864434|Posterior Cruciate Retaining|posterior cruciate retaining
400973|NCT01864421|Infant, Newborn|infant, newborn
400974|NCT01864421|Delivery, Obstetric|delivery, obstetric
400975|NCT01864421|Umbilical Cord|umbilical cord
400976|NCT01864408|Patient counseling|patient counseling
400977|NCT01864408|Patient satisfaction|patient satisfaction
400978|NCT01864408|Pelvic organ prolapse|pelvic organ prolapse
400979|NCT01864395|cardiovascular surgery|cardiovascular surgery
400980|NCT01864395|cardiac surgery|cardiac surgery
400981|NCT01864395|cardiopulmonary bypass|cardiopulmonary bypass
400982|NCT01864395|IV fluids|iv fluids
400983|NCT01864395|blood pressure|blood pressure
400984|NCT01864395|heart-lung machine|heart-lung machine
400985|NCT01864395|hemofilter|hemofilter
400986|NCT01864395|online MUF|online muf
400987|NCT01864395|offline MUF|offline muf
400988|NCT01864395|modified ultrafiltration|modified ultrafiltration
400989|NCT01864395|multiple-pass hemofiltration|multiple-pass hemofiltration
400990|NCT01864395|centrifugation method|centrifugation method
400991|NCT01864395|blood transfusion|blood transfusion
400992|NCT01864395|plasma proteins|plasma proteins
400993|NCT01864395|post-cardiopulmonary bypass|post-cardiopulmonary bypass
400994|NCT01864395|hemoglobin|hemoglobin
400995|NCT01864395|clotting factors|clotting factors
400996|NCT01864395|systemic blood pressure|systemic blood pressure
400997|NCT01864395|cardiac index|cardiac index
400998|NCT01864395|cytokines|cytokines
400999|NCT01864395|post-operative bleeding|post-operative bleeding
401000|NCT01864395|protamine administration|protamine administration
401001|NCT01864395|patient size|patient size
401002|NCT01864395|allogeneic transfusion|allogeneic transfusion
401003|NCT01864395|total protein|total protein
401004|NCT01864395|albumin|albumin
401005|NCT01864395|vasoactive inotrope score|vasoactive inotrope score
401006|NCT01864395|fluid balance|fluid balance
401007|NCT01864395|chest tube loss|chest tube loss
401008|NCT01864395|length of stay|length of stay
401009|NCT01864395|ventilation time|ventilation time
401010|NCT01864395|markers of inflammation|markers of inflammation
401011|NCT01864382|Trunk performance|trunk performance
401012|NCT01864382|exercise,|exercise,
401013|NCT01864382|"core stability,"|"core stability,"
401014|NCT01864382|sitting balance|sitting balance
401015|NCT01864369|Heart Failure|heart failure
401016|NCT01864369|e-counseling|e-counseling
401017|NCT01864369|quality of life|quality of life
401018|NCT01864369|self-care|self-care
401019|NCT01864356|IVF failure|ivf failure
401020|NCT01864356|Repeated IVF failure|repeated ivf failure
401021|NCT01864356|Implantation failure|implantation failure
401022|NCT01864356|Repeated implantation failure|repeated implantation failure
401023|NCT01864356|IVF|ivf
401024|NCT01864356|NT100|nt100
401025|NCT01864343|Myocardial Infarction|myocardial infarction
401026|NCT01864343|Myocardial Reperfusion Injury|myocardial reperfusion injury
401027|NCT01864343|Reperfusion Injury|reperfusion injury
401028|NCT01864343|Anterior Wall Myocardial Infarction|anterior wall myocardial infarction
401029|NCT01864343|Inferior Wall Myocardial Infarction|inferior wall myocardial infarction
401030|NCT01864343|Myocardial Ischemia|myocardial ischemia
401031|NCT01864330|topical lubricants|topical lubricants
401032|NCT01864330|optical coherence tomography|optical coherence tomography
401033|NCT01864330|tear break up time|tear break up time
401034|NCT01864330|Schirmer I test|schirmer i test
401035|NCT01864317|7-Tesla Magnetic Resonance Imaging|7-tesla magnetic resonance imaging
401036|NCT01864317|Intraocular Pressure|intraocular pressure
401037|NCT01864317|Retinal Nerve Fiber Thickness|retinal nerve fiber thickness
401038|NCT01864317|Visual Field Test|visual field test
401039|NCT01864304|Williams Syndrome|williams syndrome
401040|NCT01864291|Auditory Brainstem Implant|auditory brainstem implant
401041|NCT01864291|ABI|abi
401042|NCT01864291|Nucleus 24|nucleus 24
401043|NCT01864291|Deafness|deafness
401044|NCT01864291|Hearing loss|hearing loss
401045|NCT01864291|Non-tumor|non-tumor
401046|NCT01864291|Non-NF2|non-nf2
401047|NCT01864291|Pediatric|pediatric
401048|NCT01864291|ABI541|abi541
401049|NCT01864265|Rheumatoid arthritis|rheumatoid arthritis
401050|NCT01864265|functional MRI|functional mri
401051|NCT01864265|Prediction of Response|prediction of response
401052|NCT01864265|Certolizumab Pegol|certolizumab pegol
401053|NCT01864239|Adherence|adherence
401054|NCT01864187|Pharmacokinetics|pharmacokinetics
401055|NCT01864187|Dexmedetomidine|dexmedetomidine
401057|NCT01864122|nutrient biomarkers|nutrient biomarkers
401058|NCT01864122|food frequency questionnaire|food frequency questionnaire
401059|NCT01864122|predictors of CVD|predictors of cvd
401060|NCT01864122|fatty acids|fatty acids
401061|NCT01864122|phylloquinone|phylloquinone
401062|NCT01864122|dihydrophylloquinone|dihydrophylloquinone
401063|NCT01864109|CYCLOPHOSPHAMIDE (CYTOXAN)|cyclophosphamide (cytoxan)
401064|NCT01864109|DOXORUBICIN/ADRIAMYCIN|doxorubicin/adriamycin
401065|NCT01864109|ETOPOSIDE (VP-16)|etoposide (vp-16)
401066|NCT01864109|IFOSFAMIDE|ifosfamide
401067|NCT01864109|IRINOTECAN (CPT-11) CAMPTOSAR|irinotecan (cpt-11) camptosar
401068|NCT01864109|TEMOZOLOMIDE|temozolomide
401069|NCT01864109|VINCRISTINE|vincristine
401070|NCT01864109|13-068|13-068
401071|NCT01864096|localized|localized
401072|NCT01864096|prostate|prostate
401073|NCT01864096|cancer|cancer
401074|NCT01864096|metformin|metformin
401075|NCT01864096|active surveillance|active surveillance
401076|NCT01864083|FACBC PET/PEM|facbc pet/pem
401077|NCT01864083|MR|mr
401078|NCT01864083|11-177|11-177
401079|NCT01864070|Liver cancer|liver cancer
401080|NCT01864070|Neuroendocrine tumors|neuroendocrine tumors
401081|NCT01864070|NET|net
401082|NCT01864070|Liver dominant disease|liver dominant disease
401083|NCT01864070|TheraSphere|therasphere
401084|NCT01864070|Yttrium-90|yttrium-90
401085|NCT01864070|Y-90|y-90
401086|NCT01864070|Everolimus|everolimus
401087|NCT01864070|Afinitor|afinitor
401088|NCT01864070|Zortress|zortress
401089|NCT01864070|RAD001|rad001
401090|NCT01864070|Microspheres|microspheres
401091|NCT01864057|thiamine deficiency|thiamine deficiency
401092|NCT01864031|Alcohol|alcohol
401093|NCT01864031|Drinking|drinking
401094|NCT01864031|Abstainers|abstainers
401095|NCT01864031|Former drinkers|former drinkers
401096|NCT01864031|Ex-drinkers|ex-drinkers
401097|NCT01864031|Aetiology|aetiology
401098|NCT01864031|Initial presentation|initial presentation
401099|NCT01864031|Chronic Stable Angina|chronic stable angina
401100|NCT01864031|Unstable Angina|unstable angina
401101|NCT01864031|Coronary Heart Disease Not Otherwise Specified|coronary heart disease not otherwise specified
401102|NCT01864031|Acute Myocardial Infarction|acute myocardial infarction
401103|NCT01864031|Heart Failure|heart failure
401104|NCT01864031|ST elevation Myocardial Infarction (STEMI)|st elevation myocardial infarction (stemi)
401105|NCT01864031|non-ST elevation Myocardial Infarction (nSTEMI)|non-st elevation myocardial infarction (nstemi)
401106|NCT01864031|Myocardial Infarction Not Otherwise Specified (MI NOS)|myocardial infarction not otherwise specified (mi nos)
401107|NCT01864031|Ventricular Arrhythmias|ventricular arrhythmias
401108|NCT01864031|Cardiac Arrest|cardiac arrest
401109|NCT01864031|Abdominal Aortic Aneurysm|abdominal aortic aneurysm
401110|NCT01864031|Peripheral Arterial Disease|peripheral arterial disease
401111|NCT01864031|Ischaemic Stroke|ischaemic stroke
401112|NCT01864031|Subarachnoid Haemorrhagic Stroke|subarachnoid haemorrhagic stroke
401113|NCT01864031|Intracerebral haemorrhagic Stroke|intracerebral haemorrhagic stroke
401114|NCT01864031|Stroke Not Otherwise Specified|stroke not otherwise specified
401115|NCT01864031|Sudden Cardiac Death|sudden cardiac death
401116|NCT01864031|Unheralded Coronary Death|unheralded coronary death
401117|NCT01864031|Mortality|mortality
401118|NCT01864031|Coronary Heart Disease (CHD)|coronary heart disease (chd)
401119|NCT01864031|Cardiovascular Disease (CVD)|cardiovascular disease (cvd)
401120|NCT01864031|Fatal Cardiovascular Disease (fatal CVD)|fatal cardiovascular disease (fatal cvd)
401121|NCT01864005|Non-ST or ST Elevation Acute Coronary Syndromes, Ticagrelor, Clopidogrel, Antiplatelet Effect|non-st or st elevation acute coronary syndromes, ticagrelor, clopidogrel, antiplatelet effect
401122|NCT01863992|home ventilation|home ventilation
401123|NCT01863979|Atrial Fibrillation|atrial fibrillation
401124|NCT01863979|Thromboembolism|thromboembolism
401125|NCT01863966|Achalasia|achalasia
401126|NCT01863966|Hot water drinking therapy|hot water drinking therapy
401127|NCT01863966|Pneumatic dilation|pneumatic dilation
401128|NCT01863914|ESRD|esrd
401129|NCT01863914|Diabetes mellitus|diabetes mellitus
401130|NCT01863914|Endothelial progenitor cells|endothelial progenitor cells
401131|NCT01863914|Hemodialysis|hemodialysis
401132|NCT01863914|rosuvastatin|rosuvastatin
401133|NCT01863875|Cochlear Implant|cochlear implant
401134|NCT01863875|Hearing loss|hearing loss
401135|NCT01863875|Language Development|language development
401136|NCT01863875|Quality of life|quality of life
401137|NCT01863862|Rectal cancer|rectal cancer
401138|NCT01863862|Chemoradiation|chemoradiation
401139|NCT01863862|Complete pathological response|complete pathological response
401140|NCT01863849|uncontrolled,|uncontrolled,
401141|NCT01863849|open,|open,
401142|NCT01863849|multi-centre|multi-centre
401143|NCT01863849|immunogenicity and tolerability|immunogenicity and tolerability
401144|NCT01863849|two groups according to age (18-59 years and ≥60 years)|two groups according to age (18-59 years and ≥60 years)
401145|NCT01863836|Radial endobronchial ultrasound|radial endobronchial ultrasound
401146|NCT01863836|Peripheral lung lesion|peripheral lung lesion
401147|NCT01863836|Fluoroscopy|fluoroscopy
401148|NCT01863836|Lung cancer|lung cancer
401149|NCT01863823|Symptomatic patients|symptomatic patients
401150|NCT01863823|asymptomatic individuals|asymptomatic individuals
401151|NCT01863823|clinical trial|clinical trial
401152|NCT01863810|Diabetic Neuropathy|diabetic neuropathy
401153|NCT01863810|Neuropathic Pain|neuropathic pain
401154|NCT01863810|Pregabalin|pregabalin
401155|NCT01863784|Hepatic Impairment|hepatic impairment
401156|NCT01863784|Mild and moderate hepatic impairment|mild and moderate hepatic impairment
401157|NCT01863784|Normal hepatic function|normal hepatic function
401158|NCT01863784|Pharmacokinetics|pharmacokinetics
401159|NCT01863784|JNJ-38518168|jnj-38518168
401160|NCT01863771|Ulcerative Colitis|ulcerative colitis
401161|NCT01863771|Japanese|japanese
401162|NCT01863771|Subcutaneous|subcutaneous
401163|NCT01863771|Golimumab|golimumab
401164|NCT01863745|ggastrointestinal stromal tumors|ggastrointestinal stromal tumors
401165|NCT01863745|gastrointestinal,|gastrointestinal,
401166|NCT01863745|stromal,|stromal,
401167|NCT01863745|tumors,|tumors,
401168|NCT01863745|GIST,|gist,
401169|NCT01863745|AMN107,|amn107,
401170|NCT01863745|nilotinib|nilotinib
401171|NCT01863732|AIN457, ankylosing spondylitis, chronic inflammatory disease, inflammatory back pain, PFS, pre-filled syringe, secukinumab, self-injection|ain457, ankylosing spondylitis, chronic inflammatory disease, inflammatory back pain, pfs, pre-filled syringe, secukinumab, self-injection
401172|NCT01863719|Colistin|colistin
401173|NCT01863719|Multi Drug Resistant|multi drug resistant
401174|NCT01863719|Nosocomial Pneumonia|nosocomial pneumonia
401175|NCT01863719|Pneumococcal Infections|pneumococcal infections
401176|NCT01863706|Misoprostol|misoprostol
401177|NCT01863706|Oxytocin|oxytocin
401178|NCT01863706|Post Partum Hemorrhage (PPH)|post partum hemorrhage (pph)
401179|NCT01863706|Third stage of labour|third stage of labour
401180|NCT01863680|Infertility|infertility
401181|NCT01863680|COL-1620|col-1620
401182|NCT01863680|progesterone gel|progesterone gel
401183|NCT01863680|Fertilization in Vitro|fertilization in vitro
401184|NCT01863680|Embryo Transfer|embryo transfer
401185|NCT01863654|Bioequivalence|bioequivalence
401186|NCT01863654|Mexico|mexico
401187|NCT01863654|Asthma|asthma
401188|NCT01863654|Montelukast|montelukast
401189|NCT01863654|Chewable|chewable
401190|NCT01863641|lupus nephritis|lupus nephritis
401191|NCT01863641|proteinuria|proteinuria
401192|NCT01863641|SLE|sle
401193|NCT01863641|calcitriol|calcitriol
401194|NCT01863628|Prodromal Symptoms|prodromal symptoms
401195|NCT01863628|bipolar disorder|bipolar disorder
401196|NCT01863628|Neuropsychological Tests|neuropsychological tests
401197|NCT01863628|Magnetic Resonance Imaging|magnetic resonance imaging
401198|NCT01863628|Treatment Outcome|treatment outcome
401199|NCT01863628|aerobic exercise|aerobic exercise
401200|NCT01863628|psychotherapy|psychotherapy
401201|NCT01863615|pharmacokinetics|pharmacokinetics
401202|NCT01863615|Isotretinoin|isotretinoin
401203|NCT01863615|bioequivalence|bioequivalence
401204|NCT01863615|Mexico|mexico
401205|NCT01863576|Chagas disease|chagas disease
401206|NCT01863576|Chagas Cardiomyopathy|chagas cardiomyopathy
401207|NCT01863576|Trypanosoma cruzi|trypanosoma cruzi
401208|NCT01863576|Omega-3|omega-3
401209|NCT01863576|Cytokines|cytokines
401210|NCT01863576|Lipid profile|lipid profile
401211|NCT01863576|Nutritional assessment|nutritional assessment
401212|NCT01863563|tonsillectomy|tonsillectomy
401213|NCT01863563|adenoidectomy|adenoidectomy
401214|NCT01863563|obstructive sleep apnea|obstructive sleep apnea
401215|NCT01863524|Abdominal Aortic Aneurysm (AAA),|abdominal aortic aneurysm (aaa),
401216|NCT01863524|Echocardiography (TTE),|echocardiography (tte),
401217|NCT01863524|Acute Coronary Syndrome (ACS)|acute coronary syndrome (acs)
401218|NCT01863524|Patients over 65 years old|patients over 65 years old
401219|NCT01863511|Treatment options for acute decompensated heart failure|treatment options for acute decompensated heart failure
401220|NCT01863511|Ultrafiltration|ultrafiltration
401221|NCT01863511|tolvaptan|tolvaptan
401222|NCT01863498|pectus excavatum|pectus excavatum
401223|NCT01863498|pain control|pain control
401224|NCT01863485|advanced cancer|advanced cancer
401225|NCT01863459|ADHD|adhd
401228|NCT01863459|Anxiety Disorders|anxiety disorders
401229|NCT01863459|Depression|depression
401230|NCT01863459|Attention|attention
401231|NCT01863459|Attention Deficit|attention deficit
401232|NCT01863446|Pregnancy|pregnancy
401233|NCT01863446|Melatonin|melatonin
401234|NCT01863446|Contractions|contractions
401235|NCT01863446|Light|light
401236|NCT01863420|gastric cancer|gastric cancer
401237|NCT01863420|rectal cancer|rectal cancer
401238|NCT01863420|bone marrow toxicity|bone marrow toxicity
401239|NCT01863420|IMRT|imrt
401240|NCT01863420|hematologic toxicity|hematologic toxicity
401241|NCT01863407|Ileus|ileus
401242|NCT01863407|Intestinal Obstruction|intestinal obstruction
401243|NCT01863407|Intestinal Diseases|intestinal diseases
401244|NCT01863407|Gastrointestinal Diseases|gastrointestinal diseases
401245|NCT01863407|Digestive System Diseases|digestive system diseases
401246|NCT01863394|Screening|screening
401247|NCT01863394|Malnutrition|malnutrition
401248|NCT01863394|Community Management of Acute Malnutrition|community management of acute malnutrition
401249|NCT01863381|Hydrocephalus|hydrocephalus
401250|NCT01863381|Idiopathic intracranial hypertension|idiopathic intracranial hypertension
401251|NCT01863381|Pseudotumor cerebri|pseudotumor cerebri
401252|NCT01863381|ICP|icp
401253|NCT01863381|Intracranial pressure|intracranial pressure
401254|NCT01863381|CSF pressure|csf pressure
401255|NCT01863381|VIIP|viip
401256|NCT01863368|Dry eye syndrome|dry eye syndrome
401257|NCT01863368|Systane Ultra|systane ultra
401258|NCT01863368|Optive|optive
401259|NCT01863368|Ocular Surface Staining|ocular surface staining
401260|NCT01863368|OSDI|osdi
401261|NCT01863368|Eye drops|eye drops
401262|NCT01863355|IntravenousPCA, fentanyl, postoperative pain, laparoscopic gastrectomy|intravenouspca, fentanyl, postoperative pain, laparoscopic gastrectomy
401263|NCT01863342|central sensitization; osteoarthritis; epidural analgesia|central sensitization; osteoarthritis; epidural analgesia
401264|NCT01863329|Optic nerve sheath diameter|optic nerve sheath diameter
401265|NCT01863329|Hydrocephalus|hydrocephalus
401266|NCT01863329|Intracranial hypertension|intracranial hypertension
401267|NCT01863316|LMA Supreme, i-gel, supraglottic airway|lma supreme, i-gel, supraglottic airway
401268|NCT01863303|colorectal cancer|colorectal cancer
401269|NCT01863303|epidemiology|epidemiology
401270|NCT01863303|industry|industry
401271|NCT01863303|genetic|genetic
401272|NCT01863290|prison|prison
401273|NCT01863290|reentry|reentry
401274|NCT01863290|health care utilization|health care utilization
401275|NCT01863264|dysphagia|dysphagia
401276|NCT01863264|swallowing|swallowing
401277|NCT01863264|infant|infant
401278|NCT01863264|premature|premature
401279|NCT01863264|neonate|neonate
401280|NCT01863264|thermal|thermal
401281|NCT01863264|cold|cold
401282|NCT01863264|bolus|bolus
401283|NCT01863264|temperature|temperature
401284|NCT01863264|deglutition|deglutition
401285|NCT01863264|NICU|nicu
401286|NCT01863264|bottle|bottle
401287|NCT01863264|nippling|nippling
401288|NCT01863251|Opiates|opiates
401289|NCT01863251|ATS|ats
401290|NCT01863251|HIV Risks|hiv risks
401291|NCT01863238|Cystic Fibrosis|cystic fibrosis
401292|NCT01863199|Wet AMD|wet amd
401293|NCT01863199|AMD|amd
401294|NCT01863199|Choroidal neovascularization|choroidal neovascularization
401295|NCT01863199|Neovascular membrane|neovascular membrane
401296|NCT01863186|lofexidine|lofexidine
401297|NCT01863186|opioid dependence|opioid dependence
401298|NCT01863186|acute withdrawal syndrome|acute withdrawal syndrome
401299|NCT01863186|opioid withdrawal|opioid withdrawal
401300|NCT01863173|Thalassemia cardiomyopathy|thalassemia cardiomyopathy
401301|NCT01863173|metoprolol succinate|metoprolol succinate
401302|NCT01863173|echocardiography|echocardiography
401303|NCT01863173|six minute walk test|six minute walk test
401304|NCT01863160|Safety|safety
401305|NCT01863160|Tolerability|tolerability
401306|NCT01863160|Pharmacokinetic profile|pharmacokinetic profile
401307|NCT01863160|ZEP-3 Cream (0.1% and 1.0%)|zep-3 cream (0.1% and 1.0%)
401308|NCT01863160|administered topically|administered topically
401309|NCT01863147|Type 2 diabetes|type 2 diabetes
401310|NCT01863147|left ventricular mass|left ventricular mass
401311|NCT01863147|inhibitor of dipeptidyl peptidase-4|inhibitor of dipeptidyl peptidase-4
401312|NCT01863121|cirrhosis|cirrhosis
401313|NCT01863121|CTPK|ctpk
401314|NCT01863121|CTP|ctp
401315|NCT01863121|MELD|meld
401316|NCT01863121|Severity Score|severity score
401317|NCT01863108|Melanoma|melanoma
401318|NCT01863108|Immunotherapy|immunotherapy
401319|NCT01863108|Dermatology|dermatology
401320|NCT01863108|cancer vaccine|cancer vaccine
513204|NCT01376570|HIV|hiv
401321|NCT01863108|Plasmacytoid dendritic cell line|plasmacytoid dendritic cell line
401322|NCT01863108|Advanced Medicinal Therapy Product|advanced medicinal therapy product
401323|NCT01863108|allogeneic|allogeneic
401324|NCT01863082|Resistant Hypertension|resistant hypertension
401325|NCT01863069|inhaled|inhaled
401326|NCT01863069|interferon beta-1a|interferon beta-1a
401327|NCT01863069|healthy subjects|healthy subjects
401328|NCT01863056|Sedentary time|sedentary time
401329|NCT01863056|Non Exercise Activity|non exercise activity
401330|NCT01863056|Sit Stand Workstation|sit stand workstation
401331|NCT01863043|Premature Infant|premature infant
401332|NCT01863043|Nutrition|nutrition
401333|NCT01863043|Enteral|enteral
401334|NCT01863030|Resorbable mesh|resorbable mesh
401335|NCT01863030|Phasix mesh|phasix mesh
401336|NCT01863017|Obesity|obesity
401337|NCT01863017|Over weight|over weight
401338|NCT01862991|Induced Abortion|induced abortion
401339|NCT01862991|Mifepristone|mifepristone
401340|NCT01862991|Dilation and Evacuation|dilation and evacuation
401341|NCT01862991|Cervical Preparation|cervical preparation
401342|NCT01862991|Osmotic Dilators|osmotic dilators
401343|NCT01862978|Stroke|stroke
401344|NCT01862978|Heparin|heparin
401345|NCT01862978|Nadroparin|nadroparin
401346|NCT01862965|firstline|firstline
401347|NCT01862965|treatment|treatment
401348|NCT01862965|prednisone|prednisone
401349|NCT01862965|everolimus|everolimus
401350|NCT01862939|type 2 diabetes mellitus|type 2 diabetes mellitus
401351|NCT01862926|connective tissue disease|connective tissue disease
401352|NCT01862926|interstitial lung disease|interstitial lung disease
401353|NCT01862926|pulmonary fibrosis|pulmonary fibrosis
401354|NCT01862926|rituximab|rituximab
401355|NCT01862926|scleroderma|scleroderma
401356|NCT01862926|polymyositis|polymyositis
401357|NCT01862926|dermatomyositis|dermatomyositis
401358|NCT01862913|depression|depression
401359|NCT01862913|adolescents|adolescents
401360|NCT01862900|Breast Cancer|breast cancer
401361|NCT01862900|Metastatic|metastatic
401362|NCT01862900|Lung metastases|lung metastases
401363|NCT01862900|Liver metastases|liver metastases
401364|NCT01862900|Stereotactic body radiation|stereotactic body radiation
401365|NCT01862900|anti-OX40 antibody|anti-ox40 antibody
401366|NCT01862900|MEDI6469|medi6469
401367|NCT01862900|Immunotherapy|immunotherapy
401368|NCT01862861|Bioidentical Hormone Replacement Therapy|bioidentical hormone replacement therapy
401369|NCT01862848|Topical Compounded Pain Creams and Pain Perception|topical compounded pain creams and pain perception
401370|NCT01862822|Paediatrics|paediatrics
401371|NCT01862822|Urinary tract infection|urinary tract infection
401372|NCT01862822|Urine collection|urine collection
401373|NCT01862809|Oral Microbiota|oral microbiota
401374|NCT01862809|Cigarette Smoking|cigarette smoking
401375|NCT01862809|Tobacco- Related Cancer|tobacco- related cancer
401376|NCT01862796|Food Intake|food intake
401377|NCT01862796|Weight Loss|weight loss
401378|NCT01862796|Compliance|compliance
401379|NCT01862783|Erythrocytes|erythrocytes
401380|NCT01862783|Parasites|parasites
401381|NCT01862783|Plasmodium Falciparum|plasmodium falciparum
401382|NCT01862783|Placenta|placenta
401383|NCT01862783|Resistant|resistant
401384|NCT01862770|Lung Cancer|lung cancer
401385|NCT01862770|Smokers|smokers
401386|NCT01862770|Genetic Risk Communication|genetic risk communication
401387|NCT01862770|Smoking Cessation|smoking cessation
401388|NCT01862757|Obesity|obesity
401389|NCT01862757|Insulin|insulin
401390|NCT01862757|Skeletal Muscle|skeletal muscle
401391|NCT01862757|Strength Testing|strength testing
401392|NCT01862744|Parkinson's Disease|parkinson's disease
401393|NCT01862744|MRI|mri
401394|NCT01862744|Cognitive|cognitive
401395|NCT01862731|Muscle Force|muscle force
401396|NCT01862731|Knee|knee
401397|NCT01862731|Magnetic Resonance Imaging|magnetic resonance imaging
401398|NCT01862731|Quadriceps|quadriceps
401399|NCT01862731|Ultrasound|ultrasound
401400|NCT01862718|Fusion|fusion
401401|NCT01862718|Tracking|tracking
401402|NCT01862718|Ablation|ablation
401403|NCT01862718|Hepatic Neoplasms|hepatic neoplasms
401404|NCT01862666|Barrett's Esophagus|barrett's esophagus
401405|NCT01862666|Dysplasia|dysplasia
401406|NCT01862666|Intramucosal Adenocarcinoma|intramucosal adenocarcinoma
401407|NCT01862666|EMR|emr
401408|NCT01862666|Endoscopy|endoscopy
401409|NCT01862653|Post Traumatic Stress Disorder|post traumatic stress disorder
401410|NCT01862653|Sleep Disturbance|sleep disturbance
401411|NCT01862653|Acupuncture|acupuncture
401412|NCT01862640|OPC-34712|opc-34712
401413|NCT01862640|brexpiprazole|brexpiprazole
401414|NCT01862640|Dementia|dementia
401415|NCT01862640|Alzheimer's Disease|alzheimer's disease
401416|NCT01862640|Cognitive Disorders|cognitive disorders
401417|NCT01862640|Memory|memory
401418|NCT01862640|Agitation|agitation
401419|NCT01862627|Macular retinoschisis|macular retinoschisis
401420|NCT01862627|Macular detachment|macular detachment
401421|NCT01862627|vitrectomy|vitrectomy
710215|NCT00589680|Diabetic Ketosis|diabetic ketosis
401422|NCT01862614|Degree of pulpal anesthesia obtained.|degree of pulpal anesthesia obtained.
401423|NCT01862614|Primary infiltration in the lower first molar.|primary infiltration in the lower first molar.
401424|NCT01862614|Buffered local anesthetic.|buffered local anesthetic.
401425|NCT01862588|septic shock|septic shock
401426|NCT01862588|acute kidney injury|acute kidney injury
401427|NCT01862588|renal resistive index|renal resistive index
401428|NCT01862562|Laparoscopic surgery|laparoscopic surgery
401429|NCT01862562|Colorectal cancer|colorectal cancer
401430|NCT01862562|Elderly patient|elderly patient
401431|NCT01862562|Randomized control study|randomized control study
401432|NCT01862536|Randomized trial|randomized trial
401435|NCT01862536|Phosphodiesterase inhibitor|phosphodiesterase inhibitor
401436|NCT01862536|Pulmonary hypertension|pulmonary hypertension
401437|NCT01862510|Celiac Disease|celiac disease
401438|NCT01862510|Hypothyroidism|hypothyroidism
401439|NCT01862510|Celiac Sprue|celiac sprue
401440|NCT01862510|Malabsorption|malabsorption
401441|NCT01862497|Intradialytic Hypertension|intradialytic hypertension
401442|NCT01862497|Hemodialysis|hemodialysis
401443|NCT01862497|Hypertension|hypertension
401444|NCT01862497|Extracellular Volume|extracellular volume
401445|NCT01862497|Endothelial Cell Dysfunction|endothelial cell dysfunction
401446|NCT01862497|Endothelin 1|endothelin 1
401447|NCT01862497|Carvedilol|carvedilol
401448|NCT01862484|ADHD|adhd
401449|NCT01862484|Diet|diet
401450|NCT01862484|Functional Magnetic Resonance Imaging|functional magnetic resonance imaging
401451|NCT01862471|Deep Vein Thrombosis|deep vein thrombosis
401452|NCT01862471|Neuromuscular Electrical Stimulation|neuromuscular electrical stimulation
401453|NCT01862471|Intermittent Pneumatic Compression|intermittent pneumatic compression
401454|NCT01862471|Doppler Ultrasound|doppler ultrasound
401455|NCT01862458|empyema|empyema
401456|NCT01862458|tPA|tpa
401457|NCT01862458|dornase|dornase
401458|NCT01862445|Chronic Lymphoid Leukemia, Chlorambucil, Rituximab|chronic lymphoid leukemia, chlorambucil, rituximab
401459|NCT01862393|electrical stimulation|electrical stimulation
401460|NCT01862393|torque|torque
401461|NCT01862380|Adrenocortical function|adrenocortical function
401462|NCT01862380|Adrenal hyperplasia, Congenital|adrenal hyperplasia, congenital
401463|NCT01862380|21-hydroxylase|21-hydroxylase
401464|NCT01862380|deficiency|deficiency
401465|NCT01862380|cortisol|cortisol
401466|NCT01862380|replacement therapy|replacement therapy
401467|NCT01862380|Woman|woman
401468|NCT01862380|Healthy people|healthy people
401469|NCT01862354|Postoperative analgesia|postoperative analgesia
401470|NCT01862354|Abdominoplasty|abdominoplasty
401471|NCT01862354|Continuous wound infusion|continuous wound infusion
401472|NCT01862354|Transverse abdominal plan block|transverse abdominal plan block
401473|NCT01862354|Local anesthetics : Ropivacaine|local anesthetics : ropivacaine
401474|NCT01862354|Regional anesthesia|regional anesthesia
401475|NCT01862341|Constipation|constipation
401476|NCT01862341|Bowel movement|bowel movement
401477|NCT01862341|Intestinal health|intestinal health
401478|NCT01862328|MLN4924|mln4924
401479|NCT01862328|Solid Tumors|solid tumors
401480|NCT01862315|Hepatic Arterial Infusion (HAI)|hepatic arterial infusion (hai)
401481|NCT01862315|Floxuridine (FUDR)|floxuridine (fudr)
401482|NCT01862315|Dexamethasone (DEX)|dexamethasone (dex)
401483|NCT01862315|Gemcitabine|gemcitabine
401484|NCT01862315|Oxaliplatin|oxaliplatin
401485|NCT01862315|13-066|13-066
401486|NCT01862302|Prevention delirium|prevention delirium
401487|NCT01862302|Cardiac surgery|cardiac surgery
401488|NCT01862289|difficult asthma|difficult asthma
401489|NCT01862289|hyperventilation syndrome|hyperventilation syndrome
401490|NCT01862289|prevalence|prevalence
401491|NCT01862263|Diabetes,|diabetes,
401492|NCT01862263|Type 2 diabetes,|type 2 diabetes,
401493|NCT01862263|Diabetes mellitus,|diabetes mellitus,
401494|NCT01862263|insulin,|insulin,
401495|NCT01862237|Type II diabetes|type ii diabetes
401496|NCT01862237|aortic valve stenosis|aortic valve stenosis
401497|NCT01862237|left ventricular remodeling|left ventricular remodeling
401498|NCT01862237|aortic valve replacement surgery|aortic valve replacement surgery
401499|NCT01862224|Active rheumatoid arthritis despite methotrexate therapy|active rheumatoid arthritis despite methotrexate therapy
401500|NCT01862224|JNJ-38518168|jnj-38518168
401501|NCT01862224|Synovial|synovial
401502|NCT01862211|alpha antitrypsin, hepatic disease, genetic, polymorphism|alpha antitrypsin, hepatic disease, genetic, polymorphism
401503|NCT01862185|semiquantitative|semiquantitative
401504|NCT01862185|procalcitonin|procalcitonin
401505|NCT01862185|sepsis|sepsis
401506|NCT01862185|antibiotics|antibiotics
401507|NCT01862185|mortality|mortality
401508|NCT01862172|Cortical focal atrophy|cortical focal atrophy
401509|NCT01862172|Stroke|stroke
401510|NCT01862172|Internal capsule|internal capsule
401511|NCT01862172|Corticospinal tract|corticospinal tract
401512|NCT01862172|Wallerian degeneration|wallerian degeneration
401513|NCT01862172|Primary motor area.|primary motor area.
401514|NCT01862159|bariatric surgery|bariatric surgery
401515|NCT01862159|postoperative complications|postoperative complications
401516|NCT01862146|TCA|tca
513430|NCT01375595|HV|hv
401517|NCT01862146|FMD|fmd
401518|NCT01862146|IMT|imt
401519|NCT01862146|Smoking|smoking
401520|NCT01862133|Electronic Health Record|electronic health record
401521|NCT01862133|Health Information Technology|health information technology
401522|NCT01862133|Patient Privacy|patient privacy
401523|NCT01862133|Personal Health Information|personal health information
401524|NCT01862120|Recently diagnosed|recently diagnosed
401525|NCT01862120|Regulatory T Cells|regulatory t cells
401526|NCT01862120|Tolerance Induction|tolerance induction
401527|NCT01862120|Paediatrics|paediatrics
401528|NCT01862120|Low dose|low dose
401529|NCT01862120|IL-2|il-2
401530|NCT01862107|Biomarkers|biomarkers
401531|NCT01862107|Immune Responses|immune responses
401532|NCT01862107|Lumbar Puncture|lumbar puncture
401533|NCT01862107|Neurological Diseases|neurological diseases
401534|NCT01862107|Novel Pathogens|novel pathogens
401535|NCT01862068|Pronostic factors|pronostic factors
401536|NCT01862068|Neutrophils|neutrophils
401537|NCT01862068|Granulomatosis with polyangiitis|granulomatosis with polyangiitis
401538|NCT01862068|Microscopic polyangiitis|microscopic polyangiitis
401539|NCT01862068|ANCA associated vasculitis|anca associated vasculitis
401540|NCT01862068|Proteomics|proteomics
401542|NCT01862055|Anxiety|anxiety
401543|NCT01862055|Cesarean Section|cesarean section
401544|NCT01862055|Spinal anesthesia|spinal anesthesia
401545|NCT01862055|Hypotension|hypotension
401546|NCT01862042|Spinal Muscular Atrophy (SMA) type 1|spinal muscular atrophy (sma) type 1
401547|NCT01862042|Supportive care|supportive care
401548|NCT01862042|Palliative care|palliative care
401549|NCT01862029|Mitochondria in Diabetes|mitochondria in diabetes
401550|NCT01862029|Obesity|obesity
401551|NCT01862029|Roflumilast|roflumilast
401552|NCT01862029|Phosphodiesterase-4|phosphodiesterase-4
401553|NCT01862029|Pre-Diabetes|pre-diabetes
401554|NCT01862016|Acute respiratory distress syndrome|acute respiratory distress syndrome
401555|NCT01862016|APRV ventilatory mode|aprv ventilatory mode
401556|NCT01862016|Spontaneous breathing|spontaneous breathing
401557|NCT01862016|Intensive Care Unit|intensive care unit
401558|NCT01862003|Colorectal cancer|colorectal cancer
401559|NCT01862003|Metastatic Colorectal cancer|metastatic colorectal cancer
401560|NCT01862003|Recurrent Colorectal cancer|recurrent colorectal cancer
401561|NCT01862003|FOLFIRI|folfiri
401562|NCT01862003|AZD8931|azd8931
401563|NCT01862003|Chemotherapy|chemotherapy
401564|NCT01862003|EGFR|egfr
401565|NCT01861990|Glioma|glioma
401566|NCT01861990|Glioblastoma|glioblastoma
401567|NCT01861990|Pediatric|pediatric
401568|NCT01861990|Child|child
401569|NCT01861990|Brain tumor|brain tumor
401570|NCT01861990|Astrocytoma|astrocytoma
401571|NCT01861990|Medulloblastoma|medulloblastoma
401572|NCT01861990|PNET|pnet
401573|NCT01861977|Cognitive Therapy|cognitive therapy
401574|NCT01861977|Health Education|health education
401575|NCT01861977|Secondary Prevention|secondary prevention
401576|NCT01861977|Cardiovascular Disease|cardiovascular disease
401577|NCT01861964|XOS|xos
401578|NCT01861964|Xylooligosarcharide|xylooligosarcharide
401579|NCT01861964|Prebiotic|prebiotic
401580|NCT01861951|soft tissue sarcoma|soft tissue sarcoma
401581|NCT01861951|firstline treatment|firstline treatment
401582|NCT01861951|eldery patients|eldery patients
401583|NCT01861938|melanoma|melanoma
401584|NCT01861938|vaccine|vaccine
401585|NCT01861938|Resectable AJCC stage IV|resectable ajcc stage iv
401586|NCT01861938|AJCC stages IIb-c, III|ajcc stages iib-c, iii
401587|NCT01861938|Patients with low-burden|patients with low-burden
401588|NCT01861938|failed|failed
401589|NCT01861938|respond|respond
401590|NCT01861938|one treatment line|one treatment line
401591|NCT01861912|Carcinoma, Hepatocellular|carcinoma, hepatocellular
401592|NCT01861912|Arsenic trioxide|arsenic trioxide
401593|NCT01861899|Sacro-iliac Joint|sacro-iliac joint
401594|NCT01861886|Birth control|birth control
401595|NCT01861886|Permanent Contraception|permanent contraception
401596|NCT01861873|liver function|liver function
401597|NCT01861873|galactose|galactose
401598|NCT01861873|18-F-deoxy-galactose|18-f-deoxy-galactose
401599|NCT01861860|stenting using IVUS in long lEsion|stenting using ivus in long lesion
401600|NCT01861834|Total parenteral nutrition|total parenteral nutrition
401601|NCT01861834|TPN|tpn
401602|NCT01861834|Intestinal Failure|intestinal failure
401603|NCT01861834|Short Bowel Syndrome|short bowel syndrome
401604|NCT01861834|Cholestasis|cholestasis
401605|NCT01861834|Intestinal failure associated liver disease|intestinal failure associated liver disease
401606|NCT01861834|Parenteral nutrition associated liver disease|parenteral nutrition associated liver disease
401607|NCT01861821|Epidural catheter|epidural catheter
401608|NCT01861821|Epidural analgesia|epidural analgesia
401609|NCT01861821|Labor epidural analgesia|labor epidural analgesia
401610|NCT01861821|Analgesic efficacy|analgesic efficacy
401611|NCT01861821|Multiport epidural catheter|multiport epidural catheter
401612|NCT01861821|Uniport epidural catheter|uniport epidural catheter
401613|NCT01861821|Flexible epidural catheter|flexible epidural catheter
401614|NCT01861808|Spinal Cord Injuries|spinal cord injuries
401615|NCT01861808|Cerebrospinal Fluid|cerebrospinal fluid
401616|NCT01861795|Drug therapy|drug therapy
401617|NCT01861769|Cognitive Processing Therapy|cognitive processing therapy
401618|NCT01861769|Consultation|consultation
401619|NCT01861756|Shared Decision Making|shared decision making
401620|NCT01861756|Decision Aids|decision aids
401621|NCT01861743|Multi-modal Pain Management|multi-modal pain management
401622|NCT01861743|Lumbar fusion|lumbar fusion
401623|NCT01861743|misTLIF|mistlif
401624|NCT01861730|BCG Vaccinated|bcg vaccinated
401625|NCT01861730|HIV Negative|hiv negative
401626|NCT01861717|excess growth hormone|excess growth hormone
401627|NCT01861717|excess GH|excess gh
401628|NCT01861717|gigantism|gigantism
401629|NCT01861717|pituitary tumor|pituitary tumor
401630|NCT01861717|pituitary adenoma|pituitary adenoma
401631|NCT01861717|growth hormone tumor|growth hormone tumor
401632|NCT01861717|GH secreting adenoma|gh secreting adenoma
401633|NCT01861717|Somatuline|somatuline
401634|NCT01861717|lanreotide|lanreotide
401635|NCT01861704|Mild to moderate hearing loss|mild to moderate hearing loss
401636|NCT01861691|Transverse colon cancer|transverse colon cancer
401637|NCT01861691|Descending colon cancer|descending colon cancer
401638|NCT01861691|Laparoscopic surgery|laparoscopic surgery
401639|NCT01861691|Randomized controlled trial|randomized controlled trial
401640|NCT01861678|Rectal cancer|rectal cancer
401641|NCT01861678|Anterior resection|anterior resection
401642|NCT01861678|High tie of inferior mesenteric artery|high tie of inferior mesenteric artery
401643|NCT01861678|Low tie of inferior mesenteric artery|low tie of inferior mesenteric artery
401644|NCT01861678|Randomized controlled trial|randomized controlled trial
401645|NCT01861652|Restless legs syndrome, Ekbom syndrome, Restless legs|restless legs syndrome, ekbom syndrome, restless legs
401646|NCT01861600|Stool composition|stool composition
401647|NCT01861535|VIN|vin
401648|NCT01861535|Imiquimod|imiquimod
401649|NCT01861535|Surgery|surgery
401650|NCT01861535|HPV|hpv
401651|NCT01861535|Patient satisfaction|patient satisfaction
401652|NCT01861522|TAU-284|tau-284
401653|NCT01861522|Bepotastine besilate|bepotastine besilate
401654|NCT01861522|Histamine H1 receptor antagonists|histamine h1 receptor antagonists
401655|NCT01861522|children|children
401656|NCT01861509|BP-C1|bp-c1
401657|NCT01861509|Metronomic chemotherapy|metronomic chemotherapy
401658|NCT01861509|Platinum analogue|platinum analogue
401659|NCT01861509|Cis-diammineplatinum(II) complexed with a polymer containing benzene polycarboxylic acids derived from lignin|cis-diammineplatinum(ii) complexed with a polymer containing benzene polycarboxylic acids derived from lignin
401660|NCT01861509|Benzene polycarboxylic acids complex with cis-diammineplatinum(II)|benzene polycarboxylic acids complex with cis-diammineplatinum(ii)
401661|NCT01861509|Breast cancer|breast cancer
401662|NCT01861509|Cisplatin|cisplatin
401663|NCT01861509|Metastatic Breast Cancer|metastatic breast cancer
401664|NCT01861509|Cis-diammineplatinum(II) complex, containing mono-deprotonated benzene-poly-carboxylic acids, derived from lignin, and hydroxyl group as O-donor ligands|cis-diammineplatinum(ii) complex, containing mono-deprotonated benzene-poly-carboxylic acids, derived from lignin, and hydroxyl group as o-donor ligands
401665|NCT01861496|Cisplatin|cisplatin
401666|NCT01861496|Liposomal formulation|liposomal formulation
401667|NCT01861496|DRP (Drug Response Prediction)|drp (drug response prediction)
401668|NCT01861457|nasal sanitizer®|nasal sanitizer®
401669|NCT01861457|S. aureus|s. aureus
401670|NCT01861457|general bacteria|general bacteria
401671|NCT01861457|nasal carriage|nasal carriage
401672|NCT01861457|decolonization|decolonization
401673|NCT01861431|HIV, prevention, microfinance, sex work, Mongolia|hiv, prevention, microfinance, sex work, mongolia
401674|NCT01861418|chronic low back pain|chronic low back pain
401675|NCT01861418|low back pain|low back pain
401676|NCT01861418|lumbopelvic manipulation|lumbopelvic manipulation
401677|NCT01861418|Chicago manipulation|chicago manipulation
401678|NCT01861418|EMG median frequency|emg median frequency
401679|NCT01861418|electromyography|electromyography
401680|NCT01861418|reliability|reliability
401681|NCT01861392|postural balance sensory motor trayning physical therapy modalities diabetes mellitus|postural balance sensory motor trayning physical therapy modalities diabetes mellitus
401682|NCT01861366|Implementation|implementation
401683|NCT01861366|Guidelines|guidelines
401684|NCT01861366|Nutrition|nutrition
401685|NCT01861366|Nursing home|nursing home
401686|NCT01861327|Carbon dioxide|carbon dioxide
401687|NCT01861327|aortic aneurysm|aortic aneurysm
401688|NCT01861327|angioplasty|angioplasty
401689|NCT01861327|Critical lower limb ischemia|critical lower limb ischemia
401690|NCT01861288|Inflammatory Bowel Disease|inflammatory bowel disease
401691|NCT01861288|Fecal Calprotectin|fecal calprotectin
401692|NCT01861288|Clinical IBD score (SCCAI, PUCAI, aPCDAI)|clinical ibd score (sccai, pucai, apcdai)
401693|NCT01861288|Endoscopic deep remission|endoscopic deep remission
401694|NCT01861288|Histopathologic deep remission|histopathologic deep remission
401695|NCT01861288|Immunological deep remission|immunological deep remission
401696|NCT01861288|Treatment algorithm|treatment algorithm
401697|NCT01861275|osa|osa
401698|NCT01861275|cerebral palsy|cerebral palsy
401699|NCT01861275|thrombolysis in cerebral palsy|thrombolysis in cerebral palsy
401700|NCT01861275|sleep registration|sleep registration
401701|NCT01861262|emergency|emergency
401702|NCT01861262|drug poisoning|drug poisoning
401703|NCT01861262|StO2 measurement|sto2 measurement
401704|NCT01861262|blood pressure|blood pressure
401705|NCT01861262|hemodynamic failure|hemodynamic failure
401706|NCT01861223|acquired resistance|acquired resistance
401707|NCT01861223|gefitinib|gefitinib
401708|NCT01861223|erlotinib|erlotinib
401709|NCT01861210|Homosexuality, Male|homosexuality, male
401710|NCT01861197|Efficacy|efficacy
401711|NCT01861197|Dovitinib|dovitinib
401712|NCT01861197|Squamous NSCLC|squamous nsclc
401713|NCT01861184|Lower respiratory tract infection|lower respiratory tract infection
401714|NCT01861184|LRTI|lrti
401715|NCT01861184|Pneumococcal carriage|pneumococcal carriage
401716|NCT01861158|Parenting|parenting
401717|NCT01861158|Adolescence|adolescence
401718|NCT01861158|Delinquency|delinquency
401719|NCT01861158|Online intervention|online intervention
401720|NCT01861158|Juvenile Justice|juvenile justice
401721|NCT01861145|Intranasal steroids|intranasal steroids
401722|NCT01861132|Pregnancy, cesarean delivery, blood pressure, cardiac output|pregnancy, cesarean delivery, blood pressure, cardiac output
401723|NCT01861106|Allogeneic Donors|allogeneic donors
401724|NCT01861106|Peripheral Blood Stem Cell|peripheral blood stem cell
401725|NCT01861106|Immunodeficiency|immunodeficiency
401726|NCT01861106|Myelodysplasia|myelodysplasia
401727|NCT01861106|Haploidentical|haploidentical
401728|NCT01861093|Unrelated Hematopoietic Stem Cell Transplantation|unrelated hematopoietic stem cell transplantation
401729|NCT01861093|Cryopreserved Cord Blood Units|cryopreserved cord blood units
401730|NCT01861093|National Cord Blood Program|national cord blood program
401731|NCT01861080|target organ damage|target organ damage
401732|NCT01861080|incident hypertension|incident hypertension
401733|NCT01861080|cohort|cohort
401734|NCT01861054|Cancer Stem Cells|cancer stem cells
401735|NCT01861054|Novel targeted therapy|novel targeted therapy
401736|NCT01861054|CXCR1/2 Inhibitors|cxcr1/2 inhibitors
401737|NCT01861041|low dose|low dose
401738|NCT01861041|different baricity|different baricity
401739|NCT01861041|spinal anesthesia|spinal anesthesia
401740|NCT01861028|total knee replacement|total knee replacement
401741|NCT01861028|total knee arthroplasty|total knee arthroplasty
401742|NCT01861028|patient-specific|patient-specific
401743|NCT01861002|Relapse|relapse
401744|NCT01861002|Lymphoblastic|lymphoblastic
401745|NCT01861002|Leukemia|leukemia
401746|NCT01861002|Azacytidine|azacytidine
401747|NCT01861002|Refractory|refractory
401748|NCT01861002|Myelogenous|myelogenous
401749|NCT01861002|Acute|acute
401750|NCT01861002|Childhood|childhood
401751|NCT01861002|Pediatric|pediatric
401753|NCT01861002|AML|aml
401754|NCT01861002|Methylation|methylation
401755|NCT01861002|Epigenetic therapy|epigenetic therapy
401756|NCT01860989|parasitemia|parasitemia
401757|NCT01860963|ASIL|asil
401758|NCT01860963|Anal dysplasia|anal dysplasia
401759|NCT01860963|IBD|ibd
401760|NCT01860963|HPV DNA|hpv dna
401761|NCT01860950|Healthy Adults|healthy adults
401762|NCT01860950|Pain Perception|pain perception
401763|NCT01860937|T cell Immunotherapy|t cell immunotherapy
401764|NCT01860937|CD19 Targeted Therapy|cd19 targeted therapy
401765|NCT01860937|Chimeric Antigen Receptor (CAR) Modified T cells|chimeric antigen receptor (car) modified t cells
401766|NCT01860937|Conditioning Chemotherapy|conditioning chemotherapy
401767|NCT01860937|13-052|13-052
401768|NCT01860924|exercise|exercise
401769|NCT01860924|depression|depression
401770|NCT01860924|smoking|smoking
401771|NCT01860898|lung|lung
401772|NCT01860898|cancer|cancer
401773|NCT01860898|thoracic|thoracic
401774|NCT01860898|chest|chest
401775|NCT01860898|pulmonary|pulmonary
401776|NCT01860885|naloxone|naloxone
401777|NCT01860885|children|children
401778|NCT01860885|opioid|opioid
401779|NCT01860885|respiratory depression|respiratory depression
401780|NCT01860885|safety|safety
401781|NCT01860872|Cystic Fibrosis|cystic fibrosis
401782|NCT01860872|Pulmonary perfusion|pulmonary perfusion
401783|NCT01860872|Inflammatory markers|inflammatory markers
401784|NCT01860872|MRI|mri
401785|NCT01860872|CT of chest|ct of chest
401786|NCT01860872|Lung Clearance Index|lung clearance index
401787|NCT01860859|cesarean|cesarean
401788|NCT01860859|ultrasound|ultrasound
401789|NCT01860859|hysterotomy|hysterotomy
401790|NCT01860859|uterus|uterus
401791|NCT01860859|suture|suture
401792|NCT01860846|Crohn's Disease|crohn's disease
401793|NCT01860833|Knee Osteoarthritis|knee osteoarthritis
401794|NCT01860820|IPC/TEDS|ipc/teds
401795|NCT01860820|Geko device|geko device
401796|NCT01860807|methamphetamine|methamphetamine
401797|NCT01860807|ibudilast|ibudilast
401798|NCT01860807|HIV|hiv
401799|NCT01860781|Schizophrenia|schizophrenia
401800|NCT01860781|Injection|injection
401801|NCT01860781|Switch|switch
401802|NCT01860781|Paliperidone|paliperidone
710216|NCT00589680|Ketoacidosis, Diabetic|ketoacidosis, diabetic
401803|NCT01860781|refractory, chronic akathisia, poor complianc|refractory, chronic akathisia, poor complianc
401804|NCT01860768|Acute aortic dissection|acute aortic dissection
401805|NCT01860768|Serum biomarkers|serum biomarkers
401806|NCT01860768|Early diagnosis|early diagnosis
401807|NCT01860755|Sport-related concussion|sport-related concussion
401808|NCT01860755|Dizziness|dizziness
401809|NCT01860755|Neck pain|neck pain
401810|NCT01860755|Headaches|headaches
401811|NCT01860755|Physiotherapy|physiotherapy
401812|NCT01860755|Treatment|treatment
401813|NCT01860742|Peptide Receptor Radionuclide Therapy (PRRT)|peptide receptor radionuclide therapy (prrt)
401814|NCT01860742|Neuroendocrine Tumors|neuroendocrine tumors
401815|NCT01860742|Interferon alpha|interferon alpha
401816|NCT01860716|Melatonin, liver transplant, oxidative stress|melatonin, liver transplant, oxidative stress
401817|NCT01860703|Ferriprox®|ferriprox®
401818|NCT01860703|LI|li
401819|NCT01860703|DFP|dfp
401820|NCT01860703|Deferiprone|deferiprone
401821|NCT01860703|Healthy Volunteers|healthy volunteers
401822|NCT01860690|MTX|mtx
401823|NCT01860690|Ectopic pregnancy|ectopic pregnancy
401824|NCT01860690|medical treatment|medical treatment
401825|NCT01860677|cranial stimulation|cranial stimulation
401826|NCT01860677|BOLD (Blood Oxygenation Level Dependent)|bold (blood oxygenation level dependent)
401827|NCT01860677|fMRI (Functional Magnetic Resonance Imaging)|fmri (functional magnetic resonance imaging)
401828|NCT01860677|spectroscopy|spectroscopy
401830|NCT01860664|allergic|allergic
401831|NCT01860664|conjunctivitis|conjunctivitis
401832|NCT01860664|corticosteroid|corticosteroid
401833|NCT01860664|hydrocortisone|hydrocortisone
401834|NCT01860664|ophthalmic|ophthalmic
401835|NCT01860664|ointment|ointment
401836|NCT01860651|Inflammatory Bowel Disease|inflammatory bowel disease
401837|NCT01860651|Ulcerative Colitis|ulcerative colitis
401838|NCT01860651|Crohn´s Disease|crohn´s disease
401839|NCT01860651|Children|children
401840|NCT01860651|Adolescence|adolescence
401841|NCT01860651|E-health web-monitoring|e-health web-monitoring
401842|NCT01860651|Adherence|adherence
401843|NCT01860651|Disease activity|disease activity
401844|NCT01860651|Fecal Calprotectin|fecal calprotectin
401845|NCT01860599|prediabetes|prediabetes
401846|NCT01860599|EPC's|epc's
401847|NCT01860599|vascular reactivity|vascular reactivity
401848|NCT01860586|pvr|pvr
401849|NCT01860586|rd|rd
401850|NCT01860586|Proliferative Vitreoretinopathy|proliferative vitreoretinopathy
401851|NCT01860586|retinal detachment|retinal detachment
401852|NCT01860586|detachment|detachment
401853|NCT01860573|Amino acids|amino acids
401854|NCT01860573|Protein|protein
401855|NCT01860560|OSA|osa
401856|NCT01860560|Obstructive Sleep Apnea|obstructive sleep apnea
401857|NCT01860560|High Flow Therapy|high flow therapy
401858|NCT01860560|CPAP|cpap
401859|NCT01860560|HFT|hft
401860|NCT01860560|Continuous Positive Airway Pressure|continuous positive airway pressure
401861|NCT01860560|Mild OSA|mild osa
401862|NCT01860560|Moderate OSA|moderate osa
401863|NCT01860534|pain|pain
401864|NCT01860534|mydriasis|mydriasis
401865|NCT01860534|light|light
401866|NCT01860521|Termination of pregnancy|termination of pregnancy
401867|NCT01860521|Second trimester|second trimester
401868|NCT01860521|Programmed intermittent epidural bolus|programmed intermittent epidural bolus
401869|NCT01860521|Continuous epidural infusion|continuous epidural infusion
401870|NCT01860521|Epidural analgesia|epidural analgesia
401871|NCT01860521|Legally Induced Abortion|legally induced abortion
401872|NCT01860508|Progression free Survival|progression free survival
401873|NCT01860495|growth factors|growth factors
401874|NCT01860495|periodontal pockets|periodontal pockets
401875|NCT01860482|Refractory Reflux Esophagitis|refractory reflux esophagitis
401876|NCT01860482|GERD|gerd
401877|NCT01860482|Phase 4|phase 4
401878|NCT01860456|Chronic myeloid leukemia|chronic myeloid leukemia
401879|NCT01860456|Imatinib|imatinib
401880|NCT01860456|Nilotinib|nilotinib
401881|NCT01860456|Polymorphism, Single Nucleotide|polymorphism, single nucleotide
401882|NCT01860456|Pharmacokinetics|pharmacokinetics
401883|NCT01860456|ATP-Binding Cassette Transporters|atp-binding cassette transporters
401884|NCT01860456|SLC Transporters|slc transporters
401885|NCT01860456|Treatment outcome|treatment outcome
401886|NCT01860456|Toxicity|toxicity
401887|NCT01860443|depression|depression
401888|NCT01860443|adolescents|adolescents
401889|NCT01860417|Degenerative Disc Disease,|degenerative disc disease,
401890|NCT01860417|Intervertebral Disc Disease|intervertebral disc disease
401891|NCT01860417|Low Back Pain|low back pain
401892|NCT01860417|Nucleus pulposus|nucleus pulposus
401893|NCT01860417|Stem cell|stem cell
401894|NCT01860417|Cellular therapy|cellular therapy
401895|NCT01860417|Regenerative therapy|regenerative therapy
401896|NCT01860417|Mesenchymal stem cells|mesenchymal stem cells
401897|NCT01860417|Bone marrow|bone marrow
401898|NCT01860417|Musculoskeletal Diseases|musculoskeletal diseases
401899|NCT01860417|Mesenchymal Stromal Cells (allogenic)|mesenchymal stromal cells (allogenic)
401900|NCT01860404|Concussion|concussion
401901|NCT01860404|Branched chain amino acids|branched chain amino acids
401902|NCT01860404|BCAA|bcaa
401903|NCT01860404|HIT HEADS|hit heads
401904|NCT01860391|Silver|silver
401905|NCT01860391|Fluoride|fluoride
401906|NCT01860391|Diammine Silver Fluoride|diammine silver fluoride
401907|NCT01860391|Saliva|saliva
401908|NCT01860378|Whooping Cough|whooping cough
401909|NCT01860378|Pertussis|pertussis
401910|NCT01860378|Tdap vaccination|tdap vaccination
401911|NCT01860378|Randomized placebo controlled factorial trial|randomized placebo controlled factorial trial
401912|NCT01860365|Quality of life|quality of life
401913|NCT01860365|Integrative medicine|integrative medicine
401914|NCT01860365|Supportive care|supportive care
401915|NCT01860365|Cancer|cancer
401916|NCT01860365|Chemotherapy|chemotherapy
401917|NCT01860352|Fish Oil|fish oil
401918|NCT01860352|colon health|colon health
401919|NCT01860352|fatty acid metabolism|fatty acid metabolism
401920|NCT01860339|Huntington's Disease|huntington's disease
401921|NCT01860339|HD|hd
401922|NCT01860339|Huntington Disease|huntington disease
401923|NCT01860326|hepatic impairment|hepatic impairment
401924|NCT01860326|mild and moderate hepatic impairment|mild and moderate hepatic impairment
401925|NCT01860326|Alisporivir|alisporivir
401926|NCT01860313|effectiveness|effectiveness
401927|NCT01860313|distance learning|distance learning
401928|NCT01860313|mental health|mental health
401929|NCT01860300|Tic Disorders|tic disorders
401930|NCT01860300|Tourette Syndrome|tourette syndrome
401931|NCT01860287|opioid|opioid
401932|NCT01860287|subjective|subjective
401933|NCT01860287|stress|stress
401934|NCT01860287|buprenorphine|buprenorphine
401935|NCT01860274|Mesh|mesh
401936|NCT01860274|Graft|graft
401937|NCT01860274|Patency|patency
401939|NCT01860261|AIDS|aids
401940|NCT01860261|sedentary|sedentary
401941|NCT01860261|fitness|fitness
401942|NCT01860261|aging|aging
401943|NCT01860261|V02max|v02max
401944|NCT01860261|d-dimer|d-dimer
401945|NCT01860261|IL-6|il-6
401946|NCT01860261|CRP|crp
401947|NCT01860261|ChiWalking|chiwalking
401948|NCT01860261|ChiRunning|chirunning
401949|NCT01860261|aerobic exercise|aerobic exercise
401950|NCT01860261|strength training|strength training
401951|NCT01860248|vapocoolant effectiveness|vapocoolant effectiveness
401952|NCT01860248|arterial puncture|arterial puncture
401953|NCT01860235|Local anesthesia|local anesthesia
401954|NCT01860235|Pain measurement|pain measurement
401955|NCT01860235|Pain perception|pain perception
401956|NCT01860235|Dental anesthesia|dental anesthesia
401957|NCT01860235|Root planing|root planing
401958|NCT01860222|Hepatocellular carcinoma|hepatocellular carcinoma
401959|NCT01860222|CSPH|csph
401960|NCT01860222|Hepatectomy|hepatectomy
401961|NCT01860222|percutaneous local ablative|percutaneous local ablative
401962|NCT01860222|therapy (PLAT)|therapy (plat)
401963|NCT01860222|randomized controlled trials(RCTs)|randomized controlled trials(rcts)
401964|NCT01860209|obstructive sleep apnea|obstructive sleep apnea
401965|NCT01860209|overhydration|overhydration
401966|NCT01860209|end stage renal disease|end stage renal disease
401967|NCT01860209|intermittent ambulatory hemodialysis|intermittent ambulatory hemodialysis
401968|NCT01860209|polysomnography|polysomnography
401969|NCT01860209|bioimpedance|bioimpedance
401970|NCT01860209|leg fluid shift|leg fluid shift
401971|NCT01860209|neck circumference|neck circumference
401972|NCT01860183|kidney transplantation|kidney transplantation
401973|NCT01860183|chronic allograft dysfunction|chronic allograft dysfunction
401974|NCT01860183|mycophenolate mofetil|mycophenolate mofetil
401975|NCT01860183|Chronic|chronic
401976|NCT01860170|Blood and Marrow Transplant (BMT)|blood and marrow transplant (bmt)
401977|NCT01860170|MRD|mrd
401978|NCT01860170|MUD|mud
401979|NCT01860170|GVHD|gvhd
401980|NCT01860157|rTMS|rtms
401981|NCT01860157|depression|depression
401982|NCT01860157|magnetic|magnetic
401983|NCT01860144|bevacizumab|bevacizumab
401984|NCT01860144|overall survival|overall survival
401985|NCT01860144|adverse events|adverse events
401986|NCT01860144|tumor resection rate|tumor resection rate
401987|NCT01860131|bariatrics, lifestyle and behavioral modification programs|bariatrics, lifestyle and behavioral modification programs
401988|NCT01860079|Early discharge|early discharge
401989|NCT01860079|STEMI|stemi
401990|NCT01860079|PPCI|ppci
401991|NCT01860066|COPD|copd
401992|NCT01860014|Pulmonary hemorrhage|pulmonary hemorrhage
401993|NCT01860014|Mortality|mortality
401994|NCT01860014|Newborn|newborn
401995|NCT01860001|cancer|cancer
401996|NCT01860001|metabolic acidosis|metabolic acidosis
401997|NCT01859988|Eczema|eczema
401998|NCT01859962|Liver diseases|liver diseases
401999|NCT01859962|Virus diseases|virus diseases
402000|NCT01859962|Ribavirin|ribavirin
402001|NCT01859962|protease inhibitor|protease inhibitor
402002|NCT01859962|NS5B polymerase inhibitor|ns5b polymerase inhibitor
402003|NCT01859962|NS5A inhibitor|ns5a inhibitor
402004|NCT01859949|Genotropin(somatropin)|genotropin(somatropin)
402005|NCT01859949|SGA|sga
514088|NCT01372657|iol|iol
402006|NCT01859949|Short Stature|short stature
402007|NCT01859949|Long-term|long-term
402008|NCT01859949|Safety|safety
402009|NCT01859923|Tuberculosis|tuberculosis
402010|NCT01859923|Tuberculosis, Multidrug-Resistant|tuberculosis, multidrug-resistant
402011|NCT01859923|Mycobacterium Infections|mycobacterium infections
402012|NCT01859923|Actinomycetales Infections|actinomycetales infections
402013|NCT01859923|Gram-Positive Infections|gram-positive infections
402014|NCT01859923|Bacterial Infections|bacterial infections
402015|NCT01859923|Pediatric|pediatric
402016|NCT01859884|Kidney transplantation|kidney transplantation
402017|NCT01859884|Increased risk donor kidneys|increased risk donor kidneys
402018|NCT01859884|Kidney donation|kidney donation
402019|NCT01859884|Organ donation|organ donation
402020|NCT01859884|Human Immunodeficiency Virus|human immunodeficiency virus
402021|NCT01859884|Hepatitis B|hepatitis b
402022|NCT01859884|Hepatitis C|hepatitis c
402023|NCT01859884|Infectious disease|infectious disease
402024|NCT01859884|Disease transmission|disease transmission
402025|NCT01859884|Centers for Disease Control (CDC)|centers for disease control (cdc)
402026|NCT01859884|Web-based intervention|web-based intervention
402027|NCT01859871|Living kidney donation|living kidney donation
402028|NCT01859871|End-stage renal disease|end-stage renal disease
402029|NCT01859871|Latinos|latinos
402030|NCT01859871|Undocumented Immigrants|undocumented immigrants
402031|NCT01859871|Bilingual|bilingual
402032|NCT01859871|Spanish|spanish
402033|NCT01859871|Website|website
402034|NCT01859871|Dialysis|dialysis
402035|NCT01859871|Hispanics|hispanics
402036|NCT01859871|Transplantation|transplantation
402037|NCT01859858|mCRC (metastatic colorectal cancer)|mcrc (metastatic colorectal cancer)
402038|NCT01859858|CRC (colorectal cancer)|crc (colorectal cancer)
402039|NCT01859858|Advanced colorectal cancer|advanced colorectal cancer
402040|NCT01859858|Metastatic colorectal cancer|metastatic colorectal cancer
402041|NCT01859858|Colon cancer|colon cancer
402042|NCT01859845|Melanoma|melanoma
402043|NCT01859845|Opportunistic surveillance|opportunistic surveillance
402044|NCT01859845|Melanoma simulation model|melanoma simulation model
402045|NCT01859845|Smartphone devices|smartphone devices
402046|NCT01859832|renal transplant|renal transplant
402047|NCT01859832|kidney transplantation|kidney transplantation
402048|NCT01859832|immune status|immune status
402049|NCT01859832|immunosuppressive medications|immunosuppressive medications
402050|NCT01859819|Pediatric|pediatric
402051|NCT01859819|Lymphoma (NOT primary mediastinal B-cell lymphoma)|lymphoma (not primary mediastinal b-cell lymphoma)
402052|NCT01859819|B-Cell---Burkitt's like|b-cell---burkitt's like
402053|NCT01859819|Rituximab|rituximab
402054|NCT01859819|Liposomal ARA-C|liposomal ara-c
402055|NCT01859806|periampullary tumour|periampullary tumour
402056|NCT01859806|isolated Roux loop PJ|isolated roux loop pj
402058|NCT01859793|dipeptidyl peptidase-4 inhibitor|dipeptidyl peptidase-4 inhibitor
402059|NCT01859793|endothelium, vascular|endothelium, vascular
402060|NCT01859793|diabetes type 2|diabetes type 2
402061|NCT01859793|nitric oxide|nitric oxide
402062|NCT01859793|inflammation|inflammation
402063|NCT01859780|Poison control|poison control
402064|NCT01859780|Child resistant packaging|child resistant packaging
402065|NCT01859780|prescription vials|prescription vials
402066|NCT01859780|prescription blisters|prescription blisters
402067|NCT01859780|drug packaging|drug packaging
402068|NCT01859767|Alzheimer's disease|alzheimer's disease
402069|NCT01859767|SPECT|spect
402070|NCT01859754|Primary Immune Deficiency Syndrome|primary immune deficiency syndrome
402071|NCT01859754|Primary immunodeficiency Disease (PIDD)|primary immunodeficiency disease (pidd)
402072|NCT01859754|PID|pid
402073|NCT01859741|Newly diagnosed Stage IV Small Cell Lung Cancer|newly diagnosed stage iv small cell lung cancer
402074|NCT01859728|biliary cancer|biliary cancer
402075|NCT01859728|irinotecan|irinotecan
402076|NCT01859728|cisplatin|cisplatin
402077|NCT01859728|gemcitabine|gemcitabine
402078|NCT01859715|Drug Interactions|drug interactions
402079|NCT01859715|CYP2D6|cyp2d6
402080|NCT01859715|opioid efficacy|opioid efficacy
402081|NCT01859715|pain|pain
402082|NCT01859715|nausea|nausea
402083|NCT01859702|Aqueous Humor|aqueous humor
402084|NCT01859702|Moxifloxacin|moxifloxacin
402085|NCT01859702|Vigadexa|vigadexa
402086|NCT01859663|Polycystic Ovary Syndrome (PCOS)|polycystic ovary syndrome (pcos)
402087|NCT01859663|Diet|diet
402088|NCT01859663|Exercise|exercise
402089|NCT01859663|Questionnaires|questionnaires
402090|NCT01859663|Health Beliefs|health beliefs
402091|NCT01859637|Filgrastim, immunogenicity, severe chronic neutropenia|filgrastim, immunogenicity, severe chronic neutropenia
402092|NCT01859624|LOPD|lopd
402093|NCT01859624|Pompe Disease|pompe disease
402094|NCT01859598|diabetes|diabetes
402095|NCT01859598|basal insulin|basal insulin
402096|NCT01859598|effectiveness and safety|effectiveness and safety
402097|NCT01859598|oral antidiabetic drugs|oral antidiabetic drugs
402098|NCT01859598|real world clinical practice|real world clinical practice
402099|NCT01859585|preemptive analgesia|preemptive analgesia
402100|NCT01859585|lumbar fusion|lumbar fusion
402101|NCT01859585|Parecoxib|parecoxib
402102|NCT01859585|Ketorolac|ketorolac
402103|NCT01859572|Stroke|stroke
402104|NCT01859572|Cerebral Infarction|cerebral infarction
402105|NCT01859572|Brain Disorders|brain disorders
402106|NCT01859572|Central Nervous System Diseases|central nervous system diseases
402107|NCT01859572|Nervous System Diseases|nervous system diseases
402108|NCT01859572|Vascular Diseases|vascular diseases
402109|NCT01859572|Cardiovascular Diseases|cardiovascular diseases
402110|NCT01859572|Brain Infarction|brain infarction
402111|NCT01859572|Brain Ischaemia|brain ischaemia
402112|NCT01859559|ultrasound|ultrasound
402113|NCT01859559|peripheral intravenous access|peripheral intravenous access
402114|NCT01859559|operator experience|operator experience
402115|NCT01859546|SMS|sms
402116|NCT01859520|Spermatozoa|spermatozoa
402117|NCT01859520|DNA fragmentation|dna fragmentation
402118|NCT01859520|Swim-up|swim-up
402119|NCT01859520|Density gradient|density gradient
402120|NCT01859507|Vaginismus|vaginismus
402121|NCT01859507|Botox|botox
402122|NCT01859507|Sex|sex
402123|NCT01859507|Clostridium|clostridium
402124|NCT01859507|Botulinum|botulinum
402125|NCT01859507|Neurotoxin|neurotoxin
402126|NCT01859507|Perineal|perineal
402127|NCT01859507|Muscles|muscles
402128|NCT01859455|Hypercholesterolemia,|hypercholesterolemia,
402129|NCT01859455|LDL cholesterol lowering,|ldl cholesterol lowering,
402130|NCT01859455|proprotein convertase subtilisin/kexin type 9 (PCSK9),|proprotein convertase subtilisin/kexin type 9 (pcsk9),
402131|NCT01859455|LGT209,|lgt209,
402132|NCT01859455|drug safety,|drug safety,
402133|NCT01859455|pharmacokinetics,|pharmacokinetics,
402134|NCT01859455|pharmacodynamics|pharmacodynamics
402135|NCT01859429|Cancer patients|cancer patients
402136|NCT01859429|Psycho-oncological Care Provision|psycho-oncological care provision
402137|NCT01859429|Structured Screening|structured screening
402138|NCT01859429|Stepped care|stepped care
402139|NCT01859403|veteran|veteran
402140|NCT01859403|obesity|obesity
402141|NCT01859403|personalized genomics|personalized genomics
402142|NCT01859390|Antioxidants|antioxidants
402143|NCT01859390|Vitamins|vitamins
402144|NCT01859390|Inflammation|inflammation
402145|NCT01859390|Oxidative stress|oxidative stress
402146|NCT01859364|Tobacco|tobacco
402147|NCT01859364|Smoking|smoking
402148|NCT01859364|Smoking Cessation|smoking cessation
402149|NCT01859364|Outcome|outcome
402150|NCT01859364|Nicotine Dependence|nicotine dependence
402151|NCT01859325|HIV-MAG pDNA Prime|hiv-mag pdna prime
402152|NCT01859325|HIV Therapy|hiv therapy
402153|NCT01859325|Therapeutic Vaccine|therapeutic vaccine
402154|NCT01859312|Glucocorticoids|glucocorticoids
402155|NCT01859312|Adrenal Insufficiency|adrenal insufficiency
402156|NCT01859312|Congenital Adrenal Hyperplasia (CAH)|congenital adrenal hyperplasia (cah)
402157|NCT01859312|Adrenal|adrenal
402158|NCT01859299|Oral Tolerance|oral tolerance
402159|NCT01859299|Uveitis|uveitis
402160|NCT01859299|AMD|amd
402161|NCT01859273|renal failure|renal failure
402162|NCT01859273|medication adherence|medication adherence
402163|NCT01859273|hypertension|hypertension
402164|NCT01859260|chronic kidney disease, acute kidney injury, obstructive sleep apnea|chronic kidney disease, acute kidney injury, obstructive sleep apnea
402165|NCT01859247|cervical dystonia|cervical dystonia
402166|NCT01859247|torticollis|torticollis
402167|NCT01859247|rTMS|rtms
402168|NCT01859234|multiple myeloma|multiple myeloma
402169|NCT01859234|PET scan|pet scan
402170|NCT01859221|Prostate cancer|prostate cancer
402171|NCT01859221|Oligometastatic prostate cancer|oligometastatic prostate cancer
402172|NCT01859221|Proton radiation|proton radiation
402173|NCT01859195|HIV/STI|hiv/sti
402174|NCT01859195|Prevention|prevention
402175|NCT01859195|Microbicides, Topical|microbicides, topical
402176|NCT01859169|bili duct neoplasms|bili duct neoplasms
402177|NCT01859169|bile duct cancer|bile duct cancer
402178|NCT01859169|photodynamic therapy|photodynamic therapy
402179|NCT01859169|biliary drainage|biliary drainage
402180|NCT01859156|Carbon Monoxide|carbon monoxide
402181|NCT01859156|Carboxyhemoglobin|carboxyhemoglobin
402182|NCT01859156|End-tidal carbon dioxide|end-tidal carbon dioxide
402183|NCT01859156|Capnography|capnography
402184|NCT01859143|Trivalent|trivalent
402185|NCT01859143|Influenza|influenza
402186|NCT01859143|FluMist Quadrivalent|flumist quadrivalent
402187|NCT01859143|Vaccine|vaccine
402188|NCT01859143|Prevention|prevention
402189|NCT01859143|Healthy|healthy
402190|NCT01859117|Peripheral arterial disease|peripheral arterial disease
402191|NCT01859117|diabetic foot|diabetic foot
402192|NCT01859091|Lipolysis|lipolysis
402193|NCT01859091|Cryolipolysis|cryolipolysis
402194|NCT01859091|Fat Reduction|fat reduction
402195|NCT01859065|Non-urgent ED visits|non-urgent ed visits
402196|NCT01859065|Neonates|neonates
402197|NCT01859065|Newborn care|newborn care
402198|NCT01859052|migraine|migraine
402199|NCT01859052|obesity|obesity
402200|NCT01859052|low fat diet|low fat diet
402201|NCT01859052|low carbohydrate diet|low carbohydrate diet
514298|NCT01371734|MDD|mdd
402202|NCT01859039|Egg allergy|egg allergy
402203|NCT01859039|Anaphylaxis|anaphylaxis
402204|NCT01859039|Children|children
402205|NCT01859039|Influenza vaccine|influenza vaccine
402206|NCT01859026|Epidermal growth factor receptor (EGFR)|epidermal growth factor receptor (egfr)
402207|NCT01859026|EGFR mutation|egfr mutation
402208|NCT01859026|Kirsten rat sarcoma 2 viral oncogene homolog(KRAS)|kirsten rat sarcoma 2 viral oncogene homolog(kras)
402209|NCT01859026|KRAS mutation|kras mutation
402210|NCT01859026|Non-Small Cell Lung Cancer (NSCLC)|non-small cell lung cancer (nsclc)
402211|NCT01859026|Advanced-stage IV|advanced-stage iv
402212|NCT01859000|Adolescents|adolescents
402213|NCT01859000|Hurricane Katrina|hurricane katrina
402214|NCT01859000|Family-based treatment|family-based treatment
402215|NCT01859000|Multidimensional Family Therapy|multidimensional family therapy
402216|NCT01859000|Group CBT|group cbt
402217|NCT01858974|multiplex PCR|multiplex pcr
402218|NCT01858974|MALDI-TOF|maldi-tof
402219|NCT01858974|pneumonia|pneumonia
402220|NCT01858974|microbiological investigation|microbiological investigation
402221|NCT01858974|intensive care|intensive care
402222|NCT01858948|Bipolar disorder|bipolar disorder
402223|NCT01858948|Second-generation antipsychotics|second-generation antipsychotics
402224|NCT01858948|Obesity|obesity
402225|NCT01858948|Cardiometabolic risk|cardiometabolic risk
402226|NCT01858922|Hodgkin's Lymphoma|hodgkin's lymphoma
402227|NCT01858922|ABVE-PC|abve-pc
402228|NCT01858922|doxorubicin|doxorubicin
402229|NCT01858922|bleomycin|bleomycin
402230|NCT01858922|vincristine|vincristine
402231|NCT01858922|etoposide|etoposide
402232|NCT01858922|prednisone|prednisone
402233|NCT01858922|cyclophosphamide|cyclophosphamide
402234|NCT01858922|DECA|deca
402235|NCT01858922|decadron|decadron
402236|NCT01858922|cisplatin|cisplatin
402237|NCT01858922|cytarabine|cytarabine
402238|NCT01858922|Radiation|radiation
402239|NCT01858909|Sepsis|sepsis
402240|NCT01858896|hypoglycemia|hypoglycemia
402241|NCT01858896|GLP-1|glp-1
402242|NCT01858896|Type 2 diabetes|type 2 diabetes
402243|NCT01858896|endothelial function|endothelial function
402244|NCT01858870|Lacosamide|lacosamide
402245|NCT01858870|Partial Crisis|partial crisis
402246|NCT01858857|geriatric psychiatry|geriatric psychiatry
402247|NCT01858857|pharmacovigilance|pharmacovigilance
402248|NCT01858818|CAIS Computer Assisted Infusion System|cais computer assisted infusion system
402249|NCT01858818|real life drinking behavior|real life drinking behavior
402250|NCT01858818|family history of alcoholism|family history of alcoholism
402251|NCT01858818|conditioning|conditioning
402252|NCT01858818|instrumental learning|instrumental learning
402253|NCT01858818|habitization|habitization
402254|NCT01858805|esophagus carcinoma|esophagus carcinoma
402255|NCT01858805|surgery|surgery
402256|NCT01858805|circulating tumor cells|circulating tumor cells
402257|NCT01858779|stroke|stroke
402258|NCT01858779|atrial fibrillation|atrial fibrillation
402259|NCT01858779|secondary prevention of stroke|secondary prevention of stroke
402260|NCT01858779|peripheral pulse measurement|peripheral pulse measurement
402261|NCT01858766|Hepatitis|hepatitis
402262|NCT01858766|HCV Genotype 1|hcv genotype 1
402263|NCT01858766|HCV Genotype 2|hcv genotype 2
402264|NCT01858766|HCV Genotype 3|hcv genotype 3
402265|NCT01858766|HCV Genotype 4|hcv genotype 4
402266|NCT01858766|HCV Genotype 5|hcv genotype 5
402267|NCT01858766|HCV Genotype 6|hcv genotype 6
402268|NCT01858766|treatment naive|treatment naive
402269|NCT01858753|burn scars|burn scars
402270|NCT01858753|restrictive|restrictive
402271|NCT01858753|contractures|contractures
402272|NCT01858753|autologous fibroblasts|autologous fibroblasts
402273|NCT01858727|forced-air|forced-air
402274|NCT01858727|hypothermia|hypothermia
402275|NCT01858727|TUR-P surgery|tur-p surgery
402276|NCT01858727|core temperatures|core temperatures
402277|NCT01858727|prewarming|prewarming
402278|NCT01858727|general anaesthesia|general anaesthesia
402279|NCT01858714|obesity|obesity
402280|NCT01858714|overweight|overweight
402281|NCT01858714|weight loss|weight loss
402282|NCT01858701|myopia|myopia
402283|NCT01858701|hyperopia|hyperopia
402284|NCT01858701|astigmatism|astigmatism
402285|NCT01858701|contact lenses|contact lenses
402286|NCT01858688|Prostate Cancer|prostate cancer
402287|NCT01858688|MRI|mri
402288|NCT01858688|Active surveillance in prostate cancer|active surveillance in prostate cancer
402289|NCT01858675|ProADM|proadm
402290|NCT01858675|ProANP|proanp
402291|NCT01858675|proendothelin|proendothelin
402292|NCT01858675|proAVP|proavp
402293|NCT01858675|Cr 51|cr 51
402294|NCT01858675|Volemia|volemia
402295|NCT01858675|fluid management|fluid management
402296|NCT01858675|ICU patients|icu patients
402297|NCT01858675|poly trauma patients|poly trauma patients
402298|NCT01858662|metastatic colorectal cancer|metastatic colorectal cancer
402299|NCT01858662|Liver|liver
402300|NCT01858662|cetuximab|cetuximab
402301|NCT01858662|Pathological response|pathological response
402302|NCT01858649|metastatic|metastatic
402303|NCT01858649|colorectal|colorectal
402304|NCT01858649|cancer|cancer
402305|NCT01858649|liver|liver
402306|NCT01858649|Bevacizumab|bevacizumab
402307|NCT01858649|Pathological response|pathological response
402308|NCT01858623|Healthy Normotensive Participants|healthy normotensive participants
402309|NCT01858623|Fixed dose combination|fixed dose combination
402310|NCT01858623|Pharmacokinetics|pharmacokinetics
402311|NCT01858623|Losartan|losartan
402312|NCT01858623|Hydrochlorothiazide|hydrochlorothiazide
402313|NCT01858610|Fixed dose combination|fixed dose combination
402314|NCT01858610|Pharmacokinetics|pharmacokinetics
402315|NCT01858610|Irbesartan|irbesartan
402316|NCT01858610|Hydrochlorothiazide|hydrochlorothiazide
402317|NCT01858610|Pharmacodynamics|pharmacodynamics
402318|NCT01858610|Normotensive Participants|normotensive participants
402319|NCT01858597|GDM, FGF|gdm, fgf
402320|NCT01858584|GER|ger
402321|NCT01858584|Alginate|alginate
402322|NCT01858584|Regurgitation|regurgitation
402323|NCT01858584|questionnaire|questionnaire
402324|NCT01858571|Childhood Cancer|childhood cancer
402325|NCT01858532|Diabetes|diabetes
402326|NCT01858532|Nephropathy|nephropathy
402327|NCT01858519|pancreatic enzyme replacement therapy|pancreatic enzyme replacement therapy
402328|NCT01858519|antibodies|antibodies
402329|NCT01858519|porcine viruses|porcine viruses
402330|NCT01858519|epidemiology|epidemiology
402331|NCT01858519|prospective|prospective
402332|NCT01858506|Type 2 diabetes mellitus|type 2 diabetes mellitus
402333|NCT01858506|Lifestyle counselling|lifestyle counselling
402334|NCT01858506|Lifestyle assessment|lifestyle assessment
402335|NCT01858506|Randomized controlled trial|randomized controlled trial
402336|NCT01858506|Diabetes education|diabetes education
402337|NCT01858493|Urinary incontinence|urinary incontinence
402339|NCT01858493|Quality of life|quality of life
402340|NCT01858493|Stigma|stigma
402341|NCT01858493|Community-dwelling older women|community-dwelling older women
402342|NCT01858493|Continence promotion|continence promotion
402343|NCT01858480|CHF|chf
402344|NCT01858467|Airway, Cesarean|airway, cesarean
402345|NCT01858402|Pediatric spinal anesthesia, paracetamol, dipyrone|pediatric spinal anesthesia, paracetamol, dipyrone
402346|NCT01858389|Non-small cell lung cancer|non-small cell lung cancer
402347|NCT01858389|T790M mutation. dacomitinib|t790m mutation. dacomitinib
402348|NCT01858376|LDL cholesterol|ldl cholesterol
402349|NCT01858376|anti-hyperlipidemic|anti-hyperlipidemic
402350|NCT01858376|hyperlipidemic|hyperlipidemic
402351|NCT01858376|Capros|capros
402352|NCT01858376|Natural Supplement|natural supplement
402353|NCT01858363|Peripheral arterial disease|peripheral arterial disease
402354|NCT01858363|claudication|claudication
402355|NCT01858363|drug-coated balloon|drug-coated balloon
402356|NCT01858363|drug-eluting balloon|drug-eluting balloon
402357|NCT01858350|CAM|cam
402358|NCT01858350|Sedation|sedation
402359|NCT01858350|MRI|mri
402360|NCT01858350|Music Therapy|music therapy
402361|NCT01858337|weaning|weaning
402362|NCT01858337|infants|infants
402363|NCT01858337|vegetables|vegetables
402364|NCT01858337|repeated-exposure|repeated-exposure
402365|NCT01858324|Preeclampsia|preeclampsia
402366|NCT01858324|Hypertensive disorders of pregnancy|hypertensive disorders of pregnancy
402367|NCT01858324|Patient education|patient education
402368|NCT01858324|Educationnal tools|educationnal tools
402369|NCT01858324|Pamphlet|pamphlet
402370|NCT01858324|Video|video
402371|NCT01858324|Knowledge|knowledge
402372|NCT01858324|Anxiety|anxiety
402373|NCT01858324|Satisfaction|satisfaction
402374|NCT01858311|Stroke survivors|stroke survivors
402375|NCT01858311|TIA survivors|tia survivors
402376|NCT01858311|Vitamin E|vitamin e
402377|NCT01858311|Carotech|carotech
402378|NCT01858311|Tocotrienol|tocotrienol
402379|NCT01858298|Dental caries|dental caries
402380|NCT01858298|Quality of Life|quality of life
402381|NCT01858298|Pulpectomy|pulpectomy
402382|NCT01858298|Tooth extraction|tooth extraction
402383|NCT01858285|Epilepsy|epilepsy
402384|NCT01858285|Ohtahara|ohtahara
402385|NCT01858285|Dravet|dravet
402386|NCT01858285|MMPEI|mmpei
402387|NCT01858285|EMEE|emee
402388|NCT01858285|EIEE|eiee
402389|NCT01858246|Hearing Loss, Conductive|hearing loss, conductive
402390|NCT01858246|Bone Conduction|bone conduction
402391|NCT01858246|bone conduction thresholds better than 45 dBHL|bone conduction thresholds better than 45 dbhl
402392|NCT01858233|Gestational diabetes|gestational diabetes
402393|NCT01858220|Gastroparesis|gastroparesis
402394|NCT01858220|Small bowel video capsule|small bowel video capsule
402395|NCT01858220|gastric retention|gastric retention
402396|NCT01858207|HCC|hcc
402397|NCT01858207|hepatocellular carcinoma|hepatocellular carcinoma
402398|NCT01858207|liver cancer|liver cancer
402399|NCT01858194|Tachycardia, Renal Sympathetic Denervation|tachycardia, renal sympathetic denervation
402400|NCT01858194|Catheter Ablation|catheter ablation
402401|NCT01858194|Cardioverter-Defibrillator|cardioverter-defibrillator
402402|NCT01858142|Pediatric anesthesia|pediatric anesthesia
402403|NCT01858142|Pre-operative anxiety|pre-operative anxiety
402404|NCT01858142|parental presence|parental presence
402405|NCT01858142|children|children
402406|NCT01858142|elective surgical procedures|elective surgical procedures
402407|NCT01858142|mask induction|mask induction
402408|NCT01858129|TTN|ttn
402409|NCT01858103|Mucopolysaccharidosis IVA Type A|mucopolysaccharidosis iva type a
402410|NCT01858103|MPS IVA Type A|mps iva type a
402411|NCT01858103|Mucopolysaccharidosis IVA|mucopolysaccharidosis iva
402412|NCT01858103|MPS IVA|mps iva
402413|NCT01858103|Morquio A Syndrome|morquio a syndrome
402414|NCT01858103|Lysosomal Storage Disorder|lysosomal storage disorder
402415|NCT01858103|LSD|lsd
402416|NCT01858103|N-acetylgalactosamine-6-sulfatase|n-acetylgalactosamine-6-sulfatase
402417|NCT01858103|N-acetylgalactosamine-6-sulfate|n-acetylgalactosamine-6-sulfate
402418|NCT01858090|spinal anesthesia|spinal anesthesia
402419|NCT01858090|caesarean section|caesarean section
402420|NCT01858090|local anesthetics|local anesthetics
402421|NCT01858090|levobupivacaine|levobupivacaine
402422|NCT01858090|sufentanil|sufentanil
402423|NCT01858090|fentanyl|fentanyl
402424|NCT01858090|above 18 years of age|above 18 years of age
402425|NCT01858090|pregnant women|pregnant women
402426|NCT01858090|multiparous|multiparous
402427|NCT01858090|nulliparous|nulliparous
402428|NCT01858064|ADHD|adhd
402429|NCT01858064|OROS-MPH|oros-mph
402430|NCT01858064|Adults|adults
402431|NCT01858064|Functional Magnetic Resonance Imaging|functional magnetic resonance imaging
402432|NCT01858051|Vitamin D|vitamin d
402433|NCT01858051|Perioperative immune regulation|perioperative immune regulation
402434|NCT01858051|LL-37|ll-37
402435|NCT01858051|Hospital-acquired infection|hospital-acquired infection
402436|NCT01858051|Surgical site infections|surgical site infections
402437|NCT01858038|Scar|scar
402438|NCT01858012|insulin resistance|insulin resistance
402439|NCT01857999|Renin-aldosterone system|renin-aldosterone system
402440|NCT01857999|Hemodynamic|hemodynamic
402441|NCT01857999|Low cardiac output|low cardiac output
402442|NCT01857999|Vasodilation|vasodilation
402443|NCT01857999|Natriuretic peptide|natriuretic peptide
402444|NCT01857986|Endotracheal intubation|endotracheal intubation
402445|NCT01857986|Mechanical ventilation|mechanical ventilation
402446|NCT01857986|Critical care|critical care
402447|NCT01857973|HCL|hcl
402448|NCT01857973|Type 1 Diabetes|type 1 diabetes
402449|NCT01857973|Sensor|sensor
402450|NCT01857960|Acne|acne
402451|NCT01857960|Treatment|treatment
402452|NCT01857960|Cost|cost
402453|NCT01857960|Behavior|behavior
402454|NCT01857947|AECOPD Mr ProADM Biomarkers ER Outcome|aecopd mr proadm biomarkers er outcome
402455|NCT01857934|Anti-GD2 monoclonal antibody|anti-gd2 monoclonal antibody
402456|NCT01857934|hu14.18K322A|hu14.18k322a
402457|NCT01857934|High-risk neuroblastoma|high-risk neuroblastoma
402458|NCT01857934|Phase II|phase ii
402459|NCT01857934|Allogeneic NK cells|allogeneic nk cells
402460|NCT01857908|Adenocarcinoma|adenocarcinoma
402461|NCT01857908|Abiraterone|abiraterone
402462|NCT01857908|Abiraterone Acetate|abiraterone acetate
402463|NCT01857908|Zytiga|zytiga
402464|NCT01857908|Correlative study|correlative study
402465|NCT01857908|Castrate Resistant Prostate Cancer|castrate resistant prostate cancer
402466|NCT01857908|Abiraterone Correlative study|abiraterone correlative study
402467|NCT01857895|Nausea|nausea
402468|NCT01857895|subcutaneous infusion|subcutaneous infusion
402469|NCT01857895|exenatide|exenatide
402470|NCT01857882|breast cancer|breast cancer
402471|NCT01857882|breast reconstruction|breast reconstruction
402472|NCT01857882|shared decision making|shared decision making
402473|NCT01857882|decision support intervention|decision support intervention
402474|NCT01857869|Efficacy|efficacy
402475|NCT01857869|Sporozoite challenge model|sporozoite challenge model
402476|NCT01857869|Malaria|malaria
402477|NCT01857869|Immunogenicity|immunogenicity
402478|NCT01857869|Malaria- naïve adults|malaria- naïve adults
402479|NCT01857869|Safety|safety
402480|NCT01857856|Phospholamban|phospholamban
402481|NCT01857856|cardiomyopathy|cardiomyopathy
402482|NCT01857856|Eplerenone|eplerenone
402483|NCT01857856|presymptomatic|presymptomatic
402484|NCT01857830|Telomerase|telomerase
402485|NCT01857830|Telomere Length|telomere length
402486|NCT01857830|Psychological Stress|psychological stress
402487|NCT01857830|Amyloid beta proteins|amyloid beta proteins
402488|NCT01857830|Meditation|meditation
402489|NCT01857804|peri-implantitis|peri-implantitis
402490|NCT01857804|surgical therapy|surgical therapy
402491|NCT01857804|systemic antibiotics|systemic antibiotics
402492|NCT01857804|local antiseptics|local antiseptics
402493|NCT01857778|Breastfeeding|breastfeeding
402494|NCT01857778|Breast tissue|breast tissue
402495|NCT01857778|Breast pump|breast pump
402496|NCT01857765|rehabilitation|rehabilitation
402497|NCT01857765|reconstructive surgery|reconstructive surgery
402498|NCT01857752|Retinoblastoma|retinoblastoma
402499|NCT01857726|hepatocellular carcinoma|hepatocellular carcinoma
402500|NCT01857726|portal vein invasion|portal vein invasion
402501|NCT01857726|transarterial chemoembolization|transarterial chemoembolization
514687|NCT01370057|AIS|ais
402502|NCT01857726|transarterial chemoinfusion|transarterial chemoinfusion
402503|NCT01857674|Laryngeal edema|laryngeal edema
402504|NCT01857674|Post-extubation|post-extubation
402505|NCT01857674|Acute respiratory distress|acute respiratory distress
402506|NCT01857674|Ultrasonography|ultrasonography
402507|NCT01857674|Intensive care unit|intensive care unit
402508|NCT01857661|tinnitus|tinnitus
402509|NCT01857661|hearing loss|hearing loss
402510|NCT01857661|hearing devices|hearing devices
402511|NCT01857648|Physical Activity|physical activity
402512|NCT01857648|Health Promotion|health promotion
402513|NCT01857648|Primary Health Care|primary health care
402514|NCT01857648|Intervention Studies|intervention studies
402515|NCT01857648|Public health Practice|public health practice
402516|NCT01857635|Acute respiratory failure|acute respiratory failure
402517|NCT01857635|Hypercapnia|hypercapnia
402518|NCT01857635|Non invasive ventilation|non invasive ventilation
402519|NCT01857635|Transcutaneous CO2 measurement|transcutaneous co2 measurement
402520|NCT01857622|anticoagulant|anticoagulant
402521|NCT01857622|DU-176b|du-176b
402522|NCT01857622|edoxaban|edoxaban
402523|NCT01857622|factor Xa|factor xa
402524|NCT01857622|oral|oral
402525|NCT01857622|atrial fibrillation|atrial fibrillation
402526|NCT01857622|severe renal impairment|severe renal impairment
402527|NCT01857609|Metformin|metformin
402528|NCT01857609|Proton pump inhibitor|proton pump inhibitor
402529|NCT01857609|Drug interaction|drug interaction
402530|NCT01857596|Female Sexual Dysfunction|female sexual dysfunction
402738|NCT01857089|prevention|prevention
402531|NCT01857596|Hypoactive Sexual Desire Disorder|hypoactive sexual desire disorder
402532|NCT01857596|Sexual Interest/Arousal Disorder|sexual interest/arousal disorder
402533|NCT01857596|Lorexys|lorexys
402534|NCT01857596|Premenopausal female health|premenopausal female health
402535|NCT01857583|anticoagulant|anticoagulant
402536|NCT01857583|DU-176b|du-176b
402537|NCT01857583|edoxaban|edoxaban
402538|NCT01857583|factor Xa|factor xa
402539|NCT01857583|oral|oral
402540|NCT01857583|orthopedic surgery of lower limbs|orthopedic surgery of lower limbs
402541|NCT01857583|severe renal impairment|severe renal impairment
402542|NCT01857570|Radius fracture|radius fracture
402543|NCT01857570|Scaphoid fracture|scaphoid fracture
402544|NCT01857570|Tomography, x-ray computed|tomography, x-ray computed
402545|NCT01857557|Exercise|exercise
402546|NCT01857557|Fitness program|fitness program
402547|NCT01857544|Retinal Vein Occlusion|retinal vein occlusion
402548|NCT01857544|Central Retinal Vein Occlusion|central retinal vein occlusion
402549|NCT01857544|Macular Edema|macular edema
402550|NCT01857531|Smoking Cessation|smoking cessation
402551|NCT01857531|Quit Smoking|quit smoking
402552|NCT01857531|Ganaxolone|ganaxolone
402553|NCT01857531|Nicotine Patch|nicotine patch
402554|NCT01857505|Total Hip replacement|total hip replacement
402555|NCT01857505|Fracture table|fracture table
402556|NCT01857505|DePuySynthes|depuysynthes
402557|NCT01857505|Direct anterior approach hip replacement|direct anterior approach hip replacement
402558|NCT01857505|Posterior approach hip replacement|posterior approach hip replacement
402559|NCT01857492|abdominal pain|abdominal pain
402560|NCT01857492|pancreatitis|pancreatitis
402561|NCT01857492|chronic abdominal pain|chronic abdominal pain
402562|NCT01857492|visceral pain|visceral pain
402563|NCT01857492|meditation|meditation
402564|NCT01857492|tDCS|tdcs
402565|NCT01857492|noninvasive brain stimulation|noninvasive brain stimulation
402566|NCT01857492|EEG|eeg
402567|NCT01857492|Kirtan Kriya|kirtan kriya
402568|NCT01857479|ABPA|abpa
402569|NCT01857453|Adult Patients Medulloblatoma Standard risk group Chemotherapy Radiotherapy Quality of Life|adult patients medulloblatoma standard risk group chemotherapy radiotherapy quality of life
402570|NCT01857440|Glaucoma|glaucoma
402571|NCT01857440|Pupil|pupil
402572|NCT01857440|Melanopsin|melanopsin
402573|NCT01857388|school-based program, mental health, implementation|school-based program, mental health, implementation
402574|NCT01857375|Diabetes - insulin administration|diabetes - insulin administration
402575|NCT01857362|Orfadin|orfadin
402576|NCT01857362|Nitisinone|nitisinone
402577|NCT01857362|Bioequivalence|bioequivalence
402578|NCT01857349|Efficacy|efficacy
402579|NCT01857349|surgical scrubs|surgical scrubs
402580|NCT01857349|Total Knee Arthroplasty|total knee arthroplasty
402581|NCT01857323|asthma|asthma
402582|NCT01857323|chronic obstructive pulmonary disease|chronic obstructive pulmonary disease
402583|NCT01857323|COPD|copd
402584|NCT01857323|Albuterol Spiromax®|albuterol spiromax®
402585|NCT01857310|Folic Acid|folic acid
402586|NCT01857310|Zinc|zinc
402587|NCT01857310|Semen|semen
402588|NCT01857310|In vitro fertilization|in vitro fertilization
402589|NCT01857310|Assisted reproductive technology|assisted reproductive technology
402590|NCT01857310|Ovulation induction|ovulation induction
402591|NCT01857310|Intrauterine insemination|intrauterine insemination
402592|NCT01857310|Pregnancy|pregnancy
402593|NCT01857310|Live Birth|live birth
402594|NCT01857310|Abortion, spontaneous|abortion, spontaneous
402595|NCT01857284|Tauroursodeoxycholic Acid|tauroursodeoxycholic acid
402596|NCT01857284|Primary Biliary Cirrhosis|primary biliary cirrhosis
402597|NCT01857284|Safety|safety
402598|NCT01857284|Efficacy|efficacy
402599|NCT01857258|green tea|green tea
402600|NCT01857258|catechins|catechins
402601|NCT01857258|vascular endothelial function|vascular endothelial function
402602|NCT01857258|postprandial hyperglycemia|postprandial hyperglycemia
402603|NCT01857258|oxidative stress|oxidative stress
402604|NCT01857245|addiction|addiction
402605|NCT01857245|Adherence (attribute)|adherence (attribute)
402606|NCT01857245|Adverse effects|adverse effects
402607|NCT01857245|Agonist|agonist
402608|NCT01857245|Antiviral Agents|antiviral agents
402609|NCT01857245|arm|arm
402610|NCT01857245|base|base
402611|NCT01857245|care delivery|care delivery
402612|NCT01857245|Caring|caring
402613|NCT01857245|Chronic Hepatitis C|chronic hepatitis c
402614|NCT01857245|Clinic|clinic
402615|NCT01857245|Clinical Trials|clinical trials
402616|NCT01857245|Complex|complex
402617|NCT01857245|Computer Simulation|computer simulation
402618|NCT01857245|cost|cost
402619|NCT01857245|cost effective|cost effective
402620|NCT01857245|cost effectiveness|cost effectiveness
402621|NCT01857245|Data|data
402622|NCT01857245|Development|development
402623|NCT01857245|Directly Observed Therapy|directly observed therapy
402624|NCT01857245|Disease|disease
402625|NCT01857245|Dose|dose
402626|NCT01857245|Drug resistance|drug resistance
402627|NCT01857245|drug resistant virus|drug resistant virus
402628|NCT01857245|Educational aspects|educational aspects
402629|NCT01857245|Epidemic|epidemic
402630|NCT01857245|experience|experience
402631|NCT01857245|Frequencies (time pattern)|frequencies (time pattern)
402632|NCT01857245|Fright|fright
402633|NCT01857245|Genotype|genotype
402634|NCT01857245|Group Therapy|group therapy
402635|NCT01857245|Health Care Costs|health care costs
402636|NCT01857245|Health Personnel|health personnel
402637|NCT01857245|Healthcare Systems|healthcare systems
402638|NCT01857245|Hepatitis C|hepatitis c
402639|NCT01857245|Hepatitis C Prevalence|hepatitis c prevalence
402640|NCT01857245|Hepatitis C Transmission|hepatitis c transmission
402641|NCT01857245|Hepatitis C virus|hepatitis c virus
402642|NCT01857245|HIV|hiv
402643|NCT01857245|Homelessness|homelessness
402644|NCT01857245|improved|improved
402645|NCT01857245|Incidence|incidence
402646|NCT01857245|Infection|infection
402647|NCT01857245|Injecting drug user|injecting drug user
402648|NCT01857245|Injection of therapeutic agent|injection of therapeutic agent
402649|NCT01857245|Intensive Care|intensive care
402650|NCT01857245|Interferons|interferons
402651|NCT01857245|Intervention|intervention
402652|NCT01857245|Knowledge|knowledge
402653|NCT01857245|Life|life
402654|NCT01857245|Liver diseases|liver diseases
402655|NCT01857245|Liver Failure|liver failure
402656|NCT01857245|liver transplantation|liver transplantation
402657|NCT01857245|Living Costs|living costs
402658|NCT01857245|Mental disorders|mental disorders
402659|NCT01857245|Methadone|methadone
402660|NCT01857245|methadone clinic/center|methadone clinic/center
402661|NCT01857245|Modeling|modeling
402662|NCT01857245|Mortality Vital Statistics|mortality vital statistics
402663|NCT01857245|Motivation|motivation
402664|NCT01857245|multidisciplinary|multidisciplinary
402665|NCT01857245|Opiates|opiates
402666|NCT01857245|Oral|oral
402667|NCT01857245|Outcome|outcome
402668|NCT01857245|Patients|patients
402669|NCT01857245|Persons|persons
402670|NCT01857245|Pharmaceutical Preparations|pharmaceutical preparations
402671|NCT01857245|Physicians|physicians
402672|NCT01857245|pill (pharmacologic)|pill (pharmacologic)
402673|NCT01857245|Play|play
402674|NCT01857245|Poverty|poverty
402675|NCT01857245|Primary Health Care|primary health care
402676|NCT01857245|programs|programs
402677|NCT01857245|Psychiatric therapeutic procedure|psychiatric therapeutic procedure
402678|NCT01857245|psychosocial|psychosocial
402679|NCT01857245|Publishing|publishing
402680|NCT01857245|Quality-Adjusted Life Years|quality-adjusted life years
402681|NCT01857245|Randomized|randomized
402682|NCT01857245|Randomized Controlled Trials|randomized controlled trials
402683|NCT01857245|randomized trial|randomized trial
402684|NCT01857245|Recruitment Activity|recruitment activity
402685|NCT01857245|Regimen|regimen
402686|NCT01857245|Resistance|resistance
402687|NCT01857245|Resistance development|resistance development
402688|NCT01857245|response|response
402689|NCT01857245|Risk|risk
402690|NCT01857245|risk perception|risk perception
402691|NCT01857245|Role|role
402692|NCT01857245|Site|site
402693|NCT01857245|skills|skills
402694|NCT01857245|Social support|social support
402695|NCT01857245|standard care|standard care
402696|NCT01857245|substance abuse treatment|substance abuse treatment
402697|NCT01857245|success|success
402698|NCT01857245|Time|time
402699|NCT01857245|Treatment outcome|treatment outcome
402700|NCT01857245|Treatment Protocols|treatment protocols
402701|NCT01857245|treatment site|treatment site
402702|NCT01857245|Trust|trust
402703|NCT01857245|United States|united states
402704|NCT01857245|Viral|viral
402705|NCT01857245|Virus|virus
402706|NCT01857219|fMRI|fmri
402707|NCT01857206|Influenza|influenza
402708|NCT01857206|children and adolescents|children and adolescents
402709|NCT01857206|trivalent vaccine|trivalent vaccine
402710|NCT01857206|cell culture|cell culture
402711|NCT01857206|embryonated chicken eggs|embryonated chicken eggs
402712|NCT01857193|Open label|open label
402713|NCT01857193|dose escalation|dose escalation
402714|NCT01857193|ER+|er+
402715|NCT01857193|LEE011|lee011
402716|NCT01857193|CDK4/6|cdk4/6
402717|NCT01857193|everolimus|everolimus
402718|NCT01857193|advanced breast cancer|advanced breast cancer
402719|NCT01857193|mTOR|mtor
402720|NCT01857193|HR positive|hr positive
402721|NCT01857193|HER2 negative|her2 negative
402722|NCT01857167|omega-3 fatty acids|omega-3 fatty acids
402723|NCT01857167|randomized controlled trial|randomized controlled trial
402724|NCT01857154|Bone mineral density|bone mineral density
402725|NCT01857154|Bone mineral content|bone mineral content
402726|NCT01857154|Bone density|bone density
402727|NCT01857154|Bone health|bone health
402728|NCT01857154|Dual-energy x-ray absorptiometry|dual-energy x-ray absorptiometry
402729|NCT01857141|dexmedetomidine|dexmedetomidine
402730|NCT01857141|heart rate variability|heart rate variability
402731|NCT01857141|preemptive epidural|preemptive epidural
402732|NCT01857141|gastrectomy|gastrectomy
402733|NCT01857115|Multiple myeloma|multiple myeloma
402734|NCT01857115|Diagnosis|diagnosis
402735|NCT01857115|Weekly|weekly
402736|NCT01857115|CCyd|ccyd
402737|NCT01857089|Pressure Ulcer|pressure ulcer
402739|NCT01857076|Type 2 Diabetes mellitus|type 2 diabetes mellitus
402740|NCT01857076|Grade I obesity|grade i obesity
402741|NCT01857076|Inadequate glycemic control|inadequate glycemic control
402742|NCT01857011|Anemia, Iron-Deficiency|anemia, iron-deficiency
402743|NCT01857011|bariatric surgery|bariatric surgery
402744|NCT01857011|abdominoplasty|abdominoplasty
402745|NCT01857011|surgery, plastic|surgery, plastic
402746|NCT01857011|iron|iron
402747|NCT01856998|Therapeutic Equivalence|therapeutic equivalence
402748|NCT01856998|Propofol|propofol
402749|NCT01856985|Medical abortion|medical abortion
402750|NCT01856985|Misoprostol|misoprostol
402751|NCT01856985|Mifepristone|mifepristone
402752|NCT01856972|Limited Dorsiflexion Range of Motion|limited dorsiflexion range of motion
402753|NCT01856972|Gastrocnemius tightness|gastrocnemius tightness
402754|NCT01856972|Soleus tightness|soleus tightness
402755|NCT01856959|magnesium sulfate|magnesium sulfate
402756|NCT01856959|nebulized|nebulized
402757|NCT01856959|lung function|lung function
402758|NCT01856933|GBM|gbm
402759|NCT01856933|Glioblastoma Multiforme|glioblastoma multiforme
402760|NCT01856933|Gliosarcoma|gliosarcoma
402761|NCT01856920|Calcitonin|calcitonin
402762|NCT01856920|T-cells|t-cells
402763|NCT01856920|Immune Response|immune response
402764|NCT01856920|HLA Patients|hla patients
402765|NCT01856920|Vaccine|vaccine
402766|NCT01856907|prediabetes|prediabetes
402767|NCT01856907|impaired fasting/impaired glucose tolerance|impaired fasting/impaired glucose tolerance
402768|NCT01856907|post gestational diabetes|post gestational diabetes
402769|NCT01856907|diabetes prevention|diabetes prevention
402770|NCT01856894|polycystic ovary syndrome|polycystic ovary syndrome
402771|NCT01856894|Anti-Mullerian Hormone|anti-mullerian hormone
402772|NCT01856894|obesity|obesity
402773|NCT01856881|Type 2 diabetes|type 2 diabetes
402774|NCT01856868|BMD|bmd
402775|NCT01856868|Becker muscular dystrophy|becker muscular dystrophy
402776|NCT01856868|epicatechin|epicatechin
402777|NCT01856868|clinical trial|clinical trial
402778|NCT01856868|neuromuscular disease|neuromuscular disease
402779|NCT01856855|Prostate Cancer|prostate cancer
402780|NCT01856855|Prostate Adenocarcinoma|prostate adenocarcinoma
402781|NCT01856855|Radiation|radiation
402782|NCT01856855|SBRT|sbrt
402783|NCT01856855|Stereotactic Body Radiation Therapy|stereotactic body radiation therapy
402784|NCT01856842|Pulmonary Arteriovenous Malformations|pulmonary arteriovenous malformations
402785|NCT01856842|Hereditary Hemorrhagic Telangiectasia (HHT)|hereditary hemorrhagic telangiectasia (hht)
402786|NCT01856842|Embolization|embolization
402787|NCT01856842|reperfusion rates|reperfusion rates
402788|NCT01856777|Medical Abortion|medical abortion
402789|NCT01856777|Pregnancy Test|pregnancy test
402790|NCT01856777|continuing pregnancy|continuing pregnancy
402791|NCT01856764|Atopic dermatitis|atopic dermatitis
402792|NCT01856751|Haemophilia|haemophilia
402793|NCT01856751|TGA|tga
402794|NCT01856751|TEM|tem
402795|NCT01856738|Parkinson's disease|parkinson's disease
402796|NCT01856738|Visual hallucinations|visual hallucinations
402797|NCT01856738|Rivastigmine|rivastigmine
402798|NCT01856738|Cholinesterase inhibitor|cholinesterase inhibitor
402799|NCT01856738|Randomized controlled trial|randomized controlled trial
402800|NCT01856738|Cost-effectiveness analysis|cost-effectiveness analysis
402801|NCT01856712|alcohol|alcohol
402802|NCT01856712|veterans|veterans
402803|NCT01856699|supratentorial superficial siderosis|supratentorial superficial siderosis
402804|NCT01856699|intracerebral hemorrhage|intracerebral hemorrhage
402805|NCT01856699|cerebral amyloid angiopathy|cerebral amyloid angiopathy
402806|NCT01856686|ADD|add
402807|NCT01856686|ADHD|adhd
402808|NCT01856686|Proteins|proteins
402809|NCT01856686|Dietary|dietary
402810|NCT01856686|Nutrition|nutrition
402811|NCT01856686|QEEG|qeeg
402812|NCT01856686|ERP|erp
402813|NCT01856686|ICA|ica
402814|NCT01856673|Mental Health|mental health
402815|NCT01856673|Displacement|displacement
402816|NCT01856673|Torture|torture
402817|NCT01856673|Violence|violence
402818|NCT01856673|Post-Traumatic Stress Disorder|post-traumatic stress disorder
402819|NCT01856673|Depression|depression
402820|NCT01856673|Anxiety|anxiety
402821|NCT01856673|Community-based intervention|community-based intervention
402822|NCT01856673|Prevention trial|prevention trial
402823|NCT01856673|Disabled Persons|disabled persons
402824|NCT01856660|Obesity|obesity
402825|NCT01856660|Weight Loss|weight loss
402826|NCT01856660|Body Weight Change|body weight change
402827|NCT01856660|Taste|taste
402828|NCT01856660|Taste Phenotype|taste phenotype
402829|NCT01856660|Lifestyle Intervention|lifestyle intervention
402830|NCT01856647|Psoriasis|psoriasis
402831|NCT01856647|Obesity|obesity
402832|NCT01856634|Tuberculosis|tuberculosis
402833|NCT01856634|Tuberculosis, Multidrug-Resistant|tuberculosis, multidrug-resistant
402834|NCT01856634|Mycobacterium Infections|mycobacterium infections
402835|NCT01856634|Actinomycetales Infections|actinomycetales infections
402836|NCT01856634|Gram-Positive Infections|gram-positive infections
402837|NCT01856634|Bacterial Infections|bacterial infections
402838|NCT01856634|Pediatric|pediatric
402931|NCT01856127|Sexual Dysfunction|sexual dysfunction
402839|NCT01856582|Primary Immunodeficiency Disease(s)|primary immunodeficiency disease(s)
402840|NCT01856582|Mixed Donor Chimerism|mixed donor chimerism
402841|NCT01856582|bone marrow failure syndromes|bone marrow failure syndromes
402842|NCT01856582|allogeneic hematopoietic stem cell transplant (HSCT)|allogeneic hematopoietic stem cell transplant (hsct)
402843|NCT01856582|children|children
402844|NCT01856556|safety|safety
402845|NCT01856556|tolerability|tolerability
402846|NCT01856556|pharmacokinetics|pharmacokinetics
402847|NCT01856543|Breast cancer|breast cancer
402848|NCT01856543|Status post mastectomy|status post mastectomy
402849|NCT01856543|plan to receive PMRT|plan to receive pmrt
402850|NCT01856543|Topical|topical
402851|NCT01856543|steroid cream|steroid cream
402852|NCT01856543|emollient skin care|emollient skin care
402853|NCT01856543|Eucerin|eucerin
402854|NCT01856543|Mometasone Furoate 0.1%|mometasone furoate 0.1%
402855|NCT01856517|pressor response|pressor response
402856|NCT01856517|chronotropic response|chronotropic response
402857|NCT01856504|Heart Disease|heart disease
402858|NCT01856504|Coronary Artery Disease|coronary artery disease
402859|NCT01856504|Coronary Arteriosclerosis|coronary arteriosclerosis
402860|NCT01856491|RELIANCE 4-FRONT|reliance 4-front
402861|NCT01856491|Implantable Cardioverter Defibrillator (ICD)|implantable cardioverter defibrillator (icd)
402862|NCT01856491|Cardiac Resynchronization Therapy - Defibrillator (CRT-D)|cardiac resynchronization therapy - defibrillator (crt-d)
402863|NCT01856465|Bariatric surgery|bariatric surgery
402864|NCT01856465|NAFLD|nafld
402865|NCT01856465|Steatohepatitis|steatohepatitis
402866|NCT01856465|Simple Steatosis|simple steatosis
402867|NCT01856465|Intestinal Microbiota|intestinal microbiota
402868|NCT01856452|Sentinel lymph node|sentinel lymph node
402869|NCT01856452|multimodal|multimodal
402870|NCT01856452|breast cancer|breast cancer
402871|NCT01856439|ProSavin|prosavin
402872|NCT01856439|Gene therapy|gene therapy
402873|NCT01856426|Hepatitis C infected subjects|hepatitis c infected subjects
402874|NCT01856413|Prevention|prevention
402875|NCT01856413|Hepatitis B virus re-infection|hepatitis b virus re-infection
402876|NCT01856413|HBV-DNA negative|hbv-dna negative
402877|NCT01856413|Liver transplantation|liver transplantation
402878|NCT01856400|ventricular arrythmias|ventricular arrythmias
402879|NCT01856400|SERCA2a|serca2a
402880|NCT01856400|Chronic Kidney Disease|chronic kidney disease
402881|NCT01856400|microvolt T wave alternans|microvolt t wave alternans
402882|NCT01856387|preeclampsia|preeclampsia
402883|NCT01856387|eclampsia|eclampsia
402884|NCT01856387|prediction|prediction
402885|NCT01856387|neutrophil-to Lymphocyte ratio|neutrophil-to lymphocyte ratio
402886|NCT01856361|Male infertility|male infertility
402887|NCT01856361|Low sperm count|low sperm count
402888|NCT01856361|Poor sperm motility|poor sperm motility
402889|NCT01856361|Poor Sperm shape and morphology|poor sperm shape and morphology
402890|NCT01856335|Seizures|seizures
402891|NCT01856335|Epilepsy|epilepsy
402892|NCT01856322|Colorectal Cancer|colorectal cancer
402893|NCT01856322|Liver Metastasis|liver metastasis
402894|NCT01856322|Sulindac|sulindac
402895|NCT01856309|Rheumatoid Arthritis|rheumatoid arthritis
402896|NCT01856309|Sirukumab|sirukumab
402897|NCT01856309|CNTO 136|cnto 136
402898|NCT01856309|CNTO136ARA3002|cnto136ara3002
402899|NCT01856309|SIRROUND-D|sirround-d
402900|NCT01856309|CNTO136ARA3003|cnto136ara3003
402901|NCT01856309|SIRROUND-T|sirround-t
402902|NCT01856309|SIRROUND-LTE|sirround-lte
402903|NCT01856270|Traumatic brain injury|traumatic brain injury
402904|NCT01856270|Post-traumatic headache|post-traumatic headache
402905|NCT01856270|Drug therapy|drug therapy
402906|NCT01856257|Kidney Transplantation|kidney transplantation
402907|NCT01856257|Transplantation|transplantation
402908|NCT01856257|NULOJIX|nulojix
402909|NCT01856257|belatacept|belatacept
402910|NCT01856257|chronic immunosuppression|chronic immunosuppression
402911|NCT01856244|Parkinson's Disease|parkinson's disease
402912|NCT01856244|treadmill training|treadmill training
402913|NCT01856244|gait|gait
402914|NCT01856244|balance|balance
402915|NCT01856244|mobility|mobility
402916|NCT01856231|COPD|copd
402917|NCT01856231|Physical activity|physical activity
402918|NCT01856218|Mucopolysaccharidosis type 7, MPS 7, Sly syndrome, enzyme replacement therapy, rare disease, lysosomal storage disease, metabolic disorder|mucopolysaccharidosis type 7, mps 7, sly syndrome, enzyme replacement therapy, rare disease, lysosomal storage disease, metabolic disorder
402919|NCT01856205|Japanese Encephalitis, Randomized Controlled Trial, intravenous immunoglobulin, safety, efficacy, Nepal|japanese encephalitis, randomized controlled trial, intravenous immunoglobulin, safety, efficacy, nepal
402920|NCT01856179|Conversion of ALA and SDA|conversion of ala and sda
402921|NCT01856179|Metabolism of n-3 fatty acids|metabolism of n-3 fatty acids
402922|NCT01856166|Nulliparous|nulliparous
402923|NCT01856166|Singleton|singleton
402924|NCT01856166|delivery|delivery
402925|NCT01856166|pregnancy|pregnancy
402926|NCT01856153|Bioavailability|bioavailability
402927|NCT01856153|Strawberry polyphenols|strawberry polyphenols
402928|NCT01856153|Time Influence|time influence
402929|NCT01856140|adipose derived mesenchymal stem cell|adipose derived mesenchymal stem cell
402930|NCT01856140|allogeneic stem cell|allogeneic stem cell
402932|NCT01856127|Antidepressant|antidepressant
402933|NCT01856127|Major Depressant|major depressant
402934|NCT01856127|SSRI|ssri
402935|NCT01856127|SNRI|snri
402936|NCT01856127|Vilazodone|vilazodone
402937|NCT01856127|Sertraline|sertraline
402938|NCT01856114|Advanced Cancers|advanced cancers
402939|NCT01856114|Cancer with evidence of active disease|cancer with evidence of active disease
402940|NCT01856114|Exercise induced breakthrough dyspnea|exercise induced breakthrough dyspnea
402941|NCT01856114|Shortness of breath|shortness of breath
402942|NCT01856114|Fentanyl Buccal Tablets|fentanyl buccal tablets
402943|NCT01856114|FBT|fbt
402944|NCT01856114|Placebo|placebo
402945|NCT01856114|Walk tests|walk tests
402946|NCT01856114|Questionnaires|questionnaires
402947|NCT01856114|Surveys|surveys
402948|NCT01856101|TCC|tcc
402949|NCT01856101|Failure of platinum based chemotherapy|failure of platinum based chemotherapy
402950|NCT01856088|Coronary artery|coronary artery
402951|NCT01856088|Drug eluting stent|drug eluting stent
402952|NCT01856088|thrombosis|thrombosis
402953|NCT01856075|Atrial Fibrillation|atrial fibrillation
402954|NCT01856075|Dronedarone|dronedarone
402955|NCT01856075|Cohort|cohort
402956|NCT01856075|Effectiveness|effectiveness
402957|NCT01856062|ovulation induction|ovulation induction
402958|NCT01856062|dexamethasone|dexamethasone
402959|NCT01856049|HLHS|hlhs
402960|NCT01856049|Hypoplastic Left Heart Syndrome|hypoplastic left heart syndrome
402961|NCT01856049|UCB (umbilical cord blood)|ucb (umbilical cord blood)
402962|NCT01856049|Umbilical cord blood|umbilical cord blood
402963|NCT01856049|Cord blood|cord blood
402964|NCT01856049|Cardiac regeneration|cardiac regeneration
402965|NCT01856036|Ductal Histology|ductal histology
402966|NCT01856036|Unifocal|unifocal
402967|NCT01856036|Estrogen Receptor Positive|estrogen receptor positive
402968|NCT01856036|her2neu negative|her2neu negative
402969|NCT01856023|melanoma|melanoma
402970|NCT01856023|metastatic|metastatic
402971|NCT01856023|skin cancer|skin cancer
402972|NCT01856023|Stage IV|stage iv
402973|NCT01856023|interleukin-2|interleukin-2
402974|NCT01856010|Dementia|dementia
402975|NCT01856010|Aggression|aggression
402976|NCT01856010|Agitation|agitation
402977|NCT01855984|ADHD|adhd
402978|NCT01855984|Children|children
402979|NCT01855984|Tocotrienol|tocotrienol
402980|NCT01855958|Osteoarthritis|osteoarthritis
402981|NCT01855958|Electro acupuncture|electro acupuncture
402982|NCT01855958|Deep intramuscular stimulation|deep intramuscular stimulation
402983|NCT01855958|Transcranial Magnetic Stimulation|transcranial magnetic stimulation
402984|NCT01855958|Pain pressure threshold|pain pressure threshold
402985|NCT01855958|Conditioned pain modulation|conditioned pain modulation
402986|NCT01855958|Clinical trial|clinical trial
402987|NCT01855945|Influenza|influenza
402988|NCT01855919|Chronic Low Back Pain|chronic low back pain
402989|NCT01855919|CLBP|clbp
402990|NCT01855906|Total knee replacement|total knee replacement
402991|NCT01855906|Gap balanced|gap balanced
402992|NCT01855906|Measured resection|measured resection
402993|NCT01855893|Neck pain|neck pain
402994|NCT01855880|psoriasis|psoriasis
402995|NCT01855880|dermatology|dermatology
402996|NCT01855880|monoclonal antibody|monoclonal antibody
402997|NCT01855867|HIV|hiv
402998|NCT01855867|PEP|pep
402999|NCT01855867|nPEP|npep
403000|NCT01855867|Prophylaxis|prophylaxis
403001|NCT01855867|Post Exposure Prophylaxis|post exposure prophylaxis
403002|NCT01855867|exposure to HIV|exposure to hiv
403003|NCT01855867|HIV prevention|hiv prevention
403004|NCT01855841|ERCP|ercp
403005|NCT01855841|virgin papilla|virgin papilla
403006|NCT01855841|risk of post-ERCP acute pancreatitis|risk of post-ercp acute pancreatitis
403007|NCT01855802|Greece|greece
403008|NCT01855802|Ophthalmology|ophthalmology
403009|NCT01855802|Glaucoma|glaucoma
403010|NCT01855802|Generics|generics
403011|NCT01855802|Perception|perception
403012|NCT01855776|Physical Activity/Walking|physical activity/walking
403013|NCT01855776|Full-time employees|full-time employees
403014|NCT01855776|RCT|rct
403015|NCT01855776|Incentives|incentives
403016|NCT01855776|Wireless pedometer|wireless pedometer
403017|NCT01855763|gestational diabetes|gestational diabetes
403018|NCT01855763|type 2 diabetes|type 2 diabetes
403019|NCT01855763|pregnancy|pregnancy
403020|NCT01855763|metformin|metformin
403021|NCT01855763|insulin|insulin
403022|NCT01855750|Lymphoma|lymphoma
403023|NCT01855750|B-cell lymphoma|b-cell lymphoma
403024|NCT01855750|Non-germinal center B-cell subtype|non-germinal center b-cell subtype
403025|NCT01855750|Diffuse large B-cell lymphoma|diffuse large b-cell lymphoma
403026|NCT01855750|Bruton's tyrosine kinase inhibitor|bruton's tyrosine kinase inhibitor
403027|NCT01855750|PCI-32765|pci-32765
403028|NCT01855750|JNJ-54179060|jnj-54179060
403029|NCT01855750|Ibrutinib|ibrutinib
403030|NCT01855750|Rituximab|rituximab
403031|NCT01855750|Cyclophosphamide|cyclophosphamide
403032|NCT01855750|Doxorubicin|doxorubicin
403033|NCT01855750|Vincristine|vincristine
403034|NCT01855750|Prednisone|prednisone
403035|NCT01855737|gene guided|gene guided
403036|NCT01855737|warfarin dose|warfarin dose
403037|NCT01855737|Chinese|chinese
403038|NCT01855711|Alosetron hydrochloride|alosetron hydrochloride
403039|NCT01855711|Global Improvement Scale(GIS)|global improvement scale(gis)
403040|NCT01855711|Diarrhea-predominant IBS|diarrhea-predominant ibs
403041|NCT01855698|hematologic neoplasm, profhylaxis, arterial and venous thromboembolism|hematologic neoplasm, profhylaxis, arterial and venous thromboembolism
403042|NCT01855685|XCGD, lentivirus, cellular therapy|xcgd, lentivirus, cellular therapy
403043|NCT01855672|Migraine, occipital nerve, stimulation|migraine, occipital nerve, stimulation
403044|NCT01855659|Lung diseases,|lung diseases,
403045|NCT01855659|Obstructive,|obstructive,
403046|NCT01855659|Peak Inspiratory Flow|peak inspiratory flow
403047|NCT01855659|[C08.381.495.389]|[c08.381.495.389]
403048|NCT01855620|Contraception|contraception
403049|NCT01855620|Implant|implant
403050|NCT01855620|Obesity|obesity
403051|NCT01855607|chemotherapy induced neuropathy|chemotherapy induced neuropathy
403052|NCT01855542|metabolic acidosis, plasmalyte solution, 0.9% normal saline|metabolic acidosis, plasmalyte solution, 0.9% normal saline
403053|NCT01855529|ropivacaine, pain, mastectomy|ropivacaine, pain, mastectomy
403054|NCT01855516|Antithrombotic prophylaxis|antithrombotic prophylaxis
403055|NCT01855503|Metastatic|metastatic
403056|NCT01855503|Breast Cancer|breast cancer
403057|NCT01855503|Metastatic Breast Cancer|metastatic breast cancer
403058|NCT01855503|Breast|breast
403059|NCT01855503|Biopsy|biopsy
403060|NCT01855503|Molecular|molecular
403061|NCT01855503|Genetic|genetic
403062|NCT01855464|pneumothorax|pneumothorax
403063|NCT01855464|primary pneumothorax|primary pneumothorax
403064|NCT01855464|lung collapse|lung collapse
403065|NCT01855451|Human Papilloma Virus|human papilloma virus
403066|NCT01855451|HPV|hpv
403067|NCT01855451|Oropharyngeal|oropharyngeal
403068|NCT01855451|Squamous Cell|squamous cell
403069|NCT01855451|Carcinoma|carcinoma
403070|NCT01855438|Live donor kidney transplantation|live donor kidney transplantation
403071|NCT01855438|Living donation|living donation
403072|NCT01855438|Patient education|patient education
403073|NCT01855438|Kidney transplant candidates|kidney transplant candidates
403074|NCT01855412|PAD|pad
403075|NCT01855412|LIBERTY|liberty
403076|NCT01855412|Observational|observational
403077|NCT01855399|Peer Support|peer support
403078|NCT01855399|Self Management|self management
403079|NCT01855399|Health Disparities|health disparities
403080|NCT01855373|Blood Sugar|blood sugar
403081|NCT01855373|Endothelial Function|endothelial function
403082|NCT01855373|Blood Vessel Health|blood vessel health
403083|NCT01855360|amyloid|amyloid
403084|NCT01855360|amyloidosis|amyloidosis
403085|NCT01855360|cardiac amyloidosis|cardiac amyloidosis
403086|NCT01855360|senile amyloidosis|senile amyloidosis
403087|NCT01855360|familial amyloidosis|familial amyloidosis
403088|NCT01855360|transthyretin amyloidosis|transthyretin amyloidosis
403089|NCT01855347|Prematurity|prematurity
403090|NCT01855347|Hypoxia|hypoxia
403091|NCT01855347|Necrotizing Enterocolitis|necrotizing enterocolitis
403092|NCT01855347|Near Infrared Spectroscopy|near infrared spectroscopy
403093|NCT01855347|Abdominal tissue oxygenation|abdominal tissue oxygenation
403094|NCT01855347|NICU|nicu
403095|NCT01855334|Dialysis|dialysis
403096|NCT01855334|ESRD|esrd
403097|NCT01855334|Cardiovascular disease|cardiovascular disease
403098|NCT01855334|spironolactone|spironolactone
403099|NCT01855334|L-arginine|l-arginine
403100|NCT01855334|myocardial perfusion|myocardial perfusion
403101|NCT01855334|coronary flow reserve|coronary flow reserve
403102|NCT01855334|diastolic function|diastolic function
403103|NCT01855321|uncontrolled diabetes|uncontrolled diabetes
403104|NCT01855321|vitamin D deficiency|vitamin d deficiency
403105|NCT01855295|Dialysis|dialysis
403106|NCT01855295|End Stage Renal Disease|end stage renal disease
403107|NCT01855295|Protein supplementation|protein supplementation
403108|NCT01855295|Inflammation|inflammation
403109|NCT01855295|Quality of Life|quality of life
403110|NCT01855282|Diabetes Type II,|diabetes type ii,
403111|NCT01855282|Overweight,|overweight,
403112|NCT01855282|Obesity,|obesity,
403113|NCT01855282|Behavioral Intervention,|behavioral intervention,
403114|NCT01855282|Latino, farm worker|latino, farm worker
403115|NCT01855282|randomized controlled intervention|randomized controlled intervention
403116|NCT01855269|probiotic|probiotic
403117|NCT01855269|infantile colic|infantile colic
403118|NCT01855256|hyperhidrosis|hyperhidrosis
403119|NCT01855256|oxybutynin|oxybutynin
403120|NCT01855243|Type 2 D M|type 2 d m
403121|NCT01855243|sliding scale insulin|sliding scale insulin
403122|NCT01855243|70/30 insulin|70/30 insulin
403123|NCT01855243|basals insulin|basals insulin
403124|NCT01855243|supplemental insulin|supplemental insulin
403125|NCT01855217|morbid|morbid
403126|NCT01855217|obesity|obesity
403127|NCT01855217|sugammadex|sugammadex
403128|NCT01855217|pharmacodynamics|pharmacodynamics
403129|NCT01855204|Computed Tomography, Spiral|computed tomography, spiral
403130|NCT01855204|Urography|urography
403131|NCT01855204|Radiation dosage|radiation dosage
403132|NCT01855204|Contrast media|contrast media
403133|NCT01855178|nocturnal|nocturnal
403134|NCT01855178|epilepsy|epilepsy
403235|NCT01854801|EHS|ehs
403135|NCT01855165|chronic heart failure|chronic heart failure
403136|NCT01855165|drug-drug interactions|drug-drug interactions
403137|NCT01855165|pharmacist's intervention|pharmacist's intervention
403138|NCT01855152|Dementia|dementia
403139|NCT01855152|Care Homes|care homes
403140|NCT01855152|Quality of life|quality of life
403141|NCT01855152|Antipsychotic medication|antipsychotic medication
403142|NCT01855152|Behavioural symptoms|behavioural symptoms
403143|NCT01855152|Cost effectiveness|cost effectiveness
403144|NCT01855152|Implementation|implementation
403145|NCT01855152|Person centred care|person centred care
403146|NCT01855152|Social interaction|social interaction
403147|NCT01855139|Non-valvular atrial fibrillation|non-valvular atrial fibrillation
403148|NCT01855139|Stroke|stroke
403149|NCT01855139|Systemic embolism|systemic embolism
403150|NCT01855139|Oral anticoagulation|oral anticoagulation
403151|NCT01855139|Real-life setting|real-life setting
403152|NCT01855139|Preventive measure|preventive measure
403153|NCT01855126|light|light
403154|NCT01855126|circadian rhythms|circadian rhythms
403155|NCT01855126|dim light melatonin onset|dim light melatonin onset
403156|NCT01855126|sleep|sleep
403157|NCT01855113|PAIN|pain
403158|NCT01855113|ORTHODONTIC TREATMENT|orthodontic treatment
403159|NCT01855113|INVISALIGN|invisalign
403160|NCT01855100|Treatment of acute deep vein thrombosis|treatment of acute deep vein thrombosis
403161|NCT01855100|Prevention of recurrence|prevention of recurrence
403162|NCT01855100|Oral anticoagulation|oral anticoagulation
403163|NCT01855100|Real-life setting|real-life setting
403164|NCT01855074|Schizophrenia|schizophrenia
403165|NCT01855074|Schizophreniform Disorder|schizophreniform disorder
403166|NCT01855074|Schizoaffective Disorder|schizoaffective disorder
403167|NCT01855074|Risperidone|risperidone
403168|NCT01855074|Risperdal consta|risperdal consta
403169|NCT01855061|Feasibility studies|feasibility studies
403170|NCT01855061|Sequence analysis, DNA|sequence analysis, dna
403171|NCT01855061|Biological markers|biological markers
403172|NCT01855061|Solid tumors|solid tumors
403173|NCT01855061|Neoplasm metastasis|neoplasm metastasis
403174|NCT01855061|Irinotecan|irinotecan
403175|NCT01855061|Pharmacokinetics SN-38|pharmacokinetics sn-38
403176|NCT01855061|Carboxylesterase activity within metastasis|carboxylesterase activity within metastasis
403177|NCT01855048|N-Rephasin® SAL200|n-rephasin® sal200
403178|NCT01855048|endolysin|endolysin
403179|NCT01855048|Placebo|placebo
403180|NCT01855035|ischemic stroke|ischemic stroke
403181|NCT01855035|ECG monitoring|ecg monitoring
403182|NCT01855035|atrial fibrillation (/flutter)|atrial fibrillation (/flutter)
403183|NCT01855022|Motivational interviewing|motivational interviewing
403184|NCT01855022|Interactive voice response|interactive voice response
403185|NCT01855022|Hospital readmission|hospital readmission
403186|NCT01855009|Quality of Life|quality of life
403187|NCT01855009|Body Weight and Measures|body weight and measures
403188|NCT01855009|Malnutrition|malnutrition
403189|NCT01855009|Adolescent Nutrition Sciences|adolescent nutrition sciences
403190|NCT01855009|Sleep Initiation and Maintenance Disorder|sleep initiation and maintenance disorder
403191|NCT01855009|Motor Activity|motor activity
403192|NCT01855009|Drinking|drinking
403193|NCT01854983|fluorescence colposcopy|fluorescence colposcopy
403194|NCT01854983|cervical cancer|cervical cancer
403195|NCT01854957|Multiple sclerosis|multiple sclerosis
403196|NCT01854957|Mesenchymal stem cells|mesenchymal stem cells
403197|NCT01854931|Tai Ji Quan|tai ji quan
403198|NCT01854931|fall prevention|fall prevention
403199|NCT01854931|community dissemination|community dissemination
403200|NCT01854918|High cholesterol|high cholesterol
403201|NCT01854918|Raised cholesterol|raised cholesterol
403202|NCT01854918|Cholesterol|cholesterol
403203|NCT01854918|Elevated Cholesterol|elevated cholesterol
403204|NCT01854892|low back pain|low back pain
403205|NCT01854892|manipulation|manipulation
403206|NCT01854892|laser therapy|laser therapy
403207|NCT01854892|osteopathic|osteopathic
403208|NCT01854892|chiropractic|chiropractic
403209|NCT01854892|mobilization|mobilization
403210|NCT01854892|muscle energy|muscle energy
403211|NCT01854892|physical therapy|physical therapy
403212|NCT01854892|muscle|muscle
403213|NCT01854892|spine|spine
403214|NCT01854892|adjustment|adjustment
403215|NCT01854892|rehabilitation|rehabilitation
403216|NCT01854866|Pleural Effusion|pleural effusion
403217|NCT01854866|ascites|ascites
403218|NCT01854866|Malignant|malignant
403219|NCT01854853|unsafe sex|unsafe sex
403220|NCT01854853|safer sex|safer sex
403221|NCT01854853|HIV|hiv
403222|NCT01854853|STI|sti
403223|NCT01854853|Pregnancy|pregnancy
403224|NCT01854840|hyaline membrane disease|hyaline membrane disease
403225|NCT01854840|placenta|placenta
403226|NCT01854840|betamethasone|betamethasone
403227|NCT01854827|Biliary atresia|biliary atresia
403228|NCT01854827|Hepatic portoenterostomy|hepatic portoenterostomy
403229|NCT01854827|Intravenous immunoglobulin|intravenous immunoglobulin
403230|NCT01854801|IEI-EMF|iei-emf
403231|NCT01854801|WI-FI|wi-fi
403232|NCT01854801|DECT|dect
403233|NCT01854801|Electro-sensitivity|electro-sensitivity
403234|NCT01854801|Radiofrequency|radiofrequency
403236|NCT01854801|Idiopathic|idiopathic
403237|NCT01854801|Environmental|environmental
403238|NCT01854801|Intolerance fields|intolerance fields
403239|NCT01854801|Mobile phone|mobile phone
403240|NCT01854788|Airway clearance techniques|airway clearance techniques
403241|NCT01854788|Mucus clearance|mucus clearance
403242|NCT01854788|Chest physiotherapy|chest physiotherapy
403243|NCT01854788|Autogenic drainage|autogenic drainage
403244|NCT01854788|Slow expiration with glottis opened in lateral posture(ELTGOL)|slow expiration with glottis opened in lateral posture(eltgol)
403245|NCT01854788|Temporary-positive expiratory pressure (T-PEP)|temporary-positive expiratory pressure (t-pep)
403246|NCT01854788|Non cystic fibrosis bronchiectasis|non cystic fibrosis bronchiectasis
403247|NCT01854775|Adolescents|adolescents
403248|NCT01854775|HIV-1|hiv-1
403249|NCT01854775|HIV|hiv
403250|NCT01854775|Treatment-naive|treatment-naive
403251|NCT01854775|Virologically suppressed|virologically suppressed
403252|NCT01854762|HIV|hiv
403253|NCT01854762|Treatment|treatment
403254|NCT01854762|Pregnancy|pregnancy
403255|NCT01854749|ESCC|escc
403256|NCT01854736|Allergy|allergy
403257|NCT01854736|Phleum pratense|phleum pratense
403258|NCT01854736|Rhinoconjunctivitis|rhinoconjunctivitis
403259|NCT01854736|asthma|asthma
403260|NCT01854736|positive SPT to Phleum pratense|positive spt to phleum pratense
403261|NCT01854723|Diabetes|diabetes
403262|NCT01854723|Insulin glargine|insulin glargine
403263|NCT01854723|NPH insulin|nph insulin
403264|NCT01854710|ADASUVE|adasuve
403265|NCT01854710|inhaled loxapine|inhaled loxapine
403266|NCT01854710|thorough QT/QTc study|thorough qt/qtc study
403267|NCT01854697|Chronic Hepatitis C|chronic hepatitis c
403268|NCT01854697|Interferon Free|interferon free
403269|NCT01854697|Hepatitis C Treatment Naive|hepatitis c treatment naive
403270|NCT01854697|Hepatitis C Virus|hepatitis c virus
403271|NCT01854697|Hepatitis C Genotype 1|hepatitis c genotype 1
403272|NCT01854671|postpartum contraception|postpartum contraception
403273|NCT01854671|contraceptive counseling|contraceptive counseling
403274|NCT01854632|influenza vaccine|influenza vaccine
403275|NCT01854632|trivalent live-attenuated influenza vaccine|trivalent live-attenuated influenza vaccine
403276|NCT01854632|efficacy|efficacy
403277|NCT01854632|Africa|africa
403278|NCT01854632|Senegal|senegal
403279|NCT01854619|chronic rhinosinusitis|chronic rhinosinusitis
403280|NCT01854619|sinusitis|sinusitis
403281|NCT01854619|photodisinfection|photodisinfection
403282|NCT01854619|photodynamic therapy|photodynamic therapy
403283|NCT01854619|antimicrobial photodynamic therapy|antimicrobial photodynamic therapy
403284|NCT01854619|aPDT|apdt
403285|NCT01854619|PDT|pdt
403286|NCT01854619|paranasal sinus diseases|paranasal sinus diseases
403287|NCT01854619|respiratory tract infections|respiratory tract infections
403288|NCT01854619|respiratory tract diseases|respiratory tract diseases
403289|NCT01854606|Diffuse Large B-Cell Lymphoma, DBCL, AEB071, Everolimus|diffuse large b-cell lymphoma, dbcl, aeb071, everolimus
403290|NCT01854580|Comparative effectiveness research|comparative effectiveness research
403291|NCT01854580|health economic evaluation|health economic evaluation
403292|NCT01854567|Cord Blood|cord blood
403293|NCT01854567|Stem Cells|stem cells
403294|NCT01854567|MPC|mpc
403295|NCT01854567|Mesoblast|mesoblast
403296|NCT01854567|Expanded|expanded
403297|NCT01854567|AML|aml
403298|NCT01854567|ALL|all
403299|NCT01854567|NHL|nhl
403300|NCT01854567|Leukemia|leukemia
403301|NCT01854567|Lymphoma|lymphoma
403302|NCT01854554|Brain cancer|brain cancer
403303|NCT01854554|Glioblastoma|glioblastoma
403304|NCT01854554|Glioblastoma Multiforme|glioblastoma multiforme
403305|NCT01854554|GBM|gbm
403306|NCT01854554|Intensity Modulated Proton Radiotherapy|intensity modulated proton radiotherapy
403307|NCT01854554|IMPT|impt
403308|NCT01854554|Intensity Modulated Radiotherapy|intensity modulated radiotherapy
403309|NCT01854554|IMRT|imrt
403310|NCT01854554|Radiotherapy|radiotherapy
403311|NCT01854554|XRT|xrt
403312|NCT01854554|Cognitive tests|cognitive tests
403313|NCT01854554|Thinking skills tests|thinking skills tests
403314|NCT01854554|Questionnaires|questionnaires
403315|NCT01854554|Surveys|surveys
403316|NCT01854554|Quality of life|quality of life
403318|NCT01854541|Cancer|cancer
403319|NCT01854541|Radiotherapy|radiotherapy
403320|NCT01854528|Partial responder|partial responder
403321|NCT01854528|Interferon free|interferon free
403322|NCT01854528|Treatment-experienced|treatment-experienced
403323|NCT01854528|Relapser|relapser
403324|NCT01854528|Hepatitis C Virus|hepatitis c virus
403325|NCT01854528|Null responder|null responder
403326|NCT01854528|Hepatitis C Genotype 1|hepatitis c genotype 1
403327|NCT01854528|paritaprevir|paritaprevir
403328|NCT01854528|ombitasvir|ombitasvir
403329|NCT01854528|dasabuvir|dasabuvir
403330|NCT01854528|ribavirin|ribavirin
403331|NCT01854528|Viekira PAK|viekira pak
403332|NCT01854528|Chronic hepatitis C|chronic hepatitis c
403333|NCT01854502|Young children|young children
403334|NCT01854502|counseling|counseling
403335|NCT01854502|fluoride|fluoride
403336|NCT01854502|xylitol|xylitol
403337|NCT01854489|Buprenorphine|buprenorphine
403338|NCT01854489|Rifampicin|rifampicin
403339|NCT01854489|Interactions|interactions
403340|NCT01854489|Pharmakokinetics|pharmakokinetics
403341|NCT01854489|Pharmakodynamics|pharmakodynamics
403342|NCT01854476|Hemodialysis|hemodialysis
403343|NCT01854476|Bleeding|bleeding
403344|NCT01854476|Hemostatic dressing|hemostatic dressing
403345|NCT01854476|Tranexamic Acid|tranexamic acid
403346|NCT01854463|DIABETES MELLITUS|diabetes mellitus
403347|NCT01854463|VITAMIN D|vitamin d
403348|NCT01854463|ARTERIAL STIFFNESS|arterial stiffness
403349|NCT01854463|FATTY LIVER|fatty liver
403350|NCT01854463|BONE TURNOVER|bone turnover
403351|NCT01854450|Occipitoposterior position|occipitoposterior position
403352|NCT01854450|Maternal posturing|maternal posturing
403353|NCT01854450|Labor|labor
403354|NCT01854437|mg oxide|mg oxide
403355|NCT01854437|hyperphosphatemia|hyperphosphatemia
403356|NCT01854437|plasma phosphor level|plasma phosphor level
403357|NCT01854424|Fibrocyte|fibrocyte
403358|NCT01854424|Acute Respiratory Distress Syndrome|acute respiratory distress syndrome
403359|NCT01854424|Serum Amyloid P|serum amyloid p
403360|NCT01854424|Fibrosis|fibrosis
403361|NCT01854424|Mortality|mortality
403362|NCT01854411|Analgesics|analgesics
403363|NCT01854411|Ibuprofene|ibuprofene
403364|NCT01854411|Ketoprofene|ketoprofene
403365|NCT01854411|Breastmilk|breastmilk
403366|NCT01854411|Relative Infant Dose|relative infant dose
403367|NCT01854411|Theoric Infant Dose|theoric infant dose
403368|NCT01854398|Obstructive sleep apnea|obstructive sleep apnea
403369|NCT01854398|Continuous positive airway pressure|continuous positive airway pressure
403370|NCT01854398|diastolic function|diastolic function
403371|NCT01854385|Post-traumatic headache|post-traumatic headache
403372|NCT01854385|Traumatic brain injury|traumatic brain injury
403373|NCT01854385|Sumatriptan|sumatriptan
403374|NCT01854359|Multiple Sclerosis|multiple sclerosis
403375|NCT01854359|Extension Trial|extension trial
403376|NCT01854346|Autism spectrum disorder|autism spectrum disorder
403377|NCT01854346|Social skills training|social skills training
403378|NCT01854346|Group training|group training
403379|NCT01854346|Comorbidity|comorbidity
403380|NCT01854346|Intervention|intervention
403381|NCT01854346|Evidence-based|evidence-based
403382|NCT01854333|Diagnostics|diagnostics
403383|NCT01854333|ADOS|ados
403384|NCT01854333|ADI-R|adi-r
403385|NCT01854333|Psychometrics|psychometrics
403386|NCT01854333|Autism spectrum disorders|autism spectrum disorders
403387|NCT01854333|Autism|autism
403388|NCT01854307|Difference of|difference of
403389|NCT01854307|measurements|measurements
403390|NCT01854307|before and after|before and after
403391|NCT01854294|ALS|als
403392|NCT01854294|motorneuron disease|motorneuron disease
403393|NCT01854294|Central Nervous System (CNS) disease|central nervous system (cns) disease
403394|NCT01854294|neurodegeneration|neurodegeneration
403395|NCT01854294|neuroprotective|neuroprotective
403396|NCT01854294|mechanisms of action|mechanisms of action
403397|NCT01854294|pathways|pathways
403398|NCT01854294|biomarkers|biomarkers
403399|NCT01854294|Cerebral Spinal Fluid (CSF)|cerebral spinal fluid (csf)
403400|NCT01854294|blood biomarkers|blood biomarkers
403401|NCT01854294|multi-factorial|multi-factorial
403402|NCT01854294|multisystem|multisystem
403403|NCT01854294|single target|single target
403404|NCT01854294|pathogenic mechanisms|pathogenic mechanisms
403405|NCT01854294|Protein Bands Selection by Function|protein bands selection by function
403406|NCT01854294|in silico analysis|in silico analysis
403407|NCT01854294|active site|active site
403408|NCT01854294|protein|protein
403409|NCT01854294|peptide|peptide
403410|NCT01854294|embryonic stage|embryonic stage
403411|NCT01854294|endogenous|endogenous
403412|NCT01854294|master regulators|master regulators
403413|NCT01854294|fetal development|fetal development
403414|NCT01854294|embryonic development|embryonic development
403415|NCT01854294|common pathways|common pathways
403416|NCT01854294|Blood Brain Barrier (BBB)|blood brain barrier (bbb)
403417|NCT01854294|anti-inflammatory|anti-inflammatory
403418|NCT01854294|anti-apoptotic|anti-apoptotic
403419|NCT01854294|anti-oxidative|anti-oxidative
403420|NCT01854294|regenerative|regenerative
403421|NCT01854294|distress signals|distress signals
403422|NCT01854294|neurotrophin|neurotrophin
403423|NCT01854294|Motoneuronotrophic factor (MNTF)|motoneuronotrophic factor (mntf)
403424|NCT01854294|ALS model|als model
403425|NCT01854294|life span|life span
403426|NCT01854294|disease onset|disease onset
403427|NCT01854294|grip strength|grip strength
403428|NCT01854294|protein expression|protein expression
403429|NCT01854294|DNA microarray|dna microarray
403430|NCT01854294|differential expression|differential expression
403431|NCT01854294|Phase 1 clinical trial|phase 1 clinical trial
403432|NCT01854294|rare disease|rare disease
403433|NCT01854294|common underlying pathogenic mechanisms|common underlying pathogenic mechanisms
403434|NCT01854294|neurological deficits|neurological deficits
403435|NCT01854294|gene mutation|gene mutation
403436|NCT01854294|misfolded proteins|misfolded proteins
403437|NCT01854294|inadvertent errors|inadvertent errors
403438|NCT01854294|modulation of genes|modulation of genes
403535|NCT01853865|Follow-up examination|follow-up examination
403439|NCT01854294|master regulator peptide drug|master regulator peptide drug
403440|NCT01854294|ALS related genes|als related genes
403441|NCT01854294|mitochondria dysfunction|mitochondria dysfunction
403442|NCT01854294|excitotoxicity|excitotoxicity
403443|NCT01854294|axonal transport|axonal transport
403444|NCT01854294|oxidative stress|oxidative stress
403445|NCT01854294|protein aggregation|protein aggregation
403446|NCT01854294|pathogenesis|pathogenesis
403447|NCT01854294|target biomarkers|target biomarkers
403448|NCT01854294|efficacy biomarkers|efficacy biomarkers
403449|NCT01854281|Patent foramen ovale|patent foramen ovale
403450|NCT01854281|Catheter-based closure|catheter-based closure
403451|NCT01854281|Nitrogen bubbles|nitrogen bubbles
403452|NCT01854281|Decompression sickness|decompression sickness
403453|NCT01854268|cough|cough
403454|NCT01854255|Gastric|gastric
403455|NCT01854255|Cancer|cancer
403456|NCT01854255|Chemotherapy|chemotherapy
403457|NCT01854255|Intraperitoneal|intraperitoneal
403458|NCT01854229|Morphine|morphine
403459|NCT01854229|Implantable Infusion Pumps|implantable infusion pumps
403460|NCT01854229|Intrathecal Pump|intrathecal pump
403461|NCT01854216|Rotigotine|rotigotine
403462|NCT01854216|Neupro|neupro
403463|NCT01854216|Japanese|japanese
403464|NCT01854216|Caucasian|caucasian
403465|NCT01854216|Male|male
403466|NCT01854216|Female|female
403467|NCT01854216|Single dose|single dose
403468|NCT01854216|Pharmacokinetics|pharmacokinetics
403469|NCT01854203|Cisplatin|cisplatin
403470|NCT01854203|neoadjuvant chemotherapy|neoadjuvant chemotherapy
403471|NCT01854203|intensity-modulated radiation therapy|intensity-modulated radiation therapy
403472|NCT01854203|concurrent chemoradiotherapy|concurrent chemoradiotherapy
403473|NCT01854190|Obstructive sleep apnea|obstructive sleep apnea
403474|NCT01854190|Resistent hypertension|resistent hypertension
403475|NCT01854190|Endothelial function|endothelial function
403476|NCT01854190|Blood pressure|blood pressure
403477|NCT01854177|breathlessness; substance P; beta-endorphin|breathlessness; substance p; beta-endorphin
403478|NCT01854164|HGE, impaired fasting glucose, clinical trial|hge, impaired fasting glucose, clinical trial
403479|NCT01854151|Medication errors|medication errors
403480|NCT01854151|Medication dosing|medication dosing
403481|NCT01854138|primary knee arthroplasty|primary knee arthroplasty
403482|NCT01854138|primary hip arthroplasty|primary hip arthroplasty
403483|NCT01854138|negative pressure wound therapy|negative pressure wound therapy
403484|NCT01854125|immun function|immun function
403485|NCT01854125|liver function|liver function
403486|NCT01854125|ascites|ascites
403487|NCT01854125|quality of life|quality of life
403488|NCT01854125|Child-Pugh score|child-pugh score
403489|NCT01854112|Helical tomotherapy|helical tomotherapy
403490|NCT01854112|total skin electron therapy|total skin electron therapy
403491|NCT01854112|TSEB|tseb
403492|NCT01854112|irradiation 5.|irradiation 5.
403493|NCT01854099|Brain Tumor|brain tumor
403494|NCT01854086|osteoporosis|osteoporosis
403495|NCT01854086|postmenopausal|postmenopausal
403496|NCT01854086|patient compliance|patient compliance
403497|NCT01854086|compliance|compliance
403498|NCT01854086|diphosphonates|diphosphonates
403499|NCT01854086|bisphosphonates|bisphosphonates
403500|NCT01854060|Irritable bowel syndrome|irritable bowel syndrome
403501|NCT01854060|Epidimiology|epidimiology
403502|NCT01854060|Deterioration in the severity of irritable bowel syndrome|deterioration in the severity of irritable bowel syndrome
403503|NCT01854034|Advanced disease|advanced disease
403504|NCT01854034|EGFR mutation|egfr mutation
403505|NCT01854021|Anesthesia|anesthesia
403506|NCT01854021|general|general
403507|NCT01854021|Immunity|immunity
403508|NCT01854021|Tongue neoplasms|tongue neoplasms
403509|NCT01854021|immune|immune
403510|NCT01854021|general anesthesia|general anesthesia
403511|NCT01854008|Exercise, Physical activity, Rehabilitation, COPD.|exercise, physical activity, rehabilitation, copd.
403512|NCT01853995|Fixed Lingual Mandibular Growth Modificator (FLMGM)|fixed lingual mandibular growth modificator (flmgm)
403513|NCT01853995|Class II division 1 malocclusion|class ii division 1 malocclusion
403514|NCT01853995|Sagittal Occlusal Correction|sagittal occlusal correction
403515|NCT01853995|Skeletal changes|skeletal changes
403516|NCT01853995|Dental changes|dental changes
403517|NCT01853956|Mexico|mexico
403518|NCT01853956|Bioequivalence|bioequivalence
403519|NCT01853956|Alprazolam|alprazolam
403520|NCT01853956|Pharmacokinetics|pharmacokinetics
403521|NCT01853943|Transradial approach|transradial approach
403522|NCT01853943|radial occlusion|radial occlusion
403523|NCT01853943|hand grip|hand grip
403524|NCT01853943|coronary angiography|coronary angiography
403525|NCT01853930|reading rehabilitation|reading rehabilitation
403526|NCT01853930|macular degeneration|macular degeneration
403527|NCT01853930|eccentric viewing|eccentric viewing
403528|NCT01853904|Bronchoscopy|bronchoscopy
403529|NCT01853904|BAL|bal
403530|NCT01853904|Suction|suction
403531|NCT01853878|Non-Small Cell Lung Cancer|non-small cell lung cancer
403532|NCT01853878|Immunotherapy|immunotherapy
403533|NCT01853878|Antigen-Specific|antigen-specific
403534|NCT01853865|Endometrial cancer|endometrial cancer
403639|NCT01853384|venous|venous
403536|NCT01853813|colorectal cancer|colorectal cancer
403537|NCT01853813|advanced disease|advanced disease
403538|NCT01853813|LDH|ldh
403539|NCT01853800|Relative bioavailability|relative bioavailability
403540|NCT01853800|Rivaroxaban|rivaroxaban
403541|NCT01853787|COPD|copd
403542|NCT01853787|bronchial inflammation|bronchial inflammation
403543|NCT01853787|NO concentration|no concentration
403544|NCT01853787|small airways|small airways
403545|NCT01853787|LABA|laba
403546|NCT01853787|Small Airways Stretching|small airways stretching
403547|NCT01853787|Stretch and strain of small airways in COPD|stretch and strain of small airways in copd
403548|NCT01853787|Acute LABA effect on NO production|acute laba effect on no production
403549|NCT01853787|Pulmonary desufflation|pulmonary desufflation
403550|NCT01853774|Tailored navigation|tailored navigation
403551|NCT01853774|Tailored messages|tailored messages
403552|NCT01853761|abdominal fat|abdominal fat
403553|NCT01853761|metabolic syndrome|metabolic syndrome
403554|NCT01853761|microcurrent|microcurrent
403555|NCT01853761|aerobic exercise|aerobic exercise
403556|NCT01853722|DCN01|dcn01
403557|NCT01853722|Ocular Surgical Preparation|ocular surgical preparation
403558|NCT01853722|Prophylaxis against infection|prophylaxis against infection
403559|NCT01853722|Pre-operative prep|pre-operative prep
403560|NCT01853683|General Surgery|general surgery
403561|NCT01853644|Cancer|cancer
403562|NCT01853644|Recurrent|recurrent
403563|NCT01853644|Ovary|ovary
403564|NCT01853644|Fallopian Tube|fallopian tube
403565|NCT01853644|Primary Peritioneal|primary peritioneal
403566|NCT01853644|Phase II|phase ii
403567|NCT01853644|Platinum Resistant|platinum resistant
403568|NCT01853631|chronic Lymphocytic Leukemia|chronic lymphocytic leukemia
403569|NCT01853631|refractory|refractory
403570|NCT01853631|recurrent|recurrent
403571|NCT01853631|aggressive B-cell Lymphoma|aggressive b-cell lymphoma
403572|NCT01853631|CD19|cd19
403573|NCT01853631|Non-Hodgkin Lymphoma|non-hodgkin lymphoma
403574|NCT01853631|CD28|cd28
403575|NCT01853631|CD137|cd137
403576|NCT01853631|4-1BB|4-1bb
403577|NCT01853631|acute lymphocytic leukemia|acute lymphocytic leukemia
403578|NCT01853618|Blocking of Immune Suppression|blocking of immune suppression
403579|NCT01853618|Monoclonal Antibody|monoclonal antibody
403580|NCT01853618|Immunotherapy|immunotherapy
403581|NCT01853618|Ablative Therapy|ablative therapy
403582|NCT01853592|Gadolinium Contrast|gadolinium contrast
403583|NCT01853592|Cardiac MRI|cardiac mri
403584|NCT01853592|MRA|mra
403585|NCT01853592|MRI|mri
403586|NCT01853592|MRI Safety|mri safety
403587|NCT01853579|Randomized controlled trial|randomized controlled trial
403588|NCT01853579|Subclinical hypothyroidism|subclinical hypothyroidism
403589|NCT01853579|Levothyroxine|levothyroxine
403590|NCT01853579|Depression|depression
403591|NCT01853566|Muscle Strength|muscle strength
403592|NCT01853566|Growth Hormone|growth hormone
403593|NCT01853566|men|men
403594|NCT01853540|Ciliary Beat Frequency (CBF)|ciliary beat frequency (cbf)
403595|NCT01853540|Nasal Nitric Oxide (nNO)|nasal nitric oxide (nno)
403596|NCT01853540|Mucociliary Dysfunction|mucociliary dysfunction
403597|NCT01853527|CT coronary angiography|ct coronary angiography
403598|NCT01853527|Contrast stress echocardiography|contrast stress echocardiography
403599|NCT01853527|Arterial stiffness|arterial stiffness
403600|NCT01853527|Quality of life|quality of life
403601|NCT01853527|Biochemical and genetic markers|biochemical and genetic markers
403602|NCT01853514|Low income|low income
403603|NCT01853514|Fruit and vegetables|fruit and vegetables
403604|NCT01853514|Conventional produce|conventional produce
403605|NCT01853514|Organic produce|organic produce
403606|NCT01853514|Pesticide|pesticide
403607|NCT01853514|Purchasing behavior|purchasing behavior
403608|NCT01853514|Message framing|message framing
403609|NCT01853501|POF|pof
403610|NCT01853488|Osteoporosis|osteoporosis
403611|NCT01853488|BMD|bmd
403612|NCT01853488|SCI|sci
403613|NCT01853488|DXA|dxa
403614|NCT01853488|pQCT|pqct
403615|NCT01853475|pharmacokinetics|pharmacokinetics
403616|NCT01853475|safety|safety
403617|NCT01853475|tolerability|tolerability
403618|NCT01853475|bioavailability|bioavailability
403619|NCT01853449|Fentanyl Citrate|fentanyl citrate
403620|NCT01853449|Opioids|opioids
403621|NCT01853449|Exercise|exercise
403622|NCT01853436|Breast Cancer|breast cancer
403623|NCT01853436|Reconstructive Tissue Matrix|reconstructive tissue matrix
403624|NCT01853436|Acellular Dermal Matrices (ADM)|acellular dermal matrices (adm)
403625|NCT01853423|Rapamune|rapamune
403626|NCT01853423|Topical|topical
403627|NCT01853423|Pediatric|pediatric
403628|NCT01853423|Safety|safety
403629|NCT01853423|Efficiency|efficiency
403630|NCT01853423|Angiofibroma|angiofibroma
403631|NCT01853423|Skin Cream|skin cream
403632|NCT01853410|coronary artery disease|coronary artery disease
403633|NCT01853410|coronary flow reserve|coronary flow reserve
403634|NCT01853410|endothelial function|endothelial function
403635|NCT01853384|Venous leg ulcer|venous leg ulcer
403636|NCT01853384|ulcer|ulcer
403637|NCT01853384|venous stasis|venous stasis
403638|NCT01853384|compression|compression
403640|NCT01853384|venous stasis ulcer|venous stasis ulcer
403641|NCT01853384|vlu|vlu
403642|NCT01853384|wound|wound
403643|NCT01853384|varicose veins|varicose veins
403644|NCT01853384|venous insufficiency|venous insufficiency
403645|NCT01853384|dvt|dvt
403646|NCT01853384|deep vein thrombosis|deep vein thrombosis
403647|NCT01853358|hematological malignancy|hematological malignancy
403648|NCT01853358|stem cell transplantation|stem cell transplantation
403649|NCT01853345|Refractory|refractory
403650|NCT01853345|Recurrent|recurrent
403651|NCT01853345|High Risk|high risk
403652|NCT01853332|Cardiovascular Disease|cardiovascular disease
403653|NCT01853332|Diabetes|diabetes
403654|NCT01853332|Adjustment|adjustment
403655|NCT01853332|Adversity|adversity
403656|NCT01853332|Psychology|psychology
403657|NCT01853332|Midlife|midlife
403658|NCT01853332|Functioning|functioning
403659|NCT01853332|Socioeconomic|socioeconomic
403660|NCT01853332|Psychosocial outcomes|psychosocial outcomes
403661|NCT01853319|Regorafenib|regorafenib
403662|NCT01853319|Metastatic colorectal cancer|metastatic colorectal cancer
403663|NCT01853306|High grade serous ovarian cancer|high grade serous ovarian cancer
403664|NCT01853306|BRCA mutated breast cancer|brca mutated breast cancer
403665|NCT01853306|BRCA mutated|brca mutated
403666|NCT01853306|Oncology|oncology
403667|NCT01853293|Alcohol Abuse|alcohol abuse
403668|NCT01853293|Alcohol Dependence|alcohol dependence
403669|NCT01853293|Heavy drinking days|heavy drinking days
403670|NCT01853293|Kudzu|kudzu
403671|NCT01853280|ADHD|adhd
403672|NCT01853280|Attention Deficit Hyperactivity Disorder|attention deficit hyperactivity disorder
403673|NCT01853280|Deplin|deplin
403674|NCT01853280|L-methylfolate|l-methylfolate
403675|NCT01853280|Natural Treatments|natural treatments
403676|NCT01853280|Medical Food|medical food
403677|NCT01853267|Colorectal|colorectal
403678|NCT01853267|Surgery|surgery
403679|NCT01853267|Perianal|perianal
403680|NCT01853267|Abscess|abscess
403681|NCT01853241|small intestine|small intestine
403682|NCT01853241|endoscopy, gastrointestinal|endoscopy, gastrointestinal
403683|NCT01853228|Acute myeloid leukemia|acute myeloid leukemia
403684|NCT01853228|Relapsed or refractory acute myeloid leukemia|relapsed or refractory acute myeloid leukemia
403685|NCT01853228|Children|children
403686|NCT01853228|Decitabine|decitabine
403687|NCT01853228|DACOGEN|dacogen
403688|NCT01853228|Cytarabine|cytarabine
403689|NCT01853215|sternal intraosseous infusion study|sternal intraosseous infusion study
403690|NCT01853202|Cancer|cancer
403691|NCT01853202|Chemotherapy|chemotherapy
516236|NCT01363635|AKI|aki
403692|NCT01853202|Thrombosis|thrombosis
403693|NCT01853202|Prevention|prevention
403694|NCT01853202|Exercise|exercise
403695|NCT01853189|pediatrics|pediatrics
403696|NCT01853189|asthma|asthma
403697|NCT01853189|osteopathic manipulative treatment|osteopathic manipulative treatment
403698|NCT01853176|Pain, Postoperative|pain, postoperative
403699|NCT01853176|Analgesia|analgesia
403700|NCT01853176|Anesthesia, local|anesthesia, local
403701|NCT01853176|Abdominoplasty|abdominoplasty
403702|NCT01853163|Gadolinium|gadolinium
403703|NCT01853163|Contrast Agent|contrast agent
403704|NCT01853163|Long-term retention|long-term retention
403705|NCT01853137|Class II division 1 malocclusion|class ii division 1 malocclusion
403706|NCT01853137|Dentofacial orthopedics|dentofacial orthopedics
403707|NCT01853137|Fixed Lingual Mandibular Growth Modificator (FLMGM)|fixed lingual mandibular growth modificator (flmgm)
403708|NCT01853124|Diarrhea|diarrhea
403709|NCT01853098|loving-kindness meditation|loving-kindness meditation
403710|NCT01853098|mindfulness meditation|mindfulness meditation
403711|NCT01853098|compassion|compassion
403712|NCT01853072|Diabetes Type I|diabetes type i
403713|NCT01853072|Diabetes Type II|diabetes type ii
403714|NCT01853072|non-proliferative diabetic retinopathy|non-proliferative diabetic retinopathy
403715|NCT01853072|macular edema|macular edema
403716|NCT01853072|Cataract|cataract
403717|NCT01853059|Anal cancer|anal cancer
403718|NCT01853059|Squamous cell cancer|squamous cell cancer
403719|NCT01853059|Radiotherapy|radiotherapy
403720|NCT01853059|Chemoradiotherapy|chemoradiotherapy
403721|NCT01853059|Conformational radiotherapy|conformational radiotherapy
403722|NCT01853059|Intensity modulated radiation therapy|intensity modulated radiation therapy
403723|NCT01853059|IMRT|imrt
403724|NCT01853046|Regorafenib|regorafenib
403725|NCT01853046|pharmacokinetics|pharmacokinetics
403726|NCT01853046|safety|safety
403727|NCT01853046|severe renal impairment|severe renal impairment
403728|NCT01853046|Solid tumors|solid tumors
403729|NCT01853033|Tolerability|tolerability
403730|NCT01853033|Immunogenicity|immunogenicity
403731|NCT01853033|Safety|safety
403732|NCT01853033|Rheumatoid Arthritis|rheumatoid arthritis
403733|NCT01853033|Pharmacokinetics|pharmacokinetics
403734|NCT01853020|Cannabinoids|cannabinoids
403735|NCT01853020|Eyeblink Conditioning|eyeblink conditioning
403736|NCT01853020|EBC|ebc
403737|NCT01853007|End stage renal disease|end stage renal disease
403738|NCT01853007|Kidney transplantation|kidney transplantation
403739|NCT01853007|Transplant options (living and deceased donor)|transplant options (living and deceased donor)
404046|NCT01851668|transfer|transfer
403740|NCT01853007|Patient education|patient education
403741|NCT01853007|Communication skills training|communication skills training
403742|NCT01852981|Physical activity promotion|physical activity promotion
403743|NCT01852981|Intervention|intervention
403744|NCT01852981|Public Health|public health
403745|NCT01852968|hypoglycemia|hypoglycemia
403746|NCT01852968|hypoglycemia unawareness|hypoglycemia unawareness
403747|NCT01852968|type 1 diabetes, hippocampus|type 1 diabetes, hippocampus
403748|NCT01852968|glucose transport|glucose transport
403749|NCT01852968|cognitive dysfunction|cognitive dysfunction
403750|NCT01852955|Outpatient|outpatient
403751|NCT01852955|Surgery|surgery
403752|NCT01852955|Breast|breast
403753|NCT01852955|Pain|pain
403754|NCT01852942|Infection|infection
403755|NCT01852942|HIV 1|hiv 1
403756|NCT01852942|HIV|hiv
403757|NCT01852942|Losartan|losartan
403758|NCT01852942|Fibrosis|fibrosis
403759|NCT01852942|Immune Activation|immune activation
403760|NCT01852942|Immune Reconstitution|immune reconstitution
403761|NCT01852929|Memory|memory
403762|NCT01852916|RDS|rds
403763|NCT01852903|vitamin C|vitamin c
403764|NCT01852903|calcium ascorbate|calcium ascorbate
403765|NCT01852903|ascorbic acid|ascorbic acid
403766|NCT01852903|bioavailability|bioavailability
403767|NCT01852890|Ascorbate|ascorbate
403768|NCT01852890|Vitamin C|vitamin c
403769|NCT01852890|Radiation|radiation
403770|NCT01852890|Gemcitabine|gemcitabine
403771|NCT01852890|Ascorbic Acid|ascorbic acid
403772|NCT01852877|HIV Diagnosis|hiv diagnosis
403773|NCT01852877|Case Management|case management
403774|NCT01852877|Telemedicine|telemedicine
403775|NCT01852877|Patient Compliance|patient compliance
403776|NCT01852877|Prisoners|prisoners
403777|NCT01852864|Prostate cancer|prostate cancer
403778|NCT01852864|testosterone|testosterone
403779|NCT01852864|castration|castration
403780|NCT01852864|degarelix|degarelix
403781|NCT01852864|proliferation|proliferation
403782|NCT01852838|lung cancer|lung cancer
403783|NCT01852838|volatile organic compounds|volatile organic compounds
403784|NCT01852838|Warburg effect|warburg effect
403785|NCT01852838|early detection|early detection
403786|NCT01852799|Multiple myeloma|multiple myeloma
403787|NCT01852799|PAD|pad
403788|NCT01852799|ASCT|asct
403789|NCT01852799|Bone metabolites|bone metabolites
403790|NCT01852799|Bone marker|bone marker
403791|NCT01852786|Contraception|contraception
403792|NCT01852786|Hyperandrogenism|hyperandrogenism
403793|NCT01852786|Female sexual function|female sexual function
403794|NCT01852773|blunt|blunt
403795|NCT01852773|injury|injury
403796|NCT01852773|aorta|aorta
403797|NCT01852773|endovascular|endovascular
403798|NCT01852760|endoscopic ultrasound|endoscopic ultrasound
403799|NCT01852760|ulcerative colitis|ulcerative colitis
403800|NCT01852760|inflammatory bowel disease|inflammatory bowel disease
403801|NCT01852747|Spinal Deformity|spinal deformity
403802|NCT01852747|Multilevel|multilevel
403803|NCT01852747|Posterior|posterior
403804|NCT01852747|Lumbar|lumbar
403805|NCT01852747|Fusion|fusion
403806|NCT01852747|Levoscoliosis|levoscoliosis
403807|NCT01852747|Dextroscoliosis|dextroscoliosis
403808|NCT01852747|Graft|graft
403809|NCT01852721|Cardiovascular diseases|cardiovascular diseases
403810|NCT01852721|Nutritional intervention program|nutritional intervention program
403811|NCT01852721|Self-Determination Theory|self-determination theory
403812|NCT01852721|Motivational interviewing|motivational interviewing
403813|NCT01852721|Gender differences|gender differences
403814|NCT01852721|Women|women
403815|NCT01852721|Men|men
403816|NCT01852721|Motivation|motivation
403817|NCT01852721|Dietary intakes|dietary intakes
403818|NCT01852721|Mediterranean diet|mediterranean diet
403819|NCT01852721|Eating behaviors|eating behaviors
403820|NCT01852721|Lipid profile|lipid profile
403821|NCT01852708|22q|22q
403822|NCT01852708|1p36|1p36
403823|NCT01852708|Angelman|angelman
403824|NCT01852708|Cri-du-chat|cri-du-chat
403825|NCT01852708|Prader-Willi|prader-willi
403826|NCT01852708|DiGeorge|digeorge
403827|NCT01852708|Turner syndrome|turner syndrome
403828|NCT01852708|Patau syndrome|patau syndrome
403829|NCT01852708|Edwards syndrome|edwards syndrome
403830|NCT01852708|Down syndrome|down syndrome
403831|NCT01852695|Family integrated Care|family integrated care
403832|NCT01852695|Family centered care|family centered care
403833|NCT01852695|NICU family centered care|nicu family centered care
403834|NCT01852695|NICU parent program|nicu parent program
403835|NCT01852682|Peritoneal Dialysis|peritoneal dialysis
403836|NCT01852682|Hyperphosphatemia|hyperphosphatemia
403837|NCT01852656|Influenza, Human|influenza, human
403838|NCT01852656|Immunization|immunization
403839|NCT01852643|Rhinoplasty|rhinoplasty
403840|NCT01852643|Spreader graft technique|spreader graft technique
403841|NCT01852643|Lateral crural overlay technique|lateral crural overlay technique
403842|NCT01852643|Rhinomanometry|rhinomanometry
403843|NCT01852617|Smoking Cessation|smoking cessation
403844|NCT01852617|Pregnancy|pregnancy
403845|NCT01852617|Implementation|implementation
403846|NCT01852617|Knowledge translation|knowledge translation
403848|NCT01852604|Hepatitis C|hepatitis c
403849|NCT01852604|chronic hepatitis C|chronic hepatitis c
403850|NCT01852604|antiviral|antiviral
403851|NCT01852591|autologous transplant|autologous transplant
403852|NCT01852591|multiple myeloma|multiple myeloma
403853|NCT01852578|Metastatic NSCLC|metastatic nsclc
403854|NCT01852578|2nd Line|2nd line
403855|NCT01852578|Docetaxel-based treatment|docetaxel-based treatment
403856|NCT01852578|Progressed|progressed
403857|NCT01852578|Refractory|refractory
403858|NCT01852565|CYP3A4|cyp3a4
403859|NCT01852565|Lp-PLA2|lp-pla2
403860|NCT01852565|Atherosclerosis|atherosclerosis
403861|NCT01852565|healthy volunteer|healthy volunteer
403862|NCT01852565|Drug interaction|drug interaction
403863|NCT01852552|Aortic stenosis|aortic stenosis
403864|NCT01852552|Transcatheter aortic valve implantation|transcatheter aortic valve implantation
403865|NCT01852552|Aortic valve replacement|aortic valve replacement
403866|NCT01852552|Costs|costs
403867|NCT01852552|Cognitive function|cognitive function
403868|NCT01852552|Quality of life|quality of life
403869|NCT01852539|LMA insertion|lma insertion
403870|NCT01852539|dexmedetomidine|dexmedetomidine
403871|NCT01852539|propofol|propofol
403872|NCT01852526|degenerative disc disease|degenerative disc disease
403873|NCT01852526|spondylolisthesis|spondylolisthesis
403874|NCT01852526|Lumbar spine|lumbar spine
403875|NCT01852526|fusion|fusion
403876|NCT01852526|adjacent instability|adjacent instability
403877|NCT01852487|Pumpkin seed oil|pumpkin seed oil
403878|NCT01852487|Hair growth|hair growth
403879|NCT01852487|Men|men
403880|NCT01852474|motor learning|motor learning
403881|NCT01852474|cortical plasticity|cortical plasticity
403882|NCT01852474|direct current stimulation|direct current stimulation
403883|NCT01852461|natural surfactants; perfusion index|natural surfactants; perfusion index
403884|NCT01852435|diffuse large B-cell lymphoma|diffuse large b-cell lymphoma
403885|NCT01852435|follicular lymphoma grade 3B|follicular lymphoma grade 3b
403886|NCT01852409|refractory malignant ascites|refractory malignant ascites
403887|NCT01852409|Bevacizumab|bevacizumab
403888|NCT01852409|intraperitoneal|intraperitoneal
403889|NCT01852409|phase I|phase i
403890|NCT01852396|Infraclavicular block|infraclavicular block
403891|NCT01852396|Brachial Plexus|brachial plexus
403892|NCT01852396|Retroclavicular Approach|retroclavicular approach
403893|NCT01852396|Complications of retroclavicular approach|complications of retroclavicular approach
403894|NCT01852396|Success of retroclavicular approach|success of retroclavicular approach
403895|NCT01852383|Duloxetine|duloxetine
403896|NCT01852383|Antidepressant|antidepressant
403897|NCT01852383|Depression|depression
403898|NCT01852383|Dysthymic Disorder|dysthymic disorder
403899|NCT01852383|Side Effects|side effects
403900|NCT01852383|Elderly|elderly
403901|NCT01852370|Lung transplantation|lung transplantation
403902|NCT01852370|Bone Marrow Transplantation|bone marrow transplantation
403903|NCT01852370|Unrelated Donor|unrelated donor
403904|NCT01852370|Cadaveric Donor|cadaveric donor
403905|NCT01852370|Deceased Donor|deceased donor
403906|NCT01852370|HLA-mismatch|hla-mismatch
403907|NCT01852370|BOLT|bolt
403908|NCT01852370|BMT|bmt
403909|NCT01852370|HSCT|hsct
403910|NCT01852344|Methylphenidate|methylphenidate
403911|NCT01852344|Effortful Control|effortful control
403912|NCT01852344|Attention Control|attention control
403913|NCT01852344|Cognitive functions|cognitive functions
403914|NCT01852331|Schizophrenia|schizophrenia
403915|NCT01852331|Schizophrenic Disorder|schizophrenic disorder
403916|NCT01852331|Hyperprolactinemia|hyperprolactinemia
403917|NCT01852331|Hyperprolactinaemia|hyperprolactinaemia
403918|NCT01852331|Chinese herbal medicine|chinese herbal medicine
403919|NCT01852331|Traditional Chinese medicine|traditional chinese medicine
403920|NCT01852331|Peony-Glycyrrhiza Decoction|peony-glycyrrhiza decoction
403921|NCT01852331|PGD|pgd
403922|NCT01852331|Glycyrrhiza Radix|glycyrrhiza radix
403923|NCT01852331|Liquorice Root|liquorice root
403924|NCT01852331|Gancao|gancao
403925|NCT01852331|Paeoniae Alba Radix|paeoniae alba radix
403926|NCT01852331|White Peony Root|white peony root
403927|NCT01852331|Baishao|baishao
403928|NCT01852318|uremic pruritus|uremic pruritus
403929|NCT01852318|pregabalin|pregabalin
403930|NCT01852318|gabapentin|gabapentin
403931|NCT01852318|fexofenadine|fexofenadine
403932|NCT01852305|Obstructive sleep apnea|obstructive sleep apnea
403933|NCT01852305|Continuous positive airway pressure (CPAP)|continuous positive airway pressure (cpap)
403934|NCT01852305|Oximetry|oximetry
403935|NCT01852305|Bariatric Surgery|bariatric surgery
403936|NCT01852305|Anesthesia|anesthesia
403937|NCT01852305|Oxygen desaturation index (ODI)|oxygen desaturation index (odi)
403938|NCT01852292|platinum pre-treated recurrent or metastatic|platinum pre-treated recurrent or metastatic
403939|NCT01852292|Head and neck squamous cell carcinoma|head and neck squamous cell carcinoma
403940|NCT01852292|recurrent|recurrent
403941|NCT01852292|metastatic|metastatic
403942|NCT01852292|BKM120|bkm120
403943|NCT01852253|Dental implants|dental implants
403944|NCT01852253|Periodontal diseases|periodontal diseases
403945|NCT01852253|Peri-implantitis|peri-implantitis
403946|NCT01852253|Chlorhexidine|chlorhexidine
403947|NCT01852253|Microbiology|microbiology
403948|NCT01852214|Diabetes mellitus|diabetes mellitus
403949|NCT01852214|Coronary artery disease|coronary artery disease
403950|NCT01852214|prasugrel|prasugrel
403951|NCT01852214|ticagrelor|ticagrelor
403952|NCT01852188|Intrapartum|intrapartum
403954|NCT01852188|Chorioamnionitis|chorioamnionitis
403955|NCT01852175|Coronary artery disease|coronary artery disease
403956|NCT01852175|Dual antiplatelet therapy|dual antiplatelet therapy
403957|NCT01852175|prasugrel|prasugrel
403958|NCT01852175|ticagrelor|ticagrelor
403959|NCT01852162|Coronary artery disease|coronary artery disease
403960|NCT01852162|antiplatelet therapy|antiplatelet therapy
403961|NCT01852162|anticoagulant therapy|anticoagulant therapy
403962|NCT01852149|Mitral Valve Regurgitation|mitral valve regurgitation
403963|NCT01852149|Coaptation|coaptation
403964|NCT01852149|Mitral Valve Repair|mitral valve repair
403965|NCT01852149|Plication|plication
403966|NCT01852149|Leaflet|leaflet
403967|NCT01852149|Annulus|annulus
403968|NCT01852149|Mitral Annuloplasty|mitral annuloplasty
403969|NCT01852136|pen needle|pen needle
403970|NCT01852136|insulin|insulin
403971|NCT01852123|High-sensitivity troponin assay|high-sensitivity troponin assay
403972|NCT01852123|Myocardial infarction|myocardial infarction
403973|NCT01852123|Unstable angina|unstable angina
403974|NCT01852123|Myocardial injury|myocardial injury
403975|NCT01852123|Cluster randomized trial|cluster randomized trial
403976|NCT01852097|Inflammatory Bowel Disease (IBD)|inflammatory bowel disease (ibd)
403977|NCT01852097|Crohn's disease|crohn's disease
403978|NCT01852097|Ulcerative colitis|ulcerative colitis
403979|NCT01852097|Cognitive Behavioural Therapy (CBT)|cognitive behavioural therapy (cbt)
403980|NCT01852097|Medication adherence|medication adherence
403981|NCT01852071|gene therapy, hematopoietic stem cell, SCID, lentivirus|gene therapy, hematopoietic stem cell, scid, lentivirus
403982|NCT01852032|Breast Cancer|breast cancer
403983|NCT01852019|CAD|cad
403984|NCT01851993|Ondansetron|ondansetron
403985|NCT01851993|Exercise|exercise
403986|NCT01851980|Furosemide|furosemide
403987|NCT01851980|Exercise|exercise
403988|NCT01851980|Restrictive pulmonary disorder|restrictive pulmonary disorder
403989|NCT01851967|Major depressive disorder|major depressive disorder
403990|NCT01851967|Cognitive behavioral therapy|cognitive behavioral therapy
403991|NCT01851967|Computerized CBT|computerized cbt
403992|NCT01851967|Online CBT|online cbt
403993|NCT01851915|Major depression|major depression
403994|NCT01851915|Interpersonal psychotherapy|interpersonal psychotherapy
403995|NCT01851915|Cognitive Behavioral Therapy|cognitive behavioral therapy
403996|NCT01851915|Alliance|alliance
403997|NCT01851915|Return to Work|return to work
403998|NCT01851902|Atrial Fibrillation|atrial fibrillation
403999|NCT01851902|Atrial Flutter|atrial flutter
404000|NCT01851902|Arrhythmia|arrhythmia
404001|NCT01851863|functional dyspepsia|functional dyspepsia
404002|NCT01851863|depression|depression
404003|NCT01851863|compliance|compliance
404004|NCT01851850|PD|pd
404005|NCT01851850|Off periods|off periods
404006|NCT01851850|quality of life|quality of life
404007|NCT01851850|dyskinesia|dyskinesia
404008|NCT01851850|end-off-dose motor fluctuations|end-off-dose motor fluctuations
404009|NCT01851811|OSA|osa
404010|NCT01851798|OSA|osa
404011|NCT01851798|Sleep disordered breathing|sleep disordered breathing
404012|NCT01851798|anesthesia|anesthesia
404013|NCT01851798|ambulatory orthopedic surgery|ambulatory orthopedic surgery
404014|NCT01851785|Knee Arthroplasty|knee arthroplasty
404015|NCT01851785|Knee Osteoarthritis|knee osteoarthritis
404016|NCT01851785|Osteoarthritis|osteoarthritis
404017|NCT01851785|disparity|disparity
404018|NCT01851785|joint replacement|joint replacement
404019|NCT01851772|cervical|cervical
404020|NCT01851772|cancer|cancer
404021|NCT01851772|brachytherapy|brachytherapy
404022|NCT01851772|electronic|electronic
404023|NCT01851772|device|device
404024|NCT01851772|applicator|applicator
404025|NCT01851772|toxicity|toxicity
404026|NCT01851772|gynecologic|gynecologic
404027|NCT01851772|high-dose-rate (HDR)|high-dose-rate (hdr)
404028|NCT01851772|x-ray|x-ray
404029|NCT01851772|safety|safety
404030|NCT01851772|external beam radiation therapy (EBRT)|external beam radiation therapy (ebrt)
404031|NCT01851746|recurrent ovarian cancer|recurrent ovarian cancer
404032|NCT01851746|lobaplatin|lobaplatin
404033|NCT01851746|docetaxel|docetaxel
404034|NCT01851746|carboplatin|carboplatin
404035|NCT01851694|Cystic Fibrosis|cystic fibrosis
404036|NCT01851694|Diabetes|diabetes
404037|NCT01851694|Pancreatic insufficiency|pancreatic insufficiency
404038|NCT01851694|Cystic Fibrosis with Normal Glucose Tolerance|cystic fibrosis with normal glucose tolerance
404039|NCT01851694|Non-Cystic Fibrosis control group|non-cystic fibrosis control group
404040|NCT01851681|dental implants|dental implants
404041|NCT01851681|wound healing|wound healing
404042|NCT01851681|amoxicillin|amoxicillin
404043|NCT01851681|pain|pain
404044|NCT01851668|vibration|vibration
404045|NCT01851668|noise|noise
404047|NCT01851668|intraventricular hemorrhage|intraventricular hemorrhage
404048|NCT01851655|rehabilitation|rehabilitation
404049|NCT01851655|plyometric|plyometric
404050|NCT01851642|Macrophage|macrophage
404051|NCT01851642|Alpha-1 Antitrypsin Deficiency|alpha-1 antitrypsin deficiency
404052|NCT01851642|Cystic Fibrosis|cystic fibrosis
404053|NCT01851629|Locomotor training|locomotor training
404054|NCT01851629|Walking recovery|walking recovery
404055|NCT01851629|Neuroplasticity|neuroplasticity
404056|NCT01851616|glucose, blood|glucose, blood
404057|NCT01851603|Schizophrenia|schizophrenia
404058|NCT01851590|Dermatophyte onychomycosis|dermatophyte onychomycosis
404059|NCT01851590|Fungal nail infection|fungal nail infection
404060|NCT01851590|Resin Lacquer|resin lacquer
404061|NCT01851590|Amorolfine|amorolfine
404062|NCT01851590|Terbinafine|terbinafine
404063|NCT01851577|Coparenting|coparenting
404064|NCT01851577|Problem solving|problem solving
404065|NCT01851577|Child development|child development
404066|NCT01851577|Father involvement|father involvement
404067|NCT01851564|Gastrointestinal Haemorrhage|gastrointestinal haemorrhage
404068|NCT01851564|Varices|varices
404069|NCT01851564|Liver Cirrhosis|liver cirrhosis
404070|NCT01851564|Stent|stent
404071|NCT01851551|NHL|nhl
404072|NCT01851551|non-Hodgkin's lymphoma|non-hodgkin's lymphoma
404073|NCT01851551|diffuse large b-cell lymphoma|diffuse large b-cell lymphoma
404074|NCT01851551|mantle cell lymphoma|mantle cell lymphoma
404075|NCT01851538|Heart failure|heart failure
404076|NCT01851538|Biomarkers|biomarkers
404077|NCT01851538|Echocardiography|echocardiography
404078|NCT01851525|Atrial fibrillation|atrial fibrillation
404079|NCT01851525|Ablation|ablation
404080|NCT01851499|Neuropathic pain following spinal cord injury|neuropathic pain following spinal cord injury
404081|NCT01851473|Cocaine|cocaine
404082|NCT01851473|Pharmacokinetics|pharmacokinetics
404083|NCT01851473|Pharmacodynamics|pharmacodynamics
404084|NCT01851473|Drug Interactions|drug interactions
404085|NCT01851473|Acetazolamide|acetazolamide
404086|NCT01851460|Non-surgical Liver Lesions|non-surgical liver lesions
404087|NCT01851460|Chronic Granulomatous Disease (CGD)|chronic granulomatous disease (cgd)
404088|NCT01851460|Microorganisms|microorganisms
404089|NCT01851460|Bacteria|bacteria
404090|NCT01851460|Liver Lesions|liver lesions
404091|NCT01851447|Membrane Wound|membrane wound
404092|NCT01851447|Inflammatory Cytokines|inflammatory cytokines
404093|NCT01851447|Exercise|exercise
404094|NCT01851447|Plasma Membrane Repair|plasma membrane repair
404095|NCT01851447|Predictors of Outcome|predictors of outcome
404096|NCT01851434|OCT|oct
404097|NCT01851434|Multiple Sclerosis|multiple sclerosis
404098|NCT01851434|Optic Neuritis|optic neuritis
404099|NCT01851434|Magnetic Resonance Imaging (MRI)|magnetic resonance imaging (mri)
404100|NCT01851421|Lipogenesis|lipogenesis
404101|NCT01851421|Adult|adult
404102|NCT01851421|Obesity|obesity
404103|NCT01851421|LIPOLYSIS|lipolysis
404104|NCT01851421|Melanocortin-3 Receptor|melanocortin-3 receptor
404105|NCT01851408|Sorafenib|sorafenib
404106|NCT01851408|Temsirolimus|temsirolimus
404107|NCT01851408|Stage IV|stage iv
404108|NCT01851408|recurrent|recurrent
404109|NCT01851408|unresectable|unresectable
404110|NCT01851408|non-choroidal origin|non-choroidal origin
404111|NCT01851408|CCI-779|cci-779
404112|NCT01851408|BAY43-9006|bay43-9006
404113|NCT01851408|metastatic melanoma|metastatic melanoma
404114|NCT01851395|Palliative|palliative
404115|NCT01851395|Tumor Heterogeneity|tumor heterogeneity
404116|NCT01851395|Genomic and Proteomic Alterations|genomic and proteomic alterations
404117|NCT01851395|Deep Sequencing and Global Analysis|deep sequencing and global analysis
404118|NCT01851395|Clonal Evolution|clonal evolution
404119|NCT01851382|ELISA|elisa
404120|NCT01851382|Spectrometry|spectrometry
404121|NCT01851382|Protein Biomarkers|protein biomarkers
404122|NCT01851382|Proteomic Analyses|proteomic analyses
404123|NCT01851369|Solid Tumors|solid tumors
404124|NCT01851369|Lymphomas|lymphomas
404125|NCT01851369|DNA Damage|dna damage
404126|NCT01851369|Pharmacodynamics|pharmacodynamics
404127|NCT01851369|Pharmacokinetics|pharmacokinetics
404128|NCT01851356|PBR28|pbr28
404129|NCT01851356|Depression|depression
404130|NCT01851356|PET Imaging|pet imaging
404131|NCT01851356|Neuroinflammation|neuroinflammation
404132|NCT01851343|Stem Cell Infusion|stem cell infusion
404133|NCT01851343|Crohns|crohns
404134|NCT01851343|Ulcerative Colitis|ulcerative colitis
404135|NCT01851343|Inflammation|inflammation
404136|NCT01851343|Diarrhea|diarrhea
404137|NCT01851330|HCV genotype 1 (GT-1)|hcv genotype 1 (gt-1)
404138|NCT01851330|HCV|hcv
404139|NCT01851330|Sustained Virologic Response|sustained virologic response
404140|NCT01851330|Direct Acting Antiviral|direct acting antiviral
404141|NCT01851330|Combination Therapy|combination therapy
404142|NCT01851330|GS-7977|gs-7977
404143|NCT01851330|GS-5885|gs-5885
404144|NCT01851330|Ribavirin|ribavirin
404145|NCT01851330|Open Label|open label
404146|NCT01851330|Sofosbuvir|sofosbuvir
404147|NCT01851330|Additional relevant MeSH terms:|additional relevant mesh terms:
404148|NCT01851330|Hepatitis|hepatitis
404441|NCT01850082|CABG|cabg
404149|NCT01851330|Hepatitis, Chronic|hepatitis, chronic
404150|NCT01851330|Hepatitis C|hepatitis c
404151|NCT01851330|Hepatitis C, Chronic|hepatitis c, chronic
404152|NCT01851330|Liver Diseases|liver diseases
404153|NCT01851330|Digestive System Diseases|digestive system diseases
404154|NCT01851330|Hepatitis, Viral, Human|hepatitis, viral, human
404155|NCT01851330|Virus Diseases|virus diseases
404156|NCT01851330|Enterovirus Infections|enterovirus infections
404157|NCT01851330|Picornaviridae Infections|picornaviridae infections
404158|NCT01851330|RNA Virus Infections|rna virus infections
404159|NCT01851330|Flaviviridae Infections|flaviviridae infections
404160|NCT01851330|Antiviral Agents|antiviral agents
404161|NCT01851330|Anti-Infective Agents|anti-infective agents
404162|NCT01851330|Therapeutic Uses|therapeutic uses
404163|NCT01851330|Pharmacologic Actions|pharmacologic actions
404164|NCT01851330|Antimetabolites|antimetabolites
404165|NCT01851330|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action
404166|NCT01851304|beta-Glucans|beta-glucans
404167|NCT01851304|Bitter|bitter
404168|NCT01851304|Bread|bread
404169|NCT01851304|Coffee|coffee
404170|NCT01851304|Gentiana lutea|gentiana lutea
404171|NCT01851304|Melanoidins|melanoidins
404172|NCT01851304|Microencapsulation|microencapsulation
404173|NCT01851278|injection|injection
404174|NCT01851278|arthritis|arthritis
404175|NCT01851278|corticosteroid|corticosteroid
404176|NCT01851265|oncology, cancer, tumour, neoplasm, anticancer drug, food effect, area under the curve, pharmacokinetics, olaparib, solid tumour, metabolites, drug availability|oncology, cancer, tumour, neoplasm, anticancer drug, food effect, area under the curve, pharmacokinetics, olaparib, solid tumour, metabolites, drug availability
404177|NCT01851252|Cirrhotics|cirrhotics
404178|NCT01851252|Esophageal varices|esophageal varices
404179|NCT01851252|Portal Hypertension|portal hypertension
404180|NCT01851239|Venous Thromboembolism Prophylaxis|venous thromboembolism prophylaxis
404181|NCT01851239|ICU|icu
404182|NCT01851213|genomics|genomics
404183|NCT01851213|cancer|cancer
404184|NCT01851213|registry|registry
404185|NCT01851213|neoplasm metastasis|neoplasm metastasis
404186|NCT01851200|Testicular neoplasms|testicular neoplasms
516813|NCT01361386|Asia|asia
404187|NCT01851200|Germ Cell cancers|germ cell cancers
404188|NCT01851200|Embryonal Carcinoma|embryonal carcinoma
404189|NCT01851200|Metastatic|metastatic
404190|NCT01851200|Brentuximab Vedotin|brentuximab vedotin
404191|NCT01851187|Psychological intervention,|psychological intervention,
404192|NCT01851187|prenatal period,|prenatal period,
404193|NCT01851187|cesarean section rate,|cesarean section rate,
404194|NCT01851187|stage of labor|stage of labor
404195|NCT01851148|osteopathic manipulative treatment|osteopathic manipulative treatment
404196|NCT01851148|migraine|migraine
404197|NCT01851135|Quality of life|quality of life
404198|NCT01851135|Neuropsychological disorders|neuropsychological disorders
404199|NCT01851135|Neurofibromatosis type 1|neurofibromatosis type 1
404200|NCT01851122|l-theanine|l-theanine
404201|NCT01851122|alertness|alertness
404202|NCT01851122|well-being|well-being
404203|NCT01851109|ovarian cancer|ovarian cancer
404204|NCT01851109|prevention|prevention
404205|NCT01851109|prophylactic surgery|prophylactic surgery
404206|NCT01851109|risk|risk
404207|NCT01851109|biomarkers|biomarkers
404208|NCT01851109|screening|screening
404209|NCT01851109|symptoms|symptoms
404210|NCT01851096|Hsp90|hsp90
404211|NCT01851096|SNX-5422|snx-5422
404212|NCT01851096|Erlotinib|erlotinib
404213|NCT01851096|Lung adenocarcinoma|lung adenocarcinoma
404214|NCT01851083|Traumatic Brain Injury|traumatic brain injury
404215|NCT01851083|TBI|tbi
404216|NCT01851083|pediatric|pediatric
404217|NCT01851083|acute|acute
404218|NCT01851083|stem cells|stem cells
404219|NCT01851057|Epilepsy|epilepsy
404220|NCT01851044|Platelet Rich Plasma|platelet rich plasma
404221|NCT01851044|Whole Blood Injection|whole blood injection
404222|NCT01851044|Lateral Epicondylitis|lateral epicondylitis
404223|NCT01851044|Tennis Elbow|tennis elbow
404224|NCT01851031|medial or low condylar fractures|medial or low condylar fractures
404225|NCT01851031|the minor parotid anterior approach|the minor parotid anterior approach
404226|NCT01851031|the retromandibular approach|the retromandibular approach
404227|NCT01851018|Prostate cancer|prostate cancer
404228|NCT01851018|brachytherapy|brachytherapy
404229|NCT01851018|hypofractionated radiation therapy|hypofractionated radiation therapy
404230|NCT01851018|hormonal therapy|hormonal therapy
404231|NCT01851005|Dexmedetomidine|dexmedetomidine
404232|NCT01851005|Anesthesia|anesthesia
404233|NCT01851005|Recovery profile|recovery profile
404234|NCT01850992|Obstructive sleep apnea.|obstructive sleep apnea.
404235|NCT01850992|sleep|sleep
404236|NCT01850992|male hormones|male hormones
404237|NCT01850979|CYCLOSPORINE/TACROLIMUS [VA Drug Interaction]|cyclosporine/tacrolimus [va drug interaction]
404238|NCT01850966|Arthritis, Rheumatoid, Iguratimod|arthritis, rheumatoid, iguratimod
404239|NCT01850953|Varenicline|varenicline
404240|NCT01850953|Schizophrenia|schizophrenia
404241|NCT01850953|smoking|smoking
404242|NCT01850953|Lapse|lapse
404243|NCT01850940|Cirrhotic Patients|cirrhotic patients
404244|NCT01850940|Hyponatremia|hyponatremia
404245|NCT01850940|tolvaptan|tolvaptan
404246|NCT01850914|Normal pressure hydrocephalus|normal pressure hydrocephalus
404247|NCT01850914|Vascular risk factors|vascular risk factors
404248|NCT01850901|Hypertension|hypertension
404249|NCT01850901|Renal denervation|renal denervation
404250|NCT01850901|Sympathetic denervation|sympathetic denervation
404251|NCT01850888|neuroblastoma|neuroblastoma
404252|NCT01850888|pheochromocytoma|pheochromocytoma
404253|NCT01850875|Eye-Movement-Desensitization and Reprocessing|eye-movement-desensitization and reprocessing
404254|NCT01850875|EMDR|emdr
404255|NCT01850875|Chronic back pain|chronic back pain
404256|NCT01850875|CBP|cbp
404257|NCT01850875|treatment|treatment
404258|NCT01850836|Aphasia, Stroke, repetitive transcranial magnetic stimulation.|aphasia, stroke, repetitive transcranial magnetic stimulation.
404259|NCT01850797|oral anticoagulants|oral anticoagulants
404260|NCT01850797|ischemic stroke|ischemic stroke
404261|NCT01850797|blood thinner|blood thinner
404262|NCT01850797|intracranial hemorrhage|intracranial hemorrhage
404263|NCT01850784|Congenital heart disease, Growth,Neurodevelopment|congenital heart disease, growth,neurodevelopment
404264|NCT01850771|Lumbar Radiculopathy|lumbar radiculopathy
404265|NCT01850771|Disc bulge|disc bulge
404266|NCT01850771|Disc herniation|disc herniation
404267|NCT01850771|Disc degeneration|disc degeneration
404268|NCT01850758|ACL|acl
404269|NCT01850758|Anterior Cruciate Ligament|anterior cruciate ligament
404270|NCT01850758|ACL Tear|acl tear
404271|NCT01850758|Anterior Cruciate Ligament Tear|anterior cruciate ligament tear
404272|NCT01850758|Partial ACL Tear|partial acl tear
404273|NCT01850745|Chronic hepatitis C virus infection (CHC)|chronic hepatitis c virus infection (chc)
404274|NCT01850719|Tibial meniscus|tibial meniscus
404275|NCT01850719|Arthroscopy|arthroscopy
404276|NCT01850719|Meniscectomy|meniscectomy
404277|NCT01850719|Conservative treatment|conservative treatment
404278|NCT01850719|Physical therapy|physical therapy
404279|NCT01850719|Osteoarthritis knee joint|osteoarthritis knee joint
404280|NCT01850706|uNGF|ungf
404281|NCT01850706|urinary nerve growth factor|urinary nerve growth factor
404282|NCT01850706|detrusor overactivity|detrusor overactivity
404283|NCT01850706|InterStim|interstim
404284|NCT01850706|sacral neuromodulation|sacral neuromodulation
404285|NCT01850706|sacral nerve stimulation|sacral nerve stimulation
404286|NCT01850706|quality of life|quality of life
404287|NCT01850706|questionnaire|questionnaire
404288|NCT01850706|urodynamic detrusor overactivity|urodynamic detrusor overactivity
404289|NCT01850706|overactive bladder|overactive bladder
404290|NCT01850693|coronary artery disease|coronary artery disease
404291|NCT01850693|stroke|stroke
404292|NCT01850693|coronary CT angiography|coronary ct angiography
404293|NCT01850667|Hepatocellular carcinoma|hepatocellular carcinoma
404294|NCT01850667|Stereotactic body radiotherapy|stereotactic body radiotherapy
404295|NCT01850667|Stereotactic ablative radiotherapy|stereotactic ablative radiotherapy
404296|NCT01850654|colorectal cancer|colorectal cancer
404297|NCT01850654|colon cancer|colon cancer
404298|NCT01850654|rectal cancer|rectal cancer
404299|NCT01850654|endometrial cancer|endometrial cancer
404300|NCT01850654|Lynch syndrome|lynch syndrome
404301|NCT01850654|Ohio colon cancer study|ohio colon cancer study
404302|NCT01850654|OSU colon study|osu colon study
404303|NCT01850641|Hemodialysis|hemodialysis
404304|NCT01850641|Hyperphosphatemia|hyperphosphatemia
404305|NCT01850628|National Surgical Adjuvant Breast and Bowel Project (NSABP)|national surgical adjuvant breast and bowel project (nsabp)
404306|NCT01850628|paclitaxel|paclitaxel
404307|NCT01850628|trastuzumab|trastuzumab
404308|NCT01850628|pertuzumab|pertuzumab
404309|NCT01850628|HER2 positive (human epidermal growth factor receptor 2)|her2 positive (human epidermal growth factor receptor 2)
404310|NCT01850628|Proteomics|proteomics
404311|NCT01850628|Neoadjuvant Therapy|neoadjuvant therapy
404312|NCT01850628|Anthracycline therapy|anthracycline therapy
404313|NCT01850628|Locally advanced|locally advanced
404314|NCT01850628|Operable|operable
404315|NCT01850628|Biomarkers|biomarkers
404316|NCT01850602|Hemodialysis|hemodialysis
404317|NCT01850602|Hyperphosphatemia|hyperphosphatemia
404318|NCT01850576|prevention|prevention
404319|NCT01850576|testing|testing
404320|NCT01850576|counseling|counseling
404321|NCT01850576|linkage|linkage
404322|NCT01850563|Demonstrate coordination of HBO with SRS treatments is feasible.|demonstrate coordination of hbo with srs treatments is feasible.
404323|NCT01850563|Demonstrate outcomes for patients treated with combination of HBO and SRS are non-inferior .|demonstrate outcomes for patients treated with combination of hbo and srs are non-inferior .
404324|NCT01850550|Weight loss|weight loss
404325|NCT01850537|DDD|ddd
404326|NCT01850537|PROW|prow
404327|NCT01850537|FUSION|fusion
404328|NCT01850537|eSPIN|espin
404329|NCT01850537|Cage|cage
404330|NCT01850537|IBF|ibf
404331|NCT01850537|Discectomy|discectomy
404332|NCT01850537|Lumbar Fusion|lumbar fusion
404333|NCT01850537|TLIF|tlif
404334|NCT01850537|MIS|mis
404335|NCT01850524|Newly Diagnosed multiple myeloma|newly diagnosed multiple myeloma
404336|NCT01850524|multiple myeloma|multiple myeloma
404337|NCT01850524|MLN9708|mln9708
404338|NCT01850524|IXAZOMIB|ixazomib
404339|NCT01850524|Proteasome inhibitor|proteasome inhibitor
404639|NCT01849029|HIV risk|hiv risk
404340|NCT01850524|Tourmaline MM2|tourmaline mm2
404341|NCT01850511|Nasal obstruction|nasal obstruction
404342|NCT01850511|Vibrissae|vibrissae
404343|NCT01850511|Nasal hair|nasal hair
404344|NCT01850498|Epilepsy|epilepsy
404345|NCT01850498|Seizure|seizure
404346|NCT01850498|Motor|motor
404347|NCT01850498|Motion|motion
404348|NCT01850498|Accelerometer|accelerometer
404349|NCT01850485|cardiac arrest|cardiac arrest
404350|NCT01850485|therapeutic hypothermia|therapeutic hypothermia
404351|NCT01850485|microcirculation|microcirculation
404352|NCT01850472|Anhedonia|anhedonia
404353|NCT01850472|Depression|depression
404354|NCT01850472|Stress|stress
404355|NCT01850472|Cortisol|cortisol
404356|NCT01850472|Inflammatory cytokines|inflammatory cytokines
404357|NCT01850472|Learning|learning
404358|NCT01850472|Magnetic resonance imaging (MRI)|magnetic resonance imaging (mri)
404359|NCT01850433|BDD|bdd
404360|NCT01850433|CBT|cbt
404361|NCT01850420|fibromyalgia|fibromyalgia
404362|NCT01850420|Myofascial|myofascial
404363|NCT01850407|Lack of Preparation for Abused Children during Medical Examination|lack of preparation for abused children during medical examination
404364|NCT01850381|Parkinson Disease|parkinson disease
404365|NCT01850381|Efficacy|efficacy
404366|NCT01850381|Safety|safety
404367|NCT01850381|Tolerability|tolerability
404368|NCT01850381|Phase 2A|phase 2a
404369|NCT01850381|Pilot trial|pilot trial
404370|NCT01850381|human Motoneuronotrophic Factor|human motoneuronotrophic factor
404371|NCT01850381|neuroprotective agent|neuroprotective agent
404372|NCT01850381|neurodegenerative diseases|neurodegenerative diseases
404373|NCT01850381|rate of clinical progression of PD|rate of clinical progression of pd
404374|NCT01850381|UPDRS|updrs
404375|NCT01850381|Proof of principle|proof of principle
404376|NCT01850368|Hepatocellular carcinoma|hepatocellular carcinoma
404377|NCT01850368|Stereotactic ablative radiotherapy|stereotactic ablative radiotherapy
404378|NCT01850368|Stereotactic body radiotherapy|stereotactic body radiotherapy
404379|NCT01850368|Portal vein tumor thrombus|portal vein tumor thrombus
404380|NCT01850355|Autism Spectrum Disorders|autism spectrum disorders
404381|NCT01850355|Anxiety|anxiety
404382|NCT01850355|Children|children
404383|NCT01850355|Adolescents|adolescents
404384|NCT01850355|Buspar|buspar
404385|NCT01850355|Buspirone|buspirone
404386|NCT01850355|Pervasive Developmental Disorders|pervasive developmental disorders
404387|NCT01850342|Male stress urinary incontinence|male stress urinary incontinence
404388|NCT01850342|Cell-assisted lipotransfer|cell-assisted lipotransfer
404389|NCT01850342|Adipose-derived regenerative cells|adipose-derived regenerative cells
404390|NCT01850342|ADRC|adrc
404391|NCT01850342|Micrograft|micrograft
404392|NCT01850342|Fat tissue|fat tissue
404393|NCT01850342|Stem cells|stem cells
404394|NCT01850303|Elderly|elderly
404395|NCT01850303|lung cancer|lung cancer
404396|NCT01850303|switch|switch
404397|NCT01850303|maintenance|maintenance
404398|NCT01850303|Elderly patients (between 70 and 89 years)|elderly patients (between 70 and 89 years)
404399|NCT01850303|NSCLC|nsclc
404400|NCT01850290|TBI|tbi
404401|NCT01850277|Atrial fibrillation|atrial fibrillation
404402|NCT01850277|Cardiac resynchronization therapy|cardiac resynchronization therapy
404403|NCT01850277|Heart failure|heart failure
404404|NCT01850277|Rhythm control strategy|rhythm control strategy
404405|NCT01850264|cardiac resynchronization therapy; heart failure, congestive|cardiac resynchronization therapy; heart failure, congestive
404406|NCT01850251|Hip fractures|hip fractures
404407|NCT01850251|Ageing|ageing
404408|NCT01850251|Sarcopenia|sarcopenia
404409|NCT01850251|Function|function
404410|NCT01850238|Alzheimer disease|alzheimer disease
404411|NCT01850238|tau protein|tau protein
404412|NCT01850238|neurofibrillary degeneration|neurofibrillary degeneration
404413|NCT01850238|disease-modifying|disease-modifying
404414|NCT01850212|Treatment Experienced|treatment experienced
404415|NCT01850212|Male greater than or equal to 50 years|male greater than or equal to 50 years
404416|NCT01850212|Female postmenopausal|female postmenopausal
404417|NCT01850199|Gestational diabetes|gestational diabetes
404418|NCT01850199|Telemedicine|telemedicine
404419|NCT01850199|Artificial Intelligence|artificial intelligence
404420|NCT01850160|Hypertension|hypertension
404421|NCT01850160|High blood pressure|high blood pressure
404422|NCT01850160|Drug therapy combination|drug therapy combination
404423|NCT01850160|Valsartan|valsartan
404424|NCT01850160|Chlorthalidone|chlorthalidone
404425|NCT01850160|Safety|safety
404426|NCT01850160|Efficacy|efficacy
404427|NCT01850147|sunitinib|sunitinib
404428|NCT01850147|chemotherapy|chemotherapy
404429|NCT01850147|non-small cell lung cancer|non-small cell lung cancer
404430|NCT01850147|NSCLC|nsclc
404431|NCT01850121|Ankylosing Spondylitis|ankylosing spondylitis
404432|NCT01850121|infiximab|infiximab
404433|NCT01850121|single armed trial|single armed trial
404434|NCT01850095|acne|acne
404435|NCT01850095|adult|adult
404436|NCT01850095|women|women
404437|NCT01850095|TLR|tlr
404438|NCT01850095|CD1d|cd1d
404439|NCT01850095|androgens|androgens
404440|NCT01850082|Coronary artery disease|coronary artery disease
404442|NCT01850082|Coronary revascularization|coronary revascularization
404443|NCT01850082|Endoscopic vein harvest|endoscopic vein harvest
404444|NCT01850082|Saphenous vein graft|saphenous vein graft
404445|NCT01850082|Graft failure|graft failure
404446|NCT01850069|Intracranial hypertension|intracranial hypertension
404447|NCT01850069|intracranial elastance|intracranial elastance
404448|NCT01850056|drug eluting balloon catheter|drug eluting balloon catheter
404449|NCT01850017|Opiate consumption|opiate consumption
404450|NCT01850017|Visual Analogue Scale|visual analogue scale
404452|NCT01849991|Fussiness|fussiness
404453|NCT01849991|Gas|gas
404454|NCT01849991|Hydrogen Breath|hydrogen breath
404455|NCT01849991|Fecal Calprotectin|fecal calprotectin
404456|NCT01849978|breast cancer|breast cancer
404457|NCT01849978|survivor|survivor
404458|NCT01849978|exercise|exercise
404459|NCT01849978|physical activity|physical activity
404460|NCT01849978|strenuous exercise|strenuous exercise
404461|NCT01849978|moderate exercise|moderate exercise
404462|NCT01849978|enjoyable exercise|enjoyable exercise
404463|NCT01849978|enjoy exercise|enjoy exercise
404464|NCT01849978|breast cancer survivor|breast cancer survivor
404465|NCT01849965|diabetic foot ulcers|diabetic foot ulcers
404466|NCT01849965|Wagner Grade 1 or 2 ulcers|wagner grade 1 or 2 ulcers
404467|NCT01849952|glioblastoma|glioblastoma
404468|NCT01849952|miRNA|mirna
404469|NCT01849952|GBM|gbm
404470|NCT01849952|astrocytoma|astrocytoma
404471|NCT01849939|Allogeneic transplantation of hematopoietic stem cells transplantation|allogeneic transplantation of hematopoietic stem cells transplantation
404472|NCT01849939|Chronic Lymphocytic Leukemia|chronic lymphocytic leukemia
404473|NCT01849939|Donor Lymphocyte Injection|donor lymphocyte injection
404474|NCT01849939|Preemptive immunointervention|preemptive immunointervention
404475|NCT01849913|neck pain|neck pain
404476|NCT01849913|hydrocortisone|hydrocortisone
404477|NCT01849913|stress|stress
404478|NCT01849913|electromyography|electromyography
404479|NCT01849913|adolescent|adolescent
404480|NCT01849913|low-level laser therapy|low-level laser therapy
404481|NCT01849900|Menstrual cycle|menstrual cycle
404482|NCT01849900|Ovulation time|ovulation time
404483|NCT01849900|pregnancy recognition|pregnancy recognition
404484|NCT01849900|Community-based participatory research|community-based participatory research
404485|NCT01849900|Unintended pregnancy|unintended pregnancy
404486|NCT01849861|Cardiopulmonary Capacity|cardiopulmonary capacity
404487|NCT01849861|Ranges of TSH|ranges of tsh
404488|NCT01849861|Elderly Population|elderly population
404489|NCT01849835|rate of positive detection|rate of positive detection
404490|NCT01849822|neural|neural
404491|NCT01849822|prosthetic|prosthetic
404492|NCT01849822|brain machine interface|brain machine interface
404493|NCT01849822|brain computer interface|brain computer interface
404494|NCT01849822|brain control|brain control
404495|NCT01849822|paralysis|paralysis
404496|NCT01849822|tetraplegia|tetraplegia
404497|NCT01849822|quadriplegia|quadriplegia
404498|NCT01849822|spinal cord injury|spinal cord injury
404499|NCT01849796|tDCS|tdcs
404500|NCT01849796|Neuropathic|neuropathic
404501|NCT01849796|Facial|facial
404502|NCT01849796|Pain|pain
404503|NCT01849796|Neuralgia|neuralgia
404504|NCT01849796|deafferentation|deafferentation
404505|NCT01849796|Trigeminal|trigeminal
404506|NCT01849770|SALS|sals
404507|NCT01849770|Mexiletine|mexiletine
404508|NCT01849770|Safety|safety
404509|NCT01849757|Cardiopulmonary bypass|cardiopulmonary bypass
404510|NCT01849757|prime|prime
404511|NCT01849757|crystalloid|crystalloid
404512|NCT01849757|albumin|albumin
404513|NCT01849757|HES 130/0.4|hes 130/0.4
404514|NCT01849744|Focal Adhesion Kinase inhibitor|focal adhesion kinase inhibitor
404515|NCT01849744|FAK inhibitor|fak inhibitor
404516|NCT01849744|Cancer Stem Cells|cancer stem cells
404517|NCT01849744|CSC|csc
404518|NCT01849731|Diabetes Mellitus type 2;|diabetes mellitus type 2;
404519|NCT01849731|Primary Care, healthcare inequalities;|primary care, healthcare inequalities;
404520|NCT01849731|Diabetes self-management,|diabetes self-management,
404521|NCT01849731|Quality of diabetes care|quality of diabetes care
404522|NCT01849705|Obesity|obesity
404523|NCT01849705|MC4R|mc4r
404524|NCT01849705|Blood pressure|blood pressure
404525|NCT01849705|Blood glucose|blood glucose
404526|NCT01849692|Exudative Age-Related Macular Degeneration|exudative age-related macular degeneration
404527|NCT01849692|Wet AMD|wet amd
404528|NCT01849692|Choroidal neovascularization (CNV)|choroidal neovascularization (cnv)
404529|NCT01849692|Vascular endothelial growth factor (VEGF)|vascular endothelial growth factor (vegf)
404530|NCT01849679|Dysphagia|dysphagia
404531|NCT01849679|extubation|extubation
404532|NCT01849679|aspiration|aspiration
404533|NCT01849653|vaginal swabs|vaginal swabs
404534|NCT01849653|diagnosis|diagnosis
404535|NCT01849640|Malaria|malaria
404536|NCT01849640|Drug resistance|drug resistance
404537|NCT01849640|DHA-piperaquine|dha-piperaquine
404538|NCT01849640|Cambodia|cambodia
404539|NCT01849640|Transmission Blocking|transmission blocking
404540|NCT01849627|weight loss maintenance|weight loss maintenance
404541|NCT01849588|Hepatitis C positive|hepatitis c positive
404640|NCT01849029|sexual risk|sexual risk
404542|NCT01849575|Ultrasonography|ultrasonography
404543|NCT01849575|Cardiovascular diseases|cardiovascular diseases
404544|NCT01849575|Prevention|prevention
404545|NCT01849575|Risk communication|risk communication
404546|NCT01849575|Risk assessment|risk assessment
404547|NCT01849575|Behavioral change|behavioral change
404548|NCT01849562|Hepatitis C, Chronic|hepatitis c, chronic
404549|NCT01849562|Genotype 1|genotype 1
404550|NCT01849562|Hepatitis C|hepatitis c
404551|NCT01849562|Liver Diseases|liver diseases
404552|NCT01849562|Hepatitis, viral, human|hepatitis, viral, human
404553|NCT01849562|ribavirin|ribavirin
404554|NCT01849562|antiviral agents|antiviral agents
404555|NCT01849562|anti-infective agents|anti-infective agents
404556|NCT01849562|protease inhibitors|protease inhibitors
404557|NCT01849562|NS5a inhibitors|ns5a inhibitors
404558|NCT01849549|neuropsychological Study|neuropsychological study
404559|NCT01849549|brain Imaging|brain imaging
404560|NCT01849536|Open angle glaucoma|open angle glaucoma
404561|NCT01849536|Corneal biomechanics|corneal biomechanics
404562|NCT01849536|Intra ocular pressure|intra ocular pressure
404563|NCT01849536|IOP|iop
404564|NCT01849536|IOP fluctuation|iop fluctuation
404565|NCT01849536|Continuous IOP monitoring|continuous iop monitoring
404566|NCT01849536|SENSIMED Triggerfish®|sensimed triggerfish®
404567|NCT01849523|Neuroendocrine tumor|neuroendocrine tumor
404568|NCT01849523|Website|website
404569|NCT01849523|Information|information
404570|NCT01849523|Psychosocial support|psychosocial support
404571|NCT01849510|spinal metastases|spinal metastases
404572|NCT01849510|vertebral body|vertebral body
404573|NCT01849510|stereotaxis|stereotaxis
404574|NCT01849510|image-guided radiotherapy|image-guided radiotherapy
404575|NCT01849510|hypofractionated|hypofractionated
404576|NCT01849510|dose intensified|dose intensified
404577|NCT01849510|dose elevation|dose elevation
404578|NCT01849497|LDL-C, triglycerides, high cholesterol|ldl-c, triglycerides, high cholesterol
404579|NCT01849484|meningioma|meningioma
404580|NCT01849484|skull base meningioma|skull base meningioma
404581|NCT01849484|pituitary adenoma|pituitary adenoma
404582|NCT01849484|brain metastases|brain metastases
404583|NCT01849484|small cell lung carcinoma|small cell lung carcinoma
404584|NCT01849471|socioeconomic aspects|socioeconomic aspects
404585|NCT01849471|costs of therapy|costs of therapy
404586|NCT01849471|follow-up costs|follow-up costs
404587|NCT01849471|primary radiation|primary radiation
404588|NCT01849471|percutaneous|percutaneous
404589|NCT01849471|interstitial|interstitial
404590|NCT01849393|Adolescents|adolescents
404591|NCT01849393|Medication Compliance|medication compliance
404592|NCT01849393|Rewards-Based Incentive Programs|rewards-based incentive programs
404593|NCT01849380|Local Advanced Breast Neoplasms|local advanced breast neoplasms
404594|NCT01849380|Neoadjuvant Chemotherapy|neoadjuvant chemotherapy
404595|NCT01849380|S-1|s-1
404596|NCT01849341|COPD|copd
404597|NCT01849302|Appetite|appetite
404598|NCT01849302|Satiety hormones|satiety hormones
404599|NCT01849302|Dietary Protein|dietary protein
404600|NCT01849237|Mesenchymal Stromal Cells|mesenchymal stromal cells
404601|NCT01849237|Septic Shock|septic shock
404602|NCT01849237|Neutropenia|neutropenia
404603|NCT01849237|Procalcitonin|procalcitonin
404604|NCT01849237|Interleukin-6|interleukin-6
404605|NCT01849237|Interleukin-10|interleukin-10
404606|NCT01849237|C-reactive protein|c-reactive protein
404607|NCT01849237|Survival|survival
404608|NCT01849237|Organ dysfunction|organ dysfunction
404609|NCT01849224|Lower extremity edema|lower extremity edema
404610|NCT01849224|Lower leg lymphedema|lower leg lymphedema
404611|NCT01849224|Lower leg edema|lower leg edema
404612|NCT01849224|Lymphedema|lymphedema
404613|NCT01849224|Pelvic lymphadenectomy|pelvic lymphadenectomy
404614|NCT01849224|Exercise|exercise
404615|NCT01849211|ventilation|ventilation
404616|NCT01849211|face mask|face mask
404617|NCT01849211|NMBA|nmba
404618|NCT01849198|accelerometry|accelerometry
404619|NCT01849198|neuromuscular block|neuromuscular block
404620|NCT01849198|m. trapezius|m. trapezius
404621|NCT01849185|Hypercholesterolemia|hypercholesterolemia
404622|NCT01849159|Mesenchymal stem cells|mesenchymal stem cells
404623|NCT01849159|Hypoxia|hypoxia
404624|NCT01849159|Emphysema|emphysema
404625|NCT01849133|Breast cancer|breast cancer
404626|NCT01849133|conservative surgery|conservative surgery
404627|NCT01849133|intraoperative radiation therapy|intraoperative radiation therapy
404628|NCT01849133|mobile linear accelerator|mobile linear accelerator
404629|NCT01849120|near infrared spectroscopy (NIRS)|near infrared spectroscopy (nirs)
404630|NCT01849120|EQUANOX Advance 8004CB probes|equanox advance 8004cb probes
404631|NCT01849120|cerebral vascular circulation|cerebral vascular circulation
404632|NCT01849120|peripheral perfusion|peripheral perfusion
404633|NCT01849107|Radiation-induced small bowel toxicity|radiation-induced small bowel toxicity
404634|NCT01849107|Plasma citrulline|plasma citrulline
404635|NCT01849081|Non-alcoholic fatty liver disease|non-alcoholic fatty liver disease
404636|NCT01849081|Obstructive sleep apnea|obstructive sleep apnea
404637|NCT01849029|Post traumatic Stress Disorders|post traumatic stress disorders
404638|NCT01849029|PTSD|ptsd
404641|NCT01849029|substance use|substance use
404642|NCT01849029|alcohol misuse|alcohol misuse
404643|NCT01849029|Substance Abuse|substance abuse
404644|NCT01849029|Substance Addiction|substance addiction
404645|NCT01849029|Substance Dependence|substance dependence
404646|NCT01849029|Substance Use Disorders|substance use disorders
404647|NCT01849029|Alcohol-Related Disorders|alcohol-related disorders
404648|NCT01849029|Binge Drinking|binge drinking
404649|NCT01849029|Sexual Partners|sexual partners
404650|NCT01849029|Sexual Behavior|sexual behavior
404651|NCT01849029|Unsafe Sex|unsafe sex
404652|NCT01849016|Sickle Cell Disease|sickle cell disease
404653|NCT01849016|Sickle Cell Anemia|sickle cell anemia
404654|NCT01849016|Pain|pain
404655|NCT01849016|N-Acetylcysteine|n-acetylcysteine
404656|NCT01849016|Acetylcysteine|acetylcysteine
404657|NCT01849016|Oxidative stress|oxidative stress
404658|NCT01849003|Long QT Syndrome|long qt syndrome
404659|NCT01849003|LQTS|lqts
404660|NCT01849003|Long QT-3 Syndrome|long qt-3 syndrome
404661|NCT01849003|LQT-3|lqt-3
404662|NCT01849003|prolonged QT interval|prolonged qt interval
404663|NCT01849003|GS-6615|gs-6615
404664|NCT01849003|late sodium current inhibitor|late sodium current inhibitor
404665|NCT01848990|Type 1 Diabetes Mellitus|type 1 diabetes mellitus
404666|NCT01848990|Sub Cutaneous Insulin Infusion|sub cutaneous insulin infusion
404667|NCT01848990|Rapid Acting Analog Insulin|rapid acting analog insulin
404668|NCT01848990|Hylenex|hylenex
404669|NCT01848990|Halozyme|halozyme
404670|NCT01848990|Phase 4|phase 4
404671|NCT01848977|Measures|measures
404672|NCT01848977|near-Infrared spectroscopy|near-infrared spectroscopy
404673|NCT01848977|ischemia|ischemia
404674|NCT01848977|reperfusion|reperfusion
404675|NCT01848964|amputation|amputation
404676|NCT01848964|prosthesis|prosthesis
404677|NCT01848964|stump|stump
404678|NCT01848964|socket|socket
404679|NCT01848964|pressure|pressure
404680|NCT01848964|gait|gait
404681|NCT01848964|posture|posture
404682|NCT01848938|female|female
404683|NCT01848938|stress urinary incontinence|stress urinary incontinence
404684|NCT01848938|treatment|treatment
404685|NCT01848938|pelvic floor muscle training|pelvic floor muscle training
404686|NCT01848938|smartphone|smartphone
404687|NCT01848938|internet|internet
404688|NCT01848938|life style|life style
404689|NCT01848938|eHealth|ehealth
404690|NCT01848925|SANGUINATE|sanguinate
404691|NCT01848899|Coronary angiography|coronary angiography
404692|NCT01848899|Percutaneous coronary intervention|percutaneous coronary intervention
404693|NCT01848899|Contrast media|contrast media
404694|NCT01848899|Platelet activity|platelet activity
404695|NCT01848899|Thrombin generation|thrombin generation
404696|NCT01848899|Fibrinolysis|fibrinolysis
404697|NCT01848886|ERAH|erah
404698|NCT01848886|Endoscopic Radial Artery Harvest|endoscopic radial artery harvest
404699|NCT01848886|Y-graft|y-graft
404700|NCT01848886|Radial Artery Harvest|radial artery harvest
404701|NCT01848886|Total Arterial Revascularisation|total arterial revascularisation
404702|NCT01848886|CABG|cabg
404703|NCT01848886|Radial Artery Conduit|radial artery conduit
404704|NCT01848873|Hyperhomocysteinemia|hyperhomocysteinemia
404705|NCT01848873|Amlodipine-folic acid tablets|amlodipine-folic acid tablets
404706|NCT01848873|Hypertension|hypertension
404707|NCT01848873|MTHFR C677T|mthfr c677t
404708|NCT01848860|Pneumothorax|pneumothorax
404709|NCT01848860|thoracoscopy|thoracoscopy
404710|NCT01848860|mesh|mesh
404711|NCT01848860|pleurodesis|pleurodesis
404712|NCT01848860|treatment|treatment
404713|NCT01848847|Hysteroscopy|hysteroscopy
404714|NCT01848847|Bladder|bladder
404715|NCT01848847|Pain|pain
404716|NCT01848847|Feasibility|feasibility
404717|NCT01848847|Duration|duration
404718|NCT01848834|PD-1|pd-1
404719|NCT01848834|PD1|pd1
404720|NCT01848834|PD-L1|pd-l1
404721|NCT01848834|PDL1|pdl1
404722|NCT01848821|OASIS ultra|oasis ultra
404723|NCT01848821|faster healing time|faster healing time
404724|NCT01848821|better healing quality|better healing quality
404725|NCT01848821|standard of care|standard of care
404726|NCT01848795|Type 2 Diabetes|type 2 diabetes
404727|NCT01848795|Obesity|obesity
404728|NCT01848795|gastrointestinal hormones|gastrointestinal hormones
404729|NCT01848795|intestinal bypass|intestinal bypass
404730|NCT01848795|endoscopy|endoscopy
404731|NCT01848782|abstract|abstract
404732|NCT01848782|meta-analysis|meta-analysis
404733|NCT01848782|systematic review|systematic review
404734|NCT01848782|interpretation|interpretation
404735|NCT01848782|results|results
404736|NCT01848782|quality|quality
404737|NCT01848782|bias|bias
404738|NCT01848782|spin|spin
404739|NCT01848782|limits|limits
404740|NCT01848782|limitation|limitation
404741|NCT01848782|risk of bias|risk of bias
404742|NCT01848769|Asthma|asthma
404743|NCT01848769|ICS+LABA|ics+laba
404744|NCT01848769|Children|children
404745|NCT01848769|Inhalation|inhalation
404746|NCT01848769|pMDI|pmdi
404747|NCT01848756|SNX-5422|snx-5422
404748|NCT01848756|HER2 positive cancer|her2 positive cancer
404749|NCT01848743|tenofovir, lamivudine, hepatitis B, acute exacerbation|tenofovir, lamivudine, hepatitis b, acute exacerbation
404750|NCT01848704|spin|spin
404751|NCT01848704|interpretation|interpretation
404752|NCT01848704|bias|bias
404753|NCT01848652|cerebral lymphoma B cell refractory|cerebral lymphoma b cell refractory
404754|NCT01848652|Myocet|myocet
404755|NCT01848652|efficacy|efficacy
404756|NCT01848652|safety|safety
404757|NCT01848639|chronic kidney disease|chronic kidney disease
404758|NCT01848639|end-stage renal disease|end-stage renal disease
404759|NCT01848639|hemodialysis (ESRD)|hemodialysis (esrd)
404760|NCT01848639|cardiovascular morbimortality|cardiovascular morbimortality
404761|NCT01848639|aldosterone antagonist|aldosterone antagonist
404762|NCT01848639|spironolactone|spironolactone
404763|NCT01848600|limitation|limitation
404764|NCT01848600|quality|quality
404765|NCT01848600|bias|bias
404766|NCT01848600|meta-analysis|meta-analysis
404767|NCT01848600|interpretation|interpretation
404768|NCT01848600|abstract|abstract
404769|NCT01848587|Pregnancy|pregnancy
404770|NCT01848587|Acupuncture|acupuncture
404771|NCT01848587|Pelvic and low back pain|pelvic and low back pain
404772|NCT01848587|Impairment|impairment
404773|NCT01848587|Economic evaluation|economic evaluation
404774|NCT01848574|Understanding|understanding
404775|NCT01848574|Patients|patients
404776|NCT01848574|Emergency|emergency
404777|NCT01848574|Information|information
404778|NCT01848561|Ulcerative Colitis|ulcerative colitis
404779|NCT01848561|Registry|registry
404780|NCT01848561|Adalimumab|adalimumab
517564|NCT01358175|AS|as
404781|NCT01848561|Colitis|colitis
404782|NCT01848561|Gastroenteritis|gastroenteritis
404783|NCT01848561|Inflammatory Bowel Diseases|inflammatory bowel diseases
404784|NCT01848561|Gastrointestinal Diseases|gastrointestinal diseases
404785|NCT01848535|intestinal microbiota composition|intestinal microbiota composition
404786|NCT01848535|intestinal microbiota activity|intestinal microbiota activity
404787|NCT01848535|gastro-intestinal complains|gastro-intestinal complains
404788|NCT01848522|qualitative study|qualitative study
404789|NCT01848522|rehabilitation|rehabilitation
404790|NCT01848522|physical therapy|physical therapy
404791|NCT01848522|patient education|patient education
404792|NCT01848522|health care|health care
404793|NCT01848522|administration|administration
404794|NCT01848522|patient satisfaction|patient satisfaction
404795|NCT01848522|handicap|handicap
404796|NCT01848509|CPAP|cpap
404797|NCT01848509|adherence|adherence
404798|NCT01848509|SAOS|saos
404799|NCT01848509|telemedicine|telemedicine
404800|NCT01848483|Early Palliative Care|early palliative care
404801|NCT01848483|Motivational Interviewing|motivational interviewing
404802|NCT01848483|Persons Living With Human immunodeficiency virus(HIV)|persons living with human immunodeficiency virus(hiv)
404803|NCT01848483|Acquired Immunodeficiency Syndrome (AIDS)|acquired immunodeficiency syndrome (aids)
404804|NCT01848457|Osteosarcoma|osteosarcoma
404805|NCT01848457|Cancer|cancer
404806|NCT01848457|Nephrotoxicity|nephrotoxicity
404807|NCT01848457|Ototoxicity|ototoxicity
404808|NCT01848457|Cisplatin|cisplatin
404809|NCT01848457|High-dose methotrexate|high-dose methotrexate
404810|NCT01848457|Biomarkers|biomarkers
404811|NCT01848457|Patient reported outcomes|patient reported outcomes
404812|NCT01848444|Public Health|public health
404813|NCT01848444|Epidemiology|epidemiology
404814|NCT01848444|Pharmacy Toxicology|pharmacy toxicology
404815|NCT01848444|Perinatal period|perinatal period
404816|NCT01848418|ICF|icf
404817|NCT01848418|Core sets|core sets
404818|NCT01848418|Systemic sclerosis|systemic sclerosis
404819|NCT01848418|Function|function
404820|NCT01848418|Evaluation|evaluation
404821|NCT01848392|Cystic fibrosis|cystic fibrosis
404822|NCT01848392|Adults|adults
404823|NCT01848392|Physical activity|physical activity
404824|NCT01848366|Frequency|frequency
404825|NCT01848366|urgency|urgency
404826|NCT01848366|incontinence|incontinence
404827|NCT01848340|mass balance|mass balance
404828|NCT01848340|GSK1265744|gsk1265744
404829|NCT01848340|supratherapeutic|supratherapeutic
404830|NCT01848340|integrase inhibitor|integrase inhibitor
404831|NCT01848340|healthy volunteer|healthy volunteer
404832|NCT01848327|Cognition|cognition
404833|NCT01848327|Neuropsychology|neuropsychology
404834|NCT01848327|Multiple Sclerosis|multiple sclerosis
404835|NCT01848301|Optical Coherence Tomography|optical coherence tomography
404837|NCT01848301|Coronary Allograft Vasculopathy|coronary allograft vasculopathy
404838|NCT01848301|Donor Specific Antibodies|donor specific antibodies
404839|NCT01848301|Acetylcholine|acetylcholine
404840|NCT01848301|Coronary endothelial function|coronary endothelial function
404841|NCT01848301|Brachial Artery Flow Mediated Dilation|brachial artery flow mediated dilation
404842|NCT01848301|Heart transplantation|heart transplantation
404843|NCT01848288|Cataract|cataract
404844|NCT01848288|Phacoemulsification|phacoemulsification
404845|NCT01848288|Cumulative Dissipated Energy (CDE)|cumulative dissipated energy (cde)
404846|NCT01848262|ECALMIST|ecalmist
404847|NCT01848262|InSurE|insure
404848|NCT01848262|CPAP|cpap
404849|NCT01848262|Ventilation|ventilation
406136|NCT01842074|bortezomib|bortezomib
404850|NCT01848262|Vascular Catheter|vascular catheter
404851|NCT01848249|deceased donors|deceased donors
404852|NCT01848249|kidney donor|kidney donor
404853|NCT01848249|transplant recipients|transplant recipients
404854|NCT01848249|kidney transplant|kidney transplant
404855|NCT01848249|delayed graft function|delayed graft function
404856|NCT01848249|biomarkers|biomarkers
404857|NCT01848249|end stage renal disease|end stage renal disease
404858|NCT01848249|graft failure|graft failure
404859|NCT01848223|quality of life|quality of life
404861|NCT01848223|late menopause|late menopause
404862|NCT01848210|Drug therapy|drug therapy
404863|NCT01848184|PARIETEX Composite Ventral Patch|parietex composite ventral patch
404864|NCT01848184|PCO VP OR PCOVP|pco vp or pcovp
404865|NCT01848184|Primary ventral hernia repair|primary ventral hernia repair
404866|NCT01848184|Panacea|panacea
404867|NCT01848171|Hypothyroidism|hypothyroidism
404868|NCT01848171|Lipid|lipid
404869|NCT01848171|Atherosclerosis|atherosclerosis
404870|NCT01848171|Oxidative Stress|oxidative stress
404871|NCT01848171|Chronic Inflammation|chronic inflammation
404872|NCT01848171|Endothelial Function|endothelial function
404873|NCT01848171|Adipocytokine|adipocytokine
404874|NCT01848171|L-thyroxine|l-thyroxine
404875|NCT01848158|acupuncture|acupuncture
404876|NCT01848158|pediatric|pediatric
404877|NCT01848158|critical care|critical care
404878|NCT01848158|mechanical ventilation|mechanical ventilation
404879|NCT01848158|sedation|sedation
404880|NCT01848158|comfort|comfort
404881|NCT01848145|Chronic Lymphocytic Leukemia|chronic lymphocytic leukemia
404882|NCT01848145|Ofatumumab|ofatumumab
404883|NCT01848145|Rapid Infusion|rapid infusion
404884|NCT01848132|Lymphoma|lymphoma
404885|NCT01848132|Large B-Cell|large b-cell
404886|NCT01848119|Gabapentin|gabapentin
404887|NCT01848119|Cesarean section|cesarean section
404888|NCT01848106|Percutaneous Coronary Intervention|percutaneous coronary intervention
404889|NCT01848106|Coronary Artery Disease|coronary artery disease
404890|NCT01848106|Acute Coronary Syndrome|acute coronary syndrome
404891|NCT01848106|Regado|regado
404892|NCT01848106|Reg 1|reg 1
404893|NCT01848106|bivalirudin|bivalirudin
404894|NCT01848093|lung|lung
404895|NCT01848093|airway|airway
404896|NCT01848093|pulmonary exacerbation|pulmonary exacerbation
404897|NCT01848093|mucus|mucus
404898|NCT01848080|Telemedicine|telemedicine
404899|NCT01848080|Telerehabilitation|telerehabilitation
404900|NCT01848080|Acute Stroke|acute stroke
404901|NCT01848080|Tai Chi|tai chi
404902|NCT01848080|Tai Ji|tai ji
404903|NCT01848080|Rehabilitation|rehabilitation
404904|NCT01848080|Home care services|home care services
404905|NCT01848080|Single blind method|single blind method
404906|NCT01848080|Randomized controlled trial|randomized controlled trial
404907|NCT01848054|opioid dependence, buprenorphine/naloxone, sublingual|opioid dependence, buprenorphine/naloxone, sublingual
404908|NCT01848041|Blepharoptosis|blepharoptosis
404909|NCT01848041|Ptosis|ptosis
404910|NCT01848028|Patient registry|patient registry
404911|NCT01848028|Germany|germany
404912|NCT01848028|Psoriasis|psoriasis
404913|NCT01848028|psoriatic-arthritis|psoriatic-arthritis
404914|NCT01848028|Efalizumab|efalizumab
404915|NCT01848028|Psonet|psonet
404916|NCT01848028|Effectiveness|effectiveness
404917|NCT01848028|Safety|safety
404918|NCT01848015|CTCs before and after gastrectomy|ctcs before and after gastrectomy
404919|NCT01847976|breast|breast
404920|NCT01847976|bone pain|bone pain
404921|NCT01847963|Urolithiasis|urolithiasis
404922|NCT01847963|Kalladaippu Kudineer|kalladaippu kudineer
404923|NCT01847963|Siddha|siddha
404924|NCT01847963|Sindhuvallathy|sindhuvallathy
404925|NCT01847963|Kidney stones|kidney stones
404926|NCT01847911|self instructed resuscitation training|self instructed resuscitation training
404927|NCT01847898|Osteoporosis|osteoporosis
404928|NCT01847898|Vertebral Body|vertebral body
404929|NCT01847898|Compression Fracture|compression fracture
404930|NCT01847898|Kyphoplasty|kyphoplasty
404931|NCT01847885|electrical stimulation|electrical stimulation
404932|NCT01847885|neurostimulation|neurostimulation
404933|NCT01847885|neuromodulation|neuromodulation
404934|NCT01847885|post-stroke shoulder pain|post-stroke shoulder pain
404935|NCT01847885|hemiplegic shoulder pain|hemiplegic shoulder pain
404936|NCT01847872|Inactivated Poliovirus Vaccine|inactivated poliovirus vaccine
404937|NCT01847872|Randomised Control Phase IV Study|randomised control phase iv study
404938|NCT01847872|Gambia|gambia
404939|NCT01847872|IPV|ipv
404940|NCT01847872|Safety and Immunogenicity|safety and immunogenicity
404941|NCT01847872|Non-interference study|non-interference study
404942|NCT01847872|IM Jet injector|im jet injector
404943|NCT01847872|ID Jet Injector|id jet injector
404944|NCT01847859|Cardiothoracic surgery|cardiothoracic surgery
404945|NCT01847859|Post-operative|post-operative
404946|NCT01847859|Nurses|nurses
404947|NCT01847859|Cardiac|cardiac
404948|NCT01847859|Echocardiography|echocardiography
404949|NCT01847859|Pocket-size|pocket-size
404950|NCT01847859|Hand-held|hand-held
404951|NCT01847820|ROM|rom
404952|NCT01847820|PROM|prom
404953|NCT01847820|PPROM (preterm premature rupture of membranes)|pprom (preterm premature rupture of membranes)
404954|NCT01847807|5-10 gram astragalus per day|5-10 gram astragalus per day
404955|NCT01847781|Opsonophagocytic antibodies|opsonophagocytic antibodies
404956|NCT01847781|Cellular immunity|cellular immunity
404957|NCT01847781|Vaccine immunity|vaccine immunity
404958|NCT01847781|Antimicrobial peptides|antimicrobial peptides
404959|NCT01847768|asthma|asthma
404960|NCT01847768|rhinovirus|rhinovirus
404961|NCT01847768|remodeling mediators|remodeling mediators
404962|NCT01847768|human rhinovirus infection|human rhinovirus infection
404963|NCT01847729|Opiate dependence|opiate dependence
404964|NCT01847729|Opiate substitution treatment|opiate substitution treatment
404965|NCT01847729|co-addictions|co-addictions
404966|NCT01847729|Patients addicted to opiates|patients addicted to opiates
404967|NCT01847729|methadone|methadone
404968|NCT01847729|buprenorhine|buprenorhine
404969|NCT01847729|morphine|morphine
404970|NCT01847729|OST in place|ost in place
404971|NCT01847729|pathological gambling|pathological gambling
404972|NCT01847729|pharmacokinetic|pharmacokinetic
404973|NCT01847729|pharmacogenetic|pharmacogenetic
404974|NCT01847729|polymorphism|polymorphism
404975|NCT01847729|cytochrome P450 2D6|cytochrome p450 2d6
404976|NCT01847729|Therapeutic Drug Monitoring|therapeutic drug monitoring
404977|NCT01847716|Muscle weakness|muscle weakness
404978|NCT01847716|Pulmonary arterial hypertension|pulmonary arterial hypertension
404979|NCT01847716|Transforming growth factor beta|transforming growth factor beta
404980|NCT01847716|Growth and differentiation factor 15|growth and differentiation factor 15
404981|NCT01847690|Addison Disease|addison disease
404982|NCT01847677|ovarian cancer|ovarian cancer
404983|NCT01847677|neoadyuvant|neoadyuvant
404984|NCT01847677|bevacizumab|bevacizumab
404985|NCT01847651|hepatic encephalopathy|hepatic encephalopathy
404986|NCT01847651|minimal hepatic encephalopathy|minimal hepatic encephalopathy
404987|NCT01847651|cirrhosis|cirrhosis
404988|NCT01847651|lateral vastus|lateral vastus
404989|NCT01847651|muscle biopsy|muscle biopsy
404990|NCT01847651|L ornithine L aspartate|l ornithine l aspartate
404991|NCT01847651|functional magnetic resonance imaging|functional magnetic resonance imaging
404992|NCT01847651|magnetic resonance spectroscopy|magnetic resonance spectroscopy
404993|NCT01847651|cognitive testing|cognitive testing
404994|NCT01847651|Paper and pencil Hepatic Encephalopathy score (PHES)|paper and pencil hepatic encephalopathy score (phes)
404995|NCT01847651|Cogstate|cogstate
404996|NCT01847651|urine metabonomics|urine metabonomics
404997|NCT01847651|plasma metabonomics|plasma metabonomics
404998|NCT01847651|muscle metabonomics|muscle metabonomics
404999|NCT01847638|Retinal edema|retinal edema
405000|NCT01847638|Cataract|cataract
405001|NCT01847638|inflammation|inflammation
405002|NCT01847612|per operative cholangiography|per operative cholangiography
405003|NCT01847612|liver resection|liver resection
405004|NCT01847612|biliary fistula|biliary fistula
405005|NCT01847599|educational intervention|educational intervention
405006|NCT01847599|adherence|adherence
405007|NCT01847599|capecitabine|capecitabine
405008|NCT01847599|lapatinib|lapatinib
405009|NCT01847586|Alzheimer's Disease|alzheimer's disease
405010|NCT01847586|Brain stimulation|brain stimulation
405011|NCT01847586|transcranial magnetic stimulation|transcranial magnetic stimulation
405012|NCT01847573|halofuginone hydrobromide|halofuginone hydrobromide
405013|NCT01847573|anti-fibrotic|anti-fibrotic
405014|NCT01847573|anti-inflammatory|anti-inflammatory
405015|NCT01847573|muscle regeneration|muscle regeneration
405016|NCT01847573|protein synthesis inhibitor|protein synthesis inhibitor
405017|NCT01847495|Stage IV Colorectal Carcinoma|stage iv colorectal carcinoma
405018|NCT01847495|Liver metastasis|liver metastasis
405019|NCT01847495|Cyberknife|cyberknife
405020|NCT01847495|Stereotactic Body Radiotherapy|stereotactic body radiotherapy
405021|NCT01847495|SBRT|sbrt
405022|NCT01847495|Irinotecan HCl|irinotecan hcl
405023|NCT01847495|CPT-11|cpt-11
405024|NCT01847482|Cardiac arrest|cardiac arrest
405025|NCT01847482|Return of Spontaneous Circulation (ROSC)|return of spontaneous circulation (rosc)
405026|NCT01847482|IntraVascular Temperature Management (IVTM)|intravascular temperature management (ivtm)
405027|NCT01847482|Therapeutic Hypothermia|therapeutic hypothermia
405028|NCT01847482|Japan|japan
405029|NCT01847469|Alcohol Dependence|alcohol dependence
405030|NCT01847469|Post-Traumatic Stress Disorder (PTSD)|post-traumatic stress disorder (ptsd)
405031|NCT01847469|Zonisamide|zonisamide
405032|NCT01847469|Cognitive Processing Therapy (CPT)|cognitive processing therapy (cpt)
405033|NCT01847456|whole body insulin sensitivity|whole body insulin sensitivity
405034|NCT01847456|insulin action in the brain|insulin action in the brain
405035|NCT01847443|nicotine|nicotine
405036|NCT01847443|nicotine replacement therapy|nicotine replacement therapy
405037|NCT01847443|nicotine gum|nicotine gum
405038|NCT01847430|Healthy|healthy
405039|NCT01847430|Hepatitis B|hepatitis b
405040|NCT01847430|Adolescents|adolescents
405041|NCT01847430|Engerix™-B Kinder|engerix™-b kinder
405042|NCT01847417|Acetylsalicylic acid|acetylsalicylic acid
405043|NCT01847417|Pantoprazole|pantoprazole
405044|NCT01847417|Fixed dose combination|fixed dose combination
405045|NCT01847404|Fixed dose combination|fixed dose combination
405046|NCT01847404|Acetylsalicylic acid|acetylsalicylic acid
405047|NCT01847404|Pantoprazole|pantoprazole
405048|NCT01847391|Ischemic Heart Disease|ischemic heart disease
405049|NCT01847391|Heart Disease|heart disease
405050|NCT01847378|ventricular tachycardia|ventricular tachycardia
405051|NCT01847378|catheter ablation|catheter ablation
405052|NCT01847378|chagas disease|chagas disease
405053|NCT01847378|epicardial mapping|epicardial mapping
405054|NCT01847378|magnetic resonance imaging|magnetic resonance imaging
405055|NCT01847365|Retinitis Pigmentosa|retinitis pigmentosa
405056|NCT01847365|Transcorneal electrical stimulation|transcorneal electrical stimulation
405057|NCT01847365|Okustim|okustim
405058|NCT01847352|Hypoxia|hypoxia
405059|NCT01847352|Pulmonary hypertension|pulmonary hypertension
405060|NCT01847352|Iron deficiency|iron deficiency
405061|NCT01847352|Hypoxic pulmonary vasoconstriction|hypoxic pulmonary vasoconstriction
405062|NCT01847313|kidney|kidney
405063|NCT01847313|diabetes|diabetes
405064|NCT01847313|glp-1|glp-1
405065|NCT01847300|alcohol abuse|alcohol abuse
405066|NCT01847300|tobacco dependence|tobacco dependence
405067|NCT01847300|substance abuse|substance abuse
405068|NCT01847300|SBIRT|sbirt
405069|NCT01847287|Multiple sclerosis|multiple sclerosis
405070|NCT01847287|Tysabri|tysabri
405071|NCT01847287|MRI|mri
405072|NCT01847287|Natalizumab|natalizumab
405073|NCT01847274|ovarian cancer|ovarian cancer
405074|NCT01847274|platinum sensitive|platinum sensitive
405075|NCT01847274|gBRCAmut|gbrcamut
405076|NCT01847274|BRCA|brca
405077|NCT01847274|high-grade serous histology|high-grade serous histology
405078|NCT01847274|PARP inhibitor|parp inhibitor
405079|NCT01847261|soy|soy
405080|NCT01847261|whey|whey
405081|NCT01847261|muscle|muscle
405082|NCT01847261|older|older
405083|NCT01847261|mTOR|mtor
405084|NCT01847261|sarcopenia|sarcopenia
405085|NCT01847248|sepsis|sepsis
405086|NCT01847248|biomarker|biomarker
405087|NCT01847248|HSPA12B|hspa12b
405088|NCT01847235|Temozolomide|temozolomide
405089|NCT01847209|lung nodule|lung nodule
405090|NCT01847209|lung cancer|lung cancer
405091|NCT01847209|lung mass|lung mass
405092|NCT01847196|Pulmonary Embolism|pulmonary embolism
405093|NCT01847196|PE|pe
405094|NCT01847196|DVT|dvt
405095|NCT01847196|Deep Vein Thrombosis|deep vein thrombosis
405096|NCT01847196|VTE|vte
405097|NCT01847196|Venous Thromboembolism|venous thromboembolism
405098|NCT01847196|prophylaxis|prophylaxis
405099|NCT01847196|thromboprophylaxis|thromboprophylaxis
405100|NCT01847196|contraindications to thromboprophylaxis|contraindications to thromboprophylaxis
405101|NCT01847196|prophylactic|prophylactic
405102|NCT01847196|prevention|prevention
405103|NCT01847196|Inferior vena cava filter|inferior vena cava filter
405104|NCT01847196|IVC filter|ivc filter
405105|NCT01847196|filter|filter
405106|NCT01847196|prevention of pulmonary embolism|prevention of pulmonary embolism
405107|NCT01847196|trauma|trauma
405108|NCT01847196|critically-ill|critically-ill
405109|NCT01847183|heavy drinking|heavy drinking
405110|NCT01847183|prevention|prevention
405111|NCT01847183|high school|high school
405112|NCT01847183|adolescence|adolescence
405113|NCT01847157|recovery of function|recovery of function
405114|NCT01847157|stroke|stroke
405115|NCT01847157|Upper extremity|upper extremity
405116|NCT01847157|Motor|motor
405117|NCT01847157|transcranial direct current stimulation|transcranial direct current stimulation
405118|NCT01847131|Rhinitis|rhinitis
405119|NCT01847131|Oxymetazoline|oxymetazoline
405120|NCT01847092|albuminuria|albuminuria
405121|NCT01847066|wrinkles|wrinkles
405122|NCT01847066|acne scars|acne scars
405123|NCT01847066|pigmentation|pigmentation
405124|NCT01847053|Cinnamon|cinnamon
405125|NCT01847053|Bioavailability|bioavailability
405126|NCT01847053|Glucose|glucose
405127|NCT01847053|Proanthocyanidins|proanthocyanidins
405128|NCT01847040|Traumatic Brain Injury|traumatic brain injury
405129|NCT01847040|Epidemiology|epidemiology
405130|NCT01847040|Concussion|concussion
405131|NCT01847040|Outcomes|outcomes
405132|NCT01847040|PTSD|ptsd
405133|NCT01847040|Prospective|prospective
405134|NCT01847040|Longitudinal|longitudinal
405135|NCT01847040|Military|military
405136|NCT01847040|Symptoms|symptoms
405137|NCT01847040|Validation|validation
405138|NCT01847040|Screening|screening
405139|NCT01847040|Mild Traumatic Brain Injury|mild traumatic brain injury
405140|NCT01847027|Healthy|healthy
405141|NCT01847027|Stem cells|stem cells
405142|NCT01847027|Aging|aging
405143|NCT01847027|Increase stem cell replacement|increase stem cell replacement
405144|NCT01847027|decreased stem cell proliferation|decreased stem cell proliferation
405145|NCT01847014|Pulmonary Arterial Hypertension (PAH)|pulmonary arterial hypertension (pah)
405146|NCT01847014|psychometric instrument|psychometric instrument
405147|NCT01847014|PAH-SYMPACT|pah-sympact
405148|NCT01847001|Breast Cancer|breast cancer
405149|NCT01847001|Neoadjuvant|neoadjuvant
405150|NCT01847001|Experimental|experimental
405151|NCT01847001|Biomarker|biomarker
405152|NCT01847001|Breast imaging|breast imaging
407236|NCT01837160|Cardiac MRI|cardiac mri
405153|NCT01846988|Obstructive Sleep Apnea|obstructive sleep apnea
405154|NCT01846988|Pediatric Obstructive Sleep Apnea|pediatric obstructive sleep apnea
405155|NCT01846988|Auto PAP|auto pap
405156|NCT01846988|Auto-adjustable Positive Airway Pressure|auto-adjustable positive airway pressure
405157|NCT01846988|APAP|apap
405158|NCT01846988|CPAP|cpap
405159|NCT01846975|Abatacept|abatacept
405160|NCT01846975|Low disease activity|low disease activity
405161|NCT01846975|Intravenous|intravenous
405162|NCT01846975|Subcutaneous|subcutaneous
405163|NCT01846975|Rheumatoid arthritis|rheumatoid arthritis
405164|NCT01846962|Eosinophilic esophagitis (EoE)|eosinophilic esophagitis (eoe)
405165|NCT01846962|budesonide|budesonide
405166|NCT01846962|fluticasione|fluticasione
405167|NCT01846962|six-foods elimination diet|six-foods elimination diet
405168|NCT01846936|one lung ventilation|one lung ventilation
405169|NCT01846936|efficacy|efficacy
405170|NCT01846936|bronchial blocker|bronchial blocker
405171|NCT01846910|Cessation|cessation
405172|NCT01846845|Amputee|amputee
405173|NCT01846832|Hepatitis C, Chronic|hepatitis c, chronic
405174|NCT01846832|Infection|infection
405175|NCT01846832|Triple therapy|triple therapy
405176|NCT01846832|TMC435|tmc435
405177|NCT01846832|simeprevir|simeprevir
405178|NCT01846832|Pegylated interferon alfa-2a (PegIFNα-2a)|pegylated interferon alfa-2a (pegifnα-2a)
405179|NCT01846832|ribavirin (RBV)|ribavirin (rbv)
405180|NCT01846832|PEGASYS|pegasys
405181|NCT01846832|COPEGUS|copegus
405182|NCT01846806|Hepatic Encephalopathy|hepatic encephalopathy
405183|NCT01846793|Benign prostatic hyperplasia|benign prostatic hyperplasia
405184|NCT01846793|BPH|bph
405185|NCT01846793|Lower urinary tract symptoms|lower urinary tract symptoms
405186|NCT01846793|LUTS|luts
405187|NCT01846793|LUTS secondary to BPH|luts secondary to bph
405188|NCT01846793|LUTS/BPH|luts/bph
405189|NCT01846793|Benign prostatic obstruction (BPO)|benign prostatic obstruction (bpo)
405190|NCT01846793|BPO|bpo
405191|NCT01846793|Bladder outlet obstruction|bladder outlet obstruction
405192|NCT01846793|BOO|boo
405193|NCT01846767|13CO2|13co2
405194|NCT01846767|Breath test|breath test
405195|NCT01846767|Glucose oxidation|glucose oxidation
405196|NCT01846767|Diabetes mellitus|diabetes mellitus
405197|NCT01846754|Hemodialysis|hemodialysis
405198|NCT01846754|Fatigue|fatigue
405199|NCT01846754|Muscle strength|muscle strength
405200|NCT01846754|Metabolomics|metabolomics
405201|NCT01846741|Automatic Magnet Mode (AMM)|automatic magnet mode (amm)
405202|NCT01846741|Vagus Nerve Stimulation (VNS)|vagus nerve stimulation (vns)
405203|NCT01846715|Kidney disease|kidney disease
405204|NCT01846715|Renal insufficiency|renal insufficiency
405205|NCT01846715|CKD|ckd
405206|NCT01846715|Autologous cell therapy|autologous cell therapy
405207|NCT01846676|Hearing loss, rehabilitation programs, adherence to hearing aids.|hearing loss, rehabilitation programs, adherence to hearing aids.
405208|NCT01846663|Hepatic Encephalopathy|hepatic encephalopathy
405209|NCT01846663|Liver Failure|liver failure
405210|NCT01846663|Hepatic Insufficiency|hepatic insufficiency
405211|NCT01846663|Liver Diseases|liver diseases
405212|NCT01846663|Brain Diseases|brain diseases
405213|NCT01846663|Rifaximin|rifaximin
405214|NCT01846663|Cirrhosis|cirrhosis
405215|NCT01846611|Ovarian neoplasms|ovarian neoplasms
405216|NCT01846611|Peritoneal neoplasms|peritoneal neoplasms
405217|NCT01846611|Fallopian tube neoplasms|fallopian tube neoplasms
405218|NCT01846611|Advanced-relapsed epithelial ovarian cancer|advanced-relapsed epithelial ovarian cancer
405219|NCT01846611|Advanced-relapsed primary peritoneal cancer|advanced-relapsed primary peritoneal cancer
405220|NCT01846611|Advanced-relapsed fallopian tube cancer|advanced-relapsed fallopian tube cancer
405221|NCT01846611|Trabectedin|trabectedin
405222|NCT01846611|Yondelis|yondelis
405223|NCT01846611|Doxil|doxil
405224|NCT01846611|Caelyx|caelyx
405225|NCT01846611|Platinum sensitive|platinum sensitive
405226|NCT01846611|Tthird-line|tthird-line
405227|NCT01846611|BRCA|brca
405228|NCT01846611|Patient related outcome|patient related outcome
405229|NCT01846572|Stroke|stroke
405230|NCT01846572|Clopidogrel|clopidogrel
405231|NCT01846572|Aggregometry|aggregometry
405232|NCT01846572|Antiplatelet therapy|antiplatelet therapy
405233|NCT01846572|Platelet function tests|platelet function tests
405234|NCT01846559|Immune system processes|immune system processes
405235|NCT01846546|Traumatic brain injury;|traumatic brain injury;
405236|NCT01846546|Endostatin/collagen XVIII;|endostatin/collagen xviii;
405237|NCT01846546|Cerebrospinal fluid;|cerebrospinal fluid;
405238|NCT01846546|Prognosis|prognosis
405239|NCT01846507|Heavy Menstrual Bleeding|heavy menstrual bleeding
405241|NCT01846507|Lysteda|lysteda
405242|NCT01846481|Cocaine|cocaine
405243|NCT01846468|Healthy volunteers and patients,|healthy volunteers and patients,
405244|NCT01846468|renal insufficiency,|renal insufficiency,
405245|NCT01846455|Hepatic|hepatic
405246|NCT01846455|Hepatitis C Virus|hepatitis c virus
405247|NCT01846455|Suboxone|suboxone
405248|NCT01846455|Buprenorphine|buprenorphine
405249|NCT01846455|Naloxone|naloxone
405250|NCT01846442|Vulvar/vaginal atrophy|vulvar/vaginal atrophy
405251|NCT01846442|Atrophic Vaginitis|atrophic vaginitis
407632|NCT01835119|gum chewing|gum chewing
405252|NCT01846442|Dehydroepiandrosterone|dehydroepiandrosterone
405253|NCT01846442|DHEA|dhea
405254|NCT01846442|Prasterone|prasterone
405255|NCT01846442|Vaginorm|vaginorm
405256|NCT01846442|Menopause|menopause
405257|NCT01846442|Intrarosa|intrarosa
405258|NCT01846429|cancer|cancer
405259|NCT01846429|pain fibers|pain fibers
405260|NCT01846429|acid levels|acid levels
405261|NCT01846429|tumor related pain|tumor related pain
405262|NCT01846429|cancer related pain|cancer related pain
405263|NCT01846429|sodium bicarbonate|sodium bicarbonate
405264|NCT01846429|pain reliever|pain reliever
405265|NCT01846429|metastatic|metastatic
405266|NCT01846429|unresectable|unresectable
405267|NCT01846429|solid malignancy|solid malignancy
405268|NCT01846429|hematologic malignancy|hematologic malignancy
405269|NCT01846429|multiple myeloma|multiple myeloma
405270|NCT01846429|lymphoma|lymphoma
405271|NCT01846377|video game|video game
405272|NCT01846377|diet|diet
405273|NCT01846377|physical activity|physical activity
405274|NCT01846377|sedentary behavior|sedentary behavior
405275|NCT01846377|obesity|obesity
405276|NCT01846377|diabetes|diabetes
405277|NCT01846364|Thyroid|thyroid
405279|NCT01846351|choroidal neovascularization|choroidal neovascularization
405280|NCT01846351|epiretinal membrane|epiretinal membrane
405281|NCT01846351|anti-VEGF|anti-vegf
405282|NCT01846338|acne, EGCG, green tea|acne, egcg, green tea
405283|NCT01846299|Vision Impairment|vision impairment
405284|NCT01846286|Neuropathic Pain|neuropathic pain
405285|NCT01846286|Squamous cell cancer of the head and neck|squamous cell cancer of the head and neck
405286|NCT01846286|acute pain|acute pain
405287|NCT01846286|pain management|pain management
405288|NCT01846286|genome-wide analyses|genome-wide analyses
405289|NCT01846286|Squamous cell carcinoma of the head and neck|squamous cell carcinoma of the head and neck
405290|NCT01846286|chronic pain|chronic pain
405291|NCT01846286|neuropathic|neuropathic
405292|NCT01846286|locoregional squamous cell carcinoma of the head and neck|locoregional squamous cell carcinoma of the head and neck
405293|NCT01846273|Polypoidal choroidal vasculopathy|polypoidal choroidal vasculopathy
405294|NCT01846273|Visual acuity|visual acuity
405295|NCT01846273|Ranibizumab|ranibizumab
405296|NCT01846273|Verteporfin PDT|verteporfin pdt
405297|NCT01846247|stroke|stroke
405298|NCT01846234|Multiple Sclerosis|multiple sclerosis
405299|NCT01846234|Salt|salt
405300|NCT01846221|Analgesia|analgesia
405301|NCT01846221|Epidural|epidural
405302|NCT01846221|Pregnancy|pregnancy
405303|NCT01846221|Labor|labor
405304|NCT01846221|Clonidine|clonidine
405305|NCT01846221|Fentanyl|fentanyl
405306|NCT01846221|Bupivacaine|bupivacaine
405307|NCT01846221|Childbirth|childbirth
405308|NCT01846208|Egg Allergy|egg allergy
405309|NCT01846208|Egg Oral Immunotherapy|egg oral immunotherapy
405310|NCT01846208|Food Allergy|food allergy
405311|NCT01846195|blood loss|blood loss
405312|NCT01846182|Gulf War Illness|gulf war illness
405313|NCT01846182|Pregabalin|pregabalin
405314|NCT01846182|Duloxetine|duloxetine
405315|NCT01846182|Gulf War Veterans|gulf war veterans
405316|NCT01846182|Cymbalta|cymbalta
405317|NCT01846182|Lyrica|lyrica
405318|NCT01846169|food insecurity|food insecurity
405319|NCT01846169|older adults|older adults
405320|NCT01846169|nutrition|nutrition
405321|NCT01846169|food deliveries|food deliveries
405322|NCT01846156|convulsion rate|convulsion rate
405323|NCT01846130|Bed rest,|bed rest,
405324|NCT01846117|lignans|lignans
405325|NCT01846117|oxidative stress|oxidative stress
405326|NCT01846117|inflammation|inflammation
405327|NCT01846117|aging|aging
405328|NCT01846117|muscle weakness|muscle weakness
405329|NCT01846117|pain|pain
405330|NCT01846052|achromatopsia, CNGB3|achromatopsia, cngb3
405331|NCT01846013|Sit-Stand Workstations|sit-stand workstations
405332|NCT01846013|Increase Workplace Physical Activity|increase workplace physical activity
405333|NCT01846000|temporomandibular joint|temporomandibular joint
405334|NCT01846000|temporomandibular disorder|temporomandibular disorder
405335|NCT01846000|electromyography|electromyography
405336|NCT01846000|low-level laser therapy|low-level laser therapy
405337|NCT01845987|Palmoplantaris Pustulosis|palmoplantaris pustulosis
405338|NCT01845987|CNTO 1959|cnto 1959
405339|NCT01845987|Psoriasis|psoriasis
405340|NCT01845987|Anti-IL 23 Monoclonal Antibody|anti-il 23 monoclonal antibody
405341|NCT01845974|Radiofrequency Catheter Ablation|radiofrequency catheter ablation
405342|NCT01845974|Atrial Fibrillation|atrial fibrillation
405343|NCT01845948|parents|parents
405344|NCT01845948|school transition|school transition
405345|NCT01845948|parental-child relationship|parental-child relationship
405346|NCT01845935|Cryoablation|cryoablation
405347|NCT01845935|Venous vascular malformation|venous vascular malformation
405348|NCT01845935|MRI|mri
405349|NCT01845935|safety|safety
405350|NCT01845935|pain|pain
405351|NCT01845922|Refeeding Syndrome|refeeding syndrome
405352|NCT01845922|low sodium|low sodium
405353|NCT01845922|slowly absorbed carbohydrates|slowly absorbed carbohydrates
405354|NCT01845922|hypopotassemia|hypopotassemia
405355|NCT01845922|hypophosphatemia|hypophosphatemia
405356|NCT01845909|Sudden cardiac death|sudden cardiac death
405357|NCT01845909|Young adults|young adults
405358|NCT01845909|Cardiac Disease|cardiac disease
405359|NCT01845909|Arrhythmia|arrhythmia
405360|NCT01845909|Sports|sports
405361|NCT01845896|high intensity interval training|high intensity interval training
405362|NCT01845896|combined training|combined training
405363|NCT01845896|insulin resistance|insulin resistance
405364|NCT01845896|muscle contractile properties|muscle contractile properties
405365|NCT01845857|Long term health problems|long term health problems
405366|NCT01845857|chronic disease|chronic disease
405367|NCT01845831|Diabetes|diabetes
405368|NCT01845831|DPP4 inhibitors|dpp4 inhibitors
405369|NCT01845831|Sitagliptin|sitagliptin
405370|NCT01845831|Glargine|glargine
405371|NCT01845831|RCT|rct
405372|NCT01845831|basal insulin|basal insulin
405373|NCT01845831|hospital hyperglycemia|hospital hyperglycemia
405374|NCT01845831|inpatient diabetes|inpatient diabetes
405375|NCT01845818|work productivity|work productivity
405376|NCT01845818|multicenter study|multicenter study
405377|NCT01845792|Metastatic Castrate Resistant Prostate Cancer|metastatic castrate resistant prostate cancer
405378|NCT01845766|sepsis, septic shock, rehabilitation, exercise|sepsis, septic shock, rehabilitation, exercise
405379|NCT01845740|systemic lupus erythematoses|systemic lupus erythematoses
405380|NCT01845740|lupus|lupus
405381|NCT01845740|SLE|sle
405382|NCT01845727|Cutaneous leishmaniasis|cutaneous leishmaniasis
405383|NCT01845727|Topical treatment|topical treatment
405384|NCT01845727|Colombia|colombia
405385|NCT01845714|Keratoconus|keratoconus
405386|NCT01845714|Corneal cross Linking|corneal cross linking
405387|NCT01845714|Topo guided PRK|topo guided prk
405388|NCT01845714|Quality of Life|quality of life
405389|NCT01845701|malaria, cure rate, efficacy, safety|malaria, cure rate, efficacy, safety
405390|NCT01845688|Idiopathic Membranous Nephropathy|idiopathic membranous nephropathy
405391|NCT01845688|Traditional Chinese Medicine|traditional chinese medicine
405392|NCT01845688|Randomized Control Trial|randomized control trial
405393|NCT01845675|temozolomide|temozolomide
405394|NCT01845675|endostatin|endostatin
405395|NCT01845675|advanced|advanced
405396|NCT01845675|well-differentiated|well-differentiated
405397|NCT01845675|pancreatic neuroendocrine tumor|pancreatic neuroendocrine tumor
405398|NCT01845662|splenectomy|splenectomy
405399|NCT01845662|embolization|embolization
405400|NCT01845662|observation|observation
405401|NCT01845662|blood transfusion|blood transfusion
405402|NCT01845649|Vulvovaginal Atrophy|vulvovaginal atrophy
405403|NCT01845649|Dyspareunia|dyspareunia
405404|NCT01845649|Postmenopausal|postmenopausal
405405|NCT01845636|Olfaction|olfaction
405406|NCT01845636|Donepezil|donepezil
405407|NCT01845636|Alzheimer's Disease|alzheimer's disease
405408|NCT01845636|Mild Cognitive Impairment|mild cognitive impairment
405409|NCT01845636|Memory|memory
405410|NCT01845623|Asthma|asthma
405411|NCT01845623|Indacaterol|indacaterol
405412|NCT01845623|QAB149|qab149
405413|NCT01845584|IVIG in Neuromyelitis Optica spectrum disorder|ivig in neuromyelitis optica spectrum disorder
405414|NCT01845584|Patients with Neuromyelitis Optica spectrum disorder|patients with neuromyelitis optica spectrum disorder
405415|NCT01845558|Muscle soreness|muscle soreness
405416|NCT01845558|Exercise induced muscle damage|exercise induced muscle damage
405417|NCT01845558|Inflammation|inflammation
405418|NCT01845558|Proteolytic enzymes|proteolytic enzymes
405419|NCT01845558|Muscle strength Dynamometer|muscle strength dynamometer
405420|NCT01845545|microfinance|microfinance
405421|NCT01845545|under five mortality|under five mortality
405422|NCT01845545|underweight|underweight
405423|NCT01845545|malnutrition|malnutrition
405424|NCT01845506|wireless pressure sensor|wireless pressure sensor
405425|NCT01845506|Elderly|elderly
405426|NCT01845493|asthma|asthma
405427|NCT01845493|Asthmatics|asthmatics
405428|NCT01845493|allergic|allergic
405429|NCT01845493|allergies|allergies
405430|NCT01845480|health promotion|health promotion
405431|NCT01845480|obesity prevention|obesity prevention
405432|NCT01845480|Childhood obesity|childhood obesity
405433|NCT01845480|home-based|home-based
405434|NCT01845480|Lifestyle intervention|lifestyle intervention
405435|NCT01845480|Body composition|body composition
405436|NCT01845480|quality of life|quality of life
405437|NCT01845480|physical activity|physical activity
405438|NCT01845480|nutrition|nutrition
405439|NCT01845467|Secretin MRCP, diagnosis, Autoimmune pancreatitis|secretin mrcp, diagnosis, autoimmune pancreatitis
405440|NCT01845454|Barrett's Esophagus|barrett's esophagus
405441|NCT01845454|Spray cryotherapy|spray cryotherapy
405442|NCT01845441|Dexmedetomidine|dexmedetomidine
405443|NCT01845441|Endovascular procedure|endovascular procedure
405444|NCT01845441|Stroke|stroke
405445|NCT01845441|Vasospasm, intracranial|vasospasm, intracranial
405446|NCT01845441|Conscious sedation|conscious sedation
405447|NCT01845428|nephrotic|nephrotic
405448|NCT01845428|hyperlipidemia|hyperlipidemia
405449|NCT01845428|oxLDL|oxldl
405450|NCT01845428|kidney|kidney
405451|NCT01845402|Kidney Failure, Chronic|kidney failure, chronic
405452|NCT01845402|Adolescent|adolescent
405453|NCT01845402|Heart Defects, Congenital|heart defects, congenital
405454|NCT01845389|Anesthesia|anesthesia
405455|NCT01845389|Regional|regional
405456|NCT01845389|Epidural|epidural
405457|NCT01845389|Continuous spinal|continuous spinal
405458|NCT01845389|Wiley Catheter|wiley catheter
405459|NCT01845389|Geriatric|geriatric
405460|NCT01845389|TURP|turp
405461|NCT01845376|Inflammatory Markers after Inguinal Hernia Repair|inflammatory markers after inguinal hernia repair
405462|NCT01845376|Anesthetic technique for hernia repair|anesthetic technique for hernia repair
405463|NCT01845363|Obesity|obesity
405464|NCT01845363|Bariatric surgery|bariatric surgery
405465|NCT01845363|Cefazolin|cefazolin
405466|NCT01845363|antimicrobial prophylaxis|antimicrobial prophylaxis
405467|NCT01845363|administration and dosage|administration and dosage
405468|NCT01845324|Pregnancy|pregnancy
405469|NCT01845324|Diabetes Mellitus|diabetes mellitus
405470|NCT01845285|transcatheter valve replacement|transcatheter valve replacement
405471|NCT01845285|aortic valve disease|aortic valve disease
405472|NCT01845285|aortic stenosis|aortic stenosis
405473|NCT01845285|Aortic regurgitation,catheter|aortic regurgitation,catheter
405474|NCT01845285|Effective orifice area|effective orifice area
405475|NCT01845246|Colistin|colistin
405476|NCT01845246|Polymyxins|polymyxins
405477|NCT01845246|Therapeutic drug monitoring|therapeutic drug monitoring
405478|NCT01845246|Multi Drug resistant Gram negative bacterial infections|multi drug resistant gram negative bacterial infections
405479|NCT01845220|Broccoli sprouts|broccoli sprouts
405480|NCT01845220|alcohol sensitivity|alcohol sensitivity
405481|NCT01845220|sulforaphane|sulforaphane
405482|NCT01845220|alcohol metabolism|alcohol metabolism
405483|NCT01845220|in the Asian Community|in the asian community
405484|NCT01845207|Aortic stenosis|aortic stenosis
405485|NCT01845207|Aortic valve replacement|aortic valve replacement
405486|NCT01845207|Transcatheter aortic valve implantation|transcatheter aortic valve implantation
405487|NCT01845207|Outcomes|outcomes
405488|NCT01845207|Frailty|frailty
405489|NCT01845207|Elderly|elderly
405490|NCT01845194|pharmacokinetic|pharmacokinetic
405491|NCT01845194|heritability|heritability
405492|NCT01845194|drug membrane transport|drug membrane transport
405493|NCT01845194|drug biotransformation|drug biotransformation
405494|NCT01845181|Adenosine A1 receptor antagonist|adenosine a1 receptor antagonist
405495|NCT01845181|Asthma|asthma
405496|NCT01845181|adenosine receptor modulator|adenosine receptor modulator
405497|NCT01845181|COPD|copd
405498|NCT01845168|Bleeding peptic ulcer|bleeding peptic ulcer
405499|NCT01845168|NSAID and Aspirin|nsaid and aspirin
405500|NCT01845168|Computer-alert|computer-alert
405501|NCT01845168|General practitioner|general practitioner
405502|NCT01845155|Tinnitus|tinnitus
405503|NCT01845155|music therapy|music therapy
405504|NCT01845155|directive counselling|directive counselling
405505|NCT01845155|acoustic stimulation|acoustic stimulation
405506|NCT01845155|group comparison|group comparison
405507|NCT01845155|subjective evaluation|subjective evaluation
405508|NCT01845155|pitch|pitch
405509|NCT01845142|vitamin D|vitamin d
405510|NCT01845142|vitamin D deficiency|vitamin d deficiency
405511|NCT01845142|immune cells|immune cells
405512|NCT01845142|pharmacokinetic|pharmacokinetic
405513|NCT01845142|< 50 nmol/L 25(OH)D serum concentration|< 50 nmol/l 25(oh)d serum concentration
405514|NCT01845116|PNALD|pnald
405515|NCT01845116|Cholestasis|cholestasis
405516|NCT01845116|Omegaven®|omegaven®
405517|NCT01845116|Short Bowel Syndrome|short bowel syndrome
405518|NCT01845103|ANGINA|angina
405519|NCT01845103|Thoracoscopic|thoracoscopic
405520|NCT01845064|type 2 diabetes|type 2 diabetes
405521|NCT01845064|diabetes mellitus|diabetes mellitus
405522|NCT01845064|type 2 diabetes mellitus|type 2 diabetes mellitus
405523|NCT01845064|HbA1c|hba1c
405524|NCT01845064|blood glucose|blood glucose
405525|NCT01845064|glucose control|glucose control
405526|NCT01845064|DiaMedica|diamedica
405527|NCT01845064|DM-199|dm-199
405528|NCT01845064|DM199|dm199
405529|NCT01845064|recombinant human tissue kallikrein-1|recombinant human tissue kallikrein-1
405530|NCT01845064|tissue kallikrein-1|tissue kallikrein-1
405531|NCT01845051|Migraine|migraine
405532|NCT01845051|allergic rhinitis|allergic rhinitis
405533|NCT01845051|Specific Immunoglobulin E (IgE)|specific immunoglobulin e (ige)
405534|NCT01845051|nasal symptoms|nasal symptoms
405535|NCT01845051|signs of allergy.|signs of allergy.
405536|NCT01845025|Asthma|asthma
405537|NCT01845025|formoterol fumarate|formoterol fumarate
405538|NCT01845025|Foradil|foradil
405539|NCT01845025|inhaled corticosteroid|inhaled corticosteroid
405540|NCT01845025|fluticasone propionate|fluticasone propionate
405541|NCT01845025|safety|safety
405542|NCT01845012|Short daily hemodialysis|short daily hemodialysis
405543|NCT01845012|Low dialysate flow|low dialysate flow
405544|NCT01845012|End stage renal disease|end stage renal disease
405545|NCT01844999|Prostate cancer|prostate cancer
405546|NCT01844999|Decision|decision
405547|NCT01844986|BRCA|brca
405548|NCT01844986|Ovarian Cancer|ovarian cancer
405549|NCT01844986|Chemotherapy|chemotherapy
405550|NCT01844986|PARP inhibitor|parp inhibitor
405551|NCT01844986|First Line|first line
405552|NCT01844986|FIGO Stage III|figo stage iii
405553|NCT01844986|FIGO Stage IV|figo stage iv
405554|NCT01844960|Single Incision Surgery|single incision surgery
405555|NCT01844960|SILS|sils
405556|NCT01844960|Laparoscopic Gastric Band|laparoscopic gastric band
405557|NCT01844960|Morbid Obesity|morbid obesity
405558|NCT01844960|Bariatric Surgery|bariatric surgery
405559|NCT01844934|Knee Arthroplasty|knee arthroplasty
405560|NCT01844934|Knee Replacement|knee replacement
405561|NCT01844934|Prehabilitation|prehabilitation
405562|NCT01844882|The effects|the effects
405563|NCT01844882|dietary|dietary
405564|NCT01844882|fiber|fiber
405565|NCT01844882|kidney function|kidney function
405566|NCT01844882|CKD patients|ckd patients
405567|NCT01844869|omacetaxine|omacetaxine
405568|NCT01844869|omacetaxine mepesuccinate|omacetaxine mepesuccinate
405569|NCT01844869|pharmacokinetics|pharmacokinetics
405570|NCT01844869|hematologic malignancies|hematologic malignancies
405571|NCT01844869|advanced solid tumors|advanced solid tumors
405572|NCT01844843|Drug eluting stents|drug eluting stents
405573|NCT01844843|coronary artery disease|coronary artery disease
405574|NCT01844843|Percutaneous Coronary Intervention|percutaneous coronary intervention
405575|NCT01844843|Tomography, Optical Coherence|tomography, optical coherence
405576|NCT01844830|operative|operative
405577|NCT01844830|dental procedure|dental procedure
405578|NCT01844817|untreated|untreated
405579|NCT01844817|metastatic|metastatic
405580|NCT01844817|OGX-427|ogx-427
405581|NCT01844804|Bioequivalence|bioequivalence
405582|NCT01844804|Biosimilarity|biosimilarity
405583|NCT01844804|Similarity|similarity
405584|NCT01844804|PK|pk
405585|NCT01844804|Phase 1|phase 1
405586|NCT01844804|Infliximab|infliximab
405587|NCT01844804|Healthy Volunteers|healthy volunteers
405588|NCT01844804|Single-dose|single-dose
405589|NCT01844804|Immunology|immunology
405590|NCT01844791|Non-small cell lung cancer|non-small cell lung cancer
405591|NCT01844791|OCZ103-OS|ocz103-os
405592|NCT01844791|Pentamidine bis(2-hydroxyethanesulfonate)|pentamidine bis(2-hydroxyethanesulfonate)
405593|NCT01844791|platinum-gemcitabine based doublet first line therapy|platinum-gemcitabine based doublet first line therapy
405594|NCT01844778|Cystic Fibrosis, Pseudomonas aeruginosa, FEV1, tobramycin inhalation powder, TOBI,|cystic fibrosis, pseudomonas aeruginosa, fev1, tobramycin inhalation powder, tobi,
405595|NCT01844778|colistimethate|colistimethate
405596|NCT01844778|Cystic Fibrosis, Pseudomonas aeruginosa, FEV1, tobramycin inhalation powder, TOBI, colistimethate|cystic fibrosis, pseudomonas aeruginosa, fev1, tobramycin inhalation powder, tobi, colistimethate
405597|NCT01844765|Tasigna|tasigna
405598|NCT01844765|nilotinib treatment|nilotinib treatment
405599|NCT01844765|chronic phase|chronic phase
405600|NCT01844765|Ph+ CML|ph+ cml
405601|NCT01844765|accelerated phase|accelerated phase
405602|NCT01844765|newly diagnosed Ph+ CML|newly diagnosed ph+ cml
405603|NCT01844765|pediatric|pediatric
405604|NCT01844765|24 month treatment|24 month treatment
405605|NCT01844752|acne|acne
405606|NCT01844739|Propionibacterium acnes|propionibacterium acnes
405607|NCT01844739|acne|acne
405608|NCT01844726|healthy individuals|healthy individuals
405609|NCT01844726|schizophrenia|schizophrenia
405610|NCT01844726|schizoaffective disorder|schizoaffective disorder
405611|NCT01844726|learning|learning
405612|NCT01844726|memory|memory
405613|NCT01844726|cognitive enhancement|cognitive enhancement
405614|NCT01844726|fMRI|fmri
405615|NCT01844713|Kidney transplant|kidney transplant
405616|NCT01844713|Renal transplant|renal transplant
405617|NCT01844713|Sun protection|sun protection
405618|NCT01844713|Skin cancer|skin cancer
405619|NCT01844700|MC4R genotype|mc4r genotype
405620|NCT01844700|antipsychotic induced weight gain|antipsychotic induced weight gain
405621|NCT01844700|pediatric population|pediatric population
405622|NCT01844687|reinforcement, good drug effect, high, mood, cannabidiol|reinforcement, good drug effect, high, mood, cannabidiol
405623|NCT01844661|Mesenchymal stem cells|mesenchymal stem cells
405624|NCT01844661|Oncolytic adenovirus|oncolytic adenovirus
405625|NCT01844648|Parkinson's disease|parkinson's disease
405626|NCT01844648|Sialorrhea|sialorrhea
405627|NCT01844648|Tropicamide|tropicamide
405628|NCT01844648|Non-motor symptoms|non-motor symptoms
405629|NCT01844648|Thin strip delivery|thin strip delivery
405630|NCT01844622|Digestive System Diseases Disease|digestive system diseases disease
405631|NCT01844609|Comprehension|comprehension
405632|NCT01844609|Verbal Learning|verbal learning
405633|NCT01844609|Writing|writing
405634|NCT01844609|Testing|testing
405635|NCT01844596|linkage to care|linkage to care
405636|NCT01844596|hypertension management|hypertension management
405637|NCT01844596|behavioral science|behavioral science
405638|NCT01844596|cardiovascular health|cardiovascular health
405639|NCT01844596|global health|global health
405640|NCT01844596|multi-disciplinary implementation research approach|multi-disciplinary implementation research approach
405641|NCT01844596|linking and retaining|linking and retaining
405642|NCT01844596|community health workers|community health workers
405643|NCT01844596|CHWs|chws
405644|NCT01844596|behavioral communication strategy|behavioral communication strategy
405645|NCT01844596|smartphone-based tool|smartphone-based tool
405646|NCT01844596|electronic health record|electronic health record
405647|NCT01844596|retention to care|retention to care
405648|NCT01844557|Head And Neck Cancer|head and neck cancer
405649|NCT01844557|Nasopharyngeal cancer|nasopharyngeal cancer
405650|NCT01844557|Oropharyngeal cancer|oropharyngeal cancer
405651|NCT01844557|Hypopharyngeal cancer|hypopharyngeal cancer
405652|NCT01844557|Laryngeal cancer|laryngeal cancer
405653|NCT01844557|Primary cancer with cervical metastases|primary cancer with cervical metastases
405654|NCT01844557|Swallowing exercises|swallowing exercises
405655|NCT01844557|Videotape|videotape
405656|NCT01844557|Videocamera|videocamera
405657|NCT01844557|M.D. Anderson Symptom Inventory|m.d. anderson symptom inventory
405658|NCT01844557|Questionnaires|questionnaires
405659|NCT01844557|Surveys|surveys
405660|NCT01844544|drug related problems|drug related problems
405661|NCT01844544|clinical pharmacist|clinical pharmacist
405662|NCT01844544|femoral neck fractures|femoral neck fractures
405663|NCT01844544|orthopedic patients|orthopedic patients
405664|NCT01844492|decision making for incapacitated patients|decision making for incapacitated patients
405665|NCT01844492|intensive care|intensive care
405666|NCT01844492|surrogate decision making|surrogate decision making
405667|NCT01844492|patient centered care|patient centered care
405668|NCT01844492|Palliative Care|palliative care
405669|NCT01844492|End of Life|end of life
405670|NCT01844492|Quality of Communication|quality of communication
405671|NCT01844479|diabetic foot ulcer|diabetic foot ulcer
405672|NCT01844479|diabetic foot|diabetic foot
405673|NCT01844466|course of motor and visual rehabilitation|course of motor and visual rehabilitation
405674|NCT01844466|improvement of deficits|improvement of deficits
405675|NCT01844466|stroke patients|stroke patients
405676|NCT01844453|Subfertility|subfertility
405677|NCT01844453|Recurrent Implantation Failure|recurrent implantation failure
405678|NCT01844440|GERD|gerd
405679|NCT01844440|tLESR|tlesr
405680|NCT01844440|impedance|impedance
405681|NCT01844440|manometry|manometry
405682|NCT01844427|ADHD|adhd
405683|NCT01844427|Executive function deficits|executive function deficits
405684|NCT01844427|Psychiatry|psychiatry
405685|NCT01844427|Psychopharmacology|psychopharmacology
405686|NCT01844427|Namenda|namenda
405687|NCT01844414|Homeless Men|homeless men
405688|NCT01844414|Parolees|parolees
405689|NCT01844414|Hepatitis B|hepatitis b
405690|NCT01844414|Hepatitis C|hepatitis c
405691|NCT01844414|HIV|hiv
405692|NCT01844414|Community Drug Treatment|community drug treatment
405693|NCT01844414|Recidivism|recidivism
405694|NCT01844401|persistent asthma|persistent asthma
405695|NCT01844401|Albuterol Spiromax®|albuterol spiromax®
405696|NCT01844401|ProAir® HFA|proair® hfa
405697|NCT01844401|Pediatric Patients|pediatric patients
405698|NCT01844401|Phase 1|phase 1
405699|NCT01844375|oral carbohydrate loading|oral carbohydrate loading
405700|NCT01844375|walking capacity|walking capacity
405701|NCT01844362|uterus|uterus
405702|NCT01844362|transplantation|transplantation
405703|NCT01844362|infertility|infertility
405704|NCT01844349|North Africa|north africa
405705|NCT01844349|Urban women|urban women
405706|NCT01844349|Double burden of malnutrition|double burden of malnutrition
405707|NCT01844349|Iron depletion|iron depletion
405708|NCT01844349|Overweight/obesity|overweight/obesity
405709|NCT01844349|Metabolic syndrome|metabolic syndrome
405710|NCT01844349|Abdominal obesity|abdominal obesity
405711|NCT01844349|Excess body fat|excess body fat
405712|NCT01844284|Absorb™ BVS|absorb™ bvs
405713|NCT01844284|Angioplasty|angioplasty
405714|NCT01844284|Bioabsorbable|bioabsorbable
405715|NCT01844284|Bioreabsorbable|bioreabsorbable
405716|NCT01844284|BVS|bvs
405717|NCT01844284|Coronary Artery Disease|coronary artery disease
405718|NCT01844284|Coronary Artery Endothelial Responsiveness|coronary artery endothelial responsiveness
405719|NCT01844284|Coronary artery restenosis|coronary artery restenosis
405720|NCT01844284|Coronary artery stenosis|coronary artery stenosis
405721|NCT01844284|Coronary scaffold|coronary scaffold
405722|NCT01844284|Coronary Stent|coronary stent
405723|NCT01844284|Drug eluting stents|drug eluting stents
405724|NCT01844284|Everolimus|everolimus
405725|NCT01844284|Myocardial ischemia|myocardial ischemia
405726|NCT01844284|Stent thrombosis|stent thrombosis
405727|NCT01844284|Stents|stents
405728|NCT01844271|LLLT|lllt
405729|NCT01844271|muscle fatigue and recovery|muscle fatigue and recovery
405730|NCT01844271|phototherapy parameter|phototherapy parameter
405731|NCT01844258|pediatric cataract|pediatric cataract
405732|NCT01844258|lens regeneration|lens regeneration
405733|NCT01844258|endogenous lens epithelial stem cells|endogenous lens epithelial stem cells
405734|NCT01844258|visual axis opacification|visual axis opacification
405735|NCT01844258|visual function|visual function
405736|NCT01844245|Cholangiocarcinoma|cholangiocarcinoma
405737|NCT01844245|Ampullary carcinoma|ampullary carcinoma
405738|NCT01844245|Endoscopic retrograde cholangiopancreatography|endoscopic retrograde cholangiopancreatography
405739|NCT01844245|Radiofrequency ablation|radiofrequency ablation
405740|NCT01844232|Multiple sclerosis|multiple sclerosis
405741|NCT01844232|spasticity|spasticity
405742|NCT01844232|arbaclofen|arbaclofen
405743|NCT01844219|aortic surgery|aortic surgery
405744|NCT01844219|acute kidney injury|acute kidney injury
405745|NCT01844219|gray zone approach|gray zone approach
405746|NCT01844206|Post-cesarean analgesia|post-cesarean analgesia
405747|NCT01844206|Second dose of epidural morphine after surgery|second dose of epidural morphine after surgery
405748|NCT01844206|Post-operative analgesia|post-operative analgesia
405749|NCT01844206|Self-administered epidural morphine|self-administered epidural morphine
405750|NCT01844206|Pain management after cesarean|pain management after cesarean
405751|NCT01844180|Irritable Bowel Syndrome|irritable bowel syndrome
405752|NCT01844180|IBS|ibs
405753|NCT01844180|ONO-2952|ono-2952
405754|NCT01844167|noxipoint|noxipoint
405755|NCT01844167|physical therapy|physical therapy
405756|NCT01844167|cervical pain|cervical pain
405757|NCT01844167|trigger point|trigger point
405758|NCT01844167|neck pain|neck pain
405759|NCT01844167|TENS|tens
405760|NCT01844167|transcutaneous electrical nerve stimulation|transcutaneous electrical nerve stimulation
405761|NCT01844141|phenol|phenol
405762|NCT01844141|ingrown toenail|ingrown toenail
405763|NCT01844141|chemical matricectomy|chemical matricectomy
405764|NCT01844128|MMA, AFC, Ovarian reserve|mma, afc, ovarian reserve
405765|NCT01844115|Generalized Anxiety Disorder, GAD|generalized anxiety disorder, gad
405766|NCT01844102|HIV Prevention, PrePex, voluntary medical circumcision, non-surgical,|hiv prevention, prepex, voluntary medical circumcision, non-surgical,
405767|NCT01844102|medical device, wound healing, Zambia|medical device, wound healing, zambia
405768|NCT01844089|Postpartum hemorrhage|postpartum hemorrhage
405769|NCT01844089|Bakri Postpartum Balloon|bakri postpartum balloon
405770|NCT01844076|advanced stage colorectal adenocarcinoma|advanced stage colorectal adenocarcinoma
405771|NCT01844050|Chinese herbal medicine|chinese herbal medicine
405772|NCT01844050|diabetes symptoms|diabetes symptoms
405773|NCT01844011|fetal movement|fetal movement
405774|NCT01844011|pregnancy|pregnancy
405775|NCT01843998|Early stage|early stage
405776|NCT01843998|Stage 1A|stage 1a
405777|NCT01843998|Cutaneous T-cell Lymphoma|cutaneous t-cell lymphoma
405778|NCT01843998|CTCL|ctcl
405779|NCT01843985|Stage IV cancer|stage iv cancer
405780|NCT01843985|Survival|survival
405781|NCT01843959|adenovirus-36|adenovirus-36
405782|NCT01843959|Emirati population|emirati population
405783|NCT01843920|eye|eye
405784|NCT01843920|pneumatic retinopexy|pneumatic retinopexy
405785|NCT01843920|topical|topical
405786|NCT01843894|sever dry eye,keratoconjunctivitis sicca|sever dry eye,keratoconjunctivitis sicca
405787|NCT01843881|Gastric Bypass|gastric bypass
405788|NCT01843881|bariatric surgery|bariatric surgery
405789|NCT01843881|carbohydrate metabolism|carbohydrate metabolism
405790|NCT01843868|Lymphoma|lymphoma
405791|NCT01843868|Non-Hodgkin|non-hodgkin
405792|NCT01843868|Emesis|emesis
405793|NCT01843868|Chemotherapy|chemotherapy
405794|NCT01843868|Nausea|nausea
405795|NCT01843868|Vomiting|vomiting
405796|NCT01843868|Aprepitant|aprepitant
405797|NCT01843855|Gastric Bypass|gastric bypass
405798|NCT01843855|bariatric surgery|bariatric surgery
405799|NCT01843855|glucose metabolism|glucose metabolism
405800|NCT01843829|Oesophageal cancer|oesophageal cancer
405801|NCT01843816|Tragus-to-wall distance|tragus-to-wall distance
405802|NCT01843816|obesity|obesity
405803|NCT01843816|body shape|body shape
405804|NCT01843816|height|height
405805|NCT01843816|weight|weight
405806|NCT01843803|patient centered care|patient centered care
405807|NCT01843803|collaborative decision making|collaborative decision making
405808|NCT01843803|cost impact|cost impact
405809|NCT01843777|hearing loss|hearing loss
405810|NCT01843777|hearing aids|hearing aids
405811|NCT01843777|motivational interviewing|motivational interviewing
405812|NCT01843777|counseling|counseling
405813|NCT01843777|rehabilitation|rehabilitation
405814|NCT01843764|RDT|rdt
405815|NCT01843764|malaria|malaria
405816|NCT01843764|treatment follow up|treatment follow up
405817|NCT01843764|diagnosis|diagnosis
405818|NCT01843725|breast cancer|breast cancer
405819|NCT01843725|digestive cancer|digestive cancer
405820|NCT01843712|Caloric compensation|caloric compensation
405821|NCT01843712|Eating in the absence of hunger|eating in the absence of hunger
405822|NCT01843712|Children|children
405823|NCT01843712|Parental feeding practices|parental feeding practices
405824|NCT01843686|Acute 2nd and 3rd Degree Burns|acute 2nd and 3rd degree burns
405825|NCT01843686|Autologous Platelet Rich Plasma (PRP)|autologous platelet rich plasma (prp)
405826|NCT01843686|Skin Grafting|skin grafting
405827|NCT01843686|Magellan® System|magellan® system
405828|NCT01843686|Wounds|wounds
405829|NCT01843673|Lip, Oral Cavity and Pharynx|lip, oral cavity and pharynx
405830|NCT01843673|Larynx|larynx
405831|NCT01843660|Low back pain|low back pain
405832|NCT01843660|Shoulder pain|shoulder pain
405833|NCT01843660|Neck pain|neck pain
405834|NCT01843660|Tramadol hydrochloride|tramadol hydrochloride
405835|NCT01843660|Paracetamol|paracetamol
405836|NCT01843621|Dengue, Vaccine, Thailand|dengue, vaccine, thailand
405837|NCT01843608|Physical treatment|physical treatment
405838|NCT01843608|Exercise prescription to breast cancer survival|exercise prescription to breast cancer survival
405839|NCT01843608|Side cancer effect treatment|side cancer effect treatment
405840|NCT01843582|Keyword: blind spot|keyword: blind spot
405841|NCT01843569|In Vitro Maturation|in vitro maturation
405842|NCT01843569|IVM|ivm
405843|NCT01843569|Natural cycle IVF|natural cycle ivf
405844|NCT01843569|PCOS|pcos
405845|NCT01843543|Functional MRI (fMRI)|functional mri (fmri)
405846|NCT01843543|Resting state functional connectivity MRI (rs-fcMRI)|resting state functional connectivity mri (rs-fcmri)
405847|NCT01843543|Diffusion Tensor Imaging (DTI)|diffusion tensor imaging (dti)
405848|NCT01843517|Pain|pain
405849|NCT01843517|Facilitation|facilitation
405850|NCT01843517|Inhibition|inhibition
405851|NCT01843517|Oxytocin|oxytocin
405852|NCT01843517|Postpartum|postpartum
405853|NCT01843504|platelet rich plasma|platelet rich plasma
405854|NCT01843504|PRP|prp
405855|NCT01843504|plasma|plasma
405856|NCT01843504|plasma injection|plasma injection
405857|NCT01843504|patellar tendinopathy|patellar tendinopathy
405858|NCT01843504|patella tendon|patella tendon
405859|NCT01843504|patella|patella
405860|NCT01843504|ultrasound|ultrasound
405861|NCT01843504|shear wave ultrasound|shear wave ultrasound
405862|NCT01843504|tendinosis|tendinosis
405863|NCT01843504|tendinopathy|tendinopathy
405864|NCT01843504|tendinitis|tendinitis
405865|NCT01843504|jumper's knee|jumper's knee
405866|NCT01843478|women|women
405867|NCT01843478|human immunodeficiency virus|human immunodeficiency virus
405868|NCT01843478|cervical cancer screening|cervical cancer screening
405869|NCT01843478|Pap testing|pap testing
405870|NCT01843478|human papillomavirus|human papillomavirus
405871|NCT01843465|atrial fibrillation|atrial fibrillation
405872|NCT01843465|balloon cryoablation|balloon cryoablation
405873|NCT01843465|pulmonary veins|pulmonary veins
405874|NCT01843439|Acute exacerbation|acute exacerbation
405875|NCT01843439|Quality of life|quality of life
405876|NCT01843439|Magnesium deficiency|magnesium deficiency
405877|NCT01843439|Multidisciplinary intervention|multidisciplinary intervention
405878|NCT01843426|Comorbidity|comorbidity
405879|NCT01843413|unspecified adult solid tumor, protocol specific|unspecified adult solid tumor, protocol specific
405880|NCT01843400|Regorafenib|regorafenib
405881|NCT01843400|Colorectal Neoplasms|colorectal neoplasms
405882|NCT01843387|Diabetic nephropathy|diabetic nephropathy
405883|NCT01843387|Chronic kidney disease|chronic kidney disease
405884|NCT01843387|Metabolic disease|metabolic disease
405885|NCT01843387|Diabetes mellitus, type 2|diabetes mellitus, type 2
405886|NCT01843374|tremelimumab|tremelimumab
405887|NCT01843374|pleural, peritoneal|pleural, peritoneal
405888|NCT01843374|malignant mesothelioma|malignant mesothelioma
405889|NCT01843374|CTLA-4|ctla-4
405890|NCT01843361|Stroke|stroke
405891|NCT01843361|Clopidogrel|clopidogrel
405892|NCT01843361|Aggregometry|aggregometry
405893|NCT01843361|Antiplatelet therapy|antiplatelet therapy
405894|NCT01843361|Platelet function tests|platelet function tests
405895|NCT01843348|Transplant|transplant
405896|NCT01843348|Renal transplant|renal transplant
405897|NCT01843348|Rejection,allograf|rejection,allograf
405898|NCT01843348|Rejection|rejection
405899|NCT01843348|Xenograft rejection|xenograft rejection
405900|NCT01843348|Host vs graft disease|host vs graft disease
405901|NCT01843348|Kidney Transplant|kidney transplant
405902|NCT01843335|Cardiovascular Diagnostic Technique|cardiovascular diagnostic technique
405903|NCT01843335|Ultrasound|ultrasound
405904|NCT01843322|Image guided therapy|image guided therapy
405905|NCT01843322|Endovascular procedures|endovascular procedures
405906|NCT01843322|Angiography|angiography
405907|NCT01843322|Vascular surgical procedures|vascular surgical procedures
405908|NCT01843296|Spinal Anesthesia|spinal anesthesia
405909|NCT01843296|Bupivacaine|bupivacaine
405910|NCT01843296|Fentanyl|fentanyl
405911|NCT01843296|Magnesium sulfate|magnesium sulfate
405912|NCT01843296|Postoperative Pain|postoperative pain
405913|NCT01843283|Mild Cognitive Impairment|mild cognitive impairment
405914|NCT01843283|Family Caregivers|family caregivers
405915|NCT01843283|Intervention studies|intervention studies
405916|NCT01843270|general anesthesia|general anesthesia
405917|NCT01843270|body weight|body weight
405918|NCT01843270|laryngeal mask airway size|laryngeal mask airway size
405919|NCT01843257|Alcohol intake after bariatric surgery|alcohol intake after bariatric surgery
405920|NCT01843257|Alcohol and bariatric surgery|alcohol and bariatric surgery
405921|NCT01843244|plethysmography|plethysmography
405922|NCT01843231|g-Cath EZ Suture Anchor Delivery Catheter|g-cath ez suture anchor delivery catheter
405923|NCT01843231|Weight Loss Intervention|weight loss intervention
405924|NCT01843218|Localized rectal cancer in a male patient|localized rectal cancer in a male patient
405925|NCT01843179|Newly diagnosed|newly diagnosed
405926|NCT01843179|Complete Remission|complete remission
405927|NCT01843166|Pessary|pessary
405928|NCT01843166|Patient Satisfaction|patient satisfaction
405929|NCT01843166|Estrogen Cream|estrogen cream
405930|NCT01843153|pain score|pain score
405931|NCT01843140|cancer|cancer
405932|NCT01843140|fertility preservation|fertility preservation
405933|NCT01843140|infertility|infertility
405934|NCT01843140|pregnancy|pregnancy
405935|NCT01843114|Retinal blood flow|retinal blood flow
405936|NCT01843114|Retinal vessel diameter|retinal vessel diameter
406036|NCT01842607|Severe refractory asthma|severe refractory asthma
405937|NCT01843114|Fourier Domain Optical Coherence Tomography|fourier domain optical coherence tomography
405938|NCT01843114|Retinal blood velocities|retinal blood velocities
405939|NCT01843101|Optical Coherence Tomography|optical coherence tomography
405940|NCT01843101|Cornea|cornea
405941|NCT01843101|Imaging|imaging
405942|NCT01843088|Pain|pain
405943|NCT01843088|exercise|exercise
405944|NCT01843088|muscle|muscle
405945|NCT01843062|Selumetinib, Differentiated Thyroid Cancer , AZD6244|selumetinib, differentiated thyroid cancer , azd6244
405946|NCT01843036|Child Abuse|child abuse
405947|NCT01843036|Child Neglect|child neglect
405948|NCT01843036|Child Emergency Medical Care Presentations|child emergency medical care presentations
405949|NCT01843036|Child Well-Care Compliance|child well-care compliance
405950|NCT01843036|Mother Well-Care Compliance|mother well-care compliance
405951|NCT01843036|Mother Emergency Medical Care Presentations|mother emergency medical care presentations
405952|NCT01843036|Mother Mental Health|mother mental health
405953|NCT01843036|Family Connections to Community Resources|family connections to community resources
405954|NCT01843036|Parent-Child Relationship Quality|parent-child relationship quality
405955|NCT01843023|opioid dependence|opioid dependence
405956|NCT01843010|NSAIDs|nsaids
405957|NCT01843010|Hyperalgesia|hyperalgesia
405958|NCT01843010|Postlaparoscopic shoulder pain|postlaparoscopic shoulder pain
405959|NCT01842997|Flu|flu
405960|NCT01842997|non-adjuvanted H1N1 vaccine|non-adjuvanted h1n1 vaccine
405961|NCT01842997|Safety|safety
405962|NCT01842997|pregnant women|pregnant women
405963|NCT01842984|Loneliness|loneliness
405964|NCT01842984|Social isolation|social isolation
405965|NCT01842984|Depression|depression
405966|NCT01842984|Older adults|older adults
405967|NCT01842984|Social competence|social competence
405968|NCT01842984|Social integration|social integration
405969|NCT01842971|two stage hepatectomy|two stage hepatectomy
405970|NCT01842971|liver metastasis|liver metastasis
405971|NCT01842971|colorectal cancer|colorectal cancer
405972|NCT01842958|Dental Implant|dental implant
405973|NCT01842945|Procrastination|procrastination
405974|NCT01842945|internet based cognitive behavior therapy|internet based cognitive behavior therapy
405975|NCT01842945|randomized controlled trial|randomized controlled trial
405976|NCT01842932|Colonoscopy|colonoscopy
405977|NCT01842932|Anticholinergics|anticholinergics
405978|NCT01842906|positive end expiratory pressure|positive end expiratory pressure
405979|NCT01842906|acute mountain sickness|acute mountain sickness
405980|NCT01842906|prevention|prevention
405981|NCT01842906|high altitude|high altitude
405982|NCT01842893|fentanyl|fentanyl
405983|NCT01842893|breakthrough pain|breakthrough pain
405984|NCT01842893|opioid treated cancer patients|opioid treated cancer patients
405985|NCT01842880|MicroRNAs|micrornas
405986|NCT01842880|Chagas disease|chagas disease
405987|NCT01842880|Biomarkers|biomarkers
405988|NCT01842867|Syndecan-4|syndecan-4
405989|NCT01842867|Chagas disease|chagas disease
405990|NCT01842867|Biomarkers|biomarkers
405991|NCT01842854|Galectin-3|galectin-3
405992|NCT01842854|Chagas disease|chagas disease
405993|NCT01842854|Biomarkers|biomarkers
405994|NCT01842789|Acessa|acessa
405995|NCT01842789|Fibroids|fibroids
405996|NCT01842789|Halt|halt
405997|NCT01842789|Targeting Animation|targeting animation
405998|NCT01842789|Image Overlay|image overlay
405999|NCT01842789|Radiofrequency Ablation|radiofrequency ablation
406000|NCT01842789|RFA|rfa
406001|NCT01842763|Chronic daily headache|chronic daily headache
406002|NCT01842763|treated by occipital nerves stimulation|treated by occipital nerves stimulation
406003|NCT01842763|peripheral neuromodulation|peripheral neuromodulation
406004|NCT01842763|occipital nerves|occipital nerves
406005|NCT01842763|network|network
406006|NCT01842763|database|database
406007|NCT01842737|Low Back Pain|low back pain
406008|NCT01842737|Chiropractic|chiropractic
406009|NCT01842737|Spinal Manipulation|spinal manipulation
406010|NCT01842737|Massage|massage
406011|NCT01842698|Thoracotomy surgery|thoracotomy surgery
406012|NCT01842698|Anesthesia|anesthesia
406013|NCT01842698|Ultrasound-guided PVB|ultrasound-guided pvb
406014|NCT01842698|Post-operative pain|post-operative pain
406015|NCT01842685|Overactive Bladder|overactive bladder
406016|NCT01842685|Bladder Distention|bladder distention
406017|NCT01842672|pediatric non-hodgkins lymphoma|pediatric non-hodgkins lymphoma
406018|NCT01842672|pediatric acute leukemia|pediatric acute leukemia
406019|NCT01842672|clofarabine|clofarabine
406020|NCT01842672|mitoxantrone|mitoxantrone
406021|NCT01842659|MI|mi
406022|NCT01842659|amniocentesis|amniocentesis
406023|NCT01842659|cord blood|cord blood
406024|NCT01842659|placenta|placenta
406025|NCT01842659|Silver Russell Syndrome|silver russell syndrome
406026|NCT01842659|Beckwith Wiedemann Syndrome|beckwith wiedemann syndrome
406027|NCT01842646|Leukemia|leukemia
406028|NCT01842646|Myeloid Malignancies|myeloid malignancies
406029|NCT01842620|Metformin|metformin
406030|NCT01842620|Bioequivalence|bioequivalence
406031|NCT01842607|eosinophils|eosinophils
406032|NCT01842607|mepolizumab|mepolizumab
406033|NCT01842607|SB-240563|sb-240563
406034|NCT01842607|safety|safety
406035|NCT01842607|extension study|extension study
406037|NCT01842594|Sarcoma, Hydroxychloroquine, Sirolimus, PET|sarcoma, hydroxychloroquine, sirolimus, pet
406038|NCT01842581|Liver Failure|liver failure
406039|NCT01842581|Hepatic Insufficiency|hepatic insufficiency
406040|NCT01842581|Liver Diseases|liver diseases
406041|NCT01842581|Brain Diseases|brain diseases
406042|NCT01842581|Rifaximin|rifaximin
406043|NCT01842581|Cirrhosis|cirrhosis
406044|NCT01842568|Cardiac surgery|cardiac surgery
406045|NCT01842568|Troponin|troponin
406046|NCT01842568|Vascular events|vascular events
406047|NCT01842568|Myocardial injury|myocardial injury
406048|NCT01842568|Observational cohort study|observational cohort study
406049|NCT01842568|Public health|public health
406050|NCT01842555|PDT|pdt
406051|NCT01842555|Photodynamic therapy|photodynamic therapy
406052|NCT01842542|Postpartum Depression, NeuroStar TMS Therapy, TMS|postpartum depression, neurostar tms therapy, tms
406053|NCT01842503|alcohol dependence|alcohol dependence
406054|NCT01842503|cue reactivity|cue reactivity
406055|NCT01842503|alcohol self administration|alcohol self administration
406056|NCT01842490|Biomarker|biomarker
406057|NCT01842490|Carotid enhanced ultrasound|carotid enhanced ultrasound
406058|NCT01842490|Intraplaque neovascularization|intraplaque neovascularization
406059|NCT01842438|Sexual Dysfunctions, Psychological|sexual dysfunctions, psychological
406060|NCT01842425|Liver volume|liver volume
406061|NCT01842425|Gastric bypass|gastric bypass
406062|NCT01842425|Magnetic resonance imaging|magnetic resonance imaging
406063|NCT01842412|Mitochondria, Muscle|mitochondria, muscle
406064|NCT01842412|Exercise|exercise
406065|NCT01842399|Vascular Stiffness|vascular stiffness
406066|NCT01842399|Aging|aging
406067|NCT01842399|Resveratrol|resveratrol
406068|NCT01842399|Aerobic Capacity|aerobic capacity
406069|NCT01842399|Inflammation|inflammation
406070|NCT01842386|Pulmonary Alveolar Proteinosis|pulmonary alveolar proteinosis
406071|NCT01842386|Autoantibodies|autoantibodies
406072|NCT01842386|Mucocutaneous Candidiasis|mucocutaneous candidiasis
406073|NCT01842386|Anti-Granuloctye|anti-granuloctye
406074|NCT01842386|Macrophage|macrophage
406075|NCT01842373|topical anesthetics|topical anesthetics
406076|NCT01842373|laser resurfacing|laser resurfacing
406077|NCT01842360|Vaccine|vaccine
406078|NCT01842360|Chronic obstructive pulmonary disease (COPD)|chronic obstructive pulmonary disease (copd)
406079|NCT01842334|Nicotine Dependence|nicotine dependence
406080|NCT01842334|Smoking Cessation|smoking cessation
406081|NCT01842334|D-cycloserine|d-cycloserine
406082|NCT01842321|locally advanced|locally advanced
406083|NCT01842321|metastatic|metastatic
406084|NCT01842321|Breast Cancer|breast cancer
406085|NCT01842321|Molecular Apocrine|molecular apocrine
406086|NCT01842321|HER2-negative|her2-negative
406087|NCT01842321|Abiraterone acetate|abiraterone acetate
406088|NCT01842295|Obesity|obesity
406089|NCT01842295|Bariatric surgery|bariatric surgery
406090|NCT01842295|Sperm quality|sperm quality
406091|NCT01842295|Fertility|fertility
406092|NCT01842282|diabetes mellitus type 2|diabetes mellitus type 2
406093|NCT01842282|non alcoholic fatty liver disease|non alcoholic fatty liver disease
406094|NCT01842282|obesity|obesity
406095|NCT01842282|amlexanox|amlexanox
406096|NCT01842269|Mycophenolate Mofetil|mycophenolate mofetil
406097|NCT01842269|MMF|mmf
406098|NCT01842256|Telminouveau|telminouveau
406099|NCT01842256|Atorvastatin|atorvastatin
406100|NCT01842256|Pharmacokinetic|pharmacokinetic
406101|NCT01842256|Healthy volunteers|healthy volunteers
406102|NCT01842243|Ventricular dysfunction|ventricular dysfunction
406103|NCT01842243|MRI|mri
406104|NCT01842243|Echocardiography|echocardiography
406105|NCT01842243|Pacemakers|pacemakers
406106|NCT01842230|Telminuvo|telminuvo
406107|NCT01842230|Telmisartan|telmisartan
406108|NCT01842230|S-amlodipine|s-amlodipine
406109|NCT01842230|Atorvastatin|atorvastatin
406110|NCT01842230|pharmacokinetics|pharmacokinetics
406111|NCT01842230|Healthy volunteers|healthy volunteers
406112|NCT01842217|18F-FES PET|18f-fes pet
406113|NCT01842217|Nuclear Medicine|nuclear medicine
406114|NCT01842217|Premenopausal|premenopausal
406115|NCT01842217|Postmenopausal|postmenopausal
406116|NCT01842217|Estrogen receptor|estrogen receptor
406117|NCT01842217|Anxiety|anxiety
406118|NCT01842217|Depression|depression
406119|NCT01842217|Cognition|cognition
406120|NCT01842204|inguinal hernia|inguinal hernia
406121|NCT01842191|R-R MS|r-r ms
406122|NCT01842165|Peptide Receptor Radionuclide Therapy (PRRT)|peptide receptor radionuclide therapy (prrt)
406123|NCT01842165|Neuroendocrine Tumors|neuroendocrine tumors
406124|NCT01842126|Sciatica|sciatica
406125|NCT01842100|Induced abortion|induced abortion
406126|NCT01842100|Postaboral pelvic inflammatory disease|postaboral pelvic inflammatory disease
406127|NCT01842100|Sexually transmitted infections|sexually transmitted infections
406128|NCT01842100|Universal antibiotic prophylaxis|universal antibiotic prophylaxis
406129|NCT01842100|Screen-and-treat approach|screen-and-treat approach
406130|NCT01842087|Chronic Kidney Disease|chronic kidney disease
406131|NCT01842087|Fiber|fiber
406132|NCT01842087|BUN|bun
406133|NCT01842087|Serum Creatinine|serum creatinine
406134|NCT01842087|Uremic Symptoms|uremic symptoms
406135|NCT01842087|Quality of Life|quality of life
406137|NCT01842074|desensitization|desensitization
406138|NCT01842074|living kidney transplantation|living kidney transplantation
406139|NCT01842061|active living|active living
406140|NCT01842061|retirement|retirement
406141|NCT01842048|External-beam radiotherapy|external-beam radiotherapy
406142|NCT01842048|Hyperthermia|hyperthermia
406143|NCT01842035|Implantable cardiac defibrillator|implantable cardiac defibrillator
406144|NCT01842035|regadenoson|regadenoson
406145|NCT01842035|sudden cardiac death|sudden cardiac death
406146|NCT01842035|heart rate response|heart rate response
406147|NCT01842022|Glycemic load|glycemic load
406148|NCT01842022|memory|memory
406149|NCT01842022|mood|mood
406150|NCT01842009|transcranial stimulation|transcranial stimulation
406151|NCT01842009|direct current|direct current
406152|NCT01841983|Total worker health|total worker health
406153|NCT01841983|Sleep|sleep
406154|NCT01841983|MSDs|msds
406155|NCT01841983|Diet|diet
406156|NCT01841983|Physical Activity|physical activity
406157|NCT01841957|Bilateral Cataract|bilateral cataract
406158|NCT01841957|Simultaneous Cataract Surgery|simultaneous cataract surgery
406159|NCT01841957|ISBCS|isbcs
406160|NCT01841944|Fatty Acids, Omega-3|fatty acids, omega-3
406161|NCT01841944|Aged|aged
406162|NCT01841944|Myocardial Infarction|myocardial infarction
406163|NCT01841931|Opioids|opioids
406164|NCT01841931|Dependence|dependence
406165|NCT01841931|Buprenorphine|buprenorphine
406166|NCT01841931|Pain|pain
406167|NCT01841905|Alzheimer's Disease|alzheimer's disease
406168|NCT01841905|Family History|family history
406169|NCT01841905|Memory Concerns|memory concerns
406170|NCT01841866|post operative sore throat|post operative sore throat
406171|NCT01841866|laryngeal mask airway|laryngeal mask airway
406172|NCT01841866|children|children
406173|NCT01841853|Elderly|elderly
406174|NCT01841853|Health promotion|health promotion
406175|NCT01841853|Randomized controlled study|randomized controlled study
406176|NCT01841853|Immigrant|immigrant
406177|NCT01841853|Vulnerable population|vulnerable population
406178|NCT01841853|ADL|adl
406179|NCT01841853|KASAM|kasam
406180|NCT01841853|Implementation|implementation
406181|NCT01841840|Stroke|stroke
406182|NCT01841840|Hemiparetic|hemiparetic
406183|NCT01841840|Passive Vibration|passive vibration
406184|NCT01841840|Arterial Stiffness|arterial stiffness
406185|NCT01841840|Pulse Wave Velocity|pulse wave velocity
406186|NCT01841840|Wave Reflection|wave reflection
406187|NCT01841840|Body Composition|body composition
406188|NCT01841840|Autonomic Function|autonomic function
406189|NCT01841814|Lymphoma|lymphoma
406190|NCT01841814|Osteoporosis|osteoporosis
406191|NCT01841814|Chemotherapy|chemotherapy
406192|NCT01841814|Patient with|patient with
406193|NCT01841775|Hepatitis C, Chronic|hepatitis c, chronic
406194|NCT01841775|Genotype 2/3|genotype 2/3
406195|NCT01841775|Interferon α 2b|interferon α 2b
406196|NCT01841775|Ribavirin|ribavirin
406197|NCT01841775|Pharmacovigilance|pharmacovigilance
406198|NCT01841762|PAH-SYMPACT|pah-sympact
406199|NCT01841762|Pulmonary Arterial Hypertension|pulmonary arterial hypertension
406200|NCT01841762|psychometric instrument|psychometric instrument
406201|NCT01841749|Breast cancer|breast cancer
406202|NCT01841710|Bitter Taste|bitter taste
406203|NCT01841710|Pediatric Medications|pediatric medications
406204|NCT01841697|Diabetes Mellitus|diabetes mellitus
406205|NCT01841697|Diabetes Mellitus, Type 2|diabetes mellitus, type 2
406206|NCT01841697|Glucose Metabolism Disorders|glucose metabolism disorders
406207|NCT01841697|Metabolic Diseases|metabolic diseases
406208|NCT01841697|Endocrine System Diseases|endocrine system diseases
406209|NCT01841697|Glimepiride|glimepiride
406210|NCT01841697|Metformin|metformin
406211|NCT01841697|Hypoglycemic Agents|hypoglycemic agents
406212|NCT01841697|Physiological Effects of Drugs|physiological effects of drugs
406213|NCT01841697|Pharmacologic Actions|pharmacologic actions
406214|NCT01841684|HoFH|hofh
406215|NCT01841671|Polio|polio
406216|NCT01841671|IPV|ipv
406217|NCT01841671|bOPV|bopv
406218|NCT01841671|mOPV|mopv
406219|NCT01841671|vaccination|vaccination
406220|NCT01841658|Folate Status|folate status
406221|NCT01841658|Folate Biomarkers|folate biomarkers
406222|NCT01841645|CLA-enriched butter|cla-enriched butter
406223|NCT01841645|CLA metabolism|cla metabolism
406224|NCT01841645|inflammation|inflammation
406225|NCT01841632|Liver transplantation|liver transplantation
406226|NCT01841632|Allogeneic liver transplantation|allogeneic liver transplantation
406227|NCT01841632|Solid organ transplantation|solid organ transplantation
406228|NCT01841619|skin, lupus, intravenous immunoglobulin, ivig|skin, lupus, intravenous immunoglobulin, ivig
406229|NCT01841606|Spinal anesthesia|spinal anesthesia
406230|NCT01841606|Elective cesarean deliveries|elective cesarean deliveries
406231|NCT01841606|Ondansetron|ondansetron
406232|NCT01841580|Tear proteins profiles|tear proteins profiles
406233|NCT01841580|Longitudinal|longitudinal
406234|NCT01841580|Ocular surface damage|ocular surface damage
406235|NCT01841580|Trabeculectomy|trabeculectomy
406236|NCT01841567|hip|hip
406237|NCT01841567|knee|knee
406238|NCT01841554|Mitral Valve|mitral valve
406239|NCT01841554|Annuloplasty|annuloplasty
406240|NCT01841541|Tuberculosis|tuberculosis
406241|NCT01841541|Informal providers|informal providers
406242|NCT01841541|Informal carers|informal carers
406243|NCT01841541|Barriers to health system|barriers to health system
406244|NCT01841528|Polycystic Ovary Syndrome|polycystic ovary syndrome
406245|NCT01841528|Infertility|infertility
406246|NCT01841528|In-vitro fertilization|in-vitro fertilization
406247|NCT01841528|fresh embryo transfer|fresh embryo transfer
406248|NCT01841528|frozen-thawed embryo transfer|frozen-thawed embryo transfer
406249|NCT01841502|telaprevir|telaprevir
406250|NCT01841502|paroxetine|paroxetine
406251|NCT01841502|interaction|interaction
406252|NCT01841502|pharmacokinetics|pharmacokinetics
406253|NCT01841489|Chronic Lymphocytic Leukemia|chronic lymphocytic leukemia
406255|NCT01841476|Peripheral blood|peripheral blood
406256|NCT01841476|HSC|hsc
406257|NCT01841476|Mobilization|mobilization
406258|NCT01841476|CXCR4|cxcr4
406259|NCT01841476|volunteers|volunteers
406260|NCT01841463|Malignant Melanoma|malignant melanoma
406261|NCT01841450|Primary open-angle glaucoma (POAG)|primary open-angle glaucoma (poag)
406262|NCT01841450|Trabecular meshwork|trabecular meshwork
406263|NCT01841450|iStent|istent
406264|NCT01841437|Primary open-angle glaucoma (POAG)|primary open-angle glaucoma (poag)
406265|NCT01841437|Trabecular meshwork|trabecular meshwork
406266|NCT01841437|iStent|istent
406267|NCT01841424|dietary counseling|dietary counseling
406268|NCT01841424|food diary|food diary
406269|NCT01841424|obesity|obesity
406270|NCT01841424|pregnancy|pregnancy
406271|NCT01841424|weight gain|weight gain
406272|NCT01841411|bacterial vaginosis, recurrence, N-Acetyl cysteine|bacterial vaginosis, recurrence, n-acetyl cysteine
406273|NCT01841398|Cardiovascular|cardiovascular
406274|NCT01841398|Prevention|prevention
406275|NCT01841398|Ethnicity|ethnicity
406276|NCT01841398|Culture|culture
406277|NCT01841398|Internet|internet
406278|NCT01841398|Text Message|text message
406279|NCT01841385|Exercise|exercise
406280|NCT01841385|spirometry|spirometry
406281|NCT01841385|muscle strength|muscle strength
406282|NCT01841385|physical therapy modalities|physical therapy modalities
406283|NCT01841372|Obesity|obesity
406284|NCT01841372|Overweight|overweight
406285|NCT01841372|Weight Maintenance|weight maintenance
406286|NCT01841359|Hypoglycemia|hypoglycemia
406287|NCT01841359|Gastric bypass surgery|gastric bypass surgery
406288|NCT01841346|Outcome after PCI|outcome after pci
406289|NCT01841346|Middle Eastern Patients|middle eastern patients
406290|NCT01841333|Myeloid leukemia in remission|myeloid leukemia in remission
406291|NCT01841333|Recurrent myeloid leukemia|recurrent myeloid leukemia
406292|NCT01841281|Asthma|asthma
406293|NCT01841281|Severe Asthma|severe asthma
406294|NCT01841268|premature, preterm, premie, skin|premature, preterm, premie, skin
406295|NCT01841255|Preoxygenation|preoxygenation
406296|NCT01841255|Device|device
406297|NCT01841255|Tolerability|tolerability
406298|NCT01841255|Efficacy|efficacy
406299|NCT01841242|Infection|infection
406300|NCT01841242|Cardiac Resynchronization Device|cardiac resynchronization device
406301|NCT01841242|Heart Failure|heart failure
406302|NCT01841216|Gluteus Maximus|gluteus maximus
406303|NCT01841216|Gluteus Medius|gluteus medius
406304|NCT01841216|TFL|tfl
406305|NCT01841216|EMG|emg
406306|NCT01841216|Perceived Exertion|perceived exertion
406307|NCT01841216|Thera-Band|thera-band
406308|NCT01841203|Diagnosis|diagnosis
406309|NCT01841203|Rapid tests|rapid tests
406310|NCT01841203|non-treponemal serology|non-treponemal serology
406311|NCT01841203|eradication|eradication
406312|NCT01841190|Prognosis|prognosis
406313|NCT01841190|Sepsis|sepsis
406314|NCT01841190|Septic shock|septic shock
406315|NCT01841190|Procalcitonin|procalcitonin
406316|NCT01841190|SOFA|sofa
406317|NCT01841177|Congenital Heart Disease|congenital heart disease
406318|NCT01841177|Pediatrics|pediatrics
406319|NCT01841177|Milrinone|milrinone
406320|NCT01841177|Cardiopulmonary Bypass|cardiopulmonary bypass
406321|NCT01841177|Therapeutic Drug Monitoring|therapeutic drug monitoring
406322|NCT01841164|Leukotriene responsiveness|leukotriene responsiveness
406323|NCT01841164|LTE4|lte4
406324|NCT01841164|asthma|asthma
406325|NCT01841164|airway hyperresponsiveness|airway hyperresponsiveness
406326|NCT01841164|bronchoprovocation|bronchoprovocation
406327|NCT01841164|anti-asthmatic agents|anti-asthmatic agents
406328|NCT01841164|human|human
406329|NCT01841151|AD/HD in Children and Adolescents|ad/hd in children and adolescents
406330|NCT01841138|colonoscopy|colonoscopy
406331|NCT01841138|bowel preparation|bowel preparation
406332|NCT01841138|electrolytes|electrolytes
406333|NCT01841138|osmolality|osmolality
406334|NCT01841138|water|water
406335|NCT01841125|Alzheimer's Disease|alzheimer's disease
406336|NCT01841125|depressive disorder|depressive disorder
406337|NCT01841073|Prediabetes|prediabetes
406338|NCT01841073|Fermentable carbohydrate|fermentable carbohydrate
406339|NCT01841073|Appetite|appetite
406340|NCT01841073|Glucose homeostasis|glucose homeostasis
406341|NCT01841073|Weight management|weight management
406342|NCT01841060|Malignant Non-small Cell Neoplasm of Lung|malignant non-small cell neoplasm of lung
406343|NCT01841047|Retroperitoneal liposarcoma operable|retroperitoneal liposarcoma operable
406344|NCT01841034|Male|male
406345|NCT01841021|Peripheral T-Cell Lymphoma (PTCL)|peripheral t-cell lymphoma (ptcl)
406346|NCT01841021|Relapsed|relapsed
406347|NCT01841021|Refractory|refractory
519561|NCT01349543|RSV|rsv
406348|NCT01841021|CD30 Receptor|cd30 receptor
406349|NCT01841021|Large B-Cell Lymphoma|large b-cell lymphoma
406350|NCT01841008|[C17.800.621]|[c17.800.621]
406351|NCT01840995|stellate ganglion block|stellate ganglion block
406352|NCT01840982|Mixed grains|mixed grains
406353|NCT01840982|Glycemic index|glycemic index
406354|NCT01840982|Giant embryonic brown rice|giant embryonic brown rice
406355|NCT01840982|Giant embryonic rice|giant embryonic rice
406356|NCT01840982|diabetes|diabetes
406357|NCT01840969|off-pump coronary artery bypass surgery|off-pump coronary artery bypass surgery
406358|NCT01840969|common carotid artery|common carotid artery
406359|NCT01840969|speckle tracking analysis|speckle tracking analysis
406360|NCT01840969|peak strain|peak strain
406361|NCT01840956|End-stage Renal Disease|end-stage renal disease
406362|NCT01840956|Hemodialysis|hemodialysis
406363|NCT01840956|Chronic Renal Insufficiency|chronic renal insufficiency
406364|NCT01840956|Renal Dialysis|renal dialysis
406365|NCT01840956|Hemodiafiltration|hemodiafiltration
406366|NCT01840956|Blood Vessel Prosthesis|blood vessel prosthesis
406367|NCT01840956|Tissue-Engineered Vascular Graft|tissue-engineered vascular graft
406368|NCT01840956|Vascular Prosthesis Implantation|vascular prosthesis implantation
406369|NCT01840956|Kidney Diseases|kidney diseases
406370|NCT01840956|Kidney Failure, Chronic|kidney failure, chronic
406371|NCT01840956|Renal Insufficiency|renal insufficiency
406372|NCT01840956|Urologic Diseases|urologic diseases
406373|NCT01840943|Epithelial ovarian cancer|epithelial ovarian cancer
406374|NCT01840943|Recurrent epithelial ovarian carcinoma|recurrent epithelial ovarian carcinoma
406375|NCT01840943|Carcinoma|carcinoma
406376|NCT01840943|Malignancy|malignancy
406377|NCT01840943|Ovarian carcinoma|ovarian carcinoma
406378|NCT01840943|CAELYX|caelyx
406379|NCT01840943|Topotecan hydrochloride|topotecan hydrochloride
406380|NCT01840943|Topotecan|topotecan
406381|NCT01840943|Platinum-based regimen chemotherapy|platinum-based regimen chemotherapy
406382|NCT01840943|Chinese patients|chinese patients
406383|NCT01840930|Cohort|cohort
406384|NCT01840930|Cerebral Palsy|cerebral palsy
406385|NCT01840930|Children|children
406386|NCT01840930|Pain|pain
406387|NCT01840930|Orthopedic complications|orthopedic complications
406388|NCT01840930|Epidemiology|epidemiology
406389|NCT01840865|young healthy subjects|young healthy subjects
406390|NCT01840865|brain stimulation|brain stimulation
406391|NCT01840865|tSOS|tsos
406392|NCT01840865|tDCS|tdcs
406393|NCT01840865|sleep|sleep
406394|NCT01840865|daytime sleep|daytime sleep
406395|NCT01840865|nap|nap
406396|NCT01840865|memory|memory
406397|NCT01840865|memory consolidation|memory consolidation
406398|NCT01840839|aging|aging
406399|NCT01840839|cognitive decline|cognitive decline
406400|NCT01840839|brain stimulation|brain stimulation
406401|NCT01840839|tSOS|tsos
406402|NCT01840839|tDCS|tdcs
406403|NCT01840839|sleep|sleep
406404|NCT01840839|nap|nap
406405|NCT01840839|daytime sleep|daytime sleep
406406|NCT01840839|memory|memory
406407|NCT01840839|memory consolidation|memory consolidation
406408|NCT01840826|Rehospitalization|rehospitalization
406409|NCT01840826|Reutilization|reutilization
406410|NCT01840826|Depressive Symptoms|depressive symptoms
406411|NCT01840826|Pharmacotherapy|pharmacotherapy
406412|NCT01840826|Cognitive Therapy|cognitive therapy
406413|NCT01840826|Self-help|self-help
406414|NCT01840826|Complementary Therapies|complementary therapies
406415|NCT01840813|Intraumbilical misoprostol|intraumbilical misoprostol
406416|NCT01840813|Retained placenta|retained placenta
406417|NCT01840813|Active management of third stage of labour|active management of third stage of labour
406418|NCT01840800|Postoperative pain|postoperative pain
406419|NCT01840800|anterior cruciate ligament reconstruction|anterior cruciate ligament reconstruction
406420|NCT01840800|ultrasound guided nerve blocks|ultrasound guided nerve blocks
406421|NCT01840800|opioid consumption|opioid consumption
406422|NCT01840761|delayed vasospasm,|delayed vasospasm,
406423|NCT01840761|medicine,|medicine,
406424|NCT01840761|standardization|standardization
406425|NCT01840735|CF|cf
406426|NCT01840735|Cystic Fibrosis|cystic fibrosis
406427|NCT01840735|PK|pk
406428|NCT01840722|HIV|hiv
406429|NCT01840722|HCV|hcv
406430|NCT01840722|Substance abuse|substance abuse
406431|NCT01840722|women|women
406432|NCT01840709|Systemic lupus erythematosus|systemic lupus erythematosus
406433|NCT01840709|Psychotherapy|psychotherapy
406434|NCT01840683|Age-Related Macular Degeneration (AMD)|age-related macular degeneration (amd)
406435|NCT01840683|Age Related Eye Disease Study (AREDS)|age related eye disease study (areds)
406436|NCT01840683|Best-Corrected Visual Acuity (BCVA)|best-corrected visual acuity (bcva)
406437|NCT01840683|Early Treatment Diabetic Retinopathy Study (ETDRS)|early treatment diabetic retinopathy study (etdrs)
406644|NCT01839669|conservative therapy|conservative therapy
406438|NCT01840683|Heparin-Induced Extracorporeal LDL-Cholesterol Precipitation (HELP)|heparin-induced extracorporeal ldl-cholesterol precipitation (help)
406439|NCT01840683|Visual Function Questionnaire (VFQ)|visual function questionnaire (vfq)
406440|NCT01840670|Inferior Vena Cava|inferior vena cava
406441|NCT01840670|Central Venous Pressure|central venous pressure
406442|NCT01840670|Abdominal Pressure|abdominal pressure
406443|NCT01840657|CMDIR (Congenital Muscle Disease International Registry)|cmdir (congenital muscle disease international registry)
406444|NCT01840657|X-linked myotubular myopathy|x-linked myotubular myopathy
406445|NCT01840657|centronuclear myopathy|centronuclear myopathy
406446|NCT01840657|myotubularin|myotubularin
406447|NCT01840657|MTM1 gene|mtm1 gene
406448|NCT01840657|mutation|mutation
406449|NCT01840657|survival|survival
406450|NCT01840657|adverse event|adverse event
406451|NCT01840657|disease complication|disease complication
406452|NCT01840657|hospital admission|hospital admission
406453|NCT01840657|emergency room visit|emergency room visit
406454|NCT01840657|motor function|motor function
406455|NCT01840657|respiratory function|respiratory function
406456|NCT01840657|natural history study|natural history study
406457|NCT01840631|Obesity|obesity
406458|NCT01840631|Nutritional counseling|nutritional counseling
406459|NCT01840631|Physical activity|physical activity
406460|NCT01840631|Food diary|food diary
406461|NCT01840618|insulin function|insulin function
406462|NCT01840618|sleep apnea|sleep apnea
406463|NCT01840618|girls|girls
406464|NCT01840618|PCOS|pcos
406465|NCT01840618|insulin action|insulin action
406466|NCT01840592|Liver|liver
406467|NCT01840592|Sorafenib|sorafenib
406468|NCT01840592|Doxorubicin|doxorubicin
406469|NCT01840592|12-259|12-259
406470|NCT01840566|Relapsed|relapsed
406471|NCT01840566|Refractory|refractory
406472|NCT01840566|Autologous Stem Cell Transplantation|autologous stem cell transplantation
406473|NCT01840566|HIGH DOSE CHEMOTHERAPY|high dose chemotherapy
406474|NCT01840566|19-28z T cells/kg|19-28z t cells/kg
406475|NCT01840566|12-117|12-117
406476|NCT01840540|renal artery stenosis|renal artery stenosis
406477|NCT01840540|renovascular hypertension|renovascular hypertension
406478|NCT01840540|ischemic nephropathy|ischemic nephropathy
406479|NCT01840540|chronic kidney disease|chronic kidney disease
406480|NCT01840527|Biomarker|biomarker
406481|NCT01840527|BRAF|braf
406482|NCT01840527|blood-based|blood-based
406483|NCT01840514|recipient|recipient
406484|NCT01840501|Healthy|healthy
406485|NCT01840501|JNJ-42721458|jnj-42721458
406486|NCT01840501|Male|male
406487|NCT01840501|Safety|safety
406488|NCT01840501|Tolerability|tolerability
406489|NCT01840501|Pharmacokinetics|pharmacokinetics
406490|NCT01840501|Pharmacodynamics|pharmacodynamics
406491|NCT01840501|Immunogenicity|immunogenicity
406492|NCT01840436|MUCIPLIQ|mucipliq
406493|NCT01840436|Matrix therapy|matrix therapy
406494|NCT01840436|RGTA|rgta
406495|NCT01840436|Oral mucositis|oral mucositis
406496|NCT01840423|First in man study|first in man study
406497|NCT01840423|Volunteer study|volunteer study
406498|NCT01840410|Vision Impairment|vision impairment
406499|NCT01840410|Abnormal growth of blood vessels|abnormal growth of blood vessels
406500|NCT01840397|S-100B|s-100b
406501|NCT01840397|NSE|nse
406502|NCT01840384|Healthy infants|healthy infants
406503|NCT01840384|Anemia, iron-deficiency|anemia, iron-deficiency
406504|NCT01840371|ERCP|ercp
406505|NCT01840371|Sedation|sedation
406506|NCT01840371|Fentanyl|fentanyl
406507|NCT01840371|Propofol|propofol
406508|NCT01840358|Hypoglycemias|hypoglycemias
406509|NCT01840358|Insulin pump|insulin pump
406510|NCT01840358|Children|children
406511|NCT01840345|uncontrolled|uncontrolled
406512|NCT01840345|neuropathic pain|neuropathic pain
406513|NCT01840332|thyroid cancer|thyroid cancer
406514|NCT01840280|carcinoma|carcinoma
406515|NCT01840280|colorectal cancer|colorectal cancer
406516|NCT01840280|ambulant chemotherapy|ambulant chemotherapy
406517|NCT01840280|treatment cycles|treatment cycles
406518|NCT01840280|Irinotecan|irinotecan
406519|NCT01840280|Irinotecan onkovis|irinotecan onkovis
406520|NCT01840280|Quantity of Irinotecan|quantity of irinotecan
406521|NCT01840280|Packaging Sizes|packaging sizes
406522|NCT01840267|pneumoperitoneum|pneumoperitoneum
406523|NCT01840267|pediatric laparoscopy|pediatric laparoscopy
406524|NCT01840267|optic nerve sheath diameter|optic nerve sheath diameter
406525|NCT01840267|intracranial pressure|intracranial pressure
406526|NCT01840254|PONV|ponv
406527|NCT01840254|IV PCA|iv pca
406528|NCT01840254|dexmedetomidine|dexmedetomidine
406529|NCT01840254|Female|female
406530|NCT01840254|non-smoking|non-smoking
406531|NCT01840254|lumbar spine surgery|lumbar spine surgery
406532|NCT01840241|sodium bicarbonate|sodium bicarbonate
406533|NCT01840241|acute kidney injury|acute kidney injury
406534|NCT01840241|OPCAB|opcab
406535|NCT01840228|Preterm|preterm
406536|NCT01840228|Progesterone|progesterone
406537|NCT01840189|Addison disease|addison disease
406538|NCT01840189|Type 1 diabetes|type 1 diabetes
406539|NCT01840189|treatment|treatment
406540|NCT01840176|McCall culdoplasty|mccall culdoplasty
406541|NCT01840176|Total laparoscopic hysterectomy|total laparoscopic hysterectomy
406542|NCT01840176|Vaginal vault prolapse|vaginal vault prolapse
406543|NCT01840176|Sexual function|sexual function
406544|NCT01840124|Fibroids|fibroids
406545|NCT01840124|Radiofrequency ablation|radiofrequency ablation
406546|NCT01840111|smoking environment|smoking environment
406547|NCT01840111|cue-exposure|cue-exposure
406548|NCT01840111|cigarettes|cigarettes
406549|NCT01840111|nicotine|nicotine
406550|NCT01840111|fMRI|fmri
406551|NCT01840085|Diabetic foot ulcer|diabetic foot ulcer
406552|NCT01840085|plantar neuropathic ulcer|plantar neuropathic ulcer
406553|NCT01840085|plantar neuroischemic ulcer|plantar neuroischemic ulcer
406554|NCT01840085|Wagner Grade 1 or Grade 2 DFU|wagner grade 1 or grade 2 dfu
406555|NCT01840072|Ischemic stroke|ischemic stroke
406556|NCT01840072|Hypertension|hypertension
406557|NCT01840072|Antihypertensive Agents|antihypertensive agents
406558|NCT01840072|Randomized Controlled Trial|randomized controlled trial
406559|NCT01840059|Cardiac Failure|cardiac failure
406560|NCT01840059|Autonomic Denervation|autonomic denervation
406561|NCT01840020|bariatric surgery|bariatric surgery
406562|NCT01840020|alcohol drinking|alcohol drinking
406563|NCT01840020|alcoholism|alcoholism
406564|NCT01840020|ethanol|ethanol
406565|NCT01840020|metabolism|metabolism
406566|NCT01839994|prostate cancer,|prostate cancer,
406567|NCT01839994|high-dose-rate brachytherapy boost,|high-dose-rate brachytherapy boost,
406568|NCT01839994|stereotactic body radiotherapy boost,|stereotactic body radiotherapy boost,
406569|NCT01839994|conformal radiotherapy,|conformal radiotherapy,
406570|NCT01839994|randomized trial|randomized trial
406571|NCT01839942|Hernia, Ventral|hernia, ventral
406572|NCT01839929|tacrolimus|tacrolimus
406573|NCT01839929|immunosuppressant|immunosuppressant
406574|NCT01839929|FK506|fk506
406575|NCT01839903|Smoking|smoking
406576|NCT01839903|Tobacco|tobacco
406577|NCT01839903|Emergency Department|emergency department
406578|NCT01839890|Paclitaxel|paclitaxel
406579|NCT01839890|stent|stent
406580|NCT01839890|Acute infarction|acute infarction
406581|NCT01839890|Systolic time elevation|systolic time elevation
406582|NCT01839877|Metastatic colorectal Cancer|metastatic colorectal cancer
406583|NCT01839864|Promotoras|promotoras
406584|NCT01839864|Hispanic Adults|hispanic adults
406585|NCT01839864|metabolic syndrome|metabolic syndrome
406586|NCT01839864|rural|rural
406587|NCT01839864|patient attitudes|patient attitudes
406588|NCT01839864|provider cultural competency|provider cultural competency
406589|NCT01839864|patient activation measure|patient activation measure
406590|NCT01839851|Hair cortisol|hair cortisol
406591|NCT01839851|asthma|asthma
406592|NCT01839851|allergic rhinitis|allergic rhinitis
406593|NCT01839851|inhaled corticosteroids|inhaled corticosteroids
406594|NCT01839851|intranasal glucocorticoids|intranasal glucocorticoids
406595|NCT01839838|Women|women
406596|NCT01839838|age 50 and above|age 50 and above
406597|NCT01839838|with|with
406598|NCT01839838|that has been|that has been
406599|NCT01839838|surgically excised|surgically excised
406600|NCT01839825|elderly|elderly
406601|NCT01839825|fall|fall
406602|NCT01839825|acute illness|acute illness
406603|NCT01839825|care giver|care giver
406604|NCT01839812|Cardiopulmonary bypass|cardiopulmonary bypass
406605|NCT01839812|Cortisol|cortisol
406606|NCT01839812|Dexamethasone|dexamethasone
406607|NCT01839799|Patients|patients
406608|NCT01839799|with|with
406609|NCT01839799|resected|resected
406610|NCT01839786|Pulmonary Hypertension|pulmonary hypertension
406611|NCT01839786|Doppler|doppler
406612|NCT01839786|Valsalva|valsalva
406613|NCT01839773|Stomach Neoplasms|stomach neoplasms
406614|NCT01839773|Cancer of Stomach|cancer of stomach
406615|NCT01839773|Gastric Cancer|gastric cancer
406616|NCT01839773|Gastric Neoplasms|gastric neoplasms
406617|NCT01839773|Neoplasms, Gastric|neoplasms, gastric
406618|NCT01839773|Neoplasms, Stomach|neoplasms, stomach
406619|NCT01839773|Stomach Cancer|stomach cancer
406620|NCT01839773|paclitaxel|paclitaxel
406621|NCT01839773|Taxol|taxol
406622|NCT01839760|Influenza|influenza
406623|NCT01839760|Virus|virus
406624|NCT01839760|Viral shedding|viral shedding
406625|NCT01839760|Epidemiology|epidemiology
406626|NCT01839747|Pediatric|pediatric
406627|NCT01839734|CD4+|cd4+
406628|NCT01839721|Probiotics|probiotics
406629|NCT01839721|radiation-induced enteritis|radiation-induced enteritis
406630|NCT01839721|radiation-induced diarrhea|radiation-induced diarrhea
406631|NCT01839721|radiation, diarrhea, enteritis|radiation, diarrhea, enteritis
406632|NCT01839721|diet|diet
406633|NCT01839721|nutrition|nutrition
406634|NCT01839708|Intervention|intervention
406635|NCT01839695|Thoracic Aneurysm|thoracic aneurysm
406636|NCT01839695|Endovascular Aortic Repair|endovascular aortic repair
406637|NCT01839695|TEVAR|tevar
406638|NCT01839682|StabiliT|stabilit
406639|NCT01839682|Kyphoplasty|kyphoplasty
406640|NCT01839682|Vertebral|vertebral
406641|NCT01839682|Compression|compression
406642|NCT01839682|Fracture|fracture
406643|NCT01839682|Osteoporosis|osteoporosis
407234|NCT01837160|CT-PET|ct-pet
406645|NCT01839669|Foot-Function-Index|foot-function-index
406646|NCT01839669|functional movement changes|functional movement changes
406647|NCT01839669|non-surgical treatment|non-surgical treatment
406648|NCT01839669|pes planovalgus|pes planovalgus
406649|NCT01839669|posterior tibial tendon dysfunction|posterior tibial tendon dysfunction
406650|NCT01839656|Spinal Muscular Atrophy|spinal muscular atrophy
406651|NCT01839656|SMA|sma
406652|NCT01839656|SMN|smn
406653|NCT01839656|SMNRx|smnrx
406654|NCT01839656|ISIS-SMNRx|isis-smnrx
406655|NCT01839656|ISIS 396443|isis 396443
406656|NCT01839656|IONIS-SMNRx|ionis-smnrx
406657|NCT01839656|Spinraza|spinraza
406658|NCT01839656|Nusinersen|nusinersen
406659|NCT01839643|pharmacokinetic|pharmacokinetic
406660|NCT01839630|Sorafenib|sorafenib
406661|NCT01839630|Hepatocellular cancer|hepatocellular cancer
406662|NCT01839630|TACE combination|tace combination
406663|NCT01839630|Treatment pattern|treatment pattern
406664|NCT01839630|Safety|safety
406665|NCT01839630|Effectiveness|effectiveness
406666|NCT01839617|parenteral nutrition|parenteral nutrition
406667|NCT01839617|early nutrition|early nutrition
406668|NCT01839617|abdominal surgery|abdominal surgery
406669|NCT01839617|cancer|cancer
406670|NCT01839604|Child-Pugh A to B7,|child-pugh a to b7,
406671|NCT01839604|Advanced/Metastatic Hepatocellular Carcinoma,|advanced/metastatic hepatocellular carcinoma,
406672|NCT01839604|AZD9150,|azd9150,
406673|NCT01839604|Antisense Oligonucleotide Inhibitor of STAT3|antisense oligonucleotide inhibitor of stat3
406674|NCT01839578|cytokines|cytokines
406675|NCT01839578|blood purification|blood purification
406676|NCT01839578|super high flux hemodialysis|super high flux hemodialysis
406677|NCT01839565|Adverse events|adverse events
406678|NCT01839565|Osteosynthesis|osteosynthesis
406679|NCT01839565|Quality of life|quality of life
406680|NCT01839552|Fentanyl Citrate Nasal Spray (FCNS)|fentanyl citrate nasal spray (fcns)
406681|NCT01839552|Lazanda|lazanda
406682|NCT01839552|Breakthrough pain in cancer patients|breakthrough pain in cancer patients
406683|NCT01839539|colorectal cancer|colorectal cancer
406684|NCT01839539|DC-CIK|dc-cik
406685|NCT01839539|CRC|crc
406686|NCT01839526|Fabry disease|fabry disease
406687|NCT01839513|Analgesia/nociception index|analgesia/nociception index
406688|NCT01839513|Desflurane|desflurane
406689|NCT01839513|Remifentanil|remifentanil
406690|NCT01839513|Orthopedic surgery|orthopedic surgery
406691|NCT01839513|Ear-nose-throat surgery|ear-nose-throat surgery
406692|NCT01839513|Hemodynamic reactivity|hemodynamic reactivity
406693|NCT01839487|pancreatic ductal carcinoma(PDA)|pancreatic ductal carcinoma(pda)
406694|NCT01839487|Pancreatic ductal carcinoma|pancreatic ductal carcinoma
406695|NCT01839487|PEGPH20|pegph20
406696|NCT01839487|Gemcitabine|gemcitabine
406697|NCT01839487|Nab-paclitaxel|nab-paclitaxel
406698|NCT01839474|Continuous Positive Airway Pressure|continuous positive airway pressure
406699|NCT01839474|Controlled trial|controlled trial
406700|NCT01839474|Pneumonia|pneumonia
406701|NCT01839474|Children|children
406702|NCT01839461|Pharmacogenetics|pharmacogenetics
406703|NCT01839461|postoperative|postoperative
406704|NCT01839461|pediatric|pediatric
406705|NCT01839461|opioid|opioid
406706|NCT01839461|perioperative|perioperative
406707|NCT01839461|respiratory depression|respiratory depression
406708|NCT01839461|chronic pain|chronic pain
406709|NCT01839448|post partum diabetes|post partum diabetes
406710|NCT01839448|impaired fasting glucose|impaired fasting glucose
406711|NCT01839435|appendectomy|appendectomy
406712|NCT01839435|acute appendicitis|acute appendicitis
406713|NCT01839435|outpatient|outpatient
406714|NCT01839409|Circadian Rhythm|circadian rhythm
406715|NCT01839409|Exercise|exercise
406716|NCT01839409|Reflex, Vestibular Ocular|reflex, vestibular ocular
406717|NCT01839409|Postural Balance|postural balance
406718|NCT01839396|Intrepid, Vercise, PD, DBS, Boston Scientific|intrepid, vercise, pd, dbs, boston scientific
406719|NCT01839370|Pramlintide|pramlintide
406720|NCT01839370|Closed Loop|closed loop
406721|NCT01839370|Continuous Glucose Monitor (CGM)|continuous glucose monitor (cgm)
406722|NCT01839370|Diabetes Assistant (DiAs)|diabetes assistant (dias)
406723|NCT01839357|Rivaroxaban|rivaroxaban
406724|NCT01839357|Oral anticoagulant|oral anticoagulant
406725|NCT01839357|Nonvalvular atrial fibrillation|nonvalvular atrial fibrillation
406726|NCT01839357|Left atrial thrombus|left atrial thrombus
406727|NCT01839357|Transesophageal echocardiography|transesophageal echocardiography
406728|NCT01839357|Thrombus resolution|thrombus resolution
406729|NCT01839357|Stroke|stroke
406730|NCT01839357|Thromboembolism|thromboembolism
406731|NCT01839344|hyperglycemia|hyperglycemia
406732|NCT01839344|Diabetes Mellitus, Type 2|diabetes mellitus, type 2
406733|NCT01839344|endothelial dysfunction|endothelial dysfunction
406734|NCT01839344|quercetin|quercetin
406735|NCT01839344|Acarbose|acarbose
406736|NCT01839344|glucose tolerance|glucose tolerance
406737|NCT01839344|maltose|maltose
406738|NCT01839331|osteoarthritis|osteoarthritis
406739|NCT01839331|osteoarthrisis of the knee|osteoarthrisis of the knee
406740|NCT01839318|Soft contact lenses|soft contact lenses
710217|NCT00589680|Ketosis, Diabetic|ketosis, diabetic
406741|NCT01839318|Daily disposable contact lenses|daily disposable contact lenses
406742|NCT01839318|Tear Film Break Up Time|tear film break up time
406743|NCT01839318|Contact lens wettability|contact lens wettability
406744|NCT01839305|Kinematics|kinematics
406745|NCT01839305|Fibromyalgia|fibromyalgia
406746|NCT01839305|Physical Therapy|physical therapy
406747|NCT01839305|3D Kinematics|3d kinematics
406748|NCT01839305|Heart Rate Frequency|heart rate frequency
406749|NCT01839305|Hydrotherapy|hydrotherapy
406750|NCT01839292|gastric outlet obstruction|gastric outlet obstruction
406751|NCT01839292|palliative treatment|palliative treatment
406752|NCT01839292|stent|stent
406753|NCT01839266|acute PTE, prognostic factors|acute pte, prognostic factors
406754|NCT01839253|antihypertensive agents|antihypertensive agents
406755|NCT01839253|hemodynamic|hemodynamic
406756|NCT01839253|anesthetics reduction|anesthetics reduction
406757|NCT01839253|orthognathic surgery|orthognathic surgery
406758|NCT01839227|Post-operative cognitive dysfunction|post-operative cognitive dysfunction
406759|NCT01839227|regional cerebral oxygen saturation|regional cerebral oxygen saturation
406760|NCT01839227|elderly|elderly
406761|NCT01839201|anesthesia|anesthesia
406762|NCT01839201|modification of dreaming|modification of dreaming
406763|NCT01839201|suggestions|suggestions
406764|NCT01839162|Transradial approach|transradial approach
406765|NCT01839162|shield drape|shield drape
406766|NCT01839162|radiation|radiation
406767|NCT01839162|PTCA|ptca
406768|NCT01839149|Refractory Chronic Migraine|refractory chronic migraine
406769|NCT01839149|Medically Intractable Chronic Migraine|medically intractable chronic migraine
406770|NCT01839149|Oxytocin|oxytocin
406771|NCT01839149|Intranasal oxytocin|intranasal oxytocin
406772|NCT01839136|Assisted Reproductive Techniques|assisted reproductive techniques
406773|NCT01839136|Health Services Accessibility|health services accessibility
406774|NCT01839136|Ovulation Induction|ovulation induction
406775|NCT01839136|Embryo Transfer|embryo transfer
406776|NCT01839123|Amputee|amputee
406777|NCT01839110|pulmonary hypertension|pulmonary hypertension
406778|NCT01839110|right ventricular function|right ventricular function
406779|NCT01839110|ranolazine|ranolazine
406780|NCT01839097|PTCL|ptcl
406781|NCT01839097|Maximum Tolerated Dose|maximum tolerated dose
406782|NCT01839097|Belinostat|belinostat
406783|NCT01839084|Xenon|xenon
406784|NCT01839084|Isoflurane|isoflurane
406785|NCT01839084|Anesthetics, Inhalation|anesthetics, inhalation
406786|NCT01839084|Nephroprotection|nephroprotection
406787|NCT01839084|Partial nephrectomy|partial nephrectomy
406788|NCT01839084|Xenon versus Isoflurane anesthesia|xenon versus isoflurane anesthesia
406789|NCT01839058|Non Cardiac Chest Pain|non cardiac chest pain
406790|NCT01839045|Woman|woman
406791|NCT01839045|Breast Cancer|breast cancer
406792|NCT01839045|Cancer|cancer
406793|NCT01839045|Mammogram|mammogram
406794|NCT01839045|Ultrasound|ultrasound
406795|NCT01839045|Imaging|imaging
406796|NCT01839045|Biomarkers|biomarkers
406797|NCT01839045|ACR BI RAD Category 3|acr bi rad category 3
406798|NCT01839045|ACR BI RAD Category 4|acr bi rad category 4
406799|NCT01839019|Healthy volunteers|healthy volunteers
406800|NCT01839006|hydronephrosis|hydronephrosis
406801|NCT01839006|ultrasonography|ultrasonography
406802|NCT01839006|Kidney Function Test|kidney function test
406803|NCT01839006|Patients with unilateral UPJO and patients with preop HN in USG and supranormal renal function in DTPA renography|patients with unilateral upjo and patients with preop hn in usg and supranormal renal function in dtpa renography
406804|NCT01838993|anesthetics,|anesthetics,
406805|NCT01838993|local,|local,
406806|NCT01838993|lidocaine;|lidocaine;
406807|NCT01838993|nebulizers and vaporizers;|nebulizers and vaporizers;
406808|NCT01838993|complications,|complications,
406809|NCT01838993|intubation,|intubation,
406810|NCT01838993|intratracheal.|intratracheal.
406811|NCT01838980|Colonoscopy Cleaning|colonoscopy cleaning
406812|NCT01838967|cilnidipin and valsartn|cilnidipin and valsartn
406813|NCT01838967|pharmacokinetic drug drug interaction|pharmacokinetic drug drug interaction
406814|NCT01838967|oral administration|oral administration
406815|NCT01838967|healthy male subjects|healthy male subjects
406816|NCT01838954|hand osteoarthritis|hand osteoarthritis
406817|NCT01838954|short-wave diathermy|short-wave diathermy
406818|NCT01838941|Peroxisome Biogenesis Disorder|peroxisome biogenesis disorder
406819|NCT01838941|PBD|pbd
406820|NCT01838941|neonatal adrenoleukodystrophy|neonatal adrenoleukodystrophy
406821|NCT01838941|infantile Refsum disease|infantile refsum disease
406822|NCT01838941|PEX1 mutation|pex1 mutation
406823|NCT01838941|Betaine|betaine
406824|NCT01838928|Axillary brachial plexus block|axillary brachial plexus block
406825|NCT01838928|Ultrasound|ultrasound
406826|NCT01838928|Minimum effective concentration|minimum effective concentration
406827|NCT01838928|Bupivacaine|bupivacaine
406828|NCT01838928|ultrasound-guided axillary brachial plexus block|ultrasound-guided axillary brachial plexus block
406829|NCT01838915|HIV|hiv
406830|NCT01838915|immunoactivation|immunoactivation
406831|NCT01838915|bacterial translocation|bacterial translocation
406832|NCT01838915|prebiotics|prebiotics
406833|NCT01838915|glutamine|glutamine
520187|NCT01347216|Safety|safety
406834|NCT01838915|microbiota|microbiota
406835|NCT01838902|Malaria|malaria
406836|NCT01838902|Falciparum|falciparum
406837|NCT01838902|Direct membrane feeding|direct membrane feeding
406838|NCT01838902|QT-NASBA|qt-nasba
406839|NCT01838902|Asexual parasite|asexual parasite
406840|NCT01838902|Asymptomatic carrier|asymptomatic carrier
406841|NCT01838902|Gametocytocidal, Gametocyte|gametocytocidal, gametocyte
406842|NCT01838902|Transmission blocking|transmission blocking
406843|NCT01838902|Sexual stage|sexual stage
406844|NCT01838902|Primaquine|primaquine
406845|NCT01838902|Dihydroartemisinin|dihydroartemisinin
406846|NCT01838902|Piperaquine|piperaquine
406847|NCT01838902|Gambia|gambia
406848|NCT01838902|Africa|africa
406849|NCT01838889|Culturally adapted|culturally adapted
406850|NCT01838889|Group psychological intervention|group psychological intervention
406851|NCT01838889|British South Asian women|british south asian women
406852|NCT01838889|CBT|cbt
406853|NCT01838876|Major Depressive Disorder|major depressive disorder
406854|NCT01838876|MDD|mdd
406855|NCT01838876|Depression|depression
406856|NCT01838863|coagulopathy|coagulopathy
406857|NCT01838863|hemorrhagic shock|hemorrhagic shock
406858|NCT01838863|plasma|plasma
406859|NCT01838863|blood product transfusion|blood product transfusion
406860|NCT01838824|Processing Speed|processing speed
406861|NCT01838824|Intervention|intervention
406862|NCT01838824|Multiple Sclerosis|multiple sclerosis
406863|NCT01838824|Cognition|cognition
406864|NCT01838811|Processing Speed|processing speed
406865|NCT01838811|Intervention|intervention
406866|NCT01838811|Traumatic Brain Injury|traumatic brain injury
406867|NCT01838811|Cognition|cognition
406868|NCT01838798|cognitive disorders|cognitive disorders
406869|NCT01838798|quality of life|quality of life
406870|NCT01838798|Intensive care|intensive care
406871|NCT01838785|18F-DTBZ AV-133 imaging|18f-dtbz av-133 imaging
406872|NCT01838772|HCV and HIV co-infection|hcv and hiv co-infection
406873|NCT01838759|Bioimpedance spectroscopy|bioimpedance spectroscopy
406874|NCT01838759|Hypervolemia|hypervolemia
406875|NCT01838759|Hypovolemia|hypovolemia
406876|NCT01838746|Percutaneous coronary intervention|percutaneous coronary intervention
406877|NCT01838746|Coronary artery bypass grafting|coronary artery bypass grafting
406878|NCT01838746|Coronary artery bypass surgery|coronary artery bypass surgery
406879|NCT01838746|Survival|survival
406880|NCT01838746|Acute coronary syndrome|acute coronary syndrome
406881|NCT01838746|ST segment elevation myocardial infarction|st segment elevation myocardial infarction
406882|NCT01838746|Non-ST segment elevation myocardial infarction|non-st segment elevation myocardial infarction
406883|NCT01838746|Younge patient|younge patient
406884|NCT01838720|renal cell carcinoma|renal cell carcinoma
406885|NCT01838720|ischemia|ischemia
406886|NCT01838720|radio frequency ablation|radio frequency ablation
406887|NCT01838707|postoperative|postoperative
406888|NCT01838707|spine surgery|spine surgery
406889|NCT01838655|Albinism|albinism
406890|NCT01838655|Nitisinone|nitisinone
406891|NCT01838655|Melanin|melanin
406892|NCT01838655|Vision Loss|vision loss
406893|NCT01838642|Monoclonal Antibody|monoclonal antibody
406894|NCT01838642|AP24534|ap24534
406895|NCT01838642|RET Mutation Positive|ret mutation positive
406896|NCT01838642|RET Mutation Negative|ret mutation negative
406897|NCT01838642|RET Inhibitor|ret inhibitor
406898|NCT01838616|Severe chronic low back pain|severe chronic low back pain
406899|NCT01838616|Neuropathic pain|neuropathic pain
406900|NCT01838616|Constipation|constipation
406901|NCT01838590|Liver Diseases|liver diseases
406902|NCT01838590|Digestive System Diseases|digestive system diseases
406903|NCT01838590|Hepatitis, Viral, Human|hepatitis, viral, human
406904|NCT01838590|Virus Diseases|virus diseases
406905|NCT01838590|Enterovirus Infections|enterovirus infections
406906|NCT01838590|Picornaviridae Infections|picornaviridae infections
406907|NCT01838590|RNA Virus Infections|rna virus infections
406908|NCT01838590|Flaviviridae Infections|flaviviridae infections
406909|NCT01838590|Antiviral Agents|antiviral agents
406910|NCT01838590|Anti-Infective Agents|anti-infective agents
406911|NCT01838590|Therapeutic Uses|therapeutic uses
406912|NCT01838590|Pharmacologic Actions|pharmacologic actions
406913|NCT01838590|Antimetabolites|antimetabolites
406914|NCT01838590|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action
406915|NCT01838590|HCV genotype 4 (GT-4)|hcv genotype 4 (gt-4)
406916|NCT01838590|HCV|hcv
406917|NCT01838590|Sustained Virologic Response|sustained virologic response
406918|NCT01838590|Direct Acting Antiviral|direct acting antiviral
406919|NCT01838590|Combination Therapy|combination therapy
406920|NCT01838590|GS-7977|gs-7977
406921|NCT01838590|Ribavirin|ribavirin
406922|NCT01838590|Open Label|open label
406923|NCT01838590|Sofosbuvir|sofosbuvir
406924|NCT01838590|Additional relevant MeSH terms:|additional relevant mesh terms:
406925|NCT01838590|Hepatitis|hepatitis
406926|NCT01838590|Hepatitis, Chronic|hepatitis, chronic
406927|NCT01838590|Hepatitis C|hepatitis c
406928|NCT01838590|Hepatitis C, Chronic|hepatitis c, chronic
406929|NCT01838564|Pediatric Advanced Cancer|pediatric advanced cancer
406930|NCT01838564|Children|children
406931|NCT01838564|Quality of Life|quality of life
406932|NCT01838564|Health Information technology|health information technology
406933|NCT01838564|Patient reported outcomes|patient reported outcomes
406934|NCT01838525|sepsis|sepsis
407235|NCT01837160|PET-CT|pet-ct
406935|NCT01838525|alpha-1-acid glycoprotein (AGP)|alpha-1-acid glycoprotein (agp)
406936|NCT01838525|diagnosis|diagnosis
406937|NCT01838525|prognosis|prognosis
406938|NCT01838525|SIRS|sirs
406939|NCT01838486|Interstitial cystitis|interstitial cystitis
406940|NCT01838486|painful bladder syndrome|painful bladder syndrome
406941|NCT01838486|bladder hydrodistention|bladder hydrodistention
406942|NCT01838486|hyperthermia|hyperthermia
406943|NCT01838473|smokeless tobacco|smokeless tobacco
406944|NCT01838473|Nicotine|nicotine
406945|NCT01838473|Cadmium|cadmium
406946|NCT01838473|lead|lead
406947|NCT01838473|Tobacco Specific Nitrosamines|tobacco specific nitrosamines
406948|NCT01838447|Vitamin D|vitamin d
406949|NCT01838447|Congenital Heart Disease|congenital heart disease
406950|NCT01838447|Cardiac Surgery|cardiac surgery
406951|NCT01838447|Pediatrics|pediatrics
406952|NCT01838447|Phase II Clinical Trial|phase ii clinical trial
406953|NCT01838408|screening colonoscopy|screening colonoscopy
406954|NCT01838408|surveillance colonoscopy|surveillance colonoscopy
406955|NCT01838408|colonoscopy|colonoscopy
406956|NCT01838395|AML|aml
406957|NCT01838395|Acute Myeloid Leukemia|acute myeloid leukemia
406958|NCT01838395|Relapsed Acute Myeloid Leukemia|relapsed acute myeloid leukemia
406959|NCT01838395|Refractory Acute Myeloid Leukemia|refractory acute myeloid leukemia
406960|NCT01838382|pain|pain
406961|NCT01838382|total laparoscopic hysterectomy|total laparoscopic hysterectomy
406962|NCT01838356|Depression|depression
406963|NCT01838356|Vascular depression|vascular depression
406964|NCT01838356|Intracranial atherosclerosis|intracranial atherosclerosis
406965|NCT01838356|Coronary artery disease|coronary artery disease
406966|NCT01838356|Coronary artery bypass graft|coronary artery bypass graft
406967|NCT01838356|Cognitive impairment|cognitive impairment
406968|NCT01838330|Kidney Disease|kidney disease
406969|NCT01838330|Fiber|fiber
406970|NCT01838330|Dietary Intervention|dietary intervention
406971|NCT01838304|propofol sedation endoscopy|propofol sedation endoscopy
406972|NCT01838291|Ferriprox|ferriprox
406973|NCT01838291|Deferiprone|deferiprone
406974|NCT01838291|DFP|dfp
406975|NCT01838291|L1|l1
406976|NCT01838278|Vojta therapy|vojta therapy
406977|NCT01838278|Exercise Movement Technique|exercise movement technique
406978|NCT01838278|Early intervention|early intervention
406979|NCT01838252|Ectropion|ectropion
406980|NCT01838252|Hyaluronic Acid|hyaluronic acid
406981|NCT01838252|Keratoconjunctivitis Sicca|keratoconjunctivitis sicca
406982|NCT01838252|Lower eyelid retraction|lower eyelid retraction
406983|NCT01838239|Fish oil|fish oil
406984|NCT01838239|Omega-3 fatty acids|omega-3 fatty acids
406985|NCT01838226|Chronic Disease|chronic disease
406986|NCT01838226|Prevention|prevention
406987|NCT01838226|cardiovascular disease|cardiovascular disease
406988|NCT01838213|Urinary tract infection|urinary tract infection
406989|NCT01838213|ESBL|esbl
406990|NCT01838213|treatment|treatment
406991|NCT01838213|carriage|carriage
406992|NCT01838213|risk factors|risk factors
406993|NCT01838213|water contamination|water contamination
406994|NCT01838200|BCG|bcg
406995|NCT01838200|Bacillus Calmette-Guérin|bacillus calmette-guérin
406996|NCT01838200|Ipilimumab|ipilimumab
406997|NCT01838200|YERVOY|yervoy
406998|NCT01838200|Advanced Metastatic Melanoma|advanced metastatic melanoma
406999|NCT01838200|Metastatic Melanoma|metastatic melanoma
407000|NCT01838174|Optic Neuritis|optic neuritis
407001|NCT01838161|adolescents|adolescents
407002|NCT01838161|immunizations|immunizations
407003|NCT01838148|coronary artery disease|coronary artery disease
407004|NCT01838148|angina, stable|angina, stable
407005|NCT01838148|exercise test|exercise test
407006|NCT01838148|biological Markers|biological markers
407007|NCT01838148|SPECT|spect
407008|NCT01838135|wheelchair|wheelchair
407009|NCT01838135|manual wheelchair|manual wheelchair
407010|NCT01838135|rehabilitation|rehabilitation
407011|NCT01838135|self-efficacy|self-efficacy
407012|NCT01838135|older adults|older adults
407013|NCT01838135|feasibility|feasibility
407014|NCT01838135|intervention|intervention
407015|NCT01838135|training|training
407016|NCT01838122|PCOS|pcos
407017|NCT01838122|HbA1C|hba1c
407018|NCT01838122|Insulin resistance|insulin resistance
407019|NCT01838122|OGTT|ogtt
407020|NCT01838122|HOMA-IR|homa-ir
407021|NCT01838122|HOMA-B-cell|homa-b-cell
407022|NCT01838070|Hepatitis A|hepatitis a
407023|NCT01838070|Hepatitis A vaccine|hepatitis a vaccine
407024|NCT01838070|AVAXIM 160U|avaxim 160u
407025|NCT01838031|antenatal thyroid screening|antenatal thyroid screening
407026|NCT01838031|subclinical hypothyroidism|subclinical hypothyroidism
407027|NCT01838031|thyroid function|thyroid function
407028|NCT01838031|thyroid antibody|thyroid antibody
407029|NCT01838031|pregnancy outcome|pregnancy outcome
407030|NCT01838031|childhood cognitive function|childhood cognitive function
407031|NCT01838018|PKAN|pkan
407032|NCT01838018|brain iron|brain iron
407033|NCT01838018|NBIA|nbia
407034|NCT01838018|neurodegeneration with brain iron accumulation|neurodegeneration with brain iron accumulation
407035|NCT01838018|Hallervorden Spatz Syndrome|hallervorden spatz syndrome
407036|NCT01838005|Contingency management|contingency management
407037|NCT01838005|conditional cash transfer|conditional cash transfer
407038|NCT01838005|PMTCT|pmtct
407039|NCT01838005|Retention|retention
407040|NCT01838005|HIV|hiv
407041|NCT01837979|prenatal testing for fetal aneuploidy|prenatal testing for fetal aneuploidy
407042|NCT01837979|dried blood spots|dried blood spots
407043|NCT01837979|cell-free fetal DNA|cell-free fetal dna
407044|NCT01837979|detection rate|detection rate
407045|NCT01837979|cost-effectiveness|cost-effectiveness
407046|NCT01837966|re-operative anxiety|re-operative anxiety
407047|NCT01837966|breast surgery|breast surgery
407048|NCT01837966|lavender oil|lavender oil
407049|NCT01837966|aromatherapy|aromatherapy
407050|NCT01837927|Efficacy, NVA237, Tiotropium, Chronic Obstructive Pulmonary Disease, COPD|efficacy, nva237, tiotropium, chronic obstructive pulmonary disease, copd
407051|NCT01837901|transcorneal electrostimulation|transcorneal electrostimulation
407052|NCT01837888|wheelchair|wheelchair
407053|NCT01837888|manual wheelchair|manual wheelchair
407054|NCT01837888|rehabilitation|rehabilitation
407055|NCT01837888|self-efficacy|self-efficacy
407056|NCT01837888|older adults|older adults
407057|NCT01837888|feasibility|feasibility
407058|NCT01837888|intervention|intervention
407059|NCT01837888|training|training
407060|NCT01837888|Wheelchair mobility|wheelchair mobility
407061|NCT01837875|Intervention|intervention
407062|NCT01837875|Quality of life|quality of life
407063|NCT01837875|African American|african american
407064|NCT01837875|Stress|stress
407065|NCT01837862|pilomyxoid astrocytoma|pilomyxoid astrocytoma
407066|NCT01837862|Pilocytic Astrocytoma|pilocytic astrocytoma
407067|NCT01837862|Glioma|glioma
407068|NCT01837862|Optic Nerve Glioma|optic nerve glioma
407069|NCT01837862|mebendazole|mebendazole
407070|NCT01837862|Pleomorphic Xanthoastrocytoma|pleomorphic xanthoastrocytoma
407071|NCT01837862|glioblastoma multiforme|glioblastoma multiforme
407072|NCT01837862|anaplastic astrocytoma|anaplastic astrocytoma
407073|NCT01837862|gliosarcoma|gliosarcoma
407074|NCT01837862|diffuse intrinsic pontine glioma|diffuse intrinsic pontine glioma
407075|NCT01837862|DIPG|dipg
407076|NCT01837862|low-grade glioma|low-grade glioma
407077|NCT01837862|high-grade glioma|high-grade glioma
407078|NCT01837862|brainstem glioma|brainstem glioma
407079|NCT01837862|pediatric|pediatric
407080|NCT01837849|heart failure|heart failure
407081|NCT01837849|rhBNP|rhbnp
407082|NCT01837849|Dobutamine|dobutamine
407083|NCT01837836|Health education|health education
407084|NCT01837836|water handling practices|water handling practices
407085|NCT01837836|Bacteriological quality of water|bacteriological quality of water
407086|NCT01837823|Coronary artery disease|coronary artery disease
407087|NCT01837823|Lipid|lipid
407088|NCT01837823|Regression|regression
407089|NCT01837823|Plaque|plaque
407090|NCT01837810|Post tonsillectomy hemorrhage|post tonsillectomy hemorrhage
407091|NCT01837810|post operative hemorrhage|post operative hemorrhage
407092|NCT01837810|complications|complications
407093|NCT01837810|tonsillectomy|tonsillectomy
407094|NCT01837758|Platelet function|platelet function
407095|NCT01837758|hemofiltration|hemofiltration
407096|NCT01837758|Multiplate|multiplate
407097|NCT01837732|Chronic pain|chronic pain
407098|NCT01837732|elderly|elderly
407099|NCT01837732|relational touch|relational touch
407100|NCT01837706|Empathy|empathy
407101|NCT01837706|Communication|communication
407102|NCT01837706|Physician litigation|physician litigation
407103|NCT01837693|cervical cancer screening|cervical cancer screening
407104|NCT01837693|CIN|cin
407105|NCT01837693|cervical cancer|cervical cancer
407106|NCT01837693|biomarkers|biomarkers
407107|NCT01837693|sensitivity and specificity|sensitivity and specificity
407108|NCT01837680|Insulin, Long-Acting|insulin, long-acting
407109|NCT01837654|Detrusor Overactivity|detrusor overactivity
407110|NCT01837654|Plantarflexion|plantarflexion
407111|NCT01837654|Urgency|urgency
407112|NCT01837628|Urodynamic|urodynamic
407113|NCT01837628|Paraffin oil|paraffin oil
407114|NCT01837628|Lidocaine gel|lidocaine gel
407115|NCT01837628|Pain|pain
407116|NCT01837615|Ulcerative Colitis|ulcerative colitis
407117|NCT01837615|Ulcerative Proctitis|ulcerative proctitis
407118|NCT01837615|Low Level Light Therapy|low level light therapy
407119|NCT01837615|Safety|safety
407120|NCT01837615|Efficacy|efficacy
407121|NCT01837602|refractory to at least one standard therapy|refractory to at least one standard therapy
407122|NCT01837602|newly diagnosed|newly diagnosed
407123|NCT01837602|with operable triple negative breast cancer|with operable triple negative breast cancer
710218|NCT00589667|Head and Neck Cancer|head and neck cancer
407124|NCT01837589|Cystic fibrosis-DXA-QCT-Osteopenia- Osteoporosis|cystic fibrosis-dxa-qct-osteopenia- osteoporosis
407125|NCT01837576|Psoriasis Vulgaris|psoriasis vulgaris
407126|NCT01837576|Calcipotriol|calcipotriol
407127|NCT01837576|Betamethasone Dipropionate|betamethasone dipropionate
407128|NCT01837550|audiologic rehabilitation|audiologic rehabilitation
407129|NCT01837550|hearing loss|hearing loss
407130|NCT01837550|patient education|patient education
407131|NCT01837550|patient participation|patient participation
407132|NCT01837550|structured rehabilitation|structured rehabilitation
407133|NCT01837550|counseling|counseling
407134|NCT01837550|Internet|internet
407135|NCT01837524|Dietary advice|dietary advice
407136|NCT01837524|Nutritional knowledge|nutritional knowledge
407137|NCT01837524|Self-efficacy|self-efficacy
407138|NCT01837524|Nutrition|nutrition
407139|NCT01837511|Tumor antigens|tumor antigens
407140|NCT01837511|Asiatic patients|asiatic patients
407141|NCT01837511|Reverse Transciptase-Polymerase chain reaction (RT-PCR)|reverse transciptase-polymerase chain reaction (rt-pcr)
407142|NCT01837511|Non-small cell lung cancer (NSCLC)|non-small cell lung cancer (nsclc)
407143|NCT01837498|residual neuromuscular blockade, sugammadex, neostigmine, thoracic surgery|residual neuromuscular blockade, sugammadex, neostigmine, thoracic surgery
407144|NCT01837485|Irritable bowel syndrome|irritable bowel syndrome
407145|NCT01837485|Functional gastrointestinal disorders|functional gastrointestinal disorders
407146|NCT01837485|Gut flora|gut flora
407147|NCT01837485|Probiotics|probiotics
407148|NCT01837472|Irritable bowel syndrome|irritable bowel syndrome
407149|NCT01837472|Functional gastrointestinal disorders|functional gastrointestinal disorders
407150|NCT01837472|Gut flora|gut flora
407151|NCT01837472|Probiotics|probiotics
407152|NCT01837459|Obstructive Sleep Apnea|obstructive sleep apnea
407153|NCT01837459|Sleep Disordered Breathing|sleep disordered breathing
407154|NCT01837459|Vascular function|vascular function
407155|NCT01837459|Arterial stiffness|arterial stiffness
407156|NCT01837459|Polysomnography|polysomnography
407157|NCT01837459|Cytokines|cytokines
407158|NCT01837446|mucositis|mucositis
407159|NCT01837446|topical morphine|topical morphine
407160|NCT01837446|pain|pain
407161|NCT01837446|head and neck carcinoma|head and neck carcinoma
407162|NCT01837433|Efficacy|efficacy
407163|NCT01837433|safety|safety
407164|NCT01837433|short|short
407165|NCT01837433|term|term
407166|NCT01837433|subacute thyroiditis|subacute thyroiditis
407167|NCT01837407|Soft tissue loss|soft tissue loss
407168|NCT01837407|nerve defect|nerve defect
407169|NCT01837407|dorsal branch of the proper digital nerve|dorsal branch of the proper digital nerve
407170|NCT01837407|heterodigital arterialized nerve pedicle flap|heterodigital arterialized nerve pedicle flap
407171|NCT01837407|Composite Flap|composite flap
407172|NCT01837407|nerve flap|nerve flap
407173|NCT01837407|nerve transfer|nerve transfer
407174|NCT01837394|Nerve block|nerve block
407175|NCT01837394|Ultrasound|ultrasound
407176|NCT01837394|postoperative pain|postoperative pain
407177|NCT01837394|Saphenous nerve|saphenous nerve
407178|NCT01837394|Obturator nerve|obturator nerve
407179|NCT01837329|Non-Squamous|non-squamous
407180|NCT01837329|NSCLC|nsclc
407181|NCT01837329|Adenocarcinoma|adenocarcinoma
407182|NCT01837329|Lung Cancer|lung cancer
407183|NCT01837329|Tetrathiomolybdate|tetrathiomolybdate
407184|NCT01837329|Copper|copper
407185|NCT01837329|Carboplatin|carboplatin
407186|NCT01837329|Pemetrexed Platinum|pemetrexed platinum
407187|NCT01837329|Newly Diagnosed|newly diagnosed
407188|NCT01837329|Chemo-naive|chemo-naive
407189|NCT01837316|pharmacodynamics|pharmacodynamics
407190|NCT01837316|FF/VI|ff/vi
407191|NCT01837316|asthma|asthma
407192|NCT01837316|duration of action|duration of action
407193|NCT01837303|Cervical dysplasia|cervical dysplasia
407194|NCT01837303|Cervical cancer|cervical cancer
407195|NCT01837290|Renal failure,|renal failure,
407196|NCT01837290|hip fracture,|hip fracture,
407197|NCT01837290|spinal anesthesia,|spinal anesthesia,
407198|NCT01837290|dexmedetomidine|dexmedetomidine
407199|NCT01837290|patient|patient
407200|NCT01837264|Magellan MAR01|magellan mar01
407201|NCT01837264|Autologous Platelet Rich Plasma|autologous platelet rich plasma
407202|NCT01837264|Compartment Syndrome|compartment syndrome
407203|NCT01837264|Battlefield Trauma|battlefield trauma
407204|NCT01837264|Fasciotomy|fasciotomy
407205|NCT01837251|Ovarian Carcinoma|ovarian carcinoma
407206|NCT01837251|Bevacizumab|bevacizumab
407207|NCT01837251|Gemcitabine|gemcitabine
407208|NCT01837251|PLD|pld
407209|NCT01837251|pegylated liposomal doxorubicin|pegylated liposomal doxorubicin
407210|NCT01837251|Carboplatin|carboplatin
407211|NCT01837251|best therapeutic index|best therapeutic index
407212|NCT01837251|progression-free survival|progression-free survival
407213|NCT01837238|hemodialysis|hemodialysis
407214|NCT01837238|physical function|physical function
407215|NCT01837225|Fluorescence Imaging|fluorescence imaging
407216|NCT01837225|Breast Tumor Margins|breast tumor margins
407217|NCT01837225|Real-time Assessment|real-time assessment
407218|NCT01837199|Periodontal disease|periodontal disease
710219|NCT00589667|GEMCITABINE|gemcitabine
520733|NCT01345019|SRE|sre
407219|NCT01837199|Scaling and root planing|scaling and root planing
407220|NCT01837199|Metronidazole|metronidazole
407221|NCT01837199|Amoxicillin|amoxicillin
407222|NCT01837199|Generalized chronic periodontitis|generalized chronic periodontitis
407223|NCT01837199|Periodontal treatment|periodontal treatment
407224|NCT01837186|Surgery|surgery
407225|NCT01837186|NSCLC|nsclc
407226|NCT01837173|Adenocarcinoma|adenocarcinoma
407227|NCT01837173|Squamous Cell Carcinoma|squamous cell carcinoma
407228|NCT01837173|Neoadjuvant treatment|neoadjuvant treatment
407229|NCT01837173|Esophagectomy|esophagectomy
407230|NCT01837160|Angiogenesis|angiogenesis
407231|NCT01837160|Fibrosis|fibrosis
407232|NCT01837160|Aortic Stenosis|aortic stenosis
407233|NCT01837160|Imaging|imaging
407237|NCT01837147|primary prevention|primary prevention
407238|NCT01837147|sedentary|sedentary
407239|NCT01837147|overweight|overweight
407240|NCT01837147|obesity|obesity
407241|NCT01837147|breast cancer|breast cancer
407242|NCT01837147|post-menopausal|post-menopausal
407243|NCT01837147|women|women
407244|NCT01837134|telemedicine|telemedicine
407245|NCT01837134|overweight|overweight
407246|NCT01837134|obesity|obesity
407247|NCT01837121|not-attended rate|not-attended rate
407248|NCT01837121|re-visit|re-visit
407249|NCT01837121|vision|vision
407250|NCT01837121|knowledge|knowledge
407251|NCT01837121|satisfaction|satisfaction
407252|NCT01837108|healthy|healthy
407253|NCT01837095|Overall survival|overall survival
407254|NCT01837095|Progression free survival|progression free survival
407255|NCT01837082|Heart Failure|heart failure
407256|NCT01837082|Iron Deficiency|iron deficiency
407257|NCT01837082|Anemia|anemia
407258|NCT01837082|Ferric Carboxymaltose|ferric carboxymaltose
407259|NCT01837069|Hypertension|hypertension
407260|NCT01837069|Diabetes|diabetes
407261|NCT01837069|Coronary Artery Disease|coronary artery disease
407262|NCT01837069|Peripheral Vascular Disease|peripheral vascular disease
407263|NCT01837056|Toxoplasma gondii|toxoplasma gondii
407264|NCT01837056|Toxocara canis|toxocara canis
407265|NCT01837043|Delayed Graft Function|delayed graft function
407266|NCT01837043|Renal Transplantation|renal transplantation
407267|NCT01837043|Kidney Transplant|kidney transplant
407268|NCT01837017|Falls,|falls,
407269|NCT01837017|Balance,|balance,
407270|NCT01837017|Gait,|gait,
407271|NCT01837017|Older adults|older adults
407272|NCT01837004|adherence|adherence
407273|NCT01837004|cognition|cognition
407274|NCT01837004|exercise|exercise
407275|NCT01837004|aging|aging
407276|NCT01836991|gastric cancer|gastric cancer
407277|NCT01836991|surgery|surgery
407278|NCT01836991|surgery safety|surgery safety
407279|NCT01836991|effect|effect
407280|NCT01836965|Aspergers|aspergers
407281|NCT01836965|Social Skills|social skills
407282|NCT01836965|Adolescents|adolescents
407283|NCT01836965|High-functioning Autism|high-functioning autism
407284|NCT01836939|psoriasis, oral therapy|psoriasis, oral therapy
407286|NCT01836939|Trichuris suis ova|trichuris suis ova
407287|NCT01836939|TSO|tso
407288|NCT01836939|CNDO 201 Trichuris suis ova|cndo 201 trichuris suis ova
407289|NCT01836926|sphincter sparing procedures|sphincter sparing procedures
407290|NCT01836926|intersphincteric resection|intersphincteric resection
407291|NCT01836926|rectal cancer|rectal cancer
407292|NCT01836926|low rectal cancer|low rectal cancer
407293|NCT01836926|sphincter preserving procedures|sphincter preserving procedures
407294|NCT01836926|Abdominoperineal resection|abdominoperineal resection
407295|NCT01836926|laparoscopic resection of rectal cancer|laparoscopic resection of rectal cancer
407296|NCT01836926|laparoscopic versus open colorectal resection|laparoscopic versus open colorectal resection
407297|NCT01836926|laparoscopic versus open rectal surgery|laparoscopic versus open rectal surgery
407298|NCT01836926|neoadjuvant chemo-radiotherapy for rectal cancer|neoadjuvant chemo-radiotherapy for rectal cancer
407299|NCT01836913|PET/CT|pet/ct
407300|NCT01836913|Esophageal cancer|esophageal cancer
407301|NCT01836913|Radiotherapy|radiotherapy
407302|NCT01836900|OTSC|otsc
407303|NCT01836900|Upper gastrointestinal bleeding|upper gastrointestinal bleeding
407304|NCT01836887|Polyphenol|polyphenol
407305|NCT01836887|Fruit|fruit
407306|NCT01836887|Metabolic|metabolic
407307|NCT01836887|Healthy|healthy
407308|NCT01836874|Migraine|migraine
407309|NCT01836874|Indian|indian
407310|NCT01836874|Topiramate|topiramate
407311|NCT01836861|Phase I|phase i
407312|NCT01836861|healthy male volunteers|healthy male volunteers
407313|NCT01836861|ADME|adme
407314|NCT01836861|Bioavailability|bioavailability
407315|NCT01836861|PI3K inhibitor|pi3k inhibitor
407316|NCT01836861|Absorption|absorption
407317|NCT01836861|Distribution|distribution
407318|NCT01836861|Metabolism|metabolism
407319|NCT01836861|Excretion|excretion
407320|NCT01836861|safety|safety
407321|NCT01836848|subarachnoid hemorrhage|subarachnoid hemorrhage
407322|NCT01836848|near-infrared-spectroscopy|near-infrared-spectroscopy
407323|NCT01836848|indocyanine green|indocyanine green
407324|NCT01836848|secondary ischemia|secondary ischemia
407325|NCT01836835|Hyperemesis gravidarum|hyperemesis gravidarum
407326|NCT01836835|Pregnancy|pregnancy
407327|NCT01836835|Nausea|nausea
407328|NCT01836835|Nutritional status|nutritional status
407329|NCT01836835|Questionnaire|questionnaire
407330|NCT01836835|Case-control|case-control
407331|NCT01836822|mediastinal lymph node enlargement|mediastinal lymph node enlargement
407332|NCT01836822|sarcoidosis|sarcoidosis
407333|NCT01836822|bronchoscopy|bronchoscopy
407334|NCT01836822|EBUS guided transbronchial needle aspiration (EBUS-TBNA)|ebus guided transbronchial needle aspiration (ebus-tbna)
407335|NCT01836822|transbronchial needle aspiration (EBUS-TBNA)|transbronchial needle aspiration (ebus-tbna)
407336|NCT01836822|EBUS guided transbronchial forceps biopsy EBUS-TBFB)|ebus guided transbronchial forceps biopsy ebus-tbfb)
407337|NCT01836809|Total Artificial Heart|total artificial heart
407921|NCT01833676|desflurane|desflurane
407338|NCT01836809|Left Ventricular Assist Device|left ventricular assist device
407339|NCT01836809|Natriuretic peptides|natriuretic peptides
407340|NCT01836809|Heart Failure|heart failure
407341|NCT01836809|Cardiorenal Syndrome|cardiorenal syndrome
407342|NCT01836783|Allograft|allograft
407343|NCT01836783|Amnion Allograft|amnion allograft
407344|NCT01836770|Transforaminal Epidural Steroid Injections|transforaminal epidural steroid injections
407345|NCT01836757|osteoarthritis|osteoarthritis
407346|NCT01836757|CAM treatments|cam treatments
407347|NCT01836757|MSM|msm
407348|NCT01836731|weight-for age|weight-for age
407349|NCT01836731|height-for-age|height-for-age
407350|NCT01836731|water sanitation facilities|water sanitation facilities
407351|NCT01836731|hygiene behavior|hygiene behavior
407352|NCT01836718|Hepatitis C Virus|hepatitis c virus
407353|NCT01836718|Liver Transplantation|liver transplantation
407354|NCT01836718|Antiviral Therapy|antiviral therapy
407355|NCT01836718|HCV|hcv
407356|NCT01836679|Chidamide,lung cancer|chidamide,lung cancer
407357|NCT01836653|Bevacizumab|bevacizumab
407358|NCT01836653|Cetuximab|cetuximab
407359|NCT01836653|KRAS wild type colorectal cancer|kras wild type colorectal cancer
407360|NCT01836653|RAS wild type colorectal cancer|ras wild type colorectal cancer
407361|NCT01836653|liver metastasis|liver metastasis
407362|NCT01836627|Congenital Muscular Dystrophy|congenital muscular dystrophy
407363|NCT01836627|Collagen VI Deficiency|collagen vi deficiency
407364|NCT01836627|Hyperinsufflation|hyperinsufflation
407365|NCT01836627|Cough Assist|cough assist
407366|NCT01836627|LAMA2- Muscular Dystrophy|lama2- muscular dystrophy
407367|NCT01836601|safety|safety
407368|NCT01836601|patient experience|patient experience
407369|NCT01836601|family-centered rounds|family-centered rounds
407370|NCT01836575|Advanced NSCLC|advanced nsclc
407371|NCT01836575|PS2|ps2
407372|NCT01836575|Pemetrexed|pemetrexed
407373|NCT01836575|First line|first line
407374|NCT01836575|non squamous|non squamous
407375|NCT01836562|Autism stem cell MNCs|autism stem cell mncs
407376|NCT01836536|High grade glioma|high grade glioma
407377|NCT01836536|Bevacizumab|bevacizumab
407378|NCT01836536|Chemotherapy|chemotherapy
407379|NCT01836536|Myeloid Cells|myeloid cells
407380|NCT01836536|Treg|treg
407381|NCT01836510|Heart Failure|heart failure
407382|NCT01836510|Remote Monitoring|remote monitoring
407383|NCT01836510|Lung Edema|lung edema
407384|NCT01836510|Patient Monitoring|patient monitoring
407385|NCT01836510|Prediction|prediction
407386|NCT01836484|Surgically staged endometrial carcinoma|surgically staged endometrial carcinoma
407387|NCT01836484|Surgically staged cervical carcinoma|surgically staged cervical carcinoma
407388|NCT01836458|Malaria, KAE609|malaria, kae609
407389|NCT01836432|Pancreatic Cancer|pancreatic cancer
407390|NCT01836432|Immunotherapy|immunotherapy
407391|NCT01836432|Vaccine Therapy|vaccine therapy
407392|NCT01836419|classic laryngeal mask airway|classic laryngeal mask airway
407393|NCT01836419|elderly patients|elderly patients
407394|NCT01836406|ketorolac|ketorolac
407395|NCT01836406|remote ischemic preconditioning|remote ischemic preconditioning
407396|NCT01836406|partial nephrectomy|partial nephrectomy
407397|NCT01836393|Plai|plai
407398|NCT01836393|Efficacy|efficacy
407399|NCT01836393|OA knee|oa knee
407400|NCT01836393|The efficacy study of Plai cream for OA knee|the efficacy study of plai cream for oa knee
407401|NCT01836367|Actinic Keratosis|actinic keratosis
407402|NCT01836367|Face|face
407403|NCT01836367|Scalp|scalp
407404|NCT01836367|Ingenol Mebutate|ingenol mebutate
407405|NCT01836354|stroke|stroke
407406|NCT01836354|interactive educational intervention|interactive educational intervention
407407|NCT01836354|acute ischemic stroke|acute ischemic stroke
407408|NCT01836354|transient ischemic attack|transient ischemic attack
407409|NCT01836341|Afatinib|afatinib
407410|NCT01836341|Cisplatin|cisplatin
407411|NCT01836341|Carboplatin|carboplatin
407412|NCT01836341|Pemetrexed|pemetrexed
407413|NCT01836341|Radiation therapy|radiation therapy
407414|NCT01836341|EGFR mutation|egfr mutation
407415|NCT01836341|12-279|12-279
407416|NCT01836328|Methadone|methadone
407417|NCT01836328|Pain|pain
407418|NCT01836328|Neoplasms|neoplasms
407419|NCT01836328|Ratio|ratio
407420|NCT01836237|Surgical site infection rate|surgical site infection rate
407421|NCT01836237|Wound protector use|wound protector use
407422|NCT01836237|Whipple|whipple
407423|NCT01836211|Chest pain|chest pain
407424|NCT01836211|Acute coronary syndrome|acute coronary syndrome
407425|NCT01836211|Cardiac biomarkers|cardiac biomarkers
407426|NCT01836211|Computed coronary tomography angiography|computed coronary tomography angiography
407427|NCT01836211|Emergency department|emergency department
407428|NCT01836172|The treatment of diabetic complication|the treatment of diabetic complication
407429|NCT01836159|Stroke Rehabilitation|stroke rehabilitation
407430|NCT01836159|iPad|ipad
407431|NCT01836159|Fine Motor Function|fine motor function
407432|NCT01836159|Ischemic Stroke|ischemic stroke
407433|NCT01836159|Visual Neglect|visual neglect
407434|NCT01836120|second-line chemotherapy|second-line chemotherapy
407435|NCT01836120|Raltitrexed|raltitrexed
407436|NCT01836107|Clinical notes|clinical notes
407437|NCT01836107|Communication between physicians|communication between physicians
407438|NCT01836107|Quality|quality
407439|NCT01836107|Cross-cultural adaptation|cross-cultural adaptation
407440|NCT01836094|Methylene Blue|methylene blue
407441|NCT01836094|Memory|memory
407442|NCT01836094|Mental Fatigue|mental fatigue
407443|NCT01836094|Brain metabolism|brain metabolism
407444|NCT01836094|fMRI|fmri
407445|NCT01836094|psychomotor vigilance task (PVT)|psychomotor vigilance task (pvt)
407446|NCT01836094|delayed match-to-sample memory task|delayed match-to-sample memory task
407447|NCT01836094|PVT|pvt
407448|NCT01836094|DMS|dms
407449|NCT01836081|fluid responsiveness|fluid responsiveness
407450|NCT01836081|carotid artery peak velocity variation|carotid artery peak velocity variation
407451|NCT01836081|coronary disease|coronary disease
407452|NCT01836068|HIV positive|hiv positive
407453|NCT01836068|HIV-1|hiv-1
407454|NCT01836068|Bone Marrow Transplant|bone marrow transplant
407455|NCT01836068|Allogeneic BMT|allogeneic bmt
407456|NCT01836068|BMT|bmt
407457|NCT01836055|Multiple Sclerosis|multiple sclerosis
407458|NCT01836055|White Matter Lesions|white matter lesions
407459|NCT01836055|Contrast Agent|contrast agent
407460|NCT01836055|Magnetic Resonance Imaging|magnetic resonance imaging
407461|NCT01836042|Primary open-angle glaucoma (POAG)|primary open-angle glaucoma (poag)
407462|NCT01836042|Trabecular meshwork|trabecular meshwork
407463|NCT01836042|iStent|istent
407464|NCT01836029|SCCHN|scchn
407465|NCT01836029|HNSCC|hnscc
407466|NCT01836016|Pulmonary Disease, Chronic Obstructive|pulmonary disease, chronic obstructive
407467|NCT01836016|Comparative effectiveness research|comparative effectiveness research
407468|NCT01836016|Medicine, Chinese Traditional|medicine, chinese traditional
407469|NCT01836016|Humans|humans
407470|NCT01836016|Treatment Outcome|treatment outcome
407471|NCT01836003|Pregnancy|pregnancy
407472|NCT01836003|Prevention of Mother to Child Transmission|prevention of mother to child transmission
407473|NCT01836003|Short Message Service (SMS)|short message service (sms)
407474|NCT01836003|HIV infection|hiv infection
407475|NCT01836003|CD4 testing|cd4 testing
407476|NCT01836003|Antiretroviral therapy|antiretroviral therapy
407477|NCT01835990|venous thromboembolism|venous thromboembolism
407478|NCT01835990|trauma|trauma
407479|NCT01835990|mechanical methods of prophylaxis|mechanical methods of prophylaxis
407480|NCT01835977|Focal therapy|focal therapy
407481|NCT01835977|Irreversible electroporation|irreversible electroporation
407482|NCT01835977|Unilateral prostate cancer|unilateral prostate cancer
407483|NCT01835964|Glucose Variability (GV)|glucose variability (gv)
407484|NCT01835964|Continuous Glucose Monitor (CGM)|continuous glucose monitor (cgm)
407485|NCT01835951|Simulation|simulation
407486|NCT01835951|Debriefing|debriefing
407487|NCT01835951|Anaesthesia Crisis Management|anaesthesia crisis management
407488|NCT01835951|Cardiac Arrest|cardiac arrest
407489|NCT01835951|Pregnancy|pregnancy
407490|NCT01835938|Hepatitis C Virus infection|hepatitis c virus infection
407491|NCT01835938|entry inhibitor|entry inhibitor
407492|NCT01835938|kinase inhibitor|kinase inhibitor
407493|NCT01835925|adenocarcinoma of rectum|adenocarcinoma of rectum
407494|NCT01835925|rectal cancer|rectal cancer
407495|NCT01835925|stage II|stage ii
407496|NCT01835925|stage III|stage iii
407497|NCT01835912|performance|performance
407498|NCT01835912|speed|speed
407499|NCT01835912|exertion|exertion
407500|NCT01835860|BPH|bph
407501|NCT01835834|zirconia crown|zirconia crown
407502|NCT01835821|zirconia|zirconia
407503|NCT01835821|crown|crown
407504|NCT01835821|IPS e.max CAD|ips e.max cad
407505|NCT01835808|Fractional flow reserve|fractional flow reserve
407506|NCT01835795|Myofascial Pain Syndromes|myofascial pain syndromes
407507|NCT01835795|Myofascial Trigger Point|myofascial trigger point
407508|NCT01835795|Low Back Pain|low back pain
407509|NCT01835795|Lumbago|lumbago
407510|NCT01835795|Shock Waves, High-Energy|shock waves, high-energy
407511|NCT01835795|High-Energy Shock Waves|high-energy shock waves
407512|NCT01835795|Interdisciplinary Health Team|interdisciplinary health team
407513|NCT01835795|Multidisciplinary Pain Centers|multidisciplinary pain centers
407514|NCT01835782|ALS|als
407515|NCT01835782|L-Serine|l-serine
407516|NCT01835782|BMAA|bmaa
407517|NCT01835717|Preclinical phase of Alzheimer's disease|preclinical phase of alzheimer's disease
407518|NCT01835717|Asymptomatic phase of Alzheimer's disease|asymptomatic phase of alzheimer's disease
407519|NCT01835717|Cognitive normal|cognitive normal
407520|NCT01835717|Exogenous factors|exogenous factors
407521|NCT01835717|Endogenous factors|endogenous factors
407522|NCT01835717|Episodic memory test|episodic memory test
407523|NCT01835717|Executive function test|executive function test
407524|NCT01835717|Memory binding test validation into Spanish|memory binding test validation into spanish
407525|NCT01835717|Memory binding test validation into Catalan|memory binding test validation into catalan
407526|NCT01835691|Chronic Kidney Disease|chronic kidney disease
407527|NCT01835691|Vitamin D|vitamin d
407528|NCT01835691|Vitamin D2|vitamin d2
407529|NCT01835691|Vitamin D3|vitamin d3
407530|NCT01835652|Exercise|exercise
407531|NCT01835652|Parkinson's Disease|parkinson's disease
407633|NCT01835106|Postoperative Care|postoperative care
407532|NCT01835652|Positron Emission Tomography|positron emission tomography
407533|NCT01835652|fMRI|fmri
407534|NCT01835639|Glomerular Disease|glomerular disease
407535|NCT01835639|Vitamin D|vitamin d
407536|NCT01835639|Steroid-resistant nephrotic syndrome|steroid-resistant nephrotic syndrome
407537|NCT01835639|Minimal change disease|minimal change disease
407538|NCT01835639|Focal segmental glomerulosclerosis (FSGS)|focal segmental glomerulosclerosis (fsgs)
407539|NCT01835639|Membranous Nephropathy|membranous nephropathy
407540|NCT01835639|Membranoprolfierative Glomerulonephritis|membranoprolfierative glomerulonephritis
407541|NCT01835639|immunoglobulin A (IgA) Nephropathy|immunoglobulin a (iga) nephropathy
407542|NCT01835639|FSGS|fsgs
407543|NCT01835639|IgA Nephropathy|iga nephropathy
407544|NCT01835626|Locally advanced basal cell carcinoma|locally advanced basal cell carcinoma
407545|NCT01835626|Skin cancer|skin cancer
407546|NCT01835626|Radiation therapy|radiation therapy
407547|NCT01835626|Vismodegib|vismodegib
407548|NCT01835626|Head and neck cancer|head and neck cancer
407549|NCT01835626|Cutaneous malignancy|cutaneous malignancy
407550|NCT01835613|Rheumatoid Arthritis|rheumatoid arthritis
407551|NCT01835613|Early RA|early ra
407552|NCT01835613|RA|ra
407553|NCT01835613|IL-6|il-6
407554|NCT01835613|IL-6R|il-6r
407555|NCT01835613|Inhibitor|inhibitor
407556|NCT01835613|Inhibition|inhibition
407557|NCT01835613|Tocilizumab|tocilizumab
407558|NCT01835613|Biomarkers|biomarkers
407559|NCT01835613|DMARDs|dmards
407560|NCT01835613|Biological|biological
407561|NCT01835613|DAS|das
407562|NCT01835613|SDAI|sdai
407563|NCT01835613|AR/BIOM|ar/biom
407564|NCT01835613|OEG|oeg
407565|NCT01835587|Acute myeloid leukemia,|acute myeloid leukemia,
407566|NCT01835587|myelodysplastic syndromes,|myelodysplastic syndromes,
407567|NCT01835587|CC-486, oral Azacitidine,|cc-486, oral azacitidine,
407568|NCT01835587|transplantation,|transplantation,
407569|NCT01835587|allogeneic,|allogeneic,
407570|NCT01835587|HSCT.|hsct.
407571|NCT01835574|Amphetamine-type substance use|amphetamine-type substance use
407572|NCT01835561|Hepatic, Liver disease; Pharmacokinetic; Healthy|hepatic, liver disease; pharmacokinetic; healthy
407573|NCT01835509|Childhood Cancer Survivors|childhood cancer survivors
407574|NCT01835496|sickle cell disease|sickle cell disease
407575|NCT01835496|iron overload|iron overload
407576|NCT01835496|pharmacokinetics|pharmacokinetics
407577|NCT01835496|Ferriprox|ferriprox
407578|NCT01835496|deferiprone|deferiprone
407579|NCT01835457|Endotoxemia|endotoxemia
407580|NCT01835457|Autonomic Nervous System|autonomic nervous system
407581|NCT01835457|Inflammation|inflammation
407582|NCT01835457|Meditation|meditation
407583|NCT01835457|Concentration|concentration
407584|NCT01835457|Iceman|iceman
407585|NCT01835457|LPS|lps
407586|NCT01835457|Cortisol|cortisol
407587|NCT01835457|Catecholamines|catecholamines
407588|NCT01835444|Physician Assistant|physician assistant
407589|NCT01835444|Substitution|substitution
407590|NCT01835444|Hospital ward care|hospital ward care
407591|NCT01835444|Secondary health care|secondary health care
407592|NCT01835418|managed with bedtime administration of lisinopril versus amlodipine|managed with bedtime administration of lisinopril versus amlodipine
407593|NCT01835392|Remote ischemic preconditioning|remote ischemic preconditioning
407594|NCT01835392|Heart defects, congenital|heart defects, congenital
407595|NCT01835392|cardiac surgery|cardiac surgery
407596|NCT01835392|Neurodevelopmental outcomes|neurodevelopmental outcomes
407597|NCT01835379|Diabetes|diabetes
407598|NCT01835379|Diabetic Foot Ulcer|diabetic foot ulcer
407599|NCT01835379|Diabetic Foot Wound|diabetic foot wound
407600|NCT01835379|Non-healing foot wound|non-healing foot wound
407601|NCT01835379|Oasis|oasis
407602|NCT01835379|Diabetic neuropathy|diabetic neuropathy
407603|NCT01835353|prasugrel|prasugrel
407604|NCT01835353|ST elevation myocardial infarction|st elevation myocardial infarction
407605|NCT01835327|intraoperative, post-operative recovery|intraoperative, post-operative recovery
407606|NCT01835327|thoracic surgery|thoracic surgery
407607|NCT01835327|cerebral oximetry|cerebral oximetry
407608|NCT01835262|pain|pain
407609|NCT01835262|Ketamine|ketamine
407610|NCT01835262|Emergency Medicine|emergency medicine
407611|NCT01835262|morphine|morphine
407612|NCT01835249|Hypertension|hypertension
407613|NCT01835249|Nighttime blood pressure|nighttime blood pressure
407614|NCT01835236|Breast cancer|breast cancer
407615|NCT01835236|HER2-positive|her2-positive
407616|NCT01835236|Metastases|metastases
407617|NCT01835197|Phase 1|phase 1
407618|NCT01835197|Randomized|randomized
407619|NCT01835197|Double Blind|double blind
407620|NCT01835197|Placebo-Controlled|placebo-controlled
407621|NCT01835197|Single- & Multiple Dose Escalation|single- & multiple dose escalation
407622|NCT01835197|Safety|safety
407623|NCT01835197|Tolerability|tolerability
407624|NCT01835197|PK|pk
407625|NCT01835197|PD|pd
407626|NCT01835197|Pf-04965842|pf-04965842
407627|NCT01835132|Scleritis|scleritis
407628|NCT01835132|IL-1|il-1
407629|NCT01835119|gynecological malignancies|gynecological malignancies
407630|NCT01835119|postoperative|postoperative
407631|NCT01835119|bowel activity|bowel activity
407634|NCT01835080|Obstructive Sleep Apnea, OSA, Pulmonary Arterial Hypertension, PAH, sleep study, polysomnogram, Respiratory Disturbance Index, RDI|obstructive sleep apnea, osa, pulmonary arterial hypertension, pah, sleep study, polysomnogram, respiratory disturbance index, rdi
407635|NCT01835067|Macular degeneration|macular degeneration
407636|NCT01835067|Submacular haemorrhage|submacular haemorrhage
407637|NCT01835054|Mitral regurgitation|mitral regurgitation
407638|NCT01835054|Mitral valve prolapse|mitral valve prolapse
407639|NCT01835054|Echocardiography, Doppler|echocardiography, doppler
407640|NCT01835054|Stress echocardiography|stress echocardiography
407641|NCT01835054|Cardiopulmonary exercice testing|cardiopulmonary exercice testing
407642|NCT01835054|Magnetic Resonance Imaging|magnetic resonance imaging
407643|NCT01835054|Cardiac neurohormones|cardiac neurohormones
407644|NCT01835054|Visceral obesity|visceral obesity
407645|NCT01835054|Cardiometabolic risk|cardiometabolic risk
407646|NCT01835054|Risk stratification|risk stratification
407647|NCT01835028|Aortic Stenosis|aortic stenosis
407648|NCT01835028|Low Flow|low flow
407649|NCT01835028|Low Gradient|low gradient
407650|NCT01835028|Left Ventricle|left ventricle
407651|NCT01835028|Echocardiography, Doppler|echocardiography, doppler
407652|NCT01835015|First in human|first in human
407653|NCT01835015|Safety|safety
407654|NCT01835015|Tolerability|tolerability
407655|NCT01835015|Serum PK|serum pk
407656|NCT01835015|Intravitreal (IVT)|intravitreal (ivt)
407657|NCT01835015|Age-related macular degeneration|age-related macular degeneration
407658|NCT01835015|AMD|amd
407659|NCT01835015|Geographic Atrophy|geographic atrophy
407660|NCT01835015|Choroidal neovascularization|choroidal neovascularization
407661|NCT01835002|transcorneal electrostimulation|transcorneal electrostimulation
407662|NCT01834976|cardiac biomarker|cardiac biomarker
407663|NCT01834976|congenital heart disease|congenital heart disease
407664|NCT01834976|surgery|surgery
407665|NCT01834937|ExAblate|exablate
407666|NCT01834937|MRgFUS|mrgfus
407667|NCT01834937|Bone Metastases|bone metastases
407668|NCT01834937|Pain Palliation|pain palliation
407669|NCT01834924|Health literacy|health literacy
407670|NCT01834924|Patient education|patient education
407671|NCT01834911|Huntington disease|huntington disease
407672|NCT01834911|HD|hd
407673|NCT01834911|tetrabenazine|tetrabenazine
407674|NCT01834911|Stroop|stroop
407675|NCT01834898|postoperative|postoperative
407676|NCT01834898|analgesia|analgesia
407677|NCT01834898|adverse effects|adverse effects
407678|NCT01834898|opioid|opioid
407679|NCT01834898|oxycodone|oxycodone
407680|NCT01834885|COPD|copd
407681|NCT01834859|weight reduction programs|weight reduction programs
407682|NCT01834859|diet|diet
407683|NCT01834859|Caloric restriction|caloric restriction
407684|NCT01834859|weight loss|weight loss
407685|NCT01834859|weight gain|weight gain
407686|NCT01834846|comparative study|comparative study
407687|NCT01834846|Cardiac Surgical Procedures|cardiac surgical procedures
407688|NCT01834833|Acute heart failure; rehospitalisation; education; follow-up|acute heart failure; rehospitalisation; education; follow-up
407689|NCT01834820|Bronchiolitis|bronchiolitis
407690|NCT01834820|Epinephrine|epinephrine
407691|NCT01834820|Dexamethasone|dexamethasone
407692|NCT01834820|Hospitalization|hospitalization
407693|NCT01834820|Hypertonic Saline|hypertonic saline
407694|NCT01834794|Tobacco Use|tobacco use
407695|NCT01834781|multiple chemical sensitivity, re5 therapy, pulsed electromagnetic fields|multiple chemical sensitivity, re5 therapy, pulsed electromagnetic fields
407696|NCT01834742|Moviprep|moviprep
407697|NCT01834742|PEG3350|peg3350
407698|NCT01834742|Laxative|laxative
407699|NCT01834742|Stool Output|stool output
407700|NCT01834690|Liver transplantation/epidemiology|liver transplantation/epidemiology
407701|NCT01834690|Liver transplantation/pharmacology|liver transplantation/pharmacology
407702|NCT01834690|Health status/drug effects|health status/drug effects
407703|NCT01834690|Agents, immunosuppressive agents|agents, immunosuppressive agents
407704|NCT01834677|Depression|depression
407705|NCT01834677|Neurocognition|neurocognition
407706|NCT01834677|Electroconvulsive Therapy (ECT)|electroconvulsive therapy (ect)
407707|NCT01834677|Parkinson's Disease|parkinson's disease
407831|NCT01834131|community health worker|community health worker
407708|NCT01834664|Ataxic Infantile Cerebral Palsy stem cell therapy|ataxic infantile cerebral palsy stem cell therapy
407709|NCT01834651|liver metastasis|liver metastasis
407710|NCT01834651|lung metastasis|lung metastasis
407711|NCT01834651|metastatic castrate-resistant|metastatic castrate-resistant
407712|NCT01834651|prostate cancer|prostate cancer
407713|NCT01834638|schizophrenia|schizophrenia
407714|NCT01834612|blood loss, hemorrhage, hemorrhagic shcok|blood loss, hemorrhage, hemorrhagic shcok
407715|NCT01834599|placental oxygenation|placental oxygenation
407716|NCT01834599|obstetric anesthesia|obstetric anesthesia
407717|NCT01834599|NIRS|nirs
407718|NCT01834599|cerebral oximetry|cerebral oximetry
407719|NCT01834599|cerebral oximeter|cerebral oximeter
407720|NCT01834573|inflammatory bowel disease|inflammatory bowel disease
407721|NCT01834573|IBD|ibd
407722|NCT01834573|quality of life|quality of life
407723|NCT01834573|Inflammatory Bowel Disease Questionnaire|inflammatory bowel disease questionnaire
407724|NCT01834560|deep brain stimulation|deep brain stimulation
407725|NCT01834560|subgenual cortex (CG25)|subgenual cortex (cg25)
407726|NCT01834547|chess, cognition|chess, cognition
407727|NCT01834521|Breast cancer|breast cancer
407728|NCT01834521|psychosocial|psychosocial
407729|NCT01834521|website|website
407730|NCT01834521|empowerment|empowerment
407731|NCT01834508|Experienced Treatment|experienced treatment
407732|NCT01834495|Peripheral artery disease|peripheral artery disease
407733|NCT01834495|atherosclerosis|atherosclerosis
407734|NCT01834495|stent|stent
407735|NCT01834482|seizures|seizures
407736|NCT01834482|epilepsy|epilepsy
407737|NCT01834482|adult|adult
407738|NCT01834482|intractable|intractable
407739|NCT01834482|medically refractory|medically refractory
407740|NCT01834482|Atkins|atkins
407741|NCT01834482|ketogenic|ketogenic
407742|NCT01834482|diet|diet
407743|NCT01834469|Ovarian,metastasis|ovarian,metastasis
407744|NCT01834456|Medically Complex Children|medically complex children
407745|NCT01834456|Family Experience in Healthcare|family experience in healthcare
407746|NCT01834456|Patient Centered Care|patient centered care
407747|NCT01834456|Family Centered Care|family centered care
407748|NCT01834456|Case Management|case management
407749|NCT01834456|Care Management|care management
407750|NCT01834456|Care Coordination|care coordination
407751|NCT01834456|Care Plan|care plan
407752|NCT01834456|Extensivist|extensivist
407753|NCT01834456|Medical Home|medical home
407754|NCT01834456|Children with Special Health Care Needs|children with special health care needs
407755|NCT01834456|Coordinated Care|coordinated care
407756|NCT01834456|Quality in Healthcare|quality in healthcare
407757|NCT01834456|Satisfaction in Healthcare|satisfaction in healthcare
407758|NCT01834456|Cost|cost
407759|NCT01834456|Utilization|utilization
407760|NCT01834456|Impact on Family|impact on family
407761|NCT01834456|Quality of Life|quality of life
407762|NCT01834456|Palliative Care|palliative care
407763|NCT01834456|Complex Chronic Conditions|complex chronic conditions
407764|NCT01834456|Life-limiting illness|life-limiting illness
407765|NCT01834456|Integrative Care|integrative care
407766|NCT01834456|Primary Care|primary care
407767|NCT01834456|Comprehensive Care|comprehensive care
407768|NCT01834456|Behavioral Care|behavioral care
407769|NCT01834443|spatial neglect|spatial neglect
407770|NCT01834443|galvanic vestibular stimulation as therapy|galvanic vestibular stimulation as therapy
407771|NCT01834417|Pressure ulcer, spinal cord injury, on-board device|pressure ulcer, spinal cord injury, on-board device
407772|NCT01834404|Obesity|obesity
407773|NCT01834404|BMI|bmi
407774|NCT01834404|Incretin|incretin
407775|NCT01834404|Satiety|satiety
407776|NCT01834404|Phentermine|phentermine
407777|NCT01834404|Topiramate|topiramate
407778|NCT01834378|diabetes|diabetes
407779|NCT01834378|insulin resistance|insulin resistance
407780|NCT01834378|exercise|exercise
407781|NCT01834365|Hypertension|hypertension
407782|NCT01834352|Walnut hypersensitivity|walnut hypersensitivity
407783|NCT01834352|Tree nut hypersensitivity|tree nut hypersensitivity
407784|NCT01834339|vestibuloplasty|vestibuloplasty
407785|NCT01834326|dental implants|dental implants
407786|NCT01834326|deficient keratinized oral mucosa|deficient keratinized oral mucosa
407787|NCT01834313|Willingness-to-pay|willingness-to-pay
407788|NCT01834313|Patient-centredness|patient-centredness
407789|NCT01834313|Health insurers|health insurers
407790|NCT01834313|Fertility care|fertility care
407791|NCT01834300|Hepatic insulin sensitivity|hepatic insulin sensitivity
407792|NCT01834300|Muscle insulin sensitivity|muscle insulin sensitivity
407793|NCT01834300|B cell function|b cell function
407794|NCT01834300|VLDL1 TG metabolism|vldl1 tg metabolism
407795|NCT01834300|VLDL2 TG metabolism|vldl2 tg metabolism
407796|NCT01834287|Physical Activity|physical activity
407797|NCT01834287|Latinas|latinas
407798|NCT01834287|Web-based|web-based
407799|NCT01834287|Spanish-language|spanish-language
407800|NCT01834274|Drug Therapy|drug therapy
407801|NCT01834261|oxytocin|oxytocin
407802|NCT01834261|trust|trust
407803|NCT01834261|kinship|kinship
407804|NCT01834261|kin selection|kin selection
407805|NCT01834235|Pancreatic neoplasms|pancreatic neoplasms
407806|NCT01834235|Pancreatic cancer|pancreatic cancer
407807|NCT01834235|Pancreatic cancer, adult|pancreatic cancer, adult
407808|NCT01834235|Adenoma of the pancreas|adenoma of the pancreas
407809|NCT01834235|Carcinoma of the pancreas|carcinoma of the pancreas
407810|NCT01834209|Prostate neoplasms|prostate neoplasms
407811|NCT01834209|Prostate cancer|prostate cancer
407812|NCT01834209|Metastatic prostate cancer|metastatic prostate cancer
407813|NCT01834209|Metatatic castration resistant prostate cancer|metatatic castration resistant prostate cancer
407814|NCT01834209|Abiraterone acetate|abiraterone acetate
407815|NCT01834209|Prednisone|prednisone
407816|NCT01834209|Prednisolone|prednisolone
407817|NCT01834209|Early access program|early access program
407818|NCT01834196|retinal vascular disease|retinal vascular disease
407819|NCT01834196|Swept-Source Ocular Coherence Tomography|swept-source ocular coherence tomography
407820|NCT01834196|SSOCT|ssoct
407821|NCT01834183|Metastatic|metastatic
407822|NCT01834170|Pancreatic cancer|pancreatic cancer
407823|NCT01834170|Pancreatic adenocarcinoma|pancreatic adenocarcinoma
407824|NCT01834170|Endoscopic ultrasound|endoscopic ultrasound
407825|NCT01834144|Type 1 Diabetes|type 1 diabetes
407826|NCT01834144|Hypoglycaemia|hypoglycaemia
407827|NCT01834144|Glycaemic variability|glycaemic variability
407828|NCT01834144|Vigorous Intensity Physical Activity|vigorous intensity physical activity
407829|NCT01834144|Continuous Glucose Monitoring|continuous glucose monitoring
407830|NCT01834131|hypertension|hypertension
407832|NCT01834131|home health education|home health education
407833|NCT01834131|medication adherence|medication adherence
407834|NCT01834131|mobile health|mobile health
407835|NCT01834131|physician education|physician education
407836|NCT01834131|home blood pressure monitoring|home blood pressure monitoring
407837|NCT01834131|implementation|implementation
407838|NCT01834105|Postmenopausal osteoporosis; Kidney Yin deficiency syndrome; Liuwei dihuang pill; CLCF1; JAK - STAT signal pathway|postmenopausal osteoporosis; kidney yin deficiency syndrome; liuwei dihuang pill; clcf1; jak - stat signal pathway
407839|NCT01834092|Abdominal Aortic Aneurism|abdominal aortic aneurism
407840|NCT01834092|Endothelia|endothelia
407841|NCT01834092|Glycocalyx|glycocalyx
407842|NCT01834092|Reperfusion|reperfusion
407843|NCT01834092|Plasma|plasma
407844|NCT01834079|Optic Atrophy,Stem cell therapy|optic atrophy,stem cell therapy
407845|NCT01834066|muscular Dystrophy stem cell|muscular dystrophy stem cell
407846|NCT01834053|Huntington Disease,stem cell therapy|huntington disease,stem cell therapy
407847|NCT01834040|Duchenne Muscular Dystrophy|duchenne muscular dystrophy
407848|NCT01834040|Muscular Dystrophy|muscular dystrophy
407849|NCT01834040|Myopathy|myopathy
407850|NCT01834027|music|music
407851|NCT01834027|stress|stress
407852|NCT01834027|anxiety|anxiety
407853|NCT01834027|post-surgical|post-surgical
407854|NCT01834027|pain|pain
407855|NCT01834014|Liver only metastasis from KRAS Exon 2 wild type|liver only metastasis from kras exon 2 wild type
407856|NCT01834014|Liver only metastasis from RAS wild type|liver only metastasis from ras wild type
407857|NCT01834001|MRI|mri
407858|NCT01834001|Prostate Cancer|prostate cancer
407859|NCT01834001|MRI-Guided Biopsy|mri-guided biopsy
407860|NCT01834001|Radiation|radiation
407861|NCT01834001|Biochemical Failure|biochemical failure
407862|NCT01833988|bionic pancreas|bionic pancreas
407863|NCT01833988|artificial pancreas|artificial pancreas
407864|NCT01833988|insulin|insulin
407865|NCT01833988|glucagon|glucagon
407866|NCT01833988|continuous glucose monitoring (CGM)|continuous glucose monitoring (cgm)
407867|NCT01833988|outpatient|outpatient
407868|NCT01833988|insulin pump|insulin pump
407869|NCT01833988|pediatrics|pediatrics
407870|NCT01833988|children|children
407871|NCT01833988|camp|camp
407872|NCT01833988|summer camp|summer camp
407873|NCT01833975|Spinal Cord Injury stem cell|spinal cord injury stem cell
407874|NCT01833962|Lumbar fusion rates|lumbar fusion rates
407875|NCT01833962|Actifuse synthetic bone graft|actifuse synthetic bone graft
407876|NCT01833962|Baxter Healthcare|baxter healthcare
407877|NCT01833962|Other synthetic bone graft|other synthetic bone graft
407878|NCT01833949|polycystic ovary syndrome,laparoscopic ovarian drilling|polycystic ovary syndrome,laparoscopic ovarian drilling
407879|NCT01833936|Achilles|achilles
407880|NCT01833923|Advanced cancer|advanced cancer
407881|NCT01833910|Cardiopulmonary Resuscitation|cardiopulmonary resuscitation
407882|NCT01833910|Education|education
407883|NCT01833897|Bipolar Disorder|bipolar disorder
407884|NCT01833884|Hodgkin Lymphoma, Adult|hodgkin lymphoma, adult
407885|NCT01833884|Cytokines|cytokines
407886|NCT01833884|TARC|tarc
407887|NCT01833884|IL-6|il-6
407888|NCT01833884|IL1-RA|il1-ra
407889|NCT01833884|sCD30|scd30
407890|NCT01833884|TNFR1|tnfr1
407891|NCT01833845|HCV|hcv
407892|NCT01833845|Hepatitis C|hepatitis c
407893|NCT01833845|Hep-C|hep-c
407894|NCT01833832|Synergy for Cisplatin and Hyperthermia|synergy for cisplatin and hyperthermia
521588|NCT01341132|HCC|hcc
407895|NCT01833832|Rare Tumor|rare tumor
407896|NCT01833832|Poor Prognosis|poor prognosis
407897|NCT01833819|Laparoscopic cholecystectomy,|laparoscopic cholecystectomy,
407898|NCT01833819|Total intravenous anesthesia,|total intravenous anesthesia,
407899|NCT01833819|Propofol,|propofol,
407900|NCT01833819|Dexmedetomidine,|dexmedetomidine,
407901|NCT01833819|Lidocaine,|lidocaine,
407902|NCT01833819|Remifentanil,|remifentanil,
407903|NCT01833819|Postoperative analgesic consumption,|postoperative analgesic consumption,
407904|NCT01833819|Postoperative nausea and vomiting|postoperative nausea and vomiting
407905|NCT01833793|Mirena|mirena
407906|NCT01833793|Contraception|contraception
407907|NCT01833793|Amenorrhea|amenorrhea
407908|NCT01833780|carriage status|carriage status
407909|NCT01833780|Culture|culture
407910|NCT01833780|PCR|pcr
407911|NCT01833754|Osteoporosis, Bone, Renal, Insufficiency, Kidney, Hemodialysis, Impairment|osteoporosis, bone, renal, insufficiency, kidney, hemodialysis, impairment
407912|NCT01833715|Pain, Postoperative|pain, postoperative
407913|NCT01833715|Analgesics, Opioid|analgesics, opioid
407914|NCT01833715|Methadone|methadone
407915|NCT01833715|Morphine|morphine
407916|NCT01833702|Sickle cell|sickle cell
407917|NCT01833702|Pain|pain
407918|NCT01833689|glucose response|glucose response
407919|NCT01833689|glycaemic index|glycaemic index
407920|NCT01833676|sevoflurane|sevoflurane
407922|NCT01833676|protective airway reflexes|protective airway reflexes
407923|NCT01833676|elderly|elderly
407924|NCT01833663|Overactive Bladder|overactive bladder
407925|NCT01833663|Solifenacin Succinate Tablets|solifenacin succinate tablets
407926|NCT01833663|Estrogen|estrogen
407927|NCT01833650|thyroid cancer|thyroid cancer
407928|NCT01833650|radioiodine treatment|radioiodine treatment
407929|NCT01833650|xerostomia|xerostomia
407930|NCT01833650|sialadenitis|sialadenitis
407931|NCT01833637|Advanced Care Planning|advanced care planning
407932|NCT01833637|Palliative Care|palliative care
407933|NCT01833637|Women|women
407934|NCT01833598|Chronic tendinopathy|chronic tendinopathy
407935|NCT01833598|platelet rich plasma|platelet rich plasma
407936|NCT01833598|tendonitis|tendonitis
407937|NCT01833598|percutaneous tendon tenotomy|percutaneous tendon tenotomy
407938|NCT01833598|pain|pain
407939|NCT01833598|shoulder|shoulder
407940|NCT01833598|knee|knee
407941|NCT01833598|ankle|ankle
407942|NCT01833598|foot|foot
407943|NCT01833585|critical limb ischemia|critical limb ischemia
407944|NCT01833585|atherosclerosis|atherosclerosis
407945|NCT01833585|ischemic ulcer|ischemic ulcer
407946|NCT01833585|rest pain|rest pain
407947|NCT01833585|gangrene|gangrene
407948|NCT01833572|epidermal growth factor receptor|epidermal growth factor receptor
407949|NCT01833572|EGFR mutation|egfr mutation
407950|NCT01833572|Tyrosine kinase inhibitor|tyrosine kinase inhibitor
407951|NCT01833572|gefitinib|gefitinib
407952|NCT01833572|neo-adjuvant therapy|neo-adjuvant therapy
407953|NCT01833546|Solid tumor|solid tumor
407954|NCT01833546|Pancreatic cancer|pancreatic cancer
407955|NCT01833546|TH-302|th-302
407956|NCT01833546|Gemcitabine|gemcitabine
407957|NCT01833546|Evofosfamide|evofosfamide
407958|NCT01833533|Chronic Hepatitis C|chronic hepatitis c
407959|NCT01833533|Hepatitis C Virus|hepatitis c virus
407960|NCT01833533|Hepatitis C Genotype 1a|hepatitis c genotype 1a
407961|NCT01833533|Hepatitis C|hepatitis c
407962|NCT01833533|Treatment-Naïve|treatment-naïve
407963|NCT01833533|Interferon-Free|interferon-free
407964|NCT01833533|Paritaprevir|paritaprevir
407965|NCT01833533|Ombitasvir|ombitasvir
407966|NCT01833533|Dasabuvir|dasabuvir
407967|NCT01833533|Ribavirin|ribavirin
407968|NCT01833533|Viekira PAK|viekira pak
407969|NCT01833520|Sarcoma|sarcoma
407970|NCT01833520|Osteosarcoma|osteosarcoma
407971|NCT01833520|recurrent or metastatic|recurrent or metastatic
407972|NCT01833520|Ra-223 dichloride|ra-223 dichloride
407973|NCT01833520|Radium-223 chloride|radium-223 chloride
407974|NCT01833520|Alpharadin|alpharadin
407975|NCT01833507|increased activity|increased activity
407976|NCT01833507|weight loss|weight loss
407977|NCT01833507|obesity|obesity
407978|NCT01833494|Hemodialysis|hemodialysis
407979|NCT01833494|Hyperphosphatemia|hyperphosphatemia
407980|NCT01833481|Surgical approach|surgical approach
407981|NCT01833481|Direct-anterior|direct-anterior
407982|NCT01833481|Anterior-lateral|anterior-lateral
407983|NCT01833481|Posterior-lateral|posterior-lateral
407984|NCT01833481|Hip implant|hip implant
407985|NCT01833481|Total Hip Arthroplasty|total hip arthroplasty
407986|NCT01833481|Total Hip replacement|total hip replacement
407987|NCT01833481|Hip replacement|hip replacement
407988|NCT01833481|Hip prosthesis|hip prosthesis
407989|NCT01833468|ankylosing spondylitis|ankylosing spondylitis
407990|NCT01833468|Psoriatic arthritis|psoriatic arthritis
407991|NCT01833468|Foot|foot
407992|NCT01833468|FAOS|faos
407993|NCT01833468|SpA-TRI|spa-tri
407995|NCT01833442|YBOCS|ybocs
407996|NCT01833429|Resistant hypertension|resistant hypertension
407997|NCT01833429|White-coat phenomenon|white-coat phenomenon
407998|NCT01833429|Heart rate variability|heart rate variability
407999|NCT01833429|autonomic activity|autonomic activity
408000|NCT01833416|CMV infection|cmv infection
408001|NCT01833416|CMV disease|cmv disease
408002|NCT01833416|Natural history|natural history
408003|NCT01833416|Kidney transplant|kidney transplant
408004|NCT01833403|bariatric surgery, l|bariatric surgery, l
408005|NCT01833403|liver insulin resistance,|liver insulin resistance,
408006|NCT01833390|Hyperpolarized Xenon|hyperpolarized xenon
408008|NCT01833390|MagniXene|magnixene
408009|NCT01833377|obesity|obesity
408010|NCT01833377|overweight|overweight
408011|NCT01833377|BMI|bmi
408012|NCT01833364|Parkinson's Disease|parkinson's disease
408013|NCT01833364|Deep Brain Stimulation|deep brain stimulation
408014|NCT01833364|Peripheral Nerve Graft|peripheral nerve graft
408015|NCT01833351|Phase I|phase i
408016|NCT01833351|safety and pharmacokinetics,|safety and pharmacokinetics,
408017|NCT01833351|intravenous ascorbate,|intravenous ascorbate,
408018|NCT01833351|IV Vitamin C,|iv vitamin c,
408019|NCT01833351|Oncology|oncology
408020|NCT01833338|Non ST elevation myocardial infarction|non st elevation myocardial infarction
408021|NCT01833338|optical coherence tomography|optical coherence tomography
408022|NCT01833338|intravascular ultrasound|intravascular ultrasound
408023|NCT01833338|multi-slice computed tomography|multi-slice computed tomography
408024|NCT01833325|Age-Related Macular Degeneration|age-related macular degeneration
408025|NCT01833325|Macular Degeneration|macular degeneration
408026|NCT01833325|Proton radiation|proton radiation
408027|NCT01833325|Choroidal Neovascular Membranes|choroidal neovascular membranes
408028|NCT01833312|acute ischemic stroke|acute ischemic stroke
408029|NCT01833312|hypothermia|hypothermia
408030|NCT01833299|TACE|tace
408031|NCT01833299|Sorafenib|sorafenib
408032|NCT01833299|overall survival|overall survival
408033|NCT01833299|time to progression|time to progression
408034|NCT01833286|hepatocellular carcinoma|hepatocellular carcinoma
408035|NCT01833286|repeat hepatectomy|repeat hepatectomy
408036|NCT01833286|radiofrequency ablation|radiofrequency ablation
408037|NCT01833286|transcatheter arterial chemoembolization|transcatheter arterial chemoembolization
408038|NCT01833247|epilepsy|epilepsy
408039|NCT01833247|lactic acid|lactic acid
408040|NCT01833247|saliva|saliva
408041|NCT01833247|postictal|postictal
408042|NCT01833234|epilepsy|epilepsy
408043|NCT01833234|quality of life|quality of life
408044|NCT01833234|seizure severity|seizure severity
408045|NCT01833234|antiepileptic drug side effects|antiepileptic drug side effects
408046|NCT01833234|questionnaire|questionnaire
408047|NCT01833234|patient reported outcomes|patient reported outcomes
408048|NCT01833221|facial palsy|facial palsy
408049|NCT01833221|lengthening temporalis myoplasty|lengthening temporalis myoplasty
408050|NCT01833221|neurotization of facial muscles|neurotization of facial muscles
408051|NCT01833195|molecular diagnostics|molecular diagnostics
408052|NCT01833195|heart transplantation|heart transplantation
408053|NCT01833195|risk factors|risk factors
408054|NCT01833195|prognosis|prognosis
408055|NCT01833182|falls in community dwelling older adults|falls in community dwelling older adults
408056|NCT01833182|falls and ADL performance|falls and adl performance
408057|NCT01833182|tailored home intervention|tailored home intervention
408058|NCT01833169|Solid tumor|solid tumor
408059|NCT01833169|malignancy|malignancy
408060|NCT01833169|hematologic malignancy|hematologic malignancy
408061|NCT01833169|PI3K pathway activation|pi3k pathway activation
408062|NCT01833169|P13K activated tumors|p13k activated tumors
408063|NCT01833169|BKM120|bkm120
408064|NCT01833169|signature|signature
408065|NCT01833169|AML|aml
408066|NCT01833169|acute myelogenous leukemia|acute myelogenous leukemia
408067|NCT01833169|cervical|cervical
408068|NCT01833169|ovarian|ovarian
408069|NCT01833169|hepatobiliary|hepatobiliary
408070|NCT01833169|buparlisib|buparlisib
408071|NCT01833156|local edema|local edema
408072|NCT01833156|dielectric constant values|dielectric constant values
408073|NCT01833156|validation study|validation study
408074|NCT01833143|KRAS-Mutant|kras-mutant
408075|NCT01833143|Bortezomib|bortezomib
408076|NCT01833143|KRAS G12D|kras g12d
408077|NCT01833143|12-222|12-222
408078|NCT01833117|Dry eye|dry eye
408079|NCT01833117|Tear film|tear film
408080|NCT01833117|Tear break-up time|tear break-up time
408081|NCT01833117|Ocular surface|ocular surface
408082|NCT01833117|Eye drops|eye drops
408083|NCT01833104|Healthy subjects|healthy subjects
408084|NCT01833039|Mantle Cell Lymphoma|mantle cell lymphoma
408085|NCT01833039|Ibrutinib|ibrutinib
408086|NCT01833026|pulmonary disease|pulmonary disease
408087|NCT01833026|chronic obstructive airflow|chronic obstructive airflow
408088|NCT01833026|spirometry|spirometry
408089|NCT01833026|primary healthcare|primary healthcare
408090|NCT01833026|guideline-based therapy|guideline-based therapy
408091|NCT01833013|Endometriosis|endometriosis
408092|NCT01833013|Cohort study|cohort study
408093|NCT01833013|fertility|fertility
408094|NCT01833013|pregnancy|pregnancy
408095|NCT01833013|assisted reproductive technics|assisted reproductive technics
408096|NCT01833013|laparoscopy|laparoscopy
408097|NCT01833000|rectal bleeding|rectal bleeding
408098|NCT01833000|necrotizing enterolitis|necrotizing enterolitis
408099|NCT01833000|splanchnic oxygenation|splanchnic oxygenation
408100|NCT01833000|mesenteric doppler|mesenteric doppler
408101|NCT01832987|co-trimoxazole|co-trimoxazole
408102|NCT01832987|sulfamethoxazole|sulfamethoxazole
408103|NCT01832987|tuberculosis|tuberculosis
408104|NCT01832987|pharmacokinetics|pharmacokinetics
408105|NCT01832974|Adrenal Gland Cancer|adrenal gland cancer
408106|NCT01832974|Treatment Refractory Malignancies|treatment refractory malignancies
408107|NCT01832974|Metastatic Cancer|metastatic cancer
408108|NCT01832961|COPD|copd
408109|NCT01832961|physiotherapy care|physiotherapy care
408110|NCT01832961|lung function testing|lung function testing
408111|NCT01832961|inflammation|inflammation
408112|NCT01832935|Glargin|glargin
408114|NCT01832935|Cost-effectiveness|cost-effectiveness
408115|NCT01832922|bendamustine|bendamustine
408116|NCT01832922|rituximab|rituximab
408117|NCT01832922|Chronic Lymphocytic Leukemia|chronic lymphocytic leukemia
408118|NCT01832922|comorbidities|comorbidities
408119|NCT01832922|renal insufficiency|renal insufficiency
408120|NCT01832909|metabolizable energy|metabolizable energy
408121|NCT01832909|walnuts|walnuts
408122|NCT01832909|Atwater factors|atwater factors
408123|NCT01832909|energy value|energy value
408124|NCT01832896|Hereditary Angioedema|hereditary angioedema
408125|NCT01832896|Children|children
408126|NCT01832896|Adolescents|adolescents
408127|NCT01832896|Ecallantide|ecallantide
408128|NCT01832857|metastatic|metastatic
408129|NCT01832857|advanced|advanced
408130|NCT01832857|solid tumor|solid tumor
408131|NCT01832857|cancer|cancer
408132|NCT01832857|colon cancer|colon cancer
408133|NCT01832857|hepatocellular carcinoma|hepatocellular carcinoma
408134|NCT01832857|breast cancer|breast cancer
408135|NCT01832857|lung cancer|lung cancer
408136|NCT01832857|gastric cancer|gastric cancer
408137|NCT01832857|esophageal cancer|esophageal cancer
408138|NCT01832844|Scan control|scan control
408139|NCT01832844|Epidural infiltration|epidural infiltration
408140|NCT01832844|visual analogue scale (VAS)|visual analogue scale (vas)
408141|NCT01832818|Total Disc Replacement|total disc replacement
408142|NCT01832805|depression|depression
408143|NCT01832779|Achalasia|achalasia
408144|NCT01832766|schizophrenia|schizophrenia
408145|NCT01832766|dronabinol|dronabinol
408147|NCT01832766|cannabis|cannabis
408148|NCT01832766|memory|memory
408149|NCT01832766|symptoms|symptoms
408150|NCT01832753|Down syndrome|down syndrome
408151|NCT01832753|subclinical hypothyroidism|subclinical hypothyroidism
408152|NCT01832753|thyroid|thyroid
408153|NCT01832753|levothyroxine|levothyroxine
408154|NCT01832740|young healthy subjects|young healthy subjects
408155|NCT01832740|brain stimulation|brain stimulation
408156|NCT01832740|tSOS|tsos
408157|NCT01832740|tDCS|tdcs
408158|NCT01832740|sleep|sleep
408159|NCT01832740|memory|memory
408160|NCT01832740|memory consolidation|memory consolidation
408161|NCT01832727|multiple myeloma|multiple myeloma
408162|NCT01832727|oprozomib|oprozomib
408163|NCT01832727|OPZ|opz
408164|NCT01832727|ONX 0912|onx 0912
408165|NCT01832727|Onyx|onyx
408166|NCT01832727|proteasome inhibitor|proteasome inhibitor
408167|NCT01832727|oprozomib tablets|oprozomib tablets
408168|NCT01832714|Concussion|concussion
408169|NCT01832714|mTBI|mtbi
408170|NCT01832714|military|military
408171|NCT01832714|MACE|mace
408172|NCT01832714|NKI|nki
408173|NCT01832714|NOTC|notc
408174|NCT01832714|VNG|vng
408175|NCT01832714|VOG|vog
408176|NCT01832714|Neuro Kinetics|neuro kinetics
408177|NCT01832714|oculomotor|oculomotor
408178|NCT01832714|vestibular|vestibular
408179|NCT01832714|reaction time|reaction time
408180|NCT01832714|I-Portal|i-portal
408181|NCT01832714|eye tracking|eye tracking
408182|NCT01832714|Dizziness Handicap Inventory|dizziness handicap inventory
408183|NCT01832688|iron and folic acid supplements|iron and folic acid supplements
408184|NCT01832688|anemia|anemia
408185|NCT01832688|gestational weight gain|gestational weight gain
408186|NCT01832675|Endoscopy|endoscopy
408187|NCT01832675|Anesthetics, Local|anesthetics, local
408188|NCT01832675|Bupivacaine|bupivacaine
408189|NCT01832675|Lidocaine|lidocaine
408190|NCT01832649|Exercise|exercise
408191|NCT01832649|Cocaine dependence|cocaine dependence
408192|NCT01832636|L-Alanyl-L-Glutamine|l-alanyl-l-glutamine
408193|NCT01832636|Environmental enteric dysfunction|environmental enteric dysfunction
408194|NCT01832636|Tropical enteropathy|tropical enteropathy
408195|NCT01832623|Vitamin D|vitamin d
408196|NCT01832623|bone|bone
408197|NCT01832623|cardiovascular status|cardiovascular status
408198|NCT01832623|nutritional status|nutritional status
408199|NCT01832584|Red Grapes|red grapes
408200|NCT01832584|polyphenols|polyphenols
408201|NCT01832584|cyclists|cyclists
408202|NCT01832584|resveratrol|resveratrol
408203|NCT01832584|aerobic fitness|aerobic fitness
408204|NCT01832584|trained|trained
408205|NCT01832571|HIV|hiv
408206|NCT01832571|PrEP|prep
408207|NCT01832571|Female Sex Workers|female sex workers
408208|NCT01832571|Kenya|kenya
408209|NCT01832545|Aquatic exercise|aquatic exercise
408210|NCT01832545|Knee Osteoarthritis|knee osteoarthritis
408211|NCT01832545|Exercise|exercise
408212|NCT01832545|Pain|pain
408213|NCT01832545|Obesity.|obesity.
408214|NCT01832532|Sleep Apnea|sleep apnea
408215|NCT01832532|Sleep Disordered Breathing|sleep disordered breathing
408216|NCT01832532|liraglutide|liraglutide
408217|NCT01832532|glucagon-like peptide-1 agonist|glucagon-like peptide-1 agonist
408218|NCT01832532|Orexin|orexin
408219|NCT01832532|leptin,|leptin,
408220|NCT01832519|Cystic Fibrosis|cystic fibrosis
408221|NCT01832519|CF|cf
408222|NCT01832519|MRI|mri
408223|NCT01832519|vascularization|vascularization
408224|NCT01832519|perfusion|perfusion
408225|NCT01832506|Solid Tumors|solid tumors
408226|NCT01832506|MSC2156119J|msc2156119j
408227|NCT01832506|c-Met inhibitor|c-met inhibitor
408228|NCT01832506|Japanese|japanese
408229|NCT01832506|Phase 1|phase 1
408230|NCT01832480|Trichomonas vaginalis|trichomonas vaginalis
408231|NCT01832480|metronidazole|metronidazole
408232|NCT01832467|cetuximab-based chemotherapy|cetuximab-based chemotherapy
408233|NCT01832467|previously treated|previously treated
408234|NCT01832454|cerebral palsy stem cells [MNCS]|cerebral palsy stem cells [mncs]
408338|NCT01832025|implant|implant
408235|NCT01832441|Diabetes Mellitus stem cells [MNCS ]|diabetes mellitus stem cells [mncs ]
408236|NCT01832415|First line treatment|first line treatment
408237|NCT01832415|Ovarian cancer|ovarian cancer
408238|NCT01832415|Avastin|avastin
408239|NCT01832415|fallopian tube or primary peritoneal|fallopian tube or primary peritoneal
408240|NCT01832402|Advanced Cancers|advanced cancers
408241|NCT01832402|Exercise-Induced Breakthrough Dyspnea|exercise-induced breakthrough dyspnea
408242|NCT01832402|Shortness of breath|shortness of breath
408243|NCT01832402|Fentanyl pectin nasal spray|fentanyl pectin nasal spray
408244|NCT01832402|Placebo nasal spray|placebo nasal spray
408245|NCT01832402|Walk test|walk test
408246|NCT01832402|Questionnaires|questionnaires
408247|NCT01832402|Surveys|surveys
408248|NCT01832402|Mental ability tests|mental ability tests
408249|NCT01832389|Subarachnoid Haemorrhage (SAH)|subarachnoid haemorrhage (sah)
408250|NCT01832389|vasospasm|vasospasm
408251|NCT01832389|delayed cerebral ischaemia (DCI)|delayed cerebral ischaemia (dci)
408252|NCT01832389|goal directed therapy (GDT)|goal directed therapy (gdt)
408253|NCT01832389|Pulse Contour Cardiac Output (PiCCO)|pulse contour cardiac output (picco)
408254|NCT01832376|Calcific tendinitis|calcific tendinitis
408255|NCT01832376|Shoulder|shoulder
408256|NCT01832376|Needle lavage|needle lavage
408257|NCT01832376|Ultrasound-guided|ultrasound-guided
408258|NCT01832363|Severe asthma|severe asthma
408259|NCT01832363|Bronchial thermoplasty|bronchial thermoplasty
408260|NCT01832363|MagniXene|magnixene
408261|NCT01832363|Hyperpolarized Xenon|hyperpolarized xenon
408262|NCT01832363|HXe|hxe
408263|NCT01832363|HyXe|hyxe
408264|NCT01832324|Food Allergy|food allergy
408265|NCT01832324|Eosinophilic Esophagitis|eosinophilic esophagitis
408266|NCT01832324|Food Protein Induced Enterocolitis|food protein induced enterocolitis
408267|NCT01832324|iNKT Cells|inkt cells
408268|NCT01832324|T cells|t cells
408269|NCT01832311|type 2 diabetes mellitus|type 2 diabetes mellitus
408270|NCT01832311|cataract|cataract
408271|NCT01832311|cytokines|cytokines
408272|NCT01832311|chemokines|chemokines
408273|NCT01832311|aqueous humor|aqueous humor
408274|NCT01832298|Tolerability|tolerability
408275|NCT01832298|Pharmacokinetics|pharmacokinetics
408276|NCT01832285|fluvoxamine|fluvoxamine
408277|NCT01832285|cognition|cognition
408278|NCT01832285|schizophrenia|schizophrenia
408279|NCT01832285|protein expression|protein expression
408280|NCT01832272|Osteoarthritis|osteoarthritis
408281|NCT01832272|Knee|knee
408282|NCT01832272|Total knee arthroplasty|total knee arthroplasty
408283|NCT01832272|Tourniquet|tourniquet
408284|NCT01832272|Early release|early release
408285|NCT01832272|Reinflation|reinflation
408286|NCT01832246|endoscopy|endoscopy
408287|NCT01832246|endosonography|endosonography
408288|NCT01832246|stomach cancer|stomach cancer
408289|NCT01832246|tumor staging|tumor staging
408290|NCT01832220|Genomics|genomics
408291|NCT01832220|Microbiome|microbiome
408292|NCT01832220|Microflora|microflora
408293|NCT01832220|Virome|virome
408294|NCT01832220|Alpha-1|alpha-1
408295|NCT01832194|Scrotal pain|scrotal pain
408296|NCT01832194|Botox|botox
408297|NCT01832181|Diabetes|diabetes
408298|NCT01832181|MiTy|mity
408299|NCT01832181|Metformin in Women|metformin in women
408300|NCT01832181|Type 2 Diabetes Pregnancy|type 2 diabetes pregnancy
408301|NCT01832155|Yoga|yoga
408302|NCT01832155|Knee osteoarthritis|knee osteoarthritis
408303|NCT01832155|Symptom management|symptom management
408304|NCT01832155|Older women|older women
408305|NCT01832155|Pain|pain
408306|NCT01832155|Stiffness|stiffness
522056|NCT01339195|stroke|stroke
408307|NCT01832155|Physical function)|physical function)
408308|NCT01832155|Physical function of the lower extremities|physical function of the lower extremities
408309|NCT01832155|Quality of sleep|quality of sleep
408310|NCT01832155|Quality of life|quality of life
408311|NCT01832116|Pancreatic cancer|pancreatic cancer
408312|NCT01832116|Ovarian cancer|ovarian cancer
408313|NCT01832090|aging|aging
408314|NCT01832090|hands|hands
408315|NCT01832077|sensibility|sensibility
408316|NCT01832077|specificity|specificity
408317|NCT01832077|positive predictive value|positive predictive value
408318|NCT01832077|negative predictive value|negative predictive value
408319|NCT01832077|Cost-effectiveness|cost-effectiveness
408320|NCT01832064|chronic disease|chronic disease
408321|NCT01832064|patient education|patient education
408322|NCT01832064|self management|self management
408323|NCT01832051|HER2-PET|her2-pet
408324|NCT01832051|89Zr-trastuzumab|89zr-trastuzumab
408325|NCT01832051|metastatic breast cancer|metastatic breast cancer
408326|NCT01832051|clinical dilemma|clinical dilemma
408327|NCT01832038|Lacosamide|lacosamide
408328|NCT01832038|Epilepsy|epilepsy
408329|NCT01832038|Partial-onset Seizures|partial-onset seizures
408330|NCT01832025|intraoperative|intraoperative
408331|NCT01832025|postoperative|postoperative
408332|NCT01832025|complications|complications
408333|NCT01832025|discomfort|discomfort
408334|NCT01832025|external|external
408335|NCT01832025|internal|internal
408336|NCT01832025|maxillary|maxillary
408337|NCT01832025|elevation|elevation
408339|NCT01832025|reconstruction|reconstruction
408340|NCT01832025|bone|bone
408341|NCT01832025|sinus|sinus
408470|NCT01831466|skin diseases|skin diseases
408342|NCT01832012|Eliciting which type of refresher provides the greatest improvement in BLS CPR skills.|eliciting which type of refresher provides the greatest improvement in bls cpr skills.
408343|NCT01831999|Web-based|web-based
408344|NCT01831999|HIV Assessment|hiv assessment
408345|NCT01831999|Outreach|outreach
408346|NCT01831999|Retention|retention
408347|NCT01831999|Substance Abuse Treatment|substance abuse treatment
408348|NCT01831986|Schizophrenia|schizophrenia
408349|NCT01831986|Schizoaffective disorder|schizoaffective disorder
408350|NCT01831986|Pregnenolone|pregnenolone
408351|NCT01831986|L-Theanine|l-theanine
408352|NCT01831986|Augmentation|augmentation
408353|NCT01831960|Intrepid|intrepid
408354|NCT01831960|cortexolone|cortexolone
408355|NCT01831960|cortexolone 17α-propionate|cortexolone 17α-propionate
408356|NCT01831960|anti-androgen|anti-androgen
408357|NCT01831947|age-related macular degeneration|age-related macular degeneration
408358|NCT01831947|Ranibizumab|ranibizumab
408359|NCT01831934|Mitochondrial disorder|mitochondrial disorder
408360|NCT01831934|Trivalent inactivated influenza vaccine|trivalent inactivated influenza vaccine
408361|NCT01831934|Adolescents and adults|adolescents and adults
408362|NCT01831934|Immune response|immune response
408363|NCT01831934|Metabolic response|metabolic response
408364|NCT01831921|pre diabetes|pre diabetes
408365|NCT01831921|obesity|obesity
408366|NCT01831921|weight loss|weight loss
408367|NCT01831921|lifestyle|lifestyle
408368|NCT01831921|prevention|prevention
408369|NCT01831908|cardiovascular health, stroke, ischemic heart disease|cardiovascular health, stroke, ischemic heart disease
408370|NCT01831895|Hypertension|hypertension
408371|NCT01831895|Carotid Sinus|carotid sinus
408372|NCT01831869|Subclinical hypothyroidism|subclinical hypothyroidism
408373|NCT01831869|L-thyroxine|l-thyroxine
408374|NCT01831869|Lipid|lipid
408375|NCT01831869|endothelial function|endothelial function
408376|NCT01831869|inflammatory factor|inflammatory factor
408377|NCT01831869|adipocytokine|adipocytokine
408378|NCT01831856|Cardiovascular diseases|cardiovascular diseases
408379|NCT01831856|Chronic Heart Failure|chronic heart failure
408380|NCT01831843|core body temperature|core body temperature
408381|NCT01831843|humidity|humidity
408382|NCT01831843|circuit temperature|circuit temperature
408383|NCT01831830|traumatic brain injury|traumatic brain injury
408384|NCT01831830|occupational therapy|occupational therapy
408385|NCT01831830|family|family
408386|NCT01831804|diabetic foot ulcer|diabetic foot ulcer
408387|NCT01831804|pharmacodynamics|pharmacodynamics
408388|NCT01831804|pharmacokinetics|pharmacokinetics
408389|NCT01831804|ischemic|ischemic
408390|NCT01831791|male pattern hair loss|male pattern hair loss
408391|NCT01831791|hair growth|hair growth
408392|NCT01831791|hair restoration|hair restoration
408393|NCT01831791|Dutasteride|dutasteride
408394|NCT01831791|Androgenetic alopecia|androgenetic alopecia
408395|NCT01831791|safety|safety
408396|NCT01831791|efficacy|efficacy
408397|NCT01831778|mammography|mammography
408398|NCT01831778|screening|screening
408399|NCT01831752|Diabetes|diabetes
408400|NCT01831752|Type 1|type 1
408401|NCT01831752|Continuous glucose monitor|continuous glucose monitor
408402|NCT01831739|Genomics|genomics
408403|NCT01831739|Microbiome|microbiome
408404|NCT01831739|Microflora|microflora
408405|NCT01831739|Virome|virome
408406|NCT01831726|Solid tumor malignancy|solid tumor malignancy
408407|NCT01831726|hematologic malignancy|hematologic malignancy
408408|NCT01831726|mutation|mutation
408409|NCT01831726|translocations|translocations
408410|NCT01831726|FGFR|fgfr
408411|NCT01831726|PDGFR|pdgfr
408412|NCT01831726|VEGF|vegf
408413|NCT01831726|cKIT|ckit
408414|NCT01831726|FLT3|flt3
408415|NCT01831726|CSR1|csr1
408417|NCT01831726|RET|ret
408418|NCT01831726|TKI258|tki258
408419|NCT01831726|dovitinib|dovitinib
408420|NCT01831726|signature|signature
408421|NCT01831726|AML|aml
408422|NCT01831726|acute myelogenous leukemia|acute myelogenous leukemia
408423|NCT01831726|GIST|gist
408424|NCT01831726|gastrointestinal stromal tumor|gastrointestinal stromal tumor
408425|NCT01831726|Head and Neck cancer|head and neck cancer
408426|NCT01831726|Melanoma|melanoma
408427|NCT01831726|NSCLC|nsclc
408428|NCT01831726|non-small cell lung carcinoma|non-small cell lung carcinoma
408429|NCT01831726|lung cancer|lung cancer
408430|NCT01831726|ovarian cancer|ovarian cancer
408431|NCT01831726|thyroid cancer|thyroid cancer
408432|NCT01831726|amplification|amplification
408433|NCT01831648|IGF1|igf1
408434|NCT01831648|standards|standards
408435|NCT01831648|Assays|assays
408436|NCT01831648|Z-score|z-score
408437|NCT01831648|Healthy volunteers|healthy volunteers
408438|NCT01831648|Population|population
408439|NCT01831622|Decision-Making|decision-making
408440|NCT01831622|functional MRI|functional mri
408441|NCT01831622|pharmacological MRI|pharmacological mri
408442|NCT01831622|Reinforcement Learning|reinforcement learning
408443|NCT01831622|Methylphenidate|methylphenidate
408444|NCT01831609|Gastrointestinal|gastrointestinal
408445|NCT01831609|Genitourinary|genitourinary
408446|NCT01831609|Rare Cancer|rare cancer
408447|NCT01831583|sleep apnea|sleep apnea
408448|NCT01831570|Hand osteoarthritis|hand osteoarthritis
408449|NCT01831570|predictive factors|predictive factors
408450|NCT01831570|erosive hand OA|erosive hand oa
408451|NCT01831544|Heart Failure|heart failure
408452|NCT01831518|Heart Failure|heart failure
408453|NCT01831518|Cardiac Resynchronization Therapy|cardiac resynchronization therapy
408454|NCT01831518|ECG Imaging|ecg imaging
408455|NCT01831518|Body Surface Mapping|body surface mapping
408456|NCT01831505|personalized medicine|personalized medicine
408457|NCT01831505|in vivo drug sensitivity|in vivo drug sensitivity
408458|NCT01831505|chemotherapy|chemotherapy
408459|NCT01831505|lymphoma|lymphoma
408460|NCT01831505|microinjection|microinjection
408461|NCT01831492|performance|performance
408462|NCT01831492|acidosis|acidosis
408463|NCT01831492|oxidative stress|oxidative stress
408464|NCT01831492|inflammation|inflammation
408465|NCT01831492|oxygen uptake|oxygen uptake
408466|NCT01831479|Pharmacokinetics, drug-drug interaction|pharmacokinetics, drug-drug interaction
408467|NCT01831466|plaque psoriasis|plaque psoriasis
408468|NCT01831466|vulgaris|vulgaris
408469|NCT01831466|topical treatment|topical treatment
408471|NCT01831466|papulosquamous|papulosquamous
408472|NCT01831466|Tofacitinib|tofacitinib
408473|NCT01831466|CP-690550|cp-690550
408474|NCT01831466|Xeljanz|xeljanz
408475|NCT01831466|psoriasis|psoriasis
408476|NCT01831466|moderate|moderate
408477|NCT01831466|severe|severe
408478|NCT01831466|itch|itch
408479|NCT01831466|nail psoriasis|nail psoriasis
408480|NCT01831453|omega-3|omega-3
408481|NCT01831453|recurrent aphthous stomatitis|recurrent aphthous stomatitis
408482|NCT01831453|quality of life|quality of life
408483|NCT01831440|depression|depression
408484|NCT01831440|remission|remission
408485|NCT01831440|Pharmacotherapy|pharmacotherapy
408486|NCT01831440|psychotherapy|psychotherapy
408487|NCT01831440|neuroimaging|neuroimaging
408488|NCT01831440|psychology|psychology
408489|NCT01831427|ulcerative colitis|ulcerative colitis
408490|NCT01831427|moderate|moderate
408491|NCT01831427|severe|severe
408492|NCT01831414|Lung function|lung function
408493|NCT01831414|Water immersion|water immersion
408494|NCT01831414|Balneotherapy|balneotherapy
408495|NCT01831401|Acetabular component inclination|acetabular component inclination
408496|NCT01831388|Dyspnea|dyspnea
408497|NCT01831388|Breath Training Exercise|breath training exercise
408498|NCT01831388|12-261|12-261
408499|NCT01831336|International|international
408500|NCT01831336|Multicenter|multicenter
408501|NCT01831336|Observational registry|observational registry
408502|NCT01831336|Orsiro Drug Eluting Stent (DES)|orsiro drug eluting stent (des)
408503|NCT01831336|Stenting|stenting
408504|NCT01831336|Treatment of Coronary Artery Disease|treatment of coronary artery disease
408505|NCT01831336|Coronary revascularization|coronary revascularization
408506|NCT01831336|Percutaneous Coronary Intervention|percutaneous coronary intervention
408507|NCT01831336|STEMI|stemi
408508|NCT01831336|NSTEMI|nstemi
408509|NCT01831336|Ischemia|ischemia
408510|NCT01831336|Angina|angina
408511|NCT01831336|Subgroups|subgroups
408512|NCT01831336|Acute Myocardial Infarction|acute myocardial infarction
408513|NCT01831336|Diabetes|diabetes
522296|NCT01338142|women|women
408514|NCT01831336|Small Vessels|small vessels
408515|NCT01831336|Chronic Total Occlusion (CTO)|chronic total occlusion (cto)
408516|NCT01831310|Colorectal cancer|colorectal cancer
408517|NCT01831310|nutrition|nutrition
408518|NCT01831310|neutrophil phagocytosis|neutrophil phagocytosis
408519|NCT01831310|neutrophil adhesivity|neutrophil adhesivity
408520|NCT01831310|glutamine|glutamine
408521|NCT01831310|omega 3 fatty acids|omega 3 fatty acids
408522|NCT01831271|Exercise, Physical|exercise, physical
408523|NCT01831271|Physical Activity|physical activity
408524|NCT01831271|Outcome Measures|outcome measures
408525|NCT01831219|osteoarthritis|osteoarthritis
408526|NCT01831219|arthroplasty|arthroplasty
408527|NCT01831219|hip arthroplasty|hip arthroplasty
408528|NCT01831206|corneal ulcer|corneal ulcer
408529|NCT01831206|keratitis|keratitis
408530|NCT01831180|hair|hair
408531|NCT01831180|scalp|scalp
408532|NCT01831180|blood flow|blood flow
408533|NCT01831180|Caucasian|caucasian
408534|NCT01831180|Histamine stimulation|histamine stimulation
408535|NCT01831180|Wake Forest|wake forest
408536|NCT01831167|dynamic light application|dynamic light application
408537|NCT01831167|sustained attention|sustained attention
408538|NCT01831167|divided attention|divided attention
408539|NCT01831167|nursing|nursing
408540|NCT01831154|Glycemic control|glycemic control
408541|NCT01831141|Congenital Solitary Kidney|congenital solitary kidney
408542|NCT01831141|Glomerular filtration rate|glomerular filtration rate
408543|NCT01831141|Chronic kidney damage|chronic kidney damage
408544|NCT01831141|Hypertension|hypertension
408545|NCT01831141|Proteinuria|proteinuria
408546|NCT01831128|Congestive Heart Failure|congestive heart failure
408547|NCT01831128|Central Sleep Apnea|central sleep apnea
408548|NCT01831128|Sleep-Disordered Breathing|sleep-disordered breathing
408549|NCT01831115|heart failure|heart failure
408550|NCT01831115|BNP|bnp
408551|NCT01831115|acute dyspnoea|acute dyspnoea
408552|NCT01831102|insulin resistance|insulin resistance
408553|NCT01831102|ethnic disparities|ethnic disparities
408554|NCT01831102|adiponectin|adiponectin
408555|NCT01831076|Breast cancer|breast cancer
408556|NCT01831076|estrogen receptor-positive breast cancer|estrogen receptor-positive breast cancer
408557|NCT01831076|progesterone receptor-positive breast cancer|progesterone receptor-positive breast cancer
408558|NCT01831076|Postmenopausal|postmenopausal
408559|NCT01831076|Exemestane|exemestane
408560|NCT01831076|Tamoxifen|tamoxifen
408561|NCT01831063|Seizure|seizure
408562|NCT01831063|Caregivers|caregivers
408563|NCT01831063|Family Centered Care|family centered care
408564|NCT01831063|Learning modality|learning modality
408565|NCT01831050|Poliovirus|poliovirus
408566|NCT01831050|Inactivated poliovirus vaccine|inactivated poliovirus vaccine
408567|NCT01831050|Trivalent oral polio vaccine|trivalent oral polio vaccine
408568|NCT01831050|Bivalent oral polio vaccine|bivalent oral polio vaccine
408569|NCT01831050|Stool shedding index|stool shedding index
408570|NCT01831050|Polio eradication|polio eradication
408571|NCT01831037|Hepatocellular carcinoma|hepatocellular carcinoma
408572|NCT01831037|Regressed cirrhosis|regressed cirrhosis
408573|NCT01831037|Hepatitis C|hepatitis c
408574|NCT01831037|Hepatitis B|hepatitis b
408575|NCT01831037|Noninvasive markers of fibrosis|noninvasive markers of fibrosis
408576|NCT01831037|FibroTest|fibrotest
408577|NCT01831037|FibroSure|fibrosure
408578|NCT01831037|FibroScan|fibroscan
408579|NCT01831037|Transient elastography|transient elastography
408580|NCT01831024|Cold cap|cold cap
408581|NCT01831024|Scalp cooling|scalp cooling
408582|NCT01831024|Chemotherapy induced alopecia|chemotherapy induced alopecia
408583|NCT01831024|Breast cancer|breast cancer
408584|NCT01831011|randomized trial|randomized trial
408585|NCT01831011|acute ischemic stroke|acute ischemic stroke
408586|NCT01831011|mildronate|mildronate
408587|NCT01830998|Dementia|dementia
408588|NCT01830998|Olfactory|olfactory
408589|NCT01830959|Sarcoidosis, fibrosis, bronchiectasis|sarcoidosis, fibrosis, bronchiectasis
408590|NCT01830946|Protein|protein
408591|NCT01830946|Metabolism|metabolism
408592|NCT01830946|Nighttime eating|nighttime eating
408593|NCT01830946|Exercise Training|exercise training
408594|NCT01830933|Breast cancer concern, breast cancer risk perception, breast cancer risk|breast cancer concern, breast cancer risk perception, breast cancer risk
408595|NCT01830920|Acute Kidney Injury|acute kidney injury
408596|NCT01830920|AKI|aki
408597|NCT01830920|Cardiac surgery|cardiac surgery
408598|NCT01830907|Malnutrition|malnutrition
408599|NCT01830907|Gastric cancer|gastric cancer
408600|NCT01830907|preoperative nutrition|preoperative nutrition
408601|NCT01830881|pain|pain
408602|NCT01830881|anxiety|anxiety
408603|NCT01830881|surgical abortion|surgical abortion
408604|NCT01830881|midazolam|midazolam
408605|NCT01830881|benzodiazepine|benzodiazepine
408607|NCT01830868|AED|aed
408608|NCT01830868|Partial Onset Seizures|partial onset seizures
408609|NCT01830868|Retention Rate|retention rate
408610|NCT01830868|Seizure Control|seizure control
408611|NCT01830868|Antiepileptic|antiepileptic
408612|NCT01830868|Secondary generalization|secondary generalization
408613|NCT01830868|Seizure freedom rates|seizure freedom rates
408614|NCT01830842|Nicotine|nicotine
408615|NCT01830842|Smoking|smoking
408616|NCT01830842|Cigarettes|cigarettes
408617|NCT01830842|Reinforcement Learning|reinforcement learning
408618|NCT01830842|fMRI|fmri
408619|NCT01830829|BPH|bph
408620|NCT01830829|CPPS|cpps
408621|NCT01830816|Drug Therapy|drug therapy
408622|NCT01830803|howRU|howru
408623|NCT01830803|howRwe|howrwe
408624|NCT01830803|reliability|reliability
408625|NCT01830803|quality of life|quality of life
408626|NCT01830803|quality of care|quality of care
408627|NCT01830803|patient satisfaction|patient satisfaction
408628|NCT01830751|self treatment technique|self treatment technique
408629|NCT01830751|chronic|chronic
408630|NCT01830751|non specific|non specific
408631|NCT01830751|LBP|lbp
408632|NCT01830751|control trunk flexion|control trunk flexion
408633|NCT01830751|diurnal|diurnal
408634|NCT01830738|laparoscopy|laparoscopy
408635|NCT01830738|hysterectomy|hysterectomy
408636|NCT01830738|single-port trocar|single-port trocar
408637|NCT01830738|surgical technique|surgical technique
408638|NCT01830738|trocar|trocar
408639|NCT01830725|Xanthine Oxidase|xanthine oxidase
408640|NCT01830725|Gout|gout
408641|NCT01830725|Hyperuricemia|hyperuricemia
408642|NCT01830725|SNP|snp
408643|NCT01830725|Single Nucleotide Polymorphisms|single nucleotide polymorphisms
408644|NCT01830699|Rilonacept|rilonacept
408645|NCT01830699|Subacromial Bursitis treatment|subacromial bursitis treatment
408646|NCT01830699|Corticosteroid Injection|corticosteroid injection
408647|NCT01830686|Sugarcane bagasse, glucose tolerance, insulin resistance|sugarcane bagasse, glucose tolerance, insulin resistance
408648|NCT01830673|T-regulatory cells|t-regulatory cells
408649|NCT01830673|TH1, TH2 cells|th1, th2 cells
408650|NCT01830673|specific IgE|specific ige
408651|NCT01830673|specific IgG|specific igg
408652|NCT01830673|specific IgG4|specific igg4
408653|NCT01830673|IL2|il2
408654|NCT01830673|IL5|il5
408655|NCT01830673|IL10|il10
408656|NCT01830673|IL12/23|il12/23
408657|NCT01830673|Y-IFN|y-ifn
408658|NCT01830673|TNF-a|tnf-a
408659|NCT01830634|Community-dwelling elderly|community-dwelling elderly
408660|NCT01830634|Rehabilitation|rehabilitation
408661|NCT01830634|Theraband|theraband
408662|NCT01830634|Strengthening and stretching exercise|strengthening and stretching exercise
408663|NCT01830582|MRI|mri
408664|NCT01830582|rectum|rectum
408665|NCT01830582|13-019|13-019
408666|NCT01830569|Decision Support Systems, Clinical|decision support systems, clinical
408667|NCT01830569|Evidence-Based practice|evidence-based practice
408668|NCT01830569|Family Practice|family practice
408669|NCT01830543|Atrial Fibrillation|atrial fibrillation
408670|NCT01830543|Irregular heart beat|irregular heart beat
408671|NCT01830543|rivaroxaban|rivaroxaban
408672|NCT01830543|aspirin|aspirin
408673|NCT01830543|clopidogrel|clopidogrel
408674|NCT01830543|prasugrel|prasugrel
408675|NCT01830543|ticagrelor|ticagrelor
408676|NCT01830543|vitamin K antagonist|vitamin k antagonist
408677|NCT01830530|arterial hypertension|arterial hypertension
408678|NCT01830530|high altitude|high altitude
408679|NCT01830530|hypobaric hypoxia|hypobaric hypoxia
408680|NCT01830530|combination treatment|combination treatment
408681|NCT01830530|angiotensin receptor blocker|angiotensin receptor blocker
408682|NCT01830530|calcium antagonist|calcium antagonist
408683|NCT01830504|thyroid cancers|thyroid cancers
408684|NCT01830504|refractory|refractory
408685|NCT01830504|PI3K inhibitor|pi3k inhibitor
408686|NCT01830465|Non Hodgkin's Follicular Lymphoma|non hodgkin's follicular lymphoma
408687|NCT01830465|relapsed|relapsed
408688|NCT01830465|progressed|progressed
408689|NCT01830452|Chronic pain|chronic pain
408690|NCT01830452|Progrip Mesh|progrip mesh
408691|NCT01830452|Self gripping mesh|self gripping mesh
408692|NCT01830452|Lichtenstein|lichtenstein
408693|NCT01830439|tuberculosis|tuberculosis
408694|NCT01830439|PK|pk
408695|NCT01830439|PA-824|pa-824
408696|NCT01830439|food effect|food effect
408697|NCT01830439|pretomanid|pretomanid
408698|NCT01830439|CL-009|cl-009
408699|NCT01830413|stent, systematic Intracranial artery stenosis|stent, systematic intracranial artery stenosis
408700|NCT01830400|ESL|esl
408701|NCT01830400|Partial onset seizures|partial onset seizures
408702|NCT01830400|Retention Rate|retention rate
408703|NCT01830400|Seizure Control|seizure control
408704|NCT01830400|Antiepileptic|antiepileptic
408705|NCT01830400|Secondary Generalisation|secondary generalisation
408706|NCT01830387|Polymetric Clips (Hem-o-Lok)|polymetric clips (hem-o-lok)
408707|NCT01830387|Laparoscopic Appendectomy|laparoscopic appendectomy
408708|NCT01830387|Endoscopic Staplers|endoscopic staplers
408709|NCT01830374|Bulimia nervosa|bulimia nervosa
408710|NCT01830374|Eating disorder|eating disorder
408711|NCT01830374|Weight suppression|weight suppression
408712|NCT01830374|Dieting|dieting
408713|NCT01830361|AML|aml
408714|NCT01830361|Acute Myeloid Leukemia|acute myeloid leukemia
522555|NCT01337232|syntax|syntax
408715|NCT01830361|c-KIT|c-kit
408716|NCT01830361|FLT3-ITD|flt3-itd
408717|NCT01830361|t(8;21)|t(8;21)
408718|NCT01830361|chemotherapy|chemotherapy
408719|NCT01830361|midostaurin|midostaurin
408720|NCT01830348|diabetic foot ulcers|diabetic foot ulcers
408721|NCT01830348|Wagner Grade 1 or 2 foot ulcers|wagner grade 1 or 2 foot ulcers
408722|NCT01830322|metastatic|metastatic
408723|NCT01830322|pancreatic|pancreatic
408724|NCT01830322|adenocarcinoma|adenocarcinoma
408725|NCT01830322|cancer|cancer
408726|NCT01830309|Food-Effect|food-effect
408727|NCT01830309|Pharmacokinetics|pharmacokinetics
408728|NCT01830309|Pharmacodynamics|pharmacodynamics
408729|NCT01830296|Postthoracotomy pain,|postthoracotomy pain,
408730|NCT01830296|patient controlled analgesia,|patient controlled analgesia,
408731|NCT01830296|remifentanil and|remifentanil and
408732|NCT01830296|morphine.|morphine.
408733|NCT01830270|medical oncology|medical oncology
408734|NCT01830270|chemotherapy optimization|chemotherapy optimization
408735|NCT01830270|dose density|dose density
408736|NCT01830244|chemotherapy|chemotherapy
408737|NCT01830244|nab paclitaxel|nab paclitaxel
408738|NCT01830244|neoadjuvant therapy|neoadjuvant therapy
408739|NCT01830244|breast cancer|breast cancer
408740|NCT01830244|pathologic complete response|pathologic complete response
408741|NCT01830231|TCCU|tccu
408742|NCT01830231|Vinflunine|vinflunine
408743|NCT01830231|Cabazitaxel|cabazitaxel
408744|NCT01830231|Metastatic|metastatic
408745|NCT01830231|Locally advance|locally advance
408746|NCT01830192|endometrial cancer|endometrial cancer
408747|NCT01830192|score|score
408748|NCT01830192|nomogram|nomogram
408749|NCT01830192|ultrasound|ultrasound
408750|NCT01830192|HE4|he4
408751|NCT01830153|Soft tissue sarcomas|soft tissue sarcomas
408752|NCT01830153|Bone sarcomas|bone sarcomas
408753|NCT01830153|RAD001|rad001
408957|NCT01829061|HbA1C|hba1c
408754|NCT01830153|Refractory to conventional chemotherapy|refractory to conventional chemotherapy
408755|NCT01830114|alcohol abuse|alcohol abuse
408756|NCT01830114|drug abuse|drug abuse
408757|NCT01830114|hazardous alcohol use|hazardous alcohol use
408758|NCT01830114|hazardous drug use|hazardous drug use
408759|NCT01830101|recurrent glioblastoma|recurrent glioblastoma
408760|NCT01830101|re-irradiation|re-irradiation
408761|NCT01830101|continuous low-dose temozolomide|continuous low-dose temozolomide
408762|NCT01830036|cardiological treatment|cardiological treatment
408763|NCT01830036|sleep Apnea|sleep apnea
408764|NCT01830023|cardiac ultrasound|cardiac ultrasound
408765|NCT01830023|vitality|vitality
408766|NCT01830023|data|data
408767|NCT01830023|patients|patients
408768|NCT01830023|examined|examined
408769|NCT01829984|Injection Teaching|injection teaching
408770|NCT01829984|13-057|13-057
408771|NCT01829971|microRNA|microrna
408772|NCT01829971|Advanced cancer|advanced cancer
408773|NCT01829958|Geriatric|geriatric
408774|NCT01829958|Toxicity|toxicity
408775|NCT01829958|rituximab|rituximab
408776|NCT01829958|prednisone|prednisone
408777|NCT01829958|Comprehensive Geriatric Assessment (CGA)|comprehensive geriatric assessment (cga)
408778|NCT01829958|13-028|13-028
408779|NCT01829932|Diet|diet
408780|NCT01829919|Menopause|menopause
408781|NCT01829919|Hot flashes|hot flashes
408782|NCT01829919|Vasomotor symptoms|vasomotor symptoms
408783|NCT01829919|Climacteric symptoms|climacteric symptoms
408784|NCT01829919|perimenopause|perimenopause
408785|NCT01829919|Mesafem|mesafem
408786|NCT01829919|Brisdelle|brisdelle
408787|NCT01829919|Low-Dose Mesylate salt of Paroxetine (LDMP)|low-dose mesylate salt of paroxetine (ldmp)
408788|NCT01829906|weight loss|weight loss
408789|NCT01829906|bariatric surgery|bariatric surgery
408790|NCT01829906|gastric bypass|gastric bypass
408791|NCT01829906|health education|health education
408792|NCT01829906|nutrition therapy|nutrition therapy
408793|NCT01829906|diet|diet
408794|NCT01829906|exercise|exercise
408795|NCT01829906|cognitive therapy|cognitive therapy
408796|NCT01829893|Benign Prostatic Hyperplasia (BPH)|benign prostatic hyperplasia (bph)
408797|NCT01829893|pharmacokinetics|pharmacokinetics
408798|NCT01829893|bioequivalence|bioequivalence
408799|NCT01829893|finasteirde|finasteirde
408800|NCT01829893|tamsulosin|tamsulosin
408801|NCT01829880|Chronic heart failure|chronic heart failure
408802|NCT01829880|Bisoprolol|bisoprolol
408803|NCT01829880|Ramipril|ramipril
408804|NCT01829880|Pharmacokinetic|pharmacokinetic
408805|NCT01829880|Cachexia|cachexia
408806|NCT01829880|Body composition|body composition
408807|NCT01829880|Renal function|renal function
408808|NCT01829880|Iohexol|iohexol
408809|NCT01829841|MRCC|mrcc
408810|NCT01829841|Metastatic Renal Cell Cancer|metastatic renal cell cancer
408811|NCT01829841|Famitinib|famitinib
408812|NCT01829841|Sunitinib|sunitinib
408813|NCT01829828|Pain|pain
408814|NCT01829828|Cancer pain|cancer pain
408815|NCT01829828|Self-reported pain scoring tool|self-reported pain scoring tool
710220|NCT00589667|PEMETREXED|pemetrexed
408816|NCT01829828|Opioid analgesics|opioid analgesics
408817|NCT01829815|Child|child
408818|NCT01829815|Parents|parents
408819|NCT01829815|Parenting|parenting
408820|NCT01829815|Child Development|child development
408821|NCT01829815|Parent Child Relations|parent child relations
408822|NCT01829815|Malaria|malaria
408823|NCT01829815|Primary Prevention|primary prevention
408824|NCT01829815|Punishment|punishment
408825|NCT01829815|Education|education
408826|NCT01829802|HIV|hiv
408827|NCT01829802|Raltegravir|raltegravir
408828|NCT01829802|Boosted atazanavir|boosted atazanavir
408829|NCT01829789|Adolescents|adolescents
408830|NCT01829789|Teens|teens
408831|NCT01829789|Parents|parents
408832|NCT01829789|Parenting|parenting
408833|NCT01829789|Substance Abuse|substance abuse
408834|NCT01829789|Treatment Efficacy|treatment efficacy
408835|NCT01829776|Accidental falls|accidental falls
408836|NCT01829776|Multiple Sclerosis|multiple sclerosis
408837|NCT01829776|Education|education
408838|NCT01829776|Exercise|exercise
408839|NCT01829776|Postural balance|postural balance
408840|NCT01829750|Univentricular heart|univentricular heart
408841|NCT01829737|Asymptomatic Parasitemia|asymptomatic parasitemia
408842|NCT01829737|RBC Polymorphism|rbc polymorphism
408843|NCT01829737|Acquired Immunity|acquired immunity
408844|NCT01829724|Functional Brain Imaging|functional brain imaging
408845|NCT01829724|Cerebral Palsy|cerebral palsy
408846|NCT01829724|Motion Analysis|motion analysis
408847|NCT01829724|Macro- EMG|macro- emg
408848|NCT01829711|Moxetumomab Pasudotox|moxetumomab pasudotox
408849|NCT01829711|CAT-8015|cat-8015
408850|NCT01829711|Anti-cd22 recombinant immunotoxin|anti-cd22 recombinant immunotoxin
408851|NCT01829711|Biologic Therapy|biologic therapy
408852|NCT01829711|Monoclonal Antibody|monoclonal antibody
408853|NCT01829711|Pseudomonas Exotoxin|pseudomonas exotoxin
408854|NCT01829711|Targeted Therapy|targeted therapy
408855|NCT01829698|tudca PBC Cholestasis tauroursodeoxycholic acid taurolite|tudca pbc cholestasis tauroursodeoxycholic acid taurolite
408956|NCT01829061|Type II Diabetes|type ii diabetes
408856|NCT01829672|Early diagnosis of pulmonary arterial hypertension|early diagnosis of pulmonary arterial hypertension
408857|NCT01829672|dynamic dual-energy computed tomography|dynamic dual-energy computed tomography
408858|NCT01829646|DWI|dwi
408859|NCT01829646|DCE MRI|dce mri
408860|NCT01829646|ADC|adc
408861|NCT01829646|FDG PET|fdg pet
408862|NCT01829646|Hypoxia|hypoxia
408863|NCT01829646|Prognostic and predictive model|prognostic and predictive model
408864|NCT01829620|suicide|suicide
408865|NCT01829620|suicide intervention|suicide intervention
408866|NCT01829620|suicide prevention|suicide prevention
408867|NCT01829620|military|military
408868|NCT01829620|military suicide|military suicide
408869|NCT01829620|caring letters|caring letters
408870|NCT01829620|caring contacts|caring contacts
408871|NCT01829620|text messages|text messages
408872|NCT01829594|Case Management|case management
408873|NCT01829594|Frail Elderly|frail elderly
408874|NCT01829594|Health Services Administration|health services administration
408875|NCT01829594|Delivery of Health Care|delivery of health care
408876|NCT01829594|Accidental Falls|accidental falls
408877|NCT01829594|Health Status|health status
408878|NCT01829594|Health Care Economics|health care economics
408879|NCT01829542|flow-mediated dilation|flow-mediated dilation
408880|NCT01829542|blueberry polyphenols|blueberry polyphenols
408881|NCT01829542|dose-dependency|dose-dependency
408882|NCT01829529|Antibiotic prophylaxis|antibiotic prophylaxis
408883|NCT01829503|Phase II|phase ii
408884|NCT01829503|decitabine|decitabine
408885|NCT01829503|cytarabine|cytarabine
408886|NCT01829503|older patients|older patients
408887|NCT01829503|newly diagnosed|newly diagnosed
408888|NCT01829503|AML|aml
408889|NCT01829503|Newly Diagnosed AML|newly diagnosed aml
408890|NCT01829490|Vaccine|vaccine
408891|NCT01829490|Immunogenicity|immunogenicity
408892|NCT01829477|Drug Therapy|drug therapy
408893|NCT01829464|Drug Therapy|drug therapy
408894|NCT01829438|exercise tolerance|exercise tolerance
408895|NCT01829438|6MWT|6mwt
408896|NCT01829425|Hypnosis|hypnosis
408897|NCT01829425|Mind-Body Therapy|mind-body therapy
408898|NCT01829425|Anticholinergics|anticholinergics
408899|NCT01829425|Female Urogenital Diseases|female urogenital diseases
408900|NCT01829399|Tourniquet pain|tourniquet pain
408901|NCT01829399|Subcutaneous axillary local anesthetic|subcutaneous axillary local anesthetic
408902|NCT01829399|ability to tolerate tourniquet discomfort.|ability to tolerate tourniquet discomfort.
408903|NCT01829373|lung cancer|lung cancer
408904|NCT01829347|liver failure|liver failure
408905|NCT01829347|acute alcoholic hepatitis|acute alcoholic hepatitis
408906|NCT01829347|patients failing steroid therapy|patients failing steroid therapy
408907|NCT01829347|alcoholic hepatitis|alcoholic hepatitis
408908|NCT01829347|steroid failure|steroid failure
408909|NCT01829347|Lille criteria|lille criteria
408910|NCT01829347|ELAD|elad
408911|NCT01829334|dental caries|dental caries
408912|NCT01829308|implementation|implementation
408913|NCT01829308|SBIRT|sbirt
710221|NCT00589667|ALTIMA|altima
408914|NCT01829308|alcohol screening|alcohol screening
408915|NCT01829308|drug screening|drug screening
408916|NCT01829308|Brief Intervention|brief intervention
408917|NCT01829308|Referral to Treatment|referral to treatment
408918|NCT01829308|adolescents|adolescents
408919|NCT01829308|Federally Qualified Health Centers|federally qualified health centers
408920|NCT01829295|antimetabolite, noninfectious|antimetabolite, noninfectious
408921|NCT01829282|Implementation|implementation
408922|NCT01829282|HIV|hiv
408923|NCT01829282|serodiscordant couples|serodiscordant couples
408924|NCT01829282|African American|african american
408925|NCT01829282|Cultural congruency|cultural congruency
408926|NCT01829243|Milnacipran|milnacipran
408927|NCT01829243|Fibromyalgia|fibromyalgia
408928|NCT01829243|Neurocognition|neurocognition
408929|NCT01829178|cisplatin|cisplatin
408930|NCT01829178|nephrotoxicity|nephrotoxicity
408931|NCT01829178|antioxidant|antioxidant
408932|NCT01829178|urine neutrophil gelatinase-associated lipocalin (NGAL)|urine neutrophil gelatinase-associated lipocalin (ngal)
408933|NCT01829152|heart failure|heart failure
408934|NCT01829139|Common bile duct stone|common bile duct stone
408935|NCT01829139|Gallbladder in situ|gallbladder in situ
408936|NCT01829139|Choleretics|choleretics
408937|NCT01829113|Recurrent Lung Cancer|recurrent lung cancer
408938|NCT01829113|Stage IV Lung Cancer|stage iv lung cancer
408939|NCT01829113|OGX-427|ogx-427
408940|NCT01829113|Sarah Cannon Research Institute|sarah cannon research institute
408941|NCT01829113|SCRI|scri
408942|NCT01829113|OncoGenex|oncogenex
408943|NCT01829113|NSCLC|nsclc
408944|NCT01829113|Non Small Cell Lung Cancer|non small cell lung cancer
408945|NCT01829100|Adolescent|adolescent
408946|NCT01829100|Transdiagnostic therapy|transdiagnostic therapy
408947|NCT01829100|Behavioral activation|behavioral activation
408948|NCT01829100|Exposure therapy|exposure therapy
408949|NCT01829100|Depressive Disorder|depressive disorder
408950|NCT01829100|Anxiety Disorders|anxiety disorders
408951|NCT01829074|Laryngopharyngeal Reflux|laryngopharyngeal reflux
408952|NCT01829074|Hoarseness|hoarseness
408953|NCT01829074|Throat Clearing|throat clearing
408954|NCT01829074|Globus Sensation|globus sensation
408955|NCT01829061|Type I Diabetes|type i diabetes
408958|NCT01829048|PF-02545920|pf-02545920
408959|NCT01829048|safety|safety
408960|NCT01829048|schizophrenia|schizophrenia
408961|NCT01829035|TACE|tace
408962|NCT01829035|Sorafenib|sorafenib
408963|NCT01829022|Myoma|myoma
408964|NCT01829022|Uterine myomectomy|uterine myomectomy
408965|NCT01829009|Sarcopenia|sarcopenia
408966|NCT01829009|Elderly|elderly
408967|NCT01829009|Women|women
408968|NCT01829009|Resistance|resistance
408969|NCT01829009|Exercise|exercise
408970|NCT01828996|Chronic pelvic pain syndrome|chronic pelvic pain syndrome
408971|NCT01828996|Chronic prostatitis|chronic prostatitis
408972|NCT01828996|Shock wave therapy|shock wave therapy
408973|NCT01828996|Prostate|prostate
408974|NCT01828996|Pelvic floor|pelvic floor
408975|NCT01828996|Pain|pain
408976|NCT01828983|Telephone|telephone
408977|NCT01828983|Support groups|support groups
408978|NCT01828983|Social support|social support
408979|NCT01828983|Depression|depression
408980|NCT01828970|Diabetes Mellitus|diabetes mellitus
408981|NCT01828970|Hemodialysis|hemodialysis
408982|NCT01828970|Continuous glucose monitoring|continuous glucose monitoring
408983|NCT01828970|Insulin analogues|insulin analogues
408984|NCT01828957|Human Umbilical Cord Blood Derived Mesenchymal Stem Cells|human umbilical cord blood derived mesenchymal stem cells
408985|NCT01828957|Bronchopulmonary dysplasia|bronchopulmonary dysplasia
408986|NCT01828957|Premature infants|premature infants
408987|NCT01828944|Vitamin D|vitamin d
408988|NCT01828944|bone loss|bone loss
408989|NCT01828918|early diagnosis|early diagnosis
408990|NCT01828918|prediction|prediction
408991|NCT01828918|prognosis|prognosis
408992|NCT01828905|tibia fracture|tibia fracture
408993|NCT01828905|bone graft|bone graft
408994|NCT01828905|iliac crest|iliac crest
408995|NCT01828905|bone graft substitute|bone graft substitute
408996|NCT01828905|Cerament|cerament
408997|NCT01828905|void filler|void filler
408998|NCT01828905|quality of life|quality of life
408999|NCT01828905|pain|pain
409000|NCT01828905|costs of care|costs of care
409001|NCT01828892|Autologous platelet rich fibrin glue|autologous platelet rich fibrin glue
409002|NCT01828892|Enterocutaneous fistulas|enterocutaneous fistulas
409003|NCT01828892|Single low output GI fistulas|single low output gi fistulas
409004|NCT01828879|Dermatitis, Atopic|dermatitis, atopic
409005|NCT01828879|Tacrolimus|tacrolimus
409006|NCT01828866|EMDR|emdr
409007|NCT01828866|Alcohol|alcohol
409008|NCT01828866|Relapse|relapse
409009|NCT01828866|Craving|craving
409010|NCT01828853|Membrane sweeping|membrane sweeping
409011|NCT01828853|Membrane stripping|membrane stripping
409012|NCT01828853|Maternal outcomes|maternal outcomes
409013|NCT01828853|Neonatal outcomes|neonatal outcomes
409014|NCT01828840|morphine|morphine
409015|NCT01828840|fentanyl|fentanyl
409016|NCT01828840|methadone|methadone
409017|NCT01828840|epidural|epidural
409018|NCT01828840|intravenous|intravenous
409019|NCT01828840|pain|pain
409020|NCT01828840|analgesia|analgesia
409021|NCT01828827|tuberculosis|tuberculosis
409022|NCT01828827|PK|pk
409023|NCT01828827|PA-824|pa-824
409024|NCT01828827|food effect,|food effect,
409025|NCT01828827|bioavailability|bioavailability
409026|NCT01828827|pretomanid|pretomanid
409027|NCT01828827|CL-003|cl-003
409028|NCT01828814|pediatrics|pediatrics
409029|NCT01828814|Ready-to-use Supplementary Food|ready-to-use supplementary food
409030|NCT01828814|corn soy blend|corn soy blend
409031|NCT01828814|cash transfer|cash transfer
409032|NCT01828814|prevention of malnutrition|prevention of malnutrition
409033|NCT01828814|Niger|niger
409034|NCT01828801|Adverse Local Tissue Reaction|adverse local tissue reaction
409035|NCT01828801|Metal Ions|metal ions
409036|NCT01828801|Serum|serum
409037|NCT01828801|Whole Blood|whole blood
409038|NCT01828801|Metal-on-Metal|metal-on-metal
409039|NCT01828801|Total Hip Arthroplasty|total hip arthroplasty
409040|NCT01828788|Sternotomy|sternotomy
409041|NCT01828788|Anesthesia|anesthesia
409042|NCT01828788|Post-operative pain|post-operative pain
409043|NCT01828762|DC|dc
409044|NCT01828762|Immunotherapy|immunotherapy
409045|NCT01828762|TC|tc
409046|NCT01828749|blunt abdominal trauma|blunt abdominal trauma
409047|NCT01828749|CT|ct
409048|NCT01828749|radiation exposure, pediatric|radiation exposure, pediatric
409049|NCT01828736|Urothelial carcinoma|urothelial carcinoma
409050|NCT01828736|Trastuzumab|trastuzumab
409051|NCT01828736|Treatment|treatment
409052|NCT01828723|Autologous Adult Stem Cell|autologous adult stem cell
409053|NCT01828723|Adipose Derived Stem Cell|adipose derived stem cell
409054|NCT01828723|Stromal Vascular Fraction|stromal vascular fraction
409055|NCT01828723|SVF|svf
409056|NCT01828723|Antria|antria
409057|NCT01828723|Shah Rahimian|shah rahimian
409058|NCT01828723|Leonard Maliver|leonard maliver
409059|NCT01828723|David Bizousky|david bizousky
409060|NCT01828723|Rahul Gore|rahul gore
409061|NCT01828723|Lee Quist|lee quist
409062|NCT01828723|Dudley McNitt|dudley mcnitt
409063|NCT01828710|Myo-inositol|myo-inositol
409064|NCT01828710|oligoasthenoteratospermia|oligoasthenoteratospermia
409065|NCT01828710|semen parameters|semen parameters
409066|NCT01828710|IVF|ivf
409067|NCT01828697|Low-molecular-weight heparin|low-molecular-weight heparin
409068|NCT01828697|Pregnancy|pregnancy
409069|NCT01828697|Venous thrombosis|venous thrombosis
409070|NCT01828684|Migraine with Aura|migraine with aura
409071|NCT01828684|Migraine without Aura|migraine without aura
409072|NCT01828684|Photophobia|photophobia
409073|NCT01828684|Chronic Daily Headache|chronic daily headache
409074|NCT01828671|Soy|soy
409075|NCT01828671|Corn|corn
409076|NCT01828671|Flour|flour
409077|NCT01828671|Tortilla|tortilla
409078|NCT01828671|Glycemic|glycemic
409079|NCT01828671|Glucose,|glucose,
409080|NCT01828671|glycemic index|glycemic index
409081|NCT01828658|hemodialysis|hemodialysis
409082|NCT01828658|fluid management|fluid management
409083|NCT01828658|bioimpedance|bioimpedance
409084|NCT01828658|mortality|mortality
409085|NCT01828658|arterial stiffness|arterial stiffness
409086|NCT01828645|gastric emptying|gastric emptying
409087|NCT01828645|whey protein|whey protein
409088|NCT01828645|carbohydrate|carbohydrate
409089|NCT01828645|fasting|fasting
409090|NCT01828632|Obesity, Morbid; Hypoxemia; Postoperative complications; Bariatric surgery; Respiratory physical therapy; Preoperative care.|obesity, morbid; hypoxemia; postoperative complications; bariatric surgery; respiratory physical therapy; preoperative care.
409091|NCT01828619|Hematopoietic Stem Cell Transplantation|hematopoietic stem cell transplantation
409092|NCT01828619|Busulfan|busulfan
409093|NCT01828619|Fludarabine|fludarabine
409094|NCT01828606|leg lymphedema|leg lymphedema
409095|NCT01828606|volume measurement|volume measurement
409096|NCT01828606|compression therapy|compression therapy
409097|NCT01828606|interface pressure|interface pressure
409098|NCT01828606|static stiffness index (SSI)|static stiffness index (ssi)
409099|NCT01828606|volume change|volume change
409100|NCT01828580|laparoscopic Cholecystectomy|laparoscopic cholecystectomy
409101|NCT01828580|Gallbladder removal|gallbladder removal
409102|NCT01828580|laparoscope holder|laparoscope holder
409103|NCT01828567|veterans|veterans
409104|NCT01828567|health risk assessment|health risk assessment
409105|NCT01828567|primary prevention|primary prevention
409106|NCT01828567|shared decision making|shared decision making
409107|NCT01828567|Healthy Living Assessment|healthy living assessment
409108|NCT01828554|Capecitabine pharmacokinetics PK|capecitabine pharmacokinetics pk
409109|NCT01828554|Elevated Body Mass Index (BMI)|elevated body mass index (bmi)
409110|NCT01828554|Advanced Solid Tumors|advanced solid tumors
409111|NCT01828541|Burn injuries|burn injuries
409112|NCT01828528|Nonalcoholic fatty liver disease|nonalcoholic fatty liver disease
409113|NCT01828528|Nonalcoholic steatohepatitis|nonalcoholic steatohepatitis
409114|NCT01828528|Obesity|obesity
409115|NCT01828528|Bariatric surgery|bariatric surgery
409116|NCT01828528|Weight loss|weight loss
409117|NCT01828502|Cotinine|cotinine
409118|NCT01828502|Secondhand Smoke Exposure (SHSE)|secondhand smoke exposure (shse)
409119|NCT01828502|Secondhand Smoke (SHS)|secondhand smoke (shs)
409120|NCT01828476|prostate cancer|prostate cancer
409121|NCT01828476|hormone-resistant prostate cancer|hormone-resistant prostate cancer
409122|NCT01828476|recurrent prostate cancer|recurrent prostate cancer
409123|NCT01828476|stage IV prostate cancer|stage iv prostate cancer
409124|NCT01828424|acute pain|acute pain
409125|NCT01828411|Cardiac surgery|cardiac surgery
409126|NCT01828411|Echocardiography|echocardiography
409127|NCT01828411|Cerebral perfusion|cerebral perfusion
409128|NCT01828411|Intraoperative period|intraoperative period
409129|NCT01828385|Physiological Effects of Drugs|physiological effects of drugs
409130|NCT01828385|Rocuronium|rocuronium
409131|NCT01828385|Sugammadex sodium|sugammadex sodium
409132|NCT01828385|Magnesium|magnesium
409133|NCT01828385|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action
409134|NCT01828385|Neuromuscular block, antagonism|neuromuscular block, antagonism
409135|NCT01828385|Pharmacologic Actions|pharmacologic actions
409136|NCT01828372|concomitant diseases|concomitant diseases
409137|NCT01828372|multiple drug consumption|multiple drug consumption
409138|NCT01828372|therapeutic drug monitoring|therapeutic drug monitoring
409139|NCT01828372|TDM|tdm
409140|NCT01828372|drug monitoring|drug monitoring
409141|NCT01828372|drug level|drug level
409142|NCT01828372|quantification|quantification
409143|NCT01828372|drug|drug
409144|NCT01828372|drug concentration|drug concentration
409145|NCT01828372|concentration|concentration
409146|NCT01828372|therapeutic range|therapeutic range
409147|NCT01828372|therapeutic index|therapeutic index
409148|NCT01828346|TL32711|tl32711
409149|NCT01828346|Birinapant|birinapant
409150|NCT01828346|5-Azacitidine|5-azacitidine
409151|NCT01828346|Myelodysplastic syndrome|myelodysplastic syndrome
409152|NCT01828346|MDS|mds
409153|NCT01828346|Relapsed|relapsed
409154|NCT01828346|Refractory|refractory
409155|NCT01828346|Failed|failed
409156|NCT01828346|open-label|open-label
409157|NCT01828346|non-Randomized|non-randomized
409158|NCT01828346|dose-escalation|dose-escalation
409159|NCT01828346|dose-expansion|dose-expansion
409160|NCT01828333|Malaria|malaria
409161|NCT01828333|Severe|severe
409162|NCT01828333|Artesunate|artesunate
409163|NCT01828333|Quinine|quinine
409164|NCT01828333|Democratic Republic of Congo|democratic republic of congo
409165|NCT01828320|Risk: Emotional, Cognitive, Behavioral, Social, Physical|risk: emotional, cognitive, behavioral, social, physical
409166|NCT01828294|MG|mg
409167|NCT01828268|HIV|hiv
409168|NCT01828268|Metabolomics Fingerprinting|metabolomics fingerprinting
409169|NCT01828242|HbA1C|hba1c
409170|NCT01828229|Inactivity|inactivity
409171|NCT01828229|Obesity|obesity
409172|NCT01828229|Type 2 diabetes|type 2 diabetes
409173|NCT01828229|glucose metabolism|glucose metabolism
409174|NCT01828229|Lipid metabolism|lipid metabolism
409175|NCT01828229|Cognitive function|cognitive function
409176|NCT01828203|minocycline|minocycline
409177|NCT01828203|randomized control trial|randomized control trial
409178|NCT01828203|phase 3|phase 3
409179|NCT01828203|spinal cord injury|spinal cord injury
409180|NCT01828190|crohn's disease|crohn's disease
409181|NCT01828190|perianal fistulas|perianal fistulas
409182|NCT01828190|TNF alpha blockers|tnf alpha blockers
409183|NCT01828190|hyperbaric oxygen therapy|hyperbaric oxygen therapy
409184|NCT01828177|PreCision|precision
409185|NCT01828177|PDI-320|pdi-320
409186|NCT01828177|Foam|foam
409187|NCT01828164|Orthodontics|orthodontics
409188|NCT01828164|Braces|braces
409189|NCT01828164|Tooth|tooth
409190|NCT01828151|Pressure ulcer|pressure ulcer
409191|NCT01828151|Noninvasive ventilation|noninvasive ventilation
409192|NCT01828138|Proteinuria|proteinuria
409193|NCT01828138|Pregnancy|pregnancy
409194|NCT01828138|Hypertension|hypertension
409195|NCT01828138|Plasmin|plasmin
409196|NCT01828138|Plasminogen|plasminogen
409197|NCT01828138|Aldosterone|aldosterone
409198|NCT01828138|Angiotensin|angiotensin
409199|NCT01828138|Renin|renin
409200|NCT01828138|sodium chloride|sodium chloride
409201|NCT01828138|epithelial sodium channel|epithelial sodium channel
409202|NCT01828138|Placenta|placenta
409203|NCT01828125|Type 1 diabetes|type 1 diabetes
409204|NCT01828125|Hypoglycemia|hypoglycemia
409205|NCT01828125|Glucagon|glucagon
409206|NCT01828125|Hypoglycaemic hyperinsulinemic clamp|hypoglycaemic hyperinsulinemic clamp
409207|NCT01828112|Non-Small Cell Lung Cancer|non-small cell lung cancer
409208|NCT01828112|ALK|alk
409209|NCT01828112|LDK378|ldk378
409210|NCT01828112|Non-small cell lung carcinoma (NSCLC)|non-small cell lung carcinoma (nsclc)
409211|NCT01828112|treatment of lung cancer after first metastasis|treatment of lung cancer after first metastasis
409212|NCT01828112|lung cancer|lung cancer
409213|NCT01828112|lung adenocarcinoma|lung adenocarcinoma
409214|NCT01828112|Non small cell lung carcinoma|non small cell lung carcinoma
409215|NCT01828112|Non small cell lung cancer|non small cell lung cancer
409216|NCT01828112|NSCLC|nsclc
409217|NCT01828112|chemotherapy|chemotherapy
409218|NCT01828112|ALK-positive|alk-positive
409219|NCT01828112|ALK-rearranged advanced non-small cell lung cancer|alk-rearranged advanced non-small cell lung cancer
409220|NCT01828112|crizotinib|crizotinib
409221|NCT01828099|Non-Small Cell Lung Cancer|non-small cell lung cancer
409222|NCT01828099|NSCLC|nsclc
409223|NCT01828099|ALK|alk
409224|NCT01828099|LDK378|ldk378
409225|NCT01828099|Non-small cell lung carcinoma (NSCLC)|non-small cell lung carcinoma (nsclc)
409226|NCT01828099|treatment of lung cancer after first metastasis|treatment of lung cancer after first metastasis
409227|NCT01828099|lung cancer|lung cancer
409228|NCT01828099|lung adenocarcinoma|lung adenocarcinoma
409229|NCT01828099|Non small cell lung carcinoma|non small cell lung carcinoma
409230|NCT01828099|Non small cell lung cancer|non small cell lung cancer
409231|NCT01828099|non-squamous non-small cell lung cancer|non-squamous non-small cell lung cancer
409232|NCT01828086|Psoriasis, chronic plaque-type psoriasis, IL17, monoclonal antibody|psoriasis, chronic plaque-type psoriasis, il17, monoclonal antibody
409233|NCT01828034|Gemcitabine|gemcitabine
409234|NCT01828034|Cisplatin|cisplatin
409235|NCT01828034|MEK162|mek162
409237|NCT01828021|HER2 2+|her2 2+
409238|NCT01828021|FISH non-amplified|fish non-amplified
409239|NCT01828021|Relapsed|relapsed
409240|NCT01828021|Refractory|refractory
409241|NCT01828021|Advanced|advanced
409242|NCT01828021|Margetuximab|margetuximab
409243|NCT01828021|MGAH22|mgah22
409244|NCT01828008|Mabthera|mabthera
409245|NCT01828008|cytokine induced killer cell|cytokine induced killer cell
409246|NCT01827995|Low sensitivity urinary hCG|low sensitivity urinary hcg
409247|NCT01827995|follow up|follow up
409248|NCT01827995|medical abortion|medical abortion
409249|NCT01827995|rural India|rural india
409250|NCT01827995|RCT|rct
409251|NCT01827982|Healthy|healthy
409252|NCT01827982|Safety|safety
409253|NCT01827982|Tolerability|tolerability
409254|NCT01827982|Pharmacokinetic|pharmacokinetic
409255|NCT01827982|Alzheimer's Disease|alzheimer's disease
409256|NCT01827982|JNJ-54861911|jnj-54861911
409257|NCT01827969|Women|women
409258|NCT01827969|breast tumor|breast tumor
409259|NCT01827969|planned mastectomy|planned mastectomy
409260|NCT01827956|Upper aero-digestive tract tumours|upper aero-digestive tract tumours
409261|NCT01827956|FCGR3A and FCGR2A receptor polymorphism|fcgr3a and fcgr2a receptor polymorphism
409262|NCT01827956|Cetuximab efficacy|cetuximab efficacy
409263|NCT01827943|Relapsed bladder cancer|relapsed bladder cancer
409264|NCT01827930|chronic myeloid leukemia in chronic phase|chronic myeloid leukemia in chronic phase
409265|NCT01827904|ExAblate Transcranial MRgFUS|exablate transcranial mrgfus
409266|NCT01827891|acute kidney injury|acute kidney injury
409267|NCT01827891|percutaneous coronary intervention|percutaneous coronary intervention
409268|NCT01827891|remote ischemic preconditioning|remote ischemic preconditioning
409269|NCT01827839|Adults|adults
409270|NCT01827839|Safety|safety
409271|NCT01827839|Immunogenicity|immunogenicity
409272|NCT01827839|Zoster|zoster
409273|NCT01827826|Intervention|intervention
409274|NCT01827826|Telephone|telephone
409275|NCT01827826|Diabetes|diabetes
409276|NCT01827826|Prevention|prevention
409277|NCT01827813|prostate-specific antigen|prostate-specific antigen
409278|NCT01827813|digital rectal examination|digital rectal examination
409279|NCT01827813|transrectal ultrasonography|transrectal ultrasonography
409280|NCT01827813|needle biopsy|needle biopsy
409281|NCT01827813|prostate cancer|prostate cancer
409282|NCT01827800|weight loss|weight loss
409283|NCT01827800|primary care|primary care
409284|NCT01827800|eHealth|ehealth
409285|NCT01827787|metastatic breast cancer|metastatic breast cancer
409286|NCT01827774|Pelvic organ prolapse|pelvic organ prolapse
409287|NCT01827774|Graft repair|graft repair
409288|NCT01827761|chemotherapy teaching|chemotherapy teaching
409289|NCT01827761|questionnaire|questionnaire
409290|NCT01827748|Autorefractor|autorefractor
409291|NCT01827735|Interleukin 2|interleukin 2
409292|NCT01827735|Type 1 diabetes|type 1 diabetes
409293|NCT01827735|T regulatory cells|t regulatory cells
409294|NCT01827735|Adaptive trial|adaptive trial
409295|NCT01827722|Macular edema|macular edema
409296|NCT01827722|Central retinal vein occlusion|central retinal vein occlusion
409297|NCT01827722|CRVO|crvo
409298|NCT01827722|Retinal vein occlusion|retinal vein occlusion
409299|NCT01827722|RVO|rvo
409300|NCT01827722|Ozurdex|ozurdex
409301|NCT01827722|Dexamethasone intravitreal implant|dexamethasone intravitreal implant
409302|NCT01827722|Lucentis|lucentis
409303|NCT01827722|Ranibizumab|ranibizumab
409304|NCT01827709|DWI|dwi
409305|NCT01827709|ADC|adc
409306|NCT01827709|DCE-MRI|dce-mri
409307|NCT01827709|FDG-PET|fdg-pet
409308|NCT01827709|SUV|suv
409309|NCT01827709|Hypoxia|hypoxia
409310|NCT01827709|Head and neck squamous cell carcinoma|head and neck squamous cell carcinoma
409311|NCT01827696|Muscle|muscle
409312|NCT01827696|Soreness|soreness
409313|NCT01827696|Muscle function|muscle function
409314|NCT01827696|Damage|damage
409315|NCT01827696|Ginseng|ginseng
409316|NCT01827683|hyperbaric oxygen|hyperbaric oxygen
409317|NCT01827683|fibromyalgia|fibromyalgia
409318|NCT01827683|chronic pain syndrome|chronic pain syndrome
409319|NCT01827657|plasma|plasma
409320|NCT01827657|tolerability|tolerability
409321|NCT01827657|safety|safety
409322|NCT01827657|matched control|matched control
409323|NCT01827657|GSK2336805|gsk2336805
409324|NCT01827657|hepatic impairment|hepatic impairment
409325|NCT01827657|pharmacokinetics|pharmacokinetics
409326|NCT01827644|AKT inhibitor|akt inhibitor
409327|NCT01827644|formulation|formulation
409328|NCT01827644|food effect|food effect
409329|NCT01827644|bioavailability|bioavailability
409330|NCT01827644|GSK2110183|gsk2110183
409331|NCT01827631|healthy|healthy
409332|NCT01827631|GSK1605786|gsk1605786
409333|NCT01827631|CCR9 receptor antagonist|ccr9 receptor antagonist
409334|NCT01827631|Chinese subjects|chinese subjects
409335|NCT01827631|pharmacokinetics|pharmacokinetics
409336|NCT01827618|bladder|bladder
409337|NCT01827618|Cancer|cancer
409338|NCT01827618|Cystectomy|cystectomy
409339|NCT01827618|Rapamycin|rapamycin
409340|NCT01827605|Relapsed follicular Lymphoma|relapsed follicular lymphoma
409341|NCT01827605|RIT|rit
409342|NCT01827605|Zevalin|zevalin
409343|NCT01827579|Transplant|transplant
409344|NCT01827579|CD25/71 allodepleted donor T cells|cd25/71 allodepleted donor t cells
409345|NCT01827579|Infection|infection
409346|NCT01827579|Acute Myeloid Leukaemia|acute myeloid leukaemia
409347|NCT01827579|Acute Lymphoblastic Leukaemia|acute lymphoblastic leukaemia
409348|NCT01827579|Adult|adult
409349|NCT01827579|Diffuse Large B-Cell Lymphoma|diffuse large b-cell lymphoma
409350|NCT01827579|Mantle Cell Lymphoma|mantle cell lymphoma
409351|NCT01827566|Celiac Disease|celiac disease
409352|NCT01827566|Gluten Sensitivity|gluten sensitivity
409353|NCT01827566|Gluten|gluten
409354|NCT01827566|Double-blind challenge, placebo-controlled challenge|double-blind challenge, placebo-controlled challenge
409355|NCT01827566|Gluten free flour|gluten free flour
409356|NCT01827553|pancreatic cancer|pancreatic cancer
409357|NCT01827553|chemoradiotherapy|chemoradiotherapy
409358|NCT01827553|chemotherapy|chemotherapy
409359|NCT01827553|FOLFIRINOX|folfirinox
409360|NCT01827553|gemcitabine|gemcitabine
409361|NCT01827540|HIV/AIDS|hiv/aids
409362|NCT01827540|Cenicriviroc (CVC)|cenicriviroc (cvc)
409363|NCT01827540|Dolutegravir (DTG)|dolutegravir (dtg)
409364|NCT01827540|Midazolam|midazolam
409365|NCT01827540|Healthy Subjects|healthy subjects
409366|NCT01827527|Adenosine Triphosphate|adenosine triphosphate
409367|NCT01827527|Validation|validation
409368|NCT01827527|Magnetic Resonance Spectroscopy|magnetic resonance spectroscopy
409369|NCT01827527|Optical Spectroscopy|optical spectroscopy
409370|NCT01827514|cancer, erythropoetin|cancer, erythropoetin
409371|NCT01827501|postoperative delirium|postoperative delirium
409372|NCT01827501|hemodynamic management|hemodynamic management
409373|NCT01827501|goal directed therapy|goal directed therapy
409374|NCT01827475|musculoskeletal pain|musculoskeletal pain
409375|NCT01827475|acetaminophen|acetaminophen
409376|NCT01827475|ibuprofen|ibuprofen
409377|NCT01827462|Inactivated, trivalent influenza vaccine|inactivated, trivalent influenza vaccine
409379|NCT01827462|immunosenescence|immunosenescence
409380|NCT01827462|longitudinal study|longitudinal study
409381|NCT01827462|Inactivated, High-Dose trivalent influenza vaccine|inactivated, high-dose trivalent influenza vaccine
409382|NCT01827462|Inactivated, quadrivalent influenza vaccine|inactivated, quadrivalent influenza vaccine
409383|NCT01827462|young adults|young adults
409384|NCT01827449|rewarming|rewarming
409385|NCT01827449|core cooling|core cooling
409386|NCT01827449|afterdrop|afterdrop
409387|NCT01827449|hospital treatment|hospital treatment
409388|NCT01827449|hypothermia|hypothermia
409389|NCT01827436|pediatric stroke|pediatric stroke
409390|NCT01827436|hemiplegia|hemiplegia
409391|NCT01827436|physical therapy|physical therapy
409392|NCT01827436|gait training|gait training
409393|NCT01827436|transcranial magnetic stimulation|transcranial magnetic stimulation
409394|NCT01827436|gait asymmetry|gait asymmetry
409395|NCT01827423|squamous cell carcinoma antigen|squamous cell carcinoma antigen
409396|NCT01827423|sinonasal inverted papilloma|sinonasal inverted papilloma
409397|NCT01827423|clinical marker|clinical marker
409398|NCT01827423|hidden reccurence|hidden reccurence
409399|NCT01827423|surgery|surgery
409400|NCT01827397|Safety of this HIV vaccine|safety of this hiv vaccine
409401|NCT01827371|Smallpox, vaccine, IMVAMUNE, Stratis, parent protocol|smallpox, vaccine, imvamune, stratis, parent protocol
409402|NCT01827358|antibacterial agent|antibacterial agent
409403|NCT01827358|children|children
409404|NCT01827358|colonisation|colonisation
409405|NCT01827358|critically ill|critically ill
409406|NCT01827358|infants|infants
409407|NCT01827358|mupirocin|mupirocin
409408|NCT01827358|prevention|prevention
409409|NCT01827358|Staphylococcus aureus|staphylococcus aureus
409410|NCT01827345|Vitamin D|vitamin d
409411|NCT01827345|Falls|falls
409412|NCT01827345|Balance|balance
409413|NCT01827345|Physical Function|physical function
409414|NCT01827332|marijuana|marijuana
409415|NCT01827332|substance abuse|substance abuse
409416|NCT01827332|drug abuse|drug abuse
409417|NCT01827332|marijuana dependence|marijuana dependence
409418|NCT01827332|drug addiction|drug addiction
409419|NCT01827319|Angina|angina
409420|NCT01827319|Transmyocardial revascularization|transmyocardial revascularization
409421|NCT01827280|endothelial function|endothelial function
409422|NCT01827280|microvascular function|microvascular function
409423|NCT01827280|incretins|incretins
409424|NCT01827280|diabetes mellitus|diabetes mellitus
409425|NCT01827280|postprandial lipemia|postprandial lipemia
409426|NCT01827267|Lung cancer|lung cancer
409427|NCT01827267|Puma|puma
409428|NCT01827267|neratinib|neratinib
409429|NCT01827267|HKI-272|hki-272
409430|NCT01827267|PB-272|pb-272
409431|NCT01827267|Nerlynx|nerlynx
409432|NCT01827254|sutent rechallenge|sutent rechallenge
409433|NCT01827241|Gastroenterology|gastroenterology
409434|NCT01827241|Colonoscopy|colonoscopy
409435|NCT01827241|Screening|screening
409436|NCT01827241|Surveillance|surveillance
409437|NCT01827241|Symptom evaluation|symptom evaluation
409438|NCT01827241|Chart review|chart review
409439|NCT01827241|Data review|data review
409440|NCT01827241|Examination findings|examination findings
409441|NCT01827241|Resection techniques|resection techniques
409442|NCT01827241|Pathology reports|pathology reports
409443|NCT01827228|HIV|hiv
409444|NCT01827228|transmission prevention|transmission prevention
409445|NCT01827228|social network and venue|social network and venue
409446|NCT01827228|community intervention|community intervention
409447|NCT01827228|treatment as prevention|treatment as prevention
409448|NCT01827228|recent infection|recent infection
409449|NCT01827228|phylogenetics|phylogenetics
409450|NCT01827228|infection chains|infection chains
409451|NCT01827215|Preconception Care|preconception care
409452|NCT01827215|Racial Disparities|racial disparities
409453|NCT01827215|Health Information Technology|health information technology
409454|NCT01827202|renin-angiotensin-system|renin-angiotensin-system
409455|NCT01827202|RAS blockade|ras blockade
409456|NCT01827189|primary care, Medicare costs, hospitalizations|primary care, medicare costs, hospitalizations
409457|NCT01827176|Characteristic|characteristic
409458|NCT01827176|Recurrent Acute Rhinosinusitis|recurrent acute rhinosinusitis
409459|NCT01827176|Children|children
409460|NCT01827163|Paclitaxel|paclitaxel
409461|NCT01827163|Trastuzumab|trastuzumab
409462|NCT01827163|Lapatinib|lapatinib
409463|NCT01827163|HER2|her2
409464|NCT01827163|13-002|13-002
409465|NCT01827137|WT1 Analog Peptide Vaccine|wt1 analog peptide vaccine
409466|NCT01827137|12-288|12-288
409467|NCT01827124|CARBETOCIN AND OXYTOCIN AND SECOND TRIMESTER INTERRUPTION|carbetocin and oxytocin and second trimester interruption
409468|NCT01827111|Melanoma|melanoma
409469|NCT01827111|Metastatic Melanoma|metastatic melanoma
409470|NCT01827111|Advanced stage IV melanoma|advanced stage iv melanoma
409471|NCT01827111|Unresectable stage III mucosal melanoma|unresectable stage iii mucosal melanoma
409472|NCT01827111|Cutaneous melanoma|cutaneous melanoma
409473|NCT01827111|Progression-free survival|progression-free survival
409474|NCT01827111|(PFS)|(pfs)
409475|NCT01827111|ABI-007|abi-007
409476|NCT01827111|Nab-paclitaxel|nab-paclitaxel
409477|NCT01827111|Paclitaxel|paclitaxel
409478|NCT01827111|Abraxane|abraxane
409479|NCT01827111|Ipilimumab|ipilimumab
409480|NCT01827111|Yervoy|yervoy
409481|NCT01827111|BMS-734016|bms-734016
409482|NCT01827111|MDX010|mdx010
409483|NCT01827098|Immature teeth|immature teeth
409484|NCT01827098|Calcium Hydroxide|calcium hydroxide
409485|NCT01827098|Blood clot|blood clot
409486|NCT01827098|Revascularization|revascularization
409487|NCT01827098|Revitalization|revitalization
409488|NCT01827072|IVIG in Multifocal Motor Neuropathy|ivig in multifocal motor neuropathy
409489|NCT01827072|Patients with Multifocal Motor Neuropathy|patients with multifocal motor neuropathy
409490|NCT01827046|intracerebral hemorrhage|intracerebral hemorrhage
409492|NCT01827046|brain hemorrhage|brain hemorrhage
409493|NCT01827046|minimally invasive surgery|minimally invasive surgery
409494|NCT01827046|rt-PA|rt-pa
409495|NCT01827007|norepinephrine infusion|norepinephrine infusion
409496|NCT01827007|under 48 hours in ICU|under 48 hours in icu
409497|NCT01826968|Lung recruitment, cesarean, lung compliance, atelectasis|lung recruitment, cesarean, lung compliance, atelectasis
409498|NCT01826955|pneumoperitoneum, cognitive function|pneumoperitoneum, cognitive function
409499|NCT01826942|Scar prevention|scar prevention
409500|NCT01826942|CO2 fractional laser|co2 fractional laser
409501|NCT01826929|Health Services Research|health services research
409502|NCT01826929|Cardiovascular Diseases|cardiovascular diseases
409503|NCT01826929|Primary Care|primary care
409504|NCT01826929|Secondary Prevention.|secondary prevention.
409505|NCT01826903|Depression|depression
409506|NCT01826903|Cognitive Behavior Therapy|cognitive behavior therapy
409507|NCT01826903|Child Development|child development
409508|NCT01826890|Ventilator Weaning|ventilator weaning
409509|NCT01826890|Mechanical Ventilation|mechanical ventilation
409510|NCT01826890|Critical Care|critical care
409511|NCT01826890|Neurally Adjusted Ventilatory Assist|neurally adjusted ventilatory assist
409512|NCT01826890|Diaphragm|diaphragm
409513|NCT01826851|Pain management|pain management
409514|NCT01826851|Anesthetic, local|anesthetic, local
409515|NCT01826851|Nerve blockade|nerve blockade
409516|NCT01826851|Coronary Artery Bypass Surgery|coronary artery bypass surgery
409517|NCT01826851|Analgesics, opioid|analgesics, opioid
409518|NCT01826851|Postoperative complications|postoperative complications
409519|NCT01826851|Bupivacaine|bupivacaine
409520|NCT01826838|Prostate Cancer|prostate cancer
409521|NCT01826825|aging|aging
409522|NCT01826825|cognition|cognition
409523|NCT01826825|surgery|surgery
409524|NCT01826799|sleep|sleep
409525|NCT01826799|noise|noise
409526|NCT01826799|ICU|icu
409527|NCT01826799|delirium|delirium
409528|NCT01826799|RCSQ|rcsq
409529|NCT01826786|Healthy|healthy
409530|NCT01826786|Anxiety Disorders|anxiety disorders
409531|NCT01826786|Anxiety Modulation|anxiety modulation
409532|NCT01826786|Male|male
409533|NCT01826773|CardioPET|cardiopet
409534|NCT01826773|Coronary Artery Disease|coronary artery disease
409535|NCT01826773|Myocardial Perfusion Imaging|myocardial perfusion imaging
409536|NCT01826773|Coronary Angiography|coronary angiography
409537|NCT01826773|Myocardial Fatty Acid Utilization|myocardial fatty acid utilization
409538|NCT01826747|intrauterine insemination|intrauterine insemination
409539|NCT01826747|luteal phase|luteal phase
409540|NCT01826747|gonadotrophins|gonadotrophins
409541|NCT01826734|dacryolith|dacryolith
409542|NCT01826734|dacryocystorhinostomy|dacryocystorhinostomy
409543|NCT01826734|composition|composition
409544|NCT01826734|chemical analysis|chemical analysis
409545|NCT01826734|infrared spectrometry|infrared spectrometry
409546|NCT01826734|scanning electron microscopy|scanning electron microscopy
409547|NCT01826734|elemental analysis|elemental analysis
409548|NCT01826721|Solid organ transplantation|solid organ transplantation
409549|NCT01826721|Immunosuppression|immunosuppression
409550|NCT01826721|Education|education
409551|NCT01826721|E-learning|e-learning
409552|NCT01826721|Medication knowledge|medication knowledge
409553|NCT01826721|Patient satisfaction|patient satisfaction
409554|NCT01826721|Medication adherence|medication adherence
409555|NCT01826708|Chromosomal translocations|chromosomal translocations
409556|NCT01826708|psychomotor delay|psychomotor delay
409557|NCT01826695|Fibromyalgia, neurodynamic, dexterity|fibromyalgia, neurodynamic, dexterity
409558|NCT01826682|COPD, physiotherapy, exacerbation|copd, physiotherapy, exacerbation
409559|NCT01826656|intramembranous bone healing|intramembranous bone healing
409560|NCT01826656|post-menopausal osteoporosis|post-menopausal osteoporosis
409561|NCT01826656|tooth extraction|tooth extraction
409562|NCT01826630|CLn Body Wash|cln body wash
409563|NCT01826630|CLn BodyWash|cln bodywash
409564|NCT01826617|Prostate Disease Nomogram|prostate disease nomogram
409565|NCT01826617|Asian Men|asian men
409566|NCT01826604|cesarean section|cesarean section
409567|NCT01826604|Pregnant|pregnant
409568|NCT01826565|success|success
409569|NCT01826552|Orsiro hybrid stent|orsiro hybrid stent
409570|NCT01826552|Drug-eluting stent|drug-eluting stent
409571|NCT01826552|Zotarolimus-eluting stent|zotarolimus-eluting stent
409572|NCT01826552|Coronary heart disease|coronary heart disease
409573|NCT01826552|Cobalt chromium|cobalt chromium
409574|NCT01826539|Dorsal digital nerve|dorsal digital nerve
409575|NCT01826539|dorsal branch of the digital nerve|dorsal branch of the digital nerve
409576|NCT01826539|dorsal branch of the digital artery|dorsal branch of the digital artery
409577|NCT01826539|dorsal digital island flap|dorsal digital island flap
409578|NCT01826539|finger pulp defect.|finger pulp defect.
409579|NCT01826513|Obstructive sleep apnea|obstructive sleep apnea
409580|NCT01826513|Efficacy|efficacy
409581|NCT01826513|Subjective feedback|subjective feedback
409582|NCT01826513|Preference|preference
409583|NCT01826500|embryo transfer|embryo transfer
409584|NCT01826500|IVF cycle|ivf cycle
409585|NCT01826500|endometriosis|endometriosis
409586|NCT01826487|Duchenne muscular dystrophy|duchenne muscular dystrophy
409587|NCT01826487|Dystrophinopathy|dystrophinopathy
409588|NCT01826487|Nonsense mutation|nonsense mutation
409589|NCT01826487|Premature stop codon|premature stop codon
409590|NCT01826487|Becker muscular dystrophy|becker muscular dystrophy
409591|NCT01826487|DMD/BMD|dmd/bmd
409592|NCT01826487|PTC124|ptc124
409593|NCT01826487|Ataluren|ataluren
409594|NCT01826474|Duchenne muscular dystrophy|duchenne muscular dystrophy
409595|NCT01826474|DMD|dmd
409596|NCT01826474|Prosensa|prosensa
409597|NCT01826474|Duchenne|duchenne
409598|NCT01826461|atopic dermatitis|atopic dermatitis
409599|NCT01826461|eczema|eczema
409600|NCT01826461|PDI-192|pdi-192
409601|NCT01826461|Precision|precision
409602|NCT01826422|Muscular Dystrophy|muscular dystrophy
409603|NCT01826422|Duchenne Muscular Dystrophy|duchenne muscular dystrophy
409604|NCT01826422|Becker Muscular Dystrophy|becker muscular dystrophy
409605|NCT01826422|Omega 3|omega 3
409606|NCT01826422|Eicosapentaenoic fatty acid|eicosapentaenoic fatty acid
409607|NCT01826422|Docosahexaenoic fatty acid|docosahexaenoic fatty acid
409608|NCT01826383|Infant|infant
523676|NCT01332526|FFT|fft
409609|NCT01826383|Immunization|immunization
409610|NCT01826357|metabolic syndrome|metabolic syndrome
409611|NCT01826357|cluster analysis|cluster analysis
409612|NCT01826357|PCOS|pcos
409613|NCT01826318|Stress|stress
409614|NCT01826318|coping|coping
409615|NCT01826318|simulation|simulation
409616|NCT01826292|Post anesthesia care unit length of stay|post anesthesia care unit length of stay
409617|NCT01826279|Obesity|obesity
409618|NCT01826279|Gastric bypass surgery|gastric bypass surgery
409619|NCT01826279|Resveratrol|resveratrol
409620|NCT01826279|Insulin sensitivity|insulin sensitivity
409621|NCT01826279|Lipid turnover|lipid turnover
409622|NCT01826279|VLDL-triglyceride uptake|vldl-triglyceride uptake
409623|NCT01826279|Liver|liver
409624|NCT01826266|PER977|per977
409625|NCT01826266|Activated partial thromboplastin time|activated partial thromboplastin time
409626|NCT01826266|Assessment|assessment
409627|NCT01826266|D-dimer|d-dimer
409628|NCT01826266|Enrollment|enrollment
409629|NCT01826266|Investigational drug|investigational drug
409630|NCT01826266|Investigational treatment|investigational treatment
409631|NCT01826266|Period|period
409632|NCT01826266|Premature subject withdrawal|premature subject withdrawal
409633|NCT01826266|Prothrombin time|prothrombin time
409634|NCT01826266|Randomization number|randomization number
409635|NCT01826266|Study discontinuation|study discontinuation
409636|NCT01826266|Study drug|study drug
409637|NCT01826266|Subject number|subject number
409638|NCT01826266|Study treatment|study treatment
409639|NCT01826266|Thromboelastography-reaction time|thromboelastography-reaction time
409640|NCT01826253|Hypovolemia|hypovolemia
409641|NCT01826253|Fluid challenge|fluid challenge
409642|NCT01826253|Fluid expansion|fluid expansion
409643|NCT01826253|Oxygene delivery|oxygene delivery
409644|NCT01826253|Cardiac output|cardiac output
409645|NCT01826227|PET (Positron Emission Tomography)|pet (positron emission tomography)
409646|NCT01826227|18F-FDG|18f-fdg
409647|NCT01826227|Cytoreductive Surgery|cytoreductive surgery
409648|NCT01826227|13-017|13-017
409649|NCT01826214|acute myeloid leukemia|acute myeloid leukemia
409650|NCT01826214|AML|aml
409651|NCT01826214|acute lymphoblastic leukemia|acute lymphoblastic leukemia
409652|NCT01826214|ALL|all
409653|NCT01826214|leukemia|leukemia
409654|NCT01826214|acute|acute
409655|NCT01826214|LDE225|lde225
409656|NCT01826214|adult patients|adult patients
409657|NCT01826214|relapsed/refractory|relapsed/refractory
409658|NCT01826201|psoriasis|psoriasis
409659|NCT01826188|Crohn's disease|crohn's disease
409660|NCT01826188|IBD Cannabis|ibd cannabis
409661|NCT01826188|THC|thc
409662|NCT01826188|CBD|cbd
409663|NCT01826175|Optical Coherence Tomography|optical coherence tomography
409664|NCT01826175|ticagrelor|ticagrelor
409665|NCT01826175|clopidogrel|clopidogrel
409666|NCT01826123|Coagulopathy|coagulopathy
409667|NCT01826123|Hemorrhage|hemorrhage
409668|NCT01826123|Cardiac surgery|cardiac surgery
409669|NCT01826123|Point-of-Care testing|point-of-care testing
409670|NCT01826123|POC|poc
409671|NCT01826123|ROTEM|rotem
409672|NCT01826123|multiplate|multiplate
409673|NCT01826123|Multiple electrode aggregometry (MEA)|multiple electrode aggregometry (mea)
409674|NCT01826097|Cytology|cytology
409675|NCT01826097|Whole body massage vibration|whole body massage vibration
409676|NCT01826071|Osgood-Schlatter syndrome (OSS)|osgood-schlatter syndrome (oss)
409677|NCT01826071|Sinding-Larsen and Johansson syndrome (SLJ)|sinding-larsen and johansson syndrome (slj)
409678|NCT01826071|Sever's disease|sever's disease
409679|NCT01826071|apophysitis|apophysitis
409680|NCT01826058|Stereotactic body radiation therapy|stereotactic body radiation therapy
409681|NCT01826058|Radiosurgery|radiosurgery
409682|NCT01826045|Treatment of Cervical Intraepithelial Neoplasia(CIN1)|treatment of cervical intraepithelial neoplasia(cin1)
409683|NCT01826006|Myocardial Infarction|myocardial infarction
409684|NCT01826006|No-reflow|no-reflow
409685|NCT01826006|Primary PCI|primary pci
409686|NCT01826006|Coronary no-reflow phenomenon|coronary no-reflow phenomenon
409687|NCT01826006|Primary percoutaneous coronary intervention (primary PCI)|primary percoutaneous coronary intervention (primary pci)
409688|NCT01825993|Peridural catheter|peridural catheter
409689|NCT01825993|Morphine PCA|morphine pca
409690|NCT01825993|Transabdominal Block|transabdominal block
409691|NCT01825993|laparoscopic sigmoidectomy|laparoscopic sigmoidectomy
409692|NCT01825954|Fibromyalgia|fibromyalgia
409693|NCT01825954|Pain|pain
409694|NCT01825954|Brain|brain
409695|NCT01825954|Stimulation|stimulation
409696|NCT01825954|Device|device
409697|NCT01825941|migraine|migraine
409698|NCT01825941|headache|headache
409699|NCT01825941|metoclopramide|metoclopramide
409700|NCT01825941|diphenhydramine|diphenhydramine
409701|NCT01825928|Methamphetamine|methamphetamine
409702|NCT01825928|paliperidone|paliperidone
409703|NCT01825915|Laparoscopic|laparoscopic
409704|NCT01825915|Hysterectomy|hysterectomy
409705|NCT01825915|Total|total
409706|NCT01825915|Subtotal|subtotal
409707|NCT01825915|Recovery|recovery
409708|NCT01825915|Outcomes|outcomes
409709|NCT01825915|Surgery|surgery
409710|NCT01825863|Laparoscopy|laparoscopy
409711|NCT01825863|Adult|adult
409712|NCT01825863|Nerve block|nerve block
409713|NCT01825863|Ultrasonography|ultrasonography
409714|NCT01825837|bipolar I disorder|bipolar i disorder
409715|NCT01825837|Eslicarbazepine acetate|eslicarbazepine acetate
409716|NCT01825837|BIA 2-093|bia 2-093
409717|NCT01825824|Hepatocellular carcinoma|hepatocellular carcinoma
409718|NCT01825824|Stereotactic ablative radiotherapy|stereotactic ablative radiotherapy
409719|NCT01825824|Stereotactic body radiotherapy|stereotactic body radiotherapy
409720|NCT01825811|Cell mediated gene therapy|cell mediated gene therapy
409721|NCT01825811|Osteoarthritis|osteoarthritis
409722|NCT01825811|Fibrin-glue|fibrin-glue
409723|NCT01825811|Degenerative Arthritis|degenerative arthritis
409724|NCT01825798|Metformin|metformin
409725|NCT01825798|Overweight|overweight
409726|NCT01825798|Atypical Antipsychotic|atypical antipsychotic
409727|NCT01825798|Medication|medication
409728|NCT01825798|Randomized Clinical Trial|randomized clinical trial
409729|NCT01825798|Children|children
409730|NCT01825772|Cross-Sectional Studies|cross-sectional studies
409731|NCT01825772|Prevalence|prevalence
409732|NCT01825772|Peri-Implantitis|peri-implantitis
409733|NCT01825733|palonosetron, ramosetron, PONV, opioid|palonosetron, ramosetron, ponv, opioid
409734|NCT01825720|GIK, valvular heart surgery, lactate|gik, valvular heart surgery, lactate
409735|NCT01825694|Substance Abuse|substance abuse
409736|NCT01825694|Traumatic Stress|traumatic stress
409737|NCT01825681|positive affect|positive affect
409738|NCT01825681|caregivers|caregivers
409739|NCT01825681|caregiving|caregiving
409740|NCT01825681|stress|stress
409741|NCT01825681|mood|mood
409742|NCT01825681|dementia|dementia
409743|NCT01825681|Alzheimer's|alzheimer's
409744|NCT01825681|FTD|ftd
409745|NCT01825681|Lewy|lewy
409746|NCT01825681|mindfulness|mindfulness
409747|NCT01825681|help|help
409748|NCT01825642|Prostate cancer|prostate cancer
409749|NCT01825642|sexual function|sexual function
409750|NCT01825642|seminal vesicle sparing|seminal vesicle sparing
409751|NCT01825642|nerve-sparing|nerve-sparing
409752|NCT01825642|radical prostatectomy|radical prostatectomy
409753|NCT01825629|Pain|pain
409754|NCT01825629|Temporomandibular joint|temporomandibular joint
409755|NCT01825629|Manual therapy|manual therapy
409756|NCT01825629|Physical therapy|physical therapy
409757|NCT01825629|Fibromyalgia Syndrome|fibromyalgia syndrome
409758|NCT01825616|Strength|strength
409759|NCT01825616|Anaerobic power|anaerobic power
409760|NCT01825616|Muscle soreness|muscle soreness
409761|NCT01825616|Immune function|immune function
409762|NCT01825590|hemodialysis|hemodialysis
409763|NCT01825590|dialysate and serum sodium|dialysate and serum sodium
409764|NCT01825577|Alzheimer Dementia|alzheimer dementia
409765|NCT01825577|Gait|gait
409766|NCT01825564|G-tube|g-tube
409767|NCT01825564|Feeding tube|feeding tube
409768|NCT01825564|Feeding tube placement verification|feeding tube placement verification
409769|NCT01825564|Enteral feeding|enteral feeding
409770|NCT01825551|Amyotrophic Lateral Sclerosis|amyotrophic lateral sclerosis
409771|NCT01825551|Granulocyte Colony Stimulating Factor|granulocyte colony stimulating factor
409772|NCT01825538|Chronic obstructive pulmonary disease|chronic obstructive pulmonary disease
409773|NCT01825538|Pulmonary fibrosis|pulmonary fibrosis
409774|NCT01825538|Advanced care planning|advanced care planning
409775|NCT01825512|chronic iron overload|chronic iron overload
409776|NCT01825512|hereditary haemoglobinopathy|hereditary haemoglobinopathy
409777|NCT01825512|beta thalassaemia major|beta thalassaemia major
409778|NCT01825512|chelating agents|chelating agents
409779|NCT01825512|deferiprone|deferiprone
409780|NCT01825512|deferasirox|deferasirox
409781|NCT01825512|children|children
409782|NCT01825512|paediatrics|paediatrics
409783|NCT01825499|Birth weight|birth weight
409784|NCT01825499|Gestational age|gestational age
409785|NCT01825499|Very low birth weight|very low birth weight
409786|NCT01825486|Balance|balance
409787|NCT01825486|Gait characteristics|gait characteristics
409788|NCT01825473|neonate|neonate
409789|NCT01825473|apnea|apnea
409790|NCT01825473|preterm|preterm
409791|NCT01825473|reflux|reflux
409792|NCT01825473|gastroesophageal reflux|gastroesophageal reflux
409793|NCT01825473|impedance|impedance
409794|NCT01825473|erythromycin|erythromycin
409795|NCT01825473|desaturation|desaturation
409796|NCT01825473|bradycardia|bradycardia
409797|NCT01825473|hypoxia|hypoxia
409798|NCT01825460|Cervical spine|cervical spine
409799|NCT01825460|Neck pain|neck pain
409800|NCT01825460|Manual therapy|manual therapy
409801|NCT01825460|Controlled clinical trial|controlled clinical trial
409802|NCT01825447|abuse potential|abuse potential
409803|NCT01825447|abuse liability|abuse liability
409804|NCT01825447|drug liking|drug liking
409805|NCT01825447|oxycodone|oxycodone
409806|NCT01825447|naltrexone|naltrexone
409807|NCT01825447|intravenous|intravenous
409808|NCT01825447|pharmacodynamic|pharmacodynamic
409809|NCT01825434|chronic constipation|chronic constipation
409810|NCT01825434|Lactobacillus acidophilus NCFM|lactobacillus acidophilus ncfm
409811|NCT01825434|Bifidobacterium lactis HN019|bifidobacterium lactis hn019
409812|NCT01825421|Infant|infant
409813|NCT01825421|Infection|infection
409814|NCT01825421|Newborn|newborn
409815|NCT01825421|Antibiotics|antibiotics
409816|NCT01825421|Neutrophil CD64|neutrophil cd64
409817|NCT01825421|Blood Culture|blood culture
409818|NCT01825369|congenital heart disease|congenital heart disease
409819|NCT01825369|ventricular septal defect|ventricular septal defect
409820|NCT01825369|atrioventricular septal defect|atrioventricular septal defect
409821|NCT01825369|increased pulmonary blood flow|increased pulmonary blood flow
409822|NCT01825369|nitric oxide|nitric oxide
409823|NCT01825343|fall|fall
409824|NCT01825343|burn|burn
409825|NCT01825343|road traffic crash|road traffic crash
409826|NCT01825330|Alzheimer's Disease|alzheimer's disease
409827|NCT01825330|Alzheimer's|alzheimer's
409828|NCT01825330|TMS|tms
409829|NCT01825330|Cognitive Training|cognitive training
409830|NCT01825330|NeuroAD|neuroad
409831|NCT01825317|Alzheimer's disease|alzheimer's disease
409832|NCT01825317|TMS|tms
409833|NCT01825317|NeuroAd|neuroad
409834|NCT01825317|cognitive training|cognitive training
409835|NCT01825317|ADAS-Cog|adas-cog
409836|NCT01825304|mechanical ventilation|mechanical ventilation
409837|NCT01825304|Intra-abdominal hypertension|intra-abdominal hypertension
409838|NCT01825304|positive end-expiratory pressure|positive end-expiratory pressure
409839|NCT01825291|sleep apnea|sleep apnea
409840|NCT01825291|co-morbidities of sleep apnea|co-morbidities of sleep apnea
409841|NCT01825291|CPAP treatment|cpap treatment
409842|NCT01825278|respiratory rate|respiratory rate
409843|NCT01825278|tidal volume|tidal volume
409844|NCT01825278|minute ventilation|minute ventilation
409845|NCT01825278|obese patients|obese patients
409846|NCT01825278|obstructive sleep apnea|obstructive sleep apnea
409847|NCT01825252|HIV|hiv
409848|NCT01825252|sexually transmitted diseases|sexually transmitted diseases
409849|NCT01825239|ischemic cardiomyopathy|ischemic cardiomyopathy
409850|NCT01825239|cardiomyopathy|cardiomyopathy
409851|NCT01825239|left ventricular lead|left ventricular lead
409852|NCT01825239|cardiac electrophysiologic studies|cardiac electrophysiologic studies
409853|NCT01825213|Liver disease|liver disease
409854|NCT01825213|Multi Spectral CT|multi spectral ct
409855|NCT01825200|Influenza|influenza
409856|NCT01825148|Diabetes|diabetes
409857|NCT01825135|muscle strength|muscle strength
409858|NCT01825135|muscle function|muscle function
409859|NCT01825135|functional status|functional status
409860|NCT01825109|Rotavirus|rotavirus
409861|NCT01825109|Immunogenicity|immunogenicity
409862|NCT01825109|vaccine, Bangladesh|vaccine, bangladesh
409863|NCT01825096|cerebral metabolism|cerebral metabolism
409864|NCT01825096|functional magnetic resonance imaging|functional magnetic resonance imaging
409865|NCT01825096|near infrared spectroscopy|near infrared spectroscopy
409866|NCT01825083|Hypercarbia|hypercarbia
409867|NCT01825083|TOSCA monitor|tosca monitor
409868|NCT01825083|Ketamine|ketamine
409869|NCT01825083|Fentanyl|fentanyl
409870|NCT01825083|Intraoperative monitoring|intraoperative monitoring
409871|NCT01825070|Montmorency tart cherries|montmorency tart cherries
409872|NCT01825070|Inflammation|inflammation
409873|NCT01825070|Uric acid|uric acid
409874|NCT01825057|implementation study|implementation study
409875|NCT01825057|motivational interviewing|motivational interviewing
409876|NCT01825057|substance use|substance use
409877|NCT01825044|Traumatic Brain Injury|traumatic brain injury
409878|NCT01825044|TBI|tbi
409879|NCT01825044|ciclosporin|ciclosporin
409880|NCT01825044|pharmacokinetic|pharmacokinetic
409881|NCT01825044|safety|safety
409882|NCT01825044|microdialysis|microdialysis
409883|NCT01825044|mitochondrial protection|mitochondrial protection
409884|NCT01825031|HIV|hiv
409885|NCT01825018|HIV|hiv
409886|NCT01825018|AIDS|aids
409887|NCT01825018|treatment adherence|treatment adherence
409888|NCT01825005|cervical cancer|cervical cancer
409889|NCT01824966|Esophagectomy|esophagectomy
409890|NCT01824966|Signet Ring Cells|signet ring cells
409891|NCT01824953|Gastric atrophy|gastric atrophy
409892|NCT01824953|Helicobacter pylori|helicobacter pylori
409893|NCT01824953|Pepsinogen|pepsinogen
409894|NCT01824953|Gastric cancer|gastric cancer
409895|NCT01824953|Gastric adenoma|gastric adenoma
409896|NCT01824940|Cluster randomized trial|cluster randomized trial
409897|NCT01824940|Nutrition|nutrition
409898|NCT01824940|Water Sanitation Hygiene|water sanitation hygiene
409899|NCT01824940|Environmental enteropathy|environmental enteropathy
409900|NCT01824914|videolaryngoscope|videolaryngoscope
409901|NCT01824914|tracheal intubation|tracheal intubation
409902|NCT01824914|Cormack-Lehane grade|cormack-lehane grade
409903|NCT01824914|airway evaluation|airway evaluation
409904|NCT01824914|sedation|sedation
409905|NCT01824914|anesthesia|anesthesia
409906|NCT01824901|AZD4547|azd4547
409907|NCT01824901|recurrent non-small cell lung cancer|recurrent non-small cell lung cancer
409908|NCT01824888|JUC|juc
409909|NCT01824888|hand rub|hand rub
409910|NCT01824888|European standard|european standard
409911|NCT01824862|clinically significant macular edema|clinically significant macular edema
409912|NCT01824862|foveal thickness|foveal thickness
409913|NCT01824862|foveal sensitivity|foveal sensitivity
409914|NCT01824862|perimetry|perimetry
409915|NCT01824862|diabetic retinopathy|diabetic retinopathy
409916|NCT01824849|Vocal cords|vocal cords
409917|NCT01824849|Vocal cord paralysis|vocal cord paralysis
409918|NCT01824849|Arytenoid cartilage|arytenoid cartilage
409919|NCT01824823|afatinib|afatinib
409920|NCT01824823|head and neck squamous cell carcinoma|head and neck squamous cell carcinoma
409921|NCT01824810|Intramuscular Stimulation|intramuscular stimulation
409922|NCT01824810|myoActivation|myoactivation
409923|NCT01824810|Neural Prolotherapy|neural prolotherapy
409924|NCT01824810|Whiplash-Associated Disorders|whiplash-associated disorders
409925|NCT01824810|myofascial pain|myofascial pain
409926|NCT01824797|Bone mineral density|bone mineral density
409927|NCT01824797|sleeve gastrectomy|sleeve gastrectomy
409928|NCT01824797|roux-en-y|roux-en-y
409929|NCT01824797|postmenopausal females|postmenopausal females
409930|NCT01824797|bone loss|bone loss
409931|NCT01824784|Normal Eyes|normal eyes
409932|NCT01824771|Continuous veno-venoous haemofiltration|continuous veno-venoous haemofiltration
409933|NCT01824771|Plasma lactate|plasma lactate
409934|NCT01824771|Critical illness|critical illness
409935|NCT01824771|Acute kidney injurytissue perfusion|acute kidney injurytissue perfusion
409936|NCT01824771|Multiple organ dysfunction syndrome|multiple organ dysfunction syndrome
409937|NCT01824758|esmolol, injection pain, lidocaine, rocuronium|esmolol, injection pain, lidocaine, rocuronium
409938|NCT01824706|cranial prosthesis|cranial prosthesis
409939|NCT01824680|Obesity|obesity
409940|NCT01824680|Appetite regulation|appetite regulation
409941|NCT01824680|Hormones|hormones
409942|NCT01824680|Adolescents|adolescents
409943|NCT01824680|Exercise|exercise
409944|NCT01824654|Aortic Aneurysm, Abdominal|aortic aneurysm, abdominal
409945|NCT01824654|Imaging, Three-Dimensional|imaging, three-dimensional
409946|NCT01824654|Tomography Scanners, X-Ray Computed|tomography scanners, x-ray computed
409947|NCT01824654|Angiography, Digital Subtraction|angiography, digital subtraction
409948|NCT01824654|Endovascular Procedures|endovascular procedures
409949|NCT01824654|Radiography, Interventional|radiography, interventional
409950|NCT01824641|Acute myocardial infarction|acute myocardial infarction
409951|NCT01824641|Manual thrombus aspiration|manual thrombus aspiration
409952|NCT01824641|Coronary physiology|coronary physiology
409953|NCT01824615|Sunitinib|sunitinib
409954|NCT01824615|recurrent ovarian cancer|recurrent ovarian cancer
409955|NCT01824615|clear cell carcinoma|clear cell carcinoma
409956|NCT01824602|BIPOLAR I DISORDER, Eslicarbazepine acetate|bipolar i disorder, eslicarbazepine acetate
409957|NCT01824589|traumatic brain injury|traumatic brain injury
409958|NCT01824589|TBI|tbi
409959|NCT01824589|ITPR|itpr
409960|NCT01824589|intrathoracic pressure regulator|intrathoracic pressure regulator
409961|NCT01824589|hepatic encephalopathy|hepatic encephalopathy
409962|NCT01824589|pseudotumorcerebri|pseudotumorcerebri
409963|NCT01824589|obstructive hydrocephalus|obstructive hydrocephalus
409964|NCT01824589|intracranial hemorrhage|intracranial hemorrhage
409965|NCT01824576|ITPR|itpr
409966|NCT01824576|CPP|cpp
409967|NCT01824576|TBI|tbi
409968|NCT01824576|traumatic brain injury|traumatic brain injury
409969|NCT01824576|cerebral perfusion pressure|cerebral perfusion pressure
409970|NCT01824576|intrathoracic pressure regulator|intrathoracic pressure regulator
409971|NCT01824537|Human papillomavirus (HPV)|human papillomavirus (hpv)
409972|NCT01824537|Vaccination|vaccination
409973|NCT01824537|Cervical cancer prevention|cervical cancer prevention
409974|NCT01824537|Herd immunity|herd immunity
409975|NCT01824524|Pain|pain
409976|NCT01824524|Hydromorphone|hydromorphone
409977|NCT01824524|OROS|oros
409978|NCT01824511|smoking|smoking
409979|NCT01824511|nicotine|nicotine
409980|NCT01824511|tobacco|tobacco
409981|NCT01824511|anhedonia|anhedonia
409982|NCT01824511|reward|reward
409983|NCT01824511|withdrawal|withdrawal
409984|NCT01824498|omega-3 fatty acids|omega-3 fatty acids
409985|NCT01824498|sex hormones|sex hormones
409986|NCT01824498|urinary sex hormone metabolites|urinary sex hormone metabolites
409987|NCT01824485|Osteoarthritis|osteoarthritis
409988|NCT01824485|Knee|knee
409989|NCT01824485|Viscosupplementation|viscosupplementation
409990|NCT01824485|Clinical Trial|clinical trial
409991|NCT01824459|Non-intestinal type gastric cancer|non-intestinal type gastric cancer
409992|NCT01824459|Advance Gastric Cancer|advance gastric cancer
409993|NCT01824459|Recurrent Gastric Cancer|recurrent gastric cancer
409994|NCT01824459|Gastroesophageal Junction Adenocarcinoma|gastroesophageal junction adenocarcinoma
409995|NCT01824459|SOX, S-1+Oxaliplatin|sox, s-1+oxaliplatin
409996|NCT01824459|OS,|os,
409997|NCT01824459|ORR,|orr,
409998|NCT01824459|PFS,|pfs,
409999|NCT01824459|TTF,|ttf,
410000|NCT01824459|safety|safety
410001|NCT01824433|venlafaxine|venlafaxine
410002|NCT01824433|fluoxetine|fluoxetine
410003|NCT01824433|postmenopause|postmenopause
410004|NCT01824433|major depressive disorder|major depressive disorder
410005|NCT01824420|Refractory overactive bladder syndrome|refractory overactive bladder syndrome
410006|NCT01824420|Antimuscarinic agent|antimuscarinic agent
410007|NCT01824407|foot|foot
410008|NCT01824407|ulcers|ulcers
410009|NCT01824407|diabetes|diabetes
410010|NCT01824407|wound|wound
410011|NCT01824407|healing|healing
410012|NCT01824394|nMARQ|nmarq
410013|NCT01824394|Atrial Fibrillation|atrial fibrillation
410014|NCT01824394|Drug Refractory|drug refractory
410015|NCT01824394|Radio Frequency|radio frequency
410016|NCT01824381|extensive wounds|extensive wounds
410017|NCT01824381|amniotic membrane|amniotic membrane
410018|NCT01824381|healing|healing
410019|NCT01824381|patients|patients
410020|NCT01824381|phase granulation|phase granulation
410021|NCT01824329|Bladder Cancer|bladder cancer
410022|NCT01824329|Transitional cell carcinoma of the bladder|transitional cell carcinoma of the bladder
410023|NCT01824264|Type 2 Diabetes mellitus, SGLT inhibitors, dose-response|type 2 diabetes mellitus, sglt inhibitors, dose-response
410024|NCT01824251|IVIG in Chronic Inflammatory Demyelinating Polyneuropathy|ivig in chronic inflammatory demyelinating polyneuropathy
410025|NCT01824251|Patients with Chronic Inflammatory Demyelinating Polyneuropathy|patients with chronic inflammatory demyelinating polyneuropathy
410026|NCT01824225|aflibercept|aflibercept
410027|NCT01824225|intravitreal injection|intravitreal injection
410028|NCT01824212|Ventricular fibrillation|ventricular fibrillation
410029|NCT01824212|Cardiac arrest|cardiac arrest
410030|NCT01824212|Mobile technology|mobile technology
410031|NCT01824199|Esophagitis|esophagitis
410032|NCT01824173|muscle|muscle
410033|NCT01824173|mitochondria|mitochondria
410034|NCT01824173|amino acids|amino acids
410035|NCT01824173|exercise|exercise
410036|NCT01824147|ASS-Nonresponse|ass-nonresponse
410037|NCT01824147|cardiac|cardiac
410038|NCT01824147|surgery|surgery
410039|NCT01824121|Progressive Supranuclear palsy|progressive supranuclear palsy
410040|NCT01824121|stem cell therapy|stem cell therapy
410041|NCT01824108|Lumbar disc herniation|lumbar disc herniation
410042|NCT01824108|Wallis interspinous implants|wallis interspinous implants
410043|NCT01824108|lumbar discectomy|lumbar discectomy
410044|NCT01824108|interspinous dynamic stability system|interspinous dynamic stability system
410045|NCT01824082|phantom pain|phantom pain
410046|NCT01824082|traumatic limb amputation|traumatic limb amputation
410047|NCT01824082|amputees|amputees
410048|NCT01824069|Critical Ischemia|critical ischemia
410049|NCT01824069|Amputation|amputation
410050|NCT01824056|18F-FDG|18f-fdg
410051|NCT01824043|diabetic retinopathy|diabetic retinopathy
410052|NCT01824043|vitreous hemorrhage|vitreous hemorrhage
410053|NCT01824043|intravitreal ranibizumab|intravitreal ranibizumab
410054|NCT01824030|FFR, OCT, Seattle Angina Questionnaire|ffr, oct, seattle angina questionnaire
410055|NCT01824017|Type 2 diabetes|type 2 diabetes
410056|NCT01824017|metabolic syndrome|metabolic syndrome
410057|NCT01824017|oxidative stress|oxidative stress
410058|NCT01824017|GSH|gsh
410059|NCT01824004|Gastric cancer|gastric cancer
410060|NCT01824004|Adjuvant|adjuvant
410061|NCT01824004|Chemoradiotherapy|chemoradiotherapy
410062|NCT01824004|S-1|s-1
410063|NCT01824004|Cisplatin|cisplatin
410064|NCT01823991|polyphenolics|polyphenolics
410065|NCT01823991|anthocyanins|anthocyanins
410066|NCT01823991|n-3 fatty acids|n-3 fatty acids
410067|NCT01823978|metastatic|metastatic
410068|NCT01823978|castration resistant prostate cancer|castration resistant prostate cancer
410069|NCT01823978|Therapeutic Vaccine|therapeutic vaccine
410070|NCT01823978|Dendritic cell|dendritic cell
410071|NCT01823978|BPX-201|bpx-201
410072|NCT01823978|BPX201|bpx201
410073|NCT01823978|AP1903|ap1903
410074|NCT01823952|HAMS|hams
410075|NCT01823952|ORS|ors
410076|NCT01823952|Cholera|cholera
410077|NCT01823952|Diarrhea|diarrhea
410078|NCT01823939|Cholera|cholera
410079|NCT01823939|V. Cholerae O1|v. cholerae o1
410080|NCT01823939|iOWH032|iowh032
410081|NCT01823939|diarrhoea|diarrhoea
410082|NCT01823939|pharmacokinetic|pharmacokinetic
410083|NCT01823939|Bangladesh|bangladesh
410084|NCT01823926|vibrating mesh nebulizers|vibrating mesh nebulizers
410085|NCT01823926|noninvasive ventilation|noninvasive ventilation
410086|NCT01823926|residual volume|residual volume
410087|NCT01823926|pulmonary scintigraphy|pulmonary scintigraphy
410088|NCT01823926|radioaerosol|radioaerosol
410089|NCT01823926|nebulization.|nebulization.
410090|NCT01823913|Pharmacokinetics|pharmacokinetics
410091|NCT01823900|Pharmacokinetics|pharmacokinetics
410092|NCT01823887|Heart Failure|heart failure
410093|NCT01823887|Vagus Nerve|vagus nerve
410094|NCT01823887|VNS|vns
410095|NCT01823874|Virtual reality analgesia|virtual reality analgesia
410096|NCT01823874|pain control|pain control
410097|NCT01823848|constipation|constipation
410098|NCT01823848|enema|enema
410099|NCT01823822|Anorexia nervosa|anorexia nervosa
410100|NCT01823822|Protein supplements|protein supplements
410101|NCT01823822|IGF-I|igf-i
410102|NCT01823809|Coronary Artery Disease|coronary artery disease
410103|NCT01823809|Computed Tomography|computed tomography
410104|NCT01823809|Cardiac Magnetic Resonance|cardiac magnetic resonance
410105|NCT01823809|Fractional Flow Reserve|fractional flow reserve
410106|NCT01823796|Fibromyalgia|fibromyalgia
410107|NCT01823796|balance|balance
410108|NCT01823796|falls|falls
410109|NCT01823783|Duchenne muscular distrophy|duchenne muscular distrophy
410110|NCT01823783|Endomysial Fibrosis|endomysial fibrosis
410111|NCT01823783|Muscular Inflammatory Response|muscular inflammatory response
410112|NCT01823783|Calcium Homeostasis Dysfunction|calcium homeostasis dysfunction
410113|NCT01823783|Muscle biopsy|muscle biopsy
410114|NCT01823770|Restless Legs Syndrome (RLS)|restless legs syndrome (rls)
410115|NCT01823770|Rotigotine|rotigotine
410116|NCT01823770|HTA|hta
410117|NCT01823770|Cardiovascular diseases|cardiovascular diseases
410118|NCT01823770|Periodic Limb Movements in Sleep (PLMS)|periodic limb movements in sleep (plms)
410119|NCT01823770|dopaminergic agonist|dopaminergic agonist
410120|NCT01823770|Sympathetic overactivity|sympathetic overactivity
410121|NCT01823770|blood pressure|blood pressure
410122|NCT01823757|elderly|elderly
410123|NCT01823757|potential inappropriate medications|potential inappropriate medications
410124|NCT01823757|pharmaceutical care|pharmaceutical care
410125|NCT01823757|quality of life|quality of life
410126|NCT01823757|medical expenditure|medical expenditure
410127|NCT01823744|micronutrient|micronutrient
410128|NCT01823744|genomic|genomic
410129|NCT01823744|SAM/SAH ratio|sam/sah ratio
410130|NCT01823731|PCI,SOTOC, Ovarian cancer|pci,sotoc, ovarian cancer
410131|NCT01823692|Radius Fracture|radius fracture
410132|NCT01823692|Sensitivity|sensitivity
410133|NCT01823692|Reduction|reduction
410134|NCT01823692|Adequacy|adequacy
410135|NCT01823666|Dementia|dementia
410136|NCT01823666|Alzheimer's disease|alzheimer's disease
410137|NCT01823666|mild cognitive impairment|mild cognitive impairment
410138|NCT01823640|HRV|hrv
410139|NCT01823640|Pharmacodynamics / kinetics|pharmacodynamics / kinetics
410140|NCT01823640|Resistance|resistance
410141|NCT01823627|COPD|copd
410142|NCT01823627|Psychiatric inpatient|psychiatric inpatient
410143|NCT01823627|Smoking|smoking
410144|NCT01823614|HIV infection|hiv infection
410145|NCT01823614|tropism determination|tropism determination
410146|NCT01823614|genotypic methodic|genotypic methodic
410147|NCT01823614|R5-tropic variant|r5-tropic variant
410148|NCT01823614|X4-tropic variant|x4-tropic variant
410149|NCT01823601|Well-Being|well-being
410150|NCT01823601|Life Management Program|life management program
410151|NCT01823601|Breathing|breathing
410152|NCT01823601|Meditation|meditation
410153|NCT01823601|Cognitive-Behavioral Training|cognitive-behavioral training
410154|NCT01823575|malignant ureteral obstruction|malignant ureteral obstruction
410155|NCT01823575|silicone-covered metallic ureteral stent|silicone-covered metallic ureteral stent
410156|NCT01823575|double-J stent|double-j stent
410157|NCT01823562|Lyophilized Black Raspberry|lyophilized black raspberry
410158|NCT01823562|Prostate Cancer|prostate cancer
410159|NCT01823562|Surgery|surgery
410160|NCT01823549|CAM|cam
410161|NCT01823549|Alternative Medicine|alternative medicine
410162|NCT01823536|Meningitis|meningitis
410163|NCT01823510|Antiplatelet|antiplatelet
410164|NCT01823510|Ticagrelor|ticagrelor
410165|NCT01823510|Clopidogrel|clopidogrel
410166|NCT01823510|Thrombosis|thrombosis
410167|NCT01823510|Diabetes|diabetes
410168|NCT01823510|Coronary Artery Disease|coronary artery disease
410169|NCT01823497|Neonatal Intensive Care Unit|neonatal intensive care unit
410170|NCT01823497|neonate|neonate
410171|NCT01823497|pain|pain
410172|NCT01823497|morphine|morphine
410173|NCT01823497|Parent/Nurse Controlled Analgesia|parent/nurse controlled analgesia
410174|NCT01823484|hemofilter|hemofilter
410175|NCT01823484|coagulation|coagulation
410176|NCT01823484|CRRT|crrt
410177|NCT01823484|critically ill|critically ill
410178|NCT01823471|HNPCC|hnpcc
410179|NCT01823471|Hereditary non-polyposis colon carcinoma|hereditary non-polyposis colon carcinoma
410180|NCT01823471|Lynch syndrome|lynch syndrome
410181|NCT01823471|i-scan|i-scan
410182|NCT01823471|virtual chromo-endoscopy|virtual chromo-endoscopy
410183|NCT01823471|chromo-endoscopy|chromo-endoscopy
410184|NCT01823471|high definition endoscopy|high definition endoscopy
410185|NCT01823471|polyp detection|polyp detection
410186|NCT01823471|adenoma detection|adenoma detection
410187|NCT01823471|adenoma miss rate|adenoma miss rate
410188|NCT01823458|behavioral economics|behavioral economics
410189|NCT01823458|incentives|incentives
410190|NCT01823458|health behavior|health behavior
410191|NCT01823458|exercise|exercise
410192|NCT01823445|Xylitol|xylitol
410193|NCT01823445|Dental caries|dental caries
410194|NCT01823393|balloon aortic valvuloplasty indication|balloon aortic valvuloplasty indication
410195|NCT01823393|heparin|heparin
410196|NCT01823393|hemorrhagic|hemorrhagic
410197|NCT01823393|ischemic|ischemic
410198|NCT01823380|Amyotrophic lateral sclerosis|amyotrophic lateral sclerosis
410199|NCT01823380|Vitamin D|vitamin d
410200|NCT01823380|Blood Levels|blood levels
710222|NCT00589667|epidermoid/squamous cell|epidermoid/squamous cell
410201|NCT01823367|type 2 diabetes mellitus prevention|type 2 diabetes mellitus prevention
410202|NCT01823367|gestational diabetes mellitus|gestational diabetes mellitus
410203|NCT01823367|pre-diabetes|pre-diabetes
410204|NCT01823367|lifestyle interventions|lifestyle interventions
410205|NCT01823367|pediatric primary prevention of type 2 diabetes|pediatric primary prevention of type 2 diabetes
410206|NCT01823354|Restless Legs Syndrome|restless legs syndrome
410207|NCT01823354|Polysomnography|polysomnography
410208|NCT01823354|Executive cognition|executive cognition
410209|NCT01823341|Type 1 Diabetes|type 1 diabetes
410210|NCT01823341|Hypoglycemia|hypoglycemia
410211|NCT01823341|Continuous Glucose Monitoring|continuous glucose monitoring
410212|NCT01823341|Pump Suspension|pump suspension
410213|NCT01823328|Intubation|intubation
410214|NCT01823328|Airway|airway
410215|NCT01823328|Emergent intubation|emergent intubation
410216|NCT01823328|Rapid sequence intubation|rapid sequence intubation
410217|NCT01823328|Rapid sequence induction|rapid sequence induction
410218|NCT01823328|RSI|rsi
410219|NCT01823328|Ketamine|ketamine
410220|NCT01823328|Etomidate|etomidate
410221|NCT01823328|Sepsis|sepsis
410222|NCT01823328|Sedative|sedative
410223|NCT01823328|Sedation|sedation
410224|NCT01823302|Children with picky-eating behaviors|children with picky-eating behaviors
410225|NCT01823302|Children aged 2.5 - 5 years|children aged 2.5 - 5 years
410226|NCT01823302|reported by caregivers|reported by caregivers
410227|NCT01823302|with weight-for-height z-scores ≤ 25th percentile at enrollment|with weight-for-height z-scores ≤ 25th percentile at enrollment
410228|NCT01823289|Invasive Pulmonary Fungal Infection|invasive pulmonary fungal infection
410229|NCT01823289|Itraconazole|itraconazole
410230|NCT01823250|Hispanic|hispanic
410231|NCT01823250|adolescent|adolescent
410232|NCT01823250|drug abuse treatment|drug abuse treatment
410233|NCT01823250|evidence-based|evidence-based
410234|NCT01823250|family therapy|family therapy
410235|NCT01823250|adaptive family treatment|adaptive family treatment
410236|NCT01823250|Culturally Informed Family-Based Treatment for Adolescents|culturally informed family-based treatment for adolescents
410237|NCT01823237|Dystonia|dystonia
410238|NCT01823237|Transcranial Magnetic Stimulation|transcranial magnetic stimulation
410239|NCT01823237|Rehabilitation|rehabilitation
410240|NCT01823237|Plasticity|plasticity
410365|NCT01822704|Stroke|stroke
410241|NCT01823211|ICD (Implantable cardioverter-defibrillator)|icd (implantable cardioverter-defibrillator)
410242|NCT01823211|Heart rate variability|heart rate variability
410243|NCT01823211|MTWA (Microvolt T-alternans)|mtwa (microvolt t-alternans)
410244|NCT01823211|Magnetic resonance imaging (MRI)|magnetic resonance imaging (mri)
410245|NCT01823185|Clopidogrel|clopidogrel
410246|NCT01823185|Ticagrelor|ticagrelor
410247|NCT01823185|Prasugrel|prasugrel
410248|NCT01823185|Platelet aggregation inhibitor|platelet aggregation inhibitor
410249|NCT01823185|Dammam University|dammam university
410250|NCT01823185|King Fahd Hospital|king fahd hospital
410251|NCT01823185|Purinergic P2 receptor Antagonists|purinergic p2 receptor antagonists
410252|NCT01823172|breast cancer|breast cancer
410253|NCT01823172|melanoma|melanoma
410254|NCT01823172|sentinel lymph node biopsy|sentinel lymph node biopsy
410255|NCT01823172|lymphadenectomy|lymphadenectomy
410256|NCT01823159|retigabine|retigabine
410257|NCT01823159|cortical excitability|cortical excitability
410455|NCT01822340|AGHD|aghd
410258|NCT01823159|Transcranial Magnetic Stimulation|transcranial magnetic stimulation
410259|NCT01823146|oxytocin|oxytocin
410260|NCT01823146|socioemotional functioning|socioemotional functioning
410261|NCT01823146|trust|trust
410262|NCT01823146|amygdala|amygdala
410263|NCT01823146|aging|aging
410264|NCT01823120|Self harm|self harm
410265|NCT01823120|Emergency Department|emergency department
410266|NCT01823120|Repetition|repetition
410267|NCT01823120|Supportive Text messages|supportive text messages
410268|NCT01823120|Interactive|interactive
410269|NCT01823107|Meso BioMatrix|meso biomatrix
410270|NCT01823107|Breast|breast
410271|NCT01823107|Breast Cancer|breast cancer
410272|NCT01823107|Mastectomy|mastectomy
410273|NCT01823107|Biologic Mesh|biologic mesh
410274|NCT01823107|Breast Reconstruction|breast reconstruction
410275|NCT01823094|lung cancer|lung cancer
410276|NCT01823094|computed tomography|computed tomography
410277|NCT01823094|blood flow|blood flow
410278|NCT01823068|Lung cancer|lung cancer
410279|NCT01823068|RET fusion|ret fusion
410280|NCT01823068|Vandetanib|vandetanib
410281|NCT01823042|Crohn's Disease|crohn's disease
410282|NCT01823042|maintain remission|maintain remission
410283|NCT01823042|postoperative recurrence|postoperative recurrence
410284|NCT01823042|surgery|surgery
410285|NCT01823042|living quality|living quality
410286|NCT01823029|Crohn's Disease|crohn's disease
410287|NCT01823029|intravenous iron|intravenous iron
410288|NCT01823029|iron deficiency anaemia|iron deficiency anaemia
410289|NCT01823029|Oxidative Stress|oxidative stress
410290|NCT01823029|inflammation|inflammation
410291|NCT01823016|Uncontrolled, persistent asthma|uncontrolled, persistent asthma
410292|NCT01823003|Carcinoma, Non-Small-Cell Lung|carcinoma, non-small-cell lung
410293|NCT01823003|Neoplasm Metastasis|neoplasm metastasis
410294|NCT01823003|Radiosurgery|radiosurgery
410295|NCT01822990|Anti-beta2-glycoprotein antibodies|anti-beta2-glycoprotein antibodies
410296|NCT01822990|Peripheral arterial disease|peripheral arterial disease
410297|NCT01822990|Inflammation|inflammation
410298|NCT01822990|Nitric oxide|nitric oxide
410299|NCT01822990|Endothelial dysfunction|endothelial dysfunction
410300|NCT01822977|gut microbiota|gut microbiota
410301|NCT01822977|proton pump inhibitor|proton pump inhibitor
410302|NCT01822977|Clostridium difficile infection|clostridium difficile infection
410303|NCT01822977|Fecal microbiome|fecal microbiome
410304|NCT01822977|single episode of CDI|single episode of cdi
410305|NCT01822951|DAT Study|dat study
410306|NCT01822925|Diabetes|diabetes
410307|NCT01822925|Pain|pain
410308|NCT01822925|Neuropathy|neuropathy
410309|NCT01822912|Skilled Nursing Facility|skilled nursing facility
410310|NCT01822912|Heart Failure|heart failure
410311|NCT01822912|Transitional Care|transitional care
410312|NCT01822899|Novel Dry Powder Inhaler (NDPI)|novel dry powder inhaler (ndpi)
410313|NCT01822899|umeclidinium bromide (UMEC)|umeclidinium bromide (umec)
410314|NCT01822899|GSK573719|gsk573719
410315|NCT01822899|lung function|lung function
410316|NCT01822899|GW642444|gw642444
410317|NCT01822899|salmeterol (SAL)|salmeterol (sal)
410318|NCT01822899|fluticasone propionate (FP)|fluticasone propionate (fp)
410319|NCT01822899|vilanterol (VI)|vilanterol (vi)
410320|NCT01822899|Chronic obstructive pulmonary disease|chronic obstructive pulmonary disease
410321|NCT01822886|T-cell lymphoma|t-cell lymphoma
410322|NCT01822886|Romidepsin|romidepsin
410323|NCT01822860|Hypertension|hypertension
410324|NCT01822860|Endothelial dysfunction|endothelial dysfunction
410325|NCT01822847|adrenal|adrenal
410326|NCT01822847|steroids|steroids
410327|NCT01822847|cortisol|cortisol
410328|NCT01822847|stress|stress
410329|NCT01822821|Males or females|males or females
410330|NCT01822821|18 years of age or older.|18 years of age or older.
410331|NCT01822821|Non-emergency|non-emergency
410332|NCT01822821|cardiac surgery|cardiac surgery
410333|NCT01822821|midline sternotomy.|midline sternotomy.
410334|NCT01822808|acute heart failure|acute heart failure
410335|NCT01822808|left ventricular dysfunction|left ventricular dysfunction
410336|NCT01822808|hydralazine|hydralazine
410337|NCT01822808|isosorbide dinitrate|isosorbide dinitrate
410338|NCT01822795|Chronic obstructive pulmonary disease|chronic obstructive pulmonary disease
410339|NCT01822795|Endoscopic lung volume reduction|endoscopic lung volume reduction
410340|NCT01822782|Perineal tear|perineal tear
410341|NCT01822782|Perineal lesion|perineal lesion
410342|NCT01822782|Vaginal flora|vaginal flora
410343|NCT01822782|Birth|birth
410344|NCT01822769|congenital heart disease|congenital heart disease
410345|NCT01822769|adult congenital heart disease|adult congenital heart disease
410346|NCT01822769|cardiac rehabilitation|cardiac rehabilitation
410347|NCT01822769|cardiopulmonary rehabilitation|cardiopulmonary rehabilitation
410348|NCT01822769|exercise|exercise
410349|NCT01822769|cardiopulmonary exercise testing|cardiopulmonary exercise testing
410350|NCT01822769|peak vO2|peak vo2
410351|NCT01822769|quality of life|quality of life
410352|NCT01822743|Osteopathy|osteopathy
410353|NCT01822743|Sleep Apnea Syndromes|sleep apnea syndromes
410354|NCT01822743|Obstructive Sleep Apnea|obstructive sleep apnea
410355|NCT01822743|Pcrit|pcrit
410356|NCT01822743|Polysomnography|polysomnography
410357|NCT01822730|Methamphetamine-Associated Psychosis|methamphetamine-associated psychosis
410358|NCT01822730|Aripiprazole|aripiprazole
410359|NCT01822730|Risperidone|risperidone
410360|NCT01822717|Diabetes|diabetes
410361|NCT01822717|Visual Impairment|visual impairment
410362|NCT01822717|Blindness|blindness
410363|NCT01822717|Foot Care|foot care
410364|NCT01822717|Self-Management|self-management
410366|NCT01822704|Exercise|exercise
410367|NCT01822704|Rehabilitation|rehabilitation
410368|NCT01822704|Vibration|vibration
410369|NCT01822691|myelodysplastic syndromes (MDS)|myelodysplastic syndromes (mds)
410370|NCT01822691|neoplastic stem cell disorders|neoplastic stem cell disorders
410371|NCT01822691|refractory cytopenias|refractory cytopenias
410372|NCT01822691|dysplastic morphological features|dysplastic morphological features
410373|NCT01822691|acute myeloid leukemia (AML)|acute myeloid leukemia (aml)
410374|NCT01822652|Neuroblastoma|neuroblastoma
410375|NCT01822652|Solid tumor|solid tumor
410376|NCT01822652|Neuroblastoma-specific immunotherapy targeting GD2|neuroblastoma-specific immunotherapy targeting gd2
410377|NCT01822652|CAR T cells|car t cells
410378|NCT01822652|Gene Therapy|gene therapy
410379|NCT01822652|Relapsed|relapsed
410380|NCT01822652|Refractory|refractory
410381|NCT01822639|Hypertension|hypertension
410382|NCT01822639|enalapril maleate|enalapril maleate
410383|NCT01822639|healthy volunteers|healthy volunteers
410384|NCT01822639|amlodipine|amlodipine
410385|NCT01822639|pharmacokinetics|pharmacokinetics
410386|NCT01822626|overweight|overweight
410387|NCT01822626|obesity|obesity
410388|NCT01822626|children|children
410389|NCT01822626|BMI|bmi
410390|NCT01822626|counseling|counseling
410391|NCT01822626|pediatrician|pediatrician
410392|NCT01822613|esophageal cancer|esophageal cancer
410393|NCT01822600|hypoalbuminemia|hypoalbuminemia
410394|NCT01822600|peptic ulcer|peptic ulcer
410395|NCT01822600|rebleeding|rebleeding
410396|NCT01822600|hospitalization|hospitalization
410397|NCT01822587|Drug Abuse|drug abuse
410398|NCT01822587|Cocaine|cocaine
410399|NCT01822587|Addiction|addiction
410400|NCT01822561|Central Serous Chorioretinopathy|central serous chorioretinopathy
410401|NCT01822561|Eplerenone|eplerenone
410402|NCT01822561|Optical Coherence Tomography|optical coherence tomography
410403|NCT01822561|Enhanced Depth Imaging|enhanced depth imaging
410404|NCT01822561|Subretinal Fluid|subretinal fluid
410405|NCT01822548|EPC|epc
410406|NCT01822548|diabetes|diabetes
410407|NCT01822548|DPP IV inhibitors|dpp iv inhibitors
410408|NCT01822535|Quadriplegia|quadriplegia
410409|NCT01822535|Spinal Cord Injuries|spinal cord injuries
410410|NCT01822535|Body Temperature Regulation|body temperature regulation
410411|NCT01822535|Mild Cognitive Impairment|mild cognitive impairment
410412|NCT01822483|Renal transplantation|renal transplantation
410413|NCT01822483|mycophenolic acid|mycophenolic acid
410414|NCT01822483|mycophenolate mofetil|mycophenolate mofetil
410415|NCT01822483|mycophenolate sodium|mycophenolate sodium
410416|NCT01822483|area under the curve|area under the curve
410417|NCT01822470|functional dyspepsia|functional dyspepsia
410418|NCT01822470|post prandial distress syndrome|post prandial distress syndrome
410419|NCT01822470|small bowel bacteria overgrowth|small bowel bacteria overgrowth
410420|NCT01822470|epigastric pain syndrome|epigastric pain syndrome
410421|NCT01822470|diarrhea|diarrhea
410422|NCT01822470|bloating|bloating
410423|NCT01822470|post prandial fullness|post prandial fullness
410424|NCT01822470|weight loss|weight loss
410425|NCT01822444|Colorectal Cancer|colorectal cancer
410426|NCT01822444|Advanced Colorectal Cancer|advanced colorectal cancer
410427|NCT01822444|Metastatic Colorectal Cancer|metastatic colorectal cancer
410428|NCT01822444|Locally Advanced Colorectal Cancer|locally advanced colorectal cancer
410429|NCT01822444|Colon Cancer|colon cancer
410430|NCT01822444|Rectal Cancer|rectal cancer
410431|NCT01822418|Schizophrenia|schizophrenia
410432|NCT01822418|Depression|depression
410433|NCT01822418|Cognition|cognition
410434|NCT01822418|Agomelatine|agomelatine
410435|NCT01822418|Antidepressant|antidepressant
410436|NCT01822392|Online treatment|online treatment
410437|NCT01822392|Treatment of conduct problems|treatment of conduct problems
410438|NCT01822392|Parent training|parent training
410439|NCT01822366|Children|children
410440|NCT01822366|Adolescents|adolescents
410441|NCT01822366|Trauma-focused Cognitive Behavioral Therapy (TF-CBT)|trauma-focused cognitive behavioral therapy (tf-cbt)
410442|NCT01822366|Low- and Middle-Income Countries (LMIC)|low- and middle-income countries (lmic)
410443|NCT01822366|Randomized Controlled Trial (RCT)|randomized controlled trial (rct)
410444|NCT01822366|Evidence-Based Practice (EBP)|evidence-based practice (ebp)
410445|NCT01822366|Childhood Traumatic Grief (CTG)|childhood traumatic grief (ctg)
410446|NCT01822366|Post-Traumatic Stress Disorder (PTSD)|post-traumatic stress disorder (ptsd)
410447|NCT01822366|Kenya|kenya
410448|NCT01822366|Tanzania|tanzania
410449|NCT01822366|East Africa|east africa
410450|NCT01822366|Mental Health|mental health
410451|NCT01822353|food allergy|food allergy
410452|NCT01822353|milk allergy|milk allergy
410453|NCT01822353|egg allergy|egg allergy
410454|NCT01822353|nut allergy|nut allergy
410456|NCT01822314|breast|breast
410457|NCT01822314|cancer|cancer
410458|NCT01822314|unilateral|unilateral
410459|NCT01822314|non metastatic|non metastatic
410460|NCT01822314|HER2 negative|her2 negative
410461|NCT01822301|Craniomaxillofacial (CMF) Battle-injured (BI)|craniomaxillofacial (cmf) battle-injured (bi)
410462|NCT01822301|Facial Trauma|facial trauma
410463|NCT01822301|Fat Grafts|fat grafts
410464|NCT01822301|Autogenous Fat Transfers (AFT)|autogenous fat transfers (aft)
410465|NCT01822301|Wounded warriors|wounded warriors
410466|NCT01822288|Menopause|menopause
410467|NCT01822288|Tibolone|tibolone
410468|NCT01822288|Estradiol|estradiol
410469|NCT01822288|Hormone therapy|hormone therapy
410470|NCT01822275|GBM|gbm
410471|NCT01822262|Cholecystolithotomy with gallbladder reservation|cholecystolithotomy with gallbladder reservation
410472|NCT01822262|cholecystolithiasis|cholecystolithiasis
410473|NCT01822249|Rett syndrome|rett syndrome
410474|NCT01822249|EPI-743|epi-743
410475|NCT01822249|Edison|edison
410476|NCT01822236|low back pain|low back pain
410477|NCT01822236|Manual Therapy|manual therapy
410478|NCT01822236|Randomized Controlled Trial|randomized controlled trial
410479|NCT01822236|Quality of life|quality of life
410480|NCT01822223|Dental Implants|dental implants
410481|NCT01822223|Implant abutments|implant abutments
410482|NCT01822210|Botulinum Toxins|botulinum toxins
410483|NCT01822210|Injections|injections
410484|NCT01822210|Stomach|stomach
410485|NCT01822210|Tomography, X-Ray Computed|tomography, x-ray computed
410486|NCT01822197|Phototherapy|phototherapy
710223|NCT00589667|carcinoma|carcinoma
410487|NCT01822184|Neurodevelopmental Status|neurodevelopmental status
410488|NCT01822184|Pediatric Hunter syndrome patients|pediatric hunter syndrome patients
410489|NCT01822184|Central Nervous System (CNS) involvement|central nervous system (cns) involvement
410490|NCT01822184|Observational study|observational study
410491|NCT01822184|Cognitive impairment|cognitive impairment
410492|NCT01822171|Heart Failure|heart failure
410493|NCT01822171|Medication Therapy Management|medication therapy management
410494|NCT01822158|Vaginal Delivery|vaginal delivery
410495|NCT01822158|Debrief|debrief
410496|NCT01822158|Medical Team Communication|medical team communication
410497|NCT01822158|Obstetrical Safety|obstetrical safety
410498|NCT01822145|implantable-cardioverter-defibrillator|implantable-cardioverter-defibrillator
410499|NCT01822145|ventricular tachycardia|ventricular tachycardia
410500|NCT01822145|ventricular fibrillation|ventricular fibrillation
410501|NCT01822145|sudden cardiac arrest|sudden cardiac arrest
410502|NCT01822080|Endometriosis|endometriosis
410503|NCT01822080|Efficacy|efficacy
410504|NCT01822080|Safety|safety
410505|NCT01822080|Dienogest|dienogest
410506|NCT01822041|healthy volunteers|healthy volunteers
410507|NCT01822041|mass balance study|mass balance study
410508|NCT01822041|Pharmacokinetics|pharmacokinetics
410509|NCT01822028|diarrhea|diarrhea
410510|NCT01822002|Vertigo|vertigo
410511|NCT01822002|Nystagmus|nystagmus
410512|NCT01822002|BPPV = benign paroxysmal positional vertigo|bppv = benign paroxysmal positional vertigo
410513|NCT01822002|Treatment outcome|treatment outcome
410514|NCT01821963|Infection|infection
410515|NCT01821963|Hepatitis C Genotype 1 Infection|hepatitis c genotype 1 infection
410516|NCT01821963|Hepatitis C virus|hepatitis c virus
410517|NCT01821963|HCV|hcv
410518|NCT01821963|Hepatocellular Carcinoma|hepatocellular carcinoma
410519|NCT01821963|HCC|hcc
410520|NCT01821963|Liver Transplantation|liver transplantation
410521|NCT01821963|Pegylated Interferon Alfa 2a|pegylated interferon alfa 2a
410522|NCT01821963|PegIFN alfa-2a|pegifn alfa-2a
410523|NCT01821963|Ribavirin|ribavirin
410524|NCT01821963|RBV|rbv
410525|NCT01821963|Telaprevir|telaprevir
410526|NCT01821963|Incivek|incivek
410527|NCT01821963|Antiviral drugs|antiviral drugs
410528|NCT01821950|Mental health|mental health
410529|NCT01821950|Substance use|substance use
410530|NCT01821950|Substance use initiation|substance use initiation
410531|NCT01821950|Education|education
410532|NCT01821950|Mind Body Therapies|mind body therapies
410533|NCT01821950|Yoga|yoga
410534|NCT01821950|Meditation|meditation
410535|NCT01821950|Adolescent|adolescent
410536|NCT01821950|Adolescence|adolescence
410537|NCT01821950|Child|child
410538|NCT01821950|Children|children
410539|NCT01821950|Middle School|middle school
410540|NCT01821898|Eosinophil|eosinophil
410541|NCT01821898|Reflux|reflux
410542|NCT01821898|Esophagus|esophagus
410543|NCT01821898|Food allergy|food allergy
410544|NCT01821898|Trouble Swallowing|trouble swallowing
410545|NCT01821898|Pediatrics|pediatrics
410546|NCT01821885|Spirometry|spirometry
410547|NCT01821885|screening|screening
410548|NCT01821885|smoking cessation|smoking cessation
410549|NCT01821885|tobacco|tobacco
410550|NCT01821885|COPD|copd
410551|NCT01821872|paracetamol|paracetamol
410552|NCT01821872|acetaminophen|acetaminophen
410553|NCT01821872|AM404|am404
410554|NCT01821872|CSF|csf
410555|NCT01821872|pharmacokinetics|pharmacokinetics
410556|NCT01821833|omega-3|omega-3
410557|NCT01821833|fatty acids|fatty acids
410558|NCT01821833|paclitaxel|paclitaxel
410559|NCT01821833|acute pain syndrome|acute pain syndrome
410560|NCT01821833|peripheral neuropathy|peripheral neuropathy
410561|NCT01821833|chemotherapy induced neuropathy|chemotherapy induced neuropathy
410562|NCT01821820|Inflammation|inflammation
410563|NCT01821820|Oxidative stress|oxidative stress
410564|NCT01821820|Immune dysfunction|immune dysfunction
410565|NCT01821820|Metabolites|metabolites
410566|NCT01821807|spinal anesthesia|spinal anesthesia
410567|NCT01821807|spinal needle|spinal needle
410568|NCT01821807|cesarean section|cesarean section
410569|NCT01821807|headache|headache
410570|NCT01821807|backache|backache
410571|NCT01821781|Immune deficiency|immune deficiency
410572|NCT01821781|Immune disorders|immune disorders
410573|NCT01821781|Immune dysregulatory|immune dysregulatory
410574|NCT01821781|Reduced Intensity|reduced intensity
410575|NCT01821781|Alemtuzumab|alemtuzumab
410576|NCT01821781|Campath|campath
410577|NCT01821742|Shock|shock
410578|NCT01821742|Fluid bolus|fluid bolus
410579|NCT01821742|Cardiac output|cardiac output
410580|NCT01821742|Children in intensive care|children in intensive care
410581|NCT01821729|Locally Advanced|locally advanced
410582|NCT01821716|standardization|standardization
410583|NCT01821716|skin prick test|skin prick test
410584|NCT01821716|inmunotherapy|inmunotherapy
410585|NCT01821690|Traumatic Brain Injury|traumatic brain injury
410586|NCT01821690|Buspirone|buspirone
410587|NCT01821690|Behavior|behavior
410588|NCT01821690|Irritability|irritability
410589|NCT01821690|Aggression|aggression
410590|NCT01821664|Prosthetic vascular graft infection|prosthetic vascular graft infection
410591|NCT01821664|negative pressure wound therapy|negative pressure wound therapy
410592|NCT01821664|microbiology|microbiology
410593|NCT01821664|antimicrobial therapy|antimicrobial therapy
410594|NCT01821651|TAVI|tavi
410595|NCT01821651|MitraClip|mitraclip
410596|NCT01821651|image modality|image modality
410597|NCT01821651|echocardiography|echocardiography
410598|NCT01821651|angiography|angiography
410599|NCT01821638|Heart failure|heart failure
410600|NCT01821638|Cognition|cognition
410601|NCT01821638|Brain|brain
410602|NCT01821638|Older adults|older adults
410603|NCT01821625|Thrombocytopenia|thrombocytopenia
410604|NCT01821625|Hepatitis|hepatitis
410605|NCT01821625|Platelets|platelets
410606|NCT01821625|Eltrombopag|eltrombopag
410607|NCT01821625|Liver Disease|liver disease
410608|NCT01821625|Antiviral Treatment|antiviral treatment
410609|NCT01821599|Anterior Cruciate Ligament|anterior cruciate ligament
410610|NCT01821599|Knee|knee
410611|NCT01821599|Rehabilitation|rehabilitation
410612|NCT01821586|Diarrhoea;|diarrhoea;
410613|NCT01821586|Severe malnutrition;|severe malnutrition;
410614|NCT01821586|Benefiber;|benefiber;
410615|NCT01821586|ReSoMal;|resomal;
410616|NCT01821586|modified ORS|modified ors
410617|NCT01821573|botulinum toxin injection,3D motion analysis, muscular lengthening,muscle strength|botulinum toxin injection,3d motion analysis, muscular lengthening,muscle strength
410618|NCT01821560|Nicotine Addiction|nicotine addiction
410619|NCT01821560|fMRI|fmri
410620|NCT01821560|Baclofen|baclofen
410621|NCT01821508|Gastroplasty, Diabetes Mellitus Type II, Obesity|gastroplasty, diabetes mellitus type ii, obesity
410622|NCT01821495|NPC,DC-CIK|npc,dc-cik
410623|NCT01821482|Hepatocellular carcinoma, DC-CIK|hepatocellular carcinoma, dc-cik
410624|NCT01821469|bipolar disorders|bipolar disorders
410625|NCT01821469|euthymic|euthymic
410626|NCT01821469|psychotherapy|psychotherapy
410627|NCT01821469|Functional magnetic resonance imaging|functional magnetic resonance imaging
410628|NCT01821456|hematological malignancies|hematological malignancies
410629|NCT01821456|cancer|cancer
410630|NCT01821456|chemotherapy|chemotherapy
410631|NCT01821456|anti-infectives|anti-infectives
410632|NCT01821456|treatment|treatment
410633|NCT01821456|outcome|outcome
410634|NCT01821443|1 to 10 measurable brain metastases|1 to 10 measurable brain metastases
410635|NCT01821430|Chronic Pain|chronic pain
410636|NCT01821430|Narcotic Abuse|narcotic abuse
410637|NCT01821430|Opioid related disorders|opioid related disorders
410638|NCT01821430|Opiate substitution treatment|opiate substitution treatment
410639|NCT01821430|Buprenorphrine|buprenorphrine
410640|NCT01821430|Pregabalin|pregabalin
410641|NCT01821430|Methadone|methadone
410642|NCT01821417|dental implants|dental implants
410643|NCT01821417|screw-vent dental implants|screw-vent dental implants
410644|NCT01821404|Apoptosis|apoptosis
410645|NCT01821404|Atorvastatin|atorvastatin
410646|NCT01821404|Inflammation|inflammation
410647|NCT01821404|Pre-surgical trial|pre-surgical trial
410648|NCT01821404|Proliferation|proliferation
410649|NCT01821404|Prostate cancer|prostate cancer
410650|NCT01821391|actinic keratoses|actinic keratoses
410651|NCT01821391|photodynamic therapy|photodynamic therapy
410652|NCT01821391|natural daylight|natural daylight
410653|NCT01821378|Schizophrenia|schizophrenia
410654|NCT01821378|Lurasidone|lurasidone
410655|NCT01821378|Latuda|latuda
410656|NCT01821365|COPD,PETCO2,PaCO2|copd,petco2,paco2
410657|NCT01821326|capsule endoscopy|capsule endoscopy
410658|NCT01821326|obscure gastrointestinal bleeding|obscure gastrointestinal bleeding
410659|NCT01821326|rebleeding|rebleeding
410660|NCT01821326|risk factors|risk factors
410661|NCT01821313|Childhood obesity|childhood obesity
410662|NCT01821313|Inflammation|inflammation
410663|NCT01821313|Endothelial function|endothelial function
410664|NCT01821313|Exercise|exercise
410665|NCT01821300|Down syndrome|down syndrome
410666|NCT01821300|Philadelphia|philadelphia
410667|NCT01821300|The Children's Hospital of Philadelphia|the children's hospital of philadelphia
410668|NCT01821300|Body composition|body composition
410669|NCT01821300|Obesity|obesity
410670|NCT01821300|Cardiovascular|cardiovascular
410671|NCT01821261|Gums|gums
410672|NCT01821261|Gingiva|gingiva
410673|NCT01821261|Gingival Inflammation|gingival inflammation
410674|NCT01821261|Gingival Bleeding|gingival bleeding
410675|NCT01821222|Maternal health|maternal health
410676|NCT01821222|Neonatal health|neonatal health
410677|NCT01821222|mHealth|mhealth
410678|NCT01821222|Mobile phones|mobile phones
410679|NCT01821222|Access to health services|access to health services
410680|NCT01821222|Health behavior|health behavior
410681|NCT01821209|prostate cancer, robotic surgery, urethral sling,|prostate cancer, robotic surgery, urethral sling,
410682|NCT01821196|Tumor Markers, Biological|tumor markers, biological
410683|NCT01821196|PGP9.5 protein, human|pgp9.5 protein, human
410684|NCT01821196|adenocarcinoma|adenocarcinoma
410685|NCT01821170|ADHD|adhd
410686|NCT01821170|children|children
710224|NCT00589667|pharynx|pharynx
525091|NCT01326572|HIV|hiv
410687|NCT01821170|cognitive remediation|cognitive remediation
410688|NCT01821170|virtual reality|virtual reality
410689|NCT01821157|crown lengthening|crown lengthening
410690|NCT01821157|gingivoplasty|gingivoplasty
410691|NCT01821157|surgical procedures|surgical procedures
410692|NCT01821157|gingivectomy|gingivectomy
410693|NCT01821157|esthetic surgery|esthetic surgery
410694|NCT01821144|dietary salt|dietary salt
410695|NCT01821144|24 hour urinary sodium|24 hour urinary sodium
410696|NCT01821144|blood pressure|blood pressure
410697|NCT01821131|flax|flax
410698|NCT01821131|muffin|muffin
410699|NCT01821131|cholesterol|cholesterol
410700|NCT01821131|lignan|lignan
410701|NCT01821131|ALA|ala
410702|NCT01821118|Cerebral amyloid angiopathy (CAA)|cerebral amyloid angiopathy (caa)
410703|NCT01821118|cerebrovascular reactivity|cerebrovascular reactivity
410704|NCT01821118|functional MRI|functional mri
410705|NCT01821118|randomized|randomized
410706|NCT01821118|double blind|double blind
410707|NCT01821118|safety|safety
410708|NCT01821118|efficacy|efficacy
410709|NCT01821105|computed tomography|computed tomography
410710|NCT01821105|CT scan|ct scan
410711|NCT01821105|positron emission tomography|positron emission tomography
410712|NCT01821105|PET|pet
410713|NCT01821105|Metastatic Colorectal Cancer|metastatic colorectal cancer
410714|NCT01821092|osseointegrated Implant, bone level|osseointegrated implant, bone level
410715|NCT01821079|Single dose|single dose
410716|NCT01821079|Relative Bioavailability|relative bioavailability
410717|NCT01821079|Food effect|food effect
410718|NCT01821079|Healthy subjects|healthy subjects
410719|NCT01821079|Diabetes Mellitus Type 2|diabetes mellitus type 2
410720|NCT01821066|PD-0332991|pd-0332991
410721|NCT01821066|palbociclib|palbociclib
410722|NCT01821066|tamoxifen|tamoxifen
410723|NCT01821066|drug-drug interaction (DDI) study|drug-drug interaction (ddi) study
410724|NCT01821053|Preeclampsia|preeclampsia
410725|NCT01821053|Pregestational Type 1 diabetes|pregestational type 1 diabetes
410726|NCT01821053|diabetes mellitus|diabetes mellitus
410727|NCT01821053|proteinuria|proteinuria
410728|NCT01821053|plasminogen|plasminogen
410729|NCT01821053|plasmin|plasmin
410730|NCT01821053|renin|renin
410731|NCT01821053|aldosterone|aldosterone
410732|NCT01821053|angiotensin|angiotensin
410733|NCT01821053|epithelial sodium channel|epithelial sodium channel
410734|NCT01821053|ENaC|enac
410735|NCT01821040|Polymyalgia rheumatica|polymyalgia rheumatica
410736|NCT01821040|PMR|pmr
410737|NCT01821040|Modified release prednisone|modified release prednisone
410738|NCT01821027|Healthy|healthy
410739|NCT01821027|Canagliflozin (JNJ-28431754)|canagliflozin (jnj-28431754)
410740|NCT01821027|Pharmacokinetics|pharmacokinetics
410741|NCT01821027|Pharmacodynamics|pharmacodynamics
410742|NCT01821027|Simvastatin (ZOCOR)|simvastatin (zocor)
410743|NCT01821014|Diagnostic concordance|diagnostic concordance
410744|NCT01821014|Treatment concordance|treatment concordance
410745|NCT01821014|patient satisfaction|patient satisfaction
410746|NCT01821014|physician satisfaction|physician satisfaction
410747|NCT01821014|Medical Outreach Clinics|medical outreach clinics
410748|NCT01821014|Medical Brigades|medical brigades
410749|NCT01821014|Medical Missions|medical missions
410750|NCT01821014|Telemedicine|telemedicine
410751|NCT01821014|Videoconference|videoconference
410752|NCT01821014|diagnoses|diagnoses
410753|NCT01821014|treatments|treatments
410754|NCT01821014|Satellite Internet|satellite internet
410755|NCT01821014|VSAT|vsat
410756|NCT01821014|cross cultural telemedicine|cross cultural telemedicine
410757|NCT01821001|Adenomyosis|adenomyosis
410758|NCT01821001|Dysmenorrhea|dysmenorrhea
410759|NCT01821001|Abnormal Uterine bleeding|abnormal uterine bleeding
410760|NCT01821001|Heavy Menstrual Bleeding|heavy menstrual bleeding
410761|NCT01821001|Menorrhagia|menorrhagia
410762|NCT01820975|Muscle protein synthesis|muscle protein synthesis
410763|NCT01820975|Dietary protein|dietary protein
410764|NCT01820962|hematological patients|hematological patients
410765|NCT01820962|central venous catheters|central venous catheters
410766|NCT01820962|catheter related thrombosis|catheter related thrombosis
410767|NCT01820962|catheter related infections|catheter related infections
410768|NCT01820962|concentrated citrate|concentrated citrate
410769|NCT01820949|patient blood management|patient blood management
410770|NCT01820949|patients safety|patients safety
410771|NCT01820936|Healthy volunteers|healthy volunteers
410772|NCT01820936|PCI-32765|pci-32765
410773|NCT01820936|PCI-45227|pci-45227
410774|NCT01820936|Pharmacokinetics|pharmacokinetics
410775|NCT01820871|T2DM|t2dm
410776|NCT01820871|smartphone application|smartphone application
410777|NCT01820871|serum fasting glucose|serum fasting glucose
410778|NCT01820871|HbA1c|hba1c
410779|NCT01820845|Plethysmographic Variability Index|plethysmographic variability index
410780|NCT01820845|Esophageal Doppler|esophageal doppler
410781|NCT01820845|Scoliosis|scoliosis
410782|NCT01820845|Children|children
410783|NCT01820845|Age < 18 years|age < 18 years
710225|NCT00589667|larynx|larynx
410784|NCT01820845|Scheduled for Scoliosis Surgery|scheduled for scoliosis surgery
410785|NCT01820832|mild proteinuria|mild proteinuria
410786|NCT01820832|calcitriol|calcitriol
410787|NCT01820832|renal function|renal function
410788|NCT01820832|blood pressure|blood pressure
410789|NCT01820819|Inpatient|inpatient
410790|NCT01820819|Liver cirrhosis|liver cirrhosis
410791|NCT01820819|Liver Cirrhosis, Alcoholic|liver cirrhosis, alcoholic
410792|NCT01820819|Physician's Practice Patterns|physician's practice patterns
410793|NCT01820819|Liver Transplantation|liver transplantation
410794|NCT01820819|Delivery of Health Care|delivery of health care
410795|NCT01820819|Resource Allocation|resource allocation
410796|NCT01820793|antibiotic resistance|antibiotic resistance
410797|NCT01820793|E.coli|e.coli
410798|NCT01820793|cefoxitin|cefoxitin
410799|NCT01820793|pyelonephritis|pyelonephritis
410800|NCT01820780|Heart failure|heart failure
410801|NCT01820780|Disease management program|disease management program
410802|NCT01820767|Chronic Kidney Disease|chronic kidney disease
410803|NCT01820767|Vd-stadium.|vd-stadium.
410804|NCT01820767|Inflammatory patterns|inflammatory patterns
410805|NCT01820767|Paricalcitol|paricalcitol
410806|NCT01820767|Atorvastatin|atorvastatin
410807|NCT01820754|Non Small Cell Lung Cancer|non small cell lung cancer
410808|NCT01820754|Lung Cancer|lung cancer
410809|NCT01820754|Non Small Cell|non small cell
410810|NCT01820702|bone metabolism|bone metabolism
410811|NCT01820702|acid base balance|acid base balance
410812|NCT01820702|bed rest|bed rest
410813|NCT01820663|stroke|stroke
410814|NCT01820663|ketones|ketones
410815|NCT01820663|ketogenic diet|ketogenic diet
410816|NCT01820663|impairment|impairment
410817|NCT01820663|disability|disability
410818|NCT01820650|osteoarthritis|osteoarthritis
410819|NCT01820650|knee replacement|knee replacement
410820|NCT01820650|patient-specific|patient-specific
410821|NCT01820637|atherosclerosis|atherosclerosis
410823|NCT01820637|PPA|ppa
410824|NCT01820637|lower extremities|lower extremities
410825|NCT01820637|stenting|stenting
410826|NCT01820637|paclitaxel|paclitaxel
410827|NCT01820585|fibromyalgia|fibromyalgia
410828|NCT01820585|Eslicarbazepine acetate (BIA 2-093)|eslicarbazepine acetate (bia 2-093)
410829|NCT01820585|ESL|esl
410830|NCT01820559|migraine; ESL; eslicarbazepine acetate|migraine; esl; eslicarbazepine acetate
410831|NCT01820533|Smoking|smoking
410832|NCT01820533|Cellular phones|cellular phones
410833|NCT01820533|Low income population|low income population
410834|NCT01820507|Post-extubation respiratory failure|post-extubation respiratory failure
410835|NCT01820507|Endotracheal intubation|endotracheal intubation
410836|NCT01820507|Mechanical ventilation|mechanical ventilation
410837|NCT01820494|growth|growth
410838|NCT01820494|infants|infants
410839|NCT01820481|Asthma|asthma
410840|NCT01820481|Bronchial Diseases|bronchial diseases
410841|NCT01820481|Respiratory Tract Diseases|respiratory tract diseases
410842|NCT01820481|Lung Diseases, Obstructive|lung diseases, obstructive
410843|NCT01820481|Lung Diseases|lung diseases
410844|NCT01820455|MRSA decolonization|mrsa decolonization
410845|NCT01820455|MRSA subtyping|mrsa subtyping
410846|NCT01820455|MRSA infection rates|mrsa infection rates
410847|NCT01820442|lofexidine|lofexidine
410848|NCT01820442|buprenorphine|buprenorphine
410849|NCT01820442|interaction|interaction
410850|NCT01820442|pharmacodynamic|pharmacodynamic
410851|NCT01820442|ECG|ecg
410852|NCT01820442|QTc|qtc
410853|NCT01820429|Platelet aggregation|platelet aggregation
410854|NCT01820429|Aspirin|aspirin
410855|NCT01820416|Hearing Loss, Bilateral|hearing loss, bilateral
410856|NCT01820416|Hearing Loss, Sensorineural|hearing loss, sensorineural
410857|NCT01820390|Deep Brain Stimulation (DBS)|deep brain stimulation (dbs)
410858|NCT01820390|Parkinson's Disease|parkinson's disease
410859|NCT01820390|Essential Tremor|essential tremor
410860|NCT01820377|Peer-mentoring|peer-mentoring
410861|NCT01820377|Obesity|obesity
410862|NCT01820377|Type 2 Diabetes|type 2 diabetes
410863|NCT01820377|Physical Activity|physical activity
410864|NCT01820377|After-school program|after-school program
410865|NCT01820364|open-label study|open-label study
410866|NCT01820364|BRAF inhibitor|braf inhibitor
410867|NCT01820364|LGX818|lgx818
410868|NCT01820364|MEK1620|mek1620
410869|NCT01820364|MAPK1/2 inhibitor|mapk1/2 inhibitor
410870|NCT01820364|Pi3K inhibitor|pi3k inhibitor
410871|NCT01820364|FGFR|fgfr
410872|NCT01820364|c-Met|c-met
410873|NCT01820364|CDK4/6|cdk4/6
410874|NCT01820364|metastatic melanoma|metastatic melanoma
410875|NCT01820364|BRAF|braf
410876|NCT01820364|V600|v600
410877|NCT01820338|Children, Obesity, Intervention|children, obesity, intervention
410878|NCT01820325|Squamous non-small cell lung cancer|squamous non-small cell lung cancer
410879|NCT01820325|NSCLC|nsclc
410880|NCT01820325|stage IV|stage iv
410881|NCT01820325|BKM120|bkm120
410882|NCT01820286|Bipolar disorder|bipolar disorder
410883|NCT01820286|Depression|depression
410884|NCT01820286|Positive psychology|positive psychology
410885|NCT01820273|Type 2 diabetes|type 2 diabetes
410886|NCT01820273|Bariatric surgery|bariatric surgery
410887|NCT01820273|incretines|incretines
410888|NCT01820273|GLP-1|glp-1
410890|NCT01820273|gastric bypass|gastric bypass
410891|NCT01820273|foregut|foregut
410892|NCT01820273|hindgut|hindgut
410893|NCT01820247|Crohn's Disease|crohn's disease
410894|NCT01820247|enteral nutrition|enteral nutrition
410895|NCT01820247|Tripterygium Glycosides|tripterygium glycosides
410896|NCT01820247|induction remission|induction remission
410897|NCT01820234|Skin cancer|skin cancer
410898|NCT01820234|Teledermatology|teledermatology
410899|NCT01820234|Screening|screening
410900|NCT01820234|Store-and-forward|store-and-forward
410901|NCT01820221|cesarean delivery|cesarean delivery
410902|NCT01820221|wound complications|wound complications
410903|NCT01820221|skin closure methods|skin closure methods
410904|NCT01820195|Contrast Nephropathy|contrast nephropathy
410905|NCT01820195|N-Acetyl Cystein|n-acetyl cystein
410906|NCT01820195|Prophylaxy|prophylaxy
410907|NCT01820117|long-term health outcomes|long-term health outcomes
410908|NCT01820078|Chronic|chronic
410909|NCT01820078|Kidney|kidney
410910|NCT01820078|Disease|disease
410911|NCT01820078|Proteinuria|proteinuria
410912|NCT01820078|Albuminuria|albuminuria
410913|NCT01820078|Paricalcitol|paricalcitol
410914|NCT01820052|Fibromyalgia|fibromyalgia
410915|NCT01820039|e-health intervention|e-health intervention
410916|NCT01820039|infertility|infertility
410917|NCT01820039|primary care|primary care
410918|NCT01820039|referral rate|referral rate
410919|NCT01820026|healthcare infection cirrhosis antibiotic|healthcare infection cirrhosis antibiotic
410920|NCT01820013|Pelvic Girdle pain|pelvic girdle pain
410921|NCT01820013|Symphysis Pubis Dysfunction|symphysis pubis dysfunction
410922|NCT01820013|Sacroiliac Joint|sacroiliac joint
410923|NCT01820013|Sacroiliitis|sacroiliitis
410924|NCT01820013|Physiotherapy|physiotherapy
410925|NCT01820013|Physical Therapy|physical therapy
410926|NCT01820013|Orthotic Devices|orthotic devices
410927|NCT01819987|Overweight|overweight
410928|NCT01819987|mother|mother
410929|NCT01819987|childhood obesity prevention|childhood obesity prevention
410930|NCT01819987|Chinese American|chinese american
410931|NCT01819948|Breast cancer|breast cancer
410932|NCT01819948|Stage 0-IIIA|stage 0-iiia
410933|NCT01819948|No evidence of disease|no evidence of disease
410934|NCT01819935|MRSA. pneumonia|mrsa. pneumonia
410935|NCT01819935|outcomes|outcomes
410936|NCT01819922|Cardiopulmonary exercise testing|cardiopulmonary exercise testing
410937|NCT01819922|metabolic parameters|metabolic parameters
410938|NCT01819922|Diabetes Mellitus Type 2|diabetes mellitus type 2
410939|NCT01819909|Rotator cuff repair|rotator cuff repair
410940|NCT01819909|Shoulder|shoulder
410941|NCT01819909|Surgery|surgery
410942|NCT01819909|Rehabilitation|rehabilitation
410943|NCT01819909|Pulleys|pulleys
410944|NCT01819909|Jackins|jackins
410945|NCT01819870|Carvedilol|carvedilol
410946|NCT01819870|Dilatrend SR capsule|dilatrend sr capsule
410947|NCT01819870|Dilatrend Tablet|dilatrend tablet
410948|NCT01819870|Pharmacokinetics|pharmacokinetics
410949|NCT01819870|Healthy male subjects|healthy male subjects
410950|NCT01819844|Closed-loop blood glucose control|closed-loop blood glucose control
410951|NCT01819844|Continuous glucose monitoring|continuous glucose monitoring
410952|NCT01819844|Bionic pancreas|bionic pancreas
410953|NCT01819844|Artificial pancreas|artificial pancreas
410954|NCT01819831|extremity soft tissue sarcoma|extremity soft tissue sarcoma
410955|NCT01819831|proton radiation|proton radiation
410956|NCT01819831|preoperative radiation|preoperative radiation
410957|NCT01819818|Schizophrenia|schizophrenia
410958|NCT01819818|Paliperidone palmitate|paliperidone palmitate
410959|NCT01819818|Invega|invega
410960|NCT01819818|Sustenna|sustenna
410961|NCT01819818|Korea|korea
410962|NCT01819805|Chronic pain|chronic pain
410963|NCT01819805|Chronic non-malignant pain|chronic non-malignant pain
410964|NCT01819805|Non-malignant|non-malignant
410965|NCT01819805|Pain|pain
410966|NCT01819805|Extended release tablet|extended release tablet
410967|NCT01819805|Tramadol hydrochloride|tramadol hydrochloride
410968|NCT01819805|Tramadol HCl|tramadol hcl
410969|NCT01819805|Acetaminophen|acetaminophen
410970|NCT01819805|Ultracet ER|ultracet er
410971|NCT01819792|Acute Myeloid Leukemia|acute myeloid leukemia
410972|NCT01819766|Cancer|cancer
410973|NCT01819766|Colorectal Cancer|colorectal cancer
410974|NCT01819766|Neoplasm|neoplasm
410975|NCT01819766|Colorectal Neoplasm|colorectal neoplasm
410976|NCT01819766|Intestinal Neoplasms|intestinal neoplasms
410977|NCT01819766|Gastrointestinal Neoplasms|gastrointestinal neoplasms
410978|NCT01819766|Digestive System Neoplasms|digestive system neoplasms
410979|NCT01819766|Neoplasms by Site|neoplasms by site
410980|NCT01819766|Neoplasms|neoplasms
410981|NCT01819766|Digestive System Diseases|digestive system diseases
410982|NCT01819766|Gastrointestinal Diseases|gastrointestinal diseases
410983|NCT01819766|Colonic Diseases|colonic diseases
410984|NCT01819766|Intestinal Diseases|intestinal diseases
410985|NCT01819766|Inflammatory Bowel Disease|inflammatory bowel disease
410986|NCT01819766|Primary Sclerosing Cholangitis|primary sclerosing cholangitis
410987|NCT01819753|percutaneous nephrolithotomy|percutaneous nephrolithotomy
410988|NCT01819753|urinary Stones|urinary stones
410989|NCT01819753|99m-Technetium-Dimercaptosuccinic Acid|99m-technetium-dimercaptosuccinic acid
410990|NCT01819727|PKU|pku
410991|NCT01819727|PEG-PAL|peg-pal
410992|NCT01819727|BioMarin|biomarin
410993|NCT01819727|rAv-PAL PEG|rav-pal peg
410994|NCT01819727|BMN 165|bmn 165
410995|NCT01819727|open label|open label
410996|NCT01819727|Prism301|prism301
410997|NCT01819727|Pegvaliase|pegvaliase
410998|NCT01819714|Snoezelen|snoezelen
410999|NCT01819714|Multi-sensorial care session|multi-sensorial care session
411000|NCT01819714|Alzheimer's-type neurodegenerative disease|alzheimer's-type neurodegenerative disease
411001|NCT01819714|Dementia|dementia
411002|NCT01819688|laparoscopic liver resection|laparoscopic liver resection
411003|NCT01819688|cytokine release|cytokine release
411004|NCT01819675|Neuronal plasticity|neuronal plasticity
411005|NCT01819675|Neurotransmitter agents|neurotransmitter agents
411006|NCT01819675|Receptors, neurotransmitter|receptors, neurotransmitter
411007|NCT01819675|Transcranial magnetic stimulation|transcranial magnetic stimulation
411008|NCT01819675|Stroke|stroke
411009|NCT01819675|gamma-Aminobutyric Acid|gamma-aminobutyric acid
411010|NCT01819662|Pacemaker, heart failure, hospitalisation|pacemaker, heart failure, hospitalisation
411011|NCT01819649|selenium|selenium
411012|NCT01819649|selenium supplementation|selenium supplementation
411013|NCT01819649|randomised controlled trial|randomised controlled trial
411014|NCT01819649|prevention|prevention
411015|NCT01819636|Blood triglyceride|blood triglyceride
411016|NCT01819636|Bicarbonated mineral wate|bicarbonated mineral wate
411017|NCT01819636|Post-prandial triglyceridemia|post-prandial triglyceridemia
411018|NCT01819636|lipid metabolism|lipid metabolism
411019|NCT01819636|Cardiovascular risk|cardiovascular risk
411020|NCT01819623|Mild Cognitive Impairment|mild cognitive impairment
411021|NCT01819623|Cognitive training|cognitive training
411022|NCT01819610|Postoperative pain management|postoperative pain management
411023|NCT01819597|Intracranial Arterial Stenosis|intracranial arterial stenosis
411024|NCT01819597|Atherosclerosis|atherosclerosis
411025|NCT01819597|Stroke|stroke
411026|NCT01819597|EDAS|edas
411027|NCT01819597|Angiogenesis|angiogenesis
411028|NCT01819571|pulse pressure variation|pulse pressure variation
411029|NCT01819571|fluid responsiveness|fluid responsiveness
411030|NCT01819571|diastolic dysfunction|diastolic dysfunction
411031|NCT01819558|acute myeloid leukemia|acute myeloid leukemia
411032|NCT01819558|chronic myeloid leukemia|chronic myeloid leukemia
411033|NCT01819558|myelodysplastic syndrome|myelodysplastic syndrome
411034|NCT01819558|allograft|allograft
411035|NCT01819558|WT1 expression|wt1 expression
411036|NCT01819545|Alzheimer's disease|alzheimer's disease
411037|NCT01819545|diagnosis|diagnosis
411038|NCT01819545|MicRNA|micrna
411039|NCT01819545|mRNA|mrna
411040|NCT01819532|neonate|neonate
411041|NCT01819532|umbilical cord|umbilical cord
411042|NCT01819532|cord milking|cord milking
411043|NCT01819532|prematurity|prematurity
411044|NCT01819519|Intervention studies|intervention studies
411045|NCT01819519|Pregnancy|pregnancy
411046|NCT01819519|Cytomegalovirus Infections|cytomegalovirus infections
411047|NCT01819506|rehabilitation|rehabilitation
411048|NCT01819506|occupational therapy|occupational therapy
411049|NCT01819506|upper extremity|upper extremity
411050|NCT01819493|Diabetes Prevention|diabetes prevention
411051|NCT01819493|Lifestyle Intervention|lifestyle intervention
411052|NCT01819493|African American Families|african american families
411053|NCT01819480|Surgery|surgery
411054|NCT01819480|Robotic|robotic
411055|NCT01819480|Carcinoma|carcinoma
411056|NCT01819480|squamous cell of head and neck|squamous cell of head and neck
411057|NCT01819454|chronic rhinosinusitis|chronic rhinosinusitis
411058|NCT01819454|extraesophageal reflux|extraesophageal reflux
411059|NCT01819454|Restech system|restech system
411060|NCT01819454|antireflux therapy|antireflux therapy
411350|NCT01817946|Sequencing|sequencing
411061|NCT01819441|cerebral small Vessel diseases, blood pressure,CCB, ACEI|cerebral small vessel diseases, blood pressure,ccb, acei
411062|NCT01819428|EGFR mutation|egfr mutation
411063|NCT01819428|Lung Adenocarcinoma|lung adenocarcinoma
411064|NCT01819428|Firstline therapy|firstline therapy
411065|NCT01819428|Second generation of tyrosine kinase|second generation of tyrosine kinase
411066|NCT01819415|wet AMD|wet amd
411067|NCT01819415|Omega-3|omega-3
411068|NCT01819415|VEGF|vegf
411069|NCT01819415|Lipidomics|lipidomics
411070|NCT01819415|DHA|dha
411071|NCT01819415|EPA|epa
411072|NCT01819402|visceral fat metabolism; FDG-PET/CT; pioglitazone; glimepiride; adiponectin|visceral fat metabolism; fdg-pet/ct; pioglitazone; glimepiride; adiponectin
411073|NCT01819389|Chronic myeloid leukemia|chronic myeloid leukemia
411074|NCT01819389|suboptimal response|suboptimal response
411075|NCT01819389|imatinib|imatinib
411076|NCT01819389|nilotinib|nilotinib
411077|NCT01819376|Obesity|obesity
411078|NCT01819376|Overweight|overweight
411079|NCT01819376|Adolescents|adolescents
411080|NCT01819376|Teenagers|teenagers
411081|NCT01819376|Facebook|facebook
411082|NCT01819376|Social Networks|social networks
411083|NCT01819363|Pleural effusion|pleural effusion
411084|NCT01819363|Pleural elastance|pleural elastance
411085|NCT01819363|Pleurodesis|pleurodesis
411086|NCT01819363|Quality of life|quality of life
411087|NCT01819363|Computed Tomography|computed tomography
411088|NCT01819350|Dental caries|dental caries
411089|NCT01819350|Sucrose|sucrose
411090|NCT01819350|Oral administration|oral administration
411091|NCT01819350|Ion Concentration of Hydrogen|ion concentration of hydrogen
411092|NCT01819350|Pediatric medicines|pediatric medicines
411093|NCT01819324|breast cancer survivors|breast cancer survivors
411094|NCT01819324|lifestyle intervention|lifestyle intervention
411095|NCT01819324|health behaviors|health behaviors
411096|NCT01819285|Malignant Neoplasm of Prostate|malignant neoplasm of prostate
411097|NCT01819285|Tumor-node-metastasis (TNM) Staging Regional Lymph Nodes (N0-2)|tumor-node-metastasis (tnm) staging regional lymph nodes (n0-2)
411098|NCT01819285|Not suitable for local treatment with curative intent|not suitable for local treatment with curative intent
411099|NCT01819259|Nonsmoker|nonsmoker
411100|NCT01819259|ADHD|adhd
411101|NCT01819259|Nicotine|nicotine
411102|NCT01819259|Nicotine Nasal Spray|nicotine nasal spray
411103|NCT01819259|Nicotine Reinforcement|nicotine reinforcement
411104|NCT01819181|TAVI|tavi
411105|NCT01819181|women|women
411106|NCT01819181|aortic stenosis|aortic stenosis
411107|NCT01819181|VARC2|varc2
411108|NCT01819155|influenza|influenza
411109|NCT01819155|influenza vaccine|influenza vaccine
411110|NCT01819155|immunogenicity|immunogenicity
411111|NCT01819155|Africa|africa
411112|NCT01819155|Senegal|senegal
411113|NCT01819142|non healing wound|non healing wound
411114|NCT01819142|pressure ulcer|pressure ulcer
411115|NCT01819116|Tissue Oxygen Saturation|tissue oxygen saturation
411116|NCT01819116|Management of the DNC Organ Donor|management of the dnc organ donor
411117|NCT01819103|Mortality|mortality
411118|NCT01819103|Acute Myocardial Infarction|acute myocardial infarction
411119|NCT01819103|Drug Adherence|drug adherence
411120|NCT01819103|Drug Compliance|drug compliance
411247|NCT01818505|osteoarthritis|osteoarthritis
411121|NCT01819103|Health-related quality of life|health-related quality of life
411122|NCT01819090|Neuromuscular disorder|neuromuscular disorder
411123|NCT01819090|Mechanical ventilation|mechanical ventilation
411124|NCT01819090|Speech|speech
411125|NCT01819090|Respiratory failure|respiratory failure
411126|NCT01819077|Cervical cancer|cervical cancer
411127|NCT01819077|TMMR|tmmr
411128|NCT01819077|therapeutic lymphadenectomy|therapeutic lymphadenectomy
411129|NCT01819077|register study|register study
411130|NCT01819064|Atropine|atropine
411131|NCT01819064|bradycardia|bradycardia
411132|NCT01819064|tachycardia|tachycardia
411133|NCT01819025|Depression|depression
411134|NCT01819025|Behavioral activation|behavioral activation
411135|NCT01819025|Smartphone application|smartphone application
411136|NCT01819025|Face-to-face|face-to-face
411137|NCT01819025|Blended therapy|blended therapy
411138|NCT01819012|Isoflurane|isoflurane
411139|NCT01819012|mitral valve annular velocity|mitral valve annular velocity
411140|NCT01819012|tissue Doppler imaging|tissue doppler imaging
411141|NCT01819012|Monitoring|monitoring
411142|NCT01819012|echocardiography|echocardiography
411143|NCT01818999|METASTATIC BREAST CANCER|metastatic breast cancer
411144|NCT01818973|Rectal Cancer|rectal cancer
411145|NCT01818973|Bevacizumab|bevacizumab
411146|NCT01818973|capecitabine|capecitabine
411147|NCT01818973|oxaliplatin|oxaliplatin
411148|NCT01818973|preoporative IMRT|preoporative imrt
411149|NCT01818960|Stent, Myocardial Infarction, Coronary Intervention|stent, myocardial infarction, coronary intervention
411150|NCT01818947|Lung cancer|lung cancer
411151|NCT01818947|epidermal growth factor receptor mutation|epidermal growth factor receptor mutation
411152|NCT01818947|gefitinib|gefitinib
411153|NCT01818947|Iressa|iressa
411154|NCT01818934|hip dysplasia|hip dysplasia
411155|NCT01818934|screening|screening
411156|NCT01818921|Beloranib|beloranib
411157|NCT01818921|ZGN-440|zgn-440
411352|NCT01817946|CGH array|cgh array
411158|NCT01818921|ZGN-440 for injectable suspension|zgn-440 for injectable suspension
411159|NCT01818921|ZGN-433|zgn-433
411160|NCT01818908|non-Hodgkin's lymphoma|non-hodgkin's lymphoma
411161|NCT01818908|hemophagocytic lymphohistiocytosis|hemophagocytic lymphohistiocytosis
411162|NCT01818908|DA-EPOCH|da-epoch
411163|NCT01818908|rituximab|rituximab
411164|NCT01818895|Mechanical ventilation|mechanical ventilation
411165|NCT01818895|End of life|end of life
411166|NCT01818895|Extubation|extubation
411167|NCT01818895|Terminal weaning|terminal weaning
411168|NCT01818895|Complicated grief|complicated grief
411169|NCT01818882|Vscan|vscan
411170|NCT01818882|portable ultrasound|portable ultrasound
411171|NCT01818882|emergency care|emergency care
411172|NCT01818882|emergency room|emergency room
411173|NCT01818869|Safety,|safety,
411174|NCT01818869|tolerability,|tolerability,
411175|NCT01818869|Phase I,|phase i,
411176|NCT01818869|pharmacokinetic,|pharmacokinetic,
411177|NCT01818869|pharmacodynamic,|pharmacodynamic,
411178|NCT01818869|inhaled|inhaled
525703|NCT01323829|EMG|emg
411179|NCT01818856|Chronic hepatitis C|chronic hepatitis c
411180|NCT01818856|HIV-infection|hiv-infection
411181|NCT01818856|Drug interaction|drug interaction
411182|NCT01818843|Carbon monoxide|carbon monoxide
411183|NCT01818843|safety|safety
411184|NCT01818843|Adverse Reaction|adverse reaction
411185|NCT01818843|newborn|newborn
411186|NCT01818817|Ultrasound-guided paravertebral block|ultrasound-guided paravertebral block
411187|NCT01818817|regional anesthesia|regional anesthesia
411188|NCT01818817|breast surgery|breast surgery
411189|NCT01818765|Cardiac resynchronisation therapy|cardiac resynchronisation therapy
411190|NCT01818765|Endocardial|endocardial
411191|NCT01818765|Pacing|pacing
411192|NCT01818739|Endometrial Cancer|endometrial cancer
411193|NCT01818739|Robotic-Assisted Staging|robotic-assisted staging
411194|NCT01818726|Aplastic anemia|aplastic anemia
411195|NCT01818726|deferasirox|deferasirox
411196|NCT01818726|ICL670|icl670
411197|NCT01818726|renal function|renal function
411198|NCT01818726|transfusion-dependent iron overload|transfusion-dependent iron overload
411199|NCT01818726|immunosuppressive treatment|immunosuppressive treatment
411200|NCT01818726|Cyclosporine A|cyclosporine a
411201|NCT01818726|unosuppressive treatment without chelation therapy|unosuppressive treatment without chelation therapy
411202|NCT01818713|2B3-101, liposomal doxorubicin, leptomeningeal metastases|2b3-101, liposomal doxorubicin, leptomeningeal metastases
411203|NCT01818674|social network|social network
411204|NCT01818674|microclinic|microclinic
411205|NCT01818674|middle east|middle east
411206|NCT01818674|jordan|jordan
411207|NCT01818674|intervention|intervention
411208|NCT01818661|apraxia of speech|apraxia of speech
411209|NCT01818661|non-fluent aphasia|non-fluent aphasia
411210|NCT01818661|aphasia|aphasia
411211|NCT01818622|Bipolar disorder|bipolar disorder
411212|NCT01818622|Mania|mania
411213|NCT01818622|Blue-blockers|blue-blockers
411214|NCT01818622|Virtual darkness therapy|virtual darkness therapy
411215|NCT01818622|Actigraphy|actigraphy
411216|NCT01818622|Randomized controlled trial|randomized controlled trial
411217|NCT01818609|sarcopenia|sarcopenia
411218|NCT01818609|muscle|muscle
411219|NCT01818609|reduced activity|reduced activity
411220|NCT01818609|insulin sensitivity|insulin sensitivity
411221|NCT01818609|protein|protein
411222|NCT01818609|step reduction|step reduction
411223|NCT01818609|muscle protein synthesis|muscle protein synthesis
411224|NCT01818609|whey protein|whey protein
411225|NCT01818609|leg strength|leg strength
411226|NCT01818609|whole body protein|whole body protein
411227|NCT01818596|HIV|hiv
411228|NCT01818596|HIV-1 Infected|hiv-1 infected
411229|NCT01818596|Treatment Experienced|treatment experienced
411230|NCT01818596|Treatment Naive|treatment naive
411231|NCT01818583|Atrial fibrillation|atrial fibrillation
411232|NCT01818583|Atrial flutter|atrial flutter
411233|NCT01818583|Potassium|potassium
411234|NCT01818583|Cardioversion|cardioversion
411235|NCT01818570|Gastroesophageal Reflux|gastroesophageal reflux
411236|NCT01818557|glucose monitoring|glucose monitoring
411237|NCT01818557|gestational diabetes|gestational diabetes
411238|NCT01818544|Elastase Inhibition|elastase inhibition
411239|NCT01818531|Partial knee replacement|partial knee replacement
411240|NCT01818518|Preterm delivery|preterm delivery
411241|NCT01818518|Premature delivery|premature delivery
411242|NCT01818518|Premature birth|premature birth
411243|NCT01818505|antiphospholipid syndrome|antiphospholipid syndrome
411244|NCT01818505|gouty arthritis|gouty arthritis
411245|NCT01818505|Hyperuricemia|hyperuricemia
411246|NCT01818505|metabolic syndrome|metabolic syndrome
411248|NCT01818505|cardiovascular co-morbidities|cardiovascular co-morbidities
411249|NCT01818492|Emapalumab|emapalumab
411250|NCT01818453|Mood Disorders|mood disorders
411251|NCT01818453|Depression|depression
411252|NCT01818453|Genetics|genetics
411253|NCT01818453|Treatment response|treatment response
411254|NCT01818453|Treatment study|treatment study
411255|NCT01818440|Surgical Navigation|surgical navigation
411257|NCT01818440|Cancer|cancer
411258|NCT01818440|Image-guided Therapy|image-guided therapy
411351|NCT01817946|Deletion/Duplication Mutation|deletion/duplication mutation
411259|NCT01818427|hemmorhagic shock, plasma, air medical transport, randomized, multicenter|hemmorhagic shock, plasma, air medical transport, randomized, multicenter
411260|NCT01818414|Misoprostol administration & dosage|misoprostol administration & dosage
411261|NCT01818414|Abortion techniques|abortion techniques
411262|NCT01818414|Abortion Induced methods|abortion induced methods
411263|NCT01818414|Dilatation and Curettage|dilatation and curettage
411264|NCT01818401|Ancillary tailored|ancillary tailored
411265|NCT01818401|medico-economic study,|medico-economic study,
411266|NCT01818401|total knee replacement|total knee replacement
411267|NCT01818401|primary or secondary osteoarthritis|primary or secondary osteoarthritis
411268|NCT01818362|Influenza|influenza
411269|NCT01818362|T cells|t cells
411270|NCT01818349|stroke|stroke
411271|NCT01818349|exercise|exercise
411272|NCT01818349|muscle strength|muscle strength
411273|NCT01818349|gait|gait
411274|NCT01818349|rehabilitation|rehabilitation
525823|NCT01323413|stroke|stroke
411275|NCT01818336|penicillin allergy|penicillin allergy
411276|NCT01818323|Chimeric antigen receptor|chimeric antigen receptor
411277|NCT01818323|Immunotherapy|immunotherapy
411278|NCT01818323|Head and Neck Cancer|head and neck cancer
411279|NCT01818323|Phase I trial|phase i trial
411280|NCT01818323|Maximum tolerated dose|maximum tolerated dose
411281|NCT01818310|ischemia|ischemia
411282|NCT01818310|diabetes mellitus|diabetes mellitus
411283|NCT01818310|bone marrow aspirate concentrate (BMAC)|bone marrow aspirate concentrate (bmac)
411284|NCT01818284|Blood And Marrow Transplantation|blood and marrow transplantation
411285|NCT01818284|Normal allogeneic donors|normal allogeneic donors
411286|NCT01818284|Stem cell mobilization|stem cell mobilization
411287|NCT01818284|peripheral blood progenitor cells|peripheral blood progenitor cells
411288|NCT01818284|PBPC|pbpc
411289|NCT01818284|Allogeneic hematopoietic stem cell transplantation|allogeneic hematopoietic stem cell transplantation
411290|NCT01818284|HSCT|hsct
411291|NCT01818284|Donating blood stem cells|donating blood stem cells
411292|NCT01818284|C-CSF|c-csf
411293|NCT01818284|Neupogen|neupogen
411294|NCT01818284|Filgrastim|filgrastim
411295|NCT01818284|Plerixafor|plerixafor
411296|NCT01818284|Mobozil|mobozil
411297|NCT01818284|Apheresis|apheresis
411298|NCT01818271|community-stroke-rehabilitation,|community-stroke-rehabilitation,
411299|NCT01818271|group-exercise,|group-exercise,
411300|NCT01818271|balance-mobility-exercise,|balance-mobility-exercise,
411301|NCT01818271|instrumented treadmill|instrumented treadmill
411302|NCT01818258|HIV|hiv
411303|NCT01818258|Children|children
411304|NCT01818258|HAART|haart
411305|NCT01818258|Malnourished|malnourished
411306|NCT01818219|Electrical activity of the diaphragm|electrical activity of the diaphragm
411307|NCT01818219|Neuro regulation of breathing|neuro regulation of breathing
411308|NCT01818219|Abnormal respiratory mechanics|abnormal respiratory mechanics
411309|NCT01818219|Assisted mechanical ventilation|assisted mechanical ventilation
411310|NCT01818219|Pressure support|pressure support
411311|NCT01818219|Neurally adjusted ventilatory assist|neurally adjusted ventilatory assist
411312|NCT01818206|Cystic Fibrosis|cystic fibrosis
411313|NCT01818206|Bacteriophages|bacteriophages
411314|NCT01818206|Pseudomonas aeruginosa|pseudomonas aeruginosa
411315|NCT01818206|Sputum|sputum
411316|NCT01818193|Pulmonary transplant|pulmonary transplant
411317|NCT01818167|Hidradenitis Suppurativa|hidradenitis suppurativa
411318|NCT01818167|HS|hs
411319|NCT01818167|Acne Inversa|acne inversa
411320|NCT01818167|Velpeau's disease|velpeau's disease
411321|NCT01818167|Verneuil's disease|verneuil's disease
411322|NCT01818154|phototherapy|phototherapy
411323|NCT01818154|light emitting diode|light emitting diode
411324|NCT01818154|minimal erythema dose|minimal erythema dose
411325|NCT01818154|narrowband UVB|narrowband uvb
411326|NCT01818115|POAG|poag
411327|NCT01818115|PXG|pxg
411328|NCT01818115|IOL Surgery|iol surgery
411329|NCT01818115|CE Surgery|ce surgery
411330|NCT01818024|healthy volunteer|healthy volunteer
411331|NCT01818024|TNFR1|tnfr1
411332|NCT01818024|domain antibody|domain antibody
411333|NCT01818024|Lung injury|lung injury
411334|NCT01818011|Japanese, GSK1322322, pharmacokinetics, relative bioavailability, single dose, repeat dose, healthy subjects, dose-escalation, antimicrobial, over granulation,|japanese, gsk1322322, pharmacokinetics, relative bioavailability, single dose, repeat dose, healthy subjects, dose-escalation, antimicrobial, over granulation,
411335|NCT01817985|Hepatitis C (HCV) Infection|hepatitis c (hcv) infection
411336|NCT01817985|Moderate Hepatic Impairment|moderate hepatic impairment
411337|NCT01817985|Severe Hepatic Impairment|severe hepatic impairment
411338|NCT01817972|Crohn's Disease|crohn's disease
411339|NCT01817972|Crohn's colitis|crohn's colitis
411340|NCT01817972|Crohn's ileocolitis|crohn's ileocolitis
411341|NCT01817959|Pancreatic islet transplantation|pancreatic islet transplantation
411342|NCT01817959|Diabetes Mellitus Type 1|diabetes mellitus type 1
411343|NCT01817959|Islet transplantation graft survival & function|islet transplantation graft survival & function
411344|NCT01817946|Congenital Myopathy|congenital myopathy
411345|NCT01817946|Centronuclear Myopathy|centronuclear myopathy
411346|NCT01817946|Myotubular Myopathy|myotubular myopathy
411347|NCT01817946|Myotubularin|myotubularin
411348|NCT01817946|MTM1 Gene|mtm1 gene
411349|NCT01817946|Genetic testing|genetic testing
411353|NCT01817907|Apnea- Hypopnea index|apnea- hypopnea index
411354|NCT01817907|Arousal Threshold|arousal threshold
411355|NCT01817894|Unwanted facial hair growth|unwanted facial hair growth
411356|NCT01817868|Hemophilia|hemophilia
411357|NCT01817868|Turkey|turkey
411358|NCT01817868|Observational|observational
411359|NCT01817868|Adult|adult
411360|NCT01817855|Phase 1,|phase 1,
411361|NCT01817855|Safety,|safety,
411362|NCT01817855|Tolerability,|tolerability,
411363|NCT01817855|Healthy,|healthy,
411364|NCT01817855|COPD patients|copd patients
411365|NCT01817842|mHealth|mhealth
411367|NCT01817842|Ecological Momentary Assessment|ecological momentary assessment
411368|NCT01817842|Personal Informatics|personal informatics
411369|NCT01817842|Tobacco Quitline|tobacco quitline
411370|NCT01817803|Heart failure|heart failure
411371|NCT01817803|diuretics|diuretics
411372|NCT01817803|kidney|kidney
411373|NCT01817803|glomerular filtration rate|glomerular filtration rate
411374|NCT01817777|Socioeconomic category|socioeconomic category
411375|NCT01817777|Medication compliance|medication compliance
411376|NCT01817777|Metformin|metformin
411377|NCT01817777|small pack|small pack
411378|NCT01817764|umeclidinium bromide (UMEC)|umeclidinium bromide (umec)
411379|NCT01817764|vilanterol (VI)|vilanterol (vi)
411380|NCT01817764|salmeterol (SAL)|salmeterol (sal)
411381|NCT01817764|fluticasone propionate (FP)|fluticasone propionate (fp)
411382|NCT01817764|Novel Dry Powder Inhaler (NDPI)|novel dry powder inhaler (ndpi)
411383|NCT01817764|Chronic obstructive pulmonary disease|chronic obstructive pulmonary disease
411384|NCT01817764|GW642444|gw642444
411385|NCT01817764|GSK573719|gsk573719
411386|NCT01817764|lung function|lung function
411387|NCT01817751|central nervous system|central nervous system
411388|NCT01817751|Brain and Nervous System|brain and nervous system
411389|NCT01817738|Metastatic|metastatic
411390|NCT01817738|Castrate-refractory|castrate-refractory
411391|NCT01817725|Therapeutic vaccine|therapeutic vaccine
411392|NCT01817725|HBsAg clearance|hbsag clearance
411393|NCT01817725|Immune clearance|immune clearance
411394|NCT01817725|HBsAg clearance induced by vaccination|hbsag clearance induced by vaccination
411395|NCT01817725|s seroconversion in carriers after vaccination|s seroconversion in carriers after vaccination
411396|NCT01817712|Posttraumatic neuroses|posttraumatic neuroses
411397|NCT01817712|posttraumatic stress disorder|posttraumatic stress disorder
411398|NCT01817712|PTSD|ptsd
411399|NCT01817712|Supported employment|supported employment
411401|NCT01817712|CWT|cwt
411402|NCT01817712|TWP|twp
411403|NCT01817712|Individual placement and support|individual placement and support
411404|NCT01817712|Compensated work therapy|compensated work therapy
411405|NCT01817712|Transitional work program|transitional work program
411406|NCT01817699|Cholecalciferol|cholecalciferol
411407|NCT01817699|Methoxy polyethylene glycol-epoetin beta|methoxy polyethylene glycol-epoetin beta
411408|NCT01817699|Hematinics|hematinics
411409|NCT01817699|Bone Diseases, Metabolic|bone diseases, metabolic
411410|NCT01817699|Neoplasms|neoplasms
411411|NCT01817699|Cardiovascular Diseases|cardiovascular diseases
411412|NCT01817699|Graft Rejection|graft rejection
411413|NCT01817660|popliteal artery aneurysm|popliteal artery aneurysm
411414|NCT01817660|endovascular repair|endovascular repair
411415|NCT01817660|open surgical repair|open surgical repair
411416|NCT01817660|comparative study|comparative study
411417|NCT01817647|AL|al
411418|NCT01817647|Enhanced recovery after surgery (ERAS)|enhanced recovery after surgery (eras)
411419|NCT01817647|reduce postoperative complications|reduce postoperative complications
411420|NCT01817647|increased risk of delayed diagnosis and treatment of AL|increased risk of delayed diagnosis and treatment of al
411421|NCT01817647|diagnose anastomotic leak|diagnose anastomotic leak
411422|NCT01817634|Malnutrition.|malnutrition.
411423|NCT01817621|Body Image Disturbance|body image disturbance
411424|NCT01817621|Medication Adherence|medication adherence
411425|NCT01817621|Sexual Risk Behavior|sexual risk behavior
411426|NCT01817621|HIV|hiv
411427|NCT01817621|MSM|msm
411428|NCT01817608|sf-36|sf-36
411429|NCT01817608|Katz|katz
411430|NCT01817595|Type 2 Diabetes|type 2 diabetes
411431|NCT01817595|Internet Blood Glucose Monitoring|internet blood glucose monitoring
411432|NCT01817595|iphone|iphone
411433|NCT01817595|meter|meter
411434|NCT01817582|Dry Eye Disease|dry eye disease
411435|NCT01817569|Diabetes Mellitus (DM)|diabetes mellitus (dm)
411436|NCT01817569|Byetta|byetta
411437|NCT01817569|Exenatide|exenatide
411438|NCT01817543|venous leg ulcers|venous leg ulcers
411439|NCT01817543|non healing wounds|non healing wounds
411440|NCT01817530|Uterine Fibroids|uterine fibroids
411441|NCT01817530|Leiomyomata|leiomyomata
411442|NCT01817530|Elagolix|elagolix
411443|NCT01817530|Menorrhagia|menorrhagia
411444|NCT01817530|Elagolix sodium|elagolix sodium
411445|NCT01817530|Heavy Uterine Bleeding|heavy uterine bleeding
411446|NCT01817530|ABT-620|abt-620
411447|NCT01817504|Renal failure,|renal failure,
411448|NCT01817504|Transplantectomy|transplantectomy
411449|NCT01817504|Immunosuppression|immunosuppression
411450|NCT01817504|Sensitization|sensitization
411451|NCT01817491|Vegan Diet|vegan diet
411452|NCT01817491|Hypercholesterolemia|hypercholesterolemia
411453|NCT01817491|American Heart Association Diet|american heart association diet
411454|NCT01817491|Cardiovascular Risk|cardiovascular risk
411455|NCT01817491|Obesity|obesity
411456|NCT01817478|conjunctival flora|conjunctival flora
411457|NCT01817439|oral Amiodarone|oral amiodarone
411458|NCT01817439|IV Amiodarone|iv amiodarone
411459|NCT01817439|phlebitis|phlebitis
411460|NCT01817439|thrombophlebitis|thrombophlebitis
411461|NCT01817439|adverse events|adverse events
411462|NCT01817413|Calcium hydroxide|calcium hydroxide
411463|NCT01817413|Pulp regeneration|pulp regeneration
411464|NCT01817413|Regenerative endodontics|regenerative endodontics
411465|NCT01817413|Pulp revitalisation|pulp revitalisation
411466|NCT01817413|Triple antibiotic paste|triple antibiotic paste
411467|NCT01817413|Root canal therapy|root canal therapy
411468|NCT01817413|Root end closure|root end closure
411469|NCT01817413|Tooth root|tooth root
411470|NCT01817413|Tooth apex|tooth apex
411471|NCT01817413|Dental trauma|dental trauma
411472|NCT01817413|Non-vital|non-vital
411473|NCT01817413|Immature|immature
411474|NCT01817413|Incisor|incisor
411475|NCT01817413|Periapical periodontitis|periapical periodontitis
411476|NCT01817413|Dental pulp|dental pulp
411477|NCT01817374|Breast Cancer|breast cancer
411478|NCT01817374|Definity|definity
411479|NCT01817374|Ultrasound|ultrasound
411480|NCT01817361|oral health|oral health
411481|NCT01817348|Adhesive capsulitis|adhesive capsulitis
411482|NCT01817348|Frozen shoulder|frozen shoulder
411483|NCT01817348|Shoulder pain|shoulder pain
411484|NCT01817348|Intra-articular injection|intra-articular injection
411485|NCT01817348|Lidocaine injection|lidocaine injection
411486|NCT01817348|Physiotherapy|physiotherapy
411487|NCT01817348|Manipulation|manipulation
411488|NCT01817348|Stretch exercise|stretch exercise
411489|NCT01817322|kidney transplantation|kidney transplantation
411490|NCT01817309|renal failure|renal failure
411491|NCT01817309|survival|survival
411492|NCT01817309|peritoneal failure|peritoneal failure
411493|NCT01817296|Klinefelter|klinefelter
411494|NCT01817296|Fertility|fertility
411495|NCT01817283|HIV-infected immunological non-responders|hiv-infected immunological non-responders
411496|NCT01817283|Triptolide|triptolide
411497|NCT01817283|immune activation|immune activation
411498|NCT01817283|inflammation|inflammation
411499|NCT01817283|CD4 T cell|cd4 t cell
411500|NCT01817257|Cancer|cancer
411501|NCT01817257|Thrombosis|thrombosis
411502|NCT01817257|Venous thromboembolism|venous thromboembolism
411503|NCT01817257|Deep vein thrombosis|deep vein thrombosis
411504|NCT01817257|Pulmonary embolus|pulmonary embolus
411505|NCT01817244|care management|care management
411506|NCT01817244|depression|depression
411507|NCT01817244|elderly|elderly
411508|NCT01817244|Korea|korea
411509|NCT01817231|breast cancer|breast cancer
411510|NCT01817231|vitamin D|vitamin d
411511|NCT01817231|25 OH vitamin D|25 oh vitamin d
411512|NCT01817218|PRP|prp
411513|NCT01817218|chronic vascular ulcer|chronic vascular ulcer
411514|NCT01817218|primary care|primary care
411515|NCT01817192|Non-Squamous|non-squamous
411516|NCT01817192|Adjuvant Chemotherapy|adjuvant chemotherapy
411517|NCT01817179|hemiplegia, cerebral palsy, neuroprosthesis, children|hemiplegia, cerebral palsy, neuroprosthesis, children
411518|NCT01817166|cholecalciferol|cholecalciferol
411519|NCT01817166|vitamin D|vitamin d
411520|NCT01817166|immune disease|immune disease
411521|NCT01817166|clinically isolated syndrome|clinically isolated syndrome
411522|NCT01817140|oral cancer|oral cancer
411523|NCT01817140|mandibular invasion|mandibular invasion
411524|NCT01817140|SWIFT MRI|swift mri
411525|NCT01817114|Remote Ischemic Conditioning|remote ischemic conditioning
411526|NCT01817114|PCI|pci
411527|NCT01817114|STEMI|stemi
411528|NCT01817114|LAD|lad
411529|NCT01817088|Deep Brain Stimulation (DBS)|deep brain stimulation (dbs)
411530|NCT01817088|Parkinson disease|parkinson disease
411531|NCT01817088|Stereotaxis Technique|stereotaxis technique
411532|NCT01817088|Subthalamic nucleus|subthalamic nucleus
411533|NCT01817062|Capillary leakage|capillary leakage
411534|NCT01817062|Acute Abdomen|acute abdomen
411535|NCT01817062|Low birth weight|low birth weight
411536|NCT01817049|prevention|prevention
411537|NCT01817049|sport injury|sport injury
411538|NCT01817049|soccer|soccer
411539|NCT01817049|youth|youth
411540|NCT01817049|neuromuscular training|neuromuscular training
411541|NCT01817049|intervention|intervention
411542|NCT01817049|behaviour|behaviour
411543|NCT01817036|vitamin D|vitamin d
411544|NCT01817036|deficiency|deficiency
411545|NCT01817036|dose response|dose response
411546|NCT01817023|Nasopharyngeal carcinoma|nasopharyngeal carcinoma
411547|NCT01817023|current chemotherapy|current chemotherapy
411548|NCT01817023|intensity-modulated radiotherapy|intensity-modulated radiotherapy
411549|NCT01817023|low-risk|low-risk
411550|NCT01817010|Total Hip Arthroplasty|total hip arthroplasty
411551|NCT01817010|Muscle Strength|muscle strength
411552|NCT01817010|Hip Osteoarthritis|hip osteoarthritis
411553|NCT01816997|Statins|statins
411554|NCT01816997|Glucose homeostasis|glucose homeostasis
411555|NCT01816997|Diabetes|diabetes
411556|NCT01816997|Impaired fasting glucose|impaired fasting glucose
411557|NCT01816958|thalamocortical dysrhythmia|thalamocortical dysrhythmia
411558|NCT01816958|transcranial magnetic stimulation (TMS)|transcranial magnetic stimulation (tms)
411559|NCT01816958|transcranial Electrical Stimulation (tES)|transcranial electrical stimulation (tes)
411560|NCT01816958|(N-methyl-D-aspartate) NMDA-R antagonist|(n-methyl-d-aspartate) nmda-r antagonist
411561|NCT01816958|ketamine infusion|ketamine infusion
411562|NCT01816958|neuromodulation|neuromodulation
411563|NCT01816958|synergistic effect|synergistic effect
411564|NCT01816958|remission|remission
411565|NCT01816945|Depression|depression
411566|NCT01816945|Stress|stress
411567|NCT01816945|Social support|social support
411568|NCT01816945|Social capital|social capital
411569|NCT01816945|Maternal|maternal
411570|NCT01816893|Hypoglycemia|hypoglycemia
411571|NCT01816893|Autonomic Nervous System|autonomic nervous system
411572|NCT01816893|baroreflex sensitivity|baroreflex sensitivity
411573|NCT01816893|muscle sympathetic nerve activity|muscle sympathetic nerve activity
411574|NCT01816893|lower body negative pressure|lower body negative pressure
411575|NCT01816867|hernia|hernia
411576|NCT01816867|Treatment|treatment
411577|NCT01816867|laparoscopic|laparoscopic
411578|NCT01816867|open technique|open technique
411579|NCT01816854|Peripheral artery disease|peripheral artery disease
411580|NCT01816854|SFA|sfa
411581|NCT01816854|PPA|ppa
411582|NCT01816854|Self-expandable nitinol stent|self-expandable nitinol stent
411583|NCT01816854|Endovascular|endovascular
411584|NCT01816854|Stenosis|stenosis
411585|NCT01816854|Primary pantency|primary pantency
411586|NCT01816841|Direct Visual Fluorescense|direct visual fluorescense
411587|NCT01816841|Oral Examination|oral examination
411588|NCT01816841|oral cancer|oral cancer
411589|NCT01816828|HIV, MSM, unprotected anal intercourse, sexual health|hiv, msm, unprotected anal intercourse, sexual health
411590|NCT01816815|PK/PD|pk/pd
411591|NCT01816815|BAY1002670|bay1002670
411592|NCT01816802|In vitro fertilization|in vitro fertilization
411593|NCT01816802|Assisted reproductive therapy|assisted reproductive therapy
411594|NCT01816802|Time-lapse image recording|time-lapse image recording
411595|NCT01816802|Image analysis software|image analysis software
411596|NCT01816789|Starting dose|starting dose
411597|NCT01816789|rFSH|rfsh
411598|NCT01816789|controlled|controlled
411599|NCT01816789|ovarian|ovarian
411600|NCT01816789|stimulation|stimulation
411601|NCT01816789|IVF/ICSI|ivf/icsi
411602|NCT01816789|cycles|cycles
411603|NCT01816763|Health Care Quality, Access, and Evaluation|health care quality, access, and evaluation
411604|NCT01816763|Primary Health Care|primary health care
411605|NCT01816763|Medical Informatics|medical informatics
411606|NCT01816750|CT coronary angiography|ct coronary angiography
411607|NCT01816750|Coronary disease|coronary disease
411608|NCT01816750|Gemstone Spectral Imaging|gemstone spectral imaging
411609|NCT01816750|Diagnostic value|diagnostic value
411610|NCT01816750|Adaptive statistical iterative reconstruction|adaptive statistical iterative reconstruction
411611|NCT01816750|iterative reconstruction|iterative reconstruction
411612|NCT01816750|Feasibility of coronary and myocardial assessment|feasibility of coronary and myocardial assessment
411613|NCT01816750|novel Cardiac CT GSI protocol|novel cardiac ct gsi protocol
411614|NCT01816724|NOCTURIA|nocturia
411615|NCT01816724|SYMPTOMATIC QUESTIONNAIRE|symptomatic questionnaire
411616|NCT01816724|N-QOL|n-qol
411617|NCT01816711|Frail elderly|frail elderly
411618|NCT01816711|Hip fracture|hip fracture
411619|NCT01816711|Vitamin D|vitamin d
411620|NCT01816711|Geriatrics|geriatrics
411621|NCT01816698|Hypertension|hypertension
411622|NCT01816698|Taurine|taurine
411623|NCT01816698|Metabolism|metabolism
411624|NCT01816672|Wagner 1|wagner 1
411625|NCT01816672|Wagner 2|wagner 2
411626|NCT01816672|Non healing diabetic foot wound|non healing diabetic foot wound
411627|NCT01816659|Colorectal Carcinoma|colorectal carcinoma
411628|NCT01816659|Endoscopically Non- Resectable Adenomas|endoscopically non- resectable adenomas
411629|NCT01816659|Colonic lesion|colonic lesion
411630|NCT01816659|Biomarker|biomarker
411631|NCT01816659|Metformin-ER|metformin-er
411632|NCT01816659|Metformin|metformin
411633|NCT01816659|Extended release|extended release
411634|NCT01816659|Colonoscopy|colonoscopy
411635|NCT01816659|Colon cancer surgery|colon cancer surgery
411636|NCT01816646|Blood And Marrow Transplantation|blood and marrow transplantation
411637|NCT01816646|Hemorrhagic Cystitis|hemorrhagic cystitis
411638|NCT01816646|Bleeding from bladder|bleeding from bladder
411639|NCT01816646|Foley catheter|foley catheter
411640|NCT01816646|Probenecid|probenecid
411641|NCT01816646|Cidofovir|cidofovir
411642|NCT01816646|Vistide|vistide
411643|NCT01816633|non healing wound|non healing wound
411644|NCT01816620|POEMS Syndrome|poems syndrome
411645|NCT01816620|lenalidomide|lenalidomide
411646|NCT01816620|newly diagnosed|newly diagnosed
411647|NCT01816620|plasma cell disorder|plasma cell disorder
411648|NCT01816620|Dexamethasone|dexamethasone
411649|NCT01816607|Magnetic Resonance Imaging|magnetic resonance imaging
411650|NCT01816607|Magnetic Resonance Imaging, Functional|magnetic resonance imaging, functional
411651|NCT01816594|HER2|her2
411652|NCT01816594|breast cancer|breast cancer
411653|NCT01816594|neoadjuvant|neoadjuvant
411654|NCT01816594|PI3K inhibitor|pi3k inhibitor
411655|NCT01816594|first line chemotherapy|first line chemotherapy
411656|NCT01816594|trastuzumab|trastuzumab
411657|NCT01816594|GBG|gbg
411658|NCT01816594|SOLTI|solti
411659|NCT01816594|BIG|big
411660|NCT01816568|appendicitis, laparoscopy, single incision|appendicitis, laparoscopy, single incision
411661|NCT01816542|patch-testing|patch-testing
411662|NCT01816542|personal-care|personal-care
411663|NCT01816542|cosmetic|cosmetic
411664|NCT01816542|dermatitis|dermatitis
411665|NCT01816542|allergy|allergy
411666|NCT01816542|sensitive skin|sensitive skin
411667|NCT01816516|childhood obesity|childhood obesity
411668|NCT01816516|low-income|low-income
411669|NCT01816516|maternal responsiveness|maternal responsiveness
411670|NCT01816516|infant feeding|infant feeding
411671|NCT01816516|infant feeding practices|infant feeding practices
411672|NCT01816516|infant feeding style|infant feeding style
411673|NCT01816516|primary prevention|primary prevention
411674|NCT01816503|Pain|pain
411675|NCT01816503|Cancer pain|cancer pain
411676|NCT01816503|Fentanyl|fentanyl
411677|NCT01816503|Fentanyl matrix|fentanyl matrix
411678|NCT01816503|Opioid analgesic|opioid analgesic
411679|NCT01816464|Influenza|influenza
411680|NCT01816464|Vaccination|vaccination
411681|NCT01816451|aerobic capacity|aerobic capacity
411682|NCT01816451|cardiorespiratory training|cardiorespiratory training
411683|NCT01816451|blood lactate concentration|blood lactate concentration
411684|NCT01816451|heart rate|heart rate
411685|NCT01816438|abnormal histological colorectal lesions|abnormal histological colorectal lesions
411686|NCT01816425|Dental Prosthesis|dental prosthesis
411687|NCT01816425|Dental Prosthesis Design|dental prosthesis design
411688|NCT01816412|Arms|arms
411689|NCT01816412|Experimental|experimental
411690|NCT01816412|Drug Coated Angioplasty Balloon|drug coated angioplasty balloon
411691|NCT01816412|Active Comparator|active comparator
411692|NCT01816412|Standard angioplasty balloon|standard angioplasty balloon
411693|NCT01816386|acupuncture|acupuncture
411694|NCT01816386|anaesthetic recovery|anaesthetic recovery
411695|NCT01816386|perioperative care|perioperative care
411696|NCT01816386|Age 18+|age 18+
411697|NCT01816386|ASA-score ≤ 2|asa-score ≤ 2
411698|NCT01816386|Surgery: Uterus|surgery: uterus
411699|NCT01816386|Surgery: Adnex|surgery: adnex
411700|NCT01816386|Surgery: Ovaries|surgery: ovaries
411701|NCT01816373|Chest wall; Chest, funnel; pectus excavatum; congenital abnormality|chest wall; chest, funnel; pectus excavatum; congenital abnormality
411702|NCT01816360|Womens health|womens health
411703|NCT01816360|Menopause|menopause
411704|NCT01816360|Complementary therapies|complementary therapies
411705|NCT01816360|Aromatherapy|aromatherapy
411706|NCT01816360|Essential oils|essential oils
411707|NCT01816360|Yogatherapy|yogatherapy
411708|NCT01816360|Psychoneuroendocrineimmunology|psychoneuroendocrineimmunology
411709|NCT01816334|sciatica|sciatica
411710|NCT01816334|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal
411711|NCT01816334|Glucocorticoids|glucocorticoids
411712|NCT01816308|AF|af
411713|NCT01816308|MCI|mci
411714|NCT01816282|TKR|tkr
411715|NCT01816282|Blood loss|blood loss
411716|NCT01816282|Fibrin Sealant|fibrin sealant
411717|NCT01816269|Helicobacter pylori|helicobacter pylori
411718|NCT01816269|Dental scaling|dental scaling
411719|NCT01816269|Eradication|eradication
411720|NCT01816269|Reinfection|reinfection
411721|NCT01816269|Helicobacter status|helicobacter status
411722|NCT01816243|Chronic Pain|chronic pain
411723|NCT01816243|Chronic Non-Malignant Pain|chronic non-malignant pain
411724|NCT01816243|TTS-fentanyl|tts-fentanyl
411725|NCT01816243|Durogesic|durogesic
411726|NCT01816217|Difficult intubation|difficult intubation
411727|NCT01816217|Complications|complications
411728|NCT01816217|Intensive care units|intensive care units
411729|NCT01816217|Videolaryngoscope|videolaryngoscope
411730|NCT01816217|Laryngoscopy|laryngoscopy
411731|NCT01816204|anxiety treatment|anxiety treatment
411732|NCT01816204|anxiety online treatment|anxiety online treatment
411733|NCT01816204|anxiety electronic treatment|anxiety electronic treatment
411734|NCT01816204|anxiety therapist assisted|anxiety therapist assisted
411735|NCT01816178|Autism spectrum Disorders|autism spectrum disorders
411736|NCT01816178|Voice Output Communication|voice output communication
411737|NCT01816165|diabetes|diabetes
411738|NCT01816165|insulin|insulin
411739|NCT01816165|blood vessel|blood vessel
411740|NCT01816165|type 1|type 1
411741|NCT01816152|light treatment|light treatment
411742|NCT01816152|circadian rhythms|circadian rhythms
411743|NCT01816152|sleep|sleep
411744|NCT01816152|agitation|agitation
411745|NCT01816152|depression|depression
411746|NCT01816139|vaginal dryness|vaginal dryness
411747|NCT01816139|vaginal atrophy|vaginal atrophy
411748|NCT01816139|estrogen|estrogen
411749|NCT01816113|PvDBP|pvdbp
411750|NCT01816113|Malaria|malaria
411751|NCT01816113|Plasmodium vivax|plasmodium vivax
411752|NCT01816100|multiple sclerosis|multiple sclerosis
411753|NCT01816100|exercise|exercise
411755|NCT01816100|DTI|dti
411756|NCT01816100|Brain changes|brain changes
411757|NCT01816074|Mothers|mothers
411758|NCT01816074|ADHD|adhd
411759|NCT01816074|Treatment|treatment
411760|NCT01816074|Child|child
411761|NCT01816061|Veterans Health|veterans health
411762|NCT01816061|Social Adjustment|social adjustment
411763|NCT01816061|Traumatic Brain Injury (TBI)|traumatic brain injury (tbi)
710226|NCT00589667|paranasal sinus|paranasal sinus
411764|NCT01816061|Post-Traumatic Stress Disorder (PTSD)|post-traumatic stress disorder (ptsd)
411765|NCT01816061|Independent Living|independent living
411766|NCT01816061|Goals|goals
411767|NCT01816061|Education|education
411768|NCT01816048|prostate, prostate cancer|prostate, prostate cancer
411769|NCT01816022|CMPN|cmpn
411770|NCT01816022|Fracture|fracture
411771|NCT01816022|Osteoporosis|osteoporosis
411772|NCT01816022|Biochemical Bone Markers|biochemical bone markers
411773|NCT01816009|infection|infection
411774|NCT01816009|antibiotic|antibiotic
411775|NCT01816009|prosthesis|prosthesis
411776|NCT01815996|Pregnancy|pregnancy
411777|NCT01815996|pulmonary embolism|pulmonary embolism
411778|NCT01815996|myocardial infarction|myocardial infarction
411779|NCT01815996|autoimmune disease|autoimmune disease
411780|NCT01815996|healthy controls|healthy controls
411781|NCT01815983|Laryngoscopy|laryngoscopy
411782|NCT01815983|Tracheal Intubation|tracheal intubation
411783|NCT01815983|Video Laryngoscopy|video laryngoscopy
411784|NCT01815970|dyspnea|dyspnea
411785|NCT01815970|exercise|exercise
411786|NCT01815970|neuromechanical uncoupling|neuromechanical uncoupling
411787|NCT01815970|COPD|copd
411788|NCT01815970|pulmonary rehabilitation|pulmonary rehabilitation
411789|NCT01815957|coronary microcirculation|coronary microcirculation
411790|NCT01815957|coronary artery disease|coronary artery disease
411791|NCT01815957|myocardial disease|myocardial disease
411792|NCT01815957|ischemia|ischemia
411793|NCT01815944|onset time|onset time
411794|NCT01815944|ultrasound-guided supraclavicular block|ultrasound-guided supraclavicular block
411795|NCT01815944|ropivacaine|ropivacaine
411796|NCT01815944|normal saline|normal saline
411797|NCT01815944|dextrose 5%|dextrose 5%
411798|NCT01815918|Orthopedic Procedures|orthopedic procedures
411799|NCT01815918|Prostheses and Implants|prostheses and implants
411800|NCT01815918|Joint Prosthesis|joint prosthesis
411801|NCT01815918|Knee Prosthesis|knee prosthesis
411802|NCT01815918|Arthroplasty, Knee|arthroplasty, knee
411803|NCT01815918|Thromboembolism|thromboembolism
411804|NCT01815918|Inflammation|inflammation
411805|NCT01815918|B-Cell Differentiation Factor-2|b-cell differentiation factor-2
411806|NCT01815918|Differentiation Factor-2, B-Cell|differentiation factor-2, b-cell
411807|NCT01815918|B-Cell Stimulatory Factor-2|b-cell stimulatory factor-2
411808|NCT01815918|BSF-2|bsf-2
411809|NCT01815918|IFN-beta 2|ifn-beta 2
411810|NCT01815918|MGI-2|mgi-2
411811|NCT01815918|Interleukin-6 (IL-6)|interleukin-6 (il-6)
411812|NCT01815918|Steroids|steroids
411813|NCT01815918|Pregnenediones|pregnenediones
411814|NCT01815918|Hydrocortisone|hydrocortisone
411815|NCT01815918|Physiological Effects of Drugs|physiological effects of drugs
411816|NCT01815918|Therapeutic Uses|therapeutic uses
411817|NCT01815892|Hemodialysis|hemodialysis
411818|NCT01815892|Response to Furosemide|response to furosemide
411819|NCT01815879|metastatic colorectal cancer|metastatic colorectal cancer
411820|NCT01815879|liver metastases|liver metastases
411821|NCT01815879|90Y resin microsphere radioembolization|90y resin microsphere radioembolization
411822|NCT01815879|retrospective data analysis|retrospective data analysis
411823|NCT01815866|Positive Nontuberculous Mycobacteria|positive nontuberculous mycobacteria
411824|NCT01815853|Neoadjuvant|neoadjuvant
411825|NCT01815853|Chemoradiotherapy|chemoradiotherapy
411826|NCT01815853|Chemotherapy|chemotherapy
411827|NCT01815853|Locally advanced gastric cancer|locally advanced gastric cancer
411828|NCT01815853|Pathological complete response|pathological complete response
411829|NCT01815853|D2 gastrectomy|d2 gastrectomy
411830|NCT01815814|spasticity|spasticity
411831|NCT01815814|cerebral palsy|cerebral palsy
411832|NCT01815814|hemiplegia|hemiplegia
411833|NCT01815814|hemiparesis|hemiparesis
411834|NCT01815814|diplegia|diplegia
411835|NCT01815814|paraplegia|paraplegia
411836|NCT01815814|quadriplegia|quadriplegia
411837|NCT01815814|quadriparesis|quadriparesis
411838|NCT01815775|Normal pressure hydrocephalus|normal pressure hydrocephalus
411839|NCT01815775|flow MRI|flow mri
411840|NCT01815775|dementia|dementia
411841|NCT01815775|cerebrospinal fluid|cerebrospinal fluid
411842|NCT01815775|shunt|shunt
411843|NCT01815762|bioimpedance|bioimpedance
411844|NCT01815762|overhydration|overhydration
411845|NCT01815762|hemodialysis|hemodialysis
411846|NCT01815762|arterial stiffness|arterial stiffness
411847|NCT01815762|mortality|mortality
411848|NCT01815736|HIV|hiv
411849|NCT01815736|HIV 1 Infected|hiv 1 infected
411850|NCT01815736|Virologically-Suppressed|virologically-suppressed
411851|NCT01815723|Psoriasis|psoriasis
411852|NCT01815723|Dimethyl fumarate|dimethyl fumarate
411853|NCT01815723|Fumaderm®|fumaderm®
411854|NCT01815710|Clinical Pathways|clinical pathways
411855|NCT01815710|Knowledge translation|knowledge translation
411856|NCT01815710|Evaluation|evaluation
411857|NCT01815697|Lower Urinary Tract Symptoms|lower urinary tract symptoms
411858|NCT01815697|Benign Prostatic Hyperplasia|benign prostatic hyperplasia
411859|NCT01815697|Urinary Retention|urinary retention
411860|NCT01815697|Vascular Endothelium|vascular endothelium
411861|NCT01815697|Counterpulsation, External|counterpulsation, external
411862|NCT01815684|Phase I|phase i
411863|NCT01815684|ASP3652|asp3652
411864|NCT01815684|Dose escalation|dose escalation
411865|NCT01815684|Maximum Tolerated Dose (MTD)|maximum tolerated dose (mtd)
411866|NCT01815671|colonoscopy|colonoscopy
411867|NCT01815671|technique|technique
411868|NCT01815671|tilt|tilt
411869|NCT01815671|insertion|insertion
411870|NCT01815671|safety|safety
411871|NCT01815671|efficacy|efficacy
411872|NCT01815645|Cocaine related disorders|cocaine related disorders
411873|NCT01815645|Contingency Management|contingency management
411874|NCT01815645|psychosocial treatment|psychosocial treatment
411875|NCT01815632|multiple sclerosis|multiple sclerosis
411876|NCT01815632|progressive MS|progressive ms
411877|NCT01815632|stem cell|stem cell
411878|NCT01815632|cell therapy|cell therapy
411879|NCT01815632|neurodegeneration|neurodegeneration
411880|NCT01815632|CNS repair|cns repair
411881|NCT01815606|Pancreas|pancreas
411882|NCT01815606|cancer|cancer
411883|NCT01815606|EUS-FNA|eus-fna
411884|NCT01815606|19Gauge|19gauge
411885|NCT01815606|25Gauge|25gauge
411886|NCT01815606|35mm mass|35mm mass
411887|NCT01815593|Erectile Dysfunction|erectile dysfunction
411888|NCT01815593|Vascular Endothelium|vascular endothelium
411889|NCT01815593|Counterpulsation, External|counterpulsation, external
411891|NCT01815580|Treatment as Prevention|treatment as prevention
411892|NCT01815580|Seek, Test, Treat, Retain Strategies|seek, test, treat, retain strategies
411893|NCT01815567|Hypertension|hypertension
411894|NCT01815567|Retinal Disorder|retinal disorder
411895|NCT01815567|Cognitive impairment|cognitive impairment
411896|NCT01815554|Tetraplegia|tetraplegia
411897|NCT01815554|Spinal Cord Injury|spinal cord injury
411898|NCT01815554|Ventilator|ventilator
411899|NCT01815554|Diaphragmatic Pacing System|diaphragmatic pacing system
411900|NCT01815541|subcutaneous teicoplanin|subcutaneous teicoplanin
411901|NCT01815541|osteoarticular|osteoarticular
411902|NCT01815541|infections|infections
411903|NCT01815541|tolerance|tolerance
411904|NCT01815541|teicoplanin|teicoplanin
411905|NCT01815528|recurrent epithelial ovarian cancer|recurrent epithelial ovarian cancer
411906|NCT01815515|Metastatic Prostate Cancer|metastatic prostate cancer
411907|NCT01815502|Single ventricle|single ventricle
411908|NCT01815502|Fontan|fontan
411909|NCT01815502|Sildenafil|sildenafil
411910|NCT01815502|Pressure-Volume Loops|pressure-volume loops
411911|NCT01815489|Necrotizing Pancreatitis|necrotizing pancreatitis
411912|NCT01815489|Pancreatitis|pancreatitis
411913|NCT01815489|Infection|infection
411914|NCT01815489|Bacteria|bacteria
411915|NCT01815489|Microbiology|microbiology
411916|NCT01815476|DCIS|dcis
411917|NCT01815476|Early Stage Invasive breast cancer|early stage invasive breast cancer
411918|NCT01815476|Prone breast radiotherapy|prone breast radiotherapy
411919|NCT01815463|stool|stool
411920|NCT01815463|monoclonal antibody|monoclonal antibody
411921|NCT01815463|Adnab-9|adnab-9
411922|NCT01815463|FOBT|fobt
411923|NCT01815463|FIT|fit
411924|NCT01815463|iFOBT|ifobt
411925|NCT01815463|colonoscopy|colonoscopy
411926|NCT01815463|barium enema|barium enema
411927|NCT01815463|flexible sigmoidoscopy|flexible sigmoidoscopy
411928|NCT01815424|Tofacitinib|tofacitinib
411929|NCT01815424|CP-690|cp-690
411930|NCT01815424|550|550
411931|NCT01815424|Xeljanz|xeljanz
411932|NCT01815424|Jak-Inhibitor|jak-inhibitor
411933|NCT01815424|Oral Treatment|oral treatment
411934|NCT01815424|Psoriasis vulgaris|psoriasis vulgaris
411935|NCT01815424|Pruritus|pruritus
411936|NCT01815424|Itch|itch
411937|NCT01815424|DLQI|dlqi
411938|NCT01815424|moderate|moderate
411939|NCT01815424|severe|severe
411940|NCT01815424|chronic|chronic
411941|NCT01815424|plaque psoriasis|plaque psoriasis
411942|NCT01815411|Rheumatoid arthritis|rheumatoid arthritis
411943|NCT01815411|symptom score|symptom score
411944|NCT01815411|fatigue|fatigue
411945|NCT01815411|life quality|life quality
411946|NCT01815411|cytokines|cytokines
411947|NCT01815411|mRNA expression|mrna expression
411948|NCT01815411|Quality of Life|quality of life
411949|NCT01815411|Signs and Symptoms|signs and symptoms
411950|NCT01815411|Indication for Modification of Patient Physical Status|indication for modification of patient physical status
411951|NCT01815385|Term gestation|term gestation
411952|NCT01815385|Environmental exposure|environmental exposure
411953|NCT01815385|Benzo(a)pyrene|benzo(a)pyrene
411954|NCT01815385|Polycyclic aromatic hydrocarbons|polycyclic aromatic hydrocarbons
411955|NCT01815385|Adiposity|adiposity
411956|NCT01815385|Cytosine methylation|cytosine methylation
411957|NCT01815372|nerve blocks|nerve blocks
411958|NCT01815372|ultrasound-guided|ultrasound-guided
411959|NCT01815372|leg surgery|leg surgery
411960|NCT01815359|ICARuS|icarus
411961|NCT01815359|Intraperitoneal Chemotherapy|intraperitoneal chemotherapy
411962|NCT01815359|hyperthermic intraperitoneal chemotherapy|hyperthermic intraperitoneal chemotherapy
411963|NCT01815359|Optimal Surgical Debulking|optimal surgical debulking
411964|NCT01815359|Leucovorin|leucovorin
411965|NCT01815359|Floxuridine (FUDR)|floxuridine (fudr)
411966|NCT01815359|Mitomycin|mitomycin
411967|NCT01815359|12-289|12-289
411968|NCT01815346|Breast Cancer|breast cancer
411969|NCT01815346|Breast cancer survivors|breast cancer survivors
411970|NCT01815346|Chronic, taxane-based chemotherapy-induced peripheral neuropathy|chronic, taxane-based chemotherapy-induced peripheral neuropathy
411971|NCT01815346|CIPN|cipn
411972|NCT01815346|Acupuncture treatments|acupuncture treatments
411973|NCT01815346|Quality of life|quality of life
411974|NCT01815346|Hand function|hand function
411975|NCT01815346|Balance|balance
411976|NCT01815346|Questionnaires|questionnaires
411977|NCT01815346|Surveys|surveys
411978|NCT01815333|Cancer of Lymph Node|cancer of lymph node
411979|NCT01815333|Magnetic resonance imaging|magnetic resonance imaging
411980|NCT01815333|MRI|mri
411981|NCT01815333|Ultrasuperparamagnetic nanoparticle iron oxide|ultrasuperparamagnetic nanoparticle iron oxide
411982|NCT01815333|USPIO|uspio
411983|NCT01815333|Feraheme|feraheme
411984|NCT01815333|Ferumoxytole|ferumoxytole
411985|NCT01815320|Renal Transplant|renal transplant
411986|NCT01815320|Contrast-enhanced ultrasound|contrast-enhanced ultrasound
411987|NCT01815320|Acute allograft rejection|acute allograft rejection
411988|NCT01815294|Ovarian cancer|ovarian cancer
411989|NCT01815294|Breast cancer|breast cancer
411990|NCT01815294|Solid malignancy|solid malignancy
411991|NCT01815294|Advanced or refractory solid malignancy|advanced or refractory solid malignancy
411992|NCT01815294|Metastatic cancer|metastatic cancer
411993|NCT01815294|DOXIL/CAELYX|doxil/caelyx
411994|NCT01815294|Doxorubicin HCL|doxorubicin hcl
411995|NCT01815294|Bioequivalence|bioequivalence
411996|NCT01815268|Randomized Controlled Trial|randomized controlled trial
411997|NCT01815268|Influenza|influenza
411998|NCT01815268|Influenza vaccine|influenza vaccine
411999|NCT01815268|Flu Vaccine|flu vaccine
412000|NCT01815268|Fluzone|fluzone
412001|NCT01815268|HD Fluzone|hd fluzone
412002|NCT01815268|Nursing Home|nursing home
412003|NCT01815268|Hospitalization|hospitalization
412004|NCT01815268|Mortality|mortality
412005|NCT01815268|Health Care worker vaccination|health care worker vaccination
412006|NCT01815268|ADL decline|adl decline
412007|NCT01815268|Effectiveness|effectiveness
412008|NCT01815268|Elderly|elderly
412009|NCT01815268|Morbidity|morbidity
412010|NCT01815268|Nursing Home resident|nursing home resident
412011|NCT01815268|Frail|frail
412012|NCT01815268|Institutionalized|institutionalized
412013|NCT01815268|Epidemiology|epidemiology
412014|NCT01815268|CDC|cdc
412015|NCT01815268|US|us
412016|NCT01815268|city|city
412017|NCT01815255|TDF-based regimen|tdf-based regimen
412018|NCT01815255|HIV-infected children|hiv-infected children
412019|NCT01815255|Thai|thai
412020|NCT01815255|generic|generic
412021|NCT01815255|safety and efficacy|safety and efficacy
412022|NCT01815255|renal status|renal status
412023|NCT01815255|To assess effect of TDF on renal problem in HIV-infected children receiving TDF-based once daily regimen|to assess effect of tdf on renal problem in hiv-infected children receiving tdf-based once daily regimen
412024|NCT01815255|To compare the effectiveness and clinical usefulness of different tools of adherence|to compare the effectiveness and clinical usefulness of different tools of adherence
412025|NCT01815229|endotracheal|endotracheal
412026|NCT01815229|intubation|intubation
412027|NCT01815216|Bariatric surgery|bariatric surgery
412028|NCT01815216|Cognition|cognition
412029|NCT01815216|Satiety hormones|satiety hormones
412030|NCT01815216|Brain networks|brain networks
412031|NCT01815216|Inhibitory control|inhibitory control
412032|NCT01815216|Food intake|food intake
412033|NCT01815203|Caffeine effects|caffeine effects
412034|NCT01815203|Inhibitory control|inhibitory control
412035|NCT01815190|immune complex vasculitis|immune complex vasculitis
412036|NCT01815190|cutaneous vasculitis|cutaneous vasculitis
412037|NCT01815190|IgA vasculitis|iga vasculitis
412038|NCT01815190|IgA nephropathy|iga nephropathy
412039|NCT01815138|OHSS, GnRH agonist trigger, low dose hCG, PCOS, IVF|ohss, gnrh agonist trigger, low dose hcg, pcos, ivf
412040|NCT01815125|Mild traumatic brain injury|mild traumatic brain injury
412041|NCT01815125|Brain concussion|brain concussion
412042|NCT01815125|Post-concussion syndrome|post-concussion syndrome
412043|NCT01815125|Emergency department|emergency department
412044|NCT01815125|Ondansetron|ondansetron
412045|NCT01815112|Neurodegenerative disease|neurodegenerative disease
412046|NCT01815112|Elderly|elderly
412047|NCT01815112|Dementia|dementia
412048|NCT01815112|FDG-PET|fdg-pet
412049|NCT01815112|MRI|mri
412050|NCT01815112|Neuroimaging|neuroimaging
412051|NCT01815086|Radioimmunoimaging|radioimmunoimaging
412052|NCT01815086|AL Amyloidosis|al amyloidosis
412053|NCT01815086|PET/CT|pet/ct
412054|NCT01815047|Vitamin D|vitamin d
412055|NCT01815047|Pregnancy|pregnancy
412056|NCT01815047|Inflammation|inflammation
412057|NCT01815047|Infection|infection
412058|NCT01815047|Placenta|placenta
412059|NCT01815047|Cytokine|cytokine
412060|NCT01815047|Microbiome|microbiome
412061|NCT01815008|Platelet aggregation|platelet aggregation
412062|NCT01815008|Clopidogrel|clopidogrel
412063|NCT01815008|Platelet transcriptome|platelet transcriptome
412064|NCT01814995|behavioural|behavioural
412065|NCT01814995|diabetes prevention|diabetes prevention
412066|NCT01814995|overweight|overweight
412067|NCT01814995|physical activity|physical activity
412068|NCT01814995|gestational diabetes|gestational diabetes
412069|NCT01814982|Traumatic brain injury|traumatic brain injury
412070|NCT01814982|JNJ-17299425|jnj-17299425
412071|NCT01814982|Intracranial pressure|intracranial pressure
412072|NCT01814982|Intravascular bolus injection|intravascular bolus injection
412073|NCT01814969|Rectal neoplasm|rectal neoplasm
412074|NCT01814969|Preoperative hyperfractionated radiotherapy|preoperative hyperfractionated radiotherapy
412075|NCT01814969|Preoperative hyperfractionated radiochemotherapy|preoperative hyperfractionated radiochemotherapy
412076|NCT01814943|Uncomplicated peptic ulcer|uncomplicated peptic ulcer
412077|NCT01814943|Acid-suppressing drugs|acid-suppressing drugs
412078|NCT01814943|Epidemiology|epidemiology
412079|NCT01814891|vitamin A|vitamin a
412080|NCT01814891|maize|maize
412081|NCT01814891|total body reserves|total body reserves
412082|NCT01814891|Condition is vitamin A status.|condition is vitamin a status.
412083|NCT01814891|Focus: change in vitamin A status with maize feeding.|focus: change in vitamin a status with maize feeding.
412084|NCT01814891|Focus: feeding orange maize to children for 90 days.|focus: feeding orange maize to children for 90 days.
412085|NCT01814891|Focus: total body reserves of vitamin A.|focus: total body reserves of vitamin a.
412086|NCT01814878|Pain, Postoperative|pain, postoperative
412087|NCT01814878|Tramadol Hydrochloride|tramadol hydrochloride
412088|NCT01814878|Acetaminophen|acetaminophen
412089|NCT01814878|Ultracet|ultracet
412090|NCT01814865|Post-menopausal|post-menopausal
412091|NCT01814865|ER+|er+
412092|NCT01814865|Stage I-IIIA|stage i-iiia
412093|NCT01814865|Operable|operable
412094|NCT01814865|Breast Cancer|breast cancer
412095|NCT01814852|Low Intensity Shockwave|low intensity shockwave
412096|NCT01814852|Extracorporeal shockwave therapy|extracorporeal shockwave therapy
412097|NCT01814852|Erectile dysfunction|erectile dysfunction
412098|NCT01814839|RNAi therapeutic|rnai therapeutic
412099|NCT01814826|MLN4924|mln4924
412100|NCT01814826|Acute|acute
412101|NCT01814826|Myelogenous|myelogenous
412102|NCT01814826|Leukemia|leukemia
412103|NCT01814800|PIDD, PID, humoral immunity, antibody deficiency|pidd, pid, humoral immunity, antibody deficiency
412104|NCT01814787|Type 2 Diabetes|type 2 diabetes
412105|NCT01814787|Pediatrics|pediatrics
412106|NCT01814787|Computerized Decision Support System|computerized decision support system
412107|NCT01814748|Diabetes Mellitus|diabetes mellitus
412108|NCT01814748|Diabetes Mellitus, Type 2|diabetes mellitus, type 2
412109|NCT01814748|Glucose Metabolism Disorders|glucose metabolism disorders
412110|NCT01814748|Metabolic Diseases|metabolic diseases
412111|NCT01814748|Endocrine System Diseases|endocrine system diseases
412112|NCT01814748|Metformin|metformin
412113|NCT01814748|Hypoglycemic Agents|hypoglycemic agents
412114|NCT01814748|Pharmacologic Actions|pharmacologic actions
412115|NCT01814748|Therapeutic Uses|therapeutic uses
412116|NCT01814722|HIV Infections|hiv infections
412117|NCT01814722|Anti-HIV Agents|anti-hiv agents
412118|NCT01814722|Anti-Retroviral Agents|anti-retroviral agents
412119|NCT01814722|Nucleoside Reverse Transcriptase Inhibitors|nucleoside reverse transcriptase inhibitors
412120|NCT01814722|Non-nucleoside Reverse Transcriptase Inhibitor|non-nucleoside reverse transcriptase inhibitor
412121|NCT01814722|Protease inhibitors|protease inhibitors
412122|NCT01814696|Heart Failure|heart failure
412123|NCT01814696|Congestive Heart Failure|congestive heart failure
412124|NCT01814696|Medication Adherence|medication adherence
412125|NCT01814696|Medication Compliance|medication compliance
412126|NCT01814696|Telemedicine|telemedicine
412127|NCT01814696|Telehealth|telehealth
412128|NCT01814683|Vivax malaria|vivax malaria
412129|NCT01814683|Primaquine|primaquine
412130|NCT01814683|Placebo|placebo
412131|NCT01814683|Recurrence|recurrence
412132|NCT01814657|Infertility|infertility
412133|NCT01814605|Sciatic Nerve Block|sciatic nerve block
412134|NCT01814605|Subgluteal space|subgluteal space
412135|NCT01814605|Infragluteal space|infragluteal space
412136|NCT01814592|coronally positioned flap|coronally positioned flap
412137|NCT01814592|connective tissue|connective tissue
412138|NCT01814592|gingival margin|gingival margin
412139|NCT01814592|gingival recession/ treatment|gingival recession/ treatment
412140|NCT01814592|gingival recession/ surgery|gingival recession/ surgery
412141|NCT01814592|subepithelial connective tissue graft|subepithelial connective tissue graft
412142|NCT01814592|randomized controlled clinical trial|randomized controlled clinical trial
412143|NCT01814592|surgical flaps|surgical flaps
412144|NCT01814592|Treatment outcome|treatment outcome
412145|NCT01814579|vaginal|vaginal
412146|NCT01814579|cuff|cuff
412147|NCT01814579|robotic|robotic
412148|NCT01814579|hysterectomy|hysterectomy
412149|NCT01814579|vloc|vloc
412150|NCT01814579|v-loc|v-loc
412151|NCT01814579|vicryl|vicryl
412152|NCT01814579|unidirectional|unidirectional
412153|NCT01814579|barbed|barbed
412154|NCT01814579|suture|suture
412155|NCT01814527|Fish oil|fish oil
412156|NCT01814527|Omega 3 Fatty acids|omega 3 fatty acids
412157|NCT01814527|Docosahexaenoic acid|docosahexaenoic acid
412158|NCT01814527|Mild Concussion|mild concussion
412159|NCT01814527|Brain Concussion|brain concussion
412160|NCT01814527|Cerebral Concussion|cerebral concussion
412161|NCT01814514|hypertensive|hypertensive
412162|NCT01814514|phase|phase
412163|NCT01814514|success rate|success rate
412165|NCT01814501|Metastatic colon cancer|metastatic colon cancer
412166|NCT01814488|Active acute leukemia|active acute leukemia
412167|NCT01814488|PIF|pif
412168|NCT01814488|Allogeneic transplant|allogeneic transplant
412169|NCT01814488|Acute Myeloid Leukemia|acute myeloid leukemia
412170|NCT01814488|Acute Lymphoblastic Leukemia|acute lymphoblastic leukemia
412171|NCT01814488|Marrow Unrelated Donor|marrow unrelated donor
412172|NCT01814488|Cord Blood|cord blood
412173|NCT01814488|Family Haploidentical donor|family haploidentical donor
412174|NCT01814475|myelofibrosis|myelofibrosis
412175|NCT01814475|unfavourable prognostic factors|unfavourable prognostic factors
412176|NCT01814475|Allogeneic stem cell transplantation|allogeneic stem cell transplantation
412177|NCT01814475|Progression Free Survival|progression free survival
412178|NCT01814475|thrombocythemia vera|thrombocythemia vera
412179|NCT01814475|polycythemia vera|polycythemia vera
412180|NCT01814475|Reduced-intensity conditioning|reduced-intensity conditioning
412181|NCT01814462|Obstructive Sleep Apnea|obstructive sleep apnea
412182|NCT01814462|Pulse wave analysis|pulse wave analysis
412183|NCT01814449|Breast cancer|breast cancer
412184|NCT01814449|Hypoxia|hypoxia
412185|NCT01814449|Hypoxia related gene|hypoxia related gene
412186|NCT01814449|Endocrine therapy|endocrine therapy
412187|NCT01814449|Treatment resistance|treatment resistance
412188|NCT01814423|Plasmodium falciparum|plasmodium falciparum
412189|NCT01814423|malaria|malaria
412190|NCT01814423|chloroquine|chloroquine
412191|NCT01814423|pharmacokinetic|pharmacokinetic
412192|NCT01814423|children|children
412193|NCT01814410|Intravenous Ethanol|intravenous ethanol
412194|NCT01814410|Intravenous Nicotine|intravenous nicotine
412195|NCT01814410|Interactive effects|interactive effects
412196|NCT01814410|cognition|cognition
412197|NCT01814410|subjective effects|subjective effects
412198|NCT01814410|healthy subjects|healthy subjects
412199|NCT01814397|Aromatase inhibitor|aromatase inhibitor
412200|NCT01814397|Pain threshold|pain threshold
412201|NCT01814384|Ancillary tailored|ancillary tailored
412202|NCT01814384|medico-economic study,|medico-economic study,
412203|NCT01814384|total knee replacement|total knee replacement
412204|NCT01814384|primary or secondary osteoarthritis|primary or secondary osteoarthritis
412205|NCT01814371|Abscesses|abscesses
412206|NCT01814371|Furunculosis|furunculosis
412207|NCT01814371|Staphylococcus aureus colonization|staphylococcus aureus colonization
412208|NCT01814371|Staphylococcal Skin Infection|staphylococcal skin infection
412209|NCT01814371|MRSA|mrsa
412210|NCT01814345|Her2 testing (Human Epidermal Growth Factor Receptor 2)|her2 testing (human epidermal growth factor receptor 2)
412211|NCT01814332|Stress disorders, Post-traumatic|stress disorders, post-traumatic
412212|NCT01814332|Sleep|sleep
412213|NCT01814319|heart failure|heart failure
412214|NCT01814319|ejection fraction equal or less than 40%|ejection fraction equal or less than 40%
412215|NCT01814306|LMA Supreme,LMA Proseal,airway management,prone position|lma supreme,lma proseal,airway management,prone position
412216|NCT01814293|Pediatric|pediatric
412217|NCT01814293|Upper Respiratory infection|upper respiratory infection
412218|NCT01814293|Over the Counter Drugs|over the counter drugs
412219|NCT01814293|Drugs, Non-Prescription|drugs, non-prescription
412220|NCT01814293|Vaporizer|vaporizer
412221|NCT01814280|Medication errors|medication errors
412222|NCT01814280|Medication review|medication review
412223|NCT01814280|Risk stratification|risk stratification
412224|NCT01814280|Patient safety|patient safety
412225|NCT01814267|innovative care|innovative care
412226|NCT01814267|telemedicine|telemedicine
412227|NCT01814267|cost effectiveness|cost effectiveness
412228|NCT01814267|diabetes|diabetes
412229|NCT01814241|Peanut allergy|peanut allergy
412230|NCT01814215|Obesity|obesity
412231|NCT01814215|Prevention and Control|prevention and control
412232|NCT01814215|Diet|diet
412233|NCT01814215|Motor Activity|motor activity
412234|NCT01814215|Intervention Studies|intervention studies
412235|NCT01814215|Child, Preschool|child, preschool
412236|NCT01814215|Child Care|child care
412237|NCT01814215|Food Habits|food habits
412238|NCT01814215|Feeding Behavior|feeding behavior
412239|NCT01814215|Child Behavior|child behavior
412240|NCT01814163|First line treatment|first line treatment
412241|NCT01814163|Non small cell lung cancer, non squamous|non small cell lung cancer, non squamous
412242|NCT01814150|Docetaxel|docetaxel
412369|NCT01813513|Hepatitis C|hepatitis c
412243|NCT01814150|Alpha 1 Acid Glycoprotein|alpha 1 acid glycoprotein
412244|NCT01814150|Outcome|outcome
412245|NCT01814111|Hypertension|hypertension
412246|NCT01814111|Atrial Fibrillation|atrial fibrillation
412247|NCT01814111|Arrhythmias, Cardiac|arrhythmias, cardiac
412248|NCT01814111|Heart Diseases|heart diseases
412249|NCT01814111|Cardiovascular Diseases|cardiovascular diseases
412250|NCT01814098|Depressive Disorder, Major|depressive disorder, major
412251|NCT01814098|Escitalopram|escitalopram
412253|NCT01814085|Major Depressive Disorder|major depressive disorder
412254|NCT01814085|Escitalopram|escitalopram
412255|NCT01814085|Lexapro|lexapro
412256|NCT01814059|Sirolimus|sirolimus
412257|NCT01814059|Eosinophilic Esophagitis|eosinophilic esophagitis
412258|NCT01814059|Eosinophilic Gastroenteritis|eosinophilic gastroenteritis
412259|NCT01814059|T -Cells|t -cells
412260|NCT01814059|Food Allergy|food allergy
412261|NCT01814046|Metastatic|metastatic
412262|NCT01814046|Ocular Melanoma|ocular melanoma
412263|NCT01814046|Autologous Tumor-Infiltrating Lymphocytes|autologous tumor-infiltrating lymphocytes
412264|NCT01814046|Uveal Melanoma|uveal melanoma
412265|NCT01814046|Adoptive Cell Therapy|adoptive cell therapy
412266|NCT01814033|LRU|lru
412267|NCT01814033|Total Knee Arthroplasty|total knee arthroplasty
412268|NCT01814033|Total Knee Replacement|total knee replacement
412269|NCT01814033|Acute Rehabilitation Total Knee|acute rehabilitation total knee
412270|NCT01814033|Total Knee Range of Motion|total knee range of motion
412271|NCT01814033|Total Knee Acute care Outcomes|total knee acute care outcomes
412272|NCT01814020|DSO|dso
412273|NCT01814007|Lipolysis|lipolysis
412274|NCT01814007|Cryolipolysis|cryolipolysis
412275|NCT01814007|Fat Reduction|fat reduction
412276|NCT01813994|Statin; Gastric inflammation; Gastric cancer|statin; gastric inflammation; gastric cancer
412277|NCT01813968|Ischemic postconditioning|ischemic postconditioning
412278|NCT01813968|Adult cardiac surgery|adult cardiac surgery
412279|NCT01813968|Aortic valve surgery|aortic valve surgery
412280|NCT01813968|Swan-Ganz|swan-ganz
412281|NCT01813968|Cardiac index|cardiac index
412282|NCT01813955|phosphodiesterase inhibitor|phosphodiesterase inhibitor
412283|NCT01813955|Psychophysiology|psychophysiology
412284|NCT01813955|Cognition|cognition
412285|NCT01813955|Schizophrenia|schizophrenia
412286|NCT01813955|Papaverine|papaverine
412287|NCT01813942|clinical narrative report|clinical narrative report
412288|NCT01813942|time series data|time series data
412289|NCT01813942|missing value|missing value
412290|NCT01813929|Diabetes|diabetes
412291|NCT01813929|Insulin|insulin
412292|NCT01813929|Metformin|metformin
412293|NCT01813929|Vascular|vascular
412294|NCT01813929|Vessels|vessels
412295|NCT01813929|Type 1|type 1
412296|NCT01813916|Osteoarthritis|osteoarthritis
412297|NCT01813916|synovial fluid|synovial fluid
412298|NCT01813916|hyaluronic acid|hyaluronic acid
412299|NCT01813890|Bunionectomy|bunionectomy
412300|NCT01813890|Acute pain|acute pain
412301|NCT01813890|Post-operative pain|post-operative pain
412302|NCT01813890|Tapentadol IR|tapentadol ir
412303|NCT01813890|Analgesia|analgesia
412304|NCT01813890|Hallux valgus|hallux valgus
412305|NCT01813864|treatment planning|treatment planning
412306|NCT01813864|resource guide|resource guide
412307|NCT01813864|service matching|service matching
412308|NCT01813864|Service matching for substance abuse clients|service matching for substance abuse clients
412309|NCT01813864|CASPAR resource guide|caspar resource guide
412310|NCT01813864|Improved treatment planning|improved treatment planning
412311|NCT01813851|Dialysis, Exercise, Protein Energy Wasting, Nutrition and Physical Fitness|dialysis, exercise, protein energy wasting, nutrition and physical fitness
412312|NCT01813825|Mammosite|mammosite
412313|NCT01813799|Diabetic Neuropathies|diabetic neuropathies
412314|NCT01813734|RET gene mutation|ret gene mutation
412315|NCT01813721|NHL|nhl
412316|NCT01813721|Breast Cancer|breast cancer
412317|NCT01813721|Lung Cancer|lung cancer
412318|NCT01813708|Type 2 Diabetes|type 2 diabetes
412319|NCT01813708|Intensive Life-Style|intensive life-style
412320|NCT01813708|Collaborative Education|collaborative education
412321|NCT01813708|Clinical Trial|clinical trial
412322|NCT01813708|Metabolic Control|metabolic control
412323|NCT01813695|Preemptive genetic testing|preemptive genetic testing
412324|NCT01813695|Pain|pain
412325|NCT01813695|Pediatrics|pediatrics
412326|NCT01813695|Orthopedics|orthopedics
412327|NCT01813695|Pectus excavatum|pectus excavatum
412328|NCT01813695|Scoliosis|scoliosis
412329|NCT01813682|preterm infant|preterm infant
412330|NCT01813682|anemia|anemia
412331|NCT01813682|iron fortified TPN|iron fortified tpn
412332|NCT01813669|Childhood anxiety|childhood anxiety
412333|NCT01813669|Pediatric Pain|pediatric pain
412334|NCT01813669|Yoga|yoga
412335|NCT01813669|Cognitive behavioral therapy|cognitive behavioral therapy
412336|NCT01813656|Methamphetamine-Associated Psychosis|methamphetamine-associated psychosis
412337|NCT01813656|Aripiprazole|aripiprazole
412338|NCT01813643|Methamphetamine-Associated Psychosis|methamphetamine-associated psychosis
412339|NCT01813643|Aripiprazole|aripiprazole
412340|NCT01813643|Risperidone|risperidone
412341|NCT01813630|Turner's Syndrome|turner's syndrome
412342|NCT01813630|Short Stature|short stature
412343|NCT01813630|Dwarfism|dwarfism
412344|NCT01813617|Polymyositis|polymyositis
412345|NCT01813617|Dermatomyositis|dermatomyositis
412346|NCT01813617|Muscle endurance|muscle endurance
412347|NCT01813617|Muscle stength|muscle stength
412348|NCT01813617|Outcome|outcome
412349|NCT01813604|Polio|polio
412350|NCT01813604|Inactivated polio vaccine|inactivated polio vaccine
412351|NCT01813604|oral polio vaccine|oral polio vaccine
412352|NCT01813604|vaccine trial|vaccine trial
412353|NCT01813591|Chronic Migraine|chronic migraine
412354|NCT01813591|Headache|headache
412355|NCT01813591|Refractory Chronic Migraine|refractory chronic migraine
412356|NCT01813578|Systemic sclerosis|systemic sclerosis
412357|NCT01813578|Exercise|exercise
412358|NCT01813578|Physical capacity|physical capacity
412359|NCT01813578|Aerobic capacity|aerobic capacity
412360|NCT01813578|Muscle function|muscle function
412361|NCT01813578|Fatigue|fatigue
412362|NCT01813552|HCV|hcv
412363|NCT01813552|Hepatitis C|hepatitis c
412364|NCT01813552|antiviral drugs|antiviral drugs
412365|NCT01813552|liver|liver
412366|NCT01813539|malignancy|malignancy
412367|NCT01813513|HCV|hcv
412368|NCT01813513|Hepatitis C Virus|hepatitis c virus
412370|NCT01813513|antiviral drugs|antiviral drugs
412371|NCT01813513|liver|liver
412372|NCT01813474|Cancer|cancer
412373|NCT01813474|Tumour|tumour
412374|NCT01813474|Solid Malignancies|solid malignancies
412375|NCT01813461|BAL8557|bal8557
412376|NCT01813461|14C-labeled isavuconazole|14c-labeled isavuconazole
412377|NCT01813461|14C-labeled prodrug isavuconazonium sulfate (BAL8557)/([cyano-14C]ASP9766 sulfate)|14c-labeled prodrug isavuconazonium sulfate (bal8557)/([cyano-14c]asp9766 sulfate)
412378|NCT01813448|Fidaxomicin|fidaxomicin
412379|NCT01813448|OPT-80|opt-80
412380|NCT01813448|Healthy Subjects|healthy subjects
412381|NCT01813435|CAD|cad
412382|NCT01813435|ACS|acs
412383|NCT01813435|All comers|all comers
412384|NCT01813435|DAPT|dapt
412385|NCT01813435|PCI|pci
412386|NCT01813422|Cholesterol|cholesterol
412387|NCT01813422|High Cholesterol|high cholesterol
412388|NCT01813422|Elevated Cholesterol|elevated cholesterol
412389|NCT01813422|Raised Cholesterol|raised cholesterol
412390|NCT01813396|shoulder|shoulder
412391|NCT01813396|muscle stiffness|muscle stiffness
412392|NCT01813396|shoulder physical activity|shoulder physical activity
412393|NCT01813396|range of motion|range of motion
412394|NCT01813396|joint mobility|joint mobility
412395|NCT01813383|Celiac disease|celiac disease
412396|NCT01813383|HLA-DQ2.2|hla-dq2.2
412397|NCT01813383|HLA-DQ2.5|hla-dq2.5
412398|NCT01813383|HLA-DR7-DQ2|hla-dr7-dq2
412399|NCT01813383|HLA-DR3-DQ2|hla-dr3-dq2
412400|NCT01813370|TAX 3503|tax 3503
412401|NCT01813370|MSKCC IRB#07-101|mskcc irb#07-101
412402|NCT01813370|12-225|12-225
412403|NCT01813357|HIV|hiv
412404|NCT01813357|Cardiovascular disease|cardiovascular disease
412405|NCT01813357|Inflammation|inflammation
412406|NCT01813357|Statin|statin
412407|NCT01813344|Adult lymphoblastic lymphoma|adult lymphoblastic lymphoma
412408|NCT01813344|Hyper-CVAD|hyper-cvad
412409|NCT01813344|first-line treatment|first-line treatment
412410|NCT01813305|Diabetic Foot Ulcer|diabetic foot ulcer
412411|NCT01813305|Diabetes Mellitus|diabetes mellitus
412412|NCT01813305|Debridement|debridement
412413|NCT01813305|Standard of Care|standard of care
412414|NCT01813305|wounds|wounds
412415|NCT01813292|male patients|male patients
412416|NCT01813292|treated by TRUVADA® or VIREAD® for more than 60 months|treated by truvada® or viread® for more than 60 months
412417|NCT01813253|epidermal growth factor receptor|epidermal growth factor receptor
412418|NCT01813253|second line|second line
412419|NCT01813214|melanoma|melanoma
412420|NCT01813214|vemurafenib|vemurafenib
412421|NCT01813214|cobitmetinib|cobitmetinib
412422|NCT01813201|Testosterone|testosterone
412423|NCT01813201|Anabolic deterioration|anabolic deterioration
412424|NCT01813188|Fractures|fractures
412425|NCT01813188|Bone|bone
412426|NCT01813188|Stem Cells|stem cells
412427|NCT01813149|Complex Regional Pain Syndrome (CRPS)|complex regional pain syndrome (crps)
412428|NCT01813136|radioiodine refractory Differentiated Thyroid Carcinoma|radioiodine refractory differentiated thyroid carcinoma
412429|NCT01813136|pazopanib|pazopanib
412430|NCT01813136|intermittent administration|intermittent administration
412431|NCT01813136|time to treatment failure|time to treatment failure
412432|NCT01813136|TUTHYREF|tuthyref
412433|NCT01813123|gender-specific|gender-specific
412434|NCT01813123|web-based|web-based
412435|NCT01813123|drug abuse|drug abuse
412436|NCT01813123|prevention|prevention
412437|NCT01813110|inflammation|inflammation
412438|NCT01813110|omega-3|omega-3
412439|NCT01813110|fish oil|fish oil
412440|NCT01813097|To detective the effect of the treatment of combination iodine 125 seed implants and LHRH agonists for the patients with locally advanced prostate cancer.|to detective the effect of the treatment of combination iodine 125 seed implants and lhrh agonists for the patients with locally advanced prostate cancer.
412441|NCT01813071|Enterobacteriaceae Infections|enterobacteriaceae infections
412442|NCT01813071|Gram-Negative Bacterial Infections|gram-negative bacterial infections
412443|NCT01813071|Bacterial Infections|bacterial infections
412444|NCT01813071|Gastroenteritis|gastroenteritis
412445|NCT01813071|Gastrointestinal Diseases|gastrointestinal diseases
412446|NCT01813071|Digestive System Diseases|digestive system diseases
412447|NCT01813071|Intestinal Diseases|intestinal diseases
412448|NCT01813071|Shigellosis|shigellosis
412449|NCT01813058|Tranexamic acid, Blood loss|tranexamic acid, blood loss
412450|NCT01813045|Angiogenesis|angiogenesis
412451|NCT01813045|Fibrosis|fibrosis
412452|NCT01813045|Myocardial Infarction|myocardial infarction
412453|NCT01813045|Imaging|imaging
412454|NCT01813045|CT-PET|ct-pet
412455|NCT01813045|PET-CT|pet-ct
412456|NCT01813045|Cardiac MRI|cardiac mri
412457|NCT01813032|firefighters|firefighters
412458|NCT01813032|police officers|police officers
412459|NCT01813032|emergency service professionals|emergency service professionals
412460|NCT01813032|myocardial infarction|myocardial infarction
412461|NCT01813032|endothelial function|endothelial function
412462|NCT01813032|thrombosis|thrombosis
412463|NCT01813019|Obsessive compulsive disorder (OCD), obsessive fears, obsessions,|obsessive compulsive disorder (ocd), obsessive fears, obsessions,
412464|NCT01813019|compulsions, OCD SSRI resistant|compulsions, ocd ssri resistant
412465|NCT01812993|Ischemic stroke, sleep apnea, non-invasive ventilatory treatment|ischemic stroke, sleep apnea, non-invasive ventilatory treatment
412466|NCT01812980|Influenza|influenza
412467|NCT01812980|Human Immunodeficiency Virus|human immunodeficiency virus
412468|NCT01812954|moderate-to-severe psoriasis|moderate-to-severe psoriasis
412469|NCT01812954|cost utility analysis|cost utility analysis
412470|NCT01812954|cost effectiveness analysis|cost effectiveness analysis
412471|NCT01812954|systemic treatment|systemic treatment
412472|NCT01812941|burns|burns
412473|NCT01812941|trauma|trauma
412474|NCT01812928|Flexible Cystoscopy|flexible cystoscopy
412475|NCT01812928|Pain control|pain control
412476|NCT01812928|Diclofenac|diclofenac
412477|NCT01812928|Non steroidal anti inflammatory drug|non steroidal anti inflammatory drug
412478|NCT01812915|Cuff pressure|cuff pressure
412479|NCT01812915|Cylindrical cuff|cylindrical cuff
412480|NCT01812915|Endotracheal tube|endotracheal tube
412481|NCT01812915|Nitrous oxide|nitrous oxide
412482|NCT01812915|Tapered cuff|tapered cuff
412483|NCT01812902|Prostate cancer|prostate cancer
412484|NCT01812902|Prostate specific antigen|prostate specific antigen
412485|NCT01812902|lymphadenectomy|lymphadenectomy
412486|NCT01812902|Limited lymphadenectomy|limited lymphadenectomy
412487|NCT01812902|Extended lymphadenectomy|extended lymphadenectomy
412488|NCT01812902|Immunohistochemistry|immunohistochemistry
412489|NCT01812889|bacterial vaginosis, vulvovaginal candidiasis, TOL-463, intravaginal therapy, vaginitis, women, cross-over|bacterial vaginosis, vulvovaginal candidiasis, tol-463, intravaginal therapy, vaginitis, women, cross-over
412490|NCT01812863|Pain Management|pain management
412491|NCT01812863|Child|child
412492|NCT01812863|Surgery|surgery
412493|NCT01812850|Temporomandibular joint|temporomandibular joint
412494|NCT01812850|Orofacial muscular complex|orofacial muscular complex
412495|NCT01812850|Bruxism|bruxism
412496|NCT01812850|Clenching|clenching
412497|NCT01812850|Orthodontic treatment|orthodontic treatment
412498|NCT01812850|Invisalign®|invisalign®
412499|NCT01812837|actinic keratosis|actinic keratosis
412500|NCT01812837|microneedles|microneedles
412501|NCT01812837|photodynamic therapy|photodynamic therapy
412502|NCT01812837|levulan|levulan
412503|NCT01812837|Aminolevulinic acid|aminolevulinic acid
412504|NCT01812824|Preconception Health|preconception health
412505|NCT01812824|Health Information Technology|health information technology
412506|NCT01812824|Reproductive Life Plan|reproductive life plan
412507|NCT01812824|Healthcare Disparities|healthcare disparities
412508|NCT01812824|Low birth-weight|low birth-weight
412509|NCT01812824|Preterm Delivery|preterm delivery
412510|NCT01812811|pulse wave analysis|pulse wave analysis
412511|NCT01812811|pulse wave velocity|pulse wave velocity
412512|NCT01812811|Arteriograph24|arteriograph24
412513|NCT01812811|Ambulatory|ambulatory
412514|NCT01812811|diabetes|diabetes
412515|NCT01812811|reproducibility|reproducibility
412516|NCT01812811|diurnal variation|diurnal variation
412517|NCT01812798|Peanut allergy|peanut allergy
412518|NCT01812798|Threshold|threshold
412519|NCT01812798|Modelling|modelling
412520|NCT01812798|Risk assessment|risk assessment
412521|NCT01812785|Fever|fever
412522|NCT01812785|Children|children
412523|NCT01812785|Non-malaria fevers|non-malaria fevers
412524|NCT01812785|Diagnosis|diagnosis
412525|NCT01812772|urinary stents|urinary stents
412526|NCT01812772|ureteroscopy|ureteroscopy
412527|NCT01812759|Pain|pain
412528|NCT01812759|Breakthrough cancer pain|breakthrough cancer pain
412529|NCT01812759|Emergency Department|emergency department
412530|NCT01812759|ED|ed
412531|NCT01812759|Fentanyl nasal spray|fentanyl nasal spray
412532|NCT01812759|Lazanda|lazanda
412533|NCT01812759|Placebo nasal spray|placebo nasal spray
412534|NCT01812759|Hydromorphone PCA|hydromorphone pca
412535|NCT01812759|Dilaudid|dilaudid
412536|NCT01812694|Pregnancy|pregnancy
412537|NCT01812694|Weight Control|weight control
412538|NCT01812694|Weight Gain|weight gain
412539|NCT01812681|vitamin D, Respiratory distress syndrome, sepsis, preterm|vitamin d, respiratory distress syndrome, sepsis, preterm
412540|NCT01812655|pain|pain
412541|NCT01812655|anxiety|anxiety
412542|NCT01812655|children|children
412543|NCT01812655|adolescents|adolescents
412544|NCT01812655|burn|burn
412545|NCT01812655|virtual reality|virtual reality
412546|NCT01812655|distraction|distraction
412547|NCT01812642|Schizophrenia|schizophrenia
412548|NCT01812642|JNJ-37822681|jnj-37822681
412549|NCT01812642|Placebo|placebo
412550|NCT01812616|Cancer|cancer
412551|NCT01812616|Safety|safety
412552|NCT01812603|Cancer|cancer
412553|NCT01812603|Safety|safety
412554|NCT01812564|Platelet rich plasma|platelet rich plasma
412555|NCT01812564|Interventional|interventional
412556|NCT01812564|Randomized|randomized
412557|NCT01812564|Double-blind|double-blind
412558|NCT01812551|cystic fibrosis|cystic fibrosis
412559|NCT01812551|children|children
412560|NCT01812551|adolescents|adolescents
412561|NCT01812551|low bone mass|low bone mass
412562|NCT01812551|osteoporosis|osteoporosis
412563|NCT01812551|alendronate|alendronate
412564|NCT01812551|fractures|fractures
412565|NCT01812525|Bronchiolitis|bronchiolitis
412566|NCT01812525|Moderate to Severe|moderate to severe
412567|NCT01812525|Hypertonic saline|hypertonic saline
412568|NCT01812525|NaCl 3% inhalations|nacl 3% inhalations
412569|NCT01812525|Standard therapy|standard therapy
412570|NCT01812525|Wang score|wang score
412571|NCT01812525|in-patients|in-patients
412572|NCT01812512|Heart Failure|heart failure
412573|NCT01812512|Communication|communication
412574|NCT01812512|Telemedicine|telemedicine
412575|NCT01812512|Veterans|veterans
412576|NCT01812512|Nurse-patient relations|nurse-patient relations
412577|NCT01812499|blood transfusion|blood transfusion
412578|NCT01812499|adverse event|adverse event
412579|NCT01812499|incident reporting|incident reporting
412580|NCT01812473|protein binding|protein binding
412581|NCT01812473|voriconazole|voriconazole
412582|NCT01812473|pediatrics|pediatrics
412583|NCT01812473|hematology|hematology
412584|NCT01812473|intensive care|intensive care
412585|NCT01812473|albumin|albumin
412586|NCT01812473|alpha-1-acid-glycoprotein|alpha-1-acid-glycoprotein
412587|NCT01812460|COPD|copd
412588|NCT01812460|muscle strength|muscle strength
412589|NCT01812460|resistance training|resistance training
412590|NCT01812460|Physiotherapi|physiotherapi
412591|NCT01812460|m. quadriceps|m. quadriceps
412592|NCT01812460|Acute exacerbation|acute exacerbation
412593|NCT01812447|Endobronchial Valves|endobronchial valves
412594|NCT01812447|Intrabronchial Valves|intrabronchial valves
412595|NCT01812447|Bronchial Valve|bronchial valve
412596|NCT01812447|Chronic Obstructive Pulmonary Disease|chronic obstructive pulmonary disease
412597|NCT01812447|COPD|copd
412598|NCT01812447|Pulmonary Disease, Chronic Obstructive|pulmonary disease, chronic obstructive
412599|NCT01812447|Bronchoscopic Lung Volume Reduction|bronchoscopic lung volume reduction
412600|NCT01812447|BLVR|blvr
412601|NCT01812447|TLVR|tlvr
412602|NCT01812447|Emphysema|emphysema
412603|NCT01812447|Pulmonary Emphysema|pulmonary emphysema
412604|NCT01812447|Pathologic Process|pathologic process
412605|NCT01812447|Lung Diseases|lung diseases
412606|NCT01812447|Respiratory Tract Disease|respiratory tract disease
412607|NCT01812395|thyroidectomy|thyroidectomy
412608|NCT01812395|ultrasonic dissector|ultrasonic dissector
412609|NCT01812395|harmonic focus device|harmonic focus device
412610|NCT01812395|superior laryngeal nerve|superior laryngeal nerve
412611|NCT01812382|Penetration|penetration
412612|NCT01812382|Antibiotic|antibiotic
412613|NCT01812382|Microdialysis|microdialysis
412614|NCT01812382|Formulation Pharmacokinetics|formulation pharmacokinetics
412615|NCT01812382|Feasibility|feasibility
412616|NCT01812356|Atrial fibrillation|atrial fibrillation
412617|NCT01812356|maze operation|maze operation
412618|NCT01812356|cryoablation|cryoablation
412619|NCT01812343|Ankle Brachial Index|ankle brachial index
412620|NCT01812343|Maximal Exercise Test|maximal exercise test
412621|NCT01812330|ACS|acs
412622|NCT01812330|CR|cr
412623|NCT01812330|PCI|pci
412624|NCT01812330|Platelet funtion|platelet funtion
412625|NCT01812330|Ticagrelor|ticagrelor
412626|NCT01812317|firefighters|firefighters
412627|NCT01812317|fire-simulation training|fire-simulation training
412628|NCT01812317|myocardial infarction|myocardial infarction
412629|NCT01812317|endothelial function|endothelial function
412630|NCT01812317|thrombosis|thrombosis
412631|NCT01812291|Major Depression|major depression
412632|NCT01812291|Minor Depression|minor depression
412633|NCT01812291|Sub-Threshold Depression|sub-threshold depression
412634|NCT01812291|Affective Condition|affective condition
412635|NCT01812291|Mood Disorder|mood disorder
412636|NCT01812291|Light Affective Disorder|light affective disorder
412637|NCT01812291|Subclinical Depressive Symptoms|subclinical depressive symptoms
412638|NCT01812291|Diabetes Mellitus|diabetes mellitus
412639|NCT01812291|Diabetes-Related Distress|diabetes-related distress
412640|NCT01812291|Self-Care Behaviour|self-care behaviour
412641|NCT01812291|Glycaemic Control|glycaemic control
412642|NCT01812291|Inflammatory Markers|inflammatory markers
412643|NCT01812252|myelodysplastic syndrome|myelodysplastic syndrome
412735|NCT01811745|Dual-task|dual-task
412644|NCT01812252|chronic myelomonocytic leukemia|chronic myelomonocytic leukemia
412645|NCT01812252|bone marrow transplant|bone marrow transplant
412646|NCT01812252|hypomethylating agent|hypomethylating agent
412647|NCT01812252|induction chemotherapy|induction chemotherapy
412648|NCT01812239|premature birth|premature birth
412649|NCT01812239|twins|twins
412650|NCT01812239|short cervix|short cervix
412651|NCT01812213|Mild Cognitive Impairment|mild cognitive impairment
412652|NCT01812187|Alcohol|alcohol
412653|NCT01812187|Alcohol Abuse|alcohol abuse
412654|NCT01812187|Alcohol Dependence|alcohol dependence
412655|NCT01812187|Veterans|veterans
412656|NCT01812174|heart valve|heart valve
412657|NCT01812161|Electro-acupuncture|electro-acupuncture
412658|NCT01812161|HCG stimulation test|hcg stimulation test
412659|NCT01812161|Menstrual frequency|menstrual frequency
412660|NCT01812161|polycystic ovary syndrome|polycystic ovary syndrome
412661|NCT01812161|Randomized|randomized
412662|NCT01812161|controlled|controlled
412663|NCT01812161|trial|trial
412664|NCT01812148|Peritoneal Mesotheliomas|peritoneal mesotheliomas
412665|NCT01812148|hyperthermic intra-peritoneal chemotherapy (HIPEC)|hyperthermic intra-peritoneal chemotherapy (hipec)
412666|NCT01812148|Oxaliplatin|oxaliplatin
412667|NCT01812148|Cytoreductive surgery|cytoreductive surgery
412668|NCT01812148|Oxaliplatin HIPEC|oxaliplatin hipec
412669|NCT01812109|Testicular Torsion|testicular torsion
412670|NCT01812096|multiple myeloma|multiple myeloma
412671|NCT01812096|bortezomib|bortezomib
412672|NCT01812096|Subcutaneous|subcutaneous
412673|NCT01812083|Periodontitis; adverse pregnancy outcomes; IL-1 polymorphism|periodontitis; adverse pregnancy outcomes; il-1 polymorphism
412674|NCT01812070|smoking cessation|smoking cessation
412675|NCT01812070|quit smoking|quit smoking
412676|NCT01812057|Anesthesia|anesthesia
412677|NCT01812057|Cesarean Section|cesarean section
412678|NCT01812057|Pain, Postoperative|pain, postoperative
412679|NCT01812057|Postoperative Nausea and Vomiting|postoperative nausea and vomiting
412680|NCT01812057|Dexamethasone|dexamethasone
412681|NCT01812057|Injections, Spinal|injections, spinal
412682|NCT01812057|morphine|morphine
412683|NCT01812031|PET/CT|pet/ct
412684|NCT01812031|18F-fluoro-2-deoxyglucose|18f-fluoro-2-deoxyglucose
412685|NCT01812031|lung neoplasms|lung neoplasms
412686|NCT01812031|respiratory motion|respiratory motion
412687|NCT01812018|Soft Tissue Sarcoma|soft tissue sarcoma
412688|NCT01812018|Pulmonary metastases|pulmonary metastases
412689|NCT01812005|MLN8237|mln8237
412690|NCT01812005|B-cell Non Hodgkin Lymphoma|b-cell non hodgkin lymphoma
412691|NCT01812005|Rituximab|rituximab
412692|NCT01811979|eye examination, oral sucrose, premature infant pain scale|eye examination, oral sucrose, premature infant pain scale
412693|NCT01811966|preoperative volume substitution|preoperative volume substitution
412694|NCT01811966|hypovolemia|hypovolemia
412695|NCT01811966|preoperative fasting|preoperative fasting
412696|NCT01811940|cocaine dependence|cocaine dependence
412697|NCT01811940|adderall|adderall
412698|NCT01811940|topiramate|topiramate
412699|NCT01811914|focused TTE|focused tte
412700|NCT01811914|intraoperative TTE|intraoperative tte
412701|NCT01811914|transthoracic echocardiography|transthoracic echocardiography
412702|NCT01811914|high risk non-cardiac surgery|high risk non-cardiac surgery
412703|NCT01811914|hemodynamic instabilities|hemodynamic instabilities
412704|NCT01811901|inhospital delays, door-to-needle time, thrombolysis, acute ischemic stroke, SITS, SITS-WATCH, stroke registry|inhospital delays, door-to-needle time, thrombolysis, acute ischemic stroke, sits, sits-watch, stroke registry
412705|NCT01811875|Haemophilia A|haemophilia a
412706|NCT01811862|Acupuncture|acupuncture
412707|NCT01811862|Hematopoietic stem cell transplantation (HSCT)|hematopoietic stem cell transplantation (hsct)
412708|NCT01811862|13-038|13-038
412709|NCT01811849|diabetes|diabetes
412710|NCT01811823|Tuberculosis|tuberculosis
412711|NCT01811823|HIV infection|hiv infection
412712|NCT01811823|Immune responses to Influenza vaccination|immune responses to influenza vaccination
412713|NCT01811810|Men under the age of 75 with histologically confirmed high risk|men under the age of 75 with histologically confirmed high risk
412714|NCT01811797|Erectile Dysfunction|erectile dysfunction
412715|NCT01811797|Extracorporeal shockwave|extracorporeal shockwave
412716|NCT01811797|Low intensity shockwaves|low intensity shockwaves
412717|NCT01811784|Nipah virus infection|nipah virus infection
412718|NCT01811784|date palm sap|date palm sap
412719|NCT01811784|community intervention|community intervention
412720|NCT01811784|capacity building|capacity building
412721|NCT01811784|disease prevention|disease prevention
412722|NCT01811784|Bangladesh|bangladesh
412723|NCT01811784|Healthy Community people|healthy community people
412724|NCT01811784|Sap harvesters|sap harvesters
412725|NCT01811784|Date palm three owners|date palm three owners
412726|NCT01811784|Date palm sap consumers|date palm sap consumers
412727|NCT01811758|Culturally Specific Cognitive Behavioral Therapy|culturally specific cognitive behavioral therapy
412728|NCT01811758|Standard Cognitive Behavioral Therapy|standard cognitive behavioral therapy
412729|NCT01811745|Aged|aged
412730|NCT01811745|Cognition|cognition
412731|NCT01811745|Exercise|exercise
412732|NCT01811745|Falls|falls
412733|NCT01811745|Gait|gait
412734|NCT01811745|Physical function|physical function
412736|NCT01811745|Music|music
412737|NCT01811745|Postural Balance|postural balance
412738|NCT01811745|Randomized controlled trial|randomized controlled trial
412739|NCT01811732|Bacterial skin infection|bacterial skin infection
412740|NCT01811732|skin infection|skin infection
412741|NCT01811732|infection|infection
412742|NCT01811732|skin|skin
412743|NCT01811732|delafloxacin|delafloxacin
412744|NCT01811732|vancomycin|vancomycin
412745|NCT01811732|aztreonam|aztreonam
412746|NCT01811732|MRSA bacteria|mrsa bacteria
412747|NCT01811732|bacterial infection|bacterial infection
412748|NCT01811732|Anti-Infective Agents|anti-infective agents
412749|NCT01811732|Anti-Bacterial Agents|anti-bacterial agents
412750|NCT01811719|Intimate Partner Physical Violence|intimate partner physical violence
412751|NCT01811719|Intimate Partner Emotional Abuse|intimate partner emotional abuse
412752|NCT01811719|Intimate Partner Controlling Behaivor|intimate partner controlling behaivor
412753|NCT01811719|Pregnancy Outcomes|pregnancy outcomes
412754|NCT01811719|Quality of Parental Care Giving|quality of parental care giving
412755|NCT01811719|Maternal Life Course|maternal life course
412756|NCT01811693|Stroke|stroke
412757|NCT01811693|Intracerebral Hemorrhage|intracerebral hemorrhage
412758|NCT01811693|Prehospital|prehospital
412759|NCT01811693|Antihypertensive|antihypertensive
412760|NCT01811680|Stroke|stroke
412761|NCT01811680|Hemiplegia|hemiplegia
412762|NCT01811680|Variable automated treadmill treadmill|variable automated treadmill treadmill
412763|NCT01811667|Vascular Abnormalities|vascular abnormalities
412764|NCT01811654|Patellofemoral|patellofemoral
412765|NCT01811654|Hyaluronan|hyaluronan
412766|NCT01811654|Intra-articular|intra-articular
412767|NCT01811654|Hyaluronic acid|hyaluronic acid
412768|NCT01811641|season of conception|season of conception
412769|NCT01811641|maternal nutritional status|maternal nutritional status
412770|NCT01811641|infant DNA methylation|infant dna methylation
412771|NCT01811628|Cancer Prevention|cancer prevention
412772|NCT01811628|Tobacco Use Cessation|tobacco use cessation
412773|NCT01811628|Smokers|smokers
412774|NCT01811628|Recent quitters|recent quitters
412775|NCT01811628|Latino|latino
412776|NCT01811628|Hispanic|hispanic
412777|NCT01811628|Information|information
412778|NCT01811628|Interview|interview
412779|NCT01811628|Questionnaire|questionnaire
412780|NCT01811628|Survey|survey
412781|NCT01811628|Audio-recorded|audio-recorded
412782|NCT01811602|Training|training
412783|NCT01811602|Physiotherapy|physiotherapy
412784|NCT01811602|Pelvic floor muscles|pelvic floor muscles
412785|NCT01811589|ventricular catheter, hydrocephalus, shunt, brain disease|ventricular catheter, hydrocephalus, shunt, brain disease
412786|NCT01811576|Growth hormone deficiency|growth hormone deficiency
412787|NCT01811576|Insulin-like growth factor I (IGF-I)|insulin-like growth factor i (igf-i)
412788|NCT01811576|TV-1106|tv-1106
412789|NCT01811563|Total Knee Replacement|total knee replacement
412790|NCT01811563|Lower Quarter Y-Balance Test|lower quarter y-balance test
412791|NCT01811563|Functional Outcomes|functional outcomes
412792|NCT01811563|Patient Reported Outcomes|patient reported outcomes
412793|NCT01811537|Artificial Chordae|artificial chordae
412794|NCT01811537|Mitral Valve Repair|mitral valve repair
412795|NCT01811524|Brain tumor|brain tumor
412796|NCT01811524|Glioma|glioma
412797|NCT01811524|Meningioma|meningioma
412798|NCT01811524|Diagnosis|diagnosis
412799|NCT01811524|Prognosis|prognosis
412800|NCT01811524|Heredity|heredity
412801|NCT01811472|Multi-center,|multi-center,
412802|NCT01811472|randomized,|randomized,
412803|NCT01811472|double-blind,|double-blind,
412804|NCT01811472|NAFLD,|nafld,
412805|NCT01811472|elevated triglycerides|elevated triglycerides
412806|NCT01811459|Delirium|delirium
412807|NCT01811459|ICU|icu
412808|NCT01811459|Burn patients|burn patients
412809|NCT01811459|Antipsychotics|antipsychotics
412810|NCT01811459|Haloperidol|haloperidol
412811|NCT01811459|Quetiapine|quetiapine
412812|NCT01811433|Postoperative Period|postoperative period
412813|NCT01811433|Anesthesia Recovery Period|anesthesia recovery period
412814|NCT01811433|Postoperative Complications|postoperative complications
412815|NCT01811433|Pulse Oximetry|pulse oximetry
412816|NCT01811420|dental caries|dental caries
412817|NCT01811420|caries removal|caries removal
412818|NCT01811420|chemomechanical caries removal|chemomechanical caries removal
412819|NCT01811394|sacral chordoma|sacral chordoma
412820|NCT01811394|chordoma|chordoma
412821|NCT01811394|carbon ion therapy|carbon ion therapy
412822|NCT01811394|proton therapy|proton therapy
412823|NCT01811394|hypofractionation|hypofractionation
412824|NCT01811381|Alzheimer|alzheimer
412825|NCT01811381|Prevention|prevention
412826|NCT01811381|mild cognitive impairment|mild cognitive impairment
412827|NCT01811381|physical exercise|physical exercise
412828|NCT01811381|synergism|synergism
412829|NCT01811381|curcumin|curcumin
412830|NCT01811381|dietary supplement|dietary supplement
412831|NCT01811381|anti-inflammatory|anti-inflammatory
412832|NCT01811381|anti-tau|anti-tau
412833|NCT01811381|subjective memory complaints without MCI|subjective memory complaints without mci
412834|NCT01811381|plasma-exosomes|plasma-exosomes
413046|NCT01810302|aSAH|asah
412835|NCT01811381|plasm- extracellular-derived-vesicles|plasm- extracellular-derived-vesicles
412836|NCT01811355|Muscle cramps|muscle cramps
412837|NCT01811355|Cramp|cramp
412839|NCT01811355|Amyotrophic Lateral Sclerosis|amyotrophic lateral sclerosis
412840|NCT01811355|Lou Gehrig's disease|lou gehrig's disease
412841|NCT01811355|Motor Neuron Disease|motor neuron disease
412842|NCT01811355|MND|mnd
412843|NCT01811342|Hemoglobin|hemoglobin
412844|NCT01811342|Patient Monitoring|patient monitoring
412845|NCT01811277|palliative chemotherapy|palliative chemotherapy
412846|NCT01811277|ORR|orr
412847|NCT01811277|PFS|pfs
412848|NCT01811277|OS|os
412849|NCT01811277|safety|safety
412850|NCT01811277|advanced Biliary Tract Carcinoma|advanced biliary tract carcinoma
412851|NCT01811264|Metastatic|metastatic
412852|NCT01811264|Quality of life|quality of life
412853|NCT01811264|Decision making|decision making
412854|NCT01811251|Co-analgesia|co-analgesia
412855|NCT01811251|Dexamethasone|dexamethasone
412856|NCT01811251|Pregabalin|pregabalin
412857|NCT01811251|Lumbar slipped disc surgery|lumbar slipped disc surgery
412858|NCT01811251|Post-operative pain|post-operative pain
412859|NCT01811238|spinal disorders|spinal disorders
412860|NCT01811225|Women|women
412861|NCT01811225|Pregnancy|pregnancy
412862|NCT01811225|Smoking|smoking
412863|NCT01811199|Thyroid cancer|thyroid cancer
412864|NCT01811199|Breast cancer|breast cancer
412865|NCT01811199|Dexamethasone|dexamethasone
412866|NCT01811199|Emesis|emesis
412867|NCT01811186|moderate to severe non-malignant chronic pain|moderate to severe non-malignant chronic pain
412868|NCT01811173|multimorbidity|multimorbidity
412869|NCT01811173|primary care|primary care
412870|NCT01811173|physician - nurse team|physician - nurse team
412871|NCT01811173|proactive monitoring|proactive monitoring
412872|NCT01811173|support for self-care|support for self-care
412873|NCT01811173|primary caregiver|primary caregiver
412874|NCT01811160|Melatonin|melatonin
412875|NCT01811160|Second generation antipsychotic|second generation antipsychotic
412876|NCT01811160|bipolar disorder|bipolar disorder
412877|NCT01811160|schizophrenia|schizophrenia
412878|NCT01811160|Metabolic|metabolic
412879|NCT01811147|Bipolar|bipolar
412880|NCT01811147|Depression|depression
412881|NCT01811147|Mania|mania
412882|NCT01811147|Hypomania|hypomania
412883|NCT01811147|fMRI|fmri
412884|NCT01811147|antidepressant|antidepressant
412885|NCT01811134|endovascular procedure; flow diverter stent|endovascular procedure; flow diverter stent
412886|NCT01811121|Glioblastoma|glioblastoma
412887|NCT01811121|5ALA|5ala
412888|NCT01811121|fluorescence|fluorescence
412889|NCT01811121|resection|resection
412890|NCT01811108|mCRC|mcrc
412891|NCT01811108|KRAS mutation|kras mutation
412892|NCT01811108|Chemotherapy|chemotherapy
412893|NCT01811108|Anti-angiogenic agent|anti-angiogenic agent
412894|NCT01811108|Bevacizumab|bevacizumab
412895|NCT01811108|1st Line|1st line
412896|NCT01811095|Robotics|robotics
412897|NCT01811095|Computer-assisted surgery|computer-assisted surgery
412898|NCT01811095|Computer simulation|computer simulation
412899|NCT01811095|Gynecology|gynecology
412900|NCT01811095|General surgery|general surgery
412901|NCT01811069|Obese patients|obese patients
412902|NCT01811069|Upper airway patency|upper airway patency
412903|NCT01811056|medical abortion|medical abortion
412904|NCT01811056|mifepristone|mifepristone
412905|NCT01811043|breast biopsy|breast biopsy
412906|NCT01811043|anxiety|anxiety
412907|NCT01810978|congenital heart disease, probiotic, prebiotic|congenital heart disease, probiotic, prebiotic
412908|NCT01810965|Hemochromatosis type 1|hemochromatosis type 1
412909|NCT01810952|glucocorticoids|glucocorticoids
412910|NCT01810952|hyperglycemia|hyperglycemia
412911|NCT01810952|diabetes mellitus|diabetes mellitus
412912|NCT01810939|Chronic Kidney Disease|chronic kidney disease
412913|NCT01810939|Treatment of Hyperkalemia|treatment of hyperkalemia
412914|NCT01810939|Hyperkalemia|hyperkalemia
412915|NCT01810926|indication for HSCT|indication for hsct
412916|NCT01810926|matched related donor|matched related donor
412917|NCT01810926|MRD|mrd
412918|NCT01810926|Matched Unrelated Donor|matched unrelated donor
412919|NCT01810926|MUD|mud
412920|NCT01810900|anti-adhesive effect and safety, laparoscopic myomectomy|anti-adhesive effect and safety, laparoscopic myomectomy
412921|NCT01810887|Healthy|healthy
412922|NCT01810887|Darunavir|darunavir
412923|NCT01810887|JNS011|jns011
412924|NCT01810887|Ritonavir|ritonavir
412925|NCT01810874|extraperitoneal|extraperitoneal
412926|NCT01810874|transperitoneal|transperitoneal
412927|NCT01810874|laparoscopic aortic lymphadenectomy|laparoscopic aortic lymphadenectomy
412928|NCT01810874|endometrial ovarian cancer|endometrial ovarian cancer
412929|NCT01810874|ovarian cancer|ovarian cancer
412930|NCT01810874|surgical staging|surgical staging
412931|NCT01810861|serotype distribution|serotype distribution
412932|NCT01810861|streptococcus pneumoniae|streptococcus pneumoniae
527907|NCT01315379|CBT|cbt
412933|NCT01810861|pneumonia|pneumonia
412934|NCT01810848|Knee Osteoarthritis|knee osteoarthritis
412935|NCT01810848|Osteoarthritis|osteoarthritis
412936|NCT01810848|Synvisc|synvisc
412937|NCT01810848|Hylan G-F 20|hylan g-f 20
412938|NCT01810848|Exercise|exercise
412939|NCT01810848|Cardiovascular risk|cardiovascular risk
412940|NCT01810848|Knee pain|knee pain
412941|NCT01810848|Pain|pain
412942|NCT01810835|HBV mother-to-child transmission|hbv mother-to-child transmission
412943|NCT01810835|women with HBV DNA > 105 I.U./mL|women with hbv dna > 105 i.u./ml
412944|NCT01810835|France|france
412945|NCT01810822|oxidative stress|oxidative stress
412946|NCT01810822|genetic susceptibility|genetic susceptibility
412947|NCT01810822|GPX4|gpx4
412948|NCT01810822|NOX2|nox2
412949|NCT01810809|Osteoarthritis|osteoarthritis
412950|NCT01810809|Hip|hip
412951|NCT01810809|Viscosupplementation|viscosupplementation
412952|NCT01810809|Clinical Trial|clinical trial
412953|NCT01810770|Radium-223 Dichloride|radium-223 dichloride
412954|NCT01810770|Prostatic Neoplasms|prostatic neoplasms
412955|NCT01810770|Bone Metastasis|bone metastasis
412956|NCT01810731|influenza vaccine immunogenicity|influenza vaccine immunogenicity
412957|NCT01810731|HIV|hiv
412958|NCT01810731|pregnancy|pregnancy
412959|NCT01810731|influenza vaccine safety|influenza vaccine safety
412960|NCT01810718|cGVHD|cgvhd
412961|NCT01810718|steroid therapy|steroid therapy
412962|NCT01810718|Nilotinib|nilotinib
412963|NCT01810718|cGVHD steroid refractory|cgvhd steroid refractory
412964|NCT01810718|intolerant to steroid therapy|intolerant to steroid therapy
412965|NCT01810718|Tasigna|tasigna
412966|NCT01810718|MTD|mtd
412967|NCT01810705|myeloid|myeloid
412968|NCT01810705|leukemia|leukemia
412969|NCT01810679|aortic valve replacement|aortic valve replacement
412970|NCT01810679|aortic stenosis|aortic stenosis
412971|NCT01810679|aortic steno-insufficiency|aortic steno-insufficiency
412972|NCT01810679|Perceval|perceval
412973|NCT01810679|Sutureless aortic heart valve|sutureless aortic heart valve
412974|NCT01810653|Macrogol|macrogol
412975|NCT01810640|Liver biopsy|liver biopsy
412976|NCT01810640|organ donation|organ donation
412977|NCT01810640|donor management|donor management
412978|NCT01810627|Prostate|prostate
412979|NCT01810627|Cancer|cancer
412980|NCT01810614|ADPKD|adpkd
412981|NCT01810614|PKD|pkd
412982|NCT01810614|Kidney Disease|kidney disease
412983|NCT01810614|ADPKD diet|adpkd diet
412984|NCT01810601|Embryo transfer, transabdominal ultrasound, IVF, ICSI|embryo transfer, transabdominal ultrasound, ivf, icsi
412985|NCT01810588|Allogeneic transplant|allogeneic transplant
412986|NCT01810588|Hematologic Malignancies|hematologic malignancies
412987|NCT01810588|Acute Leukemia|acute leukemia
412988|NCT01810588|Myeloproliferative disorders|myeloproliferative disorders
412989|NCT01810588|Lymphoma|lymphoma
412990|NCT01810588|Myeloma|myeloma
412991|NCT01810562|Stroke|stroke
412992|NCT01810562|Tactile|tactile
412993|NCT01810562|Sensibility|sensibility
412994|NCT01810562|Stimulation|stimulation
412995|NCT01810562|Extremities|extremities
412996|NCT01810562|Arm|arm
412997|NCT01810562|Leg|leg
412998|NCT01810549|Fatigue|fatigue
412999|NCT01810536|Cystic fibrosis|cystic fibrosis
413000|NCT01810536|oxygen|oxygen
413001|NCT01810536|respiratory failure|respiratory failure
413002|NCT01810523|Acute|acute
413003|NCT01810523|lower|lower
413004|NCT01810523|extremity|extremity
413005|NCT01810523|not requiring|not requiring
413006|NCT01810523|diagnostic|diagnostic
413007|NCT01810523|imaging|imaging
413008|NCT01810510|respiration, artificial|respiration, artificial
413009|NCT01810497|External ear|external ear
413010|NCT01810497|Ear abnormalities|ear abnormalities
413011|NCT01810497|External ear cartilages|external ear cartilages
413012|NCT01810484|Ulthera® System|ulthera® system
413013|NCT01810484|Ultherapy® Treatment|ultherapy® treatment
413014|NCT01810484|Ulthera, Inc.|ulthera, inc.
413015|NCT01810484|Ultrasound treatment for skin|ultrasound treatment for skin
413016|NCT01810458|Liver|liver
413017|NCT01810458|Fibrosis|fibrosis
413018|NCT01810458|Alpha-1|alpha-1
413019|NCT01810458|AAT|aat
413020|NCT01810458|AATD|aatd
413021|NCT01810445|Bladder Cancer|bladder cancer
413022|NCT01810445|Laser|laser
413023|NCT01810445|Optical|optical
413024|NCT01810419|splenomegaly|splenomegaly
413025|NCT01810419|ultrasound|ultrasound
413026|NCT01810419|Vscan|vscan
413027|NCT01810367|PFS|pfs
413028|NCT01810354|Cefazolin|cefazolin
413029|NCT01810354|Tissue concentration|tissue concentration
413030|NCT01810354|infection|infection
413031|NCT01810354|cesarean section|cesarean section
413032|NCT01810354|obese|obese
413033|NCT01810341|Autism|autism
413034|NCT01810341|Autism Spectrum Disorders|autism spectrum disorders
413035|NCT01810341|RNA|rna
413036|NCT01810341|Gene expression|gene expression
413037|NCT01810341|Developmental Delay|developmental delay
413038|NCT01810341|Metabolites|metabolites
413039|NCT01810341|DNA|dna
413040|NCT01810302|Vasospasm|vasospasm
413041|NCT01810302|Subarachnoid hemorrhage|subarachnoid hemorrhage
413042|NCT01810302|Aneurysmal subarachnoid hemorrhage|aneurysmal subarachnoid hemorrhage
413043|NCT01810302|Nicardipine|nicardipine
413044|NCT01810302|Intrathecal|intrathecal
413045|NCT01810302|SAH|sah
413047|NCT01810289|HIV, ART, CD4|hiv, art, cd4
413048|NCT01810276|traumatic head injury|traumatic head injury
413049|NCT01810276|intracranial hemorrhage|intracranial hemorrhage
413050|NCT01810276|platelets|platelets
413051|NCT01810276|anti-platelet therapy|anti-platelet therapy
413053|NCT01810276|asprin|asprin
413054|NCT01810263|stroke|stroke
413055|NCT01810263|malnutrition|malnutrition
413056|NCT01810263|high protein|high protein
413057|NCT01810211|Shoulder|shoulder
413058|NCT01810211|Surgery|surgery
413059|NCT01810211|Posterior Shoulder Tightness|posterior shoulder tightness
413060|NCT01810211|Flexibility|flexibility
413061|NCT01810211|Range of Motion|range of motion
413062|NCT01810198|Coronary Artery Disease|coronary artery disease
413063|NCT01810198|Cardiac CT|cardiac ct
413064|NCT01810198|Catheterization|catheterization
413065|NCT01810185|Inflammatory Bowel Disease|inflammatory bowel disease
413066|NCT01810185|Crohn's disease|crohn's disease
413067|NCT01810185|Ulcerative colitis|ulcerative colitis
413068|NCT01810185|Naltrexone|naltrexone
413069|NCT01810185|Low Dose Naltrexone|low dose naltrexone
413070|NCT01810185|Inflammatory Bowel Disease Questionnaire|inflammatory bowel disease questionnaire
413071|NCT01810172|lobectomy|lobectomy
413072|NCT01810172|segmentectomy|segmentectomy
413073|NCT01810172|pneumothorax|pneumothorax
413074|NCT01810172|pleural|pleural
413075|NCT01810172|digital|digital
413076|NCT01810172|air leak|air leak
413077|NCT01810159|substance use disorders|substance use disorders
413078|NCT01810159|implementation science|implementation science
413079|NCT01810159|collaborative care|collaborative care
413080|NCT01810159|opiate disorders|opiate disorders
413081|NCT01810159|alcohol disorders|alcohol disorders
413082|NCT01810146|Patients eligible for bariatric surgery (BMI>40kg/m2)|patients eligible for bariatric surgery (bmi>40kg/m2)
413083|NCT01810133|Comorbidity|comorbidity
413084|NCT01810120|Hematologic|hematologic
413085|NCT01810120|Malignant|malignant
413086|NCT01810120|Non-Malignant|non-malignant
413087|NCT01810120|Allogeneic|allogeneic
413088|NCT01810120|Transplant|transplant
413089|NCT01810120|Non-Hodgkin Lymphoma|non-hodgkin lymphoma
413090|NCT01810120|Pediatric|pediatric
413091|NCT01810120|Acute lymphoblastic leukemia|acute lymphoblastic leukemia
413092|NCT01810120|Acute Myeloid leukemia|acute myeloid leukemia
413093|NCT01810120|Myelodysplastic Syndromes|myelodysplastic syndromes
413094|NCT01810120|T cells receptor alfa beta|t cells receptor alfa beta
413095|NCT01810094|thoracolumbar fracture|thoracolumbar fracture
413096|NCT01810094|fixation|fixation
413097|NCT01810094|fixateur interne|fixateur interne
413098|NCT01810094|minimal invasive|minimal invasive
413099|NCT01810094|percutaneous|percutaneous
413100|NCT01810081|Cholelithiasis|cholelithiasis
413101|NCT01810081|Gastric H.Pylori infection|gastric h.pylori infection
413102|NCT01810081|H.Pylori infection|h.pylori infection
413103|NCT01810081|Gastric mucosa|gastric mucosa
413104|NCT01810068|BPH- Erectile function- Transurethral- Laser|bph- erectile function- transurethral- laser
413105|NCT01810042|age-related macular degeneration|age-related macular degeneration
413106|NCT01810042|choroidal neovascularization|choroidal neovascularization
413107|NCT01810042|ranibizumab|ranibizumab
413108|NCT01810042|indocyanine angiography|indocyanine angiography
413109|NCT01810029|transcendental meditation|transcendental meditation
413110|NCT01810029|cardiac rehabilitation|cardiac rehabilitation
413111|NCT01810016|NY-ESO-1|ny-eso-1
413112|NCT01810016|Metastatic Melanoma|metastatic melanoma
413113|NCT01810016|Ipilimumab|ipilimumab
413114|NCT01810016|Phase I|phase i
413115|NCT01810016|Adjuvant|adjuvant
413116|NCT01810016|Immunologic|immunologic
413117|NCT01810016|Vaccination|vaccination
413118|NCT01810016|Immunotherapy|immunotherapy
413119|NCT01810016|Neoplasm|neoplasm
413120|NCT01810003|Cardiovascular disease|cardiovascular disease
413121|NCT01810003|Inflammation|inflammation
413122|NCT01810003|EPA/DHA supplementation|epa/dha supplementation
413123|NCT01809990|cognitive behavior therapy|cognitive behavior therapy
413497|NCT01808248|Virus Diseases|virus diseases
413124|NCT01809990|pediatric obsessive-compulsive disorder|pediatric obsessive-compulsive disorder
413125|NCT01809990|internet-delivered cognitive behavior therapy|internet-delivered cognitive behavior therapy
413126|NCT01809977|Keratoconus|keratoconus
413127|NCT01809977|remove|remove
413128|NCT01809977|cornea|cornea
413129|NCT01809977|visual acuity|visual acuity
413130|NCT01809938|Gastrointestinal tract emptying|gastrointestinal tract emptying
413131|NCT01809938|Pre-operative fasting|pre-operative fasting
413132|NCT01809938|Ultrasound|ultrasound
413133|NCT01809938|Paracetamol Absorption|paracetamol absorption
413134|NCT01809912|solid tumor|solid tumor
413135|NCT01809899|Trauma|trauma
413136|NCT01809899|Abuse|abuse
413137|NCT01809899|Domestic Violence|domestic violence
413138|NCT01809899|Rape|rape
413139|NCT01809899|Assault|assault
413140|NCT01809899|MRI|mri
413141|NCT01809886|Neuromuscular relaxants|neuromuscular relaxants
413142|NCT01809886|short-term pediatric surgery|short-term pediatric surgery
413143|NCT01809886|reverses neuromuscular blockade|reverses neuromuscular blockade
413144|NCT01809873|Malaria|malaria
413145|NCT01809873|Diagnostics|diagnostics
413146|NCT01809873|Health Services|health services
413147|NCT01809860|isavuconazole|isavuconazole
413148|NCT01809860|sirolimus|sirolimus
413149|NCT01809860|BAL8557|bal8557
413150|NCT01809860|Healthy Volunteers|healthy volunteers
413151|NCT01809847|CLL|cll
413152|NCT01809847|Chronic Lymphatic Leukemia|chronic lymphatic leukemia
413153|NCT01809847|Leukemia|leukemia
413154|NCT01809847|HLA|hla
413155|NCT01809847|Histocompatibility|histocompatibility
413156|NCT01809847|HCT|hct
413157|NCT01809847|hematopoietic stem cell transplantation|hematopoietic stem cell transplantation
413158|NCT01809847|Ofatumumab|ofatumumab
413159|NCT01809847|CD20|cd20
413160|NCT01809821|Hypertension|hypertension
413161|NCT01809821|Sleep Disorders|sleep disorders
413162|NCT01809821|Insomnia|insomnia
413163|NCT01809821|Cardiovascular Diseases|cardiovascular diseases
413164|NCT01809821|Internet treatment|internet treatment
413165|NCT01809808|Acromegaly|acromegaly
413166|NCT01809808|Pituitary tumor|pituitary tumor
413167|NCT01809795|Obesity|obesity
413168|NCT01809795|Exercise|exercise
413169|NCT01809795|Blueberry Plant|blueberry plant
413170|NCT01809743|Coronary artery disease|coronary artery disease
413171|NCT01809743|Regadenoson|regadenoson
413172|NCT01809743|Adenosine|adenosine
413173|NCT01809743|Maximal hyperemia|maximal hyperemia
413174|NCT01809743|Fractional flow reserve|fractional flow reserve
413175|NCT01809743|FFR|ffr
413176|NCT01809691|Prostate cancer|prostate cancer
413177|NCT01809691|TAK-700|tak-700
413178|NCT01809691|Bicalutamide|bicalutamide
413179|NCT01809691|S1216|s1216
413180|NCT01809691|androgen therapy|androgen therapy
413181|NCT01809691|Phase III|phase iii
413182|NCT01809678|Smoking|smoking
413183|NCT01809678|Tobacco|tobacco
413184|NCT01809678|Yoga|yoga
413185|NCT01809665|ICD therapy|icd therapy
413186|NCT01809665|CRT-P therapy|crt-p therapy
413187|NCT01809665|MRI|mri
413188|NCT01809652|Pacemaker|pacemaker
413189|NCT01809652|Defibrillator|defibrillator
413190|NCT01809652|Remote Consultation|remote consultation
413191|NCT01809639|Concussion|concussion
413192|NCT01809613|Parkinson disease|parkinson disease
413193|NCT01809613|Deep Brain Stimulation|deep brain stimulation
413194|NCT01809613|Functional Magnetic Resonance Imaging|functional magnetic resonance imaging
413195|NCT01809574|Interstitial lung disease|interstitial lung disease
413196|NCT01809574|Idiopathic pulmonary fibrosis|idiopathic pulmonary fibrosis
413197|NCT01809574|Connective tissue disease|connective tissue disease
413198|NCT01809561|endometriosis|endometriosis
413199|NCT01809561|telomere|telomere
413200|NCT01809561|telomerase|telomerase
413201|NCT01809548|complementary feeding|complementary feeding
413202|NCT01809548|premature infant|premature infant
413203|NCT01809548|body composition|body composition
413204|NCT01809548|atopy|atopy
413205|NCT01809548|neurodevelopmental outcome|neurodevelopmental outcome
413206|NCT01809548|obesity|obesity
413207|NCT01809535|endoscopic variceal ligation|endoscopic variceal ligation
413208|NCT01809535|post-EVL ulcer|post-evl ulcer
413209|NCT01809535|variceal bleeding|variceal bleeding
413210|NCT01809522|Robotic-assisted radical prostatectomy|robotic-assisted radical prostatectomy
413211|NCT01809522|Urinary continence|urinary continence
413212|NCT01809522|Posterior reconstruction of the rhabdosphincter|posterior reconstruction of the rhabdosphincter
413213|NCT01809522|Posterior musculofascial plate reconstruction|posterior musculofascial plate reconstruction
413214|NCT01809509|CYTOKINES , IL11 IL6 IMLANTATION RATE IVF.|cytokines , il11 il6 imlantation rate ivf.
413215|NCT01809496|hearing loss|hearing loss
413216|NCT01809496|hearing aids|hearing aids
413217|NCT01809496|spouses|spouses
413218|NCT01809496|rehabilitation|rehabilitation
413219|NCT01809483|mechanical corneal erosion|mechanical corneal erosion
413220|NCT01809483|bandage contact lens|bandage contact lens
413221|NCT01809483|pressure patching|pressure patching
413222|NCT01809483|erosion area|erosion area
413223|NCT01809483|pain scale|pain scale
413224|NCT01809470|Blood pressure|blood pressure
413225|NCT01809470|Appetite|appetite
413226|NCT01809470|Heart rate|heart rate
413227|NCT01809470|Salivary cortisol|salivary cortisol
413228|NCT01809457|educational poster, knowledge, dental trauma,|educational poster, knowledge, dental trauma,
413229|NCT01809431|gestational diabetes|gestational diabetes
413230|NCT01809431|women|women
413231|NCT01809431|infants|infants
413232|NCT01809431|blood glucose|blood glucose
413233|NCT01809431|weight|weight
413234|NCT01809431|adiposity|adiposity
413235|NCT01809431|health behaviors|health behaviors
413236|NCT01809431|self-efficacy|self-efficacy
413237|NCT01809392|Decitabine|decitabine
413238|NCT01809392|hematopoietic stem cell transplant|hematopoietic stem cell transplant
413239|NCT01809392|Wilms' tumor 1|wilms' tumor 1
413240|NCT01809392|cytolytic T lymphocyte|cytolytic t lymphocyte
413241|NCT01809392|Regulatory T cell|regulatory t cell
413242|NCT01809379|ovarian cancer, recurrent, chemotherapy, intraperitoneal|ovarian cancer, recurrent, chemotherapy, intraperitoneal
413243|NCT01809366|seminal plasma/uterine receptivity|seminal plasma/uterine receptivity
413244|NCT01809353|Healthy|healthy
413245|NCT01809353|Japanese|japanese
413246|NCT01809353|Caucasian|caucasian
413247|NCT01809353|Male|male
413248|NCT01809353|Pharmacokinetic|pharmacokinetic
413249|NCT01809353|JNJ-54452840|jnj-54452840
413250|NCT01809340|Depressive Disorder|depressive disorder
413251|NCT01809340|Major Depressive Disorder|major depressive disorder
413252|NCT01809340|Depression|depression
413253|NCT01809340|Bipolar Disorder Type II|bipolar disorder type ii
413254|NCT01809340|Anti-depressant|anti-depressant
413255|NCT01809340|Ketamine|ketamine
413256|NCT01809340|Minocycline|minocycline
413257|NCT01809327|Diabetes Mellitus, Type 2|diabetes mellitus, type 2
413258|NCT01809327|Diabetes Mellitus|diabetes mellitus
413259|NCT01809327|Canagliflozin (JNJ-28431754)|canagliflozin (jnj-28431754)
413260|NCT01809327|Metformin|metformin
413261|NCT01809301|Bioavailability|bioavailability
413262|NCT01809288|Women|women
413263|NCT01809288|Diet|diet
413264|NCT01809288|Obesity|obesity
413265|NCT01809288|African|african
413266|NCT01809288|Physical Activity|physical activity
413267|NCT01809275|Crohn's Disease|crohn's disease
413268|NCT01809275|Inflammatory Bowel Disease|inflammatory bowel disease
413269|NCT01809275|CDAI|cdai
413270|NCT01809249|Living donor liver transplantation|living donor liver transplantation
413271|NCT01809249|Donar safety|donar safety
413272|NCT01809210|MEK1/2 inhibitor,|mek1/2 inhibitor,
413273|NCT01809210|Non Small Cell Lung Cancer,|non small cell lung cancer,
413274|NCT01809210|metastatic,|metastatic,
413275|NCT01809210|first line treatment for Non Small Cell Lung Cancer|first line treatment for non small cell lung cancer
413276|NCT01809197|Refractive error|refractive error
413277|NCT01809197|Myopia|myopia
413278|NCT01809197|Hyperopia|hyperopia
413279|NCT01809197|Astigmatism|astigmatism
413280|NCT01809197|Presbyopia|presbyopia
413281|NCT01809197|Contact lenses|contact lenses
413282|NCT01809197|Contact lens solution|contact lens solution
413283|NCT01809197|Comfort|comfort
413284|NCT01809145|sarcoidosis|sarcoidosis
413285|NCT01809145|occupational exposure|occupational exposure
413286|NCT01809145|MELISA|melisa
413287|NCT01809132|Hepatitis, alcoholic|hepatitis, alcoholic
413288|NCT01809132|pentoxifylline|pentoxifylline
413289|NCT01809132|zinc|zinc
413290|NCT01809132|anakinra|anakinra
413291|NCT01809132|glucocorticoids|glucocorticoids
413292|NCT01809132|MELD score|meld score
413293|NCT01809132|Intestinal mucosa|intestinal mucosa
413294|NCT01809119|Kidney Neoplasms, Minimally invasive surgery, Renal cell carcinoma|kidney neoplasms, minimally invasive surgery, renal cell carcinoma
413295|NCT01809106|cancer pain|cancer pain
413296|NCT01809106|major opioid|major opioid
413297|NCT01809106|analgesics|analgesics
413298|NCT01809093|PEDF|pedf
413299|NCT01809093|TSP1|tsp1
413300|NCT01809093|Thrombospondin|thrombospondin
413301|NCT01809093|pigment epithelium derived factor|pigment epithelium derived factor
413302|NCT01809093|Wills Eye Institute|wills eye institute
413303|NCT01809093|Pars plana vitrectomy|pars plana vitrectomy
413304|NCT01809093|Vitreous levels|vitreous levels
413305|NCT01809093|Mid Atlantic Retina|mid atlantic retina
413306|NCT01809093|Blood draw|blood draw
413307|NCT01809093|Blood test|blood test
413308|NCT01809067|stress|stress
413309|NCT01809067|anxiety|anxiety
413310|NCT01809067|MRI|mri
413311|NCT01809067|aromatherapy|aromatherapy
413312|NCT01809054|Hip, Knee, Arthroplasty, venous thromboembolic events, blood loss|hip, knee, arthroplasty, venous thromboembolic events, blood loss
413313|NCT01809028|cell block, number of passes|cell block, number of passes
413314|NCT01809015|Oral Anticoagulation|oral anticoagulation
413315|NCT01809015|Regular Medical Care|regular medical care
413316|NCT01809015|Coagulation Service|coagulation service
413317|NCT01809015|Vitamin-K Antagonists|vitamin-k antagonists
413318|NCT01809015|Quality of therapy|quality of therapy
413319|NCT01809015|Atrial fibrillation|atrial fibrillation
413320|NCT01809015|Venous thromboembolism|venous thromboembolism
413321|NCT01809015|Bypass surgery|bypass surgery
413322|NCT01809015|Prosthetic heart valve|prosthetic heart valve
413323|NCT01808989|peripheral artery disease|peripheral artery disease
413324|NCT01808989|tcpo2|tcpo2
413325|NCT01808989|treadmill walking test|treadmill walking test
413326|NCT01808989|intermittent claudication|intermittent claudication
413327|NCT01808963|Enthalpy|enthalpy
413328|NCT01808963|Physiologic Monitors|physiologic monitors
413329|NCT01808963|Critical Care Medicine|critical care medicine
413330|NCT01808911|Acquired haemophilia|acquired haemophilia
413331|NCT01808911|Comparative and randomized study|comparative and randomized study
413332|NCT01808911|Cyclophosphamide|cyclophosphamide
413333|NCT01808911|Rituximab|rituximab
413334|NCT01808898|Ablation|ablation
413335|NCT01808898|Outpatient|outpatient
413336|NCT01808885|safety|safety
413337|NCT01808885|multiple sclerosis|multiple sclerosis
413338|NCT01808885|olesoxime|olesoxime
413339|NCT01808885|double-blind|double-blind
413340|NCT01808885|randomized|randomized
413341|NCT01808859|Total Knee Arthroplasty|total knee arthroplasty
413342|NCT01808859|Thigh Tourniquet|thigh tourniquet
413343|NCT01808846|Obesity|obesity
413344|NCT01808846|Insulin Resistance|insulin resistance
413345|NCT01808846|functional magnetic resonance imaging|functional magnetic resonance imaging
413346|NCT01808846|glucose|glucose
413347|NCT01808846|fructose|fructose
413348|NCT01808846|hypothalamus|hypothalamus
413349|NCT01808846|neuronal circuits|neuronal circuits
413350|NCT01808846|feeding behavior|feeding behavior
413351|NCT01808833|Frailty|frailty
413352|NCT01808833|Geriatric oncology|geriatric oncology
413353|NCT01808820|Malignant Glioma|malignant glioma
413354|NCT01808820|Glioblastoma Multiforme|glioblastoma multiforme
413355|NCT01808820|Anaplastic Astrocytoma|anaplastic astrocytoma
413356|NCT01808820|High Grade Glioma|high grade glioma
413358|NCT01808820|Dendritic Cell Vaccine|dendritic cell vaccine
413359|NCT01808820|DC Vaccine|dc vaccine
413360|NCT01808820|Leukapheresis|leukapheresis
413361|NCT01808807|cesarean section rate|cesarean section rate
413362|NCT01808807|the cesarean section rate audit|the cesarean section rate audit
413363|NCT01808794|membranes|membranes
413364|NCT01808794|Mucograft|mucograft
413365|NCT01808794|Dynamatrixw|dynamatrixw
413366|NCT01808794|ridge|ridge
413367|NCT01808794|preservation|preservation
413368|NCT01808794|bone|bone
413369|NCT01808794|allograft|allograft
413370|NCT01808794|extraction|extraction
413371|NCT01808794|site|site
413372|NCT01808794|healing|healing
413373|NCT01808781|Power|power
413374|NCT01808781|muscle strength|muscle strength
413375|NCT01808781|total knee replacement|total knee replacement
413376|NCT01808781|physical activity behavior|physical activity behavior
413498|NCT01808248|Enterovirus Infections|enterovirus infections
413377|NCT01808755|recurrent urinary tract infections|recurrent urinary tract infections
413378|NCT01808755|D Mannose|d mannose
413379|NCT01808755|cystitis|cystitis
413380|NCT01808755|antibiotic treatment|antibiotic treatment
413381|NCT01808729|fibromuscular dysplasia|fibromuscular dysplasia
413382|NCT01808729|coronary artery disease|coronary artery disease
413383|NCT01808716|low-level laser therapy|low-level laser therapy
413384|NCT01808716|muscle damage|muscle damage
413385|NCT01808703|Periodontitis|periodontitis
413386|NCT01808703|Periodontal pocket|periodontal pocket
413387|NCT01808703|Periodontal diseases|periodontal diseases
413388|NCT01808690|Adolescent|adolescent
413389|NCT01808690|Youth|youth
413390|NCT01808690|Diabetes|diabetes
413391|NCT01808690|Insulin Resistance|insulin resistance
413392|NCT01808690|Cardiovascular|cardiovascular
413393|NCT01808690|Metformin|metformin
413394|NCT01808677|Non-Small Cell Lung Cancer|non-small cell lung cancer
413395|NCT01808677|NSCLC|nsclc
413396|NCT01808677|Thoracic reirradiation|thoracic reirradiation
413397|NCT01808677|Proton beam therapy|proton beam therapy
413399|NCT01808677|Intensity modulated radiation therapy|intensity modulated radiation therapy
413400|NCT01808677|IMRT|imrt
413401|NCT01808677|Registry|registry
413402|NCT01808677|Data|data
413403|NCT01808638|Adenocarcinoma|adenocarcinoma
413404|NCT01808638|Pancreas|pancreas
413405|NCT01808638|Gemcitabine|gemcitabine
413406|NCT01808638|Atu027|atu027
413407|NCT01808625|BRAIN MALIGNANCIES , RADIATION THERAPY|brain malignancies , radiation therapy
413408|NCT01808586|Neck|neck
413409|NCT01808586|chronic pain|chronic pain
413410|NCT01808586|facet injection|facet injection
413411|NCT01808573|Neratinib|neratinib
413412|NCT01808573|Nerlynx|nerlynx
413413|NCT01808521|Purpura, Thrombotic Thrombocytopenic|purpura, thrombotic thrombocytopenic
413414|NCT01808521|TTP|ttp
413415|NCT01808508|Down syndrome|down syndrome
413416|NCT01808508|Obstructive sleep apnea syndrome|obstructive sleep apnea syndrome
413417|NCT01808508|Continuous positive airway pressure|continuous positive airway pressure
413418|NCT01808508|sham or placebo CPAP|sham or placebo cpap
413419|NCT01808495|Human corneal fibroblasts|human corneal fibroblasts
413420|NCT01808495|Fibulin-1|fibulin-1
413421|NCT01808495|Nuclear accumulation|nuclear accumulation
413422|NCT01808482|monoclonal antibody|monoclonal antibody
413423|NCT01808482|Multiple Sclerosis|multiple sclerosis
413424|NCT01808482|Interleukin-7 Receptor|interleukin-7 receptor
413425|NCT01808456|kidney transplant|kidney transplant
413426|NCT01808456|heart transplant|heart transplant
413427|NCT01808456|lung transplant|lung transplant
413428|NCT01808456|influenza vaccine|influenza vaccine
413429|NCT01808443|cryotherapy|cryotherapy
413430|NCT01808443|laser|laser
413431|NCT01808443|cutaneous warts|cutaneous warts
413432|NCT01808430|NSCLC|nsclc
413433|NCT01808404|Acceptance and Commitment Therapy|acceptance and commitment therapy
413434|NCT01808404|Mindfulness|mindfulness
413435|NCT01808404|Guided Self-Help|guided self-help
413436|NCT01808404|College|college
413437|NCT01808391|Coronary artery disease|coronary artery disease
413438|NCT01808391|Heart disease|heart disease
413439|NCT01808391|Myocardial ischemia|myocardial ischemia
413440|NCT01808391|Cardiovascular disease|cardiovascular disease
413441|NCT01808391|Arteriosclerosis|arteriosclerosis
413442|NCT01808391|Vascular disease|vascular disease
413443|NCT01808378|Bilateral limbic associated keratopathy|bilateral limbic associated keratopathy
413444|NCT01808378|Expanded Adipose Derived Stem Cells|expanded adipose derived stem cells
413445|NCT01808365|Neisseria meningitidis|neisseria meningitidis
413446|NCT01808365|Philippines|philippines
413447|NCT01808365|carriage|carriage
413448|NCT01808365|meningococcus|meningococcus
413449|NCT01808352|AE adverse event|ae adverse event
413450|NCT01808352|AIDS acquired immunodeficiency syndrome|aids acquired immunodeficiency syndrome
413451|NCT01808352|ALT (SGPT) alanine aminotransferase|alt (sgpt) alanine aminotransferase
413452|NCT01808352|ART antiretroviral therapy|art antiretroviral therapy
413453|NCT01808352|AST (SGOT) aspartate aminotransferase|ast (sgot) aspartate aminotransferase
413454|NCT01808352|DCF data collection forms|dcf data collection forms
413455|NCT01808352|DMC Data Monitoring Committee|dmc data monitoring committee
413456|NCT01808352|FDA (U.S.) Food and Drug Administration|fda (u.s.) food and drug administration
413457|NCT01808352|GCP Good Clinical Practice guidelines|gcp good clinical practice guidelines
413458|NCT01808352|HB sAg Hepatitis B surface antigen|hb sag hepatitis b surface antigen
413459|NCT01808352|ICH International Conference of Harmonisation|ich international conference of harmonisation
413460|NCT01808352|IND Investigational New Drug Application|ind investigational new drug application
413461|NCT01808352|IRB Institutional Review Board|irb institutional review board
413462|NCT01808352|IU International units|iu international units
413463|NCT01808352|mg milligram(s)|mg milligram(s)
413464|NCT01808352|mm3 cubic millimeter(s)|mm3 cubic millimeter(s)
413465|NCT01808352|PCR polymerase chain reaction|pcr polymerase chain reaction
413466|NCT01808352|SAE serious adverse event|sae serious adverse event
413467|NCT01808352|µg microgram|µg microgram
413468|NCT01808352|ULN upper limit of the normal range|uln upper limit of the normal range
413469|NCT01808352|WB Western Blot|wb western blot
413470|NCT01808339|Fluticasone Furoate, FF Inhalation Powder, morning dosing, evening dosing, efficacy, FEV1|fluticasone furoate, ff inhalation powder, morning dosing, evening dosing, efficacy, fev1
413471|NCT01808287|Transcatheter Aortic Valve Replacement|transcatheter aortic valve replacement
413472|NCT01808287|Aortic Stenosis|aortic stenosis
413473|NCT01808274|Transcatheter Aortic Valve Replacement|transcatheter aortic valve replacement
413474|NCT01808274|Aortic Stenosis|aortic stenosis
413475|NCT01808261|Ischemic Stroke|ischemic stroke
413476|NCT01808248|HCV genotype 2 (GT-2)|hcv genotype 2 (gt-2)
413477|NCT01808248|HCV genotype 3 (GT-3)|hcv genotype 3 (gt-3)
413478|NCT01808248|HCV|hcv
413479|NCT01808248|Sustained Virologic Response|sustained virologic response
413480|NCT01808248|Direct Acting Antiviral|direct acting antiviral
413481|NCT01808248|Combination Therapy|combination therapy
413482|NCT01808248|Treatment-Naïve|treatment-naïve
413483|NCT01808248|GS-7977|gs-7977
413484|NCT01808248|Ribavirin|ribavirin
413485|NCT01808248|RBV|rbv
413486|NCT01808248|Peginterferon Alfa 2a|peginterferon alfa 2a
413487|NCT01808248|PEG|peg
413488|NCT01808248|Additional relevant MeSH terms:|additional relevant mesh terms:
413489|NCT01808248|Hepatitis|hepatitis
413490|NCT01808248|Hepatitis A|hepatitis a
413491|NCT01808248|Hepatitis, Chronic|hepatitis, chronic
413492|NCT01808248|Hepatitis C|hepatitis c
413493|NCT01808248|Hepatitis C, Chronic|hepatitis c, chronic
413494|NCT01808248|Liver Diseases|liver diseases
413495|NCT01808248|Digestive System Diseases|digestive system diseases
413496|NCT01808248|Hepatitis, Viral, Human|hepatitis, viral, human
413499|NCT01808248|Picornaviridae Infections|picornaviridae infections
413500|NCT01808248|RNA Virus Infections|rna virus infections
413501|NCT01808248|Flaviviridae Infections|flaviviridae infections
413502|NCT01808248|Peginterferon alfa-2a|peginterferon alfa-2a
413503|NCT01808248|Interferon-alpha|interferon-alpha
413504|NCT01808248|Antiviral Agents|antiviral agents
413505|NCT01808248|Anti-Infective Agents|anti-infective agents
413506|NCT01808248|Therapeutic Uses|therapeutic uses
413507|NCT01808248|Pharmacologic Actions|pharmacologic actions
413508|NCT01808248|Antimetabolites|antimetabolites
413509|NCT01808248|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action
413510|NCT01808248|Immunologic Factors|immunologic factors
413511|NCT01808248|Physiological Effects of Drugs|physiological effects of drugs
413512|NCT01808196|Eosinophilic Esophagitis|eosinophilic esophagitis
413513|NCT01808196|Connective Tissue Disorders|connective tissue disorders
413514|NCT01808196|Drug trial|drug trial
413515|NCT01808183|supracondylar|supracondylar
413516|NCT01808183|pediatric|pediatric
413517|NCT01808183|humerus|humerus
413518|NCT01808183|NIRS|nirs
413519|NCT01808183|near Infrared spectroscopy|near infrared spectroscopy
413520|NCT01808183|compartment perfusion|compartment perfusion
413521|NCT01808170|Laparoscopy|laparoscopy
413522|NCT01808170|AMH|amh
413523|NCT01808170|AFC|afc
413524|NCT01808170|Endometrioma|endometrioma
413525|NCT01808170|ovarian reserve|ovarian reserve
413526|NCT01808170|Ovarian cystectomy|ovarian cystectomy
413527|NCT01808170|ovarian cyst deroofing|ovarian cyst deroofing
413528|NCT01808157|atopic dermatitis|atopic dermatitis
413529|NCT01808157|pruritus|pruritus
413530|NCT01808144|Gout|gout
413531|NCT01808131|Gout|gout
413532|NCT01808118|Spondylitis|spondylitis
413533|NCT01808118|Spondylarthropathy|spondylarthropathy
413534|NCT01808118|Ankylosing Spondyloarthritis|ankylosing spondyloarthritis
413535|NCT01808118|Spondyloarthritis|spondyloarthritis
413536|NCT01808118|Spinal Diseases|spinal diseases
413537|NCT01808118|Musculoskeletal Diseases|musculoskeletal diseases
413538|NCT01808118|Arthritis|arthritis
413539|NCT01808118|Joint Diseases|joint diseases
413540|NCT01808118|Adalimumab|adalimumab
413541|NCT01808118|Antirheumatic Agents|antirheumatic agents
413542|NCT01808118|Anti-Inflammatory Agents|anti-inflammatory agents
413543|NCT01808092|Ceftazidime,|ceftazidime,
413544|NCT01808092|Meropenem,|meropenem,
413545|NCT01808092|Anti-Bacterial Agents,|anti-bacterial agents,
413546|NCT01808092|Anti-Infective Agents,|anti-infective agents,
413547|NCT01808092|Therapeutic Uses,|therapeutic uses,
413548|NCT01808092|Pharmacologic Actions,|pharmacologic actions,
413549|NCT01808092|Physiological Effects of Drugs|physiological effects of drugs
413550|NCT01808040|breast cancer|breast cancer
413551|NCT01808040|ER positive|er positive
413552|NCT01808040|PR positive|pr positive
413553|NCT01808040|post menopausal|post menopausal
413554|NCT01808027|quality of life drug adherence drug compliance mortality|quality of life drug adherence drug compliance mortality
413555|NCT01808014|nefopam, spinal surgery, postoperative pain control|nefopam, spinal surgery, postoperative pain control
413556|NCT01807988|Relapse, Recurrence, Depression, Internet, Sick-leave|relapse, recurrence, depression, internet, sick-leave
413557|NCT01807962|Injections, Subcutaneous|injections, subcutaneous
413558|NCT01807962|Cortisone|cortisone
413559|NCT01807962|Anesthetics, Local|anesthetics, local
413560|NCT01807936|Esophageal Neoplasms|esophageal neoplasms
413561|NCT01807936|lymphadenectomy|lymphadenectomy
413562|NCT01807910|Obesity|obesity
413563|NCT01807910|NAFLD|nafld
413564|NCT01807910|NASH|nash
413565|NCT01807910|Steatosis|steatosis
413566|NCT01807897|Heart Failure|heart failure
413567|NCT01807897|Sleep Apnea|sleep apnea
413568|NCT01807897|Ventricular Ejection Fraction|ventricular ejection fraction
413569|NCT01807897|Exercise Test|exercise test
413570|NCT01807884|Microaspiration|microaspiration
413571|NCT01807884|Ventilator acquired Pneumonia|ventilator acquired pneumonia
413572|NCT01807884|Amylase|amylase
413573|NCT01807884|Mechanical ventilation|mechanical ventilation
413574|NCT01807884|Suction|suction
413575|NCT01807871|nicotine dependence|nicotine dependence
413576|NCT01807871|smoking cessation|smoking cessation
413577|NCT01807871|lapse|lapse
413578|NCT01807871|relapse|relapse
413579|NCT01807871|tobacco|tobacco
413580|NCT01807871|nicotine patch|nicotine patch
413581|NCT01807871|nicotine replacement therapy|nicotine replacement therapy
413583|NCT01807858|Necrotizing enterocolitis|necrotizing enterocolitis
413584|NCT01807858|Sepsis|sepsis
413585|NCT01807858|Length of hospital stay|length of hospital stay
413586|NCT01807858|Mortality|mortality
413587|NCT01807845|Casein micelles|casein micelles
413588|NCT01807845|vitamin D3 (cholecalciferol)|vitamin d3 (cholecalciferol)
413589|NCT01807845|Bioavailability|bioavailability
413590|NCT01807845|Nanoencapsulation|nanoencapsulation
413591|NCT01807845|Nutrition|nutrition
413592|NCT01807832|chronic cough|chronic cough
413593|NCT01807832|cough reflex hypersensitivity|cough reflex hypersensitivity
413594|NCT01807832|capsaicin|capsaicin
413595|NCT01807819|Heart Failure|heart failure
413596|NCT01807819|Myocardial Strain|myocardial strain
413597|NCT01807819|Functional Capacity|functional capacity
413598|NCT01807806|veterans, military, families|veterans, military, families
413599|NCT01807793|Stroke|stroke
413600|NCT01807793|TIA|tia
413601|NCT01807793|African American|african american
413602|NCT01807754|automated ultrasound imaging (AUS)|automated ultrasound imaging (aus)
413603|NCT01807754|digital breast tomosynthesis (DBT)|digital breast tomosynthesis (dbt)
413604|NCT01807754|photoacoustic imaging (PAT)|photoacoustic imaging (pat)
413605|NCT01807741|Bipolar Disorder|bipolar disorder
413606|NCT01807741|Depression|depression
413607|NCT01807728|Quality of life|quality of life
413608|NCT01807728|Participation|participation
413609|NCT01807728|Training|training
413610|NCT01807715|first trimester|first trimester
413611|NCT01807715|surgical abortion|surgical abortion
413612|NCT01807715|contraception|contraception
413613|NCT01807702|dichloroacetate|dichloroacetate
413614|NCT01807702|pyruvate|pyruvate
413615|NCT01807702|lactate|lactate
413616|NCT01807702|pyruvate dehydrogenase|pyruvate dehydrogenase
413617|NCT01807689|Dry mouth|dry mouth
413618|NCT01807689|Dry eyes|dry eyes
413619|NCT01807689|Saliva|saliva
413620|NCT01807689|Salivary gland biopsy|salivary gland biopsy
413621|NCT01807663|neuromuscular disease|neuromuscular disease
413622|NCT01807650|Split-Thickness Skin Graft (STSG) donor site|split-thickness skin graft (stsg) donor site
413623|NCT01807650|Split-thickness skin graft|split-thickness skin graft
413624|NCT01807650|STSG|stsg
413625|NCT01807650|Wound healing|wound healing
413626|NCT01807650|Skin grafting|skin grafting
413627|NCT01807650|Superficial wound|superficial wound
413628|NCT01807650|Partial-thickness wound|partial-thickness wound
413629|NCT01807650|Time to wound closure|time to wound closure
413630|NCT01807624|Pharmacokinetic|pharmacokinetic
413631|NCT01807611|Haploidentical donor transplantation|haploidentical donor transplantation
413632|NCT01807611|NK cell|nk cell
413633|NCT01807585|GSV|gsv
413634|NCT01807559|Single Sided Deafness|single sided deafness
413635|NCT01807559|Conductive Hearing Loss|conductive hearing loss
413636|NCT01807559|Unilateral Hearing Loss|unilateral hearing loss
413637|NCT01807559|SSD|ssd
413638|NCT01807546|Head and neck cancer|head and neck cancer
413639|NCT01807546|Platinum-resistant|platinum-resistant
413640|NCT01807546|Squamous cell carcinoma|squamous cell carcinoma
413641|NCT01807533|Environment|environment
413642|NCT01807533|Gene|gene
413643|NCT01807533|Intervention|intervention
413644|NCT01807533|Neurodevelopment|neurodevelopment
413645|NCT01807533|Pathways|pathways
413646|NCT01807533|Preterm infants|preterm infants
413647|NCT01807520|Moderate nail psoriasis|moderate nail psoriasis
413648|NCT01807520|Severe nail psoriasis|severe nail psoriasis
413649|NCT01807520|psoriasis|psoriasis
413650|NCT01807520|Secukinumab|secukinumab
413651|NCT01807507|Veins|veins
413652|NCT01807507|Vascular Access|vascular access
413653|NCT01807481|Mircera|mircera
413654|NCT01807481|PD|pd
413655|NCT01807481|Maitenance|maitenance
413656|NCT01807468|haploidentical stem cell transplantation|haploidentical stem cell transplantation
413657|NCT01807468|natural killer cell therapy|natural killer cell therapy
413658|NCT01807468|pediatric solid tumor|pediatric solid tumor
413659|NCT01807442|Acute Coronary Syndrome|acute coronary syndrome
413660|NCT01807442|Positive Psychology|positive psychology
413661|NCT01807442|Adherence to Health Behaviors|adherence to health behaviors
413662|NCT01807429|Ketamine,|ketamine,
413663|NCT01807429|Midazolam,|midazolam,
413664|NCT01807429|Morphine,|morphine,
413665|NCT01807429|visual analogue score|visual analogue score
413666|NCT01807416|Osseointegrated Implant, Bone level|osseointegrated implant, bone level
413667|NCT01807403|Obsessive-Compulsive Disorder|obsessive-compulsive disorder
413668|NCT01807403|Deep brain stimulation|deep brain stimulation
413669|NCT01807403|Subthalamic nucleus|subthalamic nucleus
413670|NCT01807403|Caudate nucleus|caudate nucleus
413671|NCT01807403|Nucleus accumbens|nucleus accumbens
413672|NCT01807390|Minimally invasive surgery|minimally invasive surgery
413673|NCT01807390|Patient perspectives|patient perspectives
413674|NCT01807390|Lung cancer|lung cancer
413675|NCT01807390|Esophageal cancer|esophageal cancer
413676|NCT01807390|Pain|pain
413677|NCT01807364|Congenital adrenal hyperplasia (CAH)|congenital adrenal hyperplasia (cah)
413678|NCT01807364|Cardiovascular risk|cardiovascular risk
413679|NCT01807364|Microvascular dysfunction|microvascular dysfunction
413680|NCT01807351|Diabetes Mellitus|diabetes mellitus
413681|NCT01807351|Hypertension|hypertension
413682|NCT01807351|Impaired Fasting Glucose|impaired fasting glucose
413683|NCT01807351|Primary Health Care|primary health care
413684|NCT01807351|Chinese|chinese
413685|NCT01807312|colonoscopy|colonoscopy
413686|NCT01807299|Physical Training|physical training
413687|NCT01807299|ADHD-Attention deficit hyperactivity disorder|adhd-attention deficit hyperactivity disorder
413688|NCT01807299|Omega 3|omega 3
413689|NCT01807286|Myeloma|myeloma
413690|NCT01807286|Untreated Systemic AL Amyloidosis|untreated systemic al amyloidosis
413691|NCT01807286|Amyloid light-chain (AL) amyloidosis|amyloid light-chain (al) amyloidosis
413692|NCT01807286|Pomalidomide|pomalidomide
413693|NCT01807286|Melphalan|melphalan
413694|NCT01807286|Alkeran|alkeran
413695|NCT01807286|Dexamethasone|dexamethasone
413696|NCT01807286|Decadron|decadron
413697|NCT01807286|Questionnaires|questionnaires
413698|NCT01807286|Surveys|surveys
413699|NCT01807273|hemiplegic|hemiplegic
413700|NCT01807273|time up and go test|time up and go test
413701|NCT01807273|motion analysis|motion analysis
413702|NCT01807273|center of mass|center of mass
413703|NCT01807247|Strengthening muscle|strengthening muscle
413704|NCT01807247|Central nervous system diseases|central nervous system diseases
413705|NCT01807247|Gait|gait
413706|NCT01807221|Heart Decompensation|heart decompensation
413707|NCT01807208|Acute myocardial infarction|acute myocardial infarction
413708|NCT01807208|patient education|patient education
413709|NCT01807208|prevention|prevention
413710|NCT01807195|contrast|contrast
413711|NCT01807195|Intensive care unit|intensive care unit
413712|NCT01807195|Acute kidney injury|acute kidney injury
413713|NCT01807169|colon|colon
413714|NCT01807169|endoscopy|endoscopy
413715|NCT01807169|resection|resection
413716|NCT01807169|clopidogrel|clopidogrel
413717|NCT01807156|Tivozanib|tivozanib
413718|NCT01807156|Advanced hepatocellular cancer|advanced hepatocellular cancer
413719|NCT01807156|Angiogenesis|angiogenesis
413720|NCT01807130|Heart Failure|heart failure
413721|NCT01807130|Medical Therapy|medical therapy
413722|NCT01807130|ICD|icd
413723|NCT01807130|CRT|crt
413724|NCT01807104|Anterior Approach|anterior approach
413725|NCT01807104|Posterior Approach|posterior approach
413726|NCT01807078|Coronary artery disease|coronary artery disease
413727|NCT01807039|hip fracture|hip fracture
413728|NCT01807039|proximal femur|proximal femur
413729|NCT01807039|pertrochanteric fracture|pertrochanteric fracture
413730|NCT01807039|subtrochanteric fracture|subtrochanteric fracture
413731|NCT01807039|subcapital fracture|subcapital fracture
413732|NCT01807039|safety issue|safety issue
413733|NCT01807039|anesthesia|anesthesia
413734|NCT01807013|cirrhosis|cirrhosis
413735|NCT01807013|liver|liver
413736|NCT01807013|elastometry|elastometry
413737|NCT01807013|ultrasound|ultrasound
413738|NCT01807013|laparoscopy|laparoscopy
413739|NCT01807013|diagnosis|diagnosis
413740|NCT01806987|school readiness|school readiness
413741|NCT01806987|literacy|literacy
413742|NCT01806987|social emotional skills|social emotional skills
413743|NCT01806987|self regulation|self regulation
413744|NCT01806987|caregiver involvement|caregiver involvement
413745|NCT01806987|socioeconomic disadvantage|socioeconomic disadvantage
413746|NCT01806974|Periodontitis|periodontitis
413747|NCT01806974|rheumatoid arthritis|rheumatoid arthritis
413748|NCT01806974|anti-interleukin 6|anti-interleukin 6
413749|NCT01806974|immunotherapy|immunotherapy
413750|NCT01806974|inflammation|inflammation
413751|NCT01806974|bacteria|bacteria
413752|NCT01806974|periodontal sulci|periodontal sulci
413753|NCT01806974|periodontal pockets|periodontal pockets
413754|NCT01806935|associated|associated
413755|NCT01806935|aged population|aged population
413756|NCT01806922|Yoga|yoga
413757|NCT01806922|Stroke|stroke
413758|NCT01806922|Standing balance|standing balance
413759|NCT01806922|Depression|depression
413760|NCT01806909|Flu Vaccine|flu vaccine
413761|NCT01806909|Healthy Volunteer|healthy volunteer
413762|NCT01806883|Hemiparesis,|hemiparesis,
413763|NCT01806883|Rehabilitation,|rehabilitation,
413764|NCT01806883|WII,|wii,
413765|NCT01806883|Upper limb,|upper limb,
413766|NCT01806883|Movement strategies.|movement strategies.
413767|NCT01806870|HIV|hiv
413768|NCT01806870|ART|art
413769|NCT01806857|Amyotrophic lateral sclerosis|amyotrophic lateral sclerosis
413770|NCT01806857|ALS|als
413771|NCT01806857|Nuedexta|nuedexta
413772|NCT01806857|Bulbar function|bulbar function
413773|NCT01806857|motor neurons|motor neurons
413774|NCT01806844|Cardiac arrest|cardiac arrest
413775|NCT01806844|Cerebral oxygenation|cerebral oxygenation
413776|NCT01806844|Pre-hospital|pre-hospital
413777|NCT01806805|Movement disorder|movement disorder
413778|NCT01806805|Myoclonus dystonia|myoclonus dystonia
413779|NCT01806805|DYT 11|dyt 11
413780|NCT01806805|Antiepileptic drugs|antiepileptic drugs
413781|NCT01806805|Zonisamide|zonisamide
413782|NCT01806805|Clinical Trial|clinical trial
413783|NCT01806805|Double-mind method|double-mind method
413784|NCT01806792|Osteoporosis|osteoporosis
413785|NCT01806779|Nicotine addiction|nicotine addiction
413786|NCT01806779|Cigarette smoking|cigarette smoking
413787|NCT01806779|Smoking cessation|smoking cessation
413788|NCT01806779|Zyban|zyban
413789|NCT01806779|Chantix|chantix
413790|NCT01806779|Nicotine patches|nicotine patches
413791|NCT01806779|varenicline|varenicline
413792|NCT01806779|bupropion|bupropion
413793|NCT01806766|cementless total hip arthroplasty|cementless total hip arthroplasty
413794|NCT01806766|ceramic on ceramic bearing|ceramic on ceramic bearing
413795|NCT01806766|ceramic on highly cross linked polyethylene|ceramic on highly cross linked polyethylene
413796|NCT01806766|young patient|young patient
413797|NCT01806753|Endoscopic submucosal dissection|endoscopic submucosal dissection
413798|NCT01806753|Sedation|sedation
413799|NCT01806753|Propofol|propofol
413800|NCT01806753|Midazolam|midazolam
413801|NCT01806740|DCE-MRI|dce-mri
413802|NCT01806740|Sorafenib response|sorafenib response
413803|NCT01806727|Diabetes|diabetes
413804|NCT01806727|Diabetes Self Management|diabetes self management
413805|NCT01806727|LIFT Diabetes|lift diabetes
413806|NCT01806727|Weight Loss|weight loss
413807|NCT01806727|Diet|diet
413808|NCT01806727|Physical Activity|physical activity
413809|NCT01806727|Overweight|overweight
413810|NCT01806727|Obese|obese
413811|NCT01806714|HPV vaccination|hpv vaccination
413812|NCT01806714|Adolescent well care|adolescent well care
413813|NCT01806714|Adolescent HPV immunization|adolescent hpv immunization
413814|NCT01806714|HPV|hpv
413815|NCT01806701|fMRI|fmri
413816|NCT01806701|neuroimaging|neuroimaging
413817|NCT01806701|PTSD|ptsd
413818|NCT01806701|adolescent|adolescent
413819|NCT01806701|trauma|trauma
413820|NCT01806701|brain|brain
413821|NCT01806688|satiety|satiety
413822|NCT01806688|appetite|appetite
413823|NCT01806688|snack|snack
413824|NCT01806662|Atopic Dermatitis|atopic dermatitis
413825|NCT01806662|Eczema|eczema
413826|NCT01806649|esophageal cancer|esophageal cancer
413827|NCT01806649|second line therapy|second line therapy
413828|NCT01806649|BKM120|bkm120
413829|NCT01806636|Coil|coil
413830|NCT01806636|RePneu|repneu
413831|NCT01806636|PneumRx|pneumrx
413832|NCT01806636|LVRC|lvrc
413833|NCT01806610|Randomized|randomized
413834|NCT01806610|Placebo-controlled trial|placebo-controlled trial
413835|NCT01806610|BPS804|bps804
413836|NCT01806610|Safety, tolerability, and PK|safety, tolerability, and pk
413837|NCT01806610|Patients with late-stage chronic kidney disease.|patients with late-stage chronic kidney disease.
413838|NCT01806597|Skin condition, itching, psoriasis vulgaris, relapsing remitting psoriasis, immune-med systemic disease, skin lesions, scaly patches, papules, plaques|skin condition, itching, psoriasis vulgaris, relapsing remitting psoriasis, immune-med systemic disease, skin lesions, scaly patches, papules, plaques
413839|NCT01806584|Vascular Injury|vascular injury
413840|NCT01806584|Arteriovenous Graft Surgery|arteriovenous graft surgery
414038|NCT01805635|Asthma|asthma
413841|NCT01806584|Hemodialysis Access|hemodialysis access
413842|NCT01806558|Breast cancer|breast cancer
413843|NCT01806558|molecular breast imaging|molecular breast imaging
413845|NCT01806558|breast lesion|breast lesion
413846|NCT01806545|Arteriovenous Fistula Surgery|arteriovenous fistula surgery
413847|NCT01806545|Vascular Injury|vascular injury
413848|NCT01806545|Hemodialysis Access|hemodialysis access
413849|NCT01806532|computed tomography and positron emission tomography|computed tomography and positron emission tomography
413850|NCT01806532|respiration, artificial|respiration, artificial
413851|NCT01806532|respiratory distress syndrome, adult|respiratory distress syndrome, adult
413852|NCT01806519|neck pain|neck pain
413853|NCT01806519|motor control|motor control
413854|NCT01806519|intervention|intervention
413855|NCT01806519|forward head posture|forward head posture
413856|NCT01806506|Bariatric surgery|bariatric surgery
413857|NCT01806506|Gastric bypass|gastric bypass
413858|NCT01806506|Sleeve gastrectomy|sleeve gastrectomy
413859|NCT01806506|Weight loss|weight loss
413860|NCT01806506|Lipoproteins|lipoproteins
413861|NCT01806506|Insulin resistance|insulin resistance
413862|NCT01806506|Incretins|incretins
413863|NCT01806506|Quality of life|quality of life
413864|NCT01806493|body composition|body composition
413865|NCT01806493|obesity|obesity
413866|NCT01806480|Breastfeeding, Preterm Infant, Neonatal Care, Support, Mothers.|breastfeeding, preterm infant, neonatal care, support, mothers.
413867|NCT01806415|Fenobam,|fenobam,
413868|NCT01806415|Pharmacokinetics|pharmacokinetics
413869|NCT01806415|side effects|side effects
413870|NCT01806389|Breast milk|breast milk
413871|NCT01806389|Breastfeeding|breastfeeding
413872|NCT01806389|Lactation|lactation
413873|NCT01806389|Buprenorphine|buprenorphine
413874|NCT01806389|Opioid|opioid
413875|NCT01806363|Pharmacokinetics|pharmacokinetics
413876|NCT01806363|Safety|safety
413877|NCT01806363|Male|male
413878|NCT01806350|Pelvic floor muscle training; incontinence; quality of life|pelvic floor muscle training; incontinence; quality of life
413879|NCT01806337|peripheral T cell lymphoma|peripheral t cell lymphoma
413880|NCT01806337|alemtuzumab|alemtuzumab
413881|NCT01806337|consolidation|consolidation
413882|NCT01806311|Pharmacokinetics|pharmacokinetics
413883|NCT01806311|Safety|safety
413884|NCT01806311|Male|male
413885|NCT01806298|Adult Growth hormone deficiency|adult growth hormone deficiency
413886|NCT01806298|Saizen®|saizen®
413887|NCT01806298|Recombinant human growth hormone (r-hGH)|recombinant human growth hormone (r-hgh)
413888|NCT01806298|Somatropin|somatropin
413889|NCT01806285|Respiratory Virus|respiratory virus
413890|NCT01806272|rhGM-CSF|rhgm-csf
413891|NCT01806272|Oral Mucositis|oral mucositis
413892|NCT01806272|Primary Nasopharyngeal Cancers|primary nasopharyngeal cancers
413893|NCT01806272|Chemoradiotherapy|chemoradiotherapy
413894|NCT01806246|rehabilitation|rehabilitation
413895|NCT01806246|adolescent|adolescent
413896|NCT01806246|heart rate variability biofeedback|heart rate variability biofeedback
413897|NCT01806246|psychoeducation|psychoeducation
413898|NCT01806220|Gastroesophageal Reflux Disease (GERD)|gastroesophageal reflux disease (gerd)
413899|NCT01806220|Chronic Laryngitis|chronic laryngitis
413900|NCT01806220|Epidermal Growth factor receptor|epidermal growth factor receptor
413901|NCT01806168|Post-traumatic stress disorder|post-traumatic stress disorder
413902|NCT01806168|Repetitive transcranial magnetic stimulation|repetitive transcranial magnetic stimulation
413903|NCT01806168|Civilians|civilians
413904|NCT01806168|Neurostimulation|neurostimulation
413905|NCT01806168|Dorsolateral prefrontal cortex|dorsolateral prefrontal cortex
413906|NCT01806155|craniotomy|craniotomy
413907|NCT01806155|headache|headache
413908|NCT01806155|postoperative|postoperative
413909|NCT01806116|myelodysplastic syndrome|myelodysplastic syndrome
413910|NCT01806116|higher-risk|higher-risk
413911|NCT01806116|acute myeloid leukemia|acute myeloid leukemia
413912|NCT01806116|relapsed /refractory|relapsed /refractory
413913|NCT01806116|decitabine|decitabine
413914|NCT01806116|hematopoietic cell transplantation|hematopoietic cell transplantation
413915|NCT01806116|bridge therapy|bridge therapy
413916|NCT01806103|antimicrobial stewardship program|antimicrobial stewardship program
413917|NCT01806103|inappropriate prescribing of antibiotics|inappropriate prescribing of antibiotics
413918|NCT01806103|physician prescribing|physician prescribing
413919|NCT01806103|antibiotic prescribing for respiratory tract infections|antibiotic prescribing for respiratory tract infections
413920|NCT01806103|respiratory tract infections|respiratory tract infections
413921|NCT01806077|Cardiovascular Diseases|cardiovascular diseases
413922|NCT01806077|Vascular Diseases|vascular diseases
413923|NCT01806077|Coronary Artery Disease|coronary artery disease
413924|NCT01806077|Coronary Disease|coronary disease
413925|NCT01806077|Arteriosclerosis|arteriosclerosis
413926|NCT01806077|Platelet Aggregation Inhibitors|platelet aggregation inhibitors
413927|NCT01806064|TRC105|trc105
413928|NCT01806064|CD105|cd105
413929|NCT01806064|RCC|rcc
413930|NCT01806064|Renal Cell Carcinoma|renal cell carcinoma
413931|NCT01806064|Axitinib|axitinib
413932|NCT01806064|INLYTA|inlyta
413933|NCT01806064|Advanced Renal Cell Carcinoma|advanced renal cell carcinoma
413934|NCT01806038|Adverse events|adverse events
413935|NCT01806038|Drug interactions|drug interactions
413936|NCT01806038|Healthcare utilization|healthcare utilization
413937|NCT01806038|Discharge medication counseling|discharge medication counseling
413938|NCT01806025|Cystic Fibrosis|cystic fibrosis
413939|NCT01806025|Haptoglobin|haptoglobin
413940|NCT01806012|Supracervical Hysterectomy|supracervical hysterectomy
413941|NCT01806012|Leiomyomas|leiomyomas
413942|NCT01806012|Adenomyosis|adenomyosis
413943|NCT01805999|Ispaghula|ispaghula
413944|NCT01805999|Gastrointestinal physiology|gastrointestinal physiology
413945|NCT01805999|Gastrointestinal response to sugars|gastrointestinal response to sugars
413946|NCT01805999|MRI|mri
413947|NCT01805999|gastrointestinal|gastrointestinal
413948|NCT01805999|stomach|stomach
413949|NCT01805999|small bowel|small bowel
413950|NCT01805999|colon|colon
413951|NCT01805986|Multiple Sclerosis, other neurological conditions|multiple sclerosis, other neurological conditions
413952|NCT01805934|Helicobacter pylori, rescue, quadruple therapy，dual therapy|helicobacter pylori, rescue, quadruple therapy，dual therapy
413953|NCT01805921|Respiratory Syncytial Virus|respiratory syncytial virus
413954|NCT01805921|RSV|rsv
413955|NCT01805921|Vaccine|vaccine
413956|NCT01805908|metastatic|metastatic
413957|NCT01805908|breast cancer|breast cancer
413958|NCT01805908|herceptin|herceptin
413959|NCT01805908|imaging|imaging
413960|NCT01805908|tumour response|tumour response
413961|NCT01805908|adenocarcinoma|adenocarcinoma
413962|NCT01805908|SPECT-CT|spect-ct
413963|NCT01805908|pertuzumab|pertuzumab
413964|NCT01805908|trastuzumab|trastuzumab
413965|NCT01805908|locally advanced|locally advanced
413966|NCT01805895|Stroke|stroke
413967|NCT01805895|Acute Intracerebral Hemorrhage|acute intracerebral hemorrhage
413968|NCT01805895|Intracerebral Hemorrhage|intracerebral hemorrhage
413969|NCT01805895|Hemorrhagic stroke|hemorrhagic stroke
413970|NCT01805895|Hemorrhage|hemorrhage
413971|NCT01805895|Minocycline|minocycline
413972|NCT01805882|Interferon Sparing|interferon sparing
413973|NCT01805882|Directly Acting Antiviral|directly acting antiviral
413974|NCT01805882|Ribavarin Sparing|ribavarin sparing
413975|NCT01805869|Third Molar|third molar
413976|NCT01805869|Specimen Acquisition|specimen acquisition
413977|NCT01805856|antimicrobial prophylaxis|antimicrobial prophylaxis
413978|NCT01805856|AMP|amp
413979|NCT01805856|surgical site infection|surgical site infection
413980|NCT01805856|SSI|ssi
413981|NCT01805856|thyroid|thyroid
413982|NCT01805856|thyroidectomy|thyroidectomy
413983|NCT01805856|parathyroid|parathyroid
413984|NCT01805856|surgery|surgery
413985|NCT01805843|Pulmonary hypertension|pulmonary hypertension
413986|NCT01805843|chronic myeloid leukemia|chronic myeloid leukemia
413987|NCT01805843|dasatinib|dasatinib
413988|NCT01805843|nilotinib|nilotinib
413989|NCT01805830|Type2DM / DPP-IV inhibitors|type2dm / dpp-iv inhibitors
413990|NCT01805817|lipid profile|lipid profile
413991|NCT01805817|bleeding scores|bleeding scores
413992|NCT01805817|menstrual pattern|menstrual pattern
413993|NCT01805817|beneficial|beneficial
413994|NCT01805817|side effects|side effects
413995|NCT01805817|changes in a year period|changes in a year period
413996|NCT01805804|dual chamber pacing, left ventricle remodeling, valsartan|dual chamber pacing, left ventricle remodeling, valsartan
413997|NCT01805791|Ulcerative Colitis,|ulcerative colitis,
413998|NCT01805791|UC|uc
413999|NCT01805791|Patients|patients
414000|NCT01805791|active|active
414001|NCT01805791|mild|mild
414002|NCT01805791|moderate|moderate
414003|NCT01805765|menopausal syndrome|menopausal syndrome
414004|NCT01805765|climacteric syndrome|climacteric syndrome
414005|NCT01805765|Hot flashes|hot flashes
414006|NCT01805765|Sweat|sweat
414007|NCT01805752|Prevention of mother to child HIV transmission|prevention of mother to child hiv transmission
414008|NCT01805752|HIV/AIDS|hiv/aids
414009|NCT01805739|transcatheter aortic valve implantation|transcatheter aortic valve implantation
414011|NCT01805739|MRI|mri
414012|NCT01805739|angiography|angiography
414013|NCT01805739|echocardiography|echocardiography
414014|NCT01805739|rotational C-arm CT|rotational c-arm ct
414015|NCT01805726|bronchoscopy|bronchoscopy
414016|NCT01805726|sedation|sedation
414017|NCT01805726|pulmonary function|pulmonary function
414018|NCT01805726|tolerance|tolerance
414019|NCT01805726|xylocain|xylocain
414020|NCT01805726|dexmedetomidine|dexmedetomidine
414021|NCT01805726|alfentanil|alfentanil
414022|NCT01805713|Biomarkers|biomarkers
414023|NCT01805700|type 1|type 1
414024|NCT01805700|diabetes|diabetes
414025|NCT01805700|caffeine-enhanced energy drink|caffeine-enhanced energy drink
414026|NCT01805700|cardiac output|cardiac output
414027|NCT01805700|glucose|glucose
414028|NCT01805700|cognitive performance|cognitive performance
414029|NCT01805674|menopause|menopause
414030|NCT01805674|quality of life|quality of life
414031|NCT01805674|soy isoflavones|soy isoflavones
414032|NCT01805674|magnolia extract|magnolia extract
414033|NCT01805661|early ambulation|early ambulation
414034|NCT01805661|knee arthroplasty|knee arthroplasty
414035|NCT01805648|ITP|itp
414036|NCT01805648|rhTPO|rhtpo
414037|NCT01805635|Children|children
414039|NCT01805635|Allergic rhinitis|allergic rhinitis
414040|NCT01805635|Atopic dermatitis|atopic dermatitis
414041|NCT01805635|Urticaria|urticaria
414042|NCT01805635|Healthy|healthy
414043|NCT01805622|community-based participatory research|community-based participatory research
414044|NCT01805622|colorectal cancer screening|colorectal cancer screening
414045|NCT01805609|practice nurse|practice nurse
414046|NCT01805609|clinical Nurse|clinical nurse
414047|NCT01805609|inpatient staff|inpatient staff
414048|NCT01805609|inpatient social worker|inpatient social worker
414049|NCT01805609|didactic training sessions|didactic training sessions
414050|NCT01805609|13-030|13-030
414051|NCT01805596|coronary artery disease|coronary artery disease
414052|NCT01805596|endothelial function|endothelial function
414053|NCT01805596|antiplatelet agent|antiplatelet agent
414054|NCT01805570|platelet inhibitor|platelet inhibitor
414055|NCT01805570|ST-segment Elevation|st-segment elevation
414056|NCT01805570|Myocardial Infarction|myocardial infarction
414057|NCT01805570|stent|stent
414058|NCT01805570|prasugrel|prasugrel
414059|NCT01805570|ticagrelor|ticagrelor
414060|NCT01805557|Diffuse Large B-cell Lymphoma (DLBCL)|diffuse large b-cell lymphoma (dlbcl)
414061|NCT01805557|Bortezomib|bortezomib
414062|NCT01805544|SF36 questionnaire|sf36 questionnaire
414063|NCT01805544|Anti Clot Treatment Scale|anti clot treatment scale
414064|NCT01805544|Satisfaction|satisfaction
414065|NCT01805544|Quality of Life|quality of life
414066|NCT01805544|Rivaroxaban|rivaroxaban
414067|NCT01805544|Prevention & control|prevention & control
414068|NCT01805544|Pulmonary embolism|pulmonary embolism
414069|NCT01805531|SF36 questionnaire|sf36 questionnaire
414070|NCT01805531|Anti Clot Treatment Scale|anti clot treatment scale
414071|NCT01805531|Satisfaction|satisfaction
414072|NCT01805531|Quality of Life|quality of life
414073|NCT01805531|Rivaroxaban|rivaroxaban
414074|NCT01805531|Stroke prevention|stroke prevention
414075|NCT01805518|CNSVS|cnsvs
414076|NCT01805518|Tower of London|tower of london
414077|NCT01805518|Letter-Number Test|letter-number test
414078|NCT01805518|Trail Making Test|trail making test
414079|NCT01805518|Vital signs|vital signs
414080|NCT01805518|Mood|mood
414081|NCT01805518|Suicidal ideation|suicidal ideation
414082|NCT01805518|ECG|ecg
414083|NCT01805518|Physical exam|physical exam
414084|NCT01805518|Blood|blood
414085|NCT01805518|Urine (Including pregnancy and drug screen)|urine (including pregnancy and drug screen)
414086|NCT01805518|Cytokines|cytokines
414087|NCT01805518|Side effects|side effects
414088|NCT01805518|Brief Psychiatric Rating Scale|brief psychiatric rating scale
414089|NCT01805518|Positive and Negative Symptom Scale|positive and negative symptom scale
414090|NCT01805505|Female infertility|female infertility
414091|NCT01805505|Oocyte donation|oocyte donation
414092|NCT01805505|Embryo transfer|embryo transfer
414093|NCT01805505|Transvaginal ultrasonography|transvaginal ultrasonography
414094|NCT01805505|Transabdominal ultrasonography|transabdominal ultrasonography
414095|NCT01805492|Heart diseases|heart diseases
414096|NCT01805492|Cardiovascular diseases|cardiovascular diseases
414097|NCT01805492|Lifestyle modification|lifestyle modification
414098|NCT01805492|Diet|diet
414099|NCT01805492|Exercise|exercise
414100|NCT01805479|exercise|exercise
414101|NCT01805479|depression|depression
414102|NCT01805479|traumatic brain injury|traumatic brain injury
414103|NCT01805466|Extracorporeal Vacuum Assisted Device Optimised (EVADO)|extracorporeal vacuum assisted device optimised (evado)
414104|NCT01805453|Glioblastoma|glioblastoma
414105|NCT01805453|Angiotensin-II inhibitors|angiotensin-ii inhibitors
414106|NCT01805453|Losartan|losartan
414107|NCT01805453|steroids|steroids
414108|NCT01805453|Radiotherapy|radiotherapy
414109|NCT01805453|Edema|edema
414110|NCT01805453|Randomized trial|randomized trial
414111|NCT01805440|Adolescent|adolescent
414112|NCT01805440|Bipolar Disorder|bipolar disorder
414113|NCT01805440|Bipolar Depression|bipolar depression
414114|NCT01805440|Manic Depression|manic depression
414115|NCT01805440|Neuroimaging|neuroimaging
414116|NCT01805440|Magnetic Resonance Spectroscopy|magnetic resonance spectroscopy
414117|NCT01805440|Uridine|uridine
414118|NCT01805440|Pyrimidines|pyrimidines
414119|NCT01805427|trough concentration|trough concentration
414120|NCT01805427|weight|weight
414121|NCT01805427|HIV|hiv
414122|NCT01805427|virological failure|virological failure
414123|NCT01805414|inpatient diabetes|inpatient diabetes
414124|NCT01805414|inpatient diabetes nutrition|inpatient diabetes nutrition
414125|NCT01805401|Decision-making|decision-making
414126|NCT01805401|Impulse control|impulse control
414127|NCT01805401|Transcranial direct current stimulation|transcranial direct current stimulation
414128|NCT01805401|Brain stimulation|brain stimulation
414129|NCT01805401|Neuromodulation|neuromodulation
414130|NCT01805401|tDCS|tdcs
414131|NCT01805401|Iowa Gambling Task|iowa gambling task
414132|NCT01805401|Stroop Word-Color Task|stroop word-color task
414133|NCT01805388|Dental Pulp Regeneration|dental pulp regeneration
414134|NCT01805375|Phase I, Cancer, CD19 positive, B-Cell lymphoma, chronic lymphocytic leukaemia|phase i, cancer, cd19 positive, b-cell lymphoma, chronic lymphocytic leukaemia
414135|NCT01805375|Waldenström Macroglobulinaemia|waldenström macroglobulinaemia
414136|NCT01805336|Relapsing-Remitting MS|relapsing-remitting ms
414137|NCT01805336|cognitive impairment|cognitive impairment
414138|NCT01805336|virtual reality|virtual reality
414139|NCT01805310|Pelvic organ prolapse|pelvic organ prolapse
414140|NCT01805310|Prolapse|prolapse
414141|NCT01805310|Cathartics|cathartics
414142|NCT01805310|Mechanical bowel preparation|mechanical bowel preparation
414143|NCT01805297|Proliferative Diabetic Retinopathy|proliferative diabetic retinopathy
414144|NCT01805284|pneumonia|pneumonia
414145|NCT01805271|ER-positive HER2-negative|er-positive her2-negative
414146|NCT01805258|India|india
414147|NCT01805258|Nevirapine|nevirapine
414148|NCT01805258|Rifampicin|rifampicin
414149|NCT01805258|Efavirenz|efavirenz
414150|NCT01805258|HIV|hiv
414151|NCT01805258|TB|tb
414152|NCT01805232|severe|severe
414153|NCT01805232|Falciaparum|falciaparum
414154|NCT01805232|Malaria|malaria
414155|NCT01805206|Prematurity|prematurity
414156|NCT01805206|Necrotizing Enterocolitis|necrotizing enterocolitis
414157|NCT01805206|Biomarkers|biomarkers
414158|NCT01805206|Intestinal Fatty Acid Binding Protein|intestinal fatty acid binding protein
414159|NCT01805206|Feeding|feeding
414160|NCT01805193|Coronary heart disease|coronary heart disease
414161|NCT01805193|computed tomography myocardial perfusion|computed tomography myocardial perfusion
414162|NCT01805193|positron emission tomography|positron emission tomography
414163|NCT01805193|oxygen 15 labelled water|oxygen 15 labelled water
414164|NCT01805193|myocardial perfusion|myocardial perfusion
414165|NCT01805193|myocardial blood flow|myocardial blood flow
414166|NCT01805167|Subject with cochlear implant|subject with cochlear implant
414167|NCT01805141|Cervix Uteri|cervix uteri
414168|NCT01805128|Schizophrenia|schizophrenia
414169|NCT01805128|Autistic Disorder|autistic disorder
414170|NCT01805128|social cognition|social cognition
414171|NCT01805115|hysteroscopy|hysteroscopy
414172|NCT01805115|misoprostol|misoprostol
414173|NCT01805102|In vitro fertilization|in vitro fertilization
414174|NCT01805102|implantation|implantation
414175|NCT01805102|miscarriage|miscarriage
414176|NCT01805102|live birth|live birth
414177|NCT01805063|firefighters|firefighters
414178|NCT01805063|myocardial infarction|myocardial infarction
414179|NCT01805063|endothelial function|endothelial function
414180|NCT01805063|thrombosis|thrombosis
414181|NCT01805063|fire suppression|fire suppression
414182|NCT01805063|non-fire emergency duty|non-fire emergency duty
414183|NCT01805063|sedentary shift|sedentary shift
414184|NCT01805050|HAGL|hagl
414185|NCT01805050|Shoulder instability|shoulder instability
414186|NCT01804998|laparoscopic sentinel lymph node biopsy|laparoscopic sentinel lymph node biopsy
414187|NCT01804998|phase 3|phase 3
414188|NCT01804998|early gastric cancer|early gastric cancer
414189|NCT01804972|Patient information|patient information
414190|NCT01804972|Vascular disease|vascular disease
414191|NCT01804972|Abdominal aortic aneurysm|abdominal aortic aneurysm
414192|NCT01804972|Varicose veins|varicose veins
414193|NCT01804972|Web based information|web based information
414194|NCT01804933|profound muscle relaxation|profound muscle relaxation
414195|NCT01804933|muscle trauma|muscle trauma
414196|NCT01804933|postoperative analgesic demand|postoperative analgesic demand
414197|NCT01804933|postoperative pulmonary function|postoperative pulmonary function
414198|NCT01804907|HAART adherence|haart adherence
414199|NCT01804907|HIV|hiv
414200|NCT01804907|Fatigue|fatigue
414201|NCT01804907|treatment|treatment
414202|NCT01804868|case vignette|case vignette
414203|NCT01804868|nurse|nurse
414204|NCT01804868|critical assessment|critical assessment
414205|NCT01804868|randomized controlled trial|randomized controlled trial
414206|NCT01804855|Obesity; mobile health; telemedicine; family-based treatment|obesity; mobile health; telemedicine; family-based treatment
414207|NCT01804829|HCV Liver Transplant Immunoglobulin PCR SVR|hcv liver transplant immunoglobulin pcr svr
414208|NCT01804816|Chronic Heart Failure|chronic heart failure
414209|NCT01804816|Heart Failure|heart failure
414210|NCT01804803|glycated hemoglobin|glycated hemoglobin
414211|NCT01804803|hyperglycemia|hyperglycemia
529533|NCT01308268|STH|sth
414212|NCT01804803|hypoglycemia|hypoglycemia
414213|NCT01804803|insulin|insulin
414214|NCT01804803|self-monitoring of blood glucose|self-monitoring of blood glucose
414215|NCT01804803|telemedicine|telemedicine
414216|NCT01804790|rectum|rectum
414217|NCT01804790|cancer|cancer
414218|NCT01804790|locally advanced|locally advanced
414219|NCT01804777|ENaC|enac
414220|NCT01804777|Amiloride|amiloride
414221|NCT01804777|Hydrochlorothiazide(HCTZ)|hydrochlorothiazide(hctz)
414222|NCT01804777|Hypertension|hypertension
414223|NCT01804777|Type II Diabetes|type ii diabetes
414224|NCT01804777|Natriuresis|natriuresis
414225|NCT01804777|Proteinuria|proteinuria
414226|NCT01804764|Severe Sepsis|severe sepsis
414227|NCT01804764|Septic Shock|septic shock
414228|NCT01804764|Sepsis Six bundle|sepsis six bundle
414229|NCT01804738|Ethnic differences|ethnic differences
414230|NCT01804738|Inter-individual variability|inter-individual variability
414231|NCT01804738|Glycemic response|glycemic response
414232|NCT01804738|Insulin response|insulin response
414233|NCT01804738|Mastication|mastication
414234|NCT01804738|Salivary alpha-amylase|salivary alpha-amylase
414235|NCT01804738|Gastric emptying|gastric emptying
414236|NCT01804738|Metagenome|metagenome
414237|NCT01804725|bike seats|bike seats
414238|NCT01804725|Erectile dysfunction|erectile dysfunction
414239|NCT01804725|Perineum|perineum
414240|NCT01804725|Impotence|impotence
414241|NCT01804712|Prostate|prostate
414242|NCT01804712|Cancer|cancer
414243|NCT01804712|Castration-resistant|castration-resistant
414244|NCT01804712|Rituximab|rituximab
414245|NCT01804712|neoadjuvant|neoadjuvant
414246|NCT01804712|Rituxan|rituxan
414247|NCT01804699|ARVC, Cardiomyopathy|arvc, cardiomyopathy
414248|NCT01804686|Chronic lymphocytic leukemia|chronic lymphocytic leukemia
414249|NCT01804686|Small lymphocytic lymphoma|small lymphocytic lymphoma
414250|NCT01804686|Mantle cell lymphoma|mantle cell lymphoma
414251|NCT01804686|Follicular lymphoma|follicular lymphoma
414252|NCT01804686|Diffuse large B-cell lymphoma|diffuse large b-cell lymphoma
414253|NCT01804686|PCI-32765|pci-32765
414254|NCT01804686|Ibrutinib|ibrutinib
414255|NCT01804686|Bruton's tyrosine kinase inhibitor|bruton's tyrosine kinase inhibitor
414256|NCT01804686|IMBRUVICA|imbruvica
414257|NCT01804686|JNJ-54179060|jnj-54179060
414258|NCT01804673|Postoperative Pain|postoperative pain
414259|NCT01804673|Fentanyl Hydrochloride|fentanyl hydrochloride
414260|NCT01804673|IONSYS|ionsys
414261|NCT01804660|Multiple Sclerosis (MS)|multiple sclerosis (ms)
414262|NCT01804660|Multiple Sclerosis associated RetroVirus (MSRV)|multiple sclerosis associated retrovirus (msrv)
414263|NCT01804660|MSRV envelop protein (MSRV-Env)|msrv envelop protein (msrv-env)
414264|NCT01804647|Multiple sclerosis (MS)|multiple sclerosis (ms)
414265|NCT01804647|Relapsing-Remitting MS|relapsing-remitting ms
414266|NCT01804647|Primary progressive MS|primary progressive ms
414267|NCT01804647|Secondary progressive MS|secondary progressive ms
414268|NCT01804647|Clinically Isolated Syndrome (CIS)|clinically isolated syndrome (cis)
414269|NCT01804647|Multiple Sclerosis associated RetroVirus (MSRV)|multiple sclerosis associated retrovirus (msrv)
414270|NCT01804647|MSRV envelop protein (MSRV-Env)|msrv envelop protein (msrv-env)
414271|NCT01804634|Solid Tumors|solid tumors
414272|NCT01804634|Neuroblastoma|neuroblastoma
414273|NCT01804634|Osteosarcoma|osteosarcoma
414274|NCT01804634|Ewing Sarcoma|ewing sarcoma
414275|NCT01804634|Rhabdomyosarcoma|rhabdomyosarcoma
414276|NCT01804634|Hepatoblastoma|hepatoblastoma
414277|NCT01804634|Desmoplastic Round Cell Tumor|desmoplastic round cell tumor
414278|NCT01804621|Exercise|exercise
414279|NCT01804621|Nutrition|nutrition
414280|NCT01804621|Mammography|mammography
414281|NCT01804621|Colorectal screening|colorectal screening
414282|NCT01804595|Worksite intervention|worksite intervention
414283|NCT01804595|Sun protection intervention|sun protection intervention
414284|NCT01804595|Operating Engineers|operating engineers
414285|NCT01804582|Family navigator|family navigator
414286|NCT01804582|Patient Centered Outcomes|patient centered outcomes
414287|NCT01804582|Pediatric Antipsychotic treatment|pediatric antipsychotic treatment
414288|NCT01804556|muscle cramps, trigger points, sleep disturbance|muscle cramps, trigger points, sleep disturbance
414289|NCT01804530|solid tumors|solid tumors
414290|NCT01804530|activating NTRK point or fusion mutations|activating ntrk point or fusion mutations
414291|NCT01804530|Tenosynovial giant cell tumor|tenosynovial giant cell tumor
414292|NCT01804530|TGCT|tgct
414293|NCT01804517|migraine|migraine
414294|NCT01804504|Metabolic syndrome|metabolic syndrome
414295|NCT01804504|Eating out of home|eating out of home
414296|NCT01804504|Nutrition education|nutrition education
414297|NCT01804465|castration resistant|castration resistant
414298|NCT01804465|prostate|prostate
414299|NCT01804465|cancer|cancer
414300|NCT01804465|ipilimumab|ipilimumab
414301|NCT01804465|provenge|provenge
414302|NCT01804465|SipT|sipt
414303|NCT01804452|Progressive Supranuclear Palsy|progressive supranuclear palsy
414304|NCT01804452|Corticobasal Degeneration|corticobasal degeneration
414305|NCT01804452|Biomarker|biomarker
414306|NCT01804452|Neuroimaging|neuroimaging
414307|NCT01804452|MRI|mri
414308|NCT01804452|Tau|tau
414309|NCT01804452|Oculomotor|oculomotor
414310|NCT01804439|Heart diseases|heart diseases
414311|NCT01804439|Cardiovascular diseases|cardiovascular diseases
414312|NCT01804439|Coronary heart disease not otherwise specified|coronary heart disease not otherwise specified
414313|NCT01804439|Cerebrovascular disorders|cerebrovascular disorders
414314|NCT01804439|Brain diseases|brain diseases
414315|NCT01804439|Central nervous system diseases|central nervous system diseases
414316|NCT01804439|Nervous system diseases|nervous system diseases
414317|NCT01804439|Atherosclerosis|atherosclerosis
414318|NCT01804439|Arteriosclerosis|arteriosclerosis
414319|NCT01804439|Pathologic processes|pathologic processes
414320|NCT01804439|Acute myocardial infarction|acute myocardial infarction
414321|NCT01804439|Myocardial infarction|myocardial infarction
414322|NCT01804439|Myocardial ischemia|myocardial ischemia
414323|NCT01804439|Infarction|infarction
414324|NCT01804439|Necrosis|necrosis
414325|NCT01804439|Unstable angina|unstable angina
414326|NCT01804439|Chronic stable angina|chronic stable angina
414327|NCT01804439|Stable angina|stable angina
414328|NCT01804439|Angina pectoris|angina pectoris
414329|NCT01804439|Chest pain|chest pain
414330|NCT01804439|Pain|pain
414331|NCT01804439|Signs and symptoms|signs and symptoms
414332|NCT01804439|Ischemia|ischemia
414333|NCT01804439|Ischemic stroke|ischemic stroke
414334|NCT01804439|Hemorrhagic stroke|hemorrhagic stroke
414335|NCT01804439|Stroke|stroke
414336|NCT01804439|Subarachnoid hemorrhage|subarachnoid hemorrhage
414337|NCT01804439|Transient ischemic attack|transient ischemic attack
414338|NCT01804439|Abdominal aortic aneurysm|abdominal aortic aneurysm
414339|NCT01804439|Aneurysm|aneurysm
414340|NCT01804439|Aortic aneurysm|aortic aneurysm
414341|NCT01804439|Aortic aneurysm, abdominal|aortic aneurysm, abdominal
414342|NCT01804439|Aortic diseases|aortic diseases
414343|NCT01804439|Peripheral arterial diseases|peripheral arterial diseases
414344|NCT01804439|Peripheral vascular diseases|peripheral vascular diseases
414345|NCT01804439|Vascular diseases|vascular diseases
414346|NCT01804439|Peripheral occlusive diseases|peripheral occlusive diseases
414347|NCT01804439|Sudden coronary death|sudden coronary death
414348|NCT01804439|Ventricular arrhythmia|ventricular arrhythmia
414349|NCT01804439|Sudden cardiac death|sudden cardiac death
414350|NCT01804439|Cardiac arrest|cardiac arrest
414351|NCT01804439|Heart failure|heart failure
414352|NCT01804426|PTSD|ptsd
414353|NCT01804426|Post Traumatic Stress Disorder|post traumatic stress disorder
414354|NCT01804426|Cortisol|cortisol
414355|NCT01804426|Alpha-Amylase|alpha-amylase
414356|NCT01804426|bio-Markers|bio-markers
414357|NCT01804413|Pegvisomant|pegvisomant
414358|NCT01804413|Growth hormone|growth hormone
414359|NCT01804413|Cortisol|cortisol
414360|NCT01804413|Glucagon|glucagon
414361|NCT01804413|Insulin|insulin
414362|NCT01804387|Chronic Hepatitis B|chronic hepatitis b
414363|NCT01804387|Telbivudine|telbivudine
414364|NCT01804387|Adefovir|adefovir
414365|NCT01804387|Lamivudine resistance|lamivudine resistance
414366|NCT01804374|osteosarcoma|osteosarcoma
414367|NCT01804374|sorafenib|sorafenib
414368|NCT01804374|everolimus|everolimus
414369|NCT01804374|sarcoma|sarcoma
414370|NCT01804361|Dry Eye Syndromes|dry eye syndromes
414371|NCT01804348|PROM|prom
414372|NCT01804335|Lymphoma|lymphoma
414373|NCT01804335|Early Stage Cutaneous T-Cell Lymphoma|early stage cutaneous t-cell lymphoma
414374|NCT01804335|CTCL|ctcl
414375|NCT01804335|CD5789 0.01% cream|cd5789 0.01% cream
414376|NCT01804322|epilepsy|epilepsy
414377|NCT01804322|chronic comorbidities|chronic comorbidities
414378|NCT01804322|educational strategies|educational strategies
414379|NCT01804322|drug interactions|drug interactions
414380|NCT01804322|drug adverse effects|drug adverse effects
414381|NCT01804309|axyllary lymph node|axyllary lymph node
414382|NCT01804309|sentinel lymph node|sentinel lymph node
414383|NCT01804309|lymphatic drainage|lymphatic drainage
414384|NCT01804309|early breast cancer|early breast cancer
414385|NCT01804309|axillary lymph node dissection|axillary lymph node dissection
414386|NCT01804296|Teen|teen
414387|NCT01804296|Adolescent|adolescent
414388|NCT01804296|Depression|depression
414389|NCT01804296|Transcranial Magnetic Stimulation|transcranial magnetic stimulation
414391|NCT01804270|Teen|teen
414392|NCT01804270|Adolescent|adolescent
414393|NCT01804270|Depression|depression
414394|NCT01804270|Transcranial Magnetic Stimulation|transcranial magnetic stimulation
414395|NCT01804270|TMS|tms
414396|NCT01804257|Adherence|adherence
414397|NCT01804257|Bipolar disorder|bipolar disorder
414398|NCT01804257|Cellular phone|cellular phone
414399|NCT01804257|Cloud computing|cloud computing
414400|NCT01804257|Computers|computers
414401|NCT01804257|Computers, handheld|computers, handheld
414402|NCT01804257|Digital health|digital health
414403|NCT01804257|Digital health feedback system|digital health feedback system
414404|NCT01804257|Ingestion Sensor|ingestion sensor
414405|NCT01804257|Medication adherence|medication adherence
414406|NCT01804257|Medication non-adherence|medication non-adherence
414407|NCT01804257|Medication nonadherence|medication nonadherence
414408|NCT01804257|Mobile phone|mobile phone
414409|NCT01804257|Mobile health|mobile health
414410|NCT01804257|Patient adherence|patient adherence
414411|NCT01804257|Patient non-adherence|patient non-adherence
414412|NCT01804257|Patient nonadherence|patient nonadherence
414413|NCT01804257|Schizophrenia|schizophrenia
414414|NCT01804257|Telehealth|telehealth
414415|NCT01804257|Telemedicine|telemedicine
414416|NCT01804257|Telenursing|telenursing
414417|NCT01804257|Wearable sensor|wearable sensor
414418|NCT01804244|Healthy|healthy
414419|NCT01804244|Pharmacokinetics|pharmacokinetics
414420|NCT01804244|Japanese|japanese
414421|NCT01804231|Prostate Cancer|prostate cancer
414422|NCT01804231|PET|pet
414423|NCT01804231|MRI|mri
414424|NCT01804231|Hybrid|hybrid
414425|NCT01804231|Recurrence|recurrence
414426|NCT01804231|Fluorocholine|fluorocholine
414427|NCT01804205|magnesium sulfate|magnesium sulfate
414428|NCT01804205|rocuronium|rocuronium
414429|NCT01804205|neuromuscular block|neuromuscular block
414430|NCT01804205|onset time|onset time
414431|NCT01804205|elderly|elderly
414432|NCT01804192|Acu-TENS|acu-tens
414433|NCT01804192|MAP|map
414435|NCT01804192|HRV|hrv
414436|NCT01804179|colon|colon
414437|NCT01804179|rectum|rectum
414438|NCT01804179|cancer|cancer
414439|NCT01804179|screening|screening
414440|NCT01804179|questionnaire|questionnaire
414441|NCT01804179|testing|testing
414442|NCT01804179|educational materials|educational materials
414443|NCT01804166|Lymphoma, T-Cell, Peripheral, Infliximab, Golimumab, Remicade, Simponi, Ulcerative Colitis, Crohn's Disease, Inflammatory Bowel Disease|lymphoma, t-cell, peripheral, infliximab, golimumab, remicade, simponi, ulcerative colitis, crohn's disease, inflammatory bowel disease
414444|NCT01804153|Feminine stress urinary incontinence|feminine stress urinary incontinence
414445|NCT01804153|Autologous expanded stem cells|autologous expanded stem cells
414446|NCT01804127|DLBCL|dlbcl
414447|NCT01804127|R-CHOP|r-chop
414448|NCT01804127|PET/CT|pet/ct
414449|NCT01804088|Peripheral artery disease|peripheral artery disease
414450|NCT01804088|Iliac arteries|iliac arteries
414451|NCT01804088|Balloon-expandable stent|balloon-expandable stent
414452|NCT01804075|NAS|nas
414453|NCT01804075|NICU|nicu
414454|NCT01804075|EMMC|emmc
414455|NCT01804049|metformin|metformin
414456|NCT01804049|muscle|muscle
414457|NCT01804049|insulin resistance|insulin resistance
414458|NCT01804049|sarcopenia|sarcopenia
414459|NCT01804049|older adults|older adults
414460|NCT01804049|impaired fasting glucose|impaired fasting glucose
414461|NCT01803997|Child|child
414462|NCT01803997|Nutrition|nutrition
414463|NCT01803997|resonance Raman spectroscopy|resonance raman spectroscopy
414464|NCT01803997|Fruit & Vegetable|fruit & vegetable
414465|NCT01803997|Children Cooking|children cooking
414466|NCT01803984|Migraine|migraine
414467|NCT01803984|Brain structure|brain structure
414468|NCT01803984|MRI|mri
414469|NCT01803971|cardiac arrest|cardiac arrest
414470|NCT01803971|peripheral venous access|peripheral venous access
414471|NCT01803971|intraosseous access|intraosseous access
414472|NCT01803945|Parkinson's disease|parkinson's disease
414473|NCT01803945|cognitive impairment|cognitive impairment
414474|NCT01803945|movement disorder|movement disorder
414475|NCT01803932|intimate partner violence|intimate partner violence
414476|NCT01803932|gender|gender
414477|NCT01803932|primary prevention intervention|primary prevention intervention
414478|NCT01803932|conflict|conflict
414479|NCT01803932|Cote d'Ivoire|cote d'ivoire
414480|NCT01803932|Ivory Coast|ivory coast
414481|NCT01803919|Spinal cord injuries|spinal cord injuries
414482|NCT01803919|Urinary tract infection|urinary tract infection
414483|NCT01803919|Urinary catheters|urinary catheters
414484|NCT01803919|Protocol|protocol
414485|NCT01803919|Randomized clinical trial|randomized clinical trial
414486|NCT01803906|mitochondrial disorder|mitochondrial disorder
414487|NCT01803906|mitochondria|mitochondria
414488|NCT01803906|oxidative phosphorylation|oxidative phosphorylation
414489|NCT01803906|oxidative phosphorylation disorders|oxidative phosphorylation disorders
414490|NCT01803906|respiratory chain disorders|respiratory chain disorders
414491|NCT01803906|mitochondrial disease|mitochondrial disease
414492|NCT01803906|melas|melas
414493|NCT01803906|kearns sayer|kearns sayer
414494|NCT01803906|NARP|narp
414495|NCT01803906|MNGIE|mngie
414496|NCT01803906|LHON|lhon
414497|NCT01803906|Mitochondrial depletion syndrome|mitochondrial depletion syndrome
414498|NCT01803906|Leigh's disease|leigh's disease
414499|NCT01803893|In vitro fertilization|in vitro fertilization
414500|NCT01803893|implantation|implantation
414501|NCT01803893|miscarriage|miscarriage
414502|NCT01803893|live birth|live birth
414503|NCT01803880|Articular cartilage|articular cartilage
414504|NCT01803880|Cartilage lesion|cartilage lesion
414505|NCT01803880|Cartilage defect|cartilage defect
414506|NCT01803880|Radiofrequency|radiofrequency
414507|NCT01803880|Debridement|debridement
414508|NCT01803880|Cartilage|cartilage
414509|NCT01803880|Coblation|coblation
414510|NCT01803880|Knee|knee
414511|NCT01803880|Meniscus|meniscus
414512|NCT01803880|Meniscectomy|meniscectomy
414513|NCT01803880|MR imaging|mr imaging
414514|NCT01803880|Mechanical debridement|mechanical debridement
414515|NCT01803880|Mechanical shaver|mechanical shaver
414516|NCT01803880|Torn meniscus|torn meniscus
414517|NCT01803880|Arthroscopic knee surgery|arthroscopic knee surgery
414518|NCT01803880|Damaged cartilage|damaged cartilage
414519|NCT01803867|MS|ms
414520|NCT01803867|Multiple Sclerosis|multiple sclerosis
414521|NCT01803841|Coronary artery disease|coronary artery disease
414522|NCT01803828|Diabetic Cardiomyopathy|diabetic cardiomyopathy
414523|NCT01803828|Genders|genders
414524|NCT01803828|Phosphodiesterase 5A inhibitors|phosphodiesterase 5a inhibitors
414525|NCT01803828|endothelial dysfunction|endothelial dysfunction
414526|NCT01803828|inflammation|inflammation
414527|NCT01803828|diabetic complications|diabetic complications
414528|NCT01803815|obstructive sleep apnea|obstructive sleep apnea
414529|NCT01803815|hypertension|hypertension
414530|NCT01803815|antihypertensive drugs|antihypertensive drugs
414531|NCT01803802|childhood sexual abuse|childhood sexual abuse
414532|NCT01803802|depression|depression
414533|NCT01803802|PTSD|ptsd
414534|NCT01803802|sexual function|sexual function
414535|NCT01803802|women|women
414536|NCT01803789|Metacarpal V Fractures|metacarpal v fractures
414537|NCT01803789|Single Kirschner Wires|single kirschner wires
414538|NCT01803789|Double Kirschner Wires|double kirschner wires
414539|NCT01803776|child|child
414540|NCT01803776|physical activity|physical activity
414541|NCT01803776|sedentary activity|sedentary activity
414542|NCT01803776|nutrition|nutrition
414543|NCT01803776|diet|diet
414544|NCT01803776|body composition|body composition
414545|NCT01803776|overweight|overweight
414546|NCT01803776|obesity|obesity
414547|NCT01803776|glucose metabolism disorders|glucose metabolism disorders
414548|NCT01803776|lipid metabolism disorders|lipid metabolism disorders
414549|NCT01803776|physical fitness|physical fitness
414550|NCT01803776|cardiovascular system|cardiovascular system
414551|NCT01803776|musculoskeletal system|musculoskeletal system
414552|NCT01803776|bone mineral density|bone mineral density
414553|NCT01803776|oral health|oral health
414554|NCT01803776|quality of life|quality of life
414555|NCT01803776|wellbeing|wellbeing
414556|NCT01803776|gene-lifestyle interaction|gene-lifestyle interaction
414557|NCT01803776|health economics|health economics
414558|NCT01803763|Omalizumab|omalizumab
414559|NCT01803763|Xolair|xolair
414560|NCT01803763|Urticaria|urticaria
414561|NCT01803763|basophils|basophils
414562|NCT01803763|chronic Urticaria|chronic urticaria
414563|NCT01803763|Fc Receptor|fc receptor
414564|NCT01803750|Primary Care Providers|primary care providers
414565|NCT01803750|Latino Populations|latino populations
414566|NCT01803750|Disseminate Cancer Prevention|disseminate cancer prevention
414567|NCT01803750|semi-structured interviews|semi-structured interviews
414568|NCT01803750|13-031|13-031
414569|NCT01803737|Weight Loss|weight loss
414570|NCT01803737|Physical Activity|physical activity
414571|NCT01803737|Dietary Intake|dietary intake
414572|NCT01803737|Weight Loss Self-Efficacy|weight loss self-efficacy
414573|NCT01803737|Motivation|motivation
414574|NCT01803724|Irritable Bowel Syndrome|irritable bowel syndrome
414575|NCT01803724|Small Intestinal Bacterial Overgrowth|small intestinal bacterial overgrowth
414576|NCT01803724|Lactulose breath test|lactulose breath test
414577|NCT01803724|Glucose breath test|glucose breath test
414578|NCT01803724|Rifaximin|rifaximin
414579|NCT01803711|Omega 3 fatty acid|omega 3 fatty acid
414580|NCT01803711|Fish oil|fish oil
414581|NCT01803711|Depression|depression
414582|NCT01803711|cancer|cancer
414583|NCT01803711|diabetes|diabetes
414584|NCT01803711|high blood pressure|high blood pressure
414585|NCT01803711|cardiovascular|cardiovascular
414586|NCT01803698|Pregnancy|pregnancy
414587|NCT01803698|Gestational weight gain|gestational weight gain
414588|NCT01803698|Primary care|primary care
414589|NCT01803698|Guidelines|guidelines
414590|NCT01803685|Intracranial Arteriovenous Malformations|intracranial arteriovenous malformations
414591|NCT01803685|Surgical removal|surgical removal
414592|NCT01803685|Endovascular embolism|endovascular embolism
414593|NCT01803685|Stereotaxic radiosurgery|stereotaxic radiosurgery
414594|NCT01803685|Outcomes|outcomes
414595|NCT01803672|Adventure-Based training|adventure-based training
414596|NCT01803672|Health education|health education
414597|NCT01803672|childhood cancer|childhood cancer
414598|NCT01803672|physical activity|physical activity
414599|NCT01803659|b-carotene|b-carotene
414600|NCT01803659|breastmilk|breastmilk
414601|NCT01803659|vitamin A|vitamin a
414602|NCT01803568|Myokine|myokine
414603|NCT01803568|Insulin sensitivity|insulin sensitivity
414604|NCT01803568|Exercise|exercise
414605|NCT01803568|Skeletal muscle|skeletal muscle
414606|NCT01803555|Budesonide/Formoterol SPIROMAX®|budesonide/formoterol spiromax®
414607|NCT01803555|SYMBICORT® TURBOHALER®|symbicort® turbohaler®
414608|NCT01803555|Asthma|asthma
414609|NCT01803542|Non-small Cell Lung Cancer|non-small cell lung cancer
414610|NCT01803542|Stereotactic radiation for Lung Cancer|stereotactic radiation for lung cancer
414611|NCT01803542|Cone beam CT for Lung Cancer|cone beam ct for lung cancer
414612|NCT01803542|PET/CT for Lung Cancer|pet/ct for lung cancer
414613|NCT01803529|thorax|thorax
414614|NCT01803529|Intercostal Muscles|intercostal muscles
414615|NCT01803529|massage|massage
414616|NCT01803529|heat-pack|heat-pack
414617|NCT01803529|hot temperature|hot temperature
414618|NCT01803516|Quality of Life|quality of life
414619|NCT01803516|Assessments|assessments
414620|NCT01803516|Radiation|radiation
414621|NCT01803516|Telangiectasias|telangiectasias
414622|NCT01803516|13-013|13-013
414623|NCT01803464|Botox|botox
414624|NCT01803464|Muscle strength|muscle strength
414625|NCT01803451|gastric bypass|gastric bypass
414626|NCT01803451|glucose metabolism|glucose metabolism
414627|NCT01803451|hypoglycemia|hypoglycemia
414628|NCT01803438|paroxysmal Atrial Fibrillation|paroxysmal atrial fibrillation
414629|NCT01803438|Cryoablation|cryoablation
414630|NCT01803438|Pulmonary Vein Isolation|pulmonary vein isolation
414631|NCT01803425|Post-marketing surveillance|post-marketing surveillance
414632|NCT01803425|Prescribing Information (PI)|prescribing information (pi)
414633|NCT01803425|Healthy infants and children|healthy infants and children
414634|NCT01803425|Streptococcus pneumoniae|streptococcus pneumoniae
414635|NCT01803425|Synflorix™|synflorix™
414636|NCT01803425|Sri Lanka|sri lanka
414637|NCT01803412|GSK2402968|gsk2402968
414638|NCT01803412|open-label extension|open-label extension
414639|NCT01803412|safety|safety
414640|NCT01803412|drisapersen|drisapersen
414641|NCT01803412|Duchenne Muscular Dystrophy|duchenne muscular dystrophy
414642|NCT01803412|tolerability|tolerability
414643|NCT01803412|Quality of Life|quality of life
414644|NCT01803399|cardiac repolarization|cardiac repolarization
414645|NCT01803399|oral|oral
414646|NCT01803399|QTc|qtc
414647|NCT01803399|GSK1322322|gsk1322322
414648|NCT01803399|antibiotic|antibiotic
414649|NCT01803399|12-lead ECG|12-lead ecg
414650|NCT01803399|placebo|placebo
414651|NCT01803399|IV|iv
414652|NCT01803399|moxifloxacin|moxifloxacin
414653|NCT01803386|ALS|als
414654|NCT01803386|EIM|eim
414655|NCT01803373|Healthy|healthy
414656|NCT01803373|Biological Availability|biological availability
414657|NCT01803373|Bioavailability|bioavailability
414658|NCT01803373|TMC207|tmc207
414659|NCT01803373|Bedaquiline|bedaquiline
414660|NCT01803373|R207910|r207910
414661|NCT01803347|phase III|phase iii
414662|NCT01803347|Adipose derived stem cells|adipose derived stem cells
414663|NCT01803347|Anal fistula|anal fistula
414664|NCT01803347|Cell therapy|cell therapy
414665|NCT01803347|Stem cell therapy|stem cell therapy
414666|NCT01803334|surgical incision|surgical incision
414667|NCT01803334|laparoscopy|laparoscopy
414668|NCT01803334|pain|pain
414669|NCT01803321|SJIA|sjia
414670|NCT01803308|Hepatitis C Infection|hepatitis c infection
414671|NCT01803308|Treatment Naïve, Chronic|treatment naïve, chronic
414672|NCT01803308|First In Human|first in human
414673|NCT01803308|Single Ascending Dose|single ascending dose
414674|NCT01803308|Multiple Ascending Dose|multiple ascending dose
414675|NCT01803295|Non Muscle Invasive Bladder Cancer|non muscle invasive bladder cancer
414676|NCT01803295|Intravesical instillation|intravesical instillation
414677|NCT01803295|Mitomycin C|mitomycin c
414678|NCT01803295|Hydrogel Reverse thermal gelation|hydrogel reverse thermal gelation
414679|NCT01803295|Drug retention|drug retention
414680|NCT01803295|Urinary Bladder Neoplasms|urinary bladder neoplasms
414681|NCT01803295|Urologic Neoplasms|urologic neoplasms
414682|NCT01803295|Urinary Bladder Diseases|urinary bladder diseases
414683|NCT01803295|Urologic Diseases|urologic diseases
414684|NCT01803295|Mitomycin|mitomycin
414685|NCT01803282|Solid Tumor|solid tumor
414686|NCT01803282|NSCLC|nsclc
414687|NCT01803282|Pancreatic|pancreatic
414688|NCT01803282|Esophagogastric|esophagogastric
414689|NCT01803282|Colorectal|colorectal
414690|NCT01803282|Breast|breast
414691|NCT01803230|children|children
414692|NCT01803204|Anxiety|anxiety
414693|NCT01803204|Orthognathic surgery|orthognathic surgery
414694|NCT01803204|Patient educational as topic|patient educational as topic
414695|NCT01803204|Patient educational handout|patient educational handout
414696|NCT01803204|Pamphlets|pamphlets
414697|NCT01803191|Transrectal ultrasound-guided prostate biopsy|transrectal ultrasound-guided prostate biopsy
414698|NCT01803191|Bacteriuria|bacteriuria
414699|NCT01803191|Antibiotic prophylaxis|antibiotic prophylaxis
414700|NCT01803191|Prostate-Specific antigen|prostate-specific antigen
414701|NCT01803178|vascular function|vascular function
414702|NCT01803178|plant sterols|plant sterols
414703|NCT01803178|blood lipids|blood lipids
414704|NCT01803165|emesis,post operative.|emesis,post operative.
414705|NCT01803165|cognitive dysfunction, post operative.|cognitive dysfunction, post operative.
414706|NCT01803165|wound infection, post operative.|wound infection, post operative.
414707|NCT01803165|pain, post operative.|pain, post operative.
414708|NCT01803165|Anesthesia, Conduction/methods|anesthesia, conduction/methods
414709|NCT01803165|Anesthesiology/methods|anesthesiology/methods
414710|NCT01803165|Arteriovenous Shunt, Surgical/adverse effects|arteriovenous shunt, surgical/adverse effects
414711|NCT01803165|Regional Blood Flow/drug effects|regional blood flow/drug effects
414712|NCT01803165|Risk Factors|risk factors
414713|NCT01803165|Thrombosis|thrombosis
414714|NCT01803165|Treatment Outcome|treatment outcome
414715|NCT01803165|Vascular Surgical Procedures/methods|vascular surgical procedures/methods
414716|NCT01803165|Vasodilation/drug effects|vasodilation/drug effects
414717|NCT01803152|Metastatic Sarcoma|metastatic sarcoma
414718|NCT01803152|Relapsed Sarcoma|relapsed sarcoma
414719|NCT01803152|Dendritic Cell|dendritic cell
414720|NCT01803152|Myeloid Derived Suppressor Cells|myeloid derived suppressor cells
414721|NCT01803152|MDSC|mdsc
414722|NCT01803152|MDSC Inhibition|mdsc inhibition
414723|NCT01803139|Breast cancer radiotherapy IMRT|breast cancer radiotherapy imrt
414724|NCT01803126|atherosclerosis|atherosclerosis
414725|NCT01803113|Pregnancy|pregnancy
414726|NCT01803113|hCG|hcg
414727|NCT01803100|Bacterial Colonization|bacterial colonization
414728|NCT01803087|adolescents|adolescents
414729|NCT01803087|adults|adults
414730|NCT01803061|Head and neck cancer|head and neck cancer
414731|NCT01803061|Quality of life|quality of life
414732|NCT01803061|Symptom-burden|symptom-burden
414733|NCT01803061|Late effects|late effects
414734|NCT01803048|Traumatic Brain Injury|traumatic brain injury
414735|NCT01803048|Diffusion Weighted Imaging|diffusion weighted imaging
414736|NCT01803048|Resting State Functional Connectivity|resting state functional connectivity
414737|NCT01803048|Cognition|cognition
414738|NCT01803035|Impetigo|impetigo
414739|NCT01803035|LTX-109|ltx-109
414740|NCT01803035|Topical|topical
414741|NCT01803035|Antibiotic|antibiotic
414742|NCT01803035|Placebo|placebo
414743|NCT01803035|Lytic|lytic
414744|NCT01803035|Peptide|peptide
414745|NCT01803035|Gram Positive|gram positive
414746|NCT01803022|Venous Thromboembolism|venous thromboembolism
414747|NCT01803022|Cancer|cancer
414748|NCT01803022|Low Molecular Weight Heparin|low molecular weight heparin
414749|NCT01802983|Aged|aged
414750|NCT01802983|Multiple organ failure|multiple organ failure
414751|NCT01802983|Extubation|extubation
414752|NCT01802983|Prognosis|prognosis
414753|NCT01802983|MODS|mods
414754|NCT01802983|invasive mechanical ventilation|invasive mechanical ventilation
414755|NCT01802970|Anakinra|anakinra
414756|NCT01802970|Nab Paclitaxel|nab paclitaxel
414757|NCT01802970|Capecitabine|capecitabine
414758|NCT01802970|Eribulin|eribulin
414759|NCT01802970|Vinorelbin|vinorelbin
414760|NCT01802931|GSK239512|gsk239512
414761|NCT01802931|H3 receptor antagonist|h3 receptor antagonist
414762|NCT01802931|drug-drug interaction|drug-drug interaction
414763|NCT01802931|pharmacokinetics|pharmacokinetics
414764|NCT01802931|ketoconazole|ketoconazole
414765|NCT01802918|single dose|single dose
414767|NCT01802918|maturation inhibitor|maturation inhibitor
414768|NCT01802918|GSK2838232|gsk2838232
414769|NCT01802918|FTIH|ftih
414770|NCT01802918|healthy subjects|healthy subjects
414771|NCT01802905|neoplasm|neoplasm
414772|NCT01802905|metastatic cancer|metastatic cancer
414773|NCT01802905|cancer genome|cancer genome
414774|NCT01802905|genomic analysis|genomic analysis
414775|NCT01802905|adults|adults
414776|NCT01802892|ronacaleret|ronacaleret
414777|NCT01802892|parathyroid hormone (PTH)|parathyroid hormone (pth)
414778|NCT01802892|CD34+cells|cd34+cells
414779|NCT01802892|calcium sensing receptor antagonist|calcium sensing receptor antagonist
414780|NCT01802892|hematopoietic stem cells|hematopoietic stem cells
414781|NCT01802892|stem cell mobilization|stem cell mobilization
414782|NCT01802892|plerixafor|plerixafor
414783|NCT01802892|healthy human volunteer, phase Ib|healthy human volunteer, phase ib
414784|NCT01802879|Hematologic Neoplasms, LBH589,|hematologic neoplasms, lbh589,
414785|NCT01802879|Panobinostat,|panobinostat,
414786|NCT01802866|Geographic atrophy|geographic atrophy
414787|NCT01802866|GA|ga
414788|NCT01802866|Dry AMD|dry amd
414789|NCT01802827|airway colonization|airway colonization
414790|NCT01802827|tracheobronchitis|tracheobronchitis
414791|NCT01802827|pneumonia|pneumonia
414792|NCT01802814|ALL|all
414793|NCT01802788|Aortic Stenosis|aortic stenosis
414794|NCT01802788|Heart Valve Prosthesis|heart valve prosthesis
414795|NCT01802788|Trans Catheter Aortic Valve Replacement|trans catheter aortic valve replacement
414796|NCT01802788|TAVR|tavr
414797|NCT01802788|Trans Catheter Aortic Valve Implant|trans catheter aortic valve implant
414798|NCT01802788|TAVI|tavi
414799|NCT01802749|second line|second line
414800|NCT01802749|platinum sensitive|platinum sensitive
414801|NCT01802749|first line bevacizumab|first line bevacizumab
414802|NCT01802749|biologic factors|biologic factors
414803|NCT01802749|clinical factors|clinical factors
414804|NCT01802736|Alcohol HIV intervention counselling|alcohol hiv intervention counselling
414805|NCT01802736|Alcohol Use in HIV infected Persons|alcohol use in hiv infected persons
414806|NCT01802697|volunteers|volunteers
414807|NCT01802684|unresectable|unresectable
414808|NCT01802684|metastatic|metastatic
414809|NCT01802684|colorectal|colorectal
414810|NCT01802684|cancer|cancer
414811|NCT01802684|OPTIMOX|optimox
414812|NCT01802684|aflibercept|aflibercept
414813|NCT01802671|Low back pain|low back pain
414814|NCT01802671|Cognitive behavioural treatment|cognitive behavioural treatment
414815|NCT01802671|internet|internet
414816|NCT01802671|disability|disability
414817|NCT01802658|Bone marrow demineralization lesions,: efficacy and tolerability, zoledronic acid|bone marrow demineralization lesions,: efficacy and tolerability, zoledronic acid
414818|NCT01802645|neoadjuvant|neoadjuvant
414819|NCT01802645|cetuximab|cetuximab
414820|NCT01802645|irinotecan|irinotecan
414821|NCT01802645|bevacizumab|bevacizumab
414822|NCT01802645|oxaliplatin|oxaliplatin
414823|NCT01802645|5-FU|5-fu
414824|NCT01802645|Resection|resection
414825|NCT01802645|colorectal liver metastases|colorectal liver metastases
414826|NCT01802645|liver resection|liver resection
414827|NCT01802645|Chemotherapy|chemotherapy
414828|NCT01802645|k-ras|k-ras
414829|NCT01802645|non-resectable|non-resectable
414830|NCT01802632|Oncology,|oncology,
414831|NCT01802632|Non Small Cell Lung Cancer,|non small cell lung cancer,
414832|NCT01802632|Metastatic,|metastatic,
414833|NCT01802632|EGFR sensitivity mutation,|egfr sensitivity mutation,
414834|NCT01802632|T790M resistance mutation|t790m resistance mutation
414835|NCT01802606|surgery|surgery
414836|NCT01802606|administration|administration
414837|NCT01802606|infection|infection
414838|NCT01802593|Pediatric|pediatric
414839|NCT01802593|Crohn's disease|crohn's disease
414840|NCT01802593|Infliximab|infliximab
414841|NCT01802593|Thiopurine|thiopurine
414842|NCT01802554|Behavioral Activation|behavioral activation
414843|NCT01802554|Caregiver|caregiver
414844|NCT01802554|Dementia|dementia
414845|NCT01802554|Cardiovascular Disease|cardiovascular disease
414846|NCT01802554|Alzheimer's Disease|alzheimer's disease
414847|NCT01802554|Coagulation|coagulation
414848|NCT01802541|diacylglycerol oil|diacylglycerol oil
414849|NCT01802541|insulin sensitivity|insulin sensitivity
414850|NCT01802541|type 2 diabetes|type 2 diabetes
414851|NCT01802541|cardiovascular disease|cardiovascular disease
414852|NCT01802541|risk factors|risk factors
414853|NCT01802528|obturator externus|obturator externus
414854|NCT01802515|addiction|addiction
414855|NCT01802515|cocaine|cocaine
414856|NCT01802515|methadone|methadone
414857|NCT01802515|opiates|opiates
414858|NCT01802515|atomoxetine|atomoxetine
414859|NCT01802502|tuberculous meningitis|tuberculous meningitis
414860|NCT01802502|rifampicin|rifampicin
414861|NCT01802502|bioequivalence|bioequivalence
414862|NCT01802502|oral administration|oral administration
414863|NCT01802502|intravenous administration|intravenous administration
414864|NCT01802489|Optic neuritis|optic neuritis
414865|NCT01802489|Multiple sclerosis|multiple sclerosis
414866|NCT01802489|Retinal nerve fibre layer|retinal nerve fibre layer
414867|NCT01802489|Axonal loss|axonal loss
414868|NCT01802489|Neuroprotection|neuroprotection
414869|NCT01802489|MRI|mri
414870|NCT01802489|Optical coherence tomography|optical coherence tomography
414871|NCT01802489|Amiloride|amiloride
414872|NCT01802489|Acid Sensing Ion Channels|acid sensing ion channels
414873|NCT01802476|PD-0332991|pd-0332991
414874|NCT01802476|Absolute Bioavailability Study|absolute bioavailability study
414875|NCT01802424|Open trial|open trial
414876|NCT01802424|Indicative prevention|indicative prevention
414877|NCT01802424|Youth anxiety|youth anxiety
414878|NCT01802424|Cognitive behavioral therapy|cognitive behavioral therapy
414879|NCT01802411|liposome bupivacaine|liposome bupivacaine
414880|NCT01802411|posterolateral thoracotomy|posterolateral thoracotomy
414881|NCT01802411|intercostal nerve block|intercostal nerve block
414882|NCT01802411|postoperative pain|postoperative pain
414883|NCT01802398|Risk Stratification|risk stratification
414885|NCT01802398|Geriatric|geriatric
414886|NCT01802385|cryptococcal meningitis|cryptococcal meningitis
414887|NCT01802385|cryptococcus|cryptococcus
414888|NCT01802385|meningitis|meningitis
414889|NCT01802385|yeast|yeast
414890|NCT01802385|fungus|fungus
414891|NCT01802372|Hypertension|hypertension
414892|NCT01802372|High Blood Pressure|high blood pressure
414893|NCT01802372|Cardiovascular Diseases|cardiovascular diseases
414894|NCT01802372|Health Insurance Coverage|health insurance coverage
414895|NCT01802372|Low income countries|low income countries
414896|NCT01802372|Ghana|ghana
414897|NCT01802372|Low resource settings|low resource settings
414898|NCT01802372|Comparative Effectiveness|comparative effectiveness
414899|NCT01802372|Global Health|global health
414900|NCT01802359|Erectile dysfunction|erectile dysfunction
414901|NCT01802359|Mirodenafil|mirodenafil
414902|NCT01802359|Bravonto|bravonto
414903|NCT01802307|Focal therapy|focal therapy
414904|NCT01802307|Brachytherapy|brachytherapy
414905|NCT01802307|Active surveillance|active surveillance
414906|NCT01802307|low risk cancer|low risk cancer
414907|NCT01802294|Randomized Controlled Trials as Topic|randomized controlled trials as topic
414908|NCT01802294|Child|child
414909|NCT01802294|Parents|parents
414910|NCT01802268|sirolimus|sirolimus
414911|NCT01802268|tacrolimus|tacrolimus
414912|NCT01802268|early conversion|early conversion
414913|NCT01802255|Inhalatory sedation|inhalatory sedation
414914|NCT01802255|Sevoflurane|sevoflurane
414915|NCT01802255|AnaConDa|anaconda
414916|NCT01802255|Nephrotoxicity|nephrotoxicity
414917|NCT01802255|Hepatotoxicity|hepatotoxicity
414918|NCT01802255|Midazolam|midazolam
414919|NCT01802255|Propofol|propofol
414920|NCT01802242|Prostate Cancer|prostate cancer
414921|NCT01802242|Prostate tumour|prostate tumour
414922|NCT01802242|Prostate radiotherapy|prostate radiotherapy
414923|NCT01802242|prostate cancer treatment|prostate cancer treatment
414924|NCT01802216|chronic kidney disease progression|chronic kidney disease progression
414925|NCT01802216|periodontal disease|periodontal disease
414926|NCT01802216|intensive periodontal disease treatment|intensive periodontal disease treatment
414927|NCT01802203|Barrett esophagus|barrett esophagus
414928|NCT01802203|Esophageal dysplasia|esophageal dysplasia
414929|NCT01802203|Upper gastrointestinal squamous dysplasia|upper gastrointestinal squamous dysplasia
414930|NCT01802203|Esophageal cancer|esophageal cancer
414931|NCT01802203|Endobronchial cancer|endobronchial cancer
414932|NCT01802203|Central airway cancer|central airway cancer
414933|NCT01802203|Central airway precancerous disease|central airway precancerous disease
414934|NCT01802203|Central airway granulation tissue|central airway granulation tissue
414935|NCT01802203|Central airway papillomatosis|central airway papillomatosis
414936|NCT01802203|Central airway sarcoidosis|central airway sarcoidosis
414937|NCT01802203|Central airway tuberculosis|central airway tuberculosis
414938|NCT01802203|Tracheal stenosis|tracheal stenosis
414939|NCT01802203|Bronchial stenosis|bronchial stenosis
414940|NCT01802190|Genetic deafness|genetic deafness
414941|NCT01802190|SLC17A8 et POU4F3 genes|slc17a8 et pou4f3 genes
414942|NCT01802177|Alopecia areata|alopecia areata
414943|NCT01802177|Excimer|excimer
414944|NCT01802177|UVB|uvb
414945|NCT01802151|probiotics|probiotics
414946|NCT01802151|microbiota|microbiota
414947|NCT01802151|survival|survival
414948|NCT01802151|gastrointestinal|gastrointestinal
414949|NCT01802151|wellness|wellness
414950|NCT01802138|refractory/relapsed neuroblastoma patients|refractory/relapsed neuroblastoma patients
414951|NCT01802112|Colonic transit|colonic transit
414952|NCT01802112|Dietary Fiber|dietary fiber
414953|NCT01802112|Radiopaque marker|radiopaque marker
414954|NCT01802099|mechanical ventilation|mechanical ventilation
414955|NCT01802099|early enteral nutrition|early enteral nutrition
414956|NCT01802099|intensive care unit|intensive care unit
414957|NCT01802099|early parenteral nutrition|early parenteral nutrition
414958|NCT01802099|critical care medicine|critical care medicine
414959|NCT01802099|nosocomial infection|nosocomial infection
414960|NCT01802099|mortality|mortality
414961|NCT01802099|shock|shock
414962|NCT01802099|vasoactive drug|vasoactive drug
414963|NCT01802086|Children|children
414964|NCT01802086|Pain|pain
414965|NCT01802086|Vaccination|vaccination
414966|NCT01802086|Emla|emla
414967|NCT01802086|Pneumococcal|pneumococcal
414968|NCT01802086|Painscale|painscale
414969|NCT01802073|Inflammation of the bile ducts|inflammation of the bile ducts
414970|NCT01802073|biliary scarring|biliary scarring
414971|NCT01802073|obstruction|obstruction
414972|NCT01802060|Persona|persona
414973|NCT01802060|E3G|e3g
414974|NCT01802060|LH|lh
414975|NCT01802060|ovulation|ovulation
414976|NCT01802047|Mothers of Preterms|mothers of preterms
414977|NCT01802047|Breastfeeding Mothers of Preterm infants|breastfeeding mothers of preterm infants
414978|NCT01802047|mother milk feeding|mother milk feeding
414979|NCT01802021|chinese medicine|chinese medicine
414980|NCT01802021|non-small cell lung cancer|non-small cell lung cancer
414981|NCT01802021|immunosuppression|immunosuppression
414982|NCT01802008|Polyp/adenoma detection rate|polyp/adenoma detection rate
414983|NCT01802008|Polyp/adenoma miss rate|polyp/adenoma miss rate
414984|NCT01802008|Colonoscopy withdrawal time|colonoscopy withdrawal time
414985|NCT01801982|PPHN; development progress after PPHN; developmental progress after sildenafil.|pphn; development progress after pphn; developmental progress after sildenafil.
414986|NCT01801969|Brain injuries|brain injuries
414987|NCT01801969|Rehabilitation services|rehabilitation services
414988|NCT01801969|Return to Work|return to work
414989|NCT01801969|Quality of life|quality of life
414990|NCT01801956|Maximum oxygen uptake|maximum oxygen uptake
414991|NCT01801956|Physical activity|physical activity
414992|NCT01801956|Physical inactivity|physical inactivity
414993|NCT01801956|Motivational interview|motivational interview
414994|NCT01801956|Cardiorespiratory fitness|cardiorespiratory fitness
414995|NCT01801956|Primary care|primary care
414996|NCT01801956|Community care|community care
414997|NCT01801930|OCV-C02|ocv-c02
414998|NCT01801930|Colorectal Cancer|colorectal cancer
414999|NCT01801930|Antigen specific cancer immunotherapeutic|antigen specific cancer immunotherapeutic
415000|NCT01801917|Polymyositis|polymyositis
415001|NCT01801917|Myositis|myositis
415002|NCT01801917|PM|pm
415003|NCT01801917|chronic muscle inflammation|chronic muscle inflammation
415004|NCT01801917|inflammatory myopathy|inflammatory myopathy
415005|NCT01801917|inclusion body myositis|inclusion body myositis
415006|NCT01801904|cetuximab-refractory|cetuximab-refractory
415007|NCT01801891|Venous ulceration|venous ulceration
415008|NCT01801891|Leg ulcers|leg ulcers
415009|NCT01801891|Venous haemodynamics|venous haemodynamics
415010|NCT01801891|Surface neuromuscular electrical stimulation|surface neuromuscular electrical stimulation
415011|NCT01801891|SNMES|snmes
415012|NCT01801878|breast cancer|breast cancer
415013|NCT01801878|loss of elasticity in irradiated breast skin|loss of elasticity in irradiated breast skin
415014|NCT01801878|Other Reconstructive Surgery|other reconstructive surgery
415015|NCT01801865|NICU|nicu
415016|NCT01801865|MRI|mri
415017|NCT01801865|Neonatal|neonatal
415018|NCT01801865|Cincinnati|cincinnati
415019|NCT01801813|Neuro-surgery|neuro-surgery
415020|NCT01801813|Post-operative complications|post-operative complications
415021|NCT01801813|Neuro-ICU resources|neuro-icu resources
415022|NCT01801800|Aneurysmal subarachnoid haemorrhage|aneurysmal subarachnoid haemorrhage
415023|NCT01801774|post-operative inflammation|post-operative inflammation
415024|NCT01801774|steroid|steroid
415025|NCT01801774|intraocular pressure|intraocular pressure
415026|NCT01801748|wheat allergy|wheat allergy
415027|NCT01801748|wheat outgrowing|wheat outgrowing
415028|NCT01801748|wheat hypersensitivity|wheat hypersensitivity
415029|NCT01801748|omega-5-gliadin|omega-5-gliadin
415030|NCT01801748|natural history of wheat hypersensitivity|natural history of wheat hypersensitivity
415031|NCT01801709|Brain Gene Therapy|brain gene therapy
415032|NCT01801709|Adeno Associated vector|adeno associated vector
415033|NCT01801709|Lysosomal sotage diseases|lysosomal sotage diseases
415034|NCT01801709|Leukodystrophies|leukodystrophies
415036|NCT01801696|effectiveness|effectiveness
415037|NCT01801696|autism|autism
415038|NCT01801696|parent stress|parent stress
415039|NCT01801683|EBM|ebm
415040|NCT01801683|general practice|general practice
415041|NCT01801670|itch|itch
415042|NCT01801670|pruritus|pruritus
415043|NCT01801670|skin|skin
415044|NCT01801670|vorinostat|vorinostat
415045|NCT01801670|cutaneous T-cell lymphoma|cutaneous t-cell lymphoma
415046|NCT01801670|mycosis fungoides|mycosis fungoides
415047|NCT01801657|bronchiectasis|bronchiectasis
415048|NCT01801657|exacerbation|exacerbation
415049|NCT01801657|virus|virus
415050|NCT01801644|bladder cancer|bladder cancer
415051|NCT01801644|neoadjuvant chemotherapy|neoadjuvant chemotherapy
415052|NCT01801644|gem/cis|gem/cis
415053|NCT01801631|Type 2 diabetes|type 2 diabetes
415054|NCT01801631|Acute Coronary Event (ACE)|acute coronary event (ace)
415055|NCT01801631|Distress|distress
415056|NCT01801631|Self-efficacy|self-efficacy
415057|NCT01801631|Quality of Life|quality of life
415058|NCT01801631|Depression|depression
415059|NCT01801631|Primary care|primary care
415060|NCT01801631|Illness representations|illness representations
415061|NCT01801618|HIV|hiv
415062|NCT01801618|PI based 2nd line ARV treatment|pi based 2nd line arv treatment
415063|NCT01801618|Virological failure|virological failure
415064|NCT01801618|Drug resistance|drug resistance
415065|NCT01801618|Cambodia|cambodia
415066|NCT01801618|Adherence|adherence
415067|NCT01801605|IBS - rectal hypersensitivity - rectal barostat - rTMS.|ibs - rectal hypersensitivity - rectal barostat - rtms.
415068|NCT01801592|OBSTRUCTIVE SLEEP APNOEA|obstructive sleep apnoea
415069|NCT01801592|INTERMITTENT CLAUDICATION|intermittent claudication
415070|NCT01801592|Respiratory disease|respiratory disease
415071|NCT01801592|Peripheral artery disease|peripheral artery disease
415072|NCT01801579|Ankle Brachial Index|ankle brachial index
415073|NCT01801579|Maximal exercise|maximal exercise
415074|NCT01801566|Mandibular Prosthesis Implantation|mandibular prosthesis implantation
415075|NCT01801566|Prostheses and Implants|prostheses and implants
415076|NCT01801566|Denture, Complete, Lower|denture, complete, lower
415077|NCT01801553|spinal manipulation|spinal manipulation
415078|NCT01801553|low back pain|low back pain
415079|NCT01801553|manual therapy|manual therapy
415080|NCT01801553|clinical predictive rule|clinical predictive rule
415081|NCT01801527|Telehealth|telehealth
415082|NCT01801527|Fatigue|fatigue
415083|NCT01801527|Breast cancer|breast cancer
415084|NCT01801527|Exercise|exercise
415085|NCT01801527|Quality of life|quality of life
415086|NCT01801527|Telerehabilitation|telerehabilitation
415087|NCT01801475|Pharmacokinetics of ondansetron in women|pharmacokinetics of ondansetron in women
415088|NCT01801475|Pharmacokinetics of ondansetron in neonates|pharmacokinetics of ondansetron in neonates
415089|NCT01801475|Term pregnancy|term pregnancy
415090|NCT01801475|Cesarean section|cesarean section
415091|NCT01801462|Medical education|medical education
415092|NCT01801462|Simulation|simulation
415093|NCT01801462|Ultrasound training|ultrasound training
415094|NCT01801462|Patient safety|patient safety
415095|NCT01801449|DIRA|dira
415096|NCT01801449|Clinical Trial|clinical trial
415097|NCT01801449|IL-1|il-1
415098|NCT01801449|Autoinflammatory Syndrome|autoinflammatory syndrome
415099|NCT01801449|Rilonacept|rilonacept
415100|NCT01801436|Multiple Myeloma|multiple myeloma
415101|NCT01801436|Bortezomib|bortezomib
415102|NCT01801436|Velcade|velcade
415103|NCT01801423|transcranial Doppler|transcranial doppler
415104|NCT01801423|stroke|stroke
415105|NCT01801423|sickle cell anemia|sickle cell anemia
415106|NCT01801423|Nigeria|nigeria
415107|NCT01801423|hydroxyurea|hydroxyurea
415108|NCT01801423|low income country|low income country
415109|NCT01801410|pre-eclampsia|pre-eclampsia
415110|NCT01801410|labor induction|labor induction
415111|NCT01801410|misoprostol|misoprostol
415112|NCT01801410|Foley catheter|foley catheter
415113|NCT01801384|pregnancy|pregnancy
415114|NCT01801384|cigarette smoking|cigarette smoking
415115|NCT01801384|incentives|incentives
415116|NCT01801384|smoking cessation|smoking cessation
415117|NCT01801384|birth outcomes|birth outcomes
415118|NCT01801371|Glioma|glioma
415119|NCT01801371|Diagnostic imaging|diagnostic imaging
415120|NCT01801371|Integrin receptor|integrin receptor
415121|NCT01801371|68Ga-BNOTA-PRGD2|68ga-bnota-prgd2
415122|NCT01801371|PET/CT|pet/ct
415123|NCT01801358|Melanoma,|melanoma,
415124|NCT01801358|melanoma of the eye,|melanoma of the eye,
415125|NCT01801358|uveal,|uveal,
415126|NCT01801358|MEK162,|mek162,
415127|NCT01801358|AEB071|aeb071
415128|NCT01801345|Human Performance|human performance
415129|NCT01801345|Clinical Performance|clinical performance
415130|NCT01801319|major depressive disorder (MDD)|major depressive disorder (mdd)
415131|NCT01801319|deep brain stimulation (DBS)|deep brain stimulation (dbs)
415132|NCT01801319|subcallosal cingulate gyrus|subcallosal cingulate gyrus
415133|NCT01801319|Therapy-Resistant Depression|therapy-resistant depression
415134|NCT01801319|Electrical Stimulation of the Brain|electrical stimulation of the brain
415135|NCT01801319|Brain Stimulation, Deep|brain stimulation, deep
415136|NCT01801293|RSV infection|rsv infection
415137|NCT01801280|immunosuppressive medication|immunosuppressive medication
415138|NCT01801280|mycophenolic acid|mycophenolic acid
415139|NCT01801280|interaction|interaction
415140|NCT01801280|proton pump inhibitor|proton pump inhibitor
415141|NCT01801280|pantoprazole|pantoprazole
415142|NCT01801280|renal transplant patients|renal transplant patients
415143|NCT01801280|pharmacokinetics|pharmacokinetics
415144|NCT01801280|pharmacodynamics|pharmacodynamics
415145|NCT01801280|bioavailability|bioavailability
415146|NCT01801267|Hydrocephalus|hydrocephalus
415147|NCT01801267|Pediatric|pediatric
415148|NCT01801267|Ventricular shunt|ventricular shunt
415149|NCT01801267|Ventriculoperitoneal shunt|ventriculoperitoneal shunt
415150|NCT01801267|Third ventriculostomy|third ventriculostomy
415151|NCT01801267|Randomized controlled trial|randomized controlled trial
415152|NCT01801254|Obesity|obesity
415153|NCT01801254|Type II diabetes|type ii diabetes
415154|NCT01801254|Cardiovascular disease|cardiovascular disease
415155|NCT01801254|Health behavior promotion|health behavior promotion
415156|NCT01801254|Neuroeconomics|neuroeconomics
415157|NCT01801254|EEG biofeedback|eeg biofeedback
415158|NCT01801254|Low-resolution electromagnetic tomography (LORETA)|low-resolution electromagnetic tomography (loreta)
415160|NCT01801176|proved by biopsy|proved by biopsy
415161|NCT01801150|Diabetes|diabetes
415162|NCT01801150|Apnea- hypopnea Syndrome|apnea- hypopnea syndrome
415163|NCT01801150|Glycemic control|glycemic control
415164|NCT01801150|Prevalence|prevalence
415165|NCT01801150|SAHS|sahs
415166|NCT01801150|life quality|life quality
415167|NCT01801124|analgesia|analgesia
415168|NCT01801124|hernia repair|hernia repair
415169|NCT01801098|TAVI|tavi
415170|NCT01801098|complete AV-block|complete av-block
415171|NCT01801098|HV-interval|hv-interval
415172|NCT01801098|permanent pacemaker|permanent pacemaker
415173|NCT01801085|Time-and-Motion|time-and-motion
415174|NCT01801085|Neoplasm|neoplasm
415175|NCT01801085|Colorectal Cancer|colorectal cancer
415176|NCT01801059|colon cancer|colon cancer
415177|NCT01801059|Colorectal Cancer Screening|colorectal cancer screening
415178|NCT01801033|Trioodothyronine (T3)|trioodothyronine (t3)
415179|NCT01801033|Thyroid Hormone Action|thyroid hormone action
415180|NCT01801033|Deiodinases|deiodinases
415181|NCT01801033|Hypothyroid|hypothyroid
415182|NCT01801033|Propylthiouracil (PTU)|propylthiouracil (ptu)
415183|NCT01801020|temperature|temperature
415184|NCT01800994|convenience|convenience
415185|NCT01800981|Functionality|functionality
415186|NCT01800981|extremities|extremities
415187|NCT01800981|ROM|rom
415188|NCT01800981|Upper and lower Extremity for burned patients|upper and lower extremity for burned patients
415189|NCT01800955|physical therapy|physical therapy
415190|NCT01800955|diathermy|diathermy
415191|NCT01800955|knee|knee
415192|NCT01800955|osteoarthritis|osteoarthritis
415193|NCT01800955|pain|pain
415194|NCT01800955|physical function|physical function
415195|NCT01800942|prevention|prevention
415196|NCT01800942|bacterial infection|bacterial infection
415197|NCT01800942|neonates|neonates
415198|NCT01800942|women in labour|women in labour
415199|NCT01800942|Azithromycin|azithromycin
415200|NCT01800916|ileostomy|ileostomy
415201|NCT01800916|Subjects|subjects
415202|NCT01800890|stoma ileostomy|stoma ileostomy
415203|NCT01800877|hypotension|hypotension
415204|NCT01800877|vasopressors|vasopressors
415205|NCT01800877|titration|titration
415206|NCT01800877|tissue perfusion|tissue perfusion
415207|NCT01800877|organ failure|organ failure
415208|NCT01800851|Kidney transplantation|kidney transplantation
415209|NCT01800851|Energy expenditure|energy expenditure
415210|NCT01800851|Weight gain|weight gain
415211|NCT01800851|Insulin resistance|insulin resistance
415212|NCT01800825|Pregnancy|pregnancy
415213|NCT01800825|Prematurity|prematurity
415214|NCT01800825|Preterm birth|preterm birth
415215|NCT01800825|bacterial vaginosis|bacterial vaginosis
415216|NCT01800799|Urinary tract infection|urinary tract infection
415217|NCT01800799|Urothelium|urothelium
415218|NCT01800799|Inflammation|inflammation
415219|NCT01800799|Apoptosis|apoptosis
415220|NCT01800773|PTSD|ptsd
415221|NCT01800773|exposure treatment|exposure treatment
415222|NCT01800773|clinical trial|clinical trial
415223|NCT01800773|trauma|trauma
415224|NCT01800760|healthy|healthy
415225|NCT01800760|obese|obese
415226|NCT01800760|women|women
415227|NCT01800747|Delayed antibiotic treatment|delayed antibiotic treatment
415228|NCT01800747|Acute respiratory infections|acute respiratory infections
415229|NCT01800747|Pediatrics|pediatrics
415230|NCT01800747|Satisfaction|satisfaction
415231|NCT01800734|Mixed meal test|mixed meal test
415232|NCT01800734|Insulin pump|insulin pump
415233|NCT01800734|Continuous glucose monitoring|continuous glucose monitoring
415234|NCT01800734|Metabolic control analysis|metabolic control analysis
415235|NCT01800734|Closed loop control|closed loop control
415236|NCT01800734|Artificial pancreas|artificial pancreas
415237|NCT01800721|HIV|hiv
415238|NCT01800721|testing|testing
415239|NCT01800721|Social Network|social network
415240|NCT01800721|African American|african american
415241|NCT01800721|MSM|msm
415242|NCT01800721|Men who have sex with men|men who have sex with men
415243|NCT01800695|GBM|gbm
415244|NCT01800682|Healthy|healthy
415245|NCT01800682|Tramodol|tramodol
415246|NCT01800682|Ultram|ultram
415247|NCT01800669|Computer based clinical decision support|computer based clinical decision support
415248|NCT01800669|medical legal partnership|medical legal partnership
415249|NCT01800669|child|child
415250|NCT01800669|pediatrics|pediatrics
415251|NCT01800643|Busulfan|busulfan
415252|NCT01800643|plasmatic dosage|plasmatic dosage
415253|NCT01800643|Stem Cell Transplantation|stem cell transplantation
415254|NCT01800578|Cerebral State Index Monitor|cerebral state index monitor
415255|NCT01800565|precocious puberty|precocious puberty
415256|NCT01800565|urinary LH|urinary lh
415257|NCT01800565|GnRH stimulation test|gnrh stimulation test
415258|NCT01800565|gonadotropins|gonadotropins
415259|NCT01800552|Infiltration|infiltration
415260|NCT01800552|Extravasation|extravasation
415261|NCT01800552|Leaking|leaking
415262|NCT01800552|PIV Infiltration|piv infiltration
415263|NCT01800552|IV Infiltration|iv infiltration
415264|NCT01800552|Ultrasound Detection of Infiltration|ultrasound detection of infiltration
415265|NCT01800552|Ultrasound Imaging|ultrasound imaging
415266|NCT01800539|Autism|autism
415267|NCT01800539|Early Intervention|early intervention
415268|NCT01800539|Minority|minority
415269|NCT01800526|Sickle Cell Disease|sickle cell disease
415270|NCT01800526|Sickle Cell Anemia|sickle cell anemia
415271|NCT01800513|Implantation Failure|implantation failure
415272|NCT01800513|In-vitro Fertilization|in-vitro fertilization
415273|NCT01800513|Infertility|infertility
415274|NCT01800513|Endometrial Biopsy|endometrial biopsy
415275|NCT01800487|Drug-induced liver injury|drug-induced liver injury
415276|NCT01800487|Tuberculosis|tuberculosis
415277|NCT01800487|Silymarin|silymarin
415278|NCT01800461|Participation|participation
415279|NCT01800461|Occupational Therapy|occupational therapy
415280|NCT01800461|Valued Activities|valued activities
415281|NCT01800448|Respiratory monitoring|respiratory monitoring
415282|NCT01800448|cardiac monitoring|cardiac monitoring
415283|NCT01800448|skin conductance monitoring|skin conductance monitoring
415284|NCT01800448|variability|variability
415285|NCT01800409|Tetraplegia|tetraplegia
415286|NCT01800396|Bacterial infection|bacterial infection
415287|NCT01800396|Dairy|dairy
415288|NCT01800396|Diarrhea|diarrhea
415289|NCT01800396|Diet|diet
415290|NCT01800396|E.Coli|e.coli
415291|NCT01800396|Gastroenteritis|gastroenteritis
415292|NCT01800396|Milk|milk
415293|NCT01800396|Stool consistency|stool consistency
415294|NCT01800383|posttraumatic stress disorder|posttraumatic stress disorder
415295|NCT01800383|fear conditioning|fear conditioning
415296|NCT01800383|proton magnetic resonance spectroscopy|proton magnetic resonance spectroscopy
415297|NCT01800383|GABA|gaba
415298|NCT01800370|Healthy|healthy
415299|NCT01800370|Male|male
415300|NCT01800357|randomized trial|randomized trial
415301|NCT01800357|acute ischemic stroke|acute ischemic stroke
415302|NCT01800357|mildronate|mildronate
415303|NCT01800344|Airway Cuff|airway cuff
415304|NCT01800344|LMA|lma
415305|NCT01800344|Ultra|ultra
415306|NCT01800344|Cuff Pressure|cuff pressure
415307|NCT01800344|Ventilation|ventilation
415308|NCT01800344|Anesthesia|anesthesia
415309|NCT01800344|Intubation|intubation
415310|NCT01800318|NESAP|nesap
415311|NCT01800318|sucrose|sucrose
415312|NCT01800318|pain|pain
415313|NCT01800318|infants|infants
415314|NCT01800305|PK & PD study|pk & pd study
415315|NCT01800305|rhEPO|rhepo
415316|NCT01800305|Pegylated rhEPO|pegylated rhepo
415317|NCT01800305|male healthy subject|male healthy subject
415318|NCT01800292|Pulmonary Artery Hypertension|pulmonary artery hypertension
415319|NCT01800292|pulmonary capillary wedge pressure|pulmonary capillary wedge pressure
415320|NCT01800292|sildenafil|sildenafil
415321|NCT01800292|echocardiography|echocardiography
415322|NCT01800292|left ventricular longitudinal wall strain|left ventricular longitudinal wall strain
415323|NCT01800292|strain rate pre and post medical therapy|strain rate pre and post medical therapy
415324|NCT01800292|speckle tracking|speckle tracking
415325|NCT01800279|Fibromyalgia Syndrome, Temporomandibular Joint, Pain.|fibromyalgia syndrome, temporomandibular joint, pain.
415326|NCT01800266|Supervision|supervision
415327|NCT01800266|Implementation|implementation
415328|NCT01800266|Community Based Mental Health Services|community based mental health services
415329|NCT01800266|Trauma Focused Cognitive Behavioral Therapy|trauma focused cognitive behavioral therapy
415330|NCT01800266|Skill Building and Behavioral Rehearsal|skill building and behavioral rehearsal
415331|NCT01800266|Symptom and Fidelity Monitoring|symptom and fidelity monitoring
415332|NCT01800266|Children|children
415333|NCT01800266|Adolescents|adolescents
415334|NCT01800214|neurodengeneration|neurodengeneration
415335|NCT01800214|neuroimaging|neuroimaging
415737|NCT01798420|COPD|copd
415336|NCT01800201|Initial occurrence Acute Myocardial Infarction (AMI)|initial occurrence acute myocardial infarction (ami)
415337|NCT01800188|Dialysis|dialysis
415338|NCT01800188|Incretin hormones|incretin hormones
415339|NCT01800149|Tooth extraction|tooth extraction
415340|NCT01800149|Ridge Preservation|ridge preservation
415341|NCT01800149|Ridge Augmentation|ridge augmentation
415342|NCT01800149|Guided Bone Regeneration|guided bone regeneration
415343|NCT01800136|pain|pain
415344|NCT01800136|neuropathic|neuropathic
415345|NCT01800136|cortical stimulation|cortical stimulation
415346|NCT01800136|motor cortex|motor cortex
415347|NCT01800136|plasticity|plasticity
415348|NCT01800136|rTMS|rtms
415349|NCT01800136|tDCS|tdcs
415350|NCT01800123|Intoxication, overdose, poisoning, EtCO2, emergency medicine|intoxication, overdose, poisoning, etco2, emergency medicine
415351|NCT01800097|stroke|stroke
415352|NCT01800097|fatigue|fatigue
415353|NCT01800097|modafinil|modafinil
415354|NCT01800084|ASIR|asir
415355|NCT01800084|image acquisition|image acquisition
415356|NCT01800084|FBP|fbp
415357|NCT01800071|Nasopharyngeal cancer|nasopharyngeal cancer
415358|NCT01800071|Epstein Barr Virus Infections|epstein barr virus infections
415359|NCT01800071|Vaccination|vaccination
415360|NCT01800045|Narcolepsy|narcolepsy
415361|NCT01800045|Cataplexy|cataplexy
415362|NCT01800045|Sleep disorder|sleep disorder
415363|NCT01800045|Excessive daytime sleepiness|excessive daytime sleepiness
415364|NCT01800006|Atrial Fibrillation|atrial fibrillation
415365|NCT01800006|Observation|observation
415366|NCT01800006|Stroke|stroke
415367|NCT01800006|Embolism|embolism
415368|NCT01799993|Gram-negative pneumonia|gram-negative pneumonia
415369|NCT01799993|Intubation|intubation
415370|NCT01799993|Mechanical ventilation|mechanical ventilation
415371|NCT01799993|Amikacin|amikacin
415372|NCT01799980|Lung cancer|lung cancer
415373|NCT01799980|Cervical mediastinoscopy|cervical mediastinoscopy
415374|NCT01799980|Endobronchial ultrasound|endobronchial ultrasound
415375|NCT01799980|Staging|staging
415376|NCT01799967|gastro-esophageal junction|gastro-esophageal junction
415377|NCT01799967|minimally invasive|minimally invasive
415378|NCT01799967|Achalasia|achalasia
415379|NCT01799967|Paraesophageal hernia|paraesophageal hernia
415380|NCT01799967|GERD|gerd
415381|NCT01799967|Epiphrenic diverticula|epiphrenic diverticula
415382|NCT01799967|Zenker's diverticulum|zenker's diverticulum
415383|NCT01799967|All minimally invasive surgeries of the gastro-esophageal junction|all minimally invasive surgeries of the gastro-esophageal junction
415384|NCT01799902|Observational|observational
415385|NCT01799902|Non-Interventional Prospective|non-interventional prospective
415386|NCT01799902|Phase IV Treatment|phase iv treatment
415387|NCT01799902|Overactive Bladder Syndrome|overactive bladder syndrome
415388|NCT01799902|Solifenacin|solifenacin
415389|NCT01799889|GS-US-339-0102|gs-us-339-0102
415390|NCT01799889|SYK inhibitor|syk inhibitor
415391|NCT01799889|GS-9973|gs-9973
415392|NCT01799889|entospletinib|entospletinib
415393|NCT01799889|CLL|cll
415394|NCT01799889|leukemia|leukemia
415395|NCT01799889|lymphoma|lymphoma
415396|NCT01799889|MCL|mcl
415397|NCT01799889|DLBCL|dlbcl
415398|NCT01799889|iNHL|inhl
415399|NCT01799889|FL|fl
415400|NCT01799889|MZL|mzl
415401|NCT01799889|LPL|lpl
415402|NCT01799889|SLL|sll
415403|NCT01799889|WM|wm
415404|NCT01799889|Waldenström's macroglobulinemia|waldenström's macroglobulinemia
415405|NCT01799876|knee|knee
415406|NCT01799876|cartilage|cartilage
415407|NCT01799876|microfracture|microfracture
415408|NCT01799876|cell therapy|cell therapy
415409|NCT01799863|Conjunctivitis, Viral|conjunctivitis, viral
415410|NCT01799863|Ketorolac|ketorolac
415411|NCT01799863|Artificial tears|artificial tears
415412|NCT01799850|muscle|muscle
415413|NCT01799850|glucose transporters|glucose transporters
415414|NCT01799850|GLUT4|glut4
415415|NCT01799850|GLUT5|glut5
415416|NCT01799850|Actos|actos
415417|NCT01799837|PTSD|ptsd
415418|NCT01799811|allograft|allograft
415419|NCT01799811|limb salvage|limb salvage
415420|NCT01799811|patency|patency
415421|NCT01799811|Cryopreserved|cryopreserved
415422|NCT01799811|open bypass|open bypass
415423|NCT01799798|Osteogenesis imperfecta|osteogenesis imperfecta
415424|NCT01799798|COL1A1/A2|col1a1/a2
415425|NCT01799798|Denosumab|denosumab
415426|NCT01799798|Bisphosphonates|bisphosphonates
415427|NCT01799798|Children|children
415428|NCT01799798|Areal bone mineral density|areal bone mineral density
415429|NCT01799759|Body Mass Percentile|body mass percentile
415430|NCT01799759|Authoritative parenting|authoritative parenting
415431|NCT01799759|Online interventions|online interventions
415432|NCT01799759|Prevention|prevention
415433|NCT01799733|Premenstrual Dysphoric Disorder|premenstrual dysphoric disorder
415434|NCT01799733|Women|women
415435|NCT01799733|Depression|depression
415436|NCT01799733|Light therapy|light therapy
415437|NCT01799733|Wake therapy|wake therapy
415438|NCT01799733|Phase|phase
415439|NCT01799733|Chronobiology|chronobiology
415440|NCT01799720|blood cholesterol|blood cholesterol
415441|NCT01799720|blood lipid profile|blood lipid profile
415442|NCT01799720|triglycerides|triglycerides
415443|NCT01799720|commercial pills|commercial pills
415444|NCT01799720|fish oil|fish oil
415445|NCT01799720|lipid peroxidation|lipid peroxidation
415446|NCT01799720|Circulating lipidic profile|circulating lipidic profile
415447|NCT01799707|vision|vision
415448|NCT01799707|restoration|restoration
415449|NCT01799707|visual field|visual field
415450|NCT01799694|Urinary incontinence|urinary incontinence
415451|NCT01799694|Autologous expanded stem cells|autologous expanded stem cells
415452|NCT01799694|Radical prostate cancer surgery|radical prostate cancer surgery
415453|NCT01799681|randomised controlled trial, postural balance, rehabilitation, exercise therapy, accidental falls|randomised controlled trial, postural balance, rehabilitation, exercise therapy, accidental falls
415454|NCT01799668|Psychotherapy|psychotherapy
415455|NCT01799668|Preferences|preferences
415456|NCT01799642|dyspnea|dyspnea
415457|NCT01799642|exercise|exercise
415458|NCT01799642|cystic fibrosis|cystic fibrosis
415459|NCT01799642|neuromechanical dissociation|neuromechanical dissociation
415460|NCT01799629|Glycerin suppositories|glycerin suppositories
415461|NCT01799629|Feeding intolerance|feeding intolerance
415462|NCT01799629|preterm infants|preterm infants
415463|NCT01799629|prophylactic use|prophylactic use
415464|NCT01799629|elimination of meconium|elimination of meconium
415465|NCT01799616|MODIC changes|modic changes
415466|NCT01799616|Chronic low back pain|chronic low back pain
415467|NCT01799616|Pamidronate|pamidronate
415468|NCT01799616|Magnetic resonance imaging|magnetic resonance imaging
415469|NCT01799616|Vertebrae|vertebrae
415470|NCT01799616|Intervertebral disc|intervertebral disc
415471|NCT01799603|Healthy|healthy
415472|NCT01799603|TMC435|tmc435
415473|NCT01799603|G008|g008
415474|NCT01799590|Migraine|migraine
415475|NCT01799590|Topiramate|topiramate
415476|NCT01799577|laparoscopy, accuracy, duration|laparoscopy, accuracy, duration
415477|NCT01799564|Geographic atrophy|geographic atrophy
415478|NCT01799564|Age-related macular degeneration|age-related macular degeneration
415479|NCT01799564|Fundus autofluorescence|fundus autofluorescence
415480|NCT01799551|Depression|depression
415481|NCT01799551|Culture|culture
415482|NCT01799551|CBT|cbt
415483|NCT01799551|Adaptation|adaptation
415484|NCT01799538|Albuterol|albuterol
415485|NCT01799538|Bronchodilator|bronchodilator
415486|NCT01799538|Nebulizer|nebulizer
415487|NCT01799538|Metered Dose Inhaler|metered dose inhaler
415488|NCT01799525|Aneurysm|aneurysm
415489|NCT01799525|subarachnoid hemorrhage|subarachnoid hemorrhage
415490|NCT01799525|vasospasm|vasospasm
415491|NCT01799525|cerebral ischemia|cerebral ischemia
415492|NCT01799525|stroke|stroke
415493|NCT01799512|medical ICU patients|medical icu patients
415494|NCT01799512|APACHE-II score ≥20|apache-ii score ≥20
415495|NCT01799499|Non Muscle Invasive Bladder Cancer|non muscle invasive bladder cancer
415496|NCT01799499|Intravesical instillation|intravesical instillation
415497|NCT01799499|Mitomycin C|mitomycin c
415498|NCT01799499|Hydrogel|hydrogel
415499|NCT01799499|Reverse thermal gelation|reverse thermal gelation
415500|NCT01799499|Drug retention|drug retention
415501|NCT01799499|Urinary Bladder Neoplasms|urinary bladder neoplasms
415502|NCT01799499|Carcinoma|carcinoma
415503|NCT01799499|Urologic Neoplasms|urologic neoplasms
415504|NCT01799499|Urogenital Neoplasms|urogenital neoplasms
415505|NCT01799499|Neoplasms by Site|neoplasms by site
415506|NCT01799499|Neoplasms|neoplasms
415507|NCT01799499|Urinary Bladder Diseases|urinary bladder diseases
415508|NCT01799499|Urologic Diseases|urologic diseases
415634|NCT01799005|diet|diet
415509|NCT01799499|Neoplasms, Glandular and Epithelial|neoplasms, glandular and epithelial
415510|NCT01799499|Neoplasms by Histologic Type Mitomycins|neoplasms by histologic type mitomycins
415511|NCT01799499|Mitomycin|mitomycin
415512|NCT01799499|Antibiotics, Antineoplastic|antibiotics, antineoplastic
415513|NCT01799499|Antineoplastic Agents|antineoplastic agents
415514|NCT01799499|Therapeutic Uses|therapeutic uses
415515|NCT01799499|Pharmacologic Actions|pharmacologic actions
415516|NCT01799499|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors
415517|NCT01799499|Enzyme Inhibitors|enzyme inhibitors
415518|NCT01799499|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action
415519|NCT01799499|Alkylating Agents|alkylating agents
415520|NCT01799486|Telbivudine|telbivudine
415521|NCT01799486|renoprotective efficacy|renoprotective efficacy
415522|NCT01799486|liver cirrhosis|liver cirrhosis
415523|NCT01799473|Tyvaso|tyvaso
415524|NCT01799473|PAH|pah
415525|NCT01799460|single-nucleotide-polymorphism|single-nucleotide-polymorphism
415526|NCT01799460|Traditional Chinese Medicine|traditional chinese medicine
415527|NCT01799460|the Comprehensive Treatment Regimen|the comprehensive treatment regimen
415528|NCT01799447|Early intervention|early intervention
415529|NCT01799447|Intervention study|intervention study
415530|NCT01799447|Infant mother relations|infant mother relations
415531|NCT01799447|First time mothers|first time mothers
415532|NCT01799447|Parental program|parental program
415533|NCT01799447|Marte Meo method|marte meo method
415534|NCT01799447|Video guidances|video guidances
415738|NCT01798420|Diabetes|diabetes
415535|NCT01799369|Surgical Apgar Score|surgical apgar score
415536|NCT01799356|Treatment, moksifloksasin|treatment, moksifloksasin
415537|NCT01799343|Prenatal care|prenatal care
415538|NCT01799343|Blood flow velocity|blood flow velocity
415539|NCT01799343|Hydrotherapy|hydrotherapy
415540|NCT01799343|Fetalplacental circulation|fetalplacental circulation
415541|NCT01799343|Uteroplacental circulation|uteroplacental circulation
415542|NCT01799330|COPD|copd
415543|NCT01799330|Rehabilitation|rehabilitation
415544|NCT01799330|Exercise|exercise
415545|NCT01799330|TCEMS|tcems
415546|NCT01799304|Locomotion|locomotion
415547|NCT01799304|cerebral palsy|cerebral palsy
415548|NCT01799304|Postural; Defect|postural; defect
415549|NCT01799291|Decision Making|decision making
415550|NCT01799291|Pediatric Bipolar Disorder|pediatric bipolar disorder
415551|NCT01799291|Assessment|assessment
415552|NCT01799291|Intervention|intervention
415553|NCT01799278|Metastatic prostate carcinoma|metastatic prostate carcinoma
415554|NCT01799265|obstructive sleep apnea|obstructive sleep apnea
415556|NCT01799265|AutoPAP|autopap
415557|NCT01799265|PAP|pap
415558|NCT01799265|sleep disordered breathing|sleep disordered breathing
415559|NCT01799265|CPAP|cpap
415560|NCT01799265|Apnea hypopnea index|apnea hypopnea index
415561|NCT01799265|AHI|ahi
415562|NCT01799252|medical abortion|medical abortion
415563|NCT01799252|doxycycline|doxycycline
415564|NCT01799252|antibiotics|antibiotics
415565|NCT01799252|adherence|adherence
415566|NCT01799252|nausea|nausea
415567|NCT01799239|stoma ileostomy|stoma ileostomy
415568|NCT01799213|Knee Osteoarthritis|knee osteoarthritis
415569|NCT01799213|NSAID|nsaid
415570|NCT01799213|Cognitive Behavioral Therapy|cognitive behavioral therapy
415571|NCT01799200|Collegiate Athletes|collegiate athletes
415572|NCT01799200|Hip Pathomorphology|hip pathomorphology
415573|NCT01799200|Age-Matched Controls|age-matched controls
415574|NCT01799200|Femoroacetabular Impingement|femoroacetabular impingement
415575|NCT01799200|Dysplasia|dysplasia
415576|NCT01799187|Immature Permanent Teeth|immature permanent teeth
415577|NCT01799161|NSCLC|nsclc
415578|NCT01799161|Lung Cancer|lung cancer
415579|NCT01799161|gp96|gp96
415580|NCT01799161|gp96 Vaccine|gp96 vaccine
415581|NCT01799161|AD100-gp96Ig-HLA A1|ad100-gp96ig-hla a1
415582|NCT01799148|Acute coronary syndrome|acute coronary syndrome
415583|NCT01799148|Air pollution.|air pollution.
415584|NCT01799148|Inflammation.|inflammation.
415585|NCT01799148|Oxidative Stress.|oxidative stress.
415586|NCT01799148|Prognosis|prognosis
415587|NCT01799109|magnesium sulfate|magnesium sulfate
415588|NCT01799109|nebulization|nebulization
415589|NCT01799109|lung function|lung function
415590|NCT01799083|Advanced solid tumors|advanced solid tumors
415591|NCT01799083|B cell lymphoma|b cell lymphoma
415592|NCT01799070|Prediction|prediction
415593|NCT01799070|Transcranial Doppler|transcranial doppler
415594|NCT01799057|Peripheral Arterial Disease|peripheral arterial disease
415595|NCT01799057|Intermittent Claudication|intermittent claudication
415596|NCT01799057|Peripheral Vascular Diseases|peripheral vascular diseases
415597|NCT01799057|Vascular Diseases|vascular diseases
415598|NCT01799057|Cardiovascular Diseases|cardiovascular diseases
415599|NCT01799057|Arterial Occlusive Diseases|arterial occlusive diseases
415600|NCT01799057|Atherosclerosis|atherosclerosis
415601|NCT01799057|Insulin Resistance|insulin resistance
415602|NCT01799057|Glucose Metabolism|glucose metabolism
415603|NCT01799057|Blood Glucose|blood glucose
415604|NCT01799057|Metformin|metformin
415605|NCT01799057|Biguanides|biguanides
415606|NCT01799057|Hypoglycemic Agents|hypoglycemic agents
415607|NCT01799057|Endothelium, Vascular|endothelium, vascular
415608|NCT01799057|Hemorheology|hemorheology
415609|NCT01799057|Blood Circulation|blood circulation
415610|NCT01799057|Regional Blood Flow|regional blood flow
415611|NCT01799057|Microcirculation|microcirculation
415612|NCT01799057|Exercise|exercise
415613|NCT01799057|Physical Fitness|physical fitness
415614|NCT01799057|Exercise Test|exercise test
415615|NCT01799057|Sedentary Lifestyle|sedentary lifestyle
415616|NCT01799057|Quality of Life|quality of life
415617|NCT01799057|Plethysmography|plethysmography
415618|NCT01799044|Irreversible electroporation|irreversible electroporation
415619|NCT01799044|IRE|ire
415620|NCT01799044|Electroporation|electroporation
415621|NCT01799044|Colorectal liver metastases|colorectal liver metastases
415622|NCT01799044|CRLM|crlm
415623|NCT01799044|Safety|safety
415624|NCT01799044|Feasibility|feasibility
415625|NCT01799044|Efficacy|efficacy
415626|NCT01799044|Single-center|single-center
415627|NCT01799044|Low Energy Direct Current|low energy direct current
415628|NCT01799044|Ablate-and-resect|ablate-and-resect
415629|NCT01799044|Nonthermal ablation|nonthermal ablation
415630|NCT01799044|Ablation|ablation
415631|NCT01799018|Xanthine Oxidase|xanthine oxidase
415632|NCT01799018|Cerebrospinal fluid|cerebrospinal fluid
415633|NCT01799005|flavanols|flavanols
415635|NCT01799005|endothelial function|endothelial function
415636|NCT01799005|blood pressure|blood pressure
415637|NCT01799005|FLAVIOLA|flaviola
415638|NCT01798992|ejection fraction|ejection fraction
415639|NCT01798992|beta-blocker|beta-blocker
415640|NCT01798992|carvedilol|carvedilol
415641|NCT01798992|metoprolol|metoprolol
415642|NCT01798992|myocardial gene expression|myocardial gene expression
415643|NCT01798992|human heart|human heart
415644|NCT01798992|ventricular remodeling|ventricular remodeling
415645|NCT01798992|wall stress|wall stress
415646|NCT01798992|adrenergic signaling|adrenergic signaling
415647|NCT01798992|myosin heavy chain|myosin heavy chain
415648|NCT01798953|Ulcerative Colitis|ulcerative colitis
415649|NCT01798953|Primary Sclerosing Cholangitis|primary sclerosing cholangitis
415650|NCT01798953|Ileal pouch-anal anastomosis|ileal pouch-anal anastomosis
415651|NCT01798953|Ileorectal anastomosis|ileorectal anastomosis
415652|NCT01798953|Surgical outcome|surgical outcome
415653|NCT01798953|Functional outcome|functional outcome
415654|NCT01798953|Failure|failure
415655|NCT01798927|Parkinson's disease|parkinson's disease
415656|NCT01798927|ankle foot orthosis (AFO)|ankle foot orthosis (afo)
415657|NCT01798927|gait|gait
415658|NCT01798901|Acute Myeloid Leukemia|acute myeloid leukemia
415659|NCT01798901|AML|aml
415660|NCT01798901|AR-42|ar-42
415661|NCT01798901|Decitabine|decitabine
415662|NCT01798888|Deep Brain Stimulation|deep brain stimulation
415663|NCT01798888|Alcohol Dependence|alcohol dependence
415664|NCT01798875|pcos|pcos
415665|NCT01798875|metformin|metformin
415666|NCT01798875|oral contraception|oral contraception
415667|NCT01798875|cyproterone acetate|cyproterone acetate
415668|NCT01798862|Failed IVF cycles|failed ivf cycles
415669|NCT01798862|IVF outcome parameters|ivf outcome parameters
415670|NCT01798862|endometrial injury|endometrial injury
415671|NCT01798862|hysteroscopy|hysteroscopy
415672|NCT01798862|pipelle sampling|pipelle sampling
415673|NCT01798862|Repeated implantation failures|repeated implantation failures
415674|NCT01798836|IVF/ICSI cycles, poor responders, ultrashort flare protocol, antagonist protocol|ivf/icsi cycles, poor responders, ultrashort flare protocol, antagonist protocol
415675|NCT01798823|children|children
415676|NCT01798823|asthma|asthma
415677|NCT01798810|Surgical Site Infection Risk Prediction|surgical site infection risk prediction
415678|NCT01798810|Bacterial species type and antibacterial sensitivities|bacterial species type and antibacterial sensitivities
415679|NCT01798810|Resource Utilization and Cost|resource utilization and cost
415680|NCT01798797|Heart Failure|heart failure
415681|NCT01798797|HFRS|hfrs
415682|NCT01798797|OptiVol|optivol
415683|NCT01798797|ICD|icd
415684|NCT01798797|CRT-D|crt-d
415685|NCT01798771|primary brain tumor|primary brain tumor
415686|NCT01798771|malignant glioma|malignant glioma
415687|NCT01798771|intraoperative MRI|intraoperative mri
415688|NCT01798771|5-ALA|5-ala
415689|NCT01798745|Heart failure|heart failure
415690|NCT01798745|JNJ-54452840|jnj-54452840
415691|NCT01798745|Anti-beta-1 adrenergic receptor auto antibodies|anti-beta-1 adrenergic receptor auto antibodies
415692|NCT01798745|Beta-1 adrenergic receptor|beta-1 adrenergic receptor
415693|NCT01798745|Antibodies|antibodies
415694|NCT01798745|Auto antibodies|auto antibodies
415695|NCT01798745|Systolic function|systolic function
415696|NCT01798719|NAFLD|nafld
415697|NCT01798719|Clinical Trial|clinical trial
415698|NCT01798719|Mediterranean Diet|mediterranean diet
415699|NCT01798719|Low Glycemic Index|low glycemic index
415700|NCT01798693|Shoulder|shoulder
415701|NCT01798693|Supplement|supplement
415702|NCT01798693|Amino Acids|amino acids
415703|NCT01798693|Collagen|collagen
415704|NCT01798693|Standard of Care|standard of care
415705|NCT01798641|Hydrocephalus|hydrocephalus
415706|NCT01798641|Cross-over|cross-over
415707|NCT01798628|Healthy volunteers|healthy volunteers
415708|NCT01798628|Abiraterone acetate|abiraterone acetate
415709|NCT01798628|Pharmacokinetics|pharmacokinetics
415710|NCT01798602|H1N1|h1n1
415711|NCT01798602|Rosuvastatin|rosuvastatin
415712|NCT01798589|ethylenediamine dihydrochloride|ethylenediamine dihydrochloride
415713|NCT01798563|Parkinson|parkinson
415714|NCT01798563|Parkinson Disease|parkinson disease
415715|NCT01798550|Enoxaparin dosing|enoxaparin dosing
415716|NCT01798550|Obesity|obesity
415717|NCT01798524|Transplant|transplant
415718|NCT01798524|Kidney|kidney
415719|NCT01798524|England|england
415720|NCT01798511|enteral nutrition|enteral nutrition
415721|NCT01798511|acute pancreatitis|acute pancreatitis
415722|NCT01798511|oral food intolerance|oral food intolerance
415723|NCT01798472|displaced femoral neck fractures|displaced femoral neck fractures
415724|NCT01798472|treatment|treatment
415725|NCT01798472|uncemented arthroplasty|uncemented arthroplasty
415726|NCT01798472|cemented arthroplasty|cemented arthroplasty
415727|NCT01798459|Attention Deficit Hyperactivity Disorder|attention deficit hyperactivity disorder
415728|NCT01798459|Methylphenidate|methylphenidate
415729|NCT01798459|Placebo|placebo
415730|NCT01798459|State anxiety|state anxiety
415731|NCT01798446|Renal cell carcinoma|renal cell carcinoma
415732|NCT01798446|Nonclear cell|nonclear cell
415733|NCT01798446|Temsirolimus resistance|temsirolimus resistance
415734|NCT01798433|Angioplasty|angioplasty
415735|NCT01798433|Transluminal|transluminal
415736|NCT01798433|Percutaneous Coronary|percutaneous coronary
415739|NCT01798420|steroids|steroids
415740|NCT01798420|Hemoglobin A1C DIFFERENCE|hemoglobin a1c difference
415741|NCT01798407|Deep Brain Stimulation|deep brain stimulation
415742|NCT01798407|Major Depressive Disorder|major depressive disorder
415743|NCT01798407|Depression|depression
415744|NCT01798407|Lateral Habenula|lateral habenula
415745|NCT01798407|Intractable Depression|intractable depression
415746|NCT01798407|Treatment Resistant Depression (TRD)|treatment resistant depression (trd)
415747|NCT01798394|pregnant|pregnant
415748|NCT01798394|smoker|smoker
415749|NCT01798394|cigarette|cigarette
415750|NCT01798394|tobacco|tobacco
415751|NCT01798355|Dental Fear|dental fear
415752|NCT01798355|Dental Phobia|dental phobia
415753|NCT01798355|Cognitive Behavior Therapy|cognitive behavior therapy
415754|NCT01798355|Specific Phobia|specific phobia
415755|NCT01798355|Children and Adolescents anxiety|children and adolescents anxiety
415756|NCT01798355|Self Efficacy|self efficacy
415757|NCT01798342|preoperative care|preoperative care
415758|NCT01798342|maltodextrine|maltodextrine
415759|NCT01798342|glutamine|glutamine
415760|NCT01798342|gastric residual volume|gastric residual volume
415761|NCT01798342|MRI|mri
415762|NCT01798329|Minimal Hepatic Encephalopathy|minimal hepatic encephalopathy
415763|NCT01798329|Pre-hepatic Portal Hypertension|pre-hepatic portal hypertension
415764|NCT01798329|portal vein thrombosis|portal vein thrombosis
415765|NCT01798316|IV Acetaminophen|iv acetaminophen
415766|NCT01798316|Laparoscopic cholecystectomy|laparoscopic cholecystectomy
415767|NCT01798316|Postoperative nausea|postoperative nausea
415768|NCT01798316|Postoperative vomiting|postoperative vomiting
415769|NCT01798277|Keywords provided by Newmarket Electrophysiology Research Group Inc:|keywords provided by newmarket electrophysiology research group inc:
415770|NCT01798277|Ventricular tachycardia|ventricular tachycardia
415771|NCT01798277|Ventricular tachyarrhythmia|ventricular tachyarrhythmia
415772|NCT01798277|Ablation|ablation
415773|NCT01798277|Coronary artery disease|coronary artery disease
415774|NCT01798277|Ischemic heart disease|ischemic heart disease
415775|NCT01798277|Amiodarone|amiodarone
415776|NCT01798277|Sotalol|sotalol
415777|NCT01798277|Anti-Arrhythmia Agents|anti-arrhythmia agents
415778|NCT01798277|Therapeutic Uses|therapeutic uses
415779|NCT01798277|Pharmacologic Actions|pharmacologic actions
415780|NCT01798277|Additional relevant MeSH terms:|additional relevant mesh terms:
415781|NCT01798277|Atrial Fibrillation|atrial fibrillation
415782|NCT01798277|Arrhythmias, Cardiac|arrhythmias, cardiac
415783|NCT01798277|Heart Diseases|heart diseases
415784|NCT01798277|Cardiovascular Diseases|cardiovascular diseases
415785|NCT01798277|Pathologic Processes|pathologic processes
415786|NCT01798277|Catheter Ablation, Radiofrequency|catheter ablation, radiofrequency
415787|NCT01798251|Elderly Gastric Cancer|elderly gastric cancer
415788|NCT01798251|Capecitabine Maintenance|capecitabine maintenance
415789|NCT01798238|Type 2 Diabetes Mellitus / Dipeptidyl peptidase-IV inhibitors|type 2 diabetes mellitus / dipeptidyl peptidase-iv inhibitors
415790|NCT01798225|Periodontal Disease|periodontal disease
415791|NCT01798225|Type 2 Diabetes Mellitus|type 2 diabetes mellitus
415792|NCT01798225|Gullah African Americans|gullah african americans
415793|NCT01798212|GERD|gerd
415794|NCT01798199|Alzheimer|alzheimer
415795|NCT01798199|virtual reality system|virtual reality system
415796|NCT01798199|Alzheimer's disease related conditions|alzheimer's disease related conditions
415797|NCT01798173|Hepatocellular carcinoma|hepatocellular carcinoma
415798|NCT01798173|Cirrhosis|cirrhosis
415799|NCT01798173|Environmental risk factors|environmental risk factors
415800|NCT01798173|Nutrition|nutrition
415801|NCT01798173|Metabolic syndrome|metabolic syndrome
415802|NCT01798147|Cholangiocellular Carcinoma|cholangiocellular carcinoma
415803|NCT01798147|TACE|tace
415804|NCT01798147|SIRT|sirt
415805|NCT01798134|To show safety|to show safety
415806|NCT01798134|and efficacy|and efficacy
415807|NCT01798134|investigational product|investigational product
415808|NCT01798121|PPD|ppd
415809|NCT01798121|Tuberculosis|tuberculosis
415810|NCT01798108|Advanced skeletal metastases|advanced skeletal metastases
415811|NCT01798108|Radium-223|radium-223
415812|NCT01798108|Radium-223 dichloride|radium-223 dichloride
415813|NCT01798108|Alpharadin|alpharadin
415814|NCT01798095|TB, Aplisol|tb, aplisol
415815|NCT01798056|≥18 years of age|≥18 years of age
415816|NCT01798056|Chemotherapy|chemotherapy
415817|NCT01798056|Solid tumours|solid tumours
415818|NCT01798056|Immunogenicity|immunogenicity
415819|NCT01798056|Herpes Zoster|herpes zoster
415820|NCT01798056|Safety|safety
415821|NCT01798056|Shingles|shingles
415822|NCT01798030|Vitamin D|vitamin d
415823|NCT01798030|Diabetes|diabetes
415824|NCT01798030|Osteoporosis|osteoporosis
415825|NCT01798030|Cardiovascular Risk|cardiovascular risk
415826|NCT01798017|menstrual regulation|menstrual regulation
415827|NCT01798017|mifepristone|mifepristone
415828|NCT01798017|misoprostol|misoprostol
415829|NCT01797991|Hypersensitivity, drug|hypersensitivity, drug
415830|NCT01797978|Sepsis|sepsis
415831|NCT01797978|Septic shock|septic shock
415832|NCT01797978|Methylene blue|methylene blue
415833|NCT01797952|lactobacillus CD 2|lactobacillus cd 2
415834|NCT01797952|oral mucositis|oral mucositis
415835|NCT01797952|hematopoietic stem cell transplantation|hematopoietic stem cell transplantation
415836|NCT01797939|Erosive reflux disease (ERD)|erosive reflux disease (erd)
415837|NCT01797939|Non-erosive reflux disease (NERD)|non-erosive reflux disease (nerd)
415838|NCT01797939|Functional heartburn (FH)|functional heartburn (fh)
415839|NCT01797926|pharmacokinetics|pharmacokinetics
415840|NCT01797926|Hypertension|hypertension
415841|NCT01797926|losartan|losartan
415842|NCT01797926|healthy volunteers|healthy volunteers
415843|NCT01797926|amlodipine|amlodipine
415844|NCT01797900|adjuvants|adjuvants
415845|NCT01797900|inductive|inductive
415846|NCT01797900|concurrent|concurrent
415847|NCT01797900|chemoradiotherapy|chemoradiotherapy
415848|NCT01797900|high-risk|high-risk
415849|NCT01797900|locally advanced|locally advanced
415851|NCT01797887|Burnout-Syndrome|burnout-syndrome
415852|NCT01797887|Ayurveda|ayurveda
415853|NCT01797887|Ayurvedic|ayurvedic
415854|NCT01797887|Traditional Indian Medicine|traditional indian medicine
415855|NCT01797887|CAM|cam
415856|NCT01797887|Whole Medical System|whole medical system
415857|NCT01797887|Diet and Lifestyle Counseling|diet and lifestyle counseling
415858|NCT01797874|pazopanib maintenance|pazopanib maintenance
415859|NCT01797874|efficacy|efficacy
415860|NCT01797874|SCLC|sclc
415861|NCT01797861|chronic central serous chorioretinopathy|chronic central serous chorioretinopathy
415862|NCT01797861|photodynamic therapy|photodynamic therapy
415863|NCT01797861|micropulse laser|micropulse laser
415864|NCT01797835|adolescents|adolescents
415865|NCT01797835|intervention|intervention
415866|NCT01797835|motivational interviewing|motivational interviewing
415867|NCT01797835|alcohol and drug use|alcohol and drug use
415868|NCT01797783|Myopia|myopia
415869|NCT01797783|Presbyopia|presbyopia
415870|NCT01797783|Refractive error|refractive error
415871|NCT01797783|Contact lenses|contact lenses
415872|NCT01797783|Multifocal|multifocal
415873|NCT01797770|mechanical bowel preparation|mechanical bowel preparation
415874|NCT01797770|Colon Cancer|colon cancer
415875|NCT01797757|EPA|epa
415876|NCT01797757|LC-PUFA|lc-pufa
415877|NCT01797757|Orlistat|orlistat
415878|NCT01797757|Obesity|obesity
415879|NCT01797744|Stroke|stroke
415880|NCT01797744|Dizziness|dizziness
415881|NCT01797744|Vestibular rehabiliation|vestibular rehabiliation
415882|NCT01797744|Balance|balance
415883|NCT01797731|Orthalign|orthalign
415884|NCT01797731|KneeAlign|kneealign
415885|NCT01797731|Total Knee Replacement|total knee replacement
415886|NCT01797731|Total Knee Arthroplasty|total knee arthroplasty
415887|NCT01797731|Degenerative joint disease|degenerative joint disease
415888|NCT01797731|Osteoarthritis|osteoarthritis
415889|NCT01797731|Unilateral|unilateral
415890|NCT01797718|Puberty|puberty
415891|NCT01797718|Constitutional|constitutional
415892|NCT01797718|Delay|delay
415893|NCT01797718|Letrozole|letrozole
415894|NCT01797718|Testosterone|testosterone
415895|NCT01797692|prostate cancer cured|prostate cancer cured
415896|NCT01797692|aged patients|aged patients
415897|NCT01797679|Osteoarthritis,Articular Cartilage, Relaxometry, Morphometry, MRI, T2 mapping, T1 rho|osteoarthritis,articular cartilage, relaxometry, morphometry, mri, t2 mapping, t1 rho
415898|NCT01797640|Tibia Fractures|tibia fractures
415899|NCT01797640|Medial Fractures|medial fractures
415900|NCT01797640|Posterior Malleolar Fractures|posterior malleolar fractures
415901|NCT01797627|Pediatric Hydrocephalus|pediatric hydrocephalus
415902|NCT01797627|Ventricular Size|ventricular size
415903|NCT01797627|Neuropsychological Outcomes|neuropsychological outcomes
415904|NCT01797627|Quality of Life|quality of life
415905|NCT01797614|intra-abdominal pressure|intra-abdominal pressure
415906|NCT01797614|spontaneous breathing trail|spontaneous breathing trail
415907|NCT01797614|weaning|weaning
415908|NCT01797588|Total Knee Arthroplasty|total knee arthroplasty
415909|NCT01797588|Pain|pain
415910|NCT01797588|Periarticular infiltration|periarticular infiltration
415911|NCT01797588|Adductor canal block|adductor canal block
415912|NCT01797588|Postoperative|postoperative
415913|NCT01797575|Bipolar Disorder|bipolar disorder
415914|NCT01797575|Mood Disorder|mood disorder
415915|NCT01797575|Bipolar Depression|bipolar depression
415916|NCT01797575|Mood Swings|mood swings
415917|NCT01797562|Contact dermatitis|contact dermatitis
415918|NCT01797562|Eczema|eczema
415919|NCT01797549|Traumatic brain injury|traumatic brain injury
415920|NCT01797549|functional near infrared spectroscopy|functional near infrared spectroscopy
415921|NCT01797523|Endometrial cancer|endometrial cancer
415922|NCT01797523|Advanced or Recurrent Endometrial Carcinoma|advanced or recurrent endometrial carcinoma
415923|NCT01797523|Metformin|metformin
415924|NCT01797523|Letrozole|letrozole
415925|NCT01797523|Femara|femara
415926|NCT01797523|Everolimus|everolimus
415927|NCT01797523|Afinitor|afinitor
415928|NCT01797523|Zortress|zortress
415929|NCT01797523|RAD001|rad001
415930|NCT01797497|Parents|parents
415931|NCT01797497|Primary Care Providers|primary care providers
415932|NCT01797497|Specialists|specialists
415933|NCT01797497|Children with Special Healthcare Needs|children with special healthcare needs
415934|NCT01797497|Referral|referral
415935|NCT01797497|Health Outcomes|health outcomes
415936|NCT01797497|Self-Efficacy|self-efficacy
415937|NCT01797497|Communication|communication
415938|NCT01797484|ischemia|ischemia
415939|NCT01797484|myocardium|myocardium
415940|NCT01797484|Ranolazine|ranolazine
415941|NCT01797484|dyskinesia|dyskinesia
415942|NCT01797484|speckle tracking echocardiography|speckle tracking echocardiography
415943|NCT01797471|Non-Small Cell Lung Cancer|non-small cell lung cancer
415944|NCT01797471|NSCLC|nsclc
415945|NCT01797471|Lung Cancer|lung cancer
415946|NCT01797458|Class II carious primary molar|class ii carious primary molar
415947|NCT01797458|Non-Restorative Caries Treatment|non-restorative caries treatment
415948|NCT01797458|Hall Technique|hall technique
415949|NCT01797458|Conventional restorations|conventional restorations
415950|NCT01797458|Children|children
415951|NCT01797445|HIV|hiv
415952|NCT01797445|Treatment Naive|treatment naive
415953|NCT01797445|HIV 1 Infected|hiv 1 infected
415954|NCT01797445|Women|women
415955|NCT01797445|Female|female
415956|NCT01797419|Respiratory|respiratory
415957|NCT01797419|Syncytial|syncytial
415958|NCT01797419|Virus|virus
415959|NCT01797419|RSV|rsv
415960|NCT01797380|Depression|depression
415961|NCT01797380|HIV|hiv
415962|NCT01797367|HIV|hiv
415963|NCT01797367|COPD|copd
415964|NCT01797367|FEV1|fev1
415965|NCT01797367|respiratory function|respiratory function
415966|NCT01797354|patients at the end of treatment|patients at the end of treatment
415967|NCT01797341|Renal Transplantation|renal transplantation
415968|NCT01797341|Kidney transplantation|kidney transplantation
415969|NCT01797341|Pancreas Transplantation|pancreas transplantation
415970|NCT01797341|Tacrolimus|tacrolimus
415971|NCT01797341|Advagraf|advagraf
415972|NCT01797341|Prograf|prograf
415973|NCT01797341|Drug Adherence|drug adherence
415974|NCT01797328|brown adipose tissue, human|brown adipose tissue, human
415975|NCT01797302|Obesity|obesity
415976|NCT01797302|Vitamin D Deficiency|vitamin d deficiency
415977|NCT01797302|Vascular Function|vascular function
415978|NCT01797302|Insulin resistance|insulin resistance
415979|NCT01797302|metabolic syndrome|metabolic syndrome
415980|NCT01797289|syncope|syncope
415981|NCT01797289|pulmonary embolism|pulmonary embolism
415982|NCT01797276|Dichloroacetate (DCA)|dichloroacetate (dca)
415983|NCT01797276|Congenital Lactic Acidosis (CLA)|congenital lactic acidosis (cla)
415984|NCT01797276|acidosis|acidosis
415985|NCT01797276|orphan disease|orphan disease
415986|NCT01797263|fibromyalgia|fibromyalgia
415987|NCT01797263|yoga|yoga
415988|NCT01797263|exercise|exercise
415989|NCT01797263|pain|pain
415990|NCT01797237|surgery|surgery
415991|NCT01797237|fixation|fixation
415992|NCT01797237|intramedullary nail|intramedullary nail
415993|NCT01797224|Autoimmune disease|autoimmune disease
415994|NCT01797224|certolizumab pegol|certolizumab pegol
415995|NCT01797224|Cimzia|cimzia
415996|NCT01797224|pregnancy|pregnancy
415997|NCT01797224|birth defect|birth defect
415998|NCT01797224|birth outcome|birth outcome
415999|NCT01797224|TNF|tnf
416000|NCT01797224|Tumor necrosis factor|tumor necrosis factor
416001|NCT01797211|Mediterranean diet; FMD; obesity; cardiovascular risk.|mediterranean diet; fmd; obesity; cardiovascular risk.
416002|NCT01797198|Phase I|phase i
416003|NCT01797198|ASP3652|asp3652
416004|NCT01797198|Gemfibrozil|gemfibrozil
416005|NCT01797198|Repaglinide|repaglinide
416006|NCT01797198|Pharmacokinetics|pharmacokinetics
416007|NCT01797185|spasticity|spasticity
416008|NCT01797172|nucleoplasty|nucleoplasty
416009|NCT01797172|pulsed radio frequency|pulsed radio frequency
416010|NCT01797172|herniated disc|herniated disc
416011|NCT01797172|cervical|cervical
416012|NCT01797172|percutaneous disc decompression|percutaneous disc decompression
416013|NCT01797172|cervical radiculopathy|cervical radiculopathy
416014|NCT01797159|Prophylactic Cranial Irradiation|prophylactic cranial irradiation
416015|NCT01797159|PCI|pci
416016|NCT01797159|Hippocampal-sparing irradiation|hippocampal-sparing irradiation
416017|NCT01797120|Post-Menopausal Patients|post-menopausal patients
416018|NCT01797120|Hormone-Receptor Positive|hormone-receptor positive
416019|NCT01797120|Resistant to Aromatase Inhibitor Therapy|resistant to aromatase inhibitor therapy
416020|NCT01797120|Fulvestrant|fulvestrant
416021|NCT01797120|Faslodex|faslodex
416022|NCT01797120|mTOR Inhibitor|mtor inhibitor
416023|NCT01797120|Everolimus|everolimus
416024|NCT01797120|RAD001|rad001
416025|NCT01797120|Afinitor|afinitor
416026|NCT01797107|Meibomian gland dysfunction|meibomian gland dysfunction
416027|NCT01797068|HEALTHCARE UTILIZATION|healthcare utilization
416028|NCT01797068|ED UTILIZATION|ed utilization
416029|NCT01797068|PRIMARY CARE UTILIZATION|primary care utilization
416030|NCT01797068|PATIENT NAVIGATION|patient navigation
416031|NCT01797068|UNDERSERVED POPULATIONS|underserved populations
416032|NCT01797068|HEALTH DISPARITIES|health disparities
416033|NCT01797055|transferrin|transferrin
416034|NCT01797055|anemia|anemia
416035|NCT01797055|iron overload|iron overload
416036|NCT01797042|Fructose|fructose
416037|NCT01797042|High fructose corn syrup|high fructose corn syrup
416038|NCT01797042|Energy regulation|energy regulation
416039|NCT01797042|Ectopic fat|ectopic fat
416040|NCT01797042|Understanding|understanding
416041|NCT01797042|potential|potential
416042|NCT01797016|Myocardial Infarction|myocardial infarction
416043|NCT01797016|flow cytometry|flow cytometry
416044|NCT01797016|Blood Cell Count|blood cell count
416045|NCT01797016|Platelet Activation|platelet activation
416046|NCT01797003|osteoarthritis|osteoarthritis
416047|NCT01797003|osteotomy|osteotomy
416048|NCT01797003|closing|closing
416049|NCT01797003|opening|opening
416050|NCT01797003|wedge|wedge
416051|NCT01797003|kne|kne
416052|NCT01797003|tibia|tibia
416053|NCT01796990|physical activity|physical activity
416054|NCT01796990|psychological well-being|psychological well-being
416055|NCT01796990|acceptance and commitment therapy|acceptance and commitment therapy
416056|NCT01796990|adults|adults
416057|NCT01796977|Nipple-sparing Mastectomy|nipple-sparing mastectomy
416058|NCT01796977|NSM|nsm
416059|NCT01796977|Nipple Sparing Mastectomy|nipple sparing mastectomy
416060|NCT01796964|Age-Related Macular Degeneration|age-related macular degeneration
416061|NCT01796964|Wet|wet
416062|NCT01796964|Exudative|exudative
416063|NCT01796964|AMD|amd
416064|NCT01796964|Intravitreal injection|intravitreal injection
416065|NCT01796964|Retina|retina
416066|NCT01796938|Lacosamide|lacosamide
416067|NCT01796938|Vimpat|vimpat
416068|NCT01796938|Single Dose|single dose
416069|NCT01796938|Pharmacokinetics|pharmacokinetics
416070|NCT01796938|Renal Impairment|renal impairment
416071|NCT01796925|Apnea|apnea
416072|NCT01796925|Respiration Disorders|respiration disorders
416073|NCT01796925|Signs and Symptoms|signs and symptoms
416074|NCT01796925|Signs and Symptoms, Respiratory|signs and symptoms, respiratory
416075|NCT01796925|Sleep Apnea Syndromes|sleep apnea syndromes
416076|NCT01796925|Sleep Apnea, Obstructive|sleep apnea, obstructive
416077|NCT01796925|Respiratory Tract Diseases|respiratory tract diseases
416078|NCT01796925|Sleep Disorders, Intrinsic|sleep disorders, intrinsic
416079|NCT01796925|Sleep Disorders|sleep disorders
416080|NCT01796925|Nervous System Diseases|nervous system diseases
416081|NCT01796912|Refractory Angina|refractory angina
416082|NCT01796912|Lipoprotein|lipoprotein
416083|NCT01796899|Healthy Volunteers|healthy volunteers
416084|NCT01796899|Brivaracetam|brivaracetam
416085|NCT01796873|Female|female
416086|NCT01796873|Hispanic|hispanic
416087|NCT01796873|Percutaneous Coronary Intervention|percutaneous coronary intervention
416088|NCT01796860|Gait|gait
416089|NCT01796860|AFO|afo
416090|NCT01796860|MS|ms
416091|NCT01796847|ICU|icu
416092|NCT01796847|Hyperglycemia|hyperglycemia
416093|NCT01796847|Length of stay|length of stay
416094|NCT01796834|Mindfulness-Based Stress Reduction|mindfulness-based stress reduction
416095|NCT01796834|Diabetes Management|diabetes management
416096|NCT01796834|Stress Reduction|stress reduction
416097|NCT01796834|Diabetes Testing|diabetes testing
416098|NCT01796821|Condyloma acuminata|condyloma acuminata
416099|NCT01796821|Genital warts|genital warts
416100|NCT01796821|Condylomata acuminata|condylomata acuminata
416101|NCT01796821|Venereal warts|venereal warts
416102|NCT01796808|pedal|pedal
416103|NCT01796808|atrophy|atrophy
416104|NCT01796808|fat grafting|fat grafting
416105|NCT01796808|adipose tissue|adipose tissue
416106|NCT01796795|common wart|common wart
416107|NCT01796795|verruca vulgaris|verruca vulgaris
416108|NCT01796769|Obstructive Sleep Apnea Syndrome|obstructive sleep apnea syndrome
416109|NCT01796769|Telemedicine|telemedicine
416110|NCT01796769|Patient Compliance|patient compliance
416111|NCT01796756|Handover|handover
416112|NCT01796756|Handoff|handoff
416113|NCT01796756|Signout|signout
416114|NCT01796756|Quality Improvement|quality improvement
416115|NCT01796756|General Internal Medicine|general internal medicine
416116|NCT01796743|MRI|mri
416117|NCT01796743|Double Inversion radial fast Spin Echo T2 mapping|double inversion radial fast spin echo t2 mapping
416118|NCT01796743|Heart failure risk stratification|heart failure risk stratification
416119|NCT01796743|30 day post hospitalization outcome|30 day post hospitalization outcome
416120|NCT01796730|efficacy|efficacy
416121|NCT01796730|safety|safety
416122|NCT01796730|Bambuterol tablets|bambuterol tablets
416123|NCT01796730|COPD|copd
416124|NCT01796717|Piperacillin/tazobactam|piperacillin/tazobactam
416125|NCT01796717|MIC|mic
416126|NCT01796704|functional capacity|functional capacity
416127|NCT01796704|NYHA class|nyha class
416128|NCT01796691|Clopidogrel|clopidogrel
416129|NCT01796691|aspirin|aspirin
416130|NCT01796691|low response|low response
416131|NCT01796691|platelet aggregation|platelet aggregation
416132|NCT01796691|Acute Coronary Syndrome|acute coronary syndrome
416133|NCT01796691|Coronary Stent Implantation|coronary stent implantation
416134|NCT01796678|sickle cell disease|sickle cell disease
416135|NCT01796678|vaso-occlusive pain episodes|vaso-occlusive pain episodes
416136|NCT01796678|arginine|arginine
416137|NCT01796678|nitric oxide|nitric oxide
416138|NCT01796652|Acute interstitial pancreatitis|acute interstitial pancreatitis
416139|NCT01796652|Home therapy|home therapy
416443|NCT01795339|Phase 1|phase 1
416140|NCT01796600|distal limbs fracture, acute trauma, imaging, cone beam computed tomography,|distal limbs fracture, acute trauma, imaging, cone beam computed tomography,
416141|NCT01796574|status epilepticus|status epilepticus
416142|NCT01796574|seizure|seizure
416143|NCT01796574|epilepsy|epilepsy
416144|NCT01796574|ketogenic diet|ketogenic diet
416145|NCT01796574|modified Atkins diet|modified atkins diet
416146|NCT01796548|Detrusor function, overactive|detrusor function, overactive
416147|NCT01796548|Urinary incontinence|urinary incontinence
416148|NCT01796548|Oxybutynin|oxybutynin
416149|NCT01796548|Lyrinel|lyrinel
416150|NCT01796509|Quality of life,|quality of life,
416151|NCT01796509|Sequela disorders,|sequela disorders,
416152|NCT01796509|Socio-professional impact,|socio-professional impact,
416153|NCT01796509|Anxiety, depression,|anxiety, depression,
416154|NCT01796509|Post traumatic stress disorder,|post traumatic stress disorder,
416155|NCT01796509|ICU acquired paresis.|icu acquired paresis.
416156|NCT01796496|Low back pain.|low back pain.
416157|NCT01796496|Manipulative therapy techniques.|manipulative therapy techniques.
416158|NCT01796496|Randomized controlled trial.|randomized controlled trial.
416159|NCT01796496|Chronic pain.|chronic pain.
416160|NCT01796483|Parkinson disease|parkinson disease
416161|NCT01796483|STN-DBS|stn-dbs
416162|NCT01796483|Impulsivity|impulsivity
416163|NCT01796483|Akinesia|akinesia
416164|NCT01796483|Noradrenergic|noradrenergic
416165|NCT01796483|system|system
416166|NCT01796470|GS-US-339-0103|gs-us-339-0103
416167|NCT01796470|SYK inhibitor|syk inhibitor
416168|NCT01796470|PI3K inhibitor|pi3k inhibitor
416169|NCT01796470|GS-9973|gs-9973
416170|NCT01796470|GS 9973|gs 9973
416171|NCT01796470|GS-1101|gs-1101
416172|NCT01796470|GS 1101|gs 1101
416173|NCT01796470|Cal-101|cal-101
416174|NCT01796470|Cal 101|cal 101
416175|NCT01796470|idelalisib|idelalisib
416176|NCT01796470|leukemia|leukemia
416177|NCT01796470|lymphoma|lymphoma
416178|NCT01796470|CLL|cll
416179|NCT01796470|MCL|mcl
416180|NCT01796470|DLBCL|dlbcl
416181|NCT01796470|iNHL|inhl
416182|NCT01796470|FL|fl
416183|NCT01796470|MZL|mzl
416184|NCT01796470|LPL|lpl
416185|NCT01796470|SLL|sll
416186|NCT01796470|WM|wm
416187|NCT01796470|Waldenström's macroglobulinemia|waldenström's macroglobulinemia
416188|NCT01796457|Hepatitis B|hepatitis b
416189|NCT01796457|Immunology|immunology
416190|NCT01796457|HBV|hbv
416191|NCT01796457|Immune tolerant|immune tolerant
416192|NCT01796457|Immune active|immune active
416193|NCT01796444|Breast Cancer|breast cancer
416194|NCT01796444|Sentinel Lymph Node Biopsy|sentinel lymph node biopsy
416195|NCT01796444|Axillary Lymph Node Dissection|axillary lymph node dissection
416196|NCT01796392|emphysema|emphysema
416197|NCT01796392|endobronchial valve|endobronchial valve
416198|NCT01796392|treatments|treatments
416199|NCT01796392|pulmonary rehabilitation|pulmonary rehabilitation
416200|NCT01796392|lung volume reduction|lung volume reduction
416201|NCT01796353|heart disease|heart disease
416202|NCT01796353|sexual dysfunction|sexual dysfunction
416203|NCT01796353|exercise test|exercise test
416204|NCT01796353|comprehensive rehabilitation|comprehensive rehabilitation
416205|NCT01796353|complex intervention|complex intervention
416206|NCT01796340|cue exposure|cue exposure
416207|NCT01796340|childhood|childhood
416208|NCT01796340|overeating|overeating
416209|NCT01796340|overweight|overweight
416210|NCT01796340|obese|obese
416211|NCT01796340|treatment|treatment
416212|NCT01796327|dacomitinib|dacomitinib
416213|NCT01796327|PF-00299804|pf-00299804
416214|NCT01796327|pharmacokinetics|pharmacokinetics
416215|NCT01796327|bioavailability|bioavailability
416216|NCT01796314|Therapeutic educational programme for Alzheimer's disease patients and their caregiver|therapeutic educational programme for alzheimer's disease patients and their caregiver
416217|NCT01796314|Alzheimer's disease, mild to moderately severe stages|alzheimer's disease, mild to moderately severe stages
416218|NCT01796314|Community dwelling patients with family caregiver|community dwelling patients with family caregiver
416219|NCT01796314|quality of life|quality of life
416220|NCT01796301|Postmenopausal Osteoporosis|postmenopausal osteoporosis
416221|NCT01796288|NSCLC|nsclc
416222|NCT01796288|oligometastatic|oligometastatic
416223|NCT01796288|second-line|second-line
416224|NCT01796288|Radiotherapy|radiotherapy
416225|NCT01796288|Erlotinib|erlotinib
416226|NCT01796262|ADHD|adhd
416227|NCT01796262|DHA|dha
416228|NCT01796262|neuropsychological task|neuropsychological task
416229|NCT01796262|fNIRS|fnirs
416230|NCT01796262|Docosahexaenoic Acid|docosahexaenoic acid
416231|NCT01796262|n-3 polyunsaturated fatty acid|n-3 polyunsaturated fatty acid
416232|NCT01796262|cognition|cognition
416233|NCT01796262|behavior|behavior
416234|NCT01796249|Analgesia Nociception Index|analgesia nociception index
416235|NCT01796249|ANI|ani
416236|NCT01796236|Bone anchored hearing aid|bone anchored hearing aid
416237|NCT01796236|Bone anchored implant|bone anchored implant
416238|NCT01796236|Abbreviated Profile of Hearing Aid Benefit (APHAB)|abbreviated profile of hearing aid benefit (aphab)
416239|NCT01796236|Health Utility Index (HUI)|health utility index (hui)
416240|NCT01796236|Holgers Index|holgers index
416241|NCT01796236|Implant stability|implant stability
416242|NCT01796223|Community mental health services|community mental health services
416243|NCT01796223|Psychotherapy|psychotherapy
416244|NCT01796223|Physician-Patient Relations|physician-patient relations
416245|NCT01796223|Norway|norway
416246|NCT01796210|Analgesia/nociception index|analgesia/nociception index
416247|NCT01796210|Bispectral index|bispectral index
416248|NCT01796210|Propofol|propofol
416249|NCT01796210|Remifentanil|remifentanil
416250|NCT01796210|Suspension laryngoscopy|suspension laryngoscopy
416251|NCT01796210|Endoscopy|endoscopy
416252|NCT01796210|Ear-nose-throat|ear-nose-throat
416253|NCT01796184|Inflammation|inflammation
416254|NCT01796184|Glycation|glycation
416255|NCT01796184|Continuous glucose monitoring|continuous glucose monitoring
416256|NCT01796184|Adult population|adult population
416257|NCT01796171|Radioimmunotherapy|radioimmunotherapy
416258|NCT01796171|Lu-177|lu-177
416259|NCT01796171|Phase I study|phase i study
416260|NCT01796171|Phase II study|phase ii study
416261|NCT01796171|Betalutin|betalutin
416262|NCT01796158|adolescents|adolescents
416263|NCT01796158|alcohol abuse|alcohol abuse
416264|NCT01796158|drug abuse|drug abuse
416265|NCT01796158|substance use|substance use
416266|NCT01796132|Depression|depression
416267|NCT01796132|Lactation|lactation
416268|NCT01796132|Breastfeeding|breastfeeding
416269|NCT01796132|Pharmacokinetics|pharmacokinetics
416270|NCT01796132|Antidepressant|antidepressant
416271|NCT01796119|Dental implants, Ridge splitting, Ridge expansion|dental implants, ridge splitting, ridge expansion
416272|NCT01796106|caries infiltration|caries infiltration
416273|NCT01796106|caries progression|caries progression
416274|NCT01796106|Icon|icon
416275|NCT01796093|Digoxin|digoxin
416276|NCT01796093|Ivabradine|ivabradine
416277|NCT01796093|Cardiac failure|cardiac failure
416278|NCT01796093|Economics|economics
416279|NCT01796067|Motivational intervention|motivational intervention
416280|NCT01796067|Positive Parenting Intervention|positive parenting intervention
416281|NCT01796067|Obesity|obesity
416282|NCT01796067|Physical Activity|physical activity
416283|NCT01796067|Diet|diet
416284|NCT01796067|African American|african american
416285|NCT01796067|Adolescent|adolescent
416286|NCT01796054|Perceived stress|perceived stress
416287|NCT01796054|Burnout|burnout
416288|NCT01796054|Mindfulness|mindfulness
416289|NCT01796054|Intent to leave nursing|intent to leave nursing
416290|NCT01796028|Prostate Cancer|prostate cancer
416291|NCT01796015|paediatrics|paediatrics
416292|NCT01796015|optic nerve sheath diameter|optic nerve sheath diameter
416293|NCT01796015|ultrasound|ultrasound
416294|NCT01796002|PTCL|ptcl
416295|NCT01795989|Coil|coil
416297|NCT01795989|safety|safety
416298|NCT01795989|efficacy|efficacy
416299|NCT01795989|musculoskeletal imaging|musculoskeletal imaging
416300|NCT01795989|Cincinnati|cincinnati
416301|NCT01795989|Safety and efficacy of a new elbow coil on pediatric patients and healthy participants|safety and efficacy of a new elbow coil on pediatric patients and healthy participants
416302|NCT01795976|Oesophageal cancer|oesophageal cancer
416303|NCT01795963|intimate partner violence|intimate partner violence
416304|NCT01795950|cell therapy|cell therapy
416305|NCT01795950|Pulmonary arterial hypertension|pulmonary arterial hypertension
416306|NCT01795898|Osteoarthritis|osteoarthritis
416307|NCT01795898|Low back pain|low back pain
416308|NCT01795898|Fentanyl transdermal patch|fentanyl transdermal patch
416309|NCT01795898|Durogesic-D-Trans|durogesic-d-trans
416310|NCT01795885|Pregnancy in Adolescence|pregnancy in adolescence
416311|NCT01795885|Contraception|contraception
416312|NCT01795859|Huntington disease|huntington disease
416313|NCT01795859|Chorea|chorea
416314|NCT01795859|Tetrabenazine|tetrabenazine
416315|NCT01795846|allergen specific immunotherapy, house dust mite (Der p), monosensitization, polysensitization, allergic rhinitis, asthma,|allergen specific immunotherapy, house dust mite (der p), monosensitization, polysensitization, allergic rhinitis, asthma,
416316|NCT01795833|Prediabetes|prediabetes
416317|NCT01795833|Prediabetic State|prediabetic state
416318|NCT01795820|ticagrelor|ticagrelor
416319|NCT01795820|clopidogrel|clopidogrel
416320|NCT01795820|platelet aggregation|platelet aggregation
416321|NCT01795781|Anticoagulant measurement|anticoagulant measurement
416322|NCT01795781|Anticoagulant reversal|anticoagulant reversal
416323|NCT01795781|Dabigatran|dabigatran
416324|NCT01795781|Rivaroxaban|rivaroxaban
416325|NCT01795768|Non randomised|non randomised
416326|NCT01795768|Open label|open label
416327|NCT01795768|Multicentre|multicentre
416328|NCT01795768|Phase II biomarker study|phase ii biomarker study
416329|NCT01795755|Horse Assisted Therapy (HAT)|horse assisted therapy (hat)
416330|NCT01795755|Equine Assisted Psychotherapy (EAP)|equine assisted psychotherapy (eap)
416331|NCT01795755|clinical trial|clinical trial
416332|NCT01795755|Randomised Controlled Trial (RCT)|randomised controlled trial (rct)
416333|NCT01795755|psychotherapy|psychotherapy
416334|NCT01795742|Asthma|asthma
416335|NCT01795742|Nebulizers|nebulizers
416336|NCT01795742|Salbutamol|salbutamol
416337|NCT01795742|Developing Countries|developing countries
416338|NCT01795729|Heart transplant|heart transplant
416542|NCT01794845|SCCHN|scchn
416339|NCT01795729|Coronary artery disease|coronary artery disease
416340|NCT01795729|Allograft vascular disease|allograft vascular disease
416341|NCT01795729|Coronary stent|coronary stent
416342|NCT01795729|Optimal medical therapy|optimal medical therapy
416343|NCT01795729|Prognosis|prognosis
416344|NCT01795703|Prostate Cancer|prostate cancer
416345|NCT01795703|Abiraterone Acetate|abiraterone acetate
416346|NCT01795703|JNJ-212082|jnj-212082
416347|NCT01795690|Anemia|anemia
416348|NCT01795690|Cancer|cancer
416349|NCT01795690|Hemoglobin|hemoglobin
416350|NCT01795690|Quality of Life|quality of life
416351|NCT01795690|FACT-An|fact-an
416352|NCT01795690|FACT-GP|fact-gp
416353|NCT01795690|Erythropoiesis-Stimulating Agents (ESA)|erythropoiesis-stimulating agents (esa)
416354|NCT01795690|Epoetin|epoetin
416355|NCT01795690|Ferric Carboxymaltose|ferric carboxymaltose
416356|NCT01795690|Blood Transfusions|blood transfusions
416357|NCT01795677|JAK2 inhibitor RUXOLITINIB|jak2 inhibitor ruxolitinib
416358|NCT01795677|Primary or secondary myelofibrosis|primary or secondary myelofibrosis
416359|NCT01795664|Asthma|asthma
416360|NCT01795664|Salmeterol xinafoate and Fluticasone propionate|salmeterol xinafoate and fluticasone propionate
416361|NCT01795664|Seretide Evohaler|seretide evohaler
416362|NCT01795664|Functional Respiratory Imaging|functional respiratory imaging
416363|NCT01795664|Computational Fluid Dynamic|computational fluid dynamic
416364|NCT01795651|teaching|teaching
416365|NCT01795651|knowledge translation|knowledge translation
416366|NCT01795651|ICU|icu
416367|NCT01795651|postgraduate|postgraduate
416368|NCT01795651|lecture|lecture
416369|NCT01795638|anthropometrics|anthropometrics
416370|NCT01795638|weight|weight
416371|NCT01795638|nutrition|nutrition
416372|NCT01795586|breast - female|breast - female
416373|NCT01795586|advanced breast cancer|advanced breast cancer
416374|NCT01795586|histologically confirmed|histologically confirmed
416375|NCT01795586|cytologically confirmed|cytologically confirmed
416376|NCT01795586|metastatic|metastatic
416377|NCT01795586|locally advanced|locally advanced
416378|NCT01795586|unresectable|unresectable
416379|NCT01795573|GVHD|gvhd
416380|NCT01795573|AML|aml
416381|NCT01795573|ALL|all
416382|NCT01795573|MDS|mds
416383|NCT01795573|CLL|cll
416384|NCT01795573|NHL|nhl
416385|NCT01795573|HL|hl
416386|NCT01795573|MM|mm
416387|NCT01795560|Periappendicular abscess|periappendicular abscess
416388|NCT01795560|Ultrasound|ultrasound
416389|NCT01795521|NSCLC, SBRT, PET, Medically Inoperable|nsclc, sbrt, pet, medically inoperable
416390|NCT01795508|Parent training|parent training
416391|NCT01795508|Child behavior|child behavior
416392|NCT01795508|Randomized Controlled Trials|randomized controlled trials
416393|NCT01795495|Spinal Fusion|spinal fusion
416394|NCT01795495|Scoliosis|scoliosis
416395|NCT01795495|Methadone|methadone
416396|NCT01795495|Magnesium|magnesium
416397|NCT01795495|Adolescents|adolescents
416398|NCT01795495|Back Surgery|back surgery
416399|NCT01795482|perioperative hypothermia|perioperative hypothermia
416400|NCT01795482|prewarming|prewarming
416401|NCT01795482|preoperative warming|preoperative warming
416402|NCT01795482|general anaesthesia|general anaesthesia
416403|NCT01795482|epidural anaesthesia|epidural anaesthesia
416404|NCT01795482|temperature measurement|temperature measurement
416405|NCT01795469|POTS|pots
416406|NCT01795469|Orthostatic|orthostatic
416407|NCT01795469|Adolescent|adolescent
416408|NCT01795456|Takayasu's arteritis|takayasu's arteritis
416409|NCT01795456|Giant Cell arteritis|giant cell arteritis
416410|NCT01795456|Arteritis|arteritis
416411|NCT01795456|Vasculitis|vasculitis
416412|NCT01795456|Aortitis|aortitis
416413|NCT01795456|Disease Activity|disease activity
416414|NCT01795456|Carotidynia|carotidynia
416415|NCT01795456|Neovascularization|neovascularization
416416|NCT01795456|Carotid Intima Media Thickness|carotid intima media thickness
416417|NCT01795443|vibration|vibration
416418|NCT01795443|proprioception|proprioception
416419|NCT01795417|wrinkles|wrinkles
416420|NCT01795417|rhytids|rhytids
416421|NCT01795417|periorbital|periorbital
416422|NCT01795404|IBSR|ibsr
416423|NCT01795404|Cancer Survivors|cancer survivors
416424|NCT01795404|Katie Byron|katie byron
416425|NCT01795404|Quality of Life|quality of life
416426|NCT01795404|Stress|stress
416427|NCT01795404|Stress reduction|stress reduction
416428|NCT01795391|Prevention|prevention
416429|NCT01795391|Dressings|dressings
416430|NCT01795391|Catheters|catheters
416431|NCT01795378|acute myelogenous leukemia|acute myelogenous leukemia
416432|NCT01795378|acute lymphoblastic leukemia|acute lymphoblastic leukemia
416433|NCT01795378|donor natural killer cells|donor natural killer cells
416434|NCT01795378|HLA-haploidentical hematopoietic cell transplantation|hla-haploidentical hematopoietic cell transplantation
416435|NCT01795352|EGFR,|egfr,
416436|NCT01795352|lung cancer,|lung cancer,
416437|NCT01795352|mutated|mutated
416438|NCT01795339|AZD3293|azd3293
416439|NCT01795339|Healthy volunteers|healthy volunteers
416440|NCT01795339|Elderly volunteers|elderly volunteers
416441|NCT01795339|Alzheimer's Disease patients|alzheimer's disease patients
416442|NCT01795339|AD patients|ad patients
416444|NCT01795339|Multiple Ascending Dose Study|multiple ascending dose study
416445|NCT01795326|Effectiveness of risk minimization|effectiveness of risk minimization
416446|NCT01795326|Metabolic monitoring|metabolic monitoring
416447|NCT01795326|Seroquel®|seroquel®
416448|NCT01795326|Seroquel® XR/quetiapine fumarate|seroquel® xr/quetiapine fumarate
416449|NCT01795287|tibial fracture|tibial fracture
416450|NCT01795287|intramedullary nailing|intramedullary nailing
416451|NCT01795287|spinal anesthesia|spinal anesthesia
416452|NCT01795287|patient safety|patient safety
416454|NCT01795248|gestational diabetes mellitus|gestational diabetes mellitus
416455|NCT01795248|incretin|incretin
416456|NCT01795248|glucose homeostasis|glucose homeostasis
416457|NCT01795248|GLP-1|glp-1
416458|NCT01795248|type 2 diabetes mellitus|type 2 diabetes mellitus
416459|NCT01795248|liraglutide|liraglutide
416460|NCT01795248|Victoza|victoza
416461|NCT01795235|men|men
416462|NCT01795222|conscious sedation|conscious sedation
416463|NCT01795222|stress psychological|stress psychological
416464|NCT01795222|dental care for children|dental care for children
416465|NCT01795222|child behavior|child behavior
416466|NCT01795222|saliva|saliva
416467|NCT01795209|Branch retinal vein occlusion|branch retinal vein occlusion
416468|NCT01795209|Macular edema|macular edema
416469|NCT01795209|Ranibizumab|ranibizumab
416470|NCT01795196|pediatric extubation failure|pediatric extubation failure
416471|NCT01795196|weaning|weaning
416472|NCT01795196|integrated pulmonary index|integrated pulmonary index
416473|NCT01795196|mechanical ventilation|mechanical ventilation
416474|NCT01795196|extubation readiness|extubation readiness
416475|NCT01795196|respiratory monitoring tool|respiratory monitoring tool
416476|NCT01795196|Endotracheal Extubation|endotracheal extubation
416477|NCT01795196|Pediatric Intensive Care Unit|pediatric intensive care unit
416478|NCT01795196|Rapid Shallow Breathing Index|rapid shallow breathing index
416479|NCT01795196|Physiologic Deadspace|physiologic deadspace
416480|NCT01795170|Pyridoxine Dependant Epilepsy|pyridoxine dependant epilepsy
416481|NCT01795170|Antiquitin Deficiency|antiquitin deficiency
416482|NCT01795170|Lysine Restricted Diet|lysine restricted diet
416483|NCT01795157|decision support systems, clinical|decision support systems, clinical
416484|NCT01795157|decision making, computer assisted|decision making, computer assisted
416485|NCT01795157|evidence based practice|evidence based practice
416486|NCT01795157|practice guidelines as topic|practice guidelines as topic
416487|NCT01795131|Nutritional anemia|nutritional anemia
416488|NCT01795131|Vitamin B12|vitamin b12
416489|NCT01795131|flu vaccine|flu vaccine
532406|NCT01296516|GDM|gdm
416490|NCT01795131|immunity|immunity
416491|NCT01795092|Cellulitis|cellulitis
416492|NCT01795092|Outpatient Medicine|outpatient medicine
416493|NCT01795079|transcranial stimulation|transcranial stimulation
416494|NCT01795079|direct current|direct current
416495|NCT01795053|ADHD preschoolers|adhd preschoolers
416496|NCT01795053|playtraining|playtraining
416497|NCT01795053|child-focused intervention|child-focused intervention
416498|NCT01795040|omega-3/omega-6 fatty acids|omega-3/omega-6 fatty acids
416499|NCT01795040|Pre-school children with ADHD symptoms|pre-school children with adhd symptoms
416500|NCT01795040|randomized controlled trial|randomized controlled trial
416501|NCT01795027|gastric cancer|gastric cancer
416502|NCT01795027|chemotherapy|chemotherapy
416503|NCT01795027|D2 resection|d2 resection
416504|NCT01795027|S-1|s-1
416505|NCT01795001|pathophysiology|pathophysiology
416506|NCT01794988|Acute Pain|acute pain
416507|NCT01794988|Low Back Pain|low back pain
416508|NCT01794988|Back Pain|back pain
416509|NCT01794988|Functional Magnetic Resonance Imaging (fMRI)|functional magnetic resonance imaging (fmri)
416510|NCT01794988|Cognitive Behavioral Therapy|cognitive behavioral therapy
416511|NCT01794988|Pain Education|pain education
416512|NCT01794975|PET|pet
416513|NCT01794975|striatum|striatum
416514|NCT01794975|receptor occupancy|receptor occupancy
416515|NCT01794975|noradrenaline|noradrenaline
416516|NCT01794975|alpha2c|alpha2c
416517|NCT01794962|Classification|classification
416518|NCT01794962|LBP|lbp
416519|NCT01794962|Cognitive functional therapy|cognitive functional therapy
416520|NCT01794962|Manual Therapy|manual therapy
416521|NCT01794949|Angioplasty|angioplasty
416522|NCT01794949|Atherosclerosis|atherosclerosis
416523|NCT01794949|Wound Healing|wound healing
416524|NCT01794936|Prostate cancer|prostate cancer
416525|NCT01794936|Nerve Sparing Prostatectomy|nerve sparing prostatectomy
416526|NCT01794936|VTI Probe|vti probe
416527|NCT01794923|Delayed onset muscle soreness|delayed onset muscle soreness
416528|NCT01794923|ibuprofen|ibuprofen
416529|NCT01794923|topical|topical
416530|NCT01794910|Pregnancy|pregnancy
416531|NCT01794910|Pelvic Floor|pelvic floor
416532|NCT01794910|Muscle strength|muscle strength
416533|NCT01794910|Exercise therapy|exercise therapy
416534|NCT01794910|natural childbirth|natural childbirth
416535|NCT01794910|cesarean section|cesarean section
416536|NCT01794910|physiotherapy|physiotherapy
416537|NCT01794884|Glutamine|glutamine
416538|NCT01794884|Cardiosurgery|cardiosurgery
416539|NCT01794884|Cardiopulmonary bypass|cardiopulmonary bypass
416540|NCT01794884|Cardiac function|cardiac function
416541|NCT01794884|Recovery|recovery
416543|NCT01794845|Head and Neck Cancer|head and neck cancer
416544|NCT01794845|Squamous Cell Carcinoma|squamous cell carcinoma
416545|NCT01794845|Recurrent|recurrent
416546|NCT01794832|HRQoL|hrqol
416547|NCT01794832|Aortic stenosis|aortic stenosis
416548|NCT01794832|Aortic valve surgery|aortic valve surgery
416549|NCT01794819|antibiotics|antibiotics
416550|NCT01794819|primary care|primary care
416551|NCT01794819|radiology/radiography|radiology/radiography
416552|NCT01794819|respiratory tract infections|respiratory tract infections
416553|NCT01794793|SOM230,|som230,
416554|NCT01794793|roll-over study|roll-over study
416555|NCT01794793|pasireotide LAR|pasireotide lar
416556|NCT01794793|Cushing's disease|cushing's disease
416557|NCT01794793|Acromegaly|acromegaly
416558|NCT01794793|neuroendocrine tumorsNETs|neuroendocrine tumorsnets
416559|NCT01794793|pituitary tumors|pituitary tumors
416560|NCT01794793|Ectopic ACTH secreting|ectopic acth secreting
416561|NCT01794793|EAS|eas
416562|NCT01794793|Dumping Syndrome|dumping syndrome
416563|NCT01794793|metastatic prostate cancer, metastatic melanoma|metastatic prostate cancer, metastatic melanoma
416564|NCT01794793|bRAF|braf
416565|NCT01794793|nRAS|nras
416566|NCT01794780|COPD|copd
416567|NCT01794780|Chronic obstructive pulmonary disease (COPD),|chronic obstructive pulmonary disease (copd),
416568|NCT01794780|Chronic obstructive lung disease (COLD),|chronic obstructive lung disease (cold),
416569|NCT01794780|Chronic obstructive airway disease (COAD),|chronic obstructive airway disease (coad),
416570|NCT01794780|Cronchitis,|cronchitis,
416571|NCT01794780|Emphysema|emphysema
416572|NCT01794767|peripheral venous catheter, children.|peripheral venous catheter, children.
416573|NCT01794754|Hand osteoarthritis|hand osteoarthritis
416574|NCT01794754|CMC1-joint|cmc1-joint
416575|NCT01794754|surgery|surgery
416576|NCT01794754|occupational therapy|occupational therapy
416577|NCT01794754|hand exercises|hand exercises
416578|NCT01794754|assistive devices|assistive devices
416579|NCT01794754|orthoses|orthoses
416580|NCT01794728|Pain Management|pain management
416581|NCT01794715|Heart failure|heart failure
416582|NCT01794715|Nurse led|nurse led
416583|NCT01794715|Outpatient clinic|outpatient clinic
416584|NCT01794715|Echocardiography|echocardiography
416585|NCT01794715|Pocket-size|pocket-size
416586|NCT01794715|Ultrasound|ultrasound
416587|NCT01794702|Leukemia|leukemia
416588|NCT01794702|Acute Leukemia|acute leukemia
532527|NCT01295931|NIR|nir
416589|NCT01794702|Acute myelogenous leukemia|acute myelogenous leukemia
416590|NCT01794702|AML|aml
416591|NCT01794702|Acute lymphoblastic leukemia|acute lymphoblastic leukemia
416592|NCT01794702|ALL|all
416593|NCT01794702|Maximum Tolerated Dose|maximum tolerated dose
416594|NCT01794702|MTD|mtd
416595|NCT01794702|Response Rate|response rate
416596|NCT01794702|Decitabine|decitabine
416597|NCT01794702|Dacogen|dacogen
416598|NCT01794702|Idarubicin|idarubicin
416599|NCT01794702|Idamycin|idamycin
416600|NCT01794702|Cytarabine|cytarabine
416601|NCT01794702|Ara-C|ara-c
416602|NCT01794702|Cytosar|cytosar
416603|NCT01794702|DepoCyt|depocyt
416604|NCT01794702|Cytosine Arabinosine Hydrochloride|cytosine arabinosine hydrochloride
416605|NCT01794676|Pancreatic cancer|pancreatic cancer
416606|NCT01794676|Thymic cancer|thymic cancer
416607|NCT01794676|Parathyroid disease|parathyroid disease
416608|NCT01794676|MEN1 syndrome|men1 syndrome
416609|NCT01794676|Genomic DNA|genomic dna
416610|NCT01794676|MEN1 gene sequence|men1 gene sequence
416611|NCT01794663|Early kidney graft dysfunction|early kidney graft dysfunction
416612|NCT01794663|renal transplantation|renal transplantation
416613|NCT01794650|T1DM, Exercise, Hypoglycaemia|t1dm, exercise, hypoglycaemia
416614|NCT01794637|End stage liver disease|end stage liver disease
416615|NCT01794637|Peripheral microcirculatory dysfunction|peripheral microcirculatory dysfunction
416616|NCT01794637|Liver transplantation|liver transplantation
416617|NCT01794637|Near infrared spectroscopy|near infrared spectroscopy
416618|NCT01794624|TMD|tmd
416619|NCT01794624|TMJD|tmjd
416620|NCT01794624|Temporomandibular Joint Disorders|temporomandibular joint disorders
416621|NCT01794624|Sleep Continuity Disturbance|sleep continuity disturbance
416622|NCT01794624|Pain Catastrophizing|pain catastrophizing
416623|NCT01794624|Cognitive Therapy|cognitive therapy
416624|NCT01794624|Behavioral Therapy|behavioral therapy
416625|NCT01794598|Heart failure|heart failure
416626|NCT01794598|depression|depression
416627|NCT01794598|depression care education|depression care education
416628|NCT01794585|traumatic brain injury|traumatic brain injury
416629|NCT01794585|balance deficits|balance deficits
416630|NCT01794585|virtual reality|virtual reality
416631|NCT01794585|home-based therapy|home-based therapy
416632|NCT01794572|Multiple Myeloma|multiple myeloma
416633|NCT01794572|Relapse|relapse
416634|NCT01794572|Complete Remission|complete remission
416635|NCT01794572|Very Good Partial Remission|very good partial remission
416636|NCT01794559|Depression, EEG, QEEG, mTBI, PTSD, efficiency, safety, suicidality|depression, eeg, qeeg, mtbi, ptsd, efficiency, safety, suicidality
416637|NCT01794546|pediatric obesity|pediatric obesity
416638|NCT01794546|telehealth|telehealth
416639|NCT01794533|Irreversible Pulpitis|irreversible pulpitis
416640|NCT01794533|Infiltration injection|infiltration injection
416641|NCT01794533|Fentanyl|fentanyl
416642|NCT01794533|Lidocaine|lidocaine
416643|NCT01794520|relapsed multiple myeloma|relapsed multiple myeloma
416644|NCT01794520|refractory multiple myeloma|refractory multiple myeloma
416645|NCT01794520|multiple myeloma|multiple myeloma
416646|NCT01794520|relapsed/refractory multiple myeloma|relapsed/refractory multiple myeloma
416647|NCT01794507|relapsed/refractory multiple myeloma|relapsed/refractory multiple myeloma
416648|NCT01794507|relapsed multiple myeloma|relapsed multiple myeloma
416649|NCT01794507|refractory multiple myeloma|refractory multiple myeloma
416650|NCT01794507|multiple myeloma|multiple myeloma
416651|NCT01794494|Peripheal arterial disease|peripheal arterial disease
416652|NCT01794494|Critical limb ischemia|critical limb ischemia
416653|NCT01794494|Bypass surgery|bypass surgery
416654|NCT01794494|Subintimal angioplasty|subintimal angioplasty
416655|NCT01794494|Health related cost|health related cost
416656|NCT01794468|Dermal blood flow|dermal blood flow
416657|NCT01794468|critically ill|critically ill
416658|NCT01794455|Depression|depression
416659|NCT01794455|Depressive Disorder|depressive disorder
416660|NCT01794455|Geriatrics|geriatrics
416661|NCT01794455|Hypertension|hypertension
416662|NCT01794429|Obesity|obesity
416663|NCT01794429|The Metabolic Syndrome/disturbances|the metabolic syndrome/disturbances
416664|NCT01794429|Drug-induced adipositas|drug-induced adipositas
416665|NCT01794429|Schizophrenia|schizophrenia
416666|NCT01794429|GLP-1 analogue|glp-1 analogue
416667|NCT01794429|cerebral effects|cerebral effects
416668|NCT01794403|Prostate Cancer|prostate cancer
416669|NCT01794403|Prostate|prostate
416670|NCT01794403|Radiation Therapy|radiation therapy
416671|NCT01794403|Hypofractionation Radiotherapy|hypofractionation radiotherapy
416672|NCT01794403|Extended Hypofractionation Radiotherapy|extended hypofractionation radiotherapy
416673|NCT01794403|Accelerated Hypofractionation Radiotherapy|accelerated hypofractionation radiotherapy
416674|NCT01794403|AHRT|ahrt
416675|NCT01794403|EHRT|ehrt
416676|NCT01794390|COPD (Chronic Obstructive Pulmonary Disease)|copd (chronic obstructive pulmonary disease)
416677|NCT01794390|Asthma|asthma
416678|NCT01794390|Pulmojet|pulmojet
416679|NCT01794390|Inhalers|inhalers
416680|NCT01794390|Respiratory|respiratory
416681|NCT01794390|Inhaler Technique|inhaler technique
416682|NCT01794390|Critical Errors|critical errors
416683|NCT01794377|Obesity|obesity
416684|NCT01794364|T2DM|t2dm
416685|NCT01794364|Diabetes Mellitus Type 2|diabetes mellitus type 2
416686|NCT01794325|Occupational radiation exposure|occupational radiation exposure
416687|NCT01794325|Transradial approach|transradial approach
416688|NCT01794325|Transfemoral approach|transfemoral approach
416689|NCT01794299|Haploidentical stem cell transplantation|haploidentical stem cell transplantation
416690|NCT01794299|Graft-versus-host disease|graft-versus-host disease
416691|NCT01794299|Immune reconstitution|immune reconstitution
416692|NCT01794299|Alloreactive T-cells|alloreactive t-cells
416693|NCT01794299|Photodepletion|photodepletion
416694|NCT01794299|Photodynamic treatment|photodynamic treatment
416695|NCT01794299|TH9402|th9402
416696|NCT01794299|Transplant-related mortality|transplant-related mortality
416697|NCT01794299|Hematologic malignancy|hematologic malignancy
416698|NCT01794273|Ephedrine|ephedrine
416699|NCT01794273|Phenylephrine|phenylephrine
416700|NCT01794273|Vasopressor|vasopressor
416701|NCT01794273|Carotid surgery|carotid surgery
416702|NCT01794273|Hypotension|hypotension
416703|NCT01794273|Haemodynamics|haemodynamics
416704|NCT01794273|Brain ischemia|brain ischemia
416705|NCT01794273|Tissue perfusion|tissue perfusion
416706|NCT01794273|Stroke|stroke
416707|NCT01794273|anaesthesia|anaesthesia
416708|NCT01794260|Osteoarthritis|osteoarthritis
416709|NCT01794260|Moderate ot severe pain|moderate ot severe pain
416710|NCT01794260|ZINGIBER CASSUMUNAR ROXB|zingiber cassumunar roxb
416711|NCT01794221|circumcision|circumcision
416712|NCT01794221|2 octyl cyanoacrylate|2 octyl cyanoacrylate
416713|NCT01794221|phimosis|phimosis
416714|NCT01794208|in-vitro fertilization|in-vitro fertilization
416715|NCT01794208|reproductive disorder|reproductive disorder
416716|NCT01794195|Parkinson's disease|parkinson's disease
416717|NCT01794195|Apathy|apathy
416718|NCT01794195|diffusion tensor imaging|diffusion tensor imaging
416719|NCT01794195|tractography|tractography
416720|NCT01794156|Inference-based therapy|inference-based therapy
416721|NCT01794156|Cognitive behavior therapy|cognitive behavior therapy
416722|NCT01794156|Obsessive compulsive disorder|obsessive compulsive disorder
416723|NCT01794156|Randomized clinical trial|randomized clinical trial
416724|NCT01794143|Treatment of Type 2 diabetes|treatment of type 2 diabetes
416725|NCT01794143|Comparative effectiveness research|comparative effectiveness research
416726|NCT01794143|Clinical trial|clinical trial
416727|NCT01794143|Patient-centered outcomes|patient-centered outcomes
416728|NCT01794117|Anakinra|anakinra
416729|NCT01794117|Pustular Psoriasis|pustular psoriasis
416730|NCT01794117|Palmoplantar Pustulosis|palmoplantar pustulosis
416731|NCT01794117|DITRA|ditra
416732|NCT01794117|Subcorneal Pustular Dermatosis|subcorneal pustular dermatosis
416733|NCT01794104|Topoisomerase Inhibitor|topoisomerase inhibitor
416734|NCT01794104|Advanced Malignancies|advanced malignancies
416735|NCT01794104|Pharmacodynamics|pharmacodynamics
416736|NCT01794104|DNA Damage|dna damage
416737|NCT01794104|Pharmacokinetics|pharmacokinetics
416738|NCT01794091|Cardiac Magnetic Resonance Imaging|cardiac magnetic resonance imaging
416739|NCT01794091|Diabetes|diabetes
416740|NCT01794078|Acute Mountain Sickness|acute mountain sickness
416741|NCT01794078|High altitude induced fatigue|high altitude induced fatigue
416742|NCT01794026|diffusion weighted|diffusion weighted
416743|NCT01794026|magnetic resonance imaging|magnetic resonance imaging
416744|NCT01794026|surgery|surgery
416745|NCT01794026|histopathology|histopathology
416746|NCT01794013|Parent training|parent training
416747|NCT01794013|DIR/ Floortime Approach|dir/ floortime approach
416748|NCT01794013|Children with developmental disabilities|children with developmental disabilities
416749|NCT01793987|blood loss between two groups|blood loss between two groups
416750|NCT01793974|LADA|lada
416751|NCT01793974|Latent Autoimmune Diabetes in Adults|latent autoimmune diabetes in adults
416752|NCT01793974|Latent Autoimmune Diabetes|latent autoimmune diabetes
416753|NCT01793974|Latent Diabetes in Adults|latent diabetes in adults
416754|NCT01793935|Schizophrenia|schizophrenia
416755|NCT01793935|Sensoril|sensoril
416756|NCT01793935|Withania Somnifera extract|withania somnifera extract
416757|NCT01793935|Total/ Positive / Negative Symptoms|total/ positive / negative symptoms
416758|NCT01793935|Stress|stress
416759|NCT01793935|Inflammation|inflammation
416760|NCT01793935|Immunomodulation|immunomodulation
416761|NCT01793909|Type 2 Diabetes|type 2 diabetes
416762|NCT01793909|Exercise Impairment|exercise impairment
416763|NCT01793909|Blood Flow|blood flow
416764|NCT01793909|Muscle Oxygen Uptake|muscle oxygen uptake
416765|NCT01793909|Exercise Training|exercise training
416766|NCT01793896|Metabolic syndrome|metabolic syndrome
416767|NCT01793896|Ageing|ageing
416768|NCT01793896|Mitochondrial density|mitochondrial density
416769|NCT01793896|Oxidative damage|oxidative damage
416770|NCT01793896|Inflammatory mediators|inflammatory mediators
416771|NCT01793896|AMPK|ampk
416772|NCT01793896|Adipogenesis|adipogenesis
416773|NCT01793883|Influenza Laninamivir Octanoate|influenza laninamivir octanoate
416774|NCT01793870|pharmacokinetic|pharmacokinetic
416775|NCT01793870|carvedilol|carvedilol
416776|NCT01793870|Stable isotope technique|stable isotope technique
416777|NCT01793857|Primary caregiver|primary caregiver
416778|NCT01793857|Survey|survey
416779|NCT01793857|Acute Otitis Media|acute otitis media
416780|NCT01793857|Ear infection|ear infection
416781|NCT01793857|Panama|panama
416782|NCT01793857|Healthcare seeking behaviour|healthcare seeking behaviour
416783|NCT01793844|diffuse large B cell lymphoma|diffuse large b cell lymphoma
416784|NCT01793844|DFS|dfs
416785|NCT01793844|OS|os
416786|NCT01793831|Crohn's diseases|crohn's diseases
416787|NCT01793831|Inflammatory bowel disease|inflammatory bowel disease
416788|NCT01793831|Fecal transplantation|fecal transplantation
416789|NCT01793831|Fecal bacteriotherapy|fecal bacteriotherapy
416790|NCT01793831|Fecal microbiota transplantation|fecal microbiota transplantation
416791|NCT01793818|Vaccine|vaccine
416792|NCT01793818|HIV-1|hiv-1
416793|NCT01793818|Tat|tat
416794|NCT01793792|intracranial, saccular, aneurysms, stenting, coiling|intracranial, saccular, aneurysms, stenting, coiling
416795|NCT01793740|sickle cell disease|sickle cell disease
416796|NCT01793740|pediatric|pediatric
416797|NCT01793740|learning disability|learning disability
416798|NCT01793740|cognitive impairment|cognitive impairment
416799|NCT01793740|memory|memory
416800|NCT01793740|attention|attention
416801|NCT01793740|Children with sickle cell disease|children with sickle cell disease
416802|NCT01793727|infants|infants
416803|NCT01793727|general anesthesia|general anesthesia
416804|NCT01793727|tracheal intubation|tracheal intubation
416805|NCT01793714|Magnetic Resonance Imaging|magnetic resonance imaging
416806|NCT01793701|Cervical Cancer, Intensity-modulated radiotherapy|cervical cancer, intensity-modulated radiotherapy
416807|NCT01793688|UNASYN-S|unasyn-s
416808|NCT01793688|High Dose|high dose
416809|NCT01793662|Aortobifemoral bypass|aortobifemoral bypass
416810|NCT01793662|Laparoscopic aortic surgery|laparoscopic aortic surgery
416811|NCT01793662|Aortoiliac occlusive disease|aortoiliac occlusive disease
416812|NCT01793662|TASC Type D Lesions|tasc type d lesions
416813|NCT01793662|Open aortic surgery|open aortic surgery
416814|NCT01793649|Respiratory health|respiratory health
416815|NCT01793649|Cystic Fibrosis|cystic fibrosis
416816|NCT01793649|Chronic Obstructive Pulmonary Disease|chronic obstructive pulmonary disease
416817|NCT01793623|atrial fibrillation|atrial fibrillation
416818|NCT01793623|genetics|genetics
416819|NCT01793623|cardiac arrhythmias|cardiac arrhythmias
416820|NCT01793623|heart disease|heart disease
416821|NCT01793610|MDMA|mdma
416822|NCT01793610|Posttraumatic stress disorder|posttraumatic stress disorder
416823|NCT01793610|sleep|sleep
416824|NCT01793610|Depression|depression
416825|NCT01793610|Safety|safety
416826|NCT01793597|ticagrelor|ticagrelor
416827|NCT01793597|Coronary artery bypass surgery|coronary artery bypass surgery
416828|NCT01793597|platelet function|platelet function
416829|NCT01793597|receptor binding|receptor binding
416830|NCT01793597|platelet reactivity|platelet reactivity
416831|NCT01793597|reversible binding|reversible binding
416832|NCT01793584|Comparative effectiveness|comparative effectiveness
416833|NCT01793584|Surgical success|surgical success
416834|NCT01793571|Abdominal Muscles/Ultrasonography|abdominal muscles/ultrasonography
416835|NCT01793571|Adult|adult
416836|NCT01793571|Ambulatory Surgical Procedures|ambulatory surgical procedures
416837|NCT01793571|Anesthetics, Local/Administration & Dosage|anesthetics, local/administration & dosage
416838|NCT01793571|Levobupivacaine/Administration & Dosage|levobupivacaine/administration & dosage
416839|NCT01793571|Levobupivacaine/Analogs & Derivatives|levobupivacaine/analogs & derivatives
416840|NCT01793571|Hernia, Inguinal/Surgery|hernia, inguinal/surgery
416841|NCT01793571|Humans|humans
416842|NCT01793571|Nerve Block/Methods|nerve block/methods
416843|NCT01793571|Pain Measurement/Methods|pain measurement/methods
416844|NCT01793571|Pain, Postoperative/Prevention & Control|pain, postoperative/prevention & control
416845|NCT01793571|Ultrasonography, Interventional|ultrasonography, interventional
416846|NCT01793558|Thermoregulation Impairment|thermoregulation impairment
416847|NCT01793558|hypothermia|hypothermia
416848|NCT01793558|Postoperative shivering|postoperative shivering
416849|NCT01793558|cesarean section|cesarean section
416850|NCT01793558|newborn|newborn
416851|NCT01793545|Endometrial Cancer|endometrial cancer
416852|NCT01793545|Gynecological Cancers|gynecological cancers
416853|NCT01793545|Screening|screening
416854|NCT01793532|PET Imaging|pet imaging
416855|NCT01793532|Epilepsy|epilepsy
416856|NCT01793532|Inflammation|inflammation
416857|NCT01793532|Brain Imaging|brain imaging
416858|NCT01793519|Rheumatoid Arthritis|rheumatoid arthritis
416859|NCT01793519|Autoimmune Diseases|autoimmune diseases
416860|NCT01793519|Anti-TNF|anti-tnf
416861|NCT01793506|immunodeficiency|immunodeficiency
416862|NCT01793493|Mild Cognitive Impairment|mild cognitive impairment
416863|NCT01793493|Cognitive Stimulation|cognitive stimulation
416864|NCT01793493|Aging|aging
416865|NCT01793493|Elderly|elderly
416866|NCT01793493|Randomized Controlled Trial|randomized controlled trial
416867|NCT01793480|Methadone in cancer pain|methadone in cancer pain
710613|NCT00588575|Barrett's Esophagus|barrett's esophagus
416868|NCT01793428|adults admitted in vital emergency unit|adults admitted in vital emergency unit
416869|NCT01793389|gingival recession|gingival recession
416870|NCT01793389|fibrin|fibrin
416871|NCT01793389|connective tissue|connective tissue
416872|NCT01793389|root coverage|root coverage
416873|NCT01793389|microsurgery|microsurgery
416874|NCT01793389|case-control studies|case-control studies
416875|NCT01793363|Tracheotomy|tracheotomy
416876|NCT01793363|Weaning from mechanical ventilation|weaning from mechanical ventilation
416877|NCT01793363|Lung ultrasound score|lung ultrasound score
416878|NCT01793350|Diabetes|diabetes
416879|NCT01793350|Mellitus|mellitus
416880|NCT01793350|Painful|painful
416881|NCT01793350|Neuropathy|neuropathy
416882|NCT01793350|Peripheral|peripheral
416883|NCT01793324|Effectiveness of risk minimization|effectiveness of risk minimization
416884|NCT01793324|Metabolic monitoring|metabolic monitoring
416885|NCT01793324|Seroquel® or Seroquel® XR/quetiapine fumarate|seroquel® or seroquel® xr/quetiapine fumarate
416886|NCT01793311|intraocular pressure|intraocular pressure
416887|NCT01793311|caffeine|caffeine
416888|NCT01793311|dosage|dosage
416889|NCT01793246|lung cancer|lung cancer
416890|NCT01793246|lung neoplasms|lung neoplasms
416891|NCT01793246|lung transplant|lung transplant
416892|NCT01793194|venous insufficiency|venous insufficiency
416893|NCT01793194|varicose veins|varicose veins
416894|NCT01793194|pregnancy|pregnancy
416895|NCT01793194|DVT|dvt
416896|NCT01793194|superficial thrombophlebitis|superficial thrombophlebitis
416897|NCT01793181|Vitamin d deficiency|vitamin d deficiency
416898|NCT01793181|Central retinal vein occlusion|central retinal vein occlusion
416899|NCT01793168|Rare Diseases|rare diseases
416900|NCT01793168|Neglected Diseases|neglected diseases
416901|NCT01793168|Orphan Diseases|orphan diseases
416902|NCT01793168|Rare Disease Research|rare disease research
416903|NCT01793168|Registries|registries
416904|NCT01793168|WAGR Syndrome|wagr syndrome
416905|NCT01793168|Ataxia|ataxia
416906|NCT01793168|Cornelia de Lange Syndrome|cornelia de lange syndrome
416907|NCT01793168|Stickler Syndrome|stickler syndrome
416908|NCT01793168|Ataxia Telangiectasia|ataxia telangiectasia
416909|NCT01793168|Kawasaki Disease|kawasaki disease
416910|NCT01793168|Batten Disease|batten disease
416911|NCT01793168|Mucolipidosis IV|mucolipidosis iv
416912|NCT01793168|Klippel-Feil Syndrome|klippel-feil syndrome
416913|NCT01793168|Multiple Endocrine Neoplasia|multiple endocrine neoplasia
416914|NCT01793168|Atypical Hemolytic Uremic Syndrome|atypical hemolytic uremic syndrome
416915|NCT01793168|Undiagnosed|undiagnosed
416916|NCT01793168|Uncommon Disease|uncommon disease
416917|NCT01793168|Kabuki Syndrome|kabuki syndrome
416918|NCT01793168|Hypersomnia|hypersomnia
416919|NCT01793168|Hyperacusis|hyperacusis
416920|NCT01793168|Kleine-Levin Syndrome|kleine-levin syndrome
416921|NCT01793168|Marinesco-Sjogren Syndrome|marinesco-sjogren syndrome
416922|NCT01793168|Leiomyosarcoma|leiomyosarcoma
416923|NCT01793168|4p-/Wolf-Hirschhorn Syndrome|4p-/wolf-hirschhorn syndrome
416924|NCT01793168|Hypophosphatasia|hypophosphatasia
416925|NCT01793168|Narcolepsy|narcolepsy
416926|NCT01793168|Wiedermann-Steiner Syndrome|wiedermann-steiner syndrome
416927|NCT01793168|Breast Implant-Associated Anaplastic Large Cell Lymphoma|breast implant-associated anaplastic large cell lymphoma
416928|NCT01793168|Autoimmune/inflammatory Syndrome Induced by Adjuvants (ASIA)|autoimmune/inflammatory syndrome induced by adjuvants (asia)
416929|NCT01793168|Hemophagocytic Lymphohistiocytosis (HLH)|hemophagocytic lymphohistiocytosis (hlh)
416930|NCT01793168|Behcet's Disease|behcet's disease
416931|NCT01793168|Alagille Syndrome|alagille syndrome
416932|NCT01793168|Inclusion body myopathy with early-onset Paget disease and frontotemporal dementia (IBMPFD)|inclusion body myopathy with early-onset paget disease and frontotemporal dementia (ibmpfd)
416933|NCT01793168|Lowe Syndrome|lowe syndrome
416934|NCT01793168|Pitt Hopkins Syndrome|pitt hopkins syndrome
416935|NCT01793168|1p36 deletion syndrome|1p36 deletion syndrome
416936|NCT01793168|Jansen metaphyseal chondrodysplasia|jansen metaphyseal chondrodysplasia
416937|NCT01793168|Cockayne Syndrome|cockayne syndrome
416938|NCT01793168|Chronic recurrent multifocal osteomyelitis (CRMO)|chronic recurrent multifocal osteomyelitis (crmo)
416939|NCT01793168|Malan syndrome|malan syndrome
416940|NCT01793168|Hereditary Sensory and Autonomic Neuropathy|hereditary sensory and autonomic neuropathy
416941|NCT01793155|Lung cancer surgery|lung cancer surgery
416942|NCT01793155|Inspiratory muscle training|inspiratory muscle training
416943|NCT01793155|Postoperative pulmonary complications|postoperative pulmonary complications
416944|NCT01793155|Functional outcomes|functional outcomes
416945|NCT01793155|Health related quality of life|health related quality of life
416946|NCT01793142|Osteoporosis|osteoporosis
416947|NCT01793142|postmenopausal|postmenopausal
416948|NCT01793142|SERM|serm
416949|NCT01793129|NICHD Neonatal Research Network|nichd neonatal research network
416950|NCT01793129|Hypoxic-ischemic encephalopathy (HIE)|hypoxic-ischemic encephalopathy (hie)
416951|NCT01793129|Hypothermia|hypothermia
416952|NCT01793129|Neonatal depression|neonatal depression
416953|NCT01793129|Perinatal asphyxia|perinatal asphyxia
416954|NCT01793116|NICHD Neonatal Research Network|nichd neonatal research network
416955|NCT01793116|Moderately Preterm|moderately preterm
416956|NCT01793090|Cobalamin C defect|cobalamin c defect
416957|NCT01793090|methylmalonic aciduria with homocystinuria|methylmalonic aciduria with homocystinuria
416958|NCT01793090|Visual function|visual function
416960|NCT01793090|ERG|erg
416961|NCT01793090|antioxidant drugs|antioxidant drugs
416962|NCT01793077|Prostate Cancer|prostate cancer
416963|NCT01793077|Phase 4|phase 4
416964|NCT01793077|Data collection|data collection
416965|NCT01793077|Observational|observational
416966|NCT01793077|Depo-Eligard|depo-eligard
416967|NCT01793077|Prospective|prospective
416968|NCT01793077|Non-interventional|non-interventional
416969|NCT01793077|Treatment|treatment
416970|NCT01793064|Pedometer,|pedometer,
416971|NCT01793064|adaptive,|adaptive,
416972|NCT01793064|exercise,|exercise,
416973|NCT01793064|reinforcement,|reinforcement,
416974|NCT01793064|goal setting,|goal setting,
416975|NCT01793064|technology,|technology,
416976|NCT01793064|email,|email,
416977|NCT01793064|weight loss|weight loss
416978|NCT01793064|mHealth|mhealth
416979|NCT01793064|eHealth|ehealth
416980|NCT01793051|Myeloma|myeloma
416981|NCT01793051|Multiple Myeloma|multiple myeloma
416982|NCT01793051|MM|mm
416983|NCT01793051|Symptom Burden|symptom burden
416984|NCT01793051|Symptom reduction|symptom reduction
416985|NCT01793051|Maintenance therapy with lenalidomide|maintenance therapy with lenalidomide
416986|NCT01793051|Minocycline|minocycline
416987|NCT01793051|Dynacin|dynacin
416988|NCT01793051|Minocin|minocin
416989|NCT01793051|Minocin PAC|minocin pac
416990|NCT01793051|Myrac|myrac
416991|NCT01793051|Solodyn|solodyn
416992|NCT01793051|Placebo|placebo
416993|NCT01793051|Sugar pill|sugar pill
416994|NCT01793051|MD Anderson Symptom Inventory|md anderson symptom inventory
416995|NCT01793051|MDASI|mdasi
416996|NCT01793051|Questionnaires|questionnaires
416997|NCT01793051|Surveys|surveys
416998|NCT01793038|PCOS|pcos
416999|NCT01793038|clomiphene citrate resistant PCOS|clomiphene citrate resistant pcos
417000|NCT01793038|Aromatase inhibitors|aromatase inhibitors
417001|NCT01793025|leukemia|leukemia
417002|NCT01793025|myeloid|myeloid
417003|NCT01793025|acute|acute
417004|NCT01793025|acute myeloid leukemia|acute myeloid leukemia
417005|NCT01793025|allogeneic|allogeneic
417006|NCT01793025|transient chimerism|transient chimerism
417007|NCT01793025|cell therapy|cell therapy
417008|NCT01793025|immunotherapy|immunotherapy
417009|NCT01793012|therapeutic drug monitoring|therapeutic drug monitoring
417010|NCT01793012|antibiotics|antibiotics
417011|NCT01793012|inflammation parameters|inflammation parameters
417012|NCT01793012|critically ill patients|critically ill patients
417013|NCT01793012|septicaemia|septicaemia
417014|NCT01793012|intensive care unit|intensive care unit
417015|NCT01792999|Breast CT|breast ct
417016|NCT01792986|Diabetes|diabetes
417017|NCT01792986|Fasting|fasting
417018|NCT01792986|Pre-diabetes|pre-diabetes
417019|NCT01792986|Hemoglobin A1C|hemoglobin a1c
417020|NCT01792973|HIV|hiv
417021|NCT01792973|HPV|hpv
417022|NCT01792973|Women|women
417023|NCT01792973|Thailand|thailand
417024|NCT01792973|Antiretrovirals|antiretrovirals
417025|NCT01792973|Cervical cancer|cervical cancer
417026|NCT01792934|Debulking, cytoreduction, RFA, SABR, palliative chemotherapy|debulking, cytoreduction, rfa, sabr, palliative chemotherapy
417027|NCT01792921|Age 7-10 years old|age 7-10 years old
417028|NCT01792921|regular education system|regular education system
417029|NCT01792921|no moderate or severe neurological and/or psychiatric disorders|no moderate or severe neurological and/or psychiatric disorders
417030|NCT01792908|ankle lateral ligament|ankle lateral ligament
417031|NCT01792908|athletic tape|athletic tape
417032|NCT01792908|position sense|position sense
417033|NCT01792908|Proprioception|proprioception
417034|NCT01792895|Posterior Neck Pain|posterior neck pain
417035|NCT01792895|Cervical spine pain|cervical spine pain
417036|NCT01792895|Manual therapy|manual therapy
417037|NCT01792856|coaching|coaching
417038|NCT01792856|early psychosis|early psychosis
417039|NCT01792856|schizophrenia|schizophrenia
417040|NCT01792830|Coronary Artery Bypass Graft surgery|coronary artery bypass graft surgery
417041|NCT01792817|Cluster Headache|cluster headache
417042|NCT01792817|GammaCore|gammacore
417043|NCT01792817|vagal nerve stimulation|vagal nerve stimulation
417044|NCT01792817|nVNS|nvns
417045|NCT01792817|VNS|vns
417046|NCT01792817|non invasive|non invasive
417047|NCT01792817|vagus nerve stimulation|vagus nerve stimulation
417048|NCT01792804|Staphylococcus aureus|staphylococcus aureus
417049|NCT01792804|Bloodstream infection|bloodstream infection
417050|NCT01792804|Oral switch|oral switch
417051|NCT01792778|IV Catheters|iv catheters
417052|NCT01792778|Blood control|blood control
417053|NCT01792765|urolithiasis|urolithiasis
417054|NCT01792765|radiation free|radiation free
417055|NCT01792765|ultrasound guidance|ultrasound guidance
417056|NCT01792765|ureteroscopy|ureteroscopy
417057|NCT01792752|HIV/AIDS|hiv/aids
417058|NCT01792752|Drug Users|drug users
417059|NCT01792752|Puerto Rico|puerto rico
417060|NCT01792739|Probiotics|probiotics
417061|NCT01792739|Diarrhea|diarrhea
417062|NCT01792739|Intentive care units|intentive care units
417063|NCT01792726|breast cancer|breast cancer
417064|NCT01792726|radiotherapy|radiotherapy
417065|NCT01792726|TARGIT|targit
417066|NCT01792726|Intrabeam|intrabeam
417067|NCT01792713|Skin alterations|skin alterations
417068|NCT01792713|Atopic Dermatitis|atopic dermatitis
417069|NCT01792687|Metastatic castrate resistant prostate cancer (CRPC)|metastatic castrate resistant prostate cancer (crpc)
417070|NCT01792674|Education|education
417071|NCT01792674|Patient simulation|patient simulation
417072|NCT01792674|In situ simulation|in situ simulation
417073|NCT01792674|Stress|stress
417074|NCT01792661|Chronic Kidney Disease|chronic kidney disease
417075|NCT01792661|Electronic Health Record|electronic health record
417076|NCT01792661|Personal Health Record|personal health record
417077|NCT01792661|Chronic Kidney Disease registry|chronic kidney disease registry
417078|NCT01792661|Glomerular Filtration Rate|glomerular filtration rate
417079|NCT01792661|Patient Navigator|patient navigator
417080|NCT01792648|Almond|almond
417081|NCT01792648|Carbohydrate|carbohydrate
417082|NCT01792648|Diet|diet
417083|NCT01792648|Cholesterol|cholesterol
417084|NCT01792635|Type 2 Diabetes Mellitus|type 2 diabetes mellitus
417085|NCT01792635|Pharmacodynamics|pharmacodynamics
417086|NCT01792635|Safety & Tolerability|safety & tolerability
417087|NCT01792622|Instrument Development|instrument development
417088|NCT01792622|Patient Reported Outcomes|patient reported outcomes
417089|NCT01792622|Pulmonary Arterial Hypertension.|pulmonary arterial hypertension.
417090|NCT01792609|Scoliosis|scoliosis
417091|NCT01792609|Cobb Angle|cobb angle
417092|NCT01792609|Screw Density|screw density
417093|NCT01792609|Outcomes Measures|outcomes measures
417094|NCT01792583|pregnancy|pregnancy
417095|NCT01792570|HIV-1|hiv-1
417096|NCT01792570|darunavir|darunavir
417097|NCT01792570|rilpivirine|rilpivirine
417098|NCT01792570|strategic study|strategic study
417099|NCT01792557|Pilonidal sinus|pilonidal sinus
417100|NCT01792557|Crystallized phenol|crystallized phenol
417101|NCT01792557|Limberg Flap|limberg flap
417102|NCT01792557|Modified Limberg Flap|modified limberg flap
417103|NCT01792557|Karydakis|karydakis
417104|NCT01792557|Recurrence|recurrence
417105|NCT01792557|Complications|complications
417106|NCT01792557|Recovery duration|recovery duration
417107|NCT01792557|Time to return to work|time to return to work
417108|NCT01792531|children|children
417109|NCT01792531|obesity|obesity
417110|NCT01792531|treatment|treatment
417111|NCT01792531|family|family
417112|NCT01792492|Thyroid Neoplasms|thyroid neoplasms
417113|NCT01792492|Optical Devices|optical devices
417114|NCT01792492|Spectrum Analysis|spectrum analysis
417115|NCT01792492|Thyroid diseases|thyroid diseases
417116|NCT01792479|NSCLC|nsclc
417117|NCT01792479|lung cancer|lung cancer
417118|NCT01792466|difficult biliary cannulation|difficult biliary cannulation
417119|NCT01792453|Gastrointestinal physiology|gastrointestinal physiology
417120|NCT01792453|MRI|mri
417121|NCT01792453|Small bowel water volumes|small bowel water volumes
417122|NCT01792453|Gastric volumes|gastric volumes
417123|NCT01792401|Critical illness|critical illness
417124|NCT01792401|Dietary supplements|dietary supplements
417125|NCT01792401|Gastrointestinal tract/physio-pathology|gastrointestinal tract/physio-pathology
417126|NCT01792388|Crohn's Disease|crohn's disease
417127|NCT01792388|Vitamin D|vitamin d
417128|NCT01792388|Intestinal Permeability|intestinal permeability
417129|NCT01792388|Tara Raftery|tara raftery
417130|NCT01792375|Cervical ripening|cervical ripening
417131|NCT01792375|Dinoprostone|dinoprostone
417132|NCT01792375|Labor induction|labor induction
417133|NCT01792375|Membrane sweeping|membrane sweeping
417134|NCT01792375|Nulliparous women|nulliparous women
417136|NCT01792362|Anti-mullerian hormone (AMH) level, poly cystic ovarian syndrome obese infertility weight loss diet|anti-mullerian hormone (amh) level, poly cystic ovarian syndrome obese infertility weight loss diet
417137|NCT01792336|Repetitive TMS (rTMS)|repetitive tms (rtms)
417138|NCT01792336|Transcranial Magnetic Stimulation (TMS)|transcranial magnetic stimulation (tms)
417139|NCT01792336|Motor Cortex|motor cortex
417140|NCT01792336|Focal Hand Dystonia|focal hand dystonia
417141|NCT01792336|Facilitation|facilitation
417142|NCT01792323|insulin pump therapy|insulin pump therapy
417143|NCT01792323|insulin bolus|insulin bolus
417144|NCT01792323|rapid acting insulin|rapid acting insulin
417145|NCT01792323|insulin lispro|insulin lispro
417146|NCT01792323|pharmacodynamics|pharmacodynamics
417147|NCT01792323|pharmacokinetics|pharmacokinetics
417148|NCT01792323|glucose clamp|glucose clamp
417149|NCT01792310|Glioma|glioma
417150|NCT01792310|Solid Tumours|solid tumours
417151|NCT01792310|Minerval|minerval
417152|NCT01792297|Sarcopenia|sarcopenia
417153|NCT01792297|Osteoporosis|osteoporosis
417154|NCT01792297|Cognition|cognition
417155|NCT01792297|Inflammation|inflammation
417156|NCT01792271|COPD|copd
417157|NCT01792271|Chronic Bronchitis|chronic bronchitis
417158|NCT01792271|Hypertonic Saline|hypertonic saline
417159|NCT01792258|Percutaneous tracheostomy|percutaneous tracheostomy
533246|NCT01293201|SAR|sar
417160|NCT01792258|Intensive Care Unit|intensive care unit
417161|NCT01792258|Ineffective Airway Clearance|ineffective airway clearance
417162|NCT01792258|Weaning failure|weaning failure
417163|NCT01792245|narrow band UVB; PUVA; psoriasis; eczema; hand|narrow band uvb; puva; psoriasis; eczema; hand
417164|NCT01792232|Diesel exhaust|diesel exhaust
417165|NCT01792232|Air pollution|air pollution
417166|NCT01792232|Airway responsiveness|airway responsiveness
417167|NCT01792232|Allergies|allergies
417168|NCT01792219|interprofessional learning|interprofessional learning
417169|NCT01792219|interprofessional collaboration|interprofessional collaboration
417170|NCT01792219|residents|residents
417171|NCT01792219|nursing homes|nursing homes
417172|NCT01792206|Stage 3 chronic kidney disease (CKD)|stage 3 chronic kidney disease (ckd)
417173|NCT01792206|Stage 4 chronic kidney disease (CKD)|stage 4 chronic kidney disease (ckd)
417174|NCT01792206|CKD|ckd
417175|NCT01792180|Gait speed|gait speed
417176|NCT01792180|Mobility|mobility
417177|NCT01792180|Falls|falls
417178|NCT01792180|Fall risk|fall risk
417179|NCT01792180|Self-management|self-management
417180|NCT01792180|Mental wellbeing|mental wellbeing
417181|NCT01792180|Elderly|elderly
417182|NCT01792115|Fatty Liver|fatty liver
417183|NCT01792115|Alpha-Tocopherol|alpha-tocopherol
417184|NCT01792115|Vitamin E|vitamin e
417185|NCT01792115|Non-Alcoholic Steatohepatitis|non-alcoholic steatohepatitis
417186|NCT01792102|Multiple Myeloma|multiple myeloma
417187|NCT01792102|Carfilzomib|carfilzomib
417188|NCT01792102|Krypolis|krypolis
417189|NCT01792102|60 minute infusion|60 minute infusion
417190|NCT01792089|de novo lipogenesis|de novo lipogenesis
417191|NCT01792089|fructose|fructose
417192|NCT01792089|roux-en-Y gastric bypass|roux-en-y gastric bypass
417193|NCT01792089|post-prandial triglycerides|post-prandial triglycerides
417194|NCT01792050|IDO|ido
417195|NCT01792050|IDO Inhibitor|ido inhibitor
417196|NCT01792050|Metastatic Breast Cancer|metastatic breast cancer
417197|NCT01792011|Elective living donor liver transplantation|elective living donor liver transplantation
417198|NCT01791985|Breast Cancer|breast cancer
417199|NCT01791985|AZD4547|azd4547
417200|NCT01791985|Safety Run-In|safety run-in
417201|NCT01791985|FGFR1|fgfr1
417202|NCT01791985|ER positive breast cancer|er positive breast cancer
417203|NCT01791985|Single arm phase IIa study|single arm phase iia study
417204|NCT01791972|Exercise-Induced Bronchoconstriction (EIB)|exercise-induced bronchoconstriction (eib)
417205|NCT01791972|Spiromax®|spiromax®
417206|NCT01791972|Albuterol sulfate|albuterol sulfate
417207|NCT01791946|lazy eye|lazy eye
417208|NCT01791946|cross eye|cross eye
417209|NCT01791946|cross eyed|cross eyed
417210|NCT01791933|LBP|lbp
417211|NCT01791933|Neck pain|neck pain
417212|NCT01791933|Integrative package|integrative package
417213|NCT01791933|CAM|cam
417214|NCT01791868|Generalized convulsive status epilepticus|generalized convulsive status epilepticus
417215|NCT01791868|Sodium valproate|sodium valproate
417216|NCT01791868|Refractory status epilepticus|refractory status epilepticus
417217|NCT01791868|Mortality|mortality
417218|NCT01791868|Epilepsy|epilepsy
417219|NCT01791868|Intensive Care Unit|intensive care unit
417220|NCT01791868|Neurological sequela|neurological sequela
417221|NCT01791868|Quality of life|quality of life
417222|NCT01791868|Adult|adult
417223|NCT01791855|Subjects with Renal Impairment|subjects with renal impairment
417224|NCT01791855|healthy|healthy
417225|NCT01791842|fibrous dysplasia of bone|fibrous dysplasia of bone
417226|NCT01791842|tocilizumab|tocilizumab
417227|NCT01791842|McCune-Albright syndrome|mccune-albright syndrome
417228|NCT01791829|Luminal A|luminal a
417229|NCT01791829|Ipsilateral Breast Tumour Recurrence|ipsilateral breast tumour recurrence
417230|NCT01791816|Vasovagal Syncope|vasovagal syncope
417231|NCT01791816|Postural Tachycardia Syndrome|postural tachycardia syndrome
417232|NCT01791816|Orthostatic Intolerance|orthostatic intolerance
417233|NCT01791816|Nitric Oxide (NO)|nitric oxide (no)
417234|NCT01791816|Orthostatic Stress|orthostatic stress
417235|NCT01791816|L-Ng-monomethyl Arginine (L-NMMA)|l-ng-monomethyl arginine (l-nmma)
417236|NCT01791816|Phenylephrine|phenylephrine
417237|NCT01791816|Sodium Nitroprusside|sodium nitroprusside
417238|NCT01791803|Smoking cessation|smoking cessation
417239|NCT01791803|Tobacco abstinence|tobacco abstinence
417240|NCT01791803|hypnotherapy|hypnotherapy
417241|NCT01791803|Nicotine replacement therapy|nicotine replacement therapy
417242|NCT01791790|old Subjects|old subjects
417243|NCT01791790|Controls|controls
417244|NCT01791790|brain stimulation|brain stimulation
417245|NCT01791790|tSOS|tsos
417246|NCT01791790|tDCS|tdcs
417247|NCT01791790|sleep|sleep
417248|NCT01791790|memory|memory
417249|NCT01791790|memory consolidation|memory consolidation
417250|NCT01791777|fidelity|fidelity
417251|NCT01791777|implementation science|implementation science
417252|NCT01791777|competence|competence
417253|NCT01791777|training|training
417254|NCT01791777|coaching|coaching
417255|NCT01791738|Total Hip Arthroplasty (THA)|total hip arthroplasty (tha)
417256|NCT01791738|Patient-Specific Instruments|patient-specific instruments
417257|NCT01791738|Acetabular Cup Placement|acetabular cup placement
417258|NCT01791738|Accuracy|accuracy
417259|NCT01791699|atrial fibrillation|atrial fibrillation
417260|NCT01791699|paroxysmal|paroxysmal
417261|NCT01791699|persistent|persistent
417262|NCT01791699|ablation|ablation
417263|NCT01791699|pulmonary vein isolation|pulmonary vein isolation
417264|NCT01791699|recurrence|recurrence
417265|NCT01791686|Dense Deposit Disease|dense deposit disease
417266|NCT01791686|DDD|ddd
417267|NCT01791673|Glaucoma|glaucoma
417268|NCT01791673|Cyclocoagulation|cyclocoagulation
417269|NCT01791673|HIFU - High Intensity Focused Ultrasound|hifu - high intensity focused ultrasound
417270|NCT01791673|Ciliary Body|ciliary body
417271|NCT01791647|Polycystic ovary syndrome|polycystic ovary syndrome
417272|NCT01791647|myoinositol|myoinositol
417273|NCT01791647|metformin|metformin
417274|NCT01791647|glucose-insulinemic metabolism|glucose-insulinemic metabolism
417275|NCT01791647|menstrual pattern|menstrual pattern
417276|NCT01791647|insulin-lowering therapies|insulin-lowering therapies
417277|NCT01791621|Irritable Bowel Syndrome|irritable bowel syndrome
417278|NCT01791621|Elimination diet|elimination diet
417279|NCT01791621|Food allergies|food allergies
417280|NCT01791608|Child, Preschool|child, preschool
417281|NCT01791608|Dietary Zinc|dietary zinc
417282|NCT01791608|Zinc sulfate|zinc sulfate
417283|NCT01791608|zinc-glycine chelate|zinc-glycine chelate
417284|NCT01791595|Phase I|phase i
417285|NCT01791595|Cancer|cancer
417286|NCT01791595|Solid Tumours|solid tumours
417287|NCT01791595|Diffuse Large B Cell Lymphoma|diffuse large b cell lymphoma
417288|NCT01791595|Monocarboxylate Transporter 1 Inhibitor|monocarboxylate transporter 1 inhibitor
417289|NCT01791595|lactate|lactate
417290|NCT01791595|Burkitt Lymphoma|burkitt lymphoma
417291|NCT01791556|HIV|hiv
417292|NCT01791556|AIDS|aids
417293|NCT01791556|Kenya|kenya
417294|NCT01791556|viral load|viral load
417295|NCT01791556|Antiretroviral therapy|antiretroviral therapy
417296|NCT01791556|randomized clinical trial|randomized clinical trial
417297|NCT01791556|ART monitoring|art monitoring
417298|NCT01791556|treatment failure|treatment failure
417299|NCT01791556|HIV resistance|hiv resistance
417300|NCT01791543|ventricular tachycardia|ventricular tachycardia
417301|NCT01791543|ablation|ablation
417302|NCT01791543|ventricular arrhythmia|ventricular arrhythmia
417303|NCT01791530|VAT|vat
417304|NCT01791530|VAP|vap
417305|NCT01791530|Transition from VAT to VAP|transition from vat to vap
417306|NCT01791504|Abdominoplasty|abdominoplasty
417307|NCT01791478|-Metastatic breast cancer, PI3K inhibitor, Endocrine therapy|-metastatic breast cancer, pi3k inhibitor, endocrine therapy
417308|NCT01791465|HIV|hiv
417309|NCT01791465|Diabetes|diabetes
417310|NCT01791400|Metoclopramide|metoclopramide
417311|NCT01791400|Sumatriptan|sumatriptan
417312|NCT01791400|migraine|migraine
417313|NCT01791400|headache|headache
417314|NCT01791387|Renal cell|renal cell
417315|NCT01791387|Kidney|kidney
417316|NCT01791387|Cancer|cancer
417317|NCT01791387|Metastatic carcinoma|metastatic carcinoma
417318|NCT01791374|Advanced Solid Tumors|advanced solid tumors
417319|NCT01791374|Advanced or Metastatic Gastric Cancer|advanced or metastatic gastric cancer
417320|NCT01791374|Advanced or Metastatic GEJ|advanced or metastatic gej
417724|NCT01789216|Grade II|grade ii
417321|NCT01791374|Gastric Cancer|gastric cancer
417322|NCT01791361|Metastatic colorectal cancer|metastatic colorectal cancer
417323|NCT01791335|Glottis|glottis
417324|NCT01791335|Respiratory Muscles|respiratory muscles
417325|NCT01791335|Upper airway|upper airway
417326|NCT01791335|Noninvasive ventilation|noninvasive ventilation
417327|NCT01791309|Vemurafenib|vemurafenib
417328|NCT01791309|Panitumumab|panitumumab
417329|NCT01791309|V600E BRAF mutation|v600e braf mutation
417330|NCT01791309|colon|colon
417331|NCT01791309|12-221|12-221
417332|NCT01791296|sedation|sedation
417333|NCT01791296|sleep|sleep
417334|NCT01791296|delirium|delirium
417335|NCT01791296|critical illness|critical illness
417336|NCT01791296|sub-syndromal delirium|sub-syndromal delirium
417337|NCT01791296|intensive care|intensive care
417338|NCT01791283|Left ventricular stroke volume|left ventricular stroke volume
417339|NCT01791283|Arterial waveform analysis|arterial waveform analysis
417340|NCT01791283|Esofageal doppler|esofageal doppler
417341|NCT01791283|Ultrasound|ultrasound
417342|NCT01791283|Cardiac magnetic Imaging|cardiac magnetic imaging
417343|NCT01791283|Limits of agreement|limits of agreement
417344|NCT01791270|Obstructive Sleep Apnea|obstructive sleep apnea
417345|NCT01791270|Hypertension|hypertension
417346|NCT01791270|β1 Subunit of Maxi-k+Channel|β1 subunit of maxi-k+channel
417347|NCT01791270|Cardiovascular Risk|cardiovascular risk
417348|NCT01791257|delayed|delayed
417349|NCT01791257|cerebral|cerebral
417350|NCT01791257|ischemia|ischemia
417351|NCT01791257|microrna|microrna
417352|NCT01791257|cerebrospinal fluid|cerebrospinal fluid
417353|NCT01791257|subarachnoid|subarachnoid
417354|NCT01791257|hemorrhage|hemorrhage
417355|NCT01791244|Multiple Sclerosis|multiple sclerosis
417356|NCT01791244|Relapsing-Remitting|relapsing-remitting
417357|NCT01791244|Rebif|rebif
417358|NCT01791244|RebiSmart|rebismart
417359|NCT01791244|Patient support program|patient support program
417360|NCT01791231|Healthy|healthy
417361|NCT01791231|Male|male
417362|NCT01791231|Canagliflozin (JNJ-28431754)|canagliflozin (jnj-28431754)
417363|NCT01791231|Radiolabeled 14C-canagliflozin|radiolabeled 14c-canagliflozin
417364|NCT01791231|Absorption|absorption
417365|NCT01791231|Metabolism|metabolism
417366|NCT01791231|Excretion|excretion
417367|NCT01791231|Radioactivity|radioactivity
417368|NCT01791218|Pulmonary vein isolation|pulmonary vein isolation
417369|NCT01791218|Paroxysmal atrial fibrillation|paroxysmal atrial fibrillation
417370|NCT01791218|Quality of life|quality of life
417371|NCT01791192|Uveitis, Fingolimod, Phase II, Visual Acuity, Vitreous Haze, OCT|uveitis, fingolimod, phase ii, visual acuity, vitreous haze, oct
417372|NCT01791114|Insulin sensitivity|insulin sensitivity
417373|NCT01791114|Diabetes Prevention|diabetes prevention
417374|NCT01791114|Obesity|obesity
417375|NCT01791114|Brown adipose tissue|brown adipose tissue
417376|NCT01791101|Thrombocytopenia|thrombocytopenia
417377|NCT01791101|Eltrombopag|eltrombopag
417378|NCT01791075|DSAEK|dsaek
417379|NCT01791075|Tan Endoglide|tan endoglide
417380|NCT01791075|Endosaver/Endoserter|endosaver/endoserter
417381|NCT01791062|cartilage tissue engineering|cartilage tissue engineering
417382|NCT01791062|hyaluronan|hyaluronan
417383|NCT01791062|hyaluronic acid|hyaluronic acid
417384|NCT01791049|Gram-positive|gram-positive
417385|NCT01791049|Infections|infections
417386|NCT01791049|Bacterial infections|bacterial infections
417387|NCT01791036|Adductor canal block|adductor canal block
417388|NCT01791036|Femoral Nerve Block|femoral nerve block
417389|NCT01791023|Depression|depression
417390|NCT01791023|Physical exercise|physical exercise
417391|NCT01791023|Stress|stress
417392|NCT01791010|Breathing exercises|breathing exercises
417393|NCT01791010|Aged|aged
417394|NCT01790997|DLBS1033|dlbs1033
417395|NCT01790997|Lumbrokinase|lumbrokinase
417396|NCT01790997|Acute ischemic stroke|acute ischemic stroke
417397|NCT01790997|Bleeding profile|bleeding profile
417398|NCT01790997|Clinical outcome|clinical outcome
417399|NCT01790997|Aspirin|aspirin
417400|NCT01790997|Clopidogrel|clopidogrel
417401|NCT01790984|Dietary extrinsic sugars, atherogenic lipoprotein phenotype, lipoprotein kinetics, fatty liver|dietary extrinsic sugars, atherogenic lipoprotein phenotype, lipoprotein kinetics, fatty liver
417402|NCT01790971|Obstructive sleep apnea|obstructive sleep apnea
417403|NCT01790971|Spinal morphine|spinal morphine
417404|NCT01790932|Metastatic|metastatic
417405|NCT01790932|Triple Negative|triple negative
417406|NCT01790919|Depression, Adults|depression, adults
417407|NCT01790906|Chronic Heart Failure|chronic heart failure
417408|NCT01790906|Renal Sympathetic Denervation|renal sympathetic denervation
417409|NCT01790893|Histoplasmosis|histoplasmosis
417410|NCT01790880|Aphasia|aphasia
417411|NCT01790880|Stroke|stroke
417412|NCT01790880|Speech Rehabilitation|speech rehabilitation
417413|NCT01790854|prasugrel|prasugrel
417414|NCT01790854|antiplatelet|antiplatelet
417415|NCT01790854|Acute Coronary Syndrome|acute coronary syndrome
417416|NCT01790815|Acute Malnutrition|acute malnutrition
417417|NCT01790815|Mid Upper Arm Circumference|mid upper arm circumference
417418|NCT01790815|Screening|screening
417419|NCT01790802|laser treatment, high risk, early AMD|laser treatment, high risk, early amd
417420|NCT01790776|urethrography|urethrography
417421|NCT01790763|Burn|burn
417422|NCT01790763|Second-degree|second-degree
417423|NCT01790750|PDA|pda
417424|NCT01790750|Echo|echo
417425|NCT01790750|PES|pes
417426|NCT01790750|Handheld echo system|handheld echo system
417427|NCT01790737|myeloma, stem cell mobilization, autologous stem cell transplantation|myeloma, stem cell mobilization, autologous stem cell transplantation
417428|NCT01790737|induction treatment, maintenance treatment|induction treatment, maintenance treatment
417429|NCT01790711|Gut bacteria|gut bacteria
417430|NCT01790711|Bacteria|bacteria
417431|NCT01790711|Fecal transplant|fecal transplant
417432|NCT01790711|Bacteriotherapy|bacteriotherapy
417433|NCT01790698|Necrotizing fasciitis|necrotizing fasciitis
417434|NCT01790698|Streptococcus pyogenes|streptococcus pyogenes
417435|NCT01790698|Staphylococcus aureus|staphylococcus aureus
417436|NCT01790698|Immunopathogenesis|immunopathogenesis
417437|NCT01790672|Antioxidants|antioxidants
417438|NCT01790672|Central Nervous System Agents|central nervous system agents
417439|NCT01790672|Wine|wine
417440|NCT01790659|leishmaniasis|leishmaniasis
417441|NCT01790659|cutaneous leishmaniasis|cutaneous leishmaniasis
417442|NCT01790659|Leishmania panamensis|leishmania panamensis
417443|NCT01790659|L panamensis|l panamensis
417444|NCT01790659|Paromomycin|paromomycin
417445|NCT01790659|Paromomycin/Gentamicin|paromomycin/gentamicin
417446|NCT01790633|rapid test|rapid test
417447|NCT01790633|screening|screening
417448|NCT01790633|ELISA|elisa
417449|NCT01790633|hepatitis B virus|hepatitis b virus
417450|NCT01790633|hepatitis C virus|hepatitis c virus
417451|NCT01790633|human immunodeficiency virus|human immunodeficiency virus
417452|NCT01790633|access to care|access to care
417453|NCT01790620|Sepsis|sepsis
417454|NCT01790620|Septic shock|septic shock
417455|NCT01790620|Acute renal failure|acute renal failure
417456|NCT01790620|Acute kidney injury|acute kidney injury
417457|NCT01790620|Continuous renal replacement therapies CRRT|continuous renal replacement therapies crrt
417458|NCT01790607|Adult healthy subjects will be matched with individual subjects by age (± 5 years, gender, and BMI (± 15%)|adult healthy subjects will be matched with individual subjects by age (± 5 years, gender, and bmi (± 15%)
417459|NCT01790594|transplantation|transplantation
417460|NCT01790594|kidney|kidney
417461|NCT01790594|pancreas|pancreas
417462|NCT01790594|immunosuppression|immunosuppression
417463|NCT01790594|calcineurin inhibitor (CNI)|calcineurin inhibitor (cni)
417464|NCT01790581|Chronic Ankle Instability|chronic ankle instability
417465|NCT01790555|Postsurgical|postsurgical
417466|NCT01790555|Pain|pain
417467|NCT01790555|THC|thc
417468|NCT01790555|Sensitization|sensitization
417469|NCT01790542|Iron|iron
417470|NCT01790542|Intestinal inflammation|intestinal inflammation
417471|NCT01790542|ROS|ros
417472|NCT01790516|Head and neck cancer|head and neck cancer
417473|NCT01790516|genetic testing|genetic testing
417474|NCT01790516|cisplatin|cisplatin
417475|NCT01790516|erbitux|erbitux
417476|NCT01790516|radiation therapy|radiation therapy
417477|NCT01790503|glioblastoma|glioblastoma
417478|NCT01790503|GBM|gbm
417479|NCT01790477|Tonsillectomy|tonsillectomy
417480|NCT01790477|Acupuncture|acupuncture
417481|NCT01790464|Glossopharyngeal nerve block|glossopharyngeal nerve block
417482|NCT01790464|Airway anesthesia|airway anesthesia
417483|NCT01790464|Awake intubation|awake intubation
417484|NCT01790451|focal therapy|focal therapy
417485|NCT01790451|irreversible electroporation|irreversible electroporation
417486|NCT01790451|prostate cancer|prostate cancer
417487|NCT01790412|pregnancy, exercise, gestational diabetes|pregnancy, exercise, gestational diabetes
417488|NCT01790399|SENTINEL NODE|sentinel node
417489|NCT01790386|hemostasis|hemostasis
417490|NCT01790386|thromboelastography|thromboelastography
417491|NCT01790386|coagulation|coagulation
417492|NCT01790386|TEG|teg
417493|NCT01790373|Suubi|suubi
417494|NCT01790373|Adolescents|adolescents
417495|NCT01790373|Poverty|poverty
417496|NCT01790373|Economic empowerment interventions|economic empowerment interventions
417497|NCT01790373|Adherence to HIV antiretroviral therapy|adherence to hiv antiretroviral therapy
417498|NCT01790373|Wisepill|wisepill
417499|NCT01790373|HIV/AIDS infected Children|hiv/aids infected children
417500|NCT01790373|Medical event monitoring system|medical event monitoring system
417501|NCT01790373|Uganda|uganda
417502|NCT01790360|MSM|msm
417503|NCT01790360|HIV|hiv
417504|NCT01790360|Substance Abuse|substance abuse
417505|NCT01790360|Sexual Behavior|sexual behavior
417506|NCT01790347|Exercise|exercise
417507|NCT01790347|Aerobic|aerobic
417508|NCT01790347|Resistance training|resistance training
417509|NCT01790347|Pregnancy|pregnancy
417510|NCT01790347|Maternal weight gain|maternal weight gain
417511|NCT01790347|IOM recommendations|iom recommendations
417512|NCT01790295|Myelofibrosis|myelofibrosis
417513|NCT01790295|Stem cell transplant|stem cell transplant
417514|NCT01790295|Ruxolitinib|ruxolitinib
417515|NCT01790282|luteal support|luteal support
417516|NCT01790282|high responder|high responder
417517|NCT01790282|ICSI|icsi
417518|NCT01790282|ivf|ivf
417519|NCT01790282|cycle outcome|cycle outcome
417520|NCT01790269|Relapsing-Remitting Multiple Sclerosis|relapsing-remitting multiple sclerosis
417521|NCT01790269|NK cells|nk cells
417522|NCT01790269|Fingolimod|fingolimod
417523|NCT01790204|mutant p53|mutant p53
417524|NCT01790204|watercress|watercress
417525|NCT01790204|Phenethyl isothyocyanate|phenethyl isothyocyanate
417526|NCT01790204|oral cells of smokers|oral cells of smokers
417527|NCT01790191|Children|children
417528|NCT01790191|Eating behaviour|eating behaviour
417529|NCT01790191|Intake|intake
417530|NCT01790191|Liking|liking
417531|NCT01790191|Conditioned liking|conditioned liking
417532|NCT01790191|Flavour|flavour
417533|NCT01790191|Nutrient|nutrient
417534|NCT01790191|Vegetable|vegetable
417535|NCT01790165|Onychomycosis|onychomycosis
417536|NCT01790165|Open Label|open label
417537|NCT01790165|PK|pk
417538|NCT01790126|Men with Biochemically Relapsed Hormone Sensitive Prostate Cancer|men with biochemically relapsed hormone sensitive prostate cancer
417539|NCT01790074|cervicogenic headache|cervicogenic headache
417540|NCT01790074|trigger point|trigger point
417541|NCT01790074|sternocleidomastoid|sternocleidomastoid
417542|NCT01790074|manual therapy|manual therapy
417543|NCT01790061|Gut bacteria|gut bacteria
417544|NCT01790061|Gut flora|gut flora
417545|NCT01790061|Bacteriotherapy|bacteriotherapy
417546|NCT01790061|Fecal Microbiota Transplantation|fecal microbiota transplantation
417547|NCT01790061|Inflammatory bowel disease|inflammatory bowel disease
417548|NCT01790061|Ulcerative colitis|ulcerative colitis
417549|NCT01790048|MAM|mam
417550|NCT01790009|ADME|adme
417551|NCT01790009|Flavanols|flavanols
417552|NCT01790009|Age|age
417553|NCT01790009|Pharmacokinetics|pharmacokinetics
417554|NCT01789996|6 minute walk test|6 minute walk test
417555|NCT01789996|idiopathic pulmonary fibrosis|idiopathic pulmonary fibrosis
417556|NCT01789996|pulmonary arterial hypertension|pulmonary arterial hypertension
417557|NCT01789983|Physical Activity|physical activity
417558|NCT01789983|Chemotherapy|chemotherapy
417559|NCT01789983|Elderly|elderly
417560|NCT01789983|Geriatric|geriatric
417561|NCT01789983|Walking|walking
417562|NCT01789983|Geriatric Assessment|geriatric assessment
417563|NCT01789983|Geriatric Oncology|geriatric oncology
417564|NCT01789970|chronic low back pain|chronic low back pain
417565|NCT01789970|hydrocodone bitartrate|hydrocodone bitartrate
417566|NCT01789970|opioids|opioids
417567|NCT01789944|Childhood Obesity|childhood obesity
417568|NCT01789918|Hypertension|hypertension
417569|NCT01789918|Blood pressure|blood pressure
417570|NCT01789918|Renal denervation|renal denervation
417571|NCT01789905|Tygacil|tygacil
417572|NCT01789905|Tigecycline|tigecycline
417573|NCT01789905|Post marketing surveillance|post marketing surveillance
417574|NCT01789905|Japanese|japanese
417575|NCT01789905|Infection|infection
417576|NCT01789879|Levonorgestrel|levonorgestrel
417577|NCT01789879|Efavirenz|efavirenz
417578|NCT01789879|Nevirapine|nevirapine
417579|NCT01789879|Pharmacokinetics|pharmacokinetics
417580|NCT01789866|DHA|dha
417581|NCT01789866|lutein|lutein
417582|NCT01789866|cognitive development|cognitive development
417583|NCT01789866|fMRI|fmri
417584|NCT01789853|stroke, rehabilitation, gait training|stroke, rehabilitation, gait training
417585|NCT01789840|BPH|bph
417586|NCT01789840|Prostate|prostate
417587|NCT01789840|Prostatic Hyperplasia|prostatic hyperplasia
417588|NCT01789840|enlarged prostate|enlarged prostate
417589|NCT01789840|LUTS|luts
417590|NCT01789840|urinary retention|urinary retention
417591|NCT01789814|Percutaneous Coronary Intervention|percutaneous coronary intervention
417592|NCT01789814|Platelet Aggregation Inhibitors|platelet aggregation inhibitors
417593|NCT01789814|bivalirudin|bivalirudin
417594|NCT01789762|Platelet transfusions|platelet transfusions
417595|NCT01789762|Pathogen reduction|pathogen reduction
417596|NCT01789762|Haemorrhagic episodes|haemorrhagic episodes
417597|NCT01789749|snare tip soft coagulation|snare tip soft coagulation
417598|NCT01789749|endoscopic mucosal resection|endoscopic mucosal resection
417599|NCT01789749|adenoma recurrence|adenoma recurrence
417600|NCT01789749|adenoma|adenoma
417601|NCT01789749|colonoscopy|colonoscopy
417602|NCT01789736|Glaucoma|glaucoma
417603|NCT01789736|Ocular hypertension|ocular hypertension
417604|NCT01789736|AR-12286|ar-12286
417605|NCT01789736|Travoprost|travoprost
417606|NCT01789710|smoking|smoking
417607|NCT01789710|homelessness|homelessness
417608|NCT01789710|contingency management|contingency management
417609|NCT01789684|cluster|cluster
417610|NCT01789684|genetic counseling|genetic counseling
417611|NCT01789684|breast cancer|breast cancer
417612|NCT01789684|HBOC|hboc
417613|NCT01789684|provider intervention|provider intervention
417614|NCT01789671|Childhood Obesity|childhood obesity
417615|NCT01789658|Oral Mucositis|oral mucositis
417616|NCT01789658|Children|children
417617|NCT01789658|Cryotherapy|cryotherapy
417618|NCT01789658|Hematopoietic Stem Cell Transplantation|hematopoietic stem cell transplantation
417619|NCT01789645|Carpal tunnel|carpal tunnel
417620|NCT01789645|Physical therapy|physical therapy
417621|NCT01789645|Surgery|surgery
417622|NCT01789645|Efficacy|efficacy
417623|NCT01789606|Self-selection and actual use/compliance trial.|self-selection and actual use/compliance trial.
417624|NCT01789580|Experimental study, moderators, online gambling,|experimental study, moderators, online gambling,
417625|NCT01789580|problem gambling prevention|problem gambling prevention
417626|NCT01789554|Out of hospital cardiac arrest|out of hospital cardiac arrest
417627|NCT01789554|Cardiopulmonary resuscitation|cardiopulmonary resuscitation
417628|NCT01789554|Bystander CPR|bystander cpr
417629|NCT01789554|Mobile phone positioning system|mobile phone positioning system
417630|NCT01789528|Phase I,|phase i,
417631|NCT01789528|open label,|open label,
417632|NCT01789528|CAZ-AVI,|caz-avi,
417633|NCT01789528|CXL,|cxl,
417634|NCT01789528|healthy volunteers,|healthy volunteers,
417635|NCT01789528|intestinal flora.|intestinal flora.
417636|NCT01789502|self-expandable metal stent; plastic stent|self-expandable metal stent; plastic stent
417637|NCT01789476|pain|pain
417638|NCT01789476|acute pain|acute pain
417639|NCT01789476|kappa agonis|kappa agonis
417640|NCT01789476|opioid analgesia|opioid analgesia
417641|NCT01789476|bunionectomy|bunionectomy
417642|NCT01789476|peripheral nervous system agents|peripheral nervous system agents
417643|NCT01789476|physiological effects of drugs|physiological effects of drugs
417644|NCT01789476|surgery|surgery
417645|NCT01789476|post-operative|post-operative
417646|NCT01789476|post-operative complications|post-operative complications
417647|NCT01789450|sensitivity|sensitivity
417648|NCT01789450|section of periareolar dermis|section of periareolar dermis
417649|NCT01789450|breast reduction|breast reduction
417650|NCT01789437|retinal vein occlusion|retinal vein occlusion
417651|NCT01789437|systemic hypertension|systemic hypertension
417652|NCT01789437|arteriolar diameter|arteriolar diameter
417653|NCT01789385|Deep brain stimulation|deep brain stimulation
417654|NCT01789385|Parkinson|parkinson
417655|NCT01789372|paroxysmal atrial fibrillation|paroxysmal atrial fibrillation
417656|NCT01789372|yoga|yoga
417657|NCT01789372|quality of life|quality of life
417658|NCT01789372|blood pressure|blood pressure
417659|NCT01789372|heart rate|heart rate
417660|NCT01789372|heart rate variability|heart rate variability
417661|NCT01789359|anthocyanin|anthocyanin
417662|NCT01789359|bioavailability|bioavailability
417663|NCT01789359|urine|urine
417664|NCT01789359|long-term|long-term
417665|NCT01789346|Scar|scar
417666|NCT01789346|Scars|scars
417667|NCT01789346|Surgical Scar|surgical scar
417668|NCT01789346|Surgical Scars|surgical scars
417669|NCT01789346|Cicatrix|cicatrix
417670|NCT01789346|Hypertrophic Cicatrix|hypertrophic cicatrix
417671|NCT01789346|Keloid|keloid
417672|NCT01789346|Hypertrophic Scar|hypertrophic scar
417673|NCT01789346|Surgical Incision|surgical incision
417674|NCT01789346|Scarring|scarring
417675|NCT01789346|Abdominoplasty|abdominoplasty
417676|NCT01789346|Tummy Tuck|tummy tuck
417677|NCT01789346|Augmentation Mammoplasty|augmentation mammoplasty
417678|NCT01789346|Breast Augmentation|breast augmentation
417679|NCT01789346|Thyroidectomy|thyroidectomy
417680|NCT01789333|Keratoconus|keratoconus
417681|NCT01789333|Ectasia|ectasia
417682|NCT01789333|UVA light|uva light
417683|NCT01789333|riboflavin|riboflavin
417684|NCT01789333|post-LASIK|post-lasik
417685|NCT01789333|irregular astigmatism|irregular astigmatism
417686|NCT01789320|uveitis|uveitis
417687|NCT01789320|intermediate uveitis|intermediate uveitis
417688|NCT01789320|posterior uveitis|posterior uveitis
417689|NCT01789320|panuveitis|panuveitis
417690|NCT01789320|noninfectious uveitis|noninfectious uveitis
417691|NCT01789320|microneedle|microneedle
417692|NCT01789320|suprachoroidal space|suprachoroidal space
417693|NCT01789320|SCS|scs
417694|NCT01789320|inflammation|inflammation
417695|NCT01789320|ocular inflammatory conditions|ocular inflammatory conditions
417696|NCT01789320|triamcinolone acetonide|triamcinolone acetonide
417697|NCT01789320|TA|ta
417698|NCT01789320|Triesence|triesence
417699|NCT01789320|injection|injection
417700|NCT01789320|IVT|ivt
417701|NCT01789320|intravitreal|intravitreal
417702|NCT01789320|corticosteroid|corticosteroid
417703|NCT01789320|sympathetic ophthalmia|sympathetic ophthalmia
417704|NCT01789320|temporal arteritis|temporal arteritis
417705|NCT01789320|vitreous haze|vitreous haze
417706|NCT01789294|lymphoid nodular hyperplasia|lymphoid nodular hyperplasia
417707|NCT01789294|food allergy|food allergy
417708|NCT01789281|Neoplasms, Carcinoid tumor, Neuroendocrine tumor|neoplasms, carcinoid tumor, neuroendocrine tumor
417709|NCT01789268|acute|acute
417710|NCT01789268|adaptive cellular immune phenotypes|adaptive cellular immune phenotypes
417711|NCT01789268|infants|infants
417712|NCT01789268|Lymphocyte|lymphocyte
417713|NCT01789268|premature|premature
417714|NCT01789268|respiratory viral infections|respiratory viral infections
417715|NCT01789229|biobank|biobank
417716|NCT01789229|fresh-frozen tissue|fresh-frozen tissue
417717|NCT01789216|Pilon fractures|pilon fractures
417718|NCT01789216|Calcaneus fractures|calcaneus fractures
417719|NCT01789216|Acute pain|acute pain
417720|NCT01789216|Chronic pain|chronic pain
417721|NCT01789216|Isolated|isolated
417722|NCT01789216|unilateral|unilateral
417723|NCT01789216|Grade I|grade i
417725|NCT01789216|open|open
417726|NCT01789216|closed|closed
417727|NCT01789203|BK infection|bk infection
417728|NCT01789203|BK viremia|bk viremia
417729|NCT01789203|BK nephropathy|bk nephropathy
417730|NCT01789203|polyomavirus|polyomavirus
417731|NCT01789203|fluoroquinolone|fluoroquinolone
417732|NCT01789203|ciprofloxacin|ciprofloxacin
417733|NCT01789190|Honeymoon|honeymoon
417734|NCT01789190|Type 1 diabetes|type 1 diabetes
417735|NCT01789177|Spirometry|spirometry
417736|NCT01789177|Postoperative Care|postoperative care
417737|NCT01789164|TBI|tbi
417738|NCT01789164|fNIRS|fnirs
417739|NCT01789164|hypercapnea|hypercapnea
417740|NCT01789164|Cerebrovascular reactivity|cerebrovascular reactivity
417741|NCT01789151|arthritis|arthritis
417742|NCT01789151|nuclear imaging|nuclear imaging
417743|NCT01789151|rheumatoid|rheumatoid
417744|NCT01789151|ankylosing spondylitis|ankylosing spondylitis
417745|NCT01789151|glucosamine|glucosamine
417746|NCT01789138|Antiretroviral Therapy|antiretroviral therapy
417747|NCT01789138|Adherence|adherence
417748|NCT01789138|Intervention|intervention
417749|NCT01789125|anxiety|anxiety
417750|NCT01789125|stress|stress
417751|NCT01789125|smoking|smoking
417752|NCT01789125|cessation|cessation
417753|NCT01789099|Lung cancer|lung cancer
417754|NCT01789099|Peptide vaccine|peptide vaccine
417755|NCT01789073|Postoperative|postoperative
417756|NCT01789073|Complications|complications
417757|NCT01789073|Elective|elective
417758|NCT01789073|Surgery|surgery
417759|NCT01789073|GI surgery|gi surgery
417760|NCT01789073|Immunonutrition|immunonutrition
417761|NCT01789073|Immune-enhancing|immune-enhancing
417762|NCT01789073|Immune-modulating|immune-modulating
417763|NCT01789073|Nutrition|nutrition
417764|NCT01789073|Pancreatic cancer|pancreatic cancer
417765|NCT01789073|Postoperative complications and length of hospital stay after major gastrointestinal (GI) elective surgery.|postoperative complications and length of hospital stay after major gastrointestinal (gi) elective surgery.
417766|NCT01789047|Parkinson's disease|parkinson's disease
417767|NCT01789047|dyskinesia|dyskinesia
417768|NCT01789047|Indonesia|indonesia
417769|NCT01789047|amantadine|amantadine
417770|NCT01789021|blood glucose monitoring systems|blood glucose monitoring systems
417771|NCT01789021|ISO 15197|iso 15197
417772|NCT01789021|system accuracy|system accuracy
417773|NCT01789008|Transient elastography|transient elastography
417774|NCT01789008|Alcoholic liver disease|alcoholic liver disease
417775|NCT01789008|liver fibrosis|liver fibrosis
417776|NCT01788982|Thyroid Cancer|thyroid cancer
417777|NCT01788982|Medullary thyroid cancer (MTC)|medullary thyroid cancer (mtc)
417778|NCT01788982|Differentiated thyroid cancer (DTC)|differentiated thyroid cancer (dtc)
417779|NCT01788969|Gait training|gait training
417780|NCT01788969|Lexapro|lexapro
417781|NCT01788969|Tizanidine|tizanidine
417782|NCT01788956|venous oximeter|venous oximeter
417783|NCT01788956|CO-Oximeter|co-oximeter
417784|NCT01788956|ICU Patients|icu patients
417785|NCT01788956|Sepsis|sepsis
417786|NCT01788956|non-invasive device|non-invasive device
417787|NCT01788943|positron emission tomography|positron emission tomography
417788|NCT01788943|nicotine receptor|nicotine receptor
417789|NCT01788917|n-3 LC-PUFA, vegetarians, fatty acids, blood lipids|n-3 lc-pufa, vegetarians, fatty acids, blood lipids
417790|NCT01788904|Acute mesenteric ischemia|acute mesenteric ischemia
417791|NCT01788904|Percutaneous endovascular revascularization|percutaneous endovascular revascularization
417792|NCT01788904|Intestinal plasma fatty acid binding protein (i-FABP)|intestinal plasma fatty acid binding protein (i-fabp)
417793|NCT01788904|Bowel necrosis|bowel necrosis
417794|NCT01788891|longitudinal observational cohort study|longitudinal observational cohort study
417795|NCT01788891|multicenter|multicenter
417796|NCT01788891|pediatrics|pediatrics
417797|NCT01788891|Asian|asian
417798|NCT01788891|treatment failure|treatment failure
417799|NCT01788891|renal status|renal status
417800|NCT01788891|toxicities|toxicities
417801|NCT01788891|therapeutic drug monitoring (TDM)|therapeutic drug monitoring (tdm)
417802|NCT01788891|drug levels in blood and hair|drug levels in blood and hair
417803|NCT01788878|socio-professional future|socio-professional future
417804|NCT01788865|covered Metal stent|covered metal stent
417805|NCT01788865|ureteral obstruction|ureteral obstruction
417806|NCT01788852|HPV|hpv
417807|NCT01788852|HIV|hiv
417808|NCT01788852|cervical/anal dysplasia|cervical/anal dysplasia
417809|NCT01788852|intraepithelial neoplasia|intraepithelial neoplasia
417810|NCT01788852|E6/E7 biomarker|e6/e7 biomarker
417811|NCT01788852|perinatally HIV-infected adolescents|perinatally hiv-infected adolescents
417812|NCT01788852|behaviorally HIV-infected adolescents|behaviorally hiv-infected adolescents
417813|NCT01788852|anal and pap smear|anal and pap smear
417814|NCT01788839|Sexual and Reproductive Health|sexual and reproductive health
417815|NCT01788839|premenopausal|premenopausal
417816|NCT01788839|postmenopausal|postmenopausal
417817|NCT01788839|12-249|12-249
417818|NCT01788839|Fertility|fertility
417819|NCT01788826|Ventral hernia|ventral hernia
417820|NCT01788826|surgical meshes|surgical meshes
417821|NCT01788826|polypropylenes|polypropylenes
417822|NCT01788813|Repeat Dose Safety|repeat dose safety
417823|NCT01788813|Allergic Asthma|allergic asthma
417824|NCT01788813|Effect on Allergen Reactivity|effect on allergen reactivity
417825|NCT01788813|Allergic Rhinitis|allergic rhinitis
417826|NCT01788813|TLR7 Agonist|tlr7 agonist
417827|NCT01788813|Pharmacodynamics|pharmacodynamics
417828|NCT01788800|Panic disorder|panic disorder
417829|NCT01788800|Physical activity|physical activity
417830|NCT01788787|Cancer Prevention|cancer prevention
417831|NCT01788787|Tobacco Use Cessation|tobacco use cessation
417832|NCT01788787|Ask Advise Connect|ask advise connect
417833|NCT01788787|AAC|aac
417834|NCT01788787|Smoking Cessation Treatment|smoking cessation treatment
417835|NCT01788787|Texas Quitline|texas quitline
417836|NCT01788787|Saliva sample|saliva sample
417837|NCT01788787|Telephone Counseling|telephone counseling
417838|NCT01788787|Nicotine replacement|nicotine replacement
417839|NCT01788787|Interviews|interviews
417840|NCT01788774|Pharmacokinetics|pharmacokinetics
417841|NCT01788774|Safety|safety
417842|NCT01788774|Risperidone ISM®|risperidone ism®
417843|NCT01788774|Intramuscular|intramuscular
417844|NCT01788774|Schizophrenia|schizophrenia
417845|NCT01788761|Probiotics|probiotics
417846|NCT01788761|Feeding Tolerance|feeding tolerance
417847|NCT01788761|Extremely Low Birthweight Infants|extremely low birthweight infants
417848|NCT01788748|fractional|fractional
534145|NCT01289665|gel|gel
417849|NCT01788748|bipolar|bipolar
417850|NCT01788748|radiofrequency|radiofrequency
417851|NCT01788748|striae|striae
417852|NCT01788748|infrared|infrared
417853|NCT01788748|combined|combined
417854|NCT01788735|unexplained infertility|unexplained infertility
417855|NCT01788735|asthma|asthma
417856|NCT01788735|allergy|allergy
417857|NCT01788709|colonoscopy|colonoscopy
417858|NCT01788709|preparation|preparation
417859|NCT01788696|Parkinsonism|parkinsonism
417860|NCT01788696|Idiopathic Parkinson Disease|idiopathic parkinson disease
417861|NCT01788683|Rotator Cuff|rotator cuff
417862|NCT01788683|Rotator Cuff Tear|rotator cuff tear
417863|NCT01788683|Supraspinatus Tear|supraspinatus tear
417864|NCT01788670|Antioxidants, Central Nervous System Agents|antioxidants, central nervous system agents
417865|NCT01788657|Depression|depression
417866|NCT01788657|Internet|internet
417867|NCT01788657|Cognitive Behavior Therapy|cognitive behavior therapy
417868|NCT01788644|Child adiposity|child adiposity
417869|NCT01788644|Infancy|infancy
417870|NCT01788644|Motor activity|motor activity
417871|NCT01788644|Feeding behavior|feeding behavior
417872|NCT01788644|Sleep|sleep
417873|NCT01788644|Stress, Physiological|stress, physiological
417874|NCT01788618|Cognitive functions|cognitive functions
417875|NCT01788618|Quality of life|quality of life
417876|NCT01788618|Cancer|cancer
417877|NCT01788605|hematologic malignancies|hematologic malignancies
417878|NCT01788605|hematopoietic stem cell transplantation|hematopoietic stem cell transplantation
417879|NCT01788605|ramosetron|ramosetron
417880|NCT01788605|emesis|emesis
417881|NCT01788592|coronary artery disease|coronary artery disease
417882|NCT01788592|drug eluting stent|drug eluting stent
417883|NCT01788579|Intimate Partner Violence (IPV)|intimate partner violence (ipv)
417884|NCT01788579|Drug Abuse|drug abuse
417885|NCT01788579|Criminal Justice|criminal justice
417886|NCT01788553|remission|remission
417887|NCT01788553|generalized anxiety disorder|generalized anxiety disorder
417888|NCT01788540|Recurrent miscarriage|recurrent miscarriage
417889|NCT01788540|Implantation failure|implantation failure
417890|NCT01788540|Intralipid|intralipid
417891|NCT01788540|ICSI / IVF failure|icsi / ivf failure
417892|NCT01788527|Diabetes|diabetes
417893|NCT01788527|Type 1|type 1
417894|NCT01788527|CGM|cgm
417895|NCT01788527|Continuous Glucose Monitor|continuous glucose monitor
417896|NCT01788527|HGM|hgm
417897|NCT01788527|HbA1c|hba1c
417898|NCT01788488|procalcitonin|procalcitonin
417899|NCT01788488|antimicrobial stewardship|antimicrobial stewardship
417900|NCT01788488|pneumonia|pneumonia
417901|NCT01788475|Diabetic Macular Edema|diabetic macular edema
417902|NCT01788475|DME|dme
417903|NCT01788475|Pars Plana Vitrectomy|pars plana vitrectomy
417904|NCT01788462|Tesamorelin|tesamorelin
417905|NCT01788462|Egrifta|egrifta
417906|NCT01788462|HIV|hiv
417907|NCT01788462|Lipodystrophy|lipodystrophy
417908|NCT01788462|Sleep Apnea|sleep apnea
417909|NCT01788449|Antibiotic Bacterial Resistance|antibiotic bacterial resistance
417910|NCT01788436|Schizophrenia|schizophrenia
417911|NCT01788436|Young healthy volunteers|young healthy volunteers
417912|NCT01788436|Elderly healthy volunteers|elderly healthy volunteers
417913|NCT01788436|Learning performance|learning performance
417914|NCT01788423|presbycusis|presbycusis
417915|NCT01788423|hearing aids|hearing aids
417916|NCT01788410|Cryoablation|cryoablation
417917|NCT01788410|Nerves|nerves
417918|NCT01788410|Facet joint|facet joint
417919|NCT01788410|Pain|pain
417920|NCT01788410|Neuralgia|neuralgia
417921|NCT01788410|Neuropathy|neuropathy
417922|NCT01788410|Image-guided|image-guided
417923|NCT01788397|physical disabilities|physical disabilities
417924|NCT01788397|rehabilitation|rehabilitation
417925|NCT01788384|acne|acne
417926|NCT01788384|Clindamycin Phosphate/Benzoyl Peroxide|clindamycin phosphate/benzoyl peroxide
417927|NCT01788384|Acanya|acanya
417928|NCT01788384|Mild to severe acne vulgaris|mild to severe acne vulgaris
417929|NCT01788358|Drug combination|drug combination
417930|NCT01788358|Nifedipine GITS|nifedipine gits
417931|NCT01788358|Candesartan Cilexetil|candesartan cilexetil
417932|NCT01788358|Hypertension|hypertension
417933|NCT01788358|Combination therapy|combination therapy
417934|NCT01788345|non-invasion ventilation|non-invasion ventilation
417935|NCT01788345|Boussignac|boussignac
417936|NCT01788332|NSCLC|nsclc
417937|NCT01788332|non-small cell|non-small cell
417938|NCT01788332|lung cancer|lung cancer
417939|NCT01788319|laser trabeculoplasty|laser trabeculoplasty
417940|NCT01788319|glaucoma|glaucoma
417941|NCT01788306|Elevated risk|elevated risk
417942|NCT01788306|opioid overdose|opioid overdose
417943|NCT01788293|Fluid management|fluid management
417944|NCT01788293|Pleth Variability Index (PVI)|pleth variability index (pvi)
417945|NCT01788293|monitoring|monitoring
417946|NCT01788293|high-risk surgery|high-risk surgery
417947|NCT01788267|Cystic Fibrosis|cystic fibrosis
417948|NCT01788267|High-Resolution peripheral Quantitative Computed Tomography|high-resolution peripheral quantitative computed tomography
417949|NCT01788267|Bone Mass Density|bone mass density
417950|NCT01788254|pharmacokinetic/genetic|pharmacokinetic/genetic
417951|NCT01788254|Cyp450 polymorphisms|cyp450 polymorphisms
417952|NCT01788254|Noninvasive functional characterization of liver heart and kidneys using MRI|noninvasive functional characterization of liver heart and kidneys using mri
417953|NCT01788241|coronary artery disease|coronary artery disease
417954|NCT01788241|Atherosclerosis|atherosclerosis
417955|NCT01788241|Coronary Stenosis|coronary stenosis
417956|NCT01788241|Cardiovascular Diseases|cardiovascular diseases
417957|NCT01788241|Non-significant coronary artery disease|non-significant coronary artery disease
417958|NCT01788241|Mild Stenosis|mild stenosis
417959|NCT01788241|Vascular Irregularities|vascular irregularities
417960|NCT01788241|Psychosocial factors|psychosocial factors
417961|NCT01788241|Personality|personality
417962|NCT01788241|Type D personality|type d personality
417963|NCT01788241|Hostility|hostility
417964|NCT01788241|Depression|depression
417965|NCT01788241|Anxiety|anxiety
417966|NCT01788241|Fatigue|fatigue
417967|NCT01788241|Social Support|social support
417968|NCT01788241|Socioeconomic Status|socioeconomic status
417969|NCT01788241|Patient Reported Outcomes|patient reported outcomes
417970|NCT01788241|Patient Perceived Symptoms|patient perceived symptoms
417971|NCT01788241|Health Status|health status
417972|NCT01788241|Quality of Life|quality of life
417973|NCT01788241|Chest pain|chest pain
417974|NCT01788241|Cardiac risk factors|cardiac risk factors
417975|NCT01788241|Metabolic Syndrome|metabolic syndrome
417976|NCT01788241|BMI|bmi
417977|NCT01788241|Obesity|obesity
417978|NCT01788241|Waist Circumference|waist circumference
417979|NCT01788241|Lifestyle|lifestyle
417980|NCT01788241|Smoking|smoking
417981|NCT01788241|Alcohol use|alcohol use
417982|NCT01788241|Activity|activity
417983|NCT01788241|Hypertension|hypertension
417984|NCT01788241|Diabetes|diabetes
417985|NCT01788241|Familial Cardiovascular Disease|familial cardiovascular disease
417986|NCT01788241|Coronary angiography|coronary angiography
417987|NCT01788241|Computed Tomography|computed tomography
417988|NCT01788228|Vaccine|vaccine
417989|NCT01788228|Occupational exposure|occupational exposure
417990|NCT01788228|Influenza|influenza
417991|NCT01788228|H5N1|h5n1
417992|NCT01788215|Polycystic Ovarian Syndrome|polycystic ovarian syndrome
417993|NCT01788215|Irregular Menstrual Cycles|irregular menstrual cycles
417994|NCT01788215|Androgen Excess in Women|androgen excess in women
417995|NCT01788202|cocaine and general anesthesia|cocaine and general anesthesia
417996|NCT01788189|Lymphoma|lymphoma
417997|NCT01788189|CD20|cd20
417998|NCT01788189|Relapse|relapse
417999|NCT01788189|Lenalidomide|lenalidomide
418000|NCT01788176|Complex Regional Pain Syndromes|complex regional pain syndromes
418001|NCT01788176|drug therapy|drug therapy
418002|NCT01788176|zoledronic acid|zoledronic acid
418003|NCT01788163|EGFR|egfr
418004|NCT01788163|aNSCLC|ansclc
418005|NCT01788163|mutation status|mutation status
418006|NCT01788163|diagnostic study|diagnostic study
418007|NCT01788163|Russia|russia
418008|NCT01788163|China|china
418009|NCT01788163|Asia|asia
418010|NCT01788137|T-cell lymphoma,DFS,OS|t-cell lymphoma,dfs,os
418011|NCT01788124|Speculum|speculum
418012|NCT01788124|Metal|metal
418013|NCT01788124|Plastic|plastic
418014|NCT01788124|Visual Analoge Scale|visual analoge scale
418015|NCT01788124|Discomfort|discomfort
418016|NCT01788085|GERD|gerd
418017|NCT01788072|Autism Spectrum Disorders|autism spectrum disorders
418018|NCT01788072|Oxytocin|oxytocin
418019|NCT01788072|Adults|adults
418020|NCT01788059|nonunion|nonunion
418021|NCT01788059|mesenchymal stem cell|mesenchymal stem cell
418022|NCT01788059|long bone|long bone
418023|NCT01788046|Secondary Hyperparathyroidism (SHPT), chronic kidney disease (CKD), hemodialysis, parathyroid hormone (PTH), hypocalcemia, bone and mineral metabolism|secondary hyperparathyroidism (shpt), chronic kidney disease (ckd), hemodialysis, parathyroid hormone (pth), hypocalcemia, bone and mineral metabolism
418121|NCT01787578|thyroid|thyroid
418024|NCT01788007|Actinic Keratosis|actinic keratosis
418025|NCT01788007|Imiquimod Topical Cream 3.75%|imiquimod topical cream 3.75%
418026|NCT01788007|Zyclara® (imiquimod) Topical Cream 3.75%|zyclara® (imiquimod) topical cream 3.75%
418027|NCT01787968|Congenital transmission|congenital transmission
418028|NCT01787968|Trypanosoma cruzi|trypanosoma cruzi
418029|NCT01787968|Chagas disease|chagas disease
418030|NCT01787955|Pylorus preserving pancreaticoduodenectomy(PPPD), Delayed gastric emptying syndrome(DGE), Braun anastomosis|pylorus preserving pancreaticoduodenectomy(pppd), delayed gastric emptying syndrome(dge), braun anastomosis
418031|NCT01787942|Lipid thickness|lipid thickness
418032|NCT01787942|Blepharoplasty|blepharoplasty
418033|NCT01787942|Tear break up time|tear break up time
418034|NCT01787942|Corneal staining|corneal staining
418035|NCT01787916|type 1 diabetes|type 1 diabetes
418036|NCT01787916|overweight|overweight
418037|NCT01787916|insulin|insulin
418038|NCT01787916|liraglutide|liraglutide
418039|NCT01787903|Type 1 diabetes mellitus|type 1 diabetes mellitus
418040|NCT01787903|Hypoglycemia unawareness|hypoglycemia unawareness
710614|NCT00588562|PH|ph
710615|NCT00588562|PH1|ph1
418041|NCT01787903|Real-time continuous glucose monitoring|real-time continuous glucose monitoring
418042|NCT01787903|Glucose control|glucose control
418043|NCT01787877|Cerebrovascular Accident, Inflammatory biomarkers|cerebrovascular accident, inflammatory biomarkers
418044|NCT01787864|Barrett's Esophagus|barrett's esophagus
418045|NCT01787864|Intestinal metaplasia|intestinal metaplasia
418046|NCT01787864|Intramucosal Adenocarcinoma|intramucosal adenocarcinoma
418047|NCT01787864|Gastric Cardia|gastric cardia
418048|NCT01787864|High Cardia Dysplasia|high cardia dysplasia
418049|NCT01787864|Radiofrequency ablation (RFA)|radiofrequency ablation (rfa)
418050|NCT01787851|Heart failure|heart failure
418051|NCT01787851|Anaplerosis|anaplerosis
418052|NCT01787851|Medium-chain fatty acid|medium-chain fatty acid
418053|NCT01787838|Pneumococcal vaccination rates, ambulatory settings|pneumococcal vaccination rates, ambulatory settings
418054|NCT01787825|intestinal disease|intestinal disease
418055|NCT01787825|inflammatory bowel disease|inflammatory bowel disease
418056|NCT01787825|crohn disease|crohn disease
418057|NCT01787825|ulcer|ulcer
418058|NCT01787825|celiac disease|celiac disease
418059|NCT01787825|angioectasia|angioectasia
418060|NCT01787825|polyp|polyp
418061|NCT01787799|Drug-eluting stents|drug-eluting stents
418062|NCT01787786|Crohn's Disease|crohn's disease
418063|NCT01787786|Ulcerative Colitis|ulcerative colitis
418064|NCT01787786|Optimal Use of infliximab|optimal use of infliximab
418065|NCT01787773|Inferior Vena Cava Filter|inferior vena cava filter
418066|NCT01787773|Vena Cava Filters|vena cava filters
418067|NCT01787747|Pharmacokinetics|pharmacokinetics
418068|NCT01787747|Healthy Volunteers|healthy volunteers
418069|NCT01787747|dextromethorphan with quinidine|dextromethorphan with quinidine
418070|NCT01787747|deuterated dextromethorphan|deuterated dextromethorphan
418071|NCT01787721|Gait|gait
418072|NCT01787721|Ankle joint|ankle joint
418073|NCT01787721|Manipulation, Chiropractic|manipulation, chiropractic
418074|NCT01787708|Vitiligo|vitiligo
418075|NCT01787708|red|red
418076|NCT01787708|laser|laser
418077|NCT01787708|light|light
418078|NCT01787695|Vitiligo|vitiligo
418079|NCT01787695|UVA1|uva1
418080|NCT01787695|Phototherapy|phototherapy
418081|NCT01787682|CHF|chf
418082|NCT01787682|Protein digestion|protein digestion
418083|NCT01787682|Fat digestion|fat digestion
418084|NCT01787682|Gut function|gut function
418085|NCT01787682|Glucose absorption|glucose absorption
418086|NCT01787682|Muscle function|muscle function
418087|NCT01787669|diabetic macular oedema|diabetic macular oedema
418088|NCT01787669|diabetic macular edema|diabetic macular edema
418089|NCT01787669|diabetic retinopathy|diabetic retinopathy
418090|NCT01787669|dexamethasone|dexamethasone
418091|NCT01787669|Ozurdex|ozurdex
418092|NCT01787669|Avastin|avastin
418093|NCT01787669|bevacizumab|bevacizumab
418094|NCT01787669|DME|dme
418095|NCT01787669|DMO|dmo
418096|NCT01787643|height-adjustable desk|height-adjustable desk
418097|NCT01787643|office workers|office workers
418098|NCT01787643|sitting occupations|sitting occupations
418099|NCT01787643|energy expenditure|energy expenditure
418100|NCT01787643|BMI|bmi
418101|NCT01787643|Weight|weight
418102|NCT01787643|Lower fat diet|lower fat diet
418103|NCT01787630|Prostatic cancer|prostatic cancer
418104|NCT01787630|Radiotherapy|radiotherapy
418105|NCT01787630|Hyaluronic acid|hyaluronic acid
418106|NCT01787617|Exercise Training|exercise training
418107|NCT01787617|Strength Training|strength training
418108|NCT01787617|African American Men|african american men
418109|NCT01787617|Insulin Resistance|insulin resistance
418110|NCT01787604|Valve-sparing|valve-sparing
418111|NCT01787604|Valve repair|valve repair
418112|NCT01787591|Vitamin E|vitamin e
418113|NCT01787591|Metabolic syndrome|metabolic syndrome
418114|NCT01787591|Liver disease|liver disease
418115|NCT01787591|Non-alcoholic liver steatohepatitis|non-alcoholic liver steatohepatitis
418116|NCT01787591|Fatty liver|fatty liver
418117|NCT01787591|Dairy consumption|dairy consumption
418118|NCT01787578|X-linked adrenoleukodystrophy|x-linked adrenoleukodystrophy
418119|NCT01787578|adrenomyeloneuropathy|adrenomyeloneuropathy
418120|NCT01787578|sobetirome|sobetirome
418122|NCT01787578|thyromimetic|thyromimetic
418123|NCT01787565|non-interventional|non-interventional
418124|NCT01787565|clinical|clinical
418125|NCT01787565|investigation|investigation
418126|NCT01787565|low|low
418127|NCT01787565|back|back
418128|NCT01787565|pain|pain
418129|NCT01787565|painPREMIER|painpremier
418130|NCT01787552|Dose escalation|dose escalation
418131|NCT01787552|Maximum Tolerated Dose|maximum tolerated dose
418132|NCT01787552|MTD|mtd
418133|NCT01787552|Safety Expansion|safety expansion
418134|NCT01787552|Safety|safety
418135|NCT01787552|Efficacy|efficacy
418136|NCT01787552|Myelofibrosis|myelofibrosis
418137|NCT01787552|Post-polycythemia vera myelofbrosis (Post PV-PMF)|post-polycythemia vera myelofbrosis (post pv-pmf)
418260|NCT01786798|Endometrial hyperplasia|endometrial hyperplasia
418138|NCT01787552|Post essential thrombocythemia myelofibrosis (Post ET-MF)|post essential thrombocythemia myelofibrosis (post et-mf)
418139|NCT01787552|Primary myelofibrosis (PMF)|primary myelofibrosis (pmf)
418140|NCT01787552|Intermediate risk myelofibrosis|intermediate risk myelofibrosis
418141|NCT01787552|High risk myelofibrosis|high risk myelofibrosis
418142|NCT01787552|Combination Treatment|combination treatment
418143|NCT01787552|Hedgehog Signaling Pathway|hedgehog signaling pathway
418144|NCT01787552|Smoothened inhibitor|smoothened inhibitor
418145|NCT01787552|JAK inhibitor|jak inhibitor
418146|NCT01787539|gastric cancer|gastric cancer
418147|NCT01787539|perioperative chemotherapy|perioperative chemotherapy
418148|NCT01787539|combined modality therapy|combined modality therapy
418149|NCT01787539|gastrectomy|gastrectomy
418150|NCT01787526|iron depletion|iron depletion
418151|NCT01787526|donor safety|donor safety
418152|NCT01787526|blood donation|blood donation
418153|NCT01787526|transfusion medicine|transfusion medicine
418154|NCT01787526|iron deficiency|iron deficiency
418155|NCT01787526|intravenous iron|intravenous iron
418157|NCT01787526|restless legs syndrome|restless legs syndrome
418158|NCT01787526|anemia|anemia
418159|NCT01787461|Trial assessing effects of an oral dietary supplement on overall facial appearance among healthy women with photodamaged skin.|trial assessing effects of an oral dietary supplement on overall facial appearance among healthy women with photodamaged skin.
418160|NCT01787448|repeat insult patch test|repeat insult patch test
418161|NCT01787435|Asthma,|asthma,
418162|NCT01787435|acid-suppressing drugs,|acid-suppressing drugs,
418163|NCT01787435|pregnancy,|pregnancy,
418164|NCT01787435|epidemiology|epidemiology
418165|NCT01787422|Telemedicine|telemedicine
418166|NCT01787383|Actinic Keratosis|actinic keratosis
418167|NCT01787383|Ingenol mebutate gel|ingenol mebutate gel
418168|NCT01787370|coronary artery disease, endothelial dysfunction|coronary artery disease, endothelial dysfunction
418169|NCT01787357|Healthy|healthy
418170|NCT01787357|Canagliflozin (JNJ-28431754)|canagliflozin (jnj-28431754)
418171|NCT01787357|Pharmacokinetics|pharmacokinetics
418172|NCT01787357|Moxifloxacin|moxifloxacin
418173|NCT01787357|Electrocardiogram Parameters|electrocardiogram parameters
418174|NCT01787357|QT/QTc Interval|qt/qtc interval
418175|NCT01787357|Therapeutic dose|therapeutic dose
418176|NCT01787357|Supra-Therapeutic dose|supra-therapeutic dose
418177|NCT01787344|Other Infantile Cerebral Palsy|other infantile cerebral palsy
418178|NCT01787305|microbiome|microbiome
418179|NCT01787305|commensals|commensals
418180|NCT01787305|autoantibodies|autoantibodies
418181|NCT01787305|autoreactive T cells|autoreactive t cells
418182|NCT01787292|Exercise|exercise
418183|NCT01787292|Magnetic Resonance Imaging|magnetic resonance imaging
418184|NCT01787292|Transcranial Magnetic Stimulation|transcranial magnetic stimulation
418185|NCT01787292|Aging|aging
418186|NCT01787214|glucose variability|glucose variability
418187|NCT01787214|glycemia|glycemia
418188|NCT01787214|type-2 diabetes|type-2 diabetes
418189|NCT01787175|Medication Therapy Management|medication therapy management
418190|NCT01787175|Clinical Decision Support Systems|clinical decision support systems
418191|NCT01787175|Medical Informatics|medical informatics
418192|NCT01787175|Patient Care Management|patient care management
418193|NCT01787175|United States Department of Veterans Affairs|united states department of veterans affairs
418194|NCT01787162|Myeloproliferative disorders|myeloproliferative disorders
418195|NCT01787162|pulmonary hypertension|pulmonary hypertension
418196|NCT01787162|pulmonary vascular diseases|pulmonary vascular diseases
418197|NCT01787149|ENIA11|enia11
418198|NCT01787149|DMARDs|dmards
418199|NCT01787149|RA|ra
418200|NCT01787149|TNF|tnf
418201|NCT01787110|Acute coronary syndrome|acute coronary syndrome
418202|NCT01787110|Acute myocardial infarction|acute myocardial infarction
418203|NCT01787110|Non ST-segment Myocardial Infarction|non st-segment myocardial infarction
418204|NCT01787110|ST-segment Myocardial Infarction|st-segment myocardial infarction
418205|NCT01787110|STEMI|stemi
418206|NCT01787110|NSTEMI|nstemi
418207|NCT01787110|Oxygen|oxygen
418208|NCT01787110|Unstable angina|unstable angina
418209|NCT01787110|Randomised trial|randomised trial
418210|NCT01787110|CMR|cmr
418211|NCT01787110|Mortality|mortality
418212|NCT01787110|RCRT|rcrt
418213|NCT01787110|RRCT|rrct
418214|NCT01787084|Aortic Stenosis|aortic stenosis
418215|NCT01787084|TAVR|tavr
418216|NCT01787071|fluids|fluids
418217|NCT01787071|crtically ill patients|crtically ill patients
418218|NCT01787071|functional hemodynamics|functional hemodynamics
418219|NCT01787071|cvp|cvp
418220|NCT01787058|WASH|wash
418221|NCT01787058|schoolchildren|schoolchildren
418222|NCT01787058|absenteeism|absenteeism
418223|NCT01787045|SEPSIS|sepsis
418224|NCT01787006|non resectable|non resectable
418225|NCT01787006|locally advanced|locally advanced
418226|NCT01787006|Cetuximab|cetuximab
418227|NCT01787006|radiation|radiation
418228|NCT01786967|overactive bladder|overactive bladder
418229|NCT01786967|urge urinary incontinence|urge urinary incontinence
418230|NCT01786967|pharmacogenetics|pharmacogenetics
418231|NCT01786954|vitreoretinal surgery|vitreoretinal surgery
418232|NCT01786954|intraocular pressure|intraocular pressure
418233|NCT01786954|applanation|applanation
418234|NCT01786954|rebound|rebound
418235|NCT01786954|tonometry|tonometry
418236|NCT01786941|Branched-chain Amino Acids|branched-chain amino acids
418237|NCT01786941|Insulin Sensitivity|insulin sensitivity
418238|NCT01786941|Exercise|exercise
418239|NCT01786941|Leucine|leucine
418240|NCT01786928|chronic obstructive pulmonary disease|chronic obstructive pulmonary disease
418241|NCT01786928|exacerbation|exacerbation
418242|NCT01786928|resistance training|resistance training
418243|NCT01786928|muscle force|muscle force
418244|NCT01786902|growth hormone|growth hormone
418245|NCT01786876|Radiolabelled|radiolabelled
418246|NCT01786876|AME|ame
418247|NCT01786850|Locally advanced Pancreatic Cancer|locally advanced pancreatic cancer
418248|NCT01786850|Noninvasive treatment|noninvasive treatment
418249|NCT01786850|High Intensity focused ultrasound|high intensity focused ultrasound
418250|NCT01786850|Magnetic Resonance|magnetic resonance
418251|NCT01786837|constipation|constipation
418252|NCT01786837|gastric emptying|gastric emptying
418253|NCT01786824|contrast induced nephropathy|contrast induced nephropathy
418254|NCT01786824|hydration strategy|hydration strategy
418255|NCT01786824|L-carnitine|l-carnitine
418256|NCT01786798|Transvaginal sonography|transvaginal sonography
418257|NCT01786798|Endometrial thickness|endometrial thickness
418258|NCT01786798|Endometrial pattern|endometrial pattern
418259|NCT01786798|Abnormal uterine bleeding|abnormal uterine bleeding
418261|NCT01786798|Endometrial cancer|endometrial cancer
418262|NCT01786772|arthroscopic partial meniscectomy|arthroscopic partial meniscectomy
418263|NCT01786772|meniscus|meniscus
418264|NCT01786772|quadriceps strength|quadriceps strength
418265|NCT01786772|quadriceps voluntary activation|quadriceps voluntary activation
418266|NCT01786772|cryotherapy|cryotherapy
418267|NCT01786772|compression|compression
418268|NCT01786772|vasopneumatic compression|vasopneumatic compression
418269|NCT01786772|intermittent pneumatic compression|intermittent pneumatic compression
418270|NCT01786759|lipids|lipids
418271|NCT01786759|preterm infants|preterm infants
418272|NCT01786759|parenteral nutrition|parenteral nutrition
418273|NCT01786759|liver function|liver function
418274|NCT01786746|depression|depression
418275|NCT01786746|cognitive behavioral therapy|cognitive behavioral therapy
418276|NCT01786746|culture|culture
418277|NCT01786746|Chinese Americans|chinese americans
418278|NCT01786746|psychotherapy|psychotherapy
418279|NCT01786733|Acute Inpatient Psychiatry|acute inpatient psychiatry
418280|NCT01786733|Continuity of Care|continuity of care
418281|NCT01786733|Behavioral Activation|behavioral activation
418282|NCT01786733|Depression|depression
418283|NCT01786720|COPD|copd
418284|NCT01786720|Triple Therapy|triple therapy
418285|NCT01786720|ICS|ics
418286|NCT01786720|LABA|laba
418287|NCT01786720|LAMA|lama
418288|NCT01786707|Type 2 Diabetes Mellitus|type 2 diabetes mellitus
418289|NCT01786707|Hyperbaric oxygen therapy (HOT)|hyperbaric oxygen therapy (hot)
418290|NCT01786707|Autologous Bone Marrow-Derived Buffy Coat|autologous bone marrow-derived buffy coat
418291|NCT01786707|Stem cells (SC)|stem cells (sc)
418292|NCT01786694|rectum|rectum
418293|NCT01786694|microdialysis|microdialysis
418294|NCT01786694|quality of life|quality of life
418295|NCT01786681|Morbid obesity|morbid obesity
418296|NCT01786681|Bariatric Surgery|bariatric surgery
418297|NCT01786681|Pulmonary Atelectasis|pulmonary atelectasis
418298|NCT01786681|Spirometry|spirometry
418299|NCT01786681|Continuous Positive Airway Pressure|continuous positive airway pressure
418300|NCT01786681|Physical Therapy Specialty|physical therapy specialty
418301|NCT01786668|Ankylosing Spondylitis|ankylosing spondylitis
418302|NCT01786668|Spondylitis|spondylitis
418303|NCT01786668|Ankylosing|ankylosing
418304|NCT01786668|Spondyloarthritis|spondyloarthritis
418305|NCT01786668|Spondyloarthropathy|spondyloarthropathy
418306|NCT01786668|Oral preparation|oral preparation
418307|NCT01786655|local anesthetic|local anesthetic
418308|NCT01786655|neosaxitoxin|neosaxitoxin
418309|NCT01786655|neoSTX|neostx
418310|NCT01786655|bupivacaine|bupivacaine
418311|NCT01786655|safety|safety
418312|NCT01786655|phase 1|phase 1
418313|NCT01786655|pharmacokinetic|pharmacokinetic
418314|NCT01786577|Neuroimaging Biomarkers|neuroimaging biomarkers
418315|NCT01786577|Cognitive Decline in Elderly|cognitive decline in elderly
418316|NCT01786577|Memory, Thinking problems for Older Adults|memory, thinking problems for older adults
418317|NCT01786577|Executive Decline|executive decline
418318|NCT01786577|Post-operative cognitive change|post-operative cognitive change
418319|NCT01786564|diabetes|diabetes
418320|NCT01786564|sleep|sleep
418321|NCT01786525|Live Donor Kidney Transplantation|live donor kidney transplantation
418322|NCT01786525|LDKT|ldkt
418323|NCT01786525|African American|african american
418324|NCT01786525|Disparity|disparity
418325|NCT01786525|Education|education
418326|NCT01786525|Patient Support|patient support
418327|NCT01786512|Pharmacokinetics|pharmacokinetics
418328|NCT01786512|Omecamtiv mecarbil|omecamtiv mecarbil
418329|NCT01786512|AMG 423|amg 423
418330|NCT01786512|Double-blind|double-blind
418331|NCT01786512|Randomized|randomized
418332|NCT01786512|Placebo-controlled|placebo-controlled
418333|NCT01786512|Oral forumlation|oral forumlation
418334|NCT01786512|CK-1827452|ck-1827452
418335|NCT01786512|Cardiac myosin activator|cardiac myosin activator
418336|NCT01786499|Burnout|burnout
418337|NCT01786499|Stress|stress
418338|NCT01786499|Provider|provider
418339|NCT01786499|Relaxation Response|relaxation response
418340|NCT01786434|colonoscopy|colonoscopy
418341|NCT01786434|pain|pain
418342|NCT01786421|Ethanol|ethanol
418343|NCT01786421|Lipemia|lipemia
418344|NCT01786421|Postprandial|postprandial
418345|NCT01786421|Triglyceride|triglyceride
418346|NCT01786395|UF-021|uf-021
418347|NCT01786395|unoprostone|unoprostone
418349|NCT01786369|Schizophrenia|schizophrenia
418350|NCT01786369|Psychotic Disorders|psychotic disorders
418351|NCT01786369|Bipolar Disorder|bipolar disorder
418352|NCT01786369|Antipsychotic Agents|antipsychotic agents
418353|NCT01786369|Drug Monitoring|drug monitoring
418354|NCT01786356|posterior capsule opacification|posterior capsule opacification
418355|NCT01786356|PCO|pco
418356|NCT01786356|after cataract|after cataract
418357|NCT01786356|intraocular lens|intraocular lens
418358|NCT01786343|Leukemia|leukemia
418359|NCT01786343|Acute myeloid leukemia|acute myeloid leukemia
418360|NCT01786343|AML|aml
418361|NCT01786343|Response rates|response rates
418362|NCT01786343|Decitabine|decitabine
418363|NCT01786343|Dacogen|dacogen
418364|NCT01786317|Fecal incontinence, ano-rectal manometry|fecal incontinence, ano-rectal manometry
418365|NCT01786304|Fecal incontinence, sacral nerve stimulation|fecal incontinence, sacral nerve stimulation
418366|NCT01786291|obstructive sleep apnea|obstructive sleep apnea
418367|NCT01786291|continuous positive airway pressure|continuous positive airway pressure
418368|NCT01786291|cardiopulmonary exercise test|cardiopulmonary exercise test
418369|NCT01786291|VE/VCO2|ve/vco2
418370|NCT01786278|adenocarcinoma|adenocarcinoma
418371|NCT01786278|esophago-gastric junction|esophago-gastric junction
418372|NCT01786278|dysphagia|dysphagia
418373|NCT01786278|brachytherapy|brachytherapy
418374|NCT01786278|endoscopic stenting|endoscopic stenting
418375|NCT01786252|embryo|embryo
418376|NCT01786252|implantation|implantation
418377|NCT01786252|blastocyst|blastocyst
418378|NCT01786252|in vitro fertilization|in vitro fertilization
418379|NCT01786252|human chorionic gonadotropin|human chorionic gonadotropin
418380|NCT01786239|Adolescence|adolescence
418381|NCT01786239|Adult|adult
418382|NCT01786239|Antipsychotic Agents|antipsychotic agents
418383|NCT01786239|Female|female
418384|NCT01786239|Human|human
418385|NCT01786239|Male|male
418386|NCT01786239|Risperidone|risperidone
418387|NCT01786239|Omega-3|omega-3
418388|NCT01786239|Schizophrenia|schizophrenia
418389|NCT01786239|Schizophreniform|schizophreniform
418390|NCT01786239|Schizoaffective|schizoaffective
418391|NCT01786239|Schizophrenia -- *drug therapy|schizophrenia -- *drug therapy
418392|NCT01786226|leiomyoma, fibroid, mifepristone, antiprogestins|leiomyoma, fibroid, mifepristone, antiprogestins
418393|NCT01786213|adenoma detection rate, colonoscopy, trainee, learning curve|adenoma detection rate, colonoscopy, trainee, learning curve
418394|NCT01786200|colon|colon
418395|NCT01786200|cancer|cancer
418396|NCT01786200|NSAID|nsaid
418397|NCT01786200|inflammation|inflammation
418398|NCT01786187|Lung Cancer|lung cancer
418399|NCT01786187|Symptoms|symptoms
418400|NCT01786174|ALS|als
418401|NCT01786174|Gilenya|gilenya
418402|NCT01786174|Fingolimod|fingolimod
418403|NCT01786148|HIV/AIDS|hiv/aids
418404|NCT01786148|Adherence|adherence
418405|NCT01786148|Self-management|self-management
418406|NCT01786148|Antiretroviral therapy|antiretroviral therapy
418407|NCT01786135|Antibodies, Monoclonal|antibodies, monoclonal
418408|NCT01786135|Antibody-Drug Conjugate|antibody-drug conjugate
418409|NCT01786135|Antigens, CD19|antigens, cd19
418410|NCT01786135|B-Lineage Lymphoblastic Lymphoma|b-lineage lymphoblastic lymphoma
418411|NCT01786135|Burkitt Lymphoma|burkitt lymphoma
418412|NCT01786135|Diffuse Large B-Cell Lymphoma|diffuse large b-cell lymphoma
418413|NCT01786135|Mantle Cell Lymphoma|mantle cell lymphoma
418414|NCT01786135|B-Cell Lymphoma|b-cell lymphoma
418415|NCT01786135|Drug Therapy|drug therapy
418416|NCT01786135|Monomethylauristatin F|monomethylauristatin f
418417|NCT01786135|Follicular Lymphoma Grade 3|follicular lymphoma grade 3
418418|NCT01786122|physical exercise|physical exercise
418419|NCT01786122|Health Related Quality of Life|health related quality of life
418420|NCT01786122|Non-Small-Cell Lung Carcinoma|non-small-cell lung carcinoma
418421|NCT01786122|digestive system neoplasms|digestive system neoplasms
418422|NCT01786122|breast neoplasms|breast neoplasms
418423|NCT01786109|anandamide|anandamide
418424|NCT01786109|cannabinoid|cannabinoid
418425|NCT01786109|fatty acid amide hydrolase|fatty acid amide hydrolase
418426|NCT01786109|gastric|gastric
418427|NCT01786109|motility|motility
418428|NCT01786109|small bowel|small bowel
418429|NCT01786109|sensory|sensory
418430|NCT01786109|motor|motor
418431|NCT01786096|Burkitt Lymphoma|burkitt lymphoma
418432|NCT01786096|Antibodies, Monoclonal|antibodies, monoclonal
418433|NCT01786096|Antibody-Drug Conjugate|antibody-drug conjugate
710616|NCT00588562|PH2|ph2
710617|NCT00588562|PH3|ph3
534875|NCT01286610|ICU|icu
418434|NCT01786096|B-Lineage Acute Lymphoblastic Leukemia|b-lineage acute lymphoblastic leukemia
418435|NCT01786096|B-Lineage Lymphoblastic Lymphoma|b-lineage lymphoblastic lymphoma
418436|NCT01786096|Burkitt Leukemia|burkitt leukemia
418437|NCT01786096|Monomethylauristatin F|monomethylauristatin f
418438|NCT01786096|Antigens, CD19|antigens, cd19
418439|NCT01786096|Drug Therapy|drug therapy
418440|NCT01786083|family caregivers|family caregivers
418441|NCT01786083|dependency|dependency
418442|NCT01786083|Problem Solving Technique|problem solving technique
418443|NCT01786083|home based nursing|home based nursing
418444|NCT01786044|patient education|patient education
418445|NCT01786044|primary health care|primary health care
418446|NCT01786018|Non Hodgkin lymphomas|non hodgkin lymphomas
418447|NCT01786018|Allogeneic Transplantation|allogeneic transplantation
418448|NCT01786018|Thiotepa|thiotepa
418449|NCT01786018|Busulfan|busulfan
418450|NCT01786018|Fludarabin|fludarabin
418451|NCT01785992|Oestrogen receptor|oestrogen receptor
418452|NCT01785992|Locally advanced|locally advanced
418453|NCT01785992|Metastatic|metastatic
418454|NCT01785992|Breast cancer|breast cancer
418455|NCT01785992|Sulfatase inhibitor|sulfatase inhibitor
418456|NCT01785966|Critical care|critical care
418457|NCT01785966|quality improvement|quality improvement
418458|NCT01785966|checklist|checklist
418459|NCT01785940|Interscalene Block|interscalene block
418460|NCT01785940|Perineural catheter|perineural catheter
418461|NCT01785940|Ropivacaine|ropivacaine
418462|NCT01785940|Postoperative pain|postoperative pain
418463|NCT01785940|Home regional|home regional
418464|NCT01785927|Antituberculosis|antituberculosis
418465|NCT01785927|Dry powder aerosols|dry powder aerosols
418466|NCT01785927|Inhalation|inhalation
418467|NCT01785901|asthma|asthma
418468|NCT01785901|control rate|control rate
418469|NCT01785901|budesonide/formoterol|budesonide/formoterol
418470|NCT01785901|Non-Interventional study|non-interventional study
418471|NCT01785888|EGFR,|egfr,
418472|NCT01785888|aNSCLC,|ansclc,
418473|NCT01785888|mutation status,|mutation status,
418474|NCT01785888|diagnostic study,|diagnostic study,
418475|NCT01785888|Europe,|europe,
418476|NCT01785888|Japan|japan
418477|NCT01785875|Secondary Hyperparathyroidism (SHPT), chronic kidney disease (CKD), hemodialysis, parathyroid hormone (PTH), hypocalcemia, bone and mineral metabolism|secondary hyperparathyroidism (shpt), chronic kidney disease (ckd), hemodialysis, parathyroid hormone (pth), hypocalcemia, bone and mineral metabolism
418478|NCT01785862|sore throat pain|sore throat pain
418479|NCT01785862|tonsillopharyngitis|tonsillopharyngitis
418480|NCT01785862|upper respiratory tract infection|upper respiratory tract infection
418481|NCT01785849|Secondary Hyperparathyroidism (SHPT), chronic kidney disease (CKD), hemodialysis, parathyroid hormone (PTH), hypocalcemia, bone and mineral metabolism|secondary hyperparathyroidism (shpt), chronic kidney disease (ckd), hemodialysis, parathyroid hormone (pth), hypocalcemia, bone and mineral metabolism
418482|NCT01785823|analgesia|analgesia
418483|NCT01785823|fentanyl|fentanyl
418484|NCT01785823|total intravenous anesthesia|total intravenous anesthesia
418485|NCT01785758|complications, renal;|complications, renal;
418486|NCT01785758|kidney, failure;|kidney, failure;
418487|NCT01785758|neuromuscular block, antagonism;|neuromuscular block, antagonism;
418488|NCT01785758|neuromuscular block, rocuronium;|neuromuscular block, rocuronium;
418489|NCT01785758|safety, drug|safety, drug
418490|NCT01785758|sugammadex|sugammadex
418491|NCT01785745|conservative treatment|conservative treatment
418492|NCT01785745|shoulder|shoulder
418493|NCT01785745|neurocognitive therapeutic exercise|neurocognitive therapeutic exercise
418494|NCT01785745|traditional therapeutic exercise|traditional therapeutic exercise
418495|NCT01785745|pain|pain
418496|NCT01785719|Weight Loss|weight loss
418497|NCT01785719|Polycystic Ovary Syndrome (PCOS)|polycystic ovary syndrome (pcos)
418498|NCT01785719|Ovarian Follicle Development|ovarian follicle development
418499|NCT01785719|Metabolism|metabolism
418500|NCT01785693|Nerve block|nerve block
418501|NCT01785693|Femoropopliteal bypass|femoropopliteal bypass
418502|NCT01785693|Postoperative analgesia|postoperative analgesia
418503|NCT01785693|Peripheral circulation|peripheral circulation
418504|NCT01785693|Levobupivacaine|levobupivacaine
418505|NCT01785693|Clonidine|clonidine
418506|NCT01785693|Pain|pain
418507|NCT01785680|MAM|mam
418508|NCT01785680|SAM|sam
418509|NCT01785654|Reventilation collapse|reventilation collapse
418510|NCT01785654|Rate of reventilation collapse|rate of reventilation collapse
418511|NCT01785654|Risk factor of reventilation collapse|risk factor of reventilation collapse
418512|NCT01785654|Hemodynamic profile of reventilation collapse|hemodynamic profile of reventilation collapse
418513|NCT01785654|Biologic approach of reventilation collapse|biologic approach of reventilation collapse
418514|NCT01785641|peritoneal dialysis|peritoneal dialysis
418515|NCT01785641|peritonitis|peritonitis
418516|NCT01785628|Parkinson's disease|parkinson's disease
418517|NCT01785628|dementia|dementia
418518|NCT01785628|NMDA|nmda
418519|NCT01785628|event related potential|event related potential
418520|NCT01785628|Bereitschaftspotential|bereitschaftspotential
418521|NCT01785615|metabolic syndrome|metabolic syndrome
418522|NCT01785615|atorvastatin|atorvastatin
418523|NCT01785615|women|women
418524|NCT01785602|Atopic eczema|atopic eczema
418525|NCT01785602|Skin Diseases|skin diseases
418526|NCT01785589|coronary artery disease|coronary artery disease
418527|NCT01785589|cardiac nuclear medicine|cardiac nuclear medicine
418528|NCT01785589|myocardial perfusion imaging|myocardial perfusion imaging
418529|NCT01785589|invasive coronary angiography|invasive coronary angiography
418530|NCT01785576|couples|couples
418531|NCT01785576|head and neck cancer|head and neck cancer
418532|NCT01785576|oncology|oncology
418533|NCT01785576|spousal support|spousal support
418534|NCT01785563|NAVA|nava
418535|NCT01785563|NIV-NAVA|niv-nava
418536|NCT01785563|VLBW|vlbw
418537|NCT01785563|electrical activity of the diaphragm|electrical activity of the diaphragm
418538|NCT01785563|neural trigger, mechanical ventilation|neural trigger, mechanical ventilation
418539|NCT01785563|respiratory distress syndrome|respiratory distress syndrome
418540|NCT01785537|e-cigarette smoking|e-cigarette smoking
418541|NCT01785537|cigarette smoking|cigarette smoking
418542|NCT01785537|cardiovascular disease|cardiovascular disease
418543|NCT01785537|hospitalization|hospitalization
418544|NCT01785537|chronic obstructive pulmonary diseases|chronic obstructive pulmonary diseases
418545|NCT01785537|observational study|observational study
418546|NCT01785537|efficacy|efficacy
418547|NCT01785537|safety|safety
418548|NCT01785524|Cardiovascular Diseases|cardiovascular diseases
418549|NCT01785524|Vascular Diseases|vascular diseases
418550|NCT01785524|Arterial Occlusive Diseases|arterial occlusive diseases
418551|NCT01785524|Diabetes|diabetes
418552|NCT01785524|Exercise|exercise
418553|NCT01785524|Functional Capacity|functional capacity
418554|NCT01785511|hypertension|hypertension
418555|NCT01785511|UV radiation|uv radiation
418556|NCT01785511|coronary flow reserve|coronary flow reserve
418557|NCT01785511|nitric oxide|nitric oxide
418558|NCT01785498|children|children
418559|NCT01785498|quality of life|quality of life
418560|NCT01785498|physical activity|physical activity
418561|NCT01785498|healthy lifestyle|healthy lifestyle
418562|NCT01785485|Integrative medicine|integrative medicine
418563|NCT01785485|primary care|primary care
418564|NCT01785485|cost-effectiveness|cost-effectiveness
418565|NCT01785472|Essential hypertension|essential hypertension
418566|NCT01785472|LCZ696|lcz696
418567|NCT01785459|headache|headache
418568|NCT01785459|migraine|migraine
418569|NCT01785459|bupivacaine|bupivacaine
418570|NCT01785446|Dexmedetomidine|dexmedetomidine
418571|NCT01785446|Cisatracurion infusion|cisatracurion infusion
418572|NCT01785446|Sufentanil|sufentanil
418573|NCT01785446|Recovery Index|recovery index
418574|NCT01785446|Closed loop computer control system|closed loop computer control system
418575|NCT01785433|COPD, pharmacokinetics, tiotropium|copd, pharmacokinetics, tiotropium
418576|NCT01785420|Pre-operative Trastuzumab Protocol|pre-operative trastuzumab protocol
418577|NCT01785407|Iron bio availability|iron bio availability
418578|NCT01785407|Hepcidin|hepcidin
418579|NCT01785407|Iron absorption|iron absorption
418580|NCT01785394|pollinosis|pollinosis
418581|NCT01785394|sublingual immunotherapy|sublingual immunotherapy
418582|NCT01785394|exhaled breath temperature|exhaled breath temperature
418583|NCT01785381|Osteoporosis, hip fracture, fractures, Bone density|osteoporosis, hip fracture, fractures, bone density
418584|NCT01785368|guidelines|guidelines
418585|NCT01785368|referral guidelines|referral guidelines
418586|NCT01785368|exam delays|exam delays
418587|NCT01785368|exam relevance|exam relevance
418588|NCT01785355|periodontal disease|periodontal disease
418589|NCT01785355|CKD|ckd
418590|NCT01785355|nutrition|nutrition
418591|NCT01785355|inflammation|inflammation
418592|NCT01785355|anemia response to ESA|anemia response to esa
418593|NCT01785355|quality of life|quality of life
418594|NCT01785355|hemodialysis|hemodialysis
418595|NCT01785316|Perfusion Cancer Chemotherapy, Regional|perfusion cancer chemotherapy, regional
418596|NCT01785303|CBT|cbt
418597|NCT01785303|CPAP|cpap
418598|NCT01785303|Multidisciplinary Treatment|multidisciplinary treatment
418599|NCT01785303|Combination treatment|combination treatment
418600|NCT01785290|Delirium|delirium
418601|NCT01785290|Survival|survival
418602|NCT01785290|Side-effects|side-effects
418603|NCT01785290|QoL|qol
418604|NCT01785277|Spinal Cord Independence Measure|spinal cord independence measure
418605|NCT01785277|SCIM|scim
418606|NCT01785277|Spinal cord injury|spinal cord injury
418607|NCT01785277|Traumatic spine injury|traumatic spine injury
418608|NCT01785264|Achilles|achilles
418610|NCT01785264|Rupture|rupture
418611|NCT01785264|Acute|acute
418612|NCT01785264|Treatment|treatment
418613|NCT01785264|Outcome measure|outcome measure
418614|NCT01785251|Neuromuscular electrical stimulation|neuromuscular electrical stimulation
418615|NCT01785251|NMES|nmes
418616|NCT01785251|Deep vein thrombosis|deep vein thrombosis
418617|NCT01785251|DVT|dvt
418618|NCT01785251|total hip arthroplasty|total hip arthroplasty
418619|NCT01785251|lower limb hemodynamics|lower limb hemodynamics
535150|NCT01285479|MS|ms
418620|NCT01785238|preterm infants|preterm infants
418621|NCT01785238|acute renal failure|acute renal failure
418622|NCT01785238|nephronic reduction|nephronic reduction
418623|NCT01785199|apnea-hypopnea index|apnea-hypopnea index
418624|NCT01785199|obstructive sleep apnea|obstructive sleep apnea
418625|NCT01785199|body posture|body posture
418626|NCT01785199|ultra-wideband|ultra-wideband
418627|NCT01785186|TB|tb
418628|NCT01785186|Tuberculosis|tuberculosis
418629|NCT01785186|MAMS - Multiple-arm, multiple-stage|mams - multiple-arm, multiple-stage
418630|NCT01785186|Pulmonary|pulmonary
418631|NCT01785186|SQ109|sq109
418632|NCT01785186|High dose rifampicin|high dose rifampicin
418633|NCT01785186|moxifloxacin|moxifloxacin
418634|NCT01785173|Endoscopes|endoscopes
418635|NCT01785173|Esophago-gastro-duodenoscopy|esophago-gastro-duodenoscopy
418636|NCT01785173|Transnasal endoscopy|transnasal endoscopy
418637|NCT01785173|Nasal anesthesia|nasal anesthesia
418638|NCT01785147|Tobacco addition|tobacco addition
418639|NCT01785134|Obesity|obesity
418640|NCT01785134|Bariatric Surgery|bariatric surgery
418641|NCT01785134|Insulin Sensitivity|insulin sensitivity
418642|NCT01785108|Diamyd|diamyd
418643|NCT01785108|Diabetes|diabetes
418644|NCT01785108|Juvenile Diabetes|juvenile diabetes
418645|NCT01785108|Diabetes type 1|diabetes type 1
418646|NCT01785108|Autoimmune Diabetes|autoimmune diabetes
418647|NCT01785108|Insulin dependent Diabetes|insulin dependent diabetes
418648|NCT01785108|Type 1 diabetes|type 1 diabetes
418649|NCT01785108|Type 1 diabetes mellitus|type 1 diabetes mellitus
418650|NCT01785108|rhGAD65|rhgad65
418651|NCT01785108|GAD|gad
418652|NCT01785108|GAD65|gad65
418653|NCT01785108|GAD-alum|gad-alum
418654|NCT01785108|Diabetes Mellitus|diabetes mellitus
418655|NCT01785108|Diabetes Mellitus, Type 1|diabetes mellitus, type 1
418656|NCT01785108|Glucose Metabolism Disorders|glucose metabolism disorders
418657|NCT01785108|Metabolic Diseases|metabolic diseases
418658|NCT01785108|Vitamin D|vitamin d
418659|NCT01785108|Ibuprofen|ibuprofen
418660|NCT01785082|13-C-Methacetin|13-c-methacetin
418661|NCT01785082|partial liver resection|partial liver resection
418662|NCT01785082|liver function tests|liver function tests
418663|NCT01785056|Systemic Sclerosis|systemic sclerosis
418664|NCT01785056|Diffuse Scleroderma|diffuse scleroderma
418665|NCT01785056|SSc|ssc
418666|NCT01785043|DIABETES Mellitus Type 2|diabetes mellitus type 2
418667|NCT01785043|Difficult control|difficult control
418668|NCT01785017|critical|critical
418669|NCT01785017|asthma|asthma
418670|NCT01785017|children|children
418671|NCT01785004|Adiposity|adiposity
418672|NCT01785004|Body composition|body composition
418673|NCT01785004|Vitamin D|vitamin d
418674|NCT01785004|Adipokines|adipokines
418675|NCT01785004|Omega-3 fatty acid|omega-3 fatty acid
418676|NCT01784991|Pain|pain
418677|NCT01784991|Opioids|opioids
418678|NCT01784991|Hydromorphone|hydromorphone
418679|NCT01784991|regimen|regimen
418680|NCT01784978|cancer|cancer
418681|NCT01784978|renal|renal
418682|NCT01784978|metastatic|metastatic
418683|NCT01784978|clear|clear
418684|NCT01784978|cell|cell
418685|NCT01784978|Sunitinib|sunitinib
418686|NCT01784978|Everolimus|everolimus
418687|NCT01784978|Alternating|alternating
418688|NCT01784939|hereditary hemochromatosis C282Y homozygous|hereditary hemochromatosis c282y homozygous
418689|NCT01784939|Iron Reabsorption Index (IRI)|iron reabsorption index (iri)
418690|NCT01784939|Hepcidin / ferritin (H / F) ratio|hepcidin / ferritin (h / f) ratio
418691|NCT01784926|cataract surgery|cataract surgery
418692|NCT01784926|scleral suturing|scleral suturing
418693|NCT01784926|Verisyse|verisyse
418694|NCT01784926|Late in-the-bag IOL dislocation|late in-the-bag iol dislocation
418695|NCT01784913|Prostate|prostate
418696|NCT01784913|cancer|cancer
418697|NCT01784913|vaccine|vaccine
418698|NCT01784874|Rabies|rabies
418699|NCT01784874|Human Diploid Cell Vaccine|human diploid cell vaccine
418700|NCT01784874|Imovax® Rabies|imovax® rabies
418701|NCT01784848|high blood pressure|high blood pressure
418702|NCT01784848|hypertension|hypertension
418703|NCT01784848|bariatric surgery|bariatric surgery
418704|NCT01784848|Laparoscopic Roux-en-Y gastric bypass (LRYGB)|laparoscopic roux-en-y gastric bypass (lrygb)
418705|NCT01784848|obesity|obesity
418706|NCT01784835|Osteopathic manipulative treatment|osteopathic manipulative treatment
418707|NCT01784835|neonatology|neonatology
418708|NCT01784835|neonatal care|neonatal care
418709|NCT01784835|prematurity|prematurity
418710|NCT01784835|complementary and alternative medicine|complementary and alternative medicine
418711|NCT01784835|length of stay|length of stay
418712|NCT01784822|Ventral hernia|ventral hernia
418713|NCT01784822|Graft repair|graft repair
418714|NCT01784809|HIV|hiv
418715|NCT01784809|STIs|stis
418716|NCT01784809|Condom Use|condom use
418717|NCT01784809|Criminal Justice|criminal justice
418718|NCT01784809|Drug Use|drug use
418719|NCT01784796|cardiovascular disease|cardiovascular disease
418720|NCT01784796|women's health|women's health
418721|NCT01784796|psychological stress|psychological stress
418722|NCT01784796|Veterans|veterans
418723|NCT01784796|stroke|stroke
418724|NCT01784783|HIV transmission|hiv transmission
418725|NCT01784783|PMTCT|pmtct
418726|NCT01784783|Discordancy|discordancy
418727|NCT01784783|Home-based testing|home-based testing
418728|NCT01784783|Couple counseling|couple counseling
418729|NCT01784783|Couple testing|couple testing
418730|NCT01784783|Facility delivery|facility delivery
418731|NCT01784783|Exclusive breastfeeding|exclusive breastfeeding
418732|NCT01784783|Family planning|family planning
418733|NCT01784783|Postpartum contraceptives|postpartum contraceptives
418734|NCT01784783|Linkage to care|linkage to care
418735|NCT01784783|ART initiation|art initiation
418736|NCT01784770|Legionnaires' disease|legionnaires' disease
418737|NCT01784770|Legionella pneumophila|legionella pneumophila
418738|NCT01784770|Zithromax|zithromax
418739|NCT01784770|Zithromac|zithromac
418740|NCT01784770|Japanese|japanese
418741|NCT01784770|Regulatory Post Marketing Commitment Plan|regulatory post marketing commitment plan
418742|NCT01784744|Autism|autism
418743|NCT01784744|ASD|asd
418744|NCT01784744|Aspergers|aspergers
418745|NCT01784744|Autism Spectrum Disorder|autism spectrum disorder
418746|NCT01784692|Immulina|immulina
418747|NCT01784692|Elderly|elderly
418748|NCT01784692|Immune|immune
418749|NCT01784679|Hereditary Inclusion Body Myopathy|hereditary inclusion body myopathy
418750|NCT01784679|GNE Myopathy|gne myopathy
418751|NCT01784679|Nonaka Disease|nonaka disease
418752|NCT01784679|Quadriceps Sparing Myopathy|quadriceps sparing myopathy
418753|NCT01784679|distal myopathy with rimmed vacuoles|distal myopathy with rimmed vacuoles
418754|NCT01784679|ultragenyx|ultragenyx
418755|NCT01784679|rare disease|rare disease
418756|NCT01784666|Bipolar Disorder|bipolar disorder
418757|NCT01784666|Depression|depression
418758|NCT01784666|Lithium|lithium
418759|NCT01784666|Valproate|valproate
418760|NCT01784666|Isradipine|isradipine
418761|NCT01784653|Substance abuse|substance abuse
418762|NCT01784653|Drug abuse|drug abuse
418763|NCT01784653|Alcohol abuse|alcohol abuse
418764|NCT01784653|Tobacco|tobacco
418765|NCT01784653|Adolescent|adolescent
418766|NCT01784627|substance use|substance use
418767|NCT01784627|alcohol abuse|alcohol abuse
418768|NCT01784627|cannabis abuse|cannabis abuse
418769|NCT01784627|nicotine dependence|nicotine dependence
418770|NCT01784627|adolescents|adolescents
418771|NCT01784601|Interscalene block|interscalene block
418772|NCT01784601|Hemidiaphragm palsy|hemidiaphragm palsy
418773|NCT01784575|Quality of care|quality of care
418774|NCT01784575|Pediatric|pediatric
418775|NCT01784575|Pregnancy|pregnancy
418776|NCT01784575|Low-income|low-income
418777|NCT01784575|Low literacy|low literacy
418778|NCT01784562|Chronic thromboembolic pulmonary hypertension|chronic thromboembolic pulmonary hypertension
418779|NCT01784549|NSCL|nscl
418780|NCT01784549|biomarkers|biomarkers
418781|NCT01784549|Customized Neoadjuvant Therapy|customized neoadjuvant therapy
418782|NCT01784523|antiphospholipid autoantibodies|antiphospholipid autoantibodies
418783|NCT01784523|antiphospholipid positive|antiphospholipid positive
418784|NCT01784497|Health Related Quality of Life (HRQL)|health related quality of life (hrql)
418785|NCT01784497|Living Donor Liver Transplantation(LDLT)|living donor liver transplantation(ldlt)
418786|NCT01784471|Foot Symptoms|foot symptoms
418787|NCT01784471|Diabetes|diabetes
418788|NCT01784471|Peripheral Vascular Disease|peripheral vascular disease
418789|NCT01784471|Magic Foot shoe|magic foot shoe
418790|NCT01784458|severe sepsis|severe sepsis
418791|NCT01784458|intra-abdominal hypertension|intra-abdominal hypertension
418792|NCT01784458|intra-abdominal pressure|intra-abdominal pressure
418793|NCT01784445|Endoscopic Retrograde Cholangiopancreatography,|endoscopic retrograde cholangiopancreatography,
418794|NCT01784432|low-level laser therapy|low-level laser therapy
418795|NCT01784432|muscle performance|muscle performance
418796|NCT01784432|strength training|strength training
418797|NCT01784432|gene expression|gene expression
418798|NCT01784432|microarrays|microarrays
418799|NCT01784419|Cystic fibrosis|cystic fibrosis
418800|NCT01784419|Ivacaftor|ivacaftor
418801|NCT01784419|Genotype|genotype
418802|NCT01784419|Phenotype|phenotype
418803|NCT01784419|Sweat chloride|sweat chloride
418804|NCT01784419|Pancreatic sufficient|pancreatic sufficient
418805|NCT01784406|Self-management intervention|self-management intervention
418806|NCT01784406|Psychosocial care|psychosocial care
418807|NCT01784406|Autonomy-supportive|autonomy-supportive
418808|NCT01784406|Gynaecological cancer survivors|gynaecological cancer survivors
418809|NCT01784406|Guided self-Determination|guided self-determination
418810|NCT01784367|Hypercapnia|hypercapnia
418811|NCT01784367|noninvasive ventilation|noninvasive ventilation
418812|NCT01784367|acute respiratory failure|acute respiratory failure
418813|NCT01784367|endotracheal intubation|endotracheal intubation
418814|NCT01784367|invasive mechanical ventilation|invasive mechanical ventilation
418815|NCT01784341|Bipolar, Circadian, Melatonin|bipolar, circadian, melatonin
418816|NCT01784328|Peristeen Bowel Irrigation System|peristeen bowel irrigation system
418817|NCT01784328|Cauda Equina Syndrome|cauda equina syndrome
418818|NCT01784328|Lower Motor Neuron Neurogenic Bowel|lower motor neuron neurogenic bowel
418819|NCT01784315|The presence of parasites in the blood|the presence of parasites in the blood
418820|NCT01784289|Interleukin 7|interleukin 7
418821|NCT01784289|adipose tissue|adipose tissue
418822|NCT01784276|Children|children
418823|NCT01784276|Autism Spectrum Disorders|autism spectrum disorders
418824|NCT01784276|Electronic Screen Media|electronic screen media
418825|NCT01784276|Dental fear|dental fear
418826|NCT01784263|Intervention|intervention
418827|NCT01784263|Autism|autism
418828|NCT01784263|Treatment sensitivity|treatment sensitivity
418829|NCT01784263|School aged|school aged
418830|NCT01784263|Cognitive behavioral therapy|cognitive behavioral therapy
418831|NCT01784250|Clonidine|clonidine
418832|NCT01784250|Propranolol|propranolol
418833|NCT01784250|Third molar|third molar
418834|NCT01784250|Anxiety|anxiety
418835|NCT01784237|Endoscopes|endoscopes
418836|NCT01784237|Esophago-gastro-duodenoscopy|esophago-gastro-duodenoscopy
418837|NCT01784237|Transnasal endoscopy|transnasal endoscopy
418838|NCT01784237|Anterior meatoscopy|anterior meatoscopy
418839|NCT01784198|pregnancy|pregnancy
418840|NCT01784198|protein requirements|protein requirements
418841|NCT01784198|Indicator Amino acid oxidation|indicator amino acid oxidation
418842|NCT01784198|Stable isotopes|stable isotopes
418843|NCT01784185|EBUS guided transbronchial needle aspiration (EBUS-TBNA)|ebus guided transbronchial needle aspiration (ebus-tbna)
418844|NCT01784185|virtual bronchoscopy (VB)|virtual bronchoscopy (vb)
418845|NCT01784185|VB guided transbronchial needle aspiration VB-TBNA)|vb guided transbronchial needle aspiration vb-tbna)
418846|NCT01784185|mediastinal sampling|mediastinal sampling
418847|NCT01784185|transbronchial needle aspiration (TBNA)|transbronchial needle aspiration (tbna)
418848|NCT01784172|efficacy|efficacy
418849|NCT01784172|safety|safety
418850|NCT01784172|electroacupuncture|electroacupuncture
418851|NCT01784172|simple female stress urinary incontinence|simple female stress urinary incontinence
418852|NCT01784159|ICU|icu
418853|NCT01784159|Sepsis|sepsis
418854|NCT01784159|Aspirin|aspirin
418855|NCT01784159|Septic shock|septic shock
418856|NCT01784133|rosacea|rosacea
418857|NCT01784120|breast cancer|breast cancer
418858|NCT01784120|doxorubicin|doxorubicin
418859|NCT01784120|genexol-PM|genexol-pm
418860|NCT01784120|paclitaxel|paclitaxel
418861|NCT01784107|SCLC|sclc
418862|NCT01784107|belotecan|belotecan
418863|NCT01784107|Ifosfamide|ifosfamide
418864|NCT01784081|palliative care|palliative care
418865|NCT01784081|decision aid|decision aid
418866|NCT01784068|Ph+ CML-CP|ph+ cml-cp
418867|NCT01784068|chronic phase|chronic phase
418868|NCT01784068|nilotinib treatment|nilotinib treatment
418869|NCT01784068|2 years treatment|2 years treatment
418870|NCT01784068|MR 4.5|mr 4.5
418871|NCT01784068|Loss of MR 4|loss of mr 4
418872|NCT01784068|Loss of MMR|loss of mmr
418873|NCT01784055|NeoChord|neochord
418874|NCT01784055|DS1000|ds1000
418875|NCT01784055|Mitral Valve|mitral valve
418876|NCT01784055|Mitral Valve Regurgitation|mitral valve regurgitation
418877|NCT01784055|MR|mr
418878|NCT01784055|Mitral Valve Repair|mitral valve repair
418879|NCT01784055|Mitral Valve Prolapse|mitral valve prolapse
418880|NCT01784055|Artificial Chordae|artificial chordae
418881|NCT01784042|breast cancer|breast cancer
418882|NCT01784042|omega-3 fatty acids|omega-3 fatty acids
418883|NCT01784029|adolescents|adolescents
418884|NCT01784029|minority|minority
418885|NCT01783964|Elacytarabine|elacytarabine
418886|NCT01783964|pharmacokinetic|pharmacokinetic
418887|NCT01783964|Microdose|microdose
418888|NCT01783964|Mass Balance Recovery|mass balance recovery
418889|NCT01783951|Gastric cancer|gastric cancer
418890|NCT01783951|S-1|s-1
418891|NCT01783951|DC-CIK|dc-cik
418892|NCT01783951|T cell|t cell
418893|NCT01783912|Smoking|smoking
418894|NCT01783912|Nicotine Dependence|nicotine dependence
418895|NCT01783912|Mental Disorders|mental disorders
418896|NCT01783886|Diabetic Macular Edema|diabetic macular edema
418897|NCT01783886|DME|dme
418898|NCT01783886|VEGF Trap-Eye|vegf trap-eye
418899|NCT01783886|best-corrected visual acuity (BCVA)|best-corrected visual acuity (bcva)
418900|NCT01783860|Azithromycin|azithromycin
418901|NCT01783860|Doxycycline|doxycycline
418902|NCT01783860|Posterior Blepharitis|posterior blepharitis
418903|NCT01783847|Erythropoietin|erythropoietin
418904|NCT01783847|Traumatic Optic Neuropathy|traumatic optic neuropathy
418905|NCT01783847|Visual function|visual function
418906|NCT01783834|Pemetrexed|pemetrexed
418907|NCT01783834|Gefitinib|gefitinib
418908|NCT01783834|iressa|iressa
418909|NCT01783834|alimta|alimta
418910|NCT01783821|Acute respiratory distress syndrome (ARDS)|acute respiratory distress syndrome (ards)
418911|NCT01783808|COPD|copd
418912|NCT01783808|Physical capacity|physical capacity
418913|NCT01783808|Physical activity|physical activity
418914|NCT01783808|Inflammatory markers|inflammatory markers
418915|NCT01783808|Health related quality of life|health related quality of life
418916|NCT01783795|Dent|dent
418917|NCT01783795|Dents|dents
418918|NCT01783795|Dent Disease|dent disease
418919|NCT01783795|Dent genetic testing|dent genetic testing
418920|NCT01783795|CLCN5|clcn5
418921|NCT01783795|OCRL1|ocrl1
418922|NCT01783795|Genetic testing for Dent Disease|genetic testing for dent disease
418923|NCT01783795|Hereditary study for Dent Disease|hereditary study for dent disease
418924|NCT01783782|Capsule Endoscopy|capsule endoscopy
418925|NCT01783782|colon cleansing|colon cleansing
418926|NCT01783782|children|children
418927|NCT01783782|age 2 -18 years|age 2 -18 years
418928|NCT01783769|neurosurgery|neurosurgery
418929|NCT01783769|operating room personnel|operating room personnel
418930|NCT01783769|sterile procedures|sterile procedures
418931|NCT01783769|infection|infection
418932|NCT01783769|Conditions requiring surgery|conditions requiring surgery
418933|NCT01783743|Trichiasis|trichiasis
418934|NCT01783743|Trachoma|trachoma
418935|NCT01783743|Mass treatment|mass treatment
418936|NCT01783730|Rheumatoid arthritis|rheumatoid arthritis
418937|NCT01783704|hip fracture|hip fracture
418938|NCT01783704|randomized controlled trial|randomized controlled trial
418939|NCT01783704|exercise|exercise
418940|NCT01783691|Sickle cell disease|sickle cell disease
418941|NCT01783652|Adolescent depression|adolescent depression
418942|NCT01783652|internet intervention|internet intervention
418943|NCT01783639|Carotid|carotid
418944|NCT01783639|Carotid artery stenting|carotid artery stenting
418945|NCT01783639|Stent|stent
418946|NCT01783639|Embolic protection|embolic protection
418947|NCT01783639|Atherosclerotic Disease|atherosclerotic disease
418948|NCT01783600|Peripheral Arterial Disease|peripheral arterial disease
418949|NCT01783600|Infrapopliteal lesions|infrapopliteal lesions
418950|NCT01783600|balloon catheter|balloon catheter
418951|NCT01783574|Depression|depression
418952|NCT01783574|Major Depressive Disorder (MDD)|major depressive disorder (mdd)
418953|NCT01783561|caffeine|caffeine
418954|NCT01783561|intubation|intubation
418955|NCT01783561|hemodynamic|hemodynamic
418956|NCT01783548|allergic rhinitis|allergic rhinitis
418957|NCT01783548|pediatric subjects|pediatric subjects
418958|NCT01783548|BDP nasal aerosol|bdp nasal aerosol
418959|NCT01783535|intraocular retinoblastoma|intraocular retinoblastoma
418960|NCT01783509|GENETICALLY CONFIRMED limb girdle muscular dystrophy|genetically confirmed limb girdle muscular dystrophy
418961|NCT01783483|CABG|cabg
418962|NCT01783483|Valve replacement|valve replacement
418963|NCT01783483|sternal closure|sternal closure
418964|NCT01783483|midline sternotomy|midline sternotomy
418965|NCT01783483|sternal plates|sternal plates
418966|NCT01783470|adipose tissue, brown|adipose tissue, brown
418967|NCT01783470|obesity|obesity
418968|NCT01783470|Adrenergic beta-3 Receptor Agonists|adrenergic beta-3 receptor agonists
418969|NCT01783470|thermogenesis|thermogenesis
418970|NCT01783470|metabolism|metabolism
418971|NCT01783457|First psychotic episode|first psychotic episode
418972|NCT01783457|Individual psychoeducation|individual psychoeducation
418973|NCT01783457|Telemedicine|telemedicine
418974|NCT01783457|BDNF|bdnf
418975|NCT01783457|Oxidative stress|oxidative stress
418976|NCT01783444|Estrogen receptor positive, locally advanced, metastatic breast cancer, Everolimus, Exemestane, Capecitabine|estrogen receptor positive, locally advanced, metastatic breast cancer, everolimus, exemestane, capecitabine
418977|NCT01783418|mindfulness-based meditation|mindfulness-based meditation
418978|NCT01783418|pediatric cancer|pediatric cancer
418979|NCT01783418|adolescence|adolescence
418980|NCT01783418|quality of life|quality of life
418981|NCT01783418|sleep|sleep
418982|NCT01783418|affect|affect
418983|NCT01783418|health psychology|health psychology
418984|NCT01783405|LDLR mutation|ldlr mutation
418985|NCT01783405|Statin|statin
418986|NCT01783405|Cardiovascular disease|cardiovascular disease
418987|NCT01783392|overactive bladder|overactive bladder
418988|NCT01783392|transcutaneous posterior tibial nerve stimulation|transcutaneous posterior tibial nerve stimulation
418989|NCT01783392|placebo PTNS|placebo ptns
418990|NCT01783379|invasive fungal infection|invasive fungal infection
418991|NCT01783379|micafungin|micafungin
418992|NCT01783379|intensive care|intensive care
418993|NCT01783379|pharmacokinetics|pharmacokinetics
418994|NCT01783366|nasogastric tube, tube exchange catheter|nasogastric tube, tube exchange catheter
418995|NCT01783353|Recalcitrant cutaneous warts|recalcitrant cutaneous warts
418996|NCT01783353|verruca|verruca
418997|NCT01783340|Malaria|malaria
418998|NCT01783340|P falciparum|p falciparum
418999|NCT01783340|Chloroquine|chloroquine
419000|NCT01783340|Azithromycin|azithromycin
419001|NCT01783340|Immunization|immunization
419002|NCT01783327|Diabetes Mellitus, Type 1|diabetes mellitus, type 1
419003|NCT01783327|Self care|self care
419004|NCT01783327|Coping skills|coping skills
419005|NCT01783327|Adolescent|adolescent
419006|NCT01783327|Internet|internet
419904|NCT01779258|xerosis|xerosis
419007|NCT01783327|Intervention Studies|intervention studies
419008|NCT01783327|Chronic Disease|chronic disease
419009|NCT01783314|hepatic fibrosis|hepatic fibrosis
419010|NCT01783314|Eovist|eovist
419011|NCT01783314|gadoxetate disodium|gadoxetate disodium
419012|NCT01783314|biomarker|biomarker
419013|NCT01783314|liver biopsy|liver biopsy
419014|NCT01783314|liver function|liver function
419015|NCT01783314|MRI|mri
419016|NCT01783314|Hepatitis C|hepatitis c
419017|NCT01783301|follicle stimulating hormone|follicle stimulating hormone
419018|NCT01783301|ovarian stimulation|ovarian stimulation
419019|NCT01783301|antimullerian hormone|antimullerian hormone
419020|NCT01783301|antral follicle count|antral follicle count
419021|NCT01783301|assisted reproductive technologies|assisted reproductive technologies
419022|NCT01783288|Postural tachycardia syndrome|postural tachycardia syndrome
419023|NCT01783288|orthostatic intolerance|orthostatic intolerance
419024|NCT01783288|orthostatic tachycardia|orthostatic tachycardia
419025|NCT01783288|POTS|pots
419026|NCT01783275|Obesity|obesity
419027|NCT01783275|Type 2 diabetes|type 2 diabetes
419028|NCT01783275|Liver|liver
419029|NCT01783236|VATS|vats
419030|NCT01783236|thoracic surgery|thoracic surgery
419031|NCT01783236|acetaminophen|acetaminophen
419032|NCT01783236|ofirmev|ofirmev
419033|NCT01783236|lung surgery|lung surgery
419034|NCT01783236|thoracoscopic|thoracoscopic
419035|NCT01783236|intravenous acetaminophen|intravenous acetaminophen
419036|NCT01783158|head and neck carcinoma|head and neck carcinoma
419037|NCT01783158|chromoendoscopy|chromoendoscopy
419038|NCT01783158|Lugol's solution|lugol's solution
419039|NCT01783158|esophageal carcinoma|esophageal carcinoma
419040|NCT01783158|synchronous tumors|synchronous tumors
419041|NCT01783158|deglutition|deglutition
419042|NCT01783158|deglutition disorders|deglutition disorders
419043|NCT01783158|Newly diagnosed HNSCC|newly diagnosed hnscc
419044|NCT01783145|survivorship care|survivorship care
419045|NCT01783145|testicular cancer|testicular cancer
419046|NCT01783145|shared care model|shared care model
419047|NCT01783119|Ulcerative Colitis|ulcerative colitis
419048|NCT01783119|Aloe Vera|aloe vera
419049|NCT01783106|Crohn's|crohn's
419050|NCT01783106|antibiotics|antibiotics
419051|NCT01783106|hydroxychloroquine|hydroxychloroquine
419052|NCT01783106|ciprofloxacin|ciprofloxacin
419053|NCT01783106|doxycycline|doxycycline
419054|NCT01783080|Chronic depression|chronic depression
419055|NCT01783080|Dysthymic disorder|dysthymic disorder
419056|NCT01783080|Double Depression|double depression
419057|NCT01783080|Behavioral Activation therapy|behavioral activation therapy
419058|NCT01783080|Work impairment|work impairment
419059|NCT01783080|Unemployment|unemployment
419060|NCT01783067|Biofortification|biofortification
419061|NCT01783067|Pearl millet|pearl millet
419062|NCT01783067|Iron absorption|iron absorption
419063|NCT01783067|Zinc absorption|zinc absorption
419064|NCT01783054|NEOADJUVANT GEMCITABINE AND ABRAXANE CHEMOTHERAPY|neoadjuvant gemcitabine and abraxane chemotherapy
419065|NCT01783054|SURGERY|surgery
419066|NCT01783054|RESECTABLE ADENOCARCINOMA OF THE PANCREAS|resectable adenocarcinoma of the pancreas
419067|NCT01783041|Prematurity|prematurity
419068|NCT01783041|Carnitine supplementation|carnitine supplementation
419069|NCT01783041|Neonatal Intensive Care|neonatal intensive care
419070|NCT01783041|MRI|mri
419071|NCT01783041|Amplitude-integrated EEG|amplitude-integrated eeg
419072|NCT01783041|NICU Network Neurobehavioral Scale|nicu network neurobehavioral scale
419073|NCT01783041|Bayley Scale of Infant Development III|bayley scale of infant development iii
419074|NCT01783028|asthma|asthma
419075|NCT01783015|Rheumatoid arthritis|rheumatoid arthritis
419076|NCT01783015|etanercept|etanercept
419077|NCT01783015|methotrexate|methotrexate
419078|NCT01783015|infliximab|infliximab
419079|NCT01783015|adalimumab|adalimumab
419080|NCT01783015|anti-drug antibody|anti-drug antibody
419081|NCT01782989|geographic atrophy|geographic atrophy
419082|NCT01782989|non-exudative age-related macular degeneration|non-exudative age-related macular degeneration
419083|NCT01782989|macular degeneration|macular degeneration
419084|NCT01782989|dry macular degeneration|dry macular degeneration
419085|NCT01782989|dry AMD|dry amd
419086|NCT01782976|Glioblastoma|glioblastoma
419087|NCT01782976|GBM|gbm
419088|NCT01782976|Intracranial glioblastoma|intracranial glioblastoma
419089|NCT01782976|Recurrent|recurrent
419090|NCT01782976|MD Anderson Symptom Inventory for Brain Tumors|md anderson symptom inventory for brain tumors
419091|NCT01782976|MDASI-BT|mdasi-bt
419092|NCT01782976|Questionnaire|questionnaire
419093|NCT01782976|Survey|survey
419094|NCT01782963|Newly diagnosed|newly diagnosed
419095|NCT01782950|HIV|hiv
419096|NCT01782950|Tuberculosis|tuberculosis
419097|NCT01782950|Antituberculosis drugs|antituberculosis drugs
419098|NCT01782911|Androgen|androgen
419099|NCT01782911|IVF|ivf
419100|NCT01782911|Resveratrol|resveratrol
419101|NCT01782911|PCOS.|pcos.
419102|NCT01782898|Anesthesia|anesthesia
419103|NCT01782898|MEDOC neuro sensory analyzer|medoc neuro sensory analyzer
419104|NCT01782898|Pain|pain
419105|NCT01782898|Quality of recovery|quality of recovery
419106|NCT01782885|Osteoarthritis|osteoarthritis
419107|NCT01782885|Platelet-Rich Plasma|platelet-rich plasma
419108|NCT01782885|Intra-articular|intra-articular
419109|NCT01782885|Injection|injection
419110|NCT01782807|Ovarian function|ovarian function
535756|NCT01282450|NSCLC|nsclc
419111|NCT01782807|Hysterectomy|hysterectomy
419112|NCT01782807|Salpingectomy|salpingectomy
419113|NCT01782807|Anti mullerian hormone|anti mullerian hormone
419114|NCT01782794|Vaccination|vaccination
419115|NCT01782794|Acceptability|acceptability
419116|NCT01782794|General population|general population
419117|NCT01782794|Hepatitis B|hepatitis b
419118|NCT01782794|Vaccine coverage|vaccine coverage
419119|NCT01782781|Analgesia|analgesia
419120|NCT01782781|Local infiltration analgesia|local infiltration analgesia
419121|NCT01782781|Pain, relief|pain, relief
419122|NCT01782781|Pain, Postoperative|pain, postoperative
419123|NCT01782781|Ropivacaine|ropivacaine
419124|NCT01782781|Ketorolac|ketorolac
419125|NCT01782781|Epinephrine|epinephrine
419126|NCT01782781|Adrenergic Agonists|adrenergic agonists
419127|NCT01782781|Sympathomimetics|sympathomimetics
419128|NCT01782781|Therapeutic Uses|therapeutic uses
419129|NCT01782781|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal
419130|NCT01782781|Analgesics, Non-Narcotic|analgesics, non-narcotic
419131|NCT01782781|Analgesics|analgesics
419132|NCT01782781|Opioids|opioids
419133|NCT01782781|Morphine|morphine
419134|NCT01782781|Pain|pain
419135|NCT01782781|Postoperative Complications|postoperative complications
419136|NCT01782781|Physiological Effects of Drugs|physiological effects of drugs
419137|NCT01782781|Anesthetics, Local|anesthetics, local
419138|NCT01782781|Anesthetics|anesthetics
419139|NCT01782768|Neural respiratory drive in different level of NPPV|neural respiratory drive in different level of nppv
419140|NCT01782755|Probiotics|probiotics
419141|NCT01782755|Ventilator Associated Pneumonia (VAP)|ventilator associated pneumonia (vap)
419142|NCT01782755|Infection|infection
419143|NCT01782755|Antibiotic-Associated Diarrhea|antibiotic-associated diarrhea
419144|NCT01782755|C-Difficile|c-difficile
419145|NCT01782742|Mild to Moderate Alzheimer's Disease|mild to moderate alzheimer's disease
419146|NCT01782729|Dermatitis, Atopic|dermatitis, atopic
419147|NCT01782729|Tacrolimus|tacrolimus
419148|NCT01782716|Mortality|mortality
419149|NCT01782716|Length|length
419150|NCT01782716|hospitalization|hospitalization
419151|NCT01782716|cardiac surgery|cardiac surgery
419152|NCT01782716|patients|patients
419153|NCT01782703|Atopic Dermatitis|atopic dermatitis
419154|NCT01782703|Filaggrin|filaggrin
419155|NCT01782703|Biomarkers|biomarkers
419156|NCT01782703|Eczema|eczema
419157|NCT01782664|PASI|pasi
419158|NCT01782664|DLQI|dlqi
419159|NCT01782664|GSK2586184|gsk2586184
419160|NCT01782664|plaque-type psoriasis|plaque-type psoriasis
419161|NCT01782664|PGA|pga
419162|NCT01782664|inflammatory gene transcription|inflammatory gene transcription
419163|NCT01782664|JAK-1 inhibitor|jak-1 inhibitor
419164|NCT01782664|serum neopterin|serum neopterin
419165|NCT01782664|skin biopsy|skin biopsy
419166|NCT01782664|ACR response criteria|acr response criteria
419167|NCT01782664|VAS itch score|vas itch score
419168|NCT01782651|HER2 positive|her2 positive
419169|NCT01782651|Breast Cancer|breast cancer
419170|NCT01782651|treatment patterns|treatment patterns
419171|NCT01782638|Parkinson's disease|parkinson's disease
419172|NCT01782638|Deep brain stimulation|deep brain stimulation
419173|NCT01782638|Gait|gait
419174|NCT01782638|Freezing|freezing
419175|NCT01782638|Electrode placements|electrode placements
419176|NCT01782625|diving|diving
419177|NCT01782625|cognitive impairment|cognitive impairment
419178|NCT01782625|nitrogen narcosis|nitrogen narcosis
419179|NCT01782625|narcosis|narcosis
419180|NCT01782625|end tidal carbon dioxide|end tidal carbon dioxide
419181|NCT01782625|arterial carbon dioxide|arterial carbon dioxide
419182|NCT01782625|immersion|immersion
419183|NCT01782612|Balanced Anesthesia|balanced anesthesia
419184|NCT01782612|Nerve Block|nerve block
419185|NCT01782612|Postoperative Recovery|postoperative recovery
419186|NCT01782612|Delirium|delirium
419187|NCT01782612|Postoperative Complications|postoperative complications
419188|NCT01782612|Stress|stress
419189|NCT01782612|Inflammation|inflammation
419190|NCT01782586|kidney transplant|kidney transplant
419191|NCT01782586|gene expression markers|gene expression markers
419192|NCT01782586|renal allograft function|renal allograft function
419193|NCT01782573|pre - disinfection scrubbing solution|pre - disinfection scrubbing solution
419194|NCT01782573|surgical site culture|surgical site culture
419195|NCT01782573|surgical site infection|surgical site infection
419196|NCT01782573|liver tumors|liver tumors
419197|NCT01782573|hepatectomy|hepatectomy
419198|NCT01782573|chlorhexidine gluconate|chlorhexidine gluconate
419199|NCT01782560|Laryngomalacia|laryngomalacia
419200|NCT01782560|Acid-reflux|acid-reflux
419201|NCT01782547|diabetes mellitus|diabetes mellitus
419202|NCT01782547|adolescents|adolescents
419203|NCT01782521|Bracket failure rate|bracket failure rate
419204|NCT01782521|Orthodontic bonding|orthodontic bonding
419205|NCT01782521|Primer|primer
419206|NCT01782508|melanoma,adjuvant therapy,kit mutated melanoma|melanoma,adjuvant therapy,kit mutated melanoma
419207|NCT01782495|Hepatitis C Genotype 4|hepatitis c genotype 4
419208|NCT01782495|Chronic Hepatitis|chronic hepatitis
419209|NCT01782495|Interferon-Free|interferon-free
419210|NCT01782495|Hepatitis C Virus (HCV)|hepatitis c virus (hcv)
419211|NCT01782495|Renal Transplant|renal transplant
419212|NCT01782495|Liver Transplant|liver transplant
419213|NCT01782495|Hepatitis C Genotype 1|hepatitis c genotype 1
419214|NCT01782482|Color contact lenses|color contact lenses
419215|NCT01782482|Refractive error|refractive error
419216|NCT01782482|Myopia|myopia
419217|NCT01782469|Synovitis|synovitis
419218|NCT01782469|Rheumatoid Arthritis|rheumatoid arthritis
419219|NCT01782443|Progressive|progressive
419220|NCT01782443|Metastatic|metastatic
419221|NCT01782430|Preoxygenation|preoxygenation
419222|NCT01782430|Intubation|intubation
419223|NCT01782417|osteoarthritis|osteoarthritis
419224|NCT01782417|Hispanic|hispanic
419225|NCT01782417|behavior|behavior
419226|NCT01782417|intervention|intervention
419227|NCT01782417|Spanish|spanish
419228|NCT01782391|mild cognitive impairment|mild cognitive impairment
419229|NCT01782391|dementia|dementia
419230|NCT01782391|MCI|mci
419231|NCT01782391|brain stimulation|brain stimulation
419232|NCT01782391|tSOS|tsos
419233|NCT01782391|tDCS|tdcs
419234|NCT01782391|sleep|sleep
419235|NCT01782391|memory|memory
419236|NCT01782391|memory consolidation|memory consolidation
419237|NCT01782378|Persian Gulf Syndrome|persian gulf syndrome
419238|NCT01782378|Veterans Health|veterans health
419239|NCT01782378|Executive Function|executive function
419240|NCT01782378|Memory|memory
419241|NCT01782378|Attention|attention
419242|NCT01782378|Cognition|cognition
419243|NCT01782378|Laser Therapy, Low-Level|laser therapy, low-level
419244|NCT01782378|Phototherapy|phototherapy
419245|NCT01782378|Light Therapy|light therapy
419246|NCT01782378|Depression|depression
419247|NCT01782365|mild cognitive impairment|mild cognitive impairment
419248|NCT01782365|dementia|dementia
419249|NCT01782365|MCI|mci
419250|NCT01782365|brain stimulation|brain stimulation
419251|NCT01782365|tSOS|tsos
419252|NCT01782365|tDCS|tdcs
419253|NCT01782365|sleep|sleep
419254|NCT01782365|nap|nap
419255|NCT01782365|daytime sleep|daytime sleep
419256|NCT01782365|memory|memory
419257|NCT01782365|memory consolidation|memory consolidation
419258|NCT01782352|age-related macular degeneration|age-related macular degeneration
419259|NCT01782352|incidence|incidence
419260|NCT01782352|progression|progression
419261|NCT01782326|COPD, QVA149, FLAME( EFfect of Indacaterol Glycopyronium Vs Fluticasone salmeterol on COPD Exacerbations)|copd, qva149, flame( effect of indacaterol glycopyronium vs fluticasone salmeterol on copd exacerbations)
419262|NCT01782287|Neoplasm Metastasis|neoplasm metastasis
419263|NCT01782287|Brain metastasis|brain metastasis
419264|NCT01782287|Lung cancer|lung cancer
419265|NCT01782274|Neoplasm Metastasis|neoplasm metastasis
419266|NCT01782274|Brain metastasis|brain metastasis
419267|NCT01782274|Breast cancer|breast cancer
419268|NCT01782261|autoimmune disease|autoimmune disease
419269|NCT01782261|diabetes type 1|diabetes type 1
419270|NCT01782261|incretin effect|incretin effect
419271|NCT01782222|Parkinson's Disease|parkinson's disease
419272|NCT01782222|Rotigotine|rotigotine
419273|NCT01782222|Apathy|apathy
419274|NCT01782222|Nonmotor|nonmotor
419275|NCT01782222|Motor|motor
419276|NCT01782222|Neupro|neupro
419277|NCT01782209|BK virus viremia|bk virus viremia
419278|NCT01782209|renal transplant|renal transplant
419279|NCT01782209|other viral pathogens|other viral pathogens
419280|NCT01782183|sore throat|sore throat
419281|NCT01782183|thermal camera photo|thermal camera photo
419282|NCT01782183|normal tonsils and pharynx|normal tonsils and pharynx
419283|NCT01782183|redness of tonsils and/or pharynx|redness of tonsils and/or pharynx
419284|NCT01782183|exudates on tonsils|exudates on tonsils
419285|NCT01782183|petechiae of the palate|petechiae of the palate
419286|NCT01782170|Gingivitis|gingivitis
419287|NCT01782170|Biomarkers|biomarkers
419288|NCT01782170|Biological Markers of Inflammation|biological markers of inflammation
419289|NCT01782157|dementia|dementia
419290|NCT01782144|Obesity|obesity
419291|NCT01782144|Foot pain|foot pain
419292|NCT01782105|weight gain|weight gain
419293|NCT01782105|healthy lifestyle|healthy lifestyle
419294|NCT01782105|gestational diabetes|gestational diabetes
419295|NCT01782105|adipokins|adipokins
419296|NCT01782105|glycemic regulation|glycemic regulation
419297|NCT01782092|diabetes|diabetes
419298|NCT01782079|Lactobacillus brevis|lactobacillus brevis
419299|NCT01782079|Oral health|oral health
419300|NCT01782079|Bacterial adhesion|bacterial adhesion
419301|NCT01782040|Premenstrual syndrome|premenstrual syndrome
419302|NCT01782040|Physical distress|physical distress
419303|NCT01782040|Behavioral changes|behavioral changes
419304|NCT01782027|healthy controls|healthy controls
419305|NCT01782027|Tangier Disease|tangier disease
419306|NCT01782027|Adenosine triphosphate-binding cassette transporter 1 (ABCA1)|adenosine triphosphate-binding cassette transporter 1 (abca1)
419307|NCT01782027|apoA-I|apoa-i
419308|NCT01782027|LCAT deficiency|lcat deficiency
419309|NCT01782027|Scavenger receptor BI (SRBI) deficiency|scavenger receptor bi (srbi) deficiency
419310|NCT01782027|CETP deficiency|cetp deficiency
419311|NCT01782014|Screening colonoscopy|screening colonoscopy
419312|NCT01782014|Water method|water method
419313|NCT01782014|Carbon dioxide method|carbon dioxide method
419314|NCT01782014|Air method|air method
419315|NCT01782014|Water versus carbon dioxide versus air insufflation colonoscopy|water versus carbon dioxide versus air insufflation colonoscopy
419316|NCT01782014|Adenoma Detection Rate|adenoma detection rate
419317|NCT01782014|Pain Scores in colonoscopy|pain scores in colonoscopy
419318|NCT01782001|Vitamin A|vitamin a
419319|NCT01782001|Zinc|zinc
419320|NCT01782001|Malaria|malaria
419321|NCT01782001|Morbidity|morbidity
419322|NCT01782001|MRDR|mrdr
419323|NCT01781988|lung cancer|lung cancer
419324|NCT01781988|gemcitabine|gemcitabine
419325|NCT01781988|carboplatin|carboplatin
419326|NCT01781988|pemetrexed|pemetrexed
419327|NCT01781949|HIV infection|hiv infection
419328|NCT01781949|Targeted screening|targeted screening
419329|NCT01781949|Nontargeted screening|nontargeted screening
419330|NCT01781949|Emergency department|emergency department
419331|NCT01781949|Urgent care|urgent care
419332|NCT01781949|Effectiveness|effectiveness
419333|NCT01781923|Cognitive remediation|cognitive remediation
419334|NCT01781923|Social Cognition|social cognition
419335|NCT01781910|branched chain amino acids, exercise, delayed onset muscle soreness|branched chain amino acids, exercise, delayed onset muscle soreness
419336|NCT01781897|acupuncture|acupuncture
419337|NCT01781897|electro-acupuncture|electro-acupuncture
419338|NCT01781871|Pneumococcal vaccination|pneumococcal vaccination
419339|NCT01781871|immunogenicity|immunogenicity
419340|NCT01781871|solid organ transplant|solid organ transplant
419341|NCT01781858|Pulmonary embolism|pulmonary embolism
419342|NCT01781858|Chronic thromboembolic pulmonary hypertension|chronic thromboembolic pulmonary hypertension
419343|NCT01781858|Venous thromboembolism|venous thromboembolism
419344|NCT01781793|dyspnea, exercise endurance, lung disease|dyspnea, exercise endurance, lung disease
419345|NCT01781780|Obesity|obesity
419346|NCT01781780|Weight Loss|weight loss
419347|NCT01781780|Breakfast|breakfast
419348|NCT01781767|UCP2|ucp2
419349|NCT01781767|Thyroid function|thyroid function
419350|NCT01781767|Thyroid carcinoma|thyroid carcinoma
419351|NCT01781754|Glycemic control|glycemic control
419352|NCT01781754|Metabolic control|metabolic control
419353|NCT01781754|Oxidative stress|oxidative stress
419354|NCT01781754|Diabetes|diabetes
419355|NCT01781728|recurrent|recurrent
419356|NCT01781728|unresectable|unresectable
419357|NCT01781728|residual|residual
419358|NCT01781728|stereotactic body radiation therapy (SBRT)|stereotactic body radiation therapy (sbrt)
419359|NCT01781728|palliative management|palliative management
419360|NCT01781715|STEMI, Multivessel Coronary Artery Disease, Primary PCI, multivessel stenting, zotarolimus-eluting stent|stemi, multivessel coronary artery disease, primary pci, multivessel stenting, zotarolimus-eluting stent
419361|NCT01781689|cortical activation|cortical activation
419362|NCT01781689|motor function|motor function
419363|NCT01781689|activity of daily living|activity of daily living
419364|NCT01781650|Warm Water Infusion colonoscopy|warm water infusion colonoscopy
419365|NCT01781650|Water Immersion colonoscopy|water immersion colonoscopy
419366|NCT01781650|Water Exchange colonoscopy|water exchange colonoscopy
419367|NCT01781650|Painless unsedated colonoscopy|painless unsedated colonoscopy
419368|NCT01781650|Adenoma detection rate|adenoma detection rate
419369|NCT01781650|Adenoma resection rate|adenoma resection rate
419370|NCT01781637|Xolair|xolair
419371|NCT01781637|omalizumab|omalizumab
419372|NCT01781637|peanut|peanut
419373|NCT01781637|oral desensitization|oral desensitization
419374|NCT01781611|lupus|lupus
419375|NCT01781611|dipyridamole|dipyridamole
419376|NCT01781598|Total knee arthroplasty|total knee arthroplasty
419377|NCT01781598|Patient specific instruments|patient specific instruments
419378|NCT01781598|Patient matched cutting blocks|patient matched cutting blocks
419379|NCT01781598|Alignment|alignment
419380|NCT01781598|Learning curve|learning curve
419381|NCT01781598|VISIONAIRE|visionaire
419382|NCT01781585|Sustained low-efficiency dialysis;|sustained low-efficiency dialysis;
419383|NCT01781585|Continuous venovenous hemofiltration;|continuous venovenous hemofiltration;
419384|NCT01781585|hemodynamic stability,|hemodynamic stability,
419385|NCT01781585|Intracranial pressure|intracranial pressure
419386|NCT01781546|drug eluting balloon|drug eluting balloon
419387|NCT01781546|bare metal stent|bare metal stent
419388|NCT01781546|coronary artery disease|coronary artery disease
419389|NCT01781546|acute coronary syndrome|acute coronary syndrome
419390|NCT01781546|percutaneous coronary intervention|percutaneous coronary intervention
419391|NCT01781546|DEB|deb
419392|NCT01781546|BMS|bms
419393|NCT01781520|Pancreatic Cancer|pancreatic cancer
419394|NCT01781520|S1|s1
419395|NCT01781520|DC-CIK|dc-cik
419396|NCT01781507|Asthma|asthma
419397|NCT01781507|Allergic rhinitis|allergic rhinitis
419398|NCT01781507|Cetirizine|cetirizine
419399|NCT01781507|Impulse oscillometry|impulse oscillometry
710618|NCT00588562|PHI|phi
710619|NCT00588562|PHII|phii
419400|NCT01781481|Psychosocial Stress and Adjustment|psychosocial stress and adjustment
419401|NCT01781481|Pediatric Chronic Illness|pediatric chronic illness
419402|NCT01781481|Decision-support tool|decision-support tool
419403|NCT01781481|Integrated Health Care|integrated health care
419404|NCT01781481|Case Complexity|case complexity
419405|NCT01781442|Metastatic Renal Cell Carcinoma|metastatic renal cell carcinoma
419406|NCT01781416|cardiovascular risk|cardiovascular risk
419407|NCT01781416|SCORE|score
419408|NCT01781416|cardiovascular primary prevention|cardiovascular primary prevention
419409|NCT01781416|risk factors|risk factors
419410|NCT01781403|Temozolomide|temozolomide
419411|NCT01781403|capecitabine|capecitabine
419412|NCT01781403|rectal cancer|rectal cancer
419413|NCT01781390|Acute Myocardial Infarction|acute myocardial infarction
419414|NCT01781390|STEMI|stemi
419415|NCT01781390|Heart Attack|heart attack
419416|NCT01781390|AMI|ami
419417|NCT01781390|Stem Cells|stem cells
419418|NCT01781377|NAUSEA|nausea
419419|NCT01781377|VOMITING|vomiting
419420|NCT01781377|CESAREAN SECTION|cesarean section
419421|NCT01781377|PREVENTION|prevention
419422|NCT01781377|PROPOFOL|propofol
419423|NCT01781364|Brain Oscillations|brain oscillations
419424|NCT01781364|Cognitive Performance|cognitive performance
419425|NCT01781325|musculoskeletal, physical therapy|musculoskeletal, physical therapy
419426|NCT01781299|Breast Cancer|breast cancer
419427|NCT01781299|Mastectomy|mastectomy
419428|NCT01781299|Immediate reconstruction|immediate reconstruction
419429|NCT01781286|Obesity|obesity
419430|NCT01781286|Snacking|snacking
419431|NCT01781286|Appetite|appetite
419432|NCT01781286|Protein|protein
419433|NCT01781286|Soy|soy
419434|NCT01781286|Reward driven eating|reward driven eating
419435|NCT01781286|Satiety|satiety
419436|NCT01781273|impaired driving|impaired driving
419437|NCT01781260|Prone position|prone position
419438|NCT01781260|Cardiac output|cardiac output
419439|NCT01781260|Liver Circulation|liver circulation
419440|NCT01781247|Stress Disorders, Post-Traumatic|stress disorders, post-traumatic
419441|NCT01781247|Myocardial Infarction|myocardial infarction
419442|NCT01781247|Psychotherapy|psychotherapy
419443|NCT01781247|Preventive Therapy|preventive therapy
419444|NCT01781247|Randomized Controlled Trial|randomized controlled trial
419445|NCT01781247|Cardiovascular Diseases|cardiovascular diseases
419446|NCT01781247|Psychological Stress|psychological stress
419447|NCT01781247|Biomarkers|biomarkers
419448|NCT01781195|Advagraf|advagraf
419449|NCT01781195|MELD-score|meld-score
419450|NCT01781195|Na-MELD-score|na-meld-score
419451|NCT01781195|liver function|liver function
419452|NCT01781195|LiMAx-test|limax-test
419453|NCT01781195|infection rate|infection rate
419454|NCT01781195|HLA-DR status|hla-dr status
419455|NCT01781195|immunostatus|immunostatus
419456|NCT01781169|Vitamin D,|vitamin d,
419457|NCT01781169|Oral supplementation,|oral supplementation,
419458|NCT01781169|Obese males|obese males
419459|NCT01781156|phosphorus|phosphorus
419460|NCT01781156|hemodialysis|hemodialysis
419461|NCT01781156|cardiac biomarkers|cardiac biomarkers
419462|NCT01781117|Benign prostatic obstruction (BPO)|benign prostatic obstruction (bpo)
419463|NCT01781117|Detrusor overactivity (DO)|detrusor overactivity (do)
419464|NCT01781117|Urinary nerve growth factor (NGF)|urinary nerve growth factor (ngf)
419465|NCT01781104|constipation gastric emptying gastrointestinal motility ghrelin|constipation gastric emptying gastrointestinal motility ghrelin
419466|NCT01781078|Single chamber pacing|single chamber pacing
419467|NCT01781078|Dual chamber pacing|dual chamber pacing
419468|NCT01781078|MRI|mri
419469|NCT01781078|MR scans|mr scans
419470|NCT01781052|Iloprost Compliance|iloprost compliance
419471|NCT01781039|"hair cell"|"hair cell"
419472|NCT01781039|"hearing aid"|"hearing aid"
419473|NCT01781039|"hearing loss"|"hearing loss"
419474|NCT01781039|"auditory nerve"|"auditory nerve"
419475|NCT01781039|synaptopathy|synaptopathy
419476|NCT01781026|B-raf V600E|b-raf v600e
419477|NCT01781026|V600K mutation|v600k mutation
419478|NCT01781026|metastatic melanoma|metastatic melanoma
419479|NCT01781013|Depression screening|depression screening
419480|NCT01781013|Depression monitoring|depression monitoring
419481|NCT01781013|Chronic illness|chronic illness
419482|NCT01781013|Behavioral health|behavioral health
419483|NCT01781013|Care management|care management
419484|NCT01781013|Automatic telephone assessment|automatic telephone assessment
419485|NCT01781013|Clinical decision support|clinical decision support
419486|NCT01781013|Suicide alert|suicide alert
419487|NCT01781000|Cognitive Training|cognitive training
419488|NCT01781000|Neuroplasticity|neuroplasticity
419489|NCT01781000|MEG|meg
419490|NCT01781000|MATRICS|matrics
419491|NCT01780987|DVT|dvt
419492|NCT01780987|PE|pe
419493|NCT01780987|VTE|vte
419494|NCT01780974|Hypertension|hypertension
419495|NCT01780974|Vascular Risk|vascular risk
419496|NCT01780974|Alzheimer's Risk|alzheimer's risk
419497|NCT01780974|fish oil|fish oil
419498|NCT01780974|Lipoic acid|lipoic acid
419499|NCT01780961|Esophageal Cancer|esophageal cancer
419500|NCT01780961|ESBX|esbx
536293|NCT01279863|VRI|vri
419501|NCT01780948|Drug Interaction|drug interaction
419502|NCT01780948|Pharmacokinetics|pharmacokinetics
419503|NCT01780948|Everolimus|everolimus
419504|NCT01780948|Atorvastatin|atorvastatin
419505|NCT01780922|Inflammation|inflammation
419506|NCT01780922|Oxidative Stress|oxidative stress
419507|NCT01780922|Vaccinium macrocarpon|vaccinium macrocarpon
419508|NCT01780896|Topographical Memory|topographical memory
419509|NCT01780896|Non-Topographical Memory|non-topographical memory
419510|NCT01780896|Vestibular Function|vestibular function
419511|NCT01780896|Alzheimer's Disease|alzheimer's disease
419512|NCT01780883|melatonin|melatonin
419513|NCT01780883|childhood autism|childhood autism
419514|NCT01780883|6-Sulphatoxymelatonin|6-sulphatoxymelatonin
419515|NCT01780883|autistic disorder|autistic disorder
419516|NCT01780883|dose-effect relation|dose-effect relation
419517|NCT01780870|Overweight|overweight
419518|NCT01780870|Obesity|obesity
419519|NCT01780870|Obese|obese
419520|NCT01780870|Weight loss|weight loss
419521|NCT01780857|palmoplantar pustulosis|palmoplantar pustulosis
419522|NCT01780857|psoriasis|psoriasis
419523|NCT01780844|Kidney Transplantation|kidney transplantation
419524|NCT01780844|de novo Kidney Transplantation|de novo kidney transplantation
419525|NCT01780844|ASKP1240|askp1240
419526|NCT01780818|Warm Water Infusion colonoscopy|warm water infusion colonoscopy
419527|NCT01780818|Water Immersion colonoscopy|water immersion colonoscopy
419528|NCT01780818|Water Exchange colonoscopy|water exchange colonoscopy
419529|NCT01780818|Painless unsedated colonoscopy|painless unsedated colonoscopy
419530|NCT01780818|Adenoma detection rate|adenoma detection rate
419531|NCT01780818|Adenoma resection rate|adenoma resection rate
419532|NCT01780792|multiple sclerosis|multiple sclerosis
419533|NCT01780792|mobility|mobility
419534|NCT01780792|cognition|cognition
419535|NCT01780792|neuroplasticity|neuroplasticity
419536|NCT01780792|videogame play|videogame play
419537|NCT01780779|Diffusion weighted MRI|diffusion weighted mri
419538|NCT01780779|Patient outcome assessment|patient outcome assessment
419539|NCT01780779|Treatment response|treatment response
419540|NCT01780779|Histopathology|histopathology
419541|NCT01780766|Whole body MRI|whole body mri
419542|NCT01780766|Multiple myeloma|multiple myeloma
419543|NCT01780766|Diffusion Weighted MRI|diffusion weighted mri
419544|NCT01780766|Whole body scan|whole body scan
419545|NCT01780753|Primaquine|primaquine
419546|NCT01780753|Vivax malaria|vivax malaria
419547|NCT01780753|G6PD|g6pd
419548|NCT01780740|Bypass Surgery, Coronary Artery|bypass surgery, coronary artery
419549|NCT01780740|Atrial fibrillation|atrial fibrillation
419550|NCT01780740|Ischaemia-reperfusion injury|ischaemia-reperfusion injury
419551|NCT01780740|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors
419552|NCT01780740|Statins, HMG-CoA|statins, hmg-coa
419553|NCT01780727|echocardiography|echocardiography
419554|NCT01780727|hemodynamic management|hemodynamic management
419555|NCT01780714|smoking|smoking
419556|NCT01780714|cigarette|cigarette
419557|NCT01780714|exposure|exposure
419558|NCT01780714|biomarker|biomarker
419559|NCT01780714|human smoking topography (HST)|human smoking topography (hst)
419560|NCT01780714|modified risk tobacco product (MRTP)|modified risk tobacco product (mrtp)
419561|NCT01780714|THS 2.1|ths 2.1
419562|NCT01780701|prostate cancer aggressiveness|prostate cancer aggressiveness
419563|NCT01780701|magnetic resonance imaging|magnetic resonance imaging
419564|NCT01780701|fatty acid synthase|fatty acid synthase
419565|NCT01780688|Modified risk tobacco product (MRTP)|modified risk tobacco product (mrtp)
419566|NCT01780688|Smoking|smoking
419567|NCT01780688|Nicotine profile|nicotine profile
419568|NCT01780675|Prophylactic Cranial Irradiation|prophylactic cranial irradiation
419569|NCT01780675|Hippocampal Avoidance Prophylactic Cranial Irradiation|hippocampal avoidance prophylactic cranial irradiation
419570|NCT01780649|IMSI|imsi
419571|NCT01780649|ICSI|icsi
419572|NCT01780649|ART Assisted reproductive technology|art assisted reproductive technology
419573|NCT01780649|Spermatozoa|spermatozoa
419574|NCT01780649|male infertility|male infertility
419575|NCT01780649|vacuoles|vacuoles
419576|NCT01780636|Non relaxing puborectalis syndrome|non relaxing puborectalis syndrome
419577|NCT01780636|Botulinum toxin A|botulinum toxin a
419578|NCT01780636|Botox|botox
419579|NCT01780636|Constipation|constipation
419580|NCT01780623|fatigue|fatigue
419581|NCT01780623|sleep|sleep
419582|NCT01780623|quality of life|quality of life
419583|NCT01780623|light|light
419584|NCT01780623|cancer|cancer
419585|NCT01780610|endometrium preparation protocols|endometrium preparation protocols
419586|NCT01780610|frozen-thawed embryo transfer|frozen-thawed embryo transfer
419587|NCT01780610|irregular cycle|irregular cycle
419588|NCT01780610|randomized controlled trial|randomized controlled trial
419589|NCT01780597|Heart transplantation|heart transplantation
419590|NCT01780597|Ev Vivo Perfusion|ev vivo perfusion
419591|NCT01780597|Cardiac function|cardiac function
419592|NCT01780584|congenital heart surgery, thyroid hormones|congenital heart surgery, thyroid hormones
419593|NCT01780571|Obesity|obesity
419594|NCT01780571|general anaesthesia|general anaesthesia
419595|NCT01780571|preoxygenation|preoxygenation
419596|NCT01780571|atelectasis|atelectasis
419597|NCT01780558|endometrium preparation protocols|endometrium preparation protocols
419598|NCT01780558|frozen-thawed embryo transfer|frozen-thawed embryo transfer
419599|NCT01780558|natural cycles|natural cycles
419600|NCT01780558|hormone replacement therapy cycles|hormone replacement therapy cycles
419601|NCT01780558|randomized controlled trial|randomized controlled trial
419602|NCT01780545|OGX-427|ogx-427
419603|NCT01780545|Docetaxel|docetaxel
419604|NCT01780519|Alzheimer's disease (AD)|alzheimer's disease (ad)
419605|NCT01780506|HIV|hiv
419606|NCT01780506|Treatment Naive|treatment naive
419607|NCT01780506|HIV 1 Infected|hiv 1 infected
419608|NCT01780506|Female|female
419609|NCT01780506|Women|women
419610|NCT01780493|Nipple|nipple
419611|NCT01780493|Technique|technique
419612|NCT01780493|Ureter|ureter
419613|NCT01780493|Vesicoureteral Reflux|vesicoureteral reflux
419614|NCT01780480|Ischemic Stroke|ischemic stroke
419615|NCT01780480|Convalescence|convalescence
419616|NCT01780480|Randomized Controlled Trial|randomized controlled trial
419617|NCT01780480|Pilot Study|pilot study
419618|NCT01780480|Traditional Chinese Medicine|traditional chinese medicine
419619|NCT01780467|Loss aversion|loss aversion
419620|NCT01780467|Dopamine|dopamine
419621|NCT01780467|Parkinson's disease|parkinson's disease
419622|NCT01780454|End Stage Renal Disease|end stage renal disease
419623|NCT01780454|Renal Transplant|renal transplant
419624|NCT01780454|Bone Marrow Transplant|bone marrow transplant
419625|NCT01780454|Tolerance|tolerance
419626|NCT01780454|Chimerism|chimerism
419627|NCT01780454|ESRD|esrd
419628|NCT01780441|Tuberous Sclerosis Complex|tuberous sclerosis complex
419629|NCT01780441|TSC|tsc
419630|NCT01780441|Autism|autism
419631|NCT01780441|ASD|asd
419632|NCT01780441|Biomarkers|biomarkers
419633|NCT01780441|Infants|infants
419634|NCT01780428|Pain|pain
419635|NCT01780428|Nausea|nausea
419636|NCT01780428|Vomiting|vomiting
419637|NCT01780415|Blastocoele fluid|blastocoele fluid
419638|NCT01780415|Human DNA|human dna
419639|NCT01780415|molecular diagnosis|molecular diagnosis
419640|NCT01780402|feeding difficulty|feeding difficulty
419641|NCT01780402|eating difficulty|eating difficulty
419642|NCT01780402|dementia|dementia
419643|NCT01780402|nursing home|nursing home
419644|NCT01780402|careful hand feeding|careful hand feeding
419645|NCT01780389|Knee|knee
419646|NCT01780389|Pain|pain
419647|NCT01780389|Osteoarthritis|osteoarthritis
419648|NCT01780376|whole-body vibration|whole-body vibration
419649|NCT01780376|latency|latency
419650|NCT01780376|reflex response|reflex response
419651|NCT01780376|muscle|muscle
419652|NCT01780337|Oxytocin|oxytocin
419653|NCT01780337|Arrhythmia|arrhythmia
419654|NCT01780298|COPD|copd
419655|NCT01780298|Biomarkers|biomarkers
419656|NCT01780298|Cigarette Smoke|cigarette smoke
419657|NCT01780298|Lung Inflammation|lung inflammation
419659|NCT01780298|Sputum|sputum
419660|NCT01780285|Hiatal hernia|hiatal hernia
419661|NCT01780285|Gastro-oesophageal reflux disease|gastro-oesophageal reflux disease
419662|NCT01780285|Laparoscopic hiatal repair|laparoscopic hiatal repair
419663|NCT01780285|Laparoscopic anti-reflux surgery|laparoscopic anti-reflux surgery
419664|NCT01780285|Partially absorbable lightweight mesh|partially absorbable lightweight mesh
419665|NCT01780285|Polytetrafluoroethylene|polytetrafluoroethylene
419666|NCT01780285|PTFE|ptfe
419667|NCT01780285|Nitinol|nitinol
419668|NCT01780285|Nitinol-framed lightweight PTFE mesh|nitinol-framed lightweight ptfe mesh
419669|NCT01780259|Healthy|healthy
419670|NCT01780259|Esketamine|esketamine
419671|NCT01780259|Pharmacokinetics|pharmacokinetics
419672|NCT01780259|Intranasal|intranasal
419673|NCT01780246|Spinal Muscular Atrophy|spinal muscular atrophy
419674|NCT01780246|SMA|sma
419675|NCT01780246|SMN|smn
419676|NCT01780246|SMNRx|smnrx
419677|NCT01780246|ISIS-SMNRx|isis-smnrx
419678|NCT01780246|ISIS 396443|isis 396443
419679|NCT01780220|abiraterone|abiraterone
419680|NCT01780220|biochemically-relapsing|biochemically-relapsing
419681|NCT01780220|prostate adenocarcinoma|prostate adenocarcinoma
419682|NCT01780181|lung cancer|lung cancer
419683|NCT01780181|traditional Chinese medicine|traditional chinese medicine
419684|NCT01780168|Mitochondrial Disorders|mitochondrial disorders
419685|NCT01780168|Urea Cycle Disorders|urea cycle disorders
419686|NCT01780168|Organic Acidemias|organic acidemias
419687|NCT01780168|Fatty Acid Oxidation Defects|fatty acid oxidation defects
419688|NCT01780155|Oxidative Stress|oxidative stress
419689|NCT01780155|Hyperoxia|hyperoxia
419690|NCT01780155|Brochopulmonary Dysplasia|brochopulmonary dysplasia
419691|NCT01780155|Retinopathy of Prematurity|retinopathy of prematurity
419692|NCT01780155|Very Low Birth Rate|very low birth rate
419693|NCT01780142|Airflow Obstruction|airflow obstruction
419694|NCT01780142|Airflow Inflammation|airflow inflammation
419695|NCT01780142|Corticosteroid Resistance|corticosteroid resistance
419696|NCT01780142|Exacerbations|exacerbations
419697|NCT01780142|Quality of Life|quality of life
419698|NCT01780116|schizophrenia|schizophrenia
419699|NCT01780116|adherence therapy|adherence therapy
419700|NCT01780116|medication|medication
419701|NCT01780116|randomized controlled trial|randomized controlled trial
419702|NCT01780116|cost-effectiveness|cost-effectiveness
419703|NCT01780090|autism|autism
419704|NCT01780090|prosody|prosody
419705|NCT01780090|speech|speech
419706|NCT01780090|autism spectrum disorder|autism spectrum disorder
419707|NCT01780077|Scar|scar
419708|NCT01780077|Scar prevention|scar prevention
419709|NCT01780077|Fibrosis|fibrosis
419710|NCT01780051|Diabetes Mellitus, Type 2|diabetes mellitus, type 2
419711|NCT01780051|Pharmacokinetics|pharmacokinetics
419712|NCT01780038|Cigarette Smoking|cigarette smoking
419713|NCT01780038|Nicotine Dependence|nicotine dependence
419714|NCT01780038|Smoking Abstinence|smoking abstinence
419715|NCT01780038|Health Literacy|health literacy
419716|NCT01780038|Genetic Predisposition Testing|genetic predisposition testing
419717|NCT01780038|Heredity|heredity
419718|NCT01780025|Hearing|hearing
419719|NCT01780025|Thresholds|thresholds
419720|NCT01780025|Coupling to the inner ear|coupling to the inner ear
419721|NCT01780012|osteoporosis|osteoporosis
419722|NCT01780012|fragility fracture|fragility fracture
419723|NCT01780012|secondary prevention|secondary prevention
419724|NCT01779999|central venous catheters|central venous catheters
419725|NCT01779999|thrombosis|thrombosis
419726|NCT01779999|secondary prevention|secondary prevention
419727|NCT01779973|Skype|skype
419728|NCT01779973|compliance|compliance
419729|NCT01779973|remote dosing|remote dosing
419730|NCT01779973|suboxone|suboxone
419731|NCT01779973|opiate|opiate
419732|NCT01779973|opiates|opiates
419733|NCT01779973|heroin|heroin
419734|NCT01779973|oxycontin|oxycontin
419735|NCT01779973|Philadelphia|philadelphia
419736|NCT01779960|Pulmonary Disease, Chronic Obstructive|pulmonary disease, chronic obstructive
419737|NCT01779960|Motor activity|motor activity
419738|NCT01779960|Climatologic station|climatologic station
419739|NCT01779908|Vitamin D supplementation|vitamin d supplementation
419740|NCT01779908|Insulin resistance|insulin resistance
419741|NCT01779895|Dust mite|dust mite
419742|NCT01779895|Perennial allergic rhinitis|perennial allergic rhinitis
419743|NCT01779869|PET MR myocardial perfusion imaging|pet mr myocardial perfusion imaging
419744|NCT01779856|End Stage Renal Disease, Hemodialysis, Arrhythmia, Reveal ICM|end stage renal disease, hemodialysis, arrhythmia, reveal icm
419745|NCT01779843|Newly diagnosed|newly diagnosed
419746|NCT01779804|foot , ankle, injury|foot , ankle, injury
419747|NCT01779791|Lymphoma|lymphoma
419748|NCT01779791|Refractory follicular lymphoma|refractory follicular lymphoma
419749|NCT01779791|Chemoimmunotherapy-resistant follicular lymphoma|chemoimmunotherapy-resistant follicular lymphoma
419750|NCT01779791|PCI-32765|pci-32765
419751|NCT01779791|Ibrutinib|ibrutinib
419752|NCT01779791|IMBRUVICA|imbruvica
419753|NCT01779765|IBS|ibs
419754|NCT01779765|Diarrhea|diarrhea
419755|NCT01779765|Constipation|constipation
419756|NCT01779765|Fibers|fibers
419757|NCT01779739|vaginal prolapse|vaginal prolapse
419758|NCT01779739|sexual function|sexual function
419759|NCT01779739|sexual dysfunction|sexual dysfunction
419760|NCT01779739|prolapse surgery|prolapse surgery
419761|NCT01779726|Organization|organization
419762|NCT01779726|of fast track|of fast track
419763|NCT01779713|Aneurysmal subarachnoid hemorrhage|aneurysmal subarachnoid hemorrhage
419764|NCT01779713|Vasospasm|vasospasm
419765|NCT01779713|Transcriptomic|transcriptomic
419766|NCT01779713|Case-Control Study|case-control study
419767|NCT01779700|psychosis|psychosis
419768|NCT01779700|schizophrenia|schizophrenia
419769|NCT01779700|cognition|cognition
419770|NCT01779700|fingolimod|fingolimod
419771|NCT01779687|pharmacokinetic|pharmacokinetic
419772|NCT01779687|interaction|interaction
419773|NCT01779687|cholesterol|cholesterol
419774|NCT01779687|raltegravir|raltegravir
419775|NCT01779687|atorvastatin|atorvastatin
419776|NCT01779661|Neurodevelopment, Infant-Aquatics, Prematurity|neurodevelopment, infant-aquatics, prematurity
419777|NCT01779648|deep vein thrombosis|deep vein thrombosis
419778|NCT01779648|intermittent pneumatic compression|intermittent pneumatic compression
419779|NCT01779648|venous hemodynamics|venous hemodynamics
419780|NCT01779635|Heparin-grafted membrane|heparin-grafted membrane
419781|NCT01779635|Circuit lifespan|circuit lifespan
419782|NCT01779635|Continuous renal replacement therapy|continuous renal replacement therapy
419783|NCT01779635|Anticoagulation free|anticoagulation free
419784|NCT01779635|Bleeding risk|bleeding risk
419785|NCT01779635|Acute kidney injury|acute kidney injury
419786|NCT01779635|Critical illness|critical illness
419787|NCT01779622|mixed meal¨|mixed meal¨
419788|NCT01779622|insulin|insulin
419789|NCT01779622|glucagon|glucagon
419790|NCT01779622|GIP|gip
419791|NCT01779622|GLP-1|glp-1
419792|NCT01779596|diabetes|diabetes
419793|NCT01779596|endothelial function|endothelial function
419794|NCT01779596|exercise|exercise
419795|NCT01779596|blood flow|blood flow
419796|NCT01779596|bosentan|bosentan
419797|NCT01779583|Advanced gastric cancer|advanced gastric cancer
419798|NCT01779570|Influenza|influenza
419799|NCT01779570|Macrolide|macrolide
419800|NCT01779570|Anti-inflammatory|anti-inflammatory
419801|NCT01779557|CAPD|capd
419802|NCT01779557|efficacy|efficacy
419803|NCT01779557|safety|safety
419804|NCT01779557|survival rate|survival rate
419805|NCT01779544|rehabilitation,surgery,brief intervention, exercises|rehabilitation,surgery,brief intervention, exercises
419806|NCT01779531|HER2-negative Luminal B breast cancer|her2-negative luminal b breast cancer
419807|NCT01779518|HCV|hcv
419808|NCT01779518|Sustained Virologic Response|sustained virologic response
419809|NCT01779518|Direct Acting Antiviral|direct acting antiviral
419810|NCT01779518|GS-7977|gs-7977
419811|NCT01779518|Pegylated interferon|pegylated interferon
419812|NCT01779518|Ribavirin|ribavirin
419813|NCT01779518|Open Label|open label
419814|NCT01779518|Sofosbuvir|sofosbuvir
419815|NCT01779518|Liver transplant|liver transplant
419816|NCT01779518|Hepatitis|hepatitis
419817|NCT01779518|Hepatitis, Chronic|hepatitis, chronic
419818|NCT01779518|Hepatitis C|hepatitis c
419819|NCT01779518|Hepatitis C, Chronic|hepatitis c, chronic
419820|NCT01779518|Liver Diseases|liver diseases
419821|NCT01779518|Digestive System Diseases|digestive system diseases
419822|NCT01779518|Hepatitis, Viral, Human|hepatitis, viral, human
419823|NCT01779518|Virus Diseases|virus diseases
419824|NCT01779518|Enterovirus Infections|enterovirus infections
419825|NCT01779518|Picornaviridae Infections|picornaviridae infections
419826|NCT01779518|RNA Virus Infections|rna virus infections
419827|NCT01779518|Flaviviridae Infections|flaviviridae infections
419828|NCT01779518|Antiviral Agents|antiviral agents
419829|NCT01779518|Anti-Infective Agents|anti-infective agents
419830|NCT01779518|Therapeutic Uses|therapeutic uses
419831|NCT01779518|Pharmacologic Actions|pharmacologic actions
419832|NCT01779518|Antimetabolites|antimetabolites
419833|NCT01779518|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action
419834|NCT01779492|Oxycodone, controlled release formulation|oxycodone, controlled release formulation
419835|NCT01779479|German Breast Group|german breast group
419836|NCT01779479|GBG Forschungs GmbH|gbg forschungs gmbh
419837|NCT01779479|GBG|gbg
419838|NCT01779479|GBG 74|gbg 74
419839|NCT01779479|Genevieve|genevieve
419840|NCT01779479|Breast Cancer|breast cancer
419841|NCT01779479|Primary Breast Cancer|primary breast cancer
419842|NCT01779479|Cabazitaxel|cabazitaxel
419843|NCT01779479|Paclitaxel|paclitaxel
419844|NCT01779479|neo-adjuvant|neo-adjuvant
419845|NCT01779479|triple negative|triple negative
419846|NCT01779479|luminal B|luminal b
419847|NCT01779453|Atorvastatin|atorvastatin
419848|NCT01779453|Drug-drug interaction|drug-drug interaction
419849|NCT01779453|Combination therapy|combination therapy
419850|NCT01779440|Mental Illness|mental illness
419851|NCT01779440|Tobacco Smoking|tobacco smoking
419852|NCT01779440|Young Adults|young adults
419853|NCT01779440|Treatment Engagement|treatment engagement
419854|NCT01779440|Motivational Intervention|motivational intervention
419855|NCT01779427|traumatic brain injury (TBI)|traumatic brain injury (tbi)
419856|NCT01779427|intracranial edema|intracranial edema
419857|NCT01779427|brain edema|brain edema
419858|NCT01779427|craniocerebral trauma|craniocerebral trauma
419859|NCT01779427|head injury|head injury
419860|NCT01779427|brain hemorrhage, traumatic|brain hemorrhage, traumatic
419861|NCT01779427|subdural hematoma|subdural hematoma
419862|NCT01779427|brain concussion|brain concussion
419863|NCT01779427|head injuries, closed|head injuries, closed
419864|NCT01779427|epidural hematoma|epidural hematoma
419865|NCT01779427|extra-axial hemorrhage|extra-axial hemorrhage
419866|NCT01779427|cortical contusion|cortical contusion
419867|NCT01779427|wounds and injuries|wounds and injuries
419868|NCT01779427|disorders of environmental origin|disorders of environmental origin
419869|NCT01779427|trauma, nervous system|trauma, nervous system
419870|NCT01779427|brain injuries|brain injuries
419871|NCT01779427|attention deficit hyperactivity disorder (ADHD)|attention deficit hyperactivity disorder (adhd)
419872|NCT01779427|attention|attention
419873|NCT01779414|Suicide Ideation|suicide ideation
419874|NCT01779401|PCI|pci
419875|NCT01779401|platelet function monitoring|platelet function monitoring
419876|NCT01779401|Thrombelastography|thrombelastography
419877|NCT01779401|clopidogrel|clopidogrel
419878|NCT01779401|cilostazol|cilostazol
419879|NCT01779401|in-stent thrombosis|in-stent thrombosis
419880|NCT01779388|Lung nodule|lung nodule
419881|NCT01779388|PET scanner|pet scanner
419882|NCT01779388|Bronchoscopy|bronchoscopy
419883|NCT01779388|Electromagnetic navigation|electromagnetic navigation
419884|NCT01779375|Children|children
419885|NCT01779375|Pediatric|pediatric
419886|NCT01779349|benign prostatic hyperplasia (BPH)|benign prostatic hyperplasia (bph)
419887|NCT01779349|acoustic vibration|acoustic vibration
419888|NCT01779336|Advanced Refractory Solid Tumors|advanced refractory solid tumors
419889|NCT01779323|SUI|sui
419890|NCT01779323|stress urinary incontinence|stress urinary incontinence
419891|NCT01779323|male|male
419892|NCT01779323|transobturator sling|transobturator sling
419893|NCT01779297|new integrative weaning indexes|new integrative weaning indexes
419894|NCT01779297|mechanical ventilation|mechanical ventilation
419895|NCT01779297|ICU|icu
419896|NCT01779284|glaucoma|glaucoma
419897|NCT01779284|fixed combinations|fixed combinations
419898|NCT01779284|24-hour monitoring|24-hour monitoring
419899|NCT01779271|Pelubi|pelubi
419900|NCT01779271|Pelubiprofen|pelubiprofen
419901|NCT01779271|Loxoprofen|loxoprofen
419902|NCT01779271|Anti-pyretic|anti-pyretic
419903|NCT01779271|Fever|fever
419905|NCT01779258|dry skin|dry skin
419906|NCT01779258|dermatitis|dermatitis
419907|NCT01779258|eczema|eczema
419908|NCT01779258|emollient|emollient
419909|NCT01779258|corticosteroid|corticosteroid
419910|NCT01779258|flare|flare
419911|NCT01779232|endometriosis|endometriosis
419912|NCT01779232|ivf|ivf
419913|NCT01779232|ovarian reserve|ovarian reserve
419914|NCT01779232|danazol|danazol
419915|NCT01779219|intraoperative magnetic resonance|intraoperative magnetic resonance
419916|NCT01779219|stereotactic biopsy|stereotactic biopsy
419917|NCT01779219|brain tumor|brain tumor
419918|NCT01779219|frameless stereotaxy|frameless stereotaxy
419919|NCT01779219|image-guided neurosurgery|image-guided neurosurgery
419920|NCT01779193|group B streptococcus|group b streptococcus
419921|NCT01779193|pregnancy|pregnancy
419922|NCT01779193|probiotics|probiotics
419923|NCT01779180|Vitamin A supplementation|vitamin a supplementation
419924|NCT01779180|BCG vaccination|bcg vaccination
419925|NCT01779180|diphtheria-tetanus-pertussis vaccination|diphtheria-tetanus-pertussis vaccination
419926|NCT01779180|measles vaccination|measles vaccination
419927|NCT01779180|atopy|atopy
419928|NCT01779167|WM|wm
419929|NCT01779154|eosinophilic esophagitis|eosinophilic esophagitis
419930|NCT01779154|eosinophilic gastritis|eosinophilic gastritis
419931|NCT01779154|eosinophilic enteritis|eosinophilic enteritis
419932|NCT01779154|eosinophilic colitis|eosinophilic colitis
419933|NCT01779141|Type 1 Diabetes Mellitus - T1DM|type 1 diabetes mellitus - t1dm
419934|NCT01779141|Pregnancy|pregnancy
419935|NCT01779141|Insulin Pump|insulin pump
419936|NCT01779141|Glucose Sensor|glucose sensor
419937|NCT01779141|Continuous Subcutaneous Insulin Infusion - CSII|continuous subcutaneous insulin infusion - csii
419938|NCT01779141|Sensor Augmented Pump - SAP|sensor augmented pump - sap
419939|NCT01779141|Continuous Glucose Monitoring - CGM|continuous glucose monitoring - cgm
419940|NCT01779115|Registry,Diabetes,Health Maintenance Organization|registry,diabetes,health maintenance organization
419941|NCT01779089|diabetic nephropathy|diabetic nephropathy
419942|NCT01779089|diabetic kidney disease|diabetic kidney disease
419943|NCT01779089|minocycline|minocycline
419944|NCT01779089|proteinuria|proteinuria
419945|NCT01779089|albuminuria|albuminuria
419946|NCT01779063|lymphedema|lymphedema
419947|NCT01779063|self-care|self-care
419948|NCT01779063|breast cancer|breast cancer
419949|NCT01779024|Addiction|addiction
419950|NCT01779024|Alcohol|alcohol
419951|NCT01779024|Alcohol Clamp|alcohol clamp
419952|NCT01778998|incision|incision
419953|NCT01778998|pre-cut|pre-cut
419954|NCT01778998|wound architecture|wound architecture
419955|NCT01778998|OCT|oct
419956|NCT01778985|Pelvic organ prolapse|pelvic organ prolapse
419957|NCT01778985|Menopause|menopause
419958|NCT01778985|Estrogen|estrogen
419959|NCT01778985|Premarin|premarin
419960|NCT01778972|Fall prevention|fall prevention
419961|NCT01778972|Home exercise|home exercise
419962|NCT01778972|Strength training|strength training
419963|NCT01778972|Balance training|balance training
419964|NCT01778946|Nicotine|nicotine
419965|NCT01778946|Down Syndrome|down syndrome
419966|NCT01778946|Mild Cognitive Impairment|mild cognitive impairment
419967|NCT01778946|Event Related Potential|event related potential
419968|NCT01778946|Memory|memory
419969|NCT01778946|Attention|attention
419970|NCT01778946|Trisomy 21|trisomy 21
419971|NCT01778946|Neuroprotection|neuroprotection
419972|NCT01778946|Cognitive Enhancement|cognitive enhancement
419973|NCT01778946|Alzheimer's Disease|alzheimer's disease
419974|NCT01778946|Dementia|dementia
419975|NCT01778946|APOE|apoe
419976|NCT01778933|Renal cell carcinoma|renal cell carcinoma
419977|NCT01778933|Renal nodules|renal nodules
419978|NCT01778907|Pharmacogenetics|pharmacogenetics
419979|NCT01778907|Depression|depression
419980|NCT01778907|Depressive Disorder|depressive disorder
419981|NCT01778907|Cytochrome P-450 CYP2D6|cytochrome p-450 cyp2d6
419982|NCT01778907|Antidepressive Agents, Tricyclic|antidepressive agents, tricyclic
419983|NCT01778907|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation
419984|NCT01778907|Poor Metabolizer Due to Cytochrome P450 CYP2D6 Variant|poor metabolizer due to cytochrome p450 cyp2d6 variant
419985|NCT01778907|Intermediate Metabolizer Due to Cytochrome P450 CYP2D6 Variant|intermediate metabolizer due to cytochrome p450 cyp2d6 variant
419986|NCT01778907|Ultrarapid Metabolizer Due to Cytochrome P450 CYP2D6 Variant|ultrarapid metabolizer due to cytochrome p450 cyp2d6 variant
419987|NCT01778907|Multicenter studies|multicenter studies
710227|NCT00589667|head/neck squamous cell carcinoma|head/neck squamous cell carcinoma
419988|NCT01778894|Diastolic Dysfunction, Diastolic Heart Failure, Diastolic|diastolic dysfunction, diastolic heart failure, diastolic
419989|NCT01778894|Echocardiography|echocardiography
419990|NCT01778881|Bruxism|bruxism
419991|NCT01778881|Physical therapy modalities|physical therapy modalities
419992|NCT01778881|Massage|massage
419993|NCT01778881|Muscle stretching exercises|muscle stretching exercises
419994|NCT01778881|Relaxation therapy|relaxation therapy
419995|NCT01778881|Imagination|imagination
419996|NCT01778855|stroke|stroke
419997|NCT01778855|hypothermia|hypothermia
419998|NCT01778855|thrombolysis|thrombolysis
419999|NCT01778855|imaging|imaging
420000|NCT01778855|collateral circulation|collateral circulation
420001|NCT01778855|recanalization|recanalization
420002|NCT01778855|reperfusion|reperfusion
420003|NCT01778842|antiplatelet effect|antiplatelet effect
420004|NCT01778842|prasugrel|prasugrel
420005|NCT01778842|clopidogrel|clopidogrel
420006|NCT01778842|acute coronary syndrome|acute coronary syndrome
420007|NCT01778816|Achilles tendon, muscle volume, Achilles tendon length, force, ATRS, Hannover, AOFAS|achilles tendon, muscle volume, achilles tendon length, force, atrs, hannover, aofas
420008|NCT01778777|rotator cuff tear arthropathy|rotator cuff tear arthropathy
420009|NCT01778777|inverse prosthesis|inverse prosthesis
420010|NCT01778777|safety|safety
420011|NCT01778777|universe reverse|universe reverse
420012|NCT01778751|Self-Management Support|self-management support
420013|NCT01778751|Depression|depression
420014|NCT01778751|Home Telehealth|home telehealth
420015|NCT01778725|Chorioamnionitis, S100B, Brain, Neuro-development|chorioamnionitis, s100b, brain, neuro-development
420016|NCT01778712|Multi-level intervention|multi-level intervention
420017|NCT01778712|Menopause|menopause
420018|NCT01778712|Body composition|body composition
420019|NCT01778712|Abdominal adipose tissue|abdominal adipose tissue
420020|NCT01778712|Visceral adipose tissue|visceral adipose tissue
420021|NCT01778712|Perceived stress|perceived stress
420022|NCT01778712|Computed tomography|computed tomography
420023|NCT01778712|Dual energy X-ray absorptiometry|dual energy x-ray absorptiometry
420024|NCT01778699|Lactobacillus brevis CD2|lactobacillus brevis cd2
420025|NCT01778699|caries incidence|caries incidence
420026|NCT01778699|plaque-pH|plaque-ph
420027|NCT01778686|Positron Emission Tomography|positron emission tomography
420028|NCT01778686|Serotonin|serotonin
420029|NCT01778686|5-HT2A|5-ht2a
420030|NCT01778686|Radioligand|radioligand
420031|NCT01778660|Fecal Incontinence|fecal incontinence
420032|NCT01778660|Treatment options|treatment options
420033|NCT01778660|Patient Satisfaction|patient satisfaction
420034|NCT01778647|ADHD|adhd
420035|NCT01778647|Omega- 3 Fatty acids|omega- 3 fatty acids
420036|NCT01778647|CGI|cgi
420037|NCT01778647|Conners rating scale|conners rating scale
420038|NCT01778647|Stimulants|stimulants
420039|NCT01778634|Ureaplasma parvum|ureaplasma parvum
420040|NCT01778634|Ureaplasma urealyticum|ureaplasma urealyticum
420041|NCT01778634|prematurity|prematurity
420042|NCT01778634|bronchopulmonary dysplasia|bronchopulmonary dysplasia
420043|NCT01778634|azithromycin|azithromycin
420044|NCT01778621|Acupuncture|acupuncture
420045|NCT01778621|AMH|amh
420046|NCT01778621|PCOS|pcos
420047|NCT01778608|Sedation|sedation
420048|NCT01778595|Microbiome|microbiome
420049|NCT01778595|Feces|feces
420050|NCT01778595|Cancer Screening|cancer screening
420051|NCT01778582|Emotion|emotion
420052|NCT01778582|Informed Consent|informed consent
420053|NCT01778569|Imaging|imaging
420054|NCT01778569|Cardiovascular Risk Factors|cardiovascular risk factors
420055|NCT01778569|Inflammation|inflammation
420056|NCT01778569|Lipoproteins|lipoproteins
420057|NCT01778569|Metabolic Dysfunction|metabolic dysfunction
420058|NCT01778556|Lipodystrophy|lipodystrophy
420059|NCT01778556|Leptin|leptin
420060|NCT01778556|Energy Expenditure|energy expenditure
420061|NCT01778556|Diabetes|diabetes
420062|NCT01778556|Hypertriglyceridemia|hypertriglyceridemia
420063|NCT01778543|Coloboma|coloboma
420064|NCT01778530|Glioblastoma|glioblastoma
420065|NCT01778530|Anti-Angiogenesis|anti-angiogenesis
420066|NCT01778530|Radiotherapy|radiotherapy
420067|NCT01778530|Malignant Glioma|malignant glioma
420068|NCT01778530|Progression|progression
420069|NCT01778517|Psychogenic Movement Disorders|psychogenic movement disorders
420070|NCT01778504|PANDAS|pandas
420071|NCT01778504|Natural History Study|natural history study
420072|NCT01778504|Mental Illness|mental illness
420073|NCT01778504|Autism|autism
420074|NCT01778504|Obsessive Compulsive Disorder|obsessive compulsive disorder
420075|NCT01778491|Phenotype-Genotype correlation|phenotype-genotype correlation
420076|NCT01778491|Phenotype|phenotype
420077|NCT01778491|Phenotypes|phenotypes
420078|NCT01778491|Age Related Macular Degeneration|age related macular degeneration
420079|NCT01778478|Anxiety|anxiety
420080|NCT01778478|Depression|depression
420081|NCT01778478|Adolescents and Adults|adolescents and adults
420082|NCT01778478|Cancer Diagnosis|cancer diagnosis
420083|NCT01778465|Chronic Rhinosinusitis|chronic rhinosinusitis
710228|NCT00589654|amenorrhea|amenorrhea
420084|NCT01778465|Aspirin exacerbated respiratory disease|aspirin exacerbated respiratory disease
420085|NCT01778465|Asthma|asthma
420086|NCT01778465|Aspirin sensitivity|aspirin sensitivity
420087|NCT01778465|Salicylate|salicylate
420088|NCT01778452|Endometrial priming, genomic expression. Natural cycle. Antagonist GnRH.|endometrial priming, genomic expression. natural cycle. antagonist gnrh.
420089|NCT01778439|Phase 1|phase 1
420090|NCT01778439|Dose escalation|dose escalation
420091|NCT01778439|relapsed or refractory|relapsed or refractory
420092|NCT01778439|solid tumor|solid tumor
420093|NCT01778426|Chronic neuropathic pain syndrome|chronic neuropathic pain syndrome
420094|NCT01778426|Spinal Cord Stimulation|spinal cord stimulation
420095|NCT01778426|Painstim devices|painstim devices
420096|NCT01778426|Efficacy|efficacy
420097|NCT01778426|Safety|safety
420098|NCT01778400|Ultrasound|ultrasound
420099|NCT01778400|Radiofrequency|radiofrequency
420100|NCT01778400|Ethanol|ethanol
420101|NCT01778400|Predominantly cystic thyroid nodule|predominantly cystic thyroid nodule
420102|NCT01778400|Thyroid nodule|thyroid nodule
420103|NCT01778400|Thyroid|thyroid
420104|NCT01778374|Emergency Medicine|emergency medicine
420105|NCT01778374|Screening|screening
420106|NCT01778374|Point of care testing|point of care testing
420107|NCT01778374|Video assisted counseling|video assisted counseling
420108|NCT01778361|Human immunodeficiency virus|human immunodeficiency virus
420109|NCT01778361|low bone mineral density|low bone mineral density
420110|NCT01778361|osteopenia|osteopenia
420111|NCT01778361|osteoporosis|osteoporosis
420112|NCT01778361|fracture|fracture
420113|NCT01778348|Type 1 diabetes|type 1 diabetes
420114|NCT01778348|Closed-loop glucose control|closed-loop glucose control
420115|NCT01778348|Artificial Pancreas|artificial pancreas
420116|NCT01778348|Continuous subcutaneous insulin infusion|continuous subcutaneous insulin infusion
420117|NCT01778348|Continuous glucose monitoring|continuous glucose monitoring
420118|NCT01778335|recanalization|recanalization
420119|NCT01778335|endovascular|endovascular
420120|NCT01778335|thrombectomy|thrombectomy
420121|NCT01778309|aseptic inflammation|aseptic inflammation
420122|NCT01778309|skeletal muscle function|skeletal muscle function
420123|NCT01778309|exercise|exercise
420124|NCT01778296|Dorsal branch of the digital nerve;|dorsal branch of the digital nerve;
420125|NCT01778296|dorsal digital artery;|dorsal digital artery;
420126|NCT01778296|dorsal digital island flap;|dorsal digital island flap;
420127|NCT01778296|neurocutaneous island flap.|neurocutaneous island flap.
420128|NCT01778270|pleural effusion|pleural effusion
420129|NCT01778270|pleural drainage|pleural drainage
420130|NCT01778270|thorax impedance|thorax impedance
420131|NCT01778270|respiration parameters|respiration parameters
420132|NCT01778270|heart sounds analysis|heart sounds analysis
420133|NCT01778257|Mate extracts|mate extracts
420134|NCT01778257|Obesity|obesity
420135|NCT01778257|abdominal fat|abdominal fat
420136|NCT01778244|schizophrenia; dyslipidemia|schizophrenia; dyslipidemia
420137|NCT01778231|Focus|focus
420138|NCT01778231|uptake|uptake
420139|NCT01778231|Lutein|lutein
420140|NCT01778231|Zeaxanthin|zeaxanthin
420141|NCT01778231|individuals|individuals
420142|NCT01778218|Coronary Artery Disease|coronary artery disease
420143|NCT01778218|CAD|cad
420144|NCT01778192|Bowel preparation|bowel preparation
420145|NCT01778192|Polyethylene glycol|polyethylene glycol
420146|NCT01778192|Sodium picosulphate|sodium picosulphate
420147|NCT01778179|Lentigines|lentigines
420148|NCT01778179|Cryotherapy|cryotherapy
420149|NCT01778179|hyperpigmentation|hyperpigmentation
420150|NCT01778166|Early enteral nutrition|early enteral nutrition
420151|NCT01778166|Laparoscopic gastrointestinal surgery|laparoscopic gastrointestinal surgery
420152|NCT01778166|Immuno-enhanced nutrition|immuno-enhanced nutrition
420153|NCT01778153|Fitness training|fitness training
420154|NCT01778153|Personal training|personal training
420155|NCT01778140|Clinical Decision Support Systems|clinical decision support systems
420156|NCT01778140|Contrast-induced nephropathy|contrast-induced nephropathy
420157|NCT01778127|Cancer Survivor|cancer survivor
420158|NCT01778127|Physical Activity|physical activity
420159|NCT01778127|Health Outcomes|health outcomes
420160|NCT01778127|Rewards-Based Intervention|rewards-based intervention
420161|NCT01778127|Cardiovascular Health|cardiovascular health
420162|NCT01778127|Musculoskeletal Health|musculoskeletal health
420163|NCT01778127|Exercise|exercise
420164|NCT01778114|Vitamin D2|vitamin d2
420165|NCT01778114|Vitamin D3|vitamin d3
420166|NCT01778114|Vitamin D|vitamin d
420167|NCT01778114|Orange Juice|orange juice
420168|NCT01778101|preterm infants|preterm infants
420169|NCT01778101|reflux|reflux
420170|NCT01778101|impedance|impedance
420171|NCT01778101|pH|ph
420172|NCT01778101|monitoring|monitoring
420173|NCT01778101|lansoprazole|lansoprazole
420174|NCT01778075|Healthy|healthy
420175|NCT01778075|Ultracet extended release (ER)|ultracet extended release (er)
420176|NCT01778075|Tramadol hydrochloride|tramadol hydrochloride
420177|NCT01778075|Acetaminophen|acetaminophen
420178|NCT01778075|Bioequivalence|bioequivalence
420179|NCT01778036|Neck movement|neck movement
710620|NCT00588562|PHIII|phiii
420180|NCT01778036|motor control|motor control
420181|NCT01778036|disability|disability
420182|NCT01778036|psychological variables|psychological variables
420183|NCT01778036|Head Movements|head movements
420184|NCT01778036|Physical therapy|physical therapy
420185|NCT01778036|Fear avoidance|fear avoidance
420186|NCT01778036|Self Efficacy|self efficacy
420187|NCT01778036|Catastrophizing|catastrophizing
420188|NCT01778036|Fly test|fly test
420189|NCT01778036|Postural sway|postural sway
420190|NCT01778010|cocaine|cocaine
420191|NCT01778010|modafinil|modafinil
420192|NCT01778010|self-administration|self-administration
420193|NCT01778010|DRD4|drd4
420194|NCT01777906|nasal polyps|nasal polyps
420195|NCT01777906|nasal steriod sprays|nasal steriod sprays
420196|NCT01777893|Type-2 diabetes mellitus|type-2 diabetes mellitus
420197|NCT01777893|Obesity|obesity
420198|NCT01777893|High protein diet|high protein diet
420199|NCT01777893|Low GI|low gi
420200|NCT01777893|Physical activity|physical activity
420201|NCT01777815|NeoChord|neochord
420202|NCT01777815|DS1000|ds1000
420203|NCT01777815|Mitral Valve|mitral valve
420204|NCT01777815|Mitral Valve Regurgitation|mitral valve regurgitation
420205|NCT01777815|MR|mr
420206|NCT01777815|Mitral Valve Repair|mitral valve repair
420207|NCT01777815|Mitral Valve Prolapse|mitral valve prolapse
420208|NCT01777815|Artificial Chordae|artificial chordae
420209|NCT01777789|fMRI|fmri
420210|NCT01777789|Dementia|dementia
420211|NCT01777789|Alzheimer's disease|alzheimer's disease
420212|NCT01777789|functional neuroimaging|functional neuroimaging
420213|NCT01777789|Memory|memory
420214|NCT01777776|Open-label dose escalation|open-label dose escalation
420215|NCT01777776|BRAF inhibitor|braf inhibitor
420216|NCT01777776|LEE011|lee011
420217|NCT01777776|CDK4/6|cdk4/6
420218|NCT01777776|LGX818|lgx818
420219|NCT01777776|RAF kinase inhibitor|raf kinase inhibitor
420220|NCT01777776|Metastatic melanoma|metastatic melanoma
420221|NCT01777776|BRAF|braf
420222|NCT01777776|V600|v600
420223|NCT01777750|Myocardial Infarction|myocardial infarction
420224|NCT01777750|Myocardial Reperfusion Injury|myocardial reperfusion injury
420225|NCT01777750|Reperfusion Injury|reperfusion injury
420226|NCT01777750|Anterior Wall Myocardial Infarction|anterior wall myocardial infarction
420227|NCT01777750|Inferior Wall Myocardial Infarction|inferior wall myocardial infarction
420228|NCT01777750|Pathologic Processes|pathologic processes
420229|NCT01777750|Myocardial Ischemia|myocardial ischemia
420230|NCT01777737|Idiopathic Pulmonary Fibrosis|idiopathic pulmonary fibrosis
420231|NCT01777737|Trimethoprim-sulfamethoxazole|trimethoprim-sulfamethoxazole
420232|NCT01777737|Pneumocystis jiroveci|pneumocystis jiroveci
420233|NCT01777711|mental contrasting|mental contrasting
420234|NCT01777711|weight loss|weight loss
420235|NCT01777711|obese couples|obese couples
420236|NCT01777711|obesity|obesity
420237|NCT01777711|overweight|overweight
420238|NCT01777711|planning|planning
420239|NCT01777711|health|health
420240|NCT01777711|diet|diet
420241|NCT01777711|exercise|exercise
420242|NCT01777711|physical activity|physical activity
420243|NCT01777711|goal|goal
420244|NCT01777711|goal-setting|goal-setting
420245|NCT01777698|body composition|body composition
420246|NCT01777698|hepatocellular carcinoma|hepatocellular carcinoma
420247|NCT01777698|chemoembolization|chemoembolization
420248|NCT01777685|Sulpiride|sulpiride
420249|NCT01777685|Therapeutic drug monitoring|therapeutic drug monitoring
420250|NCT01777685|Pharmacokinetics|pharmacokinetics
420251|NCT01777659|exercise|exercise
420252|NCT01777659|neuromodulation|neuromodulation
420253|NCT01777659|blood flow|blood flow
420254|NCT01777659|exercise capacity|exercise capacity
420255|NCT01777646|Mesenchymal Strmal Cells (MSC)|mesenchymal strmal cells (msc)
420256|NCT01777646|Amyotrophic Lateral Sclerosis (ALS)|amyotrophic lateral sclerosis (als)
420257|NCT01777646|Neuroprotection|neuroprotection
420258|NCT01777646|Neurodegeneration|neurodegeneration
420259|NCT01777646|Stem cells|stem cells
420260|NCT01777594|hepatocellular carcinoma|hepatocellular carcinoma
420261|NCT01777594|HCC|hcc
420262|NCT01777594|liver|liver
420263|NCT01777594|liver cancer|liver cancer
420264|NCT01777594|sorafenib|sorafenib
420265|NCT01777581|sciatica radiculopathy lumbar disc lumbosacral disc|sciatica radiculopathy lumbar disc lumbosacral disc
420266|NCT01777555|Parkinson's Disease|parkinson's disease
420267|NCT01777555|Motor fluctuations|motor fluctuations
420268|NCT01777555|levodopa|levodopa
420269|NCT01777555|inhaled drugs|inhaled drugs
420270|NCT01777555|Off episodes|off episodes
420271|NCT01777542|Rett syndrome|rett syndrome
420272|NCT01777542|RTT|rtt
420273|NCT01777542|IGF-1|igf-1
420274|NCT01777542|autism spectrum disorder|autism spectrum disorder
420275|NCT01777529|Measles|measles
420276|NCT01777529|Mumps|mumps
420277|NCT01777529|Rubella|rubella
420278|NCT01777516|Platelet Aggregation|platelet aggregation
420279|NCT01777516|Cardiovascular Diseases|cardiovascular diseases
420280|NCT01777516|Salicylic Acid|salicylic acid
420281|NCT01777503|acute coronary syndrome|acute coronary syndrome
420282|NCT01777503|elderly|elderly
420283|NCT01777503|percutaneous revascularization|percutaneous revascularization
420284|NCT01777503|antiaggregant drugs|antiaggregant drugs
420285|NCT01777490|Caregivers - Not professionals|caregivers - not professionals
420286|NCT01777490|Frail Elderly|frail elderly
420287|NCT01777490|Long-term Care|long-term care
420288|NCT01777490|Quality of Life|quality of life
420289|NCT01777451|Whole Body Imaging|whole body imaging
420290|NCT01777451|Magnetic Resonance Imaging|magnetic resonance imaging
420291|NCT01777451|Neurofibromatosis 1|neurofibromatosis 1
420292|NCT01777451|Diffusion Magnetic Resonance Imaging|diffusion magnetic resonance imaging
420293|NCT01777451|Peripheral Nerve Sheath Tumors, Malignant|peripheral nerve sheath tumors, malignant
420294|NCT01777412|NMO|nmo
420295|NCT01777412|NMOSD|nmosd
420296|NCT01777412|NMO-IgG|nmo-igg
420297|NCT01777412|Aquaporin-4|aquaporin-4
420298|NCT01777412|AQP4|aqp4
420299|NCT01777412|anti-AQP4|anti-aqp4
420300|NCT01777386|scar|scar
420301|NCT01777386|contracture|contracture
420302|NCT01777386|perforator flap|perforator flap
420303|NCT01777386|preexpanded perforator flap|preexpanded perforator flap
420304|NCT01777386|perforator vessel|perforator vessel
420305|NCT01777386|artery diameter|artery diameter
420306|NCT01777373|conducting airway, bronchiolization|conducting airway, bronchiolization
420307|NCT01777360|severe|severe
420308|NCT01777360|uncontrolled|uncontrolled
420309|NCT01777347|Keywords provided by ASSISTANCE PUBLIQUE HOPITAUX DE PARIS:|keywords provided by assistance publique hopitaux de paris:
420310|NCT01777347|Acute Viral bronchiolitis|acute viral bronchiolitis
420311|NCT01777347|Hypertonic saline|hypertonic saline
420312|NCT01777347|Hospitalization|hospitalization
420313|NCT01777347|Infants|infants
420314|NCT01777347|Hospital admissions|hospital admissions
420315|NCT01777347|Additional relevant MeSH terms:|additional relevant mesh terms:
420316|NCT01777347|Bronchiolitis|bronchiolitis
420317|NCT01777347|Bronchiolitis, Viral|bronchiolitis, viral
420318|NCT01777347|Bronchial Diseases|bronchial diseases
420319|NCT01777347|Respiratory Tract Diseases|respiratory tract diseases
420320|NCT01777347|Lung Diseases, Obstructive|lung diseases, obstructive
420321|NCT01777347|Respiratory Tract Infections|respiratory tract infections
420322|NCT01777347|Virus Diseases|virus diseases
420323|NCT01777321|Herpes Zoster|herpes zoster
420324|NCT01777321|Intramuscular|intramuscular
420325|NCT01777321|Subcutaneous|subcutaneous
420326|NCT01777321|Safety|safety
420327|NCT01777321|≥50 years of age|≥50 years of age
420328|NCT01777321|Adults|adults
420329|NCT01777321|Immunogenicity|immunogenicity
420330|NCT01777321|Elderly|elderly
420331|NCT01777308|Immunogenicity|immunogenicity
420332|NCT01777308|Booster|booster
420333|NCT01777308|Healthy|healthy
420334|NCT01777308|Vaccine response|vaccine response
420335|NCT01777308|Safety|safety
420336|NCT01777308|Neisseria meningiditis|neisseria meningiditis
420337|NCT01777308|Antibody persistence|antibody persistence
420338|NCT01777308|Meningococcal conjugate vaccine|meningococcal conjugate vaccine
420339|NCT01777295|Adults|adults
420340|NCT01777295|Reactogenicity|reactogenicity
420341|NCT01777295|Naive|naive
420342|NCT01777295|Immune responses|immune responses
420343|NCT01777295|Read-outs|read-outs
420344|NCT01777295|Hepatitis B|hepatitis b
420345|NCT01777295|Healthy|healthy
420346|NCT01777282|albiglutide|albiglutide
420347|NCT01777282|Japanese|japanese
420348|NCT01777282|glucagon-like peptide-1|glucagon-like peptide-1
420349|NCT01777282|GSK716155|gsk716155
420350|NCT01777256|systemic lupus erythematosus|systemic lupus erythematosus
420351|NCT01777256|adaptive design|adaptive design
420352|NCT01777256|clinical safety and efficacy|clinical safety and efficacy
420353|NCT01777256|pharmacodynamics|pharmacodynamics
420354|NCT01777243|pharmacokinetic|pharmacokinetic
420355|NCT01777243|systemic amyloidosis|systemic amyloidosis
420356|NCT01777243|safety|safety
420357|NCT01777243|dose escalation|dose escalation
420358|NCT01777243|Carboxy Pyrrolidine Hexanoyl Pyrrolidine Carboxylate (CPHPC)|carboxy pyrrolidine hexanoyl pyrrolidine carboxylate (cphpc)
420359|NCT01777243|biomarker|biomarker
420360|NCT01777243|GSK2315698|gsk2315698
420361|NCT01777243|GSK2398852|gsk2398852
420362|NCT01777243|SAP|sap
420363|NCT01777243|pharmacodynamic|pharmacodynamic
420364|NCT01777243|co-administration|co-administration
420365|NCT01777243|intravenous|intravenous
420366|NCT01777217|Urination Disorder|urination disorder
420367|NCT01777217|Overactive Bladder|overactive bladder
420368|NCT01777217|Prostate Cancer Radiation|prostate cancer radiation
420369|NCT01777217|Vesicare|vesicare
420370|NCT01777204|Renal transplant, Gastrointestinal motility, Biomagnetism|renal transplant, gastrointestinal motility, biomagnetism
420371|NCT01777178|bicarbonate|bicarbonate
420372|NCT01777178|dialysis|dialysis
420373|NCT01777165|GFR|gfr
420374|NCT01777165|Acute Kidney Injury|acute kidney injury
420375|NCT01777165|High Risk cardiac surgery|high risk cardiac surgery
420376|NCT01777152|Antibodies, Monoclonal|antibodies, monoclonal
420377|NCT01777152|Antibody-Drug Conjugate|antibody-drug conjugate
420378|NCT01777152|Antigens, CD30|antigens, cd30
420379|NCT01777152|Drug Therapy|drug therapy
420380|NCT01777152|Hematologic Diseases|hematologic diseases
420381|NCT01777152|Lymphoma|lymphoma
420382|NCT01777152|Monomethyl auristatin E|monomethyl auristatin e
420383|NCT01777152|Lymphoma, T-Cell|lymphoma, t-cell
420384|NCT01777152|Lymphoma, Non-Hodgkin|lymphoma, non-hodgkin
420385|NCT01777152|Lymphoma, Large-Cell, Anaplastic|lymphoma, large-cell, anaplastic
420386|NCT01777139|Retigabine|retigabine
420387|NCT01777139|Drug-Resistant|drug-resistant
420388|NCT01777139|Epilepsy|epilepsy
420389|NCT01777139|Partial-Onset Seizures|partial-onset seizures
420390|NCT01777139|Safety and Tolerability|safety and tolerability
420391|NCT01777139|Immediate Release|immediate release
420392|NCT01777139|Long-Term|long-term
420393|NCT01777139|Adjunctive Therapy|adjunctive therapy
420394|NCT01777139|Asian Subjects|asian subjects
420395|NCT01777139|Efficacy|efficacy
420396|NCT01777139|GW582892|gw582892
420397|NCT01777126|cystectomy|cystectomy
420398|NCT01777126|parenteral nutrition|parenteral nutrition
420399|NCT01777126|discharge|discharge
420400|NCT01777126|outcome|outcome
420401|NCT01777113|Chronic Stroke|chronic stroke
420402|NCT01777113|Gait|gait
420403|NCT01777113|Exercise|exercise
420404|NCT01777113|High intensity aerobic training|high intensity aerobic training
420405|NCT01777113|Strength training|strength training
420406|NCT01777113|Randomized controlled trial|randomized controlled trial
420407|NCT01777100|Postoperative pain|postoperative pain
420408|NCT01777100|Patient controlled analgesia|patient controlled analgesia
420409|NCT01777100|Hyperalgesia|hyperalgesia
420410|NCT01777100|Remifentanil|remifentanil
420411|NCT01777100|Sufentanil|sufentanil
420412|NCT01777100|Morphine|morphine
420413|NCT01777100|Abdominal surgery|abdominal surgery
420414|NCT01777100|Safety|safety
420415|NCT01777087|Pain|pain
420416|NCT01777087|Functional Magnetic Resonance Imaging|functional magnetic resonance imaging
420417|NCT01777074|Vaccination|vaccination
420418|NCT01777074|Acceptability|acceptability
420419|NCT01777074|Hepatitis B|hepatitis b
420420|NCT01777061|Prostate Cancer|prostate cancer
420421|NCT01777061|Recurrent Prostate Cancer|recurrent prostate cancer
420422|NCT01777061|PET Scan|pet scan
420423|NCT01777061|FDG-PET|fdg-pet
420424|NCT01777061|[11C]Acetate|[11c]acetate
420425|NCT01777061|C11-Acetate|c11-acetate
420426|NCT01777035|mechanical ventilation|mechanical ventilation
420427|NCT01777035|physical therapy|physical therapy
420428|NCT01777035|occupational therapy|occupational therapy
420429|NCT01777035|ICU acquired weakness|icu acquired weakness
420430|NCT01777035|critical illness myopathy|critical illness myopathy
420431|NCT01777022|Education, Stillbirth, Prevention, Management|education, stillbirth, prevention, management
420432|NCT01777009|Total Knee Replacement|total knee replacement
420433|NCT01777009|Patellar Eversion|patellar eversion
420434|NCT01777009|Surgical Exposure|surgical exposure
420435|NCT01777009|Outcomes|outcomes
420436|NCT01777009|Quadriceps Strength|quadriceps strength
420437|NCT01777009|Straight Leg Raise|straight leg raise
420438|NCT01777009|SF-36|sf-36
420439|NCT01776996|Expanded access, HIV, maraviroc|expanded access, hiv, maraviroc
420440|NCT01776970|Motor Neuron Disease|motor neuron disease
420441|NCT01776970|Amyotrophic lateral sclerosis|amyotrophic lateral sclerosis
420442|NCT01776970|Cannabinoids|cannabinoids
420443|NCT01776970|Sativex|sativex
420444|NCT01776970|Spasticity|spasticity
420445|NCT01776957|Abortion rate|abortion rate
420446|NCT01776957|Intrauterine device|intrauterine device
420447|NCT01776944|Resting energy expenditure|resting energy expenditure
420448|NCT01776944|Handheld calorimeter|handheld calorimeter
420449|NCT01776944|Obese and overweight|obese and overweight
420450|NCT01776944|Pediatrics|pediatrics
420451|NCT01776931|Indicator Amino acid technique|indicator amino acid technique
420452|NCT01776931|Lysine requirements|lysine requirements
420453|NCT01776931|Pregnancy|pregnancy
420454|NCT01776931|Dietary protein|dietary protein
420455|NCT01776918|POLG1 Mutation|polg1 mutation
420456|NCT01776918|Phenylketonuria|phenylketonuria
420457|NCT01776905|Melanoma|melanoma
420458|NCT01776905|Cancer|cancer
420459|NCT01776892|Collagenase|collagenase
420460|NCT01776892|Needle aponeurotomy|needle aponeurotomy
420461|NCT01776866|Coronary Angiography|coronary angiography
420462|NCT01776866|Rotational Coronary Angiography|rotational coronary angiography
420463|NCT01776866|Contrast Media|contrast media
420464|NCT01776866|Radiation|radiation
420465|NCT01776866|Quantitative Coronary Angiography|quantitative coronary angiography
420466|NCT01776853|Irritable Bowel Syndrome|irritable bowel syndrome
420467|NCT01776853|Fructose|fructose
420468|NCT01776853|Fructans|fructans
420470|NCT01776853|Fermentation|fermentation
420471|NCT01776853|Breath Tests|breath tests
420472|NCT01776853|Flatulence|flatulence
420473|NCT01776853|Abdominal Pain|abdominal pain
420474|NCT01776853|Diarrhoea|diarrhoea
420475|NCT01776840|Mantle cell lymphoma|mantle cell lymphoma
420476|NCT01776840|Ibrutinib|ibrutinib
420477|NCT01776840|Bruton's tyrosine kinase inhibitor|bruton's tyrosine kinase inhibitor
420478|NCT01776840|Bendamustine hydrochloride|bendamustine hydrochloride
537469|NCT01275053|Leptin|leptin
420479|NCT01776840|Rituximab|rituximab
420480|NCT01776827|GERD|gerd
420481|NCT01776827|Hiatal Hernia|hiatal hernia
420482|NCT01776827|Paraesophageal Hernia|paraesophageal hernia
420483|NCT01776827|Biologic Mesh|biologic mesh
420484|NCT01776814|Entecair|entecair
420485|NCT01776814|Tenofovir|tenofovir
420486|NCT01776801|intracranial baroreflex|intracranial baroreflex
420487|NCT01776762|Nutrition|nutrition
420488|NCT01776762|Rehabilitation|rehabilitation
420489|NCT01776762|Weightloss|weightloss
420490|NCT01776749|low back pain|low back pain
420491|NCT01776749|failed back surgery syndrome|failed back surgery syndrome
420492|NCT01776749|spinal cord stimulation|spinal cord stimulation
420493|NCT01776749|subcutaneous stimulation|subcutaneous stimulation
420494|NCT01776749|peripheral nerve field stimulation|peripheral nerve field stimulation
420495|NCT01776736|Scoliosis|scoliosis
420496|NCT01776736|Posture correction|posture correction
420497|NCT01776723|Chronic Myelomonocytic Leukemia|chronic myelomonocytic leukemia
420498|NCT01776723|CMML|cmml
420499|NCT01776723|Leukemia|leukemia
420500|NCT01776710|Intermittent claudication|intermittent claudication
420501|NCT01776710|Behavior therapy|behavior therapy
420502|NCT01776710|Walking|walking
420503|NCT01776710|Exercise|exercise
420504|NCT01776710|Patient education|patient education
420505|NCT01776710|Randomized controlled trial|randomized controlled trial
420506|NCT01776658|Ocular pain|ocular pain
420507|NCT01776658|Dry Eye Syndrome|dry eye syndrome
420508|NCT01776658|siRNA|sirna
420509|NCT01776658|RNAi|rnai
420510|NCT01776658|TRPV1|trpv1
420511|NCT01776619|Safety|safety
420512|NCT01776619|tolerability|tolerability
420513|NCT01776619|PK|pk
420645|NCT01776099|fibers|fibers
420514|NCT01776593|bladder capacity; bladder diary; bladder oversensitivity; lower urinary tract symptoms|bladder capacity; bladder diary; bladder oversensitivity; lower urinary tract symptoms
420515|NCT01776580|Pelvic organ prolapse|pelvic organ prolapse
420516|NCT01776580|lower urinary tract symptoms|lower urinary tract symptoms
420517|NCT01776580|sexual dysfunction|sexual dysfunction
420518|NCT01776567|coronary artery disease|coronary artery disease
420519|NCT01776567|stents|stents
420520|NCT01776567|optical imaging|optical imaging
420521|NCT01776554|Influenza, Pandemic, H5N1, Children|influenza, pandemic, h5n1, children
420522|NCT01776541|Influenza, Pandemic, H5N1, Adults|influenza, pandemic, h5n1, adults
420523|NCT01776515|Low back pain|low back pain
420524|NCT01776515|Wontran|wontran
420525|NCT01776515|Wontran SR Tab.|wontran sr tab.
420526|NCT01776515|Tramadol Hydrochloride/Acetaminophen|tramadol hydrochloride/acetaminophen
420527|NCT01776489|Food allergy|food allergy
420528|NCT01776489|Sphingosine-1-phosphate|sphingosine-1-phosphate
420529|NCT01776489|Biomarker|biomarker
420530|NCT01776489|Double-blind placebo-controlled food challenge|double-blind placebo-controlled food challenge
420531|NCT01776489|Anaphylaxis|anaphylaxis
420532|NCT01776463|Z-360|z-360
420533|NCT01776463|Japanese|japanese
420534|NCT01776463|pK|pk
420535|NCT01776450|Abdominal Aortic Aneurysm|abdominal aortic aneurysm
420536|NCT01776424|Cardiovascular events|cardiovascular events
420537|NCT01776424|Rivaroxaban|rivaroxaban
420538|NCT01776424|Xarelto|xarelto
420539|NCT01776424|Anticoagulant|anticoagulant
420540|NCT01776424|Blood thinner|blood thinner
420541|NCT01776424|Aspirin|aspirin
420542|NCT01776424|ASA|asa
420543|NCT01776424|Coronary artery disease|coronary artery disease
420544|NCT01776424|CAD|cad
420545|NCT01776424|Peripheral artery disease|peripheral artery disease
420546|NCT01776424|PAD|pad
420547|NCT01776424|Artery disease|artery disease
420548|NCT01776424|Coronary artery bypass graft|coronary artery bypass graft
420549|NCT01776424|Stroke|stroke
420550|NCT01776424|Heart attack|heart attack
420551|NCT01776424|Angina|angina
420552|NCT01776424|Arterial vascular disease|arterial vascular disease
420553|NCT01776424|Myocardial infarction|myocardial infarction
420554|NCT01776424|MI|mi
420555|NCT01776424|Cardiovascular Death|cardiovascular death
420556|NCT01776424|CV Death|cv death
420557|NCT01776424|Heart disease|heart disease
420558|NCT01776398|COPD|copd
420559|NCT01776398|Chronic Obstructive Pulmonary Disease|chronic obstructive pulmonary disease
420560|NCT01776398|Lung disease|lung disease
420561|NCT01776398|Emphysema|emphysema
420562|NCT01776398|Smoking|smoking
420563|NCT01776398|Healthy Smoker|healthy smoker
420564|NCT01776398|Smoker|smoker
420565|NCT01776398|Non-smoker|non-smoker
420566|NCT01776398|IPF|ipf
420567|NCT01776398|RA-ILD|ra-ild
420568|NCT01776398|SSC-ILD|ssc-ild
420569|NCT01776398|Idiopathic Pulmonary Fibrosis|idiopathic pulmonary fibrosis
420570|NCT01776398|Rheumatoid Arthritis-Associated Interstitial Lung Disease|rheumatoid arthritis-associated interstitial lung disease
420571|NCT01776398|Scleroderma-Associated Interstitial Lung Disease|scleroderma-associated interstitial lung disease
420572|NCT01776385|[C08.785.640]|[c08.785.640]
420573|NCT01776385|(C08.528.778)|(c08.528.778)
420574|NCT01776385|[C19.642.713]|[c19.642.713]
420575|NCT01776385|mesothelium|mesothelium
537601|NCT01274611|suction|suction
420576|NCT01776372|Drainage|drainage
420577|NCT01776372|Chest tubes|chest tubes
420578|NCT01776372|Randomized Controlled Trial|randomized controlled trial
420579|NCT01776359|Muscle|muscle
420580|NCT01776359|Protein|protein
420581|NCT01776359|Diet|diet
420582|NCT01776359|Exercise|exercise
420583|NCT01776333|ICU|icu
420584|NCT01776320|Erectile Dysfunction|erectile dysfunction
420585|NCT01776320|Topical Alprostadil|topical alprostadil
420586|NCT01776307|BBI608|bbi608
420587|NCT01776294|Prehypertension|prehypertension
420588|NCT01776294|Prevalence|prevalence
420589|NCT01776294|Cardiovascular Risk Factors|cardiovascular risk factors
420590|NCT01776281|effects|effects
420591|NCT01776281|KMC|kmc
420592|NCT01776281|LBW|lbw
420593|NCT01776281|preterm|preterm
420594|NCT01776281|temperature|temperature
420595|NCT01776281|breastfeeding|breastfeeding
420596|NCT01776281|secondary hospitals|secondary hospitals
420597|NCT01776268|antimicrobial proteins|antimicrobial proteins
420598|NCT01776255|Obesity|obesity
420599|NCT01776255|Overweight|overweight
420600|NCT01776255|Lifestyle|lifestyle
420601|NCT01776255|American Indian|american indian
420602|NCT01776242|low back pain|low back pain
420603|NCT01776242|elderly|elderly
420604|NCT01776242|back pain|back pain
420605|NCT01776242|lumbar pain|lumbar pain
420606|NCT01776242|over 65|over 65
420607|NCT01776229|nightmare|nightmare
420608|NCT01776229|PTSD|ptsd
420609|NCT01776229|trauma|trauma
420610|NCT01776229|children|children
420611|NCT01776229|cognitive behavior therapy|cognitive behavior therapy
420612|NCT01776229|stress|stress
420613|NCT01776229|sleep|sleep
420614|NCT01776216|Endothelial function|endothelial function
420615|NCT01776216|Dairy|dairy
420616|NCT01776177|Allergic asthma|allergic asthma
420617|NCT01776177|Omalizumab therapy|omalizumab therapy
420618|NCT01776177|IgE profile|ige profile
420619|NCT01776164|Friedreich|friedreich
420620|NCT01776164|ataxia|ataxia
420621|NCT01776164|FRDA|frda
420622|NCT01776164|FA|fa
420623|NCT01776164|recessive|recessive
420624|NCT01776164|neurodegenerative|neurodegenerative
420625|NCT01776164|cerebellum|cerebellum
420626|NCT01776151|HIV|hiv
420627|NCT01776151|cardiovascular diseases|cardiovascular diseases
420628|NCT01776151|vascular stiffness|vascular stiffness
420629|NCT01776138|Elderly|elderly
420630|NCT01776138|Chemotherapy|chemotherapy
420631|NCT01776138|Cystectomy|cystectomy
420632|NCT01776138|Radical Cystectomy|radical cystectomy
420633|NCT01776138|University of North Carolina|university of north carolina
420634|NCT01776138|Cancer|cancer
420635|NCT01776138|Bladder Cancer|bladder cancer
420636|NCT01776138|Bladder|bladder
420637|NCT01776125|Neurofibromatosis Type One|neurofibromatosis type one
420638|NCT01776125|Scoliosis|scoliosis
420639|NCT01776112|schizophrenia|schizophrenia
420640|NCT01776112|negative symptoms|negative symptoms
420641|NCT01776112|cognitive deficits|cognitive deficits
420642|NCT01776112|synaptic plasticity|synaptic plasticity
420643|NCT01776099|type 2 diabetes|type 2 diabetes
420644|NCT01776099|nutrition|nutrition
420646|NCT01776073|Transplantation|transplantation
420647|NCT01776073|Healthcare Disparities|healthcare disparities
420648|NCT01776073|Quality Assurance|quality assurance
420649|NCT01776060|Primary Progressive Multiple Sclerosis|primary progressive multiple sclerosis
420650|NCT01776060|Multiple Sclerosis|multiple sclerosis
420651|NCT01776060|biomarker|biomarker
420652|NCT01776060|'omic|'omic
420653|NCT01776060|progression|progression
420654|NCT01776034|Self Care|self care
420655|NCT01776034|Exercise|exercise
420656|NCT01776034|Weight management|weight management
420657|NCT01776021|Urinary tract infection|urinary tract infection
420658|NCT01776021|Recurrent urinary tract infection|recurrent urinary tract infection
420659|NCT01776021|Cranberry|cranberry
420660|NCT01776021|Prevention|prevention
420661|NCT01776021|E-coli|e-coli
420662|NCT01775995|Chronic Pain|chronic pain
420663|NCT01775995|Low Back Pain|low back pain
420664|NCT01775982|French language validation|french language validation
420665|NCT01775982|The Confusion Assessment Method (CAM)|the confusion assessment method (cam)
420666|NCT01775943|Epidermal growth factor receptor|epidermal growth factor receptor
420667|NCT01775943|Mutation|mutation
420668|NCT01775943|Lung cancer|lung cancer
420669|NCT01775943|Drug sensitivity|drug sensitivity
420670|NCT01775930|Kidney Cancer|kidney cancer
420671|NCT01775930|Refractory Renal Cell Carcinoma|refractory renal cell carcinoma
420673|NCT01775930|Clear cell kidney cancer with metastatic disease|clear cell kidney cancer with metastatic disease
420674|NCT01775930|Carfilzomib|carfilzomib
420675|NCT01775891|pilsicainide|pilsicainide
420676|NCT01775891|class IC antiarrhythmic drug|class ic antiarrhythmic drug
420677|NCT01775891|paroxysmal atrial fibrillation|paroxysmal atrial fibrillation
420678|NCT01775891|catheter ablation|catheter ablation
420679|NCT01775878|Diabetes|diabetes
420680|NCT01775878|HbA1c|hba1c
420681|NCT01775878|Fructosamine|fructosamine
420682|NCT01775878|Blood Pressure|blood pressure
420683|NCT01775878|Telemonitoring|telemonitoring
420684|NCT01775865|aortic stiffness|aortic stiffness
420685|NCT01775865|endothelium-dependent dilation|endothelium-dependent dilation
420686|NCT01775865|vascular aging|vascular aging
420687|NCT01775865|oxidative stress|oxidative stress
420688|NCT01775865|inflammation|inflammation
420689|NCT01775865|nitric oxide|nitric oxide
420690|NCT01775865|nuclear factor kappa B|nuclear factor kappa b
420691|NCT01775852|Acceptance and Commitment Therapy (ACT)|acceptance and commitment therapy (act)
420692|NCT01775852|Depression|depression
420693|NCT01775852|Illness Management|illness management
420694|NCT01775852|Behavioral treatment|behavioral treatment
420695|NCT01775852|Impairment|impairment
420696|NCT01775826|physical activity|physical activity
420697|NCT01775826|sedentary behavior|sedentary behavior
420698|NCT01775826|accelerometer|accelerometer
420699|NCT01775826|GPS|gps
420700|NCT01775826|GIS|gis
420701|NCT01775826|machine learning|machine learning
420702|NCT01775813|Insulin resistance|insulin resistance
420703|NCT01775813|Puberty|puberty
420704|NCT01775813|Obesity|obesity
420705|NCT01775813|Hypogonadism|hypogonadism
420706|NCT01775813|Gonadal dysfunction|gonadal dysfunction
420707|NCT01775813|Metformin|metformin
420708|NCT01775787|smoking|smoking
420709|NCT01775774|Acute Respiratory Distress Syndrome|acute respiratory distress syndrome
421310|NCT01773135|ACTH|acth
420710|NCT01775774|Acute Lung Injury|acute lung injury
420711|NCT01775774|Allogeneic Bone Marrow-Derived Human Mesenchymal Stem Cells|allogeneic bone marrow-derived human mesenchymal stem cells
420712|NCT01775761|Thorough QTc evaluation of tafamidis compared to the effects of moxifloxacin and placebo in healthy volunteers.|thorough qtc evaluation of tafamidis compared to the effects of moxifloxacin and placebo in healthy volunteers.
420713|NCT01775748|Grape juice|grape juice
420714|NCT01775735|headache|headache
420715|NCT01775735|pain|pain
420716|NCT01775735|chronic|chronic
420717|NCT01775709|middler ear infection|middler ear infection
420718|NCT01775696|Alzheimer's disease|alzheimer's disease
420719|NCT01775696|Pittsburgh binding Compound (PiB)|pittsburgh binding compound (pib)
420720|NCT01775696|Positron Emission Tomography (PET)|positron emission tomography (pet)
420721|NCT01775696|Inflammation|inflammation
420722|NCT01775696|Anti Abeta immune responses|anti abeta immune responses
420723|NCT01775696|Blood markers|blood markers
420724|NCT01775696|MRI|mri
420725|NCT01775683|homelessness|homelessness
420726|NCT01775670|Arthrosis|arthrosis
420727|NCT01775657|pulmonary air leak|pulmonary air leak
420728|NCT01775657|Thopaz|thopaz
420729|NCT01775657|digital|digital
420730|NCT01775657|analog|analog
420731|NCT01775657|randomized|randomized
420732|NCT01775618|Hemophilia A|hemophilia a
420733|NCT01775618|Factor VIII|factor viii
420734|NCT01775618|Prophylaxis|prophylaxis
420735|NCT01775618|Pediatric|pediatric
420736|NCT01775605|Subject|subject
420737|NCT01775592|P.f resistance|p.f resistance
420738|NCT01775553|Relapsed Multiple Myeloma|relapsed multiple myeloma
420739|NCT01775553|Refractory Multiple Myeloma|refractory multiple myeloma
420740|NCT01775553|High-Dose Carfilzomib|high-dose carfilzomib
420741|NCT01775553|Standard Dose Carfilzomib|standard dose carfilzomib
420742|NCT01775553|Carfilzomib|carfilzomib
420743|NCT01775540|Dry eye|dry eye
420744|NCT01775540|Artificial tears|artificial tears
420745|NCT01775540|Ocular surface inflammation|ocular surface inflammation
420746|NCT01775501|sorafenib|sorafenib
420747|NCT01775501|FOLFOX|folfox
420748|NCT01775488|Benign Prostatic Hyperplasia|benign prostatic hyperplasia
420749|NCT01775488|BPH|bph
420750|NCT01775488|LUTS|luts
420751|NCT01775488|Vortx Rx|vortx rx
420752|NCT01775488|Histotripsy|histotripsy
420753|NCT01775462|Hypohidrotic Ectodermal Dysplasia|hypohidrotic ectodermal dysplasia
420754|NCT01775462|XLHED|xlhed
420755|NCT01775449|Anticancer drug;|anticancer drug;
420756|NCT01775449|Oxaliplatin;|oxaliplatin;
420757|NCT01775449|Digestive cancer system|digestive cancer system
420758|NCT01775449|Acute oxaliplatin-induced hypersensitivity|acute oxaliplatin-induced hypersensitivity
420759|NCT01775449|Hyperalgesia;|hyperalgesia;
420760|NCT01775449|Allodynia;|allodynia;
420761|NCT01775449|Dysesthesia|dysesthesia
420762|NCT01775449|Polyamines depleted diet|polyamines depleted diet
420763|NCT01775436|palliative care|palliative care
420764|NCT01775436|HIV/AIDS|hiv/aids
420765|NCT01775436|quality of life|quality of life
420766|NCT01775436|adherence|adherence
420767|NCT01775436|spiritual|spiritual
420768|NCT01775436|threat appraisal|threat appraisal
420769|NCT01775436|treatment congruence|treatment congruence
420770|NCT01775436|treatment preferences|treatment preferences
420771|NCT01775436|dialysis|dialysis
420772|NCT01775436|hospitalization|hospitalization
420773|NCT01775436|communication|communication
420774|NCT01775436|family intervention|family intervention
420775|NCT01775436|Family Centered Advance Care Planning|family centered advance care planning
420776|NCT01775436|decision making|decision making
420777|NCT01775436|advance care planning|advance care planning
420778|NCT01775436|end of life|end of life
420779|NCT01775397|Clostridium|clostridium
420780|NCT01775397|Difficile|difficile
420781|NCT01775397|Infections|infections
420782|NCT01775397|Immunosuppression|immunosuppression
420783|NCT01775397|Fidaxomicin|fidaxomicin
420784|NCT01775397|Vancomycin|vancomycin
420785|NCT01775397|Efficacy|efficacy
420786|NCT01775397|Stem Cells|stem cells
420787|NCT01775397|Transplantation|transplantation
420788|NCT01775397|Adult|adult
420789|NCT01775397|Dificid|dificid
420790|NCT01775384|Inflammation|inflammation
420791|NCT01775384|Oxidative stress|oxidative stress
420792|NCT01775384|Immune dysfunction|immune dysfunction
420793|NCT01775384|Metabolomics.|metabolomics.
420794|NCT01775371|Pain|pain
420795|NCT01775371|Emergency|emergency
420796|NCT01775371|Analgesia|analgesia
420797|NCT01775371|ED patients|ed patients
420798|NCT01775371|acute pain|acute pain
420799|NCT01775371|IV opioid|iv opioid
420800|NCT01775345|Partial meniscectomy|partial meniscectomy
420801|NCT01775345|Physiotherapy|physiotherapy
420802|NCT01775345|Isokinetics|isokinetics
420803|NCT01775345|Cost-effectiveness|cost-effectiveness
420804|NCT01775319|Zinc|zinc
420805|NCT01775293|Non-absorbable polypropylene mesh|non-absorbable polypropylene mesh
420806|NCT01775293|WSRS|wsrs
420807|NCT01775293|Rhytidectomy|rhytidectomy
420808|NCT01775254|Colon Cancer|colon cancer
420809|NCT01775254|FOLFOX|folfox
420810|NCT01775254|Laparoscopic Colectomy|laparoscopic colectomy
420811|NCT01775254|Open Colectomy|open colectomy
420812|NCT01775254|Robotic Colectomy|robotic colectomy
420813|NCT01775254|Quality of Life|quality of life
420814|NCT01775254|Sexual Function|sexual function
420815|NCT01775254|Peripheral Neuropathy|peripheral neuropathy
420816|NCT01775254|Demands of Illness|demands of illness
420817|NCT01775254|Cancer Survivor|cancer survivor
420818|NCT01775228|Depression, peer support, recovery, health services|depression, peer support, recovery, health services
420819|NCT01775215|Left Ventricular Function|left ventricular function
420820|NCT01775215|Aortic Valve Replacement|aortic valve replacement
420821|NCT01775215|Late Gadolinium Enhancement|late gadolinium enhancement
420822|NCT01775215|Cardiac I123 MIBG|cardiac i123 mibg
420823|NCT01775215|Longitudinal Strain|longitudinal strain
420824|NCT01775215|Brain Natriuretic Peptide|brain natriuretic peptide
420825|NCT01775215|High Sensitivity Troponin I|high sensitivity troponin i
420826|NCT01775189|Relative abuse potential study|relative abuse potential study
420827|NCT01775189|Chronic pain|chronic pain
420828|NCT01775189|oxycodone|oxycodone
420829|NCT01775189|naltrexone|naltrexone
420830|NCT01775189|opioid-related disorders|opioid-related disorders
420831|NCT01775189|drug abusers|drug abusers
420832|NCT01775176|PCOS, Weight, Insulin Sensitivity, Reproductive Function|pcos, weight, insulin sensitivity, reproductive function
420833|NCT01775163|Energy|energy
420834|NCT01775163|Metabolism|metabolism
420835|NCT01775163|Weight Loss|weight loss
420836|NCT01775163|Exercise|exercise
420837|NCT01775150|mobile phone text messaging|mobile phone text messaging
420838|NCT01775150|maternality|maternality
420839|NCT01775150|infant|infant
420840|NCT01775150|death rate|death rate
420841|NCT01775137|CF, Open-label, TIP, phase IV, extension study|cf, open-label, tip, phase iv, extension study
420842|NCT01775124|Macular degeneration,|macular degeneration,
420843|NCT01775124|age-related macular degeneration (ARMD),|age-related macular degeneration (armd),
420844|NCT01775124|vision loss,|vision loss,
420845|NCT01775124|macula damage,|macula damage,
420846|NCT01775124|retina damage,|retina damage,
420847|NCT01775124|dry macular degeneration,|dry macular degeneration,
420848|NCT01775124|wet macular degeneration,|wet macular degeneration,
420849|NCT01775124|AMD|amd
420850|NCT01775111|strength training|strength training
420851|NCT01775111|protein supplementation|protein supplementation
420852|NCT01775111|sarcopenia|sarcopenia
420853|NCT01775098|Gout|gout
420854|NCT01775098|uric acid|uric acid
420855|NCT01775098|allopurinol|allopurinol
420856|NCT01775085|Interventions|interventions
420857|NCT01775085|Meaning-Centered Group (MCG)|meaning-centered group (mcg)
420858|NCT01775085|Discussion Group (DG)|discussion group (dg)
420859|NCT01775085|Modules|modules
420860|NCT01775085|Sessions|sessions
420861|NCT01775085|12-291|12-291
420862|NCT01775072|tissue|tissue
420863|NCT01775072|blood|blood
420864|NCT01775072|salvia|salvia
420865|NCT01775072|buccal swab|buccal swab
420866|NCT01775072|Genomic Profiling|genomic profiling
420867|NCT01775072|Solid Tumors|solid tumors
420868|NCT01775072|hematologic cancer|hematologic cancer
420869|NCT01775072|Clinical Assay|clinical assay
420870|NCT01775072|Research Assay|research assay
420871|NCT01775072|12-245|12-245
420872|NCT01775046|Valiant|valiant
420873|NCT01775046|Captivia|captivia
420874|NCT01775046|Stent Graft|stent graft
420875|NCT01775046|Thoracic|thoracic
420876|NCT01775046|Aortic|aortic
420877|NCT01775033|Pediatrics|pediatrics
420878|NCT01775033|Emergency medical services|emergency medical services
420879|NCT01775033|Emergency Treatment|emergency treatment
420880|NCT01775033|Telemedicine|telemedicine
420881|NCT01775007|Lens|lens
420882|NCT01775007|Cornea|cornea
420883|NCT01775007|Presbyopia|presbyopia
420884|NCT01774994|volunteers|volunteers
420885|NCT01774942|Diabetes Mellitus|diabetes mellitus
420886|NCT01774942|C-Reactive Protein|c-reactive protein
420887|NCT01774942|Dental Implants, Single-Tooth|dental implants, single-tooth
420888|NCT01774942|Dental Prosthesis, Implant-Supported|dental prosthesis, implant-supported
420889|NCT01774929|Osteoarthritis|osteoarthritis
420890|NCT01774929|Transdermal Therapeutic System (TTS)-fentanyl|transdermal therapeutic system (tts)-fentanyl
420891|NCT01774929|Durogesic|durogesic
420892|NCT01774903|Low Back Pain|low back pain
420893|NCT01774903|TTS-fentanyl|tts-fentanyl
420894|NCT01774903|Durogesic|durogesic
420895|NCT01774877|xinfeng capsule;|xinfeng capsule;
420896|NCT01774877|rheumatoid arthritis (RA);|rheumatoid arthritis (ra);
420897|NCT01774877|randomized;|randomized;
420898|NCT01774877|double-blind;|double-blind;
420899|NCT01774851|HER-2 Gene Amplification|her-2 gene amplification
420900|NCT01774851|Esophagus Cancer|esophagus cancer
420901|NCT01774851|Gastroesophageal Junction Cancer|gastroesophageal junction cancer
420902|NCT01774851|Stomach Cancer|stomach cancer
420903|NCT01774851|Her2 Positive|her2 positive
420904|NCT01774851|Her2+|her2+
420905|NCT01774851|Esophageal Cancer|esophageal cancer
420906|NCT01774851|Metastatic|metastatic
420907|NCT01774825|Irritable bowel syndrome|irritable bowel syndrome
420908|NCT01774825|IBS|ibs
420909|NCT01774812|vitamin D|vitamin d
420910|NCT01774812|hemodialysis|hemodialysis
420911|NCT01774812|sudden cardiac death|sudden cardiac death
420912|NCT01774812|heart rate variability|heart rate variability
420913|NCT01774812|cardiac autonomic tone|cardiac autonomic tone
420914|NCT01774799|advanced dementia|advanced dementia
420915|NCT01774799|advance care planning|advance care planning
420916|NCT01774799|nursing home|nursing home
420917|NCT01774760|18F-EF5|18f-ef5
420918|NCT01774760|PET/CT|pet/ct
420919|NCT01774760|Reproducibility|reproducibility
420920|NCT01774747|Pharmacokinetics|pharmacokinetics
420921|NCT01774734|Chronic neck pain|chronic neck pain
420922|NCT01774734|Neck strength exerciser|neck strength exerciser
420923|NCT01774734|Biofeedback|biofeedback
420924|NCT01774734|Physiotherapy|physiotherapy
420925|NCT01774734|Strengthening exercise|strengthening exercise
420926|NCT01774734|Randomized trials|randomized trials
420927|NCT01774721|first-line|first-line
420928|NCT01774721|locally advanced or metastatic|locally advanced or metastatic
420929|NCT01774721|non-small cell lung cancer|non-small cell lung cancer
420930|NCT01774721|epidermal growth factor receptor|epidermal growth factor receptor
420931|NCT01774721|EGFR|egfr
420932|NCT01774721|ARCHER|archer
420933|NCT01774721|mutation|mutation
420934|NCT01774721|dacomitinib|dacomitinib
420935|NCT01774721|SFJ|sfj
420936|NCT01774721|PF-00299804|pf-00299804
420937|NCT01774695|IBS|ibs
420938|NCT01774695|physical activity|physical activity
420939|NCT01774695|exercise|exercise
420940|NCT01774682|obesity|obesity
420941|NCT01774682|surgery|surgery
420942|NCT01774669|ischemic stroke|ischemic stroke
420943|NCT01774669|hemorrhagic stroke|hemorrhagic stroke
420944|NCT01774669|upper limb|upper limb
420945|NCT01774669|virtual reality|virtual reality
420946|NCT01774669|physiotherapy|physiotherapy
420947|NCT01774669|occupational therapy|occupational therapy
420948|NCT01774656|heart-assist device|heart-assist device
420949|NCT01774643|Pancreatic cancer|pancreatic cancer
420950|NCT01774643|Liver metastases|liver metastases
420951|NCT01774643|Tumor tissue biopsy|tumor tissue biopsy
420952|NCT01774643|Blood samples|blood samples
420953|NCT01774643|Xenografts|xenografts
420954|NCT01774643|Murine|murine
420955|NCT01774643|Genomic profiling|genomic profiling
420956|NCT01774643|Circulating biomarkers|circulating biomarkers
420957|NCT01774630|Treatment, relapse, complete molecular response|treatment, relapse, complete molecular response
420958|NCT01774617|portal hypertension|portal hypertension
420959|NCT01774617|elastography|elastography
420960|NCT01774617|Hepatic venous pressure gradient measurement|hepatic venous pressure gradient measurement
420961|NCT01774604|Post ERCP acute pancreatitis|post ercp acute pancreatitis
420962|NCT01774604|Post Fine Needle Aspiration (FNA) acute pancreatitis|post fine needle aspiration (fna) acute pancreatitis
420963|NCT01774604|Indomethacin|indomethacin
420964|NCT01774604|Rectal Non Steroidal Anti-Inflammatory Drugs (NSAIDs)|rectal non steroidal anti-inflammatory drugs (nsaids)
420965|NCT01774591|Post Menopause|post menopause
420966|NCT01774591|Female|female
420967|NCT01774591|Obese|obese
420968|NCT01774578|Non-small Cell Lung Cancer|non-small cell lung cancer
420969|NCT01774578|Vaccine Therapy|vaccine therapy
420970|NCT01774578|Immunotherapy|immunotherapy
420971|NCT01774578|Second line therapy|second line therapy
420972|NCT01774578|Progressive|progressive
420973|NCT01774578|Relapsed|relapsed
420974|NCT01774565|Diabetes|diabetes
420975|NCT01774565|Insulin|insulin
420976|NCT01774565|Closed-Loop|closed-loop
420977|NCT01774565|Real-time CGM|real-time cgm
420978|NCT01774565|Subcutaneous insulin pump|subcutaneous insulin pump
420979|NCT01774565|Hospital|hospital
420980|NCT01774539|Fracture|fracture
420981|NCT01774539|Physeal injury|physeal injury
420982|NCT01774539|Diffusion MRI|diffusion mri
420983|NCT01774500|biomarkers|biomarkers
420984|NCT01774500|Emergency Department|emergency department
420985|NCT01774500|Seizures|seizures
420986|NCT01774500|epilepsy|epilepsy
420987|NCT01774500|S100b|s100b
420988|NCT01774500|copeptin|copeptin
420989|NCT01774487|Biliary Atresia|biliary atresia
420990|NCT01774487|Pentoxifylline|pentoxifylline
420991|NCT01774487|Trental|trental
420992|NCT01774487|Serum bilirubin|serum bilirubin
420993|NCT01774487|Conjugated bilirubin|conjugated bilirubin
420994|NCT01774487|Liver transplantation|liver transplantation
420995|NCT01774487|Fibrosis|fibrosis
420996|NCT01774474|Prevention|prevention
420997|NCT01774448|Dementia|dementia
420998|NCT01774448|Spouse Caregiver|spouse caregiver
420999|NCT01774448|Depression|depression
421000|NCT01774448|Mind Body Therapy|mind body therapy
421001|NCT01774448|Cognitive Therapy|cognitive therapy
421002|NCT01774448|Quality of Life|quality of life
421003|NCT01774448|Attention|attention
421004|NCT01774448|Memory|memory
421005|NCT01774435|Schizophrenia|schizophrenia
421006|NCT01774435|Schizophrenic|schizophrenic
421007|NCT01774435|Stable Schizophrenic|stable schizophrenic
421008|NCT01774422|Hypercapnia|hypercapnia
421009|NCT01774422|Respiratory Distress Syndrome|respiratory distress syndrome
421010|NCT01774422|Extracorporeal CO2 remover|extracorporeal co2 remover
421011|NCT01774422|Noninvasive ventilation|noninvasive ventilation
421012|NCT01774409|all advanced malignant tumor|all advanced malignant tumor
421311|NCT01773135|PTL|ptl
421013|NCT01774396|Hands Rejuvenation, fillers|hands rejuvenation, fillers
421014|NCT01774383|Parkinson's disease|parkinson's disease
421015|NCT01774383|sub-thalamic nucleus|sub-thalamic nucleus
421016|NCT01774383|oscillation|oscillation
421017|NCT01774383|local field potential|local field potential
421018|NCT01774344|Regorafenib|regorafenib
421019|NCT01774344|BAY73-4506|bay73-4506
421020|NCT01774318|sleep-wake-cycles|sleep-wake-cycles
421021|NCT01774318|preterm infants|preterm infants
421022|NCT01774318|aEEG|aeeg
421023|NCT01774318|conventional EEG|conventional eeg
421024|NCT01774318|polysomnography|polysomnography
421025|NCT01774292|Impact of alkalized lidocaine on coughing at extubation|impact of alkalized lidocaine on coughing at extubation
421026|NCT01774266|Gastric Cancer|gastric cancer
421027|NCT01774266|DNA methylation|dna methylation
421028|NCT01774266|Reprimo|reprimo
421029|NCT01774266|cell-free DNA|cell-free dna
421030|NCT01774266|non-invasive|non-invasive
421031|NCT01774253|DIPG|dipg
421032|NCT01774240|Delirium|delirium
421033|NCT01774240|Cardiac surgery|cardiac surgery
421034|NCT01774240|DOS scale|dos scale
421035|NCT01774227|Refractory glaucoma|refractory glaucoma
421036|NCT01774227|Transcleral cyclophotocoagulation (TSCPC)|transcleral cyclophotocoagulation (tscpc)
421037|NCT01774227|Dark iris|dark iris
421038|NCT01774227|Pops-titration|pops-titration
421039|NCT01774227|Slow-coagulation|slow-coagulation
421040|NCT01774227|Neovascular glaucoma|neovascular glaucoma
421041|NCT01774214|Resuscitation|resuscitation
421042|NCT01774214|Shock|shock
421043|NCT01774214|Fluid Therapy|fluid therapy
421044|NCT01774214|Pediatrics|pediatrics
421045|NCT01774201|Multiple sclerosis|multiple sclerosis
421046|NCT01774201|Self-assessment|self-assessment
421047|NCT01774201|Physical endurance|physical endurance
421048|NCT01774201|Respiratory function|respiratory function
421049|NCT01774201|Fatigue|fatigue
421050|NCT01774188|Enhanced Extracorporeal Counterpulsation|enhanced extracorporeal counterpulsation
421051|NCT01774188|intraocular pressure|intraocular pressure
421052|NCT01774188|Pen type tonometer|pen type tonometer
421053|NCT01774175|Bowel preparation|bowel preparation
421054|NCT01774175|PEG with ascorbic acid|peg with ascorbic acid
421055|NCT01774175|Picosulfate|picosulfate
421056|NCT01774162|Endoscopic Ultrasound|endoscopic ultrasound
421057|NCT01774162|Fine needle aspiration|fine needle aspiration
421058|NCT01774162|Fine needle biopsy|fine needle biopsy
421059|NCT01774162|ProCore|procore
421060|NCT01774136|community health workers|community health workers
421061|NCT01774136|HIV|hiv
421062|NCT01774136|PMTCT|pmtct
421063|NCT01774136|antenatal|antenatal
421064|NCT01774136|postnatal|postnatal
421065|NCT01774136|breastfeeding|breastfeeding
421066|NCT01774136|South Africa|south africa
421067|NCT01774110|stroke|stroke
421068|NCT01774110|gait|gait
421069|NCT01774110|acute|acute
421070|NCT01774097|Peripheral Artery Disease|peripheral artery disease
421071|NCT01774097|Intermittent Claudication|intermittent claudication
421072|NCT01774097|Autologous Stem Cells|autologous stem cells
421073|NCT01774097|ALDH cells|aldh cells
421074|NCT01774097|Claudicants|claudicants
421075|NCT01774097|PAD|pad
421076|NCT01774097|Peak Walking Time|peak walking time
421077|NCT01774097|MRI|mri
421078|NCT01774097|Vascular Flow|vascular flow
421079|NCT01774097|Anatomy|anatomy
421080|NCT01774097|Perfusion|perfusion
421081|NCT01774084|Insulin sensitivity|insulin sensitivity
421082|NCT01774084|Beta cell function|beta cell function
421083|NCT01774084|Carbohydrate preload|carbohydrate preload
421084|NCT01774084|Elective hip replacement|elective hip replacement
421085|NCT01774084|Double-blind randomized control study|double-blind randomized control study
421086|NCT01774071|89Zr-DFO-MSTP2109A|89zr-dfo-mstp2109a
421087|NCT01774071|tracer|tracer
421088|NCT01774071|pet scan|pet scan
421089|NCT01774071|12-178|12-178
421090|NCT01774058|blood flow volume|blood flow volume
421091|NCT01774058|ilomedin|ilomedin
421092|NCT01774058|measurement|measurement
421093|NCT01774058|intraarterial|intraarterial
421094|NCT01774058|neuropathy|neuropathy
421095|NCT01774045|Major depressive disorder|major depressive disorder
421096|NCT01774045|Depression|depression
421097|NCT01774019|Pancreatic|pancreatic
421098|NCT01774019|Periampullary Cancer|periampullary cancer
421099|NCT01774019|Preoperative Biliary Drainage|preoperative biliary drainage
421100|NCT01774019|Resectable|resectable
421101|NCT01774006|In vitro fertilization|in vitro fertilization
421102|NCT01774006|Embryo transfer|embryo transfer
421103|NCT01774006|Embryo culture|embryo culture
421104|NCT01774006|individual culture|individual culture
421105|NCT01774006|Group culture|group culture
421106|NCT01774006|embryo quality|embryo quality
421107|NCT01774006|Pregnancy rate|pregnancy rate
421108|NCT01774006|Implantation|implantation
421109|NCT01773993|Lyrica|lyrica
421110|NCT01773993|pregabalin|pregabalin
421111|NCT01773993|Good post marketing practice|good post marketing practice
421112|NCT01773993|Post Marketing Surveillance|post marketing surveillance
421113|NCT01773993|Regulatory Post Marketing Commitment Plan|regulatory post marketing commitment plan
421114|NCT01773993|Fibromyalgia|fibromyalgia
421115|NCT01773967|Lactobacillus rhamnosus GG|lactobacillus rhamnosus gg
421116|NCT01773967|LGG|lgg
421117|NCT01773967|Probiotic|probiotic
421118|NCT01773967|Gastroenteritis|gastroenteritis
421119|NCT01773967|acute gastroenteritis|acute gastroenteritis
421120|NCT01773967|child|child
421121|NCT01773967|pediatric|pediatric
421122|NCT01773967|RCT|rct
421123|NCT01773954|amd|amd
421124|NCT01773954|age related macular degeneration|age related macular degeneration
421125|NCT01773954|macular degeneration|macular degeneration
421126|NCT01773954|neovascular|neovascular
421127|NCT01773928|Active immunization against influenza disease|active immunization against influenza disease
421128|NCT01773889|Epithelial Ovarian Cancer|epithelial ovarian cancer
421129|NCT01773889|FIGO (Int Federation of Gyn and Ob )Stage III or Stage IV|figo (int federation of gyn and ob )stage iii or stage iv
421130|NCT01773889|Extraovarian Peritoneal Cancer|extraovarian peritoneal cancer
421131|NCT01773889|Fallopian Tube Carcinoma Failing|fallopian tube carcinoma failing
421132|NCT01773876|survival without proven invasive candidiasis|survival without proven invasive candidiasis
421133|NCT01773876|effectiveness|effectiveness
421134|NCT01773876|micafungin versus placebo|micafungin versus placebo
421135|NCT01773876|pharmacokinetic|pharmacokinetic
421136|NCT01773876|pharmacodynamic|pharmacodynamic
421137|NCT01773876|tolerance|tolerance
421138|NCT01773863|Community-acquired pneumonia|community-acquired pneumonia
421139|NCT01773863|Acute myocardial infarction|acute myocardial infarction
421140|NCT01773863|Platelet activation|platelet activation
421141|NCT01773863|Coagulation abnormalities,|coagulation abnormalities,
421142|NCT01773863|Thrombosis|thrombosis
421143|NCT01773863|Isoprosantes|isoprosantes
421144|NCT01773863|NADPH oxidase|nadph oxidase
421145|NCT01773863|Major adverse cardiac and cerebrovascular events|major adverse cardiac and cerebrovascular events
421146|NCT01773850|breast cancer|breast cancer
421147|NCT01773837|asthenia|asthenia
421148|NCT01773837|advanced cancer|advanced cancer
421149|NCT01773837|randomized controlled trial|randomized controlled trial
421150|NCT01773824|antibiotic|antibiotic
421151|NCT01773824|prescription rate|prescription rate
421152|NCT01773811|Posttraumatic Stress Disorder (PTSD)|posttraumatic stress disorder (ptsd)
421153|NCT01773811|Narrative Writing|narrative writing
421154|NCT01773759|Immunizations|immunizations
421155|NCT01773759|Child care|child care
421156|NCT01773759|School health promotion|school health promotion
421157|NCT01773746|neonatal|neonatal
421158|NCT01773746|resuscitation|resuscitation
421159|NCT01773746|room air|room air
421160|NCT01773720|cardiac index|cardiac index
421161|NCT01773720|coronary artery bypass|coronary artery bypass
421162|NCT01773720|uncalibrated pulse contour analysis|uncalibrated pulse contour analysis
421163|NCT01773720|hemodynamic monitoring|hemodynamic monitoring
421164|NCT01773707|prevention of type 1 diabetes|prevention of type 1 diabetes
421165|NCT01773707|prevention of abnormal glucose tolerance|prevention of abnormal glucose tolerance
421166|NCT01773694|Post-operative management|post-operative management
421167|NCT01773694|Post-operative complications|post-operative complications
421168|NCT01773694|Post-operative treatment|post-operative treatment
421169|NCT01773694|water|water
421170|NCT01773694|skin|skin
421171|NCT01773694|Dermatologic Surgical Procedures|dermatologic surgical procedures
421172|NCT01773655|somatic|somatic
421173|NCT01773655|germline|germline
421174|NCT01773655|mutations|mutations
421175|NCT01773655|BAP1 (BRCA associated protein-1)|bap1 (brca associated protein-1)
421176|NCT01773655|12-235|12-235
421177|NCT01773642|pediatric HIV diagnosis disclosure|pediatric hiv diagnosis disclosure
421178|NCT01773642|cognitive behavioral intervention|cognitive behavioral intervention
421179|NCT01773642|Uganda|uganda
421180|NCT01773629|Depression|depression
421181|NCT01773629|Pregnancy|pregnancy
421182|NCT01773629|Postpartum|postpartum
421183|NCT01773629|Perinatal|perinatal
421184|NCT01773616|Systemic lupus erythematosus|systemic lupus erythematosus
421185|NCT01773616|Lupus|lupus
421186|NCT01773616|Nephritis|nephritis
421187|NCT01773603|Time-lapse|time-lapse
421188|NCT01773603|morphokinetics|morphokinetics
421189|NCT01773603|blastocyst transfer|blastocyst transfer
421190|NCT01773603|eSET|eset
421191|NCT01773577|EHR|ehr
421192|NCT01773577|VHR|vhr
421193|NCT01773577|Electronic Health Record|electronic health record
421194|NCT01773564|Dressings, Prevention,|dressings, prevention,
421195|NCT01773538|quality of life|quality of life
421196|NCT01773512|Intravascular ultrasound|intravascular ultrasound
421197|NCT01773512|Virtual histology|virtual histology
421198|NCT01773512|Optical coherence tomography|optical coherence tomography
421199|NCT01773512|Coronary atherosclerosis|coronary atherosclerosis
421200|NCT01773512|Statins|statins
421201|NCT01773512|Retinal imaging|retinal imaging
421202|NCT01773499|cellulitis|cellulitis
421203|NCT01773499|ultrasound|ultrasound
421204|NCT01773486|Obesity|obesity
421205|NCT01773486|Insulin Resistance|insulin resistance
421206|NCT01773486|Endothelial dysfunction|endothelial dysfunction
421207|NCT01773486|Blood pressure|blood pressure
421208|NCT01773460|everolimus progress exemestane|everolimus progress exemestane
421209|NCT01773460|treated with exemestane and everolimus|treated with exemestane and everolimus
421210|NCT01773460|progress under this treatment|progress under this treatment
421211|NCT01773395|Advanced|advanced
421212|NCT01773369|cerebral palsy|cerebral palsy
421213|NCT01773369|physical therapy|physical therapy
421214|NCT01773369|rehabilitation|rehabilitation
421215|NCT01773369|hemiplegia|hemiplegia
421216|NCT01773356|Obesity|obesity
421217|NCT01773356|Body Weight|body weight
421218|NCT01773356|Body Composition|body composition
421219|NCT01773356|Metabolism|metabolism
421220|NCT01773356|Resting Energy Expenditure|resting energy expenditure
421221|NCT01773343|skin texture, efficacy, adverse effects|skin texture, efficacy, adverse effects
421222|NCT01773330|high resolution manometry|high resolution manometry
421223|NCT01773330|provocative swallow|provocative swallow
421224|NCT01773330|impedence|impedence
421225|NCT01773304|Obesity|obesity
421226|NCT01773304|Adults|adults
421227|NCT01773304|Bone metabolism|bone metabolism
421228|NCT01773304|Metabolic profile|metabolic profile
421229|NCT01773304|Dairy protein|dairy protein
421230|NCT01773304|Meat protein|meat protein
421231|NCT01773291|Acupuncture; laser acupuncture; traumatic brain injury|acupuncture; laser acupuncture; traumatic brain injury
421232|NCT01773278|Antioxidant treatment|antioxidant treatment
421233|NCT01773278|Oxysterols|oxysterols
421234|NCT01773278|Cholesterol deficiency|cholesterol deficiency
421235|NCT01773278|Accumulation of 7-dehydrocholesterol|accumulation of 7-dehydrocholesterol
421236|NCT01773278|electroretinogram (ERG)|electroretinogram (erg)
421237|NCT01773278|Auditory Brainstem Response (ABR)|auditory brainstem response (abr)
421238|NCT01773252|RLS|rls
421239|NCT01773252|RTLS|rtls
421240|NCT01773252|PFO|pfo
421241|NCT01773252|ASD|asd
421242|NCT01773252|shunt|shunt
421243|NCT01773252|cardiac|cardiac
421244|NCT01773252|paradoxical thromboembolism|paradoxical thromboembolism
421245|NCT01773252|interventional cardiology|interventional cardiology
421246|NCT01773252|stroke|stroke
421247|NCT01773252|migraine|migraine
421248|NCT01773252|aura|aura
421249|NCT01773252|obstructive sleep apnea|obstructive sleep apnea
421250|NCT01773252|decompression illness|decompression illness
421251|NCT01773252|neurology|neurology
421252|NCT01773252|transesophageal echocardiography|transesophageal echocardiography
421253|NCT01773252|TEE|tee
421254|NCT01773252|transthoracic echocardiography|transthoracic echocardiography
421255|NCT01773252|TTE|tte
421256|NCT01773252|transcranial Doppler|transcranial doppler
421257|NCT01773252|ultrasound|ultrasound
421258|NCT01773252|TCD|tcd
421259|NCT01773252|power m Mode|power m mode
421260|NCT01773252|indocyanine green dye|indocyanine green dye
421261|NCT01773252|ICG|icg
421262|NCT01773252|Valsalva|valsalva
421263|NCT01773239|social cognition|social cognition
421264|NCT01773239|cognitive deficits|cognitive deficits
421265|NCT01773239|prodromal schizophrenia|prodromal schizophrenia
421266|NCT01773239|recent-onset schizophrenia|recent-onset schizophrenia
421267|NCT01773239|remediation|remediation
421268|NCT01773239|computer training|computer training
421269|NCT01773239|cognitive training exercises|cognitive training exercises
421270|NCT01773226|Autologous Protein Solution|autologous protein solution
421271|NCT01773226|APS|aps
421272|NCT01773226|Osteoarthritis|osteoarthritis
421273|NCT01773226|Injection|injection
421274|NCT01773213|Lower urinary tract|lower urinary tract
421275|NCT01773213|Bladder|bladder
421276|NCT01773213|Neuropathic bladder|neuropathic bladder
421277|NCT01773213|Overactive bladder|overactive bladder
421278|NCT01773200|endothelial progenitor cells|endothelial progenitor cells
421279|NCT01773200|aneurysmal subarachnoid hemorrhage|aneurysmal subarachnoid hemorrhage
421280|NCT01773200|vasospasm|vasospasm
421281|NCT01773200|BNP|bnp
421282|NCT01773187|Myelofibrosis|myelofibrosis
421283|NCT01773187|Post-Polycythemia Vera Myelofibrosis|post-polycythemia vera myelofibrosis
421284|NCT01773187|Post-Essential Thrombocythemia Myelofibrosis|post-essential thrombocythemia myelofibrosis
421285|NCT01773187|Primary Myelofibrosis|primary myelofibrosis
421286|NCT01773187|Polycythemia|polycythemia
421287|NCT01773187|Polycythemia Vera|polycythemia vera
421288|NCT01773187|Thrombocythemia, Essential|thrombocythemia, essential
421289|NCT01773187|Thrombocythemia|thrombocythemia
421290|NCT01773187|Myeloproliferative Disorders|myeloproliferative disorders
421291|NCT01773187|Bone Marrow Disease|bone marrow disease
421292|NCT01773187|Hematologic Diseases|hematologic diseases
421293|NCT01773187|Blood Platelet Disorders|blood platelet disorders
421294|NCT01773187|Hemorrhagic Disorders|hemorrhagic disorders
421295|NCT01773187|Splenomegaly|splenomegaly
421296|NCT01773187|Pacritinib|pacritinib
421297|NCT01773187|MPN-SAF|mpn-saf
421298|NCT01773187|MPN-SAF TSS|mpn-saf tss
421299|NCT01773187|Anemia|anemia
421300|NCT01773187|Myeloproliferative|myeloproliferative
421301|NCT01773187|Myeloproliferative Neoplasm|myeloproliferative neoplasm
421302|NCT01773187|Spleen|spleen
421303|NCT01773187|Spleen volume|spleen volume
421304|NCT01773187|Thrombocytopenia|thrombocytopenia
421305|NCT01773187|SB1518|sb1518
421306|NCT01773161|Cerebral Palsy|cerebral palsy
421307|NCT01773161|Hip surgery|hip surgery
421308|NCT01773161|Quality of Life|quality of life
421309|NCT01773135|threatened preterm labor|threatened preterm labor
421312|NCT01773109|Male/female subjects 18 years of age and older|male/female subjects 18 years of age and older
421313|NCT01773109|metastatic or recurrent NSCLC|metastatic or recurrent nsclc
421314|NCT01773109|who failed 2nd line therapy|who failed 2nd line therapy
421315|NCT01773096|opioid-induced|opioid-induced
421316|NCT01773083|Inhalation trauma|inhalation trauma
421317|NCT01773083|pulmonary coagulopathy|pulmonary coagulopathy
421318|NCT01773083|heparin nebulization|heparin nebulization
421319|NCT01773083|mechanical ventilation|mechanical ventilation
421320|NCT01773070|Chronic Hepatitis C|chronic hepatitis c
421321|NCT01773070|Hepatitis C virus|hepatitis c virus
421322|NCT01773070|Direct Acting Antiviral|direct acting antiviral
421323|NCT01773070|Sustained Virologic Response|sustained virologic response
421324|NCT01773070|Hepatitis C|hepatitis c
421325|NCT01773070|Persistence of treatment-emergent substitutions|persistence of treatment-emergent substitutions
421326|NCT01773057|Computerized Decision Support System|computerized decision support system
421327|NCT01773057|Heart failure|heart failure
421328|NCT01773057|Effects on quality of care|effects on quality of care
421329|NCT01773057|Process of care|process of care
421330|NCT01773057|Patient outcomes|patient outcomes
421331|NCT01773031|Autoimmune pancreatitis|autoimmune pancreatitis
421332|NCT01773031|MR pancreatography|mr pancreatography
421333|NCT01773005|Anesthetics, Intravenous|anesthetics, intravenous
421334|NCT01772992|HIV couples adherence linkage to care viral suppression|hiv couples adherence linkage to care viral suppression
421335|NCT01772979|Trabectedin|trabectedin
421336|NCT01772979|BRCA1 and BRCA2|brca1 and brca2
421337|NCT01772979|BRCAness|brcaness
421338|NCT01772979|Ovarian cancer|ovarian cancer
421339|NCT01772966|neck|neck
421340|NCT01772966|pain|pain
421341|NCT01772966|chronic|chronic
421342|NCT01772966|manipulation|manipulation
421343|NCT01772966|control|control
421344|NCT01772966|randomized trial|randomized trial
421346|NCT01772953|MDS|mds
421347|NCT01772953|Treosulfan|treosulfan
421348|NCT01772940|First-line therapy|first-line therapy
421349|NCT01772940|Protease inhibitor|protease inhibitor
421350|NCT01772940|Non-Nucleoside Reverse transcriptase Inhibitor|non-nucleoside reverse transcriptase inhibitor
421351|NCT01772940|Resource-limited setting|resource-limited setting
421352|NCT01772927|parenteral nutrition|parenteral nutrition
421353|NCT01772927|Very low birth weight infants|very low birth weight infants
421354|NCT01772927|preterm infants|preterm infants
421355|NCT01772927|biochemical tolerance|biochemical tolerance
421356|NCT01772927|nutritional intake|nutritional intake
421357|NCT01772914|Copeptin|copeptin
421358|NCT01772914|eating|eating
421359|NCT01772914|glucose tolerance test|glucose tolerance test
421360|NCT01772914|mixed meal test|mixed meal test
421361|NCT01772914|physiological|physiological
421362|NCT01772901|influenza|influenza
421363|NCT01772901|influenza vaccines|influenza vaccines
421364|NCT01772901|infectious disease|infectious disease
421365|NCT01772901|pregnancy|pregnancy
421366|NCT01772875|urinary catheter|urinary catheter
421367|NCT01772875|UTI|uti
421368|NCT01772875|bladder lavage|bladder lavage
421369|NCT01772862|childhood|childhood
421370|NCT01772862|cancer|cancer
421371|NCT01772862|physical activity|physical activity
421372|NCT01772862|quality of life|quality of life
421373|NCT01772849|childhood|childhood
421374|NCT01772849|cancer|cancer
421375|NCT01772849|education|education
421376|NCT01772849|physical activity|physical activity
421377|NCT01772849|quality of life|quality of life
421378|NCT01772823|HIV, PrEP, FTC/TDF, Truvada®|hiv, prep, ftc/tdf, truvada®
421379|NCT01772810|Paralysis, spinal cord injury, chronic spinal cord injury, cspine injury, neck injury|paralysis, spinal cord injury, chronic spinal cord injury, cspine injury, neck injury
421380|NCT01772797|anaplastic lymphoma kinase, ALK-rearranged lung cancer, non-small cell lung cancer|anaplastic lymphoma kinase, alk-rearranged lung cancer, non-small cell lung cancer
421381|NCT01772784|subjects|subjects
421382|NCT01772771|Cancer|cancer
421383|NCT01772771|Molecular testing|molecular testing
421384|NCT01772771|Personalized Cancer Therapy Program|personalized cancer therapy program
421385|NCT01772771|Bladder|bladder
421386|NCT01772771|Bone|bone
421387|NCT01772771|Breast|breast
421388|NCT01772771|Cytology|cytology
421389|NCT01772771|Endocrine|endocrine
421390|NCT01772771|Gynecology|gynecology
421391|NCT01772771|Endocrine - Neoplasia|endocrine - neoplasia
421392|NCT01772771|genitourinary|genitourinary
421393|NCT01772771|Research Biorepository|research biorepository
421394|NCT01772771|Head and Neck|head and neck
421395|NCT01772771|Aerodigestive Tract|aerodigestive tract
421396|NCT01772771|Hematopathology|hematopathology
421397|NCT01772771|Human Cancer Genetics|human cancer genetics
421398|NCT01772771|Kidney|kidney
421399|NCT01772771|Leukemia|leukemia
421400|NCT01772771|Lower Gastrointestinal|lower gastrointestinal
421401|NCT01772771|Lymphoma|lymphoma
421402|NCT01772771|Melanoma|melanoma
421403|NCT01772771|Neurology|neurology
421404|NCT01772771|Brain|brain
421405|NCT01772771|Non-Melanoma Skin|non-melanoma skin
421406|NCT01772771|Pancreas|pancreas
421407|NCT01772771|Pediatrics|pediatrics
421408|NCT01772771|Prostate|prostate
421409|NCT01772771|Breast Cancer Patients, Serum|breast cancer patients, serum
421410|NCT01772771|Plasma|plasma
421411|NCT01772771|Soft Tissue Sarcoma|soft tissue sarcoma
421412|NCT01772771|Thoracic|thoracic
421413|NCT01772771|Lung|lung
421414|NCT01772771|S.P.O.R.E.|s.p.o.r.e.
421415|NCT01772771|Upper Gastrointestinal|upper gastrointestinal
421416|NCT01772758|CF, cystic fibrosis, exercise|cf, cystic fibrosis, exercise
421417|NCT01772745|single incision|single incision
421418|NCT01772745|cholecystectomy|cholecystectomy
421419|NCT01772745|laparoscopy|laparoscopy
421420|NCT01772732|Simotinib|simotinib
421421|NCT01772732|Non-small Cell Lung Cancer|non-small cell lung cancer
421422|NCT01772719|refractory multiple myeloma|refractory multiple myeloma
421423|NCT01772706|Head and neck cancer|head and neck cancer
421424|NCT01772706|Low level laser therapy|low level laser therapy
421425|NCT01772706|Mucositis induced by radiochemotherpy|mucositis induced by radiochemotherpy
421426|NCT01772693|ExAblate Transcranial MRgFUS|exablate transcranial mrgfus
421427|NCT01772680|Thalassemia|thalassemia
421428|NCT01772680|Diabetes|diabetes
421429|NCT01772680|Zinc|zinc
421430|NCT01772680|Iron-Overload|iron-overload
421431|NCT01772667|pulmonary fibrosis|pulmonary fibrosis
421432|NCT01772667|interstitial lung disease|interstitial lung disease
421433|NCT01772667|pulmonary rehabilitation|pulmonary rehabilitation
421434|NCT01772667|exercise capacity|exercise capacity
421435|NCT01772667|physical activity|physical activity
421436|NCT01772667|quality of life|quality of life
421437|NCT01772654|Epilepsy|epilepsy
421438|NCT01772654|Arterial Spin Labeled MRI|arterial spin labeled mri
421439|NCT01772654|Brain lesions|brain lesions
421440|NCT01772654|Cerebral blood flow|cerebral blood flow
421441|NCT01772641|cigarette|cigarette
421442|NCT01772641|smoking|smoking
421443|NCT01772641|cessation|cessation
421444|NCT01772641|varenicline|varenicline
421445|NCT01772641|scheduled reduction|scheduled reduction
421446|NCT01772641|craving|craving
421447|NCT01772628|Communication|communication
421448|NCT01772628|Healthy sexual behaviour|healthy sexual behaviour
421449|NCT01772628|Sexual and reproductive health|sexual and reproductive health
421450|NCT01772628|Adolescents|adolescents
421451|NCT01772615|EcN, Nissle, Mutaflor, Ulcerative Colitis, antibiotics, Inflammatory Bowel Diseases|ecn, nissle, mutaflor, ulcerative colitis, antibiotics, inflammatory bowel diseases
421452|NCT01772602|Amyotrophic Lateral Sclerosis|amyotrophic lateral sclerosis
421453|NCT01772602|Lou Gehrig's Disease|lou gehrig's disease
421454|NCT01772602|Motor Neuron Disease|motor neuron disease
421455|NCT01772576|Reliance|reliance
421456|NCT01772576|Implantable Cardioverter Defibrillator (ICD)|implantable cardioverter defibrillator (icd)
421457|NCT01772576|Cardiac Resynchronization Therapy - Defibrillator (CRT-D)|cardiac resynchronization therapy - defibrillator (crt-d)
421458|NCT01772550|CECT, catheter, contrast|cect, catheter, contrast
421459|NCT01772537|thoracoabdominal|thoracoabdominal
421460|NCT01772537|aneurysm|aneurysm
421461|NCT01772537|open|open
421462|NCT01772537|stent|stent
421463|NCT01772537|cardiopulmonary|cardiopulmonary
421464|NCT01772537|abdominal|abdominal
421465|NCT01772537|bypass|bypass
421466|NCT01772524|Migraine Disorders|migraine disorders
421467|NCT01772524|Phase 1|phase 1
421468|NCT01772524|ALD403|ald403
421469|NCT01772511|questionnaire|questionnaire
421470|NCT01772511|prior therapy|prior therapy
421471|NCT01772511|prior study volunteer|prior study volunteer
421472|NCT01772511|prior study patient|prior study patient
421473|NCT01772511|cancer|cancer
421474|NCT01772511|oncology|oncology
421475|NCT01772498|depression|depression
421476|NCT01772498|anxiety|anxiety
421477|NCT01772498|sleep|sleep
421478|NCT01772498|pain|pain
421479|NCT01772498|biofeedback|biofeedback
421480|NCT01772498|breathing|breathing
421481|NCT01772498|resonant|resonant
421482|NCT01772459|Scoliosis|scoliosis
421483|NCT01772459|Adolescents|adolescents
421484|NCT01772459|Questionnaire|questionnaire
421485|NCT01772459|Reliability|reliability
421486|NCT01772446|diabetes|diabetes
421487|NCT01772446|management|management
421488|NCT01772446|glycated hemoglobin|glycated hemoglobin
421489|NCT01772446|preventive activities|preventive activities
421490|NCT01772433|Low Back Pain|low back pain
421491|NCT01772433|Topical Olive Oil|topical olive oil
421492|NCT01772433|Phonophoresis|phonophoresis
421493|NCT01772407|Colon Cancer Surgery|colon cancer surgery
421494|NCT01772407|Laparoscopy|laparoscopy
421495|NCT01772407|Open surgery|open surgery
421496|NCT01772407|Costs|costs
421497|NCT01772407|Mortality|mortality
421498|NCT01772407|Morbidity|morbidity
421499|NCT01772407|Quality of life|quality of life
421500|NCT01772394|Anorexia Nervosa|anorexia nervosa
421501|NCT01772394|Cognitive remediation therapy|cognitive remediation therapy
421502|NCT01772394|Randomized clinical trial|randomized clinical trial
421503|NCT01772381|Dexamethasone, term, elective cesarean section|dexamethasone, term, elective cesarean section
421504|NCT01772368|Asthma|asthma
421505|NCT01772368|dry powder inhaler|dry powder inhaler
421506|NCT01772368|long-acting beta2-agonist|long-acting beta2-agonist
421507|NCT01772368|bronchodilation|bronchodilation
421508|NCT01772368|bronchodilator|bronchodilator
421509|NCT01772368|metered dose inhaler|metered dose inhaler
421510|NCT01772368|inhaled corticosteroid|inhaled corticosteroid
421511|NCT01772355|orbit; tumor; core biopsy|orbit; tumor; core biopsy
421512|NCT01772342|Sleep Fragmentation|sleep fragmentation
421513|NCT01772342|Quality of Life|quality of life
421514|NCT01772342|Air Filters|air filters
421515|NCT01772303|Pressure Ulcers, diabetic Ulcers, post operational wounds|pressure ulcers, diabetic ulcers, post operational wounds
421516|NCT01772277|Endoscopic dacryocystorhinostomy|endoscopic dacryocystorhinostomy
421517|NCT01772277|Mitomycin C|mitomycin c
421518|NCT01772251|Diabetes Mellitus|diabetes mellitus
421519|NCT01772251|Oral Insulin|oral insulin
421520|NCT01772238|Mexico|mexico
421521|NCT01772238|Respiratory infections|respiratory infections
421522|NCT01772238|Amoxicillin-Clavulanic Acid|amoxicillin-clavulanic acid
421523|NCT01772238|Bioequivalence|bioequivalence
421524|NCT01772225|Observational Retrospective|observational retrospective
421525|NCT01772225|Health-related quality of life (HRQoL)|health-related quality of life (hrqol)
421526|NCT01772225|Patients|patients
421527|NCT01772225|Stage IB-IIIA|stage ib-iiia
421528|NCT01772225|Burden of Illness|burden of illness
421529|NCT01772225|Non-small Cell Lung Cancer (NSCLC)|non-small cell lung cancer (nsclc)
421530|NCT01772212|Mexico|mexico
421531|NCT01772212|terbinafine|terbinafine
421532|NCT01772212|mycoses|mycoses
421533|NCT01772212|pharmacokinetics|pharmacokinetics
421534|NCT01772199|GSK239512|gsk239512
421535|NCT01772199|remyelination|remyelination
421536|NCT01772199|magnetic resonance imaging|magnetic resonance imaging
421537|NCT01772199|Relapsing Remitting Multiple Sclerosis|relapsing remitting multiple sclerosis
421538|NCT01772199|Histamine 3 Receptor Antagonist|histamine 3 receptor antagonist
421539|NCT01772199|magnetization transfer ratio|magnetization transfer ratio
421540|NCT01772186|Freezing of gait|freezing of gait
421541|NCT01772186|Parkinson's disease|parkinson's disease
421542|NCT01772186|Somatosensory stimulation|somatosensory stimulation
421543|NCT01772186|Fall prevention|fall prevention
421544|NCT01772173|diabetes|diabetes
421545|NCT01772173|computer|computer
421546|NCT01772173|retina|retina
421547|NCT01772173|vessel|vessel
421548|NCT01772173|analysis|analysis
421549|NCT01772160|Adults|adults
421550|NCT01772160|Italy|italy
421551|NCT01772160|Herpes Zoster|herpes zoster
421552|NCT01772160|Complications|complications
421553|NCT01772160|Quality of life|quality of life
421554|NCT01772160|Surveillance|surveillance
421555|NCT01772160|Burden|burden
421556|NCT01772160|Cost|cost
421557|NCT01772160|Incidence|incidence
421558|NCT01772121|HBV, HCV, chronic, India, observational study, prevalence,|hbv, hcv, chronic, india, observational study, prevalence,
421559|NCT01772121|genotypes, SNPs, viral hepatitis|genotypes, snps, viral hepatitis
421560|NCT01772108|Heart Valve Diseases|heart valve diseases
421561|NCT01772095|Donepezil (Dementis)|donepezil (dementis)
421562|NCT01772095|Elderly|elderly
421563|NCT01772069|systemic lupus erythematosus, disease activity, sleep, quality of life|systemic lupus erythematosus, disease activity, sleep, quality of life
421564|NCT01772056|Dermatitis, Atopic|dermatitis, atopic
421565|NCT01772056|Randomized Controlled Trial|randomized controlled trial
421566|NCT01772056|Child|child
421567|NCT01772056|Fluticasone|fluticasone
421568|NCT01772056|Preventive therapy|preventive therapy
421569|NCT01772043|muscular dystrophy|muscular dystrophy
421570|NCT01772043|tissue bank|tissue bank
421571|NCT01772030|Atrial Fibrillation|atrial fibrillation
421572|NCT01772030|Cryoballoon Ablation|cryoballoon ablation
421573|NCT01772017|Obstructive Sleep Apnea|obstructive sleep apnea
421574|NCT01772017|OSA|osa
421575|NCT01772017|Snoring|snoring
421576|NCT01772017|Tongue Advancement Retainer Device|tongue advancement retainer device
421577|NCT01772004|Solid Tumors|solid tumors
421578|NCT01772004|MSB0010718C|msb0010718c
421579|NCT01772004|Phase 1|phase 1
421580|NCT01772004|Pharmacokinetic|pharmacokinetic
421581|NCT01772004|anti PD-L1|anti pd-l1
421582|NCT01772004|Non-small cell lung cancer (NSCLC)|non-small cell lung cancer (nsclc)
421583|NCT01772004|Metastatic breast cancer (MBC)|metastatic breast cancer (mbc)
421584|NCT01772004|Gastric and gastroesophageal junction (GEJ) cancer|gastric and gastroesophageal junction (gej) cancer
421585|NCT01772004|Ovarian cancer|ovarian cancer
421586|NCT01772004|Colorectal cancer (CRC)|colorectal cancer (crc)
421587|NCT01772004|Castrate-resistant prostate cancer (CRPC)|castrate-resistant prostate cancer (crpc)
421588|NCT01772004|Melanoma|melanoma
421589|NCT01772004|Urothelial carcinoma|urothelial carcinoma
421590|NCT01772004|Bladder cancer|bladder cancer
421591|NCT01772004|Head and neck squamous cell carcinoma (HNSCC)|head and neck squamous cell carcinoma (hnscc)
421592|NCT01772004|Renal cell carcinoma (RCC)|renal cell carcinoma (rcc)
421593|NCT01772004|Adrenocortical carcinoma (ACC)|adrenocortical carcinoma (acc)
421594|NCT01771991|fibrosis|fibrosis
421595|NCT01771991|radiation|radiation
421596|NCT01771991|neck|neck
421597|NCT01771991|cancer|cancer
421598|NCT01771991|Sodermix|sodermix
421599|NCT01771978|ischaemia-reperfusion injury|ischaemia-reperfusion injury
421600|NCT01771978|cardiac surgery|cardiac surgery
421601|NCT01771978|oxidative stress markers|oxidative stress markers
421602|NCT01771978|troponin|troponin
421603|NCT01771978|diltiazem|diltiazem
421604|NCT01771978|acetylcystein|acetylcystein
421605|NCT01771952|Patellofemoral Chondromalacia|patellofemoral chondromalacia
421606|NCT01771952|Anterior Knee Pain|anterior knee pain
421607|NCT01771952|Patellofemoral Pain Syndrome|patellofemoral pain syndrome
421608|NCT01771952|Synvisc-One|synvisc-one
421609|NCT01771952|Hyaluronic Acid|hyaluronic acid
421610|NCT01771939|Idiopathic epiretinal membranes|idiopathic epiretinal membranes
421611|NCT01771939|25-G surgery in idiopathic epiretinal membranes|25-g surgery in idiopathic epiretinal membranes
421612|NCT01771926|resistant starch|resistant starch
421613|NCT01771926|lifestyle intervention|lifestyle intervention
421614|NCT01771913|adipocytes|adipocytes
421615|NCT01771913|cell transplantations|cell transplantations
421616|NCT01771913|mesenchymal stem cell|mesenchymal stem cell
421617|NCT01771913|immunophenotyping|immunophenotyping
421618|NCT01771913|adipose tissue|adipose tissue
421619|NCT01771913|breast reconstruction|breast reconstruction
421620|NCT01771913|mammaplasty|mammaplasty
421621|NCT01771913|magnetic resonance imaging|magnetic resonance imaging
421622|NCT01771913|fat necrosis|fat necrosis
421623|NCT01771900|heart failure|heart failure
421624|NCT01771900|exercise|exercise
421625|NCT01771900|adherence to exercise|adherence to exercise
421626|NCT01771887|Diabetic Type2|diabetic type2
421627|NCT01771887|education|education
421628|NCT01771887|self-management behaviors|self-management behaviors
421629|NCT01771887|self-efficacy|self-efficacy
421630|NCT01771887|HbA1c|hba1c
421631|NCT01771874|MDMA|mdma
421632|NCT01771874|pharmacokinetics|pharmacokinetics
421633|NCT01771874|pharmacodynamics|pharmacodynamics
421634|NCT01771874|emotions|emotions
421635|NCT01771874|Mechanism of action of MDMA|mechanism of action of mdma
421636|NCT01771874|Interaction study|interaction study
421637|NCT01771874|Effect of MDMA and bupropion on emotions|effect of mdma and bupropion on emotions
421638|NCT01771848|Malaria|malaria
421639|NCT01771848|Plasmodium falciparum|plasmodium falciparum
421640|NCT01771835|diabetes mellitus|diabetes mellitus
421641|NCT01771835|retinal venous pressure|retinal venous pressure
421642|NCT01771835|endothelin-1|endothelin-1
421643|NCT01771822|cumulative irritancy patch test (CIPT)|cumulative irritancy patch test (cipt)
421644|NCT01771809|Anti-TNF Refractory|anti-tnf refractory
421645|NCT01771809|Active Ulcerative Colitis|active ulcerative colitis
421646|NCT01771809|Immunosuppressant Refractory|immunosuppressant refractory
421647|NCT01771796|Exercise; lung cancer; aerobic training, resistance training; respiratory muscle training|exercise; lung cancer; aerobic training, resistance training; respiratory muscle training
421648|NCT01771783|RAS-Peptide Profile|ras-peptide profile
421649|NCT01771783|Renin-Angiotensin-System|renin-angiotensin-system
421650|NCT01771783|Angiotensin-Converting-Enzyme-Inhibitor|angiotensin-converting-enzyme-inhibitor
421651|NCT01771783|Angiotensin-Receptor-Antagonist|angiotensin-receptor-antagonist
421652|NCT01771783|Renin-inhibitor|renin-inhibitor
421653|NCT01771770|retinal venous pressure (RVP)|retinal venous pressure (rvp)
421654|NCT01771770|chronically reduced ambient pressure|chronically reduced ambient pressure
421655|NCT01771770|oxygen partial pressure|oxygen partial pressure
421656|NCT01771770|mountain sickness|mountain sickness
421657|NCT01771757|retinal venous pressure|retinal venous pressure
421658|NCT01771757|reduced ambient pressure|reduced ambient pressure
421659|NCT01771757|oxygen partial pressure|oxygen partial pressure
421660|NCT01771757|short-term hypoxic changes|short-term hypoxic changes
421661|NCT01771705|Transplantation|transplantation
421662|NCT01771705|Kidney|kidney
421663|NCT01771705|calcineurin inhibitor|calcineurin inhibitor
421664|NCT01771705|NFAT|nfat
421665|NCT01771705|tacrolimus|tacrolimus
421666|NCT01771692|Orthodontics|orthodontics
421667|NCT01771679|Mesenchymal Stem Cells|mesenchymal stem cells
421668|NCT01771679|Bone Marrow Cells|bone marrow cells
421669|NCT01771679|Allogeneic Transplantation|allogeneic transplantation
421670|NCT01771679|Skin Wrinkling|skin wrinkling
421671|NCT01771679|Solar Aging of Skin|solar aging of skin
421672|NCT01771679|Intravenous Administration|intravenous administration
421673|NCT01771653|Hepatitis C infection|hepatitis c infection
421674|NCT01771653|Hepatitis C Virus|hepatitis c virus
421675|NCT01771653|HCV|hcv
421676|NCT01771640|ALS intrathecal injection bone marrow mesenchymal stem cell|als intrathecal injection bone marrow mesenchymal stem cell
421677|NCT01771614|Glucotoxicity|glucotoxicity
421678|NCT01771614|Exercise|exercise
421679|NCT01771614|Beta-cell function|beta-cell function
421680|NCT01771601|Near-infrared spectroscopy, cerebral oxygenation, term newborn, reproducibility,|near-infrared spectroscopy, cerebral oxygenation, term newborn, reproducibility,
421681|NCT01771562|HIV-1|hiv-1
421682|NCT01771562|Child|child
421683|NCT01771562|Adolescent|adolescent
421684|NCT01771562|Growth|growth
421685|NCT01771562|Lipodystrophy|lipodystrophy
421686|NCT01771562|ARV treatment|arv treatment
421687|NCT01771562|Senegal|senegal
421688|NCT01771549|Adriamycin|adriamycin
421689|NCT01771549|Trastuzumab|trastuzumab
421690|NCT01771549|Brain Natriuretic Peptide (BNP)|brain natriuretic peptide (bnp)
421691|NCT01771549|Troponin|troponin
421692|NCT01771523|thyroidectomy|thyroidectomy
421693|NCT01771523|drain use|drain use
421694|NCT01771497|Breast CT|breast ct
421695|NCT01771484|tachycardia|tachycardia
421696|NCT01771484|pots|pots
421697|NCT01771484|orthostatic intolerance|orthostatic intolerance
421698|NCT01771471|back pain|back pain
421699|NCT01771471|intervertebral disc|intervertebral disc
421700|NCT01771471|lumbar spine|lumbar spine
421701|NCT01771458|Metastatic/Reccurent|metastatic/reccurent
421702|NCT01771458|Solid Tumor|solid tumor
421703|NCT01771458|Refractory|refractory
421704|NCT01771458|Molecular profile|molecular profile
421705|NCT01771458|Targeted treatment|targeted treatment
421706|NCT01771445|IL-1|il-1
421707|NCT01771445|IL-6|il-6
421708|NCT01771445|Inflammation|inflammation
421709|NCT01771419|loop-tip|loop-tip
421710|NCT01771419|ERCP|ercp
421711|NCT01771419|cannulation of CBD|cannulation of cbd
421712|NCT01771393|arthroscanner|arthroscanner
421713|NCT01771393|cone-beam computed tomodensitometry|cone-beam computed tomodensitometry
421714|NCT01771354|Volunteers|volunteers
421715|NCT01771354|Identify|identify
421716|NCT01771354|Biomarkers|biomarkers
421717|NCT01771354|Vaccine Safety|vaccine safety
421718|NCT01771341|NAVA|nava
421719|NCT01771341|post operative|post operative
421720|NCT01771328|Adrenal Hyperplasia, Congenital|adrenal hyperplasia, congenital
421721|NCT01771315|total knee arthroplasty|total knee arthroplasty
421722|NCT01771315|telephone follow-up|telephone follow-up
421723|NCT01771315|physical function|physical function
421724|NCT01771315|health related quality of life|health related quality of life
421725|NCT01771315|self-efficacy|self-efficacy
421726|NCT01771302|PRGF-Endoret|prgf-endoret
421727|NCT01771302|Bone graft|bone graft
421728|NCT01771302|Maxillary sinus|maxillary sinus
421729|NCT01771302|Vertical bone augmentation|vertical bone augmentation
421730|NCT01771289|Lung Cancer|lung cancer
421731|NCT01771276|POSE|pose
421732|NCT01771263|Anesthesia|anesthesia
421733|NCT01771263|Propofol|propofol
421734|NCT01771263|Remifentanil|remifentanil
421735|NCT01771263|NeuroSENSE|neurosense
421736|NCT01771237|HIV infection|hiv infection
421737|NCT01771224|Palmitoleic acid ulcerative colitis|palmitoleic acid ulcerative colitis
421739|NCT01771211|Word-retrieval|word-retrieval
421740|NCT01771211|tDCS|tdcs
421741|NCT01771211|fMRI|fmri
421742|NCT01771198|Chronic rhinosinusitis|chronic rhinosinusitis
421743|NCT01771198|Refractory to treatment|refractory to treatment
421744|NCT01771198|SIMVASTATIN|simvastatin
421745|NCT01771185|Diabetes|diabetes
421746|NCT01771185|metabolic surgery|metabolic surgery
421747|NCT01771185|insulin resistance|insulin resistance
421748|NCT01771159|Spinal cord injury|spinal cord injury
421749|NCT01771159|Urinary dysfunction|urinary dysfunction
421750|NCT01771159|Bladder drainage|bladder drainage
421751|NCT01771146|Non-metastatic Pancreas Cancer|non-metastatic pancreas cancer
421752|NCT01771146|Pancreatic Cancer|pancreatic cancer
421753|NCT01771146|Cancer of Pancreas|cancer of pancreas
421754|NCT01771146|Adenocarcinoma of Pancreas|adenocarcinoma of pancreas
421755|NCT01771146|Neoadjuvant|neoadjuvant
421756|NCT01771133|Obesity|obesity
421757|NCT01771133|Maternal Welfare|maternal welfare
421758|NCT01771133|Child Welfare|child welfare
421759|NCT01771133|Nutritional Sciences|nutritional sciences
421760|NCT01771133|Clinical Trial|clinical trial
421761|NCT01771133|Pregnancy|pregnancy
421762|NCT01771133|Physical activity|physical activity
421763|NCT01771133|Fetal Development|fetal development
421764|NCT01771133|Metabolic Diseases|metabolic diseases
421765|NCT01771133|Life style|life style
421766|NCT01771133|Behavior and Behavior Mechanisms|behavior and behavior mechanisms
421767|NCT01771133|LIFE-Moms|life-moms
421768|NCT01771120|Asthma|asthma
421769|NCT01771120|Rhinitis|rhinitis
421770|NCT01771120|Control|control
421771|NCT01771120|Burden|burden
421772|NCT01771081|Longitudinal Studies,|longitudinal studies,
421773|NCT01771081|Observation|observation
421774|NCT01771081|Epidemiology|epidemiology
421775|NCT01771055|Trauma|trauma
421776|NCT01771055|Hypovolemia|hypovolemia
421777|NCT01771042|weight loss|weight loss
421778|NCT01771042|metabolic syndrome|metabolic syndrome
421779|NCT01771042|sympathetic nervous system|sympathetic nervous system
421780|NCT01771042|insulin resistance|insulin resistance
421781|NCT01771042|glucose tolerance|glucose tolerance
421782|NCT01771029|Procalcitonin|procalcitonin
421783|NCT01771029|Infection|infection
421784|NCT01771029|Point-of-Care|point-of-care
421785|NCT01771016|Emergency contraception|emergency contraception
421786|NCT01771016|Emergency hormonal contraception|emergency hormonal contraception
421787|NCT01771016|Community pharmacies|community pharmacies
421788|NCT01771016|Pharmaceutical care|pharmaceutical care
421789|NCT01771016|Time to access|time to access
421790|NCT01771016|Written assessments|written assessments
421791|NCT01771016|Switzerland|switzerland
421792|NCT01771003|Partial nephrectomy|partial nephrectomy
421793|NCT01771003|renal cell carcinoma|renal cell carcinoma
421794|NCT01771003|Renal Function|renal function
421795|NCT01771003|Remote ischemia preconditioning|remote ischemia preconditioning
421796|NCT01770990|depression|depression
421797|NCT01770990|telephone-based psychotherapy|telephone-based psychotherapy
421798|NCT01770990|cognitive-behavioral psychotherapy|cognitive-behavioral psychotherapy
421799|NCT01770990|manualized psychotherapy|manualized psychotherapy
421800|NCT01770990|telephone counseling|telephone counseling
421801|NCT01770990|telephone psychological treatment|telephone psychological treatment
421802|NCT01770990|telephone-administered therapy|telephone-administered therapy
421803|NCT01770990|low-intensity treatment|low-intensity treatment
421804|NCT01770990|motivational mail|motivational mail
421805|NCT01770990|reminder|reminder
421806|NCT01770990|letter|letter
421807|NCT01770977|Light-emitting diode therapy|light-emitting diode therapy
421808|NCT01770977|Muscle performance|muscle performance
421809|NCT01770977|Aerobic performance|aerobic performance
421810|NCT01770977|Lactate|lactate
421811|NCT01770977|Creatine kinase|creatine kinase
421812|NCT01770938|Light-emitting diode therapy|light-emitting diode therapy
421813|NCT01770938|Muscle performance|muscle performance
421814|NCT01770938|Gene expression|gene expression
421815|NCT01770938|Functional performance|functional performance
421816|NCT01770912|facial pain|facial pain
421817|NCT01770912|temporomandibular joint|temporomandibular joint
421818|NCT01770912|arthrocentesis|arthrocentesis
421819|NCT01770912|steroid|steroid
421820|NCT01770899|Montelukast|montelukast
421821|NCT01770899|Singulair|singulair
421822|NCT01770899|status asthmaticus|status asthmaticus
421823|NCT01770886|Drug Safety|drug safety
421824|NCT01770873|Youth|youth
421825|NCT01770873|Violence|violence
421826|NCT01770873|Assault-injured|assault-injured
421827|NCT01770873|Mentoring|mentoring
421828|NCT01770873|Emergency Room|emergency room
421829|NCT01770873|Urban|urban
421830|NCT01770860|Adhesive Bandages|adhesive bandages
421831|NCT01770860|Dermabrasion Wounds|dermabrasion wounds
421832|NCT01770821|sip drink|sip drink
421833|NCT01770821|protein|protein
421834|NCT01770821|muscle strength|muscle strength
421835|NCT01770821|6 minutes walking test|6 minutes walking test
421836|NCT01770808|Bloating|bloating
421837|NCT01770808|Flatulence|flatulence
421838|NCT01770808|Stomach discomfort|stomach discomfort
421839|NCT01770795|non-small cell lung cancer|non-small cell lung cancer
421840|NCT01770795|gemcitabine|gemcitabine
421841|NCT01770795|genexol-PM|genexol-pm
421842|NCT01770795|paclitaxel|paclitaxel
421843|NCT01770782|Palatal Expansion Technique|palatal expansion technique
421844|NCT01770782|Orthognathic Surgery|orthognathic surgery
421845|NCT01770782|Three Dimensional images|three dimensional images
421846|NCT01770769|Femoral Neck Fracture|femoral neck fracture
421847|NCT01770769|undisplaced|undisplaced
421848|NCT01770769|minimally displaced|minimally displaced
421849|NCT01770769|internal fixation|internal fixation
421850|NCT01770769|hemiarthroplasty|hemiarthroplasty
421851|NCT01770769|harris hip score|harris hip score
421852|NCT01770769|hospital cost|hospital cost
421853|NCT01770769|society cost|society cost
421854|NCT01770769|quality of life|quality of life
421855|NCT01770769|Timed Up and go test|timed up and go test
421856|NCT01770756|Hypertension|hypertension
421857|NCT01770756|High blood pressure|high blood pressure
421858|NCT01770756|Willpower|willpower
421859|NCT01770756|Self care|self care
421860|NCT01770743|post-exposure prophylaxis|post-exposure prophylaxis
421861|NCT01770743|toxin neutralization assay|toxin neutralization assay
421862|NCT01770730|urine LAM strip test|urine lam strip test
421863|NCT01770730|diagnostics|diagnostics
421864|NCT01770730|tuberculosis|tuberculosis
421865|NCT01770704|Bipolar disorder|bipolar disorder
421866|NCT01770704|Clinical management|clinical management
421867|NCT01770704|Clinical outcomes|clinical outcomes
421868|NCT01770678|Children|children
421869|NCT01770678|Cerebral Palsy|cerebral palsy
421870|NCT01770678|Randomised|randomised
421871|NCT01770678|Constraint Induced Movement Therapy|constraint induced movement therapy
421872|NCT01770652|Renal Impairment|renal impairment
421873|NCT01770652|Kidney Impairment|kidney impairment
421874|NCT01770652|Kidney Disease|kidney disease
421875|NCT01770652|Ferriprox|ferriprox
421876|NCT01770652|Deferiprone|deferiprone
421877|NCT01770652|DFP (deferiprone)|dfp (deferiprone)
421878|NCT01770652|L1|l1
421879|NCT01770639|charcot foot|charcot foot
421880|NCT01770639|charcot neuroarthropathy|charcot neuroarthropathy
421881|NCT01770639|midfoot arthrodesis|midfoot arthrodesis
421882|NCT01770639|midfoot fusion|midfoot fusion
421883|NCT01770613|Adult|adult
421884|NCT01770613|Allogeneic|allogeneic
421885|NCT01770613|Stem|stem
421886|NCT01770613|Cells|cells
421887|NCT01770613|Myocardial|myocardial
421888|NCT01770613|Infarction|infarction
421889|NCT01770600|Age 19 to 64|age 19 to 64
421890|NCT01770600|Medically stable|medically stable
421891|NCT01770600|No current or history of psychosis|no current or history of psychosis
421892|NCT01770600|No alcohol or benzodiazepine withdrawal|no alcohol or benzodiazepine withdrawal
421893|NCT01770587|Insomnia|insomnia
421894|NCT01770587|Sleep|sleep
421895|NCT01770587|Behavioral Medicine|behavioral medicine
421896|NCT01770587|Suicide|suicide
421897|NCT01770587|Suicidal Ideation|suicidal ideation
421898|NCT01770574|calcaneal lengthening|calcaneal lengthening
421899|NCT01770574|calcium ceramics|calcium ceramics
421900|NCT01770574|noninferiority|noninferiority
421901|NCT01770574|radiostereometric analysis|radiostereometric analysis
421902|NCT01770535|Ovarian cancer, paclitaxel|ovarian cancer, paclitaxel
421903|NCT01770522|Bodyweight|bodyweight
421904|NCT01770522|Physical Acivitiy|physical acivitiy
421905|NCT01770522|Diet|diet
421906|NCT01770522|Bodymass index|bodymass index
421907|NCT01770522|Pregnancy|pregnancy
421908|NCT01770522|Postnatal|postnatal
421909|NCT01770509|Chronic venous leg ulcers|chronic venous leg ulcers
421910|NCT01770509|Venous ulcer|venous ulcer
421911|NCT01770509|Stasis ulcer|stasis ulcer
421912|NCT01770509|Varicose ulcer|varicose ulcer
421913|NCT01770496|immunization|immunization
421914|NCT01770496|vaccination|vaccination
421915|NCT01770496|immunization information system|immunization information system
421916|NCT01770496|immunization registry|immunization registry
421917|NCT01770496|reminder / recall|reminder / recall
421918|NCT01770483|Nitazoxanide,|nitazoxanide,
421919|NCT01770483|Sustained viral response|sustained viral response
421920|NCT01770483|Type 2 DIABETICS|type 2 diabetics
421921|NCT01770470|serum phosphate|serum phosphate
421922|NCT01770470|chitosan|chitosan
421923|NCT01770470|kidney disease|kidney disease
421924|NCT01770470|salivary phosphate|salivary phosphate
421925|NCT01770457|ICU population|icu population
421926|NCT01770444|Acute coronary syndrome|acute coronary syndrome
421927|NCT01770444|Cardiac computed tomographic angiography|cardiac computed tomographic angiography
421928|NCT01770444|Radiation dose reduction|radiation dose reduction
421929|NCT01770444|Medical radiation exposure|medical radiation exposure
421930|NCT01770431|Huaier Granule;|huaier granule;
421931|NCT01770431|After radical hepatectomy;|after radical hepatectomy;
421932|NCT01770431|Prevention of Recurrence and Metastasis;|prevention of recurrence and metastasis;
421933|NCT01770431|Safety.|safety.
421934|NCT01770418|Non Small Cell Lung Cancer|non small cell lung cancer
421935|NCT01770418|Cancer|cancer
421936|NCT01770418|Lung|lung
421937|NCT01770418|Proton|proton
421938|NCT01770418|Radiation|radiation
421939|NCT01770405|endomicroscopy|endomicroscopy
421940|NCT01770405|needle-based|needle-based
421941|NCT01770405|pancreatic|pancreatic
421942|NCT01770405|cyst|cyst
421943|NCT01770405|mass|mass
421944|NCT01770405|EUSFNA|eusfna
421945|NCT01770379|Rheumatoid Arthritis, RA, IL-17 blocker, subcutaneous, self-injection, AIN457, AIN457F, secukinumab, anti-TNFα, pre-filled syringe|rheumatoid arthritis, ra, il-17 blocker, subcutaneous, self-injection, ain457, ain457f, secukinumab, anti-tnfα, pre-filled syringe
421946|NCT01770366|obesity|obesity
421947|NCT01770366|weight loss surgery|weight loss surgery
421948|NCT01770366|virtual support|virtual support
421949|NCT01770366|wireless devices|wireless devices
421950|NCT01770366|Internet|internet
421951|NCT01770353|solid tumors|solid tumors
421952|NCT01770353|Triple Negative Breast Cancer|triple negative breast cancer
421953|NCT01770353|Colorectal Cancer|colorectal cancer
421954|NCT01770353|MM-398|mm-398
421955|NCT01770353|nanoliposomal irinotecan|nanoliposomal irinotecan
421956|NCT01770353|Ferumoxytol|ferumoxytol
421957|NCT01770353|ER/PR positive Breast Cancer|er/pr positive breast cancer
421958|NCT01770353|Pancreatic Cancer|pancreatic cancer
421959|NCT01770353|Ovarian Cancer|ovarian cancer
421960|NCT01770353|Gastric Cancer|gastric cancer
421961|NCT01770353|Gastro-Esophageal Junction Adenocarcinoma|gastro-esophageal junction adenocarcinoma
421962|NCT01770353|Head and Neck Cancer|head and neck cancer
421963|NCT01770353|TNBC|tnbc
421964|NCT01770340|radical prostatectomy|radical prostatectomy
421965|NCT01770340|erectile function|erectile function
421966|NCT01770340|nerve grafting|nerve grafting
421967|NCT01770340|allogenic|allogenic
421968|NCT01770340|prostate cancer|prostate cancer
421969|NCT01770340|Allogenic nerve graft|allogenic nerve graft
421970|NCT01770340|Time required for nerve grafting|time required for nerve grafting
421971|NCT01770314|Opioid Pain Medication|opioid pain medication
421972|NCT01770314|Medication Safety|medication safety
421973|NCT01770314|Correct storage|correct storage
421974|NCT01770314|Correct disposal|correct disposal
421975|NCT01770314|Correct Use|correct use
421976|NCT01770288|Anerobic exercise|anerobic exercise
421977|NCT01770288|Pain|pain
421978|NCT01770288|Analgesia|analgesia
421979|NCT01770288|Diffuse Noxious Inhibitory Control (DNIC)|diffuse noxious inhibitory control (dnic)
421980|NCT01770288|psychological stress|psychological stress
421981|NCT01770275|esophagus|esophagus
421982|NCT01770249|dysphagia|dysphagia
421983|NCT01770210|hypercholesterolemia|hypercholesterolemia
421984|NCT01770210|atorvastatin|atorvastatin
421985|NCT01770210|cardiovascular events|cardiovascular events
421986|NCT01770197|China|china
421987|NCT01770197|Stroke|stroke
421988|NCT01770197|Thrombolytic therapy|thrombolytic therapy
421989|NCT01770184|Self-management|self-management
421990|NCT01770184|Rehabilitation|rehabilitation
421991|NCT01770184|Occupational Therapy|occupational therapy
421992|NCT01770171|endometrial cancer|endometrial cancer
421993|NCT01770171|recurrent endometrial cancer|recurrent endometrial cancer
421994|NCT01770171|bevacizumab|bevacizumab
421995|NCT01770158|Acute myeloid leukemia (AML)|acute myeloid leukemia (aml)
421996|NCT01770158|Histamine Dihydrochloride|histamine dihydrochloride
421997|NCT01770158|Interleukin-2|interleukin-2
421998|NCT01770145|Motor symptoms|motor symptoms
421999|NCT01770145|Parkinson's Disease|parkinson's disease
422000|NCT01770145|Delayed Onset|delayed onset
422001|NCT01770145|Akinesia|akinesia
422002|NCT01770145|Hypomobility|hypomobility
422003|NCT01770145|Unified Parkinson Disease Rating Scale (UPDRS) motor scores|unified parkinson disease rating scale (updrs) motor scores
422004|NCT01770145|Dopamine agonist|dopamine agonist
422005|NCT01770145|Apomorphine|apomorphine
422006|NCT01770145|Apokyn|apokyn
422007|NCT01770145|Levodopa|levodopa
422008|NCT01770119|Measles|measles
422009|NCT01770119|Mumps|mumps
422010|NCT01770119|Rubella|rubella
422011|NCT01770119|Pediatric|pediatric
422012|NCT01770119|Solid-organ transplant|solid-organ transplant
422013|NCT01770119|serology|serology
422014|NCT01770119|vaccine|vaccine
422015|NCT01770106|Rheumatoid arthritis|rheumatoid arthritis
422016|NCT01770106|Bone density|bone density
422017|NCT01770106|Bone microarchitecture|bone microarchitecture
422018|NCT01770106|HR-pQCT|hr-pqct
422019|NCT01770067|Cardiac Resynchronization Therapy Devices|cardiac resynchronization therapy devices
422020|NCT01770054|metabolic syndrome|metabolic syndrome
422021|NCT01770054|diabetes mellitus|diabetes mellitus
422022|NCT01770028|Obesity|obesity
422023|NCT01770028|Pregnancy|pregnancy
422024|NCT01770028|Spouse|spouse
422025|NCT01770028|Weight loss|weight loss
422026|NCT01770028|Behavioral|behavioral
422027|NCT01770015|patient ventilated for at least five days|patient ventilated for at least five days
422028|NCT01769963|Advanced glycation end-products|advanced glycation end-products
422029|NCT01769963|chronic kidney disease|chronic kidney disease
422030|NCT01769963|nutrition|nutrition
422031|NCT01769963|inflammation|inflammation
422032|NCT01769963|insulin resistance|insulin resistance
422033|NCT01769963|endothelial function|endothelial function
422034|NCT01769950|Choline PET|choline pet
422035|NCT01769950|Choline PET-CT|choline pet-ct
422036|NCT01769950|Positron emission tomography|positron emission tomography
422037|NCT01769950|Prostate cancer|prostate cancer
422038|NCT01769937|Lupus|lupus
422040|NCT01769937|ACTH|acth
422041|NCT01769937|Acthar|acthar
422042|NCT01769924|Kidney donors|kidney donors
422043|NCT01769924|Arterial stiffness|arterial stiffness
422044|NCT01769924|Blood pressure|blood pressure
422045|NCT01769924|Nephrectomy|nephrectomy
422046|NCT01769898|Bronchiectasis|bronchiectasis
422047|NCT01769898|Theophylline|theophylline
422048|NCT01769898|Therapeutic Uses|therapeutic uses
422049|NCT01769898|HDAC|hdac
422051|NCT01769898|Random placebo study|random placebo study
422052|NCT01769898|ICS(inhaled corticosteroid)|ics(inhaled corticosteroid)
422053|NCT01769898|corticosteroid|corticosteroid
422054|NCT01769898|Inhaled corticosteroid|inhaled corticosteroid
422055|NCT01769859|Bipolar Disorder|bipolar disorder
422056|NCT01769859|Major Depressive Disorder|major depressive disorder
422057|NCT01769859|Genetics|genetics
422058|NCT01769833|HBsAg|hbsag
422059|NCT01769833|Chronic hepatitis B|chronic hepatitis b
422060|NCT01769833|PEGinterferon Alfa-2A|peginterferon alfa-2a
422061|NCT01769820|Heavy menstrual bleeding (HMB)|heavy menstrual bleeding (hmb)
422062|NCT01769820|Dexamethasone|dexamethasone
422063|NCT01769820|glucocorticoid|glucocorticoid
422064|NCT01769807|Sleep apnea|sleep apnea
422065|NCT01769807|CPAP treatment|cpap treatment
422066|NCT01769807|Plasma nitrate|plasma nitrate
422067|NCT01769807|Urinary norepinephrine|urinary norepinephrine
422068|NCT01769807|Blood pressure|blood pressure
422069|NCT01769794|Hand, Foot and Mouth Disease|hand, foot and mouth disease
422070|NCT01769794|Medicine, Chinese Traditional|medicine, chinese traditional
422071|NCT01769794|Enterovirus|enterovirus
422072|NCT01769794|Fever|fever
422073|NCT01769781|endometriosis recurrence|endometriosis recurrence
422074|NCT01769781|pelvic pain|pelvic pain
422075|NCT01769781|aromatase inhibitor|aromatase inhibitor
422076|NCT01769768|Adults, Hh (Hedgehog) pathway inhibitor, LDE225, Warfarin, Bupropion, advanced solid tumor, drug-drug interaction, pharmacokinetic|adults, hh (hedgehog) pathway inhibitor, lde225, warfarin, bupropion, advanced solid tumor, drug-drug interaction, pharmacokinetic
422077|NCT01769755|Crohn's disease|crohn's disease
422078|NCT01769755|Fistula|fistula
422079|NCT01769755|Diarrhea|diarrhea
422080|NCT01769755|Colon|colon
422081|NCT01769755|Stem cells|stem cells
422082|NCT01769742|Pneumonia|pneumonia
422083|NCT01769742|promotion of activity|promotion of activity
422084|NCT01769729|integrated primary care|integrated primary care
422085|NCT01769729|depression|depression
422086|NCT01769729|chronic low back pain|chronic low back pain
422087|NCT01769716|Global developmental delay|global developmental delay
422088|NCT01769716|Umbilical cord blood|umbilical cord blood
422089|NCT01769716|Rehabilitation|rehabilitation
422090|NCT01769690|PD|pd
422091|NCT01769690|Parkinson's Disease|parkinson's disease
422092|NCT01769690|DBS|dbs
422093|NCT01769690|deep brain stimulation|deep brain stimulation
422094|NCT01769677|Bioequivalence|bioequivalence
422095|NCT01769677|Hydrocodone bitartrate extended-release tablets|hydrocodone bitartrate extended-release tablets
422096|NCT01769664|Acne vulgaris|acne vulgaris
422097|NCT01769664|Clindamycin 1%/Benzoyl Peroxide 5% Topical Gel|clindamycin 1%/benzoyl peroxide 5% topical gel
422098|NCT01769664|Duac® Topical Gel|duac® topical gel
422099|NCT01769651|drug user patients|drug user patients
422100|NCT01769651|addiction nurses|addiction nurses
422101|NCT01769651|overdose risk|overdose risk
422102|NCT01769638|Orally disintegrating Film|orally disintegrating film
422103|NCT01769638|Film Coated Tablet|film coated tablet
422104|NCT01769638|Sildenafil|sildenafil
422105|NCT01769638|Pharmacokinetics|pharmacokinetics
422106|NCT01769625|breast|breast
422107|NCT01769625|high risk women|high risk women
422108|NCT01769625|biomarkers|biomarkers
422109|NCT01769625|vitamin D|vitamin d
422110|NCT01769612|Leishmaniasis, Leishmania|leishmaniasis, leishmania
422111|NCT01769586|Sedation|sedation
422112|NCT01769586|Endoscopy|endoscopy
422113|NCT01769586|Diphenhydramine|diphenhydramine
422114|NCT01769586|Midazolam|midazolam
422115|NCT01769573|normal|normal
422116|NCT01769560|tailored intervention|tailored intervention
422117|NCT01769560|college aged students|college aged students
422118|NCT01769560|HPV|hpv
422119|NCT01769521|Glaucoma|glaucoma
422120|NCT01769521|IOP|iop
422121|NCT01769521|Blood pressure|blood pressure
422122|NCT01769521|ECG|ecg
422123|NCT01769508|Esophagogastric Adenocarcinoma|esophagogastric adenocarcinoma
422124|NCT01769508|5-Fluorouracil|5-fluorouracil
422125|NCT01769508|Oxaliplatin|oxaliplatin
422126|NCT01769508|Lapatinib|lapatinib
422127|NCT01769508|Radiation Therapy|radiation therapy
422128|NCT01769508|Surgery|surgery
422129|NCT01769495|Emergency department, Geriatrics, mortality, readmission rates.|emergency department, geriatrics, mortality, readmission rates.
422130|NCT01769495|Patients 75 years of age and older.|patients 75 years of age and older.
422131|NCT01769482|microvascular angina|microvascular angina
422132|NCT01769482|PDE-5 inhibitors|pde-5 inhibitors
422133|NCT01769482|Heart disease|heart disease
422134|NCT01769482|Ischemia|ischemia
422135|NCT01769482|Cardiac MRI|cardiac mri
422136|NCT01769469|Tenofovir|tenofovir
422137|NCT01769469|Emtricitabine|emtricitabine
422138|NCT01769469|Truvada|truvada
422139|NCT01769469|Renal, endocrine, bone changes|renal, endocrine, bone changes
422140|NCT01769469|HIV prevention|hiv prevention
422141|NCT01769469|PrEP|prep
422142|NCT01769456|HIV, PrEP, FTC/TDF, Truvada®|hiv, prep, ftc/tdf, truvada®
422143|NCT01769443|desensitization therapy|desensitization therapy
422144|NCT01769443|bortezomib (VELCADE®)|bortezomib (velcade®)
422145|NCT01769443|plasmapheresis|plasmapheresis
422146|NCT01769430|influenza virus|influenza virus
422147|NCT01769430|aerosol transmission|aerosol transmission
422148|NCT01769430|contact transmission|contact transmission
422149|NCT01769430|large droplet transmission|large droplet transmission
422150|NCT01769430|airborne infection|airborne infection
422151|NCT01769391|NSCLC|nsclc
422152|NCT01769365|Helicobacter pylori infection|helicobacter pylori infection
422153|NCT01769352|cystoid macular edema|cystoid macular edema
422154|NCT01769339|Vulvar Candidiasis|vulvar candidiasis
422155|NCT01769339|Miconazole|miconazole
422156|NCT01769339|Hydrocortisone|hydrocortisone
422157|NCT01769339|Daktacort Feminine Care Cream|daktacort feminine care cream
422158|NCT01769326|Stroke|stroke
422159|NCT01769313|Cataract|cataract
422160|NCT01769313|Laser-assisted|laser-assisted
422161|NCT01769313|Femtosecond|femtosecond
422162|NCT01769300|Clinical decision support|clinical decision support
422163|NCT01769300|Electronic health records|electronic health records
422164|NCT01769300|Electronic medical records|electronic medical records
422165|NCT01769300|Attention deficit-hyperactivity disorder|attention deficit-hyperactivity disorder
422166|NCT01769300|Primary care Pediatric research network|primary care pediatric research network
422167|NCT01769287|Atrial fibrillation|atrial fibrillation
422168|NCT01769287|Electrophysiological Assessment|electrophysiological assessment
422169|NCT01769287|12 months post-operatively|12 months post-operatively
422170|NCT01769287|High Intensity Ultrasound|high intensity ultrasound
422171|NCT01769261|quality of health care|quality of health care
422172|NCT01769261|continuity of patient care|continuity of patient care
422173|NCT01769261|adverse effects|adverse effects
422174|NCT01769261|outcome and process assessment (health care)|outcome and process assessment (health care)
422175|NCT01769248|EUS|eus
422176|NCT01769248|FNA|fna
422177|NCT01769248|FNB|fnb
422178|NCT01769235|Acne Vulgaris|acne vulgaris
422179|NCT01769235|Clindamycin Phosphate and Benzoyl Peroxide Gel|clindamycin phosphate and benzoyl peroxide gel
422180|NCT01769235|Acanya® Gel|acanya® gel
422181|NCT01769196|Idiopathic|idiopathic
422182|NCT01769196|Pulmonary|pulmonary
422183|NCT01769196|Fibrosis|fibrosis
422184|NCT01769196|IPF|ipf
422185|NCT01769183|Proliferative Diabetic Retinopathy|proliferative diabetic retinopathy
422186|NCT01769170|CMV|cmv
422187|NCT01769170|Hematopoietic Stem Cell Transplant Recipients|hematopoietic stem cell transplant recipients
422188|NCT01769170|CMV seropositive|cmv seropositive
422189|NCT01769144|wound healing|wound healing
422190|NCT01769144|wound infection|wound infection
422191|NCT01769144|pain|pain
422192|NCT01769144|pruritus|pruritus
422193|NCT01769144|cicatrix|cicatrix
422194|NCT01769144|dressings|dressings
422195|NCT01769144|acticoat absorbent|acticoat absorbent
422197|NCT01769144|KoCarbonAg|kocarbonag
422198|NCT01769131|cervix|cervix
422199|NCT01769131|Allis|allis
422200|NCT01769131|Tenaculum|tenaculum
422201|NCT01769131|gynecology|gynecology
422202|NCT01769118|Autonomic nervous system|autonomic nervous system
422203|NCT01769105|Meibomian Gland Dysfunction|meibomian gland dysfunction
422204|NCT01769105|Lipiflow|lipiflow
422205|NCT01769092|Epilepsy|epilepsy
422206|NCT01769092|Seizure|seizure
422207|NCT01769092|Fish Oil|fish oil
422208|NCT01769053|Acute Lung Injury|acute lung injury
422209|NCT01769053|Adult Respiratory Distress Syndrome|adult respiratory distress syndrome
422210|NCT01769053|Interactive Ventilatory Support|interactive ventilatory support
422211|NCT01769053|Positive-Pressure Respiration|positive-pressure respiration
422212|NCT01769053|Ventilator-Induced Lung Injury|ventilator-induced lung injury
422213|NCT01769040|Decompensated liver cirrhosis|decompensated liver cirrhosis
422214|NCT01769040|Ascites|ascites
422215|NCT01769040|Haemodynamics|haemodynamics
422216|NCT01769040|Small intestinal bacterial overgrowth|small intestinal bacterial overgrowth
422217|NCT01769040|Pathophysiology|pathophysiology
422218|NCT01769014|adherence|adherence
422219|NCT01769001|Fabry disease|fabry disease
422220|NCT01769001|Alpha galactosidase deficiency|alpha galactosidase deficiency
422221|NCT01769001|Metabolic storage disease|metabolic storage disease
422222|NCT01768975|Knee|knee
422223|NCT01768975|Osteoarthritis|osteoarthritis
422224|NCT01768975|OA|oa
422225|NCT01768975|Knee pain|knee pain
422226|NCT01768975|Moderate pain|moderate pain
422227|NCT01768975|Severe pain|severe pain
422228|NCT01768975|Inflammation|inflammation
422229|NCT01768975|Safety|safety
422230|NCT01768975|Efficacy|efficacy
422231|NCT01768975|Randomized|randomized
422232|NCT01768975|Topical|topical
422233|NCT01768975|Gel|gel
422234|NCT01768975|Olatec|olatec
422235|NCT01768975|OLT1177|olt1177
422236|NCT01768975|Joint Diseases|joint diseases
422237|NCT01768975|Musculoskeletal Diseases|musculoskeletal diseases
422238|NCT01768975|Rheumatic Diseases|rheumatic diseases
422239|NCT01768975|Arthritis|arthritis
422240|NCT01768975|Therapeutic|therapeutic
422241|NCT01768975|Analgesic|analgesic
422242|NCT01768962|Microbicides|microbicides
422243|NCT01768962|Tenofovir|tenofovir
422244|NCT01768962|Reduced-glycerin|reduced-glycerin
422245|NCT01768962|Vaginal use|vaginal use
422246|NCT01768962|Rectal use|rectal use
422247|NCT01768962|Pharmacokinetics|pharmacokinetics
422248|NCT01768949|Acute respiratory distress syndrome|acute respiratory distress syndrome
422249|NCT01768949|Echocardiography|echocardiography
539708|NCT01265979|stromal|stromal
422250|NCT01768949|Recruitment maneuver|recruitment maneuver
422251|NCT01768936|on-demand relaparotomy|on-demand relaparotomy
422252|NCT01768936|PCT|pct
422253|NCT01768936|procalcitonin|procalcitonin
422254|NCT01768936|peritonitis|peritonitis
422255|NCT01768936|sepsis|sepsis
422256|NCT01768936|focus index|focus index
422257|NCT01768923|Early Rheumatoid Arthritis|early rheumatoid arthritis
422258|NCT01768923|Arterial stiffness|arterial stiffness
422259|NCT01768923|SDAI remission group|sdai remission group
422260|NCT01768923|Minimal disease activity remission group|minimal disease activity remission group
422261|NCT01768910|lower urinary tract|lower urinary tract
422262|NCT01768910|bladder|bladder
422263|NCT01768910|supraspinal control|supraspinal control
422264|NCT01768910|neuroimaging|neuroimaging
422265|NCT01768910|functional magnetic resonance imaging|functional magnetic resonance imaging
422266|NCT01768910|diffusion tensor imaging|diffusion tensor imaging
422267|NCT01768910|functional connectivity|functional connectivity
422268|NCT01768910|neurogenic lower urinary tract dysfunction|neurogenic lower urinary tract dysfunction
422269|NCT01768910|overactive bladder|overactive bladder
422270|NCT01768910|multiple sclerosis|multiple sclerosis
422271|NCT01768910|spinal cord injury|spinal cord injury
422272|NCT01768884|Infants|infants
422273|NCT01768884|Bronchiolitis|bronchiolitis
422274|NCT01768884|NO|no
422275|NCT01768884|inhalation|inhalation
422276|NCT01768858|Arthritis|arthritis
422277|NCT01768858|Morbus Crohn|morbus crohn
422278|NCT01768858|Adherence|adherence
422279|NCT01768858|Spondylitis|spondylitis
422280|NCT01768858|Ulcerative colitis|ulcerative colitis
422281|NCT01768858|Monoclonals|monoclonals
422282|NCT01768858|Rheumatoid|rheumatoid
422283|NCT01768858|Antibodies|antibodies
422284|NCT01768858|Ankylosing|ankylosing
422285|NCT01768858|Plaque psoriasis|plaque psoriasis
422286|NCT01768858|Psoriatic|psoriatic
422287|NCT01768858|Crohn´s disease|crohn´s disease
422288|NCT01768858|Antirheumatic Agents|antirheumatic agents
422289|NCT01768845|Chronic myelogenous leukemia (CML)|chronic myelogenous leukemia (cml)
422290|NCT01768845|Acute myelogenous leukemia (AML)|acute myelogenous leukemia (aml)
422291|NCT01768845|Myelodysplastic syndrome|myelodysplastic syndrome
422292|NCT01768845|Multiple myeloma|multiple myeloma
422293|NCT01768845|Hodgkin lymphoma|hodgkin lymphoma
422294|NCT01768845|Non Hodgkin lymphoma|non hodgkin lymphoma
422295|NCT01768845|Chronic lymphocytic leukemia (CLL)|chronic lymphocytic leukemia (cll)
422296|NCT01768845|Acute lymphocytic leukemia (ALL)|acute lymphocytic leukemia (all)
422297|NCT01768845|Severe Aplastic Anemia|severe aplastic anemia
422298|NCT01768845|Cord Blood|cord blood
422299|NCT01768845|Umbilical cord blood transplantation|umbilical cord blood transplantation
422300|NCT01768845|UBC transplantation|ubc transplantation
422301|NCT01768832|Parkinson disease|parkinson disease
422302|NCT01768832|walking|walking
422303|NCT01768832|fMRI|fmri
422304|NCT01768832|exercise|exercise
422305|NCT01768832|dance|dance
422306|NCT01768832|treadmill|treadmill
422307|NCT01768819|aging|aging
422308|NCT01768819|exercise|exercise
422309|NCT01768819|muscle strength|muscle strength
422310|NCT01768819|physical activity|physical activity
422311|NCT01768806|Autism|autism
422312|NCT01768806|Autism Spectrum Disorder|autism spectrum disorder
422313|NCT01768806|PLAY and Language for Autistic Youngsters|play and language for autistic youngsters
422314|NCT01768806|Intensive Early Intervention|intensive early intervention
422315|NCT01768806|Parent Training|parent training
422316|NCT01768793|Obesity|obesity
422317|NCT01768793|Pregnancy|pregnancy
422318|NCT01768793|Body Weight Changes|body weight changes
422319|NCT01768793|Diet Therapy|diet therapy
422320|NCT01768780|spinal anesthesia|spinal anesthesia
422321|NCT01768780|peripheral nerve stimulator|peripheral nerve stimulator
422322|NCT01768780|sensory block level|sensory block level
422323|NCT01768754|Exercise testing|exercise testing
422324|NCT01768754|Functional status|functional status
422325|NCT01768754|Pulmonary rehabilitation|pulmonary rehabilitation
422326|NCT01768741|hepatocellular carcinoma|hepatocellular carcinoma
422327|NCT01768715|Alcoholic hepatitis|alcoholic hepatitis
422328|NCT01768715|Liver transplantation|liver transplantation
422329|NCT01768715|Survival|survival
422330|NCT01768715|Alcoholism|alcoholism
422331|NCT01768702|Chronic Heart Failure of Ischemic Origin|chronic heart failure of ischemic origin
422332|NCT01768689|adherence|adherence
422333|NCT01768689|chronic myeloid leukemia|chronic myeloid leukemia
422334|NCT01768689|tyrosine kinase inhibitors|tyrosine kinase inhibitors
422335|NCT01768676|healthy male|healthy male
422336|NCT01768650|traumatic brain injury|traumatic brain injury
422337|NCT01768650|chronic pain|chronic pain
422338|NCT01768650|headache|headache
422339|NCT01768650|Veteran|veteran
422340|NCT01768637|Chronic kidney disease|chronic kidney disease
422341|NCT01768637|Platelet function|platelet function
422342|NCT01768637|aspirin|aspirin
422343|NCT01768637|antiplatelet agent|antiplatelet agent
422344|NCT01768624|chronic kidney disease|chronic kidney disease
422345|NCT01768624|dialysis|dialysis
422346|NCT01768624|pre dialysis education|pre dialysis education
422347|NCT01768624|transplantation|transplantation
422348|NCT01768624|conservative care|conservative care
422349|NCT01768598|Wrist Fracture|wrist fracture
422350|NCT01768598|Adolescents|adolescents
422351|NCT01768598|Risk Taking Behaviour|risk taking behaviour
422352|NCT01768598|Bone Microstructure|bone microstructure
422353|NCT01768546|Diabetes Prevention Program|diabetes prevention program
422354|NCT01768546|obesity|obesity
422355|NCT01768546|activity|activity
422356|NCT01768546|diabetes|diabetes
422357|NCT01768533|pediatric|pediatric
422358|NCT01768533|obesity|obesity
422359|NCT01768533|prevention|prevention
422360|NCT01768533|health behaviors|health behaviors
422361|NCT01768533|guidelines|guidelines
422362|NCT01768481|Obesity|obesity
422363|NCT01768481|Dyslipidemia|dyslipidemia
422364|NCT01768481|Cholesterol|cholesterol
422365|NCT01768481|Intima media thickness|intima media thickness
422366|NCT01768468|LAYLA|layla
422367|NCT01768468|Non-inferiority|non-inferiority
422368|NCT01768468|100mm pain VAS|100mm pain vas
422369|NCT01768442|Head and neck cancer|head and neck cancer
422370|NCT01768403|Hypercholesterolemia|hypercholesterolemia
422371|NCT01768403|Cardiovascular disease|cardiovascular disease
422372|NCT01768403|Hypertension|hypertension
422373|NCT01768403|Coronary Heart disease|coronary heart disease
422374|NCT01768403|Peripheral Arterial disease|peripheral arterial disease
422375|NCT01768390|caries|caries
422376|NCT01768390|prevention|prevention
422377|NCT01768390|orthodontics|orthodontics
422378|NCT01768390|fixed appliances|fixed appliances
422379|NCT01768390|adolescents|adolescents
422380|NCT01768377|Awake intubation|awake intubation
422381|NCT01768377|Nerve block|nerve block
422382|NCT01768377|Sedation|sedation
422383|NCT01768377|Physician satisfaction|physician satisfaction
422384|NCT01768351|anemia|anemia
422385|NCT01768351|chronic kidney disease|chronic kidney disease
422386|NCT01768351|vitamin D|vitamin d
422387|NCT01768351|paricalcitol|paricalcitol
422388|NCT01768351|hyperparathyroidism|hyperparathyroidism
422389|NCT01768325|ProCore Needle|procore needle
422390|NCT01768299|abortion|abortion
422391|NCT01768299|medical abortion|medical abortion
422392|NCT01768299|mifepristone|mifepristone
422393|NCT01768299|misoprostol|misoprostol
422394|NCT01768286|HCV genotype 1 (GT-1)|hcv genotype 1 (gt-1)
422395|NCT01768286|HCV|hcv
422396|NCT01768286|Sustained Virologic Response|sustained virologic response
422397|NCT01768286|Direct Acting Antiviral|direct acting antiviral
422398|NCT01768286|Combination Therapy|combination therapy
422399|NCT01768286|GS-7977|gs-7977
422400|NCT01768286|GS-5885|gs-5885
422401|NCT01768286|Ribavirin|ribavirin
422402|NCT01768286|Open Label|open label
422403|NCT01768286|Sofosbuvir|sofosbuvir
422404|NCT01768286|Additional relevant MeSH terms:|additional relevant mesh terms:
422405|NCT01768286|Hepatitis|hepatitis
422406|NCT01768286|Hepatitis, Chronic|hepatitis, chronic
422407|NCT01768286|Hepatitis C|hepatitis c
422408|NCT01768286|Hepatitis C, Chronic|hepatitis c, chronic
422409|NCT01768286|Liver Diseases|liver diseases
422410|NCT01768286|Digestive System Diseases|digestive system diseases
422411|NCT01768286|Hepatitis, Viral, Human|hepatitis, viral, human
422412|NCT01768286|Virus Diseases|virus diseases
422413|NCT01768286|Enterovirus Infections|enterovirus infections
422414|NCT01768286|Picornaviridae Infections|picornaviridae infections
422415|NCT01768286|RNA Virus Infections|rna virus infections
422416|NCT01768286|Flaviviridae Infections|flaviviridae infections
422417|NCT01768286|Antiviral Agents|antiviral agents
422418|NCT01768286|Anti-Infective Agents|anti-infective agents
422419|NCT01768286|Therapeutic Uses|therapeutic uses
422420|NCT01768286|Pharmacologic Actions|pharmacologic actions
422421|NCT01768286|Antimetabolites|antimetabolites
422422|NCT01768286|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action
422423|NCT01768273|PA-824,|pa-824,
422424|NCT01768273|midazolam|midazolam
422425|NCT01768273|drug-drug interaction|drug-drug interaction
422426|NCT01768273|pharmacokinetics|pharmacokinetics
422427|NCT01768273|pretomanid|pretomanid
422428|NCT01768273|CL-006|cl-006
422429|NCT01768260|visual acuity|visual acuity
422430|NCT01768260|artery flow velocity|artery flow velocity
422431|NCT01768260|Enhanced External Counterpulsation|enhanced external counterpulsation
422432|NCT01768260|Ischemic|ischemic
422433|NCT01768260|Optic Neuropathy|optic neuropathy
422434|NCT01768247|endometrium|endometrium
422435|NCT01768247|thickness|thickness
422436|NCT01768247|pregnancy|pregnancy
422437|NCT01768247|HCG|hcg
422438|NCT01768247|frozen cycles|frozen cycles
422439|NCT01768234|cognition|cognition
422440|NCT01768234|hydration|hydration
422441|NCT01768234|schoolchildren|schoolchildren
422442|NCT01768221|Palliative Care|palliative care
422443|NCT01768221|Caregiver Outlook|caregiver outlook
422444|NCT01768195|Lymphoma|lymphoma
422445|NCT01768195|Hepatitis B Virus|hepatitis b virus
422446|NCT01768195|Therapeutic Uses|therapeutic uses
422447|NCT01768195|Antiviral Agents|antiviral agents
422448|NCT01768195|rituximab|rituximab
422449|NCT01768182|folic acid; folates; Vascular Reactivity; HIV|folic acid; folates; vascular reactivity; hiv
422450|NCT01768169|metabolic syndrome,|metabolic syndrome,
422451|NCT01768169|waist, blood pressure,|waist, blood pressure,
422452|NCT01768169|fasting plasma glucose,|fasting plasma glucose,
422453|NCT01768169|HDL cholesterol,|hdl cholesterol,
422454|NCT01768169|triglycerides|triglycerides
422455|NCT01768156|ovarian cancer|ovarian cancer
422456|NCT01768156|biomarker|biomarker
422457|NCT01768156|metastatic|metastatic
422458|NCT01768143|Propofol|propofol
422459|NCT01768143|Sedation|sedation
422460|NCT01768143|Endoscopy|endoscopy
422461|NCT01768143|nonanesthesiologist|nonanesthesiologist
422462|NCT01768104|upper gastrointestinal submucosal tumors|upper gastrointestinal submucosal tumors
422463|NCT01768104|SMTs|smts
422464|NCT01768104|Gastrointestinal stromal tumors|gastrointestinal stromal tumors
422465|NCT01768104|GISTs|gists
422466|NCT01768104|Leiomyoma|leiomyoma
422467|NCT01768104|Endoscopic submucosal tunnel dissection|endoscopic submucosal tunnel dissection
422468|NCT01768104|ESTD|estd
422469|NCT01768104|Submucosal tunneling endoscopic resection|submucosal tunneling endoscopic resection
422470|NCT01768104|STER|ster
422471|NCT01768104|Submucosal endoscopic tumor resection|submucosal endoscopic tumor resection
422472|NCT01768104|SET|set
422473|NCT01768091|Esophageal achalasia|esophageal achalasia
422474|NCT01768091|Peroral endoscopic myotomy|peroral endoscopic myotomy
422475|NCT01768091|POEM|poem
422476|NCT01768091|Pneumatic dilation|pneumatic dilation
422477|NCT01768065|NEPAP|nepap
422478|NCT01768065|CPAP|cpap
422479|NCT01768065|alternative|alternative
422480|NCT01768065|OSAS|osas
422481|NCT01768052|MDD, major depression, treatment-resistant|mdd, major depression, treatment-resistant
422482|NCT01768039|Multiple sclerosis|multiple sclerosis
422483|NCT01768039|Vitamin D|vitamin d
422484|NCT01768039|EDSS|edss
422485|NCT01768039|ARR|arr
422486|NCT01768026|Dystrophic Epidermolysis Bullosa|dystrophic epidermolysis bullosa
422487|NCT01768026|Type VII Collagen|type vii collagen
422488|NCT01768026|QOL Evaluation in Epidermolysis Bullosa|qol evaluation in epidermolysis bullosa
422489|NCT01768026|Instrument for Scoring Clinical Outcomes for Research of Epidermolysis Bullosa|instrument for scoring clinical outcomes for research of epidermolysis bullosa
422490|NCT01768026|Birmingham Epidermolysis Bullosa Severity Score|birmingham epidermolysis bullosa severity score
422491|NCT01768000|Psychosis|psychosis
422492|NCT01768000|Psychosis NOS|psychosis nos
422493|NCT01768000|Schizophrenia|schizophrenia
422494|NCT01768000|Schizoaffective Disorder|schizoaffective disorder
422699|NCT01767142|Lipolysis|lipolysis
422495|NCT01768000|Bipolar Disorder|bipolar disorder
422496|NCT01767987|Acute Coronary Syndrome|acute coronary syndrome
422498|NCT01767987|Percutaneous Coronary Intervention|percutaneous coronary intervention
422499|NCT01767987|PCI|pci
422500|NCT01767987|Ranolazine|ranolazine
422501|NCT01767987|Coronary Angiogram|coronary angiogram
422502|NCT01767987|Cardioprotectant|cardioprotectant
422503|NCT01767974|Non-Small Cell lung cancer|non-small cell lung cancer
422504|NCT01767948|Hepatic Impairment|hepatic impairment
422505|NCT01767948|PCI 32765|pci 32765
422506|NCT01767948|Metabolite PCI-45227|metabolite pci-45227
422507|NCT01767948|Pharmacokinetics|pharmacokinetics
422508|NCT01767922|Super-Oxyd-Dismutase|super-oxyd-dismutase
422509|NCT01767922|SOD|sod
422510|NCT01767922|melon juce|melon juce
422511|NCT01767922|perceived stress|perceived stress
422512|NCT01767909|Intranasal insulin|intranasal insulin
422513|NCT01767909|Alzheimer's disease|alzheimer's disease
422514|NCT01767909|Amnestic mild cognitive impairment|amnestic mild cognitive impairment
422515|NCT01767909|Dementia|dementia
422516|NCT01767909|Brain diseases|brain diseases
422517|NCT01767909|Memory problems|memory problems
422518|NCT01767909|Mental disorders|mental disorders
422519|NCT01767909|Cognitive disorders|cognitive disorders
422520|NCT01767896|Influenza vaccine|influenza vaccine
422521|NCT01767883|Chronic Kidney Disease|chronic kidney disease
422522|NCT01767883|CKD|ckd
422523|NCT01767883|TRANSLATE|translate
422524|NCT01767883|Practice Facilitation|practice facilitation
422525|NCT01767883|Practice-based research|practice-based research
422526|NCT01767883|CKD Guidelines|ckd guidelines
422527|NCT01767870|advanced colorectal adenoma|advanced colorectal adenoma
422528|NCT01767870|colonoscopy|colonoscopy
422529|NCT01767870|sigmoidoscopy|sigmoidoscopy
422530|NCT01767870|fecal immunochemical test|fecal immunochemical test
422531|NCT01767857|Pivotal|pivotal
422532|NCT01767857|Colorectal|colorectal
422533|NCT01767857|Survival|survival
422534|NCT01767857|Phase 3|phase 3
422535|NCT01767844|Rheumatoid Arthritis|rheumatoid arthritis
422536|NCT01767844|Arthritis|arthritis
422537|NCT01767844|Rheumatology|rheumatology
422538|NCT01767844|Creatine|creatine
422539|NCT01767831|Type 1 Diabetes Mellitus (T1DM)|type 1 diabetes mellitus (t1dm)
422540|NCT01767831|Continuous Glucose Monitor (CGM)|continuous glucose monitor (cgm)
422541|NCT01767831|Simulation-based Education|simulation-based education
422542|NCT01767818|Parkinson's Disease|parkinson's disease
422543|NCT01767792|Neurofibromatosis Type 2|neurofibromatosis type 2
422544|NCT01767792|Progressive Vestibular Schwannomas|progressive vestibular schwannomas
422545|NCT01767779|Epilepsy|epilepsy
422546|NCT01767779|TSC|tsc
422547|NCT01767779|Tuberous Sclerosis Complex|tuberous sclerosis complex
422548|NCT01767779|Infants|infants
422549|NCT01767779|Seizures|seizures
422550|NCT01767779|Biomarkers|biomarkers
422551|NCT01767779|EEG|eeg
422552|NCT01767753|Glaucoma|glaucoma
422553|NCT01767753|SLT|slt
422554|NCT01767740|Rotator Cuff Tear|rotator cuff tear
422555|NCT01767740|Supraspinatus Tear|supraspinatus tear
422556|NCT01767727|surgical flap;|surgical flap;
422557|NCT01767727|dorsal branch of the digital artery|dorsal branch of the digital artery
422558|NCT01767714|hematopoietic stem cell transplantation|hematopoietic stem cell transplantation
422559|NCT01767701|raltegravir|raltegravir
422560|NCT01767701|MS|ms
422561|NCT01767701|RRMS|rrms
422562|NCT01767701|Charcot Project|charcot project
422563|NCT01767688|Diabetes Mellitus|diabetes mellitus
422564|NCT01767688|Diabetes Mellitus, Type 2|diabetes mellitus, type 2
422565|NCT01767688|Glucose Metabolism Disorders|glucose metabolism disorders
422566|NCT01767688|Metabolic Diseases|metabolic diseases
422567|NCT01767688|Endocrine System Diseases|endocrine system diseases
422568|NCT01767675|Secondary Cytoreductive Surgery|secondary cytoreductive surgery
422569|NCT01767675|Carboplatin|carboplatin
422570|NCT01767675|Hyperthermic Intraperitoneal Chemotherapy (HIPEC)|hyperthermic intraperitoneal chemotherapy (hipec)
422571|NCT01767675|12-275|12-275
422572|NCT01767662|TCV|tcv
422573|NCT01767649|Pregnancy|pregnancy
422574|NCT01767649|Remodelling|remodelling
422575|NCT01767649|Extracellular matrix|extracellular matrix
422576|NCT01767649|Biomarkers|biomarkers
422577|NCT01767597|rapid test|rapid test
422578|NCT01767597|screening|screening
422579|NCT01767597|ELISA|elisa
422580|NCT01767597|hepatitis B virus|hepatitis b virus
422581|NCT01767597|access to care|access to care
422582|NCT01767584|Pharmacokinetics|pharmacokinetics
422583|NCT01767584|Bioequivalence|bioequivalence
422584|NCT01767584|Mexico|mexico
422585|NCT01767584|Cephalexin|cephalexin
422586|NCT01767571|Mexico|mexico
422587|NCT01767571|Respiratory infections|respiratory infections
422588|NCT01767571|Bioequivalence|bioequivalence
422589|NCT01767571|Cepphalexin|cepphalexin
422590|NCT01767532|Cephalexin|cephalexin
422591|NCT01767532|Respiratory infections|respiratory infections
422592|NCT01767532|Mexico|mexico
422593|NCT01767532|Bioequivalence|bioequivalence
422594|NCT01767506|Trachoma|trachoma
422595|NCT01767506|Azithromycin|azithromycin
422596|NCT01767506|Mass treatment|mass treatment
422597|NCT01767493|Multiple sclerosis|multiple sclerosis
422598|NCT01767480|Intensive Robot Assisted Therapy|intensive robot assisted therapy
422599|NCT01767480|Subacute Stroke|subacute stroke
422600|NCT01767480|Brain Reorganization|brain reorganization
422601|NCT01767480|Sensory Motor|sensory motor
422602|NCT01767480|Physiological Marker|physiological marker
422603|NCT01767467|Immunogenicity|immunogenicity
422604|NCT01767467|Safety|safety
422605|NCT01767467|Herpes zoster|herpes zoster
422606|NCT01767467|Vaccination|vaccination
422607|NCT01767467|Haematologic malignancies|haematologic malignancies
422608|NCT01767454|BRAF V600E|braf v600e
422609|NCT01767454|Melanoma|melanoma
422610|NCT01767454|V600K|v600k
422611|NCT01767454|Trametinib|trametinib
422612|NCT01767454|Dabrafenib|dabrafenib
422613|NCT01767454|Ipilimumab|ipilimumab
422614|NCT01767441|bariatric surgery|bariatric surgery
422615|NCT01767441|gastric bypass|gastric bypass
422616|NCT01767441|gastric banding|gastric banding
422617|NCT01767441|sleeve gastrectomy|sleeve gastrectomy
422618|NCT01767441|weight loss|weight loss
422619|NCT01767441|Type 2 Diabetes mellitus|type 2 diabetes mellitus
422620|NCT01767441|GLP1|glp1
422621|NCT01767441|obesity|obesity
422622|NCT01767441|mixed meal test|mixed meal test
422623|NCT01767415|brain tumor|brain tumor
422624|NCT01767415|resection|resection
422625|NCT01767415|indigo carmine dye|indigo carmine dye
422626|NCT01767402|Safety|safety
422627|NCT01767402|Pneumococcal Infections|pneumococcal infections
422628|NCT01767402|Immunogenicity|immunogenicity
422629|NCT01767402|PhtD vaccine|phtd vaccine
422630|NCT01767402|Healthy adults|healthy adults
422631|NCT01767402|Reactogenicity|reactogenicity
422632|NCT01767389|utilization|utilization
422633|NCT01767389|acute pancreatitis|acute pancreatitis
422634|NCT01767389|Exenatide|exenatide
422635|NCT01767389|DPP-4 inhibitors|dpp-4 inhibitors
422636|NCT01767389|liraglutide|liraglutide
422637|NCT01767389|GLP-1 receptor agonist|glp-1 receptor agonist
422638|NCT01767389|adherence|adherence
422639|NCT01767376|Young adults|young adults
422640|NCT01767376|Adolescents|adolescents
422641|NCT01767376|Reactogenicity|reactogenicity
422642|NCT01767376|Diphtheria|diphtheria
422643|NCT01767376|pertussis|pertussis
422644|NCT01767376|Immunogenicity|immunogenicity
422645|NCT01767376|Tetanus|tetanus
422646|NCT01767376|Meningococcal vaccines|meningococcal vaccines
540210|NCT01263600|HBV|hbv
422647|NCT01767376|Safety|safety
422648|NCT01767376|Neisseria meningitidis|neisseria meningitidis
422649|NCT01767376|Healthy|healthy
422650|NCT01767363|5-alpha reductase inhibitor|5-alpha reductase inhibitor
422651|NCT01767363|benign prostatic hyperplasia treatment|benign prostatic hyperplasia treatment
422652|NCT01767363|Prostate cancer mortality|prostate cancer mortality
422653|NCT01767350|Pediatric transplantation|pediatric transplantation
422654|NCT01767350|Pharmacogenetics|pharmacogenetics
422655|NCT01767350|Pharmacokinetics|pharmacokinetics
422656|NCT01767350|Calcineurin inhibitors|calcineurin inhibitors
422657|NCT01767350|CYP3A|cyp3a
422658|NCT01767350|Pgp|pgp
422659|NCT01767337|microneedle-based delivery|microneedle-based delivery
422660|NCT01767337|hollow microneedle|hollow microneedle
422661|NCT01767337|intracutaneous|intracutaneous
422662|NCT01767337|drug delivery|drug delivery
422663|NCT01767324|microneedle-based array|microneedle-based array
422664|NCT01767324|hollow microneedle|hollow microneedle
422665|NCT01767324|intracutaneous|intracutaneous
422666|NCT01767324|drug delivery|drug delivery
422667|NCT01767324|vaccine delivery|vaccine delivery
422668|NCT01767311|Alzheimer's Disease|alzheimer's disease
422669|NCT01767311|BAN2401|ban2401
422670|NCT01767298|Fixed dose combination|fixed dose combination
422671|NCT01767298|Pharmacokinetics|pharmacokinetics
422672|NCT01767298|Valsartan|valsartan
422673|NCT01767298|Hydrochlorothiazide|hydrochlorothiazide
422674|NCT01767285|Etonogestrel Implant|etonogestrel implant
422675|NCT01767285|Implanon|implanon
422676|NCT01767285|Nexplanon|nexplanon
422677|NCT01767285|Long Acting Reversible Contraception|long acting reversible contraception
422678|NCT01767272|Fexofenadine|fexofenadine
422679|NCT01767272|Pharmacokinetics|pharmacokinetics
422680|NCT01767272|Bioavailability|bioavailability
422681|NCT01767272|Linearity|linearity
422682|NCT01767272|HPLC|hplc
422683|NCT01767272|Dose proportionality of fexofenadine in Egyptian volunteers|dose proportionality of fexofenadine in egyptian volunteers
422684|NCT01767259|Fixed dose combination|fixed dose combination
422685|NCT01767259|Pharmacokinetics|pharmacokinetics
422686|NCT01767259|Valsartan|valsartan
422687|NCT01767259|Hydrochlorothiazide|hydrochlorothiazide
422688|NCT01767233|Acute necrotizing pancreatitis|acute necrotizing pancreatitis
422689|NCT01767233|ERCP|ercp
422690|NCT01767233|Pancreatic stenting|pancreatic stenting
422691|NCT01767220|ventricular tachycardia|ventricular tachycardia
422692|NCT01767220|endocardial ablation|endocardial ablation
422693|NCT01767220|epicardial ablation|epicardial ablation
422694|NCT01767181|Light therapy|light therapy
422695|NCT01767181|physical exercise|physical exercise
422696|NCT01767181|night shift workers|night shift workers
422697|NCT01767181|genetic markers|genetic markers
422698|NCT01767181|PBMCs|pbmcs
422700|NCT01767142|Cryolipolysis|cryolipolysis
422701|NCT01767142|Fat Reduction|fat reduction
422702|NCT01767129|levodopa|levodopa
422703|NCT01767129|dyskinesia|dyskinesia
422704|NCT01767129|parkinson's disease|parkinson's disease
422705|NCT01767129|AVP-923|avp-923
422706|NCT01767129|dextromethorphan|dextromethorphan
422707|NCT01767129|quinidine|quinidine
422708|NCT01767116|Interferon-Free|interferon-free
422709|NCT01767116|Hepatitis C Genotype 1b|hepatitis c genotype 1b
422710|NCT01767116|Chronic Hepatitis C|chronic hepatitis c
422711|NCT01767116|Hepatitis C Virus|hepatitis c virus
422712|NCT01767116|Hepatitis C|hepatitis c
422713|NCT01767116|Treatment-Naive|treatment-naive
422714|NCT01767116|Paritaprevir|paritaprevir
422715|NCT01767116|Ombitasvir|ombitasvir
422716|NCT01767116|Dasabuvir|dasabuvir
422717|NCT01767116|Viekira PAK|viekira pak
422718|NCT01767116|Ribavirin|ribavirin
422719|NCT01767103|Hepatic Impairment|hepatic impairment
422720|NCT01767103|Liver Impairment|liver impairment
422721|NCT01767103|Liver Disease|liver disease
422722|NCT01767103|Ferriprox®|ferriprox®
422723|NCT01767103|LI|li
422724|NCT01767103|DFP|dfp
422725|NCT01767103|Deferiprone|deferiprone
422726|NCT01767090|Phase 2|phase 2
422727|NCT01767090|Double-blind|double-blind
422728|NCT01767090|Pelvic pain|pelvic pain
422729|NCT01767090|ASP1707|asp1707
422730|NCT01767090|Placebo-controlled|placebo-controlled
422731|NCT01767090|Endometriosis|endometriosis
422732|NCT01767077|Saturated fat|saturated fat
422733|NCT01767077|Dairy products|dairy products
422734|NCT01767077|Milk fat globule membrane|milk fat globule membrane
422735|NCT01767077|Cholesterol|cholesterol
422736|NCT01767077|Butter|butter
422737|NCT01767077|Cream|cream
422738|NCT01767064|ARIs, antibiotics, public commitment, quality improvement|aris, antibiotics, public commitment, quality improvement
422739|NCT01767051|PCOS|pcos
422740|NCT01767051|Children|children
422741|NCT01767051|Cardiovascular|cardiovascular
422742|NCT01767051|Follow-up|follow-up
422743|NCT01767025|Influence|influence
422744|NCT01767025|oxytocin|oxytocin
422745|NCT01767025|automatic imitation|automatic imitation
422746|NCT01767025|behaviour|behaviour
422747|NCT01767025|volunteers|volunteers
422748|NCT01766999|pulse oximetry|pulse oximetry
422749|NCT01766999|tumescent anesthesia|tumescent anesthesia
422750|NCT01766960|Bile acids|bile acids
422751|NCT01766960|Pharmacokinetics|pharmacokinetics
422752|NCT01766947|Glaucoma|glaucoma
422753|NCT01766947|Deep sclerectomy|deep sclerectomy
422754|NCT01766934|Peripheral blood progenitor cell mobilization|peripheral blood progenitor cell mobilization
422755|NCT01766934|allogenic hematopoetic stem cell transplantation|allogenic hematopoetic stem cell transplantation
422756|NCT01766934|recombinant human granulocyte colony stimulating factor|recombinant human granulocyte colony stimulating factor
422757|NCT01766934|filgrastim|filgrastim
422758|NCT01766921|Influenza, Pandemic, H5N1, Elderly adults|influenza, pandemic, h5n1, elderly adults
422759|NCT01766908|Timing of Umbilical Cord clamping|timing of umbilical cord clamping
422760|NCT01766908|Cord Clamp 20 seconds|cord clamp 20 seconds
422761|NCT01766908|Cord Clamp 40 seconds|cord clamp 40 seconds
422762|NCT01766908|Cord Clamp 60 seconds|cord clamp 60 seconds
422763|NCT01766895|uremia|uremia
422764|NCT01766895|HBV|hbv
422765|NCT01766895|HCV|hcv
422766|NCT01766895|seroclearance|seroclearance
422767|NCT01766882|Hemodialysis|hemodialysis
422768|NCT01766882|Blood Pressure|blood pressure
422769|NCT01766882|Hydration Status|hydration status
422770|NCT01766882|Low-sodium diet|low-sodium diet
422771|NCT01766869|Prostate Cancer|prostate cancer
422772|NCT01766869|MRI/MRS|mri/mrs
422773|NCT01766856|perforation|perforation
422774|NCT01766856|tympanoplasty|tympanoplasty
422775|NCT01766856|myringoplasty|myringoplasty
422776|NCT01766856|Eustachian tube function|eustachian tube function
422777|NCT01766856|tympanostomy tube|tympanostomy tube
422778|NCT01766817|IPF|ipf
422779|NCT01766804|Acute Lymphoblastic Leukemia|acute lymphoblastic leukemia
422780|NCT01766804|Bovine Colostrum|bovine colostrum
422781|NCT01766804|Inflammation|inflammation
422782|NCT01766804|Infection|infection
422783|NCT01766804|Toxicity|toxicity
422784|NCT01766791|resistance exercise|resistance exercise
422785|NCT01766791|muscle mass|muscle mass
422786|NCT01766791|abdominal fat|abdominal fat
422787|NCT01766791|strength|strength
422788|NCT01766791|Coronary Heart Disease (CHD)-risk|coronary heart disease (chd)-risk
422789|NCT01766791|myocardial mass|myocardial mass
422790|NCT01766778|type-2 diabetes mellitus, inadequately controlled Metformin|type-2 diabetes mellitus, inadequately controlled metformin
422791|NCT01766739|GL-ONC1|gl-onc1
422792|NCT01766739|pleural effusion|pleural effusion
422793|NCT01766739|12-169|12-169
422794|NCT01766726|HIV|hiv
422795|NCT01766726|Atherosclerosis|atherosclerosis
422796|NCT01766700|Obesity, weight loss, weight maintenance|obesity, weight loss, weight maintenance
422797|NCT01766687|Chronic Kidney Disease|chronic kidney disease
422798|NCT01766687|estimated glomerular filtration rate|estimated glomerular filtration rate
422799|NCT01766687|water intake|water intake
422800|NCT01766687|fluid intake|fluid intake
422801|NCT01766687|renal decline|renal decline
422802|NCT01766674|Kyphosis|kyphosis
422803|NCT01766648|Distal|distal
422804|NCT01766648|Femur|femur
422805|NCT01766648|Locking|locking
422806|NCT01766648|Screw|screw
422807|NCT01766648|Fracture|fracture
422808|NCT01766648|Healing|healing
422809|NCT01766622|Apoptosis|apoptosis
422810|NCT01766622|Pro-Apoptotic Effects|pro-apoptotic effects
422811|NCT01766622|PET Imaging|pet imaging
422812|NCT01766622|TL32711|tl32711
422813|NCT01766622|Relapsed Platinum Resistant or Refractory Epithelial Ovarian Cancer|relapsed platinum resistant or refractory epithelial ovarian cancer
422814|NCT01766609|Vitiligo; Intralesional; Triamcinolone acetonide|vitiligo; intralesional; triamcinolone acetonide
422815|NCT01766596|Ophthalmology|ophthalmology
422816|NCT01766596|Age-related ocular pathologies|age-related ocular pathologies
422817|NCT01766583|Open label, 3 + 3 dose escalation study followed by an expansion phase.|open label, 3 + 3 dose escalation study followed by an expansion phase.
422818|NCT01766570|insulin sensitivity,|insulin sensitivity,
422819|NCT01766570|glucose tolerance,|glucose tolerance,
422820|NCT01766570|inflammatory markers,|inflammatory markers,
422821|NCT01766570|lipid profile,|lipid profile,
422822|NCT01766570|oxidative stress,|oxidative stress,
422823|NCT01766570|pancreatic β-cell function|pancreatic β-cell function
422824|NCT01766557|Polycystic ovarian syndrome, sex hormones, ovarian function, women, fish protein, insulin sensitivity, glucose tolerance, β-cell function, inflammation|polycystic ovarian syndrome, sex hormones, ovarian function, women, fish protein, insulin sensitivity, glucose tolerance, β-cell function, inflammation
422825|NCT01766544|asthma|asthma
422826|NCT01766544|COPD|copd
422827|NCT01766544|guidelines|guidelines
422828|NCT01766544|knowledge transfer|knowledge transfer
422829|NCT01766544|medical education|medical education
422830|NCT01766544|care gaps|care gaps
422831|NCT01766531|Bioelectrical impedance|bioelectrical impedance
422832|NCT01766531|Nutrition|nutrition
422833|NCT01766531|Phase angle|phase angle
422834|NCT01766531|ICU patients|icu patients
422835|NCT01766518|liver transplantation|liver transplantation
422837|NCT01766518|Mycophenolate mofetil|mycophenolate mofetil
422838|NCT01766518|MMF|mmf
422839|NCT01766505|hypertension, heart failure, candesartan, losartan|hypertension, heart failure, candesartan, losartan
422840|NCT01766492|prostate cancer|prostate cancer
422841|NCT01766492|CyberKnife|cyberknife
422842|NCT01766479|Colorectal cancer|colorectal cancer
422843|NCT01766479|colorectal neoplasia|colorectal neoplasia
422844|NCT01766479|CT colonography|ct colonography
422845|NCT01766479|advanced neoplasia|advanced neoplasia
422846|NCT01766479|colonoscopy|colonoscopy
422847|NCT01766479|family history|family history
422848|NCT01766453|South Asian|south asian
422849|NCT01766453|Cardiovascular|cardiovascular
422850|NCT01766453|Exercise|exercise
422851|NCT01766453|Obesity|obesity
422852|NCT01766453|Visceral Adipose Tissue|visceral adipose tissue
422853|NCT01766401|Generalized Anxiety Disorder|generalized anxiety disorder
422854|NCT01766401|GAD|gad
422855|NCT01766375|idarubicin|idarubicin
422856|NCT01766375|busulfan|busulfan
422857|NCT01766375|cyclophosphamide|cyclophosphamide
422858|NCT01766375|pretreatment|pretreatment
422859|NCT01766375|high-risk acute myeloid leukemia patient|high-risk acute myeloid leukemia patient
422860|NCT01766349|Esophageal cancer|esophageal cancer
422861|NCT01766349|Respiratory muscle strength|respiratory muscle strength
422862|NCT01766349|Pulmonary function testing|pulmonary function testing
422863|NCT01766349|Functional exercise capacity|functional exercise capacity
422864|NCT01766336|Agitation|agitation
422865|NCT01766336|Aggression|aggression
422866|NCT01766336|AD patients|ad patients
422867|NCT01766323|Morphine|morphine
422868|NCT01766323|Palliation|palliation
422869|NCT01766323|Cancer|cancer
422870|NCT01766323|Hospice|hospice
422871|NCT01766323|Sleepiness|sleepiness
422872|NCT01766323|Modafinil|modafinil
422873|NCT01766310|Folic acid|folic acid
422874|NCT01766310|Folate|folate
422875|NCT01766310|Homocysteine|homocysteine
422876|NCT01766310|Obese|obese
422877|NCT01766310|Children|children
422878|NCT01766297|Breast Cancer|breast cancer
422879|NCT01766297|Proton|proton
422880|NCT01766297|Radiation|radiation
422881|NCT01766284|Human Papillomavirus|human papillomavirus
422882|NCT01766284|Optical Coherence Tomography|optical coherence tomography
422883|NCT01766284|Imaging Systems|imaging systems
422884|NCT01766284|Cervical intraepithelial neoplasia|cervical intraepithelial neoplasia
422885|NCT01766284|Cervical Cancer|cervical cancer
422886|NCT01766284|Cervical Dysplasia|cervical dysplasia
422887|NCT01766271|Coronary heart disease|coronary heart disease
422888|NCT01766271|cardiovascular disease|cardiovascular disease
422889|NCT01766271|risk|risk
422890|NCT01766258|Parkinson's Disease|parkinson's disease
422891|NCT01766258|Motor-fluctuation|motor-fluctuation
422892|NCT01766258|Wearing-off|wearing-off
422893|NCT01766245|mm|mm
422894|NCT01766206|conjugate vaccine|conjugate vaccine
422895|NCT01766206|phase IV clinical trial|phase iv clinical trial
422896|NCT01766206|Neisseria meningitidis|neisseria meningitidis
422897|NCT01766193|Delivery, obstetric|delivery, obstetric
422898|NCT01766193|Obstetric Surgical Procedures|obstetric surgical procedures
422899|NCT01766193|Vacuum Extraction, Obstetrical|vacuum extraction, obstetrical
422900|NCT01766193|Cesarean Section|cesarean section
422901|NCT01766193|Obstetrical Forceps|obstetrical forceps
422902|NCT01766193|Epidemiology|epidemiology
422903|NCT01766193|Norway|norway
422904|NCT01766180|Memory|memory
422905|NCT01766180|Fruitflow|fruitflow
422906|NCT01766180|Resveratrol (resVida)|resveratrol (resvida)
422907|NCT01766180|Cerebral blood flow|cerebral blood flow
422908|NCT01766180|Cardiopulmonary exercise test|cardiopulmonary exercise test
422909|NCT01766180|Maximal VO2|maximal vo2
422910|NCT01766167|Genotype 2|genotype 2
422911|NCT01766154|tirofiban|tirofiban
422912|NCT01766154|pharmacokinetic|pharmacokinetic
422913|NCT01766154|renal insufficiency|renal insufficiency
422914|NCT01766154|Phase 1|phase 1
422915|NCT01766154|pharmacodynamic|pharmacodynamic
422916|NCT01766141|Spinal manipulation|spinal manipulation
422917|NCT01766141|Tumor necrosis factor|tumor necrosis factor
422918|NCT01766141|Interleukin 1|interleukin 1
422919|NCT01766141|Interleukin 10|interleukin 10
422920|NCT01766141|Inflammatory cytokines|inflammatory cytokines
422921|NCT01766128|Parkinson disease|parkinson disease
422922|NCT01766128|Early stage|early stage
422923|NCT01766128|Zonisamide|zonisamide
422924|NCT01766128|UPDRS|updrs
422925|NCT01766115|HCV|hcv
422926|NCT01766115|needlestick|needlestick
422927|NCT01766115|occupational|occupational
422928|NCT01766115|transmission|transmission
422929|NCT01766115|health care worker|health care worker
422930|NCT01766115|telaprevir|telaprevir
422931|NCT01766102|Mammography|mammography
422932|NCT01766089|Caesarean delivery|caesarean delivery
422933|NCT01766089|severe pre-eclampsia|severe pre-eclampsia
422934|NCT01766089|remifentanil|remifentanil
422935|NCT01766089|dexmedetomidine|dexmedetomidine
422936|NCT01766089|cardiovascular response|cardiovascular response
422937|NCT01766076|immune activation|immune activation
422938|NCT01766076|antiretroviral therapy|antiretroviral therapy
422939|NCT01766076|atorvastatin|atorvastatin
422940|NCT01766076|immune exhaustion|immune exhaustion
422941|NCT01766076|adults|adults
422942|NCT01766076|Africa|africa
422943|NCT01766063|Multiple Sclerosis|multiple sclerosis
422944|NCT01766063|Sleep|sleep
422945|NCT01766063|Quality of life|quality of life
422946|NCT01766063|Observational study|observational study
422947|NCT01766037|obesity|obesity
422948|NCT01766037|obese|obese
422949|NCT01766037|weight loss|weight loss
422950|NCT01766024|interferon beta-1a|interferon beta-1a
422951|NCT01766024|pharmacokinetics|pharmacokinetics
422952|NCT01766024|pharmacodynamics|pharmacodynamics
422953|NCT01766024|volunteers|volunteers
422954|NCT01765998|Crohn's disease, endothelial progenitor cells, probiotic|crohn's disease, endothelial progenitor cells, probiotic
422955|NCT01765985|palmoplantar|palmoplantar
422956|NCT01765959|Insomnia|insomnia
422957|NCT01765959|Auricular acupuncture|auricular acupuncture
422958|NCT01765959|CBT|cbt
422959|NCT01765946|Insulin resistance|insulin resistance
422960|NCT01765946|Prediabetes|prediabetes
422961|NCT01765946|Longevity genes|longevity genes
422962|NCT01765946|Inflammation|inflammation
422963|NCT01765946|Metformin|metformin
422964|NCT01765933|1,3-dimethylamylamine|1,3-dimethylamylamine
422965|NCT01765894|glucose homeostasis|glucose homeostasis
422966|NCT01765894|endogenous glucose production|endogenous glucose production
422967|NCT01765894|moderate exercise|moderate exercise
422968|NCT01765894|type 2 diabetes|type 2 diabetes
422969|NCT01765894|metformin|metformin
422970|NCT01765881|Induction of labor|induction of labor
422971|NCT01765881|cervical ripening|cervical ripening
422972|NCT01765881|misoprostol,|misoprostol,
422973|NCT01765881|prostaglandin|prostaglandin
422974|NCT01765881|cost-effectiveness|cost-effectiveness
422975|NCT01765868|Betrixaban|betrixaban
422976|NCT01765868|Healthy|healthy
422977|NCT01765868|Bioavailability|bioavailability
422978|NCT01765855|Betrixaban|betrixaban
422979|NCT01765855|Healthy|healthy
422980|NCT01765855|Mass Balance|mass balance
422981|NCT01765842|Lupus Nephritis|lupus nephritis
422982|NCT01765842|remission|remission
422983|NCT01765842|immunosuppressive treatment|immunosuppressive treatment
422984|NCT01765829|Non Affective Psychosis|non affective psychosis
422985|NCT01765829|First episode|first episode
422986|NCT01765829|Discontinuation scheme|discontinuation scheme
422987|NCT01765816|Exercise|exercise
422988|NCT01765816|Elderly|elderly
422989|NCT01765816|Blood volume|blood volume
422990|NCT01765816|Hemoglobin|hemoglobin
422991|NCT01765803|Mellaril|mellaril
422992|NCT01765803|Thioridazine|thioridazine
422993|NCT01765803|CD34+|cd34+
422994|NCT01765803|Stem cells|stem cells
422995|NCT01765803|Progenitor cells|progenitor cells
422996|NCT01765803|Peripheral blood|peripheral blood
422997|NCT01765803|mobilization|mobilization
422998|NCT01765803|circulation|circulation
422999|NCT01765777|Low back pain|low back pain
423000|NCT01765777|Lower back pain|lower back pain
423001|NCT01765777|Chronic back pain|chronic back pain
423002|NCT01765751|Cervical pain|cervical pain
423003|NCT01765751|Neck pain|neck pain
423004|NCT01765751|Arm pain|arm pain
423005|NCT01765738|PICC|picc
423006|NCT01765725|Chronic Fatigue Syndrome|chronic fatigue syndrome
423007|NCT01765725|Coping|coping
423008|NCT01765725|Patient education|patient education
423009|NCT01765712|PRP|prp
423010|NCT01765712|BPTB|bptb
423011|NCT01765712|VAS|vas
423012|NCT01765712|Anterior Knee Pain|anterior knee pain
423013|NCT01765673|Swallowing|swallowing
423014|NCT01765673|Stroke|stroke
423015|NCT01765673|Sensory stimulation|sensory stimulation
423016|NCT01765673|Home based therapy|home based therapy
423017|NCT01765673|Head and Neck Cancer|head and neck cancer
423018|NCT01765660|Hematopoietic Stem Cell Transplantation|hematopoietic stem cell transplantation
423019|NCT01765660|Mesenchymal Stem Cells|mesenchymal stem cells
423020|NCT01765660|Chronic Graft-versus-host disease|chronic graft-versus-host disease
423021|NCT01765647|Celiac disease|celiac disease
423022|NCT01765647|AGY|agy
423023|NCT01765634|Hematopoietic Stem Cell Transplantation|hematopoietic stem cell transplantation
423024|NCT01765634|Mesenchymal Stem Cells|mesenchymal stem cells
423025|NCT01765634|Acute Graft-versus-host disease|acute graft-versus-host disease
423026|NCT01765621|health care expenditure|health care expenditure
423027|NCT01765621|drug drug interactions|drug drug interactions
423028|NCT01765621|electronic decision support systems|electronic decision support systems
423029|NCT01765621|pharmacogenetics|pharmacogenetics
423030|NCT01765621|Potential Reduction|potential reduction
423031|NCT01765608|Zonisamide|zonisamide
423032|NCT01765608|Zonegran|zonegran
423033|NCT01765608|Obstructive Sleep apnea|obstructive sleep apnea
423034|NCT01765608|Apnea|apnea
423035|NCT01765608|Respiration Disorders|respiration disorders
423036|NCT01765608|Sleep Disorders|sleep disorders
423037|NCT01765608|Obesity|obesity
423038|NCT01765608|Anti-Obesity Agents|anti-obesity agents
423039|NCT01765608|Carbonic Anhydrase|carbonic anhydrase
423040|NCT01765608|Carbonic Anhydrase Inhibitors|carbonic anhydrase inhibitors
423041|NCT01765608|Enzyme Inhibitors|enzyme inhibitors
423042|NCT01765608|Sulfonamides|sulfonamides
423043|NCT01765608|Therapeutic Uses|therapeutic uses
540749|NCT01261312|AML|aml
423044|NCT01765608|Pharmacologic Actions|pharmacologic actions
423045|NCT01765595|health care expenditure|health care expenditure
423046|NCT01765595|drug drug interactions|drug drug interactions
423047|NCT01765595|electronic decision support systems|electronic decision support systems
423048|NCT01765595|Potential reduction|potential reduction
423049|NCT01765530|Medical Devices|medical devices
423050|NCT01765530|Ventilator-Associated Pneumonia (VAP)|ventilator-associated pneumonia (vap)
423051|NCT01765530|Ventilator-Associated Events (VAE)|ventilator-associated events (vae)
423052|NCT01765530|Endotracheal Tube|endotracheal tube
423053|NCT01765530|Microbial Diversity|microbial diversity
423054|NCT01765530|Anti-Resistance|anti-resistance
423055|NCT01765530|Computed Tomography (CT)|computed tomography (ct)
423056|NCT01765517|Diabetes Mellitus|diabetes mellitus
423057|NCT01765504|Cardiac surgery; near infrared spectroscopy|cardiac surgery; near infrared spectroscopy
423058|NCT01765491|colonoscopy|colonoscopy
423059|NCT01765491|bowel preparation|bowel preparation
423060|NCT01765491|polyethylene glycol|polyethylene glycol
423061|NCT01765478|Rheumatoid Arthritis|rheumatoid arthritis
423062|NCT01765465|postcholecystectomy syndrome|postcholecystectomy syndrome
423063|NCT01765465|laparoscopic cholecystectomy|laparoscopic cholecystectomy
423064|NCT01765465|Rowachol|rowachol
423065|NCT01765439|bile acids|bile acids
423066|NCT01765439|metabolism|metabolism
423067|NCT01765439|probiotics|probiotics
423068|NCT01765426|Prophylactic vaccination|prophylactic vaccination
423069|NCT01765413|To identify|to identify
423070|NCT01765413|biomarkers|biomarkers
423071|NCT01765413|of vaccine safety|of vaccine safety
423072|NCT01765413|Volunteers|volunteers
423073|NCT01765400|Heart failure|heart failure
423074|NCT01765400|Antiplatelet therapy|antiplatelet therapy
423075|NCT01765400|Platelet aggregation|platelet aggregation
423076|NCT01765400|Clopidogrel|clopidogrel
423077|NCT01765400|Prasugrel|prasugrel
423078|NCT01765387|Spatherpy|spatherpy
423079|NCT01765387|Aerobic exercise|aerobic exercise
423080|NCT01765374|rituximab|rituximab
423081|NCT01765374|sonography|sonography
423082|NCT01765374|clinical response|clinical response
423083|NCT01765348|language impairment|language impairment
423084|NCT01765348|language disorders|language disorders
423085|NCT01765348|syntax treatment|syntax treatment
423086|NCT01765348|narrative-based treatment|narrative-based treatment
423087|NCT01765335|heart failure, BNP, NICaS system, readmition|heart failure, bnp, nicas system, readmition
423088|NCT01765309|Tissue expanders|tissue expanders
423089|NCT01765309|Botulinum toxin|botulinum toxin
423090|NCT01765309|Botox|botox
423092|NCT01765283|UCD|ucd
423093|NCT01765270|Diabetes|diabetes
423094|NCT01765270|Diabetes Mellitus|diabetes mellitus
423095|NCT01765270|Type 2 Diabetes|type 2 diabetes
423096|NCT01765270|Cardiovascular Disease|cardiovascular disease
423097|NCT01765270|Coronary Artery Bypass Surgery|coronary artery bypass surgery
423098|NCT01765257|Drug-naïve patients with Parkinson's disease|drug-naïve patients with parkinson's disease
423099|NCT01765257|Apathy|apathy
423100|NCT01765257|Rasagiline|rasagiline
423197|NCT01764737|safety|safety
423198|NCT01764737|tolerability|tolerability
423101|NCT01765244|Corneal trophic ulcers, limbal deficiency, cornea blindness|corneal trophic ulcers, limbal deficiency, cornea blindness
423102|NCT01765231|Lymphoma|lymphoma
423103|NCT01765231|Hepatitis B virus|hepatitis b virus
423104|NCT01765231|Therapeutic Uses|therapeutic uses
423105|NCT01765231|Antiviral Agents|antiviral agents
423106|NCT01765218|Hypoxic ischemic encephalopathy|hypoxic ischemic encephalopathy
423107|NCT01765218|HIE|hie
423108|NCT01765218|Perinatal depression|perinatal depression
423109|NCT01765218|Whole body cooling|whole body cooling
423110|NCT01765218|Therapeutic hypothermia|therapeutic hypothermia
423111|NCT01765205|congenital cardiovascular malformation|congenital cardiovascular malformation
423112|NCT01765205|newborn|newborn
423113|NCT01765192|Drug therapy|drug therapy
423114|NCT01765179|testosterone|testosterone
423115|NCT01765179|male hypogonadism|male hypogonadism
423116|NCT01765179|low testosterone|low testosterone
423117|NCT01765166|Social Skill Training|social skill training
423118|NCT01765166|Social Interaction|social interaction
423119|NCT01765166|Peer relations|peer relations
423120|NCT01765153|physical therapy|physical therapy
423121|NCT01765153|rehabilitation|rehabilitation
423122|NCT01765153|neuroplasticity|neuroplasticity
423123|NCT01765140|3,4 diaminopyridine (DAP)|3,4 diaminopyridine (dap)
423124|NCT01765101|knee osteoarthritis|knee osteoarthritis
423125|NCT01765101|therapeutic effect|therapeutic effect
423126|NCT01765101|insole|insole
423127|NCT01765088|High-grade glioma|high-grade glioma
423128|NCT01765088|chemotherapy|chemotherapy
423129|NCT01765088|Temozolomide|temozolomide
423130|NCT01765088|Interferon-alpha|interferon-alpha
423131|NCT01765075|Electrophysiological mapping|electrophysiological mapping
423132|NCT01765075|Multi-electrode catheter|multi-electrode catheter
423133|NCT01765062|Rapid maxillary expansion|rapid maxillary expansion
423134|NCT01765062|Cross bite|cross bite
423135|NCT01765062|Haas appliance|haas appliance
423136|NCT01765062|Lateral cephalograms|lateral cephalograms
423137|NCT01765049|breast density change|breast density change
423138|NCT01765049|endocrine therapy response|endocrine therapy response
423139|NCT01765049|aromatase inhibitor|aromatase inhibitor
423140|NCT01765036|contrast-enhanced endoscopic ultrasound|contrast-enhanced endoscopic ultrasound
423141|NCT01765036|pancreatic adenocarcinoma|pancreatic adenocarcinoma
423142|NCT01765010|Vitamin D|vitamin d
423143|NCT01765010|Serum sclerostin|serum sclerostin
423144|NCT01765010|Serum dickkopf1|serum dickkopf1
423145|NCT01764984|total knee arthroplasty|total knee arthroplasty
423146|NCT01764984|trabecular metal|trabecular metal
423147|NCT01764984|bone mineral density|bone mineral density
423148|NCT01764971|Chronic ITP, Cerebral dysfunction|chronic itp, cerebral dysfunction
423149|NCT01764958|mother-infant interaction|mother-infant interaction
423150|NCT01764958|general movements|general movements
423151|NCT01764958|preterm infants|preterm infants
423152|NCT01764893|Overactive Bladder|overactive bladder
423153|NCT01764880|Heparanase inhibitor|heparanase inhibitor
423154|NCT01764880|Multiple myeloma|multiple myeloma
423155|NCT01764867|major depressive disorder|major depressive disorder
423156|NCT01764867|algorithm guided treatment|algorithm guided treatment
423157|NCT01764867|treatment as usual|treatment as usual
423158|NCT01764867|escitalopram|escitalopram
423159|NCT01764867|mirtazapine|mirtazapine
423160|NCT01764867|transcranial magnetic stimulation (rTMS)|transcranial magnetic stimulation (rtms)
423161|NCT01764867|modified electroconvulsive therapy (mECT)|modified electroconvulsive therapy (mect)
423162|NCT01764867|remission|remission
423163|NCT01764867|relapse|relapse
423164|NCT01764867|quality of life|quality of life
423165|NCT01764854|Hemodialysis|hemodialysis
423166|NCT01764841|Ciprofloxacin|ciprofloxacin
423167|NCT01764841|Dry Powder for Inhalation|dry powder for inhalation
423168|NCT01764841|Exacerbation|exacerbation
423169|NCT01764841|Bronchiectasis|bronchiectasis
423170|NCT01764828|Phase I|phase i
423171|NCT01764828|Pharmacokinetics|pharmacokinetics
423172|NCT01764828|Safety measurements|safety measurements
423173|NCT01764802|Psychosexual Intervention|psychosexual intervention
423174|NCT01764802|Cancer|cancer
423175|NCT01764802|Gynecologic Cancer|gynecologic cancer
423176|NCT01764802|Breast Cancer|breast cancer
423177|NCT01764789|psychological intervention|psychological intervention
423178|NCT01764789|breast cancer|breast cancer
423179|NCT01764789|gynecologic cancer|gynecologic cancer
423180|NCT01764776|LDE225|lde225
423181|NCT01764776|Pharmacokinetics|pharmacokinetics
423182|NCT01764776|PK|pk
423183|NCT01764776|Postmenopausal women|postmenopausal women
423184|NCT01764776|normal hepatic function|normal hepatic function
423185|NCT01764776|mild hepatic impairment|mild hepatic impairment
423186|NCT01764776|moderate hepatic impairment|moderate hepatic impairment
423187|NCT01764776|severe hepatic impairment|severe hepatic impairment
423188|NCT01764750|Intrasite|intrasite
423189|NCT01764750|Antibiotic|antibiotic
423190|NCT01764750|Vancomycin|vancomycin
423191|NCT01764750|Infection|infection
423192|NCT01764750|Pharmacokinetics|pharmacokinetics
423193|NCT01764737|VX15/2503|vx15/2503
423194|NCT01764737|Semaphorin 4D|semaphorin 4d
423195|NCT01764737|SEMA4D|sema4d
423196|NCT01764737|CD100|cd100
423199|NCT01764737|pharmacokinetics|pharmacokinetics
423200|NCT01764737|immunogenicity|immunogenicity
423201|NCT01764737|multiple sclerosis|multiple sclerosis
423202|NCT01764737|monoclonal antibody|monoclonal antibody
423203|NCT01764724|Attitudes and understanding of sodium claims|attitudes and understanding of sodium claims
423204|NCT01764724|General canadian population|general canadian population
423205|NCT01764711|POTS|pots
423206|NCT01764698|anxiety disorders|anxiety disorders
423207|NCT01764698|substance use disorders|substance use disorders
423208|NCT01764698|treatment effectiveness|treatment effectiveness
423209|NCT01764698|cognitive behavioral therapy|cognitive behavioral therapy
423210|NCT01764672|Attention Deficit Hyperactivity Disorder|attention deficit hyperactivity disorder
423211|NCT01764672|Healthy Adults|healthy adults
423212|NCT01764672|Methylphenidate|methylphenidate
423213|NCT01764672|Functional connectivity|functional connectivity
423214|NCT01764672|Functional Magnetic Resonance Imaging|functional magnetic resonance imaging
423215|NCT01764659|4D-CT|4d-ct
423216|NCT01764659|Contrast Enhanced CT|contrast enhanced ct
423217|NCT01764659|Radiotherapy Simulation|radiotherapy simulation
423218|NCT01764646|Prostate cancer|prostate cancer
423219|NCT01764646|Radiation therapy|radiation therapy
423220|NCT01764633|High cholesterol|high cholesterol
423221|NCT01764633|Treatment for high cholesterol|treatment for high cholesterol
423222|NCT01764633|Lowering cholesterol|lowering cholesterol
423223|NCT01764633|Lowering high cholesterol|lowering high cholesterol
423224|NCT01764633|Hypercholesterolemia|hypercholesterolemia
423225|NCT01764620|shoulder|shoulder
423226|NCT01764620|muscle fatigue|muscle fatigue
423227|NCT01764620|kinematics|kinematics
423228|NCT01764620|athletes|athletes
423229|NCT01764607|Squamous|squamous
423230|NCT01764607|Renal|renal
423231|NCT01764607|Transplant|transplant
423232|NCT01764594|Lupus|lupus
423233|NCT01764594|SLE|sle
423234|NCT01764581|immune monitoring|immune monitoring
423235|NCT01764581|immune cell function ImmuKnow|immune cell function immuknow
423236|NCT01764581|randomized controlled trial|randomized controlled trial
423237|NCT01764581|immunosuppression management|immunosuppression management
423238|NCT01764581|infection|infection
423239|NCT01764581|rejection|rejection
423240|NCT01764581|liver transplantation|liver transplantation
423241|NCT01764581|Cylex|cylex
423242|NCT01764568|Metacognitive training|metacognitive training
423243|NCT01764568|Cognitive behavioral therapy|cognitive behavioral therapy
423244|NCT01764568|Clinical trial|clinical trial
423245|NCT01764568|Group intervention|group intervention
423246|NCT01764568|Group therapy|group therapy
423247|NCT01764568|Schizophrenia|schizophrenia
423248|NCT01764568|Psychosis|psychosis
423249|NCT01764568|Cognitive remediation|cognitive remediation
423250|NCT01764542|Ulcerative colitis|ulcerative colitis
423251|NCT01764542|dysplasia|dysplasia
423252|NCT01764542|risk factor|risk factor
423253|NCT01764542|surgery|surgery
423254|NCT01764516|zinc|zinc
423255|NCT01764516|selenium|selenium
423256|NCT01764516|serum|serum
423257|NCT01764516|epilepsy|epilepsy
423258|NCT01764516|antioxidants|antioxidants
423259|NCT01764503|ampullary tumors|ampullary tumors
423260|NCT01764503|endoscopic treatment|endoscopic treatment
423261|NCT01764490|Bloodstream infections caused by multidrug-resistant Enterobacteriaceae, extended-spectrum β-lactamase-producers, carbapenemase-producing organisms|bloodstream infections caused by multidrug-resistant enterobacteriaceae, extended-spectrum β-lactamase-producers, carbapenemase-producing organisms
423262|NCT01764464|post laminectomy pain syndrome, failed back surgery syndrome|post laminectomy pain syndrome, failed back surgery syndrome
423263|NCT01764451|Hispanic|hispanic
423264|NCT01764425|P7435|p7435
423265|NCT01764425|Healthy,overweight and or obese subjects|healthy,overweight and or obese subjects
423266|NCT01764425|Single ascending dose|single ascending dose
423267|NCT01764425|Multiple ascending dose|multiple ascending dose
423268|NCT01764425|Pharmacokinetics|pharmacokinetics
423269|NCT01764412|Healthy women|healthy women
423270|NCT01764412|Menstrual cycle|menstrual cycle
423271|NCT01764412|Hepcidin|hepcidin
423272|NCT01764412|Seric iron|seric iron
423273|NCT01764399|cardiovascular risk factors|cardiovascular risk factors
423274|NCT01764386|obesity, overweight|obesity, overweight
423275|NCT01764373|Pain|pain
423276|NCT01764373|Fitness|fitness
423277|NCT01764373|Diabetes|diabetes
423278|NCT01764373|Aerobic Exercise|aerobic exercise
423279|NCT01764334|NonST elevation myocardial infarction (NSTEMI)|nonst elevation myocardial infarction (nstemi)
423280|NCT01764334|Fractional flow reserve (FFR)|fractional flow reserve (ffr)
423281|NCT01764334|Coronary angiogram|coronary angiogram
423282|NCT01764334|Diagnosis|diagnosis
423283|NCT01764334|Coronary revascularization|coronary revascularization
423284|NCT01764334|Prognosis|prognosis
423285|NCT01764334|Health economics|health economics
423286|NCT01764321|Certolizumab Pegol|certolizumab pegol
423287|NCT01764321|Cimzia®|cimzia®
423288|NCT01764321|TNF inhibitor|tnf inhibitor
423289|NCT01764321|DMARD|dmard
423290|NCT01764321|Rheumatoid Arthritis|rheumatoid arthritis
423291|NCT01764308|acne; omega-3; isotretinoin; placebo|acne; omega-3; isotretinoin; placebo
423292|NCT01764282|HIV|hiv
423293|NCT01764282|serodiscordant couples HIV sero-conversion|serodiscordant couples hiv sero-conversion
423294|NCT01764282|anti-retroviral therapy|anti-retroviral therapy
423295|NCT01764282|intervention|intervention
423296|NCT01764256|rotavirus|rotavirus
423297|NCT01764256|vaccine|vaccine
423298|NCT01764243|Alzheimer's Disease|alzheimer's disease
423299|NCT01764243|Nicotinic Acetylcholine Receptor Agonist|nicotinic acetylcholine receptor agonist
423300|NCT01764243|Cognitive function|cognitive function
423301|NCT01764243|Dementia|dementia
423302|NCT01764243|Central Nervous System Agents|central nervous system agents
423303|NCT01764230|Hodgkin lymphoma|hodgkin lymphoma
423304|NCT01764230|Hodgkin disease|hodgkin disease
423305|NCT01764217|Cervix Cancer|cervix cancer
423306|NCT01764217|SUV|suv
423307|NCT01764217|Radiotherapy|radiotherapy
423308|NCT01764217|Outcome Prediction|outcome prediction
423309|NCT01764217|Imaging|imaging
423310|NCT01764217|PET|pet
423311|NCT01764178|Pitavastatin|pitavastatin
423312|NCT01764178|Valsartan|valsartan
423313|NCT01764165|COPD|copd
423314|NCT01764165|Sleep|sleep
423315|NCT01764165|Supplemental oxygen|supplemental oxygen
423316|NCT01764165|Breathing mechanics|breathing mechanics
423317|NCT01764165|nasal insufflation|nasal insufflation
423318|NCT01764152|Prevention,|prevention,
423319|NCT01764152|influenza,|influenza,
423320|NCT01764152|adults hospitalized,|adults hospitalized,
423321|NCT01764152|vaccines,|vaccines,
423322|NCT01764152|Effectiveness|effectiveness
423323|NCT01764139|Minimal knee changes|minimal knee changes
423324|NCT01764126|Safety|safety
423325|NCT01764126|immunogenicity|immunogenicity
423326|NCT01764126|pneumococcal|pneumococcal
423327|NCT01764126|protein|protein
423328|NCT01764126|vaccine|vaccine
423329|NCT01764113|Obesity|obesity
423330|NCT01764113|Adolescence|adolescence
423331|NCT01764113|Mindful Eating|mindful eating
423332|NCT01764087|Stomach Neoplasms|stomach neoplasms
423333|NCT01764087|Breast Neoplasms|breast neoplasms
423334|NCT01764087|Carcinoma|carcinoma
423335|NCT01764087|Neoplasms|neoplasms
423336|NCT01764087|Paclitaxel|paclitaxel
423337|NCT01764087|Tubulin Modulators|tubulin modulators
423338|NCT01764087|Antimitotic Agents|antimitotic agents
423339|NCT01764087|Protein Kinase Inhibitors|protein kinase inhibitors
423340|NCT01764087|Enzyme Inhibitors|enzyme inhibitors
423341|NCT01764087|Pharmacologic Actions|pharmacologic actions
423342|NCT01764074|Bipolar Disorder|bipolar disorder
423343|NCT01764074|Sleep Intervention|sleep intervention
423344|NCT01764074|Suicide|suicide
423345|NCT01764074|Cognitive Behavioral Therapy|cognitive behavioral therapy
423346|NCT01764074|Sleep Quality|sleep quality
423347|NCT01764061|Red Cells|red cells
423348|NCT01764061|Blood donors|blood donors
423349|NCT01764048|pain management|pain management
423350|NCT01764048|cesarean section|cesarean section
423351|NCT01764035|Psychotherapy|psychotherapy
423352|NCT01764035|Bipolar Disorder|bipolar disorder
423353|NCT01764035|Sleep Problems|sleep problems
423354|NCT01764035|Insomnia|insomnia
423355|NCT01764035|Hypersomnia|hypersomnia
423356|NCT01764035|Mindfulness|mindfulness
423357|NCT01764035|Meditation|meditation
423358|NCT01764035|Sleep Disturbance|sleep disturbance
423359|NCT01764022|breast cancer|breast cancer
423360|NCT01764022|trastuzumab|trastuzumab
423361|NCT01764009|Advanced Melanoma|advanced melanoma
423362|NCT01764009|Metastatic Melanoma|metastatic melanoma
423363|NCT01764009|Melanoma Stage III and IV|melanoma stage iii and iv
423364|NCT01763996|Drug therapy|drug therapy
423365|NCT01763983|Multiple Sclerosis|multiple sclerosis
423366|NCT01763983|Stress, Psychological|stress, psychological
423367|NCT01763983|Psychological Stress|psychological stress
423368|NCT01763983|Emotional Stress|emotional stress
423369|NCT01763983|Cognitive Deficits|cognitive deficits
423370|NCT01763983|Cognitive Dysfunction|cognitive dysfunction
423371|NCT01763970|Stereotactic|stereotactic
423372|NCT01763970|Radiotherapy|radiotherapy
423373|NCT01763970|Hypofractionated|hypofractionated
423374|NCT01763944|diet|diet
423375|NCT01763944|prostate cancer|prostate cancer
423376|NCT01763944|carbohydrate|carbohydrate
423377|NCT01763944|lifestyle|lifestyle
423378|NCT01763931|Digoxin|digoxin
423379|NCT01763918|High cholesterol, Treatment for high cholesterol, Lowering cholesterol, Lowering high cholesterol, Hypercholesterolemia|high cholesterol, treatment for high cholesterol, lowering cholesterol, lowering high cholesterol, hypercholesterolemia
423380|NCT01763905|High Cholesterol, Treatment for high cholesterol, Lowering cholesterol, Lowering high cholesterol, Hypercholesterolemia|high cholesterol, treatment for high cholesterol, lowering cholesterol, lowering high cholesterol, hypercholesterolemia
423381|NCT01763892|Pediatric|pediatric
423382|NCT01763892|Traumatic Brain Injury|traumatic brain injury
423383|NCT01763892|TBI|tbi
423384|NCT01763892|Apolipoprotein E|apolipoprotein e
423385|NCT01763892|apo-E|apo-e
423386|NCT01763892|Vasospasm|vasospasm
423387|NCT01763892|Genetics|genetics
423388|NCT01763892|Physiologic Mechanisms|physiologic mechanisms
423389|NCT01763892|Neurocognitive Outcomes|neurocognitive outcomes
423390|NCT01763892|Endothelin 1|endothelin 1
423391|NCT01763879|Thoracic surgery|thoracic surgery
423486|NCT01763502|Nutrition|nutrition
423392|NCT01763879|one lung ventilation|one lung ventilation
423393|NCT01763879|pressure-controlled ventilation|pressure-controlled ventilation
423394|NCT01763879|volume-controlled ventilation|volume-controlled ventilation
423395|NCT01763879|right ventricular function|right ventricular function
423396|NCT01763866|High cholesterol, Treatment for high cholesterol, Lowering cholesterol, Lowering high cholesterol, Hypercholesterolemia|high cholesterol, treatment for high cholesterol, lowering cholesterol, lowering high cholesterol, hypercholesterolemia
423397|NCT01763853|Acute respiratory distress syndrome (ARDS)|acute respiratory distress syndrome (ards)
423398|NCT01763853|Pulmonary edema|pulmonary edema
423399|NCT01763853|Alveolar fluid clearance|alveolar fluid clearance
423400|NCT01763853|Alveolar epithelial dysfunction|alveolar epithelial dysfunction
423401|NCT01763853|Receptor for advanced glycation end-products (RAGE)|receptor for advanced glycation end-products (rage)
423402|NCT01763853|Fluid resuscitation therapy|fluid resuscitation therapy
423403|NCT01763853|Hypovolemia|hypovolemia
423404|NCT01763853|Crystalloid|crystalloid
423405|NCT01763853|Hydroxyethyl Starch|hydroxyethyl starch
423406|NCT01763853|Intensive care unit|intensive care unit
423407|NCT01763840|Pediatric Abdominal Trauma Ultrasound Contrast|pediatric abdominal trauma ultrasound contrast
423408|NCT01763827|High cholesterol, Treatment for high cholesterol, Lowering cholesterol, Lowering high cholesterol, Hypercholesterolemia|high cholesterol, treatment for high cholesterol, lowering cholesterol, lowering high cholesterol, hypercholesterolemia
423409|NCT01763801|chemo port|chemo port
423410|NCT01763801|intravenous electrocardiographic guidance|intravenous electrocardiographic guidance
423411|NCT01763801|P maximal wave|p maximal wave
423412|NCT01763801|P submaximal wave|p submaximal wave
423413|NCT01763801|catheter tip|catheter tip
423414|NCT01763775|weight|weight
423415|NCT01763775|total body water|total body water
423416|NCT01763775|body fat|body fat
423417|NCT01763775|muscle mass|muscle mass
423418|NCT01763775|bone mass|bone mass
423419|NCT01763762|Electrical pudendal nerve stimulation|electrical pudendal nerve stimulation
423420|NCT01763762|Pelvic floor muscle training|pelvic floor muscle training
423421|NCT01763762|Transvaginal electrical stimulation|transvaginal electrical stimulation
423422|NCT01763762|Stress urinary incontinence|stress urinary incontinence
423423|NCT01763762|Comparative study|comparative study
423424|NCT01763723|Intense pulsed light,|intense pulsed light,
423425|NCT01763723|UV-exposure,|uv-exposure,
423426|NCT01763723|skin type,|skin type,
423427|NCT01763723|safety,|safety,
423428|NCT01763723|pigment,|pigment,
423429|NCT01763723|home-use|home-use
423430|NCT01763723|subjects|subjects
423431|NCT01763710|Breast cancer|breast cancer
423432|NCT01763710|Neurotoxicity|neurotoxicity
423433|NCT01763697|Taste acuity|taste acuity
423434|NCT01763697|Feeding behavior|feeding behavior
423435|NCT01763697|opioid|opioid
423436|NCT01763697|Quantitative assessment|quantitative assessment
423437|NCT01763684|Osteoarthritis|osteoarthritis
423438|NCT01763684|Osteoarthritis, Knee|osteoarthritis, knee
423439|NCT01763684|Osteonecrosis|osteonecrosis
423440|NCT01763684|Arthritis|arthritis
423441|NCT01763684|Knee Arthritis|knee arthritis
423442|NCT01763684|Knee Replacement|knee replacement
423443|NCT01763671|Lung cancer|lung cancer
423444|NCT01763671|Paclitaxel bevacizumab|paclitaxel bevacizumab
423445|NCT01763658|ITP, antioxidant therapy, oxidant status|itp, antioxidant therapy, oxidant status
423446|NCT01763645|NSCLC|nsclc
423447|NCT01763645|bevacizumab|bevacizumab
423448|NCT01763645|pharmacokinetics|pharmacokinetics
423449|NCT01763632|Hyperbilirubinemia|hyperbilirubinemia
423450|NCT01763632|Neonatal|neonatal
423451|NCT01763632|Transcutaneous Bilirubin|transcutaneous bilirubin
423452|NCT01763619|Cervical DDD|cervical ddd
423453|NCT01763619|DDD|ddd
423454|NCT01763619|degenerative disc disease|degenerative disc disease
423455|NCT01763619|C3-C7|c3-c7
423456|NCT01763606|Enoxaparin|enoxaparin
423457|NCT01763606|Aspirin|aspirin
423458|NCT01763606|stroke|stroke
423459|NCT01763606|12-264|12-264
423460|NCT01763593|Patients having cataract|patients having cataract
423461|NCT01763580|Glomerulonephritis|glomerulonephritis
423462|NCT01763580|Tacrolimus|tacrolimus
423463|NCT01763580|Nephrotic syndrome|nephrotic syndrome
423464|NCT01763567|Medtronic|medtronic
423465|NCT01763567|Diabetes|diabetes
423466|NCT01763567|Hospital|hospital
423467|NCT01763567|Continuous Glucose Monitor|continuous glucose monitor
423468|NCT01763567|Intensive Care Unit|intensive care unit
423469|NCT01763554|Lu-177|lu-177
423470|NCT01763554|Lutetium-177|lutetium-177
423471|NCT01763554|DOTA-TATE|dota-tate
423472|NCT01763554|Neuroendocrine tumors|neuroendocrine tumors
423473|NCT01763554|radiopharmaceutical|radiopharmaceutical
423474|NCT01763541|Natriuretic Peptides|natriuretic peptides
423475|NCT01763528|body weight|body weight
423476|NCT01763528|Low-density-lipoprotein-type|low-density-lipoprotein-type
423477|NCT01763515|Joint Diseases|joint diseases
423478|NCT01763515|Arthritis|arthritis
423479|NCT01763515|Osteoarthritis|osteoarthritis
423480|NCT01763502|Cognitive development|cognitive development
423481|NCT01763502|Anemia|anemia
423482|NCT01763502|Preschool|preschool
423483|NCT01763502|Food transfers|food transfers
423484|NCT01763502|Cash transfers|cash transfers
423485|NCT01763502|Early childhood|early childhood
423487|NCT01763489|randomized controlled trial|randomized controlled trial
423488|NCT01763489|applicability|applicability
423489|NCT01763489|ASSIST tool|assist tool
423490|NCT01763489|surgery|surgery
423491|NCT01763489|digestive cancer|digestive cancer
423492|NCT01763476|long infrapopliteal artery lesions|long infrapopliteal artery lesions
423493|NCT01763476|drug-coated balloon angioplasty|drug-coated balloon angioplasty
423494|NCT01763476|atherectomy|atherectomy
423495|NCT01763463|pneumonia requiring hospitalization|pneumonia requiring hospitalization
423496|NCT01763463|COPD|copd
423497|NCT01763463|long-acting bronchodilators (LABD)|long-acting bronchodilators (labd)
423498|NCT01763463|Inhaled Corticosteroids (ICS)|inhaled corticosteroids (ics)
423499|NCT01763450|Bevacizumab|bevacizumab
423500|NCT01763450|conversion therapy|conversion therapy
423501|NCT01763450|liver metastases|liver metastases
423502|NCT01763450|colorectal cancer|colorectal cancer
423503|NCT01763450|objective response rate|objective response rate
423504|NCT01763437|Chalazia|chalazia
423505|NCT01763437|Chalazion|chalazion
423506|NCT01763437|Meibomian gland dysfunction|meibomian gland dysfunction
423507|NCT01763437|Rosacea|rosacea
423508|NCT01763437|Ocular rosacea|ocular rosacea
423509|NCT01763411|Cataract|cataract
423510|NCT01763411|Vision|vision
423511|NCT01763411|Intraocular lens|intraocular lens
423512|NCT01763411|Multifocal|multifocal
423513|NCT01763411|Monofocal|monofocal
423514|NCT01763385|Erlotinib|erlotinib
423515|NCT01763385|brain radiotherapy|brain radiotherapy
423516|NCT01763385|NSCLC|nsclc
423517|NCT01763385|brain metastases|brain metastases
423518|NCT01763372|Arthroscopic|arthroscopic
423519|NCT01763372|Iliopsoas|iliopsoas
423520|NCT01763372|MRI|mri
423521|NCT01763359|acetabular fracture|acetabular fracture
423522|NCT01763359|pelvic fracture|pelvic fracture
423523|NCT01763359|hip adductor strength|hip adductor strength
423524|NCT01763359|obturator nerve palsy|obturator nerve palsy
423525|NCT01763359|modified Stoppa approach|modified stoppa approach
423526|NCT01763346|type 2 diabetes|type 2 diabetes
423527|NCT01763346|prediabetes|prediabetes
423528|NCT01763346|obesity|obesity
423529|NCT01763346|gastric banding|gastric banding
423530|NCT01763346|metformin|metformin
423531|NCT01763320|ischemic stroke|ischemic stroke
423532|NCT01763320|intracranial stenting|intracranial stenting
423533|NCT01763320|vascular risk factor management|vascular risk factor management
423534|NCT01763307|EGFRI|egfri
423535|NCT01763307|COLON CANCER|colon cancer
423536|NCT01763307|SKIN TOXICITY|skin toxicity
423537|NCT01763307|RECONVAL K1 cream|reconval k1 cream
423538|NCT01763294|multifocal refractory epilepsy|multifocal refractory epilepsy
423539|NCT01763294|tDCS|tdcs
423540|NCT01763294|neurostimulation|neurostimulation
423541|NCT01763294|seizures|seizures
423542|NCT01763268|Immunogenicity|immunogenicity
423543|NCT01763268|Reactogenicity|reactogenicity
423544|NCT01763268|Trivivac|trivivac
423545|NCT01763268|Measles|measles
423546|NCT01763268|Mump|mump
423547|NCT01763268|Rubella|rubella
423548|NCT01763255|cerebral palsy CD133 cells intrathecal injection|cerebral palsy cd133 cells intrathecal injection
423549|NCT01763242|CKD, Anaemia, Synchronization, Monthly dosing, Home Delivery|ckd, anaemia, synchronization, monthly dosing, home delivery
423550|NCT01763216|depressive symptoms|depressive symptoms
423551|NCT01763216|clinical depression|clinical depression
423552|NCT01763216|visual processing speed|visual processing speed
423553|NCT01763216|anxiety|anxiety
423554|NCT01763216|pain|pain
423555|NCT01763216|health-related quality of life|health-related quality of life
423556|NCT01763203|Self-management|self-management
423557|NCT01763203|Chronic Care Model|chronic care model
423558|NCT01763203|Community health worker|community health worker
423559|NCT01763177|nebulizer|nebulizer
423560|NCT01763177|oxygen|oxygen
423561|NCT01763177|post-operative sore throat|post-operative sore throat
423562|NCT01763164|Melanoma|melanoma
423563|NCT01763164|Cutaneous melanoma|cutaneous melanoma
423564|NCT01763164|Skin disease|skin disease
423565|NCT01763164|Skin cancer|skin cancer
423566|NCT01763164|Skin Neoplasms|skin neoplasms
423567|NCT01763164|Neoplasm Metastasis|neoplasm metastasis
423568|NCT01763151|cataract surgery, astigmatism, opposite clear corneal incision, toric IOL, IOL rotational stability|cataract surgery, astigmatism, opposite clear corneal incision, toric iol, iol rotational stability
423569|NCT01763125|circulating tumor cells|circulating tumor cells
423570|NCT01763125|CTC|ctc
423571|NCT01763125|tumor marker|tumor marker
423572|NCT01763112|Influence of training with whole body vibration device|influence of training with whole body vibration device
423573|NCT01763099|Autologous Hematopoietic Stem Cell Transplantation|autologous hematopoietic stem cell transplantation
423574|NCT01763099|Mesenchymal Stem Cells|mesenchymal stem cells
423575|NCT01763099|Cord Blood|cord blood
423576|NCT01763099|Graft failure|graft failure
423577|NCT01763086|Poor Graft Function|poor graft function
423578|NCT01763086|Mesenchymal Stem Cells|mesenchymal stem cells
423579|NCT01763086|Allogeneic hematopoietic stem cell transplantation|allogeneic hematopoietic stem cell transplantation
423580|NCT01763086|Third-party Donors|third-party donors
423581|NCT01763060|ards|ards
423582|NCT01763060|ecmo|ecmo
423583|NCT01763060|h1n1|h1n1
423584|NCT01763060|pandemics|pandemics
423585|NCT01763021|Healthy participants|healthy participants
423586|NCT01763021|PCI-32765|pci-32765
423587|NCT01763021|Rifampin|rifampin
423588|NCT01763021|PCI-45227|pci-45227
423589|NCT01763021|CYP3A4|cyp3a4
423590|NCT01763008|Pneumonia, Bacterial|pneumonia, bacterial
423591|NCT01763008|Nosocomial Infection|nosocomial infection
423592|NCT01763008|Intraabdominal Infections|intraabdominal infections
423593|NCT01763008|Urinary Tract Infection|urinary tract infection
423594|NCT01763008|Ventilator-associated pneumonia|ventilator-associated pneumonia
423595|NCT01763008|Doripenem|doripenem
423596|NCT01763008|Doribax|doribax
423597|NCT01763008|Filipino|filipino
423598|NCT01762995|Dolutegravir, pharmacokinetics, calcium, iron, drug interaction, healthy volunteers|dolutegravir, pharmacokinetics, calcium, iron, drug interaction, healthy volunteers
423599|NCT01762956|Pelvic floor|pelvic floor
423600|NCT01762956|Physical Therapy|physical therapy
423601|NCT01762956|Prostate cancer|prostate cancer
423602|NCT01762956|Radiotherapy|radiotherapy
423603|NCT01762956|Nuclear magnetic resonance|nuclear magnetic resonance
423604|NCT01762904|Antiseptics|antiseptics
423605|NCT01762904|Administration cutaneously|administration cutaneously
423606|NCT01762904|Anti-infecting agents, local|anti-infecting agents, local
423607|NCT01762891|Coumadin|coumadin
423608|NCT01762891|celecoxib|celecoxib
423609|NCT01762891|rofecoxib|rofecoxib
423610|NCT01762891|acetaminophen|acetaminophen
423611|NCT01762891|antiphospholipid syndrome and INR|antiphospholipid syndrome and inr
423612|NCT01762878|pharmacodynamics|pharmacodynamics
423613|NCT01762878|pharmacokinetics|pharmacokinetics
423614|NCT01762878|healthy volunteers|healthy volunteers
423615|NCT01762878|Pi3K-delta|pi3k-delta
423616|NCT01762878|GSK2269557|gsk2269557
423617|NCT01762878|safety|safety
423618|NCT01762878|dry powder inhaler|dry powder inhaler
423619|NCT01762865|acute bronchitis, bacteria, virus, clinical symoptoms|acute bronchitis, bacteria, virus, clinical symoptoms
423620|NCT01762852|Benlysta|benlysta
423621|NCT01762852|efficacy|efficacy
423622|NCT01762852|proteinuria|proteinuria
423623|NCT01762852|Idiopathic membranous nephropathy|idiopathic membranous nephropathy
423624|NCT01762852|GSK1550188|gsk1550188
423625|NCT01762852|anti-phospholipase A2 receptor antibodies|anti-phospholipase a2 receptor antibodies
423626|NCT01762852|safety|safety
423627|NCT01762852|placebo|placebo
423628|NCT01762852|BLyS|blys
423629|NCT01762852|belimumab|belimumab
423630|NCT01762852|Lymphostat-B|lymphostat-b
423631|NCT01762852|membrane attack complex|membrane attack complex
423632|NCT01762826|Inositol|inositol
423634|NCT01762813|Colon cancer|colon cancer
423635|NCT01762813|rectal cancer|rectal cancer
423636|NCT01762813|liver metastasis|liver metastasis
423637|NCT01762813|survival|survival
423638|NCT01762813|biomarker|biomarker
423639|NCT01762813|molecular profile|molecular profile
423640|NCT01762774|COPD|copd
423641|NCT01762774|forearm blood flow|forearm blood flow
423642|NCT01762774|soluble Epoxide Hydrolase inhibitor|soluble epoxide hydrolase inhibitor
423643|NCT01762761|eltrombopag|eltrombopag
423644|NCT01762761|TPO-R agonist|tpo-r agonist
423645|NCT01762761|Chronic ITP|chronic itp
423646|NCT01762748|Probiotic|probiotic
423647|NCT01762748|liver|liver
423648|NCT01762748|transplant|transplant
423649|NCT01762748|permeability|permeability
423650|NCT01762722|Spectroscopy, near infrared|spectroscopy, near infrared
423651|NCT01762722|Oximetry|oximetry
423652|NCT01762722|Hypoxemia|hypoxemia
423653|NCT01762722|Tissue oxygenation|tissue oxygenation
423654|NCT01762709|Video-assisted thoracoscopic surgery|video-assisted thoracoscopic surgery
423655|NCT01762709|one lung ventilation|one lung ventilation
423656|NCT01762709|low tidal volume|low tidal volume
423657|NCT01762709|acute lung injury|acute lung injury
423658|NCT01762709|lung water content|lung water content
423659|NCT01762696|marijuana|marijuana
423660|NCT01762696|intervention|intervention
423661|NCT01762696|adolescent, young adult|adolescent, young adult
423662|NCT01762696|primary care|primary care
423663|NCT01762696|mobile|mobile
423664|NCT01762683|pregnancy|pregnancy
423665|NCT01762683|obesity|obesity
423666|NCT01762683|differentiation|differentiation
423667|NCT01762670|Bacterial Vaginosis|bacterial vaginosis
423668|NCT01762670|BV|bv
423669|NCT01762657|Type 1 Diabetes|type 1 diabetes
423670|NCT01762657|Insulin Independence|insulin independence
423671|NCT01762657|Beta Regeneration|beta regeneration
423672|NCT01762657|Immune Tolerance Agent|immune tolerance agent
423673|NCT01762657|Lanzoprazole|lanzoprazole
423674|NCT01762657|Cyclosporine|cyclosporine
423675|NCT01762644|Type 1 Diabetes|type 1 diabetes
423676|NCT01762644|Insulin Independence|insulin independence
423677|NCT01762644|Beta Regeneration|beta regeneration
423678|NCT01762644|Immune Tolerance Agent|immune tolerance agent
423679|NCT01762644|Omeprazole|omeprazole
423680|NCT01762644|Cyclosporine|cyclosporine
423681|NCT01762618|Group Cognitive Behavior Therapy, Alzheimer's disease, Caregivers¡|group cognitive behavior therapy, alzheimer's disease, caregivers¡
423682|NCT01762579|Not-celiac wheat sensitivity|not-celiac wheat sensitivity
423683|NCT01762579|Gluten|gluten
423684|NCT01762579|esophagogastroduodenoscopy|esophagogastroduodenoscopy
423685|NCT01762579|Rectoscopy|rectoscopy
423686|NCT01762566|Not-celiac gluten (wheat) sensitivity|not-celiac gluten (wheat) sensitivity
423687|NCT01762566|Bioelectrical impedance analysis|bioelectrical impedance analysis
423688|NCT01762566|Bloating|bloating
423689|NCT01762566|Swelling|swelling
423690|NCT01762540|Protein breakdown|protein breakdown
423691|NCT01762540|Insulin resistance|insulin resistance
423692|NCT01762540|Glucose intolerance|glucose intolerance
423693|NCT01762540|Lipolysis|lipolysis
423694|NCT01762527|Adaptive radiotherapy|adaptive radiotherapy
423695|NCT01762527|Bladder cancer|bladder cancer
423696|NCT01762514|Nasopharyngeal carcinoma|nasopharyngeal carcinoma
423697|NCT01762514|Amifostine|amifostine
423698|NCT01762514|Myelosuppression|myelosuppression
423699|NCT01762514|Xerostomia|xerostomia
423700|NCT01762514|Mucositis|mucositis
423701|NCT01762501|Hypertension|hypertension
423702|NCT01762488|Treatment Resistant Hypertension|treatment resistant hypertension
423703|NCT01762488|Renal Denervation|renal denervation
423704|NCT01762475|Magnetic resonance imaging|magnetic resonance imaging
423705|NCT01762475|Blood oxygen level dependent signal|blood oxygen level dependent signal
423706|NCT01762475|Hypercapnia|hypercapnia
423707|NCT01762475|Endothelial progenitor cells|endothelial progenitor cells
423708|NCT01762449|Scleroderma|scleroderma
423709|NCT01762449|interstitial lung disease|interstitial lung disease
423710|NCT01762410|Advanced refractory solid tumors|advanced refractory solid tumors
423711|NCT01762371|ACL|acl
423712|NCT01762371|Knee|knee
423713|NCT01762371|Ligament|ligament
423714|NCT01762371|Cruciate|cruciate
423715|NCT01762371|Anterior|anterior
423716|NCT01762358|ACL|acl
423717|NCT01762358|Ligament|ligament
423718|NCT01762358|Knee|knee
423719|NCT01762345|Stress urinary incontinence|stress urinary incontinence
423720|NCT01762345|SUI|sui
423721|NCT01762332|nociception|nociception
423722|NCT01762332|analgesia|analgesia
423723|NCT01762332|intraoperative monitoring|intraoperative monitoring
423724|NCT01762293|CRC|crc
423725|NCT01762293|Famitinib|famitinib
423726|NCT01762293|Phase II|phase ii
423727|NCT01762293|Colorectal Cancer|colorectal cancer
423728|NCT01762280|Famitinib|famitinib
423729|NCT01762280|Advanced Solid tumor|advanced solid tumor
423730|NCT01762280|Phase I|phase i
423731|NCT01762254|pain score|pain score
423732|NCT01762254|complication|complication
423733|NCT01762241|Prostate cancer|prostate cancer
423734|NCT01762241|Androgen deprivation therapy|androgen deprivation therapy
423735|NCT01762241|Exercise|exercise
423736|NCT01762241|Xbox|xbox
423737|NCT01762228|Oropharyngeal dysphagia|oropharyngeal dysphagia
423738|NCT01762228|Elderly|elderly
423739|NCT01762228|Transcutaneous electrical stimulation|transcutaneous electrical stimulation
423740|NCT01762228|TRPV1 agonist|trpv1 agonist
423741|NCT01762215|Epilepsy|epilepsy
423742|NCT01762215|Seizure|seizure
423743|NCT01762215|Veteran|veteran
423744|NCT01762202|CLL|cll
423745|NCT01762202|Fludarabine|fludarabine
423746|NCT01762202|Cyclophosphamide|cyclophosphamide
423747|NCT01762202|Ofatumumab|ofatumumab
423748|NCT01762189|Hyperbilirubinemia|hyperbilirubinemia
423749|NCT01762189|Neonatal|neonatal
423750|NCT01762189|Incidence|incidence
423751|NCT01762189|Risk factors|risk factors
423752|NCT01762176|Early Rheumatoid Arthritis|early rheumatoid arthritis
423753|NCT01762176|Usual care|usual care
423754|NCT01762176|Intensive Care|intensive care
423755|NCT01762176|Boolean criteria|boolean criteria
423756|NCT01762163|Ischemic Stroke,adaptive design, randomized, double-blind|ischemic stroke,adaptive design, randomized, double-blind
423757|NCT01762150|collected duct carcinoma|collected duct carcinoma
423758|NCT01762150|sorafenib|sorafenib
423759|NCT01762137|Aneurysm|aneurysm
423760|NCT01762137|Coiling|coiling
423761|NCT01762137|Flow Diversion|flow diversion
423762|NCT01762124|Pulmonary valve|pulmonary valve
423763|NCT01762124|Congenital heart disease|congenital heart disease
423764|NCT01762124|Transcatheter pulmonary valve|transcatheter pulmonary valve
423765|NCT01762124|Percutaneous pulmonary valve|percutaneous pulmonary valve
423766|NCT01762111|Anti-Mullerian Hormone|anti-mullerian hormone
423767|NCT01762111|In-Vitro fertilization|in-vitro fertilization
423768|NCT01762098|In vitro fertilization|in vitro fertilization
423769|NCT01762098|Hysteroscopy|hysteroscopy
423770|NCT01762098|Endometrial biopsy|endometrial biopsy
423771|NCT01762085|neuropathic diabetic foot ulcer|neuropathic diabetic foot ulcer
423772|NCT01762085|nerve decompression surgery|nerve decompression surgery
423773|NCT01762072|homocysteine-vitamin B12-fish oil-ferritin|homocysteine-vitamin b12-fish oil-ferritin
423774|NCT01762059|bionic pancreas|bionic pancreas
423775|NCT01762059|artificial pancreas|artificial pancreas
423776|NCT01762059|insulin|insulin
423777|NCT01762059|glucagon|glucagon
423778|NCT01762059|continuous glucose monitoring|continuous glucose monitoring
423779|NCT01762059|CGM|cgm
423780|NCT01762059|outpatient|outpatient
423781|NCT01762059|insulin pump|insulin pump
423782|NCT01762046|Diabetes Mellitus, Type 2|diabetes mellitus, type 2
423972|NCT01761149|opioid,|opioid,
423783|NCT01762046|Pharmacogenetics|pharmacogenetics
423784|NCT01762046|Genetics|genetics
423785|NCT01762046|Obesity|obesity
423786|NCT01762033|Renal cell carcinoma|renal cell carcinoma
423787|NCT01762033|Renal cell cancer|renal cell cancer
423788|NCT01762033|ASONEP|asonep
423789|NCT01762033|Sonepcizumab|sonepcizumab
423790|NCT01762020|Women with Breast Cancer|women with breast cancer
423791|NCT01762020|Receiving Adjuvant Radiation Therapy|receiving adjuvant radiation therapy
423792|NCT01762007|hypospadias, bladder outlet obstruction, ultrasonography|hypospadias, bladder outlet obstruction, ultrasonography
423793|NCT01761994|nafamostat mesilate|nafamostat mesilate
423794|NCT01761994|heparin|heparin
423795|NCT01761994|continuous renal replacement therapy|continuous renal replacement therapy
423796|NCT01761981|Haemorrhagic Hereditary Telangiectasia|haemorrhagic hereditary telangiectasia
423797|NCT01761981|Rendu Osler Weber Syndrome|rendu osler weber syndrome
423798|NCT01761981|Osler Weber Rendu Syndrome|osler weber rendu syndrome
423799|NCT01761981|HHT|hht
423800|NCT01761968|chronic myeloproliferative neoplasms|chronic myeloproliferative neoplasms
423801|NCT01761968|Polycythemia Vera|polycythemia vera
423802|NCT01761968|Essential Thrombocythemia|essential thrombocythemia
423803|NCT01761968|Primary Myelofibrosis|primary myelofibrosis
423804|NCT01761968|Post-Polycythemia Vera Myelofibrosis|post-polycythemia vera myelofibrosis
710229|NCT00589654|menstrual cycle|menstrual cycle
423805|NCT01761968|Post-Essential Thrombocythemia Myelofibrosis|post-essential thrombocythemia myelofibrosis
423806|NCT01761968|Givinostat|givinostat
423807|NCT01761955|body weight|body weight
423808|NCT01761955|lipids|lipids
423809|NCT01761955|glucose|glucose
423810|NCT01761955|insulin|insulin
423811|NCT01761942|omega-3 fatty acids|omega-3 fatty acids
423812|NCT01761942|anorexia nervosa|anorexia nervosa
423813|NCT01761942|efficacy|efficacy
423814|NCT01761942|safety|safety
423815|NCT01761929|oligometastatic|oligometastatic
423816|NCT01761929|oligometastases|oligometastases
423817|NCT01761929|stereotactic body radiotherapy|stereotactic body radiotherapy
423818|NCT01761929|radiation therapy|radiation therapy
423819|NCT01761929|Oligometastasis|oligometastasis
423820|NCT01761929|Stereotactic ablative body|stereotactic ablative body
423821|NCT01761929|radiotherapy|radiotherapy
423822|NCT01761916|captopril, clonidine, pregnancy-induced hypertension,|captopril, clonidine, pregnancy-induced hypertension,
423823|NCT01761890|Chronic Myeloid Leukemia|chronic myeloid leukemia
423824|NCT01761890|Early phase|early phase
423825|NCT01761890|CML|cml
423826|NCT01761890|Dasatinib|dasatinib
423827|NCT01761877|breast cancer, nonsteroidal antiinflammatory drug , breast density, chemoprevention, aromatase inhibitors|breast cancer, nonsteroidal antiinflammatory drug , breast density, chemoprevention, aromatase inhibitors
423828|NCT01761851|Resting metabolic rate|resting metabolic rate
423829|NCT01761851|nutrition status|nutrition status
423830|NCT01761851|dietary intake|dietary intake
423831|NCT01761838|spinal manipulative therapy|spinal manipulative therapy
423832|NCT01761838|low back pain|low back pain
423833|NCT01761838|experimental pain|experimental pain
423834|NCT01761838|spinal stiffness|spinal stiffness
423835|NCT01761838|lumbar multifidus|lumbar multifidus
423836|NCT01761838|degeneration|degeneration
423837|NCT01761812|Prostate cancer|prostate cancer
423838|NCT01761812|MRI|mri
423839|NCT01761812|Elastography|elastography
423840|NCT01761812|Gadofosveset|gadofosveset
423841|NCT01761799|Influenza|influenza
423842|NCT01761799|Pertussis|pertussis
423843|NCT01761799|Vaccination|vaccination
423844|NCT01761786|Myocardial Infarction|myocardial infarction
423845|NCT01761786|Thrombosis|thrombosis
423846|NCT01761786|Acute Coronary Syndrome|acute coronary syndrome
423847|NCT01761786|Myocardial Ischemia|myocardial ischemia
423848|NCT01761786|Heart Diseases|heart diseases
423849|NCT01761786|Cardiovascular Diseases|cardiovascular diseases
423850|NCT01761786|Vascular Diseases|vascular diseases
423851|NCT01761786|Embolism and Thrombosis|embolism and thrombosis
423852|NCT01761786|Genetic Testing|genetic testing
423853|NCT01761786|Clopidogrel|clopidogrel
423854|NCT01761786|Prasugrel|prasugrel
423855|NCT01761786|Ticagrelor|ticagrelor
423856|NCT01761786|Platelet Aggregation Inhibitors|platelet aggregation inhibitors
423857|NCT01761786|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists
423858|NCT01761747|Squamous Cell Carcinoma|squamous cell carcinoma
423859|NCT01761734|Influenza vaccination|influenza vaccination
423860|NCT01761721|Endometrial cancer (MeSH)|endometrial cancer (mesh)
423861|NCT01761721|Robotics (MeSH)|robotics (mesh)
423862|NCT01761708|primary ventral hernia repair with mesh|primary ventral hernia repair with mesh
423863|NCT01761708|umbilical hernia repair|umbilical hernia repair
423864|NCT01761708|epigastric hernia repair|epigastric hernia repair
423865|NCT01761708|C-Qur V-patch|c-qur v-patch
423866|NCT01761708|Size tailored repair|size tailored repair
423867|NCT01761708|preperitoneal repair|preperitoneal repair
423868|NCT01761708|abdominal hernia|abdominal hernia
423869|NCT01761708|dual sided mesh|dual sided mesh
423870|NCT01761708|trocar-site hernia|trocar-site hernia
423871|NCT01761656|stable angina|stable angina
423872|NCT01761656|unstable angina|unstable angina
423873|NCT01761656|acute non-ST-segment elevation myocardial infarction|acute non-st-segment elevation myocardial infarction
423874|NCT01761656|PCI|pci
424263|NCT01759771|Vitamin D3|vitamin d3
423875|NCT01761656|perioperative myocardial infarction|perioperative myocardial infarction
423876|NCT01761656|major adverse cardiac events|major adverse cardiac events
423877|NCT01761643|PrEP|prep
423878|NCT01761643|Pre exposure Prophylaxis|pre exposure prophylaxis
423879|NCT01761643|Text Messaging|text messaging
423880|NCT01761643|Truvada|truvada
423881|NCT01761643|iTab|itab
423882|NCT01761643|CCTG|cctg
423883|NCT01761643|595|595
423884|NCT01761630|Asthma|asthma
423885|NCT01761630|Severe Asthma|severe asthma
423886|NCT01761630|SARP|sarp
423887|NCT01761617|Yoga|yoga
423888|NCT01761617|Chronic Low Back Pain|chronic low back pain
423889|NCT01761617|CAM|cam
423890|NCT01761617|Complementary and Alternative Medicine|complementary and alternative medicine
423891|NCT01761617|Minorities|minorities
423892|NCT01761591|CAD|cad
423893|NCT01761591|PCI|pci
423894|NCT01761591|BMS|bms
423895|NCT01761591|Svelte|svelte
423896|NCT01761591|Acrobat|acrobat
423897|NCT01761591|direct stenting|direct stenting
423898|NCT01761591|RCT|rct
423899|NCT01761578|Bioresorbable|bioresorbable
423900|NCT01761578|Coronary|coronary
423901|NCT01761578|Stent|stent
423902|NCT01761578|Vascular Remodeling|vascular remodeling
423903|NCT01761578|Angioplasty|angioplasty
423904|NCT01761578|Coronary Artery Disease|coronary artery disease
423905|NCT01761552|in ASA 4 AND ASA 4E patients|in asa 4 and asa 4e patients
423906|NCT01761539|pancreatitis|pancreatitis
423907|NCT01761539|pancreatitis, alcoholic|pancreatitis, alcoholic
423908|NCT01761526|Rotigotine|rotigotine
423909|NCT01761526|Neupro|neupro
423910|NCT01761526|Japanese|japanese
423911|NCT01761526|Caucasian|caucasian
423912|NCT01761526|Male|male
423913|NCT01761526|Female|female
423914|NCT01761526|Single dose|single dose
423915|NCT01761526|Pharmacokinetics|pharmacokinetics
423916|NCT01761500|Non-Hodgkin's lymphoma;|non-hodgkin's lymphoma;
423917|NCT01761500|Childhood and adolescence;|childhood and adolescence;
423918|NCT01761500|Survival Rate|survival rate
423919|NCT01761474|Carbon dioxide insufflation|carbon dioxide insufflation
423920|NCT01761474|Air insufflatioin|air insufflatioin
423921|NCT01761474|ERCP|ercp
423922|NCT01761474|Sedation|sedation
423923|NCT01761448|Coronary Artery Disease|coronary artery disease
423924|NCT01761448|Cardiac rehabilitation program|cardiac rehabilitation program
423925|NCT01761448|telemedical homely rehabilitation|telemedical homely rehabilitation
423926|NCT01761448|guided exercise|guided exercise
423927|NCT01761448|ECG- vest|ecg- vest
423928|NCT01761435|Influenza|influenza
423929|NCT01761435|Solid Organ Transplant Recipients|solid organ transplant recipients
423930|NCT01761396|Anxiety|anxiety
423931|NCT01761396|Fear|fear
423932|NCT01761396|Worry|worry
423933|NCT01761396|Therapy|therapy
423934|NCT01761396|Cognitive behavioral therapy|cognitive behavioral therapy
423935|NCT01761383|Chronic Schizophrenia|chronic schizophrenia
423936|NCT01761383|Nintendo Wii|nintendo wii
423937|NCT01761383|Quality of Life|quality of life
423938|NCT01761370|Non alcoholic Steatohepatitis|non alcoholic steatohepatitis
423939|NCT01761370|Intra-gastric balloon|intra-gastric balloon
423940|NCT01761357|Aortic valve stenosis|aortic valve stenosis
423941|NCT01761357|Quality of life|quality of life
423942|NCT01761357|Burden co morbidities|burden co morbidities
423943|NCT01761357|Transcatheter aortic valve implantation|transcatheter aortic valve implantation
423944|NCT01761357|Geriatric assessment|geriatric assessment
423945|NCT01761331|infant, colic, crying, acupuncture, stooling, sleep|infant, colic, crying, acupuncture, stooling, sleep
423946|NCT01761318|Diabetes mellitus type 2|diabetes mellitus type 2
423947|NCT01761318|Glucagon-Like Peptide 1|glucagon-like peptide 1
423948|NCT01761318|Magnetic Resonance Imaging|magnetic resonance imaging
423949|NCT01761318|Magnetic Resonance Spectroscopy|magnetic resonance spectroscopy
423950|NCT01761318|Steatosis|steatosis
423951|NCT01761305|Idiopathic scoliosis|idiopathic scoliosis
423952|NCT01761305|Brace|brace
423953|NCT01761305|Scoliosis specific exercise|scoliosis specific exercise
423954|NCT01761305|Physical activity|physical activity
423955|NCT01761279|Colonic polyps|colonic polyps
423956|NCT01761266|Hepatocellular Carcinoma|hepatocellular carcinoma
423957|NCT01761266|Neoplasms|neoplasms
423958|NCT01761266|Cancer|cancer
423959|NCT01761253|comorbidity, multiple chronic conditions, Medicaid, prediction of cost|comorbidity, multiple chronic conditions, medicaid, prediction of cost
423960|NCT01761253|Predictive models, cost containment, managed care|predictive models, cost containment, managed care
423961|NCT01761227|Vascular dementia|vascular dementia
423962|NCT01761227|Fufangdanshen Tablets|fufangdanshen tablets
423963|NCT01761227|Randomized Controlled trial|randomized controlled trial
423964|NCT01761227|Chinese Medicine|chinese medicine
423965|NCT01761214|bacteriology, inflammation, bronchiectasis, exacerbation|bacteriology, inflammation, bronchiectasis, exacerbation
423966|NCT01761201|Prophylaxis|prophylaxis
423967|NCT01761201|Tuberculosis|tuberculosis
423968|NCT01761201|Transplant recipients|transplant recipients
423969|NCT01761201|Transplant waiting list|transplant waiting list
423970|NCT01761188|Persistent Atrial fibrillation;LA substrate;ablation;voltage mapping|persistent atrial fibrillation;la substrate;ablation;voltage mapping
423971|NCT01761149|remifentanil,|remifentanil,
423973|NCT01761149|hyperalgesia,|hyperalgesia,
423974|NCT01761149|visual analogue score|visual analogue score
423975|NCT01761149|thyroidectomy,|thyroidectomy,
423976|NCT01761123|Prevention of Influenza|prevention of influenza
423977|NCT01761110|Opioid dependence|opioid dependence
423978|NCT01761110|Injection drug use|injection drug use
423979|NCT01761110|Buprenorphine|buprenorphine
423980|NCT01761110|Opioid agonist treatment|opioid agonist treatment
423981|NCT01761110|Access to care|access to care
423982|NCT01761110|HIV risk behaviors|hiv risk behaviors
423984|NCT01761097|Adenoma, polyp, colonoscopy.|adenoma, polyp, colonoscopy.
423985|NCT01761084|Osteoporosis|osteoporosis
423986|NCT01761084|Spine fracture|spine fracture
423987|NCT01761084|Vertebral fracture|vertebral fracture
423988|NCT01761084|Exercise Interventions|exercise interventions
423989|NCT01761084|Exercise|exercise
423990|NCT01761058|Asthma|asthma
423991|NCT01761058|Bronchial Diseases|bronchial diseases
423992|NCT01761058|Respiratory Tract Diseases|respiratory tract diseases
423993|NCT01761058|Lung Diseases, Obstructive|lung diseases, obstructive
423994|NCT01761058|Lung Diseases|lung diseases
423995|NCT01761058|Respiratory Hypersensitivity|respiratory hypersensitivity
423996|NCT01761058|Hypersensitivity, Immediate|hypersensitivity, immediate
423997|NCT01761058|Hypersensitivity|hypersensitivity
423998|NCT01761058|Immune System Disease|immune system disease
423999|NCT01761045|Monosodium L-Glutamate (MSG)|monosodium l-glutamate (msg)
424000|NCT01761045|Nucleic Acid (IMP)|nucleic acid (imp)
424001|NCT01761045|Satiety|satiety
424002|NCT01761045|Gastrointestinal Sensation|gastrointestinal sensation
424003|NCT01761045|Consommé Soups|consommé soups
424004|NCT01761045|Snack Intake|snack intake
424005|NCT01761032|Tanning|tanning
424006|NCT01761032|neuroimaging|neuroimaging
424007|NCT01761032|dopamine|dopamine
424008|NCT01761032|MRI|mri
424009|NCT01761032|SPECT|spect
424010|NCT01761019|psoriasis|psoriasis
424011|NCT01761019|Taclonex|taclonex
424012|NCT01761019|Acitretin|acitretin
424013|NCT01761019|Methotrexate|methotrexate
424014|NCT01761006|COPD|copd
424015|NCT01761006|Chronic Obstructive Pulmonary Disease|chronic obstructive pulmonary disease
424016|NCT01761006|Exhaled Nitric Oxide|exhaled nitric oxide
424017|NCT01761006|NIOX MINO|niox mino
424018|NCT01761006|Acute COPD exacerbation|acute copd exacerbation
424019|NCT01760993|Not Required|not required
424020|NCT01760980|Rate and extend of absorption of Exemestane|rate and extend of absorption of exemestane
424021|NCT01760967|Dexmedetomidine|dexmedetomidine
424022|NCT01760967|sepsis|sepsis
424023|NCT01760967|mortality|mortality
424024|NCT01760967|duration of mechanical ventilation|duration of mechanical ventilation
424025|NCT01760967|organ failure|organ failure
424026|NCT01760954|Endometriosis associated pain|endometriosis associated pain
424027|NCT01760954|Elagolix|elagolix
424028|NCT01760954|Gonadotropin-Releasing Hormone Antagonist|gonadotropin-releasing hormone antagonist
424029|NCT01760954|Dysmenorrhea (DYS)|dysmenorrhea (dys)
424030|NCT01760954|Non-Menstrual Pelvic Pain (NMPP)|non-menstrual pelvic pain (nmpp)
424031|NCT01760941|Urology|urology
424032|NCT01760941|Prostate|prostate
424033|NCT01760941|Breast|breast
424034|NCT01760941|Lung|lung
424035|NCT01760941|Chest|chest
424036|NCT01760915|asthma|asthma
424037|NCT01760915|severe|severe
424038|NCT01760902|Inflammation|inflammation
424039|NCT01760876|Optical Coherence Tomography|optical coherence tomography
424040|NCT01760876|Biofreedom Stent|biofreedom stent
424041|NCT01760863|Revision|revision
424042|NCT01760863|Knee|knee
424043|NCT01760863|Hip|hip
424044|NCT01760863|Arthroplasty|arthroplasty
424045|NCT01760863|Oral|oral
424046|NCT01760863|Antibiotics|antibiotics
424047|NCT01760863|Infection|infection
424048|NCT01760837|cow's milk allergy|cow's milk allergy
424049|NCT01760837|baked milk|baked milk
424050|NCT01760837|tolerance|tolerance
424051|NCT01760837|infants and children|infants and children
424052|NCT01760824|Sequential|sequential
424053|NCT01760824|Quadruple|quadruple
424054|NCT01760824|First|first
424055|NCT01760824|Line|line
424056|NCT01760824|Helicobacter|helicobacter
424057|NCT01760824|pylori|pylori
424058|NCT01760824|infection|infection
424059|NCT01760811|tongue|tongue
424060|NCT01760811|Squamous cell carcinoma|squamous cell carcinoma
424061|NCT01760811|locally advanced|locally advanced
424062|NCT01760811|cetuximab|cetuximab
424063|NCT01760798|osteoporosis|osteoporosis
424064|NCT01760798|Teriparatide|teriparatide
424065|NCT01760785|Veterans|veterans
424066|NCT01760785|Traumatic Brain Injury(TBI)|traumatic brain injury(tbi)
424067|NCT01760785|Alcoholism|alcoholism
424068|NCT01760772|heart disease|heart disease
424069|NCT01760772|GLP-1|glp-1
424070|NCT01760772|Exendin-9|exendin-9
424071|NCT01760772|postprandial lipids|postprandial lipids
424072|NCT01760759|HIV|hiv
424073|NCT01760759|Antiretroviral therapy adherence|antiretroviral therapy adherence
424074|NCT01760746|Proliferative Diabetic Retinopathy|proliferative diabetic retinopathy
424075|NCT01760746|Vitrectomy|vitrectomy
424076|NCT01760746|Inflammatory Cytokines|inflammatory cytokines
424077|NCT01760707|Diabetes mellitus|diabetes mellitus
424078|NCT01760707|Peripheral neuropathy|peripheral neuropathy
424079|NCT01760707|Exercise|exercise
424080|NCT01760707|Balance performance|balance performance
424081|NCT01760694|Pancreatic|pancreatic
424082|NCT01760694|Pancreas|pancreas
424083|NCT01760694|Intraoperative Radiation Therapy|intraoperative radiation therapy
424084|NCT01760694|Chemotherapy|chemotherapy
424085|NCT01760668|Sex chromosome|sex chromosome
424086|NCT01760668|Turner Syndrome|turner syndrome
424087|NCT01760668|Marfan syndrome|marfan syndrome
424088|NCT01760668|Bicuspid aortic valve|bicuspid aortic valve
424089|NCT01760668|Aortic Aneurysm|aortic aneurysm
424090|NCT01760668|Epigenetics|epigenetics
424091|NCT01760668|Transcriptome|transcriptome
424092|NCT01760668|non-coding RNA|non-coding rna
424093|NCT01760668|Electron microscopy|electron microscopy
424094|NCT01760668|Proteomics|proteomics
424095|NCT01760642|metabolite profiles|metabolite profiles
424096|NCT01760642|pharmacokinetics|pharmacokinetics
424097|NCT01760642|CYP3A|cyp3a
424098|NCT01760642|metabolomics|metabolomics
424099|NCT01760629|Encephalopathy, Newborn, Low and Middle-income countries, Hypothermia|encephalopathy, newborn, low and middle-income countries, hypothermia
424100|NCT01760616|Huaier Granule;|huaier granule;
424101|NCT01760616|After non-radical hepatectomy;|after non-radical hepatectomy;
424102|NCT01760616|Prevention of Disease Progression of Hepatocarcinoma;|prevention of disease progression of hepatocarcinoma;
424103|NCT01760616|Safety.|safety.
424104|NCT01760603|pelvic organ prolapse|pelvic organ prolapse
424105|NCT01760590|neck pain|neck pain
424106|NCT01760590|cervical pain|cervical pain
424107|NCT01760590|pain pressure thresholds|pain pressure thresholds
424108|NCT01760590|pain catastrophizing|pain catastrophizing
424109|NCT01760577|osteoarthritis, botulinum toxin, hyaluronate|osteoarthritis, botulinum toxin, hyaluronate
424110|NCT01760564|Niemann-Pick disease type C|niemann-pick disease type c
424111|NCT01760564|miglustat|miglustat
424112|NCT01760551|Fracture|fracture
424113|NCT01760551|Trauma|trauma
424114|NCT01760551|impairment|impairment
424115|NCT01760538|Cardiac transplant recipients|cardiac transplant recipients
424116|NCT01760538|Heart rate variability|heart rate variability
424117|NCT01760538|Exercise training|exercise training
424118|NCT01760525|p53, solid tumor|p53, solid tumor
424119|NCT01760512|Gastric bypass|gastric bypass
424120|NCT01760512|Robot-assisted surgery|robot-assisted surgery
424121|NCT01760512|Conventional laparoscopy|conventional laparoscopy
424122|NCT01760512|Pain assessment|pain assessment
424123|NCT01760512|Health economics outcomes|health economics outcomes
424124|NCT01760499|skin|skin
424125|NCT01760499|metastatic|metastatic
424126|NCT01760473|opioid dependence|opioid dependence
424127|NCT01760434|scoliosis|scoliosis
424128|NCT01760434|long-term outcomes|long-term outcomes
424129|NCT01760434|sagittal plane|sagittal plane
424130|NCT01760434|quality of life|quality of life
424131|NCT01760434|curve progression|curve progression
424132|NCT01760434|pulmonary function|pulmonary function
424133|NCT01760382|Acute myocardial infarction|acute myocardial infarction
424134|NCT01760382|ST elevation myocardial infarction|st elevation myocardial infarction
424135|NCT01760382|primary PCI|primary pci
424136|NCT01760382|reperfusion therapy|reperfusion therapy
424137|NCT01760382|angioplasty|angioplasty
424138|NCT01760382|stent|stent
424139|NCT01760356|Liver transplantation|liver transplantation
424140|NCT01760356|Calcineurin inhibitors|calcineurin inhibitors
424141|NCT01760356|Pharmacodynamic biomarkers|pharmacodynamic biomarkers
424142|NCT01760356|Calcineurin pathway|calcineurin pathway
424143|NCT01760356|Tacrolimus|tacrolimus
424144|NCT01760356|interindividual variability|interindividual variability
424145|NCT01760304|COPD|copd
424146|NCT01760278|Time-lapse monitoring of embryos.|time-lapse monitoring of embryos.
424147|NCT01760278|Embryoscope|embryoscope
424148|NCT01760278|IVF-ET/ICSI|ivf-et/icsi
424149|NCT01760278|Cetrorelix|cetrorelix
424150|NCT01760278|Gonal-F|gonal-f
424151|NCT01760265|dysbetalipoproteinemia|dysbetalipoproteinemia
424152|NCT01760265|artery calcium score|artery calcium score
424153|NCT01760265|carotid intima media|carotid intima media
424154|NCT01760265|ankle brachial index|ankle brachial index
424155|NCT01760265|dysbetalipoproteinemic patients|dysbetalipoproteinemic patients
424156|NCT01760252|Pancreatic Cancer|pancreatic cancer
424157|NCT01760239|Adolescent Hypertension|adolescent hypertension
424158|NCT01760239|Adolescent Pre Hypertension|adolescent pre hypertension
424159|NCT01760239|Adolescent Pre Hypertension and Obesity|adolescent pre hypertension and obesity
424160|NCT01760226|DLBCL|dlbcl
424161|NCT01760226|Diffuse large B cell lymphoma|diffuse large b cell lymphoma
424162|NCT01760226|dose adjusted|dose adjusted
424163|NCT01760226|EPOCH|epoch
424164|NCT01760226|Etoposide|etoposide
424165|NCT01760226|Doxorubicin|doxorubicin
424166|NCT01760226|Vincristine|vincristine
424167|NCT01760226|Cyclophosphamide|cyclophosphamide
424168|NCT01760226|Prednisone|prednisone
424169|NCT01760226|Rituximab|rituximab
424170|NCT01760200|Coronary angioplasty|coronary angioplasty
424171|NCT01760200|Coronary stent|coronary stent
424459|NCT01758809|Bupivacaine|bupivacaine
424172|NCT01760200|paclitaxel drug-eluting stent|paclitaxel drug-eluting stent
424173|NCT01760200|drug eluting balloon|drug eluting balloon
424174|NCT01760174|Transversus abdominis plane catheter|transversus abdominis plane catheter
424175|NCT01760161|postoperative pain|postoperative pain
424176|NCT01760161|opioid consumption|opioid consumption
424177|NCT01760161|termanalgesia|termanalgesia
424178|NCT01760161|plasmaropivacain level|plasmaropivacain level
424179|NCT01760148|Hepatitis C Virus|hepatitis c virus
424180|NCT01760148|HCV|hcv
424181|NCT01760148|Interferon|interferon
424182|NCT01760148|Prediction|prediction
424183|NCT01760148|SVR|svr
424184|NCT01760148|Sustained Virus Response|sustained virus response
424185|NCT01760135|trauma|trauma
424186|NCT01760135|nutrition|nutrition
424187|NCT01760135|hyperglycemia|hyperglycemia
424188|NCT01760122|peginterferon|peginterferon
424189|NCT01760122|HBeAg Positive|hbeag positive
424190|NCT01760122|Chronic hepatitis B|chronic hepatitis b
710230|NCT00589654|Breast cancer|breast cancer
424191|NCT01760109|Respiratory and urinary tract infections|respiratory and urinary tract infections
424192|NCT01760109|Piperacillin Sodium and Sulbactam Sodium for Injection (2:1)|piperacillin sodium and sulbactam sodium for injection (2:1)
424193|NCT01760109|Phase IV|phase iv
424194|NCT01760096|Paroxysmal Nocturnal Hemoglobinuria|paroxysmal nocturnal hemoglobinuria
424195|NCT01760096|Anemia|anemia
424196|NCT01760096|Hematologic Diseases|hematologic diseases
424197|NCT01760096|bone marrow failure|bone marrow failure
424198|NCT01760096|Immunologic Factors|immunologic factors
424199|NCT01760096|Physiological Effects of Drugs|physiological effects of drugs
424200|NCT01760096|Levamisole|levamisole
424201|NCT01760096|cyclosporine A|cyclosporine a
424202|NCT01760070|cancer|cancer
424203|NCT01760070|endoscopy|endoscopy
424204|NCT01760070|endoscopic submucosal dissection|endoscopic submucosal dissection
424205|NCT01760044|tissue oxygenation|tissue oxygenation
424206|NCT01760044|perfusion status|perfusion status
424207|NCT01760031|preconditioning|preconditioning
424208|NCT01760031|contrast-induced acute kidney injury|contrast-induced acute kidney injury
424209|NCT01760031|renal faliure|renal faliure
424210|NCT01760018|desflurane, total intravenous anesthesia, QoR-40|desflurane, total intravenous anesthesia, qor-40
424211|NCT01760005|Alzheimer's|alzheimer's
424212|NCT01760005|Alzheimer's Disease|alzheimer's disease
424213|NCT01760005|Dementia|dementia
424214|NCT01760005|Mutation|mutation
424215|NCT01760005|Genetic Mutation|genetic mutation
424216|NCT01760005|Dominantly Inherited Alzheimer's Disease|dominantly inherited alzheimer's disease
424217|NCT01760005|Dominantly Inherited Alzheimer's Network|dominantly inherited alzheimer's network
424218|NCT01760005|Autosomal Dominant Alzheimer's Disease|autosomal dominant alzheimer's disease
424219|NCT01760005|Early Onset Alzheimer's Disease|early onset alzheimer's disease
424220|NCT01760005|DIAN|dian
424221|NCT01760005|DIAN-TU|dian-tu
424222|NCT01760005|DIAN TU|dian tu
424223|NCT01759992|Frail elderly|frail elderly
424224|NCT01759992|Muscle weakness|muscle weakness
424225|NCT01759992|Institutionalization|institutionalization
424226|NCT01759992|Respiratory muscle training|respiratory muscle training
424227|NCT01759979|Cholelithiasis, Common Bile Duct|cholelithiasis, common bile duct
424228|NCT01759979|Choledocholithiasis|choledocholithiasis
424229|NCT01759966|Heart transplantation|heart transplantation
424230|NCT01759966|Autonomic cardiovascular control|autonomic cardiovascular control
424231|NCT01759966|Acute rejection|acute rejection
424232|NCT01759966|Cardiac allograft vasculopathy|cardiac allograft vasculopathy
424233|NCT01759953|Diabetes Mellitus|diabetes mellitus
424234|NCT01759953|Insulin|insulin
424235|NCT01759953|Video Games|video games
424236|NCT01759953|Medical Education|medical education
424237|NCT01759953|Educational Technology|educational technology
424238|NCT01759953|Continuing Medical Education|continuing medical education
424239|NCT01759940|carotid|carotid
424240|NCT01759940|endarterectomy|endarterectomy
424241|NCT01759940|cervical block|cervical block
424242|NCT01759927|Physical activity counselor|physical activity counselor
424243|NCT01759927|Workplace intervention|workplace intervention
424244|NCT01759927|Active and healthy lifestyle|active and healthy lifestyle
424245|NCT01759901|hepatectomy|hepatectomy
424246|NCT01759901|vascular inflow occlusion|vascular inflow occlusion
424247|NCT01759862|kidney transplant|kidney transplant
424248|NCT01759862|Aminophylline|aminophylline
424249|NCT01759862|pediatric|pediatric
424250|NCT01759849|Asthma|asthma
424251|NCT01759849|β-chain signaling|β-chain signaling
424252|NCT01759849|allergen inhalation challenges|allergen inhalation challenges
424253|NCT01759849|sputum|sputum
424254|NCT01759849|bone marrow aspirate|bone marrow aspirate
424255|NCT01759849|blood collection|blood collection
424256|NCT01759849|-methacholine challenge|-methacholine challenge
424257|NCT01759836|Prostatectomy|prostatectomy
424258|NCT01759836|Statins|statins
424259|NCT01759810|Glioblastoma, recurrent glioblastoma|glioblastoma, recurrent glioblastoma
424382|NCT01759160|Target control infusion|target control infusion
424260|NCT01759797|ALS bone marrow mesenchymal stem cell intravenous injection|als bone marrow mesenchymal stem cell intravenous injection
424261|NCT01759784|mesenchymal stem cell intraventricular injection ALS|mesenchymal stem cell intraventricular injection als
424262|NCT01759771|Prostate Cancer|prostate cancer
424264|NCT01759771|Active surveillance|active surveillance
424265|NCT01759758|boxer's fracture|boxer's fracture
424266|NCT01759758|metacarpal neck fracture|metacarpal neck fracture
424267|NCT01759758|metacarpal fracture|metacarpal fracture
424268|NCT01759732|Aplastic anemia|aplastic anemia
424269|NCT01759732|T cell dose|t cell dose
424270|NCT01759732|CD3 depletion|cd3 depletion
424271|NCT01759732|Haploidentical hematopoietic stem cell transplantation|haploidentical hematopoietic stem cell transplantation
424272|NCT01759719|platinum-chromium stents|platinum-chromium stents
424273|NCT01759719|concertina effect|concertina effect
424274|NCT01759719|stent deformation|stent deformation
424275|NCT01759719|everolimus eluting stents|everolimus eluting stents
424276|NCT01759719|stent lenght|stent lenght
424277|NCT01759693|Platelet activation|platelet activation
424278|NCT01759680|Risk of falls|risk of falls
424279|NCT01759680|Whole Body Vibration|whole body vibration
424280|NCT01759680|Nursing Home|nursing home
424281|NCT01759667|Diet-induced Thermogenesis;|diet-induced thermogenesis;
424282|NCT01759667|Respiratory Quotient;|respiratory quotient;
424283|NCT01759667|Roux-en-Y Gastric Bypass;|roux-en-y gastric bypass;
424284|NCT01759667|Energy Expenditure.|energy expenditure.
424285|NCT01759641|Dialysis|dialysis
424286|NCT01759641|Monitoring|monitoring
424287|NCT01759641|Cardiovascular stability|cardiovascular stability
424288|NCT01759641|biosignals|biosignals
424289|NCT01759628|Steatohepatitis,|steatohepatitis,
424290|NCT01759628|Helicobacter pylori,|helicobacter pylori,
424291|NCT01759628|Insulin resistance,|insulin resistance,
424292|NCT01759628|Alanine aminotransferase,|alanine aminotransferase,
424293|NCT01759628|Aspartate aminotransferase,|aspartate aminotransferase,
424294|NCT01759615|Preterm|preterm
424295|NCT01759615|SGA|sga
424296|NCT01759615|AREDF|aredf
424297|NCT01759615|Early feeding|early feeding
424298|NCT01759615|Late feeding|late feeding
424299|NCT01759615|Feed intolerence|feed intolerence
424300|NCT01759615|Necrotizing enterocolitis|necrotizing enterocolitis
424301|NCT01759602|Neuromyelitis optica|neuromyelitis optica
424302|NCT01759602|Devic's disease|devic's disease
424303|NCT01759602|NMO|nmo
424304|NCT01759602|Devic|devic
424305|NCT01759589|electroconvulsive therapy,sevoflurane,propofol,remifentanil|electroconvulsive therapy,sevoflurane,propofol,remifentanil
424306|NCT01759576|Renal Insufficiency|renal insufficiency
424307|NCT01759576|Healthy|healthy
424308|NCT01759576|Canagliflozin (JNJ-28431754)|canagliflozin (jnj-28431754)
424309|NCT01759576|Pharmacokinetics|pharmacokinetics
424310|NCT01759576|Pharmacodynamics|pharmacodynamics
424311|NCT01759576|Dialysis|dialysis
424312|NCT01759550|Gastric Procedures|gastric procedures
424313|NCT01759550|Force Triad|force triad
424314|NCT01759550|LigaSure Advance Pistol Grip|ligasure advance pistol grip
424315|NCT01759550|LigaSure Blunt Tip|ligasure blunt tip
424316|NCT01759524|local anaesthesia|local anaesthesia
424317|NCT01759524|analgesia|analgesia
424318|NCT01759524|bupivacaine|bupivacaine
424319|NCT01759524|lidocaine|lidocaine
424320|NCT01759524|clonidine|clonidine
424321|NCT01759524|sciatic nerve|sciatic nerve
424322|NCT01759524|saphenous nerve|saphenous nerve
424323|NCT01759511|Idiopathic|idiopathic
424324|NCT01759511|Pulmonary|pulmonary
424325|NCT01759511|Fibrosis|fibrosis
424326|NCT01759511|IPF|ipf
424327|NCT01759498|Inflammation|inflammation
424328|NCT01759498|Pain intensity|pain intensity
424329|NCT01759498|Flexibility|flexibility
424330|NCT01759498|RICE protocol|rice protocol
424331|NCT01759498|Swelling|swelling
424332|NCT01759485|Clozapine|clozapine
424333|NCT01759485|Schizophrenia|schizophrenia
424334|NCT01759485|Vitamin-D|vitamin-d
424335|NCT01759485|Treatment-resistant|treatment-resistant
424336|NCT01759472|leukotriene|leukotriene
424337|NCT01759472|leukotriene receptor antagonist|leukotriene receptor antagonist
424338|NCT01759420|Ondansetron|ondansetron
424339|NCT01759420|QT interval|qt interval
424340|NCT01759420|QTc|qtc
424341|NCT01759420|QT prolongation|qt prolongation
424342|NCT01759420|Drug induced QT prolongation|drug induced qt prolongation
424343|NCT01759381|Spinal Deformity|spinal deformity
424344|NCT01759381|Complex Spinal Surgery|complex spinal surgery
424345|NCT01759381|Negative Pressure Wound Therapy|negative pressure wound therapy
424346|NCT01759381|Post-Operative Infection|post-operative infection
424347|NCT01759368|self-care, heart failure, telemonitoring, health care utilization|self-care, heart failure, telemonitoring, health care utilization
424348|NCT01759342|Cystic fibrosis; pulmonary exacerbation, exercise|cystic fibrosis; pulmonary exacerbation, exercise
424349|NCT01759329|overweight|overweight
424350|NCT01759329|body weight|body weight
424351|NCT01759329|coffee|coffee
424352|NCT01759290|Angioplasty|angioplasty
424353|NCT01759290|Bioabsorbable|bioabsorbable
424354|NCT01759290|Bioresorbable|bioresorbable
424355|NCT01759290|BVS|bvs
424356|NCT01759290|Coronary Artery Endothelial Responsiveness|coronary artery endothelial responsiveness
424357|NCT01759290|Coronary Scaffold|coronary scaffold
424358|NCT01759290|Coronary Stent|coronary stent
424359|NCT01759264|Fecal Calprotectin|fecal calprotectin
424360|NCT01759264|Crohn's Disease|crohn's disease
424361|NCT01759264|Adalimumab|adalimumab
424848|NCT01756924|MRSA|mrsa
424362|NCT01759251|Meniere Disease|meniere disease
424363|NCT01759251|Betahistine Dihydrochloride|betahistine dihydrochloride
424364|NCT01759251|Vertigo|vertigo
424365|NCT01759238|colorectal cancer|colorectal cancer
424366|NCT01759238|metastases|metastases
424367|NCT01759238|non resectable|non resectable
424368|NCT01759238|chemoradiation|chemoradiation
424369|NCT01759225|Registry, Cardiovascular, CVD, Health Maintenance Organization|registry, cardiovascular, cvd, health maintenance organization
424370|NCT01759212|stem cell implantation|stem cell implantation
424371|NCT01759212|coronary artery disease|coronary artery disease
424372|NCT01759212|left ventricular assist device|left ventricular assist device
424373|NCT01759199|COPD|copd
424374|NCT01759199|ST6: The six minute Stepper Test|st6: the six minute stepper test
424375|NCT01759199|Conventional respiratory rehabilitation|conventional respiratory rehabilitation
424376|NCT01759199|Pulmonary rehabilitation|pulmonary rehabilitation
424377|NCT01759186|Asthma|asthma
424378|NCT01759186|Biomakers|biomakers
424379|NCT01759186|Phenotype|phenotype
424380|NCT01759173|Minor traumatic brain injury (TBI)|minor traumatic brain injury (tbi)
424381|NCT01759173|Concussion|concussion
424383|NCT01759160|propofol|propofol
424384|NCT01759160|cardiac depression|cardiac depression
424385|NCT01759160|induction of anesthesia|induction of anesthesia
424386|NCT01759160|hemodynamics|hemodynamics
424387|NCT01759134|Premature neonate|premature neonate
424388|NCT01759134|Post-discharge|post-discharge
424389|NCT01759134|Formula|formula
424390|NCT01759121|severe non-proliferative diabetic retinopathy|severe non-proliferative diabetic retinopathy
424391|NCT01759121|subthreshold|subthreshold
424392|NCT01759121|panretinal photocoagulation|panretinal photocoagulation
424393|NCT01759121|PASCAL|pascal
424394|NCT01759121|endpoint management|endpoint management
424395|NCT01759108|xerostomia|xerostomia
424396|NCT01759108|rebamipide|rebamipide
424397|NCT01759108|efficacy|efficacy
424398|NCT01759108|safety|safety
424399|NCT01759095|adherence|adherence
424400|NCT01759095|electronic monitoring|electronic monitoring
424401|NCT01759095|primary care|primary care
424402|NCT01759095|community pharmacy|community pharmacy
424403|NCT01759095|multidrug blister pack|multidrug blister pack
424404|NCT01759095|pill box|pill box
424405|NCT01759056|Ulcerative colitis|ulcerative colitis
424406|NCT01759043|coronary artery disease|coronary artery disease
424407|NCT01759043|Myocardial Infarction|myocardial infarction
424408|NCT01759043|Radial Artery|radial artery
424409|NCT01759043|Catheters|catheters
424410|NCT01759030|rheumatoid arthritis, DMARDs|rheumatoid arthritis, dmards
424411|NCT01759030|rituximab|rituximab
424412|NCT01759030|biosimilar|biosimilar
424413|NCT01759030|interchangeability|interchangeability
424414|NCT01759017|Crohn's disease|crohn's disease
424415|NCT01759017|Inflammatory bowel disease|inflammatory bowel disease
424416|NCT01759017|IBD|ibd
424417|NCT01759017|Infliximab|infliximab
424418|NCT01759017|PET|pet
424419|NCT01759017|PET/CT|pet/ct
424420|NCT01759004|lipoedema|lipoedema
424421|NCT01759004|obesity|obesity
424422|NCT01758978|bioequivalence, hydrocodone bitartrate extended-release tablets|bioequivalence, hydrocodone bitartrate extended-release tablets
424423|NCT01758952|Peri-operative stroke|peri-operative stroke
424424|NCT01758952|incidence|incidence
424425|NCT01758952|risk factors|risk factors
424426|NCT01758952|prospective|prospective
424427|NCT01758939|Peg Interferon,|peg interferon,
424428|NCT01758939|Ribavirin,|ribavirin,
424429|NCT01758939|HCV,|hcv,
424430|NCT01758939|Genotype IV.|genotype iv.
424431|NCT01758926|Inflammatory Bowel Disease|inflammatory bowel disease
424432|NCT01758926|Confocal Laser Endomicroscopy|confocal laser endomicroscopy
424433|NCT01758913|Bronchopulmonary dysplasia|bronchopulmonary dysplasia
424434|NCT01758913|patent ductus arteriosus|patent ductus arteriosus
424435|NCT01758913|prostaglandin|prostaglandin
424436|NCT01758913|Respiratory distress syndrome|respiratory distress syndrome
424437|NCT01758900|Single-Balloon Enteroscopy|single-balloon enteroscopy
424438|NCT01758874|Critical limb ischemia|critical limb ischemia
424439|NCT01758874|Phlebotomy|phlebotomy
424440|NCT01758874|Amputation|amputation
424441|NCT01758874|Rutherford classification Grade 3, Category 5 or 6|rutherford classification grade 3, category 5 or 6
424442|NCT01758874|Fontaine stage IV|fontaine stage iv
424443|NCT01758861|Erythropoietin|erythropoietin
424444|NCT01758861|acute kidney injury|acute kidney injury
424445|NCT01758861|valvular heart surgery|valvular heart surgery
424446|NCT01758848|overactive bladder|overactive bladder
424447|NCT01758848|pelvic floor muscles|pelvic floor muscles
424448|NCT01758848|deep abdominal muscles|deep abdominal muscles
424449|NCT01758835|ER-stress-test negative|er-stress-test negative
424450|NCT01758835|unimalleolar|unimalleolar
424451|NCT01758835|fibula|fibula
424452|NCT01758835|Weber-B fractures|weber-b fractures
424453|NCT01758822|meconium stained amniotic fluid|meconium stained amniotic fluid
424454|NCT01758822|endotracheal suction|endotracheal suction
424455|NCT01758822|non vigorous neonates|non vigorous neonates
424456|NCT01758809|Video Assisted Thoracic Surgery|video assisted thoracic surgery
424457|NCT01758809|Postoperative Pain|postoperative pain
424458|NCT01758809|Intravenous Patient Controlled Analgesia|intravenous patient controlled analgesia
424460|NCT01758809|Major Pulmonary Resection|major pulmonary resection
424461|NCT01758809|Post Pulmonary Resection|post pulmonary resection
424462|NCT01758796|ER-stress positive|er-stress positive
424463|NCT01758796|Unimalleolar fibula fracture|unimalleolar fibula fracture
424464|NCT01758796|Operative vs non-operative treatment|operative vs non-operative treatment
424465|NCT01758770|osteoporosis|osteoporosis
424466|NCT01758770|osteoarthritis|osteoarthritis
424467|NCT01758770|bone mineral density|bone mineral density
424468|NCT01758770|computed xray tomography|computed xray tomography
424469|NCT01758770|liver steatosis|liver steatosis
424470|NCT01758770|obesity|obesity
424471|NCT01758757|Proliferative diabetic retinopathy|proliferative diabetic retinopathy
424472|NCT01758757|Vitrectomy|vitrectomy
424473|NCT01758744|COPD PH|copd ph
424474|NCT01758744|COPD associated Pulmonary Hypertension|copd associated pulmonary hypertension
424475|NCT01758744|COPD and Pulmonary Hypertension|copd and pulmonary hypertension
424476|NCT01758744|Disease|disease
424477|NCT01758731|Stage IVA-B Squamous Cell Carcinomas|stage iva-b squamous cell carcinomas
424478|NCT01758731|Head and Neck Cancer|head and neck cancer
424479|NCT01758731|Heavy drinking|heavy drinking
424480|NCT01758731|Smoking|smoking
424481|NCT01758718|Down's syndrome|down's syndrome
424482|NCT01758718|entropion|entropion
424483|NCT01758718|lid plasty|lid plasty
424484|NCT01758705|Psoriasis|psoriasis
424485|NCT01758705|Related to Health Quality of Life|related to health quality of life
424486|NCT01758705|Patient Reported Outcomes|patient reported outcomes
424487|NCT01758705|Venezuelan Patients|venezuelan patients
424488|NCT01758692|spinal cord injury|spinal cord injury
424489|NCT01758692|autonomic integrity|autonomic integrity
424490|NCT01758692|autonomic dysreflexia|autonomic dysreflexia
424491|NCT01758692|baroreceptor integrity|baroreceptor integrity
424492|NCT01758692|sympathetic integrity|sympathetic integrity
424493|NCT01758692|vagal integrity|vagal integrity
424494|NCT01758679|Iodine[131I] Metuximab Injection|iodine[131i] metuximab injection
424495|NCT01758653|CO poisoning|co poisoning
424496|NCT01758640|mechanical heart valve|mechanical heart valve
424497|NCT01758640|pregnancy|pregnancy
424498|NCT01758640|warfarin|warfarin
424499|NCT01758640|phenindione|phenindione
424500|NCT01758627|Peritoneal dialysis,|peritoneal dialysis,
424501|NCT01758627|chronic kidney disease,|chronic kidney disease,
424502|NCT01758627|refractory heart failure|refractory heart failure
424503|NCT01758614|carotid artery occlusion|carotid artery occlusion
424504|NCT01758614|middle cerebral artery occlusion|middle cerebral artery occlusion
424505|NCT01758614|EC-IC bypass surgery|ec-ic bypass surgery
424506|NCT01758614|stroke|stroke
424507|NCT01758601|white fish|white fish
424508|NCT01758601|Metabolic syndrome|metabolic syndrome
424509|NCT01758601|Cardiovascular risk|cardiovascular risk
424510|NCT01758588|Primary myelofibrosis|primary myelofibrosis
424512|NCT01758575|Patients|patients
424513|NCT01758549|pancreatitis|pancreatitis
424514|NCT01758549|cholangiopancreatography, endoscopic retrograde|cholangiopancreatography, endoscopic retrograde
424515|NCT01758549|hyperamylasemia|hyperamylasemia
424516|NCT01758536|ischemic stroke|ischemic stroke
424517|NCT01758536|neural function|neural function
424518|NCT01758536|life quality|life quality
424519|NCT01758523|neuroactive steroids|neuroactive steroids
424520|NCT01758510|Amyotrophic Lateral Sclerosis|amyotrophic lateral sclerosis
424521|NCT01758510|ALS|als
424522|NCT01758510|Neurodegenerative disease|neurodegenerative disease
424523|NCT01758510|Motor Neuron Disease|motor neuron disease
424524|NCT01758510|Central Nervous System Disease|central nervous system disease
424525|NCT01758510|Neuromuscular Disease|neuromuscular disease
424526|NCT01758510|Bone marrow derived stem cell|bone marrow derived stem cell
424527|NCT01758510|stem cell therapy|stem cell therapy
424528|NCT01758510|intrathecal injection|intrathecal injection
424529|NCT01758497|Fascia Iliaca compartment block, Pain, Sensorial blockade|fascia iliaca compartment block, pain, sensorial blockade
424530|NCT01758484|Hematopoietic cell transplantation|hematopoietic cell transplantation
424531|NCT01758484|Supportive/palliative care|supportive/palliative care
424532|NCT01758471|Type 2 Diabetes|type 2 diabetes
424533|NCT01758471|gut microbiome|gut microbiome
424534|NCT01758471|incretin|incretin
424535|NCT01758471|Sulfonylurea|sulfonylurea
424536|NCT01758471|α-glucosidase inhibitor|α-glucosidase inhibitor
424537|NCT01758445|Breast|breast
424538|NCT01758445|Cancer|cancer
424539|NCT01758445|Radiation|radiation
424540|NCT01758445|Proton|proton
424541|NCT01758432|Healthy volunteers|healthy volunteers
424542|NCT01758419|post-RT|post-rt
424543|NCT01758419|myocardial perfusion images|myocardial perfusion images
424544|NCT01758406|Cardiac stem ce heart failure cardiac function intracoronary transplantation|cardiac stem ce heart failure cardiac function intracoronary transplantation
424545|NCT01758393|IgG4-related disease|igg4-related disease
424546|NCT01758393|IgG4-RD|igg4-rd
424547|NCT01758380|Type 2 Diabetes Mellitus|type 2 diabetes mellitus
424548|NCT01758380|Ramadan|ramadan
424549|NCT01758380|Vildagliptin|vildagliptin
424550|NCT01758380|Hypoglycemia|hypoglycemia
424551|NCT01758367|demethylating agent|demethylating agent
424552|NCT01758367|immunogenicity|immunogenicity
424553|NCT01758367|decitabine(DAC)|decitabine(dac)
424554|NCT01758367|donor lymphocyte infusion(DLI)|donor lymphocyte infusion(dli)
424555|NCT01758367|AML|aml
424556|NCT01758354|Pompe disease|pompe disease
424557|NCT01758354|alpha glucosidase deficiency|alpha glucosidase deficiency
424558|NCT01758341|Malignant biliary obstruction|malignant biliary obstruction
424559|NCT01758341|Endoscopic radiofrequency ablation|endoscopic radiofrequency ablation
424560|NCT01758341|Therapeutic endoscopy|therapeutic endoscopy
424561|NCT01758328|BUSULFAN|busulfan
424562|NCT01758328|FLUDARABINE|fludarabine
424563|NCT01758328|G-CSF|g-csf
424564|NCT01758328|MELPHALAN|melphalan
424565|NCT01758328|RABBIT ATG WT1|rabbit atg wt1
424566|NCT01758328|PEPTIDE SPECIFIC T CELLS|peptide specific t cells
424567|NCT01758328|12-175|12-175
424568|NCT01758315|Ambulatory|ambulatory
424569|NCT01758315|Outpatient|outpatient
424570|NCT01758315|Malpractice|malpractice
424571|NCT01758315|Quality Improvement|quality improvement
424572|NCT01758315|Patient Safety|patient safety
424573|NCT01758302|taste test|taste test
424574|NCT01758302|food consumption|food consumption
424575|NCT01758302|hunger|hunger
424576|NCT01758289|Venezuelan Patients|venezuelan patients
424577|NCT01758289|Depressive Symptoms|depressive symptoms
424578|NCT01758289|Health Related Quality of Life|health related quality of life
424579|NCT01758276|smoking, pregnancy|smoking, pregnancy
424580|NCT01758263|Hypertension|hypertension
424581|NCT01758263|Health Care Cost|health care cost
424582|NCT01758263|Monthly health care cost|monthly health care cost
424583|NCT01758250|Autoimmune diseases with cutaneous involvement|autoimmune diseases with cutaneous involvement
424584|NCT01758250|Systemic sclerosis|systemic sclerosis
424585|NCT01758250|Scleroderma|scleroderma
424586|NCT01758250|Morphea|morphea
424587|NCT01758250|Dermatomyositis|dermatomyositis
424588|NCT01758250|Cutaneous lupus|cutaneous lupus
424589|NCT01758250|Vasculitis|vasculitis
424590|NCT01758250|Sickle Cell Disease|sickle cell disease
424591|NCT01758250|Graft versus Host Disease|graft versus host disease
424592|NCT01758237|Laser Peripheral Iridotomy|laser peripheral iridotomy
424593|NCT01758237|Visual Dysphotopsia|visual dysphotopsia
424594|NCT01758237|Visual Disturbances|visual disturbances
424595|NCT01758237|Angle Closure Glaucoma|angle closure glaucoma
424596|NCT01758224|Multiple Sclerosis|multiple sclerosis
424597|NCT01758224|Functional Magnetic Stimulation|functional magnetic stimulation
424598|NCT01758224|Pulmonary Function|pulmonary function
424599|NCT01758211|Intracranial Arteriovenous Malformations|intracranial arteriovenous malformations
424600|NCT01758211|Functional Magnetic Resonance Imaging|functional magnetic resonance imaging
424601|NCT01758211|Neuronavigation|neuronavigation
424602|NCT01758185|Inactivated split influenza vaccine|inactivated split influenza vaccine
424603|NCT01758185|Immunogenicity|immunogenicity
424604|NCT01758185|Safety|safety
424605|NCT01758185|Consistence|consistence
424606|NCT01758172|pancreaticoduodenectomy|pancreaticoduodenectomy
424607|NCT01758172|postoperative patient|postoperative patient
424608|NCT01758172|colloid|colloid
424609|NCT01758172|albumin|albumin
424610|NCT01758172|hetastarch|hetastarch
424611|NCT01758146|Breast cancer|breast cancer
424612|NCT01758146|obesity|obesity
424613|NCT01758146|aromatase inhibitors|aromatase inhibitors
424614|NCT01758146|postmenopausal|postmenopausal
424615|NCT01758120|IgA nephropathy|iga nephropathy
424616|NCT01758120|Cyclophosphamide|cyclophosphamide
424617|NCT01758120|prednisone|prednisone
424618|NCT01758094|hypogonadism|hypogonadism
424619|NCT01758094|Retinol binding globulin 4|retinol binding globulin 4
424620|NCT01758094|Testosterone treatment|testosterone treatment
424621|NCT01758068|Preterms|preterms
424622|NCT01758068|Coconut Oil application|coconut oil application
424623|NCT01758068|Trans epidermal water loss|trans epidermal water loss
424624|NCT01758068|Weight gain|weight gain
424625|NCT01758055|Mesenchymal stem cell, emphysema, lung function|mesenchymal stem cell, emphysema, lung function
424626|NCT01758042|Kidney|kidney
424627|NCT01758042|Chronic Kidney Disease|chronic kidney disease
424628|NCT01758042|CKD|ckd
424629|NCT01758042|Bone Marrow|bone marrow
424630|NCT01758042|Bone Marrow Transplant|bone marrow transplant
424631|NCT01758042|BMT|bmt
424632|NCT01758042|Leukemia|leukemia
424633|NCT01758042|AML|aml
424634|NCT01758042|ALL|all
424635|NCT01758042|CML|cml
424636|NCT01758042|CLL|cll
424637|NCT01758042|MM|mm
424638|NCT01758042|NHL|nhl
424639|NCT01758042|MDS|mds
424640|NCT01758029|quality of life|quality of life
424641|NCT01758029|Testosterone Undecanoate|testosterone undecanoate
424642|NCT01758029|partner|partner
424643|NCT01758029|questionnaire|questionnaire
424644|NCT01758003|Physical Activity|physical activity
424645|NCT01758003|Sedentary Behaviour|sedentary behaviour
424646|NCT01758003|Healthy Volunteer|healthy volunteer
424647|NCT01758003|Quality of Life|quality of life
424648|NCT01758003|Exercise Capacity|exercise capacity
424649|NCT01758003|Transtheoretical Model|transtheoretical model
424650|NCT01757990|dental caries|dental caries
424651|NCT01757990|Stevioside|stevioside
424652|NCT01757990|Rebaudioside|rebaudioside
424653|NCT01757990|plaque pH|plaque ph
424654|NCT01757990|Streptococcus mutans|streptococcus mutans
424655|NCT01757977|Vivasight DL|vivasight dl
424656|NCT01757977|double lumen endotracheal tube|double lumen endotracheal tube
424657|NCT01757977|fiberoptic confirmation of tube position|fiberoptic confirmation of tube position
424658|NCT01757964|Crohns Disease|crohns disease
424659|NCT01757964|Ulcerative Colitis|ulcerative colitis
424660|NCT01757964|Inflammatory Bowel Disease|inflammatory bowel disease
424661|NCT01757964|IBD|ibd
424662|NCT01757951|Ankle|ankle
424663|NCT01757951|Fracture|fracture
424664|NCT01757951|medial malleolus|medial malleolus
424665|NCT01757951|Osteosynthesis|osteosynthesis
424666|NCT01757938|HIV|hiv
424667|NCT01757938|Prevention|prevention
424668|NCT01757938|Adult Male Circumcision|adult male circumcision
424669|NCT01757938|Uganda|uganda
424670|NCT01757938|Shang Ring|shang ring
424671|NCT01757925|activity|activity
424672|NCT01757925|gaming|gaming
424673|NCT01757925|obesity|obesity
424674|NCT01757925|Active Gaming|active gaming
424675|NCT01757925|Control|control
424676|NCT01757912|mechanical ventilation|mechanical ventilation
424677|NCT01757899|ALI|ali
424678|NCT01757899|Acute Lung Injury|acute lung injury
424679|NCT01757899|ARDS|ards
424680|NCT01757899|Acute Respiratory Distress Syndrome|acute respiratory distress syndrome
424681|NCT01757899|Pediatric Critical Care Medicine|pediatric critical care medicine
424682|NCT01757899|Inflammatory Response|inflammatory response
424683|NCT01757886|Myocardial infarction, Inflammation, Thrombus, Coronary angioplasty.|myocardial infarction, inflammation, thrombus, coronary angioplasty.
424684|NCT01757847|Binge-Eating Disorder|binge-eating disorder
424685|NCT01757847|Obesity|obesity
424686|NCT01757847|emotional eating|emotional eating
424687|NCT01757834|Thyroid Nodule|thyroid nodule
424688|NCT01757834|Thyroid Neoplasm|thyroid neoplasm
424689|NCT01757834|Differential Diagnosis|differential diagnosis
424690|NCT01757834|Elastography|elastography
424691|NCT01757834|Elasticity Imaging Technique|elasticity imaging technique
424692|NCT01757834|Sonoelastography|sonoelastography
424693|NCT01757821|Stroke|stroke
424694|NCT01757821|rTMS|rtms
424695|NCT01757821|TMS|tms
424696|NCT01757808|PAH|pah
424697|NCT01757808|Ranolazine|ranolazine
424698|NCT01757808|right ventricle|right ventricle
424699|NCT01757808|Safety|safety
424700|NCT01757808|cardiopulmonary exercise testing|cardiopulmonary exercise testing
424701|NCT01757795|acute ischemic stroke|acute ischemic stroke
424702|NCT01757795|ischemic stroke|ischemic stroke
424703|NCT01757795|stroke|stroke
424704|NCT01757769|Lower urinary tract symptoms|lower urinary tract symptoms
424705|NCT01757769|benign prostatic hyperplasia|benign prostatic hyperplasia
424706|NCT01757743|Heart Septal Defects, Atrial|heart septal defects, atrial
424707|NCT01757743|Oedema formation|oedema formation
424708|NCT01757717|radiation therapy|radiation therapy
424709|NCT01757717|HDR brachytherapy|hdr brachytherapy
424710|NCT01757717|Ir-192 high dose rate|ir-192 high dose rate
424711|NCT01757717|12-260|12-260
424712|NCT01757704|Cardiac de-airing|cardiac de-airing
424713|NCT01757704|Air emboli|air emboli
424714|NCT01757704|Trans-cranial Echo-Doppler|trans-cranial echo-doppler
424715|NCT01757704|Intraoperative Trans-esophageal Echocardiography|intraoperative trans-esophageal echocardiography
424716|NCT01757691|Acute demyelinating optic neuritis|acute demyelinating optic neuritis
424717|NCT01757691|Optic neuritis|optic neuritis
424718|NCT01757678|Coronary Artery Disease Computed Fractional Flow Reserve|coronary artery disease computed fractional flow reserve
424719|NCT01757665|Aortic valve replacement|aortic valve replacement
424720|NCT01757665|Mitral valve replacement|mitral valve replacement
424721|NCT01757626|Bone Marrow|bone marrow
424722|NCT01757626|Hu3F8|hu3f8
424723|NCT01757626|GM-CSF|gm-csf
424724|NCT01757626|12-230|12-230
424725|NCT01757587|Type 2 Diabetes|type 2 diabetes
424726|NCT01757587|Galvus|galvus
424727|NCT01757587|basal insulin|basal insulin
424728|NCT01757587|HbA1c|hba1c
424729|NCT01757574|CIDP- chronic inflammatory demyelinating neuropathy|cidp- chronic inflammatory demyelinating neuropathy
424730|NCT01757574|demyelinating neuropathy|demyelinating neuropathy
424731|NCT01757574|alemtuzumab|alemtuzumab
424732|NCT01757561|jugular bulb oxygen saturation|jugular bulb oxygen saturation
424733|NCT01757561|postoperative cognitive dysfunction|postoperative cognitive dysfunction
424734|NCT01757561|propofol|propofol
424735|NCT01757561|sevoflurane|sevoflurane
424736|NCT01757548|varicocele; male infertile;varicocelectomy|varicocele; male infertile;varicocelectomy
424737|NCT01757535|Maintenance therapy|maintenance therapy
424738|NCT01757535|AML|aml
424739|NCT01757535|Acute Myeloid Leukemia|acute myeloid leukemia
424740|NCT01757535|oral Azacitidine|oral azacitidine
424741|NCT01757535|best supportive care|best supportive care
424742|NCT01757535|complete remission|complete remission
424743|NCT01757509|Parkinson's disease|parkinson's disease
424744|NCT01757509|Set dancing|set dancing
424745|NCT01757496|Bronchiolitis|bronchiolitis
424746|NCT01757496|Respiratory Syncytial Virus|respiratory syncytial virus
424747|NCT01757496|Cough Assist|cough assist
424748|NCT01757496|Physiotherapy|physiotherapy
424749|NCT01757470|effectiveness of risk mitigation,|effectiveness of risk mitigation,
424750|NCT01757470|knowledge and understanding survey,|knowledge and understanding survey,
424751|NCT01757470|drug utilisation study,|drug utilisation study,
424752|NCT01757470|post marketing commitments|post marketing commitments
424753|NCT01757457|inflammation|inflammation
424754|NCT01757457|thrombosis|thrombosis
424755|NCT01757457|platelets|platelets
424756|NCT01757457|adhesion molecules|adhesion molecules
424757|NCT01757457|endothelium|endothelium
424758|NCT01757418|Sickle Cell Disease|sickle cell disease
424759|NCT01757418|Pain|pain
424760|NCT01757418|Immune Globulin|immune globulin
424761|NCT01757405|with Factor VIII (FVIII) or Factor IX (FIX) inhibitors|with factor viii (fviii) or factor ix (fix) inhibitors
424762|NCT01757392|Treatment|treatment
424763|NCT01757392|common wart lesions|common wart lesions
424764|NCT01757392|(verruca vulgaris)|(verruca vulgaris)
424765|NCT01757379|Short chain fatty acids|short chain fatty acids
424766|NCT01757379|Acetate|acetate
424767|NCT01757379|Propionate|propionate
424768|NCT01757379|Butyrate|butyrate
424769|NCT01757379|Bioavailability|bioavailability
424770|NCT01757314|arterial lines|arterial lines
424771|NCT01757301|Pain|pain
424772|NCT01757301|Depression|depression
424773|NCT01757301|Anxiety|anxiety
424774|NCT01757301|Musculoskeletal|musculoskeletal
424775|NCT01757301|Fibromyalgia|fibromyalgia
424776|NCT01757288|STAGE IIIA/B NSCLC / INOPERABLE LUNG CANCER|stage iiia/b nsclc / inoperable lung cancer
424777|NCT01757275|peptic ulcer bleeding|peptic ulcer bleeding
424778|NCT01757275|prevention of rebleeding|prevention of rebleeding
424779|NCT01757275|successful endoscopic haemostatic therapy|successful endoscopic haemostatic therapy
424780|NCT01757262|Coronary Heart Disease|coronary heart disease
424781|NCT01757236|Antibiotic|antibiotic
424782|NCT01757236|linezolid|linezolid
424783|NCT01757236|linezolid/rifampin|linezolid/rifampin
424784|NCT01757223|Diffuse Coronary Artery Disease (CAD)|diffuse coronary artery disease (cad)
424785|NCT01757210|Aprepitant|aprepitant
424786|NCT01757210|Pediatrics|pediatrics
424787|NCT01757210|Chemotherapy-induced nausea/vomiting|chemotherapy-induced nausea/vomiting
424788|NCT01757210|Survey|survey
424789|NCT01757184|Enzyme Replacement Therapy (ERT)|enzyme replacement therapy (ert)
424790|NCT01757184|Lysosomal Storage Disease|lysosomal storage disease
424791|NCT01757184|Late Onset Lysosomal Acid Lipase (LAL) Deficiency|late onset lysosomal acid lipase (lal) deficiency
424792|NCT01757184|Acid cholesteryl ester hydrolase deficiency, type 2|acid cholesteryl ester hydrolase deficiency, type 2
424793|NCT01757184|Acid lipase disease|acid lipase disease
424794|NCT01757184|Cholesterol ester hydrolase deficiency|cholesterol ester hydrolase deficiency
424795|NCT01757184|LAL Deficiency|lal deficiency
424796|NCT01757184|LIPA Deficiency|lipa deficiency
424797|NCT01757184|Wolman disease|wolman disease
424798|NCT01757171|Gastric Cancer|gastric cancer
424799|NCT01757158|lung cancer|lung cancer
424800|NCT01757158|lobectomy|lobectomy
424801|NCT01757158|local recurrence|local recurrence
424802|NCT01757145|Cord blood transplantation|cord blood transplantation
424803|NCT01757145|Eltrombopag|eltrombopag
424804|NCT01757145|Platelet engraftment|platelet engraftment
424805|NCT01757106|xenon anesthesia|xenon anesthesia
424806|NCT01757106|sevoflurane anesthesia|sevoflurane anesthesia
424807|NCT01757106|off-pump coronary artery bypass graft surgery|off-pump coronary artery bypass graft surgery
424808|NCT01757093|INDIRECT CALORIMETRY|indirect calorimetry
424809|NCT01757093|MECHANICAL VENTILATION|mechanical ventilation
424810|NCT01757093|WEANING VENTILATOR|weaning ventilator
424811|NCT01757093|AUTOMATIC TUBE COMPENSATION|automatic tube compensation
424812|NCT01757067|ablations|ablations
424813|NCT01757067|CHF|chf
424814|NCT01757067|PVC|pvc
424815|NCT01757054|probiotic|probiotic
424816|NCT01757054|LGG|lgg
424817|NCT01757054|BB-12|bb-12
424818|NCT01757054|fecal recovery|fecal recovery
424819|NCT01757054|healthy subjects|healthy subjects
424820|NCT01757041|Streptococcus agalactiae|streptococcus agalactiae
424821|NCT01757041|Maternal|maternal
424822|NCT01757041|Newborn|newborn
424823|NCT01757041|Africa|africa
424824|NCT01757028|Maternal and newborn health|maternal and newborn health
424825|NCT01757028|Africa|africa
424826|NCT01757015|COPD|copd
424827|NCT01757015|Chronic Obstructive Pulmonary Disease|chronic obstructive pulmonary disease
424828|NCT01757015|Moderate to severe airflow limitation|moderate to severe airflow limitation
424829|NCT01757015|GOLD spirometric classification 2 and 3|gold spirometric classification 2 and 3
424830|NCT01757015|GOLD group B and D|gold group b and d
424831|NCT01757015|NVA237|nva237
424832|NCT01757015|Salmeterol fluticasone propionate|salmeterol fluticasone propionate
424833|NCT01757002|Urban adolescents|urban adolescents
424834|NCT01757002|Acute asthma|acute asthma
424835|NCT01757002|Asthma|asthma
424836|NCT01757002|Computer tailoring|computer tailoring
424837|NCT01757002|Web-based intervention|web-based intervention
424838|NCT01757002|Puff City|puff city
424839|NCT01756950|Influenza|influenza
424840|NCT01756950|Virus|virus
424841|NCT01756950|Monoclonal|monoclonal
424842|NCT01756950|Antibody|antibody
424843|NCT01756950|Immunization|immunization
424844|NCT01756950|Treatment|treatment
424845|NCT01756937|osteoarthritis of the knee|osteoarthritis of the knee
424846|NCT01756924|prosthetic joint infection|prosthetic joint infection
424847|NCT01756924|hip arthroplasty|hip arthroplasty
424849|NCT01756924|knee arthroplasty|knee arthroplasty
424850|NCT01756911|MFM|mfm
424851|NCT01756911|Multilayer Flow Modulator|multilayer flow modulator
424852|NCT01756911|Multilayer stent|multilayer stent
424853|NCT01756911|Thoracoabdominal Aortic Aneurysm|thoracoabdominal aortic aneurysm
424854|NCT01756898|Atopic Dermatitis|atopic dermatitis
424855|NCT01756898|eczema|eczema
424856|NCT01756885|Smoking cessation|smoking cessation
424857|NCT01756885|Nicotine dependence|nicotine dependence
424858|NCT01756885|Varenicline|varenicline
424859|NCT01756885|Chantix|chantix
424860|NCT01756885|Cancer|cancer
424861|NCT01756872|infertility|infertility
424862|NCT01756872|Assisted reproductive technology|assisted reproductive technology
424863|NCT01756872|ovarian reserve|ovarian reserve
424864|NCT01756859|Portal hypertension|portal hypertension
424865|NCT01756859|HVPG|hvpg
424866|NCT01756859|MRI|mri
424867|NCT01756846|HEART score|heart score
424868|NCT01756846|risk score|risk score
424869|NCT01756846|impact|impact
424870|NCT01756846|chest pain|chest pain
424871|NCT01756833|abdominal|abdominal
424872|NCT01756833|aortic|aortic
424873|NCT01756833|aneurysm|aneurysm
424874|NCT01756820|Carpal Tunnel Syndrome|carpal tunnel syndrome
424875|NCT01756820|transverse ligament|transverse ligament
424876|NCT01756820|carpal tunnel release|carpal tunnel release
424877|NCT01756820|endoscopic|endoscopic
424878|NCT01756820|minimal invasive|minimal invasive
424879|NCT01756820|mini-open|mini-open
424880|NCT01756820|median nerve|median nerve
424881|NCT01756807|Optical Coherence Tomography|optical coherence tomography
424882|NCT01756807|Geneous Stent|geneous stent
424883|NCT01756807|Combo Stent|combo stent
424884|NCT01756794|Alcoholic hepatitis|alcoholic hepatitis
424885|NCT01756794|Liver transplantation|liver transplantation
424886|NCT01756794|Alcohol relapse|alcohol relapse
424887|NCT01756794|Alcoholic cirrhosis|alcoholic cirrhosis
424888|NCT01756781|PD-0332991|pd-0332991
424889|NCT01756781|Midazolam|midazolam
424890|NCT01756781|Drug-Drug Interaction Study|drug-drug interaction study
424891|NCT01756781|Healthy Adult Volunteer|healthy adult volunteer
424892|NCT01756768|Phase 1|phase 1
424893|NCT01756768|Mass Balance study|mass balance study
424894|NCT01756768|Radio-labeled dose|radio-labeled dose
424895|NCT01756768|PD-0332991|pd-0332991
424896|NCT01756755|Sepsis|sepsis
424897|NCT01756742|Pleural Effusion|pleural effusion
424898|NCT01756742|Respiratory physiotherapy|respiratory physiotherapy
424899|NCT01756742|Length of stay|length of stay
424900|NCT01756729|Brain tumor|brain tumor
424901|NCT01756729|Treatment|treatment
424902|NCT01756729|Minimal toxicity|minimal toxicity
424903|NCT01756729|GBM|gbm
424904|NCT01756729|Glioblastoma|glioblastoma
424905|NCT01756729|Recurrent|recurrent
424906|NCT01756729|TTFields|ttfields
424907|NCT01756716|Diabetic Nephropathy|diabetic nephropathy
424908|NCT01756703|Diabetic Nephropathy|diabetic nephropathy
424909|NCT01756690|respiratory distress syndrome, adult|respiratory distress syndrome, adult
424910|NCT01756690|blood component transfusion|blood component transfusion
424911|NCT01756690|gastrointestinal hemorrhage|gastrointestinal hemorrhage
424912|NCT01756690|blood coagulation|blood coagulation
424913|NCT01756651|Intranasal fentanyl|intranasal fentanyl
424914|NCT01756651|Cystoscopy|cystoscopy
424915|NCT01756638|Prostate cancer|prostate cancer
424916|NCT01756638|Abiraterone acetate|abiraterone acetate
424917|NCT01756638|JNJ-212082|jnj-212082
424918|NCT01756625|cetuximab|cetuximab
424919|NCT01756625|nicotine|nicotine
424920|NCT01756625|magnesium|magnesium
424921|NCT01756586|popliteal block|popliteal block
424922|NCT01756586|analgesia duration|analgesia duration
424923|NCT01756573|block duration|block duration
424924|NCT01756573|analgesia|analgesia
424925|NCT01756560|anterior cruciate ligament|anterior cruciate ligament
424926|NCT01756560|block duration|block duration
424927|NCT01756547|Nephrocalcinosis|nephrocalcinosis
424928|NCT01756547|Extreme premature|extreme premature
424929|NCT01756521|QT,|qt,
424930|NCT01756521|QTc,|qtc,
424931|NCT01756521|electrocardiogram,|electrocardiogram,
424932|NCT01756521|moxifloxacin|moxifloxacin
424933|NCT01756508|eculizumab|eculizumab
424934|NCT01756508|kidney transplantation|kidney transplantation
424935|NCT01756508|reperfusion|reperfusion
424936|NCT01756508|rejection|rejection
424937|NCT01756508|infection|infection
424938|NCT01756495|QTc,|qtc,
424939|NCT01756495|GW856553 .|gw856553 .
424940|NCT01756495|P38,|p38,
424941|NCT01756482|Respiratory|respiratory
424942|NCT01756482|Syncytial|syncytial
424943|NCT01756482|Virus|virus
424944|NCT01756482|Infections|infections
424945|NCT01756482|RSV|rsv
424946|NCT01756456|Keratitis|keratitis
424947|NCT01756456|Corneal Ulcer|corneal ulcer
424948|NCT01756443|sciatic nerve block|sciatic nerve block
424949|NCT01756443|ORIF lateral malleolus|orif lateral malleolus
424950|NCT01756443|sequential injection|sequential injection
424951|NCT01756443|premixed injection|premixed injection
424952|NCT01756443|local anaesthetics|local anaesthetics
424953|NCT01756430|Carvedilol SR|carvedilol sr
424954|NCT01756430|Carvedilol IR|carvedilol ir
424955|NCT01756430|Hypertension|hypertension
424956|NCT01756430|Essential Hypertension|essential hypertension
424957|NCT01756417|Healthy|healthy
424958|NCT01756417|Canagliflozin (JNJ-28431754)|canagliflozin (jnj-28431754)
424959|NCT01756417|Metformin|metformin
424960|NCT01756417|Pharmacokinetics|pharmacokinetics
424961|NCT01756417|Pharmacodynamics|pharmacodynamics
424962|NCT01756404|Healthy|healthy
424963|NCT01756404|Canagliflozin (JNJ-28431754)|canagliflozin (jnj-28431754)
424964|NCT01756404|Pharmacokinetics|pharmacokinetics
424965|NCT01756404|Pharmacodynamics|pharmacodynamics
424966|NCT01756404|Obesity|obesity
424967|NCT01756391|pediatric|pediatric
424968|NCT01756391|childhood|childhood
424969|NCT01756391|allergy|allergy
424970|NCT01756378|Mobilization with movement,knee osteoarthritis,|mobilization with movement,knee osteoarthritis,
424971|NCT01756352|FET|fet
424972|NCT01756352|Fluoroethyl tyrosine|fluoroethyl tyrosine
424973|NCT01756352|GBM|gbm
424974|NCT01756352|Response to treatment|response to treatment
424975|NCT01756352|Avastin|avastin
424976|NCT01756352|Brain Tumor|brain tumor
424977|NCT01756339|Pneumonia|pneumonia
424978|NCT01756339|CABP|cabp
424979|NCT01756339|CAP|cap
424980|NCT01756339|Macrolide|macrolide
424981|NCT01756326|Non-Union Fractures|non-union fractures
424982|NCT01756326|Impaired Healing|impaired healing
424983|NCT01756326|Fractures|fractures
424984|NCT01756326|Orthopedics|orthopedics
424985|NCT01756326|Bone|bone
424986|NCT01756326|Musculoskeletal Disorders|musculoskeletal disorders
424987|NCT01756300|Essential Hypertension|essential hypertension
424988|NCT01756300|Renal Denervation|renal denervation
424989|NCT01756300|Vascular Disease|vascular disease
424990|NCT01756300|Renal Catheter Ablation|renal catheter ablation
424991|NCT01756300|Primary Hypertension|primary hypertension
424992|NCT01756261|EYLEA|eylea
424993|NCT01756261|Age-Related Macular Degeneration|age-related macular degeneration
424994|NCT01756261|QOL|qol
424995|NCT01756248|EYLEA|eylea
424996|NCT01756248|Age-Related Macular Degeneration|age-related macular degeneration
424997|NCT01756235|Post-marketing observational study (PMOS) Protocol|post-marketing observational study (pmos) protocol
424998|NCT01756235|Rheumatoid Arthritis|rheumatoid arthritis
424999|NCT01756235|Physical Activity|physical activity
425000|NCT01756235|Adalimumab|adalimumab
425001|NCT01756235|Humira®|humira®
425002|NCT01756222|Bicuspid Aortic Valve Disease|bicuspid aortic valve disease
425003|NCT01756222|Bicuspid Aortic Valve|bicuspid aortic valve
425004|NCT01756222|BAV|bav
425133|NCT01755611|Mexico|mexico
425005|NCT01756196|Spinal injection; Steroid; Systemic reaction; Complication; Side effect; Diabetes mellitus; Hypertension; Risk factor|spinal injection; steroid; systemic reaction; complication; side effect; diabetes mellitus; hypertension; risk factor
425006|NCT01756170|cervical cancer|cervical cancer
425007|NCT01756170|radiotherapy|radiotherapy
425008|NCT01756170|postoperative therapy|postoperative therapy
425009|NCT01756170|chemotherapy|chemotherapy
425010|NCT01756157|Crossover|crossover
425011|NCT01756157|C1 esterase inhibitor|c1 esterase inhibitor
425012|NCT01756157|Prevention|prevention
425013|NCT01756157|C1 inhibitor|c1 inhibitor
425014|NCT01756157|Hereditary Angioedema|hereditary angioedema
425015|NCT01756157|Subcutaneous|subcutaneous
425016|NCT01756157|Recombinant human hyaluronidase|recombinant human hyaluronidase
425017|NCT01756092|Breast Cancer|breast cancer
425018|NCT01756092|Lumpectomy|lumpectomy
425019|NCT01756092|Mastectomy, Segmental|mastectomy, segmental
425020|NCT01756066|Obesity|obesity
425021|NCT01756066|Weight loss program|weight loss program
425022|NCT01756066|incentives|incentives
425023|NCT01756053|Smoking|smoking
425024|NCT01756053|Tobacco|tobacco
425025|NCT01756040|intestinal permeability|intestinal permeability
425026|NCT01756040|preterm infants|preterm infants
425027|NCT01756040|dual sugar test|dual sugar test
425028|NCT01756027|Rosacea|rosacea
425029|NCT01756027|Ulthera System|ulthera system
425030|NCT01756027|Ultherapy™ Treatment|ultherapy™ treatment
425031|NCT01756027|Ulthera, Inc.|ulthera, inc.
425032|NCT01756027|Ultrasound treatment for the skin|ultrasound treatment for the skin
425033|NCT01755988|Telemedicine|telemedicine
425034|NCT01755988|Heart Failure|heart failure
425035|NCT01755988|Self care|self care
425036|NCT01755988|Quality of life|quality of life
425037|NCT01755988|Mortality|mortality
425038|NCT01755988|Hospitalization|hospitalization
425039|NCT01755975|LENALIDOMIDE (CC-5013)|lenalidomide (cc-5013)
425040|NCT01755975|Romidepsin (Istodax)|romidepsin (istodax)
425041|NCT01755975|12-170|12-170
425042|NCT01755962|diet|diet
425043|NCT01755962|obese|obese
425044|NCT01755962|overweight|overweight
425045|NCT01755962|exercise|exercise
425046|NCT01755962|resistance training|resistance training
425047|NCT01755962|nutrition|nutrition
425048|NCT01755962|glycemic load|glycemic load
425049|NCT01755962|body composition|body composition
425050|NCT01755962|weight training|weight training
425051|NCT01755962|lifestyle|lifestyle
425052|NCT01755949|atrial fibrillation|atrial fibrillation
425053|NCT01755949|catheter ablation|catheter ablation
425054|NCT01755949|colchicine|colchicine
425160|NCT01755546|OA|oa
425055|NCT01755949|c reactive protein|c reactive protein
425056|NCT01755949|CRP|crp
425057|NCT01755936|Aortic Stenosis|aortic stenosis
425058|NCT01755936|Cardiac magnetic resonance imaging|cardiac magnetic resonance imaging
425059|NCT01755936|Late Gadolinium enhancement|late gadolinium enhancement
425060|NCT01755936|T1 mapping techniques|t1 mapping techniques
425061|NCT01755936|Replacement fibrosis|replacement fibrosis
425062|NCT01755936|Diffuse interstitial fibrosis|diffuse interstitial fibrosis
425063|NCT01755923|non-small cell lung cancer|non-small cell lung cancer
425064|NCT01755923|wild-type EGFR|wild-type egfr
425065|NCT01755923|gefitinib|gefitinib
425066|NCT01755923|docetaxel|docetaxel
425067|NCT01755923|second-line therapy|second-line therapy
425068|NCT01755910|Breast Surgery|breast surgery
425069|NCT01755910|Thoracic Paravertebral Block|thoracic paravertebral block
425070|NCT01755910|HRV|hrv
425071|NCT01755910|Autonomic Nervous System|autonomic nervous system
425072|NCT01755884|Wheat allergy|wheat allergy
425073|NCT01755884|Immunotherapy|immunotherapy
425074|NCT01755884|Desensitization|desensitization
425075|NCT01755884|Food allergy|food allergy
425076|NCT01755884|T cells|t cells
425077|NCT01755858|elamipretide|elamipretide
425078|NCT01755845|cervical cancer|cervical cancer
425079|NCT01755845|radiotherapy|radiotherapy
425080|NCT01755845|postoperative therapy|postoperative therapy
425081|NCT01755845|chemotherapy|chemotherapy
425082|NCT01755832|inflammatory rheumatic joint disease|inflammatory rheumatic joint disease
425083|NCT01755832|text message|text message
425084|NCT01755832|> 18 years|> 18 years
425085|NCT01755832|Norwegian speaking|norwegian speaking
425086|NCT01755806|Aortic annulus|aortic annulus
425087|NCT01755806|Aortic calcification|aortic calcification
425088|NCT01755806|Multislice computed tomography|multislice computed tomography
425089|NCT01755806|Cardiac cycle|cardiac cycle
425090|NCT01755767|MET diagnostic-high|met diagnostic-high
425091|NCT01755767|Unresectable|unresectable
425092|NCT01755767|Hepatocellular|hepatocellular
425093|NCT01755767|Carcinoma|carcinoma
425094|NCT01755767|c-Met inhibitor|c-met inhibitor
425095|NCT01755728|Paracetamol|paracetamol
425096|NCT01755728|Acetaminophen|acetaminophen
425097|NCT01755728|PDA|pda
425098|NCT01755728|Preterm infants|preterm infants
425099|NCT01755715|Abortion|abortion
425100|NCT01755715|Contraception|contraception
425101|NCT01755715|Intrauterine Devices|intrauterine devices
425102|NCT01755715|Intrauterine Device Expulsion|intrauterine device expulsion
425103|NCT01755702|caffeine|caffeine
425104|NCT01755702|paracetamol|paracetamol
425105|NCT01755702|tension headache|tension headache
425106|NCT01755689|pertussis|pertussis
425107|NCT01755689|Meningococcal meningitis|meningococcal meningitis
425108|NCT01755689|Meningococcal infections|meningococcal infections
425109|NCT01755689|HPV|hpv
425110|NCT01755689|Neisseria meningitidis|neisseria meningitidis
425111|NCT01755689|Vaccines, conjugate|vaccines, conjugate
425112|NCT01755689|tetanus|tetanus
425113|NCT01755689|diphtheria|diphtheria
425114|NCT01755689|Meningococcal vaccines|meningococcal vaccines
425115|NCT01755689|Immunogenicity|immunogenicity
425116|NCT01755663|CT coronary|ct coronary
425117|NCT01755663|Coronary arterial disease|coronary arterial disease
425118|NCT01755663|ivabradine|ivabradine
425119|NCT01755663|metoprolol|metoprolol
425120|NCT01755650|18F FPM|18f fpm
425121|NCT01755650|PET/CT|pet/ct
425122|NCT01755650|microdosing|microdosing
425123|NCT01755624|Non-Small Cell Lung Cancer|non-small cell lung cancer
425124|NCT01755624|NSCLC|nsclc
425125|NCT01755624|Brain metastases|brain metastases
425126|NCT01755624|Treatment|treatment
425127|NCT01755624|Minimal toxicity|minimal toxicity
425128|NCT01755624|TTFields|ttfields
425129|NCT01755624|TTF|ttf
425130|NCT01755624|Tumor Treating Fields|tumor treating fields
425131|NCT01755624|NovoCure|novocure
425132|NCT01755611|Minocycline|minocycline
425135|NCT01755611|bioequivalence|bioequivalence
425136|NCT01755598|Positive Interferon-γ release assay|positive interferon-γ release assay
425137|NCT01755598|Efficacy|efficacy
425138|NCT01755598|Adults|adults
425139|NCT01755598|Tuberculosis vaccine|tuberculosis vaccine
425140|NCT01755598|Endemic region|endemic region
425141|NCT01755585|Radiation therapy|radiation therapy
425142|NCT01755585|5-fluorouracil|5-fluorouracil
425143|NCT01755585|Cisplatin|cisplatin
425144|NCT01755585|Pharmacokinetics|pharmacokinetics
425145|NCT01755585|Matrix Metalloproteinase|matrix metalloproteinase
425146|NCT01755572|Type 2 Diabetes|type 2 diabetes
425147|NCT01755572|Hypertension|hypertension
425148|NCT01755572|Liraglutide|liraglutide
425149|NCT01755572|GLP-1|glp-1
425150|NCT01755559|malaria|malaria
425151|NCT01755559|artemisinin|artemisinin
425152|NCT01755559|artemisinin-based combination therapies|artemisinin-based combination therapies
425153|NCT01755559|Plasmodium falciparum|plasmodium falciparum
425154|NCT01755559|efficacy|efficacy
425155|NCT01755546|Chronic Pain|chronic pain
425156|NCT01755546|CLBP|clbp
425157|NCT01755546|Chronic Low Back Pain|chronic low back pain
425158|NCT01755546|Back Pain|back pain
425159|NCT01755546|Osteoarthritis|osteoarthritis
425161|NCT01755546|Neuropathic Pain|neuropathic pain
425162|NCT01755546|Nerve pain|nerve pain
425163|NCT01755546|Painful neuropathy|painful neuropathy
425164|NCT01755533|adolescent substance use|adolescent substance use
425165|NCT01755533|rural substance use|rural substance use
425166|NCT01755533|middle school prevention|middle school prevention
425167|NCT01755533|implementation processes|implementation processes
425168|NCT01755533|implementation quality|implementation quality
425169|NCT01755533|adaptation of prevention curricula|adaptation of prevention curricula
425170|NCT01755533|dissemination|dissemination
425171|NCT01755520|CABG|cabg
425172|NCT01755520|CAD|cad
425173|NCT01755520|antiplatelet drug|antiplatelet drug
425174|NCT01755520|Ticagrelor|ticagrelor
425175|NCT01755520|Aspirin|aspirin
425176|NCT01755507|PSC|psc
425177|NCT01755494|Type 2 diabetes, Saxagliptin, Metformin,Fixed dose combination tablet, Bioequivalence, pharmacokinetic, safety, tolerability|type 2 diabetes, saxagliptin, metformin,fixed dose combination tablet, bioequivalence, pharmacokinetic, safety, tolerability
425178|NCT01755468|beta-cell function, type 2 diabetes, intermittent insulin|beta-cell function, type 2 diabetes, intermittent insulin
425179|NCT01755455|Cystic fibrosis|cystic fibrosis
425180|NCT01755455|Iron|iron
425181|NCT01755455|Hepcidin|hepcidin
425182|NCT01755455|Anemia|anemia
425183|NCT01755455|Erythropoiesis|erythropoiesis
425184|NCT01755442|Ambulatory blood pressure|ambulatory blood pressure
425185|NCT01755442|Type 2 diabetes|type 2 diabetes
425186|NCT01755416|Type 1 diabetes|type 1 diabetes
425187|NCT01755416|closed loop|closed loop
425188|NCT01755416|artificial pancreas|artificial pancreas
425189|NCT01755416|insulin|insulin
425190|NCT01755416|victoza|victoza
425191|NCT01755416|liraglutide|liraglutide
425192|NCT01755338|cerebrospinal fluid|cerebrospinal fluid
425193|NCT01755338|inflammatory markers|inflammatory markers
425194|NCT01755338|heart surgery|heart surgery
425195|NCT01755338|neuronal damage|neuronal damage
425196|NCT01755338|blood brain barrier|blood brain barrier
425197|NCT01755299|Energy drinks|energy drinks
425198|NCT01755299|Wakefulness|wakefulness
425199|NCT01755299|Caffeine|caffeine
425200|NCT01755273|Pancreaticoduodenectomy|pancreaticoduodenectomy
425201|NCT01755273|Diabetes|diabetes
425202|NCT01755260|POPF|popf
425203|NCT01755260|pancreaticoduodenectomy|pancreaticoduodenectomy
425204|NCT01755260|enteral nutrition|enteral nutrition
425205|NCT01755260|parenteral nutrition|parenteral nutrition
425206|NCT01755247|acne|acne
425207|NCT01755234|Outpatient|outpatient
425208|NCT01755234|Surgery|surgery
425209|NCT01755234|Anesthesia|anesthesia
425210|NCT01755221|Laryngopharyngeal reflux (LPR)|laryngopharyngeal reflux (lpr)
425211|NCT01755221|Extraesophageal reflux|extraesophageal reflux
425212|NCT01755221|Reflux laryngitis|reflux laryngitis
425213|NCT01755221|Posterior laryngitis|posterior laryngitis
425214|NCT01755221|Proton pump inhibitor (PPI) medication|proton pump inhibitor (ppi) medication
425215|NCT01755221|Restech pH probe|restech ph probe
425216|NCT01755195|Dual Inhibitor of MET and VEGFR|dual inhibitor of met and vegfr
425217|NCT01755195|XL184|xl184
425218|NCT01755195|Metastatic Refractory|metastatic refractory
425219|NCT01755195|Soft Tissue Sarcoma|soft tissue sarcoma
425220|NCT01755195|Rare Heterogeneous Tumor|rare heterogeneous tumor
425221|NCT01755182|locoregional treatment|locoregional treatment
425222|NCT01755182|liver metastases|liver metastases
425223|NCT01755182|transarterial embolization|transarterial embolization
425224|NCT01755182|upfront treatment|upfront treatment
425225|NCT01755182|inoperable|inoperable
425226|NCT01755182|octreotide|octreotide
425227|NCT01755182|gastroenteropancreatic (GEP)primary|gastroenteropancreatic (gep)primary
425228|NCT01755182|pulmonary primary|pulmonary primary
425229|NCT01755182|primary unknown origin|primary unknown origin
425230|NCT01755182|systemic therapy|systemic therapy
425231|NCT01755169|Chronic pain|chronic pain
425232|NCT01755169|Child|child
425233|NCT01755169|Pediatric|pediatric
425234|NCT01755169|Ketamine|ketamine
425235|NCT01755130|Breast Cancer|breast cancer
425236|NCT01755130|LOUIS-3D|louis-3d
425237|NCT01755130|Breast Study|breast study
425238|NCT01755130|x-ray|x-ray
425239|NCT01755130|Multimode Laser Optoacoustic Ultrasonic Tomography System|multimode laser optoacoustic ultrasonic tomography system
425240|NCT01755130|Mass palpable or nonpalpable|mass palpable or nonpalpable
425241|NCT01755130|Breast lesions|breast lesions
425242|NCT01755130|Ductal carcinomas|ductal carcinomas
425243|NCT01755130|Lobular carcinomas|lobular carcinomas
425244|NCT01755130|Fibroadenomas|fibroadenomas
425245|NCT01755078|Phosphate binder|phosphate binder
425246|NCT01755065|laparoscopic surgery|laparoscopic surgery
425247|NCT01755065|teenager|teenager
425248|NCT01755052|Acute Myocardial Infarction|acute myocardial infarction
425249|NCT01755052|Geriatrics|geriatrics
425250|NCT01755052|Cardiology|cardiology
425251|NCT01755052|Aging|aging
425252|NCT01755052|Heart Attack|heart attack
425253|NCT01755052|Risk Factors|risk factors
425254|NCT01755052|Quality of Care|quality of care
425255|NCT01755052|Risk Models|risk models
425256|NCT01755026|Cesarean Delivery|cesarean delivery
425257|NCT01755026|Wound infection|wound infection
425258|NCT01755026|Obesity|obesity
425259|NCT01755026|Prophylactic antibiotics|prophylactic antibiotics
425260|NCT01755013|Cholangiocarcinoma|cholangiocarcinoma
425261|NCT01755013|Biliary Stricture|biliary stricture
425262|NCT01755013|Biliary obstruction|biliary obstruction
425263|NCT01755013|Bile Duct Cancer|bile duct cancer
425264|NCT01755013|PDT|pdt
425265|NCT01755013|Photodynamic Therapy|photodynamic therapy
425266|NCT01755013|Plastic optic Diffuser|plastic optic diffuser
425267|NCT01755013|Laser|laser
425268|NCT01754987|Vitamins|vitamins
425269|NCT01754987|Malignant Tumor, Tumour|malignant tumor, tumour
425270|NCT01754987|Integrative Medicine|integrative medicine
425271|NCT01754987|Complementary Medicine|complementary medicine
425272|NCT01754987|Alternative Medicine Antioxidants|alternative medicine antioxidants
425273|NCT01754987|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action
425274|NCT01754987|Pharmacologic Actions|pharmacologic actions
425275|NCT01754987|Protective Agents|protective agents
425276|NCT01754987|Physiological Effects of Drugs|physiological effects of drugs
425277|NCT01754987|Micronutrients|micronutrients
425278|NCT01754987|Growth Substances|growth substances
425279|NCT01754987|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic
425280|NCT01754987|Antineoplastic Agents|antineoplastic agents
425281|NCT01754987|Therapeutic Uses|therapeutic uses
425282|NCT01754987|Radiation-Sensitizing Agents|radiation-sensitizing agents
425283|NCT01754987|Liver Cancer|liver cancer
425284|NCT01754948|asthma|asthma
425285|NCT01754948|reactive airway disease|reactive airway disease
425286|NCT01754948|cough|cough
425287|NCT01754948|air pollution|air pollution
425288|NCT01754948|nano particles|nano particles
425289|NCT01754922|exercise tolerance|exercise tolerance
425290|NCT01754922|Veterans|veterans
425291|NCT01754922|operation enduring freedom|operation enduring freedom
425292|NCT01754922|operation Iraqi freedom|operation iraqi freedom
425293|NCT01754909|lung cancer|lung cancer
425294|NCT01754909|radiation pneumonitis|radiation pneumonitis
425295|NCT01754909|mitigation|mitigation
425296|NCT01754909|enalapril|enalapril
425297|NCT01754909|placebo|placebo
425298|NCT01754896|colorectal cancer|colorectal cancer
425299|NCT01754896|fecal immunochemical test|fecal immunochemical test
425300|NCT01754896|fecal occult blood test|fecal occult blood test
425301|NCT01754896|screening|screening
425302|NCT01754883|Posttraumatic Stess Disorder|posttraumatic stess disorder
425303|NCT01754883|Lithium|lithium
425304|NCT01754870|CLL|cll
425305|NCT01754870|SLL|sll
425306|NCT01754857|Lymphoid Leukemia|lymphoid leukemia
425307|NCT01754857|Bendamustine|bendamustine
425308|NCT01754857|Rituximab|rituximab
425309|NCT01754857|Small Lymphocytic Lymphoma|small lymphocytic lymphoma
425310|NCT01754844|Phase 1|phase 1
425311|NCT01754844|Healthy Volunteers|healthy volunteers
425312|NCT01754844|Single Ascending Dose (SAD)|single ascending dose (sad)
425313|NCT01754844|First Time in Man|first time in man
425314|NCT01754844|Pharmacokinetics|pharmacokinetics
425315|NCT01754844|Pharmacodynamics|pharmacodynamics
425316|NCT01754831|children|children
425317|NCT01754831|fluoride varnish|fluoride varnish
425318|NCT01754818|Pharmacokinetics|pharmacokinetics
425319|NCT01754818|volunteers|volunteers
425320|NCT01754805|ASP015K|asp015k
425321|NCT01754805|Rheumatoid Arthritis|rheumatoid arthritis
425322|NCT01754779|calcium phosphate|calcium phosphate
425323|NCT01754779|urolithiasis|urolithiasis
425324|NCT01754779|kidney stones|kidney stones
425325|NCT01754779|hypercalciuria|hypercalciuria
425326|NCT01754753|Mental well-being|mental well-being
425327|NCT01754753|Befriending|befriending
425328|NCT01754740|Xerostomia, Salivary flow, Burning Mouth Syndrome.|xerostomia, salivary flow, burning mouth syndrome.
425329|NCT01754727|Ankylosing Spondylitis|ankylosing spondylitis
425330|NCT01754727|Effectiveness|effectiveness
425331|NCT01754727|Post-marketing observational study (PMOS)|post-marketing observational study (pmos)
425332|NCT01754727|Adalimumab|adalimumab
425333|NCT01754727|Humira®|humira®
425334|NCT01754714|Steatohepatitis|steatohepatitis
425335|NCT01754688|Acute Bilirubin Encephalopathy|acute bilirubin encephalopathy
425336|NCT01754688|Bilirubin Induced Neurologic Dysfunction score|bilirubin induced neurologic dysfunction score
425337|NCT01754688|Hearing Test|hearing test
425338|NCT01754688|Neonate|neonate
425339|NCT01754662|Type 2 diabetes|type 2 diabetes
425340|NCT01754662|Cardiovascular risk|cardiovascular risk
425341|NCT01754662|Endothelial function|endothelial function
425342|NCT01754662|Insulin resistance|insulin resistance
425343|NCT01754662|Soy|soy
425344|NCT01754662|Isoflavones|isoflavones
425345|NCT01754662|Cocoa|cocoa
425346|NCT01754662|Diet|diet
425347|NCT01754649|intrauterine device|intrauterine device
425348|NCT01754649|insertion failure|insertion failure
425349|NCT01754636|Colorectal neoplasms|colorectal neoplasms
425350|NCT01754636|Elderly|elderly
425351|NCT01754636|Randomized clinical trials|randomized clinical trials
425352|NCT01754636|Inclusion.|inclusion.
425353|NCT01754623|Pancreas|pancreas
425354|NCT01754623|Pancreatic|pancreatic
425355|NCT01754623|Neoplasms|neoplasms
425356|NCT01754623|Stereotactic|stereotactic
425357|NCT01754623|Radiosurgery|radiosurgery
425358|NCT01754623|Borderline|borderline
425359|NCT01754623|Resectable|resectable
425360|NCT01754623|Gastrointestinal|gastrointestinal
425361|NCT01754623|Gemcitabine|gemcitabine
425362|NCT01754623|Capecitabine|capecitabine
425363|NCT01754623|Fluorouracil|fluorouracil
425364|NCT01754623|Docetaxel|docetaxel
425365|NCT01754623|SBRT|sbrt
425366|NCT01754623|GTX Chemotherapy|gtx chemotherapy
425367|NCT01754610|family trauma|family trauma
425368|NCT01754610|multi-family therapy|multi-family therapy
425369|NCT01754610|Posttraumatic Stress Disorder|posttraumatic stress disorder
425370|NCT01754610|poverty|poverty
425371|NCT01754597|Patients with breast cancer requiring surgical management with general anesthesia|patients with breast cancer requiring surgical management with general anesthesia
425372|NCT01754584|hyaluronan including concentrations|hyaluronan including concentrations
425373|NCT01754584|molecular weight|molecular weight
425374|NCT01754584|mucociliary differentiation|mucociliary differentiation
425375|NCT01754584|human respiratory epithelial cells|human respiratory epithelial cells
425376|NCT01754571|medication overuse headache|medication overuse headache
425377|NCT01754545|Infusions, Intravenous|infusions, intravenous
425378|NCT01754545|Plasma|plasma
425379|NCT01754545|ADAMTS-13 protein, human|adamts-13 protein, human
425380|NCT01754532|Schizophrenia|schizophrenia
425381|NCT01754532|Schizo-Affective Disorder|schizo-affective disorder
425382|NCT01754532|Stress|stress
425383|NCT01754532|Cortisol|cortisol
425384|NCT01754532|PANSS|panss
425385|NCT01754506|leg ulcers|leg ulcers
425386|NCT01754506|wounds|wounds
425387|NCT01754506|fish oil|fish oil
425388|NCT01754506|lipid mediators|lipid mediators
425389|NCT01754506|chronic venous stasis ulcers|chronic venous stasis ulcers
425390|NCT01754493|Major Depression|major depression
425391|NCT01754493|Irritable Bowel Syndrome|irritable bowel syndrome
425392|NCT01754493|Somatization|somatization
425393|NCT01754493|Cymbalta|cymbalta
425394|NCT01754493|Duloxetine|duloxetine
425395|NCT01754480|Fibrin Sealant|fibrin sealant
425396|NCT01754480|Parenchymous tissue open surgery|parenchymous tissue open surgery
425397|NCT01754480|Hepatic Resection|hepatic resection
425398|NCT01754480|Oxidized cellulose pads|oxidized cellulose pads
425399|NCT01754441|Spinal Muscular Atrophy|spinal muscular atrophy
425400|NCT01754441|SMA|sma
425401|NCT01754441|Motor Neuron Abnormalities|motor neuron abnormalities
425402|NCT01754428|Respiratory|respiratory
425403|NCT01754428|Syncytial|syncytial
425404|NCT01754428|Virus|virus
425405|NCT01754428|RSV|rsv
425406|NCT01754415|Aging|aging
425407|NCT01754415|Chronic illness|chronic illness
425408|NCT01754415|Resistance circuit training|resistance circuit training
425409|NCT01754402|Multiple Myeloma|multiple myeloma
425410|NCT01754376|Metastatic|metastatic
425411|NCT01754376|Unresectable|unresectable
425412|NCT01754376|V600E mutation|v600e mutation
425413|NCT01754363|Osteoarthritis|osteoarthritis
425414|NCT01754350|ketogenic diet|ketogenic diet
425415|NCT01754350|glioma|glioma
425416|NCT01754350|fasting|fasting
425417|NCT01754350|reirradiation|reirradiation
425418|NCT01754350|nutrition|nutrition
425419|NCT01754337|Type 1 diabetes|type 1 diabetes
425420|NCT01754337|Hypoglycemia|hypoglycemia
425421|NCT01754337|Insulin|insulin
425422|NCT01754337|Glucagon|glucagon
425423|NCT01754337|Closed-loop system|closed-loop system
425424|NCT01754337|Artificial pancreas|artificial pancreas
425425|NCT01754324|Neonatal Abstinence Syndrome|neonatal abstinence syndrome
425426|NCT01754324|Pharmacokinetics|pharmacokinetics
425427|NCT01754324|Methadone|methadone
425428|NCT01754324|Neonate|neonate
425429|NCT01754324|Newborn|newborn
425430|NCT01754311|HTLV-I|htlv-i
425431|NCT01754298|osteochondritis dissecans (OCD)|osteochondritis dissecans (ocd)
425432|NCT01754298|juvenile osteochondritis dissecans (JOCD)|juvenile osteochondritis dissecans (jocd)
425433|NCT01754298|knee osteochondritis dissecans|knee osteochondritis dissecans
425434|NCT01754298|retro-articular drilling|retro-articular drilling
425435|NCT01754298|trans-articular drilling|trans-articular drilling
425436|NCT01754298|stable osteochondritis dissecans lesion|stable osteochondritis dissecans lesion
425437|NCT01754272|metastatic colorectal cancer|metastatic colorectal cancer
425438|NCT01754272|mCRC|mcrc
425439|NCT01754272|Aflibercept|aflibercept
425440|NCT01754272|FOLFIRI|folfiri
425441|NCT01754272|translational research|translational research
425442|NCT01754272|retrospective|retrospective
425443|NCT01754272|noninterventional|noninterventional
425444|NCT01754272|biomarkers|biomarkers
425445|NCT01754272|angiogenesis|angiogenesis
425446|NCT01754259|type 1 diabetes|type 1 diabetes
425447|NCT01754259|type 2 diabetes|type 2 diabetes
425448|NCT01754259|exertion angina|exertion angina
425449|NCT01754259|suspected CAD|suspected cad
425450|NCT01754259|known CAD|known cad
425451|NCT01754194|Gastric Sleeve|gastric sleeve
425452|NCT01754194|Gastric Bypass|gastric bypass
425453|NCT01754194|Roux en Y|roux en y
425454|NCT01754194|Morbid Obesity|morbid obesity
425455|NCT01754194|Laparoscopy|laparoscopy
425456|NCT01754181|Glycemic control algorithm|glycemic control algorithm
425457|NCT01754181|closed loop|closed loop
425458|NCT01754181|artificial pancreas|artificial pancreas
543863|NCT01247207|DMD|dmd
425459|NCT01754168|Parkinson disease|parkinson disease
425460|NCT01754168|Cognition|cognition
425461|NCT01754155|Vitamin E|vitamin e
425462|NCT01754155|Zimmer|zimmer
425463|NCT01754155|RSA|rsa
425464|NCT01754155|Radiostereometric Analysis|radiostereometric analysis
425465|NCT01754129|Caregiver|caregiver
425466|NCT01754129|Quality of Life|quality of life
425467|NCT01754129|Parkinson's Disease|parkinson's disease
425468|NCT01754116|healthy subjects|healthy subjects
425469|NCT01754116|GSK1265744 LAP|gsk1265744 lap
425470|NCT01754116|integrase inhibitor|integrase inhibitor
425471|NCT01754116|HIV-1 infection|hiv-1 infection
425472|NCT01754116|long acting retroviral|long acting retroviral
425473|NCT01754116|relative bioavailability|relative bioavailability
425474|NCT01754103|blind|blind
425475|NCT01754103|tactile stimulation|tactile stimulation
425476|NCT01754103|cross-modality|cross-modality
425477|NCT01754103|visual qualia|visual qualia
425478|NCT01754103|resting state MRI|resting state mri
425479|NCT01754103|functional connectivity|functional connectivity
425480|NCT01754103|neuroplasticity|neuroplasticity
425481|NCT01754090|alcohol|alcohol
425482|NCT01754090|online intervention|online intervention
425483|NCT01754090|hazardous drinking|hazardous drinking
425484|NCT01754090|harmful drinking|harmful drinking
425485|NCT01754090|early intervention|early intervention
425486|NCT01754090|behavior change intervention|behavior change intervention
425487|NCT01754077|Language|language
425488|NCT01754077|Behavior change|behavior change
425489|NCT01754077|Intervention|intervention
425490|NCT01754077|Home visiting|home visiting
425491|NCT01754077|Child language development|child language development
425492|NCT01754064|Bradycardia|bradycardia
425493|NCT01754064|Tachycardia|tachycardia
425494|NCT01754064|Arrhythimas|arrhythimas
425495|NCT01754064|ICD|icd
425496|NCT01754064|pacemaker|pacemaker
425497|NCT01754064|pacing lead|pacing lead
425498|NCT01754038|Patient Reported Outcomes|patient reported outcomes
425499|NCT01754038|PRO|pro
425500|NCT01754038|Registry|registry
425501|NCT01754025|Gene Mutation|gene mutation
425502|NCT01754012|Nutrition|nutrition
425503|NCT01754012|Dietary intervention|dietary intervention
425504|NCT01754012|Aging|aging
425505|NCT01754012|Inflammation|inflammation
425506|NCT01754012|Elderly|elderly
425507|NCT01754012|Europe|europe
425508|NCT01753999|World Trade Center (WTC)|world trade center (wtc)
425509|NCT01753999|nasal symptoms|nasal symptoms
425510|NCT01753999|nasal inflammation|nasal inflammation
425511|NCT01753999|CPAP|cpap
425512|NCT01753973|Metabolic syndrome|metabolic syndrome
425513|NCT01753973|Renal transplantation|renal transplantation
425514|NCT01753895|Healthy Volunteers|healthy volunteers
425515|NCT01753882|Gait training|gait training
425516|NCT01753882|Lexapro|lexapro
425517|NCT01753882|Tizanidine|tizanidine
425518|NCT01753843|Preterm Birth|preterm birth
425519|NCT01753830|Double-blind|double-blind
425520|NCT01753830|Randomized|randomized
425521|NCT01753830|Intraarticular injection|intraarticular injection
425522|NCT01753830|Hyaluronic acid|hyaluronic acid
425523|NCT01753830|Placebo|placebo
425524|NCT01753830|Knee osteoarthritis|knee osteoarthritis
425525|NCT01753817|Coronary catheterization|coronary catheterization
425526|NCT01753817|Transradial patency|transradial patency
425527|NCT01753804|DMD|dmd
425528|NCT01753804|Myopathy|myopathy
425529|NCT01753804|Natural History|natural history
425530|NCT01753804|Muscular dystrophy|muscular dystrophy
425531|NCT01753804|Biomarkers|biomarkers
425532|NCT01753804|Muscle testing|muscle testing
425533|NCT01753778|Nerve Entrapment, Morton's neuroma, entrapment neuropathy|nerve entrapment, morton's neuroma, entrapment neuropathy
425534|NCT01753765|occipital neuralgia|occipital neuralgia
425535|NCT01753726|stretching, diaphragm, spinal movement, thoracic movement|stretching, diaphragm, spinal movement, thoracic movement
425536|NCT01753700|crossover|crossover
425537|NCT01753700|UHT milk|uht milk
425538|NCT01753700|Pasteurised milk|pasteurised milk
425539|NCT01753700|supplement|supplement
425540|NCT01753687|break up time|break up time
425541|NCT01753687|tear film thickness|tear film thickness
425542|NCT01753687|tear film osmolarity|tear film osmolarity
425543|NCT01753687|objective scattering index|objective scattering index
425544|NCT01753687|impression cytology|impression cytology
425545|NCT01753687|tear cytokines/chemokines|tear cytokines/chemokines
425546|NCT01753687|visual acuity|visual acuity
425547|NCT01753687|fluorescein staining|fluorescein staining
425548|NCT01753674|metabolic syndrome, insulin resistance, HDL cholesterol,|metabolic syndrome, insulin resistance, hdl cholesterol,
425549|NCT01753661|Hearing loss|hearing loss
425550|NCT01753661|Language|language
425551|NCT01753661|Behavior change|behavior change
425552|NCT01753661|Early Intervention|early intervention
425553|NCT01753661|Home visiting|home visiting
425554|NCT01753648|retinal blood flow|retinal blood flow
425555|NCT01753648|retinal blood velocity|retinal blood velocity
425556|NCT01753648|retinal oxygen saturation|retinal oxygen saturation
425557|NCT01753648|retinal vessel diameter|retinal vessel diameter
425558|NCT01753648|ocular perfusion pressure|ocular perfusion pressure
425559|NCT01753635|Baska mask|baska mask
425560|NCT01753635|LMA|lma
425561|NCT01753635|single use LMA device|single use lma device
425562|NCT01753635|laryngeal mask airway|laryngeal mask airway
425563|NCT01753635|supraglottic airway device|supraglottic airway device
425564|NCT01753622|Overweight, obese, pregnant, depression, outcomes|overweight, obese, pregnant, depression, outcomes
425565|NCT01753609|Over weight|over weight
425566|NCT01753609|Obesity|obesity
425567|NCT01753596|topical lubricants|topical lubricants
425568|NCT01753596|tear film thickness|tear film thickness
425569|NCT01753596|break up time|break up time
425570|NCT01753596|ocular surface disease index|ocular surface disease index
425571|NCT01753596|Schirmer I test|schirmer i test
425572|NCT01753583|optical coherence tomography|optical coherence tomography
425573|NCT01753583|corneal abrasion|corneal abrasion
425574|NCT01753583|corneal infiltrate|corneal infiltrate
425575|NCT01753570|Feron|feron
425576|NCT01753557|Pegasys|pegasys
425577|NCT01753531|Ultra Influenza A and B|ultra influenza a and b
425578|NCT01753531|Influenza Type A|influenza type a
425579|NCT01753531|Influenza Type B|influenza type b
425580|NCT01753531|Flu|flu
425581|NCT01753531|Sekisui Diagnostics|sekisui diagnostics
425582|NCT01753518|Subcuticular suture|subcuticular suture
425583|NCT01753518|Subcuticular staple|subcuticular staple
425584|NCT01753518|Skin closure|skin closure
425585|NCT01753518|Incision closure|incision closure
425586|NCT01753518|Wound|wound
425587|NCT01753505|multidetector coronary CT angiography, renal transplantation|multidetector coronary ct angiography, renal transplantation
425588|NCT01753492|Intraocular pressure|intraocular pressure
425589|NCT01753492|glaucoma|glaucoma
425590|NCT01753492|trabeculectomy|trabeculectomy
425591|NCT01753492|Ologen|ologen
425592|NCT01753479|Pancreatic adenocarcinoma|pancreatic adenocarcinoma
425593|NCT01753453|Hematopoietic stem cell transplantation|hematopoietic stem cell transplantation
425594|NCT01753453|Tumour cell mobilization|tumour cell mobilization
425595|NCT01753440|coronary artery disease|coronary artery disease
425596|NCT01753440|heart failure|heart failure
425597|NCT01753440|stem cells implantation|stem cells implantation
425598|NCT01753427|COPD,|copd,
425599|NCT01753427|symptoms,|symptoms,
425600|NCT01753427|Non-Interventional study,|non-interventional study,
425601|NCT01753414|Lung Cancer|lung cancer
425602|NCT01753401|SLE|sle
425603|NCT01753401|Lupus|lupus
425604|NCT01753375|Multiple Sclerosis|multiple sclerosis
425605|NCT01753375|Relapsing rate|relapsing rate
425606|NCT01753375|Expanded disability status scale|expanded disability status scale
425607|NCT01753375|Vitamin D3|vitamin d3
425608|NCT01753323|acute malaria, KAF156|acute malaria, kaf156
425609|NCT01753245|Anti-TNF drugs efficacy|anti-tnf drugs efficacy
425610|NCT01753245|Moderate-to-severe psoriasis vulgaris|moderate-to-severe psoriasis vulgaris
425611|NCT01753245|Gene polymorphism|gene polymorphism
425612|NCT01753232|DALI adsorber|dali adsorber
425613|NCT01753232|MONET lipoprotein filter|monet lipoprotein filter
425614|NCT01753193|Systemic Lupus Erythematosus|systemic lupus erythematosus
425615|NCT01753180|CTO|cto
425616|NCT01753180|PCI|pci
425617|NCT01753180|Angioplasty|angioplasty
425618|NCT01753154|Peritoneal Dialysis|peritoneal dialysis
425619|NCT01753154|Biocompatible dialysis solution|biocompatible dialysis solution
425620|NCT01753154|Hydration status|hydration status
425621|NCT01753154|Residual renal function|residual renal function
425622|NCT01753154|Body composition monitor|body composition monitor
425623|NCT01753154|Bioimpedance spectroscopy|bioimpedance spectroscopy
425624|NCT01753154|Cancer antigen 125|cancer antigen 125
425625|NCT01753141|Cognitive Behavioral Therapy|cognitive behavioral therapy
425626|NCT01753141|Smoking Cessation|smoking cessation
425627|NCT01753115|post-exposure prophylaxis|post-exposure prophylaxis
425628|NCT01753115|toxin neutralization assay|toxin neutralization assay
425629|NCT01753102|Estradiol|estradiol
425630|NCT01753102|Vulvar atrophy|vulvar atrophy
425631|NCT01753102|vaginal atrophy|vaginal atrophy
425632|NCT01753089|Metastatic|metastatic
425633|NCT01753076|Amyotrophic lateral sclerosis|amyotrophic lateral sclerosis
425634|NCT01753076|efficacy|efficacy
425635|NCT01753076|ozanezumab|ozanezumab
425636|NCT01753076|safety|safety
425637|NCT01753063|Obesity|obesity
425638|NCT01753063|Children|children
425639|NCT01753063|Adolescents|adolescents
425640|NCT01753063|Attrition|attrition
425641|NCT01753037|Hyperandrogenism|hyperandrogenism
425642|NCT01753037|Inflammation|inflammation
425643|NCT01753037|Insulin sensitivity|insulin sensitivity
425644|NCT01753037|Body composition|body composition
425645|NCT01753024|exocrine pancreatic insufficiency|exocrine pancreatic insufficiency
425646|NCT01753024|fecal elastase-1|fecal elastase-1
425647|NCT01753024|amylase|amylase
425648|NCT01753024|lipase|lipase
425649|NCT01753024|critical illness|critical illness
425650|NCT01753024|enteral nutrition|enteral nutrition
425651|NCT01753024|malnutrition|malnutrition
425652|NCT01753024|sepsis|sepsis
425653|NCT01753024|diabetes|diabetes
425654|NCT01753024|hyperlactacidemia|hyperlactacidemia
425655|NCT01753024|hemodialysis|hemodialysis
425656|NCT01753024|mechanical ventilation|mechanical ventilation
425657|NCT01753011|Stress urinary Incontinence|stress urinary incontinence
425658|NCT01753011|Transobturator sling|transobturator sling
425659|NCT01753011|TOT|tot
425660|NCT01752998|pain|pain
425661|NCT01752998|depression|depression
425662|NCT01752998|substance use|substance use
425663|NCT01752972|Arsenic|arsenic
425664|NCT01752972|Keratosis|keratosis
425665|NCT01752972|Linoleic acid|linoleic acid
425666|NCT01752972|Palm|palm
425667|NCT01752972|Spirulina|spirulina
425668|NCT01752972|Vitamin E|vitamin e
425669|NCT01752972|Zinc|zinc
425670|NCT01752920|FGFR|fgfr
425671|NCT01752920|ARQ 087|arq 087
425672|NCT01752920|Targeted therapy|targeted therapy
425673|NCT01752920|Molecular therapy|molecular therapy
425674|NCT01752920|Tyrosine kinase inhibitor|tyrosine kinase inhibitor
425675|NCT01752920|TKI|tki
425676|NCT01752920|Receptor tyrosine kinase|receptor tyrosine kinase
425677|NCT01752920|RTK|rtk
425678|NCT01752920|Biomarker|biomarker
425679|NCT01752920|Phase 1|phase 1
425680|NCT01752920|Phase I|phase i
425681|NCT01752920|Solid tumor|solid tumor
425682|NCT01752920|Liver Cancer|liver cancer
425683|NCT01752920|Hepatobiliary carcinoma|hepatobiliary carcinoma
425684|NCT01752920|Biliary tract cancer|biliary tract cancer
425685|NCT01752920|Cholangiocarcinoma|cholangiocarcinoma
425686|NCT01752920|Intrahepatic cholangiocarcinoma|intrahepatic cholangiocarcinoma
425687|NCT01752920|FGFR inhibitor|fgfr inhibitor
425688|NCT01752920|Targeted FGFR kinase inhibitor|targeted fgfr kinase inhibitor
425689|NCT01752920|Pan-FGFR inhibitor|pan-fgfr inhibitor
425690|NCT01752920|Selective FGFR inhibitor|selective fgfr inhibitor
425691|NCT01752920|FGFR pathway|fgfr pathway
425692|NCT01752920|FGFR signaling|fgfr signaling
425693|NCT01752920|Fibroblast growth factor|fibroblast growth factor
425694|NCT01752920|FGFR1|fgfr1
425695|NCT01752920|FGFR2|fgfr2
425696|NCT01752920|FGFR3|fgfr3
425697|NCT01752920|FGFR4|fgfr4
425698|NCT01752920|FGF|fgf
425699|NCT01752920|FGF19|fgf19
425700|NCT01752920|FGF21|fgf21
425701|NCT01752920|FGF23|fgf23
425702|NCT01752920|FGFR mutation|fgfr mutation
425703|NCT01752920|FGFR gene fusion|fgfr gene fusion
425704|NCT01752920|FGFR gene translocation|fgfr gene translocation
425705|NCT01752920|FGFR genetic aberration|fgfr genetic aberration
425706|NCT01752920|FGFR2 fusion|fgfr2 fusion
425707|NCT01752920|FGFR2 translocation|fgfr2 translocation
425708|NCT01752920|Phase 1 Clinical Trial|phase 1 clinical trial
425709|NCT01752920|Phase I Clinical Trial|phase i clinical trial
425710|NCT01752920|Clinical oncology|clinical oncology
425711|NCT01752920|Tumor|tumor
425712|NCT01752920|Tumour|tumour
425713|NCT01752920|derazantinib|derazantinib
425714|NCT01752907|Breast cancer|breast cancer
425715|NCT01752907|Chemotherapy|chemotherapy
425716|NCT01752907|Pegfilgrastim|pegfilgrastim
425717|NCT01752907|Neulasta|neulasta
425718|NCT01752907|Bone Pain|bone pain
425719|NCT01752907|Education|education
425720|NCT01752881|Influenza|influenza
425721|NCT01752881|Vaccine|vaccine
425722|NCT01752881|Immunogenicity|immunogenicity
425723|NCT01752855|Rheumatoid Arthritis|rheumatoid arthritis
425724|NCT01752842|Diabetes|diabetes
425725|NCT01752842|Diabetic Cardiomyopathy|diabetic cardiomyopathy
425726|NCT01752842|Triglycerides|triglycerides
425727|NCT01752829|Obesity|obesity
425728|NCT01752829|gastric|gastric
425729|NCT01752829|banding|banding
425730|NCT01752829|Weight|weight
425731|NCT01752829|co-morbidities|co-morbidities
425732|NCT01752829|dilatation|dilatation
425733|NCT01752829|Excess weight loss|excess weight loss
425734|NCT01752829|adjustable gastric banding|adjustable gastric banding
425735|NCT01752816|endurance training,|endurance training,
425736|NCT01752816|strength training,|strength training,
425737|NCT01752816|aerobic capacity,|aerobic capacity,
425738|NCT01752816|muscle strenght|muscle strenght
425739|NCT01752816|physical capacity|physical capacity
425740|NCT01752790|Pediatric Crohn's disease|pediatric crohn's disease
425741|NCT01752790|Biologics|biologics
425742|NCT01752790|Immunomodulators|immunomodulators
425743|NCT01752790|Top-down|top-down
425744|NCT01752790|step-up|step-up
425745|NCT01752777|HIV/AIDS, HIV infectiousness, Medication adherence, Sexual risks reduction|hiv/aids, hiv infectiousness, medication adherence, sexual risks reduction
425746|NCT01752751|Neck cancer|neck cancer
425747|NCT01752751|Head cancer|head cancer
425748|NCT01752751|Lung cancer|lung cancer
425749|NCT01752725|supracervical hysterectomy|supracervical hysterectomy
425750|NCT01752725|vessel sealing|vessel sealing
425751|NCT01752725|bipolar electrocoagulation|bipolar electrocoagulation
425752|NCT01752712|Oxytocin|oxytocin
425753|NCT01752712|Social function|social function
425754|NCT01752712|CBSST|cbsst
425755|NCT01752699|neuropathic pain,|neuropathic pain,
425756|NCT01752699|post-herpetic neuralgia,|post-herpetic neuralgia,
425757|NCT01752699|methadone,|methadone,
710231|NCT00589654|questionnaire|questionnaire
425758|NCT01752686|Triple negative breast cancer|triple negative breast cancer
425759|NCT01752686|adjuvant chemotherapy|adjuvant chemotherapy
425760|NCT01752673|randomized controlled study|randomized controlled study
425761|NCT01752660|Exercise therapy|exercise therapy
425762|NCT01752660|Aerobic training|aerobic training
426069|NCT01751139|Brazil|brazil
425763|NCT01752660|Endurance training|endurance training
425764|NCT01752647|lung cancer|lung cancer
425765|NCT01752647|screening|screening
425766|NCT01752647|low dose|low dose
425767|NCT01752647|computed tomography|computed tomography
425768|NCT01752634|Psoriatic arthritis, PsA, ACR, CASPAR, PASDAS|psoriatic arthritis, psa, acr, caspar, pasdas
425769|NCT01752621|Acromegaly|acromegaly
425770|NCT01752621|mortality|mortality
425771|NCT01752621|morbidity|morbidity
425772|NCT01752621|incidence|incidence
425773|NCT01752621|prevalence|prevalence
425774|NCT01752608|Depression|depression
425775|NCT01752608|Real-time|real-time
425776|NCT01752608|iPhone|iphone
425777|NCT01752608|CBT|cbt
425778|NCT01752608|Cognitive behavioral therapy|cognitive behavioral therapy
425779|NCT01752582|BuMA|buma
425780|NCT01752582|EXCEL|excel
425781|NCT01752582|OCT|oct
425782|NCT01752582|stent|stent
425783|NCT01752582|neointima formation|neointima formation
425784|NCT01752569|HIV|hiv
425785|NCT01752569|Kaposi's sarcoma|kaposi's sarcoma
425786|NCT01752569|Anti-retroviral therapy|anti-retroviral therapy
425787|NCT01752569|HAART|haart
425788|NCT01752569|AIDS|aids
425789|NCT01752556|Sleep apnea, Portable monitor,autoCPAP|sleep apnea, portable monitor,autocpap
425790|NCT01752543|Vasopressin|vasopressin
425791|NCT01752543|Exercise capacity|exercise capacity
425792|NCT01752543|Conivaptan|conivaptan
425793|NCT01752530|ADHD|adhd
425794|NCT01752517|small cell lung cancer|small cell lung cancer
425795|NCT01752517|chemotherapy|chemotherapy
425796|NCT01752517|vinorelbine|vinorelbine
425797|NCT01752517|ifosfamide|ifosfamide
425798|NCT01752517|third-line treatment|third-line treatment
425799|NCT01752504|HIV prevention|hiv prevention
425800|NCT01752504|HIV positive communities|hiv positive communities
425801|NCT01752491|Ascorbate|ascorbate
425802|NCT01752491|Ascorbic acid|ascorbic acid
425803|NCT01752491|Vitamin C|vitamin c
425804|NCT01752491|Radiation|radiation
425805|NCT01752491|Temozolomide|temozolomide
425806|NCT01752478|ptosis|ptosis
425807|NCT01752478|retina surgery|retina surgery
425808|NCT01752478|droopy eye lid|droopy eye lid
425809|NCT01752465|Health behaviour|health behaviour
425810|NCT01752465|Antipsychotic agents|antipsychotic agents
425811|NCT01752465|Adverse effects|adverse effects
425812|NCT01752465|Goals|goals
425813|NCT01752465|Life style|life style
425814|NCT01752439|Chronic Migraine|chronic migraine
425815|NCT01752439|Medication Overuse Headache|medication overuse headache
425816|NCT01752439|Refractory|refractory
425817|NCT01752439|transcranial direct current stimulation|transcranial direct current stimulation
425818|NCT01752426|Leukemia|leukemia
425819|NCT01752426|Chronic Lymphocytic Leukemia|chronic lymphocytic leukemia
425820|NCT01752426|CLL|cll
425821|NCT01752426|Small Lymphocytic Lymphoma|small lymphocytic lymphoma
425822|NCT01752426|SLL|sll
425823|NCT01752426|PCI-32765|pci-32765
425824|NCT01752426|Ibrutinib|ibrutinib
425825|NCT01752426|Btk inhibitor|btk inhibitor
425826|NCT01752426|Heavy water|heavy water
425827|NCT01752426|2H2O|2h2o
425828|NCT01752413|Iron depletion|iron depletion
425829|NCT01752413|blood donors|blood donors
425830|NCT01752413|iron replacement|iron replacement
425831|NCT01752400|Advanced|advanced
425832|NCT01752361|Gastrointestinal Motility|gastrointestinal motility
425833|NCT01752361|Inflammatory Bowel Disease|inflammatory bowel disease
425834|NCT01752361|Transit time|transit time
425835|NCT01752348|sepsis|sepsis
425836|NCT01752348|cytokine release|cytokine release
425837|NCT01752348|fever|fever
425838|NCT01752335|Rheumatoid Arthritis, tocilizumab, cardiovascular risk factors|rheumatoid arthritis, tocilizumab, cardiovascular risk factors
425839|NCT01752309|Early Rheumatoid arthritis|early rheumatoid arthritis
425840|NCT01752309|Rheumatoid arthritis|rheumatoid arthritis
425841|NCT01752309|Ultrasound|ultrasound
425842|NCT01752309|Predictive|predictive
425843|NCT01752309|Prognosis|prognosis
425844|NCT01752296|Morquio|morquio
425845|NCT01752296|Mucopolysaccharidosis IV|mucopolysaccharidosis iv
425846|NCT01752296|Psychological health|psychological health
425847|NCT01752283|Videoassited|videoassited
425848|NCT01752283|Thyroidectomy|thyroidectomy
425849|NCT01752283|Minimal invasive surgery|minimal invasive surgery
425850|NCT01752283|General anesthesia|general anesthesia
425851|NCT01752283|Hypnosis|hypnosis
425852|NCT01752257|Melanoma|melanoma
425853|NCT01752244|Obesity, vitamin D analogue, VDR, PPARg, PGC1a|obesity, vitamin d analogue, vdr, pparg, pgc1a
425854|NCT01752218|Femto-second Laser|femto-second laser
425855|NCT01752218|arcuate incision|arcuate incision
425856|NCT01752218|corneal astigmatism|corneal astigmatism
425857|NCT01752218|astigmatic keratotomy|astigmatic keratotomy
425858|NCT01752218|Cataract|cataract
544306|NCT01245010|Water|water
425859|NCT01752205|Esophageal Squamous Carcinoma|esophageal squamous carcinoma
425860|NCT01752205|Erlotinib|erlotinib
425861|NCT01752205|Chemoradiotherapy|chemoradiotherapy
425862|NCT01752192|Rehabilitation|rehabilitation
425863|NCT01752192|Telemedicine|telemedicine
425864|NCT01752192|Heart patients|heart patients
425865|NCT01752192|Social media|social media
426070|NCT01751139|Incidence|incidence
425866|NCT01752192|Organisational aspects|organisational aspects
425867|NCT01752179|Kinesio taping|kinesio taping
425868|NCT01752179|Piriformis syndrome|piriformis syndrome
425869|NCT01752179|Trigger point|trigger point
425871|NCT01752166|Candidemia|candidemia
425872|NCT01752166|Blood culture|blood culture
425873|NCT01752166|Diagnostics|diagnostics
425874|NCT01752153|Focus|focus
425875|NCT01752153|immunomodulatory effect|immunomodulatory effect
425876|NCT01752153|of silymarin|of silymarin
425877|NCT01752153|on cell mediated immunity|on cell mediated immunity
425878|NCT01752153|Beta-Thalassemia|beta-thalassemia
425879|NCT01752153|major patients.|major patients.
425880|NCT01752140|Prostate cancer|prostate cancer
425881|NCT01752140|Prostate biopsy|prostate biopsy
425882|NCT01752140|Vienna nomogram|vienna nomogram
425883|NCT01752127|Drug-eluting stent|drug-eluting stent
425884|NCT01752127|diabetes|diabetes
425885|NCT01752127|small vessel disease|small vessel disease
425886|NCT01752114|Precancerous conditions|precancerous conditions
425887|NCT01752114|Carcinoma|carcinoma
425888|NCT01752101|Precancerous Conditions|precancerous conditions
425889|NCT01752101|Carcinoma|carcinoma
425890|NCT01752088|apularis, MRI clinical, results|apularis, mri clinical, results
425891|NCT01752075|Multiple myeloma|multiple myeloma
425892|NCT01752062|Chronic Myeloid Leukemia|chronic myeloid leukemia
425894|NCT01752062|Pregnancy|pregnancy
425895|NCT01752049|Hereditary Hemorrhagic Telangiectasia|hereditary hemorrhagic telangiectasia
425896|NCT01752049|Anti-angiogenic Therapy|anti-angiogenic therapy
425897|NCT01752049|vascular malformations|vascular malformations
425898|NCT01752049|HHT|hht
425899|NCT01752036|stereotactic radiotherapy|stereotactic radiotherapy
425900|NCT01752036|SRS|srs
425901|NCT01751984|lipid-lowering drugs|lipid-lowering drugs
425902|NCT01751984|statin intolerance|statin intolerance
425903|NCT01751945|EmONC|emonc
425904|NCT01751945|Neonatal mortality|neonatal mortality
425905|NCT01751945|Perinatal mortality|perinatal mortality
425906|NCT01751919|CML|cml
425907|NCT01751919|GIST|gist
425908|NCT01751906|Absorb™ BVS|absorb™ bvs
425909|NCT01751906|Angioplasty|angioplasty
425910|NCT01751906|Bioabsorbable|bioabsorbable
425911|NCT01751906|BVS|bvs
425912|NCT01751906|Bioresorbable|bioresorbable
425913|NCT01751906|Coronary Artery Disease|coronary artery disease
425914|NCT01751906|Coronary Artery Endothelial Responsiveness|coronary artery endothelial responsiveness
425915|NCT01751906|Coronary artery restenosis|coronary artery restenosis
425916|NCT01751906|Coronary artery stenosis|coronary artery stenosis
425917|NCT01751906|Coronary scaffold|coronary scaffold
425918|NCT01751906|Coronary Stent|coronary stent
425919|NCT01751906|Drug eluting stents|drug eluting stents
425920|NCT01751906|Everolimus|everolimus
425921|NCT01751906|Myocardial ischemia|myocardial ischemia
425922|NCT01751906|Stent thrombosis|stent thrombosis
425923|NCT01751906|Stents|stents
425924|NCT01751893|Hand-foot syndrome|hand-foot syndrome
425925|NCT01751893|palmar-plantar erythrodysesthesia|palmar-plantar erythrodysesthesia
425926|NCT01751893|capecitabine|capecitabine
425927|NCT01751893|pegylated liposomal doxorubicin|pegylated liposomal doxorubicin
425928|NCT01751893|henna|henna
425929|NCT01751880|Gastric cancer, minimally invasive gastrectomy, Physical activity intervention|gastric cancer, minimally invasive gastrectomy, physical activity intervention
425930|NCT01751867|Myelodysplastic Syndrome|myelodysplastic syndrome
425931|NCT01751867|Dacogen|dacogen
425932|NCT01751867|Oncology|oncology
425933|NCT01751867|Decitabine|decitabine
425934|NCT01751867|Bone marrow disorders|bone marrow disorders
425935|NCT01751854|pharmacology|pharmacology
425936|NCT01751854|rehabilitation|rehabilitation
425937|NCT01751854|locomotion|locomotion
425938|NCT01751828|Depression|depression
425939|NCT01751828|Major Depressive Disorder|major depressive disorder
425940|NCT01751802|Lesch Nyhan Disease|lesch nyhan disease
425941|NCT01751802|Self-Injury|self-injury
425942|NCT01751789|illicit opioid drug use|illicit opioid drug use
425943|NCT01751789|health service utilization|health service utilization
425944|NCT01751737|prostate|prostate
425945|NCT01751737|cancer|cancer
425946|NCT01751737|biopsy|biopsy
425947|NCT01751737|18F-choline|18f-choline
425948|NCT01751737|PET|pet
425949|NCT01751737|MRI|mri
425950|NCT01751724|Premature infants|premature infants
425951|NCT01751724|Caffeine|caffeine
425952|NCT01751724|Methylxanthines|methylxanthines
425953|NCT01751724|Mechanical ventilation|mechanical ventilation
425954|NCT01751724|Oxygen|oxygen
425955|NCT01751724|Weaning|weaning
425956|NCT01751724|Bronchopulmonary dysplasia|bronchopulmonary dysplasia
425957|NCT01751698|Autism|autism
710232|NCT00589654|97-127|97-127
425958|NCT01751698|Minimally Verbal|minimally verbal
425959|NCT01751698|School Age|school age
425960|NCT01751685|kyphosis|kyphosis
425961|NCT01751672|SBIRT|sbirt
425962|NCT01751672|Substance Use|substance use
425963|NCT01751672|Screening|screening
425964|NCT01751672|Brief Intervention|brief intervention
425965|NCT01751672|Primary Care|primary care
425966|NCT01751633|Burst fractures|burst fractures
425967|NCT01751633|Thoracic or Lumbar Vertebrae/injuries [MeSH]|thoracic or lumbar vertebrae/injuries [mesh]
425968|NCT01751633|Thoracic or Lumbar Vertebrae/surgery [MeSH]|thoracic or lumbar vertebrae/surgery [mesh]
425969|NCT01751633|Spinal Fusion/methods [MeSH]|spinal fusion/methods [mesh]
425970|NCT01751633|Thoracolumbar fracture management|thoracolumbar fracture management
425971|NCT01751633|Quality of life|quality of life
425972|NCT01751633|Functional outcome|functional outcome
425973|NCT01751607|AF, catheter ablation, non-PV triggers, SNP|af, catheter ablation, non-pv triggers, snp
425974|NCT01751581|Obesity|obesity
425975|NCT01751581|Resting Metabolic Rate|resting metabolic rate
425976|NCT01751581|Sleep|sleep
425977|NCT01751581|Eating|eating
425978|NCT01751555|HBV co-infection ART TDF|hbv co-infection art tdf
425979|NCT01751529|renal malignancy|renal malignancy
425980|NCT01751529|Pilot Study|pilot study
425981|NCT01751529|LCCC 1219|lccc 1219
425982|NCT01751529|UNC Lineberger|unc lineberger
425983|NCT01751529|kidney cancer|kidney cancer
425984|NCT01751529|contrast-enhanced ultrasound|contrast-enhanced ultrasound
425985|NCT01751529|ultrasound|ultrasound
425986|NCT01751503|Foot drop deformity|foot drop deformity
425987|NCT01751503|gold standard treatment|gold standard treatment
425988|NCT01751503|Tibialis posterior tendon transfer|tibialis posterior tendon transfer
425989|NCT01751503|Interosseous route|interosseous route
425990|NCT01751503|Extramembranous or circumtibial route|extramembranous or circumtibial route
425991|NCT01751490|shoulder|shoulder
425992|NCT01751490|instability|instability
425993|NCT01751490|atraumatic|atraumatic
425994|NCT01751477|Very Low Birth Weight Infants|very low birth weight infants
425995|NCT01751477|Probiotics|probiotics
425996|NCT01751477|Necrotizing Enterocolitis|necrotizing enterocolitis
425997|NCT01751464|youth|youth
425998|NCT01751464|violence|violence
425999|NCT01751464|injury|injury
426000|NCT01751464|emergency department|emergency department
426001|NCT01751464|intervention|intervention
426002|NCT01751451|ABIRATERONE ACETATE (CB 7630)|abiraterone acetate (cb 7630)
426003|NCT01751451|DEGARELIX|degarelix
426004|NCT01751451|PREDNISONE|prednisone
426005|NCT01751451|12-187|12-187
426006|NCT01751438|Prostate cancer|prostate cancer
426007|NCT01751438|Prostate carcinoma|prostate carcinoma
426008|NCT01751438|Metastatic|metastatic
426010|NCT01751438|Best Systemic Therapy|best systemic therapy
426011|NCT01751438|BST|bst
426012|NCT01751438|Androgen deprivation therapy|androgen deprivation therapy
426013|NCT01751438|Bilateral orchiectomy|bilateral orchiectomy
426014|NCT01751438|Radiation|radiation
426015|NCT01751438|Radiation Therapy|radiation therapy
426016|NCT01751438|External beam radiation therapy|external beam radiation therapy
426017|NCT01751438|External-beam radiotherapy|external-beam radiotherapy
426018|NCT01751438|Xray therapy|xray therapy
426019|NCT01751438|XRT|xrt
426020|NCT01751438|Surgery|surgery
426021|NCT01751412|Hodgkin|hodgkin
426022|NCT01751412|Non-Hodgkin Lymphoma|non-hodgkin lymphoma
426023|NCT01751412|Mediastinal|mediastinal
426024|NCT01751412|Adult Lymphoma|adult lymphoma
426025|NCT01751412|Pediatric Lymphoma|pediatric lymphoma
426026|NCT01751386|Addiction|addiction
426027|NCT01751386|Cue-Induced Craving|cue-induced craving
426028|NCT01751386|Craving|craving
426029|NCT01751386|Anxiety|anxiety
426030|NCT01751386|Alcohol Consumption|alcohol consumption
426031|NCT01751373|Botulinum Toxin|botulinum toxin
426032|NCT01751373|Rehabilitation|rehabilitation
426033|NCT01751373|Electromyography|electromyography
426034|NCT01751373|Electroencephalography|electroencephalography
426035|NCT01751373|Transcranial Magnetic Stimulation|transcranial magnetic stimulation
426036|NCT01751347|Local anesthetics|local anesthetics
426037|NCT01751347|Elective hand surgeries|elective hand surgeries
426038|NCT01751334|Arthroplasty|arthroplasty
426039|NCT01751334|Replacement|replacement
426040|NCT01751334|Knee|knee
426041|NCT01751334|Rotational Alignment|rotational alignment
426042|NCT01751282|Stem Cells|stem cells
426043|NCT01751282|chronic wounds|chronic wounds
426044|NCT01751282|fibrin|fibrin
426045|NCT01751282|Bone marrow-derived mesenchymal stem cells|bone marrow-derived mesenchymal stem cells
426046|NCT01751256|Postcesarean Section|postcesarean section
426047|NCT01751256|Postoperative Pain|postoperative pain
426048|NCT01751256|Care, Postoperative|care, postoperative
426049|NCT01751256|Anesthesia, Local|anesthesia, local
426050|NCT01751256|Breast Feeding|breast feeding
426051|NCT01751256|Morphine|morphine
426052|NCT01751256|Pain Measurement|pain measurement
426053|NCT01751256|levobupivacaine|levobupivacaine
426054|NCT01751230|pregnancy|pregnancy
426055|NCT01751230|weight loss|weight loss
426056|NCT01751217|Substance Abuse|substance abuse
426057|NCT01751217|Adolescents|adolescents
426058|NCT01751217|Families|families
426059|NCT01751217|Functional Family Therapy|functional family therapy
426060|NCT01751217|Video|video
426061|NCT01751217|Teleconferencing|teleconferencing
426062|NCT01751217|Telemedicine|telemedicine
426063|NCT01751165|≥ 50 years of age|≥ 50 years of age
426064|NCT01751165|Herpes zoster|herpes zoster
426065|NCT01751165|Safety|safety
426066|NCT01751165|Immunogenicity|immunogenicity
426067|NCT01751165|Adults|adults
426068|NCT01751139|Endemic regions|endemic regions
426071|NCT01751139|Surveillance|surveillance
426072|NCT01751139|Dengue|dengue
426073|NCT01751126|vernal keratoconjunctivitis|vernal keratoconjunctivitis
426074|NCT01751126|ciclosporin|ciclosporin
426075|NCT01751126|cyclosporine|cyclosporine
426076|NCT01751087|abortion, induced|abortion, induced
426077|NCT01751074|Drug interaction, rosuvastatin, healthy volunteer, Lp-PLA2, atherosclerosis, darapladib, pharmacokinetics.|drug interaction, rosuvastatin, healthy volunteer, lp-pla2, atherosclerosis, darapladib, pharmacokinetics.
426078|NCT01751061|prolonged mechanical ventilation|prolonged mechanical ventilation
426079|NCT01751061|chronic critical illness|chronic critical illness
426080|NCT01751061|decision making|decision making
426081|NCT01751061|decision aid|decision aid
426082|NCT01751061|decisional support|decisional support
426083|NCT01751061|critical illness|critical illness
426084|NCT01751061|intensive care unit|intensive care unit
426085|NCT01751048|GLA-SE,LEISH-F3,leishmaniasis,MPL-SE,parent protocol,vaccine|gla-se,leish-f3,leishmaniasis,mpl-se,parent protocol,vaccine
426086|NCT01751022|heart failure|heart failure
426087|NCT01751022|cardiac pacing|cardiac pacing
426088|NCT01751022|cardiac resynchronization therapy|cardiac resynchronization therapy
426089|NCT01751022|left ventricular lead|left ventricular lead
426090|NCT01751009|vitamin A, complementary foods, malnutrition, children|vitamin a, complementary foods, malnutrition, children
426091|NCT01750983|Advanced Cancers|advanced cancers
426092|NCT01750983|Advanced Malignancies|advanced malignancies
426093|NCT01750983|Metastatic cancers|metastatic cancers
426094|NCT01750983|Ipilimumab|ipilimumab
426095|NCT01750983|Yervoy|yervoy
426096|NCT01750983|BMS-734016|bms-734016
426097|NCT01750983|MDX010|mdx010
426098|NCT01750983|Lenalidomide|lenalidomide
426099|NCT01750983|CC-5013|cc-5013
426100|NCT01750983|Revlimid|revlimid
426101|NCT01750944|Blood pressure site|blood pressure site
426102|NCT01750944|Good health|good health
426103|NCT01750944|Brachial blood pressure|brachial blood pressure
426104|NCT01750944|Ankle|ankle
426105|NCT01750944|Toe|toe
426106|NCT01750944|Walking test|walking test
426107|NCT01750944|Exercise|exercise
426108|NCT01750931|BE study of Meloxicam GSK 15mg|be study of meloxicam gsk 15mg
426109|NCT01750918|MEK inhibitor|mek inhibitor
426110|NCT01750918|anti-EGFR antibody|anti-egfr antibody
426111|NCT01750918|colorectal cancer|colorectal cancer
426112|NCT01750918|BRAF inhibitor|braf inhibitor
426113|NCT01750879|peanut|peanut
426114|NCT01750879|allergy|allergy
426115|NCT01750879|food|food
426116|NCT01750879|immunotherapy|immunotherapy
426117|NCT01750879|tolerance|tolerance
426118|NCT01750879|desensitization|desensitization
426119|NCT01750866|Prostrate Cancer|prostrate cancer
426120|NCT01750866|Castrate-resistant metastatic prostate cancer|castrate-resistant metastatic prostate cancer
426121|NCT01750866|Cabazitaxel|cabazitaxel
426122|NCT01750827|platelet function|platelet function
426123|NCT01750827|atherosclerosis,|atherosclerosis,
426124|NCT01750827|SB-659032|sb-659032
426125|NCT01750801|clinical trial|clinical trial
426126|NCT01750801|mouthwash|mouthwash
426127|NCT01750801|propolis|propolis
426128|NCT01750801|plaque|plaque
426129|NCT01750801|gingivitis|gingivitis
426130|NCT01750801|compliance|compliance
426131|NCT01750788|Stroke|stroke
426132|NCT01750788|Embolism|embolism
426133|NCT01750788|Atrial Fibrillation|atrial fibrillation
426134|NCT01750775|sinus bradycardia|sinus bradycardia
426135|NCT01750775|ventricular premature contraction|ventricular premature contraction
426136|NCT01750749|Venous ulcer|venous ulcer
426137|NCT01750749|Cell therapy|cell therapy
426138|NCT01750736|Augmented Exercise|augmented exercise
426139|NCT01750736|Cervicalgia|cervicalgia
426140|NCT01750736|Manual Therapy|manual therapy
426141|NCT01750736|Manipulation|manipulation
426142|NCT01750736|Quantitative Sensory|quantitative sensory
426143|NCT01750723|Acetazolamide|acetazolamide
426144|NCT01750723|Headache|headache
426145|NCT01750723|Migraine|migraine
426146|NCT01750710|Charcot-Marie-Tooth disease type 1A neuropathy|charcot-marie-tooth disease type 1a neuropathy
426147|NCT01750710|Isokinetic|isokinetic
426148|NCT01750710|Electromyography|electromyography
426149|NCT01750710|Walking|walking
426150|NCT01750684|Acute|acute
426151|NCT01750684|Traumatic|traumatic
426152|NCT01750684|SCI|sci
426153|NCT01750684|Spinal Cord Injury|spinal cord injury
426154|NCT01750671|ICU|icu
426155|NCT01750671|Body composition|body composition
426156|NCT01750671|Nutrition|nutrition
426157|NCT01750671|Survival|survival
426158|NCT01750671|Morbidity|morbidity
426159|NCT01750658|Biomarkers|biomarkers
426160|NCT01750658|Exacerbations|exacerbations
426161|NCT01750658|COPD|copd
426162|NCT01750593|radiofrequency|radiofrequency
426163|NCT01750593|thyroid|thyroid
426164|NCT01750593|nodule|nodule
426165|NCT01750567|Relapsed Chronic Lymphocytic Leukemia|relapsed chronic lymphocytic leukemia
426166|NCT01750567|untreated CLL patients|untreated cll patients
426167|NCT01750567|genomic deletion 11q|genomic deletion 11q
426168|NCT01750554|SpHb; hemoglobin monitoring;bupivacaine digital nerve block|sphb; hemoglobin monitoring;bupivacaine digital nerve block
426169|NCT01750515|Acupuncture|acupuncture
426170|NCT01750515|Hepatitis C (HCV)|hepatitis c (hcv)
426171|NCT01750489|COPD|copd
426172|NCT01750476|oral contraception|oral contraception
426173|NCT01750476|Depo-Provera|depo-provera
426174|NCT01750476|Mirena|mirena
426175|NCT01750463|Pediatric critically ill|pediatric critically ill
426176|NCT01750463|Masimo|masimo
426177|NCT01750463|hemoglobin|hemoglobin
426178|NCT01750463|monitoring|monitoring
426179|NCT01750463|UNC|unc
426180|NCT01750463|PICU|picu
426181|NCT01750450|Pressure Volume Area|pressure volume area
426182|NCT01750450|Pressure Flow Area|pressure flow area
426183|NCT01750450|Myocardial Work|myocardial work
426184|NCT01750437|NERD|nerd
426185|NCT01750424|Scar|scar
426186|NCT01750424|Fat Grafting|fat grafting
426187|NCT01750424|Adipose Grafting|adipose grafting
426188|NCT01750424|3-D imaging|3-d imaging
426189|NCT01750424|Manchester Scar Scale|manchester scar scale
426190|NCT01750411|Severe Asthma|severe asthma
426191|NCT01750411|SARP|sarp
426192|NCT01750398|Testosterone, Leuprolide, Goserelin|testosterone, leuprolide, goserelin
426193|NCT01750385|Esophageal Achalasia|esophageal achalasia
426194|NCT01750385|antibiotic prophylaxis|antibiotic prophylaxis
426195|NCT01750385|blood culture|blood culture
426196|NCT01750385|procalcitonin levels|procalcitonin levels
426197|NCT01750372|Artificial limbs|artificial limbs
426198|NCT01750372|Questionnaires|questionnaires
426199|NCT01750372|Mobility limitation|mobility limitation
426200|NCT01750359|antioxidants|antioxidants
426201|NCT01750359|curcumin|curcumin
426202|NCT01750359|depression|depression
426203|NCT01750346|Blepharospasm|blepharospasm
426204|NCT01750346|Treatment|treatment
426205|NCT01750346|Dystonia|dystonia
426206|NCT01750346|Acetyl-Hexapeptide|acetyl-hexapeptide
426207|NCT01750320|Breast CT|breast ct
426208|NCT01750320|Biopsy|biopsy
426209|NCT01750307|Attention Deficit Hyperactivity Disorder (ADHD)|attention deficit hyperactivity disorder (adhd)
426210|NCT01750307|Essential fatty acids (EFAs)|essential fatty acids (efas)
426211|NCT01750307|Electroencephalography (EEG)|electroencephalography (eeg)
426212|NCT01750307|Event-related potential (ERP)|event-related potential (erp)
426213|NCT01750307|Omega 3|omega 3
426214|NCT01750307|Randomised Control Trial|randomised control trial
426215|NCT01750307|Fish oil|fish oil
426216|NCT01750307|Supplementation|supplementation
426217|NCT01750307|Reading|reading
426218|NCT01750307|Spelling|spelling
426219|NCT01750307|Behaviour|behaviour
426220|NCT01750307|Emotional lability|emotional lability
426221|NCT01750294|hypertension|hypertension
426222|NCT01750294|kidney disease|kidney disease
426223|NCT01750281|Mitogen-Activated Protein Kinase Kinase inhibitor|mitogen-activated protein kinase kinase inhibitor
426224|NCT01750281|Non Small Cell Lung Cancer|non small cell lung cancer
426225|NCT01750281|Metastatic|metastatic
426226|NCT01750281|Second line treatment for Non Small Cell Lung Cancer|second line treatment for non small cell lung cancer
426227|NCT01750268|TBI|tbi
426228|NCT01750268|hazardous and harmful alcohol use|hazardous and harmful alcohol use
426229|NCT01750268|veterans|veterans
426230|NCT01750268|co-occurring disorders|co-occurring disorders
426231|NCT01750268|pharmacotherapy|pharmacotherapy
426232|NCT01750255|Pharmaceutical care|pharmaceutical care
426233|NCT01750255|Pharmacotherapy follow-up|pharmacotherapy follow-up
426234|NCT01750255|Bipolar disorder|bipolar disorder
426235|NCT01750255|Pharmacy services|pharmacy services
426236|NCT01750203|Diabetic foot ulcers, venous leg ulcers, pressure sores, acute wounds|diabetic foot ulcers, venous leg ulcers, pressure sores, acute wounds
426237|NCT01750190|anemia|anemia
426238|NCT01750190|chronic kidney disease (CKD)|chronic kidney disease (ckd)
426239|NCT01750190|non-dialysis|non-dialysis
426240|NCT01750190|Hemoglobin (Hb)|hemoglobin (hb)
426241|NCT01750190|End-Stage Renal Disease|end-stage renal disease
426242|NCT01750190|erythropoeitin|erythropoeitin
426243|NCT01750190|ASP1517|asp1517
426244|NCT01750190|erythropoeisis stimulating-agent|erythropoeisis stimulating-agent
426245|NCT01750190|AZD9941|azd9941
426246|NCT01750164|Breast Cancer|breast cancer
426247|NCT01750125|Doppler|doppler
426248|NCT01750112|Pectus excavatum|pectus excavatum
426249|NCT01750112|funnel chest|funnel chest
426250|NCT01750112|sunken chest|sunken chest
426251|NCT01750099|Labor|labor
426252|NCT01750099|analgesia|analgesia
426253|NCT01750099|epidural|epidural
426254|NCT01750099|spinal|spinal
426255|NCT01750086|osteoporosis|osteoporosis
426256|NCT01750086|postmenopausal|postmenopausal
426257|NCT01750086|denosumab|denosumab
426258|NCT01750086|teriparatide|teriparatide
426259|NCT01750086|alendronate|alendronate
426260|NCT01750086|Forteo®|forteo®
426261|NCT01750086|Prolia®|prolia®
426262|NCT01750047|pain perception|pain perception
426263|NCT01750047|postoperative pain|postoperative pain
426264|NCT01750047|demography|demography
426265|NCT01750047|smoking|smoking
426266|NCT01750047|alcohol|alcohol
426267|NCT01750034|Burns|burns
426268|NCT01750034|Wounds and injuries|wounds and injuries
426269|NCT01750034|Bandages|bandages
426270|NCT01750008|Symptomatic Uterine Fibroids|symptomatic uterine fibroids
426271|NCT01750008|Menorrhagia|menorrhagia
426272|NCT01750008|Heavy Bleeding|heavy bleeding
426273|NCT01750008|Myomas|myomas
426274|NCT01750008|Radiofrequency Ablation|radiofrequency ablation
426276|NCT01750008|Leiomyoma|leiomyoma
426277|NCT01750008|Fibroids|fibroids
426278|NCT01749995|Elderly cancer patients|elderly cancer patients
426279|NCT01749995|Screening tool|screening tool
426280|NCT01749995|Cognitive impairment|cognitive impairment
426281|NCT01749995|Freund Clock Drawing Test|freund clock drawing test
426282|NCT01749982|arsenic|arsenic
426283|NCT01749982|Bangladesh|bangladesh
426284|NCT01749982|choline|choline
426285|NCT01749982|betaine|betaine
426286|NCT01749982|methylation|methylation
426287|NCT01749956|Rectal Cancer|rectal cancer
426288|NCT01749956|Chemoradiation|chemoradiation
426289|NCT01749956|Aflibercept|aflibercept
426290|NCT01749956|Surgery|surgery
426291|NCT01749930|Intraocular pressure|intraocular pressure
426292|NCT01749917|Parkinson.|parkinson.
426293|NCT01749917|Dexterity.|dexterity.
426294|NCT01749917|Balance.|balance.
426295|NCT01749917|Exercises.|exercises.
426296|NCT01749904|Intraocular pressure|intraocular pressure
426297|NCT01749891|Age Related Wet Macular Degeneration|age related wet macular degeneration
426298|NCT01749826|Inflammation, opioids, immune system|inflammation, opioids, immune system
426299|NCT01749813|Carbohydrate Specific Diet|carbohydrate specific diet
426300|NCT01749813|Crohn's Disease|crohn's disease
426301|NCT01749813|Immunomodulators|immunomodulators
426303|NCT01749800|Attention deficits|attention deficits
426304|NCT01749800|Upper extremity weakness|upper extremity weakness
426305|NCT01749787|arthritis|arthritis
426306|NCT01749787|rheumatoid|rheumatoid
426307|NCT01749787|methotrexate|methotrexate
426308|NCT01749787|leflunomide|leflunomide
426309|NCT01749774|Physical activity|physical activity
426310|NCT01749774|Testicular cancer|testicular cancer
426311|NCT01749774|Chemotherapy|chemotherapy
426312|NCT01749774|Feasibility|feasibility
426313|NCT01749761|IDH, intradialytic hypotension,|idh, intradialytic hypotension,
426314|NCT01749761|hypotension on hemodialysis,|hypotension on hemodialysis,
426315|NCT01749761|hemodialysis,|hemodialysis,
426316|NCT01749761|Blood pressure guided biofeedback|blood pressure guided biofeedback
426317|NCT01749748|Breast diseases|breast diseases
426318|NCT01749748|magnetic resonance spectroscopy|magnetic resonance spectroscopy
426319|NCT01749722|Colorectal Cancer|colorectal cancer
426320|NCT01749722|Polyp|polyp
426321|NCT01749722|Adenoma|adenoma
426322|NCT01749722|Detection Rate|detection rate
426323|NCT01749722|Colonoscopy|colonoscopy
426324|NCT01749722|NaviAid™ G-Eye procedure|naviaid™ g-eye procedure
426325|NCT01749722|NaviAid™ G-Eye system|naviaid™ g-eye system
426326|NCT01749722|G-Eye procedure|g-eye procedure
426327|NCT01749722|G-Eye system|g-eye system
426328|NCT01749709|Stroke|stroke
426329|NCT01749709|Recovery|recovery
426330|NCT01749709|Music|music
426331|NCT01749696|Pelvic organ prolapse|pelvic organ prolapse
426332|NCT01749696|Connective tissue|connective tissue
426333|NCT01749696|Elastin|elastin
426334|NCT01749696|Collagen|collagen
426335|NCT01749670|Autism Spectrum Disorder|autism spectrum disorder
426336|NCT01749670|Exosomal miRNA expression|exosomal mirna expression
426337|NCT01749657|biomechanics|biomechanics
426338|NCT01749657|outcomes|outcomes
426339|NCT01749657|foot|foot
426340|NCT01749657|orthotic device|orthotic device
426341|NCT01749644|Cystic Fibrosis, Chronic Pseudomonas Infection, Inhaled Tobramycin|cystic fibrosis, chronic pseudomonas infection, inhaled tobramycin
426342|NCT01749631|Patients suspected to have difficult intubation|patients suspected to have difficult intubation
426343|NCT01749631|Intratracheal intubation|intratracheal intubation
426344|NCT01749631|Difficult to intubate|difficult to intubate
426345|NCT01749618|Seronegative Inflammatory Arthritis|seronegative inflammatory arthritis
426346|NCT01749618|SpA|spa
426347|NCT01749618|PsA|psa
426348|NCT01749618|Randomized|randomized
426349|NCT01749618|Behavioural Change|behavioural change
426350|NCT01749592|hearing loss|hearing loss
426351|NCT01749592|cochlear implant|cochlear implant
426352|NCT01749592|PET|pet
426353|NCT01749592|EEG|eeg
426354|NCT01749592|MEG|meg
426355|NCT01749579|propofol|propofol
426356|NCT01749579|midazolam|midazolam
426357|NCT01749579|duration of recovery|duration of recovery
426358|NCT01749579|emergency procedure|emergency procedure
426359|NCT01749566|HIV/AIDS, preexposure prophylaxis, women's health|hiv/aids, preexposure prophylaxis, women's health
426360|NCT01749527|24-hour pad test|24-hour pad test
426361|NCT01749527|Activity|activity
426362|NCT01749527|Stress urinary incontinence|stress urinary incontinence
426363|NCT01749514|Myelodysplastic Syndrome|myelodysplastic syndrome
426364|NCT01749488|Dietitian|dietitian
426365|NCT01749488|Nutritional recommendations|nutritional recommendations
426366|NCT01749488|ICU nutrition|icu nutrition
426367|NCT01749462|chronic obstructive pulmonary disease,|chronic obstructive pulmonary disease,
426368|NCT01749462|COPD,|copd,
426369|NCT01749462|Oxis,|oxis,
426370|NCT01749449|high protein|high protein
426371|NCT01749449|high carbohydrate|high carbohydrate
426372|NCT01749449|meal frequency|meal frequency
426373|NCT01749449|abdominal body fat|abdominal body fat
426374|NCT01749449|postprandial thermogenesis|postprandial thermogenesis
426375|NCT01749436|Atelectasis|atelectasis
426376|NCT01749436|Pneumoperitoneum|pneumoperitoneum
426377|NCT01749436|Hypoxemia|hypoxemia
426378|NCT01749371|Alpha-Tocopherol|alpha-tocopherol
426379|NCT01749371|Inflammation|inflammation
426380|NCT01749371|Oxidative Stress|oxidative stress
426381|NCT01749371|Malondialdehyde|malondialdehyde
426382|NCT01749371|Isoprostanes|isoprostanes
426383|NCT01749371|Lung Dysfunction|lung dysfunction
426384|NCT01749371|Wound Healing|wound healing
426385|NCT01749358|stroke|stroke
426386|NCT01749358|hemiparesis|hemiparesis
426387|NCT01749358|physical therapy|physical therapy
426388|NCT01749358|occupational therapy|occupational therapy
426389|NCT01749358|neurorehabilitation|neurorehabilitation
426390|NCT01749358|patient focused|patient focused
426391|NCT01749358|motor learning|motor learning
426392|NCT01749358|motor control|motor control
426393|NCT01749358|skill acquisition|skill acquisition
426394|NCT01749358|skill training|skill training
426395|NCT01749358|motor recovery|motor recovery
426396|NCT01749358|task oriented training|task oriented training
426397|NCT01749358|task specific training|task specific training
426398|NCT01749358|arm function|arm function
426399|NCT01749358|hand function|hand function
426400|NCT01749358|upper extremity|upper extremity
426401|NCT01749358|arm therapy|arm therapy
426402|NCT01749358|physical rehabilitation|physical rehabilitation
426403|NCT01749358|arm rehabilitation|arm rehabilitation
426404|NCT01749358|motor function|motor function
426405|NCT01749332|blood draw|blood draw
426406|NCT01749332|Perihepatic Phlebotomy|perihepatic phlebotomy
426407|NCT01749332|12-236|12-236
426408|NCT01749319|baclofen, withdrawal, interuption, spasticity, pharmacokinetics, tolerability, intravenous, oral|baclofen, withdrawal, interuption, spasticity, pharmacokinetics, tolerability, intravenous, oral
426409|NCT01749306|epidermolysis bullosa, chronic wound, wound healing, dermal repair, fibroblasts, Dermagraft|epidermolysis bullosa, chronic wound, wound healing, dermal repair, fibroblasts, dermagraft
426410|NCT01749280|Abdominal Aortic Aneurysm|abdominal aortic aneurysm
426411|NCT01749280|MRI|mri
426412|NCT01749280|USPIO|uspio
426413|NCT01749267|dentin remineralization|dentin remineralization
426414|NCT01749267|caries regression|caries regression
426415|NCT01749254|Culprit plaques|culprit plaques
426416|NCT01749254|Vulnerable Plaques|vulnerable plaques
426417|NCT01749254|PET|pet
426418|NCT01749254|calcification|calcification
426419|NCT01749254|inflammation|inflammation
426420|NCT01749228|Fed|fed
426421|NCT01749215|pharmacotherapy|pharmacotherapy
426422|NCT01749215|alcohol dependence|alcohol dependence
426423|NCT01749215|Veterans|veterans
426424|NCT01749202|Omega 3 fatty acids|omega 3 fatty acids
426425|NCT01749202|Omega 3 Index|omega 3 index
426426|NCT01749202|Stearidonic acid (SDA)|stearidonic acid (sda)
426427|NCT01749202|Red Blood Cells|red blood cells
426428|NCT01749202|Lipids|lipids
426429|NCT01749189|soy|soy
426430|NCT01749189|whey|whey
426431|NCT01749189|casein|casein
426432|NCT01749189|muscle|muscle
426433|NCT01749189|strength|strength
426434|NCT01749189|protein|protein
426435|NCT01749176|High risk Latino patients with diabetes|high risk latino patients with diabetes
426436|NCT01749137|Overweight|overweight
426437|NCT01749124|mental illness|mental illness
426438|NCT01749124|depression|depression
426439|NCT01749124|schizophrenia|schizophrenia
426440|NCT01749124|bipolar disorder|bipolar disorder
426441|NCT01749124|IVR|ivr
426442|NCT01749124|automated|automated
426443|NCT01749124|telephone|telephone
426444|NCT01749111|bone marrow transplantation|bone marrow transplantation
426445|NCT01749111|graft versus host disease|graft versus host disease
426446|NCT01749111|Acute myelogenous leukemia|acute myelogenous leukemia
426447|NCT01749111|Acute lymphoid leukemia|acute lymphoid leukemia
426448|NCT01749111|Myeloproliferative disease|myeloproliferative disease
426449|NCT01749111|Myelodysplastic syndrome|myelodysplastic syndrome
426450|NCT01749111|Chronic myeloid leukemia|chronic myeloid leukemia
426451|NCT01749111|chronic myelomonocytic leukemia|chronic myelomonocytic leukemia
426452|NCT01749098|PF-04958242|pf-04958242
426453|NCT01749098|ketamine|ketamine
426454|NCT01749098|cognition|cognition
426455|NCT01749098|healthy volunteers|healthy volunteers
426456|NCT01749085|PF-04449913|pf-04449913
426457|NCT01749085|Food Effect|food effect
426458|NCT01749085|Drug-drug interaction|drug-drug interaction
426459|NCT01749085|CYP3A4 inhibitor|cyp3a4 inhibitor
426460|NCT01749085|Pharmacokinetics|pharmacokinetics
426461|NCT01749072|non small cell lung cancer|non small cell lung cancer
426462|NCT01749072|chemotherapy|chemotherapy
426463|NCT01749072|gefitinib|gefitinib
426464|NCT01749072|vinorelbine|vinorelbine
426465|NCT01749072|ifosfamide|ifosfamide
426466|NCT01749046|Epileptic seizures, Partial seizures|epileptic seizures, partial seizures
426467|NCT01749033|Intubation|intubation
426468|NCT01749033|Airway|airway
426469|NCT01749033|Laryngeal Mask Airway|laryngeal mask airway
426470|NCT01749020|Diabetes type II, Insulin sensitivity|diabetes type ii, insulin sensitivity
426471|NCT01749007|Veterans|veterans
426472|NCT01749007|HIV|hiv
426473|NCT01749007|AIDS|aids
426474|NCT01749007|Cognitive Functioning|cognitive functioning
426475|NCT01749007|Suicide|suicide
426476|NCT01748994|Obesity|obesity
426477|NCT01748994|Fat distribution|fat distribution
426478|NCT01748994|Adipogenesis|adipogenesis
426479|NCT01748994|Adipocyte|adipocyte
426480|NCT01748994|Preadipocyte|preadipocyte
426481|NCT01748994|Ectopic fat|ectopic fat
426482|NCT01748981|Pulmonary function|pulmonary function
426483|NCT01748981|Maximal oxygen uptake|maximal oxygen uptake
426484|NCT01748981|Cardiorespiratory fitness|cardiorespiratory fitness
426485|NCT01748981|High-intensity training|high-intensity training
426486|NCT01748981|Surgery|surgery
426487|NCT01748968|Veterans|veterans
426488|NCT01748968|Human Immunodeficiency Virus Infection(HIV)/Acquired Immunodeficiency Syndrome (AIDS)|human immunodeficiency virus infection(hiv)/acquired immunodeficiency syndrome (aids)
426489|NCT01748968|Self-Directed Violence|self-directed violence
426490|NCT01748955|Major Depressive Disorder|major depressive disorder
426492|NCT01748955|Reward|reward
426493|NCT01748955|BOLD signal|bold signal
426494|NCT01748955|Suicide|suicide
426495|NCT01748929|Global Health|global health
426496|NCT01748929|Deworming|deworming
426497|NCT01748929|Postpartum|postpartum
426498|NCT01748929|Soil-Transmitted Helminths|soil-transmitted helminths
426499|NCT01748929|Pregnant Women|pregnant women
426500|NCT01748916|Papaya|papaya
426501|NCT01748916|Carrot|carrot
426502|NCT01748916|Tomato|tomato
426503|NCT01748916|Carotenoids|carotenoids
426504|NCT01748916|Lycopene|lycopene
426505|NCT01748916|Beta-carotene|beta-carotene
426506|NCT01748916|Beta-cryptoxanthin|beta-cryptoxanthin
426507|NCT01748903|intracranial aneurysm|intracranial aneurysm
426508|NCT01748903|cerebral aneurysm|cerebral aneurysm
426509|NCT01748903|packing density|packing density
426510|NCT01748903|Target Coils|target coils
426511|NCT01748903|aneurysm embolization|aneurysm embolization
426512|NCT01748877|shingles,|shingles,
426513|NCT01748877|neuropathic pain|neuropathic pain
426514|NCT01748877|post herpetic neuralgia|post herpetic neuralgia
426515|NCT01748877|sleep|sleep
426516|NCT01748864|Volunteers|volunteers
426517|NCT01748825|MK-1775|mk-1775
426518|NCT01748825|Refractory|refractory
426519|NCT01748825|Solid Tumors|solid tumors
426520|NCT01748825|Wee1 Inhibitor|wee1 inhibitor
426521|NCT01748825|Tyrosine Kinase|tyrosine kinase
426522|NCT01748812|Tumor Induced Osteomalacia|tumor induced osteomalacia
426523|NCT01748812|Hypophosphatemic Rickets|hypophosphatemic rickets
426524|NCT01748799|Cannabis dependence|cannabis dependence
426525|NCT01748799|Sativex|sativex
426526|NCT01748786|Fibromyalgia|fibromyalgia
426527|NCT01748786|Mindfulness|mindfulness
426528|NCT01748786|On-line intervention|on-line intervention
426529|NCT01748786|Chronic pain|chronic pain
426530|NCT01748760|Suicide Attempts|suicide attempts
426531|NCT01748760|Suicidal Ideation|suicidal ideation
426532|NCT01748734|Depression|depression
426533|NCT01748708|Magnetic seizure therapy|magnetic seizure therapy
426534|NCT01748708|Electroconvulsive therapy|electroconvulsive therapy
426535|NCT01748708|Treatment resistant depression|treatment resistant depression
426536|NCT01748708|Treatment resistance|treatment resistance
426537|NCT01748708|Randomized controlled trial|randomized controlled trial
426538|NCT01748695|Neuropathic pain|neuropathic pain
426539|NCT01748695|Spinal cord injury|spinal cord injury
426540|NCT01748682|Very low calorie diet|very low calorie diet
426541|NCT01748682|liquid diet|liquid diet
426542|NCT01748682|visceral fat|visceral fat
426543|NCT01748682|liver fat.|liver fat.
426544|NCT01748669|Arsenic|arsenic
426545|NCT01748669|Arsenicosis|arsenicosis
426546|NCT01748669|Garlic oil|garlic oil
426547|NCT01748669|Keratosis|keratosis
426548|NCT01748656|Noninvasive ventilation|noninvasive ventilation
426549|NCT01748656|Obesity Hypoventilation Syndrome|obesity hypoventilation syndrome
426550|NCT01748630|scoliosis, sedation, children, fentanyl consumption, pain|scoliosis, sedation, children, fentanyl consumption, pain
426551|NCT01748604|Lymphedema|lymphedema
426552|NCT01748604|Physical Therapies|physical therapies
426553|NCT01748604|Randomized controlled study|randomized controlled study
426554|NCT01748604|Decongestive lymphatic therapy|decongestive lymphatic therapy
426555|NCT01748604|Manual lymph drainage|manual lymph drainage
426556|NCT01748604|Intermittent pneumatic compression|intermittent pneumatic compression
426557|NCT01748604|Multilayer bandages|multilayer bandages
545180|NCT01241214|SAR|sar
426558|NCT01748578|Healthy|healthy
426559|NCT01748578|Interleukin 1 Receptor Inhibitor|interleukin 1 receptor inhibitor
426560|NCT01748578|Dry Eye|dry eye
426561|NCT01748565|biomarkers|biomarkers
426562|NCT01748565|oxidative stress|oxidative stress
426563|NCT01748565|BPD|bpd
426564|NCT01748565|prematurity|prematurity
426565|NCT01748526|Healthy|healthy
426566|NCT01748526|Canagliflozin (JNJ-28431754)|canagliflozin (jnj-28431754)
426567|NCT01748526|Pharmacokinetics|pharmacokinetics
426568|NCT01748526|Pharmacodynamics|pharmacodynamics
426569|NCT01748526|Indian|indian
426570|NCT01748513|morbidly obese patients,|morbidly obese patients,
426571|NCT01748513|preoperative volume-challenge,|preoperative volume-challenge,
426572|NCT01748513|transthoracic echocardiography,|transthoracic echocardiography,
426573|NCT01748513|TTE,|tte,
426574|NCT01748513|rapid weight loss,|rapid weight loss,
426575|NCT01748513|venous return,|venous return,
426576|NCT01748513|bariatric surgery,|bariatric surgery,
426577|NCT01748513|left ventricular outflow tract,|left ventricular outflow tract,
426578|NCT01748513|stroke volume,|stroke volume,
426579|NCT01748513|diastolic function,|diastolic function,
426580|NCT01748513|hypervolemia,|hypervolemia,
426581|NCT01748513|hypovolemia|hypovolemia
426582|NCT01748500|metastatic|metastatic
426583|NCT01748461|intervention study in elderly (65+)|intervention study in elderly (65+)
426584|NCT01748461|cycle ergometer|cycle ergometer
426585|NCT01748461|physical activity|physical activity
426586|NCT01748461|physical fitness|physical fitness
426587|NCT01748461|assisted living facility|assisted living facility
426588|NCT01748448|Cutaneous malignant melanoma|cutaneous malignant melanoma
426589|NCT01748448|Vitamin D|vitamin d
426590|NCT01748448|Cholecalciferol|cholecalciferol
426591|NCT01748435|Neuropathic pain|neuropathic pain
426592|NCT01748435|Lower limb amputation|lower limb amputation
426593|NCT01748435|Pre-emptive analgesia|pre-emptive analgesia
426594|NCT01748422|Neuropathic pain|neuropathic pain
426595|NCT01748422|Arteriovenous fistulae|arteriovenous fistulae
426596|NCT01748422|End stage renal disease|end stage renal disease
426597|NCT01748409|Autonomic failure, Parkinson's disease, electrophysiological assessment, neuropathological assessment|autonomic failure, parkinson's disease, electrophysiological assessment, neuropathological assessment
426598|NCT01748396|FGF-23|fgf-23
426599|NCT01748396|Calcitriol|calcitriol
426600|NCT01748396|Calcium carbonate|calcium carbonate
426601|NCT01748396|CKD Stage 3|ckd stage 3
426602|NCT01748383|Bone marrow cells|bone marrow cells
426603|NCT01748383|Acute myocardial infarction|acute myocardial infarction
426604|NCT01748383|Transplantation of autologous mononuclear|transplantation of autologous mononuclear
426605|NCT01748383|Transplantation of autologous CD133 + cells|transplantation of autologous cd133 + cells
426606|NCT01748370|vitamin D|vitamin d
426607|NCT01748370|hypogonadism|hypogonadism
426608|NCT01748370|testosterone|testosterone
426609|NCT01748370|intervention|intervention
426610|NCT01748357|Tuberculosis|tuberculosis
426611|NCT01748357|Volatile organic compounds|volatile organic compounds
426612|NCT01748357|exhaled breath|exhaled breath
426613|NCT01748357|Siemens|siemens
426614|NCT01748331|Heart Failure|heart failure
426615|NCT01748331|Hyponatremia|hyponatremia
426616|NCT01748331|Fluid restriction|fluid restriction
426617|NCT01748318|Community acquired MRSA|community acquired mrsa
426618|NCT01748318|New Mexico Honey|new mexico honey
426619|NCT01748305|GDM|gdm
426620|NCT01748305|A1GDM|a1gdm
426621|NCT01748305|A2GDM|a2gdm
426622|NCT01748292|Age related|age related
426623|NCT01748292|Macular|macular
426624|NCT01748292|sub retinal fluid|sub retinal fluid
426625|NCT01748292|Age related Macular degeneration|age related macular degeneration
426626|NCT01748279|COPD|copd
426627|NCT01748279|Atorvastatin|atorvastatin
426628|NCT01748279|statins|statins
426629|NCT01748279|COPD treatment|copd treatment
426630|NCT01748279|microarrays|microarrays
426631|NCT01748266|StO2|sto2
426632|NCT01748266|microcirculation|microcirculation
426633|NCT01748266|NIRS|nirs
426634|NCT01748227|self-management|self-management
426635|NCT01748227|peer support|peer support
426636|NCT01748227|social support|social support
426637|NCT01748214|continuous positive airway pressure|continuous positive airway pressure
426638|NCT01748214|high flow nasal cannula|high flow nasal cannula
426639|NCT01748214|hearing outcomes|hearing outcomes
426640|NCT01748214|noise exposure|noise exposure
426641|NCT01748214|preterm infants|preterm infants
426642|NCT01748201|Osteoarthritis|osteoarthritis
426643|NCT01748201|Hemarthrosis|hemarthrosis
426644|NCT01748201|Hemophilia A|hemophilia a
426645|NCT01748201|Hemophilia B|hemophilia b
426646|NCT01748201|Viscosupplementation|viscosupplementation
426647|NCT01748188|Subacromial syndrome|subacromial syndrome
426648|NCT01748188|Dexketoprofen|dexketoprofen
426649|NCT01748188|Phonophoresis|phonophoresis
426650|NCT01748188|Iontophoresis|iontophoresis
426651|NCT01748188|Ultrasounds|ultrasounds
426652|NCT01748188|VAS|vas
426653|NCT01748188|DASH score|dash score
426654|NCT01748188|Constant score|constant score
545296|NCT01240694|SLE|sle
426655|NCT01748175|Severe asthma|severe asthma
426656|NCT01748175|longitudinal study|longitudinal study
426657|NCT01748175|phenotypes|phenotypes
426658|NCT01748162|croup|croup
426659|NCT01748162|recurrent croup|recurrent croup
426660|NCT01748162|barky cough|barky cough
426661|NCT01748149|recurrent/refractory BRAFV600E-mutant gliomas|recurrent/refractory brafv600e-mutant gliomas
426662|NCT01748149|pediatrics|pediatrics
426663|NCT01748149|children|children
426664|NCT01748149|neo-adjuvant vemurafenib|neo-adjuvant vemurafenib
426665|NCT01748123|Pragmatic|pragmatic
426666|NCT01748123|Comparative Effectiveness|comparative effectiveness
426667|NCT01748110|quality of life|quality of life
426668|NCT01748110|erectile function|erectile function
426669|NCT01748097|infiltration|infiltration
426670|NCT01748097|extravasation|extravasation
426671|NCT01748097|sodium bicarbonate|sodium bicarbonate
426672|NCT01748097|capnography|capnography
426673|NCT01748097|end tidal carbon dioxide|end tidal carbon dioxide
426674|NCT01748097|chemotherapy|chemotherapy
426675|NCT01748084|Systemic sclerosis|systemic sclerosis
426676|NCT01748084|Arthritis|arthritis
426677|NCT01748084|B-cell therapy, Anti-CD20 therapy|b-cell therapy, anti-cd20 therapy
426678|NCT01748084|Quality of life|quality of life
426679|NCT01748084|Scleroderma|scleroderma
426680|NCT01748084|Lung fibrosis|lung fibrosis
426681|NCT01748084|Randomised controled trial|randomised controled trial
426682|NCT01748071|fentanyl|fentanyl
426683|NCT01748071|sufentanil|sufentanil
426684|NCT01748071|individual variation|individual variation
426685|NCT01748071|pain threshold|pain threshold
426686|NCT01748071|nacro-trend index|nacro-trend index
426687|NCT01748045|Inhaled Nitric Oxide|inhaled nitric oxide
426688|NCT01748045|Bronchopulmonary Dysplasia|bronchopulmonary dysplasia
426689|NCT01748045|Late Prematurity|late prematurity
426690|NCT01748045|Chronic Respiratory Morbidity|chronic respiratory morbidity
426691|NCT01748032|depression|depression
426692|NCT01748032|intervention studies|intervention studies
426693|NCT01748019|ST1968|st1968
426694|NCT01748019|Camptothecin|camptothecin
426695|NCT01748019|Solid tumors|solid tumors
426696|NCT01748019|Topoisomerase I|topoisomerase i
426697|NCT01747993|Urinary retention; urinary catheterization; alpha blocking agents; women; elder|urinary retention; urinary catheterization; alpha blocking agents; women; elder
426698|NCT01747980|Gaucher disease|gaucher disease
426699|NCT01747980|human glucocerebrosidase|human glucocerebrosidase
426700|NCT01747980|plant recombinant human glucocerebrosidase|plant recombinant human glucocerebrosidase
426701|NCT01747967|Antibodies|antibodies
426702|NCT01747967|Beta cells|beta cells
426703|NCT01747967|C-peptide|c-peptide
426704|NCT01747967|GAD|gad
426705|NCT01747967|Glucose|glucose
426706|NCT01747967|Glycemia|glycemia
426707|NCT01747967|Insulin|insulin
426708|NCT01747967|Meal test|meal test
426709|NCT01747967|Pancreas|pancreas
426710|NCT01747967|Proinsulin,|proinsulin,
426711|NCT01747967|T lymphocytes|t lymphocytes
426712|NCT01747954|Respiratory Insufficiency|respiratory insufficiency
426713|NCT01747954|Physiotherapy Techniques|physiotherapy techniques
426714|NCT01747954|Respiratory Mechanics|respiratory mechanics
426715|NCT01747928|usability study|usability study
426716|NCT01747915|Primary Generalized Tonic Clonic Seizures|primary generalized tonic clonic seizures
426717|NCT01747915|Epilepsy|epilepsy
426718|NCT01747915|Safety|safety
426719|NCT01747915|Efficacy|efficacy
426720|NCT01747915|Tolerability|tolerability
426721|NCT01747915|Pregabalin|pregabalin
426722|NCT01747915|Lyrica|lyrica
426723|NCT01747915|Adjunctive treatment|adjunctive treatment
426724|NCT01747915|Placebo Controlled|placebo controlled
426725|NCT01747915|Blinded|blinded
426726|NCT01747889|chest tube|chest tube
426727|NCT01747889|lung resection|lung resection
426728|NCT01747889|patient satisfaction|patient satisfaction
426729|NCT01747889|mobility|mobility
426730|NCT01747876|LEE011|lee011
426731|NCT01747876|Phase 1|phase 1
426732|NCT01747876|pediatric|pediatric
426733|NCT01747876|CDK4/6 inhibitor|cdk4/6 inhibitor
426734|NCT01747876|dose escalation|dose escalation
426735|NCT01747876|malignant rhabdoid tumors|malignant rhabdoid tumors
426736|NCT01747876|MRT|mrt
426737|NCT01747876|neuroblastoma|neuroblastoma
426738|NCT01747863|Hypoxic Ischemic encephalopathy|hypoxic ischemic encephalopathy
426739|NCT01747837|Renal sympathetic denervation|renal sympathetic denervation
426740|NCT01747837|Renal catheter ablation|renal catheter ablation
426741|NCT01747837|Ventricular tachycardia|ventricular tachycardia
426742|NCT01747824|agitation|agitation
426743|NCT01747824|excited delirium|excited delirium
426744|NCT01747824|pain|pain
426745|NCT01747824|unexplained-in-custody-death|unexplained-in-custody-death
426746|NCT01747824|UICD|uicd
426747|NCT01747824|visual analog scale|visual analog scale
426748|NCT01747824|VAS|vas
426749|NCT01747824|altered mental status|altered mental status
426750|NCT01747824|AMS|ams
426751|NCT01747811|Mild traumatic brain injury|mild traumatic brain injury
426752|NCT01747811|Concussion|concussion
426753|NCT01747811|Sleep problems|sleep problems
426754|NCT01747811|brain imaging|brain imaging
426755|NCT01747811|functional magnetic resonance imaging (FMRI)|functional magnetic resonance imaging (fmri)
426756|NCT01747785|Heart failure|heart failure
426757|NCT01747785|HFpEF|hfpef
426758|NCT01747785|Dyspnea|dyspnea
426759|NCT01747785|Fatigue|fatigue
426760|NCT01747785|Shortness of Breath|shortness of breath
426761|NCT01747785|exercise|exercise
426762|NCT01747785|strain|strain
426763|NCT01747785|myocardial deformation|myocardial deformation
426764|NCT01747785|cardiac rehabilitation|cardiac rehabilitation
426765|NCT01747785|cardiac hemodynamics|cardiac hemodynamics
426766|NCT01747772|Non-focal Liver Disease|non-focal liver disease
426767|NCT01747772|Fibrosis|fibrosis
426768|NCT01747772|Shear Wave Sonoelastography|shear wave sonoelastography
426769|NCT01747772|Metavir Liver Fibrosis Grading|metavir liver fibrosis grading
426770|NCT01747759|• Knee osteoarthritis|• knee osteoarthritis
426771|NCT01747759|Total knee arthroplasty|total knee arthroplasty
426772|NCT01747759|Selfcare|selfcare
426773|NCT01747759|Booklet|booklet
426774|NCT01747759|Rehabilitation|rehabilitation
426775|NCT01747746|Rivaroxaban|rivaroxaban
426776|NCT01747746|Warfarin|warfarin
426777|NCT01747746|Anticoagulation|anticoagulation
426778|NCT01747746|Stroke|stroke
426779|NCT01747746|Thrombo-embolism|thrombo-embolism
426780|NCT01747746|Bleeding|bleeding
426781|NCT01747746|Atrial Fibrillation|atrial fibrillation
426782|NCT01747746|Cardioversion|cardioversion
426783|NCT01747733|Endoscopy|endoscopy
426784|NCT01747733|ERCP|ercp
426785|NCT01747733|PCS|pcs
426786|NCT01747733|Sedation|sedation
426787|NCT01747733|Bispectral index|bispectral index
426788|NCT01747720|breast cancer|breast cancer
426789|NCT01747720|mammographic breast density|mammographic breast density
426790|NCT01747720|vitamin D|vitamin d
426791|NCT01747720|prevention|prevention
426792|NCT01747720|randomized controlled trial|randomized controlled trial
426793|NCT01747707|gastric cancer|gastric cancer
426794|NCT01747707|gastroesophageal junction cancer|gastroesophageal junction cancer
426795|NCT01747707|chemotherapy|chemotherapy
426796|NCT01747707|docetaxel|docetaxel
426797|NCT01747707|cisplatin|cisplatin
426798|NCT01747707|S-1|s-1
426799|NCT01747694|COPD,Respiratory muscle training,Exercise tolerance|copd,respiratory muscle training,exercise tolerance
426800|NCT01747681|chondral defect|chondral defect
426801|NCT01747681|microfracture|microfracture
426802|NCT01747681|arthroscopy|arthroscopy
426803|NCT01747681|cartilage repair|cartilage repair
426804|NCT01747681|outcome study|outcome study
426805|NCT01747681|Lysholm score|lysholm score
426806|NCT01747668|Mother and Infant Pairs|mother and infant pairs
426807|NCT01747655|Early Observational Advanced|early observational advanced
426808|NCT01747655|Parkinson's Disease|parkinson's disease
426809|NCT01747642|Hepatocellular carcinoma|hepatocellular carcinoma
426810|NCT01747642|Oncoxin|oncoxin
426811|NCT01747642|Surafenib|surafenib
426812|NCT01747629|Asthma|asthma
426813|NCT01747629|dry powder inhaler|dry powder inhaler
426814|NCT01747629|short-acting beta2-agonist|short-acting beta2-agonist
426815|NCT01747629|SABA|saba
426816|NCT01747629|bronchoconstriction|bronchoconstriction
426817|NCT01747629|bronchodilation|bronchodilation
426818|NCT01747629|bronchodilator|bronchodilator
426819|NCT01747629|metered dose inhaler|metered dose inhaler
426820|NCT01747629|Albuterol Spiromax®|albuterol spiromax®
426821|NCT01747616|Chitosan-N-Acetylcysteine|chitosan-n-acetylcysteine
426822|NCT01747616|contact lenses|contact lenses
426823|NCT01747616|safety and tolerability|safety and tolerability
426824|NCT01747603|Late preterm infant|late preterm infant
426825|NCT01747603|Complications|complications
426826|NCT01747603|Hospital readmissions|hospital readmissions
426827|NCT01747603|Follow-up|follow-up
426828|NCT01747603|Pilot study|pilot study
426829|NCT01747577|Muscarine antagonist|muscarine antagonist
426830|NCT01747577|Prostatectomy|prostatectomy
426831|NCT01747577|Uroflowmetry|uroflowmetry
426832|NCT01747564|Pharmacokinetics|pharmacokinetics
426833|NCT01747564|Mirabegron|mirabegron
426834|NCT01747564|Phase 1|phase 1
426835|NCT01747564|YM178|ym178
426836|NCT01747551|Advanced|advanced
426837|NCT01747538|Uveitis|uveitis
426838|NCT01747538|Non-infectious Uveitis|non-infectious uveitis
426839|NCT01747538|Intermediate Uveitis|intermediate uveitis
426840|NCT01747538|Posterior Uveitis|posterior uveitis
426841|NCT01747538|Panuveitis|panuveitis
426842|NCT01747512|99mTc Pertechnetate|99mtc pertechnetate
426843|NCT01747512|thyroidectomy|thyroidectomy
426844|NCT01747512|thyroid neoplasms|thyroid neoplasms
426845|NCT01747473|Subjects|subjects
426846|NCT01747460|Subjects|subjects
426847|NCT01747408|subarachnoid hemorrhage|subarachnoid hemorrhage
426848|NCT01747395|Heart Failure|heart failure
426849|NCT01747395|Exercise and Physical Fitness|exercise and physical fitness
426850|NCT01747382|Treatment-resistant Hypertension|treatment-resistant hypertension
426851|NCT01747382|Chronic Kidney Disease|chronic kidney disease
426852|NCT01747382|Symplicity catheters|symplicity catheters
710233|NCT00589641|adolescents|adolescents
426853|NCT01747382|Renal denervation|renal denervation
426854|NCT01747369|surveillance study|surveillance study
426855|NCT01747369|prospective|prospective
426856|NCT01747369|observational|observational
426857|NCT01747369|health center-based|health center-based
426858|NCT01747369|pneumonia, bacterial|pneumonia, bacterial
426859|NCT01747369|pneumonia, viral|pneumonia, viral
426860|NCT01747369|meningitis, bacterial|meningitis, bacterial
426861|NCT01747369|Africa south of the Sahara|africa south of the sahara
426862|NCT01747343|Incontinence|incontinence
426863|NCT01747343|Enuresis|enuresis
426864|NCT01747330|cystic fibrosis|cystic fibrosis
426865|NCT01747317|FFR|ffr
426866|NCT01747317|fractional flow reserve|fractional flow reserve
426867|NCT01747317|CT|ct
426868|NCT01747317|Computed Tomography|computed tomography
426869|NCT01747304|Atypical Femur Fracture|atypical femur fracture
426870|NCT01747304|DXA|dxa
426871|NCT01747278|Pneumocystis carinii pneumonia|pneumocystis carinii pneumonia
426872|NCT01747278|prophylaxis|prophylaxis
426873|NCT01747278|trimethoprim/sulfamethoxazole|trimethoprim/sulfamethoxazole
426874|NCT01747239|Ovarian cancer|ovarian cancer
426875|NCT01747239|Platinum refractory|platinum refractory
426876|NCT01747226|Oral malodor|oral malodor
426877|NCT01747226|Halitosis|halitosis
426878|NCT01747226|Bad Breath|bad breath
426879|NCT01747226|Mouth rinses|mouth rinses
426880|NCT01747226|Mouthwashes|mouthwashes
426881|NCT01747226|Amine fluoride/Stannous fluoride|amine fluoride/stannous fluoride
426882|NCT01747226|Zinc ions|zinc ions
426883|NCT01747226|Chlorhexidine|chlorhexidine
426884|NCT01747213|Neurodegenerative|neurodegenerative
426885|NCT01747213|Cholinergic|cholinergic
426886|NCT01747213|Single Dose|single dose
426887|NCT01747213|Inhibitor|inhibitor
426888|NCT01747213|Tolerability|tolerability
426889|NCT01747213|Clinical Trial|clinical trial
426890|NCT01747213|Alzheimer Disease|alzheimer disease
426891|NCT01747213|Healthy Volunteers|healthy volunteers
426892|NCT01747213|Neurotransmitters|neurotransmitters
426893|NCT01747200|Repetitive TMS (rTMS)|repetitive tms (rtms)
426894|NCT01747187|Septic shock|septic shock
426895|NCT01747187|Critical care|critical care
426896|NCT01747187|cardiac failure|cardiac failure
426897|NCT01747174|STEMI|stemi
426898|NCT01747174|Microvascular Obstruction|microvascular obstruction
426899|NCT01747174|No-reflow|no-reflow
426900|NCT01747174|Adenosine|adenosine
426901|NCT01747174|Sodium Nitroprusside|sodium nitroprusside
426902|NCT01747148|Antisense|antisense
426903|NCT01747148|Influenza|influenza
426904|NCT01747148|IV Injection|iv injection
426905|NCT01747148|RNA Based Therapeutic|rna based therapeutic
426906|NCT01747148|RNA Interference|rna interference
426907|NCT01747135|2-Hydroxypropyl-B-Cyclodextrin|2-hydroxypropyl-b-cyclodextrin
426908|NCT01747135|Niemann-Pick Disease, Type C1|niemann-pick disease, type c1
426909|NCT01747135|Neurodegeneration|neurodegeneration
426910|NCT01747122|epidurals|epidurals
426911|NCT01747122|wound catheters|wound catheters
426912|NCT01747122|liver resection|liver resection
426913|NCT01747122|liver surgery|liver surgery
426914|NCT01747109|Acute hypoxemic respiratory failure|acute hypoxemic respiratory failure
426915|NCT01747109|Preoxygenation|preoxygenation
426916|NCT01747109|Crash induction|crash induction
426917|NCT01747096|Gastroenteropancreatic Neuroendocrine Tumors|gastroenteropancreatic neuroendocrine tumors
426918|NCT01747096|immuno PET (iPET)|immuno pet (ipet)
426919|NCT01747096|Gallium (68-Ga)|gallium (68-ga)
426920|NCT01747096|DOTANOC|dotanoc
426921|NCT01747070|Electro Acupuncture|electro acupuncture
426922|NCT01747070|Knee Osteoarthritis|knee osteoarthritis
426923|NCT01747070|Chronic pain|chronic pain
426924|NCT01747070|Cortical Excitability|cortical excitability
426925|NCT01747044|Fibromyalgia|fibromyalgia
426926|NCT01747044|Diffuse Noxious Inhibitory Controls|diffuse noxious inhibitory controls
426927|NCT01747044|Milnacipran|milnacipran
426928|NCT01747031|iFR|ifr
426929|NCT01747031|FFR|ffr
426930|NCT01747031|instantaneous wave-free ratio|instantaneous wave-free ratio
426931|NCT01747031|fractional flow reserve|fractional flow reserve
426932|NCT01747018|Platelet-Rich Plasma|platelet-rich plasma
426933|NCT01747018|Knee pain|knee pain
426934|NCT01747018|osteoarthritis|osteoarthritis
426935|NCT01747018|degenerative chondropathy|degenerative chondropathy
426936|NCT01747018|Intraarticular injection|intraarticular injection
426937|NCT01747005|abdominal hysterectomy|abdominal hysterectomy
426938|NCT01747005|enhanced recovery after surgery|enhanced recovery after surgery
426939|NCT01747005|inflammatory response|inflammatory response
426940|NCT01747005|ERAS|eras
426941|NCT01747005|combined spinal-epidural anesthesia|combined spinal-epidural anesthesia
426942|NCT01746979|TH-302|th-302
426943|NCT01746979|Evofosfamide|evofosfamide
426944|NCT01746979|Pancreatic Cancer|pancreatic cancer
426945|NCT01746979|EMR200592-001|emr200592-001
426946|NCT01746966|gleno-humeral joint synovitis|gleno-humeral joint synovitis
426947|NCT01746966|anterior shoulder US|anterior shoulder us
426948|NCT01746966|rotator interval|rotator interval
426949|NCT01746940|Surgery|surgery
426950|NCT01746940|Surgeries|surgeries
426951|NCT01746940|Nasal|nasal
426952|NCT01746940|Cavities|cavities
426953|NCT01746940|Diagnosis|diagnosis
426954|NCT01746940|Diagnostic|diagnostic
426955|NCT01746940|Nose|nose
426956|NCT01746940|Rhinoplasty|rhinoplasty
426957|NCT01746940|Endoscopy|endoscopy
426958|NCT01746940|Bronchoscopy|bronchoscopy
426959|NCT01746927|cricoid pressure, glidescope|cricoid pressure, glidescope
426960|NCT01746901|Relative abuse potential study; oxycodone; nalteone; Opioid-related disorders; drug abusers|relative abuse potential study; oxycodone; nalteone; opioid-related disorders; drug abusers
426961|NCT01746901|Chronic pain|chronic pain
426962|NCT01746875|Angiogenesis inhibitors|angiogenesis inhibitors
426963|NCT01746875|Photochemotherapy|photochemotherapy
426964|NCT01746875|Vascular Endothelium Growth Factors|vascular endothelium growth factors
426965|NCT01746875|Aflibercept|aflibercept
426966|NCT01746862|Saizen®|saizen®
426967|NCT01746862|Recombinant human growth hormone (r-hGH)|recombinant human growth hormone (r-hgh)
426968|NCT01746862|Idiopathic short stature|idiopathic short stature
426969|NCT01746862|Height velocity|height velocity
426970|NCT01746862|Bone age|bone age
426971|NCT01746849|LUPRON DEPOT|lupron depot
426972|NCT01746849|PALIFERMIN|palifermin
426973|NCT01746849|12-077|12-077
426974|NCT01746823|Keratoconus|keratoconus
426975|NCT01746823|Proteomics|proteomics
426976|NCT01746810|Metastatic|metastatic
426977|NCT01746810|Lung Cancer|lung cancer
426978|NCT01746810|NSCLC|nsclc
426979|NCT01746797|infertility|infertility
426980|NCT01746797|depression|depression
426981|NCT01746797|IVF|ivf
426982|NCT01746797|IUI|iui
426983|NCT01746797|fertility treatment|fertility treatment
426984|NCT01746784|Cystic Fibrosis|cystic fibrosis
426985|NCT01746784|F508del-CFTR|f508del-cftr
426986|NCT01746784|N6022|n6022
426987|NCT01746784|S-Nitrosoglutathione|s-nitrosoglutathione
426988|NCT01746771|HM781-36B, Paclitaxel, Trastuzumab|hm781-36b, paclitaxel, trastuzumab
426989|NCT01746758|Reproductive health, mHealth, Cluster randomised trial|reproductive health, mhealth, cluster randomised trial
426990|NCT01746693|retinal vessel diameter|retinal vessel diameter
426991|NCT01746693|retinal oxygen saturation|retinal oxygen saturation
426992|NCT01746693|high resolution functional and anatomical imaging|high resolution functional and anatomical imaging
426993|NCT01746693|inner retinal function|inner retinal function
426994|NCT01746693|flicker response|flicker response
426995|NCT01746680|rheumatoid arthritis|rheumatoid arthritis
426996|NCT01746680|RA|ra
426997|NCT01746680|tacrolimus|tacrolimus
426998|NCT01746680|Disease Activity Score 28|disease activity score 28
426999|NCT01746680|EULAR|eular
427000|NCT01746667|Social Anxiety Disorder|social anxiety disorder
427001|NCT01746667|Social Phobia|social phobia
427002|NCT01746667|Virtual Reality|virtual reality
427003|NCT01746667|Exposure|exposure
427004|NCT01746654|S.aureus|s.aureus
427005|NCT01746654|Methicillin Resistant S.aureus (MRSA)|methicillin resistant s.aureus (mrsa)
427006|NCT01746654|Nasal carrier status|nasal carrier status
427007|NCT01746654|Prophylaxis|prophylaxis
427008|NCT01746641|Remifentanil|remifentanil
427009|NCT01746641|Propofol|propofol
427010|NCT01746641|Sedation|sedation
427011|NCT01746641|Endoscopy|endoscopy
427012|NCT01746641|Gastroenterology|gastroenterology
427013|NCT01746641|Target controlled infusion effect site|target controlled infusion effect site
427014|NCT01746628|type 0 myomata|type 0 myomata
427015|NCT01746628|type 1 myomata|type 1 myomata
427016|NCT01746628|type 2 myomata|type 2 myomata
427017|NCT01746628|bleeding|bleeding
427018|NCT01746628|hemorrhage|hemorrhage
427019|NCT01746628|hysteroscopy|hysteroscopy
427020|NCT01746628|FloSeal|floseal
427021|NCT01746615|branch retinal vein occlusion|branch retinal vein occlusion
427022|NCT01746615|dynamic vessel analyzer|dynamic vessel analyzer
427023|NCT01746615|fourier-domain OCT|fourier-domain oct
427024|NCT01746615|retinal oxygen saturation|retinal oxygen saturation
427025|NCT01746602|topical lubricants|topical lubricants
427026|NCT01746602|tear film thickness|tear film thickness
427027|NCT01746602|anti-glaucoma drugs|anti-glaucoma drugs
427028|NCT01746602|break up time|break up time
427029|NCT01746602|anti-glaucoma treatment|anti-glaucoma treatment
427030|NCT01746589|LASIK|lasik
427031|NCT01746576|volunteers|volunteers
427032|NCT01746563|Proliferative Diabetic Retinopathy|proliferative diabetic retinopathy
427033|NCT01746563|Ranibizumab|ranibizumab
427034|NCT01746563|Panretinal Photocoagulation|panretinal photocoagulation
427035|NCT01746524|Arthroplasty|arthroplasty
427036|NCT01746524|Replacement|replacement
427037|NCT01746524|Knee|knee
427038|NCT01746511|glycerin suppositories|glycerin suppositories
427039|NCT01746511|glycerin shaves|glycerin shaves
427040|NCT01746511|neonatal hyperbilirubinemia|neonatal hyperbilirubinemia
427041|NCT01746511|idiopathic hyperbilirubinemia|idiopathic hyperbilirubinemia
427042|NCT01746511|jaundice|jaundice
427043|NCT01746511|neonatal jaundice|neonatal jaundice
427044|NCT01746511|prematurity|prematurity
427045|NCT01746498|Alzheimer disease|alzheimer disease
427046|NCT01746498|Direct current stimulation|direct current stimulation
427047|NCT01746498|cognitive function|cognitive function
427048|NCT01746498|memory|memory
427049|NCT01746485|Volunteers|volunteers
427050|NCT01746459|Sustainability of Innovations|sustainability of innovations
427051|NCT01746459|Knowledge Translation|knowledge translation
427052|NCT01746459|Gerontology|gerontology
427053|NCT01746459|Mobility|mobility
427054|NCT01746420|elbow|elbow
427055|NCT01746407|Emergency Department|emergency department
427056|NCT01746407|Infection|infection
427057|NCT01746407|Sepsis|sepsis
427058|NCT01746394|obesity|obesity
427059|NCT01746394|pregnant women|pregnant women
427060|NCT01746394|nutrition assessment|nutrition assessment
427061|NCT01746394|health behavior|health behavior
427062|NCT01746381|amyotrophic lateral sclerosis|amyotrophic lateral sclerosis
427063|NCT01746381|non-invasive ventilation|non-invasive ventilation
427064|NCT01746381|home ventilation|home ventilation
427065|NCT01746381|IVAPS|ivaps
427066|NCT01746381|neuromuscular diseases|neuromuscular diseases
427067|NCT01746368|advance directives|advance directives
427068|NCT01746355|atypical facial pain|atypical facial pain
427069|NCT01746355|atypical odontalgia|atypical odontalgia
427070|NCT01746355|repetitive transcranial magnetic stimulation|repetitive transcranial magnetic stimulation
427071|NCT01746355|neuropathic pain|neuropathic pain
427072|NCT01746355|chronic pain|chronic pain
427073|NCT01746355|assessment|assessment
427074|NCT01746329|Obesity, insulin resistance, muscle perfusion|obesity, insulin resistance, muscle perfusion
427075|NCT01746303|Working memory|working memory
427076|NCT01746303|Long-term memory|long-term memory
427077|NCT01746303|Neurocognition|neurocognition
427078|NCT01746303|Dietary supplementation|dietary supplementation
427079|NCT01746303|dementia|dementia
427080|NCT01746290|Cardiac Arrest, cardiopulmonary resuscitation, automated external defibrillators, smartphones|cardiac arrest, cardiopulmonary resuscitation, automated external defibrillators, smartphones
427081|NCT01746277|non small cell lung cancer|non small cell lung cancer
427082|NCT01746277|chemotherapy|chemotherapy
427083|NCT01746277|epidermal growth factor receptor tyrosine kinase inhibitor|epidermal growth factor receptor tyrosine kinase inhibitor
427084|NCT01746277|retreatment|retreatment
427085|NCT01746264|Obesity|obesity
427086|NCT01746264|Endothelial dysfunction|endothelial dysfunction
427087|NCT01746264|Vitamin D deficiency|vitamin d deficiency
427088|NCT01746251|EGFR mutation|egfr mutation
427089|NCT01746251|Resected|resected
427090|NCT01746238|soft tissue|soft tissue
427091|NCT01746238|high grade|high grade
427092|NCT01746225|Metastatic|metastatic
427093|NCT01746225|Breast|breast
427094|NCT01746225|Cancer|cancer
427095|NCT01746225|HER2-negative Stage IV|her2-negative stage iv
427096|NCT01746225|No previous chemotherapy|no previous chemotherapy
427097|NCT01746212|Degenerative Disc Disease|degenerative disc disease
427098|NCT01746212|InQu Bone Graft Extender and Substitute|inqu bone graft extender and substitute
427099|NCT01746212|Anterior Lumbar Interbody Fusion|anterior lumbar interbody fusion
427100|NCT01746212|Oswestry Disability Index|oswestry disability index
427101|NCT01746212|Visual Analog Scale|visual analog scale
427102|NCT01746212|Stand-alone ALIF|stand-alone alif
427103|NCT01746212|Bone Marrow Aspirate Concentrate|bone marrow aspirate concentrate
427104|NCT01746212|Fusion rate|fusion rate
427105|NCT01746212|Disc Height|disc height
427106|NCT01746212|Mean Optical Density|mean optical density
427107|NCT01746212|Integrated Optical Density|integrated optical density
427108|NCT01746173|T Cell lymphoma|t cell lymphoma
427109|NCT01746160|dental implant|dental implant
427110|NCT01746160|healing|healing
427111|NCT01746160|implant stability|implant stability
427114|NCT01746147|allogeneic SCT|allogeneic sct
427115|NCT01746108|Pneumococcal infection|pneumococcal infection
427116|NCT01746108|Synflorix|synflorix
427117|NCT01746108|Children|children
427118|NCT01746108|Immunogenicity|immunogenicity
427119|NCT01746108|Safety|safety
427120|NCT01746095|Cystic Fibrosis|cystic fibrosis
427121|NCT01746095|MRSA|mrsa
427122|NCT01746095|Methicillin-resistant Staphylococcus aureus|methicillin-resistant staphylococcus aureus
427123|NCT01746095|Lung infection|lung infection
427124|NCT01746095|AeroVanc|aerovanc
427125|NCT01746095|Vancomycin|vancomycin
427126|NCT01746082|influenza, H3N2, H3N2v, vaccine, unadjuvanted, Parent Protocol|influenza, h3n2, h3n2v, vaccine, unadjuvanted, parent protocol
427127|NCT01746069|smoking|smoking
427128|NCT01746069|smoke cessation|smoke cessation
427129|NCT01746069|sms|sms
427130|NCT01746069|quit smoke|quit smoke
427131|NCT01746056|Warts|warts
427132|NCT01746056|Verruca|verruca
427133|NCT01746056|Heat patch|heat patch
427134|NCT01746043|Esophageal cancer|esophageal cancer
427135|NCT01746043|Chemotherapy|chemotherapy
427136|NCT01746043|Radiation therapy|radiation therapy
427137|NCT01746043|XRT|xrt
427138|NCT01746043|Chemoradiation|chemoradiation
427139|NCT01746043|CXRT|cxrt
427140|NCT01746043|Symptom Burden|symptom burden
427141|NCT01746043|Armodafinil|armodafinil
427142|NCT01746043|Nuvigil|nuvigil
427143|NCT01746043|Minocycline|minocycline
427144|NCT01746043|Dynacin|dynacin
427145|NCT01746043|Minocin|minocin
427146|NCT01746043|Minocin PAC|minocin pac
427147|NCT01746043|Myrac|myrac
427148|NCT01746043|Solodyn|solodyn
427149|NCT01746043|Placebo|placebo
427150|NCT01746043|Sugar pill|sugar pill
427151|NCT01746043|Questionnaires|questionnaires
427152|NCT01746043|Surveys|surveys
427153|NCT01745952|Epilepsies, Partial|epilepsies, partial
427154|NCT01745952|Transcranial Magnetic Stimulation|transcranial magnetic stimulation
427155|NCT01745939|Back pain|back pain
427156|NCT01745913|Leukemia|leukemia
427157|NCT01745913|Lymphoma|lymphoma
427158|NCT01745900|Diabetes|diabetes
427159|NCT01745900|Gestational Diabetes|gestational diabetes
427160|NCT01745900|Female|female
427161|NCT01745887|Dry Eye Syndrome|dry eye syndrome
427162|NCT01745887|Interleukin 1 Receptor Inhibitor|interleukin 1 receptor inhibitor
427163|NCT01745874|Rectal cancer|rectal cancer
427164|NCT01745874|Whole-body MRI|whole-body mri
427165|NCT01745874|FDG-PET-CT|fdg-pet-ct
427166|NCT01745874|preoperative staging|preoperative staging
427167|NCT01745848|Roflumilast|roflumilast
427168|NCT01745848|COPD|copd
427169|NCT01745822|Hepatitis B|hepatitis b
427170|NCT01745822|Hepatitis B sAg|hepatitis b sag
427171|NCT01745822|Hepatitis B eAg|hepatitis b eag
427172|NCT01745822|pregnancy|pregnancy
427173|NCT01745796|Pseudomonas Aeruginosa|pseudomonas aeruginosa
427174|NCT01745796|Ventilated Acquired Pneumonia|ventilated acquired pneumonia
427175|NCT01745796|Transmission modes|transmission modes
427176|NCT01745718|prostate cancer|prostate cancer
427177|NCT01745718|targeted biopsies|targeted biopsies
427178|NCT01745718|cytological imprints|cytological imprints
427179|NCT01745718|histology|histology
427180|NCT01745705|Manipulation|manipulation
427181|NCT01745705|Balance|balance
427182|NCT01745705|Proprioception|proprioception
427183|NCT01745679|Ceftriaxone|ceftriaxone
427184|NCT01745679|Adverse drug effects|adverse drug effects
427185|NCT01745679|Therapeutic monitoring|therapeutic monitoring
427186|NCT01745679|Meningitis|meningitis
427187|NCT01745666|Long QT syndrome, stress tests|long qt syndrome, stress tests
427188|NCT01745640|Multiple myeloma|multiple myeloma
427189|NCT01745640|dexamethasone|dexamethasone
427190|NCT01745640|pomalidomide|pomalidomide
427191|NCT01745640|response|response
427192|NCT01745640|safety|safety
427193|NCT01745640|del 17p|del 17p
427194|NCT01745640|t 4-14|t 4-14
427195|NCT01745614|Bioequivalence|bioequivalence
427196|NCT01745614|Nimesulide|nimesulide
427197|NCT01745614|Pharmacokinetics|pharmacokinetics
427198|NCT01745614|Mexico|mexico
427199|NCT01745588|CC-4047(Pomalidomide)Pomalyst|cc-4047(pomalidomide)pomalyst
427200|NCT01745588|Clarithromycin|clarithromycin
427201|NCT01745588|Biaxin|biaxin
427202|NCT01745588|DEXAMETHASONE|dexamethasone
427203|NCT01745588|(ClaPD)|(clapd)
427204|NCT01745588|Stem cell|stem cell
427205|NCT01745588|12-138|12-138
427206|NCT01745575|Bioequivalence|bioequivalence
427207|NCT01745575|Alprazolam|alprazolam
427208|NCT01745575|Anxiety disorders|anxiety disorders
427209|NCT01745575|Mexico|mexico
427210|NCT01745562|Alprazolam|alprazolam
427211|NCT01745562|Anxiety disorders|anxiety disorders
427212|NCT01745562|Bioequivalence|bioequivalence
427213|NCT01745562|Mexico|mexico
427214|NCT01745549|diabetes|diabetes
427215|NCT01745549|insulin therapy|insulin therapy
427216|NCT01745549|needle|needle
427217|NCT01745536|Oocyte vitrification|oocyte vitrification
427218|NCT01745536|survival rate|survival rate
427219|NCT01745536|egg banking|egg banking
427220|NCT01745536|ovum donation|ovum donation
427221|NCT01745523|Oocyte vitrification|oocyte vitrification
427222|NCT01745523|survival rate|survival rate
427223|NCT01745523|egg banking|egg banking
427224|NCT01745523|ovum donation|ovum donation
427225|NCT01745510|docosahexaenoic acid|docosahexaenoic acid
427226|NCT01745510|n-3 fatty acids|n-3 fatty acids
427227|NCT01745510|necrotizing enterocolitis|necrotizing enterocolitis
427228|NCT01745510|preterm infants|preterm infants
427229|NCT01745497|Autism Spectrum Disorder|autism spectrum disorder
427230|NCT01745497|Insomnia|insomnia
427231|NCT01745484|SPECT|spect
427232|NCT01745484|Toxicity|toxicity
427233|NCT01745484|Non-small-cell lung cancer|non-small-cell lung cancer
427234|NCT01745484|Definitive Radiotherapy|definitive radiotherapy
427235|NCT01745484|Radiation pneumonitis|radiation pneumonitis
427236|NCT01745484|Randomized study|randomized study
427237|NCT01745471|Abdominal Adipose|abdominal adipose
427238|NCT01745471|Gluteal Adipose|gluteal adipose
427239|NCT01745471|Polycystic Ovary Syndrome|polycystic ovary syndrome
427240|NCT01745471|Obesity|obesity
427241|NCT01745471|Women|women
427242|NCT01745445|limited-stage small cell lung cancer|limited-stage small cell lung cancer
427243|NCT01745445|concurrent chemo-radiotherapy|concurrent chemo-radiotherapy
427244|NCT01745432|ADBLOCK|adblock
427245|NCT01745432|Adhesion Barrier System|adhesion barrier system
427246|NCT01745432|laparoscopic surgery|laparoscopic surgery
427247|NCT01745432|myomectomy|myomectomy
427248|NCT01745419|COPD|copd
427249|NCT01745419|Exacerbation|exacerbation
427250|NCT01745419|Haptoglobin|haptoglobin
427251|NCT01745393|Smoking Cessation|smoking cessation
546080|NCT01237678|ADC|adc
427252|NCT01745393|Secondhand Smoke|secondhand smoke
427253|NCT01745393|Passive Smoking|passive smoking
427254|NCT01745393|Cotinine|cotinine
427255|NCT01745393|Nicotine Replacement Products|nicotine replacement products
427256|NCT01745380|operative|operative
427257|NCT01745380|dental procedure|dental procedure
427258|NCT01745367|Tivozanib hydrochloride|tivozanib hydrochloride
427259|NCT01745367|triple negative breast cancer|triple negative breast cancer
427260|NCT01745367|paclitaxel|paclitaxel
427261|NCT01745367|pharmacokinetics|pharmacokinetics
427262|NCT01745367|biomarkers|biomarkers
427263|NCT01745367|metastatic breast cancer|metastatic breast cancer
427264|NCT01745367|mBC|mbc
427265|NCT01745367|TNBC|tnbc
427266|NCT01745328|recurrent urinary tract infection|recurrent urinary tract infection
427267|NCT01745328|antibiotics|antibiotics
427268|NCT01745328|traditional chinese medicine|traditional chinese medicine
427269|NCT01745315|total laparoscopic hysterectomy|total laparoscopic hysterectomy
427270|NCT01745315|LigaSure|ligasure
427271|NCT01745315|EnSeal|enseal
427272|NCT01745315|Halo PKS Cutting forceps|halo pks cutting forceps
427273|NCT01745315|electrothermal bipolar vessel sealer|electrothermal bipolar vessel sealer
427274|NCT01745315|advanced bipolar device|advanced bipolar device
427275|NCT01745302|lung cancer|lung cancer
427276|NCT01745302|traditional Chinese medicine|traditional chinese medicine
427277|NCT01745302|EGFR-TKI|egfr-tki
427278|NCT01745289|Breast Cancer|breast cancer
427279|NCT01745289|Survival|survival
427280|NCT01745289|Recurrence|recurrence
427281|NCT01745276|Pin fixation|pin fixation
427282|NCT01745276|Osteotomy|osteotomy
427283|NCT01745276|hemicallotasis|hemicallotasis
427284|NCT01745250|lip|lip
427285|NCT01745250|fillers|fillers
427286|NCT01745250|Hyaluronic acid|hyaluronic acid
427287|NCT01745237|Sarcoidosis|sarcoidosis
427288|NCT01745237|Cardiac Magnetic Resonance|cardiac magnetic resonance
427289|NCT01745198|homocysteinemia|homocysteinemia
427290|NCT01745198|dementia|dementia
427291|NCT01745198|depression|depression
427292|NCT01745198|vitamin B12|vitamin b12
427293|NCT01745198|folate|folate
427294|NCT01745198|mild cognitive impairment|mild cognitive impairment
427295|NCT01745198|alzheimer's|alzheimer's
427296|NCT01745198|homocysteine|homocysteine
427297|NCT01745185|Fabry Disease|fabry disease
427298|NCT01745185|immunity|immunity
427299|NCT01745185|antibody|antibody
427300|NCT01745159|tacrolimus|tacrolimus
427301|NCT01745159|Protopic|protopic
427302|NCT01745159|pediatric|pediatric
427303|NCT01745159|atopic dermatitis|atopic dermatitis
427304|NCT01745159|China|china
427305|NCT01745146|traumatic brain injury|traumatic brain injury
427306|NCT01745146|TBI|tbi
427307|NCT01745146|head injury|head injury
427308|NCT01745146|brain injury|brain injury
427309|NCT01745146|Psych-educational treatment|psych-educational treatment
427310|NCT01745146|Anger|anger
427311|NCT01745146|irritability|irritability
427312|NCT01745146|anger management|anger management
427313|NCT01745133|Olux E foam|olux e foam
427314|NCT01745133|Sorilux foam|sorilux foam
427315|NCT01745120|gene therapy|gene therapy
427316|NCT01745120|β thalassemia|β thalassemia
427317|NCT01745120|hemoglobin|hemoglobin
427318|NCT01745120|anemia|anemia
427319|NCT01745120|CD34|cd34
427320|NCT01745107|T2-3N0M0 disease of esophageal neoplasm|t2-3n0m0 disease of esophageal neoplasm
427321|NCT01745107|postoperative radiotherapy|postoperative radiotherapy
427322|NCT01745107|intensity modulated radiation therapy|intensity modulated radiation therapy
427323|NCT01745107|survival|survival
427324|NCT01745094|mirabegron|mirabegron
427325|NCT01745094|solifenacin|solifenacin
427326|NCT01745068|fragility fracture|fragility fracture
427327|NCT01745068|osteoporosis|osteoporosis
427328|NCT01745068|fall prevention|fall prevention
427329|NCT01745068|integrated program|integrated program
427330|NCT01745068|interorganizational collaboration|interorganizational collaboration
427331|NCT01745068|Canada|canada
427332|NCT01745068|controlled clinical trial|controlled clinical trial
427333|NCT01745068|evaluation|evaluation
427334|NCT01745055|Pharmacokinetics|pharmacokinetics
427335|NCT01745055|oral JAK inhibitor|oral jak inhibitor
427336|NCT01745055|methotrexate (MTX)|methotrexate (mtx)
427337|NCT01745055|rheumatoid arthritis (RA)|rheumatoid arthritis (ra)
427338|NCT01745042|Postmenopausal Women|postmenopausal women
427339|NCT01745042|Body Composition|body composition
427340|NCT01745042|Metabolic Syndrome|metabolic syndrome
427341|NCT01745042|Menopause Symptoms|menopause symptoms
427342|NCT01745029|Gastrointestinal Motility|gastrointestinal motility
427343|NCT01745029|Inflammatory Bowel Disease|inflammatory bowel disease
427344|NCT01745029|Transit time|transit time
427345|NCT01745016|dietary supplement|dietary supplement
427346|NCT01745016|carnosine|carnosine
427347|NCT01745003|Fibromyalgia|fibromyalgia
427348|NCT01744990|Nuts|nuts
427349|NCT01744990|allergy|allergy
427350|NCT01744990|Oral food challenge|oral food challenge
427351|NCT01744990|skin testing|skin testing
427352|NCT01744990|basophil activation tests|basophil activation tests
427353|NCT01744990|specific IgE's|specific ige's
427354|NCT01744964|apomorphine|apomorphine
427355|NCT01744964|dopamine transporter gene|dopamine transporter gene
427356|NCT01744964|SLC6A3|slc6a3
427357|NCT01744964|cold pressor test|cold pressor test
427358|NCT01744964|tolerance|tolerance
427359|NCT01744964|experimental pain|experimental pain
427360|NCT01744964|dopamine agonist|dopamine agonist
427361|NCT01744951|Adoption|adoption
427362|NCT01744951|Foster care|foster care
427363|NCT01744951|Substance abuse|substance abuse
427364|NCT01744951|Older children|older children
427365|NCT01744951|Mental health|mental health
427366|NCT01744938|Postoperative Complications,|postoperative complications,
427367|NCT01744938|mortality,|mortality,
427368|NCT01744938|length of Stay,|length of stay,
427369|NCT01744938|economics|economics
427370|NCT01744912|Lymphoma|lymphoma
427371|NCT01744912|monoclonal antibody|monoclonal antibody
427372|NCT01744912|immunomodulatory agent|immunomodulatory agent
427373|NCT01744912|ublituximab|ublituximab
427374|NCT01744912|lenalidomide|lenalidomide
427375|NCT01744899|Lumbosacral spine|lumbosacral spine
427376|NCT01744899|Nerve roots|nerve roots
427377|NCT01744899|Sitting|sitting
427378|NCT01744899|H-reflex|h-reflex
427379|NCT01744886|One-Lung Ventilation|one-lung ventilation
427380|NCT01744886|Thoracic Surgical Procedures|thoracic surgical procedures
427381|NCT01744886|Cardiac Surgical Procedures|cardiac surgical procedures
427678|NCT01743547|Yoga|yoga
427382|NCT01744834|Reward-based learning|reward-based learning
427383|NCT01744834|Pavlovian-to-instrumental transfer|pavlovian-to-instrumental transfer
427384|NCT01744834|Functional imaging|functional imaging
427385|NCT01744834|alcohol use disorder risk|alcohol use disorder risk
427386|NCT01744821|High Risk|high risk
427388|NCT01744808|Normal|normal
427389|NCT01744795|cardiac output|cardiac output
427390|NCT01744795|thermodilution|thermodilution
427391|NCT01744795|esophageal doppler|esophageal doppler
427392|NCT01744795|trending ability|trending ability
427393|NCT01744782|Nephropathic Cystinosis|nephropathic cystinosis
427394|NCT01744782|Cysteamine|cysteamine
427395|NCT01744782|Delayed-release Cysteamine|delayed-release cysteamine
427396|NCT01744782|CTNS Protein, Human|ctns protein, human
427397|NCT01744782|Orphan Disease|orphan disease
427398|NCT01744769|thyroid cancer|thyroid cancer
427399|NCT01744769|hypothyroidism|hypothyroidism
427400|NCT01744769|metabolic parameters|metabolic parameters
427401|NCT01744769|Hypothyroidism after levothyroxine withdrawal|hypothyroidism after levothyroxine withdrawal
427402|NCT01744756|Subconjunctival Bevacizumab|subconjunctival bevacizumab
427403|NCT01744756|Recurrent pterygium|recurrent pterygium
427404|NCT01744743|preconception|preconception
427405|NCT01744743|hypothyroidism|hypothyroidism
427406|NCT01744743|neurocognitive development|neurocognitive development
427407|NCT01744730|Bacterial infections|bacterial infections
427408|NCT01744730|Obesity|obesity
427409|NCT01744730|pharmacokinetics|pharmacokinetics
427410|NCT01744730|clindamycin|clindamycin
427411|NCT01744717|Pain|pain
427412|NCT01744717|mechanical ventilation|mechanical ventilation
427413|NCT01744717|uncommunicative|uncommunicative
427414|NCT01744717|Adult ICU patients pain|adult icu patients pain
427415|NCT01744704|Nerve Growth Factor|nerve growth factor
427416|NCT01744704|Ophthalmic Solutions|ophthalmic solutions
427417|NCT01744704|Eye Drops|eye drops
427418|NCT01744704|rh-NGF|rh-ngf
427419|NCT01744691|CLL|cll
427420|NCT01744691|SLL|sll
427421|NCT01744665|CML, chronic myeloid leukemia, stop, niotinib, discontinue, imatinib, switch, MR4.5, undetectable, bcr-abl|cml, chronic myeloid leukemia, stop, niotinib, discontinue, imatinib, switch, mr4.5, undetectable, bcr-abl
427422|NCT01744652|Advanced Cancers|advanced cancers
427423|NCT01744652|Advanced Malignancies|advanced malignancies
427424|NCT01744652|Unresectable|unresectable
427425|NCT01744652|Metastatic|metastatic
427426|NCT01744652|Crizotinib|crizotinib
427427|NCT01744652|PF-02341066|pf-02341066
427428|NCT01744652|Xalkori|xalkori
427429|NCT01744652|Dasatinib|dasatinib
427430|NCT01744652|BMS-354825|bms-354825
427431|NCT01744652|Sprycel|sprycel
427432|NCT01744639|Hepatocellular carcinoma|hepatocellular carcinoma
427433|NCT01744639|Radioablation|radioablation
427434|NCT01744626|Chronic Lymphocytic Leukemia|chronic lymphocytic leukemia
427435|NCT01744626|Small Lymphocytic Lymphoma|small lymphocytic lymphoma
427436|NCT01744613|Clopidogrel|clopidogrel
427437|NCT01744613|platelet inhibition|platelet inhibition
427438|NCT01744613|antiplatelet therapy|antiplatelet therapy
427439|NCT01744613|peripheral arterial disease|peripheral arterial disease
427440|NCT01744613|endovascular treatment|endovascular treatment
427441|NCT01744613|angioplasty|angioplasty
427442|NCT01744613|stenting|stenting
427443|NCT01744600|Dementia|dementia
427444|NCT01744600|Music Therapy|music therapy
427445|NCT01744587|EBV|ebv
427446|NCT01744587|EGCG|egcg
427447|NCT01744561|Exercise|exercise
427448|NCT01744561|Motivation|motivation
427449|NCT01744561|Feedback|feedback
427450|NCT01744561|web-based diary|web-based diary
427451|NCT01744561|pedometer|pedometer
427452|NCT01744535|smartphone|smartphone
427453|NCT01744535|smartphone app|smartphone app
427454|NCT01744535|smartphone application|smartphone application
427455|NCT01744535|obesity|obesity
427456|NCT01744535|overweight|overweight
427457|NCT01744535|self monitoring|self monitoring
427458|NCT01744496|Parkinson's Disease|parkinson's disease
427459|NCT01744496|Rotigotine|rotigotine
427460|NCT01744496|Chronic Pain|chronic pain
427461|NCT01744496|Nonmotor symptoms|nonmotor symptoms
427462|NCT01744483|pneumonia|pneumonia
427463|NCT01744483|endotracheal intubation|endotracheal intubation
427464|NCT01744470|Renal|renal
427465|NCT01744470|Transplantation|transplantation
427466|NCT01744470|Tacrolimus|tacrolimus
427467|NCT01744457|tear film osmolarity|tear film osmolarity
427468|NCT01744457|objective scattering index|objective scattering index
427469|NCT01744457|tear break up time|tear break up time
427470|NCT01744457|Schirmer I test|schirmer i test
427471|NCT01744418|ESRD|esrd
427472|NCT01744418|HEMODIALYSIS|hemodialysis
427473|NCT01744418|CHRONIC RENAL INSUFFICIENCY|chronic renal insufficiency
427474|NCT01744418|Renal Dialysis|renal dialysis
427475|NCT01744418|Hemodiafiltration|hemodiafiltration
427476|NCT01744418|Blood Vessel Prosthesis|blood vessel prosthesis
427477|NCT01744418|Tissue-Engineered Vascular Graft|tissue-engineered vascular graft
427478|NCT01744418|Vascular Prosthesis Implantation|vascular prosthesis implantation
427479|NCT01744405|Chagas disease|chagas disease
427480|NCT01744405|lactation|lactation
427481|NCT01744405|breastmilk|breastmilk
427482|NCT01744405|postpartum period|postpartum period
427483|NCT01744405|infants|infants
427484|NCT01744405|pediatric clinical pharmacology|pediatric clinical pharmacology
427485|NCT01744405|developmental clinical pharmacology|developmental clinical pharmacology
427486|NCT01744405|parasitology|parasitology
427487|NCT01744405|trypanosoma cruzi|trypanosoma cruzi
427488|NCT01744405|nifurtimox|nifurtimox
427489|NCT01744353|newly diagnosed|newly diagnosed
427490|NCT01744353|advanced pancreatic cancer|advanced pancreatic cancer
427491|NCT01744353|pancreatic cancer|pancreatic cancer
427492|NCT01744353|metastatic pancreatic cancer|metastatic pancreatic cancer
427493|NCT01744353|pancreas|pancreas
427494|NCT01744340|Head and Neck|head and neck
427495|NCT01744340|Colon|colon
427496|NCT01744314|Elbow trauma,Heterotopic Ossification,Indomethacin, Prophylaxis|elbow trauma,heterotopic ossification,indomethacin, prophylaxis
427497|NCT01744301|Seizure|seizure
427498|NCT01744301|Acid-suppressing drugs|acid-suppressing drugs
427499|NCT01744301|Epidemiology|epidemiology
427500|NCT01744288|Phase 1 Safety ,|phase 1 safety ,
427501|NCT01744288|pharmacodynamic,|pharmacodynamic,
427502|NCT01744288|Ticagrelor,|ticagrelor,
427503|NCT01744288|Clopidogrel,|clopidogrel,
427504|NCT01744288|Platelets|platelets
427505|NCT01744275|Epilepsy|epilepsy
427506|NCT01744275|Omega 3 fatty acids|omega 3 fatty acids
427507|NCT01744262|intraocular pressure, total intravenous anesthesia, laparoscopic prostatectomy|intraocular pressure, total intravenous anesthesia, laparoscopic prostatectomy
427508|NCT01744249|Advanced neuroendocrine tumours of non-pancreatic origin|advanced neuroendocrine tumours of non-pancreatic origin
427509|NCT01744249|axitinib|axitinib
427510|NCT01744236|GLP-1 Receptor Agonists, DPP-4 inhibitors|glp-1 receptor agonists, dpp-4 inhibitors
427511|NCT01744223|iCaspase9|icaspase9
427512|NCT01744223|iCasp9|icasp9
427513|NCT01744223|Inducible Caspase|inducible caspase
427514|NCT01744223|AP1903|ap1903
427515|NCT01744223|Dimerizer drug|dimerizer drug
427516|NCT01744223|T depleted|t depleted
427517|NCT01744223|Suicide gene|suicide gene
427518|NCT01744223|CD-34 selection|cd-34 selection
427519|NCT01744223|haplotransplantation|haplotransplantation
427520|NCT01744223|Graft versus host disease|graft versus host disease
427521|NCT01744223|Allogenic transplantation|allogenic transplantation
427522|NCT01744197|Pain control|pain control
427523|NCT01744197|Needle stick pain|needle stick pain
427524|NCT01744197|Venipuncture pain|venipuncture pain
427525|NCT01744184|gastroscopy|gastroscopy
427526|NCT01744184|diagnostic|diagnostic
427527|NCT01744184|entonox|entonox
427528|NCT01744158|cerebral palsy|cerebral palsy
427529|NCT01744158|spasticity|spasticity
427530|NCT01744158|dystonia|dystonia
427531|NCT01744158|hypertonia|hypertonia
427532|NCT01744158|register|register
427533|NCT01744158|motor function|motor function
427534|NCT01744132|eye care utilization|eye care utilization
427535|NCT01744132|ophthalmology|ophthalmology
427536|NCT01744132|educational intervention|educational intervention
427537|NCT01744132|public health screening|public health screening
427538|NCT01744093|HIV|hiv
427539|NCT01744093|COPD|copd
427540|NCT01744093|Chronic Obstructive Pulmonary Disease|chronic obstructive pulmonary disease
427541|NCT01744093|Emphysema|emphysema
427542|NCT01744080|Rotator cuff|rotator cuff
427543|NCT01744067|Renal transplantation|renal transplantation
427544|NCT01744067|Interventional study|interventional study
427545|NCT01744067|Glomerular filtration rate|glomerular filtration rate
427546|NCT01744067|Renal function|renal function
427547|NCT01744067|Proteinuria|proteinuria
427548|NCT01744067|Cardiovascular risk markers|cardiovascular risk markers
427549|NCT01744067|Blood pressure|blood pressure
427550|NCT01744067|Flow mediated vasodilation|flow mediated vasodilation
427551|NCT01744067|Heart rate variability|heart rate variability
427552|NCT01744067|Pulse wave velocity|pulse wave velocity
427553|NCT01744067|Lipids|lipids
427554|NCT01744067|Blood glucose|blood glucose
427555|NCT01744067|Bone mineral density|bone mineral density
427556|NCT01744067|Body composition|body composition
427557|NCT01744067|Fat distribution|fat distribution
427558|NCT01744067|Body mass index|body mass index
427559|NCT01744067|Fatty acid composition|fatty acid composition
427560|NCT01744067|Tacrolimus pharmacokinetics|tacrolimus pharmacokinetics
427561|NCT01744067|Omega-3 fatty acids|omega-3 fatty acids
427562|NCT01744067|Marine n-3 fatty acids|marine n-3 fatty acids
427563|NCT01744067|Fatty acids|fatty acids
427564|NCT01744067|Gas chromatography|gas chromatography
427565|NCT01744067|Interstitial fibrosis|interstitial fibrosis
427566|NCT01744067|Inflammation|inflammation
427567|NCT01744041|depression|depression
427568|NCT01744041|pregnancy|pregnancy
427569|NCT01744041|postpartum|postpartum
427570|NCT01744041|psychotherapy|psychotherapy
427571|NCT01744028|COPD, remote patient monitoring, Hub, exacerbations, EXACT|copd, remote patient monitoring, hub, exacerbations, exact
427572|NCT01744015|Low back pain|low back pain
427573|NCT01744002|Shoulder, Impingement syndrome, Neck|shoulder, impingement syndrome, neck
427574|NCT01743976|neuropathic pain|neuropathic pain
427575|NCT01743976|diabetic neuropathy|diabetic neuropathy
427576|NCT01743976|neuropathic pain after back surgery|neuropathic pain after back surgery
427577|NCT01743963|efficacy|efficacy
427578|NCT01743963|glucocorticoid|glucocorticoid
427579|NCT01743950|Glioblastoma|glioblastoma
427580|NCT01743950|anaplastic glioma|anaplastic glioma
427581|NCT01743937|Ischemic preconditioning|ischemic preconditioning
427582|NCT01743937|Ticagrelor|ticagrelor
427583|NCT01743937|Antiplatelet therapy|antiplatelet therapy
427584|NCT01743937|Acute coronary syndrome|acute coronary syndrome
427585|NCT01743924|Broccoli; Isothiocyanates; Pharmacokinetics; Sulforaphane; Myrosinase|broccoli; isothiocyanates; pharmacokinetics; sulforaphane; myrosinase
427586|NCT01743911|Tadalafil|tadalafil
427587|NCT01743911|Resistant Hypertension|resistant hypertension
427588|NCT01743911|Left Ventricle Diastolic Dysfunction|left ventricle diastolic dysfunction
427589|NCT01743911|Brain natriuretic peptide|brain natriuretic peptide
427590|NCT01743885|Hemangioma|hemangioma
427591|NCT01743885|Beta-blocker|beta-blocker
427592|NCT01743885|Acebutolol|acebutolol
427593|NCT01743885|Propranolol|propranolol
427594|NCT01743885|Randomized controlled trial|randomized controlled trial
427595|NCT01743885|Infants|infants
427596|NCT01743872|Optical Coherence Tomography|optical coherence tomography
427597|NCT01743872|Contrast|contrast
427598|NCT01743872|Dextran|dextran
427599|NCT01743872|Carbon Dioxide|carbon dioxide
427600|NCT01743872|Imaging|imaging
427601|NCT01743872|Catheter|catheter
427602|NCT01743872|Lower Extremity Artery|lower extremity artery
427603|NCT01743859|Myeloid|myeloid
427604|NCT01743859|Leukemia|leukemia
427605|NCT01743807|Relapsed|relapsed
427606|NCT01743807|Minimal Residual Disease|minimal residual disease
427607|NCT01743807|MRD|mrd
427608|NCT01743807|Acute Lymphoblastic Leukemia|acute lymphoblastic leukemia
427609|NCT01743807|Acute Myelogenous Leukemia|acute myelogenous leukemia
427610|NCT01743807|ALL|all
427611|NCT01743807|AML|aml
427612|NCT01743807|GNKG168|gnkg168
427613|NCT01743807|Pediatric|pediatric
427614|NCT01743807|Childhood|childhood
427615|NCT01743781|comprehensive eye examination|comprehensive eye examination
427616|NCT01743781|acceptance|acceptance
427617|NCT01743781|glaucoma|glaucoma
427618|NCT01743781|diabetic retinopathy|diabetic retinopathy
427619|NCT01743768|Antisense oligonucleotide|antisense oligonucleotide
427620|NCT01743768|Asthma|asthma
427621|NCT01743768|Healthy subjects|healthy subjects
427622|NCT01743768|Phase 1|phase 1
427623|NCT01743768|Transcription factor GATA-3|transcription factor gata-3
427624|NCT01743768|Oral inhalation|oral inhalation
427625|NCT01743755|Community-acquired pneumonia|community-acquired pneumonia
427626|NCT01743755|Dexamethasone|dexamethasone
427627|NCT01743755|Corticosteroid|corticosteroid
427628|NCT01743742|Oral vitamin E and vitamin C|oral vitamin e and vitamin c
427629|NCT01743729|SAR 1118|sar 1118
427630|NCT01743716|Major Depressive Disorder|major depressive disorder
427631|NCT01743716|MDD|mdd
427632|NCT01743716|depression|depression
427633|NCT01743716|adolescent|adolescent
427634|NCT01743703|traumatic injuries|traumatic injuries
427635|NCT01743703|Whole-body MRI|whole-body mri
427636|NCT01743703|Skeletal survey|skeletal survey
427637|NCT01743703|Children|children
427638|NCT01743703|Diagnostic|diagnostic
427639|NCT01743690|Probiotic|probiotic
427640|NCT01743690|Candida|candida
427641|NCT01743690|Oral Lichen Planus|oral lichen planus
427642|NCT01743677|TQT study|tqt study
427643|NCT01743677|CP-690,550|cp-690,550
427644|NCT01743664|Posttraumatic Stress Disorders|posttraumatic stress disorders
427645|NCT01743664|Multiple Sclerosis|multiple sclerosis
427646|NCT01743664|Eye Movement Desensitization Reprocessing|eye movement desensitization reprocessing
427647|NCT01743664|Psychotherapy|psychotherapy
427648|NCT01743664|Anxiety|anxiety
427649|NCT01743664|Depression|depression
427650|NCT01743664|Quality of Life|quality of life
427651|NCT01743651|spasticity|spasticity
427652|NCT01743651|multiple sclerosis|multiple sclerosis
427653|NCT01743651|arbaclofen|arbaclofen
427654|NCT01743612|healthy subject|healthy subject
427655|NCT01743612|hand blood flow|hand blood flow
427656|NCT01743612|laser speckle contrast imaging|laser speckle contrast imaging
427657|NCT01743586|Lung cancer|lung cancer
427658|NCT01743586|Chest physiotherapy|chest physiotherapy
427659|NCT01743586|Respiratory muscle strength|respiratory muscle strength
427660|NCT01743586|Dyspnea, Functional capacity|dyspnea, functional capacity
427661|NCT01743586|Quality of life|quality of life
427662|NCT01743560|Breast Neoplasms|breast neoplasms
427663|NCT01743560|Neoplasms|neoplasms
427664|NCT01743560|Breast diseases|breast diseases
427665|NCT01743560|Skin diseases|skin diseases
427666|NCT01743560|Exemestane|exemestane
427667|NCT01743560|Antibiotics, Antineoplastic|antibiotics, antineoplastic
427668|NCT01743560|Everolimus|everolimus
427669|NCT01743560|Antineoplastic Agents|antineoplastic agents
427670|NCT01743560|Therapeutic Uses|therapeutic uses
427671|NCT01743560|Pharmacologic Actions|pharmacologic actions
427672|NCT01743560|Immunosuppressive Agents|immunosuppressive agents
427673|NCT01743560|Physiological Effects of Drugs|physiological effects of drugs
427674|NCT01743560|Aromatase Inhibitors|aromatase inhibitors
427675|NCT01743560|Enzyme Inhibitors|enzyme inhibitors
427676|NCT01743560|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action
427677|NCT01743547|Women|women
427679|NCT01743547|Ovarian Cancer|ovarian cancer
427680|NCT01743547|Lifestyle|lifestyle
427681|NCT01743521|Hepatitis C|hepatitis c
427682|NCT01743521|Individualised therapy|individualised therapy
427683|NCT01743521|Response-guided therapy|response-guided therapy
427684|NCT01743521|Telaprevir|telaprevir
427685|NCT01743521|PEG-IFN|peg-ifn
427686|NCT01743521|Ribavirin|ribavirin
427687|NCT01743521|Hepatitis|hepatitis
427688|NCT01743508|incomplete abortion|incomplete abortion
427689|NCT01743508|misoprostol treatment|misoprostol treatment
427690|NCT01743508|midwife|midwife
427691|NCT01743508|uganda|uganda
427692|NCT01743495|Medical Costs|medical costs
427693|NCT01743495|improved IADLs|improved iadls
427694|NCT01743495|and/or ADL's|and/or adl's
427695|NCT01743495|decreased nursing home admissions|decreased nursing home admissions
427696|NCT01743482|Testicular Cancer|testicular cancer
427697|NCT01743482|Germ Cell Tumors|germ cell tumors
427698|NCT01743482|Salvage Therapy|salvage therapy
427699|NCT01743482|Pazopanib|pazopanib
427700|NCT01743469|Advanced|advanced
427701|NCT01743469|Metastatic|metastatic
427702|NCT01743469|Hepatocellular cancer|hepatocellular cancer
427703|NCT01743469|Ovarian cancer|ovarian cancer
427704|NCT01743469|Renal cell cancer|renal cell cancer
427705|NCT01743469|Gastric carcinoma|gastric carcinoma
427706|NCT01743456|Postoperative cognitive dysfunction|postoperative cognitive dysfunction
427707|NCT01743456|Coronary artery bypass graft surgery|coronary artery bypass graft surgery
427708|NCT01743456|Postoperative cognitive improvement|postoperative cognitive improvement
427709|NCT01743456|Postoperative delirium|postoperative delirium
427710|NCT01743443|Corneal sensitivity|corneal sensitivity
427711|NCT01743443|Cross-linking|cross-linking
427712|NCT01743443|Keratoconus|keratoconus
427713|NCT01743430|telerehabilitation|telerehabilitation
427714|NCT01743430|stroke|stroke
427715|NCT01743430|Berg balance scale|berg balance scale
427716|NCT01743430|stroke impact scale|stroke impact scale
427717|NCT01743430|mobility|mobility
427718|NCT01743417|Cognitive rehabilitation|cognitive rehabilitation
427719|NCT01743417|malaria|malaria
427720|NCT01743417|neuropsychology|neuropsychology
427721|NCT01743417|attention|attention
427722|NCT01743417|working memory|working memory
427723|NCT01743404|atherosclerosis|atherosclerosis
427724|NCT01743404|inflammation|inflammation
427725|NCT01743404|intima-media thickness|intima-media thickness
427726|NCT01743391|IVF treatment|ivf treatment
427727|NCT01743391|Office-hysteroscopy|office-hysteroscopy
427728|NCT01743391|Endometrial biopsy|endometrial biopsy
427729|NCT01743352|Large arteries|large arteries
427730|NCT01743352|stiffness|stiffness
427731|NCT01743352|intima media thickness|intima media thickness
427732|NCT01743352|ultrasound imaging|ultrasound imaging
427733|NCT01743339|Randomized Controlled Trial|randomized controlled trial
427734|NCT01743339|Cognitive Therapy|cognitive therapy
427735|NCT01743339|Stress Disorders, Post-Traumatic|stress disorders, post-traumatic
427736|NCT01743339|Depression|depression
427737|NCT01743339|Sleep|sleep
427738|NCT01743326|Zygapophyseal Joint|zygapophyseal joint
427739|NCT01743313|glucose metabolism disorders|glucose metabolism disorders
427740|NCT01743313|metabolic syndrome|metabolic syndrome
427741|NCT01743313|joint replacement|joint replacement
427742|NCT01743313|osteoarthritis|osteoarthritis
427743|NCT01743300|sunitinib|sunitinib
427744|NCT01743300|pharmacokinetics|pharmacokinetics
427745|NCT01743300|phenotyping|phenotyping
427746|NCT01743300|interaction|interaction
427747|NCT01743287|osteoarthritis of the knee|osteoarthritis of the knee
427748|NCT01743274|acute coronary syndromes|acute coronary syndromes
427749|NCT01743274|non-ST elevation myocardial infarction|non-st elevation myocardial infarction
427750|NCT01743274|angioplasty|angioplasty
427751|NCT01743274|fractional flow reserve|fractional flow reserve
427752|NCT01743274|optical coherence tomography|optical coherence tomography
427753|NCT01743261|severe brain injury|severe brain injury
427754|NCT01743261|graded intensive rehabilitation|graded intensive rehabilitation
427755|NCT01743248|vestibular schwannoma|vestibular schwannoma
427756|NCT01743248|balance|balance
427757|NCT01743248|psychological factors|psychological factors
427758|NCT01743235|HSDD|hsdd
427759|NCT01743209|androgen antagonists|androgen antagonists
427760|NCT01743196|Folic acid|folic acid
427761|NCT01743196|Folate|folate
427762|NCT01743196|Pharmacokinetics|pharmacokinetics
427763|NCT01743196|Women of Child Bearing Age|women of child bearing age
427764|NCT01743183|hypertension|hypertension
427765|NCT01743170|Blood pressure control|blood pressure control
427766|NCT01743170|Hypertension|hypertension
427767|NCT01743170|Office blood pressure|office blood pressure
427768|NCT01743170|Self-measured blood pressure|self-measured blood pressure
427769|NCT01743170|Telemonitoring|telemonitoring
427770|NCT01743144|emergence agitation in children|emergence agitation in children
427771|NCT01743144|sevoflurane|sevoflurane
427772|NCT01743144|general anesthesia|general anesthesia
427773|NCT01743144|magnesium sulphate|magnesium sulphate
427774|NCT01743105|diaphragm movement|diaphragm movement
427775|NCT01743105|ultrasound|ultrasound
427776|NCT01743105|emergency room|emergency room
427777|NCT01743092|Pathological gambling|pathological gambling
427778|NCT01743092|treatment|treatment
427779|NCT01743092|online counselling|online counselling
427781|NCT01743092|workbook|workbook
427782|NCT01743079|Telbivudine|telbivudine
427783|NCT01743079|Lamivudine|lamivudine
427784|NCT01743079|safety|safety
427785|NCT01743079|efficacy|efficacy
427786|NCT01743079|pregnancy|pregnancy
427787|NCT01743066|Arsenic|arsenic
427788|NCT01743066|Arsenicosis|arsenicosis
427789|NCT01743066|Buccal cells|buccal cells
427790|NCT01743066|Serum|serum
427791|NCT01743066|Vitamin E|vitamin e
427792|NCT01743066|Cholesterol|cholesterol
427793|NCT01743040|Coronary Artery Disease|coronary artery disease
427794|NCT01743040|Nuclear Stress Test|nuclear stress test
427795|NCT01743040|CT Angiography|ct angiography
427796|NCT01743040|Angiography|angiography
427797|NCT01743027|Allergic conjunctivitis|allergic conjunctivitis
427798|NCT01743027|Olopatadine HCl solution|olopatadine hcl solution
427799|NCT01743027|Conjunctival Allergen Challenge|conjunctival allergen challenge
427800|NCT01743027|Itching eyes|itching eyes
427801|NCT01743027|Ocular allergies|ocular allergies
427802|NCT01743027|PATADAY|pataday
427803|NCT01743027|PATANOL|patanol
427804|NCT01743014|diabetes|diabetes
427805|NCT01743014|diabetic nephropathy|diabetic nephropathy
427806|NCT01743014|vascular inflammation|vascular inflammation
427807|NCT01743014|oxidative stress|oxidative stress
427808|NCT01743014|endothelial dysfunction|endothelial dysfunction
427809|NCT01743014|Asymmetric dimethylarginine|asymmetric dimethylarginine
427810|NCT01743014|High sensitivity CRP|high sensitivity crp
427811|NCT01743014|albumine to creatinine ratio|albumine to creatinine ratio
427812|NCT01743014|isoprostane|isoprostane
427813|NCT01743014|clopidogrel|clopidogrel
427814|NCT01743014|ramipril|ramipril
427815|NCT01743014|carotid intima media thickness|carotid intima media thickness
427816|NCT01743001|exercise capacity|exercise capacity
427817|NCT01743001|Eisenmenger Syndrome|eisenmenger syndrome
427818|NCT01742988|Lymphoma|lymphoma
427819|NCT01742988|DLBCL|dlbcl
427820|NCT01742988|MYC|myc
427821|NCT01742988|Diffuse Large B-Cell Lymphoma|diffuse large b-cell lymphoma
427822|NCT01742988|HGBL|hgbl
427823|NCT01742988|High-grade B-Cell Lymphoma|high-grade b-cell lymphoma
427824|NCT01742988|Double-hit Lymphoma (DHL)|double-hit lymphoma (dhl)
427825|NCT01742988|Triple-hit Lymphoma (THL)|triple-hit lymphoma (thl)
427826|NCT01742988|Double-expressor Lymphoma (DEL)|double-expressor lymphoma (del)
427827|NCT01742988|P13K|p13k
427828|NCT01742988|HDAC|hdac
427829|NCT01742988|Open-Label|open-label
427830|NCT01742962|Prostatectomy|prostatectomy
427831|NCT01742962|Prostate cancer|prostate cancer
427832|NCT01742962|Orgasm|orgasm
427833|NCT01742962|Urinary incontinence|urinary incontinence
427834|NCT01742962|Climacturia(orgasm related urinary incontinence)|climacturia(orgasm related urinary incontinence)
427835|NCT01742962|Penis|penis
427836|NCT01742962|Dysorgasmia (pain in relation to orgasm)|dysorgasmia (pain in relation to orgasm)
427837|NCT01742962|Pain|pain
427838|NCT01742962|Anorgasmia|anorgasmia
427839|NCT01742962|Penile shortening|penile shortening
427840|NCT01742962|Erectile dysfunction|erectile dysfunction
427841|NCT01742923|hypertension|hypertension
427842|NCT01742923|medication adherence|medication adherence
427843|NCT01742923|motivational interviewing|motivational interviewing
427844|NCT01742897|Osteoarthritis, Knee|osteoarthritis, knee
427845|NCT01742897|Transdermal therapeutic system (TTS) fentanyl|transdermal therapeutic system (tts) fentanyl
427846|NCT01742897|Durogesic|durogesic
427847|NCT01742884|Dry Eye Syndrome|dry eye syndrome
427848|NCT01742871|Antivitamin K|antivitamin k
427849|NCT01742871|Bleeding|bleeding
427850|NCT01742871|Haemorrhage|haemorrhage
427851|NCT01742871|Nutritional status|nutritional status
427852|NCT01742871|impedancemetry|impedancemetry
427853|NCT01742845|Ultrasound-guided|ultrasound-guided
427854|NCT01742845|regional anaesthesia|regional anaesthesia
427855|NCT01742845|Cervical block|cervical block
427856|NCT01742832|Vilazodone|vilazodone
427857|NCT01742832|Citalopram|citalopram
427858|NCT01742832|Major Depressive Disorder|major depressive disorder
427859|NCT01742819|Glaucoma, Optical Coherence Tomography, Progression|glaucoma, optical coherence tomography, progression
427860|NCT01742806|Gastric cancer|gastric cancer
427861|NCT01742806|Minimally invasive surgery|minimally invasive surgery
427862|NCT01742806|Distal gastrectomy|distal gastrectomy
427863|NCT01742806|Bio-absorbable Felt|bio-absorbable felt
427864|NCT01742793|relapsed /refractory Hodgkin lymphoma|relapsed /refractory hodgkin lymphoma
427865|NCT01742793|mature T-cell lymphoma|mature t-cell lymphoma
427866|NCT01742793|multiple myeloma|multiple myeloma
427867|NCT01742780|Intraosseous Vascular Access|intraosseous vascular access
427868|NCT01742780|IO Access|io access
427869|NCT01742780|IO Vascular Access|io vascular access
427870|NCT01742780|EZ-IO|ez-io
427871|NCT01742767|NSCLC; split dose Cisplatinum; Pemetrexed|nsclc; split dose cisplatinum; pemetrexed
427872|NCT01742741|Diabetes Mellitus, Type 1 (T1DM)|diabetes mellitus, type 1 (t1dm)
427873|NCT01742741|Continuous Glucose Monitor (CGM)|continuous glucose monitor (cgm)
427874|NCT01742741|Artificial Pancreas (AP)|artificial pancreas (ap)
427875|NCT01742741|Insulin Pump|insulin pump
427876|NCT01742741|Closed Loop Control (CLC)|closed loop control (clc)
427877|NCT01742741|Open Loop treatment|open loop treatment
427878|NCT01742741|Diabetes Assistant|diabetes assistant
427879|NCT01742741|DiAs|dias
427880|NCT01742728|oxidative stress, antioxidant, periodontitis, serum immunoglobulin G|oxidative stress, antioxidant, periodontitis, serum immunoglobulin g
427881|NCT01742728|antibody titer|antibody titer
427882|NCT01742715|ARDS|ards
427883|NCT01742715|Lung compliance|lung compliance
427884|NCT01742702|Blood pressure|blood pressure
427885|NCT01742702|Hypertension|hypertension
427886|NCT01742702|Arterial stiffness|arterial stiffness
427887|NCT01742702|Cardiac output|cardiac output
427888|NCT01742702|Vascular resistance|vascular resistance
427889|NCT01742702|Pulse wave reflection|pulse wave reflection
427890|NCT01742702|Head-up tilt|head-up tilt
427891|NCT01742689|Renal colic|renal colic
427892|NCT01742689|Pain|pain
427893|NCT01742689|Desmopressin|desmopressin
427894|NCT01742689|Urinary obstruction|urinary obstruction
427895|NCT01742689|Indomethacin|indomethacin
427896|NCT01742676|tacrolimus|tacrolimus
427897|NCT01742676|kidney|kidney
427898|NCT01742663|Diclofenac Sodium Gel 3%|diclofenac sodium gel 3%
427899|NCT01742663|Solaraze® (diclofenac sodium) Gel 3%|solaraze® (diclofenac sodium) gel 3%
427900|NCT01742663|Actinic Keratosis|actinic keratosis
427901|NCT01742650|ankle; fracture; syndesmosis;|ankle; fracture; syndesmosis;
427902|NCT01742637|Acne Vulgaris|acne vulgaris
427903|NCT01742637|Adapalene and Benzoyl Peroxide Gel 0.1%/2.5%|adapalene and benzoyl peroxide gel 0.1%/2.5%
427904|NCT01742637|Epiduo®|epiduo®
427905|NCT01742624|immunosuppressant|immunosuppressant
427906|NCT01742624|new-onset diabetes after kidney transplantation|new-onset diabetes after kidney transplantation
427907|NCT01742624|NODAT|nodat
427908|NCT01742611|CKD|ckd
427909|NCT01742611|Not on dialysis|not on dialysis
427910|NCT01742611|ASP1585|asp1585
427911|NCT01742611|Bixalomer|bixalomer
427912|NCT01742598|TAVI|tavi
427913|NCT01742598|TAVR|tavr
427914|NCT01742598|aortic stenosis|aortic stenosis
427915|NCT01742598|Transcatheter|transcatheter
427916|NCT01742598|valvular heart disease|valvular heart disease
427917|NCT01742598|aortic valve stenosis|aortic valve stenosis
427918|NCT01742598|aortic valve replacement|aortic valve replacement
427919|NCT01742598|transcatheter aortic valve implantation|transcatheter aortic valve implantation
427920|NCT01742585|CKD|ckd
427921|NCT01742585|Not on dialysis|not on dialysis
427922|NCT01742585|ASP1585|asp1585
427923|NCT01742585|Bixalomer|bixalomer
427924|NCT01742572|weight loss|weight loss
427925|NCT01742572|obesity|obesity
427926|NCT01742572|overweight|overweight
427927|NCT01742572|diet|diet
427928|NCT01742559|Treatment|treatment
427929|NCT01742546|myofascial pain syndrome|myofascial pain syndrome
427930|NCT01742546|therapeutic ultrasound|therapeutic ultrasound
427931|NCT01742546|combine therapy|combine therapy
427932|NCT01742533|Hormone Replacement Therapy，|hormone replacement therapy，
427933|NCT01742533|Premature Ovarian Failure，|premature ovarian failure，
427934|NCT01742533|Stem Cell Therapy|stem cell therapy
427935|NCT01742520|Preterm infant|preterm infant
427936|NCT01742520|pain|pain
427937|NCT01742520|neurodevelopment|neurodevelopment
427938|NCT01742507|Stent, OCT|stent, oct
427939|NCT01742494|Esophageal Achalasia,|esophageal achalasia,
427940|NCT01742494|Peroral endoscopic myotomy,|peroral endoscopic myotomy,
427941|NCT01742494|Water-jet assisted|water-jet assisted
427942|NCT01742481|childhood cancer survivors|childhood cancer survivors
427943|NCT01742481|long-term follow-up care|long-term follow-up care
427944|NCT01742481|health communication|health communication
427945|NCT01742481|ethnic/racial minorities|ethnic/racial minorities
427946|NCT01742481|longterm survivors|longterm survivors
427947|NCT01742468|n-3 LC-PUFA, DHA, rheumatoid arthritis|n-3 lc-pufa, dha, rheumatoid arthritis
427948|NCT01742455|Peripheral artery disease|peripheral artery disease
427949|NCT01742455|Arterial Occlusive Diseases|arterial occlusive diseases
427950|NCT01742455|Vascular Diseases|vascular diseases
427951|NCT01742455|Cardiovascular Diseases|cardiovascular diseases
427952|NCT01742455|Coronary Artery Disease|coronary artery disease
427953|NCT01742455|Myocardial Ischemia|myocardial ischemia
427954|NCT01742455|Arteriosclerosis|arteriosclerosis
427955|NCT01742455|Pathologic Processes|pathologic processes
427956|NCT01742442|Cancer|cancer
427957|NCT01742442|elderly OR older|elderly or older
427958|NCT01742442|chemotherapy|chemotherapy
427959|NCT01742442|geriatric assessment|geriatric assessment
427960|NCT01742429|Helicobacter pylori|helicobacter pylori
427961|NCT01742429|second line treatment|second line treatment
427962|NCT01742416|Arterial Cannulation|arterial cannulation
427963|NCT01742416|Ultrasound|ultrasound
427964|NCT01742416|Palpation Method|palpation method
427965|NCT01742416|Pediatrics|pediatrics
427966|NCT01742416|Cardiac Surgery|cardiac surgery
427967|NCT01742416|Craniotomies|craniotomies
427968|NCT01742416|Cranial Vault Surgery|cranial vault surgery
427969|NCT01742416|Abdominal Procedures|abdominal procedures
427970|NCT01742403|Prostate|prostate
427971|NCT01742403|IGRT|igrt
427972|NCT01742403|VMAT|vmat
427973|NCT01742390|schizophrenia|schizophrenia
427974|NCT01742390|risperidone|risperidone
427975|NCT01742390|paliperidone|paliperidone
427976|NCT01742390|aripiprazole|aripiprazole
427977|NCT01742377|GERD|gerd
427978|NCT01742377|Dyspepsia|dyspepsia
427979|NCT01742377|Ambulatory 24-hour Esophageal pH Monitoring|ambulatory 24-hour esophageal ph monitoring
427980|NCT01742377|Minimal change erosions|minimal change erosions
427981|NCT01742364|disposable syringe jet injector (DSJI)|disposable syringe jet injector (dsji)
427982|NCT01742364|DSJI|dsji
427983|NCT01742364|BCG|bcg
427984|NCT01742364|tuberculosis|tuberculosis
427985|NCT01742364|intradermal delivery|intradermal delivery
427986|NCT01742364|South Africa|south africa
427987|NCT01742338|Chronic Obstructive Pulmonary Disease|chronic obstructive pulmonary disease
427988|NCT01742338|COPD|copd
427989|NCT01742338|Chronic bronchitis|chronic bronchitis
427990|NCT01742338|emphysema|emphysema
427991|NCT01742338|Corticosteroids|corticosteroids
427992|NCT01742325|fatigue|fatigue
427993|NCT01742325|walking|walking
427994|NCT01742325|childhood cancer|childhood cancer
427995|NCT01742325|sleep disturbance|sleep disturbance
427996|NCT01742312|neoadjuvant chemotherapy|neoadjuvant chemotherapy
427997|NCT01742312|oesophageal cancer|oesophageal cancer
427998|NCT01742312|cardiorespiratory performance|cardiorespiratory performance
427999|NCT01742299|Glivec/Gleevec|glivec/gleevec
428000|NCT01742299|CML|cml
428001|NCT01742299|GIST|gist
428002|NCT01742299|Imatinib mesylate|imatinib mesylate
428003|NCT01742286|pediatric|pediatric
428004|NCT01742286|anaplastic lymphoma kinase|anaplastic lymphoma kinase
428005|NCT01742286|ALK|alk
428006|NCT01742286|ALK-activated tumors|alk-activated tumors
428007|NCT01742286|neuroblastoma|neuroblastoma
428008|NCT01742286|rhabdomyosarcoma|rhabdomyosarcoma
428009|NCT01742286|anaplastic large-cell lymphoma|anaplastic large-cell lymphoma
428010|NCT01742286|inflammatory myofibroblastic tumor|inflammatory myofibroblastic tumor
428011|NCT01742260|Cranioplasty|cranioplasty
428012|NCT01742260|Mesenchymal stromal cells|mesenchymal stromal cells
428013|NCT01742260|Bioceramic polymer|bioceramic polymer
428014|NCT01742247|Moisturizer, laser|moisturizer, laser
428015|NCT01742221|HemaMax, NM-IL-12, HSARS, Safety|hemamax, nm-il-12, hsars, safety
428016|NCT01742195|Endobronchial ultrasound|endobronchial ultrasound
428017|NCT01742195|Bronchoscopy|bronchoscopy
428018|NCT01742195|Patient satisfaction|patient satisfaction
428019|NCT01742182|Parkinson's Disease|parkinson's disease
428020|NCT01742182|Excessive Daytime Sleepiness|excessive daytime sleepiness
428021|NCT01742182|Circadian Rhythms|circadian rhythms
428022|NCT01742182|Light Therapy|light therapy
428023|NCT01742169|Colorectal Cancer Screening|colorectal cancer screening
428024|NCT01742169|Fecal Occult Blood Testing|fecal occult blood testing
428025|NCT01742156|CAD|cad
428026|NCT01742156|microangiopathy|microangiopathy
428027|NCT01742156|patients|patients
428028|NCT01742156|more likely|more likely
428029|NCT01742156|to have tortuosity|to have tortuosity
428030|NCT01742156|of conjunctival vessels|of conjunctival vessels
428031|NCT01742143|Quality of life|quality of life
428032|NCT01742143|cancer|cancer
428034|NCT01742130|Contrast-induced nephropathy|contrast-induced nephropathy
428035|NCT01742130|Contrast media|contrast media
428036|NCT01742130|Angiography|angiography
428037|NCT01742130|Coronary percutaneous intervention|coronary percutaneous intervention
428038|NCT01742117|percutaneous coronary intervention|percutaneous coronary intervention
428039|NCT01742117|angioplasty|angioplasty
428040|NCT01742104|glaucoma|glaucoma
428041|NCT01742104|primary open-angle glaucoma|primary open-angle glaucoma
428042|NCT01742104|observational study|observational study
428043|NCT01742104|quality of life|quality of life
428044|NCT01742091|Postmenopausal females|postmenopausal females
428045|NCT01742091|Volunteers|volunteers
428046|NCT01742078|Postmenopausal females|postmenopausal females
428047|NCT01742078|Volunteers|volunteers
428048|NCT01742065|Colorectal Cancer Screening|colorectal cancer screening
428049|NCT01742065|Cancer Screening|cancer screening
428050|NCT01742065|Pragmatic Trial|pragmatic trial
428051|NCT01742052|relapsing-remitting multiple sclerosis|relapsing-remitting multiple sclerosis
428052|NCT01742052|RRMS|rrms
428053|NCT01742026|High risk aspergillosis infection patients|high risk aspergillosis infection patients
428054|NCT01742013|Chronic Fatigue|chronic fatigue
428055|NCT01742013|CFS|cfs
428056|NCT01742013|ICF|icf
428057|NCT01742013|human placenta|human placenta
428058|NCT01742000|postmenopause|postmenopause
428059|NCT01742000|phytoestrogen|phytoestrogen
428060|NCT01742000|atherosclerosis|atherosclerosis
428061|NCT01742000|intima-media thickness|intima-media thickness
428062|NCT01741974|perimenopause|perimenopause
428063|NCT01741974|phytoestrogen|phytoestrogen
428064|NCT01741974|atherosclerosis|atherosclerosis
428065|NCT01741974|intima-media thickness|intima-media thickness
428066|NCT01741961|uncontrolled glaucoma|uncontrolled glaucoma
428067|NCT01741961|glaucoma drainage device|glaucoma drainage device
428068|NCT01741948|Provoked vestibulodynia|provoked vestibulodynia
428069|NCT01741948|Hormonal contraceptives|hormonal contraceptives
428070|NCT01741922|Low dose|low dose
428071|NCT01741922|aspirin|aspirin
428073|NCT01741922|Hypertension|hypertension
428074|NCT01741922|blood pressure|blood pressure
428075|NCT01741909|azythromycin|azythromycin
428076|NCT01741909|community acquired pneumonia|community acquired pneumonia
428077|NCT01741909|intravenous|intravenous
428078|NCT01741909|oral|oral
428079|NCT01741883|Randomized Controlled Trial|randomized controlled trial
428080|NCT01741883|Patients´ Expectations|patients´ expectations
428081|NCT01741883|Breast Cancer|breast cancer
428082|NCT01741883|Adjuvant Endocrine Treatment|adjuvant endocrine treatment
428083|NCT01741883|Nocebo|nocebo
428084|NCT01741870|Nutritional supplement|nutritional supplement
428085|NCT01741870|Nutritional status|nutritional status
428086|NCT01741870|Physical functional activity|physical functional activity
428087|NCT01741870|Nursing home elderly|nursing home elderly
428088|NCT01741844|Acquired Immune Deficiency Syndrome|acquired immune deficiency syndrome
428089|NCT01741844|TMC125|tmc125
428090|NCT01741844|Etravirine|etravirine
428091|NCT01741844|Intelence|intelence
428092|NCT01741844|AIDS|aids
428093|NCT01741831|Acquired Immune Deficiency Syndrome|acquired immune deficiency syndrome
428094|NCT01741831|AIDS|aids
428095|NCT01741831|TMC114|tmc114
428096|NCT01741831|Darunavir|darunavir
428097|NCT01741831|Prezista|prezista
428098|NCT01741818|IVC|ivc
428099|NCT01741818|ultrasonography|ultrasonography
428100|NCT01741818|IVC collapsibility index|ivc collapsibility index
428101|NCT01741818|IVC diameter|ivc diameter
428102|NCT01741792|Relapsed DLBCL|relapsed dlbcl
428103|NCT01741792|Refractory DLBCL|refractory dlbcl
428104|NCT01741792|adult DLBCL|adult dlbcl
428105|NCT01741792|Lymphoma|lymphoma
428106|NCT01741792|Non-Hodgkin Lymphoma|non-hodgkin lymphoma
428107|NCT01741792|Lymphatic diseases|lymphatic diseases
428108|NCT01741792|Lymphoproliferative disorders|lymphoproliferative disorders
428109|NCT01741792|bispecific antibody|bispecific antibody
428110|NCT01741792|anti-CD19|anti-cd19
428111|NCT01741792|Immunotherapeutic treatment|immunotherapeutic treatment
428112|NCT01741792|Immunoproliferative disorders|immunoproliferative disorders
428113|NCT01741779|whole body vibration training|whole body vibration training
428114|NCT01741779|hypocaloric diet|hypocaloric diet
428115|NCT01741779|prehypertension|prehypertension
428116|NCT01741779|hypertension|hypertension
428117|NCT01741779|obesity|obesity
428118|NCT01741779|arterial function|arterial function
428119|NCT01741779|arterial stiffness|arterial stiffness
428120|NCT01741779|pulse wave velocity|pulse wave velocity
428121|NCT01741779|autonomic function|autonomic function
428122|NCT01741779|endothelial function|endothelial function
428123|NCT01741779|adipocytokines|adipocytokines
428124|NCT01741766|prehypertension|prehypertension
428125|NCT01741766|hypertension|hypertension
428126|NCT01741766|obesity|obesity
428127|NCT01741766|stretching|stretching
428128|NCT01741766|arterial function|arterial function
428129|NCT01741766|arterial stiffness|arterial stiffness
428130|NCT01741766|pulse wave velocity|pulse wave velocity
428131|NCT01741766|autonomic function|autonomic function
428132|NCT01741766|endothelial function|endothelial function
428133|NCT01741753|Docetaxel Pretreated|docetaxel pretreated
428134|NCT01741753|Castrate Resistant|castrate resistant
428135|NCT01741753|Metastatic|metastatic
428136|NCT01741740|pain, hernia, chronic, discomfort, retrospective|pain, hernia, chronic, discomfort, retrospective
428137|NCT01741675|Questionnaires|questionnaires
428138|NCT01741675|Quality of Life|quality of life
428139|NCT01741675|Response rate|response rate
428140|NCT01741649|Surgical wound infection|surgical wound infection
428141|NCT01741649|Clorhexidine|clorhexidine
428142|NCT01741649|Povidone|povidone
428143|NCT01741610|Anaesthesia Spinal|anaesthesia spinal
428144|NCT01741610|Ephedrine|ephedrine
428145|NCT01741610|Fluid Therapy|fluid therapy
428146|NCT01741610|Hypotension|hypotension
428147|NCT01741558|Myocardial Ischemia|myocardial ischemia
428148|NCT01741558|Myocardial Infarction|myocardial infarction
428149|NCT01741558|Methotrexate|methotrexate
428150|NCT01741558|Inflammation|inflammation
428151|NCT01741558|Anti-Inflammatory Agents|anti-inflammatory agents
428152|NCT01741558|Inflammation Mediators|inflammation mediators
428153|NCT01741532|Pantothenate Kinase-associated Neurodegeneration|pantothenate kinase-associated neurodegeneration
428154|NCT01741532|PKAN|pkan
428155|NCT01741532|NBIA|nbia
428156|NCT01741532|Deferiprone|deferiprone
428157|NCT01741532|Ferriprox|ferriprox
428158|NCT01741532|Neurodegeneration with brain iron accumulation|neurodegeneration with brain iron accumulation
428160|NCT01741519|PD|pd
428161|NCT01741519|landiolol|landiolol
428162|NCT01741519|esmolol|esmolol
428163|NCT01741519|healthy volunteers phase I study|healthy volunteers phase i study
428164|NCT01741506|Lung cancer|lung cancer
428165|NCT01741506|Surgery|surgery
428166|NCT01741506|Thromboembolism|thromboembolism
428167|NCT01741506|Bleeding|bleeding
428168|NCT01741493|Rheumatoid Arthritis|rheumatoid arthritis
428169|NCT01741493|Methotrexate|methotrexate
428170|NCT01741493|Tolerability|tolerability
428171|NCT01741493|Pharmacokinetics|pharmacokinetics
428172|NCT01741493|Safety|safety
428173|NCT01741493|Tofacitinib|tofacitinib
428174|NCT01741480|Outcomes|outcomes
428175|NCT01741480|Early warning systems|early warning systems
428176|NCT01741480|ICU transfer|icu transfer
428177|NCT01741454|Tolterodine|tolterodine
428178|NCT01741454|Tamsulosin|tamsulosin
428179|NCT01741454|Ureteral Obstruction|ureteral obstruction
428180|NCT01741441|Duodenogastroesophageal reflux|duodenogastroesophageal reflux
428181|NCT01741441|Weakly acidic reflux|weakly acidic reflux
428182|NCT01741441|Gastric emptying|gastric emptying
428183|NCT01741441|Laparoscopic fundoplication|laparoscopic fundoplication
428184|NCT01741428|CVD Risk score|cvd risk score
428185|NCT01741428|Physical activity|physical activity
428186|NCT01741428|Overweight|overweight
428187|NCT01741428|Cholesterol|cholesterol
428188|NCT01741428|LDL-Cholesterol|ldl-cholesterol
428189|NCT01741428|HDL-Cholesterol|hdl-cholesterol
428190|NCT01741428|Triglycerides|triglycerides
428191|NCT01741428|HbA1C|hba1c
428192|NCT01741428|Quality of life|quality of life
428193|NCT01741402|Control posture|control posture
428194|NCT01741402|Gait|gait
428195|NCT01741402|Virtual Reality|virtual reality
428196|NCT01741402|Elderly|elderly
428197|NCT01741389|Circadian variation, hemostasis, melatonin, tetraplegia|circadian variation, hemostasis, melatonin, tetraplegia
428198|NCT01741363|iFOBT|ifobt
428199|NCT01741363|one-day sample|one-day sample
428200|NCT01741363|two-day sample|two-day sample
428201|NCT01741363|Helicobacter pylori stool antigen|helicobacter pylori stool antigen
428202|NCT01741350|Methadone-maintenance|methadone-maintenance
428203|NCT01741350|HIV|hiv
428204|NCT01741350|Risk behavior|risk behavior
428205|NCT01741350|Injection drug use|injection drug use
428206|NCT01741350|Condom use|condom use
428207|NCT01741350|Health care participation|health care participation
428208|NCT01741350|Opioid replacement therapy|opioid replacement therapy
428209|NCT01741337|central sleep apneas syndrome|central sleep apneas syndrome
428210|NCT01741337|heart failure|heart failure
428211|NCT01741337|all coronary reperfusions|all coronary reperfusions
428212|NCT01741337|adaptive servo-ventilation treatment|adaptive servo-ventilation treatment
428213|NCT01741311|viral load|viral load
428214|NCT01741311|HIV|hiv
428215|NCT01741311|CD4|cd4
428216|NCT01741311|methadone maintenance|methadone maintenance
428217|NCT01741311|substance use|substance use
428218|NCT01741311|Antiretroviral therapy (ART)|antiretroviral therapy (art)
428219|NCT01741298|Metabolic syndrome|metabolic syndrome
428220|NCT01741285|Asthma|asthma
428221|NCT01741285|Adenosine|adenosine
428222|NCT01741285|Small airways|small airways
428223|NCT01741285|Smokers|smokers
428224|NCT01741285|Ex-smokers|ex-smokers
428225|NCT01741272|rotator cuff tear|rotator cuff tear
428226|NCT01741272|arthroscopically assisted|arthroscopically assisted
428227|NCT01741272|health related quality of life(HRQL)|health related quality of life(hrql)
428228|NCT01741272|functional outcome|functional outcome
428229|NCT01741259|analgesia|analgesia
428230|NCT01741259|meperidine|meperidine
428231|NCT01741259|epidural|epidural
428232|NCT01741246|Episodic migraine|episodic migraine
428233|NCT01741246|Chronic migraine|chronic migraine
428234|NCT01741246|Magnetic resonance imaging|magnetic resonance imaging
428235|NCT01741246|Positron emission tomography|positron emission tomography
428236|NCT01741233|SNPs|snps
428237|NCT01741233|vitamin D|vitamin d
428238|NCT01741233|Vitamin D status|vitamin d status
428239|NCT01741233|UVB irradiation|uvb irradiation
428240|NCT01741233|genetics|genetics
428241|NCT01741181|25(OH)Vitamin D|25(oh)vitamin d
428242|NCT01741181|Diabetes mellitus|diabetes mellitus
428243|NCT01741181|Endothelial Function|endothelial function
428244|NCT01741142|Major Depressive Disorder|major depressive disorder
428245|NCT01741129|Nasal CPAP|nasal cpap
428246|NCT01741129|Nasal IMV|nasal imv
428247|NCT01741129|Surfactant|surfactant
428248|NCT01741129|Preterm infants|preterm infants
428249|NCT01741116|castration-resistant prostate cancer|castration-resistant prostate cancer
428250|NCT01741116|TKI258|tki258
428251|NCT01741116|FGF23|fgf23
428252|NCT01741090|Autologous Mesenchymal stem cell|autologous mesenchymal stem cell
428253|NCT01741090|alcoholic liver cirrhosis|alcoholic liver cirrhosis
428254|NCT01741077|pregnancy|pregnancy
428255|NCT01741077|folic acid supplementation|folic acid supplementation
428256|NCT01741077|reproduction|reproduction
428257|NCT01741077|folate|folate
428258|NCT01741064|Secondary Hyperparathyroidism|secondary hyperparathyroidism
428259|NCT01741064|Renal Transplantation|renal transplantation
428260|NCT01741064|Myocardial Infarction|myocardial infarction
428261|NCT01741064|Fracture|fracture
428262|NCT01741064|Graft Failure|graft failure
428263|NCT01741051|Air pollution|air pollution
428264|NCT01741051|Particulate matter|particulate matter
428265|NCT01741051|Mongolia|mongolia
428266|NCT01741051|Pregnancy|pregnancy
428267|NCT01741051|Intrauterine growth restriction (IUGR)|intrauterine growth restriction (iugr)
428268|NCT01741051|Fetal growth|fetal growth
428269|NCT01741051|Birth weight|birth weight
428270|NCT01741051|Gestational age|gestational age
428271|NCT01741038|Cancer Vaccine|cancer vaccine
428272|NCT01741038|AlloStim®|allostim®
428273|NCT01741038|Immunovative|immunovative
428274|NCT01741038|Immunotherapy|immunotherapy
428275|NCT01741038|Allogeneic Cell Therapy|allogeneic cell therapy
428276|NCT01741038|Cryoablation|cryoablation
428277|NCT01741012|Lupus|lupus
428278|NCT01740986|Asthma|asthma
428279|NCT01740973|SILC|silc
428280|NCT01740973|lap. cholecystectomy|lap. cholecystectomy
428281|NCT01740973|trocar-site hernia|trocar-site hernia
428282|NCT01740960|delta-9-tetrahydrocannabinol|delta-9-tetrahydrocannabinol
428283|NCT01740960|THC|thc
428284|NCT01740960|Cannabis|cannabis
428285|NCT01740947|Selective decontamination of the digestive tract|selective decontamination of the digestive tract
428286|NCT01740947|anastomotic leakage|anastomotic leakage
428287|NCT01740947|colorectal cancer|colorectal cancer
428288|NCT01740934|rosacea|rosacea
428289|NCT01740934|anatabine|anatabine
428290|NCT01740934|Anatabloc|anatabloc
428291|NCT01740934|dermatology|dermatology
428292|NCT01740921|GLP-1 analogues|glp-1 analogues
428293|NCT01740921|microvascular|microvascular
428294|NCT01740921|inflammation|inflammation
428295|NCT01740921|fat tissue|fat tissue
428296|NCT01740921|clot structure|clot structure
428297|NCT01740908|hyperbaric oxygen|hyperbaric oxygen
428298|NCT01740908|stem cell|stem cell
428299|NCT01740882|incisional hernia|incisional hernia
428300|NCT01740882|mesh fixation|mesh fixation
428301|NCT01740882|absorbable tacks|absorbable tacks
428302|NCT01740869|autism|autism
428303|NCT01740869|autism spectrum|autism spectrum
428304|NCT01740869|stem cells|stem cells
428305|NCT01740869|children|children
428306|NCT01740856|cardiac catheterization|cardiac catheterization
428307|NCT01740856|safety|safety
428308|NCT01740856|nursing care|nursing care
428309|NCT01740856|rest|rest
428310|NCT01740856|Patients|patients
428311|NCT01740817|diabetes|diabetes
428312|NCT01740817|obesity|obesity
428313|NCT01740817|inflammation|inflammation
428314|NCT01740804|Circulating tumor cell|circulating tumor cell
428315|NCT01740804|Non-small cell lung cancer|non-small cell lung cancer
428316|NCT01740804|chemotherapy|chemotherapy
428317|NCT01740791|Hepatitis C|hepatitis c
428319|NCT01740791|Genotype 1|genotype 1
428320|NCT01740791|Genotype 2|genotype 2
428321|NCT01740791|Genotype 3|genotype 3
428322|NCT01740791|Genotype 4|genotype 4
428323|NCT01740791|Genotype 5|genotype 5
428324|NCT01740791|Genotype 6|genotype 6
428325|NCT01740791|Liver Disease|liver disease
428326|NCT01740778|Diabetes|diabetes
428327|NCT01740778|Medical Device|medical device
428328|NCT01740778|Lancing|lancing
428329|NCT01740752|anorexia nervosa|anorexia nervosa
428330|NCT01740752|eating disorder|eating disorder
428331|NCT01740752|couples|couples
428332|NCT01740752|relationships|relationships
428333|NCT01740752|couple therapy|couple therapy
428334|NCT01740739|Health Risk Appraisal|health risk appraisal
428335|NCT01740739|HCardiac Risk Factors|hcardiac risk factors
428336|NCT01740726|Depression|depression
428337|NCT01740726|Behavioral Activation|behavioral activation
428338|NCT01740726|Fluoxetine|fluoxetine
428339|NCT01740726|Prozac|prozac
428340|NCT01740726|Treatment|treatment
428341|NCT01740726|Therapy|therapy
428342|NCT01740726|Psychotherapy|psychotherapy
428343|NCT01740726|Antidepressant|antidepressant
428344|NCT01740726|Intervention|intervention
428345|NCT01740713|chronic iron overload|chronic iron overload
428346|NCT01740713|hereditary haemoglobinopathy|hereditary haemoglobinopathy
428347|NCT01740713|beta thalassaemia major|beta thalassaemia major
428348|NCT01740700|Abdominal aortic aneurysm|abdominal aortic aneurysm
428349|NCT01740700|Endovascular|endovascular
428350|NCT01740700|Fenestration|fenestration
428351|NCT01740700|Juxtarenal|juxtarenal
428352|NCT01740700|Off-the-shelf|off-the-shelf
428353|NCT01740700|Pararenal|pararenal
428354|NCT01740687|Endometrial Ablation|endometrial ablation
428355|NCT01740687|Permanent Sterilization|permanent sterilization
428356|NCT01740687|Essure|essure
428357|NCT01740687|NovaSure|novasure
428358|NCT01740687|Prevention of Pregnancy|prevention of pregnancy
428359|NCT01740674|internet data collection|internet data collection
428360|NCT01740674|longitudinal research|longitudinal research
428361|NCT01740674|cohort retention|cohort retention
428362|NCT01740648|MEK Inhibitor|mek inhibitor
428363|NCT01740648|Trametinib|trametinib
428364|NCT01740648|Rectal Cancers|rectal cancers
428365|NCT01740648|KRAS|kras
428366|NCT01740648|BRAF|braf
428367|NCT01740648|NRAS Mutant|nras mutant
428368|NCT01740648|Fluorouracil|fluorouracil
428369|NCT01740635|rehabilitation|rehabilitation
428370|NCT01740635|wheelchair|wheelchair
428371|NCT01740635|manual wheelchair|manual wheelchair
428372|NCT01740635|wheelchair users|wheelchair users
428373|NCT01740635|older adults|older adults
428374|NCT01740635|cognitive computer games|cognitive computer games
428375|NCT01740635|home-based training|home-based training
428376|NCT01740635|community mobility|community mobility
428377|NCT01740622|Injury|injury
428378|NCT01740622|Injury Prevention|injury prevention
428379|NCT01740622|Cincinnati Home Injury Prevention|cincinnati home injury prevention
428380|NCT01740622|Injury Hazards|injury hazards
428381|NCT01740622|Modifiable Injury Hazards|modifiable injury hazards
428382|NCT01740609|Phase 1|phase 1
428383|NCT01740609|RN168|rn168
428384|NCT01740609|Healthy Volunteers|healthy volunteers
428385|NCT01740596|NYHA III|nyha iii
428386|NCT01740596|NYHA IV|nyha iv
428387|NCT01740596|ACC Stage C|acc stage c
428388|NCT01740596|Heart Failure|heart failure
428389|NCT01740596|Congestive Heart Failure|congestive heart failure
428390|NCT01740596|C-Pulse|c-pulse
428391|NCT01740596|Counterpulsation|counterpulsation
428392|NCT01740596|Heart Assist|heart assist
428393|NCT01740596|Sunshine Heart|sunshine heart
428394|NCT01740596|Left Heart Failure|left heart failure
428395|NCT01740583|mitral valve, regurgitation, annuloplasty|mitral valve, regurgitation, annuloplasty
428396|NCT01740570|Brain cancer|brain cancer
428397|NCT01740570|Malignant glioma|malignant glioma
428398|NCT01740570|Glioblastoma multiforme|glioblastoma multiforme
428399|NCT01740570|Gliosarcoma|gliosarcoma
428400|NCT01740570|Anaplastic astrocytoma|anaplastic astrocytoma
428401|NCT01740570|Anaplastic oligodendroglioma|anaplastic oligodendroglioma
428402|NCT01740570|Anaplastic oligoastrocytoma|anaplastic oligoastrocytoma
428403|NCT01740570|Cabazitaxel|cabazitaxel
428404|NCT01740570|Jevtana|jevtana
428405|NCT01740531|S303 treated RBCs|s303 treated rbcs
428406|NCT01740505|energy cost of walking|energy cost of walking
428407|NCT01740505|energy metabolism|energy metabolism
428408|NCT01740505|aged|aged
428409|NCT01740505|older adult|older adult
428410|NCT01740505|exercise|exercise
428411|NCT01740505|gait|gait
428412|NCT01740505|walking|walking
428413|NCT01740505|aerobic|aerobic
428414|NCT01740505|motor skill|motor skill
428415|NCT01740492|Ketamine|ketamine
428416|NCT01740492|Acute pain|acute pain
428417|NCT01740492|Pain control|pain control
428418|NCT01740492|Pain|pain
428419|NCT01740479|STEMI|stemi
428420|NCT01740479|ticagrelor|ticagrelor
428421|NCT01740479|multi-vessel disease|multi-vessel disease
428422|NCT01740479|culprit lesion|culprit lesion
428423|NCT01740466|Prevalence|prevalence
428424|NCT01740466|Vision disorders|vision disorders
428425|NCT01740466|Eye diseases|eye diseases
428426|NCT01740466|Visual acuity|visual acuity
428427|NCT01740466|Primary health care|primary health care
428428|NCT01740440|Healthy females|healthy females
428429|NCT01740427|breast cancer|breast cancer
428430|NCT01740427|postmenopausal women|postmenopausal women
428431|NCT01740427|estrogen-receptor positive|estrogen-receptor positive
428432|NCT01740427|HER2 negative|her2 negative
428433|NCT01740427|locoregionally recurrent|locoregionally recurrent
428434|NCT01740427|metastatic|metastatic
428435|NCT01740427|Palbociclib (PD-0332991)|palbociclib (pd-0332991)
428436|NCT01740427|PALOMA-2|paloma-2
428437|NCT01740414|prescription opioid abuse|prescription opioid abuse
428438|NCT01740414|pain|pain
428439|NCT01740414|opioid withdrawal|opioid withdrawal
428440|NCT01740414|oxycodone|oxycodone
428441|NCT01740414|ibudilast|ibudilast
428442|NCT01740401|Melanoma|melanoma
428443|NCT01740401|Advanced Malignant Melanoma|advanced malignant melanoma
428444|NCT01740401|Anti CTLA4 Blockade|anti ctla4 blockade
428445|NCT01740401|Progression Free Survival|progression free survival
428446|NCT01740401|Interventional Therapy|interventional therapy
428447|NCT01740401|Phase II Clinical Trial|phase ii clinical trial
428448|NCT01740401|Immunotherapy|immunotherapy
428449|NCT01740401|T Cell Activation|t cell activation
428450|NCT01740362|CP-690|cp-690
428451|NCT01740362|550|550
428452|NCT01740362|pharmacokinetics|pharmacokinetics
428453|NCT01740362|renal impairment|renal impairment
428454|NCT01740323|Breast Cancer|breast cancer
428455|NCT01740323|Chemotherapy|chemotherapy
428456|NCT01740323|Radiotherapy|radiotherapy
428457|NCT01740323|NF-kB|nf-kb
428458|NCT01740323|DNA Binding|dna binding
428459|NCT01740323|Curcumin|curcumin
428460|NCT01740323|IL-6|il-6
428461|NCT01740323|TNF|tnf
428462|NCT01740323|sTNFR2|stnfr2
428463|NCT01740323|IL-1-ra|il-1-ra
428464|NCT01740323|Fatigue|fatigue
428465|NCT01740323|Cytokine|cytokine
428466|NCT01740310|pregnancy,|pregnancy,
428467|NCT01740310|vaccine acceptance,|vaccine acceptance,
428468|NCT01740310|vaccination,|vaccination,
428469|NCT01740310|influenza,|influenza,
428470|NCT01740310|pertussis,|pertussis,
428471|NCT01740310|Tdap,|tdap,
428472|NCT01740310|minority,|minority,
428473|NCT01740310|African-American|african-american
428474|NCT01740297|melanoma|melanoma
428475|NCT01740297|talimogene laherparepvec|talimogene laherparepvec
428476|NCT01740297|ipilimumab|ipilimumab
428477|NCT01740297|immunotherapy|immunotherapy
428478|NCT01740271|breast cancer|breast cancer
428479|NCT01740271|non-metastatic carcinoma of the breast chemotherapy|non-metastatic carcinoma of the breast chemotherapy
428480|NCT01740271|adjuvant therapy|adjuvant therapy
428481|NCT01740271|neoadjuvant|neoadjuvant
428482|NCT01740258|malignant glioma|malignant glioma
428483|NCT01740258|Grade 4 malignant glioma|grade 4 malignant glioma
428484|NCT01740258|glioblastoma|glioblastoma
428485|NCT01740258|gliosarcoma|gliosarcoma
428486|NCT01740258|adult brain tumor|adult brain tumor
428487|NCT01740245|Laser therapy|laser therapy
428488|NCT01740245|Cervical lesions|cervical lesions
428489|NCT01740245|Polyhexamethylene biguanide|polyhexamethylene biguanide
428490|NCT01740245|Chlorhexidine|chlorhexidine
428491|NCT01740219|Health promotion|health promotion
428492|NCT01740219|Religion and medicine|religion and medicine
428493|NCT01740219|Hispanic Americans|hispanic americans
428494|NCT01740219|Randomized controlled trial|randomized controlled trial
428495|NCT01740219|Program evaluation|program evaluation
428496|NCT01740219|Neoplasms/prevention & control|neoplasms/prevention & control
428497|NCT01740219|Mass screening|mass screening
428498|NCT01740219|Female|female
428499|NCT01740219|Male|male
428500|NCT01740219|Preventive Health Services/methods|preventive health services/methods
428501|NCT01740219|Adult|adult
428502|NCT01740219|Organizations|organizations
428503|NCT01740193|Pain|pain
428504|NCT01740193|Regional Anesthesia|regional anesthesia
428505|NCT01740193|ultrasound|ultrasound
428506|NCT01740193|transversus abdominis plane|transversus abdominis plane
428507|NCT01740193|herniorrhaphy|herniorrhaphy
428508|NCT01740193|pediatrics|pediatrics
428509|NCT01740167|prodrome|prodrome
428510|NCT01740167|mental illness|mental illness
428511|NCT01740167|health promotion|health promotion
428512|NCT01740167|lifestyle behavior|lifestyle behavior
428513|NCT01740141|Pain|pain
428514|NCT01740128|spinal cord injuries|spinal cord injuries
428515|NCT01740128|paraplegia|paraplegia
428516|NCT01740128|postural balance|postural balance
428517|NCT01740128|locomotor activity|locomotor activity
428518|NCT01740128|exercise therapy|exercise therapy
428519|NCT01740128|electromyography|electromyography
428520|NCT01740128|transcranial magnetic stimulation, single pulse|transcranial magnetic stimulation, single pulse
428521|NCT01740115|HIV|hiv
428522|NCT01740115|Alcohol Use|alcohol use
428523|NCT01740115|Bone Disease|bone disease
428524|NCT01740115|Bone Mineral Density|bone mineral density
428525|NCT01740115|Bone Microarchitecture|bone microarchitecture
428526|NCT01740115|Substance Dependence|substance dependence
428527|NCT01740102|Ischemic preconditioning|ischemic preconditioning
428528|NCT01740102|Coronary artery bypass|coronary artery bypass
428529|NCT01740102|Preoperative care|preoperative care
428530|NCT01740102|Postoperative period|postoperative period
428531|NCT01740089|Hepatitis C|hepatitis c
428532|NCT01740089|Cepeginterferon alfa|cepeginterferon alfa
428533|NCT01740089|Peginterferon|peginterferon
428534|NCT01740089|Treatment|treatment
428535|NCT01740076|isoflavones, hypertension, soy, diet, nutrition, women, inflammation, hot flashes|isoflavones, hypertension, soy, diet, nutrition, women, inflammation, hot flashes
428536|NCT01740037|Integrated chronic care program|integrated chronic care program
428537|NCT01740037|specialized outpatient AF clinic|specialized outpatient af clinic
547696|NCT01230567|BCC|bcc
428538|NCT01740037|Atrial Fibrillation guideline|atrial fibrillation guideline
428539|NCT01740024|Immunotherapy|immunotherapy
428540|NCT01740024|Subcutaneous immunotherapy|subcutaneous immunotherapy
428541|NCT01740024|Skin Prick Test|skin prick test
428542|NCT01740024|Dose Response Prick Test|dose response prick test
428543|NCT01739985|Postoperative|postoperative
428544|NCT01739985|Vomiting|vomiting
428545|NCT01739985|Children|children
428546|NCT01739985|Prophylaxis|prophylaxis
428547|NCT01739985|Droperidol|droperidol
428548|NCT01739985|Ondansetron|ondansetron
428549|NCT01739985|Dexamethasone|dexamethasone
428550|NCT01739972|Desiccated thyroid extract and levothyroxine|desiccated thyroid extract and levothyroxine
428551|NCT01739959|Necrotizing fasciitis|necrotizing fasciitis
428552|NCT01739959|Fournier's gangrene|fournier's gangrene
428553|NCT01739959|Cellulitis|cellulitis
428554|NCT01739959|Serum Lactate|serum lactate
428555|NCT01739933|Delirium|delirium
428556|NCT01739933|Delirium/coma-free days|delirium/coma-free days
428557|NCT01739933|Long term cognitive impairment|long term cognitive impairment
428558|NCT01739933|Sedation|sedation
428559|NCT01739933|Intensive care|intensive care
428560|NCT01739933|Mechanical Ventilation|mechanical ventilation
428561|NCT01739933|Dexmedetomidine|dexmedetomidine
428562|NCT01739933|Propofol|propofol
428563|NCT01739933|Coma-free days|coma-free days
428564|NCT01739933|Sepsis|sepsis
428565|NCT01739933|Organ dysfunction|organ dysfunction
428566|NCT01739933|Acute Respiratory Distress|acute respiratory distress
428567|NCT01739933|Markers of inflammation|markers of inflammation
428568|NCT01739920|Povidone-Iodine|povidone-iodine
428569|NCT01739920|Ophthalmic Solutions|ophthalmic solutions
428570|NCT01739920|Endophthalmitis|endophthalmitis
428571|NCT01739920|Preoperative procedures|preoperative procedures
428572|NCT01739907|Iron deficiency|iron deficiency
428573|NCT01739907|Menstruating women|menstruating women
428574|NCT01739907|Vitamin D|vitamin d
428575|NCT01739907|Functional food|functional food
428576|NCT01739894|Advanced gastric cancer|advanced gastric cancer
428577|NCT01739894|unresectable gastric cancer|unresectable gastric cancer
428578|NCT01739894|recurrent gastric cancer|recurrent gastric cancer
428579|NCT01739894|with peritoneal metastasis|with peritoneal metastasis
428580|NCT01739894|cancer cells on peritoneal cytology|cancer cells on peritoneal cytology
428782|NCT01738867|OPRM1|oprm1
428581|NCT01739881|Exhaled breath condensate (EBC) method|exhaled breath condensate (ebc) method
428582|NCT01739881|Volatile Organic Compounds (VOCs)|volatile organic compounds (vocs)
428583|NCT01739881|Endobronchial Ultrasound (EBUS)|endobronchial ultrasound (ebus)
428584|NCT01739881|Confocal Endoscopy|confocal endoscopy
428585|NCT01739881|Exhaled alveolar gas|exhaled alveolar gas
428586|NCT01739868|Pre-diabetes|pre-diabetes
428587|NCT01739868|Type 2 diabetes|type 2 diabetes
428588|NCT01739868|Biomarkers|biomarkers
428589|NCT01739868|Diabetes risk score|diabetes risk score
428590|NCT01739842|Alcohol consumption|alcohol consumption
428591|NCT01739842|Kudzu extract|kudzu extract
428592|NCT01739842|Cerebral blood flow|cerebral blood flow
428593|NCT01739829|xenotransplantation|xenotransplantation
428594|NCT01739829|type 1 diabetes|type 1 diabetes
428595|NCT01739829|porcine islets|porcine islets
428596|NCT01739816|Compliance|compliance
428597|NCT01739816|Adherence|adherence
428598|NCT01739816|Polypharmacy|polypharmacy
428599|NCT01739816|Medicines use|medicines use
428600|NCT01739816|Medication review|medication review
428601|NCT01739816|Pharmaceutical care|pharmaceutical care
428602|NCT01739816|Primary care|primary care
428603|NCT01739816|Drug related problem|drug related problem
428604|NCT01739816|Patient safety|patient safety
428605|NCT01739803|Immunosuppressant therapy adherence|immunosuppressant therapy adherence
428606|NCT01739803|Quality of life|quality of life
428607|NCT01739803|Economic outcomes|economic outcomes
428608|NCT01739790|COPD|copd
428609|NCT01739790|Chronic Bronchitis|chronic bronchitis
428610|NCT01739790|N-acetylcysteine|n-acetylcysteine
428611|NCT01739777|Heart Failure|heart failure
428612|NCT01739777|Coronary Heart Disease|coronary heart disease
428613|NCT01739777|Adult Stem Cells|adult stem cells
428614|NCT01739777|Umbilical Progenitor Cells|umbilical progenitor cells
428615|NCT01739777|Umbilical Cord Stem Cells Allogenic|umbilical cord stem cells allogenic
428616|NCT01739777|Left Ventricular Function|left ventricular function
428617|NCT01739777|Intravenous Injection|intravenous injection
428618|NCT01739751|COPD|copd
428619|NCT01739751|Physical activity|physical activity
428620|NCT01739751|Pedometers|pedometers
428621|NCT01739751|steps|steps
428622|NCT01739751|non pharmacological treatment|non pharmacological treatment
428623|NCT01739751|rehabilitation|rehabilitation
428624|NCT01739751|exercise|exercise
428625|NCT01739738|peristalsis, kidney stones, hydronephrosis, ureteral stent|peristalsis, kidney stones, hydronephrosis, ureteral stent
428626|NCT01739725|kidney stones, ureteral stent, pain,|kidney stones, ureteral stent, pain,
428627|NCT01739712|Diabetes|diabetes
428628|NCT01739712|Sleep problems|sleep problems
428629|NCT01739712|School|school
428630|NCT01739712|Neurobehavioral|neurobehavioral
428631|NCT01739699|craniotomy|craniotomy
428632|NCT01739699|brain surgery|brain surgery
428633|NCT01739699|acetaminophen|acetaminophen
428634|NCT01739699|Tylenol|tylenol
428635|NCT01739686|Quality of Life|quality of life
428636|NCT01739686|Symptoms|symptoms
428637|NCT01739686|Palliative care|palliative care
428638|NCT01739686|Symptom management|symptom management
428639|NCT01739686|Disease management|disease management
428640|NCT01739686|Health delivery|health delivery
428641|NCT01739673|Infectious Keratitis|infectious keratitis
428642|NCT01739660|Chronic Kidney Disease Stage 5|chronic kidney disease stage 5
428643|NCT01739660|Hemodialysis|hemodialysis
428644|NCT01739660|pegloticase|pegloticase
428645|NCT01739647|AZD3293|azd3293
428646|NCT01739647|Healthy volunteers|healthy volunteers
428647|NCT01739647|Elderly volunteers|elderly volunteers
428648|NCT01739647|Phase 1|phase 1
428649|NCT01739647|Single Ascending Dose Study|single ascending dose study
428650|NCT01739634|Diarrhea|diarrhea
428651|NCT01739634|Medullary thyroid cancer|medullary thyroid cancer
428652|NCT01739608|CRC|crc
428653|NCT01739569|Diet treatment|diet treatment
428654|NCT01739569|Mental Health|mental health
428655|NCT01739569|Reaction time|reaction time
428656|NCT01739569|State of moods|state of moods
428657|NCT01739569|Working hours|working hours
428658|NCT01739569|Medical Hospital Staff|medical hospital staff
428659|NCT01739556|antiplatelet therapy|antiplatelet therapy
428660|NCT01739556|primary PCI|primary pci
428661|NCT01739556|modification|modification
428662|NCT01739517|Short bowel syndrome|short bowel syndrome
428663|NCT01739517|Cholestasis|cholestasis
428664|NCT01739517|Omegaven|omegaven
428665|NCT01739517|Parenteral nutrition-associated Liver Disease|parenteral nutrition-associated liver disease
428666|NCT01739504|Arthritis|arthritis
428667|NCT01739504|Joint pain|joint pain
428668|NCT01739504|Articular cartilage|articular cartilage
428669|NCT01739504|Mesenchymal stem cells|mesenchymal stem cells
428670|NCT01739504|Autologous|autologous
428671|NCT01739504|Adipose tissue|adipose tissue
428672|NCT01739491|Chronic lymphocytic leukemia|chronic lymphocytic leukemia
428673|NCT01739491|Bendamustine hydrochloride|bendamustine hydrochloride
428674|NCT01739491|Leukemia|leukemia
428675|NCT01739491|Filipino|filipino
428676|NCT01739465|Cholangiocarcinoma|cholangiocarcinoma
428677|NCT01739465|Pathologic|pathologic
428678|NCT01739465|Digestive System|digestive system
428679|NCT01739465|Neoplasms|neoplasms
428680|NCT01739465|Neoplasms by Site|neoplasms by site
428681|NCT01739465|Digestive System Diseases|digestive system diseases
428682|NCT01739465|Bile Duct Diseases|bile duct diseases
428683|NCT01739465|Biliary Tract Diseases|biliary tract diseases
428684|NCT01739465|Pathological Conditions|pathological conditions
428685|NCT01739465|Constriction|constriction
428686|NCT01739465|Adenocarcinoma|adenocarcinoma
428687|NCT01739465|Carcinoma|carcinoma
428688|NCT01739452|Low-risk MDS|low-risk mds
428689|NCT01739452|myelodysplastic syndrome|myelodysplastic syndrome
428690|NCT01739452|retrospective|retrospective
428691|NCT01739426|LigaSure V (TM)|ligasure v (tm)
428692|NCT01739400|Eisenmenger Syndrome|eisenmenger syndrome
428693|NCT01739400|exercise capacity|exercise capacity
428694|NCT01739387|Flutiform®|flutiform®
428695|NCT01739387|Asthma|asthma
428696|NCT01739387|COPD|copd
428697|NCT01739374|pelvic floor reconstruction|pelvic floor reconstruction
428698|NCT01739374|mesh implants|mesh implants
428699|NCT01739335|Stress Disorders, Post-Traumatic|stress disorders, post-traumatic
428700|NCT01739335|Mifepristone|mifepristone
428701|NCT01739335|Veterans|veterans
428702|NCT01739335|Clinical Trial|clinical trial
428703|NCT01739322|skin prick test|skin prick test
428704|NCT01739322|inmunotherapy|inmunotherapy
428705|NCT01739322|standarization|standarization
428706|NCT01739309|Non- Hodgkins Lymphoma|non- hodgkins lymphoma
428707|NCT01739296|osteoarthritis|osteoarthritis
428708|NCT01739296|osteoarthritis, knee|osteoarthritis, knee
428709|NCT01739296|foot orthoses|foot orthoses
428710|NCT01739296|orthotic insoles|orthotic insoles
428711|NCT01739270|analgesia|analgesia
428712|NCT01739270|regional anesthesia|regional anesthesia
428713|NCT01739270|surgery|surgery
428714|NCT01739270|duration of analgesia|duration of analgesia
428715|NCT01739270|dexamethasone added to levobupivacaine compared to levobupivacaine alone|dexamethasone added to levobupivacaine compared to levobupivacaine alone
428716|NCT01739244|Glaucoma|glaucoma
428717|NCT01739244|Open Angle Glaucoma|open angle glaucoma
428718|NCT01739244|Ocular Hypertension|ocular hypertension
428719|NCT01739244|IOP|iop
428720|NCT01739244|RNAi|rnai
428721|NCT01739244|siRNA|sirna
428722|NCT01739244|beta inhibitor|beta inhibitor
428723|NCT01739205|Type 2 diabetes and depression|type 2 diabetes and depression
428724|NCT01739179|Ventricular peritoneal Shunt|ventricular peritoneal shunt
428725|NCT01739179|Shunt Complications|shunt complications
428726|NCT01739179|Shunt Failure|shunt failure
428727|NCT01739179|Hydrocephalus|hydrocephalus
428728|NCT01739166|Health Services Research|health services research
428729|NCT01739166|Quality Assurance|quality assurance
428730|NCT01739153|Dairy|dairy
428731|NCT01739153|Cheese|cheese
428732|NCT01739153|Blood lipid concentrations|blood lipid concentrations
428733|NCT01739153|Blood lipid sizes|blood lipid sizes
428734|NCT01739153|Fecal fat|fecal fat
428735|NCT01739153|Fat digestibility|fat digestibility
428736|NCT01739153|bile acids|bile acids
428737|NCT01739127|Antipsychotic agents|antipsychotic agents
428738|NCT01739127|Adverse effects|adverse effects
428739|NCT01739127|Magnetic Resonance Imaging|magnetic resonance imaging
428740|NCT01739114|Lung aeration|lung aeration
428741|NCT01739114|Bronchopulmonary dysplasia|bronchopulmonary dysplasia
428742|NCT01739114|Positive Pressure Respiration|positive pressure respiration
428743|NCT01739114|Sustained Inflation|sustained inflation
428744|NCT01739114|Continuous Positive Airway Pressure|continuous positive airway pressure
428745|NCT01739088|Congenital heart disease|congenital heart disease
428746|NCT01739088|pediatrics|pediatrics
428747|NCT01739088|ischemia-reperfusion injury|ischemia-reperfusion injury
428748|NCT01739088|long term outcomes|long term outcomes
428749|NCT01739062|PSA test|psa test
428750|NCT01739062|Prostate cancer|prostate cancer
428751|NCT01739062|Genetic screening|genetic screening
428752|NCT01739036|Malaria|malaria
428753|NCT01739036|Vaccine|vaccine
428754|NCT01739036|Plasmodium|plasmodium
428755|NCT01739036|Falciparum|falciparum
428756|NCT01739023|paraplegia|paraplegia
428757|NCT01739023|cell therapy|cell therapy
428758|NCT01739023|Schwann cells|schwann cells
428759|NCT01739023|spinal cord injury|spinal cord injury
428760|NCT01738997|Benign|benign
428761|NCT01738997|Esophageal strictures|esophageal strictures
428762|NCT01738997|Esophagus|esophagus
428763|NCT01738997|Balloon Dilation|balloon dilation
428764|NCT01738984|exercise|exercise
428765|NCT01738984|video|video
428766|NCT01738984|DVD|dvd
428767|NCT01738984|mother|mother
428768|NCT01738984|infant|infant
428769|NCT01738971|emergency contraception|emergency contraception
428770|NCT01738971|community pharmacy|community pharmacy
428771|NCT01738958|Probiotic bacteria|probiotic bacteria
428772|NCT01738958|Caries dentalis|caries dentalis
428773|NCT01738958|QLF|qlf
428774|NCT01738932|endometriosis|endometriosis
428775|NCT01738932|mannan-binding lectin|mannan-binding lectin
428776|NCT01738932|immunology|immunology
428777|NCT01738893|Gabapentin|gabapentin
428778|NCT01738893|Bioequivalence|bioequivalence
428779|NCT01738893|Pharmacokinetics|pharmacokinetics
428780|NCT01738893|Mexico|mexico
428781|NCT01738867|Pharmacogenetics|pharmacogenetics
428783|NCT01738867|Pharmacodynamics|pharmacodynamics
428784|NCT01738867|Addiction|addiction
428785|NCT01738867|mu opioid receptors|mu opioid receptors
428786|NCT01738854|laryngeal mask airway supreme|laryngeal mask airway supreme
428787|NCT01738854|airway sealing|airway sealing
428788|NCT01738854|intracuff pressure|intracuff pressure
428789|NCT01738841|Combined measles-mumps-rubella-varicella vaccine|combined measles-mumps-rubella-varicella vaccine
428790|NCT01738841|Priorix-Tetra™|priorix-tetra™
428791|NCT01738841|MMRV|mmrv
428792|NCT01738841|children|children
428793|NCT01738841|Post-marketing surveillance|post-marketing surveillance
428794|NCT01738841|Philippines|philippines
428795|NCT01738815|bladder cancer|bladder cancer
428796|NCT01738815|hematuria|hematuria
428797|NCT01738815|sodium valproate|sodium valproate
428798|NCT01738815|valproic acid|valproic acid
428799|NCT01738802|Type 2 Diabetes|type 2 diabetes
428800|NCT01738802|carotid intima medial thickness|carotid intima medial thickness
428801|NCT01738802|micronutrient|micronutrient
428802|NCT01738802|anti-oxidant|anti-oxidant
428803|NCT01738789|Adnexal masses|adnexal masses
428804|NCT01738789|Magnetic resonance imaging|magnetic resonance imaging
428805|NCT01738789|Ovarian tumor|ovarian tumor
428806|NCT01738776|hip fracture|hip fracture
428807|NCT01738776|risk factors|risk factors
428808|NCT01738776|vitamin K1|vitamin k1
428809|NCT01738776|vitamin D|vitamin d
428810|NCT01738776|bone turnover markers|bone turnover markers
428811|NCT01738776|osteocalcin|osteocalcin
428812|NCT01738776|undercarboxylated osteocalcin|undercarboxylated osteocalcin
428813|NCT01738776|bone specific alkaline phosphatase (BALP)|bone specific alkaline phosphatase (balp)
428814|NCT01738776|insulin like growth factor 1 (IGF1)|insulin like growth factor 1 (igf1)
428815|NCT01738776|parathyroid hormone (PTH)|parathyroid hormone (pth)
428816|NCT01738763|Glucose|glucose
428817|NCT01738763|Insulin|insulin
428818|NCT01738763|3-O-methyl-D-chiro-inositol|3-o-methyl-d-chiro-inositol
428819|NCT01738750|surgical choice|surgical choice
428820|NCT01738750|cost of care|cost of care
428821|NCT01738750|decision making|decision making
428822|NCT01738750|health care|health care
428823|NCT01738750|health care cost|health care cost
428824|NCT01738750|pediatric|pediatric
428825|NCT01738750|children|children
428826|NCT01738750|appendicitis|appendicitis
428827|NCT01738750|patient satisfaction|patient satisfaction
428828|NCT01738711|Idiopathic pulmonary fibrosis|idiopathic pulmonary fibrosis
428829|NCT01738711|Cognitive behavioural therapy|cognitive behavioural therapy
428830|NCT01738711|Anxiety|anxiety
428831|NCT01738711|Quality of life|quality of life
428832|NCT01738685|Breast Cancer.|breast cancer.
428833|NCT01738685|Adjuvant Endocrine therapy.|adjuvant endocrine therapy.
428834|NCT01738672|Nitrous oxide|nitrous oxide
428835|NCT01738672|labor and delivery|labor and delivery
428836|NCT01738672|analgesia|analgesia
428837|NCT01738659|sodium ,diuretics, PCWP|sodium ,diuretics, pcwp
428838|NCT01738646|vorinostat|vorinostat
428839|NCT01738646|SAHA|saha
428840|NCT01738646|bevacizumab|bevacizumab
428841|NCT01738646|AVASTIN|avastin
428842|NCT01738646|malignant glioma|malignant glioma
428843|NCT01738646|GBM|gbm
428844|NCT01738646|glioblastoma multiforme|glioblastoma multiforme
428845|NCT01738646|brain tumor|brain tumor
428846|NCT01738633|Esophageal Cancer|esophageal cancer
428847|NCT01738633|Quality of Life|quality of life
428848|NCT01738620|esophageal cancer|esophageal cancer
428849|NCT01738620|sleep disturbance|sleep disturbance
428850|NCT01738620|quality of life|quality of life
428851|NCT01738607|fecal incontinence, dietary fiber|fecal incontinence, dietary fiber
428852|NCT01738581|focal hand dystonia (FHD)|focal hand dystonia (fhd)
428853|NCT01738581|repetitive transcranial magnetic stimulation (rTMS)|repetitive transcranial magnetic stimulation (rtms)
428854|NCT01738581|sensorimotor retraining|sensorimotor retraining
428855|NCT01738568|High intensity aerobic training|high intensity aerobic training
428856|NCT01738555|amdoxovir|amdoxovir
428857|NCT01738555|zidovudine|zidovudine
428858|NCT01738555|HIV|hiv
428859|NCT01738555|HAART|haart
428860|NCT01738555|antiretroviral|antiretroviral
428861|NCT01738542|Bosentan|bosentan
428862|NCT01738542|Peripheral Arterial Disease|peripheral arterial disease
428863|NCT01738529|confocal laser endomicroscopy|confocal laser endomicroscopy
428864|NCT01738529|Crohn´disease|crohn´disease
428865|NCT01738503|Opioid Dependence, Buprenorphine, Depot, SUBUTEX, RBP-6000|opioid dependence, buprenorphine, depot, subutex, rbp-6000
428866|NCT01738490|Bone anchored hearing aid|bone anchored hearing aid
428867|NCT01738490|Bone anchored implant|bone anchored implant
428868|NCT01738490|Implant stability|implant stability
428869|NCT01738490|Wide diameter implant|wide diameter implant
428870|NCT01738490|Linear incision|linear incision
428871|NCT01738490|Ponto|ponto
428872|NCT01738477|Booster|booster
428873|NCT01738477|Tdap|tdap
428874|NCT01738477|Immunogenicity|immunogenicity
428875|NCT01738477|Repeat dose|repeat dose
428876|NCT01738477|Safety|safety
428877|NCT01738477|BoostrixTM|boostrixtm
428878|NCT01738477|Persistence|persistence
428879|NCT01738464|Pelvic Pain|pelvic pain
428880|NCT01738464|Interstitial Cystitis|interstitial cystitis
428881|NCT01738464|Microbiome|microbiome
428882|NCT01738464|Prostatitis|prostatitis
428883|NCT01738464|Chronic|chronic
428884|NCT01738464|Depression|depression
428885|NCT01738451|ECG intervals and morphology|ecg intervals and morphology
428886|NCT01738451|BRAF-mutation positive tumor|braf-mutation positive tumor
428887|NCT01738451|Holter monitor|holter monitor
428888|NCT01738451|BRAF inhibitor|braf inhibitor
428889|NCT01738451|GSK2118436|gsk2118436
428890|NCT01738451|safety|safety
428891|NCT01738451|cancer|cancer
428893|NCT01738451|pharmacokinetics|pharmacokinetics
428894|NCT01738438|Metastatic|metastatic
428895|NCT01738438|Triple Negative|triple negative
428896|NCT01738438|Stage IV|stage iv
428897|NCT01738425|GIC-1001|gic-1001
428898|NCT01738425|opioid agonist|opioid agonist
428899|NCT01738425|sulfide|sulfide
428900|NCT01738425|colonoscopy|colonoscopy
428901|NCT01738425|gicare|gicare
428902|NCT01738425|Phase I|phase i
428903|NCT01738425|safety|safety
428904|NCT01738425|tolerability|tolerability
428905|NCT01738425|pharmacokinetics|pharmacokinetics
428906|NCT01738425|healthy subjects|healthy subjects
428907|NCT01738425|single ascending dose|single ascending dose
428908|NCT01738425|multiple ascending dose|multiple ascending dose
428909|NCT01738425|SAD|sad
428910|NCT01738425|MAD|mad
428911|NCT01738425|food effect|food effect
428912|NCT01738412|Stroke|stroke
428913|NCT01738399|Insulin resistance|insulin resistance
428914|NCT01738399|Coffee|coffee
428915|NCT01738399|Glucose metabolism|glucose metabolism
428916|NCT01738386|Adaptation|adaptation
428917|NCT01738386|Coping|coping
428918|NCT01738386|Presenile Dementia|presenile dementia
428919|NCT01738386|Caregiver Burden|caregiver burden
428920|NCT01738373|autologous stem cell transplantation|autologous stem cell transplantation
428921|NCT01738373|lymphoma|lymphoma
428922|NCT01738373|multiple myeloma|multiple myeloma
428923|NCT01738360|Arsenic trioxide|arsenic trioxide
428924|NCT01738360|Systemic Lupus|systemic lupus
428925|NCT01738360|clinically|clinically
428926|NCT01738360|biologically active|biologically active
428927|NCT01738334|Meditation|meditation
428928|NCT01738334|Cognition|cognition
428929|NCT01738334|Attention Deficit Disorder with Hyperactivity|attention deficit disorder with hyperactivity
428930|NCT01738308|Healing Touch|healing touch
428931|NCT01738308|Pediatrics|pediatrics
428932|NCT01738308|surgery|surgery
428933|NCT01738308|stress|stress
428934|NCT01738308|pain|pain
428935|NCT01738308|Pediatric Stress|pediatric stress
428936|NCT01738308|maladaptive behaviors|maladaptive behaviors
428937|NCT01738308|energy medicine|energy medicine
428938|NCT01738308|emergence delirium|emergence delirium
428939|NCT01738308|emergence agitation|emergence agitation
428940|NCT01738308|length of stay|length of stay
428941|NCT01738308|ease of wake up|ease of wake up
428942|NCT01738308|distress parents|distress parents
428943|NCT01738308|distress pediatric patients|distress pediatric patients
428944|NCT01738308|Pediatric Post-Traumatic Stress Disorder|pediatric post-traumatic stress disorder
428945|NCT01738295|acetylcholine|acetylcholine
428946|NCT01738295|cholinergic system|cholinergic system
428947|NCT01738295|visual perception|visual perception
428948|NCT01738295|visual attention|visual attention
428949|NCT01738295|multiple objects tracking|multiple objects tracking
428950|NCT01738295|perceptual learning|perceptual learning
428951|NCT01738295|vision training|vision training
428952|NCT01738282|baclofene|baclofene
428953|NCT01738282|Alcohol dependence|alcohol dependence
428954|NCT01738282|Maintenance of abstinence|maintenance of abstinence
428955|NCT01738269|Ovarian cancer, HE4, normal range|ovarian cancer, he4, normal range
428956|NCT01738256|Cognitive Behavior Therapy|cognitive behavior therapy
428957|NCT01738256|Acceptance Commitment Therapy|acceptance commitment therapy
428958|NCT01738256|Psychological Stress|psychological stress
428959|NCT01738256|Metabolic Syndrome|metabolic syndrome
428960|NCT01738256|Overweight|overweight
428961|NCT01738256|Life Style|life style
428962|NCT01738243|Thyroid|thyroid
428963|NCT01738243|Thyroid Eye Disease|thyroid eye disease
428964|NCT01738243|Thyroid Orbitopathy|thyroid orbitopathy
428965|NCT01738243|Eyelid Retraction|eyelid retraction
428966|NCT01738243|Upper Eyelid Retraction|upper eyelid retraction
428967|NCT01738217|Intra-operative imaging|intra-operative imaging
428968|NCT01738217|NIR Fluorescence|nir fluorescence
428969|NCT01738217|Liver surgery|liver surgery
428970|NCT01738217|Tumoral margins|tumoral margins
428971|NCT01738204|endometriosis|endometriosis
428972|NCT01738204|dysmenorrhea|dysmenorrhea
428973|NCT01738204|pelvic pain|pelvic pain
428974|NCT01738204|women's health|women's health
428975|NCT01738204|adolescence|adolescence
428976|NCT01738204|biorepository|biorepository
428977|NCT01738204|observational|observational
428978|NCT01738204|women|women
428979|NCT01738204|female|female
428980|NCT01738204|gynecology|gynecology
428981|NCT01738204|fertility|fertility
428982|NCT01738204|infertility|infertility
428983|NCT01738191|Parkinson's disease|parkinson's disease
428984|NCT01738152|HYALOGYN VAGINAL GEL|hyalogyn vaginal gel
428985|NCT01738152|vaginal dryness|vaginal dryness
428986|NCT01738152|12-232|12-232
428987|NCT01738126|cerebellum|cerebellum
428988|NCT01738126|fMRI|fmri
428989|NCT01738126|DTI|dti
428990|NCT01738126|pain|pain
428991|NCT01738126|heat|heat
428992|NCT01738126|noxious|noxious
428993|NCT01738126|aversion|aversion
428994|NCT01738126|unpleasantness|unpleasantness
428995|NCT01738126|anger|anger
428996|NCT01738126|aversive stimulus|aversive stimulus
428997|NCT01738126|motor|motor
428998|NCT01738126|human|human
428999|NCT01738126|image analysis|image analysis
429000|NCT01738126|perception|perception
429001|NCT01738126|central nervous system|central nervous system
429002|NCT01738126|sensory|sensory
429003|NCT01738126|somatosensory cortex|somatosensory cortex
429004|NCT01738126|trigeminal system|trigeminal system
429005|NCT01738126|white matter|white matter
429006|NCT01738113|Ilizarov|ilizarov
429007|NCT01738113|distraction osteogenesis|distraction osteogenesis
429008|NCT01738113|Muscle architecture|muscle architecture
429009|NCT01738113|muscle mechanics|muscle mechanics
429010|NCT01738113|Rehabilitation|rehabilitation
429011|NCT01738087|patients|patients
429012|NCT01738087|Adult|adult
429013|NCT01738074|rotavirus|rotavirus
429014|NCT01738074|trivalent genetic reassortment vaccine|trivalent genetic reassortment vaccine
429015|NCT01738074|Phase three clinical trials|phase three clinical trials
429016|NCT01738061|Older workers|older workers
429017|NCT01738061|Multidimensional intervention|multidimensional intervention
429018|NCT01738061|Worksite health promotion|worksite health promotion
429019|NCT01738061|Taiwan|taiwan
429020|NCT01738048|Pain|pain
429021|NCT01738048|Neuropathic pain|neuropathic pain
429022|NCT01738048|Chronic pain|chronic pain
429023|NCT01738035|IgA nephropathy|iga nephropathy
429024|NCT01738022|Sleep apnea|sleep apnea
429025|NCT01738022|Pathophysiology|pathophysiology
429026|NCT01738009|Sleep Apnea|sleep apnea
429027|NCT01738009|Pathophysiology|pathophysiology
429028|NCT01737983|cystic fibrosis|cystic fibrosis
429029|NCT01737983|probiotics|probiotics
429030|NCT01737983|Lactobacillus reuteri|lactobacillus reuteri
429031|NCT01737957|Proliferative Diabetic retinopathy|proliferative diabetic retinopathy
429032|NCT01737957|Pan-retinal photocoagulation|pan-retinal photocoagulation
429033|NCT01737944|methotrexate injection, subcutaneous, autoinjector|methotrexate injection, subcutaneous, autoinjector
429034|NCT01737931|SPM 962|spm 962
429035|NCT01737931|rotigotine|rotigotine
429036|NCT01737931|application site reaction|application site reaction
429037|NCT01737918|urge urinary incontinence, cesa, vasa, TOT, solifenacin|urge urinary incontinence, cesa, vasa, tot, solifenacin
429038|NCT01737905|Asthma|asthma
429039|NCT01737905|Safety|safety
429040|NCT01737905|Efficacy|efficacy
429041|NCT01737905|Epinephrine|epinephrine
429042|NCT01737905|Bronchodilator|bronchodilator
429043|NCT01737905|Metered dose inhaler|metered dose inhaler
429044|NCT01737892|Asthma|asthma
429045|NCT01737892|Pharmacokinetics|pharmacokinetics
429046|NCT01737892|Epinephrine|epinephrine
429047|NCT01737892|Bronchodilator|bronchodilator
429048|NCT01737892|Metered dose inhaler|metered dose inhaler
429049|NCT01737879|Anemia, Chronic Kidney Disease, End Stage Renal Disease, erythropoiesis-stimulating agents, Hemodialysis, Hemoglobin|anemia, chronic kidney disease, end stage renal disease, erythropoiesis-stimulating agents, hemodialysis, hemoglobin
429050|NCT01737866|Heart, Failure, Renal, Insufficiency, Cardiac, Kidney, Hemodialysis, Impairment, omecamtiv mecarbil, cardiac myosin activator, CK-1827452|heart, failure, renal, insufficiency, cardiac, kidney, hemodialysis, impairment, omecamtiv mecarbil, cardiac myosin activator, ck-1827452
429051|NCT01737853|Primary Open-Angle Glaucoma|primary open-angle glaucoma
429052|NCT01737853|Ocular Hypertension|ocular hypertension
429053|NCT01737853|Ganfort|ganfort
429054|NCT01737840|dyspepsia|dyspepsia
429055|NCT01737840|pantoprazole|pantoprazole
429056|NCT01737840|ranitidine|ranitidine
429057|NCT01737840|emergency department|emergency department
429058|NCT01737827|INC280, advanced hepatocellular carcinoma, c-MET pathway dysregulation|inc280, advanced hepatocellular carcinoma, c-met pathway dysregulation
429059|NCT01737814|sickle cell disease|sickle cell disease
429060|NCT01737814|vaso-occlusive crisis|vaso-occlusive crisis
429061|NCT01737801|Lung function|lung function
429062|NCT01737801|Physiotherapy|physiotherapy
429063|NCT01737788|Cervical cerclage|cervical cerclage
429064|NCT01737788|Uterine Cervical Incompetence|uterine cervical incompetence
429065|NCT01737775|diaphragmatic dysfunction|diaphragmatic dysfunction
429066|NCT01737775|ultrasonography|ultrasonography
429067|NCT01737775|respiratory distress|respiratory distress
429068|NCT01737775|abdominal surgery|abdominal surgery
429069|NCT01737775|Age|age
429070|NCT01737775|gender|gender
429071|NCT01737775|biometric|biometric
429072|NCT01737775|body mass index|body mass index
429073|NCT01737775|ASA score|asa score
429074|NCT01737775|smoking status|smoking status
429075|NCT01737775|history of respiratory disease|history of respiratory disease
429076|NCT01737762|Venous leg ulcer|venous leg ulcer
429077|NCT01737762|ulcer|ulcer
429078|NCT01737762|Venous stasis|venous stasis
429079|NCT01737762|compression|compression
429080|NCT01737762|venous|venous
429081|NCT01737762|venous stasis ulcer|venous stasis ulcer
429082|NCT01737762|vlu|vlu
429083|NCT01737762|wound|wound
429084|NCT01737762|varicose veins|varicose veins
429085|NCT01737762|venous insufficiency|venous insufficiency
429087|NCT01737762|deep vein thrombosis|deep vein thrombosis
429088|NCT01737749|Stroke|stroke
429089|NCT01737736|Stroke|stroke
429090|NCT01737723|Stroke|stroke
429091|NCT01737710|Influenza Vaccines|influenza vaccines
429092|NCT01737710|Dermatitis|dermatitis
429093|NCT01737710|Injections, Intradermal|injections, intradermal
429094|NCT01737710|Injections, Intramuscular|injections, intramuscular
429095|NCT01737710|Skin Diseases|skin diseases
429096|NCT01737710|Skin Diseases, Eczematous|skin diseases, eczematous
429097|NCT01737710|Hypersensitivity, Immediate|hypersensitivity, immediate
429098|NCT01737710|Hypersensitivity|hypersensitivity
429099|NCT01737710|Immune System Diseases|immune system diseases
429100|NCT01737710|Genetic Diseases, Inborn|genetic diseases, inborn
429101|NCT01737710|Skin Diseases, Genetic|skin diseases, genetic
429102|NCT01737671|Brain tumor|brain tumor
429103|NCT01737671|Malignant Fourth Ventricular Brain Tumors|malignant fourth ventricular brain tumors
429104|NCT01737671|Ependymoma involving brain|ependymoma involving brain
429105|NCT01737671|Ependymoma involving spine|ependymoma involving spine
429106|NCT01737671|Recurrent ependymoma involving brain and/or spine|recurrent ependymoma involving brain and/or spine
429107|NCT01737671|Recurrent atypical teratoid/rhabdoid tumor involving brain|recurrent atypical teratoid/rhabdoid tumor involving brain
429108|NCT01737671|Recurrent atypical teratoid/rhabdoid tumor involving spine|recurrent atypical teratoid/rhabdoid tumor involving spine
429109|NCT01737671|AT/RT|at/rt
429110|NCT01737671|Ommaya reservoir catheter|ommaya reservoir catheter
429111|NCT01737671|Methotrexate|methotrexate
429112|NCT01737671|Medulloblastoma|medulloblastoma
429113|NCT01737671|ATRT|atrt
429114|NCT01737671|Atypical teratoid rhabdoid tumor|atypical teratoid rhabdoid tumor
429115|NCT01737671|Ependymoma|ependymoma
429116|NCT01737671|Pediatric brain tumor|pediatric brain tumor
429117|NCT01737671|Intraventricular chemotherapy|intraventricular chemotherapy
429118|NCT01737632|Adolescents|adolescents
429119|NCT01737632|Residential Treatment|residential treatment
429120|NCT01737632|Outpatient Treatment|outpatient treatment
429121|NCT01737632|Substance Abuse|substance abuse
429122|NCT01737632|Delinquency|delinquency
429123|NCT01737632|Family Therapy|family therapy
429124|NCT01737632|Multidimensional Family therapy|multidimensional family therapy
429125|NCT01737606|Cerebral pulsatility|cerebral pulsatility
429126|NCT01737606|Fast Cerebral Pulsatility Imaging or FCPI|fast cerebral pulsatility imaging or fcpi
429127|NCT01737606|MRI|mri
429128|NCT01737606|Arteriel Spin Labelling|arteriel spin labelling
429129|NCT01737606|Cognitive tasks|cognitive tasks
429130|NCT01737606|Aging|aging
429131|NCT01737593|acetaminophen|acetaminophen
429132|NCT01737593|emergence agitation|emergence agitation
429133|NCT01737593|children|children
429134|NCT01737593|sevoflurane|sevoflurane
429135|NCT01737580|influenza, human|influenza, human
429136|NCT01737580|influenza vaccines|influenza vaccines
429137|NCT01737580|older adults|older adults
429138|NCT01737580|immune response|immune response
429139|NCT01737554|Central venous access device|central venous access device
429140|NCT01737554|Catheter resistance monitoring|catheter resistance monitoring
429141|NCT01737541|Cerebrovascular Disorders|cerebrovascular disorders
429142|NCT01737541|Cardiovascular Diseases|cardiovascular diseases
429143|NCT01737541|Intracerebral Hemorrhage|intracerebral hemorrhage
429144|NCT01737541|Serotonin Uptake Inhibitors|serotonin uptake inhibitors
429145|NCT01737541|Therapeutic Uses|therapeutic uses
429146|NCT01737528|severe symptomatic native aortic valve stenosis|severe symptomatic native aortic valve stenosis
429147|NCT01737528|inoperable or high risk for open aortic valve replacement|inoperable or high risk for open aortic valve replacement
429148|NCT01737476|age 18-65|age 18-65
429149|NCT01737463|Ampulla of Vater adenoma|ampulla of vater adenoma
429150|NCT01737450|Metastatic head and neck cancer|metastatic head and neck cancer
429151|NCT01737450|PI3K inhibitor|pi3k inhibitor
429152|NCT01737450|Recurrent head and meck cancer|recurrent head and meck cancer
429153|NCT01737450|Progressive head and neck cancer|progressive head and neck cancer
429154|NCT01737450|BKM120|bkm120
429155|NCT01737411|surgery, solifenacin, urge urinary incontinence|surgery, solifenacin, urge urinary incontinence
429156|NCT01737398|FAP|fap
429157|NCT01737398|Familial Amyloid Polyneuropathy|familial amyloid polyneuropathy
429158|NCT01737398|TTR|ttr
429159|NCT01737398|Transthyretin|transthyretin
429160|NCT01737398|Amyloidosis|amyloidosis
429161|NCT01737385|microcirculation|microcirculation
429162|NCT01737385|proximal humeral fractures|proximal humeral fractures
429163|NCT01737385|O2C|o2c
429164|NCT01737372|Multiple Sclerosis|multiple sclerosis
429165|NCT01737372|Secondary Progressive Multiple Sclerosis|secondary progressive multiple sclerosis
429166|NCT01737372|Clinically Isolated Syndrome|clinically isolated syndrome
429167|NCT01737359|amdoxovir|amdoxovir
429168|NCT01737359|zidovudine|zidovudine
429169|NCT01737359|tenofovir DF|tenofovir df
429170|NCT01737359|HIV|hiv
429171|NCT01737359|HAART|haart
429172|NCT01737359|antiretroviral|antiretroviral
429173|NCT01737346|glioblastoma, recurrent, refractory, CCNU, procarbazine|glioblastoma, recurrent, refractory, ccnu, procarbazine
429174|NCT01737320|gram negative bacteremia|gram negative bacteremia
429175|NCT01737320|Duration of antibiotic treatment|duration of antibiotic treatment
429176|NCT01737320|safety|safety
429177|NCT01737320|efficacy|efficacy
429178|NCT01737320|short-course|short-course
429179|NCT01737307|Fluoride Varnish|fluoride varnish
429180|NCT01737307|CPP-ACP paste|cpp-acp paste
429181|NCT01737307|Dry mouth|dry mouth
429182|NCT01737307|Burning sensation|burning sensation
429183|NCT01737307|Chemotherapy|chemotherapy
429184|NCT01737294|Phase IV|phase iv
429185|NCT01737294|Peripheral Neuropathic Pain|peripheral neuropathic pain
429186|NCT01737294|QUTENZA|qutenza
429187|NCT01737281|Smoking|smoking
429188|NCT01737281|Tobacco control|tobacco control
429189|NCT01737281|Counseling|counseling
429190|NCT01737281|mental health|mental health
429191|NCT01737268|patients|patients
429192|NCT01737268|Major depressive episode|major depressive episode
429193|NCT01737268|FK949E|fk949e
429194|NCT01737255|Li-Fraumeni Syndrome|li-fraumeni syndrome
429195|NCT01737255|Whole Body Magnetic Resonance Imaging|whole body magnetic resonance imaging
429196|NCT01737255|TP53|tp53
429197|NCT01737255|Psychological Impact|psychological impact
429198|NCT01737242|Prostate cancer|prostate cancer
429199|NCT01737242|PSA|psa
429200|NCT01737216|Aged|aged
429201|NCT01737216|patients|patients
429202|NCT01737203|Viagra|viagra
429203|NCT01737203|ODT|odt
429204|NCT01737203|bioquivalence|bioquivalence
429205|NCT01737190|esophageal pressure|esophageal pressure
429206|NCT01737190|ARDSnet protocol|ardsnet protocol
429207|NCT01737177|MCL|mcl
429208|NCT01737177|Mantle Cell Lymphoma|mantle cell lymphoma
429209|NCT01737177|RELAPSED-REFRACTORY|relapsed-refractory
429210|NCT01737164|Glucose|glucose
429211|NCT01737164|Lipid|lipid
429212|NCT01737164|Metabolism|metabolism
429213|NCT01737164|Non Diabetic|non diabetic
429214|NCT01737164|Healthy|healthy
429215|NCT01737138|Resistant hypertension|resistant hypertension
429216|NCT01737138|All-cause mortality|all-cause mortality
429217|NCT01737138|Renal function|renal function
429218|NCT01737112|Lung Cancer|lung cancer
429219|NCT01737112|integrin αvβ3 receptor|integrin αvβ3 receptor
429220|NCT01737112|99mTc-3PRGD2|99mtc-3prgd2
429221|NCT01737112|SPECT/CT|spect/ct
429222|NCT01737112|efficacy and safety|efficacy and safety
429223|NCT01737099|omega-3|omega-3
429224|NCT01737099|DHA|dha
429225|NCT01737099|triglycerides|triglycerides
429226|NCT01737099|lipids|lipids
429227|NCT01737099|cardiovascular|cardiovascular
429228|NCT01737099|hypertriglyceridemia|hypertriglyceridemia
429229|NCT01737073|chronic pain|chronic pain
429230|NCT01737073|opioid|opioid
429231|NCT01737073|cognitive behavior therapy|cognitive behavior therapy
429232|NCT01737060|Reversed prosthesis, Philos, Severe displaced|reversed prosthesis, philos, severe displaced
429233|NCT01737047|HIV|hiv
429234|NCT01737047|Ageing|ageing
429235|NCT01737034|partitioning of weight gain|partitioning of weight gain
429236|NCT01737034|refeeding|refeeding
429237|NCT01737034|catch-up fat phenomenon|catch-up fat phenomenon
429238|NCT01737034|glycemic index|glycemic index
429239|NCT01737021|PICU|picu
429240|NCT01737021|Critical illness|critical illness
429241|NCT01737021|Outcomes|outcomes
429242|NCT01737021|Mental health|mental health
429243|NCT01737021|Education|education
429244|NCT01737021|Randomized Controlled Trial (RCT)|randomized controlled trial (rct)
429245|NCT01737021|Pilot|pilot
429246|NCT01737021|Feasibility|feasibility
429247|NCT01737008|Head and neck|head and neck
429248|NCT01737008|Squamous cell carcinoma|squamous cell carcinoma
429249|NCT01737008|Phase 1|phase 1
429250|NCT01737008|Dacomitinib|dacomitinib
429251|NCT01737008|Radiation|radiation
429252|NCT01737008|Radiotherapy|radiotherapy
429253|NCT01737008|Chemotherapy|chemotherapy
429254|NCT01737008|Chemoradiation|chemoradiation
429255|NCT01737008|Chemoradiotherapy|chemoradiotherapy
429256|NCT01737008|Cisplatin|cisplatin
429257|NCT01737008|Pharmacokinetics|pharmacokinetics
429258|NCT01737008|Maximum tolerated dose|maximum tolerated dose
429259|NCT01737008|Safety|safety
429260|NCT01737008|Human epidermal growth factor receptor|human epidermal growth factor receptor
429261|NCT01737008|Previously Untreated|previously untreated
429262|NCT01737008|Local or Locally Advanced|local or locally advanced
429263|NCT01736995|Substance Abuse|substance abuse
429264|NCT01736995|Adolescents|adolescents
429265|NCT01736995|Families|families
429266|NCT01736995|Functional Family Therapy|functional family therapy
429267|NCT01736995|Cognitive Behavioral Therapy|cognitive behavioral therapy
429268|NCT01736995|Motivational Therapy|motivational therapy
429269|NCT01736995|Contingency Management|contingency management
429270|NCT01736982|Cigarette Smoking|cigarette smoking
429271|NCT01736982|Homeless|homeless
429272|NCT01736982|Contingency Management|contingency management
429273|NCT01736982|Smoking Cessation|smoking cessation
429274|NCT01736956|aortic stenosis|aortic stenosis
429275|NCT01736956|hypoplastic left heart syndrome|hypoplastic left heart syndrome
429276|NCT01736956|fetal aortic valvuloplasty|fetal aortic valvuloplasty
429277|NCT01736943|Bortezomib|bortezomib
429278|NCT01736943|Doxil|doxil
429279|NCT01736930|Type 1 Diabetes|type 1 diabetes
429280|NCT01736930|Hypoglycemia|hypoglycemia
429281|NCT01736930|Continuous Glucose Monitoring|continuous glucose monitoring
429282|NCT01736930|Pump Suspension|pump suspension
429283|NCT01736917|Fosaprepitant|fosaprepitant
429284|NCT01736917|5HT3 Receptor Antagonists|5ht3 receptor antagonists
429285|NCT01736917|Dexamethasone|dexamethasone
429286|NCT01736917|Germ Cell Tumors|germ cell tumors
429287|NCT01736917|Testis Cancer|testis cancer
429288|NCT01736917|Rescue Medications|rescue medications
429289|NCT01736904|advanced colorectal cancer|advanced colorectal cancer
429290|NCT01736904|FOLFIRI|folfiri
429291|NCT01736904|XELIRI|xeliri
429292|NCT01736891|Motor fluctuations|motor fluctuations
429293|NCT01736891|Parkinson´s Disease|parkinson´s disease
429294|NCT01736891|Rasagiline|rasagiline
429295|NCT01736878|Medullary Thyroid Carcinoma|medullary thyroid carcinoma
429296|NCT01736878|Sorafenib|sorafenib
429297|NCT01736878|Efficacy|efficacy
429298|NCT01736852|Premature Rupture of Membrane (Pregnancy)|premature rupture of membrane (pregnancy)
429299|NCT01736852|PROM|prom
429300|NCT01736852|Cervical Ripening|cervical ripening
429301|NCT01736852|Induced Labor|induced labor
429302|NCT01736826|plasma nucleosome concentration|plasma nucleosome concentration
429303|NCT01736826|plasma free DNA concentration|plasma free dna concentration
429304|NCT01736813|colorectal cancer|colorectal cancer
429305|NCT01736813|liver metastases|liver metastases
429306|NCT01736813|chemotherapy|chemotherapy
429307|NCT01736813|chemokine|chemokine
429308|NCT01736813|CCR5 inhibition|ccr5 inhibition
429309|NCT01736800|Temozolomide|temozolomide
429310|NCT01736800|Topotecan|topotecan
429311|NCT01736800|Central Nervous System Metastases|central nervous system metastases
429312|NCT01736800|Chemotherapy|chemotherapy
429313|NCT01736800|Brain Metastases|brain metastases
429314|NCT01736800|Solid Tumors|solid tumors
429315|NCT01736787|Cauliflower Mushroom extract|cauliflower mushroom extract
429316|NCT01736787|immunity|immunity
429317|NCT01736774|Manual therapy|manual therapy
429318|NCT01736774|Exercise|exercise
429319|NCT01736748|obesity|obesity
429320|NCT01736748|physical activity|physical activity
429321|NCT01736748|metabolism|metabolism
429322|NCT01736748|environment|environment
429323|NCT01736748|obese children, as defined by a body mass index > 95th percentile|obese children, as defined by a body mass index > 95th percentile
429324|NCT01736748|for age and sex|for age and sex
429325|NCT01736722|Laser Induced Thermal Therapy|laser induced thermal therapy
429326|NCT01736722|Metastatic cancer|metastatic cancer
429327|NCT01736722|Brain Tumor|brain tumor
429328|NCT01736722|Visualase|visualase
429329|NCT01736722|Treatment resistant|treatment resistant
429330|NCT01736722|Magnetic Resonance Thermal Imaging|magnetic resonance thermal imaging
429331|NCT01736722|Magnetic Imaging|magnetic imaging
429332|NCT01736709|2012-2013 trivalent seasonal influenza vaccine|2012-2013 trivalent seasonal influenza vaccine
429333|NCT01736709|immunogenicity,|immunogenicity,
429334|NCT01736709|safety|safety
429335|NCT01736696|Psoriasis|psoriasis
429336|NCT01736696|PASI|pasi
429337|NCT01736696|plaques|plaques
429338|NCT01736696|skin biopsy|skin biopsy
429339|NCT01736696|immunomodulation|immunomodulation
429340|NCT01736683|ACE-011|ace-011
429341|NCT01736683|anemia|anemia
429342|NCT01736683|dose-ranging|dose-ranging
429343|NCT01736683|intermediate-1 risk myelodysplastic syndromes|intermediate-1 risk myelodysplastic syndromes
429344|NCT01736683|low risk myelodysplastic syndromes (MDS)|low risk myelodysplastic syndromes (mds)
429345|NCT01736683|multicenter|multicenter
429346|NCT01736683|open-label|open-label
429347|NCT01736683|parallel|parallel
429348|NCT01736683|phase 2|phase 2
429349|NCT01736683|randomized|randomized
429350|NCT01736683|Sotatercept|sotatercept
429351|NCT01736683|Non-proliferative chronic myelomonocytic leukemia (CMML)|non-proliferative chronic myelomonocytic leukemia (cmml)
429352|NCT01736683|hemoglobin|hemoglobin
429353|NCT01736683|transfusions|transfusions
429354|NCT01736644|blood loss|blood loss
429355|NCT01736644|bipolar sealer|bipolar sealer
429356|NCT01736644|aquamantys|aquamantys
429357|NCT01736644|total knee replacement|total knee replacement
429358|NCT01736644|primary total knee arthroplasty|primary total knee arthroplasty
429359|NCT01736631|social phobia|social phobia
429360|NCT01736631|bipolar disorder|bipolar disorder
429361|NCT01736631|cognitive behavioural therapy|cognitive behavioural therapy
429362|NCT01736618|subcutaneous implantable defibrillator, post approval study, sudden cardiac arrest, Cameron Health defibrillator|subcutaneous implantable defibrillator, post approval study, sudden cardiac arrest, cameron health defibrillator
429363|NCT01736605|Massage|massage
429364|NCT01736605|Meditation|meditation
429365|NCT01736605|Breast Cancer|breast cancer
429366|NCT01736605|Breast Surgery|breast surgery
429367|NCT01736605|Breast Reconstruction|breast reconstruction
429368|NCT01736566|Primary Care|primary care
429369|NCT01736566|Cardiology|cardiology
429370|NCT01736566|Hypertrophic Cardiomyopathy|hypertrophic cardiomyopathy
429371|NCT01736566|Dilated Cardiomyopathy|dilated cardiomyopathy
429372|NCT01736566|Whole Genome Sequencing|whole genome sequencing
429471|NCT01736111|text message|text message
429373|NCT01736553|Spinal Muscular Atrophy (SMA) Biomarkers|spinal muscular atrophy (sma) biomarkers
429374|NCT01736553|Healthy controls|healthy controls
429375|NCT01736553|Infants|infants
429376|NCT01736540|iron overload, liver iron concentration (LIC), cardiac siderosis, transfusional siderosis, magnetic resonance imaging (MRI)|iron overload, liver iron concentration (lic), cardiac siderosis, transfusional siderosis, magnetic resonance imaging (mri)
429377|NCT01736514|xanthine oxidase inhibitor|xanthine oxidase inhibitor
429378|NCT01736514|Uric acid lowering drug|uric acid lowering drug
429379|NCT01736488|Hypertension|hypertension
429380|NCT01736488|Antihypertensive efficacy|antihypertensive efficacy
429381|NCT01736488|Neurohormonal markers|neurohormonal markers
429382|NCT01736488|Blood Pressure Response|blood pressure response
429383|NCT01736488|Exercise|exercise
429384|NCT01736462|Cornea|cornea
429385|NCT01736462|Endothelial cell density|endothelial cell density
429386|NCT01736449|pterygium|pterygium
429387|NCT01736449|bevacizumab|bevacizumab
429388|NCT01736449|recurrence of pterygium|recurrence of pterygium
429389|NCT01736436|MDS|mds
429390|NCT01736436|Myelodysplastic syndrome|myelodysplastic syndrome
429391|NCT01736436|Low and intermediate risk|low and intermediate risk
429392|NCT01736436|Transfusion-dependent patients|transfusion-dependent patients
429393|NCT01736436|Transfusion|transfusion
429394|NCT01736436|Anemia|anemia
429395|NCT01736423|YM060|ym060
429396|NCT01736423|Ramosetron|ramosetron
429397|NCT01736423|long term study|long term study
429398|NCT01736423|Diarrhea-predominant Irritable Bowel Syndrome|diarrhea-predominant irritable bowel syndrome
429399|NCT01736423|Female|female
429400|NCT01736397|CKD|ckd
429401|NCT01736397|Chronic Kidney Disease|chronic kidney disease
429402|NCT01736397|Phosphorus|phosphorus
429403|NCT01736397|Iron Deficiency|iron deficiency
429404|NCT01736397|Iron Deficiency Anemia|iron deficiency anemia
429405|NCT01736397|Elevated Phosphorus|elevated phosphorus
429406|NCT01736371|Sevoflurane|sevoflurane
429407|NCT01736371|Cisatracurium infusion consumption|cisatracurium infusion consumption
429408|NCT01736371|Closed loop computer control system|closed loop computer control system
429409|NCT01736371|Recovery Index|recovery index
429410|NCT01736358|Sprix|sprix
429411|NCT01736358|Intranasal ketoralac|intranasal ketoralac
429412|NCT01736358|Ketoralac|ketoralac
429413|NCT01736358|Urolithiasis|urolithiasis
429414|NCT01736358|Kidney stone|kidney stone
429415|NCT01736358|Uretal stone|uretal stone
429416|NCT01736358|Ureteroscopic removal of stones|ureteroscopic removal of stones
429417|NCT01736358|URS|urs
429418|NCT01736358|Pain management|pain management
429419|NCT01736358|Pain|pain
429420|NCT01736332|Methamphetamine|methamphetamine
429421|NCT01736332|Amphetamines|amphetamines
429422|NCT01736332|Opiates|opiates
429423|NCT01736332|Oral Opiates (poppy seeds)|oral opiates (poppy seeds)
429424|NCT01736332|Intranasal amphetamines|intranasal amphetamines
429425|NCT01736319|Artemisinin-based Combination Therapies|artemisinin-based combination therapies
429426|NCT01736319|Recrudescence|recrudescence
429427|NCT01736319|DHA-PPQ|dha-ppq
429428|NCT01736319|Parasite Clearance Rate|parasite clearance rate
429429|NCT01736306|Breast Cancer|breast cancer
429430|NCT01736306|Breast Milk|breast milk
429431|NCT01736306|Epigenetics|epigenetics
429432|NCT01736293|Retinal Degeneration|retinal degeneration
429433|NCT01736280|Symptoms|symptoms
429434|NCT01736280|Immunogenetics|immunogenetics
429435|NCT01736280|Digestive Disorders|digestive disorders
429436|NCT01736280|Gastrointestinal|gastrointestinal
429437|NCT01736267|Auditory Brainstem Implant|auditory brainstem implant
429438|NCT01736267|ABI|abi
429439|NCT01736267|Nucleus 24|nucleus 24
429440|NCT01736267|Deafness|deafness
429441|NCT01736267|Hearing loss|hearing loss
429442|NCT01736267|Non-tumor|non-tumor
429443|NCT01736267|Non-NF2|non-nf2
429444|NCT01736267|ABI541|abi541
429445|NCT01736228|xenotransplantation|xenotransplantation
429446|NCT01736228|type 1 diabetes|type 1 diabetes
429447|NCT01736228|porcine islets|porcine islets
429448|NCT01736215|Anemia - cancer related|anemia - cancer related
429449|NCT01736215|Eprex (Erythropoietin alfa)|eprex (erythropoietin alfa)
429450|NCT01736202|oral fat|oral fat
429451|NCT01736202|insulin sensitivity|insulin sensitivity
429452|NCT01736189|Rheumatoid arthritis|rheumatoid arthritis
429453|NCT01736189|Methotrexate|methotrexate
429454|NCT01736176|Safety and efficacy|safety and efficacy
429455|NCT01736176|Advanced Parkinson's disease|advanced parkinson's disease
429456|NCT01736176|levodopa-carbidopa intestinal gel,|levodopa-carbidopa intestinal gel,
429457|NCT01736176|carbidopa|carbidopa
429458|NCT01736176|levodopa|levodopa
429459|NCT01736176|Non-Motor Symptom Scale|non-motor symptom scale
429460|NCT01736150|Hemodialysis|hemodialysis
429461|NCT01736137|Heart failure|heart failure
429462|NCT01736137|Autonomic Nervous System|autonomic nervous system
429463|NCT01736137|Heart rate|heart rate
429464|NCT01736137|Quality of life|quality of life
429465|NCT01736124|computerize cognitive training|computerize cognitive training
429466|NCT01736124|dementia|dementia
429467|NCT01736124|cognitive decline|cognitive decline
429468|NCT01736124|Diabetes Mellitus, Type 2|diabetes mellitus, type 2
429469|NCT01736111|obesity|obesity
429470|NCT01736111|weight loss|weight loss
429472|NCT01736085|tobacco cessation|tobacco cessation
429473|NCT01736085|smoking cessation|smoking cessation
429474|NCT01736085|nicotine|nicotine
429475|NCT01736085|telephone counseling|telephone counseling
429476|NCT01736085|self-help|self-help
429477|NCT01736085|smoking abstinence|smoking abstinence
429478|NCT01736085|tobacco use disorder|tobacco use disorder
429479|NCT01736085|nicotine replacement therapy|nicotine replacement therapy
429480|NCT01736085|voucher|voucher
429481|NCT01736072|Rectal Cancer|rectal cancer
429482|NCT01736072|Colorectal Cancer|colorectal cancer
429483|NCT01736072|Laparoscopic Surgery|laparoscopic surgery
429484|NCT01736072|Robotic Surgery|robotic surgery
429485|NCT01736072|Robotic Assisted Laparoscopic Surgery|robotic assisted laparoscopic surgery
429486|NCT01736059|Stem cells|stem cells
429487|NCT01736059|intravitreal|intravitreal
429488|NCT01736059|bone marrow CD34+ cells|bone marrow cd34+ cells
429489|NCT01736059|retinal disease|retinal disease
429490|NCT01736059|clinical trial|clinical trial
429491|NCT01736059|autologous|autologous
429492|NCT01736046|CT Enterography|ct enterography
429493|NCT01736046|Crohn's Disease|crohn's disease
429494|NCT01736046|Inflammatory Bowel Disease|inflammatory bowel disease
429495|NCT01736033|Lower Urinary Tracts Symptoms|lower urinary tracts symptoms
429496|NCT01736033|5 alpha reductase inhibitor|5 alpha reductase inhibitor
429497|NCT01736033|Proscar|proscar
429498|NCT01736033|Finasteride|finasteride
429499|NCT01736033|alpha blocker|alpha blocker
429500|NCT01736033|Tamsulosin|tamsulosin
429501|NCT01736033|Harnal D|harnal d
429502|NCT01736007|alopecia areata child|alopecia areata child
429503|NCT01736007|scalp|scalp
429504|NCT01735994|Eating disorders|eating disorders
429505|NCT01735994|body image|body image
429506|NCT01735994|female athletes|female athletes
429507|NCT01735994|female athlete triad|female athlete triad
429508|NCT01735994|eating disorder prevention|eating disorder prevention
429509|NCT01735994|cluster randomization|cluster randomization
429510|NCT01735994|risk factors|risk factors
429511|NCT01735994|prevention|prevention
429512|NCT01735981|Huntington's Disease|huntington's disease
429513|NCT01735981|gait|gait
429514|NCT01735981|exercise|exercise
429515|NCT01735981|balance|balance
429516|NCT01735981|video game|video game
429517|NCT01735968|Imatinib mesylate|imatinib mesylate
429518|NCT01735968|STI571|sti571
429519|NCT01735968|BYL719|byl719
429520|NCT01735968|GIST|gist
429521|NCT01735968|3rd line GIST|3rd line gist
429522|NCT01735955|Tasigna|tasigna
429523|NCT01735955|CML|cml
429524|NCT01735955|GIST|gist
429525|NCT01735955|nilotinib|nilotinib
429526|NCT01735890|Safety|safety
429527|NCT01735890|Pharmacokinetics|pharmacokinetics
429528|NCT01735877|Hemispatial neglect, Stroke|hemispatial neglect, stroke
429529|NCT01735864|Indigo naturalis extract in oil|indigo naturalis extract in oil
429530|NCT01735851|Thoracic epidural analgesia|thoracic epidural analgesia
429531|NCT01735851|Paravertebral block|paravertebral block
429532|NCT01735851|pain|pain
429533|NCT01735851|postoperative|postoperative
429534|NCT01735825|coronary artery disease|coronary artery disease
429535|NCT01735825|stent|stent
429536|NCT01735825|restenosis|restenosis
429537|NCT01735812|cryoablation|cryoablation
429538|NCT01735812|uterine fibroid|uterine fibroid
429539|NCT01735812|uterine myoma|uterine myoma
429540|NCT01735812|who completed her family planning|who completed her family planning
429541|NCT01735812|but wishes to preserve her uterus|but wishes to preserve her uterus
429542|NCT01735786|Endoscopic Hemostasis|endoscopic hemostasis
429543|NCT01735786|EndoClot Absorbable Polysaccharide Hemostat|endoclot absorbable polysaccharide hemostat
429544|NCT01735786|Colonic Polyps|colonic polyps
429545|NCT01735773|hemodialysis|hemodialysis
429546|NCT01735773|inflammation|inflammation
429547|NCT01735773|iron|iron
429548|NCT01735773|peritoneal dialysis|peritoneal dialysis
429549|NCT01735773|prohepcidin|prohepcidin
429550|NCT01735773|uremia|uremia
429551|NCT01735760|airway management|airway management
429552|NCT01735760|cricothyroid membrane|cricothyroid membrane
429553|NCT01735747|Lymphoma|lymphoma
429554|NCT01735734|Skin disease|skin disease
429555|NCT01735734|Capillary Malformation|capillary malformation
429556|NCT01735734|Laser therapy|laser therapy
429557|NCT01735721|Sinus Floor Augmentation|sinus floor augmentation
429558|NCT01735721|Bone Transplantation|bone transplantation
429559|NCT01735721|Bone Substitute|bone substitute
429560|NCT01735708|pain|pain
429561|NCT01735708|depression|depression
429562|NCT01735708|HIV|hiv
429563|NCT01735708|adherence|adherence
429564|NCT01735695|Meconium|meconium
429565|NCT01735695|concentration|concentration
429566|NCT01735695|level|level
429567|NCT01735682|older adults|older adults
429568|NCT01735682|exercise|exercise
429569|NCT01735682|balance|balance
429570|NCT01735682|gait|gait
429571|NCT01735682|fall|fall
429572|NCT01735682|rehabilitation|rehabilitation
429573|NCT01735682|vibration|vibration
429574|NCT01735682|muscle|muscle
429575|NCT01735669|Remifentanil|remifentanil
429576|NCT01735669|Breech presentation|breech presentation
429577|NCT01735669|Nitrous oxide|nitrous oxide
429578|NCT01735669|Pregnancy complications|pregnancy complications
429579|NCT01735669|Caesarean section|caesarean section
429580|NCT01735669|Fetal version|fetal version
429581|NCT01735656|Coronary heart disease;|coronary heart disease;
429582|NCT01735656|Percutaneous coronary intervention;|percutaneous coronary intervention;
429583|NCT01735656|Bifurcation lesion;|bifurcation lesion;
429584|NCT01735656|Double kissing culotte technique;|double kissing culotte technique;
429585|NCT01735656|clinical trial|clinical trial
429586|NCT01735643|type 2 diabetes mellitus|type 2 diabetes mellitus
429587|NCT01735643|physical activity|physical activity
429588|NCT01735643|lifestyle change|lifestyle change
429589|NCT01735643|motivation|motivation
429590|NCT01735643|patient empowerment|patient empowerment
429591|NCT01735630|Agitation|agitation
429592|NCT01735630|Aggression|aggression
429593|NCT01735630|patients|patients
429594|NCT01735617|congenital adrenal hyperplasia|congenital adrenal hyperplasia
429595|NCT01735617|glucocorticoids|glucocorticoids
429596|NCT01735617|cortisol|cortisol
429598|NCT01735591|Liver cirrhosis|liver cirrhosis
429599|NCT01735591|Liver transplantation|liver transplantation
429600|NCT01735591|Probiotics|probiotics
429601|NCT01735591|Mortality|mortality
429602|NCT01735591|Liver function|liver function
429603|NCT01735591|Infections|infections
429604|NCT01735578|splanchnic oxygen saturations|splanchnic oxygen saturations
429605|NCT01735565|NET formation|net formation
429606|NCT01735565|neutraphil extracellular traps|neutraphil extracellular traps
429607|NCT01735565|post-engraftment immune system|post-engraftment immune system
429608|NCT01735552|gut reperfusion injury|gut reperfusion injury
429609|NCT01735552|blood transfusions|blood transfusions
429610|NCT01735552|premature infants|premature infants
429611|NCT01735552|anemia|anemia
429612|NCT01735552|regional oxygen saturations|regional oxygen saturations
429613|NCT01735552|necrotizing enterocolitis|necrotizing enterocolitis
429614|NCT01735552|mesenteric oxygenation|mesenteric oxygenation
429615|NCT01735539|old age|old age
429616|NCT01735539|sarcopenia|sarcopenia
429617|NCT01735539|essential amino acid|essential amino acid
429618|NCT01735539|arginine|arginine
429619|NCT01735539|contrast enhanced ultrasound|contrast enhanced ultrasound
429620|NCT01735539|muscle microcirculation|muscle microcirculation
429621|NCT01735539|muscle protein synthesis|muscle protein synthesis
429622|NCT01735526|Allogeneic and autologous|allogeneic and autologous
429623|NCT01735526|hematopoietic stem-cell transplantation|hematopoietic stem-cell transplantation
429624|NCT01735526|Lung diffusing capacity|lung diffusing capacity
429625|NCT01735526|for nitric oxide|for nitric oxide
429626|NCT01735526|carbon monoxide|carbon monoxide
429627|NCT01735526|Lung tissue density|lung tissue density
429628|NCT01735526|microvascular damage|microvascular damage
429629|NCT01735513|transaortic TAVI or TAVR|transaortic tavi or tavr
429630|NCT01735513|embolic protection device|embolic protection device
429631|NCT01735513|EmbolX|embolx
429632|NCT01735513|efficacy|efficacy
429633|NCT01735513|during transaortic TAVI|during transaortic tavi
429634|NCT01735513|reduce the incidence of new foci of restricted diffusion on diffusion-weighted MRI|reduce the incidence of new foci of restricted diffusion on diffusion-weighted mri
429635|NCT01735500|Prei-procedural|prei-procedural
429636|NCT01735500|Elevation|elevation
429637|NCT01735500|cardia Troponin T|cardia troponin t
429638|NCT01735500|in stable|in stable
429639|NCT01735500|unknown|unknown
429640|NCT01735474|manual therapy|manual therapy
429641|NCT01735474|respiratory disease|respiratory disease
429642|NCT01735474|thoracic movement|thoracic movement
429643|NCT01735448|smoking cessation|smoking cessation
429644|NCT01735448|tobacco|tobacco
429645|NCT01735448|addiction|addiction
429646|NCT01735448|Aboriginal|aboriginal
429647|NCT01735448|youth|youth
429648|NCT01735448|Indigenous|indigenous
429649|NCT01735448|pharmacological|pharmacological
429650|NCT01735448|focus group|focus group
429651|NCT01735448|interview|interview
429652|NCT01735435|geriatric patients|geriatric patients
429653|NCT01735435|nutritional support|nutritional support
429654|NCT01735422|Infertility|infertility
429655|NCT01735422|Ovulation induction|ovulation induction
429656|NCT01735422|Recombinant human Luteinizing Hormone (r-hLH)|recombinant human luteinizing hormone (r-hlh)
429657|NCT01735422|Urinary human Chorionic Gonadotrophin (u-hCG)|urinary human chorionic gonadotrophin (u-hcg)
429658|NCT01735422|Recombinant human Follicle Stimulating Hormone (Gonal-f®)|recombinant human follicle stimulating hormone (gonal-f®)
429659|NCT01735409|Advanced Nasopharyngeal Carcinoma|advanced nasopharyngeal carcinoma
429660|NCT01735409|Abraxane|abraxane
429661|NCT01735409|Cisplatin|cisplatin
429662|NCT01735409|Dose|dose
429663|NCT01735396|African American men|african american men
429664|NCT01735396|metastatic prostate cancer|metastatic prostate cancer
429665|NCT01735396|castration resistant|castration resistant
429666|NCT01735357|Eicosapentaenoic acid|eicosapentaenoic acid
429667|NCT01735357|Docosahexaenoic acid|docosahexaenoic acid
429668|NCT01735357|Cardiovascular risk|cardiovascular risk
429669|NCT01735357|Platelet function|platelet function
429670|NCT01735357|Endothelial function|endothelial function
429671|NCT01735357|Vascular function|vascular function
429672|NCT01735357|young males|young males
429673|NCT01735331|Vascular endothelial growth factor, Recurrent Pregnancy Loss|vascular endothelial growth factor, recurrent pregnancy loss
429674|NCT01735305|Coronary Artery Disease|coronary artery disease
429675|NCT01735305|antiplatelet therapy|antiplatelet therapy
429676|NCT01735292|Ventilation, timer|ventilation, timer
429677|NCT01735279|tobacco dependence|tobacco dependence
429678|NCT01735279|tobacco treatment|tobacco treatment
429679|NCT01735279|omega 3 series|omega 3 series
429680|NCT01735279|polyunsaturated fatty acids|polyunsaturated fatty acids
429681|NCT01735266|Colonoscopy|colonoscopy
429682|NCT01735253|metabolic surgery|metabolic surgery
429683|NCT01735253|gastric bypass|gastric bypass
429684|NCT01735253|duodenojejunal bypass|duodenojejunal bypass
429685|NCT01735253|type 2 DM|type 2 dm
429686|NCT01735240|Phase I,|phase i,
429687|NCT01735240|healthy volunteers,|healthy volunteers,
429688|NCT01735240|fixed-sequence,|fixed-sequence,
429689|NCT01735240|open-label,|open-label,
429690|NCT01735240|ketoconazole,|ketoconazole,
429691|NCT01735240|combination,|combination,
429692|NCT01735240|safety|safety
429693|NCT01735227|pantoprazole|pantoprazole
429694|NCT01735227|omeprazole|omeprazole
429695|NCT01735227|anti - platelet effect|anti - platelet effect
429696|NCT01735188|Natural history study|natural history study
429697|NCT01735175|biosimilars|biosimilars
429698|NCT01735175|Pegfilgrastim,|pegfilgrastim,
429699|NCT01735175|G-CSF,|g-csf,
429700|NCT01735175|neutropenia,|neutropenia,
429701|NCT01735175|breast cancer,|breast cancer,
429702|NCT01735175|myelosuppressive chemotherapy,|myelosuppressive chemotherapy,
429703|NCT01735175|supportive care|supportive care
429704|NCT01735175|granulocyte-colony-stimulating factor|granulocyte-colony-stimulating factor
429705|NCT01735162|Renal angina|renal angina
429706|NCT01735162|AKI|aki
429707|NCT01735162|Pediatric Intensive Care|pediatric intensive care
429708|NCT01735123|infant formula|infant formula
429709|NCT01735123|diet|diet
549197|NCT01223248|RT|rt
429710|NCT01735123|diabetes mellitus, type 1|diabetes mellitus, type 1
429711|NCT01735123|autoimmunity|autoimmunity
429712|NCT01735097|Arsenic|arsenic
429713|NCT01735097|Keratosis|keratosis
429714|NCT01735097|Nigella sativa|nigella sativa
429715|NCT01735097|Palm|palm
429716|NCT01735097|Vitamin E|vitamin e
429717|NCT01735084|randomized controlled trial|randomized controlled trial
429718|NCT01735084|pneumococcal conjugate vaccines|pneumococcal conjugate vaccines
429719|NCT01735084|booster dose|booster dose
429720|NCT01735084|immunogenicity|immunogenicity
429721|NCT01735084|nasopharyngeal carriage|nasopharyngeal carriage
429722|NCT01735084|Australian Indigenous|australian indigenous
429723|NCT01735084|pediatric|pediatric
429724|NCT01735071|ovarian cancer|ovarian cancer
429725|NCT01735071|bevacizumab|bevacizumab
429726|NCT01735071|trabectedin|trabectedin
429727|NCT01735071|carboplatin|carboplatin
429728|NCT01735071|randomized trial|randomized trial
429729|NCT01735071|phase II|phase ii
429730|NCT01735032|focal epilepsy|focal epilepsy
429731|NCT01735032|pre-surgical evaluation|pre-surgical evaluation
429732|NCT01735032|multimodal imaging|multimodal imaging
429733|NCT01735032|SEEG|seeg
429734|NCT01735019|EC95, effective concentration in 95% of subjects|ec95, effective concentration in 95% of subjects
429735|NCT01735006|Human Papillomavirus 16|human papillomavirus 16
429736|NCT01735006|Human Papillomavirus 18|human papillomavirus 18
429737|NCT01735006|vaccine|vaccine
429738|NCT01735006|Cervical Intraepithelial Neoplasia|cervical intraepithelial neoplasia
429739|NCT01735006|cervical Cancer|cervical cancer
429740|NCT01735006|Vaginal intraepithelial neoplasia|vaginal intraepithelial neoplasia
429741|NCT01735006|Vulvar intraepithelial neoplasia|vulvar intraepithelial neoplasia
429742|NCT01734980|Endobronchial Ultrasound|endobronchial ultrasound
429743|NCT01734980|transbronchial needle aspiration|transbronchial needle aspiration
429744|NCT01734967|confocal laser endomicroscopy|confocal laser endomicroscopy
429745|NCT01734967|Pancreatic Neoplasms|pancreatic neoplasms
429746|NCT01734967|CHRONIC PANCREATITIS|chronic pancreatitis
429747|NCT01734967|Endoscopic ultrasound|endoscopic ultrasound
429748|NCT01734954|Nerve block|nerve block
429749|NCT01734954|Sciatic nerve|sciatic nerve
429750|NCT01734954|Ultrasonography|ultrasonography
429751|NCT01734954|Orthopedics|orthopedics
429752|NCT01734954|Hallux Valgus|hallux valgus
429753|NCT01734954|Amputation|amputation
429754|NCT01734954|Arthrodesis|arthrodesis
429755|NCT01734954|Arthroscopy|arthroscopy
429756|NCT01734954|Fracture fixation|fracture fixation
429757|NCT01734954|Osteotomy|osteotomy
429758|NCT01734954|Tendon transfer|tendon transfer
429759|NCT01734954|Tenodesis|tenodesis
429760|NCT01734954|Tenotomy|tenotomy
429761|NCT01734954|Orthopedic procedure|orthopedic procedure
429762|NCT01734941|Autism|autism
429763|NCT01734941|Trichuris Suis Ova|trichuris suis ova
429764|NCT01734941|Behavior|behavior
429765|NCT01734941|Irritability|irritability
429766|NCT01734928|Multiple Myeloma|multiple myeloma
429767|NCT01734928|Pomalidomide|pomalidomide
429768|NCT01734915|Advanced|advanced
429769|NCT01734915|EGFR mutation|egfr mutation
429770|NCT01734889|nitisinone|nitisinone
429771|NCT01734889|Orfadin|orfadin
429772|NCT01734889|suspension|suspension
429773|NCT01734889|taste|taste
429774|NCT01734889|acceptability|acceptability
429775|NCT01734876|Parkinson´s disease|parkinson´s disease
429776|NCT01734876|Pain|pain
429777|NCT01734876|Sleep|sleep
429778|NCT01734876|HPA axis function|hpa axis function
429779|NCT01734876|Health Related Quality of Life|health related quality of life
429780|NCT01734850|HIV-1|hiv-1
429781|NCT01734837|Laparoscopic appendectomy|laparoscopic appendectomy
429782|NCT01734837|appendical stump closure|appendical stump closure
429783|NCT01734824|bone marrow edema, denosumab, PTH 1-84|bone marrow edema, denosumab, pth 1-84
429784|NCT01734811|Vaccine|vaccine
429785|NCT01734811|Bronchospasm|bronchospasm
429786|NCT01734798|locally advanced bladder cancer|locally advanced bladder cancer
429787|NCT01734798|Postoperative radiotherapy|postoperative radiotherapy
429788|NCT01734798|Adjuvant chemotherapy|adjuvant chemotherapy
429789|NCT01734798|Radical Cystectomy|radical cystectomy
429790|NCT01734759|medication palatability|medication palatability
429791|NCT01734759|medication taste|medication taste
429792|NCT01734746|ovarian cancer|ovarian cancer
429793|NCT01734746|sentinel node|sentinel node
429794|NCT01734733|Parkinson's Disease|parkinson's disease
429795|NCT01734733|Xenotransplantation|xenotransplantation
429796|NCT01734733|choroid plexus|choroid plexus
429797|NCT01734707|atherosclerosis|atherosclerosis
429798|NCT01734707|regression|regression
429799|NCT01734707|Allicor|allicor
429800|NCT01734707|garlic|garlic
429801|NCT01734707|intima-media thickness|intima-media thickness
429802|NCT01734642|Medication errors, patients hospitalized, ADRs, adverse events|medication errors, patients hospitalized, adrs, adverse events
429803|NCT01734629|Coronary Disease|coronary disease
429804|NCT01734629|COPD|copd
429805|NCT01734629|Spirometry|spirometry
429806|NCT01734629|Coronary tomography|coronary tomography
429807|NCT01734616|Microvascular|microvascular
429808|NCT01734616|Muscle|muscle
429809|NCT01734616|Nutrition|nutrition
429810|NCT01734616|Exercise|exercise
429811|NCT01734616|Ageing|ageing
429812|NCT01734603|Assessment|assessment
429813|NCT01734603|Rehabilitation|rehabilitation
429814|NCT01734603|Walking Constant Test|walking constant test
429815|NCT01734603|Walking Graded test|walking graded test
429816|NCT01734603|Six minute Walking test|six minute walking test
429817|NCT01734603|Walking Distance|walking distance
429818|NCT01734590|Flour,|flour,
429819|NCT01734590|carbohydrate,|carbohydrate,
429820|NCT01734590|digestibility|digestibility
429821|NCT01734590|subjects|subjects
429822|NCT01734577|Back pain|back pain
429823|NCT01734551|Prenatal opiate exposure|prenatal opiate exposure
429824|NCT01734551|neonatal withdrawal|neonatal withdrawal
429825|NCT01734551|Pharmacologic treatment|pharmacologic treatment
429826|NCT01734525|candidemia|candidemia
429827|NCT01734525|intensive care unit|intensive care unit
429828|NCT01734525|1,3 beta-D-glucan|1,3 beta-d-glucan
429829|NCT01734512|pediatric recurrent progressive low-grade gliomas|pediatric recurrent progressive low-grade gliomas
429830|NCT01734512|pediatric progressive low-grade gliomas|pediatric progressive low-grade gliomas
429831|NCT01734512|everolimus|everolimus
429832|NCT01734512|mTOR inhibition|mtor inhibition
429833|NCT01734499|Breast cancer|breast cancer
429834|NCT01734499|Survivorship|survivorship
429835|NCT01734499|Coping|coping
429836|NCT01734499|Quality of Life|quality of life
429837|NCT01734473|COPD|copd
429838|NCT01734473|Protein synthesis|protein synthesis
429839|NCT01734473|Protein breakdown|protein breakdown
429840|NCT01734473|Muscle wasting|muscle wasting
429841|NCT01734473|Leucine|leucine
429842|NCT01734473|Hydrolyzed|hydrolyzed
429843|NCT01734473|Casein protein|casein protein
429844|NCT01734473|Carbohydrates|carbohydrates
429845|NCT01734460|pregnancy, snoring, fetal growth|pregnancy, snoring, fetal growth
429846|NCT01734434|Health care access, Pregnant women|health care access, pregnant women
429847|NCT01734421|Smoking cessation|smoking cessation
429848|NCT01734421|Primary health care|primary health care
429849|NCT01734421|Young people|young people
429850|NCT01734421|Cellular phone|cellular phone
429851|NCT01734408|immunogenicity|immunogenicity
429852|NCT01734408|safety|safety
429853|NCT01734408|inactivated EV71 vaccine|inactivated ev71 vaccine
429854|NCT01734395|Alzheimer's disease|alzheimer's disease
429855|NCT01734395|Caregiver's Burden in Alzheimer's disease|caregiver's burden in alzheimer's disease
429856|NCT01734395|Galantamine|galantamine
429857|NCT01734395|Razadyne|razadyne
429858|NCT01734395|Reminyl|reminyl
429859|NCT01734369|Dermatomyositis|dermatomyositis
429860|NCT01734369|Inclusion Body Myositis|inclusion body myositis
429861|NCT01734369|Myositis|myositis
429862|NCT01734369|Polymyositis|polymyositis
429863|NCT01734369|Military|military
429864|NCT01734356|iPS|ips
429865|NCT01734356|fibroblast|fibroblast
429866|NCT01734356|arrhythmias|arrhythmias
429867|NCT01734356|valvulopathies|valvulopathies
429868|NCT01734356|electrophysiology|electrophysiology
429869|NCT01734356|genetics|genetics
429870|NCT01734343|posterior capsule opacification|posterior capsule opacification
429871|NCT01734343|PCO|pco
430177|NCT01732874|DHA|dha
429872|NCT01734343|after cataract|after cataract
429873|NCT01734343|intraocular lens|intraocular lens
429874|NCT01734330|behavior cognitive therapy|behavior cognitive therapy
429876|NCT01734330|randomized clinical trial|randomized clinical trial
429877|NCT01734304|vaccination|vaccination
429878|NCT01734304|postremission therapy|postremission therapy
429879|NCT01734304|acute myeloid leukemia|acute myeloid leukemia
429880|NCT01734304|dendritic cells|dendritic cells
429881|NCT01734291|Family psychoeducation|family psychoeducation
429882|NCT01734291|Major depressive disorder|major depressive disorder
429883|NCT01734291|Family burden|family burden
429884|NCT01734174|transesophageal and transthoracic echocardiogram|transesophageal and transthoracic echocardiogram
429885|NCT01734174|thermodilution|thermodilution
429886|NCT01734174|left ventricular volume|left ventricular volume
429887|NCT01734174|ejection volume|ejection volume
429888|NCT01734161|cesarean section|cesarean section
429889|NCT01734161|nausea|nausea
429890|NCT01734161|vomiting|vomiting
429891|NCT01734161|dexamethasone|dexamethasone
429892|NCT01734161|postoperative nausea and vomiting|postoperative nausea and vomiting
429893|NCT01734161|antiemetics|antiemetics
429894|NCT01734148|pediatric|pediatric
429895|NCT01734148|sleep difficulties in children|sleep difficulties in children
429896|NCT01734148|Sleep Education|sleep education
429897|NCT01734135|B type natriuretic peptide|b type natriuretic peptide
429898|NCT01734135|heart failure|heart failure
429899|NCT01734135|cardiac imaging|cardiac imaging
429900|NCT01734135|quality of care|quality of care
429901|NCT01734122|Stereotactic Radiosurgery|stereotactic radiosurgery
429902|NCT01734122|Essential Tremor|essential tremor
429903|NCT01734122|Parkinsonian Tremor|parkinsonian tremor
429904|NCT01734122|Quality of Life|quality of life
429905|NCT01734122|Severity of Tremor|severity of tremor
429906|NCT01734109|Negative Pressure Wound Therapy|negative pressure wound therapy
429907|NCT01734109|Irrigation Therapy|irrigation therapy
429908|NCT01734109|Pressure Ulcers|pressure ulcers
429909|NCT01734109|Sacral Ulcers|sacral ulcers
429910|NCT01734096|hypertension|hypertension
429911|NCT01734096|obesity|obesity
429912|NCT01734096|white coat hypertension|white coat hypertension
429913|NCT01734096|resistant hypertension|resistant hypertension
429914|NCT01734083|rehabilitation|rehabilitation
429915|NCT01734083|exercise|exercise
429916|NCT01734083|fall|fall
429917|NCT01734083|muscle|muscle
429918|NCT01734083|vibration|vibration
429919|NCT01734083|mobility|mobility
429920|NCT01734083|cognition|cognition
429921|NCT01734070|anthocyanins|anthocyanins
429922|NCT01734070|catechins|catechins
429923|NCT01734070|chlorogenic acid|chlorogenic acid
429924|NCT01734070|flavanol glycosides|flavanol glycosides
429925|NCT01734057|Recombinant Human Thrombopoietin|recombinant human thrombopoietin
429926|NCT01734057|rhTPO|rhtpo
429927|NCT01734057|Rituximab|rituximab
429928|NCT01734057|Dexamethasone|dexamethasone
429929|NCT01734044|Recombinant Human Thrombopoietin|recombinant human thrombopoietin
429930|NCT01734044|rhTPO|rhtpo
429931|NCT01734044|Dexamethasone|dexamethasone
429932|NCT01733953|Cardiovascular Disease|cardiovascular disease
429933|NCT01733953|Childhood ALL|childhood all
429934|NCT01733953|Childhood NHL|childhood nhl
429935|NCT01733927|HIV screening|hiv screening
429936|NCT01733927|Rapid test for HIV|rapid test for hiv
429937|NCT01733914|shoulder pain|shoulder pain
429938|NCT01733914|acupuncture|acupuncture
429939|NCT01733901|Coronary heart disease|coronary heart disease
429940|NCT01733901|PCI|pci
429941|NCT01733901|Renal sympathetic denervation|renal sympathetic denervation
429942|NCT01733901|Hypertension|hypertension
429943|NCT01733901|Diabetes|diabetes
429944|NCT01733888|caries|caries
429945|NCT01733888|caries infiltration|caries infiltration
429946|NCT01733888|fluorosis treatment|fluorosis treatment
429947|NCT01733875|Safety|safety
429948|NCT01733875|Pharmacokinetics|pharmacokinetics
429949|NCT01733875|Food effect|food effect
429950|NCT01733875|Healthy subjects|healthy subjects
429951|NCT01733862|Impact|impact
429952|NCT01733862|Vaccination|vaccination
429953|NCT01733862|Hospitalizations|hospitalizations
429954|NCT01733862|Rotavirus gastroenteritis|rotavirus gastroenteritis
429955|NCT01733862|Japan|japan
429956|NCT01733849|Bulgaria|bulgaria
429957|NCT01733849|Primary care settings|primary care settings
429958|NCT01733849|Children|children
429959|NCT01733849|Latvia|latvia
429960|NCT01733849|Acute gastroenteritis|acute gastroenteritis
429961|NCT01733810|Esophagitis|esophagitis
429962|NCT01733810|Reflux esophagitis|reflux esophagitis
429963|NCT01733810|Gastroesophageal reflux disease|gastroesophageal reflux disease
429964|NCT01733810|Acid|acid
429965|NCT01733810|Inflammation|inflammation
429966|NCT01733810|Esophagus|esophagus
429967|NCT01733810|Cytokines|cytokines
429968|NCT01733810|Esophageal squamous cell|esophageal squamous cell
429969|NCT01733810|Reflux|reflux
429970|NCT01733810|Squamous epithelium|squamous epithelium
429971|NCT01733797|Trismus|trismus
429972|NCT01733797|Therabite|therabite
429973|NCT01733797|Wooden spatula|wooden spatula
429974|NCT01733797|Head and Neck cancer|head and neck cancer
429975|NCT01733784|Sleep Apnea|sleep apnea
429976|NCT01733784|Pathophysiology|pathophysiology
429977|NCT01733771|complementary medicine|complementary medicine
429978|NCT01733771|hospitalized|hospitalized
429979|NCT01733758|albiglutide|albiglutide
429980|NCT01733758|Japanese|japanese
429981|NCT01733758|GSK716155|gsk716155
429982|NCT01733758|Type 2 diabetes mellitus|type 2 diabetes mellitus
429983|NCT01733758|glucagon-like peptide 1|glucagon-like peptide 1
429984|NCT01733745|dry eye|dry eye
429985|NCT01733745|lipid deficiency|lipid deficiency
429986|NCT01733745|meibomian gland|meibomian gland
429987|NCT01733732|Dry eye|dry eye
429988|NCT01733732|Lipid deficiency|lipid deficiency
429989|NCT01733732|Inflammatory markers|inflammatory markers
429990|NCT01733706|No Nicotine Electronic Cigarette|no nicotine electronic cigarette
429991|NCT01733706|Antismoke intervention|antismoke intervention
429992|NCT01733693|Buprenorphine|buprenorphine
429993|NCT01733693|Methadone|methadone
429994|NCT01733693|Cognition|cognition
429995|NCT01733680|ADHD|adhd
429996|NCT01733680|executive function|executive function
429997|NCT01733680|emotional self-regulation|emotional self-regulation
429998|NCT01733667|synechia|synechia
429999|NCT01733667|Fess|fess
430000|NCT01733667|sinus surgery|sinus surgery
430001|NCT01733654|depression|depression
430002|NCT01733654|major depressive disorder|major depressive disorder
430003|NCT01733628|Hypertension|hypertension
430004|NCT01733628|Bevacizumab Response Predictors|bevacizumab response predictors
430005|NCT01733628|Metastatic Breast Cancer|metastatic breast cancer
430006|NCT01733628|Metastatic Colon Cancer|metastatic colon cancer
430007|NCT01733615|Mucopolysaccharidosis Type IVA|mucopolysaccharidosis type iva
430008|NCT01733615|Mucopolysaccharidosis Type IV|mucopolysaccharidosis type iv
430009|NCT01733615|MPS Type IVA|mps type iva
430010|NCT01733615|MPS Type IV|mps type iv
430011|NCT01733615|Morquio Syndrome|morquio syndrome
430012|NCT01733615|Morquio Syndrome Type A|morquio syndrome type a
430013|NCT01733615|Urine biomarkers|urine biomarkers
430014|NCT01733589|Recombinant human endostatin|recombinant human endostatin
430015|NCT01733589|Non-small-Cell Lung Cancer|non-small-cell lung cancer
430016|NCT01733589|chemoradiotherapy|chemoradiotherapy
430017|NCT01733563|sugar sweetened beverages|sugar sweetened beverages
430018|NCT01733563|fructose|fructose
430019|NCT01733563|lipogenesis|lipogenesis
430020|NCT01733563|beta-oxidation|beta-oxidation
430021|NCT01733550|Intraocular Pressure|intraocular pressure
430022|NCT01733550|Tonometry, Ocular|tonometry, ocular
430023|NCT01733550|iCare|icare
430024|NCT01733537|traffic accidents, motorcycle, injury, conspicuity|traffic accidents, motorcycle, injury, conspicuity
430025|NCT01733524|adolescence|adolescence
430026|NCT01733524|self care|self care
430027|NCT01733485|Asthma|asthma
430028|NCT01733485|Electrophilic Fatty Acids|electrophilic fatty acids
430029|NCT01733485|Inflammation|inflammation
430030|NCT01733472|anaesthetic techniques|anaesthetic techniques
430031|NCT01733472|subarachnoid|subarachnoid
430032|NCT01733472|analgesia|analgesia
430033|NCT01733459|PCOS, DLBS3233, metformin,oral anti-hyperglycemic agent|pcos, dlbs3233, metformin,oral anti-hyperglycemic agent
430034|NCT01733446|High frequency jet ventilation|high frequency jet ventilation
430035|NCT01733407|inherited neuropathies|inherited neuropathies
430036|NCT01733394|Epilepsy|epilepsy
430037|NCT01733394|Generic|generic
430038|NCT01733381|Barefoot running, minimally shod running, non-invasive measures of autonomic nervous system (ANS) functioning and mood state.|barefoot running, minimally shod running, non-invasive measures of autonomic nervous system (ans) functioning and mood state.
430039|NCT01733368|CRT|crt
430040|NCT01733368|Optimization|optimization
430041|NCT01733368|Responders|responders
430042|NCT01733329|Buccal Misoprostol|buccal misoprostol
430043|NCT01733329|Uterine Atony|uterine atony
430044|NCT01733329|Postpartum Hemorrhage|postpartum hemorrhage
430045|NCT01733316|Nephropathic Cystinosis|nephropathic cystinosis
430046|NCT01733316|Cysteamine|cysteamine
430047|NCT01733316|Delayed-Release Cysteamine|delayed-release cysteamine
430048|NCT01733316|Orphan Disease|orphan disease
430049|NCT01733316|CTNS Protein, Human|ctns protein, human
430050|NCT01733290|Botulinum Toxin A (BoNT-A)|botulinum toxin a (bont-a)
430051|NCT01733290|Dysfunctional voiding|dysfunctional voiding
430052|NCT01733277|Neuropathic pain|neuropathic pain
430053|NCT01733277|Knee osteoarthritis|knee osteoarthritis
430054|NCT01733277|MRI|mri
430055|NCT01733238|PNT2258|pnt2258
430056|NCT01733238|Lymphoma|lymphoma
430057|NCT01733238|Non-Hodgkin's Lymphoma|non-hodgkin's lymphoma
430058|NCT01733238|NHL|nhl
430059|NCT01733212|Nausea|nausea
430060|NCT01733212|Vomiting|vomiting
430061|NCT01733212|Cesaraen|cesaraen
430062|NCT01733212|Ginger|ginger
430063|NCT01733212|cesarean section|cesarean section
430064|NCT01733199|Parkinson's disease|parkinson's disease
430065|NCT01733199|Behavioural addictions|behavioural addictions
430066|NCT01733199|Pathological gambling|pathological gambling
430067|NCT01733199|Dopamine agonist|dopamine agonist
430068|NCT01733199|Dopamine dysregulation syndrome|dopamine dysregulation syndrome
430069|NCT01733199|Pharmacokinetic|pharmacokinetic
430070|NCT01733199|Pramipexole|pramipexole
430071|NCT01733186|human umbilical cord blood-derived mesenchymal stem cells|human umbilical cord blood-derived mesenchymal stem cells
430072|NCT01733186|MSC|msc
430073|NCT01733186|cartilage lesion|cartilage lesion
430074|NCT01733186|cartilage defect|cartilage defect
430075|NCT01733186|degenerative arthritis|degenerative arthritis
430076|NCT01733186|stem cell implantation|stem cell implantation
430077|NCT01733173|mass in posterior fossa|mass in posterior fossa
430078|NCT01733173|benign|benign
430079|NCT01733173|malignant|malignant
430080|NCT01733173|surgical resection|surgical resection
430081|NCT01733173|MRI|mri
430082|NCT01733173|fMRI|fmri
430083|NCT01733173|DTI|dti
430084|NCT01733173|12-121|12-121
430085|NCT01733160|Atrial Fibrillation|atrial fibrillation
430086|NCT01733160|Stroke|stroke
430087|NCT01733160|Anticoagulants|anticoagulants
430088|NCT01733147|Barrett's esophagus|barrett's esophagus
430089|NCT01733147|Obesity|obesity
430090|NCT01733147|Omega-3 fatty acid|omega-3 fatty acid
430091|NCT01733134|acute heart failure|acute heart failure
430092|NCT01733134|emergency department|emergency department
430093|NCT01733134|copeptin|copeptin
430094|NCT01733134|adh antagonists|adh antagonists
430095|NCT01733108|Healthy|healthy
430096|NCT01733108|Canagliflozin (JNJ-28431754)|canagliflozin (jnj-28431754)
430097|NCT01733108|Pharmacokinetics|pharmacokinetics
430098|NCT01733108|Pharmacodynamics|pharmacodynamics
430099|NCT01733108|Glyburide (MICRONASE)|glyburide (micronase)
430100|NCT01733056|Dermatology|dermatology
430101|NCT01733056|Influenza Vaccine|influenza vaccine
430102|NCT01733030|PTSD|ptsd
430103|NCT01733017|heart failure|heart failure
430104|NCT01733017|nutrition therapy|nutrition therapy
430105|NCT01733017|symptoms|symptoms
430106|NCT01733017|quality of life|quality of life
430107|NCT01733017|lycopene|lycopene
430108|NCT01733017|omega-3 fatty acids|omega-3 fatty acids
430109|NCT01733004|Cancer|cancer
430110|NCT01733004|Hepatocellular Carcinoma|hepatocellular carcinoma
430111|NCT01733004|Oncology|oncology
430112|NCT01733004|Phase I|phase i
430113|NCT01733004|ErbB3|erbb3
430114|NCT01733004|IGF-1R|igf-1r
430115|NCT01733004|Everolimus|everolimus
430116|NCT01733004|Gemcitabine|gemcitabine
430117|NCT01733004|Abraxane|abraxane
430118|NCT01732991|Prostatic Hypertrophy, Benign|prostatic hypertrophy, benign
430119|NCT01732991|Greenlight laser|greenlight laser
430120|NCT01732991|Prostatic photovaporization|prostatic photovaporization
430121|NCT01732991|Prostatic MRI|prostatic mri
430122|NCT01732991|Prostatic contrast-enhanced ultrasound|prostatic contrast-enhanced ultrasound
430123|NCT01732991|Urinary irritative signs|urinary irritative signs
430124|NCT01732991|Postoperative necrotic area|postoperative necrotic area
430125|NCT01732978|Crying record|crying record
430126|NCT01732978|Newborn|newborn
430127|NCT01732965|Vitiligo|vitiligo
430128|NCT01732965|Phototherapy|phototherapy
430129|NCT01732965|Photochemotherapy|photochemotherapy
430130|NCT01732952|the prevalence,lipid abnormalities,CV risks|the prevalence,lipid abnormalities,cv risks
430131|NCT01732926|iNHL|inhl
430132|NCT01732926|indolent NHL|indolent nhl
430133|NCT01732926|follicular lymphoma|follicular lymphoma
430134|NCT01732926|CAL-101|cal-101
430135|NCT01732926|rituximab|rituximab
430136|NCT01732926|bendamustine|bendamustine
430137|NCT01732926|small lymphocytic lymphoma|small lymphocytic lymphoma
430138|NCT01732926|lymphoplasmacytoid lymphoma|lymphoplasmacytoid lymphoma
430139|NCT01732926|Waldenstrom macroglobulinemia|waldenstrom macroglobulinemia
430140|NCT01732926|LPL|lpl
430141|NCT01732926|WM|wm
430142|NCT01732926|Marginal zone lymphoma|marginal zone lymphoma
430143|NCT01732926|MZL|mzl
430144|NCT01732926|SLL|sll
430145|NCT01732926|FL|fl
430146|NCT01732926|GS-1101|gs-1101
430147|NCT01732926|PI3K inhibitor|pi3k inhibitor
430148|NCT01732926|idelalisib|idelalisib
430149|NCT01732913|iNHL|inhl
430150|NCT01732913|indolent NHL|indolent nhl
430151|NCT01732913|follicular lymphoma|follicular lymphoma
430152|NCT01732913|CAL-101|cal-101
430153|NCT01732913|Rituximab|rituximab
430154|NCT01732913|Small lymphocytic lymphoma|small lymphocytic lymphoma
430155|NCT01732913|lymphoplasmacytoid lymphoma|lymphoplasmacytoid lymphoma
430156|NCT01732913|Waldenstrom macroglobulinemia|waldenstrom macroglobulinemia
430157|NCT01732913|LPL|lpl
430158|NCT01732913|WM|wm
430159|NCT01732913|Marginal zone lymphoma|marginal zone lymphoma
430160|NCT01732913|MZL|mzl
430161|NCT01732913|SLL|sll
430162|NCT01732913|FL|fl
430163|NCT01732913|GS-1101|gs-1101
430164|NCT01732913|idelalisib|idelalisib
430165|NCT01732900|In vitro fertilization|in vitro fertilization
430166|NCT01732900|Assisted reproduction|assisted reproduction
430167|NCT01732900|pregnancy outcome|pregnancy outcome
430168|NCT01732900|cumulus cells|cumulus cells
430169|NCT01732887|cochlear implants|cochlear implants
430170|NCT01732887|speech comprehension|speech comprehension
430171|NCT01732887|cognitive training|cognitive training
430172|NCT01732887|cognitive fitness|cognitive fitness
430173|NCT01732887|intervention|intervention
430174|NCT01732887|memory|memory
430175|NCT01732887|attention|attention
430176|NCT01732887|rehabilitation|rehabilitation
430178|NCT01732874|Preterm infant|preterm infant
430179|NCT01732874|Inflammation|inflammation
430180|NCT01732874|Growth|growth
430181|NCT01732874|Developement|developement
430182|NCT01732861|Chronic Lymphocytic Leukemia|chronic lymphocytic leukemia
430183|NCT01732861|Small Lymphocytic Leukemia|small lymphocytic leukemia
430184|NCT01732848|Volunteers|volunteers
430185|NCT01732835|Aortic Insufficiency (AI) Aortic Regurgitation (AR)|aortic insufficiency (ai) aortic regurgitation (ar)
430186|NCT01732822|Peripheral artery disease Atherothrombotic events Atherosclerosis|peripheral artery disease atherothrombotic events atherosclerosis
430187|NCT01732809|wrinkles|wrinkles
430188|NCT01732809|botulinum toxin|botulinum toxin
430189|NCT01732783|Wild-type RAS|wild-type ras
430190|NCT01732783|Metastatic Colorectal Cancer|metastatic colorectal cancer
430191|NCT01732783|Vectibix|vectibix
430192|NCT01732744|biofilm, castor bean, sodium hypochlorite, alkaline peroxide|biofilm, castor bean, sodium hypochlorite, alkaline peroxide
430193|NCT01732731|Cerebral palsy|cerebral palsy
430194|NCT01732731|treadmill training|treadmill training
430195|NCT01732718|sickle cell disease|sickle cell disease
430196|NCT01732718|endothelial function|endothelial function
430197|NCT01732718|albuminuria|albuminuria
430198|NCT01732718|atorvastatin|atorvastatin
430199|NCT01732718|soluble fms-like tyrosine kinase-1|soluble fms-like tyrosine kinase-1
430200|NCT01732705|Type 2 diabetes|type 2 diabetes
430201|NCT01732705|Insulin sensitivity|insulin sensitivity
430202|NCT01732705|High intensity interval training|high intensity interval training
430203|NCT01732692|Bowel preparation, MOVIPREP®|bowel preparation, moviprep®
710621|NCT00588562|PH NonI-NonII|ph noni-nonii
430204|NCT01732679|stroke, rehabilitation, multidisciplinary, description|stroke, rehabilitation, multidisciplinary, description
430205|NCT01732666|Opioid-induced hyperalgesia (OIH)|opioid-induced hyperalgesia (oih)
430206|NCT01732653|virtual reality,|virtual reality,
430207|NCT01732653|falls,|falls,
430208|NCT01732653|elderly,|elderly,
430209|NCT01732653|Parkinson's disease,|parkinson's disease,
430210|NCT01732653|MCI|mci
430211|NCT01732640|Squamous cell carcinoma of the head and neck|squamous cell carcinoma of the head and neck
430212|NCT01732627|Meningitis|meningitis
430213|NCT01732627|Meningococcal Meningitis|meningococcal meningitis
430214|NCT01732627|Menactra®|menactra®
430215|NCT01732627|Menomune® A/C/Y/W-135|menomune® a/c/y/w-135
430216|NCT01732614|Diabetic Macular Edema|diabetic macular edema
430217|NCT01732614|DME|dme
430218|NCT01732614|Laser|laser
430219|NCT01732614|Topcon|topcon
430220|NCT01732614|EndPoint Management|endpoint management
430221|NCT01732601|Suicide Attempt|suicide attempt
430222|NCT01732601|Suicidal Ideation|suicidal ideation
430223|NCT01732601|NSSI|nssi
430224|NCT01732601|Substance Use|substance use
430225|NCT01732588|Bioavailability|bioavailability
430226|NCT01732575|everyday activities|everyday activities
430227|NCT01732575|rehabilitation|rehabilitation
430228|NCT01732575|mental illness|mental illness
430229|NCT01732575|occupational therapy|occupational therapy
430230|NCT01732562|Primary Total Knee Arthroplasty|primary total knee arthroplasty
430231|NCT01732562|Patient Expectations|patient expectations
430232|NCT01732562|Patient Satisfaction|patient satisfaction
430233|NCT01732562|Patient Education|patient education
430234|NCT01732562|e-Learning|e-learning
430235|NCT01732536|corticosteroid-eluting sinus implant|corticosteroid-eluting sinus implant
430236|NCT01732536|chronic rhinosinusitis|chronic rhinosinusitis
430237|NCT01732536|mometasone furoate|mometasone furoate
430238|NCT01732536|polyposis|polyposis
430239|NCT01732523|Carotid stenosis|carotid stenosis
430240|NCT01732523|Vasa Vasorum|vasa vasorum
430241|NCT01732523|Ultrasonography|ultrasonography
430242|NCT01732497|Underarm Hair|underarm hair
430243|NCT01732497|Underarm Hair Reduction|underarm hair reduction
430244|NCT01732497|Axillary Hair|axillary hair
430245|NCT01732497|Axillary Hair Reduction|axillary hair reduction
430246|NCT01732497|Underarm Odor|underarm odor
430247|NCT01732497|Axillary Odor|axillary odor
430248|NCT01732471|EMR 700733_510, Genetic disorder, Phenylketonuria, phenylalanine, Kuvan, sapropterin dihydrochloride|emr 700733_510, genetic disorder, phenylketonuria, phenylalanine, kuvan, sapropterin dihydrochloride
430249|NCT01732419|Rehabilitation, exercise therapy, coronary artery disease|rehabilitation, exercise therapy, coronary artery disease
430250|NCT01732393|Quercetin|quercetin
430251|NCT01732393|Chemotherapy|chemotherapy
430252|NCT01732393|Mucositis|mucositis
430253|NCT01732393|Hematologic Malignancies|hematologic malignancies
430254|NCT01732367|Tenofovir|tenofovir
430255|NCT01732367|Lamivudine|lamivudine
430256|NCT01732367|Adefovir|adefovir
430257|NCT01732367|Chronic Hepatitis B|chronic hepatitis b
430258|NCT01732354|Hepatitis B virus, Tenofovir|hepatitis b virus, tenofovir
430259|NCT01732341|STEMI|stemi
430260|NCT01732341|BMS|bms
430261|NCT01732341|Self-expanding stent|self-expanding stent
430262|NCT01732315|Adolescent vaccination|adolescent vaccination
430263|NCT01732315|Immunization rates|immunization rates
430264|NCT01732315|Barriers to vaccination|barriers to vaccination
430265|NCT01732315|Attitudes|attitudes
430266|NCT01732315|Intentions|intentions
430267|NCT01732302|Drug Utilization Review|drug utilization review
430268|NCT01732302|Aged|aged
430269|NCT01732302|Aged, 80 and over|aged, 80 and over
430365|NCT01731925|progressive|progressive
430270|NCT01732302|Primary Health Care|primary health care
430271|NCT01732289|Age-related hearing loss|age-related hearing loss
430273|NCT01732289|Single nucleotide polymorphism|single nucleotide polymorphism
430274|NCT01732289|environmental factors|environmental factors
430275|NCT01732276|Triple-negative breast cancer|triple-negative breast cancer
430276|NCT01732276|Epidermal growth factor receptor|epidermal growth factor receptor
430277|NCT01732276|Gefitinib|gefitinib
430278|NCT01732250|Gram-Negative Bacterial Infections|gram-negative bacterial infections
430279|NCT01732250|Resistant Bacteria|resistant bacteria
430280|NCT01732250|Drug Resistance, Bacterial|drug resistance, bacterial
430281|NCT01732250|Colistin|colistin
430282|NCT01732237|Healthy|healthy
430283|NCT01732237|JNJ-42396302|jnj-42396302
430284|NCT01732237|JNJ-42692507|jnj-42692507
430285|NCT01732237|JNJ-53773187|jnj-53773187
430286|NCT01732237|Pharmacokinetics|pharmacokinetics
430287|NCT01732211|Phase 2|phase 2
430288|NCT01732211|Randomized|randomized
430289|NCT01732211|Double Blind|double blind
430290|NCT01732211|Placebo Controlled|placebo controlled
430291|NCT01732211|Parallel|parallel
430292|NCT01732211|20 Week Safety|20 week safety
430293|NCT01732211|Tolerability|tolerability
430294|NCT01732211|and Efficacy Study|and efficacy study
430295|NCT01732185|Congenital lung malformation|congenital lung malformation
430296|NCT01732185|Congenital Cystic Adenomatoid Malformation|congenital cystic adenomatoid malformation
430297|NCT01732185|Cystic lung disease|cystic lung disease
430298|NCT01732172|Urethritis|urethritis
430299|NCT01732172|Prevalence of a chronic inflammatory male genital tract|prevalence of a chronic inflammatory male genital tract
430300|NCT01732159|Ambulatory surgery|ambulatory surgery
430301|NCT01732159|Checklist|checklist
430302|NCT01732159|Cancellation|cancellation
430303|NCT01732146|Hypoxic Ischemic Encephalopathy|hypoxic ischemic encephalopathy
430304|NCT01732146|Term neonate|term neonate
430305|NCT01732146|Neuroprotection|neuroprotection
430306|NCT01732146|erythropoietin|erythropoietin
430307|NCT01732133|Hypotension|hypotension
430308|NCT01732133|Cesarean delivery|cesarean delivery
430309|NCT01732120|off-clamp|off-clamp
430310|NCT01732120|partial nephrectomy|partial nephrectomy
430311|NCT01732120|renal cancer treatment|renal cancer treatment
430312|NCT01732120|renal ischemia|renal ischemia
430313|NCT01732107|Dovitinib|dovitinib
430314|NCT01732107|FGFR3 Mutations|fgfr3 mutations
430315|NCT01732107|BCG-Refractory Urothelial Carcinoma|bcg-refractory urothelial carcinoma
430316|NCT01732094|Poor ovarian response|poor ovarian response
430317|NCT01732094|Poor ovarian responders|poor ovarian responders
430318|NCT01732094|Bologna criteria for poor ovarian response|bologna criteria for poor ovarian response
430319|NCT01732081|Hepatitis B|hepatitis b
430320|NCT01732068|Poor ovarian response|poor ovarian response
430321|NCT01732068|Poor ovarian responders|poor ovarian responders
430322|NCT01732068|Bologna criteria for poor ovarian response|bologna criteria for poor ovarian response
430323|NCT01732055|Pregnancy|pregnancy
430324|NCT01732055|Antenatal|antenatal
430325|NCT01732055|Major Depressive Disorder|major depressive disorder
430326|NCT01732055|Psychotherapy|psychotherapy
430327|NCT01732055|Antidepressant Medication|antidepressant medication
430328|NCT01732055|Partners|partners
430329|NCT01732055|Spouses|spouses
430330|NCT01732055|Interpersonal Psychotherapy|interpersonal psychotherapy
430331|NCT01732042|retinal venous pressure|retinal venous pressure
430332|NCT01732029|pulse oximeter|pulse oximeter
430333|NCT01732029|oxygen saturation|oxygen saturation
430334|NCT01732029|heart rate|heart rate
430335|NCT01732029|calibration|calibration
430336|NCT01732029|accuracy|accuracy
430337|NCT01732016|pulse oximeter|pulse oximeter
430338|NCT01732016|oxygen saturation|oxygen saturation
430339|NCT01732016|heart rate|heart rate
430340|NCT01732016|calibration|calibration
430341|NCT01732016|accuracy|accuracy
430342|NCT01732003|Omega-3|omega-3
430343|NCT01732003|Skeletal Muscle|skeletal muscle
430344|NCT01732003|Eicosapentaenoic acid|eicosapentaenoic acid
430345|NCT01732003|Docosahexaenoic acid|docosahexaenoic acid
430346|NCT01732003|Exercise|exercise
430347|NCT01732003|Membrane Composition|membrane composition
430348|NCT01732003|Lipid Metabolism|lipid metabolism
430349|NCT01731990|Peripheral artery disease|peripheral artery disease
430350|NCT01731990|Intermittent claudication|intermittent claudication
430351|NCT01731990|magnetic resonance imaging|magnetic resonance imaging
430352|NCT01731977|Psychotherapy, Psychotic disorders, Caregiver|psychotherapy, psychotic disorders, caregiver
430353|NCT01731964|Macular Degeneration|macular degeneration
430354|NCT01731964|Visual Impairment|visual impairment
430355|NCT01731964|Implantable Telescope|implantable telescope
430356|NCT01731951|Myelofibrosis|myelofibrosis
430357|NCT01731951|Myelodysplastic Syndromes|myelodysplastic syndromes
430358|NCT01731951|Myeloproliferative Neoplasm|myeloproliferative neoplasm
430359|NCT01731951|Imetelstat|imetelstat
430360|NCT01731951|GRN163L|grn163l
430361|NCT01731938|Fibrin Sealant|fibrin sealant
430362|NCT01731938|Soft tissue open surgery|soft tissue open surgery
430363|NCT01731938|Oxidized cellulose pads|oxidized cellulose pads
430364|NCT01731925|midgut carcinoid tumors|midgut carcinoid tumors
430366|NCT01731925|advanced|advanced
430367|NCT01731925|metastatic|metastatic
430368|NCT01731899|major depression|major depression
430369|NCT01731899|fibromyalgia|fibromyalgia
430370|NCT01731899|agomelatine|agomelatine
430371|NCT01731899|Becks' Depression Inventory (BDI)|becks' depression inventory (bdi)
430372|NCT01731899|Pittsburgh's Sleep Quality Index (PSQI)|pittsburgh's sleep quality index (psqi)
430373|NCT01731886|Stem cell transplant|stem cell transplant
430374|NCT01731886|plasma cell myeloma|plasma cell myeloma
430375|NCT01731886|multiple myeloma|multiple myeloma
430376|NCT01731873|postoperative pain|postoperative pain
430377|NCT01731873|children|children
430378|NCT01731873|pharmacogenetic|pharmacogenetic
430379|NCT01731873|opioid adverse effects|opioid adverse effects
430380|NCT01731873|respiratory depression|respiratory depression
430381|NCT01731873|analgesia|analgesia
430382|NCT01731873|genetic polymorphisms|genetic polymorphisms
430383|NCT01731873|chronic postsurgical pain|chronic postsurgical pain
430384|NCT01731860|PET/CT|pet/ct
430385|NCT01731860|Philips|philips
430386|NCT01731847|dysphagia,endoscopy, electrical stimulation,stroke|dysphagia,endoscopy, electrical stimulation,stroke
430387|NCT01731834|Pain|pain
430388|NCT01731834|Stress|stress
430389|NCT01731834|Physiotherapy|physiotherapy
430390|NCT01731834|Children|children
430391|NCT01731821|Pancreaticoduodenectomy|pancreaticoduodenectomy
430392|NCT01731821|Pancreaticojejunostomy|pancreaticojejunostomy
550110|NCT01219595|UTI|uti
430393|NCT01731808|Nursing counseling|nursing counseling
430394|NCT01731808|diabetic foot|diabetic foot
430395|NCT01731795|acute respiratory distress syndrome, mechanical ventilation|acute respiratory distress syndrome, mechanical ventilation
430396|NCT01731782|colorectal surgery|colorectal surgery
430397|NCT01731769|Seroma Formation|seroma formation
430398|NCT01731769|Axillary Lymph Node Dissection|axillary lymph node dissection
430399|NCT01731769|Breast cancer|breast cancer
430400|NCT01731769|Early Vacuum Assisted Closure|early vacuum assisted closure
430401|NCT01731756|Palm|palm
430402|NCT01731756|Arsenic|arsenic
430403|NCT01731756|Keratosis|keratosis
430404|NCT01731756|Salicylic acid|salicylic acid
430405|NCT01731756|Azadirachta indica|azadirachta indica
430406|NCT01731756|Neem|neem
430407|NCT01731730|Postsurgical pain|postsurgical pain
430408|NCT01731730|Total knee arthroplasty|total knee arthroplasty
430409|NCT01731730|Total knee replacement|total knee replacement
430410|NCT01731717|depression|depression
430411|NCT01731717|stepped care|stepped care
430412|NCT01731717|evidence-based medicine|evidence-based medicine
430413|NCT01731717|health services research|health services research
430414|NCT01731717|psychotherapy|psychotherapy
430415|NCT01731717|complex intervention|complex intervention
430416|NCT01731717|guideline|guideline
430417|NCT01731704|5 or more brain metastases|5 or more brain metastases
430418|NCT01731704|proven diagnosis of a non-hematopoietic malignancy|proven diagnosis of a non-hematopoietic malignancy
430419|NCT01731704|non-small cell lung cancer or germ cell malignancy|non-small cell lung cancer or germ cell malignancy
430420|NCT01731665|Crohn's disease|crohn's disease
430421|NCT01731665|ulcerative colitis|ulcerative colitis
430422|NCT01731665|epidemiology|epidemiology
430423|NCT01731665|Korea|korea
430424|NCT01731652|bladder cancer|bladder cancer
430425|NCT01731652|carcinoma in situ|carcinoma in situ
430426|NCT01731652|non muscle invasive bladder cancer|non muscle invasive bladder cancer
430427|NCT01731587|Non-small cell lung cancer (NSCLC)|non-small cell lung cancer (nsclc)
430428|NCT01731587|exploratory study|exploratory study
430429|NCT01731587|L-BLP25|l-blp25
430430|NCT01731561|Granulomatosis with Polyangiitis|granulomatosis with polyangiitis
430431|NCT01731561|Microscopic polyangiitis|microscopic polyangiitis
430432|NCT01731561|Renal limited forms|renal limited forms
430433|NCT01731561|ANCA-associated vasculitis|anca-associated vasculitis
430434|NCT01731561|Rituximab|rituximab
430435|NCT01731535|osteoporosis, low trauma fracture, non-union fracture, delayed healing fracture, bisphosphonate|osteoporosis, low trauma fracture, non-union fracture, delayed healing fracture, bisphosphonate
430436|NCT01731509|congenital diaphragmatic hernia|congenital diaphragmatic hernia
430437|NCT01731509|fetoscopy|fetoscopy
430438|NCT01731509|fetal endoscopic tracheal occlusion|fetal endoscopic tracheal occlusion
430439|NCT01731509|pulmonary hypoplasia|pulmonary hypoplasia
430440|NCT01731509|fetal surgery|fetal surgery
430441|NCT01731509|fetal lung|fetal lung
430442|NCT01731496|Human Papillomavirus|human papillomavirus
430443|NCT01731483|virulence factors|virulence factors
430444|NCT01731457|ischemia, reperfusion, kidney, transplantation|ischemia, reperfusion, kidney, transplantation
430445|NCT01731444|blood loss|blood loss
430446|NCT01731444|burn|burn
430447|NCT01731444|hemostasis|hemostasis
430448|NCT01731431|Gestational Diabetes,|gestational diabetes,
430449|NCT01731431|Insulin,|insulin,
430450|NCT01731431|Glyburide,|glyburide,
430451|NCT01731431|Glycemia|glycemia
430452|NCT01731418|Post Traumatic Stress Disorder|post traumatic stress disorder
430453|NCT01731418|Depression|depression
430454|NCT01731418|Intimate Partner violence|intimate partner violence
430455|NCT01731418|Narrative Exposure Therapy|narrative exposure therapy
430456|NCT01731405|Medication Guides|medication guides
430457|NCT01731405|FDA|fda
430458|NCT01731405|Prototype|prototype
430459|NCT01731405|Format|format
430460|NCT01731392|Diarrhea|diarrhea
430461|NCT01731392|Children|children
430462|NCT01731392|Lactobacilli|lactobacilli
430463|NCT01731379|spectroscopy|spectroscopy
430464|NCT01731379|nerve|nerve
430465|NCT01731379|muscle|muscle
430466|NCT01731379|fat|fat
430467|NCT01731353|invasive fungal infection|invasive fungal infection
430468|NCT01731353|Web-based registry|web-based registry
430469|NCT01731340|Calcium Supplements|calcium supplements
430470|NCT01731340|Dairy Foods|dairy foods
430471|NCT01731340|Cardiovascular Diseases|cardiovascular diseases
430472|NCT01731340|Osteoporosis|osteoporosis
430473|NCT01731340|Postmenopause|postmenopause
430474|NCT01731340|Vitamin D|vitamin d
430475|NCT01731340|Micronutrients|micronutrients
430476|NCT01731340|Primary Prevention|primary prevention
430477|NCT01731340|Bone Health|bone health
430478|NCT01731327|Phase 1|phase 1
430479|NCT01731327|relative bioavailability|relative bioavailability
430480|NCT01731327|modified release|modified release
430481|NCT01731327|tofacitinib|tofacitinib
430482|NCT01731327|CP-690|cp-690
430483|NCT01731327|550|550
430484|NCT01731327|pharmacokinetic|pharmacokinetic
430485|NCT01731301|Chronic hepatitis C|chronic hepatitis c
430486|NCT01731301|HCV|hcv
430487|NCT01731301|End stage renal disease|end stage renal disease
430488|NCT01731301|ESRD|esrd
430489|NCT01731301|Boceprevir|boceprevir
430490|NCT01731301|Ribavirin|ribavirin
430491|NCT01731301|Peg-interferon|peg-interferon
430492|NCT01731301|Triple therapy|triple therapy
430493|NCT01731288|pregnancy|pregnancy
430494|NCT01731288|childbirth|childbirth
430495|NCT01731288|pain|pain
430496|NCT01731288|vulvodynia|vulvodynia
430497|NCT01731288|provoked vestibulodynia|provoked vestibulodynia
430498|NCT01731275|Healthy volunteers|healthy volunteers
430499|NCT01731275|immunogenicity|immunogenicity
430500|NCT01731275|anti-E6011 antibody|anti-e6011 antibody
430501|NCT01731262|Arthritis, Rheumatoid|arthritis, rheumatoid
430502|NCT01731262|Sonic hedgehog protein, human|sonic hedgehog protein, human
430503|NCT01731262|Neovascularization, Pathologic|neovascularization, pathologic
430504|NCT01731262|Synovitis|synovitis
430505|NCT01731249|Sublingual immunotherapy|sublingual immunotherapy
430506|NCT01731249|Birch pollen extract solution|birch pollen extract solution
430507|NCT01731249|Allergic rhinoconjunctivitis|allergic rhinoconjunctivitis
430508|NCT01731236|Carnitine metabolism|carnitine metabolism
430509|NCT01731236|gut flora|gut flora
430510|NCT01731223|Insomnia|insomnia
430511|NCT01731223|Primary health care|primary health care
430512|NCT01731197|obesity, isolated soy protein, satiety, food intake|obesity, isolated soy protein, satiety, food intake
430513|NCT01731184|acute traumatic pain, pre-hospital setting, Midazolam|acute traumatic pain, pre-hospital setting, midazolam
430514|NCT01731171|mania|mania
430515|NCT01731171|manic episode|manic episode
430516|NCT01731171|mixed episode|mixed episode
430517|NCT01731171|bipolar disorder|bipolar disorder
430518|NCT01731171|schizoaffective disorder|schizoaffective disorder
430519|NCT01731171|probiotics|probiotics
430520|NCT01731171|probiotic supplement|probiotic supplement
430521|NCT01731171|relapse prevention|relapse prevention
430522|NCT01731171|new mood episode|new mood episode
430523|NCT01731171|re-hospitalization|re-hospitalization
430524|NCT01731145|Tremor|tremor
430525|NCT01731145|SNUMAP|snumap
430526|NCT01731145|accelerometry|accelerometry
430527|NCT01731145|gyroscope|gyroscope
430528|NCT01731145|clinical rating scale|clinical rating scale
430529|NCT01731132|HRQoL|hrqol
430530|NCT01731132|IUD|iud
430531|NCT01731132|Contraception|contraception
430532|NCT01731132|SEC-QoL|sec-qol
430533|NCT01731119|Latuda,lurasidone,antipsychotics,autism, mood, psychosis|latuda,lurasidone,antipsychotics,autism, mood, psychosis
430534|NCT01731093|aged|aged
430535|NCT01731093|health|health
430536|NCT01731093|brain|brain
430537|NCT01731054|lupus nephritis|lupus nephritis
430538|NCT01731054|normal healthy volunteer|normal healthy volunteer
430539|NCT01731054|MRI|mri
430540|NCT01731041|coronary disease, platelet function, platelet inhibitors|coronary disease, platelet function, platelet inhibitors
430541|NCT01731002|Glaucoma|glaucoma
430542|NCT01730989|menopause|menopause
430543|NCT01730989|Kupperman|kupperman
430544|NCT01730989|hot flushes|hot flushes
430545|NCT01730989|isoflavones|isoflavones
430546|NCT01730989|magnolia|magnolia
430547|NCT01730989|chaste tree|chaste tree
430548|NCT01730976|asthma, elderly, vitamin D|asthma, elderly, vitamin d
430549|NCT01730924|Atrial fibrillation|atrial fibrillation
430550|NCT01730924|Contact force|contact force
430551|NCT01730924|Ablation|ablation
430552|NCT01730911|Bleeding|bleeding
430553|NCT01730911|Cramping|cramping
430554|NCT01730911|Pregnancy with intrauterine device in place|pregnancy with intrauterine device in place
430555|NCT01730911|Intrauterine device expulsion|intrauterine device expulsion
430556|NCT01730911|Intrauterine device removal|intrauterine device removal
430557|NCT01730859|Balance exercise|balance exercise
430558|NCT01730859|Ankle|ankle
430559|NCT01730859|Postural stability|postural stability
430560|NCT01730859|Taping|taping
430561|NCT01730859|Biodex|biodex
430562|NCT01730846|smoking lapse behavior|smoking lapse behavior
430563|NCT01730846|smoking cessation|smoking cessation
430564|NCT01730846|doxazosin|doxazosin
430565|NCT01730846|medication effect on smoking lapse behavior|medication effect on smoking lapse behavior
430566|NCT01730846|medication effect on smoking cessation|medication effect on smoking cessation
430567|NCT01730846|stress|stress
430568|NCT01730807|Atrial Flutter|atrial flutter
430569|NCT01730807|Ablation|ablation
430570|NCT01730807|Type I Atrial Flutter|type i atrial flutter
430571|NCT01730807|Atrial Arrhythmia|atrial arrhythmia
430572|NCT01730794|Acute Respiratory Failure|acute respiratory failure
430573|NCT01730794|Mechanical Ventilation|mechanical ventilation
430574|NCT01730794|NAVA|nava
430575|NCT01730794|Lung protective ventilation|lung protective ventilation
430576|NCT01730794|invasive ventilation|invasive ventilation
430577|NCT01730794|noninvasive ventilation|noninvasive ventilation
430578|NCT01730781|Cannabis dependence|cannabis dependence
430579|NCT01730781|Brain Imaging|brain imaging
430580|NCT01730781|Schizophrenia|schizophrenia
430581|NCT01730781|Control|control
710234|NCT00589641|suicidal ideation and behavior|suicidal ideation and behavior
710235|NCT00589641|depression|depression
430582|NCT01730768|schizophrenia, chronic stable schizophrenia, cognition, memory, visual learning, CogState|schizophrenia, chronic stable schizophrenia, cognition, memory, visual learning, cogstate
430583|NCT01730755|Polycythemia|polycythemia
430584|NCT01730716|Human spinal cord derived neural stem cell transplantation|human spinal cord derived neural stem cell transplantation
430585|NCT01730716|ALS|als
430586|NCT01730703|walking|walking
430587|NCT01730703|incentives|incentives
430588|NCT01730703|elderly|elderly
430589|NCT01730690|Bacterial meningitis in adults|bacterial meningitis in adults
430590|NCT01730690|determinants of in-hospital mortality|determinants of in-hospital mortality
430591|NCT01730677|Lapatinib|lapatinib
430592|NCT01730677|Vinorelbine|vinorelbine
430593|NCT01730664|ertapenem|ertapenem
430594|NCT01730664|tuberculosis|tuberculosis
430595|NCT01730664|pharmacokinetics|pharmacokinetics
430596|NCT01730651|cervical cancer with metastatic lymphadenopathies|cervical cancer with metastatic lymphadenopathies
430597|NCT01730638|thyroid,|thyroid,
430598|NCT01730638|endocrine tumour|endocrine tumour
430599|NCT01730638|Nuclear medicine,|nuclear medicine,
430600|NCT01730638|molecular imaging|molecular imaging
430601|NCT01730638|ImmunoTEP|immunotep
430602|NCT01730625|Attention bias modification treatment (ABMT)|attention bias modification treatment (abmt)
430603|NCT01730625|Attention biases|attention biases
430604|NCT01730625|Anxious children|anxious children
430605|NCT01730625|Cognitive Behavioral Therapy (CBT)|cognitive behavioral therapy (cbt)
430606|NCT01730612|ImmunoTEP|immunotep
430607|NCT01730612|HER2 negative|her2 negative
430608|NCT01730612|Breast Cancer|breast cancer
430609|NCT01730586|Colorectal Cancer|colorectal cancer
430610|NCT01730586|Cancer of Gastrointestinal Tract|cancer of gastrointestinal tract
430611|NCT01730586|CIMP-high Colorectal Adenocarcinoma|cimp-high colorectal adenocarcinoma
430612|NCT01730586|Small Bowel Adenocarcinomas|small bowel adenocarcinomas
430613|NCT01730586|Colorectal|colorectal
430614|NCT01730586|Small bowel cancer|small bowel cancer
430615|NCT01730586|Abraxane|abraxane
430616|NCT01730586|Nab-Paclitaxel|nab-paclitaxel
430617|NCT01730586|Paclitaxel (Protein-Bound)|paclitaxel (protein-bound)
430618|NCT01730586|ABI-007|abi-007
430619|NCT01730573|interscalene|interscalene
430620|NCT01730573|suprascapular|suprascapular
430621|NCT01730573|axillary|axillary
430622|NCT01730547|Mesenchymal stem cells|mesenchymal stem cells
430623|NCT01730547|Multiple Sclerosis|multiple sclerosis
430624|NCT01730547|Autoimmune diseases|autoimmune diseases
430625|NCT01730534|Phase IIIb|phase iiib
430626|NCT01730534|T2DM|t2dm
430627|NCT01730534|cardiovascular events|cardiovascular events
430628|NCT01730495|Chronic fatigue syndrome|chronic fatigue syndrome
430629|NCT01730495|CFS|cfs
430630|NCT01730495|Myalgic Encephalomyelitis (ME)|myalgic encephalomyelitis (me)
430631|NCT01730495|CFS/ME|cfs/me
430632|NCT01730495|Tumor necrosis factor-alpha|tumor necrosis factor-alpha
430633|NCT01730495|TNF-alpha|tnf-alpha
430634|NCT01730495|Etanercept|etanercept
430635|NCT01730482|excretion|excretion
430636|NCT01730482|healthy volunteer|healthy volunteer
430637|NCT01730482|migalastat hydrochloride|migalastat hydrochloride
430638|NCT01730482|AT1001|at1001
430639|NCT01730482|pharmacokinetics|pharmacokinetics
430640|NCT01730482|Fabry disease|fabry disease
430641|NCT01730469|Pharmacokinetics|pharmacokinetics
430642|NCT01730469|GR181413|gr181413
430643|NCT01730469|Safety|safety
430644|NCT01730469|AT1001|at1001
430645|NCT01730469|Migalastat hydrochloride|migalastat hydrochloride
430646|NCT01730443|traumatic brain injury|traumatic brain injury
430647|NCT01730430|non-AD dementias|non-ad dementias
430648|NCT01730430|healthy elderly controls|healthy elderly controls
430649|NCT01730417|Phase 1|phase 1
430650|NCT01730417|no carrier added metaiodobenzylguanidine|no carrier added metaiodobenzylguanidine
430651|NCT01730417|radiation dosimetry|radiation dosimetry
430652|NCT01730378|Influenza vaccine|influenza vaccine
430653|NCT01730365|spectroscopy|spectroscopy
430654|NCT01730365|tumour|tumour
430655|NCT01730365|biopsy|biopsy
430656|NCT01730365|malignancy|malignancy
430755|NCT01729910|primary care|primary care
430657|NCT01730352|immune thrombocytopenic purpura|immune thrombocytopenic purpura
430658|NCT01730352|chronic immune thrombocytopenic purpura|chronic immune thrombocytopenic purpura
430659|NCT01730352|secondary immune thrombocytopenic purpura|secondary immune thrombocytopenic purpura
430660|NCT01730352|Helicobacter pylori infection|helicobacter pylori infection
430661|NCT01730352|Helicobacter pylori gastritis|helicobacter pylori gastritis
430662|NCT01730352|children|children
430663|NCT01730352|adolescents|adolescents
430664|NCT01730339|Skin scarring|skin scarring
430665|NCT01730339|cicatrix|cicatrix
430666|NCT01730339|breast scar|breast scar
430667|NCT01730339|hypertrophic scar|hypertrophic scar
430668|NCT01730326|Headache|headache
430669|NCT01730326|paracetamol|paracetamol
430670|NCT01730326|dexketoprofen|dexketoprofen
430671|NCT01730326|emergency department|emergency department
430672|NCT01730313|Nodding syndrome|nodding syndrome
430673|NCT01730287|Stepwise Excavation|stepwise excavation
430674|NCT01730287|Pulpal vitality|pulpal vitality
430675|NCT01730287|Deep caries lesions|deep caries lesions
430676|NCT01730287|Clinical symptoms|clinical symptoms
430677|NCT01730287|Radiographic evaluation|radiographic evaluation
430678|NCT01730261|Traumatic Brain Injury|traumatic brain injury
430679|NCT01730261|TBI|tbi
430680|NCT01730261|Executive Dysfunction|executive dysfunction
430681|NCT01730261|Emotional Regulation|emotional regulation
430682|NCT01730261|Problem Solving|problem solving
430683|NCT01730261|Self-regulation|self-regulation
430684|NCT01730261|Cognitive Rehabilitation|cognitive rehabilitation
430685|NCT01730261|Metacognitive Strategies|metacognitive strategies
430686|NCT01730261|Cognitive-behavioral therapy|cognitive-behavioral therapy
430687|NCT01730261|Online Therapy|online therapy
430688|NCT01730261|Group therapy|group therapy
430689|NCT01730261|Group videoconference|group videoconference
430690|NCT01730261|Telehealth|telehealth
430691|NCT01730261|Telerehabilitation|telerehabilitation
430692|NCT01730248|Myelofibrosis,|myelofibrosis,
430693|NCT01730248|PMF,|pmf,
430694|NCT01730248|PPV-MF,|ppv-mf,
430695|NCT01730248|PET-MF,|pet-mf,
430696|NCT01730248|Primary Myelofibrosis,|primary myelofibrosis,
430697|NCT01730248|Post-polycythemia vera myelofibrosis,|post-polycythemia vera myelofibrosis,
430698|NCT01730248|Post-essential thrombocythemia myelofibrosis|post-essential thrombocythemia myelofibrosis
430699|NCT01730222|pancreatic adenocarcinoma|pancreatic adenocarcinoma
430700|NCT01730222|stage III disease|stage iii disease
430701|NCT01730222|stage IV disease|stage iv disease
430702|NCT01730222|chemotherapy|chemotherapy
430703|NCT01730209|Tuberous Sclerosis Complex|tuberous sclerosis complex
430704|NCT01730209|TSC|tsc
430705|NCT01730209|Autism|autism
430706|NCT01730209|Learning problems|learning problems
430707|NCT01730209|Everolimus|everolimus
430708|NCT01730209|RAD001|rad001
430709|NCT01730209|Treatment|treatment
430710|NCT01730209|Cognition|cognition
430711|NCT01730209|Intellectual disability|intellectual disability
430712|NCT01730170|Epilepsy|epilepsy
430713|NCT01730170|Pregnancy|pregnancy
430714|NCT01730144|Nasal Spray Vaccine|nasal spray vaccine
430715|NCT01730144|Nasal Cells|nasal cells
430716|NCT01730131|Immune Reconstitution Syndrome|immune reconstitution syndrome
430717|NCT01730131|Human Immunodeficiency Virus|human immunodeficiency virus
430718|NCT01730131|Multiple Sclerosis|multiple sclerosis
430719|NCT01730118|Metastatic Solid Tumors|metastatic solid tumors
430720|NCT01730118|Human Epidermal Growth Factor Receptor 2 Expression (HER2/neu)|human epidermal growth factor receptor 2 expression (her2/neu)
430721|NCT01730118|Trastuzumab Exposure|trastuzumab exposure
430722|NCT01730118|Dendritic Cell Vaccine|dendritic cell vaccine
430723|NCT01730118|Breast Cancer|breast cancer
430724|NCT01730105|Adaptive Thermogenesis|adaptive thermogenesis
430725|NCT01730105|Adipose Tissue|adipose tissue
430726|NCT01730105|Body Composition|body composition
430727|NCT01730105|Body Weight Regulation|body weight regulation
430728|NCT01730105|Brown Adipose Tissue|brown adipose tissue
430729|NCT01730092|Vascular Inflammation|vascular inflammation
430730|NCT01730092|Microarray|microarray
430731|NCT01730092|Right Ventricular Function|right ventricular function
430732|NCT01730092|Endothelial Dysfunction|endothelial dysfunction
430733|NCT01730092|Magnetic Resonance Imaging|magnetic resonance imaging
430734|NCT01730079|Attention Deficit Hyperactivity Disorder|attention deficit hyperactivity disorder
430735|NCT01730079|Autism|autism
430736|NCT01730079|Near Infrared Spectroscopy|near infrared spectroscopy
430737|NCT01730079|Brain Activity|brain activity
430738|NCT01730066|Probiotics|probiotics
430739|NCT01730066|Pathogenic enteric bacteria|pathogenic enteric bacteria
430740|NCT01730066|Oropharyngeal flora|oropharyngeal flora
430741|NCT01730066|CRP|crp
430742|NCT01730066|WBC|wbc
430743|NCT01729949|Nutrition|nutrition
430744|NCT01729949|Polyphenols|polyphenols
430745|NCT01729949|Berries|berries
430746|NCT01729949|Overweight|overweight
430747|NCT01729949|Lipid Panels|lipid panels
430748|NCT01729936|Sitting time|sitting time
430749|NCT01729936|Overweight|overweight
430750|NCT01729936|Obese|obese
430751|NCT01729936|Primary Health Care|primary health care
430752|NCT01729910|overweight|overweight
430753|NCT01729910|obesity|obesity
430754|NCT01729910|rural|rural
430756|NCT01729897|gastroscopy|gastroscopy
430757|NCT01729897|sedation|sedation
430758|NCT01729897|etomidate|etomidate
430759|NCT01729871|Atrial Fibrillation|atrial fibrillation
430760|NCT01729871|Irregular heart beat|irregular heart beat
430761|NCT01729871|Catheter Ablation|catheter ablation
430762|NCT01729871|Rivaroxaban|rivaroxaban
430763|NCT01729793|TNFalpha|tnfalpha
430764|NCT01729793|IL6|il6
430765|NCT01729793|postprandial|postprandial
430766|NCT01729793|digestive|digestive
430767|NCT01729793|inflammation|inflammation
430768|NCT01729793|IL1beta|il1beta
430769|NCT01729793|CRP|crp
430770|NCT01729793|CBC|cbc
430771|NCT01729793|ESR|esr
430772|NCT01729780|EEG-NF|eeg-nf
430773|NCT01729780|Neurofeedback|neurofeedback
430774|NCT01729780|Prevention|prevention
430775|NCT01729780|ACS|acs
430776|NCT01729741|Drain or no drain|drain or no drain
430777|NCT01729741|Thyroid surgery|thyroid surgery
430778|NCT01729741|Randomized Trial|randomized trial
430779|NCT01729728|Tonsillectomy|tonsillectomy
430780|NCT01729728|Dental surgery|dental surgery
430781|NCT01729728|Ear surgery|ear surgery
430782|NCT01729728|Nose surgery|nose surgery
430783|NCT01729728|Throat surgery|throat surgery
430784|NCT01729715|Pediatric|pediatric
430785|NCT01729715|Insomnia|insomnia
430786|NCT01729702|1- Hypertrophic cardiomyopathy|1- hypertrophic cardiomyopathy
430787|NCT01729702|2- BNP|2- bnp
430788|NCT01729702|3- NT-proBNP|3- nt-probnp
430789|NCT01729702|4- Neurohormons|4- neurohormons
430790|NCT01729663|melanoma|melanoma
430791|NCT01729663|irradiated-allogeneic cells|irradiated-allogeneic cells
430792|NCT01729663|therapeutic vaccine|therapeutic vaccine
430793|NCT01729663|Interferon alpha 2-b|interferon alpha 2-b
430794|NCT01729650|Psychotic Disorders,|psychotic disorders,
430795|NCT01729650|Heart Diseases|heart diseases
430796|NCT01729637|Lung Transplantation|lung transplantation
430797|NCT01729637|Respiratory Mechanics|respiratory mechanics
430798|NCT01729637|Isolated lung perfusion|isolated lung perfusion
430799|NCT01729637|Ex-vivo lung perfusion|ex-vivo lung perfusion
430800|NCT01729637|Lung mechanics|lung mechanics
430801|NCT01729624|Wegener Granulomatosis|wegener granulomatosis
430802|NCT01729624|Microscopic Polyangiitis|microscopic polyangiitis
430803|NCT01729624|Churg-Strauss Syndrome|churg-strauss syndrome
430804|NCT01729624|Antibodies, Antineutrophil Cytoplasmic|antibodies, antineutrophil cytoplasmic
430805|NCT01729611|Scleroderma|scleroderma
430806|NCT01729611|Cirrhosis|cirrhosis
430807|NCT01729598|cognitively normal elderly population|cognitively normal elderly population
430808|NCT01729598|safety and tolerability|safety and tolerability
430809|NCT01729585|cystic fibrosis|cystic fibrosis
430810|NCT01729585|quality of life|quality of life
430811|NCT01729572|schizophrenia|schizophrenia
430812|NCT01729572|Schizoaffective Disorder|schizoaffective disorder
430813|NCT01729572|disease management|disease management
430814|NCT01729572|treatment|treatment
430815|NCT01729572|rehabilitation|rehabilitation
430816|NCT01729572|pharmacotherapy|pharmacotherapy
430817|NCT01729559|venous thromboembolic disease|venous thromboembolic disease
430818|NCT01729559|deep vein thrombosis|deep vein thrombosis
430819|NCT01729559|pulmonary embolism|pulmonary embolism
430820|NCT01729559|trauma|trauma
430821|NCT01729559|antithrombotic prophylaxis|antithrombotic prophylaxis
430822|NCT01729546|SMBG (self-monitoring of blood glucose)|smbg (self-monitoring of blood glucose)
430823|NCT01729546|POCT|poct
430824|NCT01729546|System Accuracy|system accuracy
430825|NCT01729533|ICSI|icsi
430826|NCT01729533|IMSI|imsi
430827|NCT01729533|Pregnancy|pregnancy
430828|NCT01729533|Sperm morphology|sperm morphology
430829|NCT01729533|Unexplained infertility|unexplained infertility
430830|NCT01729520|Total knee arthroplasty|total knee arthroplasty
430831|NCT01729520|Total knee replacement|total knee replacement
430832|NCT01729520|Strength training|strength training
430833|NCT01729520|Resistance training|resistance training
430834|NCT01729520|Physical therapy modalities|physical therapy modalities
430835|NCT01729520|Fatigue|fatigue
430836|NCT01729507|Smoking cessation|smoking cessation
430837|NCT01729507|Add on and smoking cessation|add on and smoking cessation
430838|NCT01729507|Therapy for tobacco dependence|therapy for tobacco dependence
430839|NCT01729507|Transcranial direct current stimulation|transcranial direct current stimulation
430840|NCT01729494|belatacept|belatacept
430841|NCT01729494|rabbit antithymocyte globulin|rabbit antithymocyte globulin
430842|NCT01729494|alemtuzumab|alemtuzumab
430843|NCT01729494|corticosteroid withdrawal|corticosteroid withdrawal
430844|NCT01729468|Low Dose Acetylsalicylic Acid|low dose acetylsalicylic acid
430845|NCT01729468|Prevention|prevention
430846|NCT01729468|Pre-eclampsia|pre-eclampsia
430847|NCT01729468|Intra-uterine Growth Restriction|intra-uterine growth restriction
430848|NCT01729468|Primiparous Women|primiparous women
430849|NCT01729468|Bilateral Uterine Artery Notches|bilateral uterine artery notches
430850|NCT01729468|First Quarter|first quarter
430851|NCT01729455|Belimumab|belimumab
430852|NCT01729455|Connective Tissue Diseases|connective tissue diseases
430853|NCT01729455|Lupus|lupus
430854|NCT01729455|Additional relevant MeSH terms:|additional relevant mesh terms:
431061|NCT01728649|Stroke|stroke
430855|NCT01729455|Lupus Erythematosus, Systemic|lupus erythematosus, systemic
430856|NCT01729455|Autoimmune Diseases|autoimmune diseases
430857|NCT01729455|SLE|sle
430858|NCT01729455|Systemic Lupus Erythematosus|systemic lupus erythematosus
430859|NCT01729455|Autoimmune Disease|autoimmune disease
430860|NCT01729455|Antibodies|antibodies
430861|NCT01729455|Immune System Diseases|immune system diseases
430862|NCT01729429|Papillomavirus Vaccines|papillomavirus vaccines
430863|NCT01729429|Intervention Studies|intervention studies
430864|NCT01729429|Health Services Research|health services research
430865|NCT01729429|Cancer of Cervix|cancer of cervix
430866|NCT01729416|colon|colon
430867|NCT01729416|cancer|cancer
430868|NCT01729416|screening|screening
430869|NCT01729416|water exchange|water exchange
430870|NCT01729416|air|air
430871|NCT01729416|method|method
430872|NCT01729416|polyp|polyp
430873|NCT01729416|adenoma|adenoma
430874|NCT01729416|detection|detection
430875|NCT01729416|rate|rate
430876|NCT01729416|sedation|sedation
430877|NCT01729416|time|time
430878|NCT01729416|procedure|procedure
430879|NCT01729390|Feeding behavior|feeding behavior
430880|NCT01729364|elective CABG|elective cabg
430881|NCT01729364|renal impairment|renal impairment
430882|NCT01729364|GFR|gfr
430883|NCT01729364|renal blood flow|renal blood flow
430884|NCT01729364|colloid|colloid
430885|NCT01729364|crystalloid|crystalloid
430886|NCT01729364|thermodilution technique|thermodilution technique
430887|NCT01729364|oxygen supply demand|oxygen supply demand
430888|NCT01729351|Primary Care|primary care
430889|NCT01729351|Particle size|particle size
430890|NCT01729351|beclomethasone dipropionate|beclomethasone dipropionate
430891|NCT01729351|Asthma Management|asthma management
430892|NCT01729351|Maintenance Therapy|maintenance therapy
430893|NCT01729351|Metered-Dose Inhaler|metered-dose inhaler
430894|NCT01729351|Smoking|smoking
430895|NCT01729325|Post-traumatic Stress disorder (PTSD)|post-traumatic stress disorder (ptsd)
430896|NCT01729325|Aggressive Behavior|aggressive behavior
430897|NCT01729325|Appetitive Aggression|appetitive aggression
430898|NCT01729325|Resilience|resilience
430899|NCT01729325|Preventive Narrative Exposure Therapy|preventive narrative exposure therapy
430900|NCT01729299|ghrelin|ghrelin
430901|NCT01729299|glucose control|glucose control
430902|NCT01729299|GLP-1|glp-1
430903|NCT01729299|Exendin (9-39)|exendin (9-39)
430904|NCT01729299|insulin|insulin
430905|NCT01729260|Glioblastoma|glioblastoma
430906|NCT01729260|mebendazole|mebendazole
430907|NCT01729260|temozolomide|temozolomide
430908|NCT01729247|Asthma|asthma
430909|NCT01729234|age related Endothelial Dysfunction|age related endothelial dysfunction
430910|NCT01729221|Hepatocellular carcinoma|hepatocellular carcinoma
430911|NCT01729221|Hepatitis C virus|hepatitis c virus
430912|NCT01729208|myopia progression|myopia progression
430913|NCT01729208|myopia control|myopia control
430914|NCT01729195|bioabsorbable implant|bioabsorbable implant
430915|NCT01729195|bone screw|bone screw
430916|NCT01729195|local antibiotic prophylaxis|local antibiotic prophylaxis
430917|NCT01729195|syndesmosis injury|syndesmosis injury
430918|NCT01729195|ankle fracture|ankle fracture
430919|NCT01729195|ciprofloxacin|ciprofloxacin
430920|NCT01729182|Low dose Aspirin(LDA)|low dose aspirin(lda)
430921|NCT01729182|Gastric ulcer or duodenal ulcer|gastric ulcer or duodenal ulcer
430922|NCT01729182|Nexium|nexium
430923|NCT01729169|Sarcoidosis|sarcoidosis
430924|NCT01729169|Cardiac sarcoidosis|cardiac sarcoidosis
430925|NCT01729169|18-FDG PET|18-fdg pet
430926|NCT01729169|68Ga-DOTANOC PET|68ga-dotanoc pet
430927|NCT01729156|Type 2 diabetes|type 2 diabetes
430928|NCT01729156|Hepatic fatty acid oxidation|hepatic fatty acid oxidation
430929|NCT01729156|Dyslipidemia|dyslipidemia
430930|NCT01729156|Metformin|metformin
430931|NCT01729143|black pepper|black pepper
430932|NCT01729143|metabolic chamber|metabolic chamber
430933|NCT01729143|respiratory chamber|respiratory chamber
430934|NCT01729117|Type 2 diabetes|type 2 diabetes
430935|NCT01729117|Obesity|obesity
430936|NCT01729117|Insulin|insulin
430937|NCT01729117|Hispanic|hispanic
430938|NCT01729117|Low-income|low-income
430939|NCT01729117|Meal replacement|meal replacement
430940|NCT01729104|Lymphoma|lymphoma
430941|NCT01729104|Mantle cell lymphoma|mantle cell lymphoma
430942|NCT01729104|MCL|mcl
430943|NCT01729104|Relapsed|relapsed
430944|NCT01729104|Refractory|refractory
430945|NCT01729104|Carfilzomib|carfilzomib
430946|NCT01729104|Rituximab|rituximab
430947|NCT01729104|Rituxan|rituxan
430948|NCT01729104|Lenalidomide|lenalidomide
430949|NCT01729104|CC-5013|cc-5013
430950|NCT01729104|Revlimid|revlimid
430951|NCT01729065|Spinal Accessory Nerve Palsy, Cranial Nerve XI, shoulder weakness, neck stiffness, head and neck cancer, neck dissection|spinal accessory nerve palsy, cranial nerve xi, shoulder weakness, neck stiffness, head and neck cancer, neck dissection
430952|NCT01729052|Acupuncture|acupuncture
430953|NCT01729052|Children|children
430954|NCT01729052|Postoperative nausea and vomiting|postoperative nausea and vomiting
430955|NCT01729052|Postoperative pain|postoperative pain
430956|NCT01729052|Parental attitudes|parental attitudes
430957|NCT01729052|Parental expectations|parental expectations
430958|NCT01729039|rehabilitation|rehabilitation
430959|NCT01729039|aged|aged
430960|NCT01729039|aged, 80 and over|aged, 80 and over
430961|NCT01729039|vestibular diseases|vestibular diseases
430962|NCT01729026|Veterans|veterans
430963|NCT01729026|Posttraumatic Stress Disorder|posttraumatic stress disorder
430964|NCT01729026|dog adoption|dog adoption
430965|NCT01729026|companion animal|companion animal
430966|NCT01729013|vitamin D|vitamin d
430967|NCT01729013|fat|fat
430968|NCT01729013|biopsy|biopsy
430969|NCT01729000|prematurity|prematurity
430970|NCT01729000|infection control|infection control
430971|NCT01729000|necrotizing entercolitis|necrotizing entercolitis
430972|NCT01728974|Obstructive Sleep Apnea|obstructive sleep apnea
550784|NCT01216644|ECF|ecf
430973|NCT01728974|Pathophysiology|pathophysiology
430974|NCT01728961|HIV 1|hiv 1
430975|NCT01728961|NVP|nvp
430976|NCT01728961|malaria|malaria
430977|NCT01728961|Children|children
430978|NCT01728961|Youth|youth
430979|NCT01728961|nevirapine|nevirapine
430980|NCT01728961|Coartem Dispersible|coartem dispersible
430981|NCT01728961|Artemether|artemether
430982|NCT01728961|Lumefantrine|lumefantrine
430983|NCT01728961|Pharmacokinetics|pharmacokinetics
430984|NCT01728948|Sorafenib|sorafenib
430985|NCT01728948|renal cell carcinoma(RCC)|renal cell carcinoma(rcc)
430986|NCT01728948|elderly|elderly
430987|NCT01728948|effectiveness|effectiveness
430988|NCT01728948|safety|safety
430989|NCT01728935|HBV|hbv
430990|NCT01728935|Tenofovir|tenofovir
430991|NCT01728935|HBV DNA|hbv dna
430992|NCT01728935|HBsAg|hbsag
430993|NCT01728935|Resistance|resistance
430994|NCT01728922|Clinically isolated syndrome|clinically isolated syndrome
430995|NCT01728922|Multiple sclerosis|multiple sclerosis
430996|NCT01728922|Vitamin D|vitamin d
430997|NCT01728922|Immune response|immune response
430998|NCT01728922|CD4 T cell subsets|cd4 t cell subsets
430999|NCT01728922|Cytokine|cytokine
431000|NCT01728909|Oxytocin|oxytocin
431001|NCT01728909|Syntocinon|syntocinon
431002|NCT01728909|Social Cognition|social cognition
431003|NCT01728909|Social Approach Behaviors|social approach behaviors
431004|NCT01728896|Acute pancreatitis, nutrition|acute pancreatitis, nutrition
431005|NCT01728883|Diabetic Retinopathy|diabetic retinopathy
431006|NCT01728883|Diabetic Macular Edema|diabetic macular edema
431007|NCT01728883|Macular Edema|macular edema
431008|NCT01728883|Maculopathy|maculopathy
431009|NCT01728883|home monitoring|home monitoring
431010|NCT01728883|shape discrimination hyperacuity|shape discrimination hyperacuity
431011|NCT01728883|Psychophysical Testing|psychophysical testing
431012|NCT01728870|Pediatric|pediatric
431013|NCT01728870|Crohn's disease|crohn's disease
431014|NCT01728870|Mild to moderate Crohn's Disease|mild to moderate crohn's disease
431015|NCT01728870|Diet|diet
431016|NCT01728870|Enteral Nutrition|enteral nutrition
431017|NCT01728857|Lipolysis|lipolysis
431018|NCT01728857|Cryolipolysis|cryolipolysis
431019|NCT01728857|Fat Reduction|fat reduction
431020|NCT01728831|Red Cell Transfusion|red cell transfusion
431021|NCT01728831|Cerebral tissue oxygenation|cerebral tissue oxygenation
431022|NCT01728831|Traumatic brain injury|traumatic brain injury
431023|NCT01728805|Cutaneous T-Cell Lymphoma (CTCL)|cutaneous t-cell lymphoma (ctcl)
431024|NCT01728805|myocis fungoides (MF)|myocis fungoides (mf)
431025|NCT01728805|Sezary Syndrome (SS)|sezary syndrome (ss)
431026|NCT01728792|Prophylactic vaccination|prophylactic vaccination
431027|NCT01728766|Breast milk zinc transfer|breast milk zinc transfer
431028|NCT01728766|Bangladeshi infants|bangladeshi infants
431029|NCT01728766|appropriate-for-gestational-age|appropriate-for-gestational-age
431030|NCT01728766|small-for-gestational-age|small-for-gestational-age
431031|NCT01728766|plasma zinc|plasma zinc
431032|NCT01728740|Bioequivalence|bioequivalence
431033|NCT01728740|Acarbose|acarbose
431034|NCT01728740|Metformin|metformin
431035|NCT01728740|FDC|fdc
431036|NCT01728727|liver cirrhosis|liver cirrhosis
431037|NCT01728727|end stage liver disease|end stage liver disease
431038|NCT01728727|umbilical cord|umbilical cord
431039|NCT01728727|mesenchymal stem cells|mesenchymal stem cells
431040|NCT01728727|HBV|hbv
431041|NCT01728714|Diabetes; compliance|diabetes; compliance
431042|NCT01728701|Malaria|malaria
431043|NCT01728701|Plasmodium falciparum|plasmodium falciparum
431044|NCT01728701|PfSPZ Challenge|pfspz challenge
431045|NCT01728701|Chemoprophylaxis|chemoprophylaxis
431046|NCT01728701|PfSPZ-CVac|pfspz-cvac
431047|NCT01728688|liver cirrhosis|liver cirrhosis
431048|NCT01728688|stem cell|stem cell
431049|NCT01728688|peripheral blood|peripheral blood
431050|NCT01728688|autologous|autologous
431051|NCT01728688|HBV|hbv
431052|NCT01728688|end stage liver disease|end stage liver disease
431053|NCT01728675|Aging|aging
431054|NCT01728675|Skeletal muscle|skeletal muscle
431055|NCT01728675|Biomarkers|biomarkers
431056|NCT01728675|Adaptation|adaptation
431057|NCT01728662|emphysema|emphysema
431058|NCT01728662|lung volume reduction therapy|lung volume reduction therapy
431059|NCT01728649|Acute Ischemic Stroke|acute ischemic stroke
431060|NCT01728649|Mild Hypothermia|mild hypothermia
431062|NCT01728649|Hypothermia|hypothermia
431063|NCT01728623|Thyroid cancer|thyroid cancer
431064|NCT01728610|irritable bowel syndrome|irritable bowel syndrome
431065|NCT01728610|probiotic|probiotic
431067|NCT01728610|bloating|bloating
431068|NCT01728610|diarrhoea|diarrhoea
431069|NCT01728610|constipation|constipation
431070|NCT01728597|no history of cardiovascular diseases|no history of cardiovascular diseases
431071|NCT01728571|COPD|copd
431072|NCT01728571|asthma|asthma
431073|NCT01728571|pulmonary function|pulmonary function
431074|NCT01728571|pneumonia|pneumonia
431075|NCT01728558|Sedation|sedation
431076|NCT01728558|Delirium|delirium
431077|NCT01728558|Goal Directed|goal directed
431078|NCT01728558|Dexmedetomidine|dexmedetomidine
431079|NCT01728558|Mortality|mortality
431080|NCT01728558|Mechanical ventilation|mechanical ventilation
431081|NCT01728558|Intensive care|intensive care
431082|NCT01728558|Critically Ill|critically ill
431083|NCT01728545|Cord blood registry|cord blood registry
431084|NCT01728545|Umbilical Cord Blood|umbilical cord blood
431085|NCT01728545|fetal blood|fetal blood
431086|NCT01728545|placenta|placenta
431087|NCT01728545|Placental Blood Stem Cell Transplantation|placental blood stem cell transplantation
431088|NCT01728545|hematopoietic progenitor cells|hematopoietic progenitor cells
431089|NCT01728545|Hematopoietic Stem Cell Transplantation|hematopoietic stem cell transplantation
431090|NCT01728545|cord blood unit total nucleated cell|cord blood unit total nucleated cell
431091|NCT01728545|TNC|tnc
431092|NCT01728545|CD34-positive(+) cell|cd34-positive(+) cell
431093|NCT01728545|human leukocyte antigen|human leukocyte antigen
431094|NCT01728545|HLA|hla
431095|NCT01728545|allogeneic transplantation|allogeneic transplantation
431096|NCT01728519|Allergy|allergy
431097|NCT01728519|Birch Pollen|birch pollen
431098|NCT01728519|Immunotherapy|immunotherapy
431099|NCT01728506|breast cancer survivor|breast cancer survivor
431100|NCT01728506|Weight loss|weight loss
431101|NCT01728506|Exercise|exercise
431102|NCT01728493|Prevalence|prevalence
431103|NCT01728493|Primary aldosteronism|primary aldosteronism
431104|NCT01728493|Organ damage|organ damage
431105|NCT01728493|Mineralocorticoid receptor antagonists|mineralocorticoid receptor antagonists
431106|NCT01728441|PAD|pad
431107|NCT01728441|stenting|stenting
431108|NCT01728441|angioplasty|angioplasty
431109|NCT01728428|hemifacial spasm|hemifacial spasm
431110|NCT01728428|observational study|observational study
431111|NCT01728428|clinical manifestation|clinical manifestation
431112|NCT01728428|treatment|treatment
431113|NCT01728428|Chinese|chinese
431114|NCT01728415|Exercise|exercise
431115|NCT01728415|Hemodialysis|hemodialysis
431116|NCT01728415|Physical therapy|physical therapy
431117|NCT01728415|high-intensity|high-intensity
431118|NCT01728389|allogenic stem cell transplantation|allogenic stem cell transplantation
431119|NCT01728389|peripheral blood stem cells|peripheral blood stem cells
431120|NCT01728389|intrabone|intrabone
431121|NCT01728389|intra-bone|intra-bone
431122|NCT01728389|leukemia|leukemia
431123|NCT01728389|lymphoma|lymphoma
431124|NCT01728363|Staphylococcal|staphylococcal
431125|NCT01728350|traumatic brain injury|traumatic brain injury
431126|NCT01728350|volunteering|volunteering
431127|NCT01728350|well being|well being
431128|NCT01728350|cortisol|cortisol
431129|NCT01728337|botulinum toxin,|botulinum toxin,
431130|NCT01728337|wrinkles|wrinkles
431131|NCT01728298|House Dust Mite|house dust mite
431132|NCT01728298|allergy|allergy
431133|NCT01728298|rhinitis|rhinitis
431134|NCT01728298|asthma|asthma
431135|NCT01728285|specific allergen immunotherapy|specific allergen immunotherapy
431136|NCT01728285|sublingual immunotherapy|sublingual immunotherapy
431137|NCT01728285|allergen tablets|allergen tablets
431138|NCT01728285|compliance|compliance
431139|NCT01728285|electronic compliance device|electronic compliance device
431140|NCT01728272|metoprolol, atrial fibrillation|metoprolol, atrial fibrillation
431141|NCT01728246|Osteoarthritis|osteoarthritis
431142|NCT01728246|Celecoxib|celecoxib
431143|NCT01728246|Tramadol|tramadol
431144|NCT01728246|Paracetamol|paracetamol
431145|NCT01728233|Molecular Targeted Therapy|molecular targeted therapy
431146|NCT01728233|Neoadjuvant therapy|neoadjuvant therapy
431147|NCT01728233|Dacomitinib|dacomitinib
431148|NCT01728220|Inhaled nitric oxide (iNO)|inhaled nitric oxide (ino)
431149|NCT01728220|Pulmonary hypertension (PH)|pulmonary hypertension (ph)
431150|NCT01728220|Chronic obstructive pulmonary disease (COPD)|chronic obstructive pulmonary disease (copd)
431151|NCT01728220|Long term oxygen therapy (LTOT)|long term oxygen therapy (ltot)
431152|NCT01728207|NHL|nhl
431153|NCT01728207|CLL|cll
431154|NCT01728207|follicular lymphoma|follicular lymphoma
431155|NCT01728207|mantle cell lymphoma|mantle cell lymphoma
431156|NCT01728207|marginal zone lymphoma|marginal zone lymphoma
431157|NCT01728207|chronic lymphocytic leukemia|chronic lymphocytic leukemia
431158|NCT01728207|small lymphocytic lymphoma|small lymphocytic lymphoma
431159|NCT01728194|Depression|depression
431160|NCT01728194|Depressive Disorder|depressive disorder
431161|NCT01728194|Behavioral Symptoms|behavioral symptoms
431162|NCT01728194|Mood Disorders|mood disorders
431163|NCT01728194|Mental Disorders|mental disorders
431164|NCT01728194|Escitalopram|escitalopram
431165|NCT01728194|Central Nervous System Agents|central nervous system agents
431166|NCT01728194|Therapeutic Uses|therapeutic uses
431167|NCT01728194|Pharmacologic Actions|pharmacologic actions
431168|NCT01728194|Physiological Effects of Drugs|physiological effects of drugs
431169|NCT01728194|Muscarinic Antagonists|muscarinic antagonists
431170|NCT01728194|Antidepressive Agents|antidepressive agents
431171|NCT01728194|Psychotropic Drugs|psychotropic drugs
431172|NCT01728194|Serotonin Uptake Inhibitors|serotonin uptake inhibitors
431173|NCT01728194|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors
431174|NCT01728194|Serotonin Agents|serotonin agents
431175|NCT01728194|Magnetic Resonance Imaging, Functional|magnetic resonance imaging, functional
431176|NCT01728194|fMRI|fmri
431177|NCT01728194|Magnetic Resonance Imaging|magnetic resonance imaging
431178|NCT01728168|lupin|lupin
431179|NCT01728168|peanut|peanut
431180|NCT01728168|soy|soy
431181|NCT01728168|pea|pea
431182|NCT01728168|legumes|legumes
431183|NCT01728168|cross-reactivity|cross-reactivity
431184|NCT01728168|sensitization|sensitization
431185|NCT01728168|atopy|atopy
431186|NCT01728155|NEUROBLASTOMA, LOW RISK, INTERMEDIATE RISK|neuroblastoma, low risk, intermediate risk
431187|NCT01728142|DANA|dana
431188|NCT01728142|ANAM|anam
431189|NCT01728142|Concussion|concussion
431190|NCT01728142|mild traumatic brain injury|mild traumatic brain injury
431191|NCT01728129|Concussion|concussion
431192|NCT01728129|Mild traumatic brain injury|mild traumatic brain injury
431193|NCT01728129|DANA|dana
431194|NCT01728129|MACE|mace
431195|NCT01728116|glycemic control, type 2 diabetes, device, obese|glycemic control, type 2 diabetes, device, obese
431196|NCT01728090|handwashing|handwashing
431197|NCT01728090|hand sanitizer|hand sanitizer
431198|NCT01728090|absenteeism|absenteeism
431199|NCT01728090|school age children|school age children
431200|NCT01728090|preschool children|preschool children
431201|NCT01728077|Brivaracetam|brivaracetam
431202|NCT01728077|Long-term Follow-up|long-term follow-up
431203|NCT01728077|Epilepsy|epilepsy
431204|NCT01728077|Partial Onset Seizures|partial onset seizures
431205|NCT01728077|Adjunctive treatment|adjunctive treatment
431206|NCT01728064|Friedreich's|friedreich's
431207|NCT01728064|Ataxia|ataxia
431208|NCT01728064|FRDA|frda
431209|NCT01728064|FA|fa
431210|NCT01728064|EPI-743|epi-743
431211|NCT01728064|Edison|edison
431212|NCT01728038|Bronchiolitis|bronchiolitis
431213|NCT01728038|Cough|cough
431214|NCT01728038|Ear Infection|ear infection
431215|NCT01728038|Respiratory Infection|respiratory infection
431216|NCT01728038|Wheezing|wheezing
431217|NCT01728025|Long QT syndrome|long qt syndrome
431218|NCT01728025|Ranolazine|ranolazine
431219|NCT01728012|Successful transplantation|successful transplantation
431220|NCT01728012|Long-term observation|long-term observation
431221|NCT01727999|TPO response|tpo response
431222|NCT01727999|ITP|itp
431223|NCT01727999|immune thrombocytopenia|immune thrombocytopenia
431224|NCT01727973|Graves' orbitopathy|graves' orbitopathy
431225|NCT01727973|Graves´ ophthalmopathy|graves´ ophthalmopathy
431226|NCT01727973|Thyroid eye disease|thyroid eye disease
431227|NCT01727973|Thyroid-associated ophthalmopathy|thyroid-associated ophthalmopathy
431228|NCT01727973|Doxycycline|doxycycline
431229|NCT01727973|EUGOGO|eugogo
431230|NCT01727973|CAS|cas
431231|NCT01727960|Education|education
431232|NCT01727960|Neck pain|neck pain
431233|NCT01727960|Shoulder pain|shoulder pain
431234|NCT01727960|Prevalence|prevalence
431235|NCT01727960|Associated factors|associated factors
431236|NCT01727960|Students|students
431237|NCT01727934|Antisense|antisense
431238|NCT01727934|miR-122 antagonist|mir-122 antagonist
431239|NCT01727934|host factor|host factor
431240|NCT01727934|Chronic hepatitis C|chronic hepatitis c
431241|NCT01727934|Hepatitis C|hepatitis c
431242|NCT01727921|ProCore FNA biopsy|procore fna biopsy
431243|NCT01727908|Familial Gastric Cancer Screening|familial gastric cancer screening
431244|NCT01727895|Betaglucan, immune modulation, immunoparalysis, immune suppression|betaglucan, immune modulation, immunoparalysis, immune suppression
431245|NCT01727882|Paroled offenders|paroled offenders
431246|NCT01727882|Interactive Voice Response|interactive voice response
431247|NCT01727882|Stress|stress
431248|NCT01727882|Mental symptoms|mental symptoms
431249|NCT01727882|Alcohol consumption|alcohol consumption
431250|NCT01727882|Substance use|substance use
431251|NCT01727856|rehabilitation|rehabilitation
431252|NCT01727856|physical therapy|physical therapy
431253|NCT01727856|telemedicine|telemedicine
431254|NCT01727843|fracture|fracture
431255|NCT01727843|hip|hip
431256|NCT01727843|tranexamic acid|tranexamic acid
431257|NCT01727843|topical|topical
431258|NCT01727817|Diabetes Mellitus, Type 1|diabetes mellitus, type 1
431259|NCT01727817|Continuous Glucose Monitor|continuous glucose monitor
431260|NCT01727817|Artificial Pancreas|artificial pancreas
431261|NCT01727817|Insulin Pump|insulin pump
431262|NCT01727817|Closed Loop|closed loop
431263|NCT01727817|Open Loop|open loop
431264|NCT01727817|Diabetes Assistant|diabetes assistant
431265|NCT01727817|DiAs|dias
431266|NCT01727817|Cell Phone|cell phone
431267|NCT01727791|pharmacokinetic|pharmacokinetic
431268|NCT01727791|pregabalin|pregabalin
431269|NCT01727791|lactation|lactation
431270|NCT01727765|Asthma, inspiratory muscle training|asthma, inspiratory muscle training
431271|NCT01727739|Tibial tunnel widening|tibial tunnel widening
431272|NCT01727739|Interference screws|interference screws
431273|NCT01727726|OPC-34712|opc-34712
431274|NCT01727726|brexpiprazole|brexpiprazole
431275|NCT01727726|Major Depressive Disorder|major depressive disorder
431276|NCT01727726|Adjunctive Treatment|adjunctive treatment
431277|NCT01727713|Tourette Syndrome|tourette syndrome
431278|NCT01727713|Basal Ganglia Diseases|basal ganglia diseases
431279|NCT01727713|Brain Diseases|brain diseases
431280|NCT01727713|Central Nervous System Diseases|central nervous system diseases
431281|NCT01727713|Tic Disorders|tic disorders
431282|NCT01727713|Tics|tics
431283|NCT01727713|Movement Disorders|movement disorders
431284|NCT01727713|Mental Disorders|mental disorders
431285|NCT01727713|Aripiprazole|aripiprazole
431286|NCT01727700|Tourette Syndrome|tourette syndrome
431287|NCT01727700|Basal Ganglia Diseases|basal ganglia diseases
431288|NCT01727700|Brain Diseases|brain diseases
431289|NCT01727700|Central Nervous System Diseases|central nervous system diseases
431290|NCT01727700|Tic Disorders|tic disorders
431291|NCT01727700|Tics|tics
431292|NCT01727700|Movement Disorders|movement disorders
431293|NCT01727700|Mental Disorders|mental disorders
431294|NCT01727700|Aripiprazole|aripiprazole
431295|NCT01727687|To asses the training effects on traffic safety between normal and patients with Parkinson's disease|to asses the training effects on traffic safety between normal and patients with parkinson's disease
431296|NCT01727674|Depression|depression
431297|NCT01727674|experiences of communication|experiences of communication
431298|NCT01727661|diabetes mellitus|diabetes mellitus
431299|NCT01727661|cardiopulmonary fitness|cardiopulmonary fitness
431300|NCT01727661|lung function|lung function
431301|NCT01727661|muscular oxygenation|muscular oxygenation
431302|NCT01727648|Stroke rehabilitation|stroke rehabilitation
431303|NCT01727648|Comparative efficacy research|comparative efficacy research
431304|NCT01727648|Combined therapy|combined therapy
431305|NCT01727648|Robot-Assisted Therapy|robot-assisted therapy
431306|NCT01727648|Constraint-Induced Therapy|constraint-induced therapy
431307|NCT01727648|Kinematic analysis|kinematic analysis
431308|NCT01727635|Breast cancer, survivors, partners, group therapy|breast cancer, survivors, partners, group therapy
431309|NCT01727609|Preterm|preterm
431310|NCT01727609|Very low birth weight|very low birth weight
431311|NCT01727609|Feeding|feeding
431312|NCT01727609|Enteral|enteral
431313|NCT01727609|Milk|milk
431314|NCT01727609|Sepsis|sepsis
431315|NCT01727609|Necrotizing enterocolitis (NEC)|necrotizing enterocolitis (nec)
431316|NCT01727583|Healthy|healthy
431317|NCT01727570|Cancer|cancer
431318|NCT01727570|Colon|colon
431319|NCT01727570|Rectum|rectum
431320|NCT01727570|Surgery|surgery
431321|NCT01727557|Hemodialysis and AV fistula|hemodialysis and av fistula
431322|NCT01727544|superior semicircular canal|superior semicircular canal
431323|NCT01727544|non-vestibular dizziness|non-vestibular dizziness
431324|NCT01727544|vestibular dizziness|vestibular dizziness
431325|NCT01727531|chloroquine|chloroquine
431326|NCT01727531|WBRT|wbrt
431327|NCT01727531|survival|survival
431328|NCT01727531|brain metastasis|brain metastasis
431329|NCT01727531|radiotherapy|radiotherapy
431330|NCT01727531|SNPs|snps
431331|NCT01727531|gene coding|gene coding
431332|NCT01727531|immunoregulatory enzyme IDO2|immunoregulatory enzyme ido2
431333|NCT01727518|natural history|natural history
431334|NCT01727518|lung function|lung function
431335|NCT01727518|general population|general population
431336|NCT01727518|COPD|copd
431337|NCT01727505|hypoxemia|hypoxemia
431338|NCT01727505|desaturation|desaturation
431339|NCT01727505|mechanical ventilation|mechanical ventilation
431340|NCT01727505|preterm infants|preterm infants
431341|NCT01727505|volume guarantee ventilation|volume guarantee ventilation
431342|NCT01727492|prevention|prevention
431343|NCT01727492|noise-induced tinnitus|noise-induced tinnitus
431344|NCT01727492|noise-induced hearing loss|noise-induced hearing loss
431345|NCT01727492|young population|young population
431346|NCT01727479|Peak VO2 consumption|peak vo2 consumption
431347|NCT01727479|3km time trial|3km time trial
431348|NCT01727479|fatigue perception|fatigue perception
431349|NCT01727479|lactate|lactate
431350|NCT01727479|time to complete|time to complete
431351|NCT01727440|severe acne|severe acne
431352|NCT01727440|severe acne vulgaris|severe acne vulgaris
431353|NCT01727440|acne|acne
431354|NCT01727440|acne vulgaris|acne vulgaris
431355|NCT01727440|isotretinoin|isotretinoin
431356|NCT01727440|Accutane|accutane
431357|NCT01727440|Sortret|sortret
431358|NCT01727440|Amnesteem|amnesteem
431359|NCT01727440|Claravis|claravis
431360|NCT01727440|Clarus|clarus
431361|NCT01727440|Decutan|decutan
431362|NCT01727440|Isotane|isotane
431363|NCT01727440|Izotek|izotek
431364|NCT01727440|Oratane|oratane
431365|NCT01727440|Isotret|isotret
431366|NCT01727440|Roaccutane|roaccutane
431367|NCT01727427|Unsuspected|unsuspected
431368|NCT01727427|pulmonary embolism|pulmonary embolism
431369|NCT01727427|cancer|cancer
431370|NCT01727414|ADHD|adhd
431371|NCT01727414|Inattention|inattention
431372|NCT01727414|Methylphenidate|methylphenidate
431373|NCT01727414|Pharmacogenetics|pharmacogenetics
431374|NCT01727401|Fondaparinux|fondaparinux
431375|NCT01727401|medical patient|medical patient
431376|NCT01727401|vein thromboembolism|vein thromboembolism
431377|NCT01727401|prophylaxis|prophylaxis
431378|NCT01727401|thrombocytopenia|thrombocytopenia
431379|NCT01727388|rectal examination|rectal examination
431380|NCT01727388|colorectal cancer|colorectal cancer
431381|NCT01727375|delirium, light, ICU, sleep|delirium, light, icu, sleep
431382|NCT01727362|Breast Cancer|breast cancer
431383|NCT01727362|Acupuncture|acupuncture
431384|NCT01727362|Quality of Life|quality of life
431385|NCT01727258|Tooth Sensitivity|tooth sensitivity
431387|NCT01727232|Rituximab|rituximab
431388|NCT01727232|Efficacy|efficacy
431389|NCT01727232|Anti-CD20|anti-cd20
431390|NCT01727232|Regimen|regimen
431391|NCT01727206|Erdheim-Chester disease|erdheim-chester disease
431392|NCT01727206|Tocilizumab|tocilizumab
431393|NCT01727206|Treatment|treatment
431394|NCT01727206|Phase II|phase ii
431395|NCT01727193|myasthenia gravis|myasthenia gravis
431396|NCT01727193|leflunomide|leflunomide
431397|NCT01727167|cardiac disease|cardiac disease
431398|NCT01727167|mitochondrial biogenesis|mitochondrial biogenesis
431399|NCT01727167|carbon monoxide|carbon monoxide
431400|NCT01727141|COPD, QVA149|copd, qva149
431401|NCT01727128|Hepatic impairment|hepatic impairment
431402|NCT01727128|Clinical pharmacology study|clinical pharmacology study
431403|NCT01727128|Volunteer study|volunteer study
431404|NCT01727063|Chronic ischemic heart disease|chronic ischemic heart disease
431405|NCT01727063|Coronary artery disease|coronary artery disease
431406|NCT01727063|Angina pectoris|angina pectoris
431407|NCT01727063|Myocardial ischemia|myocardial ischemia
431408|NCT01727063|Cardiac surgery|cardiac surgery
431409|NCT01727037|Emphysema|emphysema
431410|NCT01727037|Chronic obstructive pulmonary disease|chronic obstructive pulmonary disease
431411|NCT01727037|COPD|copd
431412|NCT01727037|Bulla|bulla
431413|NCT01727037|Interventional bronchoscopy|interventional bronchoscopy
431414|NCT01727037|Lung volume reduction|lung volume reduction
431415|NCT01727024|Breezhaler|breezhaler
431416|NCT01727024|Respimat|respimat
431417|NCT01727024|Indacaterol|indacaterol
431418|NCT01727024|Tiotropium|tiotropium
431419|NCT01727011|Single fraction|single fraction
431420|NCT01727011|Elderly|elderly
431421|NCT01727011|Breast Irradiation|breast irradiation
431422|NCT01726959|methotrexate|methotrexate
431423|NCT01726946|Chronic Hepatitis C|chronic hepatitis c
431424|NCT01726946|HCV|hcv
431425|NCT01726946|CHC|chc
431426|NCT01726933|psoriasis, systemic treatment|psoriasis, systemic treatment
431427|NCT01726920|Migraine|migraine
431428|NCT01726920|Naratriptan|naratriptan
431429|NCT01726920|Naproxen|naproxen
431430|NCT01726907|submandibular gland|submandibular gland
431431|NCT01726907|robotic|robotic
431432|NCT01726907|endoscopic|endoscopic
431433|NCT01726907|face lift|face lift
431434|NCT01726907|hairline|hairline
431435|NCT01726894|Focal Therapy|focal therapy
431436|NCT01726881|chronic|chronic
431437|NCT01726881|Spinal Cord Injury patients|spinal cord injury patients
431438|NCT01726855|tendon repair|tendon repair
431439|NCT01726829|Type 1 Diabetes|type 1 diabetes
431440|NCT01726829|Artificial Pancreas|artificial pancreas
431441|NCT01726829|Closed Loop|closed loop
431442|NCT01726816|Diabetic nephropathy|diabetic nephropathy
431443|NCT01726816|Albumin creatinine ratio|albumin creatinine ratio
431444|NCT01726816|Probucol|probucol
431445|NCT01726803|Low Back Pain|low back pain
431446|NCT01726803|Primary Care|primary care
431447|NCT01726803|Physical Therapy|physical therapy
431448|NCT01726790|corneal endothelium|corneal endothelium
431449|NCT01726790|Bevacizumab|bevacizumab
431450|NCT01726790|Intravitreal injection|intravitreal injection
431451|NCT01726790|Confoscan|confoscan
431452|NCT01726777|Randomized controlled clinical trial|randomized controlled clinical trial
431453|NCT01726777|Diabetes|diabetes
431454|NCT01726777|Vitamin D|vitamin d
431455|NCT01726777|Oral glucose tolerance|oral glucose tolerance
431456|NCT01726777|Blood glucose|blood glucose
431457|NCT01726777|Insulin resistance|insulin resistance
431458|NCT01726751|Spinal cord stimulation|spinal cord stimulation
431459|NCT01726751|Irritable bowel syndrome|irritable bowel syndrome
431460|NCT01726751|Abdominal pain|abdominal pain
431461|NCT01726751|Diarrhea|diarrhea
431462|NCT01726738|Melanoma|melanoma
431463|NCT01726738|Stage III|stage iii
431464|NCT01726738|Stage IV|stage iv
431465|NCT01726738|Unresectable|unresectable
431466|NCT01726738|BRAF Mutant|braf mutant
431467|NCT01726738|Dabrafenib|dabrafenib
431468|NCT01726738|Trametinib|trametinib
431469|NCT01726738|Kinome|kinome
431470|NCT01726738|Resistance|resistance
431471|NCT01726738|Sequencing|sequencing
431472|NCT01726738|Mutations|mutations
431473|NCT01726738|Kinases|kinases
431474|NCT01726738|Mechanism|mechanism
431475|NCT01726725|hemifacial spasm|hemifacial spasm
431476|NCT01726725|microvascular decompression surgery|microvascular decompression surgery
431477|NCT01726725|desflurane|desflurane
431478|NCT01726712|Patient Care Management|patient care management
431479|NCT01726712|Primary Health Care|primary health care
431480|NCT01726712|HIV|hiv
431481|NCT01726712|Patient Acceptance of Health Care|patient acceptance of health care
431482|NCT01726686|Total Knee Arthroplasty|total knee arthroplasty
431483|NCT01726673|Stroke|stroke
431484|NCT01726673|Cerebrovascular Accident|cerebrovascular accident
431485|NCT01726673|Cerebral Stroke|cerebral stroke
431486|NCT01726673|CVA|cva
431487|NCT01726673|Robotic therapy|robotic therapy
431488|NCT01726673|Upper extremity recovery|upper extremity recovery
431489|NCT01726673|tDCS|tdcs
431490|NCT01726673|Non-invasive brain stimulation|non-invasive brain stimulation
431491|NCT01726660|Stroke|stroke
431492|NCT01726660|Cerebrovascular Accident|cerebrovascular accident
431493|NCT01726660|Cerebral stroke|cerebral stroke
431494|NCT01726660|CVA|cva
431495|NCT01726660|robotic therapy|robotic therapy
431496|NCT01726660|upper extremity recovery|upper extremity recovery
431497|NCT01726660|kinematic training|kinematic training
431498|NCT01726647|obese women|obese women
431499|NCT01726647|fat mass distribution|fat mass distribution
431500|NCT01726647|Metabolomic profiles|metabolomic profiles
431501|NCT01726634|upper limb|upper limb
431502|NCT01726634|functional test|functional test
431503|NCT01726634|elastic tape|elastic tape
431504|NCT01726595|critical care|critical care
431505|NCT01726595|severe sepsis|severe sepsis
431506|NCT01726595|microvascular function|microvascular function
431507|NCT01726595|ultrasound|ultrasound
431508|NCT01726582|pancreas|pancreas
431509|NCT01726582|adenocarcinoma|adenocarcinoma
431510|NCT01726582|molecular profile|molecular profile
431511|NCT01726582|molecular profiling|molecular profiling
431512|NCT01726582|pancreatic cancer|pancreatic cancer
431513|NCT01726582|pancreas cancer|pancreas cancer
431514|NCT01726582|cancer|cancer
431515|NCT01726582|molecular target|molecular target
431516|NCT01726582|pancreas head|pancreas head
431517|NCT01726582|pancreas neck|pancreas neck
431518|NCT01726582|pancreas uncinate|pancreas uncinate
431519|NCT01726582|pancreas body|pancreas body
431520|NCT01726582|pancreas tail|pancreas tail
431521|NCT01726569|glaucoma|glaucoma
431522|NCT01726569|educational intervention|educational intervention
431523|NCT01726569|post-operative satisfaction|post-operative satisfaction
431524|NCT01726569|knowledges|knowledges
431525|NCT01726556|Pleural effusion|pleural effusion
431526|NCT01726556|Semirigid thoracoscopy|semirigid thoracoscopy
431527|NCT01726556|Rigid thoracoscopy|rigid thoracoscopy
431528|NCT01726543|canaloplasty|canaloplasty
431529|NCT01726543|non-penetrating deep sclerectomy|non-penetrating deep sclerectomy
431530|NCT01726543|glaucoma|glaucoma
431531|NCT01726543|cataract|cataract
431532|NCT01726543|ophthalmology|ophthalmology
431533|NCT01726543|glaucoma surgery|glaucoma surgery
431534|NCT01726530|transdermal fentanyl patch, postoperative pain,|transdermal fentanyl patch, postoperative pain,
431535|NCT01726517|HCV genotype 1 (GT-1)|hcv genotype 1 (gt-1)
431536|NCT01726517|HCV|hcv
431537|NCT01726517|Sustained Virologic Response|sustained virologic response
431538|NCT01726517|Direct Acting Antiviral|direct acting antiviral
431539|NCT01726517|Combination Therapy|combination therapy
431540|NCT01726517|GS-7977|gs-7977
431541|NCT01726517|GS-5885|gs-5885
431542|NCT01726517|Ribavirin|ribavirin
431543|NCT01726517|Open Label|open label
431544|NCT01726517|Sofosbuvir|sofosbuvir
431545|NCT01726517|Treatment-Naïve|treatment-naïve
431546|NCT01726517|Protease Inhibitors|protease inhibitors
431547|NCT01726517|PI|pi
431548|NCT01726504|chronic functional constipation|chronic functional constipation
431549|NCT01726504|electro-acupuncture|electro-acupuncture
431550|NCT01726504|multi-center randomized controlled trial|multi-center randomized controlled trial
431551|NCT01726504|efficacy|efficacy
431552|NCT01726504|safety|safety
431553|NCT01726491|Insulin resistance|insulin resistance
431554|NCT01726491|Exercise|exercise
431555|NCT01726491|Type 2 diabetes mellitus|type 2 diabetes mellitus
431556|NCT01726491|Obesity|obesity
431557|NCT01726491|Epigenetic studies|epigenetic studies
431558|NCT01726478|Oxytocin|oxytocin
431559|NCT01726478|Uterine tone|uterine tone
431560|NCT01726478|Mulago Hospital|mulago hospital
431561|NCT01726478|Dose|dose
431562|NCT01726478|Side effects|side effects
431563|NCT01726465|N-Acetylcysteine|n-acetylcysteine
431564|NCT01726465|Methylprednisolone|methylprednisolone
431565|NCT01726465|Liver ischemia reperfusion injury|liver ischemia reperfusion injury
431566|NCT01726465|Pringle manoeuvre|pringle manoeuvre
431567|NCT01726465|Hepatic resection|hepatic resection
431568|NCT01726426|Chronic arsenic poisoning|chronic arsenic poisoning
431569|NCT01726426|Palmer arsenical keratosis|palmer arsenical keratosis
431570|NCT01726413|Diabetic neuropathy|diabetic neuropathy
431571|NCT01726400|Hepatitis C|hepatitis c
431572|NCT01726400|Interferon|interferon
431573|NCT01726400|Ribavirin|ribavirin
431574|NCT01726400|Hepcidin|hepcidin
431575|NCT01726400|Iron metabolism|iron metabolism
431576|NCT01726361|Multidimension Treatment Foster Care|multidimension treatment foster care
431577|NCT01726361|Adolescents|adolescents
431578|NCT01726361|Disadvantaged families|disadvantaged families
431579|NCT01726361|Out-of-home placement|out-of-home placement
431580|NCT01726361|Conduct Disorder|conduct disorder
431581|NCT01726361|Family program|family program
431582|NCT01726361|Denmark|denmark
431583|NCT01726361|Youth|youth
431584|NCT01726348|Human Immunodeficiency Virus-Type 1|human immunodeficiency virus-type 1
431585|NCT01726348|HIV-1|hiv-1
431586|NCT01726348|TMC114|tmc114
431587|NCT01726348|Darunavir|darunavir
431588|NCT01726348|Ritonavir|ritonavir
431589|NCT01726348|Filipino|filipino
431590|NCT01726335|Schizophrenia|schizophrenia
431591|NCT01726335|Risperidone|risperidone
431592|NCT01726335|Risperdal consta|risperdal consta
431593|NCT01726283|fruste keratoconus|fruste keratoconus
431594|NCT01726283|ectasia|ectasia
431595|NCT01726257|Infrarenal|infrarenal
431596|NCT01726257|Abdominal|abdominal
431597|NCT01726257|Aortic|aortic
431598|NCT01726257|Aneurysm|aneurysm
431599|NCT01726257|AAA|aaa
431600|NCT01726257|Endologix|endologix
431601|NCT01726257|EVAS|evas
431602|NCT01726257|EndoVascular|endovascular
431603|NCT01726257|Sealing|sealing
431604|NCT01726257|System|system
431605|NCT01726231|Laparoscopic access|laparoscopic access
431606|NCT01726231|Abdominal wall lifting|abdominal wall lifting
431607|NCT01726231|Direct trocar insertion|direct trocar insertion
431608|NCT01726231|Safety endoscopy|safety endoscopy
431609|NCT01726218|Stroke|stroke
431610|NCT01726218|Physical Medicine & Rehabilitation|physical medicine & rehabilitation
431611|NCT01726218|Neurology|neurology
431612|NCT01726218|Neurophysiology|neurophysiology
431613|NCT01726218|Neuroscience|neuroscience
431614|NCT01726218|Transcranial Magnetic Stimulation (TMS)|transcranial magnetic stimulation (tms)
431615|NCT01726179|caries infiltration|caries infiltration
431616|NCT01726179|caries arrest|caries arrest
431617|NCT01726179|dental anxiety|dental anxiety
431618|NCT01726179|dental stress|dental stress
431619|NCT01726166|Infant|infant
431620|NCT01726166|contamination rates|contamination rates
431621|NCT01726166|urinary catheterization|urinary catheterization
431622|NCT01726166|suprapubic aspiration|suprapubic aspiration
431623|NCT01726153|Condom Use|condom use
431624|NCT01726153|HIV+ gay males|hiv+ gay males
431625|NCT01726153|Intervention|intervention
431626|NCT01726153|Tailored|tailored
431627|NCT01726153|On-line|on-line
431628|NCT01726153|Internet|internet
431629|NCT01726153|Web-based|web-based
431630|NCT01726140|intubation|intubation
431631|NCT01726140|respiratory failure|respiratory failure
431632|NCT01726140|cardiac surgery|cardiac surgery
431633|NCT01726114|Diabetes|diabetes
431634|NCT01726114|Diabetes Mellitus|diabetes mellitus
431635|NCT01726114|continuous Glucose Monitor|continuous glucose monitor
431636|NCT01726088|Modafinil|modafinil
431637|NCT01726088|p50|p50
431638|NCT01726088|Attentional Bias|attentional bias
431639|NCT01726075|diabetic retinopathy|diabetic retinopathy
431640|NCT01726062|Motivational Incentives|motivational incentives
431641|NCT01726062|Motivational Interviewing|motivational interviewing
431642|NCT01726062|Secondhand Smoke|secondhand smoke
431643|NCT01726062|Neonatal Intensive Care Unit|neonatal intensive care unit
431644|NCT01726062|NICU|nicu
431645|NCT01726062|High respiratory risk infants|high respiratory risk infants
431646|NCT01726062|Low birth weight infants|low birth weight infants
431647|NCT01726062|Environmental Tobacco Smoke|environmental tobacco smoke
431648|NCT01726062|Smoking|smoking
431649|NCT01726062|Contingency management|contingency management
431650|NCT01726062|Infants|infants
431651|NCT01726062|Children|children
431652|NCT01726049|HFpEF|hfpef
431653|NCT01726049|PH|ph
431654|NCT01726036|neonatal circumcision|neonatal circumcision
431655|NCT01726036|neonatal surgical pain|neonatal surgical pain
431656|NCT01726036|Mogen|mogen
431657|NCT01726036|Gomco|gomco
431658|NCT01726023|Ceftazidime-avibactam,|ceftazidime-avibactam,
431659|NCT01726023|Metronidazole,|metronidazole,
431660|NCT01726023|Meropenem,|meropenem,
431661|NCT01726023|Anti-Bacterial Agents,|anti-bacterial agents,
431662|NCT01726023|Anti-Infective Agents,|anti-infective agents,
431663|NCT01726023|Therapeutic Uses,|therapeutic uses,
431664|NCT01726023|Pharmacologic Actions,|pharmacologic actions,
431665|NCT01726023|Physiological Effects of Drugs|physiological effects of drugs
431666|NCT01725997|acromioclavicular joint dislocation|acromioclavicular joint dislocation
431667|NCT01725997|ac joint dislocation|ac joint dislocation
431668|NCT01725997|acromioclavicular joint separation|acromioclavicular joint separation
431669|NCT01725997|hook plate|hook plate
431670|NCT01725997|Rockwood|rockwood
431671|NCT01725984|Male Incontinence|male incontinence
431672|NCT01725984|AdVance Male Sling|advance male sling
431673|NCT01725984|AdVance XP Male Sling|advance xp male sling
431674|NCT01725984|Male Sling|male sling
431675|NCT01725971|Silicosis|silicosis
431676|NCT01725971|forced oscillations|forced oscillations
431677|NCT01725971|respiratory mechanics|respiratory mechanics
431678|NCT01725945|DASH|dash
431679|NCT01725945|diet|diet
431680|NCT01725945|asthma|asthma
431681|NCT01725945|adults|adults
431682|NCT01725945|asthma control|asthma control
431683|NCT01725932|culture, depression, cognitive therapy, behaviour therapy,|culture, depression, cognitive therapy, behaviour therapy,
431685|NCT01725919|stroke|stroke
431686|NCT01725919|hemiparesis|hemiparesis
431687|NCT01725919|rehabilitation|rehabilitation
431688|NCT01725919|constraint induced movement therapy|constraint induced movement therapy
431689|NCT01725919|CI therapy|ci therapy
431690|NCT01725906|genotypic resistance guided therapy|genotypic resistance guided therapy
431691|NCT01725893|Claw Toe|claw toe
431692|NCT01725880|Spinal Cord Injury|spinal cord injury
431693|NCT01725880|HuCNS-SC cells|hucns-sc cells
431694|NCT01725880|Human Neural Stem Cells|human neural stem cells
431695|NCT01725880|Neural Stem Cells|neural stem cells
431696|NCT01725880|Stem Cells|stem cells
431697|NCT01725867|temporomandibular joint disorder|temporomandibular joint disorder
431698|NCT01725867|myofascial pain|myofascial pain
431699|NCT01725867|manual myofascial release|manual myofascial release
431700|NCT01725867|physical therapy|physical therapy
431701|NCT01725867|oral appliance|oral appliance
431702|NCT01725841|To determine the prevalence of ESBL-producing among Enterobacteriaceae isolates in Taiwan|to determine the prevalence of esbl-producing among enterobacteriaceae isolates in taiwan
431703|NCT01725841|To determine the susceptibility of ertapenem and other antimicrobial agents against Enterobacteriaceae isolates with and without expression of ESBLs|to determine the susceptibility of ertapenem and other antimicrobial agents against enterobacteriaceae isolates with and without expression of esbls
431704|NCT01725841|To determine the molecular typing of the Enterobacteriaceae isolates with expression of ESBLs|to determine the molecular typing of the enterobacteriaceae isolates with expression of esbls
431705|NCT01725841|To analyze the association between geographic area, hospital types against the antimicrobial susceptibility|to analyze the association between geographic area, hospital types against the antimicrobial susceptibility
431706|NCT01725828|Cricothyroid membrane|cricothyroid membrane
431707|NCT01725828|Ultrasound|ultrasound
431708|NCT01725828|Neck landmarks|neck landmarks
431709|NCT01725828|External palpation|external palpation
431710|NCT01725789|Acute isovolemic anemia after gastrectomy for gastric cancer|acute isovolemic anemia after gastrectomy for gastric cancer
431711|NCT01725776|Pulmonary hypertension|pulmonary hypertension
431712|NCT01725776|Cardiac surgery|cardiac surgery
431713|NCT01725776|Cardiopulmonary Bypass (CPB)|cardiopulmonary bypass (cpb)
431714|NCT01725750|Traumatic Brain Injury|traumatic brain injury
431715|NCT01725750|TBI|tbi
431716|NCT01725750|Fatigue|fatigue
431717|NCT01725750|Post-TBI Fatigue|post-tbi fatigue
431718|NCT01725750|PTBIF|ptbif
431719|NCT01725750|Depressed Mood|depressed mood
431720|NCT01725750|Excessive Daytime Sleepiness|excessive daytime sleepiness
431721|NCT01725750|Circadian Rhythm|circadian rhythm
431722|NCT01725750|Anxiety|anxiety
431723|NCT01725750|Cognitive Dysfunction|cognitive dysfunction
431724|NCT01725750|Intervention|intervention
431725|NCT01725750|Treatment|treatment
431726|NCT01725737|ADHD|adhd
431727|NCT01725737|GlyTI-M|glyti-m
431728|NCT01725724|Autologous blood transfusion|autologous blood transfusion
431729|NCT01725724|Allogeneic blood transfusion|allogeneic blood transfusion
431730|NCT01725724|Infection rate|infection rate
431731|NCT01725685|healthy volunteers|healthy volunteers
431732|NCT01725685|Umeclidinium|umeclidinium
431733|NCT01725685|tolerability|tolerability
431734|NCT01725685|Safety|safety
431735|NCT01725685|Fluticasone Furoate|fluticasone furoate
431736|NCT01725685|Pharmacokinetics|pharmacokinetics
431737|NCT01725672|healthy volunteers|healthy volunteers
431738|NCT01725672|Diabetes mellitus|diabetes mellitus
431739|NCT01725672|glimepiride|glimepiride
431740|NCT01725672|pharmacokinetics|pharmacokinetics
431741|NCT01725672|metformin|metformin
431742|NCT01725659|Stroke|stroke
431743|NCT01725659|electric stimulation|electric stimulation
431744|NCT01725659|robotics|robotics
431745|NCT01725659|motor learning|motor learning
431746|NCT01725646|Hypertriglyceridemia, omega-3-acid ethyl ester|hypertriglyceridemia, omega-3-acid ethyl ester
431747|NCT01725633|Stretching|stretching
431748|NCT01725633|Nonlinear Aerobic Training|nonlinear aerobic training
431749|NCT01725633|14-170|14-170
431750|NCT01725607|dexmedetomidine, thoracic epidural anesthesia|dexmedetomidine, thoracic epidural anesthesia
431751|NCT01725581|OSAT|osat
431752|NCT01725581|Pelvic Examination|pelvic examination
431753|NCT01725581|Validation|validation
431754|NCT01725581|Reliability|reliability
431755|NCT01725542|HCV-HIV Co-Infection|hcv-hiv co-infection
431756|NCT01725542|Quadruple therapy|quadruple therapy
431757|NCT01725542|null responder to a standard Pegylated interferon/Ribavirin regimen|null responder to a standard pegylated interferon/ribavirin regimen
431758|NCT01725529|Hepatitis C, Chronic|hepatitis c, chronic
431759|NCT01725529|TMC435|tmc435
431760|NCT01725529|Ribavirin|ribavirin
431761|NCT01725529|peginterferon-alpha (PegIFNα-2a)|peginterferon-alpha (pegifnα-2a)
431762|NCT01725503|creatine synthesis|creatine synthesis
431763|NCT01725490|chemoprevention, metformin, familial adenomatous polyposis|chemoprevention, metformin, familial adenomatous polyposis
431764|NCT01725464|thoracotomy|thoracotomy
431765|NCT01725464|oxygen saturation|oxygen saturation
431766|NCT01725464|postoperative|postoperative
710236|NCT00589641|substance abuse|substance abuse
431767|NCT01725438|Circulating Trophoblastic Cells|circulating trophoblastic cells
431768|NCT01725438|Non-Invasive Prenatal Diagnosis|non-invasive prenatal diagnosis
431769|NCT01725438|Genetic analysis|genetic analysis
431770|NCT01725438|Trisomy 21|trisomy 21
431771|NCT01725438|Down's Syndrome|down's syndrome
431772|NCT01725425|snack food (chips)|snack food (chips)
431773|NCT01725425|fruit (red grapes) consumed in each condition|fruit (red grapes) consumed in each condition
431774|NCT01725425|mood|mood
431775|NCT01725399|post-operative vomiting|post-operative vomiting
431776|NCT01725373|left main, stent,angioplasty|left main, stent,angioplasty
431777|NCT01725360|asthma|asthma
431778|NCT01725360|airway hyperresponsiveness|airway hyperresponsiveness
431779|NCT01725347|nutrition assessment|nutrition assessment
431780|NCT01725347|children|children
431781|NCT01725347|preschool|preschool
431782|NCT01725347|eating behavior|eating behavior
431783|NCT01725347|Head Start|head start
431784|NCT01725347|digital technology|digital technology
431785|NCT01725334|Schizophrenia|schizophrenia
431786|NCT01725334|Negative Symptoms|negative symptoms
431787|NCT01725334|Treatment Resistance|treatment resistance
431788|NCT01725334|Deep Brain Stimulation|deep brain stimulation
431789|NCT01725334|Electrical Stimulation|electrical stimulation
431790|NCT01725334|Mental Disorders|mental disorders
431791|NCT01725334|Brain Diseases|brain diseases
431792|NCT01725334|Neurologic Manifestations|neurologic manifestations
431793|NCT01725334|Signs and Symptoms|signs and symptoms
431794|NCT01725321|Colonoscopy|colonoscopy
431795|NCT01725321|colonic adenoma|colonic adenoma
431796|NCT01725321|serrated polyps|serrated polyps
431797|NCT01725308|FK949E|fk949e
431798|NCT01725308|Major depressive episode|major depressive episode
431799|NCT01725308|patients|patients
431800|NCT01725295|fibromyalgia treatment|fibromyalgia treatment
431801|NCT01725295|physical therapy|physical therapy
431802|NCT01725295|hydrotherapy|hydrotherapy
431803|NCT01725282|patients|patients
431804|NCT01725282|FK949E|fk949e
431805|NCT01725269|AIR001|air001
431806|NCT01725269|sodium nitrite|sodium nitrite
431808|NCT01725269|Pulmonary Arterial Hypertension|pulmonary arterial hypertension
431809|NCT01725269|inhaled sodium nitrite|inhaled sodium nitrite
431810|NCT01725256|AIR001|air001
431811|NCT01725256|sodium nitrite|sodium nitrite
431812|NCT01725256|PAH|pah
431813|NCT01725256|Pulmonary Arterial Hypertension|pulmonary arterial hypertension
431814|NCT01725256|inhaled sodium nitrite|inhaled sodium nitrite
431815|NCT01725243|pregnancy|pregnancy
431816|NCT01725243|postpartum hemorrhage|postpartum hemorrhage
431817|NCT01725243|Cesarean delivery|cesarean delivery
431818|NCT01725243|carbetocin|carbetocin
431819|NCT01725243|failure to progress in labor|failure to progress in labor
431820|NCT01725230|Fostamatinib,|fostamatinib,
431821|NCT01725230|simvastatin,|simvastatin,
431822|NCT01725230|rosuvastatin,|rosuvastatin,
431823|NCT01725230|Phase I,|phase i,
431824|NCT01725230|Healthy Subjects,|healthy subjects,
431825|NCT01725230|Pharmacokinetics|pharmacokinetics
431826|NCT01725217|Meningitis|meningitis
431827|NCT01725217|children|children
431828|NCT01725217|adolescents|adolescents
431829|NCT01725217|adults|adults
431830|NCT01725217|MenACWY|menacwy
431831|NCT01725204|dasatinib|dasatinib
431832|NCT01725204|Protein Kinase Inhibitors|protein kinase inhibitors
431833|NCT01725204|pegylated IFN-alpha 2B|pegylated ifn-alpha 2b
431834|NCT01725204|Interferon-alpha|interferon-alpha
431835|NCT01725178|Mild Cognitive Impairment|mild cognitive impairment
431836|NCT01725178|Dementia|dementia
431837|NCT01725178|Memory disorders|memory disorders
431838|NCT01725178|Physical fitness|physical fitness
431839|NCT01725152|fragile x syndrome|fragile x syndrome
431840|NCT01725152|ganaxolone|ganaxolone
431841|NCT01725152|anxiety|anxiety
431842|NCT01725152|attention|attention
431843|NCT01725152|pediatric|pediatric
431844|NCT01725126|metformin|metformin
431845|NCT01725126|diabetes|diabetes
431846|NCT01725126|obesity|obesity
431847|NCT01725126|liraglutide|liraglutide
431848|NCT01725100|GSK1120212|gsk1120212
431849|NCT01725100|DMSO content|dmso content
431850|NCT01725100|pharmacokinetics|pharmacokinetics
431851|NCT01725100|solid tumors|solid tumors
431852|NCT01725100|MEK inhibitor|mek inhibitor
431853|NCT01725100|dissolution|dissolution
431854|NCT01725100|trametinib|trametinib
431855|NCT01725100|relative bioavailability|relative bioavailability
431856|NCT01725074|Coronary Heart Disease, multimorbidity, primary care, case management, loneliness, depression, social support|coronary heart disease, multimorbidity, primary care, case management, loneliness, depression, social support
431857|NCT01725048|Major depressive disorder|major depressive disorder
431858|NCT01725048|Neoplasms|neoplasms
431859|NCT01725035|De Novo Lipogenesis|de novo lipogenesis
431860|NCT01725035|Fatty Liver|fatty liver
431861|NCT01725035|Hepatic Steatosis|hepatic steatosis
431862|NCT01725035|Gene variants|gene variants
431863|NCT01725022|stem cell transplant|stem cell transplant
431864|NCT01725022|bowel microbiota|bowel microbiota
431865|NCT01725022|home care|home care
431866|NCT01725009|Healthy volunteers|healthy volunteers
431867|NCT01725009|Japanese|japanese
431868|NCT01725009|Caucasian|caucasian
431869|NCT01724983|pain|pain
431870|NCT01724983|mood|mood
431871|NCT01724983|depression|depression
431872|NCT01724983|respiration|respiration
431873|NCT01724970|anesthesia|anesthesia
431874|NCT01724970|postanesthetic recovery|postanesthetic recovery
431875|NCT01724970|ventilation|ventilation
431876|NCT01724970|bariatric surgery|bariatric surgery
431877|NCT01724957|Fractional flow reserve,|fractional flow reserve,
431878|NCT01724957|coronary bifurcation stenosis,|coronary bifurcation stenosis,
431879|NCT01724957|intracoronary ECG,|intracoronary ecg,
431880|NCT01724957|coronary stent|coronary stent
431881|NCT01724957|Coronary bifurcation lesions|coronary bifurcation lesions
431882|NCT01724957|icECG|icecg
431883|NCT01724944|Interval debulking surgery|interval debulking surgery
431884|NCT01724944|IDS|ids
431885|NCT01724944|NACT|nact
431886|NCT01724944|Neoadjuvant chemotherapy|neoadjuvant chemotherapy
431887|NCT01724944|Lymphadenectomy|lymphadenectomy
431888|NCT01724944|Ovarian cancer|ovarian cancer
431889|NCT01724931|antifolate|antifolate
431890|NCT01724931|antiinflammatory|antiinflammatory
431891|NCT01724931|autoimmune disease|autoimmune disease
431892|NCT01724931|hematological treatment|hematological treatment
431893|NCT01724931|rheumatic disease|rheumatic disease
431894|NCT01724931|folic acid antagonist|folic acid antagonist
431895|NCT01724931|enzyme inhibitor|enzyme inhibitor
431896|NCT01724918|IV lacosamide|iv lacosamide
431897|NCT01724918|focal epilepsy|focal epilepsy
431898|NCT01724918|EEG|eeg
431899|NCT01724918|EKG|ekg
431900|NCT01724905|Diet|diet
431901|NCT01724905|Obesity|obesity
431902|NCT01724905|Chronic disease|chronic disease
431903|NCT01724879|philadelphia chromosome|philadelphia chromosome
431904|NCT01724879|BCR-ABL|bcr-abl
431905|NCT01724879|ALL|all
431906|NCT01724879|acute lymphoblastic leukemia|acute lymphoblastic leukemia
431907|NCT01724879|dasatinib|dasatinib
431908|NCT01724879|Sprycel|sprycel
431909|NCT01724853|Carpometacarpal|carpometacarpal
431910|NCT01724853|osteoarthritis|osteoarthritis
431911|NCT01724853|outcome measures|outcome measures
431912|NCT01724827|Dental caries|dental caries
431913|NCT01724827|inlays|inlays
431914|NCT01724827|composite resins|composite resins
431915|NCT01724827|IPS-Empress ceramic|ips-empress ceramic
431916|NCT01724827|bicuspid|bicuspid
431917|NCT01724827|FDI dental restorations evaluation criteria|fdi dental restorations evaluation criteria
431918|NCT01724801|EGFR mutant|egfr mutant
431919|NCT01724775|complete mesocolic excision|complete mesocolic excision
431920|NCT01724775|colon cancer|colon cancer
431921|NCT01724775|efficacy|efficacy
431922|NCT01724775|safety|safety
431923|NCT01724762|Baths|baths
431924|NCT01724762|Anxiety|anxiety
431925|NCT01724762|Acute Coronary Syndrome|acute coronary syndrome
431926|NCT01724762|Education, Nursing|education, nursing
431927|NCT01724749|Atherosclerosis|atherosclerosis
431928|NCT01724749|Sodium-Fluoride|sodium-fluoride
431929|NCT01724749|18F-Sodium Fluoride|18f-sodium fluoride
431930|NCT01724749|18F-NaF|18f-naf
431931|NCT01724749|fluorodeoxyglucose|fluorodeoxyglucose
431932|NCT01724749|18F-FDG|18f-fdg
431933|NCT01724749|FDG|fdg
431934|NCT01724749|Positron emission tomography|positron emission tomography
431935|NCT01724749|PET|pet
431936|NCT01724736|microbiome|microbiome
431937|NCT01724736|prebiotic|prebiotic
431938|NCT01724736|cobiotic|cobiotic
431939|NCT01724736|NM504|nm504
431940|NCT01724736|GI microbiome|gi microbiome
431941|NCT01724723|hepatitis during anti-tuberculous treatment|hepatitis during anti-tuberculous treatment
431942|NCT01724723|tuberculosis|tuberculosis
431943|NCT01724723|hepatitis B virus|hepatitis b virus
431944|NCT01724723|viral load|viral load
431945|NCT01724723|entecavir|entecavir
431946|NCT01724697|liver cirrhosis|liver cirrhosis
431947|NCT01724697|end stage liver disease|end stage liver disease
431948|NCT01724697|HBV|hbv
431949|NCT01724697|autologous|autologous
431950|NCT01724697|stem cell|stem cell
431951|NCT01724697|bone morrow|bone morrow
431952|NCT01724671|MRSA|mrsa
431953|NCT01724671|Bacteremia|bacteremia
431954|NCT01724671|ABSSSI|absssi
431955|NCT01724671|Pneumonia|pneumonia
431956|NCT01724671|Vancomycin|vancomycin
431957|NCT01724671|Ceftaroline|ceftaroline
431958|NCT01724658|female sexual function|female sexual function
431959|NCT01724658|postmenopause|postmenopause
431960|NCT01724658|testosterone|testosterone
431961|NCT01724645|Korean Traditional diets|korean traditional diets
431962|NCT01724645|hypertension|hypertension
431963|NCT01724645|diabetes|diabetes
431964|NCT01724632|Overweight|overweight
431965|NCT01724632|Obesity|obesity
431966|NCT01724632|Weight Loss|weight loss
431967|NCT01724606|Whole Brain Radiotherapy (WBRT)|whole brain radiotherapy (wbrt)
431968|NCT01724606|Sorafenib (BAY 43-9006)|sorafenib (bay 43-9006)
431969|NCT01724606|12-046|12-046
431970|NCT01724593|functional recovery, critical illness, pediatrics|functional recovery, critical illness, pediatrics
710237|NCT00589628|Childhood|childhood
431971|NCT01724567|Interval Training|interval training
431972|NCT01724567|Weight Loss|weight loss
431973|NCT01724567|Secondary Prevention|secondary prevention
431974|NCT01724567|Rehabilitation|rehabilitation
431975|NCT01724567|Cardiovascular Risk Factors|cardiovascular risk factors
431976|NCT01724528|Febuxostat, Tumor lysis syndrome, leukemia, lymphoma|febuxostat, tumor lysis syndrome, leukemia, lymphoma
431977|NCT01724515|insulin resistance|insulin resistance
431978|NCT01724502|insulin resistance|insulin resistance
431979|NCT01724463|Systemic Inflammatory Response Syndrome (SIRS)|systemic inflammatory response syndrome (sirs)
431980|NCT01724463|Sepsis|sepsis
431981|NCT01724463|Severe Sepsis|severe sepsis
431982|NCT01724463|Septic Shock|septic shock
431983|NCT01724463|Electronic Health Record|electronic health record
431984|NCT01724463|Health Screening|health screening
431985|NCT01724463|Goal Directed Therapy|goal directed therapy
431986|NCT01724463|Infant|infant
431987|NCT01724463|Child|child
431988|NCT01724463|Pediatric|pediatric
431989|NCT01724463|Adolescent|adolescent
431990|NCT01724463|Critical Illness|critical illness
431991|NCT01724463|Outcomes Research|outcomes research
431992|NCT01724463|Resource Utilization|resource utilization
431993|NCT01724450|Breast Cancer|breast cancer
431994|NCT01724450|Heart Failure|heart failure
431995|NCT01724450|Cardiotoxicity|cardiotoxicity
431996|NCT01724450|Biomarkers|biomarkers
431997|NCT01724411|Overweight and Obesity|overweight and obesity
431998|NCT01724411|Appetite|appetite
431999|NCT01724411|Gut hormones and obesity|gut hormones and obesity
432000|NCT01724411|Resistant Starch|resistant starch
432001|NCT01724411|Gut microbiota and obesity|gut microbiota and obesity
432002|NCT01724411|SmartPill|smartpill
432003|NCT01724398|mesenchymal stem cells|mesenchymal stem cells
432004|NCT01724398|plasma exchange|plasma exchange
432005|NCT01724398|liver failure|liver failure
432006|NCT01724398|hepatitis B virus|hepatitis b virus
432007|NCT01724385|bevacizumab,|bevacizumab,
432008|NCT01724385|proliferative diabetic retinopathy,|proliferative diabetic retinopathy,
432009|NCT01724385|vitreous hemorrhage,|vitreous hemorrhage,
432010|NCT01724359|Schizophrenia|schizophrenia
432011|NCT01724359|Paliperidone extended-release (ER)|paliperidone extended-release (er)
432012|NCT01724359|Antipsychotic agents|antipsychotic agents
432013|NCT01724346|CLL, SLL|cll, sll
432014|NCT01724333|EORTC QLQ-C30|eortc qlq-c30
432015|NCT01724333|Oral health|oral health
432016|NCT01724333|Quality of life|quality of life
432017|NCT01724333|Questionnaires|questionnaires
432018|NCT01724333|Patient reported|patient reported
432019|NCT01724333|outcomes|outcomes
432020|NCT01724320|solid tumors|solid tumors
432021|NCT01724320|first-in-man|first-in-man
432022|NCT01724320|phase I|phase i
432023|NCT01724320|cancer|cancer
432024|NCT01724320|galectin|galectin
432025|NCT01724281|lateral ventricles|lateral ventricles
432026|NCT01724281|Asymetry|asymetry
432027|NCT01724255|Caesarian section|caesarian section
432028|NCT01724255|Surgical Wound|surgical wound
432029|NCT01724242|Vaginal dryness|vaginal dryness
432030|NCT01724242|Breast Cancer|breast cancer
432031|NCT01724242|Urinary Incontinence|urinary incontinence
432032|NCT01724242|Quality of Life|quality of life
432033|NCT01724242|Sexual Satisfaction|sexual satisfaction
432034|NCT01724229|Incontinence-associated dermatitis|incontinence-associated dermatitis
432035|NCT01724229|Skin care regimen for moisture-associated conditions|skin care regimen for moisture-associated conditions
432036|NCT01724229|Perineal skin care|perineal skin care
432037|NCT01724229|Fungal infection in perineal area|fungal infection in perineal area
432038|NCT01724203|Probiotics for infants|probiotics for infants
432039|NCT01724203|Bacterial and viral infections in infants|bacterial and viral infections in infants
432040|NCT01724190|Type 1 Diabetes|type 1 diabetes
432041|NCT01724190|Vitamin D|vitamin d
432042|NCT01724190|Clinical Remission|clinical remission
432043|NCT01724177|Lenalidomide|lenalidomide
432044|NCT01724177|ATL|atl
432045|NCT01724177|ATLL|atll
432046|NCT01724138|deferasirox|deferasirox
432047|NCT01724125|serious mental illness|serious mental illness
432048|NCT01724099|Obesity|obesity
432049|NCT01724099|Herbal product|herbal product
432050|NCT01724099|Korean Medicine|korean medicine
432051|NCT01724086|Chronic hepatitis C|chronic hepatitis c
432052|NCT01724086|Chronic hepatitis C-infected patients|chronic hepatitis c-infected patients
432053|NCT01724086|TMC647055|tmc647055
432054|NCT01724086|TMC435|tmc435
432055|NCT01724086|Ritonavir|ritonavir
432056|NCT01724086|Ribavirin|ribavirin
432057|NCT01724086|Genotype 1a|genotype 1a
432058|NCT01724086|Genotype 1b|genotype 1b
432059|NCT01724086|GSK2336805|gsk2336805
432060|NCT01724073|food to food fortification strategy|food to food fortification strategy
432061|NCT01724073|leafy vegetable|leafy vegetable
432062|NCT01724073|iron|iron
432063|NCT01724073|zinc|zinc
432064|NCT01724073|vitamin A|vitamin a
432065|NCT01724073|growth|growth
432066|NCT01724047|Autism|autism
432067|NCT01724047|School Based Intervention|school based intervention
432068|NCT01724034|Weaning|weaning
432069|NCT01724034|Mechanical Ventilation|mechanical ventilation
432070|NCT01724034|Lung Ultrasound|lung ultrasound
432071|NCT01723995|nipple/injure|nipple/injure
432072|NCT01723995|breastfeeding|breastfeeding
432073|NCT01723995|pain|pain
432074|NCT01723995|laser|laser
432075|NCT01723956|Cervical Dysplasia|cervical dysplasia
432076|NCT01723956|Cin 2|cin 2
432077|NCT01723956|Cin 3|cin 3
432078|NCT01723956|HIV positive women|hiv positive women
432079|NCT01723956|South Africa|south africa
432080|NCT01723904|Rotigotine|rotigotine
432081|NCT01723904|Neupro|neupro
432082|NCT01723865|Heart failure|heart failure
432083|NCT01723865|Remote Monitoring|remote monitoring
432084|NCT01723865|ICD|icd
432085|NCT01723865|Follow-up|follow-up
432086|NCT01723852|Vitamin D|vitamin d
432087|NCT01723852|Infectious diseases|infectious diseases
432088|NCT01723852|cognitive development|cognitive development
432089|NCT01723852|Bone mineral density|bone mineral density
432090|NCT01723852|Immunoregulation|immunoregulation
432091|NCT01723852|Allergy|allergy
432092|NCT01723852|Growth|growth
432093|NCT01723839|CLL|cll
432094|NCT01723839|FCR|fcr
432095|NCT01723839|Rituximab|rituximab
432096|NCT01723839|Lenalidomide|lenalidomide
432097|NCT01723839|Cyclophosphamide|cyclophosphamide
432098|NCT01723813|Immunotherapy|immunotherapy
432099|NCT01723813|Tumor-specific peptides|tumor-specific peptides
432100|NCT01723813|GM-CT-01|gm-ct-01
432101|NCT01723761|air pollution|air pollution
432102|NCT01723761|pacemaker|pacemaker
432103|NCT01723761|ICD|icd
432104|NCT01723761|remote monitoring|remote monitoring
432105|NCT01723761|supraventricular arrhythmias|supraventricular arrhythmias
432106|NCT01723761|ventricular arrhythmias|ventricular arrhythmias
432107|NCT01723748|Acromegaly|acromegaly
432108|NCT01723748|Somatostatin treatment|somatostatin treatment
432109|NCT01723748|metabolic effect|metabolic effect
432110|NCT01723722|Neonatal Abstinence Syndrome|neonatal abstinence syndrome
432111|NCT01723722|Methadone|methadone
432112|NCT01723722|Diluted Deodorized Tincture of Opium|diluted deodorized tincture of opium
432113|NCT01723722|dDTO|ddto
432114|NCT01723722|Phenobarbital|phenobarbital
432115|NCT01723709|multiple sclerosis|multiple sclerosis
432116|NCT01723709|immune response|immune response
432117|NCT01723709|genetic|genetic
432118|NCT01723709|progression|progression
432119|NCT01723709|relapse|relapse
432120|NCT01723709|biomarkers|biomarkers
432121|NCT01723709|disease|disease
432122|NCT01723709|proteomics|proteomics
432123|NCT01723709|genome|genome
432124|NCT01723709|gene|gene
432125|NCT01723696|In-utero smoke;|in-utero smoke;
432126|NCT01723696|Pulmonary function testing;|pulmonary function testing;
432127|NCT01723696|Wheeze;|wheeze;
432128|NCT01723696|Vitamin C;|vitamin c;
432129|NCT01723696|Forced expiratory flows|forced expiratory flows
432130|NCT01723683|Preterm infants|preterm infants
432131|NCT01723683|RDS|rds
432132|NCT01723683|Surfactant|surfactant
432133|NCT01723683|MISTCPAP|mistcpap
432134|NCT01723683|CPAP|cpap
432135|NCT01723657|Leukemia|leukemia
432136|NCT01723657|Myeloid|myeloid
432137|NCT01723657|Acute|acute
432138|NCT01723657|Young|young
432139|NCT01723657|CETLAM|cetlam
432140|NCT01723644|antibiotherapy, community acquired pneumonia, procalcitonin guided guidelines, clinical reassessment|antibiotherapy, community acquired pneumonia, procalcitonin guided guidelines, clinical reassessment
432141|NCT01723631|Multiple sclerosis|multiple sclerosis
432142|NCT01723631|TRAP|trap
432143|NCT01723631|TRAP-Myéline|trap-myéline
432144|NCT01723605|insitu repair|insitu repair
432145|NCT01723605|intestinal motility|intestinal motility
432146|NCT01723592|chemotherapy|chemotherapy
432147|NCT01723592|vaginal flora|vaginal flora
432148|NCT01723553|aphasia|aphasia
432149|NCT01723553|logopenic|logopenic
432150|NCT01723553|PCA|pca
432151|NCT01723553|LPA|lpa
432152|NCT01723540|Cholecystectomy,minilaparotomy,laparascopy,ultrasonic dissection|cholecystectomy,minilaparotomy,laparascopy,ultrasonic dissection
432153|NCT01723527|Cocaine|cocaine
432154|NCT01723527|Heroin|heroin
432155|NCT01723527|HIV|hiv
432156|NCT01723527|Contingency Management|contingency management
432157|NCT01723527|Incentives|incentives
432158|NCT01723527|Criminal Justice|criminal justice
432159|NCT01723527|Methadone|methadone
432160|NCT01723527|Buprenorphine|buprenorphine
432161|NCT01723527|Employment|employment
432162|NCT01723527|Job Training|job training
432163|NCT01723527|Wage Subsidies|wage subsidies
432164|NCT01723514|Migraine|migraine
432165|NCT01723501|chlorhexidine|chlorhexidine
432166|NCT01723501|sepsis|sepsis
432167|NCT01723501|neonatal|neonatal
432168|NCT01723501|whole-body skin cleansing|whole-body skin cleansing
432169|NCT01723488|AD|ad
432170|NCT01723475|Phase I|phase i
432171|NCT01723475|Dose Escalation|dose escalation
432172|NCT01723475|Prostate cancer|prostate cancer
432173|NCT01723475|Antibodies|antibodies
432174|NCT01723475|Bispecific T-cell Engager (BiTE)|bispecific t-cell engager (bite)
432175|NCT01723436|Decision fatigue|decision fatigue
432176|NCT01723423|breast cancer|breast cancer
432177|NCT01723423|evidence based medicine|evidence based medicine
432178|NCT01723423|reconstruction|reconstruction
432179|NCT01723423|mastectomy|mastectomy
432180|NCT01723423|outcomes|outcomes
432181|NCT01723423|quality of life|quality of life
432182|NCT01723384|methamphetamine|methamphetamine
432183|NCT01723384|alcohol|alcohol
432184|NCT01723384|HIV|hiv
432185|NCT01723384|sexual behavior|sexual behavior
432186|NCT01723371|Pulmonary Arterial Hypertension (PAH|pulmonary arterial hypertension (pah
432187|NCT01723371|Pediatrics|pediatrics
432188|NCT01723371|Right Heart Failure (RHF)|right heart failure (rhf)
432189|NCT01723371|Carvedilol|carvedilol
432190|NCT01723371|Beta-blockers|beta-blockers
432191|NCT01723358|pediatrics|pediatrics
432192|NCT01723358|dysphagia|dysphagia
432193|NCT01723345|elective percutaneous coronary intervention|elective percutaneous coronary intervention
432194|NCT01723345|omega 3 polyunsaturated fatty acids (PUFAs)|omega 3 polyunsaturated fatty acids (pufas)
432195|NCT01723345|short-term MACE|short-term mace
432196|NCT01723345|long-term MACE|long-term mace
432197|NCT01723332|Transition from pediatric to adult clinical care|transition from pediatric to adult clinical care
432198|NCT01723319|ADHD|adhd
432199|NCT01723319|TMS|tms
432200|NCT01723319|brain stimulation|brain stimulation
432201|NCT01723319|clinical improvement|clinical improvement
432202|NCT01723306|T cells|t cells
432203|NCT01723306|gene transfer|gene transfer
432204|NCT01723306|immunotherapy|immunotherapy
432205|NCT01723306|metastatic cancers|metastatic cancers
432206|NCT01723306|lung cancer|lung cancer
432207|NCT01723306|gastric cancer|gastric cancer
432208|NCT01723306|colorectal cancer|colorectal cancer
432209|NCT01723306|solid tumors|solid tumors
432210|NCT01723293|Fetal heart rate, pregnancy, fetus, cardiovascular system|fetal heart rate, pregnancy, fetus, cardiovascular system
432211|NCT01723267|IVF|ivf
432212|NCT01723267|3D ultrasound|3d ultrasound
432213|NCT01723267|SonoAVC|sonoavc
432214|NCT01723267|patients in IVF treatment|patients in ivf treatment
432215|NCT01723254|Vaccines|vaccines
432216|NCT01723254|Phase 1|phase 1
432217|NCT01723254|Allergic Rhinitis|allergic rhinitis
432218|NCT01723241|volunteers|volunteers
432219|NCT01723228|Parkinson's Disease|parkinson's disease
432220|NCT01723228|Cognition|cognition
432221|NCT01723228|Rasagiline|rasagiline
432222|NCT01723215|Attention bias modification|attention bias modification
432223|NCT01723215|resilience|resilience
432224|NCT01723215|combat|combat
432225|NCT01723215|PTSD|ptsd
432226|NCT01723215|Depression|depression
432227|NCT01723215|Anxiety|anxiety
432228|NCT01723202|BRAF|braf
432229|NCT01723202|BRAFi|brafi
432230|NCT01723202|thyroid cancer|thyroid cancer
432231|NCT01723202|thyroid carcinoma|thyroid carcinoma
432232|NCT01723189|central apnoeas|central apnoeas
432233|NCT01723189|stroke|stroke
432234|NCT01723176|goal-directed echocardiography|goal-directed echocardiography
432235|NCT01723176|cardiopulmonary failure|cardiopulmonary failure
432236|NCT01723176|critical care ultrasound|critical care ultrasound
432237|NCT01723163|veteran|veteran
432238|NCT01723163|smoking cessation|smoking cessation
432239|NCT01723150|Klebsiella pneumoniae|klebsiella pneumoniae
432240|NCT01723137|Pain|pain
432241|NCT01723137|Pain measurement|pain measurement
432242|NCT01723137|Visual analog scale|visual analog scale
432243|NCT01723137|Anxiety|anxiety
432244|NCT01723137|Stress|stress
432245|NCT01723137|Opioid|opioid
432246|NCT01723137|Emergency department|emergency department
432247|NCT01723137|Demographics|demographics
432248|NCT01723124|Dense breast tissue|dense breast tissue
432249|NCT01723124|breast cancer screening|breast cancer screening
432250|NCT01723124|molecular breast imaging|molecular breast imaging
432251|NCT01723124|breast cancer|breast cancer
432252|NCT01723124|breast|breast
432253|NCT01723111|hepcidin|hepcidin
432254|NCT01723111|ESA|esa
432255|NCT01723111|hemodialysis|hemodialysis
432256|NCT01723111|peritoneal dialysis|peritoneal dialysis
432257|NCT01723111|iron metabolism|iron metabolism
432258|NCT01723111|dialysis modality|dialysis modality
432259|NCT01723098|Pregnancy, cardiovascular system, physical exercise|pregnancy, cardiovascular system, physical exercise
432260|NCT01723085|Anti-Mullerian hormone|anti-mullerian hormone
432261|NCT01723085|Myomectomy|myomectomy
432262|NCT01723085|Laparotomy|laparotomy
432263|NCT01723072|Chronic spontanous urticaria, refractory CSU, Angioedema|chronic spontanous urticaria, refractory csu, angioedema
432264|NCT01723046|Upper extremity|upper extremity
432265|NCT01723046|Rehabilitation|rehabilitation
432266|NCT01723046|Robot assisted therapy|robot assisted therapy
432267|NCT01723046|Robotics|robotics
432268|NCT01723046|Devices|devices
432269|NCT01723046|Orthosis|orthosis
432270|NCT01723046|clinical outcome|clinical outcome
432271|NCT01723033|PTSD|ptsd
432272|NCT01723033|OCD|ocd
432273|NCT01723020|Solid Tumors|solid tumors
432274|NCT01723020|Multiple Myeloma|multiple myeloma
432275|NCT01723007|Weight loss|weight loss
432276|NCT01723007|cholesterol|cholesterol
432277|NCT01722968|Metastatic breast cancer|metastatic breast cancer
710238|NCT00589628|Uveitis|uveitis
432278|NCT01722955|Prewarmed fluid|prewarmed fluid
432279|NCT01722955|monitored anesthesia care|monitored anesthesia care
432280|NCT01722955|core body temperature|core body temperature
432384|NCT01722448|muscle|muscle
432281|NCT01722955|anesthetic satisfaction|anesthetic satisfaction
432282|NCT01722942|Chagas cardiomyopathy|chagas cardiomyopathy
432283|NCT01722942|sudden cardiac death|sudden cardiac death
432284|NCT01722942|primary prevention of death|primary prevention of death
432285|NCT01722942|amiodarone|amiodarone
432286|NCT01722942|implantable cardioverter defibrillator|implantable cardioverter defibrillator
432287|NCT01722903|colorectal cancer|colorectal cancer
432288|NCT01722903|liver metastases|liver metastases
432289|NCT01722903|lung metastases|lung metastases
432290|NCT01722890|HER2-positive breast cancer|her2-positive breast cancer
432291|NCT01722890|durable complete response|durable complete response
432292|NCT01722890|cytogenetic characteristics|cytogenetic characteristics
432293|NCT01722890|molecular characteristics|molecular characteristics
432294|NCT01722890|trastuzumab|trastuzumab
432295|NCT01722877|Restenosis|restenosis
432296|NCT01722877|aspiration|aspiration
432297|NCT01722877|in-stent restenosis|in-stent restenosis
432298|NCT01722877|atherectomy|atherectomy
432299|NCT01722877|superficial femoral artery|superficial femoral artery
432300|NCT01722877|popliteal artery|popliteal artery
432301|NCT01722851|Breast Cancer|breast cancer
432302|NCT01722851|miRNAs|mirnas
432303|NCT01722851|Newly diagnosed|newly diagnosed
432304|NCT01722851|Recurrent|recurrent
432305|NCT01722838|Black MSM|black msm
432306|NCT01722838|HIV Prevention|hiv prevention
432307|NCT01722799|angioplasty|angioplasty
432308|NCT01722799|Percutaneous Transluminal Coronary Angioplasty|percutaneous transluminal coronary angioplasty
432309|NCT01722799|Drug elluting Balloon|drug elluting balloon
432310|NCT01722799|Coronary Balloon|coronary balloon
432311|NCT01722799|Dilatation|dilatation
432312|NCT01722786|severe bleeding|severe bleeding
432313|NCT01722786|dabigatran|dabigatran
432314|NCT01722786|rivaroxaban|rivaroxaban
432315|NCT01722786|apixaban|apixaban
432316|NCT01722786|edoxaban|edoxaban
432317|NCT01722786|PCC|pcc
432318|NCT01722786|aPCC|apcc
432319|NCT01722786|rVIIa|rviia
432320|NCT01722786|hemodialysis|hemodialysis
432321|NCT01722786|antidots|antidots
432322|NCT01722786|idarucizumab|idarucizumab
432323|NCT01722773|COPD|copd
432324|NCT01722760|Neonatal|neonatal
432325|NCT01722760|Preterm|preterm
432326|NCT01722760|Bronchopulmonary Dysplasia|bronchopulmonary dysplasia
432327|NCT01722760|Nasal Continuous Positive airway Pressure (CPAP)|nasal continuous positive airway pressure (cpap)
432328|NCT01722760|Oxygen|oxygen
432329|NCT01722760|Vitamin A|vitamin a
432330|NCT01722760|Vitamin D|vitamin d
432331|NCT01722760|Nitrogen oxide (NO)|nitrogen oxide (no)
432332|NCT01722760|Reference material|reference material
432333|NCT01722734|Malaria|malaria
432334|NCT01722734|ACTs|acts
432335|NCT01722708|Abnormal vaginal flora|abnormal vaginal flora
432336|NCT01722708|clindamycin Vs metronidazole|clindamycin vs metronidazole
432337|NCT01722708|High risk pregnancies for preterm labor|high risk pregnancies for preterm labor
432338|NCT01722708|Preterm labor|preterm labor
432339|NCT01722708|Late abortion|late abortion
432340|NCT01722708|bacterial vaginosis|bacterial vaginosis
432341|NCT01722682|Diabetes|diabetes
432342|NCT01722669|quercetin|quercetin
432343|NCT01722669|isoquercetin|isoquercetin
432344|NCT01722669|pharmacokinetic|pharmacokinetic
432345|NCT01722669|pharmacodynamic|pharmacodynamic
432346|NCT01722656|PED|ped
432347|NCT01722656|AMD|amd
432348|NCT01722656|CNV|cnv
432349|NCT01722630|dopamine|dopamine
432350|NCT01722630|laparoscopy|laparoscopy
432351|NCT01722630|fluid management|fluid management
432352|NCT01722578|Cirrhosis|cirrhosis
432353|NCT01722578|Encephalopathy|encephalopathy
432354|NCT01722578|L-ornithine L-aspartate|l-ornithine l-aspartate
432355|NCT01722565|Parastomal hernias|parastomal hernias
432356|NCT01722565|Tolerance of lightweight meshes|tolerance of lightweight meshes
432357|NCT01722565|laparoscopic abdominoperineal resection|laparoscopic abdominoperineal resection
432358|NCT01722552|HIV|hiv
432359|NCT01722552|AIDS|aids
432360|NCT01722552|antiretroviral therapy|antiretroviral therapy
432361|NCT01722552|adherence|adherence
432362|NCT01722552|China|china
432363|NCT01722539|intermittent|intermittent
432364|NCT01722539|preventive|preventive
432365|NCT01722539|treatment|treatment
432366|NCT01722539|malaria|malaria
432367|NCT01722539|soil transmitted helminths|soil transmitted helminths
432368|NCT01722539|schistosomiasis|schistosomiasis
432369|NCT01722539|schoolchildren|schoolchildren
432370|NCT01722526|Human acid sphingomyelinase deficiency|human acid sphingomyelinase deficiency
432371|NCT01722513|Contrast Induced Nephropathy|contrast induced nephropathy
432372|NCT01722500|International|international
432373|NCT01722500|Childhood|childhood
432374|NCT01722500|Obesity|obesity
432375|NCT01722500|ISCOLE|iscole
432376|NCT01722500|Pennington Biomedical Research Center|pennington biomedical research center
432377|NCT01722500|PBRC|pbrc
432378|NCT01722500|longitudinal|longitudinal
432379|NCT01722500|multinational|multinational
432380|NCT01722487|CLL, SLL|cll, sll
432381|NCT01722474|Pulse Wave Analysis|pulse wave analysis
432382|NCT01722474|Arterial Stiffness|arterial stiffness
432383|NCT01722461|Excessive underarm sweating|excessive underarm sweating
432385|NCT01722448|muscle dysfunction|muscle dysfunction
432386|NCT01722448|choline|choline
432387|NCT01722448|exercise|exercise
432388|NCT01722448|exertional rhabdomyolysis|exertional rhabdomyolysis
432389|NCT01722448|rhabdomyolysis|rhabdomyolysis
432390|NCT01722435|opioid dependence|opioid dependence
432391|NCT01722435|opiate substitution treatment|opiate substitution treatment
432392|NCT01722435|methadone|methadone
432393|NCT01722435|completion|completion
432394|NCT01722435|termination|termination
432395|NCT01722422|sepsis|sepsis
432396|NCT01722422|shock|shock
432397|NCT01722422|hyperoxia|hyperoxia
432398|NCT01722422|hypertonic saline|hypertonic saline
432399|NCT01722409|dexmedetomidine, endovascular coil embolization|dexmedetomidine, endovascular coil embolization
432400|NCT01722357|bariatric surgery|bariatric surgery
432401|NCT01722357|physical activity|physical activity
432402|NCT01722357|morbid obesity|morbid obesity
432403|NCT01722344|Severe mental illness|severe mental illness
432404|NCT01722344|Vocational rehabilitation|vocational rehabilitation
432405|NCT01722344|Supported employment|supported employment
432406|NCT01722344|Individual placement and support|individual placement and support
432407|NCT01722344|Cognitive remediation|cognitive remediation
432408|NCT01722344|Social skill training|social skill training
432409|NCT01722279|bariatric surgery|bariatric surgery
432410|NCT01722279|long-term outcomes|long-term outcomes
432411|NCT01722279|obesity|obesity
432412|NCT01722266|Liraglutide|liraglutide
432413|NCT01722266|Glucagon|glucagon
432414|NCT01722266|Systolic blood pressure|systolic blood pressure
432415|NCT01722266|Weight|weight
432416|NCT01722266|Carbohydrate intake|carbohydrate intake
432417|NCT01722266|Insulin dose|insulin dose
432418|NCT01722266|HbA1c|hba1c
432419|NCT01722266|Post-prandial glucagon|post-prandial glucagon
432420|NCT01722253|electroacupuncture|electroacupuncture
432421|NCT01722253|acupuncture|acupuncture
432422|NCT01722253|pain management|pain management
432423|NCT01722214|Psoriasis|psoriasis
432424|NCT01722214|Vascular Inflammation|vascular inflammation
432425|NCT01722214|Coronary Atherosclerosis|coronary atherosclerosis
432426|NCT01722214|Ascending aorta|ascending aorta
432427|NCT01722214|Pet scan|pet scan
432429|NCT01722188|Optim|optim
432430|NCT01722188|Insulation|insulation
432431|NCT01722149|malignant pleural mesothelioma|malignant pleural mesothelioma
432432|NCT01722149|re-directed T cells|re-directed t cells
432433|NCT01722149|FAP|fap
432434|NCT01722149|fibroblast activation protein|fibroblast activation protein
432435|NCT01722149|CD8 positive T cells|cd8 positive t cells
432436|NCT01722149|pleural effusion|pleural effusion
432437|NCT01722123|Decision fatigue|decision fatigue
432438|NCT01722071|Oxytocin|oxytocin
432439|NCT01722071|Functional Magnetic Resonance Imaging|functional magnetic resonance imaging
432440|NCT01722071|Social|social
432441|NCT01722071|Motivation|motivation
432442|NCT01722058|peptide|peptide
432443|NCT01722058|colon|colon
432444|NCT01722058|flat lesions|flat lesions
432445|NCT01722045|AMD|amd
432446|NCT01722032|childhood obesity, early childhood, nutrition|childhood obesity, early childhood, nutrition
432447|NCT01722019|venous insufficiency|venous insufficiency
432448|NCT01722006|methamphetamine|methamphetamine
432449|NCT01722006|subjective|subjective
432450|NCT01722006|conditioning|conditioning
432451|NCT01722006|preference|preference
432452|NCT01721993|oral zoledronic acid|oral zoledronic acid
432453|NCT01721967|chest pain|chest pain
432454|NCT01721967|dyspnea|dyspnea
432455|NCT01721954|colon|colon
432456|NCT01721954|rectum|rectum
432457|NCT01721954|metastatic colorectal cancer|metastatic colorectal cancer
432458|NCT01721954|liver metastases|liver metastases
432459|NCT01721941|hepatocellular carcinoma|hepatocellular carcinoma
432460|NCT01721941|HCC|hcc
432461|NCT01721941|liver cancer|liver cancer
432462|NCT01721941|hepatoma|hepatoma
432463|NCT01721941|TACE|tace
432464|NCT01721941|transarterial chemoembolization|transarterial chemoembolization
432465|NCT01721941|TH302|th302
432466|NCT01721928|Acute kidney injury|acute kidney injury
432467|NCT01721928|Deep venous thrombosis|deep venous thrombosis
432468|NCT01721928|Dialysis|dialysis
432469|NCT01721928|Prophylaxis|prophylaxis
432470|NCT01721915|Polycystic Ovary Syndrome (PCOS)|polycystic ovary syndrome (pcos)
432471|NCT01721915|glucose metabolism|glucose metabolism
432472|NCT01721915|Vitamin D deficiency|vitamin d deficiency
432473|NCT01721915|vitamin D supplementation|vitamin d supplementation
432474|NCT01721915|pharmakogenetics|pharmakogenetics
432475|NCT01721915|women|women
432476|NCT01721863|Atrial Fibrillation|atrial fibrillation
432477|NCT01721863|Exercise Training|exercise training
432478|NCT01721863|Endothelial Function|endothelial function
432479|NCT01721863|Autonomic Nerve Modulation|autonomic nerve modulation
432480|NCT01721863|Exercise Capacity|exercise capacity
432481|NCT01721863|Quality of Life|quality of life
432482|NCT01721850|infant nutrition, infantile colic|infant nutrition, infantile colic
432483|NCT01721824|Supported employment|supported employment
432484|NCT01721824|Individual Placement and Support|individual placement and support
432485|NCT01721824|Workability|workability
432486|NCT01721824|Return to work|return to work
432487|NCT01721798|AE adverse event|ae adverse event
432488|NCT01721798|AIDS acquired immunodeficiency syndrome|aids acquired immunodeficiency syndrome
432489|NCT01721798|ALT (SGPT) alanine aminotransferase|alt (sgpt) alanine aminotransferase
432490|NCT01721798|ART antiretroviral therapy|art antiretroviral therapy
432491|NCT01721798|AST (SGOT) aspartate aminotransferase|ast (sgot) aspartate aminotransferase
432492|NCT01721798|DCF data collection forms|dcf data collection forms
432493|NCT01721798|DMC Data Monitoring Committee|dmc data monitoring committee
432494|NCT01721798|FDA (U.S.) Food and Drug Administration|fda (u.s.) food and drug administration
432495|NCT01721798|GCP Good Clinical Practice guidelines|gcp good clinical practice guidelines
432496|NCT01721798|HB sAg Hepatitis B surface antigen|hb sag hepatitis b surface antigen
432497|NCT01721798|ICH International Council for Harmonization|ich international council for harmonization
432498|NCT01721798|IND Investigational New Drug Application|ind investigational new drug application
432499|NCT01721798|IRB Institutional Review Board|irb institutional review board
432500|NCT01721798|IU International units|iu international units
432501|NCT01721798|mg milligram(s)|mg milligram(s)
432502|NCT01721798|mm3 cubic millimeter(s)|mm3 cubic millimeter(s)
432503|NCT01721798|PCR polymerase chain reaction|pcr polymerase chain reaction
432504|NCT01721798|SAE serious adverse event|sae serious adverse event
432505|NCT01721798|µg microgram|µg microgram
432506|NCT01721798|ULN upper limit of the normal range|uln upper limit of the normal range
432507|NCT01721798|WB Western Blot|wb western blot
432508|NCT01721785|Nodal imaging|nodal imaging
432509|NCT01721785|Restaging|restaging
432510|NCT01721733|EPI743|epi743
432511|NCT01721733|Leigh syndrome|leigh syndrome
432512|NCT01721733|respiratory chain disease|respiratory chain disease
432513|NCT01721733|mitochondrial disorders|mitochondrial disorders
432514|NCT01721720|Peer and Family Networks|peer and family networks
432515|NCT01721720|Longitudinal Outcome|longitudinal outcome
432516|NCT01721720|MRI Imaging|mri imaging
432517|NCT01721720|Genetics|genetics
432518|NCT01721720|Childhood Psychiatric Disorders|childhood psychiatric disorders
432519|NCT01721707|glaucoma|glaucoma
432520|NCT01721707|ocular hypertension|ocular hypertension
432521|NCT01721707|latanoprost|latanoprost
432522|NCT01721707|brinzolamide|brinzolamide
432523|NCT01721694|bacterial ocular inflammation|bacterial ocular inflammation
432524|NCT01721694|blepharitis|blepharitis
432525|NCT01721694|keratitis|keratitis
432526|NCT01721694|conjunctivitis|conjunctivitis
432527|NCT01721655|Spironolactone|spironolactone
432528|NCT01721655|Preterm Infants|preterm infants
432529|NCT01721655|Chronic Lung Disease|chronic lung disease
432530|NCT01721655|Bronchopulmonary Dysplasia|bronchopulmonary dysplasia
432531|NCT01721655|Electrolyte Supplementation|electrolyte supplementation
432532|NCT01721642|access|access
432533|NCT01721642|closure|closure
432534|NCT01721642|trans-apical|trans-apical
432535|NCT01721642|trans-catheter aortic valve implantation|trans-catheter aortic valve implantation
432536|NCT01721642|TAVI|tavi
432537|NCT01721642|trans-catheter aortic valve repair|trans-catheter aortic valve repair
432538|NCT01721642|TAVR|tavr
432539|NCT01721629|Nasal cpap weaning|nasal cpap weaning
432540|NCT01721629|Premature infants|premature infants
432541|NCT01721629|Respiratory distress syndrome|respiratory distress syndrome
432542|NCT01721629|Randomized controlled trial|randomized controlled trial
432543|NCT01721603|BRAFV600E melanoma patients|brafv600e melanoma patients
432544|NCT01721603|melanoma|melanoma
432545|NCT01721603|stereotactic radiosurgery|stereotactic radiosurgery
432546|NCT01721603|BRAFV600E melanoma brain metastases|brafv600e melanoma brain metastases
432547|NCT01721603|dabrafenib|dabrafenib
432548|NCT01721603|SRS|srs
432549|NCT01721590|high on-treatment platelet reactivity|high on-treatment platelet reactivity
432550|NCT01721590|Coronary Heart Disease|coronary heart disease
432551|NCT01721590|Tongxinluo|tongxinluo
432552|NCT01721577|glioblastoma|glioblastoma
432553|NCT01721577|gliosarcoma|gliosarcoma
432554|NCT01721577|anaplastic astrocytoma|anaplastic astrocytoma
432555|NCT01721577|anaplastic oligodendroglioma|anaplastic oligodendroglioma
432556|NCT01721577|anaplastic oligoastrocytoma|anaplastic oligoastrocytoma
432557|NCT01721577|AXL1717|axl1717
432558|NCT01721577|IGF-1 receptor inhibitor|igf-1 receptor inhibitor
432559|NCT01721577|picropodophyllin|picropodophyllin
432560|NCT01721551|Dialysis fatigue,|dialysis fatigue,
432561|NCT01721551|exercise intolerance,|exercise intolerance,
432562|NCT01721551|muscle atrophy,|muscle atrophy,
432563|NCT01721551|cachexia,|cachexia,
432564|NCT01721551|disability,|disability,
432565|NCT01721551|Sleep disorders|sleep disorders
432566|NCT01721551|Depression|depression
432567|NCT01721551|Mental Fatigue,|mental fatigue,
432568|NCT01721551|Cognitive function|cognitive function
710239|NCT00589615|vitamin D|vitamin d
432569|NCT01721551|Physical Fatigue|physical fatigue
432570|NCT01721538|stroke|stroke
432571|NCT01721538|prevention|prevention
432572|NCT01721538|obesity|obesity
432573|NCT01721538|weight reduction|weight reduction
432574|NCT01721525|BIBW2992 (AFATINIB)|bibw2992 (afatinib)
432575|NCT01721525|CARBOPLATIN|carboplatin
432576|NCT01721525|RIBAVIRIN-ICN (VIRAZOLE)|ribavirin-icn (virazole)
432577|NCT01721525|TAXOL (PACLITAXEL)|taxol (paclitaxel)
432578|NCT01721525|OROPHARYNX|oropharynx
432579|NCT01721525|HPV associated|hpv associated
432580|NCT01721525|12-150|12-150
432581|NCT01721512|Prospective observational study|prospective observational study
432582|NCT01721512|Breast feeding|breast feeding
432583|NCT01721512|Infant formula|infant formula
432584|NCT01721512|Infant|infant
432585|NCT01721512|Indonesia|indonesia
432586|NCT01721499|Stress|stress
432587|NCT01721499|obesity|obesity
432588|NCT01721499|overeating|overeating
432589|NCT01721486|tonsillitis|tonsillitis
432590|NCT01721486|recurrent tonsillitis|recurrent tonsillitis
432591|NCT01721486|obstructed air passages|obstructed air passages
432592|NCT01721486|swallowing difficulties|swallowing difficulties
432593|NCT01721473|Tobacco|tobacco
432594|NCT01721473|Positron Emission Tomography|positron emission tomography
432595|NCT01721473|Marijuana|marijuana
432596|NCT01721473|Caffeine|caffeine
432597|NCT01721473|Menthol|menthol
432598|NCT01721460|SubThalamic Nucleus|subthalamic nucleus
432599|NCT01721460|Microelectrode recording|microelectrode recording
432600|NCT01721460|Deep Brain Stimulation Electrode implantation|deep brain stimulation electrode implantation
432601|NCT01721447|Atrial fibrillation|atrial fibrillation
432602|NCT01721447|stroke|stroke
432603|NCT01721447|TEE|tee
432604|NCT01721447|Left atrial thrombus|left atrial thrombus
432605|NCT01721434|levosimendan|levosimendan
432606|NCT01721434|diaphragm function|diaphragm function
432607|NCT01721434|mechanically ventilated patients|mechanically ventilated patients
432608|NCT01721434|neuro-mechanical efficiency|neuro-mechanical efficiency
432609|NCT01721421|haemodialysis|haemodialysis
432610|NCT01721421|Crossover|crossover
432611|NCT01721421|Treatment time|treatment time
432612|NCT01721421|nutritional status|nutritional status
432613|NCT01721395|Cough|cough
432614|NCT01721395|Nocturnal Cough|nocturnal cough
432615|NCT01721395|Agave|agave
432616|NCT01721395|Sleep Quality|sleep quality
432617|NCT01721395|Childhood cough|childhood cough
432618|NCT01721382|cystic fibrosis|cystic fibrosis
432619|NCT01721382|CF|cf
432620|NCT01721382|CFRD|cfrd
432621|NCT01721382|sitagliptin|sitagliptin
432622|NCT01721382|incretins|incretins
432623|NCT01721382|GLP1|glp1
432624|NCT01721382|GIP|gip
432625|NCT01721382|beta cell function|beta cell function
432626|NCT01721382|adolescents|adolescents
432627|NCT01721330|ADHD|adhd
432628|NCT01721330|Attention Deficit Hyperactivity Disorder|attention deficit hyperactivity disorder
432629|NCT01721330|Psychopharmacology|psychopharmacology
432630|NCT01721330|Psychiatry|psychiatry
432631|NCT01721330|Non-stimulant treatment|non-stimulant treatment
432632|NCT01721317|Ezogabine/Retigabine|ezogabine/retigabine
432633|NCT01721317|Adjunctive Treatment|adjunctive treatment
432634|NCT01721317|Safety|safety
432635|NCT01721317|Efficacy|efficacy
432636|NCT01721317|Epilepsy|epilepsy
432637|NCT01721317|Tolerability|tolerability
432638|NCT01721317|Immediate Release|immediate release
432639|NCT01721317|GW582892|gw582892
432640|NCT01721317|Dose-Optimization|dose-optimization
432641|NCT01721317|Partial-Onset Seizures|partial-onset seizures
432642|NCT01721304|decision making|decision making
432643|NCT01721304|abnormal uterine bleeding|abnormal uterine bleeding
432644|NCT01721304|adaptive conjoint analysis|adaptive conjoint analysis
432645|NCT01721304|satisfaction|satisfaction
432646|NCT01721304|regret|regret
432647|NCT01721291|CHRONIC OBSTRUCTIVE PULMONARY DISEASE|chronic obstructive pulmonary disease
432648|NCT01721291|ASTHMA|asthma
432649|NCT01721291|SALBUTAMOL|salbutamol
432650|NCT01721291|ALBUTEROL|albuterol
432651|NCT01721291|VENTOLIN|ventolin
432652|NCT01721291|LUNG PHYSIOLOGY|lung physiology
432653|NCT01721291|LUNG DEPOSITION|lung deposition
432654|NCT01721291|INHALERS|inhalers
432655|NCT01721291|DRUG THERAPY|drug therapy
432656|NCT01721265|HCV|hcv
432657|NCT01721265|Hepatitis C|hepatitis c
432658|NCT01721265|IDX184|idx184
432659|NCT01721265|IDX719|idx719
432660|NCT01721252|non-small cell lung cancer|non-small cell lung cancer
432661|NCT01721252|Erlotinib|erlotinib
432662|NCT01721252|TarcevaTM|tarcevatm
432663|NCT01721252|proteomic signature|proteomic signature
432664|NCT01721239|ICU|icu
432665|NCT01721239|Follow-up consultations|follow-up consultations
432666|NCT01721239|Quality of life|quality of life
432667|NCT01721239|Sense Of Coherence|sense of coherence
432668|NCT01721239|RCT multicenter study|rct multicenter study
432669|NCT01721226|Linkage to HIV care following release from prison|linkage to hiv care following release from prison
432670|NCT01721226|Anti-retroviral therapy adherence after release from prison|anti-retroviral therapy adherence after release from prison
710240|NCT00589615|bone density|bone density
432671|NCT01721226|HIV loads after release from prison|hiv loads after release from prison
432672|NCT01721226|information technology and ART adherence|information technology and art adherence
432673|NCT01721226|information technology and linkage to HIV care|information technology and linkage to hiv care
432674|NCT01721213|Epilepsy|epilepsy
432675|NCT01721213|survey|survey
432676|NCT01721213|retigabine|retigabine
432677|NCT01721213|patient information leaflet|patient information leaflet
432678|NCT01721213|physician's guide|physician's guide
432679|NCT01721213|Trobalt™|trobalt™
432680|NCT01721200|Rheumatoid Arthritis|rheumatoid arthritis
432681|NCT01721200|web based interactive learning tool|web based interactive learning tool
432682|NCT01721187|fMRI|fmri
432683|NCT01721187|Satiety|satiety
432684|NCT01721187|Willingness to Pay|willingness to pay
432685|NCT01721187|Incentive Delay|incentive delay
432686|NCT01721187|Dietary Disinhibition|dietary disinhibition
432687|NCT01721174|Pancreatic cancer|pancreatic cancer
432688|NCT01721174|Cholangiocarcinoma|cholangiocarcinoma
432689|NCT01721174|Endoscopic radiofrequency ablation|endoscopic radiofrequency ablation
432690|NCT01721161|Optic Neuritis|optic neuritis
432691|NCT01721135|moxifloxacin|moxifloxacin
432692|NCT01721135|GSK2190915|gsk2190915
432693|NCT01721135|pharmacokinetics|pharmacokinetics
432694|NCT01721135|QTc|qtc
432695|NCT01721109|Adolescents|adolescents
432696|NCT01721109|HIV-1|hiv-1
432697|NCT01721109|HIV|hiv
432698|NCT01721109|Treatment Naive|treatment naive
432699|NCT01721096|Angioplasty|angioplasty
432700|NCT01721096|Drug eluting stents|drug eluting stents
432701|NCT01721096|Stents|stents
432702|NCT01721096|Real world|real world
432703|NCT01721083|intramuscular injection|intramuscular injection
432704|NCT01721083|bunch|bunch
432705|NCT01721083|z-track|z-track
432706|NCT01721070|Area under curve, time to maximum concentration|area under curve, time to maximum concentration
432707|NCT01721031|Catheter Related Bladder Discomfort|catheter related bladder discomfort
432708|NCT01721031|Dorsal Penile Nerve Block|dorsal penile nerve block
432709|NCT01721018|Oncolytic virus|oncolytic virus
432710|NCT01721018|HSV1716|hsv1716
432711|NCT01721018|Mesothelioma|mesothelioma
432712|NCT01721018|MPM|mpm
432713|NCT01721018|Woll|woll
432714|NCT01721018|Sheffield|sheffield
432715|NCT01721018|Weston Park|weston park
432716|NCT01721018|Virttu|virttu
432717|NCT01721018|Crusade|crusade
432718|NCT01721005|atrial fibrillation|atrial fibrillation
432719|NCT01721005|thromboembolism|thromboembolism
432720|NCT01721005|patient education|patient education
432721|NCT01720979|TBI|tbi
432722|NCT01720979|Traumatic Brain Injury|traumatic brain injury
432723|NCT01720979|Children|children
432724|NCT01720979|Prognosis|prognosis
432725|NCT01720979|Neurocognition|neurocognition
432726|NCT01720966|Adhesions|adhesions
432727|NCT01720966|laparoscopy|laparoscopy
432728|NCT01720966|laparotomy|laparotomy
432729|NCT01720966|liver resection|liver resection
432730|NCT01720966|colorectal malignancy|colorectal malignancy
432731|NCT01720953|Borderline Personality Disorder|borderline personality disorder
432732|NCT01720953|Mentalization Based Therapy|mentalization based therapy
432733|NCT01720953|DNA methylation|dna methylation
432734|NCT01720953|BDNF|bdnf
432735|NCT01720953|Cortisol|cortisol
432736|NCT01720953|Neuropsychology|neuropsychology
432737|NCT01720927|Acute Pharyngitis, GABHS|acute pharyngitis, gabhs
432738|NCT01720888|Autologous|autologous
432739|NCT01720888|Bone Marrow|bone marrow
432740|NCT01720888|Mesenchymal Stem Cells|mesenchymal stem cells
432741|NCT01720888|Ischemic Dilated Cardiomyopathy|ischemic dilated cardiomyopathy
432742|NCT01720862|migraine|migraine
432743|NCT01720862|episodic migraine|episodic migraine
432744|NCT01720862|chronic migraine|chronic migraine
432745|NCT01720862|obesity|obesity
432746|NCT01720862|non-obese|non-obese
432747|NCT01720823|Obstructive Sleep Apnea syndrome|obstructive sleep apnea syndrome
432748|NCT01720823|polysomnography|polysomnography
432749|NCT01720823|Home monitoring|home monitoring
432750|NCT01720797|Malocclusion|malocclusion
432751|NCT01720797|Accelerated tooth movement|accelerated tooth movement
432752|NCT01720797|Braces|braces
432753|NCT01720797|Orthodontic treatment|orthodontic treatment
432754|NCT01720797|Propel|propel
432755|NCT01720771|bacteriotherapy|bacteriotherapy
432756|NCT01720771|caries|caries
432757|NCT01720771|preschool children|preschool children
432758|NCT01720771|probiotics|probiotics
432759|NCT01720745|EUS|eus
432760|NCT01720745|FNA|fna
432761|NCT01720745|Wet suction|wet suction
432762|NCT01720745|Dry suction|dry suction
432763|NCT01720745|Solid lesions|solid lesions
432764|NCT01720719|Non-alcoholic Fatty Liver Disease|non-alcoholic fatty liver disease
432765|NCT01720719|Dyslipidemias|dyslipidemias
432766|NCT01720719|Diabetes Mellitus|diabetes mellitus
432767|NCT01720719|atorvastatin|atorvastatin
432768|NCT01720719|Vitamin E|vitamin e
432769|NCT01720706|Liver tumour|liver tumour
432770|NCT01720706|Kidney tumour|kidney tumour
432771|NCT01720706|Hepatectomy|hepatectomy
432772|NCT01720706|Nephrectomy|nephrectomy
432773|NCT01720706|Metastatic Colon Cancer|metastatic colon cancer
432774|NCT01720706|Renal Cell Carcinoma|renal cell carcinoma
432775|NCT01720693|partial nephrectomy|partial nephrectomy
432776|NCT01720693|hypoperfusion|hypoperfusion
432777|NCT01720693|renal function|renal function
432778|NCT01720680|COPD|copd
432779|NCT01720680|Functional Imaging|functional imaging
432780|NCT01720680|Patient Reported Outcome (PRO)|patient reported outcome (pro)
432781|NCT01720680|Lung Function|lung function
432782|NCT01720680|AlphaCore|alphacore
432783|NCT01720680|Computational Fluid Dynamics|computational fluid dynamics
432784|NCT01720667|Seizures|seizures
432785|NCT01720667|Neonates|neonates
432786|NCT01720667|Anticonvulsants|anticonvulsants
432787|NCT01720667|Treatment|treatment
432788|NCT01720667|Levetiracetam|levetiracetam
432789|NCT01720667|Phenobarbital|phenobarbital
432790|NCT01720654|Expedited Partner Therapy|expedited partner therapy
432791|NCT01720654|MSM|msm
432792|NCT01720654|Peru|peru
432793|NCT01720654|Gonorrhea|gonorrhea
432794|NCT01720654|Chlamydia|chlamydia
432795|NCT01720641|MSM|msm
432796|NCT01720641|Transgender Women|transgender women
432797|NCT01720641|Partner Notification|partner notification
432798|NCT01720641|Syphilis|syphilis
432799|NCT01720641|Peru|peru
432800|NCT01720628|Angiogenin, Behçet's disease, bFGF, VEGF|angiogenin, behçet's disease, bfgf, vegf
432801|NCT01720615|EEG|eeg
432802|NCT01720615|AEP|aep
432803|NCT01720615|Propofol|propofol
432804|NCT01720615|Sevoflurane|sevoflurane
432805|NCT01720615|Remifentanil|remifentanil
432806|NCT01720615|General anesthesia|general anesthesia
432807|NCT01720589|Obesity|obesity
432808|NCT01720589|Dietary fat|dietary fat
432809|NCT01720589|Energy expenditure|energy expenditure
432810|NCT01720589|Food intake|food intake
432811|NCT01720563|Cancer-related fatigue|cancer-related fatigue
432812|NCT01720563|astragalus polysaccharides|astragalus polysaccharides
432813|NCT01720563|concurrent chemoradiotherapy|concurrent chemoradiotherapy
432814|NCT01720563|squamous cell carcinoma of head and neck|squamous cell carcinoma of head and neck
432815|NCT01720550|Cancer-related fatigue|cancer-related fatigue
432816|NCT01720550|Palliative Treatment|palliative treatment
432817|NCT01720550|Astragalus polysaccharides|astragalus polysaccharides
432818|NCT01720537|High Cholesterol|high cholesterol
432819|NCT01720537|Dyslipidemia|dyslipidemia
432820|NCT01720524|persistent pulmonary hypertension|persistent pulmonary hypertension
432821|NCT01720524|newborn|newborn
432822|NCT01720524|neonates|neonates
432823|NCT01720524|iv sildenafil|iv sildenafil
432824|NCT01720524|hypoxic respiratory failure and at risk of persistent pulmonary hypertension of the newborn|hypoxic respiratory failure and at risk of persistent pulmonary hypertension of the newborn
432825|NCT01720472|Aging|aging
432826|NCT01720472|Healthy Aging|healthy aging
432827|NCT01720472|Physical Performance|physical performance
432828|NCT01720472|Physical Functioning|physical functioning
432829|NCT01720472|Cognitive Functioning|cognitive functioning
432830|NCT01720472|Fitness|fitness
432831|NCT01720472|Physical Activity|physical activity
432832|NCT01720433|laparoscopic pain prospective blinded trial|laparoscopic pain prospective blinded trial
432833|NCT01720420|edentulous|edentulous
432834|NCT01720420|maxilla|maxilla
432835|NCT01720420|mandible|mandible
432836|NCT01720420|dental implant|dental implant
432837|NCT01720420|bar|bar
432838|NCT01720420|overdenture|overdenture
432839|NCT01720420|Oral Health Impact Profile (OHIP)|oral health impact profile (ohip)
432840|NCT01720420|survival rate|survival rate
432841|NCT01720420|technical complications|technical complications
432842|NCT01720420|marginal bone level|marginal bone level
432843|NCT01720420|soft tissue|soft tissue
432844|NCT01720407|Dermatology/ Skin cancers/Lentigo maligna melanoma|dermatology/ skin cancers/lentigo maligna melanoma
432845|NCT01720381|monitoring|monitoring
432846|NCT01720381|blood glucose|blood glucose
432847|NCT01720381|intensive care unit|intensive care unit
432848|NCT01720368|IBD|ibd
432849|NCT01720368|Crohn's|crohn's
432850|NCT01720342|Medtronic Enable® aortic bioprosthesis|medtronic enable® aortic bioprosthesis
432851|NCT01720342|Aortic valve stenosis|aortic valve stenosis
432852|NCT01720342|Aortic valve insufficiency|aortic valve insufficiency
432853|NCT01720342|"Real world patients"|"real world patients"
432854|NCT01720316|Glycine|glycine
432855|NCT01720316|Glycine decarboxylase|glycine decarboxylase
432856|NCT01720316|Psychosis|psychosis
432857|NCT01720316|Mutation|mutation
432858|NCT01720277|Randomized Controlled Trial|randomized controlled trial
432859|NCT01720277|Influenza|influenza
432860|NCT01720277|Influenza vaccine|influenza vaccine
432861|NCT01720277|Flu Vaccine|flu vaccine
432862|NCT01720277|Fluzone|fluzone
432863|NCT01720277|HD Fluzone|hd fluzone
432864|NCT01720277|Nursing Homes|nursing homes
432865|NCT01720277|Hospitalization|hospitalization
432866|NCT01720277|Mortality|mortality
432867|NCT01720277|Health Care worker vaccination|health care worker vaccination
432868|NCT01720277|ADL decline|adl decline
432869|NCT01720277|Pilot|pilot
432870|NCT01720277|Effectiveness|effectiveness
432871|NCT01720251|allergic rhinitis|allergic rhinitis
432872|NCT01720251|birch pollen|birch pollen
432873|NCT01720251|immunotherapy|immunotherapy
432874|NCT01720238|Compensated Liver Cirrhosis|compensated liver cirrhosis
432875|NCT01720238|Early Antiviral Therapy|early antiviral therapy
432876|NCT01720238|Cost Effectiveness|cost effectiveness
432877|NCT01720225|Leukemia|leukemia
432878|NCT01720225|Myelodysplastic syndromes|myelodysplastic syndromes
432879|NCT01720225|MDS|mds
432880|NCT01720225|Low and Intermediate-1 Risk Disease|low and intermediate-1 risk disease
432881|NCT01720225|Decitabine|decitabine
432882|NCT01720225|DAC|dac
432883|NCT01720225|Dacogen|dacogen
432884|NCT01720225|Azacitidine|azacitidine
432885|NCT01720225|AZA|aza
432886|NCT01720225|5-azacytidine|5-azacytidine
432887|NCT01720225|5-aza|5-aza
432888|NCT01720225|Vidaza|vidaza
432889|NCT01720225|5-AZC|5-azc
432890|NCT01720225|AZA-CR|aza-cr
432891|NCT01720225|Ladakamycin|ladakamycin
432892|NCT01720225|NSC-102816|nsc-102816
432893|NCT01720212|YM178|ym178
432894|NCT01720212|Mirabegron|mirabegron
432895|NCT01720212|OCAS|ocas
432896|NCT01720212|Chinese Healthy Volunteers|chinese healthy volunteers
432897|NCT01720212|PK|pk
432898|NCT01720212|Safety|safety
432899|NCT01720199|universal prevention|universal prevention
432900|NCT01720199|primary prevention|primary prevention
432901|NCT01720199|health promotion|health promotion
432902|NCT01720199|wellbeing|wellbeing
432903|NCT01720199|smoking|smoking
432904|NCT01720199|alcohol|alcohol
432905|NCT01720199|diet|diet
432906|NCT01720199|physical activity|physical activity
432907|NCT01720199|emotional and social skills|emotional and social skills
432908|NCT01720186|Lung Cancer|lung cancer
432909|NCT01720186|PET/CT|pet/ct
432910|NCT01720186|FDG|fdg
432911|NCT01720186|Respiratory synchronization|respiratory synchronization
432912|NCT01720160|Systolic Heart Failure|systolic heart failure
432913|NCT01720160|Congestive Heart Failure|congestive heart failure
432914|NCT01720160|Reduced left ventricular ejection fraction|reduced left ventricular ejection fraction
432915|NCT01720160|HFrEF|hfref
432916|NCT01720147|Fanconi Anemia|fanconi anemia
432917|NCT01720147|FA|fa
432918|NCT01720147|Quercetin|quercetin
432919|NCT01720043|multiple myeloma|multiple myeloma
432920|NCT01720030|Renal|renal
432921|NCT01720030|Acute Kidney Injury|acute kidney injury
432922|NCT01720030|AKI|aki
432923|NCT01720030|Levosimendan|levosimendan
432924|NCT01720030|Simdax|simdax
432925|NCT01720030|Renal perfusion|renal perfusion
432926|NCT01720030|Mortality|mortality
432927|NCT01720030|Renal flow|renal flow
432928|NCT01720017|Airtraq|airtraq
432929|NCT01720017|laryngoscope|laryngoscope
432930|NCT01720017|airway|airway
432931|NCT01720017|difficult|difficult
432932|NCT01720017|training|training
432933|NCT01720017|manikin|manikin
432934|NCT01720004|human labour|human labour
432935|NCT01720004|hands-and-knees positioning|hands-and-knees positioning
432936|NCT01720004|pilot trial|pilot trial
432937|NCT01719991|Primary care|primary care
432938|NCT01719991|Self-management|self-management
432939|NCT01719991|Self-support|self-support
432940|NCT01719991|Nurse case management|nurse case management
432941|NCT01719978|Local Anaesthetics|local anaesthetics
432942|NCT01719978|Mepivacaine|mepivacaine
432943|NCT01719978|hyaluronoglucosaminidase|hyaluronoglucosaminidase
432944|NCT01719978|Hemodynamic|hemodynamic
432945|NCT01719978|Electrocardiography and Dentistry.|electrocardiography and dentistry.
432946|NCT01719965|Community Advisory Board|community advisory board
432947|NCT01719965|Focus Group Discussion|focus group discussion
432948|NCT01719965|Interview|interview
432949|NCT01719965|Community Engagement|community engagement
432950|NCT01719965|Thailand|thailand
432951|NCT01719952|pregnancy|pregnancy
432952|NCT01719952|anaesthesia|anaesthesia
432953|NCT01719952|caesarean section|caesarean section
432954|NCT01719926|Colorectal|colorectal
432955|NCT01719926|Esophageal|esophageal
432956|NCT01719926|Indomethacin|indomethacin
432957|NCT01719926|PIFA|pifa
432958|NCT01719900|Dietary intervention|dietary intervention
432959|NCT01719900|Dietary fibre|dietary fibre
432960|NCT01719900|Obesity|obesity
432961|NCT01719900|Metabolic syndrome|metabolic syndrome
432962|NCT01719900|Weight loss|weight loss
432963|NCT01719900|Glucose regulation|glucose regulation
432964|NCT01719900|Pulse fibre|pulse fibre
432965|NCT01719887|humerus|humerus
432966|NCT01719887|humeral|humeral
432967|NCT01719887|shaft|shaft
432968|NCT01719887|diaphysis|diaphysis
432969|NCT01719887|fracture|fracture
432970|NCT01719887|RCT|rct
432971|NCT01719874|Influenza|influenza
432972|NCT01719874|monoclonal antibody|monoclonal antibody
432973|NCT01719848|Physical examinations, Percentage of glottic opening(POGO)|physical examinations, percentage of glottic opening(pogo)
432974|NCT01719835|T-Cell Lymphoma|t-cell lymphoma
432975|NCT01719835|Untreated|untreated
432976|NCT01719822|Treatment Outcome [E01.789.800]|treatment outcome [e01.789.800]
432977|NCT01719822|Rehabilitation [N02.421.784]|rehabilitation [n02.421.784]
432978|NCT01719822|Physical Fitness [I03.621]|physical fitness [i03.621]
710241|NCT00589602|Adult leukemia|adult leukemia
432979|NCT01719822|Lung Diseases, Obstructive [C08.381.495]|lung diseases, obstructive [c08.381.495]
432980|NCT01719822|Pulmonary Disease, Chronic Obstructive [C08.381.495.389]|pulmonary disease, chronic obstructive [c08.381.495.389]
432981|NCT01719822|Bronchitis, Chronic [C08.381.495.389.500]|bronchitis, chronic [c08.381.495.389.500]
432982|NCT01719809|Glaucoma|glaucoma
432983|NCT01719809|Eye Drop|eye drop
432984|NCT01719809|Eye Drop Technique|eye drop technique
432985|NCT01719809|Training|training
432986|NCT01719809|Instilling Eye Drops|instilling eye drops
432987|NCT01719783|influenza|influenza
432988|NCT01719783|vaccine|vaccine
432989|NCT01719783|pandemic|pandemic
432990|NCT01719770|cardiac arrest|cardiac arrest
433188|NCT01718756|lornoxicam|lornoxicam
432991|NCT01719770|therapeutic hypothermia|therapeutic hypothermia
432992|NCT01719770|skeletal muscle paralysis|skeletal muscle paralysis
432993|NCT01719770|shivering|shivering
432994|NCT01719770|serum drug levels|serum drug levels
432995|NCT01719770|basal metabolism|basal metabolism
432996|NCT01719757|Targin, Cancer Pain|targin, cancer pain
432997|NCT01719744|ENMD-2076|enmd-2076
432998|NCT01719744|advanced|advanced
432999|NCT01719744|metastatic|metastatic
433000|NCT01719744|soft tissue sarcoma|soft tissue sarcoma
433001|NCT01719731|BPD|bpd
433002|NCT01719718|ventral hernia|ventral hernia
433003|NCT01719705|caesarean delivery|caesarean delivery
433004|NCT01719705|spinal anesthesia|spinal anesthesia
433005|NCT01719705|pregabalin|pregabalin
433006|NCT01719705|postoperative pain|postoperative pain
433007|NCT01719705|morphine|morphine
433008|NCT01719679|school located vaccine program|school located vaccine program
433009|NCT01719666|MPFL|mpfl
433010|NCT01719666|patella|patella
433011|NCT01719666|dislocation|dislocation
433012|NCT01719666|release|release
433013|NCT01719653|Colonoscopy|colonoscopy
433014|NCT01719653|Bowel Preparation|bowel preparation
433015|NCT01719653|MiraLAX|miralax
433016|NCT01719653|Gatorade|gatorade
433017|NCT01719653|PEG-3350|peg-3350
433018|NCT01719653|MoviPrep|moviprep
433019|NCT01719653|SUPREP|suprep
433020|NCT01719653|Chicago Bowel Preparation Scale|chicago bowel preparation scale
433021|NCT01719653|Boston Bowel Preparation Scale|boston bowel preparation scale
433022|NCT01719640|mesenchymal stem cells|mesenchymal stem cells
433023|NCT01719640|bone marrow mononeclear cells|bone marrow mononeclear cells
433024|NCT01719640|type 2 diabetes mellitus|type 2 diabetes mellitus
433025|NCT01719627|HIV, Maraviroc, PrEP, Ex vivo infection, rectal mucosa.|hiv, maraviroc, prep, ex vivo infection, rectal mucosa.
433026|NCT01719614|Healthy participants|healthy participants
433027|NCT01719614|Rilpivirine|rilpivirine
433028|NCT01719614|Metformin|metformin
433029|NCT01719614|Pharmacokinetics|pharmacokinetics
433030|NCT01719601|Moderate to severe acute non-cancer pain|moderate to severe acute non-cancer pain
433031|NCT01719601|Immediate release tapentadol hydrochloride|immediate release tapentadol hydrochloride
433032|NCT01719601|Tapentadol IR|tapentadol ir
433033|NCT01719601|Nucynta IR|nucynta ir
433034|NCT01719588|Moderate to severe chronic non-cancer pain|moderate to severe chronic non-cancer pain
433035|NCT01719588|Prolonged release tapentadol hydrochloride|prolonged release tapentadol hydrochloride
433036|NCT01719588|Tapentadol PR|tapentadol pr
433037|NCT01719588|Extended release tapentadol hydrochloride|extended release tapentadol hydrochloride
433038|NCT01719588|Nucynta PR|nucynta pr
433039|NCT01719549|Gastric Cancer|gastric cancer
433040|NCT01719549|Dovitinib|dovitinib
433041|NCT01719523|Tourette syndrome|tourette syndrome
433042|NCT01719523|Tics|tics
433043|NCT01719523|Tic Disorders|tic disorders
433044|NCT01719510|Group B Streptococcus,|group b streptococcus,
433045|NCT01719510|Vaginal screening|vaginal screening
433046|NCT01719510|Per partum antibiotic prophylaxis|per partum antibiotic prophylaxis
433047|NCT01719510|Meningitis|meningitis
433048|NCT01719510|Neonatal infection|neonatal infection
433049|NCT01719510|PCR|pcr
433050|NCT01719510|Streptococcus agalactiae.|streptococcus agalactiae.
433051|NCT01719445|Energy Intake|energy intake
433052|NCT01719432|Filgrastim|filgrastim
433053|NCT01719432|Obese|obese
433054|NCT01719432|Non-obese|non-obese
433055|NCT01719432|Pharmacokinetics|pharmacokinetics
433056|NCT01719406|Gestational diabetes|gestational diabetes
433057|NCT01719406|Exercise|exercise
433058|NCT01719406|Diet|diet
433059|NCT01719406|Fruits|fruits
433060|NCT01719406|Vegetables|vegetables
433061|NCT01719406|Whole grains|whole grains
433062|NCT01719406|pregnancy weight|pregnancy weight
433063|NCT01719393|Asthma|asthma
433064|NCT01719393|Pulse spectrum analysis|pulse spectrum analysis
433065|NCT01719393|lung function|lung function
433066|NCT01719393|exhaled nitric oxide|exhaled nitric oxide
433067|NCT01719393|metabolites|metabolites
433068|NCT01719393|exhaled breath condensate|exhaled breath condensate
433069|NCT01719380|Open-label dose escalation; BRAF inhibitor; LGX818; PI3K inhibitor; BYL719; EGFR; cetuximab; metastatic colorectal cancer; KRAS; BRAF; V600|open-label dose escalation; braf inhibitor; lgx818; pi3k inhibitor; byl719; egfr; cetuximab; metastatic colorectal cancer; kras; braf; v600
433070|NCT01719367|Baseline (pre-atenolol)|baseline (pre-atenolol)
710242|NCT00589602|lymphoma|lymphoma
433071|NCT01719367|Post-atenolol|post-atenolol
433072|NCT01719354|Community Mental Health Centers|community mental health centers
433073|NCT01719354|Norway|norway
433074|NCT01719354|Aftercare|aftercare
433075|NCT01719328|yoga,|yoga,
433076|NCT01719328|exercise|exercise
433077|NCT01719328|affect|affect
433078|NCT01719328|mind/body therapies|mind/body therapies
433079|NCT01719328|stress, psychological|stress, psychological
433080|NCT01719302|Soft tissue sarcoma|soft tissue sarcoma
433081|NCT01719302|gemcitabine|gemcitabine
433082|NCT01719302|docetaxel|docetaxel
433083|NCT01719302|pazopanib|pazopanib
433084|NCT01719289|depression|depression
433085|NCT01719289|problem solving|problem solving
433086|NCT01719263|emphysema|emphysema
433087|NCT01719263|InterVapor|intervapor
433088|NCT01719263|treatments|treatments
433089|NCT01719263|pulmonary rehabilitation|pulmonary rehabilitation
433090|NCT01719263|lung volume reduction|lung volume reduction
433091|NCT01719263|endoscopic lung volume reduction|endoscopic lung volume reduction
433092|NCT01719237|Onset|onset
433093|NCT01719237|Duration|duration
433094|NCT01719237|Upper Limb Block|upper limb block
433095|NCT01719237|Ultrasound guided supraclavicular block|ultrasound guided supraclavicular block
433096|NCT01719237|Ropivacaine|ropivacaine
433097|NCT01719237|Chloroprocaine|chloroprocaine
433098|NCT01719211|MVP, mitral valve|mvp, mitral valve
433099|NCT01719198|adenoma|adenoma
433100|NCT01719198|calprotectin|calprotectin
433101|NCT01719159|Progressive multiple sclerosis|progressive multiple sclerosis
433102|NCT01719159|Monoclonal antibodies|monoclonal antibodies
433103|NCT01719159|Mabthera|mabthera
433104|NCT01719159|Intrathecal treatment|intrathecal treatment
433105|NCT01719146|Anemia|anemia
433106|NCT01719146|Chronic Kidney Disease|chronic kidney disease
433107|NCT01719146|Erythropoiesis Stimulating Agents|erythropoiesis stimulating agents
433108|NCT01719146|Erythropoietin|erythropoietin
433109|NCT01719146|Iron|iron
433110|NCT01719146|Iron Deficiency|iron deficiency
433111|NCT01719133|allergy|allergy
433112|NCT01719133|birch|birch
433113|NCT01719120|Insomnia|insomnia
433114|NCT01719120|Cognitive-Behavioral Therapy|cognitive-behavioral therapy
433115|NCT01719120|Internet-Based|internet-based
433116|NCT01719120|Self-Help|self-help
433117|NCT01719120|Randomized Controlled Trial|randomized controlled trial
433118|NCT01719107|Functional abdominal pain|functional abdominal pain
433119|NCT01719107|Probiotics|probiotics
433120|NCT01719107|Lactobacilus reuteri|lactobacilus reuteri
433121|NCT01719081|Sacroiliac Joint|sacroiliac joint
433122|NCT01719081|Ultrasound|ultrasound
433123|NCT01719081|Fluoroscopy|fluoroscopy
433124|NCT01719081|Chronic Pain|chronic pain
433125|NCT01719068|Mesothelioma|mesothelioma
433126|NCT01719068|Lung Cancer|lung cancer
433127|NCT01719068|Early Detection|early detection
433128|NCT01719055|stimulation|stimulation
433129|NCT01719055|implantable|implantable
433130|NCT01719055|pulse generator|pulse generator
433131|NCT01719055|back pain|back pain
433132|NCT01719055|chronic pain|chronic pain
433133|NCT01719055|leg pain|leg pain
433134|NCT01719029|continuous glucose monitoring|continuous glucose monitoring
433135|NCT01719029|gestational diabetes|gestational diabetes
433136|NCT01719029|diet therapy|diet therapy
433137|NCT01719016|Reversible ischemia|reversible ischemia
433138|NCT01719016|microvascular dysfunction|microvascular dysfunction
433139|NCT01718977|Intervention|intervention
433140|NCT01718977|Body Weight Supported Treadmill Training|body weight supported treadmill training
433141|NCT01718977|Arm Cycle Ergometry Training|arm cycle ergometry training
433142|NCT01718977|carotid-to-femoral pulse wave velocity|carotid-to-femoral pulse wave velocity
433143|NCT01718951|spondyloarthropathy|spondyloarthropathy
433144|NCT01718951|ankylosing spondylitis|ankylosing spondylitis
433145|NCT01718938|Gastroparesis|gastroparesis
433146|NCT01718938|Diabetic|diabetic
433147|NCT01718938|Idiopathic|idiopathic
433148|NCT01718938|Delayed gastric emptying|delayed gastric emptying
433149|NCT01718912|periodontal disease|periodontal disease
433150|NCT01718912|bleeding on probing|bleeding on probing
433151|NCT01718912|periodontal pockets|periodontal pockets
433152|NCT01718912|disabled|disabled
433153|NCT01718886|Obesity|obesity
433154|NCT01718886|Weight loss|weight loss
433155|NCT01718886|Weight control|weight control
433156|NCT01718886|Intragastric balloon|intragastric balloon
433157|NCT01718886|gastric balloon|gastric balloon
433158|NCT01718873|metastatic|metastatic
433159|NCT01718873|stage IV|stage iv
433160|NCT01718860|Cost Analysis|cost analysis
433161|NCT01718860|Postoperative Complications|postoperative complications
433162|NCT01718860|Length of Stay|length of stay
433163|NCT01718860|Intensive Care Units|intensive care units
433164|NCT01718847|EGFR Tyrosine Kinase Inhibitor|egfr tyrosine kinase inhibitor
433165|NCT01718847|Aquired resistance to EGFR TKI|aquired resistance to egfr tki
433166|NCT01718847|Pan-Her inhibitor|pan-her inhibitor
433167|NCT01718834|prophylactic vaccine|prophylactic vaccine
433168|NCT01718834|chronic HCV patients|chronic hcv patients
433169|NCT01718834|healthy risk volunteers|healthy risk volunteers
433170|NCT01718808|Metastatic Colorectal Cancer|metastatic colorectal cancer
433171|NCT01718808|KRAS|kras
433172|NCT01718808|BRAF|braf
433173|NCT01718808|Wild-type Metastatic|wild-type metastatic
433174|NCT01718808|Cetuximab|cetuximab
433175|NCT01718808|Capecitabine|capecitabine
433176|NCT01718808|Phase II Trial|phase ii trial
433177|NCT01718808|Elderly Patients|elderly patients
433178|NCT01718795|Airway|airway
433179|NCT01718795|Cardiac Arrest|cardiac arrest
433180|NCT01718795|CPR|cpr
433181|NCT01718795|Ventilation|ventilation
433182|NCT01718782|laryngeal mask, leakage pressure, ventilation|laryngeal mask, leakage pressure, ventilation
433183|NCT01718769|Nutritional assessment|nutritional assessment
433184|NCT01718769|children|children
433185|NCT01718769|malnutrition|malnutrition
433186|NCT01718756|Orthopaedic|orthopaedic
433187|NCT01718756|General anaesthesia|general anaesthesia
433189|NCT01718756|patient controlled analgesia|patient controlled analgesia
433190|NCT01718756|morphine consumption|morphine consumption
433191|NCT01718730|TMS|tms
433192|NCT01718730|Adolescent|adolescent
433193|NCT01718730|Child|child
433194|NCT01718730|MDD|mdd
433195|NCT01718730|Major depressive disorder|major depressive disorder
433196|NCT01718730|Mild MDD|mild mdd
433197|NCT01718730|Mild depression|mild depression
433198|NCT01718730|SSRI|ssri
433199|NCT01718730|Motor cortex|motor cortex
433200|NCT01718730|Cortical excitability|cortical excitability
433201|NCT01718730|Cortical inhibition|cortical inhibition
433202|NCT01718730|Cortical silent period|cortical silent period
433203|NCT01718730|Motor threshold|motor threshold
433204|NCT01718730|Intracortical facilitation|intracortical facilitation
433205|NCT01718730|Intracortical inhibition|intracortical inhibition
433206|NCT01718730|gamma-aminobutyric acid (GABA)|gamma-aminobutyric acid (gaba)
433207|NCT01718730|Glutamate|glutamate
433208|NCT01718730|N-methyl-D-aspartate (NMDA)|n-methyl-d-aspartate (nmda)
433209|NCT01718730|Magnetic resonance spectroscopy|magnetic resonance spectroscopy
433210|NCT01718730|MRS|mrs
433211|NCT01718717|Thoracotomy|thoracotomy
433212|NCT01718717|Thoracic epidural analgesia|thoracic epidural analgesia
433213|NCT01718717|Arrythmiogenesis|arrythmiogenesis
433214|NCT01718717|Atrial fibrillation|atrial fibrillation
433215|NCT01718717|Sympathetic outflow|sympathetic outflow
433216|NCT01718704|rehabilitation|rehabilitation
433217|NCT01718704|erectile dysfunction|erectile dysfunction
433218|NCT01718704|incontinence|incontinence
433219|NCT01718678|Multiple sclerosis|multiple sclerosis
433220|NCT01718678|Melatonin|melatonin
433221|NCT01718678|Fatigue|fatigue
433222|NCT01718678|Quality of life|quality of life
433223|NCT01718652|Healthy|healthy
433224|NCT01718652|Canagliflozin (JNJ-28431754)|canagliflozin (jnj-28431754)
433225|NCT01718652|Pharmacokinetics|pharmacokinetics
433226|NCT01718652|Cyclosporine|cyclosporine
433227|NCT01718600|carotid artery stenting|carotid artery stenting
433228|NCT01718600|neuropsychological testing|neuropsychological testing
433229|NCT01718600|microembolization|microembolization
433230|NCT01718600|MRI|mri
433231|NCT01718587|umbilical cord mesenchyma stem cell|umbilical cord mesenchyma stem cell
433232|NCT01718587|liver cirrhosis|liver cirrhosis
433233|NCT01718587|antiviral therapy|antiviral therapy
433234|NCT01718574|self-help book|self-help book
433235|NCT01718574|support service|support service
433236|NCT01718561|Airway assessment|airway assessment
433237|NCT01718561|Intubation|intubation
433238|NCT01718561|Mask ventilation|mask ventilation
433239|NCT01718535|Cyp2C19|cyp2c19
433240|NCT01718535|Genotyping|genotyping
433241|NCT01718535|Spartan|spartan
433242|NCT01718535|Comparison|comparison
433243|NCT01718535|Sequencing|sequencing
433244|NCT01718496|dyspnea|dyspnea
433245|NCT01718496|COPD|copd
433246|NCT01718496|exercise tolerance|exercise tolerance
433247|NCT01718496|opioids|opioids
433248|NCT01718496|morphine|morphine
433249|NCT01718496|single dose oral Morphine|single dose oral morphine
433250|NCT01718470|Systolic blood pressure|systolic blood pressure
433251|NCT01718470|Heart rate|heart rate
433252|NCT01718470|Laryngeal mask|laryngeal mask
433253|NCT01718470|Endotracheal tube|endotracheal tube
433254|NCT01718470|craniotomy|craniotomy
433255|NCT01718457|Endobarrier|endobarrier
433256|NCT01718457|Diabetes|diabetes
433257|NCT01718457|Obesity|obesity
433258|NCT01718457|Weight|weight
433259|NCT01718457|BMI|bmi
433260|NCT01718457|Lipid profile|lipid profile
433261|NCT01718457|fatty liver|fatty liver
433262|NCT01718457|gut peptides|gut peptides
433263|NCT01718457|HbA1c|hba1c
433264|NCT01718444|PCOS|pcos
433265|NCT01718444|Polycystic ovary syndrome|polycystic ovary syndrome
433266|NCT01718444|Infertility|infertility
433267|NCT01718444|Anovulation|anovulation
433268|NCT01718444|Clomiphene citrate|clomiphene citrate
433269|NCT01718444|Clomid|clomid
433270|NCT01718444|Progestin|progestin
433271|NCT01718444|Provera|provera
433272|NCT01718444|Progesterone|progesterone
433273|NCT01718444|Endometrial shedding|endometrial shedding
433274|NCT01718392|combined training|combined training
433275|NCT01718392|insulin resistance|insulin resistance
433276|NCT01718379|Myelodysplasia|myelodysplasia
433277|NCT01718340|PCOS|pcos
433278|NCT01718340|Hyper insulinaemia|hyper insulinaemia
433279|NCT01718340|metformin|metformin
433280|NCT01718340|recurrent abortion|recurrent abortion
433281|NCT01718327|Cholangiocarcinoma|cholangiocarcinoma
433282|NCT01718314|Hysteroscopy|hysteroscopy
433283|NCT01718314|Misoprostol|misoprostol
433284|NCT01718314|Lidocaine|lidocaine
433285|NCT01718314|Visual analogue score|visual analogue score
433286|NCT01718301|HCV|hcv
433287|NCT01718301|HIV|hiv
433288|NCT01718301|Coinfection|coinfection
433289|NCT01718288|PAD; iloprost; walking distance; cardiovascular events|pad; iloprost; walking distance; cardiovascular events
433290|NCT01718275|Appendicitis|appendicitis
433291|NCT01718275|Pediatrics|pediatrics
433292|NCT01718275|Children|children
433293|NCT01718275|Non-operative|non-operative
433294|NCT01718262|Ropivacaine Level|ropivacaine level
433295|NCT01718262|continuous peripheral nerve blocks.|continuous peripheral nerve blocks.
433296|NCT01718249|Deep Brain Stimulation (DBS)|deep brain stimulation (dbs)
433297|NCT01718249|Post-coma|post-coma
433298|NCT01718249|Consciousness|consciousness
433299|NCT01718249|Vegetative state|vegetative state
433300|NCT01718249|Minimally conscious state|minimally conscious state
433301|NCT01718236|caesarean section|caesarean section
433302|NCT01718236|rocuronium|rocuronium
433303|NCT01718236|sugammadex|sugammadex
433304|NCT01718210|GM-CSF|gm-csf
433305|NCT01718210|recurrent implantation failure|recurrent implantation failure
433306|NCT01718210|pregnancy rate|pregnancy rate
433307|NCT01718210|IVF|ivf
433308|NCT01718197|Severe Asthma|severe asthma
433309|NCT01718197|Bronchoscopy|bronchoscopy
433310|NCT01718184|sulcoflex|sulcoflex
433311|NCT01718184|toric|toric
433312|NCT01718184|corneal implantation|corneal implantation
433313|NCT01718171|Appendicitis|appendicitis
433314|NCT01718171|SIRS|sirs
433315|NCT01718171|C-reactive protein|c-reactive protein
433316|NCT01718132|Quality of the anaesthetic care in a PACU|quality of the anaesthetic care in a pacu
433317|NCT01718132|reduction of postoperative pain|reduction of postoperative pain
433318|NCT01718132|reduction of postoperative nausea and vomiting|reduction of postoperative nausea and vomiting
433319|NCT01718132|quality markers|quality markers
433320|NCT01718106|coronary artery disease|coronary artery disease
433321|NCT01718106|drug eluting stent|drug eluting stent
433322|NCT01718106|bioabsorbable polymer|bioabsorbable polymer
433323|NCT01718106|percutaneous coronary intervention|percutaneous coronary intervention
433324|NCT01718106|restenosis|restenosis
433325|NCT01718106|late thrombosis|late thrombosis
433326|NCT01718093|Adolescents|adolescents
433327|NCT01718080|Obese, Lean, Pubertal, Prepubertal, Glucose, Adolescents, Type 2 Diabetes|obese, lean, pubertal, prepubertal, glucose, adolescents, type 2 diabetes
433328|NCT01718067|Chest physiotherapy|chest physiotherapy
433329|NCT01718067|Rehabilitation|rehabilitation
433330|NCT01718067|Chronic respiratory diseases|chronic respiratory diseases
433331|NCT01718054|Vascular function|vascular function
433332|NCT01718054|Ready to use supplementary foods|ready to use supplementary foods
433333|NCT01718054|Chloroquine|chloroquine
433334|NCT01718054|Children|children
433335|NCT01718054|Growth|growth
433336|NCT01718054|Nitric Oxide|nitric oxide
433337|NCT01718041|Growth hormone|growth hormone
433338|NCT01718041|Growth hormone deficiency|growth hormone deficiency
433339|NCT01718041|Growth|growth
433340|NCT01718041|Pediatric growth hormone deficiency|pediatric growth hormone deficiency
433341|NCT01718041|Long acting growth hormone|long acting growth hormone
433342|NCT01718041|GHD|ghd
433343|NCT01718041|PGHD|pghd
433344|NCT01718041|VRS 317|vrs 317
433345|NCT01718041|Exten|exten
433346|NCT01718041|Versartis|versartis
433347|NCT01718028|Systane BALANCE|systane balance
433348|NCT01718028|Dry eye|dry eye
433349|NCT01718028|lipid deficiency|lipid deficiency
433350|NCT01718028|NITFBUT|nitfbut
433351|NCT01718015|Vascular Endothelial Growth Factor|vascular endothelial growth factor
433352|NCT01718015|Brain-Derived Neurothropic Factor|brain-derived neurothropic factor
433353|NCT01718015|Diabetes Mellitus|diabetes mellitus
433354|NCT01718015|CD-163|cd-163
433355|NCT01718015|Cerebrospinal fluid|cerebrospinal fluid
433356|NCT01718015|Peripheral Nervous System Diseases|peripheral nervous system diseases
433357|NCT01718015|Mass spectrometry|mass spectrometry
433358|NCT01718002|Nursing|nursing
433359|NCT01718002|Simulation|simulation
433360|NCT01718002|Education|education
433361|NCT01717989|Dialysis|dialysis
433362|NCT01717989|Prospective Payment System|prospective payment system
433363|NCT01717989|Center for Medicare and Medicaide Services|center for medicare and medicaide services
433364|NCT01717989|End Stage Renal Disease|end stage renal disease
433365|NCT01717989|Concomitant Medications Dosage /Treatment patterns|concomitant medications dosage /treatment patterns
433366|NCT01717976|emergency department use|emergency department use
433367|NCT01717976|Veterans|veterans
433368|NCT01717950|Human Hookworm|human hookworm
433369|NCT01717950|Necator americanus|necator americanus
433370|NCT01717950|Hookworm|hookworm
433371|NCT01717950|Hookworm Disease|hookworm disease
433372|NCT01717950|Iron-deficiency anemia|iron-deficiency anemia
433373|NCT01717950|Soil-transmitted helminth infection|soil-transmitted helminth infection
433374|NCT01717950|Neglected Tropical Disease|neglected tropical disease
433375|NCT01717950|Na-APR-1|na-apr-1
433376|NCT01717937|retinovascular disease|retinovascular disease
433377|NCT01717937|imaging|imaging
433378|NCT01717937|fluorescein angiography|fluorescein angiography
433379|NCT01717937|FA|fa
433380|NCT01717937|angiography|angiography
433381|NCT01717937|optical coherence tomography|optical coherence tomography
433382|NCT01717937|OCT|oct
433383|NCT01717937|phase variance|phase variance
433384|NCT01717937|comparison|comparison
433385|NCT01717937|age-related macular degeneration|age-related macular degeneration
433386|NCT01717937|diabetic retinopathy|diabetic retinopathy
433387|NCT01717937|hypertensive retinopathy|hypertensive retinopathy
433388|NCT01717937|retinal vein occlusion|retinal vein occlusion
433389|NCT01717937|retinal artery occlusion|retinal artery occlusion
433490|NCT01717625|prematurity|prematurity
433390|NCT01717924|Signet ring cell|signet ring cell
433391|NCT01717924|gastric adenocarcinoma|gastric adenocarcinoma
433392|NCT01717924|peri-operative chemotherapy|peri-operative chemotherapy
433393|NCT01717924|surgery|surgery
433394|NCT01717911|Newly diagnosed type 2 diabetes|newly diagnosed type 2 diabetes
433395|NCT01717911|Insulin, metformin, sitagliptin|insulin, metformin, sitagliptin
433396|NCT01717911|beta-cell function, glycemic control|beta-cell function, glycemic control
433397|NCT01717898|Castrate-resistant prostate cancer|castrate-resistant prostate cancer
433398|NCT01717885|Pharmacokinetics|pharmacokinetics
433399|NCT01717885|Antimalarial|antimalarial
433400|NCT01717885|HIV|hiv
433401|NCT01717885|Antiretrovirals|antiretrovirals
433402|NCT01717885|Childhood development|childhood development
433403|NCT01717885|Pregnancy|pregnancy
433404|NCT01717872|glottis, laryngoscopy, laryngoscope blade|glottis, laryngoscopy, laryngoscope blade
433405|NCT01717859|Rheumatoid Arthritis|rheumatoid arthritis
433406|NCT01717846|Apoptosos|apoptosos
433407|NCT01717846|Rheumatoid Arthritis|rheumatoid arthritis
433408|NCT01717846|T cells, B cells|t cells, b cells
433409|NCT01717846|DAS28|das28
433410|NCT01717846|Clinical Disease activity Index|clinical disease activity index
433411|NCT01717846|CDAI|cdai
433412|NCT01717833|ICU acquired weakness|icu acquired weakness
433413|NCT01717833|Critical illness polyneuromyopathy|critical illness polyneuromyopathy
433414|NCT01717833|post ICU rehabilitation|post icu rehabilitation
433415|NCT01717833|neuromuscular electrical rehabilitation|neuromuscular electrical rehabilitation
433416|NCT01717833|handgrip|handgrip
433417|NCT01717820|Obesity|obesity
433418|NCT01717820|Postmenopausal women|postmenopausal women
433419|NCT01717820|Body composition|body composition
433420|NCT01717820|Resveratrol|resveratrol
433421|NCT01717820|Inflammatory biomarkers|inflammatory biomarkers
433422|NCT01717820|Bone formation|bone formation
433423|NCT01717820|Adipose metabolism|adipose metabolism
433424|NCT01717807|epithelial growth factor receptors|epithelial growth factor receptors
433425|NCT01717807|lung cancer|lung cancer
433426|NCT01717807|advanced tumor of pancrease|advanced tumor of pancrease
433427|NCT01717807|erlotinib|erlotinib
433428|NCT01717807|C11-Erlotinib PET/CT|c11-erlotinib pet/ct
433429|NCT01717794|operative time|operative time
433430|NCT01717794|laparoscopy|laparoscopy
433431|NCT01717794|total hysterectomy|total hysterectomy
433432|NCT01717794|pelvic lymphadenectomy|pelvic lymphadenectomy
433433|NCT01717794|endometrial cancer|endometrial cancer
433434|NCT01717794|Thunderbeat|thunderbeat
433435|NCT01717781|operative time|operative time
433436|NCT01717781|laparoscopy|laparoscopy
433437|NCT01717781|radical hysterectomy|radical hysterectomy
433438|NCT01717781|pelvic lymphadenectomy|pelvic lymphadenectomy
433439|NCT01717781|cervical cancer|cervical cancer
433440|NCT01717781|thunderbeat|thunderbeat
433441|NCT01717768|hypogonadism|hypogonadism
433442|NCT01717768|Gonadal Disorders|gonadal disorders
433443|NCT01717768|Endocrine System Diseases|endocrine system diseases
433444|NCT01717768|Testosterone|testosterone
433445|NCT01717768|Testosterone enanthate|testosterone enanthate
433446|NCT01717768|Testosterone undecanoate|testosterone undecanoate
433447|NCT01717768|Testosterone 17 beta-cypionate|testosterone 17 beta-cypionate
433448|NCT01717768|Methyltestosterone|methyltestosterone
433449|NCT01717768|Androgens|androgens
433450|NCT01717768|Hormones|hormones
433451|NCT01717768|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists
433452|NCT01717768|Physiological Effects of Drugs|physiological effects of drugs
433453|NCT01717768|Pharmacologic Actions|pharmacologic actions
433454|NCT01717768|Therapeutic Uses|therapeutic uses
433455|NCT01717768|Anabolic Agents|anabolic agents
433456|NCT01717755|basilar|basilar
433457|NCT01717755|stroke|stroke
433458|NCT01717755|mechanical|mechanical
433459|NCT01717755|thrombolysis|thrombolysis
433460|NCT01717755|intra-arterial|intra-arterial
433461|NCT01717755|trombectomy|trombectomy
433462|NCT01717742|Randomized controlled trial|randomized controlled trial
433463|NCT01717742|Pleural Empyema|pleural empyema
433465|NCT01717742|DNase|dnase
433466|NCT01717729|HCC, RFA, Iodine-125, Recurrence|hcc, rfa, iodine-125, recurrence
433467|NCT01717716|boys|boys
433468|NCT01717716|obesity|obesity
433469|NCT01717716|glucose|glucose
433470|NCT01717716|sucrose|sucrose
433471|NCT01717716|high-fructose corn syrup-55|high-fructose corn syrup-55
433472|NCT01717703|prevention|prevention
433473|NCT01717690|MRSA|mrsa
433474|NCT01717690|chlorhexidine|chlorhexidine
433475|NCT01717664|Relapsing Remitting Multiple Sclerosis|relapsing remitting multiple sclerosis
433476|NCT01717664|MAP|map
433477|NCT01717664|antibiotic|antibiotic
433478|NCT01717664|Interferon beta 1-a|interferon beta 1-a
433479|NCT01717664|MS|ms
433480|NCT01717664|MRI|mri
433481|NCT01717664|EDSS|edss
433482|NCT01717664|relapse rate|relapse rate
433483|NCT01717651|Atrophy|atrophy
433484|NCT01717651|Muscle wasting|muscle wasting
433485|NCT01717651|Sepsis|sepsis
433486|NCT01717638|Meningococcal disease, vaccines, children, persistence|meningococcal disease, vaccines, children, persistence
433487|NCT01717625|montelukast|montelukast
433488|NCT01717625|BPD|bpd
433489|NCT01717625|singulair|singulair
433491|NCT01717612|gastric varices, thrombin, histoacryl|gastric varices, thrombin, histoacryl
433492|NCT01717599|Post ERCP pancreatitis|post ercp pancreatitis
433493|NCT01717599|Diclofenac|diclofenac
433494|NCT01717599|NSAID|nsaid
433495|NCT01717586|preeclampsia|preeclampsia
433496|NCT01717586|pravastatin|pravastatin
433497|NCT01717586|Pravachol®|pravachol®
433498|NCT01717586|statin|statin
433499|NCT01717586|high-risk pregnancy|high-risk pregnancy
433500|NCT01717586|safety|safety
433501|NCT01717586|fetal morbidity and mortality|fetal morbidity and mortality
433502|NCT01717586|maternal morbidity and mortality|maternal morbidity and mortality
433503|NCT01717586|neonatal mortality|neonatal mortality
433504|NCT01717586|premature delivery|premature delivery
433505|NCT01717586|preemie|preemie
433506|NCT01717573|STEMI|stemi
433507|NCT01717573|No-reflow|no-reflow
433508|NCT01717573|Primary percutaneous intervention|primary percutaneous intervention
433509|NCT01717573|Deferred stenting|deferred stenting
433510|NCT01717560|chronic hepatitis C|chronic hepatitis c
433511|NCT01717560|illicit drug use|illicit drug use
433512|NCT01717560|Substance-Related Disorders|substance-related disorders
433513|NCT01717560|multidisciplinary care|multidisciplinary care
433514|NCT01717560|integrated care|integrated care
433515|NCT01717560|mental health care|mental health care
433516|NCT01717560|intensive case management|intensive case management
433517|NCT01717547|Veterans|veterans
433518|NCT01717547|Yoga|yoga
433519|NCT01717547|Stress|stress
433520|NCT01717534|Diarrhea|diarrhea
433521|NCT01717534|Children|children
433522|NCT01717534|Heat-treated lactobacilli|heat-treated lactobacilli
433523|NCT01717521|intraoperative monitoring|intraoperative monitoring
433524|NCT01717521|hysterectomy|hysterectomy
433525|NCT01717521|robotic-assisted|robotic-assisted
433526|NCT01717521|abdominal gynecological surgery|abdominal gynecological surgery
433527|NCT01717508|MDD|mdd
433528|NCT01717508|depression|depression
433529|NCT01717508|major depressive disorder|major depressive disorder
433530|NCT01717508|adolescent|adolescent
433531|NCT01717495|Pacemaker|pacemaker
433532|NCT01717495|Implantable-cardioverter defibrillator|implantable-cardioverter defibrillator
433533|NCT01717495|Cardiac Pacing, Artificial/adverse effects|cardiac pacing, artificial/adverse effects
433534|NCT01717495|Venous thrombosis|venous thrombosis
433535|NCT01717495|Pulmonary embolism|pulmonary embolism
433536|NCT01717495|Phlebography|phlebography
433537|NCT01717495|Biological markers|biological markers
433538|NCT01717495|Computed tomography angiography|computed tomography angiography
433539|NCT01717482|Bronchoscopy|bronchoscopy
433540|NCT01717482|Metformin|metformin
433541|NCT01717469|Pacemaker|pacemaker
433542|NCT01717469|Pacemaker implantation|pacemaker implantation
433543|NCT01717469|Coronary sinus|coronary sinus
433544|NCT01717469|Ventricular dysfunction|ventricular dysfunction
433545|NCT01717469|Right ventricular pacing|right ventricular pacing
433546|NCT01717469|Left ventricular pacing|left ventricular pacing
433547|NCT01717456|Fecal incontinence|fecal incontinence
433548|NCT01717456|Frail elders|frail elders
433549|NCT01717456|Home health care|home health care
433550|NCT01717456|Nurse|nurse
433551|NCT01717456|Patient education|patient education
433552|NCT01717443|Human Papillomavirus|human papillomavirus
433553|NCT01717443|Renal transplantation|renal transplantation
433554|NCT01717430|Injections, epidural|injections, epidural
433555|NCT01717430|Injections, intra-articular|injections, intra-articular
433556|NCT01717430|Chronic pain|chronic pain
433557|NCT01717430|Neck pain|neck pain
433558|NCT01717430|Back pain|back pain
433559|NCT01717430|Low back pain|low back pain
433560|NCT01717430|Sciatica|sciatica
433561|NCT01717430|Sacroiliac joint|sacroiliac joint
433562|NCT01717430|Corticosteroids|corticosteroids
433563|NCT01717430|Dexamethasone|dexamethasone
433564|NCT01717430|Adrenocorticotropic hormone|adrenocorticotropic hormone
433565|NCT01717430|Adrenal insufficiency|adrenal insufficiency
433566|NCT01717430|Hemoglobin A, glycosylated|hemoglobin a, glycosylated
433567|NCT01717417|impacted canine|impacted canine
433568|NCT01717417|miniscrew|miniscrew
433569|NCT01717417|cone beam|cone beam
433570|NCT01717404|IBS|ibs
433571|NCT01717391|radiotherapy|radiotherapy
433572|NCT01717391|Positron-Emission Tomography and Computed Tomography|positron-emission tomography and computed tomography
433573|NCT01717391|chemotherapy|chemotherapy
433574|NCT01717391|bone marrow|bone marrow
433575|NCT01717378|Patient Recruitment|patient recruitment
433576|NCT01717378|Research Subject Recruitment|research subject recruitment
433577|NCT01717378|Research Subject Selection|research subject selection
433578|NCT01717378|Selection of Subjects|selection of subjects
433579|NCT01717378|Health Surveys|health surveys
433580|NCT01717378|Health Questionnaires|health questionnaires
433581|NCT01717378|Health Interviews|health interviews
433582|NCT01717365|SCOPE|scope
433583|NCT01717352|Weight loss|weight loss
433584|NCT01717274|Functional Endoscopic Sinus Surgery|functional endoscopic sinus surgery
433585|NCT01717274|Hot water irrigation|hot water irrigation
433586|NCT01717261|breast cancer|breast cancer
433587|NCT01717261|early breast cancer|early breast cancer
433992|NCT01715402|metastasis|metastasis
433588|NCT01717261|partial breast irradiation|partial breast irradiation
433589|NCT01717261|preoperative radiation|preoperative radiation
433590|NCT01717222|Lignocaine|lignocaine
433591|NCT01717222|Laparoscopic cholecystectomy|laparoscopic cholecystectomy
433592|NCT01717222|Pain relief|pain relief
433593|NCT01717209|heart failure|heart failure
433594|NCT01717209|hypertension, pulmonary|hypertension, pulmonary
433595|NCT01717209|heart failure, right-sided|heart failure, right-sided
433596|NCT01717209|heart-assist devices|heart-assist devices
433597|NCT01717209|Heart Transplantation|heart transplantation
433598|NCT01717196|sample adequacy|sample adequacy
433599|NCT01717196|diagnostic accuracy|diagnostic accuracy
433600|NCT01717196|complications|complications
433601|NCT01717183|Patient|patient
433602|NCT01717170|Non-infectious Uveitis, Tocilizumab|non-infectious uveitis, tocilizumab
433603|NCT01717157|Healthy|healthy
433604|NCT01717157|Fentanyl|fentanyl
433605|NCT01717157|Transdermal patch|transdermal patch
433606|NCT01717157|DUROGESIC|durogesic
433607|NCT01717144|therapeutic education|therapeutic education
433608|NCT01717144|Parkinson's disease|parkinson's disease
433609|NCT01717144|quality of life|quality of life
433610|NCT01717131|Invasive breast cancer|invasive breast cancer
433611|NCT01717118|Evaluation|evaluation
433612|NCT01717118|Immunogenicity|immunogenicity
433613|NCT01717118|Levels|levels
433614|NCT01717118|Women|women
433616|NCT01717118|Vaccine|vaccine
433617|NCT01717118|Mexico|mexico
433618|NCT01717105|Non-small cell lung cancer (NSCLC)|non-small cell lung cancer (nsclc)
433619|NCT01717105|Epidermal growth factor receptor (EGFR) positive mutation|epidermal growth factor receptor (egfr) positive mutation
433620|NCT01717066|Hepatocellular Carcinoma|hepatocellular carcinoma
433621|NCT01717066|ginsenoside Rg3|ginsenoside rg3
433622|NCT01717040|Bipolar Disorder|bipolar disorder
433623|NCT01717040|Insulin Resistance|insulin resistance
433624|NCT01717027|pharmacokinetics|pharmacokinetics
433625|NCT01717027|bioavailability|bioavailability
433626|NCT01717027|oxycodone|oxycodone
433627|NCT01717027|management of moderate to severe pain|management of moderate to severe pain
433628|NCT01717014|rectal cancer|rectal cancer
433629|NCT01717014|stapler|stapler
433630|NCT01717001|kinematics|kinematics
433631|NCT01717001|knee joint|knee joint
433632|NCT01716988|Micafungin|micafungin
433633|NCT01716988|pharmacokinetics|pharmacokinetics
433634|NCT01716988|invasive candidiasis|invasive candidiasis
433635|NCT01716988|intensive care|intensive care
433636|NCT01716975|Schizophrenia|schizophrenia
433637|NCT01716975|Cognition|cognition
433638|NCT01716975|Cognition Impairment|cognition impairment
433639|NCT01716975|Alpha-7 nAChR|alpha-7 nachr
433640|NCT01716962|Acute respiratory distress syndrome, Fluid responsiveness, Pulse pressure variation|acute respiratory distress syndrome, fluid responsiveness, pulse pressure variation
433641|NCT01716962|Pleth variability index, Passive leg raising test|pleth variability index, passive leg raising test
433642|NCT01716949|rectal cancer|rectal cancer
433643|NCT01716949|recurrent rectal cancer|recurrent rectal cancer
433644|NCT01716949|hyperthermia|hyperthermia
433645|NCT01716949|radiation|radiation
433646|NCT01716949|chemoradiation|chemoradiation
433647|NCT01716949|5-FU|5-fu
433648|NCT01716949|capecitabine|capecitabine
433649|NCT01716949|oxaliplatin|oxaliplatin
433650|NCT01716936|Thoracic Insufficiency Syndrome|thoracic insufficiency syndrome
433651|NCT01716936|Early Onset Spinal Deformity|early onset spinal deformity
433652|NCT01716884|STEMI|stemi
433653|NCT01716884|reperfution|reperfution
433654|NCT01716884|primary PCI|primary pci
433655|NCT01716858|Schizophrenia|schizophrenia
433656|NCT01716858|Sulforaphane|sulforaphane
433657|NCT01716858|Psychosis|psychosis
433658|NCT01716858|Cognition|cognition
433659|NCT01716858|Oxidative stress|oxidative stress
433660|NCT01716858|Antioxidant|antioxidant
433661|NCT01716858|Anti-inflammatory|anti-inflammatory
554130|NCT01202591|ER+|er+
433662|NCT01716845|autism|autism
433663|NCT01716845|autism spectrum disorders|autism spectrum disorders
433664|NCT01716845|RNA|rna
433665|NCT01716845|gene expression|gene expression
433666|NCT01716845|developmental delay|developmental delay
433667|NCT01716819|Heart failure, abdominal obesity, RAAS|heart failure, abdominal obesity, raas
433668|NCT01716806|Antibody-Drug Conjugate|antibody-drug conjugate
433669|NCT01716806|Antibodies, Monoclonal|antibodies, monoclonal
433670|NCT01716806|Hematologic Diseases|hematologic diseases
433671|NCT01716806|Hodgkin Disease|hodgkin disease
433672|NCT01716806|Antigens, CD30|antigens, cd30
433673|NCT01716806|Lymphoma|lymphoma
433674|NCT01716806|monomethylauristatin E|monomethylauristatin e
433675|NCT01716806|Drug Therapy|drug therapy
433676|NCT01716806|CD30-expression|cd30-expression
433677|NCT01716806|PTCL|ptcl
433678|NCT01716793|Primary AML|primary aml
433679|NCT01716793|Risk-adapted treatment|risk-adapted treatment
433680|NCT01716793|Hematopoietic transplantation|hematopoietic transplantation
433681|NCT01716793|CD34+ cell selection|cd34+ cell selection
433682|NCT01716767|Carpal tunnel syndrome|carpal tunnel syndrome
433683|NCT01716767|hand pain|hand pain
433684|NCT01716767|wrist pain|wrist pain
433685|NCT01716767|arm pain|arm pain
433686|NCT01716767|topical menthol|topical menthol
433687|NCT01716754|asthma|asthma
433688|NCT01716754|asthma control|asthma control
433689|NCT01716754|allergy|allergy
433690|NCT01716754|atopic|atopic
433691|NCT01716754|IgE|ige
433692|NCT01716754|double-blind|double-blind
433693|NCT01716754|placebo|placebo
433694|NCT01716754|omalizumab|omalizumab
433695|NCT01716741|Gaucher disease|gaucher disease
433696|NCT01716741|lysosomal storage disorder|lysosomal storage disorder
433697|NCT01716741|metabolic disease|metabolic disease
433698|NCT01716741|medical records review|medical records review
433699|NCT01716728|Lysosomal Acid Lipase Deficiency|lysosomal acid lipase deficiency
433700|NCT01716728|Cholesterol Ester Storage Disease|cholesterol ester storage disease
433701|NCT01716728|Wolman Disease|wolman disease
433702|NCT01716728|Lysosomal Storage Disorder|lysosomal storage disorder
433703|NCT01716728|Metabolic Disease|metabolic disease
433704|NCT01716728|Recessive Inheritance|recessive inheritance
433705|NCT01716702|Prostate Cancer|prostate cancer
433706|NCT01716702|Psychosocial Intervention|psychosocial intervention
433707|NCT01716702|Sexual Rehabilitation|sexual rehabilitation
433708|NCT01716702|Online Intervention|online intervention
433709|NCT01716663|Symptomatic paroxysmal|symptomatic paroxysmal
433710|NCT01716663|Atrial fibrillation|atrial fibrillation
433711|NCT01716663|Observational|observational
433712|NCT01716663|Acute procedural outcomes|acute procedural outcomes
433713|NCT01716663|Ablation|ablation
433714|NCT01716650|ankle|ankle
433715|NCT01716650|saphenous nerve block|saphenous nerve block
433716|NCT01716637|Alzheimer's Disease|alzheimer's disease
433717|NCT01716637|Dementia|dementia
433718|NCT01716637|Cognitive decline|cognitive decline
433719|NCT01716637|Cognitive disorder|cognitive disorder
433720|NCT01716637|Degenerative brain disease|degenerative brain disease
433721|NCT01716637|Cognitive impairment|cognitive impairment
433722|NCT01716637|Memory loss|memory loss
433723|NCT01716637|TNF-alpha|tnf-alpha
433724|NCT01716624|Pediatric|pediatric
433725|NCT01716611|liver cirrhosis|liver cirrhosis
433726|NCT01716611|hyponatemia|hyponatemia
433727|NCT01716611|ascites|ascites
433728|NCT01716611|vaptans|vaptans
433729|NCT01716611|antidiuretic hormon|antidiuretic hormon
433730|NCT01716611|arginine vasopressin|arginine vasopressin
433731|NCT01716598|COPD|copd
433732|NCT01716598|TLD Therapy|tld therapy
433733|NCT01716598|Targeted Lung Denervation Therapy|targeted lung denervation therapy
433734|NCT01716598|IPS|ips
433735|NCT01716598|Innovative Pulmonary Solutions, Inc.|innovative pulmonary solutions, inc.
433736|NCT01716598|Holaira, Inc.|holaira, inc.
433737|NCT01716585|Hepatitis C Virus|hepatitis c virus
433738|NCT01716585|Hepatitis C Genotype 1|hepatitis c genotype 1
433739|NCT01716585|Hepatitis C|hepatitis c
433740|NCT01716585|Treatment-Naïve|treatment-naïve
433741|NCT01716585|Interferon-Free|interferon-free
433742|NCT01716585|Chronic Hepatitis C|chronic hepatitis c
433743|NCT01716585|Viekira Pak|viekira pak
433744|NCT01716585|ombitasvir|ombitasvir
433745|NCT01716585|paritaprevir|paritaprevir
433746|NCT01716585|dasabuvir|dasabuvir
433747|NCT01716572|Upper gastrointestinal bleeding|upper gastrointestinal bleeding
433748|NCT01716572|Endoscopy|endoscopy
433749|NCT01716572|Erythromycin|erythromycin
433750|NCT01716572|Gastric lavage|gastric lavage
433751|NCT01716546|Advanced cancer of the stomach|advanced cancer of the stomach
433752|NCT01716546|Chemotherapy - naive patients|chemotherapy - naive patients
433753|NCT01716546|DCF|dcf
433754|NCT01716533|Serological|serological
433755|NCT01716533|Adults|adults
433756|NCT01716533|Clostridium difficile|clostridium difficile
433757|NCT01716533|Adult CDI patients|adult cdi patients
433758|NCT01716520|long-acting muscarinic antagonist|long-acting muscarinic antagonist
433759|NCT01716520|long-acting beta-agonist|long-acting beta-agonist
433760|NCT01716520|Chronic Obstructive Pulmonary Disease|chronic obstructive pulmonary disease
433761|NCT01716520|vilanterol|vilanterol
433762|NCT01716520|umeclidinium|umeclidinium
433763|NCT01716507|RRD|rrd
433764|NCT01716507|Rhegmatogenous|rhegmatogenous
433765|NCT01716507|Retinal|retinal
433766|NCT01716507|Detachment|detachment
433767|NCT01716507|PPV|ppv
433768|NCT01716507|Pars Plana Vitrectomy|pars plana vitrectomy
433769|NCT01716507|Gauge|gauge
433770|NCT01716494|asthma|asthma
433771|NCT01716481|Stroke|stroke
433772|NCT01716481|Mesenchymal stem cells|mesenchymal stem cells
433773|NCT01716481|Stem cells|stem cells
433774|NCT01716481|Neurogenesis|neurogenesis
433775|NCT01716468|Ketogenic Diet, Advanced Cancer, Neoplasm|ketogenic diet, advanced cancer, neoplasm
433776|NCT01716468|Low carbohydrate|low carbohydrate
433777|NCT01716442|rituximab|rituximab
433778|NCT01716442|nephrotic|nephrotic
433779|NCT01716442|refractory|refractory
433780|NCT01716429|vegetarian|vegetarian
433781|NCT01716429|vegan|vegan
433782|NCT01716429|low calorie|low calorie
433783|NCT01716429|weight Loss|weight loss
433784|NCT01716429|infertility|infertility
433785|NCT01716429|PCOS|pcos
433786|NCT01716403|C hepatitis, telaprevir concentration, ribavirin oncentration, anemia|c hepatitis, telaprevir concentration, ribavirin oncentration, anemia
433787|NCT01716377|Neck Pain|neck pain
433788|NCT01716377|Musculoskeletal pain|musculoskeletal pain
433789|NCT01716377|Venlafaxine|venlafaxine
433790|NCT01716351|Randomized Clinical Control Trial|randomized clinical control trial
433791|NCT01716351|Complementary and Alternative Medicine|complementary and alternative medicine
433792|NCT01716351|Yoga|yoga
433793|NCT01716351|Electrophysiology|electrophysiology
433794|NCT01716351|Implantable Cardioverter Defibrillator|implantable cardioverter defibrillator
433795|NCT01716351|Psychosocial|psychosocial
433796|NCT01716351|Anxiety|anxiety
433797|NCT01716351|Self-Compassion|self-compassion
433798|NCT01716351|Anti-Tachycardia Pacing Events|anti-tachycardia pacing events
433799|NCT01716338|glyburide|glyburide
433800|NCT01716338|glybenclamide|glybenclamide
433801|NCT01716338|hypoglycemia|hypoglycemia
433802|NCT01716312|Safety Of Omalizumab In Patients With SLE|safety of omalizumab in patients with sle
433803|NCT01716312|Systemic Lupus Erythematosus|systemic lupus erythematosus
433804|NCT01716299|HIV|hiv
433805|NCT01716299|Diagnostics|diagnostics
433806|NCT01716247|Mammography (CESM)|mammography (cesm)
433807|NCT01716247|MRI|mri
433808|NCT01716247|Breast screening|breast screening
433809|NCT01716247|12-214|12-214
433810|NCT01716208|Fresh Frozen Plasma|fresh frozen plasma
433811|NCT01716208|Complement|complement
433812|NCT01716208|Monoclonal Antibody|monoclonal antibody
433813|NCT01716195|Human Papillomavirus|human papillomavirus
433814|NCT01716195|HPV|hpv
433815|NCT01716143|atrial fibrillation|atrial fibrillation
433816|NCT01716143|catheter ablation|catheter ablation
433817|NCT01716143|Mapping|mapping
433818|NCT01716130|Fluzone Intradermal vaccine|fluzone intradermal vaccine
433819|NCT01716117|Large aneurysm|large aneurysm
433820|NCT01716117|Giant aneurysm|giant aneurysm
433821|NCT01716117|Wide neck aneurysm|wide neck aneurysm
433822|NCT01716091|focus of study is postoperative enfectious morbidity and postoperative GİS functionally recovery|focus of study is postoperative enfectious morbidity and postoperative gis functionally recovery
433823|NCT01716078|Brachial Plexus|brachial plexus
433824|NCT01716078|Nerve Block|nerve block
433825|NCT01716078|Nerve Conduction|nerve conduction
433826|NCT01716065|Anesthesia, Circulating tumor cells|anesthesia, circulating tumor cells
433827|NCT01716052|Mammogram|mammogram
433828|NCT01716052|Ibuprofen|ibuprofen
433829|NCT01716052|Pain management|pain management
433830|NCT01716039|Moderately to severely active Ulcerative Colitis|moderately to severely active ulcerative colitis
433831|NCT01716026|high myopia|high myopia
433832|NCT01716026|choroidal neovascularization|choroidal neovascularization
433833|NCT01716000|vaginal gel|vaginal gel
433834|NCT01716000|vaginal coating|vaginal coating
433835|NCT01716000|sensory perceptions|sensory perceptions
433836|NCT01715987|Hepatitis B|hepatitis b
433837|NCT01715987|Antiviral|antiviral
433838|NCT01715987|Tubular dysfunction|tubular dysfunction
433839|NCT01715987|Entecavir|entecavir
433840|NCT01715987|Tenofovir|tenofovir
433841|NCT01715974|G-CSF, IVF failure,pregnancy|g-csf, ivf failure,pregnancy
433842|NCT01715961|70 years old|70 years old
433843|NCT01715961|DLBCL|dlbcl
433844|NCT01715961|Rituximab-CHOP|rituximab-chop
433845|NCT01715961|Sarcopenia|sarcopenia
433846|NCT01715948|CROS hearing aid|cros hearing aid
433847|NCT01715948|Bone-anchored hearing device|bone-anchored hearing device
433848|NCT01715935|Clear cells renal carcinoma|clear cells renal carcinoma
433849|NCT01715935|everolimus|everolimus
433850|NCT01715935|neo-adjuvant treatment|neo-adjuvant treatment
433851|NCT01715922|Cryptococcal meningitis|cryptococcal meningitis
433852|NCT01715922|HIV Infections|hiv infections
433853|NCT01715922|Oral treatment|oral treatment
433854|NCT01715922|High dose of fluconazole|high dose of fluconazole
433855|NCT01715922|Flucytosine|flucytosine
433856|NCT01715922|Burundi|burundi
433857|NCT01715922|Ivory Coast|ivory coast
433858|NCT01715896|Rheumatoid Arthritis|rheumatoid arthritis
433859|NCT01715896|Golimumab|golimumab
433860|NCT01715896|Mavrilimumab|mavrilimumab
433861|NCT01715883|Lung transplant|lung transplant
433862|NCT01715883|Pulmonary Graft Dysfunction|pulmonary graft dysfunction
433863|NCT01715883|Sodium Nitrite|sodium nitrite
433864|NCT01715870|Age related macular degeneration|age related macular degeneration
433865|NCT01715870|Food habits|food habits
433866|NCT01715870|Life style|life style
433867|NCT01715870|Risk factors|risk factors
433868|NCT01715870|questionnaire|questionnaire
433869|NCT01715857|Economics, Pharmaceutical|economics, pharmaceutical
433870|NCT01715857|Physician's Practice Patterns|physician's practice patterns
433871|NCT01715857|Chinese|chinese
433872|NCT01715857|Sevoflurane|sevoflurane
433873|NCT01715844|L-citrulline|l-citrulline
433874|NCT01715844|ADMA|adma
433875|NCT01715844|Asthma|asthma
433876|NCT01715844|Obesity|obesity
433877|NCT01715805|MDD|mdd
433878|NCT01715805|Major Depressive Disorder|major depressive disorder
433879|NCT01715792|Solid organ transplant rejection|solid organ transplant rejection
433880|NCT01715792|United Kingdom|united kingdom
433881|NCT01715792|Influenza|influenza
433882|NCT01715792|H1N1|h1n1
433883|NCT01715792|Pandemrix™|pandemrix™
433884|NCT01715779|Liver transplantation|liver transplantation
433885|NCT01715779|ENABLE|enable
433886|NCT01715779|observational|observational
433887|NCT01715779|mortality|mortality
433888|NCT01715779|Thromboembolic Events|thromboembolic events
433889|NCT01715779|Hepatic decompensation|hepatic decompensation
433890|NCT01715779|Long-Term follow-up|long-term follow-up
433891|NCT01715779|TEE|tee
433892|NCT01715766|Proteomics study|proteomics study
433893|NCT01715766|biomarker study of pain|biomarker study of pain
433894|NCT01715753|Function|function
433895|NCT01715753|Muscle mass|muscle mass
433896|NCT01715740|Chinese herbal medicine|chinese herbal medicine
433897|NCT01715740|Urticaria|urticaria
433898|NCT01715740|Antipruritics|antipruritics
433899|NCT01715740|Phase III clinical trial|phase iii clinical trial
433900|NCT01715727|diffusion kurtosis imaging|diffusion kurtosis imaging
433901|NCT01715727|parkinson disease|parkinson disease
433902|NCT01715727|parkinsonism|parkinsonism
433903|NCT01715727|diagnosis|diagnosis
433904|NCT01715727|differential diagnosis|differential diagnosis
433905|NCT01715714|Coronary Artery Disease|coronary artery disease
433906|NCT01715714|Statins|statins
433907|NCT01715714|Coronary Artery Bypass Grafting|coronary artery bypass grafting
433908|NCT01715714|Cardiac Surgery|cardiac surgery
433909|NCT01715675|asthma|asthma
433910|NCT01715675|allergy|allergy
433911|NCT01715675|sitostanol|sitostanol
433912|NCT01715675|cytokines|cytokines
433913|NCT01715675|Th1|th1
433914|NCT01715675|Treg|treg
433915|NCT01715675|antibodies|antibodies
433916|NCT01715675|IgE|ige
433917|NCT01715675|vaccination|vaccination
433918|NCT01715662|rehabilitation|rehabilitation
433919|NCT01715662|lower limb amputation|lower limb amputation
433920|NCT01715662|unilateral transtibial amputation|unilateral transtibial amputation
433921|NCT01715662|unilateral transfemoral amputation|unilateral transfemoral amputation
433922|NCT01715662|older adults|older adults
433923|NCT01715662|cognitive computer games|cognitive computer games
433924|NCT01715662|home-based training|home-based training
433925|NCT01715662|Nintendo Wii|nintendo wii
433926|NCT01715662|virtual reality|virtual reality
433927|NCT01715649|Type 2 diabetes|type 2 diabetes
433928|NCT01715649|self-management|self-management
433929|NCT01715649|remote patient monitoring|remote patient monitoring
433930|NCT01715623|polymorphism|polymorphism
433931|NCT01715623|serum Ig|serum ig
433932|NCT01715597|uterine leiomyoma|uterine leiomyoma
433933|NCT01715597|laparoscopic myomectomy|laparoscopic myomectomy
433934|NCT01715597|intraoperative blood loss|intraoperative blood loss
433935|NCT01715597|ascorbic acid|ascorbic acid
433936|NCT01715584|Hypertension|hypertension
433937|NCT01715584|Sevoflurane|sevoflurane
433938|NCT01715584|Inhaled Anesthetic|inhaled anesthetic
433939|NCT01715584|Angiotensin Converting Enzyme Inhibitor|angiotensin converting enzyme inhibitor
433940|NCT01715584|Angiotensin II Receptor Blocking Agent|angiotensin ii receptor blocking agent
433941|NCT01715571|erectile dysfunction|erectile dysfunction
433942|NCT01715571|vibratory stimulation|vibratory stimulation
433943|NCT01715571|viberect|viberect
433944|NCT01715545|day-3 poor quality embryo|day-3 poor quality embryo
433945|NCT01715545|vitrification|vitrification
433946|NCT01715545|clinical outcome|clinical outcome
433947|NCT01715532|Huachansu|huachansu
433948|NCT01715532|Na+/K+-ATPase α3|na+/k+-atpase α3
433949|NCT01715532|transcatheter arterial chemoembolization|transcatheter arterial chemoembolization
433950|NCT01715532|randomized controlled trial|randomized controlled trial
433951|NCT01715519|Vilazodone|vilazodone
433952|NCT01715519|PTSD|ptsd
433953|NCT01715519|Depression|depression
433954|NCT01715506|Dementia|dementia
433955|NCT01715506|Resident|resident
433956|NCT01715506|Nursinghome|nursinghome
433957|NCT01715506|Use of restraint|use of restraint
433958|NCT01715506|Agitation|agitation
433959|NCT01715493|COPD|copd
433960|NCT01715493|Asthma|asthma
433961|NCT01715493|Lysozyme Hydrochloride|lysozyme hydrochloride
433962|NCT01715480|broccoli sprout|broccoli sprout
433963|NCT01715480|sickle cell|sickle cell
433964|NCT01715480|NRF2|nrf2
433965|NCT01715467|Dupuytren|dupuytren
433966|NCT01715467|Contracture|contracture
433967|NCT01715467|Auxilium|auxilium
433968|NCT01715467|XIAFLEX|xiaflex
433969|NCT01715441|Metastatic colorectal cancer patients|metastatic colorectal cancer patients
433970|NCT01715441|KRAS mutation|kras mutation
433971|NCT01715441|Sorafenib|sorafenib
433972|NCT01715428|diabetes, cardiovascular risk|diabetes, cardiovascular risk
433973|NCT01715415|Hepatitis C|hepatitis c
433974|NCT01715415|Treatment-Experienced|treatment-experienced
433975|NCT01715415|Null responder|null responder
433976|NCT01715415|Partial Responder|partial responder
433977|NCT01715415|Chronic Hepatitis|chronic hepatitis
433978|NCT01715415|Hepatitis C Genotype 1|hepatitis c genotype 1
433979|NCT01715415|Interferon-Free|interferon-free
433980|NCT01715415|Hepatitis C Virus|hepatitis c virus
433981|NCT01715415|Relapser|relapser
433982|NCT01715415|Non responder|non responder
433983|NCT01715415|Viekira Pak|viekira pak
433984|NCT01715415|ombitasvir|ombitasvir
433985|NCT01715415|ribavirin|ribavirin
433986|NCT01715415|ritonavir|ritonavir
433987|NCT01715415|paritaprevir|paritaprevir
433988|NCT01715415|dasabuvir|dasabuvir
433989|NCT01715402|liver tumor|liver tumor
433990|NCT01715402|carcinoma|carcinoma
433991|NCT01715402|cholangiocarcinoma|cholangiocarcinoma
433993|NCT01715389|Asthma|asthma
433994|NCT01715389|Goals|goals
433995|NCT01715389|Shared Decision Making|shared decision making
433996|NCT01715389|Patient Portal|patient portal
433997|NCT01715389|Electronic Medical Record|electronic medical record
433998|NCT01715376|traditional chinese medicine|traditional chinese medicine
433999|NCT01715376|complementary therapies|complementary therapies
434000|NCT01715376|traditional chinese medicine syndrome scale|traditional chinese medicine syndrome scale
434001|NCT01715350|Alzheimer's Disease|alzheimer's disease
434002|NCT01715337|muscle fibre|muscle fibre
434003|NCT01715337|capillary|capillary
434004|NCT01715337|rehabilitation|rehabilitation
434005|NCT01715337|exercise training|exercise training
434006|NCT01715324|In vitro fertilization|in vitro fertilization
434007|NCT01715324|Antagonist protocol|antagonist protocol
434008|NCT01715324|Growth Hormone|growth hormone
434009|NCT01715311|COPD|copd
434010|NCT01715311|Chronic obstructive pulmonary disease|chronic obstructive pulmonary disease
434011|NCT01715311|indacaterol|indacaterol
434012|NCT01715311|tiotropium|tiotropium
434013|NCT01715298|Anticholinergic|anticholinergic
434014|NCT01715298|Antimuscarinic|antimuscarinic
434015|NCT01715298|Chronic Obstructive Airway Disease|chronic obstructive airway disease
434016|NCT01715298|Chronic Obstructive Lung Disease|chronic obstructive lung disease
434017|NCT01715298|Chronic Obstructive Pulmonary Disease|chronic obstructive pulmonary disease
434018|NCT01715298|COPD|copd
434019|NCT01715298|LAMA|lama
434020|NCT01715298|Lung Disease|lung disease
434021|NCT01715298|Lung Diseases, Obstructive|lung diseases, obstructive
434022|NCT01715298|Lung Function|lung function
434023|NCT01715298|Muscarinic receptor antagonist|muscarinic receptor antagonist
434024|NCT01715298|Pulmonary Disease, Chronic Obstructive|pulmonary disease, chronic obstructive
434025|NCT01715298|Respiratory Tract Diseases|respiratory tract diseases
434026|NCT01715285|Prostate neoplasms|prostate neoplasms
434027|NCT01715285|Prostate cancer|prostate cancer
434028|NCT01715285|Metastatic prostate cancer|metastatic prostate cancer
434029|NCT01715285|Abiraterone acetate|abiraterone acetate
434030|NCT01715285|ZYTIGA|zytiga
434031|NCT01715285|Prednisone|prednisone
434032|NCT01715285|Androgen deprivation therapy|androgen deprivation therapy
434033|NCT01715259|Renal insufficiency|renal insufficiency
434034|NCT01715259|Renal impairment|renal impairment
434035|NCT01715259|End-stage renal disease|end-stage renal disease
434036|NCT01715259|Abiraterone acetate|abiraterone acetate
434037|NCT01715259|Pharmacokinetics|pharmacokinetics
434038|NCT01715246|healthy babbies|healthy babbies
434039|NCT01715246|infant formula|infant formula
434040|NCT01715246|growth|growth
434041|NCT01715246|HMO|hmo
434042|NCT01715220|Nitroglycerin|nitroglycerin
434043|NCT01715220|Biliary Colic|biliary colic
434044|NCT01715220|Cholelithiasis|cholelithiasis
434045|NCT01715220|Abdominal Pain.|abdominal pain.
434046|NCT01715194|OSAS|osas
434047|NCT01715194|CPAP|cpap
434048|NCT01715194|Adherence|adherence
434049|NCT01715194|Telemedicine|telemedicine
434050|NCT01715168|Doxil generic|doxil generic
434051|NCT01715168|Caelyx generic|caelyx generic
434052|NCT01715168|generic treatment|generic treatment
434053|NCT01715168|ovarian cancer|ovarian cancer
434054|NCT01715168|ovary|ovary
434055|NCT01715168|progressed|progressed
434056|NCT01715168|recurred cancer|recurred cancer
434057|NCT01715168|platinum based therapy|platinum based therapy
434058|NCT01715155|Metastatic Breast Cancer,|metastatic breast cancer,
554621|NCT01200537|IVF|ivf
434059|NCT01715155|retrospective study,|retrospective study,
434060|NCT01715155|disease progression,|disease progression,
434061|NCT01715155|clinical management|clinical management
434062|NCT01715142|Pancreatic cancer|pancreatic cancer
434063|NCT01715142|Nab-paclitaxel|nab-paclitaxel
434064|NCT01715142|Gemcitabine|gemcitabine
434065|NCT01715142|Neoadjuvant chemotherapy|neoadjuvant chemotherapy
434066|NCT01715116|Cardiac arrhythmias|cardiac arrhythmias
434067|NCT01715116|Implantable Cardioverter-Defibrillator|implantable cardioverter-defibrillator
434068|NCT01715116|Patient Safety|patient safety
434069|NCT01715116|Quality of life|quality of life
434070|NCT01715103|HIV infection|hiv infection
434071|NCT01715103|mucosa|mucosa
434072|NCT01715103|immunological parameters|immunological parameters
434073|NCT01715103|genital sampling|genital sampling
434074|NCT01715103|healthy women volunteers|healthy women volunteers
434075|NCT01715077|melanoma|melanoma
434076|NCT01715077|stage IV|stage iv
434077|NCT01715077|stage III|stage iii
434078|NCT01715077|unresectable|unresectable
434079|NCT01715064|Prostate Cancer|prostate cancer
434080|NCT01715064|Exercise|exercise
434081|NCT01715064|Cortical Inhibition|cortical inhibition
434082|NCT01715064|Cortical Silent Period|cortical silent period
434083|NCT01715064|Transcranial Magnetic Stimulation|transcranial magnetic stimulation
434084|NCT01715051|cocaine|cocaine
434085|NCT01715051|D-serine|d-serine
434086|NCT01715051|Drug dependence|drug dependence
434087|NCT01715038|malnutrition|malnutrition
434088|NCT01715038|stunting|stunting
434089|NCT01715038|LNS|lns
434090|NCT01715038|micronutrient powder|micronutrient powder
434091|NCT01715038|hemoglobin|hemoglobin
434092|NCT01715025|measured|measured
434093|NCT01715025|heavy menstrual bleeding|heavy menstrual bleeding
434094|NCT01715025|combined oral contraceptive|combined oral contraceptive
434095|NCT01715025|alkaline haematin method|alkaline haematin method
434096|NCT01715012|Burn|burn
434097|NCT01715012|Diabetes|diabetes
434098|NCT01715012|Skin graft|skin graft
434099|NCT01715012|Donor site|donor site
434100|NCT01714999|olecranon|olecranon
434101|NCT01714999|prepatellar|prepatellar
434102|NCT01714999|bursa|bursa
434103|NCT01714999|trauma|trauma
434104|NCT01714999|laceration|laceration
434105|NCT01714999|bursectomy|bursectomy
434106|NCT01714999|bursa reconstruction|bursa reconstruction
434107|NCT01714986|Diabetes mellitus|diabetes mellitus
434108|NCT01714986|Depression|depression
434109|NCT01714986|Anxiety|anxiety
434110|NCT01714986|Alexithymia|alexithymia
434111|NCT01714986|Self Image|self image
434112|NCT01714986|HbA1c|hba1c
434113|NCT01714986|Psychoeducation|psychoeducation
434114|NCT01714947|Drug Therapy|drug therapy
434115|NCT01714934|IDIOPATHIC PULMONARY FIBROSIS|idiopathic pulmonary fibrosis
434116|NCT01714934|MICROASPIRATION|microaspiration
434117|NCT01714908|NSCLC|nsclc
434118|NCT01714908|EGFR mutation|egfr mutation
434119|NCT01714908|unresectable|unresectable
434120|NCT01714908|erlotinib|erlotinib
434121|NCT01714908|concurrent radiotherapy|concurrent radiotherapy
434122|NCT01714895|Interstitial glucose dynamics|interstitial glucose dynamics
434123|NCT01714895|Accuracy of continuous glucose monitoring under hypoglycemia|accuracy of continuous glucose monitoring under hypoglycemia
434124|NCT01714895|Glucose clamp|glucose clamp
434125|NCT01714882|Infertility|infertility
434126|NCT01714882|In Vitro Fertilization (IVF)|in vitro fertilization (ivf)
434127|NCT01714882|Stress Management|stress management
434128|NCT01714882|Stress Reduction|stress reduction
434129|NCT01714869|Swedish massage|swedish massage
434130|NCT01714869|massage|massage
434131|NCT01714869|osteoarthritis|osteoarthritis
434132|NCT01714869|knee|knee
434133|NCT01714843|ASP0456|asp0456
434134|NCT01714843|constipation|constipation
434135|NCT01714843|irritable bowel syndrome (IBS)|irritable bowel syndrome (ibs)
434136|NCT01714843|linaclotide|linaclotide
434137|NCT01714804|Bone Morphogenetic Protein (BMP)|bone morphogenetic protein (bmp)
434138|NCT01714804|Demineralized bone matrix (DBM)|demineralized bone matrix (dbm)
434139|NCT01714804|Fusion rates|fusion rates
434140|NCT01714804|Interbody fusion|interbody fusion
434141|NCT01714804|Lumbar spine|lumbar spine
434142|NCT01714804|Transverse lumbar interbody fusion (TLIF)|transverse lumbar interbody fusion (tlif)
434143|NCT01714804|Patient reported outcomes|patient reported outcomes
434144|NCT01714804|Posterolateral lumbar fusion (PLF)|posterolateral lumbar fusion (plf)
434145|NCT01714791|Coronary Artery Bypass Graft|coronary artery bypass graft
434146|NCT01714791|Osteopathic Medicine|osteopathic medicine
434147|NCT01714791|Vital Capacity|vital capacity
434148|NCT01714791|Quality of Life|quality of life
434149|NCT01714791|Cardiac rehabilitation|cardiac rehabilitation
434150|NCT01714765|Metastatic Clear Cell Renal Cancer Dovitinib Everolimus Cohort Maximum administered dose maximum tolerated dose|metastatic clear cell renal cancer dovitinib everolimus cohort maximum administered dose maximum tolerated dose
434151|NCT01714752|Diagnosis|diagnosis
434152|NCT01714752|Left ventricular end diastolic pressure (LVEDP)|left ventricular end diastolic pressure (lvedp)
554810|NCT01199939|HIV|hiv
434153|NCT01714752|Exercise echocardiography|exercise echocardiography
434154|NCT01714752|Left atrial remodeling|left atrial remodeling
434155|NCT01714726|MEDI2070|medi2070
434156|NCT01714726|inflammatory bowel disease|inflammatory bowel disease
434157|NCT01714726|moderate to severe Crohn's disease|moderate to severe crohn's disease
434158|NCT01714713|Schizophrenia|schizophrenia
434159|NCT01714713|Cognition|cognition
434160|NCT01714713|Cognition Impairment|cognition impairment
434161|NCT01714713|Alpha-7 nAChR|alpha-7 nachr
434162|NCT01714700|protein|protein
434163|NCT01714700|resistance exercise ghrelin|resistance exercise ghrelin
434164|NCT01714700|overweight|overweight
434165|NCT01714674|cardiac troponin T|cardiac troponin t
434166|NCT01714674|cTnT|ctnt
434167|NCT01714674|exercise|exercise
434168|NCT01714674|dietary nitrate|dietary nitrate
434169|NCT01714661|Schizophrenia|schizophrenia
434170|NCT01714661|Cognition|cognition
434171|NCT01714661|Cognition Impairment|cognition impairment
434172|NCT01714661|Alpha-7 nAChR|alpha-7 nachr
434173|NCT01714648|OVULATION INDUCTION|ovulation induction
434174|NCT01714635|cataract|cataract
434175|NCT01714635|IOL|iol
434176|NCT01714635|intraocular lens|intraocular lens
434177|NCT01714622|metabolic syndrome|metabolic syndrome
434178|NCT01714622|insulin resistance|insulin resistance
434179|NCT01714622|gastric cancer|gastric cancer
434180|NCT01714609|portal hypertension|portal hypertension
434181|NCT01714609|sorafenib|sorafenib
434182|NCT01714596|Oral Antibiotic|oral antibiotic
434183|NCT01714596|Intravenous Antibiotic|intravenous antibiotic
434184|NCT01714596|Wound infection|wound infection
434185|NCT01714596|Randomized Controlled Trial|randomized controlled trial
434186|NCT01714583|Mechanical ventilation|mechanical ventilation
434187|NCT01714583|ARDS|ards
434188|NCT01714583|acute lung injury|acute lung injury
434189|NCT01714583|cardiac function|cardiac function
434190|NCT01714583|cardiac index|cardiac index
434191|NCT01714583|heart-lung interaction|heart-lung interaction
434192|NCT01714531|Mild TBI|mild tbi
434193|NCT01714518|Interstitial Lung Disease|interstitial lung disease
434194|NCT01714518|Diagnosis|diagnosis
434195|NCT01714518|Cryobiopsy|cryobiopsy
434196|NCT01714518|Video-assisted thoracic surgery|video-assisted thoracic surgery
434197|NCT01714518|Lung biopsy|lung biopsy
434198|NCT01714505|Diabetes Mellitus, Type 1|diabetes mellitus, type 1
434199|NCT01714505|Continuous Glucose Monitor|continuous glucose monitor
434200|NCT01714505|Artificial Pancreas|artificial pancreas
434201|NCT01714505|Insulin Pump|insulin pump
434202|NCT01714505|Closed Loop control|closed loop control
434203|NCT01714505|Open Loop treatment|open loop treatment
434204|NCT01714492|Total Knee Arthroplasty (TKA)|total knee arthroplasty (tka)
434205|NCT01714492|in vivo mechanics|in vivo mechanics
434206|NCT01714492|kinematics|kinematics
434207|NCT01714492|fluoroscopy|fluoroscopy
434208|NCT01714440|genomics of kidney transplantation|genomics of kidney transplantation
434209|NCT01714440|genetic variation|genetic variation
434210|NCT01714440|recipient genotypes|recipient genotypes
434211|NCT01714440|donor genotypes|donor genotypes
434212|NCT01714414|HIV|hiv
434213|NCT01714414|Fozivudine|fozivudine
434214|NCT01714414|Zidovudine|zidovudine
434215|NCT01714414|FATI|fati
434216|NCT01714388|remifentanil|remifentanil
434217|NCT01714388|heart rate|heart rate
434218|NCT01714388|autonomic nervous system|autonomic nervous system
434219|NCT01714388|heart rate variability|heart rate variability
434220|NCT01714388|autonomic nervous activity|autonomic nervous activity
434221|NCT01714388|vagotonic effect|vagotonic effect
434222|NCT01714388|single dose|single dose
434223|NCT01714362|oculocardiac effect|oculocardiac effect
434224|NCT01714362|bradycardia|bradycardia
434225|NCT01714362|HRV|hrv
434226|NCT01714349|Spinal cord injury|spinal cord injury
434227|NCT01714349|nerve transfer|nerve transfer
434228|NCT01714349|tetraplegia|tetraplegia
434229|NCT01714349|quadriplegia|quadriplegia
434230|NCT01714336|Arbeitsgemeinschaft für Osteosynthesefragen (AO) fracture|arbeitsgemeinschaft für osteosynthesefragen (ao) fracture
434231|NCT01714336|Orthopaedic Trauma Association (OTA) fracture|orthopaedic trauma association (ota) fracture
434232|NCT01714323|Cigarette smoking|cigarette smoking
434233|NCT01714323|Tobacco smoking|tobacco smoking
434234|NCT01714323|Tobacco use disorder|tobacco use disorder
434235|NCT01714310|severe mood dysregulation|severe mood dysregulation
434236|NCT01714310|irritability|irritability
434237|NCT01714310|lisdexamfetamine|lisdexamfetamine
434238|NCT01714310|fluoxetine|fluoxetine
434239|NCT01714310|newly recognized syndrome|newly recognized syndrome
434240|NCT01714297|cemented total hip arthroplasty|cemented total hip arthroplasty
434241|NCT01714297|blood loss|blood loss
434242|NCT01714297|wound discharge|wound discharge
434243|NCT01714297|thromboprophylaxis|thromboprophylaxis
434244|NCT01714297|biomarkers|biomarkers
434245|NCT01714284|psoriasis|psoriasis
434246|NCT01714258|cardiac output|cardiac output
434247|NCT01714258|fick method|fick method
434248|NCT01714258|thermodilution|thermodilution
434249|NCT01714245|Eczema|eczema
434250|NCT01714245|Atopic Dermatitis|atopic dermatitis
434251|NCT01714245|Compromised Skin|compromised skin
434252|NCT01714245|Inflamed Skin|inflamed skin
434253|NCT01714219|prostatic neoplasms|prostatic neoplasms
434254|NCT01714219|prostatectomy|prostatectomy
434255|NCT01714219|robotics|robotics
434256|NCT01714219|urinary incontinence|urinary incontinence
434257|NCT01714206|Healthy|healthy
434258|NCT01714206|Canagliflozin (JNJ-28431754)|canagliflozin (jnj-28431754)
434259|NCT01714206|Pharmacokinetics|pharmacokinetics
434260|NCT01714206|Digoxin (LANOXIN)|digoxin (lanoxin)
434261|NCT01714193|Healthy|healthy
434262|NCT01714193|Canagliflozin (JNJ-28431754)|canagliflozin (jnj-28431754)
434263|NCT01714193|Pharmacokinetics|pharmacokinetics
434264|NCT01714193|Contraceptives, Oral|contraceptives, oral
434265|NCT01714193|Ethinyl Estradiol|ethinyl estradiol
434266|NCT01714193|Levonorgestrel|levonorgestrel
434267|NCT01714193|LEVORA|levora
434268|NCT01714180|Acyclovir|acyclovir
434269|NCT01714180|Pharmacokinetics|pharmacokinetics
434270|NCT01714180|Obese|obese
434271|NCT01714180|Non-obese|non-obese
434272|NCT01714180|Weight|weight
434273|NCT01714180|Distribution|distribution
434274|NCT01714180|Clearance|clearance
434275|NCT01714167|Chronic|chronic
434276|NCT01714167|Ischemic Stroke|ischemic stroke
434277|NCT01714167|Intracerebral Hemorrhage|intracerebral hemorrhage
434278|NCT01714167|Bone Marrow Mesenchymal Stem Cell|bone marrow mesenchymal stem cell
434279|NCT01714141|Technology based intervention|technology based intervention
434280|NCT01714141|Emerging adults|emerging adults
434281|NCT01714141|African Americans|african americans
434282|NCT01714141|Asthma|asthma
434283|NCT01714141|Controller medications|controller medications
434284|NCT01714141|Motivational intervention|motivational intervention
434285|NCT01714128|NCI protocol #8762|nci protocol #8762
434286|NCT01714128|Estrogen receptor positive breast cancer|estrogen receptor positive breast cancer
434287|NCT01714128|recurrent breast cancer|recurrent breast cancer
434288|NCT01714128|stage IV breast cancer|stage iv breast cancer
434289|NCT01714102|Obesity|obesity
434290|NCT01714102|Insulin resistance|insulin resistance
434291|NCT01714102|Metabolic syndrome|metabolic syndrome
434292|NCT01714102|Pre-diabetes|pre-diabetes
434293|NCT01714089|Relapsing remitting multiple sclerosis|relapsing remitting multiple sclerosis
434294|NCT01714089|RR-MS|rr-ms
434295|NCT01714063|pediatric|pediatric
434296|NCT01714063|asthma|asthma
434297|NCT01714063|metered dose inhaler|metered dose inhaler
434298|NCT01714063|valved holding chamber|valved holding chamber
434299|NCT01714063|pMDI|pmdi
434300|NCT01714063|VHC|vhc
434301|NCT01714050|seasonal affective disorder|seasonal affective disorder
434302|NCT01714050|winter depression|winter depression
434303|NCT01714050|cognitive-behavioral therapy|cognitive-behavioral therapy
434304|NCT01714050|light therapy|light therapy
434305|NCT01714037|Safety|safety
434306|NCT01714037|Efficacy|efficacy
434307|NCT01714037|HSP90|hsp90
434308|NCT01714037|Debio 0932|debio 0932
434309|NCT01714037|Standard of care treatment, NSCLC|standard of care treatment, nsclc
434310|NCT01714024|Dental|dental
434311|NCT01714024|Implant|implant
434312|NCT01714024|UNC Dental School|unc dental school
434313|NCT01714024|Trabecular Metal|trabecular metal
434314|NCT01714024|Titanium|titanium
434315|NCT01714024|Healthy Volunteers|healthy volunteers
434316|NCT01714024|Diabetic|diabetic
434317|NCT01714024|Osteopenic|osteopenic
434318|NCT01714024|Bone Inductive Properties|bone inductive properties
434319|NCT01714024|Osseous Healing|osseous healing
434320|NCT01714024|GO Health|go health
434321|NCT01714024|Offenbacher|offenbacher
434322|NCT01714024|Zimmer Dental, Inc.|zimmer dental, inc.
434323|NCT01714011|Randomized|randomized
434324|NCT01714011|Controlled|controlled
434325|NCT01714011|Trial|trial
434326|NCT01714011|Safety|safety
434327|NCT01714011|Efficacy|efficacy
434328|NCT01714011|Aripiprazole|aripiprazole
434329|NCT01714011|Ziprasidone|ziprasidone
434330|NCT01714011|Metabolic Syndrome|metabolic syndrome
434331|NCT01713998|Ulthera® System|ulthera® system
434332|NCT01713998|Ultherapy™ Treatment|ultherapy™ treatment
434333|NCT01713998|Ulthera, Inc.|ulthera, inc.
434334|NCT01713998|Ultrasound treatment for skin tightening|ultrasound treatment for skin tightening
434335|NCT01713985|Ulthera® System|ulthera® system
434336|NCT01713985|Ultherapy™ Treatment|ultherapy™ treatment
434337|NCT01713985|Ulthera, Inc.|ulthera, inc.
434338|NCT01713985|Ultrasound treatment for skin tightening|ultrasound treatment for skin tightening
434339|NCT01713972|BRAFi|brafi
434340|NCT01713972|BRAF-mutated|braf-mutated
434341|NCT01713959|Underarm sweating|underarm sweating
434342|NCT01713946|TSC seizures|tsc seizures
434343|NCT01713946|TSC epilepsy|tsc epilepsy
434344|NCT01713946|mTOR inhibitor|mtor inhibitor
434345|NCT01713946|RAD001|rad001
434346|NCT01713946|Everolimus|everolimus
434347|NCT01713933|Ulthera® System|ulthera® system
434348|NCT01713933|Ultherapy™ treatment|ultherapy™ treatment
434349|NCT01713933|Ulthera, Inc.|ulthera, inc.
434350|NCT01713907|Ultherapy™ treatment|ultherapy™ treatment
434351|NCT01713907|Ulthera® System|ulthera® system
434352|NCT01713907|Ulthera, Inc.|ulthera, inc.
434353|NCT01713907|Ultrasound treatment for skin tightening|ultrasound treatment for skin tightening
434354|NCT01713894|Counseling|counseling
434355|NCT01713894|Limits of viability|limits of viability
434356|NCT01713881|Polyp|polyp
434357|NCT01713881|colonoscopy|colonoscopy
434358|NCT01713881|surveillance|surveillance
434359|NCT01713868|Breastfeeding|breastfeeding
434360|NCT01713868|Safe Sleep|safe sleep
434361|NCT01713868|Messaging|messaging
434362|NCT01713868|Social Media|social media
434363|NCT01713855|ITP|itp
434364|NCT01713855|Rituximab|rituximab
434365|NCT01713855|Vaccine|vaccine
434366|NCT01713855|Immune Reconstitution|immune reconstitution
434367|NCT01713842|Tocilizumab|tocilizumab
434368|NCT01713842|Polymyalgia Rheumatica|polymyalgia rheumatica
434369|NCT01713842|Glucocorticotherapy|glucocorticotherapy
434370|NCT01713842|PMR-AS|pmr-as
434371|NCT01713829|cranberry|cranberry
434372|NCT01713829|gamma delta T cell|gamma delta t cell
434373|NCT01713829|improvement in immune cell function in healthy humans|improvement in immune cell function in healthy humans
434374|NCT01713829|proliferation|proliferation
434375|NCT01713816|Glutathione|glutathione
434376|NCT01713816|Ascorbate|ascorbate
434377|NCT01713816|Alzheimer's disease|alzheimer's disease
434378|NCT01713816|Aging|aging
434379|NCT01713816|Magnetic Resonance Spectroscopy|magnetic resonance spectroscopy
434380|NCT01713790|physical functional performance|physical functional performance
434381|NCT01713790|postural balance|postural balance
434382|NCT01713790|reaction time|reaction time
434383|NCT01713790|mobility|mobility
434384|NCT01713790|muscle strength|muscle strength
434385|NCT01713790|cognition|cognition
434386|NCT01713777|Seizures|seizures
434387|NCT01713764|diabetes|diabetes
434388|NCT01713764|obesity|obesity
434389|NCT01713764|mindful eating|mindful eating
434390|NCT01713764|positive affect|positive affect
434391|NCT01713764|low carbohydrate|low carbohydrate
434392|NCT01713764|diet|diet
434393|NCT01713751|Surgical site infection|surgical site infection
434394|NCT01713751|Cesarean section|cesarean section
434396|NCT01713738|rituximab|rituximab
434397|NCT01713738|bleeding score|bleeding score
434398|NCT01713738|platelet count|platelet count
434399|NCT01713738|health-related quality of life|health-related quality of life
434400|NCT01713738|HRQL|hrql
434401|NCT01713725|Chronic urticaria|chronic urticaria
434402|NCT01713725|Chronic spontaneous urticaria|chronic spontaneous urticaria
434403|NCT01713725|Autoimmune and non autoimmune urticaria|autoimmune and non autoimmune urticaria
434404|NCT01713725|UAS7|uas7
434405|NCT01713712|Pregnancy|pregnancy
434406|NCT01713712|Obesity|obesity
434407|NCT01713712|Nutrition therapy|nutrition therapy
434408|NCT01713699|CTC, cytology, meningeal carcinomatosis, leptomeningeal metastases|ctc, cytology, meningeal carcinomatosis, leptomeningeal metastases
434409|NCT01713686|Ulthera® System|ulthera® system
434410|NCT01713686|Ultherapy™ Treatment|ultherapy™ treatment
434411|NCT01713686|Ulthera, Inc.|ulthera, inc.
434412|NCT01713686|Micro-focused Ultrasound with Visualization (MFU-V)|micro-focused ultrasound with visualization (mfu-v)
434413|NCT01713673|Hyperhidrosis|hyperhidrosis
434414|NCT01713673|Axillary sweating|axillary sweating
434415|NCT01713673|Ulthera® System|ulthera® system
434416|NCT01713673|Ultherapy™ Treatment|ultherapy™ treatment
434417|NCT01713673|Ulthera, Inc.|ulthera, inc.
434418|NCT01713660|Cataract surgery|cataract surgery
434419|NCT01713660|Femtosecond laser|femtosecond laser
434420|NCT01713660|Corneal incisions|corneal incisions
434421|NCT01713647|Bio-equivalence, crossover|bio-equivalence, crossover
434422|NCT01713634|Bone resorption|bone resorption
434423|NCT01713634|Diet|diet
434424|NCT01713621|P. falciparum|p. falciparum
434425|NCT01713621|malaria|malaria
434426|NCT01713608|malaria|malaria
434427|NCT01713608|dose escalation|dose escalation
434428|NCT01713608|safety|safety
434429|NCT01713608|tolerability|tolerability
434430|NCT01713608|maximum tolerated dose|maximum tolerated dose
434431|NCT01713595|Acute Lung Injury|acute lung injury
434432|NCT01713595|Mechanical Ventilation|mechanical ventilation
434433|NCT01713569|Ulthera® System|ulthera® system
434434|NCT01713569|Ultherapy™ Treatment|ultherapy™ treatment
434435|NCT01713569|Ulthera, Inc.|ulthera, inc.
434436|NCT01713569|Ultrasound treatment for skin tightening|ultrasound treatment for skin tightening
434437|NCT01713556|PTSD, Propranolol|ptsd, propranolol
434438|NCT01713543|falls|falls
434439|NCT01713517|Mosquito Control|mosquito control
434440|NCT01713517|Insecticide Resistance|insecticide resistance
434441|NCT01713491|brain ischemia|brain ischemia
434442|NCT01713491|thrombolytic therapy|thrombolytic therapy
434443|NCT01713491|Impaired cognition|impaired cognition
434444|NCT01713491|dementia|dementia
434445|NCT01713478|hepatic cirrhosis|hepatic cirrhosis
434446|NCT01713478|subclinical myocardial dysfunction|subclinical myocardial dysfunction
434447|NCT01713478|echocardiography|echocardiography
434448|NCT01713478|specific biomarkers|specific biomarkers
434449|NCT01713478|vascular assessment|vascular assessment
434450|NCT01713465|Diabetes|diabetes
434451|NCT01713465|Hypertension|hypertension
434452|NCT01713465|Hypercholesterolemia|hypercholesterolemia
434453|NCT01713465|Obesity|obesity
434454|NCT01713452|Surgical Stomas|surgical stomas
434455|NCT01713452|ileostomy|ileostomy
434456|NCT01713452|surgical site infection|surgical site infection
434457|NCT01713439|Relapsed/Refractory Neuroblastoma|relapsed/refractory neuroblastoma
434458|NCT01713439|Retroviral vector injections|retroviral vector injections
434459|NCT01713439|Allogeneic neuroblastoma cells|allogeneic neuroblastoma cells
434460|NCT01713439|Lymphotactin|lymphotactin
434461|NCT01713439|Interleukin-2 (IL-2)|interleukin-2 (il-2)
434462|NCT01713426|Post herpetic neuralgia|post herpetic neuralgia
434463|NCT01713426|Qutenza|qutenza
434464|NCT01713426|NGX-4010|ngx-4010
434465|NCT01713426|Peripheral Neuropathic Pain|peripheral neuropathic pain
434466|NCT01713426|Pregabalin|pregabalin
434467|NCT01713413|Oxymizer|oxymizer
434468|NCT01713413|endurance time|endurance time
434469|NCT01713413|exercise test|exercise test
434470|NCT01713413|nasal cannula|nasal cannula
434471|NCT01713413|COPD|copd
434472|NCT01713413|ILD|ild
434473|NCT01713413|oxygenation|oxygenation
434474|NCT01713400|Acute Graft vs. Host Disease (aGVHD)|acute graft vs. host disease (agvhd)
434475|NCT01713400|Graft vs. Host Disease (GVHD)|graft vs. host disease (gvhd)
434476|NCT01713387|adjuvant chemotherapy|adjuvant chemotherapy
434477|NCT01713374|endothelial function|endothelial function
434478|NCT01713374|sympathetic nervous system|sympathetic nervous system
434479|NCT01713361|total knee arthroplasty|total knee arthroplasty
434480|NCT01713361|Prophylaxis|prophylaxis
434481|NCT01713348|CGM|cgm
434482|NCT01713348|MDI|mdi
434483|NCT01713322|parent education|parent education
434484|NCT01713322|pain management|pain management
434485|NCT01713322|immunization|immunization
434486|NCT01713322|infant|infant
434487|NCT01713309|Filgrastim|filgrastim
434488|NCT01713309|G-CSF|g-csf
434489|NCT01713309|Heparin-binding protein|heparin-binding protein
434490|NCT01713309|critically ill|critically ill
434491|NCT01713309|acute respiratory failure|acute respiratory failure
434492|NCT01713296|SCLC|sclc
434493|NCT01713296|2nd Line|2nd line
434494|NCT01713296|Relapsed or Refractory|relapsed or refractory
434495|NCT01713270|Hypertension|hypertension
434496|NCT01713270|Atrial Fibrillation|atrial fibrillation
434497|NCT01713270|Arrhythmias, Cardiac|arrhythmias, cardiac
434498|NCT01713270|Heart Diseases|heart diseases
434499|NCT01713257|Critically ill patients|critically ill patients
434500|NCT01713244|Hepatocellular Carcinoma|hepatocellular carcinoma
434501|NCT01713244|Radiofrequency Ablation|radiofrequency ablation
434502|NCT01713244|Hepatectomy|hepatectomy
434503|NCT01713244|Recurrence|recurrence
434504|NCT01713231|osteogenesis imperfecta|osteogenesis imperfecta
434505|NCT01713231|high-dose vitamin D|high-dose vitamin d
434506|NCT01713231|bone density|bone density
434507|NCT01713231|muscle function|muscle function
434508|NCT01713218|Pancreas|pancreas
434509|NCT01713218|Cancer|cancer
434510|NCT01713218|Hedgehog inhibitor|hedgehog inhibitor
434511|NCT01713218|Neoadjuvant chemotherapy|neoadjuvant chemotherapy
434512|NCT01713218|Dynamic imaging|dynamic imaging
434513|NCT01713205|trauma ; sepsis; Multiple Organ Dysfunction Syndrome; Prediction; risk|trauma ; sepsis; multiple organ dysfunction syndrome; prediction; risk
434514|NCT01713153|postpartum hemorrhage|postpartum hemorrhage
434515|NCT01713153|prevention|prevention
434516|NCT01713153|misoprostol|misoprostol
434517|NCT01713153|Uniject|uniject
434518|NCT01713153|oxytocin|oxytocin
434519|NCT01713140|strength training|strength training
434520|NCT01713140|resistance training|resistance training
434521|NCT01713140|fatigue|fatigue
434522|NCT01713140|knee extension|knee extension
434523|NCT01713140|total knee arthroplasty|total knee arthroplasty
434524|NCT01713140|total knee replacement|total knee replacement
434525|NCT01713140|electromyography|electromyography
434526|NCT01713140|physical therapy modalities|physical therapy modalities
434527|NCT01713101|Gastrointestinal Hemorrhage|gastrointestinal hemorrhage
434528|NCT01713101|Peptic Ulcer Hemorrhage|peptic ulcer hemorrhage
434529|NCT01713101|Hematemesis|hematemesis
434530|NCT01713101|Melena|melena
434531|NCT01713101|Tranexamic acid|tranexamic acid
434532|NCT01713088|multisystemic therapy, RCT, young offenders, U.K.|multisystemic therapy, rct, young offenders, u.k.
434533|NCT01713075|chronic obstructive pulmonary disease|chronic obstructive pulmonary disease
434534|NCT01713075|Symbicort|symbicort
434535|NCT01713075|long-term use|long-term use
434536|NCT01713049|FLT PET|flt pet
434537|NCT01713049|breast neoplasms|breast neoplasms
434538|NCT01713049|mammography|mammography
434539|NCT01713049|breast ultrasound|breast ultrasound
434540|NCT01713036|Mass balance, bioavailability, cancer, 14C|mass balance, bioavailability, cancer, 14c
434541|NCT01713023|type 1 diabetes|type 1 diabetes
434542|NCT01713023|fructose|fructose
434543|NCT01713023|glucose|glucose
434544|NCT01713023|TAS1R2|tas1r2
434545|NCT01713023|oxidative stress|oxidative stress
434546|NCT01713010|Keywords provided by Atlantic Health System:|keywords provided by atlantic health system:
434547|NCT01713010|Rapid Shallow Breathing Index|rapid shallow breathing index
434548|NCT01713010|Mechanical Ventilation|mechanical ventilation
434549|NCT01713010|Additional relevant MeSH terms:|additional relevant mesh terms:
434550|NCT01713010|Respiration Disorders|respiration disorders
434551|NCT01713010|Traumatic Brain Injury|traumatic brain injury
434552|NCT01713010|Weaning Failure|weaning failure
434553|NCT01713010|Mechanical ventilation complication|mechanical ventilation complication
434554|NCT01712997|Treatment of|treatment of
434555|NCT01712984|Influenza|influenza
434556|NCT01712984|Fluzone® Intradermal vaccine|fluzone® intradermal vaccine
434557|NCT01712984|Influenza Virus Vaccine USP Quadrivalent|influenza virus vaccine usp quadrivalent
434558|NCT01712984|Influenza Virus Vaccine USP Trivalent Types A and B|influenza virus vaccine usp trivalent types a and b
434559|NCT01712971|surgery|surgery
434560|NCT01712971|pancreas|pancreas
434561|NCT01712971|tumour|tumour
434562|NCT01712971|blood loss|blood loss
434563|NCT01712958|CRC miRNA|crc mirna
434564|NCT01712945|Alemtuzumab|alemtuzumab
434565|NCT01712945|Palifermin|palifermin
434566|NCT01712945|Reconstitution|reconstitution
434567|NCT01712945|Thymus|thymus
434568|NCT01712919|Locoregionally advanced nasopharyngeal carcinoma|locoregionally advanced nasopharyngeal carcinoma
434569|NCT01712919|cetuximab|cetuximab
434570|NCT01712919|chemoradiation|chemoradiation
434571|NCT01712893|breast cancer|breast cancer
434572|NCT01712893|adjuvant therapy|adjuvant therapy
434573|NCT01712893|Ovarian suppression|ovarian suppression
434574|NCT01712854|COPD|copd
434575|NCT01712854|Chronic Obstructive Lung Disease|chronic obstructive lung disease
434576|NCT01712854|Long acting beta agonist|long acting beta agonist
434577|NCT01712841|Dry AMD|dry amd
434578|NCT01712841|Age-related macular degeneration|age-related macular degeneration
434579|NCT01712841|Optical coherenece tomography|optical coherenece tomography
434580|NCT01712841|Imaging|imaging
434581|NCT01712841|Blood flow|blood flow
434582|NCT01712828|Lenalidomide,|lenalidomide,
434583|NCT01712828|Revlimid,|revlimid,
434584|NCT01712828|pharmacokinetics,|pharmacokinetics,
434585|NCT01712828|healthy male subjects|healthy male subjects
434586|NCT01712789|Multiple Myeloma|multiple myeloma
434587|NCT01712789|Relapsed Multiple Myeloma|relapsed multiple myeloma
434588|NCT01712789|Relapsed and refractory Multiple Myeloma|relapsed and refractory multiple myeloma
434589|NCT01712789|Pomalidomide|pomalidomide
434590|NCT01712789|Dexamethasone|dexamethasone
434591|NCT01712776|Vapocoolant|vapocoolant
434592|NCT01712763|Endometriosis|endometriosis
434593|NCT01712763|long acting GnRH antagonist|long acting gnrh antagonist
434594|NCT01712763|Degarelix|degarelix
434595|NCT01712763|Recurrence|recurrence
434596|NCT01712763|Pelvic Pain|pelvic pain
434597|NCT01712750|Regional tissue oximetry|regional tissue oximetry
434598|NCT01712750|Cardiopulmonary bypass|cardiopulmonary bypass
434599|NCT01712750|Cardiac surgical procedures|cardiac surgical procedures
434600|NCT01712737|raisins, grapes, snacks, appetite, food intake|raisins, grapes, snacks, appetite, food intake
434601|NCT01712724|exercise therapy|exercise therapy
434602|NCT01712724|rehabilitation|rehabilitation
434603|NCT01712711|Steatohepatitis,|steatohepatitis,
434604|NCT01712711|Helicobacter pylori,|helicobacter pylori,
434605|NCT01712711|Insulin resistance,|insulin resistance,
434606|NCT01712711|Alanine aminotransferase,|alanine aminotransferase,
434607|NCT01712711|Aspartate aminotransferase,|aspartate aminotransferase,
434608|NCT01712698|trauma|trauma
434609|NCT01712698|spinal cord injury|spinal cord injury
434610|NCT01712698|cervical spine|cervical spine
434611|NCT01712685|Kidney Neoplasm|kidney neoplasm
434612|NCT01712685|RCC|rcc
434613|NCT01712685|Biodistribution of 18F-VM4-037|biodistribution of 18f-vm4-037
434614|NCT01712685|CAIX Staining|caix staining
434615|NCT01712685|Tumor Angiogenesis|tumor angiogenesis
434616|NCT01712672|Dental Plaque|dental plaque
434617|NCT01712672|Biofilm|biofilm
434618|NCT01712672|Bacterial Interactions|bacterial interactions
434619|NCT01712672|Receptor Polysaccharide|receptor polysaccharide
434620|NCT01712672|Oral Streptococci|oral streptococci
434621|NCT01712659|JAK 1/2|jak 1/2
434622|NCT01712659|Human T-Cell Lymphotropic Virus 1|human t-cell lymphotropic virus 1
434623|NCT01712659|HTLV-1|htlv-1
434624|NCT01712659|Janus Kinase Inhibitor|janus kinase inhibitor
434625|NCT01712646|Oxytocin|oxytocin
434626|NCT01712646|Childhood Onset Schizophrenia|childhood onset schizophrenia
434627|NCT01712646|Double Blind|double blind
434628|NCT01712633|fMRI|fmri
434629|NCT01712633|Brain Perfusion|brain perfusion
434630|NCT01712620|Magnetic Resonance Imaging|magnetic resonance imaging
434631|NCT01712607|laparoscopy|laparoscopy
434632|NCT01712607|surgery|surgery
434633|NCT01712607|warm-up|warm-up
434634|NCT01712607|preoperative|preoperative
434635|NCT01712607|surgical skills|surgical skills
434636|NCT01712594|United Kingdom Overnight closed loop|united kingdom overnight closed loop
434637|NCT01712581|normal myocardial T1, T2 and T2* values|normal myocardial t1, t2 and t2* values
434638|NCT01712555|Anophthalmic orbits|anophthalmic orbits
434639|NCT01712555|autologous fat|autologous fat
434640|NCT01712555|platelet rich plasma|platelet rich plasma
434641|NCT01712555|orbital atrophy|orbital atrophy
434642|NCT01712555|anophthalmos|anophthalmos
434643|NCT01712555|cannula|cannula
434644|NCT01712529|Systemic lupus erythematosus|systemic lupus erythematosus
434645|NCT01712529|endothelium|endothelium
434646|NCT01712529|exercise|exercise
434647|NCT01712516|COPD, QVA149|copd, qva149
434648|NCT01712503|Cataract|cataract
434649|NCT01712503|Astigmatism|astigmatism
434650|NCT01712503|Toric|toric
434651|NCT01712503|Phacoemulsification|phacoemulsification
434652|NCT01712503|Intraocular lens|intraocular lens
434653|NCT01712490|Hodgkin Lymphoma|hodgkin lymphoma
434654|NCT01712490|Hodgkins Lymphoma|hodgkins lymphoma
434655|NCT01712490|Antibody, Monoclonal|antibody, monoclonal
434656|NCT01712490|Antibody-Drug Conjugate|antibody-drug conjugate
434657|NCT01712490|Antigens, CD-30|antigens, cd-30
434658|NCT01712490|Immunotherapy|immunotherapy
434659|NCT01712490|Lymphoma|lymphoma
434660|NCT01712490|Lymphoma, Classical|lymphoma, classical
434661|NCT01712490|ECHELON-1|echelon-1
434662|NCT01712451|adiposity|adiposity
434663|NCT01712438|Previously untreated patients|previously untreated patients
434664|NCT01712425|vaccine|vaccine
434665|NCT01712425|recently HIV-1 infected individuals|recently hiv-1 infected individuals
434666|NCT01712373|Multiple sclerosis|multiple sclerosis
434667|NCT01712373|Ginseng|ginseng
434668|NCT01712373|Fatigue|fatigue
434669|NCT01712373|Quality of life|quality of life
434670|NCT01712360|Tinea Pedis|tinea pedis
434671|NCT01712360|Tinea Cruris|tinea cruris
434672|NCT01712360|Athlete foot|athlete foot
434673|NCT01712360|Jock itch|jock itch
434674|NCT01712321|Social Anxiety Disorder|social anxiety disorder
434675|NCT01712321|Social Anxiety|social anxiety
434676|NCT01712321|Social Phobia|social phobia
434677|NCT01712321|SAD|sad
434678|NCT01712295|Warts|warts
434679|NCT01712295|salicylic acid|salicylic acid
434680|NCT01712295|ethyl pyruvate|ethyl pyruvate
434681|NCT01712282|Physical Activity|physical activity
434682|NCT01712282|Accelerometer|accelerometer
434683|NCT01712256|CD4|cd4
434684|NCT01712256|Clinical trial|clinical trial
434685|NCT01712256|Human immunodeficiency virus-1 (HIV-1)|human immunodeficiency virus-1 (hiv-1)
434686|NCT01712256|HIV|hiv
434687|NCT01712256|Immunomodulary|immunomodulary
434688|NCT01712256|Infection|infection
434689|NCT01712256|Phase II|phase ii
434690|NCT01712256|Re-boost|re-boost
434691|NCT01712256|Vaccine|vaccine
434692|NCT01712256|Vacc-4x|vacc-4x
434693|NCT01712230|hormone therapy|hormone therapy
434694|NCT01712230|obesity|obesity
434695|NCT01712230|menopause|menopause
434696|NCT01712230|disease /disorder proneness /risk|disease /disorder proneness /risk
434697|NCT01712230|insulin sensitivity /resistance|insulin sensitivity /resistance
434698|NCT01712230|metabolic syndrome|metabolic syndrome
434699|NCT01712230|women's health|women's health
434700|NCT01712217|Non-small cell lung cancer|non-small cell lung cancer
434701|NCT01712204|Prophylaxis of Acute Gout Flares|prophylaxis of acute gout flares
434702|NCT01712204|Urate-Lowering Therapy|urate-lowering therapy
434703|NCT01712204|Hyperuricemia|hyperuricemia
434704|NCT01712204|Gouty arthritis|gouty arthritis
434705|NCT01712191|NUsurface|nusurface
434706|NCT01712191|Meniscus|meniscus
434707|NCT01712191|Knee|knee
434708|NCT01712191|KOOS|koos
434709|NCT01712178|Pharmacodynamic,Pharmacokinetic|pharmacodynamic,pharmacokinetic
434710|NCT01712165|Folic acid supplement|folic acid supplement
434711|NCT01712165|Neural tube defect-affected pregnancy|neural tube defect-affected pregnancy
434712|NCT01712165|Homocysteine concentration|homocysteine concentration
434713|NCT01712165|Plasma Folate concentration|plasma folate concentration
434714|NCT01712165|Plasma vitamin B12 concentration|plasma vitamin b12 concentration
434715|NCT01712152|Duchenne muscular dystrophy|duchenne muscular dystrophy
434716|NCT01712152|carrier|carrier
434717|NCT01712152|cardiac MRI|cardiac mri
434718|NCT01712152|myocardial fibrosis|myocardial fibrosis
434719|NCT01712152|female|female
434720|NCT01712087|spasticity|spasticity
434721|NCT01712087|muscle spasticity|muscle spasticity
434722|NCT01712087|muscle rigidity|muscle rigidity
434723|NCT01712087|motor neuron disease|motor neuron disease
434724|NCT01712087|hyperreflexia|hyperreflexia
434725|NCT01712074|Randomized|randomized
434726|NCT01712074|Double Blind|double blind
434727|NCT01712074|Safety and Efficacy|safety and efficacy
434728|NCT01712061|Diabetic nephropathy|diabetic nephropathy
434729|NCT01712061|type 2 diabetes|type 2 diabetes
434730|NCT01712061|albuminuria|albuminuria
434731|NCT01712061|chemokine antagonist|chemokine antagonist
434732|NCT01712035|Wet AMD|wet amd
434733|NCT01712035|Age-related macular degeneration|age-related macular degeneration
434734|NCT01712035|Optical coherenece tomography|optical coherenece tomography
434735|NCT01712035|Imaging|imaging
434736|NCT01712035|Blood flow|blood flow
434737|NCT01712009|Breast cancer|breast cancer
434738|NCT01712009|Chemotherapy|chemotherapy
434739|NCT01712009|Neulasta|neulasta
434740|NCT01712009|Pegfilgrastim|pegfilgrastim
434741|NCT01712009|Naproxen|naproxen
434742|NCT01712009|Loratadine|loratadine
434743|NCT01712009|Non-steroidal antiinflammatory drug (NSAID)|non-steroidal antiinflammatory drug (nsaid)
434744|NCT01712009|Anti-histamine|anti-histamine
434745|NCT01712009|Bone Pain|bone pain
434746|NCT01711996|hydronephrosis|hydronephrosis
434747|NCT01711996|biopsy|biopsy
434748|NCT01711996|biomarker|biomarker
434749|NCT01711957|Complications|complications
434750|NCT01711957|Mortality|mortality
434751|NCT01711957|Liver transplantation|liver transplantation
434752|NCT01711957|Platelet count|platelet count
434753|NCT01711957|Survival|survival
434754|NCT01711944|childhood cancer|childhood cancer
434755|NCT01711944|Internet communication|internet communication
434756|NCT01711944|parents|parents
434757|NCT01711944|caregivers|caregivers
434758|NCT01711944|problem solving|problem solving
434759|NCT01711931|percutaneous coronary intervention|percutaneous coronary intervention
434760|NCT01711931|bioresorbable vascular scaffold stents|bioresorbable vascular scaffold stents
434761|NCT01711931|everolimus|everolimus
434762|NCT01711931|biolimus|biolimus
434763|NCT01711918|gastroparesis|gastroparesis
434764|NCT01711918|domperidone|domperidone
434765|NCT01711918|nausea|nausea
434766|NCT01711918|vomiting|vomiting
434767|NCT01711892|Prostatic Neoplasms|prostatic neoplasms
434768|NCT01711892|Prostate Cancer|prostate cancer
434769|NCT01711892|Exercise|exercise
434770|NCT01711892|Soccer|soccer
434771|NCT01711892|Androgen Deprivation Therapy|androgen deprivation therapy
434772|NCT01711892|Body Composition|body composition
434773|NCT01711892|Cardiovascular fitness|cardiovascular fitness
434774|NCT01711892|Bone Health|bone health
434775|NCT01711892|Health Related Quality of Life|health related quality of life
434776|NCT01711866|Rotigotine|rotigotine
434777|NCT01711866|Neupro|neupro
434778|NCT01711866|Switch|switch
434779|NCT01711866|Dopamine agonists|dopamine agonists
434780|NCT01711840|Bronchial asthma|bronchial asthma
434781|NCT01711840|Symbicort Turbuhaler|symbicort turbuhaler
434782|NCT01711827|isavuconazole|isavuconazole
434783|NCT01711827|prednisone|prednisone
434784|NCT01711827|prednisolone|prednisolone
434785|NCT01711827|BAL8557|bal8557
434786|NCT01711827|healthy volunteers|healthy volunteers
434787|NCT01711814|Rheumatoid Arthritis|rheumatoid arthritis
434788|NCT01711814|ASP015K|asp015k
434789|NCT01711788|Hematopoietic stem cells|hematopoietic stem cells
434790|NCT01711788|Umbilical cord blood transplantation|umbilical cord blood transplantation
434791|NCT01711788|Intrabone infusion|intrabone infusion
434792|NCT01711788|Platelet recovery|platelet recovery
434793|NCT01711788|Neutrophil recovery|neutrophil recovery
434794|NCT01711788|Pediatric patients|pediatric patients
434795|NCT01711736|Immunogenicity|immunogenicity
434796|NCT01711736|Children|children
434797|NCT01711736|Safety|safety
434798|NCT01711736|Seasonal influenza|seasonal influenza
434799|NCT01711736|Fluarix|fluarix
434800|NCT01711723|darapladib|darapladib
434801|NCT01711723|Lp-PLA2- inhibitor|lp-pla2- inhibitor
434802|NCT01711723|healthy volunteer|healthy volunteer
434803|NCT01711723|renal impairment|renal impairment
434804|NCT01711723|pharmacokinetics|pharmacokinetics
434805|NCT01711710|Breast cancer|breast cancer
434806|NCT01711710|reconstruction|reconstruction
434807|NCT01711710|augmentation|augmentation
434808|NCT01711710|cohesive silicone gel|cohesive silicone gel
434809|NCT01711710|breast implant|breast implant
434810|NCT01711710|rupture|rupture
434811|NCT01711710|capsular contracture|capsular contracture
434812|NCT01711684|Neoplasm Metastasis|neoplasm metastasis
434813|NCT01711684|Melanoma|melanoma
434814|NCT01711645|Acellular|acellular
434815|NCT01711645|Adacel®|adacel®
434816|NCT01711645|Diptheria toxoids|diptheria toxoids
434817|NCT01711645|Pertussis|pertussis
434818|NCT01711645|postpartum|postpartum
434819|NCT01711645|Tdap|tdap
434820|NCT01711645|Tetanus|tetanus
434821|NCT01711645|women|women
434822|NCT01711632|VEMURAFENIB|vemurafenib
434823|NCT01711632|BRAF Inhibitor|braf inhibitor
434824|NCT01711632|12-200|12-200
434825|NCT01711632|Zelboraf™|zelboraf™
434826|NCT01711606|Fragile-X Syndrome|fragile-x syndrome
434827|NCT01711606|registry|registry
434828|NCT01711606|non-interventional trial|non-interventional trial
434829|NCT01711606|patient-related outcome study|patient-related outcome study
434830|NCT01711606|drug utilization|drug utilization
434831|NCT01711606|effectiveness|effectiveness
434832|NCT01711606|treatment patterns|treatment patterns
434833|NCT01711606|patient characteristics under real life conditions|patient characteristics under real life conditions
434834|NCT01711606|quality of life|quality of life
434835|NCT01711606|economics|economics
434836|NCT01711593|Asthma|asthma
434837|NCT01711593|Allergic|allergic
434838|NCT01711593|Inflammation|inflammation
434839|NCT01711593|Airway|airway
434840|NCT01711593|Challenge|challenge
434841|NCT01711593|Chemokines|chemokines
434842|NCT01711593|Tolerization|tolerization
434843|NCT01711580|Recurrent glioma|recurrent glioma
434844|NCT01711580|Quality of life|quality of life
434845|NCT01711580|Glioblastoma multiforme|glioblastoma multiforme
434846|NCT01711580|Anaplastic glioma|anaplastic glioma
434847|NCT01711580|Cognition|cognition
434848|NCT01711580|Re-irradiation|re-irradiation
434849|NCT01711567|Chronic Hepatitis B|chronic hepatitis b
434850|NCT01711567|TENOFOVIR|tenofovir
434851|NCT01711567|ENTECAVIR|entecavir
434852|NCT01711567|PARTIAL RESPONDER|partial responder
434853|NCT01711502|metastatic breast cancer,|metastatic breast cancer,
434854|NCT01711502|epidemiology,|epidemiology,
434855|NCT01711502|retrospective cohort|retrospective cohort
434856|NCT01711489|isavuconazole|isavuconazole
434857|NCT01711489|mycophenolate mofetil (MMF)|mycophenolate mofetil (mmf)
434858|NCT01711489|BAL8557|bal8557
434859|NCT01711489|BAL4815|bal4815
434860|NCT01711489|healthy volunteers|healthy volunteers
434861|NCT01711489|Mycophenolic acid (MPA)|mycophenolic acid (mpa)
434862|NCT01711489|Phenolic glucuronide of MPA (MPAG)|phenolic glucuronide of mpa (mpag)
434863|NCT01711489|CellCept|cellcept
434864|NCT01711476|PCOS|pcos
434865|NCT01711476|Bdiet|bdiet
434866|NCT01711476|Ddiet|ddiet
434867|NCT01711476|OGTT|ogtt
434868|NCT01711463|Pharmacodynamics|pharmacodynamics
434869|NCT01711463|Fluticasone furoate (FF)|fluticasone furoate (ff)
434870|NCT01711463|novel dry powder device|novel dry powder device
434871|NCT01711463|Safety and tolerability|safety and tolerability
434872|NCT01711463|vilanterol(VI)|vilanterol(vi)
434873|NCT01711463|Healthy Chinese subjects|healthy chinese subjects
434874|NCT01711463|Pharmacokinetics|pharmacokinetics
434875|NCT01711437|colonoscopy|colonoscopy
434876|NCT01711437|colon cleansing|colon cleansing
434877|NCT01711437|children|children
434878|NCT01711437|age 2 -18 years|age 2 -18 years
434879|NCT01711411|HIV prevention|hiv prevention
434880|NCT01711411|PrePex|prepex
434881|NCT01711411|voluntary medical male circumcision|voluntary medical male circumcision
434882|NCT01711411|non-surgical|non-surgical
434883|NCT01711411|medical device|medical device
434884|NCT01711411|wound healing|wound healing
434885|NCT01711411|Kenya|kenya
434886|NCT01711398|solid tumor|solid tumor
434887|NCT01711398|peptide|peptide
434888|NCT01711385|Oral Health|oral health
434889|NCT01711385|Prediabetes|prediabetes
434890|NCT01711385|Diabetes|diabetes
434891|NCT01711385|Periodontitis|periodontitis
434892|NCT01711385|Early Identification|early identification
434893|NCT01711385|Prevention|prevention
434894|NCT01711372|ADHD|adhd
434895|NCT01711320|Omeprazole|omeprazole
434896|NCT01711320|Metformin|metformin
434897|NCT01711307|Achilles|achilles
434898|NCT01711307|Rupture|rupture
434899|NCT01711294|Pancreatic Cystic Lesions|pancreatic cystic lesions
434900|NCT01711294|PCL|pcl
434901|NCT01711294|EUS-FNA|eus-fna
434902|NCT01711281|Heart Failure|heart failure
434903|NCT01711281|Implantable Cardioverter-Defibrillator|implantable cardioverter-defibrillator
434904|NCT01711281|Intracardiac Impedance Measurement|intracardiac impedance measurement
434905|NCT01711281|Cardiac Resynchronization Therapy|cardiac resynchronization therapy
434906|NCT01711281|Home Monitoring|home monitoring
434907|NCT01711281|Reverse Remodeling|reverse remodeling
434908|NCT01711268|Sunitinib|sunitinib
434909|NCT01711268|Renal Cell Carcinoma|renal cell carcinoma
434910|NCT01711268|Therapeutic Drug Monitoring|therapeutic drug monitoring
434911|NCT01711268|Pharmacokinetic|pharmacokinetic
434912|NCT01711268|Treatment toxicity|treatment toxicity
434913|NCT01711255|Multiple sclerosis|multiple sclerosis
434914|NCT01711255|Coagulation|coagulation
434915|NCT01711255|Alternative Medicine|alternative medicine
434916|NCT01711255|Clotting|clotting
434917|NCT01711255|Complementary Medicine|complementary medicine
434918|NCT01711255|Inflammation|inflammation
434919|NCT01711242|gastric cancer|gastric cancer
434920|NCT01711242|radiotherapy|radiotherapy
434921|NCT01711242|postoperative therapy|postoperative therapy
434922|NCT01711242|chemotherapy|chemotherapy
434923|NCT01711229|oral acetaminophen|oral acetaminophen
434924|NCT01711229|IV acetaminophen|iv acetaminophen
434925|NCT01711229|Ofirmev|ofirmev
434926|NCT01711229|equianalgesic|equianalgesic
434927|NCT01711229|arthroscopic rotator cuff repair|arthroscopic rotator cuff repair
434928|NCT01711216|Dydrogesterone|dydrogesterone
434929|NCT01711216|Irregular Menstrual Cycle|irregular menstrual cycle
434930|NCT01711216|Progestins|progestins
434931|NCT01711203|Spondylolysis|spondylolysis
434932|NCT01711203|Spondylolisthesis|spondylolisthesis
434933|NCT01711203|Rehabilitation|rehabilitation
434934|NCT01711203|Physical Therapy|physical therapy
434935|NCT01711203|Children|children
434936|NCT01711190|glaucoma|glaucoma
434937|NCT01711190|trabeculectomy|trabeculectomy
434938|NCT01711190|astigmatism|astigmatism
434939|NCT01711190|intraocular pressure|intraocular pressure
434940|NCT01711177|primary open angle glaucoma|primary open angle glaucoma
434941|NCT01711177|retinal oximetry|retinal oximetry
434942|NCT01711164|HCV|hcv
434943|NCT01711164|T regulatory cells (Tregs)|t regulatory cells (tregs)
434944|NCT01711164|FGL2|fgl2
434945|NCT01711151|ILD|ild
434946|NCT01711138|Physical Activity|physical activity
434947|NCT01711138|Physical Fitness|physical fitness
434948|NCT01711138|Transportation|transportation
434949|NCT01711138|Environment Design|environment design
434950|NCT01711138|Child|child
434951|NCT01711138|Adolescent|adolescent
434952|NCT01711086|asthma|asthma
434953|NCT01711086|dry powder inhaler|dry powder inhaler
434954|NCT01711047|catheter ablation|catheter ablation
434955|NCT01711047|atrial fibrillation|atrial fibrillation
434956|NCT01711047|pulmonary vein isolation|pulmonary vein isolation
434957|NCT01711047|linear ablation|linear ablation
434958|NCT01711047|CFAE ablation|cfae ablation
434959|NCT01711034|Solid tumors|solid tumors
434960|NCT01711021|ADHD|adhd
434961|NCT01711008|Breakfast size|breakfast size
434962|NCT01711008|Exercise|exercise
434963|NCT01711008|Cognitive performance|cognitive performance
434964|NCT01711008|Mood|mood
434965|NCT01711008|Appetite|appetite
434966|NCT01711008|Active women|active women
434967|NCT01710956|concurrent chemoradiation in patients with limited disease small cell lung cancer|concurrent chemoradiation in patients with limited disease small cell lung cancer
434968|NCT01710943|Web-based CBT|web-based cbt
434969|NCT01710943|PTSD|ptsd
434970|NCT01710943|Alcohol Misuse|alcohol misuse
434971|NCT01710943|Substance Misuse|substance misuse
434972|NCT01710943|Integrated Primary Care|integrated primary care
434973|NCT01710943|OEF/OIF Veterans|oef/oif veterans
434974|NCT01710930|Allergic Broncho-Pulmonary Aspergillosis|allergic broncho-pulmonary aspergillosis
434975|NCT01710917|Chronic pain|chronic pain
434976|NCT01710917|Severe pain|severe pain
434977|NCT01710917|Oxycodon|oxycodon
434978|NCT01710917|Naloxon|naloxon
434979|NCT01710917|Opioid-induced constipation|opioid-induced constipation
434980|NCT01710917|Opioid|opioid
434981|NCT01710917|Quality of life|quality of life
434982|NCT01710917|Laxative|laxative
434983|NCT01710917|Analgesic rescue medication|analgesic rescue medication
434984|NCT01710904|Chronic pain|chronic pain
434985|NCT01710904|Severe pain|severe pain
434986|NCT01710904|Oxycodone|oxycodone
434987|NCT01710904|Naloxone|naloxone
434988|NCT01710904|Opioid-induced constipation|opioid-induced constipation
434989|NCT01710904|Opioid|opioid
434990|NCT01710904|Quality of life|quality of life
434991|NCT01710904|Laxative|laxative
434992|NCT01710904|Analgesic rescue medication|analgesic rescue medication
434993|NCT01710891|endotracheal intubation|endotracheal intubation
434994|NCT01710891|direct laryngoscopy|direct laryngoscopy
434995|NCT01710891|video laryngoscopy|video laryngoscopy
434996|NCT01710865|Caries prevention|caries prevention
434997|NCT01710865|pit and fissure sealants|pit and fissure sealants
434998|NCT01710852|Atrial Fibrillation|atrial fibrillation
434999|NCT01710852|Paroxysmal Atrial Fibrillation|paroxysmal atrial fibrillation
435000|NCT01710852|AF|af
435001|NCT01710839|CRVO|crvo
435002|NCT01710839|BRVO|brvo
435003|NCT01710839|HRVO|hrvo
435004|NCT01710839|Macular edema|macular edema
435005|NCT01710839|vein occlusion|vein occlusion
435006|NCT01710813|pompe disease|pompe disease
435007|NCT01710813|alglucosidase alfa|alglucosidase alfa
435008|NCT01710813|anaphylaxis|anaphylaxis
435009|NCT01710813|severe cutaneous|severe cutaneous
435010|NCT01710813|systemic immune complex-mediated reactions|systemic immune complex-mediated reactions
435011|NCT01710800|impedance|impedance
435012|NCT01710800|reflux|reflux
435013|NCT01710800|GERD|gerd
435014|NCT01710787|operative|operative
435015|NCT01710787|dental procedure|dental procedure
435016|NCT01710774|Diabetic Foot|diabetic foot
435017|NCT01710774|Diabetes Mellitus|diabetes mellitus
435018|NCT01710774|Foot Ulcer|foot ulcer
435019|NCT01710774|Wound Healing|wound healing
435020|NCT01710774|Delivery of Health Care|delivery of health care
435021|NCT01710774|Depression|depression
435022|NCT01710774|sequela|sequela
435023|NCT01710774|Sick Leave|sick leave
435024|NCT01710774|Quality of Life|quality of life
435025|NCT01710774|Amputation|amputation
435026|NCT01710774|Legg ulcer|legg ulcer
435027|NCT01710761|nitric oxide|nitric oxide
435028|NCT01710761|cycling performance|cycling performance
435029|NCT01710761|lactate|lactate
435030|NCT01710761|VO2|vo2
435031|NCT01710748|Percutaneous coronary intervention|percutaneous coronary intervention
435032|NCT01710748|Drug eluting stent|drug eluting stent
435033|NCT01710748|Neointimal hyperplasia|neointimal hyperplasia
435034|NCT01710748|Diabetes Mellitus|diabetes mellitus
435035|NCT01710735|TP|tp
435036|NCT01710735|Myofascial pain|myofascial pain
435037|NCT01710709|Aripiprazole, Intramuscular (IM) Depot, Bipolar|aripiprazole, intramuscular (im) depot, bipolar
435038|NCT01710683|Discectomy|discectomy
435039|NCT01710683|1st postoperative day|1st postoperative day
435040|NCT01710683|Intensive exercise training|intensive exercise training
435041|NCT01710683|Randomized controlled trial|randomized controlled trial
435042|NCT01710670|Brivaracetam|brivaracetam
435043|NCT01710670|Ethanol|ethanol
435044|NCT01710670|Pharmacodynamics|pharmacodynamics
435045|NCT01710670|Pharmacokinetic|pharmacokinetic
435046|NCT01710670|Interaction|interaction
435047|NCT01710657|Lacosamide|lacosamide
435048|NCT01710657|Epilepsy|epilepsy
435049|NCT01710657|Partial Onset Seizures|partial onset seizures
435050|NCT01710631|Sleep|sleep
435051|NCT01710618|Protein Expression of Sciatic Nerve|protein expression of sciatic nerve
435052|NCT01710618|traumatized sciatic nerve|traumatized sciatic nerve
435053|NCT01710605|Circulating tumor cells|circulating tumor cells
435054|NCT01710605|Breast Cancer|breast cancer
435055|NCT01710605|Hormone-receptors positive|hormone-receptors positive
435056|NCT01710579|Primary esophageal achalasia|primary esophageal achalasia
435057|NCT01710579|endoscopic myotomy|endoscopic myotomy
435058|NCT01710579|high resolution manometry|high resolution manometry
435059|NCT01710566|Postpartum hemorrhage|postpartum hemorrhage
435060|NCT01710566|prevention|prevention
435061|NCT01710566|oxytocin|oxytocin
435062|NCT01710566|misoprostol|misoprostol
435063|NCT01710566|Uniject|uniject
435064|NCT01710566|community|community
435065|NCT01710527|Healthy Volunteers|healthy volunteers
435066|NCT01710488|COPD exacerbation|copd exacerbation
435067|NCT01710488|fluoroquinolones,|fluoroquinolones,
435068|NCT01710449|Lung Transplant|lung transplant
435069|NCT01710423|Obesity|obesity
435070|NCT01710423|Nutrition|nutrition
435071|NCT01710423|Home Food Preparation|home food preparation
435072|NCT01710423|Peer Mentoring|peer mentoring
435073|NCT01710423|Early Head Start|early head start
435074|NCT01710423|Cooking|cooking
435075|NCT01710423|Diet|diet
435076|NCT01710410|transcranial direct current stimulation|transcranial direct current stimulation
435077|NCT01710410|nicotine dependence|nicotine dependence
435078|NCT01710410|dorsolateral prefrontal cortex|dorsolateral prefrontal cortex
435079|NCT01710410|nicotine replacement therapy|nicotine replacement therapy
435080|NCT01710410|nicotine patch|nicotine patch
435081|NCT01710410|addiction|addiction
435082|NCT01710410|smoking cessation|smoking cessation
435083|NCT01710410|neuroplasticity|neuroplasticity
435084|NCT01710397|Antiretroviral therapy|antiretroviral therapy
435085|NCT01710397|South Africa|south africa
435086|NCT01710384|late preterm, betamethasone,|late preterm, betamethasone,
435087|NCT01710332|Persistent|persistent
435088|NCT01710332|Central|central
435089|NCT01710332|Serous|serous
435090|NCT01710332|Chorioretinopathy|chorioretinopathy
435091|NCT01710332|Regeneron|regeneron
435092|NCT01710332|CSR|csr
435093|NCT01710332|CSCR|cscr
435094|NCT01710319|Immunoregulation|immunoregulation
435095|NCT01710319|Natural Killer Cells|natural killer cells
435096|NCT01710306|Women|women
435097|NCT01710306|Veterans|veterans
435098|NCT01710306|PTSD|ptsd
435099|NCT01710306|Access to Care|access to care
435100|NCT01710306|Shared Decision Making|shared decision making
435101|NCT01710293|Electronic Health Records|electronic health records
435102|NCT01710293|Diagnostic Delay|diagnostic delay
435103|NCT01710293|Triggers|triggers
435104|NCT01710280|Lipemia|lipemia
435105|NCT01710280|Vascular function|vascular function
435106|NCT01710280|Blood pressure|blood pressure
435108|NCT01710254|Atrial Fibrillation|atrial fibrillation
435109|NCT01710228|MS|ms
435110|NCT01710228|Natalizumab|natalizumab
435111|NCT01710228|copaxone|copaxone
435112|NCT01710215|Colorectal Neoplasms|colorectal neoplasms
435113|NCT01710215|Colorectal Cancer|colorectal cancer
435114|NCT01710215|Colon Cancer|colon cancer
435115|NCT01710215|Mass Screening|mass screening
435116|NCT01710215|Health Services Research|health services research
435117|NCT01710215|Comparative Effectiveness Research|comparative effectiveness research
435118|NCT01710202|Hydrocortisone|hydrocortisone
435119|NCT01710202|Cortisol|cortisol
435120|NCT01710202|Testosterone|testosterone
435121|NCT01710202|Stress|stress
435122|NCT01710202|Serotonin|serotonin
435123|NCT01710202|5-HTTLPR|5-httlpr
435124|NCT01710202|Amygdala|amygdala
435125|NCT01710202|Depression|depression
435126|NCT01710189|Tick-Borne Encephalitis Virus|tick-borne encephalitis virus
435127|NCT01710163|Lithium Carbonate|lithium carbonate
435128|NCT01710163|Lithium|lithium
435129|NCT01710163|Central Nervous System Agents|central nervous system agents
435130|NCT01710163|Therapeutic Uses|therapeutic uses
435131|NCT01710163|Pharmacologic Actions|pharmacologic actions
435132|NCT01710163|Enzyme Inhibitors|enzyme inhibitors
435133|NCT01710163|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action
435134|NCT01710163|Neurotransmitter Agents|neurotransmitter agents
435135|NCT01710163|Physiological Effects of Drugs|physiological effects of drugs
435136|NCT01710163|Antimanic Agents|antimanic agents
435137|NCT01710163|Tranquilizing Agents|tranquilizing agents
435138|NCT01710163|Central Nervous System Depressants|central nervous system depressants
435139|NCT01710163|Psychotropic Drugs|psychotropic drugs
435140|NCT01710163|Sensory System Agents|sensory system agents
435141|NCT01710163|Antipsychotic Agents|antipsychotic agents
435142|NCT01710163|Antidepressive Agents|antidepressive agents
435143|NCT01710150|typical aflutter (AFLT)|typical aflutter (aflt)
435144|NCT01710150|CTI ablation|cti ablation
435145|NCT01710150|Atrial Fibrillation (AF)|atrial fibrillation (af)
435146|NCT01710150|PVI|pvi
435147|NCT01710137|Smoking cessation|smoking cessation
435148|NCT01710137|Nicotine dependence|nicotine dependence
435149|NCT01710137|Varenicline|varenicline
435150|NCT01710137|Chantix|chantix
435151|NCT01710137|HIV|hiv
435152|NCT01710137|AIDS|aids
435153|NCT01710124|grocery purchases|grocery purchases
435154|NCT01710124|financial incentives|financial incentives
435155|NCT01710124|obesogenic home food environment|obesogenic home food environment
435156|NCT01710111|Human challenge model|human challenge model
435157|NCT01710111|Quarantine study|quarantine study
435158|NCT01710111|Influenza virus|influenza virus
435159|NCT01710111|Modes of transmission|modes of transmission
435160|NCT01710111|Droplet spray|droplet spray
435161|NCT01710111|Droplet nuclei|droplet nuclei
435162|NCT01710111|Secondary attack rate|secondary attack rate
435163|NCT01710111|Face shield|face shield
435164|NCT01710111|Hand hygiene|hand hygiene
435165|NCT01710111|Fomites|fomites
435166|NCT01710111|Environmental deposition|environmental deposition
435167|NCT01710111|Environmental dispersion|environmental dispersion
435168|NCT01710098|testosterone|testosterone
435169|NCT01710098|S3-Adherence|s3-adherence
435170|NCT01710098|Quality of Life|quality of life
435171|NCT01710085|Diffusion weighted MRI|diffusion weighted mri
435172|NCT01710085|Curative surgery|curative surgery
435173|NCT01710085|Recurrence|recurrence
435174|NCT01710072|aneurysm, inflammation, MRI|aneurysm, inflammation, mri
435175|NCT01710059|Health Status Disparities|health status disparities
435176|NCT01710059|Minority Health|minority health
435177|NCT01710059|Pediatrics|pediatrics
435178|NCT01710059|Behavioral Intervention|behavioral intervention
435179|NCT01710059|Cellular Phone|cellular phone
435180|NCT01710059|Peer Group|peer group
435181|NCT01710046|plaque psoriasis|plaque psoriasis
435182|NCT01710046|tofacitinib|tofacitinib
435183|NCT01710046|biopsy|biopsy
435184|NCT01710046|Janus Kinase|janus kinase
435185|NCT01710046|randomized placebo controlled clinical trial|randomized placebo controlled clinical trial
435186|NCT01710046|psoriasis vulgaris|psoriasis vulgaris
435187|NCT01710033|CP-690,550|cp-690,550
435188|NCT01710033|kidney transplant|kidney transplant
435189|NCT01710020|CP-690|cp-690
435190|NCT01710020|550|550
435191|NCT01710020|pharmacokinetics|pharmacokinetics
435192|NCT01710020|end-stage renal disease|end-stage renal disease
435193|NCT01710007|HMG-CoA reductase inhibitors|hmg-coa reductase inhibitors
435194|NCT01709994|cardiovascular events|cardiovascular events
435195|NCT01709994|chronic kidney disease|chronic kidney disease
435196|NCT01709994|bleedings|bleedings
435197|NCT01709994|progression|progression
435198|NCT01709994|antiinflammatory effects|antiinflammatory effects
435199|NCT01709968|Nocturnal Leg Cramps|nocturnal leg cramps
435200|NCT01709968|Quality of life|quality of life
435201|NCT01709968|Quality of sleep|quality of sleep
435202|NCT01709955|Obesity|obesity
435203|NCT01709955|Overweight|overweight
435204|NCT01709955|Glucomannan|glucomannan
435205|NCT01709942|GnRH antagonist|gnrh antagonist
435206|NCT01709942|PCOS|pcos
435207|NCT01709942|OHSS|ohss
435208|NCT01709942|COH|coh
435209|NCT01709942|IVF|ivf
435210|NCT01709916|Glaucoma|glaucoma
435211|NCT01709916|intra ocular pressure|intra ocular pressure
435212|NCT01709916|diurnal fluctuations|diurnal fluctuations
435213|NCT01709903|chronic obstructive pulmonary disease|chronic obstructive pulmonary disease
435214|NCT01709877|Multiport laparoscopy|multiport laparoscopy
435215|NCT01709877|Single Port Laparoscopy|single port laparoscopy
435216|NCT01709877|Symptomatic Gallstones|symptomatic gallstones
435217|NCT01709864|Anticholinergic|anticholinergic
435218|NCT01709864|Antimuscarinic|antimuscarinic
435219|NCT01709864|Chronic Obstructive Airway Disease|chronic obstructive airway disease
435220|NCT01709864|Chronic Obstructive Lung Disease|chronic obstructive lung disease
435221|NCT01709864|Chronic Obstructive Pulmonary Disease|chronic obstructive pulmonary disease
435222|NCT01709864|COPD|copd
435223|NCT01709864|LAMA|lama
435224|NCT01709864|Lung Disease|lung disease
435225|NCT01709864|Lung Diseases, Obstructive|lung diseases, obstructive
435226|NCT01709864|Lung Function|lung function
435227|NCT01709864|Muscarinic receptor antagonist|muscarinic receptor antagonist
435228|NCT01709864|Pulmonary Disease, Chronic Obstructive|pulmonary disease, chronic obstructive
435229|NCT01709864|Respiratory Tract Diseases|respiratory tract diseases
435230|NCT01709851|Type 1 diabetes|type 1 diabetes
435231|NCT01709851|Intravascular continuous glucose monitoring|intravascular continuous glucose monitoring
435232|NCT01709851|Subcutaneous continuous glucose monitoring|subcutaneous continuous glucose monitoring
435233|NCT01709838|Non-transfusion dependent thalassemia|non-transfusion dependent thalassemia
435234|NCT01709838|NTDT|ntdt
435235|NCT01709838|deferasirox|deferasirox
435236|NCT01709838|ICL670|icl670
435237|NCT01709838|LIC|lic
435238|NCT01709838|Liver Iron Concentration|liver iron concentration
435239|NCT01709825|probiotics|probiotics
435240|NCT01709825|cold|cold
435241|NCT01709825|flu|flu
435242|NCT01709825|immune function|immune function
435243|NCT01709825|microbiota|microbiota
435244|NCT01709799|Cognitive Training|cognitive training
435245|NCT01709799|Aging|aging
435246|NCT01709799|Seniors|seniors
435247|NCT01709786|Hemorrhage|hemorrhage
435248|NCT01709786|Hemoglobin|hemoglobin
435249|NCT01709786|Non-invasive monitoring|non-invasive monitoring
435250|NCT01709786|Medical device accuracy|medical device accuracy
435251|NCT01709760|ENIA11|enia11
435252|NCT01709760|MTX|mtx
435253|NCT01709760|RA|ra
435254|NCT01709760|TNF|tnf
435255|NCT01709747|Hydromorphone Hydrochloride|hydromorphone hydrochloride
435256|NCT01709747|Hydromorphone|hydromorphone
435257|NCT01709747|Pain|pain
435258|NCT01709747|Chronic Pain|chronic pain
435259|NCT01709747|Implantable Pump|implantable pump
435260|NCT01709747|Pump|pump
435261|NCT01709747|Intrathecal|intrathecal
435262|NCT01709734|prostate cancer CRPC|prostate cancer crpc
435263|NCT01709721|Hydromorphone|hydromorphone
435264|NCT01709721|Hydromorphone Hydrochloride|hydromorphone hydrochloride
435265|NCT01709721|Pain Management|pain management
435266|NCT01709721|Non-narcotic analgesics|non-narcotic analgesics
435267|NCT01709708|Migraine|migraine
435268|NCT01709708|Headache|headache
435269|NCT01709708|Chronic Migraine|chronic migraine
435270|NCT01709708|Marcaine|marcaine
435271|NCT01709708|Tx360|tx360
435272|NCT01709695|Intuniv|intuniv
435273|NCT01709695|Attention Deficit Hyperactivity Disorder|attention deficit hyperactivity disorder
435274|NCT01709695|fMRI|fmri
435275|NCT01709682|atrial fibrillation|atrial fibrillation
435276|NCT01709682|arrhythmias|arrhythmias
435277|NCT01709682|anti-arrhythmic agents|anti-arrhythmic agents
435278|NCT01709669|acute coronary syndrome|acute coronary syndrome
435279|NCT01709669|gratitude|gratitude
435280|NCT01709669|health behavior|health behavior
435281|NCT01709669|myocardial infarction|myocardial infarction
435282|NCT01709669|unstable angina|unstable angina
435283|NCT01709617|carbohydrate, glycogen, glucose|carbohydrate, glycogen, glucose
435284|NCT01709604|acute paraquat poisoning|acute paraquat poisoning
435285|NCT01709604|hemoperfusion|hemoperfusion
435286|NCT01709604|continuous blood purification|continuous blood purification
435287|NCT01709591|intrapartum pain management, epidural|intrapartum pain management, epidural
435288|NCT01709565|Sepsis|sepsis
435289|NCT01709565|Lactic acid|lactic acid
435290|NCT01709565|Shock|shock
435291|NCT01709565|Resuscitation|resuscitation
435292|NCT01709539|Cancer diagnosis center|cancer diagnosis center
435293|NCT01709539|Time to diagnosis|time to diagnosis
435294|NCT01709539|Survival|survival
435295|NCT01709539|Health economics|health economics
435296|NCT01709539|Biomarkers|biomarkers
435297|NCT01709526|Psychosocial functioning|psychosocial functioning
435404|NCT01709058|Injections, Intramuscular|injections, intramuscular
435298|NCT01709526|Cognitive performance of inpatients|cognitive performance of inpatients
435299|NCT01709526|Psychiatric diseases|psychiatric diseases
435300|NCT01709487|HIPEC|hipec
435301|NCT01709487|ovarian carcinoma|ovarian carcinoma
435302|NCT01709487|Bordet|bordet
435303|NCT01709474|SLE|sle
435304|NCT01709474|Vitamin D3|vitamin d3
435305|NCT01709474|Vitamin D deficiency|vitamin d deficiency
435306|NCT01709474|IFN alpha expression|ifn alpha expression
435307|NCT01709448|Neoplasms, Squamous Cell|neoplasms, squamous cell
435308|NCT01709448|Papillomavirus Infections|papillomavirus infections
435309|NCT01709448|HIV|hiv
435310|NCT01709422|Propofol|propofol
435311|NCT01709422|Midazolam|midazolam
435312|NCT01709422|Meperidine|meperidine
435313|NCT01709409|Prematurity|prematurity
435314|NCT01709383|Aphasia|aphasia
435315|NCT01709383|Stroke|stroke
435316|NCT01709383|Transcranial Direct Current Stimulation|transcranial direct current stimulation
435317|NCT01709383|Neuroplasticity|neuroplasticity
435318|NCT01709357|manual therapy|manual therapy
435319|NCT01709357|trigger point|trigger point
435320|NCT01709357|range of motion|range of motion
435321|NCT01709357|pain threshold|pain threshold
435322|NCT01709357|pain perception|pain perception
435323|NCT01709292|Thyroid Cancer|thyroid cancer
435324|NCT01709292|ERK|erk
435325|NCT01709292|Extracellular-signal-regulated kinase|extracellular-signal-regulated kinase
435326|NCT01709292|Biomarkers|biomarkers
435327|NCT01709292|Papillary thyroid cancer|papillary thyroid cancer
435328|NCT01709292|PTC|ptc
435329|NCT01709292|BRAF mutated|braf mutated
435330|NCT01709292|Vemurafenib|vemurafenib
435331|NCT01709292|PLX4032|plx4032
435332|NCT01709292|RO5185426|ro5185426
435333|NCT01709292|Zelboraf™|zelboraf™
435334|NCT01709279|Ischemic heart failure|ischemic heart failure
435335|NCT01709279|Myocardial regeneration|myocardial regeneration
435336|NCT01709279|ADRC|adrc
435337|NCT01709253|hpofractionation study using proton beam therapy|hpofractionation study using proton beam therapy
435338|NCT01709240|Chitosan|chitosan
435339|NCT01709240|Plasma|plasma
435340|NCT01709240|Incision Closure|incision closure
435341|NCT01709227|Acute kidney injury|acute kidney injury
435342|NCT01709227|AKI|aki
435343|NCT01709227|cardiopulmonary bypass|cardiopulmonary bypass
435344|NCT01709214|Osteoarthritis|osteoarthritis
435345|NCT01709214|Knee|knee
435346|NCT01709214|Pain|pain
435348|NCT01709214|OA|oa
435349|NCT01709214|Arthritis|arthritis
435350|NCT01709201|Alcohol abuse|alcohol abuse
435351|NCT01709201|Drug abuse|drug abuse
435352|NCT01709201|Diabetes Mellitus|diabetes mellitus
435353|NCT01709201|Persistent Asthma|persistent asthma
435354|NCT01709201|Juvenile Arthritis|juvenile arthritis
435355|NCT01709201|Ulcerative Colitis|ulcerative colitis
435356|NCT01709188|Musical Dual Task Training|musical dual task training
435357|NCT01709188|dementia|dementia
435358|NCT01709188|attention control|attention control
435359|NCT01709188|dual task cost|dual task cost
435360|NCT01709188|gait stability|gait stability
435361|NCT01709175|Cancer|cancer
435362|NCT01709175|Breast Cancer|breast cancer
435363|NCT01709175|Gynecologic Cancer|gynecologic cancer
435364|NCT01709175|Strength Training|strength training
435365|NCT01709175|Exercise|exercise
435366|NCT01709175|Physical Activity|physical activity
435367|NCT01709175|Fatigue|fatigue
435368|NCT01709175|Quality of Life|quality of life
435369|NCT01709175|Strength|strength
435370|NCT01709175|Fitness|fitness
435371|NCT01709175|Cancer Survivor|cancer survivor
435372|NCT01709175|Survivor|survivor
435373|NCT01709123|Diabetes Mellitus, Juvenile Onset|diabetes mellitus, juvenile onset
435374|NCT01709123|Cardiovascular Diseases|cardiovascular diseases
435375|NCT01709123|Hyperglycemia|hyperglycemia
435376|NCT01709123|Hyperketonemia|hyperketonemia
435377|NCT01709110|Bone Loss|bone loss
435378|NCT01709110|Vertebral fractures|vertebral fractures
435379|NCT01709097|Adherence|adherence
435380|NCT01709097|Compliance|compliance
435381|NCT01709097|Kidney Transplant Recipient|kidney transplant recipient
435382|NCT01709097|An electronic drug dispenser|an electronic drug dispenser
435383|NCT01709097|The Portal|the portal
435384|NCT01709084|Human immunodeficiency virus-type 1 infection|human immunodeficiency virus-type 1 infection
435385|NCT01709084|HIV-1|hiv-1
435386|NCT01709084|Infectious diseases|infectious diseases
435387|NCT01709084|Ribonucleic acid|ribonucleic acid
435388|NCT01709084|RNA|rna
435389|NCT01709084|Tenofovir disoproxil fumarate|tenofovir disoproxil fumarate
435390|NCT01709084|Emtricitabine|emtricitabine
435391|NCT01709084|Rilpivirine|rilpivirine
435392|NCT01709084|Efavirenz|efavirenz
435393|NCT01709084|Edurant|edurant
435394|NCT01709084|TMC278|tmc278
435395|NCT01709084|R278474|r278474
435396|NCT01709084|Fixed dose combination|fixed dose combination
435397|NCT01709071|Vaccination|vaccination
435398|NCT01709071|Inactivated poliomyelitis vaccine|inactivated poliomyelitis vaccine
435399|NCT01709071|poliomyelitis|poliomyelitis
435400|NCT01709071|Sabin strains|sabin strains
435401|NCT01709058|Back Pain|back pain
435402|NCT01709058|Therapeutics|therapeutics
435403|NCT01709058|Aged|aged
435406|NCT01709058|Ozone|ozone
435407|NCT01709058|Geriatric Assessment|geriatric assessment
435408|NCT01709058|Trace Elements|trace elements
435409|NCT01709058|Oxidative stress|oxidative stress
435410|NCT01709045|Endarterectomy, Carotid|endarterectomy, carotid
435411|NCT01709045|Carotid Arteries|carotid arteries
435412|NCT01709032|Thalassemia|thalassemia
435413|NCT01709032|Chelation|chelation
435414|NCT01709032|Transfusion|transfusion
435415|NCT01709032|Safety|safety
435416|NCT01709006|Head and neck cancer|head and neck cancer
435417|NCT01708980|Arthroplasty, Replacement, Knee|arthroplasty, replacement, knee
435418|NCT01708980|Electromyography|electromyography
435419|NCT01708980|Resistance training|resistance training
435420|NCT01708980|Physical Therapy Modalities|physical therapy modalities
435421|NCT01708967|transnasal endoscopy|transnasal endoscopy
435422|NCT01708967|pretreatment method|pretreatment method
435423|NCT01708928|Ulthera® System|ulthera® system
435424|NCT01708928|Ultherapy™ Treatment|ultherapy™ treatment
435425|NCT01708928|Ulthera, Inc.|ulthera, inc.
435426|NCT01708928|Ultrasound treatment for skin tightening|ultrasound treatment for skin tightening
435427|NCT01708876|uncomplicated|uncomplicated
435428|NCT01708876|plasmodium|plasmodium
435429|NCT01708876|knowlesi|knowlesi
435430|NCT01708876|malaria|malaria
435431|NCT01708876|infection|infection
435432|NCT01708863|Hypoplastic Left Heart Syndrome|hypoplastic left heart syndrome
435433|NCT01708863|Stage II palliative surgery|stage ii palliative surgery
435434|NCT01708863|Glenn procedure|glenn procedure
435435|NCT01708863|Congenital heart defect|congenital heart defect
435436|NCT01708863|Congenital heart disease|congenital heart disease
435437|NCT01708863|Underdeveloped left ventricle|underdeveloped left ventricle
435438|NCT01708837|Postoperative Cognitive Dysfunction|postoperative cognitive dysfunction
435439|NCT01708837|Bispectral index|bispectral index
435440|NCT01708824|colorectal cancer|colorectal cancer
435441|NCT01708824|cancer survivor|cancer survivor
435442|NCT01708824|western pattern diet|western pattern diet
435443|NCT01708824|physical activity|physical activity
435444|NCT01708824|behavioral intervention|behavioral intervention
435445|NCT01708824|acceptability|acceptability
435446|NCT01708824|feasibility|feasibility
435447|NCT01708824|randomized controlled trial|randomized controlled trial
435448|NCT01708824|compliance|compliance
435449|NCT01708811|Contractility|contractility
435450|NCT01708811|human|human
435451|NCT01708811|myometrium|myometrium
435452|NCT01708811|hyponatraemia|hyponatraemia
435453|NCT01708798|Diastolic heart failure|diastolic heart failure
435454|NCT01708785|obesity|obesity
435455|NCT01708785|overweight|overweight
435456|NCT01708785|overweight children|overweight children
435457|NCT01708785|overweight parents|overweight parents
435458|NCT01708785|overeating|overeating
435459|NCT01708785|eating in the absence of hunger|eating in the absence of hunger
435460|NCT01708785|families with overweight child|families with overweight child
435461|NCT01708785|body mass index|body mass index
435462|NCT01708785|BMI|bmi
435463|NCT01708785|weight|weight
435464|NCT01708785|childhood obesity|childhood obesity
435465|NCT01708785|treatment|treatment
435466|NCT01708785|cue exposure treatment|cue exposure treatment
435467|NCT01708785|cravings|cravings
435468|NCT01708785|habituation to food cues|habituation to food cues
435469|NCT01708785|psychophysiological response to food cues|psychophysiological response to food cues
435470|NCT01708785|intervention|intervention
435471|NCT01708785|experiments|experiments
435472|NCT01708785|family based treatment|family based treatment
435473|NCT01708785|behavioral treatment|behavioral treatment
435474|NCT01708772|TNF alpha|tnf alpha
435475|NCT01708772|SOFA score|sofa score
435476|NCT01708759|Serum Il-8|serum il-8
435477|NCT01708759|IL8 polymorphism|il8 polymorphism
435478|NCT01708759|critically ill patients|critically ill patients
435479|NCT01708733|HCV carrier|hcv carrier
435480|NCT01708733|Chinese herbal medicine|chinese herbal medicine
435481|NCT01708733|Liver function|liver function
435482|NCT01708733|HCV RNA titer|hcv rna titer
435483|NCT01708720|Vaccination|vaccination
435484|NCT01708720|Inactivated Poliomyelitis Vaccine|inactivated poliomyelitis vaccine
435485|NCT01708720|Polio|polio
435486|NCT01708720|Sabin|sabin
435487|NCT01708681|Seafood|seafood
435488|NCT01708681|Meat|meat
435489|NCT01708681|Egg|egg
435490|NCT01708681|Milk|milk
435491|NCT01708681|Postprandial lipid metabolism|postprandial lipid metabolism
435492|NCT01708681|Postprandial glucose metabolism|postprandial glucose metabolism
435493|NCT01708681|Triglycerides|triglycerides
435494|NCT01708681|Cholesterol|cholesterol
435495|NCT01708681|Postprandial incretins|postprandial incretins
435496|NCT01708681|Postprandial hormones|postprandial hormones
435497|NCT01708668|Fever|fever
435498|NCT01708668|Patient controlled epidural analgesia|patient controlled epidural analgesia
435499|NCT01708668|Labor analgesia|labor analgesia
435500|NCT01708668|Epidural analgesia|epidural analgesia
435501|NCT01708668|Combined spinal-epidural analgesia|combined spinal-epidural analgesia
435502|NCT01708655|Cystic Fibrosis|cystic fibrosis
435503|NCT01708655|Sweat Evaporimeter|sweat evaporimeter
435504|NCT01708629|psoriasis, brodalumab, AMG 827|psoriasis, brodalumab, amg 827
435505|NCT01708603|psoriasis, brodalumab, AMG 827|psoriasis, brodalumab, amg 827
435506|NCT01708590|psoriasis, brodalumab (AMG 827)|psoriasis, brodalumab (amg 827)
435507|NCT01708577|heart rate|heart rate
435508|NCT01708577|sweating|sweating
435509|NCT01708577|respiration|respiration
435510|NCT01708577|acceleration of body movement|acceleration of body movement
435511|NCT01708577|heart activity.|heart activity.
435512|NCT01708551|Hyperhidrosis|hyperhidrosis
435513|NCT01708551|Axillary sweating|axillary sweating
435514|NCT01708551|Ulthera® System|ulthera® system
435515|NCT01708551|Ultherapy™ Treatment|ultherapy™ treatment
435516|NCT01708551|Ulthera, Inc.|ulthera, inc.
435517|NCT01708538|keratoconus, corneal collagen crosslinking, riboflavin, corneal ectasia|keratoconus, corneal collagen crosslinking, riboflavin, corneal ectasia
435518|NCT01708525|Ulthera® System|ulthera® system
435519|NCT01708525|Ultherapy® Treatment|ultherapy® treatment
435520|NCT01708525|Ulthera, Inc.|ulthera, inc.
435521|NCT01708525|Ultrasound treatment for skin tightening|ultrasound treatment for skin tightening
435522|NCT01708512|Ulthera® System|ulthera® system
435523|NCT01708512|Ultherapy™ Treatment|ultherapy™ treatment
435524|NCT01708512|Ulthera, Inc.|ulthera, inc.
435525|NCT01708512|Ultrasound treatment for skin tightening|ultrasound treatment for skin tightening
435526|NCT01708499|Ulthera® System|ulthera® system
435527|NCT01708499|Ultherapy™ Treatment|ultherapy™ treatment
435528|NCT01708499|Ulthera, Inc.|ulthera, inc.
435529|NCT01708499|Ultrasound treatment for skin tightening|ultrasound treatment for skin tightening
435530|NCT01708486|asthma|asthma
435531|NCT01708486|Dry Powder Inhalers|dry powder inhalers
435532|NCT01708486|FSI-10 questionnaire|fsi-10 questionnaire
435533|NCT01708460|Ulthera® System|ulthera® system
435534|NCT01708460|Ultherapy™ Treatment|ultherapy™ treatment
435535|NCT01708460|Ulthera, Inc.|ulthera, inc.
435536|NCT01708460|Ultrasound treatment for skin tightening|ultrasound treatment for skin tightening
435537|NCT01708434|Skin laxity|skin laxity
435538|NCT01708434|Knees|knees
435539|NCT01708408|biorepository|biorepository
435540|NCT01708408|biobank|biobank
435541|NCT01708408|registry|registry
435542|NCT01708408|community|community
435543|NCT01708408|biospecimens|biospecimens
435544|NCT01708408|volunteers|volunteers
435545|NCT01708408|chronic disease|chronic disease
435546|NCT01708408|longitudinal|longitudinal
435547|NCT01708408|blood|blood
435548|NCT01708408|electronic health records|electronic health records
435549|NCT01708408|follow-up|follow-up
435550|NCT01708395|Ulcerative colitis|ulcerative colitis
435551|NCT01708382|Ulthera® System|ulthera® system
435552|NCT01708382|Ultherapy™ Treatment|ultherapy™ treatment
435553|NCT01708382|Ulthera, Inc.|ulthera, inc.
435554|NCT01708382|Ultrasound treatment for skin tightening|ultrasound treatment for skin tightening
435555|NCT01708369|human carboxylesterase-1|human carboxylesterase-1
435556|NCT01708369|human carboxylesterase-2|human carboxylesterase-2
435557|NCT01708369|alcohol|alcohol
435558|NCT01708369|pharmacokinetics|pharmacokinetics
435559|NCT01708356|Air Pollution|air pollution
435560|NCT01708356|Particulate Matter|particulate matter
435561|NCT01708356|Exercise|exercise
435562|NCT01708356|Respiratory Rate|respiratory rate
435563|NCT01708356|Inflammation|inflammation
435564|NCT01708356|Oxidative Stress|oxidative stress
435565|NCT01708356|Plethysmography|plethysmography
435566|NCT01708343|Myofascial Pain Syndrome,|myofascial pain syndrome,
435567|NCT01708343|intramuscular stimulation,|intramuscular stimulation,
435568|NCT01708343|acupuncture,|acupuncture,
435569|NCT01708343|sleep quality,|sleep quality,
435570|NCT01708343|pain threshold.|pain threshold.
435571|NCT01708330|manual vacuum aspiration|manual vacuum aspiration
435572|NCT01708330|missed abortion|missed abortion
435573|NCT01708330|incomplete abortion|incomplete abortion
435574|NCT01708330|nonviable pregnancy|nonviable pregnancy
435575|NCT01708330|topical lidocaine|topical lidocaine
435576|NCT01708317|ACASI|acasi
435577|NCT01708317|Gonorrhea|gonorrhea
435578|NCT01708317|Chlamydia|chlamydia
435579|NCT01708317|Emergency Department|emergency department
435580|NCT01708317|Youth|youth
435581|NCT01708317|Adolescents|adolescents
435582|NCT01708317|Computer|computer
435583|NCT01708317|Questionnaire|questionnaire
435584|NCT01708304|Dementia|dementia
435585|NCT01708304|Alzheimer's Disease|alzheimer's disease
435586|NCT01708304|Exercise|exercise
435587|NCT01708304|Caregiver|caregiver
435588|NCT01708304|Behavior modification|behavior modification
435589|NCT01708291|youth|youth
435590|NCT01708291|Stress|stress
435591|NCT01708291|mindfulness|mindfulness
435592|NCT01708291|foster care|foster care
435593|NCT01708291|stress reduction|stress reduction
435594|NCT01708291|high risk teens|high risk teens
435595|NCT01708278|COPD|copd
435596|NCT01708278|Emphysema|emphysema
435597|NCT01708278|chronic bronchitis|chronic bronchitis
435598|NCT01708278|Quercetin|quercetin
435599|NCT01708278|flavonoids|flavonoids
435600|NCT01708265|Mitral Valve Insufficiency|mitral valve insufficiency
435601|NCT01708265|Mitral Valve Regurgitation|mitral valve regurgitation
435602|NCT01708265|Asymptomatic Mitral Valve Regurgitation|asymptomatic mitral valve regurgitation
435603|NCT01708265|Asymptomatic Mitral Valve Insufficiency|asymptomatic mitral valve insufficiency
435604|NCT01708265|Mitral Valve Repair|mitral valve repair
435605|NCT01708265|Watchful Waiting|watchful waiting
435606|NCT01708252|Ulthera® System|ulthera® system
435607|NCT01708252|Ultherapy™ Treatment|ultherapy™ treatment
435608|NCT01708252|Ulthera, Inc.|ulthera, inc.
435609|NCT01708252|Ultrasound treatment for skin tightening|ultrasound treatment for skin tightening
435610|NCT01708239|Pregnancy|pregnancy
435611|NCT01708239|Deep vein thrombosis|deep vein thrombosis
435612|NCT01708239|Clinical probability|clinical probability
435613|NCT01708239|D-Dimer|d-dimer
435614|NCT01708239|Compression ultrasonography|compression ultrasonography
435615|NCT01708226|OCD|ocd
435616|NCT01708226|obsessive compulsive disorder|obsessive compulsive disorder
435617|NCT01708226|children|children
435618|NCT01708213|soft tissue|soft tissue
435619|NCT01708213|augmentation|augmentation
435620|NCT01708213|correction|correction
435621|NCT01708213|wrinkles|wrinkles
435622|NCT01708200|Memory|memory
435623|NCT01708200|Intervention|intervention
435624|NCT01708200|Computerized|computerized
435625|NCT01708200|Psychoeducational|psychoeducational
435626|NCT01708200|Mental Illness|mental illness
435627|NCT01708187|Peroneal tendon|peroneal tendon
435628|NCT01708174|medulloblastoma,|medulloblastoma,
435629|NCT01708174|relapsed,|relapsed,
435630|NCT01708174|pediatric,|pediatric,
435631|NCT01708174|children,|children,
435632|NCT01708174|adults,|adults,
435633|NCT01708174|Hh pathway inhibitor,|hh pathway inhibitor,
435634|NCT01708174|LDE225|lde225
435635|NCT01708161|PIK3CA mutation|pik3ca mutation
435636|NCT01708161|advanced solid tumor|advanced solid tumor
435637|NCT01708161|breast cancer|breast cancer
435638|NCT01708161|ovarian cancer|ovarian cancer
435639|NCT01708161|cancers with a mass|cancers with a mass
435640|NCT01708161|bulky tumor|bulky tumor
435641|NCT01708161|nodule|nodule
435642|NCT01708161|lump|lump
435643|NCT01708161|advanced cancer|advanced cancer
435644|NCT01708161|advanced solid malignancies|advanced solid malignancies
435645|NCT01708122|Intranasal fentanyl|intranasal fentanyl
435646|NCT01708122|Cystoscopy|cystoscopy
435647|NCT01708070|asthma|asthma
435648|NCT01708070|depression|depression
435649|NCT01708070|anxiety|anxiety
435650|NCT01708057|COPD|copd
435651|NCT01708057|Chronic obstructive pulmonary disease|chronic obstructive pulmonary disease
435652|NCT01708044|Pramlintide,|pramlintide,
435653|NCT01708044|insulin,|insulin,
435654|NCT01708044|type 1 diabetes,|type 1 diabetes,
435655|NCT01708044|reduction in postprandial glucose,|reduction in postprandial glucose,
435656|NCT01708044|pramlintide:insulin dose-ratio|pramlintide:insulin dose-ratio
435657|NCT01708018|Pregnancy|pregnancy
435658|NCT01708018|Stress, Psychological|stress, psychological
435659|NCT01708018|Low Back Pain|low back pain
435660|NCT01708018|Breech Presentation|breech presentation
435661|NCT01708018|Relaxation|relaxation
435662|NCT01708018|Hydrotherapy|hydrotherapy
435663|NCT01708018|Acupressure|acupressure
435664|NCT01708018|WATSU|watsu
435665|NCT01708005|Mild Cognitive Impairment|mild cognitive impairment
435666|NCT01708005|Vitamin D|vitamin d
435667|NCT01708005|Cholecalciferol|cholecalciferol
435668|NCT01708005|Lecitone®Se-Vitamin D3|lecitone®se-vitamin d3
435669|NCT01707979|Near infrared light|near infrared light
435670|NCT01707979|Diabetic neuropathy|diabetic neuropathy
435671|NCT01707979|Sensory neuropathy|sensory neuropathy
435672|NCT01707979|Autonomic neuropathy|autonomic neuropathy
435673|NCT01707979|Vagus|vagus
435674|NCT01707979|Sudomotor function|sudomotor function
435675|NCT01707979|Monofilament|monofilament
435676|NCT01707979|Impedance|impedance
435677|NCT01707966|adenocarcinoma of the prostate|adenocarcinoma of the prostate
435678|NCT01707966|metastatic castration-resistant prostate cancer|metastatic castration-resistant prostate cancer
435679|NCT01707966|maintenance therapy|maintenance therapy
435680|NCT01707966|orteronel|orteronel
435681|NCT01707966|TAK-700|tak-700
435682|NCT01707927|EOA|eoa
435683|NCT01707914|oxidative stress|oxidative stress
435684|NCT01707914|dyslipidemia|dyslipidemia
435685|NCT01707914|inflammation|inflammation
435686|NCT01707901|GERD|gerd
435687|NCT01707862|Intravenous leiomyomatosis|intravenous leiomyomatosis
435688|NCT01707862|Surgery|surgery
435689|NCT01707862|Smooth muscle tumor|smooth muscle tumor
435690|NCT01707849|Hepatitis C|hepatitis c
435691|NCT01707849|Liver Fibrosis|liver fibrosis
435692|NCT01707849|m-TOR inhibitors|m-tor inhibitors
435693|NCT01707810|Liver transplatation|liver transplatation
435694|NCT01707797|dental caries|dental caries
435695|NCT01707797|high risk|high risk
435696|NCT01707797|dental cavities|dental cavities
435697|NCT01707797|children dental care|children dental care
435698|NCT01707784|Pregnancy|pregnancy
435699|NCT01707784|Stress|stress
435700|NCT01707784|Anxiety|anxiety
435701|NCT01707784|Cortisol|cortisol
435702|NCT01707784|Copeptin|copeptin
435703|NCT01707784|Gestational diabetes|gestational diabetes
435704|NCT01707758|pancreatic cancer|pancreatic cancer
435705|NCT01707758|nanoparticle|nanoparticle
435706|NCT01707758|proteases|proteases
435707|NCT01707758|cell survival|cell survival
435708|NCT01707758|tumor progression|tumor progression
435709|NCT01707758|angiogenesis|angiogenesis
435710|NCT01707758|tissue remodeling/invasion|tissue remodeling/invasion
435711|NCT01707732|Obesity|obesity
435712|NCT01707732|thromboprophylaxis|thromboprophylaxis
435713|NCT01707732|Enoxaparin|enoxaparin
435714|NCT01707719|Alzheimer's disease|alzheimer's disease
435715|NCT01707719|Oxidative stress|oxidative stress
435716|NCT01707719|HPA axis|hpa axis
435717|NCT01707706|Insomnia|insomnia
435718|NCT01707706|Depression|depression
435719|NCT01707706|Electroacupuncture|electroacupuncture
435720|NCT01707706|Acupuncture|acupuncture
435721|NCT01707706|Randomized Clinical Trial|randomized clinical trial
435722|NCT01707706|Traditional Chinese Medicine|traditional chinese medicine
435723|NCT01707693|physical activity|physical activity
435724|NCT01707693|prevention|prevention
435725|NCT01707693|coronary heart disease|coronary heart disease
435726|NCT01707693|women|women
435727|NCT01707680|weaning|weaning
435728|NCT01707680|mechanical ventilation|mechanical ventilation
435729|NCT01707680|dexmedetomidine|dexmedetomidine
435730|NCT01707680|propofol|propofol
435731|NCT01707680|midazolam|midazolam
435732|NCT01707654|defect;|defect;
435733|NCT01707654|dorsal branch of the proper digital nerve;|dorsal branch of the proper digital nerve;
435734|NCT01707654|proper digital nerve;|proper digital nerve;
435735|NCT01707654|finger sensory reconstruction.|finger sensory reconstruction.
435736|NCT01707628|NHL|nhl
435737|NCT01707628|influenza vaccination|influenza vaccination
435738|NCT01707628|rituximab|rituximab
435739|NCT01707615|proanthocyanidin,atherosclerosis, carotid plaque|proanthocyanidin,atherosclerosis, carotid plaque
435740|NCT01707602|Intradermal|intradermal
435741|NCT01707602|transcutaneous|transcutaneous
435742|NCT01707602|influenza|influenza
435743|NCT01707602|routes of vaccination|routes of vaccination
435744|NCT01707602|T cell responses|t cell responses
435745|NCT01707602|humoral responses|humoral responses
435746|NCT01707602|skin|skin
435747|NCT01707602|clinical trial|clinical trial
435748|NCT01707602|Novel application of influenza vaccine|novel application of influenza vaccine
435749|NCT01707602|Transcutaneous vaccination(hair follicular targeting)|transcutaneous vaccination(hair follicular targeting)
435750|NCT01707602|Intradermal vaccination(micro-needle)|intradermal vaccination(micro-needle)
435751|NCT01707589|monitoring|monitoring
435752|NCT01707589|heart rate|heart rate
435753|NCT01707589|respiration rate|respiration rate
435754|NCT01707589|temperature|temperature
435755|NCT01707589|motion|motion
435756|NCT01707589|noninvasive|noninvasive
435757|NCT01707589|physiologic parameters|physiologic parameters
435758|NCT01707589|NICU|nicu
435759|NCT01707576|Follow-Up Studies|follow-up studies
435760|NCT01707576|Adolescent|adolescent
435761|NCT01707576|Depressive Disorder, Major/diagnosis|depressive disorder, major/diagnosis
435762|NCT01707576|Attempted/prevention & control|attempted/prevention & control
435763|NCT01707576|Self-report questionnaire|self-report questionnaire
435764|NCT01707576|emmergency department|emmergency department
435765|NCT01707576|parental perception|parental perception
435766|NCT01707576|Emergency|emergency
435767|NCT01707563|Marfan syndrome|marfan syndrome
435768|NCT01707563|Variability|variability
435769|NCT01707563|Fibrillin 1|fibrillin 1
435770|NCT01707563|clinical expression|clinical expression
435771|NCT01707537|OCV|ocv
435772|NCT01707537|cholera|cholera
435773|NCT01707511|Arterial carbondioxide pressure|arterial carbondioxide pressure
435774|NCT01707511|Colon surgery|colon surgery
435775|NCT01707511|End-tidal carbondioxide|end-tidal carbondioxide
435776|NCT01707511|Laparoscopic Trendelenburg|laparoscopic trendelenburg
435777|NCT01707498|BCI|bci
435778|NCT01707498|TETRAPLEGIA|tetraplegia
435779|NCT01707498|COMMUNICATION|communication
435780|NCT01707498|P300|p300
435781|NCT01707498|ASSISTIVE TECHNOLOGIE|assistive technologie
435782|NCT01707485|Antibiotics|antibiotics
435783|NCT01707472|Liver Fibrosis|liver fibrosis
435784|NCT01707472|Fibrosis|fibrosis
435785|NCT01707472|HIV|hiv
435786|NCT01707472|HCV|hcv
435787|NCT01707472|GS-6624|gs-6624
435788|NCT01707472|Hepatitis|hepatitis
435789|NCT01707472|Hepatitis C|hepatitis c
435790|NCT01707459|platelet function|platelet function
435791|NCT01707459|perioperative complications|perioperative complications
435792|NCT01707459|major adverse cardiac events (MACE)|major adverse cardiac events (mace)
435793|NCT01707459|thromboelastography|thromboelastography
435794|NCT01707459|polymorphism analysis|polymorphism analysis
435795|NCT01707459|coronary stents|coronary stents
435796|NCT01707459|non-cardiac surgery|non-cardiac surgery
435797|NCT01707446|Cardiac surgery|cardiac surgery
435798|NCT01707446|Delirium|delirium
435799|NCT01707446|Cerebral Oximetry|cerebral oximetry
435800|NCT01707433|spondyloepiphyseal dysplasia|spondyloepiphyseal dysplasia
435801|NCT01707433|multiple epiphyseal dysplasia|multiple epiphyseal dysplasia
435802|NCT01707433|bilateral Legg Calve Perthes|bilateral legg calve perthes
435803|NCT01707433|bilateral proximal femoral epiphyseal dysplasia|bilateral proximal femoral epiphyseal dysplasia
435804|NCT01707433|GALNS|galns
435805|NCT01707420|pediatric pain|pediatric pain
435806|NCT01707420|post operative pain|post operative pain
435807|NCT01707420|opioids|opioids
435808|NCT01707420|emergence agitation|emergence agitation
435809|NCT01707420|preoperative anxiety|preoperative anxiety
435810|NCT01707420|pharmacogenomics|pharmacogenomics
435811|NCT01707407|CC-4047|cc-4047
435812|NCT01707407|Pomalidomide|pomalidomide
435813|NCT01707407|Ketoconazole|ketoconazole
435814|NCT01707407|Fluvoxamine|fluvoxamine
435815|NCT01707407|Carbamazepine|carbamazepine
435816|NCT01707407|DDI|ddi
435817|NCT01707407|safety|safety
435818|NCT01707407|tolerability|tolerability
435819|NCT01707407|pharmacokinetic|pharmacokinetic
435820|NCT01707368|Psoriasis|psoriasis
435821|NCT01707368|Psoriasis vulgaris|psoriasis vulgaris
435822|NCT01707368|Plaque Psoriasis|plaque psoriasis
435823|NCT01707368|Daivobet® Gel|daivobet® gel
435824|NCT01707368|Germany|germany
435825|NCT01707355|education, knowledge, poster, dental trauma|education, knowledge, poster, dental trauma
435826|NCT01707342|Healthy male participants|healthy male participants
435827|NCT01707342|Absolute bioavailability|absolute bioavailability
435828|NCT01707342|Bioavailability|bioavailability
435829|NCT01707342|Pharmacokinetics|pharmacokinetics
435830|NCT01707342|Simeprevir|simeprevir
435831|NCT01707342|TMC435|tmc435
435832|NCT01707342|[3H]-TMC435|[3h]-tmc435
435833|NCT01707342|Hepatitis C virus|hepatitis c virus
435834|NCT01707342|HCV|hcv
435835|NCT01707316|Healthy|healthy
435836|NCT01707316|JNJ-28431754|jnj-28431754
435837|NCT01707316|Canagliflozin|canagliflozin
435838|NCT01707316|Pharmacokinetics|pharmacokinetics
435839|NCT01707316|Pharmacodynamics|pharmacodynamics
435840|NCT01707303|ICU|icu
435841|NCT01707303|Critical Care|critical care
435842|NCT01707303|Intensive Care|intensive care
435843|NCT01707303|Critical Illness|critical illness
435844|NCT01707303|Acute Respiratory Failure|acute respiratory failure
435845|NCT01707303|Mechanical Ventilation|mechanical ventilation
435846|NCT01707303|Physical Therapy|physical therapy
435847|NCT01707303|Strength|strength
435848|NCT01707303|Functional Status|functional status
435849|NCT01707303|Short Physical Performance Battery|short physical performance battery
435850|NCT01707277|Heart failure with preserved ejection fraction|heart failure with preserved ejection fraction
435851|NCT01707277|Inspiratory muscle training|inspiratory muscle training
435852|NCT01707277|Exercise capacity|exercise capacity
435853|NCT01707264|AL amyloidosis|al amyloidosis
435854|NCT01707264|Primary amyloidosis|primary amyloidosis
435855|NCT01707251|Obesity, Morbid|obesity, morbid
435856|NCT01707251|Bariatric Surgery|bariatric surgery
435857|NCT01707251|Laparoscopy|laparoscopy
435858|NCT01707251|Intravenous Ibuprofen|intravenous ibuprofen
435859|NCT01707251|Analgesia|analgesia
435860|NCT01707251|Morphine|morphine
435861|NCT01707225|GI Bleeding|gi bleeding
435862|NCT01707225|Gastrointestinal bleeding|gastrointestinal bleeding
435863|NCT01707225|LVAD|lvad
435864|NCT01707212|parent education|parent education
435865|NCT01707212|pain management|pain management
435866|NCT01707212|immunization|immunization
435867|NCT01707212|infant|infant
435868|NCT01707199|P. falciparum|p. falciparum
435869|NCT01707199|Sulphadoxine-pyrimethamine|sulphadoxine-pyrimethamine
435870|NCT01707199|Artesunate|artesunate
435871|NCT01707199|Artemisinin Combination Therapy (ACT)|artemisinin combination therapy (act)
435872|NCT01707173|SIDS|sids
435873|NCT01707121|morbidity|morbidity
435874|NCT01707121|sick-leave|sick-leave
435875|NCT01707121|hospital stay|hospital stay
435876|NCT01707108|dental implants|dental implants
435877|NCT01707108|bone loss|bone loss
435878|NCT01707095|Electrosurgery|electrosurgery
435879|NCT01707095|Radiofrequency energy|radiofrequency energy
435880|NCT01707095|Monopolar instruments|monopolar instruments
435881|NCT01707095|Capacitive coupling|capacitive coupling
435882|NCT01707095|Thermal injury|thermal injury
435883|NCT01707095|Surgical complications|surgical complications
435884|NCT01707056|levothyroxine|levothyroxine
435885|NCT01707056|synthroid|synthroid
435886|NCT01707056|coffee|coffee
435887|NCT01707056|absorption|absorption
435888|NCT01707056|tea|tea
435889|NCT01707056|thyroid carcinoma|thyroid carcinoma
435890|NCT01707043|plaque psoriasis|plaque psoriasis
435891|NCT01707043|taclonex|taclonex
435892|NCT01707043|crossover|crossover
435893|NCT01707030|clinical trial|clinical trial
435894|NCT01707030|veteran|veteran
435895|NCT01707030|substance use disorder|substance use disorder
435896|NCT01706978|rotator cuff tear|rotator cuff tear
435897|NCT01706952|Endoscopic sinus surgery|endoscopic sinus surgery
435898|NCT01706952|Bleeding|bleeding
435899|NCT01706952|Topical Vasocontriction|topical vasocontriction
435900|NCT01706952|Cocaine|cocaine
435901|NCT01706952|Adrenaline|adrenaline
435902|NCT01706939|Reduced radiotherapy|reduced radiotherapy
435903|NCT01706939|Randomization, Phase III|randomization, phase iii
435904|NCT01706939|Reduced radiation therapy|reduced radiation therapy
435905|NCT01706939|head and neck|head and neck
435906|NCT01706939|oropharynx|oropharynx
436208|NCT01705639|sleep|sleep
435907|NCT01706939|unknown primary (cervical lymph nodes)|unknown primary (cervical lymph nodes)
435908|NCT01706939|nasopharynx primary|nasopharynx primary
435910|NCT01706939|p16|p16
435911|NCT01706926|Rheumatoid Arthritis|rheumatoid arthritis
435912|NCT01706926|Mavrilimumab|mavrilimumab
435913|NCT01706926|CAM-3001|cam-3001
435914|NCT01706887|Nedd4-2|nedd4-2
435915|NCT01706887|blood pressure|blood pressure
435916|NCT01706887|polymorphism|polymorphism
435917|NCT01706887|salt intake|salt intake
435918|NCT01706887|between 18 and 35 years old|between 18 and 35 years old
435919|NCT01706887|BMI between 18 and 28 Kg per m2|bmi between 18 and 28 kg per m2
435920|NCT01706887|no active disease|no active disease
435921|NCT01706887|no alcool or drug abuse or smoke|no alcool or drug abuse or smoke
435922|NCT01706874|Rheumatoid arthritis|rheumatoid arthritis
435923|NCT01706874|P.gingivalis|p.gingivalis
435924|NCT01706874|Periodontal disease|periodontal disease
435925|NCT01706874|Plaque control|plaque control
435926|NCT01706874|Prophylaxis|prophylaxis
435927|NCT01706874|Oral hygiene instruction|oral hygiene instruction
435928|NCT01706835|solid tumor|solid tumor
435929|NCT01706835|aldoxorubicin|aldoxorubicin
435930|NCT01706835|phase 1|phase 1
435931|NCT01706835|pharmacokinetic|pharmacokinetic
435932|NCT01706835|INNO-206|inno-206
435933|NCT01706796|Pain|pain
435934|NCT01706744|Hospital Readmissions|hospital readmissions
435935|NCT01706744|Community Health Services|community health services
435936|NCT01706744|Preventive Health Services|preventive health services
435937|NCT01706744|Norway|norway
435938|NCT01706731|Buddhist monks|buddhist monks
435939|NCT01706731|CBT|cbt
435940|NCT01706731|elderly|elderly
435941|NCT01706731|depression|depression
435942|NCT01706718|Beetroot|beetroot
435943|NCT01706718|Blood pressure|blood pressure
435944|NCT01706718|Vascular function|vascular function
435945|NCT01706705|Cervical Cancer|cervical cancer
435946|NCT01706705|Radiation therapy|radiation therapy
435947|NCT01706705|XRT|xrt
435948|NCT01706705|External beam therapy|external beam therapy
435949|NCT01706705|Brachytherapy|brachytherapy
435950|NCT01706705|Intracavitary brachytherapy|intracavitary brachytherapy
435951|NCT01706705|ICBT|icbt
435952|NCT01706705|MRI compatible intracavitary applicators|mri compatible intracavitary applicators
435953|NCT01706705|Computed tomography|computed tomography
435954|NCT01706705|CT|ct
435955|NCT01706705|Magnetic resonance imaging|magnetic resonance imaging
435956|NCT01706705|MRI|mri
435957|NCT01706705|MRI compatible applicators|mri compatible applicators
435958|NCT01706705|3D image guided treatment planning|3d image guided treatment planning
435959|NCT01706705|2D treatment planning|2d treatment planning
435960|NCT01706692|Methotrexate|methotrexate
435961|NCT01706692|Acitretin|acitretin
435962|NCT01706692|Cyclosporine A|cyclosporine a
435963|NCT01706692|Systemic PUVA|systemic puva
435964|NCT01706692|Infliximab|infliximab
435965|NCT01706692|Adalimumab|adalimumab
435966|NCT01706692|Etanercept|etanercept
435967|NCT01706692|Ustekinumab|ustekinumab
435968|NCT01706692|Fumaric acids|fumaric acids
435969|NCT01706692|Psoriasis|psoriasis
435970|NCT01706692|Psoriatic arthritis|psoriatic arthritis
435971|NCT01706692|Skin disease|skin disease
435972|NCT01706679|Healthy volunteers|healthy volunteers
435973|NCT01706666|Maintenance|maintenance
435974|NCT01706666|Consolidation|consolidation
435975|NCT01706653|Polyphenol|polyphenol
435976|NCT01706653|Fruit|fruit
435977|NCT01706653|Metabolic|metabolic
435978|NCT01706653|Healthy|healthy
435979|NCT01706627|cancer|cancer
435980|NCT01706627|melatonin|melatonin
435981|NCT01706627|adjuvant therapy|adjuvant therapy
435982|NCT01706627|quality of life|quality of life
435983|NCT01706627|survival|survival
435984|NCT01706627|adverse events|adverse events
435985|NCT01706627|oxidative stress|oxidative stress
435986|NCT01706588|diclofenac, postsurgical pain, oral surgery|diclofenac, postsurgical pain, oral surgery
435987|NCT01706562|Neutropenia|neutropenia
435988|NCT01706562|Hematologic malignancy|hematologic malignancy
435989|NCT01706562|Itraconazole|itraconazole
435990|NCT01706562|Fungal infection|fungal infection
435991|NCT01706562|Antifungal agent|antifungal agent
435992|NCT01706562|Neutropenic fever|neutropenic fever
435993|NCT01706549|Chronic pain|chronic pain
435994|NCT01706549|Hysterectomy|hysterectomy
435995|NCT01706549|Quality of life|quality of life
435996|NCT01706523|Autism Spectrum Disorders|autism spectrum disorders
435997|NCT01706523|Autism|autism
435998|NCT01706523|Asperger|asperger
435999|NCT01706523|Pervasive Developmental Disorder - Not otherwise specified|pervasive developmental disorder - not otherwise specified
436000|NCT01706510|Clopidogrel|clopidogrel
436001|NCT01706510|Ticagrelor|ticagrelor
436002|NCT01706510|Coronary Artery Disease|coronary artery disease
436003|NCT01706510|Myocardial Ischemia|myocardial ischemia
436004|NCT01706510|Coronary Disease|coronary disease
436005|NCT01706510|Heart Diseases|heart diseases
436006|NCT01706510|Cardiovascular Diseases|cardiovascular diseases
436007|NCT01706510|Arteriosclerosis|arteriosclerosis
436008|NCT01706510|Arterial Occlusive Diseases|arterial occlusive diseases
436009|NCT01706510|Vascular Diseases|vascular diseases
436010|NCT01706510|Platelet Aggregation Inhibitors|platelet aggregation inhibitors
436011|NCT01706510|Hematologic Agents|hematologic agents
436012|NCT01706510|Therapeutic Uses|therapeutic uses
436013|NCT01706510|Pharmacologic Actions|pharmacologic actions
436014|NCT01706510|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists
436015|NCT01706510|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists
436016|NCT01706510|Purinergic Antagonists|purinergic antagonists
436017|NCT01706510|Purinergic Agents|purinergic agents
436018|NCT01706510|Physiological Effects of Drugs|physiological effects of drugs
436019|NCT01706497|cerebral tissue oxygen saturation|cerebral tissue oxygen saturation
436020|NCT01706497|congenital cardiac surgery|congenital cardiac surgery
436021|NCT01706497|pediatric intensive care unit|pediatric intensive care unit
436022|NCT01706497|Near Infra-Red Spectroscopy|near infra-red spectroscopy
436023|NCT01706497|early warning monitor|early warning monitor
436024|NCT01706497|outcome prediction|outcome prediction
436025|NCT01706484|randomized clinical trial|randomized clinical trial
436026|NCT01706484|chronic rhinosinusitis|chronic rhinosinusitis
436027|NCT01706484|herbal extract BNO 1016|herbal extract bno 1016
436028|NCT01706484|exacerbation|exacerbation
436029|NCT01706484|pharmacoeconomic|pharmacoeconomic
436030|NCT01706484|quality of life|quality of life
436031|NCT01706471|verLowCNI|verlowcni
436032|NCT01706458|Vaccine|vaccine
436033|NCT01706458|pTVG-HP|ptvg-hp
436034|NCT01706458|Prostate Cancer|prostate cancer
436035|NCT01706458|Castrate Resistant|castrate resistant
436036|NCT01706445|cystic fibrosis|cystic fibrosis
436037|NCT01706445|exercise|exercise
436038|NCT01706445|children|children
436039|NCT01706445|cardiorespiratory fitness|cardiorespiratory fitness
436040|NCT01706445|muscle strength|muscle strength
436041|NCT01706445|pulmonary function|pulmonary function
436042|NCT01706445|quality of life|quality of life
436043|NCT01706419|vitamin A|vitamin a
436044|NCT01706419|iron|iron
436045|NCT01706419|zinc|zinc
436046|NCT01706419|school children|school children
436047|NCT01706419|fortified rice|fortified rice
436048|NCT01706419|morbidity|morbidity
436049|NCT01706419|growth|growth
436050|NCT01706406|female sexual arousal|female sexual arousal
436051|NCT01706406|female sexual desire|female sexual desire
436052|NCT01706406|psychoeducational intervention|psychoeducational intervention
436053|NCT01706393|probiotics|probiotics
436054|NCT01706393|intestinal microbiome|intestinal microbiome
436055|NCT01706393|radiotherapy|radiotherapy
436056|NCT01706380|Substance use disorders|substance use disorders
436057|NCT01706380|Adolescents|adolescents
436058|NCT01706380|Retention|retention
436059|NCT01706380|Mobile telephone|mobile telephone
436060|NCT01706380|Follow-up|follow-up
436061|NCT01706380|Interactive voice response|interactive voice response
436062|NCT01706367|Clostridium difficile|clostridium difficile
436063|NCT01706367|vaccine|vaccine
436064|NCT01706354|end stage renal disease|end stage renal disease
436065|NCT01706354|vascular access|vascular access
436066|NCT01706354|regional anaesthesia|regional anaesthesia
436067|NCT01706341|cesarean section|cesarean section
436068|NCT01706341|intravenous fluid|intravenous fluid
436069|NCT01706341|a glucose-containing solution|a glucose-containing solution
436070|NCT01706341|fetal hypoglycemia|fetal hypoglycemia
436071|NCT01706341|neonatal hypoglycemia|neonatal hypoglycemia
436072|NCT01706328|Vilanterol (VI)|vilanterol (vi)
436073|NCT01706328|Novel Dry Powder Inhaler (NDPI)|novel dry powder inhaler (ndpi)
436074|NCT01706328|FEV1|fev1
436075|NCT01706328|Fluticasone Furoate (FF)|fluticasone furoate (ff)
436076|NCT01706328|COPD|copd
436077|NCT01706302|General Practice Research Database|general practice research database
436078|NCT01706302|Burden of Disease|burden of disease
436079|NCT01706302|Clinical Practice Research Datalink|clinical practice research datalink
436080|NCT01706302|Hospital Episode Statistics|hospital episode statistics
436081|NCT01706302|Office of National Statistics|office of national statistics
436082|NCT01706302|RSV|rsv
436083|NCT01706289|diabetes|diabetes
436084|NCT01706289|cardiovascular autonomic neuropathy|cardiovascular autonomic neuropathy
436085|NCT01706289|VAP 1|vap 1
436086|NCT01706237|Myopia|myopia
436087|NCT01706237|LASIK|lasik
436088|NCT01706224|Pertussis antibodies|pertussis antibodies
436089|NCT01706224|Bordetella pertussis|bordetella pertussis
436090|NCT01706224|sero-prevalence|sero-prevalence
436091|NCT01706224|Healthcare professionals (HCP)|healthcare professionals (hcp)
436092|NCT01706224|Spain|spain
436093|NCT01706211|non insulin dependent diabetes mellitus, rosiglitazone|non insulin dependent diabetes mellitus, rosiglitazone
436094|NCT01706198|respiratory|respiratory
436095|NCT01706198|adult|adult
436096|NCT01706198|asthma|asthma
436097|NCT01706185|Patients|patients
436098|NCT01706185|Tumor antigens|tumor antigens
436099|NCT01706185|Bladder cancer|bladder cancer
436100|NCT01706172|TMD|tmd
436101|NCT01706172|temporomandibular|temporomandibular
436102|NCT01706172|dextrose|dextrose
436103|NCT01706172|prolotherapy|prolotherapy
436104|NCT01706146|atrial fibrillation|atrial fibrillation
436105|NCT01706146|reveal xt|reveal xt
436312|NCT01705171|GLUT 5|glut 5
436106|NCT01706146|oral anticoagulation|oral anticoagulation
436107|NCT01706146|dabigatran|dabigatran
436108|NCT01706146|rivaroxaban|rivaroxaban
436109|NCT01706146|apixaban|apixaban
436110|NCT01706133|Frailty, emergency services, elderly|frailty, emergency services, elderly
436111|NCT01706120|prognostic factors|prognostic factors
436112|NCT01706120|biologic factors|biologic factors
436113|NCT01706120|clinical factors|clinical factors
436114|NCT01706120|routine clinical practice|routine clinical practice
436115|NCT01706107|Quality of life|quality of life
436116|NCT01706094|stroke|stroke
436117|NCT01706094|head position|head position
436118|NCT01706081|acupuncture|acupuncture
436119|NCT01706068|acute ECG changes|acute ecg changes
436120|NCT01706068|acute illness of gallbladder|acute illness of gallbladder
436121|NCT01706068|acute illness of biliary tract|acute illness of biliary tract
436122|NCT01706055|Multiple Sclerosis (MS)|multiple sclerosis (ms)
436123|NCT01706055|Interferon|interferon
436124|NCT01706003|Migraine|migraine
436125|NCT01706003|Headaches|headaches
436126|NCT01706003|Telemedicine|telemedicine
436127|NCT01705990|HIV|hiv
436128|NCT01705990|AIDS|aids
436129|NCT01705990|HIV vaccine|hiv vaccine
436130|NCT01705990|HIV prevention|hiv prevention
436131|NCT01705977|Antibodies|antibodies
436132|NCT01705977|Lupus|lupus
436133|NCT01705977|SLE|sle
436134|NCT01705977|Systemic Lupus Erythematosus|systemic lupus erythematosus
436135|NCT01705977|Autoimmune Disease|autoimmune disease
436136|NCT01705977|Belimumab|belimumab
436137|NCT01705964|Status asthmaticus|status asthmaticus
436138|NCT01705964|Asthma exacerbation|asthma exacerbation
436139|NCT01705964|Epinephrine|epinephrine
436140|NCT01705964|Adjunctive therapy|adjunctive therapy
436141|NCT01705951|Smoking|smoking
436142|NCT01705951|Insulin resistance|insulin resistance
436143|NCT01705951|Metabolic Syndrome|metabolic syndrome
436144|NCT01705951|Endothelial Function|endothelial function
436145|NCT01705951|Smoking Cessation|smoking cessation
436146|NCT01705951|Resistance Training|resistance training
436147|NCT01705951|Nicotine Replacement|nicotine replacement
436148|NCT01705951|Exercise|exercise
436149|NCT01705951|Cardiovascular Disease|cardiovascular disease
436150|NCT01705951|Arterial Stiffness|arterial stiffness
436151|NCT01705951|Body Composition|body composition
436152|NCT01705912|fall|fall
436153|NCT01705912|prevention|prevention
436154|NCT01705899|Type 1 Diabetes|type 1 diabetes
436155|NCT01705899|Islet transplant|islet transplant
436156|NCT01705899|Kidney transplant|kidney transplant
436157|NCT01705886|Osteoarthritis|osteoarthritis
436158|NCT01705886|Joint Disease|joint disease
436159|NCT01705886|Arthritis|arthritis
436160|NCT01705886|Musculoskeletal Disease|musculoskeletal disease
436161|NCT01705886|Knee osteoarthritis|knee osteoarthritis
436162|NCT01705873|HIV|hiv
436163|NCT01705873|cardiovascular|cardiovascular
436164|NCT01705873|risk|risk
436165|NCT01705873|mortality|mortality
436166|NCT01705860|Collagen, collagenase, scar|collagen, collagenase, scar
436167|NCT01705847|chronic lymphocytic leukemia (CLL)|chronic lymphocytic leukemia (cll)
436168|NCT01705847|non-Hodgkin lymphoma (NHL)|non-hodgkin lymphoma (nhl)
436169|NCT01705847|Hodgkin lymphoma (HL)|hodgkin lymphoma (hl)
436170|NCT01705847|indolent non-Hodgkin lymphoma (iNHL)|indolent non-hodgkin lymphoma (inhl)
436171|NCT01705847|diffuse large B-cell lymphoma-activated B-cell (DLBCL-ABC)|diffuse large b-cell lymphoma-activated b-cell (dlbcl-abc)
436172|NCT01705847|DLBCL-germinal center B-cell (GCB)|dlbcl-germinal center b-cell (gcb)
436173|NCT01705847|mantle cell lymphoma (MCL)|mantle cell lymphoma (mcl)
436174|NCT01705847|GS-9820|gs-9820
436175|NCT01705847|phosphatidylinositol 3-kinase (PI3K)|phosphatidylinositol 3-kinase (pi3k)
436176|NCT01705834|Arthritis|arthritis
436177|NCT01705834|Stiffness|stiffness
436178|NCT01705834|Range of movement|range of movement
436179|NCT01705834|Goniometry|goniometry
436180|NCT01705834|Digital|digital
436181|NCT01705834|Dataglove|dataglove
436182|NCT01705834|Outcome|outcome
436183|NCT01705821|Skull base|skull base
436184|NCT01705821|Pituitary|pituitary
436185|NCT01705821|Robotics|robotics
436186|NCT01705821|Endonasal surgery|endonasal surgery
436187|NCT01705821|Sinus surgery|sinus surgery
436188|NCT01705769|treatment|treatment
436189|NCT01705769|severe acute malnutrition|severe acute malnutrition
436190|NCT01705756|Colchicine|colchicine
436191|NCT01705756|Anakinra|anakinra
436192|NCT01705756|Colchicine resistance|colchicine resistance
436193|NCT01705756|Familial Mediterranean fever|familial mediterranean fever
436194|NCT01705743|anaesthesia|anaesthesia
436195|NCT01705743|middle aged|middle aged
436196|NCT01705743|minimal alveolar concentration|minimal alveolar concentration
436197|NCT01705743|sevoflurane|sevoflurane
436198|NCT01705743|nitrous oxide|nitrous oxide
436199|NCT01705743|isoelectric EEG|isoelectric eeg
436200|NCT01705678|Males|males
436201|NCT01705678|Metabolic syndrome|metabolic syndrome
436202|NCT01705678|Otherwise healthy|otherwise healthy
436203|NCT01705652|nexrutine|nexrutine
436204|NCT01705652|prostate cancer|prostate cancer
436205|NCT01705639|diabetes|diabetes
436206|NCT01705639|melatonin|melatonin
436207|NCT01705639|glucose tolerance|glucose tolerance
436209|NCT01705626|Peripheral Nervous System Diseases|peripheral nervous system diseases
436210|NCT01705626|Neuromuscular Diseases|neuromuscular diseases
436211|NCT01705613|Attention Deficit/Hyperactivity Disorder|attention deficit/hyperactivity disorder
436212|NCT01705613|ADHD|adhd
436213|NCT01705613|Methylphenidate Immediate-release|methylphenidate immediate-release
436214|NCT01705613|Cost-effectiveness|cost-effectiveness
436215|NCT01705613|Cost-utility|cost-utility
436216|NCT01705613|QALYs|qalys
436217|NCT01705600|Central Sensitization|central sensitization
436218|NCT01705600|Low Back Pain|low back pain
436219|NCT01705600|Pain|pain
436220|NCT01705600|Pain Catastrophizing|pain catastrophizing
436221|NCT01705600|Brence|brence
436222|NCT01705587|osteoporosis|osteoporosis
436223|NCT01705587|atypical femoral fractures|atypical femoral fractures
436224|NCT01705587|prior bisphosphonate treatment|prior bisphosphonate treatment
436225|NCT01705587|postmenopausal women|postmenopausal women
436226|NCT01705587|bone loss|bone loss
436227|NCT01705574|HIV-1|hiv-1
436228|NCT01705574|HIV|hiv
436229|NCT01705574|Treatment-Naive|treatment-naive
436230|NCT01705574|Women|women
436231|NCT01705574|WAVES|waves
436232|NCT01705561|fertility|fertility
436233|NCT01705561|chemotherapy|chemotherapy
436234|NCT01705561|breast cancer|breast cancer
436235|NCT01705561|latin american women|latin american women
436236|NCT01705561|pre menopausal|pre menopausal
436237|NCT01705548|Brain metastasis|brain metastasis
436238|NCT01705535|Fecal incontinence|fecal incontinence
436239|NCT01705535|Pelvic floor muscle exercises|pelvic floor muscle exercises
436240|NCT01705535|Physiotherapy|physiotherapy
436241|NCT01705522|IBD|ibd
436242|NCT01705522|ulcerative colitis|ulcerative colitis
436243|NCT01705522|Crohn's disease|crohn's disease
436244|NCT01705522|NAFLD|nafld
436245|NCT01705522|biomarkers|biomarkers
436246|NCT01705522|vitamin D|vitamin d
436247|NCT01705509|The Effects of Ranolazine on CPET Parameters in Ischemic|the effects of ranolazine on cpet parameters in ischemic
436248|NCT01705509|Cardiomyopathy Patients|cardiomyopathy patients
436249|NCT01705496|Phase II|phase ii
436250|NCT01705496|FIAU|fiau
436251|NCT01705496|Fialuridine|fialuridine
436252|NCT01705496|Prosthetic|prosthetic
436253|NCT01705496|Joint|joint
436254|NCT01705496|Infection|infection
436255|NCT01705496|PET-CT|pet-ct
436256|NCT01705483|ASP9853|asp9853
436257|NCT01705483|Docetaxel|docetaxel
436258|NCT01705483|Paclitaxel|paclitaxel
436259|NCT01705470|Furosemide|furosemide
436260|NCT01705470|Anemia|anemia
436261|NCT01705470|LV dysfunction|lv dysfunction
436262|NCT01705470|blood transfusion|blood transfusion
436263|NCT01705457|multiple sclerosis|multiple sclerosis
436264|NCT01705457|Vitamin A|vitamin a
436265|NCT01705457|retinoic acid receptor|retinoic acid receptor
436266|NCT01705457|retinoic x receptor|retinoic x receptor
436267|NCT01705444|Urinary retention|urinary retention
436268|NCT01705444|Foley catheter|foley catheter
436269|NCT01705444|The Spanner|the spanner
436270|NCT01705444|Quality of life|quality of life
436271|NCT01705431|Emotional Disturbance|emotional disturbance
436272|NCT01705431|Behavioral Disturbance|behavioral disturbance
436273|NCT01705431|EBD|ebd
436274|NCT01705431|Middle School|middle school
436275|NCT01705431|Special Education|special education
436276|NCT01705431|School Psychology|school psychology
436277|NCT01705418|Parkinson disease|parkinson disease
436278|NCT01705418|Deep brain stimulation|deep brain stimulation
436279|NCT01705418|behavior and psychiatric symptoms improvement|behavior and psychiatric symptoms improvement
436280|NCT01705405|cancer|cancer
436281|NCT01705405|prostate|prostate
436282|NCT01705379|Neisseria meningitidis, conjugate vaccine, phase IV clinical trial|neisseria meningitidis, conjugate vaccine, phase iv clinical trial
436283|NCT01705366|Osteoarthritis|osteoarthritis
436284|NCT01705366|Joint Disease|joint disease
436285|NCT01705366|Arthritis|arthritis
436286|NCT01705366|Musculoskeletal Disease|musculoskeletal disease
436287|NCT01705353|Stroke|stroke
436288|NCT01705353|Cerebrovascular Accident|cerebrovascular accident
436289|NCT01705353|HMGB-1|hmgb-1
436290|NCT01705353|cytokines|cytokines
436291|NCT01705353|functional recovery|functional recovery
436292|NCT01705353|inflammation|inflammation
436293|NCT01705353|immune response|immune response
436294|NCT01705327|Parkinson's|parkinson's
436295|NCT01705327|Biomarkers|biomarkers
436296|NCT01705327|Neurodegenerative disorder|neurodegenerative disorder
436297|NCT01705314|human influenza children|human influenza children
436298|NCT01705288|laparotomy|laparotomy
436299|NCT01705288|hysterectomy|hysterectomy
436300|NCT01705262|compliance|compliance
436301|NCT01705262|Bowel preparations|bowel preparations
436302|NCT01705262|Moviprep|moviprep
436303|NCT01705262|Phosphoral|phosphoral
436304|NCT01705223|prophylactic|prophylactic
436305|NCT01705223|vaccine|vaccine
436306|NCT01705184|Stop and go|stop and go
436307|NCT01705184|Non-small cell lung cancer|non-small cell lung cancer
436308|NCT01705184|Non-squamous|non-squamous
436309|NCT01705184|Bevacizumab|bevacizumab
436310|NCT01705171|IBS|ibs
436311|NCT01705171|fructose intolerance|fructose intolerance
436313|NCT01705171|GLUT 2|glut 2
436314|NCT01705158|ovarian cancer in relapse|ovarian cancer in relapse
436315|NCT01705158|sensitive in platin|sensitive in platin
436316|NCT01705145|Cystic Fibrosis|cystic fibrosis
436317|NCT01705119|Mechanically Ventilated|mechanically ventilated
436318|NCT01705119|Critical Care|critical care
436319|NCT01705093|strawberry, cardiovascular, obesity, adolescent|strawberry, cardiovascular, obesity, adolescent
436320|NCT01705080|Renal Denervation|renal denervation
436321|NCT01705080|Renal artery|renal artery
436322|NCT01705067|Osteoarthritis, Degenerative Knee Disease, TKA|osteoarthritis, degenerative knee disease, tka
436323|NCT01705054|Angina|angina
436324|NCT01705054|Stable ischemic heart disease|stable ischemic heart disease
436325|NCT01705054|Quality of Life|quality of life
436326|NCT01705054|Seattle Angina Questionnaire (SAQ)|seattle angina questionnaire (saq)
436327|NCT01705015|exercise|exercise
436328|NCT01705002|phase 1|phase 1
436329|NCT01705002|dose escalating|dose escalating
436330|NCT01705002|prodrug|prodrug
436331|NCT01705002|mitomycin C|mitomycin c
436332|NCT01705002|Capecitabine|capecitabine
436333|NCT01704989|Glaucoma, SLT|glaucoma, slt
436334|NCT01704963|Recurrent mature B-cell neoplasms|recurrent mature b-cell neoplasms
436335|NCT01704963|B-cell malignancies|b-cell malignancies
436336|NCT01704963|Bruton's Tyrosine Kinase (Btk) Inhibitor|bruton's tyrosine kinase (btk) inhibitor
436337|NCT01704963|PCI-32765|pci-32765
436338|NCT01704963|Tumor|tumor
436339|NCT01704963|Pharmacokinetics|pharmacokinetics
436340|NCT01704963|Japanese|japanese
436341|NCT01704937|Fecal Microbiota Transplant|fecal microbiota transplant
436342|NCT01704937|Clostridium difficile|clostridium difficile
436343|NCT01704937|Diarrhea|diarrhea
436344|NCT01704924|Prevena|prevena
436345|NCT01704924|negative pressure wound therapy|negative pressure wound therapy
436346|NCT01704924|Incisional wound vac|incisional wound vac
436347|NCT01704911|Transradial|transradial
436348|NCT01704911|Transfemoral|transfemoral
436349|NCT01704911|Coronary Intervention|coronary intervention
436350|NCT01704898|efavirenz|efavirenz
436351|NCT01704898|bioequivalence|bioequivalence
436352|NCT01704898|fasting|fasting
436353|NCT01704898|healthy volunteers|healthy volunteers
436354|NCT01704885|Childhood Cancer|childhood cancer
436355|NCT01704885|Sibling Play intervention|sibling play intervention
436356|NCT01704885|Sibling Behavioral Intervention|sibling behavioral intervention
436357|NCT01704885|Siblings of Cancer Patients|siblings of cancer patients
436358|NCT01704872|Neuroblastoma|neuroblastoma
436359|NCT01704872|Refractory neuroblastoma|refractory neuroblastoma
436360|NCT01704872|ch14.18/CHO|ch14.18/cho
436361|NCT01704859|fracture|fracture
436362|NCT01704833|Psychosis|psychosis
436363|NCT01704833|Paranoia|paranoia
436364|NCT01704833|Cognitive Behavioral Therapy|cognitive behavioral therapy
436365|NCT01704833|Delusions|delusions
436366|NCT01704833|Group Therapy|group therapy
436367|NCT01704820|Colon Polyps|colon polyps
436368|NCT01704820|Colon Cancer screening|colon cancer screening
436369|NCT01704820|Colonoscopy|colonoscopy
436370|NCT01704807|Low Back Pain|low back pain
436371|NCT01704807|Chronic|chronic
436372|NCT01704807|Orthotic Device|orthotic device
436373|NCT01704807|Applied Kinesiology|applied kinesiology
436374|NCT01704807|Manual Muscle Testing|manual muscle testing
436375|NCT01704807|Chiropractic|chiropractic
436376|NCT01704794|Sickle Cell Anemia|sickle cell anemia
436377|NCT01704794|Quality of Life|quality of life
436378|NCT01704794|Antioxidant|antioxidant
436379|NCT01704794|Anti inflammatory|anti inflammatory
436380|NCT01704794|Sorghum bicolor|sorghum bicolor
436381|NCT01704781|CD4|cd4
436382|NCT01704781|Clinical trial|clinical trial
436383|NCT01704781|Dose escalation assessment lenalidomide|dose escalation assessment lenalidomide
436384|NCT01704781|Human immunodeficiency virus-1 (HIV-1)|human immunodeficiency virus-1 (hiv-1)
436385|NCT01704781|HIV|hiv
436386|NCT01704781|Immunomodulatory|immunomodulatory
436387|NCT01704781|Infection|infection
436388|NCT01704781|Lenalidomide|lenalidomide
436389|NCT01704781|Phase I/II|phase i/ii
436390|NCT01704781|Vaccine|vaccine
436391|NCT01704781|Vacc-4x|vacc-4x
436392|NCT01704768|Randomized Controlled Trial|randomized controlled trial
436393|NCT01704768|School-Based Intervention|school-based intervention
436394|NCT01704755|Cirrhosis|cirrhosis
436395|NCT01704755|Hepatitis C|hepatitis c
436396|NCT01704755|Child Pugh A|child pugh a
436397|NCT01704755|Compensated Cirrhosis|compensated cirrhosis
436398|NCT01704755|Hepatitis C Genotype 1|hepatitis c genotype 1
436399|NCT01704755|Cirrhotic|cirrhotic
436400|NCT01704755|Chronic Hepatitis C|chronic hepatitis c
436401|NCT01704755|Hepatitis C Virus|hepatitis c virus
436402|NCT01704755|ombitasvir|ombitasvir
436403|NCT01704755|paritaprevir|paritaprevir
436404|NCT01704755|dasabuvir|dasabuvir
436405|NCT01704755|Interferon-Free|interferon-free
436406|NCT01704755|Viekira Pak|viekira pak
436407|NCT01704742|Non-Hodgkin's Lymphoma|non-hodgkin's lymphoma
436408|NCT01704742|Hodgkin's Lymphoma|hodgkin's lymphoma
436409|NCT01704742|Kenya|kenya
436410|NCT01704742|Epstein Barr Virus (EBV)|epstein barr virus (ebv)
436411|NCT01704742|Human Immunodeficiency Virus (HIV)|human immunodeficiency virus (hiv)
436710|NCT01703637|Saxagliptin|saxagliptin
436412|NCT01704742|Kaposi's Sarcoma Herpes Virus (KSHV)|kaposi's sarcoma herpes virus (kshv)
436413|NCT01704729|Myopia|myopia
436414|NCT01704729|Focus groups|focus groups
436415|NCT01704729|refraction|refraction
436416|NCT01704729|Glasses|glasses
436417|NCT01704729|spectacles|spectacles
436418|NCT01704716|neuroblastoma|neuroblastoma
436419|NCT01704716|immunotherapy|immunotherapy
436420|NCT01704716|MAT|mat
436421|NCT01704716|antibody treatment|antibody treatment
436422|NCT01704703|colorectal cancer|colorectal cancer
436423|NCT01704703|FOLFIRI|folfiri
436424|NCT01704703|Panitumumab|panitumumab
436425|NCT01704703|KRAS, PIK3Ca,BRAF and NRAS genes|kras, pik3ca,braf and nras genes
436426|NCT01704703|highly sensitive techniques|highly sensitive techniques
436427|NCT01704690|Esophageal cancer|esophageal cancer
436428|NCT01704690|Chemotherapy|chemotherapy
436429|NCT01704690|Efficacy|efficacy
436430|NCT01704690|Toxicity|toxicity
436431|NCT01704677|Chronic low back pain|chronic low back pain
436432|NCT01704677|Degenerated disc|degenerated disc
436433|NCT01704677|Total disc replacement|total disc replacement
436434|NCT01704677|Multidisciplinary rehabilitation|multidisciplinary rehabilitation
436435|NCT01704677|Long term results|long term results
436436|NCT01704664|malnutrition,|malnutrition,
436437|NCT01704664|perioperative artificial nutrition,|perioperative artificial nutrition,
436438|NCT01704664|immunonutrition,|immunonutrition,
436439|NCT01704664|gastrectomy,|gastrectomy,
436440|NCT01704664|lymphocytes,|lymphocytes,
436441|NCT01704664|interleukin,|interleukin,
436442|NCT01704664|blood platelets,|blood platelets,
436443|NCT01704664|phagocytic and bactericidal activity of blood platelets|phagocytic and bactericidal activity of blood platelets
436444|NCT01704651|Ovary|ovary
436445|NCT01704651|Ovarian|ovarian
436446|NCT01704651|Fallopian|fallopian
436447|NCT01704651|Peritoneal|peritoneal
436448|NCT01704651|Cancer|cancer
436449|NCT01704651|Gynecological|gynecological
436450|NCT01704651|Female|female
436451|NCT01704625|pain|pain
436452|NCT01704625|headache|headache
436453|NCT01704612|local anesthetic|local anesthetic
436454|NCT01704612|sciatic|sciatic
436455|NCT01704612|diabetes|diabetes
436456|NCT01704612|block|block
436457|NCT01704612|duration|duration
436458|NCT01704599|Psoriasis|psoriasis
436459|NCT01704599|Adalimumab|adalimumab
436460|NCT01704599|B vitamins|b vitamins
436461|NCT01704599|Homocysteine|homocysteine
436462|NCT01704599|Folic acid|folic acid
436463|NCT01704599|Cyanocobalamin|cyanocobalamin
436464|NCT01704599|Pyridoxine|pyridoxine
436465|NCT01704599|Vitamin B6|vitamin b6
436466|NCT01704599|Vitamin B9|vitamin b9
436467|NCT01704599|Vitamin B12|vitamin b12
436468|NCT01704586|Differentiated thyroid carcinoma|differentiated thyroid carcinoma
436469|NCT01704586|PET/CT|pet/ct
436470|NCT01704586|Radioiodine Remnant Ablation|radioiodine remnant ablation
436471|NCT01704586|I-124|i-124
436472|NCT01704586|Quality of life|quality of life
436473|NCT01704573|PET Scan|pet scan
436474|NCT01704547|Breast cancer|breast cancer
436475|NCT01704547|Lumpectomy|lumpectomy
436476|NCT01704547|Breast Irradiation|breast irradiation
436477|NCT01704534|Hidradenitis suppurativa|hidradenitis suppurativa
436478|NCT01704534|Acne ectopica|acne ectopica
436479|NCT01704534|Inverse acne|inverse acne
436480|NCT01704534|Ustekinumab|ustekinumab
436481|NCT01704534|Stelara|stelara
436482|NCT01704521|Hepatitis C|hepatitis c
436483|NCT01704521|HCV|hcv
436484|NCT01704521|Hemophilia|hemophilia
436485|NCT01704508|Falciparum malaria|falciparum malaria
436486|NCT01704508|children|children
436487|NCT01704508|treatment|treatment
436488|NCT01704495|Uncontrolled Asthma,|uncontrolled asthma,
436489|NCT01704495|Exacerbation,|exacerbation,
436490|NCT01704495|Safety|safety
436491|NCT01704469|Opioid induced hyperalgesia|opioid induced hyperalgesia
436492|NCT01704456|provoked vestibulodynia|provoked vestibulodynia
436493|NCT01704456|dyspareunia|dyspareunia
436494|NCT01704456|vulvodynia|vulvodynia
436495|NCT01704456|mindfulness|mindfulness
436496|NCT01704456|cognitive behavioural therapy|cognitive behavioural therapy
436497|NCT01704443|provoked vestibulodynia|provoked vestibulodynia
436498|NCT01704443|dyspareunia|dyspareunia
436499|NCT01704443|vulvodynia|vulvodynia
436500|NCT01704443|mindfulness|mindfulness
436501|NCT01704443|cognitive behavioural therapy|cognitive behavioural therapy
436502|NCT01704430|Cardiac surgery|cardiac surgery
436503|NCT01704430|Cardiac bypass|cardiac bypass
436504|NCT01704430|Intensive Care|intensive care
436505|NCT01704430|Nosocomial infection|nosocomial infection
436506|NCT01704430|Glutamine|glutamine
436507|NCT01704430|Randomized trial|randomized trial
436508|NCT01704404|Long acting muscarinic antagonist|long acting muscarinic antagonist
436509|NCT01704404|Chronic Bronchitis|chronic bronchitis
436510|NCT01704404|Emphysema|emphysema
436511|NCT01704404|Chronic Obstructive Pulmonary Disease|chronic obstructive pulmonary disease
436512|NCT01704404|COPD|copd
436513|NCT01704352|Cognitive Behavioral Therapy|cognitive behavioral therapy
436514|NCT01704352|CBT-I|cbt-i
436515|NCT01704339|End stage renal failure|end stage renal failure
436516|NCT01704339|Neuropathic pain|neuropathic pain
436517|NCT01704339|Critical digital ischaemia|critical digital ischaemia
436518|NCT01704326|Deuce|deuce
436519|NCT01704326|Journey Deuce|journey deuce
436520|NCT01704326|Knee pain|knee pain
436521|NCT01704326|Osteoarthritis|osteoarthritis
436522|NCT01704326|Bicompartmental|bicompartmental
436523|NCT01704326|Femoral|femoral
436524|NCT01704326|Medial|medial
436525|NCT01704313|Vascular access|vascular access
436526|NCT01704313|Haemodialysis|haemodialysis
436527|NCT01704313|Suturing technique|suturing technique
436528|NCT01704300|Abdominal aortic aneurysm|abdominal aortic aneurysm
436529|NCT01704300|Acute Myocardial Infarction|acute myocardial infarction
436530|NCT01704300|Coronary heart disease not otherwise specified|coronary heart disease not otherwise specified
436531|NCT01704300|Haemorrhagic stroke|haemorrhagic stroke
436532|NCT01704300|Heart failure|heart failure
436533|NCT01704300|Ischaemic stroke|ischaemic stroke
436534|NCT01704300|Peripheral arterial disease|peripheral arterial disease
436535|NCT01704300|Stable angina|stable angina
436536|NCT01704300|Unheralded coronary death|unheralded coronary death
436537|NCT01704300|Unstable angina|unstable angina
436538|NCT01704300|Ventricular arrhythmias, cardiac arrest and sudden cardiac death|ventricular arrhythmias, cardiac arrest and sudden cardiac death
436539|NCT01704300|Transient Ischemic Attack|transient ischemic attack
436540|NCT01704287|Programmed Cell Death-1 (PD1, PD-1)|programmed cell death-1 (pd1, pd-1)
436541|NCT01704287|Programmed Death-Ligand 1 (PDL1, PD-L1)|programmed death-ligand 1 (pdl1, pd-l1)
436542|NCT01704274|biochemical|biochemical
436543|NCT01704274|recurrence|recurrence
436544|NCT01704274|prostate|prostate
436545|NCT01704274|cancer|cancer
436546|NCT01704274|active|active
436547|NCT01704274|surveillence|surveillence
436548|NCT01704248|eye drops self-instillation|eye drops self-instillation
436549|NCT01704235|screening|screening
436550|NCT01704222|Children|children
436551|NCT01704222|nursery|nursery
436552|NCT01704222|CMV|cmv
436553|NCT01704222|Infection|infection
436554|NCT01704183|relapse-remitting multiple sclerosis|relapse-remitting multiple sclerosis
436555|NCT01704183|heart rate variability|heart rate variability
436556|NCT01704183|fingolimod|fingolimod
436557|NCT01704183|cardiac autonomic regulation|cardiac autonomic regulation
436558|NCT01704157|Osteoarthritis|osteoarthritis
436559|NCT01704157|knee|knee
436560|NCT01704157|chronic pain|chronic pain
436561|NCT01704144|Efavirenz|efavirenz
436562|NCT01704144|rifampin|rifampin
436563|NCT01704144|Pharmacokinetics|pharmacokinetics
436564|NCT01704144|Drug-drug interactions|drug-drug interactions
436565|NCT01704144|Drug-gene interactions|drug-gene interactions
436566|NCT01704144|Children|children
436567|NCT01704131|Levosimendan|levosimendan
436568|NCT01704131|Children|children
436569|NCT01704131|Pharmacokinetics|pharmacokinetics
436570|NCT01704118|I-gel|i-gel
436571|NCT01704118|ProSeal laryngeal mask|proseal laryngeal mask
436572|NCT01704118|small infants|small infants
436573|NCT01704118|neonates|neonates
436574|NCT01704105|Chlorine water treatment|chlorine water treatment
436575|NCT01704105|Point-of-use water treatment|point-of-use water treatment
436576|NCT01704105|Household water treatment with safe storage|household water treatment with safe storage
436577|NCT01704105|Handwashing with soap|handwashing with soap
436578|NCT01704105|Hand hygiene|hand hygiene
436579|NCT01704105|Latrines|latrines
436580|NCT01704105|Water|water
436581|NCT01704105|Sanitation|sanitation
436582|NCT01704105|Handwashing|handwashing
436583|NCT01704105|Breast Feeding|breast feeding
436584|NCT01704105|Complementary Feeding|complementary feeding
436585|NCT01704105|Micronutrients|micronutrients
436586|NCT01704105|Malnutrition|malnutrition
436587|NCT01704105|Nutrition Disorders|nutrition disorders
436588|NCT01704105|Diarrhea|diarrhea
436589|NCT01704105|Child Development|child development
436590|NCT01704105|Child potties|child potties
436591|NCT01704105|Point-of-use fortification|point-of-use fortification
436592|NCT01704105|Lipid-based nutrient supplement|lipid-based nutrient supplement
436593|NCT01704105|Exclusive breastfeeding|exclusive breastfeeding
436594|NCT01704105|Environmental enteropathy|environmental enteropathy
436595|NCT01704105|Tropical enteropathy|tropical enteropathy
436596|NCT01704105|Gut function|gut function
436597|NCT01704105|Intestinal parasitic infection|intestinal parasitic infection
436598|NCT01704105|Soil transmitted helminths|soil transmitted helminths
436599|NCT01704105|Intestinal protozoans|intestinal protozoans
436600|NCT01704105|Antibody response|antibody response
436601|NCT01704079|Parathyroid Diseases|parathyroid diseases
436602|NCT01704079|Renal Insufficiency|renal insufficiency
436603|NCT01704079|Kidney Failure, Chronic|kidney failure, chronic
436604|NCT01704079|Hyperparathyroidism, Secondary|hyperparathyroidism, secondary
436605|NCT01704079|Vitamin D|vitamin d
436606|NCT01704079|Hyperparathyroidism|hyperparathyroidism
436607|NCT01704079|Kidney Diseases|kidney diseases
436608|NCT01704079|Kidney Failure|kidney failure
436609|NCT01704079|Renal Insufficiency, Chronic|renal insufficiency, chronic
436610|NCT01704066|ARDS|ards
436611|NCT01704066|Chest radiograph|chest radiograph
436612|NCT01704066|Berlin Definition|berlin definition
436613|NCT01704066|Inter-observer agreement|inter-observer agreement
436614|NCT01704053|New Oral Anticoagulants|new oral anticoagulants
436615|NCT01704053|Dabigatran|dabigatran
436616|NCT01704053|Rivaroxaban|rivaroxaban
436617|NCT01704053|Thrombelastometry/-graphy (ROTEM, TEG)|thrombelastometry/-graphy (rotem, teg)
436618|NCT01704053|Multiple Platelet Function Analyzer (Multiplate)|multiple platelet function analyzer (multiplate)
436619|NCT01704040|Healthy volunteers and asthma|healthy volunteers and asthma
436620|NCT01704040|CNTO 3157|cnto 3157
436621|NCT01704040|Rhinovirus|rhinovirus
436622|NCT01704027|Localized|localized
436623|NCT01704027|High risk|high risk
436624|NCT01704014|occurrence of|occurrence of
436625|NCT01704001|ART-123|art-123
436626|NCT01704001|Disseminated Intravascular Coagulation|disseminated intravascular coagulation
436627|NCT01704001|Pharmacokinetics|pharmacokinetics
436628|NCT01703988|Spinal Muscular Atrophy|spinal muscular atrophy
436629|NCT01703988|SMA|sma
436630|NCT01703988|SMN|smn
436631|NCT01703988|SMNRx|smnrx
436632|NCT01703988|ISIS-SMNRx|isis-smnrx
436633|NCT01703988|ISIS 396443|isis 396443
436634|NCT01703975|Simulation efficiency|simulation efficiency
436635|NCT01703975|Collaborative learning|collaborative learning
436636|NCT01703962|Glioma|glioma
436637|NCT01703962|IDH1|idh1
436638|NCT01703962|Spectroscopy|spectroscopy
436639|NCT01703962|Plasma|plasma
436640|NCT01703936|economic intervention|economic intervention
436641|NCT01703936|ex-combatant|ex-combatant
436642|NCT01703936|agriculture|agriculture
436643|NCT01703936|life skills|life skills
436644|NCT01703910|Genomic expression profile in tumor samples|genomic expression profile in tumor samples
436645|NCT01703910|Adult patients|adult patients
436646|NCT01703910|metastatic disease status and progression after two lines of systemic therapy|metastatic disease status and progression after two lines of systemic therapy
436647|NCT01703897|gastric by-pass surgery|gastric by-pass surgery
436648|NCT01703884|Malria diagnosis|malria diagnosis
436649|NCT01703884|Malaria prevention in pregnancy|malaria prevention in pregnancy
436650|NCT01703884|ANC services improvement|anc services improvement
436651|NCT01703832|acute stress reaction|acute stress reaction
436652|NCT01703832|stress|stress
436653|NCT01703832|stress perception|stress perception
436654|NCT01703832|physiological stress response|physiological stress response
436655|NCT01703832|Neurexan|neurexan
436656|NCT01703819|acute stress reaction|acute stress reaction
436657|NCT01703819|stress|stress
436658|NCT01703819|stress perception|stress perception
436659|NCT01703819|physiological stress response|physiological stress response
436660|NCT01703819|Neurexan|neurexan
436661|NCT01703806|Mitral regurgitation|mitral regurgitation
436662|NCT01703806|Mitral valve repair|mitral valve repair
436663|NCT01703806|Watchful waiting|watchful waiting
436664|NCT01703767|patient satisfaction|patient satisfaction
436665|NCT01703767|Gulf War 1 Veteran|gulf war 1 veteran
436666|NCT01703767|Desert Storm Veteran|desert storm veteran
436667|NCT01703754|Genetically Modified Organism|genetically modified organism
436668|NCT01703754|Metastatic Breast Cancer|metastatic breast cancer
436669|NCT01703754|Recurrent Breast Cancer|recurrent breast cancer
436670|NCT01703754|Breast Cancer|breast cancer
436671|NCT01703754|Palifosfamide|palifosfamide
436672|NCT01703754|INXN1001|inxn1001
436673|NCT01703754|INXN2001|inxn2001
436674|NCT01703754|Adenoviral vector|adenoviral vector
436675|NCT01703715|Hydration|hydration
436676|NCT01703715|Elderly patients|elderly patients
436677|NCT01703715|Age 65 years and over|age 65 years and over
436678|NCT01703715|Admitted acutely to medical admissions ward|admitted acutely to medical admissions ward
436679|NCT01703689|Quality indicators|quality indicators
436680|NCT01703689|quality of care|quality of care
436681|NCT01703689|nursing home|nursing home
436682|NCT01703689|long-term care unit|long-term care unit
436683|NCT01703689|nursing home organisation|nursing home organisation
436684|NCT01703689|nursing home structure|nursing home structure
436685|NCT01703689|disability|disability
436686|NCT01703689|dependence|dependence
436687|NCT01703689|functional decline|functional decline
436688|NCT01703689|functional impairment|functional impairment
436689|NCT01703689|older adults|older adults
436690|NCT01703689|elderly|elderly
436691|NCT01703689|audit and feedback|audit and feedback
436692|NCT01703689|cooperative work|cooperative work
436693|NCT01703689|geriatrician|geriatrician
436694|NCT01703689|medication|medication
436695|NCT01703689|hospitalisation|hospitalisation
436696|NCT01703689|comorbidity|comorbidity
436697|NCT01703676|Hypogonadism, Klinefelter Syndrome, Cardiovascular Risk, Epigenetics, Methylation of Genes|hypogonadism, klinefelter syndrome, cardiovascular risk, epigenetics, methylation of genes
436698|NCT01703676|Cardiovascular risk factors|cardiovascular risk factors
436699|NCT01703676|Gonadal status|gonadal status
436700|NCT01703676|Gene expression|gene expression
436701|NCT01703676|Methylation|methylation
436702|NCT01703663|Stroke|stroke
436703|NCT01703663|Sleep Apnea|sleep apnea
436704|NCT01703650|CT|ct
436705|NCT01703650|pancreas adenocarcinoma|pancreas adenocarcinoma
436706|NCT01703650|RECIST|recist
436707|NCT01703650|perfusion|perfusion
436708|NCT01703637|Sitagliptin|sitagliptin
436709|NCT01703637|Vildagliptin|vildagliptin
436711|NCT01703637|Diabetes Mellitus, Type 2|diabetes mellitus, type 2
436712|NCT01703624|glycopyrronium bromide|glycopyrronium bromide
436713|NCT01703624|glycopyrrolate|glycopyrrolate
436714|NCT01703624|oral inhalation|oral inhalation
436715|NCT01703624|COPD|copd
436716|NCT01703624|chronic obstructive pulmonary disease|chronic obstructive pulmonary disease
436717|NCT01703624|lung function|lung function
436718|NCT01703624|pharmacokinetics|pharmacokinetics
436719|NCT01703624|tolerability|tolerability
436720|NCT01703624|safety|safety
436721|NCT01703624|cross-over|cross-over
436722|NCT01703624|single-dose|single-dose
436723|NCT01703624|dose-ranging|dose-ranging
436724|NCT01703611|Nutrition|nutrition
436725|NCT01703611|Medical Nutrition Therapy|medical nutrition therapy
436726|NCT01703611|Diabetes Mellitus|diabetes mellitus
436727|NCT01703611|Nutrition outcomes|nutrition outcomes
436728|NCT01703611|Evidence Based Guidelines|evidence based guidelines
436729|NCT01703598|Parkinson's disease|parkinson's disease
436730|NCT01703598|Deep Brain Stimulation|deep brain stimulation
436731|NCT01703585|genomic analysis|genomic analysis
436732|NCT01703585|genome|genome
436733|NCT01703585|tumor|tumor
436734|NCT01703585|tissue|tissue
436735|NCT01703585|archival|archival
436736|NCT01703585|biopsy|biopsy
436737|NCT01703585|core needle|core needle
436738|NCT01703585|fine needle|fine needle
436740|NCT01703585|gene|gene
436741|NCT01703585|expression|expression
436742|NCT01703585|sequencing|sequencing
436743|NCT01703572|Phase 1|phase 1
557975|NCT01186549|pain|pain
436744|NCT01703572|Dose escalation|dose escalation
436745|NCT01703572|relapsed or refractory|relapsed or refractory
436746|NCT01703572|lymphoid malignancies|lymphoid malignancies
436747|NCT01703559|Glare|glare
436748|NCT01703559|Starbursts|starbursts
436749|NCT01703559|Halos|halos
436750|NCT01703559|Reduced Contrast Sensitivity|reduced contrast sensitivity
436751|NCT01703559|Night Vision Disturbances|night vision disturbances
436752|NCT01703559|NVD|nvd
436753|NCT01703559|NVDs|nvds
436754|NCT01703546|Morbid Obesity|morbid obesity
436755|NCT01703546|Weight Loss Surgery|weight loss surgery
436756|NCT01703546|Laparoscopic Adjustable Gastric Band|laparoscopic adjustable gastric band
436757|NCT01703546|Laparoscopic Gastric Plication|laparoscopic gastric plication
436758|NCT01703546|Imbrication|imbrication
436759|NCT01703533|Autism|autism
436760|NCT01703533|Rett's Syndrome|rett's syndrome
436761|NCT01703533|Rett Disorder|rett disorder
436762|NCT01703533|Rett's Disorder|rett's disorder
436763|NCT01703533|Ataxia|ataxia
436764|NCT01703520|Males breast cancer|males breast cancer
436765|NCT01703520|Finasteride|finasteride
436766|NCT01703520|PROSCAR®|proscar®
436767|NCT01703520|PROPECIA®|propecia®
436768|NCT01703494|C. difficile|c. difficile
436769|NCT01703494|fecal transplant|fecal transplant
436770|NCT01703494|stool transplant|stool transplant
436771|NCT01703494|fecal flora reconstitution|fecal flora reconstitution
436772|NCT01703494|fecal microbiota transplant|fecal microbiota transplant
436773|NCT01703494|FMT|fmt
436774|NCT01703481|Tumor|tumor
436775|NCT01703481|Fibroblast Growth Factor Receptor (FGFR)|fibroblast growth factor receptor (fgfr)
436776|NCT01703481|Non-Small Cell Lung Cancer (NSCLC)|non-small cell lung cancer (nsclc)
436777|NCT01703481|Small Cell Lung Cancer (SCLC)|small cell lung cancer (sclc)
436778|NCT01703481|JNJ-42756493|jnj-42756493
436779|NCT01703455|Salivary gland cancer metastatic disease recurrent disease clinical trial|salivary gland cancer metastatic disease recurrent disease clinical trial
436780|NCT01703429|Multiple Sclerosis|multiple sclerosis
436781|NCT01703429|MS|ms
436782|NCT01703429|Complementary and Alternative|complementary and alternative
436783|NCT01703429|CAM|cam
436784|NCT01703416|COPD|copd
436785|NCT01703416|GOLD group C and D|gold group c and d
436786|NCT01703416|CDLM questionnaire|cdlm questionnaire
436787|NCT01703416|visual scale - physician evaluation|visual scale - physician evaluation
436788|NCT01703403|physical therapy|physical therapy
436789|NCT01703403|treated at NTUH and received rehabilitation at the PTC in recent ten years.|treated at ntuh and received rehabilitation at the ptc in recent ten years.
436790|NCT01703390|metastatic colorectal cancer|metastatic colorectal cancer
436791|NCT01703390|mCRC|mcrc
436792|NCT01703390|ERCC-1|ercc-1
436793|NCT01703390|ERCC1|ercc1
436794|NCT01703390|AGMT|agmt
436795|NCT01703364|CLL|cll
436796|NCT01703364|Lenalidomide|lenalidomide
436797|NCT01703364|Revlimid|revlimid
436798|NCT01703364|AGMT|agmt
436799|NCT01703364|T cell|t cell
436800|NCT01703351|pain control, VATS|pain control, vats
436801|NCT01703338|assessment model|assessment model
436802|NCT01703338|biomechanical changes|biomechanical changes
436803|NCT01703338|functional activities|functional activities
436804|NCT01703338|magnetic resonance imaging (MRI)|magnetic resonance imaging (mri)
436805|NCT01703338|causal relationship|causal relationship
436806|NCT01703338|core muscles activation pattern|core muscles activation pattern
436807|NCT01703338|pathological changes|pathological changes
436808|NCT01703338|early rehabilitation|early rehabilitation
436809|NCT01703338|core stability exercise|core stability exercise
436810|NCT01703338|minimally invasive lumbar spinal fusion surgery|minimally invasive lumbar spinal fusion surgery
436811|NCT01703325|Psoriatic nails|psoriatic nails
436812|NCT01703325|Triamcinolone injection|triamcinolone injection
436813|NCT01703325|clobetasol propionate|clobetasol propionate
436814|NCT01703312|Allergies, asthma, IgE|allergies, asthma, ige
436815|NCT01703299|imipenem|imipenem
436816|NCT01703299|ertapenem|ertapenem
436817|NCT01703299|resistance|resistance
436818|NCT01703299|commensal flora|commensal flora
436819|NCT01703273|Extreme Obesity Keywords: obesity, adiposity, psychosocial, healthcare, co-morbidities, low key intervention, quality of life|extreme obesity keywords: obesity, adiposity, psychosocial, healthcare, co-morbidities, low key intervention, quality of life
436820|NCT01703260|Drug therapy|drug therapy
436821|NCT01703247|Arrhythmias|arrhythmias
436822|NCT01703247|Ablation|ablation
436823|NCT01703234|FGF-23 , ramipril, endothelial dysfunction|fgf-23 , ramipril, endothelial dysfunction
436824|NCT01703195|Vaginal Cancer|vaginal cancer
436825|NCT01703195|Malignancies involving the vagina|malignancies involving the vagina
436826|NCT01703195|Middle third and the distal third of the vagina|middle third and the distal third of the vagina
436827|NCT01703195|Pre and post radiation therapy|pre and post radiation therapy
436828|NCT01703195|Diffusion weighted magnetic resonance imaging|diffusion weighted magnetic resonance imaging
436830|NCT01703195|Magnetic resonance imaging|magnetic resonance imaging
436831|NCT01703195|MRI|mri
436832|NCT01703195|Tumor involvement|tumor involvement
436833|NCT01703195|Response to radiation therapy|response to radiation therapy
436834|NCT01703195|XRT|xrt
436835|NCT01703182|transcutaneous oximetry|transcutaneous oximetry
436836|NCT01703182|transcutaneous carbon dioxide|transcutaneous carbon dioxide
436837|NCT01703182|leg amputation|leg amputation
436838|NCT01703182|wound healing failure|wound healing failure
436839|NCT01703182|amputation revision|amputation revision
436840|NCT01703169|severe aplastic anemia|severe aplastic anemia
436841|NCT01703169|very severe aplastic anemia|very severe aplastic anemia
436842|NCT01703169|moderate aplastic anemia|moderate aplastic anemia
436843|NCT01703169|bleeding|bleeding
436844|NCT01703156|Low Risk ACS, Acute Coronary Syndrome, Stress Testing, Non-Stress Testing|low risk acs, acute coronary syndrome, stress testing, non-stress testing
436845|NCT01703130|ISPB|ispb
436846|NCT01703130|Brachial Plexus Block|brachial plexus block
436847|NCT01703130|Anesthesia|anesthesia
436848|NCT01703130|Pain Management|pain management
436849|NCT01703130|Surgery|surgery
436850|NCT01703117|Alzheimer's Disease|alzheimer's disease
436851|NCT01703117|Dementia|dementia
436852|NCT01703104|Sorghum bicolor|sorghum bicolor
436853|NCT01703104|sickle cell anaemia|sickle cell anaemia
436854|NCT01703104|haematological parameters|haematological parameters
436855|NCT01703065|Prostate cancer|prostate cancer
436856|NCT01703065|Bone metastases|bone metastases
436857|NCT01703039|Major Depression|major depression
436858|NCT01703039|Major Depressive Disorder|major depressive disorder
436859|NCT01703039|Depression|depression
436860|NCT01703039|Riluzole|riluzole
436861|NCT01703039|Glutamate|glutamate
436862|NCT01703039|Sertraline|sertraline
436863|NCT01703013|Demonstrate that DEFA4 is a reliable biomarker for the prediction of adrenal insufficiency|demonstrate that defa4 is a reliable biomarker for the prediction of adrenal insufficiency
436864|NCT01703000|drug eluting coronary stent|drug eluting coronary stent
436865|NCT01702987|ubiquinol (coenzyme Q10)|ubiquinol (coenzyme q10)
436866|NCT01702974|HIV|hiv
436867|NCT01702974|cholecalciferol|cholecalciferol
436868|NCT01702974|sodium phenylbutyrate|sodium phenylbutyrate
436869|NCT01702974|antimicrobial peptides|antimicrobial peptides
436870|NCT01702974|immune response|immune response
436871|NCT01702974|inflammation|inflammation
436872|NCT01702961|Lymphoma|lymphoma
436873|NCT01702961|Hodgkin's Disease|hodgkin's disease
436874|NCT01702948|Functional Magnetic Resonance Imaging (fMRI)|functional magnetic resonance imaging (fmri)
436875|NCT01702948|Nicotine|nicotine
436876|NCT01702948|Repetitive TMS (rTMS)|repetitive tms (rtms)
436877|NCT01702948|fMRI|fmri
436878|NCT01702935|Ovarian Failure|ovarian failure
436879|NCT01702935|Premature Ovarian Failure|premature ovarian failure
436880|NCT01702935|Infertility|infertility
436881|NCT01702935|Primary Ovarian Insufficiency|primary ovarian insufficiency
436882|NCT01702935|Stem Cells|stem cells
436883|NCT01702922|Stress|stress
436884|NCT01702922|Marriage|marriage
436885|NCT01702922|Dyadic Coping|dyadic coping
436886|NCT01702922|Mother|mother
436887|NCT01702922|Father|father
436888|NCT01702909|Metastatic Renal Cell|metastatic renal cell
436889|NCT01702909|Metastatic Kidney Cancer|metastatic kidney cancer
436890|NCT01702896|Metastatic Melanoma|metastatic melanoma
436891|NCT01702883|prescriptions|prescriptions
436892|NCT01702883|hypertension|hypertension
436893|NCT01702883|high cholesterol|high cholesterol
436894|NCT01702883|diabetes|diabetes
436895|NCT01702883|depression|depression
436896|NCT01702883|adherence|adherence
436897|NCT01702870|Magnetic resonance imaging|magnetic resonance imaging
436898|NCT01702857|Dengue|dengue
436899|NCT01702857|Dengue fever|dengue fever
436900|NCT01702857|Dengue Hemorrhagic Fever|dengue hemorrhagic fever
436901|NCT01702857|Flavivirus|flavivirus
436902|NCT01702844|Nab paclitaxel|nab paclitaxel
436903|NCT01702844|Abraxane|abraxane
436904|NCT01702844|First Line|first line
436905|NCT01702844|Non small cell lung cancer|non small cell lung cancer
436906|NCT01702844|NSCLC|nsclc
436907|NCT01702844|Phase II|phase ii
436908|NCT01702844|Non-Randomized|non-randomized
436909|NCT01702844|Elderly|elderly
436910|NCT01702844|Lineberger|lineberger
436911|NCT01702844|UNC|unc
436912|NCT01702844|LCCC 1210|lccc 1210
436913|NCT01702831|Newly Diagnosed multiple myeloma|newly diagnosed multiple myeloma
436914|NCT01702818|Hypoactive Sexual Desire Disorder|hypoactive sexual desire disorder
436915|NCT01702818|HSDD|hsdd
436916|NCT01702818|Cortisol|cortisol
436917|NCT01702818|DHEA|dhea
436918|NCT01702818|Stress Hormones|stress hormones
436919|NCT01702818|Sexual Desire|sexual desire
436920|NCT01702818|Mood|mood
436921|NCT01702818|Sexual Function|sexual function
436922|NCT01702818|Childhood Maltreatment|childhood maltreatment
436923|NCT01702818|Childhood Abuse|childhood abuse
436924|NCT01702805|NICHD Neonatal Research Network|nichd neonatal research network
436925|NCT01702805|Very Low Birth Weight (VLBW)|very low birth weight (vlbw)
436926|NCT01702805|Extremely Low Birth Weight (ELBW)|extremely low birth weight (elbw)
436927|NCT01702805|Transfusions|transfusions
436928|NCT01702792|Immunotherapy, cancer vaccine, glioblastoma, hybridoma|immunotherapy, cancer vaccine, glioblastoma, hybridoma
436929|NCT01702779|Weaning from mechanical ventilation|weaning from mechanical ventilation
436930|NCT01702779|Lung ultrasound|lung ultrasound
436931|NCT01702779|Oxygen inhalation therapy|oxygen inhalation therapy
436932|NCT01702740|Cutaneous lupus erythematosus|cutaneous lupus erythematosus
436933|NCT01702740|Systemic lupus erythematosus|systemic lupus erythematosus
436934|NCT01702740|Lupus erythematosus|lupus erythematosus
436935|NCT01702740|Human anti-IL 6 monoclonal antibody|human anti-il 6 monoclonal antibody
436936|NCT01702740|Sirukumab|sirukumab
436937|NCT01702727|Amblyopia|amblyopia
436938|NCT01702727|I-BiT TM|i-bit tm
436939|NCT01702727|Interactive games|interactive games
436940|NCT01702727|Binocular|binocular
436941|NCT01702675|Safety|safety
436942|NCT01702675|Pharmacokinetics|pharmacokinetics
436943|NCT01702675|Tolerability|tolerability
436944|NCT01702675|Healthy men|healthy men
436945|NCT01702636|Intracerebral Hemorrhage|intracerebral hemorrhage
436946|NCT01702636|ICH|ich
436947|NCT01702636|Stroke|stroke
436948|NCT01702636|Cerebrovascular Disorders|cerebrovascular disorders
436949|NCT01702636|Brain Diseases|brain diseases
436950|NCT01702636|Central Nervous System Diseases|central nervous system diseases
436951|NCT01702636|Nervous System Diseases|nervous system diseases
436952|NCT01702636|Vascular Diseases|vascular diseases
436953|NCT01702636|Cardiovascular Diseases|cardiovascular diseases
436954|NCT01702636|Tranexamic Acid|tranexamic acid
436955|NCT01702636|Antifibrinolytic Agents|antifibrinolytic agents
436956|NCT01702636|Fibrin Modulating Agents|fibrin modulating agents
436957|NCT01702636|Pharmacologic Actions|pharmacologic actions
436958|NCT01702636|Cardiovascular Agents|cardiovascular agents
436959|NCT01702636|Therapeutic Uses|therapeutic uses
436960|NCT01702636|Hematologic Agents|hematologic agents
436961|NCT01702636|Hemostatics|hemostatics
436962|NCT01702636|Contrast Media|contrast media
436963|NCT01702636|Angiography|angiography
436964|NCT01702636|Cerebral Angiography|cerebral angiography
436965|NCT01702636|Tomography, X-Ray Computed|tomography, x-ray computed
436966|NCT01702584|stent|stent
436967|NCT01702584|intracranial aneurysm|intracranial aneurysm
436968|NCT01702584|embolization|embolization
436969|NCT01702584|adverse event|adverse event
436970|NCT01702532|provoked craving|provoked craving
436971|NCT01702506|Dacomitinib|dacomitinib
436972|NCT01702506|PF-00299804|pf-00299804
436973|NCT01702506|fed|fed
436974|NCT01702506|fasted|fasted
436975|NCT01702506|antacid|antacid
436976|NCT01702506|relative Bioavailability|relative bioavailability
436977|NCT01702493|SRT2104|srt2104
436978|NCT01702493|Modified Release|modified release
436979|NCT01702493|Bioavailability|bioavailability
436980|NCT01702493|Crossover|crossover
436981|NCT01702480|Consumer Healthcare|consumer healthcare
436982|NCT01702480|Ketones|ketones
436983|NCT01702480|Medium Chain Triglycerides|medium chain triglycerides
436984|NCT01702480|Age related cognitive decline|age related cognitive decline
436985|NCT01702480|GSK Nutrition|gsk nutrition
436986|NCT01702467|Lp-PLA2|lp-pla2
436987|NCT01702467|Alzheimer's disease|alzheimer's disease
436988|NCT01702454|GSK Biologicals quadrivalent influenza vaccine|gsk biologicals quadrivalent influenza vaccine
436989|NCT01702454|Influenza|influenza
436990|NCT01702454|Children|children
436991|NCT01702454|Safety|safety
436992|NCT01702454|Immunogenicity|immunogenicity
436993|NCT01702428|Safety|safety
436994|NCT01702428|Consistency study|consistency study
436995|NCT01702428|Measles, mumps and rubella diseases|measles, mumps and rubella diseases
436996|NCT01702428|Healthy children|healthy children
436997|NCT01702428|Immunogenicity|immunogenicity
436998|NCT01702415|Cystic fibrosis|cystic fibrosis
436999|NCT01702415|Bone density|bone density
437000|NCT01702402|intervention|intervention
437001|NCT01702389|opioid induced hyperalgesia|opioid induced hyperalgesia
437002|NCT01702389|Pain|pain
437003|NCT01702389|Postoperative pain|postoperative pain
437004|NCT01702389|Hyperalgesia|hyperalgesia
437005|NCT01702363|Chronic Obstructive Pulmonary Disease (COPD), GSK573719, Pharmacogenetics|chronic obstructive pulmonary disease (copd), gsk573719, pharmacogenetics
437006|NCT01702350|Healthy Subjects|healthy subjects
437007|NCT01702350|Relative Bioavailability|relative bioavailability
437008|NCT01702350|Pharmacokinetics|pharmacokinetics
437009|NCT01702350|Elderly Subjects|elderly subjects
437010|NCT01702337|Gardasil|gardasil
437011|NCT01702337|Prevalence-model|prevalence-model
437012|NCT01702337|Cervarix|cervarix
437013|NCT01702337|economic|economic
437014|NCT01702337|health|health
437015|NCT01702324|Psoriasis Vulgaris|psoriasis vulgaris
437016|NCT01702324|Plaque|plaque
437017|NCT01702324|Topical|topical
437018|NCT01702324|Treatment|treatment
437019|NCT01702311|Diabetes|diabetes
437020|NCT01702311|Point of care testing|point of care testing
437021|NCT01702311|Hypoglycemia|hypoglycemia
437022|NCT01702311|Basal bolus insulin|basal bolus insulin
437023|NCT01702285|Advanced Solid Tumors|advanced solid tumors
437024|NCT01702285|EGFR|egfr
437025|NCT01702285|HDAC|hdac
437026|NCT01702285|Her2|her2
437027|NCT01702285|Open-Label|open-label
558374|NCT01185067|DHF|dhf
437028|NCT01702285|Dose-Escalation|dose-escalation
437029|NCT01702246|sickle cell disease|sickle cell disease
437030|NCT01702246|statins|statins
437031|NCT01702246|vaso-occlusive pain|vaso-occlusive pain
437032|NCT01702246|inflammation|inflammation
437033|NCT01702246|biomarkers|biomarkers
437034|NCT01702220|Generalized Anxiety Disorder|generalized anxiety disorder
437035|NCT01702220|Geriatric|geriatric
437036|NCT01702207|Prograf®|prograf®
437037|NCT01702207|Advagraf®|advagraf®
437038|NCT01702207|tacrolimus|tacrolimus
437039|NCT01702207|kidney transplant|kidney transplant
437040|NCT01702207|renal transplant|renal transplant
437041|NCT01702207|cardiovascular risk|cardiovascular risk
437042|NCT01702207|Framingham Risk|framingham risk
437043|NCT01702207|Reynolds Risk|reynolds risk
437044|NCT01702207|immunosuppression|immunosuppression
437045|NCT01702194|OIC|oic
437046|NCT01702194|Opioid Induced Constipation|opioid induced constipation
437047|NCT01702194|Constipation|constipation
437048|NCT01702181|Atopic Dermatitis, Eczema|atopic dermatitis, eczema
437049|NCT01702168|PTSD|ptsd
437050|NCT01702168|EBT|ebt
437051|NCT01702168|EST|est
437052|NCT01702168|Community|community
437053|NCT01702168|Latino|latino
437054|NCT01702142|Addiction Treatment|addiction treatment
437055|NCT01702129|EGFR|egfr
437056|NCT01702129|liposomes|liposomes
437057|NCT01702129|immunoliposomes|immunoliposomes
437058|NCT01702116|rectal adenocarcinoma|rectal adenocarcinoma
437059|NCT01702116|Standard APR|standard apr
437060|NCT01702116|Extralevator APR|extralevator apr
437061|NCT01702090|HIV-1|hiv-1
437062|NCT01702090|TMC114|tmc114
437063|NCT01702090|Darunavir|darunavir
437064|NCT01702090|PREZISTA|prezista
437065|NCT01702090|Ritonavir|ritonavir
437066|NCT01702090|Antiretrovirals|antiretrovirals
437067|NCT01702090|Early access|early access
437068|NCT01702090|Early treatment|early treatment
437069|NCT01702090|Treatment naive|treatment naive
437070|NCT01702077|neurofeedback|neurofeedback
437071|NCT01702077|biofeedback|biofeedback
437072|NCT01702077|real-time fMRI|real-time fmri
437073|NCT01702077|rt-fMRI|rt-fmri
437074|NCT01702077|functional connectivity|functional connectivity
437075|NCT01702077|fMRI|fmri
437076|NCT01702064|CML|cml
437077|NCT01702064|CP-CML|cp-cml
437078|NCT01702064|Chronic Phase-CML (CP-CML)|chronic phase-cml (cp-cml)
437079|NCT01702064|chronic myeloid leukemia|chronic myeloid leukemia
437080|NCT01702051|Pancreatogenic diabetes|pancreatogenic diabetes
437081|NCT01702051|Autologou Islet Transplantation|autologou islet transplantation
437082|NCT01702051|Pancreas|pancreas
437083|NCT01702051|Pancreatectomy|pancreatectomy
437084|NCT01702025|Hypoxia|hypoxia
437085|NCT01702025|Altitude|altitude
437086|NCT01702025|Exercise|exercise
437087|NCT01702012|Diabetes-Obesity|diabetes-obesity
437088|NCT01701999|Botulism Vaccine|botulism vaccine
437089|NCT01701973|obesity|obesity
437090|NCT01701973|growth hormone|growth hormone
437091|NCT01701947|Factor XI deficiency|factor xi deficiency
437092|NCT01701947|EAP|eap
437093|NCT01701947|postpartum hemorrhage|postpartum hemorrhage
437094|NCT01701947|surgery|surgery
437095|NCT01701947|delivery|delivery
437096|NCT01701947|Child birth|child birth
437097|NCT01701934|COPD|copd
437098|NCT01701934|Intrabdominal adiposity|intrabdominal adiposity
437099|NCT01701934|Body composition|body composition
437100|NCT01701934|Triglycerides|triglycerides
437101|NCT01701934|Cholesterol|cholesterol
437102|NCT01701921|cardiac surgery|cardiac surgery
437103|NCT01701921|pregabalin|pregabalin
437104|NCT01701921|postoperative pain|postoperative pain
437105|NCT01701908|PPCs|ppcs
437106|NCT01701908|abdominal surgery|abdominal surgery
437107|NCT01701908|postoperative infections|postoperative infections
437108|NCT01701908|postoperative residual curarization|postoperative residual curarization
437109|NCT01701908|tracheal re-intubation|tracheal re-intubation
437110|NCT01701908|mortality|mortality
437111|NCT01701908|ICU stay|icu stay
437112|NCT01701895|Complera|complera
437113|NCT01701895|short-term|short-term
437114|NCT01701895|long-term|long-term
437115|NCT01701895|compliance|compliance
437116|NCT01701895|caloric|caloric
437117|NCT01701895|intake|intake
437118|NCT01701895|HIV|hiv
437119|NCT01701895|positive|positive
437120|NCT01701895|women|women
437121|NCT01701856|relapsing-remitting multiple sclerosis|relapsing-remitting multiple sclerosis
437122|NCT01701856|natalizumab|natalizumab
437123|NCT01701856|de-escalation|de-escalation
437124|NCT01701856|interferon beta-1b|interferon beta-1b
437125|NCT01701830|omentin-1|omentin-1
437126|NCT01701830|carotid atherosclerosis|carotid atherosclerosis
437127|NCT01701830|kidney disease|kidney disease
437128|NCT01701817|Atrial Fibrillation|atrial fibrillation
437129|NCT01701817|Irregular heart beat|irregular heart beat
437130|NCT01701804|Failed Back Surgery Syndrome|failed back surgery syndrome
437131|NCT01701791|Depression|depression
437132|NCT01701791|Primary care|primary care
558490|NCT01184586|MHQ|mhq
437133|NCT01701791|Computerized decision support system|computerized decision support system
437134|NCT01701791|General practitioner|general practitioner
437135|NCT01701778|Dexmedetomidine|dexmedetomidine
437136|NCT01701778|Postoperative pain reaction|postoperative pain reaction
437137|NCT01701778|anesthesia|anesthesia
437138|NCT01701778|children|children
437139|NCT01701765|Severe mental disorders|severe mental disorders
437140|NCT01701765|Discharge|discharge
437141|NCT01701765|Outcome evaluation|outcome evaluation
437142|NCT01701752|Influenza A|influenza a
437143|NCT01701726|Essential Hypertension|essential hypertension
437144|NCT01701726|Acupuncture|acupuncture
437145|NCT01701726|Specificity|specificity
437146|NCT01701726|Acupoints effect|acupoints effect
437147|NCT01701726|randomized controlled trials|randomized controlled trials
437148|NCT01701713|TDCS|tdcs
437149|NCT01701713|STROKE|stroke
437150|NCT01701713|APHASIA|aphasia
437151|NCT01701713|NAMING|naming
437152|NCT01701700|portable electronic magnifiers|portable electronic magnifiers
437153|NCT01701687|Cirrhosis|cirrhosis
437154|NCT01701687|Alcoholic liver disease|alcoholic liver disease
437155|NCT01701687|Decompensated liver cirrhosis|decompensated liver cirrhosis
437156|NCT01701687|Hazardous alcohol|hazardous alcohol
437157|NCT01701674|skin cancer|skin cancer
437158|NCT01701661|venous surgery|venous surgery
437159|NCT01701661|compression therapy|compression therapy
437160|NCT01701648|Vitiligo, amniotic membrane, malanocytes, C02 laser.|vitiligo, amniotic membrane, malanocytes, c02 laser.
437161|NCT01701635|Disclosure|disclosure
437162|NCT01701635|HIV-infected children|hiv-infected children
437163|NCT01701635|Resource-limited settings|resource-limited settings
437164|NCT01701622|Blood Pressure|blood pressure
437165|NCT01701622|Gout|gout
437166|NCT01701622|allopurinol|allopurinol
437167|NCT01701622|febuxostat|febuxostat
437168|NCT01701622|uric acid|uric acid
437169|NCT01701609|early-onset schizophrenia|early-onset schizophrenia
437170|NCT01701609|adolescents|adolescents
437171|NCT01701609|cognition|cognition
437172|NCT01701609|cognitive remediation therapy|cognitive remediation therapy
437173|NCT01701596|Rotational atherectomy|rotational atherectomy
437174|NCT01701596|Coronary dissection|coronary dissection
437175|NCT01701596|Percutaneous coronary intervention|percutaneous coronary intervention
437176|NCT01701596|Calcification|calcification
437177|NCT01701583|Chronic Idiopathic Urticaria|chronic idiopathic urticaria
437178|NCT01701583|CIU|ciu
437179|NCT01701583|Urticaria|urticaria
437180|NCT01701583|Chronic Hives|chronic hives
437181|NCT01701583|Xolair|xolair
437182|NCT01701570|Type 2 Diabetes|type 2 diabetes
437183|NCT01701570|Exercise|exercise
437184|NCT01701570|Rate of Perceived Exertion|rate of perceived exertion
437185|NCT01701557|Ketoacidosis Fluids|ketoacidosis fluids
437186|NCT01701518|Ozurdex|ozurdex
437187|NCT01701518|Dexamethasone|dexamethasone
437188|NCT01701518|Epiretinal membrane|epiretinal membrane
437189|NCT01701518|Macular edema|macular edema
437190|NCT01701505|operative|operative
437191|NCT01701505|dental procedure|dental procedure
437192|NCT01701492|pediatric|pediatric
437193|NCT01701492|hematopoietic stem cell transplantation|hematopoietic stem cell transplantation
437194|NCT01701492|allogeneic bone marrow transplantation|allogeneic bone marrow transplantation
437195|NCT01701479|Neuroblastoma|neuroblastoma
437196|NCT01701479|Refractory neuroblastoma|refractory neuroblastoma
437197|NCT01701479|Relapsed neuroblastoma|relapsed neuroblastoma
437198|NCT01701479|ch14.18/CHO|ch14.18/cho
437199|NCT01701479|Aldesleukin (IL-2)|aldesleukin (il-2)
437200|NCT01701466|Patients|patients
437201|NCT01701466|with|with
437202|NCT01701453|duration of DAPT|duration of dapt
437203|NCT01701427|Hyperalgesia|hyperalgesia
437204|NCT01701427|Persistent pain|persistent pain
437205|NCT01701427|deep pain|deep pain
437206|NCT01701427|electrical stimulation|electrical stimulation
437207|NCT01701427|groin hernia|groin hernia
437208|NCT01701414|Femur|femur
437209|NCT01701414|Hip|hip
437210|NCT01701414|Fracture|fracture
437211|NCT01701414|Femoral neck|femoral neck
437212|NCT01701414|Femoral head|femoral head
437213|NCT01701401|HCV genotype 1 (GT-1)|hcv genotype 1 (gt-1)
437214|NCT01701401|HCV|hcv
437215|NCT01701401|Sustained Virologic Response|sustained virologic response
437216|NCT01701401|Direct Acting Antiviral|direct acting antiviral
437217|NCT01701401|Combination Therapy|combination therapy
437218|NCT01701401|GS-7977|gs-7977
437219|NCT01701401|GS-5885|gs-5885
437220|NCT01701401|Ribavirin|ribavirin
437221|NCT01701401|Open Label|open label
437222|NCT01701401|Sofosbuvir|sofosbuvir
437223|NCT01701401|Additional relevant MeSH terms:|additional relevant mesh terms:
437224|NCT01701401|Hepatitis|hepatitis
437225|NCT01701401|Hepatitis, Chronic|hepatitis, chronic
437226|NCT01701401|Hepatitis C|hepatitis c
437227|NCT01701401|Hepatitis C, Chronic|hepatitis c, chronic
437228|NCT01701401|Liver Diseases|liver diseases
437229|NCT01701401|Digestive System Diseases|digestive system diseases
437230|NCT01701401|Hepatitis, Viral, Human|hepatitis, viral, human
558610|NCT01184053|UNC|unc
437231|NCT01701401|Virus Diseases|virus diseases
437232|NCT01701401|Enterovirus Infections|enterovirus infections
437233|NCT01701401|Picornaviridae Infections|picornaviridae infections
437234|NCT01701401|RNA Virus Infections|rna virus infections
437235|NCT01701401|Flaviviridae Infections|flaviviridae infections
437236|NCT01701401|Antiviral Agents|antiviral agents
437237|NCT01701401|Anti-Infective Agents|anti-infective agents
437238|NCT01701401|Therapeutic Uses|therapeutic uses
437239|NCT01701401|Pharmacologic Actions|pharmacologic actions
437240|NCT01701401|Antimetabolites|antimetabolites
437241|NCT01701401|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action
437242|NCT01701388|Ekso|ekso
437243|NCT01701388|Exoskeleton|exoskeleton
437244|NCT01701388|Spinal Cord Injury|spinal cord injury
437245|NCT01701388|Motor Complete Incomplete|motor complete incomplete
437246|NCT01701362|post-traumatic peripheral neuropathic pain|post-traumatic peripheral neuropathic pain
437247|NCT01701349|ATC|atc
437248|NCT01701349|Anaplastic Thyroid Cancer|anaplastic thyroid cancer
437249|NCT01701349|Stage IVC Anaplastic Thyroid Cancer|stage ivc anaplastic thyroid cancer
437250|NCT01701349|Thyroid Cancer|thyroid cancer
437251|NCT01701349|Head and Neck Tumors|head and neck tumors
437252|NCT01701336|Hepatitis|hepatitis
437253|NCT01701336|Hepatitis C|hepatitis c
437254|NCT01701336|HCV|hcv
437255|NCT01701336|vaccine|vaccine
437256|NCT01701336|adenovirus|adenovirus
437257|NCT01701336|MVA|mva
437258|NCT01701336|T cells|t cells
437259|NCT01701336|ELISpot|elispot
437260|NCT01701310|Adenocarcinoma|adenocarcinoma
437261|NCT01701310|Anemia|anemia
437262|NCT01701310|Blood Transfusion|blood transfusion
437263|NCT01701310|Colorectal surgery|colorectal surgery
437264|NCT01701310|Preoperative care|preoperative care
437265|NCT01701310|Perioperative care|perioperative care
437266|NCT01701310|Postoperative care|postoperative care
437267|NCT01701310|Iron|iron
437268|NCT01701310|Hematinics|hematinics
437269|NCT01701310|Hepcidin|hepcidin
437270|NCT01701310|Quality of life|quality of life
437271|NCT01701310|Postoperative complications|postoperative complications
437272|NCT01701297|Cirrhosis, ascites, infection|cirrhosis, ascites, infection
437273|NCT01701284|repetitive Transcranial Magnetic Stimulation|repetitive transcranial magnetic stimulation
437274|NCT01701284|Cancer Survivors|cancer survivors
437275|NCT01701284|Depression|depression
437276|NCT01701284|Anxiety|anxiety
437277|NCT01701271|Baldness|baldness
437278|NCT01701271|Androgenetic Alopecia|androgenetic alopecia
437279|NCT01701271|Alopecia|alopecia
437280|NCT01701258|Depression|depression
437281|NCT01701258|Childhood Sexual Abuse|childhood sexual abuse
437282|NCT01701258|Dopamine|dopamine
437283|NCT01701258|MRI|mri
437284|NCT01701258|PET|pet
437285|NCT01701258|ERP|erp
437286|NCT01701258|Stress|stress
437287|NCT01701258|Reward|reward
437288|NCT01701258|Childhood trauma|childhood trauma
437289|NCT01701258|Amisulpride|amisulpride
437290|NCT01701245|vagus nerve stimulation|vagus nerve stimulation
437291|NCT01701245|vagal nerve stimulation|vagal nerve stimulation
437292|NCT01701245|nVNS|nvns
437293|NCT01701245|VNS|vns
437294|NCT01701245|cluster headache|cluster headache
437295|NCT01701245|chronic|chronic
437296|NCT01701245|non invasive|non invasive
437297|NCT01701245|gammacore|gammacore
437298|NCT01701232|lymphoma, non-Hodgkin's|lymphoma, non-hodgkin's
437299|NCT01701219|Staphylococcus aureus bacteremia|staphylococcus aureus bacteremia
437300|NCT01701219|Methicillin-resistant Staphylococcus aureus bacteremia|methicillin-resistant staphylococcus aureus bacteremia
437301|NCT01701219|MRSA bacteremia|mrsa bacteremia
437302|NCT01701219|Blood|blood
437303|NCT01701219|Adult|adult
437304|NCT01701219|Infections|infections
437305|NCT01701219|Blood Culture|blood culture
437306|NCT01701206|HIV|hiv
437307|NCT01701206|social networking|social networking
437308|NCT01701206|at-risk populations|at-risk populations
437309|NCT01701206|sexual risk behaviors|sexual risk behaviors
437310|NCT01701180|Male Volunteers|male volunteers
437311|NCT01701154|Pompe respiratory|pompe respiratory
437312|NCT01701141|Positron Emission Tomography (PET)|positron emission tomography (pet)
437313|NCT01701141|Magnetic resonance imaging (MRI)|magnetic resonance imaging (mri)
437314|NCT01701141|reward|reward
437315|NCT01701141|stress|stress
437316|NCT01701141|learning|learning
437317|NCT01701141|Major Depressive Disorder|major depressive disorder
437318|NCT01701141|Anhedonia|anhedonia
437319|NCT01701128|Physical activity, treadmill training, rehabilitation|physical activity, treadmill training, rehabilitation
437320|NCT01701115|Interscalene Block|interscalene block
437321|NCT01701076|Relapsed / refractory multiple myeloma|relapsed / refractory multiple myeloma
437322|NCT01701076|2nd line treatment|2nd line treatment
437323|NCT01701050|circulating tumor cells|circulating tumor cells
437324|NCT01701050|CTC|ctc
437325|NCT01701050|metastatic breast cancer|metastatic breast cancer
437326|NCT01701050|endocrine therapy|endocrine therapy
437327|NCT01701050|hormone therapy|hormone therapy
437328|NCT01701037|Melanoma, B-RAF, biomarkers, targeted therapy, resistance|melanoma, b-raf, biomarkers, targeted therapy, resistance
437329|NCT01701024|Acne|acne
437330|NCT01701011|coping|coping
437331|NCT01701011|intervention|intervention
437332|NCT01701011|waiting-period|waiting-period
437333|NCT01700985|psoriasis|psoriasis
437334|NCT01700985|plaque psoriasis|plaque psoriasis
437335|NCT01700985|122-0551|122-0551
437336|NCT01700985|steroid|steroid
437337|NCT01700959|Melatonin|melatonin
437338|NCT01700959|Neurocognitive impairment|neurocognitive impairment
437339|NCT01700959|Sleep disturbance|sleep disturbance
437340|NCT01700959|Childhood cancer survivors|childhood cancer survivors
437341|NCT01700946|leukemia|leukemia
437342|NCT01700946|lymphoma|lymphoma
437343|NCT01700946|Non-Hodgkins|non-hodgkins
437344|NCT01700933|Exercise therapy|exercise therapy
437345|NCT01700920|Osteonecrosis of the femoral head|osteonecrosis of the femoral head
437346|NCT01700920|Stem Cell|stem cell
437347|NCT01700920|Mesenchymal Stem Cells|mesenchymal stem cells
437348|NCT01700920|Femoral Head|femoral head
437349|NCT01700907|Postoperative cognitive dysfunction|postoperative cognitive dysfunction
437350|NCT01700907|elderly patients|elderly patients
437351|NCT01700907|long surgery|long surgery
437352|NCT01700894|Physical Activity|physical activity
437353|NCT01700894|African American|african american
437354|NCT01700894|Adherence|adherence
437355|NCT01700881|Rheumatoid Arthritis, Diet, Fat-Restricted, Diet, Vegetarian|rheumatoid arthritis, diet, fat-restricted, diet, vegetarian
437356|NCT01700868|Diabetes Mellitus, Type 2|diabetes mellitus, type 2
437357|NCT01700868|Diet, Vegetarian|diet, vegetarian
437358|NCT01700868|Diet, Fat-Restricted|diet, fat-restricted
437359|NCT01700868|Glycemic Index|glycemic index
437360|NCT01700855|Electroacupuncture|electroacupuncture
437361|NCT01700855|Analgesia|analgesia
437362|NCT01700855|Anesthesia|anesthesia
437363|NCT01700855|Nasal septoplasty|nasal septoplasty
437364|NCT01700855|Mammaplasty|mammaplasty
437365|NCT01700842|ceftaroline, infection, CAPB, CAP, ABSSSI, cSSTI|ceftaroline, infection, capb, cap, absssi, cssti
437366|NCT01700829|Ketamine|ketamine
437367|NCT01700829|Midazolam|midazolam
437368|NCT01700829|Major Depressive Disorder|major depressive disorder
437369|NCT01700829|Suicidal ideation|suicidal ideation
437370|NCT01700829|Suicide|suicide
437371|NCT01700829|Depression|depression
437372|NCT01700829|Treatment|treatment
437373|NCT01700829|Ketamine Treatment|ketamine treatment
437374|NCT01700816|Delirium|delirium
437375|NCT01700816|Hematopoietic stem cell transplantation|hematopoietic stem cell transplantation
437376|NCT01700816|Bone marrow transplantation|bone marrow transplantation
437377|NCT01700816|Bright Light Therapy|bright light therapy
437378|NCT01700803|Betadine|betadine
437379|NCT01700803|Povidine Iodine|povidine iodine
437380|NCT01700803|Hand scrubbing|hand scrubbing
437381|NCT01700803|Cesarean section wound infections|cesarean section wound infections
437382|NCT01700803|post cesarean section|post cesarean section
437383|NCT01700790|HIV|hiv
437384|NCT01700790|AIDS|aids
437385|NCT01700790|Tuberculosis|tuberculosis
437386|NCT01700790|Rifampin|rifampin
437387|NCT01700790|Lopinavir|lopinavir
437388|NCT01700790|Pharmacokinetic|pharmacokinetic
437389|NCT01700777|bimanual training|bimanual training
437390|NCT01700777|lower limb|lower limb
437391|NCT01700777|intensive rehabilitation|intensive rehabilitation
437392|NCT01700777|regular rehabilitation|regular rehabilitation
437393|NCT01700777|hemiplegia|hemiplegia
437394|NCT01700725|Gulf War Illness|gulf war illness
437395|NCT01700725|xylitol|xylitol
437396|NCT01700725|nasal irrigation|nasal irrigation
437397|NCT01700725|Desert Storm|desert storm
437398|NCT01700725|Persian Gulf Conflicts|persian gulf conflicts
437399|NCT01700725|neti pot|neti pot
437400|NCT01700725|cytokines|cytokines
437401|NCT01700725|nasal mucus|nasal mucus
437402|NCT01700725|inflammatory mediator|inflammatory mediator
437403|NCT01700725|lactoferrin|lactoferrin
437404|NCT01700725|lysozyme|lysozyme
437405|NCT01700712|Caries, probiotic bacteria|caries, probiotic bacteria
437406|NCT01700699|thyroid cancer|thyroid cancer
437407|NCT01700699|tyrosine kinase inhibitors|tyrosine kinase inhibitors
437408|NCT01700699|BRAF|braf
437409|NCT01700699|Sorafenib|sorafenib
437410|NCT01700699|Pazopanib|pazopanib
437411|NCT01700699|Sunitinib|sunitinib
437412|NCT01700699|Cabozantinib|cabozantinib
437707|NCT01699295|exercise|exercise
437413|NCT01700673|maintenance treatment|maintenance treatment
437414|NCT01700673|stem cell transplant|stem cell transplant
437415|NCT01700673|cytarabine-based chemotherapy|cytarabine-based chemotherapy
437416|NCT01700647|Larynx cancer|larynx cancer
437417|NCT01700647|Volatile organic compounds|volatile organic compounds
437418|NCT01700647|Diagnosis|diagnosis
437419|NCT01700647|Bronchoscopy|bronchoscopy
437420|NCT01700647|Cancer staging|cancer staging
437421|NCT01700634|fMRI, BOLD, pressure stimuli|fmri, bold, pressure stimuli
437422|NCT01700621|rotavirus|rotavirus
437423|NCT01700582|lung cancer|lung cancer
437424|NCT01700582|biomarkers|biomarkers
437425|NCT01700582|EGFR|egfr
437426|NCT01700582|KRAS|kras
437427|NCT01700582|ALK|alk
437428|NCT01700582|HER2|her2
437429|NCT01700582|PI3K|pi3k
437430|NCT01700582|BRAF|braf
437431|NCT01700569|high-grade|high-grade
437432|NCT01700569|glioma|glioma
437433|NCT01700569|epigenetic|epigenetic
437434|NCT01700556|Alzheimer Disease|alzheimer disease
437435|NCT01700556|Family Caregiver|family caregiver
437436|NCT01700556|Caregiver Burden|caregiver burden
437437|NCT01700556|Home Care Services|home care services
437438|NCT01700556|Assistive Technologies|assistive technologies
437439|NCT01700543|Stemless shoulder implant|stemless shoulder implant
437440|NCT01700543|Osteoarthritis|osteoarthritis
437441|NCT01700543|Rheumatoid Arthritis|rheumatoid arthritis
437442|NCT01700543|Hemi Shoulder Arthroplasty|hemi shoulder arthroplasty
437443|NCT01700543|Total Shoulder Arthroplasty|total shoulder arthroplasty
437444|NCT01700543|Prospective|prospective
437445|NCT01700543|Multi-center|multi-center
437446|NCT01700543|Europe|europe
437447|NCT01700543|Non-Controlled|non-controlled
437448|NCT01700543|Good Bone Stock|good bone stock
437449|NCT01700530|mitochondria|mitochondria
437450|NCT01700530|fitness|fitness
437451|NCT01700530|statins|statins
437452|NCT01700530|cholesterol|cholesterol
437453|NCT01700530|metabolic syndrome|metabolic syndrome
437454|NCT01700517|total knee arthroplasty, analgesia, ultrasonography|total knee arthroplasty, analgesia, ultrasonography
437455|NCT01700504|Axillary drainage volume|axillary drainage volume
437456|NCT01700504|Lavage with gentamicin solution|lavage with gentamicin solution
437457|NCT01700491|Paravertebral Catheter|paravertebral catheter
437458|NCT01700491|Epidural Catheter|epidural catheter
437459|NCT01700491|Analgesia|analgesia
437460|NCT01700491|Hypotension|hypotension
437461|NCT01700491|Analgesia,Epidural|analgesia,epidural
437462|NCT01700491|Analgesia,Paravertebral|analgesia,paravertebral
437463|NCT01700478|Myomectomy|myomectomy
437464|NCT01700465|Hemodialysis|hemodialysis
437465|NCT01700465|Hemodynamics|hemodynamics
437466|NCT01700452|Lung cancer|lung cancer
437467|NCT01700452|Pulmonary nodules|pulmonary nodules
437468|NCT01700452|FISH Test|fish test
437469|NCT01700439|Aortic valve|aortic valve
437470|NCT01700439|Heart valve|heart valve
437471|NCT01700439|Tissue valve|tissue valve
437472|NCT01700439|Bioprosthesis|bioprosthesis
437473|NCT01700439|Valve disorder|valve disorder
437474|NCT01700439|Valve disease|valve disease
437475|NCT01700439|Cardiac surgery|cardiac surgery
437476|NCT01700439|Less invasive cardiac surgery|less invasive cardiac surgery
437477|NCT01700439|Aortic valve stenosis|aortic valve stenosis
437478|NCT01700439|Aortic valve regurgitation|aortic valve regurgitation
437479|NCT01700439|Bovine pericardium|bovine pericardium
437480|NCT01700426|Iron Deficiency|iron deficiency
437481|NCT01700426|Iron Deficiency Anemia|iron deficiency anemia
437482|NCT01700413|acute|acute
437483|NCT01700413|myeloid|myeloid
437484|NCT01700413|leukemia|leukemia
437485|NCT01700413|CETLAM|cetlam
437486|NCT01700413|Idarubicin|idarubicin
437487|NCT01700400|Lung Cancer|lung cancer
437488|NCT01700400|Non Small Cell Lung Cancer|non small cell lung cancer
437489|NCT01700400|Advanced Lung Cancer|advanced lung cancer
437490|NCT01700387|Migraine|migraine
437491|NCT01700387|Chronic Migraine|chronic migraine
437492|NCT01700387|Cognitive Efficiency|cognitive efficiency
437493|NCT01700387|Pilot Study|pilot study
437494|NCT01700387|Long Term Effect|long term effect
437495|NCT01700374|pregnancy|pregnancy
437496|NCT01700374|stress, psychological|stress, psychological
437497|NCT01700374|stress, physiological|stress, physiological
437498|NCT01700374|maternal-fetal relations|maternal-fetal relations
437499|NCT01700361|sexual arousal|sexual arousal
437500|NCT01700361|pelvic floor sEMG|pelvic floor semg
437501|NCT01700348|moderate gingivitis|moderate gingivitis
437502|NCT01700322|Coronary artery disease|coronary artery disease
437503|NCT01700322|coronary stenting|coronary stenting
437504|NCT01700322|platelet aggregation|platelet aggregation
437505|NCT01700309|Obesity prevention; Adolescent; Physical activity; Health counselling|obesity prevention; adolescent; physical activity; health counselling
437506|NCT01700283|Colorectal Cancer、Fatigue、Muscle strength、Metabolomics|colorectal cancer、fatigue、muscle strength、metabolomics
437507|NCT01700257|Lung cancer screening|lung cancer screening
437508|NCT01700257|Smokers or former smokers|smokers or former smokers
437509|NCT01700257|Family history of lung cancer|family history of lung cancer
437510|NCT01700231|hepatorenal syndrome, liver regeneration, liver dysfunction|hepatorenal syndrome, liver regeneration, liver dysfunction
437511|NCT01700218|telemonitoring|telemonitoring
437512|NCT01700205|Formula Feeding|formula feeding
437513|NCT01700205|Mother|mother
437514|NCT01700205|Moms|moms
437515|NCT01700205|Infants|infants
437516|NCT01700205|Babies|babies
437517|NCT01700205|Baby|baby
437518|NCT01700205|growth|growth
437519|NCT01700205|energy balance|energy balance
437520|NCT01700166|Autologous|autologous
437521|NCT01700166|Cord Blood|cord blood
437522|NCT01700166|Stem Cells|stem cells
437523|NCT01700166|Pediatric stroke|pediatric stroke
437524|NCT01700166|Children with ischemic stroke|children with ischemic stroke
437525|NCT01700166|Cerebral Palsy|cerebral palsy
437526|NCT01700166|Perinatal AIS|perinatal ais
437527|NCT01700153|Robotic-assisted therapy|robotic-assisted therapy
437528|NCT01700153|cerebral palsy|cerebral palsy
437529|NCT01700153|ICF|icf
437530|NCT01700127|immune response|immune response
437531|NCT01700127|infants|infants
437532|NCT01700127|rotavirus vaccine|rotavirus vaccine
437533|NCT01700114|Pigmented Skin Lesions|pigmented skin lesions
437534|NCT01700114|Dermatology|dermatology
437535|NCT01700114|Skin Cancer|skin cancer
437536|NCT01700114|Melanoma|melanoma
437537|NCT01700114|MelaFind|melafind
437538|NCT01700088|hypoxemia|hypoxemia
437539|NCT01700088|Post Pulmonary Resection|post pulmonary resection
437540|NCT01700075|atherosclerosis, development of concept, weight loss therapy|atherosclerosis, development of concept, weight loss therapy
437541|NCT01700062|medium-calorie|medium-calorie
437542|NCT01700062|standard calorie|standard calorie
437543|NCT01700062|parenteral nutrition|parenteral nutrition
437544|NCT01700049|advanced BCC|advanced bcc
437545|NCT01700049|high risk|high risk
437546|NCT01700049|locally advanced|locally advanced
437547|NCT01700023|acute heart failure|acute heart failure
437548|NCT01700010|Urothelial|urothelial
437549|NCT01700010|Bladder|bladder
437550|NCT01700010|Cancer|cancer
437551|NCT01699997|Schizophrenia|schizophrenia
437552|NCT01699997|Oxytocin|oxytocin
437553|NCT01699997|RCT|rct
437554|NCT01699984|Cognitive impairment.|cognitive impairment.
437555|NCT01699984|Geriatrics.|geriatrics.
437556|NCT01699984|Hospital admission.|hospital admission.
437557|NCT01699984|Hospital discharge.|hospital discharge.
437558|NCT01699958|Problem solving therapy|problem solving therapy
437559|NCT01699958|Behavior change|behavior change
437560|NCT01699945|Verbal autopsies|verbal autopsies
437561|NCT01699945|Maternal deaths|maternal deaths
437562|NCT01699945|Still births|still births
437563|NCT01699919|perioperative lignocaine infusion|perioperative lignocaine infusion
437564|NCT01699919|elective open abdominal surgeries|elective open abdominal surgeries
437565|NCT01699919|postoperative pain|postoperative pain
437566|NCT01699906|Obesity|obesity
437567|NCT01699880|tracheal intubation|tracheal intubation
437568|NCT01699880|preoxygenation|preoxygenation
437569|NCT01699880|desaturation|desaturation
437570|NCT01699880|hypoxemia|hypoxemia
437571|NCT01699880|oxygen therapy|oxygen therapy
437572|NCT01699880|high flow nasal cannula oxygen therapy|high flow nasal cannula oxygen therapy
437573|NCT01699867|lumpectomy|lumpectomy
437574|NCT01699867|breast cancer|breast cancer
437575|NCT01699867|optical coherence tomography|optical coherence tomography
437576|NCT01699867|tumor margin|tumor margin
437577|NCT01699867|imaging|imaging
437578|NCT01699828|buspirone|buspirone
437579|NCT01699828|smoking cessation|smoking cessation
437580|NCT01699828|dopamine|dopamine
437581|NCT01699828|PET imaging|pet imaging
437582|NCT01699828|[11C]-(+)-PHNO|[11c]-(+)-phno
437583|NCT01699815|acetaminophen|acetaminophen
437584|NCT01699815|timing|timing
437585|NCT01699815|arthroplasty|arthroplasty
437586|NCT01699789|Community Partnered Participatory Research|community partnered participatory research
437587|NCT01699789|Community Engagement|community engagement
437588|NCT01699789|Implementation|implementation
437589|NCT01699789|Community Based Participatory Research|community based participatory research
437590|NCT01699789|Quality Improvement|quality improvement
437591|NCT01699789|Evidence Based Practice|evidence based practice
437592|NCT01699789|Patient Centered Outcomes Research|patient centered outcomes research
437593|NCT01699776|Digoxin|digoxin
437594|NCT01699776|Ivabradine|ivabradine
437595|NCT01699776|with atrial fibrillation.|with atrial fibrillation.
437596|NCT01699750|contact lenses|contact lenses
437597|NCT01699750|contact lens solution|contact lens solution
437598|NCT01699750|myopia|myopia
437599|NCT01699750|astigmatism|astigmatism
437600|NCT01699737|Diabetes|diabetes
437601|NCT01699724|JZoloft|jzoloft
437602|NCT01699724|Sertraline hydrochloride|sertraline hydrochloride
437603|NCT01699724|ODT|odt
437604|NCT01699724|bioequivalence|bioequivalence
437605|NCT01699711|APP function (amyloid precursor protein, cognitive stimulation, alzheimer disease. program|app function (amyloid precursor protein, cognitive stimulation, alzheimer disease. program
437606|NCT01699698|Pancreatic adenocarcinoma|pancreatic adenocarcinoma
437607|NCT01699685|Moderate to severe COPD patients are included|moderate to severe copd patients are included
437608|NCT01699685|NVA|nva
437609|NCT01699685|QAB|qab
437610|NCT01699672|Patient education|patient education
437611|NCT01699672|information|information
437612|NCT01699672|communication|communication
437613|NCT01699659|Allergic Rhinitis|allergic rhinitis
437614|NCT01699659|Allergen Immunotherapy|allergen immunotherapy
437737|NCT01699204|Diesel exhaust|diesel exhaust
437615|NCT01699646|Intrapartum fetal surveillance|intrapartum fetal surveillance
437617|NCT01699646|cardiotocography|cardiotocography
437618|NCT01699646|STAN|stan
437619|NCT01699646|ST-Analysis|st-analysis
437620|NCT01699646|metabolic acidosis in umbilical artery|metabolic acidosis in umbilical artery
437621|NCT01699646|operative delivery|operative delivery
437622|NCT01699633|Drug-drug interactions|drug-drug interactions
437623|NCT01699633|Drug-gene interactions|drug-gene interactions
437624|NCT01699633|Nevirapine|nevirapine
437625|NCT01699633|Rifampicin|rifampicin
437626|NCT01699633|children|children
437627|NCT01699620|Bone anchored hearing aid|bone anchored hearing aid
437628|NCT01699620|Soft tissue healing|soft tissue healing
437629|NCT01699620|Implant stability|implant stability
437630|NCT01699620|Linear incision|linear incision
437631|NCT01699620|Dermatome technique|dermatome technique
437632|NCT01699620|Hearing Aids|hearing aids
437633|NCT01699620|Implants, Artificial|implants, artificial
437634|NCT01699620|Surgical Procedures, Operative|surgical procedures, operative
437635|NCT01699607|Cigarette Smokers|cigarette smokers
437636|NCT01699607|Healthy Non Smokers|healthy non smokers
437637|NCT01699607|Amphetamine|amphetamine
437638|NCT01699607|PET|pet
437639|NCT01699607|Controls|controls
437640|NCT01699594|asthma|asthma
437641|NCT01699594|allergies|allergies
437642|NCT01699594|mannitol|mannitol
437643|NCT01699594|methacholine|methacholine
437644|NCT01699581|Hodgkin's Lymphoma|hodgkin's lymphoma
437645|NCT01699581|Multiple Myeloma|multiple myeloma
437646|NCT01699581|Non-Hodgkin's Lymphoma|non-hodgkin's lymphoma
437647|NCT01699568|dental implant stability|dental implant stability
437648|NCT01699568|dental implant surface treatment|dental implant surface treatment
437649|NCT01699568|resonance frequence analysis|resonance frequence analysis
437650|NCT01699555|Multiple sclerosis|multiple sclerosis
437651|NCT01699555|GNbAC1|gnbac1
437652|NCT01699555|Monoclonal antibody|monoclonal antibody
437653|NCT01699555|Multiple Sclerosis Associated Retrovirus (MSRV)|multiple sclerosis associated retrovirus (msrv)
437654|NCT01699542|Refractory Anastomotic esophageal strictures|refractory anastomotic esophageal strictures
437655|NCT01699516|allogeneic transplantation; intestinal graft-vs.-host disease; contrast enhanced ultrasound sonography|allogeneic transplantation; intestinal graft-vs.-host disease; contrast enhanced ultrasound sonography
437656|NCT01699503|Dementia|dementia
437657|NCT01699503|Alzheimer's Disease|alzheimer's disease
437658|NCT01699503|Mild Cognitive Impairment|mild cognitive impairment
437659|NCT01699503|Screening|screening
437660|NCT01699490|Major Depressive Disorder|major depressive disorder
437661|NCT01699490|Antidepressants|antidepressants
437662|NCT01699490|Insulin|insulin
437663|NCT01699490|Fluoxetine|fluoxetine
437664|NCT01699477|FUS|fus
437665|NCT01699477|focused ultrasound|focused ultrasound
437666|NCT01699477|functional brain disorders|functional brain disorders
437667|NCT01699477|neuropathic pain|neuropathic pain
437668|NCT01699477|movement disorders|movement disorders
437669|NCT01699464|Glaucoma|glaucoma
437670|NCT01699438|Irritable Bowel Syndrome|irritable bowel syndrome
437671|NCT01699438|Inflammation|inflammation
437672|NCT01699438|Mesalazine|mesalazine
437673|NCT01699425|Stress urinary incontinence.|stress urinary incontinence.
437674|NCT01699425|Suburethral sling.|suburethral sling.
437675|NCT01699425|Single-incision suburethral sling.|single-incision suburethral sling.
437676|NCT01699425|Ajust.|ajust.
437677|NCT01699425|Transobturator tape.|transobturator tape.
437678|NCT01699412|Bone Marrow Transplantation|bone marrow transplantation
437679|NCT01699412|Graft vs Host Disease|graft vs host disease
437680|NCT01699412|Oral Manifestations|oral manifestations
437681|NCT01699399|colonoscopy|colonoscopy
437682|NCT01699399|pain|pain
437683|NCT01699399|sedation|sedation
437684|NCT01699399|water|water
437685|NCT01699360|Kidney Transplantation|kidney transplantation
437686|NCT01699360|Immunosuppressive Agents|immunosuppressive agents
437687|NCT01699360|Hydrocortisone|hydrocortisone
437688|NCT01699360|Cortisone|cortisone
437689|NCT01699347|OK432, CYSTIC MALFORMATION|ok432, cystic malformation
437690|NCT01699334|Whiplash injuries|whiplash injuries
437691|NCT01699334|patient education|patient education
437692|NCT01699334|illness perceptions|illness perceptions
437693|NCT01699334|RCT|rct
437694|NCT01699334|motor vehicle accidents|motor vehicle accidents
437695|NCT01699321|physical activity|physical activity
437696|NCT01699321|barbershop|barbershop
437697|NCT01699321|cancer prevention|cancer prevention
437698|NCT01699321|exercise|exercise
437699|NCT01699321|men's health|men's health
437700|NCT01699321|African American men|african american men
437701|NCT01699308|Traumatic Brain Injury|traumatic brain injury
437702|NCT01699308|Growth Hormone|growth hormone
437703|NCT01699308|Neuroimaging|neuroimaging
437704|NCT01699295|academic achievement|academic achievement
437705|NCT01699295|elementary school|elementary school
437706|NCT01699295|physical activity|physical activity
437708|NCT01699282|oral anticoagulant|oral anticoagulant
437709|NCT01699282|in the long term (> 12 months)|in the long term (> 12 months)
437710|NCT01699269|High grade brain tumor|high grade brain tumor
437711|NCT01699269|Glioma|glioma
437712|NCT01699269|Glioblastoma Multiform|glioblastoma multiform
437713|NCT01699269|Brain Cancer|brain cancer
437714|NCT01699269|Diffusion-Weighted Magnetic Resonance Imaging|diffusion-weighted magnetic resonance imaging
437715|NCT01699269|High order diffusion tensor|high order diffusion tensor
437716|NCT01699269|Imaging guided biopsy|imaging guided biopsy
437717|NCT01699269|Histopathologic evaluation|histopathologic evaluation
437718|NCT01699269|Infiltration percentage|infiltration percentage
437719|NCT01699256|General Practice|general practice
437720|NCT01699256|Low Back Pain|low back pain
437721|NCT01699256|Guideline|guideline
437722|NCT01699256|Health Plan Implementation|health plan implementation
437723|NCT01699256|Referral and Consultation|referral and consultation
437724|NCT01699243|pregnancy|pregnancy
437725|NCT01699243|labor|labor
437726|NCT01699243|epidural|epidural
437727|NCT01699243|fetal intervention|fetal intervention
437728|NCT01699230|Elective cardiac surgery|elective cardiac surgery
437729|NCT01699230|with sternotomy and|with sternotomy and
437730|NCT01699230|cardiopulmonary bypass|cardiopulmonary bypass
437731|NCT01699230|for coronary artery|for coronary artery
437732|NCT01699230|bypass graft.|bypass graft.
437733|NCT01699217|Chronic Myeloid Leukaemia|chronic myeloid leukaemia
437734|NCT01699217|Philadelphia positive|philadelphia positive
437735|NCT01699217|BCR-ABL positive|bcr-abl positive
437736|NCT01699204|Air pollution|air pollution
437738|NCT01699204|Airway responsiveness|airway responsiveness
437739|NCT01699204|Asthma|asthma
437740|NCT01699204|Anti-oxidant|anti-oxidant
437741|NCT01699191|Irritable Bowel Syndrome|irritable bowel syndrome
437742|NCT01699191|Celiac Desease|celiac desease
437743|NCT01699191|Probiotic|probiotic
437744|NCT01699191|Lactobacillus plantarum|lactobacillus plantarum
437745|NCT01699191|Bifidobacterium breve|bifidobacterium breve
437746|NCT01699191|Lactobacillus casei|lactobacillus casei
437747|NCT01699191|Bifidobacterium animalis|bifidobacterium animalis
437748|NCT01699165|rhinitis|rhinitis
437749|NCT01699165|allergic|allergic
437750|NCT01699165|seasonal|seasonal
437751|NCT01699165|double blind|double blind
437752|NCT01699165|doubleblind|doubleblind
437753|NCT01699165|randomized|randomized
437754|NCT01699165|randomised|randomised
437755|NCT01699165|placebo|placebo
437756|NCT01699165|crossover|crossover
437757|NCT01699165|clinical|clinical
437758|NCT01699165|nasal|nasal
437759|NCT01699165|filter|filter
437760|NCT01699165|controlled|controlled
437761|NCT01699165|trial|trial
437762|NCT01699165|hayfever|hayfever
437764|NCT01699165|fever|fever
437765|NCT01699165|efficacy|efficacy
437766|NCT01699165|safety|safety
437767|NCT01699165|prevention|prevention
437768|NCT01699165|adult|adult
437769|NCT01699165|grass|grass
437770|NCT01699165|pollen|pollen
437771|NCT01699165|symptom|symptom
437772|NCT01699165|Total nasal symptom score|total nasal symptom score
437773|NCT01699165|acoustic rhinometry|acoustic rhinometry
437774|NCT01699152|Chronic Lymphocytic Leukemia|chronic lymphocytic leukemia
437775|NCT01699152|Small Lymphocytic Lymphoma|small lymphocytic lymphoma
437776|NCT01699139|supine position|supine position
437777|NCT01699126|Obstructive Sleep Apnea|obstructive sleep apnea
437778|NCT01699126|CPAP|cpap
437779|NCT01699126|Endothelium dysfunction|endothelium dysfunction
437780|NCT01699126|Hypertension|hypertension
437781|NCT01699113|YF476|yf476
437782|NCT01699113|gastrin receptor antagonist|gastrin receptor antagonist
437783|NCT01699113|gastric pH|gastric ph
437784|NCT01699113|gastrin|gastrin
437785|NCT01699113|rabeprazole|rabeprazole
437786|NCT01699113|proton-pump inhibitor|proton-pump inhibitor
437787|NCT01699113|gastric function|gastric function
437788|NCT01699113|healthy subjects|healthy subjects
437789|NCT01699100|offloading|offloading
437790|NCT01699100|plantar pressure|plantar pressure
437791|NCT01699100|insole|insole
437792|NCT01699100|foot ulcer|foot ulcer
437793|NCT01699087|PRK|prk
437794|NCT01699087|myopia|myopia
437795|NCT01699087|astigmatism|astigmatism
437796|NCT01699074|Korean White Ginseng|korean white ginseng
437797|NCT01699074|Type 2 diabetes|type 2 diabetes
437798|NCT01699074|Metabolic syndrome|metabolic syndrome
437799|NCT01699048|multivessel PCI,MIDCAB,CABG|multivessel pci,midcab,cabg
437800|NCT01699048|Hybrid coronary revascularization|hybrid coronary revascularization
437801|NCT01699035|stroke|stroke
437802|NCT01699035|work|work
437803|NCT01699035|vocational rehabilitation|vocational rehabilitation
437804|NCT01699022|Contraceptive|contraceptive
437805|NCT01699022|Injectable|injectable
437806|NCT01699009|Migraines, diet, vegan, vegetarian, plant-based|migraines, diet, vegan, vegetarian, plant-based
437807|NCT01698996|abscess|abscess
437808|NCT01698996|packing|packing
437809|NCT01698996|emergency medicine|emergency medicine
437810|NCT01698996|wound care|wound care
437811|NCT01698996|incision and drainage|incision and drainage
437812|NCT01698970|Probiotic|probiotic
437813|NCT01698970|capsules|capsules
437814|NCT01698970|Crohn's disease|crohn's disease
437815|NCT01698970|recurrent endoscopic ileo-colonic lesions|recurrent endoscopic ileo-colonic lesions
437816|NCT01698957|Pregnant women|pregnant women
437817|NCT01698957|Uterine Artery Doppler Velocimetry|uterine artery doppler velocimetry
710243|NCT00589602|myelodysplastic syndromes|myelodysplastic syndromes
437818|NCT01698918|metastatic breast cancer, locally advanced breast cancer, HER2-, ER+, everolimus, Afinitor|metastatic breast cancer, locally advanced breast cancer, her2-, er+, everolimus, afinitor
437819|NCT01698905|Phase II, single arm, open label, nilotinib, treatment-free remission, MR4.5, confirmed loss of MR4, loss of MMR, Ph+ CML-CP|phase ii, single arm, open label, nilotinib, treatment-free remission, mr4.5, confirmed loss of mr4, loss of mmr, ph+ cml-cp
437820|NCT01698892|I.V. sedation, midazolam, bronchoscopy|i.v. sedation, midazolam, bronchoscopy
437821|NCT01698866|Low grade lymphoma|low grade lymphoma
437822|NCT01698866|follicular lymphoma|follicular lymphoma
437823|NCT01698866|indolent lymphoproliferative disorders|indolent lymphoproliferative disorders
437824|NCT01698866|Vaccin GenHevac B Pasteur|vaccin genhevac b pasteur
437825|NCT01698840|Vitamin D|vitamin d
437826|NCT01698840|Transitional Formula|transitional formula
437827|NCT01698827|gastrostomy|gastrostomy
437828|NCT01698827|tube|tube
437829|NCT01698827|endoscopic|endoscopic
437830|NCT01698827|replacement|replacement
437831|NCT01698827|tube rupture|tube rupture
437832|NCT01698827|durability|durability
437833|NCT01698827|tube loss|tube loss
437834|NCT01698827|balloon rupture|balloon rupture
437835|NCT01698814|ocular safety|ocular safety
437836|NCT01698814|allergic conjunctivitis|allergic conjunctivitis
437837|NCT01698801|Lenalidomide|lenalidomide
437838|NCT01698801|dexamethasone|dexamethasone
437839|NCT01698801|newly diagnosed multiple myeloma|newly diagnosed multiple myeloma
437840|NCT01698788|diabetic macular edema|diabetic macular edema
437841|NCT01698788|taut posterior hyaloid membrane|taut posterior hyaloid membrane
437842|NCT01698788|ozurdex|ozurdex
437843|NCT01698762|Musculoskeletal Diseases|musculoskeletal diseases
437844|NCT01698762|Osteoarthritis|osteoarthritis
437845|NCT01698762|OA|oa
437846|NCT01698762|Rheumatoid Arthritis|rheumatoid arthritis
437847|NCT01698762|RA|ra
437848|NCT01698762|Osteoporosis|osteoporosis
437849|NCT01698762|OP|op
437850|NCT01698762|Multimedia Patient Decision Aids|multimedia patient decision aids
437851|NCT01698762|MM-PtDAs|mm-ptdas
437852|NCT01698762|DVD|dvd
437853|NCT01698762|Comparative Effectiveness Research Summary Guide|comparative effectiveness research summary guide
437854|NCT01698762|CERSG|cersg
437855|NCT01698762|Booklet|booklet
437856|NCT01698762|Questionnaires|questionnaires
437857|NCT01698762|Surveys|surveys
437858|NCT01698749|Ozurdex|ozurdex
437859|NCT01698749|Diabetic macular edema|diabetic macular edema
437860|NCT01698749|Central macular thickness|central macular thickness
437861|NCT01698736|ABO isoagglutinins|abo isoagglutinins
437862|NCT01698736|ABO incompatible transplantation|abo incompatible transplantation
437863|NCT01698736|immunoadsorption|immunoadsorption
437864|NCT01698736|membrane filtration|membrane filtration
437865|NCT01698736|plasmapheresis|plasmapheresis
437866|NCT01698723|ACLF|aclf
437867|NCT01698723|HEV|hev
437868|NCT01698723|Ribavirin|ribavirin
437869|NCT01698710|Premalignant|premalignant
437870|NCT01698710|Malignant|malignant
437871|NCT01698684|ED|ed
437872|NCT01698645|quality of life|quality of life
437873|NCT01698645|PecFent|pecfent
437874|NCT01698645|Lazanda|lazanda
437875|NCT01698645|fentanyl|fentanyl
437876|NCT01698645|intranasal|intranasal
437877|NCT01698645|breakthrough cancer pain|breakthrough cancer pain
437878|NCT01698632|Adnexal masses|adnexal masses
437879|NCT01698632|Ovarian cysts|ovarian cysts
437880|NCT01698632|Ovarian tumors|ovarian tumors
437881|NCT01698606|childhood obesity|childhood obesity
437882|NCT01698606|multidisciplinary|multidisciplinary
437883|NCT01698606|preschool children|preschool children
437884|NCT01698606|community-based|community-based
437885|NCT01698606|lifestyle intervention|lifestyle intervention
437886|NCT01698606|family-centered|family-centered
437887|NCT01698593|Bupivacaine|bupivacaine
437888|NCT01698593|digital nerve block|digital nerve block
437889|NCT01698593|epinephrine|epinephrine
437890|NCT01698593|duration of action|duration of action
437891|NCT01698593|pain|pain
437892|NCT01698593|touch|touch
437893|NCT01698593|pressure|pressure
437894|NCT01698593|temperature|temperature
437895|NCT01698580|accidental falls|accidental falls
437896|NCT01698580|aged|aged
437897|NCT01698580|aged, 80 and over|aged, 80 and over
437898|NCT01698580|prevention and control|prevention and control
437899|NCT01698567|Infants|infants
437900|NCT01698567|Cardiopulmonary bypass|cardiopulmonary bypass
437901|NCT01698567|anticoaglution|anticoaglution
437902|NCT01698541|Renal|renal
437903|NCT01698541|Transplantation|transplantation
437904|NCT01698541|Elderly|elderly
437905|NCT01698528|Diabetes|diabetes
437906|NCT01698528|diabetes technologies|diabetes technologies
437907|NCT01698528|telemedicine|telemedicine
437908|NCT01698502|Incretin|incretin
437909|NCT01698502|Training|training
437910|NCT01698502|Glucagon like peptide|glucagon like peptide
437911|NCT01698502|glucose dependent insulinotropic peptide|glucose dependent insulinotropic peptide
437912|NCT01698502|Gut|gut
437913|NCT01698502|Exercise|exercise
437914|NCT01698502|Insulin|insulin
437915|NCT01698502|Focus:|focus:
437916|NCT01698502|Gut hormone|gut hormone
437917|NCT01698502|adaptations|adaptations
437918|NCT01698476|pulmonary TB|pulmonary tb
437919|NCT01698476|cholecalciferol|cholecalciferol
437920|NCT01698476|sodium phenylbutyrate|sodium phenylbutyrate
437921|NCT01698476|antimicrobial peptides|antimicrobial peptides
437922|NCT01698476|immune response|immune response
437923|NCT01698463|Falls, Fractures, Osteoporosis, Frailty, Older Adults.|falls, fractures, osteoporosis, frailty, older adults.
437924|NCT01698450|FUS|fus
437925|NCT01698450|focused ultrasound|focused ultrasound
437926|NCT01698450|functional brain disorder|functional brain disorder
437927|NCT01698450|neuropathic pain|neuropathic pain
437928|NCT01698450|movement disorders|movement disorders
437929|NCT01698450|malignant brain tumors|malignant brain tumors
437930|NCT01698437|FUS|fus
437931|NCT01698437|focused ultrasound|focused ultrasound
437932|NCT01698437|functional brain disorders|functional brain disorders
437933|NCT01698437|neuropathic pain|neuropathic pain
437934|NCT01698437|movement disorders|movement disorders
437935|NCT01698437|malignant of brain tumors|malignant of brain tumors
437936|NCT01698411|hypertension|hypertension
437937|NCT01698411|sleep|sleep
437938|NCT01698411|insomnia|insomnia
437939|NCT01698372|Cardiac surgery.|cardiac surgery.
437940|NCT01698372|Wound healing.|wound healing.
437941|NCT01698372|Leg wound infection.|leg wound infection.
437942|NCT01698372|Wound care.|wound care.
437943|NCT01698346|Pertussis|pertussis
437944|NCT01698346|Infants|infants
437945|NCT01698346|Vaccination|vaccination
437946|NCT01698346|Pregnancy|pregnancy
437947|NCT01698333|122-0551|122-0551
437948|NCT01698333|steroid|steroid
437949|NCT01698333|HPA|hpa
437950|NCT01698307|Crohn's Disease|crohn's disease
437951|NCT01698307|Deep Remission|deep remission
437952|NCT01698307|Complications|complications
437953|NCT01698294|gut microbiome|gut microbiome
437954|NCT01698294|hormones|hormones
437955|NCT01698294|women|women
437956|NCT01698294|race|race
437957|NCT01698294|phytoestrogens|phytoestrogens
437958|NCT01698255|Depression|depression
437959|NCT01698255|Geriatrics|geriatrics
437960|NCT01698242|Heart failure|heart failure
437961|NCT01698242|Self-Management|self-management
437962|NCT01698242|Behavioral Clinical Trial|behavioral clinical trial
437963|NCT01698229|Cerebrospinal fluid|cerebrospinal fluid
437964|NCT01698229|Lumbar puncture|lumbar puncture
437965|NCT01698229|Spinal tap|spinal tap
437966|NCT01698229|Late infantile neuronal ceroid lipofuscinosis|late infantile neuronal ceroid lipofuscinosis
437967|NCT01698229|Batten disease|batten disease
437968|NCT01698216|Paliperidone|paliperidone
437969|NCT01698216|Palmitate|palmitate
437970|NCT01698216|switching|switching
437971|NCT01698216|schizophrenia|schizophrenia
437972|NCT01698216|subjective well-being|subjective well-being
437973|NCT01698177|Influenza|influenza
437974|NCT01698177|Cancer|cancer
437975|NCT01698177|Vaccination|vaccination
437976|NCT01698177|Immune response to influenza vaccination|immune response to influenza vaccination
437977|NCT01698164|lipid profiles|lipid profiles
437978|NCT01698164|coronary heart disease|coronary heart disease
437979|NCT01698164|menopausal syndrome|menopausal syndrome
437980|NCT01698164|MMSE|mmse
437981|NCT01698164|MENQOL|menqol
437982|NCT01698164|HAD|had
437983|NCT01698151|Chronic obstructive Pulmonary Disease|chronic obstructive pulmonary disease
437984|NCT01698151|COPD|copd
437985|NCT01698138|Spinal cord injury|spinal cord injury
437986|NCT01698138|Neurogenic overactive bladder|neurogenic overactive bladder
437987|NCT01698138|Onabotulinum toxin A|onabotulinum toxin a
437988|NCT01698138|Prevention|prevention
437989|NCT01698138|Botulinum Toxins, Type A|botulinum toxins, type a
437990|NCT01698125|Delirium|delirium
437991|NCT01698125|Autonomic cardiovascular control|autonomic cardiovascular control
437992|NCT01698125|Abdominal surgery|abdominal surgery
437993|NCT01698125|Tilt-test|tilt-test
437994|NCT01698086|Multiple Sclerosis|multiple sclerosis
437995|NCT01698086|Balance|balance
437996|NCT01698086|Fatigue|fatigue
437997|NCT01698086|Eye movement|eye movement
437998|NCT01698073|Teen pregnancy prevention|teen pregnancy prevention
437999|NCT01698073|American Indian|american indian
438000|NCT01698073|Group-randomized trial|group-randomized trial
438001|NCT01698060|Prevention of Avian Influenza|prevention of avian influenza
438002|NCT01698047|Depressive symptoms|depressive symptoms
438003|NCT01698047|sub-threshold depression|sub-threshold depression
438004|NCT01698047|resiliency|resiliency
438005|NCT01698047|Health Promotion|health promotion
438006|NCT01698047|minority health|minority health
438007|NCT01698034|volunteering|volunteering
438008|NCT01698034|cardiovascular health|cardiovascular health
438009|NCT01698021|Creatine Kinase, MB form|creatine kinase, mb form
438010|NCT01698021|Troponin|troponin
438011|NCT01698021|Acute coronary syndrome|acute coronary syndrome
438012|NCT01698021|myocardial infarction|myocardial infarction
438013|NCT01698021|Unstable angina|unstable angina
438014|NCT01697995|right ventricle|right ventricle
438015|NCT01697995|radiotracer uptake|radiotracer uptake
438016|NCT01697995|Myocardial Perfusion Imaging|myocardial perfusion imaging
438017|NCT01697995|balanced ischemia|balanced ischemia
438018|NCT01697982|pilot study|pilot study
438019|NCT01697982|psychosocial intervention|psychosocial intervention
438020|NCT01697982|advanced cancer|advanced cancer
438021|NCT01697969|allergic conjunctivitis|allergic conjunctivitis
438022|NCT01697969|Pataday|pataday
438023|NCT01697969|Olopatadine|olopatadine
438024|NCT01697956|Pediatric Subjects|pediatric subjects
438025|NCT01697943|Gastric Malignant Tumor|gastric malignant tumor
438026|NCT01697943|Total Gastrectomy|total gastrectomy
438027|NCT01697943|Reconstruction|reconstruction
438028|NCT01697930|PET Imaging|pet imaging
438029|NCT01697930|18F] 4-L-Fluoroglutam (2S,4R)|18f] 4-l-fluoroglutam (2s,4r)
438030|NCT01697930|12-168|12-168
438031|NCT01697917|Adenocarcinoma of Esophagogastric Junction|adenocarcinoma of esophagogastric junction
438032|NCT01697917|Total Gastrectomy|total gastrectomy
438033|NCT01697917|Proximal Gastrectomy|proximal gastrectomy
438034|NCT01697891|Radiation Treatment|radiation treatment
438035|NCT01697891|Head and Neck Cancer|head and neck cancer
438036|NCT01697891|Dysphagia|dysphagia
438037|NCT01697878|obstructive sleep apnea|obstructive sleep apnea
438038|NCT01697878|obesity|obesity
438039|NCT01697878|respiratory function|respiratory function
438040|NCT01697878|weight loss surgery|weight loss surgery
438041|NCT01697865|Reverse total shoulder|reverse total shoulder
438042|NCT01697852|vector control|vector control
438043|NCT01697852|LLIN|llin
438044|NCT01697852|IRS|irs
438045|NCT01697826|Clindamycin|clindamycin
438046|NCT01697826|Clotrimazole|clotrimazole
438047|NCT01697826|Vaginal formulation|vaginal formulation
438048|NCT01697826|Bacterial vaginosis|bacterial vaginosis
438049|NCT01697826|Candidiasis|candidiasis
438050|NCT01697826|Trichomoniasis|trichomoniasis
438051|NCT01697826|Mixed vaginitis|mixed vaginitis
438052|NCT01697826|Infective vaginitis|infective vaginitis
438053|NCT01697787|Treatment, diagnosis|treatment, diagnosis
438054|NCT01697761|Crohn's disease,acupuncture,moxibustion,inflammation factors|crohn's disease,acupuncture,moxibustion,inflammation factors
438055|NCT01697748|cesarean section incisions|cesarean section incisions
438056|NCT01697748|silver|silver
438057|NCT01697748|c-section|c-section
438058|NCT01697748|wound infection|wound infection
438059|NCT01697748|scar appearance|scar appearance
438060|NCT01697748|post operative pain|post operative pain
438061|NCT01697722|Primary care|primary care
438062|NCT01697722|Asthma management|asthma management
438063|NCT01697722|Inhaled corticosteroids|inhaled corticosteroids
438064|NCT01697722|Extra-fine hydrofluoroalkane|extra-fine hydrofluoroalkane
438065|NCT01697722|Long-acting beta-agonist|long-acting beta-agonist
438066|NCT01697722|Fixed-dose combination therapy|fixed-dose combination therapy
438067|NCT01697709|cannabis|cannabis
438068|NCT01697709|marijuana|marijuana
438069|NCT01697709|pharmacotherapy|pharmacotherapy
438070|NCT01697696|COPD, NVA237, QAB149, glycopyrronium bromide|copd, nva237, qab149, glycopyrronium bromide
438071|NCT01697605|Phase I, open-label, dose escalation, BGJ398, Japanese, Asian, FGF-R|phase i, open-label, dose escalation, bgj398, japanese, asian, fgf-r
438072|NCT01697566|Gynecology|gynecology
438073|NCT01697566|Endometrial Cancer Chemoprevention|endometrial cancer chemoprevention
438074|NCT01697566|Obese|obese
438075|NCT01697566|Body Mass Index (BMI) >/= 35 kg.m2|body mass index (bmi) >/= 35 kg.m2
438076|NCT01697566|Post-menopausal|post-menopausal
438077|NCT01697566|Hyperinsulinemia|hyperinsulinemia
438078|NCT01697566|Metformin|metformin
438079|NCT01697566|Placebo|placebo
438080|NCT01697566|Sugar pill|sugar pill
438081|NCT01697566|Lifestyle intervention|lifestyle intervention
438082|NCT01697566|Diet|diet
438083|NCT01697566|Exercise|exercise
438084|NCT01697514|recurrent medulloblastoma|recurrent medulloblastoma
438085|NCT01697397|Irritable bowel syndrome|irritable bowel syndrome
438086|NCT01697397|IBS|ibs
438087|NCT01697397|Gastrointestinal pain|gastrointestinal pain
438088|NCT01697397|Gastrointestinal functional disorder|gastrointestinal functional disorder
438089|NCT01697384|prostate cancer, PSA|prostate cancer, psa
438090|NCT01697358|FBSS|fbss
438091|NCT01697358|post laminectomy syndrome|post laminectomy syndrome
438092|NCT01697358|SCS|scs
438093|NCT01697358|RCT|rct
438094|NCT01697358|back pain|back pain
438095|NCT01697345|Vaginal Testosterone|vaginal testosterone
438096|NCT01697345|Vaginal atrophy|vaginal atrophy
438097|NCT01697345|Female Sexual Dysfunction|female sexual dysfunction
438098|NCT01697345|Aromatase Inhibitors|aromatase inhibitors
438099|NCT01697332|COPD|copd
438100|NCT01697319|Mucopolysaccharidosis IVA Type A|mucopolysaccharidosis iva type a
438101|NCT01697319|MPS IVA Type A|mps iva type a
438102|NCT01697319|Mucopolysaccharidosis IVA|mucopolysaccharidosis iva
438103|NCT01697319|MPS IVA|mps iva
438104|NCT01697319|Morquio A Syndrome|morquio a syndrome
438105|NCT01697319|Lysosomal Storage Disorder|lysosomal storage disorder
438106|NCT01697319|LSD|lsd
438107|NCT01697319|N-acetylgalactosamine-6-sulfatase|n-acetylgalactosamine-6-sulfatase
438108|NCT01697319|N-acetylgalactosamine-6-sulfate|n-acetylgalactosamine-6-sulfate
438109|NCT01697319|sulfatase|sulfatase
438110|NCT01697319|galactose-6-sulfatase|galactose-6-sulfatase
438111|NCT01697319|GALNS|galns
438112|NCT01697319|enzyme replacement therapy|enzyme replacement therapy
438113|NCT01697319|ERT|ert
438114|NCT01697319|MOR-006|mor-006
438115|NCT01697319|CPET|cpet
438116|NCT01697319|Limited ambulation|limited ambulation
438117|NCT01697319|Grip/ Pinch|grip/ pinch
438118|NCT01697306|non muscle invasive bladder cancer|non muscle invasive bladder cancer
438119|NCT01697280|Polio supplementary immunization activities|polio supplementary immunization activities
438120|NCT01697280|Routine EPI vaccine|routine epi vaccine
438121|NCT01697280|Integration of polio NID and routine EPI|integration of polio nid and routine epi
438122|NCT01697267|vasculitis|vasculitis
438123|NCT01697267|ANCA vasculitis|anca vasculitis
438124|NCT01697267|microscopic polyangiitis|microscopic polyangiitis
438125|NCT01697267|granulomatosis|granulomatosis
438126|NCT01697267|Wegener's|wegener's
438127|NCT01697267|AAV|aav
438128|NCT01697267|vasculitides|vasculitides
438129|NCT01697241|Exercise Therapy|exercise therapy
438130|NCT01697241|Education|education
438131|NCT01697241|Osteoarthritis|osteoarthritis
438132|NCT01697241|Hip|hip
438133|NCT01697241|Hip replacement|hip replacement
438134|NCT01697228|Diabetes|diabetes
438135|NCT01697228|Vitamin D|vitamin d
438136|NCT01697228|Proinflammatory markers|proinflammatory markers
438137|NCT01697189|professional drivers|professional drivers
438138|NCT01697189|sleepiness|sleepiness
438139|NCT01697189|stress|stress
438140|NCT01697189|safe driving|safe driving
438141|NCT01697189|training|training
438142|NCT01697163|De Novo Resistance|de novo resistance
438143|NCT01697163|Iressa|iressa
438144|NCT01697163|EGFR mutation|egfr mutation
438145|NCT01697163|lung cancer|lung cancer
438146|NCT01697150|Type 1 diabetes mellitus|type 1 diabetes mellitus
438147|NCT01697150|closed loop artificial pancreas|closed loop artificial pancreas
438148|NCT01697124|Physical activity|physical activity
438149|NCT01697124|children|children
438150|NCT01697124|Head Start|head start
438151|NCT01697124|SPARK-EC|spark-ec
438152|NCT01697111|YAZ|yaz
438153|NCT01697111|Flexible regimen|flexible regimen
438154|NCT01697111|Drospirenone|drospirenone
438155|NCT01697111|Ethinylestradiol Betadex|ethinylestradiol betadex
438156|NCT01697111|Endometriosis|endometriosis
438157|NCT01697111|Dienogest|dienogest
438158|NCT01697111|Japanese Patients|japanese patients
438159|NCT01697098|Dexamethasone|dexamethasone
438160|NCT01697098|preterm labour|preterm labour
438161|NCT01697098|respiratory distress|respiratory distress
438162|NCT01697085|sea buckthorn|sea buckthorn
438163|NCT01697085|mucous membrane|mucous membrane
438164|NCT01697085|dryness|dryness
438165|NCT01697085|metabolic syndrome|metabolic syndrome
438166|NCT01697085|vaginal atrophy|vaginal atrophy
438167|NCT01697072|Gastric Cancer|gastric cancer
438168|NCT01697072|First Line Treatment Gastroesophageal Junction (GEJ)|first line treatment gastroesophageal junction (gej)
438169|NCT01697072|Gastroesophageal Junction Cancer (GEJ)|gastroesophageal junction cancer (gej)
438170|NCT01697072|GEJ Cancer|gej cancer
438171|NCT01697059|appendicitis|appendicitis
438172|NCT01697046|peri-exposure|peri-exposure
438173|NCT01697046|chemoprophylaxis|chemoprophylaxis
438174|NCT01696942|Crohn's disease|crohn's disease
438175|NCT01696942|certolizumab|certolizumab
438176|NCT01696942|mesalamine|mesalamine
438177|NCT01696942|recurrence|recurrence
438178|NCT01696929|tocilizumab|tocilizumab
438179|NCT01696929|safety|safety
438180|NCT01696929|tolerability|tolerability
438181|NCT01696929|efficacy|efficacy
438182|NCT01696929|schizophrenia|schizophrenia
438183|NCT01696929|improvement|improvement
438184|NCT01696929|cognition|cognition
438185|NCT01696929|psychotic symptoms|psychotic symptoms
438186|NCT01696929|baseline IL-6 levels|baseline il-6 levels
438187|NCT01696916|COPD|copd
438188|NCT01696916|carbon dioxide|carbon dioxide
438189|NCT01696916|6-minute walking test|6-minute walking test
438190|NCT01696903|Postoperative pancreatic fistula|postoperative pancreatic fistula
438191|NCT01696903|Pancreatic texture|pancreatic texture
438192|NCT01696903|Pancreatic duct diameter|pancreatic duct diameter
438193|NCT01696903|Pancreatic consistency|pancreatic consistency
438194|NCT01696903|Pancreaticoduodenectomy|pancreaticoduodenectomy
438195|NCT01696890|chronic heart failure|chronic heart failure
438196|NCT01696890|telemonitoring|telemonitoring
438197|NCT01696890|first line practitioners|first line practitioners
438198|NCT01696890|integrated approach|integrated approach
438199|NCT01696890|efficacy|efficacy
438200|NCT01696838|Crohn's disease|crohn's disease
438201|NCT01696838|acupuncture|acupuncture
438202|NCT01696838|moxibustion|moxibustion
438203|NCT01696838|fMRI|fmri
438204|NCT01696838|Gut|gut
438205|NCT01696812|electrodeposition|electrodeposition
438206|NCT01696812|Subthalamic Nucleus|subthalamic nucleus
438207|NCT01696812|Deep Brain Stimulation|deep brain stimulation
438208|NCT01696812|Parkinson Disease|parkinson disease
438209|NCT01696773|tomato|tomato
438210|NCT01696773|tangerine tomato|tangerine tomato
438211|NCT01696773|carotenoids|carotenoids
438212|NCT01696773|lycopene|lycopene
438213|NCT01696773|flavonoids|flavonoids
438214|NCT01696747|gastroparesis|gastroparesis
438215|NCT01696747|idiopathic gastroparesis|idiopathic gastroparesis
438216|NCT01696747|diabetic gastroparesis|diabetic gastroparesis
438217|NCT01696747|post-Nissen gastroparesis|post-nissen gastroparesis
438218|NCT01696721|Proton Therapy|proton therapy
438219|NCT01696721|Pediatrics|pediatrics
438220|NCT01696721|Radiation Oncology|radiation oncology
438221|NCT01696721|Photon Therapy|photon therapy
438222|NCT01696682|minimally invasive esophagectomy|minimally invasive esophagectomy
438223|NCT01696682|anastomotic leakage|anastomotic leakage
438224|NCT01696682|gastric conduit|gastric conduit
438225|NCT01696669|Ewing's Sarcoma|ewing's sarcoma
438226|NCT01696669|P6 protocol MSKCC|p6 protocol mskcc
438227|NCT01696669|Gemcitabine|gemcitabine
438228|NCT01696669|Docetaxel|docetaxel
438229|NCT01696656|Gastrointestinal drugs|gastrointestinal drugs
438230|NCT01696656|Antibiotics|antibiotics
438231|NCT01696656|Vitamins|vitamins
438232|NCT01696656|Minerals|minerals
438233|NCT01696656|Intestinal insufficiency|intestinal insufficiency
438234|NCT01696656|Short Bowel syndrome|short bowel syndrome
438235|NCT01696656|Adjuvant therapy|adjuvant therapy
438236|NCT01696656|Antacids|antacids
438237|NCT01696656|Gastrointestinal motility modifiers|gastrointestinal motility modifiers
438238|NCT01696656|Micronutrients|micronutrients
438239|NCT01696643|Opioid|opioid
438240|NCT01696643|Constipation|constipation
438241|NCT01696643|Chronic|chronic
438242|NCT01696643|Pain|pain
438243|NCT01696630|anesthesia, epidural anagesia, colorectal surgery, xenon, hemodynamic change|anesthesia, epidural anagesia, colorectal surgery, xenon, hemodynamic change
438245|NCT01696604|pharmacokinetics|pharmacokinetics
438246|NCT01696604|FTIH|ftih
438247|NCT01696604|SARM|sarm
438248|NCT01696591|Alzheimer, Mesenchymal Stem Cells, Umbilical Cord Blood|alzheimer, mesenchymal stem cells, umbilical cord blood
438249|NCT01696578|PTSD|ptsd
438250|NCT01696578|Depression|depression
438251|NCT01696578|Anxiety|anxiety
438252|NCT01696578|Chronic pain|chronic pain
438253|NCT01696578|Anger|anger
438254|NCT01696578|Heart rate variability|heart rate variability
438255|NCT01696578|Disability|disability
438256|NCT01696565|myelosuppression|myelosuppression
438257|NCT01696565|chemotherapy|chemotherapy
438258|NCT01696565|Astragalus membranaceus|astragalus membranaceus
438259|NCT01696565|hematopoietic response|hematopoietic response
438260|NCT01696552|Gonarthritis|gonarthritis
438261|NCT01696552|TKR|tkr
438262|NCT01696552|Conventional|conventional
438263|NCT01696552|Positioning Guides|positioning guides
438264|NCT01696552|PSPG|pspg
438265|NCT01696552|CT Perth|ct perth
438266|NCT01696539|Prostate Cancer|prostate cancer
438267|NCT01696526|vitamin D|vitamin d
438268|NCT01696526|bioeffiency|bioeffiency
438269|NCT01696526|vitamin d fortified fish|vitamin d fortified fish
438270|NCT01696500|IVIG in Stevens-Johnson syndrome|ivig in stevens-johnson syndrome
438271|NCT01696500|Toxic Epidermal Necrolysis|toxic epidermal necrolysis
438272|NCT01696500|Patients with Stevens-Johnson syndrome|patients with stevens-johnson syndrome
438273|NCT01696500|Toxic Epidermal Necrolysis unresponsive to corticosteroids|toxic epidermal necrolysis unresponsive to corticosteroids
438274|NCT01696487|non-alcoholic fatty liver disease|non-alcoholic fatty liver disease
438275|NCT01696487|non-alcoholic steatohepatitis|non-alcoholic steatohepatitis
438276|NCT01696487|NAFLD|nafld
438277|NCT01696487|NASH|nash
438278|NCT01696474|Refractory cold agglutinin disease|refractory cold agglutinin disease
438279|NCT01696474|Bortezomib|bortezomib
438280|NCT01696474|blood-transfusion|blood-transfusion
438281|NCT01696448|Appetite Suppression|appetite suppression
438282|NCT01696448|CAR-191|car-191
438283|NCT01696435|Depression|depression
438284|NCT01696435|Depressive Symptoms|depressive symptoms
438285|NCT01696435|Mood|mood
438286|NCT01696435|Geriatric|geriatric
438287|NCT01696435|Prevention|prevention
438288|NCT01696422|Dengue|dengue
438289|NCT01696422|tetravalent attenuated Vaccine|tetravalent attenuated vaccine
438290|NCT01696422|Healthy adults|healthy adults
438291|NCT01696396|IBD, Crohn's Disease|ibd, crohn's disease
438292|NCT01696383|Intraocular Pressure (IOP)|intraocular pressure (iop)
438293|NCT01696383|Glaucoma|glaucoma
438294|NCT01696383|Ocular hypertension|ocular hypertension
438295|NCT01696383|DuoTrav|duotrav
438296|NCT01696383|Prostaglandin analogue|prostaglandin analogue
438297|NCT01696383|Beta-blocker|beta-blocker
438298|NCT01696370|Trimetazidine|trimetazidine
438299|NCT01696357|Asthma|asthma
438300|NCT01696357|Adolescents|adolescents
438301|NCT01696357|Self-monitoring|self-monitoring
438302|NCT01696357|Quality of life|quality of life
438303|NCT01696357|Biomedical device|biomedical device
438304|NCT01696357|Symptom monitoring|symptom monitoring
438305|NCT01696357|Self-management|self-management
438306|NCT01696344|LSPAF|lspaf
438307|NCT01696344|AF termination|af termination
438308|NCT01696344|PVAI|pvai
438309|NCT01696344|nonPV triggers|nonpv triggers
438310|NCT01696344|Long-standing persistent|long-standing persistent
438311|NCT01696305|Thyroid disease|thyroid disease
438312|NCT01696305|Hyalobarrier|hyalobarrier
438313|NCT01696305|Thyroidectomy|thyroidectomy
438314|NCT01696305|anti-adhesive effect|anti-adhesive effect
438315|NCT01696240|Pulmonary Hypertension|pulmonary hypertension
438316|NCT01696240|Exercise Capacity|exercise capacity
438317|NCT01696240|Cardiopulmonary Exercise Test|cardiopulmonary exercise test
438318|NCT01696240|Udenafil (Zydena)|udenafil (zydena)
438319|NCT01696240|Phosphodiesterase Type 5 Inhibitors|phosphodiesterase type 5 inhibitors
438320|NCT01696227|Nissle 1917|nissle 1917
438321|NCT01696227|Probiotic|probiotic
438322|NCT01696227|Uropathogen|uropathogen
438323|NCT01696214|asthma,smokers|asthma,smokers
438324|NCT01696201|Pregnancy, outcomes, depression, mood, physical exercise|pregnancy, outcomes, depression, mood, physical exercise
438325|NCT01696188|Interscalene|interscalene
438326|NCT01696188|nerve block|nerve block
438327|NCT01696188|nerve catheter|nerve catheter
438328|NCT01696188|in-plane|in-plane
438329|NCT01696188|out-of-plane|out-of-plane
438330|NCT01696188|anterolateral approach|anterolateral approach
438331|NCT01696188|posterior approach|posterior approach
438332|NCT01696188|shoulder surgery|shoulder surgery
438333|NCT01696175|ScvO2|scvo2
438334|NCT01696175|venous|venous
438335|NCT01696175|oxymetry|oxymetry
438336|NCT01696175|lactate|lactate
438337|NCT01696175|children|children
438338|NCT01696175|PICU|picu
438339|NCT01696175|Admission parameters of shock|admission parameters of shock
438340|NCT01696162|Knee pain|knee pain
438341|NCT01696162|Anterior knee pain|anterior knee pain
438342|NCT01696162|Patellofemoral|patellofemoral
438343|NCT01696162|Patellofemoral syndrome|patellofemoral syndrome
438344|NCT01696162|Runners knee|runners knee
438345|NCT01696149|TENS, sympathetic skin response, skin temperature|tens, sympathetic skin response, skin temperature
438346|NCT01696136|Ablation|ablation
438347|NCT01696136|Multi-electrode catheter|multi-electrode catheter
438348|NCT01696136|Single-tip catheter|single-tip catheter
438349|NCT01696136|Holter|holter
438350|NCT01696123|Alzheimer disease|alzheimer disease
438351|NCT01696123|Cholinesterase inhibitors|cholinesterase inhibitors
438352|NCT01696123|MLC601|mlc601
438353|NCT01696123|NeuroAiD|neuroaid
438354|NCT01696123|neuroprotection|neuroprotection
438355|NCT01696123|neuroregeneration|neuroregeneration
438356|NCT01696110|Bivalirudin|bivalirudin
438357|NCT01696110|Acute myocardial infarction|acute myocardial infarction
438358|NCT01696110|percutaneous transluminal coronary angioplasty|percutaneous transluminal coronary angioplasty
438359|NCT01696084|AML|aml
438360|NCT01696084|Acute Myeloid Leukemia|acute myeloid leukemia
438361|NCT01696084|high risk AML|high risk aml
438362|NCT01696084|secondary AML|secondary aml
438363|NCT01696084|AML in elderly|aml in elderly
438364|NCT01696032|Ovarian Cancer|ovarian cancer
438365|NCT01696019|magnetic resonance imaging|magnetic resonance imaging
438366|NCT01696019|cognition|cognition
438367|NCT01696019|Tai Chi|tai chi
438368|NCT01696019|physical exercise|physical exercise
438369|NCT01696019|mental exercise|mental exercise
438370|NCT01696019|intervention trial|intervention trial
438371|NCT01696019|prevention|prevention
438372|NCT01696019|dementia|dementia
438373|NCT01696019|Alzheimer disease|alzheimer disease
438374|NCT01696019|mild cognitive impairment|mild cognitive impairment
438375|NCT01696006|perfusion computed tomography|perfusion computed tomography
438376|NCT01696006|coronary artery disease|coronary artery disease
438377|NCT01695993|Nausea|nausea
438378|NCT01695993|Quality of life|quality of life
438379|NCT01695993|Chemotherapy|chemotherapy
438380|NCT01695993|Expectancy|expectancy
438381|NCT01695980|adenotonsillectomy|adenotonsillectomy
438382|NCT01695967|nasal obstruction|nasal obstruction
438383|NCT01695954|HIV|hiv
438384|NCT01695954|Hyperlipidemia|hyperlipidemia
438385|NCT01695954|Pharmacokinetics|pharmacokinetics
438386|NCT01695954|Statins|statins
438387|NCT01695954|Darunavir|darunavir
438388|NCT01695954|Efavirenz|efavirenz
438389|NCT01695954|Pitavastatin|pitavastatin
438390|NCT01695928|Velocity|velocity
438391|NCT01695928|Location|location
438392|NCT01695928|Periodontal status|periodontal status
438393|NCT01695915|constipation|constipation
438394|NCT01695915|children|children
438395|NCT01695915|healthy|healthy
438396|NCT01695915|rectal diameter|rectal diameter
438397|NCT01695863|Miralax with gatorade and dulcolax|miralax with gatorade and dulcolax
438398|NCT01695863|Movi pre|movi pre
438399|NCT01695863|Patient satisfaction and efficacy|patient satisfaction and efficacy
438400|NCT01695850|Randomized controlled trial|randomized controlled trial
438401|NCT01695850|Drugs,Chinese Herbal|drugs,chinese herbal
438402|NCT01695850|Constipation/drug therapy|constipation/drug therapy
438403|NCT01695837|Diet counseling|diet counseling
438404|NCT01695837|primary care|primary care
438405|NCT01695824|catheter ablation|catheter ablation
438406|NCT01695811|Keratoconus, PKP, femtosecond laser assisted keratoplasty|keratoconus, pkp, femtosecond laser assisted keratoplasty
438407|NCT01695798|poliomyelitis|poliomyelitis
438408|NCT01695798|oral polio vaccine|oral polio vaccine
438409|NCT01695798|OPV|opv
438410|NCT01695798|seroconversion|seroconversion
438411|NCT01695798|mucosal immunity|mucosal immunity
438412|NCT01695798|malnutrition|malnutrition
438413|NCT01695798|IPV|ipv
438414|NCT01695798|Inactivated polio vaccine|inactivated polio vaccine
438415|NCT01695798|Pakistan|pakistan
438416|NCT01695759|Anemia Secondary|anemia secondary
438417|NCT01695759|Chronic Kidney Disease|chronic kidney disease
438418|NCT01695720|Knee Injuries|knee injuries
438419|NCT01695720|Meniscus Injuries|meniscus injuries
438420|NCT01695720|Articular Cartilage Injuries|articular cartilage injuries
438421|NCT01695720|Orthopaedic Diagnostic|orthopaedic diagnostic
438422|NCT01695720|Magnetic Resonance Imaging|magnetic resonance imaging
438423|NCT01695707|atopic dermatitis|atopic dermatitis
438424|NCT01695707|eczema|eczema
438425|NCT01695681|Quality of life|quality of life
438426|NCT01695681|Celiac Disease/diet therapy|celiac disease/diet therapy
438427|NCT01695681|Celiac Disease/diagnosis|celiac disease/diagnosis
438428|NCT01695681|Prospective Studies|prospective studies
438429|NCT01695668|Graft versus Host Disease (GVHD)|graft versus host disease (gvhd)
438430|NCT01695668|dry eyes|dry eyes
438431|NCT01695668|Bone marrow transplant (BMT)|bone marrow transplant (bmt)
438432|NCT01695668|Restasis|restasis
438433|NCT01695668|Lotemax|lotemax
438434|NCT01695642|lasik, intralase, microkeratome|lasik, intralase, microkeratome
438435|NCT01695603|Brain injury|brain injury
438436|NCT01695603|Controlled ventilation|controlled ventilation
438437|NCT01695603|Intellivent|intellivent
438438|NCT01695603|Capnia control|capnia control
438439|NCT01695590|Myeloma|myeloma
438440|NCT01695590|PRLX93936|prlx93936
438441|NCT01695577|Traumatic brain injury|traumatic brain injury
438442|NCT01695577|Dizziness|dizziness
438443|NCT01695577|Vestibular rehabilitation|vestibular rehabilitation
438444|NCT01695577|Balance rehabilitation|balance rehabilitation
438445|NCT01695564|atrial enlargement|atrial enlargement
438446|NCT01695564|left atrial appendage|left atrial appendage
438447|NCT01695551|Radiofrequency ablation|radiofrequency ablation
438448|NCT01695551|fast heart rhythm|fast heart rhythm
438449|NCT01695551|ventricle|ventricle
438450|NCT01695551|catheter ablation|catheter ablation
438451|NCT01695551|ablation|ablation
438452|NCT01695538|Yoga|yoga
438453|NCT01695538|atrial tachycardia|atrial tachycardia
438454|NCT01695525|Neurocardiogenic Syncope|neurocardiogenic syncope
438455|NCT01695525|Yoga|yoga
438456|NCT01695486|BIS|bis
438457|NCT01695486|Comfort|comfort
438458|NCT01695486|open muscle biopsy|open muscle biopsy
438459|NCT01695473|Prostate cancer|prostate cancer
438460|NCT01695473|High-risk prostate cancer|high-risk prostate cancer
438461|NCT01695473|Radical prostatectomy|radical prostatectomy
438462|NCT01695473|BKM120|bkm120
438463|NCT01695460|Migraine|migraine
438464|NCT01695460|Vitamin D|vitamin d
438465|NCT01695434|multiple sclerosis|multiple sclerosis
438466|NCT01695434|MRI|mri
438467|NCT01695434|Copaxone|copaxone
438468|NCT01695434|healthy controls|healthy controls
438469|NCT01695434|glatiramer acetate|glatiramer acetate
438470|NCT01695421|Transcutaneous Electric Nerve Stimulation|transcutaneous electric nerve stimulation
438471|NCT01695421|Oxygen Consumption|oxygen consumption
438472|NCT01695421|Heart Failure|heart failure
438473|NCT01695408|Drug Treatment|drug treatment
438474|NCT01695408|Treatment pathways|treatment pathways
438475|NCT01695408|Clinical routine|clinical routine
438476|NCT01695408|Registry|registry
438477|NCT01695408|Outcomes|outcomes
438478|NCT01695408|Survival|survival
438479|NCT01695408|Patient-related outcomes|patient-related outcomes
438480|NCT01695408|Quality of life|quality of life
438481|NCT01695408|Steroids|steroids
438482|NCT01695408|Azathioprine|azathioprine
438483|NCT01695408|N-Acetylcysteine|n-acetylcysteine
438484|NCT01695408|Pirfenidone|pirfenidone
438485|NCT01695408|Tyrosine kinase inhibitors|tyrosine kinase inhibitors
438486|NCT01695408|Nintedanib|nintedanib
438487|NCT01695408|multicenter|multicenter
438488|NCT01695408|Germany|germany
438489|NCT01695408|Safety|safety
438490|NCT01695408|Adverse event|adverse event
438491|NCT01695395|intellectual disability|intellectual disability
438492|NCT01695395|mental disorder|mental disorder
438493|NCT01695395|dual diagnosis|dual diagnosis
438494|NCT01695395|provision|provision
438495|NCT01695395|needs assessment|needs assessment
438496|NCT01695395|quality of life|quality of life
438497|NCT01695382|Cancer|cancer
438498|NCT01695382|Palliative Care|palliative care
438499|NCT01695382|Patient Navigation|patient navigation
438500|NCT01695356|Melasma|melasma
438501|NCT01695356|sunscreens|sunscreens
438502|NCT01695356|visible light|visible light
438503|NCT01695356|ultraviolet light|ultraviolet light
438504|NCT01695343|Cystic Fibrosis|cystic fibrosis
438505|NCT01695343|Pseudomonas aeruginosa (Pa)|pseudomonas aeruginosa (pa)
438506|NCT01695343|CF|cf
438507|NCT01695330|Multiple Myeloma|multiple myeloma
438508|NCT01695330|Relapsed|relapsed
438509|NCT01695330|Refractory|refractory
438510|NCT01695330|Bortezomib|bortezomib
438511|NCT01695330|Subcutaneous|subcutaneous
438512|NCT01695330|Oncotherapeutics|oncotherapeutics
438513|NCT01695317|Migraine|migraine
438514|NCT01695317|Preventive medication|preventive medication
438515|NCT01695304|Cryptosporidiosis|cryptosporidiosis
438516|NCT01695304|Waterborne disease|waterborne disease
438517|NCT01695304|Diarrheal disease|diarrheal disease
438518|NCT01695304|Ceramic water filters|ceramic water filters
438519|NCT01695304|infants|infants
438520|NCT01695304|young children|young children
438521|NCT01695304|drinking water|drinking water
438522|NCT01695304|Kenya|kenya
438523|NCT01695291|Obsessive compulsive disorder|obsessive compulsive disorder
438524|NCT01695278|motivational interviewing|motivational interviewing
438525|NCT01695278|telephone counseling|telephone counseling
438526|NCT01695278|medical education|medical education
438527|NCT01695278|diabetes self management|diabetes self management
438528|NCT01695265|Airflow Obstruction|airflow obstruction
438529|NCT01695226|Celecoxib|celecoxib
438530|NCT01695226|Clinical trial, Phase II|clinical trial, phase ii
438531|NCT01695226|Oligonucleotide Array Sequence Analysis|oligonucleotide array sequence analysis
438532|NCT01695213|uncemented hip|uncemented hip
438533|NCT01695213|bone remodeling|bone remodeling
438534|NCT01695213|DEXA|dexa
438535|NCT01695213|clinical evaluation|clinical evaluation
438536|NCT01695187|Herpes, Herpes Labialis, nanoemulsion, NanoBio, NB-001|herpes, herpes labialis, nanoemulsion, nanobio, nb-001
438537|NCT01695174|Primary Sclerosing Cholangitis|primary sclerosing cholangitis
438538|NCT01695174|Xifaxan|xifaxan
438539|NCT01695161|Mucopolysaccharidosis|mucopolysaccharidosis
438540|NCT01695161|Fabry disease|fabry disease
438541|NCT01695148|beta-carotene biofortified maize|beta-carotene biofortified maize
438542|NCT01695148|micronutrients|micronutrients
438543|NCT01695148|vitamin A|vitamin a
438544|NCT01695148|serum retinol|serum retinol
438545|NCT01695148|dark adaptation|dark adaptation
438546|NCT01695135|Prostate neoplasms|prostate neoplasms
438547|NCT01695135|Prostate cancer|prostate cancer
438548|NCT01695135|Metastatic castration resistant prostate cancer|metastatic castration resistant prostate cancer
438549|NCT01695135|Abiraterone acetate|abiraterone acetate
438550|NCT01695135|JNJ-212082|jnj-212082
438551|NCT01695122|Head and Neck Cancer|head and neck cancer
438552|NCT01695122|Oropharyngeal cancer|oropharyngeal cancer
438553|NCT01695122|Oral cavity cancer|oral cavity cancer
438554|NCT01695122|Chemoradiation|chemoradiation
438555|NCT01695122|valproic acid|valproic acid
438556|NCT01695122|histone deacetylase|histone deacetylase
438557|NCT01695109|GLP1|glp1
438558|NCT01695109|obesity|obesity
438559|NCT01695109|fMRI|fmri
438560|NCT01695109|ghrelin|ghrelin
438561|NCT01695083|Non alcoholic steatohepatitis|non alcoholic steatohepatitis
438562|NCT01695083|Liver fibrosis,Steatosis|liver fibrosis,steatosis
438563|NCT01695083|Liver inflammation|liver inflammation
438564|NCT01695083|Morbid obesity|morbid obesity
438565|NCT01695083|Non invasive tests|non invasive tests
438566|NCT01695031|Urban adolescents|urban adolescents
438567|NCT01695031|Acute asthma|acute asthma
438568|NCT01695031|Emergency department|emergency department
438569|NCT01695031|Computer tailoring|computer tailoring
438570|NCT01695031|Web-based intervention|web-based intervention
438571|NCT01695018|oral epithelial dysplasia|oral epithelial dysplasia
438572|NCT01695018|p16 methylation|p16 methylation
438573|NCT01695018|diagnostic reagents|diagnostic reagents
438574|NCT01695018|early diagnosis|early diagnosis
438575|NCT01694992|Stroke|stroke
438576|NCT01694992|Early Ambulation|early ambulation
438577|NCT01694992|Rehabilitation|rehabilitation
438578|NCT01694992|Physical Therapy|physical therapy
438579|NCT01694992|Randomized controlled trial|randomized controlled trial
438580|NCT01694979|Pelvic floor|pelvic floor
438581|NCT01694979|Rehabilitation|rehabilitation
438582|NCT01694979|Respiration|respiration
438583|NCT01694979|Urinary incontinence|urinary incontinence
438584|NCT01694953|MNGIE|mngie
438585|NCT01694953|Mitochondrial|mitochondrial
438586|NCT01694953|Mitochondrial Neurogastrointestinal encephalopathy|mitochondrial neurogastrointestinal encephalopathy
438587|NCT01694940|mitochondrial disorders|mitochondrial disorders
438588|NCT01694940|Mito Disease|mito disease
438589|NCT01694940|Mitochondria|mitochondria
438590|NCT01694940|Mitochondrial disease|mitochondrial disease
438591|NCT01694940|Mitochondrial myopathy, encephalopathy, lactic acidosis, and stroke (MELAS) Syndrome|mitochondrial myopathy, encephalopathy, lactic acidosis, and stroke (melas) syndrome
438592|NCT01694940|Myoclonic Epilepsy with Ragged Red Fibers (MERRF)|myoclonic epilepsy with ragged red fibers (merrf)
438593|NCT01694940|Leber Hereditary Optic Neuropathy (LHON)|leber hereditary optic neuropathy (lhon)
438594|NCT01694940|Leigh Syndrome|leigh syndrome
438595|NCT01694940|Neuropathy, ataxia, and retinitis pigmentosa (NARP)|neuropathy, ataxia, and retinitis pigmentosa (narp)
438596|NCT01694940|Kearns Sayre syndrome|kearns sayre syndrome
438597|NCT01694940|Alpers Huttenlocher|alpers huttenlocher
438598|NCT01694940|Pearson|pearson
438599|NCT01694940|Mitochondrial Neurogastrointestinal Encephalopathy (MNGIE)|mitochondrial neurogastrointestinal encephalopathy (mngie)
438600|NCT01694940|Barth Syndrome|barth syndrome
438601|NCT01694940|Coenzyme Q (CoQ) Deficiency|coenzyme q (coq) deficiency
438602|NCT01694940|Chronic progressive external ophthalmoplegia (CPEO)|chronic progressive external ophthalmoplegia (cpeo)
560384|NCT01176721|NMS|nms
438603|NCT01694940|DAD|dad
438604|NCT01694940|Diabetes and Deafness|diabetes and deafness
438605|NCT01694940|Encephalopathy|encephalopathy
438606|NCT01694940|Encephalomyopathy|encephalomyopathy
438701|NCT01694459|angioplasty|angioplasty
438607|NCT01694940|Familial Bilateral Striatal Necrosis (FBSN)|familial bilateral striatal necrosis (fbsn)
438608|NCT01694940|Hepatocerebral Disease|hepatocerebral disease
438609|NCT01694940|Leukoencephalopathy|leukoencephalopathy
438610|NCT01694940|Maternally Inherited Leigh Syndrome (MILS)|maternally inherited leigh syndrome (mils)
438611|NCT01694940|Complex I Deficiency|complex i deficiency
438612|NCT01694940|Complex II Deficiency|complex ii deficiency
438613|NCT01694940|Complex III Deficiency|complex iii deficiency
438614|NCT01694940|Complex IV Deficiency|complex iv deficiency
438615|NCT01694940|Complex V Deficiency|complex v deficiency
438739|NCT01694329|Otitis media|otitis media
438616|NCT01694940|mitochondrial DNA depletion syndrome|mitochondrial dna depletion syndrome
438617|NCT01694940|mtDNA depletion syndrome|mtdna depletion syndrome
438618|NCT01694927|Mesenchymal stem cell|mesenchymal stem cell
438619|NCT01694927|Spinal cord injury|spinal cord injury
438620|NCT01694914|Corneal Transplantation|corneal transplantation
438621|NCT01694914|corneal organ culture medium|corneal organ culture medium
438622|NCT01694914|free animal compound medium|free animal compound medium
438623|NCT01694888|Students practice, Lecture; Nursing records; Nursing education; Midwifery|students practice, lecture; nursing records; nursing education; midwifery
438624|NCT01694875|cervix cancer|cervix cancer
438626|NCT01694875|APTIMA|aptima
438627|NCT01694862|quasi experimental|quasi experimental
438628|NCT01694862|evaluation|evaluation
438629|NCT01694862|intervention|intervention
438630|NCT01694862|service integration|service integration
438631|NCT01694862|cost analysis|cost analysis
438632|NCT01694862|HIV|hiv
438633|NCT01694862|FP|fp
438634|NCT01694862|PNC|pnc
438635|NCT01694862|Sub-Saharan Africa|sub-saharan africa
438636|NCT01694849|PPARs|ppars
438637|NCT01694849|NASH|nash
438638|NCT01694849|Non-Alcoholic Steatohepatitis|non-alcoholic steatohepatitis
438639|NCT01694849|Liver Diseases|liver diseases
438640|NCT01694849|Fibrosis|fibrosis
438641|NCT01694836|Allergic rhinitis|allergic rhinitis
438642|NCT01694836|Allergic rhinoconjunctivitis|allergic rhinoconjunctivitis
438643|NCT01694836|Allergy induced asthma|allergy induced asthma
438644|NCT01694836|Birch (Betula alba)|birch (betula alba)
438645|NCT01694836|Hayfever|hayfever
438646|NCT01694836|Immunotherapy|immunotherapy
438647|NCT01694823|Cartilage repair|cartilage repair
438648|NCT01694823|Cartilage defects|cartilage defects
438649|NCT01694823|cell sheet|cell sheet
438650|NCT01694823|Autologous chondrocyte implantation|autologous chondrocyte implantation
438651|NCT01694810|acne vulgaris|acne vulgaris
438652|NCT01694758|Benchmarking could improve quality of patient care|benchmarking could improve quality of patient care
438653|NCT01694758|ESC and ATP III Guidelines|esc and atp iii guidelines
438654|NCT01694745|Newborns|newborns
438655|NCT01694745|Premature|premature
438656|NCT01694745|Pain|pain
438657|NCT01694745|Pain assessment|pain assessment
438658|NCT01694745|Endotracheal Intubation|endotracheal intubation
438659|NCT01694745|Analgesia|analgesia
438660|NCT01694745|Sedation|sedation
438661|NCT01694745|Longterm effects of pain|longterm effects of pain
438662|NCT01694745|Epidemiology|epidemiology
438663|NCT01694732|Chronic obstructive pulmonary disease|chronic obstructive pulmonary disease
438664|NCT01694732|Varenicline|varenicline
438665|NCT01694732|Smoking cessation|smoking cessation
438666|NCT01694719|Depression|depression
438667|NCT01694719|Major Depressive Disorder|major depressive disorder
438668|NCT01694719|Behavioral Activation|behavioral activation
438669|NCT01694719|Cognitive Training|cognitive training
438670|NCT01694680|AMD|amd
438671|NCT01694680|Lutein|lutein
438672|NCT01694680|Visual function|visual function
438673|NCT01694680|Early signs of AMD|early signs of amd
438674|NCT01694680|AREDS-category 2|areds-category 2
438675|NCT01694641|time lapse monitoring|time lapse monitoring
438676|NCT01694641|blastocyst|blastocyst
438677|NCT01694641|single embryo transfer|single embryo transfer
438678|NCT01694641|clinical pregnancy|clinical pregnancy
438679|NCT01694641|implantation rate|implantation rate
438680|NCT01694615|Lung Transplantation|lung transplantation
438681|NCT01694615|Acute Rejection|acute rejection
438682|NCT01694602|Cachexia|cachexia
438683|NCT01694602|Sarcopenia|sarcopenia
438684|NCT01694602|De Novo|de novo
438685|NCT01694602|Deuterated|deuterated
438686|NCT01694589|pancreatic cancer|pancreatic cancer
438687|NCT01694589|resectable pancreatic cancer|resectable pancreatic cancer
438688|NCT01694576|Nasopharyngeal carcinoma staged N2-3M0|nasopharyngeal carcinoma staged n2-3m0
438689|NCT01694576|Adjuvant chemotherapy|adjuvant chemotherapy
438690|NCT01694563|Atrial Fibrillation|atrial fibrillation
438691|NCT01694550|pacemaker|pacemaker
438692|NCT01694550|ICD / CRTD|icd / crtd
438693|NCT01694550|corrected QT-interval|corrected qt-interval
438694|NCT01694537|lumbrokinase|lumbrokinase
438695|NCT01694537|fibrinolytic|fibrinolytic
438696|NCT01694537|plasmin-antiplasmin complex|plasmin-antiplasmin complex
438697|NCT01694537|euglobulin clot lysis time|euglobulin clot lysis time
438698|NCT01694537|platelet aggregation|platelet aggregation
438699|NCT01694511|Endoscopy, Gastrointestinal|endoscopy, gastrointestinal
438700|NCT01694485|Ulcerative Colitis, IBD|ulcerative colitis, ibd
438702|NCT01694459|heparin|heparin
438703|NCT01694459|trial|trial
438704|NCT01694446|Intestinal lipoprotein|intestinal lipoprotein
438705|NCT01694446|Apo B48 and apoB100|apo b48 and apob100
438706|NCT01694446|Pancreatic clamp|pancreatic clamp
438707|NCT01694407|Prevention|prevention
438708|NCT01694394|atrial fibrillation|atrial fibrillation
438709|NCT01694394|implantable cardiac monitor|implantable cardiac monitor
438710|NCT01694394|left atrial enlargement|left atrial enlargement
438711|NCT01694394|CHA2DS2 VASc Score|cha2ds2 vasc score
438712|NCT01694394|cardiovascular risk|cardiovascular risk
438713|NCT01694381|Acute Ischemic Stroke|acute ischemic stroke
438714|NCT01694381|TS01|ts01
438715|NCT01694381|Mutant pro-urokinase|mutant pro-urokinase
438717|NCT01694381|C1 inhibitor|c1 inhibitor
438718|NCT01694381|Safety|safety
438719|NCT01694381|Stroke|stroke
438720|NCT01694381|Tolerability|tolerability
438721|NCT01694381|Ischemia|ischemia
438722|NCT01694381|Cerebral Infarction|cerebral infarction
438723|NCT01694381|Cerebrovascular Disorders|cerebrovascular disorders
438724|NCT01694381|Vascular Diseases|vascular diseases
438725|NCT01694381|Cardiovascular Diseases|cardiovascular diseases
438726|NCT01694381|Brain Infarction|brain infarction
438727|NCT01694381|Brain Ischemia|brain ischemia
438728|NCT01694381|Fibrinolytic Agents|fibrinolytic agents
438729|NCT01694381|Thrombolytic Agents|thrombolytic agents
438730|NCT01694381|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action
438731|NCT01694381|Pharmacologic Actions|pharmacologic actions
438732|NCT01694381|Cardiovascular Agents|cardiovascular agents
438733|NCT01694381|Therapeutic Uses|therapeutic uses
438734|NCT01694381|Hematologic Agents|hematologic agents
438735|NCT01694368|Near infrared spectroscopy; lipid core; vulnerable plaque|near infrared spectroscopy; lipid core; vulnerable plaque
438736|NCT01694329|Streptococcus pneumoniae|streptococcus pneumoniae
438737|NCT01694329|Pneumococcal Conjugate Vaccines|pneumococcal conjugate vaccines
438738|NCT01694329|Immunization|immunization
438740|NCT01694316|Computerized neurobehavioral intervention|computerized neurobehavioral intervention
438741|NCT01694277|Gastrointestinal Stromal Tumour|gastrointestinal stromal tumour
438742|NCT01694277|GIST|gist
438743|NCT01694277|non-resectable|non-resectable
438744|NCT01694277|metastatic|metastatic
438745|NCT01694277|second line treatment|second line treatment
438746|NCT01694277|resistance to imatinib|resistance to imatinib
438747|NCT01694277|tyrosine kinase inhibitor|tyrosine kinase inhibitor
438748|NCT01694264|HBV surface antigen|hbv surface antigen
438749|NCT01694264|Anti-HBc positive|anti-hbc positive
438750|NCT01694264|Anti-TNFα Treatment|anti-tnfα treatment
438751|NCT01694264|Reactivation|reactivation
438752|NCT01694251|mitral valve area|mitral valve area
438753|NCT01694251|pressure half time|pressure half time
438754|NCT01694251|3 dimensional transesophageal echocardiography|3 dimensional transesophageal echocardiography
438755|NCT01694251|computed tomography|computed tomography
438756|NCT01694238|Colostomy|colostomy
438757|NCT01694238|Surgical technique|surgical technique
438758|NCT01694225|Breast cancer|breast cancer
438759|NCT01694225|Anti-estrogen therapy|anti-estrogen therapy
438760|NCT01694212|Macular edema|macular edema
438761|NCT01694212|Cataract|cataract
438762|NCT01694212|Diabetic retinopathy|diabetic retinopathy
438763|NCT01694212|Anti-inflammatory agents,Non-steroidal|anti-inflammatory agents,non-steroidal
438764|NCT01694199|Pulsed Radiofrequency Energy (PRFE)|pulsed radiofrequency energy (prfe)
438765|NCT01694199|Pain|pain
438766|NCT01694199|Postsurgical|postsurgical
438767|NCT01694199|Opioids|opioids
438768|NCT01694199|Pain relief|pain relief
438769|NCT01694199|Medical device|medical device
438770|NCT01694199|Endorphins|endorphins
438771|NCT01694173|Type 2 diabetes mellitus, F18-FDG labelled stem cells|type 2 diabetes mellitus, f18-fdg labelled stem cells
438772|NCT01694160|kidney transplant patients|kidney transplant patients
438773|NCT01694160|Albuminuria|albuminuria
438774|NCT01694147|relationship|relationship
438775|NCT01694147|endothelial injury|endothelial injury
438776|NCT01694147|vascular permeability|vascular permeability
438777|NCT01694147|severe sepsis related ALI/ARDS|severe sepsis related ali/ards
438778|NCT01694134|Discopathy|discopathy
438779|NCT01694134|Modic I|modic i
438780|NCT01694134|Corticoids|corticoids
438781|NCT01694134|Local Anaesthetic|local anaesthetic
438782|NCT01694134|Intradiscal injection|intradiscal injection
438783|NCT01694121|HIV prevention|hiv prevention
438784|NCT01694121|African American men|african american men
438785|NCT01694121|evaluation study|evaluation study
438786|NCT01694095|Geographic atrophy, prognosis, risk factors, natural history|geographic atrophy, prognosis, risk factors, natural history
438787|NCT01694082|brief intervention|brief intervention
438788|NCT01694082|web-based interventions|web-based interventions
438789|NCT01694082|computer-based interventions|computer-based interventions
438790|NCT01694082|harm reduction|harm reduction
438791|NCT01694082|young adult|young adult
438792|NCT01694082|college student|college student
438793|NCT01694069|piperacillin|piperacillin
438794|NCT01694069|tazobactam|tazobactam
438795|NCT01694069|pseudomonas aeruginosa|pseudomonas aeruginosa
438796|NCT01694069|cystic fibrosis|cystic fibrosis
438797|NCT01694069|pulmonary exacerbation|pulmonary exacerbation
438798|NCT01694069|continuous infusion|continuous infusion
438799|NCT01694069|beta lactam|beta lactam
438800|NCT01694030|Attachment security priming|attachment security priming
438801|NCT01694030|depressed mood|depressed mood
438802|NCT01694017|HIV,treatment,cost effectiveness,drug toxicity,QOL,costs|hiv,treatment,cost effectiveness,drug toxicity,qol,costs
438803|NCT01694004|Nutrient absorption|nutrient absorption
438804|NCT01694004|Duodenal feeding tube|duodenal feeding tube
438805|NCT01694004|Gut-brain-gut axis|gut-brain-gut axis
438806|NCT01693978|PTSD|ptsd
438807|NCT01693978|Prolonged Exposure|prolonged exposure
438808|NCT01693978|Comorbidity|comorbidity
438809|NCT01693978|Treatment|treatment
438810|NCT01693978|Methadone Maintenance|methadone maintenance
438811|NCT01693978|Substance Use Disorder|substance use disorder
438812|NCT01693939|Lasik|lasik
438813|NCT01693939|Myopia|myopia
438814|NCT01693939|Femtosecond Laser|femtosecond laser
438815|NCT01693926|Obesity|obesity
438816|NCT01693926|Children|children
438817|NCT01693926|Physical activity|physical activity
438818|NCT01693926|Stress|stress
438819|NCT01693926|Snacking|snacking
438820|NCT01693900|joint replacement|joint replacement
438821|NCT01693900|total hip replacement|total hip replacement
438822|NCT01693900|regional pain block|regional pain block
438823|NCT01693900|ultrasound guidance|ultrasound guidance
438824|NCT01693900|fascia iliaca compartment block|fascia iliaca compartment block
438825|NCT01693887|IFI|ifi
438826|NCT01693887|empirical therapy|empirical therapy
438827|NCT01693887|preemptive therapy|preemptive therapy
438828|NCT01693887|Itraconazole|itraconazole
438829|NCT01693874|anxiety|anxiety
438830|NCT01693874|depression|depression
438831|NCT01693874|cognition|cognition
438832|NCT01693874|MBSR|mbsr
438833|NCT01693874|mindfulness|mindfulness
438834|NCT01693874|stress|stress
438835|NCT01693874|elderly|elderly
438836|NCT01693861|Colorectal|colorectal
438837|NCT01693861|Cancer|cancer
438838|NCT01693861|Metastatic|metastatic
438839|NCT01693861|Chronotherapy|chronotherapy
438840|NCT01693861|Urine|urine
438841|NCT01693861|Nucleosides|nucleosides
438842|NCT01693861|Chemotherapy|chemotherapy
438843|NCT01693861|Treated with chemotherapy|treated with chemotherapy
438844|NCT01693848|Colorectal|colorectal
438845|NCT01693848|Cancer|cancer
438846|NCT01693848|Metastatic|metastatic
438847|NCT01693848|Control|control
438848|NCT01693848|Urine|urine
438849|NCT01693848|Nucleosides|nucleosides
438850|NCT01693848|Surgery|surgery
438851|NCT01693848|General anesthesia|general anesthesia
438852|NCT01693848|Scheduled for surgery|scheduled for surgery
438853|NCT01693835|Colorectal|colorectal
438854|NCT01693835|Cancer|cancer
438855|NCT01693835|Metastatic|metastatic
438856|NCT01693835|Healthy|healthy
438857|NCT01693835|Control|control
438858|NCT01693835|Circadian|circadian
438859|NCT01693835|Urine|urine
438860|NCT01693835|Nucleosides|nucleosides
438861|NCT01693822|metastatic renal cell carcinoma|metastatic renal cell carcinoma
438862|NCT01693822|predominant clear cell histology|predominant clear cell histology
438863|NCT01693822|Unsuitable for nephrectomy|unsuitable for nephrectomy
438864|NCT01693822|unsuitable for 'watch and wait' policy|unsuitable for 'watch and wait' policy
438865|NCT01693809|Caffeine|caffeine
438866|NCT01693809|Vestibular Evoked Myogenic Potentials|vestibular evoked myogenic potentials
438867|NCT01693809|dizziness|dizziness
438868|NCT01693809|vertigo|vertigo
438869|NCT01693809|tinnitus|tinnitus
438870|NCT01693770|Bone Metastasis|bone metastasis
438871|NCT01693770|Pain Palliation|pain palliation
438872|NCT01693770|High Intensity Focused Ultrasound|high intensity focused ultrasound
438873|NCT01693757|Anterior Cruciate Ligament|anterior cruciate ligament
438874|NCT01693757|Hamstrings versus patellar tendon|hamstrings versus patellar tendon
438875|NCT01693757|Hop test|hop test
438876|NCT01693757|Return to sports|return to sports
438877|NCT01693744|Pseudoexfoliation, chronic kidney disease|pseudoexfoliation, chronic kidney disease
438878|NCT01693731|Breast cancer|breast cancer
438879|NCT01693731|Periodontal Diseases|periodontal diseases
438880|NCT01693731|Aromatase Inhibitors|aromatase inhibitors
438881|NCT01693731|Oral Health Related Quality of Life|oral health related quality of life
438882|NCT01693718|cancer|cancer
438883|NCT01693718|advanced|advanced
438884|NCT01693718|oral cavity|oral cavity
438885|NCT01693718|larynx|larynx
438886|NCT01693705|Tracheostomy|tracheostomy
438887|NCT01693692|Fibromyalgia|fibromyalgia
438888|NCT01693679|Tebivudine eGFR non-Tebivudine|tebivudine egfr non-tebivudine
438889|NCT01693666|Pregnancy|pregnancy
438890|NCT01693666|Obesity|obesity
438891|NCT01693666|Weight gain|weight gain
438892|NCT01693666|Obstetric complications|obstetric complications
560718|NCT01175460|s-1|s-1
438893|NCT01693666|Lifestyle intervention|lifestyle intervention
438894|NCT01693653|Behcet's syndrome|behcet's syndrome
438895|NCT01693653|oral ulcers|oral ulcers
438896|NCT01693640|Behcet's|behcet's
438897|NCT01693614|Diffuse large B-cell lymphoma, Mantle cell lymphoma, Follicular lymphoma, PI3K inhibitor, Non-Hodgkin lymphoma, NHL|diffuse large b-cell lymphoma, mantle cell lymphoma, follicular lymphoma, pi3k inhibitor, non-hodgkin lymphoma, nhl
438898|NCT01693601|Myelofibrosis|myelofibrosis
438899|NCT01693601|Panobinostat|panobinostat
438900|NCT01693601|Ruxolitinib|ruxolitinib
438901|NCT01693588|Pain|pain
438902|NCT01693588|Postoperative Pain|postoperative pain
438903|NCT01693588|Surgical Pain|surgical pain
438904|NCT01693588|Neurosurgical Pain|neurosurgical pain
438905|NCT01693575|Small pupil cataract surgery|small pupil cataract surgery
438906|NCT01693575|Intraoperative floppy iris syndrome (IFIS)|intraoperative floppy iris syndrome (ifis)
438907|NCT01693562|Advanced solid tumors|advanced solid tumors
438908|NCT01693549|HER-2 negative|her-2 negative
438909|NCT01693549|Metastatic breast adenocarcinoma|metastatic breast adenocarcinoma
438910|NCT01693536|Elderly|elderly
438911|NCT01693536|Sodium reduction|sodium reduction
438912|NCT01693536|Fitness increase|fitness increase
438913|NCT01693536|Primary Care|primary care
438914|NCT01693523|Pancreatic Cancer|pancreatic cancer
438915|NCT01693523|Pancreatic adenocarcinoma|pancreatic adenocarcinoma
438916|NCT01693523|Locally advanced|locally advanced
438917|NCT01693523|Metastatic disease|metastatic disease
438918|NCT01693523|Symptom reduction|symptom reduction
438919|NCT01693523|Minocycline|minocycline
438920|NCT01693523|Dynacin|dynacin
438921|NCT01693523|Minocin|minocin
438922|NCT01693523|Minocin PAC|minocin pac
438923|NCT01693523|Myrac|myrac
438924|NCT01693523|Solodyn|solodyn
438925|NCT01693523|Placebo|placebo
438926|NCT01693523|Sugar Pill|sugar pill
438927|NCT01693523|Questionnaires|questionnaires
438928|NCT01693523|Surveys|surveys
438929|NCT01693510|Excess gestational weight gain (GWG)|excess gestational weight gain (gwg)
438930|NCT01693510|Obesity|obesity
438931|NCT01693510|Type 2 diabetes|type 2 diabetes
438932|NCT01693510|Elevated fats in the blood|elevated fats in the blood
438933|NCT01693510|High blood pressure|high blood pressure
438934|NCT01693497|Posttraumatic Stress Disorder|posttraumatic stress disorder
438935|NCT01693497|PTSD|ptsd
438936|NCT01693497|psychotherapy|psychotherapy
438937|NCT01693497|randomized trial|randomized trial
438938|NCT01693497|gestalt|gestalt
438939|NCT01693484|Calcaneus|calcaneus
438940|NCT01693484|Fracture|fracture
438941|NCT01693484|Indocyanine Green|indocyanine green
438942|NCT01693484|Angiography|angiography
438943|NCT01693484|Open Reduction and Internal Fixation|open reduction and internal fixation
438944|NCT01693471|asthma|asthma
438945|NCT01693471|SF-36|sf-36
438946|NCT01693471|HRQOL|hrqol
438948|NCT01693458|prevention|prevention
438949|NCT01693458|HIV-positive|hiv-positive
438950|NCT01693458|education|education
438951|NCT01693445|Gastrointestinal neoplasms|gastrointestinal neoplasms
438952|NCT01693445|Oxaliplatin|oxaliplatin
438953|NCT01693445|Irinotecan|irinotecan
438954|NCT01693445|S-1|s-1
438955|NCT01693432|Esophageal neoplasms|esophageal neoplasms
438956|NCT01693432|Docetaxel|docetaxel
438957|NCT01693432|S-1|s-1
438958|NCT01693419|pancreas neoplasm|pancreas neoplasm
438959|NCT01693419|gemcitabine|gemcitabine
438960|NCT01693419|erlotinib|erlotinib
438961|NCT01693419|S-1|s-1
438962|NCT01693406|human milk|human milk
438963|NCT01693406|infant growth|infant growth
438964|NCT01693406|obesity|obesity
438965|NCT01693406|diabetes|diabetes
438966|NCT01693406|breastfeeding|breastfeeding
438967|NCT01693393|primary Sjogren´s Syndrome|primary sjogren´s syndrome
438968|NCT01693393|Cyclosporine|cyclosporine
438969|NCT01693380|Influenza|influenza
438970|NCT01693380|Vaccination|vaccination
438971|NCT01693380|Vaccines|vaccines
438972|NCT01693380|Schoolchildren|schoolchildren
438973|NCT01693380|Effectiveness|effectiveness
438974|NCT01693380|Intervention studies|intervention studies
438975|NCT01693380|Adolescents|adolescents
438976|NCT01693380|Laboratory Confirmed Influenza|laboratory confirmed influenza
438977|NCT01693367|Femoral fracture|femoral fracture
438978|NCT01693367|Periprosthetic fracture|periprosthetic fracture
438979|NCT01693367|Fracture fixation, internal|fracture fixation, internal
438980|NCT01693367|Distal femur fractures|distal femur fractures
438981|NCT01693367|Dynamic Locking Screw|dynamic locking screw
438982|NCT01693367|WOMAC|womac
438983|NCT01693354|dialysis|dialysis
438984|NCT01693354|mortality|mortality
438985|NCT01693354|cardiovascular stability|cardiovascular stability
438986|NCT01693354|inflammation|inflammation
438987|NCT01693354|quality of life|quality of life
438988|NCT01693341|Chronic stroke patients|chronic stroke patients
438989|NCT01693341|Stroke rehabilitation|stroke rehabilitation
438990|NCT01693341|Caregiver|caregiver
438991|NCT01693341|Caregiver-mediated intervention|caregiver-mediated intervention
438992|NCT01693328|quality of life|quality of life
438993|NCT01693328|PecFent|pecfent
438994|NCT01693328|Lazanda|lazanda
438995|NCT01693328|fentanyl|fentanyl
438996|NCT01693328|intranasal|intranasal
438997|NCT01693328|breakthrough cancer pain|breakthrough cancer pain
438998|NCT01693302|Blood Glucose|blood glucose
438999|NCT01693302|Meal insulin|meal insulin
439000|NCT01693289|Metformin|metformin
439001|NCT01693289|letrozole|letrozole
439002|NCT01693289|ovarian drilling|ovarian drilling
439003|NCT01693289|clomiphene resistance|clomiphene resistance
439004|NCT01693289|polycystic ovary.|polycystic ovary.
439005|NCT01693276|pancreatic cancer|pancreatic cancer
439006|NCT01693263|end stage renal disease (ESRD)|end stage renal disease (esrd)
439007|NCT01693263|brachiocephalic fistula (BCF)|brachiocephalic fistula (bcf)
439008|NCT01693263|cephalic arch stenosis (CAS)|cephalic arch stenosis (cas)
439009|NCT01693263|dialysis|dialysis
439010|NCT01693250|technology|technology
439011|NCT01693250|healthy weight management|healthy weight management
439012|NCT01693250|primary care setting|primary care setting
439013|NCT01693224|Tests, Diagnostic|tests, diagnostic
439014|NCT01693224|Mycobacterium tuberculosis|mycobacterium tuberculosis
439015|NCT01693224|Mycobacterium tuberculosis antigens|mycobacterium tuberculosis antigens
439017|NCT01693224|Tuberculosis|tuberculosis
439018|NCT01693224|Tuberculosis, Pulmonary|tuberculosis, pulmonary
439019|NCT01693224|Tuberculosis, Miliary|tuberculosis, miliary
439020|NCT01693224|Lipoarabinomannan|lipoarabinomannan
439021|NCT01693211|femtosecond laser|femtosecond laser
439022|NCT01693211|cataract|cataract
439023|NCT01693211|control study|control study
439024|NCT01693211|prospective|prospective
439025|NCT01693198|allergy|allergy
439026|NCT01693198|cyanobacteria|cyanobacteria
439027|NCT01693198|sweet water swimming|sweet water swimming
439028|NCT01693185|colonoscopy|colonoscopy
439029|NCT01693185|remifentanil|remifentanil
439030|NCT01693185|midazolam|midazolam
439031|NCT01693185|meperidine|meperidine
439032|NCT01693172|exercise|exercise
439033|NCT01693172|neoplasm|neoplasm
439034|NCT01693159|Painful cetuximab-induced rhagades|painful cetuximab-induced rhagades
439035|NCT01693159|Radioimmunotherapy|radioimmunotherapy
439036|NCT01693159|Head and neck cancer|head and neck cancer
439037|NCT01693146|Oxygen|oxygen
439038|NCT01693146|High Flow|high flow
439039|NCT01693146|COPD|copd
439040|NCT01693146|Hypercapnia|hypercapnia
439041|NCT01693120|ablation|ablation
439042|NCT01693120|atrial fibrillation|atrial fibrillation
439043|NCT01693120|Radio frequency|radio frequency
439044|NCT01693107|Atrial Fibrillation|atrial fibrillation
439045|NCT01693107|Catheter Ablation|catheter ablation
439046|NCT01693107|Electrophysiology|electrophysiology
439047|NCT01693107|Cardiac Arrhythmias|cardiac arrhythmias
439048|NCT01693081|Parkinson's disease|parkinson's disease
439049|NCT01693081|inhaled apomorphine|inhaled apomorphine
439050|NCT01693081|"convert off to on"|"convert off to on"
439051|NCT01693068|Cutaneous Melanoma|cutaneous melanoma
439052|NCT01693068|Dacarbazine|dacarbazine
439053|NCT01693068|Pimasertib|pimasertib
439054|NCT01693068|N-Ras|n-ras
439055|NCT01693055|orbital Computed Tomography|orbital computed tomography
439056|NCT01693055|baggy eyelids|baggy eyelids
439057|NCT01693055|orbital fat prolapse|orbital fat prolapse
439058|NCT01693055|UltheraTM|ultheratm
439059|NCT01693055|high intensity focused ultrasound|high intensity focused ultrasound
439060|NCT01693042|heart failure|heart failure
439061|NCT01693042|old myocardial infarction|old myocardial infarction
439062|NCT01693042|bone marrow-derived mononuclear cells|bone marrow-derived mononuclear cells
439063|NCT01693042|chronic|chronic
439064|NCT01693042|ischemic|ischemic
439065|NCT01693029|erythropoietin alfa|erythropoietin alfa
439066|NCT01693029|CKD 5d|ckd 5d
439067|NCT01693016|non-invasive Hb measurement in children|non-invasive hb measurement in children
439068|NCT01693003|COPD|copd
439069|NCT01692990|Appetite|appetite
439070|NCT01692990|Fish oil|fish oil
439071|NCT01692990|Long-chain n-3 fatty acids|long-chain n-3 fatty acids
439072|NCT01692912|Psoriatic Arthritis|psoriatic arthritis
439073|NCT01692912|Randomized|randomized
439074|NCT01692912|Single blind|single blind
439075|NCT01692912|Treat to target|treat to target
439076|NCT01692899|Retention Rates|retention rates
439077|NCT01692899|of Adalimumab|of adalimumab
439078|NCT01692899|Etanercept and Infliximab|etanercept and infliximab
439079|NCT01692899|as First and Second-Line Biotherapy|as first and second-line biotherapy
439080|NCT01692899|in Patients with Rheumatoid Arthritis|in patients with rheumatoid arthritis
439081|NCT01692899|in Daily Practice.|in daily practice.
439082|NCT01692899|TNF inhibitors|tnf inhibitors
439083|NCT01692899|biotherapy|biotherapy
439084|NCT01692899|retrospective study|retrospective study
439085|NCT01692886|13vPnC|13vpnc
439086|NCT01692886|7vPnC|7vpnc
439087|NCT01692886|Healthy subjects|healthy subjects
439088|NCT01692886|China|china
439089|NCT01692873|pancreatic tumor|pancreatic tumor
439090|NCT01692860|the impact of a higher dairy-based protein diet in|the impact of a higher dairy-based protein diet in
710244|NCT00589602|plasma cell disorders|plasma cell disorders
439091|NCT01692860|combination with energy restriction on muscle health,|combination with energy restriction on muscle health,
439092|NCT01692860|metabolic health (including blood pressure) in overweight|metabolic health (including blood pressure) in overweight
439093|NCT01692860|and obese, middle aged adults|and obese, middle aged adults
439094|NCT01692847|patient deterioration|patient deterioration
439095|NCT01692847|rapid response teams|rapid response teams
439096|NCT01692847|acute care teams|acute care teams
439097|NCT01692847|early warning scoring|early warning scoring
439098|NCT01692834|bioequivalence|bioequivalence
439099|NCT01692834|pharmacokinetics|pharmacokinetics
439100|NCT01692834|tolerability|tolerability
439101|NCT01692834|safety|safety
439102|NCT01692834|ciclosporin|ciclosporin
439103|NCT01692834|cyclosporine|cyclosporine
439104|NCT01692834|cyclosporine A|cyclosporine a
439105|NCT01692834|Sandimmune|sandimmune
439106|NCT01692834|Sandimmun|sandimmun
439107|NCT01692834|CicloMulsion|ciclomulsion
439108|NCT01692834|NeuroSTAT|neurostat
439109|NCT01692821|retinal oxygen saturation|retinal oxygen saturation
439110|NCT01692821|retinal blood flow|retinal blood flow
439111|NCT01692821|hyperoxia|hyperoxia
439112|NCT01692821|hypoxia|hypoxia
439113|NCT01692808|Crohn|crohn
439114|NCT01692808|vitamin D|vitamin d
439115|NCT01692808|remission|remission
439116|NCT01692808|inflammation|inflammation
439117|NCT01692808|tolerance|tolerance
439118|NCT01692795|Myocardial infarction|myocardial infarction
439119|NCT01692795|Antiplatelets|antiplatelets
439120|NCT01692795|Lipid lowering agents|lipid lowering agents
439121|NCT01692795|ACE inhibitors|ace inhibitors
439122|NCT01692795|Angiotensin Receptor Blockers|angiotensin receptor blockers
439123|NCT01692795|Beta blockers|beta blockers
439124|NCT01692795|Blood pressure lowering drugs|blood pressure lowering drugs
439125|NCT01692782|ADHD|adhd
439126|NCT01692782|Attention deficit hyperactivity disorder|attention deficit hyperactivity disorder
439127|NCT01692769|Trauma|trauma
439128|NCT01692769|Pediatric|pediatric
439129|NCT01692769|Intravenous Fluid|intravenous fluid
439130|NCT01692769|Normal Saline|normal saline
439131|NCT01692769|Ringer's Lactate|ringer's lactate
439132|NCT01692743|Telemedicine|telemedicine
439133|NCT01692743|Inflammatory bowel disease|inflammatory bowel disease
439134|NCT01692743|Crohn's disease|crohn's disease
439135|NCT01692743|Ulcerative colitis|ulcerative colitis
439136|NCT01692743|Quality of life|quality of life
439137|NCT01692743|Health care utilization|health care utilization
439138|NCT01692730|Smoking Cessation|smoking cessation
439139|NCT01692730|Web Assisted Tobacco Intervention|web assisted tobacco intervention
439140|NCT01692691|Melanoma Metastatic|melanoma metastatic
439141|NCT01692678|Advanced or Metastatic liposarcoma or leiomyosarcoma|advanced or metastatic liposarcoma or leiomyosarcoma
439142|NCT01692678|Sarcoma|sarcoma
439143|NCT01692678|L-sarcoma|l-sarcoma
439144|NCT01692678|Liposarcoma|liposarcoma
439145|NCT01692678|Leiomyosarcoma|leiomyosarcoma
439146|NCT01692678|Trabectedin|trabectedin
439147|NCT01692678|Dacarbazine|dacarbazine
439148|NCT01692678|Yondelis|yondelis
439149|NCT01692678|Chinese patients|chinese patients
439150|NCT01692678|Overall survival|overall survival
439151|NCT01692678|Pharmacokinetics|pharmacokinetics
439152|NCT01692665|meibomian gland dysfunction|meibomian gland dysfunction
439153|NCT01692665|keratometric value|keratometric value
439154|NCT01692665|ocular aberration|ocular aberration
439155|NCT01692626|Cetuximab rash|cetuximab rash
439156|NCT01692626|Erbitux rash|erbitux rash
439157|NCT01692626|Rash|rash
439158|NCT01692626|Pimecrolimus|pimecrolimus
439159|NCT01692626|1% Topical pimecrolimus cream|1% topical pimecrolimus cream
439160|NCT01692600|Late oral radiation toxicity|late oral radiation toxicity
439161|NCT01692600|head and neck cancer patients|head and neck cancer patients
439162|NCT01692600|optical coherence tomography|optical coherence tomography
439163|NCT01692600|subsurface imaging|subsurface imaging
439164|NCT01692600|mirometer-resolution imaging|mirometer-resolution imaging
439165|NCT01692600|vascular imaging|vascular imaging
439166|NCT01692600|Doppler optical coherence tomography|doppler optical coherence tomography
439167|NCT01692600|speckle variance optical coherence tomography|speckle variance optical coherence tomography
439168|NCT01692587|PSA|psa
439169|NCT01692587|protein|protein
439170|NCT01692587|prostate|prostate
439171|NCT01692574|depression and obesity treatment|depression and obesity treatment
439172|NCT01692561|Dysautonomia|dysautonomia
439173|NCT01692561|Postural orthostatic tachycardic hypotension|postural orthostatic tachycardic hypotension
439174|NCT01692561|Neurocardiogenic vasovagal syncope|neurocardiogenic vasovagal syncope
439175|NCT01692509|Non invasive ventilation|non invasive ventilation
439176|NCT01692509|Respiratory failure|respiratory failure
439177|NCT01692509|Respiratory comfort|respiratory comfort
439178|NCT01692496|Advanced|advanced
439179|NCT01692496|Metastatic|metastatic
439180|NCT01692496|Liposarcoma|liposarcoma
439181|NCT01692496|Pazopanib|pazopanib
439182|NCT01692483|Prostate neoplasms|prostate neoplasms
439183|NCT01692483|Prostate cancer|prostate cancer
710245|NCT00589589|burns|burns
439184|NCT01692483|Castration resistant prostate cancer|castration resistant prostate cancer
439185|NCT01692483|Hormone refractory prostate cancer|hormone refractory prostate cancer
439186|NCT01692483|Abiraterone acetate|abiraterone acetate
439187|NCT01692483|Taxane|taxane
439188|NCT01692470|Human immunodeficiency virus type 1 (HIV-1) infection|human immunodeficiency virus type 1 (hiv-1) infection
439189|NCT01692470|HIV-1|hiv-1
439190|NCT01692470|Anti-retroviral naive|anti-retroviral naive
439191|NCT01692470|ARV|arv
439192|NCT01692470|Filipino patients|filipino patients
439193|NCT01692470|Rilpivirine hydrochloride|rilpivirine hydrochloride
439194|NCT01692470|Edurant|edurant
439195|NCT01692457|Rheumatoid Arthritis|rheumatoid arthritis
439295|NCT01692158|subjects|subjects
439196|NCT01692457|Psoriatic Arthritis|psoriatic arthritis
439197|NCT01692457|Ankylosing Spondylitis|ankylosing spondylitis
439198|NCT01692457|Arthritis|arthritis
439199|NCT01692457|Spondylitis|spondylitis
439200|NCT01692457|Joint pain|joint pain
439201|NCT01692457|CNTO148|cnto148
439202|NCT01692457|Golimumab|golimumab
439203|NCT01692457|Simponi|simponi
439204|NCT01692457|Filipino|filipino
439205|NCT01692457|Post-Marketing|post-marketing
439206|NCT01692457|Surveillance|surveillance
439207|NCT01692444|Chronic Obstructive Pulmonary Disease|chronic obstructive pulmonary disease
439208|NCT01692444|Fibrosis|fibrosis
439209|NCT01692444|Fibroblast|fibroblast
439210|NCT01692444|Lung attenuation|lung attenuation
439211|NCT01692444|Pletysmography|pletysmography
439212|NCT01692418|Anaemia|anaemia
439213|NCT01692418|Blood transfusion|blood transfusion
439214|NCT01692418|Surgery|surgery
439215|NCT01692418|Iron|iron
439216|NCT01692418|Ferric carboxymaltose|ferric carboxymaltose
439217|NCT01692392|Pectus carinatum|pectus carinatum
439218|NCT01692392|Quality of life|quality of life
439219|NCT01692392|Pain, postoperative|pain, postoperative
439220|NCT01692392|Somatosensory disorders|somatosensory disorders
439221|NCT01692379|Acute ischemic stroke|acute ischemic stroke
439222|NCT01692379|endovascular treatment|endovascular treatment
439223|NCT01692379|clinical trial|clinical trial
439224|NCT01692353|Flow mediated dilation|flow mediated dilation
439225|NCT01692353|Carotid intima-media thickness|carotid intima-media thickness
439226|NCT01692353|Ankle-brachial index|ankle-brachial index
439227|NCT01692353|Smokeless tobacco|smokeless tobacco
439228|NCT01692353|Biological markers|biological markers
439229|NCT01692353|Nicotine|nicotine
439230|NCT01692353|Tobacco-specific nitrosamines|tobacco-specific nitrosamines
439231|NCT01692353|Polycyclic aromatic hydrocarbons|polycyclic aromatic hydrocarbons
439232|NCT01692353|Aromatic amines|aromatic amines
439233|NCT01692353|Mercapturic acid metabolites|mercapturic acid metabolites
439234|NCT01692353|Cholesterol|cholesterol
439235|NCT01692353|Blood lipids|blood lipids
439236|NCT01692353|Oxidative stress|oxidative stress
439237|NCT01692353|Inflammation|inflammation
439238|NCT01692353|Cytokines|cytokines
439239|NCT01692340|tomato|tomato
439240|NCT01692340|prostate cancer|prostate cancer
439241|NCT01692340|metabolism|metabolism
439242|NCT01692327|glucose intolerance (20)|glucose intolerance (20)
439243|NCT01692327|Control (20)|control (20)
439244|NCT01692314|Endothelial function|endothelial function
439245|NCT01692314|Microvascular reactivity|microvascular reactivity
439246|NCT01692314|Obesity|obesity
439247|NCT01692314|Adolescents|adolescents
439248|NCT01692301|hypertension, elderly, central aortic pulse pressure, central pulse pressure, pulse wave velocity|hypertension, elderly, central aortic pulse pressure, central pulse pressure, pulse wave velocity
439249|NCT01692262|Metastatic Castrate-Resistant Prostate Cancer (mCRPC),|metastatic castrate-resistant prostate cancer (mcrpc),
439250|NCT01692262|adenocarcinoma of the prostate,|adenocarcinoma of the prostate,
439251|NCT01692262|prostate cancer,|prostate cancer,
439252|NCT01692262|progressive disease,|progressive disease,
439253|NCT01692262|advanced disease.|advanced disease.
439254|NCT01692249|chronic shoulder pain|chronic shoulder pain
439255|NCT01692249|rotator cuff tendinopathy|rotator cuff tendinopathy
439256|NCT01692249|sap therapy|sap therapy
439257|NCT01692249|balneotherapy|balneotherapy
439258|NCT01692236|MRI|mri
439259|NCT01692236|HIV|hiv
439260|NCT01692236|Neurocognitive Disorders|neurocognitive disorders
439261|NCT01692236|Major Depression|major depression
439262|NCT01692236|Vasculopathy|vasculopathy
439263|NCT01692223|Personal genomics|personal genomics
439264|NCT01692223|Genome Sequencing Results|genome sequencing results
439265|NCT01692223|12-167|12-167
439266|NCT01692210|Breast Cancer|breast cancer
439267|NCT01692210|Dexmedetomidine|dexmedetomidine
439268|NCT01692210|Unilateral mastectomy|unilateral mastectomy
439269|NCT01692210|Blood sample collections|blood sample collections
439270|NCT01692210|Immune system|immune system
439271|NCT01692210|White blood cell levels|white blood cell levels
439272|NCT01692197|Leukemia|leukemia
439273|NCT01692197|Acute Myeloid Leukemia|acute myeloid leukemia
439274|NCT01692197|Acute Myelogenous Leukemia|acute myelogenous leukemia
439275|NCT01692197|AML|aml
439276|NCT01692197|Relapsed or Refractory|relapsed or refractory
439277|NCT01692197|High-Risk Myelodysplastic Syndromes|high-risk myelodysplastic syndromes
439278|NCT01692197|HRMDS|hrmds
439279|NCT01692197|E7070|e7070
439280|NCT01692197|Idarubicin|idarubicin
439281|NCT01692197|Idamycin|idamycin
439282|NCT01692197|Cytarabine|cytarabine
439283|NCT01692197|Cytarabine (ARA-C)|cytarabine (ara-c)
439284|NCT01692197|Cytosar|cytosar
439285|NCT01692197|DepoCyt|depocyt
439286|NCT01692197|Cytosine Arabinosine Hydrochloride|cytosine arabinosine hydrochloride
439287|NCT01692197|Dexamethasone|dexamethasone
439288|NCT01692197|Decadron|decadron
439289|NCT01692184|AVL-292|avl-292
439290|NCT01692184|Safety|safety
439291|NCT01692184|Pharmacokinetics|pharmacokinetics
439292|NCT01692184|Pharmacodynamics|pharmacodynamics
439293|NCT01692184|Pharmacology, Clinical|pharmacology, clinical
439294|NCT01692171|Subjects|subjects
439296|NCT01692145|Dry eye syndromes|dry eye syndromes
439297|NCT01692145|Corneal diseases|corneal diseases
439298|NCT01692145|Conjunctival diseases|conjunctival diseases
439299|NCT01692132|Chronic Constipation|chronic constipation
439300|NCT01692132|Prucalopride|prucalopride
439301|NCT01692132|Post Marketing Surveillance|post marketing surveillance
439302|NCT01692119|chronic heart failure|chronic heart failure
439303|NCT01692119|medication adherence|medication adherence
439304|NCT01692119|pharmacy|pharmacy
439305|NCT01692119|interdisciplinary care|interdisciplinary care
439306|NCT01692119|randomized controlled trial|randomized controlled trial
439307|NCT01692119|mortality|mortality
439308|NCT01692119|hospitalization|hospitalization
439309|NCT01692106|Heller myotomy|heller myotomy
439310|NCT01692093|SCORAD|scorad
439311|NCT01692093|Atopic dermatits|atopic dermatits
439312|NCT01692093|Skin health|skin health
439313|NCT01692067|Rape|rape
439314|NCT01692067|Women|women
439315|NCT01692067|Military|military
439316|NCT01692067|Veterans|veterans
439317|NCT01692067|Post-traumatic Stress Disorder|post-traumatic stress disorder
439318|NCT01692067|Traumatic Brain Injury|traumatic brain injury
439319|NCT01692041|asthma|asthma
439320|NCT01692041|children|children
439321|NCT01692028|vitamin D|vitamin d
439322|NCT01692028|Associational study|associational study
439323|NCT01692002|Diabetes Mellitus|diabetes mellitus
439324|NCT01692002|Propionate|propionate
439325|NCT01691976|Mild cognitive impairment|mild cognitive impairment
439326|NCT01691976|Androgen deprivation therapy|androgen deprivation therapy
439327|NCT01691963|Epiglottis|epiglottis
439328|NCT01691963|Intubation|intubation
439329|NCT01691963|Laryngoscopy|laryngoscopy
439330|NCT01691950|Trauma|trauma
439331|NCT01691950|Limb reconstruction|limb reconstruction
439332|NCT01691950|Amputation|amputation
439333|NCT01691950|Functional outcome|functional outcome
439334|NCT01691950|Sensing|sensing
439335|NCT01691937|Thoracic paravertebral block|thoracic paravertebral block
439336|NCT01691937|Postoperative pain|postoperative pain
439337|NCT01691937|Right lobe hepatectomy|right lobe hepatectomy
439338|NCT01691937|Patient controlled analgesia|patient controlled analgesia
439339|NCT01691924|Adenosine A2a receptor antagonist|adenosine a2a receptor antagonist
439340|NCT01691924|adenosine receptor modulator|adenosine receptor modulator
439341|NCT01691924|Cancer|cancer
439342|NCT01691911|Vascular disease|vascular disease
439343|NCT01691911|Open aortic aneurysm repair|open aortic aneurysm repair
439344|NCT01691911|Endovascular aneurysm repair|endovascular aneurysm repair
439345|NCT01691911|Carotid endartrectomy|carotid endartrectomy
439346|NCT01691911|Lower limb surgical revascularisation|lower limb surgical revascularisation
439347|NCT01691911|Major lower limb amputation|major lower limb amputation
439348|NCT01691859|extension study|extension study
439349|NCT01691859|Severe refractory asthma|severe refractory asthma
439350|NCT01691859|safety|safety
439351|NCT01691859|SB-240563|sb-240563
439352|NCT01691859|mepolizumab|mepolizumab
439353|NCT01691859|eosinophils|eosinophils
439354|NCT01691833|Vitamin D|vitamin d
439355|NCT01691833|nonunion|nonunion
439356|NCT01691833|long bone fracture|long bone fracture
439357|NCT01691833|hypovitaminosis D|hypovitaminosis d
439358|NCT01691820|Adolescent females|adolescent females
439359|NCT01691820|Cytomegalovirus (CMV)|cytomegalovirus (cmv)
439360|NCT01691807|Non-Hodgkin's Lymphoma|non-hodgkin's lymphoma
439361|NCT01691807|drug-drug interaction|drug-drug interaction
439362|NCT01691807|ofatumumab|ofatumumab
439363|NCT01691807|bendamustine|bendamustine
439364|NCT01691781|Hyperparathyroidism|hyperparathyroidism
439365|NCT01691781|Renin-angiotensin-aldosterone system|renin-angiotensin-aldosterone system
439366|NCT01691781|ACE inhibitors|ace inhibitors
439367|NCT01691768|microbicides|microbicides
439368|NCT01691768|women|women
439369|NCT01691768|HIV prevention|hiv prevention
439370|NCT01691768|PrEP|prep
439371|NCT01691768|Tenofovir gel|tenofovir gel
439372|NCT01691742|Postoperative constipation|postoperative constipation
439373|NCT01691742|Urogynecologic Surgery|urogynecologic surgery
439374|NCT01691742|MiraLax|miralax
439375|NCT01691742|Docusate Sodium|docusate sodium
439376|NCT01691716|Achilles tendinopathy|achilles tendinopathy
439377|NCT01691716|Tendoactive|tendoactive
439378|NCT01691716|Eccentric training|eccentric training
439379|NCT01691703|Fiber Optic Technology/methods|fiber optic technology/methods
439380|NCT01691703|Intubation, Intratracheal/methods|intubation, intratracheal/methods
439381|NCT01691703|Laryngoscopy/methods|laryngoscopy/methods
439382|NCT01691664|Esophageal Cancer|esophageal cancer
439383|NCT01691664|DC-CIK|dc-cik
439384|NCT01691664|immunotherapy|immunotherapy
439385|NCT01691664|cellular therapy|cellular therapy
439386|NCT01691664|radiation therapy|radiation therapy
439387|NCT01691651|Keratoconus|keratoconus
439388|NCT01691651|Tetanus toxin|tetanus toxin
439389|NCT01691625|Locally advanced esophageal carcinoma|locally advanced esophageal carcinoma
439390|NCT01691625|DC-CIK|dc-cik
439391|NCT01691625|Immunotherapy|immunotherapy
439392|NCT01691612|Role of Pin-1 enzyme in Asthma|role of pin-1 enzyme in asthma
439393|NCT01691599|Infection|infection
439900|NCT01689519|melanoma|melanoma
439394|NCT01691599|Open tibia fractures|open tibia fractures
439395|NCT01691599|Closed tibia fractures|closed tibia fractures
439396|NCT01691599|Wound infection|wound infection
439397|NCT01691586|implantable defibrillators|implantable defibrillators
439398|NCT01691586|remote patient monitoring|remote patient monitoring
439399|NCT01691586|patient-reported outcomes|patient-reported outcomes
439400|NCT01691586|cost-effectiveness|cost-effectiveness
439401|NCT01691573|ablation|ablation
439402|NCT01691573|procedure|procedure
439403|NCT01691573|pediatric|pediatric
439404|NCT01691573|european|european
439405|NCT01691573|cardiac|cardiac
439406|NCT01691573|arrhythmias|arrhythmias
439407|NCT01691573|registry|registry
439408|NCT01691573|observational|observational
439409|NCT01691573|prospective|prospective
439410|NCT01691573|catheter|catheter
439411|NCT01691573|cryoablation|cryoablation
439412|NCT01691573|atrioventricular|atrioventricular
439413|NCT01691547|GW642444 (Vilanterol)|gw642444 (vilanterol)
439414|NCT01691547|pharmacokinetics|pharmacokinetics
439415|NCT01691547|pharmacodynamics|pharmacodynamics
439416|NCT01691547|GSK573719 (Umeclidinium)|gsk573719 (umeclidinium)
439417|NCT01691547|healthy subjects|healthy subjects
439418|NCT01691547|GW685698 (Fluticasone Furoate)|gw685698 (fluticasone furoate)
439419|NCT01691534|Tuberculosis|tuberculosis
439420|NCT01691534|EBA|eba
439421|NCT01691534|PA824|pa824
439422|NCT01691534|pretomanid|pretomanid
439423|NCT01691534|TMC207|tmc207
439424|NCT01691521|safety|safety
439425|NCT01691521|SB-240563|sb-240563
439426|NCT01691521|efficacy|efficacy
439427|NCT01691521|placebo|placebo
439428|NCT01691521|eosinophils|eosinophils
439429|NCT01691521|mepolizumab|mepolizumab
439430|NCT01691521|Severe refractory asthma|severe refractory asthma
439431|NCT01691508|Safety|safety
439432|NCT01691508|Steroid Reduction|steroid reduction
439433|NCT01691508|Efficacy|efficacy
439434|NCT01691508|SB-240563|sb-240563
439435|NCT01691508|Eosinophils|eosinophils
439436|NCT01691508|Quality of Life|quality of life
439437|NCT01691508|Mepolizumab|mepolizumab
439438|NCT01691508|Severe Refractory Asthma|severe refractory asthma
439439|NCT01691495|Physician Adherence|physician adherence
439440|NCT01691495|superficial vein thrombosis|superficial vein thrombosis
439441|NCT01691495|Fondaparinux|fondaparinux
439442|NCT01691469|Bioequivalence|bioequivalence
439443|NCT01691469|Montelukast Sodium|montelukast sodium
439444|NCT01691469|crossover|crossover
439445|NCT01691456|Bioequivalence|bioequivalence
439446|NCT01691456|Montelukast Sodium|montelukast sodium
439447|NCT01691456|crossover|crossover
439448|NCT01691404|Flavonoids|flavonoids
439449|NCT01691404|Quercetin|quercetin
439450|NCT01691404|Epicatechin|epicatechin
439451|NCT01691404|Vascular function|vascular function
439452|NCT01691404|Blood pressure|blood pressure
439453|NCT01691404|Endothelial function|endothelial function
439454|NCT01691391|Advanced CRC|advanced crc
439455|NCT01691378|Veterans|veterans
439456|NCT01691378|Window to Hope|window to hope
439457|NCT01691378|Cognitive Behavioral Therapy|cognitive behavioral therapy
439458|NCT01691378|Traumatic Brain Injury|traumatic brain injury
439459|NCT01691378|Hopelessness|hopelessness
439460|NCT01691378|Suicide|suicide
439461|NCT01691365|Antioxidant|antioxidant
439462|NCT01691365|vitamins|vitamins
439463|NCT01691365|Diet|diet
439464|NCT01691352|Wound infection|wound infection
439465|NCT01691352|Ostomy reversal|ostomy reversal
439466|NCT01691339|Influenza|influenza
439467|NCT01691339|Influenza virus vaccine|influenza virus vaccine
439468|NCT01691339|Fluzone® (Influenza Virus Vaccine) 2012-2013 Formulation|fluzone® (influenza virus vaccine) 2012-2013 formulation
439469|NCT01691339|Fluzone® High-Dose (Influenza Virus Vaccine) 2012-2013 Formulation|fluzone® high-dose (influenza virus vaccine) 2012-2013 formulation
439470|NCT01691339|Trivalent Inactivated Influenza Vaccine|trivalent inactivated influenza vaccine
439471|NCT01691339|Fluzone® Intradermal (Influenza Virus Vaccine) 2012-2013 Formulation|fluzone® intradermal (influenza virus vaccine) 2012-2013 formulation
439472|NCT01691326|Influenza|influenza
439473|NCT01691326|Fluzone® (Influenza Virus Vaccine) 2012-2013 Formulation|fluzone® (influenza virus vaccine) 2012-2013 formulation
561471|NCT01172275|OCD|ocd
439474|NCT01691326|Influenza virus vaccine|influenza virus vaccine
439475|NCT01691326|Trivalent Inactivated Influenza Vaccine|trivalent inactivated influenza vaccine
439476|NCT01691313|vanoxerine|vanoxerine
439477|NCT01691313|atrial fibrillation|atrial fibrillation
439478|NCT01691313|atrial flutter|atrial flutter
439479|NCT01691313|a-fib|a-fib
439480|NCT01691300|C11-acetate PET/CT|c11-acetate pet/ct
439481|NCT01691300|Multiple myeloma|multiple myeloma
439482|NCT01691300|Pretreatment staging|pretreatment staging
439483|NCT01691300|Response assessment|response assessment
439484|NCT01691287|Type 1 Diabetes|type 1 diabetes
439485|NCT01691287|Metabolic Control|metabolic control
439486|NCT01691287|Quality of Life|quality of life
439487|NCT01691274|Epilepsy|epilepsy
439488|NCT01691274|Phase 1|phase 1
439489|NCT01691274|Multiple Dose|multiple dose
439490|NCT01691274|Safety|safety
439491|NCT01691274|Pharmacokinetics|pharmacokinetics
439492|NCT01691274|Toleration|toleration
439493|NCT01691248|Clostridium difficile|clostridium difficile
439494|NCT01691248|Clostridium difficile-Associated Diarrhea|clostridium difficile-associated diarrhea
439495|NCT01691248|Prophylaxis|prophylaxis
439496|NCT01691248|Hematopoietic Stem Cell Transplantation|hematopoietic stem cell transplantation
439497|NCT01691235|SIMpill|simpill
439498|NCT01691235|HCV|hcv
439499|NCT01691235|Chronic Hepatitis C Virus|chronic hepatitis c virus
439500|NCT01691222|Bedside percutaneous tracheostomy|bedside percutaneous tracheostomy
439501|NCT01691222|Intensive Care Unit|intensive care unit
439502|NCT01691222|Dedicated Double-lumen tube|dedicated double-lumen tube
439503|NCT01691222|Ineffective Airway Clearance|ineffective airway clearance
439504|NCT01691222|weaning failure|weaning failure
439505|NCT01691209|Phoenix|phoenix
439506|NCT01691209|Hydrocortison|hydrocortison
439507|NCT01691209|mild atopic dermatitis|mild atopic dermatitis
439508|NCT01691209|efficacy|efficacy
439509|NCT01691209|safety|safety
439510|NCT01691196|Obesity|obesity
439511|NCT01691196|Peritoneal dialysis|peritoneal dialysis
439512|NCT01691196|Inflammation|inflammation
439513|NCT01691196|Macrophages|macrophages
439514|NCT01691196|Innate immunity|innate immunity
439515|NCT01691183|Hertel|hertel
439516|NCT01691183|exophthalmometer|exophthalmometer
439517|NCT01691183|proptosis|proptosis
439518|NCT01691183|eye disease|eye disease
439519|NCT01691170|Pattelofemoral pain syndrome|pattelofemoral pain syndrome
439520|NCT01691170|Stretching|stretching
439521|NCT01691170|Strengthening|strengthening
439522|NCT01691157|Subacromial impingement syndrome|subacromial impingement syndrome
439523|NCT01691157|Rotator cuff|rotator cuff
439524|NCT01691157|Exercise|exercise
439525|NCT01691157|Physiotherapy|physiotherapy
439526|NCT01691144|cancer|cancer
439527|NCT01691144|gynecological|gynecological
439528|NCT01691144|expectations|expectations
439529|NCT01691144|satisfaction|satisfaction
439530|NCT01691144|cooperation|cooperation
439531|NCT01691131|Physical activity in daily life|physical activity in daily life
439532|NCT01691131|Balance|balance
439533|NCT01691131|COPD|copd
439534|NCT01691131|Exercise training|exercise training
439535|NCT01691118|Hypertension|hypertension
439536|NCT01691118|Angiotensin Receptor Blocker|angiotensin receptor blocker
439537|NCT01691118|Diastolic Dysfunction|diastolic dysfunction
439538|NCT01691105|Tobacco Use Cessation|tobacco use cessation
439539|NCT01691105|Smoking Cessation|smoking cessation
439540|NCT01691105|Nicotine Replacement Therapy|nicotine replacement therapy
439541|NCT01691105|Hospitalized Smokers|hospitalized smokers
439542|NCT01691092|Depression|depression
439543|NCT01691092|Ketamine|ketamine
439544|NCT01691092|PET|pet
439545|NCT01691092|PTSD|ptsd
439546|NCT01691053|End stage renal disease|end stage renal disease
439547|NCT01691053|Hemodialysis|hemodialysis
439548|NCT01691053|Spironolactone|spironolactone
439549|NCT01691053|Left ventricular hypertrophy|left ventricular hypertrophy
439550|NCT01691040|Hepcidin|hepcidin
439551|NCT01691040|Iron|iron
439552|NCT01691040|Anemia of Chronic Disease|anemia of chronic disease
439553|NCT01691040|Anemia|anemia
439554|NCT01691040|Cancer|cancer
439555|NCT01691040|Interleukin-6|interleukin-6
439556|NCT01691040|Iron restriction|iron restriction
439557|NCT01691040|Lymphoma|lymphoma
439558|NCT01691040|CLL|cll
439559|NCT01691040|Multiple Myeloma|multiple myeloma
439560|NCT01691040|Hodgkin|hodgkin
439561|NCT01691040|anti-hepcidin|anti-hepcidin
439562|NCT01691027|scotoma, central|scotoma, central
439563|NCT01691027|visual motor coordination|visual motor coordination
439564|NCT01690988|Delirium|delirium
439565|NCT01690988|ketamine|ketamine
439566|NCT01690988|surgery|surgery
439567|NCT01690988|neurological complications|neurological complications
439568|NCT01690962|diabetic neuropathy, diet, vegan, vegetarian|diabetic neuropathy, diet, vegan, vegetarian
439569|NCT01690949|inflammation|inflammation
439570|NCT01690949|COPD|copd
439571|NCT01690949|respiratory disease|respiratory disease
439572|NCT01690949|healthy volunteers|healthy volunteers
439573|NCT01690936|Almonds|almonds
439574|NCT01690936|Body weight|body weight
439575|NCT01690936|Snacking|snacking
439576|NCT01690910|Ventilator|ventilator
439577|NCT01690910|Mobility Limitations|mobility limitations
439578|NCT01690910|Critical Care|critical care
439579|NCT01690910|Rifton Gait Trainer|rifton gait trainer
439580|NCT01690897|Female sexual desire|female sexual desire
439581|NCT01690897|Psychoeducational intervention|psychoeducational intervention
439582|NCT01690897|Mindfulness|mindfulness
439583|NCT01690884|Adenosine|adenosine
439584|NCT01690884|Ticagrelor|ticagrelor
439585|NCT01690884|Microdialysis|microdialysis
439586|NCT01690871|Malignant PEComa|malignant pecoma
439587|NCT01690871|Angiomyolipoma|angiomyolipoma
439588|NCT01690871|Tuberous Sclerosis Complex|tuberous sclerosis complex
439589|NCT01690871|Pi3kinase /m-tor inhibitors|pi3kinase /m-tor inhibitors
439590|NCT01690858|Foetal loss|foetal loss
439591|NCT01690858|complement|complement
439592|NCT01690858|antiangiogenic factors|antiangiogenic factors
439593|NCT01690858|Repeated fetal losses|repeated fetal losses
439594|NCT01690832|Contrast induced acute kidney injury|contrast induced acute kidney injury
440207|NCT01688063|Cutometer|cutometer
439595|NCT01690819|Acute Respiratory Distress Syndrome|acute respiratory distress syndrome
439596|NCT01690819|Acute Brain Injury|acute brain injury
439598|NCT01690793|ACUTE EXACERBATION OF ASTHMA|acute exacerbation of asthma
439599|NCT01690780|fracture|fracture
439600|NCT01690780|pediatric|pediatric
439601|NCT01690780|oral morphine|oral morphine
439602|NCT01690780|ibuprofen|ibuprofen
439603|NCT01690767|Urethral catheterization|urethral catheterization
439604|NCT01690767|Lidocaine|lidocaine
439605|NCT01690754|SMS|sms
439606|NCT01690754|tuberculosis|tuberculosis
439607|NCT01690754|impact evaluation|impact evaluation
439608|NCT01690741|Cancer|cancer
439609|NCT01690741|Malignancy|malignancy
439610|NCT01690741|Solid tumors|solid tumors
439611|NCT01690728|Obesity|obesity
439612|NCT01690728|Gastric bypass|gastric bypass
439613|NCT01690715|Hepatocellular Carcinoma|hepatocellular carcinoma
439614|NCT01690715|Thrombosis|thrombosis
439615|NCT01690715|Portal Vein Invasion|portal vein invasion
439616|NCT01690702|breast cancer|breast cancer
439617|NCT01690702|tailored|tailored
439618|NCT01690702|high-risk|high-risk
439619|NCT01690676|FMD|fmd
439620|NCT01690676|epicatechin|epicatechin
439621|NCT01690676|apple polyphenol|apple polyphenol
439622|NCT01690676|borderline hypertension|borderline hypertension
439623|NCT01690650|Preterm|preterm
439624|NCT01690650|Newborn|newborn
439625|NCT01690650|Neonate|neonate
439626|NCT01690650|Cerebral oxygenation|cerebral oxygenation
439627|NCT01690650|Oxygen|oxygen
439628|NCT01690637|Oseltamivir|oseltamivir
439629|NCT01690637|Tamiflu|tamiflu
439630|NCT01690611|Balance Training|balance training
439631|NCT01690611|Walking|walking
439632|NCT01690611|Falls|falls
439633|NCT01690598|Epithelial ovarian cancer|epithelial ovarian cancer
439634|NCT01690598|BRCA mutation|brca mutation
439635|NCT01690598|Platinum resistant|platinum resistant
439636|NCT01690598|Platinum sensitive|platinum sensitive
439637|NCT01690598|Relapsed ovarian cancer|relapsed ovarian cancer
439638|NCT01690572|drug eluting balloon|drug eluting balloon
439639|NCT01690572|constrictive remodeling|constrictive remodeling
439640|NCT01690559|Ciprofloxacin|ciprofloxacin
439641|NCT01690559|sepsis|sepsis
439642|NCT01690559|infection|infection
439643|NCT01690559|pneumonia|pneumonia
439644|NCT01690559|peritonitis|peritonitis
439645|NCT01690559|cholecystitis|cholecystitis
439646|NCT01690559|cholangitis|cholangitis
439647|NCT01690559|anthrax|anthrax
439648|NCT01690546|Opioid Addiction|opioid addiction
439649|NCT01690546|Addiction|addiction
439650|NCT01690546|Drug Dependence|drug dependence
439651|NCT01690533|Avelox|avelox
439652|NCT01690533|Laryngopharyngitis|laryngopharyngitis
439653|NCT01690533|Tonsillitis|tonsillitis
439654|NCT01690533|Bronchitis acute|bronchitis acute
439655|NCT01690533|Pneumonia|pneumonia
439656|NCT01690533|Secondary infection in chronic respiratory diseases Sinusitis|secondary infection in chronic respiratory diseases sinusitis
439657|NCT01690507|demethylating agent|demethylating agent
439658|NCT01690507|immunogenicity|immunogenicity
439659|NCT01690494|STI|sti
439660|NCT01690494|sexually transmitted infection|sexually transmitted infection
439661|NCT01690494|HIV|hiv
439662|NCT01690494|criminal justice|criminal justice
439663|NCT01690494|probation|probation
439664|NCT01690494|couples|couples
439665|NCT01690494|drug use|drug use
439666|NCT01690442|HIV|hiv
439667|NCT01690442|AIDS|aids
439668|NCT01690442|Prevention|prevention
439669|NCT01690429|Arousal detection|arousal detection
439670|NCT01690429|Pulse Wave Amplitude|pulse wave amplitude
439671|NCT01690429|Obstructive Sleep Apnea|obstructive sleep apnea
439672|NCT01690429|Daytime sleepiness|daytime sleepiness
439673|NCT01690429|Cardiorespiratory risk|cardiorespiratory risk
439674|NCT01690377|Dendritic Cells|dendritic cells
439675|NCT01690364|Motor evoked potential monitoring|motor evoked potential monitoring
439676|NCT01690364|General Anesthesia|general anesthesia
439677|NCT01690364|Neurosurgery|neurosurgery
439678|NCT01690364|Cisatracurium|cisatracurium
439679|NCT01690364|Vecuronium|vecuronium
439680|NCT01690338|TOFr (train of four ratio)|tofr (train of four ratio)
439681|NCT01690338|airway extubation|airway extubation
439682|NCT01690338|PACU (postanesthesia care unit)|pacu (postanesthesia care unit)
439683|NCT01690338|PORC (postoperative residual curarization)|porc (postoperative residual curarization)
439684|NCT01690325|Neoadjuvant chemotherapy|neoadjuvant chemotherapy
439685|NCT01690325|Neoadjuvant cytotoxic-antiangiogenic therapy|neoadjuvant cytotoxic-antiangiogenic therapy
439686|NCT01690325|Bevacizumab|bevacizumab
439687|NCT01690325|PET|pet
439688|NCT01690312|Humans|humans
439689|NCT01690312|Cardiovascular Disease|cardiovascular disease
439690|NCT01690312|Statins|statins
439691|NCT01690312|Fish Oil|fish oil
439692|NCT01690312|DHA|dha
439693|NCT01690312|EPA|epa
439694|NCT01690312|High-DHA|high-dha
439695|NCT01690312|Triglycerides|triglycerides
439696|NCT01690312|Total cholesterol [TC]|total cholesterol [tc]
439697|NCT01690312|Lipoproteins|lipoproteins
439698|NCT01690312|High-density lipoprotein [HDL2, HDL3]|high-density lipoprotein [hdl2, hdl3]
439699|NCT01690312|Low-density lipoprotein [LDL1+2+3+4]|low-density lipoprotein [ldl1+2+3+4]
439700|NCT01690312|Lipoprotein A [Lp(a)]|lipoprotein a [lp(a)]
439701|NCT01690312|Intermediate-density lipoprotein (IDL)|intermediate-density lipoprotein (idl)
439702|NCT01690312|Very low-density lipoprotein (VLDL1+2, VLDL3)|very low-density lipoprotein (vldl1+2, vldl3)
439703|NCT01690312|Remnant Lipoproteins|remnant lipoproteins
439704|NCT01690312|High-sensitivity C-Reactive Protein [hs-CRP]|high-sensitivity c-reactive protein [hs-crp]
439705|NCT01690312|Homocysteine|homocysteine
439706|NCT01690312|Essential Fatty Acid Profile|essential fatty acid profile
439707|NCT01690312|Apolipoprotein B|apolipoprotein b
439708|NCT01690312|Apolipoprotein A-1|apolipoprotein a-1
439709|NCT01690312|Glucose|glucose
439710|NCT01690312|Insulin|insulin
439711|NCT01690312|Fasted|fasted
439712|NCT01690312|Post-Prandial|post-prandial
439713|NCT01690299|Psoriasis|psoriasis
439714|NCT01690299|arthritis|arthritis
439715|NCT01690299|psoriatic|psoriatic
439716|NCT01690299|palmoplantar|palmoplantar
439717|NCT01690299|scalp|scalp
439718|NCT01690299|psoriasis pill|psoriasis pill
439719|NCT01690299|psoriasis tablet|psoriasis tablet
439720|NCT01690299|plaque psoriasis|plaque psoriasis
439721|NCT01690299|plaque type psoriasis|plaque type psoriasis
439722|NCT01690299|moderate to severe plaque type psoriasis|moderate to severe plaque type psoriasis
439723|NCT01690299|psoriatic arthritis|psoriatic arthritis
439724|NCT01690286|Healthy|healthy
439725|NCT01690286|Ketoconazole|ketoconazole
439726|NCT01690286|JNJ-38518168|jnj-38518168
439727|NCT01690286|Pharmacokinetics|pharmacokinetics
439728|NCT01690273|exercise|exercise
439729|NCT01690273|mobility|mobility
439730|NCT01690273|strengthening|strengthening
439731|NCT01690273|physiotherapy|physiotherapy
439732|NCT01690260|Bone|bone
439733|NCT01690260|Morphogenetic|morphogenetic
439734|NCT01690260|Protein|protein
439735|NCT01690260|Ilizarow|ilizarow
439736|NCT01690260|Autologous|autologous
439737|NCT01690260|Osteoarthritis|osteoarthritis
439738|NCT01690247|mesenchymal stem cells|mesenchymal stem cells
439739|NCT01690247|liver transplantation|liver transplantation
439740|NCT01690247|clinical trial|clinical trial
439741|NCT01690247|rejection|rejection
439742|NCT01690234|Low back pain|low back pain
439743|NCT01690234|Return to work|return to work
439744|NCT01690234|Sickness absence|sickness absence
439745|NCT01690234|Rehabilitation|rehabilitation
439746|NCT01690234|Multidisciplinary intervention|multidisciplinary intervention
439747|NCT01690221|Anal|anal
439748|NCT01690221|Fissure|fissure
439749|NCT01690221|Pain|pain
439750|NCT01690208|Diabetes|diabetes
439751|NCT01690208|Structure Care|structure care
439752|NCT01690182|Gastrointestinal physiology|gastrointestinal physiology
439753|NCT01690182|MRI|mri
439754|NCT01690182|gastric volumes|gastric volumes
439755|NCT01690182|satiety|satiety
439756|NCT01690156|In-plane|in-plane
439757|NCT01690156|Ultrasound-guided regional anesthesia performance|ultrasound-guided regional anesthesia performance
439758|NCT01690156|Probe position|probe position
439759|NCT01690156|Needle visualization|needle visualization
439760|NCT01690130|nicotine|nicotine
439761|NCT01690130|craving|craving
439762|NCT01690130|smoking|smoking
439763|NCT01690130|TMS|tms
439764|NCT01690130|prefrontal cortex|prefrontal cortex
439765|NCT01690117|family caregiver|family caregiver
439766|NCT01690117|dementia|dementia
439767|NCT01690117|intervention|intervention
439768|NCT01690117|implementation|implementation
439769|NCT01690104|rifampicin|rifampicin
439770|NCT01690104|pregnane X receptor|pregnane x receptor
439771|NCT01690104|blood pressure|blood pressure
439772|NCT01690091|chronic heart failure|chronic heart failure
439773|NCT01690091|type 2 diabetes|type 2 diabetes
439774|NCT01690091|metformin|metformin
439775|NCT01690091|insulin resistance|insulin resistance
439776|NCT01690078|Airway modeling|airway modeling
710246|NCT00589589|hypoglycemia|hypoglycemia
439777|NCT01690078|Pierre Robin Sequence or PRS|pierre robin sequence or prs
439778|NCT01690078|Micrognathia|micrognathia
439779|NCT01690078|Subglottic Stenosis or SGS|subglottic stenosis or sgs
439780|NCT01690065|chronic myeloid leukemia|chronic myeloid leukemia
439781|NCT01690065|myeloid blastic phase|myeloid blastic phase
439782|NCT01690065|bcr-abl(+) acute myeloid leukemia|bcr-abl(+) acute myeloid leukemia
439783|NCT01690065|nilotinib|nilotinib
439784|NCT01690052|dry mouth|dry mouth
439785|NCT01690039|renal tubular acidosis|renal tubular acidosis
439786|NCT01690039|V-ATPase|v-atpase
439787|NCT01690039|kidney stones|kidney stones
439788|NCT01689974|Metastatic Melanoma|metastatic melanoma
439789|NCT01689974|Radiation Therapy|radiation therapy
439790|NCT01689974|Immunology|immunology
439791|NCT01689974|Abscopal|abscopal
439792|NCT01689961|Nutrition|nutrition
439793|NCT01689961|Physical activity|physical activity
439794|NCT01689961|Gestational weight gain|gestational weight gain
439795|NCT01689961|Pregnancy outcomes|pregnancy outcomes
439796|NCT01689961|Birth|birth
439797|NCT01689948|Home care, rehabilitation therapy, Alzheimer's disease|home care, rehabilitation therapy, alzheimer's disease
439798|NCT01689935|Acne vulgaris|acne vulgaris
440308|NCT01687634|pregnancy|pregnancy
439799|NCT01689935|Photodynamic Therapy|photodynamic therapy
439800|NCT01689935|Side-effects|side-effects
439801|NCT01689935|Pain|pain
439802|NCT01689909|Insomnia|insomnia
439803|NCT01689909|Depression|depression
439804|NCT01689909|Suicidal ideation|suicidal ideation
439805|NCT01689909|Zolpidem CR|zolpidem cr
439806|NCT01689909|Placebo|placebo
439807|NCT01689896|Hypogonadism|hypogonadism
439808|NCT01689896|Low testosterone|low testosterone
439809|NCT01689896|Pain|pain
439810|NCT01689883|stroke|stroke
439811|NCT01689883|electrical stimulation|electrical stimulation
439812|NCT01689870|OX40|ox40
439813|NCT01689870|Anti-OX40|anti-ox40
439814|NCT01689870|Ipilimumab|ipilimumab
439815|NCT01689870|Melanoma|melanoma
439816|NCT01689857|hypertropic scar, Vancouver scar scale, silicon gel sheet|hypertropic scar, vancouver scar scale, silicon gel sheet
439817|NCT01689844|controlled high blood pressure|controlled high blood pressure
439818|NCT01689818|insomnia, elderly, exercise training|insomnia, elderly, exercise training
439819|NCT01689805|Atopic dermatitis|atopic dermatitis
439820|NCT01689805|Filaggrin|filaggrin
439821|NCT01689779|vitamin D|vitamin d
439822|NCT01689779|surgery|surgery
439823|NCT01689779|acute stress|acute stress
439824|NCT01689766|Renal Cell|renal cell
439825|NCT01689753|Renal dialyse|renal dialyse
439826|NCT01689753|Catheter, indwelling|catheter, indwelling
439827|NCT01689753|Catheter-related infection|catheter-related infection
439828|NCT01689740|MDMA|mdma
439829|NCT01689740|Posttraumatic stress disorder|posttraumatic stress disorder
439830|NCT01689740|PTSD|ptsd
439831|NCT01689740|Israel|israel
439832|NCT01689740|psychotherapy|psychotherapy
439833|NCT01689727|Pituitary Tumors|pituitary tumors
439834|NCT01689714|Ovarian Carcinoma|ovarian carcinoma
439835|NCT01689714|Recurrent Endometrial Carcinoma|recurrent endometrial carcinoma
439836|NCT01689701|Erosive Gastritis|erosive gastritis
439837|NCT01689701|Hizikia Fusiformis|hizikia fusiformis
439838|NCT01689675|musculoskeletal|musculoskeletal
439839|NCT01689675|pain|pain
439840|NCT01689675|pain management|pain management
439841|NCT01689675|computer based intervention|computer based intervention
439842|NCT01689662|Metastatic Renal Cell Carcinoma|metastatic renal cell carcinoma
439843|NCT01689649|Epilepsy|epilepsy
439844|NCT01689649|Seizures|seizures
439845|NCT01689649|Topiramate|topiramate
439846|NCT01689649|Anti-epileptic drug|anti-epileptic drug
439847|NCT01689649|Nervous disorder|nervous disorder
439848|NCT01689636|Ovarian Cancer|ovarian cancer
439849|NCT01689623|Healthy participants|healthy participants
439850|NCT01689623|TMC435|tmc435
439851|NCT01689623|HMG-CoA reductase inhibitors|hmg-coa reductase inhibitors
439852|NCT01689623|Atorvastatin|atorvastatin
439853|NCT01689623|Simvastatin|simvastatin
439854|NCT01689623|Pharmacokinetic interaction|pharmacokinetic interaction
439855|NCT01689610|Nab-Paclitaxel|nab-paclitaxel
439856|NCT01689610|Abraxane|abraxane
439857|NCT01689610|Nabucco|nabucco
439858|NCT01689610|safety|safety
439859|NCT01689610|breast cancer|breast cancer
439860|NCT01689610|daily routine|daily routine
439861|NCT01689610|peripheral neuropathy|peripheral neuropathy
439862|NCT01689610|iOMEDICO|iomedico
439863|NCT01689584|BRCA1|brca1
439864|NCT01689584|BRCA2|brca2
439866|NCT01689584|co-segregation|co-segregation
439867|NCT01689584|genetic counseling|genetic counseling
439868|NCT01689584|PALB2|palb2
439869|NCT01689571|PDE4 inhibitor|pde4 inhibitor
439870|NCT01689571|Allergen Challenge|allergen challenge
439871|NCT01689571|Asthma|asthma
439872|NCT01689558|nasopharynx cancer,Image department of nose pharynx ministry|nasopharynx cancer,image department of nose pharynx ministry
439873|NCT01689545|HIV|hiv
439874|NCT01689545|drug abuse|drug abuse
439875|NCT01689545|social stigma|social stigma
439876|NCT01689545|Vietnam|vietnam
561949|NCT01170598|elderly|elderly
439877|NCT01689532|Active Rheumatoid Arthritis Unresponsive to Methotrexate or Sulfasalazine|active rheumatoid arthritis unresponsive to methotrexate or sulfasalazine
439878|NCT01689532|Sirukumab|sirukumab
439879|NCT01689532|Human Anti-IL-6 Monoclonal Antibody|human anti-il-6 monoclonal antibody
439880|NCT01689519|Zelboraf|zelboraf
439881|NCT01689519|vemurafenib|vemurafenib
439882|NCT01689519|RG7204|rg7204
439883|NCT01689519|PLX4032|plx4032
439884|NCT01689519|Genentech MEK inhibitor|genentech mek inhibitor
439885|NCT01689519|Genentech BRAF inhibitor|genentech braf inhibitor
439886|NCT01689519|Roche MEK inhibitor|roche mek inhibitor
439887|NCT01689519|Roche BRAF inhibitor|roche braf inhibitor
439888|NCT01689519|RO5185426|ro5185426
439889|NCT01689519|metastatic melanoma|metastatic melanoma
439890|NCT01689519|BRAF positive melanoma|braf positive melanoma
439891|NCT01689519|BRAF mutant melanoma|braf mutant melanoma
439892|NCT01689519|advanced melanoma|advanced melanoma
439893|NCT01689519|Genentech RAF inhibitor|genentech raf inhibitor
439894|NCT01689519|Roche RAF inhibitor|roche raf inhibitor
439895|NCT01689519|BRAF V600E kinase inhibitor|braf v600e kinase inhibitor
439896|NCT01689519|Oncogenic BRAF inhibitor|oncogenic braf inhibitor
439897|NCT01689519|BRAF kinase inhibitor|braf kinase inhibitor
439898|NCT01689519|GDC-0973|gdc-0973
439899|NCT01689519|XL518|xl518
439901|NCT01689480|Muscular Dystrophy|muscular dystrophy
439902|NCT01689480|Facioscapulohumeral|facioscapulohumeral
439903|NCT01689480|Physical training|physical training
439904|NCT01689480|Exercise|exercise
439905|NCT01689454|IVF|ivf
439906|NCT01689454|embryo culture|embryo culture
439907|NCT01689454|Ongoing pregnancy rate|ongoing pregnancy rate
439908|NCT01689454|Ongoing implantation rate|ongoing implantation rate
439909|NCT01689454|Miscarriage|miscarriage
439910|NCT01689428|IVF|ivf
439911|NCT01689428|Embryo culture|embryo culture
439912|NCT01689428|Ongoing Pregnancy rate|ongoing pregnancy rate
439913|NCT01689428|Ongoing Implantation rate|ongoing implantation rate
439914|NCT01689428|Miscarriage|miscarriage
439915|NCT01689415|Renal nerve denervation|renal nerve denervation
439916|NCT01689389|Schizophrenia|schizophrenia
439917|NCT01689389|Bipolar episodes|bipolar episodes
439918|NCT01689389|France|france
439919|NCT01689389|Xeroquel|xeroquel
439920|NCT01689389|Real-life|real-life
439921|NCT01689363|hyaluronidase|hyaluronidase
439922|NCT01689363|enzymes with tissue spreading activity|enzymes with tissue spreading activity
439923|NCT01689363|allergic reaction|allergic reaction
439924|NCT01689363|intradermal skin testing|intradermal skin testing
439925|NCT01689350|Cyclophosphamide|cyclophosphamide
439926|NCT01689350|genotype-based therapy|genotype-based therapy
439927|NCT01689350|prospective study|prospective study
439928|NCT01689337|Microfracture surgery|microfracture surgery
439929|NCT01689337|Cartilage repair|cartilage repair
439930|NCT01689337|Knee surgery|knee surgery
439931|NCT01689324|Pertussis|pertussis
439932|NCT01689324|Tetanus|tetanus
439933|NCT01689324|Diphtheria|diphtheria
439934|NCT01689324|Acellular pertussis|acellular pertussis
439935|NCT01689324|ADACEL®|adacel®
439936|NCT01689324|Tdap vaccine|tdap vaccine
439937|NCT01689311|Uterine contraction|uterine contraction
439938|NCT01689311|Dose response|dose response
439939|NCT01689311|Non-laboring|non-laboring
439940|NCT01689311|Laboring|laboring
439941|NCT01689311|Laboring with oxytocin augmentation|laboring with oxytocin augmentation
439942|NCT01689311|Oxytocin|oxytocin
439943|NCT01689311|Ergonovine|ergonovine
439944|NCT01689311|Prostaglandin F2alpha|prostaglandin f2alpha
439945|NCT01689311|Misoprostol|misoprostol
439946|NCT01689298|Uterine contraction|uterine contraction
439947|NCT01689298|Dose response|dose response
439948|NCT01689298|Oxytocin pretreatment|oxytocin pretreatment
439949|NCT01689298|Oxytocin|oxytocin
439950|NCT01689298|Carbetocin|carbetocin
439951|NCT01689285|bioequivalence|bioequivalence
439952|NCT01689285|pharmacokinetics|pharmacokinetics
439953|NCT01689285|valacyclovir|valacyclovir
439954|NCT01689285|paediatric formulation|paediatric formulation
439955|NCT01689272|Kidney transplantation,functional status,survival.|kidney transplantation,functional status,survival.
439956|NCT01689246|Alzheimer's Disease|alzheimer's disease
439957|NCT01689246|Alzheimer Disease|alzheimer disease
439958|NCT01689246|TRx0237|trx0237
439959|NCT01689246|AD|ad
439960|NCT01689246|Neurodegenerative Diseases|neurodegenerative diseases
439961|NCT01689246|Dementia|dementia
439962|NCT01689246|Brain Diseases|brain diseases
439963|NCT01689233|Alzheimer's Disease|alzheimer's disease
439964|NCT01689233|Alzheimer Disease|alzheimer disease
439965|NCT01689233|TRx0237|trx0237
439966|NCT01689233|AD|ad
439967|NCT01689233|Neurodegenerative Diseases|neurodegenerative diseases
439968|NCT01689233|Dementia|dementia
439969|NCT01689233|Brain Diseases|brain diseases
439970|NCT01689207|Phase I, Safety, tolerability, healthy.|phase i, safety, tolerability, healthy.
439971|NCT01689155|Meningitis|meningitis
439972|NCT01689155|Meningococcal Infection|meningococcal infection
439973|NCT01689155|Menactra®|menactra®
562079|NCT01170039|Amitiza|amitiza
439974|NCT01689103|Alcohol use disorders|alcohol use disorders
439975|NCT01689103|Treatment|treatment
439976|NCT01689103|Outpatient|outpatient
439977|NCT01689103|Therapeutic alliance|therapeutic alliance
439978|NCT01689051|Type 2 diabetes|type 2 diabetes
439979|NCT01689051|Blod pressure|blod pressure
439980|NCT01689051|Glucagon-like peptide-1|glucagon-like peptide-1
439981|NCT01689051|Human physiology|human physiology
439982|NCT01689051|Blood flow|blood flow
439983|NCT01688999|Kidney Cancer|kidney cancer
439984|NCT01688999|Tyrosine Kinase Inhibitor|tyrosine kinase inhibitor
439985|NCT01688999|Bladder Cancer|bladder cancer
439986|NCT01688986|Complex Disease|complex disease
439987|NCT01688986|DNA Biorepository|dna biorepository
439988|NCT01688986|Genotype-Phenotype Correlation|genotype-phenotype correlation
439989|NCT01688986|Genetics|genetics
439990|NCT01688986|Environmental Factors|environmental factors
439991|NCT01688947|Pain|pain
439992|NCT01688947|Neuralgia, Postherpetic|neuralgia, postherpetic
439993|NCT01688934|Pain|pain
439994|NCT01688934|Osteoarthritis|osteoarthritis
439995|NCT01688934|Knee|knee
439996|NCT01688921|Injections, Jet|injections, jet
439997|NCT01688921|Influenza Vaccines|influenza vaccines
439998|NCT01688908|Esophageal Squamous Cell Carcinoma|esophageal squamous cell carcinoma
439999|NCT01688908|Endoscopic Screening|endoscopic screening
440000|NCT01688908|Efficacy|efficacy
440001|NCT01688908|Cost-utility|cost-utility
440610|NCT01686204|Intestine|intestine
440002|NCT01688908|High risk region|high risk region
440004|NCT01688895|erythropoietic|erythropoietic
440005|NCT01688895|protoporphyria|protoporphyria
440006|NCT01688895|cutaneous|cutaneous
440007|NCT01688895|porphyria|porphyria
440008|NCT01688882|bullous pemphigoid|bullous pemphigoid
440009|NCT01688882|QGE031|qge031
440010|NCT01688869|brain concussion|brain concussion
440011|NCT01688856|hand|hand
440012|NCT01688856|arm|arm
440013|NCT01688856|stroke|stroke
440014|NCT01688856|hemiplegia|hemiplegia
440015|NCT01688856|electrical stimulation|electrical stimulation
440016|NCT01688856|recovery|recovery
440017|NCT01688856|rehabilitation|rehabilitation
440018|NCT01688843|bradycardia|bradycardia
440019|NCT01688843|sinus node dysfunction|sinus node dysfunction
440020|NCT01688817|Colorectal Neoplasms|colorectal neoplasms
440021|NCT01688817|Colonoscopy|colonoscopy
440022|NCT01688817|Early Detection of Cancer|early detection of cancer
440023|NCT01688817|Patient Selection|patient selection
440024|NCT01688817|Patient Participation|patient participation
440025|NCT01688817|Physicians, Primary Care|physicians, primary care
440026|NCT01688817|Conscious Sedation|conscious sedation
440027|NCT01688804|Sedentary behavior|sedentary behavior
440028|NCT01688804|Physical activity|physical activity
440029|NCT01688804|Obesity|obesity
440030|NCT01688804|Mobile health|mobile health
440031|NCT01688804|Smartphone|smartphone
440032|NCT01688778|Type 2 diabetes|type 2 diabetes
440033|NCT01688778|Quality of life|quality of life
440034|NCT01688778|Lifestyle intervention|lifestyle intervention
440035|NCT01688778|Telemedicine|telemedicine
440036|NCT01688778|Videoconference|videoconference
440037|NCT01688765|Schizophrenia|schizophrenia
440038|NCT01688765|Schizoaffective disorder|schizoaffective disorder
440039|NCT01688765|Bipolar disorder|bipolar disorder
440040|NCT01688739|Migraine|migraine
440041|NCT01688726|Dry eye|dry eye
440042|NCT01688726|Ocular surface|ocular surface
440043|NCT01688726|Vision complaint|vision complaint
440044|NCT01688726|Tear film stability|tear film stability
440045|NCT01688726|Time controlled functional visual acuity|time controlled functional visual acuity
440046|NCT01688726|Tear film kinetics|tear film kinetics
440047|NCT01688700|Esophageal Squamous Cell Carcinoma|esophageal squamous cell carcinoma
440048|NCT01688700|neoadjuvant therapy|neoadjuvant therapy
440049|NCT01688700|Nimotuzumab|nimotuzumab
440050|NCT01688648|Coronary artery bypass graft|coronary artery bypass graft
440051|NCT01688648|dexmedetomidine|dexmedetomidine
440052|NCT01688648|lidocaine|lidocaine
440053|NCT01688648|myocardial injury|myocardial injury
440054|NCT01688648|arrhythmia|arrhythmia
440055|NCT01688648|blood electrolyte balance|blood electrolyte balance
440056|NCT01688635|Volunteers|volunteers
440057|NCT01688596|Local|local
440058|NCT01688596|Anesthesia|anesthesia
440059|NCT01688596|Pain|pain
440060|NCT01688596|Laparoscopic hysterectomy|laparoscopic hysterectomy
440061|NCT01688596|Trocar site|trocar site
440062|NCT01688596|Port site|port site
440063|NCT01688583|Chronic pain|chronic pain
440064|NCT01688583|Chronic non-cancer pain|chronic non-cancer pain
440065|NCT01688583|Fentanyl matrix|fentanyl matrix
440066|NCT01688583|Transdermal system|transdermal system
440067|NCT01688570|neuromuscular fatigue|neuromuscular fatigue
440068|NCT01688570|motor impairment|motor impairment
440069|NCT01688557|narrow band imaging|narrow band imaging
440070|NCT01688557|dual focus|dual focus
440071|NCT01688557|responsive insertion technique|responsive insertion technique
440072|NCT01688557|scope guide|scope guide
440073|NCT01688557|colonoscopy|colonoscopy
440074|NCT01688557|colorectal cancer screening|colorectal cancer screening
440075|NCT01688544|Ilaprazole|ilaprazole
440076|NCT01688544|Intragastric pH|intragastric ph
440077|NCT01688544|Serum Gastrin|serum gastrin
440078|NCT01688544|Pharmacokinetics|pharmacokinetics
440079|NCT01688518|Evaluation|evaluation
440080|NCT01688518|Depth and Duration|depth and duration
440081|NCT01688518|Anesthesia|anesthesia
440082|NCT01688505|cerebral small vessel diseases|cerebral small vessel diseases
440083|NCT01688505|cognitive impairment|cognitive impairment
440084|NCT01688505|Blood pressure variability|blood pressure variability
440085|NCT01688492|MDX-010 (Ipilimumab)|mdx-010 (ipilimumab)
440086|NCT01688492|ABIRATERONE ACETATE (CB 7630)|abiraterone acetate (cb 7630)
440087|NCT01688492|PREDNISONE|prednisone
440088|NCT01688492|Immunotherapy-naïve|immunotherapy-naïve
440089|NCT01688492|castration resistant prostate cancer (CRPC)|castration resistant prostate cancer (crpc)
440090|NCT01688492|12-120|12-120
440091|NCT01688479|Postoperative radiotherapy|postoperative radiotherapy
440092|NCT01688479|breast cancer|breast cancer
440093|NCT01688466|Immune Modulatory|immune modulatory
440094|NCT01688466|Systemic Absorption|systemic absorption
440095|NCT01688466|Oral Agent|oral agent
440096|NCT01688453|overweight/obesity|overweight/obesity
440097|NCT01688453|adolescence|adolescence
440098|NCT01688453|care management|care management
440099|NCT01688440|Endotracheal Cares|endotracheal cares
440100|NCT01688440|Neonate|neonate
440101|NCT01688440|TAC's|tac's
440102|NCT01688440|Endotracheal Suctioning|endotracheal suctioning
440103|NCT01688440|Tracheal Aspirate Culture|tracheal aspirate culture
440104|NCT01688440|Oral Cares|oral cares
440105|NCT01688440|Neonate oxygen Therapy|neonate oxygen therapy
440106|NCT01688401|diffuse intrinsic pontine glioma (DIPG)|diffuse intrinsic pontine glioma (dipg)
440107|NCT01688401|intra-arterial chemotherapy|intra-arterial chemotherapy
440108|NCT01688401|angiography|angiography
440109|NCT01688388|Breast Cancer|breast cancer
440110|NCT01688388|Carcinoma|carcinoma
440111|NCT01688388|Radiotherapy|radiotherapy
440112|NCT01688388|Intraoperative Radiotherapy|intraoperative radiotherapy
440113|NCT01688388|IORT|iort
440114|NCT01688375|obstructive jaundice|obstructive jaundice
440115|NCT01688375|ursodeoxycholic acid|ursodeoxycholic acid
440116|NCT01688362|Prospective Randomized Controlled Double Blinded Trial|prospective randomized controlled double blinded trial
440117|NCT01688362|Rotator Cuff Tear|rotator cuff tear
440118|NCT01688362|Platelet Rich Plasma|platelet rich plasma
440119|NCT01688362|Corticosteroid|corticosteroid
440120|NCT01688362|Ultrasound|ultrasound
440121|NCT01688349|Glucocorticoids|glucocorticoids
440122|NCT01688349|adipose tissue|adipose tissue
440123|NCT01688349|Cushing|cushing
440124|NCT01688349|lipodystrophy|lipodystrophy
440125|NCT01688349|11 beta-HSD1|11 beta-hsd1
440126|NCT01688336|Pancreatic|pancreatic
440127|NCT01688336|Phase II|phase ii
440128|NCT01688336|FOLFIRINOX|folfirinox
440129|NCT01688336|Unresectable|unresectable
440130|NCT01688336|Regimen|regimen
440131|NCT01688336|First-line|first-line
440132|NCT01688336|Resectable|resectable
440133|NCT01688336|Borderline|borderline
440134|NCT01688336|Oxaliplatin|oxaliplatin
440135|NCT01688336|Leucovorin|leucovorin
440136|NCT01688336|Irinotecan|irinotecan
440138|NCT01688336|Lineberger|lineberger
440139|NCT01688336|University of North Carolina|university of north carolina
440140|NCT01688323|Geriatrics|geriatrics
440141|NCT01688323|Oncology|oncology
440142|NCT01688323|Biological Markers|biological markers
440143|NCT01688323|Survey Instruments|survey instruments
440144|NCT01688323|p16|p16
440145|NCT01688323|Geriatric Oncology|geriatric oncology
440146|NCT01688323|Biological Markers of Aging|biological markers of aging
440147|NCT01688323|Symptom Assessment|symptom assessment
440148|NCT01688323|Cancer|cancer
440149|NCT01688323|Older Persons|older persons
440150|NCT01688323|Head and Neck Cancer|head and neck cancer
440151|NCT01688310|Gomco clamp instrument|gomco clamp instrument
440152|NCT01688310|Tissue adhesive|tissue adhesive
440153|NCT01688310|Open surgical circumcision|open surgical circumcision
440154|NCT01688310|Minimally-invasive circumcision|minimally-invasive circumcision
440155|NCT01688297|Influenza|influenza
440156|NCT01688297|H1N1|h1n1
440157|NCT01688297|flu|flu
440158|NCT01688297|seasonal|seasonal
440159|NCT01688284|uterine natural killer cells|uterine natural killer cells
440160|NCT01688284|recurrent miscarriages|recurrent miscarriages
440161|NCT01688284|alloimmunity|alloimmunity
440162|NCT01688271|simulation|simulation
440163|NCT01688271|ultrasound|ultrasound
440164|NCT01688271|perineural infusion|perineural infusion
440165|NCT01688271|continuous peripheral nerve block|continuous peripheral nerve block
440166|NCT01688245|young adults|young adults
440167|NCT01688245|alcohol consumption|alcohol consumption
440168|NCT01688245|mobile health|mobile health
440169|NCT01688245|text message|text message
440170|NCT01688232|colorectal cancer|colorectal cancer
440171|NCT01688232|tumor resection|tumor resection
440172|NCT01688232|immunoscore|immunoscore
440173|NCT01688232|lymphocytic density|lymphocytic density
562407|NCT01168921|CLL|cll
440174|NCT01688232|CD3|cd3
440175|NCT01688232|CD8|cd8
440176|NCT01688232|CD45RO|cd45ro
440177|NCT01688232|biopsy|biopsy
440178|NCT01688232|genetic feature of the tumor|genetic feature of the tumor
440179|NCT01688232|relapse|relapse
440180|NCT01688232|immunohistochemistry|immunohistochemistry
440181|NCT01688232|image analysis software|image analysis software
440182|NCT01688219|SAPHO syndrome|sapho syndrome
440183|NCT01688219|Innate immunity|innate immunity
440184|NCT01688219|TNF alpha|tnf alpha
440185|NCT01688219|Polymorphonuclear neutrophils|polymorphonuclear neutrophils
440186|NCT01688219|Propionibacterium acnes|propionibacterium acnes
440187|NCT01688219|Interleukin-8|interleukin-8
440188|NCT01688180|bronchiectasis|bronchiectasis
440189|NCT01688180|depression|depression
440190|NCT01688180|anxiety|anxiety
440191|NCT01688167|HIV|hiv
440192|NCT01688167|Male circumcision|male circumcision
440193|NCT01688167|Sexual risk reduction|sexual risk reduction
440194|NCT01688167|Stages of change|stages of change
440195|NCT01688141|CKD|ckd
440196|NCT01688128|Mild cognitive impairment|mild cognitive impairment
440197|NCT01688128|Cognitive rehabilitation|cognitive rehabilitation
440198|NCT01688128|Cognitive therapy|cognitive therapy
440199|NCT01688128|Spaced retrieval Training|spaced retrieval training
440200|NCT01688128|Alzheimer's disease|alzheimer's disease
440201|NCT01688128|Memory enhancement|memory enhancement
440202|NCT01688128|U-healthcare|u-healthcare
440203|NCT01688089|volunteer|volunteer
440204|NCT01688089|study|study
440205|NCT01688063|Skin Elasticity|skin elasticity
440206|NCT01688063|Scar Elasticity|scar elasticity
440208|NCT01688063|Dermal Torque Meter|dermal torque meter
440209|NCT01688050|Blunt thoracic aortic injury|blunt thoracic aortic injury
440210|NCT01688050|Transection|transection
440211|NCT01688050|Endovascular graft|endovascular graft
440212|NCT01688024|mitomycin C|mitomycin c
440213|NCT01688011|Myelodysplastic Syndromes|myelodysplastic syndromes
440214|NCT01688011|MDS|mds
440215|NCT01688011|Acute Myeloid Leukemia|acute myeloid leukemia
440216|NCT01688011|AML|aml
440217|NCT01688011|Registry|registry
440218|NCT01688011|Connect®|connect®
440219|NCT01687972|cesarean section|cesarean section
440220|NCT01687972|insorb staples|insorb staples
440221|NCT01687972|absorbable staples|absorbable staples
440222|NCT01687972|transverse skin incision|transverse skin incision
440223|NCT01687959|cholelithiasis|cholelithiasis
440224|NCT01687959|laparoscopic cholecystectomy|laparoscopic cholecystectomy
440225|NCT01687959|endoscopic sphincterotomy|endoscopic sphincterotomy
440226|NCT01687959|choledocholithiasis|choledocholithiasis
440227|NCT01687946|Biology of Fibrosis|biology of fibrosis
440228|NCT01687933|Labor pain|labor pain
440229|NCT01687933|Virtual reality|virtual reality
440230|NCT01687933|the first stage of labor|the first stage of labor
440231|NCT01687933|Pain relief|pain relief
440232|NCT01687933|Simulator|simulator
440233|NCT01687920|Cardiac disorders|cardiac disorders
440234|NCT01687907|fear of childbirth|fear of childbirth
440235|NCT01687907|outcome of delivery|outcome of delivery
440236|NCT01687907|music|music
440237|NCT01687907|mother-baby relationship|mother-baby relationship
440238|NCT01687894|cerebral oxygen saturation|cerebral oxygen saturation
440239|NCT01687894|beach chair position|beach chair position
440240|NCT01687894|hemodynamic|hemodynamic
440241|NCT01687894|jugular venous oximetry|jugular venous oximetry
440242|NCT01687881|Chiropractic|chiropractic
440243|NCT01687881|Manipulative therapy|manipulative therapy
440244|NCT01687881|Cervicogenic headache|cervicogenic headache
440245|NCT01687855|Obstructive Sleep|obstructive sleep
440246|NCT01687855|Apnoea|apnoea
440247|NCT01687855|tongue|tongue
440248|NCT01687855|alteration|alteration
440249|NCT01687829|Macular Holes|macular holes
440250|NCT01687829|Internal limiting membrane|internal limiting membrane
440251|NCT01687829|peeling|peeling
440252|NCT01687829|Surgery|surgery
440253|NCT01687816|Influenza-Like-Illness|influenza-like-illness
440254|NCT01687816|nasal swabs|nasal swabs
440255|NCT01687816|Detection of influenza|detection of influenza
440256|NCT01687816|sensitivity of detection assays|sensitivity of detection assays
440257|NCT01687803|Obesity|obesity
440258|NCT01687803|Sedentary lifestyle|sedentary lifestyle
440259|NCT01687803|Body weight|body weight
440260|NCT01687803|Physical fitness|physical fitness
440261|NCT01687790|molecular breast imaging|molecular breast imaging
440262|NCT01687790|breast disease|breast disease
440263|NCT01687790|breast biopsy|breast biopsy
440264|NCT01687777|Supraspinatus tendon|supraspinatus tendon
440265|NCT01687777|Mesenchymal stem cells|mesenchymal stem cells
440266|NCT01687777|OrthADAPT|orthadapt
440267|NCT01687777|Rotator cuff|rotator cuff
440268|NCT01687764|Generalized Anxiety Disorder (GAD)|generalized anxiety disorder (gad)
440269|NCT01687764|Separation Anxiety Disorder (SeAD)|separation anxiety disorder (sead)
440270|NCT01687764|Social Anxiety Disorder (SoAD)|social anxiety disorder (soad)
440271|NCT01687751|feasibility studies|feasibility studies
440272|NCT01687751|conscious sedation/|conscious sedation/
440273|NCT01687751|dexmedetomidine/|dexmedetomidine/
440274|NCT01687751|midazolam/|midazolam/
440275|NCT01687751|infusions, subcutaneous/|infusions, subcutaneous/
440276|NCT01687751|palliative care/|palliative care/
440277|NCT01687751|terminal care/|terminal care/
440278|NCT01687751|terminally ill/|terminally ill/
440279|NCT01687751|neoplasms/|neoplasms/
440280|NCT01687751|treatment outcome|treatment outcome
440281|NCT01687751|Precedex|precedex
440282|NCT01687751|"end of life"|"end of life"
440283|NCT01687751|Dying|dying
440284|NCT01687751|Advanced cancer|advanced cancer
440285|NCT01687751|mood/delirium/delirious|mood/delirium/delirious
440286|NCT01687738|non small cell lung cancer|non small cell lung cancer
440287|NCT01687738|health disparities|health disparities
440288|NCT01687712|IVF|ivf
440289|NCT01687712|In vitro fertilization|in vitro fertilization
440290|NCT01687712|Controlled ovarian stimulation|controlled ovarian stimulation
440291|NCT01687712|Follitropin|follitropin
440292|NCT01687712|AFOLIA|afolia
440293|NCT01687712|Finox|finox
440294|NCT01687699|cardiovascular event|cardiovascular event
440295|NCT01687699|hemodialysis|hemodialysis
440296|NCT01687699|spironolactone|spironolactone
440297|NCT01687673|Advanced HCC|advanced hcc
440298|NCT01687673|Temsirolimus|temsirolimus
440299|NCT01687673|TORISEL|torisel
440300|NCT01687673|Sorafenib|sorafenib
440301|NCT01687660|acupuncture|acupuncture
440302|NCT01687660|migraine prophylaxis|migraine prophylaxis
440303|NCT01687647|Lung cancer screening|lung cancer screening
440304|NCT01687647|Asbestos exposed workers|asbestos exposed workers
440305|NCT01687647|Sputum analysis|sputum analysis
440306|NCT01687647|Automated cytometry|automated cytometry
440307|NCT01687647|Predictive biomarkers|predictive biomarkers
440309|NCT01687634|home healthcare visits|home healthcare visits
440310|NCT01687634|breast feeding|breast feeding
440311|NCT01687634|nutrition|nutrition
440312|NCT01687634|community health workers|community health workers
440313|NCT01687621|Omphalitis|omphalitis
440314|NCT01687621|Neonate|neonate
440315|NCT01687621|Zambia|zambia
440316|NCT01687621|Neonatal mortality|neonatal mortality
440317|NCT01687621|Umbilical cord infection|umbilical cord infection
440318|NCT01687608|Hemophilia B|hemophilia b
440319|NCT01687608|factor IX deficiency|factor ix deficiency
440320|NCT01687608|gene therapy|gene therapy
440321|NCT01687595|herpes simplex virus type 2,|herpes simplex virus type 2,
440322|NCT01687595|genital herpes|genital herpes
440323|NCT01687582|type 2 diabetes|type 2 diabetes
440324|NCT01687582|psoriasis|psoriasis
440325|NCT01687582|exenatide|exenatide
440326|NCT01687582|liraglutide|liraglutide
440327|NCT01687569|Glycaemic Response|glycaemic response
440328|NCT01687556|EGCG|egcg
440329|NCT01687556|green tea|green tea
440330|NCT01687543|Clostridium difficile|clostridium difficile
440331|NCT01687543|WBC|wbc
440332|NCT01687543|CRP|crp
440333|NCT01687543|Lactate|lactate
440334|NCT01687543|Urea|urea
440335|NCT01687543|Creatinine|creatinine
440336|NCT01687517|sarcoidosis|sarcoidosis
440337|NCT01687517|healthy volunteers|healthy volunteers
440338|NCT01687504|pharmacokinetics|pharmacokinetics
440339|NCT01687504|children|children
440340|NCT01687504|HIV|hiv
440341|NCT01687504|Tuberculosis|tuberculosis
440342|NCT01687504|Pharmacogenetics|pharmacogenetics
440343|NCT01687491|Enoxaparin|enoxaparin
440344|NCT01687491|Acute Coronary Syndrome|acute coronary syndrome
440345|NCT01687491|Factor X|factor x
440346|NCT01687465|glaucoma|glaucoma
440347|NCT01687465|laser|laser
440348|NCT01687465|SLT|slt
440349|NCT01687465|ALT|alt
440350|NCT01687374|proximal humeral fracture|proximal humeral fracture
440351|NCT01687335|chemotherapy|chemotherapy
440352|NCT01687322|quality of life|quality of life
440353|NCT01687322|functioning|functioning
440354|NCT01687296|PEF|pef
440355|NCT01687296|inhaled|inhaled
440356|NCT01687296|Fluticasone Propionate|fluticasone propionate
440357|NCT01687296|safety|safety
440358|NCT01687296|prednisone|prednisone
440359|NCT01687296|acute exacerbation|acute exacerbation
440360|NCT01687296|asthma|asthma
440361|NCT01687296|efficacy|efficacy
440362|NCT01687283|fluticasone propionate inhalation solution|fluticasone propionate inhalation solution
440363|NCT01687283|budesonide suspension for inhalation|budesonide suspension for inhalation
440364|NCT01687283|efficacy|efficacy
440365|NCT01687283|severe persistent asthma|severe persistent asthma
440366|NCT01687283|pharmacokinetics|pharmacokinetics
440367|NCT01687283|safety|safety
440368|NCT01687244|BCG Refractory or Relapsed Superficial Bladder Cancer|bcg refractory or relapsed superficial bladder cancer
440369|NCT01687244|rAd-IFN|rad-ifn
440370|NCT01687244|Syn3|syn3
440371|NCT01687244|Intravesical|intravesical
440372|NCT01687244|transitional cell carcinoma of the bladder|transitional cell carcinoma of the bladder
440373|NCT01687244|superficial non-muscle invasive tumor|superficial non-muscle invasive tumor
440374|NCT01687244|Interferon alpha2b|interferon alpha2b
440375|NCT01687244|INSTILADRIN|instiladrin
710247|NCT00589589|hyperglycemia|hyperglycemia
440376|NCT01687231|Neutropenic Diet, Non-Neutropenic Diet, Allogeneic SCT|neutropenic diet, non-neutropenic diet, allogeneic sct
440377|NCT01687192|Seroconversion|seroconversion
440378|NCT01687192|Immunosuppressed treatment|immunosuppressed treatment
440379|NCT01687192|HPV vaccination|hpv vaccination
440380|NCT01687192|Immunogenicity|immunogenicity
440382|NCT01687179|TSC|tsc
440383|NCT01687179|lymphangioleiomyomatosis|lymphangioleiomyomatosis
440384|NCT01687166|Paroxysmal Atrial Fibrillation|paroxysmal atrial fibrillation
440385|NCT01687166|Cardiac Arrhythmias|cardiac arrhythmias
440386|NCT01687166|Heart Disease|heart disease
440387|NCT01687166|Cardiovascular Disease|cardiovascular disease
440388|NCT01687166|Radiofrequency Ablation|radiofrequency ablation
440389|NCT01687153|traumatic brain injury (TBI)|traumatic brain injury (tbi)
440390|NCT01687153|post traumatic stress disorder (PTSD)|post traumatic stress disorder (ptsd)
440391|NCT01687153|Alzheimer's disease (AD)|alzheimer's disease (ad)
440392|NCT01687153|mild cognitive impairment (MCI)|mild cognitive impairment (mci)
440393|NCT01687153|dementia|dementia
440394|NCT01687153|biomarkers|biomarkers
440395|NCT01687153|amyloid|amyloid
440396|NCT01687153|neuroimaging|neuroimaging
440397|NCT01687153|cognition disorder|cognition disorder
440398|NCT01687153|tau|tau
440399|NCT01687127|folic acid|folic acid
440400|NCT01687127|folate|folate
440401|NCT01687127|5-methyltetrahydrofolate|5-methyltetrahydrofolate
440402|NCT01687127|supplements|supplements
440403|NCT01687127|women|women
440404|NCT01687127|one-carbon metabolism|one-carbon metabolism
440405|NCT01687127|methionine|methionine
440406|NCT01687127|DNA methylation|dna methylation
440407|NCT01687127|in vivo kinetics|in vivo kinetics
440408|NCT01687114|compliance, proanthocyanidin, phenoic acids, cranberry|compliance, proanthocyanidin, phenoic acids, cranberry
440409|NCT01687101|acute migraine|acute migraine
440410|NCT01687101|acute migraine treatment|acute migraine treatment
440411|NCT01687101|topical treatment|topical treatment
440412|NCT01687075|coronary angioplasty|coronary angioplasty
440413|NCT01687075|de novo lesion|de novo lesion
440414|NCT01687062|NaFeEDTA|nafeedta
440416|NCT01687062|injera|injera
440417|NCT01687062|iron absorption|iron absorption
440418|NCT01687049|nonmetastatic|nonmetastatic
440419|NCT01687049|localized|localized
440420|NCT01687049|prostate|prostate
440421|NCT01687049|active surveillance|active surveillance
440422|NCT01687036|Atrial fibrillation|atrial fibrillation
440423|NCT01687036|Cryoablation|cryoablation
440424|NCT01687023|Tai Chi|tai chi
440425|NCT01687023|Wearable sensors|wearable sensors
440426|NCT01687023|Movement|movement
440427|NCT01687010|CRP, PCT, IL-6, Diagnosis, Prediction|crp, pct, il-6, diagnosis, prediction
440428|NCT01686997|Bariatric surgery|bariatric surgery
440429|NCT01686997|Roux-en-Y Gastric Bypass|roux-en-y gastric bypass
440430|NCT01686958|Prostate Cancer|prostate cancer
440431|NCT01686958|High intensity transurethral ultrasound ablation|high intensity transurethral ultrasound ablation
440432|NCT01686958|MRI-guided|mri-guided
440433|NCT01686958|Minimally invasive|minimally invasive
440434|NCT01686958|Real-time temperature feedback control|real-time temperature feedback control
440435|NCT01686932|vildagliptin|vildagliptin
440436|NCT01686932|sitagliptin|sitagliptin
440437|NCT01686932|continuous glucose monitoring (CGM)|continuous glucose monitoring (cgm)
440438|NCT01686932|glycemic fluctuations|glycemic fluctuations
440439|NCT01686932|MAGE|mage
440440|NCT01686932|impact of hypoglycemia on heart function (cardiac dysfuction measured via ECG)|impact of hypoglycemia on heart function (cardiac dysfuction measured via ecg)
440441|NCT01686932|difference in glycemic profile of vildagliptin compared to sitagliptin|difference in glycemic profile of vildagliptin compared to sitagliptin
440442|NCT01686919|Gastric bypass|gastric bypass
440443|NCT01686919|Questionnaires|questionnaires
440444|NCT01686919|Diet|diet
440445|NCT01686919|Milk|milk
440446|NCT01686906|Keratoconus|keratoconus
440447|NCT01686906|Bowman layer|bowman layer
440448|NCT01686893|Oxygen, Insufflation, COPD, High Flow Treatment|oxygen, insufflation, copd, high flow treatment
440449|NCT01686880|Hepatocellular Carcinoma|hepatocellular carcinoma
440450|NCT01686880|Liver Cirrhosis|liver cirrhosis
440451|NCT01686880|radioembolization|radioembolization
440452|NCT01686880|SIRT|sirt
440453|NCT01686880|TARE|tare
440454|NCT01686880|Sirspheres|sirspheres
440455|NCT01686880|neoadjuvant|neoadjuvant
440456|NCT01686880|liver cancer|liver cancer
440457|NCT01686867|improved cookstove|improved cookstove
440458|NCT01686867|ventilated cookstove|ventilated cookstove
440459|NCT01686867|behavior change|behavior change
440460|NCT01686867|adoption|adoption
440461|NCT01686867|indoor air pollution|indoor air pollution
440462|NCT01686867|DLCO|dlco
440463|NCT01686867|spirometry|spirometry
440464|NCT01686867|biomass fuel|biomass fuel
440465|NCT01686854|cognitive-behavioral approach|cognitive-behavioral approach
440466|NCT01686854|obesity treatment|obesity treatment
440467|NCT01686841|Lipolysis|lipolysis
440468|NCT01686841|Cryolipolysis|cryolipolysis
440469|NCT01686841|Fat Reduction|fat reduction
440470|NCT01686828|insulin|insulin
440471|NCT01686828|androgens|androgens
440472|NCT01686828|insulin resistance|insulin resistance
440473|NCT01686828|testosterone|testosterone
440474|NCT01686828|estradiol|estradiol
440475|NCT01686828|obesity|obesity
440476|NCT01686815|metabolic side effects|metabolic side effects
440477|NCT01686815|atypical antipsychotics|atypical antipsychotics
440478|NCT01686815|FSIVGTT|fsivgtt
440479|NCT01686802|oral morphine|oral morphine
440480|NCT01686802|ibuprofen|ibuprofen
440481|NCT01686802|post-operative pain|post-operative pain
440482|NCT01686776|Plasma albumine|plasma albumine
440483|NCT01686776|Plasma volume|plasma volume
440484|NCT01686776|Transcapillary escape rate|transcapillary escape rate
440485|NCT01686776|Inflammation|inflammation
440486|NCT01686776|Circulation|circulation
440487|NCT01686750|HIV|hiv
440488|NCT01686750|injection drug use|injection drug use
440489|NCT01686750|men who have sex with men|men who have sex with men
440490|NCT01686750|voluntary counselling and testing|voluntary counselling and testing
440491|NCT01686750|risk reduction|risk reduction
440492|NCT01686750|sexually transmitted infections|sexually transmitted infections
440493|NCT01686750|community viral load|community viral load
440494|NCT01686750|antiretroviral therapy|antiretroviral therapy
440495|NCT01686724|Attention Deficit Hyperactivity Disorder|attention deficit hyperactivity disorder
440496|NCT01686724|Psychosocial Intervention|psychosocial intervention
440497|NCT01686724|Behavioral Intervention|behavioral intervention
440498|NCT01686724|School-home collaborative intervention|school-home collaborative intervention
440499|NCT01686698|cirrhosis, VSL#3, cognitive function, falls, quality of life|cirrhosis, vsl#3, cognitive function, falls, quality of life
440500|NCT01686685|ASD|asd
440501|NCT01686685|autism|autism
440502|NCT01686685|prematurity|prematurity
440503|NCT01686685|oxygen-dependant gene activation|oxygen-dependant gene activation
440504|NCT01686685|CXCR4|cxcr4
440505|NCT01686685|Language delay|language delay
440506|NCT01686685|Cognitive delay|cognitive delay
440507|NCT01686672|Cystic Fibrosis|cystic fibrosis
440508|NCT01686672|Behavioral Intervention|behavioral intervention
440509|NCT01686672|Children|children
440510|NCT01686659|Transfusion|transfusion
440511|NCT01686659|Continuous Hemoglobin Monitoring|continuous hemoglobin monitoring
440512|NCT01686659|SpHb|sphb
440513|NCT01686646|alertness|alertness
440514|NCT01686633|asthma|asthma
440515|NCT01686633|pharmacogenetics|pharmacogenetics
440516|NCT01686633|adult|adult
440517|NCT01686633|vilanterol|vilanterol
440518|NCT01686633|adolescents|adolescents
440519|NCT01686633|fluticasone furoate|fluticasone furoate
440520|NCT01686620|Mealtime insulin|mealtime insulin
440521|NCT01686620|Ultra-rapid acting insulin|ultra-rapid acting insulin
440522|NCT01686620|Prandial insulin|prandial insulin
440523|NCT01686607|Hepatic toxicity|hepatic toxicity
440524|NCT01686607|Renal toxicity|renal toxicity
440525|NCT01686607|Micafungin|micafungin
440526|NCT01686607|Hepatocellular carcinoma|hepatocellular carcinoma
440527|NCT01686607|Antifungals (parenteral)|antifungals (parenteral)
440528|NCT01686594|Mycosis fungoides|mycosis fungoides
440529|NCT01686594|Psoralen and UVA (PUVA)|psoralen and uva (puva)
440530|NCT01686594|Photochemotherapy|photochemotherapy
440531|NCT01686594|Maintenance treatment|maintenance treatment
440532|NCT01686594|Immune function|immune function
440533|NCT01686542|atrial fibrillation|atrial fibrillation
440534|NCT01686529|Pterygium|pterygium
440535|NCT01686529|bevacizumab|bevacizumab
440536|NCT01686529|autoconjunctival graft|autoconjunctival graft
440537|NCT01686516|age|age
440538|NCT01686516|microstructure|microstructure
440539|NCT01686516|diffusion MRI|diffusion mri
440540|NCT01686490|AICD|aicd
440541|NCT01686490|focus groups|focus groups
440542|NCT01686490|cognitive-behavioral video/workbook training|cognitive-behavioral video/workbook training
440543|NCT01686490|pre-implant concern/distress about upcoming AICD|pre-implant concern/distress about upcoming aicd
440544|NCT01686464|magnetic|magnetic
440545|NCT01686464|oxygen|oxygen
440546|NCT01686464|Bell's Palsy|bell's palsy
440547|NCT01686464|acupuncture|acupuncture
440548|NCT01686438|cost effectiveness|cost effectiveness
440549|NCT01686438|patient satisfaction|patient satisfaction
440550|NCT01686425|Cholestasis|cholestasis
440551|NCT01686425|Malignancy|malignancy
440552|NCT01686425|ERCP|ercp
440553|NCT01686425|PTC|ptc
440554|NCT01686425|EUS-BD|eus-bd
440555|NCT01686412|Breast Cancer|breast cancer
440556|NCT01686412|Hepatocellular carcinoma|hepatocellular carcinoma
440557|NCT01686399|Sustainable diet|sustainable diet
440558|NCT01686399|Health promotion|health promotion
440559|NCT01686399|Obesity|obesity
440560|NCT01686386|Relapsed|relapsed
440561|NCT01686386|Multiple Myeloma|multiple myeloma
440562|NCT01686386|Lenalidomide|lenalidomide
440563|NCT01686386|Bendamustine|bendamustine
440564|NCT01686373|Aphasia|aphasia
440565|NCT01686373|Brain|brain
440566|NCT01686373|Stimulation|stimulation
440567|NCT01686373|Communication|communication
440568|NCT01686373|Stoke|stoke
440569|NCT01686373|Post|post
440570|NCT01686373|Phase II Clinical Trial|phase ii clinical trial
440571|NCT01686373|Treatment|treatment
440572|NCT01686373|tDCS|tdcs
440573|NCT01686373|Fridriksson|fridriksson
440574|NCT01686347|epidural analgesia|epidural analgesia
440575|NCT01686347|fetal cardiac rythm|fetal cardiac rythm
440576|NCT01686347|ropivacaine|ropivacaine
440577|NCT01686347|sufentanil|sufentanil
440578|NCT01686334|in complete remission|in complete remission
440579|NCT01686334|Adult (>18 years) at very high risk of relapse|adult (>18 years) at very high risk of relapse
440580|NCT01686321|elderly patients|elderly patients
440581|NCT01686321|bendamustine|bendamustine
440582|NCT01686308|cataract|cataract
440583|NCT01686308|circadian rhythm|circadian rhythm
440584|NCT01686308|pupillometry|pupillometry
440585|NCT01686308|blue light transmission|blue light transmission
440586|NCT01686308|questionnaire|questionnaire
440587|NCT01686308|sleep|sleep
440588|NCT01686295|androgenetic alopecia|androgenetic alopecia
440589|NCT01686295|Baldness|baldness
440590|NCT01686282|Blood pressure|blood pressure
440591|NCT01686282|Arterial Stiffness|arterial stiffness
440592|NCT01686282|Blueberry Supplementation|blueberry supplementation
440593|NCT01686282|Aortic Blood Pressure|aortic blood pressure
440594|NCT01686282|Hypertension|hypertension
440595|NCT01686282|Postmenopausal|postmenopausal
440596|NCT01686282|Pulse Wave Velocity|pulse wave velocity
440597|NCT01686269|Endothelial progenitor cell|endothelial progenitor cell
440598|NCT01686269|coronary artery bypass|coronary artery bypass
440599|NCT01686256|Ovarian Cancer|ovarian cancer
440600|NCT01686256|Endometrial Cancer|endometrial cancer
440601|NCT01686243|epidural|epidural
440602|NCT01686230|acupuncture|acupuncture
440603|NCT01686230|Angina|angina
440604|NCT01686230|Stable Angina Pectoris|stable angina pectoris
440605|NCT01686217|ASP015K Extended Release|asp015k extended release
440606|NCT01686217|ASP015K Immediate Release|asp015k immediate release
440607|NCT01686217|Food Effect|food effect
440608|NCT01686217|Healthy Volunteers|healthy volunteers
440609|NCT01686204|Yogurt|yogurt
440611|NCT01686204|Inflammation|inflammation
440612|NCT01686204|Obese|obese
440613|NCT01686191|heart transplantation|heart transplantation
440614|NCT01686191|chronic renal insufficiency|chronic renal insufficiency
440615|NCT01686191|pharmacogenomics|pharmacogenomics
440616|NCT01686191|cyclosporine|cyclosporine
440617|NCT01686191|tacrolimus|tacrolimus
440618|NCT01686178|Smoking|smoking
440619|NCT01686178|Smoking Cessation|smoking cessation
440620|NCT01686178|Tobacco Use Cessation|tobacco use cessation
440621|NCT01686178|Social Networks|social networks
440622|NCT01686178|Social Control, Informal|social control, informal
440623|NCT01686139|Diabetic mellitus|diabetic mellitus
440624|NCT01686139|Diabetic foot ulcers|diabetic foot ulcers
440625|NCT01686139|Ischemic Limb|ischemic limb
440626|NCT01686126|endometrial hyperplasia|endometrial hyperplasia
440627|NCT01686126|endometrial adenocarcinoma|endometrial adenocarcinoma
440628|NCT01686126|Gynecological Cancer|gynecological cancer
440629|NCT01686113|Taste|taste
440630|NCT01686113|Fat Taste|fat taste
440631|NCT01686113|Threshold Testing|threshold testing
440632|NCT01686100|Coronary artery bypass grafting|coronary artery bypass grafting
440633|NCT01686100|Saphenous vein grafts|saphenous vein grafts
440634|NCT01686074|Motor control|motor control
440635|NCT01686074|walking|walking
440636|NCT01686074|physical activity|physical activity
440637|NCT01686074|Muscle activity|muscle activity
440638|NCT01686022|Grass|grass
440639|NCT01686022|Major allergen|major allergen
440640|NCT01686022|cross-reactivity|cross-reactivity
440641|NCT01686009|pain|pain
440642|NCT01686009|analgesia|analgesia
440643|NCT01686009|ketamine|ketamine
440644|NCT01686009|intranasal|intranasal
440645|NCT01686009|emergency|emergency
440646|NCT01685996|tobacco|tobacco
440647|NCT01685996|smoking cessation|smoking cessation
440648|NCT01685996|nicotine|nicotine
440649|NCT01685996|cigarettes|cigarettes
440650|NCT01685996|nicotine withdrawal|nicotine withdrawal
440651|NCT01685983|Prostate Cancer|prostate cancer
440652|NCT01685983|Metastatic-castration resistant prostate cancer|metastatic-castration resistant prostate cancer
440653|NCT01685983|Prostate specific antigen|prostate specific antigen
440654|NCT01685983|Abiraterone acetate|abiraterone acetate
440655|NCT01685983|JNJ-212082|jnj-212082
440656|NCT01685983|Abiraterone|abiraterone
440657|NCT01685983|Prednisolone|prednisolone
440658|NCT01685983|Androgen Deprivation|androgen deprivation
440659|NCT01685983|Docetaxel-based chemotherapy|docetaxel-based chemotherapy
440660|NCT01685970|Bowel preparation|bowel preparation
440661|NCT01685970|colonoscopy|colonoscopy
440662|NCT01685970|polyethylene glycol|polyethylene glycol
440663|NCT01685970|picosulfate|picosulfate
440664|NCT01685957|Weight loss|weight loss
440665|NCT01685957|Dietary intervention|dietary intervention
440666|NCT01685957|Self-help book|self-help book
440667|NCT01685957|Cooking|cooking
440668|NCT01685957|Dietitian|dietitian
440669|NCT01685957|Dietary therapy|dietary therapy
440670|NCT01685931|Schizophrenia|schizophrenia
440671|NCT01685931|Paliperidone Palmitate|paliperidone palmitate
440672|NCT01685931|Oral Antipsychotics|oral antipsychotics
440673|NCT01685931|Invega Sustenna|invega sustenna
440674|NCT01685918|Rheumatoid arthritis|rheumatoid arthritis
440675|NCT01685918|aged|aged
440676|NCT01685905|rheumatic disease, latent tuberculosis|rheumatic disease, latent tuberculosis
440677|NCT01685879|postprandial glycemic response|postprandial glycemic response
440678|NCT01685879|postprandial insulin response|postprandial insulin response
440679|NCT01685879|rice|rice
440680|NCT01685879|appetite|appetite
440681|NCT01685879|hunger|hunger
440682|NCT01685866|anesthesia|anesthesia
440683|NCT01685866|venous access|venous access
440684|NCT01685840|Heart Failure|heart failure
440685|NCT01685814|multiple myeloma|multiple myeloma
440686|NCT01685814|autologous stem cell transplant|autologous stem cell transplant
440687|NCT01685814|allogeneic stem cell transplant|allogeneic stem cell transplant
440688|NCT01685814|lenalidomide|lenalidomide
440689|NCT01685814|bortezomib|bortezomib
440690|NCT01685775|Gallbladder|gallbladder
440691|NCT01685775|cholecystectomy|cholecystectomy
440692|NCT01685775|NOTES|notes
440693|NCT01685775|natural orifice transluminal endoscopic surgery|natural orifice transluminal endoscopic surgery
440694|NCT01685775|gallstone|gallstone
440695|NCT01685762|Endometrial hyperplasia|endometrial hyperplasia
440696|NCT01685762|Uterus|uterus
440697|NCT01685762|Pilot|pilot
440698|NCT01685762|Metformin|metformin
440699|NCT01685723|Cancer patients|cancer patients
440700|NCT01685723|Smoking cessation|smoking cessation
440701|NCT01685723|Risk communication|risk communication
440702|NCT01685710|Arteriovenous fistula|arteriovenous fistula
440703|NCT01685710|Patency|patency
440704|NCT01685710|GTN patch|gtn patch
440705|NCT01685684|Low back pain|low back pain
440706|NCT01685684|Chronic back pain|chronic back pain
440707|NCT01685684|Back pain|back pain
440708|NCT01685684|Opioid|opioid
440709|NCT01685684|Oxycodone|oxycodone
440710|NCT01685684|DETERx|deterx
440711|NCT01685684|Chronic pain|chronic pain
440712|NCT01685684|Chronic low back pain|chronic low back pain
440713|NCT01685684|CLBP|clbp
440714|NCT01685684|Xtampza|xtampza
440715|NCT01685671|CKD-11101|ckd-11101
440716|NCT01685671|NESP|nesp
440717|NCT01685671|Darbepoetin alfa|darbepoetin alfa
440718|NCT01685671|Anemia|anemia
440719|NCT01685671|subcutaneous|subcutaneous
440720|NCT01685671|Pharmacokinetics|pharmacokinetics
440721|NCT01685671|Phase 1|phase 1
440722|NCT01685632|intra peritonal chemo hyperthermia|intra peritonal chemo hyperthermia
440723|NCT01685632|peritoneal carcinomatosis|peritoneal carcinomatosis
440724|NCT01685632|colorectal cancer|colorectal cancer
440725|NCT01685632|ovarian cancer|ovarian cancer
440727|NCT01685619|Acute Myeloid Leukemia|acute myeloid leukemia
440728|NCT01685619|MDS|mds
440729|NCT01685619|Myelodysplastic Syndrome|myelodysplastic syndrome
440730|NCT01685619|Prognostic|prognostic
440731|NCT01685619|Economic|economic
440732|NCT01685606|Leukemia|leukemia
440733|NCT01685606|Lymphoma|lymphoma
440734|NCT01685606|Mantle cell|mantle cell
440735|NCT01685606|DLBCL|dlbcl
440736|NCT01685606|DLBC|dlbc
440737|NCT01685606|Diffuse large B cell|diffuse large b cell
440738|NCT01685606|T cell|t cell
440739|NCT01685606|AML|aml
440740|NCT01685606|ALL|all
440741|NCT01685593|abdominal binder|abdominal binder
440742|NCT01685580|primary lung cancer|primary lung cancer
440743|NCT01685580|lobectomy|lobectomy
440744|NCT01685580|pneumonectomy|pneumonectomy
440745|NCT01685580|non-invasive ventilation|non-invasive ventilation
440746|NCT01685567|carotid artery disease|carotid artery disease
440747|NCT01685567|reverse flow|reverse flow
440748|NCT01685554|perfusion|perfusion
440749|NCT01685554|cardiopulmonary bypass|cardiopulmonary bypass
440750|NCT01685554|hypothermia|hypothermia
440751|NCT01685554|cerebral oxygenation|cerebral oxygenation
440752|NCT01685528|Anxiety|anxiety
440753|NCT01685528|Depression|depression
440754|NCT01685528|Geriatric|geriatric
440755|NCT01685528|Veteran|veteran
440756|NCT01685502|Glucobay OD|glucobay od
440757|NCT01685502|Diabetes Mellitus|diabetes mellitus
440758|NCT01685489|Prostate|prostate
440759|NCT01685489|Neoplasm|neoplasm
440760|NCT01685489|Adenocarcinoma|adenocarcinoma
440761|NCT01685489|Cancer|cancer
440762|NCT01685489|Metastatic|metastatic
440763|NCT01685489|Castrate resistant|castrate resistant
440764|NCT01685489|Docetaxel|docetaxel
440765|NCT01685489|PSK|psk
440766|NCT01685489|Krestin|krestin
440767|NCT01685489|Trametes versicolor|trametes versicolor
440768|NCT01685489|Safety|safety
440769|NCT01685489|Maximum tolerated dose|maximum tolerated dose
440770|NCT01685489|Mushroom|mushroom
440771|NCT01685489|Natural|natural
440772|NCT01685489|Immunotherapy|immunotherapy
440773|NCT01685476|Cochlear microphonic potential|cochlear microphonic potential
440774|NCT01685476|non invasive method|non invasive method
440775|NCT01685476|indirect monitoring|indirect monitoring
440776|NCT01685476|intracranial pressure|intracranial pressure
440777|NCT01685463|methamphetamine, craving, TMS, cortical excitability, prefrontal cortex|methamphetamine, craving, tms, cortical excitability, prefrontal cortex
563124|NCT01165801|AMD|amd
440778|NCT01685450|Cochlear microphonic potential|cochlear microphonic potential
440779|NCT01685450|non invasive method|non invasive method
440780|NCT01685450|indirect measurement|indirect measurement
440781|NCT01685450|intracranial pressure|intracranial pressure
440782|NCT01685450|adults|adults
440783|NCT01685437|Peyronie's disease, penile plaque, penile curvature|peyronie's disease, penile plaque, penile curvature
440784|NCT01685424|Etoricoxib|etoricoxib
440785|NCT01685424|ARCOXIA|arcoxia
440786|NCT01685424|Osteoarthritis|osteoarthritis
440787|NCT01685424|Rheumatoid Arthritis|rheumatoid arthritis
440788|NCT01685424|Ankylosing Spondylitis|ankylosing spondylitis
440789|NCT01685424|Gout|gout
440790|NCT01685424|Arthritis|arthritis
440791|NCT01685385|Dyspnoea|dyspnoea
440792|NCT01685385|BNP|bnp
440793|NCT01685385|Chronic heart failure|chronic heart failure
440794|NCT01685385|congestive heart failure|congestive heart failure
440795|NCT01685346|advanced (stage IV) non-small cell lung cancer (NSCLC)|advanced (stage iv) non-small cell lung cancer (nsclc)
440796|NCT01685346|biofeedback-mediated stress management (BFSM)|biofeedback-mediated stress management (bfsm)
440797|NCT01685333|subject|subject
440798|NCT01685320|Force|force
440799|NCT01685320|Pressure|pressure
440800|NCT01685320|Intubation|intubation
440801|NCT01685320|laryngoscopy|laryngoscopy
440802|NCT01685307|ileal digestibility|ileal digestibility
440803|NCT01685307|metabolism|metabolism
440804|NCT01685307|stable isotopes|stable isotopes
440805|NCT01685294|Major Depressive Disorder (MDD)|major depressive disorder (mdd)
440806|NCT01685294|Suicidality|suicidality
440807|NCT01685294|Incarcerated Populations|incarcerated populations
440808|NCT01685294|Prisons|prisons
440809|NCT01685294|Interpersonal Psychotherapy (IPT)|interpersonal psychotherapy (ipt)
440810|NCT01685281|ADHD , Inattention|adhd , inattention
440811|NCT01685268|Prostate Cancer|prostate cancer
440812|NCT01685255|FIGO Stage III or IV EOC|figo stage iii or iv eoc
440813|NCT01685255|PPC FTC|ppc ftc
440814|NCT01685255|increasing CA 125|increasing ca 125
440815|NCT01685216|VPRIV|vpriv
440816|NCT01685216|velaglucerase alfa|velaglucerase alfa
440817|NCT01685203|Hepatitis C Virus|hepatitis c virus
440818|NCT01685203|Ribavirin-Free|ribavirin-free
440819|NCT01685203|Hepatitis C Genotype 1|hepatitis c genotype 1
440820|NCT01685203|Hepatitis C|hepatitis c
440821|NCT01685203|Interferon-Free|interferon-free
440822|NCT01685203|Chronic Hepatitis C|chronic hepatitis c
440823|NCT01685203|Compensated cirrhosis|compensated cirrhosis
440824|NCT01685203|Hepatitis C Genotype 4|hepatitis c genotype 4
440825|NCT01685203|Paritaprevir|paritaprevir
440826|NCT01685203|Ombitasvir|ombitasvir
440827|NCT01685203|Ritonavir|ritonavir
440828|NCT01685203|Ribavirin|ribavirin
440829|NCT01685177|Morbid obesity|morbid obesity
440830|NCT01685177|Sleeve gastrectomy|sleeve gastrectomy
440831|NCT01685177|Duodenal Switch|duodenal switch
440832|NCT01685177|SADI-S|sadi-s
440833|NCT01685164|nulliparous|nulliparous
440834|NCT01685164|IUD|iud
440835|NCT01685164|IUS|ius
440836|NCT01685164|insertion|insertion
440837|NCT01685164|expulsion|expulsion
440838|NCT01685151|Drug therapy|drug therapy
440839|NCT01685138|Non-Small Cell Lung Cancer|non-small cell lung cancer
440840|NCT01685138|Non small cell lung carcinoma|non small cell lung carcinoma
440841|NCT01685138|NSCLC|nsclc
440842|NCT01685138|ALK|alk
440843|NCT01685138|LDK378|ldk378
440844|NCT01685138|Ceritinib|ceritinib
440845|NCT01685138|crizotinib naïve adult patients|crizotinib naïve adult patients
440846|NCT01685138|ALK-activated non-small cell lung cancer|alk-activated non-small cell lung cancer
440847|NCT01685138|treatment of lung cancer after first metastasis|treatment of lung cancer after first metastasis
440848|NCT01685138|lung cancer|lung cancer
440849|NCT01685138|lung adenocarcinoma|lung adenocarcinoma
440850|NCT01685112|adults|adults
440851|NCT01685112|ECMO|ecmo
440852|NCT01685099|diagnosis, inflammation-associated markers, pleural effusion, tuberculosis, tuberculous pleurisy|diagnosis, inflammation-associated markers, pleural effusion, tuberculosis, tuberculous pleurisy
440853|NCT01685086|latent tuberculosis infection, tuberculosis, chronic kidney disease, peritoneal dialysis, hemodialysis|latent tuberculosis infection, tuberculosis, chronic kidney disease, peritoneal dialysis, hemodialysis
440854|NCT01685073|marijuana|marijuana
440855|NCT01685073|cannabis|cannabis
440856|NCT01685073|treatment|treatment
440857|NCT01685073|insomnia|insomnia
440858|NCT01685073|relapse|relapse
440859|NCT01685060|Non-Small Cell Lung Cancer|non-small cell lung cancer
440860|NCT01685060|NSCLC|nsclc
440861|NCT01685060|ALK|alk
440862|NCT01685060|LDK378|ldk378
440863|NCT01685060|Ceritinib|ceritinib
440864|NCT01685047|Coronary Artery Disease|coronary artery disease
440865|NCT01685047|Ventricular Arrhythmias|ventricular arrhythmias
440866|NCT01685047|ST Segment Changes|st segment changes
440867|NCT01685034|Eosinophilic esophagitis|eosinophilic esophagitis
440868|NCT01685034|Environmental allergens|environmental allergens
440869|NCT01685034|Allergy immunotherapy|allergy immunotherapy
440870|NCT01685034|Tolerance|tolerance
440871|NCT01685034|Allergic rhinitis|allergic rhinitis
440872|NCT01685034|Asthma|asthma
563226|NCT01165203|HIV|hiv
440873|NCT01685034|Seasonal variation|seasonal variation
440874|NCT01685021|B-ALL|b-all
440875|NCT01685021|CD19|cd19
440876|NCT01685021|MOR208|mor208
440877|NCT01685021|MOR00208|mor00208
440878|NCT01685021|Xmab5574|xmab5574
440879|NCT01685021|B-cell acute lymphoblastic leukemia|b-cell acute lymphoblastic leukemia
440880|NCT01685021|Fc-optimized Anti-CD19 Antibody|fc-optimized anti-cd19 antibody
440881|NCT01685008|NHL|nhl
440882|NCT01685008|CD19|cd19
440883|NCT01685008|MOR208|mor208
440884|NCT01685008|MOR00208|mor00208
440885|NCT01685008|Xmab5574|xmab5574
440886|NCT01685008|B-Cell Non-Hodgkin´s Lymphoma|b-cell non-hodgkin´s lymphoma
440887|NCT01685008|Fc-optimized Anti-CD19 Antibody|fc-optimized anti-cd19 antibody
440888|NCT01685008|Tafasitamab|tafasitamab
440889|NCT01684982|Primary PCI|primary pci
440890|NCT01684982|Drug Eluting Stent|drug eluting stent
440891|NCT01684969|Nausea|nausea
440892|NCT01684969|vomiting|vomiting
440893|NCT01684969|gastrointestinal symptoms|gastrointestinal symptoms
440894|NCT01684969|palliative care|palliative care
440895|NCT01684956|intradermal|intradermal
440896|NCT01684956|pharmacokinetics|pharmacokinetics
440897|NCT01684956|microneedle|microneedle
440898|NCT01684956|insulin|insulin
440899|NCT01684956|glucagon|glucagon
440900|NCT01684943|Pharmacokinetics|pharmacokinetics
440901|NCT01684930|Cardiovascular Diseases|cardiovascular diseases
440902|NCT01684930|Vascular Diseases|vascular diseases
440903|NCT01684930|Arterial Occlusive Diseases|arterial occlusive diseases
440904|NCT01684930|Exercise|exercise
440905|NCT01684930|Functional Capacity|functional capacity
440906|NCT01684852|dry eye, sicca, HA, Hyaluronic Acid, ectoin, ectoine, bitop|dry eye, sicca, ha, hyaluronic acid, ectoin, ectoine, bitop
440907|NCT01684839|Painful digital neuroma|painful digital neuroma
440908|NCT01684839|nerve defect|nerve defect
440909|NCT01684839|dorsal branch of the digital nerve|dorsal branch of the digital nerve
440910|NCT01684839|digital nerve|digital nerve
440911|NCT01684839|pedicled nerve flap|pedicled nerve flap
440912|NCT01684839|Pain Disorder Associated with Psychological and Physical Factors|pain disorder associated with psychological and physical factors
440913|NCT01684826|X-rays|x-rays
440914|NCT01684826|Image processing|image processing
440915|NCT01684826|Cardiovascular procedure|cardiovascular procedure
440916|NCT01684813|Diabetes mellitus.|diabetes mellitus.
440917|NCT01684813|Acute coronary syndrome.|acute coronary syndrome.
440918|NCT01684813|Percutaneous coronary intervention.|percutaneous coronary intervention.
440919|NCT01684787|chronic hepatitis C|chronic hepatitis c
440920|NCT01684787|normal ALT|normal alt
440921|NCT01684787|HIV/HCV patients|hiv/hcv patients
440922|NCT01684761|Multicenter Study|multicenter study
440923|NCT01684761|Randomized Controlled Trial|randomized controlled trial
440924|NCT01684761|Individualized Medicine|individualized medicine
440925|NCT01684761|Immunotherapy|immunotherapy
440926|NCT01684761|Myelin Proteins|myelin proteins
440927|NCT01684761|Biological Agents|biological agents
440928|NCT01684748|angiotensin II|angiotensin ii
440929|NCT01684748|obesity|obesity
440930|NCT01684748|diabetes|diabetes
440931|NCT01684735|diffusion-weighted magnetic resonance imaging|diffusion-weighted magnetic resonance imaging
440932|NCT01684722|vitamin D3|vitamin d3
440933|NCT01684722|omega-3 fatty acids|omega-3 fatty acids
440934|NCT01684722|fish oil|fish oil
440935|NCT01684722|diabetes|diabetes
440936|NCT01684722|kidney disease|kidney disease
440937|NCT01684722|albuminuria|albuminuria
440938|NCT01684722|urine albumin excretion|urine albumin excretion
440939|NCT01684722|glomerular filtration rate|glomerular filtration rate
440940|NCT01684722|diabetic kidney disease|diabetic kidney disease
440941|NCT01684709|Type 2 Diabetes|type 2 diabetes
440942|NCT01684709|Informal Caregivers|informal caregivers
440943|NCT01684709|Self Care|self care
440944|NCT01684709|Quality of Life|quality of life
440945|NCT01684709|Health Information Technology|health information technology
440946|NCT01684696|Lung cancer|lung cancer
440947|NCT01684696|stigma|stigma
440948|NCT01684696|virtual intervention|virtual intervention
440949|NCT01684696|mHealth|mhealth
440950|NCT01684683|Bronchiectasis|bronchiectasis
440951|NCT01684683|Theophylline|theophylline
440952|NCT01684683|Therapeutic Uses|therapeutic uses
440953|NCT01684683|HDAC|hdac
440954|NCT01684683|HAT|hat
440955|NCT01684683|Random placebo study|random placebo study
440956|NCT01684657|Stuttering|stuttering
440957|NCT01684644|ADHD|adhd
440958|NCT01684644|Parent Training|parent training
440959|NCT01684644|RCT|rct
440960|NCT01684644|Preschool|preschool
440961|NCT01684618|Preterm|preterm
440962|NCT01684618|Neonate|neonate
440963|NCT01684618|Newborn|newborn
440964|NCT01684618|Cerebral oxygenation|cerebral oxygenation
440965|NCT01684618|CPAP|cpap
440966|NCT01684605|CKD-11101|ckd-11101
440967|NCT01684605|NESP|nesp
440968|NCT01684605|Darbepoetin alfa|darbepoetin alfa
440969|NCT01684605|Anemia|anemia
440970|NCT01684605|intravenous|intravenous
440971|NCT01684605|Pharmacokinetics|pharmacokinetics
440972|NCT01684605|Phase 1|phase 1
563391|NCT01164449|ICU|icu
440973|NCT01684592|smoking cessation|smoking cessation
440974|NCT01684592|relapse prevention|relapse prevention
440975|NCT01684592|pregnancy|pregnancy
440976|NCT01684592|postpartum|postpartum
440977|NCT01684579|Breast Cancer|breast cancer
440978|NCT01684579|African-American Women|african-american women
440979|NCT01684579|Aerobic Exercise|aerobic exercise
440980|NCT01684553|Eating speed|eating speed
440981|NCT01684553|energy intake|energy intake
440982|NCT01684540|sinusitis, rhinosinusitis, ectoin, ectoine, bitop, SNS, SNS01|sinusitis, rhinosinusitis, ectoin, ectoine, bitop, sns, sns01
440983|NCT01684514|confocal laser endomicroscopy|confocal laser endomicroscopy
440984|NCT01684514|inflammatory bowel disease|inflammatory bowel disease
440985|NCT01684514|colitis, ulcerative|colitis, ulcerative
440986|NCT01684501|prosthesis|prosthesis
440987|NCT01684501|amputees|amputees
440988|NCT01684501|gait|gait
440989|NCT01684488|Depression/therapy;|depression/therapy;
440990|NCT01684488|Developing Countries;|developing countries;
440991|NCT01684488|Interpersonal Relations;|interpersonal relations;
440992|NCT01684488|Life Change Events;|life change events;
440993|NCT01684488|Psychotherapy, Group;|psychotherapy, group;
440994|NCT01684488|Resilience, Psychological;|resilience, psychological;
440995|NCT01684488|Sierra Leone;|sierra leone;
440996|NCT01684488|Survivors/psychology;|survivors/psychology;
440997|NCT01684488|Social Adjustment;|social adjustment;
440998|NCT01684488|Social Behavior;|social behavior;
440999|NCT01684488|War|war
441000|NCT01684475|Novel Treatment Parkinson's disease|novel treatment parkinson's disease
441001|NCT01684462|Acute Ischemic Stroke|acute ischemic stroke
441002|NCT01684462|Albumin|albumin
441003|NCT01684449|Soft tissue sarcoma|soft tissue sarcoma
441004|NCT01684449|Gemcitabine|gemcitabine
441005|NCT01684449|Rapamycin|rapamycin
441006|NCT01684449|Sirolimus|sirolimus
441007|NCT01684449|mTOR inhibitor|mtor inhibitor
441008|NCT01684449|Molecular biomarkers|molecular biomarkers
441009|NCT01684410|Cystic Fibrosis|cystic fibrosis
441010|NCT01684410|Alpha1-proteinase inhibitor|alpha1-proteinase inhibitor
441011|NCT01684410|Alpha1-antitrypsin|alpha1-antitrypsin
441012|NCT01684384|Pulmonary Disease, Chronic Obstructive|pulmonary disease, chronic obstructive
441013|NCT01684384|COPD|copd
441014|NCT01684384|Exacerbation|exacerbation
441015|NCT01684384|Functional Respiratory Imaging|functional respiratory imaging
441016|NCT01684384|High Resolution Computed Tomography|high resolution computed tomography
441017|NCT01684384|HRCT scan|hrct scan
441018|NCT01684384|Patient Reported Outcome|patient reported outcome
441020|NCT01684384|Computational Fluid Dynamic|computational fluid dynamic
441021|NCT01684384|CFD|cfd
441022|NCT01684384|Lung function parameters|lung function parameters
441023|NCT01684371|Osteoarthritis|osteoarthritis
441024|NCT01684371|Osteoarthritic pain|osteoarthritic pain
441025|NCT01684371|Arthritic pain|arthritic pain
441026|NCT01684371|Arthritis|arthritis
441027|NCT01684371|joint inflammation|joint inflammation
441028|NCT01684371|Arthralgia|arthralgia
441029|NCT01684358|Prostate-specific antigen|prostate-specific antigen
441030|NCT01684358|Contraceptive implant|contraceptive implant
441031|NCT01684358|Biological marker|biological marker
441032|NCT01684358|Condoms|condoms
441033|NCT01684358|Women|women
441034|NCT01684345|Uveitis|uveitis
441035|NCT01684345|Non-infectious Uveitis|non-infectious uveitis
441036|NCT01684345|Intermediate Uveitis|intermediate uveitis
441037|NCT01684345|Posterior Uveitis|posterior uveitis
441038|NCT01684345|Panuveitis|panuveitis
441039|NCT01684332|Antioxidant|antioxidant
441040|NCT01684332|glucose metabolism|glucose metabolism
441041|NCT01684332|jam|jam
441042|NCT01684332|polyphenols|polyphenols
441043|NCT01684332|postprandial|postprandial
441044|NCT01684332|strawberry|strawberry
441045|NCT01684319|Constipation|constipation
441046|NCT01684319|Gastroeosphageal reflux|gastroeosphageal reflux
441047|NCT01684319|Colics|colics
441048|NCT01684306|RsfMRI, brain plasticity, cognitive enhancer|rsfmri, brain plasticity, cognitive enhancer
441049|NCT01684293|Cocaine|cocaine
441050|NCT01684293|Cognitive Impairment|cognitive impairment
441051|NCT01684293|Cognitive Rehabilitation|cognitive rehabilitation
441052|NCT01684280|abdominal adipose tissue; microRNA|abdominal adipose tissue; microrna
441053|NCT01684267|Stroke|stroke
441054|NCT01684267|Gait|gait
441055|NCT01684267|Rehabilitation|rehabilitation
441056|NCT01684254|Cerebral Palsy|cerebral palsy
441057|NCT01684254|Home monitoring|home monitoring
441058|NCT01684254|Gait|gait
441059|NCT01684254|Sensorized Shoe|sensorized shoe
441060|NCT01684241|Biontech|biontech
441061|NCT01684241|Biontech RNA Pharmaceuticals GmbH|biontech rna pharmaceuticals gmbh
441062|NCT01684241|Biontech RNA|biontech rna
441063|NCT01684241|MERIT|merit
441064|NCT01684241|RNA|rna
441065|NCT01684241|Immuno Therapy|immuno therapy
441066|NCT01684241|RB_0001-01|rb_0001-01
441067|NCT01684241|Ribological|ribological
441068|NCT01684241|Melanoma|melanoma
441069|NCT01684241|RBL001|rbl001
441070|NCT01684241|RBL002|rbl002
441071|NCT01684241|cancer vaccine|cancer vaccine
441072|NCT01684228|End stage renal disease|end stage renal disease
441073|NCT01684228|hemodialysis|hemodialysis
441074|NCT01684228|breath test|breath test
441075|NCT01684228|volatile organic compound|volatile organic compound
441076|NCT01684228|dialysis adequacy|dialysis adequacy
441077|NCT01684215|Phase 1/2|phase 1/2
441078|NCT01684215|PD-0332991|pd-0332991
441079|NCT01684215|palbociclib|palbociclib
441080|NCT01684215|Cyclin Dependent Kinase 4/6 inhibitor|cyclin dependent kinase 4/6 inhibitor
441081|NCT01684215|Japanese|japanese
441082|NCT01684215|solid tumors|solid tumors
441083|NCT01684215|breast cancer|breast cancer
441084|NCT01684215|A5481010|a5481010
441085|NCT01684176|Stroke|stroke
441086|NCT01684176|Ischemic Attack, Transient|ischemic attack, transient
441087|NCT01684176|Medication adherence|medication adherence
441088|NCT01684176|Motivational interviewing|motivational interviewing
441089|NCT01684176|Stroke prevention|stroke prevention
441090|NCT01684163|depression|depression
441091|NCT01684163|MDD|mdd
441092|NCT01684163|GLYX-13|glyx-13
441093|NCT01684163|HDRS-17|hdrs-17
441094|NCT01684163|HAMD-17|hamd-17
441095|NCT01684150|Leukemia|leukemia
441096|NCT01684150|Advanced hematologic malignancies|advanced hematologic malignancies
441097|NCT01684150|Epizyme|epizyme
441098|NCT01684150|Phase 1|phase 1
441099|NCT01684150|Mixed Lineage Leukemia (MLL)|mixed lineage leukemia (mll)
441100|NCT01684137|Food supplements|food supplements
441101|NCT01684137|Asthma bronchiale|asthma bronchiale
441102|NCT01684124|oxygen|oxygen
441103|NCT01684124|critical illness|critical illness
441104|NCT01684124|mechanical ventilation|mechanical ventilation
441105|NCT01684111|Non Small Cell Lung Cancer - Stage IV|non small cell lung cancer - stage iv
441106|NCT01684111|NSCLC Stage IV|nsclc stage iv
441107|NCT01684098|recurrent or metastatic cancer|recurrent or metastatic cancer
441108|NCT01684098|head and neck cancer|head and neck cancer
441109|NCT01684098|pancreas cancer|pancreas cancer
441110|NCT01684098|bladder cancer|bladder cancer
441111|NCT01684098|testicular cancer|testicular cancer
441112|NCT01684085|sleep deprivation, PTSD,prevention|sleep deprivation, ptsd,prevention
441113|NCT01684072|varicella vaccine|varicella vaccine
441114|NCT01684072|gelatin|gelatin
441115|NCT01684046|multi-purpose solution|multi-purpose solution
441116|NCT01684046|silicone hydrogel|silicone hydrogel
441117|NCT01684046|contact lenses|contact lenses
441118|NCT01684046|comfort|comfort
441119|NCT01684046|Opti-Free|opti-free
441120|NCT01684046|RevitaLens|revitalens
441121|NCT01684033|multi-purpose solution|multi-purpose solution
441122|NCT01684033|silicone hydrogel|silicone hydrogel
441123|NCT01684033|contact lenses|contact lenses
441124|NCT01684033|comfort|comfort
441125|NCT01684033|Opti-Free|opti-free
441126|NCT01684033|Biotrue|biotrue
441127|NCT01684020|rhinoplasty|rhinoplasty
441128|NCT01684020|external rhinoplasty|external rhinoplasty
441129|NCT01684020|open rhinoplasty|open rhinoplasty
441130|NCT01684020|nose job|nose job
441131|NCT01684007|Intraocular lens|intraocular lens
441132|NCT01684007|Multifocal intraocular lens (MIOL)|multifocal intraocular lens (miol)
441133|NCT01683994|Angiogenesis Inhibitors|angiogenesis inhibitors
441134|NCT01683994|Small Molecules|small molecules
441135|NCT01683994|Tyrosine Kinase Inhibitor|tyrosine kinase inhibitor
441136|NCT01683981|Idiopathic Pulmonary Arterial Hypertension|idiopathic pulmonary arterial hypertension
441137|NCT01683981|Eisenmenger Syndrome|eisenmenger syndrome
441138|NCT01683981|Exercise Capacity|exercise capacity
441139|NCT01683981|Quality of Life|quality of life
441140|NCT01683955|Tranexamic Acid|tranexamic acid
441141|NCT01683955|Blood transfusion|blood transfusion
441142|NCT01683955|Total hip arthroplasty|total hip arthroplasty
441143|NCT01683942|cup disc ratio measurement|cup disc ratio measurement
441144|NCT01683942|digital stereo optic disc images|digital stereo optic disc images
441145|NCT01683929|Obesity|obesity
441146|NCT01683929|Overweight|overweight
441147|NCT01683929|Sugar consumption|sugar consumption
441148|NCT01683929|Metabolic syndrome|metabolic syndrome
441149|NCT01683929|Artificially sweetened foods and beverages|artificially sweetened foods and beverages
441150|NCT01683916|spinal cord injury|spinal cord injury
441151|NCT01683916|stress hormone|stress hormone
441152|NCT01683916|surgery|surgery
441153|NCT01683916|bispectral index value|bispectral index value
441154|NCT01683916|volatile anesthetic|volatile anesthetic
441155|NCT01683903|heart failure|heart failure
441156|NCT01683903|cardiac rehabilitation|cardiac rehabilitation
441157|NCT01683903|myocardial infarction|myocardial infarction
441158|NCT01683890|Bladder symptoms|bladder symptoms
441159|NCT01683890|Sexual function|sexual function
441160|NCT01683890|Quality of life|quality of life
441161|NCT01683890|Simple hysterectomy|simple hysterectomy
441162|NCT01683851|pediatric|pediatric
441163|NCT01683851|conscious sedation|conscious sedation
441164|NCT01683851|mouthpiece|mouthpiece
441165|NCT01683851|airway|airway
441166|NCT01683851|isolite system|isolite system
441167|NCT01683838|spinal cord injury|spinal cord injury
441168|NCT01683838|muscle spasticity|muscle spasticity
441169|NCT01683825|Amyloidosis|amyloidosis
441170|NCT01683825|Cardiac|cardiac
441171|NCT01683825|Heart|heart
441172|NCT01683825|Imaging|imaging
441173|NCT01683825|Diagnosis|diagnosis
441174|NCT01683799|Osteoarthritis|osteoarthritis
441175|NCT01683799|Insomnia|insomnia
441176|NCT01683799|Chronic pain|chronic pain
441177|NCT01683799|Cognitive Behavioral Therapy for Insomnia|cognitive behavioral therapy for insomnia
441178|NCT01683799|Inflammation|inflammation
441179|NCT01683799|Inflammatory cytokines|inflammatory cytokines
441180|NCT01683773|Tuberculosis|tuberculosis
441181|NCT01683773|Phase I|phase i
441182|NCT01683773|MVA85A|mva85a
441183|NCT01683773|AERAS-402|aeras-402
441184|NCT01683760|Fluconazole|fluconazole
441185|NCT01683747|sepsis|sepsis
441186|NCT01683747|shock|shock
441187|NCT01683747|placebo controlled|placebo controlled
441188|NCT01683747|double blinded|double blinded
441189|NCT01683747|interventional|interventional
441190|NCT01683708|sepsis|sepsis
441191|NCT01683708|jaundice|jaundice
441192|NCT01683708|symbiotic|symbiotic
441193|NCT01683708|translocation|translocation
441194|NCT01683708|abdominal collection|abdominal collection
441195|NCT01683708|morbidity|morbidity
441196|NCT01683695|Lupus Arthritis, Systemic Lupus Erythematosus, AMG 557, Lupus|lupus arthritis, systemic lupus erythematosus, amg 557, lupus
441197|NCT01683682|Non-Small Lung Cancer|non-small lung cancer
441198|NCT01683682|NSCLC Stage IV|nsclc stage iv
441199|NCT01683669|ALI|ali
441200|NCT01683669|ARDS|ards
441201|NCT01683669|Noisy pressure support ventilation|noisy pressure support ventilation
441202|NCT01683656|HIV|hiv
441203|NCT01683656|Atherosclerosis|atherosclerosis
441204|NCT01683656|Niacin/laropiprant|niacin/laropiprant
441205|NCT01683656|HDL|hdl
441206|NCT01683630|Influenza|influenza
441207|NCT01683630|Influenza type A|influenza type a
441208|NCT01683630|Influenza type B|influenza type b
441209|NCT01683630|hospitalization|hospitalization
441210|NCT01683630|Manitoba|manitoba
441211|NCT01683630|Canada|canada
441212|NCT01683617|Psychological stress|psychological stress
441213|NCT01683591|Acute stroke|acute stroke
441214|NCT01683591|Dysphagia|dysphagia
441215|NCT01683591|High-resolution manometry|high-resolution manometry
441216|NCT01683578|mechanical ventilation|mechanical ventilation
441217|NCT01683578|lung function|lung function
441218|NCT01683578|abdominal surgery, open|abdominal surgery, open
441219|NCT01683578|systemic inflammation|systemic inflammation
441220|NCT01683552|ITCH|itch
441221|NCT01683539|Schizophrenia|schizophrenia
441222|NCT01683539|Chronic Mental Disorder|chronic mental disorder
441223|NCT01683539|Employment|employment
441224|NCT01683539|Cognitive remediation|cognitive remediation
441225|NCT01683539|Vocational rehabilitation|vocational rehabilitation
441226|NCT01683539|Brain-derived Neurotrophic Factor (BDNF)|brain-derived neurotrophic factor (bdnf)
441227|NCT01683526|Urgent endotrachel intubation|urgent endotrachel intubation
441228|NCT01683526|Direct laryngoscopy|direct laryngoscopy
441229|NCT01683526|Video laryngoscopy|video laryngoscopy
441230|NCT01683526|Glidescope|glidescope
441231|NCT01683526|Critical Care|critical care
441232|NCT01683513|OHSS|ohss
441233|NCT01683513|mataphase II oocytes (MII)|mataphase ii oocytes (mii)
441234|NCT01683513|good quality embryo's|good quality embryo's
441235|NCT01683513|pregnancy|pregnancy
441236|NCT01683474|aortic valve stenosis|aortic valve stenosis
441237|NCT01683474|Calcification|calcification
441238|NCT01683474|TAVI|tavi
441239|NCT01683474|aortic valve Prosthesis|aortic valve prosthesis
441240|NCT01683461|HIV|hiv
441241|NCT01683461|AIDS|aids
441242|NCT01683448|Perioperative medications|perioperative medications
441243|NCT01683448|cardiac surgery|cardiac surgery
441244|NCT01683448|outcomes|outcomes
441245|NCT01683396|Erosive Osteoarthritis|erosive osteoarthritis
441246|NCT01683396|Osteoarthritis|osteoarthritis
441247|NCT01683396|Osteoarthritis of the Hand|osteoarthritis of the hand
441248|NCT01683383|Hypoxic ischemic encephalopathy|hypoxic ischemic encephalopathy
441249|NCT01683383|Therapeutic hypothermia|therapeutic hypothermia
441250|NCT01683383|Whole body cooling|whole body cooling
441251|NCT01683383|Transport cooling|transport cooling
441252|NCT01683357|Liver Metastases|liver metastases
441253|NCT01683357|Surgery|surgery
441254|NCT01683357|Intraoperative Ultrasound|intraoperative ultrasound
441255|NCT01683331|Kidney transplant|kidney transplant
441256|NCT01683331|New onset diabetes|new onset diabetes
441257|NCT01683331|Prevention|prevention
441258|NCT01683331|Insulin|insulin
441259|NCT01683305|biomarker,|biomarker,
441260|NCT01683305|NAF|naf
441261|NCT01683305|Subjects|subjects
441262|NCT01683292|apomorphine|apomorphine
441263|NCT01683292|inhaled|inhaled
441264|NCT01683292|motor fluctuations|motor fluctuations
441265|NCT01683279|pediatric|pediatric
441266|NCT01683279|acute lymphoblastic leukemia|acute lymphoblastic leukemia
441267|NCT01683279|CD19|cd19
441268|NCT01683279|Chimeric Antigen Receptor|chimeric antigen receptor
441269|NCT01683240|cholangiography|cholangiography
441270|NCT01683240|cholangioscopy|cholangioscopy
441271|NCT01683240|mother-baby|mother-baby
441272|NCT01683240|cholangioscope|cholangioscope
441273|NCT01683240|Frimberger cholangioscope|frimberger cholangioscope
441274|NCT01683240|short access cholangioscopy|short access cholangioscopy
441275|NCT01683240|ERCP|ercp
441276|NCT01683240|gallstone therapy|gallstone therapy
441277|NCT01683227|drug use; emergency department; brief intervention|drug use; emergency department; brief intervention
441278|NCT01683201|Total hip replacement|total hip replacement
441279|NCT01683201|Functional exercise class|functional exercise class
441280|NCT01683201|Randomised controlled trial|randomised controlled trial
441281|NCT01683188|melanoma|melanoma
441282|NCT01683188|skin cancer|skin cancer
441283|NCT01683188|Stage IV|stage iv
441284|NCT01683175|Erlotinib|erlotinib
441285|NCT01683175|adjuvant therapy|adjuvant therapy
441286|NCT01683175|radical operation|radical operation
441287|NCT01683175|IIIA NSCLC|iiia nsclc
441288|NCT01683175|EGFR mutation|egfr mutation
441289|NCT01683162|parenteral nutrition|parenteral nutrition
441290|NCT01683162|lipid emulsion|lipid emulsion
441291|NCT01683162|olive oil|olive oil
441292|NCT01683162|liver function|liver function
441293|NCT01683162|fatty acid|fatty acid
441294|NCT01683162|clinical outcomes|clinical outcomes
441295|NCT01683149|Refractory|refractory
441296|NCT01683149|Relapsed|relapsed
441297|NCT01683149|Recurrent|recurrent
441298|NCT01683149|Pediatric|pediatric
441299|NCT01683149|Malignancy|malignancy
441300|NCT01683123|Allogeneic HSCT|allogeneic hsct
441301|NCT01683123|Busulfan|busulfan
441302|NCT01683123|Fludarabina|fludarabina
441303|NCT01683084|Abdominal Aortic Aneurysm|abdominal aortic aneurysm
441305|NCT01683084|telmisartan|telmisartan
441306|NCT01683071|Total knee arthroplasty|total knee arthroplasty
441307|NCT01683071|Analgesia|analgesia
441308|NCT01683071|Pain management|pain management
441309|NCT01683058|Schizophrenia|schizophrenia
441310|NCT01683045|non-paroxysmal atrial fibrillation|non-paroxysmal atrial fibrillation
441311|NCT01683045|persistent atrial fibrillation|persistent atrial fibrillation
441312|NCT01683045|atrial fibrillation|atrial fibrillation
441313|NCT01683045|heart palpitations|heart palpitations
441314|NCT01683045|irregular heart beat|irregular heart beat
441315|NCT01683045|temperature-controlled radiofrequency ablation|temperature-controlled radiofrequency ablation
441316|NCT01683045|radiofrequency energy|radiofrequency energy
441317|NCT01683045|TCRF energy|tcrf energy
441318|NCT01683045|RF energy|rf energy
441319|NCT01683045|epicardial and endocardial lesions|epicardial and endocardial lesions
441320|NCT01683045|concomitant heart surgery|concomitant heart surgery
441321|NCT01683045|surgical ablation|surgical ablation
441322|NCT01683019|Depression|depression
441323|NCT01683019|magnetic field|magnetic field
441324|NCT01683019|alpha frequency|alpha frequency
441325|NCT01683019|EEG|eeg
441326|NCT01683019|NeoSync EEG Synchronization Therapy|neosync eeg synchronization therapy
441327|NCT01682993|corneal cross linking|corneal cross linking
441328|NCT01682993|topography guided excimer laser|topography guided excimer laser
441329|NCT01682993|Keratoconus|keratoconus
441330|NCT01682993|Pellucid marginal degeneration|pellucid marginal degeneration
441331|NCT01682993|Post Excimer ectasia|post excimer ectasia
441332|NCT01682980|Osteoarthritis|osteoarthritis
441333|NCT01682980|Pain|pain
441334|NCT01682980|Exercise|exercise
441335|NCT01682980|Function|function
441336|NCT01682980|Cartilage quality|cartilage quality
441337|NCT01682967|Parturients|parturients
441338|NCT01682967|Analgesia, epidural|analgesia, epidural
441339|NCT01682967|Headache, post-dural puncture|headache, post-dural puncture
441340|NCT01682954|lifestyle risk reduction|lifestyle risk reduction
441341|NCT01682941|soy, isoflavones, functional food, prostate cancer|soy, isoflavones, functional food, prostate cancer
441342|NCT01682928|Oligohydramnios|oligohydramnios
441343|NCT01682928|Hydrotherapy|hydrotherapy
441344|NCT01682928|Pregnancy|pregnancy
441345|NCT01682915|ADHD|adhd
441346|NCT01682915|endophenotype|endophenotype
441347|NCT01682915|executive function|executive function
441348|NCT01682915|diffusion spectrum imaging|diffusion spectrum imaging
441349|NCT01682915|resting-state fMRI|resting-state fmri
441350|NCT01682915|frontostriatal and frontoparietal circuitries|frontostriatal and frontoparietal circuitries
441351|NCT01682915|DAT1|dat1
441352|NCT01682876|Prevention of meningococcal disease, children, vaccine|prevention of meningococcal disease, children, vaccine
441353|NCT01682863|COPD, QAB149, QVA149, indacaterol maleate, gylcopyrronium bromide|copd, qab149, qva149, indacaterol maleate, gylcopyrronium bromide
441354|NCT01682850|COPD|copd
441355|NCT01682850|Chronic Obstructive Lung Disease|chronic obstructive lung disease
441356|NCT01682850|lung cancer|lung cancer
441357|NCT01682850|emphysema|emphysema
441358|NCT01682850|Pulmonary Rehabilitation|pulmonary rehabilitation
441359|NCT01682785|Major depressive disorder|major depressive disorder
441360|NCT01682785|Metabolic syndrome|metabolic syndrome
441361|NCT01682785|Thyroid dysfunction|thyroid dysfunction
441362|NCT01682785|incidence|incidence
441363|NCT01682772|Olaparib|olaparib
441364|NCT01682772|Adenocarcinoma|adenocarcinoma
441365|NCT01682772|Prostate|prostate
441366|NCT01682759|diabetes|diabetes
441367|NCT01682746|Brain Tumor|brain tumor
441368|NCT01682746|Photodynamic Therapy|photodynamic therapy
563820|NCT01162681|SLE|sle
441369|NCT01682746|Photochemotherapy|photochemotherapy
441370|NCT01682746|Astrocytoma|astrocytoma
441371|NCT01682746|Pilocytic Astrocytoma|pilocytic astrocytoma
441372|NCT01682746|Low grade Astrocytoma|low grade astrocytoma
441373|NCT01682746|Anaplastic Astrocytoma|anaplastic astrocytoma
441374|NCT01682746|Glioblastoma|glioblastoma
441375|NCT01682746|GBM|gbm
441376|NCT01682746|Chordoma|chordoma
441377|NCT01682746|Germinoma|germinoma
441378|NCT01682746|Germ Cell Tumor|germ cell tumor
441379|NCT01682746|Non-germinaoma|non-germinaoma
441380|NCT01682746|CNS Lymphoma|cns lymphoma
441381|NCT01682746|Craniopharyngioma|craniopharyngioma
441382|NCT01682746|Brain Stem Glioma|brain stem glioma
441383|NCT01682746|Ependymoma|ependymoma
441384|NCT01682746|Mixed Glioma|mixed glioma
441385|NCT01682746|Optic Nerve Glioma|optic nerve glioma
441386|NCT01682746|Subependymoma|subependymoma
441387|NCT01682746|Medulloblastoma|medulloblastoma
441388|NCT01682746|Meningioma|meningioma
441389|NCT01682746|Metastatic Brain Tumors|metastatic brain tumors
441390|NCT01682746|Oligodendroglioma|oligodendroglioma
441391|NCT01682746|Pituitary Tumors|pituitary tumors
441392|NCT01682746|Primitive Neuroectodermal|primitive neuroectodermal
441393|NCT01682746|PNET|pnet
441394|NCT01682746|Desmoplastic Neuroepithelial Tumor|desmoplastic neuroepithelial tumor
441395|NCT01682746|DNET|dnet
441396|NCT01682733|Obesity|obesity
441397|NCT01682733|Weight loss|weight loss
441398|NCT01682733|Gastric reduction (volume)|gastric reduction (volume)
441399|NCT01682733|BMI 30-40|bmi 30-40
441400|NCT01682720|HCV|hcv
441401|NCT01682720|Genotype 2|genotype 2
441402|NCT01682720|Genotype 3|genotype 3
441403|NCT01682707|intubation|intubation
441404|NCT01682707|coronary disease|coronary disease
441405|NCT01682707|hemodynamic response|hemodynamic response
441406|NCT01682707|anesthesia with tracheal intubation|anesthesia with tracheal intubation
441407|NCT01682707|assessment of hemodynamic response|assessment of hemodynamic response
441408|NCT01682681|Epilepsy|epilepsy
441409|NCT01682681|Topiramate|topiramate
441410|NCT01682681|Topmax|topmax
441411|NCT01682668|parkinson's disease|parkinson's disease
441412|NCT01682668|subthalamic nucleus|subthalamic nucleus
441413|NCT01682668|akinesia|akinesia
441414|NCT01682668|gait initiation|gait initiation
441415|NCT01682668|neuronal activity|neuronal activity
441416|NCT01682668|before STN stimulation|before stn stimulation
441417|NCT01682668|with STN stimulation|with stn stimulation
441418|NCT01682668|functional MRI|functional mri
441419|NCT01682642|endometriosis|endometriosis
441420|NCT01682642|pregnancy|pregnancy
441421|NCT01682642|In Vitro Fertilization (IVF)/Intra Cytoplastic Sperm Injection (ICSI)|in vitro fertilization (ivf)/intra cytoplastic sperm injection (icsi)
441422|NCT01682642|peritoneal implants|peritoneal implants
441423|NCT01682642|embryo quality|embryo quality
441424|NCT01682629|Pediatric|pediatric
441425|NCT01682629|Cardiac|cardiac
441426|NCT01682629|Arrest|arrest
441427|NCT01682629|Simulation|simulation
441428|NCT01682629|Debriefing|debriefing
441429|NCT01682629|Realism|realism
441430|NCT01682616|Safety|safety
441431|NCT01682616|Small Lymphocytic Lymphoma|small lymphocytic lymphoma
441432|NCT01682616|Chronic Lymphocytic Leukemia|chronic lymphocytic leukemia
441433|NCT01682616|Rituximab|rituximab
441434|NCT01682616|Tolerability|tolerability
441435|NCT01682616|Pharmacokinetics|pharmacokinetics
441436|NCT01682616|ABT-199|abt-199
441437|NCT01682616|Cancer|cancer
441438|NCT01682616|Preliminary|preliminary
441439|NCT01682616|Efficacy|efficacy
441440|NCT01682616|Maximum Tolerated Dose|maximum tolerated dose
441441|NCT01682616|Venetoclax|venetoclax
441442|NCT01682603|Nerve growth factor|nerve growth factor
441443|NCT01682603|P2X3 receptor|p2x3 receptor
441444|NCT01682603|Transient Receptor Potential Vanilloid 1 (TRPV-1) receptor|transient receptor potential vanilloid 1 (trpv-1) receptor
441445|NCT01682603|Bladder function|bladder function
441446|NCT01682603|Glomerular filtration rate|glomerular filtration rate
441447|NCT01682603|Detrusor overactivity|detrusor overactivity
441448|NCT01682603|Spinal cord injury|spinal cord injury
441449|NCT01682590|septic shock; acute renal failure; renal remplacement therapy; mortality; intensive care; critical care; acute kidney injury|septic shock; acute renal failure; renal remplacement therapy; mortality; intensive care; critical care; acute kidney injury
441450|NCT01682577|Perindopril|perindopril
441451|NCT01682577|Perindoprilat|perindoprilat
441452|NCT01682577|Bioequivalence|bioequivalence
441453|NCT01682577|Pharmacokinetic|pharmacokinetic
441454|NCT01682577|Angiotensin-converting enzyme inhibitor|angiotensin-converting enzyme inhibitor
441455|NCT01682564|Candemore|candemore
441456|NCT01682564|Atacand|atacand
441457|NCT01682564|Candesartan cilexetil|candesartan cilexetil
441458|NCT01682564|Primary Hypertension|primary hypertension
441459|NCT01682564|Congestive Hypertension|congestive hypertension
441460|NCT01682551|High altitude illness|high altitude illness
441461|NCT01682551|Chinese medicine body constitution|chinese medicine body constitution
441462|NCT01682551|Chinese Medicine|chinese medicine
441463|NCT01682551|High altitude medicine|high altitude medicine
441464|NCT01682551|Mountain trekking|mountain trekking
441465|NCT01682538|Orfadin|orfadin
441466|NCT01682538|Nitisinone|nitisinone
441467|NCT01682538|Bioequivalence|bioequivalence
441468|NCT01682538|Bioavailability|bioavailability
441469|NCT01682525|Fertility preservation|fertility preservation
441470|NCT01682525|Ovarian Tissue|ovarian tissue
441471|NCT01682525|Cryopreservation|cryopreservation
441472|NCT01682525|Assisted Reproductive Technology|assisted reproductive technology
441473|NCT01682499|neuropathy|neuropathy
441474|NCT01682499|taxane|taxane
441475|NCT01682499|paclitaxel|paclitaxel
441476|NCT01682499|calcium|calcium
441477|NCT01682499|magnesium|magnesium
441478|NCT01682499|prevention|prevention
441479|NCT01682486|Medical device|medical device
441480|NCT01682486|Endotracheal Tube(s), ETT|endotracheal tube(s), ett
441481|NCT01682486|Bactiguard Coated ETT|bactiguard coated ett
441482|NCT01682486|Tolerability|tolerability
441483|NCT01682486|Safety|safety
441484|NCT01682486|Performance|performance
441485|NCT01682486|Bacterial colonization on ETT surface|bacterial colonization on ett surface
441486|NCT01682486|Hospital Acquired Infections, HAI|hospital acquired infections, hai
441487|NCT01682486|Ventilator Associated Pneumonia, VAP|ventilator associated pneumonia, vap
441488|NCT01682473|PI3K inhibitor|pi3k inhibitor
441489|NCT01682473|clinical trial|clinical trial
441490|NCT01682447|COPD|copd
441491|NCT01682447|Cognitive Dysfunction|cognitive dysfunction
441492|NCT01682447|Pulmonary Rehabilitation|pulmonary rehabilitation
441493|NCT01682447|Quality of life|quality of life
441494|NCT01682447|Cognitive rehabilitation|cognitive rehabilitation
441495|NCT01682408|R406,|r406,
441496|NCT01682408|Fostamatinib,|fostamatinib,
441497|NCT01682408|Phase I,|phase i,
441498|NCT01682408|Healthy Subjects,|healthy subjects,
441499|NCT01682408|Pharmacokinetics,|pharmacokinetics,
441500|NCT01682408|Fed/Fasted|fed/fasted
441501|NCT01682395|Intestinal volvulus|intestinal volvulus
441502|NCT01682395|Colon, sigmoid|colon, sigmoid
441503|NCT01682395|Anastomosis, surgical|anastomosis, surgical
441504|NCT01682395|Anastomotic leak|anastomotic leak
441505|NCT01682395|Malawi|malawi
441506|NCT01682395|Developing Country|developing country
441507|NCT01682382|age-related macular degeneration|age-related macular degeneration
441508|NCT01682382|choroidal neovascular age-related macular degeneration|choroidal neovascular age-related macular degeneration
441509|NCT01682382|genetics|genetics
441510|NCT01682382|macular pigment optical density (MPOD)|macular pigment optical density (mpod)
441511|NCT01682356|heart failure|heart failure
441512|NCT01682356|hypertension, pulmonary|hypertension, pulmonary
441513|NCT01682356|oxygen consumption|oxygen consumption
441514|NCT01682356|exercise tolerance|exercise tolerance
442003|NCT01680224|Obesity|obesity
441515|NCT01682317|eating frequency|eating frequency
441516|NCT01682304|preeclampsia|preeclampsia
441517|NCT01682304|hypertension|hypertension
441518|NCT01682304|blood pressure|blood pressure
441519|NCT01682304|pregnancy induced hypertension|pregnancy induced hypertension
441520|NCT01682304|chronic hypertension|chronic hypertension
441521|NCT01682291|Prehypertension|prehypertension
441522|NCT01682291|Life-style modifications|life-style modifications
441523|NCT01682291|Dietary supplementation|dietary supplementation
441524|NCT01682278|Health complaints|health complaints
441525|NCT01682278|Amalgam|amalgam
441526|NCT01682278|Mercury|mercury
441527|NCT01682278|Plasma|plasma
441528|NCT01682278|Cytokine|cytokine
441529|NCT01682226|CYCLOPHOSPHAMIDE (CYTOXAN)|cyclophosphamide (cytoxan)
441530|NCT01682226|CYCLOSPORINE|cyclosporine
441531|NCT01682226|FLUDARABINE|fludarabine
441532|NCT01682226|G-CSF|g-csf
441533|NCT01682226|MYCOPHENOLATE MOFETIL (MMF)|mycophenolate mofetil (mmf)
441534|NCT01682226|Cord Blood Transplantation|cord blood transplantation
441535|NCT01682226|CliniMACS|clinimacs
441536|NCT01682226|12-153|12-153
441537|NCT01682213|Dabrafenib|dabrafenib
441538|NCT01682213|(GSK2118436)|(gsk2118436)
441539|NCT01682213|BRAFV600E/K|brafv600e/k
441540|NCT01682213|Resected AJCC Stage IIIC|resected ajcc stage iiic
441541|NCT01682213|12-124|12-124
441542|NCT01682200|moderate|moderate
441543|NCT01682200|facial acne|facial acne
441544|NCT01682200|acne vulgaris|acne vulgaris
441545|NCT01682161|Schizophrenia|schizophrenia
441546|NCT01682161|Paliperidone Palmitate|paliperidone palmitate
441547|NCT01682161|Invega Sustenna|invega sustenna
441548|NCT01682161|Antipsychotics|antipsychotics
441549|NCT01682161|Atypical antipsychotics|atypical antipsychotics
441550|NCT01682161|Medication Satisfaction and Adherence|medication satisfaction and adherence
441551|NCT01682148|Dysport|dysport
441552|NCT01682148|arm spasticity|arm spasticity
441553|NCT01682148|Modified Ashworth Scale|modified ashworth scale
441554|NCT01682148|neuromuscular junction|neuromuscular junction
441555|NCT01682148|Botulinum toxin|botulinum toxin
441556|NCT01682148|upper limb spasticity|upper limb spasticity
441557|NCT01682122|Blood Pressure|blood pressure
441558|NCT01682122|Pediatrics|pediatrics
441559|NCT01682122|Infant, Newborn|infant, newborn
441560|NCT01682122|Cardiology|cardiology
441561|NCT01682109|prophylaxis|prophylaxis
441562|NCT01682109|herpes zoster|herpes zoster
441563|NCT01682109|herpes simplex|herpes simplex
441564|NCT01682109|valacyclovir|valacyclovir
441565|NCT01682109|palatability|palatability
441566|NCT01682109|paediatric|paediatric
441567|NCT01682096|Chest pain|chest pain
441568|NCT01682096|Emergency room|emergency room
441569|NCT01682096|Acute coronary syndrome|acute coronary syndrome
441570|NCT01682096|Computed tomography coronary angiography|computed tomography coronary angiography
441571|NCT01682096|Stress echocardiography|stress echocardiography
441572|NCT01682083|MEK inhibitor|mek inhibitor
441573|NCT01682083|trametinib|trametinib
441574|NCT01682083|Oncology|oncology
441575|NCT01682083|adjuvant melanoma|adjuvant melanoma
441576|NCT01682083|dabrafenib|dabrafenib
441577|NCT01682083|dabrafenib and trametinib combination therapy|dabrafenib and trametinib combination therapy
441578|NCT01682083|BRAF mutation-positive melanoma|braf mutation-positive melanoma
441579|NCT01682083|BRAF inhibitor|braf inhibitor
441580|NCT01682070|Sublingual immunotherapy|sublingual immunotherapy
441581|NCT01682070|Dose range finding|dose range finding
441582|NCT01682070|Dose tolerability|dose tolerability
441583|NCT01682070|grass pollen|grass pollen
441584|NCT01682070|Allergic rhinitis/rhinoconjunctivitis|allergic rhinitis/rhinoconjunctivitis
441585|NCT01682070|Safety|safety
441586|NCT01682070|Immunogenicity|immunogenicity
441587|NCT01682057|High Blood Pressure|high blood pressure
441588|NCT01682057|Hypertension|hypertension
441589|NCT01682057|Resistant Hypertension|resistant hypertension
441590|NCT01682018|emphysema|emphysema
441591|NCT01682018|lung transplantation|lung transplantation
441592|NCT01682005|Cost|cost
441593|NCT01682005|Children|children
441594|NCT01682005|Rotavirus|rotavirus
441595|NCT01682005|Rotavirus vaccination|rotavirus vaccination
441596|NCT01682005|Clinical|clinical
441597|NCT01681992|Safety|safety
441598|NCT01681992|Measles, mumps and rubella diseases|measles, mumps and rubella diseases
441599|NCT01681992|Immunogenicity|immunogenicity
441600|NCT01681979|fluticasone propionate|fluticasone propionate
441601|NCT01681979|asthma|asthma
441602|NCT01681979|pregnancy|pregnancy
441603|NCT01681979|major congenital malformations|major congenital malformations
441604|NCT01681927|idiopathic edema nocturia|idiopathic edema nocturia
441605|NCT01681914|adult HIV positive patients|adult hiv positive patients
441606|NCT01681875|Biomarkers of exposure|biomarkers of exposure
441607|NCT01681875|Compensatory smoking|compensatory smoking
441608|NCT01681875|Nicotine dependence|nicotine dependence
441609|NCT01681875|Reduced nicotine cigarettes|reduced nicotine cigarettes
441610|NCT01681875|Tobacco withdrawal|tobacco withdrawal
441611|NCT01681862|Hypertension|hypertension
441612|NCT01681862|African American|african american
441613|NCT01681862|Personal Health Record|personal health record
442004|NCT01680224|Weight Gain|weight gain
441614|NCT01681862|Faith-based Organizations|faith-based organizations
441615|NCT01681849|PTSD|ptsd
441616|NCT01681849|childhood abuse|childhood abuse
441617|NCT01681823|Prostate Cancer|prostate cancer
441618|NCT01681823|Prostatic Neoplasms|prostatic neoplasms
441619|NCT01681823|Prostate Specific Antigen|prostate specific antigen
441620|NCT01681823|Modified Citrus Pectin|modified citrus pectin
441621|NCT01681823|PectaSol-C|pectasol-c
441622|NCT01681823|Biochemical Relapse|biochemical relapse
441623|NCT01681797|fluorescent angiography|fluorescent angiography
441624|NCT01681797|reconstructive surgery|reconstructive surgery
441625|NCT01681797|perforator flap|perforator flap
441626|NCT01681784|lower urinary tract symptoms|lower urinary tract symptoms
441627|NCT01681784|biomarkers|biomarkers
441628|NCT01681784|urodynamic studies|urodynamic studies
441629|NCT01681758|cardiac surgery|cardiac surgery
441630|NCT01681758|Pulse pressure variation|pulse pressure variation
441631|NCT01681758|intravenous fluids|intravenous fluids
441632|NCT01681732|Asthma|asthma
441633|NCT01681732|child|child
441634|NCT01681732|pediatric|pediatric
441635|NCT01681719|VO2|vo2
441636|NCT01681719|VCO2|vco2
441637|NCT01681719|VE/VO2|ve/vo2
441638|NCT01681719|heart rate|heart rate
441639|NCT01681706|HIV|hiv
441640|NCT01681706|Indicator disease|indicator disease
441641|NCT01681654|Head/Neck Cancer|head/neck cancer
441642|NCT01681654|Exercise|exercise
441643|NCT01681654|Progressive Strength Training|progressive strength training
441644|NCT01681654|Quality of Life|quality of life
441645|NCT01681654|Cancer|cancer
441646|NCT01681654|Randomized Controlled Trial|randomized controlled trial
441647|NCT01681654|Nutrition|nutrition
441648|NCT01681654|Lifestyle Intervention|lifestyle intervention
441649|NCT01681641|Patients|patients
441650|NCT01681641|Nursing|nursing
441651|NCT01681641|Parkinsons disease|parkinsons disease
441652|NCT01681641|Deep Brain Stimulation|deep brain stimulation
441653|NCT01681641|Spouses|spouses
441654|NCT01681628|Thought Field Therapy.|thought field therapy.
441655|NCT01681628|Post-traumatic stress disorder.|post-traumatic stress disorder.
441656|NCT01681628|Post-traumatic stress disorder check list for Civilians.|post-traumatic stress disorder check list for civilians.
441657|NCT01681628|Uganda|uganda
441658|NCT01681628|Ugandan therapists.|ugandan therapists.
441659|NCT01681628|Community treatment.|community treatment.
441660|NCT01681615|Challenge test for Aspirin Hypersensitivity|challenge test for aspirin hypersensitivity
441661|NCT01681615|Challenge test for Acetylsalicylic Hypersensitivity|challenge test for acetylsalicylic hypersensitivity
441662|NCT01681602|Alzheimer Disease|alzheimer disease
441663|NCT01681602|Exercise|exercise
441664|NCT01681602|Cognition|cognition
441665|NCT01681602|Quality of life|quality of life
441666|NCT01681602|Cardiovascular fitness|cardiovascular fitness
441667|NCT01681602|Behavioural or psychological symptoms|behavioural or psychological symptoms
441668|NCT01681602|Physical fitness|physical fitness
441670|NCT01681589|Traumatic Brain Injury|traumatic brain injury
441671|NCT01681589|Rehabilitation|rehabilitation
441672|NCT01681589|Therapy|therapy
441673|NCT01681576|hypertension, salt sensitivity, valsartan, LCZ696|hypertension, salt sensitivity, valsartan, lcz696
441674|NCT01681537|Relapsed|relapsed
441675|NCT01681537|Refractory|refractory
441676|NCT01681524|Flurpiridaz F18 Injection|flurpiridaz f18 injection
441677|NCT01681524|Positron Emission Tomography Myocardial Perfusion Imaging|positron emission tomography myocardial perfusion imaging
441678|NCT01681524|Single Positron Emission Computed Tomography|single positron emission computed tomography
441679|NCT01681524|Coronary Artery Disease|coronary artery disease
441680|NCT01681524|Myocardia Ischemia|myocardia ischemia
441681|NCT01681524|Coronary Disease|coronary disease
441682|NCT01681524|Heart Diseases|heart diseases
441683|NCT01681524|Cardiovascular Diseases|cardiovascular diseases
441684|NCT01681524|Arteriosclerosis|arteriosclerosis
441685|NCT01681524|Arterial Occlusive Diseases|arterial occlusive diseases
441686|NCT01681524|Vascular Diseases|vascular diseases
441687|NCT01681511|Catheter Associated Urinary Tract Infections|catheter associated urinary tract infections
441688|NCT01681511|CAUTI|cauti
441689|NCT01681498|pregnant|pregnant
441690|NCT01681498|fetal ecg|fetal ecg
441691|NCT01681498|ecg|ecg
441692|NCT01681485|Traditional Chinese medicine|traditional chinese medicine
441693|NCT01681485|Non small cell lung cancer|non small cell lung cancer
441694|NCT01681485|Surgery|surgery
441695|NCT01681485|Chemotherapy|chemotherapy
441696|NCT01681485|Radiation therapy|radiation therapy
441697|NCT01681472|Colon cancer|colon cancer
441698|NCT01681472|5,10-methylenetetrahydrofolate|5,10-methylenetetrahydrofolate
441699|NCT01681472|Rectal Neoplasms|rectal neoplasms
441700|NCT01681472|Colorectal Neoplasms|colorectal neoplasms
441701|NCT01681472|Intestinal Neoplasms|intestinal neoplasms
441702|NCT01681472|Gastrointestinal Neoplasms|gastrointestinal neoplasms
441703|NCT01681472|Digestive System Neoplasms|digestive system neoplasms
441704|NCT01681472|Gastrointestinal Diseases|gastrointestinal diseases
441705|NCT01681472|Therapeutic Uses|therapeutic uses
441706|NCT01681472|Pharmacokinetics|pharmacokinetics
441707|NCT01681472|Pharmacodynamics|pharmacodynamics
441708|NCT01681459|Free fatty acid|free fatty acid
441709|NCT01681459|Triglyceride|triglyceride
441710|NCT01681459|Gastric emptying|gastric emptying
441711|NCT01681459|Satiety hormones|satiety hormones
441712|NCT01681459|Appetite|appetite
441713|NCT01681459|Severe obesity|severe obesity
441714|NCT01681446|hepatocellular carcinoma|hepatocellular carcinoma
441715|NCT01681446|interferon-alpha|interferon-alpha
441716|NCT01681446|miR-26|mir-26
441717|NCT01681433|OGX-427|ogx-427
441718|NCT01681433|Abiraterone Acetate|abiraterone acetate
441719|NCT01681420|HIV counseling|hiv counseling
441720|NCT01681420|Blood donor HIV testing|blood donor hiv testing
441721|NCT01681420|Brazil|brazil
441722|NCT01681420|Blood banks|blood banks
441723|NCT01681420|Blood donors|blood donors
441724|NCT01681407|Depression|depression
441725|NCT01681407|Selective Serotonin Reuptake Inhibitors|selective serotonin reuptake inhibitors
441726|NCT01681407|MicroRNAs|micrornas
441727|NCT01681407|Proteome|proteome
441728|NCT01681368|NF-Kappa B Pathway|nf-kappa b pathway
441729|NCT01681368|Response Biomarkers|response biomarkers
441730|NCT01681368|Progression-Free Survival|progression-free survival
441731|NCT01681368|Pharmacokinetics|pharmacokinetics
441732|NCT01681368|Pharmacodynamics|pharmacodynamics
441733|NCT01681355|Healthy, term, Asian infants|healthy, term, asian infants
441734|NCT01681355|Infant formula|infant formula
441735|NCT01681342|stade Ib to IV cervix cancer|stade ib to iv cervix cancer
441736|NCT01681342|ambulatory high dose rate brachytherapy|ambulatory high dose rate brachytherapy
441737|NCT01681329|Cognitive-behavioral therapy|cognitive-behavioral therapy
441738|NCT01681329|Interpretation modification training|interpretation modification training
441739|NCT01681329|Randomized clinical trial|randomized clinical trial
441740|NCT01681329|Adults|adults
441741|NCT01681316|Chronic Stable Angina|chronic stable angina
441742|NCT01681316|Randomized Controlled Trial|randomized controlled trial
441743|NCT01681316|Traditional Chinese Medicine|traditional chinese medicine
441744|NCT01681264|Pain|pain
441745|NCT01681264|Pain Management|pain management
441746|NCT01681264|Back pain|back pain
441747|NCT01681264|Neck pain|neck pain
441748|NCT01681238|perioperative fluid optimization|perioperative fluid optimization
441749|NCT01681238|goal-directed therapy|goal-directed therapy
441750|NCT01681238|elderly|elderly
441751|NCT01681238|high-risk surgery|high-risk surgery
441752|NCT01681225|ARDS|ards
441753|NCT01681225|mechanical ventilation|mechanical ventilation
441754|NCT01681225|ALI|ali
441755|NCT01681225|esophageal pressure|esophageal pressure
441756|NCT01681199|statin|statin
441757|NCT01681199|atherosclerosis|atherosclerosis
441758|NCT01681199|Coronary heart disease|coronary heart disease
441759|NCT01681199|OPN|opn
441760|NCT01681199|OPG|opg
441761|NCT01681173|Nutritional support|nutritional support
441762|NCT01681173|Diet therapy|diet therapy
441763|NCT01681173|Diabetes prevention|diabetes prevention
441764|NCT01681173|Insoluble fiber|insoluble fiber
441765|NCT01681173|Healthy life style|healthy life style
441766|NCT01681173|Weight loss|weight loss
441767|NCT01681160|MAGGOT THERAPY|maggot therapy
441768|NCT01681160|DIABETIC FOOT|diabetic foot
441769|NCT01681160|NURSING CARE|nursing care
441770|NCT01681160|DRESSING|dressing
441771|NCT01681147|Gestational Diabetes|gestational diabetes
441772|NCT01681147|postpartum|postpartum
441773|NCT01681147|nutrition|nutrition
441774|NCT01681147|exercise|exercise
441775|NCT01681134|tacrolimus|tacrolimus
441776|NCT01681134|Advagraf®|advagraf®
441777|NCT01681134|Prograf®|prograf®
441778|NCT01681134|Glomerular Filtration Rate|glomerular filtration rate
441779|NCT01681134|Effective Renal Plasma Flow|effective renal plasma flow
441780|NCT01681134|Pharmacokinetics|pharmacokinetics
441781|NCT01681134|Pharmacodynamics|pharmacodynamics
441782|NCT01681095|Physiological Effects of Drugs|physiological effects of drugs
441783|NCT01681095|Cardiovascular Agents|cardiovascular agents
441784|NCT01681095|Therapeutic Uses|therapeutic uses
441785|NCT01681095|Pharmacologic Actions|pharmacologic actions
441786|NCT01681095|Mannitol|mannitol
441787|NCT01681095|Cardiac Surgery|cardiac surgery
441788|NCT01681095|Cardioplegic Solutions|cardioplegic solutions
441789|NCT01681095|HTK solution|htk solution
441790|NCT01681095|Myocardial protection|myocardial protection
441791|NCT01681095|Coronary Artery Disease|coronary artery disease
441792|NCT01681095|Myocardial Ischemia|myocardial ischemia
441793|NCT01681095|Coronary Disease|coronary disease
441794|NCT01681095|Heart Diseases|heart diseases
441795|NCT01681056|autosuggestion|autosuggestion
441796|NCT01681056|quality of life|quality of life
441797|NCT01681056|geriatric|geriatric
441798|NCT01681056|serum cortisol|serum cortisol
441799|NCT01681056|Interferon gamma|interferon gamma
441800|NCT01681056|interleukin-2|interleukin-2
441801|NCT01681056|interleukin-6|interleukin-6
441802|NCT01681056|neuroplasticity|neuroplasticity
441803|NCT01681043|Sleep|sleep
441804|NCT01681017|Perinatal Mortality|perinatal mortality
441805|NCT01681017|Asphyxia|asphyxia
441806|NCT01681017|Stillbirth|stillbirth
441807|NCT01681017|Neonatal Death|neonatal death
441808|NCT01681017|Resuscitation|resuscitation
441809|NCT01681017|Helping Babies Breathe|helping babies breathe
442005|NCT01680224|Dissonance|dissonance
441810|NCT01681017|among births greater than one thousand five hundred grams|among births greater than one thousand five hundred grams
441811|NCT01681004|si joint|si joint
441812|NCT01681004|si joint pain|si joint pain
441813|NCT01681004|si joint injury|si joint injury
441814|NCT01681004|si joint treatment|si joint treatment
441815|NCT01681004|si joint injections|si joint injections
441816|NCT01681004|si joint inflammation|si joint inflammation
441817|NCT01681004|si joint problems|si joint problems
441818|NCT01681004|si joint symptoms|si joint symptoms
441819|NCT01681004|hypermobile si joint|hypermobile si joint
441820|NCT01681004|si joint arthritis|si joint arthritis
441821|NCT01681004|si joint pain treatment|si joint pain treatment
441822|NCT01681004|inflamed si joint|inflamed si joint
441823|NCT01681004|si joint sclerosis|si joint sclerosis
441824|NCT01681004|locked si joint|locked si joint
441825|NCT01681004|si joint injuries|si joint injuries
441826|NCT01681004|si joint disease|si joint disease
441827|NCT01681004|si joint infection|si joint infection
441828|NCT01681004|sacroiliac joint pelvic pain|sacroiliac joint pelvic pain
441829|NCT01681004|sacroiliac joint arthritis treatment|sacroiliac joint arthritis treatment
441830|NCT01680965|Graft vs. Host Disease|graft vs. host disease
441831|NCT01680965|GVHD|gvhd
441832|NCT01680965|chronic graft versus host disease (cGVHD)|chronic graft versus host disease (cgvhd)
441833|NCT01680965|Allogeneic Transplant|allogeneic transplant
441834|NCT01680965|Ofatumumab|ofatumumab
441835|NCT01680952|RECORD study|record study
441836|NCT01680939|Pediatrics|pediatrics
441837|NCT01680939|Obstructive Sleep Apnea|obstructive sleep apnea
441838|NCT01680939|Adenotonsillectomy|adenotonsillectomy
441839|NCT01680939|Analgesia|analgesia
441840|NCT01680926|type 2 diabetes mellitus|type 2 diabetes mellitus
441841|NCT01680926|insulin|insulin
441842|NCT01680926|hbA1c|hba1c
441843|NCT01680926|body weight|body weight
441844|NCT01680900|menopause|menopause
441845|NCT01680900|hot flashes|hot flashes
441846|NCT01680900|vilazodone|vilazodone
441847|NCT01680887|Cocaine dependence|cocaine dependence
441848|NCT01680874|Clostridium difficile|clostridium difficile
441849|NCT01680874|Diarrhea|diarrhea
441850|NCT01680874|Infection|infection
441851|NCT01680874|Lactobacilli|lactobacilli
441852|NCT01680874|Bifidobacteria|bifidobacteria
441853|NCT01680874|Lactobacillus acidophilus|lactobacillus acidophilus
441854|NCT01680874|Lactobacillus paracasei|lactobacillus paracasei
441855|NCT01680874|Bifidobacterium lactis|bifidobacterium lactis
441856|NCT01680874|Yogurt|yogurt
441857|NCT01680874|Probiotics|probiotics
441858|NCT01680861|Kidney transplant patients|kidney transplant patients
441859|NCT01680848|Dental caries,|dental caries,
441860|NCT01680848|Caries diagnosis,|caries diagnosis,
441861|NCT01680848|Caries treatment,|caries treatment,
441862|NCT01680848|Caries risk,|caries risk,
441863|NCT01680848|Practice pattern,|practice pattern,
441864|NCT01680848|Clinical epidemiology,|clinical epidemiology,
441865|NCT01680848|Dental Practice-Based Research Network|dental practice-based research network
441866|NCT01680822|Nontuberculous, Atypical, Mycobacterial|nontuberculous, atypical, mycobacterial
441867|NCT01680809|Venous insufficiency|venous insufficiency
441868|NCT01680809|Venous stasis ulcerations|venous stasis ulcerations
441869|NCT01680809|Compression stockings|compression stockings
441870|NCT01680809|Compression stocking compliance|compression stocking compliance
441871|NCT01680796|Multiple Myeloma|multiple myeloma
441872|NCT01680796|Relapsed Multiple Myeloma|relapsed multiple myeloma
441873|NCT01680796|Refractory Multiple Myeloma|refractory multiple myeloma
441874|NCT01680783|noninvasive ventilation|noninvasive ventilation
441875|NCT01680783|acute hypoxemic respiratory failure|acute hypoxemic respiratory failure
441876|NCT01680783|Acute respiratory distress syndrome|acute respiratory distress syndrome
441877|NCT01680783|shock|shock
441878|NCT01680770|shock|shock
441879|NCT01680770|transthoracic echocardiography|transthoracic echocardiography
441880|NCT01680770|critical care|critical care
441881|NCT01680757|Left Atrial Appendage|left atrial appendage
441882|NCT01680757|LARIAT|lariat
441883|NCT01680757|atrial fibrillation|atrial fibrillation
442008|NCT01680224|Obesity Prevention|obesity prevention
441884|NCT01680757|contraindication to oral anticoagulation therapy|contraindication to oral anticoagulation therapy
441885|NCT01680744|Transplantation|transplantation
441886|NCT01680744|Terminal creatinine|terminal creatinine
441887|NCT01680744|Renal function|renal function
441888|NCT01680744|GFR|gfr
441889|NCT01680731|Pelvic floor injury|pelvic floor injury
441890|NCT01680731|Levator ani muscle|levator ani muscle
441891|NCT01680718|oxytocin|oxytocin
441892|NCT01680718|vasopressin|vasopressin
441893|NCT01680718|intranasal administration|intranasal administration
441894|NCT01680718|healthy sample|healthy sample
441895|NCT01680705|Chronic Rhinosinusitis|chronic rhinosinusitis
441896|NCT01680705|Endoscopic Sinus Surgery|endoscopic sinus surgery
441897|NCT01680705|Sinonasal saline irrigation|sinonasal saline irrigation
441898|NCT01680705|Frequency|frequency
441899|NCT01680705|Postoperative|postoperative
441900|NCT01680705|High Volume|high volume
441901|NCT01680705|Randomized Control Trial|randomized control trial
441902|NCT01680705|Single Blinded|single blinded
441903|NCT01680705|Prospective Study|prospective study
441904|NCT01680705|Quality of Life|quality of life
441905|NCT01680705|Endoscopic Sinus Score|endoscopic sinus score
441906|NCT01680692|Analgesia TKA|analgesia tka
441907|NCT01680692|Total knee arthroplasty|total knee arthroplasty
441908|NCT01680692|Continuous femoral catheter|continuous femoral catheter
441909|NCT01680692|Continuous tibial catheter|continuous tibial catheter
441910|NCT01680692|Single shot sciatic|single shot sciatic
441911|NCT01680679|Influenza|influenza
441912|NCT01680679|India|india
441913|NCT01680679|Children|children
441914|NCT01680679|Trivalent Influenza Vaccine (TIV)|trivalent influenza vaccine (tiv)
441915|NCT01680679|Inactivated poliovirus vaccine (IPV)|inactivated poliovirus vaccine (ipv)
441916|NCT01680679|Direct influenza vaccine effectiveness|direct influenza vaccine effectiveness
441917|NCT01680679|Total influenza vaccine effectiveness|total influenza vaccine effectiveness
441918|NCT01680679|Indirect influenza vaccine effectiveness|indirect influenza vaccine effectiveness
441919|NCT01680640|non alcoholic fatty liver disease|non alcoholic fatty liver disease
441920|NCT01680640|NAFLD|nafld
441921|NCT01680640|synbiotic|synbiotic
441922|NCT01680640|gut microbiota|gut microbiota
441923|NCT01680640|intervention|intervention
441924|NCT01680640|RCT|rct
441925|NCT01680640|biomarkers|biomarkers
441926|NCT01680588|Alzheimer|alzheimer
441927|NCT01680575|Neutropenia|neutropenia
441928|NCT01680575|Paclitaxel|paclitaxel
441929|NCT01680575|Carboplatin|carboplatin
441930|NCT01680575|Epithelial ovarian cancer|epithelial ovarian cancer
441931|NCT01680562|in-vivo skin imaging|in-vivo skin imaging
441932|NCT01680562|non-invasive non-melanoma skin cancer diagnostics|non-invasive non-melanoma skin cancer diagnostics
441933|NCT01680523|cervical cancer|cervical cancer
441934|NCT01680523|bulky early-stage|bulky early-stage
441935|NCT01680523|locally advanced|locally advanced
441936|NCT01680523|radical hysterectomy|radical hysterectomy
441937|NCT01680523|concurrent chemoradiation therapy|concurrent chemoradiation therapy
441938|NCT01680484|non-stress test|non-stress test
441939|NCT01680471|emergence agitation|emergence agitation
441940|NCT01680471|midazolam|midazolam
441941|NCT01680471|sevoflurane|sevoflurane
441942|NCT01680471|strabismus|strabismus
441943|NCT01680458|antifungal treatment|antifungal treatment
441944|NCT01680458|prophylaxis|prophylaxis
441945|NCT01680458|administration|administration
441946|NCT01680458|Japanese|japanese
441947|NCT01680458|infants|infants
441948|NCT01680458|fluconazole|fluconazole
441949|NCT01680458|Diflucan|diflucan
441950|NCT01680458|Regulatory Post Marketing Commitment Plan.|regulatory post marketing commitment plan.
441951|NCT01680445|osteoarthritis, arthritis|osteoarthritis, arthritis
441952|NCT01680432|constipation|constipation
441953|NCT01680432|probiotics|probiotics
441954|NCT01680432|bifidobacterium|bifidobacterium
441955|NCT01680432|cheese|cheese
441956|NCT01680419|Veterans|veterans
441957|NCT01680419|Reintegration|reintegration
441958|NCT01680419|Resilience|resilience
441959|NCT01680419|Marital|marital
441960|NCT01680419|Spouse|spouse
441961|NCT01680419|Behavioral intervention|behavioral intervention
441962|NCT01680419|PTSD|ptsd
441963|NCT01680419|Integrative therapies|integrative therapies
441964|NCT01680419|Complementary therapies|complementary therapies
441965|NCT01680419|Massage|massage
441966|NCT01680419|Meditation|meditation
441967|NCT01680419|Mindfulness|mindfulness
441968|NCT01680419|Compassion|compassion
441969|NCT01680419|Mental health|mental health
441970|NCT01680406|Plasmodium vivax|plasmodium vivax
441971|NCT01680406|malaria|malaria
441972|NCT01680406|Ethiopia|ethiopia
441973|NCT01680406|Sub-Saharan Africa|sub-saharan africa
441974|NCT01680406|primaquine|primaquine
441975|NCT01680406|artemether lumefantrine|artemether lumefantrine
441976|NCT01680406|chloroquine|chloroquine
441977|NCT01680380|sleep apnea|sleep apnea
441978|NCT01680380|snoring|snoring
441979|NCT01680315|Satiety,|satiety,
441980|NCT01680315|satiation,|satiation,
441981|NCT01680315|anticipation,|anticipation,
441982|NCT01680315|food intake|food intake
441983|NCT01680302|Atrial fibrillation|atrial fibrillation
441984|NCT01680302|Prevention|prevention
441985|NCT01680302|Exercise|exercise
441986|NCT01680289|Dentin bonding agents|dentin bonding agents
441987|NCT01680289|Composite restorations|composite restorations
441988|NCT01680289|Dental restoration failure|dental restoration failure
441989|NCT01680276|intellectual disability|intellectual disability
441990|NCT01680276|developmental disability|developmental disability
441991|NCT01680276|challenging behaviour|challenging behaviour
441992|NCT01680276|behavioural intervention|behavioural intervention
441993|NCT01680276|training|training
441994|NCT01680263|Kinesiotaping|kinesiotaping
441995|NCT01680263|pes anserinus tendino-bursitis|pes anserinus tendino-bursitis
441996|NCT01680263|nonsteroidal anti-inflammatory drugs|nonsteroidal anti-inflammatory drugs
441997|NCT01680263|physical therapy|physical therapy
441998|NCT01680250|Total liver volume|total liver volume
441999|NCT01680250|Liver cyst|liver cyst
442000|NCT01680237|cognitive behavior therapy|cognitive behavior therapy
442001|NCT01680237|exposure in-vivo|exposure in-vivo
442002|NCT01680237|panic disorder with agoraphobia|panic disorder with agoraphobia
442006|NCT01680224|College,University Students|college,university students
442007|NCT01680224|Eating Disorders|eating disorders
442009|NCT01680224|Selective Prevention|selective prevention
442010|NCT01680224|Effectiveness|effectiveness
442011|NCT01680211|Blood Sugar,|blood sugar,
442012|NCT01680211|Lipoproteins,|lipoproteins,
442013|NCT01680211|Salacia,|salacia,
442015|NCT01680211|Prediabetes,|prediabetes,
442016|NCT01680211|Hyperlipidemia,|hyperlipidemia,
442017|NCT01680211|Herbal supplement|herbal supplement
442018|NCT01680198|Vitamin D|vitamin d
442019|NCT01680198|Paracalcitol|paracalcitol
442020|NCT01680198|Chronic kidney disease|chronic kidney disease
442021|NCT01680198|Endothelial dysfunction|endothelial dysfunction
442022|NCT01680198|Flow mediated vasodilation|flow mediated vasodilation
442023|NCT01680185|Hyperglycemia|hyperglycemia
442024|NCT01680185|NODAT|nodat
442025|NCT01680185|Insulin pump|insulin pump
442026|NCT01680185|Semiclosed loop|semiclosed loop
442027|NCT01680172|cancer|cancer
442028|NCT01680172|depression|depression
442029|NCT01680172|anxiety|anxiety
442030|NCT01680172|palliative care|palliative care
442031|NCT01680159|Infliximab|infliximab
442032|NCT01680159|REMICADE|remicade
442033|NCT01680159|TA-650|ta-650
442034|NCT01680159|psoriasis|psoriasis
442035|NCT01680107|d-cycloserine, cognitive-behaviour therapy, panic disorder|d-cycloserine, cognitive-behaviour therapy, panic disorder
442036|NCT01680094|HIV Infection|hiv infection
442037|NCT01680094|Panobinostat|panobinostat
442038|NCT01680094|Lentivirus Infections|lentivirus infections
442039|NCT01680094|Retroviridae Infections|retroviridae infections
442040|NCT01680094|RNA Virus Infections|rna virus infections
442041|NCT01680094|Virus Diseases|virus diseases
442042|NCT01680094|Sexually Transmitted Diseases, Viral|sexually transmitted diseases, viral
442043|NCT01680094|Sexually Transmitted Diseases|sexually transmitted diseases
442044|NCT01680094|Immunologic Deficiency Syndromes|immunologic deficiency syndromes
442045|NCT01680094|Immune System Diseases|immune system diseases
442046|NCT01680094|Histone Deacetylase Inhibitors|histone deacetylase inhibitors
442047|NCT01680094|Therapeutic Uses|therapeutic uses
442048|NCT01680068|Macular hole|macular hole
442049|NCT01680068|Vitreoretinal surgery|vitreoretinal surgery
442050|NCT01680068|Macular surgery|macular surgery
442051|NCT01680068|Air tamponade|air tamponade
442052|NCT01680042|inflammatory halo|inflammatory halo
442054|NCT01680016|Rabies virus, postexposure, vaccine schedule, children, older adults|rabies virus, postexposure, vaccine schedule, children, older adults
442055|NCT01679964|HIV infection|hiv infection
442056|NCT01679964|Raltegravir|raltegravir
442057|NCT01679964|Adverse event|adverse event
442058|NCT01679964|Life quality|life quality
442059|NCT01679951|Rheumatoid arthritis|rheumatoid arthritis
442060|NCT01679951|Swollen and tender joints|swollen and tender joints
442061|NCT01679951|Methotrexate|methotrexate
442062|NCT01679951|Immunology|immunology
442063|NCT01679951|Dose range finding study|dose range finding study
442064|NCT01679938|obesity prevention|obesity prevention
442065|NCT01679938|cluster-randomized controlled trial|cluster-randomized controlled trial
442066|NCT01679938|preschool-aged children|preschool-aged children
442067|NCT01679925|Early puberty|early puberty
442068|NCT01679925|Psychosocial impact|psychosocial impact
442069|NCT01679925|Qualitative assessment|qualitative assessment
442070|NCT01679912|Hereditary angioedema|hereditary angioedema
442071|NCT01679912|Emergency Medical Service|emergency medical service
442072|NCT01679912|Health care coast|health care coast
442073|NCT01679912|Telephone|telephone
442074|NCT01679899|diabetes|diabetes
442075|NCT01679899|type 2 diabetes mellitus|type 2 diabetes mellitus
442076|NCT01679899|osteopenia|osteopenia
442077|NCT01679899|osteoporosis|osteoporosis
442078|NCT01679899|glycemic variability|glycemic variability
442079|NCT01679899|bone markers|bone markers
442080|NCT01679899|osteocalcin|osteocalcin
442081|NCT01679899|NTX|ntx
442082|NCT01679899|CTX|ctx
442083|NCT01679899|BALP|balp
442084|NCT01679886|Position emission tomography;|position emission tomography;
442085|NCT01679886|Rubidium;|rubidium;
442086|NCT01679886|Women;|women;
442087|NCT01679886|Overweighted patients|overweighted patients
442088|NCT01679873|confidence|confidence
442089|NCT01679873|funding sources|funding sources
442090|NCT01679873|conflicts of interests|conflicts of interests
442091|NCT01679873|general practitioner|general practitioner
442092|NCT01679847|Elemene|elemene
442093|NCT01679847|pharmacokinetics|pharmacokinetics
442094|NCT01679847|Blood-brain barrier|blood-brain barrier
442095|NCT01679821|Temporomandibular disorders.|temporomandibular disorders.
442096|NCT01679821|Dental prosthesis.|dental prosthesis.
442097|NCT01679821|Dental students|dental students
442098|NCT01679808|copd|copd
442099|NCT01679808|airway obstruction|airway obstruction
442100|NCT01679808|Tracheobronchomalacia|tracheobronchomalacia
442101|NCT01679795|hormone replacement therapy; Dopplervelocimetry; Flow-mediated dilation; menopause; tibolone|hormone replacement therapy; dopplervelocimetry; flow-mediated dilation; menopause; tibolone
442102|NCT01679782|COPD, nervous system, peripheral muscle dysfunction|copd, nervous system, peripheral muscle dysfunction
442103|NCT01679756|Colorectal cancer|colorectal cancer
442104|NCT01679756|Laparoscopic right hemicolectomy|laparoscopic right hemicolectomy
442105|NCT01679756|Intracorporeal anastomosis|intracorporeal anastomosis
442106|NCT01679743|Metastatic Breast Cancer|metastatic breast cancer
442107|NCT01679743|Metastatic Lung Cancer|metastatic lung cancer
442108|NCT01679743|Monoclonal Antibody|monoclonal antibody
442109|NCT01679743|18FLT|18flt
442110|NCT01679743|Surgery|surgery
442111|NCT01679717|Osteoarthritis|osteoarthritis
442112|NCT01679717|CMC1-joint|cmc1-joint
442113|NCT01679717|Postoperative therapy|postoperative therapy
442114|NCT01679717|Interposition arthroplasty of the thumb|interposition arthroplasty of the thumb
442115|NCT01679717|Occupational therapy|occupational therapy
442116|NCT01679652|Essential hypertension|essential hypertension
442117|NCT01679652|Nitric oxide|nitric oxide
442118|NCT01679652|Nebivolol|nebivolol
442119|NCT01679652|Fractional excretion of sodium|fractional excretion of sodium
442120|NCT01679626|cricoid pressure (CP)|cricoid pressure (cp)
442121|NCT01679626|backward upward rightward pressure (BURP)|backward upward rightward pressure (burp)
442122|NCT01679626|AP-rima distances|ap-rima distances
442123|NCT01679626|Glottic area|glottic area
442124|NCT01679626|Extralaryngeal manoeuvres|extralaryngeal manoeuvres
442125|NCT01679600|Rehabilitation|rehabilitation
442126|NCT01679600|Robotics-assisted Treadmill Exercise|robotics-assisted treadmill exercise
442127|NCT01679600|Aerobic Capacity|aerobic capacity
442128|NCT01679600|Exercise Testing|exercise testing
442129|NCT01679574|PCO|pco
442130|NCT01679561|implantation failure|implantation failure
442131|NCT01679561|recurrent abortion|recurrent abortion
442132|NCT01679561|intralipid|intralipid
442133|NCT01679535|Infant nutrition disorder|infant nutrition disorder
442134|NCT01679535|Child nutrition disorders|child nutrition disorders
442135|NCT01679535|Malnutrition|malnutrition
442136|NCT01679535|Protein-energy malnutrition|protein-energy malnutrition
442137|NCT01679522|endometrial cancer|endometrial cancer
442138|NCT01679522|laparoscopic surgical staging|laparoscopic surgical staging
442139|NCT01679522|single-port|single-port
442140|NCT01679522|four-port|four-port
442141|NCT01679496|LDL-cholesterol|ldl-cholesterol
442142|NCT01679470|cancer|cancer
442143|NCT01679470|lung|lung
442144|NCT01679470|laser|laser
442145|NCT01679470|ablation|ablation
442146|NCT01679470|airway obstruction|airway obstruction
442147|NCT01679444|MRS|mrs
442148|NCT01679444|Heavy dose drinkers|heavy dose drinkers
442149|NCT01679444|Alcohol|alcohol
442150|NCT01679444|NIAAA|niaaa
442151|NCT01679431|Aortic Stenosis|aortic stenosis
442152|NCT01679431|Obesity, Abdominal|obesity, abdominal
442153|NCT01679431|Metabolic Syndrome X|metabolic syndrome x
442154|NCT01679431|Insulin Resistance|insulin resistance
442155|NCT01679431|Echocardiography, Doppler|echocardiography, doppler
442156|NCT01679431|Multidetector Computed Tomography|multidetector computed tomography
442157|NCT01679431|Magnetic Resonance Imaging|magnetic resonance imaging
442158|NCT01679418|PONV|ponv
442159|NCT01679418|thyroid|thyroid
442160|NCT01679418|surgery|surgery
442161|NCT01679418|nausea and vomiting|nausea and vomiting
442162|NCT01679418|postoperative|postoperative
442163|NCT01679405|metastatic biliary tract cancer|metastatic biliary tract cancer
442164|NCT01679392|Transversus abdominis plane block|transversus abdominis plane block
442165|NCT01679392|Ultrasound guided nerve block|ultrasound guided nerve block
442166|NCT01679379|Cesarean Section|cesarean section
442167|NCT01679379|Obese Women|obese women
442168|NCT01679379|Surgical Site Infection|surgical site infection
442169|NCT01679353|inguinal hernia, caudal analgesia, magnesium|inguinal hernia, caudal analgesia, magnesium
442170|NCT01679340|Gastric cancer|gastric cancer
442171|NCT01679340|D2 surgery|d2 surgery
442172|NCT01679340|S-1|s-1
442173|NCT01679340|Oxaliplatin|oxaliplatin
442174|NCT01679340|cisplatin|cisplatin
442175|NCT01679314|COPD|copd
442176|NCT01679314|vagus nerve stimulation|vagus nerve stimulation
442177|NCT01679314|vagal nerve stimulation|vagal nerve stimulation
442178|NCT01679314|nVNS|nvns
442179|NCT01679314|VNS|vns
442180|NCT01679314|non invasive|non invasive
442181|NCT01679314|gammacore|gammacore
442182|NCT01679301|oxygen|oxygen
442183|NCT01679288|Hand-Held ultrasonography|hand-held ultrasonography
442184|NCT01679288|Abdominal Aortic Aneurysm|abdominal aortic aneurysm
442185|NCT01679288|Abdominal Aortic Atherosclerosis|abdominal aortic atherosclerosis
442186|NCT01679288|Cardiovascular risk|cardiovascular risk
442187|NCT01679288|Primary Health Care|primary health care
442188|NCT01679275|Heart Defects, congenital|heart defects, congenital
442189|NCT01679275|Patient Monitoring|patient monitoring
442190|NCT01679275|Infant, Newborn|infant, newborn
442191|NCT01679275|Physiology|physiology
442192|NCT01679249|extracellular fluid volume|extracellular fluid volume
442193|NCT01679249|hypotension|hypotension
442194|NCT01679249|hemodialysis|hemodialysis
442195|NCT01679236|Smoking|smoking
442196|NCT01679236|Smoking cessation|smoking cessation
442197|NCT01679236|Nicotine|nicotine
442198|NCT01679236|Tobacco|tobacco
442199|NCT01679236|Mindfulness|mindfulness
442200|NCT01679236|Meditation|meditation
442201|NCT01679236|MBSR|mbsr
442202|NCT01679236|Mindfulness Training|mindfulness training
442203|NCT01679236|Behavioral Intervention|behavioral intervention
442204|NCT01679236|Alcohol|alcohol
442205|NCT01679236|Young Adults|young adults
442206|NCT01679223|Breast reconstruction|breast reconstruction
442207|NCT01679223|Hydroxyproline concentration|hydroxyproline concentration
442208|NCT01679223|neoangiogenesis|neoangiogenesis
442209|NCT01679223|collagen deposition|collagen deposition
442210|NCT01679197|Nonalcoholic fatty liver disease|nonalcoholic fatty liver disease
442211|NCT01679197|NAFLD|nafld
442212|NCT01679197|Nonalcoholic steatohepatitis|nonalcoholic steatohepatitis
442213|NCT01679197|NASH|nash
442214|NCT01679197|Lipodystrophy|lipodystrophy
442215|NCT01679197|Leptin|leptin
442216|NCT01679197|Metreleptin|metreleptin
442217|NCT01679197|Hypertriglyceridemia|hypertriglyceridemia
442218|NCT01679197|Diabetes mellitus|diabetes mellitus
442219|NCT01679171|Elderly|elderly
442220|NCT01679171|Intensive care unit|intensive care unit
442221|NCT01679171|Outcome|outcome
442222|NCT01679171|Comprehensive geriatric assessment|comprehensive geriatric assessment
442223|NCT01679158|Using POSE as a treatment for Obesity|using pose as a treatment for obesity
442224|NCT01679145|Reward- based learning|reward- based learning
442225|NCT01679145|Pavlovian-to-instrumental transfer|pavlovian-to-instrumental transfer
442226|NCT01679145|Functional imaging|functional imaging
442227|NCT01679145|Relapse risk|relapse risk
442228|NCT01679119|Diffuse large b cell lymphoma|diffuse large b cell lymphoma
442229|NCT01679119|Inotuzumab Ozogamicin|inotuzumab ozogamicin
442230|NCT01679119|Gemcitabine|gemcitabine
442231|NCT01679119|Rituximab|rituximab
442232|NCT01679119|Cyclophosphamide|cyclophosphamide
442233|NCT01679119|Vincristine|vincristine
442234|NCT01679119|Prednisolone|prednisolone
442235|NCT01679106|renal transplant|renal transplant
442236|NCT01679106|flank incision|flank incision
442237|NCT01679093|postoperative analgesia|postoperative analgesia
442238|NCT01679093|paracetamol|paracetamol
442239|NCT01679093|5-HT3 antagonist|5-ht3 antagonist
442240|NCT01679093|ondansetron|ondansetron
442241|NCT01679093|PainMatcher|painmatcher
442242|NCT01679080|Drug therapy|drug therapy
442243|NCT01679080|Adult|adult
442244|NCT01679067|HIV|hiv
442245|NCT01679067|GALT|galt
442246|NCT01679054|Neoplasm|neoplasm
442247|NCT01679054|Gastric Cancer|gastric cancer
442248|NCT01679054|Cost|cost
442249|NCT01679028|T89 Safety in Healthy Japanese population|t89 safety in healthy japanese population
442250|NCT01679015|Burning|burning
442251|NCT01679015|Dryness|dryness
442252|NCT01679015|Itching|itching
442253|NCT01679015|Blurry Vision|blurry vision
442254|NCT01679002|Epilepsy|epilepsy
442255|NCT01679002|Oxcarbazepine|oxcarbazepine
442256|NCT01679002|Eslicarbazepine Acetate|eslicarbazepine acetate
442257|NCT01679002|BIA 2-093|bia 2-093
442258|NCT01678989|Bipolar disorder|bipolar disorder
442259|NCT01678989|Children|children
442260|NCT01678989|Cranial MRI|cranial mri
442261|NCT01678976|Eslicarbazepine acetate|eslicarbazepine acetate
442262|NCT01678976|Epilepsy|epilepsy
442263|NCT01678976|Oxcarbazepine|oxcarbazepine
442264|NCT01678963|Neovascular AMD|neovascular amd
442265|NCT01678963|Wet AMD|wet amd
442266|NCT01678963|AMD|amd
442267|NCT01678963|Age related macular degeneration|age related macular degeneration
442268|NCT01678950|Cardiac output monitoring|cardiac output monitoring
442269|NCT01678950|Echocardiography|echocardiography
442270|NCT01678950|Pulse contour system|pulse contour system
442271|NCT01678937|Immunosuppression|immunosuppression
442272|NCT01678911|Pelvic Pain|pelvic pain
442273|NCT01678911|Chronic Pelvic Pain|chronic pelvic pain
442274|NCT01678911|Irritable Bowel Syndrome|irritable bowel syndrome
442275|NCT01678911|IBS|ibs
442276|NCT01678911|Ulcerative Colitis|ulcerative colitis
442277|NCT01678911|UC|uc
442278|NCT01678911|Interstitial Cystitis|interstitial cystitis
442279|NCT01678911|IC|ic
442280|NCT01678911|Prostatitis|prostatitis
442281|NCT01678911|Pain|pain
442282|NCT01678898|Fabry disease|fabry disease
442283|NCT01678898|Alpha galactosidase deficiency|alpha galactosidase deficiency
442284|NCT01678898|Metabolic storage disease|metabolic storage disease
442285|NCT01678859|infertility|infertility
442286|NCT01678859|cervical|cervical
442287|NCT01678859|mucus|mucus
442288|NCT01678859|sperm|sperm
442289|NCT01678859|interaction|interaction
442290|NCT01678846|corporal punishment|corporal punishment
442291|NCT01678846|violence|violence
442292|NCT01678846|education|education
442293|NCT01678846|depression|depression
442294|NCT01678846|anxiety|anxiety
442295|NCT01678846|conduct disorder|conduct disorder
442296|NCT01678833|Drug Abuse/Dependence|drug abuse/dependence
442297|NCT01678794|Chronic heart failure (CHF)|chronic heart failure (chf)
442298|NCT01678794|cardiac and renal dysfunction|cardiac and renal dysfunction
442299|NCT01678781|Abdominal pain|abdominal pain
442300|NCT01678781|Diarrhea|diarrhea
442301|NCT01678781|Mebeverine hydrochloride|mebeverine hydrochloride
442302|NCT01678781|Constipation|constipation
442303|NCT01678781|Pinaverium bromide|pinaverium bromide
442304|NCT01678781|Irritable bowel syndrome|irritable bowel syndrome
442305|NCT01678781|Bloating|bloating
442306|NCT01678781|Quality of life|quality of life
442307|NCT01678755|schizophrenia|schizophrenia
442308|NCT01678742|Diet|diet
442309|NCT01678742|Incretins|incretins
442310|NCT01678742|Gastrointestinal Hormones|gastrointestinal hormones
442311|NCT01678742|Fish Proteins|fish proteins
442312|NCT01678729|refractive surgery|refractive surgery
442313|NCT01678729|pupil|pupil
442314|NCT01678729|Pupil size|pupil size
442315|NCT01678716|Anemia|anemia
442316|NCT01678716|Breastfeeding|breastfeeding
442317|NCT01678716|Complementary feeding|complementary feeding
442318|NCT01678716|Stunting|stunting
442319|NCT01678716|Wasting|wasting
442320|NCT01678716|Underweight|underweight
442321|NCT01678716|Micronutrient powder|micronutrient powder
442322|NCT01678716|Behavior change counseling|behavior change counseling
442323|NCT01678716|Frontline health worker|frontline health worker
442324|NCT01678703|late abortion|late abortion
442325|NCT01678703|laminaria|laminaria
442326|NCT01678703|Misoprostol|misoprostol
442327|NCT01678703|Cervical preparation|cervical preparation
442328|NCT01678677|non-typeable Haemophilus influenzae|non-typeable haemophilus influenzae
442329|NCT01678677|immunogenicity|immunogenicity
442330|NCT01678677|reactogenicity|reactogenicity
442331|NCT01678677|safety|safety
442332|NCT01678664|cancer|cancer
442333|NCT01678664|neuroendocrine tumors|neuroendocrine tumors
442334|NCT01678664|gastrointestinal tract|gastrointestinal tract
442335|NCT01678664|metastases|metastases
442336|NCT01678664|liver|liver
442337|NCT01678664|hepatic|hepatic
442338|NCT01678651|time-lapse, FSH, kinetics|time-lapse, fsh, kinetics
442339|NCT01678638|inguinal hernia|inguinal hernia
442340|NCT01678638|premature infants|premature infants
442341|NCT01678638|anesthesia safety|anesthesia safety
442342|NCT01678638|neurodevelopmental outcome|neurodevelopmental outcome
442343|NCT01678638|preterm infants|preterm infants
442344|NCT01678638|neonatal prematurity|neonatal prematurity
442345|NCT01678625|Residual neuromuscular blockade|residual neuromuscular blockade
442346|NCT01678625|Train-of-four|train-of-four
442347|NCT01678625|Acceleromyography|acceleromyography
442348|NCT01678625|Electromyography|electromyography
442349|NCT01678612|Copper|copper
442350|NCT01678612|Health-Acquired Infections|health-acquired infections
442351|NCT01678612|Bacterial Load|bacterial load
442352|NCT01678612|Intensive Care Units, Pediatric|intensive care units, pediatric
442353|NCT01678599|Chagas Disease|chagas disease
442354|NCT01678599|PCR|pcr
442355|NCT01678599|diagnosis|diagnosis
442356|NCT01678586|Pain|pain
442357|NCT01678586|Pain management|pain management
442358|NCT01678573|Healthy|healthy
442359|NCT01678573|Pharmacokinetics|pharmacokinetics
442360|NCT01678573|Abiraterone acetate|abiraterone acetate
442361|NCT01678573|Abiraterone|abiraterone
442362|NCT01678573|JNJ-212082|jnj-212082
442363|NCT01678573|Zytiga|zytiga
442364|NCT01678573|Chinese|chinese
442365|NCT01678573|Fasted|fasted
442366|NCT01678560|Obstructive sleep apnea PAP adherence efficacy economics|obstructive sleep apnea pap adherence efficacy economics
442367|NCT01678547|Stroke|stroke
442368|NCT01678547|Robot|robot
442369|NCT01678547|Treatment|treatment
442370|NCT01678547|Rehabilitation|rehabilitation
442371|NCT01678534|Cerebral infarction|cerebral infarction
442372|NCT01678534|Cellular therapy|cellular therapy
442373|NCT01678521|Hypercholesterolemia|hypercholesterolemia
442374|NCT01678521|LDL-apheresis|ldl-apheresis
442375|NCT01678521|Coronary artery disease|coronary artery disease
442376|NCT01678521|PTX3|ptx3
442377|NCT01678521|CRP|crp
442378|NCT01678521|IL6|il6
442379|NCT01678521|IL10|il10
442380|NCT01678482|Acne, LED, blue light|acne, led, blue light
442381|NCT01678456|Atrial Fibrillation|atrial fibrillation
442382|NCT01678456|Critical Event Committee|critical event committee
442383|NCT01678456|Serious adverse events|serious adverse events
442384|NCT01678456|Thromboembolic complications|thromboembolic complications
442385|NCT01678456|Cardiac and noncardiac complications|cardiac and noncardiac complications
442386|NCT01678456|Bleeding complications|bleeding complications
442387|NCT01678456|Acute heart failure|acute heart failure
442388|NCT01678456|Syncope|syncope
442389|NCT01678456|Resuscitation|resuscitation
442390|NCT01678430|Chronic Lymphocytic Leukaemia|chronic lymphocytic leukaemia
442391|NCT01678430|Less fit|less fit
442392|NCT01678430|CD20 antibody|cd20 antibody
442393|NCT01678430|Ofatumumab|ofatumumab
442394|NCT01678430|Chlorambucil|chlorambucil
442395|NCT01678430|Bendamustine|bendamustine
442396|NCT01678378|Adolescent|adolescent
442397|NCT01678378|Intervention|intervention
442398|NCT01678378|Female|female
442399|NCT01678378|Male|male
442400|NCT01678378|Interpersonal Relations|interpersonal relations
442401|NCT01678378|School Health Services|school health services
442402|NCT01678378|Community-Based Participatory Research|community-based participatory research
442403|NCT01678378|Randomized Controlled Trial|randomized controlled trial
442404|NCT01678378|Health Care Provider|health care provider
442405|NCT01678378|Training Program|training program
442406|NCT01678378|Harm Reduction|harm reduction
442407|NCT01678378|Prevention|prevention
442408|NCT01678378|Reproductive Coercion|reproductive coercion
442409|NCT01678378|Tech-Based Abuse|tech-based abuse
442410|NCT01678378|Social Environment|social environment
442411|NCT01678378|Sexual Partners|sexual partners
442412|NCT01678365|complicated appendicitis|complicated appendicitis
442413|NCT01678365|Children|children
442414|NCT01678365|conservative therapy|conservative therapy
442415|NCT01678365|Study population: Children 1 month - 14 years with Complicated appendicitis|study population: children 1 month - 14 years with complicated appendicitis
442416|NCT01678365|Type of the study: prospective, open randomized|type of the study: prospective, open randomized
442417|NCT01678352|Glioma|glioma
442418|NCT01678352|Vaccine|vaccine
442419|NCT01678352|Immunotherapy|immunotherapy
442420|NCT01678352|WHO Grade II|who grade ii
442421|NCT01678339|ACS|acs
442422|NCT01678339|AMI|ami
442423|NCT01678326|Diseases Classified Elsewhere|diseases classified elsewhere
442424|NCT01678313|Benign prostatic hyperplasia (BPH)|benign prostatic hyperplasia (bph)
442425|NCT01678313|Lower urinary tract symptoms (LUTS)|lower urinary tract symptoms (luts)
442426|NCT01678313|Prostatic specific antigen (PSA)|prostatic specific antigen (psa)
442427|NCT01678313|Cyclooxygenase-2 (COX-2)|cyclooxygenase-2 (cox-2)
442428|NCT01678300|Ulcerative Colitis|ulcerative colitis
442429|NCT01678287|ASP1941|asp1941
442430|NCT01678274|Turner Syndrome|turner syndrome
442431|NCT01678274|Aortic Aneurysm|aortic aneurysm
442432|NCT01678274|Ischemic heart disease|ischemic heart disease
442433|NCT01678274|Hypertension|hypertension
442434|NCT01678274|Congenital Heart Defect|congenital heart defect
442435|NCT01678274|Pulse Wave Velocity|pulse wave velocity
442436|NCT01678274|Augmentation Index|augmentation index
442437|NCT01678274|Central Blood Pressure|central blood pressure
442438|NCT01678274|Agatston Score|agatston score
442439|NCT01678274|Segment involvement score|segment involvement score
442440|NCT01678261|Sex chromosome|sex chromosome
442441|NCT01678261|Turner Syndrome|turner syndrome
442442|NCT01678261|Klinefelter Syndrome|klinefelter syndrome
442443|NCT01678261|Triple X Syndrome|triple x syndrome
442444|NCT01678261|47 XYY syndrome|47 xyy syndrome
442445|NCT01678261|Aortic Aneurysm|aortic aneurysm
442446|NCT01678261|Epigenetics|epigenetics
442447|NCT01678261|Transcriptome|transcriptome
442448|NCT01678261|non-coding RNA|non-coding rna
442449|NCT01678235|diabetes|diabetes
442450|NCT01678235|insulin pump|insulin pump
442451|NCT01678235|glulisine|glulisine
442452|NCT01678235|aspart|aspart
442453|NCT01678235|glycemic index|glycemic index
442454|NCT01678222|Lymphocyte|lymphocyte
442455|NCT01678222|Prostaglandin Endoperoxidase Synthase 2|prostaglandin endoperoxidase synthase 2
442456|NCT01678222|COX-2|cox-2
442457|NCT01678209|Attention Deficit Hyperactivity Disorder|attention deficit hyperactivity disorder
442458|NCT01678209|Stimulant|stimulant
442459|NCT01678209|Non-stimulant|non-stimulant
442460|NCT01678209|Drug|drug
442461|NCT01678209|Methylphenidate|methylphenidate
442462|NCT01678209|Atomoxetine|atomoxetine
442463|NCT01678209|Strattera|strattera
442464|NCT01678209|Concerta|concerta
442465|NCT01678209|MACRO|macro
442466|NCT01678209|Medication|medication
442467|NCT01678209|Treatment|treatment
442468|NCT01678209|Youth|youth
442469|NCT01678209|Adolescent|adolescent
442470|NCT01678209|Functional Magnetic Resonance Imaging|functional magnetic resonance imaging
442471|NCT01678209|Brain scan|brain scan
442472|NCT01678209|Imaging|imaging
442473|NCT01678209|Response inhibition|response inhibition
442474|NCT01678209|Inattentive|inattentive
442475|NCT01678209|Hyperactive|hyperactive
442476|NCT01678209|Combined|combined
442477|NCT01678209|Medication Treatment|medication treatment
442478|NCT01678209|Brain Imaging|brain imaging
442479|NCT01678196|Family Members|family members
442480|NCT01678196|Community Outreach|community outreach
442481|NCT01678196|Internet|internet
442482|NCT01678170|blood-oxygen functional imaging technology|blood-oxygen functional imaging technology
442483|NCT01678170|diagnosis|diagnosis
442484|NCT01678157|Esophageal Hernia|esophageal hernia
442485|NCT01678157|Hernia, Esophageal|hernia, esophageal
442486|NCT01678157|Hernia, Paraesophageal|hernia, paraesophageal
442487|NCT01678157|Hiatal Hernia|hiatal hernia
442488|NCT01678157|Paraesophageal Hiatal Hernia|paraesophageal hiatal hernia
442489|NCT01678157|Sliding Esophageal Hernia|sliding esophageal hernia
442490|NCT01678157|Sliding Hiatal Hernia|sliding hiatal hernia
442491|NCT01678144|mitral valve|mitral valve
442492|NCT01678144|mitral surgery|mitral surgery
442493|NCT01678144|mitral repair|mitral repair
442494|NCT01678144|mitral annuloplasty|mitral annuloplasty
442495|NCT01678144|mitral valve surgery|mitral valve surgery
442496|NCT01678144|mitral valve repair|mitral valve repair
442497|NCT01678144|mitral valve annuloplasty|mitral valve annuloplasty
442498|NCT01678118|Patient Navigation|patient navigation
442499|NCT01678118|Tobacco dependent|tobacco dependent
442500|NCT01678118|smoking|smoking
442501|NCT01678118|Cessation|cessation
442502|NCT01678118|11-028|11-028
442503|NCT01678105|Recurrent Adenoid Cystic Carcinoma of the Salivary Glands|recurrent adenoid cystic carcinoma of the salivary glands
442504|NCT01678105|Metastatic Adenoid Cystic Carcinoma of the Salivary Glands|metastatic adenoid cystic carcinoma of the salivary glands
442505|NCT01678105|Salivary Gland Cancers|salivary gland cancers
442506|NCT01678105|ACC|acc
442507|NCT01678105|Dovitinib|dovitinib
442508|NCT01678105|TKI258|tki258
442509|NCT01678105|RTK Inhibitor|rtk inhibitor
442510|NCT01678079|Pregnancy|pregnancy
442511|NCT01678079|Micronutrient Powder|micronutrient powder
442512|NCT01678079|Calcium|calcium
442514|NCT01678079|Bangladesh|bangladesh
442515|NCT01678066|Noninvasive cardiac output.|noninvasive cardiac output.
442516|NCT01678066|Pediatrics.|pediatrics.
442517|NCT01678053|Botulinum Toxins, Type A|botulinum toxins, type a
442518|NCT01678040|Ventricular Volume|ventricular volume
442519|NCT01678040|Cardiac Magnetic Resonance|cardiac magnetic resonance
442520|NCT01678040|Echocardiogram|echocardiogram
442521|NCT01678027|Stomach neoplasm|stomach neoplasm
442522|NCT01678027|Helicobacter pylori|helicobacter pylori
442523|NCT01678014|Anorexia|anorexia
442524|NCT01678014|DBS|dbs
442525|NCT01678014|Capsulotomy|capsulotomy
442526|NCT01678014|Signs and Symptoms|signs and symptoms
442527|NCT01678001|plantar fascia|plantar fascia
442528|NCT01678001|plantar fascitis|plantar fascitis
442529|NCT01678001|botulinum toxin|botulinum toxin
442530|NCT01678001|Xeomin|xeomin
442531|NCT01677988|NEOADJUVANT FOLFIRINOX CHEMOTHERAPY|neoadjuvant folfirinox chemotherapy
442532|NCT01677988|LOCALIZED PANCREATIC HEAD ADENOCARCINOMA|localized pancreatic head adenocarcinoma
442533|NCT01677988|RADIATION THERAPY|radiation therapy
442534|NCT01677962|locally advanced, unresectable pancreatic adenocarcinoma|locally advanced, unresectable pancreatic adenocarcinoma
442535|NCT01677962|Poly ICLC|poly iclc
442536|NCT01677962|dendritic cells|dendritic cells
442537|NCT01677936|diabetes|diabetes
442538|NCT01677936|blood pressure|blood pressure
442539|NCT01677936|lipid|lipid
442540|NCT01677936|waist circumference|waist circumference
442541|NCT01677936|BMI|bmi
442542|NCT01677923|weight|weight
442543|NCT01677923|body mass index|body mass index
442544|NCT01677923|lipid profile|lipid profile
442545|NCT01677923|glucose profile|glucose profile
442546|NCT01677845|Localized Prostate Cancer|localized prostate cancer
442547|NCT01677845|Radiation|radiation
442548|NCT01677806|Percutaneous vertebroplasty|percutaneous vertebroplasty
442549|NCT01677741|Children and Adolescents|children and adolescents
442550|NCT01677741|BRAF|braf
442551|NCT01677741|dabrafenib|dabrafenib
442552|NCT01677741|dose escalation|dose escalation
442553|NCT01677741|BRF116013|brf116013
442554|NCT01677741|V600-mutation positive|v600-mutation positive
442555|NCT01677741|BRF|brf
442556|NCT01677728|colorectal liver metastases|colorectal liver metastases
442557|NCT01677728|chemotherapy|chemotherapy
442558|NCT01677728|cetuximab|cetuximab
442559|NCT01677728|bevacizumab|bevacizumab
442560|NCT01677689|oral temperature|oral temperature
442561|NCT01677689|respiratory symptom|respiratory symptom
442562|NCT01677689|cough|cough
442563|NCT01677689|nasal obstruction|nasal obstruction
442564|NCT01677689|sore throat|sore throat
442565|NCT01677689|fever|fever
442566|NCT01677676|Influenza A|influenza a
442567|NCT01677663|autism|autism
442568|NCT01677663|clinical phenotypes|clinical phenotypes
442569|NCT01677663|neuropsychology|neuropsychology
442570|NCT01677663|imaging endophenotypes|imaging endophenotypes
442571|NCT01677663|family-based cohort|family-based cohort
442572|NCT01677663|knoutout mice|knoutout mice
442573|NCT01677650|Spinal Fusion|spinal fusion
442574|NCT01677650|Opioid Analgesia|opioid analgesia
442575|NCT01677637|osteopenia, postmenopausal|osteopenia, postmenopausal
442576|NCT01677624|Hypervascular tumor|hypervascular tumor
442577|NCT01677624|arteriovenous malformation|arteriovenous malformation
442578|NCT01677624|arterial embolization|arterial embolization
442579|NCT01677611|Resveratrol|resveratrol
442580|NCT01677611|SIRT1|sirt1
442581|NCT01677611|AMPK|ampk
442582|NCT01677598|Plaque Psoriasis|plaque psoriasis
442583|NCT01677598|Ustekinumab|ustekinumab
442584|NCT01677598|CNTO 1275|cnto 1275
442585|NCT01677598|Asia-Pacific|asia-pacific
442586|NCT01677572|Aducanumab|aducanumab
442587|NCT01677572|BIIB037|biib037
442588|NCT01677546|diabetes|diabetes
442589|NCT01677546|insulin pump|insulin pump
442590|NCT01677546|bolus calculator|bolus calculator
442591|NCT01677546|Contour Link|contour link
442592|NCT01677533|Panel management|panel management
442593|NCT01677533|Clinical microsystems|clinical microsystems
442594|NCT01677533|Hypertension management|hypertension management
442595|NCT01677533|Smoking cessation|smoking cessation
442596|NCT01677533|Continuing medical education|continuing medical education
442597|NCT01677533|Quality improvement,|quality improvement,
442598|NCT01677533|Population health|population health
442599|NCT01677520|adipose-derived stem cells|adipose-derived stem cells
442600|NCT01677520|viable ADSCs|viable adscs
442601|NCT01677520|apoptosis|apoptosis
442602|NCT01677520|necrosis|necrosis
442603|NCT01677520|cryopreservation|cryopreservation
442604|NCT01677507|glaucoma|glaucoma
442605|NCT01677507|aqueous humor dynamics|aqueous humor dynamics
442606|NCT01677507|intraocular pressure|intraocular pressure
442607|NCT01677468|Hepatocellular carcinoma|hepatocellular carcinoma
442712|NCT01677104|Liraglutide|liraglutide
442608|NCT01677468|Transarterial chemoembolization|transarterial chemoembolization
442609|NCT01677455|Hsp90 inhibitor|hsp90 inhibitor
442610|NCT01677455|ganetespib|ganetespib
442611|NCT01677455|STA 9090|sta 9090
442612|NCT01677442|nonintubated|nonintubated
442613|NCT01677442|anaesthesia|anaesthesia
442614|NCT01677442|VATS|vats
442615|NCT01677429|panic disorder|panic disorder
442616|NCT01677429|balance impairment|balance impairment
442617|NCT01677429|virtual reality|virtual reality
442618|NCT01677416|Rheumatoid arthritis|rheumatoid arthritis
442619|NCT01677416|Ultrasonography|ultrasonography
442620|NCT01677416|Synovitis|synovitis
442621|NCT01677416|Foot joints|foot joints
442622|NCT01677403|Bronchiectasis|bronchiectasis
442623|NCT01677403|Tobramycin|tobramycin
442624|NCT01677403|nebulised|nebulised
442625|NCT01677390|Antibody-Drug Conjugate|antibody-drug conjugate
442626|NCT01677390|monomethylauristatin F|monomethylauristatin f
442627|NCT01677390|Carcinoma, Renal Cell|carcinoma, renal cell
442628|NCT01677390|Antigens, CD70|antigens, cd70
442629|NCT01677390|Drug Therapy|drug therapy
442630|NCT01677377|Schizophrenia|schizophrenia
442631|NCT01677377|Schizophrenic|schizophrenic
442632|NCT01677377|Schizophrenias|schizophrenias
442633|NCT01677364|induction of labour|induction of labour
442634|NCT01677364|heart disease patients|heart disease patients
442635|NCT01677351|clonidine|clonidine
442636|NCT01677351|cataract surgery|cataract surgery
442637|NCT01677351|arrythmia|arrythmia
442638|NCT01677351|anesthesic medication|anesthesic medication
442639|NCT01677286|AL Amyloidosis|al amyloidosis
442640|NCT01677286|Primary Amyloidosis|primary amyloidosis
442641|NCT01677286|Hereditary Amyloidosis|hereditary amyloidosis
442642|NCT01677286|Familial Amyloidosis|familial amyloidosis
442643|NCT01677286|SSA Amyloidosis|ssa amyloidosis
442644|NCT01677286|Senile Systemic Amyloidosis|senile systemic amyloidosis
442645|NCT01677286|AA Amyloidosis|aa amyloidosis
442646|NCT01677286|Secondary Amyloidosis|secondary amyloidosis
442647|NCT01677286|Localized Amyloidosis|localized amyloidosis
442648|NCT01677286|Systemic Amyloidosis|systemic amyloidosis
442649|NCT01677273|Respiratory chambers|respiratory chambers
442650|NCT01677273|Energy expenditure|energy expenditure
442651|NCT01677273|Appetite|appetite
442652|NCT01677273|Dairy proteins|dairy proteins
442653|NCT01677273|Diet induced thermogenesis|diet induced thermogenesis
442654|NCT01677273|Obesity|obesity
442655|NCT01677260|Biguanide|biguanide
442656|NCT01677260|anti-hyperglycaemic|anti-hyperglycaemic
442657|NCT01677260|bioavailability|bioavailability
442658|NCT01677260|bioequivalence|bioequivalence
442659|NCT01677260|metformin|metformin
442660|NCT01677260|pharmacokinetics|pharmacokinetics
442661|NCT01677247|sulphonylurea|sulphonylurea
442662|NCT01677247|anti-hyperglycaemic|anti-hyperglycaemic
442663|NCT01677247|bioavailability|bioavailability
442664|NCT01677247|bioequivalence|bioequivalence
442665|NCT01677247|glimepiride|glimepiride
442666|NCT01677247|pharmacokinetics|pharmacokinetics
442667|NCT01677234|Blood pressure|blood pressure
442668|NCT01677221|acne|acne
442669|NCT01677221|inflammatory acne|inflammatory acne
442670|NCT01677221|intense pulsed light|intense pulsed light
442671|NCT01677208|Acute Ischemic Stroke|acute ischemic stroke
442672|NCT01677208|Randomized Controlled Trial|randomized controlled trial
442673|NCT01677208|Traditional Chinese Medicine|traditional chinese medicine
442674|NCT01677195|Mycotoxins|mycotoxins
442675|NCT01677195|Aflatoxin|aflatoxin
442676|NCT01677195|Fumonisin|fumonisin
442677|NCT01677195|Aflatoxicosis|aflatoxicosis
442678|NCT01677195|Dietary|dietary
442679|NCT01677195|Cancer|cancer
442680|NCT01677182|Drug therapy|drug therapy
442681|NCT01677156|ASGES|asges
442682|NCT01677156|Corus CAD|corus cad
442683|NCT01677156|Age/Sex/Gene Expression Score|age/sex/gene expression score
442684|NCT01677156|Gene Expression|gene expression
442686|NCT01677156|CAD|cad
442687|NCT01677156|CVD|cvd
442688|NCT01677156|CHD|chd
442689|NCT01677156|Precision Medicine|precision medicine
442690|NCT01677156|Clinical Utility|clinical utility
442691|NCT01677156|Registry|registry
442692|NCT01677156|Coronary Artery Disease|coronary artery disease
442693|NCT01677156|Angina Pectoris|angina pectoris
442694|NCT01677156|Chest Pain|chest pain
442695|NCT01677156|Cardiovascular Disease|cardiovascular disease
442696|NCT01677156|Coronary Heart Disease|coronary heart disease
442697|NCT01677156|PRESET|preset
442698|NCT01677143|Local anesthetic|local anesthetic
442699|NCT01677143|Preemptive analgesia|preemptive analgesia
442700|NCT01677143|Postoperative pain|postoperative pain
442701|NCT01677143|Laparoscopy|laparoscopy
442702|NCT01677143|Gynecological surgery|gynecological surgery
442703|NCT01677143|Day-case surgery|day-case surgery
442704|NCT01677130|Clinical efficacy|clinical efficacy
442705|NCT01677130|safety|safety
442706|NCT01677130|of HFOV treatment|of hfov treatment
442707|NCT01677130|of patients|of patients
442708|NCT01677104|GLP-1|glp-1
442709|NCT01677104|DPP-IV inhibitor|dpp-iv inhibitor
442710|NCT01677104|microcirculation|microcirculation
442711|NCT01677104|Exenatide|exenatide
442713|NCT01677104|Linagliptin|linagliptin
442714|NCT01677091|Balance,Hemiplegia,Cervical vibration,Prism adaptation,Rehabilitation|balance,hemiplegia,cervical vibration,prism adaptation,rehabilitation
442715|NCT01677078|Major depressive disorder|major depressive disorder
442716|NCT01677078|rTMS|rtms
442717|NCT01677078|Neuronavigation|neuronavigation
442718|NCT01677065|Bioavailability|bioavailability
442719|NCT01677065|Oxycodone|oxycodone
442720|NCT01677065|Healthy Volunteers|healthy volunteers
442721|NCT01677039|Bioavailability|bioavailability
442722|NCT01677039|oxycodone|oxycodone
442723|NCT01677039|ethanol interaction|ethanol interaction
442724|NCT01677039|healthy volunteers|healthy volunteers
442725|NCT01677013|Type 2; diabetes mellitus; stem cell; safety; efficacy|type 2; diabetes mellitus; stem cell; safety; efficacy
442726|NCT01677000|bone infection|bone infection
442727|NCT01677000|staphylococcus aureus|staphylococcus aureus
442728|NCT01677000|registry|registry
442729|NCT01676987|Asthma|asthma
442730|NCT01676987|Budesonide|budesonide
442731|NCT01676987|Adrenergic beta-2 receptor agonists.|adrenergic beta-2 receptor agonists.
442732|NCT01676974|Drug Resistance, Microbial|drug resistance, microbial
442733|NCT01676974|Enterobacteriaceae|enterobacteriaceae
442734|NCT01676974|ESBL|esbl
442735|NCT01676974|Carbapenemase|carbapenemase
442736|NCT01676974|Travel|travel
442737|NCT01676948|SJIA|sjia
442738|NCT01676948|Systemic Juvenile Idiopathic Arthritis|systemic juvenile idiopathic arthritis
442739|NCT01676948|children|children
710248|NCT00589589|glucose monitoring|glucose monitoring
442740|NCT01676948|systemic autoinflammatory disease, ACZ885, canakinumab|systemic autoinflammatory disease, acz885, canakinumab
442741|NCT01676948|human monoclonal anti-interleukin-1β (IL-1 β) antibody|human monoclonal anti-interleukin-1β (il-1 β) antibody
442742|NCT01676948|hildhood immunizations vaccinations|hildhood immunizations vaccinations
442743|NCT01676909|self-management|self-management
442744|NCT01676896|children|children
442745|NCT01676896|asthma|asthma
442746|NCT01676896|quality of life|quality of life
442747|NCT01676896|self-management|self-management
442748|NCT01676883|Body constitution|body constitution
442749|NCT01676883|Anthropometry|anthropometry
442750|NCT01676883|Electric impedance|electric impedance
442751|NCT01676870|exercise training|exercise training
442752|NCT01676870|exercise therapy|exercise therapy
442753|NCT01676870|physical fitness|physical fitness
442754|NCT01676870|risk factors|risk factors
442755|NCT01676857|chronic pain, prostatitis, pelvic pain|chronic pain, prostatitis, pelvic pain
442756|NCT01676844|Phosphorus|phosphorus
442757|NCT01676844|Phosphate|phosphate
442758|NCT01676844|Hypophosphataemia|hypophosphataemia
442759|NCT01676844|Osteopenia|osteopenia
442760|NCT01676844|Prematurity|prematurity
442761|NCT01676805|Developing Novel Treatment Approaches|developing novel treatment approaches
442762|NCT01676805|Developing Therapeutic Agents|developing therapeutic agents
442763|NCT01676805|Analysis of Genetic and Genomic Biology|analysis of genetic and genomic biology
442764|NCT01676805|New Prognostic and Diagnostic Models|new prognostic and diagnostic models
442765|NCT01676805|Analysis of Cellular and Molecular Biology|analysis of cellular and molecular biology
442766|NCT01676792|condyloma acuminate|condyloma acuminate
442767|NCT01676792|ano-genital warts|ano-genital warts
442768|NCT01676792|genital warts|genital warts
442769|NCT01676792|cutaneous condyloma|cutaneous condyloma
442770|NCT01676792|Vulva pre-cancerous lesions|vulva pre-cancerous lesions
442771|NCT01676792|Vulvar Intraepitheral Neoplasia|vulvar intraepitheral neoplasia
442772|NCT01676792|VIN|vin
442773|NCT01676792|EGW|egw
442774|NCT01676779|melanoma|melanoma
442775|NCT01676779|no evidence of disease|no evidence of disease
442776|NCT01676779|resection|resection
442777|NCT01676779|macro-metastases|macro-metastases
442778|NCT01676766|Stargardt Disease|stargardt disease
442779|NCT01676766|Macular degeneration|macular degeneration
442780|NCT01676766|Retinal dystrophy|retinal dystrophy
442781|NCT01676740|hematinic therapy|hematinic therapy
442782|NCT01676740|blood transfusion|blood transfusion
442783|NCT01676740|joint replacement|joint replacement
442784|NCT01676727|Transcatheter Aortic valve Implantation|transcatheter aortic valve implantation
442785|NCT01676727|Heart Valve Diseases|heart valve diseases
442786|NCT01676727|Cardiovascular Diseases|cardiovascular diseases
442787|NCT01676714|Dovitinib|dovitinib
442788|NCT01676714|Fibroblast Growth Factor Receptor Biomarkers|fibroblast growth factor receptor biomarkers
442789|NCT01676714|Anti-Vascular Endothelial Growth Factor Therapy|anti-vascular endothelial growth factor therapy
442790|NCT01676688|alpha-1 antitrypsin|alpha-1 antitrypsin
442791|NCT01676688|deficiency|deficiency
442792|NCT01676688|Alfalastin|alfalastin
442793|NCT01676688|safety|safety
442794|NCT01676675|whole virus|whole virus
442795|NCT01676675|inactivated|inactivated
442796|NCT01676675|influenza|influenza
442797|NCT01676675|H5N1 vaccine|h5n1 vaccine
442798|NCT01676675|safety|safety
442799|NCT01676675|immunogenicity|immunogenicity
442800|NCT01676662|Urinary Incontinence|urinary incontinence
442801|NCT01676662|Urinary Incontinence, Stress|urinary incontinence, stress
442802|NCT01676662|Urination Disorders|urination disorders
442803|NCT01676662|Urologic Diseases|urologic diseases
442804|NCT01676662|Urological Manifestations|urological manifestations
442805|NCT01676662|Signs and Symptoms|signs and symptoms
442806|NCT01676636|Pregnancy|pregnancy
442807|NCT01676636|Calcium|calcium
442808|NCT01676636|Supplements|supplements
442809|NCT01676623|Child nutrition|child nutrition
442810|NCT01676623|Stunting|stunting
442811|NCT01676623|Exclusive breastfeeding|exclusive breastfeeding
442812|NCT01676623|Complementary feeding|complementary feeding
442813|NCT01676623|Social franchise|social franchise
442814|NCT01676623|Mass media|mass media
442815|NCT01676623|Counseling|counseling
442816|NCT01676623|Facility-based|facility-based
442817|NCT01676610|Pulse Oximetry|pulse oximetry
442818|NCT01676610|Pediatrics|pediatrics
442819|NCT01676610|Pakistan|pakistan
442820|NCT01676610|Hypoxemia|hypoxemia
442821|NCT01676610|Neonatal Sepsis|neonatal sepsis
442822|NCT01676610|Pneumonia|pneumonia
442823|NCT01676558|diffuse large B cell lymphoma|diffuse large b cell lymphoma
442824|NCT01676558|radioimmunotherapy|radioimmunotherapy
442825|NCT01676558|131I-rituximab|131i-rituximab
442826|NCT01676532|School Board Health Center|school board health center
442827|NCT01676532|Pediatrics|pediatrics
442828|NCT01676506|Wet AMD|wet amd
442829|NCT01676506|genetic polymorphisms|genetic polymorphisms
442830|NCT01676506|Ranibizumab|ranibizumab
442831|NCT01676480|Prostate cancer|prostate cancer
442832|NCT01676480|ADT|adt
442833|NCT01676480|Endurance training|endurance training
442834|NCT01676454|Vasopressin|vasopressin
442835|NCT01676454|Trauma|trauma
442836|NCT01676454|Injury|injury
442837|NCT01676441|spinal cord injury|spinal cord injury
442838|NCT01676441|mesenchymal stem cell|mesenchymal stem cell
442839|NCT01676428|Kidney|kidney
442840|NCT01676428|Renal|renal
442841|NCT01676428|Radiotherapy|radiotherapy
442842|NCT01676428|Stereotactic|stereotactic
442843|NCT01676428|Cancer|cancer
442844|NCT01676415|Sinus disease|sinus disease
442845|NCT01676415|Sinonasal complaints|sinonasal complaints
442846|NCT01676415|Chronic sinusitis|chronic sinusitis
442847|NCT01676415|Nasal polyps|nasal polyps
442848|NCT01676415|Chronic rhinosinusitis without nasal polyps|chronic rhinosinusitis without nasal polyps
442849|NCT01676415|Glucocorticoids|glucocorticoids
442850|NCT01676415|Prednisone|prednisone
442851|NCT01676415|Topical mometasone|topical mometasone
442852|NCT01676415|Anti-inflammatory agents|anti-inflammatory agents
442853|NCT01676402|Influenza A (H1)|influenza a (h1)
442854|NCT01676402|Influenza A (H3)|influenza a (h3)
442855|NCT01676402|Influenza B|influenza b
442856|NCT01676402|DNA Vaccine|dna vaccine
442857|NCT01676402|Trivalent Inactivated Vaccine (TIV)|trivalent inactivated vaccine (tiv)
442858|NCT01676402|Healthy Adults|healthy adults
442859|NCT01676402|Intradermal (ID)|intradermal (id)
442860|NCT01676389|Autism Spectrum Disorders|autism spectrum disorders
442861|NCT01676376|CABG|cabg
442862|NCT01676376|SVG|svg
442863|NCT01676376|nitinol mesh|nitinol mesh
442864|NCT01676376|external saphenous vein graft support|external saphenous vein graft support
442865|NCT01676363|diflunisal|diflunisal
442866|NCT01676363|anti-inflammatory agents, non-steroidal|anti-inflammatory agents, non-steroidal
442867|NCT01676363|antiviral agents|antiviral agents
442868|NCT01676350|Intraosseous (IO) vascular access|intraosseous (io) vascular access
442869|NCT01676337|Text messaging|text messaging
442870|NCT01676337|Clinic appointment attendance|clinic appointment attendance
442871|NCT01676337|Emergency department|emergency department
442872|NCT01676337|Primary care|primary care
442873|NCT01676324|Fecal Calprotectin|fecal calprotectin
442874|NCT01676311|cognition|cognition
442875|NCT01676311|seizures|seizures
442876|NCT01676311|electroencephalography|electroencephalography
442877|NCT01676311|transcranial magnetic stimulation|transcranial magnetic stimulation
442878|NCT01676311|huperzine|huperzine
442879|NCT01676311|chinese club moss|chinese club moss
442880|NCT01676298|Cyp2C19|cyp2c19
442881|NCT01676298|Genotyping|genotyping
442882|NCT01676298|Spartan|spartan
442883|NCT01676298|Reproducibility|reproducibility
442884|NCT01676285|Cirrhosis|cirrhosis
442885|NCT01676285|cirrhotic cardiomyopathy|cirrhotic cardiomyopathy
442886|NCT01676285|cardiac remodeling|cardiac remodeling
442887|NCT01676285|cardiomyopathy|cardiomyopathy
442888|NCT01676285|metoprolol succinate|metoprolol succinate
442889|NCT01676285|betablockers|betablockers
442890|NCT01676259|siRNA|sirna
442891|NCT01676259|RNA interference (RNAi)|rna interference (rnai)
442892|NCT01676259|Cancer|cancer
442893|NCT01676259|Pancreatic ductal adenocarcinoma|pancreatic ductal adenocarcinoma
442894|NCT01676259|Locally Advanced Pancreatic cancer|locally advanced pancreatic cancer
442895|NCT01676259|Solid tumor|solid tumor
442896|NCT01676259|Non operable pancreatic ductal adenocarcinoma|non operable pancreatic ductal adenocarcinoma
442897|NCT01676207|coronary collateral circulation|coronary collateral circulation
442898|NCT01676207|extracardiac coronary collaterals|extracardiac coronary collaterals
442899|NCT01676207|coronary artery disease|coronary artery disease
442900|NCT01676207|coronary circulation|coronary circulation
442901|NCT01676207|internal mammary artery|internal mammary artery
442902|NCT01676194|Transarterial Chemoembolization|transarterial chemoembolization
442903|NCT01676194|Liver transplantation|liver transplantation
442904|NCT01676194|Hepatocellular carcinoma|hepatocellular carcinoma
442905|NCT01676181|Obstructive sleep apnea syndrome|obstructive sleep apnea syndrome
442906|NCT01676181|Children|children
442907|NCT01676181|Polysomnography|polysomnography
442908|NCT01676181|Surgery|surgery
442909|NCT01676181|Coblation|coblation
442910|NCT01676181|Tonsils|tonsils
442911|NCT01676181|Tonsillectomy|tonsillectomy
442912|NCT01676155|Tuberculosis, latent tuberculosis infection, apoptosis, predictor|tuberculosis, latent tuberculosis infection, apoptosis, predictor
442913|NCT01676129|temporomandibular joint disorders|temporomandibular joint disorders
442914|NCT01676129|nocipoint|nocipoint
442915|NCT01676129|physical therapy|physical therapy
442916|NCT01676103|Parkinson's Disease (PD)|parkinson's disease (pd)
442917|NCT01676103|Orthostatic hypotension (OH)|orthostatic hypotension (oh)
442918|NCT01676077|LGMD2B|lgmd2b
442919|NCT01676077|Miyoshi Myopathy|miyoshi myopathy
442920|NCT01676077|Dysferlin|dysferlin
442921|NCT01676077|Dysferlinopathy|dysferlinopathy
442922|NCT01676077|Limb Girdle muscular dystrophy type 2b|limb girdle muscular dystrophy type 2b
442923|NCT01676077|Muscular Dystrophy|muscular dystrophy
442924|NCT01676064|intraocular pressure|intraocular pressure
442925|NCT01676064|perioperative fluid|perioperative fluid
442926|NCT01676064|trendelenburg position|trendelenburg position
442927|NCT01676064|laparoscopic gynecologic surgery|laparoscopic gynecologic surgery
565819|NCT01154296|HIV|hiv
442928|NCT01676038|Total Knee Replacement, Computer-Assisted Surgery|total knee replacement, computer-assisted surgery
442929|NCT01676025|pheochromocytoma|pheochromocytoma
442930|NCT01676025|aldosteronism|aldosteronism
442931|NCT01676025|cushing's syndrome|cushing's syndrome
442932|NCT01676025|adrenal incidentaloma|adrenal incidentaloma
442933|NCT01676025|Conn's syndrome|conn's syndrome
442934|NCT01675999|Neoadjuvant chemotherapy|neoadjuvant chemotherapy
442935|NCT01675999|Locally advanced malignant neoplasm|locally advanced malignant neoplasm
442936|NCT01675999|colon cancer|colon cancer
442937|NCT01675973|Ranolazine|ranolazine
442938|NCT01675973|renal impairment|renal impairment
442939|NCT01675960|chronic irritability|chronic irritability
442940|NCT01675960|chronic pain|chronic pain
442941|NCT01675960|Neurologically impaired|neurologically impaired
442942|NCT01675960|gabapentin|gabapentin
442943|NCT01675921|Asthma|asthma
442944|NCT01675921|Facebook|facebook
442945|NCT01675921|teenagers|teenagers
442946|NCT01675921|ACT|act
442947|NCT01675895|Hyperbaric Levobupivacaine|hyperbaric levobupivacaine
442948|NCT01675895|İntrathecal|intrathecal
442949|NCT01675895|Lidocaine|lidocaine
442950|NCT01675895|TUR-P|tur-p
442951|NCT01675882|Food allergy|food allergy
442952|NCT01675882|Immediate hypersensitivity|immediate hypersensitivity
442953|NCT01675882|Whole peanut extract|whole peanut extract
442954|NCT01675882|Allergenic product|allergenic product
442955|NCT01675882|Specific Immunotherapy|specific immunotherapy
442956|NCT01675882|Epicutaneous Immunotherapy (EPIT)|epicutaneous immunotherapy (epit)
442957|NCT01675869|Attention-Deficit/Hyperactivity Disorder|attention-deficit/hyperactivity disorder
442958|NCT01675869|Executive function|executive function
442959|NCT01675869|Preschooler|preschooler
442960|NCT01675869|Metacognition|metacognition
442961|NCT01675856|Glasgow-Blatchford score|glasgow-blatchford score
442962|NCT01675856|Gastrointestinal bleeding|gastrointestinal bleeding
442963|NCT01675843|Infertility|infertility
442964|NCT01675843|PCOS|pcos
442965|NCT01675843|IUI|iui
442966|NCT01675817|heparin rebound|heparin rebound
442967|NCT01675817|protamine|protamine
442968|NCT01675817|cardiopulmonary bypass|cardiopulmonary bypass
442969|NCT01675817|cardiac surgery|cardiac surgery
442970|NCT01675817|anti-Xa|anti-xa
442971|NCT01675817|anti-IIa|anti-iia
442972|NCT01675804|ADHD|adhd
442973|NCT01675778|hydromorphone|hydromorphone
442974|NCT01675778|acute pain|acute pain
442975|NCT01675778|emergency department|emergency department
442976|NCT01675765|Cancer|cancer
442977|NCT01675765|Cancer vaccine|cancer vaccine
442978|NCT01675765|Listeria monocytogenes|listeria monocytogenes
442979|NCT01675765|Listeria-based vaccines|listeria-based vaccines
442980|NCT01675765|Pemetrexed|pemetrexed
442981|NCT01675765|Cisplatin|cisplatin
442982|NCT01675765|T regulatory cells|t regulatory cells
442983|NCT01675765|Mesothelin|mesothelin
442984|NCT01675765|Malignant Pleural Mesothelioma|malignant pleural mesothelioma
442985|NCT01675765|Chemotherapy|chemotherapy
442986|NCT01675765|Standard of care|standard of care
442987|NCT01675765|Naive|naive
442988|NCT01675765|Front-line|front-line
442989|NCT01675765|Immunotherapy|immunotherapy
442990|NCT01675765|MPM|mpm
442991|NCT01675752|colonoscopy, narrow-band imaging|colonoscopy, narrow-band imaging
442992|NCT01675739|colonoscopy|colonoscopy
442993|NCT01675739|bowel preparation|bowel preparation
442994|NCT01675739|short message service|short message service
442995|NCT01675713|Lifestyle|lifestyle
442996|NCT01675713|Physical activity|physical activity
442997|NCT01675700|Myofascial pain|myofascial pain
442998|NCT01675700|Trigger point|trigger point
442999|NCT01675700|Nitroglycerin|nitroglycerin
443000|NCT01675687|dietary habits and obesity|dietary habits and obesity
443001|NCT01675687|exercise habits and obesity|exercise habits and obesity
443002|NCT01675687|cognition and obesity|cognition and obesity
443003|NCT01675674|Mucopolysaccharidoses|mucopolysaccharidoses
443004|NCT01675674|Prevalence|prevalence
443005|NCT01675674|Pediatric|pediatric
443006|NCT01675674|Rheumatology|rheumatology
443007|NCT01675674|Mucopolysaccharidosis I|mucopolysaccharidosis i
443008|NCT01675674|Mucopolysaccharidosis II|mucopolysaccharidosis ii
443009|NCT01675674|Mucopolysaccharidosis IV|mucopolysaccharidosis iv
443010|NCT01675674|Mucopolysaccharidosis VI|mucopolysaccharidosis vi
443011|NCT01675648|Opiate dependent|opiate dependent
443012|NCT01675648|inpatient detoxification|inpatient detoxification
443013|NCT01675622|Cancer Pain|cancer pain
443014|NCT01675596|Aortic Stenosis|aortic stenosis
443015|NCT01675596|Transfemoral|transfemoral
443016|NCT01675596|Transcatheter Heart Valve|transcatheter heart valve
443017|NCT01675583|Diabetic Wounds|diabetic wounds
443018|NCT01675583|Hyperbaric Oxygen|hyperbaric oxygen
443019|NCT01675583|Laser Speckle Imaging|laser speckle imaging
443020|NCT01675583|Hyperbaric Oxygenation|hyperbaric oxygenation
443021|NCT01675570|RX-10045|rx-10045
443022|NCT01675570|Dry Eye Disease|dry eye disease
443023|NCT01675557|chronic kidney disease|chronic kidney disease
443024|NCT01675544|Heart failure|heart failure
443025|NCT01675531|Targin|targin
443026|NCT01675531|Chemotherapy Induced Peripheral Neuropathy (CIPN)|chemotherapy induced peripheral neuropathy (cipn)
443027|NCT01675518|Plasma concentration|plasma concentration
443028|NCT01675518|ASP7991|asp7991
443029|NCT01675518|food effect|food effect
443030|NCT01675518|PTH (parathyroid hormone)|pth (parathyroid hormone)
443031|NCT01675492|Astigmatism|astigmatism
443032|NCT01675492|refractive|refractive
443033|NCT01675492|error|error
443034|NCT01675492|LASIK|lasik
443035|NCT01675479|refractive|refractive
443036|NCT01675479|errors|errors
443037|NCT01675466|non-specific abdominal pain|non-specific abdominal pain
443038|NCT01675466|undifferentiated abdominal pain|undifferentiated abdominal pain
443039|NCT01675466|appendicitis|appendicitis
443040|NCT01675466|appendicectomy|appendicectomy
443041|NCT01675466|appendectomy|appendectomy
443042|NCT01675466|surgery|surgery
443043|NCT01675466|laparoscopy|laparoscopy
443044|NCT01675466|antibiotics|antibiotics
443045|NCT01675466|randomised controlled trial|randomised controlled trial
443046|NCT01675466|randomized controlled trial|randomized controlled trial
443047|NCT01675466|controlled clinical trial|controlled clinical trial
443048|NCT01675466|randomised|randomised
443049|NCT01675466|placebo|placebo
443050|NCT01675453|Organ dysfunction|organ dysfunction
443051|NCT01675453|Hypertonic solution|hypertonic solution
443052|NCT01675453|Extravascular water|extravascular water
443053|NCT01675453|Cardiopulmonary Bypass|cardiopulmonary bypass
443054|NCT01675414|ASD|asd
443055|NCT01675414|autism|autism
443056|NCT01675414|gastrointestinal|gastrointestinal
443057|NCT01675414|gastrointestinal conditions in children with ASD|gastrointestinal conditions in children with asd
443058|NCT01675401|Body Weight|body weight
443059|NCT01675401|Obesity|obesity
443060|NCT01675401|Weight Loss|weight loss
443061|NCT01675401|Vascular Function Markers|vascular function markers
443062|NCT01675388|Neonatal hypoxemic respiratory failure|neonatal hypoxemic respiratory failure
443063|NCT01675388|Extra Corporeal Membrane Oxygenation|extra corporeal membrane oxygenation
443064|NCT01675388|Neurodevelopmental outcomes|neurodevelopmental outcomes
443065|NCT01675388|Neuroimaging|neuroimaging
443066|NCT01675362|Extracorporeal shockwave lithotripsy (ESWL)|extracorporeal shockwave lithotripsy (eswl)
443067|NCT01675362|Kidney calculi|kidney calculi
443068|NCT01675362|Renal protection|renal protection
443069|NCT01675362|Antioxidants|antioxidants
443070|NCT01675362|Calcium channel blockers|calcium channel blockers
443071|NCT01675362|Angiotensin receptor blockers|angiotensin receptor blockers
443072|NCT01675349|Standardization|standardization
443073|NCT01675349|Immunotherapy|immunotherapy
443074|NCT01675349|Skin prick test|skin prick test
443075|NCT01675323|Restless Legs Syndrome|restless legs syndrome
443076|NCT01675323|RLS|rls
443077|NCT01675310|obesity, polycystic ovary syndrome, gestational diabetes|obesity, polycystic ovary syndrome, gestational diabetes
443078|NCT01675297|Risedronate, cholecalciferol, BMD|risedronate, cholecalciferol, bmd
443079|NCT01675284|Avian Influenza|avian influenza
443080|NCT01675284|Influenza A Virus Subtype H5N1|influenza a virus subtype h5n1
443081|NCT01675284|Inactivated H5N1 Influenza Virion Vaccine|inactivated h5n1 influenza virion vaccine
443082|NCT01675284|Phase I|phase i
443083|NCT01675284|Preventive H5N1 vaccination|preventive h5n1 vaccination
443084|NCT01675271|gestational diabetes|gestational diabetes
443085|NCT01675271|inflammation|inflammation
443086|NCT01675271|autonomic nervous system|autonomic nervous system
443087|NCT01675245|Multiple Myeloma|multiple myeloma
443088|NCT01675245|Cancer|cancer
443089|NCT01675245|Velcade|velcade
443090|NCT01675245|Bortezomib|bortezomib
443091|NCT01675245|Chinese patients|chinese patients
443092|NCT01675232|Atopic dermatitis|atopic dermatitis
443093|NCT01675232|Topical corticosteroid|topical corticosteroid
443094|NCT01675232|Pediatric|pediatric
443095|NCT01675232|Eczema|eczema
443096|NCT01675219|bladder cancer|bladder cancer
443097|NCT01675219|recurrence|recurrence
443098|NCT01675219|photodynamic diagnosis|photodynamic diagnosis
443099|NCT01675219|PDD|pdd
443100|NCT01675219|cost analysis|cost analysis
443101|NCT01675206|Vascular calcification|vascular calcification
443102|NCT01675206|Hemodialysis|hemodialysis
443103|NCT01675206|Matrix Gla Protein|matrix gla protein
443104|NCT01675206|Vitamin K2|vitamin k2
443105|NCT01675193|Amblyopia|amblyopia
443106|NCT01675193|Vision-Screening|vision-screening
443107|NCT01675180|pregnancy, oral health, attitude, awareness, streptococcus mutans, lactobacilli, oxidative stress|pregnancy, oral health, attitude, awareness, streptococcus mutans, lactobacilli, oxidative stress
443108|NCT01675167|CLBP|clbp
443109|NCT01675167|Chronic Low Back Pain|chronic low back pain
443110|NCT01675167|Chronic Pain|chronic pain
443111|NCT01675167|Back Pain|back pain
443112|NCT01675154|hypertriglyceridemia|hypertriglyceridemia
443113|NCT01675141|NK Cell Function|nk cell function
443114|NCT01675141|Immunomodulatory Drugs|immunomodulatory drugs
443115|NCT01675141|T Cell Activity|t cell activity
443116|NCT01675141|Immune Stimulatory Effects|immune stimulatory effects
443117|NCT01675141|Extended Dosing|extended dosing
710249|NCT00589563|graft versus host disease|graft versus host disease
443118|NCT01675128|Human Eukaryotic Translation Initiation Factor 4E (eIF4E) protein|human eukaryotic translation initiation factor 4e (eif4e) protein
443119|NCT01675128|Refractory|refractory
443120|NCT01675128|Oncogene|oncogene
443121|NCT01675128|Maximum Tolerated Dose|maximum tolerated dose
443122|NCT01675128|Safety|safety
443123|NCT01675115|Ischemic stroke|ischemic stroke
443124|NCT01675115|Traditional Chinese Medication|traditional chinese medication
443125|NCT01675115|Aspirin|aspirin
443126|NCT01675102|del 17p|del 17p
443127|NCT01675102|chronic lymphocytic leukemia|chronic lymphocytic leukemia
443128|NCT01675102|cll|cll
443129|NCT01675102|mutation|mutation
443130|NCT01675102|p53|p53
443131|NCT01675089|bone disease|bone disease
443132|NCT01675089|kidney transplantation|kidney transplantation
443133|NCT01675089|bisphosphonates|bisphosphonates
443134|NCT01675076|Hematoma|hematoma
443135|NCT01675076|novel oral anti-coagulant (NOAC)|novel oral anti-coagulant (noac)
443136|NCT01675076|Device surgery|device surgery
443137|NCT01675037|hypothalamic|hypothalamic
443138|NCT01675037|pituitary,|pituitary,
443139|NCT01675037|endoscopic third ventriculostomy|endoscopic third ventriculostomy
443140|NCT01675037|hydrocephalus|hydrocephalus
443141|NCT01675024|Neupro, Pharmacokinetics, healthy Chinese subjects|neupro, pharmacokinetics, healthy chinese subjects
443142|NCT01674998|REM Sleep Behavior Disorder|rem sleep behavior disorder
443143|NCT01674998|RBD|rbd
443144|NCT01674998|Dream|dream
443145|NCT01674998|Dreams|dreams
443146|NCT01674985|Decitabine|decitabine
443147|NCT01674985|microtransplantation|microtransplantation
443148|NCT01674985|myelodysplastic syndromes|myelodysplastic syndromes
443149|NCT01674985|chemotherapy|chemotherapy
443150|NCT01674972|NAFLD|nafld
443151|NCT01674972|NASH|nash
443152|NCT01674972|GLP-1|glp-1
443153|NCT01674959|gastric cancer|gastric cancer
443154|NCT01674959|radiation|radiation
443155|NCT01674959|chemotherapy|chemotherapy
443156|NCT01674946|GI-physiology|gi-physiology
443157|NCT01674946|CDCA|cdca
443158|NCT01674946|bile acids|bile acids
443159|NCT01674946|TGR5|tgr5
443160|NCT01674946|satiation peptides|satiation peptides
443161|NCT01674933|dental|dental
443162|NCT01674933|prevention|prevention
443163|NCT01674933|caries|caries
443164|NCT01674933|oral|oral
443165|NCT01674933|children|children
443166|NCT01674920|Pediatric obesity|pediatric obesity
443167|NCT01674920|resiliency|resiliency
443168|NCT01674920|physical activity|physical activity
443169|NCT01674920|dietary patterns|dietary patterns
443170|NCT01674920|children|children
443171|NCT01674881|Mindfulness|mindfulness
443172|NCT01674881|breast cancer|breast cancer
443173|NCT01674881|chronic pain|chronic pain
443174|NCT01674881|mediators|mediators
443175|NCT01674881|distress|distress
443176|NCT01674881|Breast cancer survivors|breast cancer survivors
443177|NCT01674881|Effectiveness of MBCT on chronic pain|effectiveness of mbct on chronic pain
443178|NCT01674881|Potential mediators and moderators|potential mediators and moderators
443179|NCT01674881|Effectiveness of MBCT on psychological symptoms|effectiveness of mbct on psychological symptoms
443180|NCT01674868|stroke|stroke
443181|NCT01674868|recovery|recovery
443182|NCT01674868|fluoxetine|fluoxetine
443183|NCT01674868|aphasia|aphasia
443184|NCT01674868|neglect|neglect
443185|NCT01674868|motor|motor
443186|NCT01674855|PEG-G-CSF|peg-g-csf
443187|NCT01674842|Triple negative|triple negative
443188|NCT01674842|Stage II|stage ii
443189|NCT01674842|Stage III|stage iii
443190|NCT01674803|drug-eluting stent|drug-eluting stent
443191|NCT01674803|zotarolimus|zotarolimus
443192|NCT01674803|everolimus|everolimus
443193|NCT01674803|sirolimus|sirolimus
443194|NCT01674803|all comers population|all comers population
443195|NCT01674803|target vessel failure|target vessel failure
443196|NCT01674803|coronary artery disease|coronary artery disease
443197|NCT01674803|durable polymer|durable polymer
443198|NCT01674803|biodegradable polymer|biodegradable polymer
443199|NCT01674777|ASP1941|asp1941
443200|NCT01674777|Food effect|food effect
443201|NCT01674777|Pharmacokinetics|pharmacokinetics
443202|NCT01674751|pre-ordering|pre-ordering
443203|NCT01674751|healthy eating|healthy eating
443204|NCT01674751|mindfulness|mindfulness
443205|NCT01674751|incentives|incentives
443206|NCT01674751|employees|employees
443207|NCT01674738|Non Small Cell Lung Cancer|non small cell lung cancer
443208|NCT01674738|NSCLC Stage IV|nsclc stage iv
443209|NCT01674738|Non-Squamous Advanced Non-Small-Cell Lung-Cancer (Stage IV)|non-squamous advanced non-small-cell lung-cancer (stage iv)
443210|NCT01674725|Hepatitis C virus|hepatitis c virus
443211|NCT01674725|Hepatitis C Genotype 1|hepatitis c genotype 1
443212|NCT01674725|Hepatitis C|hepatitis c
443213|NCT01674725|Interferon-Free|interferon-free
443214|NCT01674725|Chronic Hepatitis C|chronic hepatitis c
443215|NCT01674725|Ombitasvir|ombitasvir
443216|NCT01674725|Ribavirin|ribavirin
443217|NCT01674725|Viekira PAK|viekira pak
443218|NCT01674725|Dasabuvir|dasabuvir
443219|NCT01674725|Paritaprevir|paritaprevir
443220|NCT01674712|Fibrates|fibrates
443221|NCT01674712|Dyslipidemia|dyslipidemia
443222|NCT01674686|Vasospasm|vasospasm
443223|NCT01674686|Sarpogrelate|sarpogrelate
443224|NCT01674686|Statin|statin
443225|NCT01674673|panic disorder|panic disorder
443226|NCT01674673|SSRIs pharmacotherapy|ssris pharmacotherapy
443227|NCT01674673|Cognitive Behavioral therapy|cognitive behavioral therapy
443228|NCT01674660|hemodialysis|hemodialysis
443229|NCT01674660|blood pressure variability|blood pressure variability
443230|NCT01674660|volume status|volume status
443231|NCT01674647|rivaroxaban|rivaroxaban
443232|NCT01674647|oral anticoagulant|oral anticoagulant
443233|NCT01674647|nonvalvular atrial fibrillation|nonvalvular atrial fibrillation
443234|NCT01674647|cardioversion|cardioversion
443235|NCT01674647|stroke|stroke
443236|NCT01674647|transient ischemic attack|transient ischemic attack
443237|NCT01674647|thromboembolism|thromboembolism
443238|NCT01674647|cardiovascular event|cardiovascular event
443239|NCT01674634|XIAFLEX|xiaflex
443240|NCT01674634|XIAPEX|xiapex
443241|NCT01674634|Dupuytren's disease|dupuytren's disease
443242|NCT01674634|contracture|contracture
443243|NCT01674621|BA058|ba058
443244|NCT01674621|Abaloparatide-SC|abaloparatide-sc
443245|NCT01674621|abaloparatide|abaloparatide
443246|NCT01674621|Abaloparatide-TD|abaloparatide-td
443247|NCT01674621|Osteo|osteo
443248|NCT01674621|Osteoporosis|osteoporosis
443249|NCT01674621|Transdermal|transdermal
443250|NCT01674621|Patch|patch
443251|NCT01674608|intensive care|intensive care
443252|NCT01674608|mobilization|mobilization
443253|NCT01674608|rehabilitation|rehabilitation
443254|NCT01674608|critical care|critical care
443255|NCT01674595|Olea sensitization|olea sensitization
443256|NCT01674582|Glioma|glioma
443257|NCT01674582|Brain tumors|brain tumors
443258|NCT01674582|Brain metastases|brain metastases
443259|NCT01674582|MRI|mri
443260|NCT01674582|Cognitive measurement|cognitive measurement
443261|NCT01674582|Neuropsychological evaluation|neuropsychological evaluation
443262|NCT01674582|DW-MRI|dw-mri
443263|NCT01674582|P-MRI|p-mri
443264|NCT01674582|MRS|mrs
443265|NCT01674569|VEGF|vegf
443266|NCT01674569|PDGF|pdgf
443267|NCT01674569|AMD|amd
443268|NCT01674556|pancreatic|pancreatic
443269|NCT01674556|cancer|cancer
443270|NCT01674556|adenocarcinoma|adenocarcinoma
443271|NCT01674556|Ultrasound|ultrasound
443272|NCT01674556|CEUS|ceus
443273|NCT01674543|Physical exercise|physical exercise
443274|NCT01674543|Schizophrenia|schizophrenia
443275|NCT01674543|symptoms|symptoms
443276|NCT01674543|IGF-1|igf-1
443277|NCT01674517|Bioequivalence|bioequivalence
443278|NCT01674517|Montelukast Sodium|montelukast sodium
443279|NCT01674517|crossover|crossover
443280|NCT01674504|Bioequivalence|bioequivalence
443281|NCT01674504|Montelukast Sodium|montelukast sodium
443282|NCT01674504|crossover|crossover
443283|NCT01674478|NEC, SBS, enterostomy, fish oil, Microlipid, Intralipid,|nec, sbs, enterostomy, fish oil, microlipid, intralipid,
443284|NCT01674478|enteral fat|enteral fat
443285|NCT01674465|Kidney fibrosis|kidney fibrosis
443286|NCT01674465|Kidney hypoxia|kidney hypoxia
443287|NCT01674465|Calcineurin inhibitors|calcineurin inhibitors
443288|NCT01674452|Stroke|stroke
443289|NCT01674452|Exercise and Physical Fitness|exercise and physical fitness
443290|NCT01674439|Adipose-derived regenerative cells|adipose-derived regenerative cells
443291|NCT01674439|Cell therapy|cell therapy
443292|NCT01674439|Autologous fat transfer|autologous fat transfer
443293|NCT01674439|Tissue engineering|tissue engineering
443294|NCT01674439|Craniofacial microsomia|craniofacial microsomia
443295|NCT01674426|functional hypothalamic amenorrhea|functional hypothalamic amenorrhea
443296|NCT01674426|stress induced anovulation|stress induced anovulation
443297|NCT01674413|Crohn's Disease|crohn's disease
443298|NCT01674413|Crohn's|crohn's
443299|NCT01674413|Crohns|crohns
443300|NCT01674413|Inflammatory Bowel Disease|inflammatory bowel disease
443301|NCT01674413|IBD|ibd
443302|NCT01674413|Humira|humira
443303|NCT01674413|Adalimumab|adalimumab
443304|NCT01674413|Adalimumab injection|adalimumab injection
443305|NCT01674413|Higgins|higgins
443306|NCT01674413|Calprotectin|calprotectin
443307|NCT01674413|biomarkers|biomarkers
443308|NCT01674413|Gastroenterology|gastroenterology
443309|NCT01674413|University of Michigan|university of michigan
443310|NCT01674413|U of M|u of m
443311|NCT01674387|electroacupuncture therapy|electroacupuncture therapy
443312|NCT01674387|neck pain|neck pain
443313|NCT01674387|McGill Pain Questionnaire|mcgill pain questionnaire
443314|NCT01674387|Acupuncture Therapy|acupuncture therapy
443315|NCT01674387|Electroacupuncture|electroacupuncture
443316|NCT01674387|Meridians|meridians
443317|NCT01674348|Diabetes Mellitus|diabetes mellitus
443318|NCT01674335|Fibromyalgia|fibromyalgia
443319|NCT01674335|Chronic pain|chronic pain
443320|NCT01674335|Chronic fatigue|chronic fatigue
443321|NCT01674335|Activity pacing|activity pacing
443322|NCT01674335|Operant learning|operant learning
443323|NCT01674335|Energy conservation|energy conservation
443324|NCT01674335|Treatment|treatment
443325|NCT01674335|Intervention|intervention
443326|NCT01674335|Biopsychosocial factors|biopsychosocial factors
443327|NCT01674335|Coping|coping
443328|NCT01674335|Mood|mood
443329|NCT01674335|Quality of life|quality of life
443330|NCT01674322|Healthy participants|healthy participants
443331|NCT01674322|Ibrutinib|ibrutinib
443332|NCT01674322|PCI-32765|pci-32765
443333|NCT01674322|B-cell malignancies|b-cell malignancies
443334|NCT01674322|CYP3A4|cyp3a4
443335|NCT01674296|Body Weight/physiology*|body weight/physiology*
443336|NCT01674296|Diet*/statistics & numerical data|diet*/statistics & numerical data
443337|NCT01674296|Diet*/trends|diet*/trends
443338|NCT01674296|Exercise/physiology*|exercise/physiology*
443339|NCT01674296|Female|female
443340|NCT01674296|Humans|humans
443341|NCT01674296|Longitudinal Studies|longitudinal studies
443342|NCT01674296|Middle Aged|middle aged
443343|NCT01674296|Obesity/epidemiology*|obesity/epidemiology*
443344|NCT01674296|Seasons*|seasons*
443345|NCT01674296|Time Factors|time factors
443346|NCT01674257|Atherosclerosis|atherosclerosis
443347|NCT01674257|Stroke|stroke
443348|NCT01674257|Positron-emission tomography|positron-emission tomography
443349|NCT01674257|Ferumoxytol|ferumoxytol
443350|NCT01674257|Magnetic resonance imaging|magnetic resonance imaging
443351|NCT01674257|Genetics|genetics
443352|NCT01674257|Calcification|calcification
443353|NCT01674257|Inflammation|inflammation
443354|NCT01674257|Flurodeoxyglucose F18|flurodeoxyglucose f18
443355|NCT01674257|Radiopharmaceuticals|radiopharmaceuticals
443356|NCT01674218|tuberculosis, safety, PA-824, QTc interval, moxifloxacin, healthy volunteers, crossover|tuberculosis, safety, pa-824, qtc interval, moxifloxacin, healthy volunteers, crossover
443357|NCT01674179|Fibromyalgia|fibromyalgia
443358|NCT01674179|qEEG|qeeg
443359|NCT01674179|Sleep|sleep
443360|NCT01674179|Pain|pain
443361|NCT01674153|Intra-dialytic exercise|intra-dialytic exercise
443362|NCT01674153|Toxin removal|toxin removal
443363|NCT01674153|Hemodiafiltration|hemodiafiltration
443364|NCT01674153|Inter-compartmental resistance|inter-compartmental resistance
443365|NCT01674153|Cardiac output|cardiac output
443366|NCT01674140|estrogen receptor-positive breast cancer|estrogen receptor-positive breast cancer
443367|NCT01674140|HER2-negative breast cancer|her2-negative breast cancer
443368|NCT01674140|stage IA breast cancer|stage ia breast cancer
443369|NCT01674140|stage IB breast cancer|stage ib breast cancer
443370|NCT01674140|stage II breast cancer|stage ii breast cancer
443371|NCT01674140|stage IIIA breast cancer|stage iiia breast cancer
443372|NCT01674140|stage IIIB breast cancer|stage iiib breast cancer
443373|NCT01674140|stage IIIC breast cancer|stage iiic breast cancer
443374|NCT01674140|progesterone receptor-positive breast cancer|progesterone receptor-positive breast cancer
443375|NCT01674140|male breast cancer|male breast cancer
443376|NCT01674114|Cesarean Section|cesarean section
443377|NCT01674114|Anesthetics, Local|anesthetics, local
443378|NCT01674101|Lower extremity malignancy|lower extremity malignancy
443379|NCT01674088|Irritable Bowel Syndrome|irritable bowel syndrome
443380|NCT01674088|breath testing|breath testing
443381|NCT01674088|carbon-13|carbon-13
443382|NCT01674075|safety|safety
443383|NCT01674075|J-Tip Delivery System|j-tip delivery system
443384|NCT01674075|pharmacokinetic profile|pharmacokinetic profile
443385|NCT01674049|nutrition|nutrition
443386|NCT01674049|nutrient|nutrient
443387|NCT01674049|timing|timing
443388|NCT01674049|diabetes|diabetes
443389|NCT01674049|family history|family history
443390|NCT01674049|dairy|dairy
443391|NCT01673971|hemangioma|hemangioma
443392|NCT01673958|Eccentric exercise|eccentric exercise
443393|NCT01673958|Aging|aging
443394|NCT01673958|Heart failure|heart failure
443395|NCT01673958|Muscle strength loss|muscle strength loss
443396|NCT01673958|Sarcopenia|sarcopenia
443397|NCT01673945|EUS-FNA, Forward viewing EUS scope, Curvilinear EUS scope|eus-fna, forward viewing eus scope, curvilinear eus scope
443398|NCT01673932|stroke|stroke
443399|NCT01673932|chronic stroke|chronic stroke
443400|NCT01673932|ischemic stroke|ischemic stroke
443401|NCT01673932|umbilical cord blood|umbilical cord blood
443402|NCT01673932|mononuclear cell|mononuclear cell
443403|NCT01673932|transplant|transplant
443404|NCT01673906|positron-emission tomography|positron-emission tomography
443405|NCT01673906|neuroendocrine tumors|neuroendocrine tumors
443406|NCT01673906|endosonography|endosonography
443407|NCT01673906|tomography, X-ray computed|tomography, x-ray computed
443408|NCT01673906|biopsy, fine needle|biopsy, fine needle
443409|NCT01673906|sensitivity and sensibility|sensitivity and sensibility
443410|NCT01673893|ClearWay|clearway
443411|NCT01673893|Glycoprotein|glycoprotein
443412|NCT01673893|Primary Coronary Intervention|primary coronary intervention
443413|NCT01673893|Abciximab|abciximab
443414|NCT01673893|ST Elevation Myocardial Infarction|st elevation myocardial infarction
443415|NCT01673893|Non-ST Elevation Myocardial Infarction|non-st elevation myocardial infarction
443416|NCT01673893|Medicare|medicare
443417|NCT01673893|Medicaid|medicaid
443418|NCT01673893|Registry|registry
443419|NCT01673893|catheterization|catheterization
443420|NCT01673893|readmission|readmission
443421|NCT01673893|Acute Coronary Syndrome|acute coronary syndrome
443422|NCT01673893|ClearwayRx Catheter|clearwayrx catheter
443423|NCT01673841|bypass grafting|bypass grafting
443424|NCT01673828|Brain Injuries|brain injuries
443425|NCT01673828|Pregnanolone|pregnanolone
443426|NCT01673828|Epilepsy|epilepsy
443427|NCT01673815|optic disk|optic disk
443428|NCT01673815|fundoscopy|fundoscopy
443429|NCT01673815|pediatric|pediatric
443430|NCT01673815|clinical examination|clinical examination
443431|NCT01673802|Cholangiocarcinoma|cholangiocarcinoma
443432|NCT01673789|Stem Cell Educator|stem cell educator
443433|NCT01673789|Cord blood stem cells|cord blood stem cells
443434|NCT01673789|Immune modulation|immune modulation
443435|NCT01673789|Alopecia Areata|alopecia areata
443436|NCT01673776|Proximal femoral fracture|proximal femoral fracture
443437|NCT01673776|multimodal intervention|multimodal intervention
443438|NCT01673776|goal directed therapy (GDT)|goal directed therapy (gdt)
443439|NCT01673776|hemodynamic intervention|hemodynamic intervention
443440|NCT01673776|outcome|outcome
443441|NCT01673763|ERCP|ercp
443442|NCT01673763|endoscopy|endoscopy
443443|NCT01673763|pancreatitis|pancreatitis
443444|NCT01673750|Adolescents|adolescents
443445|NCT01673750|Body Image|body image
443446|NCT01673698|obesity|obesity
443447|NCT01673698|weight loss|weight loss
443448|NCT01673685|COPD|copd
443449|NCT01673685|Oxygen cylinder|oxygen cylinder
443450|NCT01673685|Portable oxygen cylinder|portable oxygen cylinder
443451|NCT01673685|Battery powered delivery device|battery powered delivery device
443452|NCT01673685|mobility|mobility
443453|NCT01673685|dyspnoea|dyspnoea
443454|NCT01673685|Quality of Life|quality of life
443455|NCT01673685|Cost effectiveness|cost effectiveness
443456|NCT01673646|SOM230|som230
443457|NCT01673646|Pasireotide|pasireotide
443458|NCT01673646|acromegaly|acromegaly
443459|NCT01673646|Phase II|phase ii
443460|NCT01673646|growth disorder|growth disorder
443461|NCT01673646|gigantism|gigantism
443462|NCT01673646|Pituitary adenoma|pituitary adenoma
443463|NCT01673646|pituitary gigantism|pituitary gigantism
443464|NCT01673594|ADHD|adhd
443465|NCT01673594|Naltrexone|naltrexone
443466|NCT01673594|SODAS MPH|sodas mph
443467|NCT01673594|Stimulant-Induced Euphoria|stimulant-induced euphoria
443468|NCT01673594|Substance Abuse|substance abuse
443469|NCT01673594|Adults|adults
443470|NCT01673581|Low Risk|low risk
443471|NCT01673555|GSK1278863|gsk1278863
443472|NCT01673555|Pulmonary artery pressure|pulmonary artery pressure
443473|NCT01673529|Pruritus|pruritus
443474|NCT01673529|TRPV1|trpv1
443475|NCT01673529|Cowhage|cowhage
443476|NCT01673529|Atopic Dermatitis|atopic dermatitis
443477|NCT01673529|Capsaicin|capsaicin
443478|NCT01673529|Itch|itch
443479|NCT01673529|Histamine|histamine
443480|NCT01673529|healthy volunteers|healthy volunteers
443481|NCT01673529|SB705498|sb705498
443482|NCT01673529|Clinical|clinical
443483|NCT01673516|Renal sympathetic denervation|renal sympathetic denervation
443484|NCT01673516|Impedance cardiography|impedance cardiography
443485|NCT01673503|Myopia|myopia
443486|NCT01673503|refractive surgery|refractive surgery
443487|NCT01673503|all femtosecond laser|all femtosecond laser
443488|NCT01673503|ReLEx flex|relex flex
443489|NCT01673503|ReLEx smile|relex smile
443490|NCT01673490|Benign Prostatic Hyperplasia|benign prostatic hyperplasia
443491|NCT01673490|dutasteride and tamsulosin|dutasteride and tamsulosin
443492|NCT01673464|mild Traumatic Brain Injury|mild traumatic brain injury
443493|NCT01673464|mTBI|mtbi
443494|NCT01673464|Concussion|concussion
443495|NCT01673451|insomnia|insomnia
443496|NCT01673438|solid tumor|solid tumor
443497|NCT01673438|aldoxorubicin|aldoxorubicin
443498|NCT01673438|phase 1|phase 1
443499|NCT01673438|INNO-206|inno-206
443500|NCT01673438|doxorubicin|doxorubicin
443501|NCT01673425|Influenza|influenza
443502|NCT01673425|Influenza Vaccines|influenza vaccines
443503|NCT01673425|Vaccines, Attenuated|vaccines, attenuated
443504|NCT01673425|Immunity, Mucosal|immunity, mucosal
443505|NCT01673412|venous leg ulcer healing prognostic factors|venous leg ulcer healing prognostic factors
443506|NCT01673399|repeated implantation failure (RIF)|repeated implantation failure (rif)
443507|NCT01673399|atosiban|atosiban
443508|NCT01673399|pregnancy|pregnancy
443509|NCT01673386|Tivozanib hydrochloride|tivozanib hydrochloride
443510|NCT01673386|renal cell carcinoma|renal cell carcinoma
443511|NCT01673386|subject preference|subject preference
443512|NCT01673386|quality of life|quality of life
443513|NCT01673373|Renal Artery Stenosis|renal artery stenosis
443514|NCT01673373|Renal Artery Obstruction|renal artery obstruction
443515|NCT01673373|Renovascular Hypertension|renovascular hypertension
443516|NCT01673373|Resistant Hypertension|resistant hypertension
443517|NCT01673373|Renal Revascularization|renal revascularization
443518|NCT01673373|Atherosclerotic Renal Artery Stenosis|atherosclerotic renal artery stenosis
443519|NCT01673373|Atherosclerotic Renal Artery Stenosis (ARAS)|atherosclerotic renal artery stenosis (aras)
443520|NCT01673373|Renal Artery Stenosis (RAS)|renal artery stenosis (ras)
443521|NCT01673373|Uncontrolled hypertension|uncontrolled hypertension
443522|NCT01673373|Hypertension|hypertension
443523|NCT01673373|Systolic blood pressure|systolic blood pressure
443524|NCT01673373|Blood pressure|blood pressure
443525|NCT01673360|vaginal repair|vaginal repair
443526|NCT01673360|urinary slings|urinary slings
443527|NCT01673360|POP|pop
443528|NCT01673360|SUI|sui
443529|NCT01673360|prolapse|prolapse
443530|NCT01673360|incontinence|incontinence
443531|NCT01673347|allograft|allograft
443532|NCT01673347|great toe|great toe
443533|NCT01673334|Pancreas Tumor EUS FNA Core Biopsy Procore FNB|pancreas tumor eus fna core biopsy procore fnb
443534|NCT01673321|Yogurt|yogurt
443535|NCT01673321|Milk|milk
443536|NCT01673321|Protein|protein
443537|NCT01673321|Food intake|food intake
443538|NCT01673321|Appetite|appetite
443539|NCT01673321|Glucose|glucose
443540|NCT01673321|Insulin|insulin
443541|NCT01673295|Lupus Nephritis|lupus nephritis
443542|NCT01673295|Rituximab|rituximab
443543|NCT01673282|Lacosamide|lacosamide
443544|NCT01673282|Vimpat|vimpat
443545|NCT01673282|Focal Epilepsy|focal epilepsy
443546|NCT01673282|Drug Load|drug load
443547|NCT01673282|AED|aed
443548|NCT01673282|SP1065|sp1065
443549|NCT01673269|ERCP|ercp
443550|NCT01673269|Direct cholangioscopic examination of the common bile duct|direct cholangioscopic examination of the common bile duct
443551|NCT01673269|Choledocholithiasis|choledocholithiasis
443552|NCT01673269|Cholangiocarcinoma|cholangiocarcinoma
443553|NCT01673269|Benign stricture of common bile duct|benign stricture of common bile duct
443554|NCT01673243|Smoking cessation|smoking cessation
443555|NCT01673243|Household smoking bans|household smoking bans
443556|NCT01673243|Cancer|cancer
443557|NCT01673243|Sickle cell disease|sickle cell disease
443558|NCT01673204|surrogate marker,|surrogate marker,
443559|NCT01673204|circulating soluble TNF receptor,|circulating soluble tnf receptor,
443560|NCT01673204|diabetic nephropathy|diabetic nephropathy
443561|NCT01673178|Type 2 diabetes|type 2 diabetes
443562|NCT01673178|safety|safety
443563|NCT01673178|multiple dose|multiple dose
443564|NCT01673178|intravenous|intravenous
443565|NCT01673152|Obesity|obesity
443566|NCT01673152|Overweight|overweight
443567|NCT01673152|Satiety|satiety
443568|NCT01673152|Oligofructose|oligofructose
443569|NCT01673152|Prebiotic|prebiotic
443570|NCT01673139|Atrial fibrillation|atrial fibrillation
443571|NCT01673139|Exercise|exercise
443572|NCT01673126|vegetative state|vegetative state
443573|NCT01673126|minimally conscious state|minimally conscious state
443574|NCT01673126|disorders of consciousness|disorders of consciousness
443575|NCT01673126|transcranial direct current stimulation|transcranial direct current stimulation
443576|NCT01673113|cryolipolysis, sensory nerve function, Zeltiq|cryolipolysis, sensory nerve function, zeltiq
443577|NCT01673100|physical activity|physical activity
443578|NCT01673100|percutaneous coronary intervention|percutaneous coronary intervention
443579|NCT01673100|heart disease|heart disease
443580|NCT01673087|stress biology|stress biology
443581|NCT01673087|cortisol|cortisol
443582|NCT01673087|adrenocorticotropin|adrenocorticotropin
443583|NCT01673087|salivary biomarkers|salivary biomarkers
443584|NCT01673061|Abscess|abscess
443585|NCT01673061|Boils|boils
443586|NCT01673061|Anesthetics, Local|anesthetics, local
443587|NCT01673061|Lidocaine|lidocaine
443588|NCT01673061|Vapocoolant|vapocoolant
443589|NCT01673061|1,1,1,3,3-Pentafluoropropane|1,1,1,3,3-pentafluoropropane
443590|NCT01673061|1,1,1,2-Tetrafluoroethane|1,1,1,2-tetrafluoroethane
443591|NCT01673048|Elastic stable intramedullary nailing|elastic stable intramedullary nailing
443592|NCT01673048|biomechanical testing|biomechanical testing
443593|NCT01673048|fracture|fracture
443594|NCT01673048|femur|femur
443595|NCT01673048|treatment|treatment
443596|NCT01673048|children|children
443597|NCT01673048|adolescents|adolescents
443598|NCT01673009|Gleevec|gleevec
443599|NCT01672996|Use in Abdominal|use in abdominal
443600|NCT01672996|Contrast Enhanced|contrast enhanced
443601|NCT01672996|Computed Tomography|computed tomography
443602|NCT01672996|Optimize concentration|optimize concentration
443603|NCT01672996|dosage of Ioforminol Injection|dosage of ioforminol injection
443604|NCT01672983|Japanese|japanese
443605|NCT01672983|Hepatitis C|hepatitis c
443606|NCT01672983|Genotype 2|genotype 2
443607|NCT01672983|Genotype 1b|genotype 1b
443608|NCT01672983|paritaprevir|paritaprevir
443609|NCT01672983|ombitasvir|ombitasvir
443610|NCT01672983|ritonavir|ritonavir
443611|NCT01672983|VIEKIRAX Combination Tablets|viekirax combination tablets
443612|NCT01672944|Biological specimen banks|biological specimen banks
443613|NCT01672944|Health education|health education
443614|NCT01672944|Tissue banks|tissue banks
443615|NCT01672944|Health care survey|health care survey
443616|NCT01672944|Tissue|tissue
443617|NCT01672918|PET/CT|pet/ct
443618|NCT01672918|Lymphoma|lymphoma
443619|NCT01672918|Lymphadenopathy|lymphadenopathy
443620|NCT01672918|ALPS|alps
443621|NCT01672905|recurrent prostate cancer|recurrent prostate cancer
443622|NCT01672905|stage I prostate cancer|stage i prostate cancer
443623|NCT01672905|stage IIA prostate cancer|stage iia prostate cancer
443624|NCT01672905|stage IIB prostate cancer|stage iib prostate cancer
443625|NCT01672905|stage III prostate cancer|stage iii prostate cancer
443626|NCT01672892|gastrointestinal complications|gastrointestinal complications
443627|NCT01672892|perioperative/postoperative complications|perioperative/postoperative complications
443628|NCT01672892|radiation toxicity|radiation toxicity
443629|NCT01672892|urinary complications|urinary complications
443630|NCT01672892|urinary tract toxicity|urinary tract toxicity
443631|NCT01672892|endometrial clear cell carcinoma|endometrial clear cell carcinoma
443632|NCT01672892|endometrial papillary serous carcinoma|endometrial papillary serous carcinoma
443633|NCT01672892|stage IA endometrial carcinoma|stage ia endometrial carcinoma
443634|NCT01672892|stage IB endometrial carcinoma|stage ib endometrial carcinoma
443635|NCT01672892|stage II endometrial carcinoma|stage ii endometrial carcinoma
443636|NCT01672892|stage IIIA endometrial carcinoma|stage iiia endometrial carcinoma
443637|NCT01672892|stage IIIB endometrial carcinoma|stage iiib endometrial carcinoma
443638|NCT01672892|stage IIIC endometrial carcinoma|stage iiic endometrial carcinoma
443639|NCT01672892|endometrial adenocarcinoma|endometrial adenocarcinoma
443640|NCT01672892|cervical adenocarcinoma|cervical adenocarcinoma
443641|NCT01672892|stage IB cervical cancer|stage ib cervical cancer
443642|NCT01672892|stage IIA cervical cancer|stage iia cervical cancer
443643|NCT01672892|stage IIB cervical cancer|stage iib cervical cancer
443644|NCT01672879|NASH|nash
443645|NCT01672879|cirrhosis|cirrhosis
443646|NCT01672879|Compensated Liver disease|compensated liver disease
443647|NCT01672879|Monoclonal antibody|monoclonal antibody
443648|NCT01672879|LOXL2|loxl2
443649|NCT01672879|Simtuzumab|simtuzumab
443650|NCT01672879|Nonalcoholic Steatohepatitis|nonalcoholic steatohepatitis
443651|NCT01672879|Hepatic venous pressure gradient|hepatic venous pressure gradient
443652|NCT01672879|HVPG|hvpg
443653|NCT01672879|NAFLD|nafld
443655|NCT01672879|Liver biopsy|liver biopsy
443656|NCT01672879|Liver fibrosis|liver fibrosis
443657|NCT01672879|Ishak|ishak
443658|NCT01672866|NASH|nash
443659|NCT01672866|noncirrhotic|noncirrhotic
443660|NCT01672866|Monoclonal antibody|monoclonal antibody
443661|NCT01672866|LOXL2|loxl2
443662|NCT01672866|Simtuzumab|simtuzumab
443663|NCT01672866|Nonalcoholic Steatohepatitis|nonalcoholic steatohepatitis
443664|NCT01672866|NAFLD|nafld
443665|NCT01672866|Liver biopsy|liver biopsy
443666|NCT01672866|MRE|mre
443667|NCT01672866|Liver fibrosis|liver fibrosis
443668|NCT01672866|Ishak|ishak
443669|NCT01672853|PSC|psc
443670|NCT01672853|Sclerosis|sclerosis
443671|NCT01672853|Monoclonal antibody|monoclonal antibody
443672|NCT01672853|LOXL2|loxl2
443673|NCT01672853|Simtuzumab|simtuzumab
443674|NCT01672853|Primary sclerosing cholangitis|primary sclerosing cholangitis
443675|NCT01672853|Liver fibrosis|liver fibrosis
443676|NCT01672853|Liver disease|liver disease
443677|NCT01672853|MRCP|mrcp
443678|NCT01672853|MRE|mre
443679|NCT01672853|Liver biopsy|liver biopsy
443680|NCT01672840|Stage 1 Hypertension|stage 1 hypertension
443681|NCT01672840|cocoa consumption|cocoa consumption
443682|NCT01672840|Blood pressure|blood pressure
443683|NCT01672840|Endothelial function|endothelial function
443684|NCT01672840|arterial stiffness|arterial stiffness
443685|NCT01672827|Alzheimer's Disease|alzheimer's disease
443686|NCT01672827|Mild Cognitive Impairment|mild cognitive impairment
443687|NCT01672827|Positron Emission Tomography (PET)|positron emission tomography (pet)
443688|NCT01672827|PET Images|pet images
443689|NCT01672814|Keratoconus|keratoconus
443690|NCT01672814|Collagen Crosslinking|collagen crosslinking
443691|NCT01672814|Riboflavin|riboflavin
443692|NCT01672814|Microwave|microwave
443693|NCT01672814|Keraflex|keraflex
443694|NCT01672775|Renal Cell Carcinoma|renal cell carcinoma
443695|NCT01672775|AGS-16C3F|ags-16c3f
443696|NCT01672775|Pharmacokinetics of AGS-16C3F|pharmacokinetics of ags-16c3f
443697|NCT01672762|glucose excretion|glucose excretion
443698|NCT01672762|ipragliflozin|ipragliflozin
443699|NCT01672762|hypoglycemic agents|hypoglycemic agents
443700|NCT01672762|serum Insulin|serum insulin
443701|NCT01672762|diabetes mellitus|diabetes mellitus
443702|NCT01672762|blood glucose|blood glucose
443703|NCT01672749|Scoliosis [MESH]|scoliosis [mesh]
443704|NCT01672749|Pediatrics [MESH]|pediatrics [mesh]
443705|NCT01672749|Early onset|early onset
443706|NCT01672749|Growth guidance|growth guidance
443707|NCT01672749|Growing rod|growing rod
443708|NCT01672749|Trolley|trolley
443709|NCT01672749|Dual growing rod technique|dual growing rod technique
443710|NCT01672736|Relapsed or relapse/refractory Multiple Myeloma|relapsed or relapse/refractory multiple myeloma
443711|NCT01672723|opioids|opioids
443712|NCT01672723|social connection|social connection
443713|NCT01672710|Hubbard detoxification|hubbard detoxification
443714|NCT01672710|Exercise|exercise
443715|NCT01672710|Sauna therapy|sauna therapy
443716|NCT01672710|Niacin|niacin
443717|NCT01672710|Gulf War illness|gulf war illness
443718|NCT01672697|anal incontinence|anal incontinence
443719|NCT01672697|genital trauma|genital trauma
443720|NCT01672697|physical therapy|physical therapy
443721|NCT01672697|anal manometry|anal manometry
443722|NCT01672684|quality of life|quality of life
443723|NCT01672658|TBI,|tbi,
443724|NCT01672658|vestibular|vestibular
443725|NCT01672645|Smoking cessation|smoking cessation
443726|NCT01672645|vaccine|vaccine
443727|NCT01672645|Phase 1|phase 1
443728|NCT01672619|craniosynostoses|craniosynostoses
443729|NCT01672619|Osteogenesis Distraction|osteogenesis distraction
443730|NCT01672619|craniotomy|craniotomy
443731|NCT01672593|Autologous platelet rich fibrin glue;|autologous platelet rich fibrin glue;
443732|NCT01672593|Enterocutaneous fistulas;|enterocutaneous fistulas;
443733|NCT01672593|Single low output GI fistulas;|single low output gi fistulas;
443734|NCT01672580|social networks|social networks
443735|NCT01672580|nutrition|nutrition
443736|NCT01672580|vitamins|vitamins
443737|NCT01672580|chlorine|chlorine
443738|NCT01672567|Coronary Artery Disease|coronary artery disease
443739|NCT01672567|Egg Consumption|egg consumption
443740|NCT01672567|Endothelial Function|endothelial function
443741|NCT01672554|Schizophrenia|schizophrenia
443742|NCT01672554|Anxiety disorder|anxiety disorder
443743|NCT01672541|dating violence|dating violence
443744|NCT01672541|healthy relationship behaviors|healthy relationship behaviors
443745|NCT01672528|Patient Reported Outcome Measures|patient reported outcome measures
443746|NCT01672528|PROMs|proms
443747|NCT01672528|Cardiac arrhythmia|cardiac arrhythmia
443748|NCT01672528|Cardiac ablation|cardiac ablation
443749|NCT01672502|sleep|sleep
443750|NCT01672502|firefighter|firefighter
443751|NCT01672502|fire|fire
443752|NCT01672502|apnea|apnea
443753|NCT01672502|insomnia|insomnia
443754|NCT01672502|shift|shift
443755|NCT01672502|narcolepsy|narcolepsy
443756|NCT01672502|restless leg|restless leg
443758|NCT01672502|fatigue|fatigue
443759|NCT01672502|Optalert|optalert
443760|NCT01672502|actigraph|actigraph
443761|NCT01672502|actigraphy|actigraphy
443762|NCT01672502|actiwatch|actiwatch
443763|NCT01672502|safety|safety
443764|NCT01672502|sleepiness|sleepiness
443765|NCT01672502|sleepy|sleepy
443766|NCT01672502|work|work
443767|NCT01672502|hours|hours
443768|NCT01672502|FEMA|fema
443769|NCT01672502|drowsy|drowsy
443770|NCT01672489|Drowsy|drowsy
443771|NCT01672489|Drive|drive
443772|NCT01672489|Driving|driving
443773|NCT01672489|Shift Work Disorder|shift work disorder
443774|NCT01672489|SWD|swd
443775|NCT01672489|EEG|eeg
443776|NCT01672489|ECG|ecg
443777|NCT01672489|Actiwatch|actiwatch
443778|NCT01672489|Diary|diary
443779|NCT01672489|Bioharness|bioharness
443780|NCT01672489|Q-Sensor|q-sensor
443781|NCT01672489|Q Sensor|q sensor
443782|NCT01672489|Liberty Mutual|liberty mutual
443783|NCT01672489|sleep|sleep
443784|NCT01672489|impaired|impaired
443785|NCT01672489|Optalert|optalert
443786|NCT01672489|tracker|tracker
443787|NCT01672489|vehicle|vehicle
443788|NCT01672489|questionnaire|questionnaire
443789|NCT01672489|survey|survey
443790|NCT01672476|Fimasartan|fimasartan
443791|NCT01672450|Histologically or cytologically proven melanoma; Stages III-IV; accessible cutaneous, subcutaneous, and/or nodal lesions; ECOG performance status 0 to 2|histologically or cytologically proven melanoma; stages iii-iv; accessible cutaneous, subcutaneous, and/or nodal lesions; ecog performance status 0 to 2
443792|NCT01672437|Birth and parent preparation|birth and parent preparation
443793|NCT01672437|Parenting stress|parenting stress
443794|NCT01672437|Depression|depression
443795|NCT01672437|self-efficacy|self-efficacy
443796|NCT01672437|social network and support|social network and support
443797|NCT01672424|NPO|npo
443798|NCT01672424|Gastric Emptying|gastric emptying
443799|NCT01672424|Ice Chips|ice chips
443800|NCT01672424|Protein Drink|protein drink
443801|NCT01672424|Ultrasound|ultrasound
443802|NCT01672411|prostate cancer, PSA, markers, diagnosis, prognosis, pro-PSA|prostate cancer, psa, markers, diagnosis, prognosis, pro-psa
443803|NCT01672398|CarePartner|carepartner
443804|NCT01672398|informal caregiver|informal caregiver
443805|NCT01672398|interactive voice response|interactive voice response
443806|NCT01672398|transition|transition
443807|NCT01672398|post-discharge|post-discharge
443808|NCT01672398|chronic illness|chronic illness
443809|NCT01672398|readmission|readmission
443810|NCT01672398|self-care|self-care
443811|NCT01672385|CarePartner|carepartner
443812|NCT01672385|informal caregiver|informal caregiver
443813|NCT01672385|interactive voice response|interactive voice response
443814|NCT01672385|transition|transition
443815|NCT01672385|post-discharge|post-discharge
443816|NCT01672385|chronic illness|chronic illness
443817|NCT01672385|readmission|readmission
443818|NCT01672385|self-care|self-care
443819|NCT01672359|cognitive functioning|cognitive functioning
443820|NCT01672359|immune function|immune function
443821|NCT01672359|cytokines|cytokines
443822|NCT01672359|growth factors|growth factors
443823|NCT01672359|quality of life|quality of life
443824|NCT01672359|dietary supplementation|dietary supplementation
710250|NCT00589563|infection|infection
443825|NCT01672359|Ginkgo biloba|ginkgo biloba
443826|NCT01672359|Improvement of cognitive function|improvement of cognitive function
443827|NCT01672346|PAF|paf
443828|NCT01672320|Robotic|robotic
443829|NCT01672320|Arthroplasty|arthroplasty
443830|NCT01672320|Total Hip Arthroplasty|total hip arthroplasty
443831|NCT01672320|Cup Positioning|cup positioning
443832|NCT01672320|Outcomes|outcomes
443833|NCT01672307|hypotrichosis of eyebrows|hypotrichosis of eyebrows
443834|NCT01672307|thinning eyebrows|thinning eyebrows
443835|NCT01672307|minoxidil|minoxidil
443836|NCT01672307|placebo|placebo
443837|NCT01672307|randomized|randomized
443838|NCT01672294|caregiver|caregiver
443839|NCT01672294|end of life|end of life
443840|NCT01672294|self-disclosure|self-disclosure
443841|NCT01672268|cardiac computed tomography|cardiac computed tomography
443842|NCT01672268|Transcatheter Aortic Valve Implantation|transcatheter aortic valve implantation
443843|NCT01672268|safety and efficacy|safety and efficacy
443844|NCT01672255|exercise|exercise
443845|NCT01672255|diabetes|diabetes
443846|NCT01672255|SSRIs|ssris
443847|NCT01672216|Exercise Therapy|exercise therapy
443848|NCT01672216|Biofeedback (Psychology)|biofeedback (psychology)
443849|NCT01672216|Adult|adult
443850|NCT01672216|Chronic Obstipation/*therapy|chronic obstipation/*therapy
443851|NCT01672216|EMG - Biofeedback|emg - biofeedback
443852|NCT01672216|EMG - Triggered Stimulation|emg - triggered stimulation
443853|NCT01672216|Augmented biofeedback|augmented biofeedback
443854|NCT01672177|Geriatrics|geriatrics
443855|NCT01672177|Aged|aged
443856|NCT01672177|Aging|aging
443857|NCT01672177|Chronic disease|chronic disease
443858|NCT01672177|Self management|self management
443859|NCT01672164|proteogenomic biomarker panels|proteogenomic biomarker panels
443860|NCT01672151|Refractory Immune Thrombocytopenic Purpura|refractory immune thrombocytopenic purpura
443861|NCT01672151|rapamycin|rapamycin
443862|NCT01672151|regulatory T cells|regulatory t cells
443863|NCT01672138|PVAI|pvai
443864|NCT01672138|NPAF|npaf
443865|NCT01672138|Non-PV triggers|non-pv triggers
443866|NCT01672112|analgesic efficacy|analgesic efficacy
443867|NCT01672112|oral codeine|oral codeine
443868|NCT01672112|oral oxycodone|oral oxycodone
443869|NCT01672112|postcraniotomy|postcraniotomy
443870|NCT01672099|vitamin K2|vitamin k2
443871|NCT01672099|menaquinone-7|menaquinone-7
443872|NCT01672099|vascular health|vascular health
443873|NCT01672073|pressure|pressure
443874|NCT01672073|waveform|waveform
443875|NCT01672073|arterial|arterial
443876|NCT01672047|The 25(OH) vitamin D level|the 25(oh) vitamin d level
443877|NCT01672047|The 1.25(OH) vitamin D level|the 1.25(oh) vitamin d level
443878|NCT01672047|The intact PTH level|the intact pth level
443879|NCT01672047|The calcification score of coronary artery|the calcification score of coronary artery
443880|NCT01672047|The microalbuminuria level|the microalbuminuria level
443881|NCT01672021|Breast Cancer|breast cancer
443882|NCT01672021|MRI PET-CT|mri pet-ct
443883|NCT01672008|NOX-100|nox-100
443884|NCT01671995|Heart failure|heart failure
443885|NCT01671995|Quality of life|quality of life
443886|NCT01671969|determine effects of diet on renal and other parameters|determine effects of diet on renal and other parameters
443887|NCT01671956|IBD|ibd
443888|NCT01671956|UC|uc
443889|NCT01671956|Colitis|colitis
443890|NCT01671956|Ulcerative Colitis|ulcerative colitis
443891|NCT01671943|small malignant invasive breast tumors|small malignant invasive breast tumors
443892|NCT01671917|Total knee arthroplasty|total knee arthroplasty
443893|NCT01671917|Total knee replacement|total knee replacement
443894|NCT01671917|Knee osteoarthritis|knee osteoarthritis
443895|NCT01671917|Education|education
443896|NCT01671917|Exercise|exercise
443897|NCT01671917|Handicap|handicap
443898|NCT01671917|Function|function
443899|NCT01671917|Cost-effectiveness|cost-effectiveness
443900|NCT01671917|Cost-utility|cost-utility
443901|NCT01671917|Quality of life|quality of life
443902|NCT01671891|rectal cancer|rectal cancer
443903|NCT01671891|circulating tumor cells|circulating tumor cells
443904|NCT01671891|predict responses|predict responses
443905|NCT01671865|FSHD|fshd
443906|NCT01671865|magnetic resonance imaging|magnetic resonance imaging
443907|NCT01671865|magnetic resonance spectroscopy|magnetic resonance spectroscopy
443908|NCT01671826|Multiple Myeloma|multiple myeloma
443909|NCT01671826|Autologous Stem Cell Transplantation|autologous stem cell transplantation
443910|NCT01671826|Elderly Patients|elderly patients
443911|NCT01671813|positive|positive
443912|NCT01671813|diffuse|diffuse
443913|NCT01671813|B-Cell|b-cell
443914|NCT01671813|elderly|elderly
443915|NCT01671813|EBV|ebv
443916|NCT01671813|DLBCL|dlbcl
443917|NCT01671813|malignant|malignant
443918|NCT01671813|pilot|pilot
443919|NCT01671800|Hyperhidrosis|hyperhidrosis
443920|NCT01671800|Botulinum Toxin|botulinum toxin
443921|NCT01671800|Amputation|amputation
443922|NCT01671800|Phantom limb pain|phantom limb pain
443923|NCT01671787|Hepatitis B|hepatitis b
443924|NCT01671787|HBV|hbv
443925|NCT01671787|GS-7340|gs-7340
443926|NCT01671787|TDF|tdf
443927|NCT01671787|Tenofovir disoproxil fumarate|tenofovir disoproxil fumarate
443928|NCT01671787|Gilead|gilead
443929|NCT01671787|Viread|viread
443930|NCT01671761|Healthy|healthy
443931|NCT01671761|Control|control
443932|NCT01671748|Venous Leg Ulcer|venous leg ulcer
443933|NCT01671748|Varicose Ulcer|varicose ulcer
443934|NCT01671748|Chronic ulcer|chronic ulcer
443935|NCT01671748|Chronic wound|chronic wound
443936|NCT01671748|Ultrasound therapy|ultrasound therapy
443937|NCT01671748|MIST device|mist device
443938|NCT01671748|Wound healing|wound healing
443939|NCT01671748|Low frequency non contact ultrasound|low frequency non contact ultrasound
443940|NCT01671735|prevention|prevention
443941|NCT01671735|diabetes|diabetes
443942|NCT01671722|Bioequivalence|bioequivalence
443943|NCT01671722|Montelukast Sodium|montelukast sodium
443944|NCT01671722|crossover|crossover
443945|NCT01671709|Bioequivalence|bioequivalence
443946|NCT01671709|Montelukast Sodium|montelukast sodium
443947|NCT01671709|crossover|crossover
443948|NCT01671683|rectal cancer|rectal cancer
443949|NCT01671683|neoadjuvant chemoradiotherapy|neoadjuvant chemoradiotherapy
443950|NCT01671683|Capecitabine|capecitabine
443951|NCT01671670|Functional dyspepsia|functional dyspepsia
443952|NCT01671670|postprandial distress syndrome|postprandial distress syndrome
443953|NCT01671657|In vitro fertilization|in vitro fertilization
443954|NCT01671657|Assisted reproductive therapy|assisted reproductive therapy
443955|NCT01671657|Time-lapse image recording|time-lapse image recording
443956|NCT01671657|Image analysis software|image analysis software
443957|NCT01671644|In vitro fertilization|in vitro fertilization
443958|NCT01671644|Assisted reproductive therapy|assisted reproductive therapy
443959|NCT01671644|Time-lapse image recording|time-lapse image recording
443960|NCT01671644|Image analysis software|image analysis software
443961|NCT01671618|Aortic dissection|aortic dissection
443962|NCT01671618|Aortic dilation|aortic dilation
443963|NCT01671618|Aortic Aneurysm|aortic aneurysm
443964|NCT01671618|ultrasound|ultrasound
443965|NCT01671618|point-of-care|point-of-care
443966|NCT01671618|echocardiography|echocardiography
443967|NCT01671592|Cancer|cancer
443968|NCT01671592|colorectal|colorectal
443969|NCT01671592|tumor|tumor
443970|NCT01671592|neoplasms|neoplasms
443971|NCT01671592|carcinoma|carcinoma
443972|NCT01671592|vaccine|vaccine
443973|NCT01671566|Congenital Heart defect|congenital heart defect
443974|NCT01671566|Exercise and Physical fitness|exercise and physical fitness
443975|NCT01671566|Rehabilitation|rehabilitation
443976|NCT01671566|Quality of life|quality of life
443977|NCT01671566|Behaviour|behaviour
443978|NCT01671540|COPD|copd
443979|NCT01671540|IPV|ipv
443980|NCT01671527|Deep Brain Stimulation|deep brain stimulation
443981|NCT01671527|DBS|dbs
443982|NCT01671527|Transcranial Magnetic Stimulation|transcranial magnetic stimulation
443983|NCT01671527|TMS|tms
443984|NCT01671527|Cervical Dystonia|cervical dystonia
443985|NCT01671527|Dystonia|dystonia
443986|NCT01671527|Control|control
443987|NCT01671527|Healthy|healthy
443988|NCT01671514|mitochondrial biogenesis|mitochondrial biogenesis
443989|NCT01671514|skeletal muscle|skeletal muscle
443990|NCT01671514|epicatechin|epicatechin
443991|NCT01671501|HIV|hiv
443992|NCT01671501|Acquired Immunodeficiency Syndrome|acquired immunodeficiency syndrome
443993|NCT01671501|Alcoholism|alcoholism
443994|NCT01671501|Alcoholic Intoxication|alcoholic intoxication
443995|NCT01671501|Substance-Related Disorders|substance-related disorders
443996|NCT01671501|Intervention Studies|intervention studies
443997|NCT01671501|Primary Health Care|primary health care
443998|NCT01671501|therapy|therapy
443999|NCT01671501|prevention & control|prevention & control
444000|NCT01671488|Anal Cancer|anal cancer
444001|NCT01671488|Mitomycin|mitomycin
444002|NCT01671488|5-Fluorouracil|5-fluorouracil
444003|NCT01671488|5-FU|5-fu
444004|NCT01671488|IMRT|imrt
444005|NCT01671488|ADXS11-001|adxs11-001
444006|NCT01671475|Altered Mental Status|altered mental status
444007|NCT01671475|Non-convulsive seizure|non-convulsive seizure
444008|NCT01671475|Electroencephalography|electroencephalography
444009|NCT01671462|HPV|hpv
444010|NCT01671462|Cervical Cancer|cervical cancer
444011|NCT01671462|Cervical Neoplasms|cervical neoplasms
444012|NCT01671449|Gastric cancer|gastric cancer
444013|NCT01671449|S-1|s-1
444014|NCT01671449|Cisplatin|cisplatin
444015|NCT01671449|Oxaliplatin|oxaliplatin
444016|NCT01671436|Depression|depression
444017|NCT01671436|Guided Imagery|guided imagery
444018|NCT01671436|Psychotherapy|psychotherapy
444019|NCT01671436|Meditation|meditation
444020|NCT01671423|Cellulitis|cellulitis
444021|NCT01671423|Skin infection|skin infection
444022|NCT01671423|Prednisone|prednisone
444023|NCT01671423|Steroid|steroid
444024|NCT01671423|Anti-inflammatory|anti-inflammatory
444025|NCT01671410|Neonatal Abstinence Syndrome|neonatal abstinence syndrome
444026|NCT01671410|buprenorphine|buprenorphine
444027|NCT01671410|morphine|morphine
444028|NCT01671410|benzodiazepine|benzodiazepine
444029|NCT01671397|Obesity|obesity
444030|NCT01671397|weight loss|weight loss
444031|NCT01671397|sleep hygiene|sleep hygiene
444032|NCT01671397|diet|diet
444033|NCT01671397|exercise|exercise
444034|NCT01671384|Valproate|valproate
444035|NCT01671384|levocarnitine|levocarnitine
444036|NCT01671384|SMA|sma
444037|NCT01671384|physiotherapy|physiotherapy
444038|NCT01671384|placebo|placebo
444039|NCT01671371|syncope|syncope
444040|NCT01671371|point of care|point of care
444041|NCT01671371|ultrasound|ultrasound
444042|NCT01671371|echocardiography|echocardiography
444043|NCT01671358|MRSA|mrsa
444044|NCT01671358|Contamination|contamination
444045|NCT01671358|Isolation|isolation
444046|NCT01671332|Carcinoma, non small cell lung|carcinoma, non small cell lung
444047|NCT01671332|Second line|second line
444048|NCT01671332|Third line|third line
444049|NCT01671319|breast cancer|breast cancer
444050|NCT01671319|female|female
444051|NCT01671319|women|women
444052|NCT01671319|adjuvant|adjuvant
444053|NCT01671306|Coronary collaterals|coronary collaterals
444054|NCT01671306|diabetes mellitus|diabetes mellitus
444055|NCT01671306|monocyte subsets|monocyte subsets
444056|NCT01671280|pneumonia|pneumonia
444057|NCT01671280|pelvic inflammatory disease|pelvic inflammatory disease
444058|NCT01671280|Zithromax|zithromax
444059|NCT01671280|Zithromac|zithromac
444060|NCT01671280|Japanese|japanese
444061|NCT01671280|Regulatory Post Marketing Commitment Plan|regulatory post marketing commitment plan
444062|NCT01671228|dialysis|dialysis
444063|NCT01671228|chronic kidney failure|chronic kidney failure
444064|NCT01671228|informed choice|informed choice
444065|NCT01671228|patient decision making|patient decision making
444066|NCT01671228|decision aid|decision aid
444067|NCT01671215|endometrium|endometrium
444068|NCT01671215|myometrium|myometrium
444069|NCT01671215|fibroids|fibroids
444070|NCT01671215|uterine malformations|uterine malformations
444071|NCT01671176|Wide diameter implant|wide diameter implant
444072|NCT01671176|ISQ|isq
444073|NCT01671176|Ponto|ponto
444074|NCT01671176|Bone anchored implant|bone anchored implant
444075|NCT01671163|Cancer|cancer
444076|NCT01671163|Radiation therapy|radiation therapy
444077|NCT01671163|Fiducial markers|fiducial markers
444078|NCT01671150|inflammation|inflammation
444079|NCT01671150|depression|depression
444080|NCT01671150|social cognition|social cognition
444081|NCT01671150|neural activity|neural activity
444082|NCT01671137|Lactobacillus GG|lactobacillus gg
444083|NCT01671137|Functional Abdominal Pain|functional abdominal pain
444084|NCT01671137|Children|children
444085|NCT01671137|Acute|acute
444086|NCT01671137|Gastroenteritis|gastroenteritis
444087|NCT01671124|TG|tg
444088|NCT01671124|TC|tc
444089|NCT01671124|HDL|hdl
444090|NCT01671124|LDL|ldl
444091|NCT01671124|Albumin|albumin
444092|NCT01671124|Hemoglobin|hemoglobin
444093|NCT01671124|Hematocrit|hematocrit
444094|NCT01671124|Uric acid|uric acid
444095|NCT01671124|Sodium|sodium
444096|NCT01671124|Potassium|potassium
444097|NCT01671124|Calcium|calcium
444098|NCT01671098|nitric oxide|nitric oxide
444099|NCT01671098|sinuplasty|sinuplasty
444100|NCT01671072|Chondrocyte cells|chondrocyte cells
444101|NCT01671072|Osteoarthritis|osteoarthritis
444102|NCT01671072|Gene therapy|gene therapy
444103|NCT01671033|Panic disorder|panic disorder
444104|NCT01671033|cognitive behavior therapy|cognitive behavior therapy
444105|NCT01671033|Internet|internet
444106|NCT01671020|fimasartan|fimasartan
444107|NCT01671020|absolute bioavailability|absolute bioavailability
444108|NCT01670994|cancer|cancer
444109|NCT01670994|immunotherapy|immunotherapy
444110|NCT01670994|immunochemotherapy|immunochemotherapy
444111|NCT01670994|targeted|targeted
444112|NCT01670994|metastatic|metastatic
444113|NCT01670994|interleukin-2|interleukin-2
444114|NCT01670994|antitumor|antitumor
444115|NCT01670994|TCR|tcr
444116|NCT01670994|T-cell receptor|t-cell receptor
444117|NCT01670994|p53|p53
444118|NCT01670994|p53 gene|p53 gene
444119|NCT01670994|p53 tumor supressor protein|p53 tumor supressor protein
444120|NCT01670994|HLA-A2 positive|hla-a2 positive
444121|NCT01670994|HLA-A*0201/p53 aa264-272|hla-a*0201/p53 aa264-272
444122|NCT01670994|HLA complex|hla complex
444123|NCT01670994|multiple myeloma|multiple myeloma
444124|NCT01670994|IFN-γ and TNF-α|ifn-γ and tnf-α
444125|NCT01670994|refractory|refractory
444126|NCT01670994|relapsed|relapsed
444127|NCT01670981|Ischemic dilated cardiomyopathy|ischemic dilated cardiomyopathy
444128|NCT01670981|Heart failure|heart failure
444129|NCT01670981|ixCELL|ixcell
444130|NCT01670981|ixCELL DCM|ixcell dcm
444131|NCT01670981|IDCM|idcm
444132|NCT01670981|DCM|dcm
444133|NCT01670981|stem cells|stem cells
444134|NCT01670981|MSC|msc
444135|NCT01670981|cell therapy|cell therapy
444136|NCT01670955|Anemia|anemia
444137|NCT01670955|preoperative|preoperative
444138|NCT01670955|gynecological patients|gynecological patients
444139|NCT01670955|Sorghum bicolor|sorghum bicolor
444140|NCT01670955|Packed Cells Volume|packed cells volume
444141|NCT01670942|pneumothorax|pneumothorax
444142|NCT01670942|trauma|trauma
444143|NCT01670942|commercial air travel|commercial air travel
444144|NCT01670929|recurrent miscarriages|recurrent miscarriages
444145|NCT01670929|progesterone|progesterone
444146|NCT01670916|Necrotizing enterocolitis|necrotizing enterocolitis
444147|NCT01670916|Probiotics|probiotics
444148|NCT01670916|Preterm|preterm
444149|NCT01670916|Infant|infant
444150|NCT01670890|temozolomide(TMZ)|temozolomide(tmz)
444151|NCT01670890|cisplatin(CDDP)|cisplatin(cddp)
444152|NCT01670890|recurrent malignant gliomas|recurrent malignant gliomas
444153|NCT01670851|eLAPE,|elape,
444154|NCT01670851|perineum,|perineum,
444155|NCT01670851|pelvic floor reconstruction|pelvic floor reconstruction
444156|NCT01670838|subarachnoid haemorrhage|subarachnoid haemorrhage
444157|NCT01670838|cardiopulmonary complications|cardiopulmonary complications
444158|NCT01670825|Occipital neuralgia|occipital neuralgia
444159|NCT01670825|corticosteroid injection|corticosteroid injection
444160|NCT01670825|pulsed radiofrequency|pulsed radiofrequency
444161|NCT01670812|chronic lymphocytic leukemia|chronic lymphocytic leukemia
444162|NCT01670812|ultra-high risk|ultra-high risk
444163|NCT01670812|fresh frozen plasma|fresh frozen plasma
444164|NCT01670812|methylprednisolone|methylprednisolone
444165|NCT01670812|rituximab|rituximab
444166|NCT01670799|Ketorolac|ketorolac
444167|NCT01670799|Bioavailability|bioavailability
444168|NCT01670799|Pain|pain
444169|NCT01670760|Deep Tissue Temperature|deep tissue temperature
444170|NCT01670760|Zero Heat Flux Thermometry|zero heat flux thermometry
444171|NCT01670760|Thermometry|thermometry
444172|NCT01670760|Core Temperature|core temperature
444173|NCT01670708|Substance Use|substance use
444174|NCT01670708|Illicit Drug Use|illicit drug use
444175|NCT01670708|Criminal Behavior|criminal behavior
444176|NCT01670695|IgG4-related disease|igg4-related disease
444177|NCT01670695|IgG4-RD|igg4-rd
444178|NCT01670682|Stage III|stage iii
444179|NCT01670643|AMD|amd
444180|NCT01670643|vision rehabilitation|vision rehabilitation
444181|NCT01670643|video camera magnifier|video camera magnifier
444182|NCT01670643|IVI|ivi
444183|NCT01670643|DASS|dass
444184|NCT01670630|speculum|speculum
444185|NCT01670630|vagina|vagina
444186|NCT01670630|cervix|cervix
444187|NCT01670630|examination|examination
444188|NCT01670578|P.R.P.|p.r.p.
444189|NCT01670578|viscosupplementation|viscosupplementation
444190|NCT01670578|double-blind randomized|double-blind randomized
444191|NCT01670578|intra-articular injections|intra-articular injections
444192|NCT01670578|knee degenerative pathology|knee degenerative pathology
444193|NCT01670578|early osteoarthritis|early osteoarthritis
444194|NCT01670565|Diffuse cutaneous systemic sclerosis|diffuse cutaneous systemic sclerosis
444195|NCT01670565|Early Diffuse cutaneous systemic sclerosis|early diffuse cutaneous systemic sclerosis
444196|NCT01670539|Lung Cancer|lung cancer
444197|NCT01670539|Telemonitoring|telemonitoring
444198|NCT01670539|Rural|rural
444199|NCT01670539|Nursing|nursing
444200|NCT01670526|Traumatic Brain Injury|traumatic brain injury
444201|NCT01670526|Cognitive Impairment|cognitive impairment
444202|NCT01670526|Rivastigmine|rivastigmine
444203|NCT01670526|Pharmacologic Actions|pharmacologic actions
444204|NCT01670526|TBI|tbi
444205|NCT01670526|Memory|memory
444206|NCT01670526|Cholinesterase Inhibitors|cholinesterase inhibitors
444207|NCT01670526|Cognition|cognition
444208|NCT01670526|Head Trauma|head trauma
444209|NCT01670513|Psoriasis|psoriasis
444210|NCT01670500|germline mutation|germline mutation
444211|NCT01670500|BRCA1 mutation|brca1 mutation
444212|NCT01670500|BRCA2 mutation|brca2 mutation
444213|NCT01670487|Vapocoolant|vapocoolant
444214|NCT01670474|Temporary hemodialysis catheters|temporary hemodialysis catheters
444215|NCT01670474|Non-cuffed hemodialysis catheters|non-cuffed hemodialysis catheters
444216|NCT01670474|Thrombolysis|thrombolysis
444217|NCT01670474|rt-PA|rt-pa
444218|NCT01670474|Thrombosis|thrombosis
444219|NCT01670474|Lifespan|lifespan
444220|NCT01670474|Blood flow rate|blood flow rate
444221|NCT01670474|Catheter related bacteriemia|catheter related bacteriemia
444222|NCT01670461|advance care planning, palliative care, pediatric|advance care planning, palliative care, pediatric
444223|NCT01670448|Postoperative pain|postoperative pain
444224|NCT01670448|Chronic pain prevention|chronic pain prevention
444225|NCT01670448|Regional anesthesia|regional anesthesia
444226|NCT01670448|Mastectomy|mastectomy
444227|NCT01670435|Ciprofloxacin|ciprofloxacin
444228|NCT01670435|sepsis|sepsis
444229|NCT01670435|infection|infection
444230|NCT01670435|pneumonia|pneumonia
444231|NCT01670435|peritonitis|peritonitis
444232|NCT01670435|cholecystitis|cholecystitis
444233|NCT01670435|cholangitis|cholangitis
444234|NCT01670435|anthrax|anthrax
444235|NCT01670422|CSOJ|csoj
444236|NCT01670422|recurrence|recurrence
444237|NCT01670422|life-threatening complications|life-threatening complications
444238|NCT01670422|risk factors|risk factors
444239|NCT01670409|Esophageal squamous cell carcinoma|esophageal squamous cell carcinoma
444240|NCT01670409|SMART|smart
444241|NCT01670409|IMRT|imrt
444242|NCT01670409|Chemotherapy|chemotherapy
444243|NCT01670396|coronary stent implant|coronary stent implant
444244|NCT01670396|polymorphism|polymorphism
444245|NCT01670396|G protein|g protein
444246|NCT01670396|drug-eluting stent|drug-eluting stent
444247|NCT01670396|restenosis|restenosis
444248|NCT01670383|Cardiac Arrest|cardiac arrest
444249|NCT01670383|Sepsis|sepsis
444250|NCT01670383|Biological Markers|biological markers
444251|NCT01670383|Anti-Inflammation Agents|anti-inflammation agents
444252|NCT01670383|Antioxidants|antioxidants
444253|NCT01670370|Rituximab|rituximab
444254|NCT01670370|Gemcitabine|gemcitabine
444255|NCT01670370|Oxaliplatin|oxaliplatin
444256|NCT01670370|Diffuse large B-cell lymphoma|diffuse large b-cell lymphoma
444257|NCT01670357|Dry Eye Syndrome|dry eye syndrome
444258|NCT01670318|Chronic total occlusion|chronic total occlusion
444259|NCT01670318|Bifurcation lesion|bifurcation lesion
444260|NCT01670318|Left main trunk lesion|left main trunk lesion
444261|NCT01670318|Small vessel disease|small vessel disease
444262|NCT01670318|Multi vessel disease|multi vessel disease
444263|NCT01670292|Low Back Pain|low back pain
444264|NCT01670279|Major Depressive Disorder (MDD)|major depressive disorder (mdd)
444265|NCT01670266|ONO-9054|ono-9054
444266|NCT01670266|ocular hypertension|ocular hypertension
444267|NCT01670266|OHT|oht
444268|NCT01670266|Open angle-glaucoma|open angle-glaucoma
444269|NCT01670266|OAG|oag
444270|NCT01670266|Glaucoma|glaucoma
444271|NCT01670266|Eye diseases|eye diseases
444272|NCT01670240|IPAA|ipaa
444273|NCT01670240|Pouchitis|pouchitis
444274|NCT01670240|Ulcerative colitis|ulcerative colitis
444275|NCT01670240|Pouch|pouch
444276|NCT01670240|Adalimumab|adalimumab
444277|NCT01670240|Humira|humira
444278|NCT01670227|EARLY CHILDHOOD|early childhood
444279|NCT01670227|UNIVERSAL PREVENTION|universal prevention
444280|NCT01670214|RM|rm
444281|NCT01670214|R-CM|r-cm
444282|NCT01670214|based on ICHD-2 criteria|based on ichd-2 criteria
444283|NCT01670188|Pneumatic sequential compression device (SCD)|pneumatic sequential compression device (scd)
444284|NCT01670188|Peripherally Inserted Central Catheters (PICC)|peripherally inserted central catheters (picc)
444285|NCT01670175|Histologic verification of solid tumor, including lymphomas|histologic verification of solid tumor, including lymphomas
444286|NCT01670175|Original diagnosis or relapse|original diagnosis or relapse
444287|NCT01670162|Pigment Epithelium of Eye|pigment epithelium of eye
444288|NCT01670162|Wet macular degeneration|wet macular degeneration
444289|NCT01670162|Macular degeneration|macular degeneration
444290|NCT01670149|Clostridium difficile|clostridium difficile
444291|NCT01670149|Diarrhoea|diarrhoea
444292|NCT01670149|Rifaximin|rifaximin
444293|NCT01670136|sildenafil|sildenafil
444294|NCT01670136|preterm infants|preterm infants
444295|NCT01670136|persistent pulmonary hypertension of the newborn|persistent pulmonary hypertension of the newborn
444296|NCT01670123|Mobile phone|mobile phone
444297|NCT01670123|electronic intervention|electronic intervention
444298|NCT01670123|behavioral intervention|behavioral intervention
444299|NCT01670123|telehealth|telehealth
444300|NCT01670123|bipolar disorder|bipolar disorder
444301|NCT01670110|Polycystic Liver Disease|polycystic liver disease
444302|NCT01670110|Autosomal dominant polycystic kidney disease|autosomal dominant polycystic kidney disease
444303|NCT01670110|Autosomal dominant polycystic liver disease|autosomal dominant polycystic liver disease
444304|NCT01670110|Somatostatin analogs|somatostatin analogs
444305|NCT01670110|Pasireotide LAR|pasireotide lar
444306|NCT01670110|SOM230|som230
444307|NCT01670097|Advanced Cancers|advanced cancers
444308|NCT01670097|Hematologic Disorder|hematologic disorder
444309|NCT01670097|Solid Tumors|solid tumors
444310|NCT01670097|Dyspnea|dyspnea
444311|NCT01670097|Difficulty breathing|difficulty breathing
444312|NCT01670097|Shortness of breath|shortness of breath
444313|NCT01670097|Dexamethasone|dexamethasone
444314|NCT01670097|Decadron|decadron
444315|NCT01670097|Placebo|placebo
444316|NCT01670097|Sugar pill|sugar pill
444317|NCT01670097|Questionnaires|questionnaires
444318|NCT01670097|Surveys|surveys
444319|NCT01670097|Spirometer|spirometer
444320|NCT01670097|Phone calls|phone calls
444321|NCT01670071|Schizophrenia|schizophrenia
444322|NCT01670071|Paliperidone|paliperidone
444323|NCT01670071|Risperidone|risperidone
444324|NCT01670071|Paliperidone extended-release (ER)|paliperidone extended-release (er)
444325|NCT01670071|Risperidone immediate-release (IR)|risperidone immediate-release (ir)
444326|NCT01670019|Depression|depression
444327|NCT01670019|Antidepressant|antidepressant
444328|NCT01670019|Antipsychotic|antipsychotic
444329|NCT01669993|Outcomes|outcomes
444330|NCT01669993|Quality improvement|quality improvement
444331|NCT01669993|Patient Safety|patient safety
444332|NCT01669993|PACU|pacu
444333|NCT01669993|Complications|complications
444334|NCT01669993|Adverse events|adverse events
444335|NCT01669993|Respiratory arrest|respiratory arrest
444336|NCT01669993|Pain|pain
444337|NCT01669993|PONV|ponv
444338|NCT01669993|Age|age
444339|NCT01669993|Neonate|neonate
444340|NCT01669993|Infant|infant
444341|NCT01669993|Child|child
444342|NCT01669993|Ambulatory|ambulatory
444343|NCT01669993|Inpatient|inpatient
444344|NCT01669993|General Anesthesia|general anesthesia
444345|NCT01669993|Otolaryngology|otolaryngology
444346|NCT01669993|Tonsillectomy|tonsillectomy
444347|NCT01669993|Obstructive sleep apnea|obstructive sleep apnea
444348|NCT01669980|Infections|infections
444349|NCT01669980|Pediatrics|pediatrics
444350|NCT01669980|Teflaro|teflaro
444351|NCT01669980|Ceftriaxone|ceftriaxone
444352|NCT01669980|cephalosporin|cephalosporin
444353|NCT01669980|Vancomycin|vancomycin
444354|NCT01669980|Clindamycin|clindamycin
444355|NCT01669980|Amoxicillin Clavulanate|amoxicillin clavulanate
444356|NCT01669980|Linezolid|linezolid
444357|NCT01669980|MRSA|mrsa
444358|NCT01669980|pneumonia|pneumonia
444359|NCT01669954|HIV|hiv
444360|NCT01669954|Bone mineral density|bone mineral density
444361|NCT01669954|Osteoporosis|osteoporosis
444362|NCT01669954|Vitamin D|vitamin d
444363|NCT01669954|Fractures|fractures
444364|NCT01669941|Pregnancy|pregnancy
444365|NCT01669941|Plasmodium|plasmodium
444366|NCT01669941|Malaria|malaria
444367|NCT01669941|Prevention|prevention
444368|NCT01669941|Kenya|kenya
444369|NCT01669941|Piperaquine|piperaquine
444370|NCT01669941|Dihydroartemisinin-Piperaquine|dihydroartemisinin-piperaquine
444371|NCT01669941|Sulfadoxine Pyrimethamine|sulfadoxine pyrimethamine
444372|NCT01669876|Randomized|randomized
444373|NCT01669876|Double-Blind|double-blind
444374|NCT01669876|Dietary Supplements|dietary supplements
444375|NCT01669863|ARDS|ards
444376|NCT01669850|Chronic kidney disease|chronic kidney disease
444377|NCT01669850|Arteriovenous fistula|arteriovenous fistula
444378|NCT01669850|Surgical anastomosis|surgical anastomosis
444379|NCT01669850|Complications|complications
444380|NCT01669850|Patency|patency
444381|NCT01669850|Dialysis access|dialysis access
444382|NCT01669837|Inguinal hernia|inguinal hernia
444383|NCT01669837|Laparoscopy|laparoscopy
444384|NCT01669837|Surgical tissue glue|surgical tissue glue
444385|NCT01669811|Refractory Reflux Esophagitis,|refractory reflux esophagitis,
444386|NCT01669811|Japanese,|japanese,
444387|NCT01669811|Nexium,|nexium,
444388|NCT01669811|twice daily,|twice daily,
444389|NCT01669811|oral administration|oral administration
444390|NCT01669798|Recurrent epithelial ovarian carcinoma|recurrent epithelial ovarian carcinoma
444391|NCT01669798|Persistent epithelial ovarian carcinoma|persistent epithelial ovarian carcinoma
444392|NCT01669798|Bevacizumab resistant epithelial ovarian carcinoma|bevacizumab resistant epithelial ovarian carcinoma
444393|NCT01669746|Androgenetic Alopecia|androgenetic alopecia
444394|NCT01669746|Male Pattern Baldness|male pattern baldness
444395|NCT01669746|Female Pattern Baldness|female pattern baldness
444396|NCT01669746|Hair Loss|hair loss
444397|NCT01669746|Baldness|baldness
444398|NCT01669733|Breast Surgery|breast surgery
444399|NCT01669733|Breast Biopsy|breast biopsy
444400|NCT01669733|Music Therapy|music therapy
444401|NCT01669720|Metastatic|metastatic
444402|NCT01669720|Colorectal|colorectal
444403|NCT01669720|Colorectal Cancer|colorectal cancer
444404|NCT01669720|Resected or Ablated Metastatic Colorectal Cancer|resected or ablated metastatic colorectal cancer
444405|NCT01669707|Endostar|endostar
444406|NCT01669707|advanced Non-small cell lung cancer|advanced non-small cell lung cancer
444407|NCT01669707|Continued Pumping into vein|continued pumping into vein
444408|NCT01669707|Gemcitabine|gemcitabine
444409|NCT01669707|Carboplatin|carboplatin
444410|NCT01669694|Pelvic Pain|pelvic pain
444411|NCT01669694|Pelvic Floor Physical Therapy|pelvic floor physical therapy
444412|NCT01669694|Biomarkers|biomarkers
444413|NCT01669681|Severe asthma|severe asthma
444414|NCT01669681|Medical economic|medical economic
444415|NCT01669681|care|care
444416|NCT01669681|Cost efficiency|cost efficiency
444417|NCT01669681|CPAM|cpam
444418|NCT01669681|EQ5D|eq5d
444419|NCT01669642|ketamine sedation|ketamine sedation
444420|NCT01669642|pediatric|pediatric
444421|NCT01669642|abscess drainage|abscess drainage
444422|NCT01669642|fracture reduction|fracture reduction
444423|NCT01669616|Type 2 Diabetes|type 2 diabetes
444424|NCT01669616|Adults 18 years and older|adults 18 years and older
444425|NCT01669603|Common cold|common cold
444426|NCT01669577|predictors|predictors
444427|NCT01669577|trauma|trauma
444428|NCT01669577|mortality|mortality
444429|NCT01669564|Quality of Life|quality of life
444430|NCT01669564|Tobacco Use Cessation|tobacco use cessation
444431|NCT01669564|Physical Activity|physical activity
444432|NCT01669538|Galantamine|galantamine
444433|NCT01669538|Nicotine Bitartrate|nicotine bitartrate
444434|NCT01669538|Nicotine Tartrate|nicotine tartrate
444435|NCT01669538|Nicotine dependence|nicotine dependence
444436|NCT01669538|Tobacco Dependence|tobacco dependence
444437|NCT01669512|Malaria vaccine|malaria vaccine
444438|NCT01669512|Matrix M|matrix m
444439|NCT01669499|Bone metastases, radiotherapy, dexamethasone, pain flare|bone metastases, radiotherapy, dexamethasone, pain flare
444441|NCT01669486|ICU|icu
444442|NCT01669486|Mechanical ventilation|mechanical ventilation
444443|NCT01669486|CPOT|cpot
444444|NCT01669486|BPS|bps
444445|NCT01669473|Diabetes|diabetes
444446|NCT01669447|dmri, mnvc, lucentis|dmri, mnvc, lucentis
444447|NCT01669434|Perioperative Period|perioperative period
444448|NCT01669421|Alpha 1|alpha 1
444449|NCT01669408|ischemic stroke|ischemic stroke
444450|NCT01669408|hemorrhagic stroke|hemorrhagic stroke
444451|NCT01669408|prehospital cooling|prehospital cooling
444452|NCT01669408|induction of cooling|induction of cooling
444453|NCT01669408|ambulance|ambulance
444454|NCT01669408|emergency room|emergency room
444455|NCT01669408|cold infusions|cold infusions
444456|NCT01669408|hypothermia|hypothermia
444457|NCT01669408|normothermia|normothermia
444458|NCT01669395|Severe heart failure|severe heart failure
444459|NCT01669395|Homebased rehabilitation|homebased rehabilitation
444460|NCT01669395|Physical exercise|physical exercise
444461|NCT01669395|Activities of daily living|activities of daily living
444462|NCT01669395|Intersectoral Cooperation|intersectoral cooperation
444463|NCT01669382|AngioSeal, ExoSeal, PCI, puncture site|angioseal, exoseal, pci, puncture site
444464|NCT01669369|Lithium Carbonate|lithium carbonate
444465|NCT01669369|Chemotherapy|chemotherapy
444466|NCT01669369|prognosis|prognosis
444467|NCT01669356|malnutrition|malnutrition
444468|NCT01669356|parenteral supplement|parenteral supplement
444469|NCT01669356|rest metabolic rate|rest metabolic rate
444470|NCT01669356|postoperative complications|postoperative complications
444471|NCT01669343|Aromatase Inhibitors|aromatase inhibitors
444472|NCT01669330|Gastroesophageal Reflux|gastroesophageal reflux
444473|NCT01669330|Fundoplication|fundoplication
444474|NCT01669330|Surgical Procedures|surgical procedures
444475|NCT01669317|Cherry Juice Pilot|cherry juice pilot
444476|NCT01669304|migraine variant|migraine variant
444477|NCT01669304|chronic dizziness|chronic dizziness
444478|NCT01669304|pharmacologic dissection|pharmacologic dissection
444479|NCT01669278|sheath|sheath
444480|NCT01669278|flexible|flexible
444481|NCT01669278|endoscopy|endoscopy
444482|NCT01669278|otolaryngology|otolaryngology
444483|NCT01669278|office|office
444484|NCT01669265|Breast cancer|breast cancer
444485|NCT01669265|OSNA|osna
444486|NCT01669265|sentinel lymph node|sentinel lymph node
444487|NCT01669252|Breast cancer|breast cancer
444488|NCT01669252|Eribulin|eribulin
444489|NCT01669252|Neoadjuvant|neoadjuvant
444490|NCT01669252|PAM50|pam50
444491|NCT01669252|Triple-negative|triple-negative
444492|NCT01669252|Luminal A|luminal a
444493|NCT01669252|Luminal B|luminal b
444494|NCT01669239|Breast Cancer|breast cancer
444495|NCT01669239|HER2 positive|her2 positive
444496|NCT01669239|Neoadjuvant|neoadjuvant
444497|NCT01669239|Liposomal doxorubicin|liposomal doxorubicin
444498|NCT01669239|Paclitaxel|paclitaxel
444499|NCT01669239|Trastuzumab|trastuzumab
444500|NCT01669239|Pertuzumab|pertuzumab
444501|NCT01669239|Safety|safety
444502|NCT01669226|Ovarian Cancer|ovarian cancer
444503|NCT01669226|intraperitoneal chemotherapy|intraperitoneal chemotherapy
444504|NCT01669213|5-HT3 receptor antagonist|5-ht3 receptor antagonist
444505|NCT01669213|hypotension|hypotension
444506|NCT01669213|spinal anesthesia|spinal anesthesia
444507|NCT01669174|Chronic Obstructive Pulmonary Disease|chronic obstructive pulmonary disease
444508|NCT01669174|COPD; cachexia; muscle wasting|copd; cachexia; muscle wasting
444509|NCT01669161|Upper|upper
444510|NCT01669161|Limb|limb
444511|NCT01669161|Deficits|deficits
444512|NCT01669161|Rehabilitation|rehabilitation
444513|NCT01669161|VNS|vns
444514|NCT01669148|breast cancer|breast cancer
444515|NCT01669148|imaging|imaging
444516|NCT01669135|cerebral oximetry|cerebral oximetry
444517|NCT01669135|cesarean delivery|cesarean delivery
444518|NCT01669109|Yoga|yoga
444519|NCT01669109|Colorectal Neoplasms|colorectal neoplasms
444520|NCT01669109|Quality of Life|quality of life
444521|NCT01669109|Randomized Controlled Trial|randomized controlled trial
444522|NCT01669096|adults|adults
444523|NCT01669096|Tuberculosis vaccine|tuberculosis vaccine
444524|NCT01669096|HIV negative|hiv negative
444525|NCT01669096|healthy|healthy
444526|NCT01669096|mRNA expression|mrna expression
444527|NCT01669083|Oxytocin Antagonist|oxytocin antagonist
444528|NCT01669083|Embryo/Blastocyst Implantation|embryo/blastocyst implantation
444529|NCT01669070|bioavailability|bioavailability
444530|NCT01669070|Fluticasone Furoate|fluticasone furoate
444531|NCT01669070|pharmacokinetics|pharmacokinetics
444532|NCT01669070|dose proportionality|dose proportionality
444533|NCT01669057|Congenital heart disease|congenital heart disease
444534|NCT01669057|DNA variation|dna variation
444535|NCT01669057|methylation|methylation
444536|NCT01669057|risk factors|risk factors
444537|NCT01669057|supplements|supplements
444538|NCT01669031|automated perimetry|automated perimetry
444539|NCT01669031|visual fields|visual fields
444540|NCT01669031|reliability|reliability
444541|NCT01669031|vision tests/standards|vision tests/standards
444542|NCT01669031|randomized controlled trial|randomized controlled trial
444543|NCT01669031|false positive reactions|false positive reactions
444544|NCT01669031|false negative reactions|false negative reactions
444545|NCT01669031|fixation, ocular|fixation, ocular
444546|NCT01669031|mean deviation|mean deviation
444547|NCT01669031|variability|variability
444548|NCT01669031|program|program
444549|NCT01669031|software|software
444550|NCT01669031|glaucoma/diagnosis|glaucoma/diagnosis
444551|NCT01669031|visual field tests/methods|visual field tests/methods
444552|NCT01669031|aged|aged
444553|NCT01669031|humans|humans
444554|NCT01669031|female|female
444555|NCT01669031|male|male
444556|NCT01669031|prospective studies|prospective studies
444557|NCT01669031|reproducibility of results|reproducibility of results
444558|NCT01669005|neutropenia|neutropenia
444559|NCT01669005|multiplex PCR|multiplex pcr
444560|NCT01669005|infection|infection
444561|NCT01668992|Parenting|parenting
444562|NCT01668992|Discipline|discipline
444563|NCT01668992|Family interventions|family interventions
444564|NCT01668992|Thailand|thailand
444565|NCT01668992|Migration|migration
444566|NCT01668953|Lateral Epicondylitis|lateral epicondylitis
444567|NCT01668953|Tennis Elbow|tennis elbow
444568|NCT01668953|Platelet Rich Plasma|platelet rich plasma
444569|NCT01668953|Whole Blood|whole blood
444570|NCT01668953|Tendon Fenestration|tendon fenestration
444571|NCT01668940|Morning Sickness|morning sickness
444572|NCT01668940|Lillipops Iced Soothies|lillipops iced soothies
444573|NCT01668940|Pregnancy|pregnancy
444574|NCT01668940|Obstetrics|obstetrics
444575|NCT01668914|Breast Cancer|breast cancer
444576|NCT01668914|Clinically Axillary Node -Positive|clinically axillary node -positive
444577|NCT01668914|Sentinel Lymph Node Biopsy|sentinel lymph node biopsy
444578|NCT01668914|Internal Mammary|internal mammary
444579|NCT01668901|warfarin|warfarin
444580|NCT01668901|aspirin|aspirin
444581|NCT01668875|head down postural drainage|head down postural drainage
444582|NCT01668849|Plant exosomes|plant exosomes
444583|NCT01668849|Grape exosomes|grape exosomes
444584|NCT01668849|Grape extract|grape extract
444585|NCT01668849|Oral mucositis|oral mucositis
444586|NCT01668849|Head and Neck Cancer|head and neck cancer
444587|NCT01668849|Immune response|immune response
444588|NCT01668836|sirtuin|sirtuin
444589|NCT01668836|atherosclerosis|atherosclerosis
444590|NCT01668836|longevity|longevity
444591|NCT01668836|calorie restriction|calorie restriction
444592|NCT01668836|resveratrol|resveratrol
444593|NCT01668836|vascular reactivity|vascular reactivity
444594|NCT01668810|prescription|prescription
444595|NCT01668810|schizophrenia|schizophrenia
444596|NCT01668810|depression|depression
444597|NCT01668810|bipolar disorder|bipolar disorder
444598|NCT01668771|Self-Affirmation|self-affirmation
444599|NCT01668771|Affect|affect
444600|NCT01668771|Alcohol|alcohol
444601|NCT01668758|Near Infrared Spectroscopy|near infrared spectroscopy
444602|NCT01668758|Traumatic Brain Injury|traumatic brain injury
444603|NCT01668745|Child mortality|child mortality
444604|NCT01668745|Measles vaccine|measles vaccine
444605|NCT01668745|Non-specific effects|non-specific effects
444606|NCT01668693|Endometrial receptivity|endometrial receptivity
444607|NCT01668693|recurrent implantation failure|recurrent implantation failure
444608|NCT01668693|predictor tool|predictor tool
444610|NCT01668693|customized microarray|customized microarray
444611|NCT01668693|personalized embryo transfer|personalized embryo transfer
444612|NCT01668680|Metronomic Chemotherapy|metronomic chemotherapy
444613|NCT01668680|Anti-Angiogenic|anti-angiogenic
444614|NCT01668680|Maintenance Treatment|maintenance treatment
444615|NCT01668680|Colorectal Cancer Metastatic|colorectal cancer metastatic
444616|NCT01668667|gabapentin enacarbil|gabapentin enacarbil
444617|NCT01668667|Horizant|horizant
444618|NCT01668654|Epilepsy|epilepsy
444619|NCT01668654|Partial Onset epilepsy|partial onset epilepsy
444620|NCT01668654|Lennox-Gastaut Syndrome|lennox-gastaut syndrome
444621|NCT01668654|Open-label extension study|open-label extension study
444622|NCT01668641|Methotrexate insufficient responders|methotrexate insufficient responders
444623|NCT01668628|quality of life|quality of life
444624|NCT01668628|depression|depression
444625|NCT01668628|BCM (body composition minitor)|bcm (body composition minitor)
444626|NCT01668628|hydrational status|hydrational status
444627|NCT01668615|idiopathicthrombocytopenic purpura|idiopathicthrombocytopenic purpura
444628|NCT01668615|all-trans retinoic acid|all-trans retinoic acid
444629|NCT01668615|regulory T cells|regulory t cells
444630|NCT01668602|Rehabilitation|rehabilitation
444631|NCT01668602|Gait disorders|gait disorders
444632|NCT01668576|mesenchymal stem cells|mesenchymal stem cells
444633|NCT01668576|Lung transplantation|lung transplantation
444634|NCT01668563|Aneurysm|aneurysm
444635|NCT01668563|Intracranial Aneurysm|intracranial aneurysm
444636|NCT01668563|Vascular Diseases|vascular diseases
444637|NCT01668563|Cardiovascular Diseases|cardiovascular diseases
444638|NCT01668563|Intracranial Arterial Diseases|intracranial arterial diseases
445727|NCT01663467|tinnitus|tinnitus
444639|NCT01668563|Cerebrovascular Disorders|cerebrovascular disorders
444640|NCT01668563|Brain Diseases|brain diseases
444641|NCT01668563|Central Nervous System Diseases|central nervous system diseases
444642|NCT01668563|Nervous System Diseases|nervous system diseases
444643|NCT01668550|Phase I|phase i
444644|NCT01668550|Src/Abl inhibitor|src/abl inhibitor
444645|NCT01668550|Solid Tumours|solid tumours
444646|NCT01668550|Cancer|cancer
444647|NCT01668511|Immunogenicity|immunogenicity
444648|NCT01668511|Safety|safety
444649|NCT01668511|Tolerability|tolerability
444650|NCT01668511|Osteoarthritis|osteoarthritis
444651|NCT01668511|Pharmacokinetics|pharmacokinetics
444652|NCT01668498|Can preemptive treatment of panitumumab mediated skin|can preemptive treatment of panitumumab mediated skin
444653|NCT01668498|toxicity with oral doxycycline be replaced by local treatment with erythromycin?|toxicity with oral doxycycline be replaced by local treatment with erythromycin?
444654|NCT01668498|Panitumumab|panitumumab
444655|NCT01668485|Type 1 diabetes mellitus|type 1 diabetes mellitus
444656|NCT01668485|hypoglycemia counterregulation,|hypoglycemia counterregulation,
444657|NCT01668485|pancreatic islet transplantation|pancreatic islet transplantation
444658|NCT01668472|Pregnant|pregnant
444659|NCT01668472|leaking fluid|leaking fluid
444660|NCT01668459|Transitional cell carcinoma|transitional cell carcinoma
444661|NCT01668459|Bladder cancer|bladder cancer
444662|NCT01668459|Cancer|cancer
444663|NCT01668459|Oncology|oncology
444664|NCT01668459|Cabazitaxel|cabazitaxel
444665|NCT01668446|Sildenafil|sildenafil
444666|NCT01668446|Endometrial thickness|endometrial thickness
444667|NCT01668446|Frozen embryo transfer|frozen embryo transfer
444668|NCT01668446|ultrasonographic endometrial thickness|ultrasonographic endometrial thickness
444669|NCT01668446|endometrial pattern|endometrial pattern
444670|NCT01668446|Implantation rate|implantation rate
444671|NCT01668446|chemical pregnancy rate|chemical pregnancy rate
444672|NCT01668433|G6PD|g6pd
444673|NCT01668433|Primaquine|primaquine
444674|NCT01668433|Methylene blue|methylene blue
444675|NCT01668420|thermal stimulation|thermal stimulation
444676|NCT01668420|lower extremity|lower extremity
444677|NCT01668420|temperature|temperature
444678|NCT01668420|efficacy|efficacy
444679|NCT01668407|Parkinson's disease|parkinson's disease
444680|NCT01668407|PSP|psp
444681|NCT01668407|Robot|robot
444682|NCT01668407|Gait rehabilitation|gait rehabilitation
444683|NCT01668381|hepatocellular carcinoma|hepatocellular carcinoma
444684|NCT01668381|Catheter Ablation|catheter ablation
444685|NCT01668381|T-Lymphocytes, Regulatory|t-lymphocytes, regulatory
444686|NCT01668381|IL-10|il-10
444687|NCT01668381|TGF-β|tgf-β
444688|NCT01668381|IFN-γ|ifn-γ
444689|NCT01668368|ARDS|ards
444690|NCT01668368|Esophageal pressure|esophageal pressure
444691|NCT01668368|pleural pressure|pleural pressure
444692|NCT01668368|pulmonary compliance|pulmonary compliance
444693|NCT01668355|Delivery of Healthcare|delivery of healthcare
444694|NCT01668355|Health Services Research|health services research
444695|NCT01668355|Integrated Healthcare Systems|integrated healthcare systems
444696|NCT01668355|Healthcare Quality, Access, and Evaluation|healthcare quality, access, and evaluation
444697|NCT01668355|Primary Care|primary care
444698|NCT01668355|Quality Improvement|quality improvement
444699|NCT01668355|Psychotic Disorders|psychotic disorders
444700|NCT01668355|Medical Home|medical home
444701|NCT01668355|Psychiatry|psychiatry
444702|NCT01668355|Patient Care Management|patient care management
444703|NCT01668355|Nursing Care Management|nursing care management
444704|NCT01668355|Treatment Costs|treatment costs
444705|NCT01668329|Septic shock|septic shock
444706|NCT01668329|Inflammatory process|inflammatory process
444707|NCT01668329|Cytokines|cytokines
444708|NCT01668329|Hormonal response|hormonal response
444709|NCT01668329|Oxydative stress|oxydative stress
444710|NCT01668316|Overweight|overweight
444711|NCT01668316|Obese|obese
444712|NCT01668316|Postpartum|postpartum
444713|NCT01668316|Weight loss|weight loss
444714|NCT01668316|Inflammation|inflammation
444715|NCT01668316|Obesity|obesity
444716|NCT01668316|Cardiovascular|cardiovascular
444717|NCT01668303|juvenile drug court|juvenile drug court
444718|NCT01668303|adolescents|adolescents
444719|NCT01668303|substance abuse|substance abuse
444720|NCT01668303|delinquency|delinquency
444721|NCT01668303|family therapy|family therapy
444722|NCT01668303|multidimensional family therapy|multidimensional family therapy
444723|NCT01668290|Coronary Artery Disease|coronary artery disease
444724|NCT01668290|Stress Echocardiography|stress echocardiography
444725|NCT01668290|Single Photon Emission Computed Tomography|single photon emission computed tomography
444726|NCT01668290|Cardiac Computed Tomographic Angiography|cardiac computed tomographic angiography
444727|NCT01668290|outcomes|outcomes
444728|NCT01668277|Pulmonary Hypertensive Crisis|pulmonary hypertensive crisis
444729|NCT01668277|Pediatrics|pediatrics
444730|NCT01668277|Hypertonic Saline|hypertonic saline
444731|NCT01668264|Pediatrics|pediatrics
444732|NCT01668264|Congenital Heart Disease|congenital heart disease
444733|NCT01668264|Diastolic Function|diastolic function
444734|NCT01668264|Echocardiograph|echocardiograph
444735|NCT01668264|MRI|mri
445728|NCT01663467|smartphone|smartphone
444736|NCT01668251|Turner syndrome|turner syndrome
444737|NCT01668251|Diagnosis, prenatal|diagnosis, prenatal
444738|NCT01668238|Thyroid tumor|thyroid tumor
444739|NCT01668238|Breast tumor|breast tumor
444740|NCT01668238|Fourier Transform Infrared Spectrometry|fourier transform infrared spectrometry
444741|NCT01668238|Tumor Diagnosis|tumor diagnosis
444742|NCT01668186|Peroxisome biogenesis disorders|peroxisome biogenesis disorders
444743|NCT01668186|PBD|pbd
444744|NCT01668186|Zellweger spectrum|zellweger spectrum
444745|NCT01668186|Rhizomelic chondrodysplasia punctata|rhizomelic chondrodysplasia punctata
444746|NCT01668186|RCDP|rcdp
444747|NCT01668173|HSP90 Inhibitor|hsp90 inhibitor
444748|NCT01668173|AUY922|auy922
444749|NCT01668173|12-076|12-076
444750|NCT01668160|clinical outcomes|clinical outcomes
444751|NCT01668160|radiographic outcomes|radiographic outcomes
444752|NCT01668160|total hip arthroplasty|total hip arthroplasty
444753|NCT01668160|survivorship|survivorship
444754|NCT01668147|PET Imaging|pet imaging
444755|NCT01668147|Efavirenz|efavirenz
444756|NCT01668147|Ritonavir|ritonavir
444757|NCT01668147|[11C] desmethyl-loperamide|[11c] desmethyl-loperamide
444758|NCT01668147|Healthy volunteers|healthy volunteers
444759|NCT01668108|carcinoma|carcinoma
444760|NCT01668108|breast cancer|breast cancer
444761|NCT01668108|non-small cell lung cancer|non-small cell lung cancer
444762|NCT01668108|ovarial cancer|ovarial cancer
444763|NCT01668108|ambulant chemotherapy|ambulant chemotherapy
444764|NCT01668108|treatment cycles|treatment cycles
444765|NCT01668108|Paclitaxel|paclitaxel
444766|NCT01668108|Paclitaxel onkovis|paclitaxel onkovis
444767|NCT01668108|Quantity of Paclitaxel|quantity of paclitaxel
444768|NCT01668108|Packaging Sizes|packaging sizes
444769|NCT01668082|Patients with newly identified brain mass|patients with newly identified brain mass
444770|NCT01668069|nausea|nausea
444771|NCT01668069|vomiting|vomiting
444772|NCT01668069|pregnancy|pregnancy
444773|NCT01668069|ondansetron|ondansetron
444774|NCT01668069|doxylamine|doxylamine
444775|NCT01668069|vitamin B6|vitamin b6
444776|NCT01668069|pyridoxine|pyridoxine
444777|NCT01668056|in vitro fertilization|in vitro fertilization
444778|NCT01668056|ovarian stimulation|ovarian stimulation
444779|NCT01668056|follicular waves|follicular waves
444780|NCT01668056|luteal phase|luteal phase
444781|NCT01668043|HIV-1|hiv-1
444782|NCT01668043|CD4|cd4
444783|NCT01668043|antibody|antibody
444784|NCT01668043|immunotherapy|immunotherapy
444785|NCT01668030|Facial|facial
444786|NCT01668030|Partial thickness|partial thickness
444787|NCT01668017|Advanced solid tumors|advanced solid tumors
444788|NCT01668017|Hepatocellular carcinoma|hepatocellular carcinoma
444789|NCT01668017|cancer, liver|cancer, liver
444790|NCT01667991|Colonization|colonization
444791|NCT01667991|infection|infection
444792|NCT01667991|multidrug-resistant bacteria|multidrug-resistant bacteria
444793|NCT01667991|guideline|guideline
444794|NCT01667978|contraception|contraception
444795|NCT01667978|mini pill|mini pill
444796|NCT01667978|norethindrone|norethindrone
444797|NCT01667978|atazanavir|atazanavir
444798|NCT01667978|ritonavir|ritonavir
444799|NCT01667978|norvir|norvir
444800|NCT01667978|reyataz|reyataz
444801|NCT01667978|pregnancy prevent|pregnancy prevent
444802|NCT01667978|birth control|birth control
444803|NCT01667978|HIV|hiv
444804|NCT01667978|AIDS|aids
444805|NCT01667978|antiviral|antiviral
444806|NCT01667978|antiretroviral|antiretroviral
444807|NCT01667965|palliative radiation|palliative radiation
444808|NCT01667965|12-172|12-172
444809|NCT01667952|Family History Questionnaire (FHQ)|family history questionnaire (fhq)
444810|NCT01667952|Blood sample|blood sample
444811|NCT01667952|Salvia sample|salvia sample
444812|NCT01667952|12-145|12-145
444813|NCT01667939|adequacy|adequacy
444814|NCT01667939|diet|diet
444815|NCT01667939|pregnancy|pregnancy
444816|NCT01667913|Hip Fracture|hip fracture
444817|NCT01667913|6-minutes walking test|6-minutes walking test
444818|NCT01667913|Reliability|reliability
444819|NCT01667887|Far Cortical Locking|far cortical locking
444820|NCT01667887|Distal Femur Fracture|distal femur fracture
444821|NCT01667887|Locking Plate|locking plate
444822|NCT01667887|MotionLoc|motionloc
444823|NCT01667887|Fracture Fixation|fracture fixation
444824|NCT01667874|Randomized controlled trial|randomized controlled trial
444825|NCT01667874|early joint infection|early joint infection
444826|NCT01667874|gentamicin impregnated sponges|gentamicin impregnated sponges
444827|NCT01667861|Glaucoma|glaucoma
444828|NCT01667861|Wind instruments|wind instruments
444829|NCT01667848|pain|pain
444830|NCT01667835|yoga|yoga
444831|NCT01667835|postmenopausal, sedentary South Asian women|postmenopausal, sedentary south asian women
444832|NCT01667796|Multiple sclerosis|multiple sclerosis
444833|NCT01667796|Healthy controls|healthy controls
444834|NCT01667796|Pharmacokinetics|pharmacokinetics
444835|NCT01667796|Vitamin D|vitamin d
444836|NCT01667783|Obesity|obesity
444837|NCT01667783|Diabetes|diabetes
444838|NCT01667757|coronary atherosclerosis|coronary atherosclerosis
444839|NCT01667757|drug eluting stent|drug eluting stent
444840|NCT01667757|intravascular ultrasound|intravascular ultrasound
444841|NCT01667757|fractional flow reserve|fractional flow reserve
444842|NCT01667744|Angina|angina
444843|NCT01667744|Acute Coronary Syndrome|acute coronary syndrome
444844|NCT01667744|Emotional Distress|emotional distress
444845|NCT01667744|Citalopram|citalopram
444846|NCT01667744|Health Care Utilization|health care utilization
444847|NCT01667731|Hepatitis C|hepatitis c
444848|NCT01667731|Chronic|chronic
444849|NCT01667731|HCV|hcv
444850|NCT01667731|HIV|hiv
444851|NCT01667731|Human Immunodeficiency Virus|human immunodeficiency virus
444852|NCT01667731|Co-Infected|co-infected
444853|NCT01667718|eradication|eradication
444854|NCT01667718|helicobacter pylori|helicobacter pylori
444855|NCT01667718|bismuth|bismuth
444856|NCT01667705|Stress|stress
444857|NCT01667705|Anxiety|anxiety
444858|NCT01667705|Skyceiling|skyceiling
444859|NCT01667705|Nature|nature
444860|NCT01667692|H-pylori|h-pylori
444861|NCT01667692|eradication|eradication
444862|NCT01667692|azithromycin|azithromycin
444863|NCT01667692|clarithromycin|clarithromycin
444864|NCT01667679|Migraine|migraine
444865|NCT01667679|Headaches|headaches
444866|NCT01667679|Sumatriptan|sumatriptan
444867|NCT01667666|trauma|trauma
444868|NCT01667666|acute lung injury|acute lung injury
444869|NCT01667666|adult respiratory distress syndrome|adult respiratory distress syndrome
444870|NCT01667640|Brain metastases|brain metastases
444871|NCT01667640|radiation|radiation
444872|NCT01667640|sector|sector
444873|NCT01667640|singular|singular
444874|NCT01667640|solitary|solitary
444875|NCT01667640|neurocognition|neurocognition
444876|NCT01667627|IBS|ibs
444877|NCT01667627|Probiotic|probiotic
444878|NCT01667627|hs-CRP|hs-crp
444879|NCT01667627|Cholinergic status|cholinergic status
444880|NCT01667627|Micro-inflammation|micro-inflammation
444881|NCT01667601|mindfulness-based program|mindfulness-based program
444882|NCT01667601|Psychoeducation|psychoeducation
444883|NCT01667601|schizophrenia|schizophrenia
444884|NCT01667601|Chinese|chinese
444885|NCT01667601|outpatients|outpatients
444886|NCT01667588|Chronic Kidney Disease (CKD)|chronic kidney disease (ckd)
444887|NCT01667588|Pediatrics|pediatrics
444888|NCT01667588|Sleep Disorders|sleep disorders
444889|NCT01667549|Breastfeeding|breastfeeding
444890|NCT01667549|Flavor learning|flavor learning
444891|NCT01667549|Mother|mother
444892|NCT01667549|Moms|moms
444893|NCT01667549|Infants|infants
444894|NCT01667549|Babies|babies
444895|NCT01667549|Baby|baby
444896|NCT01667549|Food Habits|food habits
444897|NCT01667549|Fruits|fruits
444898|NCT01667549|Vegetables|vegetables
444899|NCT01667536|PROSTATE CANCER|prostate cancer
444900|NCT01667536|HIGH-RISK|high-risk
444901|NCT01667536|PROSTATECTOMY SURGERY|prostatectomy surgery
444902|NCT01667536|NEWLY DIAGNOSED|newly diagnosed
444903|NCT01667523|capsaicin|capsaicin
444904|NCT01667523|cinnamaldehyde|cinnamaldehyde
444905|NCT01667510|Prehypertension|prehypertension
444906|NCT01667510|anti oxidation|anti oxidation
444907|NCT01667510|lycopene|lycopene
444908|NCT01667497|Cognitive fatigue|cognitive fatigue
444909|NCT01667497|multiple sclerosis|multiple sclerosis
444910|NCT01667484|Cognitive Impairment|cognitive impairment
444911|NCT01667484|Multiple Sclerosis|multiple sclerosis
444912|NCT01667484|Processing Speed|processing speed
444913|NCT01667484|Treatment|treatment
444914|NCT01667445|total knee arthroplasty|total knee arthroplasty
444915|NCT01667445|epimorph|epimorph
444916|NCT01667445|analgesia|analgesia
444917|NCT01667406|kisspeptin|kisspeptin
444918|NCT01667406|infertility|infertility
444919|NCT01667406|in vitro fertilisation|in vitro fertilisation
444920|NCT01667354|Parental Childhood Vaccine Hesitancy|parental childhood vaccine hesitancy
444921|NCT01667341|HSV|hsv
444922|NCT01667341|Herpes|herpes
444923|NCT01667341|genital infection|genital infection
444924|NCT01667341|vaccine|vaccine
444925|NCT01667328|Anxiety|anxiety
444926|NCT01667328|Presurgical anxiety|presurgical anxiety
444927|NCT01667328|Breast Cancer|breast cancer
444928|NCT01667302|NK/T-cell lymphoma|nk/t-cell lymphoma
444929|NCT01667302|Radiotherapy|radiotherapy
444930|NCT01667302|Adjuvant chemotherapy|adjuvant chemotherapy
444931|NCT01667289|NK/T-cell lymphoma|nk/t-cell lymphoma
444932|NCT01667289|Methotrexate|methotrexate
444933|NCT01667289|Radiotherapy|radiotherapy
444934|NCT01667289|Concurrent chemoradiation|concurrent chemoradiation
444935|NCT01667276|AE adverse event|ae adverse event
444936|NCT01667276|AIDS acquired immunodeficiency syndrome|aids acquired immunodeficiency syndrome
444937|NCT01667276|ALT (SGPT) alanine aminotransferase|alt (sgpt) alanine aminotransferase
444938|NCT01667276|ART antiretroviral therapy|art antiretroviral therapy
444939|NCT01667276|AST (SGOT) aspartate aminotransferase|ast (sgot) aspartate aminotransferase
444940|NCT01667276|DCF data collection forms|dcf data collection forms
444941|NCT01667276|DMC Data Monitoring Committee|dmc data monitoring committee
710622|NCT00588562|Primary Hyperoxaluria|primary hyperoxaluria
444942|NCT01667276|FDA (U.S.) Food and Drug Administration|fda (u.s.) food and drug administration
444943|NCT01667276|GCP Good Clinical Practice guidelines|gcp good clinical practice guidelines
445729|NCT01663467|Web|web
444944|NCT01667276|HB sAg Hepatitis B surface antigen|hb sag hepatitis b surface antigen
444945|NCT01667276|ICH International Conference of Harmonisation|ich international conference of harmonisation
444946|NCT01667276|IND Investigational New Drug Application|ind investigational new drug application
444947|NCT01667276|IRB Institutional Review Board|irb institutional review board
444948|NCT01667276|IU international units|iu international units
444949|NCT01667276|mg milligram(s)|mg milligram(s)
444950|NCT01667276|mm3 cubic millimeter(s)|mm3 cubic millimeter(s)
444951|NCT01667276|PCR polymerase chain reaction|pcr polymerase chain reaction
444952|NCT01667276|SAE serious adverse event|sae serious adverse event
444953|NCT01667276|µg microgram|µg microgram
444954|NCT01667276|ULN upper limit of the normal range|uln upper limit of the normal range
444955|NCT01667276|WB Western Blot|wb western blot
444956|NCT01667263|All-trans retinoic acid|all-trans retinoic acid
444957|NCT01667263|primary immune thrombocytopenia|primary immune thrombocytopenia
444958|NCT01667263|corticosteroid-resistant|corticosteroid-resistant
444959|NCT01667263|refractory|refractory
444960|NCT01667263|danazol|danazol
444961|NCT01667250|vagus nerve stimulation|vagus nerve stimulation
444962|NCT01667250|vagal nerve stimulation|vagal nerve stimulation
444963|NCT01667250|nVNS|nvns
444964|NCT01667250|VNS|vns
444965|NCT01667250|chronic migraine|chronic migraine
444966|NCT01667250|migraine|migraine
444967|NCT01667250|non invasive|non invasive
444968|NCT01667250|gammacore|gammacore
444969|NCT01667237|Pulmonary rehabilitation program|pulmonary rehabilitation program
444970|NCT01667237|Lung cancer|lung cancer
444971|NCT01667237|Lung resection surgery|lung resection surgery
444972|NCT01667237|Home-based|home-based
444973|NCT01667224|Actiponin|actiponin
444974|NCT01667224|Obesity|obesity
444975|NCT01667224|Abdominal fat|abdominal fat
444976|NCT01667211|Advanced uterine cervical cancer|advanced uterine cervical cancer
444977|NCT01667185|pediatric|pediatric
444978|NCT01667185|diabetes mellitus|diabetes mellitus
444979|NCT01667159|Depression|depression
444980|NCT01667159|Alcohol Use|alcohol use
444981|NCT01667159|Outpatient Therapy|outpatient therapy
444982|NCT01667133|Leukemia|leukemia
444983|NCT01667133|Leukemia, Myeloid|leukemia, myeloid
444984|NCT01667133|Leukemia, Myelogenous, Chronic, BCR-ABL Positive|leukemia, myelogenous, chronic, bcr-abl positive
444985|NCT01667133|Neoplasms by Histologic Type|neoplasms by histologic type
444986|NCT01667133|Neoplasms|neoplasms
444987|NCT01667133|Lymphoproliferative Disorders|lymphoproliferative disorders
444988|NCT01667133|Lymphatic Diseases|lymphatic diseases
444989|NCT01667133|Immunoproliferative Disorders|immunoproliferative disorders
444990|NCT01667133|Immune System Diseases|immune system diseases
444991|NCT01667133|Myeloproliferative Disorders|myeloproliferative disorders
444992|NCT01667133|Bone Marrow Diseases|bone marrow diseases
444993|NCT01667133|Hematologic Diseases|hematologic diseases
444994|NCT01667120|Ketorolac|ketorolac
444995|NCT01667120|postoperative pain|postoperative pain
444996|NCT01667120|bleeding events|bleeding events
444997|NCT01667094|Pulmonary exacerbation|pulmonary exacerbation
444998|NCT01667094|Continuous infusion|continuous infusion
444999|NCT01667094|Antipseudomonal beta-lactams|antipseudomonal beta-lactams
445000|NCT01667068|Cardiac Diseases|cardiac diseases
445001|NCT01667068|HIV-Infection|hiv-infection
445002|NCT01667068|AIDS|aids
445003|NCT01667068|Antiretroviral Therapy|antiretroviral therapy
445004|NCT01667068|Cardiovascular Medication|cardiovascular medication
445005|NCT01667068|Risk Factors|risk factors
445006|NCT01667068|coronary heart disease|coronary heart disease
445007|NCT01667068|heart failure|heart failure
445008|NCT01667068|metabolic syndrome|metabolic syndrome
445009|NCT01667055|drug allergy|drug allergy
445010|NCT01667055|drug hypersensitivity|drug hypersensitivity
445011|NCT01667055|beta-lactam allergy|beta-lactam allergy
445012|NCT01667055|penicillin allergy|penicillin allergy
445013|NCT01667055|adverse drug reaction|adverse drug reaction
445014|NCT01667042|Scleroderma Lung|scleroderma lung
445015|NCT01667042|Gastroesophageal Reflux|gastroesophageal reflux
445016|NCT01667042|Microaspiration|microaspiration
445017|NCT01667042|Cough|cough
445018|NCT01667016|International|international
445019|NCT01667016|Multicenter|multicenter
445020|NCT01667016|Observational registry|observational registry
445021|NCT01667016|Orsiro Drug Eluting Stent (DES)|orsiro drug eluting stent (des)
445022|NCT01667016|Stenting|stenting
445023|NCT01667016|Treatment of Coronary Artery Disease|treatment of coronary artery disease
445024|NCT01667016|Coronary revascularization|coronary revascularization
445025|NCT01667016|Percutaneous Coronary Intervention|percutaneous coronary intervention
445026|NCT01667016|STEMI|stemi
445027|NCT01667016|NSTEMI|nstemi
445028|NCT01667016|Ischemia|ischemia
445029|NCT01667016|Angina|angina
445030|NCT01667016|Subgroups|subgroups
445031|NCT01667016|Acute Myocardial Infarction|acute myocardial infarction
445032|NCT01667016|Diabetes|diabetes
445033|NCT01667016|Small Vessels|small vessels
445034|NCT01667016|Chronic Total Occlusion (CTO)|chronic total occlusion (cto)
445035|NCT01667003|International|international
445036|NCT01667003|Multicenter|multicenter
445037|NCT01667003|Observational registry|observational registry
445934|NCT01662622|anaesthesia|anaesthesia
445038|NCT01667003|Orsiro Drug Eluting Stent (DES)|orsiro drug eluting stent (des)
445039|NCT01667003|Stenting|stenting
445040|NCT01667003|Treatment of Coronary Artery Disease|treatment of coronary artery disease
445041|NCT01667003|Coronary revascularization|coronary revascularization
445042|NCT01667003|Percutaneous Coronary Intervention|percutaneous coronary intervention
445043|NCT01667003|STEMI|stemi
445044|NCT01667003|NSTEMI|nstemi
445045|NCT01667003|Ischemia|ischemia
445046|NCT01667003|Angina|angina
445047|NCT01667003|Subgroups|subgroups
445048|NCT01667003|Acute Myocardial Infarction|acute myocardial infarction
445049|NCT01667003|Diabetes|diabetes
445050|NCT01667003|Small Vessels|small vessels
445051|NCT01666990|Tripterygium wilfordii Hook F (TwHF)|tripterygium wilfordii hook f (twhf)
445053|NCT01666990|CD4|cd4
445054|NCT01666990|immune over-activation|immune over-activation
445055|NCT01666964|Traumatic brain injury|traumatic brain injury
445056|NCT01666964|hypopituitarism|hypopituitarism
445057|NCT01666938|Diabetes Mellitus|diabetes mellitus
445058|NCT01666938|Telephone|telephone
445059|NCT01666938|Physical activity|physical activity
445060|NCT01666912|adolescence|adolescence
445061|NCT01666912|contraception|contraception
445062|NCT01666912|postpartum|postpartum
445063|NCT01666912|rapid repeat pregnancy|rapid repeat pregnancy
445064|NCT01666873|osteoarthritis|osteoarthritis
445065|NCT01666860|anterior lumbar interbody fusion|anterior lumbar interbody fusion
445066|NCT01666847|Umbilical Cord Milking|umbilical cord milking
445067|NCT01666847|Extremely Low Birth Weight Infant (ELBW)|extremely low birth weight infant (elbw)
445068|NCT01666834|mechanical ventilation, ARDS, Ventilator strategy, outcome|mechanical ventilation, ards, ventilator strategy, outcome
445069|NCT01666821|macular degeneration; choroidal neovascularization|macular degeneration; choroidal neovascularization
445070|NCT01666782|Influenza vaccine|influenza vaccine
445071|NCT01666782|Oncology|oncology
445072|NCT01666782|Chemotherapy|chemotherapy
445073|NCT01666769|Extracorporeal membrane oxygenation|extracorporeal membrane oxygenation
445074|NCT01666769|ECMO|ecmo
445075|NCT01666769|Extracorporeal life support|extracorporeal life support
445076|NCT01666769|Micafungin|micafungin
445077|NCT01666769|Mycamine|mycamine
445078|NCT01666769|Pharmacokinetics|pharmacokinetics
445079|NCT01666743|Community-Acquired Pneumonia|community-acquired pneumonia
445080|NCT01666743|Lung|lung
445081|NCT01666743|Adult|adult
445082|NCT01666743|Infections|infections
445083|NCT01666691|Obese|obese
445084|NCT01666691|Obesity|obesity
445085|NCT01666691|Overweight|overweight
445086|NCT01666691|Weight loss|weight loss
445087|NCT01666691|Weight reduction|weight reduction
445088|NCT01666691|Beloranib|beloranib
445089|NCT01666678|Bioequivalence|bioequivalence
445090|NCT01666665|Burn|burn
445091|NCT01666652|Dengue|dengue
445092|NCT01666652|Dengue fever|dengue fever
445093|NCT01666652|Dengue Hemorrhagic Fever|dengue hemorrhagic fever
445094|NCT01666652|Flavivirus|flavivirus
445095|NCT01666626|crohn's disease|crohn's disease
445096|NCT01666626|ultrasound|ultrasound
445097|NCT01666626|intestinal fibrosis|intestinal fibrosis
445098|NCT01666626|shear wave imaging|shear wave imaging
445099|NCT01666626|acoustic radiation force impulse|acoustic radiation force impulse
445100|NCT01666613|Phase I, Healthy volunteers, pharmacokinetics|phase i, healthy volunteers, pharmacokinetics
445101|NCT01666613|Bioavailability|bioavailability
445102|NCT01666613|AUC|auc
445103|NCT01666548|haemolytic uraemic syndrome|haemolytic uraemic syndrome
445104|NCT01666548|complications of HUS|complications of hus
445105|NCT01666548|renal replacement treatment|renal replacement treatment
445106|NCT01666548|renal function outcome|renal function outcome
445107|NCT01666548|neuropsychological sequelae|neuropsychological sequelae
445108|NCT01666548|psychological adjustment|psychological adjustment
445109|NCT01666548|quality of life|quality of life
445110|NCT01666535|Influenza vaccine|influenza vaccine
445111|NCT01666535|Immune response|immune response
445112|NCT01666535|Remicade (infliximab)|remicade (infliximab)
445113|NCT01666535|Inflammatory bowel disease|inflammatory bowel disease
445114|NCT01666522|sarcopenia|sarcopenia
445115|NCT01666522|osteopenia/osteoporosis|osteopenia/osteoporosis
445116|NCT01666522|older adults|older adults
445117|NCT01666522|vitamin D supplementation|vitamin d supplementation
445118|NCT01666522|physical activity|physical activity
445119|NCT01666496|Adolescent|adolescent
445120|NCT01666496|risk|risk
445121|NCT01666496|HIV|hiv
445122|NCT01666496|video games|video games
445123|NCT01666483|hysterectomy|hysterectomy
445124|NCT01666483|single-port|single-port
445125|NCT01666483|micro-laparoscopy|micro-laparoscopy
445126|NCT01666470|Quality of life|quality of life
445127|NCT01666457|Supporting Oral Feeding in Fragile Infants (SOFFI)|supporting oral feeding in fragile infants (soffi)
445128|NCT01666457|Infant Oral Feeding|infant oral feeding
445129|NCT01666457|Infant Growth|infant growth
445130|NCT01666457|Preterm infant oral feeding|preterm infant oral feeding
445131|NCT01666457|Preterm infant growth|preterm infant growth
445132|NCT01666457|Neonatal Intensive Care Unit (NICU)|neonatal intensive care unit (nicu)
445133|NCT01666444|recurrent epithelial ovarian cancer|recurrent epithelial ovarian cancer
445134|NCT01666444|recurrent fallopian tube cancer|recurrent fallopian tube cancer
445135|NCT01666444|recurrent primary peritoneal cavity cancer|recurrent primary peritoneal cavity cancer
445136|NCT01666444|ovarian serous cystadenocarcinoma|ovarian serous cystadenocarcinoma
445137|NCT01666444|ovarian endometrioid adenocarcinoma|ovarian endometrioid adenocarcinoma
445138|NCT01666444|ovarian mucinous cystadenocarcinoma|ovarian mucinous cystadenocarcinoma
445139|NCT01666444|ovarian undifferentiated adenocarcinoma|ovarian undifferentiated adenocarcinoma
445140|NCT01666444|ovarian clear cell cystadenocarcinoma|ovarian clear cell cystadenocarcinoma
445141|NCT01666444|ovarian mixed epithelial carcinoma|ovarian mixed epithelial carcinoma
445142|NCT01666444|Brenner tumor|brenner tumor
445143|NCT01666405|Fecal Incontinence|fecal incontinence
445144|NCT01666405|Bowel Incontinence|bowel incontinence
445145|NCT01666392|Omega-3 fatty acid|omega-3 fatty acid
445146|NCT01666392|Fish oil|fish oil
445147|NCT01666392|Muscle mass|muscle mass
445148|NCT01666392|Muscle strength|muscle strength
445149|NCT01666392|Older adults|older adults
445150|NCT01666392|Circulating inflammatory cytokines|circulating inflammatory cytokines
445151|NCT01666392|Skeletal muscle mass|skeletal muscle mass
445152|NCT01666392|Upper body strength|upper body strength
445153|NCT01666392|Lower body strength|lower body strength
445154|NCT01666379|Hallux valgus|hallux valgus
445155|NCT01666379|Forefoot|forefoot
445156|NCT01666379|transdermal fentanyl|transdermal fentanyl
445157|NCT01666340|Exercise|exercise
445158|NCT01666340|Elderly|elderly
445159|NCT01666340|Mortality|mortality
445160|NCT01666340|Morbidity|morbidity
445161|NCT01666340|Prognosis|prognosis
445162|NCT01666340|Longevity|longevity
445163|NCT01666327|Crohn's Disease|crohn's disease
445164|NCT01666327|Ulcerative Colitis|ulcerative colitis
445165|NCT01666314|castrate resistant prostate cancer,|castrate resistant prostate cancer,
445166|NCT01666314|CRPC,|crpc,
445167|NCT01666314|orteronel,|orteronel,
445168|NCT01666314|TAK-700|tak-700
445169|NCT01666301|Erythropoietin stimulating agents|erythropoietin stimulating agents
445170|NCT01666301|Hemoglobin|hemoglobin
445171|NCT01666301|Reticulocytes|reticulocytes
445172|NCT01666301|Variability|variability
445173|NCT01666262|FLU|flu
445174|NCT01666262|H1N1|h1n1
445175|NCT01666262|GPO|gpo
445176|NCT01666262|PLAIV|plaiv
445177|NCT01666249|FMH; anti-Rh; efficacy|fmh; anti-rh; efficacy
445178|NCT01666236|Age-Related Macular Degeneration|age-related macular degeneration
445179|NCT01666236|Pigment Epithelial Detachment|pigment epithelial detachment
445180|NCT01666236|Polypoidal Choroidal Vasculopathy|polypoidal choroidal vasculopathy
445181|NCT01666223|Type 2 diabetes|type 2 diabetes
445182|NCT01666223|GLP-1|glp-1
445183|NCT01666223|Bile acid|bile acid
445184|NCT01666223|TGR-5|tgr-5
445185|NCT01666197|Acute Joint Pain|acute joint pain
445186|NCT01666184|Biomarkers study|biomarkers study
445187|NCT01666171|estrogen receptor-negative breast cancer|estrogen receptor-negative breast cancer
445188|NCT01666171|progesterone receptor-negative breast cancer|progesterone receptor-negative breast cancer
445189|NCT01666171|stage IB breast cancer|stage ib breast cancer
445190|NCT01666171|stage II breast cancer|stage ii breast cancer
445191|NCT01666171|stage IIIA breast cancer|stage iiia breast cancer
445192|NCT01666171|stage IIIC breast cancer|stage iiic breast cancer
445193|NCT01666145|Hepatocellular Cancer|hepatocellular cancer
445194|NCT01666145|Hepatocellular Carcinoma|hepatocellular carcinoma
445195|NCT01666145|Hepatoma|hepatoma
445196|NCT01666145|Liver Cancer, Adult|liver cancer, adult
445197|NCT01666145|Liver Cell Carcinoma, Adult|liver cell carcinoma, adult
445198|NCT01666132|LVEF < 40%|lvef < 40%
445199|NCT01666119|Opioid dependence|opioid dependence
445200|NCT01666119|Suboxone|suboxone
445201|NCT01666119|addiction|addiction
445202|NCT01666119|BEMA Buprenorphine NX|bema buprenorphine nx
445203|NCT01666119|oral transmucosal|oral transmucosal
445204|NCT01666093|peripheral artery disease|peripheral artery disease
445205|NCT01666093|endovascular procedure|endovascular procedure
445206|NCT01666093|non-healing ulcer|non-healing ulcer
445207|NCT01666080|second stem cell transplant|second stem cell transplant
445208|NCT01666080|donor hematopoietic engraftment|donor hematopoietic engraftment
445209|NCT01666080|hematopoietic stem cell transplantation|hematopoietic stem cell transplantation
445210|NCT01666080|inherited metabolic disorder|inherited metabolic disorder
445211|NCT01666067|insulin resistance|insulin resistance
445212|NCT01666054|Weaning|weaning
445213|NCT01666054|mechanical ventilation|mechanical ventilation
445214|NCT01666054|Proportional Assist Ventilation|proportional assist ventilation
445215|NCT01666041|insulin resistance|insulin resistance
445216|NCT01666028|Type 1 Diabetes|type 1 diabetes
445217|NCT01666028|Closed Loop glucose control|closed loop glucose control
445218|NCT01666028|Artificial Pancreas|artificial pancreas
445219|NCT01666028|CSII|csii
445220|NCT01666028|CGM|cgm
445221|NCT01666015|pediatric|pediatric
445222|NCT01666015|exercise|exercise
445223|NCT01666015|hematopoietic stem cell transplantation|hematopoietic stem cell transplantation
445224|NCT01666015|cancer|cancer
445225|NCT01666015|quality of life|quality of life
445226|NCT01666015|immune system|immune system
445227|NCT01666015|physical activity levels|physical activity levels
445228|NCT01665937|liver cancer|liver cancer
445935|NCT01662622|middle aged|middle aged
445229|NCT01665937|advanced liver cancer|advanced liver cancer
445230|NCT01665937|advanced hepatocellular cancer|advanced hepatocellular cancer
445231|NCT01665911|Caries|caries
445232|NCT01665898|cold biopsy forceps|cold biopsy forceps
445233|NCT01665898|cold snare biopsy|cold snare biopsy
445234|NCT01665885|hypothermia|hypothermia
445235|NCT01665885|induction of hypothermia|induction of hypothermia
445236|NCT01665885|non invasive cooling|non invasive cooling
445237|NCT01665885|external cooling|external cooling
445238|NCT01665885|surface cooling|surface cooling
445239|NCT01665885|endovascular cooling|endovascular cooling
445240|NCT01665885|cooling catheter|cooling catheter
445241|NCT01665885|stroke|stroke
445242|NCT01665885|shivering|shivering
445243|NCT01665885|neuro monitoring|neuro monitoring
445244|NCT01665885|coagulation|coagulation
445245|NCT01665872|Mothers|mothers
445246|NCT01665872|Depression|depression
445247|NCT01665872|Stress|stress
445248|NCT01665872|Trauma|trauma
445249|NCT01665872|Public Housing|public housing
445250|NCT01665859|readmission|readmission
445251|NCT01665859|recurrence|recurrence
445252|NCT01665859|umbilical|umbilical
445253|NCT01665859|epigastric|epigastric
445254|NCT01665859|hernia|hernia
445255|NCT01665859|outcome|outcome
445256|NCT01665859|morbidity|morbidity
445257|NCT01665846|HIV associated neurocognitive disorders|hiv associated neurocognitive disorders
445258|NCT01665846|MRI|mri
445259|NCT01665846|Ferumoxytol|ferumoxytol
445260|NCT01665833|Angina|angina
445261|NCT01665833|SYNTAX|syntax
445262|NCT01665833|Coronary|coronary
445263|NCT01665833|PCI|pci
445264|NCT01665833|CABG|cabg
445265|NCT01665820|chest|chest
445266|NCT01665820|pathology|pathology
445267|NCT01665807|influenza|influenza
445268|NCT01665807|vaccine|vaccine
445269|NCT01665807|administration|administration
445270|NCT01665781|Hemoglobin|hemoglobin
445271|NCT01665781|Erythropoietin|erythropoietin
445272|NCT01665781|Acute Mountain sickness|acute mountain sickness
445273|NCT01665742|Obesity|obesity
445274|NCT01665742|Chronic inflammation|chronic inflammation
445275|NCT01665742|Anti-inflammatory dietary intervention|anti-inflammatory dietary intervention
445276|NCT01665742|Genetic susceptibility|genetic susceptibility
445277|NCT01665729|etiology|etiology
445278|NCT01665729|pathogenesis|pathogenesis
445279|NCT01665729|minor ischaemic stroke|minor ischaemic stroke
445280|NCT01665729|types|types
445281|NCT01665729|intervention|intervention
445282|NCT01665703|[18F]|[18f]
445283|NCT01665703|Fluorodeoxyglucose Positron Emission Tomography-Magnetic Resonance Imaging|fluorodeoxyglucose positron emission tomography-magnetic resonance imaging
445284|NCT01665703|FDG-PET-MRI|fdg-pet-mri
445285|NCT01665703|Renal Cell Carcinoma|renal cell carcinoma
445286|NCT01665703|Pilot Study|pilot study
445287|NCT01665703|LCCC 1213|lccc 1213
445288|NCT01665703|UNC Lineberger|unc lineberger
445289|NCT01665690|patient delivered partner therapy|patient delivered partner therapy
445290|NCT01665690|expedited partner therapy|expedited partner therapy
445291|NCT01665690|partner notification|partner notification
445292|NCT01665690|gonorrhea|gonorrhea
445293|NCT01665690|chlamydia|chlamydia
445294|NCT01665677|Graft vs Host Disease|graft vs host disease
445295|NCT01665677|GVHD|gvhd
445296|NCT01665677|Allogeneic hematopoietic stem cell transplantation|allogeneic hematopoietic stem cell transplantation
445297|NCT01665677|HSCT|hsct
445298|NCT01665677|Atorvastatin|atorvastatin
445299|NCT01665664|Indirect calorimetry|indirect calorimetry
445300|NCT01665664|hypocaloric feeding|hypocaloric feeding
445301|NCT01665638|Healthy|healthy
445302|NCT01665638|Clearance|clearance
445303|NCT01665638|Canagliflozin|canagliflozin
445304|NCT01665638|JNJ-28431754|jnj-28431754
445305|NCT01665638|Placebo|placebo
445306|NCT01665638|Somatostatin|somatostatin
445307|NCT01665638|C-peptide|c-peptide
445308|NCT01665625|Pancreatic cancer|pancreatic cancer
445309|NCT01665625|Intra-arterial infusion|intra-arterial infusion
445310|NCT01665625|Gemcitabine|gemcitabine
445311|NCT01665612|Contact lens|contact lens
445312|NCT01665612|Care solution|care solution
445313|NCT01665612|MPDS|mpds
445314|NCT01665612|comfort|comfort
445315|NCT01665586|dexmedetomidine|dexmedetomidine
445316|NCT01665586|sedation in elderly patient|sedation in elderly patient
445317|NCT01665586|spinal anesthesia|spinal anesthesia
445318|NCT01665573|Fear Conditioning|fear conditioning
445319|NCT01665573|Cannabinoids|cannabinoids
445320|NCT01665573|Fear Response|fear response
445321|NCT01665560|smoking|smoking
445322|NCT01665560|fMRI|fmri
445323|NCT01665560|odors|odors
445324|NCT01665560|taste|taste
445325|NCT01665547|clomiphene resistant|clomiphene resistant
445326|NCT01665547|pcos|pcos
445327|NCT01665547|induction of ovulation|induction of ovulation
445328|NCT01665547|l-carnitine|l-carnitine
445329|NCT01665534|hypertension|hypertension
445330|NCT01665534|inflammation|inflammation
445331|NCT01665534|salt intake|salt intake
445332|NCT01665521|Acute Coronary Syndrome|acute coronary syndrome
445333|NCT01665521|Chest pain|chest pain
445334|NCT01665521|Risk Stratification|risk stratification
445335|NCT01665521|HEART Pathway|heart pathway
445336|NCT01665521|Emergency Department|emergency department
445337|NCT01665508|angina|angina
445338|NCT01665508|cardiopulmonary testing|cardiopulmonary testing
445339|NCT01665508|metabolomics|metabolomics
445340|NCT01665508|nebivolol|nebivolol
445341|NCT01665495|pericardial effusion|pericardial effusion
445342|NCT01665495|cardiac tamponade|cardiac tamponade
445343|NCT01665495|pericardiocentesis|pericardiocentesis
445344|NCT01665495|pericardial drainage|pericardial drainage
445345|NCT01665495|prevention|prevention
445346|NCT01665482|Inflammation|inflammation
445347|NCT01665482|Insulin sensitivity|insulin sensitivity
445348|NCT01665482|Interleukin-6 (IL-6)|interleukin-6 (il-6)
445349|NCT01665482|C-peptide|c-peptide
445350|NCT01665482|Saturated fatty acid (SFA)|saturated fatty acid (sfa)
445351|NCT01665482|Monounsaturated fatty acid (MUFA)|monounsaturated fatty acid (mufa)
445352|NCT01665482|Carbohydrate (CARB)|carbohydrate (carb)
445353|NCT01665469|anti oxidation|anti oxidation
445354|NCT01665469|lycopene|lycopene
445355|NCT01665469|Ox-LDL|ox-ldl
445356|NCT01665456|complications|complications
445357|NCT01665417|Icotinib|icotinib
445358|NCT01665417|EGFR positive mutation|egfr positive mutation
445359|NCT01665417|First-line treatment|first-line treatment
445360|NCT01665417|Maintenance treatment|maintenance treatment
445361|NCT01665378|prepregnancy|prepregnancy
445362|NCT01665378|micronutrient|micronutrient
445363|NCT01665378|supplementation|supplementation
445364|NCT01665378|maternal|maternal
445365|NCT01665378|child|child
445366|NCT01665378|health|health
445367|NCT01665365|Myocardial infarction|myocardial infarction
445368|NCT01665365|Remote ischemic conditioning|remote ischemic conditioning
445369|NCT01665365|Clinical outcome|clinical outcome
445370|NCT01665339|preload|preload
445371|NCT01665339|anthropometric measures|anthropometric measures
445372|NCT01665339|cardiovascular risk factors|cardiovascular risk factors
445373|NCT01665326|Pompe disease|pompe disease
445374|NCT01665326|Glycogen Storage Disease Type II|glycogen storage disease type ii
445375|NCT01665326|Acid Maltase Deficiency|acid maltase deficiency
445376|NCT01665326|CRIM Status|crim status
445377|NCT01665326|Acid Alpha-Glucosidase Deficiency|acid alpha-glucosidase deficiency
445378|NCT01665326|Alglucosidase alfa|alglucosidase alfa
445379|NCT01665326|Myozyme|myozyme
445380|NCT01665326|Enzyme replacement therapy|enzyme replacement therapy
445381|NCT01665326|Immune Tolerance Induction|immune tolerance induction
445382|NCT01665326|Lumizyme|lumizyme
445383|NCT01665326|Immunomodulation|immunomodulation
445384|NCT01665326|Anti-drug antibodies|anti-drug antibodies
445385|NCT01665313|attention|attention
445386|NCT01665300|myocardial deformation imaging|myocardial deformation imaging
445387|NCT01665300|Trastuzumab|trastuzumab
445388|NCT01665287|Cerebral Oximetry|cerebral oximetry
445389|NCT01665287|Near infrared spectroscopy|near infrared spectroscopy
445390|NCT01665287|Fullterm|fullterm
445391|NCT01665287|Infant|infant
445392|NCT01665274|xelox|xelox
445393|NCT01665274|advanced gastric cancer|advanced gastric cancer
445394|NCT01665261|Congenital heart disease|congenital heart disease
445395|NCT01665261|Newborn|newborn
445396|NCT01665261|Pulse oximetry|pulse oximetry
445397|NCT01665261|Screening|screening
445398|NCT01665248|18-F Sodium Fluoride|18-f sodium fluoride
445399|NCT01665248|Acute coronary syndrome|acute coronary syndrome
445400|NCT01665248|Stable Angina|stable angina
445401|NCT01665196|IgG4-related disease|igg4-related disease
445402|NCT01665196|IgG4-RD|igg4-rd
445403|NCT01665196|18F-FDG|18f-fdg
445404|NCT01665196|PET/CT|pet/ct
445405|NCT01665183|argininosuccinate synthetase|argininosuccinate synthetase
445406|NCT01665183|arginine|arginine
445407|NCT01665183|arginine deiminase|arginine deiminase
445408|NCT01665170|Pascoflair|pascoflair
445409|NCT01665170|tsst|tsst
445410|NCT01665170|passiflora incarnata|passiflora incarnata
445411|NCT01665170|non smoking male|non smoking male
445412|NCT01665170|and female volunteers|and female volunteers
445413|NCT01665157|Diet Control before Colonoscopy|diet control before colonoscopy
445414|NCT01665144|Secondary Progressive Multiple Sclerosis|secondary progressive multiple sclerosis
445415|NCT01665118|Radio frequency|radio frequency
445416|NCT01665118|thigh|thigh
445417|NCT01665118|circumference|circumference
445418|NCT01665118|reduction|reduction
445419|NCT01665105|Pulse Rate Variability|pulse rate variability
445420|NCT01665105|Skin Blood Flow|skin blood flow
445421|NCT01665105|Skin Temperature|skin temperature
445422|NCT01665105|Electroacupuncture|electroacupuncture
445423|NCT01665105|Zusanli|zusanli
445424|NCT01665105|Yanglingquan|yanglingquan
445425|NCT01665079|anaesthetics iv|anaesthetics iv
445426|NCT01665079|propofol|propofol
445427|NCT01665079|pharmacokinetics|pharmacokinetics
445428|NCT01665079|pharmacodynamic|pharmacodynamic
445429|NCT01665053|Drug-Eluting Stents|drug-eluting stents
445430|NCT01665040|neurostimulation|neurostimulation
445431|NCT01665040|spinal cord stimulation|spinal cord stimulation
445432|NCT01665040|peripheral nerve stimulation|peripheral nerve stimulation
445433|NCT01665027|caesarean section,|caesarean section,
445434|NCT01665027|vacuum,|vacuum,
445435|NCT01665027|fetal head extraction,|fetal head extraction,
445436|NCT01665027|maternal complication,|maternal complication,
445437|NCT01665027|fetal complication|fetal complication
445438|NCT01665014|autologous hematopoietic stem cell transplantation|autologous hematopoietic stem cell transplantation
445439|NCT01665014|total marrow irradiation|total marrow irradiation
445440|NCT01665014|melphalan|melphalan
445441|NCT01665014|multiple myeloma|multiple myeloma
445442|NCT01665001|Acute lymphoblastic leukemia|acute lymphoblastic leukemia
445443|NCT01665001|Induction|induction
445444|NCT01665001|Consolidation|consolidation
445445|NCT01665001|Minimal residual disease|minimal residual disease
445446|NCT01665001|Hematopoietic stem cell transplantation|hematopoietic stem cell transplantation
445447|NCT01664975|Peripheral T-cell lymphoma;chemotherapy;|peripheral t-cell lymphoma;chemotherapy;
445448|NCT01664975|RR;PFS;OS|rr;pfs;os
445449|NCT01664936|18F-FDG PET/CT scan|18f-fdg pet/ct scan
445450|NCT01664936|131I therapy|131i therapy
445451|NCT01664936|Cerenkov Luminescence Imaging|cerenkov luminescence imaging
445452|NCT01664936|12-050|12-050
445453|NCT01664936|Lymphoma|lymphoma
445454|NCT01664936|Leukemia|leukemia
445455|NCT01664936|Metastatic Lymph Nodes|metastatic lymph nodes
445456|NCT01664923|prostate cancer|prostate cancer
445457|NCT01664923|enzalutamide|enzalutamide
445458|NCT01664923|MDV3100|mdv3100
445459|NCT01664884|INTERNALIZED STIGMA|internalized stigma
445460|NCT01664884|INSIGHT|insight
445461|NCT01664884|SOCIAL ADEQUACY|social adequacy
445462|NCT01664884|BIPOLAR DISORDER|bipolar disorder
445463|NCT01664884|SCHIZOPHRENIA|schizophrenia
445464|NCT01664858|Coronary Heart Disease|coronary heart disease
445465|NCT01664858|Ischaemic Heart Disease|ischaemic heart disease
445466|NCT01664858|Angina|angina
445467|NCT01664858|Cardiac Magnetic Resonance Imaging|cardiac magnetic resonance imaging
445468|NCT01664845|hepatitis c|hepatitis c
445469|NCT01664845|metformin|metformin
445470|NCT01664845|pegylated interferon|pegylated interferon
445471|NCT01664832|Premature Infants|premature infants
445472|NCT01664832|snychronized ventilation|snychronized ventilation
445473|NCT01664832|non-invasive ventilation|non-invasive ventilation
445475|NCT01664806|Electrosurgery|electrosurgery
445476|NCT01664806|Radiofrequency energy|radiofrequency energy
445477|NCT01664806|Monopolar instruments|monopolar instruments
445478|NCT01664806|Capacitive coupling|capacitive coupling
445479|NCT01664806|Thermal injury|thermal injury
445480|NCT01664806|Surgical complications|surgical complications
445481|NCT01664793|influenza|influenza
445482|NCT01664793|vaccination|vaccination
445483|NCT01664793|strategies|strategies
445484|NCT01664793|children/adolescents|children/adolescents
445485|NCT01664780|standard|standard
445486|NCT01664780|values|values
445487|NCT01664780|share|share
445488|NCT01664780|wave velocity|wave velocity
445489|NCT01664780|in ARFI imaging|in arfi imaging
445490|NCT01664767|COPD|copd
445491|NCT01664767|Thermal water|thermal water
445492|NCT01664767|Oxidative stress|oxidative stress
445493|NCT01664767|Inflammation|inflammation
445494|NCT01664741|Nicotine dependence|nicotine dependence
445495|NCT01664741|cigarette|cigarette
445496|NCT01664741|smoking|smoking
445497|NCT01664741|nicotine replacement therapy|nicotine replacement therapy
445498|NCT01664741|positron emission tomography|positron emission tomography
445499|NCT01664728|Prostate neoplasms|prostate neoplasms
445500|NCT01664728|Hormone refractory prostate cancer|hormone refractory prostate cancer
445501|NCT01664728|Castration resistant prostate cancer|castration resistant prostate cancer
445502|NCT01664728|Castration refractory prostate cancer|castration refractory prostate cancer
445503|NCT01664728|Abiraterone acetate|abiraterone acetate
445504|NCT01664728|CB7630|cb7630
445505|NCT01664715|Overweight|overweight
445506|NCT01664715|Obesity|obesity
445507|NCT01664715|Exercise|exercise
445508|NCT01664715|Weight Loss|weight loss
445509|NCT01664702|Dairy|dairy
445510|NCT01664702|obesity|obesity
445511|NCT01664676|liraglutide|liraglutide
445512|NCT01664676|victoza|victoza
445513|NCT01664676|GLP-1|glp-1
445514|NCT01664676|kidney|kidney
445515|NCT01664676|diabetes|diabetes
445516|NCT01664676|renal|renal
445517|NCT01664676|diabetic nephropathy|diabetic nephropathy
445518|NCT01664663|Radiotherapy|radiotherapy
445519|NCT01664663|Dose escalation|dose escalation
445520|NCT01664663|Normal tissue constraints|normal tissue constraints
445521|NCT01664663|Locally advanced disease|locally advanced disease
445522|NCT01664663|Good performance status|good performance status
445523|NCT01664650|menopause|menopause
445524|NCT01664650|pre-diabetes|pre-diabetes
445525|NCT01664637|diabetic gastroparesis|diabetic gastroparesis
445526|NCT01664637|delayed gastric emptying|delayed gastric emptying
445527|NCT01664637|gastroparesis|gastroparesis
445528|NCT01664637|diabetes mellitus, Type 1|diabetes mellitus, type 1
445529|NCT01664637|diabetes mellitus, Type 2|diabetes mellitus, type 2
445530|NCT01664624|Drug Therapy|drug therapy
445531|NCT01664611|Remote Ischaemic Conditioning|remote ischaemic conditioning
445532|NCT01664611|Remodeling|remodeling
445533|NCT01664611|Heart Failure|heart failure
445534|NCT01664611|Myocardial Infarction|myocardial infarction
445535|NCT01664611|Ischaemia/Reperfusion Injury|ischaemia/reperfusion injury
445536|NCT01664611|successful primary percutaneous coronary intervention following a first STEMI|successful primary percutaneous coronary intervention following a first stemi
445537|NCT01664585|headache|headache
445538|NCT01664585|women|women
445539|NCT01664585|exercise|exercise
445540|NCT01664585|fear avoidance|fear avoidance
445541|NCT01664585|physical activity|physical activity
445542|NCT01664572|laser Doppler flowmetry, skin blood flow|laser doppler flowmetry, skin blood flow
445543|NCT01664559|intrauterine device|intrauterine device
445544|NCT01664559|ketorolac|ketorolac
445545|NCT01664559|toradol|toradol
445546|NCT01664559|mirena|mirena
445547|NCT01664559|paragard|paragard
445548|NCT01664559|pain control|pain control
445549|NCT01664520|Subarachnoid hemorrhage|subarachnoid hemorrhage
445550|NCT01664520|Dexmedetomidine|dexmedetomidine
445551|NCT01664520|Autoregulation|autoregulation
445552|NCT01664520|Intracranial pressure|intracranial pressure
445553|NCT01664520|Cerebral oxygenation|cerebral oxygenation
445554|NCT01664507|croup, dose, epinephrine|croup, dose, epinephrine
445555|NCT01664273|electroporation|electroporation
445556|NCT01664273|gen electrotransfer|gen electrotransfer
445557|NCT01664273|muscle|muscle
445558|NCT01664273|plasmid AMEP|plasmid amep
445559|NCT01664260|Posttraumatic Stress Disorder|posttraumatic stress disorder
445560|NCT01664260|N-acetylcysteine|n-acetylcysteine
445561|NCT01664260|Magnetic Resonance Imaging|magnetic resonance imaging
445562|NCT01664234|infants with cleft palate|infants with cleft palate
445563|NCT01664234|Pierre Robin|pierre robin
445564|NCT01664234|Treacher Collins|treacher collins
445565|NCT01664234|trisomy 21|trisomy 21
445566|NCT01664221|subject|subject
445567|NCT01664195|subjects|subjects
445568|NCT01664169|adenocarcinoma of the pancreas|adenocarcinoma of the pancreas
445569|NCT01664169|recurrent pancreatic cancer|recurrent pancreatic cancer
445570|NCT01664169|stage III pancreatic cancer|stage iii pancreatic cancer
445571|NCT01664169|stage IV pancreatic cancer|stage iv pancreatic cancer
445572|NCT01664169|stage IIB pancreatic cancer|stage iib pancreatic cancer
445573|NCT01664156|Cold hypersensitivity|cold hypersensitivity
445574|NCT01664156|Korean red ginseng|korean red ginseng
445575|NCT01664156|Infrared thermography|infrared thermography
445576|NCT01664156|Cold stress test|cold stress test
445577|NCT01664156|Distal-dorsal difference|distal-dorsal difference
445578|NCT01664091|tissue expander|tissue expander
445579|NCT01664091|acellular dermal matrix|acellular dermal matrix
445580|NCT01664078|Abdominal Aortic Aneurysm|abdominal aortic aneurysm
445581|NCT01664065|Patient Safety|patient safety
445582|NCT01664065|Tolerability|tolerability
445583|NCT01664065|Pharmacokinetics|pharmacokinetics
445584|NCT01664039|Glaucoma|glaucoma
445585|NCT01664039|Ocular hypertension|ocular hypertension
445586|NCT01664000|Tumors|tumors
445587|NCT01664000|carcinoma|carcinoma
445588|NCT01664000|apoptosis|apoptosis
445589|NCT01664000|p53|p53
445590|NCT01664000|p21|p21
445591|NCT01664000|Caspase3|caspase3
445592|NCT01664000|PARP|parp
445593|NCT01664000|MDM2|mdm2
445594|NCT01664000|PUMA|puma
445595|NCT01663974|Bipolar Disorders|bipolar disorders
445596|NCT01663974|Sub-syndromal symptoms|sub-syndromal symptoms
445597|NCT01663974|Acute depressive episode|acute depressive episode
445598|NCT01663974|Symptomatic remission|symptomatic remission
445599|NCT01663974|Functioning remission|functioning remission
445600|NCT01663961|Phase I|phase i
445601|NCT01663961|Pharmacokinetics|pharmacokinetics
445602|NCT01663961|YM178 Oral Controlled Absorption System (OCAS)|ym178 oral controlled absorption system (ocas)
445603|NCT01663961|Digoxin (Lanoxin)|digoxin (lanoxin)
445604|NCT01663961|DDI (Drug-drug interaction)|ddi (drug-drug interaction)
445605|NCT01663961|Open-label|open-label
445606|NCT01663961|Steady-state|steady-state
445607|NCT01663961|subjects|subjects
445608|NCT01663948|Plastic bronchitis|plastic bronchitis
445609|NCT01663948|PB|pb
445610|NCT01663935|levodopa|levodopa
445611|NCT01663935|Albinism|albinism
445612|NCT01663935|dopamine|dopamine
445613|NCT01663935|oculocutaneous albinism|oculocutaneous albinism
445614|NCT01663935|vision|vision
445615|NCT01663935|retina function|retina function
445616|NCT01663909|Pain|pain
445617|NCT01663909|Scoliosis|scoliosis
445618|NCT01663909|Rehabilitation|rehabilitation
445619|NCT01663909|Cognitive-behavioral interventions|cognitive-behavioral interventions
445620|NCT01663909|Adolescents|adolescents
445621|NCT01663883|Blood flow autoregulation|blood flow autoregulation
445622|NCT01663883|optic nerve head blood flow|optic nerve head blood flow
445623|NCT01663883|isometric exercise|isometric exercise
445624|NCT01663883|Autoregulation|autoregulation
445625|NCT01663883|ocular physiology|ocular physiology
445626|NCT01663870|Cancer Prevention|cancer prevention
445627|NCT01663870|Breast cancer survivors|breast cancer survivors
445628|NCT01663870|Cancer survivorship clinic|cancer survivorship clinic
445629|NCT01663870|eHealth technology|ehealth technology
445630|NCT01663870|Internet|internet
445631|NCT01663870|HealthATM website|healthatm website
446037|NCT01662050|Older|older
445632|NCT01663870|Questionnaire|questionnaire
445633|NCT01663870|Clinic stakeholders|clinic stakeholders
445634|NCT01663870|Clinic nurses|clinic nurses
445635|NCT01663870|Physicians|physicians
445636|NCT01663870|Case managers|case managers
445637|NCT01663870|Oncology patient navigators|oncology patient navigators
445638|NCT01663870|Audio recorded interviews|audio recorded interviews
445639|NCT01663844|Cognitive behavior therapy|cognitive behavior therapy
445640|NCT01663844|Internet treatment|internet treatment
445641|NCT01663844|Self-help treatment|self-help treatment
445642|NCT01663844|Insomnia|insomnia
445643|NCT01663844|Depression|depression
445644|NCT01663844|ICBT|icbt
445645|NCT01663844|CBT-i|cbt-i
445646|NCT01663844|CBT-d|cbt-d
445647|NCT01663831|Outdoor Malaria Transmission|outdoor malaria transmission
445648|NCT01663831|Anopheles|anopheles
445649|NCT01663831|Topical repellent|topical repellent
445650|NCT01663831|Early biting vector|early biting vector
445651|NCT01663831|Long Lasting Insecticidal Net (LLIN)|long lasting insecticidal net (llin)
445652|NCT01663831|Cambodia|cambodia
445653|NCT01663805|Extended Criteria Donor|extended criteria donor
445654|NCT01663805|Delayed Graft Function|delayed graft function
445655|NCT01663805|DGF|dgf
445656|NCT01663805|Deceased donors aged ≥ 60 years|deceased donors aged ≥ 60 years
445657|NCT01663805|aged between 50 and 59 years|aged between 50 and 59 years
445658|NCT01663805|history of systemic hypertension|history of systemic hypertension
445659|NCT01663805|terminal creatinine levels > 1.5 mg/dL|terminal creatinine levels > 1.5 mg/dl
445660|NCT01663805|death by a cerebrovascular accident|death by a cerebrovascular accident
445661|NCT01663792|urokinase receptor|urokinase receptor
445662|NCT01663792|protein expression|protein expression
445663|NCT01663792|seaweed (Undaria pinnatifida)|seaweed (undaria pinnatifida)
445664|NCT01663766|GVHD (acute or chronic)|gvhd (acute or chronic)
445665|NCT01663766|acute myeloid or lymphoblastic leukemia (AML or ALL)|acute myeloid or lymphoblastic leukemia (aml or all)
445666|NCT01663766|myelodysplastic syndrome|myelodysplastic syndrome
445667|NCT01663766|Chronic myelogenous leukemia (CML)|chronic myelogenous leukemia (cml)
445668|NCT01663766|Multiple Myeloma (MM)|multiple myeloma (mm)
445669|NCT01663766|Non-Hodgekin lymphoma (NHL-both follicular & diffuse large cell)|non-hodgekin lymphoma (nhl-both follicular & diffuse large cell)
445670|NCT01663766|Chronic lymphocytic leukemia or small lymphocytic leukemia (CLL or SLL)|chronic lymphocytic leukemia or small lymphocytic leukemia (cll or sll)
445671|NCT01663753|2-fluoro-2-deoxy-d-glucose-positron emission tomography|2-fluoro-2-deoxy-d-glucose-positron emission tomography
445672|NCT01663753|Positron emission tomography|positron emission tomography
445673|NCT01663753|Magnetic resonance imaging|magnetic resonance imaging
445674|NCT01663753|Diffusion weighted MRI|diffusion weighted mri
445675|NCT01663753|Squamous-cell cervical carcinoma|squamous-cell cervical carcinoma
445676|NCT01663753|Sensitivity|sensitivity
445677|NCT01663714|Non-Hodgkin's Lymphoma|non-hodgkin's lymphoma
445678|NCT01663714|tositumomab and iodine I 131 tositumomab|tositumomab and iodine i 131 tositumomab
445679|NCT01663714|Bexxar|bexxar
445680|NCT01663714|cycolophosphamide, vacristine, and pednisone|cycolophosphamide, vacristine, and pednisone
445681|NCT01663701|Sepsis|sepsis
445682|NCT01663701|Severe sepsis|severe sepsis
445683|NCT01663701|Tuberculosis|tuberculosis
445684|NCT01663701|Bundle|bundle
445685|NCT01663701|Zambia|zambia
445686|NCT01663675|Down syndrome|down syndrome
445687|NCT01663649|Depression|depression
445688|NCT01663649|Online-Therapy|online-therapy
445689|NCT01663649|Deprexis|deprexis
445690|NCT01663649|Self-help|self-help
445691|NCT01663636|vaccines|vaccines
445692|NCT01663636|SMS|sms
445693|NCT01663636|mobile phones|mobile phones
445694|NCT01663623|Wegener's Granulomatosis|wegener's granulomatosis
445695|NCT01663623|anti-MPO|anti-mpo
445696|NCT01663623|WG|wg
445697|NCT01663623|Belimumab|belimumab
445698|NCT01663623|GPA|gpa
445699|NCT01663623|anti-proteinase 3|anti-proteinase 3
445700|NCT01663623|anti-neutrophil cytoplasmic antibody|anti-neutrophil cytoplasmic antibody
445701|NCT01663623|anti-myeloperoxidase|anti-myeloperoxidase
445702|NCT01663623|Granulomatosis with polyangiitis|granulomatosis with polyangiitis
445703|NCT01663623|Vasculitis|vasculitis
445704|NCT01663623|Autoimmune Diseases|autoimmune diseases
445705|NCT01663623|Microscopic Polyangiitis|microscopic polyangiitis
445706|NCT01663623|anti-PR3|anti-pr3
445707|NCT01663623|ANCA|anca
445708|NCT01663623|MPA|mpa
445709|NCT01663623|Systemic Vasculitis|systemic vasculitis
445710|NCT01663584|Spinal Muscular Atrophy (SMA)|spinal muscular atrophy (sma)
445711|NCT01663584|Carrier Screening|carrier screening
445712|NCT01663584|Genetic Testing|genetic testing
445713|NCT01663558|anal dysplasia|anal dysplasia
445714|NCT01663558|HPV|hpv
445715|NCT01663558|HIV|hiv
445716|NCT01663558|MSM|msm
445717|NCT01663545|Epilepsy|epilepsy
445718|NCT01663545|Epileptic Focus|epileptic focus
445719|NCT01663545|Inflammation|inflammation
445720|NCT01663545|P-Glycoprotein|p-glycoprotein
445721|NCT01663545|PET Imaging|pet imaging
445722|NCT01663532|Schizophrenia|schizophrenia
445723|NCT01663519|Diabetic foot|diabetic foot
445724|NCT01663519|Offloading|offloading
445725|NCT01663519|Prevention|prevention
445726|NCT01663519|Orthotics|orthotics
445730|NCT01663441|Chemotherapy|chemotherapy
445731|NCT01663441|Thrombocytopenia|thrombocytopenia
445732|NCT01663441|Interleukin-11|interleukin-11
445733|NCT01663441|Platelet|platelet
445734|NCT01663428|birth related brachial plexus injury|birth related brachial plexus injury
445735|NCT01663428|brachial plexus|brachial plexus
445736|NCT01663428|splint|splint
445737|NCT01663415|MDV3100|mdv3100
445738|NCT01663415|prostate|prostate
445739|NCT01663415|cancer|cancer
445740|NCT01663415|enzalutamide|enzalutamide
445741|NCT01663389|mass balance|mass balance
445742|NCT01663389|radiolabel|radiolabel
445743|NCT01663389|oral|oral
445744|NCT01663389|IV|iv
445745|NCT01663389|GSK1322322|gsk1322322
445746|NCT01663389|healthy volunteer|healthy volunteer
445747|NCT01663389|antibiotic|antibiotic
445748|NCT01663363|refractive|refractive
445749|NCT01663363|LASIK|lasik
445750|NCT01663337|Posttraumatic Stress Disorder|posttraumatic stress disorder
445751|NCT01663337|PTSD|ptsd
445752|NCT01663337|Alcohol Abuse|alcohol abuse
445753|NCT01663337|Alcohol Dependance|alcohol dependance
445754|NCT01663337|Alcoholism|alcoholism
445755|NCT01663337|Comorbid|comorbid
445756|NCT01663337|Relapse Prevention (RP)|relapse prevention (rp)
445757|NCT01663337|Cognitive Processing Therapy (CPT)|cognitive processing therapy (cpt)
445758|NCT01663324|Tinnitus|tinnitus
445759|NCT01663324|chronic subjective Tinnitus|chronic subjective tinnitus
445760|NCT01663324|transcranial magnetic stimulation|transcranial magnetic stimulation
445761|NCT01663324|rTMS|rtms
445762|NCT01663324|hearing disorders|hearing disorders
445763|NCT01663311|rTMS|rtms
445764|NCT01663311|repetitive transcranial magnetic stimulation|repetitive transcranial magnetic stimulation
445765|NCT01663311|chronic tinnitus|chronic tinnitus
445766|NCT01663311|subjective tinnitus|subjective tinnitus
445767|NCT01663311|double cone coil|double cone coil
445768|NCT01663298|DNA methylation|dna methylation
445769|NCT01663298|FGF2|fgf2
445770|NCT01663298|Wound healing|wound healing
445771|NCT01663298|Smoking|smoking
445772|NCT01663298|Diabetes|diabetes
445773|NCT01663298|Implant|implant
445774|NCT01663285|Urothelial|urothelial
445775|NCT01663285|Bladder|bladder
445776|NCT01663285|Cancer|cancer
445777|NCT01663272|oncology|oncology
445778|NCT01663272|pancrease|pancrease
445779|NCT01663233|Essential hypertension|essential hypertension
445780|NCT01663233|High blood pressure|high blood pressure
445781|NCT01663220|type 2 diabetes|type 2 diabetes
445782|NCT01663220|beta cell function|beta cell function
445783|NCT01663220|meal tolerance test|meal tolerance test
445784|NCT01663220|maximum stimulation test|maximum stimulation test
445785|NCT01663220|method standardization|method standardization
445786|NCT01663220|insulin secretion|insulin secretion
445787|NCT01663220|prediabetes|prediabetes
445788|NCT01663220|insulin sensitivity|insulin sensitivity
445789|NCT01663207|type 2 diabetes|type 2 diabetes
445790|NCT01663207|beta cell function|beta cell function
445791|NCT01663207|meal tolerance test|meal tolerance test
445792|NCT01663207|maximum stimulation test|maximum stimulation test
445793|NCT01663207|method standardization|method standardization
445794|NCT01663207|insulin secretion|insulin secretion
445795|NCT01663207|prediabetes|prediabetes
445796|NCT01663207|insulin sensitivity|insulin sensitivity
445923|NCT01662661|JNJ-47910382|jnj-47910382
445797|NCT01663194|N/L ratio, STEMI, primary PCI, Long-term mortality|n/l ratio, stemi, primary pci, long-term mortality
445798|NCT01663168|HIV|hiv
445799|NCT01663168|Tuberculosis|tuberculosis
445800|NCT01663168|Rifabutin|rifabutin
445801|NCT01663168|HIV Protease Inhibitors|hiv protease inhibitors
445802|NCT01663168|EARNEST trial|earnest trial
445803|NCT01663168|Randomized Controlled Trial|randomized controlled trial
445804|NCT01663168|Pilot Projects|pilot projects
445805|NCT01663168|Second-line ART|second-line art
445806|NCT01663168|Drug Toxicity|drug toxicity
445807|NCT01663168|Pharmacokinetics|pharmacokinetics
445808|NCT01663168|Drug Interactions|drug interactions
445809|NCT01663155|lung cancer|lung cancer
445810|NCT01663155|chest x-ray|chest x-ray
445811|NCT01663155|CT scan|ct scan
445812|NCT01663155|computer aided detection (CAD)|computer aided detection (cad)
445813|NCT01663155|screening|screening
445814|NCT01663155|smokers|smokers
445815|NCT01663142|Crohn's disease|crohn's disease
445816|NCT01663142|gastrointestinal tract|gastrointestinal tract
445817|NCT01663129|Children|children
445818|NCT01663129|Osteoporosis|osteoporosis
445819|NCT01663129|Vertebral Compression Fractures|vertebral compression fractures
445820|NCT01663129|Chronic Illness|chronic illness
445821|NCT01663129|Glucocorticoids|glucocorticoids
445822|NCT01663129|Bone Fragility|bone fragility
445823|NCT01663116|Rheumatoid arthritis|rheumatoid arthritis
445824|NCT01663116|Expanded adipose derived allogeneic adult stem cells (eASCs)|expanded adipose derived allogeneic adult stem cells (eascs)
445825|NCT01663103|Interleukin-1|interleukin-1
445826|NCT01663103|Endothelium, Vascular|endothelium, vascular
445827|NCT01663103|Vascular Stiffness|vascular stiffness
445828|NCT01663103|Oxidative Stress|oxidative stress
445829|NCT01663103|Inflammation|inflammation
445830|NCT01663103|Endothelial cells|endothelial cells
445831|NCT01663090|Newly diagnosed|newly diagnosed
445832|NCT01663077|Clozapine|clozapine
445833|NCT01663077|Schizophrenia|schizophrenia
445834|NCT01663077|Remissia|remissia
445835|NCT01663077|polymorphism|polymorphism
445836|NCT01663064|Abdominal aortic aneurysm|abdominal aortic aneurysm
445837|NCT01663064|Endovascular|endovascular
445838|NCT01663064|Fenestration|fenestration
445839|NCT01663064|Juxtarenal|juxtarenal
445840|NCT01663064|Off-the-shelf|off-the-shelf
445841|NCT01663064|Pararenal|pararenal
445842|NCT01663038|Clopidogrel|clopidogrel
445843|NCT01663038|Aspirin|aspirin
445844|NCT01663038|Combination|combination
445845|NCT01663038|Pharmacokinetics|pharmacokinetics
445846|NCT01663038|Phase 1|phase 1
445847|NCT01663025|Randomised controlled trial|randomised controlled trial
445848|NCT01663025|Pain|pain
445849|NCT01663025|Anxiety|anxiety
445850|NCT01663025|Ambulatory surgery|ambulatory surgery
445851|NCT01663025|Hand massage|hand massage
445852|NCT01663025|Local anaesthetic|local anaesthetic
445853|NCT01662973|Primary Biliary Cirrhosis|primary biliary cirrhosis
445854|NCT01662973|Mesenchymal Stem Cells|mesenchymal stem cells
445855|NCT01662973|Serum alkaline phosphatase|serum alkaline phosphatase
445856|NCT01662973|Serum Bilirubin|serum bilirubin
445857|NCT01662960|stroke|stroke
445858|NCT01662960|hemiparesis|hemiparesis
445859|NCT01662960|arm movement|arm movement
445860|NCT01662960|sensory functioning|sensory functioning
445861|NCT01662947|blood pressure|blood pressure
445862|NCT01662934|dysmenorrhea|dysmenorrhea
445863|NCT01662934|transcutaneous electrical nerve stimulation|transcutaneous electrical nerve stimulation
445864|NCT01662934|heat therapy|heat therapy
445865|NCT01662921|bolus treatment|bolus treatment
445866|NCT01662895|Brain hemorrhage|brain hemorrhage
445867|NCT01662895|Cerebral Hemorrhage|cerebral hemorrhage
445868|NCT01662895|Deferoxamine|deferoxamine
445869|NCT01662895|Hi-DEF Trial|hi-def trial
445870|NCT01662856|Vascular Surgery|vascular surgery
445871|NCT01662856|Fibrin Sealant|fibrin sealant
445872|NCT01662856|Polytetrafluoroethylene (PTFE) grafts|polytetrafluoroethylene (ptfe) grafts
445873|NCT01662843|Dyspnea|dyspnea
445874|NCT01662843|Ultrasonography|ultrasonography
445875|NCT01662843|Emergencies|emergencies
445876|NCT01662843|Critical Care|critical care
445877|NCT01662830|Obesity|obesity
445878|NCT01662830|Meal replacements|meal replacements
445879|NCT01662804|INTERLEUKIN 2|interleukin 2
445880|NCT01662804|MAB 3F8|mab 3f8
445881|NCT01662804|GD2-positive tumor|gd2-positive tumor
445882|NCT01662804|12-116|12-116
445883|NCT01662791|Parkinson's Disease|parkinson's disease
445884|NCT01662791|Small Bowel Bacterial Overgrowth|small bowel bacterial overgrowth
445885|NCT01662791|Weight Loss|weight loss
445886|NCT01662791|Gastrointestinal|gastrointestinal
445887|NCT01662791|Rifaximin|rifaximin
445888|NCT01662778|Monodisperse aerosols|monodisperse aerosols
445889|NCT01662778|Asthmatics|asthmatics
445890|NCT01662778|Pharmacokinetics|pharmacokinetics
445891|NCT01662778|AMP Challenge|amp challenge
445892|NCT01662778|Multiple Breath Nitrogen Washout|multiple breath nitrogen washout
445893|NCT01662765|Umbilical pilonidal sinus|umbilical pilonidal sinus
445894|NCT01662765|Treatment|treatment
445895|NCT01662765|Surgery|surgery
445896|NCT01662765|Conservative|conservative
445897|NCT01662765|Investigational treatment|investigational treatment
445898|NCT01662765|After care|after care
445899|NCT01662752|Early colonic cancer|early colonic cancer
445900|NCT01662752|Sentinel lymph node mapping|sentinel lymph node mapping
445901|NCT01662752|Sentinel lymph node biopsy|sentinel lymph node biopsy
445902|NCT01662752|Near infrared imaging|near infrared imaging
445903|NCT01662752|Indocyanine green|indocyanine green
445904|NCT01662752|Laparoscopic|laparoscopic
445905|NCT01662739|Population-Based Cancer Registry|population-based cancer registry
445906|NCT01662739|Stomach|stomach
445907|NCT01662739|Epidemiology|epidemiology
445908|NCT01662739|Risk Factor|risk factor
445909|NCT01662739|Biomolecular Features|biomolecular features
445910|NCT01662713|skin cancer|skin cancer
445911|NCT01662713|optical imaging|optical imaging
445912|NCT01662713|optical coherence tomography|optical coherence tomography
445913|NCT01662713|optical frequency domain imaging|optical frequency domain imaging
445914|NCT01662700|P. vivax infection|p. vivax infection
445915|NCT01662700|Artesunate|artesunate
445916|NCT01662700|Chloroquine|chloroquine
445917|NCT01662700|Primaquine|primaquine
445918|NCT01662661|Healthy participants|healthy participants
445919|NCT01662661|Hepatitis C|hepatitis c
445920|NCT01662661|Relative bioavailability|relative bioavailability
445921|NCT01662661|Bioavailability|bioavailability
445922|NCT01662661|Pharmacokinetics|pharmacokinetics
445924|NCT01662648|Schizophrenia|schizophrenia
445925|NCT01662648|Paliperidone|paliperidone
445926|NCT01662648|Paliperidone extended-release (ER)|paliperidone extended-release (er)
445927|NCT01662635|Non-small cell lung cancer.|non-small cell lung cancer.
445928|NCT01662635|Diagnosis,|diagnosis,
445929|NCT01662635|Adenocarcinoma,|adenocarcinoma,
445930|NCT01662635|ALK,|alk,
445931|NCT01662635|FISH,|fish,
445932|NCT01662635|IHC|ihc
445933|NCT01662635|RT-qPCR|rt-qpcr
445936|NCT01662622|minimal alveolar concentration|minimal alveolar concentration
445937|NCT01662622|sevoflurane|sevoflurane
445938|NCT01662622|isoelectric EEG|isoelectric eeg
445939|NCT01662609|pancreas|pancreas
445940|NCT01662609|high-risk|high-risk
445941|NCT01662596|Risk factors,|risk factors,
445942|NCT01662596|prenatal diagnosis,|prenatal diagnosis,
445943|NCT01662596|fetal malformations|fetal malformations
445944|NCT01662583|Influenza|influenza
445945|NCT01662583|text message|text message
445946|NCT01662583|vaccination|vaccination
445947|NCT01662570|Pediatric Obesity|pediatric obesity
445948|NCT01662570|Child Overweight|child overweight
445949|NCT01662557|Pediatric Obesity|pediatric obesity
445950|NCT01662544|Infants|infants
445951|NCT01662544|Bronchiolitis|bronchiolitis
445952|NCT01662544|Hypoxia|hypoxia
445953|NCT01662544|Emergency Department|emergency department
445954|NCT01662544|Length of Stay|length of stay
445955|NCT01662544|Pediatrics|pediatrics
445956|NCT01662466|testosterone|testosterone
445957|NCT01662466|DHEA|dhea
445958|NCT01662466|IVF|ivf
445959|NCT01662466|egg quality|egg quality
445960|NCT01662466|pregnancy rates|pregnancy rates
445961|NCT01662453|epilepsy|epilepsy
445962|NCT01662453|seizures|seizures
445963|NCT01662453|mortality|mortality
445964|NCT01662453|sudep|sudep
445965|NCT01662453|risk factors|risk factors
445966|NCT01662440|Rabies|rabies
445967|NCT01662440|JE|je
445968|NCT01662440|accelerated schedule|accelerated schedule
445969|NCT01662427|Quality of life|quality of life
445970|NCT01662427|Noctural Parkinson's Disease Symptoms|noctural parkinson's disease symptoms
445971|NCT01662401|children|children
445972|NCT01662401|laparoscopic appendectomy|laparoscopic appendectomy
445973|NCT01662401|iliohypogastric nerve block|iliohypogastric nerve block
445974|NCT01662401|rectus sheath nerve block|rectus sheath nerve block
445975|NCT01662401|ilioinguinal nerve block|ilioinguinal nerve block
445976|NCT01662388|proximal caries, composite restoration, proximal contact|proximal caries, composite restoration, proximal contact
445977|NCT01662362|Chagas Disease|chagas disease
445978|NCT01662362|Trypanosoma cruzi|trypanosoma cruzi
445979|NCT01662362|American trypanosomiasis|american trypanosomiasis
445980|NCT01662362|South American trypanosomiasis|south american trypanosomiasis
445981|NCT01662362|kissing bugs|kissing bugs
445982|NCT01662362|reduviid bugs|reduviid bugs
445983|NCT01662336|Human Immunodeficiency Virus infection|human immunodeficiency virus infection
445984|NCT01662323|Heart failure, general practitioner, medical therapy, quality of live|heart failure, general practitioner, medical therapy, quality of live
445985|NCT01662310|Schizophrenia|schizophrenia
445986|NCT01662310|Paliperidone|paliperidone
445987|NCT01662310|Paliperidone Extended-Release|paliperidone extended-release
445988|NCT01662297|Quetiapine|quetiapine
445989|NCT01662297|Trazodone|trazodone
445990|NCT01662297|Insomnia|insomnia
445991|NCT01662297|Dual Diagnosis|dual diagnosis
445992|NCT01662271|obesity|obesity
445993|NCT01662271|adiposity|adiposity
445994|NCT01662271|psychosocial|psychosocial
445995|NCT01662271|healthcare|healthcare
445996|NCT01662271|co-morbidities|co-morbidities
445997|NCT01662271|youth with extreme obesity|youth with extreme obesity
445998|NCT01662271|weight loss|weight loss
445999|NCT01662258|Community-acquired pneumonia|community-acquired pneumonia
446000|NCT01662258|Targeted strategy|targeted strategy
446001|NCT01662258|Empiric therapy|empiric therapy
446002|NCT01662232|Green tea|green tea
446003|NCT01662232|EGCG|egcg
446004|NCT01662232|Cardiovascular diseases|cardiovascular diseases
446005|NCT01662232|Endothelial function|endothelial function
446006|NCT01662232|Flow-mediated dilation|flow-mediated dilation
446007|NCT01662219|superficial cervical plexus block|superficial cervical plexus block
446008|NCT01662219|quality of recovery|quality of recovery
446009|NCT01662206|adults|adults
446010|NCT01662206|probiotics|probiotics
446011|NCT01662206|immune function|immune function
446012|NCT01662206|microbiota|microbiota
446013|NCT01662206|digestive health|digestive health
446014|NCT01662193|Cholecalciferol|cholecalciferol
446015|NCT01662193|Calciol|calciol
569550|NCT01138761|EASI|easi
446016|NCT01662193|vitamin D3|vitamin d3
446017|NCT01662193|Diabetes Mellitus|diabetes mellitus
446018|NCT01662193|Diabetes Mellitus Type 2|diabetes mellitus type 2
446019|NCT01662193|glucose metabolism disorders|glucose metabolism disorders
446020|NCT01662193|ergocalciferol|ergocalciferol
446021|NCT01662193|calcium|calcium
446022|NCT01662193|adipicytokines|adipicytokines
446023|NCT01662193|inflammatory biomarkers|inflammatory biomarkers
446024|NCT01662180|subfertility, IUI, rec FSH, FSH, E2, AMH|subfertility, iui, rec fsh, fsh, e2, amh
446025|NCT01662141|Cardiac output|cardiac output
446026|NCT01662141|Perivascular Probe|perivascular probe
446027|NCT01662128|Breast Cancer|breast cancer
446028|NCT01662115|ILEUS|ileus
446029|NCT01662089|Female pattern hair loss|female pattern hair loss
446030|NCT01662076|Cancer|cancer
446031|NCT01662076|Fatigue|fatigue
446032|NCT01662076|Chemotherapy|chemotherapy
446033|NCT01662076|Pediatrics|pediatrics
446034|NCT01662076|Homeopathy|homeopathy
446035|NCT01662050|MCL|mcl
446036|NCT01662050|Mantle Cell Lymphoma|mantle cell lymphoma
446038|NCT01662037|Pulmonary vascular resistance|pulmonary vascular resistance
446039|NCT01662037|Heart defects, Congenital|heart defects, congenital
446040|NCT01662037|Receptors, endothelin|receptors, endothelin
446041|NCT01662037|Bosentan|bosentan
446042|NCT01662024|Obesity|obesity
446043|NCT01662024|BMI|bmi
446044|NCT01662024|Weight loss|weight loss
446045|NCT01662024|Gastric restriction|gastric restriction
446046|NCT01662024|Bariatrics|bariatrics
446047|NCT01662011|patient-ventilator interaction|patient-ventilator interaction
446048|NCT01662011|neurally adjusted ventilatory assist|neurally adjusted ventilatory assist
446049|NCT01662011|diaphragm electrical activity|diaphragm electrical activity
446050|NCT01662011|pressure support ventilation|pressure support ventilation
446051|NCT01661998|Adolescent Idiopathic Scoliosis|adolescent idiopathic scoliosis
446052|NCT01661998|Spinal Deformity|spinal deformity
446053|NCT01661998|Treatment Outcomes|treatment outcomes
446054|NCT01661985|Mycoplasma genitalium|mycoplasma genitalium
446055|NCT01661985|Chlamydia trachomatis|chlamydia trachomatis
446056|NCT01661985|Treatment|treatment
446057|NCT01661985|Antibiotic resistance|antibiotic resistance
446058|NCT01661972|colorectal cancer|colorectal cancer
446059|NCT01661972|all solid tumors|all solid tumors
446060|NCT01661972|metastatic|metastatic
446061|NCT01661972|refractory|refractory
446062|NCT01661972|advanced solid tumors|advanced solid tumors
446063|NCT01661959|Scoliosis|scoliosis
446064|NCT01661959|Multi-center Database Registry|multi-center database registry
446065|NCT01661959|Spinal Deformity|spinal deformity
446066|NCT01661959|Adolescent Idiopathic Scoliosis|adolescent idiopathic scoliosis
446067|NCT01661946|vascular endothelial growth factor|vascular endothelial growth factor
446068|NCT01661946|macular edema|macular edema
446069|NCT01661946|diabetic retinopathy|diabetic retinopathy
446070|NCT01661933|celiac disease|celiac disease
446071|NCT01661933|hookworm|hookworm
446072|NCT01661933|probiotic|probiotic
446073|NCT01661920|Community Acquired Pneumonia.|community acquired pneumonia.
446074|NCT01661920|Treatment duration|treatment duration
446075|NCT01661907|Elderly|elderly
446076|NCT01661907|Anesthesia and postoperative analgesia|anesthesia and postoperative analgesia
446077|NCT01661907|Postoperative period|postoperative period
446078|NCT01661907|Delirium|delirium
446079|NCT01661907|Postoperative complications|postoperative complications
446080|NCT01661881|Newly diagnosed|newly diagnosed
446081|NCT01661868|BRCA1 mutation|brca1 mutation
446082|NCT01661868|BRCA2 mutation|brca2 mutation
446083|NCT01661855|Autism Spectrum Disorders|autism spectrum disorders
446084|NCT01661842|Autoimmune Hepatitis|autoimmune hepatitis
446085|NCT01661842|Mesenchymal stem cells|mesenchymal stem cells
446086|NCT01661842|serum albumin|serum albumin
446087|NCT01661842|serum Tbil|serum tbil
446088|NCT01661842|serum immunoglobulin G(IgG)|serum immunoglobulin g(igg)
446089|NCT01661816|breast cancer|breast cancer
446090|NCT01661816|everyday issues|everyday issues
446091|NCT01661816|couple|couple
446092|NCT01661803|bupivacaine|bupivacaine
446093|NCT01661803|clonidine|clonidine
446094|NCT01661803|pediatric spinal|pediatric spinal
446095|NCT01661803|efficacy|efficacy
446096|NCT01661803|duration|duration
446097|NCT01661803|quality|quality
446098|NCT01661803|side effects|side effects
446099|NCT01661803|intrathecal bupivacaine alone|intrathecal bupivacaine alone
446100|NCT01661803|bupivacaine plus clonidine|bupivacaine plus clonidine
446101|NCT01661790|Bevacizumab;|bevacizumab;
446102|NCT01661790|non-small cell lung cancer;|non-small cell lung cancer;
446103|NCT01661790|malignant pleural effusion;|malignant pleural effusion;
446104|NCT01661790|intrapleural administration|intrapleural administration
446105|NCT01661777|Eustachian tube dysfunction|eustachian tube dysfunction
446106|NCT01661777|Endolymphatic hydrops|endolymphatic hydrops
446107|NCT01661777|Diuretic|diuretic
446108|NCT01661777|Low salt diet|low salt diet
446109|NCT01661777|Myringotomy|myringotomy
446110|NCT01661777|Pressure equalization tube|pressure equalization tube
446111|NCT01661777|Ear tube|ear tube
446112|NCT01661777|Ear fullness|ear fullness
446113|NCT01661777|Ear pressure|ear pressure
446114|NCT01661777|Allergy|allergy
446115|NCT01661777|Nasal steroid|nasal steroid
446116|NCT01661777|Antihistamine|antihistamine
446117|NCT01661764|Colorectal Neoplasm|colorectal neoplasm
446118|NCT01661751|Group ACYW135 Meninigococcal Polysaccharide Vaccine|group acyw135 meninigococcal polysaccharide vaccine
446119|NCT01661738|Group ACYW135 Meninigococcal Polysaccharide Vaccine|group acyw135 meninigococcal polysaccharide vaccine
446120|NCT01661725|Group ACYW135 Meningococcal Polysaccharide Vaccine|group acyw135 meningococcal polysaccharide vaccine
446121|NCT01661712|obstructive sleep apnoea,|obstructive sleep apnoea,
446122|NCT01661712|continuous transcutaneous electrical stimulation|continuous transcutaneous electrical stimulation
446123|NCT01661699|Obstructive Sleep Apnea|obstructive sleep apnea
446124|NCT01661686|esophageal cancer|esophageal cancer
446125|NCT01661686|esophageal stenosis|esophageal stenosis
446126|NCT01661686|stent|stent
446127|NCT01661686|endoscopy|endoscopy
446128|NCT01661634|Acute decompensated heart failure|acute decompensated heart failure
446129|NCT01661621|Lower urinary tract symptoms (LUTS)|lower urinary tract symptoms (luts)
446233|NCT01661205|catheter ablation|catheter ablation
446130|NCT01661621|International Prostate Symptom Score (IPSS)|international prostate symptom score (ipss)
446131|NCT01661621|Antimuscarinics|antimuscarinics
446132|NCT01661621|α-blockers|α-blockers
446133|NCT01661608|Gastric Restriction|gastric restriction
446134|NCT01661595|Fatigue|fatigue
446135|NCT01661595|Fatigability|fatigability
446136|NCT01661595|Surface Electromyography (sEMG)|surface electromyography (semg)
446137|NCT01661595|cyclic guanosine monophosphate (cGMP)|cyclic guanosine monophosphate (cgmp)
446138|NCT01661595|Nitric Oxide (NO)|nitric oxide (no)
446139|NCT01661595|NO-cGMP|no-cgmp
446140|NCT01661595|Phosphodiesterase (PDE)|phosphodiesterase (pde)
446141|NCT01661595|Sildenafil|sildenafil
446142|NCT01661595|Tadalafil|tadalafil
446143|NCT01661595|Isotope|isotope
446144|NCT01661595|Infusion|infusion
446145|NCT01661595|Anabolism|anabolism
446146|NCT01661595|Upregulation|upregulation
446147|NCT01661595|Accelerometer|accelerometer
446148|NCT01661595|Placebo|placebo
446149|NCT01661595|Nitrosylation|nitrosylation
446150|NCT01661582|Air Pollution|air pollution
446151|NCT01661582|Myocardial Ischaemia|myocardial ischaemia
446152|NCT01661582|Coronary Blood Flow|coronary blood flow
446153|NCT01661582|Diesel Exhaust|diesel exhaust
446154|NCT01661582|Troponin|troponin
446155|NCT01661582|Electrocardiography|electrocardiography
446156|NCT01661569|Mindfulness|mindfulness
446157|NCT01661569|meditation|meditation
446158|NCT01661569|stress|stress
446159|NCT01661569|well-being|well-being
446160|NCT01661569|work stress|work stress
446161|NCT01661569|blood pressure|blood pressure
446162|NCT01661569|cortisol|cortisol
446163|NCT01661556|Melasma, miconazole, hydroquinone|melasma, miconazole, hydroquinone
446164|NCT01661530|asthma|asthma
446165|NCT01661530|pregnancy|pregnancy
446166|NCT01661530|diet|diet
446167|NCT01661530|vitamin E|vitamin e
446168|NCT01661517|substance use treatment|substance use treatment
446169|NCT01661439|Recurrent miscarriages|recurrent miscarriages
446170|NCT01661439|recurrent pregnancy loss|recurrent pregnancy loss
446172|NCT01661439|anti coagulants in pregnancy|anti coagulants in pregnancy
446173|NCT01661426|Adults|adults
446174|NCT01661426|Weight loss|weight loss
446175|NCT01661426|Diet|diet
446176|NCT01661426|Insulin Resistance|insulin resistance
446177|NCT01661426|Fatty acid composition|fatty acid composition
446178|NCT01661413|Acute Leukemia|acute leukemia
446179|NCT01661413|Pediatrics|pediatrics
446180|NCT01661413|Intrathecal methotrexate|intrathecal methotrexate
446181|NCT01661413|Chemotherapy|chemotherapy
446182|NCT01661413|Nausea|nausea
446183|NCT01661413|Vomiting|vomiting
446184|NCT01661400|Glioma includes ependymoma and medulloblastoma|glioma includes ependymoma and medulloblastoma
446185|NCT01661387|Adrenal insufficiency|adrenal insufficiency
446186|NCT01661387|DuoCort|duocort
446187|NCT01661387|Congenital adrenal hyperplasia (CAH)|congenital adrenal hyperplasia (cah)
446188|NCT01661387|Modified release|modified release
446189|NCT01661387|Hydrocortisone|hydrocortisone
446190|NCT01661361|vancomycin|vancomycin
446191|NCT01661361|levels|levels
446192|NCT01661361|central venous port device|central venous port device
446193|NCT01661361|peripherally obtained levels|peripherally obtained levels
446194|NCT01661361|dose adjustments|dose adjustments
446195|NCT01661361|TDM|tdm
446196|NCT01661348|Cesarian section|cesarian section
446197|NCT01661348|Pregnancy|pregnancy
446198|NCT01661348|Incision management|incision management
446199|NCT01661335|Nausea|nausea
446200|NCT01661335|Vomiting|vomiting
446201|NCT01661335|Children|children
446202|NCT01661335|Aprepitant|aprepitant
446203|NCT01661335|Emend®|emend®
446204|NCT01661322|Acute ischaemic stroke|acute ischaemic stroke
446205|NCT01661322|TIA|tia
446206|NCT01661309|Hyperhomocysteinemia|hyperhomocysteinemia
446207|NCT01661309|Methylcobalamin|methylcobalamin
446208|NCT01661309|Cardiovascular disease|cardiovascular disease
446209|NCT01661309|Plasma total homocysteine|plasma total homocysteine
446210|NCT01661309|Vegetarians|vegetarians
446211|NCT01661296|cutaneous leishmaniasis, heat therapy, antimony|cutaneous leishmaniasis, heat therapy, antimony
446212|NCT01661283|MPNST|mpnst
446213|NCT01661283|malignant peripheral nerve sheath tumors|malignant peripheral nerve sheath tumors
446214|NCT01661283|RAD001|rad001
446215|NCT01661283|Everolimus|everolimus
446216|NCT01661283|Bevacizumab|bevacizumab
446217|NCT01661283|Sarcoma|sarcoma
446218|NCT01661283|Avastin|avastin
446219|NCT01661283|mTOR inhibitor|mtor inhibitor
446220|NCT01661257|Crohn's disease|crohn's disease
446221|NCT01661257|Infliximab|infliximab
446222|NCT01661257|T-cell immunoglobulin- and mucin-domain-containing molecule 3 (TIM-3)|t-cell immunoglobulin- and mucin-domain-containing molecule 3 (tim-3)
446223|NCT01661231|Vascular intervention|vascular intervention
446224|NCT01661231|Endovascular|endovascular
446225|NCT01661231|Peripheral stent|peripheral stent
446226|NCT01661218|catheters|catheters
446227|NCT01661218|Central Venous|central venous
446228|NCT01661218|complications|complications
446229|NCT01661218|cancer|cancer
446230|NCT01661205|Persistent AF|persistent af
446231|NCT01661205|Longstanding Persistent AF|longstanding persistent af
446232|NCT01661205|Ablation|ablation
446234|NCT01661192|Type 1 Diabetes|type 1 diabetes
446235|NCT01661192|newly diagnosed|newly diagnosed
446236|NCT01661192|Beta cell preservation|beta cell preservation
446237|NCT01661179|Medullary Thyroid Carcinoma|medullary thyroid carcinoma
446238|NCT01661179|Medullary Thyroid Cancer|medullary thyroid cancer
446239|NCT01661179|Vandetanib|vandetanib
446240|NCT01661166|Male adult subjects|male adult subjects
446241|NCT01661166|aged 30-90 years|aged 30-90 years
446242|NCT01661166|RARP|rarp
446243|NCT01661166|AUA symptom score greater than 7 will be included|aua symptom score greater than 7 will be included
446244|NCT01661114|Gemcitabine, Infusional 5-Fluorouracil,Cisplatin|gemcitabine, infusional 5-fluorouracil,cisplatin
446245|NCT01661114|Advanced Pancreatic and Biliary Cancers|advanced pancreatic and biliary cancers
446246|NCT01661114|untreated & previously treated pancreatic & biliary cancer.|untreated & previously treated pancreatic & biliary cancer.
446247|NCT01661101|Perioperative myocardial infarction|perioperative myocardial infarction
446248|NCT01661101|Myocardial injury|myocardial injury
446249|NCT01661101|noncardiac surgery|noncardiac surgery
446250|NCT01661088|Neoadjuvant FOLFIRINOX|neoadjuvant folfirinox
446251|NCT01661088|FDR-Gemcitabine|fdr-gemcitabine
446252|NCT01661088|Concurrent|concurrent
446253|NCT01661088|IMRT|imrt
446254|NCT01661088|Borderline Resectable Pancreatic Cancer|borderline resectable pancreatic cancer
446255|NCT01661075|mTBI|mtbi
446256|NCT01661075|concussion|concussion
446257|NCT01661075|mild traumatic brain injury|mild traumatic brain injury
446258|NCT01661075|athlete|athlete
446259|NCT01661075|college|college
446260|NCT01661075|football|football
446261|NCT01661075|soccer|soccer
446262|NCT01661036|Cognitive Testing|cognitive testing
446263|NCT01661036|Survey|survey
446264|NCT01661036|Interview|interview
446265|NCT01661023|Breast Cancer|breast cancer
446266|NCT01661023|Epidemiology|epidemiology
446267|NCT01661010|Infertility|infertility
446268|NCT01661010|Turner's Syndrome|turner's syndrome
446269|NCT01661010|X-Chromosome|x-chromosome
446270|NCT01661010|Y-Chromosome|y-chromosome
446271|NCT01661010|Aneuploidy|aneuploidy
446272|NCT01660997|Proteasome Inhibitor|proteasome inhibitor
446273|NCT01660997|Induction Combination Therapy|induction combination therapy
446274|NCT01660997|Maintenance Strategy|maintenance strategy
446275|NCT01660997|Potent Anti-Myeloma Effect|potent anti-myeloma effect
446276|NCT01660997|Precursor Disease|precursor disease
446277|NCT01660984|Thyroid Tumor|thyroid tumor
446278|NCT01660984|Multiple Endocrine Neoplasia 2|multiple endocrine neoplasia 2
446279|NCT01660984|Pheochromocytoma|pheochromocytoma
446280|NCT01660984|RET Mutations|ret mutations
446281|NCT01660958|Micronutrient Deficiencies|micronutrient deficiencies
446282|NCT01660958|Early Child Development|early child development
446283|NCT01660958|Infant Growth|infant growth
446284|NCT01660958|Iron Deficiency|iron deficiency
446285|NCT01660945|statins, insulin resistance|statins, insulin resistance
446286|NCT01660932|insulin resistance|insulin resistance
446287|NCT01660919|insulin resistance|insulin resistance
446288|NCT01660893|operative|operative
446289|NCT01660893|dental procedure|dental procedure
446290|NCT01660867|hospital admission within 7 days of 3% NaCl nebulizer vs dexamethasone|hospital admission within 7 days of 3% nacl nebulizer vs dexamethasone
446291|NCT01660854|Plasmodium|plasmodium
446292|NCT01660854|falciparum|falciparum
446293|NCT01660854|malaria|malaria
446294|NCT01660854|heterologous|heterologous
446295|NCT01660854|immunity|immunity
446296|NCT01660841|Magnetic resonance imaging|magnetic resonance imaging
446297|NCT01660841|central nervous system|central nervous system
446298|NCT01660841|contrast media|contrast media
446299|NCT01660841|gadobutrol|gadobutrol
446300|NCT01660828|Exercise induced (high sensitive) troponin release|exercise induced (high sensitive) troponin release
446301|NCT01660828|Ischemia reperfusion injury|ischemia reperfusion injury
446302|NCT01660828|Remote ischemic preconditioning|remote ischemic preconditioning
446304|NCT01660789|Diabetes|diabetes
446305|NCT01660789|Physical activity|physical activity
446306|NCT01660776|diffuse large B-cell lymphoma (DLBCL)|diffuse large b-cell lymphoma (dlbcl)
446307|NCT01660776|Hodgkin lymphoma|hodgkin lymphoma
446308|NCT01660776|metastatic breast cancer.|metastatic breast cancer.
446309|NCT01660776|non-small cell lung cancer|non-small cell lung cancer
446310|NCT01660750|newly diagnosed multiple myeloma|newly diagnosed multiple myeloma
446311|NCT01660750|transplant eligible multiple myeloma|transplant eligible multiple myeloma
446312|NCT01660737|Hay fever|hay fever
446313|NCT01660737|Pascallerg|pascallerg
446314|NCT01660711|neoadjuvant|neoadjuvant
446315|NCT01660711|chemotherapy|chemotherapy
446316|NCT01660711|resectable|resectable
446317|NCT01660711|adjuvant|adjuvant
446318|NCT01660711|pancreas|pancreas
446319|NCT01660711|cancer|cancer
446320|NCT01660711|adenocarcinoma|adenocarcinoma
446321|NCT01660711|surgery|surgery
446322|NCT01660685|Weight loss|weight loss
446323|NCT01660685|Web-based|web-based
446324|NCT01660685|Journaling|journaling
446325|NCT01660685|Body Mass Index between 27 and 45|body mass index between 27 and 45
446326|NCT01660659|Indoor air pollution|indoor air pollution
446327|NCT01660659|pneumococcal carriage|pneumococcal carriage
446328|NCT01660646|Tuberculosis case finding|tuberculosis case finding
446329|NCT01660633|Multiple Myeloma|multiple myeloma
446330|NCT01660633|High-Dose Melphalan|high-dose melphalan
446331|NCT01660633|Propylene Glycol-Free|propylene glycol-free
446332|NCT01660633|Autologous Stem Cell Transplantation|autologous stem cell transplantation
446333|NCT01660633|Captisol|captisol
446334|NCT01660620|betaxolol/ retinopathy of prematurity|betaxolol/ retinopathy of prematurity
446335|NCT01660594|coronary disease|coronary disease
446336|NCT01660594|tomography, x-ray computed|tomography, x-ray computed
446337|NCT01660594|calcium|calcium
446338|NCT01660594|exercise test|exercise test
446339|NCT01660581|CD133+|cd133+
446340|NCT01660581|stem cells|stem cells
446341|NCT01660581|Coronary Artery Disease|coronary artery disease
446342|NCT01660581|Stable Angina Pectoris|stable angina pectoris
446343|NCT01660555|Microbiota|microbiota
446344|NCT01660555|HITChip|hitchip
446345|NCT01660555|biopsies|biopsies
446346|NCT01660555|colon|colon
446347|NCT01660555|protected biopsies|protected biopsies
446348|NCT01660529|Subjects with metastatic breast cancer who have failed at least one standard|subjects with metastatic breast cancer who have failed at least one standard
446349|NCT01660529|of care regimen|of care regimen
446350|NCT01660516|Camellia sinensis|camellia sinensis
446351|NCT01660516|flavonoids|flavonoids
446352|NCT01660516|cardiovascular risk|cardiovascular risk
446353|NCT01660516|flow mediated dilation|flow mediated dilation
446354|NCT01660503|Calcium absorption|calcium absorption
446355|NCT01660503|Osteoporosis|osteoporosis
446356|NCT01660503|Bone Health|bone health
446357|NCT01660503|Adolescent|adolescent
446358|NCT01660490|Radiographic Image Enhancement,|radiographic image enhancement,
446359|NCT01660490|Intraoperative Care|intraoperative care
446360|NCT01660490|Femoral Fractures|femoral fractures
446361|NCT01660490|Femoral Neck Fractures|femoral neck fractures
446362|NCT01660490|Hip Fractures, Internal Fixators|hip fractures, internal fixators
446363|NCT01660490|Fracture Fixation Internal|fracture fixation internal
446364|NCT01660490|Fracture Fixation Intramedullary|fracture fixation intramedullary
446365|NCT01660490|Fractures Bone|fractures bone
446366|NCT01660477|Isavuconazole|isavuconazole
446367|NCT01660477|Lopinavir/ritonavir|lopinavir/ritonavir
446368|NCT01660477|Healthy Volunteers|healthy volunteers
446369|NCT01660477|BAL8557|bal8557
446370|NCT01660477|Kaletra ®|kaletra ®
446371|NCT01660464|Program evaluation|program evaluation
446372|NCT01660464|ADHD|adhd
446373|NCT01660451|Clinical trial, phase II|clinical trial, phase ii
446374|NCT01660451|Phosphatidylinositol 3-Kinase|phosphatidylinositol 3-kinase
446375|NCT01660451|Class I, Non-Hodgkin's lymphoma|class i, non-hodgkin's lymphoma
446376|NCT01660438|Stress urinary incontinence|stress urinary incontinence
446377|NCT01660438|Suburethral sling|suburethral sling
446378|NCT01660425|Attention deficit-/hyperactivity disorder|attention deficit-/hyperactivity disorder
446379|NCT01660425|parenting enhancement training|parenting enhancement training
446380|NCT01660425|guided self-help|guided self-help
446381|NCT01660425|methylphenidate|methylphenidate
446382|NCT01660412|Pain|pain
446383|NCT01660412|Alkalinization|alkalinization
446384|NCT01660412|Technetium 99m Sulfur Colloid|technetium 99m sulfur colloid
446385|NCT01660412|sentinel lymphoscintigraphy?|sentinel lymphoscintigraphy?
446386|NCT01660399|salvage chemotherapy|salvage chemotherapy
446387|NCT01660399|advanced squamous cell lung cancer|advanced squamous cell lung cancer
446388|NCT01660399|Boanmycin|boanmycin
446389|NCT01660386|Type 2 Diabetes|type 2 diabetes
446390|NCT01660386|Dpp-4 inhibitor|dpp-4 inhibitor
446391|NCT01660386|Sulfonylurea|sulfonylurea
446392|NCT01660386|beta cell function|beta cell function
446393|NCT01660373|ticagrelor|ticagrelor
446394|NCT01660373|tirofiban|tirofiban
446395|NCT01660373|glycoprotein IIa/IIIa inhibitors|glycoprotein iia/iiia inhibitors
446396|NCT01660373|P2Y12 blockers|p2y12 blockers
446397|NCT01660373|acute coronary syndrome|acute coronary syndrome
446398|NCT01660360|Tanibirumab Phase I trial|tanibirumab phase i trial
446399|NCT01660334|Systemic Mycosis|systemic mycosis
446400|NCT01660334|Scedosporium infection|scedosporium infection
446401|NCT01660334|Scedosporisis|scedosporisis
446402|NCT01660334|Japanese|japanese
446403|NCT01660334|voriconazole|voriconazole
446404|NCT01660334|VFEND|vfend
446405|NCT01660334|Regulatory Post Marketing Commitment Plan.|regulatory post marketing commitment plan.
446406|NCT01660321|Pediculosis capitis|pediculosis capitis
446407|NCT01660321|Head Lice|head lice
446408|NCT01660295|Severe renal insufficiency certoparin|severe renal insufficiency certoparin
446409|NCT01660295|Severe renal insufficiency|severe renal insufficiency
446410|NCT01660243|Pruritus|pruritus
446411|NCT01660243|Renal dialysis|renal dialysis
446412|NCT01660243|Receptors, Opioid, kappa|receptors, opioid, kappa
446413|NCT01660243|Sleep Disorders|sleep disorders
446414|NCT01660243|Quality of Life|quality of life
446415|NCT01660230|APC, 3K3A, 3K3A-APC, volunteer, healthy|apc, 3k3a, 3k3a-apc, volunteer, healthy
446416|NCT01660217|atopic dermatitis|atopic dermatitis
446417|NCT01660217|eczema action plan|eczema action plan
446418|NCT01660217|patient education|patient education
446419|NCT01660217|written handout|written handout
446420|NCT01660217|investigator's global assessment|investigator's global assessment
446421|NCT01660217|randomized controlled trial|randomized controlled trial
446422|NCT01660204|pneumonia, anti-bacterial agents, (cost)efficacy|pneumonia, anti-bacterial agents, (cost)efficacy
446423|NCT01660191|LDL, HDL|ldl, hdl
446424|NCT01660178|newborns|newborns
446425|NCT01660178|intensive care unit|intensive care unit
446426|NCT01660178|early stimulation|early stimulation
446427|NCT01660165|Nutritional status|nutritional status
446428|NCT01660165|Mental Health|mental health
446429|NCT01660165|Omega-3|omega-3
446430|NCT01660165|Pregnancy|pregnancy
446431|NCT01660165|Postpartum depression|postpartum depression
446432|NCT01660152|male erectile disorder|male erectile disorder
446433|NCT01660152|prostate cancer|prostate cancer
446434|NCT01660152|Laparoscopic prostatectomy|laparoscopic prostatectomy
446435|NCT01660126|Aged|aged
446436|NCT01660126|Cardiovascular disease|cardiovascular disease
446437|NCT01660126|Levothyroxine|levothyroxine
446438|NCT01660126|Randomised controlled trial|randomised controlled trial
446439|NCT01660126|Quality of life|quality of life
446440|NCT01660126|Subclinical hypothyroidism|subclinical hypothyroidism
446441|NCT01660100|Atrial fibrillation ablation|atrial fibrillation ablation
446442|NCT01660087|Exhaled breath condensate (EBC) method|exhaled breath condensate (ebc) method
446443|NCT01660087|Volatile Organic Compounds (VOCs)|volatile organic compounds (vocs)
446444|NCT01660087|Endobronchial Ultrasound (EBUS)|endobronchial ultrasound (ebus)
446445|NCT01660087|Confocal Endoscopy|confocal endoscopy
446446|NCT01660087|Exhaled alveolar gas|exhaled alveolar gas
446447|NCT01660074|glycemic index, resistant starch, glycemic response|glycemic index, resistant starch, glycemic response
446448|NCT01660061|Antiphospholipid syndrome|antiphospholipid syndrome
446449|NCT01660061|Antiphospholipid antibodies|antiphospholipid antibodies
446450|NCT01660061|Vitamin-K antagonists|vitamin-k antagonists
446451|NCT01660061|International normalized ratio|international normalized ratio
446452|NCT01660061|Chromogenic factor X|chromogenic factor x
446453|NCT01660048|Laparoscopic total extraperitoneal Inguinal hernia repair|laparoscopic total extraperitoneal inguinal hernia repair
446454|NCT01660022|Healthy|healthy
446455|NCT01660022|Volunteers|volunteers
446456|NCT01660009|Endothelial Function|endothelial function
446457|NCT01660009|Hypoglycemia|hypoglycemia
446458|NCT01660009|Mitochondria|mitochondria
446459|NCT01659996|Meningitis|meningitis
446460|NCT01659996|Meningococcal Infection|meningococcal infection
446461|NCT01659996|Diphtheria|diphtheria
446462|NCT01659996|Pertussis|pertussis
446463|NCT01659996|Menactra®|menactra®
446464|NCT01659996|Pentacel®|pentacel®
446465|NCT01659983|complicated appendicitis|complicated appendicitis
446466|NCT01659983|wound closure|wound closure
446467|NCT01659983|infection|infection
446468|NCT01659957|Alcoholism|alcoholism
446469|NCT01659957|Couples|couples
446470|NCT01659944|Drug-drug interaction|drug-drug interaction
446471|NCT01659879|Parents|parents
446472|NCT01659879|Caregivers|caregivers
446473|NCT01659879|Anxiety|anxiety
446474|NCT01659879|Consumer satisfaction|consumer satisfaction
446475|NCT01659866|Infection|infection
446476|NCT01659866|Antibiotic resistance|antibiotic resistance
446477|NCT01659866|Prostate biopsy|prostate biopsy
446478|NCT01659840|laser,|laser,
446479|NCT01659840|quality of life,|quality of life,
446480|NCT01659840|orofacial pain|orofacial pain
446481|NCT01659814|Major Depressive Disorder|major depressive disorder
446482|NCT01659814|Anhedonia|anhedonia
446483|NCT01659814|Dopamine|dopamine
446484|NCT01659814|Electroencephalography (EEG)|electroencephalography (eeg)
446485|NCT01659814|Positron Emission Tomography (PET)|positron emission tomography (pet)
446486|NCT01659814|Reward|reward
446487|NCT01659801|cataract|cataract
446488|NCT01659801|cataract surgery|cataract surgery
446489|NCT01659801|intaocular lens|intaocular lens
446490|NCT01659801|toric lens|toric lens
446491|NCT01659788|Advanced Reproductive Age|advanced reproductive age
446492|NCT01659788|poor ovarian response|poor ovarian response
446493|NCT01659788|Mitochondrial dysfunction|mitochondrial dysfunction
446494|NCT01659788|Mitochondrial nutrients|mitochondrial nutrients
446495|NCT01659788|Coenzyme Q10|coenzyme q10
446496|NCT01659788|Electron transfer chain|electron transfer chain
446497|NCT01659762|inflammatory bowel disease|inflammatory bowel disease
446498|NCT01659762|Crohn's disease|crohn's disease
446499|NCT01659749|Genetics|genetics
446500|NCT01659749|Metabolic|metabolic
446501|NCT01659749|Nutrition|nutrition
446502|NCT01659749|Maternal PKU|maternal pku
446503|NCT01659749|Phenylketonuria (PKU)|phenylketonuria (pku)
446504|NCT01659723|Radio therapy|radio therapy
446505|NCT01659723|STRI|stri
446506|NCT01659723|Urinary bladder|urinary bladder
446507|NCT01659723|Hyperbaric Oxygen|hyperbaric oxygen
446508|NCT01659697|lifestyle|lifestyle
446509|NCT01659697|diabetes prevention|diabetes prevention
446510|NCT01659697|BMI|bmi
446511|NCT01659697|physical activity|physical activity
446512|NCT01659684|congenital CMV infection|congenital cmv infection
446513|NCT01659684|standard immunoglobulins|standard immunoglobulins
446514|NCT01659684|immunoglobulin therapy|immunoglobulin therapy
446515|NCT01659684|IgG CMV avidity index|igg cmv avidity index
446516|NCT01659684|Cytomegalovirus|cytomegalovirus
446517|NCT01659658|MLN9708|mln9708
446518|NCT01659658|Amyloidosis|amyloidosis
446519|NCT01659658|Light Chain|light chain
446520|NCT01659658|IXAZOMIB|ixazomib
446521|NCT01659658|Tourmaline AL1|tourmaline al1
446522|NCT01659658|Drug Therapy|drug therapy
446523|NCT01659606|dyskeratosis congenita|dyskeratosis congenita
446524|NCT01659606|bone marrow failure|bone marrow failure
446525|NCT01659606|aplastic anemia|aplastic anemia
446526|NCT01659606|bone marrow transplantation|bone marrow transplantation
446527|NCT01659606|reduced intensity conditioning|reduced intensity conditioning
446528|NCT01659606|campath|campath
446529|NCT01659606|fludarabine|fludarabine
446530|NCT01659606|telomere|telomere
446531|NCT01659593|cognitive disorders|cognitive disorders
446532|NCT01659593|multiple sclerosis|multiple sclerosis
446533|NCT01659593|neuropsychology|neuropsychology
446534|NCT01659580|Angina Pectoris Treatment Prevention|angina pectoris treatment prevention
446535|NCT01659554|Primary peritoneal|primary peritoneal
446536|NCT01659541|spinal cord injury|spinal cord injury
446537|NCT01659541|paralysis|paralysis
446538|NCT01659541|cough|cough
446539|NCT01659541|cervical spinal cord injury|cervical spinal cord injury
446540|NCT01659541|thoracic spinal cord injury|thoracic spinal cord injury
446541|NCT01659528|Penis|penis
446542|NCT01659528|Micropenis|micropenis
446543|NCT01659528|Nomograms|nomograms
446544|NCT01659528|Ultrasound|ultrasound
446545|NCT01659528|Fetus|fetus
446546|NCT01659502|Patients|patients
446547|NCT01659489|adnexal torsion|adnexal torsion
446548|NCT01659489|laparoscopy|laparoscopy
446549|NCT01659476|methacholine|methacholine
446550|NCT01659476|deep inspiration|deep inspiration
446551|NCT01659476|bronchoprotective effect|bronchoprotective effect
446552|NCT01659476|bronchodilating effect|bronchodilating effect
446553|NCT01659463|CARIES INFILTRATION|caries infiltration
446554|NCT01659463|CARIES LESION|caries lesion
446555|NCT01659463|INFILTRANT|infiltrant
446556|NCT01659450|overweight|overweight
446557|NCT01659450|obesity|obesity
446558|NCT01659450|low energy dense|low energy dense
446559|NCT01659437|M. ulcerans|m. ulcerans
446560|NCT01659437|Buruli ulcer|buruli ulcer
446561|NCT01659437|drug trial|drug trial
446562|NCT01659437|clarithromycin|clarithromycin
446563|NCT01659424|Rectal cancer|rectal cancer
446564|NCT01659411|Congenital Heart Disease|congenital heart disease
446565|NCT01659411|Pulmonary Arterial Hypertension|pulmonary arterial hypertension
446566|NCT01659398|Alzheimer's Disease|alzheimer's disease
446567|NCT01659398|cerebral blood flow|cerebral blood flow
446568|NCT01659398|ophthalmic blood flow|ophthalmic blood flow
446569|NCT01659398|blood viscosity|blood viscosity
446570|NCT01659372|temporomandibular disorder|temporomandibular disorder
446571|NCT01659372|myofascial pain syndrome|myofascial pain syndrome
446572|NCT01659333|Peritoneal, Dialysis|peritoneal, dialysis
446573|NCT01659307|Acute Lung Injury|acute lung injury
446574|NCT01659307|Acute Respiratory Distress Syndrome|acute respiratory distress syndrome
446575|NCT01659307|Aspirin|aspirin
446576|NCT01659294|Type 2 diabetes|type 2 diabetes
446577|NCT01659294|outcomes|outcomes
446578|NCT01659294|case management|case management
446579|NCT01659281|Artesunate|artesunate
446580|NCT01659281|Mefloquine|mefloquine
446581|NCT01659281|Plasmodium Falciparum|plasmodium falciparum
446582|NCT01659281|Thailand|thailand
446583|NCT01659281|Uncomplicated Plasmodium Falciparum malaria|uncomplicated plasmodium falciparum malaria
446584|NCT01659268|teaching|teaching
446585|NCT01659268|patient simulation|patient simulation
446586|NCT01659268|laryngeal masks|laryngeal masks
446587|NCT01659268|baccalaureate nursing education|baccalaureate nursing education
446588|NCT01659268|teaching strategies|teaching strategies
446589|NCT01659268|simulation|simulation
446590|NCT01659242|Rheumatoid arthritis|rheumatoid arthritis
446591|NCT01659242|Ultrasound|ultrasound
446592|NCT01659242|Magnetic Resonance Imaging|magnetic resonance imaging
446593|NCT01659229|knee osteoarthritis|knee osteoarthritis
710623|NCT00588562|Primary Oxalosis|primary oxalosis
446594|NCT01659216|Electrical Pudendal Nerve Stimulation|electrical pudendal nerve stimulation
446595|NCT01659216|Urgency-Frequency Syndrome|urgency-frequency syndrome
446596|NCT01659216|long-term efficacy|long-term efficacy
446597|NCT01659203|extraskeletal chondrosarcoma|extraskeletal chondrosarcoma
446598|NCT01659164|Cognitive Behavioral Therapy|cognitive behavioral therapy
446599|NCT01659164|Dialectical Behavioral Therapy|dialectical behavioral therapy
446600|NCT01659164|Group Treatment|group treatment
446601|NCT01659164|ADHD|adhd
446602|NCT01659151|metastatic|metastatic
446603|NCT01659151|melanoma|melanoma
446604|NCT01659151|cell transfer|cell transfer
446605|NCT01659151|ACT|act
446606|NCT01659151|T-cell|t-cell
446607|NCT01659151|immunotherapy|immunotherapy
446608|NCT01659151|antibodies|antibodies
446609|NCT01659151|lymphocytes|lymphocytes
446610|NCT01659112|core stabilization, upper extremity, kinetic chain, movement|core stabilization, upper extremity, kinetic chain, movement
446611|NCT01659099|DLBCL|dlbcl
446612|NCT01659099|aa-IPI > or equal to 1|aa-ipi > or equal to 1
446613|NCT01659099|Diagnosis|diagnosis
446614|NCT01659099|18 to 60 years|18 to 60 years
446615|NCT01659099|Lymphoma|lymphoma
446616|NCT01659086|Influenza|influenza
446617|NCT01659086|Immunogenicity|immunogenicity
446618|NCT01659086|H9N2|h9n2
446619|NCT01659086|Safety|safety
446620|NCT01659073|Caloric Vestibular Stimulation|caloric vestibular stimulation
446621|NCT01659073|Functional Imaging|functional imaging
446622|NCT01659060|Cacao|cacao
446623|NCT01659060|Chocolate|chocolate
446624|NCT01659060|Theobromine|theobromine
446625|NCT01659060|Flavonoids|flavonoids
446626|NCT01659060|Pregnant women|pregnant women
446627|NCT01659060|Hypertension pregnancy-induced|hypertension pregnancy-induced
446628|NCT01659060|Pre-eclampsia|pre-eclampsia
446629|NCT01659060|Epicatechin|epicatechin
446630|NCT01659047|Chronic Lymphocytic Leukemia|chronic lymphocytic leukemia
446631|NCT01659047|CLL|cll
446632|NCT01659047|CAL-101|cal-101
446633|NCT01659047|Ofatumumab|ofatumumab
446634|NCT01659034|Anti-platelet therapy|anti-platelet therapy
446635|NCT01659021|CLL|cll
446636|NCT01659021|Chronic Lymphocytic Leukemia|chronic lymphocytic leukemia
446637|NCT01659021|GS-1101|gs-1101
446638|NCT01659021|CAL-101|cal-101
446639|NCT01659021|Ofatumumab|ofatumumab
446640|NCT01659008|acute cyclical heavy menstrual bleeding|acute cyclical heavy menstrual bleeding
446641|NCT01658995|Implanon|implanon
446642|NCT01658995|Etonogestrel subdermal implant|etonogestrel subdermal implant
446643|NCT01658995|Nexplanon|nexplanon
446644|NCT01658995|Contraception|contraception
446645|NCT01658995|Irregular Bleeding|irregular bleeding
446646|NCT01658995|Menometrorrhagia|menometrorrhagia
446647|NCT01658956|GCSF|gcsf
446648|NCT01658956|Chemotherapy|chemotherapy
446649|NCT01658956|Breast cancer|breast cancer
446650|NCT01658956|Prophylaxis|prophylaxis
446651|NCT01658917|Tissue Acquisition|tissue acquisition
446652|NCT01658904|Autologous Transplant|autologous transplant
446653|NCT01658904|Proteasome Inhibitor|proteasome inhibitor
446654|NCT01658904|Melphalan|melphalan
446655|NCT01658904|Filgrastim|filgrastim
446656|NCT01658839|pediatric glaucoma|pediatric glaucoma
446657|NCT01658839|pediatric ocular hypertension|pediatric ocular hypertension
446658|NCT01658839|travoprost|travoprost
446659|NCT01658826|AIC316|aic316
446660|NCT01658826|Viral shedding|viral shedding
446661|NCT01658813|Metastatic Gastrointestinal|metastatic gastrointestinal
446662|NCT01658813|Metastatic Kidney|metastatic kidney
446663|NCT01658813|Metastatic Lung|metastatic lung
446664|NCT01658800|H5N1 Influenza|h5n1 influenza
446665|NCT01658800|H5N1 Influenza vaccine|h5n1 influenza vaccine
446666|NCT01658787|Aorta|aorta
446667|NCT01658761|Myopic traction maculopathy|myopic traction maculopathy
446668|NCT01658761|vitrectomy|vitrectomy
446669|NCT01658761|internal limiting membrane|internal limiting membrane
446670|NCT01658761|Retrospective, case control study|retrospective, case control study
446671|NCT01658748|Pilot Study|pilot study
446672|NCT01658748|Longitudinal Study|longitudinal study
446673|NCT01658748|Amygdaloid Body|amygdaloid body
446674|NCT01658748|Insula of Reil|insula of reil
446675|NCT01658748|Cortex, prefrontal|cortex, prefrontal
446676|NCT01658748|Stimulation, Deep Brain|stimulation, deep brain
446677|NCT01658748|Chronic Post Traumatic Stress Disorder|chronic post traumatic stress disorder
446678|NCT01658748|Combat Stress Disorder|combat stress disorder
446679|NCT01658748|Social Adjustments|social adjustments
446680|NCT01658748|Positron-Emission Tomography, Computed Tomography|positron-emission tomography, computed tomography
446681|NCT01658735|Chronic low back pain|chronic low back pain
446682|NCT01658735|Electrotherapy|electrotherapy
446683|NCT01658735|H-Wave|h-wave
446684|NCT01658735|H wave|h wave
446685|NCT01658735|TENS|tens
446686|NCT01658735|Trial|trial
446687|NCT01658683|Coronary Artery Disease|coronary artery disease
446688|NCT01658683|Cardiac Rehabilitation|cardiac rehabilitation
446689|NCT01658683|Exercise Maintenance|exercise maintenance
446690|NCT01658683|Facilitator|facilitator
446691|NCT01658683|Managed Home Exercise|managed home exercise
446692|NCT01658683|Community Based Exercise|community based exercise
570383|NCT01136577|LED|led
446693|NCT01658670|Heart failure|heart failure
446694|NCT01658670|exercise|exercise
446695|NCT01658670|adherence|adherence
446696|NCT01658670|quality of life|quality of life
446697|NCT01658644|Patient satisfaction|patient satisfaction
446698|NCT01658644|Memory recall|memory recall
446699|NCT01658644|Patient-clinician communication|patient-clinician communication
446700|NCT01658644|health communication|health communication
446701|NCT01658644|clinical care team recall|clinical care team recall
446702|NCT01658644|hospital quality of care|hospital quality of care
446703|NCT01658618|Venous leg ulcer|venous leg ulcer
446704|NCT01658618|ulcer|ulcer
446705|NCT01658618|venous stasis|venous stasis
446706|NCT01658618|compression|compression
446707|NCT01658618|venous|venous
446708|NCT01658618|venous stasis ulcer|venous stasis ulcer
446710|NCT01658618|hp802-247-09-029|hp802-247-09-029
446711|NCT01658605|GSK1605786|gsk1605786
446712|NCT01658605|ulcerative colitis|ulcerative colitis
446713|NCT01658605|CCR9 antagonist|ccr9 antagonist
446714|NCT01658605|proof of concept|proof of concept
446715|NCT01658592|Alcohol Addiction;|alcohol addiction;
446716|NCT01658592|Deep Brain Stimulation;|deep brain stimulation;
446717|NCT01658592|Nucleus Accumbens;|nucleus accumbens;
446718|NCT01658592|Ventral Anterior Internal capsule;|ventral anterior internal capsule;
446719|NCT01658553|solid tumors|solid tumors
446720|NCT01658540|Drug Eluting Balloon (DEB) technology|drug eluting balloon (deb) technology
446721|NCT01658540|long SFA lesions disease|long sfa lesions disease
446722|NCT01658527|metastatic|metastatic
446723|NCT01658527|prostate cancer|prostate cancer
446724|NCT01658488|Iron deficiency anemia|iron deficiency anemia
446725|NCT01658488|rice|rice
446726|NCT01658475|IgG titer|igg titer
446727|NCT01658475|periodontopathic bacteria|periodontopathic bacteria
446728|NCT01658462|locally recurrent or metastatic breast cancer|locally recurrent or metastatic breast cancer
446729|NCT01658462|Docetaxel|docetaxel
446730|NCT01658462|Nintedanib|nintedanib
446731|NCT01658436|advanced pancreatic neuroendocrine tumor|advanced pancreatic neuroendocrine tumor
446732|NCT01658436|BEZ235|bez235
446733|NCT01658436|pNET|pnet
446734|NCT01658423|pubic hair|pubic hair
446735|NCT01658423|sprint velocity|sprint velocity
446736|NCT01658423|vertical jump height|vertical jump height
446737|NCT01658423|body composition|body composition
446738|NCT01658423|maximal voluntary torque|maximal voluntary torque
446739|NCT01658410|Coronary artery disease|coronary artery disease
446740|NCT01658410|bypass grafting|bypass grafting
446741|NCT01658397|Healthy subjects|healthy subjects
446742|NCT01658397|Fasting|fasting
446743|NCT01658397|Weight loss|weight loss
446744|NCT01658371|HIV|hiv
446745|NCT01658358|ErbB receptor|erbb receptor
446746|NCT01658358|tyrosine kinase inhibitor|tyrosine kinase inhibitor
446747|NCT01658358|Anthracycline|anthracycline
446748|NCT01658345|aortic stenosis|aortic stenosis
446749|NCT01658345|asymptomatic|asymptomatic
446750|NCT01658345|microvascular dysfunction|microvascular dysfunction
446751|NCT01658345|Cardiac MRI|cardiac mri
446752|NCT01658332|lung cancer|lung cancer
446753|NCT01658332|circulating tumor cells|circulating tumor cells
446754|NCT01658332|prospective|prospective
446755|NCT01658332|monocentrique trial|monocentrique trial
446756|NCT01658306|remote ischemic preconditioning|remote ischemic preconditioning
446757|NCT01658306|random-controlled|random-controlled
446758|NCT01658306|double blind|double blind
446759|NCT01658306|RIPC|ripc
446760|NCT01658293|stroke|stroke
446761|NCT01658293|follow up|follow up
446762|NCT01658293|upper limb|upper limb
446763|NCT01658293|rehabilitation|rehabilitation
446764|NCT01658280|transbronchial needle aspiration|transbronchial needle aspiration
446765|NCT01658280|ultrasound guided transbronchial needle aspiration|ultrasound guided transbronchial needle aspiration
446766|NCT01658280|sensitivity|sensitivity
446767|NCT01658280|hilar/mediastinal adenopathy|hilar/mediastinal adenopathy
446768|NCT01658254|Clinical trials|clinical trials
446769|NCT01658254|Basic results|basic results
446770|NCT01658254|Registry|registry
446771|NCT01658228|Depression|depression
446772|NCT01658228|Dysthymia|dysthymia
446773|NCT01658228|Cognitive Impairment|cognitive impairment
446774|NCT01658228|Cognitive Decline|cognitive decline
446775|NCT01658228|Memory|memory
446776|NCT01658215|Smoking cessation|smoking cessation
446777|NCT01658215|Nicotine|nicotine
446778|NCT01658215|Tobacco Use Disorder|tobacco use disorder
446779|NCT01658215|Central Nervous System Agents|central nervous system agents
446780|NCT01658202|Smoking cessation|smoking cessation
446781|NCT01658202|Nicotine|nicotine
446782|NCT01658202|Tobacco Use Disorder|tobacco use disorder
446783|NCT01658202|Central Nervous System Agents|central nervous system agents
446784|NCT01658176|Estrogen receptor positive|estrogen receptor positive
446785|NCT01658176|Her-2 negative|her-2 negative
446786|NCT01658176|advanced breast cancer|advanced breast cancer
446787|NCT01658176|Breast Cancer|breast cancer
446788|NCT01658163|abdominoplasty,|abdominoplasty,
446789|NCT01658163|skin closure, dressings|skin closure, dressings
446790|NCT01658150|Cognition|cognition
446791|NCT01658150|Schizophrenia|schizophrenia
446792|NCT01658150|Schizoaffective disorder|schizoaffective disorder
446793|NCT01658137|diet|diet
446794|NCT01658137|dietary pattern|dietary pattern
446795|NCT01658137|gene|gene
446796|NCT01658137|gene expression|gene expression
446797|NCT01658137|epigenomics|epigenomics
446798|NCT01658137|diet-gene interaction|diet-gene interaction
446799|NCT01658137|inflammation|inflammation
446800|NCT01658137|9p21|9p21
446801|NCT01658137|fruits|fruits
446802|NCT01658137|vegetables|vegetables
446803|NCT01658124|haemorrhage,antifibrinolytic, clinical trial,|haemorrhage,antifibrinolytic, clinical trial,
446804|NCT01658111|Stroke|stroke
446805|NCT01658111|Robots|robots
446806|NCT01658111|EEG|eeg
446807|NCT01658111|EMG|emg
446808|NCT01658098|postpartum|postpartum
446809|NCT01658098|depression|depression
446810|NCT01658098|edinburgh postpartum depression scale|edinburgh postpartum depression scale
446811|NCT01658098|mexican population|mexican population
446812|NCT01658085|Thyroidectomy|thyroidectomy
446813|NCT01658085|Multinodular goiter|multinodular goiter
446814|NCT01658085|Harmonic Focus|harmonic focus
446815|NCT01658085|budget impact|budget impact
446816|NCT01658085|Harmonic scalpel|harmonic scalpel
446817|NCT01658072|Total Hip Arthroplasty|total hip arthroplasty
446818|NCT01658072|Total Hip Replacement|total hip replacement
446819|NCT01658046|COPD|copd
446820|NCT01658046|exercise|exercise
446821|NCT01658046|neuromuscular electrical stimulation|neuromuscular electrical stimulation
446822|NCT01658033|Metastatic Breast Cancer, Her-2 negative Breast Cancer|metastatic breast cancer, her-2 negative breast cancer
446823|NCT01658033|Avastin, FOLFOX regimen|avastin, folfox regimen
446824|NCT01658020|Acute exacerbation of Chronic obstructive pulmonary disease|acute exacerbation of chronic obstructive pulmonary disease
446825|NCT01658020|Acute Exacerbation|acute exacerbation
446826|NCT01658020|Chronic obstructive pulmonary disease(COPD)|chronic obstructive pulmonary disease(copd)
446827|NCT01658020|Zabofloxacin|zabofloxacin
446828|NCT01658020|Moxifloxacin|moxifloxacin
446829|NCT01657994|cerebral palsy|cerebral palsy
446830|NCT01657994|gait training|gait training
446831|NCT01657994|robotic|robotic
446832|NCT01657994|functional electrical stimulation|functional electrical stimulation
446833|NCT01657981|Pharmacokinetics|pharmacokinetics
446834|NCT01657981|Phase 1|phase 1
446835|NCT01657981|14C-labeled|14c-labeled
446836|NCT01657968|Acute tonsillitis|acute tonsillitis
446837|NCT01657968|Procalcitonin|procalcitonin
446838|NCT01657968|Streptococcal antigen test|streptococcal antigen test
446839|NCT01657968|Centor Criteria|centor criteria
446840|NCT01657968|Infection marker|infection marker
446841|NCT01657942|MRgFUS|mrgfus
446842|NCT01657942|Prostate|prostate
446843|NCT01657942|Intermediate Risk Prostate Lesions|intermediate risk prostate lesions
446844|NCT01657942|Focal Prostate treatment|focal prostate treatment
446845|NCT01657942|InSightec|insightec
446846|NCT01657942|ExAblate|exablate
446847|NCT01657942|Non-invasive|non-invasive
446848|NCT01657942|Prostate cancer|prostate cancer
446849|NCT01657942|Gleason 7|gleason 7
446850|NCT01657929|Influenza|influenza
446851|NCT01657929|Avian|avian
446852|NCT01657929|H5N1|h5n1
446853|NCT01657929|H5-VLP|h5-vlp
446854|NCT01657929|GLA|gla
446855|NCT01657929|GLA-AF|gla-af
446856|NCT01657916|mid-urethral sling|mid-urethral sling
446857|NCT01657916|Align urethral support system|align urethral support system
446858|NCT01657916|tension free vaginal tape|tension free vaginal tape
446859|NCT01657916|cough stress test|cough stress test
446860|NCT01657916|pelvic exam|pelvic exam
446861|NCT01657916|PFDI-20|pfdi-20
446862|NCT01657916|PFIQ|pfiq
446863|NCT01657916|SSQ|ssq
446864|NCT01657916|Urinary retention|urinary retention
446865|NCT01657916|mesh erosion|mesh erosion
446866|NCT01657916|urodynamics|urodynamics
446867|NCT01657890|isavuconazole|isavuconazole
446868|NCT01657890|BAL8557|bal8557
446869|NCT01657864|Aseptic Meningitis|aseptic meningitis
446870|NCT01657864|Epidemiology|epidemiology
446871|NCT01657864|Bipolar Disorder|bipolar disorder
446872|NCT01657864|Lamotrigine|lamotrigine
446873|NCT01657864|Epilepsy|epilepsy
446874|NCT01657838|Isavuconazole|isavuconazole
446875|NCT01657838|Ketoconazole|ketoconazole
446876|NCT01657838|Healthy Volunteers|healthy volunteers
446877|NCT01657838|BAL8557|bal8557
446878|NCT01657838|BAL4815|bal4815
446879|NCT01657825|isavuconazole|isavuconazole
446880|NCT01657825|warfarin|warfarin
446881|NCT01657825|Healthy Volunteers|healthy volunteers
446882|NCT01657825|BAL8557|bal8557
446883|NCT01657825|Coumadin|coumadin
446884|NCT01657812|dexmedetomidine|dexmedetomidine
446885|NCT01657812|Epidural Anesthesia|epidural anesthesia
446886|NCT01657812|stress response|stress response
446887|NCT01657812|anesthesia recovery|anesthesia recovery
446888|NCT01657786|ondanstron|ondanstron
446889|NCT01657786|gene polymorphism|gene polymorphism
446890|NCT01657786|postoperative nausea and vomiting|postoperative nausea and vomiting
710624|NCT00588562|Hyperoxaluria|hyperoxaluria
446891|NCT01657786|laparoscopic surgery under general anesthesia|laparoscopic surgery under general anesthesia
446892|NCT01657760|craving|craving
446893|NCT01657760|dopamine|dopamine
446894|NCT01657760|citalopram|citalopram
446895|NCT01657760|ssri|ssri
446896|NCT01657747|Ovarian carcinoma|ovarian carcinoma
446897|NCT01657747|Staging|staging
446898|NCT01657747|Early treatment follow-up|early treatment follow-up
446899|NCT01657747|Identifying tumor recurrence|identifying tumor recurrence
446900|NCT01657747|Whole body diffusion-weighted MRI|whole body diffusion-weighted mri
446901|NCT01657734|therapy-induced inflammatory response with|therapy-induced inflammatory response with
446902|NCT01657734|magnetic resonance imaging|magnetic resonance imaging
446903|NCT01657695|HCC|hcc
446904|NCT01657695|Computed tomography|computed tomography
446905|NCT01657695|Gene expression|gene expression
446906|NCT01657695|Fractional growth|fractional growth
446907|NCT01657682|FLT3|flt3
446908|NCT01657682|Crenolanib|crenolanib
446909|NCT01657682|Acute|acute
446910|NCT01657682|Myeloid|myeloid
446911|NCT01657682|AML|aml
446912|NCT01657669|Choroidal neovascularization due to AMD|choroidal neovascularization due to amd
446913|NCT01657643|Health related quality of life|health related quality of life
446914|NCT01657643|Functional Status|functional status
446915|NCT01657630|Insulin Pump Therapy|insulin pump therapy
446916|NCT01657630|Type 1 Diabetes|type 1 diabetes
446917|NCT01657630|Treatment Satisfaction|treatment satisfaction
446918|NCT01657604|CML|cml
446919|NCT01657604|Tasigna|tasigna
446920|NCT01657604|Nilotinib|nilotinib
446921|NCT01657604|Interferon|interferon
446922|NCT01657591|skin cancer|skin cancer
446923|NCT01657591|unresectable|unresectable
446924|NCT01657591|BRAF|braf
446925|NCT01657578|neonates|neonates
446926|NCT01657578|reflux disease|reflux disease
446927|NCT01657578|population pharmacokinetics, omeprazole|population pharmacokinetics, omeprazole
446928|NCT01657565|LOS|los
446929|NCT01657565|Ileus|ileus
446930|NCT01657565|Fever|fever
446931|NCT01657565|reoperation|reoperation
446932|NCT01657552|Drug interaction|drug interaction
446933|NCT01657552|INCIVEK (telaprevir),|incivek (telaprevir),
446934|NCT01657552|SB-497115 (eltrombopag)|sb-497115 (eltrombopag)
446935|NCT01657552|Pharmacokinetics|pharmacokinetics
446936|NCT01657552|Thrombocytopenia|thrombocytopenia
446937|NCT01657552|VICTRELIS (boceprevir)|victrelis (boceprevir)
446938|NCT01657526|Healthy adults|healthy adults
446939|NCT01657526|Safety|safety
446940|NCT01657526|Reactogenicity|reactogenicity
446941|NCT01657526|Immunogenicity|immunogenicity
446942|NCT01657526|Non-typeable H. Influenzae (NTHi)|non-typeable h. influenzae (nthi)
446943|NCT01657513|psoriasis|psoriasis
446944|NCT01657513|treatment failure|treatment failure
446945|NCT01657513|tnf-alfa|tnf-alfa
446946|NCT01657500|endothelial keratoplasty|endothelial keratoplasty
446947|NCT01657487|COPD|copd
446948|NCT01657487|Fluticasone/Salmeterol|fluticasone/salmeterol
446949|NCT01657487|high dose|high dose
446950|NCT01657448|Symptom of Dysuria|symptom of dysuria
446951|NCT01657435|Total hip replacement|total hip replacement
446952|NCT01657435|Total hip arthroplasty|total hip arthroplasty
446953|NCT01657435|Hip joint replacement|hip joint replacement
446954|NCT01657435|Hip prosthesis replacement|hip prosthesis replacement
446955|NCT01657422|Nutrition|nutrition
446956|NCT01657422|Physical Activity|physical activity
446957|NCT01657422|Adolescents|adolescents
446958|NCT01657409|botulinum toxin|botulinum toxin
446959|NCT01657409|detrusor overactivity|detrusor overactivity
446960|NCT01657396|Oral Care|oral care
446961|NCT01657396|Oral Hygiene|oral hygiene
446962|NCT01657396|Intensive Care|intensive care
446963|NCT01657396|Mechanical Ventilation|mechanical ventilation
446964|NCT01657396|Chlorhexidine|chlorhexidine
446965|NCT01657331|Hodgkin Lymphoma|hodgkin lymphoma
446966|NCT01657331|Hodgkin Disease|hodgkin disease
446967|NCT01657331|Hodgkin's Disease|hodgkin's disease
446968|NCT01657331|Anaplastic Large Cell Lymphoma|anaplastic large cell lymphoma
446969|NCT01657331|ALCL|alcl
446970|NCT01657331|SGN+Benda|sgn+benda
446971|NCT01657331|Bendamustine|bendamustine
446972|NCT01657331|Brentuximab Vedotin|brentuximab vedotin
446973|NCT01657318|diabetic foot|diabetic foot
446974|NCT01657318|leg ulcer|leg ulcer
446975|NCT01657305|Split-Thickness Skin Graft (STSG) donor site|split-thickness skin graft (stsg) donor site
446976|NCT01657305|Split-thickness skin graft|split-thickness skin graft
446977|NCT01657305|STSG|stsg
446978|NCT01657305|Wound healing|wound healing
446979|NCT01657305|Skin grafting|skin grafting
446980|NCT01657305|Superficial wound|superficial wound
446981|NCT01657305|Partial-thickness wound|partial-thickness wound
446982|NCT01657305|Time to wound closure|time to wound closure
446983|NCT01657292|Wound healing|wound healing
446984|NCT01657292|Burn wound|burn wound
446985|NCT01657292|Superficial partial-thickness burn wound|superficial partial-thickness burn wound
446986|NCT01657292|Grade 2a burn wounds|grade 2a burn wounds
446987|NCT01657292|Time to wound closure|time to wound closure
446988|NCT01657279|stroke|stroke
446989|NCT01657279|risk score|risk score
446990|NCT01657279|iScore|iscore
446991|NCT01657279|outcomes|outcomes
446992|NCT01657279|mortality|mortality
446993|NCT01657279|disability|disability
446994|NCT01657279|institutionalization|institutionalization
446995|NCT01657266|bromfenac|bromfenac
446996|NCT01657266|nepafenac|nepafenac
446997|NCT01657266|cataract|cataract
446998|NCT01657266|phacoemulsification cataract surgery|phacoemulsification cataract surgery
446999|NCT01657227|diabetes|diabetes
447000|NCT01657227|self-management|self-management
447001|NCT01657227|lifestyle|lifestyle
447002|NCT01657227|diet|diet
447003|NCT01657227|physical exercise|physical exercise
447004|NCT01657227|computer-assisted decision support systems|computer-assisted decision support systems
447005|NCT01657188|Heart failure, congestive|heart failure, congestive
447006|NCT01657188|Sleep apnea syndromes|sleep apnea syndromes
447007|NCT01657188|Adaptive servoventilation|adaptive servoventilation
447008|NCT01657188|Prognosis|prognosis
447009|NCT01657188|Cheyne-Stokes respiration|cheyne-stokes respiration
447010|NCT01657175|Cancer|cancer
447011|NCT01657175|long-term follow-up|long-term follow-up
447012|NCT01657175|quality of life|quality of life
447013|NCT01657175|Surgery|surgery
447014|NCT01657175|Nursing|nursing
447015|NCT01657162|BA058|ba058
447016|NCT01657162|Abaloparatide-SC|abaloparatide-sc
447017|NCT01657162|abaloparatide|abaloparatide
447018|NCT01657162|ACTIVExtend|activextend
447019|NCT01657162|osteoporosis|osteoporosis
447020|NCT01657162|fracture|fracture
447021|NCT01657162|bone loss|bone loss
447022|NCT01657136|Inappropriate sinus tachycardia|inappropriate sinus tachycardia
447023|NCT01657136|ivabradine|ivabradine
447024|NCT01657136|beta blockers|beta blockers
447025|NCT01657123|exercise capacity|exercise capacity
447026|NCT01657123|Addison's disease|addison's disease
447027|NCT01657110|acne|acne
447028|NCT01657110|inflamed lesions|inflamed lesions
447029|NCT01657110|non-inflamed lesions|non-inflamed lesions
447030|NCT01657110|complementary medicine|complementary medicine
447031|NCT01657110|essential oil|essential oil
447032|NCT01657058|soluble fiber|soluble fiber
447033|NCT01657058|second meal effect|second meal effect
447034|NCT01657058|glycemia|glycemia
447035|NCT01657058|satiety|satiety
447036|NCT01657058|Individuals|individuals
447037|NCT01657045|Cicatrix|cicatrix
447038|NCT01657045|Wound healing|wound healing
447039|NCT01657032|diarrhea|diarrhea
447040|NCT01657032|probiotics|probiotics
447041|NCT01657032|diosmectite|diosmectite
447042|NCT01657006|Heart rate variability|heart rate variability
447043|NCT01657006|ischemic heart disease|ischemic heart disease
447044|NCT01657006|myocardial ischemia|myocardial ischemia
447045|NCT01656993|Aspirin|aspirin
447046|NCT01656993|ASA|asa
447047|NCT01656993|aortopulmonary shunt|aortopulmonary shunt
447048|NCT01656993|cavopulmonary shunt|cavopulmonary shunt
447049|NCT01656993|shunt|shunt
447050|NCT01656993|TEG|teg
447051|NCT01656993|Antiplatelet|antiplatelet
447052|NCT01656967|Laryngeal Mask Airway|laryngeal mask airway
447053|NCT01656967|LMA|lma
447054|NCT01656967|Intubation|intubation
447055|NCT01656967|AMBU|ambu
447056|NCT01656967|AScope|ascope
447057|NCT01656967|Aura-I|aura-i
447058|NCT01656967|Fastrach|fastrach
447059|NCT01656967|Fiberoptic|fiberoptic
447060|NCT01656967|Disposable Fiberoptic|disposable fiberoptic
447061|NCT01656967|Blind Intubation|blind intubation
447062|NCT01656967|Fiberoptic Intubation|fiberoptic intubation
447063|NCT01656954|stroke volume|stroke volume
447064|NCT01656954|cardiac output|cardiac output
447065|NCT01656954|pulse pressure variance|pulse pressure variance
447066|NCT01656954|stroke volume variance|stroke volume variance
447067|NCT01656954|passive leg raise|passive leg raise
447068|NCT01656954|fluid challenge|fluid challenge
447069|NCT01656954|central venous pressure|central venous pressure
447070|NCT01656941|neonate|neonate
447071|NCT01656941|congenital heart disease|congenital heart disease
447072|NCT01656941|single ventricle cardiac disease|single ventricle cardiac disease
447073|NCT01656941|hypoplastic left heart syndrome|hypoplastic left heart syndrome
447074|NCT01656941|hypoplastic right heart syndrome|hypoplastic right heart syndrome
447075|NCT01656941|d-Transposition of the Great Arteries|d-transposition of the great arteries
447076|NCT01656915|inflammation|inflammation
447077|NCT01656915|response|response
447078|NCT01656915|resilience|resilience
447079|NCT01656915|cytokines|cytokines
447080|NCT01656915|pre-diabetes|pre-diabetes
447081|NCT01656902|Autologous Chondrocyte Transplantation|autologous chondrocyte transplantation
447082|NCT01656902|NOVOCART 3D plus|novocart 3d plus
447083|NCT01656902|knee joint pain|knee joint pain
447084|NCT01656902|safety|safety
447085|NCT01656902|efficacy|efficacy
447086|NCT01656902|treatment|treatment
447087|NCT01656902|TETEC|tetec
447088|NCT01656902|cartilage|cartilage
447089|NCT01656902|ACT|act
447090|NCT01656902|cartilage repair|cartilage repair
447091|NCT01656902|tissue|tissue
447092|NCT01656902|MOCART|mocart
447093|NCT01656889|Venous leg ulcer|venous leg ulcer
570805|NCT01134575|ALL|all
447094|NCT01656889|ulcer|ulcer
447095|NCT01656889|venous stasis|venous stasis
447096|NCT01656889|compression|compression
447097|NCT01656889|venous|venous
447098|NCT01656889|venous stasis ulcer|venous stasis ulcer
447099|NCT01656889|vlu|vlu
447100|NCT01656876|Comparative effectiveness research|comparative effectiveness research
447101|NCT01656876|Mirror therapy|mirror therapy
447102|NCT01656876|Stroke rehabilitation|stroke rehabilitation
447103|NCT01656876|Clinical evaluation|clinical evaluation
447104|NCT01656876|Kinematic analysis|kinematic analysis
447105|NCT01656876|Mesh glove|mesh glove
447106|NCT01656876|Combined therapy|combined therapy
447107|NCT01656863|Dehydration|dehydration
447108|NCT01656850|hyperglycemia|hyperglycemia
447109|NCT01656850|hyperinsulinemia|hyperinsulinemia
447110|NCT01656837|Substance Abuse|substance abuse
447111|NCT01656837|Child Maltreatment|child maltreatment
447112|NCT01656837|Multisystemic Therapy|multisystemic therapy
447113|NCT01656837|Child Trauma|child trauma
447114|NCT01656824|Bv8/PK-2|bv8/pk-2
447115|NCT01656824|MDSC Myeloid Derived Suppressor Cells|mdsc myeloid derived suppressor cells
447116|NCT01656824|BMDC Bone Marrow Derived Cells|bmdc bone marrow derived cells
447117|NCT01656824|Angiogenesis|angiogenesis
447118|NCT01656824|Pancreatic Cancer|pancreatic cancer
447119|NCT01656785|stroke|stroke
447120|NCT01656785|cerebrovascular disease|cerebrovascular disease
447121|NCT01656785|angiogenesis imaging|angiogenesis imaging
447122|NCT01656785|68Ga-BNOTA-PRGD2|68ga-bnota-prgd2
447123|NCT01656785|PET/CT|pet/ct
447124|NCT01656772|magnetic navigation|magnetic navigation
447125|NCT01656772|robotic control|robotic control
447126|NCT01656772|RMT ThermoCool catheter|rmt thermocool catheter
447127|NCT01656759|Blood Loss|blood loss
447128|NCT01656759|Hemoglobin|hemoglobin
447129|NCT01656759|Hematocrit|hematocrit
447130|NCT01656759|Blood Transfusions|blood transfusions
447131|NCT01656746|Colorectal Disease|colorectal disease
447133|NCT01656746|colorectal surgery|colorectal surgery
447134|NCT01656733|Smoking Cessation|smoking cessation
447135|NCT01656733|Pregnancy|pregnancy
447136|NCT01656733|Nicotrol Inhaler|nicotrol inhaler
447137|NCT01656733|Placebo Inhaler|placebo inhaler
447138|NCT01656733|Nicotine Inhaler|nicotine inhaler
447139|NCT01656720|Faecal Incontinence|faecal incontinence
447140|NCT01656720|Suppository|suppository
447141|NCT01656720|Wexner score|wexner score
447142|NCT01656707|Adolescents|adolescents
447143|NCT01656707|Substance Use Disorders|substance use disorders
447144|NCT01656694|Osteoarthritis|osteoarthritis
447145|NCT01656694|Knee|knee
447146|NCT01656694|Replacement|replacement
447147|NCT01656694|Unicompartmental|unicompartmental
447148|NCT01656694|DePuy|depuy
447149|NCT01656694|Sigma HP|sigma hp
447150|NCT01656668|Chronic|chronic
447151|NCT01656668|Acute|acute
447152|NCT01656668|Persistent|persistent
447153|NCT01656668|Longterm|longterm
447154|NCT01656668|Cough|cough
447155|NCT01656655|ptsd, parenting|ptsd, parenting
447156|NCT01656642|PD-L1|pd-l1
447157|NCT01656642|PD-1|pd-1
447158|NCT01656642|PDL1|pdl1
447159|NCT01656642|antiPD-L1|antipd-l1
447160|NCT01656642|MPDL3280A|mpdl3280a
447161|NCT01656642|Melanoma|melanoma
447162|NCT01656642|BRAF|braf
447163|NCT01656642|MPDL320A|mpdl320a
447164|NCT01656616|Pharmacoeconomics|pharmacoeconomics
447165|NCT01656616|Cost effectiveness|cost effectiveness
447166|NCT01656616|Cyanide|cyanide
447167|NCT01656616|Fire|fire
447168|NCT01656616|Emergency Medical Services|emergency medical services
447169|NCT01656616|Smoke Inhalation|smoke inhalation
447170|NCT01656603|cord blood|cord blood
447171|NCT01656603|transplantation|transplantation
447172|NCT01656603|stem cells|stem cells
447173|NCT01656603|adverse event|adverse event
447174|NCT01656590|Pompe disease|pompe disease
447175|NCT01656590|Acid Maltase Deficiency|acid maltase deficiency
447176|NCT01656577|CRF1 antagonist|crf1 antagonist
447177|NCT01656577|Stress|stress
447178|NCT01656577|Eating Behavior|eating behavior
447179|NCT01656577|Food Craving|food craving
447180|NCT01656564|HIV|hiv
447181|NCT01656564|Childhood|childhood
447182|NCT01656564|Antiviral Therapy|antiviral therapy
447183|NCT01656564|Cardiac|cardiac
447184|NCT01656564|Natural History|natural history
447185|NCT01656551|elderly|elderly
447186|NCT01656551|chemotherapy|chemotherapy
447187|NCT01656512|ALL|all
447188|NCT01656512|zoledronic acid|zoledronic acid
447189|NCT01656512|Osteoporosis|osteoporosis
447190|NCT01656486|Pancreas|pancreas
447191|NCT01656486|Pancreatic fistula|pancreatic fistula
447192|NCT01656486|Stereotactic radiation|stereotactic radiation
447193|NCT01656473|Concurrent Disorders|concurrent disorders
447194|NCT01656473|Adolescents|adolescents
447195|NCT01656473|Motivational Interviewing|motivational interviewing
447196|NCT01656473|Dialectical Behaviour Therapy|dialectical behaviour therapy
447197|NCT01656473|Caregiver Burden|caregiver burden
447198|NCT01656460|Lung Cancer|lung cancer
447199|NCT01656447|Scleroderma|scleroderma
447200|NCT01656447|Scleroderma Registry|scleroderma registry
447201|NCT01656447|Hospital for Special Surgery Scleroderma|hospital for special surgery scleroderma
447202|NCT01656434|Combined Oral Contraceptives|combined oral contraceptives
447203|NCT01656382|ABLC|ablc
447204|NCT01656382|cryptococcosis|cryptococcosis
447205|NCT01656369|Delorme operation,incontinence|delorme operation,incontinence
447206|NCT01656356|Avian Flu|avian flu
447207|NCT01656356|H5N2|h5n2
447208|NCT01656330|Healthy|healthy
447209|NCT01656330|Rivaroxaban|rivaroxaban
447210|NCT01656330|JNJ-39039039|jnj-39039039
447211|NCT01656330|BAY59-7939|bay59-7939
447212|NCT01656330|Prothrombin Complex Concentrate (PCC)|prothrombin complex concentrate (pcc)
447213|NCT01656317|SAH|sah
447214|NCT01656317|Early rehabilitation|early rehabilitation
447215|NCT01656317|Mobilisation|mobilisation
447216|NCT01656278|Arthritis, Rheumatoid/drug therapy|arthritis, rheumatoid/drug therapy
447217|NCT01656278|Arthritis, Rheumatoid/pathology|arthritis, rheumatoid/pathology
447218|NCT01656278|Disease Progression|disease progression
447219|NCT01656278|Longitudinal Studies|longitudinal studies
447220|NCT01656278|Prospective Studies|prospective studies
447221|NCT01656278|Imaging, Magnetic Resonance|imaging, magnetic resonance
447222|NCT01656278|Remission Induction|remission induction
447223|NCT01656278|Synovitis/immunology|synovitis/immunology
447224|NCT01656278|Synovitis/pathology|synovitis/pathology
447225|NCT01656278|Wrist Joint/pathology|wrist joint/pathology
447226|NCT01656278|Wrist Joint/physiopathology|wrist joint/physiopathology
447227|NCT01656252|Acute Leukemia|acute leukemia
447228|NCT01656252|Complete Remission|complete remission
447229|NCT01656252|Consolidation|consolidation
447230|NCT01656252|Consolidation Chemotherapy|consolidation chemotherapy
447231|NCT01656252|Cytarabine|cytarabine
447232|NCT01656252|Eltrombopag|eltrombopag
447233|NCT01656252|Leukemia|leukemia
447234|NCT01656252|Thrombocytopenia|thrombocytopenia
447235|NCT01656252|Thrombopoietin|thrombopoietin
447236|NCT01656239|VA106483, fedovapagon, Nocturia, males, nocturnal voids, anti-diuretic|va106483, fedovapagon, nocturia, males, nocturnal voids, anti-diuretic
447237|NCT01656226|Actinic Keratosis|actinic keratosis
447238|NCT01656226|AK|ak
447239|NCT01656213|Stroke|stroke
447240|NCT01656213|End Stage Renal Disease|end stage renal disease
447241|NCT01656213|Recovery|recovery
447242|NCT01656213|Haemodialysis|haemodialysis
447243|NCT01656200|Japanese encephalitis|japanese encephalitis
447244|NCT01656200|Japanese encephalitis vaccine|japanese encephalitis vaccine
447245|NCT01656200|T lymphocyte|t lymphocyte
447246|NCT01656200|Immune response|immune response
447247|NCT01656187|memantine|memantine
447248|NCT01656187|cognition|cognition
447249|NCT01656187|corticosteroid|corticosteroid
447250|NCT01656187|prednisone|prednisone
447251|NCT01656187|memory|memory
447252|NCT01656187|hippocampus|hippocampus
447253|NCT01656148|Multiple sclerosis|multiple sclerosis
447254|NCT01656148|Walking disablility|walking disablility
447255|NCT01656148|Mobility|mobility
447256|NCT01656148|Six Spot Step Test|six spot step test
447257|NCT01656148|Outcome measures|outcome measures
447258|NCT01656148|Fampridine-SR|fampridine-sr
447259|NCT01656148|Fampyra|fampyra
447260|NCT01656135|gold standard treatment|gold standard treatment
447261|NCT01656135|immune monitoring|immune monitoring
447262|NCT01656135|acute rejection|acute rejection
447263|NCT01656135|graft rejection|graft rejection
447264|NCT01656135|living-donor|living-donor
447265|NCT01656135|renal transplantation|renal transplantation
447266|NCT01656135|kidney transplantation|kidney transplantation
447267|NCT01656122|pharmacokinetic paramters|pharmacokinetic paramters
447268|NCT01656122|abacavir|abacavir
447269|NCT01656122|lamuvidine|lamuvidine
447270|NCT01656122|HIV-infected children|hiv-infected children
447271|NCT01656109|pharmacokinetics|pharmacokinetics
447272|NCT01656109|atazanavir/ritonavir|atazanavir/ritonavir
447273|NCT01656109|HIV-infected children|hiv-infected children
447274|NCT01656083|Mobile phone text messaging (SM)|mobile phone text messaging (sm)
447275|NCT01656083|Varenicline|varenicline
447276|NCT01656083|The compliance|the compliance
447277|NCT01656083|The abstinence rate|the abstinence rate
447278|NCT01656070|HIV|hiv
447279|NCT01656070|children|children
447280|NCT01656070|adolescents|adolescents
447281|NCT01656070|Vitamin D|vitamin d
447282|NCT01656070|immunity|immunity
447283|NCT01656070|T cell phenotype|t cell phenotype
447284|NCT01656057|Bile acids|bile acids
447285|NCT01656057|Gall bladder emptying|gall bladder emptying
447286|NCT01656057|Human|human
447287|NCT01656057|Glucagon like peptide 1|glucagon like peptide 1
447288|NCT01656057|GLP-1|glp-1
447289|NCT01656031|recurrent adult acute lymphoblastic leukemia|recurrent adult acute lymphoblastic leukemia
447290|NCT01656031|recurrent adult acute myeloid leukemia|recurrent adult acute myeloid leukemia
447291|NCT01656031|adult acute myeloid leukemia with 11q23 (MLL) abnormalities|adult acute myeloid leukemia with 11q23 (mll) abnormalities
447292|NCT01656031|adult acute myeloid leukemia with inv(16)(p13;q22)|adult acute myeloid leukemia with inv(16)(p13;q22)
447293|NCT01656031|adult acute myeloid leukemia with t(16;16)(p13;q22)|adult acute myeloid leukemia with t(16;16)(p13;q22)
447294|NCT01656031|adult acute myeloid leukemia with t(8;21)(q22;q22)|adult acute myeloid leukemia with t(8;21)(q22;q22)
447295|NCT01656031|adult acute basophilic leukemia|adult acute basophilic leukemia
447296|NCT01656031|adult acute eosinophilic leukemia|adult acute eosinophilic leukemia
447297|NCT01656031|adult erythroleukemia (M6a)|adult erythroleukemia (m6a)
447298|NCT01656031|adult pure erythroid leukemia (M6b)|adult pure erythroid leukemia (m6b)
447299|NCT01656031|adult acute megakaryoblastic leukemia (M7)|adult acute megakaryoblastic leukemia (m7)
447423|NCT01655498|bowel control|bowel control
447300|NCT01656031|adult acute minimally differentiated myeloid leukemia (M0)|adult acute minimally differentiated myeloid leukemia (m0)
447301|NCT01656031|adult acute monoblastic leukemia (M5a)|adult acute monoblastic leukemia (m5a)
447302|NCT01656031|adult acute monocytic leukemia (M5b)|adult acute monocytic leukemia (m5b)
447303|NCT01656031|adult acute myeloblastic leukemia with maturation (M2)|adult acute myeloblastic leukemia with maturation (m2)
447304|NCT01656031|adult acute myeloblastic leukemia without maturation (M1)|adult acute myeloblastic leukemia without maturation (m1)
447305|NCT01656031|adult acute myelomonocytic leukemia (M4)|adult acute myelomonocytic leukemia (m4)
447306|NCT01656018|Healthy|healthy
447307|NCT01656018|TMC278|tmc278
447308|NCT01656018|Human Immunodeficiency Virus Type 1|human immunodeficiency virus type 1
447309|NCT01656018|HIV-1|hiv-1
447310|NCT01656018|Pharmacokinetics|pharmacokinetics
447311|NCT01656018|Ex-vivo pharmacodynamics|ex-vivo pharmacodynamics
447312|NCT01656005|COPD|copd
447313|NCT01656005|Beta blockers|beta blockers
447314|NCT01656005|Cardioselective|cardioselective
447315|NCT01656005|Non-cardioselective|non-cardioselective
447316|NCT01656005|Impulse oscillometry|impulse oscillometry
447317|NCT01655992|capecitabine|capecitabine
447318|NCT01655992|Tegafur，Gimeracil and Oteracil Potassium Capsules|tegafur，gimeracil and oteracil potassium capsules
447319|NCT01655966|chronic hepatitis c|chronic hepatitis c
447320|NCT01655966|hcv|hcv
447321|NCT01655966|vitamin d|vitamin d
447322|NCT01655927|Neoplasms|neoplasms
447323|NCT01655927|Tranexamic Acid|tranexamic acid
447324|NCT01655927|Brain Tumors|brain tumors
447325|NCT01655901|Active video games|active video games
447326|NCT01655901|Food intake|food intake
447327|NCT01655901|Energy balance|energy balance
447328|NCT01655901|Adolescents|adolescents
447329|NCT01655888|Tremelimumab|tremelimumab
447330|NCT01655888|anti-CTLA-4 monoclonal antibody|anti-ctla-4 monoclonal antibody
447331|NCT01655888|malignant mesothelioma|malignant mesothelioma
447332|NCT01655875|Allogeneic Blood and Marrow Transplantation|allogeneic blood and marrow transplantation
447333|NCT01655823|Pain|pain
447334|NCT01655823|Puffer fish|puffer fish
447335|NCT01655823|Tetrodotoxin|tetrodotoxin
447337|NCT01655823|Neuropathy|neuropathy
447338|NCT01655823|Chemotherapy|chemotherapy
447339|NCT01655823|WEX Pharmaceuticals|wex pharmaceuticals
447340|NCT01655797|insomnia|insomnia
447341|NCT01655797|cognitive behavior therapy|cognitive behavior therapy
447342|NCT01655797|primary care|primary care
447343|NCT01655784|aneurysm|aneurysm
447344|NCT01655784|intracranial aneurysm|intracranial aneurysm
447345|NCT01655784|cerebral aneurysm|cerebral aneurysm
447346|NCT01655784|intracranial embolization|intracranial embolization
447347|NCT01655784|aneurysm embolization|aneurysm embolization
447348|NCT01655784|intracranial coil|intracranial coil
447349|NCT01655784|eighteen coils|eighteen coils
447350|NCT01655784|bare platinum coils|bare platinum coils
447351|NCT01655784|GDC Coil|gdc coil
447352|NCT01655784|Target Coil|target coil
447353|NCT01655771|Opioid induced constipation|opioid induced constipation
447354|NCT01655771|Constipation|constipation
447355|NCT01655758|glaucoma|glaucoma
447356|NCT01655758|24-hour IOP|24-hour iop
447357|NCT01655758|outflow drugs|outflow drugs
447358|NCT01655758|inflow drugs|inflow drugs
447359|NCT01655745|[18F]|[18f]
447360|NCT01655745|FDG Positron Emission Tomography-Magnetic Resonance Imaging|fdg positron emission tomography-magnetic resonance imaging
447361|NCT01655745|FDG-PET-MRI|fdg-pet-mri
447362|NCT01655745|Muscle-Invasive Bladder Cancer|muscle-invasive bladder cancer
447363|NCT01655745|Pilot Study|pilot study
447364|NCT01655745|LCCC 1209|lccc 1209
447365|NCT01655745|UNC Lineberger|unc lineberger
447366|NCT01655745|MDCT|mdct
447367|NCT01655732|Pregnancy|pregnancy
447368|NCT01655706|major depression|major depression
447369|NCT01655706|major depressive disorder|major depressive disorder
447370|NCT01655706|biomarkers|biomarkers
447371|NCT01655706|escitalopram|escitalopram
447372|NCT01655706|aripiprazole|aripiprazole
447373|NCT01655706|MDD|mdd
447374|NCT01655706|neuroimaging|neuroimaging
447375|NCT01655706|proteomic|proteomic
447376|NCT01655706|genomics|genomics
447377|NCT01655693|Intermediate/advanced hepatocellular carcinoma|intermediate/advanced hepatocellular carcinoma
447378|NCT01655693|After failure or intolerance to Sorafenib.|after failure or intolerance to sorafenib.
447379|NCT01655680|Schizophrenia|schizophrenia
447380|NCT01655667|Diagnosis|diagnosis
447381|NCT01655667|Primary Care|primary care
447382|NCT01655667|Comorbidities|comorbidities
447383|NCT01655667|Healthcare utilisation|healthcare utilisation
447384|NCT01655654|Hypertension|hypertension
447385|NCT01655654|Acute hospital staff|acute hospital staff
447386|NCT01655654|Exercise|exercise
447387|NCT01655654|Diet|diet
447388|NCT01655641|Blood transfusion|blood transfusion
447389|NCT01655641|Bleeding|bleeding
447390|NCT01655641|Major Gastro-intestinal surgery|major gastro-intestinal surgery
447391|NCT01655641|Tranexamic Acid|tranexamic acid
447392|NCT01655628|nasopharyngeal carcinoma|nasopharyngeal carcinoma
447393|NCT01655628|metastasis|metastasis
447394|NCT01655628|gemcitabine|gemcitabine
447395|NCT01655628|CIK cells|cik cells
447396|NCT01655615|Adolescent cognitive development|adolescent cognitive development
447397|NCT01655615|mental disorders|mental disorders
447398|NCT01655615|Mood disorders|mood disorders
447399|NCT01655615|Alcohol-Related disorders|alcohol-related disorders
447400|NCT01655615|Mental disorders diagnosed in childhood|mental disorders diagnosed in childhood
447401|NCT01655615|Substance related disorders|substance related disorders
447402|NCT01655602|Trichophytic closure|trichophytic closure
447403|NCT01655602|hair transplantation|hair transplantation
447404|NCT01655602|donor site|donor site
447405|NCT01655602|Androgenetic alopecia|androgenetic alopecia
447406|NCT01655576|drainage|drainage
447407|NCT01655576|pregnancy|pregnancy
447408|NCT01655576|active management|active management
447409|NCT01655576|postpartum hemorrhage|postpartum hemorrhage
447410|NCT01655563|Transplant|transplant
447411|NCT01655563|Pediatrics|pediatrics
447412|NCT01655563|Tacrolimus|tacrolimus
447413|NCT01655563|Prograf|prograf
447414|NCT01655537|fibromyalgia|fibromyalgia
447415|NCT01655537|cognitive dysfunction|cognitive dysfunction
447416|NCT01655524|Regadenoson|regadenoson
447417|NCT01655524|Aminophylline|aminophylline
447418|NCT01655524|ASSUAGE|assuage
447419|NCT01655524|Myocardial Perfusion Imaging (MPI)|myocardial perfusion imaging (mpi)
447420|NCT01655511|Pharmacokinetic|pharmacokinetic
447421|NCT01655511|pharmacodynamic|pharmacodynamic
447422|NCT01655498|fecal incontinence|fecal incontinence
447424|NCT01655485|child anxiety|child anxiety
447425|NCT01655485|challenging behaviors|challenging behaviors
447426|NCT01655485|time|time
447427|NCT01655485|Parent anxiety|parent anxiety
447428|NCT01655472|schizophrenia|schizophrenia
447429|NCT01655472|imaging|imaging
447430|NCT01655459|ultrasound, LMA, fiberoptic bronchoscopy|ultrasound, lma, fiberoptic bronchoscopy
447431|NCT01655446|Comparative effectiveness research|comparative effectiveness research
447432|NCT01655446|Robotic rehabilitation|robotic rehabilitation
447433|NCT01655446|Mirror therapy|mirror therapy
447434|NCT01655446|Functional electrical therapy|functional electrical therapy
447435|NCT01655446|Combined therapy|combined therapy
447436|NCT01655446|Stroke rehabilitation|stroke rehabilitation
447437|NCT01655446|Translational science|translational science
447438|NCT01655433|ST-elevation MI|st-elevation mi
447439|NCT01655433|Hypothermia|hypothermia
447440|NCT01655420|Myopia|myopia
447441|NCT01655420|Hyperopia|hyperopia
447442|NCT01655420|Astigmatism|astigmatism
447443|NCT01655420|Patient-reported outcomes|patient-reported outcomes
447444|NCT01655420|Patient satisfaction|patient satisfaction
447445|NCT01655420|Refractive Error|refractive error
447446|NCT01655420|Emmetropia|emmetropia
447447|NCT01655420|Dry eyes|dry eyes
447448|NCT01655420|Glare|glare
447449|NCT01655420|Halos|halos
447450|NCT01655420|Patient expectations|patient expectations
447451|NCT01655407|Split-thickness Autograft|split-thickness autograft
447452|NCT01655407|Engraftment|engraftment
447453|NCT01655407|Wound Closure|wound closure
447454|NCT01655407|Engineered Skin Substitute|engineered skin substitute
447455|NCT01655407|ESS-W|ess-w
447456|NCT01655407|Cultured Skin Substitutes|cultured skin substitutes
447457|NCT01655407|Burn|burn
447458|NCT01655342|pulpotomy|pulpotomy
447459|NCT01655342|primary teeth|primary teeth
447460|NCT01655342|Biodentine®|biodentine®
447461|NCT01655342|formocresol|formocresol
447462|NCT01655329|Image Processing|image processing
447463|NCT01655329|tubes|tubes
447464|NCT01655329|lines|lines
447465|NCT01655329|catheters|catheters
447466|NCT01655329|wires|wires
447467|NCT01655329|Bedside|bedside
447468|NCT01655329|chest|chest
447469|NCT01655329|radiographs|radiographs
447470|NCT01655264|Stroke|stroke
447471|NCT01655264|Tele-health|tele-health
447472|NCT01655264|Rehabilitation|rehabilitation
447473|NCT01655264|Intervention|intervention
447474|NCT01655264|Gesture recognition system|gesture recognition system
447475|NCT01655251|children|children
447476|NCT01655251|fever|fever
447477|NCT01655251|emergency department|emergency department
447478|NCT01655225|Advanced Breast Cancer|advanced breast cancer
447479|NCT01655225|Advanced Lung Cancer|advanced lung cancer
447480|NCT01655225|Mesothelioma|mesothelioma
447481|NCT01655225|Lymphoma|lymphoma
447482|NCT01655212|Cytomegalovirus|cytomegalovirus
447483|NCT01655212|Congenital infection|congenital infection
447484|NCT01655212|Sensorineural hearing loss|sensorineural hearing loss
447485|NCT01655212|Randomized controlled trial|randomized controlled trial
447486|NCT01655212|Valganciclovir|valganciclovir
447487|NCT01655199|Chronic Obstructive Pulmonary Disease|chronic obstructive pulmonary disease
447488|NCT01655199|Lung function|lung function
447489|NCT01655199|Exertional dyspnea|exertional dyspnea
447490|NCT01655199|Exercise capacity|exercise capacity
447491|NCT01655199|Pulmonary function|pulmonary function
447492|NCT01655199|Pleural pressures|pleural pressures
447493|NCT01655186|Chronic Kidney Disease|chronic kidney disease
447494|NCT01655186|Type 2 Diabetes Mellitus|type 2 diabetes mellitus
447495|NCT01655173|Asperger syndrome|asperger syndrome
447496|NCT01655173|Autistic disorder|autistic disorder
447497|NCT01655173|Adult|adult
447498|NCT01655173|Psychotherapy|psychotherapy
447499|NCT01655160|Stroke rehabilitation|stroke rehabilitation
447500|NCT01655160|Mirror therapy|mirror therapy
447501|NCT01655160|Functional performance|functional performance
447502|NCT01655160|Kinematic analysis|kinematic analysis
447503|NCT01655160|Functional magnetic resonance image|functional magnetic resonance image
447504|NCT01655160|Motor recovery|motor recovery
447505|NCT01655147|Healthy|healthy
447506|NCT01655147|Pharmacokinetics|pharmacokinetics
447507|NCT01655147|Abiraterone acetate|abiraterone acetate
447508|NCT01655147|Abiraterone|abiraterone
447509|NCT01655147|JNJ-589485|jnj-589485
447510|NCT01655147|JNJ-212082|jnj-212082
447511|NCT01655147|Zytiga|zytiga
447512|NCT01655147|Rifampicin|rifampicin
447513|NCT01655147|Rifadin|rifadin
447514|NCT01655147|CYP3A4 inducer|cyp3a4 inducer
447515|NCT01655134|Heart Failure|heart failure
447516|NCT01655134|Telemonitoring systems for congestive HF|telemonitoring systems for congestive hf
447517|NCT01655134|Biomarkers|biomarkers
447518|NCT01655108|Androgenetic Alopecia|androgenetic alopecia
447519|NCT01655108|Mesotherapy|mesotherapy
447520|NCT01655108|Minoxidil|minoxidil
447521|NCT01655108|Trichogram|trichogram
447522|NCT01655095|Colon capsule|colon capsule
447523|NCT01655095|Picosalax|picosalax
447524|NCT01655095|PEG|peg
447525|NCT01655095|Prucalopride|prucalopride
447526|NCT01655082|Smoking cessation|smoking cessation
447527|NCT01655082|Nicotine|nicotine
447528|NCT01655082|Tobacco Use Disorder|tobacco use disorder
447529|NCT01655082|Central Nervous System Agents|central nervous system agents
447530|NCT01655069|Overactive bladder (OAB)|overactive bladder (oab)
447531|NCT01655069|Solifenacin succinate suspension|solifenacin succinate suspension
447532|NCT01655069|Phase 3|phase 3
447533|NCT01655069|Pediatric|pediatric
447534|NCT01655056|Pharmacokinetics|pharmacokinetics
447535|NCT01655056|Pharmacodynamics|pharmacodynamics
447536|NCT01655056|Phase 1|phase 1
447537|NCT01655056|YM150|ym150
447538|NCT01655056|Dose-escalating|dose-escalating
447539|NCT01655056|Ethnicity|ethnicity
447540|NCT01655056|Caucasian|caucasian
447541|NCT01655056|Japanese|japanese
447542|NCT01655043|Magnetic Resonance Imaging|magnetic resonance imaging
447543|NCT01655043|regadenoson|regadenoson
447544|NCT01655017|Obesity|obesity
447545|NCT01655017|adipose tissue fibrosis|adipose tissue fibrosis
447546|NCT01655017|Adipose tissue inflammation|adipose tissue inflammation
447547|NCT01655017|Low grade systemic inflammation|low grade systemic inflammation
447548|NCT01655017|non invasive device|non invasive device
447549|NCT01655017|Bariatric surgery|bariatric surgery
447550|NCT01655004|hormone receptor positive|hormone receptor positive
447551|NCT01655004|breast cancer|breast cancer
447553|NCT01654939|hepatitis C|hepatitis c
447554|NCT01654926|Feasibility of using the FlexFlowTM ultrafiltration pump in a non hospital environment|feasibility of using the flexflowtm ultrafiltration pump in a non hospital environment
447555|NCT01654913|hemoglobin determination|hemoglobin determination
447556|NCT01654913|oxygen|oxygen
447557|NCT01654887|Comparative Effectiveness|comparative effectiveness
447558|NCT01654887|Lung Ultrasound versus Chest X-ray|lung ultrasound versus chest x-ray
447559|NCT01654887|Pneumonia|pneumonia
447560|NCT01654887|Emergency Department|emergency department
447561|NCT01654848|liver transplantation|liver transplantation
447562|NCT01654848|thrombocytes|thrombocytes
447563|NCT01654848|heparin-induced thrombocytopenia|heparin-induced thrombocytopenia
447564|NCT01654848|multivariate analysis of associated factors of HIT 2 after OLT|multivariate analysis of associated factors of hit 2 after olt
447565|NCT01654848|laboratory investigations of HIT-antibodies|laboratory investigations of hit-antibodies
447566|NCT01654822|HPV|hpv
447567|NCT01654822|cervix|cervix
447568|NCT01654796|Depression|depression
447569|NCT01654796|Treatment Resistant Depression|treatment resistant depression
447570|NCT01654783|5-ASA, ulcerative colitis, active, remission, adherence|5-asa, ulcerative colitis, active, remission, adherence
447571|NCT01654770|VCE, DBE,OGIB|vce, dbe,ogib
447572|NCT01654770|consecutive|consecutive
447573|NCT01654770|patients|patients
447574|NCT01654731|PBC|pbc
447575|NCT01654731|Bezafibrate|bezafibrate
447576|NCT01654692|metastatic melanoma|metastatic melanoma
447577|NCT01654692|Ipilimumab|ipilimumab
447578|NCT01654679|wound infection|wound infection
447579|NCT01654679|surgery|surgery
447580|NCT01654679|surgical wound infection rate|surgical wound infection rate
447581|NCT01654679|wound healing|wound healing
447582|NCT01654666|Remote ischemic preconditioning|remote ischemic preconditioning
447583|NCT01654666|Stroke secondary prevention|stroke secondary prevention
571376|NCT01132534|OGD|ogd
447584|NCT01654666|Carotid artery stenting|carotid artery stenting
447585|NCT01654666|Carotid stenosis|carotid stenosis
447586|NCT01654666|Inflammation|inflammation
447587|NCT01654653|Heart disease|heart disease
447588|NCT01654653|cardiac surgery|cardiac surgery
447589|NCT01654653|CABG|cabg
447590|NCT01654653|Totilac|totilac
447591|NCT01654653|Voluven|voluven
447592|NCT01654653|6% HES|6% hes
447593|NCT01654640|schizophrenia|schizophrenia
447594|NCT01654640|obesity|obesity
447595|NCT01654640|clozapine|clozapine
447596|NCT01654640|metformin|metformin
447597|NCT01654627|Guided Tissue Regeneration|guided tissue regeneration
447598|NCT01654627|Dental Implants|dental implants
447599|NCT01654627|Membrane, Synthetic|membrane, synthetic
447600|NCT01654614|Keratoconus match index|keratoconus match index
447601|NCT01654614|keratoconus probability index|keratoconus probability index
447602|NCT01654614|ocular response analyzer|ocular response analyzer
447603|NCT01654614|Pentacam|pentacam
447604|NCT01654614|forme fruste keratoconus|forme fruste keratoconus
447605|NCT01654601|Schizophrenia|schizophrenia
447606|NCT01654588|BRONCHIAL CHALLANGE TEST, ASTHMA, METACHLINE, ADENOSINE|bronchial challange test, asthma, metachline, adenosine
447607|NCT01654575|Methotrexate|methotrexate
447608|NCT01654575|Knee Osteoarthritis|knee osteoarthritis
447609|NCT01654575|Synovitis|synovitis
447610|NCT01654575|Pain reduction|pain reduction
447611|NCT01654575|Function scores|function scores
447612|NCT01654549|Steatohepatitis,|steatohepatitis,
447613|NCT01654549|Helicobacter pylori,|helicobacter pylori,
447614|NCT01654549|Insulin resistance,|insulin resistance,
447615|NCT01654549|Alanine aminotransferase,|alanine aminotransferase,
447616|NCT01654549|Aspartate aminotransferase,|aspartate aminotransferase,
447617|NCT01654536|PAR|par
447618|NCT01654523|Trichotillomania|trichotillomania
447619|NCT01654497|Brain|brain
447620|NCT01654497|Glioma|glioma
447621|NCT01654497|glioblastoma|glioblastoma
447622|NCT01654497|metastases|metastases
447623|NCT01654497|cancer|cancer
447624|NCT01654497|ETS2101|ets2101
447625|NCT01654497|leptomeningeal|leptomeningeal
447626|NCT01654497|astrocytoma|astrocytoma
447627|NCT01654497|oligodendroglioma|oligodendroglioma
447628|NCT01654497|meningioma|meningioma
447629|NCT01654471|Walking Impairment Questionnaire|walking impairment questionnaire
447630|NCT01654471|Peripheral arterial occlusive disease|peripheral arterial occlusive disease
447631|NCT01654471|Korean version|korean version
447632|NCT01654458|Sexual Dysfunctions, Psychological|sexual dysfunctions, psychological
447633|NCT01654458|Psychotherapy, Group|psychotherapy, group
447634|NCT01654458|Genital Neoplasms, Female|genital neoplasms, female
447635|NCT01654458|Endometrial Neoplasms|endometrial neoplasms
447636|NCT01654458|Fallopian Tube Neoplasms|fallopian tube neoplasms
447637|NCT01654458|Ovarian Neoplasms|ovarian neoplasms
447638|NCT01654458|Urogenital Neoplasms|urogenital neoplasms
447639|NCT01654458|Uterine Cervical Neoplasms|uterine cervical neoplasms
447640|NCT01654458|Uterine Neoplasms|uterine neoplasms
447641|NCT01654458|Vaginal Neoplasms|vaginal neoplasms
447642|NCT01654458|Vulvar Neoplasms|vulvar neoplasms
447643|NCT01654445|Minor stroke|minor stroke
447644|NCT01654419|sliding jig|sliding jig
447645|NCT01654419|Class II malocclusion|class ii malocclusion
447646|NCT01654419|Distalization mechanics|distalization mechanics
447647|NCT01654419|Intermaxillary elastics|intermaxillary elastics
447648|NCT01654406|Cesarian scar|cesarian scar
447649|NCT01654406|Fractional CO2 laser|fractional co2 laser
447650|NCT01654393|Triage nurse|triage nurse
447651|NCT01654393|Ottawa ankle rules|ottawa ankle rules
447652|NCT01654354|Qualitative Evaluation of abdominal CT image using 4 point scale: Excellent(4)/ Good(3) / Fair(2) / Unacceptable(1)|qualitative evaluation of abdominal ct image using 4 point scale: excellent(4)/ good(3) / fair(2) / unacceptable(1)
447653|NCT01654328|contrast media|contrast media
447654|NCT01654328|kidney injury|kidney injury
447655|NCT01654328|hydration|hydration
447656|NCT01654315|RTP Only Group|rtp only group
447657|NCT01654315|Myomo Only Group|myomo only group
447658|NCT01654315|Myomo + RTP Group|myomo + rtp group
447659|NCT01654289|respiratory tract infections|respiratory tract infections
447660|NCT01654289|common cold|common cold
447661|NCT01654289|exercise|exercise
447662|NCT01654289|influenza|influenza
447663|NCT01654289|meditation|meditation
447664|NCT01654263|13-valent|13-valent
447665|NCT01654263|23-valent|23-valent
447667|NCT01654263|parent protocol|parent protocol
447668|NCT01654263|Pneumococcal infections|pneumococcal infections
447669|NCT01654263|vaccine|vaccine
447670|NCT01654250|ADHD|adhd
447671|NCT01654250|methylphenidate extended-release|methylphenidate extended-release
447672|NCT01654237|work|work
447673|NCT01654237|WMSD|wmsd
447674|NCT01654237|prevalence|prevalence
447675|NCT01654237|occupational risks|occupational risks
447676|NCT01654237|industry|industry
447677|NCT01654237|questionnaires|questionnaires
447678|NCT01654237|musculoskeletal pain|musculoskeletal pain
447679|NCT01654237|lifestyle|lifestyle
447680|NCT01654224|Influenza in Long Term Care Setting|influenza in long term care setting
447681|NCT01654224|High dose Inactivated influenza vaccine|high dose inactivated influenza vaccine
447682|NCT01654224|Standard dose inactivated influenza vaccine|standard dose inactivated influenza vaccine
447683|NCT01654172|Diabetes|diabetes
447684|NCT01654172|peripheral neuropathy|peripheral neuropathy
447685|NCT01654172|Cocoa flavanols|cocoa flavanols
447686|NCT01654159|intraocular lenses|intraocular lenses
447687|NCT01654159|evaluation|evaluation
447688|NCT01654159|cataract|cataract
447689|NCT01654146|Ovarian cancer|ovarian cancer
447690|NCT01654146|Epithelial ovarian carcinoma|epithelial ovarian carcinoma
447691|NCT01654146|Fallopian tube carcinoma|fallopian tube carcinoma
447692|NCT01654146|Primary serous peritoneal carcinoma|primary serous peritoneal carcinoma
447693|NCT01654146|Gynaecological carcinoma|gynaecological carcinoma
447694|NCT01654146|Randomised controlled trial|randomised controlled trial
447695|NCT01654133|Aortic Aneurysm, abdominal|aortic aneurysm, abdominal
447696|NCT01654120|insulin|insulin
447697|NCT01654120|Type II Diabetes|type ii diabetes
447698|NCT01654120|liraglutide|liraglutide
447699|NCT01654120|Glucagon-Like Peptide 1|glucagon-like peptide 1
447700|NCT01654107|tobacco|tobacco
447701|NCT01654107|smoking cessation|smoking cessation
447702|NCT01654107|nicotine dependence|nicotine dependence
447703|NCT01654081|Lung Cancer|lung cancer
447704|NCT01654081|POSITIVE NON SMALL CELL CARCINOMA|positive non small cell carcinoma
447705|NCT01654081|ISG15|isg15
447706|NCT01654081|IRINOTECAN|irinotecan
447707|NCT01654068|Female Breast Cancer|female breast cancer
447708|NCT01654068|Kidney Cancer|kidney cancer
447709|NCT01654068|Lung Cancer|lung cancer
447710|NCT01654068|Prostate Cancer|prostate cancer
447711|NCT01654068|Vertebral metastasis|vertebral metastasis
447712|NCT01654055|Morphine|morphine
447713|NCT01654055|Adverse events|adverse events
447714|NCT01654055|Predictive factors|predictive factors
447715|NCT01654042|anticoagulation|anticoagulation
447716|NCT01654042|warfarin|warfarin
447717|NCT01654042|monitoring|monitoring
447718|NCT01654042|bleeding|bleeding
447719|NCT01654042|thromboembolism|thromboembolism
447720|NCT01654029|Stroke|stroke
447721|NCT01654029|Communication impairments|communication impairments
447722|NCT01654029|Nurse-patient communication|nurse-patient communication
447723|NCT01654029|Patient-centred care|patient-centred care
447724|NCT01654016|varicose veins|varicose veins
447725|NCT01654016|inflammation|inflammation
447726|NCT01654003|Goal-directed therapy|goal-directed therapy
447727|NCT01654003|severe sepsis|severe sepsis
447728|NCT01654003|emergency surgery|emergency surgery
447729|NCT01654003|vasopressor|vasopressor
447730|NCT01654003|dynamic flow-related parameters|dynamic flow-related parameters
447731|NCT01653977|Hypovolemic shock|hypovolemic shock
447732|NCT01653977|trauma|trauma
447733|NCT01653977|emergency|emergency
447734|NCT01653977|surgery|surgery
447735|NCT01653977|GDT|gdt
447736|NCT01653977|Picco|picco
447737|NCT01653964|suspicious|suspicious
447738|NCT01653964|lesion|lesion
447739|NCT01653964|breast|breast
447740|NCT01653964|cancer|cancer
447741|NCT01653964|screening|screening
447742|NCT01653964|mammogram|mammogram
447743|NCT01653964|negative|negative
447744|NCT01653938|CHF|chf
447745|NCT01653925|Prostatic Neoplasms|prostatic neoplasms
447746|NCT01653925|Low grade prostate cancer|low grade prostate cancer
447747|NCT01653912|cancer|cancer
447748|NCT01653912|ovarian|ovarian
447749|NCT01653912|platinum-resistant|platinum-resistant
447750|NCT01653899|Type I Diabetes|type i diabetes
447751|NCT01653886|Palatability|palatability
447752|NCT01653886|Taste|taste
447753|NCT01653873|fracture|fracture
447754|NCT01653873|vertebral column|vertebral column
447755|NCT01653873|osteoporosis|osteoporosis
447756|NCT01653873|predictor|predictor
447757|NCT01653873|vertebroplasty|vertebroplasty
447758|NCT01653860|Behavior therapy|behavior therapy
447759|NCT01653860|Group therapy|group therapy
447760|NCT01653847|transplant|transplant
447761|NCT01653847|kidney|kidney
447762|NCT01653847|renal disease|renal disease
447763|NCT01653834|lymphopenia|lymphopenia
447764|NCT01653821|carotid body|carotid body
447765|NCT01653821|heart failure|heart failure
447766|NCT01653821|chemoreceptor|chemoreceptor
447767|NCT01653821|hypersensitivity|hypersensitivity
447768|NCT01653808|CKD dialysis|ckd dialysis
447769|NCT01653808|hemodialysis|hemodialysis
447770|NCT01653808|hemodiafiltration|hemodiafiltration
447771|NCT01653808|Elisio dialyzer|elisio dialyzer
447772|NCT01653808|efficacy|efficacy
447773|NCT01653808|biocompatibility|biocompatibility
447774|NCT01653782|LPB|lpb
447775|NCT01653782|RCT|rct
447776|NCT01653782|Intervention study|intervention study
447777|NCT01653782|Cost effectiveness|cost effectiveness
447778|NCT01653782|Yoga|yoga
447779|NCT01653782|evidence based|evidence based
447780|NCT01653782|advice to stay active|advice to stay active
447781|NCT01653782|exercise training|exercise training
447782|NCT01653769|CoSeal|coseal
447783|NCT01653769|Surgical bleeding|surgical bleeding
447784|NCT01653769|hemostasis|hemostasis
447785|NCT01653769|Aortic anastamoses|aortic anastamoses
447786|NCT01653769|bleeding|bleeding
447787|NCT01653769|Cardiac surgery|cardiac surgery
447788|NCT01653769|Aneurysms|aneurysms
447789|NCT01653769|Aortic Dissection|aortic dissection
447790|NCT01653756|Asthma|asthma
447791|NCT01653756|Allergen Challenge|allergen challenge
447792|NCT01653743|Japanese|japanese
447793|NCT01653730|portable oxygen concentrator|portable oxygen concentrator
447794|NCT01653730|6-minute walk test|6-minute walk test
447795|NCT01653730|chronic obstructive lung disease|chronic obstructive lung disease
447796|NCT01653730|pulmonary fibrosis|pulmonary fibrosis
447797|NCT01653730|long term oxygen therapy|long term oxygen therapy
447798|NCT01653717|Advanced Cancers|advanced cancers
447799|NCT01653717|Leukemia|leukemia
447800|NCT01653717|B-cell Chronic Lymphocytic Leukemia|b-cell chronic lymphocytic leukemia
447801|NCT01653717|B-CLL|b-cll
447802|NCT01653717|CD19 positivity|cd19 positivity
447803|NCT01653717|CD19-specific T cells|cd19-specific t cells
447804|NCT01653717|T-Cell Infusion|t-cell infusion
447805|NCT01653717|Gene Transfer|gene transfer
447806|NCT01653717|Leukapheresis|leukapheresis
447807|NCT01653717|Fludarabine|fludarabine
447808|NCT01653717|Fludarabine Phosphate|fludarabine phosphate
447809|NCT01653717|Fludara|fludara
447810|NCT01653717|Cyclophosphamide|cyclophosphamide
447811|NCT01653717|Cytoxan|cytoxan
447812|NCT01653717|Neosar|neosar
447813|NCT01653691|Pediatric|pediatric
447814|NCT01653691|Burns|burns
447815|NCT01653691|Scars|scars
447816|NCT01653691|Pulse Dye laser|pulse dye laser
447817|NCT01653678|vitamin D-3|vitamin d-3
447818|NCT01653678|omega-3 fatty acids|omega-3 fatty acids
447819|NCT01653678|fish oil|fish oil
447820|NCT01653678|hypertension|hypertension
447821|NCT01653678|blood pressure|blood pressure
447822|NCT01653652|grass pollen|grass pollen
447823|NCT01653652|allergic rhinitis|allergic rhinitis
447824|NCT01653652|TNSS|tnss
447825|NCT01653652|miniRQLQ|minirqlq
447826|NCT01653639|BAY14-2222|bay14-2222
447827|NCT01653639|Pharmacokinetics|pharmacokinetics
448021|NCT01652560|HER2-negative breast cancer|her2-negative breast cancer
447828|NCT01653613|B-cell adult acute lymphoblastic leukemia|b-cell adult acute lymphoblastic leukemia
447829|NCT01653613|B-cell childhood acute lymphoblastic leukemia|b-cell childhood acute lymphoblastic leukemia
447830|NCT01653613|untreated adult acute lymphoblastic leukemia|untreated adult acute lymphoblastic leukemia
447831|NCT01653613|untreated childhood acute lymphoblastic leukemia|untreated childhood acute lymphoblastic leukemia
447832|NCT01653600|peripheral arterial disease|peripheral arterial disease
447833|NCT01653600|atherosclerosis|atherosclerosis
447834|NCT01653600|nitinol|nitinol
447835|NCT01653600|stents|stents
447836|NCT01653587|Transradial Approach|transradial approach
447837|NCT01653587|Transfemoral Approach|transfemoral approach
447838|NCT01653587|Vascular Closure Device|vascular closure device
447839|NCT01653574|Famitinib Malate|famitinib malate
447840|NCT01653574|Metastatic Breast Cancer|metastatic breast cancer
447841|NCT01653574|HER-2 negative|her-2 negative
447842|NCT01653561|Metastatic breast cancer|metastatic breast cancer
447843|NCT01653561|Apatinib|apatinib
447844|NCT01653561|non-triple-negative|non-triple-negative
447845|NCT01653548|emotion dysregulation|emotion dysregulation
447846|NCT01653548|borderline personality disorder|borderline personality disorder
447847|NCT01653548|anxiety|anxiety
447848|NCT01653548|depression|depression
447849|NCT01653548|negative emotions|negative emotions
447850|NCT01653548|outpatient interventions for negative emotions|outpatient interventions for negative emotions
447851|NCT01653548|psychological distress|psychological distress
447852|NCT01653548|emotion regulation problems|emotion regulation problems
447853|NCT01653535|Prevention|prevention
447854|NCT01653535|Health Service Use|health service use
447855|NCT01653535|Behavioral Intervention|behavioral intervention
447856|NCT01653535|Conduct Problems|conduct problems
447857|NCT01653535|Anti-Social Behavior|anti-social behavior
447858|NCT01653509|cold sore|cold sore
447859|NCT01653496|Gastric cancer|gastric cancer
447860|NCT01653496|Perioperative care|perioperative care
447861|NCT01653496|Enhanced recovery after surgery|enhanced recovery after surgery
447862|NCT01653496|Multimodal rehabilitation|multimodal rehabilitation
447863|NCT01653496|Fast track surgery|fast track surgery
447864|NCT01653496|Gastrectomy|gastrectomy
447865|NCT01653483|Asthma|asthma
447866|NCT01653483|Umeclidinium|umeclidinium
447867|NCT01653483|Adolescent|adolescent
447868|NCT01653483|Pharmacokinetics|pharmacokinetics
447869|NCT01653457|Fibromyalgia|fibromyalgia
447870|NCT01653457|Magnetic Resonance Spectroscopy|magnetic resonance spectroscopy
447871|NCT01653457|Memantine|memantine
447872|NCT01653457|electroencephalic cordance|electroencephalic cordance
447873|NCT01653405|anticoagulants|anticoagulants
447874|NCT01653405|pharmacists|pharmacists
447875|NCT01653405|quality improvement|quality improvement
447876|NCT01653405|quality of health care|quality of health care
447877|NCT01653392|Maternal Mortality|maternal mortality
447878|NCT01653392|Obstetric Labor, Premature|obstetric labor, premature
447879|NCT01653392|Eclampsia|eclampsia
447880|NCT01653392|Pre-Eclampsia|pre-eclampsia
447881|NCT01653392|Abortion, Spontaneous|abortion, spontaneous
447882|NCT01653392|Diabetes, Gestational|diabetes, gestational
447883|NCT01653392|Pregnancy, Ectopic|pregnancy, ectopic
447884|NCT01653392|Hydatidiform Mole|hydatidiform mole
447885|NCT01653392|Fetal death|fetal death
447886|NCT01653392|Live birth|live birth
447887|NCT01653392|Still birth|still birth
447888|NCT01653392|Premature Birth|premature birth
447889|NCT01653392|Sex ratio|sex ratio
447890|NCT01653392|Birth weight|birth weight
447891|NCT01653366|Breast Cancer|breast cancer
447892|NCT01653353|nursing home|nursing home
447893|NCT01653353|vitamin D supplements|vitamin d supplements
447894|NCT01653353|calcium supplements|calcium supplements
447895|NCT01653353|guideline adherence|guideline adherence
447896|NCT01653340|Refractory Chronic Migraine|refractory chronic migraine
447897|NCT01653340|Medically Intractable Chronic Migraine|medically intractable chronic migraine
447898|NCT01653340|High Frequency Spinal Cord Stimulator|high frequency spinal cord stimulator
447899|NCT01653327|mucositis|mucositis
447900|NCT01653327|head and neck|head and neck
447901|NCT01653327|cancer|cancer
447902|NCT01653327|radiation therapy|radiation therapy
447903|NCT01653327|chemoradiation|chemoradiation
447904|NCT01653327|oral|oral
447905|NCT01653327|pain|pain
447906|NCT01653275|Mediterranean Diet|mediterranean diet
447907|NCT01653275|Bone turnover|bone turnover
447908|NCT01653275|postmenopausal women|postmenopausal women
447909|NCT01653262|Brivaracetam|brivaracetam
447910|NCT01653262|Levetiracetam|levetiracetam
447911|NCT01653262|Epilepsy|epilepsy
447912|NCT01653262|Nonpsychotic behavior|nonpsychotic behavior
447913|NCT01653249|human papillomavirus (HPV)|human papillomavirus (hpv)
447914|NCT01653249|vaccine|vaccine
447915|NCT01653249|treatment|treatment
447916|NCT01653210|Insulin Pump|insulin pump
447917|NCT01653210|Continuous Glucose Monitor|continuous glucose monitor
447918|NCT01653210|Premenopausal women|premenopausal women
447919|NCT01653184|AMD|amd
447920|NCT01653184|Vision loss|vision loss
447921|NCT01653184|omega-3|omega-3
447922|NCT01653184|supplement|supplement
447923|NCT01653184|age related macular degeneration|age related macular degeneration
447924|NCT01653171|Acetylcysteine, Simethicone, Stomach Neoplasms|acetylcysteine, simethicone, stomach neoplasms
447925|NCT01653158|non-hematologic cancer|non-hematologic cancer
447926|NCT01653158|advanced solid tumors|advanced solid tumors
447927|NCT01653158|prostrate cancer|prostrate cancer
447928|NCT01653145|Appetite|appetite
447929|NCT01653145|Satiety|satiety
447930|NCT01653132|PD|pd
447931|NCT01653119|Acute coronary syndrome|acute coronary syndrome
447932|NCT01653119|Diabetes mellitus|diabetes mellitus
447933|NCT01653119|Statins|statins
447934|NCT01653119|High loading dose|high loading dose
447935|NCT01653119|Recurrent events|recurrent events
447936|NCT01653106|cryotherapy|cryotherapy
447937|NCT01653106|Melphalan|melphalan
447938|NCT01653106|Mucositis|mucositis
447939|NCT01653080|Solid Tumor|solid tumor
447940|NCT01653080|Eye|eye
447941|NCT01653080|Orbit|orbit
447942|NCT01653067|Non Hodgkin´s Lymphoma|non hodgkin´s lymphoma
447943|NCT01653067|Diffuse Large B-Cell Lymphoma|diffuse large b-cell lymphoma
447944|NCT01653067|Aggressive Lymphoma|aggressive lymphoma
447945|NCT01653067|Aggressive Non Hodgkin´s Lymphoma|aggressive non hodgkin´s lymphoma
447946|NCT01653067|NHL|nhl
447947|NCT01653067|aNHL|anhl
447948|NCT01653067|Temsirolimus|temsirolimus
447949|NCT01653067|Torisel|torisel
447950|NCT01653067|Relapsed Non Hodgkin´s Lymphoma|relapsed non hodgkin´s lymphoma
447951|NCT01653067|Relapsed Diffuse Large B-Cell Lymphoma|relapsed diffuse large b-cell lymphoma
447952|NCT01653067|aggressive NHL|aggressive nhl
447953|NCT01653067|B-NHL|b-nhl
447954|NCT01653067|aggressive B-NHL|aggressive b-nhl
447955|NCT01653041|immunosuppression, identical HLA, kidney transplantation, everolimus|immunosuppression, identical hla, kidney transplantation, everolimus
447956|NCT01653002|Lung cancer|lung cancer
447957|NCT01653002|EBUS-TBNA|ebus-tbna
447958|NCT01653002|Epigenetics|epigenetics
447959|NCT01653002|shox2 protein, human|shox2 protein, human
447960|NCT01652989|weight loss|weight loss
447961|NCT01652989|weight loss maintenance|weight loss maintenance
447962|NCT01652989|community based participatory research|community based participatory research
447963|NCT01652989|overweight|overweight
447964|NCT01652976|Metastatic|metastatic
447965|NCT01652976|Pancreatic Cancer|pancreatic cancer
447966|NCT01652976|Adenocarcinoma|adenocarcinoma
447967|NCT01652950|Physical activity|physical activity
447968|NCT01652950|health-insured|health-insured
447969|NCT01652950|Financial Incentives|financial incentives
447970|NCT01652950|Benefits design|benefits design
447971|NCT01652937|Rheumatoid Arthritis|rheumatoid arthritis
447972|NCT01652937|DMARD-IR|dmard-ir
447973|NCT01652924|mechanical ventilation|mechanical ventilation
447974|NCT01652924|manual ventilation|manual ventilation
447975|NCT01652911|Islet Transplantation|islet transplantation
447976|NCT01652911|Cell Pouch|cell pouch
447977|NCT01652898|PK|pk
447978|NCT01652885|atopic dermatitis|atopic dermatitis
447979|NCT01652872|anemia|anemia
447980|NCT01652872|chronic kidney disease|chronic kidney disease
447981|NCT01652872|kidney disease|kidney disease
447982|NCT01652872|renal failure|renal failure
447983|NCT01652833|Metastatic Colorectal Cancer|metastatic colorectal cancer
447984|NCT01652820|LUNG|lung
447985|NCT01652820|DOCETAXEL|docetaxel
447986|NCT01652820|GEMCITABINE|gemcitabine
447987|NCT01652820|CARBOPLATIN|carboplatin
447988|NCT01652820|RADIOTHERAPY|radiotherapy
447989|NCT01652781|myelodysplastic syndrome|myelodysplastic syndrome
447990|NCT01652781|azacitidine|azacitidine
447991|NCT01652781|dosing schedule|dosing schedule
447992|NCT01652768|Malignant Brain Tumors|malignant brain tumors
447993|NCT01652768|Malignant Glioma|malignant glioma
447994|NCT01652768|High-grade Gliomas|high-grade gliomas
447995|NCT01652768|Oncology|oncology
447996|NCT01652768|Cancer|cancer
447997|NCT01652768|Patient Caregiver|patient caregiver
447998|NCT01652768|Caregiver Stress, Anxiety, Depression|caregiver stress, anxiety, depression
447999|NCT01652768|Palliative Care Intervention|palliative care intervention
448000|NCT01652755|cystatin C,acute kidney injury,|cystatin c,acute kidney injury,
448001|NCT01652729|Diabetes, Type 2, exenatide, Sitagliptin|diabetes, type 2, exenatide, sitagliptin
448002|NCT01652703|Japanese, hypercholesterolemia, high risk for cardiovascular events|japanese, hypercholesterolemia, high risk for cardiovascular events
448003|NCT01652677|navigation transcranial magnetic stimulation|navigation transcranial magnetic stimulation
448004|NCT01652677|stroke rehabilitation|stroke rehabilitation
448005|NCT01652651|Learning Disorders|learning disorders
448006|NCT01652638|subjects|subjects
448007|NCT01652625|Yunnan Baiyao|yunnan baiyao
448008|NCT01652625|recurrent aphthous stomatitis|recurrent aphthous stomatitis
448009|NCT01652625|clinical trial|clinical trial
448010|NCT01652612|positive end expiratory pressure|positive end expiratory pressure
448011|NCT01652599|Eltrombopag|eltrombopag
448012|NCT01652599|Dexamethasone|dexamethasone
448013|NCT01652599|High-dose|high-dose
448014|NCT01652599|ITP|itp
448015|NCT01652586|cardiac ablation|cardiac ablation
448016|NCT01652573|X linked hypophosphatemia|x linked hypophosphatemia
448017|NCT01652573|calcitonin|calcitonin
448018|NCT01652573|FGF twenty three|fgf twenty three
448019|NCT01652560|bevacizumab|bevacizumab
448020|NCT01652560|neoadjuvant chemotherapy|neoadjuvant chemotherapy
448022|NCT01652547|Melanoma|melanoma
448023|NCT01652547|Merkel cell carcinoma|merkel cell carcinoma
448024|NCT01652547|Metastatic skin cancer|metastatic skin cancer
448025|NCT01652534|Freezing of gait|freezing of gait
448026|NCT01652534|gait dysfunction|gait dysfunction
448027|NCT01652521|lung compliance|lung compliance
448028|NCT01652521|pleural effusion|pleural effusion
448029|NCT01652521|esophageal pressure|esophageal pressure
448030|NCT01652508|smoking cessation|smoking cessation
448031|NCT01652508|Acceptance and Commitment Therapy|acceptance and commitment therapy
448032|NCT01652508|primary care setting|primary care setting
448033|NCT01652508|randomised controlled trial|randomised controlled trial
448034|NCT01652495|rotatory cuff calcific tendonitis|rotatory cuff calcific tendonitis
448035|NCT01652495|corticosteroids|corticosteroids
448036|NCT01652495|US guided percutaneous treatment|us guided percutaneous treatment
448037|NCT01652495|methylprednisolone|methylprednisolone
448038|NCT01652495|triamcinolone|triamcinolone
448039|NCT01652495|hypothalamus pituitary adrenal axis|hypothalamus pituitary adrenal axis
448040|NCT01652469|squamous cell|squamous cell
448041|NCT01652469|NSCLC|nsclc
448042|NCT01652469|TKI|tki
448043|NCT01652469|Erlotinib|erlotinib
448044|NCT01652469|Docetaxel|docetaxel
448045|NCT01652469|VeriStrat|veristrat
448046|NCT01652469|protein signature|protein signature
448047|NCT01652456|addiction support|addiction support
448048|NCT01652456|addiction specialist|addiction specialist
448049|NCT01652456|lung cancer|lung cancer
448050|NCT01652456|head and neck cancer|head and neck cancer
448051|NCT01652443|OEF/OIF Veterans|oef/oif veterans
448052|NCT01652443|Relationships|relationships
448053|NCT01652430|PTSD|ptsd
448054|NCT01652430|Suicidal ideation|suicidal ideation
448055|NCT01652430|Cognitive processes|cognitive processes
448056|NCT01652417|Methylprednisolone|methylprednisolone
448057|NCT01652417|prednisone|prednisone
448058|NCT01652417|renal sarcoidosis treatment|renal sarcoidosis treatment
448059|NCT01652404|ICU|icu
448060|NCT01652404|sepsis|sepsis
448061|NCT01652404|antibiotic therapy|antibiotic therapy
448062|NCT01652404|procalcitonin|procalcitonin
448063|NCT01652378|cocaine addiction|cocaine addiction
448064|NCT01652378|neuroimaging|neuroimaging
448065|NCT01652378|functional magnetic resonance imaging (fMRI)|functional magnetic resonance imaging (fmri)
448066|NCT01652365|Malaria Diagnosis|malaria diagnosis
448067|NCT01652365|Rapid Diagnostic Tests|rapid diagnostic tests
448068|NCT01652365|RDTs|rdts
448069|NCT01652365|Private Sector|private sector
448070|NCT01652365|Retail Sector|retail sector
448071|NCT01652365|Drug Shops|drug shops
448072|NCT01652352|Disabled|disabled
448073|NCT01652352|Disability|disability
448074|NCT01652352|Power wheelchair|power wheelchair
448075|NCT01652352|Wheelchair|wheelchair
448076|NCT01652352|Wheelchair mounted robotic arm|wheelchair mounted robotic arm
448077|NCT01652352|WMRA|wmra
448078|NCT01652352|Assistive|assistive
448079|NCT01652352|Assistive robot|assistive robot
448080|NCT01652352|Assistive robotics|assistive robotics
448081|NCT01652352|Rehabilitation robot|rehabilitation robot
448082|NCT01652352|Rehabilitation engineering|rehabilitation engineering
448083|NCT01652352|Rehabilitation robotics|rehabilitation robotics
448084|NCT01652300|Oral health|oral health
448085|NCT01652300|education|education
448086|NCT01652300|knowledge|knowledge
448087|NCT01652300|attitude|attitude
448088|NCT01652300|performance|performance
448089|NCT01652274|Child Passenger Safety|child passenger safety
448090|NCT01652274|Parental perception of vulnerability|parental perception of vulnerability
448091|NCT01652274|Neonatology|neonatology
448092|NCT01652274|Newborn|newborn
448093|NCT01652261|advanced stage|advanced stage
448094|NCT01652248|Heart failure|heart failure
448095|NCT01652248|Pacemaker|pacemaker
448096|NCT01652248|cardiac resynchronization therapy|cardiac resynchronization therapy
448097|NCT01652235|Abdominal aortic aneurysm|abdominal aortic aneurysm
448098|NCT01652235|Endovascular|endovascular
448099|NCT01652235|Fenestration|fenestration
448100|NCT01652235|Juxtarenal|juxtarenal
448101|NCT01652235|Off-the-shelf|off-the-shelf
448102|NCT01652235|Pararenal|pararenal
448103|NCT01652222|Alzheimer|alzheimer
448104|NCT01652222|caregiver|caregiver
448105|NCT01652222|dementia|dementia
448106|NCT01652222|social support|social support
448107|NCT01652222|Montessori|montessori
448108|NCT01652222|Therapeutic game|therapeutic game
448109|NCT01652196|colorectal cancer|colorectal cancer
448110|NCT01652196|rectal cancer|rectal cancer
448111|NCT01652196|FOLFOX|folfox
448112|NCT01652196|Aflibercept|aflibercept
448113|NCT01652183|Intravenous paracetamol|intravenous paracetamol
448114|NCT01652183|catheter related bladder discomfort|catheter related bladder discomfort
448115|NCT01652183|urologic surgery|urologic surgery
448116|NCT01652157|prospective|prospective
448117|NCT01652157|observational|observational
448118|NCT01652157|pancreatic insufficiency|pancreatic insufficiency
448119|NCT01652157|pancreatic enzyme replacement therapy|pancreatic enzyme replacement therapy
448120|NCT01652157|fibrosing colonopathy|fibrosing colonopathy
448121|NCT01652157|patients with cystic fibrosis|patients with cystic fibrosis
448122|NCT01652131|general anesthesia|general anesthesia
448123|NCT01652131|volume kinetics|volume kinetics
448124|NCT01652118|bronchopulmonary dysplasia|bronchopulmonary dysplasia
448125|NCT01652118|clarithromycin|clarithromycin
448126|NCT01652118|preterm babies|preterm babies
448127|NCT01652105|Gastric bypass|gastric bypass
448128|NCT01652105|Preoperative diet|preoperative diet
448129|NCT01652105|Prodimed|prodimed
448130|NCT01652092|immunodeficiency disorder|immunodeficiency disorder
448131|NCT01652092|histiocytic disorder|histiocytic disorder
448132|NCT01652079|Epithelial|epithelial
448133|NCT01652079|Primary|primary
448134|NCT01652053|InterCushion|intercushion
448135|NCT01652040|Spinal Cord Injury|spinal cord injury
448136|NCT01652040|Rehabilitation|rehabilitation
448137|NCT01652040|Electrical Stimulation|electrical stimulation
448138|NCT01652040|Testosterone|testosterone
448139|NCT01652040|Body Composition|body composition
448140|NCT01652040|Lipid and Glucose profile|lipid and glucose profile
448141|NCT01652040|Ectopic Adiposity|ectopic adiposity
448142|NCT01652027|FVIII inhibitors|fviii inhibitors
448143|NCT01652014|Transplantation|transplantation
448144|NCT01652014|Hematopoietic Stem Cell Transplantation|hematopoietic stem cell transplantation
448145|NCT01652001|Xerostomia|xerostomia
448146|NCT01652001|Antidepressant agents|antidepressant agents
448147|NCT01652001|Antihypertensive agents|antihypertensive agents
448148|NCT01651988|ketamine|ketamine
448149|NCT01651988|propofol anesthesia|propofol anesthesia
448150|NCT01651975|Dysphagia|dysphagia
448151|NCT01651975|Thickening liquid|thickening liquid
448152|NCT01651975|Thickening agent|thickening agent
448153|NCT01651975|Fluoroscopic swallow study|fluoroscopic swallow study
448154|NCT01651975|Aspiration|aspiration
448155|NCT01651975|History of dysphagia|history of dysphagia
448156|NCT01651975|DSS|dss
448157|NCT01651975|Age > 18|age > 18
448158|NCT01651975|comprehensive DSS|comprehensive dss
448159|NCT01651975|informed consent|informed consent
448160|NCT01651962|Labor Pain|labor pain
448161|NCT01651962|Analgesia, Epidural|analgesia, epidural
448162|NCT01651923|subjects|subjects
448163|NCT01651910|Cancer Pain|cancer pain
448164|NCT01651910|Breakthrough Pain|breakthrough pain
448165|NCT01651910|Unmet Needs|unmet needs
448166|NCT01651910|Supportive care needs|supportive care needs
448167|NCT01651897|delirium|delirium
448168|NCT01651897|emergency department|emergency department
448169|NCT01651897|natural course|natural course
448170|NCT01651897|outcomes|outcomes
448171|NCT01651897|elderly|elderly
448172|NCT01651884|Stroke|stroke
448173|NCT01651884|Anomia|anomia
448174|NCT01651871|Agents, anti allergic|agents, anti allergic
448175|NCT01651871|Nasal congestion|nasal congestion
448176|NCT01651871|Sneezing|sneezing
448177|NCT01651871|Nasal discharge|nasal discharge
448178|NCT01651871|D prostanoid (DP) receptor antagonist|d prostanoid (dp) receptor antagonist
448179|NCT01651832|Colorectal Neoplasms/*drug therapy/*secondary|colorectal neoplasms/*drug therapy/*secondary
448180|NCT01651832|Health Services Accessibility|health services accessibility
448181|NCT01651832|Humans|humans
448182|NCT01651832|Supportive Care Needs|supportive care needs
448183|NCT01651832|Psychooncology|psychooncology
448184|NCT01651832|Rural Population|rural population
448185|NCT01651832|Primary Health Care/*methods|primary health care/*methods
448186|NCT01651832|Treatment Outcome|treatment outcome
448187|NCT01651832|Socioeconomic Factors|socioeconomic factors
448188|NCT01651832|Quality Assurance, Health Care|quality assurance, health care
448189|NCT01651832|Quality of Life|quality of life
448190|NCT01651832|Adult|adult
448191|NCT01651832|Aged|aged
448192|NCT01651832|Aged, 80 and over|aged, 80 and over
448193|NCT01651819|HTLV-1|htlv-1
448194|NCT01651819|neurogenic bladder|neurogenic bladder
448195|NCT01651819|physical therapy|physical therapy
448196|NCT01651819|Tropical Spastic Paraparesis|tropical spastic paraparesis
448197|NCT01651806|Blood loss|blood loss
448198|NCT01651806|transfusion rates|transfusion rates
448199|NCT01651806|complications|complications
448200|NCT01651793|cacao|cacao
448201|NCT01651793|theobromine|theobromine
448202|NCT01651793|flavanols|flavanols
448203|NCT01651793|caffeine|caffeine
448204|NCT01651793|sustained attention|sustained attention
448205|NCT01651793|vigilance|vigilance
448206|NCT01651793|vigor|vigor
448207|NCT01651793|vitality|vitality
448208|NCT01651793|energy|energy
448209|NCT01651793|fatigue|fatigue
448210|NCT01651780|Transcatheter aortic valve replacement|transcatheter aortic valve replacement
448211|NCT01651780|Aortic valve replacement|aortic valve replacement
448212|NCT01651780|Severe aortic stenosis|severe aortic stenosis
448213|NCT01651767|Chronic hepatitis C virus infection|chronic hepatitis c virus infection
448214|NCT01651767|JNJ-47910382|jnj-47910382
448215|NCT01651767|Pharmacokinetics|pharmacokinetics
448216|NCT01651767|Caucasian genotype-1|caucasian genotype-1
448217|NCT01651767|Non-structural protein 5A (NS5A) inhibitor|non-structural protein 5a (ns5a) inhibitor
448218|NCT01651741|Intestinal Microbiota|intestinal microbiota
448219|NCT01651741|Probiotics|probiotics
448220|NCT01651741|Seaweed|seaweed
448221|NCT01651741|Healthy Subject|healthy subject
448222|NCT01651728|Simvastatin|simvastatin
448223|NCT01651728|Pneumonia|pneumonia
448224|NCT01651728|Elderly|elderly
448225|NCT01651728|TNF-α|tnf-α
448226|NCT01651728|IFN-ϒ|ifn-ϒ
448227|NCT01651728|PAI-1|pai-1
448228|NCT01651728|CRP|crp
448229|NCT01651702|Arrhythmia|arrhythmia
448230|NCT01651702|Electroanatomical mapping|electroanatomical mapping
448231|NCT01651689|Scalp biopsy|scalp biopsy
448232|NCT01651689|Hair count|hair count
448233|NCT01651689|Vertical section|vertical section
448234|NCT01651689|Horizontal section|horizontal section
448235|NCT01651689|Thais|thais
448236|NCT01651676|VQ11 questionnaire|vq11 questionnaire
448237|NCT01651676|COPD|copd
448238|NCT01651676|LBD|lbd
448239|NCT01651663|Influenza|influenza
448240|NCT01651650|Asthma|asthma
448241|NCT01651650|PIF|pif
448242|NCT01651637|Respiratory Distress syndrome|respiratory distress syndrome
448243|NCT01651637|Complications of prematurity|complications of prematurity
448244|NCT01651624|Colorectal Cancer|colorectal cancer
448245|NCT01651624|Screening|screening
448246|NCT01651624|Fecal Occult Blood Test|fecal occult blood test
448247|NCT01651624|CT Colonography|ct colonography
448248|NCT01651624|Virtual Colonoscopy|virtual colonoscopy
448249|NCT01651624|Colonoscopy|colonoscopy
448250|NCT01651611|Tobacco Cessation|tobacco cessation
448251|NCT01651611|Public Housing|public housing
448252|NCT01651611|Community Health Workers|community health workers
448253|NCT01651611|Motivational Interviewing|motivational interviewing
448254|NCT01651611|Patient centered|patient centered
448255|NCT01651611|Low-income|low-income
448256|NCT01651611|Tobacco Treatment Advocates|tobacco treatment advocates
448257|NCT01651611|Social Epidemiology|social epidemiology
448258|NCT01651611|Smoking cessation predictors|smoking cessation predictors
448259|NCT01651611|Behavioral Intervention|behavioral intervention
448260|NCT01651611|Non-pharmacologic|non-pharmacologic
448261|NCT01651585|viral disease|viral disease
448262|NCT01651585|cytomegalovirus infection|cytomegalovirus infection
448263|NCT01651585|is the first cause|is the first cause
448264|NCT01651585|of congenital|of congenital
448265|NCT01651585|neurological handicap|neurological handicap
448266|NCT01651585|of infectious origin.|of infectious origin.
448267|NCT01651572|Postoperative residual curarization|postoperative residual curarization
448268|NCT01651572|Residual neuromuscular block|residual neuromuscular block
448269|NCT01651572|Complications|complications
448270|NCT01651572|Postoperative|postoperative
448271|NCT01651572|Neuromuscular function|neuromuscular function
448272|NCT01651572|Neuromuscular block|neuromuscular block
448273|NCT01651559|modified PASI|modified pasi
448274|NCT01651559|narrow band UVB phototherapy|narrow band uvb phototherapy
448275|NCT01651559|Dead Sea Minerals|dead sea minerals
448276|NCT01651559|Skin auto-Fluorescence|skin auto-fluorescence
448277|NCT01651559|Skin wash samples|skin wash samples
448278|NCT01651546|Clean Intermittent Self Catheterization|clean intermittent self catheterization
448279|NCT01651546|acceptance|acceptance
448280|NCT01651546|test|test
448281|NCT01651533|Mental practice group|mental practice group
448282|NCT01651533|Active control group|active control group
448283|NCT01651520|Neurodegeneration|neurodegeneration
448284|NCT01651520|Disability|disability
448285|NCT01651520|Cognition|cognition
448286|NCT01651520|Prognosis|prognosis
448287|NCT01651507|Pulmonary Langerhans cell histiocytosis|pulmonary langerhans cell histiocytosis
448288|NCT01651494|DAS181|das181
448289|NCT01651494|Influenza|influenza
448290|NCT01651494|inhalation|inhalation
448291|NCT01651494|inpatient clinic|inpatient clinic
448292|NCT01651494|Multi-Dose|multi-dose
448293|NCT01651494|recombinant neuraminidase|recombinant neuraminidase
448294|NCT01651481|Rhinitis|rhinitis
448295|NCT01651468|mild bleeding disorder|mild bleeding disorder
448296|NCT01651455|Cystic Fibrosis|cystic fibrosis
448297|NCT01651455|Pseudomonas Aeruginosa|pseudomonas aeruginosa
448298|NCT01651429|Sleep Deprivation|sleep deprivation
448299|NCT01651416|Home management of malaria|home management of malaria
448300|NCT01651416|Seasonal malaria chemoprevention|seasonal malaria chemoprevention
448301|NCT01651403|Hepatitis|hepatitis
448302|NCT01651403|Hepatitis B|hepatitis b
448303|NCT01651403|HBV|hbv
448304|NCT01651390|Restenosis|restenosis
448305|NCT01651390|Drug coated balloon|drug coated balloon
448306|NCT01651390|Drug eluting stent|drug eluting stent
448307|NCT01651390|Paclitaxel|paclitaxel
448308|NCT01651390|Sirolimus|sirolimus
448309|NCT01651377|Pramipexole|pramipexole
448310|NCT01651377|Mirapex|mirapex
448311|NCT01651377|Cocaine|cocaine
448312|NCT01651364|Cocaine|cocaine
448313|NCT01651364|Cabergoline|cabergoline
448314|NCT01651351|for this study|for this study
448315|NCT01651351|volunteers|volunteers
448316|NCT01651351|Focus|focus
448317|NCT01651351|Condition:|condition:
448318|NCT01651338|Acupuncture|acupuncture
448319|NCT01651338|quality of life|quality of life
448320|NCT01651325|Isavuconazole|isavuconazole
448321|NCT01651325|dextromethorphan|dextromethorphan
448322|NCT01651325|dextrorphan|dextrorphan
448323|NCT01651325|DXM|dxm
448324|NCT01651325|Healthy Volunteers|healthy volunteers
448325|NCT01651325|BAL4815|bal4815
448326|NCT01651312|Radioactivity|radioactivity
448327|NCT01651312|Excretion rate|excretion rate
448328|NCT01651312|Human subjects|human subjects
448329|NCT01651312|Pharmacokinetics|pharmacokinetics
448330|NCT01651312|YM178|ym178
448331|NCT01651312|Radio-labeled|radio-labeled
448332|NCT01651312|Phase 1|phase 1
448333|NCT01651299|copperhead snake envenomation|copperhead snake envenomation
448334|NCT01651286|General anesthesia|general anesthesia
448335|NCT01651286|Positive-pressure ventilation|positive-pressure ventilation
448336|NCT01651286|Masks|masks
448337|NCT01651247|Toddlers|toddlers
448338|NCT01651247|Retrospective|retrospective
448339|NCT01651247|Porcine circovirus type 1 (PCV-1)|porcine circovirus type 1 (pcv-1)
448340|NCT01651247|Infants|infants
448341|NCT01651247|Laboratory evaluations|laboratory evaluations
448342|NCT01651247|IPV|ipv
448343|NCT01651221|gustatory response|gustatory response
448344|NCT01651221|olfactory response|olfactory response
448345|NCT01651208|Coronary stents|coronary stents
448346|NCT01651208|Medication adherence|medication adherence
448347|NCT01651208|Antiplatelet medications|antiplatelet medications
448348|NCT01651208|Motivational Interviewing|motivational interviewing
448349|NCT01651182|Blood transfusion|blood transfusion
448350|NCT01651182|Blood loss|blood loss
448351|NCT01651182|Postoperative complications|postoperative complications
448352|NCT01651182|Outcome|outcome
448353|NCT01651169|Paired Transcranial Magnetic Stimulation|paired transcranial magnetic stimulation
448354|NCT01651169|Methamphetamine abuse, ADHD, Methylphenidate|methamphetamine abuse, adhd, methylphenidate
448355|NCT01651169|We study the effect of Methamphetamine abuse on Intracortical Inhibition, in ADHD patients, treated with Methylphenidate.|we study the effect of methamphetamine abuse on intracortical inhibition, in adhd patients, treated with methylphenidate.
448356|NCT01651130|pregnancy|pregnancy
448357|NCT01651130|postpartum hemorrhage|postpartum hemorrhage
448358|NCT01651130|Cesarean delivery|cesarean delivery
448359|NCT01651130|carbetocin|carbetocin
448360|NCT01651117|Diabetes Mellitus|diabetes mellitus
448361|NCT01651117|Mentors|mentors
448362|NCT01651117|Glucose control|glucose control
448363|NCT01651117|Hemoglobin A, Glycosylated|hemoglobin a, glycosylated
448364|NCT01651117|Randomized Controlled Trial|randomized controlled trial
448365|NCT01651117|Veterans|veterans
448366|NCT01651104|Influenza, Trivalent, Adjuvanted, Adjuvant, MF59, MF-59, Fluad, Seasonal|influenza, trivalent, adjuvanted, adjuvant, mf59, mf-59, fluad, seasonal
448367|NCT01651078|Metastatic Brain Tumors|metastatic brain tumors
448368|NCT01651078|Progression|progression
448369|NCT01651078|Radiation Necrosis|radiation necrosis
448370|NCT01651078|Quality of Life|quality of life
448371|NCT01651052|Aortic valve replacement/regurgitation|aortic valve replacement/regurgitation
448372|NCT01651039|Panobinostat|panobinostat
448373|NCT01651039|Lenalidomide|lenalidomide
448374|NCT01651039|Dexamethasone|dexamethasone
448375|NCT01651000|Parathyroid Diseases|parathyroid diseases
448376|NCT01651000|Renal Insufficiency|renal insufficiency
448377|NCT01651000|Kidney Failure, Chronic|kidney failure, chronic
448378|NCT01651000|Hyperparathyroidism, Secondary|hyperparathyroidism, secondary
448379|NCT01651000|Vitamin D|vitamin d
448380|NCT01651000|Hyperparathyroidism|hyperparathyroidism
448381|NCT01651000|Kidney Diseases|kidney diseases
448382|NCT01651000|Kidney Failure|kidney failure
448383|NCT01651000|Renal Insufficiency, Chronic|renal insufficiency, chronic
448384|NCT01650987|carcinoma|carcinoma
448385|NCT01650987|uterus|uterus
448386|NCT01650987|Not metastatic|not metastatic
448387|NCT01650974|high flow nasal oxygen therapy|high flow nasal oxygen therapy
448388|NCT01650974|diagnostic bronchoscopy|diagnostic bronchoscopy
448389|NCT01650948|age-related macular degeneration|age-related macular degeneration
448390|NCT01650948|AMD|amd
448391|NCT01650935|Nephrolithiasis|nephrolithiasis
448392|NCT01650935|Recurrent stone former|recurrent stone former
448393|NCT01650935|DASH|dash
448394|NCT01650935|Urine oxalate|urine oxalate
448395|NCT01650935|Urine calcium oxalate supersaturation|urine calcium oxalate supersaturation
448396|NCT01650896|Delirium|delirium
448397|NCT01650896|Dementia|dementia
448398|NCT01650896|Instrumental activities of daily living|instrumental activities of daily living
448399|NCT01650883|Vitamin D3|vitamin d3
448400|NCT01650883|Vitamin D 25 OH|vitamin d 25 oh
448401|NCT01650870|Cathartics|cathartics
448402|NCT01650870|Laxatives|laxatives
448403|NCT01650870|Lactulose|lactulose
448404|NCT01650870|Gastrointestinal Agents|gastrointestinal agents
448405|NCT01650870|Therapeutic Uses|therapeutic uses
448406|NCT01650870|Pharmacologic Actions|pharmacologic actions
448407|NCT01650857|Pulmonary hypertension|pulmonary hypertension
448408|NCT01650857|Rehabilitation|rehabilitation
448409|NCT01650857|Exercise capacity|exercise capacity
448410|NCT01650857|Body composition|body composition
448411|NCT01650857|Health related Quality of Life|health related quality of life
448412|NCT01650831|Helicobacter Pylori|helicobacter pylori
448413|NCT01650831|13C Urea Breath Test|13c urea breath test
448414|NCT01650831|BreathID|breathid
448415|NCT01650818|Amyotrophic lateral sclerosis|amyotrophic lateral sclerosis
448416|NCT01650818|Aerobic training|aerobic training
448417|NCT01650818|Peak oxygen consumption|peak oxygen consumption
448418|NCT01650818|Quality of life|quality of life
448419|NCT01650805|Leukemia|leukemia
448420|NCT01650805|Leukemia, Myeloid|leukemia, myeloid
448421|NCT01650805|Leukemia, Myelogenous, Chronic, BCR-ABL Positive|leukemia, myelogenous, chronic, bcr-abl positive
448422|NCT01650805|Neoplasms by Histologic Type|neoplasms by histologic type
448423|NCT01650805|Neoplasms|neoplasms
448424|NCT01650805|Lymphoproliferative Disorders|lymphoproliferative disorders
448425|NCT01650805|Lymphatic Diseases|lymphatic diseases
448426|NCT01650805|Immunoproliferative Disorders|immunoproliferative disorders
448427|NCT01650805|Immune System Diseases|immune system diseases
448428|NCT01650805|Myeloproliferative Disorders|myeloproliferative disorders
448429|NCT01650805|Bone Marrow Diseases|bone marrow diseases
448430|NCT01650805|Hematologic Diseases|hematologic diseases
448431|NCT01650792|Chagas disease|chagas disease
448432|NCT01650792|Heart failure|heart failure
448433|NCT01650792|Stroke|stroke
448434|NCT01650792|Dementia|dementia
448435|NCT01650779|alpha-galactosidase A|alpha-galactosidase a
448436|NCT01650779|a-GAL|a-gal
448437|NCT01650779|Fabry|fabry
448438|NCT01650779|GL-3|gl-3
448439|NCT01650779|Fabrazyme|fabrazyme
448440|NCT01650701|follicular lymphoma|follicular lymphoma
448441|NCT01650701|non-hodgkins follicular lymphoma|non-hodgkins follicular lymphoma
448442|NCT01650701|treatment for follicular lymphoma|treatment for follicular lymphoma
448443|NCT01650701|rituximab treatment|rituximab treatment
448444|NCT01650701|rituximab and lenalidomide treatment|rituximab and lenalidomide treatment
448445|NCT01650688|Epiblepharon, general anesthesia, positional change|epiblepharon, general anesthesia, positional change
448446|NCT01650675|pregnancy|pregnancy
448447|NCT01650675|screening|screening
448448|NCT01650675|motivation|motivation
448449|NCT01650662|Acute Myocardial Infarction|acute myocardial infarction
448450|NCT01650662|Cyclosporine A|cyclosporine a
448451|NCT01650662|Reperfusion|reperfusion
448452|NCT01650662|Clinical Trial|clinical trial
448453|NCT01650649|lofexidine|lofexidine
448454|NCT01650649|methadone|methadone
448455|NCT01650649|interaction|interaction
448456|NCT01650649|pharmacodynamic|pharmacodynamic
448458|NCT01650649|QTc|qtc
448459|NCT01650636|Videophone-delivered stress management intervention|videophone-delivered stress management intervention
448460|NCT01650636|Chronic fatigue syndrome|chronic fatigue syndrome
448461|NCT01650636|Symptoms|symptoms
448462|NCT01650636|Neuroimmune processes|neuroimmune processes
448463|NCT01650636|Psychosocial|psychosocial
448464|NCT01650623|Parkinson´s Disease|parkinson´s disease
448465|NCT01650623|Rehabilitation|rehabilitation
448466|NCT01650623|Cognition|cognition
448467|NCT01650610|Parkinson´s Disease|parkinson´s disease
448468|NCT01650610|Rehabilitation|rehabilitation
448469|NCT01650610|Cognition|cognition
448470|NCT01650597|Healthy volunteers|healthy volunteers
448471|NCT01650597|Pharmacokinetics|pharmacokinetics
448472|NCT01650597|Free fatty amides|free fatty amides
448473|NCT01650558|Malaria|malaria
448474|NCT01650558|HIV|hiv
448475|NCT01650558|Prophylaxis|prophylaxis
448476|NCT01650558|Antiretroviral therapy|antiretroviral therapy
448477|NCT01650545|case-control study|case-control study
448478|NCT01650545|aerosolized liposomal cyclosporine A|aerosolized liposomal cyclosporine a
448479|NCT01650545|bronchiolitis obliterans syndrome|bronchiolitis obliterans syndrome
448480|NCT01650545|Lung Transplantation|lung transplantation
448481|NCT01650545|Lung function|lung function
448482|NCT01650519|knee surgery, arthroscopy; orthopaedic, orthopedic surgery|knee surgery, arthroscopy; orthopaedic, orthopedic surgery
448483|NCT01650506|Triple Negative|triple negative
448484|NCT01650506|Basal-like|basal-like
448485|NCT01650493|remineralization|remineralization
448486|NCT01650493|demineralzation|demineralzation
448487|NCT01650493|in situ|in situ
448488|NCT01650493|dentrifice|dentrifice
448489|NCT01650480|COPD|copd
448490|NCT01650480|holistic|holistic
448491|NCT01650480|pilot|pilot
448492|NCT01650480|intervention|intervention
448493|NCT01650467|abl polymorphisms|abl polymorphisms
448494|NCT01650454|Alzheimer|alzheimer
448495|NCT01650454|Sleep|sleep
448496|NCT01650454|Somnolence|somnolence
448497|NCT01650441|Asthma|asthma
448498|NCT01650441|NEXThaler®|nexthaler®
448499|NCT01650441|Formoterol|formoterol
448500|NCT01650441|Beclomethasone Dipropionate|beclomethasone dipropionate
448501|NCT01650441|Computational Fluid Dynamics|computational fluid dynamics
448502|NCT01650441|Functional Imaging|functional imaging
448503|NCT01650441|Central and Peripheral Airways|central and peripheral airways
448504|NCT01650441|Asthma Control Test (ACT™)|asthma control test (act™)
448505|NCT01650441|Asthma Control Questionnaire (ACQ)|asthma control questionnaire (acq)
448506|NCT01650428|Rectal Cancer|rectal cancer
448507|NCT01650428|Bevacizumab|bevacizumab
448508|NCT01650428|Neoadjuvant|neoadjuvant
448509|NCT01650428|Chemotherapy|chemotherapy
448510|NCT01650428|Randomised|randomised
448511|NCT01650415|Cerebral Palsy|cerebral palsy
448512|NCT01650415|Erythropoietin|erythropoietin
448513|NCT01650415|Rehabilitation|rehabilitation
448514|NCT01650402|Hypertension, systolic|hypertension, systolic
448515|NCT01650402|Elderly (> or equal to 75 years)|elderly (> or equal to 75 years)
448516|NCT01650402|Cerebrovascular disease|cerebrovascular disease
448517|NCT01650389|Tuberculosis|tuberculosis
448518|NCT01650389|HIV|hiv
448519|NCT01650389|BCG|bcg
448520|NCT01650389|Infant|infant
448521|NCT01650376|Ovarian Neoplasms|ovarian neoplasms
448522|NCT01650376|Cancer of the Ovary|cancer of the ovary
448523|NCT01650376|Ovarian Cancer|ovarian cancer
448524|NCT01650376|Uterine Neoplasms|uterine neoplasms
448525|NCT01650376|Cancer of the Uterus|cancer of the uterus
448526|NCT01650376|Uterine Cancer|uterine cancer
448527|NCT01650376|Olaparib|olaparib
448528|NCT01650376|AZD2281|azd2281
448529|NCT01650376|Carboplatin|carboplatin
448530|NCT01650376|Paclitaxel|paclitaxel
448531|NCT01650376|Relapsed|relapsed
448532|NCT01650363|Complementary and alternative medicine|complementary and alternative medicine
448533|NCT01650363|Post operative recovery|post operative recovery
448534|NCT01650363|Cardio- thoracic surgery|cardio- thoracic surgery
448535|NCT01650350|Melanoma|melanoma
448536|NCT01650350|Prostate Cancer|prostate cancer
448537|NCT01650350|Renal Cancer|renal cancer
448538|NCT01650324|DBPR108|dbpr108
448539|NCT01650324|DPP4|dpp4
448540|NCT01650324|Diabetes|diabetes
448541|NCT01650324|GLP-1|glp-1
448542|NCT01650324|Incretins|incretins
448543|NCT01650311|IBD, CD, UC, Serotonin, 5-HT|ibd, cd, uc, serotonin, 5-ht
448544|NCT01650285|Prostate Cancer|prostate cancer
448545|NCT01650285|Radical prostatectomy|radical prostatectomy
448546|NCT01650207|electroacupuncture|electroacupuncture
448547|NCT01650207|TENS|tens
448548|NCT01650207|shoulder disorder|shoulder disorder
448549|NCT01650207|hemiplegia|hemiplegia
448550|NCT01650194|abiraterone acetate|abiraterone acetate
448551|NCT01650194|prednisone|prednisone
448552|NCT01650194|enzalutamide|enzalutamide
448553|NCT01650194|cancer|cancer
448554|NCT01650194|prostate|prostate
448555|NCT01650194|MDV3100|mdv3100
448556|NCT01650181|nafld, nash, fatty liver|nafld, nash, fatty liver
448557|NCT01650168|NOMAC-E2|nomac-e2
448558|NCT01650168|Nomegestrol acetate|nomegestrol acetate
448559|NCT01650168|Estradiol|estradiol
448560|NCT01650168|Levonorgestrel|levonorgestrel
448561|NCT01650168|Safety|safety
448562|NCT01650142|Neurofibromatosis 1|neurofibromatosis 1
448563|NCT01650142|Phenotype|phenotype
448564|NCT01650142|Modifiers|modifiers
448565|NCT01650116|hypovolemia|hypovolemia
448566|NCT01650116|renal hypoperfusion|renal hypoperfusion
448567|NCT01650116|liver transplantation|liver transplantation
448568|NCT01650116|sodium|sodium
448569|NCT01650116|chloride|chloride
448570|NCT01650116|PuCO2|puco2
448571|NCT01650116|ScvO2|scvo2
448572|NCT01650116|PiCCO|picco
448573|NCT01650116|O2-delivery|o2-delivery
448574|NCT01650116|hemodynamic indexes|hemodynamic indexes
448575|NCT01650103|hypovolemia|hypovolemia
448576|NCT01650103|renal hypoperfusion|renal hypoperfusion
448577|NCT01650103|major surgery|major surgery
448578|NCT01650103|sodium|sodium
448579|NCT01650103|potassium|potassium
448580|NCT01650103|chloride|chloride
448581|NCT01650103|ScvO2|scvo2
448582|NCT01650103|hemodynamic indexes|hemodynamic indexes
448583|NCT01650090|Pulmonary relapse|pulmonary relapse
448584|NCT01650090|Osteosarcoma|osteosarcoma
448585|NCT01650090|Lung metastases|lung metastases
448586|NCT01650090|Pediatric osteosarcoma|pediatric osteosarcoma
448587|NCT01650090|Inhaled chemotherapy|inhaled chemotherapy
448588|NCT01650090|Inhaled Lipid Cisplatin|inhaled lipid cisplatin
448589|NCT01650077|Soft tissue sarcoma|soft tissue sarcoma
448590|NCT01650077|Yondelis|yondelis
448591|NCT01650077|Intolerance to doxorubicin/ifosfamide|intolerance to doxorubicin/ifosfamide
448592|NCT01650077|CHOI criteria|choi criteria
448593|NCT01650064|Hip fracture|hip fracture
448594|NCT01650064|Mortality|mortality
448595|NCT01650038|faecal transplantation|faecal transplantation
448596|NCT01650038|ulcerative colitis|ulcerative colitis
448597|NCT01650038|inflammatory bowel disease|inflammatory bowel disease
448598|NCT01650025|probiotic, obesity, BMI, metabolic profile, metabolomics|probiotic, obesity, bmi, metabolic profile, metabolomics
448599|NCT01649999|Rheumatoid Arthritis|rheumatoid arthritis
448600|NCT01649999|ASP015K|asp015k
448601|NCT01649986|Hyperlipidemia|hyperlipidemia
448602|NCT01649986|Non-pharmacologic prevention|non-pharmacologic prevention
448603|NCT01649960|Aging|aging
448604|NCT01649960|Biomarkers|biomarkers
448605|NCT01649960|CAD|cad
448606|NCT01649947|Lung cancer|lung cancer
448607|NCT01649947|Non-small cell lung cancer|non-small cell lung cancer
448608|NCT01649947|Advanced non-small cell lung cancer|advanced non-small cell lung cancer
448609|NCT01649947|Recurrent non-small cell lung cancer|recurrent non-small cell lung cancer
448610|NCT01649934|Appointments and Schedules|appointments and schedules
448611|NCT01649921|Sepsis|sepsis
448612|NCT01649921|SIRS|sirs
448613|NCT01649921|Septic shock|septic shock
448614|NCT01649921|Immunoparalysis|immunoparalysis
448615|NCT01649921|Interferon-gamma|interferon-gamma
448616|NCT01649895|Obsessive-compulsive disorder|obsessive-compulsive disorder
448617|NCT01649895|internet|internet
448618|NCT01649895|cognitive-behaviour therapy|cognitive-behaviour therapy
448619|NCT01649895|D-Cycloserine|d-cycloserine
448620|NCT01649882|endotracheal tube position|endotracheal tube position
448621|NCT01649882|intubation|intubation
448623|NCT01649869|Cytomegalovirus|cytomegalovirus
448624|NCT01649869|Hearing Loss|hearing loss
448625|NCT01649869|Infants|infants
448626|NCT01649869|Valganciclovir|valganciclovir
448627|NCT01649843|Peroral endoscopic myotomy|peroral endoscopic myotomy
448628|NCT01649843|Esophageal Achalasia|esophageal achalasia
448629|NCT01649830|low-grade glioma|low-grade glioma
448630|NCT01649830|radiotherapy|radiotherapy
448631|NCT01649830|chemotherapy|chemotherapy
448632|NCT01649765|SLE Flare Index|sle flare index
448633|NCT01649765|SRI|sri
448634|NCT01649765|belimumab|belimumab
448635|NCT01649765|efficacy|efficacy
448636|NCT01649765|safety|safety
448637|NCT01649765|B lymphocyte|b lymphocyte
448638|NCT01649765|BLyS|blys
448639|NCT01649765|SELENA SLEDAI|selena sledai
448640|NCT01649765|BILAG|bilag
448641|NCT01649765|Lupus|lupus
448642|NCT01649765|Systemic Lupus Erythematosus (SLE)|systemic lupus erythematosus (sle)
448643|NCT01649765|PGA|pga
448644|NCT01649765|Pharmacokinetics|pharmacokinetics
448645|NCT01649765|placebo|placebo
448646|NCT01649765|PRINTO|printo
448647|NCT01649752|Stem cells|stem cells
448648|NCT01649752|Uterine cavity|uterine cavity
448649|NCT01649752|Implantation|implantation
448650|NCT01649752|ICSI|icsi
448651|NCT01649739|PAH|pah
448652|NCT01649713|Fluval AB|fluval ab
448653|NCT01649713|influenza|influenza
448654|NCT01649713|vaccine|vaccine
448655|NCT01649713|immunization|immunization
448656|NCT01649713|infections|infections
448657|NCT01649661|MRI|mri
448658|NCT01649661|12-125|12-125
448659|NCT01649661|premenopausal women|premenopausal women
448660|NCT01649661|postmenopausal women|postmenopausal women
448661|NCT01649661|questionnaire|questionnaire
448662|NCT01649648|Hypoxic ischemic encephalopathy|hypoxic ischemic encephalopathy
448663|NCT01649648|Autologous cord blood|autologous cord blood
448664|NCT01649622|Leukemia|leukemia
448665|NCT01649622|Lymphoma|lymphoma
448666|NCT01649622|Acute Lymphoblastic Leukemia/Lymphoma|acute lymphoblastic leukemia/lymphoma
448667|NCT01649622|ALL|all
448668|NCT01649622|Relapsed or primary refractory B-cell/T-cell|relapsed or primary refractory b-cell/t-cell
448669|NCT01649622|Bendamustine|bendamustine
448670|NCT01649622|Bendamustine Hydrochloride|bendamustine hydrochloride
448671|NCT01649622|Bendamustine HCL|bendamustine hcl
448672|NCT01649622|CEP-18083|cep-18083
448673|NCT01649622|SDX-105|sdx-105
448674|NCT01649622|Treanda|treanda
448675|NCT01649609|BK Viremia|bk viremia
448676|NCT01649609|BK Nephropathy|bk nephropathy
448677|NCT01649609|mTOR inhibitor|mtor inhibitor
448678|NCT01649609|renal transplant|renal transplant
448679|NCT01649557|Schizophrenia|schizophrenia
448680|NCT01649544|Mitral valvulopathy|mitral valvulopathy
448681|NCT01649544|Atrial Fibrillation|atrial fibrillation
448682|NCT01649544|Amiodarone|amiodarone
448683|NCT01649544|Paroxysmal Atrial Fibrillation|paroxysmal atrial fibrillation
448684|NCT01649544|Chronic Atrial Fibrillation|chronic atrial fibrillation
448685|NCT01649544|Ultrasound Technique|ultrasound technique
448686|NCT01649492|diclofenac|diclofenac
448687|NCT01649492|CYP2C9|cyp2c9
448688|NCT01649492|bromelain|bromelain
448689|NCT01649492|pineapple juice|pineapple juice
448690|NCT01649479|Obstetrical antiphospholipid syndrome|obstetrical antiphospholipid syndrome
448691|NCT01649479|Thrombophilia|thrombophilia
448692|NCT01649466|Type 2 diabetes mellitus, diabetes|type 2 diabetes mellitus, diabetes
448693|NCT01649453|Neoplasms|neoplasms
448694|NCT01649453|Neoplasm Metastasis|neoplasm metastasis
448695|NCT01649453|Neoplastic Processes|neoplastic processes
448696|NCT01649453|Pathologic Processes|pathologic processes
448697|NCT01649440|Metabolomics|metabolomics
448698|NCT01649440|serum|serum
448699|NCT01649440|sepsis|sepsis
448700|NCT01649440|biomarkers|biomarkers
448701|NCT01649427|Pharmacokinetics Study|pharmacokinetics study
448702|NCT01649427|Tacroliums|tacroliums
448704|NCT01649427|kidney|kidney
448705|NCT01649427|transplant rejection|transplant rejection
448706|NCT01649427|allograft rejection|allograft rejection
448707|NCT01649427|xenograft rejection|xenograft rejection
448708|NCT01649427|host vs graft disease|host vs graft disease
448709|NCT01649427|renal transplant|renal transplant
448710|NCT01649401|nebulizer|nebulizer
448711|NCT01649401|PARI LC Spring SP|pari lc spring sp
448712|NCT01649388|Kidney transplant|kidney transplant
448713|NCT01649388|Delayed tolerance|delayed tolerance
448714|NCT01649388|Marrow/enriched hematopoetic stem cell transplant|marrow/enriched hematopoetic stem cell transplant
448715|NCT01649375|Ankylosing spondylitis|ankylosing spondylitis
448716|NCT01649375|AS|as
448717|NCT01649375|Chronic inflammatory disease|chronic inflammatory disease
448718|NCT01649375|Inflammatory back pain|inflammatory back pain
448719|NCT01649375|Secukinumab|secukinumab
448720|NCT01649375|Prefilled syringe|prefilled syringe
448721|NCT01649375|PFS|pfs
448722|NCT01649375|Subcutaneous injection|subcutaneous injection
448723|NCT01649375|AIN457|ain457
448724|NCT01649375|AIN457F|ain457f
448725|NCT01649375|AIN457F2310|ain457f2310
448726|NCT01649375|adult|adult
448727|NCT01649362|preterm infant|preterm infant
448728|NCT01649362|feeding difficulties|feeding difficulties
448729|NCT01649362|prefeeding oral stimulation|prefeeding oral stimulation
448730|NCT01649310|Chronic obstructive pulmonary disease (COPD)|chronic obstructive pulmonary disease (copd)
448731|NCT01649310|Muscle strenght|muscle strenght
448732|NCT01649310|Aged|aged
448733|NCT01649245|Chronic hepatitis C|chronic hepatitis c
448734|NCT01649245|Egyptian patients|egyptian patients
448735|NCT01649245|pegylated interferon|pegylated interferon
448736|NCT01649245|Ribavirin|ribavirin
448737|NCT01649245|Reiferon retard|reiferon retard
448738|NCT01649232|tdcs|tdcs
448739|NCT01649232|tms|tms
448740|NCT01649232|qeeg|qeeg
448741|NCT01649232|neuroplasticity|neuroplasticity
448742|NCT01649232|brain networks|brain networks
448743|NCT01649232|add|add
448744|NCT01649232|adhs|adhs
448745|NCT01649219|Prediabetes, objectively measured exercise, glucose and lipid metabolism, dose response, muscle metabolism.|prediabetes, objectively measured exercise, glucose and lipid metabolism, dose response, muscle metabolism.
448746|NCT01649206|Thyroid Nodule|thyroid nodule
448747|NCT01649206|Radiofrequency Thermal Ablation|radiofrequency thermal ablation
448748|NCT01649206|Pressure symptoms|pressure symptoms
448749|NCT01649206|Hyperthyroidism|hyperthyroidism
448750|NCT01649193|Rehabilitation [E02.831]|rehabilitation [e02.831]
448751|NCT01649193|Exercise [G11.427.394.380]|exercise [g11.427.394.380]
448752|NCT01649193|Health Education [I02.233.332]|health education [i02.233.332]
448753|NCT01649193|[C08]|[c08]
448754|NCT01649193|[C08.381]|[c08.381]
448755|NCT01649180|RCC|rcc
448756|NCT01649180|Clear Cell Renal Cell Carcinoma|clear cell renal cell carcinoma
448757|NCT01649180|ccRCC|ccrcc
448758|NCT01649180|Metastatic RCC|metastatic rcc
448759|NCT01649180|Recurrent RCC|recurrent rcc
448760|NCT01649180|Kidney Cancer|kidney cancer
448761|NCT01649180|Kidney Neoplasms|kidney neoplasms
448762|NCT01649180|Axitinib|axitinib
448763|NCT01649180|AG-013736|ag-013736
448764|NCT01649180|Tyrosine Kinase Inhibition|tyrosine kinase inhibition
448765|NCT01649180|TKI|tki
448766|NCT01649167|body mass index|body mass index
448767|NCT01649167|gestational diabetes|gestational diabetes
448768|NCT01649167|leptin|leptin
448769|NCT01649167|obesity|obesity
448770|NCT01649167|pregnancy.|pregnancy.
448771|NCT01649141|posttraumatic stress disorder|posttraumatic stress disorder
448772|NCT01649141|trauma-focused cognitive behavioral therapy|trauma-focused cognitive behavioral therapy
448773|NCT01649141|trauma|trauma
448774|NCT01649141|child abuse|child abuse
448775|NCT01649128|preeclampsia|preeclampsia
448776|NCT01649115|obesity|obesity
448777|NCT01649115|overweight|overweight
448778|NCT01649115|childhood obesity|childhood obesity
448779|NCT01649115|prevention|prevention
448780|NCT01649115|Z score|z score
448781|NCT01649115|weight for length|weight for length
448782|NCT01649115|WFL|wfl
448783|NCT01649115|body mass index|body mass index
448784|NCT01649115|BMI|bmi
448785|NCT01649115|prenatal|prenatal
448786|NCT01649115|maternal|maternal
448787|NCT01649115|nutrition education|nutrition education
448788|NCT01649115|health education|health education
448789|NCT01649115|health literacy|health literacy
448790|NCT01649115|health numeracy|health numeracy
448791|NCT01649115|passport|passport
448792|NCT01649115|healthy lifestyles|healthy lifestyles
448793|NCT01649115|growth|growth
448794|NCT01649115|growth chart|growth chart
448795|NCT01649102|Chronic hemodialysis|chronic hemodialysis
448796|NCT01649102|Tunneled cuffed catheter|tunneled cuffed catheter
448797|NCT01649102|Catheter-related bloodstream infection|catheter-related bloodstream infection
448798|NCT01649102|Mechanical catheter dysfunction|mechanical catheter dysfunction
448799|NCT01649102|impact of catheter design on outcome|impact of catheter design on outcome
448800|NCT01649063|Uterine contraction;|uterine contraction;
448801|NCT01649063|Shape; Frequency;|shape; frequency;
448802|NCT01649063|First stage labor;|first stage labor;
448803|NCT01649063|Fall|fall
448804|NCT01649063|Rise ratio.|rise ratio.
448805|NCT01649050|Spasticity|spasticity
448806|NCT01649050|Multiple Sclerosis|multiple sclerosis
448807|NCT01649024|Tremelimumab|tremelimumab
448808|NCT01649024|Malignant Mesothelioma|malignant mesothelioma
448809|NCT01649024|anti-CTLA-4 mAb|anti-ctla-4 mab
448810|NCT01649011|Oswestry Disability Index|oswestry disability index
448811|NCT01649011|ODI|odi
448812|NCT01649011|Roland Morris Disability Questionnaire|roland morris disability questionnaire
448813|NCT01649011|RMDQ|rmdq
448814|NCT01648998|Mineralocorticoid receptor|mineralocorticoid receptor
448815|NCT01648998|Fludrocortisone|fludrocortisone
448816|NCT01648998|Information Processing|information processing
448817|NCT01648998|Cognition|cognition
448818|NCT01648998|Depression|depression
448819|NCT01648946|Strategies of transfusion|strategies of transfusion
448820|NCT01648946|Red blood cells|red blood cells
448821|NCT01648946|Liberal|liberal
448822|NCT01648946|Restrictive|restrictive
448823|NCT01648946|Oncologic critically ill patients|oncologic critically ill patients
448824|NCT01648933|sarcoidosis|sarcoidosis
448825|NCT01648933|heart|heart
448826|NCT01648933|Rubidium|rubidium
448827|NCT01648933|PET|pet
448828|NCT01648920|Asthma|asthma
448829|NCT01648920|Suspected but undiagnosed asthma|suspected but undiagnosed asthma
448830|NCT01648907|DESIR|desir
448831|NCT01648907|SPONDYLARTHRITIS|spondylarthritis
448832|NCT01648907|EARLY INFLAMMATORY RACHIIALGIA|early inflammatory rachiialgia
448833|NCT01648907|BACK PAIN|back pain
448834|NCT01648894|Rectal cancer|rectal cancer
448835|NCT01648894|radiochemotherapy|radiochemotherapy
448836|NCT01648894|complete pathological response|complete pathological response
448837|NCT01648868|TMSAutism|tmsautism
448838|NCT01648868|Eye-tracking|eye-tracking
448839|NCT01648868|Social perception|social perception
448840|NCT01648868|Social cognition|social cognition
448841|NCT01648855|Circulating antiangiogenic factors|circulating antiangiogenic factors
448842|NCT01648855|Preeclampsia|preeclampsia
448843|NCT01648855|Developing lung|developing lung
448844|NCT01648855|Bronchopulmonary dysplasia|bronchopulmonary dysplasia
448845|NCT01648842|Preeclampsia|preeclampsia
448846|NCT01648842|Vitamin D deficiency|vitamin d deficiency
448847|NCT01648842|Pregnancy|pregnancy
448848|NCT01648842|First trimester|first trimester
448849|NCT01648777|Pneumonia|pneumonia
448850|NCT01648777|Postoperative infection|postoperative infection
448851|NCT01648777|Cardiac surgery|cardiac surgery
448852|NCT01648777|Multiperforated catheter|multiperforated catheter
448853|NCT01648777|Analgesia|analgesia
448854|NCT01648751|Pelvic organ prolapse|pelvic organ prolapse
448855|NCT01648751|Pelvic floor physical therapy|pelvic floor physical therapy
448856|NCT01648751|Vaginal estrogen|vaginal estrogen
448857|NCT01648751|Placebo|placebo
448858|NCT01648738|Subacute low back pain|subacute low back pain
448859|NCT01648738|Chronic low back pain|chronic low back pain
448860|NCT01648738|Low back pain|low back pain
448861|NCT01648738|Disability|disability
448862|NCT01648738|Education|education
448863|NCT01648738|Exercise|exercise
448864|NCT01648738|Spa therapy|spa therapy
448865|NCT01648738|Physiotherapy|physiotherapy
448866|NCT01648738|Multidisciplinary|multidisciplinary
448867|NCT01648738|Cost-effectiveness|cost-effectiveness
448868|NCT01648738|Sick leave|sick leave
448869|NCT01648725|Hypnosis|hypnosis
448870|NCT01648725|Anesthesia|anesthesia
448871|NCT01648725|Propofol|propofol
448872|NCT01648725|Closed-loop|closed-loop
448873|NCT01648712|extracorporeal circuit, platelet function|extracorporeal circuit, platelet function
448874|NCT01648699|Pain|pain
448875|NCT01648699|Cancer|cancer
448876|NCT01648699|Osmotic Release Oral System|osmotic release oral system
448877|NCT01648699|OROS Hydromorphone|oros hydromorphone
448878|NCT01648699|Jurnista|jurnista
448879|NCT01648686|Alendronate|alendronate
448880|NCT01648686|Dental extraction|dental extraction
448881|NCT01648686|Bone healing|bone healing
448882|NCT01648686|postmenopausal women|postmenopausal women
448883|NCT01648686|dental radiography|dental radiography
448884|NCT01648673|Coronary Artery Disease|coronary artery disease
448885|NCT01648673|Cardiac Rehabilitation|cardiac rehabilitation
448886|NCT01648634|Nebivolol|nebivolol
448887|NCT01648634|beta-blockade treatment|beta-blockade treatment
448888|NCT01648621|COPD|copd
448889|NCT01648621|case management|case management
448890|NCT01648595|Fentanyl|fentanyl
448891|NCT01648595|analgesia|analgesia
448892|NCT01648595|duration of the active phase|duration of the active phase
448893|NCT01648595|pain severity|pain severity
448894|NCT01648556|Purpura thrombopenic|purpura thrombopenic
448895|NCT01648556|Medullary cytogenetics|medullary cytogenetics
448896|NCT01648556|Myelodysplasic syndrome|myelodysplasic syndrome
448897|NCT01648556|bone marrow biopsy|bone marrow biopsy
448898|NCT01648517|on-small cell lung carcinoma|on-small cell lung carcinoma
448899|NCT01648517|chemotherapy naive patient|chemotherapy naive patient
448900|NCT01648504|Colonoscopy|colonoscopy
448901|NCT01648504|Screening colonoscopy|screening colonoscopy
448902|NCT01648504|Electronic education|electronic education
448903|NCT01648504|Ipad|ipad
448904|NCT01648504|Patient education|patient education
448905|NCT01648478|IRAP|irap
448906|NCT01648478|insulin sensitivity marker|insulin sensitivity marker
448907|NCT01648465|metastatic|metastatic
448908|NCT01648465|unresectable|unresectable
448909|NCT01648465|well or moderately differentiated|well or moderately differentiated
448910|NCT01648465|advanced|advanced
448911|NCT01648452|Achromatopsia|achromatopsia
448912|NCT01648452|Ciliary Neurotrophic Factor|ciliary neurotrophic factor
448913|NCT01648452|CNTF|cntf
448914|NCT01648322|Breast Cancer|breast cancer
448915|NCT01648322|Taxotere Chemotherapy|taxotere chemotherapy
448916|NCT01648322|Neulasta|neulasta
448917|NCT01648322|efficacy and safety|efficacy and safety
448918|NCT01648322|single cycle doses of F-627|single cycle doses of f-627
448919|NCT01648322|pegfilgrastim|pegfilgrastim
448920|NCT01648309|aortic stenosis|aortic stenosis
448921|NCT01648309|TAVI|tavi
448922|NCT01648309|neuropsychological|neuropsychological
448923|NCT01648309|cognitive|cognitive
448924|NCT01648309|candidates for TAVI|candidates for tavi
448925|NCT01648296|Heart Failure|heart failure
448926|NCT01648296|Obesity|obesity
448927|NCT01648296|Type 2 Diabetes Mellitus|type 2 diabetes mellitus
448928|NCT01648296|Health Normal Volunteer Subjects|health normal volunteer subjects
448929|NCT01648283|methadone polymorphisms|methadone polymorphisms
448930|NCT01648270|buprenorphine concentration-effect (miosis) relationship|buprenorphine concentration-effect (miosis) relationship
448931|NCT01648257|healthy subjects|healthy subjects
448932|NCT01648257|relative bioavailability|relative bioavailability
448934|NCT01648257|GSK1265744|gsk1265744
448935|NCT01648244|DM, T2DM, Diabetes|dm, t2dm, diabetes
448936|NCT01648231|Healthy Volunteer|healthy volunteer
448937|NCT01648218|glucocorticoid|glucocorticoid
448938|NCT01648218|diabetes mellitus|diabetes mellitus
448939|NCT01648218|post-transplant|post-transplant
448940|NCT01648218|insulin|insulin
448941|NCT01648205|ranolazine|ranolazine
448942|NCT01648205|clinical trial|clinical trial
448943|NCT01648179|GSK1322322, relative bioavailability, healthy subjects, open label, food effect, weight effect|gsk1322322, relative bioavailability, healthy subjects, open label, food effect, weight effect
448944|NCT01648166|trace|trace
448945|NCT01648166|element|element
448946|NCT01648166|lung|lung
448947|NCT01648166|cancer|cancer
448948|NCT01648166|Appalachia|appalachia
448949|NCT01648153|Efficacy|efficacy
448950|NCT01648153|Obese|obese
448951|NCT01648153|T2DM|t2dm
448952|NCT01648153|IL-18|il-18
448953|NCT01648153|Monoclonal antibody (mAb)|monoclonal antibody (mab)
448954|NCT01648140|Genotype 4|genotype 4
448955|NCT01648140|GSK2336805|gsk2336805
448956|NCT01648140|pegylated interferon|pegylated interferon
448957|NCT01648140|telaprevir|telaprevir
448958|NCT01648140|Genotype 1|genotype 1
448959|NCT01648140|chronic hepatitis C|chronic hepatitis c
448960|NCT01648140|ribavirin|ribavirin
448961|NCT01648140|NS5A inhibitor|ns5a inhibitor
448962|NCT01648140|hepatitis C virus (HCV) infection|hepatitis c virus (hcv) infection
448963|NCT01648127|Ceftaroline|ceftaroline
448964|NCT01648127|Pharmacokinetics|pharmacokinetics
448965|NCT01648127|Obesity|obesity
448966|NCT01648114|breastfeeding|breastfeeding
448967|NCT01648114|pregnancy|pregnancy
448968|NCT01648114|antenatal|antenatal
448969|NCT01648114|exclusive breastfeeding|exclusive breastfeeding
448970|NCT01648114|education|education
448971|NCT01648101|Retigabine IR|retigabine ir
448972|NCT01648101|Asian Subjects|asian subjects
448973|NCT01648101|Adjunctive Therapy|adjunctive therapy
448974|NCT01648101|Efficacy|efficacy
448975|NCT01648101|Drug-Resistant|drug-resistant
448976|NCT01648101|Safety & tolerability|safety & tolerability
448977|NCT01648101|Partial-Onset Seizures|partial-onset seizures
448978|NCT01648101|Epilepsy|epilepsy
448979|NCT01648088|staphylococcus aureus|staphylococcus aureus
448980|NCT01648088|prosthetic joint implantation|prosthetic joint implantation
448981|NCT01648075|caries|caries
448982|NCT01648075|probiotics|probiotics
448983|NCT01648075|lactobacilli|lactobacilli
448984|NCT01648062|Sleep|sleep
448985|NCT01648062|self-regulation|self-regulation
448986|NCT01648062|Implementation intentions|implementation intentions
448987|NCT01648062|intervention|intervention
448988|NCT01648062|mental simulation|mental simulation
448989|NCT01648023|LC Bead|lc bead
448990|NCT01648023|Irinotecan|irinotecan
448991|NCT01648023|ONCOZENE BEAD|oncozene bead
448992|NCT01648010|Non Muscle Invasive Bladder Cancer|non muscle invasive bladder cancer
448993|NCT01648010|Carcinoma of urinary bladder, invasive|carcinoma of urinary bladder, invasive
448994|NCT01648010|Intravesical instillation|intravesical instillation
448995|NCT01648010|Mitomycin C|mitomycin c
448996|NCT01648010|Hydrogel|hydrogel
448997|NCT01648010|Reverse thermal gelation|reverse thermal gelation
448998|NCT01648010|Drug retention|drug retention
448999|NCT01648010|radical cystectomy|radical cystectomy
449000|NCT01647997|bacterial lipopolysaccharides|bacterial lipopolysaccharides
449001|NCT01647997|hyperlactatemia|hyperlactatemia
449002|NCT01647997|muscle lactate|muscle lactate
449003|NCT01647984|Arrhythmias|arrhythmias
449004|NCT01647984|Life quality|life quality
449005|NCT01647971|Lymphoma|lymphoma
449006|NCT01647971|Rituxan|rituxan
449007|NCT01647971|Relapsed|relapsed
449008|NCT01647971|Refractory|refractory
449009|NCT01647958|TEMPO|tempo
449010|NCT01647958|TIF|tif
449011|NCT01647958|Transoral Incisionless Fundoplication|transoral incisionless fundoplication
449012|NCT01647958|EsophyX System|esophyx system
449013|NCT01647958|refractory symptoms|refractory symptoms
449014|NCT01647958|proton pump inhibitors|proton pump inhibitors
449015|NCT01647958|EndoGastric Solutions|endogastric solutions
449016|NCT01647958|EGS|egs
449017|NCT01647958|Acid Reflux|acid reflux
449018|NCT01647958|Heartburn|heartburn
449019|NCT01647958|Regurgitation|regurgitation
449020|NCT01647945|PAH WHO group 1|pah who group 1
449021|NCT01647932|Heart Failure|heart failure
449022|NCT01647932|Diuretics|diuretics
449023|NCT01647932|Diuretic resistance|diuretic resistance
449024|NCT01647919|Cognition|cognition
449025|NCT01647919|Attention|attention
449026|NCT01647919|Memory|memory
449027|NCT01647919|Mood|mood
449028|NCT01647867|Met fragments expression|met fragments expression
449029|NCT01647854|emergency medical service|emergency medical service
449030|NCT01647854|telemedicine|telemedicine
449031|NCT01647854|teleconsultation|teleconsultation
449032|NCT01647854|safety|safety
449033|NCT01647828|Newly diagnosed Stage IV Pancreatic Cancer|newly diagnosed stage iv pancreatic cancer
449034|NCT01647815|Axillary vein ultrasound|axillary vein ultrasound
449035|NCT01647815|Subclavian vein ultrasound|subclavian vein ultrasound
449036|NCT01647802|standing devices|standing devices
449037|NCT01647802|transfer devices|transfer devices
449038|NCT01647789|prostate cancer, castration resistant,|prostate cancer, castration resistant,
449039|NCT01647776|Colon Neoplasia|colon neoplasia
449040|NCT01647776|Colorectal carcinoma|colorectal carcinoma
449041|NCT01647776|colon cancer|colon cancer
449042|NCT01647776|colon polyp|colon polyp
449043|NCT01647776|colonoscopy|colonoscopy
449044|NCT01647776|sDNA test|sdna test
449045|NCT01647776|FIT tests (fecal immunochemical test)|fit tests (fecal immunochemical test)
449046|NCT01647776|relating colon neoplasia to obesity, type 2 diabetes|relating colon neoplasia to obesity, type 2 diabetes
449047|NCT01647776|colonoscopy and pathology confirmed advanced adenomas|colonoscopy and pathology confirmed advanced adenomas
449048|NCT01647763|Hemorrhoids|hemorrhoids
449049|NCT01647737|Xerostomia|xerostomia
449050|NCT01647737|Sjogren syndrome|sjogren syndrome
449051|NCT01647737|dry mouth|dry mouth
449052|NCT01647724|cervical cancer|cervical cancer
449053|NCT01647724|prevention|prevention
449054|NCT01647724|screening|screening
449055|NCT01647698|Parkinson Disease|parkinson disease
449056|NCT01647698|near transfer|near transfer
449057|NCT01647698|far transfer|far transfer
449058|NCT01647698|working memory|working memory
449059|NCT01647698|fluid intelligence|fluid intelligence
449060|NCT01647698|cognitive training|cognitive training
449061|NCT01647698|dual n-back|dual n-back
449062|NCT01647685|Vesselwall inflammation|vesselwall inflammation
449063|NCT01647685|liposomal prednisolone|liposomal prednisolone
449064|NCT01647659|MEK inhibitor GSK1120212|mek inhibitor gsk1120212
449065|NCT01647659|pharmacokinetics|pharmacokinetics
449066|NCT01647659|powder for oral solution|powder for oral solution
449067|NCT01647659|Solid Tumors|solid tumors
449068|NCT01647659|pediatric formulation|pediatric formulation
449069|NCT01647646|asthma|asthma
449070|NCT01647646|SMART|smart
573269|NCT01124214|BE|be
449071|NCT01647646|fixed dose|fixed dose
449072|NCT01647633|rhinitis|rhinitis
449073|NCT01647633|stuffy nose|stuffy nose
449074|NCT01647633|congestion|congestion
449075|NCT01647633|Sneezing|sneezing
449076|NCT01647607|Breast Cancer|breast cancer
449077|NCT01647607|Young Women|young women
449078|NCT01647607|Fertility|fertility
449079|NCT01647607|Physical Activity|physical activity
449080|NCT01647607|Survivorship|survivorship
449081|NCT01647594|Breast cancer|breast cancer
449082|NCT01647594|Young women|young women
449083|NCT01647594|Fertility|fertility
449084|NCT01647594|Physical activity|physical activity
449085|NCT01647594|Survivorship|survivorship
449086|NCT01647581|hemoclip|hemoclip
449087|NCT01647581|colonoscopy|colonoscopy
449088|NCT01647581|post-polypectomy bleed|post-polypectomy bleed
449089|NCT01647555|Cetuximab|cetuximab
449090|NCT01647555|radiotherapy|radiotherapy
449091|NCT01647555|epidermoid head and neck cancer|epidermoid head and neck cancer
449092|NCT01647542|Drug therapy|drug therapy
449093|NCT01647529|Cytomegalovirus|cytomegalovirus
449094|NCT01647529|uveitis|uveitis
449095|NCT01647529|endotheliitis|endotheliitis
449096|NCT01647529|ganciclovir|ganciclovir
449097|NCT01647503|parathyroid gland|parathyroid gland
449098|NCT01647503|primary hyperparathyroidism|primary hyperparathyroidism
449099|NCT01647503|proteins|proteins
449100|NCT01647477|non treated cancer|non treated cancer
449101|NCT01647477|oral cavity|oral cavity
449102|NCT01647477|oropharynx|oropharynx
449103|NCT01647477|hypopharynx|hypopharynx
449104|NCT01647477|larynx|larynx
449105|NCT01647477|first consultation|first consultation
449106|NCT01647438|South Asians|south asians
449107|NCT01647438|Diabetes|diabetes
449108|NCT01647438|Physical Activity|physical activity
449109|NCT01647438|Coronary Heart Disease|coronary heart disease
449110|NCT01647438|Lifestyle|lifestyle
449111|NCT01647425|head and neck cancer|head and neck cancer
449112|NCT01647425|lung cancer|lung cancer
449113|NCT01647425|tobacco use disorder|tobacco use disorder
449114|NCT01647425|alcoholism|alcoholism
449115|NCT01647412|Crohn's disease|crohn's disease
449116|NCT01647412|Inflammatory Bowel Disease|inflammatory bowel disease
449117|NCT01647412|Growth Hormone|growth hormone
449118|NCT01647412|Nutraceuticals|nutraceuticals
449119|NCT01647399|Obesity|obesity
449120|NCT01647399|Asthma|asthma
449121|NCT01647399|Vitamin D|vitamin d
449122|NCT01647399|Allergy|allergy
449123|NCT01647399|Genetic|genetic
449124|NCT01647399|Childhood|childhood
449125|NCT01647399|Pediatric|pediatric
449126|NCT01647399|cohort|cohort
449127|NCT01647399|observational|observational
449128|NCT01647399|prospective|prospective
449129|NCT01647399|molecular|molecular
449130|NCT01647373|retinal detachment|retinal detachment
449131|NCT01647373|scleral buckle|scleral buckle
449132|NCT01647373|silicone sponge|silicone sponge
449133|NCT01647373|axial length|axial length
449134|NCT01647373|surgery included silicone sponge scleral buckling|surgery included silicone sponge scleral buckling
449135|NCT01647373|retina currently attached|retina currently attached
449136|NCT01647373|at least 6 months after surgery|at least 6 months after surgery
449137|NCT01647360|Metrorrhagia|metrorrhagia
449138|NCT01647360|Menorrhagia|menorrhagia
449139|NCT01647347|bacteria|bacteria
449140|NCT01647347|bacteremia|bacteremia
449141|NCT01647347|PVP-iodine|pvp-iodine
449142|NCT01647347|periodontitis|periodontitis
449143|NCT01647321|SPMS|spms
449144|NCT01647295|visual exploration|visual exploration
449145|NCT01647295|pupil size|pupil size
449146|NCT01647295|social interactions|social interactions
449147|NCT01647295|faces|faces
449148|NCT01647295|human motion|human motion
449149|NCT01647256|Bioavailability|bioavailability
449150|NCT01647256|Fed|fed
449151|NCT01647256|Fasting|fasting
449152|NCT01647243|Knee osteoarthritis|knee osteoarthritis
449153|NCT01647243|Total knee arthroplasty|total knee arthroplasty
449154|NCT01647243|Preoperative training|preoperative training
449155|NCT01647243|Strength training|strength training
449156|NCT01647230|Anaesthesia, spinal|anaesthesia, spinal
449157|NCT01647230|Cerebral oximetry|cerebral oximetry
449158|NCT01647230|Blood pressure|blood pressure
449159|NCT01647230|Heart rate|heart rate
449160|NCT01647230|Cognitive Symptom|cognitive symptom
449161|NCT01647217|Blepharitis|blepharitis
449162|NCT01647217|Demodex|demodex
449163|NCT01647217|Mites|mites
449164|NCT01647217|Tea Tree oil|tea tree oil
449165|NCT01647217|Terpinen|terpinen
449166|NCT01647204|Nutrition|nutrition
449167|NCT01647204|older|older
449168|NCT01647204|hospital|hospital
449169|NCT01647204|volunteer|volunteer
449170|NCT01647191|HCV，|hcv，
449171|NCT01647191|drug users，|drug users，
449172|NCT01647191|intervention|intervention
449173|NCT01647165|Maintenance Strategy|maintenance strategy
449174|NCT01647165|Plasma Cell Neoplasm|plasma cell neoplasm
449175|NCT01647165|Proteasome Inhibitor|proteasome inhibitor
710625|NCT00588562|Oxalate|oxalate
449176|NCT01647165|Immunomodulatory Drugs|immunomodulatory drugs
449177|NCT01647165|Novel Therapy|novel therapy
449178|NCT01647152|Uveitis|uveitis
449179|NCT01647152|Ustekinumab|ustekinumab
449180|NCT01647152|IL 12/23|il 12/23
449181|NCT01647152|Stelara|stelara
449182|NCT01646866|autism|autism
449183|NCT01646866|siblings|siblings
449184|NCT01646866|genetic test|genetic test
449185|NCT01646866|screening|screening
449186|NCT01646840|PF-04958242|pf-04958242
449187|NCT01646840|bioequivalence|bioequivalence
449188|NCT01646840|pharmacokinetics|pharmacokinetics
449189|NCT01646840|Schizophrenia|schizophrenia
449317|NCT01646333|Executive Function|executive function
449190|NCT01646827|Schizophrenia, extended release antipsychotic|schizophrenia, extended release antipsychotic
449191|NCT01646814|Healthy volunteer|healthy volunteer
449192|NCT01646814|comparison of incidence of|comparison of incidence of
449193|NCT01646814|treatment groups.|treatment groups.
449195|NCT01646775|malignancy|malignancy
449196|NCT01646775|epidural|epidural
449197|NCT01646749|Energy intake|energy intake
449198|NCT01646749|Beef protein|beef protein
449199|NCT01646749|Satiety|satiety
449200|NCT01646749|Protein leverage hypothesis|protein leverage hypothesis
449201|NCT01646736|Lupus Nephritis|lupus nephritis
449202|NCT01646736|Cyclophosphamide|cyclophosphamide
449203|NCT01646736|Tripterygium|tripterygium
449204|NCT01646710|Tool|tool
449205|NCT01646710|FBR|fbr
449206|NCT01646710|Advocacy|advocacy
449207|NCT01646710|Development of a tool|development of a tool
449208|NCT01646710|advocacy materials|advocacy materials
449209|NCT01646697|pancreatic cancer|pancreatic cancer
449210|NCT01646697|adenocarcinoma|adenocarcinoma
449211|NCT01646697|pancreatic resection|pancreatic resection
449212|NCT01646684|Prostate cancer, pasireotide LAR, castration resistant prostatate cancer, CRPC, SOM230 LAR|prostate cancer, pasireotide lar, castration resistant prostatate cancer, crpc, som230 lar
449213|NCT01646671|Hypertension, Severe, LCZ696|hypertension, severe, lcz696
449214|NCT01646645|CMVpp65 specific T-cells|cmvpp65 specific t-cells
449215|NCT01646645|Stem Cell Transplantation|stem cell transplantation
449216|NCT01646645|12-086|12-086
449217|NCT01646632|institutionalized ADL fitness care-dependency|institutionalized adl fitness care-dependency
449218|NCT01646619|Hypoxic Ischemic Encephalopathy|hypoxic ischemic encephalopathy
449219|NCT01646619|Therapeutic Hypothermia|therapeutic hypothermia
449220|NCT01646619|Therapeutic Hypothermia plus Adjuvant Therapy|therapeutic hypothermia plus adjuvant therapy
449221|NCT01646619|Cooling|cooling
449222|NCT01646606|Bronchiolitis|bronchiolitis
449223|NCT01646606|Length of stay|length of stay
449224|NCT01646606|Pilot Projects|pilot projects
449225|NCT01646606|Oxygen saturation monitoring|oxygen saturation monitoring
449226|NCT01646580|dermatomycoses, tinea, candidiasis, children|dermatomycoses, tinea, candidiasis, children
449227|NCT01646567|psoriasis|psoriasis
449228|NCT01646554|Liver metastases|liver metastases
449229|NCT01646554|Colorectal Cancer|colorectal cancer
449230|NCT01646554|KRAS mutated|kras mutated
449231|NCT01646554|FOLFOX|folfox
449232|NCT01646554|Aflibercept|aflibercept
449233|NCT01646554|Randomized|randomized
449234|NCT01646554|Phase II-III|phase ii-iii
449235|NCT01646554|Perioperative treatment|perioperative treatment
449236|NCT01646554|Adjuvant|adjuvant
449237|NCT01646554|Neo-adjuvant|neo-adjuvant
449238|NCT01646554|Surgery|surgery
449239|NCT01646554|Progression Free Survival|progression free survival
449240|NCT01646528|Gastric Intestinal Metaplasia|gastric intestinal metaplasia
449241|NCT01646528|Confocal Laser Endomicroscopy|confocal laser endomicroscopy
449242|NCT01646515|systolic heart failure|systolic heart failure
449243|NCT01646515|udenafil|udenafil
449244|NCT01646515|exercise capacity|exercise capacity
449245|NCT01646502|chronic wound|chronic wound
449246|NCT01646502|treatment|treatment
449247|NCT01646502|biofilms|biofilms
449248|NCT01646502|venous insufficiency|venous insufficiency
449249|NCT01646502|Esp|esp
449250|NCT01646489|Antisense|antisense
449251|NCT01646489|miR-122 antagonist|mir-122 antagonist
449252|NCT01646489|Safety in healthy volunteers|safety in healthy volunteers
449253|NCT01646489|Hepatitis C|hepatitis c
449254|NCT01646463|mindfulness|mindfulness
449255|NCT01646463|stress|stress
449256|NCT01646463|coping|coping
449257|NCT01646463|emotion|emotion
449258|NCT01646463|depression|depression
449259|NCT01646463|group medical visits|group medical visits
449260|NCT01646463|prenatal healthcare|prenatal healthcare
449261|NCT01646463|preterm birth|preterm birth
449262|NCT01646463|birth weight|birth weight
449263|NCT01646463|postpartum depression|postpartum depression
449264|NCT01646463|cortisol|cortisol
449265|NCT01646463|neuroendocrine function|neuroendocrine function
449266|NCT01646463|blood pressure|blood pressure
449267|NCT01646463|health disparities|health disparities
449268|NCT01646450|NSCLC|nsclc
449269|NCT01646450|EGFR Mutation|egfr mutation
449270|NCT01646450|Elder patients|elder patients
449271|NCT01646424|COPD,|copd,
449272|NCT01646424|Patient satisfaction,|patient satisfaction,
449273|NCT01646424|fix combination,|fix combination,
449274|NCT01646424|NIS Turkey,|nis turkey,
449275|NCT01646424|turbuhaler,|turbuhaler,
449276|NCT01646424|FSI-10|fsi-10
449277|NCT01646411|cytomegalovirus (CMV) IgM &IgG|cytomegalovirus (cmv) igm &igg
449278|NCT01646411|Lyme|lyme
449279|NCT01646411|Toxoplasma|toxoplasma
449280|NCT01646411|Rubella|rubella
449281|NCT01646411|Rubeola IgM|rubeola igm
449282|NCT01646411|Rocky mountain Spotted Fever IgM|rocky mountain spotted fever igm
449283|NCT01646411|Ebv IgM|ebv igm
449284|NCT01646411|Herpes|herpes
449285|NCT01646411|Babesia|babesia
449286|NCT01646411|Measles|measles
449287|NCT01646411|Tetanus|tetanus
449288|NCT01646411|Mumps|mumps
449289|NCT01646411|Mycoplasma|mycoplasma
449290|NCT01646411|Legionella|legionella
449291|NCT01646411|Giardia|giardia
449292|NCT01646411|Syphilis|syphilis
449293|NCT01646411|Bordetella Pertussis|bordetella pertussis
449294|NCT01646411|H Pylori|h pylori
449295|NCT01646411|Antibody Titre|antibody titre
449296|NCT01646411|Elevated IgG|elevated igg
449297|NCT01646411|Abnormal IgM|abnormal igm
449298|NCT01646411|SLE|sle
449299|NCT01646398|13VPNC|13vpnc
449300|NCT01646398|23VPS|23vps
449301|NCT01646385|observational|observational
449302|NCT01646385|non-interventional|non-interventional
449303|NCT01646385|cohort|cohort
449304|NCT01646385|retrospective|retrospective
449305|NCT01646385|register|register
449306|NCT01646385|rheumatoid arthritis|rheumatoid arthritis
449307|NCT01646372|Medical Education|medical education
449308|NCT01646372|Cognitive Aid|cognitive aid
449309|NCT01646372|Crisis Resource Management|crisis resource management
449310|NCT01646372|Advanced Cardiac Life Support|advanced cardiac life support
449311|NCT01646372|Skills Retention|skills retention
449312|NCT01646346|Breast Cancer|breast cancer
449313|NCT01646346|Radiation for Breast Cancer|radiation for breast cancer
449314|NCT01646333|Parkinson Disease|parkinson disease
449315|NCT01646333|Mild Cognitive Impairment|mild cognitive impairment
449316|NCT01646333|Cognition|cognition
449318|NCT01646333|Learning|learning
449319|NCT01646333|Memory|memory
449320|NCT01646333|Problem Solving|problem solving
449321|NCT01646294|Pharmacokinetics|pharmacokinetics
449322|NCT01646294|Phase I|phase i
449323|NCT01646294|YM178|ym178
449324|NCT01646294|Modified release (Oral Controlled Absorption System (OCAS))|modified release (oral controlled absorption system (ocas))
449325|NCT01646294|Immediate release (IR)|immediate release (ir)
449326|NCT01646294|Fasted conditions|fasted conditions
449327|NCT01646294|Fed conditions|fed conditions
449328|NCT01646281|Atrial fibrillation|atrial fibrillation
449329|NCT01646281|Vernakalant|vernakalant
449330|NCT01646281|Flecainide|flecainide
449331|NCT01646281|Echocardiography|echocardiography
449332|NCT01646268|Rotigotine|rotigotine
449333|NCT01646268|Neupro phase 3|neupro phase 3
449334|NCT01646268|Early phase|early phase
449335|NCT01646268|Idiopathic Parkinson's Disease|idiopathic parkinson's disease
449336|NCT01646255|Rotigotine|rotigotine
449337|NCT01646255|Neupro phase 3|neupro phase 3
449338|NCT01646255|Advanced-stage|advanced-stage
449339|NCT01646255|Idiopathic Parkinson's Disease|idiopathic parkinson's disease
449340|NCT01646229|Hemoperfusion|hemoperfusion
449341|NCT01646229|Polymyxin-B|polymyxin-b
449342|NCT01646229|Emergency abdominal surgery|emergency abdominal surgery
449343|NCT01646229|Sepsis|sepsis
449344|NCT01646229|Endotoxin|endotoxin
449345|NCT01646216|stroke|stroke
449346|NCT01646216|treadmill|treadmill
449347|NCT01646216|walking|walking
449348|NCT01646216|hemiparesis|hemiparesis
449349|NCT01646216|training|training
449350|NCT01646203|Advanced Solid Tumors|advanced solid tumors
449351|NCT01646190|Fast-track|fast-track
449352|NCT01646190|multimodal perioperative care|multimodal perioperative care
449353|NCT01646190|enhanced recovery|enhanced recovery
449354|NCT01646190|colorectal surgery|colorectal surgery
449355|NCT01646190|elderly patients|elderly patients
449356|NCT01646190|seniors|seniors
449357|NCT01646164|Dill seed|dill seed
449358|NCT01646164|Pattern of uterus contractions|pattern of uterus contractions
449359|NCT01646164|Active phase of labor|active phase of labor
449360|NCT01646138|H1N1|h1n1
449361|NCT01646138|Influenza|influenza
449362|NCT01646138|Human|human
449363|NCT01646138|Challenge Study|challenge study
449364|NCT01646138|Healthy Volunteer|healthy volunteer
449365|NCT01646125|Non-small cell lung carcinoma (NSCLC)|non-small cell lung carcinoma (nsclc)
449366|NCT01646125|treatment of lung cancer after first metastasis|treatment of lung cancer after first metastasis
449367|NCT01646125|lung cancer|lung cancer
449368|NCT01646125|lung adenocarcinoma|lung adenocarcinoma
449369|NCT01646125|Squamous cell lung carcinoma|squamous cell lung carcinoma
449370|NCT01646125|Large-cell lung carcinoma|large-cell lung carcinoma
449371|NCT01646125|Non small cell lung carcinoma|non small cell lung carcinoma
449372|NCT01646125|Non small cell lung cancer|non small cell lung cancer
449373|NCT01646125|Non-small cell lung cancer|non-small cell lung cancer
449374|NCT01646125|NSCLC|nsclc
449375|NCT01646125|Large cell lung carcinoma|large cell lung carcinoma
449376|NCT01646125|Large cell lung cancer|large cell lung cancer
449377|NCT01646125|HSP90|hsp90
449378|NCT01646125|AUY922|auy922
449379|NCT01646125|Pemetrexed|pemetrexed
449380|NCT01646125|Docetaxel|docetaxel
449381|NCT01646125|EGFR TKI|egfr tki
449382|NCT01646125|EGFR mutations|egfr mutations
449383|NCT01646112|Uncertainty|uncertainty
449384|NCT01646112|HNPCC|hnpcc
449385|NCT01646112|Lynch Syndrome|lynch syndrome
449386|NCT01646112|Genetic Tests|genetic tests
449387|NCT01646099|Kidney transplant|kidney transplant
449388|NCT01646099|Renal transplant|renal transplant
449389|NCT01646099|Sun protection|sun protection
449390|NCT01646099|Skin cancer|skin cancer
449391|NCT01646086|Weight Loss|weight loss
449392|NCT01646086|Self-Weighing|self-weighing
449393|NCT01646086|Weight Tracking|weight tracking
449394|NCT01646073|Plaque Psoriasis|plaque psoriasis
449395|NCT01646073|Psoriasis|psoriasis
449396|NCT01646073|Placebo Controlled|placebo controlled
449397|NCT01646073|Skin Disease|skin disease
449398|NCT01646073|Double Blind|double blind
449399|NCT01646060|blood|blood
449400|NCT01646060|loss|loss
449401|NCT01646060|healthy|healthy
449402|NCT01646060|volume|volume
449403|NCT01646060|To evaluate the ability of the Zynex BVM to non-invasively detect blood loss in healthy subjects during a blood draw.|to evaluate the ability of the zynex bvm to non-invasively detect blood loss in healthy subjects during a blood draw.
449404|NCT01646047|diabetes|diabetes
449405|NCT01646047|diabetic retinopathy|diabetic retinopathy
449406|NCT01646047|nutritional supplements|nutritional supplements
449407|NCT01646047|visual function|visual function
449408|NCT01646047|macular pigment|macular pigment
449409|NCT01646047|macular threshold sensitivity|macular threshold sensitivity
449410|NCT01646047|contrast sensitivity|contrast sensitivity
449411|NCT01646047|color vision|color vision
449412|NCT01646047|optical coherence tomography|optical coherence tomography
449413|NCT01646034|oligo metastatic|oligo metastatic
449414|NCT01646034|HRD deficiency|hrd deficiency
449415|NCT01646021|Mantle cell lymphoma|mantle cell lymphoma
449416|NCT01646021|Relapsed mantle cell lymphoma|relapsed mantle cell lymphoma
449417|NCT01646021|Refractory mantle cell lymphoma|refractory mantle cell lymphoma
449418|NCT01646021|Ibrutinib|ibrutinib
449419|NCT01646021|Bruton's tyrosine kinase inhibitor|bruton's tyrosine kinase inhibitor
449420|NCT01646021|Temsirolimus|temsirolimus
449421|NCT01645956|obesity|obesity
449422|NCT01645956|exercise|exercise
449423|NCT01645956|energy intake|energy intake
449424|NCT01645956|physical activity|physical activity
449425|NCT01645943|Non-ST-elevation acute myocardial infarction|non-st-elevation acute myocardial infarction
449426|NCT01645943|Comorbidities|comorbidities
449427|NCT01645930|Drug Therapy|drug therapy
449428|NCT01645917|paroxysmal atrial fibrillation|paroxysmal atrial fibrillation
449429|NCT01645904|Hereditary Diseases|hereditary diseases
449430|NCT01645904|Genetic|genetic
449431|NCT01645904|Lynch syndrome|lynch syndrome
449432|NCT01645904|Positive or indeterminate test results for Lynch syndrome|positive or indeterminate test results for lynch syndrome
449433|NCT01645904|Social media|social media
449434|NCT01645904|Internet-based program|internet-based program
449435|NCT01645904|Questionnaire|questionnaire
449436|NCT01645904|Survey|survey
450463|NCT01641146|PTSD|ptsd
449437|NCT01645904|My Family Garden website|my family garden website
449438|NCT01645904|Interview|interview
449439|NCT01645904|Focus group|focus group
449440|NCT01645904|Website Analysis and MeasureMent Inventory|website analysis and measurement inventory
449441|NCT01645904|WAMMI|wammi
449442|NCT01645891|Diabetic Foot Ulcer|diabetic foot ulcer
449443|NCT01645878|Primiparous Mothers|primiparous mothers
449444|NCT01645878|self-efficacy,|self-efficacy,
449445|NCT01645878|hands off,|hands off,
449446|NCT01645878|hands on ,|hands on ,
449447|NCT01645878|social cognitive theory|social cognitive theory
449448|NCT01645865|HIV|hiv
449449|NCT01645865|AIDS|aids
449450|NCT01645865|PMTCT|pmtct
449451|NCT01645865|Mobile Phone|mobile phone
449452|NCT01645865|SMS|sms
449453|NCT01645839|Leptomeningeal metastasis|leptomeningeal metastasis
449454|NCT01645839|Intrathecal chemotherapy|intrathecal chemotherapy
449455|NCT01645839|Depocyte|depocyte
449456|NCT01645800|Lysozyme hydrochloride|lysozyme hydrochloride
449457|NCT01645800|COPD|copd
449458|NCT01645787|Spinal Muscular Atrophy|spinal muscular atrophy
449459|NCT01645787|4-aminopyridine|4-aminopyridine
449460|NCT01645787|dalfampridine|dalfampridine
449461|NCT01645787|Ampyra|ampyra
449462|NCT01645774|subcutaneous injection heparin|subcutaneous injection heparin
449463|NCT01645774|injection duration|injection duration
449464|NCT01645774|bruising pain|bruising pain
449465|NCT01645774|decrease pain|decrease pain
449466|NCT01645774|decrease bruising|decrease bruising
449467|NCT01645761|Helicobacter pylori eradication|helicobacter pylori eradication
449468|NCT01645761|Peptic ulcer|peptic ulcer
449469|NCT01645748|head and neck cancer|head and neck cancer
449470|NCT01645748|docetaxel|docetaxel
449471|NCT01645748|cisplatin|cisplatin
449472|NCT01645748|S-1|s-1
449473|NCT01645735|Infections|infections
449474|NCT01645735|Teflaro|teflaro
449475|NCT01645735|cephalosporin|cephalosporin
449476|NCT01645735|Ceftaroline|ceftaroline
449477|NCT01645735|antibiotics|antibiotics
449478|NCT01645735|pneumonia|pneumonia
449479|NCT01645722|Fat Grafts|fat grafts
449480|NCT01645722|Autogenous Fat Transfers (AFT)|autogenous fat transfers (aft)
449481|NCT01645722|Wounded warriors|wounded warriors
449482|NCT01645722|Amputation pain|amputation pain
449483|NCT01645696|Diabetes|diabetes
449484|NCT01645696|Type 1 Diabetes|type 1 diabetes
449485|NCT01645696|Continuous glucose monitoring|continuous glucose monitoring
449486|NCT01645696|Blood glucose|blood glucose
449487|NCT01645696|Blood glucose sensor|blood glucose sensor
449488|NCT01645696|Glucose Binding Protein (GBP)|glucose binding protein (gbp)
449489|NCT01645566|cardiopulmonary resuscitation|cardiopulmonary resuscitation
449490|NCT01645566|stress|stress
449491|NCT01645566|intervention|intervention
449492|NCT01645475|enuresis|enuresis
449493|NCT01645449|Bioequivalence|bioequivalence
449494|NCT01645449|Atorvastatin calcium|atorvastatin calcium
449495|NCT01645449|crossover|crossover
449496|NCT01645436|randomized controlled trial|randomized controlled trial
449497|NCT01645436|in-hospital exercise|in-hospital exercise
449498|NCT01645436|children|children
449499|NCT01645436|cancer|cancer
449500|NCT01645423|Bioequivalence|bioequivalence
449501|NCT01645423|Atorvastatin calcium|atorvastatin calcium
449502|NCT01645423|crossover|crossover
449503|NCT01645410|Bioequivalence|bioequivalence
449504|NCT01645410|Atorvastatin calcium|atorvastatin calcium
449505|NCT01645410|crossover|crossover
449506|NCT01645397|Asthma|asthma
449507|NCT01645397|Deep inhalation|deep inhalation
449508|NCT01645397|Exhaled nitric oxide|exhaled nitric oxide
449509|NCT01645384|Bioequivalence|bioequivalence
449510|NCT01645384|Atorvastatin calcium|atorvastatin calcium
449511|NCT01645384|crossover|crossover
449512|NCT01645371|opioid-induced constipation|opioid-induced constipation
449513|NCT01645358|COPD|copd
449514|NCT01645358|NIV|niv
449515|NCT01645358|Acute Hypercapnic Respiratory Failure|acute hypercapnic respiratory failure
449516|NCT01645358|COPD patients with hypercapnic respiratory failure|copd patients with hypercapnic respiratory failure
449517|NCT01645345|wrinkles|wrinkles
449518|NCT01645345|acne scars|acne scars
449519|NCT01645332|DLBS3233|dlbs3233
449520|NCT01645332|new onset|new onset
449521|NCT01645332|type-2-diabetes mellitus|type-2-diabetes mellitus
449522|NCT01645332|oral anti-hyperglycemic agent|oral anti-hyperglycemic agent
449523|NCT01645280|Active rheumatoid arthritis|active rheumatoid arthritis
449524|NCT01645280|Ustekinumab|ustekinumab
449525|NCT01645280|STELARA|stelara
449526|NCT01645280|CNTO 1959|cnto 1959
449527|NCT01645254|healthy volunteers|healthy volunteers
449528|NCT01645254|pharmacokinetics|pharmacokinetics
449529|NCT01645254|malaria|malaria
449530|NCT01645254|Argemone mexicana|argemone mexicana
449531|NCT01645241|Ovarian stimulation|ovarian stimulation
449532|NCT01645241|Luteal phase|luteal phase
449533|NCT01645241|Egg donors|egg donors
449534|NCT01645241|Fertility preservation|fertility preservation
449535|NCT01645202|Aortic stenosis|aortic stenosis
449536|NCT01645202|TAVI|tavi
449537|NCT01645202|Device success|device success
449538|NCT01645202|Aortic regurgitation|aortic regurgitation
449539|NCT01645189|Hunter syndrome|hunter syndrome
449540|NCT01645189|idursulfase-beta|idursulfase-beta
449541|NCT01645189|Hunterase|hunterase
449542|NCT01645189|GC1111|gc1111
449543|NCT01645176|OA|oa
449544|NCT01645176|Knee|knee
449545|NCT01645163|mHealth|mhealth
449546|NCT01645163|Complementary feeding|complementary feeding
449547|NCT01645163|ICDS|icds
449548|NCT01645150|physical activity|physical activity
449549|NCT01645150|exercise|exercise
449550|NCT01645150|training|training
449551|NCT01645150|fatigue|fatigue
449552|NCT01645150|cancer|cancer
449553|NCT01645150|TKI|tki
449554|NCT01645150|tyrosine kinase inhibitor|tyrosine kinase inhibitor
449555|NCT01645137|prematurity|prematurity
449556|NCT01645137|OMT|omt
449557|NCT01645137|complementary and alternative medicine|complementary and alternative medicine
449558|NCT01645137|neonates|neonates
449559|NCT01645137|length of stay|length of stay
449560|NCT01645124|Polycythemia|polycythemia
449561|NCT01645124|Hematocrit|hematocrit
449562|NCT01645124|Thrombosis|thrombosis
449563|NCT01645085|R406|r406
449564|NCT01645085|Fostamatinib|fostamatinib
449565|NCT01645085|Phase I|phase i
449566|NCT01645085|Healthy Subjects|healthy subjects
449567|NCT01645085|Pharmacokinetics|pharmacokinetics
449568|NCT01645085|Bioequivalence|bioequivalence
449569|NCT01645072|Drug refractory epilepsy|drug refractory epilepsy
449570|NCT01645072|Dietary therapy|dietary therapy
449571|NCT01645072|ketogenic diet|ketogenic diet
449572|NCT01645072|childhood epilepsy|childhood epilepsy
449573|NCT01645033|Cognitive Behavioral Therapy|cognitive behavioral therapy
449574|NCT01645033|computer|computer
449575|NCT01645020|absorbable mesh|absorbable mesh
449576|NCT01645020|Partially absorbed Mesh|partially absorbed mesh
449577|NCT01645020|Prolift|prolift
449578|NCT01645020|Prolift + M|prolift + m
449579|NCT01645020|mesh related complications|mesh related complications
449580|NCT01645007|Hepatitis B|hepatitis b
449581|NCT01645007|Prevalence|prevalence
449582|NCT01645007|HBsAg|hbsag
449583|NCT01645007|Vaccination|vaccination
449584|NCT01645007|Galilee|galilee
449585|NCT01644968|metastatic carcinoma|metastatic carcinoma
449586|NCT01644968|lymphoma|lymphoma
449587|NCT01644968|sarcoma|sarcoma
449588|NCT01644968|anti-OX40|anti-ox40
449589|NCT01644955|Gliomas|gliomas
449590|NCT01644955|Carboplatin|carboplatin
449591|NCT01644942|Obese|obese
449592|NCT01644942|insulin sensitive|insulin sensitive
449593|NCT01644942|insulin resistant|insulin resistant
449594|NCT01644942|myotubes|myotubes
449595|NCT01644942|lipid accumulation|lipid accumulation
449596|NCT01644929|hemiparesis|hemiparesis
449597|NCT01644929|bihemispheric transcranial direct current stimulation|bihemispheric transcranial direct current stimulation
449598|NCT01644929|ischemic stroke|ischemic stroke
449599|NCT01644929|subacute|subacute
449600|NCT01644929|rehabilitation|rehabilitation
449601|NCT01644929|physiotherapy|physiotherapy
449602|NCT01644929|ergotherapy|ergotherapy
449603|NCT01644916|COPD|copd
449604|NCT01644916|Integrated care|integrated care
449605|NCT01644916|IPCL|ipcl
449606|NCT01644890|NK105, Paclitaxel, Breast cancer, Micelle|nk105, paclitaxel, breast cancer, micelle
449607|NCT01644851|veterans|veterans
449608|NCT01644851|neuropsychology|neuropsychology
449609|NCT01644851|neuroimaging|neuroimaging
449610|NCT01644851|attention|attention
449611|NCT01644851|working memory|working memory
449612|NCT01644851|inhibition|inhibition
449613|NCT01644851|magnetic resonance imaging, functional|magnetic resonance imaging, functional
449614|NCT01644851|trauma|trauma
449615|NCT01644851|stress|stress
449616|NCT01644851|anxiety|anxiety
449617|NCT01644851|emotion|emotion
449618|NCT01644851|prefrontal cortex|prefrontal cortex
449619|NCT01644838|Hyoscine,|hyoscine,
449620|NCT01644838|Promethazine,|promethazine,
449621|NCT01644838|The first stage of labor,|the first stage of labor,
449622|NCT01644838|Labor pain|labor pain
449623|NCT01644825|platinum resistant|platinum resistant
449624|NCT01644825|platinum refractory|platinum refractory
449625|NCT01644799|recurrent grade 1 follicular lymphoma|recurrent grade 1 follicular lymphoma
449626|NCT01644799|recurrent grade 2 follicular lymphoma|recurrent grade 2 follicular lymphoma
449627|NCT01644799|recurrent grade 3 follicular lymphoma|recurrent grade 3 follicular lymphoma
449628|NCT01644786|head and neck|head and neck
449629|NCT01644786|HNSCC|hnscc
449630|NCT01644786|orophaynx|orophaynx
449631|NCT01644786|hypopharynx|hypopharynx
449632|NCT01644786|larynx|larynx
449633|NCT01644786|nasopharynx|nasopharynx
449634|NCT01644786|oral cavity|oral cavity
449635|NCT01644786|prospective study|prospective study
449636|NCT01644786|predictive models for HNSCC|predictive models for hnscc
449637|NCT01644786|genomic analyses|genomic analyses
449638|NCT01644786|outcome prediction|outcome prediction
449639|NCT01644760|Diaphragmatic excursion|diaphragmatic excursion
449640|NCT01644760|normality|normality
449641|NCT01644747|Resistant Depression|resistant depression
449642|NCT01644747|Moods disorders|moods disorders
449643|NCT01644747|Unipolar depression|unipolar depression
449644|NCT01644747|Bipolar disorder|bipolar disorder
449645|NCT01644747|tDCS|tdcs
449646|NCT01644721|Child mortality|child mortality
449647|NCT01644721|Measles vaccine|measles vaccine
449648|NCT01644721|Non-specific effects|non-specific effects
449649|NCT01644708|Obesity|obesity
449650|NCT01644708|Overweight|overweight
449651|NCT01644708|Individual empowerment|individual empowerment
449652|NCT01644708|Physical parameters|physical parameters
449653|NCT01644708|Self esteem|self esteem
449654|NCT01644695|BARS|bars
449655|NCT01644695|Bony Anchoring Reinforcement System|bony anchoring reinforcement system
449656|NCT01644695|Hernia|hernia
449657|NCT01644695|Incisional|incisional
449658|NCT01644695|Recurrent|recurrent
449659|NCT01644695|abdominal wall reconstruction|abdominal wall reconstruction
449660|NCT01644695|abdominal wall defect|abdominal wall defect
449661|NCT01644695|mesh|mesh
449662|NCT01644695|component separation|component separation
449663|NCT01644682|Visceral leishmaniasis|visceral leishmaniasis
449664|NCT01644682|insecticide|insecticide
449665|NCT01644682|wall lining|wall lining
449666|NCT01644682|KO TAB123|ko tab123
449667|NCT01644682|Household|household
449668|NCT01644682|Kala-azar endemic area|kala-azar endemic area
449669|NCT01644656|portal hypertension|portal hypertension
449670|NCT01644656|cirrhosis|cirrhosis
449671|NCT01644656|ARFI|arfi
449672|NCT01644656|diagnostic study|diagnostic study
449673|NCT01644643|Ceftazidime,|ceftazidime,
449674|NCT01644643|avibactam,|avibactam,
449675|NCT01644643|metronidazone,|metronidazone,
449676|NCT01644643|Anti-Infectives|anti-infectives
449677|NCT01644604|Hypertension|hypertension
449678|NCT01644604|Vascular Diseases|vascular diseases
449679|NCT01644604|Cardiovascular Diseases|cardiovascular diseases
449680|NCT01644604|Renal denervation|renal denervation
573961|NCT01121224|Stents|stents
449681|NCT01644578|MRI|mri
449682|NCT01644578|real-time imaging|real-time imaging
449683|NCT01644578|workflow|workflow
449684|NCT01644552|aniridia|aniridia
449685|NCT01644552|positive angle kappa|positive angle kappa
449686|NCT01644539|Satiation|satiation
449687|NCT01644539|Brain activation|brain activation
449688|NCT01644539|Gut peptides|gut peptides
449689|NCT01644526|dialysis|dialysis
449690|NCT01644526|vascular access|vascular access
449691|NCT01644526|arteriovenous grafts|arteriovenous grafts
449692|NCT01644526|valve system|valve system
449693|NCT01644513|Age Related Macular Degeneration|age related macular degeneration
449694|NCT01644513|Choroidal Neovascular|choroidal neovascular
449695|NCT01644513|anti-VEGF Therapy|anti-vegf therapy
449696|NCT01644409|OAB|oab
449697|NCT01644409|Overactive bladder|overactive bladder
449698|NCT01644409|Urgency|urgency
449699|NCT01644409|Incontinence|incontinence
449700|NCT01644396|Moderate to Severe Plaque Psoriasis|moderate to severe plaque psoriasis
449701|NCT01644383|meaning of life|meaning of life
449702|NCT01644383|logotherapy|logotherapy
449703|NCT01644383|HIV-infected teenagers|hiv-infected teenagers
449704|NCT01644383|adherence|adherence
449705|NCT01644370|HIV-infected children|hiv-infected children
449706|NCT01644370|T cell response|t cell response
449707|NCT01644370|asthma|asthma
449708|NCT01644292|Mobility Impairment|mobility impairment
449709|NCT01644292|Manual Wheelchair|manual wheelchair
449710|NCT01644292|Older Adults|older adults
449711|NCT01644279|aging|aging
449712|NCT01644279|sarcopenia|sarcopenia
449713|NCT01644279|mitochondria|mitochondria
449714|NCT01644279|skeletal muscle|skeletal muscle
449715|NCT01644279|apoptosis|apoptosis
449716|NCT01644253|chronic lymphocytic leukemia|chronic lymphocytic leukemia
449717|NCT01644253|CLL|cll
449718|NCT01644253|previously untreated chronic lymphocytic leukemia|previously untreated chronic lymphocytic leukemia
449719|NCT01644253|peripheral T-cell lymphoma|peripheral t-cell lymphoma
449720|NCT01644253|PTCL|ptcl
449721|NCT01644227|Hip surgery|hip surgery
449722|NCT01644227|dual mobility cup|dual mobility cup
449723|NCT01644227|dislocation|dislocation
449724|NCT01644227|total hip arthroplasty|total hip arthroplasty
449725|NCT01644214|Pelvic organ prolapse|pelvic organ prolapse
449726|NCT01644214|Pessary|pessary
449727|NCT01644162|Non-Invasive Positive-Pressure Ventilation|non-invasive positive-pressure ventilation
449728|NCT01644162|Disease Exacerbation|disease exacerbation
449729|NCT01644162|Respiratory Failure|respiratory failure
449730|NCT01644149|Jet Injector|jet injector
449731|NCT01644149|Stratis®|stratis®
449732|NCT01644149|PharmaJet|pharmajet
449733|NCT01644149|Jet Injection|jet injection
449734|NCT01644123|Spasticity|spasticity
449735|NCT01644123|Diagnostic Algorithm|diagnostic algorithm
449736|NCT01644097|Quality of Life|quality of life
449737|NCT01644084|albumin|albumin
449738|NCT01644084|hydroxyethyl starch 130/0.4|hydroxyethyl starch 130/0.4
449739|NCT01644084|cardiopulmonary bypass|cardiopulmonary bypass
449740|NCT01644071|violent video games|violent video games
449741|NCT01644071|serotonergic system|serotonergic system
449742|NCT01644058|immediate-loading|immediate-loading
449743|NCT01644058|patient-based outcomes|patient-based outcomes
449744|NCT01644045|Asthma|asthma
449745|NCT01644045|COPD|copd
449746|NCT01644045|emergency medical service|emergency medical service
449747|NCT01644045|teleconsultation|teleconsultation
450562|NCT01640665|metastatic|metastatic
449748|NCT01644045|telemedicine|telemedicine
449749|NCT01644032|telemedicine|telemedicine
449750|NCT01644032|teleconsultation|teleconsultation
449751|NCT01644032|analgesia|analgesia
449752|NCT01644032|emergency|emergency
449753|NCT01644032|prehospital|prehospital
449755|NCT01644019|teleconsultation|teleconsultation
449756|NCT01644019|telemedicine|telemedicine
449757|NCT01644019|emergency medical service|emergency medical service
449758|NCT01644006|acute coronary syndrome|acute coronary syndrome
449759|NCT01644006|telemedicine|telemedicine
449760|NCT01644006|teleconsultation|teleconsultation
449761|NCT01644006|emergency medical service|emergency medical service
449762|NCT01643993|IVF|ivf
449763|NCT01643993|embryo|embryo
449764|NCT01643967|Ozone|ozone
449765|NCT01643967|Sunflower oil|sunflower oil
449766|NCT01643967|diabetes Mellitus|diabetes mellitus
449767|NCT01643954|prostatectomy|prostatectomy
449768|NCT01643954|surgery|surgery
449769|NCT01643954|prostate cancer|prostate cancer
449770|NCT01643941|Staphylococcus aureus|staphylococcus aureus
449771|NCT01643941|vaccine|vaccine
449772|NCT01643941|Staphylococcal infection|staphylococcal infection
449773|NCT01643928|extension trial|extension trial
449774|NCT01643928|rheumatoid arthritis|rheumatoid arthritis
449775|NCT01643928|rituximab|rituximab
449776|NCT01643915|Audiovisual distraction|audiovisual distraction
449777|NCT01643915|Pediatric dentistry|pediatric dentistry
449778|NCT01643902|Stroke|stroke
449779|NCT01643902|Wake up|wake up
449780|NCT01643902|IV tPA|iv tpa
449781|NCT01643902|Thrombolytic|thrombolytic
449782|NCT01643889|Healthy|healthy
449783|NCT01643889|Domperidone|domperidone
449784|NCT01643889|Cardiac Repolarization|cardiac repolarization
449785|NCT01643876|Denture stomatitis|denture stomatitis
449786|NCT01643876|Denture Plaque|denture plaque
449787|NCT01643876|Oral Candidiasis|oral candidiasis
449788|NCT01643876|Oral Hygiene|oral hygiene
449789|NCT01643850|Pigmented Villonodular Synovitis|pigmented villonodular synovitis
449790|NCT01643850|PVNS|pvns
449791|NCT01643850|Giant cell tumor of the tendon sheath|giant cell tumor of the tendon sheath
449792|NCT01643850|GCCTS|gccts
449793|NCT01643850|Tenosynovial giant cell tumor (localized or diffused type)|tenosynovial giant cell tumor (localized or diffused type)
449794|NCT01643850|GCTS|gcts
449795|NCT01643850|MCS110|mcs110
449796|NCT01643837|Mastalgia|mastalgia
449797|NCT01643837|Breast Pain|breast pain
449798|NCT01643837|Osteopathic Manipulative Medicine|osteopathic manipulative medicine
449799|NCT01643837|Osteopathic Manipulative Treatment|osteopathic manipulative treatment
449800|NCT01643811|early gastric cancer, diabetes, hypertension|early gastric cancer, diabetes, hypertension
449801|NCT01643785|therapeutic efficacy endonase addictive effect|therapeutic efficacy endonase addictive effect
449802|NCT01643759|osteoarthritis disorders|osteoarthritis disorders
449803|NCT01643733|Angioplasty|angioplasty
449804|NCT01643707|Sick Sinus Syndrome|sick sinus syndrome
449805|NCT01643707|Bradycardia|bradycardia
449806|NCT01643616|Sciatic Nerve|sciatic nerve
449807|NCT01643616|Ultrasound|ultrasound
449808|NCT01643616|Anesthesia, Regional|anesthesia, regional
449809|NCT01643616|Orthopedic Surgery|orthopedic surgery
449810|NCT01643603|accelerated phase chronic myelogenous leukemia|accelerated phase chronic myelogenous leukemia
449811|NCT01643603|adult acute lymphoblastic leukemia in remission|adult acute lymphoblastic leukemia in remission
449812|NCT01643603|adult acute myeloid leukemia in remission|adult acute myeloid leukemia in remission
449813|NCT01643603|adult acute myeloid leukemia with 11q23 (MLL) abnormalities|adult acute myeloid leukemia with 11q23 (mll) abnormalities
449814|NCT01643603|adult acute myeloid leukemia with del(5q)|adult acute myeloid leukemia with del(5q)
449815|NCT01643603|adult acute myeloid leukemia with inv(16)(p13;q22)|adult acute myeloid leukemia with inv(16)(p13;q22)
449816|NCT01643603|adult acute myeloid leukemia with t(15;17)(q22;q12)|adult acute myeloid leukemia with t(15;17)(q22;q12)
449817|NCT01643603|adult acute myeloid leukemia with t(16;16)(p13;q22)|adult acute myeloid leukemia with t(16;16)(p13;q22)
449818|NCT01643603|adult acute myeloid leukemia with t(8;21)(q22;q22)|adult acute myeloid leukemia with t(8;21)(q22;q22)
449819|NCT01643603|adult grade III lymphomatoid granulomatosis|adult grade iii lymphomatoid granulomatosis
449820|NCT01643603|adult nasal type extranodal NK/T-cell lymphoma|adult nasal type extranodal nk/t-cell lymphoma
449821|NCT01643603|anaplastic large cell lymphoma|anaplastic large cell lymphoma
450029|NCT01643135|bleeding|bleeding
449822|NCT01643603|angioimmunoblastic T-cell lymphoma|angioimmunoblastic t-cell lymphoma
449823|NCT01643603|blastic phase chronic myelogenous leukemia|blastic phase chronic myelogenous leukemia
449824|NCT01643603|chronic phase chronic myelogenous leukemia|chronic phase chronic myelogenous leukemia
449825|NCT01643603|contiguous stage II adult Burkitt lymphoma|contiguous stage ii adult burkitt lymphoma
449826|NCT01643603|contiguous stage II adult diffuse large cell lymphoma|contiguous stage ii adult diffuse large cell lymphoma
449827|NCT01643603|contiguous stage II adult diffuse mixed cell lymphoma|contiguous stage ii adult diffuse mixed cell lymphoma
449828|NCT01643603|contiguous stage II adult diffuse small cleaved cell lymphoma|contiguous stage ii adult diffuse small cleaved cell lymphoma
449829|NCT01643603|contiguous stage II adult immunoblastic large cell lymphoma|contiguous stage ii adult immunoblastic large cell lymphoma
449830|NCT01643603|contiguous stage II adult lymphoblastic lymphoma|contiguous stage ii adult lymphoblastic lymphoma
449831|NCT01643603|contiguous stage II grade 1 follicular lymphoma|contiguous stage ii grade 1 follicular lymphoma
449832|NCT01643603|contiguous stage II grade 2 follicular lymphoma|contiguous stage ii grade 2 follicular lymphoma
449833|NCT01643603|contiguous stage II grade 3 follicular lymphoma|contiguous stage ii grade 3 follicular lymphoma
449834|NCT01643603|contiguous stage II mantle cell lymphoma|contiguous stage ii mantle cell lymphoma
449835|NCT01643603|contiguous stage II marginal zone lymphoma|contiguous stage ii marginal zone lymphoma
449836|NCT01643603|contiguous stage II small lymphocytic lymphoma|contiguous stage ii small lymphocytic lymphoma
449837|NCT01643603|cutaneous B-cell non-Hodgkin lymphoma|cutaneous b-cell non-hodgkin lymphoma
449838|NCT01643603|de novo myelodysplastic syndromes|de novo myelodysplastic syndromes
449839|NCT01643603|extranodal marginal zone B-cell lymphoma of mucosa-associated lymphoid tissue|extranodal marginal zone b-cell lymphoma of mucosa-associated lymphoid tissue
449840|NCT01643603|hepatosplenic T-cell lymphoma|hepatosplenic t-cell lymphoma
449841|NCT01643603|intraocular lymphoma|intraocular lymphoma
449842|NCT01643603|nodal marginal zone B-cell lymphoma|nodal marginal zone b-cell lymphoma
449843|NCT01643603|noncontiguous stage II adult Burkitt lymphoma|noncontiguous stage ii adult burkitt lymphoma
449844|NCT01643603|noncontiguous stage II adult diffuse large cell lymphoma|noncontiguous stage ii adult diffuse large cell lymphoma
449845|NCT01643603|noncontiguous stage II adult diffuse mixed cell lymphoma|noncontiguous stage ii adult diffuse mixed cell lymphoma
449846|NCT01643603|noncontiguous stage II adult diffuse small cleaved cell lymphoma|noncontiguous stage ii adult diffuse small cleaved cell lymphoma
710251|NCT00589563|adult favorable prognosis Hodgkin lymphoma|adult favorable prognosis hodgkin lymphoma
574238|NCT01119768|GI|gi
449847|NCT01643603|noncontiguous stage II adult immunoblastic large cell lymphoma|noncontiguous stage ii adult immunoblastic large cell lymphoma
449848|NCT01643603|noncontiguous stage II adult lymphoblastic lymphoma|noncontiguous stage ii adult lymphoblastic lymphoma
449849|NCT01643603|noncontiguous stage II grade 1 follicular lymphoma|noncontiguous stage ii grade 1 follicular lymphoma
449850|NCT01643603|noncontiguous stage II grade 2 follicular lymphoma|noncontiguous stage ii grade 2 follicular lymphoma
449851|NCT01643603|noncontiguous stage II grade 3 follicular lymphoma|noncontiguous stage ii grade 3 follicular lymphoma
449852|NCT01643603|noncontiguous stage II mantle cell lymphoma|noncontiguous stage ii mantle cell lymphoma
449853|NCT01643603|noncontiguous stage II marginal zone lymphoma|noncontiguous stage ii marginal zone lymphoma
449854|NCT01643603|noncontiguous stage II small lymphocytic lymphoma|noncontiguous stage ii small lymphocytic lymphoma
449855|NCT01643603|noncutaneous extranodal lymphoma|noncutaneous extranodal lymphoma
449856|NCT01643603|peripheral T-cell lymphoma|peripheral t-cell lymphoma
449857|NCT01643603|previously treated myelodysplastic syndromes|previously treated myelodysplastic syndromes
449858|NCT01643603|recurrent adult acute lymphoblastic leukemia|recurrent adult acute lymphoblastic leukemia
449859|NCT01643603|recurrent adult acute myeloid leukemia|recurrent adult acute myeloid leukemia
449860|NCT01643603|recurrent adult Burkitt lymphoma|recurrent adult burkitt lymphoma
449861|NCT01643603|recurrent adult diffuse large cell lymphoma|recurrent adult diffuse large cell lymphoma
449862|NCT01643603|recurrent adult diffuse mixed cell lymphoma|recurrent adult diffuse mixed cell lymphoma
449863|NCT01643603|recurrent adult diffuse small cleaved cell lymphoma|recurrent adult diffuse small cleaved cell lymphoma
449864|NCT01643603|recurrent adult grade III lymphomatoid granulomatosis|recurrent adult grade iii lymphomatoid granulomatosis
449865|NCT01643603|recurrent adult Hodgkin lymphoma|recurrent adult hodgkin lymphoma
449866|NCT01643603|recurrent adult immunoblastic large cell lymphoma|recurrent adult immunoblastic large cell lymphoma
449867|NCT01643603|recurrent adult lymphoblastic lymphoma|recurrent adult lymphoblastic lymphoma
449868|NCT01643603|recurrent adult T-cell leukemia/lymphoma|recurrent adult t-cell leukemia/lymphoma
449869|NCT01643603|recurrent cutaneous T-cell non-Hodgkin lymphoma|recurrent cutaneous t-cell non-hodgkin lymphoma
449870|NCT01643603|recurrent grade 1 follicular lymphoma|recurrent grade 1 follicular lymphoma
449871|NCT01643603|recurrent grade 2 follicular lymphoma|recurrent grade 2 follicular lymphoma
449872|NCT01643603|recurrent grade 3 follicular lymphoma|recurrent grade 3 follicular lymphoma
449873|NCT01643603|recurrent mantle cell lymphoma|recurrent mantle cell lymphoma
449874|NCT01643603|recurrent marginal zone lymphoma|recurrent marginal zone lymphoma
449875|NCT01643603|recurrent mycosis fungoides/Sezary syndrome|recurrent mycosis fungoides/sezary syndrome
449876|NCT01643603|recurrent small lymphocytic lymphoma|recurrent small lymphocytic lymphoma
449877|NCT01643603|refractory chronic lymphocytic leukemia|refractory chronic lymphocytic leukemia
449878|NCT01643603|refractory hairy cell leukemia|refractory hairy cell leukemia
449879|NCT01643603|relapsing chronic myelogenous leukemia|relapsing chronic myelogenous leukemia
449880|NCT01643603|small intestine lymphoma|small intestine lymphoma
449881|NCT01643603|splenic marginal zone lymphoma|splenic marginal zone lymphoma
449882|NCT01643603|stage I adult Burkitt lymphoma|stage i adult burkitt lymphoma
449883|NCT01643603|stage I adult diffuse large cell lymphoma|stage i adult diffuse large cell lymphoma
449884|NCT01643603|stage I adult diffuse mixed cell lymphoma|stage i adult diffuse mixed cell lymphoma
449885|NCT01643603|stage I adult diffuse small cleaved cell lymphoma|stage i adult diffuse small cleaved cell lymphoma
449886|NCT01643603|stage I adult Hodgkin lymphoma|stage i adult hodgkin lymphoma
449887|NCT01643603|stage I adult immunoblastic large cell lymphoma|stage i adult immunoblastic large cell lymphoma
449888|NCT01643603|stage I adult lymphoblastic lymphoma|stage i adult lymphoblastic lymphoma
449889|NCT01643603|stage I adult T-cell leukemia/lymphoma|stage i adult t-cell leukemia/lymphoma
449890|NCT01643603|stage I chronic lymphocytic leukemia|stage i chronic lymphocytic leukemia
449891|NCT01643603|stage I cutaneous T-cell non-Hodgkin lymphoma|stage i cutaneous t-cell non-hodgkin lymphoma
450563|NCT01640665|Phase 1|phase 1
449892|NCT01643603|stage I grade 1 follicular lymphoma|stage i grade 1 follicular lymphoma
449893|NCT01643603|stage I grade 2 follicular lymphoma|stage i grade 2 follicular lymphoma
449894|NCT01643603|stage I grade 3 follicular lymphoma|stage i grade 3 follicular lymphoma
449895|NCT01643603|stage I mantle cell lymphoma|stage i mantle cell lymphoma
449896|NCT01643603|stage I marginal zone lymphoma|stage i marginal zone lymphoma
449897|NCT01643603|stage I small lymphocytic lymphoma|stage i small lymphocytic lymphoma
449898|NCT01643603|stage IA mycosis fungoides/Sezary syndrome|stage ia mycosis fungoides/sezary syndrome
449899|NCT01643603|stage IB mycosis fungoides/Sezary syndrome|stage ib mycosis fungoides/sezary syndrome
449900|NCT01643603|stage II adult Hodgkin lymphoma|stage ii adult hodgkin lymphoma
449901|NCT01643603|stage II chronic lymphocytic leukemia|stage ii chronic lymphocytic leukemia
449902|NCT01643603|stage II cutaneous T-cell non-Hodgkin lymphoma|stage ii cutaneous t-cell non-hodgkin lymphoma
449903|NCT01643603|stage IIA mycosis fungoides/Sezary syndrome|stage iia mycosis fungoides/sezary syndrome
449904|NCT01643603|stage IIB mycosis fungoides/Sezary syndrome|stage iib mycosis fungoides/sezary syndrome
449905|NCT01643603|stage III adult Burkitt lymphoma|stage iii adult burkitt lymphoma
449906|NCT01643603|stage III adult diffuse large cell lymphoma|stage iii adult diffuse large cell lymphoma
710626|NCT00588562|Cystinuria|cystinuria
449907|NCT01643603|stage III adult diffuse mixed cell lymphoma|stage iii adult diffuse mixed cell lymphoma
449908|NCT01643603|stage III adult diffuse small cleaved cell lymphoma|stage iii adult diffuse small cleaved cell lymphoma
449909|NCT01643603|stage III adult Hodgkin lymphoma|stage iii adult hodgkin lymphoma
449910|NCT01643603|stage III adult immunoblastic large cell lymphoma|stage iii adult immunoblastic large cell lymphoma
449911|NCT01643603|stage III adult lymphoblastic lymphoma|stage iii adult lymphoblastic lymphoma
449912|NCT01643603|stage III adult T-cell leukemia/lymphoma|stage iii adult t-cell leukemia/lymphoma
449913|NCT01643603|stage III chronic lymphocytic leukemia|stage iii chronic lymphocytic leukemia
449914|NCT01643603|stage III cutaneous T-cell non-Hodgkin lymphoma|stage iii cutaneous t-cell non-hodgkin lymphoma
449915|NCT01643603|stage III grade 1 follicular lymphoma|stage iii grade 1 follicular lymphoma
449916|NCT01643603|stage III grade 2 follicular lymphoma|stage iii grade 2 follicular lymphoma
449917|NCT01643603|stage III grade 3 follicular lymphoma|stage iii grade 3 follicular lymphoma
449918|NCT01643603|stage III mantle cell lymphoma|stage iii mantle cell lymphoma
449919|NCT01643603|stage III marginal zone lymphoma|stage iii marginal zone lymphoma
449920|NCT01643603|stage III small lymphocytic lymphoma|stage iii small lymphocytic lymphoma
449921|NCT01643603|stage IIIA mycosis fungoides/Sezary syndrome|stage iiia mycosis fungoides/sezary syndrome
449922|NCT01643603|stage IIIB mycosis fungoides/Sezary syndrome|stage iiib mycosis fungoides/sezary syndrome
449923|NCT01643603|stage IV adult Burkitt lymphoma|stage iv adult burkitt lymphoma
449924|NCT01643603|stage IV adult diffuse large cell lymphoma|stage iv adult diffuse large cell lymphoma
449925|NCT01643603|stage IV adult diffuse mixed cell lymphoma|stage iv adult diffuse mixed cell lymphoma
449926|NCT01643603|stage IV adult diffuse small cleaved cell lymphoma|stage iv adult diffuse small cleaved cell lymphoma
449927|NCT01643603|stage IV adult Hodgkin lymphoma|stage iv adult hodgkin lymphoma
449928|NCT01643603|stage IV adult immunoblastic large cell lymphoma|stage iv adult immunoblastic large cell lymphoma
449929|NCT01643603|stage IV adult lymphoblastic lymphoma|stage iv adult lymphoblastic lymphoma
449930|NCT01643603|stage IV adult T-cell leukemia/lymphoma|stage iv adult t-cell leukemia/lymphoma
449931|NCT01643603|stage IV chronic lymphocytic leukemia|stage iv chronic lymphocytic leukemia
449932|NCT01643603|stage IV cutaneous T-cell non-Hodgkin lymphoma|stage iv cutaneous t-cell non-hodgkin lymphoma
449933|NCT01643603|stage IV grade 1 follicular lymphoma|stage iv grade 1 follicular lymphoma
449934|NCT01643603|stage IV grade 2 follicular lymphoma|stage iv grade 2 follicular lymphoma
449935|NCT01643603|stage IV grade 3 follicular lymphoma|stage iv grade 3 follicular lymphoma
449936|NCT01643603|stage IV mantle cell lymphoma|stage iv mantle cell lymphoma
449937|NCT01643603|stage IV marginal zone lymphoma|stage iv marginal zone lymphoma
449938|NCT01643603|stage IV small lymphocytic lymphoma|stage iv small lymphocytic lymphoma
449939|NCT01643603|stage IVA mycosis fungoides/Sezary syndrome|stage iva mycosis fungoides/sezary syndrome
449940|NCT01643603|stage IVB mycosis fungoides/Sezary syndrome|stage ivb mycosis fungoides/sezary syndrome
449941|NCT01643603|T-cell large granular lymphocyte leukemia|t-cell large granular lymphocyte leukemia
449942|NCT01643603|testicular lymphoma|testicular lymphoma
449943|NCT01643603|Waldenström macroglobulinemia|waldenström macroglobulinemia
449944|NCT01643577|Idiopathic|idiopathic
449945|NCT01643577|gastroparesis|gastroparesis
449946|NCT01643577|delayed gastric emptying|delayed gastric emptying
449947|NCT01643577|nausea|nausea
449948|NCT01643577|vomiting|vomiting
449949|NCT01643577|abdominal pain|abdominal pain
449950|NCT01643577|bloating|bloating
449951|NCT01643564|Transplant|transplant
449952|NCT01643564|Cytokines|cytokines
449953|NCT01643564|Graft Dysfunction|graft dysfunction
449954|NCT01643551|Heart Failure|heart failure
449955|NCT01643551|Left Ventricular Assist Device|left ventricular assist device
449956|NCT01643551|Reperfusion Injury|reperfusion injury
449957|NCT01643551|Neuron Specific Enolase|neuron specific enolase
449958|NCT01643538|physical activity|physical activity
449959|NCT01643538|adults age 65 and older|adults age 65 and older
449960|NCT01643538|financial incentives|financial incentives
449961|NCT01643525|Ischemic Stroke|ischemic stroke
449962|NCT01643486|peritoneal dialysis|peritoneal dialysis
449963|NCT01643486|phosphate|phosphate
449964|NCT01643486|iTouch|itouch
449965|NCT01643473|Hypertension|hypertension
449966|NCT01643473|Latinos|latinos
449967|NCT01643473|Medication Adherence|medication adherence
449968|NCT01643473|Blood Pressure Control|blood pressure control
449969|NCT01643473|Patient-centered|patient-centered
449970|NCT01643473|Black|black
449971|NCT01643460|Intraductal papillary mucinous neoplasms (IPMNs)|intraductal papillary mucinous neoplasms (ipmns)
449972|NCT01643460|Mucinous cystadenomas [MCN])|mucinous cystadenomas [mcn])
449973|NCT01643460|Invasive IPMNs or mucinous cystadenocarcinomas) tumors|invasive ipmns or mucinous cystadenocarcinomas) tumors
449974|NCT01643447|Hepatocellular Carcinoma|hepatocellular carcinoma
449975|NCT01643447|Ulinastatin|ulinastatin
449976|NCT01643447|Hepatic Failure|hepatic failure
449977|NCT01643434|Resistant Hypertension|resistant hypertension
449978|NCT01643408|Acute Lymphoblastic Leukemia|acute lymphoblastic leukemia
449979|NCT01643408|Lymphoblastic Lymphoma|lymphoblastic lymphoma
449980|NCT01643408|Erwinaze|erwinaze
449981|NCT01643408|asparaginase|asparaginase
449982|NCT01643408|Eusa Pharma|eusa pharma
449983|NCT01643408|Pharmacokinetic study|pharmacokinetic study
449984|NCT01643408|NSAA|nsaa
449985|NCT01643395|Trauma|trauma
449986|NCT01643395|vertebral|vertebral
449987|NCT01643395|compression fracture|compression fracture
449988|NCT01643395|spinal|spinal
449989|NCT01643395|acute|acute
449990|NCT01643395|vertebroplasty|vertebroplasty
449991|NCT01643395|conservative treatment|conservative treatment
449992|NCT01643382|diabetes|diabetes
449993|NCT01643382|kidney transplant|kidney transplant
449994|NCT01643382|end stage renal disease|end stage renal disease
449995|NCT01643382|delayed draft function|delayed draft function
449996|NCT01643369|meditation|meditation
449997|NCT01643369|compassion|compassion
449998|NCT01643369|inflammation|inflammation
449999|NCT01643369|immune system|immune system
450000|NCT01643356|weight|weight
450001|NCT01643356|pregnancy|pregnancy
450002|NCT01643356|behavioral intervention|behavioral intervention
450003|NCT01643356|obesity|obesity
450004|NCT01643343|autism spectrum disorders|autism spectrum disorders
450005|NCT01643343|autism|autism
450006|NCT01643343|joint attention|joint attention
450007|NCT01643343|imitation|imitation
450008|NCT01643343|fluency|fluency
450009|NCT01643330|Cardiomegaly|cardiomegaly
450010|NCT01643330|Heart Diseases|heart diseases
450011|NCT01643330|Cardiovascular Diseases|cardiovascular diseases
450012|NCT01643304|Menorrhagia|menorrhagia
450013|NCT01643304|Heavy menstrual bleeding|heavy menstrual bleeding
450014|NCT01643304|Uterine Hemorrhage|uterine hemorrhage
450015|NCT01643304|Menstruation Disturbancies|menstruation disturbancies
450016|NCT01643252|Corneal Ectasia|corneal ectasia
450017|NCT01643252|Refractive surgery|refractive surgery
450018|NCT01643252|Cross-Linking|cross-linking
450019|NCT01643239|Modified constraint-induced therapy|modified constraint-induced therapy
450020|NCT01643239|Children with cerebral palsy|children with cerebral palsy
450021|NCT01643239|Kinematic analysis|kinematic analysis
450022|NCT01643239|Group therapy|group therapy
450023|NCT01643148|biomarker|biomarker
450024|NCT01643148|BMI|bmi
450025|NCT01643148|breast cancer|breast cancer
450026|NCT01643148|CA-15-3|ca-15-3
450027|NCT01643148|leptin|leptin
450028|NCT01643135|tranexamic acid|tranexamic acid
450030|NCT01643135|blood transfusion|blood transfusion
450031|NCT01643135|spine surgery|spine surgery
450032|NCT01643122|Endometriosis, Validation study|endometriosis, validation study
450033|NCT01643109|Cerebral Palsy|cerebral palsy
450034|NCT01643109|Hemiplegia|hemiplegia
450035|NCT01643109|Constraint Induced Movement Therapy|constraint induced movement therapy
450036|NCT01643096|Zataria multiflora Boiss Sumac TEF temperament|zataria multiflora boiss sumac tef temperament
450037|NCT01643083|Post-prandial distress syndrome|post-prandial distress syndrome
450038|NCT01643070|Rectal cancer|rectal cancer
450039|NCT01643070|Liver metastases|liver metastases
450040|NCT01643070|Capecitabine|capecitabine
450041|NCT01643070|Oxaliplatin|oxaliplatin
450042|NCT01643057|Apnea|apnea
450043|NCT01643057|Prematurity|prematurity
450044|NCT01643057|Biomarkers|biomarkers
450045|NCT01643057|Stochastic Resonance|stochastic resonance
450046|NCT01643057|Neonatal|neonatal
450047|NCT01643044|pregnancy|pregnancy
450048|NCT01643044|screening|screening
450049|NCT01643044|motivation|motivation
450050|NCT01643031|Diabetes|diabetes
450051|NCT01643031|Platelets aggregation inhibitors|platelets aggregation inhibitors
450052|NCT01643031|Platelet function tests|platelet function tests
450053|NCT01643018|cystic echinococcosis|cystic echinococcosis
450054|NCT01643018|liver cyst hydatique|liver cyst hydatique
450055|NCT01643018|treatment|treatment
450056|NCT01643018|surgery|surgery
450057|NCT01643018|laparoscopy|laparoscopy
450058|NCT01643005|HIV|hiv
450059|NCT01642992|Coronary bifurcation lesion|coronary bifurcation lesion
450060|NCT01642992|Drug-eluting stent|drug-eluting stent
450061|NCT01642979|Paroxysmal Nocturnal Hemoglobinuria|paroxysmal nocturnal hemoglobinuria
450062|NCT01642979|Anemia|anemia
450063|NCT01642979|Hematologic Diseases|hematologic diseases
450064|NCT01642979|bone marrow failure|bone marrow failure
450065|NCT01642979|Immunologic Factors|immunologic factors
450066|NCT01642979|Physiological Effects of Drugs|physiological effects of drugs
450067|NCT01642979|Levamisole|levamisole
450068|NCT01642979|cyclosporine A|cyclosporine a
450069|NCT01642966|ticagrelor|ticagrelor
450070|NCT01642966|doppler echocardiography|doppler echocardiography
450071|NCT01642953|Gastric cancer surgery|gastric cancer surgery
450072|NCT01642953|Early oral feeding|early oral feeding
450073|NCT01642953|Fast track surgery|fast track surgery
450074|NCT01642927|LVAD|lvad
450075|NCT01642927|IABP|iabp
450076|NCT01642927|Heart Failure|heart failure
450077|NCT01642927|Thrombosis|thrombosis
450078|NCT01642927|Hemorrhage|hemorrhage
450079|NCT01642914|Chronic Constipation|chronic constipation
450080|NCT01642914|Abdominal Bloating|abdominal bloating
450081|NCT01642914|Linaclotide|linaclotide
450082|NCT01642901|spinal cord injury|spinal cord injury
450083|NCT01642901|bone mineral density|bone mineral density
450084|NCT01642875|Periampullary tumor|periampullary tumor
574588|NCT01118572|Celecox|celecox
450085|NCT01642875|Chronic pancreatitis|chronic pancreatitis
450086|NCT01642875|Pancreatoduodenectomy|pancreatoduodenectomy
450087|NCT01642875|Oral Nutrition|oral nutrition
450088|NCT01642875|Enteral Nutrition|enteral nutrition
450089|NCT01642849|high protein diet|high protein diet
450090|NCT01642849|high carbohydrate diet|high carbohydrate diet
450091|NCT01642849|weight loss|weight loss
450092|NCT01642849|oxidative stress|oxidative stress
450093|NCT01642849|inflammation|inflammation
450094|NCT01642849|cardiovascular risk factors|cardiovascular risk factors
450095|NCT01642823|retinoblastoma|retinoblastoma
450096|NCT01642810|Online treatment for Fibromyalgia Syndrome|online treatment for fibromyalgia syndrome
450097|NCT01642810|Acceptance-based behavioural treatment|acceptance-based behavioural treatment
450098|NCT01642797|confocal laser endomicroscopy|confocal laser endomicroscopy
450099|NCT01642797|gastric intestinal metaplasia|gastric intestinal metaplasia
450100|NCT01642797|gastric intraepithelial neoplasia|gastric intraepithelial neoplasia
450101|NCT01642797|gastric carcinoma|gastric carcinoma
450102|NCT01642784|STEMI|stemi
450103|NCT01642784|NSTEMI|nstemi
450104|NCT01642784|revascularization|revascularization
450105|NCT01642784|stents|stents
450106|NCT01642771|Triple-negative Breast Cancer|triple-negative breast cancer
450107|NCT01642771|Post-operative adjuvant Chemotherapy|post-operative adjuvant chemotherapy
450108|NCT01642771|Docetaxel|docetaxel
450109|NCT01642771|Capecitabine|capecitabine
450110|NCT01642771|Epirubicin|epirubicin
450111|NCT01642771|Cyclophosphamide|cyclophosphamide
450112|NCT01642771|Fluorouracil|fluorouracil
450113|NCT01642758|Thalassemia intermedia|thalassemia intermedia
450114|NCT01642758|Fetal hemoglobin|fetal hemoglobin
450115|NCT01642758|Hemoglobin|hemoglobin
450116|NCT01642732|Prostate|prostate
450117|NCT01642732|Cancer|cancer
450118|NCT01642732|Everolimus|everolimus
450119|NCT01642732|Radiation|radiation
450120|NCT01642719|Sleep disturbance|sleep disturbance
450121|NCT01642719|Aging|aging
450122|NCT01642719|Sleep restriction|sleep restriction
450123|NCT01642719|Health status|health status
450124|NCT01642719|Glucose tolerance|glucose tolerance
450125|NCT01642719|Inflammation|inflammation
450126|NCT01642706|Regulatory B cells|regulatory b cells
450127|NCT01642706|Rheumatoid arthritis|rheumatoid arthritis
450128|NCT01642706|Biomarker|biomarker
450129|NCT01642693|root resorption|root resorption
450130|NCT01642693|low-power laser|low-power laser
450131|NCT01642693|orthodontic tooth movement|orthodontic tooth movement
450132|NCT01642693|pulp changes|pulp changes
450133|NCT01642680|Physical activity program|physical activity program
450134|NCT01642680|Chemotherapy|chemotherapy
450135|NCT01642680|Metabolic syndrome|metabolic syndrome
450136|NCT01642680|Reducing cardiovascular risk factors|reducing cardiovascular risk factors
450137|NCT01642680|low physical activity level|low physical activity level
450138|NCT01642628|Mirror|mirror
450139|NCT01642628|Body Image|body image
450140|NCT01642628|Mastectomy|mastectomy
450141|NCT01642615|Drug therapy|drug therapy
450142|NCT01642602|Drug Therapy|drug therapy
450143|NCT01642589|Meningitis|meningitis
450144|NCT01642589|Meningococcal disease|meningococcal disease
450145|NCT01642589|Menactra®|menactra®
450146|NCT01642589|Adacel®|adacel®
450147|NCT01642576|obesity|obesity
450148|NCT01642576|men|men
450149|NCT01642576|sexual function|sexual function
450150|NCT01642576|urinary tract symptoms|urinary tract symptoms
450151|NCT01642576|endothelial function|endothelial function
450152|NCT01642576|inflammation|inflammation
450153|NCT01642576|quality of life|quality of life
450154|NCT01642563|Platelet transfusion|platelet transfusion
450155|NCT01642563|Leukemia|leukemia
450156|NCT01642563|Transfusion transmissible infections|transfusion transmissible infections
450157|NCT01642563|Chemotherapy|chemotherapy
450158|NCT01642563|Allogeneic hemopoietic stem cell transplant|allogeneic hemopoietic stem cell transplant
450159|NCT01642550|Anorexia nervosa|anorexia nervosa
450160|NCT01642550|Anorexia|anorexia
450161|NCT01642550|Eating disorders|eating disorders
450162|NCT01642524|resuscitation|resuscitation
450163|NCT01642511|Breast Cancer|breast cancer
450164|NCT01642511|Sentinel Lymph Node Biopsy|sentinel lymph node biopsy
450165|NCT01642511|Internal Mammary|internal mammary
450166|NCT01642511|Lymphoscintigraphy|lymphoscintigraphy
450167|NCT01642498|High Blood Pressure|high blood pressure
450168|NCT01642498|Hypertension|hypertension
450169|NCT01642498|Resistant Hypertension|resistant hypertension
450170|NCT01642485|Insulin clamp|insulin clamp
450171|NCT01642485|Glucose clamp|glucose clamp
450172|NCT01642485|Moxifloxacin|moxifloxacin
450174|NCT01642485|Fasted|fasted
450175|NCT01642485|QT/QTC interval|qt/qtc interval
450176|NCT01642485|TQT|tqt
450177|NCT01642485|ECG|ecg
450178|NCT01642485|Meal effects|meal effects
450179|NCT01642485|C Peptide|c peptide
450180|NCT01642485|Japanese Caucasian bridging|japanese caucasian bridging
450181|NCT01642485|TQT bridging|tqt bridging
710627|NCT00588562|Cystine|cystine
450182|NCT01642485|FDA standard breakfast|fda standard breakfast
450183|NCT01642485|Adaptive study design|adaptive study design
450184|NCT01642459|arteriovenous fistula|arteriovenous fistula
450185|NCT01642459|hemodialysis|hemodialysis
450186|NCT01642459|aneurysm|aneurysm
450187|NCT01642459|vascular stenosis|vascular stenosis
450188|NCT01642459|cannulation|cannulation
450189|NCT01642446|precise hepatectomy|precise hepatectomy
450190|NCT01642446|hepatocellular carcinoma|hepatocellular carcinoma
450191|NCT01642446|cirrhotic|cirrhotic
450192|NCT01642446|portal hypertension|portal hypertension
450193|NCT01642446|safety|safety
450194|NCT01642446|combined interventional treatment|combined interventional treatment
450195|NCT01642394|Diabetes Mellitus|diabetes mellitus
450196|NCT01642394|Chronic Disease|chronic disease
450197|NCT01642394|Education|education
450198|NCT01642394|Primary Care|primary care
450199|NCT01642394|Self care|self care
450200|NCT01642394|Self Management|self management
450201|NCT01642381|Drinking|drinking
450202|NCT01642381|Alcohol Problems|alcohol problems
450203|NCT01642381|Alcoholism|alcoholism
450204|NCT01642381|Moderation-Oriented Treatment|moderation-oriented treatment
450205|NCT01642381|Controlled Drinking|controlled drinking
450206|NCT01642381|Reduced Drinking|reduced drinking
450207|NCT01642381|Heavy Drinking|heavy drinking
450208|NCT01642381|Problematic Drinking|problematic drinking
450209|NCT01642381|Non-Abstinence-based Drinking|non-abstinence-based drinking
450210|NCT01642368|Omega-3 fatty acids|omega-3 fatty acids
450211|NCT01642368|Omega-3 to omega-6 ratio|omega-3 to omega-6 ratio
450212|NCT01642368|Cognitive response|cognitive response
450213|NCT01642368|Physical performance|physical performance
450214|NCT01642329|Myocardial Infarction|myocardial infarction
450215|NCT01642329|Angina, Unstable|angina, unstable
450216|NCT01642316|washback, reading comprehension|washback, reading comprehension
450217|NCT01642303|vodcasting,listening,language education|vodcasting,listening,language education
450218|NCT01642277|Overactive Bladder|overactive bladder
450219|NCT01642277|OAB|oab
450220|NCT01642277|Urinary Tract Infection|urinary tract infection
450221|NCT01642277|UTI|uti
450222|NCT01642277|Microbiome|microbiome
450223|NCT01642277|Bacteria|bacteria
450224|NCT01642277|Solifenacin|solifenacin
450225|NCT01642277|16S rRNA sequence|16s rrna sequence
450226|NCT01642264|Tobacco Cessation|tobacco cessation
450227|NCT01642264|Continuing Education|continuing education
450228|NCT01642264|Pediatric|pediatric
450229|NCT01642264|Respiratory Therapist|respiratory therapist
450230|NCT01642264|Nurse|nurse
450231|NCT01642251|Veliparib|veliparib
450232|NCT01642251|Small cell lung cancer|small cell lung cancer
450233|NCT01642238|Antiplatelet|antiplatelet
450234|NCT01642238|ticagrelor|ticagrelor
450235|NCT01642238|clopidogrel|clopidogrel
450236|NCT01642238|bivalirudin|bivalirudin
450237|NCT01642238|thrombosis|thrombosis
450238|NCT01642212|EoE|eoe
450239|NCT01642199|obesity|obesity
450240|NCT01642199|weight loss|weight loss
450241|NCT01642199|lay health coach|lay health coach
450242|NCT01642199|peer coach|peer coach
450243|NCT01642199|mentor coach|mentor coach
450244|NCT01642199|reduced intensity weight loss program|reduced intensity weight loss program
450245|NCT01642186|LETROZOLE|letrozole
450246|NCT01642186|LUPRON DEPOT|lupron depot
450247|NCT01642186|RAD001 (EVEROLIMUS)|rad001 (everolimus)
450248|NCT01642186|11-211|11-211
450249|NCT01642147|Cerebral blood flow|cerebral blood flow
450250|NCT01642147|Transcranial Doppler|transcranial doppler
450251|NCT01642147|Emergence from general anesthesia|emergence from general anesthesia
450252|NCT01642134|Antiplatelet|antiplatelet
450253|NCT01642134|Anticoagulation|anticoagulation
450254|NCT01642056|Oxidative Stress|oxidative stress
450255|NCT01642056|Oxidative Phosphorylation|oxidative phosphorylation
450256|NCT01642056|Mitochondrial Disease|mitochondrial disease
450257|NCT01642043|greater trochanteric pain syndrome|greater trochanteric pain syndrome
450258|NCT01642043|trochanteric bursitis|trochanteric bursitis
450259|NCT01642043|lateral hip pain|lateral hip pain
450260|NCT01642030|Quantitative sensory testing|quantitative sensory testing
450261|NCT01642030|Cold pressor test|cold pressor test
450262|NCT01642030|Opioid dependence|opioid dependence
450263|NCT01642030|Methadone maintenance|methadone maintenance
450264|NCT01642030|Buprenorphine maintenance|buprenorphine maintenance
450265|NCT01642030|Abuse liability|abuse liability
450266|NCT01642030|Diffuse Noxious Inhibitory Controls (DNIC)|diffuse noxious inhibitory controls (dnic)
450267|NCT01642030|Temporal Summation|temporal summation
450268|NCT01642017|Phase I, Pazopanib, Frail elderly patients, Pharmacokinetics|phase i, pazopanib, frail elderly patients, pharmacokinetics
450269|NCT01641991|Bacillus anthracis, anthrax, vaccine, BioThrax®, dose-sparing|bacillus anthracis, anthrax, vaccine, biothrax®, dose-sparing
450270|NCT01641913|Eosinophilic Esophagitis|eosinophilic esophagitis
450271|NCT01641900|sleep|sleep
450272|NCT01641900|memory|memory
450273|NCT01641900|schizophrenia|schizophrenia
450274|NCT01641900|eszopiclone|eszopiclone
450275|NCT01641887|GERD|gerd
450276|NCT01641887|Heartburn|heartburn
450277|NCT01641887|Decision Aid|decision aid
450278|NCT01641874|Knee|knee
574828|NCT01117896|CPR|cpr
450279|NCT01641874|Osteoarthritis|osteoarthritis
450280|NCT01641874|McKenzie system|mckenzie system
450281|NCT01641874|Exercise|exercise
450282|NCT01641874|Mechanical Diagnosis and Therapy|mechanical diagnosis and therapy
450283|NCT01641874|Directional preference|directional preference
450284|NCT01641861|Chemo-mechanical caries removal|chemo-mechanical caries removal
450285|NCT01641861|Papacarie®|papacarie®
450286|NCT01641848|Total Ankle Arthroplasty|total ankle arthroplasty
450287|NCT01641809|HIV -1|hiv -1
450288|NCT01641809|GSK1265744|gsk1265744
450289|NCT01641809|maintenance phase|maintenance phase
450290|NCT01641809|dose selection|dose selection
450291|NCT01641796|Cutaneous Leishmaniasis|cutaneous leishmaniasis
450293|NCT01641796|Lesion|lesion
450294|NCT01641796|Topical|topical
450295|NCT01641796|Treatment|treatment
450296|NCT01641796|Cream|cream
450297|NCT01641796|Expanded Access|expanded access
450298|NCT01641783|advanced|advanced
450299|NCT01641783|paclitaxel|paclitaxel
450300|NCT01641783|capecitabine|capecitabine
450301|NCT01641783|first line therapy|first line therapy
450302|NCT01641757|hemodialysis|hemodialysis
450303|NCT01641757|periodontitis|periodontitis
450304|NCT01641744|Parent Child Relationship|parent child relationship
450305|NCT01641744|Maltreatment|maltreatment
450306|NCT01641744|Risk Behaviors|risk behaviors
450307|NCT01641744|Social and Emotional Development|social and emotional development
450308|NCT01641744|Violence and Abuse|violence and abuse
450309|NCT01641744|Policy|policy
450310|NCT01641731|cow's milk protein allergy|cow's milk protein allergy
450311|NCT01641731|oral tolerance induction|oral tolerance induction
450312|NCT01641718|Hernia, Inguinal|hernia, inguinal
450313|NCT01641705|rheumatoid arthritis|rheumatoid arthritis
450314|NCT01641705|respiratory mechanics|respiratory mechanics
450315|NCT01641705|time of disease|time of disease
450316|NCT01641692|Asthma|asthma
450317|NCT01641692|Pharmacokinetics|pharmacokinetics
450318|NCT01641692|GSK573719|gsk573719
450319|NCT01641692|Adults|adults
450320|NCT01641692|Pharmacogenetics|pharmacogenetics
450321|NCT01641679|Recurrent differentiated thyroid cancer|recurrent differentiated thyroid cancer
450322|NCT01641679|I124-PET/CT|i124-pet/ct
450323|NCT01641679|FDG-PET/CT|fdg-pet/ct
450324|NCT01641653|Nondiabetics undergoing hernia repair.|nondiabetics undergoing hernia repair.
450325|NCT01641640|HCV genotype 1 (GT-1)|hcv genotype 1 (gt-1)
450326|NCT01641640|HCV genotype 4 (GT-4)|hcv genotype 4 (gt-4)
450327|NCT01641640|HCV genotype 5 (GT-5)|hcv genotype 5 (gt-5)
450328|NCT01641640|HCV genotype 6 (GT-6)|hcv genotype 6 (gt-6)
450329|NCT01641640|HCV|hcv
450330|NCT01641640|Sustained Virologic Response|sustained virologic response
450331|NCT01641640|Direct Acting Antiviral|direct acting antiviral
450332|NCT01641640|Combination Therapy|combination therapy
450333|NCT01641640|Treatment-Naïve|treatment-naïve
450334|NCT01641640|GS-7977|gs-7977
450335|NCT01641640|Ribavirin|ribavirin
450336|NCT01641640|RBV|rbv
450337|NCT01641640|Peginterferon Alfa 2a|peginterferon alfa 2a
450338|NCT01641640|PEG|peg
450339|NCT01641627|knee arthritis|knee arthritis
450340|NCT01641627|muscle atrophy|muscle atrophy
450341|NCT01641627|proprioceptive stimulation|proprioceptive stimulation
450342|NCT01641627|vibrations|vibrations
450343|NCT01641614|Mitral valve|mitral valve
450344|NCT01641614|valve replacement|valve replacement
450345|NCT01641614|arrested heart|arrested heart
450346|NCT01641614|beating heart|beating heart
450347|NCT01641601|Induction of labor|induction of labor
450348|NCT01641601|Outpatient cervical ripening|outpatient cervical ripening
450349|NCT01641588|cognitive executive function|cognitive executive function
450350|NCT01641588|posture|posture
450351|NCT01641588|cognitive performance|cognitive performance
450352|NCT01641588|heart rate|heart rate
450353|NCT01641588|eeg|eeg
450354|NCT01641575|CO-1.01|co-1.01
450355|NCT01641575|CO-101|co-101
450356|NCT01641575|gemcitabine elaidate|gemcitabine elaidate
450357|NCT01641575|hENT1|hent1
450358|NCT01641575|nucleoside equilibrative transporter|nucleoside equilibrative transporter
450359|NCT01641575|solid tumor|solid tumor
450360|NCT01641575|non-small-cell lung cancer|non-small-cell lung cancer
450361|NCT01641575|NSCLC|nsclc
450362|NCT01641575|lung cancer|lung cancer
450363|NCT01641562|BREAST CANCER,|breast cancer,
450364|NCT01641562|TAXANES,|taxanes,
450462|NCT01641146|Trauma reduction|trauma reduction
450365|NCT01641562|SUBCLINICAL CARDIAC DYSFUNCTION ,|subclinical cardiac dysfunction ,
450366|NCT01641562|DIAGNOSTIC TOOLS,|diagnostic tools,
450367|NCT01641562|PREDICTIVE MODELS|predictive models
450368|NCT01641549|Prosthetic valve thrombosis|prosthetic valve thrombosis
450369|NCT01641549|Fibrinolytic therapy|fibrinolytic therapy
450370|NCT01641549|Emergency surgery|emergency surgery
450371|NCT01641536|Hepatitis, Chronic|hepatitis, chronic
450372|NCT01641536|Virus Diseases|virus diseases
450373|NCT01641536|DNA Virus Infections|dna virus infections
450374|NCT01641536|Hepatitis B|hepatitis b
450375|NCT01641536|Liver|liver
450376|NCT01641536|Chronic Disease|chronic disease
450377|NCT01641536|HBV|hbv
574932|NCT01117506|GES|ges
450378|NCT01641523|Cranioplasty prosthesis|cranioplasty prosthesis
450379|NCT01641523|Hydroxyapatite|hydroxyapatite
450380|NCT01641523|PolyMethylMethacrylate|polymethylmethacrylate
450381|NCT01641523|Autologous Bone|autologous bone
450382|NCT01641510|reduced-function CYP2C19 allele|reduced-function cyp2c19 allele
450383|NCT01641510|high platelet reactivity|high platelet reactivity
450384|NCT01641510|clopidogrel|clopidogrel
450385|NCT01641510|prasugrel|prasugrel
450386|NCT01641497|endometrial cancer|endometrial cancer
450387|NCT01641497|IMRT|imrt
450388|NCT01641497|age over 70|age over 70
450389|NCT01641471|Total Knee Arthroplasty (TKA)|total knee arthroplasty (tka)
450390|NCT01641471|Transcutaneous Electrical Nerve Stimulation (TENS)|transcutaneous electrical nerve stimulation (tens)
450391|NCT01641471|Pain|pain
450392|NCT01641471|Function|function
450393|NCT01641471|Knee Osteoarthritis|knee osteoarthritis
450394|NCT01641458|Genotyping|genotyping
450395|NCT01641458|Area-under-the concentration-time curve|area-under-the concentration-time curve
450396|NCT01641458|Toxicity|toxicity
450397|NCT01641458|5-fluorouracil|5-fluorouracil
450398|NCT01641458|Capecitabine|capecitabine
450399|NCT01641419|Pain|pain
450400|NCT01641419|Ropivacaine|ropivacaine
450401|NCT01641419|sciatic block|sciatic block
450402|NCT01641419|dexamethasone|dexamethasone
450403|NCT01641406|NAC Protocol|nac protocol
450404|NCT01641406|NAC and Oncotype Guided Hormonal therapy for breast cancer|nac and oncotype guided hormonal therapy for breast cancer
450405|NCT01641406|Neoadjuvant and Oncotype|neoadjuvant and oncotype
450406|NCT01641406|NAC CCAM 1101|nac ccam 1101
450407|NCT01641393|Exocrine Pancreatic Insufficiency|exocrine pancreatic insufficiency
450408|NCT01641393|Cystic Fibrosis|cystic fibrosis
450409|NCT01641393|Pancreatic Insufficiency|pancreatic insufficiency
450410|NCT01641380|Depoprovera|depoprovera
450411|NCT01641380|Contraception|contraception
450412|NCT01641380|Appointment adherence/attendance|appointment adherence/attendance
450413|NCT01641380|Pregnancy Prevention|pregnancy prevention
450414|NCT01641354|Hemiepiphysiodesis|hemiepiphysiodesis
450415|NCT01641341|Irritable Bowel Syndrome|irritable bowel syndrome
450416|NCT01641341|Genova Diagnostics kit|genova diagnostics kit
450417|NCT01641341|Stool test|stool test
450418|NCT01641341|Rome III|rome iii
450419|NCT01641341|Practice-based research|practice-based research
450420|NCT01641341|treatable parasite|treatable parasite
450421|NCT01641341|Pancreatic insufficiency|pancreatic insufficiency
450422|NCT01641341|Bowel dysbiosis|bowel dysbiosis
450423|NCT01641341|High levels of inflammation, C. difficile, or H. pylori|high levels of inflammation, c. difficile, or h. pylori
450424|NCT01641328|Mild Cognitive Impairment|mild cognitive impairment
450425|NCT01641328|MCI|mci
450426|NCT01641328|Meditation|meditation
450427|NCT01641328|Mindfulness|mindfulness
450428|NCT01641328|Cognitive Activation|cognitive activation
450429|NCT01641328|Cognitive Training|cognitive training
450430|NCT01641328|Tai Chi|tai chi
450431|NCT01641315|rabies|rabies
450432|NCT01641315|rabies immunoglobulin|rabies immunoglobulin
450433|NCT01641289|Falciparum malaria|falciparum malaria
450434|NCT01641289|Paracetamol|paracetamol
450435|NCT01641289|Renal function|renal function
450436|NCT01641289|Oxidative stress|oxidative stress
450437|NCT01641276|biofeedback response|biofeedback response
450438|NCT01641263|Depression Prevention|depression prevention
450439|NCT01641263|Sleep Disturbances|sleep disturbances
450440|NCT01641263|Inflammatory Markers|inflammatory markers
450441|NCT01641263|Treatments for Sleep Problems|treatments for sleep problems
450442|NCT01641224|Irritable bowel syndrome,|irritable bowel syndrome,
450443|NCT01641224|Pinaverium|pinaverium
450444|NCT01641224|Herbal medication for IBS,|herbal medication for ibs,
450445|NCT01641224|Tong Xie Yao Fang (Formula for pain and diarrhea)|tong xie yao fang (formula for pain and diarrhea)
450446|NCT01641198|Implant, acid-etched fixture, machined collar, bone healing|implant, acid-etched fixture, machined collar, bone healing
450447|NCT01641185|prostate|prostate
450448|NCT01641185|IPI|ipi
450449|NCT01641185|hypofractionation|hypofractionation
450450|NCT01641185|carbon ions|carbon ions
450451|NCT01641185|proton|proton
450452|NCT01641172|taste|taste
450453|NCT01641172|smell|smell
450454|NCT01641172|cancer|cancer
450455|NCT01641172|nutrition|nutrition
450456|NCT01641159|Cocaine|cocaine
450457|NCT01641159|Crack|crack
450458|NCT01641159|Buspirone|buspirone
450459|NCT01641159|Relapse Prevention|relapse prevention
450460|NCT01641146|HIV risk reduction|hiv risk reduction
450461|NCT01641146|Stress reduction|stress reduction
450464|NCT01641133|pneumococcal conjugate vaccine|pneumococcal conjugate vaccine
450465|NCT01641133|Synflorix|synflorix
450466|NCT01641133|Prevnar 13|prevnar 13
450467|NCT01641133|Pneumococcal diseases|pneumococcal diseases
450468|NCT01641120|Multiple Sclerosis|multiple sclerosis
450469|NCT01641120|Intramuscular Injections|intramuscular injections
450470|NCT01641120|Relapsing Remitting|relapsing remitting
450471|NCT01641107|Ph+|ph+
450472|NCT01641107|BCR-ABL+|bcr-abl+
450473|NCT01641107|ALL|all
450474|NCT01641107|Ponatinib|ponatinib
450475|NCT01641107|stem cell transplantation|stem cell transplantation
450476|NCT01641094|Hepatitis C|hepatitis c
450477|NCT01641094|Liver|liver
450478|NCT01641094|Immunology|immunology
450479|NCT01641094|Genotype 1|genotype 1
450480|NCT01641094|Treatment|treatment
450481|NCT01641094|Chronic|chronic
450482|NCT01641094|RNA Virus Infections|rna virus infections
450483|NCT01641094|Ribavirin|ribavirin
450484|NCT01641094|Peginterferon alfa-2a|peginterferon alfa-2a
450485|NCT01641094|Protease Inhibitors|protease inhibitors
450486|NCT01641094|Telaprevir|telaprevir
450487|NCT01641068|Memory|memory
450488|NCT01641068|Attention|attention
450489|NCT01641068|Chemo-brain|chemo-brain
450490|NCT01641068|Survivor|survivor
450491|NCT01641068|Treatment|treatment
450492|NCT01641042|Meningococcal vaccines|meningococcal vaccines
450493|NCT01641042|Vaccines, conjugate|vaccines, conjugate
450494|NCT01641042|Neisseria meningitidis|neisseria meningitidis
450495|NCT01641042|Immunocompromised patient|immunocompromised patient
450496|NCT01641016|short cycle therapy|short cycle therapy
450497|NCT01641016|young people|young people
450498|NCT01641016|HIV|hiv
450499|NCT01641003|cancer stem cells|cancer stem cells
450500|NCT01640990|Healthy male volunteers, intravenous infusion, GW328267X, dose escalation,|healthy male volunteers, intravenous infusion, gw328267x, dose escalation,
450501|NCT01640977|Open PLIF|open plif
450502|NCT01640977|MAS PLIF|mas plif
450503|NCT01640977|Lumbar spine|lumbar spine
450504|NCT01640964|Portal hypertension, cirrhosis, TIPSS, MRI, MRA, portal pressure, portal pressure gradient|portal hypertension, cirrhosis, tipss, mri, mra, portal pressure, portal pressure gradient
450505|NCT01640951|Psoriasis|psoriasis
450506|NCT01640951|Plaque|plaque
450507|NCT01640951|Inflammatory skin disease|inflammatory skin disease
450508|NCT01640951|Scaly patches|scaly patches
450509|NCT01640951|AIN457|ain457
450510|NCT01640951|Secukinumab|secukinumab
450511|NCT01640951|Moderate to Severe Plaque-type Psoriasis|moderate to severe plaque-type psoriasis
450512|NCT01640925|nosocomial infection|nosocomial infection
450513|NCT01640925|hospital acquired infection|hospital acquired infection
450514|NCT01640925|chlorhexidine|chlorhexidine
450515|NCT01640925|pneumonia, ventilator-associated|pneumonia, ventilator-associated
450516|NCT01640925|catheter-related infections|catheter-related infections
450517|NCT01640925|urinary tract infections, catheter-related|urinary tract infections, catheter-related
450518|NCT01640925|surgical site infection|surgical site infection
450519|NCT01640912|Scar|scar
450520|NCT01640912|Scar prevention|scar prevention
450521|NCT01640912|Fibrosis|fibrosis
450522|NCT01640899|Orthotic Devices|orthotic devices
450523|NCT01640899|Activities of Daily Living|activities of daily living
450524|NCT01640899|Pain Measurement|pain measurement
450525|NCT01640899|Lower Extremity|lower extremity
450526|NCT01640899|Foot|foot
450527|NCT01640899|Personal Satisfaction|personal satisfaction
450528|NCT01640886|Staphylococcus aureus|staphylococcus aureus
450529|NCT01640886|methicillin resistant|methicillin resistant
450530|NCT01640886|MRSA|mrsa
450531|NCT01640886|MSSA|mssa
450532|NCT01640886|Blood Culture|blood culture
450533|NCT01640886|Diagnostic|diagnostic
450534|NCT01640873|Type 2 Diabetes|type 2 diabetes
450535|NCT01640860|docetaxel|docetaxel
450536|NCT01640860|cisplatin|cisplatin
450537|NCT01640860|combined modality therapy|combined modality therapy
450538|NCT01640847|Painful bone metastases|painful bone metastases
450539|NCT01640847|Bone Cancer|bone cancer
450540|NCT01640847|Bone Cancer Pain|bone cancer pain
450541|NCT01640847|Patients with|patients with
450542|NCT01640821|Health-At-Every-Size intervention|health-at-every-size intervention
450543|NCT01640782|adenocarcinoma of the stomach|adenocarcinoma of the stomach
450544|NCT01640782|adenocarcinoma of the gastroesophageal junction|adenocarcinoma of the gastroesophageal junction
450545|NCT01640769|Cardiomyopathy|cardiomyopathy
450546|NCT01640769|Cardiac Resynchronization Therapy|cardiac resynchronization therapy
450547|NCT01640756|Glaucoma Implant|glaucoma implant
450548|NCT01640756|Trabeculectomy|trabeculectomy
450549|NCT01640756|POAG|poag
450550|NCT01640743|Kidney transplantation|kidney transplantation
450551|NCT01640743|Regulatory T cells|regulatory t cells
450552|NCT01640743|Tolerance|tolerance
450553|NCT01640743|Tacrolimus|tacrolimus
450554|NCT01640743|Rejection|rejection
450555|NCT01640691|pandemic influenza|pandemic influenza
450556|NCT01640691|pandemic influenza vaccine|pandemic influenza vaccine
450557|NCT01640691|Influenza|influenza
450558|NCT01640691|Orthomyxoviruses|orthomyxoviruses
450559|NCT01640691|A/H5N1|a/h5n1
450560|NCT01640665|histologically|histologically
450561|NCT01640665|unresectable|unresectable
450564|NCT01640665|Breast Cancer|breast cancer
450565|NCT01640665|GI Tumors|gi tumors
450566|NCT01640665|Sorafenib|sorafenib
450567|NCT01640665|Capecitabine|capecitabine
450568|NCT01640639|left ventricular function|left ventricular function
450569|NCT01640626|Health Education|health education
450570|NCT01640626|Soil-transmitted helminthiasis|soil-transmitted helminthiasis
450572|NCT01640626|Trichuris|trichuris
450573|NCT01640626|Hookworm|hookworm
710628|NCT00588562|APRT|aprt
575217|NCT01116427|MS|ms
450574|NCT01640626|Prevention and control|prevention and control
450575|NCT01640613|carotid endarterectomy|carotid endarterectomy
450576|NCT01640613|regional anaesthesia|regional anaesthesia
450577|NCT01640613|ultrasound guided block|ultrasound guided block
450578|NCT01640600|To determine whether 4-8 year-old children exposed to nicotine or antidepressants in utero have more behavioral problems.|to determine whether 4-8 year-old children exposed to nicotine or antidepressants in utero have more behavioral problems.
450579|NCT01640600|To determine whether 4-8 year-old children exposed to nicotine or antidepressants in utero have more cognitive problems.|to determine whether 4-8 year-old children exposed to nicotine or antidepressants in utero have more cognitive problems.
450580|NCT01640600|To determine whether 4-8 year-old children exposed to nicotine or antidepressants in utero have poorer motor development.|to determine whether 4-8 year-old children exposed to nicotine or antidepressants in utero have poorer motor development.
450581|NCT01640587|Uncomplicated falciparum infection|uncomplicated falciparum infection
450582|NCT01640587|Mefloquine-artesunate|mefloquine-artesunate
450583|NCT01640587|Dihydroartemisinin-piperaquine|dihydroartemisinin-piperaquine
450584|NCT01640574|Vivax|vivax
450585|NCT01640574|Chloroquine|chloroquine
450586|NCT01640574|Primaquine|primaquine
450587|NCT01640574|Dihydroartemisinin-Piperaquine|dihydroartemisinin-piperaquine
450588|NCT01640561|HIV affected|hiv affected
450589|NCT01640561|Child Neurodevelopment|child neurodevelopment
450590|NCT01640561|Low and Middle Income Country|low and middle income country
450591|NCT01640535|PAR|par
450592|NCT01640522|Hepatocellular carcinoma|hepatocellular carcinoma
450593|NCT01640522|Cholangio carcinoma|cholangio carcinoma
450594|NCT01640522|Primary Liver Cancer|primary liver cancer
450595|NCT01640522|Bile Duct CancerPancreatic Cancer|bile duct cancerpancreatic cancer
450596|NCT01640522|Gallbladder Cancer|gallbladder cancer
450597|NCT01640522|Colorectal Carcinoma|colorectal carcinoma
450598|NCT01640522|Other Primary Cancers with Liver Metastases|other primary cancers with liver metastases
450599|NCT01640509|Radiotherapy, Targeted|radiotherapy, targeted
450600|NCT01640496|Ulcerative Colitis|ulcerative colitis
450601|NCT01640496|Inflammatory Bowel disease|inflammatory bowel disease
450602|NCT01640496|IBD|ibd
450603|NCT01640496|Vitamin D|vitamin d
450604|NCT01640470|assistive technology|assistive technology
450605|NCT01640470|environmental modification|environmental modification
450606|NCT01640470|caregiver|caregiver
450607|NCT01640470|client-centred|client-centred
450608|NCT01640457|degenerative disc|degenerative disc
450609|NCT01640457|herniated disc|herniated disc
450610|NCT01640457|sequestrectomy|sequestrectomy
450611|NCT01640457|Autologous Disc Chondrocyte Transplantation|autologous disc chondrocyte transplantation
450612|NCT01640457|nucleotomy|nucleotomy
450613|NCT01640457|safety|safety
450614|NCT01640457|efficacy|efficacy
450615|NCT01640457|treatment|treatment
450616|NCT01640457|lumbar spine|lumbar spine
450617|NCT01640457|low back pain|low back pain
450618|NCT01640457|adjacent degenerative disc|adjacent degenerative disc
450619|NCT01640457|black disc|black disc
450620|NCT01640457|NOVOCART|novocart
450621|NCT01640444|colorectal carcinoma|colorectal carcinoma
450622|NCT01640444|BRAF and PIK3K|braf and pik3k
450623|NCT01640444|FOLFIRI -Bevacizumab -Cetuximab|folfiri -bevacizumab -cetuximab
450624|NCT01640444|circulating tumor cells|circulating tumor cells
450625|NCT01640431|lumbar disc herniation|lumbar disc herniation
450626|NCT01640431|clinical trial|clinical trial
450627|NCT01640431|exercise therapy|exercise therapy
450628|NCT01640431|TENS|tens
450629|NCT01640418|pressure ulcer|pressure ulcer
450630|NCT01640418|dressing|dressing
450631|NCT01640418|prevention|prevention
450632|NCT01640418|higher risk patients|higher risk patients
450633|NCT01640405|colorectal cancer|colorectal cancer
450634|NCT01640405|FOLFOX|folfox
450635|NCT01640405|Bevacizumab|bevacizumab
450636|NCT01640405|FOLFOXIRI|folfoxiri
450637|NCT01640405|circulating tumor cell|circulating tumor cell
450638|NCT01640392|Gay men|gay men
450639|NCT01640392|African American males|african american males
450640|NCT01640392|Unprotected anal sex|unprotected anal sex
450641|NCT01640392|HIV risk|hiv risk
450642|NCT01640392|behavioral intervention|behavioral intervention
450643|NCT01640392|group-level intervention|group-level intervention
450644|NCT01640379|Pelvic Inflammatory Disease (PID)|pelvic inflammatory disease (pid)
450645|NCT01640379|Community Health Nursing|community health nursing
450646|NCT01640379|Text Messaging|text messaging
450647|NCT01640379|mobile health (mhealth)|mobile health (mhealth)
450648|NCT01640379|Adolescents|adolescents
450649|NCT01640366|surgical incision|surgical incision
450650|NCT01640366|reduction mammoplasty|reduction mammoplasty
450651|NCT01640366|healing complications|healing complications
450652|NCT01640366|negative pressure wound therapy|negative pressure wound therapy
450653|NCT01640353|si joint|si joint
450654|NCT01640353|si joint pain|si joint pain
450655|NCT01640353|si joint injury|si joint injury
450656|NCT01640353|si joint treatment|si joint treatment
450657|NCT01640353|si joint injections|si joint injections
450658|NCT01640353|si joint inflammation|si joint inflammation
450659|NCT01640353|si joint problems|si joint problems
450660|NCT01640353|si joint symptoms|si joint symptoms
450661|NCT01640353|hypermobile si joint|hypermobile si joint
450662|NCT01640353|si joint arthritis|si joint arthritis
450663|NCT01640353|si joint pain treatment|si joint pain treatment
450664|NCT01640353|inflamed si joint|inflamed si joint
450665|NCT01640353|si joint sclerosis|si joint sclerosis
450666|NCT01640353|locked si joint|locked si joint
450667|NCT01640353|si joint injuries|si joint injuries
450668|NCT01640353|si joint disease|si joint disease
450669|NCT01640353|si joint infection|si joint infection
450670|NCT01640353|sacroiliac joint pelvic pain|sacroiliac joint pelvic pain
450671|NCT01640353|sacroiliac joint arthritis treatment|sacroiliac joint arthritis treatment
450672|NCT01640340|ondansetron|ondansetron
450673|NCT01640340|palonosetron|palonosetron
450674|NCT01640340|emetogenic chemotherapy|emetogenic chemotherapy
450675|NCT01640340|HEC|hec
450676|NCT01640327|Interpandemic influenza|interpandemic influenza
450677|NCT01640327|Adult|adult
450678|NCT01640327|Elderly|elderly
450679|NCT01640327|Safety|safety
450680|NCT01640327|Tolerability|tolerability
450681|NCT01640327|Immunology|immunology
450682|NCT01640314|Influenza|influenza
450683|NCT01640314|Adults|adults
450684|NCT01640314|Elderly|elderly
450685|NCT01640314|Immunology|immunology
450686|NCT01640314|Safety|safety
450687|NCT01640288|COPD|copd
450688|NCT01640288|Pulmonary Function Testing|pulmonary function testing
450689|NCT01640288|MRI|mri
450690|NCT01640288|Normal Lung Function|normal lung function
450691|NCT01640288|Current Smoker|current smoker
450692|NCT01640288|Non Smoker|non smoker
450693|NCT01640288|Ex Smoker|ex smoker
450694|NCT01640275|General Anesthesia|general anesthesia
450695|NCT01640275|Alzheimers Disease|alzheimers disease
450696|NCT01640275|Cognitive decline|cognitive decline
450697|NCT01640262|prostate biopsy|prostate biopsy
450698|NCT01640262|prostate cancer|prostate cancer
450699|NCT01640262|Magnetic Resonance Imaging|magnetic resonance imaging
450700|NCT01640262|Neoplasm Staging|neoplasm staging
450701|NCT01640236|Ocular flare|ocular flare
450702|NCT01640197|Cognitive performance|cognitive performance
450703|NCT01640197|Cerebral blood flow|cerebral blood flow
450704|NCT01640197|Subjective sleep|subjective sleep
450705|NCT01640197|Subjective mood|subjective mood
450706|NCT01640197|Subjective health|subjective health
450707|NCT01640184|hyperparathyroidism|hyperparathyroidism
450708|NCT01640184|vitamin D|vitamin d
450709|NCT01640184|ultrasonic ablation|ultrasonic ablation
450710|NCT01640184|surgery|surgery
450711|NCT01640171|anesthesia|anesthesia
450712|NCT01640171|pain|pain
450713|NCT01640171|intravitreal|intravitreal
450714|NCT01640171|anti-vegf|anti-vegf
450715|NCT01640158|mild Traumatic Brain Injury|mild traumatic brain injury
450716|NCT01640158|Cognitive remediation|cognitive remediation
450717|NCT01640158|computer|computer
450718|NCT01640119|metabolic acidosis|metabolic acidosis
450719|NCT01640119|renal death|renal death
450720|NCT01640106|Language|language
450721|NCT01640106|Fatty acids|fatty acids
450722|NCT01640106|Nutrition|nutrition
450723|NCT01640106|Developmental delay|developmental delay
450724|NCT01640093|Healthy participants|healthy participants
450725|NCT01640093|Bioavailability|bioavailability
450726|NCT01640093|Pharmacokinetics|pharmacokinetics
450727|NCT01640093|Abiraterone acetate|abiraterone acetate
450728|NCT01640093|Abiraterone|abiraterone
450729|NCT01640080|Major depressive disorder|major depressive disorder
450730|NCT01640080|Treatment resistant depression|treatment resistant depression
450731|NCT01640080|Depression|depression
450732|NCT01640080|Esketamine|esketamine
450733|NCT01640067|amyotrophic lateral sclerosis|amyotrophic lateral sclerosis
450734|NCT01640067|motor neuron disease|motor neuron disease
450735|NCT01640067|stem cells|stem cells
450736|NCT01640067|safety|safety
450737|NCT01640067|ALS-FRS-Functional scale R and FVC (%) variation|als-frs-functional scale r and fvc (%) variation
450738|NCT01640067|Survival analysis|survival analysis
450739|NCT01640067|Changes in quality of life scales|changes in quality of life scales
450740|NCT01640054|Rheumatoid Arthritis|rheumatoid arthritis
450741|NCT01640015|Blood pressure|blood pressure
450742|NCT01640015|eating episode|eating episode
450743|NCT01640015|eating frequency|eating frequency
450744|NCT01640015|insulin sensitivity|insulin sensitivity
450745|NCT01640002|overactive bladder|overactive bladder
450746|NCT01640002|HTLV-1|htlv-1
450747|NCT01640002|Propantheline|propantheline
450748|NCT01640002|anticholinergic|anticholinergic
450749|NCT01639989|Doppler, Pregnancy|doppler, pregnancy
450750|NCT01639976|Missed abortion, early pregnancy loss.|missed abortion, early pregnancy loss.
450751|NCT01639950|Self-Report|self-report
450752|NCT01639950|Survey Scale|survey scale
450753|NCT01639950|Validate|validate
450754|NCT01639950|Pain Severity|pain severity
450755|NCT01639950|Reliability|reliability
450756|NCT01639937|Cardiac MRI|cardiac mri
450757|NCT01639937|Congestive Heart Failure|congestive heart failure
450758|NCT01639937|Cardiac Fibrosis|cardiac fibrosis
450759|NCT01639937|Late Gadolinium Enhancement|late gadolinium enhancement
450760|NCT01639924|Upper GI Disease|upper gi disease
450761|NCT01639924|Small Bowel Disease|small bowel disease
450762|NCT01639924|Digestive Disease|digestive disease
450763|NCT01639924|Gastrointestinal Disease|gastrointestinal disease
450764|NCT01639924|Lower GI Disease|lower gi disease
450765|NCT01639911|malignant solid tumor|malignant solid tumor
450766|NCT01639911|advanced non-hematologic|advanced non-hematologic
450767|NCT01639898|POEMS|poems
450768|NCT01639898|VEGF|vegf
450769|NCT01639898|Free light|free light
450770|NCT01639898|lenalidomide|lenalidomide
450771|NCT01639898|dexamethasone|dexamethasone
450772|NCT01639885|p53 overexpression|p53 overexpression
450773|NCT01639885|platinum-resistant|platinum-resistant
450774|NCT01639872|Schizophrenia|schizophrenia
450775|NCT01639872|Cannabis Abuse|cannabis abuse
450776|NCT01639872|Cannabis Dependence|cannabis dependence
450777|NCT01639872|Dual Diagnosis|dual diagnosis
450778|NCT01639872|Clozapine|clozapine
450779|NCT01639872|Risperidone|risperidone
450780|NCT01639859|prostate cancer|prostate cancer
450781|NCT01639859|elastography|elastography
450782|NCT01639859|elasticity|elasticity
450783|NCT01639820|Cervical cancer|cervical cancer
450784|NCT01639820|early stage carcinoma|early stage carcinoma
450785|NCT01639820|FIGO IA1 IA2 IB1 IIA|figo ia1 ia2 ib1 iia
450786|NCT01639820|sentinel lymph node biopsy|sentinel lymph node biopsy
450787|NCT01639820|pelvic lymphadenectomy|pelvic lymphadenectomy
450788|NCT01639820|Surgery of uterine cervical carcinoma|surgery of uterine cervical carcinoma
450789|NCT01639820|medico economic impact|medico economic impact
450790|NCT01639820|quality of life|quality of life
450791|NCT01639807|Open Angle Glaucoma or Ocular hypertension|open angle glaucoma or ocular hypertension
450792|NCT01639794|LUTS (Lower Urinary Tract Symptoms)|luts (lower urinary tract symptoms)
450793|NCT01639794|Overactive Bladder (OAB)Vesitirim|overactive bladder (oab)vesitirim
450794|NCT01639794|Solifenacin|solifenacin
450795|NCT01639794|Anti-muscarinic treatment|anti-muscarinic treatment
450796|NCT01639794|Cholinergic receptor antagonist|cholinergic receptor antagonist
450797|NCT01639794|Storage Symptom improvement|storage symptom improvement
450798|NCT01639781|flavanols|flavanols
450799|NCT01639781|age related cardiovascular effects|age related cardiovascular effects
450800|NCT01639768|Sublingual immunotherapy|sublingual immunotherapy
450801|NCT01639768|Dose range finding|dose range finding
450802|NCT01639768|Dose tolerability|dose tolerability
450803|NCT01639768|Birch pollen|birch pollen
450804|NCT01639768|Allergic rhinitis/rhinoconjunctivitis|allergic rhinitis/rhinoconjunctivitis
450806|NCT01639768|Immunogenicity|immunogenicity
450807|NCT01639729|pharmacokinetics|pharmacokinetics
450808|NCT01639729|area under curve|area under curve
450809|NCT01639729|time to maximum concentration|time to maximum concentration
450810|NCT01639716|Survey, interleukin status|survey, interleukin status
450811|NCT01639703|CT perfusion|ct perfusion
450812|NCT01639703|Hepatocellular Carcinoma|hepatocellular carcinoma
450813|NCT01639703|Xenetix|xenetix
450814|NCT01639703|Contrast agent|contrast agent
450815|NCT01639690|BUSULFAN|busulfan
450816|NCT01639690|G-CSF|g-csf
450817|NCT01639690|CliniMACS-CD34 Reagent System|clinimacs-cd34 reagent system
450818|NCT01639690|Blood transfusion|blood transfusion
450819|NCT01639690|10-164|10-164
450820|NCT01639690|Autologous CD34+ cells transduced with TNS9.3.55, a lentiviral vector encoding the human β-globin gene|autologous cd34+ cells transduced with tns9.3.55, a lentiviral vector encoding the human β-globin gene
450821|NCT01639677|Obesity|obesity
450822|NCT01639677|weight loss|weight loss
450823|NCT01639677|surgery|surgery
450824|NCT01639677|gastric bypass|gastric bypass
450825|NCT01639677|VBG|vbg
450826|NCT01639651|Physical Therapy|physical therapy
450827|NCT01639651|Glenohumeral Internal Rotation Deficits|glenohumeral internal rotation deficits
450828|NCT01639651|Joint Mobilization|joint mobilization
450829|NCT01639651|Posterior capsule|posterior capsule
450830|NCT01639651|Capsular contracture|capsular contracture
450831|NCT01639638|Recurrent and non-recurrent genital condyloma|recurrent and non-recurrent genital condyloma
450832|NCT01639612|Stem Cell|stem cell
450833|NCT01639612|Grade IV Malignant Glioma|grade iv malignant glioma
450834|NCT01639599|non-smoker|non-smoker
450835|NCT01639599|female|female
450836|NCT01639599|IV PCA|iv pca
450837|NCT01639599|patient-controlled analgesia|patient-controlled analgesia
450838|NCT01639573|Patients with Scleroderma|patients with scleroderma
450839|NCT01639560|smoking|smoking
450840|NCT01639560|tobacco dependence|tobacco dependence
450841|NCT01639560|nicotine dependence|nicotine dependence
450842|NCT01639547|PEGASYS® PLUS RIBAVIRIN|pegasys® plus ribavirin
450843|NCT01639534|Biomarkers of ischemia|biomarkers of ischemia
450844|NCT01639534|Carotid Stenting procedure|carotid stenting procedure
450845|NCT01639534|Levels Xanthine Hypoxanthine and Inosine|levels xanthine hypoxanthine and inosine
450846|NCT01639534|peripheral blood|peripheral blood
450847|NCT01639508|Lung|lung
450848|NCT01639508|XL184 (CABOZANTINIB)|xl184 (cabozantinib)
450849|NCT01639508|KIF5B/RET Positive|kif5b/ret positive
450850|NCT01639508|RET Fusion Positive|ret fusion positive
450851|NCT01639508|12-097|12-097
450852|NCT01639508|Genotypes: ROS1 or NTRK Fusions or Increased MET or AXL Activity|genotypes: ros1 or ntrk fusions or increased met or axl activity
575518|NCT01115699|rTMS|rtms
450853|NCT01639495|Drug refractory|drug refractory
450854|NCT01639495|Atrial fibrillation|atrial fibrillation
450855|NCT01639495|Antiarrhythmic drug failure|antiarrhythmic drug failure
450856|NCT01639495|Atrial tachyarrhythmias|atrial tachyarrhythmias
450857|NCT01639469|Parkinson Disease|parkinson disease
450858|NCT01639469|Quality of Life|quality of life
450859|NCT01639469|Exercise Therapy|exercise therapy
450860|NCT01639456|acute myelogenous leukemia|acute myelogenous leukemia
450861|NCT01639443|quality improvement|quality improvement
450862|NCT01639443|Organization and Administration|organization and administration
450863|NCT01639443|Costs and cost analysis|costs and cost analysis
450864|NCT01639443|Patient satisfaction|patient satisfaction
450865|NCT01639443|Health plan implementation|health plan implementation
450866|NCT01639404|Cerebral Palsy|cerebral palsy
450867|NCT01639404|Umbilical Cord Blood|umbilical cord blood
450868|NCT01639404|Rehabilitation|rehabilitation
450869|NCT01639365|Ventricular tachycardia|ventricular tachycardia
450870|NCT01639365|Catheter ablation|catheter ablation
450871|NCT01639365|Tissue contact|tissue contact
450872|NCT01639352|Hepatocellular Carcinoma|hepatocellular carcinoma
450873|NCT01639352|HCC|hcc
450874|NCT01639352|SOM230|som230
450875|NCT01639352|Pasireotide LAR|pasireotide lar
450876|NCT01639339|Antibodies|antibodies
450877|NCT01639339|Systemic Lupus Erythematosus|systemic lupus erythematosus
450878|NCT01639339|Autoimmune Disease|autoimmune disease
450879|NCT01639339|Glomerulonephritis|glomerulonephritis
450880|NCT01639339|Belimumab|belimumab
450881|NCT01639339|Lupus|lupus
450882|NCT01639339|Nephritis|nephritis
450883|NCT01639339|Kidney Diseases|kidney diseases
450884|NCT01639339|SLE|sle
450885|NCT01639300|Relapsing Forms of Multiple Sclerosis|relapsing forms of multiple sclerosis
450886|NCT01639300|Progressive Forms of Multiple Sclerosis|progressive forms of multiple sclerosis
450887|NCT01639300|GNbAC1|gnbac1
450888|NCT01639300|Monoclonal antibody|monoclonal antibody
450889|NCT01639300|Multiple Sclerosis Associated Retrovirus (MSRV)|multiple sclerosis associated retrovirus (msrv)
450890|NCT01639261|steroid-refractory|steroid-refractory
450891|NCT01639261|bronchiolitis obliterans|bronchiolitis obliterans
450892|NCT01639261|allogeneic stem cell transplantation|allogeneic stem cell transplantation
450893|NCT01639261|interferon gamma|interferon gamma
450894|NCT01639248|Breast Cancer|breast cancer
450895|NCT01639235|Secondhand Smoke|secondhand smoke
450896|NCT01639235|Flight Attendants|flight attendants
450897|NCT01639235|Lung function|lung function
450898|NCT01639235|Cardiac function|cardiac function
450899|NCT01639235|Reproductive health|reproductive health
450900|NCT01639222|Drug therapy|drug therapy
450901|NCT01639222|Increase in calcium urinary excretion and PTH decrease in serum|increase in calcium urinary excretion and pth decrease in serum
450902|NCT01639209|Retinal detachment|retinal detachment
450903|NCT01639209|Pneumatic retinopexy|pneumatic retinopexy
450904|NCT01639209|Vitrectomy|vitrectomy
450905|NCT01639196|Chronic pain|chronic pain
450906|NCT01639196|Psychological adjustment|psychological adjustment
450907|NCT01639196|Writing|writing
450908|NCT01639196|Brief intervention|brief intervention
450909|NCT01639196|Online|online
450910|NCT01639196|Internet interventions|internet interventions
450911|NCT01639183|oral inflammation|oral inflammation
450912|NCT01639183|systemic inflammation|systemic inflammation
450913|NCT01639183|compliance|compliance
450914|NCT01639183|power toothbrushing|power toothbrushing
450915|NCT01639183|nursing home residents|nursing home residents
450916|NCT01639170|Pneumoperitoneum|pneumoperitoneum
450917|NCT01639170|Free air|free air
450918|NCT01639170|Surgery|surgery
450919|NCT01639170|Perforation|perforation
450920|NCT01639170|Radiograph|radiograph
450921|NCT01639144|Infection|infection
450922|NCT01639144|delayed wound healing|delayed wound healing
450923|NCT01639144|platelet-rich plasma|platelet-rich plasma
450924|NCT01639131|Gemcitabine|gemcitabine
450925|NCT01639131|Docetaxel|docetaxel
450926|NCT01639131|Filgrastim|filgrastim
450927|NCT01639131|Pegfilgrastim|pegfilgrastim
450928|NCT01639118|primary ventral hernia repair with mesh|primary ventral hernia repair with mesh
450929|NCT01639118|umbilical hernia repair|umbilical hernia repair
450930|NCT01639118|epigastric hernia repair|epigastric hernia repair
450931|NCT01639118|C-Qur V-patch|c-qur v-patch
450932|NCT01639118|Size tailored repair|size tailored repair
450933|NCT01639118|preperitoneal repair|preperitoneal repair
450934|NCT01639118|abdominal hernia|abdominal hernia
450935|NCT01639118|dual sided mesh|dual sided mesh
450936|NCT01639092|Resistance of Entecavir|resistance of entecavir
450937|NCT01639079|cigarette smoking behavior|cigarette smoking behavior
450938|NCT01639079|smoking cessation|smoking cessation
450939|NCT01639079|Latino smoking cessation|latino smoking cessation
450940|NCT01639066|Resistance of Adefovir|resistance of adefovir
450941|NCT01639053|Breast Augmentation|breast augmentation
450942|NCT01639053|Breast Reconstruction|breast reconstruction
450943|NCT01639053|Breast Revision|breast revision
450944|NCT01639053|Silicone breast implants|silicone breast implants
575628|NCT01115140|Folate|folate
450945|NCT01639001|Crizotinib|crizotinib
450946|NCT01639001|ALK positive|alk positive
450948|NCT01639001|Anaplastic Lymphoma Kinase|anaplastic lymphoma kinase
450950|NCT01639001|Non-Small Cell Lung Cancer|non-small cell lung cancer
450951|NCT01639001|Frontline|frontline
450952|NCT01639001|1L|1l
450953|NCT01639001|Previously Untreated|previously untreated
450954|NCT01639001|East Asian|east asian
450955|NCT01639001|Non-Squamous|non-squamous
450956|NCT01638962|Exercise Therapy|exercise therapy
450957|NCT01638962|Gait|gait
450958|NCT01638962|Joint load|joint load
450959|NCT01638962|Knee Joint|knee joint
450960|NCT01638962|Middle Aged|middle aged
450961|NCT01638962|Osteoarthritis, Knee/therapy|osteoarthritis, knee/therapy
450962|NCT01638962|Pain Management|pain management
450963|NCT01638949|Alzheimer's disease|alzheimer's disease
450964|NCT01638949|MCI|mci
450965|NCT01638949|genetic|genetic
450966|NCT01638949|AV45-PET|av45-pet
450967|NCT01638936|Combination|combination
450968|NCT01638936|Multiple Myeloma|multiple myeloma
450969|NCT01638923|Heavy Menstrual Bleeding|heavy menstrual bleeding
450970|NCT01638923|Efficacy|efficacy
450971|NCT01638923|Safety|safety
450972|NCT01638923|Oral contraceptive|oral contraceptive
450973|NCT01638923|Estradiol valerate|estradiol valerate
450974|NCT01638923|Dienogest|dienogest
450975|NCT01638910|Efficacy|efficacy
450976|NCT01638910|Safety|safety
450977|NCT01638910|oral contraception|oral contraception
450978|NCT01638910|estradiol valerate|estradiol valerate
450979|NCT01638910|dienogest|dienogest
450980|NCT01638897|ICD|icd
450981|NCT01638897|CRTD|crtd
450982|NCT01638897|DF4|df4
450983|NCT01638884|Prospective Memory|prospective memory
450984|NCT01638884|Healthy Aging|healthy aging
450985|NCT01638884|Alzheimer Disease|alzheimer disease
450986|NCT01638884|Brain Imaging|brain imaging
450987|NCT01638832|NASH; coronary artery disease|nash; coronary artery disease
450988|NCT01638806|Acute Coronary Syndrome|acute coronary syndrome
450989|NCT01638806|Myocardial infarction|myocardial infarction
450990|NCT01638806|Angioplasty|angioplasty
450991|NCT01638806|Prehospital emergency care|prehospital emergency care
450992|NCT01638806|Biological markers|biological markers
450993|NCT01638806|Troponin|troponin
450994|NCT01638806|Point-of-Care systems|point-of-care systems
450995|NCT01638767|In Vitro Fertilization long protocol|in vitro fertilization long protocol
450996|NCT01638767|NuvaRing|nuvaring
450997|NCT01638767|Marvelon|marvelon
450998|NCT01638767|In vitro fertilization|in vitro fertilization
450999|NCT01638715|Rheumatoid Arthritis|rheumatoid arthritis
451000|NCT01638715|Biologic therapies|biologic therapies
451001|NCT01638715|Biomarker|biomarker
451002|NCT01638715|Mode of Action|mode of action
451003|NCT01638702|Catheterisation, Central Venous|catheterisation, central venous
451004|NCT01638702|Catheters, Indwelling|catheters, indwelling
451005|NCT01638689|Mechanism of Action of escitalopram|mechanism of action of escitalopram
451006|NCT01638676|Unresectable melanoma|unresectable melanoma
451007|NCT01638676|Stage IIIC and Stage IV BRAFV600E+ Melanoma|stage iiic and stage iv brafv600e+ melanoma
451008|NCT01638663|Tolvaptan|tolvaptan
451009|NCT01638663|L-NMMA|l-nmma
451010|NCT01638663|Healthy subjects|healthy subjects
451011|NCT01638663|Nephrology|nephrology
451012|NCT01638663|Cardiology|cardiology
451013|NCT01638624|Propofol|propofol
451014|NCT01638624|antioxidant capacity|antioxidant capacity
451015|NCT01638624|total knee arthroplasty|total knee arthroplasty
451016|NCT01638624|Propofol,antioxidant|propofol,antioxidant
451017|NCT01638611|Healthy male volunteers|healthy male volunteers
451018|NCT01638572|Neuroblastoma|neuroblastoma
451019|NCT01638572|B4GALNT3|b4galnt3
451020|NCT01638572|Prognosis|prognosis
451021|NCT01638559|liver transplant|liver transplant
451022|NCT01638559|allograft function|allograft function
451023|NCT01638559|anti-rejection|anti-rejection
451024|NCT01638559|immunosuppression withdrawal|immunosuppression withdrawal
451025|NCT01638559|tolerance|tolerance
451026|NCT01638520|Immune Therapy|immune therapy
451027|NCT01638520|Interleukin 4|interleukin 4
451028|NCT01638520|monoclonal antibody|monoclonal antibody
451029|NCT01638507|TARGET LESION REVASCULARIZATION (TLR)|target lesion revascularization (tlr)
451030|NCT01638507|TARGET VESSEL REVASCULARIZATION (TVR)|target vessel revascularization (tvr)
451031|NCT01638507|Coronary Artery Disease|coronary artery disease
451032|NCT01638507|MYOCARDIAL INFARCTION (MI)|myocardial infarction (mi)
451033|NCT01638507|PERCUTANEOUS CORONARY INTERVENTION (PCI)|percutaneous coronary intervention (pci)
451034|NCT01638507|STENT THROMBOSIS|stent thrombosis
451035|NCT01638507|TARGET LESION FAILURE (TLF)|target lesion failure (tlf)
451036|NCT01638494|25-Hydroxyvitamin D|25-hydroxyvitamin d
451037|NCT01638494|dietary counseling|dietary counseling
451038|NCT01638494|pediatrics|pediatrics
451039|NCT01638494|allergy|allergy
451040|NCT01638494|bone metabolism|bone metabolism
451041|NCT01638468|Pulmonary Embolism|pulmonary embolism
451042|NCT01638468|Acute Pulmonary Embolism|acute pulmonary embolism
451043|NCT01638468|Sub-massive Pulmonary Embolism|sub-massive pulmonary embolism
451044|NCT01638468|Massive Pulmonary Embolism|massive pulmonary embolism
451045|NCT01638468|Pulmonary Thromboembolism|pulmonary thromboembolism
451046|NCT01638442|Male subjects, healthy|male subjects, healthy
451047|NCT01638403|narcolepsy|narcolepsy
451048|NCT01638403|excessive daytime sleepiness|excessive daytime sleepiness
451049|NCT01638403|cataplexy|cataplexy
451050|NCT01638377|Back on Track|back on track
451051|NCT01638377|convicted drinking drivers|convicted drinking drivers
451052|NCT01638377|naltrexone|naltrexone
451053|NCT01638377|alcohol dependence|alcohol dependence
451054|NCT01638351|Diabetes mellitus|diabetes mellitus
451055|NCT01638351|Resistance exercise|resistance exercise
451056|NCT01638351|Elderly|elderly
451057|NCT01638351|Skeletal muscle dysfunction|skeletal muscle dysfunction
451058|NCT01638351|Metabolomics|metabolomics
451059|NCT01638338|Alcohol|alcohol
451060|NCT01638338|Risky drinking|risky drinking
451061|NCT01638338|Web site|web site
451062|NCT01638338|Primary Care|primary care
451063|NCT01638338|General Practice|general practice
451064|NCT01638338|Local Community|local community
451065|NCT01638338|Mayors|mayors
451066|NCT01638312|HIV, fructose|hiv, fructose
451067|NCT01638299|Type 1 Diabetes Mellitus|type 1 diabetes mellitus
451068|NCT01638299|Artificial Pancreas|artificial pancreas
451069|NCT01638273|Pregabalin, GLARS|pregabalin, glars
451070|NCT01638260|NEAT|neat
451071|NCT01638260|liraglutide|liraglutide
451072|NCT01638260|glycemic control|glycemic control
451073|NCT01638247|Male breast cancer|male breast cancer
451074|NCT01638247|neoadjuvant, adjuvant or metastatic situation|neoadjuvant, adjuvant or metastatic situation
451075|NCT01638247|anti-hormonal therapy|anti-hormonal therapy
451076|NCT01638234|atopic dermatitis|atopic dermatitis
451077|NCT01638234|eczema|eczema
451078|NCT01638182|phylloquinone,|phylloquinone,
451079|NCT01638182|menaquinone-7|menaquinone-7
451080|NCT01638182|vitamin K-status|vitamin k-status
451081|NCT01638182|efficacy|efficacy
451082|NCT01638156|Aortic stenosis|aortic stenosis
451083|NCT01638143|vitamin K2|vitamin k2
451084|NCT01638143|menaquinone-7|menaquinone-7
451085|NCT01638143|bioavailability|bioavailability
451086|NCT01638091|Narrow band imaging|narrow band imaging
451087|NCT01638091|Screening colonoscopy|screening colonoscopy
451088|NCT01638091|Histology|histology
451089|NCT01638078|coronary restenosis|coronary restenosis
451090|NCT01638065|vein identification|vein identification
451091|NCT01638065|vascular access|vascular access
451092|NCT01638052|Tympanomastoid Surgery|tympanomastoid surgery
451093|NCT01638052|Cochlear Implant|cochlear implant
451094|NCT01638052|Mastoidectomy|mastoidectomy
451095|NCT01638052|Cholesteatoma|cholesteatoma
451096|NCT01638052|Pediatrics|pediatrics
451097|NCT01638052|Clonidine|clonidine
451098|NCT01638052|Bupivacaine|bupivacaine
451099|NCT01638052|Greater Auricular Nerve Block|greater auricular nerve block
451100|NCT01638052|Regional Anesthesia|regional anesthesia
451101|NCT01638026|Gnrh agonist|gnrh agonist
451102|NCT01638013|Smyraf|smyraf
451103|NCT01638013|Rheumatoid Arthritis|rheumatoid arthritis
451104|NCT01638013|Peficitinib|peficitinib
451105|NCT01638013|ASP015K|asp015k
451106|NCT01638000|Vesitrim|vesitrim
451107|NCT01638000|Frequency|frequency
451108|NCT01638000|Urgency|urgency
451109|NCT01638000|Urgency incontinence|urgency incontinence
451110|NCT01638000|Urinary incontinence|urinary incontinence
451111|NCT01638000|Overactive Bladder (OAB)|overactive bladder (oab)
451112|NCT01638000|Micturition|micturition
451113|NCT01638000|Mirabegron|mirabegron
451114|NCT01638000|YM178|ym178
451115|NCT01638000|Vesicare|vesicare
451116|NCT01638000|Solifenacin|solifenacin
451117|NCT01637987|Peripheral intravenous catheter|peripheral intravenous catheter
451118|NCT01637987|Vein visualization|vein visualization
451119|NCT01637987|Transillumination|transillumination
451120|NCT01637987|Near infrared light|near infrared light
451121|NCT01637948|Chinese medicine|chinese medicine
451122|NCT01637948|gingivitis|gingivitis
451123|NCT01637948|cytokine|cytokine
451124|NCT01637948|microbial|microbial
451125|NCT01637935|Drug therapy|drug therapy
451126|NCT01637909|Prehypertension, Hypertension|prehypertension, hypertension
451127|NCT01637883|benzydamine HCl|benzydamine hcl
451128|NCT01637883|endotracheal tube|endotracheal tube
451129|NCT01637883|postoperative sore throat|postoperative sore throat
451130|NCT01637870|Cesarean delivery|cesarean delivery
451131|NCT01637870|Postpartum infection|postpartum infection
451132|NCT01637870|Wound complications|wound complications
451133|NCT01637870|Wound seroma|wound seroma
451134|NCT01637870|Wound separation|wound separation
451135|NCT01637870|Wound infection|wound infection
451136|NCT01637870|Negative pressure|negative pressure
451137|NCT01637857|foof hypersensitivity|foof hypersensitivity
451138|NCT01637857|anal fissures|anal fissures
451139|NCT01637857|ano-rectal manometry|ano-rectal manometry
451140|NCT01637844|Pregnant women|pregnant women
451141|NCT01637844|HBsAg positive|hbsag positive
451142|NCT01637844|HBeAg positive|hbeag positive
451143|NCT01637844|Telbivudine|telbivudine
451144|NCT01637831|Obstructive Sleep Apnea|obstructive sleep apnea
451237|NCT01637402|CRPC|crpc
451145|NCT01637831|Idiopathic Pulmonary Fibrosis|idiopathic pulmonary fibrosis
451146|NCT01637818|Inguinal hernia repair|inguinal hernia repair
451147|NCT01637818|long-term follow-up|long-term follow-up
451148|NCT01637818|Surgical technique|surgical technique
451149|NCT01637792|peritoneal dialysis|peritoneal dialysis
451150|NCT01637792|dose|dose
451151|NCT01637792|residual kidney function|residual kidney function
451152|NCT01637792|technique survival|technique survival
451153|NCT01637792|patient survival|patient survival
451154|NCT01637792|peritonitis|peritonitis
451155|NCT01637779|randomized controlled trial|randomized controlled trial
451156|NCT01637779|parent education|parent education
451157|NCT01637779|pain management|pain management
451158|NCT01637779|infant|infant
451159|NCT01637779|immunization|immunization
451160|NCT01637766|Spinal Metastases|spinal metastases
451161|NCT01637766|Spinal Metastatic Disease|spinal metastatic disease
451162|NCT01637766|Cord Compression|cord compression
451163|NCT01637766|Intra-arterial Chemotherapy|intra-arterial chemotherapy
451164|NCT01637766|Spinal Tumors|spinal tumors
451165|NCT01637740|myopia|myopia
451166|NCT01637740|pseudoexfoliation syndrome|pseudoexfoliation syndrome
451167|NCT01637740|optical low coherence reflectometry|optical low coherence reflectometry
451168|NCT01637740|ocular optical components|ocular optical components
451169|NCT01637740|cataract|cataract
451170|NCT01637727|Long term effects of gestational diabetes mellitus in a population of parous women|long term effects of gestational diabetes mellitus in a population of parous women
451171|NCT01637727|Gestational diabetes mellitus- GDM is defined as glucose intolerance diagnosed during pregnancy and not present shortly after birth|gestational diabetes mellitus- gdm is defined as glucose intolerance diagnosed during pregnancy and not present shortly after birth
451172|NCT01637701|benign prostatic hypertrophy|benign prostatic hypertrophy
451173|NCT01637701|bipolar transurethral resection of the prostate|bipolar transurethral resection of the prostate
451174|NCT01637701|plasmakinetic enucleation of the prostate|plasmakinetic enucleation of the prostate
451175|NCT01637688|cow milk allergy|cow milk allergy
451176|NCT01637688|amino acid formula|amino acid formula
451177|NCT01637675|sodium tanshinone IIA sulfonate|sodium tanshinone iia sulfonate
451178|NCT01637675|pulmonary hypertension|pulmonary hypertension
451179|NCT01637649|dysphagia,diaphragm, ultrasonography, inspiration, expiration,|dysphagia,diaphragm, ultrasonography, inspiration, expiration,
451180|NCT01637636|rifampin,|rifampin,
451181|NCT01637636|ketoconazole,|ketoconazole,
451182|NCT01637636|CYP3A4,|cyp3a4,
451183|NCT01637636|tasimelteon,|tasimelteon,
451184|NCT01637636|VEC-162|vec-162
451185|NCT01637636|Pharmacokinetics|pharmacokinetics
451186|NCT01637623|Hypertension|hypertension
451187|NCT01637623|High Blood Pressure|high blood pressure
451188|NCT01637623|Sleep Apnea|sleep apnea
451189|NCT01637623|Obstructive Sleep Apnea|obstructive sleep apnea
451190|NCT01637623|OSA|osa
451191|NCT01637610|placental alpha microglobulin-1|placental alpha microglobulin-1
451192|NCT01637610|AmniSure|amnisure
451193|NCT01637610|preterm|preterm
451194|NCT01637610|rupture of fetal membranes|rupture of fetal membranes
451195|NCT01637597|Non-small cell lung cancer(NSCLC)|non-small cell lung cancer(nsclc)
451196|NCT01637571|GERD|gerd
451197|NCT01637571|NCCP|nccp
451198|NCT01637571|chest pain|chest pain
451199|NCT01637571|reflux|reflux
451200|NCT01637571|GERD related non-cardiac chest pain|gerd related non-cardiac chest pain
451201|NCT01637545|facial bones|facial bones
451202|NCT01637545|Post operative nasea vomiting|post operative nasea vomiting
451203|NCT01637545|fractures|fractures
451204|NCT01637545|reduction|reduction
451205|NCT01637519|kidney stones|kidney stones
451206|NCT01637519|ureteral stones|ureteral stones
451207|NCT01637519|stent|stent
451208|NCT01637506|urine|urine
451209|NCT01637506|stool|stool
451210|NCT01637506|kidney stones|kidney stones
451211|NCT01637493|Pegylation|pegylation
451212|NCT01637493|G-CSF|g-csf
451213|NCT01637493|Pharmacokinetics|pharmacokinetics
451214|NCT01637493|Pharmacodynamics|pharmacodynamics
451215|NCT01637467|critical illness|critical illness
451216|NCT01637467|myopathy|myopathy
451217|NCT01637467|electrical muscle stimulation|electrical muscle stimulation
451218|NCT01637454|noradrenaline terlipressin type 2 HRS|noradrenaline terlipressin type 2 hrs
451219|NCT01637441|bladder prolapse (cystocele)|bladder prolapse (cystocele)
451220|NCT01637441|Pelvic organ prolapse repair|pelvic organ prolapse repair
451221|NCT01637441|coelioscopic|coelioscopic
451222|NCT01637441|prosthetic surgery|prosthetic surgery
451223|NCT01637441|vaginal approach|vaginal approach
451224|NCT01637441|Randomized study|randomized study
451225|NCT01637441|laparoscopic sacropexy|laparoscopic sacropexy
451226|NCT01637441|vaginal mesh surgery|vaginal mesh surgery
451227|NCT01637441|Stage II|stage ii
451228|NCT01637441|Clavien Dindo|clavien dindo
451229|NCT01637415|alcohol withdrawal syndrome|alcohol withdrawal syndrome
451230|NCT01637415|prediction|prediction
451231|NCT01637415|severity|severity
451232|NCT01637415|alcohol use disorder|alcohol use disorder
451233|NCT01637415|complicated alcohol withdrawal|complicated alcohol withdrawal
451234|NCT01637415|alcohol withdrawal seizures|alcohol withdrawal seizures
451235|NCT01637415|delirium tremens|delirium tremens
451236|NCT01637415|PAWSS|pawss
451238|NCT01637402|prostate|prostate
451239|NCT01637402|cancer|cancer
451240|NCT01637376|Lung neoplasms|lung neoplasms
451241|NCT01637376|Non Small cell lung carcinoma|non small cell lung carcinoma
451242|NCT01637376|Non small cell lung cancer|non small cell lung cancer
451243|NCT01637376|Large cell carcinoma|large cell carcinoma
451244|NCT01637376|squamous cell carcinoma|squamous cell carcinoma
451245|NCT01637376|adenocarcinoma|adenocarcinoma
451246|NCT01637363|Psychoeducation|psychoeducation
451247|NCT01637363|Stress|stress
451248|NCT01637363|Sickness absence|sickness absence
451249|NCT01637363|Psychiatric symptoms|psychiatric symptoms
451250|NCT01637363|Locus of control|locus of control
451251|NCT01637363|Self reported health|self reported health
451252|NCT01637324|To assess VCT and linkage into care|to assess vct and linkage into care
451253|NCT01637324|nPEP|npep
451254|NCT01637324|STIs|stis
451255|NCT01637324|anal dysplasia/cancer|anal dysplasia/cancer
451256|NCT01637324|hyperlipidemia|hyperlipidemia
451257|NCT01637324|diabetes|diabetes
451258|NCT01637324|Proportion of first-time MSM clients attending multidisciplinary services who undergo HIV testing|proportion of first-time msm clients attending multidisciplinary services who undergo hiv testing
451259|NCT01637324|Proportion of MSM clients who have repeated HIV testing during the first six months after the first negative HIV test|proportion of msm clients who have repeated hiv testing during the first six months after the first negative hiv test
451385|NCT01636674|computed tomography|computed tomography
451260|NCT01637324|Proportion of HIV-positive MSM who receive HIV care within three months after HIV diagnosis or enrolment|proportion of hiv-positive msm who receive hiv care within three months after hiv diagnosis or enrolment
451261|NCT01637324|Proportion of HIV-positive MSM who still remain in HIV care at six months after enrollment|proportion of hiv-positive msm who still remain in hiv care at six months after enrollment
451262|NCT01637311|Peroral endoscopic myotomy|peroral endoscopic myotomy
451263|NCT01637311|Heller myotomy|heller myotomy
451264|NCT01637311|persistent/recurrent achalasia.|persistent/recurrent achalasia.
451265|NCT01637298|Histological HGAIN|histological hgain
451266|NCT01637298|detected biomarkers|detected biomarkers
451267|NCT01637298|MSM population|msm population
451268|NCT01637298|HPV subtypes|hpv subtypes
451269|NCT01637298|AIN study|ain study
451270|NCT01637298|HIV-positive and HIV-negative MSM|hiv-positive and hiv-negative msm
451271|NCT01637298|anal cytology and biomarkers|anal cytology and biomarkers
451272|NCT01637298|likelihood of AIN development at month 12 and yearly thereafter|likelihood of ain development at month 12 and yearly thereafter
451273|NCT01637272|Dumping syndrome|dumping syndrome
451274|NCT01637272|SOM230|som230
451275|NCT01637272|pasireotide LAR|pasireotide lar
451276|NCT01637259|proteinuria|proteinuria
451278|NCT01637233|HIV-1 infection|hiv-1 infection
451279|NCT01637233|neurocognitive function|neurocognitive function
451280|NCT01637233|switch study|switch study
451281|NCT01637220|Anaphylaxis|anaphylaxis
451282|NCT01637220|Neutrophils|neutrophils
451283|NCT01637220|Platelet activating factor|platelet activating factor
451284|NCT01637220|Neutrophil Extracellular Traps (NETs)|neutrophil extracellular traps (nets)
451285|NCT01637168|Disorders of cognitive function|disorders of cognitive function
451286|NCT01637155|Cholecalciferol|cholecalciferol
451287|NCT01637129|Childhood stroke|childhood stroke
451288|NCT01637129|Perinatal stroke|perinatal stroke
451289|NCT01637129|Pediatric stroke|pediatric stroke
451290|NCT01637129|Presumed perinatal stroke|presumed perinatal stroke
451291|NCT01637129|Children who have hemiparesis|children who have hemiparesis
451292|NCT01637103|Cancer|cancer
451293|NCT01637103|Depression|depression
451294|NCT01637103|Anxiety|anxiety
451295|NCT01637103|Fatigue|fatigue
451296|NCT01637103|Sleep|sleep
451297|NCT01637103|Quality of life|quality of life
451298|NCT01637103|Cognitive therapy|cognitive therapy
451299|NCT01637103|Bright light therapy|bright light therapy
451300|NCT01637064|Myositis|myositis
451301|NCT01637064|Acthar treatment|acthar treatment
451302|NCT01637038|ischemia/reperfusion injury|ischemia/reperfusion injury
451303|NCT01637038|remote ischemic postconditioning|remote ischemic postconditioning
451304|NCT01637012|ALEX|alex
451305|NCT01637012|coronary stent|coronary stent
451306|NCT01637012|cobalt-chromium|cobalt-chromium
451307|NCT01637012|sirolimus|sirolimus
451308|NCT01637012|OCT|oct
451309|NCT01636999|Sedara|sedara
451310|NCT01636999|Nitrous Oxide|nitrous oxide
451311|NCT01636999|Butorphanol|butorphanol
451312|NCT01636999|Visual Analog Scale|visual analog scale
451313|NCT01636986|myopia|myopia
451314|NCT01636986|contact lenses|contact lenses
451315|NCT01636986|dry eyes|dry eyes
451316|NCT01636986|comfort|comfort
451317|NCT01636986|replacement|replacement
451318|NCT01636973|Lung cancer|lung cancer
451319|NCT01636947|chemotherapy|chemotherapy
451320|NCT01636947|nausea|nausea
451321|NCT01636947|vomiting|vomiting
451322|NCT01636947|emetogenic|emetogenic
451323|NCT01636947|cancer|cancer
451324|NCT01636947|antiemetics|antiemetics
451325|NCT01636947|tumor|tumor
451326|NCT01636934|Lung Cancer|lung cancer
451327|NCT01636934|Non Small Cell Lung Cancer|non small cell lung cancer
451328|NCT01636934|NSCLC|nsclc
451329|NCT01636934|Symptom Burden|symptom burden
451330|NCT01636934|Chemoradiation|chemoradiation
451332|NCT01636934|Minocycline|minocycline
451333|NCT01636934|Dynacin|dynacin
451334|NCT01636934|Minocin|minocin
451335|NCT01636934|Minocin PAC|minocin pac
451336|NCT01636934|Myrac|myrac
451337|NCT01636934|Solodyn|solodyn
451338|NCT01636934|Placebo|placebo
451339|NCT01636934|Sugar Pill|sugar pill
451340|NCT01636934|Questionnaires|questionnaires
451341|NCT01636934|Surveys|surveys
451342|NCT01636895|malaria|malaria
451343|NCT01636895|pregnancy|pregnancy
451344|NCT01636895|prevention|prevention
451345|NCT01636895|treatment|treatment
451346|NCT01636895|molecular markers|molecular markers
451347|NCT01636882|Melanoma|melanoma
451348|NCT01636882|CALM|calm
451349|NCT01636869|bupivacaine level|bupivacaine level
451350|NCT01636869|periarticular block|periarticular block
451351|NCT01636869|total knee arthroplasty|total knee arthroplasty
451352|NCT01636856|oropharyngeal exercises, obstructive sleep apnea, speech therapy, magnetic resonance, PCRIT, negative expiratory pressure, snore|oropharyngeal exercises, obstructive sleep apnea, speech therapy, magnetic resonance, pcrit, negative expiratory pressure, snore
451353|NCT01636830|Toothbrushing|toothbrushing
451354|NCT01636830|gingival recession|gingival recession
451355|NCT01636804|Quicksite|quicksite
451356|NCT01636804|Quickflex|quickflex
451357|NCT01636804|St. Jude Medical|st. jude medical
451358|NCT01636778|Thrombocytopenia|thrombocytopenia
451359|NCT01636778|Hepatitis C, chronic|hepatitis c, chronic
451360|NCT01636739|Intussusceptions|intussusceptions
451361|NCT01636739|Special Drug Use Investigation|special drug use investigation
451362|NCT01636739|Rotavirus|rotavirus
451363|NCT01636726|COPD|copd
451364|NCT01636726|AMI|ami
451365|NCT01636726|Asthma|asthma
451366|NCT01636726|LABAs|labas
451367|NCT01636700|Tramadol infiltration|tramadol infiltration
451368|NCT01636700|Analgesic effect|analgesic effect
451369|NCT01636700|Serum IL-6|serum il-6
451370|NCT01636687|Psoriasis|psoriasis
451371|NCT01636687|Moderate to Severe Plaque-type Psoriasis|moderate to severe plaque-type psoriasis
451372|NCT01636687|Skin condition|skin condition
451373|NCT01636687|skin disease|skin disease
451374|NCT01636687|itching condition|itching condition
451375|NCT01636687|psoriasis vulgaris|psoriasis vulgaris
451376|NCT01636687|relapsing/remitting psoriasis|relapsing/remitting psoriasis
451377|NCT01636687|immune-mediated systemic disease|immune-mediated systemic disease
451378|NCT01636687|skin lesions|skin lesions
451379|NCT01636687|red skin lesions|red skin lesions
451380|NCT01636687|scaly patches|scaly patches
451381|NCT01636687|papules|papules
451382|NCT01636687|plaques|plaques
451383|NCT01636687|itching|itching
451384|NCT01636674|positron emission tomography|positron emission tomography
451386|NCT01636674|fluordeoxyglucose|fluordeoxyglucose
451387|NCT01636674|colon cancer|colon cancer
451388|NCT01636674|cancer|cancer
451389|NCT01636674|staging|staging
451390|NCT01636674|imaging|imaging
451391|NCT01636648|Aortic Valve Replacement|aortic valve replacement
451392|NCT01636648|Aortic Valve Bioprosthesis|aortic valve bioprosthesis
451393|NCT01636622|Advanced Cancers|advanced cancers
451394|NCT01636622|Advanced Malignancy|advanced malignancy
451395|NCT01636622|BRAF Mutation|braf mutation
451396|NCT01636622|Advanced solid tumor|advanced solid tumor
451397|NCT01636622|Lymphoma|lymphoma
451398|NCT01636622|Vemurafenib|vemurafenib
451399|NCT01636622|PLX4032|plx4032
451400|NCT01636622|RO5185426|ro5185426
451401|NCT01636622|Carboplatin|carboplatin
451402|NCT01636622|Paraplatin|paraplatin
451403|NCT01636622|Paclitaxel|paclitaxel
451404|NCT01636622|Taxol|taxol
451405|NCT01636596|Alzheimer's Disease|alzheimer's disease
451406|NCT01636596|Mild Cognitive Impairment|mild cognitive impairment
451407|NCT01636596|Insulin|insulin
451408|NCT01636596|Pulsatile|pulsatile
451409|NCT01636583|zinc|zinc
451410|NCT01636583|absorption|absorption
451411|NCT01636583|bio-availability|bio-availability
451412|NCT01636583|aqueous zinc|aqueous zinc
451413|NCT01636583|zinc deficiency|zinc deficiency
451414|NCT01636583|zinc fortification|zinc fortification
451415|NCT01636570|Vitamin D|vitamin d
451416|NCT01636570|Cholecalciferol|cholecalciferol
451417|NCT01636570|Heart Failure|heart failure
451418|NCT01636570|Congestive heart failure|congestive heart failure
451419|NCT01636570|Cardiomyopathy|cardiomyopathy
451420|NCT01636570|Strength|strength
451421|NCT01636570|Parathyroid Hormone|parathyroid hormone
451422|NCT01636570|Calcium|calcium
451423|NCT01636570|Quality of Life|quality of life
451424|NCT01636570|C reactive protein|c reactive protein
451425|NCT01636570|Cardiopulmonary exercise testing|cardiopulmonary exercise testing
451426|NCT01636570|Prognosis|prognosis
451427|NCT01636557|Rheumatoid arthritis|rheumatoid arthritis
451428|NCT01636557|sirukumab|sirukumab
576260|NCT01112813|Stroke|stroke
451429|NCT01636557|CNTO 136|cnto 136
451430|NCT01636557|CYP450 enzyme|cyp450 enzyme
451431|NCT01636557|anti-interleukin-6 monoclonal antibody|anti-interleukin-6 monoclonal antibody
451432|NCT01636466|Chronic allograft failure|chronic allograft failure
451433|NCT01636466|Kidney Transplantation|kidney transplantation
451434|NCT01636453|wide-neck|wide-neck
451435|NCT01636453|saccular|saccular
451436|NCT01636453|intracranial aneurysms|intracranial aneurysms
451437|NCT01636453|ICA|ica
451438|NCT01636453|Stent assisted coiling|stent assisted coiling
451439|NCT01636453|Liberty Stent|liberty stent
451440|NCT01636440|Conditioned Pain Modulation|conditioned pain modulation
451441|NCT01636427|myocardial infarction|myocardial infarction
451442|NCT01636427|coronary angiography|coronary angiography
451443|NCT01636427|STEMI|stemi
451444|NCT01636427|NSTEMI|nstemi
451445|NCT01636414|Total joint arthroplasty, blood loss|total joint arthroplasty, blood loss
451446|NCT01636388|Relapsed Hodgkins Lymphoma|relapsed hodgkins lymphoma
451447|NCT01636388|Refractory Hodgkins Lymphoma|refractory hodgkins lymphoma
451448|NCT01636388|Allogeneic Stem Cell Transplantation|allogeneic stem cell transplantation
451449|NCT01636388|Adoptive Immunotherapy|adoptive immunotherapy
451450|NCT01636388|Cellular Therapy|cellular therapy
451451|NCT01636388|Cytotoxic T cell lymphocytes|cytotoxic t cell lymphocytes
451452|NCT01636362|Partial-thickness second degree burns|partial-thickness second degree burns
451453|NCT01636362|Mepitel Ag|mepitel ag
451454|NCT01636362|Silver dressing|silver dressing
451455|NCT01636349|Type 2 diabetes|type 2 diabetes
451456|NCT01636349|hypertension|hypertension
451457|NCT01636349|obesity|obesity
451458|NCT01636349|metabolic syndrome|metabolic syndrome
451459|NCT01636297|Parkinson's disease|parkinson's disease
451460|NCT01636297|Exercise|exercise
451461|NCT01636284|Liver Cancer|liver cancer
451462|NCT01636284|HCC|hcc
451463|NCT01636284|first line HCC|first line hcc
451464|NCT01636284|Pexa-Vec|pexa-vec
451465|NCT01636284|JX-594|jx-594
451466|NCT01636271|CV Risk|cv risk
451467|NCT01636271|Cardiovascular Disease|cardiovascular disease
451468|NCT01636271|Atherosclerosis|atherosclerosis
451469|NCT01636271|Acute coronary syndrome|acute coronary syndrome
451470|NCT01636258|Prediabetes|prediabetes
451471|NCT01636258|Overweight|overweight
451472|NCT01636258|African American|african american
451473|NCT01636258|Women|women
451474|NCT01636258|Cooking|cooking
451475|NCT01636258|Nutrition|nutrition
451476|NCT01636258|Exercise|exercise
451477|NCT01636258|Stress Management|stress management
451478|NCT01636245|71 vaccine|71 vaccine
451479|NCT01636245|HFMD|hfmd
451480|NCT01636245|consistency of three consecutive lots|consistency of three consecutive lots
451481|NCT01636245|immunogenicity|immunogenicity
451482|NCT01636232|Vitamin D|vitamin d
451483|NCT01636232|infection|infection
451484|NCT01636232|disease severity|disease severity
451485|NCT01636232|mortality|mortality
451486|NCT01636232|critically ill|critically ill
451487|NCT01636232|sepsis|sepsis
451488|NCT01636219|Spirometry,|spirometry,
451489|NCT01636219|Cough|cough
451490|NCT01636193|Rotavirus|rotavirus
451491|NCT01636193|Rotarix|rotarix
451492|NCT01636193|Drug Use Investigation|drug use investigation
451493|NCT01636193|Safety|safety
451494|NCT01636180|STEMI|stemi
451495|NCT01636180|NSTEMI|nstemi
451496|NCT01636180|clopidogrel|clopidogrel
451497|NCT01636180|Areplex|areplex
451498|NCT01636180|REL-0609|rel-0609
451499|NCT01636154|fire-heat syndrome|fire-heat syndrome
451500|NCT01636154|blood stasis syndrome|blood stasis syndrome
451501|NCT01636154|method of clearing heat|method of clearing heat
451502|NCT01636154|method of promoting blood circulation|method of promoting blood circulation
451503|NCT01636154|medicinal fractions-based herbal combinations|medicinal fractions-based herbal combinations
451504|NCT01636141|Safety|safety
451505|NCT01636141|Tolerability|tolerability
451506|NCT01636141|Pharmacokinetics|pharmacokinetics
451507|NCT01636141|Dose escalation|dose escalation
451508|NCT01636141|Randomized|randomized
451509|NCT01636141|Healthy volunteers|healthy volunteers
451510|NCT01636141|Topical|topical
451511|NCT01636141|OLT1177|olt1177
451512|NCT01636141|Olatec|olatec
451513|NCT01636141|Pain|pain
451514|NCT01636141|Inflammation|inflammation
451515|NCT01636128|Urinary|urinary
451516|NCT01636128|biomarkers|biomarkers
451517|NCT01636128|DFMO|dfmo
451518|NCT01636128|sulindac|sulindac
451519|NCT01636102|Influenza|influenza
451520|NCT01636102|Adults|adults
451521|NCT01636102|Elderly|elderly
451522|NCT01636102|Immunology|immunology
451523|NCT01636102|Safety|safety
451524|NCT01636089|intensive care unit|intensive care unit
451525|NCT01636076|COPD|copd
451526|NCT01636063|Induced Abortion|induced abortion
451527|NCT01636063|Abortion Techniques|abortion techniques
451528|NCT01636063|Mifepristone|mifepristone
451529|NCT01636063|Misoprostol|misoprostol
451530|NCT01636063|Initial Cervical Dilation|initial cervical dilation
451531|NCT01636050|squat exercise|squat exercise
451532|NCT01636037|schizophrenia|schizophrenia
451533|NCT01636037|negative symptoms|negative symptoms
451534|NCT01636037|deficit syndrome|deficit syndrome
451535|NCT01636037|SANS|sans
451536|NCT01636037|Sinemet|sinemet
451537|NCT01636037|L-dopa|l-dopa
451538|NCT01636037|levodopa|levodopa
451539|NCT01636037|carbidopa|carbidopa
451540|NCT01636037|augmentation|augmentation
451541|NCT01636037|antipsychotics|antipsychotics
451542|NCT01636024|Phase 1,|phase 1,
451543|NCT01636024|healthy volunteers,|healthy volunteers,
451544|NCT01636024|safety,|safety,
451545|NCT01636024|tolerability,|tolerability,
451546|NCT01636024|pharmacokinetics,|pharmacokinetics,
451547|NCT01636024|pharmacodynamics,|pharmacodynamics,
451548|NCT01636024|single ascending dose study,|single ascending dose study,
451549|NCT01636024|multiple|multiple
451550|NCT01636011|Parkinson's Disease|parkinson's disease
451551|NCT01636011|Osteopathic Manipulative Medicine|osteopathic manipulative medicine
451552|NCT01636011|Speech|speech
451553|NCT01636011|Pulmonary Function|pulmonary function
451554|NCT01635998|renal sympathetic denervation|renal sympathetic denervation
451555|NCT01635998|renal catheter ablation|renal catheter ablation
451556|NCT01635998|hypertension|hypertension
451557|NCT01635985|Phase I, Healthy male volunteers, pharmacokinetics|phase i, healthy male volunteers, pharmacokinetics
451558|NCT01635972|Isavuconazole|isavuconazole
451559|NCT01635972|Bupropion|bupropion
451560|NCT01635972|Bupropion hydrochloride|bupropion hydrochloride
451561|NCT01635972|Healthy Volunteers|healthy volunteers
451562|NCT01635972|BAL8557|bal8557
451563|NCT01635972|BAL4815|bal4815
451564|NCT01635972|BAL8728|bal8728
451565|NCT01635959|upper gastro-intestinal symptoms, GERD|upper gastro-intestinal symptoms, gerd
451566|NCT01635946|Isavuconazole|isavuconazole
451567|NCT01635946|Atorvastatin|atorvastatin
451568|NCT01635946|Healthy Volunteers|healthy volunteers
451569|NCT01635946|BAL8557|bal8557
451570|NCT01635946|BAL4815|bal4815
451571|NCT01635946|BAL8728|bal8728
451572|NCT01635933|contact lenses|contact lenses
451573|NCT01635933|color contact lenses|color contact lenses
451574|NCT01635933|myopia|myopia
451575|NCT01635920|contact lenses|contact lenses
451576|NCT01635920|color contact lenses|color contact lenses
451577|NCT01635920|myopia|myopia
451578|NCT01635894|female pelvic floor condition|female pelvic floor condition
451579|NCT01635894|pelvic floor training|pelvic floor training
451580|NCT01635894|supervised pelvic floor training|supervised pelvic floor training
451581|NCT01635894|practice nurse|practice nurse
451582|NCT01635894|nurse specialist|nurse specialist
451583|NCT01635842|Patient|patient
451584|NCT01635842|information leaflet|information leaflet
451585|NCT01635842|informed consent|informed consent
451586|NCT01635842|awareness|awareness
451587|NCT01635829|Healthy participants|healthy participants
451588|NCT01635829|Hepatitis C virus|hepatitis c virus
451589|NCT01635829|Telaprevir|telaprevir
451590|NCT01635829|Phenytoin|phenytoin
451591|NCT01635829|Carbamazepine|carbamazepine
451592|NCT01635829|HCV|hcv
451593|NCT01635829|Interaction|interaction
451594|NCT01635816|Immunogenicity|immunogenicity
451595|NCT01635816|SA 14-14-2 JE vaccine|sa 14-14-2 je vaccine
451596|NCT01635816|Bangladesh|bangladesh
451597|NCT01635803|bevacizumab|bevacizumab
451598|NCT01635803|ranibizumab|ranibizumab
451599|NCT01635803|retinal vein occlusions|retinal vein occlusions
451600|NCT01635803|randomized clinical trial|randomized clinical trial
451601|NCT01635803|Macular edema|macular edema
451602|NCT01635790|bevacizumab|bevacizumab
451603|NCT01635790|ranibizumab|ranibizumab
451604|NCT01635790|diabetic macular edema|diabetic macular edema
451605|NCT01635790|randomized clinical trial|randomized clinical trial
451606|NCT01635777|PKDL|pkdl
451607|NCT01635777|miltefosine|miltefosine
451608|NCT01635764|hidradenitis suppurativa|hidradenitis suppurativa
451609|NCT01635764|open-label|open-label
451610|NCT01635764|acne inversa|acne inversa
451611|NCT01635764|PIONEER (OPEN-LABEL EXTENSION)|pioneer (open-label extension)
451612|NCT01635764|adalimumab|adalimumab
451613|NCT01635764|HS|hs
451614|NCT01635764|acne|acne
451615|NCT01635764|tumor necrosis factor|tumor necrosis factor
451616|NCT01635764|abscess|abscess
451617|NCT01635764|inflammatory nodule|inflammatory nodule
451618|NCT01635751|Pregabalin|pregabalin
451619|NCT01635751|GLARS|glars
451620|NCT01635738|Probiotics|probiotics
451621|NCT01635738|Lactobacillus paracasei GMNL-133|lactobacillus paracasei gmnl-133
451622|NCT01635738|Lactobacillus fermentum GM-090|lactobacillus fermentum gm-090
451623|NCT01635738|Atopic dermatitis|atopic dermatitis
451624|NCT01635738|Asthma|asthma
451625|NCT01635738|Lactobacillus paracasei|lactobacillus paracasei
451626|NCT01635738|Lactobacillus fermentum|lactobacillus fermentum
451627|NCT01635738|efficacy and safety|efficacy and safety
451628|NCT01635725|colonoscopy|colonoscopy
451629|NCT01635725|bowel cleanliness|bowel cleanliness
451630|NCT01635725|bowel rating scale|bowel rating scale
451631|NCT01635712|Hematological Malignancy|hematological malignancy
451632|NCT01635712|Hsp90|hsp90
451633|NCT01635699|DNA oxidation|dna oxidation
451634|NCT01635699|obstructive sleep apnea|obstructive sleep apnea
451635|NCT01635699|lipid peroxidation|lipid peroxidation
451636|NCT01635699|oxidative stresses|oxidative stresses
451637|NCT01635673|Exercise|exercise
451638|NCT01635673|Latino|latino
451639|NCT01635673|Hispanic|hispanic
451640|NCT01635673|Boys|boys
451641|NCT01635660|Out-of-hospital|out-of-hospital
451642|NCT01635660|airway management|airway management
451643|NCT01635660|intubation|intubation
451745|NCT01635075|psychiatric|psychiatric
451644|NCT01635660|video laryngoscope|video laryngoscope
451645|NCT01635634|Fibromyalgia|fibromyalgia
451646|NCT01635634|Cupping|cupping
451647|NCT01635621|Olokizumab|olokizumab
451648|NCT01635621|OKZ|okz
451649|NCT01635621|CDP6038|cdp6038
451650|NCT01635621|Crohn's Disease|crohn's disease
451651|NCT01635621|CDAI|cdai
451652|NCT01635621|IBDQ|ibdq
451653|NCT01635608|Pharmacokinetics|pharmacokinetics
451654|NCT01635608|Talinolol|talinolol
451655|NCT01635608|Amoxicillin|amoxicillin
451656|NCT01635608|Acetaminophen|acetaminophen
451657|NCT01635608|Magnetic Resonance Imaging|magnetic resonance imaging
451658|NCT01635582|Hand exercises|hand exercises
451659|NCT01635582|Hand function|hand function
451660|NCT01635582|Computer based exercises|computer based exercises
451661|NCT01635582|Therapeutic gaming|therapeutic gaming
451662|NCT01635569|Obsessive-compulsive disorder|obsessive-compulsive disorder
451663|NCT01635569|Pediatric|pediatric
451664|NCT01635569|Group-based|group-based
451665|NCT01635569|Cognitive-behavioural therapy|cognitive-behavioural therapy
451666|NCT01635556|borderline personality disorder|borderline personality disorder
451667|NCT01635556|dialectical behavior therapy|dialectical behavior therapy
451668|NCT01635556|psychological treatment|psychological treatment
451669|NCT01635530|doxycycline|doxycycline
451670|NCT01635530|ceftriaxone|ceftriaxone
451671|NCT01635517|Diuretics|diuretics
451672|NCT01635517|Vasopressins|vasopressins
451673|NCT01635517|Sodium|sodium
451674|NCT01635504|HIV lipoatrophy|hiv lipoatrophy
451675|NCT01635504|masseter hypertrophy|masseter hypertrophy
451676|NCT01635504|parotid enlargement|parotid enlargement
451677|NCT01635504|botulinum toxin|botulinum toxin
451678|NCT01635491|Gastrointestinal Motility|gastrointestinal motility
451679|NCT01635491|Transit time|transit time
451680|NCT01635426|Aspirin|aspirin
451681|NCT01635426|Clopidogrel|clopidogrel
451682|NCT01635426|Unexplained recurrent pregnancy loss|unexplained recurrent pregnancy loss
451683|NCT01635426|Uterine artery pulsatility index|uterine artery pulsatility index
451684|NCT01635400|Irinotecan|irinotecan
451685|NCT01635400|UGT1A1 Gene Polymorphisms|ugt1a1 gene polymorphisms
451686|NCT01635400|Small Cell Carcinoma of Lung|small cell carcinoma of lung
451687|NCT01635348|gait speed|gait speed
451688|NCT01635348|cognitive processing speed|cognitive processing speed
451689|NCT01635335|HIV prevention|hiv prevention
451690|NCT01635335|adolescents|adolescents
451691|NCT01635335|Latinos|latinos
451692|NCT01635335|Hispanics|hispanics
451693|NCT01635335|family|family
451694|NCT01635335|health promotion|health promotion
451695|NCT01635335|disease prevention|disease prevention
451696|NCT01635335|family communication|family communication
451697|NCT01635335|parental supervision|parental supervision
451698|NCT01635322|deformity|deformity
451699|NCT01635322|adult|adult
451700|NCT01635322|lumbar|lumbar
451701|NCT01635322|thoraco-lumbar|thoraco-lumbar
451702|NCT01635322|Sagittal vertebral Alignement (SVA)|sagittal vertebral alignement (sva)
451703|NCT01635322|Oswestry Disability Index (ODI)|oswestry disability index (odi)
451704|NCT01635257|pulmonary embolism diagnosis|pulmonary embolism diagnosis
451705|NCT01635257|ultrasound|ultrasound
451706|NCT01635244|Aortic valve prosthesis|aortic valve prosthesis
451707|NCT01635244|Aortic valve hemodynamics|aortic valve hemodynamics
451708|NCT01635244|Prosthesis-patient mismatch|prosthesis-patient mismatch
451709|NCT01635244|Left ventricular diastolic function|left ventricular diastolic function
451710|NCT01635244|Left ventricular remodeling|left ventricular remodeling
451711|NCT01635231|Nephrology|nephrology
451712|NCT01635231|sodium-channels|sodium-channels
451713|NCT01635231|water-channels|water-channels
451714|NCT01635231|BCM|bcm
451715|NCT01635231|central blood pressure|central blood pressure
451716|NCT01635218|Depression|depression
451717|NCT01635218|Perimenopause|perimenopause
451718|NCT01635218|Postmenopause|postmenopause
451719|NCT01635218|Homeopathy|homeopathy
451720|NCT01635205|Paraspinous block|paraspinous block
451721|NCT01635205|Non-responsive chronic pelvic pain|non-responsive chronic pelvic pain
451722|NCT01635192|renin|renin
451723|NCT01635192|angiotensin|angiotensin
451724|NCT01635192|probiotic|probiotic
451725|NCT01635192|glucose absorption|glucose absorption
451726|NCT01635192|intestinal|intestinal
451727|NCT01635179|Videolaryngoscopy|videolaryngoscopy
451728|NCT01635179|Bronchial Aspiration|bronchial aspiration
451729|NCT01635179|Hypoxia|hypoxia
451730|NCT01635166|Arthroplasty|arthroplasty
451731|NCT01635166|Replacement|replacement
451732|NCT01635166|Hip|hip
451733|NCT01635166|Cementless|cementless
451734|NCT01635166|Ceramic on Ceramic|ceramic on ceramic
451735|NCT01635153|HIV|hiv
451736|NCT01635153|Tuberculosis|tuberculosis
451737|NCT01635153|Nutrition|nutrition
451738|NCT01635140|DIPG|dipg
451739|NCT01635140|Hypofractionated Radiotherapy|hypofractionated radiotherapy
451740|NCT01635140|Radiotherapy|radiotherapy
451741|NCT01635140|Median survival|median survival
451742|NCT01635101|Moderate to severe acute pain following surgery or trauma|moderate to severe acute pain following surgery or trauma
451743|NCT01635088|Asthma|asthma
451744|NCT01635088|FEV1 and IOS change after mometasone for asthma|fev1 and ios change after mometasone for asthma
451746|NCT01635075|comorbidity|comorbidity
451747|NCT01635075|craving|craving
451748|NCT01635075|tobacco|tobacco
451749|NCT01635049|in vitro fertilization|in vitro fertilization
451750|NCT01635049|assisted reproduction techniques|assisted reproduction techniques
451751|NCT01635049|noninvasive imaging of embryos|noninvasive imaging of embryos
451752|NCT01635049|time lapse imaging of embryos|time lapse imaging of embryos
451753|NCT01635049|traditional morphological grading of embryos|traditional morphological grading of embryos
451754|NCT01635049|prediction of blastocysts|prediction of blastocysts
451755|NCT01635049|infertility|infertility
451756|NCT01635049|preimplantation genetic diagnosis|preimplantation genetic diagnosis
451757|NCT01635049|comprehensive chromosome screening|comprehensive chromosome screening
451758|NCT01635036|in vitro fertilization|in vitro fertilization
451759|NCT01635036|assisted reproduction techniques|assisted reproduction techniques
451760|NCT01635036|noninvasive imaging of embryos|noninvasive imaging of embryos
451761|NCT01635036|time lapse imaging of embryos|time lapse imaging of embryos
451762|NCT01635036|traditional morphological grading of embryos|traditional morphological grading of embryos
451763|NCT01635036|prediction of blastocyst formation|prediction of blastocyst formation
451764|NCT01635036|infertility|infertility
451765|NCT01635036|male factor female factor|male factor female factor
451766|NCT01635036|embryo viability|embryo viability
451767|NCT01635023|Phase I|phase i
451768|NCT01635023|healthy volunteers|healthy volunteers
451769|NCT01635023|AZD6244|azd6244
451770|NCT01635023|pharmacokinetics|pharmacokinetics
451771|NCT01635023|AUC|auc
451772|NCT01635023|Cmax|cmax
451773|NCT01635023|tmax|tmax
451774|NCT01635023|AUC(0-t)|auc(0-t)
451775|NCT01635010|obstructive sleep apnea|obstructive sleep apnea
451776|NCT01635010|inflammation|inflammation
451777|NCT01635010|oxidative stress|oxidative stress
451778|NCT01635010|arterial stiffness|arterial stiffness
451779|NCT01634997|Screening for Type 2 Diabetes|screening for type 2 diabetes
451780|NCT01634984|expression of CDK5RAP2|expression of cdk5rap2
451781|NCT01634971|Postoperative pancreatic fistula(POPF);|postoperative pancreatic fistula(popf);
451782|NCT01634971|Postpancreatectomy hemorrhage(PPH);|postpancreatectomy hemorrhage(pph);
451783|NCT01634971|Delayed gastric emptying (DGE);|delayed gastric emptying (dge);
451784|NCT01634971|Bile leakage after pancreatic surgery;|bile leakage after pancreatic surgery;
451785|NCT01634971|Anastomotic leakage|anastomotic leakage
451786|NCT01634958|Allergic Rhinitis|allergic rhinitis
451787|NCT01634958|Hayfever|hayfever
451788|NCT01634958|Immunotherapy|immunotherapy
451789|NCT01634958|Dose-Finding-Study|dose-finding-study
451790|NCT01634945|anemia|anemia
451791|NCT01634945|malaria|malaria
451792|NCT01634945|malnutrition|malnutrition
451793|NCT01634945|iron fortification|iron fortification
451794|NCT01634945|intermittent preventive treatment|intermittent preventive treatment
451795|NCT01634945|subsaharan africa|subsaharan africa
451796|NCT01634945|ivory coast|ivory coast
451797|NCT01634945|young children|young children
451798|NCT01634932|Iron deficiency|iron deficiency
451799|NCT01634932|Biofortification|biofortification
451800|NCT01634932|Pearl Millet|pearl millet
451801|NCT01634932|Benin|benin
451802|NCT01634919|Chronic hepatitis C|chronic hepatitis c
451803|NCT01634919|Liver fibrosis|liver fibrosis
451804|NCT01634919|ARFI(Acoustic radiation force impulse)|arfi(acoustic radiation force impulse)
451805|NCT01634906|Apolipoprotein B, erythrocytes, statins|apolipoprotein b, erythrocytes, statins
451806|NCT01634893|Refractory or Relapsed Solid Tumors|refractory or relapsed solid tumors
451807|NCT01634880|Salivary Gland Malignancies|salivary gland malignancies
451808|NCT01634880|Panitumumab|panitumumab
451809|NCT01634880|Postoperative|postoperative
451810|NCT01634880|Radiotherapy|radiotherapy
451811|NCT01634841|walnuts|walnuts
451812|NCT01634841|age related cognitive decline|age related cognitive decline
451813|NCT01634841|age related macular degeneration|age related macular degeneration
451814|NCT01634841|healthy elderly subjects|healthy elderly subjects
451815|NCT01634802|Clinical Decision Support Systems|clinical decision support systems
451816|NCT01634802|Electronic Medical Record|electronic medical record
451817|NCT01634802|Resource constrained countries|resource constrained countries
451818|NCT01634802|HIV|hiv
451819|NCT01634789|bioavailability|bioavailability
451820|NCT01634763|Phase I, open-label, dose escalation, oral LDK378, Japanese patients with tumors characterized by ALK genetic alterations|phase i, open-label, dose escalation, oral ldk378, japanese patients with tumors characterized by alk genetic alterations
451821|NCT01634750|N-Acetyl-D-mannosamine (ManNAc)|n-acetyl-d-mannosamine (mannac)
451822|NCT01634750|HIBM|hibm
451823|NCT01634750|GNE Myopathy|gne myopathy
451824|NCT01634737|shellfish|shellfish
451825|NCT01634737|tropomyosin|tropomyosin
451826|NCT01634737|mites|mites
451827|NCT01634737|food allergy|food allergy
451828|NCT01634724|GnRH agonist withdrawal|gnrh agonist withdrawal
451829|NCT01634724|OHSS|ohss
451830|NCT01634724|E2|e2
451831|NCT01634724|VEGF|vegf
451832|NCT01634711|ACL|acl
451833|NCT01634711|Anterior Cruciate Ligament|anterior cruciate ligament
451834|NCT01634711|Ligament|ligament
451835|NCT01634711|Resorbable polymer|resorbable polymer
451836|NCT01634711|Knee ligament|knee ligament
451837|NCT01634698|chronic liver disease|chronic liver disease
451838|NCT01634698|cirrhosis|cirrhosis
451839|NCT01634698|vitamin A|vitamin a
451840|NCT01634698|RDR test|rdr test
451841|NCT01634698|retinol-binding protein|retinol-binding protein
451842|NCT01634685|Rectal cancer|rectal cancer
451843|NCT01634685|Bavituximab|bavituximab
451844|NCT01634685|Capecitabine|capecitabine
451845|NCT01634685|Radiation Therapy|radiation therapy
451846|NCT01634672|Gastroesophageal Reflux Disease|gastroesophageal reflux disease
451847|NCT01634672|peritoneal dialysis|peritoneal dialysis
451848|NCT01634672|hemodialysis|hemodialysis
451849|NCT01634659|contact lenses|contact lenses
451850|NCT01634659|myopia|myopia
451851|NCT01634646|Observational study|observational study
451852|NCT01634633|Endometrial nerve fibres|endometrial nerve fibres
451853|NCT01634620|Chronic Obstructive Pulmonary Disease (COPD)|chronic obstructive pulmonary disease (copd)
451854|NCT01634620|Chronic Obstructive Airways Disease|chronic obstructive airways disease
451855|NCT01634620|Chronic Bronchitis|chronic bronchitis
451856|NCT01634620|Chronic Emphysema|chronic emphysema
451857|NCT01634620|Asthma|asthma
451858|NCT01634607|osteopenia|osteopenia
451859|NCT01634607|vitamin D deficiency|vitamin d deficiency
451860|NCT01634607|HIV-infected patients|hiv-infected patients
451861|NCT01634607|bone health|bone health
451862|NCT01634607|Bone mineral density (BMD)|bone mineral density (bmd)
451863|NCT01634607|HIV-uninfected patients|hiv-uninfected patients
451864|NCT01634607|effects of TDF on the patients' bone|effects of tdf on the patients' bone
451865|NCT01634594|Deliberate hypotension, QTc, Tp-e, heart rate variability|deliberate hypotension, qtc, tp-e, heart rate variability
451866|NCT01634555|Advanced Malignant Solid Tumors|advanced malignant solid tumors
451867|NCT01634516|Diet|diet
451868|NCT01634516|Pregnant|pregnant
451869|NCT01634503|3+3 design|3+3 design
451870|NCT01634503|Phase 1|phase 1
451871|NCT01634503|Cervical Intraepithelial Neoplasia|cervical intraepithelial neoplasia
451872|NCT01634503|Adult|adult
451873|NCT01634503|Safety|safety
451874|NCT01634503|Dose Finding|dose finding
451875|NCT01634490|cow's milk allergy|cow's milk allergy
451876|NCT01634490|formulas|formulas
451877|NCT01634490|probiotics|probiotics
451878|NCT01634477|morbidity|morbidity
451879|NCT01634477|mortality|mortality
451880|NCT01634477|HIV-infected patients|hiv-infected patients
451881|NCT01634477|prospective cohort study|prospective cohort study
451882|NCT01634477|highly active antiretroviral therapy (HAART)|highly active antiretroviral therapy (haart)
451883|NCT01634477|opportunistic infections|opportunistic infections
451884|NCT01634477|Non HIV-related illness|non hiv-related illness
451885|NCT01634477|cardiovascular disease (CVD)|cardiovascular disease (cvd)
451886|NCT01634477|HIV negative patients|hiv negative patients
451887|NCT01634477|Thai HIV-infected patients|thai hiv-infected patients
451888|NCT01634451|Sedation|sedation
451889|NCT01634451|Quality|quality
451890|NCT01634438|coronary angiography|coronary angiography
451891|NCT01634425|NSTEMI|nstemi
451892|NCT01634425|Point of Care Biomarkers|point of care biomarkers
451893|NCT01634334|Secondhand smoke|secondhand smoke
451894|NCT01634295|CKD-828|ckd-828
451895|NCT01634295|Hypertension|hypertension
451896|NCT01634295|Stage 2 Hypertension|stage 2 hypertension
451897|NCT01634295|S-Amlodipine|s-amlodipine
451898|NCT01634295|Telmisartan|telmisartan
451899|NCT01634269|Valvular Heart Disease|valvular heart disease
451900|NCT01634269|Severe Aortic Stenosis|severe aortic stenosis
451901|NCT01634269|Aortic Valve Replacement|aortic valve replacement
451902|NCT01634243|SPM 962|spm 962
451903|NCT01634243|rotigotine|rotigotine
451904|NCT01634243|Parkinson's disease|parkinson's disease
451905|NCT01634204|weight reduction|weight reduction
451906|NCT01634204|web-based intervention|web-based intervention
451907|NCT01634204|cost-effective|cost-effective
451908|NCT01634204|overweight|overweight
451909|NCT01634204|obesity|obesity
451910|NCT01634204|cardiovascular risk|cardiovascular risk
451911|NCT01634191|Apremilast|apremilast
451912|NCT01634191|pharmacokinetic|pharmacokinetic
451913|NCT01634191|safety|safety
451914|NCT01634191|Pharmacokinetics and safety in healthy volunteer subjects|pharmacokinetics and safety in healthy volunteer subjects
451915|NCT01634178|Apremilast,|apremilast,
451916|NCT01634178|pharmacokinetic|pharmacokinetic
451917|NCT01634178|safety|safety
451918|NCT01634178|Safety and pharmacokinetics in healthy volunteer subjects|safety and pharmacokinetics in healthy volunteer subjects
451919|NCT01634126|Colon|colon
451920|NCT01634126|Rectal|rectal
451921|NCT01634126|Cancer|cancer
451922|NCT01634126|Screening|screening
451923|NCT01634126|FIT|fit
451924|NCT01634126|Fecal|fecal
451925|NCT01634061|Castration-resistant prostate cancer, abiraterone acetate, BEZ235, BKM120, dose escalation, abiraterone acetate failure|castration-resistant prostate cancer, abiraterone acetate, bez235, bkm120, dose escalation, abiraterone acetate failure
451926|NCT01634048|high protein diet|high protein diet
451927|NCT01634048|meal replacements|meal replacements
451928|NCT01634048|low calorie diet|low calorie diet
451929|NCT01634048|intra hepatocellular lipid|intra hepatocellular lipid
451930|NCT01634035|glycated hemoglobin|glycated hemoglobin
451931|NCT01634035|mean plasma glucose|mean plasma glucose
451932|NCT01634022|Acupuncture|acupuncture
451933|NCT01634022|Antidepressant|antidepressant
451934|NCT01634022|Monotherapy|monotherapy
451935|NCT01634022|Depression|depression
451936|NCT01634022|Alternative treatments|alternative treatments
451937|NCT01634009|Severe acute malnutrition|severe acute malnutrition
451938|NCT01634009|Ready to use therapeutic food|ready to use therapeutic food
451939|NCT01634009|Soy protein|soy protein
451940|NCT01634009|Community based management|community based management
451941|NCT01634009|Efficacy|efficacy
451942|NCT01634009|Management of Children with SAM in Bangladesh|management of children with sam in bangladesh
451943|NCT01633996|Acupuncture|acupuncture
451944|NCT01633996|Antidepressant|antidepressant
451945|NCT01633996|Augmentation|augmentation
451946|NCT01633996|Depression|depression
451947|NCT01633983|Central Serous Chorioretinopathy|central serous chorioretinopathy
451948|NCT01633983|Methotrexate|methotrexate
451949|NCT01633957|anticoagulation|anticoagulation
451950|NCT01633957|bleeding|bleeding
451951|NCT01633957|CYP2C9|cyp2c9
451952|NCT01633957|CYP4F2|cyp4f2
451953|NCT01633957|VKORC1|vkorc1
451954|NCT01633957|warfarin dosing|warfarin dosing
451955|NCT01633957|Heart Valve Diseases|heart valve diseases
451956|NCT01633957|pharmacogenomics|pharmacogenomics
451957|NCT01633944|CLBP|clbp
451958|NCT01633944|Chronic Low Back Pain|chronic low back pain
451959|NCT01633944|Chronic Pain|chronic pain
451960|NCT01633944|Back Pain|back pain
451961|NCT01633918|intervention|intervention
451962|NCT01633918|health education|health education
451963|NCT01633918|physical activity|physical activity
451964|NCT01633918|sedentary behavior|sedentary behavior
451965|NCT01633918|health promotion|health promotion
451966|NCT01633918|evaluation|evaluation
451967|NCT01633918|RE-AIM|re-aim
451968|NCT01633905|alcohol-dependence|alcohol-dependence
451969|NCT01633905|event-related potentials|event-related potentials
451970|NCT01633905|emotion|emotion
451971|NCT01633905|crossmodal|crossmodal
451972|NCT01633905|peripheral processing|peripheral processing
451973|NCT01633892|Craniomaxillofacial (CMF)|craniomaxillofacial (cmf)
451974|NCT01633892|Battle-injured (BI)|battle-injured (bi)
451975|NCT01633892|Facial Trauma|facial trauma
451976|NCT01633892|Fat Grafts|fat grafts
451977|NCT01633892|Autogenous Fat Transfers (AFT)|autogenous fat transfers (aft)
451978|NCT01633892|Wounded warriors|wounded warriors
451979|NCT01633892|Adipose Tissue|adipose tissue
451980|NCT01633879|parenting, prevention, HIV/AIDS, adolescents, Latino|parenting, prevention, hiv/aids, adolescents, latino
451981|NCT01633866|Magnetic Resonance Imaging|magnetic resonance imaging
451982|NCT01633853|chronic kidney disease mineral and bone disorder|chronic kidney disease mineral and bone disorder
451983|NCT01633853|vitamin D2|vitamin d2
451984|NCT01633853|parathyroid hormone|parathyroid hormone
451985|NCT01633840|double-blind placebo-controlled food challenges|double-blind placebo-controlled food challenges
451986|NCT01633840|food allergy|food allergy
451987|NCT01633840|food hypersensitivity|food hypersensitivity
451988|NCT01633840|triangle test|triangle test
451989|NCT01633840|validated recipes|validated recipes
451990|NCT01633814|Physiological Processes|physiological processes
451991|NCT01633814|Exercise|exercise
451992|NCT01633814|Hormone replacement therapy|hormone replacement therapy
451993|NCT01633775|Refractory primary open angle glaucoma|refractory primary open angle glaucoma
451994|NCT01633775|trabeculectomy|trabeculectomy
451995|NCT01633775|ahmed valve implant|ahmed valve implant
451996|NCT01633749|Influenza|influenza
451997|NCT01633749|Vaccine|vaccine
451998|NCT01633749|CHMP criteria|chmp criteria
451999|NCT01633736|single blinded|single blinded
452000|NCT01633736|randomised|randomised
452001|NCT01633736|controlled|controlled
452002|NCT01633736|physiotherapy|physiotherapy
452003|NCT01633736|children|children
452004|NCT01633736|cerebral palsy|cerebral palsy
452005|NCT01633710|Ankle brachial pressure index|ankle brachial pressure index
452006|NCT01633710|Colour duplex ultrasound|colour duplex ultrasound
452007|NCT01633710|Diabetes|diabetes
452008|NCT01633710|Photoplethysmography|photoplethysmography
452009|NCT01633697|emphysema|emphysema
452010|NCT01633697|chronic bronchitis|chronic bronchitis
452011|NCT01633684|diabetes mellitus|diabetes mellitus
452012|NCT01633684|bone|bone
452013|NCT01633671|Misadventures to Patients During Surgical and Medical Care|misadventures to patients during surgical and medical care
452261|NCT01632475|Lung injury|lung injury
452014|NCT01633671|Pulmonary Embolism Without Acute Cor Pulmonale|pulmonary embolism without acute cor pulmonale
452015|NCT01633671|Pulmonary Embolism Without Mention of Acute Cor Pulmonale|pulmonary embolism without mention of acute cor pulmonale
452016|NCT01633658|vitamin D|vitamin d
452017|NCT01633632|Smoking cessation|smoking cessation
452018|NCT01633632|Yoga|yoga
452019|NCT01633632|Cognitive behavioral therapy|cognitive behavioral therapy
452020|NCT01633619|Prosthetic Joint Infection|prosthetic joint infection
452021|NCT01633606|severity of illness|severity of illness
452022|NCT01633606|scoring|scoring
452023|NCT01633606|medium care|medium care
452024|NCT01633606|intensive care|intensive care
452025|NCT01633606|staffing|staffing
452026|NCT01633580|ICSI|icsi
452027|NCT01633580|GnRH antagonist|gnrh antagonist
452028|NCT01633580|corifollitropin alfa|corifollitropin alfa
452029|NCT01633567|Smoking Cessation|smoking cessation
452030|NCT01633567|Cigarette Smoking|cigarette smoking
452031|NCT01633567|Tobacco|tobacco
452032|NCT01633567|LGBT|lgbt
452033|NCT01633567|LGBTQ|lgbtq
452034|NCT01633554|ST-2, IL-33, prediction, fibrosis, hepatitis B|st-2, il-33, prediction, fibrosis, hepatitis b
452035|NCT01633528|low dose aspirin endometrial thickness pregnancy rate ICSI IVF embryo transfer|low dose aspirin endometrial thickness pregnancy rate icsi ivf embryo transfer
452036|NCT01633515|Basal cell carcinoma (BCC)|basal cell carcinoma (bcc)
452037|NCT01633515|Cryotherapy|cryotherapy
452038|NCT01633515|Cryosurgery|cryosurgery
452039|NCT01633476|CMV|cmv
452040|NCT01633476|ANCA associated vasculitis|anca associated vasculitis
452041|NCT01633476|CD4+CD28- T-cells|cd4+cd28- t-cells
452042|NCT01633476|Valaciclovir|valaciclovir
452043|NCT01633463|EMERGENCY CANCER PAIN, ASSESSMENT, TREATMENT ADEQUACY.|emergency cancer pain, assessment, treatment adequacy.
452044|NCT01633437|tyramine|tyramine
452045|NCT01633437|MAOI|maoi
452046|NCT01633437|cheese effect|cheese effect
452047|NCT01633437|depression|depression
452048|NCT01633398|Heart Failure|heart failure
452049|NCT01633398|HF|hf
452050|NCT01633385|bronchial inflammation|bronchial inflammation
452051|NCT01633385|Bronchiolitis obliterans|bronchiolitis obliterans
452052|NCT01633385|Sputum|sputum
452053|NCT01633385|Blood|blood
452054|NCT01633385|Inflammation|inflammation
452055|NCT01633385|adaptive immune system|adaptive immune system
452056|NCT01633385|innate immune system|innate immune system
452057|NCT01633372|Primary Myelofibrosis|primary myelofibrosis
452058|NCT01633372|PMF|pmf
452059|NCT01633372|Post Polycythemia Vera Fibrosis|post polycythemia vera fibrosis
452060|NCT01633372|PPV-MF|ppv-mf
452061|NCT01633372|Post Essential Thrombocythemia Myelofibrosis|post essential thrombocythemia myelofibrosis
452062|NCT01633372|PET-MF|pet-mf
452063|NCT01633333|Colonoscopy|colonoscopy
452064|NCT01633333|Colorectal cancer|colorectal cancer
452065|NCT01633333|Colorectal adenomas|colorectal adenomas
452066|NCT01633333|Pain|pain
452067|NCT01633320|Analgesia/Nociception index|analgesia/nociception index
452068|NCT01633307|education|education
452069|NCT01633307|intravenous infusion|intravenous infusion
452070|NCT01633294|premature rupture of membranes|premature rupture of membranes
452071|NCT01633294|term pregnancy|term pregnancy
452072|NCT01633294|chorioamnionitis|chorioamnionitis
452073|NCT01633294|endometritis|endometritis
452074|NCT01633294|neonatal sepsis|neonatal sepsis
452075|NCT01633294|antibiotic prophylaxis|antibiotic prophylaxis
452076|NCT01633281|peripheral neuropathy|peripheral neuropathy
452077|NCT01633281|acupuncture|acupuncture
452078|NCT01633281|Bortezomib|bortezomib
452079|NCT01633281|Thalidomide|thalidomide
452080|NCT01633268|MRI (Magnetic Resonance Imaging)|mri (magnetic resonance imaging)
452081|NCT01633268|Traumatic Brain Injury|traumatic brain injury
452082|NCT01633255|Anti-Angiogenic|anti-angiogenic
452083|NCT01633255|Dynamic Contrast Enhanced Magnetic Resonance Imaging|dynamic contrast enhanced magnetic resonance imaging
452084|NCT01633255|PET/CT Imaging Studies|pet/ct imaging studies
452085|NCT01633242|MRI|mri
452086|NCT01633242|Muscular Dystrophy|muscular dystrophy
452087|NCT01633242|Cardiac|cardiac
452088|NCT01633242|Myocardium|myocardium
452089|NCT01633242|Intramyocardial fat|intramyocardial fat
452090|NCT01633229|Immune Suppression|immune suppression
452091|NCT01633229|BMSC|bmsc
452092|NCT01633229|GVHD|gvhd
452093|NCT01633229|Marrow Failure|marrow failure
452094|NCT01633229|Regimen Related Toxicity|regimen related toxicity
452095|NCT01633229|Graft-Versus-Host Disease|graft-versus-host disease
452096|NCT01633216|poliovirus,|poliovirus,
452097|NCT01633216|trivalent oral polio vaccine,|trivalent oral polio vaccine,
452098|NCT01633216|bivalent oral polio vaccine,|bivalent oral polio vaccine,
452099|NCT01633216|monovalent oral polio vaccine|monovalent oral polio vaccine
452100|NCT01633203|gastric cancer|gastric cancer
452101|NCT01633203|combination chemotherapy|combination chemotherapy
452102|NCT01633203|HER-2 gene|her-2 gene
452103|NCT01633203|quality of life|quality of life
452104|NCT01633190|Surveillance|surveillance
452105|NCT01633190|Rotavirus|rotavirus
452106|NCT01633190|Gastroenteritis|gastroenteritis
452107|NCT01633177|vitamin D|vitamin d
452108|NCT01633177|omega-3 fatty acids|omega-3 fatty acids
452109|NCT01633177|Type 2 diabetes|type 2 diabetes
452110|NCT01633177|Oral glucose tolerance test (OGTT)|oral glucose tolerance test (ogtt)
452111|NCT01633177|Insulin sensitivity|insulin sensitivity
452112|NCT01633177|Beta-cell function|beta-cell function
452113|NCT01633164|Spinal Cord Injury|spinal cord injury
452114|NCT01633164|Self-Efficacy|self-efficacy
452115|NCT01633164|Life Satisfaction|life satisfaction
452116|NCT01633164|Community Participation|community participation
452117|NCT01633138|cognitive remediation therapy|cognitive remediation therapy
452118|NCT01633138|substance abuse treatment|substance abuse treatment
452119|NCT01633125|Group music therapy|group music therapy
452120|NCT01633125|prisoners|prisoners
452121|NCT01633125|Anxiety|anxiety
452122|NCT01633125|Depression|depression
452123|NCT01633125|Self-esteem|self-esteem
452124|NCT01633099|decitabine|decitabine
452125|NCT01633099|acute myeloid leukemia|acute myeloid leukemia
452226|NCT01632605|m-TOR|m-tor
452126|NCT01633099|elderly patient|elderly patient
452127|NCT01633060|BKM120|bkm120
452128|NCT01633060|fulvestrant|fulvestrant
452129|NCT01633060|breast cancer|breast cancer
452130|NCT01633060|metastatic|metastatic
452131|NCT01633060|locally advanced|locally advanced
452132|NCT01633060|AI treated|ai treated
452133|NCT01633060|mTOR inhibitor|mtor inhibitor
452134|NCT01633060|PI3K|pi3k
452135|NCT01633060|PIK3CA|pik3ca
452136|NCT01633060|PTEN|pten
452137|NCT01633060|HER2-|her2-
452138|NCT01633060|HR+|hr+
452139|NCT01633047|Anterior Cruciate Ligament|anterior cruciate ligament
452140|NCT01633047|Electric Stimulation Therapy|electric stimulation therapy
452141|NCT01633034|intervertebral disc degeneration|intervertebral disc degeneration
452142|NCT01633034|back pain|back pain
452143|NCT01633034|spine surgery|spine surgery
452144|NCT01633021|Support|support
452145|NCT01633021|Cancer|cancer
452146|NCT01633021|Network|network
452147|NCT01633021|Sickle Cell Disease|sickle cell disease
452148|NCT01633021|Sickle Trait|sickle trait
452149|NCT01633021|Diabetes|diabetes
452150|NCT01633021|Sickle Cell Trait / Sickle Cell Disease|sickle cell trait / sickle cell disease
452151|NCT01633008|Modified Brief Pain Inventory|modified brief pain inventory
452152|NCT01633008|Quality of Life|quality of life
452153|NCT01633008|Pain-Related Coping|pain-related coping
452154|NCT01633008|Pain-Related Anxiety|pain-related anxiety
452155|NCT01633008|Depression|depression
452156|NCT01632982|opioid abuse|opioid abuse
452157|NCT01632982|substance abuse|substance abuse
452158|NCT01632982|methadone maintenance treatment|methadone maintenance treatment
452159|NCT01632982|mobile technology|mobile technology
452160|NCT01632982|technology-based intervention|technology-based intervention
452161|NCT01632982|behavioral intervention|behavioral intervention
452162|NCT01632982|psychosocial treatment|psychosocial treatment
452163|NCT01632969|12-136|12-136
452164|NCT01632956|Support Groups|support groups
452165|NCT01632956|Breast cancer|breast cancer
452166|NCT01632956|Mandarin speaking|mandarin speaking
452167|NCT01632956|12-105|12-105
452168|NCT01632943|Uncontrolled Hypertension|uncontrolled hypertension
452169|NCT01632930|diagnosis|diagnosis
452170|NCT01632930|prostate cancer|prostate cancer
452171|NCT01632930|urine|urine
452172|NCT01632930|medical economics|medical economics
452173|NCT01632917|Healthy volunteers|healthy volunteers
452174|NCT01632904|Polycythemia Vera|polycythemia vera
452175|NCT01632904|PV|pv
452176|NCT01632878|Secondary prevention post MI|secondary prevention post mi
452177|NCT01632865|occlusion|occlusion
452178|NCT01632865|recanalization|recanalization
452179|NCT01632865|stenting|stenting
452180|NCT01632839|PISQ-R|pisq-r
452181|NCT01632839|new sexuality questionnaire|new sexuality questionnaire
452182|NCT01632826|Relapsed|relapsed
452183|NCT01632826|refractory multiple myeloma|refractory multiple myeloma
452184|NCT01632826|pomalidomide|pomalidomide
452185|NCT01632813|neurocognitive testing|neurocognitive testing
452186|NCT01632813|critical illness|critical illness
452187|NCT01632813|executive function|executive function
452188|NCT01632813|intelligence|intelligence
452189|NCT01632800|Magnetic fields discomfort|magnetic fields discomfort
452190|NCT01632787|Anxiety|anxiety
452191|NCT01632787|Binocular|binocular
452192|NCT01632787|Chronic Headache|chronic headache
452193|NCT01632787|Dizziness|dizziness
452194|NCT01632787|Vertical Heterophoria|vertical heterophoria
452195|NCT01632787|Vision Dysfunction|vision dysfunction
452196|NCT01632761|anemia|anemia
452197|NCT01632761|vitamin D3|vitamin d3
452198|NCT01632761|omega-3 fatty acids|omega-3 fatty acids
452199|NCT01632761|fish oil|fish oil
452200|NCT01632761|primary prevention|primary prevention
452201|NCT01632735|Continuing Care|continuing care
452202|NCT01632735|Youth Substance Abuse|youth substance abuse
452203|NCT01632735|Recovery Support|recovery support
452204|NCT01632735|Mobile Texting|mobile texting
452205|NCT01632722|colorectal cancer, liver metastasis, bevacizumab, perioperative/postoperative chemotherapy|colorectal cancer, liver metastasis, bevacizumab, perioperative/postoperative chemotherapy
452206|NCT01632696|Antibodies, Monoclonal|antibodies, monoclonal
452207|NCT01632696|Biologics|biologics
452208|NCT01632696|F(ab')2|f(ab')2
452209|NCT01632696|Positron-emission tomography (PET)|positron-emission tomography (pet)
452210|NCT01632696|Phosphatidylserine (PS)|phosphatidylserine (ps)
452211|NCT01632696|Solid Tumors|solid tumors
452212|NCT01632696|Tumor Imaging|tumor imaging
452213|NCT01632683|difficult airway|difficult airway
452214|NCT01632683|video laryngoscopy|video laryngoscopy
452215|NCT01632670|music|music
452216|NCT01632670|cardiac catheterization|cardiac catheterization
452217|NCT01632670|endothelial function|endothelial function
452218|NCT01632631|suitable for endovascular exclusion|suitable for endovascular exclusion
452219|NCT01632605|ADPKD|adpkd
452220|NCT01632605|Autosomal dominant polycystic kidney disease|autosomal dominant polycystic kidney disease
452221|NCT01632605|Sirolimus|sirolimus
452222|NCT01632605|Rapamune|rapamune
452223|NCT01632605|Polycystic liver disease|polycystic liver disease
452224|NCT01632605|Rapamycin|rapamycin
452225|NCT01632605|Mammalian target of rapamycin|mammalian target of rapamycin
452227|NCT01632605|m-TOR inhibition|m-tor inhibition
452228|NCT01632553|Observation|observation
452229|NCT01632553|Domestic Violence|domestic violence
452230|NCT01632553|Partner Abuse|partner abuse
452231|NCT01632553|Spousal Abuse|spousal abuse
452232|NCT01632553|Battered Women|battered women
452233|NCT01632553|Abused Women|abused women
452234|NCT01632553|Cortisol|cortisol
452235|NCT01632553|Mental Health|mental health
452236|NCT01632553|Depression|depression
452237|NCT01632553|Anxiety|anxiety
452238|NCT01632553|Posttraumatic Stress Disorders|posttraumatic stress disorders
452239|NCT01632527|Age-Related Macular Degeneration|age-related macular degeneration
452240|NCT01632527|Dry AMD with GA|dry amd with ga
452241|NCT01632527|Geographic Atrophy of Age-Related Macular Degeneration|geographic atrophy of age-related macular degeneration
452242|NCT01632527|Stem Cell Transplantation|stem cell transplantation
452243|NCT01632527|Stem Cell transplant|stem cell transplant
452244|NCT01632527|Stem cells for AMD|stem cells for amd
452245|NCT01632527|Human neural stem cells|human neural stem cells
452246|NCT01632527|multipotent stem cells|multipotent stem cells
452247|NCT01632527|Macular Degeneration|macular degeneration
452248|NCT01632527|Dry AMD|dry amd
452249|NCT01632527|Human central nervous system stemcells|human central nervous system stemcells
452250|NCT01632527|dry age-related macular degeneration|dry age-related macular degeneration
452251|NCT01632514|hypocalcemia|hypocalcemia
452252|NCT01632514|vitamin D deficiency|vitamin d deficiency
452253|NCT01632514|cholecalciferol|cholecalciferol
452254|NCT01632514|thyroidectomy|thyroidectomy
452255|NCT01632488|Irritable Bowel Syndrome|irritable bowel syndrome
452256|NCT01632488|Inflammatory Bowel Disease|inflammatory bowel disease
452257|NCT01632488|Confocal Laser Endomicroscopy|confocal laser endomicroscopy
452258|NCT01632475|Human umbilical cord blood-derived mesenchymal stem cells|human umbilical cord blood-derived mesenchymal stem cells
452259|NCT01632475|Premature infants|premature infants
452260|NCT01632475|Bronchopulmonary dysplasia|bronchopulmonary dysplasia
452262|NCT01632475|Lung diseases|lung diseases
452263|NCT01632475|Hyperplasia|hyperplasia
452264|NCT01632475|Ventilator-induced lung injury|ventilator-induced lung injury
452265|NCT01632475|Respiratory lung diseases|respiratory lung diseases
452266|NCT01632475|Pathologic Processes|pathologic processes
452267|NCT01632475|Infant, Premature, Diseases|infant, premature, diseases
452268|NCT01632475|Infant, Newborn, Diseases|infant, newborn, diseases
452269|NCT01632462|Crohn's disease|crohn's disease
452270|NCT01632462|VSL#3|vsl#3
452271|NCT01632462|probiotics|probiotics
452272|NCT01632462|metabolic profile|metabolic profile
452273|NCT01632449|bioequivalence|bioequivalence
452274|NCT01632436|Hepatic impairment|hepatic impairment
452275|NCT01632436|Metastatic Cancer|metastatic cancer
452276|NCT01632410|autonomic nerve system|autonomic nerve system
452277|NCT01632410|post stroke|post stroke
452278|NCT01632410|focus of study: to describe the autonomic nerve system function post stroke|focus of study: to describe the autonomic nerve system function post stroke
452279|NCT01632410|autonomic nervous system|autonomic nervous system
452280|NCT01632397|PrEP|prep
452281|NCT01632397|HIV|hiv
452282|NCT01632397|Adherence|adherence
452283|NCT01632397|MSM|msm
452284|NCT01632397|Men having sex with men|men having sex with men
452285|NCT01632384|Smoker|smoker
452286|NCT01632384|Non-Smoker|non-smoker
452287|NCT01632384|Healthy|healthy
452288|NCT01632384|Drug free|drug free
452289|NCT01632384|MRI|mri
452290|NCT01632371|In-stent Restenosis|in-stent restenosis
452291|NCT01632371|Drug Eluting Stent|drug eluting stent
452292|NCT01632371|Paclitaxel Coated Balloon|paclitaxel coated balloon
452293|NCT01632371|Scoring Balloon|scoring balloon
452294|NCT01632371|Cutting Balloon|cutting balloon
452295|NCT01632371|Angiographic follow-up|angiographic follow-up
452296|NCT01632371|Optical coherence tomography (OCT)|optical coherence tomography (oct)
452297|NCT01632358|safety|safety
452298|NCT01632358|tolerability|tolerability
452299|NCT01632358|pharmacokinetics|pharmacokinetics
452300|NCT01632280|Obesity|obesity
452301|NCT01632280|Gastric Banding|gastric banding
452302|NCT01632280|Transcranial Direct Current Stimulation|transcranial direct current stimulation
452303|NCT01632241|Systemic Lupus Erythematosus|systemic lupus erythematosus
452304|NCT01632241|African Continental Ancestry Group|african continental ancestry group
452305|NCT01632241|Autoimmune Disease|autoimmune disease
452306|NCT01632241|Antibodies|antibodies
452307|NCT01632241|Minority Groups|minority groups
452308|NCT01632241|Black Race|black race
452309|NCT01632241|African Americans|african americans
452310|NCT01632241|SLE|sle
452311|NCT01632241|Belimumab|belimumab
452312|NCT01632241|Lupus|lupus
452313|NCT01632215|gabapentine|gabapentine
452314|NCT01632215|postoperative pain|postoperative pain
452315|NCT01632202|submucosal myomas|submucosal myomas
452316|NCT01632202|intrauterine adhesions|intrauterine adhesions
452317|NCT01632202|hysteroscopic myomectomy|hysteroscopic myomectomy
452318|NCT01632202|seprafilm|seprafilm
452319|NCT01632189|Varenicline|varenicline
452320|NCT01632189|PET imaging|pet imaging
452321|NCT01632189|[11C]-(+)-PHNO PET|[11c]-(+)-phno pet
452322|NCT01632189|neuroimaging in smokers|neuroimaging in smokers
452323|NCT01632176|dating abuse|dating abuse
452324|NCT01632176|dating violence|dating violence
452325|NCT01632176|domestic violence|domestic violence
452326|NCT01632176|sexual violence|sexual violence
452327|NCT01632176|sexual assault|sexual assault
452328|NCT01632176|youth violence|youth violence
452329|NCT01632176|underage alcohol use|underage alcohol use
452330|NCT01632176|alcohol use|alcohol use
452331|NCT01632098|psychosocial|psychosocial
452332|NCT01632098|healthcare|healthcare
452333|NCT01632098|co-morbidities|co-morbidities
452334|NCT01632098|extremely obese adolescents|extremely obese adolescents
452335|NCT01632059|ADMA|adma
452336|NCT01632059|DDAH II|ddah ii
452337|NCT01632059|SAPS|saps
452338|NCT01632059|SOFA|sofa
452339|NCT01632059|Sepsis|sepsis
452340|NCT01632059|Procalcitonin|procalcitonin
452341|NCT01632059|ICU|icu
452342|NCT01632059|mortality|mortality
452343|NCT01632059|length of stay|length of stay
452344|NCT01632046|peritoneal dialysis|peritoneal dialysis
452345|NCT01632046|bicarbonate/lactate buffer|bicarbonate/lactate buffer
452346|NCT01632046|peritoneal transport capacity|peritoneal transport capacity
452347|NCT01632046|ultrafiltration|ultrafiltration
452348|NCT01632046|children|children
452349|NCT01632033|Peripheral artery disease|peripheral artery disease
452350|NCT01632033|claudication|claudication
452351|NCT01632033|walking|walking
452352|NCT01632033|questionnaire|questionnaire
452353|NCT01632020|colorectal tumor|colorectal tumor
452354|NCT01632020|colorectal cancer|colorectal cancer
452355|NCT01632020|colorectal carcinoma|colorectal carcinoma
452356|NCT01632020|neoplasms, colorectal|neoplasms, colorectal
452357|NCT01632020|Metformin|metformin
452358|NCT01631994|metoclopramide video capsule endoscopy gastric transit time|metoclopramide video capsule endoscopy gastric transit time
452359|NCT01631955|Acute cystitis|acute cystitis
452360|NCT01631955|Antibiotics|antibiotics
452361|NCT01631955|Quality of life|quality of life
452362|NCT01631929|Diabetes|diabetes
452363|NCT01631929|Ketoacidosis|ketoacidosis
452364|NCT01631929|Children|children
452365|NCT01631916|community-acquired pneumonia|community-acquired pneumonia
452366|NCT01631916|children|children
452367|NCT01631916|respiratory infections|respiratory infections
452368|NCT01631864|Hypertension, obesity, insulin sensitivity, lipolysis, LCZ696|hypertension, obesity, insulin sensitivity, lipolysis, lcz696
452369|NCT01631851|Autism|autism
452370|NCT01631851|Irritability|irritability
452371|NCT01631851|Disruptive Behavior|disruptive behavior
452372|NCT01631851|Aggression|aggression
452373|NCT01631851|Behavior Therapy|behavior therapy
452374|NCT01631851|Cognitive Behavioral Therapy|cognitive behavioral therapy
452375|NCT01631838|Tocotrienols|tocotrienols
452376|NCT01631838|Platelet aggregation|platelet aggregation
452377|NCT01631838|Metabolic syndrome|metabolic syndrome
452378|NCT01631838|Platelet activation|platelet activation
452379|NCT01631838|Thrombosis|thrombosis
452380|NCT01631825|SPM 962|spm 962
452381|NCT01631825|rotigotine|rotigotine
452382|NCT01631825|Parkinson's disease|parkinson's disease
452383|NCT01631825|concomitant use of L-dopa|concomitant use of l-dopa
452384|NCT01631812|SPM 962|spm 962
452385|NCT01631812|rotigotine|rotigotine
452386|NCT01631812|Parkinson's disease|parkinson's disease
452387|NCT01631812|concomitant use of L-dopa|concomitant use of l-dopa
452388|NCT01631799|epidural anesthesia|epidural anesthesia
452389|NCT01631799|femoral block|femoral block
452390|NCT01631799|patient control analgesia|patient control analgesia
452391|NCT01631786|Ovaries|ovaries
452392|NCT01631786|Imaging|imaging
452393|NCT01631786|Ultrasonography|ultrasonography
452394|NCT01631786|Synchrotron|synchrotron
452395|NCT01631786|Histology|histology
452396|NCT01631773|Aspirin-exacerbated respiratory disease|aspirin-exacerbated respiratory disease
452397|NCT01631773|Nasal polyp|nasal polyp
452398|NCT01631760|Asthma|asthma
452399|NCT01631760|Asthma Exacerbations|asthma exacerbations
452400|NCT01631747|Pregnancy|pregnancy
452401|NCT01631747|Weight gain|weight gain
452402|NCT01631747|Obesity|obesity
452403|NCT01631747|Pregnancy and weight gain|pregnancy and weight gain
452404|NCT01631721|adolescent couple decision-making|adolescent couple decision-making
452405|NCT01631721|parenting practices|parenting practices
452406|NCT01631721|sexual risk behavior|sexual risk behavior
452407|NCT01631708|Hereditary haemochromatosis|hereditary haemochromatosis
452408|NCT01631708|Moderate iron overload|moderate iron overload
452409|NCT01631708|Serum ferritin|serum ferritin
452410|NCT01631708|Treatment|treatment
452411|NCT01631682|Posttraumatic Stress Disorder|posttraumatic stress disorder
452412|NCT01631682|PTSD|ptsd
452413|NCT01631682|Anxiety|anxiety
452414|NCT01631682|Fear of spiders|fear of spiders
452415|NCT01631682|Reconsolidation|reconsolidation
452416|NCT01631682|Reconsolidation blockade|reconsolidation blockade
452417|NCT01631669|Ossification|ossification
452418|NCT01631669|Heterotopic Ossification|heterotopic ossification
452419|NCT01631656|Rosacea, Laser, Finacea Gel, Azelaic Acid,|rosacea, laser, finacea gel, azelaic acid,
452420|NCT01631643|Blood glucose monitor|blood glucose monitor
452421|NCT01631643|Pattern management|pattern management
452422|NCT01631643|Pattern guide|pattern guide
452423|NCT01631643|Education|education
452424|NCT01631630|Alcohol|alcohol
452425|NCT01631630|Alcohol Dependence|alcohol dependence
452426|NCT01631630|Alcohol Use|alcohol use
452427|NCT01631630|Nicotine Dependence|nicotine dependence
452428|NCT01631630|Nicotine|nicotine
452429|NCT01631617|Investigator-Blinded|investigator-blinded
452430|NCT01631617|Skin Biopsy|skin biopsy
452431|NCT01631617|Randomized|randomized
452432|NCT01631617|Antibiotics|antibiotics
452433|NCT01631617|Topical|topical
452434|NCT01631604|risk of falling|risk of falling
452435|NCT01631604|gait patterns|gait patterns
452436|NCT01631604|muscle activity|muscle activity
452437|NCT01631604|fall prevention|fall prevention
452438|NCT01631604|motor impairment|motor impairment
452439|NCT01631578|mitochondrial injection|mitochondrial injection
452440|NCT01631565|Palliative Care|palliative care
452441|NCT01631565|Survival|survival
452442|NCT01631565|Quality of life|quality of life
452443|NCT01631552|Gastric adenocarcinoma (GC)|gastric adenocarcinoma (gc)
452444|NCT01631552|Esophageal cancer (EC)|esophageal cancer (ec)
452445|NCT01631552|Hepatocellular carcinoma (HCC)|hepatocellular carcinoma (hcc)
452446|NCT01631552|Non-small cell lung cancer (NSCLC)|non-small cell lung cancer (nsclc)
452447|NCT01631552|Small cell lung cancer (SCLC)|small cell lung cancer (sclc)
452448|NCT01631552|Ovarian epithelial cancer (OEC)|ovarian epithelial cancer (oec)
452449|NCT01631552|Triple-negative breast cancer (TNBC)|triple-negative breast cancer (tnbc)
452450|NCT01631552|Hormone-refractory prostate cancer (HRPC)|hormone-refractory prostate cancer (hrpc)
452451|NCT01631552|Head and neck cancers- squamous cell (SCCHN)|head and neck cancers- squamous cell (scchn)
452452|NCT01631552|Renal cell cancer -clear cell (RCC)|renal cell cancer -clear cell (rcc)
452453|NCT01631552|Bladder cancer|bladder cancer
452454|NCT01631552|Endometrial Cancer|endometrial cancer
452455|NCT01631552|Cervical Cancer|cervical cancer
452456|NCT01631552|Metastatic non-triple negative breast cancer|metastatic non-triple negative breast cancer
452457|NCT01631552|Glioblastoma multiforme|glioblastoma multiforme
452458|NCT01631552|Follicular thyroid cancer|follicular thyroid cancer
452459|NCT01631552|pancreatic cancer|pancreatic cancer
452460|NCT01631539|chemoembolization|chemoembolization
452461|NCT01631539|DC Bead™|dc bead™
452462|NCT01631539|Irinotecan|irinotecan
452463|NCT01631539|Cetuximab|cetuximab
452464|NCT01631539|5FU/LV|5fu/lv
452465|NCT01631539|KRAS|kras
452466|NCT01631539|metastatic colorectal cancer|metastatic colorectal cancer
452467|NCT01631526|Lung cancer|lung cancer
452468|NCT01631526|vitamin D|vitamin d
452469|NCT01631526|pharmacokinetics|pharmacokinetics
452470|NCT01631513|Chronic Low Back Pain|chronic low back pain
452471|NCT01631513|Osteoarthritis Pain In The Hip or Knee|osteoarthritis pain in the hip or knee
452472|NCT01631513|Oxycodone|oxycodone
452473|NCT01631513|Morphine, Hydrocodone|morphine, hydrocodone
452474|NCT01631513|Tapentadol|tapentadol
452475|NCT01631513|NUCYNTA ER|nucynta er
452476|NCT01631500|Integrative medicine|integrative medicine
452477|NCT01631500|Acupuncture|acupuncture
452478|NCT01631500|Minor mental health problems|minor mental health problems
452479|NCT01631500|Medically unexplained symptoms|medically unexplained symptoms
452480|NCT01631500|Minor mental health problems (e.g. minor depression and anxiety) and Medically unexplained symptoms (e.g. IBS, fibromyalgia, etc)|minor mental health problems (e.g. minor depression and anxiety) and medically unexplained symptoms (e.g. ibs, fibromyalgia, etc)
452481|NCT01631487|Healthy|healthy
452482|NCT01631487|JNJ-39439335|jnj-39439335
452483|NCT01631487|Japanese|japanese
452484|NCT01631487|Caucasian|caucasian
452485|NCT01631487|Male|male
452486|NCT01631474|Intrepid|intrepid
452487|NCT01631474|acne|acne
452488|NCT01631474|antiandrogen|antiandrogen
452489|NCT01631461|pain|pain
452490|NCT01631461|breast feeding|breast feeding
452491|NCT01631461|yeast|yeast
452492|NCT01631461|candida albicance|candida albicance
452493|NCT01631461|staphylococcus aureus|staphylococcus aureus
452494|NCT01631461|Signs and symptoms|signs and symptoms
452495|NCT01631448|Fibrin sealant|fibrin sealant
452496|NCT01631448|renal transplantation|renal transplantation
452497|NCT01631448|surgical complication|surgical complication
452498|NCT01631435|All subjects will have evidence of active symptoms associated with Crohn's disease|all subjects will have evidence of active symptoms associated with crohn's disease
452499|NCT01631409|clinical research|clinical research
452500|NCT01631409|coronary heart disease|coronary heart disease
452501|NCT01631409|cardiac shock wave therapy|cardiac shock wave therapy
452502|NCT01631409|ischemic heart disease|ischemic heart disease
452503|NCT01631409|myocardial revascularization|myocardial revascularization
452504|NCT01631409|observational research|observational research
452505|NCT01631409|prospective research|prospective research
452506|NCT01631396|Morbid obesity|morbid obesity
452507|NCT01631396|Bariatric Surgery|bariatric surgery
452508|NCT01631396|Neuromuscular block reversal|neuromuscular block reversal
452509|NCT01631383|Cocaine Use|cocaine use
452510|NCT01631305|Euthyroid Sick Syndromes|euthyroid sick syndromes
452511|NCT01631305|Thyroxine|thyroxine
452512|NCT01631305|Intensive care|intensive care
452513|NCT01631279|NSCLC|nsclc
452514|NCT01631279|non-small cell lung cancer|non-small cell lung cancer
452515|NCT01631279|non-squamous, non-small cell lung cancer|non-squamous, non-small cell lung cancer
452516|NCT01631279|solid tumors|solid tumors
452517|NCT01631279|lung cancer|lung cancer
452518|NCT01631240|Sodium|sodium
452519|NCT01631240|Potassium|potassium
452520|NCT01631240|Iodine|iodine
452521|NCT01631240|Creatinine|creatinine
452522|NCT01631214|Osteoporosis, Osteoporosis-postmenopausal, Bone Diseases-Metabolic, Bone Diseases, Musculoskeletal Diseases|osteoporosis, osteoporosis-postmenopausal, bone diseases-metabolic, bone diseases, musculoskeletal diseases
452523|NCT01631201|Chlamydia|chlamydia
452524|NCT01631188|Minimally Invasive Surgery|minimally invasive surgery
452525|NCT01631188|Port Access Surgery|port access surgery
452526|NCT01631188|Heart|heart
452527|NCT01631188|Pacing|pacing
452528|NCT01631188|Wire|wire
452529|NCT01631188|MICS|mics
452530|NCT01631188|Cardiac Bypass|cardiac bypass
452531|NCT01631188|Epicardial pacing|epicardial pacing
452532|NCT01631188|pacing catheter|pacing catheter
452533|NCT01631188|pacing wire|pacing wire
452534|NCT01631188|pacing swan|pacing swan
452535|NCT01631188|pacing pulmonary catheter|pacing pulmonary catheter
452536|NCT01631188|Pulmonary Endovent|pulmonary endovent
452537|NCT01631188|Catheter|catheter
452538|NCT01631188|Aortic Valve Surgery|aortic valve surgery
452539|NCT01631188|Edwards Lifesciences|edwards lifesciences
452540|NCT01631175|sarcoma|sarcoma
452541|NCT01631175|distress|distress
452542|NCT01631175|tumor|tumor
452543|NCT01631175|quality of life|quality of life
452544|NCT01631175|cancer|cancer
452545|NCT01631162|Asthma|asthma
452546|NCT01631162|COPD|copd
452547|NCT01631149|urology|urology
452548|NCT01631149|muscle relaxation|muscle relaxation
452549|NCT01631149|laparoscopy|laparoscopy
452550|NCT01631149|anesthesia|anesthesia
452551|NCT01631149|rocuronium|rocuronium
452552|NCT01631136|Non Small Cell Lung Cancer|non small cell lung cancer
452553|NCT01631136|IFCT|ifct
452554|NCT01631136|Maintenance|maintenance
452555|NCT01631136|Switch|switch
452556|NCT01631123|Twins|twins
452557|NCT01631123|High carbohydrat diet|high carbohydrat diet
452558|NCT01631123|High fat diet|high fat diet
452559|NCT01631123|Isocaloric|isocaloric
452560|NCT01631123|Nutrigenomics|nutrigenomics
452561|NCT01631110|Influenza|influenza
452562|NCT01631110|Virus|virus
452563|NCT01631110|Vaccination|vaccination
452564|NCT01631110|Inflexal V|inflexal v
452565|NCT01631084|Diabetes|diabetes
452566|NCT01631084|Structured care|structured care
452567|NCT01631071|Influenza|influenza
452568|NCT01631071|Virus|virus
452569|NCT01631071|Vaccination|vaccination
452570|NCT01631071|Virosomal influenza vaccine|virosomal influenza vaccine
452571|NCT01631058|kidney transplantation|kidney transplantation
452572|NCT01631058|chronic renal failure|chronic renal failure
452573|NCT01631058|immunosuppressive therapy|immunosuppressive therapy
452574|NCT01631058|elderly|elderly
452575|NCT01631058|pharmacokinetic|pharmacokinetic
452576|NCT01631058|tacrolimus|tacrolimus
452577|NCT01631058|everolimus|everolimus
452578|NCT01631058|mycophenolate sodium|mycophenolate sodium
452579|NCT01631058|serious adverse events|serious adverse events
452580|NCT01631058|biopsy|biopsy
452581|NCT01631058|Cystatin C|cystatin c
452582|NCT01631058|metabolic effects|metabolic effects
452583|NCT01631058|Left Ventricular Mass (LVM)|left ventricular mass (lvm)
452584|NCT01631058|Left Ventricle Ejection Fraction|left ventricle ejection fraction
452585|NCT01631045|Obesity|obesity
452586|NCT01631032|Allergic rhinitis|allergic rhinitis
452587|NCT01631032|Chinese herbal products|chinese herbal products
452588|NCT01631032|Qi deficiency|qi deficiency
452589|NCT01631019|Chronic Obstructive Pulmonary Disease|chronic obstructive pulmonary disease
452590|NCT01631019|Pulmonary Rehabilitation|pulmonary rehabilitation
452591|NCT01631019|Mobile phone|mobile phone
452592|NCT01631019|Biomarker|biomarker
452593|NCT01631006|CPAP|cpap
452594|NCT01631006|Hypertrophic cardiomyopathy|hypertrophic cardiomyopathy
452595|NCT01631006|Blood Pressure|blood pressure
452596|NCT01631006|The focus of the present study is to evaluate the acute hemodynamic effects of CPAP in patients with non-obstructive and obstructive hypertrophic cardiomyopathy|the focus of the present study is to evaluate the acute hemodynamic effects of cpap in patients with non-obstructive and obstructive hypertrophic cardiomyopathy
452597|NCT01630993|umbilical cord milking|umbilical cord milking
452598|NCT01630993|umbilical cord stripping|umbilical cord stripping
452599|NCT01630993|umbilical cord clamping|umbilical cord clamping
452600|NCT01630993|placental transfusion|placental transfusion
452601|NCT01630993|placental residual blood volume|placental residual blood volume
452602|NCT01630980|Systematic review and meta-analysis|systematic review and meta-analysis
452603|NCT01630980|Evidence-based medicine (EBM)|evidence-based medicine (ebm)
452604|NCT01630980|Evidence-based nutrition (EBN)|evidence-based nutrition (ebn)
452605|NCT01630980|Clinical practice guidelines|clinical practice guidelines
452606|NCT01630980|Clinical trials|clinical trials
452607|NCT01630980|Tree nuts|tree nuts
452608|NCT01630980|Cardiometabolic risk factors|cardiometabolic risk factors
452609|NCT01630980|Triglycerides|triglycerides
452610|NCT01630980|Cholesterol|cholesterol
452611|NCT01630980|Glycemic control|glycemic control
452612|NCT01630980|Insulin resistance|insulin resistance
452613|NCT01630980|Body weight|body weight
452614|NCT01630980|Blood pressure|blood pressure
452615|NCT01630967|castrate resistance|castrate resistance
452616|NCT01630967|PSA progression|psa progression
452617|NCT01630967|LHRH antagonism|lhrh antagonism
452618|NCT01630954|Hydatidiform mole|hydatidiform mole
452619|NCT01630954|Molar pregnancy|molar pregnancy
452620|NCT01630954|H Mole|h mole
452621|NCT01630954|GTN|gtn
452622|NCT01630954|GTD|gtd
452623|NCT01630941|Osteoarthritis of the hip|osteoarthritis of the hip
452624|NCT01630941|Uncemented Total Hip Arthroplasty|uncemented total hip arthroplasty
452625|NCT01630941|DXA|dxa
452626|NCT01630941|BMD|bmd
452627|NCT01630941|PET|pet
452628|NCT01630941|CT|ct
452629|NCT01630941|Biochemical bone markers|biochemical bone markers
452630|NCT01630928|Renal denervation|renal denervation
452631|NCT01630928|Resistant Hypertension|resistant hypertension
452632|NCT01630928|Cardiovascular disease|cardiovascular disease
452633|NCT01630928|Diabetes|diabetes
452634|NCT01630928|Quality of LIfe|quality of life
452635|NCT01630889|Kidney|kidney
452636|NCT01630889|ESRD|esrd
452637|NCT01630889|End Stage Renal Disease|end stage renal disease
452638|NCT01630889|Anemia|anemia
452639|NCT01630889|Oral anemia treatment|oral anemia treatment
452640|NCT01630889|Hemoglobin levels|hemoglobin levels
452641|NCT01630889|Hemodialysis|hemodialysis
452642|NCT01630889|CKD|ckd
452643|NCT01630889|Chronic Kidney Disease|chronic kidney disease
452644|NCT01630889|Peritoneal|peritoneal
452645|NCT01630889|HD|hd
452646|NCT01630889|PD|pd
452647|NCT01630889|Hb|hb
452648|NCT01630889|Erythropoietin|erythropoietin
452649|NCT01630889|Blood count|blood count
452650|NCT01630876|Epiretinal membrane|epiretinal membrane
452651|NCT01630876|triamcinolone acetonide|triamcinolone acetonide
452652|NCT01630863|Central serous chorioretinopathy|central serous chorioretinopathy
452653|NCT01630863|photodynamic therapy|photodynamic therapy
452654|NCT01630863|safe and effective dose|safe and effective dose
452655|NCT01630824|education program|education program
452656|NCT01630824|kidney transplantation|kidney transplantation
452657|NCT01630824|renal transplantation|renal transplantation
452658|NCT01630824|evaluation|evaluation
452659|NCT01630811|Adults|adults
452660|NCT01630798|barrett's esophgus|barrett's esophgus
452661|NCT01630798|High grade dysplasia|high grade dysplasia
452662|NCT01630798|Esophageal adenocarcinoma|esophageal adenocarcinoma
452663|NCT01630772|women with preeclampsia|women with preeclampsia
452664|NCT01630772|physical therapy|physical therapy
452665|NCT01630772|maternal-fetal hemodynamics|maternal-fetal hemodynamics
452666|NCT01630772|perinatal outcomes|perinatal outcomes
452667|NCT01630759|Gestational diabetes|gestational diabetes
452668|NCT01630759|telemonitoring|telemonitoring
452669|NCT01630759|telehealth|telehealth
452670|NCT01630759|feasibility study|feasibility study
452671|NCT01630733|Metastatic|metastatic
452672|NCT01630733|Stage IV|stage iv
452673|NCT01630733|Advanced|advanced
452674|NCT01630733|lung cancer|lung cancer
452675|NCT01630720|ascorbic acid|ascorbic acid
452676|NCT01630720|cholecalciferol|cholecalciferol
452677|NCT01630720|vitamin C|vitamin c
452678|NCT01630720|vitamin D|vitamin d
452679|NCT01630720|hypovitaminosis|hypovitaminosis
452680|NCT01630720|mood|mood
452681|NCT01630720|distress|distress
452682|NCT01630694|Difficult airway management|difficult airway management
452683|NCT01630694|anesthesia|anesthesia
452684|NCT01630694|difficult intubation|difficult intubation
452685|NCT01630629|Lactation|lactation
452686|NCT01630629|Weaning|weaning
452687|NCT01630629|Bone Density|bone density
452688|NCT01630629|Endocrine|endocrine
452689|NCT01630629|Physiological Properties|physiological properties
452690|NCT01630629|Bone Metabolism|bone metabolism
452691|NCT01630590|Prostate Cancer|prostate cancer
452692|NCT01630590|Metastatic Prostate Cancer|metastatic prostate cancer
452693|NCT01630590|Prostate adenocarcinoma|prostate adenocarcinoma
452694|NCT01630590|Androgen-Dependent Prostate Cancer|androgen-dependent prostate cancer
452695|NCT01630590|Cabozantinib|cabozantinib
452696|NCT01630590|XL 184|xl 184
452697|NCT01630590|Androgen Ablation|androgen ablation
452698|NCT01630577|acute circulatory failure|acute circulatory failure
452699|NCT01630577|hemodynamic stability|hemodynamic stability
452700|NCT01630577|hypovolemia|hypovolemia
452701|NCT01630551|tears|tears
452702|NCT01630551|dry eyes|dry eyes
452703|NCT01630551|ocular surface disease|ocular surface disease
452704|NCT01630538|Transplantation|transplantation
452705|NCT01630525|Alzheimer's disease|alzheimer's disease
452706|NCT01630525|neurodegenerative signs|neurodegenerative signs
452707|NCT01630499|Cancer|cancer
452708|NCT01630499|Breast cancer|breast cancer
452709|NCT01630499|Breast cancer prevention|breast cancer prevention
452710|NCT01630499|Breast cancer recurrence|breast cancer recurrence
452711|NCT01630499|Weight loss|weight loss
452712|NCT01630499|Weight management|weight management
452713|NCT01630499|Overweight|overweight
452714|NCT01630499|Obesity|obesity
452715|NCT01630486|renal progression|renal progression
452716|NCT01630486|mortality|mortality
452717|NCT01630486|complications|complications
452718|NCT01630486|risk factors|risk factors
452719|NCT01630486|role of biochemical parameters|role of biochemical parameters
452720|NCT01630486|genetic influence|genetic influence
452721|NCT01630473|Tooth crowding|tooth crowding
452722|NCT01630473|Teeth malpositions|teeth malpositions
452723|NCT01630473|corticotomy|corticotomy
452724|NCT01630473|orthodontics|orthodontics
452725|NCT01630473|tooth movement|tooth movement
452726|NCT01630473|periodontal parameters|periodontal parameters
452727|NCT01630460|Craniometaphyseal dysplasia|craniometaphyseal dysplasia
452728|NCT01630460|bone|bone
452729|NCT01630460|hyperostosis|hyperostosis
452730|NCT01630460|osteoblast|osteoblast
452731|NCT01630460|osteoclast|osteoclast
452732|NCT01630447|cherubism|cherubism
452733|NCT01630447|bone|bone
452734|NCT01630447|autoinflammatory disorder|autoinflammatory disorder
452735|NCT01630447|osteoblast|osteoblast
452736|NCT01630447|osteoclast|osteoclast
452737|NCT01630447|mandible|mandible
452738|NCT01630447|maxilla|maxilla
452739|NCT01630421|Aplasia cutis congenita|aplasia cutis congenita
452740|NCT01630421|bone|bone
452741|NCT01630421|osteoblast|osteoblast
452742|NCT01630421|osteoclast|osteoclast
452743|NCT01630421|skin|skin
452744|NCT01630408|Preserved ejection fraction|preserved ejection fraction
452745|NCT01630408|Left ventricular hypertrophy|left ventricular hypertrophy
452746|NCT01630408|Activated vitamin D|activated vitamin d
452747|NCT01630408|Cardiac lusitropic effect|cardiac lusitropic effect
452748|NCT01630408|Hospitalizations|hospitalizations
452749|NCT01630356|Secondhand Smoke|secondhand smoke
452750|NCT01630356|Nicotine|nicotine
452751|NCT01630356|Indoor Air Pollution|indoor air pollution
452752|NCT01630343|Geriatric hip fracture|geriatric hip fracture
452753|NCT01630343|pain management|pain management
452754|NCT01630304|telecommunications|telecommunications
452755|NCT01630304|Africa|africa
452756|NCT01630304|randomized controlled trial|randomized controlled trial
452757|NCT01630278|Prematurity|prematurity
452758|NCT01630278|patent ductus arteriosus|patent ductus arteriosus
452759|NCT01630278|ibuprofen|ibuprofen
452760|NCT01630265|Discharge Instructions|discharge instructions
452761|NCT01630265|Video Discharge Instructions|video discharge instructions
452762|NCT01630265|Video|video
452763|NCT01630265|Emergency Department Discharge Instructions|emergency department discharge instructions
452764|NCT01630265|ED Discharge|ed discharge
452765|NCT01630226|BRCA1|brca1
452766|NCT01630226|pathological complete response|pathological complete response
452767|NCT01630226|neoadjuvant chemotherapy|neoadjuvant chemotherapy
452768|NCT01630213|Vitamin D3|vitamin d3
452769|NCT01630213|Left ventricular mass|left ventricular mass
452770|NCT01630213|Echocardiography|echocardiography
452771|NCT01630213|Left ventricular systolic and diastolic function|left ventricular systolic and diastolic function
452772|NCT01630200|COPD|copd
452773|NCT01630200|comorbidity|comorbidity
452774|NCT01630200|arterial stiffness|arterial stiffness
452775|NCT01630200|roflumilast|roflumilast
452776|NCT01630187|Carbetocin|carbetocin
452777|NCT01630187|Uterotonic drug|uterotonic drug
452778|NCT01630187|elective cesarean section|elective cesarean section
452779|NCT01630174|IMRT,Pemetrexed,Cisplatin , Esophageal Cancer|imrt,pemetrexed,cisplatin , esophageal cancer
452780|NCT01630161|relapse|relapse
452781|NCT01630161|prevention|prevention
452782|NCT01630161|smoking|smoking
452783|NCT01630161|habit|habit
452784|NCT01630161|Forever Free|forever free
452785|NCT01630148|Thromboprophylaxis|thromboprophylaxis
452786|NCT01630148|Bemiparin|bemiparin
452787|NCT01630148|Low Molecular Weight Heparin|low molecular weight heparin
452788|NCT01630148|Major Gynaecological Surgeries|major gynaecological surgeries
452789|NCT01630148|Benign Gynaecological Surgeries|benign gynaecological surgeries
452790|NCT01630122|Trans-thoracic Needle Biopsy (TNB)|trans-thoracic needle biopsy (tnb)
452791|NCT01630122|Endobronchial Ultrasound Guided Transbronchial Needle Aspiration (EBUS-TBNA)|endobronchial ultrasound guided transbronchial needle aspiration (ebus-tbna)
452792|NCT01630122|Trans-esophageal Ultrasound Scanning with FNA (EUS-FNA)|trans-esophageal ultrasound scanning with fna (eus-fna)
452793|NCT01630083|IMAB362|imab362
452794|NCT01630083|ASP8951|asp8951
452795|NCT01630083|zolbetuximab|zolbetuximab
452796|NCT01630070|Critical limb ischemia|critical limb ischemia
452797|NCT01630070|Rest pain|rest pain
452798|NCT01630070|Minor tissue loss|minor tissue loss
452799|NCT01630070|Below the knee|below the knee
452800|NCT01630031|atrial fibrillation|atrial fibrillation
452801|NCT01630031|paroxysmal|paroxysmal
452802|NCT01630031|contact force|contact force
452803|NCT01630031|radiofrequency|radiofrequency
452804|NCT01630031|catheter ablation|catheter ablation
452805|NCT01630031|pulmonary vein isolation|pulmonary vein isolation
452806|NCT01630031|recurrence|recurrence
452807|NCT01630031|follow-up|follow-up
452808|NCT01630018|Epithelial Ovarian Cancer|epithelial ovarian cancer
452809|NCT01630018|Belotecan|belotecan
452810|NCT01630018|Topotecan|topotecan
452811|NCT01629992|Vomiting|vomiting
452812|NCT01629992|Nausea|nausea
452813|NCT01629992|Postoperative pain|postoperative pain
452814|NCT01629992|Feeling|feeling
452815|NCT01629966|Generalized Anxiety Disorder|generalized anxiety disorder
452816|NCT01629966|GAD|gad
452817|NCT01629940|X-linked Hypohidrotic Ectodermal Dysplasia|x-linked hypohidrotic ectodermal dysplasia
452818|NCT01629940|Hypohidrotic Ectodermal Dysplasia|hypohidrotic ectodermal dysplasia
452819|NCT01629940|XLHED|xlhed
452820|NCT01629940|HED|hed
452821|NCT01629927|X-linked hypohidrotic ectodermal dysplasia|x-linked hypohidrotic ectodermal dysplasia
452822|NCT01629927|Hypohidrotic ectodermal dysplasia|hypohidrotic ectodermal dysplasia
452823|NCT01629927|HED|hed
452824|NCT01629927|XLHED|xlhed
452825|NCT01629914|Attention-deficit/hyperactivity disorder|attention-deficit/hyperactivity disorder
452826|NCT01629914|executive functioning|executive functioning
452827|NCT01629914|mindfulness meditation|mindfulness meditation
452828|NCT01629914|magnetic resonance imaging|magnetic resonance imaging
452829|NCT01629914|healthy|healthy
452830|NCT01629901|Healthy volunteer|healthy volunteer
452831|NCT01629888|Plant sterol|plant sterol
452832|NCT01629888|Hypercholesterolemia|hypercholesterolemia
452833|NCT01629888|dairy|dairy
452834|NCT01629810|Motion platform at appropriate settings.|motion platform at appropriate settings.
452835|NCT01629810|Relief of pain.|relief of pain.
452836|NCT01629810|Improvement in quality of life, cognition, and mood.|improvement in quality of life, cognition, and mood.
452837|NCT01629810|Effects of WBPA on cognition, mood, behavior, and functioning.|effects of wbpa on cognition, mood, behavior, and functioning.
452838|NCT01629810|Dose response effect .|dose response effect .
452839|NCT01629810|Gather data for long-term (2 year) study|gather data for long-term (2 year) study
452840|NCT01629745|B-cell childhood acute lymphoblastic leukemia|b-cell childhood acute lymphoblastic leukemia
452841|NCT01629745|untreated childhood acute lymphoblastic leukemia|untreated childhood acute lymphoblastic leukemia
452842|NCT01629693|contact lenses|contact lenses
452843|NCT01629693|myopia|myopia
452844|NCT01629693|astigmatism|astigmatism
452845|NCT01629680|moxaverine|moxaverine
452846|NCT01629680|ocular blood flow|ocular blood flow
452847|NCT01629654|Poststroke fatigue|poststroke fatigue
452848|NCT01629654|Health promotion|health promotion
452849|NCT01629654|Patient education|patient education
452850|NCT01629641|goniometry|goniometry
452851|NCT01629641|outcome measures|outcome measures
452852|NCT01629641|shoulder assessment|shoulder assessment
452853|NCT01629628|Crohn Disease|crohn disease
452854|NCT01629628|Colitis Granulomatous|colitis granulomatous
452855|NCT01629628|Crohn's Disease|crohn's disease
452856|NCT01629628|Enteritis Regional|enteritis regional
452857|NCT01629628|Ileitis Regional|ileitis regional
452858|NCT01629628|Ileitis Terminal|ileitis terminal
452859|NCT01629628|Ileocolitis|ileocolitis
452860|NCT01629615|breast cancer|breast cancer
452861|NCT01629615|metastatic|metastatic
452862|NCT01629615|triple negative breast cancer|triple negative breast cancer
452863|NCT01629615|BKM120|bkm120
452864|NCT01629615|SOLTI|solti
452865|NCT01629615|PI3K inhibitor|pi3k inhibitor
452866|NCT01629602|defect;|defect;
452867|NCT01629602|dorsal branch of the proper digital nerve;|dorsal branch of the proper digital nerve;
452868|NCT01629602|proper digital nerve;|proper digital nerve;
452869|NCT01629602|vascularized nerve graft|vascularized nerve graft
452870|NCT01629589|Adacel® vaccine|adacel® vaccine
452871|NCT01629589|Tetanus|tetanus
452872|NCT01629589|Diphtheria|diphtheria
452873|NCT01629589|whooping cough|whooping cough
452874|NCT01629589|Pertussis|pertussis
452875|NCT01629589|BOOSTRIX® vaccine|boostrix® vaccine
452876|NCT01629537|Post Traumatic Stress Disorder|post traumatic stress disorder
452877|NCT01629485|Mastery Learning|mastery learning
452878|NCT01629485|Surgical Education|surgical education
452879|NCT01629485|Laparoscopic Hernia Repair|laparoscopic hernia repair
452880|NCT01629485|Part vs Whole Task|part vs whole task
452881|NCT01629485|Contextual Interference|contextual interference
452882|NCT01629485|laparoscopy|laparoscopy
452883|NCT01629485|training|training
452884|NCT01629485|curriculum|curriculum
452885|NCT01629472|Gender norms|gender norms
452886|NCT01629472|Financial Autonomy|financial autonomy
452887|NCT01629472|Economic Well-being|economic well-being
452888|NCT01629459|exercise|exercise
452889|NCT01629459|strength|strength
452890|NCT01629459|training|training
452891|NCT01629459|barth syndrome|barth syndrome
452892|NCT01629459|mitochondria|mitochondria
452893|NCT01629459|amino acid|amino acid
452894|NCT01629459|protein|protein
452895|NCT01629446|Phase 1|phase 1
452896|NCT01629446|Normal healthy volunteers|normal healthy volunteers
452897|NCT01629446|Mass Balance|mass balance
452898|NCT01629433|idiopathic detrusor overactivity|idiopathic detrusor overactivity
452899|NCT01629433|neurogenic dysfunction|neurogenic dysfunction
452900|NCT01629433|onabotulinumtoxinA|onabotulinumtoxina
452901|NCT01629420|Gonadotropin-Releasing Hormone (GnRH) antagonist|gonadotropin-releasing hormone (gnrh) antagonist
452902|NCT01629381|knee arthroscopy|knee arthroscopy
452903|NCT01629381|venous thromboembolism|venous thromboembolism
452904|NCT01629381|prevention|prevention
452905|NCT01629355|Auditory Brainstem Response|auditory brainstem response
452906|NCT01629355|ABR|abr
452907|NCT01629355|SD-BERA|sd-bera
452908|NCT01629329|Headache|headache
452909|NCT01629329|prochlorperazine|prochlorperazine
452910|NCT01629329|excedrin migraine|excedrin migraine
453216|NCT01627886|crossover|crossover
452911|NCT01629329|treatment efficacy|treatment efficacy
452912|NCT01629329|pain scores|pain scores
452914|NCT01629316|prisoners|prisoners
452915|NCT01629316|test|test
452916|NCT01629316|treat|treat
452917|NCT01629316|link coordination|link coordination
452918|NCT01629316|retain|retain
452919|NCT01629316|behavioral|behavioral
452920|NCT01629316|intervention|intervention
452921|NCT01629316|text reminders|text reminders
452922|NCT01629316|motivational interviewing|motivational interviewing
452923|NCT01629316|medication adherence|medication adherence
452924|NCT01629303|constipation|constipation
452925|NCT01629303|sacral nerve modulation|sacral nerve modulation
452926|NCT01629277|Closed-loop insulin delivery|closed-loop insulin delivery
452927|NCT01629277|Non-compliant behaviours during adolescence|non-compliant behaviours during adolescence
452928|NCT01629264|Cornea|cornea
452929|NCT01629264|biomechanics|biomechanics
452930|NCT01629264|pregnancy|pregnancy
452931|NCT01629264|keratoconus|keratoconus
452932|NCT01629264|refractive surgery|refractive surgery
452933|NCT01629251|Closed-loop insulin delivery|closed-loop insulin delivery
452934|NCT01629251|Post-prandial hypoglycaemia|post-prandial hypoglycaemia
452935|NCT01629251|Meal insulin dosing|meal insulin dosing
452936|NCT01629238|cardiovascular risk|cardiovascular risk
452937|NCT01629238|dairy enriched product with plant sterols|dairy enriched product with plant sterols
452938|NCT01629238|general practitioners|general practitioners
452939|NCT01629238|adults followed by general practitioners|adults followed by general practitioners
452940|NCT01629225|men and women|men and women
452941|NCT01629225|in southwestern Han Chinese|in southwestern han chinese
452942|NCT01629186|CPR|cpr
452943|NCT01629186|flexible bronchoscope|flexible bronchoscope
452944|NCT01629186|resuscitation|resuscitation
452945|NCT01629186|ventilation|ventilation
452946|NCT01629173|plantar pressure|plantar pressure
452947|NCT01629173|metatarsalgia|metatarsalgia
452948|NCT01629173|insole|insole
452949|NCT01629147|Constipation|constipation
452950|NCT01629108|Normative Data|normative data
452951|NCT01629108|Vestibular|vestibular
452952|NCT01629108|Auditory|auditory
452953|NCT01629108|Healthy Volunteers|healthy volunteers
452954|NCT01629108|Hearing|hearing
452955|NCT01629095|Liver Transplantation|liver transplantation
452956|NCT01629095|Genetics|genetics
452957|NCT01629082|Myelodysplastic Syndromes|myelodysplastic syndromes
452958|NCT01629082|Acute Myeloid Leukemia (AML)|acute myeloid leukemia (aml)
452959|NCT01629082|Chronic Myelomonocytic Leukemia (CMML)|chronic myelomonocytic leukemia (cmml)
452960|NCT01629069|stress|stress
452961|NCT01629069|mindfulness|mindfulness
452962|NCT01629069|coping|coping
452963|NCT01629056|atrial fibrillation|atrial fibrillation
452964|NCT01629056|ablation|ablation
452965|NCT01629056|contact|contact
452966|NCT01629043|Parkinson's|parkinson's
452967|NCT01629043|Quality of Care|quality of care
452968|NCT01629043|Improvement|improvement
452969|NCT01629043|Mobility|mobility
452970|NCT01629043|Cognition|cognition
452971|NCT01629043|Caregiver burden|caregiver burden
452972|NCT01629043|Center difference|center difference
452973|NCT01629030|sternal wound infection|sternal wound infection
452974|NCT01629030|coronary artery bypass graft|coronary artery bypass graft
452975|NCT01629030|risk factor|risk factor
452976|NCT01629004|colorectal cancer|colorectal cancer
452977|NCT01629004|screening|screening
452978|NCT01629004|fecal occult blood testing|fecal occult blood testing
452979|NCT01629004|mailed invitation|mailed invitation
452980|NCT01628991|Behavioral Intervention Program|behavioral intervention program
452981|NCT01628991|Vaginal Cones|vaginal cones
452982|NCT01628991|Stress Urinary Incontinence|stress urinary incontinence
452983|NCT01628991|treatment|treatment
452984|NCT01628991|Women|women
452985|NCT01628978|depth of endotracheal tube placement|depth of endotracheal tube placement
452986|NCT01628978|endotracheal intubation|endotracheal intubation
452987|NCT01628978|endobronchial intubation|endobronchial intubation
452988|NCT01628965|SPM 962|spm 962
452989|NCT01628965|rotigotine|rotigotine
452990|NCT01628965|Parkinson's disease|parkinson's disease
452991|NCT01628965|monotherapy|monotherapy
452992|NCT01628939|low back pain|low back pain
452993|NCT01628939|facet joint pain|facet joint pain
452994|NCT01628913|Pancreatic|pancreatic
452995|NCT01628913|Neuroendocrine tumors|neuroendocrine tumors
452996|NCT01628913|PNET|pnet
452997|NCT01628913|BEZ235|bez235
452998|NCT01628913|Everolimus|everolimus
452999|NCT01628900|pyelonephritis|pyelonephritis
453000|NCT01628900|Infection|infection
453001|NCT01628900|Antibiotic treatment|antibiotic treatment
453002|NCT01628887|Breast Cancer|breast cancer
453003|NCT01628874|Lumbar Puncture|lumbar puncture
453004|NCT01628874|J-Tip|j-tip
453005|NCT01628874|Jet injection|jet injection
453006|NCT01628874|Local Analgesia|local analgesia
453007|NCT01628861|occupation|occupation
453008|NCT01628861|work|work
453010|NCT01628861|sedentary behaviour|sedentary behaviour
453011|NCT01628861|office worker|office worker
453012|NCT01628861|adult|adult
453013|NCT01628861|education|education
453014|NCT01628861|point-of-choice prompt|point-of-choice prompt
453015|NCT01628848|SPM 962|spm 962
453016|NCT01628848|rotigotine|rotigotine
453017|NCT01628848|Parkinson's disease|parkinson's disease
453018|NCT01628848|concomitant use of L-dopa|concomitant use of l-dopa
453019|NCT01628835|overweight|overweight
453020|NCT01628835|pregnancy|pregnancy
453021|NCT01628835|diet counselling|diet counselling
453022|NCT01628835|glycemic|glycemic
453023|NCT01628822|Fibromyalgia|fibromyalgia
453024|NCT01628822|Relaxation|relaxation
453025|NCT01628822|Improving the quality of life|improving the quality of life
453026|NCT01628809|MBSR|mbsr
453027|NCT01628809|mindfulness|mindfulness
453028|NCT01628809|stress|stress
453029|NCT01628783|Depression|depression
453030|NCT01628783|emotional processing|emotional processing
453031|NCT01628783|fMRI|fmri
453032|NCT01628783|autobiographic memory|autobiographic memory
453033|NCT01628783|moderator of treatment response|moderator of treatment response
453034|NCT01628783|mediator of treatment response|mediator of treatment response
453035|NCT01628770|iron|iron
453036|NCT01628770|monofer|monofer
453037|NCT01628770|Pakistan|pakistan
453038|NCT01628731|loop diuretics|loop diuretics
453039|NCT01628731|fluid balance|fluid balance
453040|NCT01628731|urine output|urine output
453041|NCT01628731|acute renal dysfunction|acute renal dysfunction
453042|NCT01628718|OEF/OIF|oef/oif
453043|NCT01628718|Veterans|veterans
453044|NCT01628718|Psychotherapy|psychotherapy
453045|NCT01628718|PTSD|ptsd
453046|NCT01628705|Green tea|green tea
453047|NCT01628705|oxLDL|oxldl
453048|NCT01628705|fat mass|fat mass
453049|NCT01628679|provoked|provoked
453050|NCT01628679|vulvar|vulvar
453051|NCT01628679|vestibulodynia|vestibulodynia
453052|NCT01628679|vestibulitis|vestibulitis
453053|NCT01628666|Arrhythmia|arrhythmia
453054|NCT01628666|Device Procedure|device procedure
453055|NCT01628666|Antibiotics|antibiotics
453056|NCT01628666|Infection|infection
453057|NCT01628666|Cluster|cluster
453058|NCT01628653|Mild cognitive impairment|mild cognitive impairment
453059|NCT01628653|Cognitive rehabilitation|cognitive rehabilitation
453060|NCT01628653|Cognitive therapy|cognitive therapy
453061|NCT01628653|Spaced retrieval Training|spaced retrieval training
453062|NCT01628653|Alzheimer's disease|alzheimer's disease
453063|NCT01628653|Memory enhancement|memory enhancement
453064|NCT01628653|U-healthcare|u-healthcare
453065|NCT01628627|Diabetic Neuropathy, Painful|diabetic neuropathy, painful
453066|NCT01628575|periodontally accelerated orthodontics PAO|periodontally accelerated orthodontics pao
453067|NCT01628562|Remifentanil|remifentanil
453068|NCT01628562|Esmolol|esmolol
453069|NCT01628562|Intracranial surgery|intracranial surgery
453070|NCT01628562|Heart rate|heart rate
453071|NCT01628562|Blood pressure|blood pressure
453072|NCT01628549|acne|acne
453073|NCT01628536|Black Cohosh|black cohosh
453074|NCT01628536|Ductal Carcinoma in situ|ductal carcinoma in situ
453075|NCT01628536|Breast Cancer|breast cancer
453076|NCT01628523|Respiratory failure|respiratory failure
453077|NCT01628523|Mechanical ventilation|mechanical ventilation
453078|NCT01628523|Acute lung injury|acute lung injury
453079|NCT01628510|preterm|preterm
453080|NCT01628471|Phase I b : advanced solid malignancy|phase i b : advanced solid malignancy
453081|NCT01628471|Phase II a: stage III b or IV, Non Small Cell Lung Cancer|phase ii a: stage iii b or iv, non small cell lung cancer
453082|NCT01628458|Pancreatic cancer|pancreatic cancer
453083|NCT01628458|locally advanced|locally advanced
453084|NCT01628458|irresectable|irresectable
453085|NCT01628458|Radiofrequency|radiofrequency
453086|NCT01628458|RFA|rfa
453087|NCT01628445|Diabetes|diabetes
453088|NCT01628445|Insulin|insulin
453089|NCT01628419|Health promotion|health promotion
453090|NCT01628419|Intervention|intervention
453091|NCT01628419|Workplace|workplace
453092|NCT01628419|Exercise program|exercise program
453093|NCT01628380|HIPEC|hipec
453094|NCT01628380|Ovarian Cancer|ovarian cancer
453095|NCT01628380|Cytoreductive Surgery|cytoreductive surgery
453096|NCT01628354|Choroidal neovascularization|choroidal neovascularization
453097|NCT01628354|Lucentis|lucentis
453098|NCT01628328|colonic stenting|colonic stenting
453099|NCT01628328|colorectal cancer obstruction|colorectal cancer obstruction
453100|NCT01628328|circulating tumor cell|circulating tumor cell
453101|NCT01628315|Multiple Sclerosis|multiple sclerosis
453102|NCT01628315|ASA|asa
453103|NCT01628315|MRI|mri
453104|NCT01628315|Lesion activity|lesion activity
453105|NCT01628302|Hypertension,plasma renin activity,salt consumption|hypertension,plasma renin activity,salt consumption
453106|NCT01628289|diabetic retinopathy|diabetic retinopathy
453107|NCT01628289|screening|screening
453108|NCT01628289|co-payment|co-payment
453109|NCT01628289|health service|health service
453110|NCT01628276|Multiple Sclerosis|multiple sclerosis
453111|NCT01628276|MRI Scans|mri scans
453112|NCT01628263|PICU|picu
453113|NCT01628263|Follow up|follow up
453114|NCT01628263|PTSD|ptsd
453115|NCT01628224|Task saturation|task saturation
453116|NCT01628211|hyperthermic chemotherapy|hyperthermic chemotherapy
453117|NCT01628211|intraperitoneal chemotherapy|intraperitoneal chemotherapy
453118|NCT01628211|second-look laparoscopy|second-look laparoscopy
453119|NCT01628211|peritoneal carcinosis|peritoneal carcinosis
453120|NCT01628211|mucinous colorectal cancer|mucinous colorectal cancer
453121|NCT01628198|Hypertension|hypertension
453122|NCT01628198|renal denervation|renal denervation
453123|NCT01628198|renal ablation|renal ablation
453124|NCT01628198|uncontrolled high blood pressure|uncontrolled high blood pressure
453125|NCT01628172|renal sympathetic denervation|renal sympathetic denervation
453126|NCT01628172|renal catheter ablation|renal catheter ablation
453127|NCT01628172|hypertension|hypertension
453128|NCT01628146|Presbyopia|presbyopia
453129|NCT01628146|hyperopia|hyperopia
453130|NCT01628146|Supracor|supracor
453131|NCT01628146|contrast sensitivity|contrast sensitivity
453132|NCT01628133|Transfusion|transfusion
453133|NCT01628133|Neonate|neonate
453134|NCT01628133|Infant, Very Low Birth Weight|infant, very low birth weight
453135|NCT01628133|Patent Ductus Arteriosus|patent ductus arteriosus
453136|NCT01628133|Packed Red Blood Cell|packed red blood cell
453137|NCT01628120|Chronic renal failure|chronic renal failure
453138|NCT01628120|Hemodialysis|hemodialysis
453139|NCT01628107|Chronic renal failure|chronic renal failure
453140|NCT01628107|hemodialysis|hemodialysis
453141|NCT01628081|psoriasis|psoriasis
453142|NCT01628081|Alga Dunaliella Bardawil|alga dunaliella bardawil
453143|NCT01628068|Left atrial appendage occlusion|left atrial appendage occlusion
453144|NCT01628068|gastrointestinal bleeding|gastrointestinal bleeding
453145|NCT01628055|IVIg|ivig
453146|NCT01628055|Acute Ischemic Stroke|acute ischemic stroke
453147|NCT01628055|Stroke|stroke
453148|NCT01628055|CVA|cva
453149|NCT01628055|Cerebrovascular Accident|cerebrovascular accident
453150|NCT01628029|Advanced Cancers|advanced cancers
453151|NCT01628029|Metastatic|metastatic
453152|NCT01628029|Locally advanced|locally advanced
453153|NCT01628029|Sleep disturbance|sleep disturbance
453154|NCT01628029|Sleep problems|sleep problems
453155|NCT01628029|Litebook|litebook
453156|NCT01628029|Melatonin|melatonin
453157|NCT01628029|Methylphenidate|methylphenidate
453158|NCT01628029|Methylphenidate hydrochloride|methylphenidate hydrochloride
453159|NCT01628029|Ritalin|ritalin
453160|NCT01628029|Concerta|concerta
453161|NCT01628029|Placebo|placebo
453162|NCT01628029|Supportive counseling|supportive counseling
453163|NCT01628029|Questionnaires|questionnaires
453164|NCT01628029|Study Diaries|study diaries
453165|NCT01628016|depression|depression
453166|NCT01628016|attention|attention
453167|NCT01628016|training|training
453168|NCT01628016|modification|modification
453169|NCT01628003|Traumatic Brain Injury|traumatic brain injury
453170|NCT01628003|long-term outcome|long-term outcome
453171|NCT01628003|Brain Reserves|brain reserves
453172|NCT01628003|Cognitive Reserves|cognitive reserves
453173|NCT01628003|Emotional Reserves|emotional reserves
453174|NCT01628003|Patients 1 year or more after Moderate or Severe Traumatic Brain Injury|patients 1 year or more after moderate or severe traumatic brain injury
453175|NCT01627990|cytotoxic chemotherapy|cytotoxic chemotherapy
453176|NCT01627990|G-CSF|g-csf
453177|NCT01627990|Solid tumour|solid tumour
453178|NCT01627990|Malignant haematological tumour|malignant haematological tumour
453179|NCT01627977|chromovitrectomy|chromovitrectomy
578495|NCT01103115|AIS|ais
453180|NCT01627977|epiretinal membrane|epiretinal membrane
453181|NCT01627964|Heart Wall Motion Function|heart wall motion function
453182|NCT01627951|Plasmodium falciparum|plasmodium falciparum
453183|NCT01627951|malaria|malaria
453184|NCT01627938|Multiple Sclerosis|multiple sclerosis
453185|NCT01627938|MS|ms
453186|NCT01627938|Mitoxantrone|mitoxantrone
453187|NCT01627938|Dexrazoxane|dexrazoxane
453188|NCT01627938|Cardioxane|cardioxane
453189|NCT01627938|cardiotoxicity|cardiotoxicity
453190|NCT01627938|cardiac toxicity|cardiac toxicity
453191|NCT01627938|cardiotoxic side effects|cardiotoxic side effects
453192|NCT01627938|cardiac MRI|cardiac mri
453193|NCT01627938|cranial MRI|cranial mri
453194|NCT01627938|LVEF|lvef
453195|NCT01627938|neurological outcome|neurological outcome
453196|NCT01627925|nasal positive airway pressure|nasal positive airway pressure
453197|NCT01627925|upper airway obstruction|upper airway obstruction
453198|NCT01627925|mask ventilation|mask ventilation
453199|NCT01627912|wine|wine
453200|NCT01627912|inflammation|inflammation
453201|NCT01627912|oxidative stress|oxidative stress
453202|NCT01627912|randomized control trial|randomized control trial
453203|NCT01627912|postprandial intervention|postprandial intervention
453204|NCT01627912|platelet aggregation|platelet aggregation
453205|NCT01627912|haemostasis|haemostasis
453206|NCT01627912|robola|robola
453207|NCT01627912|cabernet sauvignon|cabernet sauvignon
453208|NCT01627912|alcohol|alcohol
453209|NCT01627912|PAF metabolism|paf metabolism
453210|NCT01627899|Blood glucose monitor|blood glucose monitor
453211|NCT01627899|Pattern management|pattern management
453212|NCT01627899|Pattern guide|pattern guide
453213|NCT01627899|Education|education
453214|NCT01627886|Bioequivalence|bioequivalence
453215|NCT01627886|Ibandronate Sodium|ibandronate sodium
453217|NCT01627873|Major abdominal surgery|major abdominal surgery
453218|NCT01627873|analgesic method|analgesic method
453219|NCT01627873|Fentanyl|fentanyl
453220|NCT01627873|Remifentanyl|remifentanyl
453221|NCT01627873|Postoperative cognitive disorder|postoperative cognitive disorder
453222|NCT01627873|Pro and anti inflammatory cytokines|pro and anti inflammatory cytokines
453223|NCT01627860|Epilepsy|epilepsy
453224|NCT01627860|Topiramate|topiramate
453225|NCT01627860|Neuro-surgical patients|neuro-surgical patients
453226|NCT01627860|Nervous disorder|nervous disorder
453227|NCT01627860|Seizures|seizures
453228|NCT01627847|Bioequivalence|bioequivalence
453229|NCT01627847|Ropinirole Hydrochloride|ropinirole hydrochloride
453230|NCT01627847|crossover|crossover
453231|NCT01627834|Bioequivalence|bioequivalence
453232|NCT01627834|Ropinirole Hydrochloride|ropinirole hydrochloride
453233|NCT01627834|crossover|crossover
453234|NCT01627821|Heart Failure|heart failure
453235|NCT01627808|intraoperative monitoring|intraoperative monitoring
453236|NCT01627808|fluid management|fluid management
453237|NCT01627795|Malignant Mesothelioma|malignant mesothelioma
453238|NCT01627795|Cancer|cancer
453239|NCT01627795|Anti cancer agents|anti cancer agents
453240|NCT01627782|Major depressive disorder|major depressive disorder
453241|NCT01627782|Treatment-resistant depression|treatment-resistant depression
453242|NCT01627782|Ketamine|ketamine
453243|NCT01627769|scars|scars
453244|NCT01627769|blisters|blisters
453245|NCT01627769|second degree burns|second degree burns
453246|NCT01627769|cryosurgery|cryosurgery
453247|NCT01627769|keloid scars|keloid scars
453248|NCT01627769|hypertrophic scars|hypertrophic scars
453249|NCT01627756|Thoracic Surgery|thoracic surgery
453250|NCT01627756|Endotoxins|endotoxins
453251|NCT01627756|Respiration, Artificial|respiration, artificial
453252|NCT01627756|Immune System|immune system
453253|NCT01627743|CDLM|cdlm
453254|NCT01627743|visual scale - physician evaluation|visual scale - physician evaluation
453255|NCT01627743|COPD|copd
453256|NCT01627743|GOLD group C and D|gold group c and d
453257|NCT01627717|maraviroc|maraviroc
453258|NCT01627717|boceprevir|boceprevir
453259|NCT01627717|HIV|hiv
453260|NCT01627717|HCV|hcv
453261|NCT01627717|drug interaction|drug interaction
453262|NCT01627717|pharmacokinetics|pharmacokinetics
453263|NCT01627704|PET/CT,fluoroestradiol (18F)|pet/ct,fluoroestradiol (18f)
453264|NCT01627704|breast cancer|breast cancer
453265|NCT01627704|metastatic|metastatic
453266|NCT01627704|prediction of response|prediction of response
453267|NCT01627704|hormone therapy|hormone therapy
453268|NCT01627678|HIV-1, Vacc-C5|hiv-1, vacc-c5
453269|NCT01627665|dabigatran|dabigatran
453270|NCT01627665|rivaroxaban|rivaroxaban
453271|NCT01627665|PKC|pkc
453272|NCT01627665|PKD|pkd
453273|NCT01627665|p-glycoprotein|p-glycoprotein
453274|NCT01627665|polymorphism|polymorphism
453275|NCT01627652|hypoxia|hypoxia
453276|NCT01627626|xerostomia|xerostomia
453277|NCT01627626|pilocarpine mouthwash|pilocarpine mouthwash
453278|NCT01627626|minor salivary gland secretion|minor salivary gland secretion
453279|NCT01627613|Peptide|peptide
453280|NCT01627600|stroke|stroke
453281|NCT01627600|myocardial infarction|myocardial infarction
453282|NCT01627600|cardiovascular health|cardiovascular health
453283|NCT01627600|population study|population study
453284|NCT01627587|preterm labor|preterm labor
453285|NCT01627574|Pregnancy|pregnancy
453286|NCT01627574|STI prevention|sti prevention
453287|NCT01627574|adolescents|adolescents
453288|NCT01627574|probation|probation
453289|NCT01627561|Immune response|immune response
453290|NCT01627561|Human papillomavirus|human papillomavirus
453291|NCT01627561|HPV vaccine|hpv vaccine
453292|NCT01627561|Safety|safety
453293|NCT01627548|PTSD|ptsd
453294|NCT01627548|Couples|couples
453295|NCT01627548|Combat Veteran|combat veteran
453296|NCT01627548|Warfighter|warfighter
453297|NCT01627548|OEF|oef
453298|NCT01627548|OIF|oif
453299|NCT01627548|OND|ond
453300|NCT01627548|Structured Approach Therapy|structured approach therapy
453301|NCT01627548|Trauma|trauma
453302|NCT01627535|Brain Tumor|brain tumor
453303|NCT01627509|continuous glucose monitoring system|continuous glucose monitoring system
453304|NCT01627509|hypoglycemia|hypoglycemia
453305|NCT01627509|insulin regimen|insulin regimen
453306|NCT01627509|basal bolus therapy|basal bolus therapy
453307|NCT01627509|modern premixed insulin|modern premixed insulin
453308|NCT01627509|diabetes control|diabetes control
453309|NCT01627496|malnutrition|malnutrition
453310|NCT01627496|elderly care|elderly care
453311|NCT01627496|quality of life|quality of life
453312|NCT01627496|hospital|hospital
453313|NCT01627483|elderly|elderly
453314|NCT01627483|hip fracture|hip fracture
453315|NCT01627483|osteoporosis|osteoporosis
453316|NCT01627483|fall risk|fall risk
453317|NCT01627483|medication review|medication review
453318|NCT01627470|non-invasive arterial pressure|non-invasive arterial pressure
453319|NCT01627470|emergency|emergency
453320|NCT01627470|intensive care|intensive care
453321|NCT01627457|Coronary Artery Disease|coronary artery disease
453322|NCT01627457|Guided Exercise System including ECG Vest with vital signs sensors and PDA|guided exercise system including ecg vest with vital signs sensors and pda
453323|NCT01627457|Validation Telemedical Device in regard to accuracy and safety of data|validation telemedical device in regard to accuracy and safety of data
453324|NCT01627457|Homely Rehabilitation|homely rehabilitation
453325|NCT01627457|Practicability and technical problems at home|practicability and technical problems at home
453326|NCT01627444|Acupuncture|acupuncture
453327|NCT01627444|Anxiety|anxiety
453328|NCT01627444|Human Milk|human milk
453329|NCT01627444|Very low birth weight infants|very low birth weight infants
453330|NCT01627444|Mother of very low birth weight infants|mother of very low birth weight infants
453332|NCT01627431|Peripheral revascularization|peripheral revascularization
453333|NCT01627431|Antiplatelet therapy|antiplatelet therapy
453334|NCT01627431|Residual platelet activity|residual platelet activity
453335|NCT01627418|COPD|copd
453336|NCT01627418|CORD|cord
453337|NCT01627418|COAD|coad
453338|NCT01627379|nonresectable|nonresectable
453339|NCT01627379|advanced|advanced
453340|NCT01627379|metastatic esophageal squamous cell cancer|metastatic esophageal squamous cell cancer
453341|NCT01627379|Panitumumab|panitumumab
453342|NCT01627353|Hysterectomy|hysterectomy
453343|NCT01627353|Pain Prevention|pain prevention
453344|NCT01627353|Wound Infiltration|wound infiltration
453345|NCT01627340|Engerix™-B|engerix™-b
453346|NCT01627340|hepatitis B|hepatitis b
453347|NCT01627340|adults|adults
453348|NCT01627340|Type 2 diabetes mellitus|type 2 diabetes mellitus
453349|NCT01627327|Cardiovascular event|cardiovascular event
453350|NCT01627327|Cardiovascular disease|cardiovascular disease
453351|NCT01627275|Naive T Cell Depletion|naive t cell depletion
453352|NCT01627275|Donor Lymphocyte Infusion|donor lymphocyte infusion
453353|NCT01627275|Allogeneic Hematopoietic Stem Cell Transplant|allogeneic hematopoietic stem cell transplant
453354|NCT01627262|diverticular disease|diverticular disease
453355|NCT01627262|colonic diverticulosis|colonic diverticulosis
453356|NCT01627262|mesalamine|mesalamine
453357|NCT01627262|placebo|placebo
453358|NCT01627262|randomized|randomized
453359|NCT01627249|Diabetic Macular Edema|diabetic macular edema
453360|NCT01627249|anti-vascular endothelial growth factor|anti-vascular endothelial growth factor
453361|NCT01627223|Spontaneous Severe Acute Exacerbation of Chronic Hepatitis B|spontaneous severe acute exacerbation of chronic hepatitis b
453362|NCT01627223|Lamivudine (Zeffix®)|lamivudine (zeffix®)
453363|NCT01627223|Entecavir (Baraclude®)|entecavir (baraclude®)
453364|NCT01627210|Diabetes Mellitus|diabetes mellitus
453365|NCT01627197|Effects of Chemotherapy|effects of chemotherapy
453366|NCT01627197|intraarterial chemotherapy|intraarterial chemotherapy
453367|NCT01627145|overactive bladder syndrome|overactive bladder syndrome
453368|NCT01627145|derusor overactivity|derusor overactivity
453369|NCT01627145|urodynamic studies|urodynamic studies
453370|NCT01627145|bladder oversensitivity|bladder oversensitivity
453371|NCT01627119|CTGF|ctgf
453372|NCT01627119|Peritoneal metastasis|peritoneal metastasis
453373|NCT01627093|Head and Neck Cancer|head and neck cancer
453374|NCT01627093|Head and Neck Malignancies|head and neck malignancies
453375|NCT01627093|Chart Review|chart review
453376|NCT01627093|Proton Radiation Therapy|proton radiation therapy
453377|NCT01627080|Esophagus|esophagus
453378|NCT01627080|Esophageal Cancer|esophageal cancer
453379|NCT01627080|Radiation therapy|radiation therapy
453380|NCT01627080|RT|rt
453381|NCT01627080|Chemotherapy|chemotherapy
453382|NCT01627080|Mid thoracic tumor|mid thoracic tumor
453383|NCT01627080|Distal esophageal tumor|distal esophageal tumor
453384|NCT01627080|Gastroesophageal junction tumor|gastroesophageal junction tumor
453385|NCT01627080|Cardiac biomarkers|cardiac biomarkers
453386|NCT01627067|Breast Cancer|breast cancer
453387|NCT01627067|Hormone Receptor Positive Metastatic Breast Cancer|hormone receptor positive metastatic breast cancer
453388|NCT01627067|Hormone-sensitive|hormone-sensitive
453389|NCT01627067|Postmenopausal|postmenopausal
453390|NCT01627067|Body Mass Index|body mass index
453391|NCT01627067|BMI|bmi
453392|NCT01627067|Everolimus|everolimus
453393|NCT01627067|Afinitor|afinitor
453394|NCT01627067|RAD001|rad001
453395|NCT01627067|Exemestane|exemestane
453396|NCT01627067|Aromasin|aromasin
453397|NCT01627067|Metformin|metformin
453398|NCT01627028|Thai traditional massage|thai traditional massage
453399|NCT01627028|Bone formation|bone formation
453400|NCT01627028|Bone resorption|bone resorption
453401|NCT01627015|Fully formula fed|fully formula fed
453402|NCT01627002|Phase 1|phase 1
453403|NCT01627002|First in Human|first in human
453404|NCT01627002|Healthy Volunteers|healthy volunteers
453405|NCT01627002|Lipopolysaccharide Challenge|lipopolysaccharide challenge
453406|NCT01626976|safety|safety
453407|NCT01626976|tolerability|tolerability
453408|NCT01626976|pharmacokinetics|pharmacokinetics
453409|NCT01626976|oral|oral
453410|NCT01626976|single ascending dose|single ascending dose
453411|NCT01626976|placebo-controlled|placebo-controlled
453412|NCT01626976|healthy subjects|healthy subjects
453413|NCT01626963|single-port access|single-port access
453414|NCT01626963|laparoscopic surgery|laparoscopic surgery
453415|NCT01626963|surgical trauma|surgical trauma
453416|NCT01626950|Breast cancer|breast cancer
453417|NCT01626950|living conditions|living conditions
453418|NCT01626950|social fragility|social fragility
453419|NCT01626937|Acute respiratory failure|acute respiratory failure
453420|NCT01626937|Chronic obstructive pulmonary disease|chronic obstructive pulmonary disease
453421|NCT01626937|Non invasive ventilation|non invasive ventilation
453422|NCT01626937|Out of hospital|out of hospital
453423|NCT01626924|Perinatal Asphyxia|perinatal asphyxia
453424|NCT01626924|Neonatal encephalopathy|neonatal encephalopathy
453425|NCT01626924|Oxygen shortage at birth|oxygen shortage at birth
453426|NCT01626924|Antenatal asphyxia|antenatal asphyxia
453427|NCT01626924|hypoxia-ischaemia|hypoxia-ischaemia
453428|NCT01626924|birth asphyxia|birth asphyxia
453429|NCT01626924|asphyxia neonatorum|asphyxia neonatorum
453430|NCT01626911|severe acute pancreatitis;|severe acute pancreatitis;
453431|NCT01626911|continuous regional arterial infusion;|continuous regional arterial infusion;
453432|NCT01626911|low molecular weight heparin|low molecular weight heparin
453433|NCT01626885|Schizophrenia|schizophrenia
453434|NCT01626885|Antipsychotic Agents|antipsychotic agents
453435|NCT01626885|Mental Disorder|mental disorder
453436|NCT01626885|Psychotropic Drugs|psychotropic drugs
453437|NCT01626885|Dopamine Agents|dopamine agents
453438|NCT01626885|Central Nervous System Agents|central nervous system agents
453439|NCT01626872|Schizophrenia|schizophrenia
453440|NCT01626872|Antipsychotic Agents|antipsychotic agents
453441|NCT01626872|Mental Disorder|mental disorder
453442|NCT01626872|Psychotropic Drugs|psychotropic drugs
453443|NCT01626872|Dopamine Agents|dopamine agents
453444|NCT01626872|Risperidone|risperidone
453445|NCT01626872|Central Nervous System Agents|central nervous system agents
453446|NCT01626859|Schizophrenia|schizophrenia
453447|NCT01626859|Antipsychotic Agents|antipsychotic agents
453448|NCT01626859|Mental Disorder|mental disorder
453449|NCT01626859|Psychotropic Drugs|psychotropic drugs
453450|NCT01626859|Dopamine Agents|dopamine agents
453451|NCT01626859|Central Nervous System Agents|central nervous system agents
453452|NCT01626846|Neurofibromatosis|neurofibromatosis
453453|NCT01626833|anorexia nervosa|anorexia nervosa
453454|NCT01626833|GH|gh
453455|NCT01626833|Growth velocity|growth velocity
453456|NCT01626820|Immunogenicity|immunogenicity
453457|NCT01626820|Influenza|influenza
453458|NCT01626820|Safety|safety
453459|NCT01626820|Adults|adults
453460|NCT01626820|Fluviral|fluviral
453461|NCT01626807|Safe Routes to School|safe routes to school
453462|NCT01626807|Walking School Bus|walking school bus
453463|NCT01626807|Cluster Randomized Controlled Trial|cluster randomized controlled trial
453464|NCT01626807|Physical Activity|physical activity
453465|NCT01626807|Obesity|obesity
453466|NCT01626807|Overweight|overweight
453467|NCT01626755|Phantom limb pain|phantom limb pain
453468|NCT01626755|Chronic pain|chronic pain
453469|NCT01626755|Amputation|amputation
453470|NCT01626755|Peripheral vascular disease|peripheral vascular disease
453471|NCT01626729|Food Labeling|food labeling
453472|NCT01626677|Umbilical Cord Blood|umbilical cord blood
453473|NCT01626677|Mesenchymal Stem Cells|mesenchymal stem cells
453474|NCT01626677|Cartilage injury|cartilage injury
453475|NCT01626677|Osteoarthritis|osteoarthritis
453476|NCT01626664|Adult T cell Leukemia-Lymphoma (ATL)|adult t cell leukemia-lymphoma (atl)
453477|NCT01626651|Healthy|healthy
453478|NCT01626651|Ketoconazole|ketoconazole
453479|NCT01626651|Ibrutinib|ibrutinib
453480|NCT01626638|Patients with malignant and pre-malignant pharyngo laryngeal tumors|patients with malignant and pre-malignant pharyngo laryngeal tumors
453481|NCT01626625|nonunion|nonunion
453482|NCT01626625|stem cells|stem cells
453483|NCT01626625|autograft|autograft
453484|NCT01626625|hydroxyapatite|hydroxyapatite
453485|NCT01626599|ECG|ecg
453486|NCT01626599|Accelerometer|accelerometer
453487|NCT01626599|Device|device
453488|NCT01626586|Youth|youth
453489|NCT01626586|Family|family
453490|NCT01626586|Group Therapy|group therapy
453491|NCT01626586|Type 1 Diabetes Mellitus|type 1 diabetes mellitus
453492|NCT01626586|Self-Management|self-management
453493|NCT01626573|Rheumatoid Arthritis|rheumatoid arthritis
453494|NCT01626573|RA|ra
453495|NCT01626573|Active|active
453496|NCT01626547|symptomatic anameia|symptomatic anameia
453497|NCT01626508|breast milk|breast milk
453498|NCT01626508|breast-milk bank|breast-milk bank
453499|NCT01626508|plasma profile|plasma profile
453500|NCT01626508|essential fatty acids|essential fatty acids
453501|NCT01626495|Biological: CART19|biological: cart19
453502|NCT01626443|PCOS|pcos
453503|NCT01626443|Metabolic disorders|metabolic disorders
453504|NCT01626443|Ovarian functionality|ovarian functionality
453505|NCT01626443|Myo-inositol|myo-inositol
453506|NCT01626443|D-chiro-inositol|d-chiro-inositol
453507|NCT01626430|Gamma delta TRF|gamma delta trf
453508|NCT01626430|Insulin sensitivity|insulin sensitivity
453509|NCT01626430|Postprandial lipaemia|postprandial lipaemia
453510|NCT01626430|Inflammatory markers|inflammatory markers
453511|NCT01626430|NF-κB|nf-κb
453512|NCT01626417|Stroke|stroke
453513|NCT01626417|Tibion|tibion
453514|NCT01626417|Bionics|bionics
453515|NCT01626417|Rehab|rehab
453516|NCT01626417|Therapy|therapy
453517|NCT01626417|Robotics|robotics
453518|NCT01626417|Intention|intention
453519|NCT01626404|Thoratec Corporation|thoratec corporation
453520|NCT01626391|Alzheimer's Disease|alzheimer's disease
453521|NCT01626391|TRx0237|trx0237
453522|NCT01626391|Safety Study|safety study
453523|NCT01626391|AD|ad
453524|NCT01626378|Behavioral Variant Frontotemporal Dementia|behavioral variant frontotemporal dementia
453525|NCT01626378|bvFTD|bvftd
453526|NCT01626378|Frontotemporal Dementia|frontotemporal dementia
453527|NCT01626365|double-lumen tube|double-lumen tube
453528|NCT01626365|intubation|intubation
453529|NCT01626365|thermosoftening|thermosoftening
453530|NCT01626352|Diffuse Large B-Cell Lymphoma|diffuse large b-cell lymphoma
453531|NCT01626352|Ofatumumab|ofatumumab
453532|NCT01626352|Bendamustine|bendamustine
453533|NCT01626339|Anti vascular endothelial growth factor|anti vascular endothelial growth factor
453534|NCT01626339|retinal vessels|retinal vessels
453535|NCT01626326|smoking|smoking
453536|NCT01626326|smoking cessation|smoking cessation
453537|NCT01626326|mobile app|mobile app
453538|NCT01626313|Veteran families|veteran families
453539|NCT01626313|OEF|oef
453540|NCT01626313|OIF|oif
453541|NCT01626313|OND|ond
453542|NCT01626313|Resiliency|resiliency
453543|NCT01626313|Psycho educational training|psycho educational training
453544|NCT01626313|Stress|stress
453545|NCT01626313|Military|military
453546|NCT01626287|perineal|perineal
453547|NCT01626287|postpartum|postpartum
453548|NCT01626287|pain|pain
453549|NCT01626287|treatment|treatment
453550|NCT01626287|ice and black tea|ice and black tea
453551|NCT01626287|maternal satisfaction|maternal satisfaction
453552|NCT01626274|Polysomnography|polysomnography
453553|NCT01626274|Long term vital signs monitoring|long term vital signs monitoring
453554|NCT01626274|In-ear sensor system|in-ear sensor system
453555|NCT01626274|Photoplethysmographic micro-optic device|photoplethysmographic micro-optic device
453556|NCT01626274|High wearing comfort|high wearing comfort
453557|NCT01626248|Immunological|immunological
453558|NCT01626248|biomarkers|biomarkers
453559|NCT01626248|observational|observational
453560|NCT01626248|RRMS|rrms
453561|NCT01626248|Relapsing|relapsing
453562|NCT01626248|Remitting Multiple Sclerosis|remitting multiple sclerosis
453563|NCT01626235|pain control|pain control
453564|NCT01626235|fractures|fractures
453565|NCT01626235|sprains|sprains
453566|NCT01626235|strains|strains
453567|NCT01626235|dysmenorrhea|dysmenorrhea
453568|NCT01626235|kidney stones|kidney stones
453569|NCT01626235|gouty arthritis|gouty arthritis
453570|NCT01626235|opioids|opioids
453571|NCT01626235|NSDAIDs|nsdaids
453572|NCT01626235|Emergency Department|emergency department
453573|NCT01626235|patient reported outcomes|patient reported outcomes
453574|NCT01626222|Postmenopausal|postmenopausal
453575|NCT01626222|Estrogen Receptor Positive|estrogen receptor positive
453576|NCT01626222|HER2 negative|her2 negative
453577|NCT01626222|Locally Advanced|locally advanced
453578|NCT01626222|Metastatic Breast Cancer|metastatic breast cancer
453579|NCT01626222|Everolimus (RAD001)|everolimus (rad001)
453580|NCT01626222|Exemestane|exemestane
453581|NCT01626209|Breast cancer, NSCLC, SCCHN, esophageal cancer|breast cancer, nsclc, scchn, esophageal cancer
453582|NCT01626183|T-cell childhood acute lymphoblastic leukemia|t-cell childhood acute lymphoblastic leukemia
453583|NCT01626183|recurrent childhood acute lymphoblastic leukemia|recurrent childhood acute lymphoblastic leukemia
453584|NCT01626144|Exemestane|exemestane
453585|NCT01626144|Metabolism|metabolism
453586|NCT01626144|Metabolizing enzyme genotype|metabolizing enzyme genotype
453587|NCT01626144|Breast cancer|breast cancer
453588|NCT01626131|combat disorders|combat disorders
453589|NCT01626131|exercise therapy|exercise therapy
453590|NCT01626105|Hemophilia A|hemophilia a
453591|NCT01626105|Factor VIII|factor viii
453592|NCT01626105|Inhibitors|inhibitors
453593|NCT01626105|Immunogenicity|immunogenicity
453594|NCT01626105|Pharmacogenetics|pharmacogenetics
453595|NCT01626105|Mutation|mutation
453596|NCT01626105|Nonsynonymous Single Nucleotide Polymorphisms|nonsynonymous single nucleotide polymorphisms
453597|NCT01626105|Class II Human Leukocyte Antigens|class ii human leukocyte antigens
453598|NCT01626092|bone marrow transplantation|bone marrow transplantation
453599|NCT01626092|reduced intensity conditioning|reduced intensity conditioning
453600|NCT01626092|Adrenoleukodystrophy|adrenoleukodystrophy
453601|NCT01626092|Metachromatic Leukodystrophy|metachromatic leukodystrophy
453602|NCT01626092|Globoid Cell Leukodystrophy|globoid cell leukodystrophy
453603|NCT01626092|Wolman's disease|wolman's disease
453604|NCT01626092|GM1 gangliosidosis|gm1 gangliosidosis
453605|NCT01626092|Tay Sachs disease|tay sachs disease
453606|NCT01626092|Sanfilippo syndrome|sanfilippo syndrome
453607|NCT01626092|Sandhoff disease|sandhoff disease
453608|NCT01626092|inherited metabolic|inherited metabolic
453609|NCT01626092|I-cell disease|i-cell disease
453610|NCT01626092|mucolipidosis II|mucolipidosis ii
453611|NCT01626079|Functional Mitral Regurgitation|functional mitral regurgitation
453612|NCT01626079|Mitral Valve Regurgitation|mitral valve regurgitation
453613|NCT01626079|Symptomatic Heart Failure|symptomatic heart failure
453614|NCT01626079|Functional MR|functional mr
453615|NCT01626079|MitraClip|mitraclip
453616|NCT01626079|Mitral Valve Insufficiency|mitral valve insufficiency
453617|NCT01626079|Cardiopulmonary exercise testing|cardiopulmonary exercise testing
453618|NCT01626079|COAPT CAS|coapt cas
453619|NCT01626079|COAPT Continued Access Study|coapt continued access study
453620|NCT01626079|MitraClip NT|mitraclip nt
453621|NCT01626053|psychological|psychological
453622|NCT01626053|intervention|intervention
453623|NCT01626053|stages of change|stages of change
453624|NCT01626053|motivational interviewing|motivational interviewing
453625|NCT01626053|coping skills|coping skills
453627|NCT01626053|psychological testing|psychological testing
453628|NCT01626053|integrated care|integrated care
453629|NCT01626053|behavioral health|behavioral health
453630|NCT01626027|Coronary Heart Disease|coronary heart disease
453631|NCT01626027|Depression|depression
453632|NCT01626027|Health Care Services|health care services
453633|NCT01626014|Stage III ovarian cancer|stage iii ovarian cancer
453634|NCT01626014|Stage IV ovarian cancer|stage iv ovarian cancer
453635|NCT01626014|recurrent ovarian cancer|recurrent ovarian cancer
453636|NCT01626014|primary peritoneal cancer|primary peritoneal cancer
453637|NCT01626014|fallopian tube cancer|fallopian tube cancer
453638|NCT01626001|Esophagus Cancer|esophagus cancer
453639|NCT01626001|Lung Cancer|lung cancer
453640|NCT01626001|4-dimensional computed tomography|4-dimensional computed tomography
453641|NCT01626001|4D CT|4d ct
453642|NCT01625975|Growth modulation|growth modulation
453643|NCT01625975|Eight plate|eight plate
453644|NCT01625975|Leg length discrepancy|leg length discrepancy
453645|NCT01625975|Varus/valgus deformities|varus/valgus deformities
453646|NCT01625975|Pediatric|pediatric
453647|NCT01625962|PTSD|ptsd
453648|NCT01625962|mTBI|mtbi
453649|NCT01625962|mild TBI|mild tbi
453650|NCT01625962|extracranial injury|extracranial injury
453651|NCT01625962|ECI|eci
453652|NCT01625962|Brain Indices|brain indices
453653|NCT01625949|myocardial infarction|myocardial infarction
453654|NCT01625936|metastatic|metastatic
453655|NCT01625936|locally advanced|locally advanced
453656|NCT01625936|unresectable|unresectable
453657|NCT01625923|Gastroparesis|gastroparesis
453658|NCT01625923|Idiopathic|idiopathic
453659|NCT01625923|Olanzapine|olanzapine
453660|NCT01625910|Childhood obesity treatment|childhood obesity treatment
453661|NCT01625910|Motivational interviewing|motivational interviewing
453662|NCT01625897|Schizophrenia|schizophrenia
453663|NCT01625897|Antipsychotic Agents|antipsychotic agents
453664|NCT01625897|Mental Disorder|mental disorder
453665|NCT01625897|Psychotropic Drugs|psychotropic drugs
453666|NCT01625897|Dopamine Agents|dopamine agents
453667|NCT01625897|Risperidone|risperidone
453668|NCT01625897|Central Nervous System Agents|central nervous system agents
453669|NCT01625884|Statin|statin
453670|NCT01625884|Hypercholesterolemia|hypercholesterolemia
453671|NCT01625871|malaria|malaria
453672|NCT01625871|vivax|vivax
453673|NCT01625871|artemether/lumefantrine|artemether/lumefantrine
453674|NCT01625871|Sudan|sudan
453675|NCT01625858|LMA Supreme|lma supreme
453676|NCT01625845|Major Depressive Disorder|major depressive disorder
453677|NCT01625845|Depression|depression
453678|NCT01625845|Depressive Symptoms|depressive symptoms
453679|NCT01625845|Cardiovascular Disease (CVD)|cardiovascular disease (cvd)
453680|NCT01625845|Coronary Artery Disease (CAD)|coronary artery disease (cad)
453681|NCT01625845|Heart Disease|heart disease
453682|NCT01625845|Endothelial Function|endothelial function
453683|NCT01625845|Inflammation|inflammation
453684|NCT01625832|intermittent coronary sinus occlusion|intermittent coronary sinus occlusion
453685|NCT01625832|collateral flow index|collateral flow index
453686|NCT01625832|collateral circulation|collateral circulation
453687|NCT01625832|coronary artery occlusion|coronary artery occlusion
453688|NCT01625819|Tai Chi|tai chi
453689|NCT01625793|Hepatitis C|hepatitis c
453690|NCT01625793|interferon|interferon
453691|NCT01625793|stress|stress
453692|NCT01625793|social behavior|social behavior
453693|NCT01625767|Nicotine|nicotine
453694|NCT01625767|Smoking|smoking
453695|NCT01625767|Adolescent|adolescent
453696|NCT01625767|Tobacco|tobacco
453697|NCT01625754|Ceramides|ceramides
453698|NCT01625754|Lipids|lipids
453699|NCT01625728|Voice|voice
453700|NCT01625728|aerodynamics|aerodynamics
453701|NCT01625728|acoustics|acoustics
453702|NCT01625715|peanut allergy|peanut allergy
453703|NCT01625702|no-prior chemotherapy|no-prior chemotherapy
453704|NCT01625689|Influenza vaccines|influenza vaccines
453705|NCT01625689|Influenza, Human|influenza, human
453706|NCT01625689|Live Attenuated Influenza Vaccine|live attenuated influenza vaccine
453707|NCT01625676|Aphasia|aphasia
453708|NCT01625676|Rehabilitation of Speech and Language Disorders|rehabilitation of speech and language disorders
453709|NCT01625663|barth syndrome|barth syndrome
453710|NCT01625663|heart failure|heart failure
453711|NCT01625663|mitochondria|mitochondria
453712|NCT01625663|metabolism|metabolism
453713|NCT01625663|amino acid|amino acid
453714|NCT01625650|Rheumatoid Arthritis|rheumatoid arthritis
453715|NCT01625650|Registry|registry
453716|NCT01625650|RA|ra
453717|NCT01625650|Biologic|biologic
453718|NCT01625650|Medications|medications
453719|NCT01625650|Rheumatology|rheumatology
453720|NCT01625637|Nicotine|nicotine
453721|NCT01625637|Smoking|smoking
453722|NCT01625637|Adolescent|adolescent
453723|NCT01625637|Tobacco|tobacco
453724|NCT01625611|Alcohol|alcohol
453725|NCT01625611|Drinking|drinking
453726|NCT01625611|Drinkers|drinkers
453727|NCT01625611|Alcohol Drinking|alcohol drinking
453728|NCT01625611|Naltrexone|naltrexone
453729|NCT01625611|Alcohol Dependence|alcohol dependence
453730|NCT01625611|Alcohol Abuse|alcohol abuse
453731|NCT01625611|Alcohol-Related Disorders|alcohol-related disorders
453732|NCT01625611|Ethanol|ethanol
453733|NCT01625611|Alcoholism|alcoholism
453734|NCT01625598|Nonproliferative diabetic retinopathy|nonproliferative diabetic retinopathy
453735|NCT01625598|diabetic macular edema|diabetic macular edema
453736|NCT01625598|proliferative diabetic retinopathy|proliferative diabetic retinopathy
453737|NCT01625598|ophthalmologists|ophthalmologists
453738|NCT01625598|dilated eye exam|dilated eye exam
453739|NCT01625585|Push-and-Pull Enteroscopy|push-and-pull enteroscopy
453740|NCT01625585|Single-Balloon-Enteroscopy|single-balloon-enteroscopy
453741|NCT01625572|general anaesthesia|general anaesthesia
453742|NCT01625572|epidural catheter|epidural catheter
453743|NCT01625572|intravenous pain therapy|intravenous pain therapy
453744|NCT01625546|Major Depressive Disorder|major depressive disorder
453745|NCT01625546|Whole Body Hyperthermia|whole body hyperthermia
453746|NCT01625533|Coronary Angiography|coronary angiography
453747|NCT01625533|Rotational Coronary Angiography|rotational coronary angiography
453748|NCT01625533|Contrast media|contrast media
453749|NCT01625533|Radiation|radiation
453750|NCT01625520|Progressive metastatic|progressive metastatic
453751|NCT01625520|postoperative persistent|postoperative persistent
453752|NCT01625468|Secondhand smoke exposure|secondhand smoke exposure
453753|NCT01625468|Smoke-free homes|smoke-free homes
453754|NCT01625468|Smoke-free home bans|smoke-free home bans
453755|NCT01625455|Sezary Syndrome|sezary syndrome
453756|NCT01625455|Pruritus|pruritus
453757|NCT01625455|Aprepitant|aprepitant
453758|NCT01625455|Neurokinin-1|neurokinin-1
453759|NCT01625442|Metabolic syndrome|metabolic syndrome
453760|NCT01625442|hypercholesterolemia|hypercholesterolemia
453761|NCT01625442|hypertriglyceridemia|hypertriglyceridemia
453762|NCT01625442|hyperglycemia|hyperglycemia
453763|NCT01625416|Posttraumatic Stress Disorder|posttraumatic stress disorder
453764|NCT01625416|Depression|depression
453766|NCT01625416|Traumatic Brain Injury|traumatic brain injury
453767|NCT01625416|Alcohol Use|alcohol use
453768|NCT01625416|Drug Use|drug use
453769|NCT01625416|Information Technology|information technology
453770|NCT01625403|Recombinant BNP|recombinant bnp
453771|NCT01625403|Diuretics|diuretics
453772|NCT01625403|Acute decompensated heart failure|acute decompensated heart failure
453773|NCT01625403|Acute renal injury|acute renal injury
453774|NCT01625403|Heart function|heart function
453775|NCT01625403|Renal function|renal function
453776|NCT01625390|hemophilia, haemophilia, inhibitor, FVIIa, Factor VII activated, bypassing|hemophilia, haemophilia, inhibitor, fviia, factor vii activated, bypassing
453777|NCT01625377|Everolimus,|everolimus,
453778|NCT01625377|liver transplantation,|liver transplantation,
453779|NCT01625377|early introduction,|early introduction,
453780|NCT01625377|renal function|renal function
453781|NCT01625364|Health Education|health education
453782|NCT01625364|Health Counseling|health counseling
453783|NCT01625364|Patient Education|patient education
453784|NCT01625338|HCV genotype 2 (GT-2)|hcv genotype 2 (gt-2)
453785|NCT01625338|HCV genotype 3 (GT-3)|hcv genotype 3 (gt-3)
453786|NCT01625338|HCV|hcv
453787|NCT01625338|Sustained Virologic Response|sustained virologic response
453788|NCT01625338|Direct Acting Antiviral|direct acting antiviral
453789|NCT01625338|Combination Therapy|combination therapy
453790|NCT01625338|GS-7977|gs-7977
453791|NCT01625338|Ribavirin|ribavirin
453792|NCT01625338|Open Label|open label
453793|NCT01625325|obesity, adiposity, psychosocial, healthcare, co-morbidities, low key intervention, quality of life|obesity, adiposity, psychosocial, healthcare, co-morbidities, low key intervention, quality of life
453794|NCT01625299|intestinal permeability|intestinal permeability
453795|NCT01625299|diet|diet
453796|NCT01625299|gluten|gluten
453797|NCT01625299|dairy|dairy
453798|NCT01625286|advanced breast cancer,|advanced breast cancer,
453799|NCT01625286|metastatic breast cancer,|metastatic breast cancer,
453800|NCT01625286|ER+ve breast cancer,|er+ve breast cancer,
453801|NCT01625286|Estrogen receptor positive breast cancer,|estrogen receptor positive breast cancer,
453802|NCT01625286|PIK3CA mutated advanced or metastatic breast cancer|pik3ca mutated advanced or metastatic breast cancer
453803|NCT01625286|AKT inhibitor|akt inhibitor
453804|NCT01625273|F19|f19
453805|NCT01625273|Lactobacillus paracasei paracasei|lactobacillus paracasei paracasei
453806|NCT01625260|cancer|cancer
453807|NCT01625260|immunotherapy|immunotherapy
453808|NCT01625260|targeted|targeted
454316|NCT01622920|ultrasound|ultrasound
453809|NCT01625260|non-muscle invasive|non-muscle invasive
453810|NCT01625260|interleukin-2|interleukin-2
453811|NCT01625260|antitumor|antitumor
453812|NCT01625260|TCR|tcr
453813|NCT01625260|T-cell receptor|t-cell receptor
453814|NCT01625260|p53|p53
453815|NCT01625260|p53 gene|p53 gene
453816|NCT01625260|p53 tumor supressor protein|p53 tumor supressor protein
453817|NCT01625260|urothelial cancer|urothelial cancer
453818|NCT01625260|bladder cancer|bladder cancer
453819|NCT01625260|HLA-A2 positive|hla-a2 positive
453820|NCT01625260|HLA-A*0201/p53 aa264-272|hla-a*0201/p53 aa264-272
453821|NCT01625260|HLA complex|hla complex
453822|NCT01625260|refractory|refractory
453823|NCT01625260|relapsed|relapsed
453824|NCT01625260|BCG|bcg
453825|NCT01625260|multi-focal|multi-focal
453826|NCT01625260|carcinoma in situ|carcinoma in situ
453827|NCT01625260|transitional cell carcinoma|transitional cell carcinoma
453828|NCT01625260|gemcitabine|gemcitabine
453829|NCT01625234|Cancer|cancer
453830|NCT01625234|Tumors|tumors
453831|NCT01625234|ALK|alk
453832|NCT01625234|NSCLC|nsclc
453833|NCT01625234|Advanced Malignancies|advanced malignancies
453834|NCT01625234|Carcinoma, Non-Small-Cell Lung|carcinoma, non-small-cell lung
453835|NCT01625234|Inflammatory Myofibroblastic Tumors|inflammatory myofibroblastic tumors
453836|NCT01625221|FENIX|fenix
453837|NCT01625182|chronic inflammatory demyelinating polyradiculoneuropathy, CIDP, FTY720, fingolimod.|chronic inflammatory demyelinating polyradiculoneuropathy, cidp, fty720, fingolimod.
453838|NCT01625169|Pharmacokinetics|pharmacokinetics
453839|NCT01625169|HIV|hiv
453840|NCT01625169|Breast milk|breast milk
453841|NCT01625130|sulforaphane|sulforaphane
453842|NCT01625130|ozone|ozone
453843|NCT01625130|airway inflammation|airway inflammation
453844|NCT01625130|broccoli sprouts|broccoli sprouts
453845|NCT01625130|NRF2|nrf2
453846|NCT01625130|controls|controls
453847|NCT01625117|Treatment of ex-combatants|treatment of ex-combatants
453848|NCT01625117|Narrative Exposure Therapy for ex-combatants|narrative exposure therapy for ex-combatants
453849|NCT01625117|Appetitive Aggression|appetitive aggression
453850|NCT01625117|Posttraumatic Stress Disorder|posttraumatic stress disorder
453851|NCT01625104|Myocardial Infarction|myocardial infarction
453852|NCT01625104|Time to Treatment|time to treatment
453853|NCT01625104|Door to Balloon Time|door to balloon time
453854|NCT01625091|HIV|hiv
453855|NCT01625091|women|women
453856|NCT01625091|drinking|drinking
453857|NCT01625091|Naltrexone|naltrexone
453858|NCT01625078|Baska Mask|baska mask
453859|NCT01625078|Supraglottic airway device|supraglottic airway device
453860|NCT01625078|Children|children
453861|NCT01625078|Pediatric|pediatric
453862|NCT01625065|medication compliance|medication compliance
453863|NCT01625065|adherence|adherence
453864|NCT01625065|toxicological analyzes|toxicological analyzes
453865|NCT01625065|GC-MS|gc-ms
453866|NCT01625065|HPLC|hplc
453867|NCT01625065|pain patients|pain patients
453868|NCT01625065|opioid misuse|opioid misuse
453869|NCT01625065|patients with current pain|patients with current pain
453870|NCT01625052|mask size|mask size
453871|NCT01625052|Baska mask|baska mask
453872|NCT01625052|supraglottic airway|supraglottic airway
453873|NCT01625052|airway management|airway management
453874|NCT01625039|Occupational health|occupational health
453875|NCT01625039|cognitive behavioural therapy|cognitive behavioural therapy
453876|NCT01625039|physiotherapy|physiotherapy
453877|NCT01625039|physical activity|physical activity
453878|NCT01625026|Morbidly obesity|morbidly obesity
453879|NCT01625026|Gastric bypass|gastric bypass
453880|NCT01625026|Cholecystolithiasis|cholecystolithiasis
453881|NCT01625013|osteoarthritis|osteoarthritis
453882|NCT01625013|viscosupplementation|viscosupplementation
453883|NCT01625013|Active|active
453884|NCT01625013|Knee|knee
453885|NCT01625013|Synvisc-One|synvisc-one
453886|NCT01625000|Schizophrenia|schizophrenia
453887|NCT01625000|Antipsychotic Agents|antipsychotic agents
453888|NCT01625000|Acute Schizophrenia|acute schizophrenia
453889|NCT01625000|Mental Disorder|mental disorder
453890|NCT01625000|Psychotropic Drugs|psychotropic drugs
453891|NCT01625000|Dopamine Agents|dopamine agents
453892|NCT01625000|Risperidone|risperidone
453893|NCT01625000|Central Nervous System Agents|central nervous system agents
453894|NCT01624987|Treatment of ex-combatants|treatment of ex-combatants
453895|NCT01624987|FORNET for ex-combatants|fornet for ex-combatants
453896|NCT01624987|Appetitive Aggression|appetitive aggression
453897|NCT01624987|Post-traumatic Stress Disorder|post-traumatic stress disorder
453898|NCT01624961|Controlled human malaria infection (CHMI)|controlled human malaria infection (chmi)
453899|NCT01624961|Malaria challenge|malaria challenge
453900|NCT01624961|Plasmodium falciparum|plasmodium falciparum
453901|NCT01624961|PfSPZ Challenge|pfspz challenge
453902|NCT01624948|BK virus|bk virus
453903|NCT01624948|Kidney Transplantation|kidney transplantation
453904|NCT01624948|Immunologic Monitoring|immunologic monitoring
453905|NCT01624935|PTSD|ptsd
453906|NCT01624935|earthquake|earthquake
453907|NCT01624935|disaster|disaster
453908|NCT01624935|global mental health|global mental health
455303|NCT01618669|regadenoson|regadenoson
453909|NCT01624935|disaster mental health|disaster mental health
453910|NCT01624935|depression|depression
453911|NCT01624870|Aortic Valve Stenosis|aortic valve stenosis
453912|NCT01624870|Valvular Heart Disease|valvular heart disease
453913|NCT01624870|Transcatheter Aortic Valve Implantation|transcatheter aortic valve implantation
453914|NCT01624844|ultrasound|ultrasound
453915|NCT01624831|Psychosis|psychosis
453916|NCT01624831|schizophrenia|schizophrenia
453917|NCT01624831|schizoaffective disorder|schizoaffective disorder
453918|NCT01624831|Bipolar disorder with psychotic features|bipolar disorder with psychotic features
453919|NCT01624831|Major depression with psychotic features|major depression with psychotic features
453920|NCT01624831|Psychosis NOS|psychosis nos
453921|NCT01624831|Social Cognition|social cognition
453922|NCT01624818|coping|coping
453923|NCT01624818|physical activity|physical activity
453924|NCT01624818|psychosocial|psychosocial
453925|NCT01624818|children|children
453926|NCT01624818|heart disease|heart disease
453927|NCT01624818|habilitation|habilitation
453928|NCT01624792|Protein metabolism|protein metabolism
453929|NCT01624792|casein protein|casein protein
453930|NCT01624792|EPA|epa
453931|NCT01624792|Fish oil|fish oil
453932|NCT01624779|autologous adipose tissue|autologous adipose tissue
453933|NCT01624753|interstitial lung disease|interstitial lung disease
453934|NCT01624753|interstitial pneumonia|interstitial pneumonia
453935|NCT01624753|idiopathic pulmonary fibrosis|idiopathic pulmonary fibrosis
453936|NCT01624727|Coronary heart disease|coronary heart disease
453937|NCT01624727|metabolic syndrome|metabolic syndrome
453938|NCT01624727|CT angiography|ct angiography
453939|NCT01624714|Treatment Refractory|treatment refractory
453940|NCT01624701|Cord blood|cord blood
453941|NCT01624701|unrelated donor|unrelated donor
453942|NCT01624701|allogeneic|allogeneic
453943|NCT01624701|cell dose|cell dose
453944|NCT01624688|Tattoo|tattoo
453945|NCT01624688|Tattoo Removal|tattoo removal
453946|NCT01624675|Autistic disorder in children and adolescents|autistic disorder in children and adolescents
453947|NCT01624675|Risperidone (R064766)|risperidone (r064766)
453948|NCT01624675|Children|children
453949|NCT01624675|Adolescents|adolescents
453950|NCT01624675|Irritability|irritability
453951|NCT01624675|Autistic disorder|autistic disorder
453952|NCT01624649|Attention-deficit hyperactivity disorder|attention-deficit hyperactivity disorder
453953|NCT01624649|Developmental disorder|developmental disorder
453954|NCT01624649|Atomoxetine|atomoxetine
453955|NCT01624649|Methylphenidate|methylphenidate
453956|NCT01624649|Psychiatric disorder|psychiatric disorder
453957|NCT01624636|AMD|amd
453958|NCT01624636|Age-related Macular Degeneration|age-related macular degeneration
453959|NCT01624636|Wet AMD|wet amd
453960|NCT01624636|Neovascular AMD|neovascular amd
453961|NCT01624623|radiation|radiation
453962|NCT01624623|Calypso|calypso
453963|NCT01624623|prostatectomy|prostatectomy
453964|NCT01624610|Irritable bowel syndrome|irritable bowel syndrome
453965|NCT01624610|Diarrhea|diarrhea
453966|NCT01624610|abdominal pain|abdominal pain
453967|NCT01624610|diet|diet
453968|NCT01624610|nutrition|nutrition
453969|NCT01624597|Road traffic safety|road traffic safety
453970|NCT01624584|child|child
453971|NCT01624584|anxiety|anxiety
453972|NCT01624584|CBT|cbt
453973|NCT01624558|malignant hyperthermia|malignant hyperthermia
453974|NCT01624545|chronic subdural hematoma|chronic subdural hematoma
453975|NCT01624545|burr hole trepanation|burr hole trepanation
453976|NCT01624545|radiologic follow-up|radiologic follow-up
453977|NCT01624545|outcome|outcome
453978|NCT01624545|recurrence|recurrence
453979|NCT01624532|Anthrax vaccine|anthrax vaccine
453980|NCT01624519|Arterial Lactate|arterial lactate
453981|NCT01624519|Central Venous Lactate|central venous lactate
453982|NCT01624519|Peripheral Venous Lactate|peripheral venous lactate
453983|NCT01624506|GERD|gerd
453984|NCT01624506|Fundoplication|fundoplication
453985|NCT01624506|Magnetic Sphincter Augmentation|magnetic sphincter augmentation
453986|NCT01624493|Vascular Disrupting Agents|vascular disrupting agents
453987|NCT01624493|BNC105P|bnc105p
453988|NCT01624493|Partially platinum sensitive|partially platinum sensitive
453989|NCT01624480|Pediatric Narcolepsy|pediatric narcolepsy
453990|NCT01624467|Advanced Solid Tumors|advanced solid tumors
453991|NCT01624454|colonoscopy|colonoscopy
453992|NCT01624454|bowel cleansing|bowel cleansing
453993|NCT01624428|Tobacco|tobacco
453994|NCT01624428|Adolescent|adolescent
453995|NCT01624428|Nicotine|nicotine
453996|NCT01624428|Magnetic Resonance Imaging|magnetic resonance imaging
453997|NCT01624428|Varenicline|varenicline
453998|NCT01624389|[18F]AV-45 PET amyloid binding imaging|[18f]av-45 pet amyloid binding imaging
453999|NCT01624389|Alzheimer's disease|alzheimer's disease
454000|NCT01624376|non-invasive management|non-invasive management
454001|NCT01624376|Fistula|fistula
454002|NCT01624376|Crohn's Disease|crohn's disease
454003|NCT01624376|local administration|local administration
454004|NCT01624376|non-invasive|non-invasive
454005|NCT01624363|Pancreatic cysts incidentally found during EUS|pancreatic cysts incidentally found during eus
454006|NCT01624350|Anorectal Fistulas|anorectal fistulas
455404|NCT01618344|neoplasms|neoplasms
454007|NCT01624337|Plasmodium falciparum|plasmodium falciparum
454008|NCT01624337|Plasmodium vivax|plasmodium vivax
454009|NCT01624324|aminoglycoside|aminoglycoside
454010|NCT01624324|KIM-1|kim-1
454011|NCT01624324|DPOAE|dpoae
454012|NCT01624324|nephrotoxicity|nephrotoxicity
454013|NCT01624324|ototoxicity|ototoxicity
454014|NCT01624311|High ammonia level|high ammonia level
454015|NCT01624311|Hyperammonemia|hyperammonemia
454016|NCT01624311|Poor suck|poor suck
454017|NCT01624311|Lethargy|lethargy
454018|NCT01624311|Coma|coma
454019|NCT01624311|Encephalopathy|encephalopathy
454020|NCT01624311|Seizures|seizures
454021|NCT01624311|Brain edema|brain edema
454022|NCT01624311|Urea Cycle Disorder|urea cycle disorder
454023|NCT01624311|Ornithine Transcarbamylase Deficiency|ornithine transcarbamylase deficiency
454024|NCT01624311|Carbamoyl Phosphate Synthetase Deficiency|carbamoyl phosphate synthetase deficiency
454025|NCT01624311|Citrullinemia|citrullinemia
454026|NCT01624311|Argininosuccinic Aciduria|argininosuccinic aciduria
454027|NCT01624311|Organic Acidemia|organic acidemia
454028|NCT01624311|Propionic Aciduria|propionic aciduria
454029|NCT01624311|Methylmalonic Aciduria|methylmalonic aciduria
454030|NCT01624311|Isovaleric Aciduria|isovaleric aciduria
454031|NCT01624298|Randomized controlled trial|randomized controlled trial
454032|NCT01624298|Traumatized youth|traumatized youth
454033|NCT01624298|HIV risk|hiv risk
454034|NCT01624272|Physical Therapy|physical therapy
454035|NCT01624272|Respiratory Muscle Training|respiratory muscle training
454036|NCT01624272|Elderly|elderly
454037|NCT01624220|Spinal tumor|spinal tumor
454038|NCT01624220|Tumor of the mid or lower spine|tumor of the mid or lower spine
454039|NCT01624220|Non-small cell lung cancer|non-small cell lung cancer
454040|NCT01624220|Breast cancer|breast cancer
454041|NCT01624220|Prostate cancer|prostate cancer
454042|NCT01624220|Renal cell cancer|renal cell cancer
454043|NCT01624220|Melanoma|melanoma
454044|NCT01624220|Gastrointestinal cancer|gastrointestinal cancer
454045|NCT01624220|Sarcoma|sarcoma
454046|NCT01624220|Thyroid cancer|thyroid cancer
454047|NCT01624220|Head and neck primary cancer|head and neck primary cancer
454048|NCT01624220|Carcinoma of unknown primary|carcinoma of unknown primary
454049|NCT01624220|Fiducial markers|fiducial markers
454050|NCT01624220|Gold seed markers|gold seed markers
454051|NCT01624220|Spinal stereotactic body radiation therapy|spinal stereotactic body radiation therapy
454052|NCT01624220|Spinal SBRT|spinal sbrt
454053|NCT01624220|Stereotactic Radiotherapy|stereotactic radiotherapy
454054|NCT01624207|Atorva|atorva
454055|NCT01624207|generic|generic
454056|NCT01624207|atorvastatin|atorvastatin
454057|NCT01624207|hypercholesterolemia|hypercholesterolemia
454058|NCT01624181|ion mobility spectrometry|ion mobility spectrometry
454059|NCT01624181|hospital-acquired pneumonia|hospital-acquired pneumonia
454060|NCT01624181|microbiological investigation|microbiological investigation
454061|NCT01624181|intensive care|intensive care
454062|NCT01624168|anxiety|anxiety
454063|NCT01624168|sleep quality|sleep quality
454064|NCT01624168|tai chi chuan|tai chi chuan
454065|NCT01624168|young adults|young adults
454066|NCT01624155|teratogens|teratogens
454067|NCT01624155|contraception|contraception
454068|NCT01624155|electronic medical record|electronic medical record
454069|NCT01624142|Hypercholesterolemia|hypercholesterolemia
454070|NCT01624142|Elevated Cholesterol|elevated cholesterol
454071|NCT01624142|High Cholesterol|high cholesterol
454072|NCT01624142|Homozygous Familial Hypercholesterolemia|homozygous familial hypercholesterolemia
454073|NCT01624142|PCSK9 mutations|pcsk9 mutations
454074|NCT01624142|Severe Familial Hypercholesterolemia|severe familial hypercholesterolemia
454075|NCT01624103|Arm Injuries|arm injuries
454076|NCT01624103|Wounds and Injuries|wounds and injuries
454077|NCT01624103|Lidocaine|lidocaine
454078|NCT01624103|Levobupivacaine|levobupivacaine
454079|NCT01624103|Bupivacaine|bupivacaine
454080|NCT01624103|Anesthetics|anesthetics
454081|NCT01624103|Central Nervous System Depressants|central nervous system depressants
454082|NCT01624103|Physiological Effects of Drugs|physiological effects of drugs
454083|NCT01624090|Cancer Stem Cell|cancer stem cell
454084|NCT01624090|Thoracic Malignancies|thoracic malignancies
454085|NCT01624090|Mythramycin Treatment|mythramycin treatment
454086|NCT01624090|Lung Tumors|lung tumors
454087|NCT01624090|Metastatic Lung Tumors|metastatic lung tumors
454088|NCT01624077|Regulatory T cells|regulatory t cells
454089|NCT01624077|Liver Transplantation|liver transplantation
454090|NCT01624077|Rejection|rejection
454091|NCT01624077|Tolerance|tolerance
454092|NCT01624077|Cell tolerance|cell tolerance
454093|NCT01624077|Survival|survival
454094|NCT01624064|Renal Insufficiency, Chronic|renal insufficiency, chronic
454095|NCT01624064|Uncertain aetiology|uncertain aetiology
454096|NCT01624064|ACEI|acei
454097|NCT01624051|cisplatin based chemotherapy|cisplatin based chemotherapy
454098|NCT01624051|non-small cell lung cancer|non-small cell lung cancer
454099|NCT01624051|lean body mass|lean body mass
454100|NCT01624051|sarcopenia|sarcopenia
454101|NCT01624038|Hydroxyurea|hydroxyurea
454102|NCT01624038|Erythropoitin therapy|erythropoitin therapy
454103|NCT01624038|Thalassemia intermedia|thalassemia intermedia
454104|NCT01624025|AGC, second-line, docetaxel, epirubicin|agc, second-line, docetaxel, epirubicin
454105|NCT01624012|NIV NAVA|niv nava
454106|NCT01624012|non-invasive ventilation|non-invasive ventilation
454107|NCT01623973|hemiparetic|hemiparetic
454108|NCT01623973|cognitive|cognitive
454109|NCT01623973|balance|balance
454110|NCT01623960|severe haemophilia|severe haemophilia
454111|NCT01623960|quality of life|quality of life
454112|NCT01623947|glutamine|glutamine
454113|NCT01623947|cycling performance|cycling performance
454114|NCT01623947|mental function|mental function
454115|NCT01623934|Gestational diabetes|gestational diabetes
454116|NCT01623934|Adiponectin|adiponectin
454117|NCT01623934|Leptin|leptin
454118|NCT01623934|Single Nucleotides Polymorphisms|single nucleotides polymorphisms
454119|NCT01623934|Insulin resistance|insulin resistance
454120|NCT01623921|Lung|lung
454121|NCT01623921|Contusion|contusion
454122|NCT01623921|Injury|injury
454123|NCT01623921|Cyclooxygenase|cyclooxygenase
454124|NCT01623921|Statin|statin
454125|NCT01623908|Breast neoplasms|breast neoplasms
454126|NCT01623908|Zoledronate|zoledronate
454127|NCT01623908|Bone loss|bone loss
454128|NCT01623882|Diabetes Mellitus|diabetes mellitus
454129|NCT01623882|Wounds|wounds
454130|NCT01623882|Ulcers|ulcers
454131|NCT01623843|FAI|fai
454132|NCT01623843|randomized|randomized
454133|NCT01623843|hip arthroscopy|hip arthroscopy
454134|NCT01623843|lavage|lavage
454135|NCT01623843|osteochondroplasty|osteochondroplasty
454136|NCT01623830|reconsolidation|reconsolidation
454137|NCT01623830|fear of flying|fear of flying
454138|NCT01623830|virtual reality|virtual reality
454139|NCT01623830|virtual reality exposure therapy|virtual reality exposure therapy
454140|NCT01623804|Ultrasound therapy|ultrasound therapy
454141|NCT01623804|Tibiofemoral joint, medial|tibiofemoral joint, medial
454142|NCT01623804|Nonsurgical|nonsurgical
454143|NCT01623791|Pre-eclampsia|pre-eclampsia
454144|NCT01623791|Proteinuria|proteinuria
454145|NCT01623791|Protein - creatinine ratio|protein - creatinine ratio
454146|NCT01623791|Dipstick proteinuria|dipstick proteinuria
454147|NCT01623791|Severity of disease|severity of disease
454148|NCT01623778|HBeAg seroconversion|hbeag seroconversion
454149|NCT01623778|Peginterferon alfa-2a|peginterferon alfa-2a
454150|NCT01623778|chronic hepatitis B(CHB|chronic hepatitis b(chb
454151|NCT01623778|Optimal therapy|optimal therapy
454152|NCT01623778|Response guild treatment(RGT);|response guild treatment(rgt);
454153|NCT01623765|Endobronchial ultrasound, lung cancer|endobronchial ultrasound, lung cancer
454154|NCT01623739|Dental implants|dental implants
454155|NCT01623739|Esthetic score|esthetic score
454156|NCT01623739|Immediate implants|immediate implants
454157|NCT01623739|Early placement|early placement
454158|NCT01623726|Transcranial Direct Current Stimulation|transcranial direct current stimulation
454159|NCT01623726|Schizophrenia|schizophrenia
454160|NCT01623713|schizophrenia|schizophrenia
454161|NCT01623713|iloperidone|iloperidone
454162|NCT01623713|Risperidone|risperidone
454163|NCT01623713|Efficacy|efficacy
454164|NCT01623713|Safety|safety
454165|NCT01623700|clopidogrel|clopidogrel
454166|NCT01623700|aspirin|aspirin
454167|NCT01623700|percutaneous coronary intervention|percutaneous coronary intervention
454168|NCT01623700|coronary stenting|coronary stenting
454169|NCT01623700|antiplatelet|antiplatelet
454170|NCT01623687|total hip arthroplasty|total hip arthroplasty
454171|NCT01623687|bone metabolism|bone metabolism
454172|NCT01623687|mineralisation|mineralisation
454173|NCT01623674|Sleep deprivation in surgeons during night shifts and the effect on performance.|sleep deprivation in surgeons during night shifts and the effect on performance.
454174|NCT01623661|Nephrology|nephrology
454175|NCT01623661|chronic kidney disease|chronic kidney disease
454176|NCT01623661|sodium-channels|sodium-channels
454177|NCT01623661|water-channels|water-channels
454178|NCT01623661|BCM|bcm
454179|NCT01623648|whey protein|whey protein
454180|NCT01623648|hunger|hunger
454181|NCT01623609|Phase 1|phase 1
454182|NCT01623609|Healthy volunteers|healthy volunteers
454183|NCT01623609|Naloxegol|naloxegol
454184|NCT01623609|Bioequivalence|bioequivalence
454185|NCT01623583|lidocaine|lidocaine
454186|NCT01623583|tetracaine|tetracaine
454187|NCT01623583|Renal dialysis|renal dialysis
454188|NCT01623570|Luteinizing Hormone|luteinizing hormone
454189|NCT01623570|Hypogonadotropic Hypogonadism|hypogonadotropic hypogonadism
454190|NCT01623570|Ovulation Induction|ovulation induction
454191|NCT01623570|Chorionic Gonadotropin|chorionic gonadotropin
454192|NCT01623557|Malaria|malaria
454193|NCT01623557|Vaccine|vaccine
454194|NCT01623557|Plasmodium|plasmodium
454195|NCT01623557|falciparum|falciparum
454196|NCT01623544|Asthma|asthma
454197|NCT01623544|Comparative Effectiveness|comparative effectiveness
454198|NCT01623544|Symbicort|symbicort
454199|NCT01623531|Fibrinogen|fibrinogen
454200|NCT01623531|cardiac surgery|cardiac surgery
454201|NCT01623531|high risk|high risk
454202|NCT01623531|cardiopulmonary bypass|cardiopulmonary bypass
454203|NCT01623531|bleeding|bleeding
454204|NCT01623531|blood transfusion|blood transfusion
454205|NCT01623505|Smoking Cessation|smoking cessation
455405|NCT01618344|adolescent|adolescent
454206|NCT01623505|Psychiatric Illness|psychiatric illness
454207|NCT01623505|Pharmacotherapy|pharmacotherapy
454208|NCT01623492|Eisenmenger|eisenmenger
454209|NCT01623466|PK and Safety|pk and safety
454210|NCT01623453|crohn's disease|crohn's disease
454211|NCT01623453|fistula|fistula
454212|NCT01623453|complex|complex
454213|NCT01623427|pediatric|pediatric
454214|NCT01623427|laparoscopy|laparoscopy
454215|NCT01623427|vacuum|vacuum
454216|NCT01623427|dressing|dressing
454217|NCT01623362|Dentifrices|dentifrices
454218|NCT01623362|Dental Caries|dental caries
454219|NCT01623362|Fluorides|fluorides
454220|NCT01623362|Nails|nails
454221|NCT01623362|pH|ph
454222|NCT01623349|Recurrent|recurrent
454223|NCT01623349|High Grade|high grade
454224|NCT01623349|Serous|serous
454225|NCT01623349|Triple Negative|triple negative
454226|NCT01623336|HEPATITIS|hepatitis
454227|NCT01623336|HEPATITIS C|hepatitis c
454228|NCT01623336|PEGINTERFERON|peginterferon
454229|NCT01623336|BIOEQUIVALENCE|bioequivalence
454230|NCT01623336|TREATMENT|treatment
454231|NCT01623297|Laparoscopy|laparoscopy
454232|NCT01623297|Surgery|surgery
454233|NCT01623297|Acute Phase Reaction|acute phase reaction
454234|NCT01623297|Aged|aged
454235|NCT01623297|Aged 80 and over|aged 80 and over
454236|NCT01623297|Confusion|confusion
454237|NCT01623297|Inflammation|inflammation
454238|NCT01623297|Delirium|delirium
454239|NCT01623284|aphasia|aphasia
454240|NCT01623284|apraxia of speech|apraxia of speech
454241|NCT01623284|language|language
454242|NCT01623271|CRPS I|crps i
454243|NCT01623232|vaccine|vaccine
454244|NCT01623232|influenzavirus A|influenzavirus a
454245|NCT01623232|influenzavirus B|influenzavirus b
454246|NCT01623232|adjuvant|adjuvant
454247|NCT01623219|PTSD|ptsd
454248|NCT01623219|trauma|trauma
454249|NCT01623219|combat trauma|combat trauma
454250|NCT01623219|veterans|veterans
454251|NCT01623219|telemedicine|telemedicine
454252|NCT01623219|prolonged exposure|prolonged exposure
454253|NCT01623193|Cardioplegia|cardioplegia
454254|NCT01623193|Blood transfusion|blood transfusion
454255|NCT01623193|Cardiac function|cardiac function
454256|NCT01623193|Myocardial edema|myocardial edema
454257|NCT01623193|Coronary artery disease|coronary artery disease
454258|NCT01623193|Valve disease|valve disease
454259|NCT01623180|DES|des
454260|NCT01623180|coronary stent|coronary stent
454261|NCT01623180|bare metal stent|bare metal stent
454262|NCT01623180|high bleeding|high bleeding
454263|NCT01623180|MI|mi
454264|NCT01623180|angina|angina
454265|NCT01623167|Pancytopenia|pancytopenia
454266|NCT01623167|Immunosuppression|immunosuppression
454267|NCT01623167|Hematopoesis|hematopoesis
454268|NCT01623167|Autoimmunity|autoimmunity
454269|NCT01623167|Thrombocytopenia|thrombocytopenia
454270|NCT01623154|Helicobacter pylori|helicobacter pylori
454271|NCT01623141|CRPS|crps
454272|NCT01623141|TPBS|tpbs
454273|NCT01623141|Pressure pain thresholds|pressure pain thresholds
454274|NCT01623141|limb pain of other origin|limb pain of other origin
454275|NCT01623128|Breastfeeding initiation|breastfeeding initiation
454276|NCT01623128|Breastfeeding duration|breastfeeding duration
454277|NCT01623128|WIC|wic
454278|NCT01623128|Video education|video education
454279|NCT01623128|Breastfeeding rates|breastfeeding rates
454280|NCT01623115|PCSK9|pcsk9
454281|NCT01623102|Bevacizumab|bevacizumab
454282|NCT01623102|gemcitabine|gemcitabine
454283|NCT01623102|cisplatin|cisplatin
454284|NCT01623102|EGFR wild-type|egfr wild-type
454285|NCT01623089|severe asthma, phenotype, data|severe asthma, phenotype, data
454286|NCT01623076|Neuromyelitis Optica|neuromyelitis optica
454287|NCT01623076|Neuromyelitis Optica Spectrum Disorder|neuromyelitis optica spectrum disorder
454288|NCT01623076|Transverse Myelitis|transverse myelitis
454289|NCT01623076|Optic Neuritis|optic neuritis
454290|NCT01623076|Biorepository|biorepository
454291|NCT01623063|endometrium|endometrium
454292|NCT01623063|infertility|infertility
454293|NCT01623063|uterus|uterus
454294|NCT01623063|histeroscopy|histeroscopy
454295|NCT01623037|Lipolysis|lipolysis
454296|NCT01623037|Cryolipolysis|cryolipolysis
454297|NCT01623037|Fat Reduction|fat reduction
454298|NCT01623011|Shoulder|shoulder
454299|NCT01623011|Sub-acromial|sub-acromial
454300|NCT01623011|Rotator Cuff|rotator cuff
454301|NCT01623011|Impingement|impingement
454302|NCT01622998|Pharmacotherapy|pharmacotherapy
454303|NCT01622998|Titration|titration
454304|NCT01622998|Smoking Cessation|smoking cessation
454305|NCT01622959|emergency departement|emergency departement
454306|NCT01622959|acute pain|acute pain
454307|NCT01622959|acupuncture|acupuncture
454308|NCT01622959|morphine|morphine
454309|NCT01622946|total hip arthroplasty|total hip arthroplasty
454310|NCT01622946|tranexamic acid|tranexamic acid
454311|NCT01622946|postoperative blood loss|postoperative blood loss
454312|NCT01622933|melanoma|melanoma
454313|NCT01622933|recurrent|recurrent
454314|NCT01622933|metastatic|metastatic
454315|NCT01622920|enamel erosion|enamel erosion
454317|NCT01622920|reproducibility|reproducibility
454318|NCT01622920|human central incisor|human central incisor
454319|NCT01622920|reliability|reliability
454320|NCT01622907|Catheter ablation, radiofrequency|catheter ablation, radiofrequency
454321|NCT01622907|Epicardially applied radiofrequency ablation|epicardially applied radiofrequency ablation
454322|NCT01622907|Minimally invasive surgical approach|minimally invasive surgical approach
454323|NCT01622894|Alzheimer genetics|alzheimer genetics
454324|NCT01622855|Rape|rape
454325|NCT01622855|Secondary prevention|secondary prevention
454326|NCT01622855|Intervention|intervention
454327|NCT01622842|Impedance|impedance
454328|NCT01622842|Electrical|electrical
454329|NCT01622842|Tissue|tissue
454330|NCT01622842|Excitation frequency|excitation frequency
454331|NCT01622842|arterial distension|arterial distension
454332|NCT01622842|distension wave form|distension wave form
454333|NCT01622777|Rosuvastatin|rosuvastatin
454334|NCT01622777|Diabetic polyneuropathy|diabetic polyneuropathy
454335|NCT01622777|Nerve conduction|nerve conduction
454336|NCT01622777|Oxidative stress|oxidative stress
454337|NCT01622777|Nerve growth factor|nerve growth factor
454338|NCT01622764|RO5323441|ro5323441
454339|NCT01622764|bevacizumab|bevacizumab
454340|NCT01622764|PET imaging|pet imaging
454341|NCT01622764|recurrent glioblastoma|recurrent glioblastoma
454342|NCT01622751|REM sleep|rem sleep
454343|NCT01622751|Adiponectin|adiponectin
454344|NCT01622751|Prader-Willi syndrome|prader-willi syndrome
454345|NCT01622725|ventral hernia|ventral hernia
454346|NCT01622712|inguinal hernia|inguinal hernia
454347|NCT01622699|Jaundice|jaundice
454348|NCT01622699|Neonatal Jaundice|neonatal jaundice
454349|NCT01622699|Hyperbilirubinemia|hyperbilirubinemia
454350|NCT01622699|Transcutaneous bilirubin measurement|transcutaneous bilirubin measurement
454351|NCT01622699|Transcutaneous bilirubinometry|transcutaneous bilirubinometry
454352|NCT01622699|jaundice meter|jaundice meter
454353|NCT01622699|Visual assessment of bilirubin|visual assessment of bilirubin
454354|NCT01622699|Newborn|newborn
454355|NCT01622686|Prescription Labels|prescription labels
454356|NCT01622686|Low Health Literacy|low health literacy
454357|NCT01622686|Limited English Proficiency|limited english proficiency
454358|NCT01622686|Spanish|spanish
454359|NCT01622660|URETER|ureter
454360|NCT01622660|URINARY BLADDER|urinary bladder
454361|NCT01622660|renal pelvis|renal pelvis
454362|NCT01622660|GEMCITABINE|gemcitabine
454363|NCT01622660|GW786034 (PAZOPANIB)|gw786034 (pazopanib)
454364|NCT01622660|11-191|11-191
454365|NCT01622647|NCPAP|ncpap
454366|NCT01622634|cardiovascular disease|cardiovascular disease
454367|NCT01622634|diabetes mellitus|diabetes mellitus
454368|NCT01622621|Lung|lung
454369|NCT01622621|Cancer|cancer
454370|NCT01622608|Adolescent vaccination|adolescent vaccination
454371|NCT01622608|Immunization rates|immunization rates
454372|NCT01622608|Informational kiosk|informational kiosk
454373|NCT01622608|Tailored health messaging|tailored health messaging
454374|NCT01622608|Barriers to vaccination|barriers to vaccination
454375|NCT01622608|Attitudes|attitudes
454376|NCT01622608|Intentions|intentions
454377|NCT01622595|Aspergillosis|aspergillosis
454378|NCT01622595|Candidemia|candidemia
454379|NCT01622595|Candidiasis|candidiasis
454380|NCT01622595|C. Difficile|c. difficile
454381|NCT01622595|cytomegalovirus|cytomegalovirus
454382|NCT01622595|respiratory syncytial virus (RSV)|respiratory syncytial virus (rsv)
454383|NCT01622595|Influenza|influenza
454384|NCT01622595|CONS|cons
454385|NCT01622582|Multiple Myeloma, Engraftment syndrome|multiple myeloma, engraftment syndrome
454386|NCT01622556|Chronic Myeloid Leukemia|chronic myeloid leukemia
454387|NCT01622556|Acute Myeloid Leukemia|acute myeloid leukemia
454388|NCT01622556|Acute Lymphoblastic Leukemia|acute lymphoblastic leukemia
454389|NCT01622556|Non-Hodgkins Lymphoma|non-hodgkins lymphoma
454390|NCT01622556|Hodgkin's Disease|hodgkin's disease
454391|NCT01622556|Myelodysplastic Syndromes|myelodysplastic syndromes
454392|NCT01622556|Myeloproliferative Disorder|myeloproliferative disorder
454393|NCT01622504|Intranasal|intranasal
454394|NCT01622504|nasal spray|nasal spray
454395|NCT01622504|opioid|opioid
454396|NCT01622504|overdose|overdose
454397|NCT01622491|H1N1|h1n1
454398|NCT01622491|pandemic|pandemic
454399|NCT01622491|influenza|influenza
454400|NCT01622491|pneumonia|pneumonia
454401|NCT01622491|vaccine|vaccine
454402|NCT01622491|effectiveness|effectiveness
454403|NCT01622491|Manitoba|manitoba
454404|NCT01622491|Canada|canada
454405|NCT01622478|sentinel lymph node biopsy|sentinel lymph node biopsy
454406|NCT01622478|neoadjuvant chemotherapy|neoadjuvant chemotherapy
454407|NCT01622478|breast cancer|breast cancer
454408|NCT01622478|locally advanced breast cancer|locally advanced breast cancer
454409|NCT01622478|positive axillary lymph node|positive axillary lymph node
454410|NCT01622478|negative conversion|negative conversion
454411|NCT01622465|Hip arthroplasty|hip arthroplasty
454412|NCT01622465|Aged|aged
454413|NCT01622465|Rehabilitation|rehabilitation
454414|NCT01622465|Exercise therapy|exercise therapy
454415|NCT01622452|Postoperative cognitive dysfunction|postoperative cognitive dysfunction
455406|NCT01618344|young adult|young adult
454416|NCT01622452|Cognitive decline|cognitive decline
454417|NCT01622452|Valve surgery|valve surgery
454418|NCT01622452|Cardiac surgery|cardiac surgery
454419|NCT01622452|Diffusion Tensor Imaging|diffusion tensor imaging
454420|NCT01622452|Brain Morphometry|brain morphometry
454421|NCT01622452|1H-Magnetic Resonance Spectroscopy|1h-magnetic resonance spectroscopy
454422|NCT01622439|Lymphoma|lymphoma
454423|NCT01622439|Diffuse large B-cell lymphoma|diffuse large b-cell lymphoma
454424|NCT01622439|Valproate|valproate
454425|NCT01622439|R-CHOP|r-chop
454426|NCT01622439|CD 20|cd 20
454427|NCT01622413|lumbar spine|lumbar spine
454428|NCT01622413|herniated disc|herniated disc
454429|NCT01622413|slipped disc|slipped disc
454430|NCT01622413|disc herniation|disc herniation
454431|NCT01622413|discectomy|discectomy
454432|NCT01622413|nucleotomy|nucleotomy
454433|NCT01622413|disc surgery|disc surgery
454434|NCT01622413|endoscopy|endoscopy
454435|NCT01622413|spine|spine
454436|NCT01622400|Cardiovascular risk, Therapeutic education, General practice|cardiovascular risk, therapeutic education, general practice
454437|NCT01622387|Coronary artery bypass surgery|coronary artery bypass surgery
454438|NCT01622387|Arteries|arteries
454439|NCT01622387|Veins|veins
454440|NCT01622387|Conduits|conduits
454441|NCT01622374|Music|music
454442|NCT01622374|dental anxiety|dental anxiety
454443|NCT01622374|"music for the mind"|"music for the mind"
454444|NCT01622374|mozart|mozart
454445|NCT01622374|iranian traditional music|iranian traditional music
454446|NCT01622361|Neoadjuvant|neoadjuvant
454447|NCT01622361|endocrine therapy|endocrine therapy
454448|NCT01622361|premenopausal|premenopausal
454449|NCT01622361|hormone responsive|hormone responsive
454450|NCT01622361|HER2 negative|her2 negative
454451|NCT01622361|lymph node positive|lymph node positive
454452|NCT01622348|Psoriasis|psoriasis
454453|NCT01622348|Plaque Psoriasis|plaque psoriasis
454454|NCT01622309|Oxidative Stress|oxidative stress
454455|NCT01622309|Obesity|obesity
454456|NCT01622309|Solanum melongena|solanum melongena
454457|NCT01622218|Medical clown|medical clown
454458|NCT01622192|Probing|probing
454459|NCT01622192|manual probe|manual probe
454460|NCT01622192|automated probe|automated probe
454461|NCT01622192|Periodontal disease|periodontal disease
454462|NCT01622179|surgery|surgery
454463|NCT01622179|suture method|suture method
454464|NCT01622179|blood supply|blood supply
454465|NCT01622140|T-SPOT.TB|t-spot.tb
454466|NCT01622140|QuantiFERON-TB Gold In-Tube|quantiferon-tb gold in-tube
454467|NCT01622140|Latent tuberculosis infection|latent tuberculosis infection
454468|NCT01622140|Tuberculin skin test|tuberculin skin test
454469|NCT01622140|Discordance|discordance
454470|NCT01622140|Predictive value|predictive value
454471|NCT01622140|Tuberculosis disease development|tuberculosis disease development
454472|NCT01622114|Obesity|obesity
454473|NCT01622114|Weight reduction|weight reduction
454474|NCT01622114|premenopausal Women|premenopausal women
454475|NCT01622114|Menstrual cycle|menstrual cycle
454476|NCT01622114|quality of life|quality of life
454477|NCT01622114|food cravings|food cravings
454478|NCT01622101|Energy expenditure|energy expenditure
454479|NCT01622101|Appetite|appetite
454480|NCT01622101|Bioactive herbal compounds|bioactive herbal compounds
454481|NCT01622101|blood pressure|blood pressure
454482|NCT01622088|ALS, Motor Neuron Disease, Amyotrophic Lateral Sclerosis|als, motor neuron disease, amyotrophic lateral sclerosis
454483|NCT01622062|Rabies|rabies
454484|NCT01622062|Verorab®|verorab®
454485|NCT01622062|Favirab®|favirab®
454486|NCT01622036|Malnutrition|malnutrition
454487|NCT01622036|pre-cachexia|pre-cachexia
454488|NCT01622036|cancer|cancer
454489|NCT01622036|cachexia|cachexia
454490|NCT01622036|MNA|mna
454491|NCT01622036|weight loss|weight loss
454492|NCT01622023|insemination|insemination
454493|NCT01622023|donor sperm|donor sperm
454494|NCT01622023|natural cycle|natural cycle
454495|NCT01622010|Heart Failure|heart failure
454496|NCT01622010|Patient Education as Topic|patient education as topic
454497|NCT01622010|Physical Therapy Specialty|physical therapy specialty
454498|NCT01621997|peritoneal dialysis|peritoneal dialysis
454499|NCT01621997|retraining|retraining
454500|NCT01621997|peritonitis|peritonitis
454501|NCT01621984|Cerebral palsy|cerebral palsy
454502|NCT01621984|brain injury|brain injury
454503|NCT01621984|spinal cord injuries|spinal cord injuries
454504|NCT01621984|muscular disease|muscular disease
454505|NCT01621971|inhaled milrinone|inhaled milrinone
454506|NCT01621971|pulmonary hypertension|pulmonary hypertension
454507|NCT01621971|mitral regurgitation|mitral regurgitation
454508|NCT01621971|mitral valve surgery|mitral valve surgery
454509|NCT01621958|balance loss|balance loss
454510|NCT01621958|dynamic stability|dynamic stability
454511|NCT01621958|motor learning|motor learning
454512|NCT01621958|plasticity|plasticity
454513|NCT01621945|Neisseria meningitidis B:14, P1-7, 16|neisseria meningitidis b:14, p1-7, 16
454514|NCT01621945|Serum bactericidal activity|serum bactericidal activity
454515|NCT01621945|OMV vaccine|omv vaccine
454516|NCT01621932|Anterior approach|anterior approach
454517|NCT01621906|Breast|breast
454518|NCT01621906|brain metastases|brain metastases
454519|NCT01621906|18F-FLT-PET Imaging|18f-flt-pet imaging
454520|NCT01621906|FLT(3'DEOXY-3'FLUOROTHYMIDINE)|flt(3'deoxy-3'fluorothymidine)
454521|NCT01621906|MR Imaging|mr imaging
454522|NCT01621906|12-039|12-039
454523|NCT01621893|bone marrow edema|bone marrow edema
454524|NCT01621893|bone marrow defects|bone marrow defects
454525|NCT01621880|radiation-induced brain necrosis|radiation-induced brain necrosis
454526|NCT01621880|nasopharyngeal carcinoma|nasopharyngeal carcinoma
454527|NCT01621880|Bevacizumab|bevacizumab
454528|NCT01621880|Methylprednisolone|methylprednisolone
454529|NCT01621867|Cystic fibrosis|cystic fibrosis
454530|NCT01621867|Gene therapy|gene therapy
454531|NCT01621867|CFTR gene|cftr gene
454532|NCT01621867|Gene expression|gene expression
454533|NCT01621867|Non-viral|non-viral
454534|NCT01621867|Multi dose|multi dose
454535|NCT01621854|cancer|cancer
454536|NCT01621854|nucleoside analogue|nucleoside analogue
454537|NCT01621854|advanced solid tumours|advanced solid tumours
454538|NCT01621828|pre-operative anxiety|pre-operative anxiety
454539|NCT01621828|multimedia information|multimedia information
454540|NCT01621828|operating theatre|operating theatre
454541|NCT01621815|ADHD|adhd
454542|NCT01621815|Attention Deficit/Hyperactivity Disorder|attention deficit/hyperactivity disorder
454543|NCT01621815|Conduct|conduct
454544|NCT01621815|Depression|depression
454545|NCT01621815|Anxiety|anxiety
454546|NCT01621815|PDD|pdd
454547|NCT01621815|Pervasive Developmental Disorders|pervasive developmental disorders
454548|NCT01621802|Safety|safety
454549|NCT01621802|Measles, mumps and rubella diseases|measles, mumps and rubella diseases
454550|NCT01621802|Immunogenicity|immunogenicity
454551|NCT01621789|lutein|lutein
454552|NCT01621789|zeaxanthin|zeaxanthin
454553|NCT01621789|trypan blue|trypan blue
454554|NCT01621789|dye|dye
454555|NCT01621776|post-prandial hyperglycemia|post-prandial hyperglycemia
454556|NCT01621737|oxytocin|oxytocin
454557|NCT01621724|Gene therapy|gene therapy
454558|NCT01621724|WT1 TCR|wt1 tcr
454559|NCT01621724|AML|aml
454560|NCT01621724|CML|cml
454561|NCT01621711|substance abuse|substance abuse
454562|NCT01621711|Substance Dependence|substance dependence
454563|NCT01621711|Substance, addiction|substance, addiction
454564|NCT01621711|Alcohol Abuse|alcohol abuse
454565|NCT01621711|prevention and control|prevention and control
454566|NCT01621711|preventative health services|preventative health services
454567|NCT01621711|patient centered care|patient centered care
454568|NCT01621698|VATS|vats
454569|NCT01621698|Paravertebral blocks.|paravertebral blocks.
454570|NCT01621698|Thoracoscopic surgery.|thoracoscopic surgery.
454571|NCT01621698|Analgesia.|analgesia.
454572|NCT01621685|Capsaicin|capsaicin
454573|NCT01621685|Cough|cough
454574|NCT01621685|Cough reflex|cough reflex
454575|NCT01621685|Inhalation agents|inhalation agents
454576|NCT01621685|Inhalation challenge|inhalation challenge
454577|NCT01621685|TRPV1 receptor|trpv1 receptor
454578|NCT01621672|Revlimid|revlimid
454579|NCT01621672|progression free|progression free
454580|NCT01621672|Lenalidomide|lenalidomide
454581|NCT01621659|multidisciplinary team|multidisciplinary team
454582|NCT01621659|exercise|exercise
454583|NCT01621659|nutrition|nutrition
454584|NCT01621659|cardiology|cardiology
454585|NCT01621659|physiotherapy|physiotherapy
454586|NCT01621659|imaging|imaging
454587|NCT01621646|lutein|lutein
454588|NCT01621646|eggs|eggs
454589|NCT01621646|mild cognitive impairment|mild cognitive impairment
454590|NCT01621646|elderly|elderly
454591|NCT01621633|hepatic impairment|hepatic impairment
454592|NCT01621607|fMRI|fmri
454593|NCT01621607|Monoamines|monoamines
454594|NCT01621607|Environment|environment
454595|NCT01621607|Genes|genes
454596|NCT01621607|Reward Learning|reward learning
454597|NCT01621594|Cardiac|cardiac
454598|NCT01621594|Computed Tomography|computed tomography
454599|NCT01621594|Radiation Reduction|radiation reduction
454600|NCT01621594|Iterative Reconstruction|iterative reconstruction
454601|NCT01621581|Gene Therapy|gene therapy
454602|NCT01621581|Parkinson's Disease|parkinson's disease
454603|NCT01621581|Convection-Ehanced Delivery|convection-ehanced delivery
454604|NCT01621581|Viral Vector|viral vector
454605|NCT01621568|VEGF|vegf
454606|NCT01621568|Anti-Angiogenesis|anti-angiogenesis
454607|NCT01621568|Targeted Agent|targeted agent
454608|NCT01621555|shoulder surgery|shoulder surgery
454609|NCT01621555|Pain sensitivity|pain sensitivity
454610|NCT01621555|Rowe score|rowe score
454611|NCT01621555|Constant Score|constant score
454612|NCT01621555|Surgical Outcome|surgical outcome
454613|NCT01621555|Postoperative pain|postoperative pain
454614|NCT01621542|Cancer|cancer
454615|NCT01621542|Vaccine|vaccine
454616|NCT01621542|Oncology|oncology
454617|NCT01621542|Malignancies|malignancies
454618|NCT01621542|Wilms' Tumor|wilms' tumor
454619|NCT01621542|WT1|wt1
454620|NCT01621542|Ovarian|ovarian
454621|NCT01621542|Glioblastoma [GBM]|glioblastoma [gbm]
454622|NCT01621542|Acute myeloid leukemia [AML]|acute myeloid leukemia [aml]
455714|NCT01616914|outcome|outcome
454623|NCT01621529|Positron-Emission Tomography|positron-emission tomography
454624|NCT01621529|PET Scan|pet scan
454625|NCT01621529|FDG|fdg
454626|NCT01621529|SUV|suv
454627|NCT01621529|Invasive Breast cancer|invasive breast cancer
454628|NCT01621529|Surgery compare|surgery compare
454629|NCT01621529|Tumor measurement|tumor measurement
454630|NCT01621516|Beta-cell function|beta-cell function
454631|NCT01621516|Liver/small bowel transplant|liver/small bowel transplant
454632|NCT01621516|Donor pancreas|donor pancreas
454633|NCT01621516|Diabetes|diabetes
454634|NCT01621516|Long-term immunesuppression|long-term immunesuppression
454635|NCT01621477|Hematologic malignancy|hematologic malignancy
454636|NCT01621477|Hematopoietic cell transplant|hematopoietic cell transplant
454637|NCT01621464|Neuromediated syncope|neuromediated syncope
454638|NCT01621464|Tilt test|tilt test
454639|NCT01621464|Pacemaker|pacemaker
454640|NCT01621464|CLS sensor|cls sensor
454641|NCT01621438|coronary artery|coronary artery
454642|NCT01621438|atherosclerosis|atherosclerosis
454643|NCT01621438|angina pectoris|angina pectoris
454644|NCT01621425|breast cancer|breast cancer
454645|NCT01621425|prostate carcinoma|prostate carcinoma
454646|NCT01621425|docetaxel|docetaxel
454647|NCT01621425|lean body mass|lean body mass
454648|NCT01621425|Body Surface Area|body surface area
454649|NCT01621425|body weight|body weight
454650|NCT01621425|dexascan|dexascan
454651|NCT01621412|Medication Adherence|medication adherence
454652|NCT01621412|HIV infection|hiv infection
454653|NCT01621412|Disclosure|disclosure
454654|NCT01621373|neonatology|neonatology
454655|NCT01621373|intratracheal intubation|intratracheal intubation
454656|NCT01621373|propofol|propofol
454657|NCT01621360|Randomized controlled trial|randomized controlled trial
454658|NCT01621360|Intention to treat|intention to treat
454659|NCT01621347|HIV|hiv
454660|NCT01621347|Pregnancy|pregnancy
454661|NCT01621347|Postpartum|postpartum
454662|NCT01621347|Women|women
454663|NCT01621347|Medication Adherence|medication adherence
454664|NCT01621308|Diabetes Mellitus type 1|diabetes mellitus type 1
454665|NCT01621308|Intraperitoneal insulin administration|intraperitoneal insulin administration
454666|NCT01621308|Subcutaneous insulin administration|subcutaneous insulin administration
454667|NCT01621308|Continuous intraperitoneal insulin infusion|continuous intraperitoneal insulin infusion
454668|NCT01621282|journal club|journal club
454669|NCT01621269|Multiple Sclerosis|multiple sclerosis
454670|NCT01621269|MS|ms
454671|NCT01621269|Fingolimod|fingolimod
454672|NCT01621269|Gilenya|gilenya
454673|NCT01621269|Neutralizing Antibodies|neutralizing antibodies
454674|NCT01621269|NAb|nab
454675|NCT01621243|necuparanib|necuparanib
454676|NCT01621243|gemcitabine|gemcitabine
454677|NCT01621243|heparin|heparin
454678|NCT01621243|low molecular weight heparin|low molecular weight heparin
454679|NCT01621243|nab-Paclitaxel|nab-paclitaxel
454680|NCT01621230|Bupivacaine|bupivacaine
454681|NCT01621230|Fentanyl|fentanyl
454682|NCT01621230|Epidural|epidural
454683|NCT01621230|Second Stage of Labor|second stage of labor
454684|NCT01621230|Randomized Controlled Trial|randomized controlled trial
454685|NCT01621217|Anal cancer|anal cancer
454686|NCT01621217|Locally advanced anal cancer|locally advanced anal cancer
454687|NCT01621217|Cetuximab|cetuximab
454688|NCT01621217|5-fluoruracil|5-fluoruracil
454689|NCT01621217|Mitomycin C|mitomycin c
454690|NCT01621217|Radiotherapy|radiotherapy
454691|NCT01621204|Thrombocytopenia|thrombocytopenia
454692|NCT01621204|ITP|itp
454693|NCT01621204|Platelets|platelets
454694|NCT01621204|Bleeding|bleeding
454695|NCT01621204|Immune|immune
454696|NCT01621204|Eltrombopag|eltrombopag
454697|NCT01621204|IVIG|ivig
454698|NCT01621165|treatment of bipolar, mania|treatment of bipolar, mania
454699|NCT01621165|double-blind, placebo-controlled study|double-blind, placebo-controlled study
454700|NCT01621165|drug intervention|drug intervention
454701|NCT01621165|add-on study|add-on study
454702|NCT01621165|prazosin|prazosin
454703|NCT01621165|alpha-1 adrenergic antagonist|alpha-1 adrenergic antagonist
454704|NCT01621152|Acute renal failure|acute renal failure
454705|NCT01621152|acute kidney injury|acute kidney injury
454706|NCT01621152|electronic surveillance|electronic surveillance
454707|NCT01621152|AKI|aki
454708|NCT01621152|sniffer|sniffer
454709|NCT01621152|AKIN|akin
454710|NCT01621152|improvement in the process of care and outcomes|improvement in the process of care and outcomes
454711|NCT01621126|Shoulder instability|shoulder instability
454712|NCT01621126|Latarjet procedure|latarjet procedure
454713|NCT01621126|Nerve injury|nerve injury
454714|NCT01621113|Spinal Cord Injuries|spinal cord injuries
454715|NCT01621113|4-Aminopyridine|4-aminopyridine
454716|NCT01621113|Physical Therapy Modalities|physical therapy modalities
454717|NCT01621113|Randomized Controlled Trial|randomized controlled trial
454718|NCT01621113|Rehabilitation|rehabilitation
454719|NCT01621113|Walking|walking
454720|NCT01621100|Cancer pain|cancer pain
454721|NCT01621100|OROS|oros
454722|NCT01621100|Osmotic release oral system|osmotic release oral system
454723|NCT01621100|Hydromorphone|hydromorphone
454724|NCT01621100|Painkiller|painkiller
454725|NCT01621100|Opioid analgesic|opioid analgesic
454726|NCT01621100|Korean patients|korean patients
454727|NCT01621061|high altitude illness|high altitude illness
454728|NCT01621061|pulmonary hypertension|pulmonary hypertension
454729|NCT01621061|sleep apnea|sleep apnea
454730|NCT01621061|hypoxia|hypoxia
454731|NCT01621048|Head and Neck Neoplasmsr|head and neck neoplasmsr
454732|NCT01621048|Radiotherapy|radiotherapy
454733|NCT01621048|Xerostomia|xerostomia
454734|NCT01621048|Deglutition Disorders|deglutition disorders
454735|NCT01621022|smoking cessation|smoking cessation
454736|NCT01621022|tobacco dependence|tobacco dependence
454737|NCT01621009|smoking cessation medications|smoking cessation medications
454738|NCT01621009|smoking cessation counseling|smoking cessation counseling
454739|NCT01620996|preintervention and postintervention cohort longitudinal prospective study|preintervention and postintervention cohort longitudinal prospective study
454740|NCT01620983|arthroplasty|arthroplasty
454741|NCT01620983|pain|pain
454742|NCT01620970|Transitional Cell Carcinoma|transitional cell carcinoma
454743|NCT01620970|Metastatic disease|metastatic disease
454744|NCT01620970|Bladder tumors, Recurrent|bladder tumors, recurrent
454745|NCT01620970|Angiogenesis|angiogenesis
454746|NCT01620970|PF03446962|pf03446962
454747|NCT01620970|Transforming growth factor beta|transforming growth factor beta
454748|NCT01620970|Activin receptor like kinase 1|activin receptor like kinase 1
454749|NCT01620970|Monoclonal Antibody|monoclonal antibody
454750|NCT01620970|Locally advanced or metastatic disease|locally advanced or metastatic disease
454751|NCT01620970|Failure of one platinum-based chemotherapy|failure of one platinum-based chemotherapy
454752|NCT01620970|Measurable disease|measurable disease
454753|NCT01620957|Default-mode network|default-mode network
454754|NCT01620957|Difussion tensor imaging|difussion tensor imaging
454755|NCT01620957|Cortical thickness|cortical thickness
454756|NCT01620957|Coma|coma
454757|NCT01620957|Vegetative state|vegetative state
454758|NCT01620957|Minimally conscious state|minimally conscious state
454759|NCT01620957|Neural correlate of consciousness|neural correlate of consciousness
454760|NCT01620892|unicondylar knee arthroplasty|unicondylar knee arthroplasty
454761|NCT01620892|partial knee replacement|partial knee replacement
454762|NCT01620866|EMDR|emdr
454763|NCT01620866|bipolar disorder|bipolar disorder
454764|NCT01620866|trauma|trauma
454765|NCT01620866|subsyndromal symptoms|subsyndromal symptoms
454766|NCT01620866|PTSD|ptsd
454767|NCT01620853|Non-small cell lung cancer (NSCLC)|non-small cell lung cancer (nsclc)
454768|NCT01620853|ALK probe|alk probe
454769|NCT01620853|FISH|fish
454770|NCT01620853|Chromosomal aberrations|chromosomal aberrations
454771|NCT01620840|oral administration of Lacosamide is not possible or adequate|oral administration of lacosamide is not possible or adequate
454772|NCT01620827|follow up|follow up
454773|NCT01620827|cell phone|cell phone
454774|NCT01620827|hospital landline|hospital landline
454775|NCT01620814|misoprostol|misoprostol
454776|NCT01620814|dinoprostone|dinoprostone
454777|NCT01620814|cervical ripening|cervical ripening
454778|NCT01620814|diagnostic hysteroscopy|diagnostic hysteroscopy
454779|NCT01620801|AAV|aav
454780|NCT01620801|AAV8|aav8
454781|NCT01620801|Adeno-associated virus|adeno-associated virus
454782|NCT01620801|Adeno-associated viral vectors|adeno-associated viral vectors
454783|NCT01620801|Hemophilia|hemophilia
454784|NCT01620801|Hemophilia B|hemophilia b
454785|NCT01620801|Severe hemophilia B|severe hemophilia b
454786|NCT01620801|Factor IX deficiency|factor ix deficiency
454787|NCT01620801|Factor IX|factor ix
454788|NCT01620801|FIX|fix
454789|NCT01620762|Cat allergy|cat allergy
454790|NCT01620762|Rhinoconjunctivitis|rhinoconjunctivitis
454791|NCT01620749|melanoma metastatic diagnosis|melanoma metastatic diagnosis
454792|NCT01620736|Raltegravir|raltegravir
454793|NCT01620736|HTLV|htlv
454794|NCT01620736|Integrase|integrase
454795|NCT01620723|Breastfeeding|breastfeeding
454796|NCT01620723|Breastfeeding self efficacy|breastfeeding self efficacy
454797|NCT01620710|prostatectomy|prostatectomy
454798|NCT01620658|Occupational Exposure to Radiation|occupational exposure to radiation
454799|NCT01620632|laparoscopy assisted ERCP|laparoscopy assisted ercp
454800|NCT01620632|altered gastric anatomy|altered gastric anatomy
454801|NCT01620619|Shoulder|shoulder
454802|NCT01620619|Bankart|bankart
454803|NCT01620619|Anterior Instability|anterior instability
454804|NCT01620619|Rotator Cuff|rotator cuff
454805|NCT01620606|FAP|fap
454806|NCT01620606|RAP|rap
454807|NCT01620606|Abdominal Pain|abdominal pain
454808|NCT01620606|IBS|ibs
454809|NCT01620593|Prostate Cancer|prostate cancer
454810|NCT01620593|Metformin|metformin
454811|NCT01620593|Castration therapy|castration therapy
454812|NCT01620580|sleep disturbance|sleep disturbance
454813|NCT01620580|tiredness|tiredness
454814|NCT01620580|itching & numbness|itching & numbness
454815|NCT01620567|lutein|lutein
454816|NCT01620567|avocados|avocados
454817|NCT01620567|chickpeas|chickpeas
454818|NCT01620567|potatoes|potatoes
454819|NCT01620567|elderly|elderly
454820|NCT01620554|Sleep disorder|sleep disorder
454821|NCT01620554|Obstructive Sleep Apnoea|obstructive sleep apnoea
455715|NCT01616901|Obese|obese
454822|NCT01620554|Excessive Daytime Sleepiness|excessive daytime sleepiness
454823|NCT01620528|Gonadotropin-Releasing Hormone Antagonist|gonadotropin-releasing hormone antagonist
454824|NCT01620528|Endometriosis associated pain|endometriosis associated pain
454825|NCT01620528|Dysmenorrhea (DYS)|dysmenorrhea (dys)
454826|NCT01620528|Non-Menstrual Pelvic Pain (NMPP)|non-menstrual pelvic pain (nmpp)
454827|NCT01620528|Elagolix|elagolix
454828|NCT01620515|Prostate|prostate
454829|NCT01620515|Prostate Cancer|prostate cancer
454830|NCT01620515|Localized Prostate Cancer|localized prostate cancer
454831|NCT01620515|T1c Prostate Cancer|t1c prostate cancer
454832|NCT01620515|Focal Therapy|focal therapy
454833|NCT01620515|NX-1207|nx-1207
454834|NCT01620411|Active Duty|active duty
454835|NCT01620411|Comprehensive Medical Management|comprehensive medical management
454836|NCT01620411|Spinal Cord Stimulator|spinal cord stimulator
454837|NCT01620411|Veteran|veteran
454838|NCT01620411|sustained|sustained
454839|NCT01620411|military|military
454840|NCT01620398|cardiovascular diseases|cardiovascular diseases
454841|NCT01620398|secondary prevention|secondary prevention
454842|NCT01620398|diet|diet
454843|NCT01620385|Cochlear implants|cochlear implants
454844|NCT01620359|Breast cancer|breast cancer
454845|NCT01620359|Breast tumor|breast tumor
454846|NCT01620359|stage 1 disease|stage 1 disease
454847|NCT01620359|T1 M0 N0|t1 m0 n0
454848|NCT01620346|advanced maternal age|advanced maternal age
454849|NCT01620346|infertility|infertility
454850|NCT01620346|IMSI|imsi
454851|NCT01620346|ICSI|icsi
454852|NCT01620346|implantation|implantation
454853|NCT01620320|Left main coronary artery|left main coronary artery
454854|NCT01620320|Coronary artery disease|coronary artery disease
454855|NCT01620320|Stress echography|stress echography
454856|NCT01620320|Intrastent stenosis|intrastent stenosis
454857|NCT01620307|H1N1 patients with severe hypoxemia requiring ventilator support|h1n1 patients with severe hypoxemia requiring ventilator support
454858|NCT01620294|surgical site infection|surgical site infection
454859|NCT01620294|elective colorectal surgery|elective colorectal surgery
454860|NCT01620294|level of surgical site infection|level of surgical site infection
454861|NCT01620294|complication of surgical site infection|complication of surgical site infection
454862|NCT01620294|type of changed bandage|type of changed bandage
454863|NCT01620294|frequency of bandage changing|frequency of bandage changing
454864|NCT01620281|Back Pain|back pain
454865|NCT01620268|leflunomide|leflunomide
454866|NCT01620268|orotic acid|orotic acid
454867|NCT01620268|Polyoma BK Viruria|polyoma bk viruria
454868|NCT01620268|Polyoma BK Viremia|polyoma bk viremia
454869|NCT01620268|Polyoma BK Nephropathy|polyoma bk nephropathy
454870|NCT01620268|Renal Allograft Rejection|renal allograft rejection
454871|NCT01620242|recurrent or metastatic head and neck cancer|recurrent or metastatic head and neck cancer
454872|NCT01620242|cabazitaxel|cabazitaxel
454873|NCT01620203|Premature infants|premature infants
454874|NCT01620203|Intracranial hemorrhage|intracranial hemorrhage
454875|NCT01620203|Intraventricular hemorrhage|intraventricular hemorrhage
454876|NCT01620203|Cerebral oxygenation|cerebral oxygenation
454877|NCT01620203|Brain function|brain function
454878|NCT01620203|Cerebral perfusion|cerebral perfusion
454879|NCT01620177|Cannabis|cannabis
454880|NCT01620177|Marijuana|marijuana
454881|NCT01620177|Marihuana|marihuana
454882|NCT01620177|Alcohol|alcohol
454883|NCT01620177|Driving|driving
454884|NCT01620164|three-dimensional vision|three-dimensional vision
454885|NCT01620164|Parkinson|parkinson
454886|NCT01620151|Post-operative pain|post-operative pain
454887|NCT01620151|Wound bleeding requiring exploration|wound bleeding requiring exploration
454888|NCT01620151|PTH|pth
454889|NCT01620151|RLN complication|rln complication
454890|NCT01620151|Hypocalcaemia complication|hypocalcaemia complication
454891|NCT01620138|Non-functioning pituitary adenomas|non-functioning pituitary adenomas
454892|NCT01620138|Prolactinomas|prolactinomas
454893|NCT01620138|Cabergoline|cabergoline
454894|NCT01620138|Pasireotide|pasireotide
454895|NCT01620138|somatostatin receptors|somatostatin receptors
454896|NCT01620138|Dopamine receptors|dopamine receptors
454897|NCT01620125|Lactobacillus|lactobacillus
454898|NCT01620125|Gut microbiota|gut microbiota
454899|NCT01620125|Diabetes mellitus|diabetes mellitus
454900|NCT01620112|brachial plexus|brachial plexus
454901|NCT01620112|lidocaine|lidocaine
454902|NCT01620112|alfa 2 adrenergic receptor clonidine|alfa 2 adrenergic receptor clonidine
454903|NCT01620112|orthopedic procedure|orthopedic procedure
454904|NCT01620099|Asthma|asthma
454905|NCT01620099|Cigarette smoke|cigarette smoke
454906|NCT01620099|Small airways|small airways
454907|NCT01620099|Lung function|lung function
454908|NCT01620099|Asthma control|asthma control
454909|NCT01620086|Schizophrenia|schizophrenia
454910|NCT01620086|Auditory hallucinations (AH)|auditory hallucinations (ah)
454911|NCT01620086|Phantom sound perception|phantom sound perception
454912|NCT01620086|repetitive transcranial magnetic stimulation (rTMS)|repetitive transcranial magnetic stimulation (rtms)
454913|NCT01620086|Percent habituation in the P50 amplitude with 250 ms ISI|percent habituation in the p50 amplitude with 250 ms isi
454914|NCT01620073|Male partner|male partner
456312|NCT01614275|Autism|autism
454915|NCT01620073|HIV counseling and testing|hiv counseling and testing
454916|NCT01620073|Home based|home based
454917|NCT01620073|Pregnancy|pregnancy
454918|NCT01620060|Schizophrenia|schizophrenia
454919|NCT01620060|autism|autism
454920|NCT01620060|bipolar|bipolar
454921|NCT01620060|Lurasidone|lurasidone
454922|NCT01620060|Latuda|latuda
454923|NCT01620047|Regional Anesthesia|regional anesthesia
454924|NCT01620047|Post-operative pain management|post-operative pain management
454925|NCT01620047|Femoral Nerve Block|femoral nerve block
454926|NCT01620047|Total Knee Replacement|total knee replacement
454927|NCT01620021|wearable sensors|wearable sensors
454928|NCT01620021|kinematics|kinematics
454929|NCT01620021|gait|gait
454930|NCT01620008|cord clamping (delayed or immediate)|cord clamping (delayed or immediate)
454931|NCT01620008|Myelin content|myelin content
454932|NCT01620008|Ferritin|ferritin
454933|NCT01619995|urge incontinence|urge incontinence
454934|NCT01619956|dental implants|dental implants
454935|NCT01619956|osteotome sinus floor elevation|osteotome sinus floor elevation
454936|NCT01619956|survival rate|survival rate
454937|NCT01619956|sinus grafting|sinus grafting
454938|NCT01619956|bone remodeling|bone remodeling
454939|NCT01619956|RCT|rct
454940|NCT01619956|radiographic analysis|radiographic analysis
454941|NCT01619943|Minor head injury|minor head injury
454942|NCT01619943|CT scan|ct scan
454943|NCT01619943|Canadian CT Head Rules|canadian ct head rules
454944|NCT01619943|The New Orleans Criteria|the new orleans criteria
454945|NCT01619930|Depression|depression
454946|NCT01619930|Behavioral activation|behavioral activation
454947|NCT01619917|burn|burn
454948|NCT01619917|scar|scar
454949|NCT01619917|laser|laser
454950|NCT01619917|fractional|fractional
454951|NCT01619917|vascular|vascular
454952|NCT01619904|Pancreas Transplantation|pancreas transplantation
454953|NCT01619904|Goal-directed therapy|goal-directed therapy
454954|NCT01619904|Outcomes|outcomes
454955|NCT01619904|Immunometric|immunometric
454956|NCT01619878|plasmodium|plasmodium
454957|NCT01619878|P. falciparum|p. falciparum
454958|NCT01619878|malaria|malaria
454959|NCT01619878|infant|infant
454960|NCT01619878|neonate|neonate
454961|NCT01619865|GA-68|ga-68
454962|NCT01619865|Gallium 68|gallium 68
454963|NCT01619865|GA-68 PET|ga-68 pet
454964|NCT01619852|Surgery|surgery
454965|NCT01619852|Breast|breast
454966|NCT01619852|Pain|pain
454967|NCT01619852|Chronic Pain|chronic pain
454968|NCT01619852|Lidocaine|lidocaine
454969|NCT01619852|Anesthesia|anesthesia
454970|NCT01619852|Gynecologic|gynecologic
454971|NCT01619852|Urologic|urologic
454972|NCT01619839|Nektar|nektar
454973|NCT01619839|NKTR-181|nktr-181
454974|NCT01619826|physical activity|physical activity
454975|NCT01619826|fitness|fitness
454976|NCT01619826|brain health|brain health
454977|NCT01619826|cognition|cognition
454978|NCT01619826|scholastic achievement|scholastic achievement
454979|NCT01619826|preadolescent children|preadolescent children
454980|NCT01619800|Chronotropic Incompetence|chronotropic incompetence
454981|NCT01619800|Pacemaker|pacemaker
454982|NCT01619800|Mount Sinai School of Medicine|mount sinai school of medicine
454983|NCT01619774|Melanoma|melanoma
454984|NCT01619774|Metastatic melanoma|metastatic melanoma
454985|NCT01619774|Refractory or Resistant to BRAF Inhibitor|refractory or resistant to braf inhibitor
454986|NCT01619774|Advanced melanoma|advanced melanoma
454987|NCT01619774|GSK2118436|gsk2118436
454988|NCT01619774|GSK1120212|gsk1120212
454989|NCT01619735|Kidney Calculi|kidney calculi
454990|NCT01619735|Kidney Stones|kidney stones
454991|NCT01619735|Nephrolithiasis|nephrolithiasis
454992|NCT01619735|Renal Stones|renal stones
454993|NCT01619722|PKU|pku
454994|NCT01619722|Osteoporosis|osteoporosis
454995|NCT01619722|HMP|hmp
454996|NCT01619722|Life quality|life quality
454997|NCT01619722|Neuropsychological|neuropsychological
454998|NCT01619722|Nutritial evaluation|nutritial evaluation
454999|NCT01619722|Phenylketonuria|phenylketonuria
455000|NCT01619722|Hyperphenylalaninemia|hyperphenylalaninemia
455001|NCT01619709|Intracerebral Hemorrhage|intracerebral hemorrhage
455002|NCT01619709|Cerebral Amyloid angiopathy|cerebral amyloid angiopathy
455003|NCT01619709|Amyloid imaging|amyloid imaging
455004|NCT01619709|18F-AV-45|18f-av-45
455005|NCT01619696|chemotherapy|chemotherapy
455006|NCT01619696|rectal adenocarcinoma|rectal adenocarcinoma
455007|NCT01619696|proctectomy|proctectomy
455008|NCT01619696|Fmiso TEP|fmiso tep
455009|NCT01619696|MRI|mri
455010|NCT01619657|Cystic Fibrosis|cystic fibrosis
455011|NCT01619657|Hypertonic Saline|hypertonic saline
455012|NCT01619657|Infant|infant
455013|NCT01619657|Newborn|newborn
455014|NCT01619657|Prevention|prevention
455015|NCT01619644|RTS|rts
455016|NCT01619644|Rubinstein Taybi|rubinstein taybi
455017|NCT01619644|explorative phase 2|explorative phase 2
455018|NCT01619644|clinical approach|clinical approach
455019|NCT01619644|biological approach|biological approach
455020|NCT01619644|motor skills|motor skills
455021|NCT01619631|Depression|depression
455022|NCT01619631|Tai Chi|tai chi
455023|NCT01619631|Alternative medicine|alternative medicine
455024|NCT01619631|Mind body medicine|mind body medicine
455025|NCT01619618|recurrent squamous cell carcinoma of the hypopharynx|recurrent squamous cell carcinoma of the hypopharynx
455026|NCT01619618|stage IV squamous cell carcinoma of the hypopharynx|stage iv squamous cell carcinoma of the hypopharynx
455027|NCT01619618|recurrent squamous cell carcinoma of the larynx|recurrent squamous cell carcinoma of the larynx
455145|NCT01619241|lung cancer|lung cancer
455028|NCT01619618|stage IVA squamous cell carcinoma of the larynx|stage iva squamous cell carcinoma of the larynx
455029|NCT01619618|stage IVB squamous cell carcinoma of the larynx|stage ivb squamous cell carcinoma of the larynx
455030|NCT01619618|stage IVC squamous cell carcinoma of the larynx|stage ivc squamous cell carcinoma of the larynx
455031|NCT01619618|recurrent squamous cell carcinoma of the lip and oral cavity|recurrent squamous cell carcinoma of the lip and oral cavity
455032|NCT01619618|stage IVA squamous cell carcinoma of the lip and oral cavity|stage iva squamous cell carcinoma of the lip and oral cavity
455033|NCT01619618|stage IVB squamous cell carcinoma of the lip and oral cavity|stage ivb squamous cell carcinoma of the lip and oral cavity
455034|NCT01619618|stage IVC squamous cell carcinoma of the lip and oral cavity|stage ivc squamous cell carcinoma of the lip and oral cavity
455035|NCT01619618|recurrent metastatic squamous neck cancer with occult primary|recurrent metastatic squamous neck cancer with occult primary
455036|NCT01619618|recurrent squamous cell carcinoma of the nasopharynx|recurrent squamous cell carcinoma of the nasopharynx
455037|NCT01619618|stage IV squamous cell carcinoma of the nasopharynx|stage iv squamous cell carcinoma of the nasopharynx
455038|NCT01619618|recurrent squamous cell carcinoma of the oropharynx|recurrent squamous cell carcinoma of the oropharynx
455039|NCT01619618|stage IVA squamous cell carcinoma of the oropharynx|stage iva squamous cell carcinoma of the oropharynx
455040|NCT01619618|stage IVB squamous cell carcinoma of the oropharynx|stage ivb squamous cell carcinoma of the oropharynx
455041|NCT01619618|stage IVC squamous cell carcinoma of the oropharynx|stage ivc squamous cell carcinoma of the oropharynx
455042|NCT01619618|recurrent squamous cell carcinoma of the paranasal sinus and nasal cavity|recurrent squamous cell carcinoma of the paranasal sinus and nasal cavity
455043|NCT01619618|stage IVA squamous cell carcinoma of the paranasal sinus and nasal cavity|stage iva squamous cell carcinoma of the paranasal sinus and nasal cavity
710735|NCT00588146|Iron deficiency anemia|iron deficiency anemia
455044|NCT01619618|stage IVB squamous cell carcinoma of the paranasal sinus and nasal cavity|stage ivb squamous cell carcinoma of the paranasal sinus and nasal cavity
455045|NCT01619618|stage IVC squamous cell carcinoma of the paranasal sinus and nasal cavity|stage ivc squamous cell carcinoma of the paranasal sinus and nasal cavity
455046|NCT01619618|recurrent salivary gland cancer|recurrent salivary gland cancer
455047|NCT01619618|stage IVA salivary gland cancer|stage iva salivary gland cancer
455048|NCT01619618|stage IVB salivary gland cancer|stage ivb salivary gland cancer
455049|NCT01619618|stage IVC salivary gland cancer|stage ivc salivary gland cancer
455050|NCT01619605|tryptases|tryptases
455051|NCT01619605|anaphylaxis|anaphylaxis
455052|NCT01619605|shrimp allergy|shrimp allergy
455053|NCT01619592|patients|patients
455054|NCT01619592|adaptable|adaptable
455055|NCT01619592|insulin|insulin
455056|NCT01619592|schemes|schemes
455057|NCT01619579|Fibromyalgia|fibromyalgia
455058|NCT01619579|Pain|pain
455059|NCT01619579|Non-Invasive|non-invasive
455060|NCT01619579|Arthritis|arthritis
455061|NCT01619579|Rheumatoid Disease|rheumatoid disease
455062|NCT01619566|Fibromyalgia|fibromyalgia
455063|NCT01619566|Duloxetine|duloxetine
455064|NCT01619566|Cymbalta|cymbalta
455065|NCT01619566|Pain|pain
455066|NCT01619566|Peripheral Nerve|peripheral nerve
455067|NCT01619566|Biopsy|biopsy
455068|NCT01619566|Predictive|predictive
455069|NCT01619553|keloid|keloid
455070|NCT01619553|fibrosis|fibrosis
455071|NCT01619553|wound healing|wound healing
455072|NCT01619553|scar|scar
455073|NCT01619540|COPD|copd
455074|NCT01619540|Left Ventricular Failure|left ventricular failure
455075|NCT01619540|Valsalva Manoeuver|valsalva manoeuver
455076|NCT01619527|Healthy participants|healthy participants
455077|NCT01619527|Darunavir|darunavir
455078|NCT01619527|Cobicistat|cobicistat
455079|NCT01619527|Bioequivalence|bioequivalence
455080|NCT01619527|Fixed dose combination|fixed dose combination
455081|NCT01619527|Pharmacokinetics|pharmacokinetics
455082|NCT01619527|Human immunodeficiency virus|human immunodeficiency virus
455083|NCT01619527|Protease inhibitor|protease inhibitor
455084|NCT01619488|Lap-Band|lap-band
455085|NCT01619488|morbid obesity|morbid obesity
455086|NCT01619488|adolescents|adolescents
455087|NCT01619475|Living Donor|living donor
455088|NCT01619475|Liver Transplantation|liver transplantation
455089|NCT01619475|Quality of Life|quality of life
455090|NCT01619475|Biosamples|biosamples
455091|NCT01619475|Liver Recipient|liver recipient
455092|NCT01619462|pneumococcal|pneumococcal
455093|NCT01619462|vaccine|vaccine
455094|NCT01619462|papua new guinea|papua new guinea
455095|NCT01619449|Acute Kidney Injury|acute kidney injury
455096|NCT01619449|Continuous Renal Replacement Therapy|continuous renal replacement therapy
455097|NCT01619449|Liver Transplant|liver transplant
455098|NCT01619423|Metastatic colorectal cancer|metastatic colorectal cancer
455099|NCT01619423|stage IV|stage iv
455100|NCT01619423|FOLFOX6|folfox6
455101|NCT01619423|Chemotherapy|chemotherapy
455102|NCT01619423|PledOx|pledox
455103|NCT01619423|Mangafodipir|mangafodipir
455104|NCT01619423|Febrile neutropenia|febrile neutropenia
455105|NCT01619423|Oxidative stress|oxidative stress
455106|NCT01619423|Antioxidant|antioxidant
455107|NCT01619423|neutropenia|neutropenia
455108|NCT01619423|neuropathy|neuropathy
455109|NCT01619397|Condom|condom
455110|NCT01619397|Medical Device|medical device
455111|NCT01619384|posttraumatic stress|posttraumatic stress
455112|NCT01619384|irritable bowel|irritable bowel
455113|NCT01619371|breast pump|breast pump
455114|NCT01619371|engorgement|engorgement
455115|NCT01619371|lactation|lactation
455116|NCT01619332|Healthy volunteers,|healthy volunteers,
455117|NCT01619332|Diabetes|diabetes
455118|NCT01619332|Glucose|glucose
455119|NCT01619332|Pharmacokinetics|pharmacokinetics
455120|NCT01619319|schizophrenia prodrome|schizophrenia prodrome
455121|NCT01619319|clinical high risk of psychosis|clinical high risk of psychosis
455122|NCT01619293|CCT|cct
455123|NCT01619293|brain|brain
455124|NCT01619293|trauma|trauma
455125|NCT01619293|injury|injury
455126|NCT01619280|Acute Lung Injury|acute lung injury
455127|NCT01619280|Acute Respiratory Distress Syndrome|acute respiratory distress syndrome
455128|NCT01619280|Sodium Nitroprusside|sodium nitroprusside
455129|NCT01619280|adult|adult
455130|NCT01619280|Safety|safety
455131|NCT01619280|Dose Finding|dose finding
455132|NCT01619280|Phase 1|phase 1
455133|NCT01619280|3 + 3 design|3 + 3 design
455134|NCT01619280|Nebulizers and Vaporizers|nebulizers and vaporizers
455135|NCT01619280|High-Frequency Ventilation|high-frequency ventilation
455136|NCT01619280|nitric oxide|nitric oxide
455137|NCT01619280|lung injury|lung injury
455138|NCT01619280|Pulmonary Gas Exchange|pulmonary gas exchange
455139|NCT01619280|Pulmonary Alveoli|pulmonary alveoli
455140|NCT01619267|pacemaker defibrillator infection|pacemaker defibrillator infection
455141|NCT01619254|Intestinal parasitic infections|intestinal parasitic infections
455142|NCT01619254|Anaemia|anaemia
455143|NCT01619254|School-aged children|school-aged children
455144|NCT01619254|Hand washing and nail clipping|hand washing and nail clipping
455146|NCT01619241|F-18 FLT PET/CT|f-18 flt pet/ct
455147|NCT01619228|premature infant|premature infant
455148|NCT01619228|neonate|neonate
455149|NCT01619228|skin maturation|skin maturation
455150|NCT01619228|stratum corneum maturation|stratum corneum maturation
455151|NCT01619228|ontogeny of neonatal skin maturation|ontogeny of neonatal skin maturation
455152|NCT01619228|sunflower oil|sunflower oil
455153|NCT01619228|effect of Vitamin B3 on premature skin maturation|effect of vitamin b3 on premature skin maturation
455154|NCT01619228|skin acidity|skin acidity
455155|NCT01619228|stratum corneum barrier integrity|stratum corneum barrier integrity
455156|NCT01619228|stratum corneum lipid composition|stratum corneum lipid composition
455157|NCT01619228|stratum corneum biomarkers|stratum corneum biomarkers
455158|NCT01619228|stratum corneum cytokines|stratum corneum cytokines
455159|NCT01619228|stratum corneum structural proteins|stratum corneum structural proteins
455160|NCT01619202|accident prevention|accident prevention
455161|NCT01619202|Adolescent|adolescent
455162|NCT01619202|examination, automobile driver|examination, automobile driver
455163|NCT01619202|Driving simulator|driving simulator
455164|NCT01619202|Young drivers|young drivers
455165|NCT01619202|Driving education|driving education
455166|NCT01619189|Cell therapy|cell therapy
455167|NCT01619189|Limbal deficiency|limbal deficiency
455168|NCT01619189|Limbal stem cell|limbal stem cell
455169|NCT01619189|Transplantation|transplantation
455170|NCT01619176|Rheumatoid Arthritis|rheumatoid arthritis
455171|NCT01619176|blood|blood
455172|NCT01619176|gut intestinal microbiome|gut intestinal microbiome
455173|NCT01619163|Prednisolone,|prednisolone,
455174|NCT01619163|pain,|pain,
455175|NCT01619163|inflammation,|inflammation,
455176|NCT01619163|mobility|mobility
455177|NCT01619163|Function|function
455178|NCT01619150|knee|knee
455179|NCT01619150|osteoarthritis|osteoarthritis
455180|NCT01619150|central sensitization|central sensitization
455181|NCT01619150|mechanical detection|mechanical detection
455182|NCT01619150|pain threshold|pain threshold
455183|NCT01619150|quantitative sensory testing|quantitative sensory testing
455184|NCT01619150|pain biomarkers|pain biomarkers
455185|NCT01619150|COX-2 inhibitors|cox-2 inhibitors
455186|NCT01619150|etoricoxib.|etoricoxib.
455187|NCT01619137|ununion wound|ununion wound
455188|NCT01619137|soap|soap
455189|NCT01619137|irrigation|irrigation
455190|NCT01619137|Povidone-iodine|povidone-iodine
455191|NCT01619137|normal salin|normal salin
455192|NCT01619124|osteonecrosis|osteonecrosis
455193|NCT01619124|children|children
455194|NCT01619124|pediatric|pediatric
455195|NCT01619124|acute lymphoblastic leukaemia|acute lymphoblastic leukaemia
455196|NCT01619124|lymphoblastic lymphoma|lymphoblastic lymphoma
455197|NCT01619111|metastatic breast cancer|metastatic breast cancer
455198|NCT01619111|circulating tumor cells|circulating tumor cells
455199|NCT01619111|lapatinib|lapatinib
455200|NCT01619098|Hospital readmission|hospital readmission
455201|NCT01619098|Care transition|care transition
455202|NCT01619098|Discharge-transfer intervention|discharge-transfer intervention
455203|NCT01619098|Community health worker|community health worker
455204|NCT01619098|Patient Navigatgor|patient navigatgor
455205|NCT01619072|postpartum hemorrhage|postpartum hemorrhage
455206|NCT01619072|treatment|treatment
455207|NCT01619072|misoprostol|misoprostol
455208|NCT01619072|home births|home births
455209|NCT01619046|GreenGene™F, Previously Treated Patients|greengene™f, previously treated patients
455210|NCT01619033|Renal impairment|renal impairment
455211|NCT01619020|Healthy|healthy
455212|NCT01619020|Colon|colon
455213|NCT01619007|Treatment of Venous Thromboembolism|treatment of venous thromboembolism
455214|NCT01619007|Thromboembolism|thromboembolism
455215|NCT01619007|Venous Thromboembolism|venous thromboembolism
455216|NCT01619007|Embolism and Thrombosis|embolism and thrombosis
455217|NCT01619007|Vascular Diseases|vascular diseases
455218|NCT01619007|Cardiovascular Diseases|cardiovascular diseases
455219|NCT01619007|Thrombosis|thrombosis
455220|NCT01618994|Robotic Simulator|robotic simulator
455222|NCT01618994|Robotic Surgeons|robotic surgeons
455223|NCT01618994|Intuitive Surgical|intuitive surgical
455224|NCT01618994|simulation modules|simulation modules
455225|NCT01618994|benchmarks|benchmarks
455226|NCT01618994|Morristown Protocol|morristown protocol
455227|NCT01618994|Study Surgeons|study surgeons
455228|NCT01618994|Control Surgeons|control surgeons
455229|NCT01618994|Expert Surgeons|expert surgeons
455230|NCT01618994|dual-console daVinci system|dual-console davinci system
455231|NCT01618994|blinded skill assessment|blinded skill assessment
455232|NCT01618981|Heart failure with preserved ejection fraction|heart failure with preserved ejection fraction
455233|NCT01618981|atrial dyssynchrony syndrome|atrial dyssynchrony syndrome
455234|NCT01618981|left atrio-ventricular asynchrony|left atrio-ventricular asynchrony
455235|NCT01618981|pacemaker|pacemaker
455236|NCT01618981|left atrial pacing therapy|left atrial pacing therapy
455237|NCT01618929|Food allergy|food allergy
455238|NCT01618929|Asthma|asthma
455239|NCT01618929|Children|children
581004|NCT01093495|RDS|rds
455240|NCT01618929|Montelukast|montelukast
455241|NCT01618929|Inflammation|inflammation
455242|NCT01618903|Keppra Levetiracetam intravenous|keppra levetiracetam intravenous
455243|NCT01618903|Oral tablets|oral tablets
455244|NCT01618903|Bioequivalence|bioequivalence
455245|NCT01618903|Pharmacokinetics|pharmacokinetics
455246|NCT01618903|Safety|safety
455247|NCT01618903|Chinese healthy volunteers|chinese healthy volunteers
455248|NCT01618890|Prevention|prevention
455249|NCT01618890|Esophageal variceal bleeding|esophageal variceal bleeding
455250|NCT01618890|Hepatic Venous Pressure Gradient|hepatic venous pressure gradient
455251|NCT01618890|Betablocker therapy|betablocker therapy
455252|NCT01618877|Keppra Levetiracetam intravenous|keppra levetiracetam intravenous
455253|NCT01618877|Multiple dose|multiple dose
455254|NCT01618877|Safety|safety
455255|NCT01618877|Pharmacokinetics|pharmacokinetics
455256|NCT01618877|Chinese healthy volunteers|chinese healthy volunteers
455257|NCT01618851|prostate cancer|prostate cancer
455258|NCT01618838|prostate cancer|prostate cancer
455259|NCT01618812|Artificial bone graft|artificial bone graft
455260|NCT01618812|Hydroxyapatite|hydroxyapatite
455261|NCT01618812|Children|children
455262|NCT01618812|Osteotomy|osteotomy
455263|NCT01618812|Pes plano valgus|pes plano valgus
455264|NCT01618812|Flatfeet|flatfeet
455265|NCT01618786|Falls|falls
455266|NCT01618786|Fall injuries|fall injuries
455267|NCT01618786|Bone fracture|bone fracture
455268|NCT01618786|Hip fracture|hip fracture
455269|NCT01618786|Skull fracture|skull fracture
455270|NCT01618786|Wounds|wounds
455271|NCT01618786|Closed head injury|closed head injury
455272|NCT01618786|Traumatic brain injury|traumatic brain injury
455273|NCT01618786|Concussion|concussion
455274|NCT01618786|Spinal cord injury|spinal cord injury
455275|NCT01618786|Trauma|trauma
455276|NCT01618786|Older adults|older adults
455277|NCT01618786|Long-term care|long-term care
455278|NCT01618786|Compliant flooring|compliant flooring
455279|NCT01618786|Safety floors|safety floors
455280|NCT01618786|Balance|balance
455281|NCT01618786|Injury biomechanics|injury biomechanics
455282|NCT01618786|Biomedical engineering|biomedical engineering
455283|NCT01618786|Environmental hazards|environmental hazards
455284|NCT01618786|Environmental interventions|environmental interventions
455285|NCT01618786|Fall prevention|fall prevention
455286|NCT01618786|Gerontology|gerontology
455287|NCT01618773|acne|acne
455288|NCT01618773|Epiduo|epiduo
455289|NCT01618773|adapalene/ benzoyl peroxide|adapalene/ benzoyl peroxide
455290|NCT01618734|Immune Thrombocytopenia|immune thrombocytopenia
455291|NCT01618734|Thrombopoietin receptor agonist|thrombopoietin receptor agonist
455292|NCT01618721|Chronic obstructive lung disease;|chronic obstructive lung disease;
455293|NCT01618721|Interstitial lung disease;|interstitial lung disease;
455294|NCT01618721|Ultrasound Doppler;|ultrasound doppler;
455295|NCT01618721|Lung disease diagnosis;|lung disease diagnosis;
455296|NCT01618695|Partial-onset Seizures|partial-onset seizures
455297|NCT01618695|partial seizures|partial seizures
455298|NCT01618695|seizure|seizure
455299|NCT01618695|epilepsy|epilepsy
455300|NCT01618682|hand transplant|hand transplant
455301|NCT01618682|hand replant|hand replant
455302|NCT01618669|Coronary Artery Disease (CAD)|coronary artery disease (cad)
455304|NCT01618669|pharmacologic stress|pharmacologic stress
455305|NCT01618643|Barrett's|barrett's
455306|NCT01618643|High grade dysplasia|high grade dysplasia
455307|NCT01618643|HGD|hgd
455308|NCT01618643|IMC|imc
455309|NCT01618643|Intramucosal cancer|intramucosal cancer
455310|NCT01618643|Acetic acid|acetic acid
455311|NCT01618643|Chromoendoscopy|chromoendoscopy
455312|NCT01618630|burn injury|burn injury
455313|NCT01618630|children|children
455314|NCT01618630|nutrition|nutrition
455315|NCT01618630|lipid metabolism|lipid metabolism
455316|NCT01618630|insulin sensitivity|insulin sensitivity
455317|NCT01618630|amino acids|amino acids
455318|NCT01618617|Constipation|constipation
455319|NCT01618617|Probiotic|probiotic
455320|NCT01618617|Randomized Controlled Trial|randomized controlled trial
455321|NCT01618604|Conditioned Pain Modulation|conditioned pain modulation
455322|NCT01618604|Quantitative Sensory Testing|quantitative sensory testing
455323|NCT01618604|duration|duration
455324|NCT01618604|correlation|correlation
455325|NCT01618591|diarrhea|diarrhea
455326|NCT01618591|travelers' diarrhea|travelers' diarrhea
455327|NCT01618591|watery diarrhea|watery diarrhea
455328|NCT01618591|enteric illness|enteric illness
455329|NCT01618591|dysentery|dysentery
455330|NCT01618591|gastrointestinal|gastrointestinal
455331|NCT01618578|rubber hand illusion|rubber hand illusion
455332|NCT01618578|CRPS|crps
455333|NCT01618578|body image|body image
455334|NCT01618578|body ownership|body ownership
455335|NCT01618565|shoulder dystocia|shoulder dystocia
455336|NCT01618565|training|training
455337|NCT01618565|To assess the effectiveness of hands-on training versus expert demonstration|to assess the effectiveness of hands-on training versus expert demonstration
455338|NCT01618552|Chronic disease|chronic disease
581148|NCT01093066|TURB|turb
455339|NCT01618552|Cluster randomization|cluster randomization
455340|NCT01618552|Comorbidity|comorbidity
455341|NCT01618552|Depression|depression
455342|NCT01618552|Diabetes|diabetes
455343|NCT01618552|Medical history taking|medical history taking
455344|NCT01618552|Office visits|office visits
455345|NCT01618552|Patient acceptance of health care|patient acceptance of health care
455346|NCT01618552|Patient compliance|patient compliance
455347|NCT01618552|Patient simulation|patient simulation
455348|NCT01618552|Physician patient relations|physician patient relations
455349|NCT01618552|Primary health care|primary health care
455350|NCT01618552|Randomized controlled trials|randomized controlled trials
455351|NCT01618552|Self care|self care
455352|NCT01618552|Self efficacy|self efficacy
455353|NCT01618539|Total intravenous anesthesia, Bispectral Index Score|total intravenous anesthesia, bispectral index score
455354|NCT01618526|Dietary fibers|dietary fibers
455355|NCT01618526|Butyrate|butyrate
455356|NCT01618526|Short Chain Fatty Acids|short chain fatty acids
455357|NCT01618526|Colon|colon
455358|NCT01618526|Metabolic Syndrome|metabolic syndrome
455359|NCT01618513|Acromegaly|acromegaly
455360|NCT01618513|Somatostatin analogs|somatostatin analogs
455361|NCT01618513|Treatment|treatment
455362|NCT01618500|Normal Pressure Hydrocephalus|normal pressure hydrocephalus
455363|NCT01618500|Neuropsychological Test|neuropsychological test
455364|NCT01618500|Assessment of cognitive disorders/dementia|assessment of cognitive disorders/dementia
455365|NCT01618500|Neuropsychological assessment|neuropsychological assessment
455366|NCT01618487|tennis elbow|tennis elbow
455367|NCT01618487|lateral epicondylitis|lateral epicondylitis
455368|NCT01618474|gastric cancer|gastric cancer
455369|NCT01618474|adjuvant chemotherapy|adjuvant chemotherapy
455370|NCT01618461|Prescription drug information|prescription drug information
455371|NCT01618461|Medication management|medication management
455372|NCT01618435|Fusion surgery|fusion surgery
455373|NCT01618435|Degenerative olisthesis|degenerative olisthesis
455374|NCT01618435|i-FACTOR|i-factor
455375|NCT01618435|ODI|odi
455376|NCT01618435|Spinal stenosis|spinal stenosis
455377|NCT01618422|DOTS plus|dots plus
455378|NCT01618422|DOTS|dots
455379|NCT01618422|multidrug resistant tuberculosis (MDR TB)|multidrug resistant tuberculosis (mdr tb)
455380|NCT01618409|PictureRx|picturerx
455381|NCT01618409|Health Literacy|health literacy
455382|NCT01618409|Limited English Proficiency|limited english proficiency
455383|NCT01618409|Latinos|latinos
455384|NCT01618409|Spanish|spanish
455385|NCT01618396|Microcirculation|microcirculation
455386|NCT01618396|Hypnotics and Sedatives,|hypnotics and sedatives,
455387|NCT01618396|Propofol,|propofol,
455388|NCT01618396|Midazolam|midazolam
455389|NCT01618383|Parkinson's disease|parkinson's disease
455390|NCT01618383|gut|gut
455391|NCT01618383|colon|colon
455392|NCT01618383|biopsies|biopsies
455393|NCT01618383|LRRK2|lrrk2
455394|NCT01618370|Radium 223|radium 223
455395|NCT01618370|Alpharadin|alpharadin
455396|NCT01618370|Prostate Cancer|prostate cancer
455397|NCT01618370|Bone metastases|bone metastases
455398|NCT01618370|Castrate resistant prostate cancer|castrate resistant prostate cancer
455399|NCT01618370|Hormone refractory prostate cancer|hormone refractory prostate cancer
455400|NCT01618357|Veliparib|veliparib
455401|NCT01618357|ABT-888|abt-888
455402|NCT01618357|Radiation|radiation
455403|NCT01618357|POPI|popi
455407|NCT01618344|medication adherence|medication adherence
455409|NCT01618331|Endurance exercise|endurance exercise
455410|NCT01618331|Protein supplementation|protein supplementation
455411|NCT01618331|Placebo RCT|placebo rct
455412|NCT01618318|Asthma|asthma
455413|NCT01618318|Allergy|allergy
455414|NCT01618318|Diagnosis|diagnosis
455415|NCT01618318|Correlation study|correlation study
455416|NCT01618292|pelvic organ prolapse|pelvic organ prolapse
455417|NCT01618292|constipation|constipation
455418|NCT01618292|bowel dysfunction|bowel dysfunction
455419|NCT01618292|irritable bowel syndrome (IBS)|irritable bowel syndrome (ibs)
455420|NCT01618292|CRADI-8|cradi-8
455421|NCT01618292|CRAIQ-7|craiq-7
455422|NCT01618292|splinting with defecation|splinting with defecation
455423|NCT01618292|excessive straining|excessive straining
455424|NCT01618292|bowel movements|bowel movements
455425|NCT01618292|fecal incontinence|fecal incontinence
455426|NCT01618292|bowel symptoms|bowel symptoms
455427|NCT01618279|tryptase|tryptase
455428|NCT01618279|coronary|coronary
455429|NCT01618279|stemi|stemi
455430|NCT01618279|nstemi|nstemi
455431|NCT01618253|Transarterial Chemoembolization|transarterial chemoembolization
455432|NCT01618253|TACE|tace
455433|NCT01618253|Sorafenib Tosylate|sorafenib tosylate
455434|NCT01618253|Sorafenib|sorafenib
455435|NCT01618253|Nexavar|nexavar
455436|NCT01618253|External Beam Radiation Therapy|external beam radiation therapy
455437|NCT01618253|Radiation Therapy|radiation therapy
455438|NCT01618253|Radiotherapy|radiotherapy
455439|NCT01618253|Radiation|radiation
455440|NCT01618240|FEES|fees
455441|NCT01618240|PAS|pas
455442|NCT01618240|VPSR|vpsr
455443|NCT01618240|MRC|mrc
455444|NCT01618201|Inflammation|inflammation
455445|NCT01618201|Migraine|migraine
455446|NCT01618201|Headache|headache
455447|NCT01618175|Bronchiolitis, Viral|bronchiolitis, viral
455448|NCT01618175|Home oxygen therapy|home oxygen therapy
455449|NCT01618175|Home Nursing|home nursing
455450|NCT01618175|Outcome and Process Assessment (Health Care)|outcome and process assessment (health care)
455451|NCT01618175|bronchiolitis severity score|bronchiolitis severity score
455452|NCT01618149|osteoarthritis|osteoarthritis
455453|NCT01618149|periprosthetic bone loss|periprosthetic bone loss
455454|NCT01618149|dual energy x-ray absorptiometry|dual energy x-ray absorptiometry
455455|NCT01618136|PARP inhibitors|parp inhibitors
455456|NCT01618136|Malignant Solid Tumour|malignant solid tumour
455457|NCT01618136|ovarian cancer|ovarian cancer
455458|NCT01618136|triple negative breast cancer|triple negative breast cancer
455459|NCT01618136|advanced melanoma|advanced melanoma
455460|NCT01618123|Endothelial function|endothelial function
455461|NCT01618123|Coronary disease|coronary disease
455462|NCT01618123|Atherosclerosis|atherosclerosis
455463|NCT01618123|Chest pain|chest pain
455464|NCT01618110|ADHD|adhd
455465|NCT01618110|Attention Deficit/Hyperactivity Disorder|attention deficit/hyperactivity disorder
455466|NCT01618110|TMS|tms
455467|NCT01618110|Transcranial Magnetic Stimulation|transcranial magnetic stimulation
455468|NCT01618097|Osteoarthritis|osteoarthritis
455469|NCT01618097|Decision Aids|decision aids
455470|NCT01618097|Health Literacy|health literacy
455471|NCT01618084|hipreplacement|hipreplacement
455472|NCT01618084|uncemented|uncemented
455473|NCT01618084|migration|migration
455474|NCT01618084|boneremodeling|boneremodeling
455475|NCT01618071|n-3 PUFA|n-3 pufa
455476|NCT01618071|Endothelial cells|endothelial cells
455477|NCT01618071|Nitric oxide|nitric oxide
455478|NCT01618071|Oxidative stress|oxidative stress
455479|NCT01618071|Blood pressure|blood pressure
455480|NCT01618071|Vasodilation|vasodilation
455481|NCT01618071|Lipemia|lipemia
455482|NCT01618071|Unsaturated dietary fats|unsaturated dietary fats
455483|NCT01618058|HIV Infections|hiv infections
455484|NCT01618058|Anti-HIV Agents|anti-hiv agents
455485|NCT01618058|HIV-1|hiv-1
455486|NCT01618045|Diabetes|diabetes
455487|NCT01618045|FPP|fpp
455488|NCT01618045|fermented papaya preparation|fermented papaya preparation
455489|NCT01618019|n-3 PUFA|n-3 pufa
455490|NCT01618019|rheumatoid arthritis|rheumatoid arthritis
455491|NCT01618019|inflammation|inflammation
455492|NCT01618019|eicosanoids|eicosanoids
455493|NCT01618019|bone turnover markers|bone turnover markers
455494|NCT01617993|in vitro fertilization|in vitro fertilization
455495|NCT01617993|assisted reproduction|assisted reproduction
455496|NCT01617993|noninvasive imaging of embryos|noninvasive imaging of embryos
455497|NCT01617993|time lapse imaging of embryos|time lapse imaging of embryos
455498|NCT01617993|traditional morphological grading of embryos|traditional morphological grading of embryos
455499|NCT01617993|prediction of blastocysts|prediction of blastocysts
455500|NCT01617993|infertility|infertility
455501|NCT01617993|Genital Diseases, Male|genital diseases, male
455502|NCT01617993|Genital Diseases, Female|genital diseases, female
455503|NCT01617980|Hypoxia imaging|hypoxia imaging
455504|NCT01617980|FMISO-PET|fmiso-pet
455505|NCT01617980|functional MRI|functional mri
455506|NCT01617980|Intensity modulated radiation therapy|intensity modulated radiation therapy
455507|NCT01617967|RNAi therapeutic|rnai therapeutic
455508|NCT01617941|non-chronic migraine, migraine prevention|non-chronic migraine, migraine prevention
455509|NCT01617902|Hyperbilirubinemia|hyperbilirubinemia
455510|NCT01617902|cardiac|cardiac
455511|NCT01617902|surgery|surgery
455512|NCT01617902|aorta|aorta
455513|NCT01617902|prognosis|prognosis
455514|NCT01617876|Stomach Neoplasms|stomach neoplasms
455515|NCT01617876|early gastric cancer|early gastric cancer
455516|NCT01617876|magnifying endoscopy|magnifying endoscopy
455517|NCT01617876|narrow band imaging|narrow band imaging
455518|NCT01617876|acetic acid|acetic acid
455519|NCT01617876|indigocarmine|indigocarmine
455520|NCT01617837|Postoperative nausea and vomiting|postoperative nausea and vomiting
455521|NCT01617837|P6 acupressure|p6 acupressure
455522|NCT01617837|Craniotomy.|craniotomy.
455523|NCT01617824|Diabetes|diabetes
455524|NCT01617824|Kidney|kidney
455525|NCT01617824|Inflammation|inflammation
455526|NCT01617824|Metabolism|metabolism
455527|NCT01617772|Non-alcoholic steatohepatitis, Atorvastatin, L-Carnitine|non-alcoholic steatohepatitis, atorvastatin, l-carnitine
455528|NCT01617746|Asthma|asthma
455529|NCT01617746|Endothelin|endothelin
455530|NCT01617746|Airway hyperreactivity|airway hyperreactivity
455531|NCT01617720|mitral|mitral
455532|NCT01617720|valve|valve
455533|NCT01617720|annuloplasty|annuloplasty
455534|NCT01617720|mitral regurgitation|mitral regurgitation
455535|NCT01617707|sedation|sedation
455536|NCT01617707|endoscopy|endoscopy
455537|NCT01617707|midazolam|midazolam
455538|NCT01617707|propofol|propofol
455539|NCT01617707|chronic alcoholics|chronic alcoholics
455540|NCT01617694|dexmedetomidine|dexmedetomidine
455541|NCT01617694|remifentanil|remifentanil
455542|NCT01617694|target-controlled infusion|target-controlled infusion
455543|NCT01617681|Hypertension; CKD; Pediatric|hypertension; ckd; pediatric
455544|NCT01617668|Breast cancer,|breast cancer,
455545|NCT01617668|LCL161,|lcl161,
455546|NCT01617668|paclitaxel,|paclitaxel,
455547|NCT01617668|neoadjuvant,|neoadjuvant,
455548|NCT01617668|triple negative breast cancer|triple negative breast cancer
455549|NCT01617642|Porphyria|porphyria
455550|NCT01617642|Inflammation|inflammation
455551|NCT01617642|Diet|diet
455552|NCT01617642|Iron status|iron status
455553|NCT01617629|Cvac|cvac
455554|NCT01617603|diabetes type 2|diabetes type 2
455555|NCT01617603|insulin resistance|insulin resistance
455556|NCT01617603|glycaemic control|glycaemic control
455557|NCT01617603|Endothelial function|endothelial function
455558|NCT01617603|Cocoa Polyphenols|cocoa polyphenols
455559|NCT01617590|RA|ra
455560|NCT01617590|Leflunomide|leflunomide
455561|NCT01617590|Methotrexate|methotrexate
455562|NCT01617577|G-CSF|g-csf
455563|NCT01617577|granulocyte colony stimulating factor|granulocyte colony stimulating factor
455564|NCT01617577|Filgrastim|filgrastim
455565|NCT01617564|medical abortion|medical abortion
455566|NCT01617564|second trimester|second trimester
455567|NCT01617564|para cervical blockage|para cervical blockage
455568|NCT01617564|pain management|pain management
455569|NCT01617551|Essential hypertension|essential hypertension
455570|NCT01617551|Nitric oxide|nitric oxide
455571|NCT01617551|Renal denervation|renal denervation
455572|NCT01617551|Sodium|sodium
455573|NCT01617551|GFR|gfr
455574|NCT01617538|atherosclerosis|atherosclerosis
455575|NCT01617538|stenosis|stenosis
455576|NCT01617538|statin therapy|statin therapy
455577|NCT01617538|Signs and Symptoms|signs and symptoms
455578|NCT01617538|Circulatory; Change|circulatory; change
455579|NCT01617499|physical activity|physical activity
455580|NCT01617499|pedometer|pedometer
455581|NCT01617499|worksite|worksite
455582|NCT01617499|wellness|wellness
455583|NCT01617499|cardiovascular|cardiovascular
455584|NCT01617499|lifestyle program|lifestyle program
455585|NCT01617460|Autistic Disorder, children and adolescents|autistic disorder, children and adolescents
455586|NCT01617460|aripiprazole|aripiprazole
455587|NCT01617460|Long-term safety study|long-term safety study
455588|NCT01617460|children and adolescents|children and adolescents
455589|NCT01617447|Autistic Disorder, children and adolescents|autistic disorder, children and adolescents
455590|NCT01617447|Aripiprazole|aripiprazole
455591|NCT01617447|Double-blind|double-blind
455592|NCT01617447|Randomized|randomized
455593|NCT01617447|children and adolescents|children and adolescents
455594|NCT01617421|Yoga|yoga
455595|NCT01617421|Arthritis|arthritis
455596|NCT01617408|Theta Burst Stimulation|theta burst stimulation
455597|NCT01617408|Transcranial Magnetic Stimulation (TMS)|transcranial magnetic stimulation (tms)
455598|NCT01617408|Visual Cortex|visual cortex
455599|NCT01617408|Visual Processing|visual processing
455600|NCT01617395|Multiple Sclerosis|multiple sclerosis
455601|NCT01617395|Magnetic Resonance Imaging (MRI)|magnetic resonance imaging (mri)
455602|NCT01617382|HIPEC|hipec
455603|NCT01617382|Hyperthermic (heated) chemotherapy after debulking|hyperthermic (heated) chemotherapy after debulking
455604|NCT01617356|TMD|tmd
455605|NCT01617356|temporomandibular|temporomandibular
455606|NCT01617356|dextrose|dextrose
455607|NCT01617356|prolotherapy|prolotherapy
455608|NCT01617330|Particulate matter|particulate matter
455609|NCT01617330|Air pollution|air pollution
455610|NCT01617330|Diesel exhaust|diesel exhaust
455611|NCT01617330|Allergic rhinitis|allergic rhinitis
455612|NCT01617317|H1N1 2009|h1n1 2009
455613|NCT01617317|hyperimmune IVIG|hyperimmune ivig
455614|NCT01617317|mortality|mortality
455615|NCT01617317|length of stay|length of stay
455616|NCT01617317|viral load|viral load
455617|NCT01617317|cytokine|cytokine
455618|NCT01617304|advanced glycation end products|advanced glycation end products
455619|NCT01617304|insulin sensitivity|insulin sensitivity
455620|NCT01617304|obesity|obesity
455621|NCT01617304|inflammation|inflammation
455622|NCT01617304|metabolomics|metabolomics
455623|NCT01617304|appetite|appetite
455625|NCT01617291|Pre-hospital hypothermia|pre-hospital hypothermia
455626|NCT01617291|Induced therapeutic hypothermia|induced therapeutic hypothermia
455627|NCT01617291|Cardiac arrest|cardiac arrest
455628|NCT01617278|Colonoscopy|colonoscopy
455629|NCT01617278|I Scan|i scan
455630|NCT01617278|High definition white light|high definition white light
455631|NCT01617278|Adenomas|adenomas
455632|NCT01617265|intensive care|intensive care
455633|NCT01617265|mechanical ventilation|mechanical ventilation
455634|NCT01617265|sedatives|sedatives
455635|NCT01617265|morphinics|morphinics
455636|NCT01617265|oversedation|oversedation
455637|NCT01617265|mortality|mortality
455638|NCT01617265|midazolam|midazolam
455639|NCT01617265|propofol|propofol
455640|NCT01617265|pain|pain
455641|NCT01617265|agitation|agitation
455642|NCT01617252|Cardiac surgery|cardiac surgery
455643|NCT01617252|Acute respiratory failure|acute respiratory failure
455644|NCT01617252|High flow oxygen therapy|high flow oxygen therapy
455645|NCT01617239|Influenza|influenza
455646|NCT01617239|Vaccination|vaccination
455647|NCT01617239|Virosomal influenza vaccine|virosomal influenza vaccine
455648|NCT01617213|Multiple Myeloma|multiple myeloma
455649|NCT01617174|prostate|prostate
455650|NCT01617174|pain assessment|pain assessment
455651|NCT01617174|12-110|12-110
455652|NCT01617161|Low Risk|low risk
455653|NCT01617161|Intermediate Risk|intermediate risk
455654|NCT01617148|Exudative Macular Degeneration|exudative macular degeneration
455655|NCT01617148|Aflibercept|aflibercept
455656|NCT01617135|Parkinson's disease|parkinson's disease
455657|NCT01617135|Motor fluctuations|motor fluctuations
455658|NCT01617135|levodopa|levodopa
455659|NCT01617135|inhaled drugs|inhaled drugs
455660|NCT01617135|"Motor fluctuation (off episodes)"|"motor fluctuation (off episodes)"
455661|NCT01617122|PID|pid
455662|NCT01617122|PIDD|pidd
455663|NCT01617122|antibody deficiency|antibody deficiency
455664|NCT01617122|CVID|cvid
455665|NCT01617122|recurrent infections|recurrent infections
455666|NCT01617109|Vitamin D|vitamin d
455667|NCT01617109|Calcium|calcium
455668|NCT01617109|Parathyroid hormone|parathyroid hormone
455669|NCT01617109|Bone|bone
455670|NCT01617109|Bone formation|bone formation
455671|NCT01617109|Bone resorption|bone resorption
455672|NCT01617109|Micronutrients|micronutrients
455673|NCT01617109|Trace Elements|trace elements
455674|NCT01617096|HIV Infections|hiv infections
455675|NCT01617096|Anti-HIV agents|anti-hiv agents
455676|NCT01617096|HIV-1|hiv-1
455677|NCT01617083|PANS|pans
455678|NCT01617083|PANDAS|pandas
455679|NCT01617083|OCD|ocd
455680|NCT01617083|Tics|tics
455681|NCT01617083|Azithromycin|azithromycin
455682|NCT01617083|Antibiotic Treatment|antibiotic treatment
455683|NCT01617070|Tetrahydrobiopterin|tetrahydrobiopterin
455684|NCT01617070|Kuvan|kuvan
455685|NCT01617070|Phenylketonuria (PKU)|phenylketonuria (pku)
455686|NCT01617070|Large Neutral Amino Acids|large neutral amino acids
455687|NCT01617070|Serotonin|serotonin
455688|NCT01617070|Dopamine|dopamine
455689|NCT01617070|Melatonin|melatonin
455690|NCT01617057|otosclerosis|otosclerosis
455691|NCT01617057|inner ear|inner ear
455692|NCT01617057|tiludronic acid|tiludronic acid
455693|NCT01617044|Iron|iron
455694|NCT01617044|Deficiency|deficiency
455695|NCT01617044|Restless|restless
455696|NCT01617044|Leg|leg
455697|NCT01617031|aspirin|aspirin
455698|NCT01617031|diabetes mellitus|diabetes mellitus
455699|NCT01617031|coronary artery disease|coronary artery disease
455700|NCT01617018|Psoriasis; Biological therapy; Methotrexate; Cyclosporine|psoriasis; biological therapy; methotrexate; cyclosporine
455701|NCT01616979|Off-pump coronary artery bypass surgery|off-pump coronary artery bypass surgery
455702|NCT01616979|Transesophageal echocardiography|transesophageal echocardiography
455703|NCT01616966|hoarseness|hoarseness
455704|NCT01616966|sore throat|sore throat
455705|NCT01616966|vocal cord injuries|vocal cord injuries
455706|NCT01616953|dental implants|dental implants
455707|NCT01616940|HIV/AIDS|hiv/aids
455708|NCT01616940|Peer support|peer support
455709|NCT01616927|ADPKD|adpkd
455710|NCT01616927|lanreotide|lanreotide
455711|NCT01616927|polycystic kidney|polycystic kidney
455712|NCT01616927|polycystic liver|polycystic liver
455713|NCT01616914|delirium|delirium
455716|NCT01616901|Intensive Care|intensive care
455717|NCT01616901|Respiratory weaning|respiratory weaning
455718|NCT01616901|Spontaneous Breathing trial|spontaneous breathing trial
455719|NCT01616901|Work of breathing|work of breathing
455720|NCT01616888|drug eluting balloon with paclitaxel|drug eluting balloon with paclitaxel
455721|NCT01616888|in stent restenosis|in stent restenosis
455722|NCT01616888|femoropopliteal arteries|femoropopliteal arteries
455723|NCT01616888|angioplasty|angioplasty
455724|NCT01616875|Bladder cancer|bladder cancer
455725|NCT01616875|Transitional cell carcinoma|transitional cell carcinoma
455726|NCT01616875|Urothelial cancer|urothelial cancer
455727|NCT01616875|Cisplatin|cisplatin
455728|NCT01616875|Cabazitaxel|cabazitaxel
455729|NCT01616875|Chemotherapy|chemotherapy
455730|NCT01616875|Neo adjuvant chemotherapy|neo adjuvant chemotherapy
455731|NCT01616862|Pseudomonas aeruginosa|pseudomonas aeruginosa
455732|NCT01616862|cystic fibrosis|cystic fibrosis
455733|NCT01616823|Human immunodeficiency virus (HIV) positive women|human immunodeficiency virus (hiv) positive women
455734|NCT01616810|urinary tract|urinary tract
455735|NCT01616784|Adult|adult
455736|NCT01616784|Diabetes Mellitus|diabetes mellitus
455737|NCT01616784|Type 1|type 1
455738|NCT01616784|Humans|humans
455739|NCT01616784|Hypoglycemic Agents|hypoglycemic agents
455740|NCT01616784|Administration and Dosage|administration and dosage
455741|NCT01616784|Insulin|insulin
455742|NCT01616784|Self Care|self care
455743|NCT01616784|Health Education|health education
455744|NCT01616784|Insulin Infusion Systems|insulin infusion systems
455745|NCT01616784|Randomised controlled trial|randomised controlled trial
455746|NCT01616784|Patient Education as Topic|patient education as topic
455747|NCT01616784|Hemoglobin A|hemoglobin a
455748|NCT01616784|Glycosylated|glycosylated
455749|NCT01616771|laryngoscopes|laryngoscopes
455750|NCT01616745|NTM Lung disease|ntm lung disease
455751|NCT01616745|NTM Lung disease patients enrolled in SNUH|ntm lung disease patients enrolled in snuh
455752|NCT01616693|rotavirus|rotavirus
455753|NCT01616693|polio|polio
455754|NCT01616693|zinc supplement|zinc supplement
455755|NCT01616693|probiotic supplement|probiotic supplement
455756|NCT01616693|rotavirus vaccine shedding|rotavirus vaccine shedding
455757|NCT01616667|Controlled Clinical Trial|controlled clinical trial
455758|NCT01616667|Operative Surgical Procedures|operative surgical procedures
455759|NCT01616667|Treatment Outcome|treatment outcome
455760|NCT01616667|Pain Measurement|pain measurement
455761|NCT01616667|Quality of Life|quality of life
455762|NCT01616667|Questionnaires/standards|questionnaires/standards
455763|NCT01616667|Activities of Daily Living|activities of daily living
455764|NCT01616667|Biomechanics|biomechanics
455765|NCT01616667|Gait*|gait*
455766|NCT01616667|Hip Joint/physiology*|hip joint/physiology*
455767|NCT01616667|Hip Joint/surgery*|hip joint/surgery*
455768|NCT01616667|Recovery of Function/physiology|recovery of function/physiology
455769|NCT01616641|rheumatoid arthritis|rheumatoid arthritis
455770|NCT01616641|bite force|bite force
455771|NCT01616641|grip strenght|grip strenght
455772|NCT01616641|oral health|oral health
455773|NCT01616641|quality of life|quality of life
455774|NCT01616628|Incentives|incentives
455775|NCT01616628|Fruit|fruit
455776|NCT01616628|Vegetables|vegetables
455777|NCT01616602|patients|patients
455778|NCT01616602|presenting|presenting
455779|NCT01616602|elective|elective
455780|NCT01616602|colonoscopy.|colonoscopy.
455781|NCT01616589|Fragile X syndrome|fragile x syndrome
455782|NCT01616589|Fragile X full mutation|fragile x full mutation
455783|NCT01616589|Fragile X premutation|fragile x premutation
455784|NCT01616589|Fragile X intermediate|fragile x intermediate
455785|NCT01616589|CGG repeat length|cgg repeat length
455786|NCT01616576|cochlear implant|cochlear implant
455787|NCT01616576|adults|adults
455788|NCT01616576|HiResolution™|hiresolution™
455789|NCT01616576|Fidelity 120™|fidelity 120™
455790|NCT01616576|listening benefits|listening benefits
455791|NCT01616576|noise|noise
455792|NCT01616576|cochlear implant benefit|cochlear implant benefit
455793|NCT01616563|central obesity|central obesity
455794|NCT01616563|abdominal obesity|abdominal obesity
455795|NCT01616563|hypertension|hypertension
455796|NCT01616563|cardiovascular disease|cardiovascular disease
455797|NCT01616563|high cholesterol|high cholesterol
455798|NCT01616563|high triglycerides|high triglycerides
455799|NCT01616563|insulin resistance|insulin resistance
455800|NCT01616563|diabetes mellitus|diabetes mellitus
455801|NCT01616550|analgesia|analgesia
455802|NCT01616550|thoracic surgery|thoracic surgery
455803|NCT01616537|solid tumors|solid tumors
455804|NCT01616537|hematological malignancy|hematological malignancy
455805|NCT01616472|hypertension|hypertension
455806|NCT01616472|avascular necrosis|avascular necrosis
455807|NCT01616472|systemic lupus erythematosus|systemic lupus erythematosus
455808|NCT01616472|osteoporosis|osteoporosis
455809|NCT01616472|Steroid|steroid
455810|NCT01616472|diabetes|diabetes
455811|NCT01616472|cataracts|cataracts
455812|NCT01616459|Streptococcus pneumoniae|streptococcus pneumoniae
455813|NCT01616459|Haemophilus influenzae|haemophilus influenzae
455814|NCT01616459|Pneumococcal vaccine|pneumococcal vaccine
455815|NCT01616459|Infants|infants
455816|NCT01616459|Safety|safety
455817|NCT01616459|Immunogenicity|immunogenicity
455818|NCT01616446|cyclosporin|cyclosporin
455819|NCT01616446|nephrotic syndrome|nephrotic syndrome
455820|NCT01616446|pharmacokinetics|pharmacokinetics
455821|NCT01616446|children|children
455822|NCT01616433|Arthritis|arthritis
455823|NCT01616433|Preventive Behaviors|preventive behaviors
455824|NCT01616420|prevention|prevention
455825|NCT01616420|treatment|treatment
455826|NCT01616420|cost-effectiveness|cost-effectiveness
455827|NCT01616420|assisted partner notification services|assisted partner notification services
455828|NCT01616420|Kenya|kenya
455829|NCT01616420|linkage to HIV care|linkage to hiv care
455830|NCT01616420|case-finding|case-finding
455831|NCT01616407|Effects of psychostimulants on emotion recognition and empathy|effects of psychostimulants on emotion recognition and empathy
455832|NCT01616355|denture, complete;|denture, complete;
455833|NCT01616355|sodium hypochlorite;|sodium hypochlorite;
455834|NCT01616355|disinfection;|disinfection;
455835|NCT01616355|surface roughness;|surface roughness;
455836|NCT01616355|color stability.|color stability.
455837|NCT01616329|alloimmunization|alloimmunization
455838|NCT01616329|RBC|rbc
455839|NCT01616329|clinicalfactors|clinicalfactors
455840|NCT01616329|Risk|risk
455841|NCT01616303|ovarian|ovarian
455842|NCT01616303|cancer|cancer
455843|NCT01616303|neoplasm|neoplasm
455844|NCT01616303|adenocarcinoma|adenocarcinoma
455845|NCT01616303|CA125|ca125
455846|NCT01616290|peripheral artery disease|peripheral artery disease
455847|NCT01616290|PAD|pad
455848|NCT01616290|claudication|claudication
455849|NCT01616290|angioplasty|angioplasty
455850|NCT01616290|percutaneous transluminal angioplasty|percutaneous transluminal angioplasty
455851|NCT01616290|PTA|pta
455852|NCT01616290|superficial femoral artery|superficial femoral artery
455853|NCT01616290|SFA|sfa
455854|NCT01616290|popliteal artery|popliteal artery
455855|NCT01616290|PA|pa
455856|NCT01616290|PRT-201|prt-201
455857|NCT01616290|restenosis|restenosis
455858|NCT01616290|vonapanitase|vonapanitase
455859|NCT01616264|Tuberculosis|tuberculosis
455860|NCT01616264|Pleural Effusion|pleural effusion
455861|NCT01616264|Computed Tomography|computed tomography
455862|NCT01616251|Protein sources|protein sources
455863|NCT01616251|Appetite|appetite
455864|NCT01616251|Dietary fibers|dietary fibers
455865|NCT01616251|Meat|meat
455866|NCT01616251|Egg|egg
455867|NCT01616251|Legumes|legumes
455868|NCT01616225|Infertility|infertility
455869|NCT01616225|Poor Responder|poor responder
455870|NCT01616225|In Vitro Fertilization|in vitro fertilization
455871|NCT01616225|Growth Hormone|growth hormone
455872|NCT01616212|Teens|teens
455873|NCT01616212|Parenting|parenting
455874|NCT01616212|Substance Abuse|substance abuse
455875|NCT01616212|Treatment Efficacy|treatment efficacy
455876|NCT01616199|PX-866|px-866
455877|NCT01616199|BRAF-mutant cancers|braf-mutant cancers
455878|NCT01616199|Advanced melanoma|advanced melanoma
455879|NCT01616199|BRAF inhibitor|braf inhibitor
455880|NCT01616199|Vemurafenib|vemurafenib
455881|NCT01616199|Zelboraf|zelboraf
455882|NCT01616199|PI-3K inhibitor|pi-3k inhibitor
455883|NCT01616186|Renal Cell Carcinoma|renal cell carcinoma
455884|NCT01616173|Nerve Block|nerve block
455885|NCT01616173|Anesthesia Recovery Period|anesthesia recovery period
455886|NCT01616160|Nasal polyps|nasal polyps
455887|NCT01616147|Intensive Lifestyle Intervention|intensive lifestyle intervention
455888|NCT01616134|overweight,|overweight,
455889|NCT01616134|ginseng|ginseng
455890|NCT01616108|strabismus|strabismus
455891|NCT01616108|diplopia|diplopia
455892|NCT01616095|Growth hormone deficiency|growth hormone deficiency
455893|NCT01616095|hrGH therapy|hrgh therapy
455894|NCT01616095|metabolic health|metabolic health
455895|NCT01616095|adipose tissue metabolism|adipose tissue metabolism
455896|NCT01616095|adipose tissue inflammation|adipose tissue inflammation
455897|NCT01616095|adipokines|adipokines
455898|NCT01616082|fatty acid oxidation|fatty acid oxidation
455899|NCT01616082|Proton magnetic resonance spectroscopy|proton magnetic resonance spectroscopy
455900|NCT01616069|CABG|cabg
455901|NCT01616069|Echocardiography|echocardiography
455902|NCT01616069|Heart Failure|heart failure
455903|NCT01616069|Heart Function|heart function
455904|NCT01616056|Chronic graft-versus-host disease|chronic graft-versus-host disease
455905|NCT01616056|eye|eye
455906|NCT01616043|scar quality|scar quality
455907|NCT01616030|Hip fractures|hip fractures
455908|NCT01616030|Strength training|strength training
455909|NCT01616017|Cardiac output|cardiac output
455910|NCT01616017|ultrasound dilution|ultrasound dilution
455911|NCT01616017|thermodilution|thermodilution
455912|NCT01615965|prostate cancer|prostate cancer
455913|NCT01615965|lymph node|lymph node
455914|NCT01615965|micrometastasis|micrometastasis
455915|NCT01615952|Supraclavicular Block|supraclavicular block
455916|NCT01615939|Sciatic Nerve Block|sciatic nerve block
455917|NCT01615939|Continuous Nerve Block|continuous nerve block
455918|NCT01615926|dyspnea|dyspnea
455919|NCT01615926|shortness of breath|shortness of breath
455920|NCT01615926|respiratory rate|respiratory rate
455921|NCT01615926|orthopnea|orthopnea
455922|NCT01615913|onychomycosis|onychomycosis
455923|NCT01615913|terbinafine|terbinafine
455924|NCT01615913|ketoconazole|ketoconazole
455925|NCT01615913|transdermal topical therapy|transdermal topical therapy
455926|NCT01615900|Renal graft|renal graft
455927|NCT01615900|Teleconsultation|teleconsultation
455928|NCT01615900|Kidney transplant failure score|kidney transplant failure score
455929|NCT01615848|polycystic Ovary syndrome (PCOS)|polycystic ovary syndrome (pcos)
455930|NCT01615848|diet|diet
455931|NCT01615848|mediterranean diet|mediterranean diet
455932|NCT01615848|high protein diet|high protein diet
455933|NCT01615822|Malaria|malaria
455934|NCT01615822|PK|pk
455935|NCT01615822|OZ439|oz439
455936|NCT01615822|Mefloquine|mefloquine
455937|NCT01615822|Healthy Volunteers|healthy volunteers
455938|NCT01615809|Invasive pulmonary aspergillosis|invasive pulmonary aspergillosis
455939|NCT01615809|IFI|ifi
455940|NCT01615809|Leukaemia|leukaemia
455941|NCT01615809|Leukemia|leukemia
455942|NCT01615809|Pediatric|pediatric
455943|NCT01615809|Paediatrics|paediatrics
455944|NCT01615809|Amphotericin B|amphotericin b
455945|NCT01615809|Aspergillosis|aspergillosis
455946|NCT01615809|Pulmonary Aspergillosis|pulmonary aspergillosis
455947|NCT01615809|Invasive Aspergillosis|invasive aspergillosis
455948|NCT01615809|Antifungal agents|antifungal agents
455949|NCT01615809|Fungal infections|fungal infections
455950|NCT01615809|Invasive Fungal Infection|invasive fungal infection
455951|NCT01615796|GSK2140944|gsk2140944
455952|NCT01615796|antibiotics|antibiotics
455953|NCT01615796|first time in human|first time in human
455954|NCT01615796|pharmacokinetics|pharmacokinetics
455955|NCT01615796|intravenous|intravenous
455956|NCT01615796|safety|safety
455957|NCT01615796|absolute bioavailability|absolute bioavailability
455958|NCT01615796|Bacterial Type II|bacterial type ii
455959|NCT01615796|tolerability|tolerability
455960|NCT01615796|infection|infection
455961|NCT01615783|Chronic Obstructive Pulmonary Disease|chronic obstructive pulmonary disease
455962|NCT01615783|Costs|costs
455963|NCT01615783|Resource utilization|resource utilization
455964|NCT01615783|Medicaid|medicaid
455965|NCT01615757|AML|aml
455966|NCT01615757|Acute Myeloid Leukemia|acute myeloid leukemia
455967|NCT01615757|Cytarabine dose|cytarabine dose
455968|NCT01615757|Ara-c dose|ara-c dose
455969|NCT01615757|Consolidation|consolidation
455970|NCT01615744|calcaneal fractures|calcaneal fractures
455971|NCT01615744|surgical treatment|surgical treatment
455972|NCT01615744|conservative treatment|conservative treatment
455973|NCT01615744|VAS scoring|vas scoring
455974|NCT01615744|SF-36|sf-36
455975|NCT01615744|AOFAS|aofas
455976|NCT01615744|Olerud-Molander score|olerud-molander score
455977|NCT01615744|outcome|outcome
455978|NCT01615731|Mifepristone|mifepristone
455979|NCT01615731|Induced Abortion|induced abortion
455980|NCT01615731|Dilation and Evacuation|dilation and evacuation
455981|NCT01615731|Cervical preparation|cervical preparation
455982|NCT01615731|Osmotic dilators|osmotic dilators
455983|NCT01615718|noninvasive stimulation|noninvasive stimulation
455984|NCT01615718|motor function|motor function
455985|NCT01615718|transcranial stimulation|transcranial stimulation
455986|NCT01615718|transcranial ultrasound|transcranial ultrasound
455987|NCT01615718|brain stimulation|brain stimulation
455988|NCT01615705|Postphlebitic Syndrome|postphlebitic syndrome
455989|NCT01615705|Post-Thrombotic Syndrome|post-thrombotic syndrome
455990|NCT01615705|Biomarkers|biomarkers
455991|NCT01615705|Markers of Inflammation|markers of inflammation
455992|NCT01615705|Genetic Thrombophilia|genetic thrombophilia
455993|NCT01615705|Coagulation Activation|coagulation activation
455994|NCT01615692|Elastic Stockings|elastic stockings
455995|NCT01615692|Stockings, Compression|stockings, compression
455996|NCT01615692|Randomized Controlled Trials|randomized controlled trials
455997|NCT01615692|Quality of Life|quality of life
455998|NCT01615679|Non-interventional study|non-interventional study
455999|NCT01615679|Attention Deficit/Hyperactivity Disorder|attention deficit/hyperactivity disorder
456000|NCT01615679|ADHD|adhd
456001|NCT01615666|Alzheimer's disease|alzheimer's disease
456002|NCT01615666|Mild Cognitive Impairment|mild cognitive impairment
456003|NCT01615666|Frontotemporal dementia|frontotemporal dementia
456004|NCT01615666|fMRI|fmri
456005|NCT01615666|functional neuroimaging|functional neuroimaging
456006|NCT01615666|Memory|memory
456007|NCT01615653|Pancreatic cancer|pancreatic cancer
456008|NCT01615653|Pancreas cancer|pancreas cancer
456009|NCT01615653|Pain|pain
456010|NCT01615653|Celiac Plexus|celiac plexus
456011|NCT01615653|Neurolysis|neurolysis
456012|NCT01615640|Osteosarcoma|osteosarcoma
456013|NCT01615640|Response of chemotherapy|response of chemotherapy
456014|NCT01615640|Dynamic contrast medium examination|dynamic contrast medium examination
456015|NCT01615640|Diffusion-weighted MR imaging|diffusion-weighted mr imaging
456016|NCT01615627|Subcutaneous Treprostinil|subcutaneous treprostinil
456017|NCT01615614|Rilpivirine|rilpivirine
456018|NCT01615614|Rifabutin|rifabutin
456019|NCT01615614|Pharmacokinetics|pharmacokinetics
456020|NCT01615614|Healthy participants|healthy participants
456021|NCT01615601|Human Immunodeficiency Virus|human immunodeficiency virus
456022|NCT01615601|HIV|hiv
456023|NCT01615601|HIV-1|hiv-1
456024|NCT01615601|HIV type 1|hiv type 1
456025|NCT01615601|Darunavir|darunavir
456026|NCT01615601|PREZISTA|prezista
456027|NCT01615601|Etravirine|etravirine
456028|NCT01615601|INTELENCE|intelence
456029|NCT01615601|HIV symptom Distress Module|hiv symptom distress module
456030|NCT01615601|HIV-SDM|hiv-sdm
456031|NCT01615601|Antiretroviral therapy|antiretroviral therapy
456032|NCT01615601|HIV Symptom Index (HSI),|hiv symptom index (hsi),
456033|NCT01615588|manuka honey|manuka honey
456034|NCT01615588|glycaemic index|glycaemic index
456035|NCT01615588|blood glucose control|blood glucose control
456036|NCT01615588|individuals|individuals
456037|NCT01615588|current disease|current disease
456038|NCT01615588|medication use|medication use
456039|NCT01615562|Polycystic Ovary Syndrome|polycystic ovary syndrome
456040|NCT01615562|PCOS|pcos
456041|NCT01615562|Infertility|infertility
456042|NCT01615549|Cholecystectomy|cholecystectomy
456043|NCT01615549|Virtual reality device|virtual reality device
456044|NCT01615549|Training|training
456045|NCT01615536|chronic rhinosinusitis|chronic rhinosinusitis
456046|NCT01615536|canine fossa trephine|canine fossa trephine
456047|NCT01615536|canine fossa puncture|canine fossa puncture
456048|NCT01615523|Executive functions|executive functions
456049|NCT01615497|cognitive behavior therapy|cognitive behavior therapy
456050|NCT01615497|computer assisted instruction|computer assisted instruction
456051|NCT01615497|alcohol abuse therapy|alcohol abuse therapy
456052|NCT01615497|educational resource design and development|educational resource design and development
456053|NCT01615484|Lung Transplant|lung transplant
456054|NCT01615484|Emphysema|emphysema
456055|NCT01615484|Chronic Obstructive Pulmonary Disease (COPD)|chronic obstructive pulmonary disease (copd)
456056|NCT01615484|Cystic Fibrosis|cystic fibrosis
456057|NCT01615484|Pulmonary Fibrosis|pulmonary fibrosis
456058|NCT01615484|Bronchiectasis|bronchiectasis
456059|NCT01615484|Sarcoidosis|sarcoidosis
456060|NCT01615484|Pulmonary Hypertension|pulmonary hypertension
456061|NCT01615484|Alpha-1 Antitrypsin Deficiency|alpha-1 antitrypsin deficiency
456062|NCT01615471|Obesity|obesity
456063|NCT01615471|Lifestyle Intervention|lifestyle intervention
456064|NCT01615471|Group treatment|group treatment
456065|NCT01615471|Internet Intervention|internet intervention
456066|NCT01615458|Care Management|care management
456067|NCT01615458|Implementation|implementation
456068|NCT01615458|Intervention|intervention
456069|NCT01615458|Mood Disorders|mood disorders
456070|NCT01615380|smoking cessation|smoking cessation
456071|NCT01615380|Aerobic Exercise|aerobic exercise
456072|NCT01615380|Women|women
456073|NCT01615380|YMCA|ymca
456074|NCT01615367|Bipolar disorder|bipolar disorder
456075|NCT01615367|Nutrition|nutrition
456076|NCT01615367|Exercise|exercise
456077|NCT01615367|Symptoms|symptoms
456078|NCT01615367|Functioning|functioning
456079|NCT01615341|Kidney transplantation|kidney transplantation
456080|NCT01615341|Subclinical Viral Infection|subclinical viral infection
456081|NCT01615341|Renal Allograft Injury|renal allograft injury
456082|NCT01615328|anterior cervical discectomy and fusion|anterior cervical discectomy and fusion
456083|NCT01615328|bone graft substitute|bone graft substitute
456084|NCT01615328|PEEK cage|peek cage
456085|NCT01615328|hydroxyapatite|hydroxyapatite
456086|NCT01615328|demineralized bone matrix|demineralized bone matrix
456087|NCT01615328|b-tricalcium phosphate|b-tricalcium phosphate
456088|NCT01615328|Bonion|bonion
456089|NCT01615328|Cervios ChronOs|cervios chronos
456090|NCT01615315|aspirin|aspirin
456091|NCT01615315|screening|screening
456092|NCT01615315|microscopic hematuria|microscopic hematuria
456093|NCT01615302|Rectal Fistula|rectal fistula
456094|NCT01615302|Peri-anal Fistula|peri-anal fistula
456095|NCT01615302|Platelet-Rich Plasma|platelet-rich plasma
456096|NCT01615302|Mucosa advancement flap|mucosa advancement flap
456097|NCT01615276|Neuromuscular Electrical Stimulation|neuromuscular electrical stimulation
456098|NCT01615276|Ageing|ageing
456099|NCT01615276|Protein ingestion|protein ingestion
456100|NCT01615263|Video-assisted thoracoscopic surgery (VATS)|video-assisted thoracoscopic surgery (vats)
456101|NCT01615263|One lung ventilation|one lung ventilation
456102|NCT01615263|Bronchial blocker|bronchial blocker
456103|NCT01615263|Lung collapse|lung collapse
456104|NCT01615263|Double lumen tube|double lumen tube
456105|NCT01615224|missed abortion|missed abortion
456106|NCT01615224|miscarriage|miscarriage
456107|NCT01615211|Abortion|abortion
456108|NCT01615211|medical abortion|medical abortion
456109|NCT01615211|termination of pregnancy|termination of pregnancy
456110|NCT01615211|Mifepristone|mifepristone
456111|NCT01615211|misoprostol|misoprostol
456112|NCT01615211|letrozole|letrozole
456113|NCT01615211|trilostane|trilostane
456114|NCT01615211|femara|femara
456115|NCT01615211|Modrenal|modrenal
456210|NCT01614665|Immunosuppression|immunosuppression
456211|NCT01614665|Kidney|kidney
456212|NCT01614665|Liver|liver
456116|NCT01615198|Hypertension, blood pressure, LCZ696, dual inhibitor, neprilysin, NEP inhibition, vasopeptidase, ARNi, angiotensin receptor|hypertension, blood pressure, lcz696, dual inhibitor, neprilysin, nep inhibition, vasopeptidase, arni, angiotensin receptor
456117|NCT01615185|schizophrenia|schizophrenia
456118|NCT01615185|amisulpride|amisulpride
456119|NCT01615185|sulpiride|sulpiride
456120|NCT01615185|antipsychotic combination|antipsychotic combination
456121|NCT01615159|Sodium|sodium
456122|NCT01615159|Diet|diet
456123|NCT01615159|Urinary sodium excretion|urinary sodium excretion
456124|NCT01615159|Feeding study|feeding study
456125|NCT01615159|Diet maintenance|diet maintenance
456126|NCT01615146|Myelodysplasia|myelodysplasia
456127|NCT01615146|Leukemia|leukemia
456128|NCT01615146|Thrombocytopenia|thrombocytopenia
456129|NCT01615146|Platelet|platelet
456130|NCT01615146|transfusions|transfusions
456131|NCT01615146|Outpatient|outpatient
456132|NCT01615081|Malt extract|malt extract
456133|NCT01615081|carbohydrate|carbohydrate
456134|NCT01615081|glucose response|glucose response
456135|NCT01615081|insulin response|insulin response
456136|NCT01615081|Appetite|appetite
456137|NCT01615081|Appetite regulating hormones|appetite regulating hormones
456138|NCT01615055|Chemotherapy|chemotherapy
456139|NCT01615055|Cognitive|cognitive
456140|NCT01615055|Prozac|prozac
456141|NCT01615055|Fluoxetine|fluoxetine
456142|NCT01615055|FDG|fdg
456143|NCT01615055|PET|pet
456144|NCT01615042|Acute Leukemia|acute leukemia
456145|NCT01615042|Bone Marrow Transplant|bone marrow transplant
456146|NCT01615042|High Dose Lenalidomide|high dose lenalidomide
456147|NCT01615029|Multiple Myeloma|multiple myeloma
456148|NCT01615029|Daratumumab|daratumumab
456149|NCT01615029|Lenalidomide|lenalidomide
456150|NCT01615029|Dexamethasone|dexamethasone
456151|NCT01615029|Dose-escalation|dose-escalation
456152|NCT01615029|Relapsed multiple myeloma|relapsed multiple myeloma
456153|NCT01615029|Relapsed and refractory multiple myeloma|relapsed and refractory multiple myeloma
456154|NCT01615016|Preterm infant|preterm infant
456155|NCT01615016|Surfactant application|surfactant application
456278|NCT01614392|Mobility disability|mobility disability
456156|NCT01615016|Respiratory Distress Syndrome|respiratory distress syndrome
456157|NCT01615016|Minimally invasive Surfactant Application|minimally invasive surfactant application
456158|NCT01615016|INSURE (Intubate-Surfactant-Extubate)|insure (intubate-surfactant-extubate)
456159|NCT01615003|MicroRNA|microrna
456160|NCT01615003|coronary heart disease|coronary heart disease
456161|NCT01615003|unstable angina|unstable angina
456162|NCT01615003|blood stasis syndrome|blood stasis syndrome
456163|NCT01615003|Xuesaitong soft capsule|xuesaitong soft capsule
456164|NCT01614977|nontuberculous mycobacteria|nontuberculous mycobacteria
456165|NCT01614977|corticosteroids|corticosteroids
456166|NCT01614977|children|children
456167|NCT01614977|lymphadeniti|lymphadeniti
456168|NCT01614977|Therapeutic intervention in immunocompetent children with nontuberculous mycobacterial lymphadenitis.|therapeutic intervention in immunocompetent children with nontuberculous mycobacterial lymphadenitis.
456169|NCT01614964|Plasmodium falciparum|plasmodium falciparum
456170|NCT01614964|pharmacokinetics|pharmacokinetics
456171|NCT01614964|antimalarials (antimalarial drugs)|antimalarials (antimalarial drugs)
456172|NCT01614964|chloroquine (chloroquine-resistant)|chloroquine (chloroquine-resistant)
456173|NCT01614964|QT (QTc) interval|qt (qtc) interval
456174|NCT01614938|Nasopharyngeal carcinoma|nasopharyngeal carcinoma
456175|NCT01614938|Locally advanced|locally advanced
456176|NCT01614938|Cetuximab|cetuximab
456177|NCT01614938|Weekly cisplatin chemotherapy|weekly cisplatin chemotherapy
456178|NCT01614938|Intensity-modulated radiotherapy|intensity-modulated radiotherapy
456179|NCT01614886|Rivastigmine, Alzheimer's disease, Transdermal patch|rivastigmine, alzheimer's disease, transdermal patch
456180|NCT01614873|Breathing Pattern|breathing pattern
456181|NCT01614873|Mechanical Ventilation|mechanical ventilation
456182|NCT01614873|Pressure support ventilation|pressure support ventilation
456183|NCT01614873|Neurally Adjusted Ventilatory Assist|neurally adjusted ventilatory assist
456184|NCT01614860|Aldosterone|aldosterone
456185|NCT01614860|Echocardiography|echocardiography
456186|NCT01614860|Neurohormones|neurohormones
456187|NCT01614847|dry eye|dry eye
456188|NCT01614847|artificial tears|artificial tears
456189|NCT01614847|tear osmolarity|tear osmolarity
456190|NCT01614847|residence time|residence time
456191|NCT01614834|urticaria|urticaria
456192|NCT01614834|disease control|disease control
456193|NCT01614834|severity|severity
456194|NCT01614834|test|test
456195|NCT01614821|Relapsed|relapsed
456196|NCT01614821|Refractory|refractory
456197|NCT01614743|Rosacea|rosacea
456199|NCT01614730|Modified Device|modified device
456200|NCT01614717|Hypertrophic Obstructive Cardiomyopathy|hypertrophic obstructive cardiomyopathy
456201|NCT01614717|Cardiac Resynchronization Therapy|cardiac resynchronization therapy
456202|NCT01614704|Breast cancer|breast cancer
456203|NCT01614704|Fertility|fertility
456204|NCT01614678|myopia|myopia
456205|NCT01614665|Transplant|transplant
456206|NCT01614665|Prograf|prograf
456207|NCT01614665|Heart|heart
456208|NCT01614665|Advagraf|advagraf
456209|NCT01614665|Tacrolimus|tacrolimus
456213|NCT01614665|Pharmacokinetic|pharmacokinetic
456214|NCT01614665|Pediatric|pediatric
456215|NCT01614652|Congestive Heart Failure Due to LV Systolic Dysfunction|congestive heart failure due to lv systolic dysfunction
456216|NCT01614639|Acupuncture|acupuncture
456217|NCT01614639|fMRI|fmri
456218|NCT01614639|CLBP|clbp
456219|NCT01614639|Pain|pain
456220|NCT01614639|Low Back Pain|low back pain
456221|NCT01614639|Back Pain|back pain
456222|NCT01614626|HIV|hiv
456223|NCT01614626|Alcohol Use|alcohol use
456224|NCT01614626|Microbial Translocation|microbial translocation
456225|NCT01614626|Inflammation|inflammation
456226|NCT01614626|Altered Coagulation|altered coagulation
456227|NCT01614626|Russia|russia
456228|NCT01614600|contact lens|contact lens
456229|NCT01614600|dry eye syndrome|dry eye syndrome
456230|NCT01614600|symptomatic|symptomatic
456231|NCT01614600|daily disposable|daily disposable
456232|NCT01614600|myopia|myopia
456233|NCT01614587|pelvic organ prolapse|pelvic organ prolapse
456234|NCT01614587|recurrence of pelvic organ prolapse|recurrence of pelvic organ prolapse
456235|NCT01614587|genetic predisposition|genetic predisposition
456236|NCT01614587|SNP microarray analysis|snp microarray analysis
456237|NCT01614587|pelvic floor|pelvic floor
456238|NCT01614587|genetic factors|genetic factors
456239|NCT01614587|adequate prolapse repair|adequate prolapse repair
456240|NCT01614587|polymorphisms|polymorphisms
456241|NCT01614587|surgical failure|surgical failure
456242|NCT01614587|reoperation|reoperation
456243|NCT01614587|DNA|dna
456244|NCT01614587|buccal swabs|buccal swabs
456245|NCT01614587|TaqMan SNP allelic discriminiation assays|taqman snp allelic discriminiation assays
456246|NCT01614587|duplex real-time PCR|duplex real-time pcr
456247|NCT01614587|genome-wide SNP microarrays|genome-wide snp microarrays
456248|NCT01614587|next-generation sequencing|next-generation sequencing
456249|NCT01614561|Hypercholesterolemia|hypercholesterolemia
456250|NCT01614561|Lipid lowering drugs|lipid lowering drugs
456251|NCT01614561|Cholesterol level in blood|cholesterol level in blood
456252|NCT01614561|Target cholesterol levels guidelines for the management of high blood cholesterol|target cholesterol levels guidelines for the management of high blood cholesterol
456253|NCT01614548|Prostatic Neoplasms|prostatic neoplasms
456254|NCT01614548|Prostate Cancer|prostate cancer
456255|NCT01614548|Disease Management|disease management
456256|NCT01614548|Rural|rural
456257|NCT01614548|Urban|urban
456258|NCT01614522|Metastatic gastro-oesophageal carcinoma|metastatic gastro-oesophageal carcinoma
456259|NCT01614522|Recurrent gastro-oesophageal carcinoma|recurrent gastro-oesophageal carcinoma
456260|NCT01614522|Gastric cancer|gastric cancer
456261|NCT01614522|HER-1|her-1
456262|NCT01614522|HER-2|her-2
456263|NCT01614509|branch retinal vein occlusion|branch retinal vein occlusion
456264|NCT01614509|bevacizumab|bevacizumab
456265|NCT01614509|triamcinolone acetonide|triamcinolone acetonide
456266|NCT01614483|Vitamin A deficiency|vitamin a deficiency
456267|NCT01614483|Biofortification|biofortification
456268|NCT01614483|Cassava|cassava
456269|NCT01614483|B-carotene|b-carotene
456270|NCT01614483|School children|school children
456271|NCT01614483|Kenya|kenya
456272|NCT01614431|renal function|renal function
456273|NCT01614431|before and after N acetyl cysteine|before and after n acetyl cysteine
456274|NCT01614431|Cystinosis patients|cystinosis patients
456275|NCT01614405|PBC|pbc
456276|NCT01614392|Resistance Exercise|resistance exercise
456277|NCT01614392|Physical Activity|physical activity
456279|NCT01614392|Physical function|physical function
456280|NCT01614392|Muscle Strength|muscle strength
456281|NCT01614392|Older Adults|older adults
456282|NCT01614392|Mobility-Limited|mobility-limited
456283|NCT01614392|Peak power and strength|peak power and strength
456284|NCT01614366|amlodipine|amlodipine
456285|NCT01614366|DMTA07|dmta07
456286|NCT01614366|hypertension|hypertension
456287|NCT01614353|Multiple Chronic Conditions|multiple chronic conditions
456288|NCT01614353|Older Adults|older adults
456289|NCT01614353|New Prescription|new prescription
456290|NCT01614340|Home care|home care
456291|NCT01614340|Cognitive-Behavioral techniques|cognitive-behavioral techniques
456292|NCT01614340|Physical Therapy|physical therapy
456293|NCT01614340|Pain|pain
456294|NCT01614340|Older Adults|older adults
456295|NCT01614327|Diabetes Type One|diabetes type one
456296|NCT01614327|Diabetes Type Two|diabetes type two
456297|NCT01614327|PreDiabetes|prediabetes
456298|NCT01614327|Retinal Screening|retinal screening
456299|NCT01614327|RiskAnalyzer|riskanalyzer
456300|NCT01614327|Retinal Imaging|retinal imaging
456301|NCT01614327|Algorithm|algorithm
456302|NCT01614327|Diabetic Retinopathy|diabetic retinopathy
456303|NCT01614327|Microaneurysms|microaneurysms
456304|NCT01614327|Neovascularization|neovascularization
456305|NCT01614327|Intraretinal microvascular abnormalities|intraretinal microvascular abnormalities
456306|NCT01614314|Preceptorship, simulation, nursing, catheters|preceptorship, simulation, nursing, catheters
456307|NCT01614301|advanced Melanoma|advanced melanoma
456308|NCT01614288|HTO|hto
456309|NCT01614288|Arthroscopy|arthroscopy
456310|NCT01614288|Quality-of-Life|quality-of-life
456311|NCT01614288|Gait Analysis|gait analysis
456313|NCT01614275|Early Intervention|early intervention
456314|NCT01614275|Parent Training|parent training
456315|NCT01614275|EIBI|eibi
456316|NCT01614275|Applied Behavior Analysis|applied behavior analysis
456317|NCT01614249|Omega-3|omega-3
456318|NCT01614249|EPA|epa
456319|NCT01614249|Depression|depression
456320|NCT01614249|HIV infected|hiv infected
456321|NCT01614249|Pregnant women|pregnant women
456322|NCT01614236|pregabalin|pregabalin
456323|NCT01614236|analgesia|analgesia
456324|NCT01614236|postoperative pain|postoperative pain
456325|NCT01614236|orthopedic oncology patients|orthopedic oncology patients
456326|NCT01614223|Plantar fasciitis|plantar fasciitis
456327|NCT01614223|Autologous Conditioned Plasma|autologous conditioned plasma
456328|NCT01614197|Relapse|relapse
456329|NCT01614197|Lymphoblastic|lymphoblastic
456330|NCT01614197|Leukemia|leukemia
456331|NCT01614197|Refractory|refractory
456332|NCT01614197|Temsirolimus|temsirolimus
456333|NCT01614197|Acute|acute
456334|NCT01614197|Childhood|childhood
456335|NCT01614197|Pediatric|pediatric
456336|NCT01614197|ALL|all
456337|NCT01614197|NHL|nhl
456338|NCT01614197|LL|ll
456339|NCT01614197|PTL|ptl
456340|NCT01614171|osteoporosis pseudoglioma|osteoporosis pseudoglioma
456341|NCT01614171|OPPG|oppg
456342|NCT01614171|growth hormone|growth hormone
456343|NCT01614171|osteoporosis|osteoporosis
456344|NCT01614158|N-AION|n-aion
456345|NCT01614158|perimetry|perimetry
456346|NCT01614158|visual field loss|visual field loss
456347|NCT01614158|Mean Defect|mean defect
456348|NCT01614158|Total Loss Volume|total loss volume
456349|NCT01614158|D-BCVA|d-bcva
456350|NCT01614158|RAPD|rapd
456351|NCT01614158|retinal nerve fibre thickness/volume|retinal nerve fibre thickness/volume
456352|NCT01614158|optic nerve head|optic nerve head
456353|NCT01614132|medulloblastoma|medulloblastoma
456354|NCT01614132|CNS|cns
456355|NCT01614132|malignant neoplasm|malignant neoplasm
456356|NCT01614132|NOA|noa
456357|NCT01614132|neuroectodermal tumor|neuroectodermal tumor
456358|NCT01614132|Vincristin|vincristin
456359|NCT01614132|CCNU|ccnu
456360|NCT01614132|Cisplatin|cisplatin
456361|NCT01614119|Cerebral|cerebral
456362|NCT01614119|Oxygenation|oxygenation
456363|NCT01614119|Performance|performance
456364|NCT01614119|Exercise|exercise
456365|NCT01614106|HIV/AIDS|hiv/aids
456366|NCT01614106|Drug Users|drug users
456367|NCT01614106|Crack-Cocaine Use|crack-cocaine use
456368|NCT01614106|HIV Primary Care|hiv primary care
456369|NCT01614093|Schizophrenia|schizophrenia
456370|NCT01614093|Appetite|appetite
456371|NCT01614093|Oxytocin|oxytocin
456372|NCT01614080|Stroke|stroke
456373|NCT01614080|Ischemic stroke|ischemic stroke
456374|NCT01614080|thrombolysis|thrombolysis
456375|NCT01614080|toxicity of t-PA|toxicity of t-pa
456376|NCT01614067|DOR|dor
456377|NCT01614067|Infertility|infertility
456378|NCT01614067|IVF|ivf
456379|NCT01614067|ART|art
456380|NCT01614067|GnRHa|gnrha
456381|NCT01614067|GnRH Antagonist Protocol|gnrh antagonist protocol
456382|NCT01614067|Ganirelix|ganirelix
456383|NCT01614054|Smoking cessation|smoking cessation
456384|NCT01614054|Nicotine replacement therapy|nicotine replacement therapy
456385|NCT01614054|NRT|nrt
456386|NCT01614054|Inpatient|inpatient
456387|NCT01614054|General Medicine|general medicine
456388|NCT01614041|Generalized Anxiety Disorder|generalized anxiety disorder
456389|NCT01614015|Recording|recording
456390|NCT01614015|Supervision|supervision
456391|NCT01614015|Observation|observation
456392|NCT01614002|carcinoma|carcinoma
456393|NCT01614002|breast cancer|breast cancer
456394|NCT01614002|non-small cell lung cancer|non-small cell lung cancer
456395|NCT01614002|prostata cancer|prostata cancer
456396|NCT01614002|adenocarcinoma of the stomach|adenocarcinoma of the stomach
456397|NCT01614002|squamous cell carcinoma of the head and neck region|squamous cell carcinoma of the head and neck region
456398|NCT01614002|ambulant chemotherapy|ambulant chemotherapy
456399|NCT01614002|treatment cycles|treatment cycles
456400|NCT01614002|Docetaxel|docetaxel
456401|NCT01614002|Doce onkovis|doce onkovis
456402|NCT01614002|Quantity of Docetaxel|quantity of docetaxel
456403|NCT01614002|Packaging Sizes|packaging sizes
456404|NCT01613989|Hip arthroplasty|hip arthroplasty
456405|NCT01613989|navigation|navigation
456406|NCT01613976|Myelodysplastic Syndromes|myelodysplastic syndromes
456407|NCT01613976|MDS|mds
456408|NCT01613976|Chronic Myelomonocytic Leukemia|chronic myelomonocytic leukemia
456409|NCT01613976|CMML|cmml
456410|NCT01613976|Acute Myeloid Leukemia|acute myeloid leukemia
456411|NCT01613976|AML|aml
456412|NCT01613976|Panobinostat|panobinostat
456413|NCT01613976|LBH589|lbh589
456414|NCT01613976|5-Aza|5-aza
456415|NCT01613976|Azacitidine|azacitidine
456416|NCT01613963|Uveitis|uveitis
456417|NCT01613963|Scleritis|scleritis
456418|NCT01613950|gastric cancer advanced gastric or metastatic gastric cancer PI3K PIK3CA mutation Her2 amplification HSP90 inhibitor PI3K inhibitor PIK3CA amplification|gastric cancer advanced gastric or metastatic gastric cancer pi3k pik3ca mutation her2 amplification hsp90 inhibitor pi3k inhibitor pik3ca amplification
456419|NCT01613937|Latinas|latinas
456420|NCT01613937|Gestational Diabetes|gestational diabetes
456421|NCT01613937|Prevention|prevention
456422|NCT01613911|Epilepsy|epilepsy
456423|NCT01613911|Invasive monitoring|invasive monitoring
456424|NCT01613911|Human sensory perception|human sensory perception
456425|NCT01613898|Cerebrotendinous xanthomatosis (CTX),|cerebrotendinous xanthomatosis (ctx),
456426|NCT01613898|lipoprotein,atherosclerosis,|lipoprotein,atherosclerosis,
456427|NCT01613898|carotid artery intima-media thickness (cIMT).|carotid artery intima-media thickness (cimt).
456428|NCT01613833|Alpha2 macroglobulin|alpha2 macroglobulin
456429|NCT01613833|Osteoarthritis|osteoarthritis
456430|NCT01613833|plasma and synovium|plasma and synovium
456431|NCT01613807|gestational diabetes mellitus|gestational diabetes mellitus
456432|NCT01613807|insulin analogues in pregnancy|insulin analogues in pregnancy
456433|NCT01613794|Deep vein thrombosis|deep vein thrombosis
456434|NCT01613794|Pulmonary embolism|pulmonary embolism
456435|NCT01613794|Rosuvastatin treatment|rosuvastatin treatment
456436|NCT01613794|Pharmacologic actions|pharmacologic actions
456437|NCT01613781|hemifacial spasm|hemifacial spasm
456438|NCT01613781|microvascular decompression|microvascular decompression
456439|NCT01613781|neuromuscular blockade|neuromuscular blockade
456440|NCT01613781|electromyography|electromyography
456441|NCT01613755|Effect Dipyridamole on pharmacokinetics of metformin|effect dipyridamole on pharmacokinetics of metformin
456442|NCT01613729|Dyslipidemia|dyslipidemia
456443|NCT01613729|Rosuvastatin|rosuvastatin
456444|NCT01613729|Efficacy|efficacy
456445|NCT01613729|Safety|safety
456446|NCT01613716|Diabetes|diabetes
456447|NCT01613716|Macular Edema|macular edema
456448|NCT01613716|Epiretinal Membrane|epiretinal membrane
456449|NCT01613716|Vitrectomy|vitrectomy
456450|NCT01613703|ONO-2952|ono-2952
456451|NCT01613703|Healthy adult subjects|healthy adult subjects
456452|NCT01613703|single doe|single doe
456453|NCT01613703|PET study|pet study
456454|NCT01613703|Safety|safety
456455|NCT01613703|Tolerability|tolerability
456456|NCT01613690|Renal impairment|renal impairment
456457|NCT01613690|NVA237|nva237
456458|NCT01613690|Pharmacokinetics|pharmacokinetics
456459|NCT01613677|advanced cervical cancer, BKM 120, progression free survival|advanced cervical cancer, bkm 120, progression free survival
456460|NCT01613664|obesity|obesity
456461|NCT01613664|surgical management|surgical management
456462|NCT01613664|sleeve gastrectomy|sleeve gastrectomy
456463|NCT01613638|congenital malformation|congenital malformation
456464|NCT01613638|pollutants|pollutants
456465|NCT01613586|ASP3652|asp3652
456466|NCT01613586|Painful Bladder Syndrome|painful bladder syndrome
456467|NCT01613586|Interstitial Cystitis|interstitial cystitis
456468|NCT01613586|Bladder Pain Syndrome|bladder pain syndrome
456469|NCT01613573|pegylated Somatropin|pegylated somatropin
456470|NCT01613573|PEG-GH|peg-gh
456471|NCT01613573|Phase 1 study|phase 1 study
456472|NCT01613573|Pharmacokinetics|pharmacokinetics
456473|NCT01613534|chronic radiation proctopathy|chronic radiation proctopathy
456474|NCT01613534|argon plasma coagulation|argon plasma coagulation
456475|NCT01613534|sucralfate|sucralfate
456476|NCT01613521|DCE-MRI|dce-mri
456477|NCT01613521|18F-FMISO PET|18f-fmiso pet
456478|NCT01613521|11-174|11-174
456479|NCT01613495|obesity|obesity
456480|NCT01613469|fluorouracil|fluorouracil
456481|NCT01613469|leucovorin|leucovorin
456482|NCT01613469|radiotherapy|radiotherapy
456483|NCT01613469|neoadjuvant therapy|neoadjuvant therapy
456484|NCT01613443|Dabigatran, Rivaroxaban, Point of Care-testing|dabigatran, rivaroxaban, point of care-testing
456485|NCT01613417|Have confirmed or are highly suspected of brain disease|have confirmed or are highly suspected of brain disease
456486|NCT01613404|Chronic kidney disease|chronic kidney disease
456487|NCT01613404|Hemodialysis|hemodialysis
456488|NCT01613404|Eprex|eprex
456489|NCT01613404|Aranesp|aranesp
456490|NCT01613404|ESA|esa
456491|NCT01613404|Anemia|anemia
456492|NCT01613391|Visfatin|visfatin
456493|NCT01613391|Resistin|resistin
456494|NCT01613391|Apelin|apelin
456495|NCT01613391|roux-en-y gastric bypass|roux-en-y gastric bypass
456496|NCT01613391|laparoscopic adjustable gastric banding|laparoscopic adjustable gastric banding
456497|NCT01613391|morbid obesity|morbid obesity
456498|NCT01613352|Early breast cancer surgery|early breast cancer surgery
456499|NCT01613352|Psychosocial wellbeing|psychosocial wellbeing
456500|NCT01613352|Ambulatory surgery|ambulatory surgery
456501|NCT01613339|stroke|stroke
456502|NCT01613339|postural control|postural control
456503|NCT01613339|body awareness therapy|body awareness therapy
456504|NCT01613326|COPD|copd
456505|NCT01613313|Lipoma|lipoma
456506|NCT01613313|Fatty Tumor|fatty tumor
456507|NCT01613300|hodgkin|hodgkin
456508|NCT01613300|disease|disease
456509|NCT01613300|ofatumumab|ofatumumab
456510|NCT01613287|Pulmonary Hypertension|pulmonary hypertension
456511|NCT01613287|Pulmonary Arterial Hypertension|pulmonary arterial hypertension
456512|NCT01613287|TheraSorb|therasorb
456513|NCT01613287|immunoadsorption|immunoadsorption
456514|NCT01613274|colon resection|colon resection
456515|NCT01613261|TAK-733,|tak-733,
456516|NCT01613261|alisertib,|alisertib,
456517|NCT01613261|MLN8237,|mln8237,
456518|NCT01613261|Oral MEK Inhibitor,|oral mek inhibitor,
456519|NCT01613261|Oral Aurora A Kinase Inhibitor|oral aurora a kinase inhibitor
456520|NCT01613235|subarachnoid hemorrhage|subarachnoid hemorrhage
456521|NCT01613235|ischemia|ischemia
456522|NCT01613235|vasospasm|vasospasm
456523|NCT01613235|CT|ct
456524|NCT01613235|perfusion|perfusion
456525|NCT01613235|induced hypertension|induced hypertension
456526|NCT01613235|delayed cerebral ischemia|delayed cerebral ischemia
456527|NCT01613209|Hypertension|hypertension
456528|NCT01613209|ABPM|abpm
456529|NCT01613209|office blood pressure|office blood pressure
456530|NCT01613209|olmesartan|olmesartan
456531|NCT01613209|amlodipine|amlodipine
456532|NCT01613209|fixed combination|fixed combination
456533|NCT01613209|time of intake|time of intake
456534|NCT01613196|Extrapulmonary tuberculosis|extrapulmonary tuberculosis
456535|NCT01613196|FDG-TEP|fdg-tep
456536|NCT01613196|cohorts|cohorts
456537|NCT01613170|Overactive Bladder|overactive bladder
456538|NCT01613170|Vaginal Estrogen|vaginal estrogen
456539|NCT01613170|Anticholinergics|anticholinergics
456540|NCT01613170|Antimuscarinics|antimuscarinics
456541|NCT01613157|pharmacokinetics|pharmacokinetics
456542|NCT01613157|HIV infected women|hiv infected women
456543|NCT01613118|Primary FSGS|primary fsgs
456544|NCT01613118|Nephrotic syndrome|nephrotic syndrome
456545|NCT01613118|Steroid Resistant|steroid resistant
456546|NCT01613105|Diabetes Mellitus|diabetes mellitus
456547|NCT01613105|Type-2|type-2
456548|NCT01613105|Acarbose|acarbose
456549|NCT01613105|Drug Therapy|drug therapy
456550|NCT01613105|Combination|combination
456551|NCT01613092|Arrhythmia|arrhythmia
456552|NCT01613092|Device Procedure|device procedure
456553|NCT01613092|High risk patients|high risk patients
456554|NCT01613092|Antibiotics|antibiotics
456555|NCT01613092|Infection|infection
456556|NCT01613092|Cluster|cluster
456557|NCT01613079|Rheumatoid Arthritis|rheumatoid arthritis
456558|NCT01613079|Methotrexate|methotrexate
456559|NCT01613079|Tripterygium|tripterygium
456560|NCT01613066|Haematological malignancies|haematological malignancies
456561|NCT01613066|Allogeneic Cord Blood transplantation|allogeneic cord blood transplantation
456562|NCT01613066|Intrabone|intrabone
456563|NCT01613053|Gastrointestinal Stromal Tumor, GIST|gastrointestinal stromal tumor, gist
456564|NCT01613014|Alcohol|alcohol
456565|NCT01613014|Alcohol Dependence|alcohol dependence
456566|NCT01613014|Alcohol Abuse|alcohol abuse
456567|NCT01613014|Alcohol Use Disorders|alcohol use disorders
456568|NCT01613014|Alcoholism|alcoholism
456569|NCT01612988|B-cell chronic lymphocytic leukemia|b-cell chronic lymphocytic leukemia
456570|NCT01612988|relapse|relapse
456571|NCT01612988|Bendamustine|bendamustine
456572|NCT01612988|Ofatumumab|ofatumumab
456573|NCT01612988|Méthylprednisolone|méthylprednisolone
456574|NCT01612975|Chest tubes|chest tubes
456575|NCT01612975|Length of stay|length of stay
456576|NCT01612975|Pleural effusion|pleural effusion
456577|NCT01612975|Lung resection|lung resection
456578|NCT01612975|Post-operative|post-operative
456579|NCT01612975|Lung cancer|lung cancer
456580|NCT01612949|endotracheal intubation|endotracheal intubation
456581|NCT01612949|facial structure|facial structure
456582|NCT01612949|Mallampati score|mallampati score
456583|NCT01612949|computerized facial analysis|computerized facial analysis
456584|NCT01612936|Asthma|asthma
456585|NCT01612936|Allergic|allergic
456586|NCT01612936|Inflammation|inflammation
456587|NCT01612936|Constriction|constriction
456588|NCT01612936|Airway|airway
456589|NCT01612936|Challenge|challenge
456590|NCT01612936|Chemokines|chemokines
456591|NCT01612923|abortion|abortion
456592|NCT01612923|medical abortion|medical abortion
456593|NCT01612910|estrogen receptor-negative breast cancer|estrogen receptor-negative breast cancer
456594|NCT01612910|HER2-negative breast cancer|her2-negative breast cancer
456595|NCT01612910|progesterone receptor-negative breast cancer|progesterone receptor-negative breast cancer
456596|NCT01612910|recurrent breast cancer|recurrent breast cancer
456597|NCT01612910|stage II breast cancer|stage ii breast cancer
456598|NCT01612910|stage IIIA breast cancer|stage iiia breast cancer
456599|NCT01612910|stage IIIB breast cancer|stage iiib breast cancer
456600|NCT01612910|stage IIIC breast cancer|stage iiic breast cancer
456601|NCT01612910|triple-negative breast cancer|triple-negative breast cancer
456602|NCT01612897|autism|autism
456603|NCT01612897|well child care|well child care
456604|NCT01612897|screening|screening
456605|NCT01612897|computer|computer
456606|NCT01612897|reminders|reminders
456607|NCT01612871|Breast cancer,|breast cancer,
456608|NCT01612871|hormonotherapy,|hormonotherapy,
456609|NCT01612871|miRNAs,|mirnas,
456610|NCT01612871|biomarkers|biomarkers
456611|NCT01612871|hormone therapy|hormone therapy
456612|NCT01612858|Lipodystrophy|lipodystrophy
456613|NCT01612858|Insulin resistance|insulin resistance
456614|NCT01612858|HIV infection|hiv infection
456615|NCT01612845|rotator cuff|rotator cuff
456616|NCT01612845|shoulder|shoulder
456617|NCT01612845|platelet rich plasma|platelet rich plasma
456618|NCT01612845|fibrin|fibrin
456619|NCT01612793|COPD|copd
456620|NCT01612780|Sinusitis|sinusitis
456621|NCT01612780|Sinus balloon dilation patients|sinus balloon dilation patients
456622|NCT01612767|de novo coronary lesions|de novo coronary lesions
456623|NCT01612767|restenotic coronary lesions|restenotic coronary lesions
456624|NCT01612767|coronary arteries|coronary arteries
456625|NCT01612754|Reduction of noise pollution|reduction of noise pollution
456626|NCT01612754|Specifically enforced workplace rules|specifically enforced workplace rules
456627|NCT01612754|Stress|stress
456628|NCT01612754|Sound Ears (TM)|sound ears (tm)
456629|NCT01612754|Error|error
456630|NCT01612741|Diabetes Mellitus, Type-2|diabetes mellitus, type-2
456631|NCT01612741|Acarbose|acarbose
456632|NCT01612741|Drug Therapy|drug therapy
456633|NCT01612741|Combination|combination
456634|NCT01612728|Aromatase Inhibitors|aromatase inhibitors
456635|NCT01612715|Asthma, allergen challenge, T cells, Fel d 1.|asthma, allergen challenge, t cells, fel d 1.
456636|NCT01612702|postoperative nausea and vomiting|postoperative nausea and vomiting
456637|NCT01612702|postoperative pain|postoperative pain
456638|NCT01612689|Accelerometer|accelerometer
456639|NCT01612689|EMU|emu
456640|NCT01612689|Ambulatory|ambulatory
456641|NCT01612689|ECG|ecg
456642|NCT01612689|Heart rate|heart rate
456643|NCT01612663|Knee pain|knee pain
456644|NCT01612663|Acupuncture|acupuncture
456645|NCT01612663|Sham acupuncture|sham acupuncture
456646|NCT01612650|breast cancer|breast cancer
456647|NCT01612650|surveillance|surveillance
456648|NCT01612650|diagnosis|diagnosis
456649|NCT01612650|2D mammography|2d mammography
456650|NCT01612650|3D mammography|3d mammography
456651|NCT01612637|Pelvic organ prolapse|pelvic organ prolapse
456652|NCT01612637|Pelvic floor muscle training|pelvic floor muscle training
456653|NCT01612637|Prolapse symptoms|prolapse symptoms
456654|NCT01612637|Pelvic organ prolapse quantification system|pelvic organ prolapse quantification system
456655|NCT01612637|Ultrasonography|ultrasonography
456656|NCT01612637|Predictors|predictors
456657|NCT01612520|type 2 Diabetes Mellitus|type 2 diabetes mellitus
456658|NCT01612520|telenursing|telenursing
456659|NCT01612520|RCT|rct
456660|NCT01612520|economic analysis|economic analysis
456661|NCT01612507|Phase 1|phase 1
456662|NCT01612507|healthy volunteers|healthy volunteers
456663|NCT01612507|Parallel Group Study|parallel group study
456664|NCT01612507|ceftaroline fosamil different doses|ceftaroline fosamil different doses
456665|NCT01612507|safety|safety
456666|NCT01612507|Cmax|cmax
456667|NCT01612507|tmax|tmax
456668|NCT01612507|AUC|auc
456669|NCT01612481|soft tissue sarcoma|soft tissue sarcoma
456670|NCT01612481|lung metastasis|lung metastasis
456671|NCT01612481|surveillance|surveillance
456672|NCT01612468|Diabetes|diabetes
456673|NCT01612468|Liraglutide|liraglutide
456674|NCT01612468|Hypoglycaemia|hypoglycaemia
456675|NCT01612468|Hyperglycaemia|hyperglycaemia
456676|NCT01612468|CIMT|cimt
456677|NCT01612468|PWV|pwv
456678|NCT01612468|Food preference|food preference
456679|NCT01612468|Blood pressure|blood pressure
456680|NCT01612455|HIV|hiv
456681|NCT01612455|drug addiction|drug addiction
456682|NCT01612455|Russia|russia
456683|NCT01612455|case management|case management
456684|NCT01612442|complementary feeding|complementary feeding
456685|NCT01612442|mothers|mothers
456686|NCT01612442|6-24 months children|6-24 months children
456687|NCT01612442|community health volunteers|community health volunteers
456688|NCT01612442|nutrition education|nutrition education
456689|NCT01612442|agricultural education|agricultural education
456690|NCT01612429|Carbamylation|carbamylation
456691|NCT01612429|Albumin|albumin
456692|NCT01612429|Protein structure|protein structure
456693|NCT01612429|Kidney disease|kidney disease
456694|NCT01612416|Ganglion Cell complex, Retinal Nerve Fiber Layer,Glaucoma|ganglion cell complex, retinal nerve fiber layer,glaucoma
456695|NCT01612403|zinc binding protein|zinc binding protein
456696|NCT01612390|postpartum hemorrhage|postpartum hemorrhage
456697|NCT01612377|Moderate to Severe|moderate to severe
456698|NCT01612364|CRPS I|crps i
456699|NCT01612351|Head and neck cancer|head and neck cancer
456700|NCT01612351|Squamous Cell Carcinoma|squamous cell carcinoma
456701|NCT01612351|Phase II|phase ii
456702|NCT01612351|Transoral Surgery|transoral surgery
456703|NCT01612351|Induction Chemotherapy|induction chemotherapy
456704|NCT01612351|Carboplatin|carboplatin
456705|NCT01612351|Paclitaxel|paclitaxel
456706|NCT01612351|Lapatinib|lapatinib
456707|NCT01612338|breast cancer|breast cancer
456708|NCT01612338|young age of onset|young age of onset
456709|NCT01612338|family history|family history
456710|NCT01612338|screening interventions|screening interventions
456711|NCT01612338|family support|family support
456712|NCT01612325|liver tumors|liver tumors
456713|NCT01612312|Non-ST-elevation myocardial infarction|non-st-elevation myocardial infarction
456714|NCT01612312|thrombectomy|thrombectomy
456715|NCT01612312|magnetic resonance imaging|magnetic resonance imaging
456716|NCT01612312|microvascular obstruction|microvascular obstruction
456717|NCT01612286|Recombinant human endostatin|recombinant human endostatin
456718|NCT01612286|nasopharyngeal carcinoma|nasopharyngeal carcinoma
456719|NCT01612286|chemotherapy|chemotherapy
456720|NCT01612273|Vasospastic syndrome|vasospastic syndrome
456721|NCT01612273|Vascular dysregulation|vascular dysregulation
456722|NCT01612260|heart failure|heart failure
456723|NCT01612260|ventricular premature complex|ventricular premature complex
456724|NCT01612260|Shensong Yangxin capsule|shensong yangxin capsule
456725|NCT01612247|Breast Cancer|breast cancer
456726|NCT01612247|Neoadjuvant therapy|neoadjuvant therapy
456727|NCT01612234|humans|humans
456728|NCT01612234|lean|lean
456729|NCT01612234|obese|obese
456730|NCT01612234|saturated fat|saturated fat
456731|NCT01612234|monounsaturated fat|monounsaturated fat
456732|NCT01612234|insulin sensitivity|insulin sensitivity
456733|NCT01612234|inflammation|inflammation
456734|NCT01612234|oxidant stress|oxidant stress
456735|NCT01612195|anal fistula|anal fistula
456736|NCT01612195|anal continence|anal continence
456737|NCT01612195|health-related quality of life|health-related quality of life
456738|NCT01612182|end-stage renal disease|end-stage renal disease
456739|NCT01612182|renal replacement therapy|renal replacement therapy
456740|NCT01612169|HIV patients|hiv patients
456741|NCT01612169|Hospitalized patients|hospitalized patients
456742|NCT01612169|Substance Users|substance users
456743|NCT01612169|Drug Users|drug users
456744|NCT01612156|Urodynamic testing|urodynamic testing
456745|NCT01612156|pelvic floor examination|pelvic floor examination
456746|NCT01612156|Lidocaine gel|lidocaine gel
456747|NCT01612156|Surgical lubricant|surgical lubricant
456748|NCT01612156|Pain|pain
456749|NCT01612156|Embarrassment|embarrassment
456750|NCT01612117|renal failure|renal failure
456751|NCT01612117|cardiology|cardiology
456752|NCT01612117|contrast-induced nephropathy|contrast-induced nephropathy
456753|NCT01612104|Post Traumatic Stress Disorder|post traumatic stress disorder
456754|NCT01612104|Anxiety symptoms|anxiety symptoms
456755|NCT01612104|Depressive symptoms|depressive symptoms
456756|NCT01612104|Externalizing behavior|externalizing behavior
456757|NCT01612104|Reduced quality of life|reduced quality of life
456758|NCT01612091|Expert System|expert system
456759|NCT01612091|Intensive Care|intensive care
456760|NCT01612091|Telemedicine|telemedicine
456761|NCT01612091|Equipment Design|equipment design
456762|NCT01612065|Office hysteroscopy|office hysteroscopy
456763|NCT01612065|Cervical priming|cervical priming
456764|NCT01612065|Misoprostol|misoprostol
456765|NCT01612052|Vascular Surgery|vascular surgery
456766|NCT01612039|ulcerative colitis|ulcerative colitis
456767|NCT01612013|N-acetylcysteine|n-acetylcysteine
456768|NCT01612013|angiography|angiography
456769|NCT01612013|contrast medium|contrast medium
456770|NCT01612013|contrast-induced nephropathy|contrast-induced nephropathy
456771|NCT01612013|sodium bicarbonate|sodium bicarbonate
456772|NCT01612000|Influenza|influenza
456773|NCT01611974|transplant|transplant
456774|NCT01611974|treatment|treatment
456775|NCT01611974|resistant|resistant
456776|NCT01611974|CMV|cmv
456777|NCT01611974|refractory|refractory
456778|NCT01611974|cytomegalovirus|cytomegalovirus
456779|NCT01611961|Docetaxel|docetaxel
456780|NCT01611961|Lipid Microsphere|lipid microsphere
456781|NCT01611961|Neoplasms|neoplasms
456782|NCT01611961|Antineoplastic Agents|antineoplastic agents
456783|NCT01611961|Pharmacologic Actions|pharmacologic actions
456784|NCT01611961|Therapeutic Uses|therapeutic uses
456785|NCT01611935|trauma|trauma
456786|NCT01611935|shock|shock
456787|NCT01611935|vasopressin|vasopressin
456788|NCT01611935|blood transfusion|blood transfusion
456789|NCT01611922|eye|eye
456790|NCT01611922|eyelid|eyelid
456791|NCT01611922|contact lenses|contact lenses
456792|NCT01611922|dry eye disease|dry eye disease
456793|NCT01611909|p-menthane-3,8-diol oil extract|p-menthane-3,8-diol oil extract
456794|NCT01611909|topical therapy|topical therapy
456795|NCT01611896|Graves' hyperthyroidism|graves' hyperthyroidism
456796|NCT01611896|Graves' disease|graves' disease
456797|NCT01611896|Selenium|selenium
456798|NCT01611896|Quality of Life|quality of life
456799|NCT01611896|ThyPRO|thypro
456800|NCT01611896|Autoimmunity|autoimmunity
456801|NCT01611857|Advanced solid tumors|advanced solid tumors
456802|NCT01611857|First-Line Metastatic GE cancer|first-line metastatic ge cancer
456803|NCT01611857|c-Met Inhibitor|c-met inhibitor
456804|NCT01611857|Tivantinib|tivantinib
456805|NCT01611857|FOLFOX|folfox
456806|NCT01611844|delayed-type hypersensitivity reaction to tuberculin intradermal injection|delayed-type hypersensitivity reaction to tuberculin intradermal injection
456807|NCT01611844|tuberculosis skin test|tuberculosis skin test
456808|NCT01611844|BD micro-needle|bd micro-needle
456809|NCT01611844|medical device|medical device
456810|NCT01611844|spectroscopy|spectroscopy
456811|NCT01611831|fibromyalgia|fibromyalgia
456812|NCT01611831|Acceptation & Commitment Therapy|acceptation & commitment therapy
456813|NCT01611831|randomized controlled trial|randomized controlled trial
456814|NCT01611818|Depression|depression
456815|NCT01611818|Computer-delivered psychotherapy|computer-delivered psychotherapy
456816|NCT01611818|Randomized-controlled trial|randomized-controlled trial
456817|NCT01611792|Stabilization exercise|stabilization exercise
457021|NCT01610908|Schroth|schroth
456818|NCT01611792|Strength and conditioning exercise|strength and conditioning exercise
456819|NCT01611792|Physical therapy|physical therapy
456820|NCT01611792|Rehabilitation|rehabilitation
456821|NCT01611779|obstructive sleep apnea|obstructive sleep apnea
456822|NCT01611779|tongue suspension|tongue suspension
456823|NCT01611766|secondary cytoreductive surgery|secondary cytoreductive surgery
456824|NCT01611766|Ovarian Cancer|ovarian cancer
456825|NCT01611766|surgery|surgery
456826|NCT01611766|recurrence|recurrence
456827|NCT01611753|Shock, Septic|shock, septic
456828|NCT01611753|Erythrocyte Transfusion|erythrocyte transfusion
456829|NCT01611753|Ischemia|ischemia
456830|NCT01611740|Preterm infant|preterm infant
456831|NCT01611740|Bacterial infection|bacterial infection
456832|NCT01611740|Diagnosis of proven or suspected bacterial infection|diagnosis of proven or suspected bacterial infection
456833|NCT01611727|BRCA1|brca1
456834|NCT01611727|survival|survival
456835|NCT01611727|metastatic disease|metastatic disease
456836|NCT01611727|cisplatin|cisplatin
456837|NCT01611714|Racial/ethnic disparities|racial/ethnic disparities
456838|NCT01611714|Imaging|imaging
456839|NCT01611714|Emergency|emergency
456840|NCT01611714|Headache|headache
456841|NCT01611675|Metastatic|metastatic
456842|NCT01611675|Unresectable|unresectable
456843|NCT01611675|Clearly progressive|clearly progressive
456844|NCT01611675|BRAF mutation|braf mutation
456845|NCT01611649|infant formula|infant formula
456846|NCT01611649|dairy lipids|dairy lipids
456847|NCT01611649|omega-3|omega-3
456848|NCT01611636|allergy|allergy
456849|NCT01611636|autoimmune diseases|autoimmune diseases
456850|NCT01611636|rheumatic diseases|rheumatic diseases
456851|NCT01611623|Solid tumor malignancy|solid tumor malignancy
456852|NCT01611623|Hsp90|hsp90
456853|NCT01611610|outcome measures|outcome measures
456854|NCT01611610|spinal muscular atrophy|spinal muscular atrophy
456855|NCT01611597|accelerometry|accelerometry
456856|NCT01611597|neuromuscular disease|neuromuscular disease
456858|NCT01611584|Florescence|florescence
456859|NCT01611584|Lung cancer|lung cancer
456860|NCT01611571|osteoporosis|osteoporosis
456861|NCT01611571|male|male
456862|NCT01611545|Pharmacogenomics|pharmacogenomics
456863|NCT01611545|Pharmacogenetics|pharmacogenetics
456864|NCT01611545|Clopidogrel|clopidogrel
456865|NCT01611545|Plavix|plavix
456866|NCT01611532|Acute pancreatitis|acute pancreatitis
456867|NCT01611532|Intraabdominal pressure|intraabdominal pressure
456868|NCT01611532|Critical illness|critical illness
456869|NCT01611519|urinary bladder|urinary bladder
456870|NCT01611519|urinary catheterization|urinary catheterization
456871|NCT01611519|epidural analgesia|epidural analgesia
456872|NCT01611519|catheters, indwelling|catheters, indwelling
456873|NCT01611493|Dental Implants|dental implants
456874|NCT01611493|Jaw, Edentulous, Partially/rehabilitation|jaw, edentulous, partially/rehabilitation
456875|NCT01611493|Jaw, Edentulous, Partially/surgery|jaw, edentulous, partially/surgery
456876|NCT01611493|randomised Clinical Trials|randomised clinical trials
456877|NCT01611493|Humans|humans
456878|NCT01611467|CC-223|cc-223
456879|NCT01611467|safety|safety
456880|NCT01611467|tolerability|tolerability
456881|NCT01611467|pharmacokinetic|pharmacokinetic
456882|NCT01611467|AME (Absorption, Metabolism, and Excretion)|ame (absorption, metabolism, and excretion)
456883|NCT01611467|FE (Food Effect)|fe (food effect)
456884|NCT01611454|Occupational Exposure to Radiation|occupational exposure to radiation
456885|NCT01611441|Osteoarthritis of the knee|osteoarthritis of the knee
456886|NCT01611441|Biomarkers|biomarkers
456887|NCT01611428|Ipragliflozin|ipragliflozin
456888|NCT01611428|Healthy|healthy
456889|NCT01611428|Absolute Bioavailability|absolute bioavailability
456890|NCT01611428|Pharmacokinetics|pharmacokinetics
456891|NCT01611415|Phase 1|phase 1
456892|NCT01611415|Ipragliflozin|ipragliflozin
456893|NCT01611415|Furosemide|furosemide
456894|NCT01611415|Pharmacokinetics|pharmacokinetics
456895|NCT01611415|Pharmacodynamics|pharmacodynamics
456896|NCT01611402|Tuberculosis|tuberculosis
456897|NCT01611402|HIV Infection|hiv infection
456898|NCT01611402|Transcriptional Signature|transcriptional signature
456899|NCT01611402|IRIS|iris
456900|NCT01611376|impedance cardiography|impedance cardiography
456901|NCT01611376|Flotrac/Vigileo|flotrac/vigileo
456902|NCT01611376|cardiac output|cardiac output
456903|NCT01611363|Ipragliflozin|ipragliflozin
456904|NCT01611363|Phase 1|phase 1
456905|NCT01611363|Healthy|healthy
456906|NCT01611363|Diabetes Mellitus|diabetes mellitus
456907|NCT01611363|Pharmacokinetics|pharmacokinetics
456908|NCT01611363|Pharmacodynamics|pharmacodynamics
456909|NCT01611350|Indoor Air Pollution|indoor air pollution
456910|NCT01611350|Marketing Methods for Increasing Technology Adoption|marketing methods for increasing technology adoption
456911|NCT01611350|Optimal Contracts for Technology Adoption|optimal contracts for technology adoption
456912|NCT01611337|schizophrenia, insight|schizophrenia, insight
456913|NCT01611324|Varicose Veins|varicose veins
456914|NCT01611324|Phlebectomy|phlebectomy
456915|NCT01611324|Local Anesthesia|local anesthesia
456916|NCT01611298|allogeneic stem cell transplant|allogeneic stem cell transplant
456917|NCT01611298|malignant diseases|malignant diseases
456918|NCT01611298|Acute lymphoblastic leukemia|acute lymphoblastic leukemia
456919|NCT01611298|acute myelogenous leukemia|acute myelogenous leukemia
456920|NCT01611298|Chronic myelogenous leukemia|chronic myelogenous leukemia
456921|NCT01611298|myelodysplastic syndrome|myelodysplastic syndrome
456922|NCT01611298|Hodgkin lymphoma|hodgkin lymphoma
456923|NCT01611298|non-Hodgkin lymphoma|non-hodgkin lymphoma
456924|NCT01611298|myeloproliferative disorder|myeloproliferative disorder
456925|NCT01611298|non-malignant disease|non-malignant disease
456926|NCT01611285|UPHOLD|uphold
456927|NCT01611285|robotic surgery|robotic surgery
456928|NCT01611285|decision analysis|decision analysis
456929|NCT01611285|FDA|fda
456930|NCT01611285|decision node|decision node
456931|NCT01611285|outcome node|outcome node
456932|NCT01611272|Unstable angina|unstable angina
456933|NCT01611259|MALT Lymphoma|malt lymphoma
456934|NCT01611259|Lenalidomide|lenalidomide
456935|NCT01611259|Rituximab|rituximab
456936|NCT01611259|AGMT|agmt
456937|NCT01611233|metal on metal|metal on metal
456938|NCT01611233|hip replacement|hip replacement
456939|NCT01611233|ASR|asr
456940|NCT01611233|DePuy|depuy
456941|NCT01611220|Anorexia Nervosa|anorexia nervosa
456942|NCT01611220|Relapse prevention|relapse prevention
456943|NCT01611220|Cognitive Dissonance|cognitive dissonance
456944|NCT01611220|Inpatient treatment|inpatient treatment
456945|NCT01611220|Cognitive behavior therapy|cognitive behavior therapy
456946|NCT01611207|wound healing impairments,|wound healing impairments,
456947|NCT01611207|negative pressure wound therapy,|negative pressure wound therapy,
456948|NCT01611207|health services research,|health services research,
456949|NCT01611207|germany|germany
456950|NCT01611194|HBO2|hbo2
456951|NCT01611194|HBOT|hbot
456952|NCT01611194|mTBI|mtbi
456953|NCT01611194|Brain injury|brain injury
456954|NCT01611194|PCS|pcs
456955|NCT01611194|PTSD|ptsd
456956|NCT01611194|hyperbaric oxygen|hyperbaric oxygen
456957|NCT01611181|Iron supplementation|iron supplementation
456958|NCT01611181|Iron deficiency|iron deficiency
456959|NCT01611181|Hip arthroplasty|hip arthroplasty
456960|NCT01611181|Knee arthroplasty|knee arthroplasty
456961|NCT01611142|Monoclonal antibody|monoclonal antibody
456962|NCT01611142|Peripheral T-cell Lymphoma|peripheral t-cell lymphoma
456963|NCT01611142|cancer|cancer
456964|NCT01611142|hematologic malignancy|hematologic malignancy
456965|NCT01611129|Disability Evaluation|disability evaluation
456966|NCT01611103|Cognitive Enhancement|cognitive enhancement
456967|NCT01611103|tDCS|tdcs
456968|NCT01611103|stimulation|stimulation
456969|NCT01611103|elderly|elderly
456970|NCT01611103|older adults|older adults
456971|NCT01611090|Chronic lymphocytic leukemia|chronic lymphocytic leukemia
456972|NCT01611090|Small lymphocytic lymphoma|small lymphocytic lymphoma
456973|NCT01611090|Relapsed or refractory chronic lymphocytic leukemia|relapsed or refractory chronic lymphocytic leukemia
456974|NCT01611090|Relapsed or refractory small lymphocytic lymphoma|relapsed or refractory small lymphocytic lymphoma
456975|NCT01611090|Ibrutinib|ibrutinib
456976|NCT01611090|PCI-32765|pci-32765
456977|NCT01611090|JNJ-54179060|jnj-54179060
456978|NCT01611090|Bruton's tyrosine kinase inhibitor|bruton's tyrosine kinase inhibitor
456979|NCT01611090|Bendamustine|bendamustine
456980|NCT01611090|Rituximab|rituximab
456981|NCT01611064|Hand|hand
456982|NCT01611064|Surgery|surgery
456983|NCT01611064|Tourniquet|tourniquet
456984|NCT01611064|Pain|pain
456985|NCT01611064|Oxygen|oxygen
456986|NCT01611051|breast cancer|breast cancer
456987|NCT01611051|neutropenia|neutropenia
456988|NCT01611051|febrile neutropenia|febrile neutropenia
456989|NCT01611012|Asthma|asthma
456990|NCT01611012|Inflammation|inflammation
456991|NCT01611012|Phenotype|phenotype
456992|NCT01611012|Sputum|sputum
456993|NCT01610986|Fructose|fructose
456994|NCT01610986|Exercise|exercise
456995|NCT01610986|Lactic acid|lactic acid
456996|NCT01610986|Monocarboxylic Acid Transporters|monocarboxylic acid transporters
456997|NCT01610973|Fuch's dystrophy|fuch's dystrophy
456998|NCT01610973|Corneal graft|corneal graft
456999|NCT01610960|Non invasive ventilation|non invasive ventilation
457000|NCT01610960|Helmet|helmet
457001|NCT01610960|NEXT Helmet|next helmet
457002|NCT01610960|Work of breathing|work of breathing
457003|NCT01610960|Intensive care|intensive care
457004|NCT01610947|Spondyloarthritis|spondyloarthritis
457005|NCT01610947|Anti-TNF|anti-tnf
457006|NCT01610947|Adalimumab|adalimumab
457007|NCT01610947|Etanercept|etanercept
457008|NCT01610947|Infliximab|infliximab
457009|NCT01610934|MODY|mody
457010|NCT01610934|Monogenic diabetes|monogenic diabetes
457011|NCT01610934|Non-autoimmune diabetes|non-autoimmune diabetes
457012|NCT01610934|MODY3|mody3
457013|NCT01610921|asthma|asthma
457014|NCT01610921|small airways disease|small airways disease
457015|NCT01610921|inflammation|inflammation
457016|NCT01610921|provocation|provocation
457017|NCT01610921|adenosine|adenosine
457018|NCT01610908|Adolescent|adolescent
457019|NCT01610908|Idiopathic|idiopathic
457020|NCT01610908|Scoliosis|scoliosis
457022|NCT01610908|Exercises|exercises
457023|NCT01610908|Conservative treatment|conservative treatment
457024|NCT01610895|Colonoscopy|colonoscopy
457025|NCT01610895|low fibre diet|low fibre diet
457026|NCT01610895|clear fluids|clear fluids
457027|NCT01610895|Bowel Preparation|bowel preparation
457028|NCT01610869|Recurrence|recurrence
457029|NCT01610869|Ovarian Neoplasms|ovarian neoplasms
457030|NCT01610869|Ovarian Diseases|ovarian diseases
457031|NCT01610869|Fallopian Tube Neoplasms|fallopian tube neoplasms
457032|NCT01610869|Neoplasms|neoplasms
457033|NCT01610869|Carcinoma|carcinoma
457034|NCT01610869|Neoplasms by site|neoplasms by site
457035|NCT01610856|bowel preparation|bowel preparation
457036|NCT01610856|bowel purgative|bowel purgative
583179|NCT01084694|HSCT|hsct
457037|NCT01610856|bowel cleansing|bowel cleansing
457038|NCT01610856|colonoscopy|colonoscopy
457039|NCT01610843|Sarcoidosis|sarcoidosis
457040|NCT01610843|WISE|wise
457041|NCT01610843|Sarcoid Study|sarcoid study
457042|NCT01610843|Worldwide Sarcoidosis Research Study|worldwide sarcoidosis research study
457043|NCT01610830|Purpura, Schoenlein-Henoch|purpura, schoenlein-henoch
457044|NCT01610830|adults|adults
457045|NCT01610830|children|children
457046|NCT01610830|pronostic factors|pronostic factors
457047|NCT01610817|Patient information and active participation|patient information and active participation
457048|NCT01610817|Patient safety|patient safety
457049|NCT01610817|Health education|health education
457050|NCT01610817|Adverse drug event|adverse drug event
457051|NCT01610817|Primary care|primary care
457052|NCT01610817|Antihypertensive drugs|antihypertensive drugs
457053|NCT01610765|HSV|hsv
457054|NCT01610765|pharmacokinetics|pharmacokinetics
457055|NCT01610765|herpes|herpes
457056|NCT01610765|neonates|neonates
457057|NCT01610752|Pregnancy|pregnancy
457058|NCT01610752|Gestational weight gain|gestational weight gain
457059|NCT01610726|colon|colon
457060|NCT01610726|rectum|rectum
457061|NCT01610726|recovery|recovery
457062|NCT01610726|surgery|surgery
457063|NCT01610674|Diabetes mellitus|diabetes mellitus
457064|NCT01610674|Surgery|surgery
457065|NCT01610674|Implementation|implementation
457066|NCT01610674|Quality of care|quality of care
457067|NCT01610674|Quality indicators|quality indicators
457068|NCT01610661|carbohydrate|carbohydrate
457069|NCT01610661|inflammation|inflammation
457070|NCT01610661|glucose homeostasis|glucose homeostasis
457071|NCT01610661|gene expression|gene expression
457072|NCT01610648|OSA|osa
457073|NCT01610648|metabolic syndrome|metabolic syndrome
457074|NCT01610648|Apnea-hypopnea index|apnea-hypopnea index
457075|NCT01610648|Oxygen desaturation index|oxygen desaturation index
457076|NCT01610635|RCT|rct
457077|NCT01610635|blood donation frequency|blood donation frequency
457078|NCT01610635|quality of life|quality of life
457079|NCT01610635|iron deficiency|iron deficiency
457080|NCT01610622|Cardiac Output|cardiac output
457081|NCT01610622|Blood volumes|blood volumes
457082|NCT01610622|Neonates|neonates
457083|NCT01610609|Statin treatment|statin treatment
457084|NCT01610609|Cardiovascular disease|cardiovascular disease
457085|NCT01610609|High cholesterol|high cholesterol
457086|NCT01610609|Care management|care management
457087|NCT01610596|Psoriasis|psoriasis
457088|NCT01610596|Skin Diseases|skin diseases
457089|NCT01610596|Halobetasol|halobetasol
457090|NCT01610596|Vasoconstrictor Agents|vasoconstrictor agents
457091|NCT01610596|Therapeutic Uses|therapeutic uses
457092|NCT01610596|Pharmacologic Actions|pharmacologic actions
457093|NCT01610596|Anti-Inflammatory Agents|anti-inflammatory agents
457094|NCT01610596|Physiological Effects of Drugs|physiological effects of drugs
457095|NCT01610583|Genetic Literacy|genetic literacy
457096|NCT01610583|Latino|latino
457097|NCT01610570|Dose Limiting Toxicity|dose limiting toxicity
457098|NCT01610570|Maximum Tolerated Dose|maximum tolerated dose
457099|NCT01610570|Radiographic Response|radiographic response
457100|NCT01610570|Time to Progression|time to progression
457101|NCT01610570|Bone Tumors|bone tumors
457102|NCT01610557|Diabetic Macular Edema|diabetic macular edema
457103|NCT01610557|Ranibizumab|ranibizumab
457104|NCT01610557|Bevacizumab|bevacizumab
457105|NCT01610544|Thymoma|thymoma
457106|NCT01610544|Insulin Growth Factor|insulin growth factor
457107|NCT01610544|Cell Proliferation|cell proliferation
457108|NCT01610544|Non Small Cell Lung Cancer|non small cell lung cancer
457109|NCT01610544|PET/CT Imaging Sessions|pet/ct imaging sessions
457110|NCT01610531|Cohort|cohort
457111|NCT01610531|Melanoma|melanoma
457112|NCT01610531|targeted screening|targeted screening
457113|NCT01610531|risks function|risks function
457114|NCT01610531|cost effectiveness|cost effectiveness
457115|NCT01610518|postprandial blood glucose|postprandial blood glucose
457116|NCT01610518|dietary fiber|dietary fiber
457117|NCT01610518|beta-glucan|beta-glucan
457118|NCT01610492|IMGN|imgn
457119|NCT01610492|anti-PLA2R antibodies|anti-pla2r antibodies
457120|NCT01610492|pharmacokinetics|pharmacokinetics
457121|NCT01610492|belimumab|belimumab
457122|NCT01610492|Benlysta|benlysta
457123|NCT01610492|Idiopathic Membranous Glomerulonephropathy|idiopathic membranous glomerulonephropathy
457124|NCT01610492|safety|safety
457125|NCT01610492|GSK1550188|gsk1550188
457126|NCT01610492|Lymphostat-B|lymphostat-b
457127|NCT01610492|membrane attack complex|membrane attack complex
457128|NCT01610466|Education|education
457129|NCT01610466|Simulation|simulation
457130|NCT01610466|Technical skills training|technical skills training
457131|NCT01610466|Laparoscopy|laparoscopy
457132|NCT01610466|Bariatric Surgery|bariatric surgery
457133|NCT01610453|prolonged labor|prolonged labor
457134|NCT01610453|cesarean section|cesarean section
457135|NCT01610453|duration of labor|duration of labor
457136|NCT01610440|Duchenne muscular dystrophy|duchenne muscular dystrophy
457137|NCT01610440|Human Umbilical Cord Mesenchymal Stem Cells|human umbilical cord mesenchymal stem cells
457138|NCT01610427|CMI|cmi
457139|NCT01610427|HIV|hiv
457140|NCT01610427|Antiretroviral therapy-naïve|antiretroviral therapy-naïve
457141|NCT01610414|Observer-blind|observer-blind
457142|NCT01610414|Efficacy|efficacy
457143|NCT01610414|Immunogenicity|immunogenicity
457144|NCT01610414|Vaccination|vaccination
457145|NCT01610414|Safety|safety
457146|NCT01610414|Adult autologous haematopoietic cell transplant recipients|adult autologous haematopoietic cell transplant recipients
457147|NCT01610414|Herpes Zoster|herpes zoster
457148|NCT01610388|healthy subjects|healthy subjects
457149|NCT01610388|double-blind|double-blind
457150|NCT01610388|FTIH|ftih
457151|NCT01610388|dose-escalation|dose-escalation
457152|NCT01610388|absolute bioavailability|absolute bioavailability
457153|NCT01610388|GSK1322322|gsk1322322
457154|NCT01610388|BAL|bal
457155|NCT01610375|Endometrial cancer|endometrial cancer
457156|NCT01610362|rabies|rabies
457157|NCT01610362|immunoglobulin|immunoglobulin
457158|NCT01610362|dosage|dosage
457159|NCT01610336|EGFR|egfr
457160|NCT01610336|c-MET|c-met
457161|NCT01610336|Lung cancer|lung cancer
457162|NCT01610336|Gefitinib|gefitinib
457163|NCT01610336|Erlotinib|erlotinib
457164|NCT01610323|Pregnancy|pregnancy
457165|NCT01610323|Obesity|obesity
457166|NCT01610323|Physical activity|physical activity
457167|NCT01610323|Cardiorespiratory fitness|cardiorespiratory fitness
457168|NCT01610323|Muscular Fitness|muscular fitness
457169|NCT01610323|Weight gain|weight gain
457170|NCT01610323|Fetal growth|fetal growth
457172|NCT01610310|PEG|peg
457173|NCT01610310|Inteferon|inteferon
457174|NCT01610310|PK|pk
457175|NCT01610310|Subcutaneous|subcutaneous
457176|NCT01610310|PEGylated|pegylated
457177|NCT01610310|Autoinjector|autoinjector
457178|NCT01610310|Injectable|injectable
457179|NCT01610310|MS|ms
457180|NCT01610297|hematopoietic stem cell transplantation, beta-thalassemia major, deferasirox, iron overload|hematopoietic stem cell transplantation, beta-thalassemia major, deferasirox, iron overload
457181|NCT01610284|Breast cancer|breast cancer
457182|NCT01610284|Hormone receptor positive|hormone receptor positive
457183|NCT01610284|HER2-negative|her2-negative
457184|NCT01610284|Metastatic|metastatic
457185|NCT01610284|Locally advanced|locally advanced
457186|NCT01610284|PI3K|pi3k
457187|NCT01610284|Fulvestrant|fulvestrant
457188|NCT01610284|Refractory|refractory
457189|NCT01610284|Aromatase inhibitor|aromatase inhibitor
457190|NCT01610271|Prevention|prevention
457191|NCT01610271|Surgical Site Infection|surgical site infection
457192|NCT01610271|Air Barrier System|air barrier system
457193|NCT01610271|Implant Infection|implant infection
457194|NCT01610258|pregnancy, chorioamnionitis, PPROM, Treg|pregnancy, chorioamnionitis, pprom, treg
457195|NCT01610245|Influenza|influenza
457196|NCT01610232|Infrared LED|infrared led
457197|NCT01610232|Treadmill Training|treadmill training
457198|NCT01610232|Strength Muscle|strength muscle
457199|NCT01610232|Fatigue Muscle|fatigue muscle
457200|NCT01610232|Aerobic Capacity|aerobic capacity
457201|NCT01610232|Cellulite|cellulite
457202|NCT01610232|Osteoporosis|osteoporosis
457203|NCT01610206|recurrent|recurrent
457204|NCT01610206|persistent|persistent
457205|NCT01610193|Pancreatic Stone Protein|pancreatic stone protein
457206|NCT01610193|Abdominal pain|abdominal pain
457207|NCT01610193|Acute appendicitis|acute appendicitis
457208|NCT01610193|Alvarado score|alvarado score
457209|NCT01610193|Appendectomy|appendectomy
457210|NCT01610193|Sensitivity and specificity|sensitivity and specificity
457211|NCT01610180|Eltrombopag|eltrombopag
457212|NCT01610180|ITP|itp
457213|NCT01610180|LPD|lpd
457214|NCT01610180|leukemia|leukemia
457215|NCT01610180|Immune ThrombocytoPenia|immune thrombocytopenia
457216|NCT01610154|glucagon|glucagon
457217|NCT01610154|dipeptidyl peptidase-4 inhibitor|dipeptidyl peptidase-4 inhibitor
457218|NCT01610141|warfarin metabolism|warfarin metabolism
457219|NCT01610141|pharmacogenetics|pharmacogenetics
457220|NCT01610141|CYP2C9|cyp2c9
457221|NCT01610141|genotyping|genotyping
457222|NCT01610141|VKORC1|vkorc1
457223|NCT01610141|CYP4F2|cyp4f2
457224|NCT01610141|anticoagulation|anticoagulation
457225|NCT01610141|atrial fibrillation|atrial fibrillation
457226|NCT01610141|deep vein thrombosis|deep vein thrombosis
457227|NCT01610141|pulmonary embolism|pulmonary embolism
457228|NCT01610141|Artificial Heart Valve|artificial heart valve
457452|NCT01609660|probiotics|probiotics
457229|NCT01610128|urticaria, patient reported outcome|urticaria, patient reported outcome
457230|NCT01610115|Pregnancy|pregnancy
457231|NCT01610102|clinical follow-up|clinical follow-up
457232|NCT01610102|up to 7 years|up to 7 years
457233|NCT01610102|all patients enrolled in the main study|all patients enrolled in the main study
457234|NCT01610089|citrullinemia|citrullinemia
457235|NCT01610089|argininosuccinate synthetase deficiency|argininosuccinate synthetase deficiency
457236|NCT01610089|nitric oxide|nitric oxide
457237|NCT01610089|urea|urea
457238|NCT01610076|Code Status|code status
457239|NCT01610076|Do not resuscitate (DNR)|do not resuscitate (dnr)
457240|NCT01610076|Do not intubate (DNI)|do not intubate (dni)
457241|NCT01610076|CPR|cpr
457242|NCT01610076|Cardiopulmonary resuscitation|cardiopulmonary resuscitation
457243|NCT01610076|video|video
457244|NCT01610076|advanced directives|advanced directives
457245|NCT01610063|Algorithm|algorithm
457246|NCT01610063|Depression|depression
457247|NCT01610063|Assurex|assurex
457248|NCT01610063|GeneSight|genesight
457249|NCT01610050|castration-resistant prostate cancer, advanced breast cancer|castration-resistant prostate cancer, advanced breast cancer
457250|NCT01610037|chronic obstructive pulmonary disease|chronic obstructive pulmonary disease
457251|NCT01610037|COPD|copd
457252|NCT01610037|QVA149|qva149
457253|NCT01610037|QAB149|qab149
457254|NCT01610037|NVA237|nva237
457255|NCT01610037|Indacaterol maleate|indacaterol maleate
457256|NCT01610037|Glycopyronnium bromide|glycopyronnium bromide
457257|NCT01610011|Schizophrenia|schizophrenia
457258|NCT01610011|Psychotic Disorders|psychotic disorders
457259|NCT01610011|N-methyl-D-aspartate receptor|n-methyl-d-aspartate receptor
457260|NCT01610011|Glycine augmentation|glycine augmentation
457261|NCT01610011|Glycine|glycine
457262|NCT01610011|Glycine Pharmacodynamics|glycine pharmacodynamics
457263|NCT01610011|Glycine Bioavailability|glycine bioavailability
457264|NCT01610011|Magnetic Resonance Spectroscopy|magnetic resonance spectroscopy
457265|NCT01610011|Glycine Decarboxylase|glycine decarboxylase
457266|NCT01610011|Glycine Decarboxylase Mutation|glycine decarboxylase mutation
457267|NCT01609998|Influenza A (H1)|influenza a (h1)
457268|NCT01609998|Influenza A (H3)|influenza a (h3)
457269|NCT01609998|Influenza B|influenza b
457270|NCT01609998|DNA Vaccine|dna vaccine
457271|NCT01609998|Trivalent Inactivated Vaccine (TIV)|trivalent inactivated vaccine (tiv)
457272|NCT01609998|Healthy Adolescents|healthy adolescents
457273|NCT01609998|Healthy Children|healthy children
457274|NCT01609985|Cardiac Resynchronization Therapy Defibrillator (CRT-D) Devices|cardiac resynchronization therapy defibrillator (crt-d) devices
457275|NCT01609972|Back pain|back pain
457276|NCT01609972|Spinal Cord Stimulation|spinal cord stimulation
457277|NCT01609959|Hypertension|hypertension
457278|NCT01609959|Angiotensin II Receptor Blocker|angiotensin ii receptor blocker
457279|NCT01609959|Azilsartan|azilsartan
457280|NCT01609959|Valsartan|valsartan
457281|NCT01609946|presenting for FNAB or surgery|presenting for fnab or surgery
457282|NCT01609933|Hepatitis C Virus (HCV)|hepatitis c virus (hcv)
457283|NCT01609933|Hepatitis C Genotype 1|hepatitis c genotype 1
457284|NCT01609933|Chronic Hepatitis C|chronic hepatitis c
457285|NCT01609933|HCV|hcv
457286|NCT01609920|MRI|mri
457287|NCT01609920|lymph node metastases|lymph node metastases
457288|NCT01609920|breast cancer|breast cancer
457289|NCT01609920|gadofosveset|gadofosveset
457290|NCT01609907|Drug interaction|drug interaction
457291|NCT01609907|YH14700|yh14700
457292|NCT01609907|Rosuvastatin|rosuvastatin
457293|NCT01609907|Valsartan|valsartan
457294|NCT01609907|Yuhan|yuhan
457295|NCT01609894|Postnatal development|postnatal development
457296|NCT01609894|Breast milk fortification|breast milk fortification
457297|NCT01609894|Composition of breast milk|composition of breast milk
457298|NCT01609881|Inflammation|inflammation
457299|NCT01609868|premature infant feeding protein|premature infant feeding protein
457300|NCT01609855|Adenoma Detection Rate|adenoma detection rate
457301|NCT01609855|Anti-spasmotic drug|anti-spasmotic drug
457302|NCT01609842|Acute Coronary Syndrome|acute coronary syndrome
457303|NCT01609842|adherence|adherence
457304|NCT01609816|adult grade III lymphomatoid granulomatosis|adult grade iii lymphomatoid granulomatosis
457305|NCT01609816|adult nasal type extranodal NK/T-cell lymphoma|adult nasal type extranodal nk/t-cell lymphoma
457306|NCT01609816|anaplastic large cell lymphoma|anaplastic large cell lymphoma
457307|NCT01609816|angioimmunoblastic T-cell lymphoma|angioimmunoblastic t-cell lymphoma
457308|NCT01609816|contiguous stage II adult Burkitt lymphoma|contiguous stage ii adult burkitt lymphoma
457309|NCT01609816|contiguous stage II adult diffuse large cell lymphoma|contiguous stage ii adult diffuse large cell lymphoma
457310|NCT01609816|contiguous stage II adult diffuse mixed cell lymphoma|contiguous stage ii adult diffuse mixed cell lymphoma
457311|NCT01609816|contiguous stage II adult diffuse small cleaved cell lymphoma|contiguous stage ii adult diffuse small cleaved cell lymphoma
457312|NCT01609816|contiguous stage II adult immunoblastic large cell lymphoma|contiguous stage ii adult immunoblastic large cell lymphoma
457313|NCT01609816|contiguous stage II adult lymphoblastic lymphoma|contiguous stage ii adult lymphoblastic lymphoma
457314|NCT01609816|contiguous stage II grade 1 follicular lymphoma|contiguous stage ii grade 1 follicular lymphoma
457315|NCT01609816|contiguous stage II grade 2 follicular lymphoma|contiguous stage ii grade 2 follicular lymphoma
457453|NCT01609660|cytokine|cytokine
457316|NCT01609816|contiguous stage II grade 3 follicular lymphoma|contiguous stage ii grade 3 follicular lymphoma
457317|NCT01609816|contiguous stage II mantle cell lymphoma|contiguous stage ii mantle cell lymphoma
457318|NCT01609816|contiguous stage II marginal zone lymphoma|contiguous stage ii marginal zone lymphoma
457319|NCT01609816|contiguous stage II small lymphocytic lymphoma|contiguous stage ii small lymphocytic lymphoma
457320|NCT01609816|cutaneous B-cell non-Hodgkin lymphoma|cutaneous b-cell non-hodgkin lymphoma
457321|NCT01609816|extranodal marginal zone B-cell lymphoma of mucosa-associated lymphoid tissue|extranodal marginal zone b-cell lymphoma of mucosa-associated lymphoid tissue
457322|NCT01609816|hepatosplenic T-cell lymphoma|hepatosplenic t-cell lymphoma
457323|NCT01609816|intraocular lymphoma|intraocular lymphoma
457324|NCT01609816|nodal marginal zone B-cell lymphoma|nodal marginal zone b-cell lymphoma
457325|NCT01609816|noncontiguous stage II adult Burkitt lymphoma|noncontiguous stage ii adult burkitt lymphoma
457326|NCT01609816|noncontiguous stage II adult diffuse large cell lymphoma|noncontiguous stage ii adult diffuse large cell lymphoma
457327|NCT01609816|noncontiguous stage II adult diffuse mixed cell lymphoma|noncontiguous stage ii adult diffuse mixed cell lymphoma
457328|NCT01609816|noncontiguous stage II adult diffuse small cleaved cell lymphoma|noncontiguous stage ii adult diffuse small cleaved cell lymphoma
457329|NCT01609816|noncontiguous stage II adult immunoblastic large cell lymphoma|noncontiguous stage ii adult immunoblastic large cell lymphoma
457330|NCT01609816|noncontiguous stage II adult lymphoblastic lymphoma|noncontiguous stage ii adult lymphoblastic lymphoma
457331|NCT01609816|noncontiguous stage II grade 1 follicular lymphoma|noncontiguous stage ii grade 1 follicular lymphoma
457332|NCT01609816|noncontiguous stage II grade 2 follicular lymphoma|noncontiguous stage ii grade 2 follicular lymphoma
457333|NCT01609816|noncontiguous stage II grade 3 follicular lymphoma|noncontiguous stage ii grade 3 follicular lymphoma
457334|NCT01609816|noncontiguous stage II mantle cell lymphoma|noncontiguous stage ii mantle cell lymphoma
457335|NCT01609816|noncontiguous stage II marginal zone lymphoma|noncontiguous stage ii marginal zone lymphoma
457336|NCT01609816|noncontiguous stage II small lymphocytic lymphoma|noncontiguous stage ii small lymphocytic lymphoma
457337|NCT01609816|noncutaneous extranodal lymphoma|noncutaneous extranodal lymphoma
457338|NCT01609816|peripheral T-cell lymphoma|peripheral t-cell lymphoma
457339|NCT01609816|recurrent adult Burkitt lymphoma|recurrent adult burkitt lymphoma
457340|NCT01609816|recurrent adult diffuse large cell lymphoma|recurrent adult diffuse large cell lymphoma
457341|NCT01609816|recurrent adult diffuse mixed cell lymphoma|recurrent adult diffuse mixed cell lymphoma
457342|NCT01609816|recurrent adult diffuse small cleaved cell lymphoma|recurrent adult diffuse small cleaved cell lymphoma
457343|NCT01609816|recurrent adult grade III lymphomatoid granulomatosis|recurrent adult grade iii lymphomatoid granulomatosis
457344|NCT01609816|recurrent adult Hodgkin lymphoma|recurrent adult hodgkin lymphoma
457345|NCT01609816|recurrent adult immunoblastic large cell lymphoma|recurrent adult immunoblastic large cell lymphoma
457346|NCT01609816|recurrent adult lymphoblastic lymphoma|recurrent adult lymphoblastic lymphoma
457347|NCT01609816|recurrent adult T-cell leukemia/lymphoma|recurrent adult t-cell leukemia/lymphoma
457348|NCT01609816|recurrent cutaneous T-cell non-Hodgkin lymphoma|recurrent cutaneous t-cell non-hodgkin lymphoma
457349|NCT01609816|recurrent grade 1 follicular lymphoma|recurrent grade 1 follicular lymphoma
457350|NCT01609816|recurrent grade 2 follicular lymphoma|recurrent grade 2 follicular lymphoma
457351|NCT01609816|recurrent grade 3 follicular lymphoma|recurrent grade 3 follicular lymphoma
457352|NCT01609816|recurrent mantle cell lymphoma|recurrent mantle cell lymphoma
457353|NCT01609816|recurrent marginal zone lymphoma|recurrent marginal zone lymphoma
457354|NCT01609816|recurrent mycosis fungoides/Sezary syndrome|recurrent mycosis fungoides/sezary syndrome
457355|NCT01609816|recurrent small lymphocytic lymphoma|recurrent small lymphocytic lymphoma
457356|NCT01609816|refractory hairy cell leukemia|refractory hairy cell leukemia
457357|NCT01609816|refractory multiple myeloma|refractory multiple myeloma
457358|NCT01609816|small intestine lymphoma|small intestine lymphoma
457359|NCT01609816|splenic marginal zone lymphoma|splenic marginal zone lymphoma
457360|NCT01609816|stage I adult Burkitt lymphoma|stage i adult burkitt lymphoma
457361|NCT01609816|stage I adult diffuse large cell lymphoma|stage i adult diffuse large cell lymphoma
457362|NCT01609816|stage I adult diffuse mixed cell lymphoma|stage i adult diffuse mixed cell lymphoma
457363|NCT01609816|stage I adult diffuse small cleaved cell lymphoma|stage i adult diffuse small cleaved cell lymphoma
457364|NCT01609816|stage I adult Hodgkin lymphoma|stage i adult hodgkin lymphoma
457365|NCT01609816|stage I adult immunoblastic large cell lymphoma|stage i adult immunoblastic large cell lymphoma
457366|NCT01609816|stage I adult lymphoblastic lymphoma|stage i adult lymphoblastic lymphoma
457367|NCT01609816|stage I adult T-cell leukemia/lymphoma|stage i adult t-cell leukemia/lymphoma
457368|NCT01609816|stage I cutaneous T-cell non-Hodgkin lymphoma|stage i cutaneous t-cell non-hodgkin lymphoma
457369|NCT01609816|stage I grade 1 follicular lymphoma|stage i grade 1 follicular lymphoma
457370|NCT01609816|stage I grade 2 follicular lymphoma|stage i grade 2 follicular lymphoma
457371|NCT01609816|stage I grade 3 follicular lymphoma|stage i grade 3 follicular lymphoma
457372|NCT01609816|stage I mantle cell lymphoma|stage i mantle cell lymphoma
457373|NCT01609816|stage I marginal zone lymphoma|stage i marginal zone lymphoma
457374|NCT01609816|stage I multiple myeloma|stage i multiple myeloma
457375|NCT01609816|stage I small lymphocytic lymphoma|stage i small lymphocytic lymphoma
457376|NCT01609816|stage IA mycosis fungoides/Sezary syndrome|stage ia mycosis fungoides/sezary syndrome
457377|NCT01609816|stage IB mycosis fungoides/Sezary syndrome|stage ib mycosis fungoides/sezary syndrome
457378|NCT01609816|stage II adult Hodgkin lymphoma|stage ii adult hodgkin lymphoma
457379|NCT01609816|stage II adult T-cell leukemia/lymphoma|stage ii adult t-cell leukemia/lymphoma
457380|NCT01609816|stage II cutaneous T-cell non-Hodgkin lymphoma|stage ii cutaneous t-cell non-hodgkin lymphoma
457381|NCT01609816|stage II multiple myeloma|stage ii multiple myeloma
583706|NCT01082666|VAP|vap
457382|NCT01609816|stage IIA mycosis fungoides/Sezary syndrome|stage iia mycosis fungoides/sezary syndrome
457383|NCT01609816|stage IIB mycosis fungoides/Sezary syndrome|stage iib mycosis fungoides/sezary syndrome
457384|NCT01609816|stage III adult Burkitt lymphoma|stage iii adult burkitt lymphoma
457385|NCT01609816|stage III adult diffuse large cell lymphoma|stage iii adult diffuse large cell lymphoma
457386|NCT01609816|stage III adult diffuse mixed cell lymphoma|stage iii adult diffuse mixed cell lymphoma
457627|NCT01608685|Tuberculosis|tuberculosis
457387|NCT01609816|stage III adult diffuse small cleaved cell lymphoma|stage iii adult diffuse small cleaved cell lymphoma
457388|NCT01609816|stage III adult Hodgkin lymphoma|stage iii adult hodgkin lymphoma
457389|NCT01609816|stage III adult immunoblastic large cell lymphoma|stage iii adult immunoblastic large cell lymphoma
457390|NCT01609816|stage III adult lymphoblastic lymphoma|stage iii adult lymphoblastic lymphoma
457391|NCT01609816|stage III adult T-cell leukemia/lymphoma|stage iii adult t-cell leukemia/lymphoma
457392|NCT01609816|stage III cutaneous T-cell non-Hodgkin lymphoma|stage iii cutaneous t-cell non-hodgkin lymphoma
457393|NCT01609816|stage III grade 1 follicular lymphoma|stage iii grade 1 follicular lymphoma
457394|NCT01609816|stage III grade 2 follicular lymphoma|stage iii grade 2 follicular lymphoma
457395|NCT01609816|stage III grade 3 follicular lymphoma|stage iii grade 3 follicular lymphoma
457396|NCT01609816|stage III mantle cell lymphoma|stage iii mantle cell lymphoma
457397|NCT01609816|stage III marginal zone lymphoma|stage iii marginal zone lymphoma
457398|NCT01609816|stage III multiple myeloma|stage iii multiple myeloma
457399|NCT01609816|stage III small lymphocytic lymphoma|stage iii small lymphocytic lymphoma
457400|NCT01609816|stage IIIA mycosis fungoides/Sezary syndrome|stage iiia mycosis fungoides/sezary syndrome
457401|NCT01609816|stage IIIB mycosis fungoides/Sezary syndrome|stage iiib mycosis fungoides/sezary syndrome
457402|NCT01609816|stage IV adult Burkitt lymphoma|stage iv adult burkitt lymphoma
457403|NCT01609816|stage IV adult diffuse large cell lymphoma|stage iv adult diffuse large cell lymphoma
457404|NCT01609816|stage IV adult diffuse mixed cell lymphoma|stage iv adult diffuse mixed cell lymphoma
457405|NCT01609816|stage IV adult diffuse small cleaved cell lymphoma|stage iv adult diffuse small cleaved cell lymphoma
457406|NCT01609816|stage IV adult Hodgkin lymphoma|stage iv adult hodgkin lymphoma
457407|NCT01609816|stage IV adult immunoblastic large cell lymphoma|stage iv adult immunoblastic large cell lymphoma
457408|NCT01609816|stage IV adult lymphoblastic lymphoma|stage iv adult lymphoblastic lymphoma
457409|NCT01609816|stage IV adult T-cell leukemia/lymphoma|stage iv adult t-cell leukemia/lymphoma
457410|NCT01609816|stage IV cutaneous T-cell non-Hodgkin lymphoma|stage iv cutaneous t-cell non-hodgkin lymphoma
457411|NCT01609816|stage IV grade 1 follicular lymphoma|stage iv grade 1 follicular lymphoma
457412|NCT01609816|stage IV grade 2 follicular lymphoma|stage iv grade 2 follicular lymphoma
457413|NCT01609816|stage IV grade 3 follicular lymphoma|stage iv grade 3 follicular lymphoma
457414|NCT01609816|stage IV mantle cell lymphoma|stage iv mantle cell lymphoma
457415|NCT01609816|stage IV marginal zone lymphoma|stage iv marginal zone lymphoma
457416|NCT01609816|stage IV small lymphocytic lymphoma|stage iv small lymphocytic lymphoma
457417|NCT01609816|stage IVA mycosis fungoides/Sezary syndrome|stage iva mycosis fungoides/sezary syndrome
457418|NCT01609816|stage IVB mycosis fungoides/Sezary syndrome|stage ivb mycosis fungoides/sezary syndrome
457419|NCT01609816|T-cell large granular lymphocyte leukemia|t-cell large granular lymphocyte leukemia
457420|NCT01609816|testicular lymphoma|testicular lymphoma
457421|NCT01609816|Waldenström macroglobulinemia|waldenström macroglobulinemia
457422|NCT01609751|probiotic|probiotic
457423|NCT01609751|lactobacillus|lactobacillus
457424|NCT01609751|colonic diseases|colonic diseases
457425|NCT01609751|dietary fibre|dietary fibre
457426|NCT01609738|Cardiac pacing|cardiac pacing
457427|NCT01609738|Left ventricular septal pacing|left ventricular septal pacing
457428|NCT01609738|Feasibility and safety|feasibility and safety
457429|NCT01609738|Lead stability|lead stability
457430|NCT01609738|Hemodynamics|hemodynamics
457431|NCT01609738|Left ventricular dyssynchrony|left ventricular dyssynchrony
457432|NCT01609738|Pacing for heart failure|pacing for heart failure
457433|NCT01609738|Cardiac resynchronization therapy|cardiac resynchronization therapy
457434|NCT01609725|Coronary artery disease|coronary artery disease
457435|NCT01609725|C reactive protein|c reactive protein
457436|NCT01609725|Periodontitis|periodontitis
457437|NCT01609725|Periodontal therapy|periodontal therapy
457438|NCT01609725|Flow-mediated dilation|flow-mediated dilation
457439|NCT01609712|Improvement of lung function (FEV1, PEF)|improvement of lung function (fev1, pef)
457440|NCT01609712|Visual Analog Scale|visual analog scale
457441|NCT01609712|Oswestry Disability Index|oswestry disability index
457442|NCT01609712|Radiographs pre and post Op|radiographs pre and post op
457443|NCT01609699|body circumference|body circumference
457444|NCT01609699|Non-Invasive Reduction|non-invasive reduction
457445|NCT01609686|cardiac surgery|cardiac surgery
457446|NCT01609686|renal dysfunction|renal dysfunction
457447|NCT01609686|pharmacokinetics|pharmacokinetics
457448|NCT01609686|tranexamic acid|tranexamic acid
457449|NCT01609673|Immunosuppression|immunosuppression
457450|NCT01609673|Chronic Kidney Disease|chronic kidney disease
457451|NCT01609673|Renal Transplant|renal transplant
457454|NCT01609660|short chain fatty acids|short chain fatty acids
583802|NCT01082237|EEG|eeg
457455|NCT01609660|complications|complications
457456|NCT01609660|colorectal surgery|colorectal surgery
457457|NCT01609647|High plate reactivity unit after loading dose of clopidogrel|high plate reactivity unit after loading dose of clopidogrel
457458|NCT01609634|Healthy|healthy
457459|NCT01609634|Term infants|term infants
457460|NCT01609634|Growth|growth
457461|NCT01609634|Body composition|body composition
457462|NCT01609595|Thalassemia|thalassemia
457463|NCT01609595|Anemia|anemia
457464|NCT01609595|Fetal hemoglobin|fetal hemoglobin
457465|NCT01609582|Drug therapy|drug therapy
457466|NCT01609556|FOLR solid tumors|folr solid tumors
457467|NCT01609530|verruca vulgaris|verruca vulgaris
457468|NCT01609530|hands|hands
457469|NCT01609530|feet|feet
457470|NCT01609530|Nd:YAG|nd:yag
457471|NCT01609530|laser|laser
457472|NCT01609530|cryotherapy|cryotherapy
457473|NCT01609517|Spinal anesthesia|spinal anesthesia
457474|NCT01609517|determinant|determinant
457475|NCT01609517|duration|duration
457476|NCT01609504|Rectal cancer|rectal cancer
457477|NCT01609504|Radiochemotherapy|radiochemotherapy
457478|NCT01609504|Transanal Endoscopic Microsurgery|transanal endoscopic microsurgery
457479|NCT01609504|Laparoscopic Resection|laparoscopic resection
457480|NCT01609478|asthma|asthma
457482|NCT01609465|stable angina|stable angina
457483|NCT01609465|STEMI|stemi
457484|NCT01609465|NSTEMI|nstemi
457486|NCT01609465|secondary prevention|secondary prevention
457487|NCT01609452|Immune Thrombocytopenic Purpura|immune thrombocytopenic purpura
457488|NCT01609452|Idiopathic Thrombocytopenic Purpura|idiopathic thrombocytopenic purpura
457489|NCT01609452|Chronic ITP|chronic itp
457490|NCT01609439|Permanent|permanent
457491|NCT01609439|temporary|temporary
457492|NCT01609439|hypocalcemia|hypocalcemia
457493|NCT01609426|Proteinuria|proteinuria
457494|NCT01609426|idiopathic|idiopathic
457495|NCT01609426|nephrotic syndrome|nephrotic syndrome
457496|NCT01609426|herpesvirus|herpesvirus
457497|NCT01609426|epidemiology|epidemiology
457498|NCT01609426|immune response|immune response
457499|NCT01609426|interferon|interferon
457500|NCT01609426|steroid dependency|steroid dependency
457501|NCT01609426|nephrotic disease: Idiopathic nephrotic syndrome|nephrotic disease: idiopathic nephrotic syndrome
457502|NCT01609387|Vitamine|vitamine
457503|NCT01609387|mineral|mineral
457504|NCT01609387|obese patients|obese patients
457505|NCT01609387|Vitamine en mineral shortage in obese patients|vitamine en mineral shortage in obese patients
457506|NCT01609374|Spinal Kinetics|spinal kinetics
457507|NCT01609374|artificial cervical disc|artificial cervical disc
457508|NCT01609374|cervical radiculopathy|cervical radiculopathy
457509|NCT01609374|ACDF|acdf
457510|NCT01609374|neck pain|neck pain
457511|NCT01609374|cervical spine|cervical spine
457512|NCT01609374|degenerative disc disease|degenerative disc disease
457513|NCT01609361|Rehabilitation program|rehabilitation program
457514|NCT01609361|Fast track surgery|fast track surgery
457515|NCT01609361|Laparoscopic colorectal resection|laparoscopic colorectal resection
457516|NCT01609361|Colorectal cancer|colorectal cancer
457517|NCT01609361|Morbidity|morbidity
457518|NCT01609348|Depression|depression
457519|NCT01609348|Alzheimer's Disease|alzheimer's disease
457520|NCT01609322|fear of falling|fear of falling
457521|NCT01609322|agoraphobia|agoraphobia
457522|NCT01609309|Stomach Neoplasms|stomach neoplasms
457523|NCT01609309|Laparoscopy|laparoscopy
457524|NCT01609296|Peripheral Arterial Disease|peripheral arterial disease
457525|NCT01609296|Drug coated balloon|drug coated balloon
457526|NCT01609296|Superficial Femoral Artery|superficial femoral artery
457527|NCT01609296|Popliteal Femoral Artery|popliteal femoral artery
457528|NCT01609296|Atherosclerosis|atherosclerosis
457529|NCT01609296|Drug eluting balloon|drug eluting balloon
457530|NCT01609244|Sleep apnea|sleep apnea
457531|NCT01609244|central sleep apnea|central sleep apnea
457532|NCT01609244|bilevel|bilevel
457533|NCT01609244|servoventilation|servoventilation
457534|NCT01609244|CPAP|cpap
457535|NCT01609192|sickle-cell anemia|sickle-cell anemia
457536|NCT01609192|spermatogenesis|spermatogenesis
457537|NCT01609192|hydroxyurea|hydroxyurea
457538|NCT01609166|Hand-foot Syndrome|hand-foot syndrome
457539|NCT01609166|capecitabine|capecitabine
457540|NCT01609166|allopurinol|allopurinol
457541|NCT01609153|schizophrenia|schizophrenia
457542|NCT01609153|amisulpride|amisulpride
457543|NCT01609153|olanzapine|olanzapine
457544|NCT01609153|polypharmacy|polypharmacy
457545|NCT01609140|Hyperlipidemia|hyperlipidemia
457546|NCT01609140|Dyslipidemia|dyslipidemia
457547|NCT01609114|phenomena and mechanism of RT-PK|phenomena and mechanism of rt-pk
457548|NCT01609114|fact for different anticancer drugs|fact for different anticancer drugs
457549|NCT01609114|different part in human|different part in human
457550|NCT01609101|Videolaryngoscopy|videolaryngoscopy
457551|NCT01609101|Palatopharyngeal distance|palatopharyngeal distance
457552|NCT01609101|Trauma|trauma
457553|NCT01609088|endothelium|endothelium
457554|NCT01609088|diabetes mellitus|diabetes mellitus
457555|NCT01609088|oxidative stress|oxidative stress
457556|NCT01609062|Mucopolysaccharidosis IVA Type A|mucopolysaccharidosis iva type a
457557|NCT01609062|MPS IVA Type A|mps iva type a
457558|NCT01609062|Mucopolysaccharidosis IVA|mucopolysaccharidosis iva
457559|NCT01609062|MPS IVA|mps iva
457560|NCT01609062|Morquio A Syndrome|morquio a syndrome
457561|NCT01609062|Lysosomal Storage Disorder|lysosomal storage disorder
457562|NCT01609062|LSD|lsd
457563|NCT01609062|N-acetylgalactosamine-6-sulfatase|n-acetylgalactosamine-6-sulfatase
457564|NCT01609062|N-acetylgalactosamine-6-sulfate|n-acetylgalactosamine-6-sulfate
457565|NCT01609062|sulfatase|sulfatase
457566|NCT01609062|galactose-6-sulfatase|galactose-6-sulfatase
457567|NCT01609062|GALNS|galns
457568|NCT01609062|enzyme replacement therapy|enzyme replacement therapy
457569|NCT01609062|ERT|ert
457570|NCT01609062|MOR-008|mor-008
457571|NCT01609062|CPET|cpet
457572|NCT01609062|MST|mst
457573|NCT01609062|muscle strength test|muscle strength test
457574|NCT01609062|physiological effect|physiological effect
457575|NCT01608984|remote ischemic preconditioning|remote ischemic preconditioning
457576|NCT01608984|coronary artery bypass grafting|coronary artery bypass grafting
457577|NCT01608984|myocardial injury|myocardial injury
457578|NCT01608971|Protamine|protamine
457579|NCT01608971|heparin level|heparin level
457580|NCT01608971|haemostasis|haemostasis
457581|NCT01608971|thromboelastometry|thromboelastometry
457582|NCT01608971|cardiac surgery|cardiac surgery
457583|NCT01608971|Patients undergoing cardiac surgery|patients undergoing cardiac surgery
457584|NCT01608958|Postpartum hemorrhage|postpartum hemorrhage
457585|NCT01608958|Oxytocin|oxytocin
457586|NCT01608958|Third stage of labor|third stage of labor
457587|NCT01608958|Hemoglobin|hemoglobin
457588|NCT01608958|Prevention|prevention
457589|NCT01608958|Intravenous|intravenous
457590|NCT01608958|Intramuscular|intramuscular
457591|NCT01608945|steroid|steroid
457592|NCT01608945|liver function|liver function
457593|NCT01608945|prognosis|prognosis
457594|NCT01608906|venous thrombosis|venous thrombosis
457595|NCT01608906|heparin|heparin
457596|NCT01608906|pulmonary embolism|pulmonary embolism
457597|NCT01608906|ICU|icu
457598|NCT01608867|Phase 1|phase 1
457599|NCT01608867|dose escalation|dose escalation
457600|NCT01608867|histologically confirmed|histologically confirmed
457601|NCT01608867|malignancy|malignancy
457602|NCT01608867|metastatic|metastatic
457603|NCT01608854|surgical site infection|surgical site infection
457604|NCT01608854|spinal surgery|spinal surgery
457605|NCT01608854|prophylactic antibiotics|prophylactic antibiotics
457606|NCT01608854|postoperative spinal drains|postoperative spinal drains
457607|NCT01608815|Salmonella infections|salmonella infections
457608|NCT01608815|Typhoid fever|typhoid fever
457609|NCT01608815|Bacterial infections|bacterial infections
457610|NCT01608815|Typhoid vaccine|typhoid vaccine
457611|NCT01608802|HIV|hiv
457612|NCT01608802|Antiretroviral therapy|antiretroviral therapy
457613|NCT01608802|Palliative care|palliative care
457614|NCT01608802|Pain|pain
457615|NCT01608789|Male sling|male sling
457616|NCT01608789|Stress Urinary Incontinence|stress urinary incontinence
457617|NCT01608789|Urination Disorders|urination disorders
457618|NCT01608789|Urologic Diseases|urologic diseases
457619|NCT01608724|Type 2 DM|type 2 dm
457620|NCT01608711|Gemcitabine|gemcitabine
457621|NCT01608711|ASP6182|asp6182
457622|NCT01608711|AGS-1C4D4|ags-1c4d4
457623|NCT01608711|Pancreatic Cancer|pancreatic cancer
457624|NCT01608698|chlormadinone acetate|chlormadinone acetate
457625|NCT01608698|drospirenone|drospirenone
457626|NCT01608698|contraceptive pills|contraceptive pills
457628|NCT01608685|Latent tuberculosis infection|latent tuberculosis infection
457629|NCT01608685|Immunosuppression|immunosuppression
457630|NCT01608685|Renal transplant recipient|renal transplant recipient
457631|NCT01608646|S-1|s-1
457632|NCT01608646|Oxaliplatin|oxaliplatin
457633|NCT01608646|Dihydropyrimidine Dehydrogenase|dihydropyrimidine dehydrogenase
457634|NCT01608620|Systematic review and meta-analysis|systematic review and meta-analysis
457635|NCT01608620|Evidence-based medicine (EBM)|evidence-based medicine (ebm)
457636|NCT01608620|Evidence-based nutrition (EBN)|evidence-based nutrition (ebn)
457637|NCT01608620|Clinical practice guidelines|clinical practice guidelines
457638|NCT01608620|Clinical trials|clinical trials
457639|NCT01608620|Dietary sugars|dietary sugars
457640|NCT01608620|Fructose|fructose
457641|NCT01608620|High fructose corn syrup|high fructose corn syrup
457642|NCT01608620|Fruit|fruit
457643|NCT01608620|Isocaloric|isocaloric
457644|NCT01608620|Hypercaloric|hypercaloric
457645|NCT01608620|Cardiometabolic risk factors|cardiometabolic risk factors
457646|NCT01608620|Triglycerides|triglycerides
457647|NCT01608620|Cholesterol|cholesterol
457648|NCT01608620|Glycemic control|glycemic control
457649|NCT01608620|Insulin resistance|insulin resistance
457650|NCT01608620|Body weight|body weight
457651|NCT01608620|Uric acid|uric acid
457652|NCT01608620|Blood pressure|blood pressure
457653|NCT01608607|Systematic review and meta-analysis|systematic review and meta-analysis
457654|NCT01608607|Evidence-based medicine (EBM)|evidence-based medicine (ebm)
711024|NCT00586833|Edema, Cardiac|edema, cardiac
457655|NCT01608607|Evidence-based nutrition (EBN)|evidence-based nutrition (ebn)
458052|NCT01607086|properties|properties
457656|NCT01608607|Clinical practice guidelines|clinical practice guidelines
457657|NCT01608607|Clinical trials|clinical trials
457658|NCT01608607|Dietary sugars|dietary sugars
457659|NCT01608607|Fructose|fructose
457660|NCT01608607|High fructose corn syrup|high fructose corn syrup
457661|NCT01608607|sucrose|sucrose
457662|NCT01608607|Isocaloric|isocaloric
457663|NCT01608607|Hypercaloric|hypercaloric
457664|NCT01608607|Glycemic control|glycemic control
457665|NCT01608607|Insulin resistance|insulin resistance
457666|NCT01608607|Body weight|body weight
457667|NCT01608607|body mass index|body mass index
457668|NCT01608607|waist circumference|waist circumference
457669|NCT01608581|prevention|prevention
457670|NCT01608581|burn|burn
457671|NCT01608581|adult|adult
457672|NCT01608581|health promotion|health promotion
457673|NCT01608581|evaluation|evaluation
457674|NCT01608581|media|media
457675|NCT01608568|Sutures|sutures
457676|NCT01608568|Pelvic Organ Prolapse|pelvic organ prolapse
457677|NCT01608568|Sacrocolpopexy|sacrocolpopexy
457678|NCT01608568|Robotic Assisted Laparoscopy|robotic assisted laparoscopy
457679|NCT01608555|cystic fibrosis|cystic fibrosis
457680|NCT01608555|bacterial load|bacterial load
457681|NCT01608555|inhaled tobramycin|inhaled tobramycin
457682|NCT01608542|fostamatinib|fostamatinib
457683|NCT01608542|FosD|fosd
457684|NCT01608542|Japanese Healthy volunteers|japanese healthy volunteers
457685|NCT01608542|Phase 1|phase 1
457686|NCT01608542|Single and Multiple Dose Study|single and multiple dose study
457687|NCT01608529|Restriction device ventilatory nasal flow|restriction device ventilatory nasal flow
457688|NCT01608529|oronasal breathing|oronasal breathing
457689|NCT01608529|nasal breathing.|nasal breathing.
457690|NCT01608516|PET/CT|pet/ct
457691|NCT01608516|68Ga-NODAGA-RGD|68ga-nodaga-rgd
457692|NCT01608516|18F-FDG|18f-fdg
457693|NCT01608516|MRI|mri
457694|NCT01608516|US ultrasound|us ultrasound
457695|NCT01608516|inflammatory atheromatous plaque|inflammatory atheromatous plaque
457696|NCT01608516|endarterectomy|endarterectomy
457697|NCT01608503|subclavian vein|subclavian vein
457698|NCT01608503|ultrasound|ultrasound
457699|NCT01608503|distance between the subclavian vein and the lung|distance between the subclavian vein and the lung
457700|NCT01608490|COPD|copd
457701|NCT01608490|RePneu|repneu
457702|NCT01608477|Heart transplantation|heart transplantation
457703|NCT01608477|Medication adherence|medication adherence
457704|NCT01608477|Behavior system factor|behavior system factor
457705|NCT01608464|Randomized trial,|randomized trial,
457706|NCT01608464|Pre-operative chemo-RT with CDDP and 5-FU|pre-operative chemo-rt with cddp and 5-fu
457707|NCT01608464|Multicenter study|multicenter study
457708|NCT01608438|Body-machine interface|body-machine interface
457709|NCT01608438|Customization|customization
457710|NCT01608438|Upper-body motion|upper-body motion
457711|NCT01608438|Motor learning|motor learning
457712|NCT01608438|Assistive Devices|assistive devices
457713|NCT01608438|Wheelchair|wheelchair
457714|NCT01608438|Computer keyboard|computer keyboard
457715|NCT01608425|diabetic foot ulcer|diabetic foot ulcer
457716|NCT01608425|ulcer monitoring|ulcer monitoring
457717|NCT01608425|telemedicine consultations|telemedicine consultations
457718|NCT01608425|cross-sectoral collaboration|cross-sectoral collaboration
457719|NCT01608412|renal transplantation|renal transplantation
457720|NCT01608412|everolimus|everolimus
457721|NCT01608412|tacrolimus|tacrolimus
457722|NCT01608412|molecular evaluation|molecular evaluation
457723|NCT01608399|major depressive disorder|major depressive disorder
457724|NCT01608399|psychotherapy|psychotherapy
457725|NCT01608399|metacognitive therapy|metacognitive therapy
457726|NCT01608386|Anterior approach|anterior approach
457727|NCT01608386|infrahepatic inferior vena cava clamping|infrahepatic inferior vena cava clamping
457728|NCT01608386|hepatic resection|hepatic resection
457729|NCT01608373|Pain|pain
457730|NCT01608373|Lidocaine|lidocaine
457731|NCT01608373|Intravenous|intravenous
457732|NCT01608373|Intraperitoneum|intraperitoneum
457733|NCT01608373|Laparoscopic cholecystectomy|laparoscopic cholecystectomy
457734|NCT01608360|Pain|pain
457735|NCT01608360|Lidocaine|lidocaine
457736|NCT01608360|Intravenous|intravenous
457737|NCT01608360|Thyroidectomy|thyroidectomy
457738|NCT01608347|LMWH|lmwh
457739|NCT01608347|enoxaparin|enoxaparin
457740|NCT01608347|recurrent miscarriage|recurrent miscarriage
457741|NCT01608347|continuing fetal viability beyond 20 weeks gestation|continuing fetal viability beyond 20 weeks gestation
457742|NCT01608321|Chronic Pain|chronic pain
457743|NCT01608321|Gulf War Illness|gulf war illness
457744|NCT01608321|Gulf War Syndrome|gulf war syndrome
457745|NCT01608321|Fibromyalgia|fibromyalgia
457746|NCT01608321|repetitive Transcranial Magnetic Stimulation|repetitive transcranial magnetic stimulation
457747|NCT01608321|Transcranial Magnetic Stimulation|transcranial magnetic stimulation
457748|NCT01608321|Veterans|veterans
457749|NCT01608308|Chronic Sinusitis|chronic sinusitis
457750|NCT01608308|Pain Relief|pain relief
584170|NCT01080950|zinc|zinc
457877|NCT01607879|Geriatric|geriatric
457751|NCT01608308|Post-Operative Opioid Requirement|post-operative opioid requirement
457752|NCT01608308|IV Acetaminophen|iv acetaminophen
457753|NCT01608308|Functional Endoscopic Sinus Surgery|functional endoscopic sinus surgery
457754|NCT01608308|FESS|fess
457755|NCT01608295|depressed|depressed
457756|NCT01608295|geriatric|geriatric
457757|NCT01608295|older adults|older adults
457758|NCT01608295|antidepressants|antidepressants
457759|NCT01608295|depression|depression
457760|NCT01608295|anxious|anxious
457761|NCT01608295|major depressive disorder|major depressive disorder
457762|NCT01608295|MDD|mdd
457763|NCT01608282|Osteoarthritis|osteoarthritis
457764|NCT01608282|Arthritis|arthritis
457765|NCT01608282|Knee|knee
457766|NCT01608282|Exercise|exercise
457767|NCT01608282|Physical Activity|physical activity
457768|NCT01608282|Web-based|web-based
457769|NCT01608256|mild cognitive impairment|mild cognitive impairment
457770|NCT01608256|Automobile Driving|automobile driving
457771|NCT01608256|cognitive aspects|cognitive aspects
457772|NCT01608217|Behavioural disturbances|behavioural disturbances
457773|NCT01608217|Pain|pain
457774|NCT01608217|Dementia|dementia
457775|NCT01608217|Alzheimer's dementia|alzheimer's dementia
457776|NCT01608217|Vascular dementia|vascular dementia
457777|NCT01608217|THC|thc
457778|NCT01608217|Cannabis|cannabis
457779|NCT01608204|Pharmacokinetics|pharmacokinetics
457780|NCT01608204|Busulfan|busulfan
457781|NCT01608204|Polymorphism|polymorphism
457782|NCT01608204|GST|gst
457783|NCT01608204|MDR-1(p-Glycoprotein)|mdr-1(p-glycoprotein)
457784|NCT01608204|Acute Myeloid Leukemia adult patients|acute myeloid leukemia adult patients
457785|NCT01608178|Pediatric Neurotransmitter Disorders|pediatric neurotransmitter disorders
457786|NCT01608178|Succinic Semialdehyde Dehydrogenase|succinic semialdehyde dehydrogenase
457787|NCT01608178|GABA|gaba
457788|NCT01608178|Epilepsy|epilepsy
457789|NCT01608165|Small renal cancer mass|small renal cancer mass
457790|NCT01608152|Leukemia|leukemia
457791|NCT01608152|Lymphoma|lymphoma
457792|NCT01608152|Game mechanics|game mechanics
457793|NCT01608152|Stem cell transplant survivors|stem cell transplant survivors
457794|NCT01608152|Hematopoietic stem cell transplantation|hematopoietic stem cell transplantation
457795|NCT01608152|HSCT|hsct
457796|NCT01608152|Internet-based|internet-based
457797|NCT01608152|Interactive and personalized intervention|interactive and personalized intervention
457798|NCT01608152|Questionnaires|questionnaires
457799|NCT01608152|Focus groups|focus groups
457800|NCT01608152|Interviews|interviews
457801|NCT01608139|Advanced Cancers|advanced cancers
457802|NCT01608139|Advanced Solid Tumors|advanced solid tumors
457803|NCT01608139|Curcumin|curcumin
457804|NCT01608139|Sorafenib|sorafenib
457805|NCT01608139|Nexavar|nexavar
457806|NCT01608139|Bay 43-9006|bay 43-9006
457807|NCT01608139|Vorinostat|vorinostat
457808|NCT01608139|SAHA|saha
457809|NCT01608139|Suberoylanilide Hydroxamic Acid|suberoylanilide hydroxamic acid
457810|NCT01608139|MSK-390|msk-390
457811|NCT01608139|Zolinza|zolinza
457812|NCT01608126|Ultrasound|ultrasound
457813|NCT01608126|Cervical Plexus|cervical plexus
457814|NCT01608126|Anesthesia, Conduction|anesthesia, conduction
457815|NCT01608126|Surgical Procedures, Elective|surgical procedures, elective
457816|NCT01608126|Atherectomy|atherectomy
457817|NCT01608113|neovascular AMD|neovascular amd
457818|NCT01608113|Optical coherence tomography|optical coherence tomography
457819|NCT01608113|reading acuity|reading acuity
457820|NCT01608113|contrast sensitivity|contrast sensitivity
457821|NCT01608074|BRCA1|brca1
457822|NCT01608074|BRCA2|brca2
457823|NCT01608074|Prophylactic surgery|prophylactic surgery
457824|NCT01608074|Salpingectomy|salpingectomy
457825|NCT01608074|Fimbriectomy|fimbriectomy
457826|NCT01608061|Mild probable Alzheimer's Disease|mild probable alzheimer's disease
457827|NCT01608048|In-vitro Fertilization|in-vitro fertilization
457828|NCT01608048|transcutaneous electrical acupoint stimulation|transcutaneous electrical acupoint stimulation
457829|NCT01608035|sciatic catheter|sciatic catheter
457830|NCT01608035|stump catheter|stump catheter
457831|NCT01608035|below knee amputation|below knee amputation
457832|NCT01608009|platinum resistant|platinum resistant
457833|NCT01608009|ovarian cancer|ovarian cancer
457834|NCT01607996|Epidural anesthesia|epidural anesthesia
457835|NCT01607996|pancreatic perfusion|pancreatic perfusion
457836|NCT01607996|pancreatic necrosectomy|pancreatic necrosectomy
457837|NCT01607983|nitric oxide|nitric oxide
457838|NCT01607983|ventricular-arterial coupling|ventricular-arterial coupling
457839|NCT01607983|congenital heart disease|congenital heart disease
457840|NCT01607970|Oxytocin|oxytocin
457841|NCT01607970|Startle|startle
457842|NCT01607970|moral dilemma|moral dilemma
457843|NCT01607970|oxytocin receptor gene|oxytocin receptor gene
457844|NCT01607957|Refractory, metastatic colorectal cancer|refractory, metastatic colorectal cancer
457845|NCT01607931|Exercise|exercise
457846|NCT01607931|Physical activity|physical activity
457847|NCT01607931|Type 2 diabetes|type 2 diabetes
457848|NCT01607931|Obesity|obesity
457849|NCT01607931|Incretin effect|incretin effect
457850|NCT01607931|GLP-1|glp-1
457851|NCT01607931|GIP|gip
457852|NCT01607931|Insulin secretion|insulin secretion
457853|NCT01607931|Glucagon|glucagon
457854|NCT01607931|Beta-cell function|beta-cell function
457855|NCT01607931|Disposition Index|disposition index
457856|NCT01607918|H pylori, eradication|h pylori, eradication
457857|NCT01607905|Selinexor|selinexor
457858|NCT01607905|KPT-330|kpt-330
457859|NCT01607905|Squamous Cell Carcinoma|squamous cell carcinoma
457860|NCT01607905|Glioblastoma multiforme|glioblastoma multiforme
457861|NCT01607905|Adenocarcinoma|adenocarcinoma
457862|NCT01607905|Melanoma|melanoma
457863|NCT01607892|Selinexor|selinexor
457864|NCT01607892|KPT-330|kpt-330
457865|NCT01607892|Multiple Myeloma|multiple myeloma
457866|NCT01607892|non-Hodgkin Lymphoma|non-hodgkin lymphoma
457867|NCT01607892|Chronic Lymphocytic Leukemia|chronic lymphocytic leukemia
457868|NCT01607892|Waldenström's macroglobulinemia|waldenström's macroglobulinemia
457869|NCT01607892|Peripheral T-Cell Lymphoma|peripheral t-cell lymphoma
457870|NCT01607892|Cutaneous T-Cell Lymphoma|cutaneous t-cell lymphoma
457871|NCT01607892|Chronic Myelocytic Leukemia|chronic myelocytic leukemia
457872|NCT01607892|Acute Lymphoblastic Leukemia|acute lymphoblastic leukemia
457873|NCT01607879|Prostate Cancer|prostate cancer
457874|NCT01607879|Men|men
457875|NCT01607879|Androgen Deprivation Therapy|androgen deprivation therapy
457876|NCT01607879|Elderly|elderly
457878|NCT01607879|Nutritional supplementation|nutritional supplementation
457879|NCT01607840|Schizophrenia|schizophrenia
457880|NCT01607840|Cognitive Improvement|cognitive improvement
457881|NCT01607840|tDCS|tdcs
457882|NCT01607840|stimulation|stimulation
457883|NCT01607827|polypectomy|polypectomy
457884|NCT01607827|colonoscopy|colonoscopy
457885|NCT01607827|polyp miss rate|polyp miss rate
457886|NCT01607827|surveillance|surveillance
457887|NCT01607827|colorectal cancer|colorectal cancer
457888|NCT01607814|cirrhosis|cirrhosis
457889|NCT01607814|oxidative stress|oxidative stress
457890|NCT01607814|NADPH oxidase|nadph oxidase
457891|NCT01607814|isoprostanes|isoprostanes
457892|NCT01607814|PUFA balance|pufa balance
457893|NCT01607814|platelet activation|platelet activation
457894|NCT01607814|coagulation abnormalities|coagulation abnormalities
457895|NCT01607801|umbilical hernia repair|umbilical hernia repair
457896|NCT01607801|recurrence|recurrence
457897|NCT01607801|choice of suture|choice of suture
457898|NCT01607801|mesh|mesh
457899|NCT01607801|mesh/non-mesh|mesh/non-mesh
457900|NCT01607788|Selection criteria|selection criteria
457901|NCT01607788|Liver transplantation|liver transplantation
457902|NCT01607788|Hepatocellular carcinoma|hepatocellular carcinoma
457903|NCT01607762|Healthy|healthy
457904|NCT01607762|Antipsychotics|antipsychotics
457905|NCT01607762|Aripiprazole|aripiprazole
457906|NCT01607762|Paliperidone|paliperidone
457907|NCT01607762|Risperidone|risperidone
457908|NCT01607762|Quetiapine|quetiapine
457909|NCT01607762|Olanzapine|olanzapine
457910|NCT01607749|Asthma Control|asthma control
457911|NCT01607749|Quality of life|quality of life
457912|NCT01607749|Children|children
457913|NCT01607749|Asthma education|asthma education
457914|NCT01607736|falls|falls
457915|NCT01607736|walking|walking
457916|NCT01607736|healthy older individuals|healthy older individuals
457917|NCT01607736|virtual gait training|virtual gait training
457918|NCT01607723|Sleep pattern|sleep pattern
457919|NCT01607723|Mechanical ventilation|mechanical ventilation
457920|NCT01607723|weaning|weaning
457921|NCT01607723|Intensive Care|intensive care
457922|NCT01607723|NAVA (Neurally Adjusted Ventilatory Assist)|nava (neurally adjusted ventilatory assist)
457923|NCT01607723|PAV+ (Proportional Assist Ventilation Plus)|pav+ (proportional assist ventilation plus)
457924|NCT01607710|fMRI|fmri
457925|NCT01607710|Generalized Anxiety Disorder|generalized anxiety disorder
457926|NCT01607697|Parkinson's Disease|parkinson's disease
457927|NCT01607671|Ischemic|ischemic
457928|NCT01607671|Optic Neuropathy|optic neuropathy
457929|NCT01607671|Non-Arteritic Anterior Ischemic Optic Neuropathy|non-arteritic anterior ischemic optic neuropathy
457930|NCT01607671|NAION|naion
457931|NCT01607671|Ischemic Optic Neuropathy|ischemic optic neuropathy
457932|NCT01607671|Intraocular Pressure|intraocular pressure
457933|NCT01607658|Testosterone|testosterone
457934|NCT01607632|posttraumatic stress|posttraumatic stress
457935|NCT01607632|depression|depression
457936|NCT01607619|CRP|crp
457937|NCT01607593|Retrospective|retrospective
457938|NCT01607593|Sertraline|sertraline
457939|NCT01607593|Posttraumatic stress disorder|posttraumatic stress disorder
457940|NCT01607554|Lung|lung
457941|NCT01607554|non small cell|non small cell
457942|NCT01607554|NSCLC|nsclc
457943|NCT01607554|Irinotecan|irinotecan
457944|NCT01607541|HIV/AIDS|hiv/aids
457945|NCT01607541|vulnerable populations|vulnerable populations
457946|NCT01607541|heterosexuals at high risk|heterosexuals at high risk
457947|NCT01607541|peer-driven intervention|peer-driven intervention
457948|NCT01607541|tailored intervention|tailored intervention
457949|NCT01607541|African-American|african-american
457950|NCT01607541|Latino/Hispanic|latino/hispanic
457951|NCT01607541|Seek, test, treat, and retain (STTR)|seek, test, treat, and retain (sttr)
457952|NCT01607515|Pulmonary hypertension|pulmonary hypertension
457953|NCT01607515|Cardiac index|cardiac index
457954|NCT01607515|impedance cardiography|impedance cardiography
457955|NCT01607502|Pulmonary hypertension|pulmonary hypertension
457956|NCT01607502|database|database
457957|NCT01607502|biomarker|biomarker
457958|NCT01607489|Early diagnosis of pulmonary arterial hypertension|early diagnosis of pulmonary arterial hypertension
457959|NCT01607489|dynamic dual-energy computed tomography|dynamic dual-energy computed tomography
457961|NCT01607463|transcutaneous electrical nerve stimulation|transcutaneous electrical nerve stimulation
457962|NCT01607450|Type 2 diabetes mellitus|type 2 diabetes mellitus
457963|NCT01607450|lean healthy control|lean healthy control
457964|NCT01607424|cognitive rehabilitation|cognitive rehabilitation
457965|NCT01607424|schizophrenia|schizophrenia
457966|NCT01607398|Japan|japan
457967|NCT01607398|COPD|copd
457968|NCT01607398|CAT|cat
457969|NCT01607398|placebo|placebo
457970|NCT01607398|serum|serum
457971|NCT01607398|Adoair250|adoair250
457972|NCT01607398|anti-inflammatory|anti-inflammatory
457973|NCT01607398|sputum|sputum
457974|NCT01607385|pharmacokinetic|pharmacokinetic
457975|NCT01607385|intestinal bile acid transporter inhibitor|intestinal bile acid transporter inhibitor
457976|NCT01607385|GSK2330672|gsk2330672
457977|NCT01607385|pharmacodynamic|pharmacodynamic
457978|NCT01607385|GSK1614235|gsk1614235
457979|NCT01607385|dose escalation|dose escalation
457980|NCT01607372|TLR7 agonist, Respiratory Allergies, Allergic Rhinitis, Mild Allergic Asthma, Repeat Dose Safety, Reduction of Allergic Reactivity|tlr7 agonist, respiratory allergies, allergic rhinitis, mild allergic asthma, repeat dose safety, reduction of allergic reactivity
457981|NCT01607359|atrial fibrillation|atrial fibrillation
457982|NCT01607359|catheter ablation|catheter ablation
457983|NCT01607359|dabigatran|dabigatran
457984|NCT01607359|warfarin|warfarin
457985|NCT01607359|oral anticoagulation|oral anticoagulation
457986|NCT01607346|Urinary Retention|urinary retention
457987|NCT01607333|Antiepileptics|antiepileptics
457988|NCT01607333|suicidality|suicidality
457989|NCT01607320|PCOS|pcos
457990|NCT01607320|Infertility|infertility
457991|NCT01607320|Anovulation|anovulation
457992|NCT01607307|daikenchuto|daikenchuto
457993|NCT01607307|postoperative ileus|postoperative ileus
457994|NCT01607307|pancreaticoduodenectomy|pancreaticoduodenectomy
457995|NCT01607281|anatomical landmark|anatomical landmark
457996|NCT01607281|internal jugular vein canulation|internal jugular vein canulation
457997|NCT01607268|autonomic failure|autonomic failure
457998|NCT01607268|mangenetic resonance|mangenetic resonance
457999|NCT01607268|neurochemistry|neurochemistry
458000|NCT01607268|neurotransmitter|neurotransmitter
458001|NCT01607268|glutamate|glutamate
458002|NCT01607255|adenoma detection|adenoma detection
458003|NCT01607255|screening colonoscopy|screening colonoscopy
458004|NCT01607255|water exchange method|water exchange method
458005|NCT01607255|chromoendoscopy|chromoendoscopy
458006|NCT01607242|total thyroidectomy|total thyroidectomy
458007|NCT01607242|voice handicap index|voice handicap index
458008|NCT01607242|swallowing disorders|swallowing disorders
458009|NCT01607242|thyroid surgery|thyroid surgery
458010|NCT01607242|voice disorders|voice disorders
458011|NCT01607229|multi-frequency|multi-frequency
458012|NCT01607229|bioelectrical impedance|bioelectrical impedance
458013|NCT01607229|body composition|body composition
458014|NCT01607229|hydration|hydration
458015|NCT01607216|Prematurity|prematurity
458016|NCT01607216|Respiratory Illness|respiratory illness
458017|NCT01607216|Lung Function|lung function
458018|NCT01607216|Lung Disease|lung disease
458019|NCT01607203|ovarian hyper stimulation syndrome (OHSS)|ovarian hyper stimulation syndrome (ohss)
458020|NCT01607203|metaphase II oocytes (MII)|metaphase ii oocytes (mii)
458021|NCT01607203|good quality embryo's|good quality embryo's
458022|NCT01607203|implantation|implantation
458023|NCT01607203|pregnancy|pregnancy
458024|NCT01607190|type 2 diabetes mellitus|type 2 diabetes mellitus
458025|NCT01607190|nonproliferative diabetic retinopathy|nonproliferative diabetic retinopathy
458026|NCT01607164|Mood management|mood management
458027|NCT01607164|self-help|self-help
458028|NCT01607164|depression|depression
458029|NCT01607164|prevention|prevention
458030|NCT01607164|cognitive behavioral|cognitive behavioral
458031|NCT01607151|hypothermia|hypothermia
458032|NCT01607151|normothermia|normothermia
458033|NCT01607151|hyperthermia|hyperthermia
458034|NCT01607138|laryngectomy|laryngectomy
458035|NCT01607138|swallowing disturbances|swallowing disturbances
458036|NCT01607138|speech disturbances|speech disturbances
458037|NCT01607138|speech intelligibility|speech intelligibility
458038|NCT01607138|voice prothesis|voice prothesis
458039|NCT01607112|Influenza|influenza
458040|NCT01607112|Healthy|healthy
458041|NCT01607112|Immunogenicity|immunogenicity
458042|NCT01607112|Elderly|elderly
458043|NCT01607112|Safety|safety
584534|NCT01079273|A/H1N1|a/h1n1
458044|NCT01607112|Adults|adults
458045|NCT01607099|colonoscopy|colonoscopy
458046|NCT01607099|bowel cleansing|bowel cleansing
458047|NCT01607099|bowel cleanness|bowel cleanness
458048|NCT01607099|efficiency|efficiency
458049|NCT01607099|compatibility|compatibility
458050|NCT01607086|Lamotrigine|lamotrigine
458051|NCT01607086|placebo|placebo
458053|NCT01607086|characteristics|characteristics
458054|NCT01607073|Dravet|dravet
458055|NCT01607073|seizures|seizures
458056|NCT01607073|verapamil|verapamil
458057|NCT01607060|Critically ill patients|critically ill patients
458058|NCT01607060|intestinal failure|intestinal failure
458059|NCT01607047|leptospirosis|leptospirosis
458060|NCT01607047|qPCR|qpcr
458061|NCT01607047|cohort|cohort
458062|NCT01607047|french west indies|french west indies
458063|NCT01607047|blood sample collection|blood sample collection
458064|NCT01607047|pronostic|pronostic
458065|NCT01607047|diagnosis|diagnosis
458066|NCT01607021|Chronic hepatitis C|chronic hepatitis c
458067|NCT01607021|interleukin 28|interleukin 28
458068|NCT01607021|Children|children
458069|NCT01606995|Stroke|stroke
458070|NCT01606995|Embolism|embolism
458071|NCT01606995|Atrial fibrillation|atrial fibrillation
458072|NCT01606982|prostate|prostate
458073|NCT01606982|MDV3100|mdv3100
458074|NCT01606982|cancer|cancer
458075|NCT01606969|Dexmedetomidine|dexmedetomidine
458076|NCT01606969|epinephrine|epinephrine
458077|NCT01606969|lidocaine|lidocaine
458078|NCT01606969|scalp infiltration|scalp infiltration
458079|NCT01606969|craniotomy|craniotomy
458080|NCT01606943|Aortic dissection|aortic dissection
458081|NCT01606943|Risk factor|risk factor
458082|NCT01606943|Feature|feature
458083|NCT01606943|Management|management
458084|NCT01606943|Outcome|outcome
458085|NCT01606930|Patient Satisfaction|patient satisfaction
458086|NCT01606930|Patient Doctor Communication|patient doctor communication
458087|NCT01606930|Shared Decision Making|shared decision making
458088|NCT01606930|Patient Activation|patient activation
458089|NCT01606891|preschooler obesity prevention|preschooler obesity prevention
458090|NCT01606891|community home visiting parents|community home visiting parents
458091|NCT01606891|preschooler excess BMI gain|preschooler excess bmi gain
458092|NCT01606891|multi-setting/component intervention|multi-setting/component intervention
458093|NCT01606878|Crizotinib|crizotinib
458094|NCT01606878|Chemotherapy|chemotherapy
458095|NCT01606878|Solid Tumors|solid tumors
458096|NCT01606878|Anaplastic Large Cell Lymphoma|anaplastic large cell lymphoma
458097|NCT01606852|sedation|sedation
458098|NCT01606852|mechanical ventilation|mechanical ventilation
458099|NCT01606852|anxiety|anxiety
458100|NCT01606852|respiratory failure|respiratory failure
458101|NCT01606826|Severe|severe
458102|NCT01606787|Kidney|kidney
458103|NCT01606787|MANNITOL|mannitol
458104|NCT01606787|PLACEBO|placebo
458105|NCT01606787|Partial Nephrectomy|partial nephrectomy
458106|NCT01606787|12-079|12-079
458107|NCT01606761|Arthritis, Rheumatoid|arthritis, rheumatoid
458108|NCT01606761|Active rheumatoid arthritis despite anti-TNF-alpha therapy|active rheumatoid arthritis despite anti-tnf-alpha therapy
458109|NCT01606761|Sirukumab|sirukumab
458110|NCT01606761|Human Anti-IL-6 monoclonal antibody|human anti-il-6 monoclonal antibody
458111|NCT01606748|Advanced Malignant Solid Tumors|advanced malignant solid tumors
458112|NCT01606748|Solid Cancers|solid cancers
458113|NCT01606748|Non-small Cell Lung Cancer|non-small cell lung cancer
458114|NCT01606748|NSCLC|nsclc
458115|NCT01606748|Breast Cancer|breast cancer
458116|NCT01606735|cataract surgery|cataract surgery
458117|NCT01606735|ocular inflammation|ocular inflammation
458118|NCT01606722|Antiretroviral therapy|antiretroviral therapy
458119|NCT01606722|Boosted-Darunavir monotherapy|boosted-darunavir monotherapy
458120|NCT01606722|Resistance|resistance
458121|NCT01606722|Proviral DNA-HIV|proviral dna-hiv
458122|NCT01606709|GnRHa trigger|gnrha trigger
458123|NCT01606709|endometrial gene profile|endometrial gene profile
458124|NCT01606709|quality of life|quality of life
458126|NCT01606696|cardiac rehabilitation|cardiac rehabilitation
458127|NCT01606696|fitness|fitness
458128|NCT01606683|Acidified milk|acidified milk
458129|NCT01606683|Beta-palmitate|beta-palmitate
458130|NCT01606683|Bifidobacteria|bifidobacteria
458131|NCT01606683|Breastfeeding|breastfeeding
458132|NCT01606683|Infant formula|infant formula
458133|NCT01606683|Galacto-oligosaccharides|galacto-oligosaccharides
458134|NCT01606683|Growth|growth
458135|NCT01606683|Infants|infants
458136|NCT01606683|Metabolomics|metabolomics
458137|NCT01606683|Prebiotics|prebiotics
458138|NCT01606670|Rotigotine|rotigotine
458139|NCT01606670|Neupro®|neupro®
458140|NCT01606657|I&D|i&d
458141|NCT01606657|Abscess|abscess
458142|NCT01606657|Irrigation|irrigation
458143|NCT01606657|Cutaneous Abscess|cutaneous abscess
458144|NCT01606644|radiation sequelae|radiation sequelae
458145|NCT01606644|hyperbaric oxygen|hyperbaric oxygen
458146|NCT01606631|severe sepsis|severe sepsis
458147|NCT01606631|toxic shock|toxic shock
458148|NCT01606618|Self-esteem|self-esteem
458149|NCT01606618|Spina Bifida|spina bifida
458150|NCT01606618|Spinal cord injury|spinal cord injury
458151|NCT01606605|Lymphoma|lymphoma
458152|NCT01606605|Prognosis|prognosis
458153|NCT01606605|Relapse|relapse
458154|NCT01606605|Gene|gene
458155|NCT01606605|microRNA|microrna
458156|NCT01606579|Leukemia|leukemia
458157|NCT01606579|acute myeloid leukemia|acute myeloid leukemia
458158|NCT01606579|AML|aml
458159|NCT01606579|chronic myeloid leukemia|chronic myeloid leukemia
458160|NCT01606579|CML|cml
458161|NCT01606579|MDS|mds
458162|NCT01606579|myelodysplastic syndrome|myelodysplastic syndrome
458163|NCT01606579|myeloproliferative neoplasia|myeloproliferative neoplasia
458164|NCT01606579|MPN|mpn
458165|NCT01606566|Recurrent|recurrent
458166|NCT01606566|Head and Neck|head and neck
458167|NCT01606566|Neoplasms|neoplasms
458168|NCT01606566|Squamous Cell Carcinoma|squamous cell carcinoma
458169|NCT01606566|Amphinex|amphinex
458170|NCT01606566|Cancer|cancer
458171|NCT01606566|Photodynamic therapy|photodynamic therapy
458172|NCT01606566|Chemotherapy|chemotherapy
458173|NCT01606566|Bleomycin|bleomycin
458174|NCT01606553|chronic heart failure|chronic heart failure
458175|NCT01606553|respiratory muscle weakness|respiratory muscle weakness
458176|NCT01606553|inspiratory muscle training|inspiratory muscle training
458177|NCT01606540|Colles fracture|colles fracture
458178|NCT01606540|Non-steroid antiinflammatory drugs|non-steroid antiinflammatory drugs
458179|NCT01606540|Bone healing|bone healing
458180|NCT01606527|Spectrum of Altitude-associated acute mountain sickness|spectrum of altitude-associated acute mountain sickness
458181|NCT01606527|hypoxia|hypoxia
458182|NCT01606527|high altitude headache|high altitude headache
458183|NCT01606527|high altitude cerebral edemat is.....|high altitude cerebral edemat is.....
458184|NCT01606488|Postoperative Cognitive Dysfunction|postoperative cognitive dysfunction
458185|NCT01606488|Postoperative Cognitive Decline|postoperative cognitive decline
458186|NCT01606488|POCD|pocd
458187|NCT01606488|Alzheimer's disease|alzheimer's disease
458188|NCT01606488|Florbetapir F 18 (18F-AV-45)|florbetapir f 18 (18f-av-45)
458189|NCT01606475|Islet transplant|islet transplant
458190|NCT01606475|Diabetes Mellitus|diabetes mellitus
458191|NCT01606475|Hypoglycemia|hypoglycemia
458192|NCT01606462|oxytocin|oxytocin
458193|NCT01606462|social cognition|social cognition
458194|NCT01606462|fMRI|fmri
458195|NCT01606462|oxytocin receptor gene|oxytocin receptor gene
458196|NCT01606449|Gastroesophageal reflux diseases|gastroesophageal reflux diseases
458197|NCT01606449|Hiatal Hernia|hiatal hernia
458198|NCT01606449|Paraesophageal Hernia|paraesophageal hernia
458199|NCT01606358|Ovarian Cancer|ovarian cancer
458200|NCT01606358|Patient with ovarian cancer|patient with ovarian cancer
458201|NCT01606345|Upper Tract Urothelial Carcinoma|upper tract urothelial carcinoma
458202|NCT01606345|UTUC|utuc
458203|NCT01606345|Kidney|kidney
458204|NCT01606345|Cancer|cancer
458205|NCT01606345|Renal|renal
458206|NCT01606319|Asthma|asthma
458207|NCT01606319|Wheezing|wheezing
458208|NCT01606319|Ibuprofen|ibuprofen
458209|NCT01606319|Acetaminophen|acetaminophen
458210|NCT01606319|exacerbations|exacerbations
458211|NCT01606319|pain|pain
458212|NCT01606319|fever|fever
458213|NCT01606306|Asthma|asthma
458214|NCT01606306|Wheezing|wheezing
458215|NCT01606306|Fluticasone|fluticasone
458216|NCT01606306|Montelukast|montelukast
458217|NCT01606306|Preschool-age|preschool-age
458218|NCT01606293|Small cell carcinomas of the cervix|small cell carcinomas of the cervix
458219|NCT01606293|Large cell carcinomas of the cervix|large cell carcinomas of the cervix
458220|NCT01606293|Online surveys|online surveys
458221|NCT01606293|Electronic surveys|electronic surveys
458222|NCT01606293|Questionnaires|questionnaires
458223|NCT01606293|Facebook|facebook
458224|NCT01606293|Social networking support groups|social networking support groups
458225|NCT01606280|Amyloidosis|amyloidosis
458226|NCT01606267|Integrated Community Case Management|integrated community case management
458227|NCT01606267|Pneumonia|pneumonia
458228|NCT01606267|Ethiopia|ethiopia
458229|NCT01606254|Schizophrenia|schizophrenia
458230|NCT01606254|Paliperidone Palmitate|paliperidone palmitate
458231|NCT01606254|JNS010|jns010
458232|NCT01606228|Schizophrenia|schizophrenia
458233|NCT01606228|Paliperidone ER|paliperidone er
458234|NCT01606228|Treatment naive patients|treatment naive patients
458235|NCT01606228|Newly diagnosed patients|newly diagnosed patients
458236|NCT01606215|multiple sclerosis|multiple sclerosis
458237|NCT01606215|mesenchymal stem cells|mesenchymal stem cells
458238|NCT01606215|bone marrow|bone marrow
458239|NCT01606215|rapidly evolving|rapidly evolving
458240|NCT01606150|neonate|neonate
458241|NCT01606150|late preterm|late preterm
458242|NCT01606150|lumbar puncture|lumbar puncture
458243|NCT01606150|analgesia|analgesia
458244|NCT01606150|pain|pain
458245|NCT01606150|lidocaine|lidocaine
458246|NCT01606098|Surgery|surgery
458247|NCT01606098|Chemotherapy|chemotherapy
458248|NCT01606085|Diabetes|diabetes
584786|NCT01078246|HIV|hiv
458249|NCT01606085|Heart Failure|heart failure
458250|NCT01606085|Quality of Life|quality of life
458251|NCT01606085|Self Care|self care
458252|NCT01606072|DDAVP|ddavp
458253|NCT01606033|stress|stress
458254|NCT01606033|Life quality|life quality
458255|NCT01606033|adjustment strategy|adjustment strategy
458256|NCT01606033|receiving an antitumor treatment|receiving an antitumor treatment
458257|NCT01606033|within a clinical trial (case)|within a clinical trial (case)
458508|NCT01604993|Arterial Stiffness|arterial stiffness
458966|NCT01602939|Mast cell|mast cell
458258|NCT01606033|according to a standard treatment (control)|according to a standard treatment (control)
458259|NCT01606020|effects of sleep deprivation|effects of sleep deprivation
458260|NCT01606020|Transcranial Magnetic Stimulation|transcranial magnetic stimulation
458261|NCT01606020|male, healthy volunteers|male, healthy volunteers
458262|NCT01605981|Nilotinib|nilotinib
458263|NCT01605981|CML patients|cml patients
458264|NCT01605981|accelerated phase|accelerated phase
458265|NCT01605968|Obstetrics|obstetrics
458266|NCT01605968|Gynecology|gynecology
458267|NCT01605968|Wound healing|wound healing
458268|NCT01605955|SPO2|spo2
458269|NCT01605929|Anesthetics, local/administration & dosage|anesthetics, local/administration & dosage
458270|NCT01605929|Brachial Plexus/ultrasonography|brachial plexus/ultrasonography
458271|NCT01605929|Humans|humans
458272|NCT01605929|Nerve Block/methods|nerve block/methods
458273|NCT01605929|Upper Extremity/surgery|upper extremity/surgery
458274|NCT01605929|Catheters, Indwelling|catheters, indwelling
458275|NCT01605929|Anesthesia, Conduction/methods|anesthesia, conduction/methods
458276|NCT01605929|Analgesia/methods|analgesia/methods
458277|NCT01605929|Nerve Block/adverse effects|nerve block/adverse effects
458278|NCT01605916|Cancer,|cancer,
458279|NCT01605916|Tumour,|tumour,
458280|NCT01605916|Metastatic,|metastatic,
458281|NCT01605916|Lung cancer,|lung cancer,
458282|NCT01605916|Non-Small Cell Lung Cancer|non-small cell lung cancer
458283|NCT01605903|Tonsillectomy|tonsillectomy
458284|NCT01605903|adenoidectomy|adenoidectomy
458285|NCT01605903|bleeding|bleeding
458286|NCT01605903|bleeding rates|bleeding rates
458287|NCT01605903|Tonsillectomy with and without adenoidectomy|tonsillectomy with and without adenoidectomy
458288|NCT01605890|HIV-2|hiv-2
458289|NCT01605877|Cataracts|cataracts
458290|NCT01605877|Intraocular lens|intraocular lens
458291|NCT01605877|Multifocal|multifocal
458292|NCT01605877|Presbyopia|presbyopia
458293|NCT01605864|pneumonia|pneumonia
458294|NCT01605864|community acquired bacterial pneumonia|community acquired bacterial pneumonia
458295|NCT01605864|CAP|cap
458296|NCT01605864|CABP|cabp
458297|NCT01605864|bacterial pneumonia|bacterial pneumonia
458298|NCT01605851|PFO|pfo
458299|NCT01605851|closure|closure
458300|NCT01605838|TBI|tbi
458301|NCT01605812|IOL;|iol;
458302|NCT01605812|capsule；|capsule；
458303|NCT01605812|PCO;|pco;
458304|NCT01605812|OCT|oct
458305|NCT01605799|PTSD|ptsd
458306|NCT01605799|Mental Health|mental health
458307|NCT01605799|War|war
458308|NCT01605799|Veterans|veterans
458309|NCT01605786|Malaria|malaria
458310|NCT01605786|Plasmodium falciparum|plasmodium falciparum
458311|NCT01605786|vaccine|vaccine
458312|NCT01605786|ADCI|adci
458313|NCT01605786|sporozoite challenge|sporozoite challenge
458314|NCT01605786|pre-erythrocytic|pre-erythrocytic
458315|NCT01605786|erythrocytic|erythrocytic
458316|NCT01605760|immunotherapy|immunotherapy
458317|NCT01605760|elderly|elderly
458318|NCT01605734|hepatocellular carcinoma|hepatocellular carcinoma
458319|NCT01605734|transarterial chemoembolization|transarterial chemoembolization
458320|NCT01605734|sorafenib|sorafenib
458321|NCT01605721|Everolimus|everolimus
458322|NCT01605721|XIENCE PRIME|xience prime
458323|NCT01605721|Drug eluting stent|drug eluting stent
458324|NCT01605708|Itching|itching
458325|NCT01605695|reference range|reference range
458326|NCT01605695|plasma|plasma
458327|NCT01605695|inducible nitric oxide synthase|inducible nitric oxide synthase
458328|NCT01605695|iNOS|inos
458329|NCT01605695|healthy adults|healthy adults
458330|NCT01605682|effect of different berry doses on mood and cognition|effect of different berry doses on mood and cognition
458331|NCT01605682|adults|adults
458332|NCT01605669|Auscultation|auscultation
458333|NCT01605669|Aortic stenosis|aortic stenosis
458334|NCT01605669|computer assisted auscultation|computer assisted auscultation
458335|NCT01605669|Aortic Stenosis Acceleration Index|aortic stenosis acceleration index
458336|NCT01605656|Cancer Prevention|cancer prevention
458337|NCT01605656|Cervix|cervix
458338|NCT01605656|Questionnaires|questionnaires
458339|NCT01605656|Focus groups|focus groups
458340|NCT01605656|Surveys|surveys
458341|NCT01605656|Interviews|interviews
458342|NCT01605643|cancer|cancer
458343|NCT01605643|tobacco use|tobacco use
458344|NCT01605643|pregnancy|pregnancy
458345|NCT01605604|mindfulness EQ adolescents|mindfulness eq adolescents
458346|NCT01605591|left-side double lumen bronchial tube|left-side double lumen bronchial tube
458347|NCT01605591|bending type|bending type
458348|NCT01605591|GlideScope videolaryngoscope|glidescope videolaryngoscope
458349|NCT01605552|Depression|depression
458350|NCT01605552|Depressive Symptoms|depressive symptoms
458351|NCT01605552|Cardiovascular Disease (CVD)|cardiovascular disease (cvd)
458352|NCT01605552|Coronary Artery Disease (CAD)|coronary artery disease (cad)
458353|NCT01605552|Heart Disease|heart disease
458354|NCT01605513|recombinant interferon, tolerated, effective|recombinant interferon, tolerated, effective
458355|NCT01605500|ICD|icd
458356|NCT01605474|foley catheter|foley catheter
458357|NCT01605474|foley bulb|foley bulb
458358|NCT01605474|induction of labor|induction of labor
458359|NCT01605474|labor|labor
458360|NCT01605448|Mild Cognitive Impairment|mild cognitive impairment
458361|NCT01605448|Alzheimer's disease|alzheimer's disease
458362|NCT01605448|Meditation|meditation
458363|NCT01605448|Default Mode Network|default mode network
458364|NCT01605422|Systematic review and meta-analysis|systematic review and meta-analysis
458365|NCT01605422|Evidence-based medicine (EBM)|evidence-based medicine (ebm)
458366|NCT01605422|Evidence-based nutrition (EBN)|evidence-based nutrition (ebn)
458367|NCT01605422|Clinical practice guidelines|clinical practice guidelines
458368|NCT01605422|Clinical trials|clinical trials
458369|NCT01605422|Dietary pulses|dietary pulses
458370|NCT01605422|legumes|legumes
458371|NCT01605422|Beans, peas, chickpeas, lentils|beans, peas, chickpeas, lentils
458372|NCT01605422|glycemic index|glycemic index
458373|NCT01605422|postprandial glycemia|postprandial glycemia
458374|NCT01605422|insulin resistance|insulin resistance
458375|NCT01605422|body weight|body weight
458376|NCT01605422|appetite|appetite
458377|NCT01605422|food intake regulation|food intake regulation
458378|NCT01605422|satiety|satiety
458379|NCT01605422|satiation|satiation
458380|NCT01605409|Refractory cardiac arrest|refractory cardiac arrest
458381|NCT01605409|Emergency cardiopulmonary bypass|emergency cardiopulmonary bypass
458382|NCT01605409|Extracorporeal life support in cardiac arrest|extracorporeal life support in cardiac arrest
458383|NCT01605383|Avascular Necrosis of Femur Head|avascular necrosis of femur head
458384|NCT01605383|Osteonecrosis of the hip|osteonecrosis of the hip
458385|NCT01605383|Osteonecrosis of the femoral head|osteonecrosis of the femoral head
458386|NCT01605383|Mesenchymal Stem Cells|mesenchymal stem cells
458387|NCT01605383|Bone marrow|bone marrow
458388|NCT01605383|Tissue engineering|tissue engineering
458389|NCT01605383|Bone Diseases|bone diseases
458390|NCT01605383|Musculoskeletal Diseases|musculoskeletal diseases
458391|NCT01605370|Hypertension, Left Ventricular Mass|hypertension, left ventricular mass
458392|NCT01605357|Brain Injuries|brain injuries
458393|NCT01605357|Hematoma, subdural|hematoma, subdural
458394|NCT01605357|Decompressive Craniectomy|decompressive craniectomy
458395|NCT01605357|Saline solution, hypertonic|saline solution, hypertonic
458396|NCT01605357|Hypernatremia|hypernatremia
458397|NCT01605357|Intracranial hemorrhages|intracranial hemorrhages
458398|NCT01605357|Head Injuries, closed|head injuries, closed
458399|NCT01605357|Intracranial pressure|intracranial pressure
458400|NCT01605357|Brain edema|brain edema
458401|NCT01605357|Critical care|critical care
458402|NCT01605357|Brain Diseases|brain diseases
458403|NCT01605357|Central Nervous System Diseases|central nervous system diseases
458404|NCT01605357|Nervous System Diseases|nervous system diseases
458405|NCT01605357|Wounds and Injuries|wounds and injuries
458406|NCT01605357|Physiological Effects of Drugs|physiological effects of drugs
458407|NCT01605357|Pharmacologic Actions|pharmacologic actions
458408|NCT01605344|Advanced colon cancer|advanced colon cancer
458409|NCT01605344|Advanced rectal cancer|advanced rectal cancer
458410|NCT01605344|Metastatic colon cancer|metastatic colon cancer
458411|NCT01605344|Metastatic rectal cancer|metastatic rectal cancer
458412|NCT01605344|Lipitor|lipitor
458413|NCT01605344|Atorvastatin|atorvastatin
458414|NCT01605344|FOLFIRI|folfiri
458415|NCT01605331|Adults|adults
458416|NCT01605331|GH deficiency|gh deficiency
458417|NCT01605318|metastatic colorectal cancer|metastatic colorectal cancer
458418|NCT01605318|colon cancer|colon cancer
458419|NCT01605318|rectal cancer|rectal cancer
458420|NCT01605318|previously treated|previously treated
458421|NCT01605292|Transradial catheterization|transradial catheterization
458422|NCT01605292|Ultrasound|ultrasound
458423|NCT01605292|Radial artery|radial artery
458424|NCT01605279|Low superior vena cava flow|low superior vena cava flow
458425|NCT01605279|Functional echocardiography|functional echocardiography
458426|NCT01605266|pediatric|pediatric
458427|NCT01605266|kidney disease|kidney disease
458428|NCT01605266|minimal change disease|minimal change disease
458429|NCT01605266|focal segmental glomerulosclerosis|focal segmental glomerulosclerosis
458430|NCT01605266|nephrotic syndrome|nephrotic syndrome
458431|NCT01605253|Post-traumatic stress disorder|post-traumatic stress disorder
458432|NCT01605253|sleep disturbance|sleep disturbance
458433|NCT01605253|insomnia|insomnia
458434|NCT01605253|cytokines|cytokines
458435|NCT01605253|anxiety|anxiety
458436|NCT01605253|traumatic event|traumatic event
458437|NCT01605253|memory|memory
458438|NCT01605240|Fracture pain|fracture pain
458439|NCT01605240|Fracture reduction|fracture reduction
458440|NCT01605240|Analgesia|analgesia
458441|NCT01605240|Acetaminophen|acetaminophen
458442|NCT01605240|Ibuprofen|ibuprofen
458443|NCT01605240|Codeine|codeine
458444|NCT01605240|Pediatric|pediatric
458445|NCT01605240|Fracture Pain Analgesia in Pediatric population|fracture pain analgesia in pediatric population
458446|NCT01605227|prostate cancer|prostate cancer
458447|NCT01605227|castration resistant prostate cancer|castration resistant prostate cancer
458448|NCT01605227|bone pain|bone pain
458449|NCT01605227|CRPC|crpc
458450|NCT01605214|Extravascular Lung Water|extravascular lung water
458451|NCT01605214|Transpulmonary Thermodilution|transpulmonary thermodilution
458452|NCT01605214|Primary Graft Dysfunction|primary graft dysfunction
459067|NCT01602432|Cancer|cancer
458453|NCT01605214|Ischemia Reperfusion Injury|ischemia reperfusion injury
458454|NCT01605201|Chondral lesions in the knee after traumatic injury|chondral lesions in the knee after traumatic injury
458455|NCT01605175|Inflammatory Bowel Disease|inflammatory bowel disease
458456|NCT01605175|Predictors Mucosal Healing|predictors mucosal healing
458457|NCT01605149|Diabetes|diabetes
458458|NCT01605136|Erythropoietic Protoporphyria|erythropoietic protoporphyria
458459|NCT01605136|EPP|epp
458460|NCT01605136|Afamelanotide|afamelanotide
458461|NCT01605123|endothelial function|endothelial function
458462|NCT01605123|children|children
458463|NCT01605123|obesity|obesity
458464|NCT01605123|cardiovascular dysfunction|cardiovascular dysfunction
458465|NCT01605123|carotid intima media thickness|carotid intima media thickness
458466|NCT01605123|blood pressure|blood pressure
458467|NCT01605123|oral glucose tolerance test|oral glucose tolerance test
458468|NCT01605110|blepharoplasty|blepharoplasty
458469|NCT01605110|hyperbaric|hyperbaric
458470|NCT01605110|oxygen|oxygen
458471|NCT01605110|ecchymosis|ecchymosis
458472|NCT01605110|edema|edema
458473|NCT01605110|wound|wound
458474|NCT01605110|healing|healing
458475|NCT01605097|prostate neoplasms|prostate neoplasms
458476|NCT01605097|interstitial radiation|interstitial radiation
458477|NCT01605097|High dose rate prostate brachytherapy|high dose rate prostate brachytherapy
458478|NCT01605097|dose escalation|dose escalation
458479|NCT01605071|menopause|menopause
458480|NCT01605071|estrogen|estrogen
458481|NCT01605071|insulin sensitivity|insulin sensitivity
458482|NCT01605071|estrogen receptors|estrogen receptors
458483|NCT01605045|Cardiac catheterization|cardiac catheterization
458484|NCT01605045|Radiation|radiation
458485|NCT01605019|Ventricular Assist Devices|ventricular assist devices
458486|NCT01605019|Heart assist pumps|heart assist pumps
458487|NCT01605019|heart pumps|heart pumps
458488|NCT01605019|sealant agents|sealant agents
458489|NCT01605006|amyotrophic lateral sclerosis|amyotrophic lateral sclerosis
458490|NCT01605006|ALS|als
458491|NCT01605006|motor neuron disease|motor neuron disease
458492|NCT01605006|diaphragm|diaphragm
458493|NCT01605006|diaphragm pacing|diaphragm pacing
458494|NCT01605006|diaphragmatic pacing|diaphragmatic pacing
458495|NCT01605006|phrenic pacing|phrenic pacing
458496|NCT01605006|phrenic nerve|phrenic nerve
458497|NCT01605006|phrenic nerve stimulation|phrenic nerve stimulation
458498|NCT01605006|NeuRx DPS|neurx dps
458499|NCT01605006|DPS|dps
458500|NCT01605006|chronic hypoventilation|chronic hypoventilation
458501|NCT01605006|respiration|respiration
458502|NCT01605006|ventilation|ventilation
458503|NCT01605006|breathing|breathing
458504|NCT01605006|Humanitarian Device Exemption|humanitarian device exemption
458505|NCT01605006|HDE|hde
458506|NCT01605006|post-approval study|post-approval study
458507|NCT01604993|Dietary Nitrates|dietary nitrates
458509|NCT01604993|Vascular|vascular
458510|NCT01604993|Blood pressure|blood pressure
458511|NCT01604954|Food labeling|food labeling
458512|NCT01604928|Overactive Bladder|overactive bladder
458513|NCT01604928|YM178|ym178
458514|NCT01604928|Mirabegron|mirabegron
458515|NCT01604928|Frequency|frequency
458516|NCT01604928|Urinary urge incontinence|urinary urge incontinence
458517|NCT01604928|Urgency|urgency
458518|NCT01604928|Urinary incontinence|urinary incontinence
458519|NCT01604928|Micturition|micturition
458520|NCT01604902|Psoriasis mRNA and miRNA|psoriasis mrna and mirna
458521|NCT01604889|Melanoma, Skin Cancer, Oncology|melanoma, skin cancer, oncology
458522|NCT01604876|Parkinson's disease|parkinson's disease
458523|NCT01604876|depression|depression
458524|NCT01604876|light therapy|light therapy
458525|NCT01604876|sleeping problems|sleeping problems
458526|NCT01604863|Solid Tumors|solid tumors
458527|NCT01604863|Cancer|cancer
458528|NCT01604863|Lung Cancer|lung cancer
458529|NCT01604863|Prostate Cancer|prostate cancer
458530|NCT01604863|Mesothelioma|mesothelioma
458531|NCT01604863|Small Cell lung Cancer|small cell lung cancer
458532|NCT01604850|HCV genotype 2 (GT-2)|hcv genotype 2 (gt-2)
458533|NCT01604850|HCV genotype 3 (GT-3)|hcv genotype 3 (gt-3)
458535|NCT01604850|Sustained Virologic Response|sustained virologic response
458536|NCT01604850|Direct Acting Antiviral|direct acting antiviral
458537|NCT01604850|Combination Therapy|combination therapy
458538|NCT01604850|Treatment Experienced|treatment experienced
458539|NCT01604850|GS-7977|gs-7977
458540|NCT01604850|Ribavirin|ribavirin
458541|NCT01604837|superior hypogastric plexus block|superior hypogastric plexus block
458542|NCT01604837|pelvic malignancy|pelvic malignancy
458543|NCT01604837|chronic pelvic pain|chronic pelvic pain
458544|NCT01604798|proteomics|proteomics
458545|NCT01604798|serum peptides|serum peptides
458546|NCT01604798|colorectal cancer|colorectal cancer
458547|NCT01604798|MALDI-TOF MS|maldi-tof ms
458548|NCT01604785|Migraine Headache|migraine headache
458549|NCT01604785|Pediatric|pediatric
458550|NCT01604759|Mouth Neoplasms|mouth neoplasms
458551|NCT01604759|Mouth Diseases|mouth diseases
458552|NCT01604733|Multi-Center Survey|multi-center survey
458553|NCT01604733|patients currently on lipid-lowering pharmacological treatment|patients currently on lipid-lowering pharmacological treatment
459274|NCT01601574|Obesity|obesity
458554|NCT01604733|level of Control of Hypercholesterolemia in Egypt|level of control of hypercholesterolemia in egypt
458555|NCT01604720|sample size|sample size
458556|NCT01604720|liver disease|liver disease
458557|NCT01604707|stress|stress
458558|NCT01604707|anxiety|anxiety
458559|NCT01604707|depression|depression
458560|NCT01604707|quality of life|quality of life
458561|NCT01604694|Abdominoplasty|abdominoplasty
458562|NCT01604694|Transversus Abdominis Plane (TAP) Block|transversus abdominis plane (tap) block
458563|NCT01604694|levobupivacaine|levobupivacaine
458564|NCT01604694|Placebo|placebo
458565|NCT01604681|Linseed Oil|linseed oil
458566|NCT01604681|Oxidative Stress|oxidative stress
458567|NCT01604681|Polymorphism, Genetic|polymorphism, genetic
458568|NCT01604681|Cardiovascular Diseases|cardiovascular diseases
458569|NCT01604655|Chest pain|chest pain
458570|NCT01604655|shortness of breath|shortness of breath
458571|NCT01604655|suspected acute coronary syndrome|suspected acute coronary syndrome
458572|NCT01604655|stress testing|stress testing
458573|NCT01604655|coronary computed tomography angiography|coronary computed tomography angiography
458574|NCT01604629|Spondylarthropathies|spondylarthropathies
458575|NCT01604629|Persistent clinical remission with anti-TNF therapy|persistent clinical remission with anti-tnf therapy
458576|NCT01604629|Standardized protocol for dose reduction anti-TNF therapy|standardized protocol for dose reduction anti-tnf therapy
458577|NCT01604590|Glioblastoma|glioblastoma
458578|NCT01604590|Imaging Biomarkers|imaging biomarkers
458579|NCT01604590|Bevacizumab|bevacizumab
458580|NCT01604590|MRI|mri
458581|NCT01604577|health literacy|health literacy
458582|NCT01604577|health numeracy|health numeracy
458583|NCT01604564|Registry|registry
458584|NCT01604564|Colitis Ulcerosa (CU)|colitis ulcerosa (cu)
458585|NCT01604564|Familial Adenomatous Polyposis(FAP)|familial adenomatous polyposis(fap)
458586|NCT01604564|IPAA|ipaa
458587|NCT01604512|Brain tumor|brain tumor
458588|NCT01604512|MRI Perfusion|mri perfusion
458589|NCT01604512|FDG PET/CT|fdg pet/ct
458590|NCT01604512|12-067|12-067
458591|NCT01604499|Healthy eating|healthy eating
458592|NCT01604499|Incentives|incentives
458593|NCT01604499|Feedback|feedback
458594|NCT01604486|Myocardial infarction|myocardial infarction
458595|NCT01604486|Ischaemic preconditioning|ischaemic preconditioning
458596|NCT01604486|Myocardial Ischaemia National Audit Project|myocardial ischaemia national audit project
458597|NCT01604486|General Practice Research Database|general practice research database
458598|NCT01604486|Hospital Episode Statistics|hospital episode statistics
458599|NCT01604486|Office for National Statistics|office for national statistics
458600|NCT01604473|Chronic Kidney Disease|chronic kidney disease
458601|NCT01604473|CKD|ckd
458602|NCT01604473|ESRD|esrd
458603|NCT01604473|AV Fistula|av fistula
458604|NCT01604473|Arterio-venous fistula|arterio-venous fistula
458605|NCT01604473|hemodialysis|hemodialysis
458606|NCT01604460|Hypothermia|hypothermia
458607|NCT01604460|Newborn|newborn
458608|NCT01604460|Plastic bag|plastic bag
458609|NCT01604460|Resuscitation|resuscitation
458610|NCT01604447|Hypothermia|hypothermia
458611|NCT01604447|Newborn|newborn
458612|NCT01604447|Incubator|incubator
458613|NCT01604447|Plastic bag|plastic bag
458614|NCT01604447|Normothermia|normothermia
458615|NCT01604434|Hypothermia|hypothermia
458616|NCT01604434|Low birth Weight|low birth weight
458617|NCT01604434|Newborn|newborn
458618|NCT01604434|Incubator|incubator
458619|NCT01604434|Plastic bag|plastic bag
458620|NCT01604421|Hypothermia|hypothermia
458621|NCT01604421|Low birth weight|low birth weight
458622|NCT01604421|Newborn|newborn
458623|NCT01604421|Plastic bag|plastic bag
458624|NCT01604421|Thermoregulation|thermoregulation
458625|NCT01604395|GHD|ghd
458626|NCT01604395|TS|ts
458627|NCT01604395|CRF|crf
458628|NCT01604395|SGA|sga
458629|NCT01604395|ISS|iss
458630|NCT01604382|Total Knee Arthroplasty (TKA)|total knee arthroplasty (tka)
458631|NCT01604369|Atrial flutter|atrial flutter
458632|NCT01604369|Cryoablation|cryoablation
458633|NCT01604369|Cavotricuspid isthmus|cavotricuspid isthmus
458634|NCT01604369|Visual analogue scale|visual analogue scale
458635|NCT01604356|retinitis pigmentosa|retinitis pigmentosa
458636|NCT01604343|Active rheumatoid arthritis despite disease-modifying antirheumatic drug therapy|active rheumatoid arthritis despite disease-modifying antirheumatic drug therapy
458637|NCT01604343|Sirukumab|sirukumab
458638|NCT01604343|Human Anti-IL-6 monoclonal antibody|human anti-il-6 monoclonal antibody
458639|NCT01604330|High dose baclofen|high dose baclofen
458640|NCT01604330|Alcoholism|alcoholism
458641|NCT01604330|Abstinence|abstinence
458642|NCT01604330|Low risk consumption|low risk consumption
458643|NCT01604330|Craving|craving
458644|NCT01604317|Hypothermia|hypothermia
458645|NCT01604317|Low birth Weight|low birth weight
458646|NCT01604317|Newborn|newborn
458647|NCT01604317|Resuscitation|resuscitation
458648|NCT01604317|Plastic bag|plastic bag
458649|NCT01604304|stone|stone
458650|NCT01604304|calculi|calculi
458651|NCT01604304|kidney|kidney
458652|NCT01604304|renal treatment|renal treatment
458653|NCT01604304|flexible ureteroscopy|flexible ureteroscopy
458654|NCT01604304|extracoporeal shockwave lithotripsy|extracoporeal shockwave lithotripsy
458655|NCT01604304|retrograde intra renal surgery|retrograde intra renal surgery
458656|NCT01604278|Indacaterol|indacaterol
458657|NCT01604278|Glycopyrronium Bromide|glycopyrronium bromide
458658|NCT01604278|COPD|copd
458659|NCT01604278|bronchodilation|bronchodilation
458660|NCT01604239|Osteoarthritis|osteoarthritis
458661|NCT01604239|Shinbaro|shinbaro
458662|NCT01604239|Herbal drug|herbal drug
458663|NCT01604226|total intravenous anesthesia|total intravenous anesthesia
458664|NCT01604226|Bispectral index monitoring|bispectral index monitoring
458665|NCT01604226|propofol|propofol
458666|NCT01604226|remifentanil|remifentanil
458667|NCT01604213|Type 2 diabetes mellitus|type 2 diabetes mellitus
458668|NCT01604213|vildagliptin|vildagliptin
458669|NCT01604213|metformin|metformin
458670|NCT01604213|atherosclerosis|atherosclerosis
458671|NCT01604213|inflammation|inflammation
458672|NCT01604213|interleukin-6|interleukin-6
458673|NCT01604213|TNF|tnf
458674|NCT01604213|atherothrombosis|atherothrombosis
458675|NCT01604213|adiponectin|adiponectin
458676|NCT01604213|MMP-9|mmp-9
458677|NCT01604213|hs-CRP|hs-crp
458678|NCT01604200|hypertension|hypertension
458679|NCT01604200|dentistry|dentistry
458680|NCT01604200|blood pressure|blood pressure
458681|NCT01604200|measurement|measurement
458682|NCT01604200|screening|screening
458683|NCT01604200|qualitative research|qualitative research
458684|NCT01604187|sublingual fentanyl|sublingual fentanyl
458685|NCT01604187|pain in coloscopy|pain in coloscopy
458686|NCT01604187|The efficacy and safety of fentanyl transmucosal tablet to placebo in patients having colonoscopy.|the efficacy and safety of fentanyl transmucosal tablet to placebo in patients having colonoscopy.
458687|NCT01604174|knee|knee
458688|NCT01604174|osteoarthritis|osteoarthritis
458689|NCT01604174|arthroplasty|arthroplasty
458690|NCT01604174|rehabilitation|rehabilitation
458691|NCT01604148|Holmium Laser Enucleation of Prostate|holmium laser enucleation of prostate
458692|NCT01604135|Collagen crosslinking|collagen crosslinking
458693|NCT01604135|Keratoconus|keratoconus
458694|NCT01604122|Survey|survey
458695|NCT01604122|burden of illness|burden of illness
458696|NCT01604122|caregivers|caregivers
458697|NCT01604122|TTR-FAP|ttr-fap
458698|NCT01604122|TTR-CM|ttr-cm
458699|NCT01604122|familial amyloid polyneuropathy|familial amyloid polyneuropathy
458700|NCT01604122|observational|observational
458701|NCT01604122|transthyretin familial amyloidosis|transthyretin familial amyloidosis
458702|NCT01604109|Caries detection/diagnosis/prevention|caries detection/diagnosis/prevention
458703|NCT01604109|Preventive Dentistry|preventive dentistry
458704|NCT01604109|Casien Phosphopeptide|casien phosphopeptide
458705|NCT01604109|Remineralization|remineralization
458706|NCT01604109|Clinical trial|clinical trial
458707|NCT01604096|Information|information
458708|NCT01604096|campaign|campaign
458709|NCT01604096|antibiotics|antibiotics
458710|NCT01604096|bacterial resistance|bacterial resistance
458711|NCT01604096|primary care|primary care
458712|NCT01604083|transfusion|transfusion
458713|NCT01604083|packed red blood cells (PRBC)|packed red blood cells (prbc)
458714|NCT01604083|Transfusion Practice|transfusion practice
458715|NCT01604083|Transfusion habits|transfusion habits
458716|NCT01604083|Outcome|outcome
458717|NCT01604083|elective surgery|elective surgery
458718|NCT01604083|ETPOS|etpos
458719|NCT01604083|ESA|esa
458720|NCT01604083|European Society of Anaesthesiology|european society of anaesthesiology
458721|NCT01604070|Hammertoe deformity|hammertoe deformity
458722|NCT01604070|podiatry|podiatry
458723|NCT01604031|B-CLL|b-cll
458724|NCT01604031|vaccine|vaccine
458725|NCT01604031|Lenalidomide|lenalidomide
458726|NCT01604031|CTL|ctl
458727|NCT01604018|Cat Allergy|cat allergy
458728|NCT01604018|Rhinoconjunctivitis|rhinoconjunctivitis
458729|NCT01604005|Mesothelioma|mesothelioma
458730|NCT01604005|radiotherapy|radiotherapy
458731|NCT01604005|prophylactic irradiation of tracts|prophylactic irradiation of tracts
458732|NCT01603992|Cannabis|cannabis
458733|NCT01603992|Craving|craving
458734|NCT01603992|Questionnaire|questionnaire
458735|NCT01603992|Non-Treatment|non-treatment
458736|NCT01603992|Drug Use|drug use
458737|NCT01603979|AV203|av203
458738|NCT01603979|Solid Tumors|solid tumors
458739|NCT01603979|ERBB3|erbb3
458740|NCT01603979|Monoclonal Antibody|monoclonal antibody
458741|NCT01603979|HER3|her3
458742|NCT01603966|platelet|platelet
458743|NCT01603966|aggregation|aggregation
458744|NCT01603966|aspirin|aspirin
458745|NCT01603966|inhibition|inhibition
458746|NCT01603966|reactivity|reactivity
458747|NCT01603940|Hypertension|hypertension
458748|NCT01603940|Diabetes Mellitus|diabetes mellitus
458749|NCT01603940|Vascular stiffness|vascular stiffness
458750|NCT01603940|Endothelial function|endothelial function
458751|NCT01603914|burns, catheter related bacteremia,|burns, catheter related bacteremia,
458752|NCT01603914|infection, central venous catheter,|infection, central venous catheter,
458753|NCT01603914|catheter-related bloodstream, adult critically ill patients|catheter-related bloodstream, adult critically ill patients
458754|NCT01603888|children with heart disease|children with heart disease
458755|NCT01603888|infants|infants
458756|NCT01603888|healthy newborns|healthy newborns
458757|NCT01603875|CPRV|cprv
458758|NCT01603875|SPEEDA|speeda
458759|NCT01603875|intradermal|intradermal
458760|NCT01603875|pre-exposure|pre-exposure
458761|NCT01603875|booster|booster
458762|NCT01603849|Prophylactic Cranial Irradiation|prophylactic cranial irradiation
458763|NCT01603849|Lung Cancer|lung cancer
458764|NCT01603849|Non Small Cell Lung Cancer|non small cell lung cancer
458765|NCT01603849|Carcinoembryonic Antigen|carcinoembryonic antigen
458766|NCT01603836|Lumbar spine|lumbar spine
458767|NCT01603836|Posterolateral fusion|posterolateral fusion
458768|NCT01603836|Allograft|allograft
458769|NCT01603836|Bone marrow concentrate|bone marrow concentrate
458770|NCT01603836|Mesenchymal stem cells|mesenchymal stem cells
458771|NCT01603836|Fusion rate|fusion rate
458772|NCT01603784|exercise|exercise
458773|NCT01603784|cognition|cognition
458774|NCT01603784|memory|memory
458775|NCT01603784|adult|adult
458776|NCT01603771|Adult|adult
458777|NCT01603771|Exercise|exercise
458778|NCT01603771|Cognition|cognition
458779|NCT01603771|MRI|mri
458780|NCT01603758|Cholesterol|cholesterol
458781|NCT01603758|Spectrometry, mass|spectrometry, mass
458782|NCT01603758|Deuterium|deuterium
458783|NCT01603758|Kinetics|kinetics
458784|NCT01603758|Cholesterol absorption|cholesterol absorption
458785|NCT01603758|Coronary Heart Disease|coronary heart disease
458786|NCT01603732|Strep exposure and heart defects|strep exposure and heart defects
458787|NCT01603719|infant formula|infant formula
458788|NCT01603719|prebiotics|prebiotics
458789|NCT01603719|beta-palmitate|beta-palmitate
458790|NCT01603719|stool flora|stool flora
458791|NCT01603719|bifidogenic|bifidogenic
458792|NCT01603563|Stepped Care|stepped care
458793|NCT01603563|Trauma-Focused Cognitive Behavioral Therapy|trauma-focused cognitive behavioral therapy
458794|NCT01603563|Preschool children|preschool children
458795|NCT01603550|energy restriction|energy restriction
458796|NCT01603550|sleep deprivation|sleep deprivation
458797|NCT01603550|cognitive performance|cognitive performance
458798|NCT01603550|brain function|brain function
458799|NCT01603537|Traumatic injuries|traumatic injuries
458800|NCT01603537|Prehospital Trauma Life Support|prehospital trauma life support
458801|NCT01603537|Traffic accidents|traffic accidents
458802|NCT01603524|Ottawa Model for Smoking Cessation|ottawa model for smoking cessation
458803|NCT01603524|Primary Care|primary care
458804|NCT01603511|rewarming|rewarming
458805|NCT01603511|core cooling|core cooling
458806|NCT01603511|afterdrop|afterdrop
458807|NCT01603511|pre-hospital treatment|pre-hospital treatment
458808|NCT01603511|hypothermia|hypothermia
458809|NCT01603498|pain measurement,|pain measurement,
458810|NCT01603498|edema,|edema,
458811|NCT01603498|trismus|trismus
458812|NCT01603407|prednisone|prednisone
458813|NCT01603407|deflazacort|deflazacort
458814|NCT01603407|muscular dystrophy|muscular dystrophy
458815|NCT01603407|neuromuscular disease|neuromuscular disease
458816|NCT01603407|multi-center|multi-center
458817|NCT01603823|vitrectomy|vitrectomy
458818|NCT01603823|cataract|cataract
458819|NCT01603823|macular edema|macular edema
458820|NCT01603810|Basal cell carcinoma|basal cell carcinoma
458821|NCT01603810|Optical Coherence Tomography|optical coherence tomography
458822|NCT01603797|internetdelivered CBT|internetdelivered cbt
458823|NCT01603797|chronic pain|chronic pain
458824|NCT01603797|acceptance and commitment therapy|acceptance and commitment therapy
458825|NCT01603797|mindfulness|mindfulness
458826|NCT01603797|guided self help|guided self help
458827|NCT01603745|PCOS|pcos
458828|NCT01603706|Heart failure|heart failure
458829|NCT01603706|Cardiac Resynchronization Therapy|cardiac resynchronization therapy
458830|NCT01603706|CRT|crt
458831|NCT01603706|Radial strain echocardiography|radial strain echocardiography
458832|NCT01603706|Ischemic cardiomyopathy|ischemic cardiomyopathy
458833|NCT01603693|Guided bone regeneration|guided bone regeneration
458834|NCT01603693|Bio Oss|bio oss
458835|NCT01603693|BondBone|bondbone
458836|NCT01603693|computerized tomography|computerized tomography
458837|NCT01603693|histological examination|histological examination
458838|NCT01603680|Ultrasonography|ultrasonography
458839|NCT01603680|Block nerve|block nerve
458840|NCT01603680|Anaesthesia|anaesthesia
458841|NCT01603680|Carpal tunnel syndrome|carpal tunnel syndrome
458842|NCT01603654|Colon preparation|colon preparation
458843|NCT01603654|Colonoscopy|colonoscopy
458844|NCT01603654|Polyethylene glycol|polyethylene glycol
458845|NCT01603654|Sodium Picosulphate|sodium picosulphate
458846|NCT01603589|coronary artery disease|coronary artery disease
458847|NCT01603589|coronary artery bypass grafting|coronary artery bypass grafting
458848|NCT01603589|cardiopulmonary bypass|cardiopulmonary bypass
458849|NCT01603589|minimal extracorporeal circulation|minimal extracorporeal circulation
458850|NCT01603485|Bioavailability|bioavailability
458851|NCT01603485|Pharmacokinetics|pharmacokinetics
458852|NCT01603485|Lersivirine|lersivirine
458853|NCT01603485|Modified-release|modified-release
458854|NCT01603472|pediatric|pediatric
458855|NCT01603472|parenteral nutrition|parenteral nutrition
458856|NCT01603472|bone disease|bone disease
458857|NCT01603472|long-term PN|long-term pn
458858|NCT01603446|pediatric|pediatric
458859|NCT01603446|MELAS|melas
458860|NCT01603446|mechanism of action of L-arginine|mechanism of action of l-arginine
458861|NCT01603420|prostate|prostate
458862|NCT01603420|cancer|cancer
458863|NCT01603420|radiation|radiation
458864|NCT01603420|proton|proton
458865|NCT01603420|chemotherapy|chemotherapy
458866|NCT01603420|high risk|high risk
458867|NCT01603368|Probiotics|probiotics
458868|NCT01603368|Lactobacillus reuteri|lactobacillus reuteri
458869|NCT01603368|Prematures|prematures
458870|NCT01603368|Enteral feeding|enteral feeding
458871|NCT01603368|Motility|motility
458872|NCT01603368|Necrotizing enterocolitis|necrotizing enterocolitis
458873|NCT01603368|Sepsis|sepsis
458874|NCT01603368|Weight|weight
458875|NCT01603355|JIA|jia
458876|NCT01603329|medication adherence|medication adherence
458877|NCT01603329|diabetes|diabetes
458878|NCT01603329|hypertension|hypertension
458879|NCT01603329|cholesterol|cholesterol
458880|NCT01603329|statins|statins
458881|NCT01603316|Food pantry|food pantry
458882|NCT01603316|Food voucher|food voucher
458883|NCT01603316|Grocery delivery|grocery delivery
458884|NCT01603316|12-099|12-099
458885|NCT01603303|Breast Cancer|breast cancer
458886|NCT01603303|Localized breast cancer|localized breast cancer
458887|NCT01603303|Postmenopausal women|postmenopausal women
458888|NCT01603303|Aromatase inhibitor|aromatase inhibitor
458889|NCT01603303|AI|ai
458890|NCT01603303|Questionnaires|questionnaires
458891|NCT01603303|Surveys|surveys
458892|NCT01603303|Luvena|luvena
458893|NCT01603303|Internet based website|internet based website
458894|NCT01603303|Phone counseling|phone counseling
458895|NCT01603303|Water-based vaginal lubricant|water-based vaginal lubricant
458896|NCT01603303|Hyalo-Gyn|hyalo-gyn
458897|NCT01603290|Acute leukemia,|acute leukemia,
458898|NCT01603290|Chemotherapy,|chemotherapy,
458899|NCT01603290|Cancer-Related Fatigue,|cancer-related fatigue,
458900|NCT01603290|Physical Fitness|physical fitness
458901|NCT01603277|Asthma|asthma
458902|NCT01603277|GM-CSF|gm-csf
458903|NCT01603277|Moderate-to-Severe Asthma|moderate-to-severe asthma
458904|NCT01603264|Bioequivalence|bioequivalence
458905|NCT01603264|Biosimilarity|biosimilarity
458906|NCT01603264|Similarity|similarity
458907|NCT01603264|PK|pk
458908|NCT01603264|Phase I|phase i
458909|NCT01603264|Trastuzumab|trastuzumab
458910|NCT01603264|Healthy Male Volunteers|healthy male volunteers
458911|NCT01603264|Single-dose|single-dose
458912|NCT01603264|HER-2|her-2
458913|NCT01603264|Oncology|oncology
458914|NCT01603251|transmission|transmission
458915|NCT01603251|anopheles|anopheles
458916|NCT01603225|Autism|autism
458917|NCT01603225|tDCS|tdcs
458918|NCT01603212|Melanoma|melanoma
458919|NCT01603212|Metastatic melanoma|metastatic melanoma
458920|NCT01603212|Advanced melanoma|advanced melanoma
458921|NCT01603212|Vemurafenib|vemurafenib
458922|NCT01603212|PLX4032|plx4032
458923|NCT01603212|RO5185426|ro5185426
458924|NCT01603212|IL-2|il-2
458925|NCT01603212|Interleukin-2|interleukin-2
458926|NCT01603212|Aldesleukin|aldesleukin
458927|NCT01603212|Proleukin|proleukin
458928|NCT01603212|Interferon Alfa-2b|interferon alfa-2b
458929|NCT01603212|Intron A|intron a
458930|NCT01603160|Sickle Cell Disease|sickle cell disease
458931|NCT01603160|Emergency Department|emergency department
458932|NCT01603160|Quality Improvement|quality improvement
458933|NCT01603147|methamphetamine|methamphetamine
458934|NCT01603147|monoclonal antibody|monoclonal antibody
458935|NCT01603121|lisofylline|lisofylline
458936|NCT01603108|Liver Transplant Recipient|liver transplant recipient
458937|NCT01603108|Recurrent Fibrosis|recurrent fibrosis
458938|NCT01603095|Achondroplasia|achondroplasia
458939|NCT01603095|dwarfism|dwarfism
458940|NCT01603069|Parkinson's disease|parkinson's disease
458941|NCT01603069|Safety|safety
458942|NCT01603069|Tolerability|tolerability
458943|NCT01603056|House dust mite induced allergic rhinitis.|house dust mite induced allergic rhinitis.
458944|NCT01603043|Geographic Atrophy|geographic atrophy
711025|NCT00586820|Coronary Atherosclerosis|coronary atherosclerosis
458945|NCT01603043|Age-Related Macular Degeneration|age-related macular degeneration
458946|NCT01603043|Intravitreal injection|intravitreal injection
458947|NCT01603030|Moxifloxacin|moxifloxacin
458948|NCT01603030|Prednisolone|prednisolone
458949|NCT01603030|LASIK|lasik
458950|NCT01603017|Magnetic Resonance Therapy|magnetic resonance therapy
458951|NCT01603017|Osteoarthrosis|osteoarthrosis
458952|NCT01603017|Osteoarthritis|osteoarthritis
458953|NCT01603004|MRI|mri
458954|NCT01603004|CT|ct
458955|NCT01603004|12-058|12-058
458956|NCT01602991|Obesity|obesity
458957|NCT01602991|Endoscopy|endoscopy
458958|NCT01602991|Nasopharyngoesophagogastroscopy|nasopharyngoesophagogastroscopy
458959|NCT01602991|Bariatric Surgery|bariatric surgery
458960|NCT01602991|Gastric Bypass Surgery|gastric bypass surgery
458961|NCT01602965|obesity|obesity
458962|NCT01602965|counselling|counselling
458963|NCT01602965|weight loss|weight loss
458964|NCT01602952|Radotinib|radotinib
458965|NCT01602952|CML-CP, AP|cml-cp, ap
458967|NCT01602939|Mastocytosis|mastocytosis
458968|NCT01602939|Mast cell disease|mast cell disease
458969|NCT01602926|hallux valgus|hallux valgus
458970|NCT01602913|Pravastatin|pravastatin
458971|NCT01602913|Adverse Events|adverse events
458972|NCT01602913|Type II Diabetes Mellitus|type ii diabetes mellitus
458973|NCT01602913|Incidence|incidence
458974|NCT01602913|Paroxetine|paroxetine
458975|NCT01602887|BA/BE|ba/be
458976|NCT01602887|PK|pk
458977|NCT01602887|PD-0332991|pd-0332991
458978|NCT01602887|PF-05089326|pf-05089326
458979|NCT01602887|Breast Cancer|breast cancer
458980|NCT01602874|children|children
458981|NCT01602874|pediatry|pediatry
458982|NCT01602874|pneumonia|pneumonia
458983|NCT01602874|intra-abdominal|intra-abdominal
458984|NCT01602874|infection|infection
458985|NCT01602861|Fibrosis|fibrosis
458986|NCT01602861|calcineurin inhibitor|calcineurin inhibitor
458987|NCT01602861|kidney transplant|kidney transplant
458988|NCT01602861|chronic rejection|chronic rejection
458989|NCT01602848|Medicaid|medicaid
458990|NCT01602848|frequent users|frequent users
458991|NCT01602848|heavy users|heavy users
458992|NCT01602848|high risk|high risk
458993|NCT01602848|high cost|high cost
458994|NCT01602848|intervention to improve care and reduce Medicaid expenditures|intervention to improve care and reduce medicaid expenditures
458995|NCT01602835|Alport syndrome|alport syndrome
458996|NCT01602835|proteinuria|proteinuria
458997|NCT01602835|glomerular disease|glomerular disease
458998|NCT01602835|hereditary nephropathy|hereditary nephropathy
458999|NCT01602835|nephropathy|nephropathy
459000|NCT01602822|HIV Prevention|hiv prevention
459001|NCT01602822|NPEP|npep
459002|NCT01602822|PEP|pep
459003|NCT01602809|Perfusion|perfusion
459004|NCT01602809|Microvessels|microvessels
459005|NCT01602809|Ultrasound|ultrasound
459006|NCT01602809|Sickle Cell Disease|sickle cell disease
459007|NCT01602783|Radical Prostatectomy|radical prostatectomy
459008|NCT01602770|Oral contraceptives|oral contraceptives
459009|NCT01602770|Adverse events|adverse events
459010|NCT01602770|Safety profile|safety profile
459011|NCT01602770|Contraceptive Agents|contraceptive agents
459012|NCT01602744|STOPP screening tool|stopp screening tool
459013|NCT01602744|START screening tool|start screening tool
459014|NCT01602744|MIP-medication inappropriate prescription|mip-medication inappropriate prescription
459015|NCT01602744|PIM-Potentially inappropriate medication|pim-potentially inappropriate medication
459016|NCT01602731|medication adherence|medication adherence
459017|NCT01602718|physical activity|physical activity
459018|NCT01602718|physical performance|physical performance
459019|NCT01602718|ESRD|esrd
459020|NCT01602718|home dialysis|home dialysis
459021|NCT01602705|Feedback (NOT MESH)|feedback (not mesh)
459022|NCT01602705|Medication errors|medication errors
459023|NCT01602705|Medication review|medication review
459024|NCT01602705|Inappropriate medication|inappropriate medication
459025|NCT01602705|Randomised controlled trial|randomised controlled trial
459026|NCT01602705|Primary Health Care|primary health care
459027|NCT01602705|Family Practice|family practice
459028|NCT01602692|Pain, postoperative|pain, postoperative
459029|NCT01602692|Postoperative Nausea and Vomiting|postoperative nausea and vomiting
459030|NCT01602692|Patient Readmission|patient readmission
459031|NCT01602692|Time to Discharge|time to discharge
459032|NCT01602640|sedation|sedation
459033|NCT01602640|critical care|critical care
459034|NCT01602640|morphine|morphine
459035|NCT01602640|fentanyl|fentanyl
459036|NCT01602640|analgesic based sedation|analgesic based sedation
459037|NCT01602601|Hunter syndrome, immunogenicity, antibodies|hunter syndrome, immunogenicity, antibodies
459038|NCT01602575|IBS, FMRI, MBSR|ibs, fmri, mbsr
459039|NCT01602562|Herpes simplex infection|herpes simplex infection
459040|NCT01602562|valaciclovir|valaciclovir
459041|NCT01602562|herpes simplex virus|herpes simplex virus
459042|NCT01602562|hematopoietic stem cell transplantation|hematopoietic stem cell transplantation
459043|NCT01602536|twitter|twitter
459044|NCT01602536|quit smoking|quit smoking
459045|NCT01602536|smoking cessation|smoking cessation
459046|NCT01602536|social media|social media
459047|NCT01602536|peer support|peer support
459048|NCT01602523|Emphysema|emphysema
459049|NCT01602523|COPD|copd
459050|NCT01602523|Sleep|sleep
459051|NCT01602497|Borderline personality disorder|borderline personality disorder
459052|NCT01602497|repetitive transcranial magnetic stimulation|repetitive transcranial magnetic stimulation
459053|NCT01602471|Endarterectomy|endarterectomy
459054|NCT01602471|K5-C200|k5-c200
459055|NCT01602471|RGD-K5|rgd-k5
459056|NCT01602471|angiogenesis|angiogenesis
459057|NCT01602471|Carotid CT Angiogram|carotid ct angiogram
459058|NCT01602458|Preventative Scar Management|preventative scar management
459059|NCT01602458|Skin Grafts|skin grafts
459060|NCT01602458|Silicone Therapy|silicone therapy
459061|NCT01602458|Silicone Pressure Garment Therapy|silicone pressure garment therapy
459062|NCT01602445|Venous Thrombosis|venous thrombosis
459063|NCT01602445|Coagulation factors|coagulation factors
459064|NCT01602445|Cancer|cancer
459065|NCT01602445|Blood|blood
459066|NCT01602432|Venous Thrombosis|venous thrombosis
459068|NCT01602432|Coagulation factors|coagulation factors
459069|NCT01602432|Blood|blood
459070|NCT01602406|Advanced HER2-positive Breast cancer or Gastric cancer|advanced her2-positive breast cancer or gastric cancer
459071|NCT01602380|hormone receptor positive breast cancer|hormone receptor positive breast cancer
459072|NCT01602380|endocrine|endocrine
459073|NCT01602380|no hormone therapy|no hormone therapy
459074|NCT01602380|hormone|hormone
459075|NCT01602380|breast|breast
459076|NCT01602380|cancer|cancer
459077|NCT01602380|neoplasm|neoplasm
459078|NCT01602380|metastatic|metastatic
459079|NCT01602380|tumour|tumour
459080|NCT01602354|Endotoxin Activity Assay|endotoxin activity assay
459081|NCT01602354|Gram negative|gram negative
459082|NCT01602354|Septic Shock|septic shock
459083|NCT01602354|EAA|eaa
459084|NCT01602341|atopic dermatitis|atopic dermatitis
459085|NCT01602328|Acute Kidney Injury|acute kidney injury
459086|NCT01602328|Acute renal failure|acute renal failure
459087|NCT01602328|Human mesenchymal stem cells|human mesenchymal stem cells
459088|NCT01602328|Allogeneic stem cells|allogeneic stem cells
459089|NCT01602315|BYL719|byl719
459090|NCT01602315|PI3K inhibitor|pi3k inhibitor
459091|NCT01602315|PIK3CA|pik3ca
459092|NCT01602315|cetuximab|cetuximab
459093|NCT01602315|EGFR|egfr
459094|NCT01602315|HNSCC|hnscc
459095|NCT01602315|RM HNSCC|rm hnscc
459096|NCT01602315|platinum-based chemotherapy|platinum-based chemotherapy
459097|NCT01602315|(RM HNSCC) patients|(rm hnscc) patients
459098|NCT01602315|resistant or ineligible/intolerant to platinum-based chemotherapy|resistant or ineligible/intolerant to platinum-based chemotherapy
459099|NCT01602315|swallowing dysfunction|swallowing dysfunction
459100|NCT01602315|G-tube|g-tube
459101|NCT01602315|alpelisib|alpelisib
459102|NCT01602302|rheumatoid arthritis|rheumatoid arthritis
459103|NCT01602302|ultrasound|ultrasound
459104|NCT01602302|remission|remission
459105|NCT01602302|biological DMARD|biological dmard
459106|NCT01602276|Parkinson's disease|parkinson's disease
459107|NCT01602276|Lewy body dementia|lewy body dementia
459108|NCT01602276|Korsakoff's syndrome|korsakoff's syndrome
459109|NCT01602276|Subcortical Dementia|subcortical dementia
459110|NCT01602276|Huntington's Disease|huntington's disease
459111|NCT01602263|Normal cognitive function|normal cognitive function
459112|NCT01602263|Aphasia|aphasia
459113|NCT01602263|Autism|autism
459114|NCT01602263|Schizophrenia|schizophrenia
459115|NCT01602250|Anesthetics, local|anesthetics, local
459116|NCT01602250|Toxicity|toxicity
459117|NCT01602250|Adverse effects|adverse effects
459118|NCT01602211|stem cell transplant|stem cell transplant
459119|NCT01602211|cancer survivors|cancer survivors
459120|NCT01602211|internet|internet
459121|NCT01602211|social media|social media
459122|NCT01602211|distress|distress
459123|NCT01602211|health care adherence|health care adherence
459124|NCT01602185|NMDA (N-Methyl-D-Aspartate) antagonists|nmda (n-methyl-d-aspartate) antagonists
459125|NCT01602185|ketamine|ketamine
459126|NCT01602185|memantine|memantine
459127|NCT01602185|dextromethorphan|dextromethorphan
459128|NCT01602185|Neuropathic pain|neuropathic pain
459129|NCT01602172|alcohol consumption|alcohol consumption
459130|NCT01602172|inpatients|inpatients
459131|NCT01602172|risk reduction behavior|risk reduction behavior
459132|NCT01602172|counseling|counseling
459133|NCT01602172|nurses|nurses
459134|NCT01602172|brief intervention|brief intervention
459135|NCT01602159|Claudication|claudication
459136|NCT01602159|SFA|sfa
459137|NCT01602159|Open Bypass|open bypass
459138|NCT01602159|Angioplasty|angioplasty
459139|NCT01602159|Stenting|stenting
459140|NCT01602146|ultramarathon central fatigue,|ultramarathon central fatigue,
459141|NCT01602133|venous puncture|venous puncture
459142|NCT01602133|seldinger technique|seldinger technique
459143|NCT01602133|ultrasound guidance|ultrasound guidance
459144|NCT01602107|Stress|stress
459145|NCT01602107|Urinary|urinary
459146|NCT01602107|Incontinence|incontinence
459147|NCT01602107|Pelvic|pelvic
459148|NCT01602107|Physiotherapy|physiotherapy
459149|NCT01602094|measles|measles
459150|NCT01602094|antibody|antibody
459151|NCT01602094|prevalence|prevalence
459152|NCT01602094|predictors|predictors
459153|NCT01602094|Donor of National Blood Centre, The Thai Red Cross Society who age 18-30 years old|donor of national blood centre, the thai red cross society who age 18-30 years old
459154|NCT01602094|Measles antibody levels|measles antibody levels
459155|NCT01602094|Predictors of adequate measles antibody levels and inadequate measles antibody levels|predictors of adequate measles antibody levels and inadequate measles antibody levels
459156|NCT01602081|Anal fistula|anal fistula
459157|NCT01602081|Ligation of the intersphincteric fistula tract|ligation of the intersphincteric fistula tract
459158|NCT01602081|LIFT|lift
459159|NCT01602081|Tissue graft|tissue graft
459160|NCT01602068|Iontophoresis|iontophoresis
459161|NCT01602068|Cataract Surgery|cataract surgery
459162|NCT01602068|Ophthalmology|ophthalmology
459163|NCT01602068|Posterior Chamber Intraocular Lens Implant|posterior chamber intraocular lens implant
459164|NCT01602042|essential tremor|essential tremor
459165|NCT01602042|motion sensors|motion sensors
459166|NCT01602042|tremor|tremor
459167|NCT01602029|Anti inflammatory|anti inflammatory
459168|NCT01602029|Schizophrenia|schizophrenia
459169|NCT01602029|Simvastatin|simvastatin
459170|NCT01602029|Ondansetron|ondansetron
459171|NCT01602016|ASD|asd
459172|NCT01602016|PDD-NOS|pdd-nos
459173|NCT01601977|COPD|copd
459174|NCT01601977|Respiratory failure|respiratory failure
459175|NCT01601977|NIV|niv
459176|NCT01601977|OSA|osa
459177|NCT01601964|VEGF, ectopic pregnancy.|vegf, ectopic pregnancy.
459178|NCT01601951|Osteoarthritis|osteoarthritis
459179|NCT01601951|Stem Cell Injections|stem cell injections
459180|NCT01601951|Bone Marrow|bone marrow
459181|NCT01601951|Autologous|autologous
459182|NCT01601938|Sepsis|sepsis
459183|NCT01601938|Shock, Septic|shock, septic
459184|NCT01601938|Selenium|selenium
459185|NCT01601938|Survival|survival
459186|NCT01601912|Whiplash Injuries|whiplash injuries
459187|NCT01601912|Chronic Pain|chronic pain
459188|NCT01601912|Exercise|exercise
459189|NCT01601912|Cognition|cognition
459190|NCT01601899|trial|trial
459191|NCT01601899|stavudine|stavudine
459192|NCT01601899|tenofovir|tenofovir
459193|NCT01601899|mitochondria|mitochondria
459194|NCT01601899|insulin resistance|insulin resistance
459195|NCT01601899|lipids|lipids
459196|NCT01601899|HOMA|homa
459197|NCT01601886|Intubation, Intratracheal|intubation, intratracheal
459198|NCT01601886|Continuous Positive Airway Pressure|continuous positive airway pressure
459199|NCT01601886|Historical Cohort Studies|historical cohort studies
459200|NCT01601886|Clinical Trial|clinical trial
459201|NCT01601873|Arteriovenous graft|arteriovenous graft
459202|NCT01601873|Propaten|propaten
459203|NCT01601873|Heparin-bonded|heparin-bonded
459204|NCT01601873|hemodialysis vascular access|hemodialysis vascular access
459205|NCT01601873|Surgical|surgical
459206|NCT01601873|Arteriovenous Shunt|arteriovenous shunt
459207|NCT01601860|Labor|labor
459208|NCT01601860|vaginal delivery|vaginal delivery
459209|NCT01601860|pain|pain
459210|NCT01601834|Phase 1|phase 1
459211|NCT01601834|Single Dose|single dose
459212|NCT01601834|Pharmacokinetics|pharmacokinetics
459213|NCT01601834|Safety|safety
459214|NCT01601834|Toleration|toleration
459215|NCT01601795|Cardioprotection|cardioprotection
459216|NCT01601769|Cervical preinvasive disease|cervical preinvasive disease
459217|NCT01601769|Colposcopy|colposcopy
459218|NCT01601769|Exocolposcopy|exocolposcopy
459219|NCT01601769|Leep|leep
459220|NCT01601756|revision knee arthroplasty|revision knee arthroplasty
459221|NCT01601756|navigation|navigation
459222|NCT01601756|joint line|joint line
459223|NCT01601743|Cocaine|cocaine
459224|NCT01601743|Exercise|exercise
459225|NCT01601730|Cocaine|cocaine
459226|NCT01601730|Modafinil|modafinil
459227|NCT01601730|Escitalopram|escitalopram
459228|NCT01601717|RTI-336|rti-336
459229|NCT01601717|Methamphetamine|methamphetamine
459230|NCT01601704|Body Weight|body weight
459231|NCT01601704|Bupropion|bupropion
459232|NCT01601704|Cardiovascular Diseases|cardiovascular diseases
459233|NCT01601704|Diabetes Mellitus|diabetes mellitus
459234|NCT01601704|Diabetes Mellitus, Type 2|diabetes mellitus, type 2
459235|NCT01601704|Endocrine System Diseases|endocrine system diseases
459236|NCT01601704|Glucose Metabolism Disorders|glucose metabolism disorders
459237|NCT01601704|Heart Diseases|heart diseases
459238|NCT01601704|Metabolic Diseases|metabolic diseases
459239|NCT01601704|Narcotic Antagonists|narcotic antagonists
459240|NCT01601704|Naltrexone|naltrexone
459241|NCT01601704|Nutrition Disorders|nutrition disorders
459242|NCT01601704|Obesity|obesity
459243|NCT01601704|Overnutrition|overnutrition
459244|NCT01601704|Overweight|overweight
459245|NCT01601691|prostate cancer|prostate cancer
459246|NCT01601691|brachytherapy|brachytherapy
459247|NCT01601691|spacer|spacer
459248|NCT01601691|side effect|side effect
459249|NCT01601678|Achalasia|achalasia
459250|NCT01601678|Heller Myotomy|heller myotomy
459251|NCT01601678|Dysphagia|dysphagia
459252|NCT01601678|Peroral Endoscopic Myotomy|peroral endoscopic myotomy
459253|NCT01601678|LHM|lhm
459254|NCT01601678|POEM|poem
459255|NCT01601665|Intraocular lens|intraocular lens
459256|NCT01601665|Cataracts|cataracts
459257|NCT01601665|Astigmatism|astigmatism
459258|NCT01601665|Toric|toric
459259|NCT01601652|cholestasis|cholestasis
459260|NCT01601652|PNAC|pnac
459261|NCT01601652|Parenteral Nutrition Associated Cholestasis|parenteral nutrition associated cholestasis
459262|NCT01601652|PNALD|pnald
459263|NCT01601652|Parenteral Nutrition Associated Liver Disease|parenteral nutrition associated liver disease
459264|NCT01601639|Gastric Antral Vascular Ectasia|gastric antral vascular ectasia
459265|NCT01601639|Argon plasma Coagulation|argon plasma coagulation
459266|NCT01601639|Endoscopic Band Ligation|endoscopic band ligation
459267|NCT01601639|GAVE|gave
459268|NCT01601587|Introductory Seminar|introductory seminar
459269|NCT01601587|Waiting list|waiting list
459270|NCT01601587|Community Mental Health Centre|community mental health centre
459271|NCT01601574|Type 2 diabetes|type 2 diabetes
459272|NCT01601574|HbA1c|hba1c
459273|NCT01601574|Overweight|overweight
459275|NCT01601561|Insulin|insulin
459276|NCT01601561|Protein metabolism|protein metabolism
459277|NCT01601561|Stress response|stress response
459278|NCT01601483|AMD|amd
459279|NCT01601483|Dry AMD|dry amd
459280|NCT01601483|Nonexudative AMD|nonexudative amd
459281|NCT01601483|MC-1101|mc-1101
459282|NCT01601470|LCZ696, sildenafil, pharmacokinetics, mild to moderate hypertension|lcz696, sildenafil, pharmacokinetics, mild to moderate hypertension
459283|NCT01601444|To assess pleural effusion by measuring internal thoracic impedance|to assess pleural effusion by measuring internal thoracic impedance
459284|NCT01601431|Screening colonoscopy|screening colonoscopy
459285|NCT01601418|YF476|yf476
459286|NCT01601418|gastrin receptor antagonist|gastrin receptor antagonist
459287|NCT01601418|pentagastrin|pentagastrin
459288|NCT01601418|gastric acid|gastric acid
459289|NCT01601418|healthy subjects|healthy subjects
459290|NCT01601405|YF476|yf476
459291|NCT01601405|gastrin receptor antagonist|gastrin receptor antagonist
459292|NCT01601405|gastrin|gastrin
459293|NCT01601405|gastric aspiration|gastric aspiration
459294|NCT01601405|healthy subjects|healthy subjects
459295|NCT01601392|Ischemic stroke|ischemic stroke
459296|NCT01601392|direct current stimulation|direct current stimulation
459297|NCT01601392|motor threshold|motor threshold
459298|NCT01601392|National institutes of Health Stroke Scale|national institutes of health stroke scale
459299|NCT01601392|Barthel index scale|barthel index scale
459300|NCT01601392|Measurement of motor power improvement|measurement of motor power improvement
459301|NCT01601379|Observational|observational
459302|NCT01601379|GERD|gerd
459303|NCT01601379|Gastroesophageal Reflux Disease|gastroesophageal reflux disease
459304|NCT01601379|Gastro-oesophageal Reflux|gastro-oesophageal reflux
459305|NCT01601379|Heartburn|heartburn
459306|NCT01601366|Adenomyosis|adenomyosis
459307|NCT01601366|Intrauterine levonorgestrel|intrauterine levonorgestrel
459308|NCT01601366|Dysmenorrhea|dysmenorrhea
459309|NCT01601366|Oral contraceptives|oral contraceptives
459310|NCT01601366|Uterus|uterus
459311|NCT01601353|Erectile Dysfunction|erectile dysfunction
459312|NCT01601327|hypogonadism|hypogonadism
459313|NCT01601327|treatment|treatment
459314|NCT01601327|testis volume|testis volume
459315|NCT01601301|Limb|limb
459316|NCT01601301|Lengthening|lengthening
459317|NCT01601301|PRECICE|precice
459318|NCT01601301|Ellipse|ellipse
459319|NCT01601301|Technologies|technologies
459320|NCT01601301|Distraction|distraction
459321|NCT01601301|Osteogenesis|osteogenesis
459322|NCT01601301|Femur|femur
459323|NCT01601301|Tibia|tibia
459324|NCT01601301|Intramedullary|intramedullary
459325|NCT01601301|Nail|nail
459326|NCT01601301|Device|device
459327|NCT01601301|Medical|medical
459328|NCT01601301|Orthopedic|orthopedic
459329|NCT01601301|Implant|implant
459330|NCT01601288|obstructive lung disease|obstructive lung disease
459331|NCT01601288|restrictive lung disease|restrictive lung disease
459332|NCT01601288|cough|cough
459333|NCT01601288|dyspnea|dyspnea
459334|NCT01601275|tuberculosis|tuberculosis
459335|NCT01601262|ED|ed
459336|NCT01601262|LI-ESWT|li-eswt
459337|NCT01601249|IVF, embryo selection, polarized light|ivf, embryo selection, polarized light
459338|NCT01601236|H.P. Acthar Gel|h.p. acthar gel
459339|NCT01601236|Acthar|acthar
459340|NCT01601236|diabetic nephropathy|diabetic nephropathy
459341|NCT01601236|proteinuria|proteinuria
459342|NCT01601236|nephrotic syndrome|nephrotic syndrome
459343|NCT01601223|Ventilatory Management|ventilatory management
459344|NCT01601223|Mechanical Ventilation|mechanical ventilation
459345|NCT01601223|Post Operative pulmonary complications|post operative pulmonary complications
459346|NCT01601223|Intra-operative complications|intra-operative complications
459347|NCT01601223|General Anesthesia|general anesthesia
459348|NCT01601223|Surgery|surgery
459349|NCT01601223|LAS VEGAS|las vegas
459350|NCT01601223|ESA (European Society of Anaesthesiology)|esa (european society of anaesthesiology)
586189|NCT01072695|HCV|hcv
459351|NCT01601223|European Society of Anaesthesiology|european society of anaesthesiology
459352|NCT01601197|immunization|immunization
459353|NCT01601197|pain management|pain management
459354|NCT01601197|infants|infants
459355|NCT01601197|tactile stimulation|tactile stimulation
459356|NCT01601184|medulloblastoma|medulloblastoma
459357|NCT01601184|sonic hedgehog pathway|sonic hedgehog pathway
459358|NCT01601184|vismodegib|vismodegib
459359|NCT01601171|GnRH deficiency|gnrh deficiency
459360|NCT01601171|hypogonadism|hypogonadism
459361|NCT01601171|anosmia|anosmia
459362|NCT01601171|infertility|infertility
459363|NCT01601171|cleft lip|cleft lip
459364|NCT01601171|cleft palate|cleft palate
459365|NCT01601171|cryptorchidism|cryptorchidism
459366|NCT01601171|microphallus|microphallus
459367|NCT01601158|Global developmental delay|global developmental delay
459368|NCT01601158|Umbilical cord blood|umbilical cord blood
459369|NCT01601158|Rehabilitation|rehabilitation
459370|NCT01601145|Lactobacillus Brevis CD2|lactobacillus brevis cd2
459371|NCT01601145|schoolchildren|schoolchildren
459372|NCT01601145|dental caries|dental caries
459373|NCT01601145|Gingivatis|gingivatis
459374|NCT01601132|pharmacokinetics|pharmacokinetics
459375|NCT01601132|colchicine|colchicine
459376|NCT01601132|theophylline|theophylline
459377|NCT01601119|Multiple Sclerosis|multiple sclerosis
459378|NCT01601119|Patient reported outcome|patient reported outcome
459379|NCT01601119|Patient reported experience|patient reported experience
459380|NCT01601106|Atherosclerosis, inflammation|atherosclerosis, inflammation
459381|NCT01601093|Respiratory and urinary tract infections|respiratory and urinary tract infections
459382|NCT01601093|Ceftazidime and Sulbactam Sodium for Injection (2:1)|ceftazidime and sulbactam sodium for injection (2:1)
459383|NCT01601093|Phase Ⅱ|phase ⅱ
459384|NCT01601080|Adherence|adherence
459385|NCT01601080|Multiple Sclerosis|multiple sclerosis
459386|NCT01601067|posttraumatic stress disorder|posttraumatic stress disorder
459387|NCT01601067|psychotherapy|psychotherapy
459388|NCT01601067|alcoholism|alcoholism
459389|NCT01601054|spine|spine
459390|NCT01601054|deformity|deformity
459391|NCT01601054|instrumentation|instrumentation
459392|NCT01601054|ALIF|alif
459393|NCT01601041|Urinary Tract Infection|urinary tract infection
459394|NCT01601041|Bacteriuria|bacteriuria
459395|NCT01601041|Pyuria|pyuria
459396|NCT01601041|Prostatitis|prostatitis
459397|NCT01601041|Intermittent Catheterization|intermittent catheterization
459398|NCT01601041|Spinal Cord Injuries|spinal cord injuries
459399|NCT01601041|Residual Urine|residual urine
459400|NCT01601028|Autoimmune Diseases|autoimmune diseases
459401|NCT01601028|Sjogren's Syndrome|sjogren's syndrome
459402|NCT01601028|Hydroxychloroquine|hydroxychloroquine
459403|NCT01601015|Tension-type headache, Effectiveness, Manual therapy|tension-type headache, effectiveness, manual therapy
459404|NCT01601002|Mirtazapine|mirtazapine
459405|NCT01600989|shock septic|shock septic
459406|NCT01600989|monocytes|monocytes
459407|NCT01600989|lymphocytes|lymphocytes
459408|NCT01600989|mitochondria|mitochondria
459409|NCT01600989|interleukins|interleukins
459410|NCT01600989|Tumor Necrosis Factor-alpha|tumor necrosis factor-alpha
459411|NCT01600989|Hypoxia-Inducible Factor 1, alpha Subunit|hypoxia-inducible factor 1, alpha subunit
459412|NCT01600976|Hepatic impairment|hepatic impairment
459413|NCT01600976|Hepatitis C|hepatitis c
459414|NCT01600976|Telaprevir|telaprevir
459415|NCT01600976|VX-950|vx-950
459416|NCT01600976|Pharmacokinetics|pharmacokinetics
459417|NCT01600976|Safety|safety
459418|NCT01600976|Unbound plasma concentrations|unbound plasma concentrations
459419|NCT01600976|Child-Pugh score|child-pugh score
459420|NCT01600963|Multi-drug resistant tuberculosis|multi-drug resistant tuberculosis
459421|NCT01600963|Pre-extensively drug resistant tuberculosis|pre-extensively drug resistant tuberculosis
459422|NCT01600963|TMC207|tmc207
459423|NCT01600963|Background regimen|background regimen
459424|NCT01600937|diabetes mellitus|diabetes mellitus
459425|NCT01600937|diabetes education|diabetes education
459426|NCT01600937|behavioral therapy|behavioral therapy
459427|NCT01600937|behavior modification|behavior modification
459428|NCT01600937|physical activity|physical activity
459429|NCT01600937|supervised exercise|supervised exercise
459430|NCT01600937|physical fitness|physical fitness
459431|NCT01600937|HbA1c|hba1c
459432|NCT01600937|modifiable cardiovascular risk factors|modifiable cardiovascular risk factors
459433|NCT01600937|quality of life|quality of life
459434|NCT01600924|diabetes mellitus|diabetes mellitus
459435|NCT01600924|muscle strength|muscle strength
459436|NCT01600924|bone strength|bone strength
459437|NCT01600924|cardiovascular risk factors|cardiovascular risk factors
459438|NCT01600924|diabetic complications|diabetic complications
459439|NCT01600911|metabolomics|metabolomics
459440|NCT01600911|nutri-metabolomics|nutri-metabolomics
459441|NCT01600911|plant food|plant food
459442|NCT01600911|blood pressure|blood pressure
459443|NCT01600898|Asymptomatic carriers of a BMPR2 mutation|asymptomatic carriers of a bmpr2 mutation
459444|NCT01600898|follow up study|follow up study
459445|NCT01600885|Guanfacine|guanfacine
459446|NCT01600885|Ketamine|ketamine
459447|NCT01600885|Functional Magnetic Resonance Imaging|functional magnetic resonance imaging
459448|NCT01600885|Prefrontal Cortex Activity|prefrontal cortex activity
459449|NCT01600885|Receptors, N-Methyl-D-Aspartate|receptors, n-methyl-d-aspartate
459450|NCT01600885|Receptors, Adrenergic, alpha-2|receptors, adrenergic, alpha-2
459451|NCT01600885|Memory, Short-Term|memory, short-term
459452|NCT01600885|Schizophrenia|schizophrenia
459453|NCT01600872|EDCs|edcs
459454|NCT01600872|PCOS|pcos
459455|NCT01600872|TAS|tas
459456|NCT01600872|TOS|tos
459457|NCT01600872|ROS|ros
459458|NCT01600872|Oxidative Stress, Endocrine-Disrupting Chemicals, Polycystic Ovary syndrome|oxidative stress, endocrine-disrupting chemicals, polycystic ovary syndrome
459459|NCT01600846|Pharmacogenetic testing|pharmacogenetic testing
459460|NCT01600846|pharmacokinetics|pharmacokinetics
459461|NCT01600846|Pharmacogenomics|pharmacogenomics
459462|NCT01600846|genetics|genetics
459463|NCT01600846|pharmacy|pharmacy
459464|NCT01600846|drug response|drug response
459465|NCT01600833|PCOS|pcos
459466|NCT01600833|Ferritin|ferritin
459467|NCT01600833|Homocysteine|homocysteine
459468|NCT01600833|Insulin Resistance|insulin resistance
459469|NCT01600833|Metabolic Syndrome|metabolic syndrome
459470|NCT01600820|Plant sterol|plant sterol
459471|NCT01600820|Hypercholesterolemia|hypercholesterolemia
459472|NCT01600820|diet|diet
459473|NCT01600820|dairy|dairy
459474|NCT01600820|LDL-C|ldl-c
459475|NCT01600820|Mildly hypercholesterolemic subjects|mildly hypercholesterolemic subjects
459476|NCT01600807|Metastatic|metastatic
459477|NCT01600807|Pancreas|pancreas
459478|NCT01600807|Cancer|cancer
459479|NCT01600807|Adenocarcinoma|adenocarcinoma
459480|NCT01600794|In Vitro Fertilization (IVF)|in vitro fertilization (ivf)
459481|NCT01600794|androgens|androgens
459482|NCT01600794|ovary function|ovary function
459483|NCT01600794|This study include the patients who are evaluated by the doctors and are sure to process the In Vitro Fertilization cycle.|this study include the patients who are evaluated by the doctors and are sure to process the in vitro fertilization cycle.
459484|NCT01600781|Improve the nutritional status|improve the nutritional status
459485|NCT01600781|QOL|qol
459486|NCT01600781|children|children
459487|NCT01600781|enhance immune response|enhance immune response
459488|NCT01600781|induction chemotherapy|induction chemotherapy
459489|NCT01600781|fewer side effects|fewer side effects
459490|NCT01600768|focus of study|focus of study
459491|NCT01600755|Cell Therapy|cell therapy
459492|NCT01600755|Autologous Cell Transplantation|autologous cell transplantation
459493|NCT01600755|Muscle-derived Cell|muscle-derived cell
459494|NCT01600755|Anal Incontinence|anal incontinence
459495|NCT01600755|Rectal Diseases|rectal diseases
459496|NCT01600755|Intestinal Diseases|intestinal diseases
459497|NCT01600755|Gastrointestinal Diseases|gastrointestinal diseases
459498|NCT01600755|Urinary Incontinence|urinary incontinence
459499|NCT01600703|Intestinal lipoprotein|intestinal lipoprotein
459500|NCT01600703|Apolipoprotein B48 and apolipoprotein B100|apolipoprotein b48 and apolipoprotein b100
459501|NCT01600703|Pancreatic clamp|pancreatic clamp
459502|NCT01600703|DPPIV inhibitor|dppiv inhibitor
459503|NCT01600690|Stem cells|stem cells
459504|NCT01600690|Regeneration|regeneration
459505|NCT01600690|Inflammation|inflammation
459506|NCT01600677|Experimental; Computerized medication delivery unit|experimental; computerized medication delivery unit
459507|NCT01600664|Type 1 diabetes|type 1 diabetes
459508|NCT01600664|"My Diabetic friend"|"my diabetic friend"
459509|NCT01600664|interactive computer game|interactive computer game
459510|NCT01600651|Receptor for advanced glycation end products (RAGE)|receptor for advanced glycation end products (rage)
459511|NCT01600651|Soluble RAGE (sRAGE)|soluble rage (srage)
459512|NCT01600651|Recruitment Maneuver|recruitment maneuver
459513|NCT01600651|Acute respiratory distress syndrome (ARDS)|acute respiratory distress syndrome (ards)
459514|NCT01600651|Alveolar epithelium|alveolar epithelium
459515|NCT01600651|Electrical Impedance Tomography|electrical impedance tomography
459516|NCT01600651|Mechanical ventilation|mechanical ventilation
459517|NCT01600651|Intensive Care Unit (ICU)|intensive care unit (icu)
459518|NCT01600638|Lipolysis|lipolysis
459519|NCT01600638|Cryolipolysis|cryolipolysis
459520|NCT01600638|Fat Reduction|fat reduction
459521|NCT01600625|meibomian gland dysfunction|meibomian gland dysfunction
459522|NCT01600625|inflammatory tear cytokine|inflammatory tear cytokine
459523|NCT01600625|minocycline|minocycline
459524|NCT01600612|postpartum hemorrhage, oxytocin, carbetocin, misopristol|postpartum hemorrhage, oxytocin, carbetocin, misopristol
459525|NCT01600586|Neonatal Intensive Care Unit (NICU)|neonatal intensive care unit (nicu)
459526|NCT01600586|Music therapy|music therapy
459527|NCT01600586|Premature infant|premature infant
459528|NCT01600586|Oral feeds|oral feeds
459529|NCT01600586|Non-Nutritive Sucking|non-nutritive sucking
459530|NCT01600586|Suck rate|suck rate
459531|NCT01600586|Suck efficiency|suck efficiency
459532|NCT01600586|Contingent music|contingent music
459533|NCT01600586|Mother's voice|mother's voice
459534|NCT01600573|ovarian cancer|ovarian cancer
459535|NCT01600534|gestational diabetes|gestational diabetes
459536|NCT01600508|stoma care|stoma care
459537|NCT01600508|videoconference|videoconference
459538|NCT01600508|costs|costs
459539|NCT01600508|quality of life|quality of life
459540|NCT01600495|pain|pain
459541|NCT01600495|electric stimulation|electric stimulation
459542|NCT01600495|nervous|nervous
459543|NCT01600495|transcutaneous|transcutaneous
459544|NCT01600495|humanized childbirth|humanized childbirth
459545|NCT01600482|Hemostasis.|hemostasis.
459546|NCT01600482|Percutaneous coronary interventions.|percutaneous coronary interventions.
459547|NCT01600482|Closure Device|closure device
459548|NCT01600469|Alzheimer's disease|alzheimer's disease
459549|NCT01600469|mild cognitive impairment|mild cognitive impairment
459550|NCT01600469|NMDA|nmda
459551|NCT01600456|PTSD|ptsd
459552|NCT01600456|Antidepressants|antidepressants
459553|NCT01600456|Cognitive behavior therapy|cognitive behavior therapy
459554|NCT01600430|Vitamin D|vitamin d
459555|NCT01600430|Newborn|newborn
459556|NCT01600430|Preterm|preterm
459557|NCT01600430|Supplementation|supplementation
459558|NCT01600430|Respiratory|respiratory
459559|NCT01600417|low back pain|low back pain
459560|NCT01600417|spine|spine
459561|NCT01600417|lumbar spine|lumbar spine
459562|NCT01600417|lumbar instability|lumbar instability
459563|NCT01600417|radiology|radiology
459564|NCT01600417|functional radiology|functional radiology
459565|NCT01600404|Mild Cognitive Impairment|mild cognitive impairment
459566|NCT01600404|Muscarinic Antagonists|muscarinic antagonists
459567|NCT01600404|Spinal Cord Injuries|spinal cord injuries
459568|NCT01600404|Urinary Bladder, Neurogenic|urinary bladder, neurogenic
459569|NCT01600404|Urinary Bladder, Overactive|urinary bladder, overactive
459570|NCT01600404|Overactive Detrusor|overactive detrusor
459571|NCT01600391|Stroke|stroke
459572|NCT01600391|Visual cues|visual cues
459573|NCT01600391|Gait rehabilitation|gait rehabilitation
459574|NCT01600391|Walking adaptability|walking adaptability
459575|NCT01600391|Turning|turning
459576|NCT01600391|Overground walking|overground walking
459577|NCT01600391|Treadmill training|treadmill training
459578|NCT01600378|diffuse parenchymal lung disease|diffuse parenchymal lung disease
459579|NCT01600378|interstitial lung disease|interstitial lung disease
459580|NCT01600378|idiopathic pulmonary fibrosis|idiopathic pulmonary fibrosis
459581|NCT01600365|Conjunctivitis|conjunctivitis
459582|NCT01600365|adenovirus.|adenovirus.
459583|NCT01600352|interstitial lung disease|interstitial lung disease
459584|NCT01600352|idiopathic pulmonary fibrosis|idiopathic pulmonary fibrosis
459585|NCT01600313|rice bran oil|rice bran oil
459586|NCT01600313|diet|diet
459587|NCT01600313|cardiovascular disease|cardiovascular disease
459588|NCT01600313|low density lipoprotein|low density lipoprotein
459589|NCT01600313|total cholesterol|total cholesterol
459590|NCT01600300|Age-related macular degeneration|age-related macular degeneration
459591|NCT01600300|electrical stimulation|electrical stimulation
459592|NCT01600300|randomized|randomized
459593|NCT01600300|double blind|double blind
459594|NCT01600287|bispectral index|bispectral index
459595|NCT01600287|propofol|propofol
459596|NCT01600287|paediatric cardiac surgery|paediatric cardiac surgery
459597|NCT01600287|closed loop anaesthesia delivery system|closed loop anaesthesia delivery system
459598|NCT01600261|without eye disease|without eye disease
459599|NCT01600248|Chronic Pain|chronic pain
459600|NCT01600248|Military|military
459601|NCT01600248|Veteran|veteran
459602|NCT01600248|Online|online
459603|NCT01600248|Acceptance|acceptance
459604|NCT01600235|Stroke, ischemic|stroke, ischemic
459605|NCT01600235|Progression|progression
459606|NCT01600235|Induced-hypertension|induced-hypertension
459607|NCT01600235|Phenylephrine|phenylephrine
459608|NCT01600209|Cancer|cancer
459609|NCT01600209|Colorectal Cancer|colorectal cancer
459610|NCT01600209|Neoplasm|neoplasm
459611|NCT01600209|Colorectal Neoplasm|colorectal neoplasm
459612|NCT01600209|Intestinal Neoplasms|intestinal neoplasms
459613|NCT01600209|Gastrointestinal Neoplasms|gastrointestinal neoplasms
459614|NCT01600209|Digestive System Neoplasms|digestive system neoplasms
459615|NCT01600209|Neoplasms by Site|neoplasms by site
459616|NCT01600209|Neoplasms|neoplasms
459617|NCT01600209|Digestive System Diseases|digestive system diseases
459618|NCT01600209|Gastrointestinal Diseases|gastrointestinal diseases
459619|NCT01600209|Colonic Diseases|colonic diseases
459620|NCT01600209|Intestinal Diseases|intestinal diseases
459621|NCT01600209|Rectal Diseases|rectal diseases
459622|NCT01600196|Hepatectomy|hepatectomy
459623|NCT01600196|Thrombectomy|thrombectomy
459624|NCT01600196|Hepatocellular carcinoma|hepatocellular carcinoma
459625|NCT01600196|Portal vein tumor thrombus|portal vein tumor thrombus
459627|NCT01600183|metatarsus|metatarsus
459628|NCT01600183|Metatarsus Adductus, also known as Metatarsus Varus|metatarsus adductus, also known as metatarsus varus
459629|NCT01600170|HIV|hiv
459630|NCT01600170|monocytes|monocytes
459631|NCT01600170|CD16+|cd16+
459632|NCT01600170|statins|statins
459633|NCT01600170|mcp1|mcp1
459634|NCT01600170|inflammation|inflammation
459635|NCT01600144|data mammography|data mammography
459636|NCT01600118|tooth mobility|tooth mobility
459637|NCT01600118|periodontal status|periodontal status
459638|NCT01600118|irregularity index|irregularity index
459639|NCT01600118|pulpal blood flow|pulpal blood flow
459640|NCT01600105|liver fibrosis|liver fibrosis
459641|NCT01600105|liver cirrhosis|liver cirrhosis
459642|NCT01600105|chronic hepatitis|chronic hepatitis
459643|NCT01600105|magnetic resonance imaging|magnetic resonance imaging
459644|NCT01600079|Varicella-zoster vaccine|varicella-zoster vaccine
459645|NCT01600079|herpes zoster|herpes zoster
459646|NCT01600079|shingles|shingles
459647|NCT01600079|Varicella-zoster virus|varicella-zoster virus
459648|NCT01600079|postherpetic neuralgia|postherpetic neuralgia
459649|NCT01600079|Herpesviridae Infections|herpesviridae infections
459650|NCT01600079|DNA Virus Infections|dna virus infections
459651|NCT01600079|Virus Diseases|virus diseases
459652|NCT01600053|Chronic|chronic
459653|NCT01600053|Lymphocytic|lymphocytic
459654|NCT01600053|Leukemia|leukemia
459655|NCT01600040|metastatic|metastatic
459656|NCT01600027|Fascia iliaca block|fascia iliaca block
459657|NCT01600027|dexmetomidine|dexmetomidine
459658|NCT01600027|fracture femur|fracture femur
459659|NCT01600027|α2 agonist|α2 agonist
459660|NCT01600001|Chronic Idiopathic Constipation (CIC)|chronic idiopathic constipation (cic)
459661|NCT01600001|Constipation|constipation
459662|NCT01600001|Functional gastrointestinal disorders|functional gastrointestinal disorders
459663|NCT01599975|HAND|hand
459664|NCT01599975|HIV Associated Neurocognitive Disorder|hiv associated neurocognitive disorder
459665|NCT01599975|Methylphenidate|methylphenidate
459666|NCT01599975|HIV Dementia|hiv dementia
459667|NCT01599949|Mantle cell lymphoma|mantle cell lymphoma
459668|NCT01599949|Ibrutinib|ibrutinib
459669|NCT01599949|Bruton's tyrosine kinase inhibitor|bruton's tyrosine kinase inhibitor
459670|NCT01599949|Rituximab|rituximab
459671|NCT01599949|Bortezomib|bortezomib
459672|NCT01599936|scorpion sting|scorpion sting
459673|NCT01599936|envenomation|envenomation
459674|NCT01599936|Anascorp|anascorp
459675|NCT01599923|scorpion|scorpion
459676|NCT01599923|envenomation|envenomation
459677|NCT01599923|Alacramyn|alacramyn
459679|NCT01599910|Physician Productivity|physician productivity
459680|NCT01599910|Electronic Documentation|electronic documentation
459681|NCT01599897|Tuberculosis|tuberculosis
459683|NCT01599897|Pulmonary|pulmonary
459684|NCT01599897|Vaccine|vaccine
459685|NCT01599884|Chronic obstructive pulmonary disease|chronic obstructive pulmonary disease
459686|NCT01599884|Chronic bronchitis|chronic bronchitis
459687|NCT01599884|N-acetylcysteine|n-acetylcysteine
459688|NCT01599871|COPD|copd
459689|NCT01599858|YF476|yf476
459690|NCT01599858|gastrin receptor antagonist|gastrin receptor antagonist
459691|NCT01599858|gastric pH|gastric ph
459692|NCT01599858|healthy subjects|healthy subjects
459693|NCT01599858|omeprazole|omeprazole
459694|NCT01599845|Lung|lung
459695|NCT01599845|Alveoli|alveoli
459696|NCT01599845|Nanoparticles|nanoparticles
459697|NCT01599845|Particulate matter|particulate matter
459698|NCT01599845|Exhaled breath condensate|exhaled breath condensate
459699|NCT01599845|Induced sputum|induced sputum
459700|NCT01599845|Forced expiratory volume|forced expiratory volume
459701|NCT01599845|Force vital capacity|force vital capacity
459702|NCT01599806|Ceftazidime, Avibactam, Doripenem, Ciprofloxacin, sulfamethoxazole/trimethoprim, Anti-Infective Agents, Complicated Urinary Tract Infection,Acute Pyelonephritis|ceftazidime, avibactam, doripenem, ciprofloxacin, sulfamethoxazole/trimethoprim, anti-infective agents, complicated urinary tract infection,acute pyelonephritis
459703|NCT01599793|castrate resistant prostate cancer|castrate resistant prostate cancer
459704|NCT01599793|CRPC|crpc
459705|NCT01599793|cabozantinib|cabozantinib
459706|NCT01599793|XL184|xl184
459707|NCT01599780|preterm|preterm
459708|NCT01599780|premature|premature
459709|NCT01599780|prematurity|prematurity
459710|NCT01599780|children|children
459711|NCT01599780|child|child
459712|NCT01599780|kid|kid
459713|NCT01599780|toddler|toddler
459714|NCT01599780|infant|infant
459715|NCT01599780|baby|baby
459716|NCT01599780|language|language
459717|NCT01599780|development|development
459718|NCT01599780|skills|skills
459719|NCT01599780|listening|listening
459720|NCT01599780|talking|talking
459721|NCT01599780|communication|communication
459722|NCT01599780|speech|speech
459723|NCT01599780|processing|processing
459724|NCT01599767|transcranial stimulation|transcranial stimulation
459725|NCT01599767|direct current|direct current
459726|NCT01599754|renal cell carcinoma|renal cell carcinoma
459727|NCT01599754|axitinib|axitinib
459728|NCT01599754|tyrosine kinase inhibitor|tyrosine kinase inhibitor
459729|NCT01599741|X-rays|x-rays
459730|NCT01599741|Endovascular angiography|endovascular angiography
459731|NCT01599741|Image processing|image processing
459732|NCT01599728|Urocortin 2|urocortin 2
459733|NCT01599728|Urocortin 3|urocortin 3
459734|NCT01599728|Forearm venous occlusion plethysmography|forearm venous occlusion plethysmography
459735|NCT01599728|Heart failure|heart failure
459736|NCT01599728|Endothelium|endothelium
459737|NCT01599728|Substance P|substance p
459738|NCT01599715|Urinary Incontinence|urinary incontinence
459739|NCT01599715|Weak bladder|weak bladder
459740|NCT01599715|Frequent urination|frequent urination
459741|NCT01599715|Overactive bladder|overactive bladder
459742|NCT01599715|Urine leakage|urine leakage
459743|NCT01599715|Stress incontinence|stress incontinence
459744|NCT01599715|Urge Incontinence|urge incontinence
459745|NCT01599715|Pelvic Floor weakness|pelvic floor weakness
459746|NCT01599715|Pelvic Floor Muscle Exercises|pelvic floor muscle exercises
459747|NCT01599715|Kegel exercises|kegel exercises
459748|NCT01599715|Self-Care|self-care
459749|NCT01599702|IBD|ibd
459750|NCT01599702|IDA|ida
459751|NCT01599702|Subjects|subjects
459752|NCT01599702|diagnosis|diagnosis
459753|NCT01599689|Delirium|delirium
459754|NCT01599689|Delirium, Dementia, Amnestic, Cognitive Disorders|delirium, dementia, amnestic, cognitive disorders
459755|NCT01599689|Confusion|confusion
459756|NCT01599689|Neurobehavioral Manifestations|neurobehavioral manifestations
459757|NCT01599689|Neurologic Manifestations|neurologic manifestations
459758|NCT01599689|Nervous System Diseases|nervous system diseases
459759|NCT01599689|Signs and Symptoms|signs and symptoms
459760|NCT01599689|Mental Disorders|mental disorders
459761|NCT01599689|Cardiac Surgery|cardiac surgery
459762|NCT01599689|Mirrors|mirrors
459763|NCT01599676|Citrulline|citrulline
459764|NCT01599676|protein-energy malnutrition|protein-energy malnutrition
459765|NCT01599676|amino acids|amino acids
459766|NCT01599676|muscle strength|muscle strength
459767|NCT01599676|resistance training|resistance training
459768|NCT01599663|Pain management|pain management
459769|NCT01599663|Pain assessment|pain assessment
459770|NCT01599663|Intensive care unit|intensive care unit
459771|NCT01599663|Adult|adult
459772|NCT01599650|Macular Edema, Branch Retinal Vein Occlusion, visual impairment|macular edema, branch retinal vein occlusion, visual impairment
459773|NCT01599637|Chronic idiopathic urticaria|chronic idiopathic urticaria
459774|NCT01599637|CIU|ciu
459775|NCT01599637|Xolair|xolair
459776|NCT01599637|IGE025|ige025
459777|NCT01599637|FcεRI|fcεri
459778|NCT01599637|IgE|ige
459779|NCT01599624|Resilience|resilience
459780|NCT01599624|Perceived stress|perceived stress
459781|NCT01599624|PTSD symptoms|ptsd symptoms
459782|NCT01599624|Depression|depression
459783|NCT01599624|Anxiety|anxiety
459784|NCT01599624|Sleep quality|sleep quality
459785|NCT01599624|United States Navy service members|united states navy service members
459786|NCT01599611|Neonatal hyperbilirubinemia|neonatal hyperbilirubinemia
459787|NCT01599611|Follow-up|follow-up
459788|NCT01599611|Motor development|motor development
459789|NCT01599611|Hearing|hearing
459790|NCT01599611|Executive function|executive function
459791|NCT01599598|perceived stress|perceived stress
459792|NCT01599598|depression|depression
459793|NCT01599598|anxiety|anxiety
459794|NCT01599598|posttraumatic stress disorder|posttraumatic stress disorder
459795|NCT01599598|military|military
459796|NCT01599598|school|school
459797|NCT01599598|training environment|training environment
459798|NCT01599598|heart rate variability|heart rate variability
459799|NCT01599598|progressive muscle relaxation|progressive muscle relaxation
459800|NCT01599598|psychophysiological coherence|psychophysiological coherence
459801|NCT01599598|coherence advantage|coherence advantage
459802|NCT01599598|stress reduction|stress reduction
459803|NCT01599598|stress regulation|stress regulation
459804|NCT01599598|independent duty corpsmen|independent duty corpsmen
459805|NCT01599585|Depression|depression
459806|NCT01599585|Behavioral Activation|behavioral activation
459807|NCT01599585|Tele-medicine|tele-medicine
459808|NCT01599572|zinc supplementation|zinc supplementation
459809|NCT01599572|serum zinc concentration|serum zinc concentration
459810|NCT01599572|lymphocyte proliferation|lymphocyte proliferation
459811|NCT01599559|previously|previously
459812|NCT01599559|untreated|untreated
459813|NCT01599546|Preterm|preterm
459814|NCT01599546|Full term|full term
459815|NCT01599546|Reading|reading
459816|NCT01599546|Dyslexia|dyslexia
459817|NCT01599546|Brain|brain
459818|NCT01599546|Diffusion tensor imaging|diffusion tensor imaging
459819|NCT01599520|cancer|cancer
459820|NCT01599520|stress|stress
459821|NCT01599520|stress management|stress management
459822|NCT01599520|Latinas|latinas
459823|NCT01599520|Hispanics|hispanics
459824|NCT01599507|Anemia|anemia
459825|NCT01599507|Renal|renal
459826|NCT01599481|Common mental illness|common mental illness
459827|NCT01599481|Supported Employment|supported employment
459828|NCT01599481|Anxiety|anxiety
459829|NCT01599481|Depression|depression
459830|NCT01599481|Sickness absence|sickness absence
459831|NCT01599468|post partum hemorrhage|post partum hemorrhage
459832|NCT01599468|transfusion|transfusion
459833|NCT01599468|tranexamic acid|tranexamic acid
459834|NCT01599455|pediatric spinal cord injury|pediatric spinal cord injury
459835|NCT01599455|blood pressure|blood pressure
459836|NCT01599455|heart rate|heart rate
459837|NCT01599455|baseline|baseline
459838|NCT01599429|AML / LMA|aml / lma
459839|NCT01599416|Oral Probiotics|oral probiotics
459840|NCT01599416|HPV DNA Index Test|hpv dna index test
459841|NCT01599416|Vaginal infection|vaginal infection
459842|NCT01599403|Rib Fracture|rib fracture
459843|NCT01599403|Intercostal Nerve Block|intercostal nerve block
459844|NCT01599403|Paravertebral Nerve Block|paravertebral nerve block
459845|NCT01599390|United States|united states
459846|NCT01599390|Burden of Disease|burden of disease
459847|NCT01599390|Influenza|influenza
459848|NCT01599364|HIV infection|hiv infection
459849|NCT01599364|Atazanavir|atazanavir
459850|NCT01599364|Lamivudine|lamivudine
459851|NCT01599364|Ritonavir|ritonavir
459852|NCT01599364|virological suppression|virological suppression
459853|NCT01599364|non-inferiority|non-inferiority
459854|NCT01599364|Combined antiretroviral therapy|combined antiretroviral therapy
459855|NCT01599351|Radiation exposure|radiation exposure
459856|NCT01599351|ERCP|ercp
459857|NCT01599338|Liraglutide|liraglutide
459858|NCT01599338|GLP-1 analogue|glp-1 analogue
459859|NCT01599338|Food preference|food preference
459860|NCT01599338|Gustative perception|gustative perception
459861|NCT01599338|Liking|liking
459862|NCT01599338|wanting|wanting
459863|NCT01599338|T2DM|t2dm
459864|NCT01599338|body mass composition|body mass composition
459865|NCT01599338|leptin|leptin
459866|NCT01599338|ghrelin|ghrelin
459867|NCT01599312|Videolaryngoscopy|videolaryngoscopy
459868|NCT01599312|Forces|forces
459869|NCT01599312|Teeth|teeth
459870|NCT01599299|ultrasound|ultrasound
459871|NCT01599299|left and right jugular vein|left and right jugular vein
459872|NCT01599299|comparison|comparison
459873|NCT01599286|Hyperammonia|hyperammonia
459874|NCT01599286|Propionic Acidemia (PA)|propionic acidemia (pa)
459875|NCT01599286|Methylmalonic Acidemia (MMA)|methylmalonic acidemia (mma)
459876|NCT01599286|Late-Onset CPS1 Deficiency (CPSD)|late-onset cps1 deficiency (cpsd)
459877|NCT01599286|Late-Onset Ornithine Transcarbamylase Deficiency (OTCD)|late-onset ornithine transcarbamylase deficiency (otcd)
459878|NCT01599286|Carbaglu|carbaglu
459879|NCT01599273|thyroid-associated ophthalmopathy|thyroid-associated ophthalmopathy
459880|NCT01599273|triamcinolone|triamcinolone
459881|NCT01599273|retraction|retraction
459882|NCT01599273|swelling|swelling
459883|NCT01599247|Suicide|suicide
459884|NCT01599247|Optimism|optimism
459885|NCT01599247|Hopelessness|hopelessness
459886|NCT01599221|Femoral fractures|femoral fractures
459887|NCT01599221|Nail|nail
459888|NCT01599221|Implant|implant
459889|NCT01599221|Elderly|elderly
459890|NCT01599221|Orthopaedics|orthopaedics
459891|NCT01599195|carotid stenosis|carotid stenosis
459892|NCT01599195|femoral artery ischemia|femoral artery ischemia
459893|NCT01599195|carotid bruit asymptomatic|carotid bruit asymptomatic
459894|NCT01599195|carotid murmur|carotid murmur
459895|NCT01599169|Burnout syndrome|burnout syndrome
459896|NCT01599169|Depression work-related|depression work-related
459897|NCT01599169|Food supplement|food supplement
459898|NCT01599156|Chronic constipation|chronic constipation
459899|NCT01599156|Reflexology|reflexology
459900|NCT01599156|Complementary medicine|complementary medicine
459901|NCT01599143|Mindfulness|mindfulness
459902|NCT01599143|Pain Disorder (Chronic physical or mental health complaints:|pain disorder (chronic physical or mental health complaints:
459903|NCT01599143|Fibromyalgia; Migraines; Back Pain; etc)|fibromyalgia; migraines; back pain; etc)
459904|NCT01599143|Anxiety Disorder/Anxiety State|anxiety disorder/anxiety state
459905|NCT01599130|Hepatitis B|hepatitis b
459906|NCT01599130|sequential peg-interferon-2a to entecavir|sequential peg-interferon-2a to entecavir
459907|NCT01599117|Heart Failure with Preserved Ejection Fraction|heart failure with preserved ejection fraction
459908|NCT01599117|Diastolic Heart Failure|diastolic heart failure
459909|NCT01599117|Exercise Capacity|exercise capacity
459910|NCT01599117|Cardiopulmonary Exercise Test|cardiopulmonary exercise test
459911|NCT01599117|Udenafil (Zydena)|udenafil (zydena)
459912|NCT01599117|Phosphodiesterase Type 5 Inhibitors|phosphodiesterase type 5 inhibitors
459913|NCT01599104|Essential hypertension|essential hypertension
459914|NCT01599104|LCZ696|lcz696
459915|NCT01599091|Fibroblasts|fibroblasts
459916|NCT01599091|Periodontal ligament|periodontal ligament
459917|NCT01599091|Gingiva|gingiva
459918|NCT01599091|Porphyromonas gingivalis|porphyromonas gingivalis
459919|NCT01599091|Chronic periodontitis|chronic periodontitis
459920|NCT01599091|( patients undergoing tooth extraction will be asked permission to use extracted tooth and gingiva for periodontal disease basic research)|( patients undergoing tooth extraction will be asked permission to use extracted tooth and gingiva for periodontal disease basic research)
459921|NCT01599078|Restenosis|restenosis
459922|NCT01599078|Angioplasty|angioplasty
459923|NCT01599078|Stent|stent
459924|NCT01599078|Atherectomy|atherectomy
459925|NCT01599078|Femoral Artery|femoral artery
459926|NCT01599078|Popliteal Artery|popliteal artery
459927|NCT01599078|Paclitaxel|paclitaxel
459928|NCT01599065|ICD|icd
459929|NCT01599065|internal cardioverter defibrillator|internal cardioverter defibrillator
459930|NCT01599065|electrocautery|electrocautery
459931|NCT01599052|Social Cognition|social cognition
459932|NCT01599052|Theory of Mind|theory of mind
459933|NCT01599052|Emotion Recognition|emotion recognition
459934|NCT01599052|Social competence|social competence
459935|NCT01599052|Brain Tumour|brain tumour
459936|NCT01599039|early diagnostics|early diagnostics
459937|NCT01599039|lymphedema|lymphedema
459938|NCT01599039|breast cancer|breast cancer
459939|NCT01599039|breast cancer related lymphedema|breast cancer related lymphedema
459940|NCT01599039|measuring methods|measuring methods
459941|NCT01599039|inverse water volumetry|inverse water volumetry
459942|NCT01599039|prevention|prevention
459943|NCT01599026|cardiology|cardiology
459944|NCT01599026|fetus of diabetic mother|fetus of diabetic mother
459945|NCT01599013|urothelial carcinoma|urothelial carcinoma
459946|NCT01599013|bladder cancer|bladder cancer
459947|NCT01599013|vinflunine|vinflunine
459948|NCT01599013|transitional cell carcinoma|transitional cell carcinoma
459949|NCT01599013|advanced or metastatic|advanced or metastatic
459950|NCT01599013|unfit|unfit
459951|NCT01599013|ineligible to cisplatin|ineligible to cisplatin
459952|NCT01599013|renal impairment|renal impairment
459953|NCT01599013|renal insufficiency|renal insufficiency
459954|NCT01599013|urologic neoplasms|urologic neoplasms
459955|NCT01599013|urogenital neoplasm|urogenital neoplasm
459956|NCT01599013|urinary neoplasms|urinary neoplasms
459957|NCT01599013|cisplatin|cisplatin
459958|NCT01599013|tubulin inhibitors|tubulin inhibitors
459959|NCT01599000|malaria|malaria
459960|NCT01599000|Plasmodium|plasmodium
459961|NCT01599000|Papua New Guinea|papua new guinea
459962|NCT01599000|artemether/lumefantrine|artemether/lumefantrine
459963|NCT01598987|Paediatric liver transplantation|paediatric liver transplantation
459964|NCT01598987|Everolimus|everolimus
459965|NCT01598987|Reduced calcineurin inhibitor|reduced calcineurin inhibitor
459966|NCT01598987|Cyclosporine, tacrolimus|cyclosporine, tacrolimus
459967|NCT01598987|Renal function|renal function
459968|NCT01598987|Composite efficacy endpoint (treated biopsy proven acute rejection death, graft loss)|composite efficacy endpoint (treated biopsy proven acute rejection death, graft loss)
459969|NCT01598987|Liver transplant|liver transplant
459970|NCT01598974|Lower Back Pain|lower back pain
459971|NCT01598974|Acupuncture|acupuncture
459972|NCT01598948|hypercholesterolemia|hypercholesterolemia
459973|NCT01598948|apheresis|apheresis
459974|NCT01598948|coronary heart disease|coronary heart disease
459975|NCT01598948|cerebrovascular disease|cerebrovascular disease
459976|NCT01598948|peripheral arterial disease|peripheral arterial disease
459977|NCT01598922|Depression|depression
459978|NCT01598922|Internet Cognitive Behavioral Therapy|internet cognitive behavioral therapy
459979|NCT01598922|fMRI|fmri
459980|NCT01598922|Neuroimaging|neuroimaging
459981|NCT01598909|blepharoplasty|blepharoplasty
459982|NCT01598909|arnica|arnica
459983|NCT01598909|homeopathy|homeopathy
459984|NCT01598896|Cannabis Dependence|cannabis dependence
459985|NCT01598896|Marijuana Dependence|marijuana dependence
459986|NCT01598896|Cannabis Use Disorders|cannabis use disorders
459987|NCT01598896|Cannabis Withdrawal|cannabis withdrawal
459988|NCT01598896|Dronabinol|dronabinol
459989|NCT01598896|Clonidine|clonidine
459990|NCT01598896|Schizophrenia|schizophrenia
459991|NCT01598870|Spontaneous bacterial peritonitis.|spontaneous bacterial peritonitis.
459992|NCT01598857|granulomatosis with polyangiitis|granulomatosis with polyangiitis
459993|NCT01598857|microscopic polyangiitis|microscopic polyangiitis
459994|NCT01598857|anti-neutrophil cytoplasmic antibodies|anti-neutrophil cytoplasmic antibodies
459995|NCT01598857|ANCA-associated vasculitis|anca-associated vasculitis
459996|NCT01598857|Wegener Granulomatosis|wegener granulomatosis
459997|NCT01598831|sepsis|sepsis
459998|NCT01598818|Vision Nearsighted|vision nearsighted
459999|NCT01598818|Vision Farsighted|vision farsighted
460000|NCT01598805|venous thromboembolism/prevention & control|venous thromboembolism/prevention & control
460001|NCT01598779|genital warts|genital warts
460002|NCT01598779|HPV types|hpv types
460003|NCT01598779|Sexually Transmitted Diseases|sexually transmitted diseases
460004|NCT01598779|Skin Diseases, Viral|skin diseases, viral
460005|NCT01598779|Tumor Virus Infections|tumor virus infections
460006|NCT01598779|Skin Diseases, Infectious|skin diseases, infectious
460007|NCT01598779|Skin Diseases|skin diseases
460008|NCT01598779|Papillomavirus Infections|papillomavirus infections
460009|NCT01598779|DNA Virus Infections|dna virus infections
460010|NCT01598779|Virus Diseases|virus diseases
460011|NCT01598779|Sexually Transmitted Diseases, Viral|sexually transmitted diseases, viral
460012|NCT01598727|parathyroid surgery|parathyroid surgery
460013|NCT01598701|Acetaminophen|acetaminophen
460014|NCT01598701|Intravenous Acetaminophen|intravenous acetaminophen
460015|NCT01598701|Opioid Requirement|opioid requirement
460016|NCT01598701|Pain|pain
460017|NCT01598701|Post-Operative Pain|post-operative pain
460018|NCT01598701|Craniotomy|craniotomy
460019|NCT01598701|Post-Craniotomy Pain|post-craniotomy pain
460020|NCT01598688|Bone marrow transplantation|bone marrow transplantation
460021|NCT01598688|Hematopoietic stem cell transplantation|hematopoietic stem cell transplantation
460022|NCT01598688|Medication management|medication management
460023|NCT01598688|Nursing care|nursing care
460024|NCT01598675|stroke|stroke
460025|NCT01598675|Gait|gait
460026|NCT01598675|walking|walking
460027|NCT01598662|IUD placement|iud placement
460028|NCT01598662|contraception|contraception
460029|NCT01598662|postpartum|postpartum
460030|NCT01598662|intrauterine device|intrauterine device
460031|NCT01598662|expulsion|expulsion
460032|NCT01598649|Dietary protein|dietary protein
460033|NCT01598649|Lupin protein|lupin protein
460034|NCT01598649|Cholesterol metabolism|cholesterol metabolism
460035|NCT01598649|Protein metabolism|protein metabolism
460036|NCT01598649|Hypercholesterolemia|hypercholesterolemia
460037|NCT01598649|Protein-enriched foods|protein-enriched foods
460038|NCT01598584|Mirtazapine|mirtazapine
460039|NCT01598584|gemcitabine|gemcitabine
460040|NCT01598584|placebo|placebo
460042|NCT01598584|pancreatic cancer|pancreatic cancer
460043|NCT01598571|Phase 1|phase 1
460044|NCT01598571|Healthy male volunteers|healthy male volunteers
460045|NCT01598571|pharmacokinetics|pharmacokinetics
460046|NCT01598571|fostamatinib|fostamatinib
460047|NCT01598571|Bioavailability|bioavailability
460048|NCT01598571|R406 plasma AUC and Cmax|r406 plasma auc and cmax
460049|NCT01598571|R406 plasma AUC0-t|r406 plasma auc0-t
460050|NCT01598571|t1/2λz|t1/2λz
460051|NCT01598571|tmax|tmax
460052|NCT01598532|mild traumatic brain injury|mild traumatic brain injury
460053|NCT01598532|mild TBI|mild tbi
460054|NCT01598532|mTBI|mtbi
460055|NCT01598519|school-based|school-based
460056|NCT01598519|adolescent suicide|adolescent suicide
460057|NCT01598519|intervention|intervention
460058|NCT01598519|screening|screening
460059|NCT01598493|Burns|burns
460060|NCT01598493|Wound Healing|wound healing
460061|NCT01598480|Burns|burns
460062|NCT01598480|Wound Healing|wound healing
460063|NCT01598467|pelvic organ prolapse|pelvic organ prolapse
460064|NCT01598467|POP|pop
460065|NCT01598467|sacrocolpopexy|sacrocolpopexy
460066|NCT01598467|sacrohysteropexy|sacrohysteropexy
460067|NCT01598467|promontofixation|promontofixation
460068|NCT01598467|colpopexy|colpopexy
460069|NCT01598467|robotic surgery|robotic surgery
460070|NCT01598467|surgical complications|surgical complications
460071|NCT01598467|mesh|mesh
460072|NCT01598467|prolapse repair|prolapse repair
460073|NCT01598441|pulmonary hypertension, pulmonary hypertensive crisis|pulmonary hypertension, pulmonary hypertensive crisis
460074|NCT01598428|age related cataract|age related cataract
460075|NCT01598428|phacoemulsification|phacoemulsification
460076|NCT01598428|anterior capsule polishing|anterior capsule polishing
460077|NCT01598428|optical coherence tomography|optical coherence tomography
460078|NCT01598428|anterior chamber depth|anterior chamber depth
460079|NCT01598402|LAHNC|lahnc
460080|NCT01598402|Locally Advanced Head and Neck Cancer|locally advanced head and neck cancer
460081|NCT01598376|entropion|entropion
460082|NCT01598376|suture|suture
460083|NCT01598376|granuloma|granuloma
460084|NCT01598376|tissue reaction|tissue reaction
460085|NCT01598350|Gait|gait
460086|NCT01598350|Orthoses|orthoses
460087|NCT01598350|Down syndrome|down syndrome
460088|NCT01598324|magnetic resonance imaging|magnetic resonance imaging
460089|NCT01598324|magnetic resonance spectroscopy|magnetic resonance spectroscopy
460090|NCT01598324|depression|depression
460091|NCT01598324|escitalopram|escitalopram
460092|NCT01598324|selective serotonin reuptake inhibitor|selective serotonin reuptake inhibitor
460093|NCT01598324|treatment-resistant depression|treatment-resistant depression
460094|NCT01598324|ziprasidone|ziprasidone
460095|NCT01598311|CDAD|cdad
460096|NCT01598311|Clostridium difficile Associated Diarrhea|clostridium difficile associated diarrhea
460097|NCT01598311|CDI|cdi
460098|NCT01598311|Clostridium difficile Infection|clostridium difficile infection
460099|NCT01598311|Diarrhea|diarrhea
460100|NCT01598298|estrogen receptor-positive breast cancer|estrogen receptor-positive breast cancer
460101|NCT01598298|progesterone receptor-positive breast cancer|progesterone receptor-positive breast cancer
460102|NCT01598298|stage IA breast cancer|stage ia breast cancer
460103|NCT01598298|stage IB breast cancer|stage ib breast cancer
460104|NCT01598298|stage II breast cancer|stage ii breast cancer
460105|NCT01598298|stage IIIA breast cancer|stage iiia breast cancer
460106|NCT01598298|stage IIIB breast cancer|stage iiib breast cancer
460107|NCT01598298|stage IIIC breast cancer|stage iiic breast cancer
460108|NCT01598298|pain|pain
460109|NCT01598298|musculoskeletal complications|musculoskeletal complications
460110|NCT01598285|Genome-Wide|genome-wide
460111|NCT01598285|GWAS|gwas
460112|NCT01598285|microRNA|microrna
460113|NCT01598285|miRNA|mirna
460114|NCT01598285|Bevacizumab Response Predictors|bevacizumab response predictors
460115|NCT01598285|Metastatic Breast Cancer|metastatic breast cancer
460116|NCT01598272|Ginseng|ginseng
460117|NCT01598272|Cordyceps|cordyceps
460118|NCT01598272|Pomegranate|pomegranate
460119|NCT01598272|Red Orange|red orange
460120|NCT01598272|Grape Seed|grape seed
460121|NCT01598272|Broccoli Seed|broccoli seed
460122|NCT01598246|Extubation failures|extubation failures
460123|NCT01598246|Sedation|sedation
460124|NCT01598220|schizophrenia|schizophrenia
460125|NCT01598220|cognitive remediation therapy|cognitive remediation therapy
460126|NCT01598220|cognition|cognition
460127|NCT01598220|quality of life|quality of life
460128|NCT01598194|solid pancreatic mass lesions|solid pancreatic mass lesions
460129|NCT01598194|22-gauge core biopsy needle|22-gauge core biopsy needle
460130|NCT01598194|reverse bevel design|reverse bevel design
460131|NCT01598194|endoscopic ultrasound|endoscopic ultrasound
460132|NCT01598194|EUS|eus
460133|NCT01598194|guided|guided
460134|NCT01598194|fine needle aspiration|fine needle aspiration
460135|NCT01598194|FNA|fna
460136|NCT01598168|rivaroxaban|rivaroxaban
460137|NCT01598168|treatment|treatment
460138|NCT01598168|venous thromboembolism|venous thromboembolism
460139|NCT01598168|arterial thromboembolism|arterial thromboembolism
460140|NCT01598168|thrombocytopenia|thrombocytopenia
460141|NCT01598155|dental biofilm|dental biofilm
460142|NCT01598155|periodontitis|periodontitis
460143|NCT01598155|maintenance|maintenance
460144|NCT01598155|randomized clinical trial|randomized clinical trial
460145|NCT01598155|biomarkers|biomarkers
460146|NCT01598155|bacterias|bacterias
460147|NCT01598155|gingival crevicular fluid|gingival crevicular fluid
460148|NCT01598142|Endoscopic retrograde cholangiopancreatography (ERCP)|endoscopic retrograde cholangiopancreatography (ercp)
460149|NCT01598142|Guidewires|guidewires
460150|NCT01598142|Cannulation|cannulation
460151|NCT01598142|Single-operator|single-operator
460152|NCT01598142|C-Hook|c-hook
460153|NCT01598129|Phase I|phase i
460154|NCT01598129|Dose escalation|dose escalation
460155|NCT01598129|oncolytic virus|oncolytic virus
460156|NCT01598103|Neurogenic detrusor overactivity|neurogenic detrusor overactivity
460157|NCT01598103|spinal cord lesions|spinal cord lesions
460158|NCT01598103|spinal cord injury|spinal cord injury
460159|NCT01598077|Breast cancer, gastric cancer, squamous cell carcinoma of head and neck, esophageal squamous cell carcinoma|breast cancer, gastric cancer, squamous cell carcinoma of head and neck, esophageal squamous cell carcinoma
460160|NCT01598077|Breast cancer|breast cancer
460161|NCT01598077|Gastric cancer|gastric cancer
460162|NCT01598077|Squamous cell carcinoma of head and neck|squamous cell carcinoma of head and neck
460163|NCT01598077|Esophageal squamous cell carcinoma|esophageal squamous cell carcinoma
460164|NCT01598051|Xarelto|xarelto
460165|NCT01598051|SPAF|spaf
460166|NCT01598051|QOL|qol
460167|NCT01598038|cancer|cancer
460168|NCT01598038|renal|renal
460169|NCT01598038|Afinitor|afinitor
460170|NCT01598038|pharmacokinetics|pharmacokinetics
460171|NCT01598025|ANTITHYMOCYTE GLOBULIN:ATG|antithymocyte globulin:atg
460172|NCT01598025|FLUDARABINE|fludarabine
460173|NCT01598025|THI0TEPA|thi0tepa
460174|NCT01598025|CliniMACS-CD34 Reagent System|clinimacs-cd34 reagent system
460175|NCT01598025|12-053|12-053
460176|NCT01598012|Ayurved Siriraj Prasaplai|ayurved siriraj prasaplai
460177|NCT01598012|primary dysmenorrhea|primary dysmenorrhea
460178|NCT01597986|isavuconazole|isavuconazole
460179|NCT01597986|ethinyl estradiol|ethinyl estradiol
460180|NCT01597986|norethindrone|norethindrone
460181|NCT01597986|contraceptive|contraceptive
460182|NCT01597986|Healthy Volunteers|healthy volunteers
460183|NCT01597986|BAL8557|bal8557
460184|NCT01597986|BAL4815|bal4815
460185|NCT01597934|Chronic hepatitis B|chronic hepatitis b
460186|NCT01597934|Partial virologic response|partial virologic response
460187|NCT01597934|YMDD mutation|ymdd mutation
460188|NCT01597921|Breast conserving surgery|breast conserving surgery
460189|NCT01597921|Radiation dermatitis|radiation dermatitis
460190|NCT01597908|BRAF inhibitor|braf inhibitor
460191|NCT01597908|Metastatic Melanoma|metastatic melanoma
460192|NCT01597908|Cancer|cancer
460193|NCT01597908|MEK inhibitor|mek inhibitor
460194|NCT01597895|maraviroc|maraviroc
460195|NCT01597895|boceprevir|boceprevir
460196|NCT01597895|telaprevir|telaprevir
460197|NCT01597895|drug interaction|drug interaction
460198|NCT01597895|pharmacokinetics|pharmacokinetics
460199|NCT01597895|HIV|hiv
460200|NCT01597882|case management|case management
460201|NCT01597882|long term conditions|long term conditions
460202|NCT01597882|aged sixty five and over|aged sixty five and over
460203|NCT01597843|education|education
460204|NCT01597843|self care|self care
460205|NCT01597843|peer group|peer group
460206|NCT01597843|Computers|computers
460207|NCT01597843|Attitude to computers|attitude to computers
460208|NCT01597830|knee|knee
460209|NCT01597830|osteoarthritis|osteoarthritis
460210|NCT01597830|loading|loading
460211|NCT01597817|Atopic dermatitis|atopic dermatitis
460212|NCT01597817|Eczema|eczema
460213|NCT01597817|Textiles|textiles
460214|NCT01597791|Urinary Retention|urinary retention
460215|NCT01597791|Urinary Catheter|urinary catheter
460216|NCT01597791|Bacteriuria|bacteriuria
460217|NCT01597778|Haplo identical transplant|haplo identical transplant
460218|NCT01597778|Cord blood transplant|cord blood transplant
460219|NCT01597778|Reduced intensity conditioning regimen|reduced intensity conditioning regimen
460220|NCT01597778|Lymphoma|lymphoma
460221|NCT01597778|Leukemia|leukemia
460222|NCT01597765|Thalassemia|thalassemia
460223|NCT01597765|Oxidative stress|oxidative stress
460224|NCT01597765|antioxidant cocktail|antioxidant cocktail
460225|NCT01597752|Immunotherapy|immunotherapy
460226|NCT01597752|Skin prick test|skin prick test
460227|NCT01597752|Standardization|standardization
460228|NCT01597752|Blomia tropicalis|blomia tropicalis
460229|NCT01597739|Active rheumatoid arthritis despite disease-modifying antirheumatic drug therapy|active rheumatoid arthritis despite disease-modifying antirheumatic drug therapy
460230|NCT01597739|Disease-modifying antirheumatic drugs|disease-modifying antirheumatic drugs
460231|NCT01597726|Abortion, Induced|abortion, induced
460232|NCT01597726|Laminaria|laminaria
460233|NCT01597726|Misoprostol|misoprostol
460234|NCT01597726|Pregnancy Trimester, Second|pregnancy trimester, second
460235|NCT01597687|pertussis infection|pertussis infection
460236|NCT01597687|Prevalence|prevalence
460237|NCT01597687|health economic burden|health economic burden
460238|NCT01597687|prolonged cough|prolonged cough
460239|NCT01597674|YF476|yf476
460240|NCT01597674|gastrin receptor antagonist|gastrin receptor antagonist
460241|NCT01597674|gastric pH|gastric ph
460242|NCT01597674|gastrin|gastrin
460243|NCT01597674|healthy subjects|healthy subjects
460244|NCT01597661|first trimester|first trimester
460245|NCT01597661|left outflow tract obstruction|left outflow tract obstruction
460246|NCT01597661|Bupropion|bupropion
460247|NCT01597661|cardiovascular malformation|cardiovascular malformation
460248|NCT01597661|antidepressants|antidepressants
460249|NCT01597661|pregnancy|pregnancy
460250|NCT01597661|cardiovascular defect|cardiovascular defect
460251|NCT01597661|congenital malformation|congenital malformation
460350|NCT01597219|Reduced intensity|reduced intensity
460351|NCT01597206|randomized controlled trial|randomized controlled trial
460352|NCT01597206|intervention|intervention
460353|NCT01597206|posterior reduced dental arch|posterior reduced dental arch
460252|NCT01597648|Combivir™, HIV, bioequivalence, Combined Formulated Tablet, Combined Formulated Tablet, HIV, bioequivalence, Combivir, Selzentry™, Celsentri™, lamivudine, zidov|combivir™, hiv, bioequivalence, combined formulated tablet, combined formulated tablet, hiv, bioequivalence, combivir, selzentry™, celsentri™, lamivudine, zidov
460253|NCT01597635|rhACE2|rhace2
460254|NCT01597635|Acute Respiratory Distress Syndrome (ARDS)|acute respiratory distress syndrome (ards)
460255|NCT01597635|Acute Lung Injury|acute lung injury
460256|NCT01597635|GSK2586881|gsk2586881
460257|NCT01597635|critical care|critical care
460258|NCT01597622|SELENA|selena
460259|NCT01597622|belimumab|belimumab
460260|NCT01597622|Lupus|lupus
460261|NCT01597622|systemic lupus erythematosus|systemic lupus erythematosus
460262|NCT01597622|PGA|pga
460263|NCT01597622|BLys|blys
460264|NCT01597622|SLE Flare Index|sle flare index
460265|NCT01597622|continuation|continuation
460266|NCT01597622|phase III|phase iii
460267|NCT01597622|BILAG|bilag
460268|NCT01597622|extension|extension
460269|NCT01597622|efficacy|efficacy
460270|NCT01597622|SRI|sri
460271|NCT01597622|B cell|b cell
460272|NCT01597622|SLEDAI|sledai
460273|NCT01597622|safety|safety
460274|NCT01597622|Asia|asia
460275|NCT01597622|B lymphocyte|b lymphocyte
460276|NCT01597557|Atrial Fibrillation|atrial fibrillation
460277|NCT01597557|Electrical Cardioversion|electrical cardioversion
460278|NCT01597557|Magnesium Sulfate|magnesium sulfate
460279|NCT01597544|Voiding dysfunction|voiding dysfunction
460280|NCT01597544|bladder catheter|bladder catheter
460281|NCT01597544|prolapse surgery|prolapse surgery
460282|NCT01597544|patient satisfaction|patient satisfaction
460283|NCT01597531|Liraglutide|liraglutide
460284|NCT01597531|Orlistat|orlistat
460285|NCT01597518|Riluzole|riluzole
460286|NCT01597518|spinal cord injury|spinal cord injury
460287|NCT01597518|treatment|treatment
460288|NCT01597505|CDAD|cdad
460289|NCT01597505|Clostridium difficile Associated Diarrhea|clostridium difficile associated diarrhea
460290|NCT01597505|CDI|cdi
460291|NCT01597505|Clostridium difficile Infection|clostridium difficile infection
460292|NCT01597505|Diarrhea|diarrhea
460293|NCT01597492|Antibodies|antibodies
460294|NCT01597492|Vaccines|vaccines
460295|NCT01597492|SLE|sle
460296|NCT01597492|Immune System Diseases|immune system diseases
460297|NCT01597492|Biological Therapy|biological therapy
460298|NCT01597492|Autoimmune Diseases|autoimmune diseases
460299|NCT01597492|Pneumococcal Vaccines|pneumococcal vaccines
460300|NCT01597492|Lupus|lupus
460301|NCT01597492|Immunoglobulins|immunoglobulins
460302|NCT01597492|Vaccination|vaccination
460303|NCT01597492|Belimumab|belimumab
460304|NCT01597492|Biological Agents|biological agents
460305|NCT01597492|Immunization|immunization
460306|NCT01597479|Ultrasound guided distal peripheral nerve blocks|ultrasound guided distal peripheral nerve blocks
460307|NCT01597453|Young ischemic stroke|young ischemic stroke
460308|NCT01597453|Families|families
460309|NCT01597453|Long-term follow-up|long-term follow-up
460310|NCT01597440|Propionic acidemia (PA)|propionic acidemia (pa)
460311|NCT01597440|Methylmalonic acidemia (MMA)|methylmalonic acidemia (mma)
460312|NCT01597440|Carbaglu NCG|carbaglu ncg
460313|NCT01597440|Hyperammonia|hyperammonia
460314|NCT01597427|Clonidine|clonidine
460315|NCT01597427|Hypertension Pulmonary|hypertension pulmonary
460316|NCT01597427|Cardiac Surgical Procedures|cardiac surgical procedures
460317|NCT01597401|Antisickling Agents|antisickling agents
460318|NCT01597388|Estrogen receptor positive|estrogen receptor positive
460319|NCT01597388|Advanced metastatic breast cancer|advanced metastatic breast cancer
460320|NCT01597388|Estrogen receptor positive advanced metastatic breast cancer|estrogen receptor positive advanced metastatic breast cancer
460321|NCT01597375|Aspirin|aspirin
460322|NCT01597375|Prasugrel|prasugrel
460323|NCT01597375|Asthma|asthma
460324|NCT01597375|AERD|aerd
460325|NCT01597375|Aspirin challenge|aspirin challenge
460326|NCT01597375|Aspirin desensitization|aspirin desensitization
460327|NCT01597375|Aspirin induced asthma|aspirin induced asthma
460328|NCT01597362|laparoscopy|laparoscopy
460329|NCT01597362|trocars|trocars
460330|NCT01597362|veress|veress
460331|NCT01597362|open|open
460332|NCT01597362|direct|direct
460333|NCT01597336|abscess|abscess
460334|NCT01597336|tPA|tpa
460335|NCT01597323|Wrinkle Reduction|wrinkle reduction
460336|NCT01597323|Skin Resurfacing|skin resurfacing
460337|NCT01597323|Skin Texture Improvement|skin texture improvement
460338|NCT01597284|Oral therapies|oral therapies
460339|NCT01597284|Cancer|cancer
460340|NCT01597284|cognitive function|cognitive function
460341|NCT01597284|compliance|compliance
460342|NCT01597258|Safety|safety
460343|NCT01597258|All cases surveillance in Japan|all cases surveillance in japan
460344|NCT01597258|ALK-positive unresectable advanced and/or recurrent non-small cell lung cancer|alk-positive unresectable advanced and/or recurrent non-small cell lung cancer
460345|NCT01597232|Transfusion trigger|transfusion trigger
460346|NCT01597232|Hemoglobin level|hemoglobin level
460347|NCT01597219|Haploidentical transplant|haploidentical transplant
460348|NCT01597219|Haematological malignancy|haematological malignancy
460349|NCT01597219|Myeloablative|myeloablative
460354|NCT01597206|patient satisfaction|patient satisfaction
460355|NCT01597206|sequential sampling|sequential sampling
460356|NCT01597193|enzalutamide|enzalutamide
460358|NCT01597193|breast cancer|breast cancer
460359|NCT01597180|contraception|contraception
460360|NCT01597180|HIV|hiv
460361|NCT01597180|pharmacokinetics|pharmacokinetics
460362|NCT01597180|pharmacodynamics|pharmacodynamics
460363|NCT01597167|mild moderate treatment-resistant depression|mild moderate treatment-resistant depression
460364|NCT01597167|magnesium sulfate|magnesium sulfate
460365|NCT01597154|Adolescent|adolescent
460366|NCT01597154|Type 2 Diabetes|type 2 diabetes
460367|NCT01597154|Peer mentorship|peer mentorship
460368|NCT01597141|Prodromal|prodromal
460369|NCT01597141|Schizophrenia|schizophrenia
460370|NCT01597141|Psychosis|psychosis
460371|NCT01597141|Family psychoeducation|family psychoeducation
460372|NCT01597141|Assertive community treatment|assertive community treatment
460373|NCT01597141|Supported employment|supported employment
460374|NCT01597141|Supported education|supported education
460375|NCT01597128|Hernia|hernia
460376|NCT01597128|human tissue|human tissue
460377|NCT01597128|mesh|mesh
460378|NCT01597115|duplex study|duplex study
460379|NCT01597115|hemodialysis access|hemodialysis access
460380|NCT01597115|maturation rate|maturation rate
460381|NCT01597115|endovascular intervention|endovascular intervention
460382|NCT01597102|encephalopathy, hepatic|encephalopathy, hepatic
460383|NCT01597102|autoregulation, cerebrovascular|autoregulation, cerebrovascular
460384|NCT01597102|liver failure|liver failure
460385|NCT01597102|liver transplantation|liver transplantation
460386|NCT01597089|Specificity|specificity
460387|NCT01597089|Bronchoalveolar Lavage|bronchoalveolar lavage
460388|NCT01597089|Film Array Assay|film array assay
460389|NCT01597089|Nasopharyngeal Swab|nasopharyngeal swab
460390|NCT01597089|Sensitivity|sensitivity
460391|NCT01597076|Morinda citrifolia|morinda citrifolia
460392|NCT01597076|noni|noni
460393|NCT01597076|advanced glycation end products|advanced glycation end products
460394|NCT01597076|oxidative stress|oxidative stress
460395|NCT01597076|quality of life|quality of life
460396|NCT01597076|metabolic syndrome|metabolic syndrome
460397|NCT01597076|safety|safety
460398|NCT01597050|Discoid Lupus Erythematosus|discoid lupus erythematosus
460399|NCT01597050|Systemic Lupus Erythematosus|systemic lupus erythematosus
460400|NCT01597037|Aphasia|aphasia
460401|NCT01597037|Speech Rehabilitation|speech rehabilitation
460402|NCT01597024|appetite|appetite
460403|NCT01597024|food|food
460404|NCT01597024|gut|gut
460405|NCT01597024|brain|brain
460406|NCT01597024|satiety|satiety
460407|NCT01597024|hunger|hunger
460408|NCT01597024|gut hormones|gut hormones
460409|NCT01597011|Hernia, Inguinal|hernia, inguinal
460410|NCT01597011|Hernia repair|hernia repair
460411|NCT01597011|Fibrin Tissue Adhesive|fibrin tissue adhesive
460412|NCT01597011|Tisseel|tisseel
460413|NCT01597011|Tissucol|tissucol
460414|NCT01597011|Recurrence|recurrence
460415|NCT01597011|Chronic Pain|chronic pain
460416|NCT01597011|Dysejaculation|dysejaculation
460417|NCT01596998|anesthesia, conduction|anesthesia, conduction
460418|NCT01596998|transversus abdominis plane block|transversus abdominis plane block
460419|NCT01596998|Vasoconstrictor Agents|vasoconstrictor agents
460420|NCT01596998|Ultrasonography|ultrasonography
460421|NCT01596985|Endometrioma|endometrioma
460422|NCT01596985|Endometriosis|endometriosis
460423|NCT01596985|Cystectomy|cystectomy
460424|NCT01596985|Ablation|ablation
460425|NCT01596985|Plasma energy|plasma energy
460426|NCT01596959|atrial flutter|atrial flutter
460427|NCT01596959|ablation|ablation
460428|NCT01596959|irrigation|irrigation
460429|NCT01596959|contact|contact
460430|NCT01596959|ECI|eci
460431|NCT01596946|contact tracing|contact tracing
460432|NCT01596946|home sampling|home sampling
460433|NCT01596946|cluster randomisation|cluster randomisation
460434|NCT01596933|head and neck cancer|head and neck cancer
460435|NCT01596933|omega-3 fatty acid supplementation|omega-3 fatty acid supplementation
460436|NCT01596933|echium oil|echium oil
460437|NCT01596933|weight loss|weight loss
460438|NCT01596933|cancer cachexia|cancer cachexia
460439|NCT01596933|body composition|body composition
460440|NCT01596933|biomarker|biomarker
460441|NCT01596933|quality of life|quality of life
460442|NCT01596920|Chronic DFUs|chronic dfus
460443|NCT01596920|Diabetic Foot Ulcers|diabetic foot ulcers
460444|NCT01596907|resting energy expenditure|resting energy expenditure
460445|NCT01596907|fat free mass|fat free mass
460446|NCT01596907|lean body mass|lean body mass
460447|NCT01596907|bariatric surgery|bariatric surgery
460448|NCT01596907|morbid obesity|morbid obesity
460449|NCT01596907|ephedrine|ephedrine
460450|NCT01596907|caffeine|caffeine
460451|NCT01596907|Low metabolic rate|low metabolic rate
460452|NCT01596907|Low lean body mass|low lean body mass
460453|NCT01596907|Weight loss rate|weight loss rate
460454|NCT01596894|Pediatric|pediatric
460455|NCT01596894|Crohn's disease|crohn's disease
460456|NCT01596894|Azithromycin|azithromycin
460457|NCT01596894|Metronidazole|metronidazole
460458|NCT01596894|Mild to moderate Crohn's Disease|mild to moderate crohn's disease
460459|NCT01596881|Multiple sclerosis|multiple sclerosis
460460|NCT01596881|Blood flow|blood flow
460461|NCT01596881|Optical Coherence Tomography|optical coherence tomography
460462|NCT01596881|Imaging|imaging
460463|NCT01596868|Advanced Nasopharyngeal Carcinoma|advanced nasopharyngeal carcinoma
460464|NCT01596868|treatment|treatment
460465|NCT01596868|Northwest China|northwest china
460466|NCT01596855|Anemia|anemia
460467|NCT01596855|Renal|renal
460468|NCT01596842|Omega-3 fatty acid|omega-3 fatty acid
460469|NCT01596842|vitamin D|vitamin d
460470|NCT01596842|ergocalciferol|ergocalciferol
460471|NCT01596842|hemodialysis|hemodialysis
460472|NCT01596829|antibiotic|antibiotic
460473|NCT01596829|probiotic|probiotic
460474|NCT01596829|antibiotic-associated diarrhoea|antibiotic-associated diarrhoea
460475|NCT01596829|faecal microbiota|faecal microbiota
460476|NCT01596816|prostate cancer|prostate cancer
460477|NCT01596803|FSHD|fshd
460478|NCT01596803|Antioxidants|antioxidants
460479|NCT01596803|Oxidative stress|oxidative stress
460480|NCT01596803|Muscle function|muscle function
460481|NCT01596803|Quality of life|quality of life
460482|NCT01596803|Activity|activity
460483|NCT01596803|(FSHD;4q35)|(fshd;4q35)
460484|NCT01596790|Bevacizumab|bevacizumab
460485|NCT01596790|Circulating tumor cells|circulating tumor cells
460486|NCT01596790|Treatment efficiency|treatment efficiency
460487|NCT01596777|Loperamide-induced obstipation|loperamide-induced obstipation
460488|NCT01596777|Methylnaltrexone|methylnaltrexone
460489|NCT01596777|oro-cecal transit time|oro-cecal transit time
460490|NCT01596777|whole gut transit time|whole gut transit time
460491|NCT01596777|Pharmacokinetics|pharmacokinetics
460492|NCT01596764|whole-gut transit time|whole-gut transit time
460493|NCT01596764|oro-cecal transit time|oro-cecal transit time
460494|NCT01596764|colon transit time|colon transit time
460495|NCT01596764|loperamide-induced obstipation|loperamide-induced obstipation
460496|NCT01596764|pharmacokinetics|pharmacokinetics
460497|NCT01596764|Methylnaltrexone|methylnaltrexone
460498|NCT01596764|Naloxone|naloxone
460499|NCT01596751|metastatic|metastatic
460500|NCT01596751|breast|breast
460501|NCT01596751|cancer|cancer
460502|NCT01596751|triple|triple
460503|NCT01596751|negative|negative
460504|NCT01596751|PLX|plx
460505|NCT01596751|Eribulin|eribulin
460506|NCT01596738|Coronary Artery Disease|coronary artery disease
460507|NCT01596738|Coronary Artery Bypass Graft|coronary artery bypass graft
460508|NCT01596738|Platelet Aggregation Inhibitors|platelet aggregation inhibitors
460509|NCT01596738|Tranexamic Acid|tranexamic acid
460510|NCT01596712|Allergy,|allergy,
460511|NCT01596712|Asthma,|asthma,
460512|NCT01596712|Atopic dermatitis,|atopic dermatitis,
460513|NCT01596712|Japanese,|japanese,
460514|NCT01596712|QGE031,|qge031,
460515|NCT01596712|IgE|ige
460516|NCT01596699|conditioning|conditioning
460517|NCT01596699|allogeneic|allogeneic
460518|NCT01596699|hematopoietic|hematopoietic
460519|NCT01596699|cell|cell
460520|NCT01596699|transplantation|transplantation
460521|NCT01596699|HCT|hct
460522|NCT01596660|Tap block|tap block
460523|NCT01596660|laparoscopic hysterectomy|laparoscopic hysterectomy
460524|NCT01596660|pain|pain
460525|NCT01596647|cancer, tumors, phase I, drug-drug interaction, pharmacokinetic, probe drug, caffeine, diclofenac, omeprazole, midazolam, CYP1A2, CYP2C9, CYP2C19, CYP3A4|cancer, tumors, phase i, drug-drug interaction, pharmacokinetic, probe drug, caffeine, diclofenac, omeprazole, midazolam, cyp1a2, cyp2c9, cyp2c19, cyp3a4
460526|NCT01596621|Bendamustine hydrochloride|bendamustine hydrochloride
460527|NCT01596621|CEP-18083|cep-18083
460528|NCT01596621|Treanda®|treanda®
460529|NCT01596621|Non-Hodgkin Lymphoma|non-hodgkin lymphoma
460530|NCT01596608|Magnetic seizure therapy|magnetic seizure therapy
460531|NCT01596608|Treatment resistance|treatment resistance
460532|NCT01596608|Open-label trial|open-label trial
460533|NCT01596608|Treatment resistant depression|treatment resistant depression
460534|NCT01596608|Treatment resistant schizophrenia|treatment resistant schizophrenia
460535|NCT01596608|Treatment resistant obsessive-compulsive disorder|treatment resistant obsessive-compulsive disorder
460536|NCT01596595|ICD|icd
460537|NCT01596595|CRT-D|crt-d
460538|NCT01596595|Defibrillation lead|defibrillation lead
460539|NCT01596582|Colorectal cancer screening|colorectal cancer screening
460540|NCT01596582|Shared decision-making|shared decision-making
460541|NCT01596582|Patient preferences|patient preferences
460542|NCT01596582|Risk assessment|risk assessment
460543|NCT01596582|Advanced colorectal neoplasia|advanced colorectal neoplasia
460544|NCT01596569|Blast Traumatic Brain Injury|blast traumatic brain injury
460545|NCT01596569|Cognitive Rehabilitation|cognitive rehabilitation
460546|NCT01596569|Transcranial Magnetic Stimulation|transcranial magnetic stimulation
460547|NCT01596569|Combined Treatment|combined treatment
460548|NCT01596556|smoking|smoking
460549|NCT01596556|exercise|exercise
460550|NCT01596556|heat tolerance|heat tolerance
460551|NCT01596556|heat stroke|heat stroke
460552|NCT01596543|sleep|sleep
460553|NCT01596543|HTT|htt
460554|NCT01596543|heat illness|heat illness
460555|NCT01596530|Breast Neoplasm|breast neoplasm
460556|NCT01596530|Breast Cancer|breast cancer
460557|NCT01596530|Breast Tumour|breast tumour
460558|NCT01596530|Cancer of Breast|cancer of breast
460559|NCT01596530|Cancer of the Breast|cancer of the breast
460560|NCT01596491|peripheral nerve injury|peripheral nerve injury
460561|NCT01596491|postherpetic neuralgia|postherpetic neuralgia
460562|NCT01596491|PNI|pni
460563|NCT01596491|PHN|phn
460564|NCT01596491|Capsaicin|capsaicin
460565|NCT01596491|QST|qst
460566|NCT01596491|quantitative sensory testing|quantitative sensory testing
460567|NCT01596491|sensory profile|sensory profile
460568|NCT01596491|neuropathic pain|neuropathic pain
460569|NCT01596478|Gambling|gambling
460570|NCT01596478|Pathological Gambling|pathological gambling
460571|NCT01596439|Healthy women|healthy women
460572|NCT01596439|consisting of a friend or relative of the patient|consisting of a friend or relative of the patient
460573|NCT01596426|CINV|cinv
460574|NCT01596413|CINV|cinv
460575|NCT01596400|CINV|cinv
460576|NCT01596387|anaesthetics iv|anaesthetics iv
460577|NCT01596387|propofol|propofol
460578|NCT01596387|pharmacokinetics|pharmacokinetics
460579|NCT01596387|pharmacodynamic|pharmacodynamic
460580|NCT01596348|Exercise|exercise
460581|NCT01596348|Barriers|barriers
460582|NCT01596348|Benefits|benefits
460583|NCT01596348|Preferences|preferences
460584|NCT01596348|Stages of change|stages of change
460585|NCT01596335|Infliximab|infliximab
460586|NCT01596335|REMICADE|remicade
460587|NCT01596335|TA-650|ta-650
460588|NCT01596335|intravenous immunoglobulin|intravenous immunoglobulin
460589|NCT01596335|Kawasaki disease|kawasaki disease
460590|NCT01596335|IVIG|ivig
460591|NCT01596322|HIV/AIDS in resource limited setting|hiv/aids in resource limited setting
460592|NCT01596322|HIV treatment outcomes in resource limited setting|hiv treatment outcomes in resource limited setting
460593|NCT01596322|Adherence to HIV treatment in resource limited setting|adherence to hiv treatment in resource limited setting
460594|NCT01596322|ART resistance in resource limited setting|art resistance in resource limited setting
460595|NCT01596309|cardiovascular risk|cardiovascular risk
460596|NCT01596309|Elderly population|elderly population
460597|NCT01596309|cocoa extract|cocoa extract
460598|NCT01596309|overweight and obesity|overweight and obesity
460599|NCT01596309|Glycemic profile|glycemic profile
460600|NCT01596309|lipid profile|lipid profile
460601|NCT01596309|antioxidant status|antioxidant status
460602|NCT01596309|inflammatory state|inflammatory state
460603|NCT01596309|Cardiovascular Risk factors in elder population|cardiovascular risk factors in elder population
460604|NCT01596296|labor induction|labor induction
460605|NCT01596296|transcervical foley catheter|transcervical foley catheter
460606|NCT01596296|dinoprostone|dinoprostone
460607|NCT01596296|parous women|parous women
460608|NCT01596283|Perioperative Fluid Management|perioperative fluid management
460609|NCT01596283|liver resection|liver resection
460610|NCT01596283|12-056|12-056
460611|NCT01596257|CliniMACS-CD34 Reagent System|clinimacs-cd34 reagent system
460612|NCT01596257|Acute Leukemia|acute leukemia
460613|NCT01596257|Myelodysplastic syndrome|myelodysplastic syndrome
460614|NCT01596257|Non Hodgkins Lymphoma|non hodgkins lymphoma
460615|NCT01596257|Hodgkins Disease|hodgkins disease
460616|NCT01596257|Multiple Myeloma|multiple myeloma
460617|NCT01596257|12-016|12-016
460618|NCT01596244|Diabetes Mellitus, Type II|diabetes mellitus, type ii
460619|NCT01596244|Disease management|disease management
460620|NCT01596244|Chronic disease|chronic disease
460621|NCT01596244|Prevention and control|prevention and control
460622|NCT01596244|Education|education
460623|NCT01596231|Alcohol consumption|alcohol consumption
460624|NCT01596231|Kudzu extract|kudzu extract
460625|NCT01596218|Steroid Refractory|steroid refractory
460626|NCT01596218|Acute|acute
460627|NCT01596205|cognitive therapy|cognitive therapy
460628|NCT01596192|allogeneic transplantation, GVHD|allogeneic transplantation, gvhd
460629|NCT01596192|Patients with acute GVHD after allogeneic hematopoietic cell transplantation|patients with acute gvhd after allogeneic hematopoietic cell transplantation
460630|NCT01596179|treatment adherence|treatment adherence
460631|NCT01596179|fatigue|fatigue
460632|NCT01596179|symptom management|symptom management
460633|NCT01596166|migraine|migraine
460634|NCT01596166|pediatric|pediatric
460635|NCT01596166|childhood|childhood
460636|NCT01596166|emergency department|emergency department
460637|NCT01596166|ketorolac|ketorolac
460638|NCT01596166|metoclopramide|metoclopramide
460639|NCT01596166|intravenous|intravenous
460640|NCT01596140|Vemurafenib|vemurafenib
460641|NCT01596140|Everolimus|everolimus
460642|NCT01596140|Afinitor|afinitor
460643|NCT01596140|RAD001|rad001
460644|NCT01596140|temsirolimus|temsirolimus
460645|NCT01596140|BRAF gene mutation|braf gene mutation
460646|NCT01596140|solid tumor|solid tumor
460647|NCT01596140|relapsed BRAF mutation positive malignant melanoma|relapsed braf mutation positive malignant melanoma
460648|NCT01596140|refractory BRAF mutation positive malignant melanoma|refractory braf mutation positive malignant melanoma
460649|NCT01596127|relapsed CD20+ lymphoid malignancies|relapsed cd20+ lymphoid malignancies
460945|NCT01594827|Vancomycin|vancomycin
460650|NCT01596127|refractory CD20+ lymphoid malignancies|refractory cd20+ lymphoid malignancies
460651|NCT01596127|Rituximab|rituximab
460652|NCT01596127|Intrathecal Rituximab|intrathecal rituximab
460653|NCT01596127|CNS|cns
460654|NCT01596127|Leptomeningeal disease|leptomeningeal disease
460655|NCT01596127|LMD|lmd
460656|NCT01596127|central nervous system disease|central nervous system disease
460657|NCT01596127|Relapsed lymphoid malignancies|relapsed lymphoid malignancies
460658|NCT01596127|refractory lymphoid malignancies|refractory lymphoid malignancies
460659|NCT01596127|CNS leukemia|cns leukemia
460660|NCT01596127|intrathecal chemotherapy|intrathecal chemotherapy
460661|NCT01596127|cerebrospinal fluid|cerebrospinal fluid
460662|NCT01596127|CSF|csf
460663|NCT01596127|lumbar puncture|lumbar puncture
460664|NCT01596127|LP|lp
460665|NCT01596114|TKI|tki
460666|NCT01596114|CML|cml
460667|NCT01596114|Stopping|stopping
460668|NCT01596114|chronic phase|chronic phase
460669|NCT01596114|in remission|in remission
460670|NCT01596088|Extravasation|extravasation
460671|NCT01596088|Anthracyclines|anthracyclines
460672|NCT01596075|Cannabidiol|cannabidiol
460673|NCT01596075|GVHD|gvhd
460674|NCT01596075|Allogeneic transplantation|allogeneic transplantation
460675|NCT01596062|Basiliximab|basiliximab
460676|NCT01596062|renal transplantation|renal transplantation
460677|NCT01596062|CNI-free|cni-free
460678|NCT01596062|everolimus|everolimus
460679|NCT01596036|cardiac rehabilitation|cardiac rehabilitation
460680|NCT01596036|referral|referral
460681|NCT01596036|enrollment|enrollment
460682|NCT01596036|timing|timing
460683|NCT01596023|COPD|copd
460684|NCT01595997|safety tolerability and immunogenicity of two different doses of DLX105 applied intra-dermally into psoriatic lesion of mild-to-moderate psoriatic patients|safety tolerability and immunogenicity of two different doses of dlx105 applied intra-dermally into psoriatic lesion of mild-to-moderate psoriatic patients
460685|NCT01595984|kidney|kidney
460686|NCT01595984|transplantation|transplantation
460687|NCT01595984|graft|graft
460688|NCT01595984|creatinin|creatinin
460689|NCT01595971|Asthma|asthma
460690|NCT01595971|Continuing education|continuing education
460691|NCT01595971|Primary health care|primary health care
460692|NCT01595958|Cardiac arrest|cardiac arrest
460693|NCT01595958|heart arrest|heart arrest
460694|NCT01595958|cyclosporine A|cyclosporine a
460695|NCT01595958|post cardiac arrest syndrome|post cardiac arrest syndrome
460696|NCT01595958|protective agent|protective agent
460697|NCT01595958|multiple organ failure|multiple organ failure
460698|NCT01595958|mitochondrial permeability transition pore|mitochondrial permeability transition pore
460699|NCT01595958|mitochondria|mitochondria
460700|NCT01595958|cardio-pulmonary resuscitation|cardio-pulmonary resuscitation
460701|NCT01595958|cardioprotection|cardioprotection
460702|NCT01595958|ischemia reperfusion|ischemia reperfusion
460703|NCT01595958|postconditioning|postconditioning
460704|NCT01595945|Caloric restriction|caloric restriction
460705|NCT01595945|Obesity|obesity
587848|NCT01065688|QOL|qol
460706|NCT01595945|Gastric bypass|gastric bypass
460707|NCT01595945|Resting metabolic rate|resting metabolic rate
460708|NCT01595932|irritable bowel syndrome (IBS)|irritable bowel syndrome (ibs)
460709|NCT01595932|bloating|bloating
460710|NCT01595932|abdominal distension|abdominal distension
460711|NCT01595932|flatulence|flatulence
460712|NCT01595932|α-Galactosidase|α-galactosidase
460713|NCT01595906|Helmet|helmet
460714|NCT01595906|Heat Tolerance Test|heat tolerance test
460715|NCT01595906|ventilation System|ventilation system
460716|NCT01595893|Polymorphic light eruption|polymorphic light eruption
460717|NCT01595893|Vitamin D3|vitamin d3
460718|NCT01595893|Photo provocation|photo provocation
460719|NCT01595893|Immune function|immune function
460720|NCT01595867|abuse liability|abuse liability
460721|NCT01595867|abuse potential|abuse potential
460722|NCT01595867|morphine|morphine
460723|NCT01595867|intranasal administration|intranasal administration
460724|NCT01595867|snorting|snorting
460725|NCT01595867|opioid abuse|opioid abuse
460726|NCT01595867|pharmacodynamic|pharmacodynamic
460727|NCT01595867|recreational drug use|recreational drug use
460728|NCT01595841|hemodialysis|hemodialysis
460729|NCT01595841|stenosis|stenosis
460730|NCT01595841|angioplasty|angioplasty
460731|NCT01595841|sirolimus|sirolimus
460732|NCT01595815|Fertilization failure, calcium ionophore, SrCl2|fertilization failure, calcium ionophore, srcl2
460733|NCT01595802|Cerebral vasospasm|cerebral vasospasm
460734|NCT01595789|Coronary Artery Disease|coronary artery disease
460735|NCT01595789|Diabetes Mellitus|diabetes mellitus
460736|NCT01595789|Left ventricular ejection fraction|left ventricular ejection fraction
460737|NCT01595789|Beta-cell function|beta-cell function
460738|NCT01595776|CLI, PAD, Buerger disease|cli, pad, buerger disease
460739|NCT01595763|Deep vein thrombosis|deep vein thrombosis
460740|NCT01595763|Primary care|primary care
460741|NCT01595763|Diagnosis|diagnosis
460742|NCT01595763|Clinical model|clinical model
460743|NCT01595750|Post-bronchodilator FEV1<70% reference|post-bronchodilator fev1<70% reference
460744|NCT01595750|Chronic bronchitis|chronic bronchitis
460745|NCT01595750|Presence of estavlished CVD,|presence of estavlished cvd,
460946|NCT01594814|AVNRT|avnrt
460746|NCT01595750|CVD equivalent or diabetes mellitus|cvd equivalent or diabetes mellitus
460747|NCT01595724|Non-interventional study|non-interventional study
460748|NCT01595724|Endometriosis,|endometriosis,
460749|NCT01595724|Quality of life|quality of life
460750|NCT01595698|Physical exercise|physical exercise
460752|NCT01595698|Schizophrenia|schizophrenia
460753|NCT01595698|neuroplasticity|neuroplasticity
460754|NCT01595685|HBeAg-positive|hbeag-positive
460755|NCT01595672|severe acute pancreatitis|severe acute pancreatitis
460756|NCT01595672|organ failure|organ failure
460757|NCT01595672|multiple organ dysfunction syndrome|multiple organ dysfunction syndrome
460758|NCT01595672|systemic complications|systemic complications
460759|NCT01595672|continuous veno-venous hemofiltration|continuous veno-venous hemofiltration
460760|NCT01595672|blood purification|blood purification
460761|NCT01595672|continuous renal replacement therapy|continuous renal replacement therapy
460762|NCT01595659|Risk|risk
460763|NCT01595659|Young drivers|young drivers
460764|NCT01595659|Alcohol|alcohol
460765|NCT01595659|Passengers|passengers
460766|NCT01595659|Gender|gender
460767|NCT01595646|Memory|memory
460768|NCT01595646|Intranasal insulin|intranasal insulin
460769|NCT01595646|Alzheimer's disease|alzheimer's disease
460770|NCT01595646|Mild Cognitive Impairment|mild cognitive impairment
460771|NCT01595633|nucleoside analogue|nucleoside analogue
460772|NCT01595633|adefovir|adefovir
460773|NCT01595633|tenofovir|tenofovir
460774|NCT01595633|hepatitis B|hepatitis b
460775|NCT01595620|Cannabis|cannabis
460776|NCT01595620|THC|thc
460777|NCT01595620|Pain|pain
460778|NCT01595594|Periodontal Diseases|periodontal diseases
460779|NCT01595594|Type 2 Diabetes Mellitus|type 2 diabetes mellitus
460780|NCT01595594|hemoglobin A1c protein|hemoglobin a1c protein
460781|NCT01595581|Testosterone|testosterone
460782|NCT01595581|ACL Reconstruction|acl reconstruction
460783|NCT01595581|Clinical outcomes|clinical outcomes
460784|NCT01595581|Lean mass|lean mass
460785|NCT01595581|Strength|strength
460786|NCT01595581|Muscle atrophy|muscle atrophy
460787|NCT01595568|Adolescents|adolescents
460788|NCT01595568|Dual Diagnosis|dual diagnosis
460789|NCT01595568|Mental Disorders|mental disorders
460790|NCT01595568|Substance Use Problems|substance use problems
460791|NCT01595568|Prevention|prevention
460792|NCT01595555|stress|stress
460793|NCT01595555|relaxation|relaxation
460794|NCT01595555|mindfulness|mindfulness
460795|NCT01595555|web-based|web-based
460796|NCT01595555|online|online
460797|NCT01595555|social media|social media
460798|NCT01595555|discussion board|discussion board
460799|NCT01595529|antibiotic therapy|antibiotic therapy
460800|NCT01595529|antimicrobial resistance|antimicrobial resistance
460801|NCT01595529|children|children
460802|NCT01595529|E.coli|e.coli
460803|NCT01595529|K.pneumoniae|k.pneumoniae
460804|NCT01595529|parent study|parent study
460805|NCT01595529|SCOUT Study|scout study
460806|NCT01595529|spectrum stool bacteria|spectrum stool bacteria
460807|NCT01595529|stool culture|stool culture
460808|NCT01595529|urinary tract infections|urinary tract infections
460809|NCT01595503|Schizophrenia, auditory hallucination|schizophrenia, auditory hallucination
460810|NCT01595451|Acupuncture|acupuncture
460811|NCT01595451|Back Pain|back pain
460812|NCT01595451|Lower Back Pain|lower back pain
460813|NCT01595451|Brigham and Women's Hospital|brigham and women's hospital
460814|NCT01595451|Massachusetts General Hospital|massachusetts general hospital
460815|NCT01595451|Effects of Acupuncture|effects of acupuncture
460816|NCT01595438|Ceftazidime, Avibactam, Doripenem, Ciprofloxacin, sulfamethoxazole/trimethoprim, Anti-Infective Agents, Complicated Urinary Tract Infection,Acute Pyelonephritis|ceftazidime, avibactam, doripenem, ciprofloxacin, sulfamethoxazole/trimethoprim, anti-infective agents, complicated urinary tract infection,acute pyelonephritis
460817|NCT01595425|Bioequivalence,|bioequivalence,
460818|NCT01595425|pharmacokinetics,|pharmacokinetics,
460819|NCT01595425|safety,|safety,
460820|NCT01595425|esomeprazole,|esomeprazole,
460821|NCT01595425|Japanese,|japanese,
460822|NCT01595425|healthy subject,|healthy subject,
460823|NCT01595425|homo-EM|homo-em
460824|NCT01595412|Laparoscopic surgery|laparoscopic surgery
460825|NCT01595412|Colorectal Surgery|colorectal surgery
460826|NCT01595412|Quality of Life|quality of life
460827|NCT01595412|Rectal Prolapse|rectal prolapse
460828|NCT01595412|Anorectal Physiology|anorectal physiology
460829|NCT01595399|bradycardia|bradycardia
460830|NCT01595399|hypoxemia|hypoxemia
460831|NCT01595399|intubation|intubation
460832|NCT01595399|premedication|premedication
460833|NCT01595373|Ghrelin|ghrelin
460834|NCT01595373|Microdialysis|microdialysis
460835|NCT01595373|Controls|controls
460836|NCT01595373|Metabolic effects of ghrelin|metabolic effects of ghrelin
460837|NCT01595360|TT-173|tt-173
460838|NCT01595360|Topical Hemostatics|topical hemostatics
460839|NCT01595360|Hemostasis|hemostasis
460840|NCT01595347|Pressure Ulcer|pressure ulcer
460841|NCT01595347|Primary Prevention|primary prevention
460842|NCT01595347|Fatty Acids|fatty acids
460843|NCT01595347|Vegetable Fats|vegetable fats
460844|NCT01595347|Olive oil|olive oil
460845|NCT01595347|"Pressure Ulcer[prevention and control][Mesh]"|"pressure ulcer[prevention and control][mesh]"
460846|NCT01595334|IVF-ET|ivf-et
460847|NCT01595334|ICSI|icsi
460848|NCT01595334|Gonadotrophins|gonadotrophins
460849|NCT01595334|rFSH|rfsh
460850|NCT01595334|rLH|rlh
460851|NCT01595334|Cetrorelix|cetrorelix
460852|NCT01595334|Leuprolide acetate|leuprolide acetate
460853|NCT01595321|Adjuvant therapy|adjuvant therapy
460854|NCT01595321|Immunotherapy|immunotherapy
460855|NCT01595321|Cytoxan|cytoxan
460856|NCT01595321|Cyclophosphamide|cyclophosphamide
460857|NCT01595321|Pancreatic Vaccine|pancreatic vaccine
460858|NCT01595321|Stereotactic radiation therapy|stereotactic radiation therapy
460859|NCT01595321|SBRT|sbrt
460860|NCT01595321|FOLFIRINOX|folfirinox
460861|NCT01595308|Male infertility|male infertility
460862|NCT01595295|CMML|cmml
460863|NCT01595295|MDS|mds
460864|NCT01595295|AML|aml
460865|NCT01595295|registry|registry
460866|NCT01595295|Vidaza|vidaza
460867|NCT01595282|pain|pain
460868|NCT01595282|suction curettage|suction curettage
460869|NCT01595269|Diabetes|diabetes
460870|NCT01595269|eHealth|ehealth
460871|NCT01595269|Type 2 Diabetes|type 2 diabetes
460872|NCT01595269|Education|education
460873|NCT01595269|Calgary Health Region|calgary health region
460874|NCT01595256|colorectal cancer,fatigue,6-minute walking test|colorectal cancer,fatigue,6-minute walking test
460875|NCT01595243|hepatocellular carcinoma|hepatocellular carcinoma
460876|NCT01595243|Needs|needs
460877|NCT01595243|Telephone consultation|telephone consultation
460878|NCT01595230|Internal Hernias|internal hernias
460879|NCT01595230|Clips|clips
460880|NCT01595230|Gastric Bypass|gastric bypass
460881|NCT01595230|Avoid|avoid
460882|NCT01595217|Biliary Tract Neoplasm|biliary tract neoplasm
460883|NCT01595217|Cholangiocarcinoma|cholangiocarcinoma
460884|NCT01595217|Diffusion magnetic resonance imaging|diffusion magnetic resonance imaging
460885|NCT01595217|Magnetic resonance imaging|magnetic resonance imaging
460886|NCT01595217|Magnetic resonance Cholangiopancreatography|magnetic resonance cholangiopancreatography
460887|NCT01595204|Cancer of Ovary, laparoscopy, operability , score.|cancer of ovary, laparoscopy, operability , score.
460888|NCT01595178|smoking|smoking
460889|NCT01595178|drinking|drinking
460890|NCT01595178|SBIRT|sbirt
460891|NCT01595178|BNI|bni
460892|NCT01595178|counseling intervention|counseling intervention
460893|NCT01595178|emergency department|emergency department
460894|NCT01595178|adults|adults
460895|NCT01595165|laparoscopic cholecystectomy|laparoscopic cholecystectomy
460896|NCT01595165|ultrasound|ultrasound
460897|NCT01595165|transversus abdominis plane block|transversus abdominis plane block
460898|NCT01595152|Urgency, urgency incontinence,USIQ|urgency, urgency incontinence,usiq
460899|NCT01595100|Waist circumference|waist circumference
460900|NCT01595100|Visceral adipose tissue|visceral adipose tissue
588095|NCT01064570|APL|apl
460901|NCT01595100|Intra-abdominal fat|intra-abdominal fat
460902|NCT01595100|Pediatrics|pediatrics
460903|NCT01595087|CRPC|crpc
460904|NCT01595035|Day surgery|day surgery
460905|NCT01595035|Orthopedic surgery|orthopedic surgery
460906|NCT01595035|Breast reconstruction surgery|breast reconstruction surgery
460907|NCT01594996|Seroquel XR|seroquel xr
460908|NCT01594996|Quetiapine XR|quetiapine xr
460909|NCT01594996|Drug utilization|drug utilization
460910|NCT01594996|Major depressive disorder (MDD)|major depressive disorder (mdd)
460911|NCT01594983|hypertriglyceridemia|hypertriglyceridemia
460912|NCT01594983|Non familial Chylocmicronemia Syndrome (non-FCS)|non familial chylocmicronemia syndrome (non-fcs)
460913|NCT01594957|LCQ908,|lcq908,
460914|NCT01594957|Hepatic Impairment,|hepatic impairment,
460915|NCT01594957|Pharmacokinetics|pharmacokinetics
460916|NCT01594931|malaria|malaria
460917|NCT01594931|antimalarial|antimalarial
460918|NCT01594931|artemisinin based combination therapy|artemisinin based combination therapy
460919|NCT01594918|metastatic|metastatic
460920|NCT01594918|CRPC|crpc
460921|NCT01594918|prostate|prostate
460922|NCT01594918|CAMP|camp
460923|NCT01594905|To explore|to explore
460924|NCT01594905|adequate management|adequate management
460925|NCT01594905|CHB|chb
460926|NCT01594905|Multidrug resistance|multidrug resistance
460927|NCT01594892|Spinal metastases|spinal metastases
460928|NCT01594892|Vertebral metastases|vertebral metastases
460929|NCT01594892|Radiosurgery|radiosurgery
460930|NCT01594892|Radiotherapy|radiotherapy
460931|NCT01594892|Stereotactic body radiotherapy|stereotactic body radiotherapy
460932|NCT01594892|Pain|pain
460933|NCT01594879|Endometrial cancer|endometrial cancer
460934|NCT01594879|LNG-IUS|lng-ius
460935|NCT01594879|oral MPA|oral mpa
460936|NCT01594866|Major depressive disorder, remission, escitalopram|major depressive disorder, remission, escitalopram
460937|NCT01594853|exercise|exercise
460938|NCT01594853|women|women
460939|NCT01594853|training|training
460940|NCT01594853|rehabilitation|rehabilitation
460941|NCT01594853|leukodystrophy|leukodystrophy
460942|NCT01594840|language development|language development
460943|NCT01594840|parental interaction|parental interaction
460944|NCT01594827|Methicillin-resistant Staphylococcus aureus|methicillin-resistant staphylococcus aureus
460947|NCT01594814|AVRT|avrt
460948|NCT01594814|WPW|wpw
460949|NCT01594801|DM|dm
460950|NCT01594801|insulin|insulin
460951|NCT01594801|injections|injections
460952|NCT01594762|Diabetic Foot Ulcer Infection|diabetic foot ulcer infection
460953|NCT01594749|NK-1 Receptor Antagonist, CINV, Emesis, MEC|nk-1 receptor antagonist, cinv, emesis, mec
460954|NCT01594684|restenosis|restenosis
460955|NCT01594684|stent|stent
460956|NCT01594684|drug eltuing balloon|drug eltuing balloon
460957|NCT01594684|peripheral arterial disease|peripheral arterial disease
460958|NCT01594671|primary knee arthroplasty|primary knee arthroplasty
460959|NCT01594671|tranexamic acid|tranexamic acid
460960|NCT01594671|topical|topical
460961|NCT01594658|Ultrasound-guided foam sclerotherapy; chronic venous ulcers|ultrasound-guided foam sclerotherapy; chronic venous ulcers
460962|NCT01594632|AE adverse event|ae adverse event
460963|NCT01594632|AIDS acquired immunodeficiency syndrome|aids acquired immunodeficiency syndrome
460964|NCT01594632|ALT (SGPT) alanine aminotransferase|alt (sgpt) alanine aminotransferase
460965|NCT01594632|ART antiretroviral therapy|art antiretroviral therapy
460966|NCT01594632|AST (SGOT) aspartate aminotransferase|ast (sgot) aspartate aminotransferase
460967|NCT01594632|DCF data collection forms|dcf data collection forms
460968|NCT01594632|DMC Data Monitoring Committee|dmc data monitoring committee
460969|NCT01594632|FDA (U.S.) Food and Drug Administration|fda (u.s.) food and drug administration
460970|NCT01594632|GCP Good Clinical Practice guidelines|gcp good clinical practice guidelines
460971|NCT01594632|HB sAg Hepatitis B surface antigen|hb sag hepatitis b surface antigen
460972|NCT01594632|ICH International Conference of Harmonization|ich international conference of harmonization
460973|NCT01594632|IND Investigational New Drug Application|ind investigational new drug application
460974|NCT01594632|IRB Institutional Review Board|irb institutional review board
460975|NCT01594632|IU International units|iu international units
460976|NCT01594632|mg milligram(s)|mg milligram(s)
460977|NCT01594632|mm3 cubic millimeter(s)|mm3 cubic millimeter(s)
460978|NCT01594632|PCR polymerase chain reaction|pcr polymerase chain reaction
460979|NCT01594632|SAE serious adverse event|sae serious adverse event
460980|NCT01594632|µg microgram|µg microgram
460981|NCT01594632|ULN upper limit of the normal range|uln upper limit of the normal range
460982|NCT01594632|WB Western Blot|wb western blot
460983|NCT01594619|Phase 1|phase 1
460984|NCT01594619|Healthy male and female volunteers|healthy male and female volunteers
460985|NCT01594619|Drug-drug interaction|drug-drug interaction
460986|NCT01594619|Pharmacokinetics|pharmacokinetics
460987|NCT01594619|Naloxegol|naloxegol
460988|NCT01594606|Animal-assisted intervention|animal-assisted intervention
460989|NCT01594606|adjudicated adolescents|adjudicated adolescents
460990|NCT01594606|empathy|empathy
460991|NCT01594593|prostate cancer|prostate cancer
460992|NCT01594593|behavioral|behavioral
460993|NCT01594593|acceptance and commitment therapy|acceptance and commitment therapy
460994|NCT01594593|distress|distress
460995|NCT01594567|Systematic review and meta-analysis|systematic review and meta-analysis
460996|NCT01594567|Evidence-based medicine (EBM)|evidence-based medicine (ebm)
460997|NCT01594567|Evidence-based nutrition (EBN)|evidence-based nutrition (ebn)
460998|NCT01594567|Clinical practice guidelines|clinical practice guidelines
460999|NCT01594567|Clinical trials|clinical trials
461000|NCT01594567|Dietary pulses|dietary pulses
461001|NCT01594567|legumes|legumes
461002|NCT01594567|Beans, peas, chickpeas, lentils|beans, peas, chickpeas, lentils
461003|NCT01594567|Cardiometabolic risk factors|cardiometabolic risk factors
461004|NCT01594567|Triglycerides|triglycerides
461005|NCT01594567|Cholesterol|cholesterol
461006|NCT01594567|Glycemic control|glycemic control
461007|NCT01594567|Insulin resistance|insulin resistance
461008|NCT01594567|Body weight|body weight
461009|NCT01594567|Uric acid|uric acid
461010|NCT01594567|Blood pressure|blood pressure
461011|NCT01594554|HCV viral genotypes|hcv viral genotypes
461012|NCT01594554|host genotypes|host genotypes
461013|NCT01594554|IL28B|il28b
461014|NCT01594554|Outcome|outcome
461015|NCT01594554|Follow-Up|follow-up
461016|NCT01594554|ITPA|itpa
461017|NCT01594554|RNA|rna
461018|NCT01594554|China|china
461019|NCT01594541|hyperhomocysteinemia|hyperhomocysteinemia
461020|NCT01594541|dementia|dementia
461021|NCT01594541|depression|depression
461022|NCT01594541|vitamin B12|vitamin b12
461023|NCT01594541|mild cognitive impairment|mild cognitive impairment
461024|NCT01594541|alzheimer's|alzheimer's
461025|NCT01594528|schizophrenia|schizophrenia
461026|NCT01594528|major depression|major depression
461027|NCT01594528|pain|pain
461028|NCT01594528|behavior|behavior
461029|NCT01594502|prostate cancer|prostate cancer
461030|NCT01594502|dutasteride|dutasteride
461031|NCT01594476|Postpartum|postpartum
461032|NCT01594476|Contraception|contraception
461033|NCT01594476|Intrauterine device|intrauterine device
461034|NCT01594476|Intrauterine system|intrauterine system
461035|NCT01594476|Mirena|mirena
461036|NCT01594476|Paragard|paragard
461037|NCT01594476|Uterine involution|uterine involution
461038|NCT01594463|Intrauterine growth restriction|intrauterine growth restriction
461039|NCT01594463|Screening|screening
461040|NCT01594463|Ultrasound|ultrasound
461041|NCT01594463|Perinatal morbidity|perinatal morbidity
461042|NCT01594463|Maternal complications|maternal complications
461043|NCT01594450|incisional ventral hernia|incisional ventral hernia
461044|NCT01594450|infected field|infected field
461045|NCT01594450|biological mesh|biological mesh
461046|NCT01594437|Cytomegalovirus|cytomegalovirus
461047|NCT01594437|Monoclonal antibody|monoclonal antibody
461048|NCT01594424|Donor-Specific Anti-HLA Antibodies|donor-specific anti-hla antibodies
461049|NCT01594424|Kidney Transplantation|kidney transplantation
461050|NCT01594411|Corus CAD|corus cad
461051|NCT01594411|ASGES|asges
461052|NCT01594411|Age/Sex/Gene Expression Score|age/sex/gene expression score
461053|NCT01594411|Gene Expression|gene expression
461054|NCT01594411|GES|ges
461055|NCT01594411|CAD|cad
461056|NCT01594411|CVD|cvd
461057|NCT01594411|CHD|chd
461058|NCT01594411|Clinical Utility|clinical utility
461059|NCT01594411|Precision Medicine|precision medicine
461060|NCT01594411|Primary care|primary care
461061|NCT01594411|Coronary Artery Disease|coronary artery disease
461062|NCT01594411|Angina Pectoris|angina pectoris
461063|NCT01594411|Chest Pain|chest pain
461064|NCT01594411|Cardiovascular Disease|cardiovascular disease
461065|NCT01594411|Coronary Heart Disease|coronary heart disease
461066|NCT01594411|IMPACT|impact
461067|NCT01594411|IMPACT-PCP|impact-pcp
461068|NCT01594398|carcinoma,non small cell lung|carcinoma,non small cell lung
461069|NCT01594398|lung diseases|lung diseases
461070|NCT01594398|lung neoplasms|lung neoplasms
461071|NCT01594398|Respiratory|respiratory
461072|NCT01594398|Carcinoma, Bronchogenic|carcinoma, bronchogenic
461073|NCT01594398|Bronchial Neoplasms|bronchial neoplasms
461074|NCT01594398|Respiratory Tract Neoplasms|respiratory tract neoplasms
461075|NCT01594398|Thoracic Neoplasms|thoracic neoplasms
461076|NCT01594398|Neoplasms by Site|neoplasms by site
461077|NCT01594398|Respiratory Tract Diseases|respiratory tract diseases
461078|NCT01594398|Erlotinib|erlotinib
461079|NCT01594398|Protein Kinase Inhibitors|protein kinase inhibitors
461080|NCT01594398|Breast Neoplasms|breast neoplasms
461081|NCT01594398|Neoplasms|neoplasms
461082|NCT01594398|Breast Diseases|breast diseases
461083|NCT01594398|Exemestane|exemestane
461084|NCT01594398|Aromatase Inhibitors|aromatase inhibitors
461085|NCT01594385|Open Abdomen|open abdomen
461086|NCT01594385|Damage Control|damage control
461087|NCT01594385|Trauma|trauma
461088|NCT01594385|Wound healing|wound healing
461089|NCT01594385|Gun shot wounds|gun shot wounds
461090|NCT01594385|Stab wounds|stab wounds
461091|NCT01594385|Automobile accidents|automobile accidents
461092|NCT01594385|Wounds and Injury|wounds and injury
461093|NCT01594372|Uterine Prolapse|uterine prolapse
461094|NCT01594372|Laparoscopy|laparoscopy
461095|NCT01594372|Hysterectomy, vaginal|hysterectomy, vaginal
461096|NCT01594359|Ferritin|ferritin
461097|NCT01594346|Vitamin E|vitamin e
461098|NCT01594346|alpha-tocopherol|alpha-tocopherol
461099|NCT01594346|cognitive decline|cognitive decline
461100|NCT01594346|Down syndrome|down syndrome
461101|NCT01594346|Aging|aging
461102|NCT01594346|Dementia|dementia
461103|NCT01594333|Myocardial Infarction|myocardial infarction
461104|NCT01594333|Stroke|stroke
461105|NCT01594333|Cardiovascular death|cardiovascular death
461106|NCT01594333|Type 2 Diabetes|type 2 diabetes
461107|NCT01594333|Metabolic Syndrome|metabolic syndrome
461108|NCT01594333|Cardiovascular Inflammation|cardiovascular inflammation
461109|NCT01594333|Atherothrombosis|atherothrombosis
461110|NCT01594307|BP|bp
461111|NCT01594294|CLEAR CARE®|clear care®
461112|NCT01594294|AOSEPT® Plus|aosept® plus
461113|NCT01594294|ReNu MultiPlus®|renu multiplus®
461114|NCT01594294|silicone hydrogel|silicone hydrogel
461115|NCT01594294|hydrogel|hydrogel
461116|NCT01594294|ACUVUE® 2®|acuvue® 2®
461117|NCT01594294|AIR OPTIX® AQUA|air optix® aqua
461118|NCT01594294|eyelid response|eyelid response
461119|NCT01594294|wettability|wettability
461120|NCT01594294|contamination|contamination
461121|NCT01594294|contact lenses|contact lenses
461122|NCT01594281|Panretinal photocoagulation|panretinal photocoagulation
461123|NCT01594281|Ranibizumab|ranibizumab
461124|NCT01594268|kidney transplant|kidney transplant
461125|NCT01594268|Certican|certican
461126|NCT01594255|Healthy volunteer|healthy volunteer
461127|NCT01594255|QT intervals|qt intervals
461128|NCT01594255|ECG|ecg
461129|NCT01594255|QT/QTc interval prolongation and proarrhythmic potential for non-antiarrhythmic drugs|qt/qtc interval prolongation and proarrhythmic potential for non-antiarrhythmic drugs
461130|NCT01594242|multiple myeloma|multiple myeloma
461131|NCT01594242|bortezomib|bortezomib
461132|NCT01594242|proteasome inhibitor|proteasome inhibitor
461133|NCT01594229|Pharmacokinetics|pharmacokinetics
461134|NCT01594229|Maximum Tolerated Dose|maximum tolerated dose
461135|NCT01594229|Safety|safety
461136|NCT01594229|Bendamustine|bendamustine
461137|NCT01594229|Non-Hodgkin's Lymphoma|non-hodgkin's lymphoma
461138|NCT01594229|Rituximab|rituximab
461139|NCT01594229|ABT-199|abt-199
461140|NCT01594229|Cancer|cancer
461141|NCT01594229|Preliminary Efficacy|preliminary efficacy
461142|NCT01594216|Postmenopausal female|postmenopausal female
461143|NCT01594203|Soft Tissue Sarcoma|soft tissue sarcoma
461144|NCT01594203|Pazopanib|pazopanib
461145|NCT01594203|F18-FDG PET/CT|f18-fdg pet/ct
461146|NCT01594177|DAFNE|dafne
461147|NCT01594177|GBG 70|gbg 70
461148|NCT01594177|GBG|gbg
461149|NCT01594177|German Breast Group|german breast group
461150|NCT01594177|GBG Forschungs GmbH|gbg forschungs gmbh
461151|NCT01594177|Afatinib|afatinib
461152|NCT01594177|neo-adjuvant|neo-adjuvant
461153|NCT01594177|HER-2 positive breast cancer|her-2 positive breast cancer
461154|NCT01594177|BIBW 2992|bibw 2992
461155|NCT01594177|1200.159|1200.159
461156|NCT01594164|High Resolution Computed Tomography|high resolution computed tomography
461157|NCT01594164|Cone Beam Computed Tomography|cone beam computed tomography
461158|NCT01594164|upper airway|upper airway
461159|NCT01594164|geometry|geometry
461160|NCT01594151|asthma|asthma
461161|NCT01594151|controlled|controlled
461162|NCT01594151|Cone Beam Computed Tomography|cone beam computed tomography
461163|NCT01594151|upper airway|upper airway
461164|NCT01594151|paediatric|paediatric
461165|NCT01594112|Remote monitoring|remote monitoring
461166|NCT01594112|Home monitoring|home monitoring
461167|NCT01594112|Defibrillators, Implantable cardioverter-defibrillator|defibrillators, implantable cardioverter-defibrillator
461168|NCT01594112|Shock|shock
461169|NCT01594112|Inappropriate diagnoses and Therapies|inappropriate diagnoses and therapies
461170|NCT01594112|Corrective actions|corrective actions
461171|NCT01594112|ID recurrences|id recurrences
461172|NCT01594112|Medical reaction time|medical reaction time
461173|NCT01594099|cervical cancer|cervical cancer
461174|NCT01594099|elderly women|elderly women
461175|NCT01594099|concurrent chemotherapy|concurrent chemotherapy
461176|NCT01594086|green tea|green tea
461177|NCT01594086|aging|aging
461178|NCT01594086|atherosclerosis|atherosclerosis
461179|NCT01594086|homocysteine|homocysteine
461180|NCT01594086|cognitive impairment|cognitive impairment
461181|NCT01594073|implantable defibrillator|implantable defibrillator
461182|NCT01594073|ventricular arrhythmias|ventricular arrhythmias
461183|NCT01594073|cardiac death|cardiac death
461184|NCT01594047|hyperalgesia|hyperalgesia
461185|NCT01594047|Patient controlled analgesia|patient controlled analgesia
461186|NCT01594047|morphine|morphine
461187|NCT01594047|methadone|methadone
461188|NCT01594047|ketamine|ketamine
461189|NCT01594021|propofol|propofol
461190|NCT01594021|anesthesia, induction|anesthesia, induction
461191|NCT01594021|hypotension|hypotension
461192|NCT01594021|cardiac output|cardiac output
461193|NCT01594008|Toll like receptors|toll like receptors
461194|NCT01594008|Inflammation|inflammation
461195|NCT01594008|Anthocyanins|anthocyanins
461196|NCT01594008|Blueberries|blueberries
461197|NCT01593995|Erlotinib|erlotinib
461198|NCT01593995|Skin side effect|skin side effect
461199|NCT01593995|EGF ointment|egf ointment
461200|NCT01593982|Repetitive Transcranial Magnetic Stimulation|repetitive transcranial magnetic stimulation
461201|NCT01593982|Cocaine Dependence|cocaine dependence
461202|NCT01593982|Cocaine Addicts|cocaine addicts
461203|NCT01593982|Attention Deficit Hyperactivity Disorder|attention deficit hyperactivity disorder
461204|NCT01593982|Cognitive Function|cognitive function
461205|NCT01593969|Essential Fatty Acid|essential fatty acid
461206|NCT01593969|Seed oil|seed oil
461207|NCT01593969|Fish oil|fish oil
461208|NCT01593969|Dietary deficiency|dietary deficiency
461209|NCT01593943|contraception|contraception
461210|NCT01593943|india|india
461211|NCT01593943|rural|rural
461212|NCT01593930|Pulp Anesthesia|pulp anesthesia
461213|NCT01593930|Articaine|articaine
461214|NCT01593930|Lidocaine|lidocaine
461215|NCT01593917|Aortic valve|aortic valve
461216|NCT01593917|Heart valve|heart valve
461217|NCT01593917|Tissue valve|tissue valve
461218|NCT01593917|Bioprosthesis|bioprosthesis
461219|NCT01593904|CCSVI, Flow, Perfusion in MS|ccsvi, flow, perfusion in ms
461220|NCT01593891|IVUS, CCSVI|ivus, ccsvi
461221|NCT01593865|Coronary Artery Bypass Grafting|coronary artery bypass grafting
461222|NCT01593865|Mammary Artery Grafts|mammary artery grafts
461223|NCT01593865|Bilateral Mammary Artery Grafting|bilateral mammary artery grafting
461224|NCT01593865|Clinical Outcomes|clinical outcomes
461225|NCT01593852|X-rays|x-rays
461226|NCT01593852|Cardiac Electrophysiology|cardiac electrophysiology
461227|NCT01593852|Image Processing, Computer-Assisted|image processing, computer-assisted
461228|NCT01593852|Catheter Ablation|catheter ablation
461229|NCT01593813|Pronator quadratus|pronator quadratus
461230|NCT01593813|distal radius fracture|distal radius fracture
461231|NCT01593813|volar plating|volar plating
461232|NCT01593800|Probiotics|probiotics
461233|NCT01593800|Lactose|lactose
461234|NCT01593787|Hypertension|hypertension
461235|NCT01593787|Renal dysfunction|renal dysfunction
461236|NCT01593787|LCZ696|lcz696
461237|NCT01593774|Melatonin|melatonin
461238|NCT01593774|Olanzapine|olanzapine
461239|NCT01593774|Metabolic side effects|metabolic side effects
461240|NCT01593774|Psychosis|psychosis
461241|NCT01593774|Hyperlipidemia|hyperlipidemia
461242|NCT01593774|Hyperglycemia|hyperglycemia
461243|NCT01593774|Weight gain|weight gain
461244|NCT01593774|Diabetes|diabetes
461245|NCT01593761|cABSSSI|cabsssi
461246|NCT01593761|MRSA|mrsa
461247|NCT01593748|Sarcoma|sarcoma
461248|NCT01593748|Soft Tissue Sarcoma|soft tissue sarcoma
461249|NCT01593722|Loa loa|loa loa
461250|NCT01593722|Immune Response|immune response
461251|NCT01593722|Therapy|therapy
461252|NCT01593709|Anti-infective agents|anti-infective agents
461253|NCT01593709|ANTI-VIRAL AGENTS|anti-viral agents
461254|NCT01593709|Healthy Volunteers|healthy volunteers
461255|NCT01593696|CD 19 Expressing B Cells|cd 19 expressing b cells
461256|NCT01593696|B Cell Lymphoma|b cell lymphoma
461257|NCT01593696|ALL|all
461258|NCT01593696|Anti-CD19 Chimeric Antigen Receptor|anti-cd19 chimeric antigen receptor
461259|NCT01593696|Adoptive Immunotherapy|adoptive immunotherapy
461260|NCT01593683|Oncology service|oncology service
461261|NCT01593683|Nursing staff|nursing staff
461262|NCT01593683|Psychosocial intervention|psychosocial intervention
461263|NCT01593683|Coping skills|coping skills
461264|NCT01593670|high risk myelodysplastic syndrome|high risk myelodysplastic syndrome
461265|NCT01593670|natural killer cells|natural killer cells
461266|NCT01593644|Dipyridamole/adenosine combination given intravenously|dipyridamole/adenosine combination given intravenously
461267|NCT01593644|slow bolus and low doses|slow bolus and low doses
461268|NCT01593644|coronary flow reserve assessment|coronary flow reserve assessment
461269|NCT01593644|transthoracic echodoppler|transthoracic echodoppler
461270|NCT01593644|Patients|patients
461271|NCT01593644|stable|stable
461272|NCT01593631|lactose malabsorption|lactose malabsorption
461273|NCT01593631|lactose intolerance|lactose intolerance
461274|NCT01593631|lactose digestion|lactose digestion
461275|NCT01593631|lactose maldigestion|lactose maldigestion
461276|NCT01593631|acid lactase|acid lactase
461277|NCT01593631|yoghurt bacteria|yoghurt bacteria
461278|NCT01593618|cancer survivor|cancer survivor
461279|NCT01593605|Impaired glucose tolerance, pre-diabetes,glycemic control,|impaired glucose tolerance, pre-diabetes,glycemic control,
461280|NCT01593605|supplements|supplements
461281|NCT01593592|Helicobacter pylori|helicobacter pylori
461282|NCT01593592|Lactobacillus reuteri|lactobacillus reuteri
461283|NCT01593592|dyspeptic patients|dyspeptic patients
461284|NCT01593592|eradication|eradication
461285|NCT01593579|melanoma|melanoma
461286|NCT01593579|autonomic failure|autonomic failure
461287|NCT01593579|hypotension|hypotension
461288|NCT01593579|akt therapy|akt therapy
461289|NCT01593566|femoral nerve block|femoral nerve block
461290|NCT01593553|Screening|screening
461291|NCT01593553|Stroke prevention|stroke prevention
461292|NCT01593553|Cost effectiveness|cost effectiveness
461293|NCT01593527|Frequent flares|frequent flares
461294|NCT01593527|Frequent attacks|frequent attacks
461295|NCT01593527|gout|gout
461296|NCT01593527|gouty arthritis|gouty arthritis
461297|NCT01593527|Chronic kidney disease|chronic kidney disease
461298|NCT01593527|renal impairment|renal impairment
461299|NCT01593527|Anti-interleukin-1β monoclonal antibody|anti-interleukin-1β monoclonal antibody
461300|NCT01593527|anti-inflammatory therapy|anti-inflammatory therapy
461301|NCT01593514|Vaccines|vaccines
461302|NCT01593514|Meningitis|meningitis
461303|NCT01593514|Meningococcal|meningococcal
461304|NCT01593501|vitamin D|vitamin d
461305|NCT01593501|cholecalciferol|cholecalciferol
461306|NCT01593501|bone mineral density|bone mineral density
461307|NCT01593501|Magnesium deficiency|magnesium deficiency
461308|NCT01593501|Calcium metabolism disorders|calcium metabolism disorders
461309|NCT01593488|recurrent|recurrent
461310|NCT01593488|CNS disease|cns disease
461311|NCT01593488|intrathecal therapy|intrathecal therapy
461312|NCT01593436|insomnia,menopause, polysomnography, mindfulness|insomnia,menopause, polysomnography, mindfulness
461313|NCT01593410|Efficacy/Safety|efficacy/safety
461314|NCT01593410|Lenalidomide and Low-Dose Dexamethasone|lenalidomide and low-dose dexamethasone
461315|NCT01593410|Chinese Subjects|chinese subjects
461316|NCT01593410|Relapsed/Refractory Multiple Myeloma|relapsed/refractory multiple myeloma
461317|NCT01593397|Obesity|obesity
461318|NCT01593397|Insulin Resistance|insulin resistance
461319|NCT01593384|Breast Cancer|breast cancer
461320|NCT01593384|Digital Breast Tomosynthesis (DBT)|digital breast tomosynthesis (dbt)
461321|NCT01593384|Digital Mammography (DM)|digital mammography (dm)
461322|NCT01593371|Adipokines|adipokines
461323|NCT01593371|leptin|leptin
461324|NCT01593371|chemerin|chemerin
461325|NCT01593371|omentin|omentin
461326|NCT01593371|metformin|metformin
461327|NCT01593371|type 2 diabetes mellitus|type 2 diabetes mellitus
461328|NCT01593358|CCSVI|ccsvi
461329|NCT01593345|Elderly|elderly
461330|NCT01593345|mobility limitations|mobility limitations
461331|NCT01593345|self-management|self-management
461332|NCT01593345|exercise|exercise
461333|NCT01593332|Rituximab|rituximab
461334|NCT01593332|Rheumatoid arthritis|rheumatoid arthritis
461335|NCT01593332|Biologics|biologics
461336|NCT01593332|Anti-tumour necrosis factor|anti-tumour necrosis factor
461337|NCT01593332|Disease-modifying anti-rheumatic drugs|disease-modifying anti-rheumatic drugs
461338|NCT01593332|DAS28|das28
461339|NCT01593332|European League Against Rheumatism response|european league against rheumatism response
461340|NCT01593293|Elderly patients|elderly patients
461341|NCT01593293|Non-squamous Non-small Cell Lung Cancer|non-squamous non-small cell lung cancer
461342|NCT01593293|Pemetrexed|pemetrexed
461343|NCT01593293|Carboplatin|carboplatin
461344|NCT01593280|anesthesia|anesthesia
461345|NCT01593280|regional anesthetic techniques: transversus abdominis plane block,|regional anesthetic techniques: transversus abdominis plane block,
461346|NCT01593280|pain, postoperative|pain, postoperative
461347|NCT01593280|surgery, cesarean section|surgery, cesarean section
461348|NCT01593280|quality of recovery|quality of recovery
461349|NCT01593267|intracranial aneurysm|intracranial aneurysm
461350|NCT01593267|subarachnoid hemorrhage|subarachnoid hemorrhage
461351|NCT01593267|randomized trial|randomized trial
461352|NCT01593267|coil embolization|coil embolization
461353|NCT01593267|clip occlusion|clip occlusion
461354|NCT01593267|vascular disorders|vascular disorders
461355|NCT01593241|Seminoma IIA/B|seminoma iia/b
461356|NCT01593241|Carboplatin|carboplatin
461358|NCT01593215|genetics|genetics
461359|NCT01593215|type 2 diabetes|type 2 diabetes
461360|NCT01593215|insulin secretion|insulin secretion
461361|NCT01593189|developmental disabilities|developmental disabilities
461362|NCT01593189|school readiness|school readiness
461363|NCT01593189|literacy|literacy
461364|NCT01593189|social emotional skills|social emotional skills
461365|NCT01593189|self regulation|self regulation
461366|NCT01593189|caregiver involvement|caregiver involvement
461367|NCT01593176|Femur|femur
461368|NCT01593176|Fracture|fracture
461369|NCT01593176|Radiostereometric Analysis|radiostereometric analysis
461370|NCT01593163|Functional echocardiography|functional echocardiography
461371|NCT01593163|power Doppler cranial ultrasonography|power doppler cranial ultrasonography
461372|NCT01593163|N-terminal probrain natriuretic peptide|n-terminal probrain natriuretic peptide
461373|NCT01593163|Patent ductus arteriosus|patent ductus arteriosus
461374|NCT01593150|Atrial Fibrillation|atrial fibrillation
461375|NCT01593150|TEE|tee
461376|NCT01593150|Early versus late DC cardioversion.|early versus late dc cardioversion.
461377|NCT01593124|Vaginal innate immune and inflammatory responses|vaginal innate immune and inflammatory responses
461378|NCT01593111|Allergies|allergies
461379|NCT01593111|Asthma|asthma
461380|NCT01593111|Environmental|environmental
461381|NCT01593111|NYC|nyc
461382|NCT01593111|Manhattan|manhattan
461383|NCT01593111|Harlem|harlem
461384|NCT01593111|Bronx|bronx
461385|NCT01593111|Brooklyn|brooklyn
461386|NCT01593111|Breathing|breathing
461387|NCT01593111|eNO|eno
461388|NCT01593111|IgE|ige
461389|NCT01593111|Allergens|allergens
461390|NCT01593111|Cockroach|cockroach
461391|NCT01593111|Dust mites|dust mites
461392|NCT01593111|Pets|pets
461393|NCT01593098|siblings|siblings
461394|NCT01593098|advanced neoplasm|advanced neoplasm
461395|NCT01593098|mRNA|mrna
461396|NCT01593098|TaqMan microRNA expression assays|taqman microrna expression assays
461397|NCT01593085|palliative cares|palliative cares
461398|NCT01593085|cancer|cancer
461399|NCT01593085|suicide risk|suicide risk
461400|NCT01593072|Multiple Ascending Dose (MAD)|multiple ascending dose (mad)
461401|NCT01593072|Ebola Virus|ebola virus
461402|NCT01593072|Post Exposure Prophylaxis|post exposure prophylaxis
461403|NCT01593072|EHF|ehf
461404|NCT01593059|International|international
461405|NCT01593059|Multicenter|multicenter
461406|NCT01593059|Observational registry|observational registry
461407|NCT01593059|Orsiro Drug Eluting Stent (DES)|orsiro drug eluting stent (des)
461408|NCT01593059|Stenting|stenting
461409|NCT01593059|Treatment of Coronary Artery Disease|treatment of coronary artery disease
461410|NCT01593059|Coronary revascularization|coronary revascularization
461411|NCT01593059|Percutaneous Coronary Intervention|percutaneous coronary intervention
461412|NCT01593059|STEMI|stemi
461413|NCT01593059|NSTEMI|nstemi
461414|NCT01593059|Ischemia|ischemia
461415|NCT01593059|Angina|angina
461416|NCT01593059|Subgroups|subgroups
461417|NCT01593059|Acute Myocardial Infarction|acute myocardial infarction
461418|NCT01593059|Diabetes|diabetes
461419|NCT01593059|Small Vessels|small vessels
461420|NCT01593059|Chronic Total Occlusion (CTO)|chronic total occlusion (cto)
461421|NCT01593046|GSK1265744 LAP|gsk1265744 lap
461422|NCT01593046|integrase inhibitor|integrase inhibitor
461423|NCT01593046|healthy subjects|healthy subjects
461424|NCT01593046|TMC278 LA|tmc278 la
461425|NCT01593046|GSK1265744LAP|gsk1265744lap
461426|NCT01593046|long acting retroviral|long acting retroviral
461427|NCT01593046|HIV-1 infection|hiv-1 infection
461428|NCT01593020|Breast cancer|breast cancer
461429|NCT01593020|Early Stage Breast Cancer Not Overexpressing HER-2|early stage breast cancer not overexpressing her-2
461430|NCT01593020|Primary invasive adenocarcinoma of the breast|primary invasive adenocarcinoma of the breast
461431|NCT01593020|Paclitaxel|paclitaxel
461432|NCT01593020|Taxol|taxol
461433|NCT01593020|Eribulin|eribulin
461434|NCT01593020|E7389|e7389
461435|NCT01593020|5-Fluorouracil|5-fluorouracil
461436|NCT01593020|5-FU|5-fu
461437|NCT01593020|Adrucil|adrucil
461438|NCT01593020|Efudex|efudex
461439|NCT01593020|Epirubicin|epirubicin
461440|NCT01593020|Ellence|ellence
461441|NCT01593020|Cyclophosphamide|cyclophosphamide
461442|NCT01593020|Cytoxan|cytoxan
461443|NCT01593020|Neosar|neosar
461444|NCT01593020|Doxorubicin|doxorubicin
461445|NCT01593020|Doxorubicin hydrochloride|doxorubicin hydrochloride
461446|NCT01593020|Adriamycin PFS|adriamycin pfs
461447|NCT01593020|Adriamycin RDF|adriamycin rdf
461448|NCT01593020|Adriamycin|adriamycin
461449|NCT01593020|Rubex|rubex
461450|NCT01593007|Heart failure|heart failure
461451|NCT01593007|respiratory muscles|respiratory muscles
461452|NCT01593007|optoelectronic plethysmography|optoelectronic plethysmography
461453|NCT01592994|HIV|hiv
461454|NCT01592994|condom use|condom use
461455|NCT01592994|India|india
461456|NCT01592994|women|women
461457|NCT01592981|Waldenstrom's macroglobulinaemia|waldenstrom's macroglobulinaemia
461458|NCT01592981|bortezomib|bortezomib
461459|NCT01592981|cyclophosphamide|cyclophosphamide
461460|NCT01592981|rituximab|rituximab
461461|NCT01592955|Glaucoma|glaucoma
461462|NCT01592955|Cyclocoagulation|cyclocoagulation
461463|NCT01592955|HIFU High Intensity Focused Ultrasound|hifu high intensity focused ultrasound
461464|NCT01592942|inguinal hernia|inguinal hernia
461465|NCT01592942|mesh fixation|mesh fixation
461466|NCT01592942|glue|glue
461467|NCT01592942|Lichtenstein|lichtenstein
461468|NCT01592929|Functional Respiratory Imaging|functional respiratory imaging
461469|NCT01592929|Magnetic Resonance Imaging|magnetic resonance imaging
461470|NCT01592929|MRI|mri
461471|NCT01592929|Pharyngometry|pharyngometry
461472|NCT01592929|Upper Airway|upper airway
461473|NCT01592929|Mouthpiece of Inhaler|mouthpiece of inhaler
461474|NCT01592929|Cone Beam Computed Tomography|cone beam computed tomography
461475|NCT01592929|CBCT|cbct
461476|NCT01592929|Computed Tomography|computed tomography
461477|NCT01592929|CT|ct
461478|NCT01592916|Fibromyalgia|fibromyalgia
461479|NCT01592916|Pain|pain
461480|NCT01592916|Women|women
461481|NCT01592916|Exercise|exercise
461482|NCT01592916|IGF1|igf1
461483|NCT01592903|Uterine fibroids|uterine fibroids
461484|NCT01592903|somatic stem cell|somatic stem cell
461485|NCT01592903|Side Population|side population
461486|NCT01592877|UWB|uwb
461487|NCT01592877|non-contact|non-contact
461488|NCT01592877|patient monitor|patient monitor
461489|NCT01592838|Belgium|belgium
588857|NCT01061372|RLS|rls
461490|NCT01592838|Quality of hospital care|quality of hospital care
461491|NCT01592838|Rotavirus vaccination|rotavirus vaccination
461492|NCT01592825|Breast Cancer|breast cancer
461493|NCT01592825|Prognostic factor|prognostic factor
461494|NCT01592825|uPA/PA-1|upa/pa-1
461495|NCT01592825|cohort|cohort
461496|NCT01592799|Influenza|influenza
461497|NCT01592799|Children|children
461498|NCT01592799|Hospitalizations|hospitalizations
461499|NCT01592799|Spain|spain
461500|NCT01592799|Burden|burden
461501|NCT01592786|Autism Spectrum Disorder (ASD)|autism spectrum disorder (asd)
461502|NCT01592786|Autism|autism
461503|NCT01592786|Autistic Disorder|autistic disorder
461504|NCT01592786|Asperger's Disorder|asperger's disorder
461505|NCT01592786|Asperger's|asperger's
461506|NCT01592786|Pervasive Developmental Disorder Not Otherwise Specified (PDD-NOS)|pervasive developmental disorder not otherwise specified (pdd-nos)
461507|NCT01592786|Memantine|memantine
461508|NCT01592786|Pediatric Disorder|pediatric disorder
461509|NCT01592773|Autistic Disorder|autistic disorder
461510|NCT01592773|Asperger's Disorder|asperger's disorder
461511|NCT01592773|Asperger's|asperger's
461512|NCT01592773|Pediatric Autism|pediatric autism
461513|NCT01592773|Pervasive Developmental Disorder Not Otherwise Specified (PDD-NOS)|pervasive developmental disorder not otherwise specified (pdd-nos)
461514|NCT01592773|Pervasive Child Development Disorder|pervasive child development disorder
461515|NCT01592760|air-Q SP|air-q sp
461516|NCT01592760|air-Q|air-q
461517|NCT01592760|i-gel|i-gel
461518|NCT01592760|supraglottic airway device|supraglottic airway device
461519|NCT01592760|laryngeal mask airway|laryngeal mask airway
461520|NCT01592747|Asperger's|asperger's
461521|NCT01592747|Pervasive Developmental Disorder Not Otherwise Specified (PDD-NOS)|pervasive developmental disorder not otherwise specified (pdd-nos)
461522|NCT01592747|Memantine|memantine
461523|NCT01592747|Pediatric Disorder|pediatric disorder
461524|NCT01592747|Randomized Controlled Trial|randomized controlled trial
461525|NCT01592734|chronic constipation|chronic constipation
461526|NCT01592734|faecal impaction|faecal impaction
461527|NCT01592734|PEG-only laxative|peg-only laxative
461528|NCT01592721|Carcinoma|carcinoma
461529|NCT01592721|Squamous cell carcinoma|squamous cell carcinoma
461530|NCT01592721|Head and neck neoplasms|head and neck neoplasms
461531|NCT01592721|Cetuximab|cetuximab
461532|NCT01592708|orthognathic surgery|orthognathic surgery
461533|NCT01592708|maxillary osteotomy|maxillary osteotomy
461534|NCT01592708|post operative nausea vomiting|post operative nausea vomiting
461535|NCT01592708|post discharge nausea vomiting|post discharge nausea vomiting
461536|NCT01592708|anesthesia|anesthesia
461537|NCT01592695|Nicotine dependence|nicotine dependence
461538|NCT01592695|Smoking cessation|smoking cessation
461539|NCT01592695|Telehealth|telehealth
461540|NCT01592695|Alcohol use|alcohol use
461541|NCT01592695|Depression|depression
461542|NCT01592695|Body weight|body weight
461543|NCT01592682|tobacco|tobacco
461544|NCT01592682|secondhand smoke|secondhand smoke
461545|NCT01592682|Chinese|chinese
461546|NCT01592682|NNAL|nnal
461547|NCT01592669|Passive leg raising, blood pressure, heart rate|passive leg raising, blood pressure, heart rate
461548|NCT01592656|Chronic Obstructive Pulmonary Disease|chronic obstructive pulmonary disease
461549|NCT01592656|GOLD stages II, III and IV|gold stages ii, iii and iv
461550|NCT01592656|Computed Tomography scan|computed tomography scan
461551|NCT01592656|Functional Respiratory Imaging|functional respiratory imaging
461552|NCT01592656|Non-Invasive Ventilation|non-invasive ventilation
461553|NCT01592656|Arterial Blood Gas|arterial blood gas
461554|NCT01592656|Hypercapnic|hypercapnic
461555|NCT01592656|Health Related Quality of Life|health related quality of life
461556|NCT01592656|Lung compliance|lung compliance
461557|NCT01592643|Corneal shield|corneal shield
461558|NCT01592643|PRK|prk
461559|NCT01592643|Myopia|myopia
461560|NCT01592643|Pain|pain
461561|NCT01592643|Vision|vision
461562|NCT01592617|cancer vaccine|cancer vaccine
461563|NCT01592617|HLA-A*24:02|hla-a*24:02
461564|NCT01592617|lung cancer|lung cancer
461565|NCT01592617|CTL|ctl
461566|NCT01592604|fracture|fracture
461567|NCT01592604|fifth metatarsal|fifth metatarsal
461568|NCT01592604|functioanl outcome|functioanl outcome
461569|NCT01592578|gastroesophgeal variceal bleeding|gastroesophgeal variceal bleeding
461570|NCT01592578|liver cirrhosis|liver cirrhosis
461571|NCT01592578|portal hypertension|portal hypertension
461572|NCT01592552|Alzheimer's Disease|alzheimer's disease
461573|NCT01592552|Multiple Sclerosis|multiple sclerosis
461574|NCT01592552|Parkinson's Disease|parkinson's disease
461575|NCT01592552|Huntington's Disease|huntington's disease
461576|NCT01592552|Amyotrophic Lateral Sclerosis (ALS)|amyotrophic lateral sclerosis (als)
461577|NCT01592539|Type 1 Diabetes|type 1 diabetes
461578|NCT01592539|Bone|bone
461579|NCT01592526|Systemic inflammatory response.|systemic inflammatory response.
461580|NCT01592526|Autonomic nervous regulation.|autonomic nervous regulation.
461581|NCT01592526|Cholinergic antiinflammatory pathway|cholinergic antiinflammatory pathway
461582|NCT01592500|GHD|ghd
461583|NCT01592500|r-hGH|r-hgh
461584|NCT01592500|Long-acting|long-acting
461585|NCT01592474|Multiple Sclerosis|multiple sclerosis
461586|NCT01592474|Avonex|avonex
461587|NCT01592474|Brain atrophy|brain atrophy
461588|NCT01592474|MRI|mri
461589|NCT01592474|Interferon-beta 1a|interferon-beta 1a
461590|NCT01592474|IFN Beta 1-a|ifn beta 1-a
461591|NCT01592474|Clinically isolated syndrome|clinically isolated syndrome
461592|NCT01592474|CIS|cis
461593|NCT01592461|Substance abuse treatment outcomes|substance abuse treatment outcomes
461594|NCT01592461|Opioid dependence|opioid dependence
461595|NCT01592461|Suboxone|suboxone
461596|NCT01592461|Methadone|methadone
461597|NCT01592448|Acetaminophen|acetaminophen
461598|NCT01592448|Patient Safety|patient safety
461599|NCT01592448|Health Literacy|health literacy
461600|NCT01592422|Small cell lung cancer|small cell lung cancer
461601|NCT01592422|Maintenance therapy|maintenance therapy
461602|NCT01592422|Immunotherapy|immunotherapy
461603|NCT01592422|Autologous cytokine-induced killer cell|autologous cytokine-induced killer cell
461604|NCT01592409|cannabis impaired driving|cannabis impaired driving
461605|NCT01592409|driving simulation|driving simulation
461606|NCT01592409|acute psychopharmacologic effects of cannabis|acute psychopharmacologic effects of cannabis
461607|NCT01592409|residual effects of cannabis|residual effects of cannabis
461608|NCT01592409|young drivers|young drivers
461609|NCT01592396|Tralokinumab|tralokinumab
461610|NCT01592396|CAT-354|cat-354
461611|NCT01592396|Asthma|asthma
461612|NCT01592357|cardiac rehabilitation|cardiac rehabilitation
461613|NCT01592357|gait speed|gait speed
461614|NCT01592357|mind body exercise|mind body exercise
461615|NCT01592357|tai chi|tai chi
461616|NCT01592357|cardiac disease|cardiac disease
461617|NCT01592357|frail elderly|frail elderly
461618|NCT01592344|Chronic pain|chronic pain
461619|NCT01592344|peripheral nerve|peripheral nerve
461620|NCT01592344|neuralgia|neuralgia
461621|NCT01592344|somatosensory nervous system|somatosensory nervous system
461622|NCT01592266|FLT|flt
461623|NCT01592266|PET|pet
461624|NCT01592266|bone marrow|bone marrow
461625|NCT01592266|AML|aml
461626|NCT01592240|PF-04950615|pf-04950615
461627|NCT01592240|RN316|rn316
461628|NCT01592227|healthy volunteer|healthy volunteer
461629|NCT01592227|pharmacokinetics|pharmacokinetics
461630|NCT01592227|paracetamol|paracetamol
461631|NCT01592214|Staphylococcus aureus, nasal decolonization, XF-73, gel formulation|staphylococcus aureus, nasal decolonization, xf-73, gel formulation
461632|NCT01592201|Schizophrenia|schizophrenia
461633|NCT01592201|Paliperidone ER|paliperidone er
461634|NCT01592201|Antipsychotics|antipsychotics
461635|NCT01592201|Mental disorder|mental disorder
461636|NCT01592201|Comparative study|comparative study
461637|NCT01592188|meditation, inflammation, children, attention|meditation, inflammation, children, attention
461638|NCT01592149|Appetite|appetite
461639|NCT01592136|Ponatinib|ponatinib
461640|NCT01592136|Tyrosine kinase inhibitor|tyrosine kinase inhibitor
461641|NCT01592123|anxiety|anxiety
461642|NCT01592123|septal surgery|septal surgery
461643|NCT01592123|septum deviation|septum deviation
461644|NCT01592123|sleep|sleep
461645|NCT01592110|Schizophrenia|schizophrenia
461646|NCT01592097|Multiple Sclerosis|multiple sclerosis
461647|NCT01592097|MS|ms
461648|NCT01592097|Autoimmune|autoimmune
461649|NCT01592084|lipid lowering therapy|lipid lowering therapy
461650|NCT01592084|survival|survival
461651|NCT01592084|ALSFRS|alsfrs
461652|NCT01592084|age|age
461653|NCT01592084|BMI|bmi
461654|NCT01592084|weight|weight
461655|NCT01592071|food sensitivity|food sensitivity
461656|NCT01592071|IgG|igg
461657|NCT01592071|obesity|obesity
461658|NCT01592071|overweight|overweight
461659|NCT01592071|body composition|body composition
461660|NCT01592071|reactive foods|reactive foods
461661|NCT01592058|weight change|weight change
461662|NCT01592058|contraception|contraception
461663|NCT01592058|birth control|birth control
461664|NCT01592058|progestin|progestin
461665|NCT01592058|progestin only|progestin only
461666|NCT01592058|weight gain|weight gain
461667|NCT01592058|depo|depo
461668|NCT01592058|Depo Provera|depo provera
461669|NCT01592058|DMPA|dmpa
461670|NCT01592058|IUD|iud
461671|NCT01592058|IUC|iuc
461672|NCT01592058|Mirena|mirena
461673|NCT01592058|Paragard|paragard
461674|NCT01592058|Implanon|implanon
461675|NCT01592058|implant|implant
461676|NCT01592032|Antibiotic-lock technique.|antibiotic-lock technique.
461677|NCT01592032|In vivo antimicrobial concentration.|in vivo antimicrobial concentration.
461678|NCT01592032|Antimicrobial bioactivity.|antimicrobial bioactivity.
461679|NCT01592006|hepatitis C virus|hepatitis c virus
461680|NCT01592006|liver transplant recipient|liver transplant recipient
461681|NCT01591993|Sensitive skin|sensitive skin
461682|NCT01591993|Lactic acid test|lactic acid test
461683|NCT01591993|Transepidermal water loss|transepidermal water loss
461684|NCT01591993|Colorimetry|colorimetry
461685|NCT01591993|Capacitance|capacitance
461686|NCT01591980|post-craniotomy pain|post-craniotomy pain
461687|NCT01591980|pregabalin|pregabalin
461688|NCT01591980|chronic post-craniotomy headache|chronic post-craniotomy headache
461689|NCT01591980|Craniotomy|craniotomy
461690|NCT01591967|Chiropractic|chiropractic
461691|NCT01591967|Blood pressure|blood pressure
461692|NCT01591967|Pulse Rate|pulse rate
461693|NCT01591967|Thoracic|thoracic
461694|NCT01591941|ACL, Knee , Injury,|acl, knee , injury,
461695|NCT01591928|Pediatrics|pediatrics
461696|NCT01591928|Congenital heart disease|congenital heart disease
461697|NCT01591928|Heterotaxy syndrome|heterotaxy syndrome
461698|NCT01591928|Intestinal malrotation|intestinal malrotation
461699|NCT01591915|Breast cancer, Mindfulness Based Stress Reduction, RCT, mood, cooping, health related quality of life|breast cancer, mindfulness based stress reduction, rct, mood, cooping, health related quality of life
461700|NCT01591876|exercise|exercise
461701|NCT01591876|kidney disease|kidney disease
461702|NCT01591876|vascular function|vascular function
461703|NCT01591876|haemodialysis|haemodialysis
461704|NCT01591863|Clostridium difficile-associated diarrhea|clostridium difficile-associated diarrhea
461705|NCT01591863|CDAD|cdad
461706|NCT01591863|Pediatric|pediatric
461707|NCT01591798|Rectal cancer|rectal cancer
461708|NCT01591798|Robotic surgery|robotic surgery
461709|NCT01591798|Laparoscopic surgery|laparoscopic surgery
461710|NCT01591785|Hand|hand
461711|NCT01591785|Foot|foot
461712|NCT01591785|Eczema|eczema
461713|NCT01591785|Atopic Dermatitis|atopic dermatitis
461714|NCT01591772|FALLOPIAN TUBE|fallopian tube
461715|NCT01591772|OVARY|ovary
461716|NCT01591772|PERITONEUM|peritoneum
461717|NCT01591772|Quality of Life|quality of life
461718|NCT01591772|structural MRI|structural mri
461719|NCT01591772|functional MRI|functional mri
461720|NCT01591772|neuropsychological assessment|neuropsychological assessment
461721|NCT01591772|12-075|12-075
461722|NCT01591759|citicoline|citicoline
461723|NCT01591759|cognitive function|cognitive function
461724|NCT01591759|function magnetic resonance imaging|function magnetic resonance imaging
461725|NCT01591759|magnetic resonance spectroscopy|magnetic resonance spectroscopy
461726|NCT01591759|diffusion tensor imaging|diffusion tensor imaging
461727|NCT01591746|Mastectomy|mastectomy
461728|NCT01591746|Mammaplasty|mammaplasty
461729|NCT01591746|Breast reconstruction|breast reconstruction
461730|NCT01591746|Tissue expansion|tissue expansion
461731|NCT01591746|Botulinum toxins, Type A|botulinum toxins, type a
461732|NCT01591746|Quality of Life|quality of life
461733|NCT01591746|Acellular dermal matrix|acellular dermal matrix
461734|NCT01591733|Borderline resectable|borderline resectable
461735|NCT01591707|autism spectrum disorders|autism spectrum disorders
461736|NCT01591707|school|school
461737|NCT01591707|language|language
461738|NCT01591707|social|social
461739|NCT01591694|child trauma|child trauma
461740|NCT01591694|maltreatment|maltreatment
461741|NCT01591694|physical abuse|physical abuse
461742|NCT01591694|sexual abuse|sexual abuse
461743|NCT01591694|emotional abuse|emotional abuse
461744|NCT01591694|abandonment|abandonment
461745|NCT01591694|domestic violence|domestic violence
461746|NCT01591694|community violence|community violence
461747|NCT01591681|Type 1 Diabetes|type 1 diabetes
461748|NCT01591681|Hypoglycemia|hypoglycemia
461749|NCT01591681|Continuous Glucose Monitoring|continuous glucose monitoring
461750|NCT01591681|Pump Suspension|pump suspension
461751|NCT01591668|Hepatitis|hepatitis
461752|NCT01591668|Hepatitis C|hepatitis c
461753|NCT01591668|Chronic HCV|chronic hcv
461754|NCT01591668|HCV|hcv
461755|NCT01591668|Treatment Naive|treatment naive
461756|NCT01591668|Gilead|gilead
461757|NCT01591668|GS-9620|gs-9620
461758|NCT01591642|physical activity|physical activity
461759|NCT01591642|functional fitness|functional fitness
461760|NCT01591642|quality of life|quality of life
461761|NCT01591629|Cannabis|cannabis
461762|NCT01591629|Marijuana|marijuana
461763|NCT01591629|Naloxone|naloxone
461764|NCT01591629|THC|thc
461765|NCT01591629|Psychotic Disorders|psychotic disorders
461766|NCT01591590|Colorectal Cancer|colorectal cancer
461767|NCT01591590|Cancer|cancer
461768|NCT01591590|Colon Cancer|colon cancer
461769|NCT01591590|Rectal Cancer|rectal cancer
461770|NCT01591590|PET|pet
461771|NCT01591590|PET-CT|pet-ct
461772|NCT01591590|MRI|mri
461773|NCT01591590|Diffusion MRI|diffusion mri
461774|NCT01591590|Apparent Diffusion Coefficient|apparent diffusion coefficient
461776|NCT01591590|Metabolic Progression Index|metabolic progression index
461777|NCT01591564|interpersonal psychotherapy|interpersonal psychotherapy
461778|NCT01591564|severe mood dysregulation|severe mood dysregulation
461779|NCT01591538|Prevalence|prevalence
461780|NCT01591538|MDRGNB|mdrgnb
461781|NCT01591538|Acquisition|acquisition
461782|NCT01591538|Middle stay|middle stay
461783|NCT01591538|Endemic area|endemic area
461784|NCT01591525|Type II Diabetes|type ii diabetes
461785|NCT01591525|Minorities|minorities
461786|NCT01591525|Diabetes Mellitus|diabetes mellitus
461787|NCT01591525|Community based screening|community based screening
461788|NCT01591512|Small Cell Lung Cancer|small cell lung cancer
461789|NCT01591512|SCLC|sclc
461790|NCT01591512|Lung Cancer|lung cancer
461791|NCT01591512|Subjects diagnosed with SCLC who will undergo treatment|subjects diagnosed with sclc who will undergo treatment
461792|NCT01591486|Helicobacter pylori (Hp)|helicobacter pylori (hp)
461793|NCT01591486|ASA users|asa users
461794|NCT01591486|peptic ulcer bleeding|peptic ulcer bleeding
461795|NCT01591486|cohorts|cohorts
461796|NCT01591473|Influenza|influenza
461797|NCT01591473|Ampligen|ampligen
461798|NCT01591473|Poly I:Poly C12U|poly i:poly c12u
461799|NCT01591473|Rintatolimod|rintatolimod
461800|NCT01591473|FluMist|flumist
461801|NCT01591408|EEG biofeedback|eeg biofeedback
461802|NCT01591408|neurofeedback|neurofeedback
461803|NCT01591408|therapy|therapy
461804|NCT01591408|adjunct|adjunct
461805|NCT01591395|inguinal hernia|inguinal hernia
461806|NCT01591395|laparoscopy|laparoscopy
461807|NCT01591395|laparoendoscopic single-site surgery|laparoendoscopic single-site surgery
461808|NCT01591382|Ketamine|ketamine
461809|NCT01591382|Postoperative pain|postoperative pain
461810|NCT01591382|Opioid dependent patients|opioid dependent patients
461811|NCT01591382|Acute pain control|acute pain control
461812|NCT01591343|Specific immunotherapy|specific immunotherapy
461813|NCT01591343|Allergic rhinitis|allergic rhinitis
461814|NCT01591343|Allergic rhinoconjunctivitis|allergic rhinoconjunctivitis
461815|NCT01591343|Asthma|asthma
461816|NCT01591304|Ulthera® System|ulthera® system
461817|NCT01591304|Ultherapy™ Treatment|ultherapy™ treatment
461818|NCT01591304|Ulthera, Inc.|ulthera, inc.
461819|NCT01591291|alcohol dependence|alcohol dependence
461820|NCT01591291|alcohol addiction|alcohol addiction
461821|NCT01591265|Compensatory dental extraction|compensatory dental extraction
461822|NCT01591265|Children 7-11 years old|children 7-11 years old
461823|NCT01591252|HIV|hiv
461824|NCT01591252|Bone mineral density|bone mineral density
461825|NCT01591252|bone turnover|bone turnover
461826|NCT01591252|fracture|fracture
461827|NCT01591252|inflammation|inflammation
461828|NCT01591239|Adolescent|adolescent
461829|NCT01591239|Parent|parent
461830|NCT01591239|Substance Abuse|substance abuse
461831|NCT01591239|Parent Training|parent training
461832|NCT01591239|Addiction|addiction
461833|NCT01591239|Family Intervention|family intervention
461834|NCT01591239|Brief Intervention|brief intervention
461835|NCT01591239|Home Intervention|home intervention
461836|NCT01591226|caffeine|caffeine
461837|NCT01591226|sodium citrate|sodium citrate
461838|NCT01591226|exercise performance|exercise performance
461839|NCT01591226|wheelchair athletes|wheelchair athletes
461840|NCT01591226|1500m|1500m
461841|NCT01591213|Cancer education|cancer education
461842|NCT01591213|Prevention education|prevention education
461843|NCT01591213|Volunteers|volunteers
461844|NCT01591200|Alcoholic|alcoholic
461845|NCT01591200|Liver|liver
461846|NCT01591200|Cirrhosis|cirrhosis
461847|NCT01591200|Stem|stem
461848|NCT01591200|Cells|cells
461849|NCT01591187|Text messaging|text messaging
461850|NCT01591187|Secondhand smoke exposure|secondhand smoke exposure
461851|NCT01591174|Functional Dyspepsia|functional dyspepsia
461852|NCT01591174|Postprandial Distress Syndrome|postprandial distress syndrome
461853|NCT01591174|ghrelin|ghrelin
461854|NCT01591174|C-13 acetate|c-13 acetate
461855|NCT01591148|Pharmacokinetics|pharmacokinetics
461856|NCT01591148|Pharmacodynamics|pharmacodynamics
461857|NCT01591135|Esophageal squamous cell carcinoma|esophageal squamous cell carcinoma
461858|NCT01591135|chemoradiotherapy|chemoradiotherapy
461859|NCT01591122|Prostate cancer|prostate cancer
461860|NCT01591122|Metastatic Castration Resistant Prostate Cancer|metastatic castration resistant prostate cancer
461861|NCT01591122|Abiraterone acetate|abiraterone acetate
461862|NCT01591122|Prednisone|prednisone
461863|NCT01591122|Zytiga|zytiga
461864|NCT01591096|Stroke|stroke
461865|NCT01591096|Childhood|childhood
461866|NCT01591096|Thrombolysis|thrombolysis
461867|NCT01591083|Peptic ulcer rebleeding, double dose of esomeprazole|peptic ulcer rebleeding, double dose of esomeprazole
461868|NCT01591070|Facial seborrhoeic dermatitis, tacrolimus|facial seborrhoeic dermatitis, tacrolimus
461869|NCT01591057|fruit|fruit
461870|NCT01591057|vegetables|vegetables
461871|NCT01591057|biomarkers|biomarkers
461872|NCT01591057|randomised controlled feeding study|randomised controlled feeding study
461873|NCT01591057|Fruit and vegetable intake biomarkers in healthy adults|fruit and vegetable intake biomarkers in healthy adults
461874|NCT01591031|laryngeal injuries|laryngeal injuries
461875|NCT01591031|vocal cord injuries|vocal cord injuries
461876|NCT01591031|hoarseness|hoarseness
461877|NCT01591031|sore throat|sore throat
461878|NCT01591018|sonolysis, brain infarction, prevention, cardiac surgery|sonolysis, brain infarction, prevention, cardiac surgery
461879|NCT01591005|sonolysis|sonolysis
461880|NCT01591005|carotid|carotid
461881|NCT01591005|endarterectomy|endarterectomy
461882|NCT01591005|stenting|stenting
461883|NCT01590992|Somatoform disorder|somatoform disorder
461884|NCT01590992|Functional Somatic Syndrome|functional somatic syndrome
461885|NCT01590992|Functional Somatic Symptoms|functional somatic symptoms
461886|NCT01590992|Somatic Symptom Disorder|somatic symptom disorder
461887|NCT01590992|globus sensation|globus sensation
461888|NCT01590992|globus pharynges|globus pharynges
461889|NCT01590992|globus hystericus|globus hystericus
461890|NCT01590979|Atrial Fibrillation New Onset|atrial fibrillation new onset
461891|NCT01590979|Ranolazine|ranolazine
461892|NCT01590979|CABG|cabg
461893|NCT01590979|valve repair/replacement|valve repair/replacement
461894|NCT01590979|Cardiac Surgery|cardiac surgery
461895|NCT01590966|spondyloarthritis|spondyloarthritis
461896|NCT01590966|Rheumatoid arthritis|rheumatoid arthritis
461897|NCT01590927|pelvic floor|pelvic floor
461898|NCT01590927|ultrasonography|ultrasonography
461899|NCT01590914|Roux-en-Y Bariatric surgery,|roux-en-y bariatric surgery,
461900|NCT01590914|Gastric banding,|gastric banding,
461901|NCT01590914|fMRI,|fmri,
461902|NCT01590914|food cues|food cues
461903|NCT01590901|Pharmacokinetics|pharmacokinetics
461904|NCT01590901|Probucol|probucol
461905|NCT01590901|healthy male subjects|healthy male subjects
461906|NCT01590875|atrial fibrillation|atrial fibrillation
461907|NCT01590875|ablation|ablation
461908|NCT01590875|pulmonary veins|pulmonary veins
461909|NCT01590875|adenosine|adenosine
461910|NCT01590862|Obesessive Compulsive Disorder|obesessive compulsive disorder
461911|NCT01590862|Major Depressive Disorder|major depressive disorder
461912|NCT01590862|Deep Brain Stimulation|deep brain stimulation
461913|NCT01590849|contraceptive agents|contraceptive agents
461914|NCT01590849|autonomic nervous system|autonomic nervous system
461915|NCT01590849|blood pressure|blood pressure
461916|NCT01590849|risk|risk
461917|NCT01590823|pharmacokinetics|pharmacokinetics
461918|NCT01590784|Depression|depression
461919|NCT01590784|Schizophrenia|schizophrenia
461920|NCT01590758|Diabetic Foot Ulcer Infection|diabetic foot ulcer infection
461921|NCT01590745|Ultrasound therapy|ultrasound therapy
461922|NCT01590745|Nerve Conduction studies|nerve conduction studies
461923|NCT01590745|Boston and Levine Questionnaire|boston and levine questionnaire
461924|NCT01590745|Neutral Angle Wrist Splint|neutral angle wrist splint
461925|NCT01590745|Canterbury CTS scale|canterbury cts scale
461926|NCT01590706|Genotype-Phenotype Association|genotype-phenotype association
461927|NCT01590706|Aged|aged
461928|NCT01590706|Middle Aged|middle aged
461929|NCT01590706|Mild Cognitive Impairment|mild cognitive impairment
461930|NCT01590706|Heart Rate Control|heart rate control
461931|NCT01590706|Biomarkers|biomarkers
461932|NCT01590693|Gait|gait
461933|NCT01590667|Fat excretion|fat excretion
461934|NCT01590654|Hepatitis|hepatitis
461935|NCT01590654|Hepatitis B|hepatitis b
461936|NCT01590654|Hepatitis B Virus|hepatitis b virus
461937|NCT01590654|HBV|hbv
461938|NCT01590654|GS-9620|gs-9620
461939|NCT01590654|Toll-like receptor (TLR)-7 Agonist|toll-like receptor (tlr)-7 agonist
461940|NCT01590641|Hepatitis|hepatitis
461941|NCT01590641|Hepatitis B|hepatitis b
461942|NCT01590641|Hepatitis B Virus|hepatitis b virus
461943|NCT01590641|HBV|hbv
461944|NCT01590641|GS-9620|gs-9620
461945|NCT01590641|Toll-like receptor (TLR)-7 Agonist|toll-like receptor (tlr)-7 agonist
461946|NCT01590628|Sickle Cell Disease & Thalassemia|sickle cell disease & thalassemia
461947|NCT01590628|Genetic disorder|genetic disorder
461948|NCT01590615|Hepatitis|hepatitis
461949|NCT01590615|Hepatitis B|hepatitis b
461951|NCT01590615|OLT|olt
461952|NCT01590615|MELD|meld
461953|NCT01590615|Renal Safety|renal safety
461954|NCT01590615|Liver Transplant|liver transplant
461955|NCT01590602|Huntington's Disease|huntington's disease
461956|NCT01590602|European Huntington's Disease Network|european huntington's disease network
461957|NCT01590602|Juvenile HD|juvenile hd
461958|NCT01590602|EHDN|ehdn
461959|NCT01590602|REGISTRY|registry
461960|NCT01590589|Huntington Disease|huntington disease
461961|NCT01590589|European HD Network|european hd network
461962|NCT01590589|Cohort|cohort
461963|NCT01590589|REGISTRY|registry
461964|NCT01590589|EHDN|ehdn
461965|NCT01590576|women|women
461966|NCT01590550|Pediatric hemodialysis|pediatric hemodialysis
461967|NCT01590550|Anticoagulation|anticoagulation
461968|NCT01590537|non-interventional|non-interventional
461969|NCT01590537|Mirena|mirena
461970|NCT01590537|Contraception|contraception
461971|NCT01590537|Russian Federation|russian federation
461972|NCT01590524|Parent|parent
461973|NCT01590524|childhood cancer|childhood cancer
461974|NCT01590524|Complementary and Alternative|complementary and alternative
461975|NCT01590511|mini fluid challenge|mini fluid challenge
461976|NCT01590511|subaortic velocity time integral|subaortic velocity time integral
461977|NCT01590498|Adenocarcinoma|adenocarcinoma
461978|NCT01590498|Prostatic Neoplasms|prostatic neoplasms
461979|NCT01590498|Carcinoma|carcinoma
461980|NCT01590498|Prostatic Diseases|prostatic diseases
461981|NCT01590485|pain|pain
461982|NCT01590485|root canal therapy|root canal therapy
461983|NCT01590472|Genetics of Mesothelioma|genetics of mesothelioma
461984|NCT01590472|Mesothelioma Consortium|mesothelioma consortium
461985|NCT01590472|GWAS|gwas
461986|NCT01590472|Asbestos|asbestos
461987|NCT01590446|Achondroplasia|achondroplasia
461988|NCT01590433|Obesity|obesity
461989|NCT01590433|Overweight|overweight
461990|NCT01590433|Exenatide|exenatide
461991|NCT01590433|Diet|diet
461992|NCT01590433|Women|women
461993|NCT01590420|OSA|osa
461994|NCT01590420|Sleep|sleep
461995|NCT01590420|CPAP|cpap
461996|NCT01590420|Cost|cost
461997|NCT01590394|obstruction|obstruction
461998|NCT01590394|bile duct|bile duct
461999|NCT01590394|malignant|malignant
462000|NCT01590342|Pulmonary embolism|pulmonary embolism
462001|NCT01590342|Right ventricular dysfunction|right ventricular dysfunction
462002|NCT01590342|Prognosis|prognosis
462003|NCT01590342|Inflammation|inflammation
462004|NCT01590329|Skin surgery|skin surgery
462005|NCT01590329|Micrografting|micrografting
462006|NCT01590329|Hypo-pigmentation|hypo-pigmentation
462007|NCT01590316|Brain Injuries|brain injuries
462008|NCT01590316|Infant, Premature|infant, premature
462009|NCT01590316|Spectroscopy, Near-Infrared|spectroscopy, near-infrared
462010|NCT01590316|Randomized Controlled Trial|randomized controlled trial
462011|NCT01590303|severe sepsis|severe sepsis
462012|NCT01590264|tinnitus|tinnitus
462013|NCT01590264|bimodal stimulation|bimodal stimulation
462014|NCT01590264|rTMS|rtms
462015|NCT01590264|Repetitive Transcranial Magnetic Stimulation|repetitive transcranial magnetic stimulation
462016|NCT01590251|Pain|pain
462017|NCT01590251|Addiction|addiction
462018|NCT01590251|Buprenorphine|buprenorphine
462019|NCT01590251|Counseling|counseling
462020|NCT01590251|Methadone|methadone
462021|NCT01590251|Yoga|yoga
462022|NCT01590238|alopecia|alopecia
462023|NCT01590186|Pain|pain
462024|NCT01590186|Front foot|front foot
462025|NCT01590186|Flat foot|flat foot
462026|NCT01590186|Metatarsalgia|metatarsalgia
462027|NCT01590173|Low molecular weight heparin|low molecular weight heparin
462028|NCT01590173|Prednisolone|prednisolone
462029|NCT01590173|Glucocorticoids|glucocorticoids
462030|NCT01590173|Recurrent implantation failure|recurrent implantation failure
462031|NCT01590173|Pregnancy rate|pregnancy rate
462032|NCT01590134|volunteers|volunteers
462033|NCT01590134|Pilot study|pilot study
462034|NCT01590134|There are no pre registration evaluations.|there are no pre registration evaluations.
462035|NCT01590134|Inclusion criteria: to be a healthy, consenting volunteer not currently receiving iron supplements.|inclusion criteria: to be a healthy, consenting volunteer not currently receiving iron supplements.
462036|NCT01590134|Exclusion criteria: 1) Needle phobia; 2) Currently receiving iron supplements; 3) Unable to provide informed consent|exclusion criteria: 1) needle phobia; 2) currently receiving iron supplements; 3) unable to provide informed consent
462037|NCT01590121|Previous flight by aeroplane|previous flight by aeroplane
462038|NCT01590108|Idiopathic Pulmonary Arterial Hypertension|idiopathic pulmonary arterial hypertension
462039|NCT01590108|IPAH|ipah
462040|NCT01590108|Apelin|apelin
462041|NCT01590108|APJ receptor|apj receptor
462042|NCT01590095|Chlorine water treatment|chlorine water treatment
462043|NCT01590095|Point-of-use water treatment|point-of-use water treatment
462044|NCT01590095|Household water treatment with safe storage|household water treatment with safe storage
462045|NCT01590095|Hand washing with soap|hand washing with soap
462046|NCT01590095|Hand hygiene|hand hygiene
462047|NCT01590095|Latrines|latrines
462048|NCT01590095|Child potties|child potties
462049|NCT01590095|Point-of-use fortification|point-of-use fortification
462050|NCT01590095|Lipid-based nutrient supplement|lipid-based nutrient supplement
462051|NCT01590095|Environmental enteropathy|environmental enteropathy
462052|NCT01590095|Tropical enteropathy|tropical enteropathy
462053|NCT01590095|Gut function|gut function
462054|NCT01590095|Intestinal parasitic infection|intestinal parasitic infection
462055|NCT01590095|Soil transmitted helminths|soil transmitted helminths
462056|NCT01590095|Intestinal protozoans|intestinal protozoans
462057|NCT01590095|Antibody response|antibody response
462058|NCT01590095|Water|water
462059|NCT01590095|Sanitation|sanitation
462060|NCT01590095|Hand washing|hand washing
462061|NCT01590095|Breast Feeding|breast feeding
462062|NCT01590095|Complementary Feeding|complementary feeding
462063|NCT01590095|Micronutrients|micronutrients
462064|NCT01590095|Malnutrition|malnutrition
462065|NCT01590095|Nutrition Disorders|nutrition disorders
462066|NCT01590095|Diarrhea|diarrhea
462067|NCT01590095|Child Development|child development
462068|NCT01590082|Melanoma|melanoma
462069|NCT01590082|Metastatic Melanoma|metastatic melanoma
462070|NCT01590082|Advanced melanoma|advanced melanoma
462071|NCT01590082|Doxycycline|doxycycline
462072|NCT01590082|Ipilimumab|ipilimumab
462073|NCT01590082|Yervoy|yervoy
462074|NCT01590082|MDX010|mdx010
462075|NCT01590082|BMS-734016|bms-734016
462076|NCT01590082|Temozolomide|temozolomide
462077|NCT01590082|Temodar|temodar
462078|NCT01590056|Mapping limbic areas of the STN|mapping limbic areas of the stn
462079|NCT01590056|neuronal responses to stimuli during surgery|neuronal responses to stimuli during surgery
462080|NCT01590017|stage IB cervical cancer|stage ib cervical cancer
462081|NCT01590017|stage IIA cervical cancer|stage iia cervical cancer
462082|NCT01590017|stage IIB cervical cancer|stage iib cervical cancer
462083|NCT01590017|stage III cervical cancer|stage iii cervical cancer
462084|NCT01590017|stage IVA cervical cancer|stage iva cervical cancer
462085|NCT01590017|cervical adenocarcinoma|cervical adenocarcinoma
462086|NCT01590017|cervical adenosquamous cell carcinoma|cervical adenosquamous cell carcinoma
462087|NCT01590017|cervical squamous cell carcinoma|cervical squamous cell carcinoma
462088|NCT01590017|HIV infection|hiv infection
462089|NCT01590004|LumbarCool system|lumbarcool system
462090|NCT01590004|Cooled radiofrequency medial ablation|cooled radiofrequency medial ablation
462091|NCT01590004|Cooled-RF neurotomy|cooled-rf neurotomy
462092|NCT01589991|toothpastes|toothpastes
462093|NCT01589991|bioavailability|bioavailability
462094|NCT01589991|sodium fluoride|sodium fluoride
462095|NCT01589991|monofluorphosphate|monofluorphosphate
462096|NCT01589991|low-fluoride|low-fluoride
462097|NCT01589978|drug-eluting stent|drug-eluting stent
462099|NCT01589978|atherosclerosis|atherosclerosis
462100|NCT01589978|everolimus|everolimus
462101|NCT01589965|HIV/AIDS|hiv/aids
462102|NCT01589965|STIs|stis
462103|NCT01589965|Lottery|lottery
462104|NCT01589952|Pegalyted interferon|pegalyted interferon
462105|NCT01589952|Entecavir|entecavir
462106|NCT01589939|Reduced Planning Target Volume|reduced planning target volume
462107|NCT01589939|radiation therapy|radiation therapy
462108|NCT01589939|Calypso|calypso
462109|NCT01589913|Implantable Cardioverter Defibrillators|implantable cardioverter defibrillators
462110|NCT01589913|Heart Failure|heart failure
462111|NCT01589913|Anxiety|anxiety
462112|NCT01589913|Depression|depression
462113|NCT01589913|Quality of Life|quality of life
462114|NCT01589913|Remote Care|remote care
462115|NCT01589913|Prevention|prevention
462116|NCT01589900|colorectal cancer|colorectal cancer
462117|NCT01589900|invasion|invasion
462118|NCT01589900|metastasis|metastasis
462119|NCT01589900|IHC|ihc
462120|NCT01589874|hepcidin|hepcidin
462121|NCT01589874|anemia|anemia
462122|NCT01589874|acute inflammation|acute inflammation
462123|NCT01589874|IL-6|il-6
462124|NCT01589874|cytokines|cytokines
462125|NCT01589848|vWD|vwd
462126|NCT01589809|Congenital, familial and genetic disorders|congenital, familial and genetic disorders
462127|NCT01589809|Nervous System Diseases|nervous system diseases
462128|NCT01589796|anesthesia|anesthesia
462129|NCT01589796|regional anesthetic techniques: transversus abdominis plane block, ilioinguinal nerve block, iliohypogastric nerve block|regional anesthetic techniques: transversus abdominis plane block, ilioinguinal nerve block, iliohypogastric nerve block
462130|NCT01589796|surgery, inguinal herniorrhaphy|surgery, inguinal herniorrhaphy
462131|NCT01589796|pain, postoperative|pain, postoperative
462132|NCT01589796|surgery, inguinal hernia repair|surgery, inguinal hernia repair
462133|NCT01589783|Pregnancy|pregnancy
462134|NCT01589783|Vitamin D|vitamin d
462135|NCT01589770|rheumatoid arthritis|rheumatoid arthritis
462136|NCT01589770|inflammation|inflammation
462137|NCT01589757|"glycaemic index"|"glycaemic index"
462138|NCT01589757|"glycemic index"|"glycemic index"
462139|NCT01589757|hyperglycaemia|hyperglycaemia
462140|NCT01589757|hyperglycemia|hyperglycemia
462141|NCT01589757|pregnancy|pregnancy
462142|NCT01589757|"dietary intervention"|"dietary intervention"
462143|NCT01589757|"education evaluation"|"education evaluation"
462144|NCT01589757|antioxidant|antioxidant
462145|NCT01589757|"Impaired Glucose Tolerance of Pregnancy"|"impaired glucose tolerance of pregnancy"
462146|NCT01589757|"Gestational Diabetes Mellitus"|"gestational diabetes mellitus"
462147|NCT01589757|"Breast Milk"|"breast milk"
462148|NCT01589744|medical device|medical device
462149|NCT01589731|Allergenicity|allergenicity
462150|NCT01589731|Cow's milk allergy|cow's milk allergy
462151|NCT01589731|Leukocyte adherence inhibition test|leukocyte adherence inhibition test
462152|NCT01589731|Polymerization|polymerization
462153|NCT01589718|Proliferative Diabetic Retinopathy|proliferative diabetic retinopathy
462154|NCT01589718|Tractional Retinal Detachment|tractional retinal detachment
462155|NCT01589718|Vitreous Hemorrhage|vitreous hemorrhage
462156|NCT01589705|Uric acid|uric acid
462157|NCT01589705|polycystic kidney disease|polycystic kidney disease
462158|NCT01589692|WRIST|wrist
462159|NCT01589692|Distal Radius Fracture|distal radius fracture
462161|NCT01589692|elderly|elderly
462162|NCT01589692|internal fixation|internal fixation
462163|NCT01589692|VLPS|vlps
462164|NCT01589692|External Fixation|external fixation
462165|NCT01589692|Multi center randomized trial|multi center randomized trial
462166|NCT01589666|Entegrion|entegrion
462167|NCT01589666|Spray-dried Solvent/Detergent Plasma|spray-dried solvent/detergent plasma
462168|NCT01589666|Fresh Frozen Plasma|fresh frozen plasma
462169|NCT01589666|Transfusion|transfusion
462170|NCT01589666|Resuscitation|resuscitation
462171|NCT01589666|Hemorrhage|hemorrhage
462172|NCT01589666|Coagulopathy|coagulopathy
462173|NCT01589627|distal radius fracture|distal radius fracture
462174|NCT01589627|wrist contracture|wrist contracture
462175|NCT01589627|dynasplint|dynasplint
462176|NCT01589601|Congestive Heart Failure|congestive heart failure
462177|NCT01589601|Heart Failure|heart failure
462178|NCT01589601|Palliative Care|palliative care
462179|NCT01589601|Palliative Medicine|palliative medicine
462180|NCT01589588|acute treatment|acute treatment
462181|NCT01589575|Intensive Care Unit|intensive care unit
462182|NCT01589549|Acute graft versus host disease|acute graft versus host disease
462183|NCT01589549|Bone marrow transplantation|bone marrow transplantation
462184|NCT01589549|Mesenchymal stromal cells|mesenchymal stromal cells
462185|NCT01589536|psychocardiological|psychocardiological
462186|NCT01589536|interval intervention|interval intervention
462187|NCT01589536|disability pension|disability pension
462188|NCT01589536|risk profile|risk profile
462189|NCT01589536|mental comorbidity|mental comorbidity
462190|NCT01589484|Tomography|tomography
462191|NCT01589484|Urinary Lithiasis|urinary lithiasis
462192|NCT01589484|Kidney Calculi|kidney calculi
462193|NCT01589471|Low anterior resection syndrome|low anterior resection syndrome
462194|NCT01589471|Botulinum toxin A|botulinum toxin a
462195|NCT01589471|Quality of life|quality of life
462196|NCT01589471|Incontinence|incontinence
462197|NCT01589471|Rectal cancer|rectal cancer
462198|NCT01589471|Anorectal manometry|anorectal manometry
462199|NCT01589458|toothpastes|toothpastes
462200|NCT01589458|saliva|saliva
462201|NCT01589458|dental caries|dental caries
462202|NCT01589458|fluoride|fluoride
462203|NCT01589445|Bangladesh|bangladesh
462204|NCT01589445|T2DM|t2dm
462205|NCT01589445|Pioglitazone|pioglitazone
462206|NCT01589445|Metformin|metformin
462207|NCT01589445|Insulin secretion and Sensitivity|insulin secretion and sensitivity
462208|NCT01589432|Diabetic peripheral neuropathy|diabetic peripheral neuropathy
462209|NCT01589419|DLT|dlt
462210|NCT01589419|radiation|radiation
462211|NCT01589419|veliparib|veliparib
462212|NCT01589419|locally advanced rectal cancer|locally advanced rectal cancer
462213|NCT01589419|ABT-888|abt-888
462214|NCT01589419|capecitabine|capecitabine
462215|NCT01589419|MTD|mtd
462216|NCT01589419|PARP|parp
462217|NCT01589406|Gynaecological Cancer|gynaecological cancer
462218|NCT01589406|Quality of Life|quality of life
462219|NCT01589406|Sexuality|sexuality
462220|NCT01589393|Trauma|trauma
462221|NCT01589393|Thromboprophylaxis|thromboprophylaxis
462222|NCT01589393|Intracranial haemorrhage|intracranial haemorrhage
462223|NCT01589393|Deep vein Thrombosis|deep vein thrombosis
462224|NCT01589380|Aortic stenosis|aortic stenosis
462225|NCT01589380|Exercise performance|exercise performance
462226|NCT01589380|cardiopulmonary exercise test|cardiopulmonary exercise test
462227|NCT01589380|fimasartan|fimasartan
462228|NCT01589367|neoadjuvant endocrine therapy|neoadjuvant endocrine therapy
462229|NCT01589367|metformin|metformin
462230|NCT01589367|postmenopausal breast cancer|postmenopausal breast cancer
462231|NCT01589328|pancreatic cancer|pancreatic cancer
462232|NCT01589328|biliary tract cancer|biliary tract cancer
462233|NCT01589328|cancer pain|cancer pain
462234|NCT01589328|depression|depression
462235|NCT01589315|ECT|ect
462236|NCT01589315|FEAST|feast
462237|NCT01589315|brain stimulation|brain stimulation
462238|NCT01589315|depression|depression
462239|NCT01589302|Bruton's Tyrosine Kinase|bruton's tyrosine kinase
462240|NCT01589302|CLL|cll
462241|NCT01589302|SLL|sll
462242|NCT01589302|B-PLL|b-pll
462243|NCT01589289|Diagnostic research|diagnostic research
462244|NCT01589289|Rapid diagnostic tests|rapid diagnostic tests
462245|NCT01589289|Neurological disorders|neurological disorders
462246|NCT01589289|Neglected Tropical Diseases|neglected tropical diseases
462247|NCT01589289|Developing countries|developing countries
462248|NCT01589263|Benign Prostatic Hyperplasia|benign prostatic hyperplasia
462249|NCT01589263|Lower Urinary Track Symptoms|lower urinary track symptoms
462250|NCT01589263|BPH|bph
462251|NCT01589263|LUTS|luts
462252|NCT01589237|Familial Chylomicronemia Syndrome (FCS) (HLP type I)|familial chylomicronemia syndrome (fcs) (hlp type i)
462253|NCT01589237|LCQ908|lcq908
462254|NCT01589211|smoking|smoking
462255|NCT01589211|cessation|cessation
462256|NCT01589211|intervention|intervention
462257|NCT01589211|brief|brief
462258|NCT01589198|Asthma|asthma
462259|NCT01589185|Pneumonia|pneumonia
462260|NCT01589185|Monoclonal antibody|monoclonal antibody
462261|NCT01589185|Staphylococcus aureus|staphylococcus aureus
462262|NCT01589146|colon-rectal cancer|colon-rectal cancer
462263|NCT01589146|heparin|heparin
462264|NCT01589146|prophylaxis|prophylaxis
462265|NCT01589146|laparoscopy|laparoscopy
462266|NCT01589133|Irregular antibody screening|irregular antibody screening
462267|NCT01589120|CHF|chf
462268|NCT01589120|video decision aid|video decision aid
462269|NCT01589094|CISPLATIN|cisplatin
462270|NCT01589094|GEMCITABINE|gemcitabine
462271|NCT01589094|GM-CSF|gm-csf
462272|NCT01589094|radical cystectomy|radical cystectomy
462273|NCT01589094|12-071|12-071
462274|NCT01589003|low GI milk mood behaviour cognitive function children|low gi milk mood behaviour cognitive function children
462275|NCT01588964|HIPEC|hipec
462276|NCT01588964|ovarian cancer|ovarian cancer
462277|NCT01588964|recurrence|recurrence
462278|NCT01588938|radiation therapy|radiation therapy
462279|NCT01588938|Calypso|calypso
462280|NCT01588925|Cochlear implantation|cochlear implantation
462281|NCT01588925|Dexamethasone|dexamethasone
462282|NCT01588925|Acid, Hyaluronic|acid, hyaluronic
462283|NCT01588912|chronic hepatitis B|chronic hepatitis b
462284|NCT01588912|HBeAg positive|hbeag positive
462285|NCT01588912|telbivudine|telbivudine
462286|NCT01588912|tenofovir|tenofovir
462287|NCT01588912|entecavir|entecavir
462288|NCT01588912|roadmap|roadmap
462289|NCT01588899|Uterine Leiomyomas|uterine leiomyomas
462290|NCT01588899|Fibroids|fibroids
462291|NCT01588899|HIFU|hifu
462292|NCT01588899|Ablation|ablation
462293|NCT01588899|High Intensity Focused Ultrasound|high intensity focused ultrasound
462294|NCT01588886|Proton pump inhibitors|proton pump inhibitors
462295|NCT01588886|Pneumonia|pneumonia
462296|NCT01588886|Retrospective cohort study|retrospective cohort study
462297|NCT01588873|Oral contraceptive pill|oral contraceptive pill
462298|NCT01588873|Hormonal contraceptive ring|hormonal contraceptive ring
462299|NCT01588873|Polycystic ovary syndrome|polycystic ovary syndrome
462300|NCT01588847|perioperative immunoediting|perioperative immunoediting
462301|NCT01588847|potential predictive biomarkers|potential predictive biomarkers
462302|NCT01588847|lymph node dissection|lymph node dissection
462303|NCT01588821|Metastatic|metastatic
462304|NCT01588821|Refractory|refractory
462305|NCT01588821|Relapsed|relapsed
462306|NCT01588808|Immobilization|immobilization
462307|NCT01588808|Protein supplementation|protein supplementation
462308|NCT01588795|Diabetic nephropathy|diabetic nephropathy
462309|NCT01588795|renal denervation|renal denervation
462310|NCT01588795|nephroprotection|nephroprotection
462311|NCT01588795|Renal failure|renal failure
462312|NCT01588795|Renal injury|renal injury
462313|NCT01588795|End stage renal disease|end stage renal disease
462314|NCT01588782|Healthy volunteers|healthy volunteers
462315|NCT01588782|Pharmacology|pharmacology
462316|NCT01588782|Pharmacokinetics|pharmacokinetics
462317|NCT01588782|Pharmacodynamics|pharmacodynamics
462318|NCT01588782|Drug-drug interactions|drug-drug interactions
462319|NCT01588782|CYP3A4|cyp3a4
462320|NCT01588782|Abiraterone acetate|abiraterone acetate
462321|NCT01588782|JNJ-589485|jnj-589485
462322|NCT01588782|JNJ-212082|jnj-212082
462323|NCT01588782|Ketoconazole|ketoconazole
462324|NCT01588769|Glioblastoma Multiforme|glioblastoma multiforme
462325|NCT01588769|Brain cancer|brain cancer
462326|NCT01588769|Immunotherapy|immunotherapy
462327|NCT01588769|Cell based therapy|cell based therapy
462328|NCT01588769|Autologous cell based therapy|autologous cell based therapy
462329|NCT01588769|Adoptive immunotherapy|adoptive immunotherapy
462330|NCT01588769|Cytotoxic T cells|cytotoxic t cells
462331|NCT01588769|Natural Killer cells|natural killer cells
462332|NCT01588756|Chronic kidney disease|chronic kidney disease
462333|NCT01588756|GFR|gfr
462334|NCT01588756|Inulin|inulin
462335|NCT01588756|51Cr-EDTA|51cr-edta
462336|NCT01588756|ASDKP-NH2|asdkp-nh2
462337|NCT01588756|Healthy male 18-35 yrs old, non smokers, non allergic|healthy male 18-35 yrs old, non smokers, non allergic
462338|NCT01588756|Or Male/female 18-80 yrs old with chronic Kidney disease|or male/female 18-80 yrs old with chronic kidney disease
462339|NCT01588730|PF|pf
462340|NCT01588730|Dynasplint|dynasplint
462341|NCT01588730|ADFD|adfd
462342|NCT01588730|AFD|afd
462343|NCT01588730|Plantar Fasciitis|plantar fasciitis
462344|NCT01588730|plantar Fasciopathy|plantar fasciopathy
462345|NCT01588717|Hyperhydrosis|hyperhydrosis
462746|NCT01586637|Pain|pain
462346|NCT01588717|Excessive Sweating|excessive sweating
462347|NCT01588717|Sweating|sweating
462348|NCT01588717|Depression|depression
462349|NCT01588717|Antidepressant|antidepressant
462350|NCT01588704|lung cancer|lung cancer
462351|NCT01588704|lung adenocarcinoma|lung adenocarcinoma
462352|NCT01588704|bevacizumab|bevacizumab
462353|NCT01588704|adjuvant chemotherapy|adjuvant chemotherapy
462354|NCT01588704|surgical resection rate|surgical resection rate
462355|NCT01588704|safety|safety
462356|NCT01588704|feasibility|feasibility
462357|NCT01588691|Traumatic Brain Injury|traumatic brain injury
462358|NCT01588678|endometrial|endometrial
462359|NCT01588678|prostate|prostate
462360|NCT01588678|breast|breast
462361|NCT01588678|gastric|gastric
462362|NCT01588678|cervical|cervical
462363|NCT01588678|ovarian|ovarian
462364|NCT01588678|neuroendocrine cancers|neuroendocrine cancers
462365|NCT01588678|soft-tissue sarcoma|soft-tissue sarcoma
462366|NCT01588678|squamous cell NSCLC|squamous cell nsclc
462367|NCT01588678|renal cell carcinoma|renal cell carcinoma
462368|NCT01588678|non-Hodgkin lymphoma|non-hodgkin lymphoma
462369|NCT01588665|pregnancy|pregnancy
462370|NCT01588665|stable isotopes|stable isotopes
462371|NCT01588665|red blood cell catabolism|red blood cell catabolism
462372|NCT01588639|Recombinant human insulin|recombinant human insulin
462373|NCT01588639|T2DM|t2dm
462374|NCT01588639|Safety|safety
462375|NCT01588639|Efficacy|efficacy
462376|NCT01588626|Healthy volunteer|healthy volunteer
462377|NCT01588626|Japanese males|japanese males
462378|NCT01588626|PK study|pk study
462379|NCT01588600|food intake, satiety, fiber|food intake, satiety, fiber
462380|NCT01588548|Advanced solid malignancies|advanced solid malignancies
462381|NCT01588548|Malignant lymphoma|malignant lymphoma
462382|NCT01588535|pain|pain
462383|NCT01588535|pain measurement|pain measurement
462384|NCT01588535|ear, middle|ear, middle
462385|NCT01588535|otitis media|otitis media
462386|NCT01588522|alopecia|alopecia
462387|NCT01588509|AMG 785, bone mineral density, alendronate|amg 785, bone mineral density, alendronate
462388|NCT01588496|hypercholesterolemia|hypercholesterolemia
462389|NCT01588496|familial hypercholesterolemia|familial hypercholesterolemia
462390|NCT01588496|homozygous familial hypercholesterolemia|homozygous familial hypercholesterolemia
462391|NCT01588470|diastolic function|diastolic function
462392|NCT01588470|mitochondria|mitochondria
462393|NCT01588470|pioglitazone|pioglitazone
462394|NCT01588470|pericardial fat|pericardial fat
462395|NCT01588444|tooth extraction|tooth extraction
462396|NCT01588444|bone grafting|bone grafting
462397|NCT01588431|Locally advanced head and neck cancer|locally advanced head and neck cancer
462398|NCT01588431|Squamous cell carcinoma of the head and neck|squamous cell carcinoma of the head and neck
462399|NCT01588418|Impaired glucose tolerance (IGT)|impaired glucose tolerance (igt)
462400|NCT01588418|Diabetes|diabetes
462401|NCT01588405|Pulmonary Arterial Hypertension|pulmonary arterial hypertension
462402|NCT01588405|UT-15C SR|ut-15c sr
462403|NCT01588405|PAH|pah
462404|NCT01588392|Physical activity|physical activity
462405|NCT01588392|preschoolers|preschoolers
462406|NCT01588353|AK160, collagenase clostridium histolyticum|ak160, collagenase clostridium histolyticum
462407|NCT01588314|Fabry disease|fabry disease
462408|NCT01588314|neuropathic pain|neuropathic pain
462409|NCT01588314|gabapentin|gabapentin
462410|NCT01588301|Cervical Cancer Screening|cervical cancer screening
462411|NCT01588301|Human Papillomavirus (HPV)|human papillomavirus (hpv)
462412|NCT01588301|Self-collected vaginal sample|self-collected vaginal sample
462413|NCT01588301|Cervical Smear|cervical smear
462414|NCT01588288|Diagnosis|diagnosis
462415|NCT01588288|Galectin 3|galectin 3
462416|NCT01588288|Puncture|puncture
462417|NCT01588288|Goiter, nodular|goiter, nodular
462418|NCT01588288|Surgery|surgery
462419|NCT01588275|cost-effectiveness|cost-effectiveness
462420|NCT01588275|effectiveness|effectiveness
462421|NCT01588275|treatment|treatment
462422|NCT01588275|CPAP|cpap
462423|NCT01588275|MRA|mra
462424|NCT01588275|compliance|compliance
462425|NCT01588210|caries|caries
462426|NCT01588210|sealant|sealant
462427|NCT01588210|fluoride|fluoride
462428|NCT01588210|prevention|prevention
462429|NCT01588210|community dentistry|community dentistry
462430|NCT01588197|Pain|pain
462431|NCT01588197|fMRI|fmri
462432|NCT01588197|real time|real time
462433|NCT01588171|Deep vein thrombosis|deep vein thrombosis
462434|NCT01588171|Pulmonary embolism|pulmonary embolism
462435|NCT01588171|Low molecular weight heparin|low molecular weight heparin
462436|NCT01588171|Enoxaparin|enoxaparin
462437|NCT01588171|Bemiparin|bemiparin
462438|NCT01588158|carpal tunnel syndrome|carpal tunnel syndrome
462439|NCT01588158|Tylenol|tylenol
462440|NCT01588158|Vicodin|vicodin
462441|NCT01588158|pain|pain
462442|NCT01588145|NSCLC|nsclc
462443|NCT01588145|HM61713|hm61713
462444|NCT01588145|EGFR-TKI|egfr-tki
462445|NCT01588145|Phase II|phase ii
462446|NCT01588145|olmutinib|olmutinib
462447|NCT01588041|Microscope mounted SDOCT|microscope mounted sdoct
462448|NCT01587976|Health related quality of life|health related quality of life
462449|NCT01587976|Colorectal liver metastasis|colorectal liver metastasis
462450|NCT01587976|surveillance|surveillance
462451|NCT01587963|hypovolemic or septic|hypovolemic or septic
462452|NCT01587950|dentinal sensitivity|dentinal sensitivity
462453|NCT01587950|potassium nitrate|potassium nitrate
462454|NCT01587950|dental pain|dental pain
462455|NCT01587937|Antibiotic stewardship.|antibiotic stewardship.
462456|NCT01587937|Clostridium difficile infection.|clostridium difficile infection.
462457|NCT01587937|Antibiotic resistance.|antibiotic resistance.
462458|NCT01587924|Renal Impairment|renal impairment
462459|NCT01587924|Anemia|anemia
462460|NCT01587924|pharmacokinetics|pharmacokinetics
462461|NCT01587924|hemodialysis|hemodialysis
462462|NCT01587924|Chronic kidney disease|chronic kidney disease
462463|NCT01587924|GSK1278863|gsk1278863
462464|NCT01587924|hemoglobin|hemoglobin
462465|NCT01587924|Prolyl hydroxylase inhibitor|prolyl hydroxylase inhibitor
462466|NCT01587924|recombinant human erythropoietin|recombinant human erythropoietin
462467|NCT01587924|erythropoiesis stimulating agents|erythropoiesis stimulating agents
462468|NCT01587924|Dialysis, Renal|dialysis, renal
462469|NCT01587911|Satiety|satiety
462470|NCT01587911|Food intake regulation|food intake regulation
462471|NCT01587911|Appetite regulation|appetite regulation
462472|NCT01587911|Dairy Protein|dairy protein
462473|NCT01587898|Anemia|anemia
462474|NCT01587898|Prolyl hydroxylase inhibitor|prolyl hydroxylase inhibitor
462475|NCT01587898|Hemoglobin|hemoglobin
462476|NCT01587898|Chronic kidney disease|chronic kidney disease
462477|NCT01587898|pharmacokinetics|pharmacokinetics
462478|NCT01587898|recombinant human erythropoietin|recombinant human erythropoietin
462479|NCT01587898|GSK1278863|gsk1278863
462480|NCT01587885|Frequent Heartburn|frequent heartburn
462481|NCT01587885|Omeprazole|omeprazole
462482|NCT01587885|Omeprazole, sodium bicarbonate drug combination|omeprazole, sodium bicarbonate drug combination
462483|NCT01587885|Gastrointestinal Agents|gastrointestinal agents
462484|NCT01587885|Therapeutic Uses|therapeutic uses
462485|NCT01587885|Pharmacologic Actions|pharmacologic actions
462486|NCT01587885|Enzyme Inhibitors|enzyme inhibitors
462487|NCT01587885|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action
462488|NCT01587885|Proton Pump Inhibitors|proton pump inhibitors
462489|NCT01587872|Colonoscopy|colonoscopy
462490|NCT01587872|Colorectal cancer|colorectal cancer
462491|NCT01587872|Screening colonoscopy|screening colonoscopy
462492|NCT01587859|esophagus|esophagus
462493|NCT01587859|gastro-esophageal reflux disease|gastro-esophageal reflux disease
462494|NCT01587859|type II-IV hiatal hernia|type ii-iv hiatal hernia
462495|NCT01587859|esophageal surgery|esophageal surgery
462496|NCT01587859|minimally invasive surgery|minimally invasive surgery
462497|NCT01587846|abdominal pain, constipation, Lactobacillus reuteri|abdominal pain, constipation, lactobacillus reuteri
462498|NCT01587833|Benzodiazepines|benzodiazepines
462499|NCT01587833|hip/femur fracture|hip/femur fracture
462500|NCT01587820|cisplatin|cisplatin
462501|NCT01587820|RADPLAT|radplat
462502|NCT01587820|intra-arterial chemotherapy|intra-arterial chemotherapy
462503|NCT01587820|head and neck cancer|head and neck cancer
462504|NCT01587807|Infection, Quality of Life, lung injury|infection, quality of life, lung injury
462505|NCT01587794|Rhegmatogenous retinal detachment|rhegmatogenous retinal detachment
462506|NCT01587794|thickness of retinal layer|thickness of retinal layer
462507|NCT01587794|outer nuclear layer|outer nuclear layer
462508|NCT01587794|photoreceptor layer|photoreceptor layer
462509|NCT01587781|Pharmacokinetics of enoxaparin|pharmacokinetics of enoxaparin
462510|NCT01587768|Acute liver injury|acute liver injury
462511|NCT01587768|antibiotics|antibiotics
462512|NCT01587742|Calcium channel blockers|calcium channel blockers
462513|NCT01587742|cancer|cancer
462514|NCT01587729|Hip/femur fracture|hip/femur fracture
462515|NCT01587729|antidepressants|antidepressants
462516|NCT01587716|Safety and tolerability, pharmacokinetics, cough, voltage gated sodium channels (VGSC), anaesthesia|safety and tolerability, pharmacokinetics, cough, voltage gated sodium channels (vgsc), anaesthesia
462517|NCT01587703|BRD3|brd3
462518|NCT01587703|GSK525762|gsk525762
462519|NCT01587703|NUT Midline Carcinoma|nut midline carcinoma
462520|NCT01587703|MYCN-amplified Solid Tumor|mycn-amplified solid tumor
462521|NCT01587703|BRD4|brd4
462522|NCT01587703|BET inhibitor|bet inhibitor
462523|NCT01587703|bromodomains|bromodomains
462524|NCT01587703|NMC|nmc
462525|NCT01587703|Colorectal C ancer|colorectal c ancer
462526|NCT01587703|Small Cell Lung Cancer|small cell lung cancer
462527|NCT01587703|Multiple Myeloma|multiple myeloma
462528|NCT01587703|Neuroblastoma|neuroblastoma
462529|NCT01587703|Oncology|oncology
462530|NCT01587677|Tuberculosis|tuberculosis
462531|NCT01587664|Swallowing disorders|swallowing disorders
462532|NCT01587664|Aspiration|aspiration
462533|NCT01587651|CAD|cad
462534|NCT01587651|prasugrel|prasugrel
462535|NCT01587651|ticagrelor|ticagrelor
462536|NCT01587651|antiplatelet|antiplatelet
462537|NCT01587651|thienopyridine|thienopyridine
462538|NCT01587651|P2Y12 Inhibitors|p2y12 inhibitors
462539|NCT01587638|new-onset diabetes|new-onset diabetes
462540|NCT01587638|carvedilol|carvedilol
462541|NCT01587638|claims analysis|claims analysis
462542|NCT01587638|beta-blocker|beta-blocker
462543|NCT01587638|Diabetes Mellitus|diabetes mellitus
462544|NCT01587625|Delayed labour|delayed labour
462545|NCT01587625|dystocia|dystocia
462546|NCT01587625|oxytocin augmentation|oxytocin augmentation
462547|NCT01587625|primiparous women|primiparous women
462548|NCT01587625|childbirth|childbirth
462549|NCT01587625|childbirth experience|childbirth experience
462550|NCT01587625|progress|progress
462551|NCT01587612|Pain|pain
462552|NCT01587612|Foot|foot
462553|NCT01587599|pharmaceutical care|pharmaceutical care
462554|NCT01587599|drug-related problems|drug-related problems
462555|NCT01587599|elderly|elderly
462556|NCT01587599|Pharmaceutical care of elderly patients with diabetes|pharmaceutical care of elderly patients with diabetes
462557|NCT01587586|Hepatitis C, Chronic|hepatitis c, chronic
462558|NCT01587586|Interferon-alpha|interferon-alpha
462559|NCT01587586|Hepatitis C Virus|hepatitis c virus
462560|NCT01587573|salivary biomarkers|salivary biomarkers
462561|NCT01587560|Shoulder|shoulder
462562|NCT01587560|Arthroplasty|arthroplasty
462563|NCT01587560|Pyrocarbon|pyrocarbon
462564|NCT01587560|Randomized controlled trial|randomized controlled trial
462565|NCT01587560|Shoulder resurfacing|shoulder resurfacing
462567|NCT01587547|IVF|ivf
462568|NCT01587547|ICSI|icsi
462569|NCT01587547|embryo selection|embryo selection
462570|NCT01587534|Unresectable Pancreatic cancer|unresectable pancreatic cancer
462571|NCT01587521|Metabolic syndrome|metabolic syndrome
462572|NCT01587521|Prevalence|prevalence
462573|NCT01587521|Quality of life|quality of life
462574|NCT01587521|Depression|depression
462575|NCT01587521|Antipsychotics|antipsychotics
462576|NCT01587482|Superficial femoral artery|superficial femoral artery
462577|NCT01587482|endovascular|endovascular
462578|NCT01587482|Drug eluting balloon|drug eluting balloon
462579|NCT01587482|Paclitaxel|paclitaxel
462580|NCT01587456|Osteoporosis|osteoporosis
462581|NCT01587430|acute myeloid leukemia|acute myeloid leukemia
462582|NCT01587430|anthracyclines|anthracyclines
462583|NCT01587430|high dose cytarabine|high dose cytarabine
462584|NCT01587430|maintenance|maintenance
462585|NCT01587404|Atrial Fibrillation|atrial fibrillation
462586|NCT01587404|Electrogram|electrogram
462587|NCT01587404|Ablation|ablation
462588|NCT01587404|Contact Force|contact force
462589|NCT01587378|miscarriage|miscarriage
462590|NCT01587378|preterm birth|preterm birth
462591|NCT01587378|prevention|prevention
462592|NCT01587326|cytokine, depression, escitalopram|cytokine, depression, escitalopram
462593|NCT01587313|hydralazine|hydralazine
462594|NCT01587313|isosorbide|isosorbide
462595|NCT01587313|bidil|bidil
462596|NCT01587313|volunteers|volunteers
462597|NCT01587313|pharmacokinetic profile|pharmacokinetic profile
462598|NCT01587287|Anterior corneal power|anterior corneal power
462599|NCT01587287|Placido topographer|placido topographer
462600|NCT01587287|Scheimpﬂug|scheimpﬂug
462601|NCT01587287|Precision|precision
462602|NCT01587287|Agreement|agreement
462603|NCT01587274|low back pain|low back pain
462604|NCT01587261|Burns|burns
462605|NCT01587261|Vitamin C|vitamin c
462606|NCT01587261|Thermal Injury|thermal injury
462607|NCT01587261|Fluid Resuscitation|fluid resuscitation
462608|NCT01587248|Breast cancer,|breast cancer,
462609|NCT01587248|Harmonic scalpel,|harmonic scalpel,
462610|NCT01587248|Electrocautery,|electrocautery,
462611|NCT01587248|Modified Radical Mastectomy,|modified radical mastectomy,
462612|NCT01587248|Randomized Controlled Trial|randomized controlled trial
462613|NCT01587209|decompression|decompression
462614|NCT01587209|intravascular bubbles|intravascular bubbles
462615|NCT01587209|neutrophil activation|neutrophil activation
462616|NCT01587196|prescription opiates/medications|prescription opiates/medications
462617|NCT01587196|vivitrol|vivitrol
462618|NCT01587196|brain imaging|brain imaging
462619|NCT01587183|Running|running
462620|NCT01587183|Blood pressure|blood pressure
462621|NCT01587170|spasticity|spasticity
462622|NCT01587170|spinal cord injury|spinal cord injury
462623|NCT01587170|zolmitriptan|zolmitriptan
462624|NCT01587144|GBM|gbm
462625|NCT01587131|Universal Influenza|universal influenza
462626|NCT01587131|Intradermal DNA-Based Vaccine|intradermal dna-based vaccine
462627|NCT01587131|Senior|senior
462628|NCT01587131|Electroporation|electroporation
462629|NCT01587131|H1|h1
462630|NCT01587131|Influenza|influenza
462631|NCT01587131|FVH1|fvh1
462632|NCT01587118|PTSD|ptsd
462633|NCT01587118|Posttraumatic Stress Disorder|posttraumatic stress disorder
462634|NCT01587118|Asenapine|asenapine
462635|NCT01587118|Adjunctive|adjunctive
462636|NCT01587118|antidepressant|antidepressant
462637|NCT01587118|neuroleptic|neuroleptic
462638|NCT01587092|walking|walking
462639|NCT01587092|physical activity|physical activity
462640|NCT01587092|sedentary behavior|sedentary behavior
462641|NCT01587092|workplace|workplace
462642|NCT01587079|COPD|copd
462643|NCT01587027|Altitude Sickness|altitude sickness
462644|NCT01587027|High Altitude Sickness|high altitude sickness
462645|NCT01587001|Sarcoidosis|sarcoidosis
462646|NCT01587001|oxidative stress|oxidative stress
462647|NCT01587001|anti-oxidant|anti-oxidant
462648|NCT01586988|HIV|hiv
462649|NCT01586988|Parenting|parenting
462650|NCT01586988|self-care|self-care
462651|NCT01586988|disclosure|disclosure
462652|NCT01586988|medication adherence|medication adherence
462653|NCT01586988|mother|mother
462654|NCT01586988|child|child
462655|NCT01586988|adolescent|adolescent
462656|NCT01586962|paracetamol|paracetamol
462657|NCT01586962|pseudoephedrine|pseudoephedrine
462658|NCT01586962|syrup|syrup
462659|NCT01586962|upper respiratory tract infection|upper respiratory tract infection
462660|NCT01586949|well-being|well-being
462661|NCT01586949|web-based intervention|web-based intervention
462662|NCT01586949|social networks|social networks
462663|NCT01586923|Anemia|anemia
462664|NCT01586923|Transfusion|transfusion
462665|NCT01586923|RBC storage age|rbc storage age
462666|NCT01586923|Tissue oxygenation|tissue oxygenation
462667|NCT01586923|Malaria|malaria
462668|NCT01586897|health information technology|health information technology
462669|NCT01586897|primary care|primary care
462670|NCT01586897|visit-independent|visit-independent
462671|NCT01586897|medication monitoring|medication monitoring
462672|NCT01586884|LV Pacing|lv pacing
462673|NCT01586884|LV Lead Placement|lv lead placement
462674|NCT01586884|LV Pacing Site|lv pacing site
462675|NCT01586884|CRT Device Placement|crt device placement
462676|NCT01586871|MPS I|mps i
462677|NCT01586871|MPS II|mps ii
462678|NCT01586871|MPS VI|mps vi
462679|NCT01586871|Mucopolysaccharidoses|mucopolysaccharidoses
462680|NCT01586858|Vasculitis|vasculitis
462681|NCT01586858|ANCA|anca
462682|NCT01586858|Rituximab|rituximab
462683|NCT01586858|Small vessel vasculitis|small vessel vasculitis
462684|NCT01586845|Randomized Controlled Trials|randomized controlled trials
462685|NCT01586845|Immunosuppression|immunosuppression
462686|NCT01586845|Adult|adult
462687|NCT01586845|Kidney Transplantation|kidney transplantation
462688|NCT01586845|Treatment Outcome|treatment outcome
462689|NCT01586832|Hospital Supplies|hospital supplies
462690|NCT01586832|Stocking of Supplies|stocking of supplies
462691|NCT01586806|Dexamethasone|dexamethasone
462692|NCT01586806|Glucocorticoids|glucocorticoids
462693|NCT01586806|Physiological Effects of Drugs|physiological effects of drugs
462694|NCT01586806|Therapeutic Uses|therapeutic uses
462695|NCT01586806|Anterior Cruciate Ligament Reconstruction|anterior cruciate ligament reconstruction
462696|NCT01586806|Regional Anesthesia, nerve block|regional anesthesia, nerve block
462697|NCT01586806|Ultrasonic Imaging|ultrasonic imaging
462698|NCT01586806|Post-Operative Complications: muscle weakness, pain, nausea and vomiting|post-operative complications: muscle weakness, pain, nausea and vomiting
462699|NCT01586806|Dexamethasone (as local anesthetic additive)|dexamethasone (as local anesthetic additive)
462700|NCT01586793|Repetitive transcranial magnetic stimulation|repetitive transcranial magnetic stimulation
462701|NCT01586793|Bipolar depression|bipolar depression
462702|NCT01586793|Randomized trial|randomized trial
462703|NCT01586793|rTMS|rtms
462704|NCT01586793|Neuromodulation|neuromodulation
462705|NCT01586780|Whey protein|whey protein
462706|NCT01586780|Soy protein|soy protein
462707|NCT01586780|Insulinogenic amino acids|insulinogenic amino acids
462708|NCT01586780|Incretins|incretins
462709|NCT01586780|Glycaemia|glycaemia
462710|NCT01586780|Insulinaemia|insulinaemia
462711|NCT01586767|Nasal cavity|nasal cavity
462712|NCT01586767|Salivary gland tumors|salivary gland tumors
462713|NCT01586767|Hard palate|hard palate
462714|NCT01586767|Sinus|sinus
462715|NCT01586767|Soft Palate|soft palate
462716|NCT01586767|Lacrimal Apparatus|lacrimal apparatus
462717|NCT01586754|metabolic syndrome|metabolic syndrome
462718|NCT01586754|obesity|obesity
462719|NCT01586754|endothelial damage|endothelial damage
462720|NCT01586754|homocysteine|homocysteine
462721|NCT01586754|microalbumin|microalbumin
462722|NCT01586754|carotis intima-media thickness|carotis intima-media thickness
462723|NCT01586728|Cystic fibrosis|cystic fibrosis
462724|NCT01586728|oxygen therapy|oxygen therapy
462725|NCT01586728|sleep|sleep
462726|NCT01586715|Extremely complex perianal fistula|extremely complex perianal fistula
462727|NCT01586715|Adipose Derived Stem Cells|adipose derived stem cells
462728|NCT01586702|Stroke, TIA, secondary prevention, support program, multifactorial intervention|stroke, tia, secondary prevention, support program, multifactorial intervention
462729|NCT01586689|Oxford House|oxford house
462730|NCT01586689|recovery|recovery
462731|NCT01586689|substance abuse|substance abuse
462732|NCT01586689|alcohol abuse|alcohol abuse
462733|NCT01586689|addiction|addiction
462734|NCT01586676|supervision|supervision
462735|NCT01586676|motivational interviewing|motivational interviewing
462736|NCT01586676|substance abuse|substance abuse
462737|NCT01586676|dissemination|dissemination
462738|NCT01586663|Diffuse Systemic Sclerosis|diffuse systemic sclerosis
462739|NCT01586663|Hand|hand
462740|NCT01586663|Range of motion|range of motion
462741|NCT01586663|Splint|splint
462742|NCT01586650|ankylosing spondylitis|ankylosing spondylitis
462743|NCT01586650|aerobic exercise|aerobic exercise
462744|NCT01586637|Fibromyalgia|fibromyalgia
462745|NCT01586637|Art Therapy|art therapy
462747|NCT01586637|Quality of life|quality of life
462748|NCT01586637|Body Image|body image
462749|NCT01586624|Phase I|phase i
462750|NCT01586624|Drug evaluation|drug evaluation
462751|NCT01586624|Oncology|oncology
462752|NCT01586624|Vandetanib|vandetanib
462753|NCT01586624|Selumetinib|selumetinib
462754|NCT01586624|Dose escalation|dose escalation
462755|NCT01586624|Clinical trial|clinical trial
462756|NCT01586624|Vascular Endothelial Growth Factor(VEGFR) inhibitor|vascular endothelial growth factor(vegfr) inhibitor
462757|NCT01586624|Epidermal Growth Factor Receptor(EGFR)inhibitor|epidermal growth factor receptor(egfr)inhibitor
462758|NCT01586624|Mitogen Activated Kinase (MEK) inhibitor|mitogen activated kinase (mek) inhibitor
462759|NCT01586624|Non small cell lung cancer|non small cell lung cancer
462760|NCT01586598|Mandibular Nerve|mandibular nerve
462761|NCT01586598|Orthognathic Surgery|orthognathic surgery
462762|NCT01586598|Sagittal Split Osteotomy|sagittal split osteotomy
462763|NCT01586598|Sensory Retraining|sensory retraining
462764|NCT01586572|Polio virus type 1,2,3|polio virus type 1,2,3
462765|NCT01586572|Poliovaccine-Oral|poliovaccine-oral
462766|NCT01586572|Poliovaccine|poliovaccine
462767|NCT01586572|Trivalent Oral Polio vaccine|trivalent oral polio vaccine
462768|NCT01586572|Monovalent oral polio vaccine|monovalent oral polio vaccine
462769|NCT01586572|Bivalent Oral polio vaccine|bivalent oral polio vaccine
462770|NCT01586546|Mind-body|mind-body
462771|NCT01586546|Psychosocial|psychosocial
462772|NCT01586546|Meditation|meditation
462773|NCT01586546|Breathing Exercises|breathing exercises
462774|NCT01586546|Guided Imagery|guided imagery
462775|NCT01586546|Visualization|visualization
462776|NCT01586533|ulcerative colitis|ulcerative colitis
462777|NCT01586533|UC|uc
462778|NCT01586533|left-sided ulcerative colitis|left-sided ulcerative colitis
462779|NCT01586533|distal ulcerative colitis|distal ulcerative colitis
462780|NCT01586533|Zoenasa|zoenasa
462781|NCT01586533|mesalamine|mesalamine
462782|NCT01586533|mesalazine|mesalazine
462783|NCT01586533|5-ASA|5-asa
462784|NCT01586533|5-aminosalicylic acid|5-aminosalicylic acid
462785|NCT01586533|N-acetylcysteine|n-acetylcysteine
462786|NCT01586533|acetylcysteine|acetylcysteine
462787|NCT01586533|NAC|nac
462788|NCT01586533|enema|enema
462789|NCT01586533|rectal gel|rectal gel
462790|NCT01586520|thyroid cancer, papillary, follicular, proteomics, genetic markers|thyroid cancer, papillary, follicular, proteomics, genetic markers
462791|NCT01586507|Pain|pain
462792|NCT01586507|ULTRAM ER|ultram er
462793|NCT01586507|Tramadol hydrochloride|tramadol hydrochloride
462794|NCT01586507|Adolescents|adolescents
462795|NCT01586494|Pain|pain
462796|NCT01586494|ULTRAM ER|ultram er
462797|NCT01586494|Tramadol hydrochloride|tramadol hydrochloride
462798|NCT01586494|Children|children
462799|NCT01586481|Diabetic foot ulcer|diabetic foot ulcer
462800|NCT01586481|Off loading|off loading
462801|NCT01586481|Compliance|compliance
462802|NCT01586481|Healing duration|healing duration
462803|NCT01586481|Amputation rate|amputation rate
462804|NCT01586455|umbilical cord blood|umbilical cord blood
462805|NCT01586455|stem cell transplantation|stem cell transplantation
462806|NCT01586455|placental stem cell|placental stem cell
462807|NCT01586455|inborn errors of metabolism|inborn errors of metabolism
462808|NCT01586455|marrow failure|marrow failure
462809|NCT01586455|Severe Combined Immunodeficiency Disease|severe combined immunodeficiency disease
462810|NCT01586455|AML|aml
462811|NCT01586455|ALL|all
462812|NCT01586455|MDS|mds
462813|NCT01586429|comparing the analgesic efficacy of ultrasound-guided nerve block catheter compared with epidural analgesia|comparing the analgesic efficacy of ultrasound-guided nerve block catheter compared with epidural analgesia
462814|NCT01586416|Colonic neoplasms|colonic neoplasms
462815|NCT01586416|Older adults|older adults
462816|NCT01586416|Psychosocial Intervention|psychosocial intervention
462817|NCT01586416|Chemotherapy adherence|chemotherapy adherence
462818|NCT01586403|Melanoma|melanoma
462819|NCT01586403|Gene Therapy|gene therapy
462820|NCT01586403|Adoptive T-Cell Transfer|adoptive t-cell transfer
462821|NCT01586403|IL-2|il-2
462822|NCT01586390|Ankle Sprain|ankle sprain
462823|NCT01586390|Ankle Distortion|ankle distortion
462824|NCT01586390|Functional treatment|functional treatment
462825|NCT01586390|Brace treatment|brace treatment
462826|NCT01586377|Complex regional pain syndrome|complex regional pain syndrome
462827|NCT01586377|Near Infrared Spectroscopy|near infrared spectroscopy
462828|NCT01586377|Vascular Occlusion Test|vascular occlusion test
462829|NCT01586364|Menopausal symptoms|menopausal symptoms
462830|NCT01586364|Vulvar and vaginal atrophy in menopausal women|vulvar and vaginal atrophy in menopausal women
462831|NCT01586364|Vaginal atrophy|vaginal atrophy
462832|NCT01586364|Urogenital atrophy|urogenital atrophy
462833|NCT01586351|Rotator cuff tears|rotator cuff tears
462834|NCT01586351|ACP|acp
462835|NCT01586351|DX Reinforcement Matrix|dx reinforcement matrix
462836|NCT01586325|Chronic hepatitis C infection|chronic hepatitis c infection
462837|NCT01586325|Asian genotype 1 chronic hepatitis C infection|asian genotype 1 chronic hepatitis c infection
462838|NCT01586325|JNJ-47910382|jnj-47910382
462839|NCT01586325|Non-structural protein 5A (NS5A) inhibitor|non-structural protein 5a (ns5a) inhibitor
462840|NCT01586312|Knee degenerative disease|knee degenerative disease
462841|NCT01586312|osteoarthritis|osteoarthritis
462842|NCT01586312|gonarthrosis|gonarthrosis
462843|NCT01586312|stem cell|stem cell
462844|NCT01586312|cellular therapy|cellular therapy
462845|NCT01586312|regenerative therapy|regenerative therapy
462846|NCT01586312|Mesenchymal stem cells|mesenchymal stem cells
462847|NCT01586312|Bone marrow|bone marrow
462848|NCT01586312|musculoskeletal Diseases|musculoskeletal diseases
462849|NCT01586312|Mesenchymal Stromal Cells (allogenic)|mesenchymal stromal cells (allogenic)
462850|NCT01586299|pleuropneumonia children|pleuropneumonia children
462851|NCT01586299|non steroidal anti inflammatory drugs|non steroidal anti inflammatory drugs
462852|NCT01586299|pleural effusion|pleural effusion
462853|NCT01586299|severe pneumonia|severe pneumonia
462854|NCT01586286|Levator Myalgia|levator myalgia
462855|NCT01586286|Pelvic Pain|pelvic pain
462856|NCT01586286|Vaginismus|vaginismus
462857|NCT01586286|Myofascial pain syndromes|myofascial pain syndromes
462858|NCT01586260|Neuroblastoma in remission|neuroblastoma in remission
462859|NCT01586260|Relapsed Neuroblastoma|relapsed neuroblastoma
462860|NCT01586260|Refractory Neuroblastoma|refractory neuroblastoma
462861|NCT01586234|Fuchs' endothelial dystrophy|fuchs' endothelial dystrophy
462862|NCT01586234|DSAEK|dsaek
462863|NCT01586234|Descemet's stripping automated endothelial keratoplasty|descemet's stripping automated endothelial keratoplasty
462864|NCT01586221|Rehabilitation|rehabilitation
462865|NCT01586221|Fingers|fingers
462866|NCT01586221|Grasp|grasp
462867|NCT01586221|Strength|strength
462868|NCT01586221|Brain Function|brain function
462869|NCT01586221|Physiopathology|physiopathology
462870|NCT01586221|Functional Laterality|functional laterality
462871|NCT01586221|Psychomotor Performance|psychomotor performance
462872|NCT01586221|Biomechanis|biomechanis
462873|NCT01586221|Touch|touch
462874|NCT01586221|Music Therapy|music therapy
462875|NCT01586221|Weight-Bearing|weight-bearing
462876|NCT01586208|refractory status epilepticus|refractory status epilepticus
462877|NCT01586208|valproic acid|valproic acid
462878|NCT01586208|phenytoin|phenytoin
462879|NCT01586208|benzodiazepines|benzodiazepines
462880|NCT01586208|Valproic acid initial dosage in status treatment|valproic acid initial dosage in status treatment
462881|NCT01586182|poor prognosis|poor prognosis
462882|NCT01586169|Albendazole|albendazole
462883|NCT01586169|Ivermectin|ivermectin
462884|NCT01586169|Azithromycin|azithromycin
462885|NCT01586169|Lymphatic filariasis|lymphatic filariasis
462886|NCT01586169|Trachoma|trachoma
462887|NCT01586169|Safety|safety
462888|NCT01586143|Paracetamol by permucosal route,|paracetamol by permucosal route,
462889|NCT01586143|Paracetamol by intraveinous route,|paracetamol by intraveinous route,
462890|NCT01586143|Pain.|pain.
462891|NCT01586143|Patient with minor trauma of lower limb and/or superior limb (sprains, muscle contusions, …).|patient with minor trauma of lower limb and/or superior limb (sprains, muscle contusions, …).
462892|NCT01586130|Knee Osteoarthritis|knee osteoarthritis
462893|NCT01586130|Exercise|exercise
462894|NCT01586130|Isokinetic|isokinetic
462895|NCT01586130|Muscle strength|muscle strength
462896|NCT01586130|Rehabilitation|rehabilitation
462897|NCT01586117|rectal cancer|rectal cancer
462898|NCT01586117|amifostine|amifostine
462899|NCT01586117|pre-operative chemo-radiation|pre-operative chemo-radiation
462900|NCT01586065|type 1 diabetes|type 1 diabetes
462901|NCT01586065|adolescents|adolescents
462902|NCT01586065|poor control|poor control
462903|NCT01586065|CGM|cgm
462904|NCT01586052|Cerebral Palsy|cerebral palsy
462905|NCT01586052|Erythropoietin|erythropoietin
462906|NCT01586052|Rehabilitation|rehabilitation
462907|NCT01586039|Melatonin|melatonin
462908|NCT01586039|Sleep|sleep
462909|NCT01586039|Light|light
462910|NCT01586039|Alertness|alertness
462911|NCT01586039|Circadian Rhythms|circadian rhythms
462912|NCT01586026|Ports|ports
462913|NCT01586026|Catheters|catheters
462914|NCT01586026|Distal Valved Catheters|distal valved catheters
462915|NCT01586026|Maintenance Flush|maintenance flush
462916|NCT01586026|subjects|subjects
462917|NCT01586026|routine maintenance flushes|routine maintenance flushes
462918|NCT01586013|propofol|propofol
462919|NCT01586013|pharmacodynamic|pharmacodynamic
462920|NCT01586013|age|age
462921|NCT01586013|ke0|ke0
462922|NCT01586000|vaginal ring|vaginal ring
462923|NCT01585974|Renal Cell Carcinoma|renal cell carcinoma
462924|NCT01585974|TKI|tki
462925|NCT01585974|Turkey|turkey
462926|NCT01585974|Observational|observational
462927|NCT01585961|Symptomatic paroxysmal|symptomatic paroxysmal
462928|NCT01585961|Atrial fibrillation|atrial fibrillation
462929|NCT01585961|Observational|observational
462930|NCT01585961|Acute procedural outcomes|acute procedural outcomes
462931|NCT01585961|Ablation|ablation
462932|NCT01585961|Drug refractory|drug refractory
462933|NCT01585961|Arrhythmia Recurrent|arrhythmia recurrent
462934|NCT01585961|Symptomatic|symptomatic
462935|NCT01585935|Infant, Extremely Low Birth Weight|infant, extremely low birth weight
462936|NCT01585935|Parenteral Nutrition|parenteral nutrition
462937|NCT01585935|Fish Oils|fish oils
462938|NCT01585935|Cholestasis|cholestasis
462939|NCT01585935|Psychomotor Disorders, Developmental|psychomotor disorders, developmental
462940|NCT01585922|noninvasive positive pressure ventilation|noninvasive positive pressure ventilation
462941|NCT01585896|Hoarding|hoarding
462942|NCT01585896|Compulsive Hoarding|compulsive hoarding
462943|NCT01585896|Self-Help|self-help
462944|NCT01585883|Lung cancer|lung cancer
462945|NCT01585883|Breathlessness|breathlessness
462946|NCT01585883|Self-management|self-management
462947|NCT01585870|Safety|safety
462948|NCT01585870|Tolerability|tolerability
462949|NCT01585870|Pharmacokinetics|pharmacokinetics
462950|NCT01585870|Clinical benefit|clinical benefit
462951|NCT01585870|Sorafenib|sorafenib
462952|NCT01585870|Eribulin|eribulin
462953|NCT01585870|advanced metastatic solid tumors|advanced metastatic solid tumors
462954|NCT01585844|sleep apnea|sleep apnea
462955|NCT01585844|pregnancy|pregnancy
462956|NCT01585844|obesity|obesity
462957|NCT01585831|Klinefelter syndrome|klinefelter syndrome
462958|NCT01585831|XXY syndrome|xxy syndrome
462959|NCT01585831|Sex Chromosome Abnormality|sex chromosome abnormality
462960|NCT01585831|Testosterone replacement therapy|testosterone replacement therapy
462961|NCT01585818|Glycemic Index|glycemic index
462962|NCT01585818|Type 2 Diabetes Mellitus|type 2 diabetes mellitus
462963|NCT01585818|Diet|diet
590684|NCT01053676|BE|be
462964|NCT01585818|Glucose Variability|glucose variability
462965|NCT01585818|Metabolic Response|metabolic response
462966|NCT01585818|Glucose Response|glucose response
462967|NCT01585766|MAb, B cell, depletion, RMS|mab, b cell, depletion, rms
462968|NCT01585753|cardiovascular function|cardiovascular function
462969|NCT01585753|maraviroc|maraviroc
462970|NCT01585740|Hyperchloraemic metabolic acidosis|hyperchloraemic metabolic acidosis
462971|NCT01585740|Neonatal acidosis|neonatal acidosis
462972|NCT01585740|Neonatal hyperchloraemia|neonatal hyperchloraemia
462973|NCT01585740|Base excess|base excess
462974|NCT01585740|Metabolic acidosis|metabolic acidosis
462975|NCT01585740|Caesarean section|caesarean section
462976|NCT01585740|Normal saline|normal saline
462977|NCT01585740|Ringer's Lactate|ringer's lactate
462978|NCT01585740|Postoperative morbidity|postoperative morbidity
462979|NCT01585727|Rectal cancer|rectal cancer
462980|NCT01585727|total mesorectal excision|total mesorectal excision
462981|NCT01585727|pelvic autonomic nerve preservation|pelvic autonomic nerve preservation
462982|NCT01585727|neurostimulation|neurostimulation
462983|NCT01585727|urogenital function|urogenital function
462984|NCT01585727|quality of life|quality of life
462985|NCT01585701|Phase I|phase i
462986|NCT01585701|Oncology|oncology
462987|NCT01585701|AGC Kinase inhibitor|agc kinase inhibitor
462988|NCT01585701|Protein Kinase inhibitor|protein kinase inhibitor
462989|NCT01585701|Clinical Trial|clinical trial
462990|NCT01585701|Multiple protein kinases|multiple protein kinases
462991|NCT01585688|NHL|nhl
462992|NCT01585688|CLL|cll
462993|NCT01585675|Lung Cancer|lung cancer
462994|NCT01585662|EUS|eus
462995|NCT01585662|pancreatic pseudocyst|pancreatic pseudocyst
462996|NCT01585662|drainage|drainage
462997|NCT01585636|SQ109|sq109
462998|NCT01585636|Tuberculosis|tuberculosis
462999|NCT01585610|smoking|smoking
463000|NCT01585610|smoking cessation|smoking cessation
463001|NCT01585610|disabled persons|disabled persons
463002|NCT01585610|behavioral research|behavioral research
463003|NCT01585597|Ischemic Stoke|ischemic stoke
463004|NCT01585597|Endovascular Reperfusion|endovascular reperfusion
463005|NCT01585597|Reperfusion Injury|reperfusion injury
463006|NCT01585597|Mild hypothermia|mild hypothermia
463007|NCT01585584|Boceprevir|boceprevir
463008|NCT01585584|Hepatitis C Genotype 3|hepatitis c genotype 3
463009|NCT01585571|Balance|balance
463010|NCT01585571|Posture|posture
463011|NCT01585571|Virtual Environment|virtual environment
463012|NCT01585571|Cerebral Palsy|cerebral palsy
463013|NCT01585571|Adults|adults
463014|NCT01585558|Menopausal symptoms|menopausal symptoms
463015|NCT01585558|Urogenital atrophy|urogenital atrophy
463016|NCT01585558|Vulvar and vaginal atrophy in menopausal women|vulvar and vaginal atrophy in menopausal women
463017|NCT01585558|Vaginal atrophy|vaginal atrophy
463018|NCT01585545|CT|ct
463019|NCT01585545|PET CT|pet ct
463020|NCT01585545|MRI|mri
463021|NCT01585545|cancer genomics|cancer genomics
463022|NCT01585545|Radiomics|radiomics
463023|NCT01585545|Radiogenomics|radiogenomics
463024|NCT01585532|Tuberculosis|tuberculosis
463025|NCT01585532|Urine|urine
463026|NCT01585532|Nucleic acid|nucleic acid
463027|NCT01585532|Alere|alere
463028|NCT01585532|Borstel|borstel
463029|NCT01585519|High Epicatechin Apples|high epicatechin apples
463030|NCT01585519|Low Epicatechin Apples|low epicatechin apples
463031|NCT01585519|Apple Extract|apple extract
463032|NCT01585519|Apple Granules|apple granules
463033|NCT01585519|Blood Pressure|blood pressure
463034|NCT01585519|Cholesterol|cholesterol
463035|NCT01585493|Lifestyle|lifestyle
463036|NCT01585493|Smoking|smoking
463037|NCT01585493|Dietary|dietary
463038|NCT01585493|Exercise|exercise
463039|NCT01585480|Obesity|obesity
463040|NCT01585480|Weight Gain Prevention|weight gain prevention
463041|NCT01585480|Workplace|workplace
463042|NCT01585480|Intervention|intervention
463043|NCT01585480|Diet|diet
463044|NCT01585480|Exercise|exercise
463045|NCT01585467|Anterior Shoulder Dislocation|anterior shoulder dislocation
463046|NCT01585467|Shoulder Dislocation|shoulder dislocation
463047|NCT01585467|Shoulder Pain|shoulder pain
463048|NCT01585467|Shoulder Deformity|shoulder deformity
463049|NCT01585454|Pregnancy|pregnancy
463050|NCT01585454|Diabetes Mellitus|diabetes mellitus
463051|NCT01585454|Weight Gain|weight gain
463052|NCT01585454|Diabetes|diabetes
463053|NCT01585441|Finasteride|finasteride
463054|NCT01585441|Central Serous Chorioretinopathy|central serous chorioretinopathy
463055|NCT01585428|Immunotherapy|immunotherapy
463056|NCT01585428|HPV-Associated Cancers|hpv-associated cancers
463057|NCT01585428|Cervical Cancer|cervical cancer
463058|NCT01585428|Oropharyngeal Cancer|oropharyngeal cancer
463059|NCT01585428|HPV Infection|hpv infection
463060|NCT01585415|Tumor Infiltrating Lymphocytes|tumor infiltrating lymphocytes
463061|NCT01585415|Immunotherapy|immunotherapy
463062|NCT01585415|Adoptive Cell Therapy|adoptive cell therapy
463063|NCT01585415|B Raf Inhibitor|b raf inhibitor
463064|NCT01585402|NT5E|nt5e
590817|NCT01053143|Adults|adults
463065|NCT01585402|Biphosphonates|biphosphonates
463066|NCT01585402|Vascular Calcifications|vascular calcifications
463067|NCT01585402|Joint Capsule Calcifications|joint capsule calcifications
463068|NCT01585402|Inherited Disease|inherited disease
463069|NCT01585389|adult brain tumor|adult brain tumor
463070|NCT01585389|childhood brain tumor|childhood brain tumor
463071|NCT01585376|alveolar childhood rhabdomyosarcoma|alveolar childhood rhabdomyosarcoma
463072|NCT01585376|embryonal childhood rhabdomyosarcoma|embryonal childhood rhabdomyosarcoma
463073|NCT01585350|melanoma|melanoma
463074|NCT01585350|peptide vaccine|peptide vaccine
463075|NCT01585350|polyICLC|polyiclc
463076|NCT01585350|lipopolysaccharide (LPS)|lipopolysaccharide (lps)
463077|NCT01585350|immunotherapy|immunotherapy
463078|NCT01585311|Subarachnoid Hemorrhage (SAH)|subarachnoid hemorrhage (sah)
463079|NCT01585311|tachycardia|tachycardia
463080|NCT01585311|Outcome|outcome
463081|NCT01585298|Multiple Sclerosis|multiple sclerosis
463082|NCT01585298|MS|ms
463083|NCT01585298|Fingolimod|fingolimod
463084|NCT01585298|Gilenya|gilenya
463085|NCT01585298|ECG|ecg
463086|NCT01585298|Bradyarrythmia|bradyarrythmia
463087|NCT01585298|conduction abnormalities|conduction abnormalities
463088|NCT01585298|first dose observation|first dose observation
463089|NCT01585285|Coronary artery bypass grafting|coronary artery bypass grafting
463090|NCT01585285|Left internal mammary artery|left internal mammary artery
463091|NCT01585285|Composite grafting|composite grafting
463092|NCT01585285|Multislice Spiral Computed Tomography Scanner|multislice spiral computed tomography scanner
463093|NCT01585285|Graft patency assessment|graft patency assessment
463094|NCT01585272|Alzheimer's dementia, AD|alzheimer's dementia, ad
463095|NCT01585259|anti-platelet;|anti-platelet;
463096|NCT01585259|safety;|safety;
463097|NCT01585259|efficacy|efficacy
463098|NCT01585246|Prostate Cancer|prostate cancer
463099|NCT01585246|Radiation Therapy|radiation therapy
463100|NCT01585246|Quality of Life|quality of life
463101|NCT01585246|Symptom Management|symptom management
463102|NCT01585233|Moderate Psoriasis|moderate psoriasis
463103|NCT01585233|Severe Psoriasis|severe psoriasis
463104|NCT01585233|Skin disease|skin disease
463105|NCT01585233|ASKP1240|askp1240
463106|NCT01585233|CD40 antigen|cd40 antigen
463107|NCT01585233|Anti-CD40 monoclonal antibody|anti-cd40 monoclonal antibody
463108|NCT01585220|WSRS|wsrs
463109|NCT01585220|GAIS|gais
463110|NCT01585220|HA filler|ha filler
463111|NCT01585220|filler|filler
463112|NCT01585207|Tourette's Disorder|tourette's disorder
463113|NCT01585207|vigabatrin|vigabatrin
463114|NCT01585181|Vaccine, Bacterial disease condition, Cholera|vaccine, bacterial disease condition, cholera
463115|NCT01585168|Reward Circuitry|reward circuitry
463116|NCT01585168|Impulsivity|impulsivity
463117|NCT01585168|Family History of Alcoholism|family history of alcoholism
463118|NCT01585168|NMDA/DA Interactions|nmda/da interactions
463119|NCT01585155|Infliximab|infliximab
463120|NCT01585155|REMICADE|remicade
463121|NCT01585155|TA-650|ta-650
463122|NCT01585090|Ankle positions|ankle positions
463123|NCT01585090|pelvic floor muscles strength|pelvic floor muscles strength
463124|NCT01585090|relaxation of pelvic floor muscles syndrome|relaxation of pelvic floor muscles syndrome
463125|NCT01585090|doing strengthening exercises of pelvic floor muscles|doing strengthening exercises of pelvic floor muscles
463126|NCT01585077|Plasmodium vivax|plasmodium vivax
463127|NCT01585077|Malaria|malaria
463128|NCT01585077|Challenge|challenge
463129|NCT01585077|Anopheles albimanus|anopheles albimanus
463130|NCT01585064|Rheumatoid Arthritis (RA)|rheumatoid arthritis (ra)
463131|NCT01585064|Anti-TNF therapy|anti-tnf therapy
463132|NCT01585064|Adalimumab|adalimumab
463133|NCT01585064|Disease activity|disease activity
463134|NCT01585064|Treating to target|treating to target
463135|NCT01585051|vitamin D|vitamin d
463136|NCT01585051|blood pressure|blood pressure
463137|NCT01585051|typ 2 diabetes mellitus|typ 2 diabetes mellitus
463138|NCT01585051|blood glucose|blood glucose
463139|NCT01585051|HbA1c|hba1c
463140|NCT01585038|endothelium|endothelium
463141|NCT01585038|inflammation|inflammation
463142|NCT01585038|oxidative stress|oxidative stress
463143|NCT01585038|HIV-1|hiv-1
463144|NCT01585025|Primary bile acid malabsorption|primary bile acid malabsorption
463145|NCT01585025|Secondary bile acid malabsorption|secondary bile acid malabsorption
463146|NCT01585025|Chronic diarrhoea|chronic diarrhoea
463147|NCT01585025|Obeticholic acid|obeticholic acid
463148|NCT01585025|SeHCAT|sehcat
463150|NCT01585025|FGF19|fgf19
463151|NCT01585012|Cervical cap insemination|cervical cap insemination
463152|NCT01585012|Collection condom|collection condom
463153|NCT01585012|Instructions for Use|instructions for use
463154|NCT01585012|Safety during intercourse|safety during intercourse
463155|NCT01585012|Acceptability of the cervical cap with condom sheath|acceptability of the cervical cap with condom sheath
463156|NCT01585012|slip|slip
463157|NCT01585012|break|break
463158|NCT01585012|ease of conversion|ease of conversion
463159|NCT01585012|adequate sample collection|adequate sample collection
463160|NCT01584947|Oral pain|oral pain
463161|NCT01584947|Local anesthetic|local anesthetic
463162|NCT01584947|Bupivacaine hydrochloride|bupivacaine hydrochloride
463163|NCT01584934|fatigue|fatigue
463164|NCT01584934|sleep quality|sleep quality
463165|NCT01584934|Chronic, disabling, unexplained fatigue with at least 4 minor criteria for CFS, according to the 1994 Fukuda case definition|chronic, disabling, unexplained fatigue with at least 4 minor criteria for cfs, according to the 1994 fukuda case definition
463166|NCT01584921|Erythropoietin|erythropoietin
463167|NCT01584921|Glomerular filtration rate|glomerular filtration rate
463168|NCT01584921|Tubular reabsorption|tubular reabsorption
463169|NCT01584921|Renal function|renal function
463170|NCT01584921|Renal perfusion|renal perfusion
463171|NCT01584908|kidney transplant recipients|kidney transplant recipients
463172|NCT01584882|Clinical decision support (CDS)|clinical decision support (cds)
463173|NCT01584882|Tobacco|tobacco
463174|NCT01584882|Behavioral|behavioral
463175|NCT01584882|Dental hygienist|dental hygienist
463176|NCT01584882|Dentist|dentist
463177|NCT01584882|Smoking|smoking
463178|NCT01584882|Electronic health record|electronic health record
463179|NCT01584869|GI-bleeding|gi-bleeding
463180|NCT01584869|capsule endoscopy|capsule endoscopy
463181|NCT01584843|Neuromuscular Agents|neuromuscular agents
463182|NCT01584843|Strabismus|strabismus
463183|NCT01584843|Botulinum Toxin Type A|botulinum toxin type a
463184|NCT01584830|Regorafenib|regorafenib
463185|NCT01584830|Colorectal|colorectal
463186|NCT01584830|Metastatic|metastatic
463187|NCT01584817|colonoscopy|colonoscopy
463188|NCT01584817|bowel preparation|bowel preparation
463189|NCT01584817|education|education
463190|NCT01584804|Su Huang antitussive capsule|su huang antitussive capsule
463191|NCT01584804|Cough variant asthma|cough variant asthma
463192|NCT01584804|Placebo|placebo
463193|NCT01584791|CAD|cad
463194|NCT01584791|PCI|pci
463195|NCT01584791|Percutaneous Coronary Intervention|percutaneous coronary intervention
463196|NCT01584778|Behçet's disease|behçet's disease
463197|NCT01584778|Eosinophil cationic protein|eosinophil cationic protein
463198|NCT01584778|Eosinophils|eosinophils
463199|NCT01584765|liver injury|liver injury
463200|NCT01584765|Rechallenge|rechallenge
463201|NCT01584765|Kaiser Permanente California|kaiser permanente california
463202|NCT01584739|Safety|safety
463203|NCT01584739|tolerability|tolerability
463204|NCT01584739|healthy|healthy
463205|NCT01584739|COPD (chronic obstructive pulmonary disease)|copd (chronic obstructive pulmonary disease)
463206|NCT01584739|pharmacokinetic|pharmacokinetic
463207|NCT01584739|pharmacodynamic|pharmacodynamic
463208|NCT01584739|inhaled|inhaled
463209|NCT01584726|magnesium|magnesium
463210|NCT01584726|nebulization|nebulization
463211|NCT01584726|asthma|asthma
463212|NCT01584726|sulfate|sulfate
463213|NCT01584726|children|children
463214|NCT01584726|pediatric|pediatric
463215|NCT01584713|Enterocutaneous fistula|enterocutaneous fistula
463216|NCT01584713|Adipose Derived Stem Cells|adipose derived stem cells
463217|NCT01584700|NYHA class III or IV|nyha class iii or iv
463218|NCT01584700|Maximal medical therapy|maximal medical therapy
463219|NCT01584700|Not eligible for CRT|not eligible for crt
463220|NCT01584687|asthma|asthma
463221|NCT01584687|difficult-to-control asthma|difficult-to-control asthma
463222|NCT01584687|mRNA expression|mrna expression
463223|NCT01584687|biomarker|biomarker
463224|NCT01584687|real time PCR|real time pcr
463225|NCT01584687|ACT|act
463226|NCT01584687|ACQ|acq
463227|NCT01584648|Randomized study|randomized study
463228|NCT01584648|combination therapy|combination therapy
463229|NCT01584648|BRAF inhibitor|braf inhibitor
463230|NCT01584648|GSK1120212|gsk1120212
463231|NCT01584648|BRAF V600E/K mutation-positive cutaneous melanoma|braf v600e/k mutation-positive cutaneous melanoma
463232|NCT01584648|trametinib|trametinib
463233|NCT01584648|GSK2118436|gsk2118436
463234|NCT01584648|MEK inhibitor|mek inhibitor
463235|NCT01584648|Phase III|phase iii
463236|NCT01584648|dabrafenib|dabrafenib
463237|NCT01584635|Less invasive treatment for Achalasia|less invasive treatment for achalasia
463238|NCT01584609|ischemic stroke|ischemic stroke
463239|NCT01584609|large vessel occlusion|large vessel occlusion
463240|NCT01584609|mechanical thrombectomy|mechanical thrombectomy
463241|NCT01584609|revascularization|revascularization
463242|NCT01584609|Penumbra System|penumbra system
463243|NCT01584609|Separator 3D|separator 3d
463244|NCT01584596|physical activity|physical activity
463245|NCT01584596|dietary|dietary
463246|NCT01584596|adults|adults
463247|NCT01584596|pedometer|pedometer
463248|NCT01584596|education|education
463249|NCT01584583|BP|bp
463250|NCT01584570|dexmedetomidine|dexmedetomidine
463251|NCT01584570|heart rate variability|heart rate variability
463252|NCT01584570|QTc interval|qtc interval
463253|NCT01584544|rectal neoplasms|rectal neoplasms
463254|NCT01584544|aged|aged
463255|NCT01584544|chemoradiotherapy|chemoradiotherapy
463256|NCT01584544|clinical trials, phase I|clinical trials, phase i
463257|NCT01584544|capecitabine|capecitabine
463258|NCT01584531|rigosertib sodium|rigosertib sodium
463259|NCT01584531|rigosertib|rigosertib
463260|NCT01584531|ON 01910.Na|on 01910.na
463261|NCT01584531|oral rigosertib|oral rigosertib
463262|NCT01584505|COPD|copd
463263|NCT01584479|periodontitis|periodontitis
463264|NCT01584466|Schizophrenia|schizophrenia
463265|NCT01584466|Substance Abuse|substance abuse
463266|NCT01584427|Dietary fibers|dietary fibers
463267|NCT01584427|Resistent Starch|resistent starch
463268|NCT01584427|Arabinoxylans|arabinoxylans
463269|NCT01584427|Postprandial lipaemia|postprandial lipaemia
463270|NCT01584427|Insulin sensitivity|insulin sensitivity
463271|NCT01584427|Body composition|body composition
463272|NCT01584427|Gene expression|gene expression
463273|NCT01584427|Metabolic rate|metabolic rate
463274|NCT01584427|Blood pressure|blood pressure
463275|NCT01584414|Zetiq CellDetect ® stain|zetiq celldetect ® stain
463397|NCT01584024|Proximal surfaces|proximal surfaces
463276|NCT01584414|distinct red/purple color to the cytoplasm of neoplastic|distinct red/purple color to the cytoplasm of neoplastic
463277|NCT01584414|distinguishes green/blue stained non-neoplastic cells and tissues|distinguishes green/blue stained non-neoplastic cells and tissues
463278|NCT01584401|Body temperature|body temperature
463279|NCT01584401|Thermometers|thermometers
463280|NCT01584401|Non invasive|non invasive
463281|NCT01584401|Medisim's non invasive thermometers|medisim's non invasive thermometers
463282|NCT01584388|Type 1 autoimmune pancreatitis|type 1 autoimmune pancreatitis
463283|NCT01584388|IgG4-related sclerosing cholangitis|igg4-related sclerosing cholangitis
463284|NCT01584388|Chronic sclerosing sialadenitis|chronic sclerosing sialadenitis
463285|NCT01584388|Lacrimal glands|lacrimal glands
463286|NCT01584388|Orbital pseudotumor|orbital pseudotumor
463287|NCT01584388|IgG4-related tubulointerstitial nephritis|igg4-related tubulointerstitial nephritis
463288|NCT01584388|Lymphadenopathy|lymphadenopathy
463289|NCT01584388|Pachymeningitis|pachymeningitis
463290|NCT01584388|Aorta|aorta
463291|NCT01584388|Peri-aortitis|peri-aortitis
463292|NCT01584388|Retroperitoneal fibrosis|retroperitoneal fibrosis
463293|NCT01584388|Riedel's thyroiditis|riedel's thyroiditis
463294|NCT01584375|Intraventricular hemorrhage|intraventricular hemorrhage
463295|NCT01584375|Preterm infant|preterm infant
463296|NCT01584375|Midline head position|midline head position
463297|NCT01584375|Lateral head Position|lateral head position
463298|NCT01584362|Taenia solium|taenia solium
463299|NCT01584362|neurocysticercosis|neurocysticercosis
463300|NCT01584362|oxfendazole|oxfendazole
463301|NCT01584362|clinical trial, phase 1|clinical trial, phase 1
463302|NCT01584362|safety|safety
463303|NCT01584362|pharmacokinetics|pharmacokinetics
463304|NCT01584336|Gastric cancer, laparoscopy-assisted total gastrectomy|gastric cancer, laparoscopy-assisted total gastrectomy
463305|NCT01584323|Preterm premature rupture of membranes|preterm premature rupture of membranes
463306|NCT01584323|pomgranate|pomgranate
463307|NCT01584323|oxidative stress|oxidative stress
463308|NCT01584323|pregnant women with Preterm premature rupture of membranes|pregnant women with preterm premature rupture of membranes
463309|NCT01584310|Nutritional assessment|nutritional assessment
463310|NCT01584310|children|children
463311|NCT01584310|malnutrition|malnutrition
463312|NCT01584297|Granulosa Cell Tumour|granulosa cell tumour
463313|NCT01584284|Genelux|genelux
463314|NCT01584284|Genelux Corporation|genelux corporation
463315|NCT01584284|GL-ONC1|gl-onc1
463316|NCT01584284|Vaccinia|vaccinia
463317|NCT01584284|Vaccinia Virus|vaccinia virus
463318|NCT01584284|Oncolytic virus|oncolytic virus
463319|NCT01584284|Oncolytic Virotherapy|oncolytic virotherapy
463320|NCT01584284|Head and Neck Cancer|head and neck cancer
463321|NCT01584284|Squamous Cell Carcinoma|squamous cell carcinoma
463322|NCT01584271|AOE|aoe
463323|NCT01584271|Ear Comfort|ear comfort
463324|NCT01584271|Dex Otic|dex otic
463325|NCT01584271|Otidin|otidin
463326|NCT01584258|Prostate cancer|prostate cancer
463327|NCT01584258|Prostate adenocarcinoma|prostate adenocarcinoma
463328|NCT01584258|Early stage prostate cancer|early stage prostate cancer
463329|NCT01584258|Organ-confined prostate cancer|organ-confined prostate cancer
463330|NCT01584258|Low-risk prostate cancer|low-risk prostate cancer
463331|NCT01584258|Intermediate-risk prostate cancer|intermediate-risk prostate cancer
463332|NCT01584232|Glucagon-like peptide-1 (GLP-1)|glucagon-like peptide-1 (glp-1)
463333|NCT01584206|Sitosterolemia|sitosterolemia
463334|NCT01584206|Ezetimibe|ezetimibe
463335|NCT01584206|Plant sterol|plant sterol
463336|NCT01584206|Cholesterol|cholesterol
463337|NCT01584193|central venous access port|central venous access port
463338|NCT01584193|ultrasound-guided venous puncture|ultrasound-guided venous puncture
463339|NCT01584193|suclavian vein|suclavian vein
463340|NCT01584193|cephalic vein|cephalic vein
463341|NCT01584180|hypothermia|hypothermia
463342|NCT01584180|induction of hypothermia|induction of hypothermia
463343|NCT01584180|cold infusion|cold infusion
463344|NCT01584180|local neck cooling|local neck cooling
463345|NCT01584180|external cooling|external cooling
463346|NCT01584180|surface cooling|surface cooling
463347|NCT01584180|non invasive cooling|non invasive cooling
463348|NCT01584180|stroke|stroke
463349|NCT01584180|intracranial hemorrhage|intracranial hemorrhage
463350|NCT01584180|cerebrovascular disease|cerebrovascular disease
463351|NCT01584180|neuro intensive care|neuro intensive care
463352|NCT01584167|hypothermia|hypothermia
463353|NCT01584167|induction of hypothermia|induction of hypothermia
463354|NCT01584167|cold infusion|cold infusion
463355|NCT01584167|whole-body cooling|whole-body cooling
463356|NCT01584167|external cooling|external cooling
463357|NCT01584167|surface cooling|surface cooling
463358|NCT01584167|non invasive cooling|non invasive cooling
463359|NCT01584167|stroke|stroke
463360|NCT01584167|intracranial hemorrhage|intracranial hemorrhage
463361|NCT01584167|cerebrovascular disease|cerebrovascular disease
463362|NCT01584167|neuro intensive care|neuro intensive care
463363|NCT01584141|Leukemia|leukemia
463364|NCT01584141|Lymphoma|lymphoma
463365|NCT01584141|Occupational Epidemiology|occupational epidemiology
463366|NCT01584141|Molecular Epidemiology|molecular epidemiology
463367|NCT01584141|Genetic Polymorphisms|genetic polymorphisms
463368|NCT01584115|Cancer.|cancer.
463369|NCT01584115|Melanoma.|melanoma.
463370|NCT01584115|Ovarian cancer.|ovarian cancer.
463371|NCT01584115|Lung cancer.|lung cancer.
463372|NCT01584115|NY-ESO-1.|ny-eso-1.
463373|NCT01584115|MPLA (monophosphoryl lipid A).|mpla (monophosphoryl lipid a).
463374|NCT01584115|Tumor antigen.|tumor antigen.
463375|NCT01584115|Bordetella pertussis.|bordetella pertussis.
463376|NCT01584102|Randomized controlled trial|randomized controlled trial
463377|NCT01584102|obesity|obesity
463378|NCT01584102|community-based participatory research|community-based participatory research
463379|NCT01584102|minority health|minority health
463380|NCT01584102|rural health|rural health
463381|NCT01584102|health promotion|health promotion
463382|NCT01584076|Amblyopia|amblyopia
463383|NCT01584076|Donepezil|donepezil
463384|NCT01584063|Mexican Americans|mexican americans
463385|NCT01584063|Pregnancy|pregnancy
463386|NCT01584063|Diabetes Mellitus Type 2|diabetes mellitus type 2
463387|NCT01584063|Prevention|prevention
463388|NCT01584063|Community health workers|community health workers
463389|NCT01584063|Community based participatory research|community based participatory research
463390|NCT01584063|Behavioral Intervention|behavioral intervention
463391|NCT01584063|Lifestyle Intervention|lifestyle intervention
463392|NCT01584037|Adenovirus|adenovirus
463393|NCT01584037|Adenovirus Type 4|adenovirus type 4
463394|NCT01584037|Adenovirus Type 7|adenovirus type 7
463395|NCT01584037|Adenovirus Type 4 and Type 7 Vaccine, Live, Oral|adenovirus type 4 and type 7 vaccine, live, oral
463396|NCT01584024|Dental caries|dental caries
463398|NCT01584024|Posterior teeth|posterior teeth
463399|NCT01584024|Carious lesions|carious lesions
463400|NCT01584024|Tooth diseases|tooth diseases
463401|NCT01584024|Preventive therapy|preventive therapy
463402|NCT01584011|Taste|taste
463403|NCT01584011|Chorda tympani nerve|chorda tympani nerve
463404|NCT01583998|Major Depressive Disorder|major depressive disorder
463405|NCT01583998|MDD|mdd
463406|NCT01583998|Depression|depression
463407|NCT01583998|Measurement Based Care|measurement based care
463408|NCT01583998|MBC|mbc
463409|NCT01583998|electronic health records|electronic health records
463410|NCT01583998|EHR|ehr
463411|NCT01583998|electronic medical records|electronic medical records
463412|NCT01583998|EMR|emr
463413|NCT01583985|opioid analgesics|opioid analgesics
463414|NCT01583985|chronic pain|chronic pain
463415|NCT01583985|musculoskeletal pain|musculoskeletal pain
463416|NCT01583972|Vitamin A deficiency|vitamin a deficiency
463417|NCT01583972|Vitamin A|vitamin a
463418|NCT01583972|retinyl palmitate|retinyl palmitate
463419|NCT01583972|malnutrition|malnutrition
463420|NCT01583972|vaccine|vaccine
463421|NCT01583972|vaccination|vaccination
463422|NCT01583972|BCG|bcg
463423|NCT01583972|tuberculosis|tuberculosis
463424|NCT01583972|polio virus|polio virus
463425|NCT01583972|tetanus toxoid|tetanus toxoid
463426|NCT01583972|hepatitis B virus|hepatitis b virus
463427|NCT01583972|thymus|thymus
463428|NCT01583972|T lymphocyte|t lymphocyte
463429|NCT01583972|B lymphocyte|b lymphocyte
463430|NCT01583972|antibody|antibody
463431|NCT01583972|bacterial translocation|bacterial translocation
463432|NCT01583972|T-cell receptor excision circle|t-cell receptor excision circle
463433|NCT01583959|rheumatoid arthritis|rheumatoid arthritis
463434|NCT01583959|folic acid|folic acid
463435|NCT01583959|methotrexate|methotrexate
463436|NCT01583946|subjective well-being|subjective well-being
463437|NCT01583946|life transitions|life transitions
463438|NCT01583946|health-related quality of life|health-related quality of life
463439|NCT01583946|health|health
463440|NCT01583946|healthcare costs|healthcare costs
463441|NCT01583933|Dental stability|dental stability
463442|NCT01583933|Occlusal stability|occlusal stability
463443|NCT01583933|Retainers|retainers
463444|NCT01583920|prostatic neoplasms|prostatic neoplasms
463445|NCT01583920|brachytherapy|brachytherapy
463446|NCT01583920|salvage therapy|salvage therapy
463447|NCT01583920|recurrent prostate cancer|recurrent prostate cancer
463448|NCT01583907|cow's milk allergy|cow's milk allergy
463449|NCT01583881|Patients with diastolic heart failure and hypertension|patients with diastolic heart failure and hypertension
463450|NCT01583855|Remote catheter ablation|remote catheter ablation
463451|NCT01583855|Atrial fibrillation|atrial fibrillation
463452|NCT01583842|neuroblastoma|neuroblastoma
463453|NCT01583842|imaging|imaging
463454|NCT01583842|124I-MIBG|124i-mibg
463455|NCT01583842|131I-MIBG|131i-mibg
463456|NCT01583842|PET/CT|pet/ct
463457|NCT01583829|ADHD|adhd
463458|NCT01583829|neurofeedback|neurofeedback
463459|NCT01583829|biofeedback|biofeedback
463460|NCT01583829|computer attention training|computer attention training
463461|NCT01583816|Actinic Keratosis|actinic keratosis
463462|NCT01583816|Resiquimod|resiquimod
463463|NCT01583790|Laparoscopic Sleeve Gastrectomy|laparoscopic sleeve gastrectomy
463464|NCT01583790|Bariatric surgery|bariatric surgery
463465|NCT01583790|Morbid Obesity|morbid obesity
463466|NCT01583777|Belinostat|belinostat
463467|NCT01583751|pilonidal sinus|pilonidal sinus
463468|NCT01583751|new technique|new technique
463469|NCT01583751|videoendoscopic|videoendoscopic
463470|NCT01583725|Obesity|obesity
463471|NCT01583725|Bariatric surgery|bariatric surgery
463472|NCT01583725|Weight loss|weight loss
463473|NCT01583725|fMRI|fmri
463474|NCT01583725|gut peptides|gut peptides
463475|NCT01583712|Confocal laser endomicroscopy|confocal laser endomicroscopy
463476|NCT01583712|Small bowel imaging|small bowel imaging
463477|NCT01583712|Graft-versus-host disease|graft-versus-host disease
463478|NCT01583712|HSCT|hsct
463479|NCT01583699|MALT-lymphoma|malt-lymphoma
463480|NCT01583699|Confocal laser endomicroscopy|confocal laser endomicroscopy
463481|NCT01583699|Gastrointestinal endoscopy|gastrointestinal endoscopy
463482|NCT01583686|Metastatic Cancer|metastatic cancer
463483|NCT01583686|Immunotherapy|immunotherapy
463484|NCT01583686|Gene Therapy|gene therapy
463485|NCT01583686|Mesothelioma|mesothelioma
463486|NCT01583686|Pancreatic Cancer|pancreatic cancer
463487|NCT01583660|NSAIDs|nsaids
463488|NCT01583660|Anti-inflammatory|anti-inflammatory
463489|NCT01583660|elderly hip fracture|elderly hip fracture
463490|NCT01583660|mortality|mortality
463491|NCT01583608|Drug eluting stent|drug eluting stent
463492|NCT01583608|Bioabsorbable|bioabsorbable
463493|NCT01583608|Bioresorbable|bioresorbable
463494|NCT01583608|Coronary Stent|coronary stent
463495|NCT01583608|Scaffold|scaffold
463496|NCT01583608|Stents|stents
463497|NCT01583608|Angioplasty|angioplasty
463498|NCT01583608|Coronary Artery Disease|coronary artery disease
463499|NCT01583608|Stentthrombosis|stentthrombosis
463500|NCT01583595|Chronic Lung Disease|chronic lung disease
463501|NCT01583595|Exercise|exercise
463502|NCT01583595|Self-efficacy|self-efficacy
463503|NCT01583582|randomized double-blind placebo-controlled study|randomized double-blind placebo-controlled study
463504|NCT01583582|peptide concentrate|peptide concentrate
463505|NCT01583582|Coldwater Shrimp|coldwater shrimp
463506|NCT01583582|antihypertensive effect|antihypertensive effect
463507|NCT01583582|mild hypertension|mild hypertension
463508|NCT01583582|moderate hypertension|moderate hypertension
463509|NCT01583582|blood pressure|blood pressure
463510|NCT01583569|Complex Dynamic Systems|complex dynamic systems
463511|NCT01583569|Biomarkers|biomarkers
463512|NCT01583569|Mood Disorders|mood disorders
463513|NCT01583556|Adult|adult
463514|NCT01583556|English speaking|english speaking
463515|NCT01583556|Fractures|fractures
463516|NCT01583556|Excellent prognosis|excellent prognosis
463517|NCT01583556|Upper Extremity|upper extremity
463518|NCT01583543|Recurrent|recurrent
463519|NCT01583543|Metastatic|metastatic
463520|NCT01583530|Belimumab|belimumab
463521|NCT01583530|Injections, Subcutaneous|injections, subcutaneous
463522|NCT01583530|Drug Administration Routes|drug administration routes
463523|NCT01583530|Injections|injections
463524|NCT01583530|Lupus Erythematosus, Systemic|lupus erythematosus, systemic
463525|NCT01583530|Lupus|lupus
463526|NCT01583530|SLE|sle
463527|NCT01583530|Systemic Lupus Erythematosus|systemic lupus erythematosus
463528|NCT01583530|Antibodies|antibodies
463529|NCT01583530|Autoimmune Disease|autoimmune disease
463530|NCT01583530|Biological Therapy|biological therapy
463531|NCT01583530|Immune System Diseases|immune system diseases
463532|NCT01583530|Pharmacokinetics|pharmacokinetics
463533|NCT01583530|Biological Availability|biological availability
463534|NCT01583517|Acute pancreatitis|acute pancreatitis
463535|NCT01583517|ERCP|ercp
463536|NCT01583517|Sphincterotomy|sphincterotomy
463537|NCT01583517|Manometry|manometry
463538|NCT01583517|Sphincter of Oddi dysfunction|sphincter of oddi dysfunction
463539|NCT01583504|Achilles|achilles
463540|NCT01583504|Tendinopathy|tendinopathy
463541|NCT01583504|Tendonitis|tendonitis
463542|NCT01583504|Injection|injection
463543|NCT01583491|platelet rich fibrin|platelet rich fibrin
463544|NCT01583491|mandibular third molar|mandibular third molar
463545|NCT01583491|periodontal problem|periodontal problem
463546|NCT01583478|incobotulinumtoxinA|incobotulinumtoxina
463547|NCT01583478|wrinkles|wrinkles
463548|NCT01583478|glabellar|glabellar
463549|NCT01583478|rhytids|rhytids
463550|NCT01583478|frown|frown
463551|NCT01583478|lines|lines
463552|NCT01583465|randomized controlled trial|randomized controlled trial
463553|NCT01583465|Blood loss, surgical|blood loss, surgical
463554|NCT01583465|Blood loss, postoperative|blood loss, postoperative
463555|NCT01583465|Wound healing|wound healing
463556|NCT01583452|Post operative ileus|post operative ileus
463557|NCT01583452|Gastrointestinal surgery|gastrointestinal surgery
463558|NCT01583452|Chewing gum|chewing gum
463559|NCT01583439|HIV Infections|hiv infections
463560|NCT01583439|Acquired Immunodeficiency Syndrome|acquired immunodeficiency syndrome
463561|NCT01583439|Anti-HIV Agents|anti-hiv agents
463562|NCT01583439|Sexually Transmitted Diseases, Viral|sexually transmitted diseases, viral
463563|NCT01583439|Immunologic Deficiency Syndromes|immunologic deficiency syndromes
463564|NCT01583439|Immune System Diseases|immune system diseases
463565|NCT01583439|Anti-Retroviral Agents|anti-retroviral agents
463566|NCT01583439|Antiviral Agents|antiviral agents
463567|NCT01583426|GeparSepto|geparsepto
463568|NCT01583426|GBG 69|gbg 69
463570|NCT01583426|German Breast Group|german breast group
463571|NCT01583426|neo-adjuvant|neo-adjuvant
463572|NCT01583426|GBG Forschungs GmbH|gbg forschungs gmbh
463573|NCT01583426|Tubular breast cancer stage II|tubular breast cancer stage ii
463574|NCT01583426|Mucinous breast cancer stage II|mucinous breast cancer stage ii
463575|NCT01583426|Invasive ductal breast cancer|invasive ductal breast cancer
463576|NCT01583426|Tubular breast cancer stage III|tubular breast cancer stage iii
463577|NCT01583426|HER-2 positive breast cancer|her-2 positive breast cancer
463578|NCT01583426|Inflammatory breast cancer|inflammatory breast cancer
463579|NCT01583413|Ventilator-associated pneumonia|ventilator-associated pneumonia
463580|NCT01583400|Depressive Disorder, Major|depressive disorder, major
463581|NCT01583400|Depressive Disorder, Minor|depressive disorder, minor
463582|NCT01583400|Dysthymic Disorder|dysthymic disorder
463583|NCT01583387|healthy adults|healthy adults
463584|NCT01583387|urinary adducts|urinary adducts
463585|NCT01583387|water intake|water intake
463586|NCT01583374|spondylitis|spondylitis
463587|NCT01583374|spondyloarthritis|spondyloarthritis
463588|NCT01583374|Spondyloarthropathy|spondyloarthropathy
463589|NCT01583374|Oral preparation|oral preparation
463590|NCT01583361|two arms|two arms
463591|NCT01583361|D2 lymphadenectomy|d2 lymphadenectomy
463592|NCT01583361|chemotherapy before and after surgery|chemotherapy before and after surgery
463593|NCT01583361|disease free survival|disease free survival
463594|NCT01583348|transvaginal|transvaginal
463595|NCT01583348|NOTES|notes
463596|NCT01583348|cholecystectomy|cholecystectomy
463597|NCT01583348|cholangiography|cholangiography
463598|NCT01583348|symptomatic gallstone disease|symptomatic gallstone disease
463599|NCT01583335|Overweight|overweight
463600|NCT01583335|Obesity|obesity
463601|NCT01583335|Predisposition|predisposition
463602|NCT01583335|Prevention|prevention
463603|NCT01583335|Diet|diet
463604|NCT01583335|Physical activity|physical activity
463605|NCT01583335|Sleep|sleep
463606|NCT01583335|Family stress|family stress
463607|NCT01583322|ovarian cancer|ovarian cancer
463608|NCT01583322|debulking surgery|debulking surgery
463609|NCT01583322|interval debulking|interval debulking
463610|NCT01583322|vargatef|vargatef
463611|NCT01583322|nintedanib|nintedanib
463612|NCT01583322|maintenance|maintenance
463613|NCT01583322|first line|first line
463614|NCT01583322|paclitaxel|paclitaxel
463615|NCT01583322|carboplatin|carboplatin
463616|NCT01583309|blood pressure|blood pressure
463617|NCT01583309|cardiovascular instability|cardiovascular instability
463618|NCT01583309|symptomatic hypotension|symptomatic hypotension
463619|NCT01583309|online hemofiltration|online hemofiltration
463620|NCT01583309|online hemodiafiltration|online hemodiafiltration
463621|NCT01583283|Multiple Myeloma|multiple myeloma
463622|NCT01583283|Relapsed|relapsed
463623|NCT01583283|Refractory|refractory
463624|NCT01583283|Histone deacetylase inhibitors|histone deacetylase inhibitors
463625|NCT01583283|Lenalidomide|lenalidomide
463626|NCT01583283|Revlimid|revlimid
463627|NCT01583283|Dexamethasone|dexamethasone
463628|NCT01583270|Arabinxylan|arabinxylan
463629|NCT01583270|Rye kernels|rye kernels
463630|NCT01583270|whole grain|whole grain
463631|NCT01583270|Dietary fibre|dietary fibre
463632|NCT01583270|Metabolic syndrome|metabolic syndrome
463633|NCT01583270|Glycemic response|glycemic response
463634|NCT01583270|Colon fermentation|colon fermentation
463635|NCT01583270|Second meal effekt|second meal effekt
463636|NCT01583270|Satiety|satiety
463637|NCT01583218|Phase III|phase iii
463638|NCT01583205|ALS|als
463639|NCT01583205|Coping Effectiveness Training|coping effectiveness training
463640|NCT01583205|Distress|distress
463641|NCT01583205|Care Giver|care giver
463642|NCT01583192|infection|infection
463643|NCT01583192|skin preparation|skin preparation
463644|NCT01583192|fore-foot surgery|fore-foot surgery
463645|NCT01583192|chloride-hexidine|chloride-hexidine
463646|NCT01583192|povidine-jodine|povidine-jodine
463647|NCT01583192|alcohol|alcohol
463648|NCT01583179|nerve block|nerve block
463649|NCT01583179|outpatient surgery|outpatient surgery
463650|NCT01583140|physical activity|physical activity
463651|NCT01583140|Latinas|latinas
463652|NCT01583127|Problem Behavior|problem behavior
463653|NCT01583114|dilated cardiomyopathy|dilated cardiomyopathy
463654|NCT01583114|heart failure|heart failure
463655|NCT01583114|genetics|genetics
463656|NCT01583114|mutation carrier|mutation carrier
463657|NCT01583114|ACE treatment|ace treatment
463658|NCT01583114|preclinical|preclinical
463659|NCT01583088|Amyotrophic lateral sclerosis,|amyotrophic lateral sclerosis,
463660|NCT01583088|Diaphragm|diaphragm
463661|NCT01583088|Mechanical ventilation|mechanical ventilation
463662|NCT01583088|Phrenic nerve stimulation|phrenic nerve stimulation
463663|NCT01583088|Respiratory insufficiency|respiratory insufficiency
463664|NCT01583062|Surgical Wound Infection|surgical wound infection
463665|NCT01583062|Facial Injuries|facial injuries
463666|NCT01583062|Orbital Fractures|orbital fractures
463667|NCT01583062|Zygomatic Fractures|zygomatic fractures
463668|NCT01583062|Mandibular Fractures|mandibular fractures
463669|NCT01583062|Jaw Injuries|jaw injuries
463670|NCT01583023|bipolar disorder|bipolar disorder
463671|NCT01583023|repetitive transcranial magnetic stimulation (rtms)|repetitive transcranial magnetic stimulation (rtms)
463672|NCT01583023|bupropion|bupropion
463673|NCT01583023|lithium a/o Epival|lithium a/o epival
463674|NCT01583010|ultrasound guided regional anaesthesia needle visualization|ultrasound guided regional anaesthesia needle visualization
463675|NCT01582997|BRAF|braf
463676|NCT01582997|Advance solid tumors|advance solid tumors
463677|NCT01582984|consent|consent
463678|NCT01582984|Patient Understanding|patient understanding
463679|NCT01582984|Knee Arthroplasty|knee arthroplasty
463680|NCT01582971|Breast Cancer|breast cancer
463681|NCT01582971|Reflexology|reflexology
463682|NCT01582971|Complementary|complementary
463683|NCT01582958|Osteopathic Manipulative Treatment|osteopathic manipulative treatment
463684|NCT01582958|Pulmonary Function Tests|pulmonary function tests
463685|NCT01582958|Biochemical Alterations|biochemical alterations
463686|NCT01582945|Treatment resistant|treatment resistant
463687|NCT01582945|suicidal ideation|suicidal ideation
463688|NCT01582945|major depressive disorder|major depressive disorder
463689|NCT01582932|plaque psoriasis|plaque psoriasis
463690|NCT01582932|pediatric|pediatric
463691|NCT01582932|mild|mild
463692|NCT01582932|moderate|moderate
463693|NCT01582919|dementia|dementia
463694|NCT01582919|Alzheimer's Disease|alzheimer's disease
463695|NCT01582919|diagnostic|diagnostic
463696|NCT01582919|biomarkers|biomarkers
463697|NCT01582919|neuroimaging|neuroimaging
463698|NCT01582919|PET|pet
463699|NCT01582919|MRI|mri
463700|NCT01582919|mild cognitive impairment|mild cognitive impairment
463701|NCT01582893|inflammation|inflammation
463702|NCT01582893|dialysis|dialysis
463703|NCT01582880|Keratoprosthesis|keratoprosthesis
463704|NCT01582880|sterile cornea ulcer|sterile cornea ulcer
463705|NCT01582867|Hemodiafiltration|hemodiafiltration
463706|NCT01582867|Hemodialysis|hemodialysis
463707|NCT01582867|Sodium|sodium
463708|NCT01582867|Artis|artis
463709|NCT01582867|renal failure|renal failure
463710|NCT01582854|Post-Stroke Cognitive Impairment (PSCI)|post-stroke cognitive impairment (psci)
463711|NCT01582854|Stroke|stroke
463712|NCT01582854|Actovegin|actovegin
463713|NCT01582854|Cognition disorders|cognition disorders
463714|NCT01582841|Colon Cancer|colon cancer
463715|NCT01582841|Lynch Syndrome|lynch syndrome
463716|NCT01582841|Genetic Screening|genetic screening
463717|NCT01582828|atrial|atrial
463718|NCT01582828|fibrillation|fibrillation
463719|NCT01582828|pvi|pvi
463720|NCT01582828|vats|vats
463721|NCT01582828|ablation|ablation
463722|NCT01582828|hybrid|hybrid
463723|NCT01582815|Major Depressive Disorder|major depressive disorder
463724|NCT01582815|Depression|depression
463725|NCT01582815|Anxiety symptoms|anxiety symptoms
463726|NCT01582815|JNJ-40411813|jnj-40411813
463727|NCT01582763|Guillain-Barré syndrome|guillain-barré syndrome
463728|NCT01582763|Polyneuropathy|polyneuropathy
463729|NCT01582763|Autoimmune Diseases|autoimmune diseases
463730|NCT01582763|Immune System Diseases|immune system diseases
463731|NCT01582763|Neuromuscular Diseases|neuromuscular diseases
463732|NCT01582763|Outcome|outcome
463733|NCT01582763|Quality of life|quality of life
463734|NCT01582763|Disability|disability
463735|NCT01582763|Prognostic Determinants|prognostic determinants
463736|NCT01582763|Treatment|treatment
463737|NCT01582763|Immunoglobulins|immunoglobulins
463738|NCT01582763|Prognosis|prognosis
463739|NCT01582763|Infections|infections
463740|NCT01582763|Anti-ganglioside antibodies|anti-ganglioside antibodies
463741|NCT01582763|Genetic polymorphisms|genetic polymorphisms
463742|NCT01582763|Electrophysiology|electrophysiology
463743|NCT01582763|Cerebrospinal Fluid|cerebrospinal fluid
463744|NCT01582763|Serum|serum
463745|NCT01582750|endoscopic ultrasound|endoscopic ultrasound
463746|NCT01582750|pre-operative concurrent chemoradiotherapy|pre-operative concurrent chemoradiotherapy
463747|NCT01582737|Xarelto|xarelto
463748|NCT01582737|SPAF|spaf
463749|NCT01582724|Menstrual pain|menstrual pain
463750|NCT01582724|Primary dysmenorrhea|primary dysmenorrhea
463751|NCT01582724|Self-care acupressure|self-care acupressure
463752|NCT01582711|LTBI|ltbi
463753|NCT01582711|LTB|ltb
463754|NCT01582711|Latent TB|latent tb
463755|NCT01582711|TB infection|tb infection
463756|NCT01582685|Breast Cancer|breast cancer
463757|NCT01582685|Obesity|obesity
463758|NCT01582685|Exercise|exercise
463759|NCT01582685|Angiogenesis|angiogenesis
463760|NCT01582672|RCC|rcc
463761|NCT01582672|Kidney Cancer|kidney cancer
463762|NCT01582659|constipation|constipation
463763|NCT01582659|children|children
463764|NCT01582659|outpatient|outpatient
463765|NCT01582633|vaccine|vaccine
463766|NCT01582633|influenza|influenza
463767|NCT01582633|needle free jet injector|needle free jet injector
463768|NCT01582633|Intradermal|intradermal
463769|NCT01582633|sparing dose|sparing dose
463770|NCT01582620|Cerebrovascular disorders|cerebrovascular disorders
463771|NCT01582620|Telemedicine|telemedicine
463772|NCT01582620|remote consultation|remote consultation
463773|NCT01582620|rural|rural
463774|NCT01582620|thrombolysis therapy|thrombolysis therapy
463775|NCT01582620|plasminogen activators|plasminogen activators
463776|NCT01582620|stroke care|stroke care
463777|NCT01582620|stroke management|stroke management
463778|NCT01582594|1000 residual serum/plasma samples|1000 residual serum/plasma samples
463779|NCT01582594|anti-HCV seronegative or seropositive|anti-hcv seronegative or seropositive
463780|NCT01582581|mental health|mental health
463781|NCT01582581|depression|depression
463782|NCT01582581|behavioral health|behavioral health
463783|NCT01582581|cognitive behavioral therapy|cognitive behavioral therapy
463785|NCT01582581|computer-assisted psychotherapy|computer-assisted psychotherapy
463786|NCT01582555|mucolysis|mucolysis
463787|NCT01582555|QOL|qol
463788|NCT01582555|endoscopy|endoscopy
463789|NCT01582555|sinus surgery|sinus surgery
463790|NCT01582529|Developmental Outcomes|developmental outcomes
463791|NCT01582529|Psychosocial Outcomes|psychosocial outcomes
463792|NCT01582529|Hypoplastic Left Heart Syndrome|hypoplastic left heart syndrome
463793|NCT01582529|Congenital Heart Disease|congenital heart disease
463794|NCT01582516|brain tumor|brain tumor
463795|NCT01582516|virotherapy|virotherapy
463796|NCT01582516|glioblastoma|glioblastoma
463797|NCT01582516|replication competent adenovirus|replication competent adenovirus
463798|NCT01582490|Mammoplasty|mammoplasty
463799|NCT01582490|Postoperative pain|postoperative pain
463800|NCT01582490|Analgesia|analgesia
463801|NCT01582477|TAP, robot-assisted prostatectomy|tap, robot-assisted prostatectomy
463802|NCT01582464|Protective Headwear|protective headwear
463803|NCT01582464|Social Marketing|social marketing
463804|NCT01582464|Theory of Planned Behavior|theory of planned behavior
463805|NCT01582425|isavuconazole|isavuconazole
463806|NCT01582425|methadone|methadone
463807|NCT01582425|Healthy Volunteers|healthy volunteers
463808|NCT01582425|BAL8557|bal8557
463809|NCT01582412|Isavuconazole|isavuconazole
463810|NCT01582412|Digoxin|digoxin
463811|NCT01582412|Healthy Volunteers|healthy volunteers
463812|NCT01582412|BAL8557|bal8557
463813|NCT01582399|Healthy Volunteers|healthy volunteers
463814|NCT01582399|CD40 receptor occupancy|cd40 receptor occupancy
463815|NCT01582399|Co-stimulation blockade|co-stimulation blockade
463816|NCT01582399|CD40 antigen|cd40 antigen
463817|NCT01582399|Anti-CD40|anti-cd40
463818|NCT01582399|ASKP1240|askp1240
463819|NCT01582360|critical illness|critical illness
463820|NCT01582360|pharmacokinetics|pharmacokinetics
463821|NCT01582360|CRRT|crrt
463822|NCT01582360|CVVH|cvvh
463823|NCT01582360|CVVHD|cvvhd
463824|NCT01582360|CVVHDF|cvvhdf
463825|NCT01582360|antiinfectives|antiinfectives
463826|NCT01582360|antibiotics|antibiotics
463827|NCT01582360|minimum inhibitory concentration|minimum inhibitory concentration
463828|NCT01582360|bacterial killing|bacterial killing
463829|NCT01582360|pharmacodynamics|pharmacodynamics
463830|NCT01582360|PK/PD index|pk/pd index
463831|NCT01582347|Opioid dependence|opioid dependence
463832|NCT01582334|Growth disorders|growth disorders
463833|NCT01582334|Saizen|saizen
463834|NCT01582334|Easypod|easypod
463835|NCT01582334|Growth hormone|growth hormone
463836|NCT01582334|Pediatric subject|pediatric subject
463837|NCT01582321|vascular ultrasound|vascular ultrasound
463838|NCT01582321|flow cytometry|flow cytometry
463839|NCT01582321|platelet aggregation|platelet aggregation
463840|NCT01582295|Bone disease|bone disease
463841|NCT01582282|Type II NIDDM|type ii niddm
463842|NCT01582243|Diabetes Mellitus, type 2|diabetes mellitus, type 2
463843|NCT01582243|vildagliptin|vildagliptin
463844|NCT01582230|Type 2 diabetes mellitus|type 2 diabetes mellitus
463845|NCT01582230|Vildagliptin|vildagliptin
463846|NCT01582217|Bleeding|bleeding
463847|NCT01582217|Risk Score|risk score
463848|NCT01582217|Outcomes|outcomes
463849|NCT01582217|Prasugrel|prasugrel
463850|NCT01582204|clear cell carcinoma|clear cell carcinoma
463851|NCT01582204|Kidney|kidney
463852|NCT01582204|MAB-124I-CG250|mab-124i-cg250
463853|NCT01582204|PET scan|pet scan
463854|NCT01582204|CT scan|ct scan
463855|NCT01582204|sunitinib|sunitinib
463856|NCT01582204|pazopanib|pazopanib
463857|NCT01582204|11-134|11-134
463858|NCT01582178|colonoscopy|colonoscopy
463859|NCT01582178|warm water immersion|warm water immersion
463860|NCT01582178|cool water immersion|cool water immersion
463861|NCT01582152|Brain Neoplasms|brain neoplasms
463862|NCT01582152|Central Nervous System Neoplasms|central nervous system neoplasms
463863|NCT01582152|Recurrent Glioblastoma|recurrent glioblastoma
463864|NCT01582152|Glioblastoma multiforme|glioblastoma multiforme
463865|NCT01582152|GBM|gbm
463866|NCT01582152|Gliosarcoma|gliosarcoma
463867|NCT01582152|TPI287|tpi287
463868|NCT01582152|Bevacizumab|bevacizumab
463869|NCT01582152|Avastin|avastin
463870|NCT01582152|Anti-VEGF Monoclonal Antibody|anti-vegf monoclonal antibody
463871|NCT01582152|rhuMAb-VEGF|rhumab-vegf
463872|NCT01582139|Artificial Pancreas Project|artificial pancreas project
463873|NCT01582139|AP Platform|ap platform
463874|NCT01582139|Insulin Pump|insulin pump
463875|NCT01582139|Continuous Glucose Monitor|continuous glucose monitor
463876|NCT01582139|Closed-Loop Control|closed-loop control
463877|NCT01582139|Control-to-Range|control-to-range
463878|NCT01582126|multiple sclerosis|multiple sclerosis
463879|NCT01582126|physical therapy|physical therapy
463880|NCT01582126|postural control|postural control
463881|NCT01582087|acute hepatic failure|acute hepatic failure
463882|NCT01582087|chronic hepatic failure|chronic hepatic failure
463883|NCT01582087|coma|coma
463884|NCT01582074|Ultrasound Tomography|ultrasound tomography
463885|NCT01582074|Tamoxifen|tamoxifen
463886|NCT01582074|Breast Cancer|breast cancer
463887|NCT01582074|Estrogen Receptor Positive|estrogen receptor positive
463888|NCT01582074|Breast Density|breast density
463889|NCT01582061|Cushing's disease|cushing's disease
463890|NCT01582061|Hormone disorder|hormone disorder
463891|NCT01582061|Cortisol|cortisol
463892|NCT01582061|Adrenocorticotropic hormone|adrenocorticotropic hormone
463893|NCT01582061|Pituitary tumor|pituitary tumor
463894|NCT01582061|SOM230|som230
463895|NCT01582061|adult|adult
463896|NCT01582035|Hepatitis C|hepatitis c
463897|NCT01582035|TMC647055HPC1005|tmc647055hpc1005
463898|NCT01582035|TMC647055|tmc647055
463899|NCT01582035|telaprevir|telaprevir
463900|NCT01581996|Chronic renal failure|chronic renal failure
463901|NCT01581996|End-stage renal disease|end-stage renal disease
463902|NCT01581996|Chronic peritoneal dialysis|chronic peritoneal dialysis
463903|NCT01581996|Serum phosphorus|serum phosphorus
463904|NCT01581996|Hyperphosphatemia|hyperphosphatemia
463905|NCT01581996|Phosphate binders|phosphate binders
463906|NCT01581996|Phosphate|phosphate
463907|NCT01581970|head and neck cancer|head and neck cancer
463908|NCT01581970|metastatic squamous cell cancer|metastatic squamous cell cancer
463909|NCT01581957|Enteral nutrition, critically ill patients|enteral nutrition, critically ill patients
463910|NCT01581944|myomectomy|myomectomy
463911|NCT01581944|GnRH|gnrh
463912|NCT01581944|blood loss|blood loss
463913|NCT01581905|Hysterectomy|hysterectomy
463914|NCT01581905|Laparoscopy|laparoscopy
463915|NCT01581905|Robotics|robotics
463916|NCT01581892|bone nonunion|bone nonunion
463917|NCT01581892|bone marrow|bone marrow
463918|NCT01581892|mononuclear|mononuclear
463919|NCT01581892|fracture|fracture
463920|NCT01581879|Bioequivalence|bioequivalence
463921|NCT01581879|Ziprasidone hydrochloride|ziprasidone hydrochloride
463922|NCT01581879|crossover|crossover
463923|NCT01581866|Bioequivalence|bioequivalence
463924|NCT01581866|Ziprasidone hydrochloride|ziprasidone hydrochloride
463925|NCT01581866|crossover|crossover
463926|NCT01581853|HIV|hiv
463927|NCT01581853|AIDS|aids
463928|NCT01581853|MONOTHERAPY|monotherapy
463929|NCT01581853|PILOT|pilot
463930|NCT01581853|LOPINAVIR/RITONAVIR|lopinavir/ritonavir
463931|NCT01581840|anus|anus
463932|NCT01581840|carcinoma|carcinoma
463933|NCT01581840|panitumumab|panitumumab
463934|NCT01581840|mitomycine|mitomycine
463935|NCT01581840|5Fu|5fu
463936|NCT01581840|radiotherapy|radiotherapy
463937|NCT01581827|Heart Failure|heart failure
463938|NCT01581827|BNP|bnp
463939|NCT01581827|NT-proBNP|nt-probnp
463940|NCT01581814|PCOS|pcos
463941|NCT01581801|gastric bypass|gastric bypass
463942|NCT01581801|sleeve gastrectomy|sleeve gastrectomy
463943|NCT01581801|reactive hypoglycemia|reactive hypoglycemia
463944|NCT01581788|Bioequivalence|bioequivalence
463945|NCT01581788|Divalproex Sodium|divalproex sodium
463946|NCT01581788|Crossover|crossover
463947|NCT01581775|Bioequivalence|bioequivalence
463948|NCT01581775|Divalproex Sodium|divalproex sodium
463949|NCT01581775|Crossover|crossover
463950|NCT01581762|EUS, FNA|eus, fna
463951|NCT01581749|low risk prostate cancer|low risk prostate cancer
463952|NCT01581749|intermediate risk prostate cancer|intermediate risk prostate cancer
463953|NCT01581749|stereotactic radiosurgery|stereotactic radiosurgery
463954|NCT01581736|insulin resistance|insulin resistance
463955|NCT01581736|mitochondria|mitochondria
463956|NCT01581723|urinary bladder tumor|urinary bladder tumor
463957|NCT01581723|monopolar TURBT|monopolar turbt
463958|NCT01581723|bipolar TURBT|bipolar turbt
463959|NCT01581710|Leukotriene Antagonists|leukotriene antagonists
463960|NCT01581710|Bronchodilator response|bronchodilator response
463961|NCT01581697|oat|oat
463962|NCT01581697|cholesterol|cholesterol
463963|NCT01581697|children|children
463964|NCT01581697|adolescent|adolescent
463965|NCT01581697|Level reduction of ceric cholesterol|level reduction of ceric cholesterol
463966|NCT01581645|Parkinson's disease|parkinson's disease
463967|NCT01581645|Parkinsonism|parkinsonism
463968|NCT01581645|Gait problems|gait problems
463969|NCT01581645|Freezing gait|freezing gait
463970|NCT01581632|atherosclerosis|atherosclerosis
463971|NCT01581632|endothelial dysfunction|endothelial dysfunction
463972|NCT01581632|coronary vasospasm|coronary vasospasm
463973|NCT01581619|Early Invasive N0|early invasive n0
463974|NCT01581619|Non-Invasive|non-invasive
463975|NCT01581606|Age Related Macular Degeneration|age related macular degeneration
463976|NCT01581606|Teleophthalmology|teleophthalmology
463977|NCT01581606|Screening|screening
463978|NCT01581606|Diagnosis|diagnosis
463979|NCT01581606|Timing|timing
463980|NCT01581606|Treatment|treatment
463981|NCT01581593|Primary Immunodeficiency|primary immunodeficiency
463982|NCT01581593|PID|pid
463983|NCT01581593|Agammaglobulinemia|agammaglobulinemia
463984|NCT01581593|Hypogammaglobulinemia|hypogammaglobulinemia
463985|NCT01581593|Antibody deficiency|antibody deficiency
463986|NCT01581580|Parkinson's Disease|parkinson's disease
463987|NCT01581580|Deep Brain Stimulation|deep brain stimulation
463988|NCT01581580|Neurophysiology|neurophysiology
463989|NCT01581580|Movement Disorder|movement disorder
463990|NCT01581580|Dystonia|dystonia
463991|NCT01581580|Parkinson Disease|parkinson disease
463992|NCT01581580|Essential Tremor|essential tremor
463993|NCT01581554|Hepatitis B|hepatitis b
463994|NCT01581554|Treatment|treatment
463995|NCT01581554|Nucleoside/Nucleotide Analogue|nucleoside/nucleotide analogue
463996|NCT01581541|Targeted Therapy|targeted therapy
463997|NCT01581541|Solid Tumors|solid tumors
463998|NCT01581541|Lymphoma|lymphoma
463999|NCT01581541|Non-Hodgkin Lymphoma|non-hodgkin lymphoma
464000|NCT01581541|Solid Tumor|solid tumor
464001|NCT01581528|T-cell childhood acute lymphoblastic leukemia|t-cell childhood acute lymphoblastic leukemia
464002|NCT01581528|untreated adult acute lymphoblastic leukemia|untreated adult acute lymphoblastic leukemia
464003|NCT01581528|T-cell adult acute lymphoblastic leukemia|t-cell adult acute lymphoblastic leukemia
464004|NCT01581528|untreated childhood acute lymphoblastic leukemia|untreated childhood acute lymphoblastic leukemia
464005|NCT01581502|Anticoagulation|anticoagulation
464006|NCT01581502|Recurrent stroke|recurrent stroke
464007|NCT01581502|Bleeding|bleeding
464008|NCT01581489|Cord clamping|cord clamping
464009|NCT01581489|iron deficiency|iron deficiency
464010|NCT01581489|Neurodevelopment|neurodevelopment
464011|NCT01581476|Adolescence|adolescence
464012|NCT01581463|pharmacokinetics of oral T3|pharmacokinetics of oral t3
464013|NCT01581450|Hyperalgesia and pain|hyperalgesia and pain
464014|NCT01581437|atrial fibrillation|atrial fibrillation
464015|NCT01581437|cardiac ablation|cardiac ablation
464016|NCT01581424|Fabry disease|fabry disease
464017|NCT01581424|kidney function|kidney function
464018|NCT01581424|kidney structure morphometry|kidney structure morphometry
464019|NCT01581424|Fabry kidney disease|fabry kidney disease
464020|NCT01581424|Podocytes|podocytes
464021|NCT01581411|central retinal vein occlusion|central retinal vein occlusion
464022|NCT01581411|macular edema|macular edema
464023|NCT01581411|vision loss|vision loss
464024|NCT01581411|relative afferent papillary defect|relative afferent papillary defect
464025|NCT01581398|Peginterferon|peginterferon
464026|NCT01581398|Pegasys|pegasys
464027|NCT01581398|Sustained virus response|sustained virus response
464028|NCT01581398|HCV|hcv
464029|NCT01581385|atherosclerosis|atherosclerosis
464030|NCT01581385|carotid artery|carotid artery
464031|NCT01581385|carotid endarterectomy|carotid endarterectomy
464032|NCT01581359|Endometriosis|endometriosis
464033|NCT01581359|GnRH treatment|gnrh treatment
464034|NCT01581359|Infertility|infertility
464036|NCT01581346|NSCLC|nsclc
464037|NCT01581346|exercise intervention|exercise intervention
464038|NCT01581346|quality of life|quality of life
464039|NCT01581333|febrile neutropenia|febrile neutropenia
464040|NCT01581333|antimicrobial treatment|antimicrobial treatment
464041|NCT01581333|procalcitonin|procalcitonin
464042|NCT01581307|liver|liver
464043|NCT01581307|pancreas|pancreas
464044|NCT01581307|chemotherapy|chemotherapy
464045|NCT01581307|radiotherapy|radiotherapy
464046|NCT01581294|Rheumatoid arthritis|rheumatoid arthritis
464047|NCT01581294|Psoriatic arthritis|psoriatic arthritis
464048|NCT01581294|Ankylosing spondylitis|ankylosing spondylitis
464049|NCT01581294|Spondyloarthritis|spondyloarthritis
464050|NCT01581281|Pediatric|pediatric
464051|NCT01581281|Children|children
464052|NCT01581281|Adolescent|adolescent
464053|NCT01581281|Headache|headache
464054|NCT01581281|Migraine|migraine
464055|NCT01581255|acute respiratory distress syndrome|acute respiratory distress syndrome
464056|NCT01581255|high frequency oscillation ventilation|high frequency oscillation ventilation
464057|NCT01581255|ventilator-induced lung injury|ventilator-induced lung injury
464058|NCT01581255|biomarkers|biomarkers
464059|NCT01581242|Clevudine and Adefovir dipivoxil|clevudine and adefovir dipivoxil
464060|NCT01581242|pharmacokinetic drug drug interaction|pharmacokinetic drug drug interaction
464061|NCT01581242|oral administration|oral administration
464062|NCT01581242|male subjects|male subjects
464063|NCT01581229|ALI;noninvasive positive pressure ventilation|ali;noninvasive positive pressure ventilation
464064|NCT01581216|Fatigue|fatigue
464065|NCT01581216|Palliative Care|palliative care
464066|NCT01581216|Exercise|exercise
464067|NCT01581190|Bananas|bananas
464068|NCT01581190|Exercise|exercise
464069|NCT01581190|Metabolomics|metabolomics
464070|NCT01581190|Oxidative stress|oxidative stress
464071|NCT01581190|Inflammation|inflammation
464072|NCT01581190|Immune function|immune function
464073|NCT01581177|asthma|asthma
464074|NCT01581177|mild-to-moderate persistent asthma|mild-to-moderate persistent asthma
464075|NCT01581177|mild asthma|mild asthma
464076|NCT01581177|moderate asthma|moderate asthma
464077|NCT01581177|persistent asthma|persistent asthma
464078|NCT01581164|blood|blood
464079|NCT01581164|hematopoietic|hematopoietic
464080|NCT01581164|stem|stem
464081|NCT01581164|cell|cell
464082|NCT01581164|transplant|transplant
464083|NCT01581164|vaccine|vaccine
464084|NCT01581164|vaccination|vaccination
464085|NCT01581164|recovery|recovery
464086|NCT01581164|immune|immune
464087|NCT01581164|system|system
464088|NCT01581151|retinal vein occlusion|retinal vein occlusion
464089|NCT01581151|ozurdex|ozurdex
464090|NCT01581151|lucentis|lucentis
464091|NCT01581151|BCVA|bcva
464092|NCT01581151|foveal thickness|foveal thickness
464093|NCT01581125|Inpatients|inpatients
464094|NCT01581125|Health Normalcy|health normalcy
464095|NCT01581125|circadian rhythm|circadian rhythm
464096|NCT01581099|Atherosclerosis|atherosclerosis
464097|NCT01581099|Cardiovascular risk factors|cardiovascular risk factors
464098|NCT01581099|Calorie restriction|calorie restriction
464099|NCT01581099|Bariatric Surgery|bariatric surgery
464100|NCT01581086|HIV|hiv
464101|NCT01581086|COPD|copd
464102|NCT01581086|Pulmonary disease|pulmonary disease
464103|NCT01581073|renal anemia|renal anemia
464104|NCT01581073|erythropoiesis stimulating agent|erythropoiesis stimulating agent
464105|NCT01581073|hemoglobin|hemoglobin
464106|NCT01581073|non-diabetes|non-diabetes
464107|NCT01581073|CKD|ckd
464108|NCT01581073|Chronic Kidney Disease patients without diabetes|chronic kidney disease patients without diabetes
464109|NCT01581047|amoxicillin|amoxicillin
464110|NCT01581047|clavulanic acid|clavulanic acid
464111|NCT01581047|cefuroxime|cefuroxime
464112|NCT01581047|Patients in the intensive care unit, with an infection which requires amoxicillin/clavulanic acid or cefuroxime|patients in the intensive care unit, with an infection which requires amoxicillin/clavulanic acid or cefuroxime
464113|NCT01581034|endothelial function|endothelial function
464114|NCT01581034|biomarkers|biomarkers
464115|NCT01581034|autonomic nervous system|autonomic nervous system
464116|NCT01581034|coronary artery disease|coronary artery disease
464117|NCT01581021|randomized|randomized
464118|NCT01581021|controlled|controlled
464119|NCT01581021|hooks|hooks
464120|NCT01581021|screws|screws
464121|NCT01581008|palliative care|palliative care
464122|NCT01581008|heart failure|heart failure
464123|NCT01581008|delivery of health care|delivery of health care
464124|NCT01580995|Chronic hepatitis C infection|chronic hepatitis c infection
464125|NCT01580982|Oncogenes|oncogenes
464126|NCT01580982|Lung and Other Thoracic Cancers|lung and other thoracic cancers
464127|NCT01580969|glioma|glioma
464128|NCT01580956|Acute respiratory failure|acute respiratory failure
464129|NCT01580956|Critical illness|critical illness
464130|NCT01580956|Mechanical ventilation|mechanical ventilation
464131|NCT01580956|Ventilation weaning|ventilation weaning
464132|NCT01580956|Intensive Care Unit|intensive care unit
464133|NCT01580956|Variable (NOISY) PSV|variable (noisy) psv
464134|NCT01580956|PSV|psv
464135|NCT01580943|Chlorhexidine|chlorhexidine
464136|NCT01580943|Cetyl pyridinium chloride|cetyl pyridinium chloride
464137|NCT01580943|Mouth rinse|mouth rinse
464138|NCT01580943|Antiplaque Efficacy|antiplaque efficacy
464139|NCT01580943|Self Efficacy|self efficacy
464140|NCT01580943|Taste Sweet|taste sweet
464141|NCT01580943|Side Effects|side effects
464142|NCT01580930|physical inactivity|physical inactivity
464143|NCT01580930|exercise training|exercise training
464144|NCT01580930|sedentary time|sedentary time
464145|NCT01580930|habitual physical activity|habitual physical activity
464146|NCT01580917|laser doppler anemometry|laser doppler anemometry
464147|NCT01580917|dynamic testing of tissue mechanical property|dynamic testing of tissue mechanical property
464148|NCT01580917|diabetic foot complications|diabetic foot complications
464149|NCT01580917|ulcer genesis|ulcer genesis
464150|NCT01580904|Pharmaceutical Care|pharmaceutical care
464151|NCT01580904|Diabetics patients|diabetics patients
464152|NCT01580904|Clinical trial|clinical trial
464153|NCT01580891|Naftifine HCl Cream 1%|naftifine hcl cream 1%
464154|NCT01580891|Naftin® (Naftifine HCl) Cream 1%|naftin® (naftifine hcl) cream 1%
464155|NCT01580891|Tinea Pedis|tinea pedis
464156|NCT01580891|Efficacy and safety|efficacy and safety
464157|NCT01580878|Butenafine Hydrochloride Cream, 1%|butenafine hydrochloride cream, 1%
464158|NCT01580878|Lotrimin Ultra® Cream, 1%|lotrimin ultra® cream, 1%
464159|NCT01580878|Interdigital Tinea Pedis|interdigital tinea pedis
464160|NCT01580878|Safety and Bioequivalence|safety and bioequivalence
464161|NCT01580865|Lupus nephritis|lupus nephritis
464162|NCT01580865|Tacrolimus|tacrolimus
464163|NCT01580865|Mycophenolate mofetil|mycophenolate mofetil
464164|NCT01580865|Complete remission|complete remission
464165|NCT01580839|ischemic stroke|ischemic stroke
464166|NCT01580839|ischemic penumbra|ischemic penumbra
464167|NCT01580839|magnetic resonance imaging|magnetic resonance imaging
464168|NCT01580839|MRI|mri
464169|NCT01580839|diffusion imaging|diffusion imaging
464170|NCT01580839|DWI|dwi
464171|NCT01580839|perfusion imaging|perfusion imaging
464172|NCT01580839|PWI|pwi
464173|NCT01580839|thrombolysis|thrombolysis
464174|NCT01580839|alteplase|alteplase
464175|NCT01580839|tPA|tpa
464176|NCT01580839|EPITHET|epithet
464177|NCT01580826|pasteurization|pasteurization
464178|NCT01580826|human milk|human milk
464179|NCT01580826|very low birth weight infants|very low birth weight infants
464180|NCT01580813|diabetes|diabetes
464181|NCT01580813|exercise|exercise
464182|NCT01580813|cardiovascular|cardiovascular
464183|NCT01580813|heart|heart
464184|NCT01580813|insulin sensitivity|insulin sensitivity
464185|NCT01580787|Parkinson´s disease|parkinson´s disease
464186|NCT01580787|Postural Balance|postural balance
464187|NCT01580787|virtual reality|virtual reality
464188|NCT01580735|NSCLC|nsclc
464189|NCT01580735|c-MET|c-met
464190|NCT01580735|EGFR mutation-positive|egfr mutation-positive
464191|NCT01580735|gefitinib|gefitinib
464192|NCT01580735|erlotinib|erlotinib
464193|NCT01580735|EGFR-TKI resistance|egfr-tki resistance
464194|NCT01580722|Anterior Cruciate Ligament,Early,Delay,Reconstruction|anterior cruciate ligament,early,delay,reconstruction
464195|NCT01580709|stricture|stricture
464196|NCT01580709|cholangiocarcinoma|cholangiocarcinoma
464197|NCT01580709|pancreatic adenocarcinoma|pancreatic adenocarcinoma
464198|NCT01580709|bile duct|bile duct
464199|NCT01580709|ERCP|ercp
464200|NCT01580696|Folate binding protein|folate binding protein
464201|NCT01580696|E39 vaccine|e39 vaccine
464202|NCT01580696|Stage I-IV ovarian cancer|stage i-iv ovarian cancer
464203|NCT01580696|Stage I-IV endometrial cancer|stage i-iv endometrial cancer
464204|NCT01580683|Atrial Fibrillation|atrial fibrillation
464205|NCT01580683|Ascorbic Acid|ascorbic acid
464206|NCT01580683|Thoracic Surgery|thoracic surgery
464207|NCT01580683|Cardiac Arrhythmias|cardiac arrhythmias
464208|NCT01580683|Cardiac Surgery|cardiac surgery
464209|NCT01580683|Vitamin C|vitamin c
464210|NCT01580683|Postoperative Complications|postoperative complications
464211|NCT01580683|Antioxidants|antioxidants
464212|NCT01580683|Inflammation|inflammation
464213|NCT01580670|Infliximab|infliximab
464214|NCT01580670|REMICADE|remicade
464215|NCT01580670|TA-650|ta-650
464216|NCT01580670|pediatric Crohn's disease|pediatric crohn's disease
464217|NCT01580657|HIV|hiv
464218|NCT01580657|Prevention|prevention
464219|NCT01580657|Methods|methods
464220|NCT01580657|Assessment reactivity|assessment reactivity
464221|NCT01580657|South Africa|south africa
464222|NCT01580657|Youth|youth
464223|NCT01580631|Narrow band imaging|narrow band imaging
464224|NCT01580631|Barrett's esophagus|barrett's esophagus
464225|NCT01580631|Gastroesophageal reflux disease|gastroesophageal reflux disease
464226|NCT01580618|pleural effusion|pleural effusion
464227|NCT01580618|malignancy|malignancy
464228|NCT01580618|loculated|loculated
464229|NCT01580579|Radiation pneumonitis|radiation pneumonitis
464230|NCT01580579|locally advanced lung cancer|locally advanced lung cancer
464231|NCT01580579|Respiratory function tests|respiratory function tests
464232|NCT01580566|Myocardial Infarction (MI)|myocardial infarction (mi)
464233|NCT01580566|Kidney function|kidney function
464234|NCT01580566|bio-markers|bio-markers
464235|NCT01580553|Heart failure|heart failure
464236|NCT01580553|L-carnitine|l-carnitine
464237|NCT01580553|injection|injection
464238|NCT01580553|safety|safety
464239|NCT01580553|efficacy|efficacy
464240|NCT01580527|postoperative artificial nutrition|postoperative artificial nutrition
464241|NCT01580527|parenteral nutrition|parenteral nutrition
464242|NCT01580527|enteral nutrition|enteral nutrition
464243|NCT01580527|postoperative complications|postoperative complications
464244|NCT01580527|cephalic pancreatoduodenectomy|cephalic pancreatoduodenectomy
464842|NCT01577810|NIRS|nirs
464245|NCT01580514|myocardial infarction|myocardial infarction
464246|NCT01580514|percutaneous coronary intervention|percutaneous coronary intervention
464247|NCT01580514|exenatide|exenatide
464248|NCT01580514|reperfusion injury|reperfusion injury
464249|NCT01580514|cardiac magnetic resonance|cardiac magnetic resonance
464250|NCT01580475|glycemic control,|glycemic control,
464251|NCT01580475|exercise training,|exercise training,
464252|NCT01580475|detraining,|detraining,
464253|NCT01580475|retraining,|retraining,
464254|NCT01580475|body composition,|body composition,
464255|NCT01580475|strength and fitness|strength and fitness
464256|NCT01580462|continuous subcutaneous insulin infusion (CSII)|continuous subcutaneous insulin infusion (csii)
464257|NCT01580462|children|children
464258|NCT01580462|adolescent|adolescent
464259|NCT01580436|Tricuspid Valve Insufficiency|tricuspid valve insufficiency
464260|NCT01580436|Cardiac Valve Annuloplasty|cardiac valve annuloplasty
464261|NCT01580436|Outcome Assessment (Health Care)|outcome assessment (health care)
464262|NCT01580423|dyspnea|dyspnea
464263|NCT01580397|Pancreatic cancer|pancreatic cancer
464264|NCT01580397|INNO-206|inno-206
464265|NCT01580397|Doxorubicin-EMCH|doxorubicin-emch
464266|NCT01580358|cancer|cancer
464267|NCT01580358|radiotherapy|radiotherapy
464268|NCT01580358|chemotherapy|chemotherapy
464269|NCT01580358|Traditional Chinese Medicine|traditional chinese medicine
464270|NCT01580358|Safety|safety
464271|NCT01580345|DHA|dha
464272|NCT01580345|Omega 3 fatty acid|omega 3 fatty acid
464273|NCT01580345|Decosa hexaenoic acid|decosa hexaenoic acid
464274|NCT01580345|Pregnancy|pregnancy
464275|NCT01580345|Newborn outcome|newborn outcome
464276|NCT01580345|Supplementation|supplementation
464277|NCT01580345|Birth size|birth size
464278|NCT01580345|gestational age|gestational age
464279|NCT01580345|India|india
464280|NCT01580345|Randomized controlled trial|randomized controlled trial
464281|NCT01580345|RCT|rct
464282|NCT01580332|biomarkers|biomarkers
464283|NCT01580332|lung cancer|lung cancer
464284|NCT01580332|solitary pulmonary nodules|solitary pulmonary nodules
464285|NCT01580332|SPN|spn
464286|NCT01580332|breath analysis|breath analysis
464287|NCT01580332|VOC|voc
464288|NCT01580332|volatile organic compounds|volatile organic compounds
464289|NCT01580332|sputum|sputum
464290|NCT01580332|auto-antibodies|auto-antibodies
464291|NCT01580319|obesity|obesity
464292|NCT01580319|cholesterol|cholesterol
464293|NCT01580319|cholesterol, LDL|cholesterol, ldl
464294|NCT01580319|cholesterol, HDL|cholesterol, hdl
464295|NCT01580319|blood glucose|blood glucose
464296|NCT01580319|Triglyceride|triglyceride
464297|NCT01580319|C-Reactive Protein - hs|c-reactive protein - hs
464298|NCT01580319|blood pressure|blood pressure
464299|NCT01580319|physical activity|physical activity
464300|NCT01580319|Sedentary Lifestyle|sedentary lifestyle
464301|NCT01580293|Hemophilia A, factor VIII, prophylaxis|hemophilia a, factor viii, prophylaxis
464302|NCT01580280|Cervicogenic|cervicogenic
464303|NCT01580280|Headache|headache
464304|NCT01580280|Neck Pain|neck pain
464305|NCT01580280|Manipulation|manipulation
464306|NCT01580280|Mobilization|mobilization
464307|NCT01580280|Exercise|exercise
464308|NCT01580267|Anemia in trauma|anemia in trauma
464309|NCT01580254|Latanoprost|latanoprost
464310|NCT01580254|IOP|iop
464311|NCT01580215|Valves|valves
464312|NCT01580215|Endobronchial|endobronchial
464313|NCT01580215|Endoscopic lung volume reduction|endoscopic lung volume reduction
464314|NCT01580215|Pulmonx|pulmonx
464315|NCT01580215|Zephyr|zephyr
464316|NCT01580215|Chartis|chartis
464317|NCT01580215|Emphysema|emphysema
464318|NCT01580215|COPD|copd
464319|NCT01580202|malignancy|malignancy
464320|NCT01580202|hepatitis B|hepatitis b
464321|NCT01580202|lamivudine|lamivudine
464322|NCT01580202|entecavir|entecavir
464323|NCT01580202|prophylaxis|prophylaxis
464324|NCT01580189|Lean tissue|lean tissue
464325|NCT01580189|Strength condition|strength condition
464326|NCT01580189|Protein|protein
464327|NCT01580189|Amino Acid|amino acid
464328|NCT01580163|the opioid dependence in rehabilitation phase|the opioid dependence in rehabilitation phase
464329|NCT01580163|community|community
464330|NCT01580150|Berries|berries
464331|NCT01580150|Starch|starch
464332|NCT01580150|Sucrose|sucrose
464333|NCT01580150|Glucose|glucose
464334|NCT01580150|Insulin|insulin
464335|NCT01580150|Postprandial|postprandial
464336|NCT01580137|acute respiratory tract infection|acute respiratory tract infection
464337|NCT01580137|common cold|common cold
464338|NCT01580137|acute bacterial rhinosinusitis|acute bacterial rhinosinusitis
464339|NCT01580137|adult|adult
464340|NCT01580137|conscript|conscript
464341|NCT01580111|Blood|blood
464342|NCT01580111|Storage|storage
464343|NCT01580111|Age|age
464344|NCT01580111|Transfusion|transfusion
464345|NCT01580111|Lactic acidosis|lactic acidosis
464346|NCT01580085|Sleep disordered breathing|sleep disordered breathing
464347|NCT01580085|gender|gender
464348|NCT01580085|hypercoagulability|hypercoagulability
464349|NCT01580046|Chronic Kidney Disease|chronic kidney disease
464350|NCT01580046|Coronary Angiography|coronary angiography
464351|NCT01580046|Contrast Media|contrast media
464352|NCT01580046|Percutaneous Coronary Intervention|percutaneous coronary intervention
464353|NCT01580046|Serum Creatinine|serum creatinine
464354|NCT01580046|Glomerular Filtration Rate|glomerular filtration rate
464355|NCT01580046|Iodixanol|iodixanol
464356|NCT01580046|Iopromide|iopromide
464357|NCT01580033|immunogenicity|immunogenicity
464359|NCT01580033|group A, C polysaccharide meningitis|group a, c polysaccharide meningitis
464360|NCT01580033|type b haemophilus Influenza|type b haemophilus influenza
464361|NCT01580020|Macular Degeneration|macular degeneration
464362|NCT01580020|Macular Edema|macular edema
464363|NCT01580020|Retinal Vein Occlusion|retinal vein occlusion
464364|NCT01580020|Choroidal Neovascularization|choroidal neovascularization
464365|NCT01580020|Signs and Symptoms|signs and symptoms
464366|NCT01580020|Retinal Degeneration|retinal degeneration
464367|NCT01580020|Retinal Diseases|retinal diseases
464368|NCT01580020|Eye Diseases|eye diseases
464369|NCT01580020|Venous Thrombosis Sensation Disorders|venous thrombosis sensation disorders
464370|NCT01580020|Dexamethasone acetate|dexamethasone acetate
464371|NCT01580020|Dexamethasone|dexamethasone
464372|NCT01580020|Dexamethasone 21-phosphate|dexamethasone 21-phosphate
464373|NCT01580020|BB 1101|bb 1101
464374|NCT01580020|Anti-Inflammatory Agents|anti-inflammatory agents
464375|NCT01580020|Therapeutic Uses|therapeutic uses
464376|NCT01580020|Vision, Low|vision, low
464377|NCT01580020|Signs|signs
464378|NCT01580020|Vision Disorders|vision disorders
464379|NCT01580007|tuberculosis|tuberculosis
464380|NCT01580007|phenylbutyrate|phenylbutyrate
464381|NCT01580007|vitamin D|vitamin d
464382|NCT01580007|cathelicidin|cathelicidin
464383|NCT01580007|antimicrobial peptide|antimicrobial peptide
464384|NCT01580007|in adults|in adults
464385|NCT01579994|adenocarcinoma|adenocarcinoma
464386|NCT01579994|Lung|lung
464387|NCT01579994|Metastatic|metastatic
464388|NCT01579994|Crizotinib|crizotinib
464389|NCT01579994|Ganetespib|ganetespib
464390|NCT01579994|STA-9090|sta-9090
464391|NCT01579994|ALK Positive Lung Cancers|alk positive lung cancers
464392|NCT01579994|12-015|12-015
464393|NCT01579981|RYGB|rygb
464394|NCT01579981|Bariatric Surgery|bariatric surgery
464395|NCT01579981|Glucagon-like-peptide 1|glucagon-like-peptide 1
464396|NCT01579942|EEG|eeg
464397|NCT01579942|Biomarker|biomarker
464398|NCT01579942|Major Depressive Disorder|major depressive disorder
464399|NCT01579942|Healthy Control|healthy control
464400|NCT01579929|Extensive Stage Small Cell Lung Cancer (ES-SCLC)|extensive stage small cell lung cancer (es-sclc)
464401|NCT01579929|CISPLATIN|cisplatin
464402|NCT01579929|ETOPOSIDE (VP-16)|etoposide (vp-16)
464403|NCT01579929|LDE-225|lde-225
464404|NCT01579929|STAR|star
464405|NCT01579929|Symptom Tracking and Reporting for Patients|symptom tracking and reporting for patients
464406|NCT01579929|11-206|11-206
464407|NCT01579916|Trivalent, Influenza, FluMist, Vaccine, Prevention|trivalent, influenza, flumist, vaccine, prevention
464408|NCT01579903|Hemophilia A|hemophilia a
464409|NCT01579903|moroctocog alfa (AF-CC)|moroctocog alfa (af-cc)
464410|NCT01579903|ReFacto AF|refacto af
464411|NCT01579903|dual-chamber syringe|dual-chamber syringe
464412|NCT01579903|bioavailability|bioavailability
464413|NCT01579877|Xerostomia|xerostomia
464414|NCT01579877|Yukmijihwang-tang|yukmijihwang-tang
464415|NCT01579877|Yin-Deficiency|yin-deficiency
464416|NCT01579877|Visual analogue scale|visual analogue scale
464417|NCT01579877|Dry mouth symptom questionnaire|dry mouth symptom questionnaire
464418|NCT01579812|Ovarian, Fallopian Tube, and Primary Peritoneal Cancer|ovarian, fallopian tube, and primary peritoneal cancer
464419|NCT01579786|post operative pain|post operative pain
464420|NCT01579786|acupuncture|acupuncture
464421|NCT01579760|radiation|radiation
464422|NCT01579760|retinopathy|retinopathy
464423|NCT01579760|macular edema|macular edema
464424|NCT01579760|anti-VEGF|anti-vegf
464425|NCT01579760|VEGF-Trap|vegf-trap
464426|NCT01579760|aflibercept|aflibercept
464427|NCT01579747|nerve stimulation|nerve stimulation
464428|NCT01579747|ultrasound|ultrasound
464429|NCT01579747|sciatic nerve block|sciatic nerve block
464430|NCT01579747|popliteal block|popliteal block
464431|NCT01579747|obese|obese
464432|NCT01579734|breast cancer chemoprevention postmenopause|breast cancer chemoprevention postmenopause
464433|NCT01579708|Diet|diet
464434|NCT01579708|Physical activity|physical activity
464435|NCT01579708|Knowledge|knowledge
464436|NCT01579708|Attitudes|attitudes
464437|NCT01579708|Habits|habits
464438|NCT01579708|Lifestyle|lifestyle
464439|NCT01579708|School-based|school-based
464440|NCT01579695|HIV with lipohypertrophy|hiv with lipohypertrophy
464441|NCT01579682|Eating Disorder|eating disorder
464442|NCT01579682|Anorexia Nervosa|anorexia nervosa
464443|NCT01579682|Eating Disorder Not Otherwise Specified|eating disorder not otherwise specified
464444|NCT01579682|Maudsley|maudsley
464445|NCT01579682|Family-Based Therapy|family-based therapy
464447|NCT01579682|Family Therapy|family therapy
464448|NCT01579669|Autism Spectrum Disorder|autism spectrum disorder
464449|NCT01579669|Primary Care Services|primary care services
464450|NCT01579669|Patient-Provider Communication|patient-provider communication
464451|NCT01579669|Adults|adults
464452|NCT01579643|cornea|cornea
464453|NCT01579643|opacity|opacity
464454|NCT01579643|congenital|congenital
464455|NCT01579630|NSCLC|nsclc
464456|NCT01579630|Nonsquamous|nonsquamous
464457|NCT01579630|Maintenance therapy|maintenance therapy
464458|NCT01579617|pregnancy|pregnancy
464459|NCT01579617|STI|sti
464460|NCT01579617|STD|std
464461|NCT01579604|Loss of upper extremities functions|loss of upper extremities functions
464462|NCT01579604|Nerve transfer|nerve transfer
464463|NCT01579578|Metastatic Gastric Cancer who progress following First Line Therapy and are Ineligible for Treatment with trastuzumab by HER2 Status|metastatic gastric cancer who progress following first line therapy and are ineligible for treatment with trastuzumab by her2 status
464464|NCT01579565|cataract|cataract
464465|NCT01579565|lens replacement|lens replacement
464466|NCT01579552|Questionnaires|questionnaires
464467|NCT01579552|telephone counseling session|telephone counseling session
464468|NCT01579552|10-104|10-104
464469|NCT01579552|Childhood Cancer Survivor Women Post Chest Radiation|childhood cancer survivor women post chest radiation
464470|NCT01579539|Methylprednisolone|methylprednisolone
464471|NCT01579539|Dry Eye Syndrome|dry eye syndrome
464472|NCT01579539|Tear Film|tear film
464473|NCT01579539|Thyroid-associated ophthalmopathy|thyroid-associated ophthalmopathy
464474|NCT01579526|Safety and Pharmacokinetics of FP01 in Healthy Volunteers|safety and pharmacokinetics of fp01 in healthy volunteers
464475|NCT01579513|Cardiopulmonary Bypass (CPB)|cardiopulmonary bypass (cpb)
464476|NCT01579513|System Inflammatory Response|system inflammatory response
464477|NCT01579513|inflammation|inflammation
464478|NCT01579513|Methylprednisolone|methylprednisolone
464479|NCT01579513|Neonates|neonates
464480|NCT01579513|Steroid|steroid
464481|NCT01579513|Cardiac Surgical Procedures|cardiac surgical procedures
464482|NCT01579513|Children|children
464483|NCT01579513|Infants|infants
464484|NCT01579513|Pediatrics|pediatrics
464485|NCT01579513|Glucocorticoid|glucocorticoid
464486|NCT01579513|Heart Disease|heart disease
464487|NCT01579513|Heart Defects, Congenital|heart defects, congenital
464488|NCT01579513|Cardiovascular Diseases|cardiovascular diseases
464489|NCT01579513|Cardiovascular Abnormalities|cardiovascular abnormalities
464490|NCT01579513|Corticosteroid|corticosteroid
464491|NCT01579513|methylprednisolone Hemisuccinate|methylprednisolone hemisuccinate
464492|NCT01579513|Hormones|hormones
464493|NCT01579513|Physiological Effects of Drugs|physiological effects of drugs
464494|NCT01579513|Randomized Clinical Trial|randomized clinical trial
464495|NCT01579487|Lipolysis|lipolysis
464496|NCT01579487|Cryolipolysis|cryolipolysis
464497|NCT01579487|Fat Reduction|fat reduction
464498|NCT01579461|Pharmacokinetics|pharmacokinetics
464499|NCT01579461|mirabegron|mirabegron
464500|NCT01579461|hepatic impairment|hepatic impairment
464501|NCT01579461|Phase 1|phase 1
464502|NCT01579448|killed oral cholera vaccine|killed oral cholera vaccine
464503|NCT01579448|boosting vaccine regimen|boosting vaccine regimen
464504|NCT01579448|safety and immunogenicity|safety and immunogenicity
464505|NCT01579435|essential tremor|essential tremor
464506|NCT01579435|primary motor cortex|primary motor cortex
464507|NCT01579435|cerebellum|cerebellum
464508|NCT01579435|transcranial direct current stimulation|transcranial direct current stimulation
464509|NCT01579435|electrophysiology|electrophysiology
464510|NCT01579422|schizophrenia|schizophrenia
464511|NCT01579422|treatment|treatment
464512|NCT01579422|social cognition|social cognition
464513|NCT01579409|Nutrition|nutrition
464514|NCT01579409|Arterial stiffness|arterial stiffness
464515|NCT01579409|Endothelial dysfunction|endothelial dysfunction
464516|NCT01579409|Microcirculation|microcirculation
464517|NCT01579409|Cardiac autonomic system.|cardiac autonomic system.
464518|NCT01579396|septeX|septex
464519|NCT01579396|high cut-off|high cut-off
464520|NCT01579396|Thoracic Surgery|thoracic surgery
464521|NCT01579396|Renal Replacement Therapy|renal replacement therapy
464522|NCT01579383|Migraine Disorders|migraine disorders
464523|NCT01579383|Phase 1|phase 1
464524|NCT01579383|ALD403|ald403
464525|NCT01579370|healthcare associated infections|healthcare associated infections
464526|NCT01579370|multidrug resistant organisms|multidrug resistant organisms
464527|NCT01579370|methicillin resistant staphylococcus aureus|methicillin resistant staphylococcus aureus
464528|NCT01579370|vancomycin resistant enterococcus|vancomycin resistant enterococcus
464529|NCT01579370|clostridium difficile|clostridium difficile
464530|NCT01579370|acinetobacter|acinetobacter
464531|NCT01579357|colorectal carcinoma|colorectal carcinoma
464532|NCT01579357|K-ras wild type|k-ras wild type
464533|NCT01579357|Capecitabine|capecitabine
464534|NCT01579357|Cetuximab|cetuximab
464535|NCT01579357|Oxaliplatin|oxaliplatin
464536|NCT01579357|Pharmacokinetics|pharmacokinetics
464537|NCT01579357|exclude a possible influence of CETUX|exclude a possible influence of cetux
464538|NCT01579357|plasma disposition|plasma disposition
464539|NCT01579357|metabolic activation|metabolic activation
464541|NCT01579357|OxPt|oxpt
464542|NCT01579344|Iodine Radioisotopes|iodine radioisotopes
464543|NCT01579344|Nasolacrimal Duct|nasolacrimal duct
464544|NCT01579344|radiation effects|radiation effects
464545|NCT01579331|IOP|iop
464546|NCT01579331|Tonometry|tonometry
464547|NCT01579331|Pascal|pascal
464548|NCT01579331|Goldmann|goldmann
464549|NCT01579331|DCT|dct
464550|NCT01579331|Dynamic Contour|dynamic contour
464551|NCT01579279|Diabetic neuropathic pain|diabetic neuropathic pain
464552|NCT01579279|Active controlled phase 2 study|active controlled phase 2 study
464553|NCT01579266|Writer's Cramp|writer's cramp
464554|NCT01579266|Focal Hand Dystonia|focal hand dystonia
464555|NCT01579266|Writer Cramp|writer cramp
464556|NCT01579266|Dystonia|dystonia
464557|NCT01579253|Recurrent glioblastoma|recurrent glioblastoma
464558|NCT01579253|Radiotherapy|radiotherapy
464559|NCT01579253|PET-MRI|pet-mri
464560|NCT01579253|FET-PET|fet-pet
464561|NCT01579240|physical activity|physical activity
464562|NCT01579240|older adults|older adults
464563|NCT01579240|Internet|internet
464564|NCT01579240|sedentary|sedentary
464565|NCT01579240|multi-week|multi-week
464566|NCT01579240|internet intervention|internet intervention
464567|NCT01579227|Healthy participants|healthy participants
464568|NCT01579214|HIV|hiv
464569|NCT01579214|Africa south of the sahara|africa south of the sahara
464570|NCT01579214|Knowledge of results|knowledge of results
464571|NCT01579214|Communication barriers|communication barriers
464572|NCT01579214|Cellular Phones|cellular phones
464573|NCT01579201|Postpartum Hemorrhage|postpartum hemorrhage
464574|NCT01579201|Uterine Atony|uterine atony
464575|NCT01579201|Obstetric Anesthesia|obstetric anesthesia
464576|NCT01579201|Cesarean Section|cesarean section
464577|NCT01579201|Carbetocin|carbetocin
464578|NCT01579188|NSCLC|nsclc
464579|NCT01579162|Hepatitis|hepatitis
464580|NCT01579162|Fatty Liver|fatty liver
464581|NCT01579123|Laser atherectomy|laser atherectomy
464582|NCT01579123|Critical Limb Ischemia|critical limb ischemia
464583|NCT01579123|Angioplasty|angioplasty
464584|NCT01579110|autoimmune hemolytic anemia|autoimmune hemolytic anemia
464585|NCT01579110|hemolytic anemia|hemolytic anemia
464586|NCT01579110|Levamisole|levamisole
464587|NCT01579110|Treatment of autoimmune hemolytic anemia|treatment of autoimmune hemolytic anemia
464588|NCT01579110|warm antibody dependant autoimmune hemolytic anemia|warm antibody dependant autoimmune hemolytic anemia
464589|NCT01579097|(PN) Parenteral nutrition|(pn) parenteral nutrition
464590|NCT01579097|oral/enteral not possible|oral/enteral not possible
464591|NCT01579058|aortic stenosis|aortic stenosis
464592|NCT01579058|beta-blocker|beta-blocker
464593|NCT01579032|CKD,|ckd,
464594|NCT01578980|Artificial Pancreas|artificial pancreas
464595|NCT01578980|Type 1 Diabetes Mellitus|type 1 diabetes mellitus
464596|NCT01578980|Control-to-Range|control-to-range
464597|NCT01578980|Closed-Loop Control|closed-loop control
464598|NCT01578980|Continuous Glucose Monitor|continuous glucose monitor
464599|NCT01578967|Hodgkin's lymphoma|hodgkin's lymphoma
464600|NCT01578967|Hodgkin lymphoma|hodgkin lymphoma
464601|NCT01578954|Leukemia|leukemia
464602|NCT01578954|Acute Myeloid Leukemia|acute myeloid leukemia
464603|NCT01578941|menstrual migraine|menstrual migraine
464604|NCT01578941|migraine|migraine
464605|NCT01578941|treximet|treximet
464606|NCT01578928|renal, impairment, endstage renal disease|renal, impairment, endstage renal disease
464607|NCT01578928|renal|renal
464608|NCT01578928|impairment|impairment
464609|NCT01578928|endstage renal disease|endstage renal disease
464610|NCT01578902|Prostatic Neoplasms|prostatic neoplasms
464611|NCT01578902|Radiotherapy|radiotherapy
464612|NCT01578902|Hypofractionation|hypofractionation
464613|NCT01578902|Low Risk Prostate Cancer|low risk prostate cancer
464614|NCT01578876|coronary artery disease|coronary artery disease
464615|NCT01578876|angina pectoris|angina pectoris
464616|NCT01578876|myocardial ischemia|myocardial ischemia
464617|NCT01578876|cardiac shock wave therapy|cardiac shock wave therapy
464618|NCT01578863|Childhood obesity|childhood obesity
464619|NCT01578863|Adolescence|adolescence
464620|NCT01578863|Predictors|predictors
464621|NCT01578863|Success|success
464622|NCT01578863|Intervention program|intervention program
464623|NCT01578850|rheumatoid arthritis|rheumatoid arthritis
464624|NCT01578850|etanercept|etanercept
464625|NCT01578850|methotrexate|methotrexate
464626|NCT01578850|DMARDs|dmards
464627|NCT01578824|Rickets|rickets
464628|NCT01578824|Vitamin D|vitamin d
464629|NCT01578824|airway hyperreactivity|airway hyperreactivity
464630|NCT01578824|Exhaled breath condensate|exhaled breath condensate
464631|NCT01578772|HIV|hiv
464632|NCT01578772|Flow-mediated dialation (FMD)|flow-mediated dialation (fmd)
464633|NCT01578772|Telmisartan|telmisartan
464634|NCT01578772|Cardiovascular disease (CVD)|cardiovascular disease (cvd)
464635|NCT01578772|HIV+ men and women age > 50 at risk for heart disease|hiv+ men and women age > 50 at risk for heart disease
464636|NCT01578759|ovarian function tests|ovarian function tests
464637|NCT01578746|Coxarthrosis|coxarthrosis
464638|NCT01578746|Hip arthroplasty|hip arthroplasty
464639|NCT01578746|Anterior approach|anterior approach
464640|NCT01578746|Direct lateral approach|direct lateral approach
464641|NCT01578746|Hardinge approach|hardinge approach
464642|NCT01578746|Smith-Petersen approach|smith-petersen approach
464643|NCT01578746|Osteoarthrosis|osteoarthrosis
464644|NCT01578733|protein requirement|protein requirement
464645|NCT01578733|female elderly|female elderly
464646|NCT01578733|healthy female subject's protein requirements|healthy female subject's protein requirements
464647|NCT01578707|Chronic|chronic
464648|NCT01578707|SLL|sll
464649|NCT01578707|CLL|cll
464650|NCT01578707|Ofatumumab|ofatumumab
464651|NCT01578707|ibrutinib|ibrutinib
464652|NCT01578707|RESONATE|resonate
464653|NCT01578707|Phase III|phase iii
464654|NCT01578707|Leukemia|leukemia
464655|NCT01578707|Lymphoma|lymphoma
464656|NCT01578681|bronchiectasis|bronchiectasis
464657|NCT01578681|respiratory therapy|respiratory therapy
464658|NCT01578681|airway clearance|airway clearance
464659|NCT01578668|lung adenocarcinoma|lung adenocarcinoma
464660|NCT01578668|brain metastases|brain metastases
464661|NCT01578668|erlotinib|erlotinib
464662|NCT01578668|pemetrexed|pemetrexed
464663|NCT01578655|custirsen sodium|custirsen sodium
464664|NCT01578655|prostate cancer|prostate cancer
464665|NCT01578655|metastatic castrate resistant prostate cancer|metastatic castrate resistant prostate cancer
464666|NCT01578655|overall survival|overall survival
464667|NCT01578642|GERD|gerd
464668|NCT01578642|LES Pressure|les pressure
464669|NCT01578642|Electrical Stimulation|electrical stimulation
464670|NCT01578629|stroke|stroke
464671|NCT01578629|ischemia|ischemia
464672|NCT01578629|TIA|tia
464673|NCT01578616|Coronary artery disease|coronary artery disease
464674|NCT01578616|Endothelial function|endothelial function
464675|NCT01578616|Optical coherence tomography|optical coherence tomography
464676|NCT01578616|Thin cap fibroatheroma|thin cap fibroatheroma
464677|NCT01578603|prevention & control|prevention & control
464678|NCT01578603|Xylitol|xylitol
464679|NCT01578603|casein phosphopeptide amorphous calcium phosphate complex|casein phosphopeptide amorphous calcium phosphate complex
464680|NCT01578603|Streptococcus mutans|streptococcus mutans
464681|NCT01578603|saliva|saliva
464682|NCT01578603|dental plaque|dental plaque
464683|NCT01578603|gingivitis|gingivitis
464684|NCT01578577|Medication Therapy Management|medication therapy management
464685|NCT01578577|Hypertension|hypertension
464686|NCT01578577|Health Literacy|health literacy
464687|NCT01578577|Medication Reconciliation|medication reconciliation
464688|NCT01578577|Medication Adherence|medication adherence
464689|NCT01578564|Cancer|cancer
464690|NCT01578564|Ovarian Cancer|ovarian cancer
464691|NCT01578564|TRPV6 Calcium channel|trpv6 calcium channel
464692|NCT01578551|Carcinoma, Non-Small-Cell Lung|carcinoma, non-small-cell lung
464693|NCT01578551|Lung adenocarcinoma|lung adenocarcinoma
464694|NCT01578538|hernia, abdominal, strangulation, emergency, wall|hernia, abdominal, strangulation, emergency, wall
464695|NCT01578525|medication safety|medication safety
464696|NCT01578525|elderly|elderly
464697|NCT01578525|pharmaceutical care|pharmaceutical care
464698|NCT01578525|hospital readmission|hospital readmission
464699|NCT01578525|drug-related readmission|drug-related readmission
464700|NCT01578525|Health Services for the Aged|health services for the aged
464701|NCT01578499|Brentuximab vedotin|brentuximab vedotin
464702|NCT01578499|ALCANZA|alcanza
464703|NCT01578486|Schizophrenia|schizophrenia
464704|NCT01578486|Cognition|cognition
464705|NCT01578486|Metabolism|metabolism
464706|NCT01578486|Antipsychotics|antipsychotics
464707|NCT01578486|Psychopathology|psychopathology
464708|NCT01578473|low testosterone|low testosterone
464709|NCT01578473|penile curvature|penile curvature
464710|NCT01578460|Pregnancy|pregnancy
464711|NCT01578460|Gestational Diabetes|gestational diabetes
464712|NCT01578460|Type 2 Diabetes Mellitus|type 2 diabetes mellitus
464713|NCT01578460|Continuous Glucose Monitor|continuous glucose monitor
464714|NCT01578460|Glucose|glucose
464715|NCT01578447|injectable contraception|injectable contraception
464716|NCT01578447|acceptability|acceptability
464717|NCT01578447|intramuscular|intramuscular
464718|NCT01578447|subcutaneous|subcutaneous
464719|NCT01578434|Nutritional Rickets|nutritional rickets
464720|NCT01578434|Calcium|calcium
464721|NCT01578434|Vitamin D|vitamin d
464722|NCT01578408|Femoral neck fractures|femoral neck fractures
464723|NCT01578408|Uncemented|uncemented
464724|NCT01578408|Hydroxyapatite|hydroxyapatite
464725|NCT01578408|Coated|coated
464726|NCT01578408|Femoral|femoral
464727|NCT01578408|Stems|stems
464728|NCT01578408|Hip fractures|hip fractures
464729|NCT01578408|THA|tha
464730|NCT01578408|THR|thr
464731|NCT01578408|Cemented|cemented
464732|NCT01578408|Fat embolism|fat embolism
464733|NCT01578408|Cognition|cognition
464734|NCT01578408|Inflammatory response|inflammatory response
464735|NCT01578408|Mobilization|mobilization
464736|NCT01578382|Martorell hypertensive ischemic leg ulcer|martorell hypertensive ischemic leg ulcer
464737|NCT01578382|Calciphylaxis (calcific uremic arteriolopathy)|calciphylaxis (calcific uremic arteriolopathy)
464738|NCT01578382|Ischemic subcutaneous arteriolosclerosis|ischemic subcutaneous arteriolosclerosis
464739|NCT01578382|Hypertension|hypertension
464740|NCT01578382|Diabetes|diabetes
464741|NCT01578382|Medial calcinosis|medial calcinosis
464742|NCT01578382|Wound healing|wound healing
464743|NCT01578369|Urinary incontinence|urinary incontinence
464744|NCT01578369|Pregnancy|pregnancy
464745|NCT01578369|Pelvic floor muscle training|pelvic floor muscle training
464746|NCT01578356|Prostate cancer|prostate cancer
464747|NCT01578343|fludarabine|fludarabine
464748|NCT01578343|mitoxantrone|mitoxantrone
464749|NCT01578343|dexamethasone|dexamethasone
464750|NCT01578343|relapsed or refractory mantle cell lymphoma|relapsed or refractory mantle cell lymphoma
464751|NCT01578343|FND regimen|fnd regimen
464752|NCT01578343|vorinostat|vorinostat
464753|NCT01578343|autologous stem cell transplantation|autologous stem cell transplantation
464754|NCT01578330|Relapsing remitting multiple sclerosis|relapsing remitting multiple sclerosis
464755|NCT01578330|Fingolimod|fingolimod
464756|NCT01578330|FTY720|fty720
464757|NCT01578317|H5N1 Vaccine|h5n1 vaccine
464758|NCT01578317|H5N1 Immunization|h5n1 immunization
464759|NCT01578317|AS03 Adjuvant|as03 adjuvant
464760|NCT01578317|Biologic Sample Collection|biologic sample collection
464761|NCT01578317|Laboratory Research Specimens|laboratory research specimens
464762|NCT01578317|Healthy Volunteer|healthy volunteer
464763|NCT01578317|HV|hv
464764|NCT01578304|Overactive bladder|overactive bladder
464765|NCT01578291|Play therapy|play therapy
464766|NCT01578291|Urinary tract infections|urinary tract infections
464767|NCT01578291|Children|children
464768|NCT01578291|Vesicoureteral reflux|vesicoureteral reflux
464769|NCT01578239|Neuroendocrine tumour|neuroendocrine tumour
464770|NCT01578239|177Lu-Dota0-Tyr3-octreotate|177lu-dota0-tyr3-octreotate
464771|NCT01578226|Cirrhosis|cirrhosis
464772|NCT01578226|Ascites|ascites
464773|NCT01578226|Decompensation|decompensation
464774|NCT01578226|Bacterial infection|bacterial infection
464775|NCT01578226|Sepsis|sepsis
464776|NCT01578226|Procalcitonin|procalcitonin
464777|NCT01578226|PCT|pct
464778|NCT01578200|CKD-MBD|ckd-mbd
464779|NCT01578200|phosphate-binder|phosphate-binder
464780|NCT01578200|vascular calcification|vascular calcification
464781|NCT01578200|mortality|mortality
464782|NCT01578200|dialysis|dialysis
464783|NCT01578200|Hemodialysis patients with hyperphosphatemia|hemodialysis patients with hyperphosphatemia
464784|NCT01578187|hair reduction|hair reduction
464785|NCT01578187|hair removal|hair removal
464786|NCT01578187|hair clearance|hair clearance
464787|NCT01578148|Cervical pain|cervical pain
464788|NCT01578148|Cervicalgia,|cervicalgia,
464789|NCT01578148|Cervicodynia|cervicodynia
464790|NCT01578148|Neck ache|neck ache
464791|NCT01578148|Neckache|neckache
464792|NCT01578148|Shoulder pain|shoulder pain
464793|NCT01578148|Shoulder impingement syndrome|shoulder impingement syndrome
464794|NCT01578122|post-thrombotic syndrome|post-thrombotic syndrome
464795|NCT01578122|prevention|prevention
464796|NCT01578122|deep vein thrombosis|deep vein thrombosis
464797|NCT01578122|elastic compression stockings|elastic compression stockings
464798|NCT01578122|compliance|compliance
464799|NCT01578122|quality of life|quality of life
464800|NCT01578096|Type 2 Diabetes|type 2 diabetes
464801|NCT01578083|Chemotherapy|chemotherapy
464802|NCT01578083|Breast Cancer|breast cancer
464803|NCT01578083|Cognitive Impairment|cognitive impairment
464804|NCT01578083|Chemo brain|chemo brain
464805|NCT01578070|Other and Unspecified Vaccines and Biological Substances Causing Adverse Effects in Therapeutic Use|other and unspecified vaccines and biological substances causing adverse effects in therapeutic use
464806|NCT01578057|alcohol|alcohol
464807|NCT01578044|Anti-coagulation|anti-coagulation
464808|NCT01578031|Sleep Apnea|sleep apnea
464809|NCT01578031|Obesity|obesity
464810|NCT01578018|lung cancer|lung cancer
464811|NCT01578018|smoking|smoking
464812|NCT01578005|acute coronary syndrome|acute coronary syndrome
464813|NCT01578005|IVUS|ivus
464814|NCT01578005|atherosclerotic plaque|atherosclerotic plaque
464815|NCT01577992|subjective pain|subjective pain
464816|NCT01577992|Multiple System Atrophy|multiple system atrophy
464817|NCT01577979|Vaccination|vaccination
464818|NCT01577979|Medical Home|medical home
464819|NCT01577979|Adolescents|adolescents
464820|NCT01577966|Patients with brain tumors associated with seizures|patients with brain tumors associated with seizures
464821|NCT01577953|Antisense oligonucleotide|antisense oligonucleotide
464822|NCT01577953|Asthma|asthma
464823|NCT01577953|Patients with asthma|patients with asthma
464824|NCT01577953|Phase 1b|phase 1b
464825|NCT01577953|Transcription factor GATA-3|transcription factor gata-3
464826|NCT01577953|Oral inhalation|oral inhalation
464827|NCT01577940|Transversus abdominis plane block|transversus abdominis plane block
464828|NCT01577940|postoperative pain|postoperative pain
464829|NCT01577940|Postoperative pain management|postoperative pain management
464830|NCT01577927|weaning|weaning
464831|NCT01577927|severe chronic diseases|severe chronic diseases
464832|NCT01577927|UTIR|utir
464833|NCT01577901|Pregnancy|pregnancy
464834|NCT01577862|ACINETOBACTER BAUMANNII|acinetobacter baumannii
464835|NCT01577862|COLISTIN|colistin
464836|NCT01577862|RIFAMPICIN|rifampicin
464837|NCT01577862|THERAPY|therapy
464838|NCT01577862|RESISTANCE|resistance
464839|NCT01577836|Radical prostatectomie|radical prostatectomie
464840|NCT01577836|Robotic assistance|robotic assistance
464841|NCT01577836|Laparotomy|laparotomy
464843|NCT01577810|near infrared spectroscopy|near infrared spectroscopy
464844|NCT01577810|heart failure|heart failure
464845|NCT01577810|cardiac output|cardiac output
464846|NCT01577810|outpatient|outpatient
464847|NCT01577810|pediatric|pediatric
464848|NCT01577797|Methamphetamine|methamphetamine
464849|NCT01577797|Drug Abuse|drug abuse
464850|NCT01577797|Substance Abuse|substance abuse
464851|NCT01577797|Amphetamine|amphetamine
464852|NCT01577797|Dependence|dependence
464853|NCT01577797|Addiction|addiction
464854|NCT01577797|Craving|craving
464855|NCT01577797|Cognitive Behavioral Therapy|cognitive behavioral therapy
464856|NCT01577797|Text Messaging|text messaging
464857|NCT01577784|Advanced renal cell carcinoma|advanced renal cell carcinoma
464858|NCT01577784|second-line treatment with pazopanib|second-line treatment with pazopanib
464859|NCT01577784|first line of treatment with a Tyrosine Kinase Inhibitor|first line of treatment with a tyrosine kinase inhibitor
464860|NCT01577771|Pneumococcal conjugate vaccine|pneumococcal conjugate vaccine
464861|NCT01577771|Immunogenicity|immunogenicity
464862|NCT01577771|Reactogenicity|reactogenicity
464863|NCT01577758|Phase 1,|phase 1,
464864|NCT01577758|Advanced gastrointestinal malignancies,|advanced gastrointestinal malignancies,
464865|NCT01577758|MLN0264,|mln0264,
464866|NCT01577758|Guanylyl Cyclase C(GCC),|guanylyl cyclase c(gcc),
464867|NCT01577758|Antibody Drug Conjugate(ADC)|antibody drug conjugate(adc)
464868|NCT01577745|Cancer|cancer
464869|NCT01577732|booster|booster
464870|NCT01577732|Infanrix-IPV+HibTM|infanrix-ipv+hibtm
464871|NCT01577732|DTPa-IPV/Hib|dtpa-ipv/hib
464872|NCT01577732|Vietnamese toddlers|vietnamese toddlers
464873|NCT01577719|Cardiovascular|cardiovascular
464874|NCT01577719|Prevention|prevention
464875|NCT01577719|Ethnicity|ethnicity
464876|NCT01577719|Culture|culture
464877|NCT01577719|Internet|internet
464878|NCT01577719|Text Message|text message
464879|NCT01577706|GABA|gaba
464880|NCT01577706|glutamate|glutamate
464881|NCT01577706|glutamine|glutamine
464882|NCT01577706|spectroscopy|spectroscopy
464883|NCT01577706|brain|brain
464884|NCT01577706|imaging|imaging
464885|NCT01577706|alprazolam|alprazolam
464886|NCT01577706|dextroamphetamine|dextroamphetamine
464887|NCT01577706|placebo|placebo
464888|NCT01577693|dutasteride|dutasteride
464889|NCT01577693|cross over study|cross over study
464890|NCT01577693|bioavailability|bioavailability
464891|NCT01577680|healthy subjects|healthy subjects
464892|NCT01577680|pharmacokinetics|pharmacokinetics
464893|NCT01577680|vilanterol|vilanterol
464894|NCT01577680|tolerability|tolerability
464895|NCT01577680|safety|safety
464896|NCT01577680|hepatic impairment|hepatic impairment
464897|NCT01577680|GW642444|gw642444
464898|NCT01577680|GSK573719|gsk573719
464899|NCT01577667|automation|automation
464900|NCT01577667|closed loop|closed loop
464901|NCT01577667|oxygenation|oxygenation
464902|NCT01577667|ventilation|ventilation
464903|NCT01577654|adenocarcinoma|adenocarcinoma
464904|NCT01577654|squamous|squamous
464905|NCT01577654|adenosquamous|adenosquamous
464906|NCT01577654|adenocarcinoma with other NSCLC variants|adenocarcinoma with other nsclc variants
464907|NCT01577654|EC145|ec145
464908|NCT01577654|EC20|ec20
464909|NCT01577654|Vintafolide|vintafolide
464910|NCT01577654|Etarfolatide|etarfolatide
464911|NCT01577628|Dermatitis|dermatitis
464912|NCT01577628|Eczema|eczema
464913|NCT01577628|Skin diseases|skin diseases
464914|NCT01577628|Skin barrier|skin barrier
464915|NCT01577628|Prevention|prevention
464916|NCT01577628|Infant|infant
464917|NCT01577628|Moisturizer|moisturizer
464918|NCT01577628|Emollient|emollient
464919|NCT01577628|Asthma|asthma
464920|NCT01577628|Food allergy|food allergy
464921|NCT01577628|Allergic rhinitis|allergic rhinitis
464922|NCT01577615|Preterm Infant|preterm infant
464923|NCT01577615|Neurobehavioral|neurobehavioral
464924|NCT01577615|Development|development
464925|NCT01577602|Medication reconciliation|medication reconciliation
464926|NCT01577602|Self report|self report
464927|NCT01577602|Electronic medical record medication list|electronic medical record medication list
464928|NCT01577589|Phase 1|phase 1
464929|NCT01577589|healthy volunteers|healthy volunteers
464930|NCT01577589|cross-over study|cross-over study
464931|NCT01577589|ceftaroline fosamil|ceftaroline fosamil
464932|NCT01577589|various infusion volumes|various infusion volumes
464933|NCT01577589|local tolerability|local tolerability
464934|NCT01577589|Cmax|cmax
464935|NCT01577589|tmax|tmax
464936|NCT01577589|AUC|auc
464937|NCT01577576|Athletes|athletes
464938|NCT01577576|Sedentary volunteers|sedentary volunteers
464939|NCT01577563|osteoarthritis (OA)|osteoarthritis (oa)
464940|NCT01577563|rheumatoid arthritis (RA)|rheumatoid arthritis (ra)
464941|NCT01577563|ankylosing spondylitis (AS)|ankylosing spondylitis (as)
464942|NCT01577563|gastrointestinal risk factors|gastrointestinal risk factors
464943|NCT01577563|NSAIDs|nsaids
464944|NCT01577550|ABBV-066|abbv-066
464945|NCT01577550|BI 655066|bi 655066
464946|NCT01577550|risankizumab|risankizumab
464947|NCT01577537|SPL7013|spl7013
464948|NCT01577537|VivaGel|vivagel
464949|NCT01577537|bacterial vaginosis|bacterial vaginosis
464950|NCT01577537|BV|bv
464951|NCT01577511|invasive potential|invasive potential
464952|NCT01577511|molecular characterisation of circulating cells|molecular characterisation of circulating cells
464953|NCT01577498|Skeletal age|skeletal age
464954|NCT01577498|Chronological age|chronological age
464955|NCT01577498|Adolescent|adolescent
464956|NCT01577472|female infertility|female infertility
464957|NCT01577472|poor ovarian response|poor ovarian response
464958|NCT01577472|controlled ovarian hyperstimulation|controlled ovarian hyperstimulation
464959|NCT01577472|IVF|ivf
464960|NCT01577472|Antagonist protocol|antagonist protocol
464961|NCT01577446|CRT|crt
464962|NCT01577446|heart failure|heart failure
464963|NCT01577446|narrow QRS|narrow qrs
464964|NCT01577446|dyssynchrony|dyssynchrony
464965|NCT01577433|HeartMate II|heartmate ii
464966|NCT01577433|heart-assist device|heart-assist device
464967|NCT01577433|left ventricular assist device|left ventricular assist device
464968|NCT01577433|driveline infection|driveline infection
464969|NCT01577433|LVAD|lvad
464970|NCT01577433|HMII LVAS driveline|hmii lvas driveline
464971|NCT01577433|silicone portion|silicone portion
464972|NCT01577433|Thoratec Corporation|thoratec corporation
464973|NCT01577420|Reflexology|reflexology
464974|NCT01577420|Breast Cancer|breast cancer
464975|NCT01577420|Complementary|complementary
464976|NCT01577407|Dyspnea|dyspnea
464977|NCT01577407|Pain|pain
464978|NCT01577394|Alzheimer disease|alzheimer disease
464979|NCT01577394|Lewy Body Disease|lewy body disease
464980|NCT01577394|Cognitive Disorders|cognitive disorders
464981|NCT01577394|Neurodegenerative Diseases|neurodegenerative diseases
464982|NCT01577394|Differential diagnosis|differential diagnosis
464983|NCT01577394|Eye movement|eye movement
464984|NCT01577381|Phase 2|phase 2
464985|NCT01577381|Advanced Dry Age-Related Macular Degeneration|advanced dry age-related macular degeneration
464986|NCT01577381|Geographic Atrophy|geographic atrophy
464987|NCT01577381|RN6G|rn6g
464988|NCT01577368|Pseudomonas|pseudomonas
464989|NCT01577368|Piperacillin|piperacillin
464990|NCT01577368|Beta-lactams|beta-lactams
464991|NCT01577368|Continuous infusion|continuous infusion
464992|NCT01577368|Intermittent infusion|intermittent infusion
464993|NCT01577368|Pharmacokinetics|pharmacokinetics
464994|NCT01577329|meditation|meditation
464995|NCT01577329|Chronic Obstructive Pulmonary Disease|chronic obstructive pulmonary disease
464996|NCT01577329|Mindfulness|mindfulness
464997|NCT01577329|Anxiety|anxiety
464998|NCT01577329|Breathing Patterns|breathing patterns
464999|NCT01577316|vaccination|vaccination
465000|NCT01577316|Influenza|influenza
465001|NCT01577316|Immunogenicity|immunogenicity
465002|NCT01577316|Safety|safety
465003|NCT01577303|social phobia|social phobia
465004|NCT01577303|social anxiety|social anxiety
465005|NCT01577303|cognitive bias modification|cognitive bias modification
465006|NCT01577290|Anxiety|anxiety
465007|NCT01577290|Depression|depression
465008|NCT01577290|Insomnia|insomnia
465009|NCT01577290|Mindfulness|mindfulness
465010|NCT01577290|Internet|internet
465011|NCT01577277|Metabolic Syndrome X|metabolic syndrome x
465012|NCT01577277|Fatty Acids, Omega-3|fatty acids, omega-3
465013|NCT01577277|Learning|learning
465014|NCT01577277|Attention|attention
465015|NCT01577277|Nutritional Status|nutritional status
465016|NCT01577277|Nutrition Assessments|nutrition assessments
465017|NCT01577277|Body Weight|body weight
465018|NCT01577277|Physical Activity|physical activity
465019|NCT01577277|Sleep|sleep
465020|NCT01577277|Child Nutrition Sciences|child nutrition sciences
465021|NCT01577264|Certolizumab Pegol|certolizumab pegol
465022|NCT01577264|Cimzia|cimzia
465023|NCT01577238|SPL7013|spl7013
465024|NCT01577238|VivaGel|vivagel
465025|NCT01577238|bacterial vaginosis|bacterial vaginosis
465026|NCT01577238|BV|bv
465027|NCT01577225|Clean surgery|clean surgery
465028|NCT01577212|stage III NSCLC|stage iii nsclc
465029|NCT01577212|(chemo)radiotherapy|(chemo)radiotherapy
465030|NCT01577212|individualized dose-escalation|individualized dose-escalation
465031|NCT01577199|IVF|ivf
465032|NCT01577199|poor responder|poor responder
465033|NCT01577199|low ovarian reserve|low ovarian reserve
465034|NCT01577199|ART|art
465035|NCT01577199|ovarian stimulation|ovarian stimulation
465036|NCT01577199|IVF protocols|ivf protocols
465037|NCT01577186|Schizophrenia|schizophrenia
465038|NCT01577186|Paliperidone Extended Release|paliperidone extended release
465039|NCT01577160|Schizophrenia|schizophrenia
465040|NCT01577160|Paliperidone Extended Release (ER)|paliperidone extended release (er)
465041|NCT01577147|pregnancy|pregnancy
465042|NCT01577134|multimorbidity|multimorbidity
465043|NCT01577134|autonomy|autonomy
465044|NCT01577134|older adults|older adults
465045|NCT01577134|physical activity|physical activity
465046|NCT01577134|intervention|intervention
465047|NCT01577134|behavior change|behavior change
465048|NCT01577121|Preterm labor|preterm labor
465049|NCT01577108|31-32 Weeks of Gestation Completed|31-32 weeks of gestation completed
465050|NCT01577108|Group B Streptococcal Infection|group b streptococcal infection
465425|NCT01575613|malaria|malaria
465051|NCT01577108|Streptococcus Group B Infection of the Infant|streptococcus group b infection of the infant
465052|NCT01577095|electroacupuncture|electroacupuncture
465053|NCT01577095|rosiglitazone|rosiglitazone
465054|NCT01577095|plasma glucose|plasma glucose
465055|NCT01577095|insulin resistance|insulin resistance
465056|NCT01577095|free fatty acid|free fatty acid
465057|NCT01577082|Adults, not adequately controlled, pre-dose morning PEF|adults, not adequately controlled, pre-dose morning pef
465058|NCT01577069|Hepatitis C|hepatitis c
465059|NCT01577069|Direct Antiviral agent (DAA)|direct antiviral agent (daa)
465060|NCT01577069|Ultra-deep pyrosequencing|ultra-deep pyrosequencing
465061|NCT01577069|Single polynucleotide polymorphisms|single polynucleotide polymorphisms
465062|NCT01577069|Treatment-resistant mutants|treatment-resistant mutants
465063|NCT01577069|Hepatitis C Virus Protease Inhibitor|hepatitis c virus protease inhibitor
465064|NCT01577056|Familial hypercholesterolaemia|familial hypercholesterolaemia
465065|NCT01577056|Postprandial dyslipidaemia|postprandial dyslipidaemia
465066|NCT01577056|Fish oil treatment|fish oil treatment
465067|NCT01577056|Cardiovascular disease|cardiovascular disease
465068|NCT01577043|acute diarrhea|acute diarrhea
465069|NCT01577043|Racecadotril|racecadotril
465070|NCT01577043|children|children
465071|NCT01577017|ovulation induction, clomiphene citrate, letrozole|ovulation induction, clomiphene citrate, letrozole
465072|NCT01576978|LUMBAR BACK pain|lumbar back pain
465073|NCT01576978|PELVIC PAIN|pelvic pain
465074|NCT01576978|PREGNANCY|pregnancy
465075|NCT01576978|HATHA YOGA|hatha yoga
465076|NCT01576965|Laparoscopic hysterectomy,laparoscopic sacrocolpopexy,bowel prep|laparoscopic hysterectomy,laparoscopic sacrocolpopexy,bowel prep
465077|NCT01576926|Sleep apnea, obstructive|sleep apnea, obstructive
465078|NCT01576926|Deglutition Disorders|deglutition disorders
465079|NCT01576913|exercise testing|exercise testing
465081|NCT01576913|VO2 max|vo2 max
465082|NCT01576900|behavior therapy|behavior therapy
465083|NCT01576900|nocturia|nocturia
465084|NCT01576900|polyuria|polyuria
465085|NCT01576874|nicotine dependence|nicotine dependence
465086|NCT01576874|hormones|hormones
465087|NCT01576848|muscle metabolism|muscle metabolism
465088|NCT01576848|intrinsically labeled protein|intrinsically labeled protein
465089|NCT01576848|protein synthesis|protein synthesis
465090|NCT01576848|insulin|insulin
465091|NCT01576848|perfusion|perfusion
465092|NCT01576835|Non-contrast|non-contrast
465093|NCT01576822|Detoxification|detoxification
465094|NCT01576822|Sauna|sauna
465095|NCT01576809|Paracetamol|paracetamol
465096|NCT01576809|acetaminophen|acetaminophen
465097|NCT01576809|phenylephrine|phenylephrine
465098|NCT01576809|guaifenesin|guaifenesin
465099|NCT01576809|syrup|syrup
465100|NCT01576809|URTI|urti
465101|NCT01576809|productive cough|productive cough
465102|NCT01576796|Radiotherapy|radiotherapy
465103|NCT01576796|Fmiso|fmiso
465104|NCT01576796|FDG PETSCAN|fdg petscan
465105|NCT01576796|FMISO PETSCAN|fmiso petscan
465106|NCT01576796|complement dose|complement dose
465107|NCT01576796|lung cancer|lung cancer
465108|NCT01576796|NSCLC|nsclc
465109|NCT01576796|hypoxic lesion|hypoxic lesion
465110|NCT01576770|propofol|propofol
465111|NCT01576770|Pain|pain
465112|NCT01576770|Synera Patch|synera patch
465113|NCT01576770|Gebauer's Ethyl Chloride topical anesthetic|gebauer's ethyl chloride topical anesthetic
465114|NCT01576757|Stem cell therapy|stem cell therapy
465115|NCT01576744|HE4|he4
465116|NCT01576744|IVF|ivf
465117|NCT01576744|Biomarker|biomarker
465118|NCT01576744|Ovarian cancer|ovarian cancer
465119|NCT01576744|Infertility|infertility
465120|NCT01576731|HIV Infection|hiv infection
465121|NCT01576731|Postexposure prophylaxis|postexposure prophylaxis
465122|NCT01576718|Dose ranging|dose ranging
465123|NCT01576718|Fluticasone Propionate|fluticasone propionate
465124|NCT01576718|Dry Powder Inhaler (DPI)|dry powder inhaler (dpi)
465125|NCT01576718|High Dose ICS|high dose ics
465126|NCT01576718|Asthma|asthma
465127|NCT01576705|Down syndrome|down syndrome
465128|NCT01576705|Young children|young children
465129|NCT01576705|Psychomotor development|psychomotor development
465130|NCT01576705|Thyroid hormone|thyroid hormone
465131|NCT01576705|Folinic acid|folinic acid
465132|NCT01576705|Psychometric tests|psychometric tests
465133|NCT01576705|GMDS|gmds
465134|NCT01576705|Griffiths|griffiths
465135|NCT01576705|Genetic factors|genetic factors
465136|NCT01576705|Biochemical factors|biochemical factors
465137|NCT01576692|recurrent neuroblastoma|recurrent neuroblastoma
465138|NCT01576692|refractory neuroblastoma|refractory neuroblastoma
465139|NCT01576692|natural killer cells|natural killer cells
465140|NCT01576679|intra-abdominal|intra-abdominal
465141|NCT01576679|abscess|abscess
465142|NCT01576679|tPA|tpa
465143|NCT01576679|alteplase|alteplase
465144|NCT01576679|cathflo|cathflo
465145|NCT01576666|Dose escalation|dose escalation
465146|NCT01576666|Maximum Tolerated Dose|maximum tolerated dose
465147|NCT01576666|MTD|mtd
465148|NCT01576666|Safety Expansion|safety expansion
465149|NCT01576666|Safety|safety
465150|NCT01576666|Preliminary Efficacy|preliminary efficacy
465151|NCT01576666|Objective Response Rate|objective response rate
465152|NCT01576666|Early progression rate|early progression rate
465153|NCT01576666|PI3K activation|pi3k activation
465154|NCT01576666|Combination Treatment|combination treatment
465155|NCT01576666|Hedgehog Signaling Pathway|hedgehog signaling pathway
465156|NCT01576666|Smoothened inhibitor|smoothened inhibitor
465157|NCT01576666|Phosphoinositide-3' kinase|phosphoinositide-3' kinase
465158|NCT01576666|Phosphatase signaling pathway|phosphatase signaling pathway
465159|NCT01576666|Advanced solid tumors|advanced solid tumors
465160|NCT01576666|metastatic breast cancer|metastatic breast cancer
465161|NCT01576666|advanced pancreatic adenocarcinoma|advanced pancreatic adenocarcinoma
465162|NCT01576666|metastatic colorectal cancer|metastatic colorectal cancer
465284|NCT01576237|stem cell apheresis|stem cell apheresis
465163|NCT01576666|recurrent glioblastoma multiforme|recurrent glioblastoma multiforme
465164|NCT01576666|gastric cancer|gastric cancer
465165|NCT01576666|gastroesophageal junction cancer|gastroesophageal junction cancer
465166|NCT01576666|triple negative metastatic breast cancer|triple negative metastatic breast cancer
465167|NCT01576666|hormone receptor positive (ER+/PR+, and Her2-) metastatic breast cancer|hormone receptor positive (er+/pr+, and her2-) metastatic breast cancer
465168|NCT01576653|IFI|ifi
465169|NCT01576640|Nicotine Dependence|nicotine dependence
465170|NCT01576640|Smoking Cessation|smoking cessation
465171|NCT01576640|Relapse Prevention|relapse prevention
465172|NCT01576640|Cognitive Behavioral Therapy|cognitive behavioral therapy
465173|NCT01576640|Schizophrenia|schizophrenia
465174|NCT01576614|Comparing telephone VS RTP in SICU rounding practices|comparing telephone vs rtp in sicu rounding practices
465175|NCT01576601|pediatrics|pediatrics
465176|NCT01576601|acute pain|acute pain
465177|NCT01576601|neurosurgery|neurosurgery
465178|NCT01576601|Pediatric patients (0-18)|pediatric patients (0-18)
465179|NCT01576601|postoperative management|postoperative management
465180|NCT01576588|Chronic lymphocytic leukemia, relapsed, elderly or unfit patients, methylprednisolone, rituximab|chronic lymphocytic leukemia, relapsed, elderly or unfit patients, methylprednisolone, rituximab
465181|NCT01576575|to determine how people absorb and break down (metabolize) and eliminate buprenorphine and if CYP3A is involved.|to determine how people absorb and break down (metabolize) and eliminate buprenorphine and if cyp3a is involved.
465182|NCT01576562|Implantable Cardioverter Defibrillator|implantable cardioverter defibrillator
465183|NCT01576562|Ventricular Assist Device|ventricular assist device
465184|NCT01576536|Myocardial infarction|myocardial infarction
465185|NCT01576536|Platelet aggregation|platelet aggregation
465186|NCT01576536|cold pressor test|cold pressor test
465187|NCT01576536|Genetics|genetics
465188|NCT01576497|EUS, EUS-FNA, Pancreatic masses|eus, eus-fna, pancreatic masses
465189|NCT01576471|T. suis ova|t. suis ova
465190|NCT01576471|Trichuris suis ova|trichuris suis ova
465191|NCT01576471|Inflammatory Bowel Disease|inflammatory bowel disease
465192|NCT01576471|TRUST-I|trust-i
465193|NCT01576471|TRUSTI|trusti
465194|NCT01576471|TRUST-1|trust-1
465195|NCT01576471|TRUST1|trust1
465196|NCT01576458|ursodeoxycholic acid|ursodeoxycholic acid
465197|NCT01576458|intrahepatic cholestasis|intrahepatic cholestasis
465198|NCT01576458|pregnancy|pregnancy
465199|NCT01576445|Total Knee Arthroplasty|total knee arthroplasty
465200|NCT01576445|function|function
465201|NCT01576432|Pain|pain
465202|NCT01576432|Breastfeeding|breastfeeding
465203|NCT01576432|Heel prick|heel prick
465204|NCT01576432|Sucrose|sucrose
465205|NCT01576432|Skin-to-skin contact|skin-to-skin contact
465206|NCT01576432|Newborn|newborn
465207|NCT01576419|PG201|pg201
465208|NCT01576419|Non-inferiority|non-inferiority
465209|NCT01576419|100mm pain VAS|100mm pain vas
465210|NCT01576406|crizotinib|crizotinib
465211|NCT01576406|xalkori|xalkori
465212|NCT01576406|PF-02341066|pf-02341066
465213|NCT01576406|hepatic impairment|hepatic impairment
465214|NCT01576406|pharmacokinetics|pharmacokinetics
465215|NCT01576406|advanced cancer|advanced cancer
465216|NCT01576393|substance abuse|substance abuse
465217|NCT01576393|treatment|treatment
465218|NCT01576393|families|families
465219|NCT01576380|Solid tumors|solid tumors
465220|NCT01576380|Advanced scirrhous gastric carcinoma|advanced scirrhous gastric carcinoma
465221|NCT01576380|Gastric Cancer|gastric cancer
465222|NCT01576380|Second-line or third-line treatment|second-line or third-line treatment
465223|NCT01576380|VEGF|vegf
465224|NCT01576380|FGFR|fgfr
465225|NCT01576380|Neoplasms|neoplasms
465226|NCT01576380|Gastric Neoplasms|gastric neoplasms
465227|NCT01576380|Cancer|cancer
465228|NCT01576380|Carcinoma|carcinoma
465229|NCT01576380|Gastric Diseases|gastric diseases
465230|NCT01576380|Female Genital Diseases|female genital diseases
465231|NCT01576380|Tumors|tumors
465232|NCT01576380|Oral Administration|oral administration
465233|NCT01576380|Capsules|capsules
465234|NCT01576380|TKI258|tki258
465235|NCT01576380|TKI-258|tki-258
465236|NCT01576380|TKI 258|tki 258
465237|NCT01576367|Cryopyrin-associated periodic syndromes (CAPS)|cryopyrin-associated periodic syndromes (caps)
465238|NCT01576367|Familial Cold Autoinflammatory Syndrome (FCAS)|familial cold autoinflammatory syndrome (fcas)
465239|NCT01576367|Muckle-Wells Syndrome (MWS)|muckle-wells syndrome (mws)
465426|NCT01575613|heterogeneity|heterogeneity
465240|NCT01576367|Neonatal Onset Multisystem Inflammatory Disease (NOMID)|neonatal onset multisystem inflammatory disease (nomid)
465241|NCT01576367|children, systemic autoinflammatory disease|children, systemic autoinflammatory disease
465242|NCT01576367|CIAS-1 gene|cias-1 gene
465243|NCT01576367|NALP-3|nalp-3
465244|NCT01576367|NLRP3|nlrp3
465245|NCT01576367|ACZ885|acz885
465246|NCT01576367|canakinumab|canakinumab
465247|NCT01576367|human monoclonal anti-human interleukin-1 antibody|human monoclonal anti-human interleukin-1 antibody
465248|NCT01576367|autosomal dominant|autosomal dominant
465249|NCT01576367|familial autoinflammatory syndrome|familial autoinflammatory syndrome
465250|NCT01576367|childhood immunizations vaccinations|childhood immunizations vaccinations
465251|NCT01576354|Multiple Sclerosis|multiple sclerosis
465252|NCT01576354|walking function|walking function
465253|NCT01576354|fampridine|fampridine
465254|NCT01576341|Epoetin alfa, ESA, HX575, CKD|epoetin alfa, esa, hx575, ckd
465255|NCT01576315|cystic fibrosis|cystic fibrosis
465256|NCT01576315|Aspergillus|aspergillus
465257|NCT01576315|itraconazole|itraconazole
465258|NCT01576315|voriconazole|voriconazole
465259|NCT01576302|Rumination|rumination
465260|NCT01576289|Esophagus|esophagus
465261|NCT01576289|Gastroesophageal reflux|gastroesophageal reflux
465262|NCT01576289|Reflux esophagitis|reflux esophagitis
465263|NCT01576289|Barrett's esophagus|barrett's esophagus
465264|NCT01576289|Stomach|stomach
465265|NCT01576289|Intestinal metaplasia stomach|intestinal metaplasia stomach
465266|NCT01576289|Helicobacter pylori infection|helicobacter pylori infection
465267|NCT01576289|Proton pump inhibitor|proton pump inhibitor
465268|NCT01576289|Duodenum|duodenum
465269|NCT01576289|Duodenal bulb|duodenal bulb
465270|NCT01576289|Celiac disease diagnosis|celiac disease diagnosis
465271|NCT01576263|Anaesthesia|anaesthesia
465272|NCT01576263|Infiltration|infiltration
465273|NCT01576263|Blood transfusion|blood transfusion
465274|NCT01576263|Autologous|autologous
465275|NCT01576263|Arthroplasty|arthroplasty
465276|NCT01576263|Replacement|replacement
465277|NCT01576263|Ropivacaine|ropivacaine
465278|NCT01576237|hemovigilance|hemovigilance
465279|NCT01576237|hemapheresis|hemapheresis
465280|NCT01576237|donor vigilance|donor vigilance
465281|NCT01576237|plasmapheresis|plasmapheresis
465282|NCT01576237|platelet apheresis|platelet apheresis
465283|NCT01576237|leukapheresis|leukapheresis
465285|NCT01576237|granulocyte apheresis|granulocyte apheresis
465286|NCT01576237|monocyte apheresis|monocyte apheresis
465287|NCT01576237|red cell apheresis|red cell apheresis
465288|NCT01576224|Volar locking plate osteosynthesis|volar locking plate osteosynthesis
465289|NCT01576224|Early mobilization|early mobilization
465290|NCT01576224|DASH|dash
465291|NCT01576211|Wilms tumor and other childhood kidney tumors|wilms tumor and other childhood kidney tumors
465292|NCT01576198|Wilms tumor and other childhood kidney tumors|wilms tumor and other childhood kidney tumors
465293|NCT01576159|Biochemical Marker|biochemical marker
465294|NCT01576159|Fitness Exercises|fitness exercises
465295|NCT01576159|Impact|impact
465296|NCT01576159|Articular Cartilage|articular cartilage
465297|NCT01576146|Clinical Trial, Phase 2|clinical trial, phase 2
465298|NCT01576146|Renal Dialysis|renal dialysis
465299|NCT01576146|Secondary Hyperparathyroidism|secondary hyperparathyroidism
465300|NCT01576146|Chronic kidney disease-mineral and bone disorder|chronic kidney disease-mineral and bone disorder
465301|NCT01576146|Parathyroid hormone|parathyroid hormone
465302|NCT01576133|Quality of Life|quality of life
465303|NCT01576120|Known, active Crohn's disease|known, active crohn's disease
465304|NCT01576120|Iieocolonic or colonic involvement|iieocolonic or colonic involvement
465305|NCT01576120|proven patency of the GI tract|proven patency of the gi tract
465306|NCT01576107|Different cancer entities|different cancer entities
465307|NCT01576094|congenital heart disease|congenital heart disease
465308|NCT01576081|bone density|bone density
465309|NCT01576081|weight bearing|weight bearing
465310|NCT01576081|muscle atrophy|muscle atrophy
465311|NCT01576081|vascular degeneration|vascular degeneration
465312|NCT01576081|gravitational loading|gravitational loading
465313|NCT01576081|muscular unloading|muscular unloading
465314|NCT01576068|COPD|copd
465315|NCT01576068|Pharmacy|pharmacy
465316|NCT01576068|Spirometry|spirometry
465317|NCT01576068|Case finding|case finding
465318|NCT01576055|Peripheral Arterial Disease|peripheral arterial disease
465319|NCT01576055|Superficial Femoral Artery|superficial femoral artery
465320|NCT01576055|Proximal Popliteal Artery|proximal popliteal artery
465321|NCT01576055|PAD|pad
465322|NCT01576055|SFA|sfa
465323|NCT01576055|PPA|ppa
465324|NCT01576055|Stent|stent
465325|NCT01576055|Gore|gore
465326|NCT01576055|Bare Metal Stent|bare metal stent
465327|NCT01576055|LifeStent|lifestent
465328|NCT01576055|atherosclerosis|atherosclerosis
465329|NCT01576055|Heparin|heparin
465330|NCT01576055|claudication|claudication
465331|NCT01576055|leg pain|leg pain
465332|NCT01576042|Ischemic heart disease|ischemic heart disease
465333|NCT01576042|Implantable Cardioverter Defibrillator|implantable cardioverter defibrillator
465334|NCT01576042|Ventricular Tachycardia|ventricular tachycardia
465427|NCT01575613|transmission|transmission
465428|NCT01575613|elimination|elimination
465335|NCT01576042|Patient with Implantable Cardioverter Defibrillator (ICD)|patient with implantable cardioverter defibrillator (icd)
465336|NCT01576016|bradycardia|bradycardia
465337|NCT01576016|MRI scans|mri scans
465338|NCT01576003|Short Bowel Syndrome|short bowel syndrome
465339|NCT01576003|Necrotizing Entercolitis (NEC)|necrotizing entercolitis (nec)
465340|NCT01576003|Atresia|atresia
465341|NCT01576003|Parenteral Nutrition|parenteral nutrition
465342|NCT01576003|Biological Markers|biological markers
465343|NCT01576003|Growth|growth
465344|NCT01575990|Colon cancer screening|colon cancer screening
465345|NCT01575990|Decision support interventions|decision support interventions
465346|NCT01575990|Health status|health status
465347|NCT01575990|Patient-centered care|patient-centered care
465348|NCT01575990|Age|age
465349|NCT01575990|Randomized controlled trial|randomized controlled trial
465350|NCT01575990|Double blind|double blind
465351|NCT01575990|UNC|unc
465352|NCT01575938|HIV infection|hiv infection
465353|NCT01575925|Pomalidomide for multiple myeloma|pomalidomide for multiple myeloma
465354|NCT01575925|renal impairment|renal impairment
465355|NCT01575925|multiple myeloma patients with renal impairment|multiple myeloma patients with renal impairment
465356|NCT01575925|Pomalidomide for patients with renal impairment due to multiple myeloma|pomalidomide for patients with renal impairment due to multiple myeloma
465357|NCT01575925|Pomalidomide|pomalidomide
465358|NCT01575925|dexamethasone|dexamethasone
465359|NCT01575925|RRMM|rrmm
465360|NCT01575925|impaired renal function in multiple myeloma|impaired renal function in multiple myeloma
465361|NCT01575925|hemodialysis|hemodialysis
465362|NCT01575925|dialysis|dialysis
465363|NCT01575925|POM|pom
465364|NCT01575925|Pomalyst|pomalyst
465365|NCT01575925|MM|mm
465366|NCT01575925|severe renal impairment|severe renal impairment
465367|NCT01575925|CrCl ≤ 30 mL/min|crcl ≤ 30 ml/min
465368|NCT01575925|Creatinine less than 30|creatinine less than 30
465369|NCT01575925|clinical trial in subjects with multiple myeloma with renal impairement|clinical trial in subjects with multiple myeloma with renal impairement
465370|NCT01575912|Schizophrenia|schizophrenia
465371|NCT01575912|Major depression|major depression
465372|NCT01575912|Pain|pain
465373|NCT01575912|Past pain experience|past pain experience
465374|NCT01575899|Helicobacter pylori|helicobacter pylori
465375|NCT01575899|Levofloxacin|levofloxacin
465376|NCT01575899|Amoxicillin/clavulanate|amoxicillin/clavulanate
465377|NCT01575899|Rabeprazole|rabeprazole
465378|NCT01575899|Eastern Taiwan|eastern taiwan
465379|NCT01575886|clinician patient communication|clinician patient communication
465380|NCT01575886|smoking cessation|smoking cessation
465381|NCT01575886|weight management|weight management
465382|NCT01575886|primary care|primary care
465383|NCT01575886|health behavior change advice|health behavior change advice
465384|NCT01575873|GIOP, Glucocorticoid, osteporosis, denosumab, BMD, Bone Mineral Density|giop, glucocorticoid, osteporosis, denosumab, bmd, bone mineral density
465385|NCT01575860|biopsy-proven diagnosis|biopsy-proven diagnosis
465386|NCT01575860|completed at least 2 cycles of salvage chemotherapy|completed at least 2 cycles of salvage chemotherapy
465387|NCT01575860|showing PET positive residual lesions|showing pet positive residual lesions
465388|NCT01575847|Acetaminophen|acetaminophen
465389|NCT01575847|Acetaminophen Toxicity|acetaminophen toxicity
465390|NCT01575834|Osteoporosis, Osteoporosis-Postmenopausal, Bone Diseases-Metabolic, Bone Diseases, Musculoskeletal Diseases|osteoporosis, osteoporosis-postmenopausal, bone diseases-metabolic, bone diseases, musculoskeletal diseases
465391|NCT01575821|children, cough, honey|children, cough, honey
465392|NCT01575808|Symptomatic PAD|symptomatic pad
465393|NCT01575808|Stenosis|stenosis
465394|NCT01575808|Occlusion|occlusion
465395|NCT01575795|Ticagrelor|ticagrelor
465396|NCT01575795|ST elevation acute myocardial infarction|st elevation acute myocardial infarction
465397|NCT01575795|Platelet reactivity|platelet reactivity
465398|NCT01575782|small cell lung cancer|small cell lung cancer
465399|NCT01575782|stage I-III|stage i-iii
465400|NCT01575782|chloroquine|chloroquine
465401|NCT01575782|Phase I|phase i
465402|NCT01575730|Peritoneal carcinomatosis from colorectal or appendiceal origin|peritoneal carcinomatosis from colorectal or appendiceal origin
465403|NCT01575717|Vitamin D|vitamin d
465404|NCT01575717|hepatocellular carcinoma|hepatocellular carcinoma
465405|NCT01575717|liver neoplasms|liver neoplasms
465406|NCT01575717|liver transplantation|liver transplantation
465407|NCT01575704|Exercise|exercise
465408|NCT01575704|Hematopoetic cell transplantation|hematopoetic cell transplantation
465409|NCT01575704|Children|children
465410|NCT01575678|enuresis|enuresis
465411|NCT01575678|melatonin|melatonin
465412|NCT01575678|circadian rhythm|circadian rhythm
465413|NCT01575678|children|children
465414|NCT01575678|blood pressure|blood pressure
465415|NCT01575678|urine production|urine production
465416|NCT01575678|activity|activity
465417|NCT01575678|sleep|sleep
465418|NCT01575665|Hyperventilation|hyperventilation
465419|NCT01575665|Chronic Idiopathic Hyperventilation|chronic idiopathic hyperventilation
465420|NCT01575665|Dysfunctional Breathing|dysfunctional breathing
465421|NCT01575665|Respiratory Alkalosis|respiratory alkalosis
465422|NCT01575665|Respiratory Acidosis|respiratory acidosis
465423|NCT01575652|peritoneal dialysis|peritoneal dialysis
465424|NCT01575652|protein losses|protein losses
465429|NCT01575587|Pharmacology|pharmacology
465430|NCT01575587|Pharmacokinetics|pharmacokinetics
465431|NCT01575587|Pharmacodynamics|pharmacodynamics
465432|NCT01575587|Abiraterone acetate|abiraterone acetate
465433|NCT01575587|Food intake|food intake
465434|NCT01575587|Caucasion|caucasion
465435|NCT01575587|Japanese|japanese
465436|NCT01575587|Healthy|healthy
465437|NCT01575561|Lurasidone|lurasidone
465438|NCT01575561|Latuda|latuda
465439|NCT01575561|Bipolar Disorder|bipolar disorder
465440|NCT01575535|untreated adult acute myeloid leukemia|untreated adult acute myeloid leukemia
465441|NCT01575535|adult acute basophilic leukemia|adult acute basophilic leukemia
465442|NCT01575535|adult acute eosinophilic leukemia|adult acute eosinophilic leukemia
465443|NCT01575535|adult erythroleukemia (M6a)|adult erythroleukemia (m6a)
465444|NCT01575535|adult pure erythroid leukemia (M6b)|adult pure erythroid leukemia (m6b)
465445|NCT01575535|adult acute megakaryoblastic leukemia (M7)|adult acute megakaryoblastic leukemia (m7)
465446|NCT01575535|adult acute minimally differentiated myeloid leukemia (M0)|adult acute minimally differentiated myeloid leukemia (m0)
465447|NCT01575535|adult acute monoblastic leukemia (M5a)|adult acute monoblastic leukemia (m5a)
465448|NCT01575535|adult acute monocytic leukemia (M5b)|adult acute monocytic leukemia (m5b)
465449|NCT01575535|adult acute myeloblastic leukemia with maturation (M2)|adult acute myeloblastic leukemia with maturation (m2)
465450|NCT01575535|adult acute myeloblastic leukemia without maturation (M1)|adult acute myeloblastic leukemia without maturation (m1)
465451|NCT01575535|adult acute myeloid leukemia with 11q23 (MLL) abnormalities|adult acute myeloid leukemia with 11q23 (mll) abnormalities
465452|NCT01575535|adult acute myeloid leukemia with del(5q)|adult acute myeloid leukemia with del(5q)
465453|NCT01575535|adult acute myeloid leukemia with inv(16)(p13;q22)|adult acute myeloid leukemia with inv(16)(p13;q22)
465454|NCT01575535|adult acute myeloid leukemia with t(16;16)(p13;q22)|adult acute myeloid leukemia with t(16;16)(p13;q22)
465455|NCT01575535|adult acute myeloid leukemia with t(8;21)(q22;q22)|adult acute myeloid leukemia with t(8;21)(q22;q22)
465456|NCT01575535|adult acute myelomonocytic leukemia (M4)|adult acute myelomonocytic leukemia (m4)
465457|NCT01575496|Tinnitus|tinnitus
465458|NCT01575496|Transcranial direct current stimulation|transcranial direct current stimulation
465459|NCT01575496|Transcranial magnetic stimulation|transcranial magnetic stimulation
465460|NCT01575470|Traumatic Brain Injury|traumatic brain injury
465461|NCT01575470|TBI|tbi
465462|NCT01575470|stem cells|stem cells
465463|NCT01575457|Adolescent Violence Prevention|adolescent violence prevention
465464|NCT01575444|Pap test|pap test
465465|NCT01575444|HPV testing|hpv testing
465466|NCT01575444|cervical cancer|cervical cancer
465467|NCT01575431|coronary artery disease|coronary artery disease
465468|NCT01575431|endothelial progenitor cells|endothelial progenitor cells
465469|NCT01575392|creatinine|creatinine
465470|NCT01575392|chronic kidney disease|chronic kidney disease
465471|NCT01575392|creatinine clearance|creatinine clearance
465472|NCT01575392|estimated glomerular filtration rate|estimated glomerular filtration rate
465473|NCT01575340|inflammatory markers|inflammatory markers
465474|NCT01575340|colorectal cancer|colorectal cancer
465475|NCT01575340|cytokines|cytokines
465476|NCT01575340|fish oil|fish oil
465477|NCT01575314|stapling device|stapling device
465478|NCT01575314|lobectomy|lobectomy
465479|NCT01575314|cost utility|cost utility
465480|NCT01575301|GLP-1R agonist|glp-1r agonist
465481|NCT01575301|biomarker|biomarker
465482|NCT01575288|arterial function|arterial function
465483|NCT01575288|cardiovascular|cardiovascular
465484|NCT01575288|aging|aging
465485|NCT01575288|endothelial function|endothelial function
465486|NCT01575288|arterial stiffness|arterial stiffness
465487|NCT01575288|vascular function|vascular function
465488|NCT01575288|Trehalose|trehalose
465489|NCT01575262|behaviour change|behaviour change
465490|NCT01575262|incentives|incentives
465491|NCT01575262|nudging|nudging
465492|NCT01575262|physical activity|physical activity
465493|NCT01575262|self-monitoring|self-monitoring
465494|NCT01575249|progression|progression
465495|NCT01575249|moderate aortic stenosis|moderate aortic stenosis
465496|NCT01575249|asymptomatic|asymptomatic
465497|NCT01575249|symptomatic|symptomatic
465498|NCT01575223|saline irrigation|saline irrigation
465499|NCT01575223|chronic rhinosinusitis|chronic rhinosinusitis
465500|NCT01575223|endoscopic sinus surgery|endoscopic sinus surgery
465501|NCT01575223|high volume saline irrigation|high volume saline irrigation
465502|NCT01575184|internal jugular vein cannulation|internal jugular vein cannulation
465503|NCT01575184|common carotid artery|common carotid artery
465504|NCT01575184|infants|infants
465505|NCT01575132|Parkinson's Disease|parkinson's disease
465506|NCT01575132|Stimulation, Deep Brain|stimulation, deep brain
465507|NCT01575132|Study, Follow-Up|study, follow-up
465508|NCT01575132|Adverse Effects|adverse effects
465509|NCT01575119|Cigarette smoker|cigarette smoker
465510|NCT01575119|Elective surgery|elective surgery
465511|NCT01575093|Healthy volunteers|healthy volunteers
465512|NCT01575067|BP|bp
465513|NCT01575041|sodium|sodium
465514|NCT01575041|salt|salt
465515|NCT01575041|potassium|potassium
465516|NCT01575041|blood pressure|blood pressure
465517|NCT01575041|flow-mediated dilatation|flow-mediated dilatation
465615|NCT01574612|Xerese|xerese
465518|NCT01575041|endothelial function|endothelial function
465519|NCT01575041|renal function|renal function
465520|NCT01575041|controlled feeding study|controlled feeding study
465521|NCT01575041|dietary intervention|dietary intervention
465522|NCT01575028|Transversus abdominis plane block|transversus abdominis plane block
465523|NCT01575028|TAP block|tap block
465524|NCT01575028|Local anesthetic infiltration|local anesthetic infiltration
465525|NCT01575028|Appendectomy|appendectomy
465526|NCT01575028|Laparoscopic appendectomy|laparoscopic appendectomy
465527|NCT01575015|Liver transplantation (E04.210.650)|liver transplantation (e04.210.650)
465528|NCT01575015|Renal replacement therapy (E05.196.353)|renal replacement therapy (e05.196.353)
465529|NCT01575015|Intra-operative period (E04.614.374)|intra-operative period (e04.614.374)
465530|NCT01575015|Safety (N06.850.135.060.075)|safety (n06.850.135.060.075)
465531|NCT01575015|Efficacy|efficacy
465532|NCT01575002|transcranial stimulation|transcranial stimulation
465533|NCT01575002|direct current stimulation|direct current stimulation
465534|NCT01574989|direct current stimulation|direct current stimulation
465535|NCT01574989|magnetic stimulation|magnetic stimulation
465536|NCT01574989|transcranial stimulation|transcranial stimulation
465537|NCT01574976|ADHD|adhd
465538|NCT01574976|probabilistic|probabilistic
465539|NCT01574976|choice|choice
465540|NCT01574976|feedback|feedback
465541|NCT01574976|practice|practice
465542|NCT01574963|Coronary artery disease|coronary artery disease
465543|NCT01574963|OPG|opg
465544|NCT01574963|RANKL|rankl
465545|NCT01574963|bone disease|bone disease
465546|NCT01574950|Delirium|delirium
465547|NCT01574937|Castration Resistant|castration resistant
465548|NCT01574937|Post Chemotherapy|post chemotherapy
465549|NCT01574924|Personality change|personality change
465550|NCT01574924|Perfectionism|perfectionism
465551|NCT01574924|Coping|coping
465552|NCT01574924|Medical Specialty|medical specialty
465553|NCT01574924|Medical Residency|medical residency
465554|NCT01574911|volumetry 3D|volumetry 3d
465555|NCT01574911|Displacement of water|displacement of water
465556|NCT01574911|lymphoedema|lymphoedema
465557|NCT01574911|Venous chronic insufficiency|venous chronic insufficiency
465558|NCT01574898|Smoking cessation|smoking cessation
465559|NCT01574898|Nicotine|nicotine
465560|NCT01574898|Tobacco Use Disorder|tobacco use disorder
465561|NCT01574898|Central Nervous System Agents|central nervous system agents
465562|NCT01574885|sleep apnea|sleep apnea
465563|NCT01574885|adenotonsillar hypertrophy|adenotonsillar hypertrophy
465564|NCT01574885|salt|salt
465565|NCT01574885|sodium chloride|sodium chloride
465566|NCT01574872|psoriasis|psoriasis
465567|NCT01574872|salt|salt
465568|NCT01574872|sodium chloride|sodium chloride
465569|NCT01574859|central hypothyroidism|central hypothyroidism
465570|NCT01574859|hypopituitarism|hypopituitarism
465571|NCT01574859|levothyroxine replacement|levothyroxine replacement
465572|NCT01574859|lipids|lipids
465573|NCT01574859|body composition|body composition
465574|NCT01574820|prediabetes|prediabetes
465575|NCT01574820|coronary artery disease|coronary artery disease
465576|NCT01574820|insulin resistance|insulin resistance
465577|NCT01574820|glucose intolerance|glucose intolerance
465578|NCT01574807|mepivacaine|mepivacaine
465579|NCT01574807|lidocaine|lidocaine
465580|NCT01574807|inferior alveolar nerve block|inferior alveolar nerve block
465581|NCT01574807|pulpal anesthesia|pulpal anesthesia
465582|NCT01574807|pain of injection|pain of injection
465583|NCT01574807|mepivacaine/lidocaine|mepivacaine/lidocaine
465584|NCT01574807|lidocaine/lidocaine|lidocaine/lidocaine
465585|NCT01574781|Down syndrome|down syndrome
465586|NCT01574781|Trisomy 13|trisomy 13
465587|NCT01574781|Trisomy 18|trisomy 18
465588|NCT01574781|Microdeletions|microdeletions
465589|NCT01574781|Pregnancy|pregnancy
465590|NCT01574781|Non-invasive|non-invasive
465591|NCT01574755|gastric inlet patches|gastric inlet patches
465592|NCT01574755|argon plasma coagulation|argon plasma coagulation
465593|NCT01574755|globus sensations|globus sensations
465594|NCT01574729|p53 gene therapy|p53 gene therapy
465595|NCT01574729|non-small cell lung cancer|non-small cell lung cancer
465596|NCT01574729|post-surgery|post-surgery
465597|NCT01574729|chemotherapy|chemotherapy
465598|NCT01574703|smoking cessation|smoking cessation
465599|NCT01574703|psychiatric disease|psychiatric disease
465600|NCT01574703|cardiovascular events|cardiovascular events
465601|NCT01574690|central venous pressure|central venous pressure
465602|NCT01574690|right heart catheter (RHC)|right heart catheter (rhc)
465603|NCT01574690|non-invasive monitor|non-invasive monitor
465604|NCT01574690|physical exam of jugular venous pressure|physical exam of jugular venous pressure
465605|NCT01574690|heart failure (HF)|heart failure (hf)
465606|NCT01574677|Colorectal cancer|colorectal cancer
465607|NCT01574677|fecal immunochemical test|fecal immunochemical test
465608|NCT01574677|Septin 9|septin 9
465609|NCT01574677|screening|screening
465610|NCT01574651|QVA149|qva149
465611|NCT01574651|Health related quality of life|health related quality of life
465612|NCT01574651|Formoterol|formoterol
465613|NCT01574651|Tiotropium|tiotropium
465614|NCT01574651|COPD|copd
465616|NCT01574612|acyclovir hydrocortisone cream|acyclovir hydrocortisone cream
465617|NCT01574612|herpes labialis|herpes labialis
465618|NCT01574612|pediatric|pediatric
465619|NCT01574599|Stroke|stroke
465620|NCT01574599|weakness|weakness
465621|NCT01574599|rehabilitation|rehabilitation
465622|NCT01574599|chronic stroke|chronic stroke
465623|NCT01574586|True Bifurcation stenosis|true bifurcation stenosis
465624|NCT01574573|Obesity|obesity
465625|NCT01574573|GERD|gerd
465626|NCT01574573|Weight loss|weight loss
465627|NCT01574560|smoke-free|smoke-free
465628|NCT01574560|tobacco exposure|tobacco exposure
465629|NCT01574560|biomarker feedback|biomarker feedback
465630|NCT01574560|nicotine|nicotine
465631|NCT01574560|cotinine|cotinine
465632|NCT01574560|secondhand smoke|secondhand smoke
465633|NCT01574547|Cat Scratch Colon.|cat scratch colon.
465634|NCT01574547|Mucosal tears.|mucosal tears.
465635|NCT01574547|Mucosal erosion.|mucosal erosion.
465636|NCT01574547|Colonoscopy.|colonoscopy.
465637|NCT01574508|efficacy|efficacy
465638|NCT01574508|safety|safety
465639|NCT01574508|intensive insulin therapy|intensive insulin therapy
465640|NCT01574495|stroke|stroke
465641|NCT01574495|error augmentation|error augmentation
465642|NCT01574495|arm recovery|arm recovery
465643|NCT01574495|massed practice|massed practice
465644|NCT01574482|Plant sterol - Hypercholesterolemia - diet - dairy|plant sterol - hypercholesterolemia - diet - dairy
465645|NCT01574469|Plant sterol - Cholesterol absorption - diet - dairy - LDL|plant sterol - cholesterol absorption - diet - dairy - ldl
465646|NCT01574443|Epilepsy|epilepsy
465647|NCT01574417|Plant stanols|plant stanols
465648|NCT01574417|Gene expression profile|gene expression profile
465649|NCT01574417|Microbiota|microbiota
465650|NCT01574404|PGS,PGD, IVF, Polar Body Biopsy, FISH, Microarray analysis|pgs,pgd, ivf, polar body biopsy, fish, microarray analysis
465651|NCT01574378|Abdominoplasty|abdominoplasty
465652|NCT01574365|CKD patients with type 2 diabetes|ckd patients with type 2 diabetes
465653|NCT01574352|Children|children
465654|NCT01574352|Overweight|overweight
465656|NCT01574352|BMI|bmi
465657|NCT01574352|Physical activity|physical activity
465658|NCT01574352|Cognitive function|cognitive function
465659|NCT01574352|Intervention study|intervention study
465660|NCT01574352|Randomized controlled trial|randomized controlled trial
465661|NCT01574352|Day camp|day camp
465662|NCT01574352|Risk factors|risk factors
465663|NCT01574339|GERD|gerd
465664|NCT01574339|LES Pressure|les pressure
465665|NCT01574339|Electrical Stimulation|electrical stimulation
465666|NCT01574326|Chronic Kidney Disease|chronic kidney disease
465667|NCT01574326|Pediatric|pediatric
465668|NCT01574326|Sevelamer Carbonate|sevelamer carbonate
465669|NCT01574326|Hyperphosphatemia|hyperphosphatemia
465670|NCT01574313|stellate ganglion block.|stellate ganglion block.
465671|NCT01574313|Meniere's disease.|meniere's disease.
465672|NCT01574313|electrocochleography.|electrocochleography.
465673|NCT01574313|vertigo.|vertigo.
465674|NCT01574313|hearing impairment.|hearing impairment.
465675|NCT01574300|Small Cell Lung Cancer (SCLC)|small cell lung cancer (sclc)
465676|NCT01574300|Non-Small Cell Lung Cancer (NSCLC)|non-small cell lung cancer (nsclc)
465677|NCT01574300|M1A or B NSCLC|m1a or b nsclc
465678|NCT01574261|Polycystic Ovary Syndrome|polycystic ovary syndrome
465679|NCT01574261|Cardiovascular risk|cardiovascular risk
465680|NCT01574261|Metabolic Syndrome|metabolic syndrome
465681|NCT01574248|ACE inhibitor|ace inhibitor
465682|NCT01574248|Angioedema|angioedema
465683|NCT01574248|Bradykinin|bradykinin
465684|NCT01574248|Swelling|swelling
465685|NCT01574222|Stages IIIB, IV, and recurrent NSCLC|stages iiib, iv, and recurrent nsclc
465686|NCT01574222|Carcinoma, Non-small cell lung|carcinoma, non-small cell lung
465687|NCT01574222|Lung Neoplasms|lung neoplasms
465688|NCT01574222|Carcinoma, Bronchogenic|carcinoma, bronchogenic
465689|NCT01574222|Thoracic Neoplasms|thoracic neoplasms
465690|NCT01574222|Neoplasms by Site|neoplasms by site
465691|NCT01574222|Neoplasms|neoplasms
465692|NCT01574222|Lung Diseases|lung diseases
465693|NCT01574209|Celiac disease|celiac disease
594171|NCT01041365|females|females
465694|NCT01574209|IBS|ibs
465695|NCT01574209|Intestinal barrier|intestinal barrier
465696|NCT01574209|Intestinal permeability|intestinal permeability
465697|NCT01574209|GI peptides|gi peptides
465698|NCT01574196|Childhood cancer|childhood cancer
465699|NCT01574196|Cancer|cancer
465700|NCT01574196|Sequels|sequels
465701|NCT01574196|Complications|complications
465702|NCT01574196|Chemotherapy|chemotherapy
465703|NCT01574196|Radiotherapy|radiotherapy
465704|NCT01574196|Surgery|surgery
465705|NCT01574196|Autonomic nervous system|autonomic nervous system
465706|NCT01574196|Parasympathetic Nervous System|parasympathetic nervous system
465707|NCT01574196|Sympathetic Nervous System|sympathetic nervous system
465708|NCT01574183|Marijuana|marijuana
465709|NCT01574183|Vilazodone|vilazodone
465710|NCT01574183|Contingency management|contingency management
465711|NCT01574183|Motivational enhancement therapy|motivational enhancement therapy
465712|NCT01574170|Breast cancer,|breast cancer,
465713|NCT01574170|Third line metastatic|third line metastatic
465714|NCT01574170|Chemotherapy,|chemotherapy,
465715|NCT01574170|Overall survival,|overall survival,
465716|NCT01574170|Quality of life.|quality of life.
465717|NCT01574144|Heart Failure|heart failure
465718|NCT01574131|Burn|burn
465719|NCT01574131|Fenofibrate|fenofibrate
465720|NCT01574131|PPAR alpha agonist|ppar alpha agonist
465721|NCT01574131|insulin sensitivity|insulin sensitivity
465722|NCT01574131|mitochondrial|mitochondrial
465723|NCT01574118|PTSD|ptsd
465724|NCT01574118|Posttraumatic Stress Disorder|posttraumatic stress disorder
465725|NCT01574118|Exposure Therapy|exposure therapy
465726|NCT01574118|Prolonged Exposure|prolonged exposure
465727|NCT01574118|Fear Memory Retrieval|fear memory retrieval
465728|NCT01574118|Compound extinction|compound extinction
465729|NCT01574118|Deepened extinction|deepened extinction
465730|NCT01574118|Psychotherapy|psychotherapy
465731|NCT01574105|Heparin Dose|heparin dose
465732|NCT01574105|Heparin Resistance|heparin resistance
465733|NCT01574105|Chest Tube Losses|chest tube losses
465734|NCT01574105|Transfusion Events|transfusion events
465735|NCT01574092|Pediatric|pediatric
465736|NCT01574092|Pediatrics|pediatrics
465737|NCT01574092|Gliomas|gliomas
465738|NCT01574092|Glioma|glioma
465739|NCT01574092|Brain tumor|brain tumor
465740|NCT01574092|Brain cancer|brain cancer
465741|NCT01574092|Cisplatin|cisplatin
465742|NCT01574092|Cisplatino|cisplatino
465743|NCT01574092|Irinotecan|irinotecan
465744|NCT01574092|Brain stem tumor|brain stem tumor
465745|NCT01574092|Brainstem gliomas|brainstem gliomas
465746|NCT01574092|Intrinsic brain stem tumor|intrinsic brain stem tumor
465747|NCT01574092|PAEDIATRIC HIGH GRADE GLIOMA|paediatric high grade glioma
465748|NCT01574092|Childhood brain stem glioma|childhood brain stem glioma
465749|NCT01574066|Community-acquired pneumonia|community-acquired pneumonia
465750|NCT01574066|Diagnosis|diagnosis
465751|NCT01574066|Emergency medicine|emergency medicine
465752|NCT01574066|Chest CT-scan|chest ct-scan
465753|NCT01574053|Huntington's Disease|huntington's disease
465754|NCT01574053|Huntington Disease|huntington disease
465755|NCT01574053|Juvenile Huntington's Disease|juvenile huntington's disease
465756|NCT01574053|Registry|registry
465757|NCT01574053|Cohort|cohort
465758|NCT01574053|CHDI|chdi
465759|NCT01574040|Lifestyle|lifestyle
465760|NCT01574040|Lifestyle modification|lifestyle modification
465761|NCT01574040|Behavior|behavior
465762|NCT01574040|Primary prevention|primary prevention
465763|NCT01574040|Healthy staff and visitors of an Academic Hospital|healthy staff and visitors of an academic hospital
465764|NCT01574027|Assess the efficacy of vitamin D for preventing colorectal cancer and identifying the populations likely (or unlikely) to benefit from vitamin D-based therapy.|assess the efficacy of vitamin d for preventing colorectal cancer and identifying the populations likely (or unlikely) to benefit from vitamin d-based therapy.
465765|NCT01574027|Evaluate the ability of Vitamin D3 (cholecalciferol) to reduce ACF's in humans.|evaluate the ability of vitamin d3 (cholecalciferol) to reduce acf's in humans.
465766|NCT01574014|Anxiety Disorder|anxiety disorder
465767|NCT01574014|Phobic Disorders|phobic disorders
465768|NCT01574001|ischemic stroke|ischemic stroke
465769|NCT01574001|smoking cessation|smoking cessation
465770|NCT01574001|antismoking interventions|antismoking interventions
465771|NCT01573988|Nutrition|nutrition
465772|NCT01573988|Eating frequency|eating frequency
465773|NCT01573988|Food intake|food intake
465774|NCT01573988|Eating behavior|eating behavior
465775|NCT01573988|Satiety|satiety
465776|NCT01573988|Ghrelin|ghrelin
465777|NCT01573975|Helicobacter pylori|helicobacter pylori
465778|NCT01573975|antibiotic resistance|antibiotic resistance
465779|NCT01573975|sequential therapy|sequential therapy
465780|NCT01573975|Taiwan|taiwan
465781|NCT01573962|Kidney Renal|kidney renal
465782|NCT01573949|Heart Failure|heart failure
465783|NCT01573949|Diabetes|diabetes
465784|NCT01573949|Pre-diabetes|pre-diabetes
465785|NCT01573949|Early type II diabetes|early type ii diabetes
465786|NCT01573949|Metformin|metformin
465787|NCT01573949|Pharmacotherapy with metformin for prevention of DM in HF patients with pre-diabetes (pre-DM) and glycemic control in HF patients with early type II DM|pharmacotherapy with metformin for prevention of dm in hf patients with pre-diabetes (pre-dm) and glycemic control in hf patients with early type ii dm
465788|NCT01573936|acquired brain injury|acquired brain injury
465789|NCT01573936|health-related quality of life|health-related quality of life
465790|NCT01573936|poliomyelitis survivor|poliomyelitis survivor
465791|NCT01573936|rehabilitation|rehabilitation
465792|NCT01573936|spinal cord injury|spinal cord injury
465793|NCT01573936|completed the WHOQOL-BREF|completed the whoqol-bref
465794|NCT01573923|Umbilical Mesenchymal Stem Cells; Liver cirrhosis|umbilical mesenchymal stem cells; liver cirrhosis
465795|NCT01573910|Bacterial conjunctivitis|bacterial conjunctivitis
465796|NCT01573910|Anti-infective|anti-infective
465797|NCT01573910|Antibiotics|antibiotics
465798|NCT01573897|Diabetes|diabetes
465799|NCT01573897|Sleep apnea|sleep apnea
465800|NCT01573897|Diabetic foot|diabetic foot
465801|NCT01573897|Microcirculation|microcirculation
465802|NCT01573858|Infertility|infertility
465803|NCT01573858|Polycystic Ovary Syndrome|polycystic ovary syndrome
465804|NCT01573858|Clomiphene citrate|clomiphene citrate
465805|NCT01573858|Acupuncture|acupuncture
465806|NCT01573845|child|child
465807|NCT01573845|communication|communication
465808|NCT01573845|diet|diet
465809|NCT01573845|food|food
465810|NCT01573845|health communication|health communication
465811|NCT01573845|nutrition|nutrition
465812|NCT01573845|parents|parents
465813|NCT01573845|primary schools|primary schools
465814|NCT01573845|school age population|school age population
465815|NCT01573845|school health|school health
465816|NCT01573819|repeat dose|repeat dose
465817|NCT01573819|PDE4|pde4
465818|NCT01573819|healthy volunteers|healthy volunteers
465819|NCT01573819|GSK356278|gsk356278
465820|NCT01573806|sepsis|sepsis
465821|NCT01573806|septic shock|septic shock
465822|NCT01573806|children|children
465823|NCT01573806|incretins|incretins
465824|NCT01573806|exenatide|exenatide
465825|NCT01573806|pharmacokinetics|pharmacokinetics
465826|NCT01573806|pharmacodynamics|pharmacodynamics
465827|NCT01573806|glucose homeostasis|glucose homeostasis
465828|NCT01573806|inflammation|inflammation
465829|NCT01573806|cytokines|cytokines
465830|NCT01573806|health-related quality of life|health-related quality of life
465831|NCT01573806|functional status|functional status
465832|NCT01573754|Porphyria, rare disease, orphan disease, iron metabolism|porphyria, rare disease, orphan disease, iron metabolism
465833|NCT01573741|depressive ketamine antidepressant|depressive ketamine antidepressant
465834|NCT01573728|Depression|depression
465835|NCT01573728|Biomarkers|biomarkers
465836|NCT01573728|Exercise|exercise
465837|NCT01573702|Non small cell lung cancer|non small cell lung cancer
465838|NCT01573702|EGFR mutant|egfr mutant
465839|NCT01573702|Phase II|phase ii
465840|NCT01573702|erlotinib|erlotinib
465841|NCT01573702|tarceva|tarceva
465842|NCT01573702|cyberknife|cyberknife
465843|NCT01573702|Lineberger|lineberger
465844|NCT01573689|bereaved children, mutual aid group, death, group intervention.|bereaved children, mutual aid group, death, group intervention.
465845|NCT01573676|bariatric surgery|bariatric surgery
465846|NCT01573676|sleep apnea|sleep apnea
465847|NCT01573676|overweight|overweight
465848|NCT01573663|Ambroxol|ambroxol
465849|NCT01573663|Levodropropizine|levodropropizine
465850|NCT01573663|Drug-drug interaction|drug-drug interaction
465851|NCT01573637|schizophrenia|schizophrenia
465852|NCT01573637|negative schizophrenia|negative schizophrenia
465853|NCT01573637|schizophrenia in post-menopausal women|schizophrenia in post-menopausal women
465854|NCT01573637|schizophrenia in women|schizophrenia in women
465855|NCT01573637|ralixifene|ralixifene
465856|NCT01573637|raloxifen|raloxifen
465857|NCT01573637|raloxifeno|raloxifeno
465858|NCT01573637|negative symptoms of schizophrenia|negative symptoms of schizophrenia
465859|NCT01573637|negative symptoms in schizophrenia|negative symptoms in schizophrenia
465860|NCT01573637|schizophrenia symptoms|schizophrenia symptoms
465861|NCT01573637|negative symptoms of psychosis|negative symptoms of psychosis
465862|NCT01573624|Fluticasone Furoate|fluticasone furoate
465863|NCT01573624|Vilanterol|vilanterol
465864|NCT01573624|Adults|adults
465865|NCT01573624|GSK573719|gsk573719
465866|NCT01573624|Asthma|asthma
465867|NCT01573611|mild cognitive impairment|mild cognitive impairment
465868|NCT01573611|dementia|dementia
465869|NCT01573611|positron emission tomography (PET)|positron emission tomography (pet)
465870|NCT01573611|F-18 Fluorodeoxyglucose (FDG)|f-18 fluorodeoxyglucose (fdg)
465871|NCT01573611|cerebral metabolism|cerebral metabolism
465872|NCT01573611|dietary supplement|dietary supplement
465873|NCT01573598|Major Depressive Disorder|major depressive disorder
465874|NCT01573598|Depression|depression
465875|NCT01573585|Physical Therapy|physical therapy
465876|NCT01573585|Exercise therapy|exercise therapy
465877|NCT01573559|Ambulatory adults with no apparent health conditions|ambulatory adults with no apparent health conditions
465878|NCT01573533|Treatment Resistant Idiopathic FSGS|treatment resistant idiopathic fsgs
465879|NCT01573533|Glomerulosclerosis|glomerulosclerosis
465880|NCT01573533|Proteinuria|proteinuria
465881|NCT01573533|Rituximab|rituximab
465882|NCT01573520|compliance|compliance
465883|NCT01573520|dialysis|dialysis
465884|NCT01573520|hyperparathyroidism|hyperparathyroidism
465885|NCT01573507|traumatic brain injury|traumatic brain injury
465886|NCT01573507|lactate|lactate
465887|NCT01573507|brain metabolism|brain metabolism
465888|NCT01573507|cerebral microdialysis|cerebral microdialysis
465889|NCT01573507|subarachnoid hemorrhage|subarachnoid hemorrhage
465890|NCT01573507|transcranial doppler|transcranial doppler
465891|NCT01573494|Cancer|cancer
465892|NCT01573494|Melanoma|melanoma
465893|NCT01573494|Circulating Tumor Cells|circulating tumor cells
465894|NCT01573481|WEANING|weaning
465895|NCT01573481|PRESSURE CONTROLLED CONTINOUS VENTILATION|pressure controlled continous ventilation
465896|NCT01573481|PRESSURE VENTILATION SUPPORT|pressure ventilation support
465897|NCT01573481|SLEEP|sleep
465898|NCT01573481|POLYGRAPHIC RECORD|polygraphic record
465899|NCT01573442|hot flashes|hot flashes
465900|NCT01573442|musculoskeletal complications|musculoskeletal complications
465901|NCT01573442|sexual dysfunction|sexual dysfunction
465902|NCT01573442|estrogen receptor-positive breast cancer|estrogen receptor-positive breast cancer
465903|NCT01573442|progesterone receptor-positive breast cancer|progesterone receptor-positive breast cancer
465904|NCT01573442|arthralgia|arthralgia
465905|NCT01573442|stage IA breast cancer|stage ia breast cancer
465906|NCT01573442|stage IB breast cancer|stage ib breast cancer
465907|NCT01573442|stage II breast cancer|stage ii breast cancer
465908|NCT01573442|stage IIIA breast cancer|stage iiia breast cancer
465909|NCT01573442|stage IIIB breast cancer|stage iiib breast cancer
465910|NCT01573442|stage IIIC breast cancer|stage iiic breast cancer
465911|NCT01573429|Biologic Sample Collection|biologic sample collection
465912|NCT01573429|Metabolism|metabolism
465913|NCT01573429|Healthy Volunteer|healthy volunteer
465914|NCT01573429|HV|hv
465915|NCT01573416|Alcohol|alcohol
465916|NCT01573416|Abuse|abuse
465917|NCT01573416|Drugs|drugs
465918|NCT01573416|Brief intervention|brief intervention
465919|NCT01573416|ASSIST|assist
465920|NCT01573403|Proton pump inhibitor (PPI)|proton pump inhibitor (ppi)
465921|NCT01573403|DLBS2411|dlbs2411
465922|NCT01573403|gastric pH|gastric ph
465923|NCT01573390|Non-invasive|non-invasive
465924|NCT01573390|tissue-oxygenation|tissue-oxygenation
465925|NCT01573390|hyperspectral|hyperspectral
465926|NCT01573390|CWC imaging system|cwc imaging system
465927|NCT01573377|polycystic ovary syndrome|polycystic ovary syndrome
465928|NCT01573377|insulin resistance|insulin resistance
465929|NCT01573364|Distal Airways|distal airways
465930|NCT01573364|Hyperinflation|hyperinflation
465931|NCT01573364|Reversibility|reversibility
465932|NCT01573338|Cyclin dependent kinases|cyclin dependent kinases
465933|NCT01573338|Drug therapy, combination|drug therapy, combination
465934|NCT01573338|Small cell lung carcinoma|small cell lung carcinoma
465935|NCT01573338|Etoposide|etoposide
465936|NCT01573338|Cisplatin|cisplatin
465937|NCT01573338|Carboplatin|carboplatin
465938|NCT01573325|Cirrhosis of the liver|cirrhosis of the liver
465939|NCT01573325|Pre-liver transplant Candidate|pre-liver transplant candidate
465940|NCT01573325|Depression|depression
465941|NCT01573325|Poor social support|poor social support
465942|NCT01573325|Liver disease symptoms|liver disease symptoms
465943|NCT01573325|Health releated quality of life|health releated quality of life
465944|NCT01573312|influenza, vaccine, H5N1, monovalent, adjuvant, ASO3|influenza, vaccine, h5n1, monovalent, adjuvant, aso3
465945|NCT01573299|Cerebral Infarction, Mobilization, Recovery|cerebral infarction, mobilization, recovery
465946|NCT01573286|Infant Nutrition Disorders|infant nutrition disorders
465947|NCT01573286|Childhood nutrition disorders|childhood nutrition disorders
465948|NCT01573286|malnutrition|malnutrition
465949|NCT01573286|post surgical syndromes|post surgical syndromes
465950|NCT01573286|necrotising enterocolitis|necrotising enterocolitis
465951|NCT01573286|intestinal atresia|intestinal atresia
465952|NCT01573286|gastroschisis|gastroschisis
465953|NCT01573273|cocaine|cocaine
465954|NCT01573273|substance abuse|substance abuse
465955|NCT01573273|drug abuse|drug abuse
465956|NCT01573273|cocaine dependence|cocaine dependence
465957|NCT01573273|drug addiction|drug addiction
465958|NCT01573260|Parkinson's Disease|parkinson's disease
465959|NCT01573260|Tango|tango
465960|NCT01573247|Acute myeloid leukemia|acute myeloid leukemia
465961|NCT01573247|Refractory Acute myeloid leukemia|refractory acute myeloid leukemia
465962|NCT01573247|FLT3 inhibitor|flt3 inhibitor
465963|NCT01573247|kinase inhibitor|kinase inhibitor
465964|NCT01573234|MySkin patch|myskin patch
465965|NCT01573234|Hydrogel bandage|hydrogel bandage
465966|NCT01573234|Occlusive dressing|occlusive dressing
465967|NCT01573208|Knee osteoarthritis|knee osteoarthritis
465968|NCT01573195|deescalation|deescalation
465969|NCT01573195|best practice alert|best practice alert
465970|NCT01573195|antimicrobial stewardship|antimicrobial stewardship
465971|NCT01573182|Zostavax|zostavax
465972|NCT01573182|Herpes Zoster|herpes zoster
465973|NCT01573182|VZV vaccination|vzv vaccination
465974|NCT01573182|Allogeneic haemopoietic stem cell transplantation|allogeneic haemopoietic stem cell transplantation
465975|NCT01573169|hemorrhagic stroke|hemorrhagic stroke
465976|NCT01573169|venous thromboembolism|venous thromboembolism
465977|NCT01573169|prevention|prevention
465978|NCT01573156|renal cancer|renal cancer
465979|NCT01573156|photodynamic therapy|photodynamic therapy
465980|NCT01573156|wst 11|wst 11
465981|NCT01573143|Surgical Procedures, Cardiac|surgical procedures, cardiac
465982|NCT01573143|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors
465983|NCT01573143|Rosuvastatin|rosuvastatin
465984|NCT01573143|Post operative atrial fibrillation|post operative atrial fibrillation
465985|NCT01573130|Depression|depression
465986|NCT01573130|Physical exercise|physical exercise
465987|NCT01573130|Internet|internet
465988|NCT01573117|hypothermia|hypothermia
465989|NCT01573117|induction of hypothermia|induction of hypothermia
465990|NCT01573117|cold infusion|cold infusion
465991|NCT01573117|nasopharyngeal cooling|nasopharyngeal cooling
465992|NCT01573117|stroke|stroke
465993|NCT01573117|intracranial hemorrhage|intracranial hemorrhage
465994|NCT01573117|cerebrovascular disease|cerebrovascular disease
465995|NCT01573117|neuro intensive care|neuro intensive care
465996|NCT01573104|Diagnosis|diagnosis
465997|NCT01573104|Acute Kidney Injury|acute kidney injury
465998|NCT01573091|Cardiac resynchronization therapy|cardiac resynchronization therapy
465999|NCT01573091|Heart failure|heart failure
466000|NCT01573078|Crohn's disease|crohn's disease
466001|NCT01573078|IBS|ibs
466002|NCT01573078|Dissociation|dissociation
466003|NCT01573078|Emotional processing|emotional processing
466004|NCT01573065|alcohol consumption|alcohol consumption
466005|NCT01573065|sexual risk behaviors|sexual risk behaviors
466006|NCT01573065|young, unhealthy drinkers|young, unhealthy drinkers
466007|NCT01573039|Kidney transplantation|kidney transplantation
466008|NCT01573039|PCR quantitative|pcr quantitative
466009|NCT01573039|cytomegalovirus|cytomegalovirus
466010|NCT01573039|antigenemia|antigenemia
466011|NCT01573026|Dental Implants|dental implants
466012|NCT01573026|Dental Implantation|dental implantation
466013|NCT01573026|Osseointegration|osseointegration
466014|NCT01573013|iron deficiency|iron deficiency
466015|NCT01573013|Lead poisoning|lead poisoning
466016|NCT01573013|cognitive development|cognitive development
466017|NCT01573013|motor activity|motor activity
466018|NCT01573000|Bexxar|bexxar
466019|NCT01573000|Non-Hodgkin's Lymphoma|non-hodgkin's lymphoma
466020|NCT01573000|Tositumomab|tositumomab
466021|NCT01573000|Anti-B1 Antibody|anti-b1 antibody
466022|NCT01573000|Radioimmunotherapy|radioimmunotherapy
466023|NCT01573000|Iodine I-131|iodine i-131
466024|NCT01573000|Iodine-131|iodine-131
466025|NCT01572987|Barrett's Esophagus|barrett's esophagus
466026|NCT01572987|Esophageal neoplasms|esophageal neoplasms
466027|NCT01572987|Radiofrequency ablation|radiofrequency ablation
466028|NCT01572987|Endoscopic mucosal resection|endoscopic mucosal resection
466029|NCT01572974|Barrett's esophagus|barrett's esophagus
466030|NCT01572974|Gastroesophageal reflux disease|gastroesophageal reflux disease
466031|NCT01572974|Quality of life|quality of life
466032|NCT01572961|Laser Doppler flowmetry, skin, microcirculation|laser doppler flowmetry, skin, microcirculation
466033|NCT01572935|childhood obesity prevalence|childhood obesity prevalence
466034|NCT01572922|Sickle cell disease|sickle cell disease
466035|NCT01572922|Thalassemia|thalassemia
466036|NCT01572922|Hemochromatosis|hemochromatosis
466037|NCT01572922|Cancer|cancer
466038|NCT01572909|Myocardial Reperfusion|myocardial reperfusion
466039|NCT01572909|Primary PCI|primary pci
466040|NCT01572909|Stenting for ST-segment Elevation Myocardial Infarction|stenting for st-segment elevation myocardial infarction
466041|NCT01572896|adoloescent|adoloescent
466042|NCT01572896|internet self-management|internet self-management
466043|NCT01572896|managing JIA|managing jia
466044|NCT01572883|adjuvant treatment with Radiotherapy and trastuzumab|adjuvant treatment with radiotherapy and trastuzumab
466045|NCT01572870|Chit1|chit1
466046|NCT01572870|Cystic Fibrosis|cystic fibrosis
466047|NCT01572870|Allergic Bronchopulmonary Aspergillosis (ABPA)|allergic bronchopulmonary aspergillosis (abpa)
466048|NCT01572870|Aspergillus|aspergillus
466049|NCT01572857|multiple myeloma|multiple myeloma
466050|NCT01572857|Proteinuria|proteinuria
466051|NCT01572857|Albuminuria|albuminuria
466052|NCT01572857|Urinary FLC|urinary flc
466053|NCT01572857|Urine creatinine|urine creatinine
466054|NCT01572844|Dermatomyositis|dermatomyositis
466055|NCT01572844|Superficial calcinosis|superficial calcinosis
466056|NCT01572844|Fractional carbon dioxide laser|fractional carbon dioxide laser
466057|NCT01572844|Sodium thiosulfate|sodium thiosulfate
466058|NCT01572831|antibiotic cessation rules|antibiotic cessation rules
466059|NCT01572831|procalcitonin|procalcitonin
466060|NCT01572831|infection|infection
466061|NCT01572831|critical care|critical care
466062|NCT01572818|Phlebotomy|phlebotomy
466063|NCT01572818|Insulin Resistance|insulin resistance
466064|NCT01572818|Iron Overload|iron overload
466065|NCT01572805|Post partum haemorrhage|post partum haemorrhage
466066|NCT01572805|Cesarean|cesarean
466067|NCT01572805|Pain|pain
594658|NCT01039597|IBD|ibd
466068|NCT01572792|COPD|copd
466069|NCT01572792|Chronic Obstructive Pulmonary Disease|chronic obstructive pulmonary disease
466070|NCT01572792|Chronic Bronchitis|chronic bronchitis
466071|NCT01572792|Emphysema|emphysema
466072|NCT01572792|Airflow Obstruction, Chronic|airflow obstruction, chronic
466073|NCT01572792|Chronic Airflow Obstruction|chronic airflow obstruction
466074|NCT01572792|Chronic Obstructive Airway Disease|chronic obstructive airway disease
466075|NCT01572792|Chronic Obstructive Lung Disease|chronic obstructive lung disease
466076|NCT01572779|dorsavi|dorsavi
466077|NCT01572779|vimove|vimove
466078|NCT01572779|biofeedback|biofeedback
466079|NCT01572779|objective movement data|objective movement data
466080|NCT01572779|back pain|back pain
466081|NCT01572766|Osteoporosis|osteoporosis
466082|NCT01572766|Pharmacist|pharmacist
466083|NCT01572766|Behavior Change|behavior change
466084|NCT01572766|FRAX|frax
466085|NCT01572766|Osteopenia|osteopenia
466086|NCT01572727|BKM120|bkm120
466087|NCT01572727|paclitaxel|paclitaxel
466088|NCT01572727|breast cancer|breast cancer
466089|NCT01572727|metastatic|metastatic
466090|NCT01572727|locally advanced|locally advanced
466091|NCT01572727|PI3K|pi3k
466092|NCT01572727|PIK3CA|pik3ca
466093|NCT01572727|PTEN|pten
466094|NCT01572714|Exercise|exercise
466095|NCT01572714|Self Care|self care
466096|NCT01572714|Fatigue|fatigue
466097|NCT01572675|Pharmacoepidemiological|pharmacoepidemiological
466098|NCT01572675|Longitudinal|longitudinal
466602|NCT01570725|relaxation|relaxation
466099|NCT01572675|Observational|observational
466100|NCT01572662|Leukemia|leukemia
466101|NCT01572662|Acute myeloid leukemia|acute myeloid leukemia
466102|NCT01572662|Acute lymphocytic leukemia|acute lymphocytic leukemia
466103|NCT01572662|Chronic myeloid leukemia|chronic myeloid leukemia
466104|NCT01572662|Chronic lymphocytic leukemia|chronic lymphocytic leukemia
466105|NCT01572662|Myeloproliferative Diseases|myeloproliferative diseases
466106|NCT01572662|Non-Hodgkins Lymphoma|non-hodgkins lymphoma
466107|NCT01572662|Hodgkins lymphoma|hodgkins lymphoma
466108|NCT01572662|Multiple myeloma|multiple myeloma
466109|NCT01572662|Myelodysplastic syndrome|myelodysplastic syndrome
466110|NCT01572662|MDS|mds
466111|NCT01572662|Fludarabine monophosphate|fludarabine monophosphate
466112|NCT01572662|Fludarabine phosphate|fludarabine phosphate
466113|NCT01572662|Fludara|fludara
466114|NCT01572662|Busulfan|busulfan
466115|NCT01572662|Busulfex|busulfex
466116|NCT01572662|Myleran|myleran
466117|NCT01572662|Tacrolimus|tacrolimus
466118|NCT01572662|Prograf|prograf
466119|NCT01572662|Methotrexate|methotrexate
466120|NCT01572662|G-CSF|g-csf
466121|NCT01572662|Filgrastim|filgrastim
466122|NCT01572662|Neupogen|neupogen
466123|NCT01572662|Stem cell transplant|stem cell transplant
466124|NCT01572662|Allogeneic Transplantation|allogeneic transplantation
466125|NCT01572636|Hurler Syndrome|hurler syndrome
466126|NCT01572623|Therapeutic strategies for carotid artery stenting|therapeutic strategies for carotid artery stenting
466127|NCT01572610|CKD patients with type 2 diabetes|ckd patients with type 2 diabetes
466128|NCT01572597|Helicobacter pylori|helicobacter pylori
466129|NCT01572597|antibiotic resistance|antibiotic resistance
466130|NCT01572597|N-acetylcystein|n-acetylcystein
466131|NCT01572597|biofilm|biofilm
466132|NCT01572597|second-line eradication treatment|second-line eradication treatment
466133|NCT01572584|Pneumothorax|pneumothorax
466134|NCT01572584|Lung ultrasound|lung ultrasound
466135|NCT01572584|Chest sonography|chest sonography
466136|NCT01572571|Emergency ultrasound|emergency ultrasound
466137|NCT01572571|Focused ultrasound|focused ultrasound
466138|NCT01572571|Point-of-care ultrasound|point-of-care ultrasound
466139|NCT01572571|Undifferentiated hypotension|undifferentiated hypotension
466140|NCT01572558|Appendectomy|appendectomy
466141|NCT01572558|Nonsurgical treatment with antibiotics|nonsurgical treatment with antibiotics
466142|NCT01572545|bone turnover|bone turnover
466143|NCT01572545|denosumab|denosumab
466144|NCT01572545|postmenopausal osteoporosis|postmenopausal osteoporosis
466145|NCT01572545|sclerostin|sclerostin
466146|NCT01572545|zolendronic acid|zolendronic acid
466147|NCT01572532|Adverse Perinatal Outcomes|adverse perinatal outcomes
466148|NCT01572532|Treatment of abnormal vaginal flora|treatment of abnormal vaginal flora
466149|NCT01572519|Relapsed Hodgkin lymphoma|relapsed hodgkin lymphoma
466150|NCT01572519|Refractory Hodgkin lymphoma|refractory hodgkin lymphoma
466151|NCT01572519|JNJ-40346527|jnj-40346527
466152|NCT01572519|Dose-escalation|dose-escalation
466153|NCT01572519|Pharmacokinetics|pharmacokinetics
466155|NCT01572506|Elderly|elderly
466156|NCT01572506|Mechanisms|mechanisms
466157|NCT01572506|Red Cell Survival|red cell survival
466158|NCT01572493|Pharmacokinetics of lL-15|pharmacokinetics of ll-15
466159|NCT01572493|Cytokine Therapy|cytokine therapy
466160|NCT01572493|Effects of rhlL-15 on T-cells and NK cells|effects of rhll-15 on t-cells and nk cells
466161|NCT01572493|Immunotherapy|immunotherapy
466162|NCT01572480|Proteasome Inhibitor|proteasome inhibitor
466163|NCT01572480|Immunomodulatory Agents|immunomodulatory agents
466164|NCT01572480|Combination Therapy|combination therapy
466165|NCT01572480|Anti-Myeloma Activity|anti-myeloma activity
466166|NCT01572480|Smoldering Multiple Myeloma|smoldering multiple myeloma
466167|NCT01572480|SMM|smm
466168|NCT01572467|Leydig cell tumor|leydig cell tumor
466169|NCT01572467|ovarian stromal cancer|ovarian stromal cancer
466170|NCT01572467|childhood malignant testicular germ cell tumor|childhood malignant testicular germ cell tumor
466171|NCT01572467|childhood malignant ovarian germ cell tumor|childhood malignant ovarian germ cell tumor
466172|NCT01572454|coronary artery bypass graft|coronary artery bypass graft
466173|NCT01572454|hypokalemia|hypokalemia
466174|NCT01572454|cardiac arrhythmia|cardiac arrhythmia
466175|NCT01572454|dexmedetomidine|dexmedetomidine
466176|NCT01572454|remifentanil|remifentanil
466177|NCT01572428|Proximal Colon Cancer|proximal colon cancer
466178|NCT01572428|Serrated Colon Lesions|serrated colon lesions
466179|NCT01572428|Narrow Band Imaging|narrow band imaging
466180|NCT01572415|Screening for Type 2 diabetes|screening for type 2 diabetes
466181|NCT01572402|Diet|diet
466182|NCT01572402|Gastrointestinal peptides|gastrointestinal peptides
466183|NCT01572402|Insulin secretion|insulin secretion
466184|NCT01572402|Oxidative stress|oxidative stress
466185|NCT01572402|Plasma lipids|plasma lipids
466186|NCT01572402|Postprandial|postprandial
466187|NCT01572402|Type 2 diabetes|type 2 diabetes
466188|NCT01572389|Diabetes Mellitus|diabetes mellitus
466189|NCT01572389|Depression|depression
466190|NCT01572389|Affective Symptoms|affective symptoms
466191|NCT01572389|Self Care|self care
466192|NCT01572389|Telemedicine|telemedicine
466193|NCT01572389|Psychotherapy|psychotherapy
467482|NCT01566890|Regadenoson|regadenoson
466194|NCT01572376|Pressure ulcers|pressure ulcers
466195|NCT01572376|Chronic wounds|chronic wounds
466196|NCT01572376|Spinal cord injury patients|spinal cord injury patients
466197|NCT01572376|Bone marrow|bone marrow
466198|NCT01572376|Mononuclear|mononuclear
466199|NCT01572376|Debridement|debridement
466200|NCT01572363|Fontan|fontan
466201|NCT01572363|Cardiac magnetic resonance imaging|cardiac magnetic resonance imaging
466202|NCT01572363|Sildenafil|sildenafil
466203|NCT01572337|NIV|niv
466204|NCT01572337|acute respiratory failure|acute respiratory failure
466205|NCT01572337|hypoxia|hypoxia
466206|NCT01572337|hypercapnia|hypercapnia
466207|NCT01572337|non-invasive ventilation|non-invasive ventilation
466208|NCT01572337|hospital ward|hospital ward
466209|NCT01572324|Cholangiocarcinoma|cholangiocarcinoma
466210|NCT01572324|gallbladder cancer|gallbladder cancer
466211|NCT01572324|Infusions|infusions
466212|NCT01572324|Intra-Arterial|intra-arterial
466213|NCT01572311|Aerobic exercise|aerobic exercise
466214|NCT01572311|Cognition|cognition
466215|NCT01572311|Dual Task|dual task
466216|NCT01572311|Gait Training|gait training
466217|NCT01572311|Group-based exercise|group-based exercise
466218|NCT01572311|Older adults|older adults
466219|NCT01572285|Hemiplegic|hemiplegic
466220|NCT01572285|Shoulder Pain|shoulder pain
466221|NCT01572285|Transforaminal|transforaminal
466222|NCT01572285|Treatment|treatment
466223|NCT01572285|Interventional|interventional
466224|NCT01572272|Distal Capnography|distal capnography
466225|NCT01572272|CO2|co2
466226|NCT01572272|neonates|neonates
466227|NCT01572272|conventional ventilation|conventional ventilation
466228|NCT01572246|electrosurgery|electrosurgery
466229|NCT01572246|Cardiac surgical procedures|cardiac surgical procedures
466230|NCT01572246|Surgical procedures, operative|surgical procedures, operative
466231|NCT01572246|Defibrillators|defibrillators
466232|NCT01572233|Fatigue,Physical Activity,Hepatitis C Virus Infection|fatigue,physical activity,hepatitis c virus infection
466233|NCT01572220|Hospitalized patients|hospitalized patients
466234|NCT01572207|Multiple Sclerosis|multiple sclerosis
466235|NCT01572207|Exercise|exercise
466236|NCT01572207|Physical activity|physical activity
466237|NCT01572207|Quality of life|quality of life
466238|NCT01572194|CF|cf
466239|NCT01572168|Fatigue|fatigue
466240|NCT01572142|Parkinson disease|parkinson disease
466241|NCT01572142|smell|smell
466242|NCT01572142|cognitive|cognitive
466243|NCT01572116|sufentanil|sufentanil
466244|NCT01572116|irreversible pulpitis|irreversible pulpitis
466245|NCT01572116|intra ligament injection|intra ligament injection
466246|NCT01572090|Body mass index|body mass index
466247|NCT01572090|Body fat|body fat
466248|NCT01572090|Obesity|obesity
466249|NCT01572090|Bariatric surgery|bariatric surgery
466250|NCT01572090|Conventional dietary treatment|conventional dietary treatment
466251|NCT01572090|Diabetes Mellitus, Type 2|diabetes mellitus, type 2
466252|NCT01572090|Cardiometabolic risk factors|cardiometabolic risk factors
466253|NCT01572090|Inflammation|inflammation
466254|NCT01572090|Adipokines|adipokines
466255|NCT01572090|Gastrointestinal hormones|gastrointestinal hormones
466256|NCT01572090|Comorbidity improvement|comorbidity improvement
466257|NCT01572090|Energy intake|energy intake
466258|NCT01572090|Energy expenditure|energy expenditure
466259|NCT01572090|Physical activity|physical activity
466260|NCT01572064|MRI|mri
466261|NCT01572064|liver biopsy|liver biopsy
466262|NCT01572064|serological markers|serological markers
466263|NCT01572051|osteoarthritis|osteoarthritis
466264|NCT01572051|knee osteoarthritis|knee osteoarthritis
466265|NCT01572051|education|education
466266|NCT01572012|Pharmacokinetics|pharmacokinetics
466267|NCT01572012|Safety|safety
466268|NCT01572012|Healthy Volunteers|healthy volunteers
466269|NCT01572012|tolerability|tolerability
466270|NCT01571999|pharmacokinetics|pharmacokinetics
466271|NCT01571999|GW642444|gw642444
466272|NCT01571999|GSK573719|gsk573719
466273|NCT01571999|vilanterol|vilanterol
466274|NCT01571999|renal impairment|renal impairment
466275|NCT01571999|safety|safety
466276|NCT01571999|COPD|copd
466277|NCT01571986|NIV|niv
466278|NCT01571986|acute respiratory failure|acute respiratory failure
466279|NCT01571986|hypoxia|hypoxia
466280|NCT01571986|hypercapnia|hypercapnia
466281|NCT01571986|non-invasive ventilation|non-invasive ventilation
466282|NCT01571986|hospital ward|hospital ward
466283|NCT01571973|pharmaceutical care|pharmaceutical care
466284|NCT01571973|depression|depression
466285|NCT01571973|compliance|compliance
466286|NCT01571973|pharmacist's intervention|pharmacist's intervention
466287|NCT01571973|Dáder|dáder
466288|NCT01571947|Insulinaemia|insulinaemia
466289|NCT01571947|inflammatory markers|inflammatory markers
466290|NCT01571947|gastrointestinal peptides|gastrointestinal peptides
466291|NCT01571947|SFA|sfa
466292|NCT01571947|dietary fats|dietary fats
466293|NCT01571947|carbohydrate|carbohydrate
466294|NCT01571947|insulin sensitivity|insulin sensitivity
466295|NCT01571934|Hemophilia A|hemophilia a
466296|NCT01571908|rocuronium|rocuronium
466297|NCT01571908|succinylcholine|succinylcholine
466298|NCT01571908|magnesiumsulphate|magnesiumsulphate
466299|NCT01571908|intubation conditions|intubation conditions
466300|NCT01571895|Autoimmune inflammatory blistering disorder|autoimmune inflammatory blistering disorder
466301|NCT01571882|Plant sterol - Policosanols - Hypercholesterolemia - Dairy|plant sterol - policosanols - hypercholesterolemia - dairy
466302|NCT01571869|Plant sterol - hypercholesterolemia - dairy - meal|plant sterol - hypercholesterolemia - dairy - meal
466303|NCT01571856|Acute Diarrhea|acute diarrhea
466304|NCT01571856|Zinc|zinc
466305|NCT01571856|Children|children
466306|NCT01571843|Hyperparathyroidism, Primary|hyperparathyroidism, primary
466307|NCT01571843|Bone Diseases, Metabolic|bone diseases, metabolic
466308|NCT01571843|Osteoporosis, Postmenopausal|osteoporosis, postmenopausal
466309|NCT01571843|Bone Loss, Postmenopausal|bone loss, postmenopausal
466310|NCT01571830|food allergy|food allergy
466311|NCT01571830|nutrient intake|nutrient intake
466312|NCT01571830|growth|growth
466313|NCT01571817|Insulin Dependent|insulin dependent
466314|NCT01571804|Anesthesia|anesthesia
466315|NCT01571804|pregabalin|pregabalin
466316|NCT01571804|sevoflurane|sevoflurane
466317|NCT01571804|laparoscopic cholecystectomy|laparoscopic cholecystectomy
466318|NCT01571791|Ketorolac|ketorolac
466319|NCT01571791|lidocaine|lidocaine
466320|NCT01571791|valvular hear diseases|valvular hear diseases
466321|NCT01571791|cesarean section|cesarean section
466322|NCT01571778|Hand Hygiene|hand hygiene
466323|NCT01571778|Non-sterile Glove Use|non-sterile glove use
466324|NCT01571765|maternal|maternal
466325|NCT01571765|newborn|newborn
466326|NCT01571765|child|child
466327|NCT01571752|Drug Abuse|drug abuse
466328|NCT01571752|Ecological Momentary Assessment (EMA)|ecological momentary assessment (ema)
466329|NCT01571752|Environment|environment
466330|NCT01571752|Genetic|genetic
466331|NCT01571752|Longitudinal|longitudinal
466332|NCT01571752|Drug Dependence|drug dependence
466333|NCT01571739|Biomarker|biomarker
466334|NCT01571739|Latent Tuberculosis|latent tuberculosis
466335|NCT01571739|IGRA|igra
466336|NCT01571739|Isoniazid|isoniazid
466337|NCT01571739|TB Lymphadenopathy|tb lymphadenopathy
466338|NCT01571739|Tuberculosis|tuberculosis
466339|NCT01571739|TB|tb
466340|NCT01571726|(18)-Fluciclatide PET/CT|(18)-fluciclatide pet/ct
466341|NCT01571726|Serum M-Protein|serum m-protein
466342|NCT01571726|Percentage of Plasma Cells in the Bone Marrow|percentage of plasma cells in the bone marrow
466343|NCT01571726|Ratio of Normal/Abnormal Percentage of Plasma Cells in the Bone Marrow|ratio of normal/abnormal percentage of plasma cells in the bone marrow
466344|NCT01571726|Multiple Myeloma|multiple myeloma
466345|NCT01571700|Mechanical Dysynchrony|mechanical dysynchrony
466346|NCT01571700|Electrical Dysynchrony|electrical dysynchrony
466347|NCT01571687|expedition|expedition
466348|NCT01571687|hypoxia|hypoxia
466349|NCT01571687|blood coagulation disorders|blood coagulation disorders
466350|NCT01571687|cell-derived microparticles|cell-derived microparticles
466351|NCT01571687|oxidative stress|oxidative stress
466352|NCT01571687|N-Acetylcystein|n-acetylcystein
466353|NCT01571687|vitamins|vitamins
466354|NCT01571674|Cervical|cervical
466355|NCT01571674|Clinical Prediction Rule|clinical prediction rule
466356|NCT01571674|Exercise|exercise
466357|NCT01571674|Manipulation|manipulation
466358|NCT01571674|Manual therapy|manual therapy
466359|NCT01571674|Mobilization|mobilization
466360|NCT01571674|Physical Therapy|physical therapy
466361|NCT01571674|Prognosis|prognosis
466362|NCT01571674|Shoulder pain|shoulder pain
466363|NCT01571674|Thoracic|thoracic
466364|NCT01571661|KGT-1142|kgt-1142
466365|NCT01571661|safety|safety
466366|NCT01571661|pharmacokinetics|pharmacokinetics
466367|NCT01571661|single-dose escalation|single-dose escalation
466368|NCT01571661|tolerability|tolerability
466369|NCT01571635|Beta-Thalassaemia|beta-thalassaemia
466370|NCT01571622|Whey protein|whey protein
466371|NCT01571622|type 2 diabetes|type 2 diabetes
466372|NCT01571596|XLH|xlh
466373|NCT01571583|Chronic HCV infection|chronic hcv infection
466374|NCT01571583|Genotype 1 chronic HCV|genotype 1 chronic hcv
466375|NCT01571583|Liver transplantation|liver transplantation
466376|NCT01571583|Hepatitis C|hepatitis c
466377|NCT01571583|Hep C|hep c
466378|NCT01571583|HCV|hcv
466379|NCT01571583|Telaprevir|telaprevir
466380|NCT01571583|Pegylated-Interferon-alfa-2a|pegylated-interferon-alfa-2a
466381|NCT01571583|Ribavirin|ribavirin
466382|NCT01571570|Healthy volunteers|healthy volunteers
466383|NCT01571570|Food effect|food effect
466384|NCT01571570|Capsule|capsule
466385|NCT01571570|Formulations|formulations
466386|NCT01571570|Liquid formulation|liquid formulation
466387|NCT01571570|Concept K|concept k
466388|NCT01571570|Concept L|concept l
466389|NCT01571570|Oral suspension|oral suspension
466390|NCT01571570|Oral solution|oral solution
466391|NCT01571570|TMC435HPC1002|tmc435hpc1002
466392|NCT01571570|TMC435|tmc435
466393|NCT01571570|HPC|hpc
466394|NCT01571518|G-CSF|g-csf
466395|NCT01571518|neutropenia|neutropenia
466396|NCT01571518|TAC|tac
466397|NCT01571505|Oral vaccines|oral vaccines
466398|NCT01571505|Vaccine Responsiveness|vaccine responsiveness
466399|NCT01571505|Tropical Enteropathy|tropical enteropathy
466400|NCT01571492|Postoperative Pain|postoperative pain
466401|NCT01571492|Nerve block|nerve block
466402|NCT01571492|Total Hip Arthroplasty|total hip arthroplasty
466403|NCT01571492|Postoperative analgesia|postoperative analgesia
466404|NCT01571492|Lumbar Plexus Catheters|lumbar plexus catheters
466405|NCT01571492|L2 Paravertebral Catheters|l2 paravertebral catheters
466406|NCT01571479|laparoscopic cholecystectomy|laparoscopic cholecystectomy
466407|NCT01571479|mini-instrument|mini-instrument
466408|NCT01571466|HIV Seronegativity|hiv seronegativity
466409|NCT01571466|HIV Preventive Vaccine|hiv preventive vaccine
466410|NCT01571453|MDD|mdd
466411|NCT01571440|Bone|bone
466412|NCT01571440|adolescents|adolescents
466413|NCT01571440|fiber|fiber
466414|NCT01571440|healthy|healthy
466415|NCT01571440|boys|boys
466416|NCT01571440|girls|girls
466417|NCT01571440|camp|camp
466418|NCT01571440|calcium|calcium
466419|NCT01571427|Behavioral intervention|behavioral intervention
466420|NCT01571427|Social engagement|social engagement
466421|NCT01571427|Conversational engagement|conversational engagement
466422|NCT01571427|Social network|social network
466423|NCT01571427|Cognitive Reserve|cognitive reserve
466424|NCT01571427|Alzheimer's disease|alzheimer's disease
466425|NCT01571401|Kidney cancer survivors|kidney cancer survivors
466426|NCT01571401|Randomized Controlled Trial|randomized controlled trial
466427|NCT01571401|Physical Activity|physical activity
466428|NCT01571401|Theory of Planned Behaviour|theory of planned behaviour
466429|NCT01571401|Quality of life|quality of life
466430|NCT01571388|dacomitinib|dacomitinib
466431|NCT01571388|PF-00299804|pf-00299804
466432|NCT01571388|hepatic impairment|hepatic impairment
466433|NCT01571388|pharmacokinetics|pharmacokinetics
466434|NCT01571375|Traumatic Brain Injury|traumatic brain injury
466435|NCT01571375|HEMS|hems
466436|NCT01571375|Out-of-hospital|out-of-hospital
466437|NCT01571375|Finland|finland
466438|NCT01571362|oxycodone|oxycodone
466439|NCT01571362|naltrexone|naltrexone
466440|NCT01571362|chronic pain|chronic pain
466441|NCT01571362|low back pain|low back pain
466442|NCT01571349|rebalanced hemostasis|rebalanced hemostasis
466443|NCT01571349|idiopathic thrombocytopenic purpura|idiopathic thrombocytopenic purpura
466444|NCT01571349|coagulation status|coagulation status
466445|NCT01571323|post partum haemorrhage at cesarean section|post partum haemorrhage at cesarean section
466446|NCT01571297|Diabetes Mellitus|diabetes mellitus
466447|NCT01571297|Delayed Gastric Emptying|delayed gastric emptying
466448|NCT01571297|Gastroparesis|gastroparesis
466449|NCT01571297|Gastrointestinal Motility Disorder|gastrointestinal motility disorder
466450|NCT01571271|biliary|biliary
466451|NCT01571271|lithotripsy|lithotripsy
466452|NCT01571271|gall stones|gall stones
466453|NCT01571271|bile duct|bile duct
466454|NCT01571271|Biliary stones|biliary stones
466455|NCT01571258|SMS|sms
466456|NCT01571258|Obesity|obesity
466457|NCT01571258|Text Messaging|text messaging
466458|NCT01571258|Intervention|intervention
466459|NCT01571258|Mobile Phone|mobile phone
466460|NCT01571245|Heart rate variability|heart rate variability
466461|NCT01571245|Attentional Bias|attentional bias
466462|NCT01571232|Macular Edema|macular edema
595165|NCT01037556|AML|aml
466463|NCT01571232|DME|dme
466464|NCT01571232|PDR|pdr
466465|NCT01571232|NPDR|npdr
466466|NCT01571232|Ozurdex|ozurdex
466467|NCT01571232|Dexamethasone|dexamethasone
466468|NCT01571232|Avastin|avastin
466469|NCT01571232|Bevacizumab|bevacizumab
466470|NCT01571219|RA|ra
466471|NCT01571219|Biosimilar|biosimilar
466472|NCT01571206|AS|as
466473|NCT01571206|Biosimilar|biosimilar
466474|NCT01571180|Obesity|obesity
466475|NCT01571180|Gastric bypass|gastric bypass
466476|NCT01571180|Medication|medication
466477|NCT01571180|Medication counseling|medication counseling
466478|NCT01571180|Dietary pattern|dietary pattern
466479|NCT01571180|Follow-up of patients|follow-up of patients
466480|NCT01571167|Methamphetamine|methamphetamine
466481|NCT01571167|Chantix|chantix
466482|NCT01571167|Varenicline|varenicline
466483|NCT01571141|HPV|hpv
466484|NCT01571141|polyhexamethylene biguanide|polyhexamethylene biguanide
466485|NCT01571141|intraepithelial lesions|intraepithelial lesions
466486|NCT01571141|regression rate|regression rate
466487|NCT01571128|HIV|hiv
466488|NCT01571128|Prevention & Control|prevention & control
466489|NCT01571128|Intervention Studies|intervention studies
466490|NCT01571128|Adolescent|adolescent
466491|NCT01571128|Gender|gender
466492|NCT01571128|Combination prevention|combination prevention
466493|NCT01571128|Pre-Exposure Prophylaxis|pre-exposure prophylaxis
466494|NCT01571128|Cash Transfer|cash transfer
466495|NCT01571128|Medical Male Circumcision|medical male circumcision
466496|NCT01571128|HIV Testing|hiv testing
466497|NCT01571128|Mobile Health|mobile health
466498|NCT01571115|insomnia|insomnia
466499|NCT01571115|resistance physical exercise|resistance physical exercise
466500|NCT01571115|stretching|stretching
466501|NCT01571089|Dialectical behavior therapy|dialectical behavior therapy
466502|NCT01571089|cognitive behavioral therapy|cognitive behavioral therapy
467579|NCT01566448|Mucositis|mucositis
466503|NCT01571089|emotion regulation|emotion regulation
466504|NCT01571089|emotion dysregulation|emotion dysregulation
466505|NCT01571089|anxiety disorders|anxiety disorders
466506|NCT01571089|skills training|skills training
466507|NCT01571076|PGS|pgs
466508|NCT01571076|CGH|cgh
466509|NCT01571076|Aneuploidy|aneuploidy
466510|NCT01571076|Advanced maternal age|advanced maternal age
466511|NCT01571076|Male factor|male factor
466512|NCT01571050|toothpastes|toothpastes
466513|NCT01571050|dental fluorosis|dental fluorosis
466514|NCT01571050|fluoride|fluoride
466515|NCT01571050|bioavailability|bioavailability
466639|NCT01570556|Hemodialysis|hemodialysis
466516|NCT01571037|mechanical circulatory assist device|mechanical circulatory assist device
466517|NCT01571024|FOLFOX6|folfox6
466518|NCT01571024|BKM120|bkm120
466519|NCT01571024|Advanced Solid Tumors|advanced solid tumors
466520|NCT01571024|Metastatic|metastatic
466521|NCT01571024|Colorectal Cancer|colorectal cancer
466522|NCT01571024|Pancreatic Cancer|pancreatic cancer
466523|NCT01571011|Adolescent|adolescent
466524|NCT01571011|Randomized Trial|randomized trial
466525|NCT01571011|Internet|internet
466526|NCT01571011|Depressive Disorder|depressive disorder
466527|NCT01571011|Primary Care|primary care
466528|NCT01571011|Prevention|prevention
466529|NCT01570985|shoulder capsulitis|shoulder capsulitis
466530|NCT01570985|frozen shoulder|frozen shoulder
466531|NCT01570985|adhesive capsulitis|adhesive capsulitis
466532|NCT01570985|distension|distension
466533|NCT01570985|corticosteroid injection|corticosteroid injection
466534|NCT01570985|intraarticular injection|intraarticular injection
466535|NCT01570972|schizophrenia|schizophrenia
466536|NCT01570972|schizoaffective disorder|schizoaffective disorder
466537|NCT01570972|bipolar disorder with psychotic features|bipolar disorder with psychotic features
466538|NCT01570972|major depression with psychotic features|major depression with psychotic features
466539|NCT01570972|recent-onset psychosis|recent-onset psychosis
466540|NCT01570972|first-episode psychosis|first-episode psychosis
466541|NCT01570972|cognitive behavioral therapy|cognitive behavioral therapy
466542|NCT01570972|multifamily group psychoeducation|multifamily group psychoeducation
466543|NCT01570946|Lifestyle changes to prevent type 2 diabetes|lifestyle changes to prevent type 2 diabetes
466544|NCT01570933|cardio-pulmonary bypass|cardio-pulmonary bypass
466545|NCT01570920|Activity limitations|activity limitations
466546|NCT01570920|restriction of participation|restriction of participation
466547|NCT01570920|chronic stroke survival|chronic stroke survival
466548|NCT01570920|physical activity|physical activity
466549|NCT01570920|walking|walking
466550|NCT01570881|postoperative delirium|postoperative delirium
466551|NCT01570881|melatonin|melatonin
466552|NCT01570881|sevoflurane|sevoflurane
466553|NCT01570868|Leukemia|leukemia
466554|NCT01570868|Chronic Myeloid Leukemia|chronic myeloid leukemia
466555|NCT01570868|CML|cml
466556|NCT01570868|Chronic Phase|chronic phase
466557|NCT01570868|Cytogenetic response|cytogenetic response
466558|NCT01570868|CCyR|ccyr
466559|NCT01570868|Major molecular response|major molecular response
466560|NCT01570868|MMR|mmr
466561|NCT01570868|Complete molecular response|complete molecular response
466562|NCT01570868|CMR|cmr
466563|NCT01570868|Ponatinib|ponatinib
466564|NCT01570868|AP24534|ap24534
466565|NCT01570855|Lung cancer|lung cancer
466566|NCT01570855|chemosensitivity|chemosensitivity
466567|NCT01570842|Gastroesophageal reflux disease|gastroesophageal reflux disease
466568|NCT01570842|GERD|gerd
466569|NCT01570842|Barrett's esophagus|barrett's esophagus
466570|NCT01570816|stroke|stroke
466571|NCT01570816|partial paralysis|partial paralysis
466572|NCT01570816|gait correction|gait correction
466573|NCT01570816|functional electrical stimulation|functional electrical stimulation
466574|NCT01570816|paraplegia|paraplegia
466575|NCT01570816|tetraplegia|tetraplegia
466576|NCT01570816|spinal cord injury|spinal cord injury
466577|NCT01570803|peripheral arterial disease,|peripheral arterial disease,
466578|NCT01570803|atherosclerosis,|atherosclerosis,
466579|NCT01570803|nitinol,|nitinol,
466580|NCT01570803|stents|stents
466581|NCT01570777|Resistant hypertension|resistant hypertension
466582|NCT01570777|Renal denervation|renal denervation
466583|NCT01570777|Standardized medication regimen|standardized medication regimen
466584|NCT01570777|Endovascular|endovascular
466585|NCT01570777|Primary hypertension|primary hypertension
466586|NCT01570777|Cardiovascular diseases|cardiovascular diseases
466587|NCT01570777|Vascular diseases|vascular diseases
466588|NCT01570764|Systemic sclerosis|systemic sclerosis
466589|NCT01570764|Interstitial lung disease|interstitial lung disease
466590|NCT01570764|Worsening|worsening
466591|NCT01570764|Cyclophosphamide|cyclophosphamide
466592|NCT01570764|Intravenous|intravenous
466593|NCT01570738|sleep disorders|sleep disorders
466594|NCT01570738|sleep apnea|sleep apnea
466595|NCT01570738|ambulatory device|ambulatory device
466596|NCT01570738|polysomnography|polysomnography
466597|NCT01570738|WatchPAT|watchpat
466598|NCT01570725|Immersive virtual reality|immersive virtual reality
466599|NCT01570725|e-health|e-health
466600|NCT01570725|surgery|surgery
466601|NCT01570725|anxiety|anxiety
466603|NCT01570725|Patients who undergo ambulatory surgical operations|patients who undergo ambulatory surgical operations
466604|NCT01570699|Cross-sectional observational study|cross-sectional observational study
466605|NCT01570699|COMT polymorphism|comt polymorphism
466606|NCT01570699|Opiate-users|opiate-users
466607|NCT01570699|Opiate dependence|opiate dependence
466608|NCT01570686|Food effect, hypertension, aliskiren|food effect, hypertension, aliskiren
466609|NCT01570673|quality of life|quality of life
466610|NCT01570673|urinary bladder|urinary bladder
466611|NCT01570673|symptoms|symptoms
466612|NCT01570673|children|children
466613|NCT01570634|Clostridium difficile|clostridium difficile
466614|NCT01570634|infection|infection
466615|NCT01570634|diarrhea|diarrhea
466616|NCT01570634|cramping|cramping
466617|NCT01570621|achalasia|achalasia
466618|NCT01570621|peroral endoscopic myotomy|peroral endoscopic myotomy
466619|NCT01570621|LES pressure|les pressure
466620|NCT01570621|postoperative complication|postoperative complication
466621|NCT01570621|symptom relief|symptom relief
466622|NCT01570621|esophageal barium|esophageal barium
466623|NCT01570608|Ranibizumab|ranibizumab
466624|NCT01570608|Bevacizumab|bevacizumab
466625|NCT01570608|Verteporfin|verteporfin
466626|NCT01570608|age-related macular degeneration|age-related macular degeneration
466627|NCT01570595|Tobacco Use Cessation|tobacco use cessation
466628|NCT01570595|Tobacco Cessation|tobacco cessation
466629|NCT01570595|Tobacco Use Disorder|tobacco use disorder
466630|NCT01570595|Tobacco Dependence|tobacco dependence
466631|NCT01570595|Tobacco-Use Disorder|tobacco-use disorder
466632|NCT01570595|Virus, Human Immunodeficiency|virus, human immunodeficiency
466633|NCT01570582|recurrent ovarian|recurrent ovarian
466634|NCT01570582|ECG|ecg
466635|NCT01570582|GOG performance|gog performance
466636|NCT01570582|Hematologic g|hematologic g
466637|NCT01570582|Blood chemistry and urinalysis h|blood chemistry and urinalysis h
466638|NCT01570569|Volunteers|volunteers
466640|NCT01570556|Inflammation|inflammation
466641|NCT01570556|Bacteriuria|bacteriuria
466642|NCT01570556|Interleukin 6|interleukin 6
466643|NCT01570556|C reactive protein|c reactive protein
466644|NCT01570543|implants|implants
466645|NCT01570543|knee implants|knee implants
466646|NCT01570543|hip implants|hip implants
466647|NCT01570543|metallic implants|metallic implants
466648|NCT01570504|Strongyloidiasis|strongyloidiasis
466649|NCT01570504|Strongyloides stercoralis|strongyloides stercoralis
466650|NCT01570504|Ivermectin|ivermectin
466651|NCT01570465|AML|aml
466652|NCT01570465|adult|adult
466653|NCT01570465|AML1310 GIMEMA study|aml1310 gimema study
466654|NCT01570452|matrilysin|matrilysin
466655|NCT01570452|MMP-7|mmp-7
466656|NCT01570452|colorectal cancer|colorectal cancer
466657|NCT01570452|adenoma|adenoma
466658|NCT01570452|lymph nodes|lymph nodes
466659|NCT01570426|Bipolar disorder|bipolar disorder
466660|NCT01570426|Mood disorders|mood disorders
466661|NCT01570426|ADHD|adhd
466662|NCT01570426|Attention Deficit Disorder with Hyperactivity|attention deficit disorder with hyperactivity
466663|NCT01570426|Attention Deficit Disorder without Hyperactivity|attention deficit disorder without hyperactivity
466664|NCT01570426|Anxiety disorders|anxiety disorders
466665|NCT01570426|Generalized anxiety disorder|generalized anxiety disorder
466666|NCT01570426|Magnetic resonance imaging|magnetic resonance imaging
466667|NCT01570426|Mental disorders|mental disorders
466668|NCT01570426|Mental disorders diagnosed in childhood|mental disorders diagnosed in childhood
466669|NCT01570426|affective neuroscience|affective neuroscience
466670|NCT01570426|emotion|emotion
466671|NCT01570426|MRI|mri
466672|NCT01570426|fMRI|fmri
466673|NCT01570426|neurocognitive tasks|neurocognitive tasks
466674|NCT01570426|imaging|imaging
466675|NCT01570426|Healthy controls|healthy controls
466676|NCT01570426|typical development|typical development
466677|NCT01570400|social phobia|social phobia
466678|NCT01570400|social anxiety|social anxiety
466679|NCT01570400|cognitive bias modification|cognitive bias modification
466680|NCT01570374|Cognitive behavioral therapy|cognitive behavioral therapy
466681|NCT01570374|Internet|internet
466682|NCT01570374|Anxiety|anxiety
466683|NCT01570374|Generalized anxiety disorder|generalized anxiety disorder
466684|NCT01570361|Atrial Fibrillation|atrial fibrillation
466685|NCT01570361|Arrhythmias, Cardiac|arrhythmias, cardiac
466686|NCT01570361|Heart Diseases|heart diseases
466687|NCT01570361|Cardiovascular Diseases|cardiovascular diseases
466688|NCT01570361|Pathologic Processes|pathologic processes
466689|NCT01570348|Crohn's Disease|crohn's disease
466690|NCT01570348|Allogeneic bone marrow transplantation|allogeneic bone marrow transplantation
466691|NCT01570348|Hematopoietic cell transplantation|hematopoietic cell transplantation
466692|NCT01570335|SBAR,|sbar,
466693|NCT01570335|SAQ,|saq,
466694|NCT01570335|Team Resource Management|team resource management
466695|NCT01570322|Dementia - Alzheimer - Quality of life|dementia - alzheimer - quality of life
466696|NCT01570309|vitamin D,|vitamin d,
466697|NCT01570309|vitamin D deficiency|vitamin d deficiency
466698|NCT01570309|coronary artery disease|coronary artery disease
466699|NCT01570309|ergocalciferol|ergocalciferol
467781|NCT01565616|HLA|hla
466700|NCT01570309|endothelial function|endothelial function
466701|NCT01570309|adhesion molecules|adhesion molecules
466702|NCT01570309|inflammation|inflammation
466703|NCT01570309|IL-12|il-12
466704|NCT01570309|interferon-gamma|interferon-gamma
466705|NCT01570309|CXCL-10|cxcl-10
466706|NCT01570309|reactive hyperemia peripheral arterial tonometry|reactive hyperemia peripheral arterial tonometry
466707|NCT01570309|endothelial dysfunction|endothelial dysfunction
466708|NCT01570309|cytokines|cytokines
466709|NCT01570309|chemokines|chemokines
466710|NCT01570296|Advanced Non-Small Cell Lung Cancer|advanced non-small cell lung cancer
466711|NCT01570296|tumors harbor molecular|tumors harbor molecular
466712|NCT01570296|alterations of PI3K pathway|alterations of pi3k pathway
466713|NCT01570296|known to overexpress EGFR|known to overexpress egfr
466714|NCT01570283|post allogeneic hematopoietic stem cell transplant|post allogeneic hematopoietic stem cell transplant
466715|NCT01570283|cytotoxic T lymphocytes|cytotoxic t lymphocytes
466716|NCT01570283|Cytomegalovirus|cytomegalovirus
466717|NCT01570283|CMV|cmv
466718|NCT01570283|adenovirus|adenovirus
466719|NCT01570283|Epstein-Barr virus|epstein-barr virus
466720|NCT01570283|EBV|ebv
466721|NCT01570283|Human polyomavirus type I|human polyomavirus type i
466722|NCT01570283|BK virus|bk virus
466723|NCT01570283|Human herpesvirus 6|human herpesvirus 6
466724|NCT01570283|HHV6|hhv6
466725|NCT01570270|Hypercholesterolemia|hypercholesterolemia
466726|NCT01570270|Endocannabinoids|endocannabinoids
466727|NCT01570257|normal pressure hydrocephalus|normal pressure hydrocephalus
466728|NCT01570257|ventriculoperitoneal shunt|ventriculoperitoneal shunt
466729|NCT01570257|overdrainage|overdrainage
466730|NCT01570257|subdural effusion|subdural effusion
466731|NCT01570231|remote ischemic preconditioning|remote ischemic preconditioning
466732|NCT01570231|octogenarian|octogenarian
466733|NCT01570231|intracranial arterial stenosis|intracranial arterial stenosis
466734|NCT01570231|stroke recurrence|stroke recurrence
466735|NCT01570218|breast cancer|breast cancer
466736|NCT01570218|gynecological cancer|gynecological cancer
466737|NCT01570218|radiotherapy|radiotherapy
466738|NCT01570218|fatigue|fatigue
466739|NCT01570218|musicotherapy|musicotherapy
466740|NCT01570192|gram negative pathogens|gram negative pathogens
466741|NCT01570192|Pseudomonas aeruginosa|pseudomonas aeruginosa
466742|NCT01570192|Acinetobacter|acinetobacter
466743|NCT01570192|HCAP|hcap
466744|NCT01570192|VABP|vabp
466745|NCT01570192|HABP|habp
466746|NCT01570179|bariatric surgery|bariatric surgery
466747|NCT01570179|residual paralysis|residual paralysis
466748|NCT01570179|surgical conditions|surgical conditions
466749|NCT01570166|Hepatocellular Carcinoma|hepatocellular carcinoma
466750|NCT01570166|RFA|rfa
466751|NCT01570166|HR|hr
466752|NCT01570127|Individualized Acupuncture|individualized acupuncture
466753|NCT01570127|Standardized Acupuncture|standardized acupuncture
466754|NCT01570127|Low Back Pain|low back pain
466755|NCT01570127|Randomized Controlled Trial|randomized controlled trial
466756|NCT01570114|Covered metallic stent|covered metallic stent
466757|NCT01570114|colon|colon
466758|NCT01570114|benign stricture|benign stricture
466759|NCT01570075|Hepatocellular Carcinoma|hepatocellular carcinoma
466760|NCT01570075|RFA|rfa
466761|NCT01570075|HR|hr
466762|NCT01570062|Inflammation|inflammation
466763|NCT01570062|Pathologic Processes|pathologic processes
466764|NCT01570049|Single arm|single arm
466765|NCT01570049|Open label|open label
466766|NCT01570049|Bendamustine HCl|bendamustine hcl
466767|NCT01570049|Non-hodgkin's lymphoma|non-hodgkin's lymphoma
466768|NCT01570036|stage I breast cancer|stage i breast cancer
466769|NCT01570036|stage II breast cancer|stage ii breast cancer
466770|NCT01570036|stage IIIA breast cancer|stage iiia breast cancer
466771|NCT01570036|stage IIIB breast cancer|stage iiib breast cancer
466772|NCT01570036|stage IIIC breast cancer|stage iiic breast cancer
466773|NCT01570036|male breast cancer|male breast cancer
466774|NCT01570023|Deglutition|deglutition
466775|NCT01570023|Exercise|exercise
466776|NCT01569997|Dementia|dementia
466777|NCT01569997|emergency hospitalization|emergency hospitalization
466778|NCT01569997|nursing home|nursing home
466779|NCT01569997|multidisciplinary meeting|multidisciplinary meeting
466780|NCT01569997|cognitive decline|cognitive decline
466781|NCT01569997|disability|disability
466782|NCT01569997|residents|residents
466783|NCT01569997|facilities|facilities
466784|NCT01569997|long term care unit|long term care unit
466785|NCT01569997|health policy|health policy
466786|NCT01569997|general practitioner|general practitioner
466787|NCT01569997|prevention|prevention
466788|NCT01569984|Colorectal|colorectal
466789|NCT01569971|Transition Program|transition program
466790|NCT01569971|Perspectives|perspectives
466791|NCT01569932|chemobrain, chemotherapy, cognitive impairments, fcMRI, neurocognitive Assessments|chemobrain, chemotherapy, cognitive impairments, fcmri, neurocognitive assessments
466792|NCT01569919|Phase II|phase ii
466793|NCT01569919|Single arm|single arm
466794|NCT01569919|Vaccine|vaccine
466795|NCT01569906|Atopic Dermatitis|atopic dermatitis
466796|NCT01569893|Telemonitoring|telemonitoring
466797|NCT01569893|Telemedicine|telemedicine
466798|NCT01569893|Diabetes mellitus|diabetes mellitus
466799|NCT01569880|Blood gas response|blood gas response
466800|NCT01569880|Exercise|exercise
466801|NCT01569880|Gas exchange|gas exchange
466802|NCT01569880|Hypoxia altitude simulation test|hypoxia altitude simulation test
466803|NCT01569880|Pulmonary function|pulmonary function
466804|NCT01569828|LCZ696|lcz696
466805|NCT01569828|pharmacokinetics|pharmacokinetics
466806|NCT01569815|Renal Impairment,|renal impairment,
466807|NCT01569815|LCZ696|lcz696
466808|NCT01569802|breast cancer screening|breast cancer screening
466809|NCT01569802|tomosynthesis|tomosynthesis
466810|NCT01569802|FFDM|ffdm
466811|NCT01569789|cytokines|cytokines
466812|NCT01569789|inflammation|inflammation
466813|NCT01569789|vagus nerve|vagus nerve
466814|NCT01569789|TNF|tnf
466815|NCT01569776|Cow milk allergy|cow milk allergy
466816|NCT01569776|CMA|cma
466817|NCT01569763|endometrial ablation|endometrial ablation
466818|NCT01569750|CD20-positive B-cell non-Hodgkin lymphoma|cd20-positive b-cell non-hodgkin lymphoma
466819|NCT01569750|Diffuse large B-cell lymphoma|diffuse large b-cell lymphoma
466820|NCT01569750|Mantle cell lymphoma|mantle cell lymphoma
466821|NCT01569750|Follicular lymphoma|follicular lymphoma
466822|NCT01569750|Ibrutinib|ibrutinib
466823|NCT01569750|R-CHOP|r-chop
466824|NCT01569750|Rituximab|rituximab
466825|NCT01569750|Cyclophosphamide|cyclophosphamide
466826|NCT01569750|Doxorubicin|doxorubicin
466827|NCT01569750|Vincristine|vincristine
466828|NCT01569750|Prednisone|prednisone
466829|NCT01569737|ella|ella
466830|NCT01569737|ulipristal acetate|ulipristal acetate
466831|NCT01569737|pregnancy|pregnancy
466832|NCT01569737|emergency contraception|emergency contraception
466833|NCT01569724|hypertriglyceridemia|hypertriglyceridemia
466834|NCT01569724|bexarotene|bexarotene
466835|NCT01569711|chronic and resistant major depressive disorder|chronic and resistant major depressive disorder
466836|NCT01569711|deep brain stimulation|deep brain stimulation
466837|NCT01569698|pediatric|pediatric
466838|NCT01569698|acute renal failure|acute renal failure
466839|NCT01569698|acute extra renal replacement therapy|acute extra renal replacement therapy
466840|NCT01569698|Intermittent Hemodialysis|intermittent hemodialysis
466841|NCT01569698|Continuous Renal Replacement Therapies|continuous renal replacement therapies
466842|NCT01569698|Peritoneal Dialysis|peritoneal dialysis
466843|NCT01569685|PTSD|ptsd
466844|NCT01569685|Traumatic Stress|traumatic stress
466845|NCT01569685|Depressions|depressions
466846|NCT01569685|Refugees|refugees
466847|NCT01569672|Navigator|navigator
466848|NCT01569659|Schizophrenia|schizophrenia
466849|NCT01569659|Refractory|refractory
466850|NCT01569659|Treatment resistant|treatment resistant
466851|NCT01569659|Lurasidone|lurasidone
466852|NCT01569646|monocytes|monocytes
466853|NCT01569646|culprit vessels|culprit vessels
466854|NCT01569620|Colorectal Cancer Screening|colorectal cancer screening
466855|NCT01569620|CRC|crc
466856|NCT01569620|Screening Colonoscopy|screening colonoscopy
466857|NCT01569620|Hispanics|hispanics
466858|NCT01569620|Latinos|latinos
466859|NCT01569607|Neurophysiology|neurophysiology
466860|NCT01569607|Transcranial Magnetic Stimulation (TMS)|transcranial magnetic stimulation (tms)
466861|NCT01569607|Neurology|neurology
466862|NCT01569607|Stroke|stroke
466863|NCT01569607|Physical Medicine and Rehabilitation|physical medicine and rehabilitation
466864|NCT01569581|Human Enterovirus 71 (EV71)|human enterovirus 71 (ev71)
466865|NCT01569581|Hand, Foot and Mouth Disease (HFMD)|hand, foot and mouth disease (hfmd)
466866|NCT01569581|Inactivated Vaccine|inactivated vaccine
466867|NCT01569581|Human Diploid cell (KMB17)|human diploid cell (kmb17)
466868|NCT01569581|Adverse reactions associated with vaccine|adverse reactions associated with vaccine
466869|NCT01569581|Efficacy|efficacy
466870|NCT01569568|Neuroimaging|neuroimaging
466871|NCT01569568|MRI|mri
466872|NCT01569568|Urea cycle|urea cycle
466873|NCT01569568|hyperammonemia|hyperammonemia
466874|NCT01569568|cognitive function|cognitive function
466875|NCT01569568|ornithine transcarbamylase deficiency|ornithine transcarbamylase deficiency
466876|NCT01569516|Alzheimer's Disease|alzheimer's disease
466877|NCT01569516|Octohydroaminoacridine Succinate|octohydroaminoacridine succinate
466878|NCT01569503|Crohn's Disease|crohn's disease
466879|NCT01569503|VNS|vns
466880|NCT01569503|vagus nerve stimulation|vagus nerve stimulation
466881|NCT01569503|inflammation|inflammation
466882|NCT01569503|Inflammatory bowel diseases|inflammatory bowel diseases
466883|NCT01569503|TNF|tnf
466884|NCT01569464|Rotigotine|rotigotine
466885|NCT01569464|Restless Legs Syndrome|restless legs syndrome
466886|NCT01569464|Neupro®|neupro®
466887|NCT01569451|Multiple Sclerosis|multiple sclerosis
466888|NCT01569451|Glatiramer Acetate|glatiramer acetate
466889|NCT01569451|Rituximab|rituximab
466890|NCT01569451|Relapsing forms of Multiple Sclerosis|relapsing forms of multiple sclerosis
466891|NCT01569451|Relapsing Multiple Sclerosis|relapsing multiple sclerosis
466892|NCT01569425|PCOS|pcos
466893|NCT01569399|Alcohol dependance|alcohol dependance
466894|NCT01569399|rTMS|rtms
466895|NCT01569399|craving|craving
466896|NCT01569399|alcohol consumption|alcohol consumption
466897|NCT01569386|pulse wave velocity|pulse wave velocity
466898|NCT01569386|low intensity physical activity|low intensity physical activity
466899|NCT01569386|hemiplegia|hemiplegia
466900|NCT01569373|Allogeneic stem cell transplant|allogeneic stem cell transplant
466901|NCT01569373|Graft versus Host Disease|graft versus host disease
466903|NCT01569360|Spinal cord injury|spinal cord injury
466904|NCT01569360|Tetraplegia|tetraplegia
466905|NCT01569360|Paraplegia|paraplegia
466906|NCT01569360|Respiratory function|respiratory function
466907|NCT01569360|Corset|corset
466908|NCT01569347|Cocaine|cocaine
466909|NCT01569347|Cocaine-induced psychosis|cocaine-induced psychosis
466910|NCT01569347|Genetic|genetic
466911|NCT01569347|Clinical|clinical
466912|NCT01569347|Biological|biological
466913|NCT01569334|identify early non invasive markers that index the endothelial lesion/ regeneration potential in association with CAV in heart transplanted recipients (HTR)|identify early non invasive markers that index the endothelial lesion/ regeneration potential in association with cav in heart transplanted recipients (htr)
466914|NCT01569308|Cardiac output|cardiac output
466915|NCT01569308|Pulse pressure variation|pulse pressure variation
466916|NCT01569308|Fluid responsiveness|fluid responsiveness
466917|NCT01569308|Low tidal volume|low tidal volume
466918|NCT01569295|Zydelig|zydelig
466919|NCT01569295|CLL|cll
466920|NCT01569295|CAL 101|cal 101
466921|NCT01569295|CAL-101|cal-101
466922|NCT01569295|GS 1101|gs 1101
466923|NCT01569295|GS-1101|gs-1101
466924|NCT01569295|PI3K|pi3k
466925|NCT01569295|Rituxan|rituxan
466926|NCT01569295|Rituximab|rituximab
466927|NCT01569295|Bendamustine|bendamustine
466928|NCT01569295|Leukemia|leukemia
466929|NCT01569295|idelalisib|idelalisib
466930|NCT01569282|Surgical bypass|surgical bypass
466931|NCT01569282|Hepaticojejunostomy|hepaticojejunostomy
466932|NCT01569282|Gastrojejunostomy|gastrojejunostomy
466933|NCT01569282|Biliary stent|biliary stent
466934|NCT01569282|Enteral stent|enteral stent
466935|NCT01569269|chemotherapy induced peripheral neuropathy|chemotherapy induced peripheral neuropathy
466936|NCT01569269|cancer|cancer
466937|NCT01569269|psychological distress|psychological distress
466938|NCT01569269|mindfulness|mindfulness
466939|NCT01569269|complementary and alternative|complementary and alternative
466940|NCT01569243|Diabetes mellitus|diabetes mellitus
466941|NCT01569243|Text messaging|text messaging
466942|NCT01569243|Physical activity|physical activity
466943|NCT01569230|Knee osteoarthritis|knee osteoarthritis
466944|NCT01569230|acupuncture|acupuncture
466945|NCT01569230|sham acupuncture|sham acupuncture
466946|NCT01569217|Diaphragm|diaphragm
466947|NCT01569217|Abdomen|abdomen
466948|NCT01569217|Breathing pattern|breathing pattern
466949|NCT01569217|dyspnea|dyspnea
466950|NCT01569191|Ocular allergy|ocular allergy
466951|NCT01569191|Tear supplement|tear supplement
466952|NCT01569191|Cold compress|cold compress
466953|NCT01569178|stem cells|stem cells
466954|NCT01569178|acute myocardial infarction|acute myocardial infarction
466955|NCT01569178|heart failure|heart failure
466956|NCT01569178|heart attack|heart attack
466957|NCT01569178|bone marrow|bone marrow
466958|NCT01569178|intracoronary reinfusion|intracoronary reinfusion
466959|NCT01569178|bone marrow derived mononuclear cells|bone marrow derived mononuclear cells
466960|NCT01569178|Left ventricular function improvement|left ventricular function improvement
466961|NCT01569178|mortality|mortality
466962|NCT01569165|Acidogenicity|acidogenicity
466963|NCT01569165|Acidulated phosphate fluoride|acidulated phosphate fluoride
466964|NCT01569165|dental plaque|dental plaque
466965|NCT01569165|water rinsing|water rinsing
466966|NCT01569139|Validation|validation
466967|NCT01569139|Concordance|concordance
466968|NCT01569139|Myocardial infarction|myocardial infarction
466969|NCT01569139|Myocardial Ischaemia National Audit Project|myocardial ischaemia national audit project
466970|NCT01569139|General Practice Research Database|general practice research database
466971|NCT01569139|Hospital Episode Statistics|hospital episode statistics
466972|NCT01569139|ONS mortality|ons mortality
466973|NCT01569113|ella|ella
466974|NCT01569113|ellaOne|ellaone
466975|NCT01569113|quickstart|quickstart
466976|NCT01569113|contraception|contraception
466977|NCT01569113|combined oral pill|combined oral pill
466978|NCT01569113|microgynon|microgynon
466979|NCT01569087|empegfilgrastim|empegfilgrastim
466980|NCT01569087|pegylated filgrastim|pegylated filgrastim
466981|NCT01569087|neutropenia|neutropenia
466982|NCT01569087|febrile neutropenia|febrile neutropenia
466983|NCT01569087|chemotherapy-associated neutropenia|chemotherapy-associated neutropenia
466984|NCT01569087|breast cancer|breast cancer
466985|NCT01569087|docetaxel|docetaxel
466986|NCT01569087|doxorubicin|doxorubicin
466987|NCT01569074|Rheumatoid Arthritis|rheumatoid arthritis
466988|NCT01569061|overactive bladder|overactive bladder
466989|NCT01569061|laser therapy|laser therapy
466990|NCT01569061|urinary incontinence|urinary incontinence
466991|NCT01569061|urinary urgency|urinary urgency
466992|NCT01569035|oligohudramnios|oligohudramnios
466993|NCT01569035|oral anti coagulant|oral anti coagulant
466994|NCT01569035|Dopplar ultrasound|dopplar ultrasound
466995|NCT01569022|post traumatic stress disorder|post traumatic stress disorder
466996|NCT01569022|continuous positive airway pressure|continuous positive airway pressure
466997|NCT01569022|oral appliance|oral appliance
466998|NCT01569009|Bronchiectasis|bronchiectasis
466999|NCT01569009|Physical activity|physical activity
467000|NCT01569009|Activity monitor|activity monitor
467001|NCT01569009|Pedometer|pedometer
467002|NCT01568996|atypical nevi|atypical nevi
467003|NCT01568996|melanoma|melanoma
467004|NCT01568996|sulforaphane|sulforaphane
467005|NCT01568996|broccoli|broccoli
467006|NCT01568996|lesions|lesions
467007|NCT01568996|STAT1|stat1
467008|NCT01568996|STAT3|stat3
467009|NCT01568970|rehabilitation|rehabilitation
467010|NCT01568970|return to work|return to work
467011|NCT01568970|sick leave|sick leave
467012|NCT01568957|Gait|gait
467013|NCT01568957|Dual-task|dual-task
467014|NCT01568957|Obstacle avoidance|obstacle avoidance
467015|NCT01568957|Attention allocation|attention allocation
467016|NCT01568944|periodontal|periodontal
467017|NCT01568944|disease|disease
467018|NCT01568944|dendritic|dendritic
467019|NCT01568944|cells|cells
467020|NCT01568944|antibiotics|antibiotics
467021|NCT01568931|thrombectomy|thrombectomy
467022|NCT01568905|smoker|smoker
467023|NCT01568905|smoking|smoking
467024|NCT01568905|nicotine levels|nicotine levels
467025|NCT01568905|tobacco|tobacco
467026|NCT01568905|nicotine|nicotine
467027|NCT01568892|ART-experienced|art-experienced
467028|NCT01568892|GSK1349572|gsk1349572
467029|NCT01568892|Integrase inhibitor resistance|integrase inhibitor resistance
467030|NCT01568892|Dolutegravir|dolutegravir
467031|NCT01568879|Recurrent gout|recurrent gout
467032|NCT01568879|Tophaceous gout|tophaceous gout
467033|NCT01568879|Gout flares|gout flares
467034|NCT01568879|Arthritis|arthritis
467035|NCT01568879|Joint Diseases|joint diseases
467036|NCT01568879|Rheumatic Diseases|rheumatic diseases
467037|NCT01568866|multiple myeloma|multiple myeloma
467038|NCT01568866|relapsed multiple myeloma|relapsed multiple myeloma
467039|NCT01568840|Physical Therapy Modalities|physical therapy modalities
467040|NCT01568840|Posture|posture
467041|NCT01568840|Muscle Stretching Exercises|muscle stretching exercises
467042|NCT01568840|Dyskinesias|dyskinesias
467043|NCT01568840|Neck pain|neck pain
467044|NCT01568814|colonoscopy|colonoscopy
467045|NCT01568814|bowel preparation|bowel preparation
467046|NCT01568814|polyethylene glycol|polyethylene glycol
467047|NCT01568814|low residue meal|low residue meal
467048|NCT01568801|Integrated Services|integrated services
467049|NCT01568801|Health Services for the Elderly|health services for the elderly
467050|NCT01568801|Community Services|community services
467051|NCT01568788|Respiratory Tract Infections; Orthomyxoviridae Infections|respiratory tract infections; orthomyxoviridae infections
467052|NCT01568775|End Stage Renal Disease|end stage renal disease
467053|NCT01568775|Dialysis|dialysis
467054|NCT01568775|aliskiren|aliskiren
467055|NCT01568775|SPP100A|spp100a
467056|NCT01568762|Asthma|asthma
467057|NCT01568762|VAK694|vak694
467058|NCT01568762|QAX576|qax576
467059|NCT01568762|QBX258|qbx258
467060|NCT01568762|pharmacokinetics|pharmacokinetics
467062|NCT01568749|Analgesia|analgesia
467063|NCT01568749|Paracetamol|paracetamol
467064|NCT01568736|Hyper IgD Syndrome (HIDS)|hyper igd syndrome (hids)
467065|NCT01568736|Mevalonate Kinase Deficiency (MKD)|mevalonate kinase deficiency (mkd)
467066|NCT01568723|Barrett's esophagus|barrett's esophagus
467067|NCT01568723|high grade dysplasia|high grade dysplasia
467068|NCT01568723|ablation|ablation
467069|NCT01568723|radiofrequency ablation|radiofrequency ablation
467070|NCT01568723|esophageal cancer|esophageal cancer
467071|NCT01568710|Blood Flow|blood flow
467072|NCT01568710|Endothelium|endothelium
467073|NCT01568710|Nitric Oxide|nitric oxide
467074|NCT01568710|Oximetry|oximetry
467075|NCT01568710|Laser Doppler|laser doppler
467076|NCT01568710|Sickle Cell Disease|sickle cell disease
467077|NCT01568697|Oral Microbiome|oral microbiome
467078|NCT01568697|Periodontitis|periodontitis
467079|NCT01568697|Oral Mucosal Immunity|oral mucosal immunity
467080|NCT01568697|Oral Infection|oral infection
467081|NCT01568697|Immune Disorder|immune disorder
467082|NCT01568697|Periodontal Disease|periodontal disease
467083|NCT01568697|Gum Disease|gum disease
467084|NCT01568697|Healthy Volunteer|healthy volunteer
467085|NCT01568697|HV|hv
467086|NCT01568684|Magnetic Resonance Spectroscopy|magnetic resonance spectroscopy
467087|NCT01568684|Depression|depression
467088|NCT01568684|Depression Treatment|depression treatment
467089|NCT01568684|Major Depression|major depression
467090|NCT01568684|Unipolar Depression|unipolar depression
467091|NCT01568671|Adult|adult
467092|NCT01568671|Body Fat Distribution|body fat distribution
467093|NCT01568671|Accelerometry|accelerometry
467094|NCT01568671|Healthy Volunteers|healthy volunteers
467095|NCT01568671|Thermoregulation|thermoregulation
467096|NCT01568671|Healthy Volunteer|healthy volunteer
467097|NCT01568671|HV|hv
467098|NCT01568658|Hereditary Myopathies|hereditary myopathies
467099|NCT01568658|Neuropathology|neuropathology
467100|NCT01568658|Muscular Dystrophy|muscular dystrophy
467101|NCT01568658|Inherited Neuromuscular Condition|inherited neuromuscular condition
467102|NCT01568658|Inherited Neuropathy|inherited neuropathy
467103|NCT01568658|Inherited Myopathy|inherited myopathy
467104|NCT01568658|Hereditary Spastic Paraplegia|hereditary spastic paraplegia
467105|NCT01568658|Healthy Volunteer|healthy volunteer
467106|NCT01568658|HV|hv
467107|NCT01568645|Sickle Cell Anemia|sickle cell anemia
467108|NCT01568645|Tyrosine Kinase Inhibitor|tyrosine kinase inhibitor
467109|NCT01568645|Platelet Derived Growth Factor|platelet derived growth factor
467110|NCT01568645|Beta Adrenergic Receptor Blocker|beta adrenergic receptor blocker
467111|NCT01568645|Pulmonary Vascular Disease|pulmonary vascular disease
467112|NCT01568645|Sickle Cell Disease|sickle cell disease
467113|NCT01568645|Pulmonary Hypertension|pulmonary hypertension
467114|NCT01568632|Dose Limiting Toxicity|dose limiting toxicity
467115|NCT01568632|Maximum Tolerated Dose|maximum tolerated dose
467116|NCT01568632|Telomerase Inhibitor|telomerase inhibitor
467117|NCT01568632|Safety|safety
467118|NCT01568632|Solid Tumor|solid tumor
467119|NCT01568632|Lymphoma|lymphoma
467120|NCT01568619|cardiopulmonary exercise test|cardiopulmonary exercise test
467121|NCT01568619|cardiac output|cardiac output
467122|NCT01568606|Heart Failure|heart failure
467123|NCT01568606|Obesity|obesity
467124|NCT01568606|Implantable Cardioverter Defibrillator|implantable cardioverter defibrillator
467125|NCT01568580|Hemophilia A|hemophilia a
467126|NCT01568580|Factor VIII|factor viii
467127|NCT01568580|Recombinant|recombinant
467128|NCT01568567|safety|safety
467129|NCT01568567|tolerance|tolerance
467130|NCT01568567|lactobacillus Reuteri|lactobacillus reuteri
467131|NCT01568541|children|children
467132|NCT01568541|dentifrice|dentifrice
467133|NCT01568541|fluoride|fluoride
467134|NCT01568541|dental fluorosis|dental fluorosis
467135|NCT01568515|HPV vaccine|hpv vaccine
467136|NCT01568515|Vaccine adherence|vaccine adherence
467137|NCT01568515|Vaccine utilization|vaccine utilization
467138|NCT01568515|Electronic Messaging|electronic messaging
467139|NCT01568502|dobutamine stress|dobutamine stress
467140|NCT01568502|inducible ischemia|inducible ischemia
467142|NCT01568476|Regional anesthesia|regional anesthesia
467143|NCT01568476|Sciatic nerve block|sciatic nerve block
467144|NCT01568476|foot surgery|foot surgery
467145|NCT01568476|ankle surgery|ankle surgery
467146|NCT01568476|Interneural local anesthetic|interneural local anesthetic
467147|NCT01568463|Inter-scalene Block|inter-scalene block
467148|NCT01568463|Regional Anesthesia|regional anesthesia
467149|NCT01568463|shoulder surgeries|shoulder surgeries
467150|NCT01568450|Oxycodone, controlled release formulation|oxycodone, controlled release formulation
467151|NCT01568437|Laparoscopic gastric-bypass surgery|laparoscopic gastric-bypass surgery
467152|NCT01568437|TAP block|tap block
467153|NCT01568424|Heart Failure|heart failure
467154|NCT01568424|Right Ventricular Failure|right ventricular failure
467155|NCT01568424|Levitronix|levitronix
467156|NCT01568424|Thoratec Corporation|thoratec corporation
467157|NCT01568411|None - normal volunteers|none - normal volunteers
467158|NCT01568398|Gastric or duodenal ulcer|gastric or duodenal ulcer
467159|NCT01568385|Gastric or duodenal ulcer|gastric or duodenal ulcer
467160|NCT01568372|pediatric|pediatric
467161|NCT01568372|tonsillectomy|tonsillectomy
467162|NCT01568372|pain management|pain management
467163|NCT01568372|nurse follow-up|nurse follow-up
467164|NCT01568346|Newly diagnosed|newly diagnosed
467165|NCT01568346|Early stage|early stage
467166|NCT01568333|Decitabine|decitabine
467167|NCT01568333|Immune thrombocytopenia|immune thrombocytopenia
467168|NCT01568320|Aorta|aorta
467169|NCT01568320|Thoracic|thoracic
467170|NCT01568320|Aortic dissection|aortic dissection
467171|NCT01568320|Rupture|rupture
467172|NCT01568320|Type B|type b
467173|NCT01568320|DeBakey type III|debakey type iii
467174|NCT01568320|Endovascular|endovascular
467175|NCT01568307|Major depressive disorder|major depressive disorder
467176|NCT01568307|Serotonin transporter|serotonin transporter
467177|NCT01568307|Sympathetic nervous system activation|sympathetic nervous system activation
467178|NCT01568307|Cardiovascular risk factors|cardiovascular risk factors
467179|NCT01568307|Serotonin re-uptake inhibitor|serotonin re-uptake inhibitor
467180|NCT01568281|Bioequivalence|bioequivalence
467181|NCT01568281|pharmacokinetics|pharmacokinetics
467182|NCT01568281|safety|safety
467183|NCT01568281|anastrozole|anastrozole
467184|NCT01568281|Arimidex|arimidex
467185|NCT01568281|Japanese|japanese
467186|NCT01568281|healthy subject|healthy subject
467187|NCT01568268|palonosetron|palonosetron
467188|NCT01568268|postoperative nausea and vomiting|postoperative nausea and vomiting
467189|NCT01568255|myopathic symptoms|myopathic symptoms
467190|NCT01568242|Cataract|cataract
467191|NCT01568242|Phacoemulsification|phacoemulsification
467192|NCT01568242|Temperature|temperature
467193|NCT01568242|Vitreous|vitreous
467194|NCT01568229|schizophrenia negative symptoms|schizophrenia negative symptoms
467195|NCT01568216|schizophrenia negative symptoms|schizophrenia negative symptoms
467196|NCT01568203|single dose, safety, healthy subjects, schizoaffective disorder, AMG 579|single dose, safety, healthy subjects, schizoaffective disorder, amg 579
467782|NCT01565603|Hypoxia|hypoxia
467197|NCT01568190|House dust mites sensitisation|house dust mites sensitisation
467198|NCT01568177|MCD|mcd
467199|NCT01568164|Epicardial Catheter-based Restoration|epicardial catheter-based restoration
467200|NCT01568164|Surgical/Left Ventricular Reconstruction|surgical/left ventricular reconstruction
467201|NCT01568164|Ventricular Remodeling|ventricular remodeling
467202|NCT01568164|Dor|dor
467203|NCT01568151|Colorectal Cancer|colorectal cancer
467204|NCT01568151|Screening|screening
467205|NCT01568151|Education|education
467206|NCT01568151|Testing|testing
467207|NCT01568138|Ventricular Remodeling|ventricular remodeling
467208|NCT01568112|BG00012|bg00012
467209|NCT01568112|gastrointestinal events|gastrointestinal events
467210|NCT01568112|flushing events|flushing events
467211|NCT01568112|dose titration|dose titration
467212|NCT01568112|pre-medication|pre-medication
467213|NCT01568112|aspirin|aspirin
467214|NCT01568073|Parkinson|parkinson
467215|NCT01568073|PD|pd
467216|NCT01568073|Wearing-off|wearing-off
467217|NCT01568073|Levodopa/DDCI|levodopa/ddci
467218|NCT01568060|Safety|safety
467219|NCT01568060|Infanrix-IPV|infanrix-ipv
467220|NCT01568060|Post-marketing surveillance|post-marketing surveillance
467221|NCT01568060|Diphtheria, tetanus, pertussis and poliomyelitis|diphtheria, tetanus, pertussis and poliomyelitis
467222|NCT01568047|Parkinson Disease|parkinson disease
467223|NCT01568047|BIA 9-1067|bia 9-1067
467224|NCT01568034|Parkinson's Disease|parkinson's disease
467225|NCT01568034|BIA 9-1067|bia 9-1067
467226|NCT01567995|eczematous|eczematous
467227|NCT01567995|dermatitis|dermatitis
467228|NCT01567982|tDCS|tdcs
467229|NCT01567982|brain stimulation|brain stimulation
467230|NCT01567982|addiction|addiction
467231|NCT01567982|substance dependence|substance dependence
467232|NCT01567982|craving|craving
467233|NCT01567982|cognition|cognition
467234|NCT01567969|mental health services|mental health services
467235|NCT01567969|child behavior disorders|child behavior disorders
467236|NCT01567969|child psychiatry|child psychiatry
467237|NCT01567956|Ulcerative colitis|ulcerative colitis
467238|NCT01567943|alcohol abuse|alcohol abuse
467239|NCT01567943|drug abuse|drug abuse
467240|NCT01567943|schizophrenia|schizophrenia
467241|NCT01567943|bipolar disorder|bipolar disorder
467242|NCT01567943|major depressive disorder|major depressive disorder
467243|NCT01567943|contingency management|contingency management
467244|NCT01567943|psychosocial treatment|psychosocial treatment
467245|NCT01567930|Temsirolimus|temsirolimus
467246|NCT01567930|HCC|hcc
467247|NCT01567930|Advanced hepatocellular carcinoma|advanced hepatocellular carcinoma
467248|NCT01567917|Venous thromboembolism|venous thromboembolism
467249|NCT01567917|Colorectal cancer|colorectal cancer
467250|NCT01567917|Postoperative period|postoperative period
467251|NCT01567917|detected on 5th~14th days after surgery (by doppler US) or the follow-up period of postoperative 1 month|detected on 5th~14th days after surgery (by doppler us) or the follow-up period of postoperative 1 month
467252|NCT01567904|thrombosis|thrombosis
467253|NCT01567904|Central Venous Line|central venous line
467254|NCT01567904|CVL|cvl
467255|NCT01567891|Ovarian Cancer|ovarian cancer
467256|NCT01567891|Cell Therapy|cell therapy
467257|NCT01567891|T Cell Therapy|t cell therapy
467258|NCT01567891|NY-ESO-1|ny-eso-1
467259|NCT01567891|Immuno-oncology|immuno-oncology
467260|NCT01567891|Metastatic|metastatic
467261|NCT01567891|Previously treated|previously treated
467262|NCT01567891|T Cell Receptor|t cell receptor
467263|NCT01567878|ultrasound|ultrasound
467264|NCT01567878|MASEI index|masei index
467265|NCT01567878|clinical and ultrasound correlation|clinical and ultrasound correlation
467266|NCT01567878|enthesis ultrasound|enthesis ultrasound
467267|NCT01567878|articular ultrasound|articular ultrasound
467268|NCT01567878|ankylosing spondylitis ultrasound|ankylosing spondylitis ultrasound
467269|NCT01567878|radiographic and ultrasound correlation|radiographic and ultrasound correlation
467270|NCT01567852|orientation|orientation
467271|NCT01567852|post-anesthesia recovery|post-anesthesia recovery
467272|NCT01567852|electroconvulsive therapy|electroconvulsive therapy
467273|NCT01567839|degree of pulpal anesthesia obtained|degree of pulpal anesthesia obtained
467274|NCT01567839|primary infiltration in the lower first molar|primary infiltration in the lower first molar
467275|NCT01567826|YELLO|yello
467276|NCT01567826|Atorvastatin|atorvastatin
467277|NCT01567826|Simvastatin|simvastatin
467278|NCT01567826|Rosuvastatin|rosuvastatin
467279|NCT01567826|lipid therapy|lipid therapy
467280|NCT01567826|Statin therapy|statin therapy
467281|NCT01567826|Coronary artery disease|coronary artery disease
467282|NCT01567826|CHD|chd
467283|NCT01567813|Warts|warts
467284|NCT01567813|Papillomavirus infections|papillomavirus infections
467285|NCT01567813|DNA virus infections|dna virus infections
467286|NCT01567813|Virus diseases|virus diseases
467287|NCT01567813|Skin diseases, viral|skin diseases, viral
467288|NCT01567813|Tumor virus infections|tumor virus infections
467289|NCT01567813|Skin diseases, infectious|skin diseases, infectious
467290|NCT01567813|Skin diseases|skin diseases
467291|NCT01567800|Procedure/Surgery: 18F-Fluoroazomycin Arabinoside (18F-FAZA)|procedure/surgery: 18f-fluoroazomycin arabinoside (18f-faza)
467292|NCT01567787|Proton Radiation Therapy|proton radiation therapy
467293|NCT01567787|Spinal tumors|spinal tumors
467294|NCT01567787|Neurofibroma(NF1)|neurofibroma(nf1)
467295|NCT01567787|Malignant peripheral nerve sheath tumor(MPNST)|malignant peripheral nerve sheath tumor(mpnst)
467296|NCT01567774|Coronary artery disease|coronary artery disease
467297|NCT01567774|dual antiplatelet therapy|dual antiplatelet therapy
467298|NCT01567774|atorvastatin|atorvastatin
467299|NCT01567774|rosuvastatin|rosuvastatin
467300|NCT01567761|IOP|iop
467301|NCT01567748|CABG|cabg
467302|NCT01567748|Coronary Artery Bypass|coronary artery bypass
467303|NCT01567748|Central Aortic Pressure|central aortic pressure
467304|NCT01567748|Peripheral Arterial Waveform|peripheral arterial waveform
467305|NCT01567735|Hepatitis C|hepatitis c
467306|NCT01567735|TMC435HPC3011|tmc435hpc3011
467307|NCT01567735|TMC435|tmc435
467308|NCT01567722|HIV infection|hiv infection
467309|NCT01567722|adult diffuse large cell lymphoma|adult diffuse large cell lymphoma
467310|NCT01567722|anal cancer|anal cancer
467311|NCT01567722|cervical cancer|cervical cancer
467312|NCT01567722|non-small cell lung cancer|non-small cell lung cancer
467313|NCT01567722|AIDS-related diffuse large cell lymphoma|aids-related diffuse large cell lymphoma
467314|NCT01567696|Revision,|revision,
467315|NCT01567683|Safety and Tolerability of Limtop and vehicle|safety and tolerability of limtop and vehicle
467316|NCT01567683|of Limtop and vehicle|of limtop and vehicle
467317|NCT01567657|Sedation in TEE|sedation in tee
467318|NCT01567657|Blood pressure drop during TEE|blood pressure drop during tee
467319|NCT01567657|Safety of sedation in TEE|safety of sedation in tee
467320|NCT01567644|Extracorporeal Shockwave Therapy|extracorporeal shockwave therapy
467321|NCT01567644|Myocardial Ischemia|myocardial ischemia
467322|NCT01567644|Refractory Angina|refractory angina
467323|NCT01567631|Classical Procedure|classical procedure
467324|NCT01567631|Intrahepatic Glisson's Approach|intrahepatic glisson's approach
467325|NCT01567631|laparoscopic hepatectomy|laparoscopic hepatectomy
467326|NCT01567631|Minimal invasive surgery|minimal invasive surgery
467327|NCT01567631|Endoscopic stapling devices|endoscopic stapling devices
467328|NCT01567618|Docetaxel|docetaxel
467329|NCT01567618|Fluorouracil|fluorouracil
467330|NCT01567618|First line therapy|first line therapy
467331|NCT01567618|Gastric cancer|gastric cancer
467332|NCT01567605|spinal cord injury|spinal cord injury
467333|NCT01567605|autonomic dysreflexia|autonomic dysreflexia
467334|NCT01567605|blood pressure|blood pressure
467335|NCT01567605|bowel care management|bowel care management
467336|NCT01567605|defecation|defecation
467337|NCT01567592|Extracorporeal Shockwave Therapy|extracorporeal shockwave therapy
596282|NCT01032252|network|network
467338|NCT01567592|Myocardial Ischemia|myocardial ischemia
467339|NCT01567592|Refractory Angina|refractory angina
467340|NCT01567579|congenital heart defects|congenital heart defects
467341|NCT01567566|home based daily exercise program|home based daily exercise program
467342|NCT01567566|local lumbopelvic stabilizer muscles|local lumbopelvic stabilizer muscles
467343|NCT01567566|hip stabilizer muscles|hip stabilizer muscles
467344|NCT01567566|real time ultrasound imaging|real time ultrasound imaging
467345|NCT01567553|inflammatory disease of the central nervous system|inflammatory disease of the central nervous system
467346|NCT01567553|early clinical deficit|early clinical deficit
467347|NCT01567553|multiple sclerosis (MS)|multiple sclerosis (ms)
467348|NCT01567540|Chronic Hepatitis C|chronic hepatitis c
467349|NCT01567540|Interferon protein 10|interferon protein 10
467350|NCT01567540|Chemokine gradients|chemokine gradients
467351|NCT01567540|Sitagliptin|sitagliptin
467352|NCT01567527|Aripiprazole|aripiprazole
467353|NCT01567527|Intramuscular (IM) Depot|intramuscular (im) depot
467354|NCT01567527|Bipolar|bipolar
467355|NCT01567514|Deep occlusal caries restored with resin composite|deep occlusal caries restored with resin composite
467356|NCT01567514|on Pit and Fissure Surface Penetrating Into Dentin|on pit and fissure surface penetrating into dentin
467357|NCT01567488|Advanced|advanced
467358|NCT01567488|Non functioning|non functioning
467359|NCT01567488|Well differentiated|well differentiated
467360|NCT01567462|bladder cancer|bladder cancer
467361|NCT01567462|transurethral resection of bladder tumors|transurethral resection of bladder tumors
467362|NCT01567423|Malaria|malaria
467363|NCT01567423|Plasmodium falciparum|plasmodium falciparum
467364|NCT01567423|Children|children
467365|NCT01567423|Efficacy|efficacy
467366|NCT01567423|Uncomplicated malaria|uncomplicated malaria
467367|NCT01567410|e-learning|e-learning
467368|NCT01567410|education|education
467369|NCT01567384|cancer|cancer
467370|NCT01567384|neoplasms|neoplasms
467371|NCT01567384|tumors|tumors
467372|NCT01567345|Pain|pain
467373|NCT01567345|cancer|cancer
467374|NCT01567345|Intrathecal|intrathecal
467375|NCT01567345|analgesia|analgesia
467376|NCT01567345|Morphine|morphine
467377|NCT01567345|Implantable pump|implantable pump
467378|NCT01567319|Sensitization|sensitization
467379|NCT01567319|Skin Prick Test|skin prick test
467380|NCT01567319|Standardization|standardization
467381|NCT01567319|sources of: D. glomerata, L. perenne, S. cereale and O. europaea|sources of: d. glomerata, l. perenne, s. cereale and o. europaea
467382|NCT01567306|Allergy|allergy
467383|NCT01567306|Allergic rhinoconjunctivitis|allergic rhinoconjunctivitis
467384|NCT01567306|Subcutaneous Immunotherapy|subcutaneous immunotherapy
467385|NCT01567306|Phleum pratense pollen extract|phleum pratense pollen extract
467386|NCT01567267|Evidence-based Medicine|evidence-based medicine
467387|NCT01567267|Good Scientific Practice|good scientific practice
467388|NCT01567267|Problem-based Learning|problem-based learning
467389|NCT01567267|Critical health literacy|critical health literacy
467390|NCT01567267|Educational intervention|educational intervention
467391|NCT01567254|guided imaginary|guided imaginary
467392|NCT01567241|clinical hypnosis|clinical hypnosis
467393|NCT01567241|relaxation music|relaxation music
467394|NCT01567241|reproduction techniques|reproduction techniques
467395|NCT01567241|insemination|insemination
467396|NCT01567241|embryo transfer|embryo transfer
467397|NCT01567241|pregnancy rate|pregnancy rate
467398|NCT01567228|obesity|obesity
467399|NCT01567228|overweight|overweight
467400|NCT01567228|dental caries|dental caries
467401|NCT01567228|school problems|school problems
467402|NCT01567228|school failure|school failure
467403|NCT01567228|child BMI > 85th percentile|child bmi > 85th percentile
467404|NCT01567228|Needing dental preventive services|needing dental preventive services
467405|NCT01567228|Needing academic support for school problems|needing academic support for school problems
467406|NCT01567215|granuloma umbilical|granuloma umbilical
467407|NCT01567202|Brain tumor|brain tumor
467408|NCT01567202|Glioma|glioma
467409|NCT01567202|Glioblastoma|glioblastoma
467410|NCT01567202|Tumor stem cells|tumor stem cells
467411|NCT01567202|Immunotherapy|immunotherapy
467412|NCT01567202|Vaccine|vaccine
467413|NCT01567189|Exercise therapy|exercise therapy
467414|NCT01567189|cost effectiveness|cost effectiveness
467415|NCT01567189|cardiac rehabilitation|cardiac rehabilitation
467416|NCT01567189|home-based exercise|home-based exercise
467417|NCT01567176|Sirtuins|sirtuins
467418|NCT01567176|Aging|aging
467419|NCT01567176|Metabolic disease|metabolic disease
467420|NCT01567163|Advanced Malignant Solid Tumors|advanced malignant solid tumors
467421|NCT01567124|Schizophrenia|schizophrenia
467422|NCT01567124|Moxonidine|moxonidine
467423|NCT01567124|Sympathetic nervous system activation|sympathetic nervous system activation
467424|NCT01567124|Cardiometabolic side effects of antipsychotics|cardiometabolic side effects of antipsychotics
467425|NCT01567111|Primary aldosteronism|primary aldosteronism
467426|NCT01567111|Aldosterone producing adenoma|aldosterone producing adenoma
467427|NCT01567111|Bilateral adrenal hyperplasia|bilateral adrenal hyperplasia
467428|NCT01567111|Metomidate-Positron emission tomography|metomidate-positron emission tomography
467429|NCT01567072|NSAID|nsaid
467430|NCT01567072|bone fracture|bone fracture
467431|NCT01567072|heal|heal
467432|NCT01567033|Diabetes|diabetes
467433|NCT01567033|Obesity|obesity
467434|NCT01567033|Home visiting|home visiting
467435|NCT01567020|Central Auditory Processing|central auditory processing
467436|NCT01567020|Traumatic Brain Injury|traumatic brain injury
467437|NCT01567020|Hearing Loss|hearing loss
467438|NCT01567007|pedometer|pedometer
467439|NCT01567007|physical activity|physical activity
467440|NCT01567007|workplace|workplace
467441|NCT01566994|smoking cessation|smoking cessation
467442|NCT01566981|Diabetes mellitus tip II|diabetes mellitus tip ii
467443|NCT01566981|eHealth solution|ehealth solution
467444|NCT01566981|Health Information Technology|health information technology
467445|NCT01566981|quality of life|quality of life
467446|NCT01566981|family medicine|family medicine
467447|NCT01566981|satisfaction with e-health care|satisfaction with e-health care
467448|NCT01566981|primary care|primary care
467449|NCT01566968|COPD|copd
467450|NCT01566968|Asthma|asthma
467451|NCT01566968|Healthy volunteers|healthy volunteers
467452|NCT01566968|Chronic cough|chronic cough
467453|NCT01566968|Smokers|smokers
467454|NCT01566968|Cough challenge|cough challenge
467455|NCT01566968|Cough challenge testing.|cough challenge testing.
467456|NCT01566955|transgastric|transgastric
467457|NCT01566955|NOTES|notes
467458|NCT01566955|Gastrotomy|gastrotomy
467459|NCT01566955|BRCA 1/2|brca 1/2
467460|NCT01566942|FOLFIRI|folfiri
467461|NCT01566942|FOLFOX|folfox
467462|NCT01566942|adjuvant chemotherapy|adjuvant chemotherapy
467463|NCT01566942|advanced colorectal cancer|advanced colorectal cancer
467464|NCT01566929|Obesity|obesity
467465|NCT01566929|In vitro fertilization|in vitro fertilization
467466|NCT01566929|Low calorie diet (LCD)|low calorie diet (lcd)
467467|NCT01566929|Obstetric outcome|obstetric outcome
467468|NCT01566929|Weight reduction|weight reduction
467469|NCT01566903|arterial stenosis|arterial stenosis
467470|NCT01566903|arteriovenous malformations|arteriovenous malformations
467471|NCT01566903|Post-treatment follow-up|post-treatment follow-up
467472|NCT01566890|sickle cell|sickle cell
467473|NCT01566890|sickle cell crisis|sickle cell crisis
467474|NCT01566890|sickle cell pain crisis|sickle cell pain crisis
467475|NCT01566890|vaso-occlusive crisis|vaso-occlusive crisis
467476|NCT01566890|vaso-occlusion|vaso-occlusion
467477|NCT01566890|sickle cell anemia|sickle cell anemia
467478|NCT01566890|sickle cell disease|sickle cell disease
467479|NCT01566890|genetic diseases|genetic diseases
467480|NCT01566890|adenosine 2A Receptor Agonists|adenosine 2a receptor agonists
467481|NCT01566890|Lexiscan|lexiscan
467483|NCT01566890|contrast-enhanced ultrasound|contrast-enhanced ultrasound
467484|NCT01566890|Hydroxyurea|hydroxyurea
467485|NCT01566877|Multiple Ascending Dose (MAD)|multiple ascending dose (mad)
467486|NCT01566877|Marburg Virus|marburg virus
467487|NCT01566877|Post Exposure Prophylaxis|post exposure prophylaxis
467488|NCT01566864|hypertension|hypertension
467489|NCT01566864|disparities|disparities
467490|NCT01566864|care management|care management
467491|NCT01566864|provider education|provider education
467492|NCT01566864|audit and feedback|audit and feedback
467493|NCT01566864|Omron|omron
467494|NCT01566864|African Americans|african americans
467495|NCT01566864|organizational change|organizational change
467496|NCT01566864|implementation research|implementation research
467497|NCT01566838|Visual analog pain score|visual analog pain score
467498|NCT01566838|Length of stay|length of stay
467499|NCT01566838|Hospital Cost|hospital cost
467500|NCT01566838|Subpleural pain catheter|subpleural pain catheter
467501|NCT01566838|Bupivacaine|bupivacaine
467502|NCT01566825|amitriptyline|amitriptyline
467503|NCT01566825|sleep dependent memory consolidation|sleep dependent memory consolidation
467504|NCT01566812|Breast Feeding|breast feeding
467505|NCT01566812|Cardiovascular Risk|cardiovascular risk
467882|NCT01565252|Egg,Omega 3, Omega 6|egg,omega 3, omega 6
467506|NCT01566799|Locally advanced breast cancer|locally advanced breast cancer
467507|NCT01566799|Neoadjuvant chemotherapy|neoadjuvant chemotherapy
467508|NCT01566799|Metformin|metformin
467509|NCT01566799|Pathologic Complete Response|pathologic complete response
467510|NCT01566773|COPD|copd
467511|NCT01566760|food effect|food effect
467512|NCT01566760|bioavailability|bioavailability
467513|NCT01566760|pharmacokinetics|pharmacokinetics
467514|NCT01566760|fesoterodine|fesoterodine
467515|NCT01566760|5-hydroxymethyl tolterodine|5-hydroxymethyl tolterodine
467516|NCT01566760|treatment of overactive bladder|treatment of overactive bladder
467517|NCT01566734|Surgical Wound Infection|surgical wound infection
467518|NCT01566734|cefazolin|cefazolin
467519|NCT01566734|Cesarean Section|cesarean section
467520|NCT01566708|Acute Tinnitus|acute tinnitus
467521|NCT01566708|Recent Onset Tinnitus|recent onset tinnitus
467522|NCT01566708|Music Therapy|music therapy
467523|NCT01566708|fMRI|fmri
467524|NCT01566708|Therapy Evaluation|therapy evaluation
467525|NCT01566682|Lung Lesion|lung lesion
467526|NCT01566682|Lung Mass|lung mass
467527|NCT01566682|Lung Nodule|lung nodule
467528|NCT01566682|Lung Cancer|lung cancer
467529|NCT01566682|Low-Dose CT|low-dose ct
467531|NCT01566682|Diagnostic|diagnostic
467532|NCT01566682|Evaluation|evaluation
467533|NCT01566682|Bioconductance|bioconductance
467534|NCT01566682|ProLung|prolung
467535|NCT01566669|Cyclooxygenase inhibitors|cyclooxygenase inhibitors
467536|NCT01566669|Morphine|morphine
467537|NCT01566669|Analgesia|analgesia
467538|NCT01566669|patient-controlled|patient-controlled
467539|NCT01566669|Gynecologic surgical procedures|gynecologic surgical procedures
467540|NCT01566656|Allogeneic hematopoietic stem cell transplantation|allogeneic hematopoietic stem cell transplantation
467541|NCT01566656|Non-myeloablative preparative regimen|non-myeloablative preparative regimen
467542|NCT01566656|Total lymphoid irradiation|total lymphoid irradiation
467543|NCT01566656|Anti-thymocyte globulin|anti-thymocyte globulin
467544|NCT01566656|Lymphoid malignancies|lymphoid malignancies
467545|NCT01566643|Helicobacter pylori|helicobacter pylori
467546|NCT01566643|antibiotic resistance|antibiotic resistance
467547|NCT01566643|sequential-concomitant hybrid therapy|sequential-concomitant hybrid therapy
467548|NCT01566630|human recombinant RLX030|human recombinant rlx030
467549|NCT01566630|Pre-eclampsia|pre-eclampsia
467550|NCT01566630|hemodynamics|hemodynamics
467551|NCT01566630|Pharmacokinetics|pharmacokinetics
467552|NCT01566604|Chronic obstructive pulmonary disease (COPD)|chronic obstructive pulmonary disease (copd)
467553|NCT01566604|NVA237|nva237
467554|NCT01566591|Bipolar Depression|bipolar depression
467555|NCT01566552|AMBISOME|ambisome
467556|NCT01566552|VISCERAL LEISHMANIASIS|visceral leishmaniasis
467557|NCT01566552|SINGLE DOSE|single dose
467558|NCT01566539|Social cooperation|social cooperation
467559|NCT01566539|Oxytocin|oxytocin
467560|NCT01566539|Vasopressin|vasopressin
467561|NCT01566539|Prisoner's Dilemma game|prisoner's dilemma game
467562|NCT01566539|Empathy|empathy
467563|NCT01566539|fMRI|fmri
467564|NCT01566513|Peer Support|peer support
467565|NCT01566513|Cost Effectiveness|cost effectiveness
467566|NCT01566513|Reducing Hospital use|reducing hospital use
467567|NCT01566513|Serious Mental Illness|serious mental illness
467568|NCT01566500|Epilepsy|epilepsy
467569|NCT01566500|Medication Adherence|medication adherence
467570|NCT01566487|Bioequivalence|bioequivalence
467571|NCT01566487|Quetiapine fumarate|quetiapine fumarate
467572|NCT01566487|crossover|crossover
467573|NCT01566461|Drug-Coated Angioplasty Balloon|drug-coated angioplasty balloon
467574|NCT01566461|Drug Coated Angioplasty Balloon|drug coated angioplasty balloon
467575|NCT01566461|Peripheral Artery Disease|peripheral artery disease
467576|NCT01566461|Experimental|experimental
467577|NCT01566461|Percutaneous Transluminal Angioplasty (PTA)|percutaneous transluminal angioplasty (pta)
467578|NCT01566448|Ketamine|ketamine
467580|NCT01566448|Oral ketamine rinse|oral ketamine rinse
467581|NCT01566409|Constipation|constipation
467582|NCT01566409|Maintenance treatment|maintenance treatment
467583|NCT01566409|Ultrasound of rectum|ultrasound of rectum
467584|NCT01566396|Fractional,|fractional,
467585|NCT01566396|RF,|rf,
467586|NCT01566396|Wrinkles|wrinkles
467587|NCT01566396|Safety|safety
467588|NCT01566396|Efficacy|efficacy
467589|NCT01566396|treatment|treatment
467590|NCT01566370|alcoholism|alcoholism
467591|NCT01566370|alcohol use disorder|alcohol use disorder
467592|NCT01566370|alcohol dependence|alcohol dependence
467593|NCT01566370|alcohol abuse|alcohol abuse
467594|NCT01566370|bipolar|bipolar
467595|NCT01566370|anticonvulsant|anticonvulsant
467596|NCT01566370|zonisamide|zonisamide
467597|NCT01566357|dental erosion|dental erosion
467598|NCT01566357|enamel|enamel
467599|NCT01566357|dentin|dentin
467600|NCT01566344|Premature Ventricular Complex|premature ventricular complex
467601|NCT01566344|Cardiomyopathy|cardiomyopathy
467602|NCT01566344|Left ventricular dysfunction|left ventricular dysfunction
467603|NCT01566344|Catheter Ablation|catheter ablation
467604|NCT01566344|Anti-Arrhythmic Agents|anti-arrhythmic agents
467605|NCT01566344|Randomized Clinical Trial|randomized clinical trial
467606|NCT01566331|Safe Delivery|safe delivery
467607|NCT01566331|reduction of pain|reduction of pain
467608|NCT01566331|reduction stage of labor|reduction stage of labor
467609|NCT01566318|Depression|depression
467610|NCT01566318|Anxiety|anxiety
467611|NCT01566318|Geriatric mental health|geriatric mental health
467612|NCT01566279|solid tumors|solid tumors
467613|NCT01566279|all comers|all comers
467614|NCT01566279|everolimus|everolimus
467615|NCT01566279|biomarker|biomarker
467616|NCT01566279|next generation sequencing|next generation sequencing
467617|NCT01566266|gut flora|gut flora
467618|NCT01566266|antibiotics|antibiotics
467619|NCT01566266|lipid metabolism|lipid metabolism
467620|NCT01566266|LDL cholesterol|ldl cholesterol
467621|NCT01566253|planned caesarian section, analgesic, PCOA|planned caesarian section, analgesic, pcoa
467622|NCT01566240|cervical cancer|cervical cancer
467623|NCT01566240|Chemotherapy|chemotherapy
467624|NCT01566240|Paclitaxel|paclitaxel
467625|NCT01566240|Carboplatin|carboplatin
467626|NCT01566240|Cisplatin|cisplatin
467627|NCT01566240|Radiotherapy|radiotherapy
467628|NCT01566240|Chemoradiation|chemoradiation
467629|NCT01566240|Brachytherapy|brachytherapy
467630|NCT01566240|Stage IB2 Cervical Cancer|stage ib2 cervical cancer
467631|NCT01566240|Stage IIA Cervical Cancer|stage iia cervical cancer
467632|NCT01566240|Stage IIB Cervical Cancer|stage iib cervical cancer
467633|NCT01566240|Stage IIIB Cervical Cancer|stage iiib cervical cancer
467634|NCT01566240|Stage IVA Cervical Cancer|stage iva cervical cancer
467635|NCT01566227|overdenture|overdenture
467636|NCT01566227|implant|implant
467637|NCT01566227|edentulism|edentulism
467638|NCT01566214|coronary heart disease (CHD)|coronary heart disease (chd)
467639|NCT01566214|myocardial infarction (MI)|myocardial infarction (mi)
467640|NCT01566214|acute coronary syndromes (ACS)|acute coronary syndromes (acs)
467641|NCT01566201|Arterial stiffness|arterial stiffness
467642|NCT01566201|Endothelial function|endothelial function
467643|NCT01566201|Left ventricular function|left ventricular function
467644|NCT01566201|Apoptosis|apoptosis
467645|NCT01566201|Nitrooxidative stress|nitrooxidative stress
467646|NCT01566175|Neovasc Reducer|neovasc reducer
467647|NCT01566175|Coronary Sinus|coronary sinus
467648|NCT01566175|Refractory Angina Pectoris|refractory angina pectoris
467649|NCT01566175|angina class 3-4|angina class 3-4
467650|NCT01566162|Lurasidone|lurasidone
467651|NCT01566162|Latuda|latuda
467652|NCT01566162|Schizophrenia|schizophrenia
467653|NCT01566136|hip fracture patients|hip fracture patients
467654|NCT01566136|cognitive impairment|cognitive impairment
467655|NCT01566136|rehabilitation model of care|rehabilitation model of care
467656|NCT01566123|retroperitoneal soft tissue sarcoma|retroperitoneal soft tissue sarcoma
467657|NCT01566123|IMRT|imrt
467658|NCT01566123|IORT|iort
467659|NCT01566110|pediatric|pediatric
467660|NCT01566110|dietary treatment|dietary treatment
467661|NCT01566110|celiac disease|celiac disease
467662|NCT01566110|T1D|t1d
467663|NCT01566097|Cluster randomized trial|cluster randomized trial
467664|NCT01566097|Decision aids|decision aids
467665|NCT01566097|Culturally-appropriate decision aids|culturally-appropriate decision aids
467666|NCT01566058|Post partum|post partum
467667|NCT01566058|mother-child relationships|mother-child relationships
467668|NCT01566045|Prostate Cancer|prostate cancer
467669|NCT01566045|Biopsy|biopsy
467670|NCT01566032|pulmonary air leak|pulmonary air leak
467671|NCT01566032|Thopaz|thopaz
467672|NCT01566032|analog|analog
467673|NCT01566032|digital|digital
467674|NCT01566006|Mycophenolate mofetil (MMF)|mycophenolate mofetil (mmf)
467675|NCT01566006|Diabetic Nephropathy|diabetic nephropathy
467676|NCT01566006|proteinuria|proteinuria
467677|NCT01566006|Diabetic Nephropathy in Chronic Kidney Disease patients stages 2-4|diabetic nephropathy in chronic kidney disease patients stages 2-4
467678|NCT01565980|Lung cancer|lung cancer
467679|NCT01565980|mindfulness therapy|mindfulness therapy
467680|NCT01565980|active treatment (radiation and/or chemotherapy)|active treatment (radiation and/or chemotherapy)
467681|NCT01565967|AutoLog|autolog
467682|NCT01565967|Post market release|post market release
467683|NCT01565967|Non-interventional|non-interventional
467684|NCT01565954|Sickle Cell Disease|sickle cell disease
467685|NCT01565954|Respiration Disorders|respiration disorders
467686|NCT01565954|Polysomnography|polysomnography
467687|NCT01565941|Cardiovascular|cardiovascular
467688|NCT01565941|Respiratory|respiratory
467689|NCT01565941|Failure|failure
467690|NCT01565941|Heart|heart
467691|NCT01565941|Lung|lung
467692|NCT01565941|Continuous glucose monitoring|continuous glucose monitoring
467693|NCT01565941|Tight glycemic control|tight glycemic control
467694|NCT01565941|Subcutaneous|subcutaneous
467695|NCT01565941|Insulin|insulin
467696|NCT01565941|Algorithm|algorithm
467697|NCT01565928|Prostate cancer|prostate cancer
467698|NCT01565928|docetaxel|docetaxel
467699|NCT01565928|MDV3100|mdv3100
467700|NCT01565928|enzalutamide|enzalutamide
467701|NCT01565928|Xtandi|xtandi
467702|NCT01565902|BAF312|baf312
467703|NCT01565902|Pharmacokinetics|pharmacokinetics
467704|NCT01565902|Hepatic impairment|hepatic impairment
467705|NCT01565876|weight bearing|weight bearing
467706|NCT01565876|physiological load|physiological load
467707|NCT01565863|Perceived Disability|perceived disability
467708|NCT01565863|Mental Wellness|mental wellness
467709|NCT01565863|Employment|employment
467710|NCT01565863|Social Integration and Engagement|social integration and engagement
467711|NCT01565863|Goal Achievement|goal achievement
467712|NCT01565850|HIV-1|hiv-1
467713|NCT01565850|HIV|hiv
467714|NCT01565850|Treatment-Naive|treatment-naive
467715|NCT01565837|Melanoma|melanoma
467716|NCT01565837|Malignant Melanoma|malignant melanoma
467717|NCT01565837|Metastatic|metastatic
467718|NCT01565837|Oligometastatic|oligometastatic
467719|NCT01565837|Radiosurgery|radiosurgery
467720|NCT01565837|Radiosurgery, Stereotactic|radiosurgery, stereotactic
467721|NCT01565837|Stereotactic Radiosurgery|stereotactic radiosurgery
467722|NCT01565837|Ipilimumab|ipilimumab
467723|NCT01565837|Yervoy|yervoy
467724|NCT01565837|MDX-010|mdx-010
467725|NCT01565837|Circulating Tumor Cells|circulating tumor cells
467726|NCT01565811|colon neoplasm, rectal neoplasm, liver metastasis|colon neoplasm, rectal neoplasm, liver metastasis
467727|NCT01565798|healthcare-acquired infections|healthcare-acquired infections
467728|NCT01565798|colonization|colonization
467729|NCT01565798|copper-alloy surfaces|copper-alloy surfaces
467730|NCT01565785|Child parent home self-management|child parent home self-management
467731|NCT01565772|Lung cancer|lung cancer
467732|NCT01565772|Stage III|stage iii
467733|NCT01565759|Gene expression|gene expression
467734|NCT01565759|Lithium|lithium
467735|NCT01565759|Healthy volunteers|healthy volunteers
467736|NCT01565759|Lymphoblastoid cell lines|lymphoblastoid cell lines
467737|NCT01565746|BAY88-8223|bay88-8223
467738|NCT01565746|radium-223 dichloride|radium-223 dichloride
467739|NCT01565746|prostate cancer|prostate cancer
467740|NCT01565720|Isavuconazole|isavuconazole
467741|NCT01565720|Healthy Volunteers|healthy volunteers
467742|NCT01565720|BAL8557|bal8557
467743|NCT01565707|Pediatric|pediatric
467744|NCT01565707|Solifenacin succinate suspension|solifenacin succinate suspension
467745|NCT01565707|Phase 3|phase 3
467746|NCT01565707|Pharmacokinetics|pharmacokinetics
467747|NCT01565707|Overactive bladder (OAB)|overactive bladder (oab)
467748|NCT01565694|Cognitive Function|cognitive function
467749|NCT01565694|Phase 3|phase 3
467750|NCT01565694|Neurogenic Detrusor Overactivity|neurogenic detrusor overactivity
467751|NCT01565694|Pharmacokinetics|pharmacokinetics
467752|NCT01565694|Ocular Accommodation|ocular accommodation
467753|NCT01565694|Urodynamics|urodynamics
467754|NCT01565681|Healthy Volunteers|healthy volunteers
467755|NCT01565681|B cell CD40 receptor occupancy|b cell cd40 receptor occupancy
467756|NCT01565681|anti-CD40 monoclonal antibody|anti-cd40 monoclonal antibody
467757|NCT01565668|FLT3-ITD positive Acute Myeloid Leukemia (AML)|flt3-itd positive acute myeloid leukemia (aml)
467759|NCT01565668|Relapse|relapse
467760|NCT01565668|Refractory|refractory
467761|NCT01565655|Rheumatoid Arthritis|rheumatoid arthritis
467762|NCT01565655|ASP015K|asp015k
467763|NCT01565642|Dementia, decision making|dementia, decision making
467764|NCT01565629|Autism|autism
467765|NCT01565629|Asperger's Syndrome|asperger's syndrome
467766|NCT01565629|Treatment|treatment
467767|NCT01565629|Cognitive-behavioral therapy|cognitive-behavioral therapy
467768|NCT01565629|Anxiety|anxiety
467769|NCT01565629|Children|children
467770|NCT01565629|Therapy|therapy
467771|NCT01565616|Severe Sickle Cell Disease|severe sickle cell disease
467772|NCT01565616|Hematopoietic cell transplantation (HCT)|hematopoietic cell transplantation (hct)
467773|NCT01565616|Hematopoietic Stem Cell Therapy|hematopoietic stem cell therapy
467774|NCT01565616|Bone Marrow Transplant|bone marrow transplant
467775|NCT01565616|Hematologic Diseases|hematologic diseases
467776|NCT01565616|Genetic Diseases|genetic diseases
467777|NCT01565616|Anemia|anemia
467778|NCT01565616|Hemolytic|hemolytic
467779|NCT01565616|Congenital|congenital
467780|NCT01565616|Human Leukocyte Antigen|human leukocyte antigen
467783|NCT01565603|Exercise|exercise
467784|NCT01565603|Sleep|sleep
467785|NCT01565603|Brain|brain
467786|NCT01565603|Neuromuscular function|neuromuscular function
467787|NCT01565603|Heart|heart
467788|NCT01565590|aneurysmal subarachnoid hemorrhage|aneurysmal subarachnoid hemorrhage
467789|NCT01565590|dexmedetomidine|dexmedetomidine
467790|NCT01565590|cytokines|cytokines
467791|NCT01565577|Neisseria meningitidis B:14, P1-7, 16|neisseria meningitidis b:14, p1-7, 16
467792|NCT01565577|Serum bactericidal activity|serum bactericidal activity
467793|NCT01565577|Menbvac|menbvac
467794|NCT01565564|Gestational diabetes mellitus|gestational diabetes mellitus
467795|NCT01565564|intervention|intervention
467796|NCT01565564|shared care|shared care
467797|NCT01565564|pregnancy outcome|pregnancy outcome
467798|NCT01565564|macrosomia|macrosomia
467799|NCT01565564|pregnancy-induced hypertension|pregnancy-induced hypertension
467800|NCT01565551|Traumatic Brain Injury|traumatic brain injury
467801|NCT01565551|Common Data Elements|common data elements
467802|NCT01565551|Prognostic Models|prognostic models
467803|NCT01565551|Neuroimaging|neuroimaging
467804|NCT01565551|Biomarkers|biomarkers
467805|NCT01565551|Genetic Variants|genetic variants
467806|NCT01565551|Concussion|concussion
467807|NCT01565551|Psychological Health|psychological health
467808|NCT01565538|Cancer|cancer
467809|NCT01565538|Non-small-cell lung cancer|non-small-cell lung cancer
467810|NCT01565538|Adenocarcinoma|adenocarcinoma
467811|NCT01565538|EGFR gene mutation|egfr gene mutation
467812|NCT01565538|Chemotherapy|chemotherapy
467813|NCT01565538|Pemetrexed|pemetrexed
467814|NCT01565538|Erlotinib|erlotinib
467815|NCT01565525|well child visit|well child visit
467816|NCT01565525|anticipatory guidance|anticipatory guidance
467817|NCT01565525|obesity prevention|obesity prevention
467818|NCT01565525|infant feeding|infant feeding
467819|NCT01565512|randomized trial|randomized trial
467820|NCT01565512|robotic prostatectomy|robotic prostatectomy
467821|NCT01565512|prostate cancer|prostate cancer
467822|NCT01565512|foley catheter discomfort|foley catheter discomfort
596971|NCT01029873|TCR|tcr
467823|NCT01565499|Neoadjuvant nab-paclitaxel luminal breast cancer|neoadjuvant nab-paclitaxel luminal breast cancer
467824|NCT01565486|operation time|operation time
467825|NCT01565486|complication rate|complication rate
467826|NCT01565486|costs|costs
467827|NCT01565486|admission time|admission time
467828|NCT01565486|RFS|rfs
467829|NCT01565486|OS|os
467830|NCT01565473|non-motor symptoms|non-motor symptoms
467831|NCT01565460|pancreas|pancreas
467832|NCT01565460|biliary|biliary
467833|NCT01565460|stricture|stricture
467834|NCT01565395|ALS|als
467835|NCT01565395|PD|pd
467836|NCT01565382|Amyloid imaging|amyloid imaging
467837|NCT01565382|Positron Emission Tomography|positron emission tomography
467838|NCT01565382|18F-AV-45|18f-av-45
467839|NCT01565382|florbetapir F 18|florbetapir f 18
467840|NCT01565382|Diagnostic imaging|diagnostic imaging
467841|NCT01565369|Amyloid imaging|amyloid imaging
467842|NCT01565369|Positron Emission Tomography|positron emission tomography
467843|NCT01565369|18F-AV-45|18f-av-45
467844|NCT01565369|florbetapir F 18|florbetapir f 18
467845|NCT01565369|Diagnostic imaging|diagnostic imaging
467846|NCT01565356|Amyloid imaging|amyloid imaging
467847|NCT01565356|Positron Emission Tomography|positron emission tomography
467848|NCT01565356|18F-AV-45|18f-av-45
467849|NCT01565356|florbetapir F 18|florbetapir f 18
467850|NCT01565356|Diagnostic imaging|diagnostic imaging
467851|NCT01565343|Amyloid imaging|amyloid imaging
467852|NCT01565343|Positron Emission Tomography|positron emission tomography
467853|NCT01565343|18F-AV-45|18f-av-45
467854|NCT01565343|florbetapir F 18|florbetapir f 18
467855|NCT01565343|Diagnostic imaging|diagnostic imaging
467856|NCT01565330|Amyloid imaging|amyloid imaging
467857|NCT01565330|Positron Emission Tomography|positron emission tomography
467858|NCT01565330|18F-AV-45|18f-av-45
467859|NCT01565330|florbetapir F 18|florbetapir f 18
467860|NCT01565330|Diagnostic imaging|diagnostic imaging
467861|NCT01565304|Teen pregnancy|teen pregnancy
467862|NCT01565304|Sexually transmitted infections|sexually transmitted infections
467863|NCT01565304|Sexual risk behaviors|sexual risk behaviors
467864|NCT01565291|Amyloid imaging|amyloid imaging
467865|NCT01565291|Positron Emission Tomography|positron emission tomography
467866|NCT01565291|18F-AV-45|18f-av-45
467867|NCT01565291|florbetapir F 18|florbetapir f 18
467868|NCT01565291|Diagnostic imaging|diagnostic imaging
467869|NCT01565278|Parenteral nutrition|parenteral nutrition
467870|NCT01565278|fish oil|fish oil
467871|NCT01565278|liver disease|liver disease
467872|NCT01565278|Omegaven|omegaven
467873|NCT01565278|hepatic|hepatic
467874|NCT01565278|liver biopsy|liver biopsy
467875|NCT01565278|bilirubin|bilirubin
467876|NCT01565265|ovarian hyperstimulation|ovarian hyperstimulation
467877|NCT01565265|GnRH antagonist|gnrh antagonist
467878|NCT01565265|GnRH agonist|gnrh agonist
467879|NCT01565265|assisted reproduction|assisted reproduction
467880|NCT01565265|FSH|fsh
467881|NCT01565265|LH|lh
467883|NCT01565239|Warfarin|warfarin
467884|NCT01565239|Monitoring|monitoring
467992|NCT01564680|Paracetamol|paracetamol
467885|NCT01565239|prothrombin time|prothrombin time
467886|NCT01565239|Fiix prothrombin time|fiix prothrombin time
467887|NCT01565239|international normalized ratio (INR)|international normalized ratio (inr)
467888|NCT01565239|new test|new test
467889|NCT01565226|Capnography|capnography
467891|NCT01565226|neonates|neonates
467892|NCT01565226|High Frequency ventilation (HFV)|high frequency ventilation (hfv)
467893|NCT01565213|primary health care,common mental disorders,|primary health care,common mental disorders,
467894|NCT01565213|group therapy|group therapy
467895|NCT01565200|HER2|her2
467896|NCT01565200|Metastatic Breast Cancer|metastatic breast cancer
467897|NCT01565187|Hand Transplantation|hand transplantation
467898|NCT01565174|cannabis|cannabis
467899|NCT01565174|THC|thc
467900|NCT01565174|COMT|comt
467901|NCT01565174|psychosis|psychosis
467902|NCT01565174|D2|d2
467903|NCT01565161|Obesity|obesity
467904|NCT01565161|Overweight|overweight
467905|NCT01565148|Diabetic Macular Edema (DME)|diabetic macular edema (dme)
467906|NCT01565109|NESC|nesc
467907|NCT01565109|NEOADJUVANT|neoadjuvant
467908|NCT01565109|GASTRIC|gastric
467909|NCT01565070|Osteoarthritis|osteoarthritis
467910|NCT01565070|Pain|pain
467911|NCT01565070|Quality of life|quality of life
467912|NCT01565057|emulsion|emulsion
467913|NCT01565057|emptying|emptying
467914|NCT01565057|protein|protein
467915|NCT01565057|layering|layering
467916|NCT01565044|Stroke|stroke
467917|NCT01565044|hemiplegia|hemiplegia
467918|NCT01565044|automatic pilot|automatic pilot
467919|NCT01565044|upper-limb rehabilitation|upper-limb rehabilitation
467920|NCT01565031|Asthma|asthma
467921|NCT01565018|Rotigotine|rotigotine
467922|NCT01565018|Neupro®|neupro®
467923|NCT01565018|Transdermal Patch|transdermal patch
467924|NCT01565018|Bioequivalence|bioequivalence
467925|NCT01565005|MCPH|mcph
467926|NCT01565005|FANCONI ANEMIA|fanconi anemia
467927|NCT01564992|Parkinson's disease|parkinson's disease
467928|NCT01564992|Pharmacogenetics|pharmacogenetics
467929|NCT01564992|Genetics|genetics
467930|NCT01564979|botulinum toxin|botulinum toxin
467931|NCT01564979|facial nerve|facial nerve
467932|NCT01564979|hemifacial spasm|hemifacial spasm
467933|NCT01564979|tears|tears
467934|NCT01564966|transplantation|transplantation
467935|NCT01564966|inflammation|inflammation
467936|NCT01564966|endothelial dysfunction|endothelial dysfunction
467937|NCT01564953|vitamin D|vitamin d
467938|NCT01564953|calcium|calcium
467939|NCT01564953|magnesium|magnesium
467940|NCT01564953|COPD|copd
467941|NCT01564953|QoL|qol
467942|NCT01564940|Cervical cap insemination|cervical cap insemination
467943|NCT01564940|Usability Study|usability study
467944|NCT01564927|deqi electroacupuncture|deqi electroacupuncture
467945|NCT01564927|BP HR HRV|bp hr hrv
467946|NCT01564875|Simvast CR|simvast cr
467947|NCT01564875|Zocor|zocor
467948|NCT01564862|Drug Therapy|drug therapy
467949|NCT01564849|Pomegranate fruit extract|pomegranate fruit extract
467950|NCT01564849|Sinusitis|sinusitis
467951|NCT01564849|rhinitis|rhinitis
467952|NCT01564849|nasal polyps|nasal polyps
467953|NCT01564823|Crohn´s disease|crohn´s disease
467954|NCT01564823|Metronidazole|metronidazole
467955|NCT01564823|Azathioprine|azathioprine
467956|NCT01564823|Adalimumab|adalimumab
467957|NCT01564823|post-chirurgic recurrence|post-chirurgic recurrence
467958|NCT01564810|liver metastasis|liver metastasis
467959|NCT01564810|colorectal cancer|colorectal cancer
467960|NCT01564810|cetuximab|cetuximab
467961|NCT01564810|chemotherapy|chemotherapy
467962|NCT01564797|Diabetes|diabetes
467963|NCT01564797|haemoglobin A1C|haemoglobin a1c
467964|NCT01564797|Hispanic|hispanic
467965|NCT01564797|Behavioural Intervention|behavioural intervention
467966|NCT01564771|Pneumococcal serotypes|pneumococcal serotypes
467967|NCT01564771|Community Acquired Pneumonia (CAP)|community acquired pneumonia (cap)
467968|NCT01564758|non-interventional|non-interventional
467969|NCT01564758|non-comparative|non-comparative
467970|NCT01564758|open-label study|open-label study
467971|NCT01564758|safety|safety
467972|NCT01564758|Linezolid|linezolid
467973|NCT01564758|gram positive infections|gram positive infections
467974|NCT01564758|Filipino|filipino
467975|NCT01564732|morbid obesity|morbid obesity
467976|NCT01564732|gastric band|gastric band
467977|NCT01564719|clergy|clergy
467978|NCT01564719|weight loss|weight loss
467979|NCT01564719|holistic|holistic
467980|NCT01564719|stress|stress
467981|NCT01564719|spiritual|spiritual
467982|NCT01564706|Amyloid imaging|amyloid imaging
467983|NCT01564706|Positron Emission Tomography|positron emission tomography
467984|NCT01564706|18F-AV-45|18f-av-45
467985|NCT01564706|florbetapir F 18|florbetapir f 18
467986|NCT01564706|Diagnostic imaging|diagnostic imaging
467987|NCT01564693|anorexia|anorexia
467988|NCT01564693|cancer|cancer
467989|NCT01564693|hypothalamus|hypothalamus
467990|NCT01564693|inflammation|inflammation
467991|NCT01564680|Lower abdominal surgery|lower abdominal surgery
467993|NCT01564680|Lornoxicam|lornoxicam
467994|NCT01564680|Morphine|morphine
467995|NCT01564667|PTSD|ptsd
467996|NCT01564667|Posttraumatic Stress|posttraumatic stress
467997|NCT01564667|Post Traumatic Stress|post traumatic stress
467998|NCT01564667|Attention Bias|attention bias
467999|NCT01564667|Threat Bias|threat bias
468000|NCT01564667|Combat|combat
468001|NCT01564667|Warzone|warzone
468002|NCT01564641|knee|knee
468003|NCT01564641|osteoarthritis|osteoarthritis
468004|NCT01564641|bicompartmental|bicompartmental
468005|NCT01564641|arthroplasty|arthroplasty
468006|NCT01564641|joint diseases|joint diseases
468007|NCT01564628|CAD|cad
468008|NCT01564615|Catheter related bloodstream infection|catheter related bloodstream infection
468009|NCT01564615|Umbilical venous catheter|umbilical venous catheter
468010|NCT01564615|Silver|silver
468011|NCT01564615|Preterm infants|preterm infants
468012|NCT01564602|2-channel single port laparoscopy|2-channel single port laparoscopy
468013|NCT01564602|multiple-channel port laparoscopy|multiple-channel port laparoscopy
468014|NCT01564576|Laparoscopic surgery|laparoscopic surgery
468015|NCT01564576|Anesthesiology|anesthesiology
468016|NCT01564576|Neuromuscular blockade|neuromuscular blockade
468017|NCT01564550|Type 2 diabetes|type 2 diabetes
468018|NCT01564550|Very-low-density-lipoprotein(VLDL)|very-low-density-lipoprotein(vldl)
468019|NCT01564550|VLDL1|vldl1
468020|NCT01564550|VLDL2|vldl2
468021|NCT01564550|hyperinsulinemia|hyperinsulinemia
468022|NCT01564550|diet|diet
468023|NCT01564537|Drug therapy|drug therapy
468024|NCT01564524|Craniomaxillofacial (CMF) Battle-injured (BI)|craniomaxillofacial (cmf) battle-injured (bi)
468025|NCT01564524|Facial Trauma|facial trauma
468026|NCT01564524|Fat Grafts|fat grafts
468027|NCT01564524|Autogenous Fat Transfers (AFT)|autogenous fat transfers (aft)
468028|NCT01564524|Wounded warriors|wounded warriors
468029|NCT01564511|Multiple Sclerosis|multiple sclerosis
468030|NCT01564511|Robotic Rahabilitation|robotic rahabilitation
468031|NCT01564511|Fatigue|fatigue
468032|NCT01564511|Gait disorder|gait disorder
468033|NCT01564498|anthocyanins|anthocyanins
468034|NCT01564498|antioxidant|antioxidant
468035|NCT01564498|polyphenols|polyphenols
468036|NCT01564498|bioavailability|bioavailability
468037|NCT01564498|cholesterol|cholesterol
468038|NCT01564498|insulin sensitivity|insulin sensitivity
468039|NCT01564498|glucose tolerance|glucose tolerance
468040|NCT01564498|atherosclerosis|atherosclerosis
468041|NCT01564498|metabolic syndrome|metabolic syndrome
468042|NCT01564446|medication|medication
468043|NCT01564446|discharge|discharge
468044|NCT01564446|adherence|adherence
468045|NCT01564446|compliance|compliance
468046|NCT01564446|secure message|secure message
468047|NCT01564433|robotics|robotics
468048|NCT01564433|rehabilitation|rehabilitation
468049|NCT01564433|gait|gait
468050|NCT01564433|cerebral palsy|cerebral palsy
468051|NCT01564420|pharmacokinetic/pharmacodynamic modeling|pharmacokinetic/pharmacodynamic modeling
468052|NCT01564420|intrathecal morphine|intrathecal morphine
468053|NCT01564420|postoperative analgesia|postoperative analgesia
468054|NCT01564420|patient-controlled analgesia device|patient-controlled analgesia device
468055|NCT01564407|ICX‐RHY‐013|icx‐rhy‐013
468056|NCT01564407|Restrictive scar contracture|restrictive scar contracture
468057|NCT01564407|Restrictive hypertrophic scar|restrictive hypertrophic scar
468058|NCT01564407|Burn Scar|burn scar
468059|NCT01564407|Burn Scar contractures|burn scar contractures
468060|NCT01564407|Scar|scar
468061|NCT01564394|qigong|qigong
468062|NCT01564394|mindfulness meditation|mindfulness meditation
468063|NCT01564394|fatigue|fatigue
468064|NCT01564394|prostate cancer|prostate cancer
468065|NCT01564381|Cardiovascular disease|cardiovascular disease
468066|NCT01564368|stage II breast cancer|stage ii breast cancer
468067|NCT01564368|stage IIIA breast cancer|stage iiia breast cancer
468068|NCT01564368|stage IIIB breast cancer|stage iiib breast cancer
468069|NCT01564368|stage IIIC breast cancer|stage iiic breast cancer
468070|NCT01564368|stage IV breast cancer|stage iv breast cancer
468071|NCT01564368|HER2-negative breast cancer|her2-negative breast cancer
468072|NCT01564368|HER2-positive breast cancer|her2-positive breast cancer
468073|NCT01564342|wound irrigation|wound irrigation
468074|NCT01564342|tap water irrigation|tap water irrigation
468075|NCT01564342|wound infection|wound infection
468076|NCT01564342|wound irrigation solution|wound irrigation solution
468077|NCT01564329|endostar|endostar
468078|NCT01564329|CT Perfusion|ct perfusion
468079|NCT01564329|Advanced Primary Lung Adenocarcinoma|advanced primary lung adenocarcinoma
468080|NCT01564303|Carnitine|carnitine
468081|NCT01564303|Phosphodiesterase type 5 (PDE5) inhibitor|phosphodiesterase type 5 (pde5) inhibitor
468082|NCT01564303|Contrast Media-induced Nephropathy (CMN)|contrast media-induced nephropathy (cmn)
468083|NCT01564290|acute diarrhea|acute diarrhea
468084|NCT01564290|probiotics|probiotics
468085|NCT01564290|children|children
468086|NCT01564264|Uterine Neoplasms|uterine neoplasms
468087|NCT01564264|Sentinel Lymph Node Biopsy|sentinel lymph node biopsy
468088|NCT01564238|calcium retention|calcium retention
468089|NCT01564238|sodium retention|sodium retention
468090|NCT01564225|XLHED|xlhed
468091|NCT01564212|heat loss|heat loss
468092|NCT01564212|laminar airflow|laminar airflow
468093|NCT01564212|operating rooms|operating rooms
468094|NCT01564160|Fish Oil|fish oil
468095|NCT01564160|EPA|epa
468096|NCT01564160|DHA|dha
468097|NCT01564160|Omega-Score|omega-score
468098|NCT01564160|Omega-3 Fatty Acids|omega-3 fatty acids
468099|NCT01564160|Green-Lipped Mussel|green-lipped mussel
468100|NCT01564160|Omega-score < 5.2%|omega-score < 5.2%
468101|NCT01564147|Therapeutic Education, Rheumatoid Arthritis|therapeutic education, rheumatoid arthritis
468102|NCT01564134|response vaccination|response vaccination
468103|NCT01564108|Intravitreal Ranibizumab|intravitreal ranibizumab
468104|NCT01564108|Non-infectious uveitis|non-infectious uveitis
468105|NCT01564108|Refractory Cystoid Macular Oedema|refractory cystoid macular oedema
468106|NCT01564108|Lucentis|lucentis
468107|NCT01564108|LIMO|limo
468108|NCT01564095|Liver transplantation|liver transplantation
468109|NCT01564095|EDC|edc
468110|NCT01564095|IRI|iri
468111|NCT01564095|graft survival|graft survival
468112|NCT01564095|graft function|graft function
468113|NCT01564095|graft preconditioning|graft preconditioning
468114|NCT01564095|Tacrolimus rinse|tacrolimus rinse
468115|NCT01564095|randomised multicenter trial|randomised multicenter trial
468116|NCT01564082|endotracheal intubation|endotracheal intubation
468117|NCT01564082|GlideScope|glidescope
468118|NCT01564069|Chronic pain|chronic pain
468119|NCT01564069|Intrathecal pain management|intrathecal pain management
468120|NCT01564056|Adjuvant systemic treatment|adjuvant systemic treatment
468121|NCT01564056|Breast cancer|breast cancer
468122|NCT01564056|Elderly patients|elderly patients
468123|NCT01564030|Pregnancy|pregnancy
468124|NCT01564030|Respiratory aspiration|respiratory aspiration
468125|NCT01564030|Gastric contents|gastric contents
468126|NCT01564030|Ultrasound|ultrasound
468127|NCT01564017|Allergy|allergy
597271|NCT01028638|PET|pet
468128|NCT01564017|Allergic rhinoconjunctivitis|allergic rhinoconjunctivitis
468129|NCT01564017|Immunotherapy|immunotherapy
468130|NCT01564017|D. pteronyssinus|d. pteronyssinus
468131|NCT01564017|house dust allergy|house dust allergy
468132|NCT01564004|breech presentation at term|breech presentation at term
468133|NCT01564004|pregnancy|pregnancy
468134|NCT01564004|external cephalic version (ECV)|external cephalic version (ecv)
468135|NCT01564004|clinical hypnosis|clinical hypnosis
468136|NCT01564004|neuro-linguistic programming (NLP)|neuro-linguistic programming (nlp)
468137|NCT01563991|surgery|surgery
468138|NCT01563991|fluid|fluid
468139|NCT01563991|morbidity|morbidity
468140|NCT01563978|Rheumatoid Arthritis|rheumatoid arthritis
468141|NCT01563965|Preoperative fasting|preoperative fasting
468142|NCT01563965|Acute phase proteins|acute phase proteins
468143|NCT01563965|Carbohydrates|carbohydrates
468144|NCT01563965|Protein hydrolizate|protein hydrolizate
468145|NCT01563965|Inflammatory response|inflammatory response
468146|NCT01563965|Surgery|surgery
468147|NCT01563939|Labour analgesia|labour analgesia
468148|NCT01563939|Pregnancy|pregnancy
468149|NCT01563939|IVPCA|ivpca
468150|NCT01563913|Parkinsons disease|parkinsons disease
468151|NCT01563913|supplement|supplement
468153|NCT01563913|dyskinesia|dyskinesia
468154|NCT01563913|abnormal movements|abnormal movements
468155|NCT01563900|fatigue|fatigue
468156|NCT01563900|multiple sclerosis|multiple sclerosis
468157|NCT01563900|sleep apnea|sleep apnea
468158|NCT01563900|CPAP|cpap
468159|NCT01563887|Type 1 Diabetes|type 1 diabetes
468160|NCT01563887|Hypoglycemia|hypoglycemia
468161|NCT01563887|Driving|driving
468162|NCT01563887|Driving safety|driving safety
468163|NCT01563887|Internet|internet
468164|NCT01563887|Web|web
468165|NCT01563887|Treatment|treatment
468166|NCT01563887|Intervention|intervention
468167|NCT01563874|Antibodies|antibodies
468168|NCT01563874|Reverse Phase Microarrays|reverse phase microarrays
468169|NCT01563874|Epigenetics|epigenetics
468170|NCT01563874|Acetylation|acetylation
468171|NCT01563874|Methylation|methylation
468172|NCT01563874|Lymphoma|lymphoma
468173|NCT01563861|contiguous stage II adult diffuse large cell lymphoma|contiguous stage ii adult diffuse large cell lymphoma
468174|NCT01563861|noncontiguous stage II adult diffuse large cell lymphoma|noncontiguous stage ii adult diffuse large cell lymphoma
468175|NCT01563861|stage III adult diffuse large cell lymphoma|stage iii adult diffuse large cell lymphoma
468176|NCT01563861|stage IV adult diffuse large cell lymphoma|stage iv adult diffuse large cell lymphoma
468177|NCT01563835|Termination of pregnancy|termination of pregnancy
468178|NCT01563835|Epidural|epidural
468179|NCT01563835|IV PCA|iv pca
468180|NCT01563822|Follicular Fluid|follicular fluid
468181|NCT01563822|uterine cavity|uterine cavity
468182|NCT01563822|Implantation rates|implantation rates
468183|NCT01563822|ICSI|icsi
468184|NCT01563796|bladder cancer|bladder cancer
468185|NCT01563796|TCC|tcc
468186|NCT01563796|urine|urine
468187|NCT01563796|protein ELISA|protein elisa
468188|NCT01563783|Fibroids|fibroids
468189|NCT01563783|Myomas|myomas
468190|NCT01563783|leiomyomata|leiomyomata
468191|NCT01563783|menorrhagia|menorrhagia
468192|NCT01563783|Acessa Procedure|acessa procedure
468291|NCT01563276|Falls|falls
468193|NCT01563783|Radiofrequency Ablation|radiofrequency ablation
468194|NCT01563783|RFA|rfa
468195|NCT01563770|Hyperlipidemia|hyperlipidemia
468196|NCT01563770|Hypertension|hypertension
468197|NCT01563770|Vasodilation|vasodilation
468198|NCT01563770|Oxidative stress|oxidative stress
468199|NCT01563770|Inflammation|inflammation
468200|NCT01563770|Hemostasis|hemostasis
468201|NCT01563770|Hemorheology|hemorheology
468202|NCT01563770|Cardiovascular diseases|cardiovascular diseases
468203|NCT01563770|Cardiovascular agents|cardiovascular agents
468204|NCT01563770|Salvia miltiorrhiza|salvia miltiorrhiza
468205|NCT01563770|Danshen|danshen
468206|NCT01563770|Danshen root extract|danshen root extract
468207|NCT01563770|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action
468208|NCT01563770|Therapeutic Uses|therapeutic uses
468209|NCT01563744|colonoscopy|colonoscopy
468210|NCT01563744|bowel preparation|bowel preparation
468211|NCT01563744|tolerability|tolerability
468212|NCT01563744|EGD-assisted|egd-assisted
468213|NCT01563731|Blood pressure medicines|blood pressure medicines
468214|NCT01563731|Lipid lowering medicines|lipid lowering medicines
468215|NCT01563731|Hypertension|hypertension
468216|NCT01563731|Stroke|stroke
468217|NCT01563731|Dementia|dementia
468218|NCT01563731|Heart attack|heart attack
468219|NCT01563731|Heart failure|heart failure
468220|NCT01563705|Neuromuscular Disorders|neuromuscular disorders
468221|NCT01563705|GSD III|gsd iii
468222|NCT01563705|glycogen storage disease|glycogen storage disease
468223|NCT01563692|RSV|rsv
468224|NCT01563692|Immune response|immune response
468225|NCT01563679|cancer|cancer
468226|NCT01563679|locoregional therapies|locoregional therapies
468227|NCT01563679|RFA|rfa
468228|NCT01563679|Cryoablation|cryoablation
468229|NCT01563679|Microwave ablation|microwave ablation
468230|NCT01563679|chemical ablation|chemical ablation
468231|NCT01563679|Irreversible electroporation|irreversible electroporation
468232|NCT01563653|predicting surgical success|predicting surgical success
468233|NCT01563653|simple diagnostic test device|simple diagnostic test device
468234|NCT01563640|dengue|dengue
468235|NCT01563588|breast cancer|breast cancer
468236|NCT01563588|chemotherapy|chemotherapy
468237|NCT01563588|first line treatment|first line treatment
468238|NCT01563588|treatments include a chemotherapy|treatments include a chemotherapy
468239|NCT01563588|last treatment not performed more than 9 months earlier|last treatment not performed more than 9 months earlier
468240|NCT01563575|Recognition Process|recognition process
468241|NCT01563575|Health Promotion|health promotion
468242|NCT01563575|HPH|hph
468243|NCT01563575|WHO|who
468244|NCT01563575|Hospitals|hospitals
468245|NCT01563575|Health Services|health services
468246|NCT01563575|Health Gain|health gain
468247|NCT01563575|Service Delivery|service delivery
468248|NCT01563575|Quality Management|quality management
468249|NCT01563536|Hepatitis C,Genotype 1|hepatitis c,genotype 1
468250|NCT01563510|Hepatolithiasis|hepatolithiasis
468251|NCT01563510|Minimal invasive surgery|minimal invasive surgery
468252|NCT01563510|Laparoscopic hepatectomy|laparoscopic hepatectomy
468253|NCT01563510|Choledochoscope|choledochoscope
468254|NCT01563484|Primary Hepatocellular Carcinoma(HCC)|primary hepatocellular carcinoma(hcc)
468255|NCT01563484|Transarterial chemoembolization (TACE)|transarterial chemoembolization (tace)
468256|NCT01563484|Liver function|liver function
468257|NCT01563484|Renal function|renal function
468258|NCT01563432|crossover|crossover
468259|NCT01563432|pharmacokinetic|pharmacokinetic
468260|NCT01563432|hyperuricemia|hyperuricemia
468261|NCT01563432|gout|gout
468262|NCT01563419|Insulin|insulin
468263|NCT01563419|Diabetes|diabetes
468264|NCT01563419|Low vision|low vision
468265|NCT01563406|Needleless connectors|needleless connectors
468266|NCT01563406|catheter hubs|catheter hubs
468267|NCT01563393|tool for nutritional evaluation|tool for nutritional evaluation
468268|NCT01563393|children|children
468269|NCT01563393|malnutrition|malnutrition
468270|NCT01563380|total knee arthroplasty|total knee arthroplasty
468271|NCT01563380|osteoarthritis|osteoarthritis
468272|NCT01563380|autologous Platelet rich plasma|autologous platelet rich plasma
468273|NCT01563380|complications|complications
468274|NCT01563380|blood loss|blood loss
468275|NCT01563380|Pain|pain
468276|NCT01563380|functional outcome|functional outcome
468277|NCT01563367|Anaemia|anaemia
468278|NCT01563367|Cardiac surgery|cardiac surgery
468279|NCT01563354|neuroendocrine carcinoma; lung; thymus; pasireotide LAR; everolimus|neuroendocrine carcinoma; lung; thymus; pasireotide lar; everolimus
468280|NCT01563328|Dolutegravir, GSK1349572, DTG, BCV, TVR, drug interaction|dolutegravir, gsk1349572, dtg, bcv, tvr, drug interaction
468281|NCT01563315|Community-Acquired Infections|community-acquired infections
468282|NCT01563315|Pneumonia/microbiology|pneumonia/microbiology
468283|NCT01563315|Pneumonia/diagnosis|pneumonia/diagnosis
468284|NCT01563315|Prognosis|prognosis
468285|NCT01563315|Prospective Studies|prospective studies
468286|NCT01563302|Advanced Cancers|advanced cancers
468287|NCT01563302|DLBCL|dlbcl
468288|NCT01563302|Advanced Lymphoma|advanced lymphoma
468289|NCT01563276|Progressive Supranuclear Palsy|progressive supranuclear palsy
468290|NCT01563276|PSP|psp
468292|NCT01563276|Gait|gait
468293|NCT01563276|Balance|balance
468294|NCT01563276|Parkinson's Disease|parkinson's disease
468296|NCT01563263|IC43|ic43
468297|NCT01563263|Pseudomonas Aeruginosa|pseudomonas aeruginosa
468298|NCT01563263|mechanically ventilated ICU patients|mechanically ventilated icu patients
468299|NCT01563263|ICU patients|icu patients
468300|NCT01563250|Acute Coronary Syndrome|acute coronary syndrome
468301|NCT01563250|Cardiac Biomarkers|cardiac biomarkers
468302|NCT01563250|point of care testing|point of care testing
468303|NCT01563224|GABA-B|gaba-b
468304|NCT01563211|breast cancer therapy|breast cancer therapy
468305|NCT01563211|toxicity|toxicity
468306|NCT01563211|side effect profile|side effect profile
468307|NCT01563198|MRI departments and facilities|mri departments and facilities
468308|NCT01563198|Noncompletion of MRI|noncompletion of mri
468309|NCT01563185|JIA|jia
468310|NCT01563185|ibuprofen|ibuprofen
468311|NCT01563185|famotidine|famotidine
468312|NCT01563185|pediatrics|pediatrics
468313|NCT01563185|for > 1 month|for > 1 month
468314|NCT01563159|Belgium|belgium
468315|NCT01563159|hospitals|hospitals
468316|NCT01563159|Rotavirus|rotavirus
468317|NCT01563146|Rotavirus|rotavirus
468318|NCT01563146|hospitals|hospitals
468319|NCT01563146|Belgium|belgium
468320|NCT01563133|endomicroscopy|endomicroscopy
468321|NCT01563133|needle-based|needle-based
468322|NCT01563133|pancreatic|pancreatic
468323|NCT01563133|cyst|cyst
468324|NCT01563133|mass|mass
468325|NCT01563133|EUSFNA|eusfna
468326|NCT01563107|Orthostatic Intolerance|orthostatic intolerance
468327|NCT01563107|Tachycardia|tachycardia
468328|NCT01563107|Orthostatic Hypotension|orthostatic hypotension
468329|NCT01563107|Sodium|sodium
468330|NCT01563094|Bone Density|bone density
468331|NCT01563094|Lactation|lactation
468332|NCT01563094|Bone Turnover Markers|bone turnover markers
468333|NCT01563081|Allergic rhinitis|allergic rhinitis
468334|NCT01563081|Pediatric|pediatric
468335|NCT01563081|Pruritus|pruritus
468336|NCT01563081|Levocetirizine|levocetirizine
468337|NCT01563068|plaque psoriasis|plaque psoriasis
468338|NCT01563068|pediatric|pediatric
468339|NCT01563068|adolescent|adolescent
468340|NCT01563042|immunogenicity|immunogenicity
468341|NCT01563042|GSK2434735|gsk2434735
468342|NCT01563042|pharmacokinetics (PK)|pharmacokinetics (pk)
468343|NCT01563042|PK|pk
468344|NCT01563042|biospecific antibody|biospecific antibody
468345|NCT01563016|schizophrenia|schizophrenia
468346|NCT01563016|Psychotic Disorders|psychotic disorders
468347|NCT01563016|Psychoses|psychoses
468348|NCT01563003|Autism|autism
468349|NCT01563003|Asperger's Syndrome|asperger's syndrome
468350|NCT01563003|Pervasive Developmental Disorder Not Otherwise Specified|pervasive developmental disorder not otherwise specified
468351|NCT01563003|Treatment|treatment
468352|NCT01563003|Cognitive-behavioral therapy|cognitive-behavioral therapy
468353|NCT01563003|Anxiety|anxiety
468354|NCT01563003|Children|children
468355|NCT01563003|Therapy|therapy
468356|NCT01562951|Crohn's disease|crohn's disease
468357|NCT01562951|mucosal inflammation|mucosal inflammation
468358|NCT01562951|lesions|lesions
468359|NCT01562938|Respiratory Syncytial Virus|respiratory syncytial virus
468360|NCT01562912|radiofrequency|radiofrequency
468361|NCT01562912|ablation|ablation
468362|NCT01562912|atrial fibrillation|atrial fibrillation
468363|NCT01562912|PVAC|pvac
468364|NCT01562899|MEK162|mek162
468365|NCT01562899|AMG 479|amg 479
468366|NCT01562899|Ganitumab|ganitumab
468367|NCT01562899|colorectal adenocarcinoma|colorectal adenocarcinoma
468368|NCT01562899|pancreatic adenocarcinoma|pancreatic adenocarcinoma
468369|NCT01562899|melanoma|melanoma
468370|NCT01562899|KRAS|kras
468371|NCT01562899|BRAF|braf
468372|NCT01562886|Rilpivirine CSF pharmacokinetics|rilpivirine csf pharmacokinetics
468373|NCT01562873|pSTAT3+|pstat3+
468374|NCT01562860|median nerve|median nerve
468375|NCT01562860|carpal tunnel syndrome|carpal tunnel syndrome
468376|NCT01562860|Pronator Teres Release|pronator teres release
468377|NCT01562782|Elevated triglycerides|elevated triglycerides
468378|NCT01562782|Diabetes Mellitus|diabetes mellitus
468379|NCT01562782|Dyslipidemia|dyslipidemia
468380|NCT01562782|Lipid Metabolic Disorders|lipid metabolic disorders
468381|NCT01562782|Body Weight|body weight
468382|NCT01562730|Coronary Artery Disease|coronary artery disease
468383|NCT01562730|Myocardial Ischemia|myocardial ischemia
468384|NCT01562730|Coronary Disease|coronary disease
468385|NCT01562730|Heart Diseases|heart diseases
468386|NCT01562730|Cardiovascular Diseases|cardiovascular diseases
468387|NCT01562730|Arteriosclerosis|arteriosclerosis
468388|NCT01562730|Arterial Occlusive Diseases|arterial occlusive diseases
468389|NCT01562730|Vascular Diseases|vascular diseases
468390|NCT01562730|iECG|iecg
468391|NCT01562730|12 leads ECG|12 leads ecg
468392|NCT01562704|mechanism of action of paracetamol in the brain structures|mechanism of action of paracetamol in the brain structures
468393|NCT01562691|nasal packing|nasal packing
468394|NCT01562691|nasal airway|nasal airway
468395|NCT01562691|septoplasty|septoplasty
468396|NCT01562691|oxygen saturation|oxygen saturation
468397|NCT01562691|postoperative pain|postoperative pain
468398|NCT01562678|fMRI|fmri
468399|NCT01562678|Liraglutide|liraglutide
468400|NCT01562678|diabetes|diabetes
468401|NCT01562678|GLP-1|glp-1
468402|NCT01562665|All patients with NSCLC attending participating hospitals|all patients with nsclc attending participating hospitals
468403|NCT01562639|maintenance therapy,|maintenance therapy,
468404|NCT01562639|repeatedly recurring,|repeatedly recurring,
468405|NCT01562639|relapsing reflux oesophagitis,|relapsing reflux oesophagitis,
468406|NCT01562639|Nexium|nexium
468407|NCT01562613|Stroke|stroke
468408|NCT01562613|Hypertension|hypertension
468409|NCT01562600|NSAIDs|nsaids
468410|NCT01562600|Gastric ulcer or duodenal ulcer|gastric ulcer or duodenal ulcer
468411|NCT01562600|Nexium|nexium
468412|NCT01562548|upper back/neck/shoulder muscle spasm|upper back/neck/shoulder muscle spasm
468413|NCT01562535|pulled elbow|pulled elbow
468414|NCT01562535|nursemaid elbow|nursemaid elbow
468415|NCT01562509|Non-Hodgkin lymphoma (NHL)|non-hodgkin lymphoma (nhl)
468416|NCT01562509|Quality of health care|quality of health care
468417|NCT01562509|Oncology Service Hospital|oncology service hospital
468418|NCT01562509|Patient-centredness|patient-centredness
468419|NCT01562509|PROMs|proms
468420|NCT01562496|Parkinson's disease|parkinson's disease
468421|NCT01562496|Neuroprotective|neuroprotective
468422|NCT01562496|Intensive exercise|intensive exercise
468423|NCT01562483|postsurgical pain|postsurgical pain
468424|NCT01562483|abdominal pain|abdominal pain
468425|NCT01562483|visceral pain|visceral pain
468426|NCT01562483|chronic pain|chronic pain
597688|NCT01026727|HIV|hiv
468427|NCT01562470|cellulite|cellulite
468428|NCT01562470|reduction|reduction
468429|NCT01562470|cream|cream
468430|NCT01562470|thighs|thighs
468431|NCT01562470|women|women
468432|NCT01562444|Long term immunogenicity study|long term immunogenicity study
468433|NCT01562418|Ergonomics|ergonomics
468434|NCT01562418|musculoskeletal symptoms|musculoskeletal symptoms
468435|NCT01562418|kinematics|kinematics
468436|NCT01562405|Relapsed|relapsed
468437|NCT01562405|Refractory|refractory
468438|NCT01562392|dietary prevention|dietary prevention
468439|NCT01562392|cognitive performance|cognitive performance
468440|NCT01562392|metabolic syndrome|metabolic syndrome
468441|NCT01562392|colonic fermentation|colonic fermentation
468442|NCT01562392|sub clinical inflammation|sub clinical inflammation
468443|NCT01562392|cognition and metabolism|cognition and metabolism
468444|NCT01562379|complementary food supplements|complementary food supplements
468445|NCT01562379|stunting|stunting
468446|NCT01562379|wasting|wasting
468447|NCT01562379|growth|growth
468448|NCT01562379|Bangladesh|bangladesh
468449|NCT01562379|infant feeding|infant feeding
468450|NCT01562366|Iliotibial Band Release|iliotibial band release
468451|NCT01562366|Trochanteric Bursectomy|trochanteric bursectomy
468452|NCT01562366|Micro debridement|micro debridement
468453|NCT01562353|Opioid Dependence|opioid dependence
468454|NCT01562353|Opioids for the treatment of pain|opioids for the treatment of pain
468455|NCT01562340|Hemodialysis|hemodialysis
468456|NCT01562340|End stage renal disease|end stage renal disease
468457|NCT01562340|Oxidative stress|oxidative stress
468458|NCT01562340|Inflammation|inflammation
468459|NCT01562340|Endothelial dysfunction|endothelial dysfunction
468460|NCT01562340|Cardiovascular disease|cardiovascular disease
468461|NCT01562340|Antioxidants|antioxidants
468462|NCT01562340|Flavonoids|flavonoids
468463|NCT01562314|Mild to Moderate Ulcerative Colitis|mild to moderate ulcerative colitis
468464|NCT01562314|GWP42003|gwp42003
468465|NCT01562301|chemotherapeutic agent toxicity|chemotherapeutic agent toxicity
468466|NCT01562301|recurrent non-small cell lung cancer|recurrent non-small cell lung cancer
468467|NCT01562301|stage IIIA non-small cell lung cancer|stage iiia non-small cell lung cancer
468468|NCT01562301|stage IIIB non-small cell lung cancer|stage iiib non-small cell lung cancer
468469|NCT01562301|stage IV non-small cell lung cancer|stage iv non-small cell lung cancer
468470|NCT01562301|carboplatin|carboplatin
468471|NCT01562301|Paraplatin|paraplatin
468472|NCT01562301|docetaxel|docetaxel
468473|NCT01562301|Taxotere|taxotere
468474|NCT01562301|Anvirzel|anvirzel
468475|NCT01562301|nerium oleander|nerium oleander
468476|NCT01562301|Advanced Non-Small Cell Lung Cancer|advanced non-small cell lung cancer
468477|NCT01562301|NSCLC|nsclc
468478|NCT01562288|HER2-positive breast cancer|her2-positive breast cancer
468479|NCT01562288|HER2-negative breast cancer|her2-negative breast cancer
468480|NCT01562288|stage IA breast cancer|stage ia breast cancer
468481|NCT01562288|stage IB breast cancer|stage ib breast cancer
468482|NCT01562288|stage II breast cancer|stage ii breast cancer
468483|NCT01562288|stage IIIA breast cancer|stage iiia breast cancer
468484|NCT01562275|GDC0973|gdc0973
468485|NCT01562275|MEK|mek
468486|NCT01562275|MEK inhibitor|mek inhibitor
468487|NCT01562275|GDC0068|gdc0068
468488|NCT01562275|Akt|akt
468489|NCT01562275|Akt inhibitor|akt inhibitor
468490|NCT01562262|Apnea|apnea
468491|NCT01562262|PVT|pvt
468492|NCT01562262|Reaction Time|reaction time
468493|NCT01562249|clinical evaluation|clinical evaluation
468689|NCT01561326|follow-up|follow-up
468494|NCT01562249|controlled clinical trial|controlled clinical trial
468495|NCT01562249|electromyography|electromyography
468496|NCT01562249|exercise program|exercise program
468497|NCT01562249|motor control|motor control
468498|NCT01562223|stage IIA prostate cancer|stage iia prostate cancer
468499|NCT01562223|stage IIB prostate cancer|stage iib prostate cancer
468500|NCT01562223|stage III prostate cancer|stage iii prostate cancer
468501|NCT01562223|stage IV prostate cancer|stage iv prostate cancer
468502|NCT01562223|adenocarcinoma of the prostate|adenocarcinoma of the prostate
468503|NCT01562210|NSCLC|nsclc
468504|NCT01562210|Olaparib|olaparib
468505|NCT01562210|CCRT|ccrt
468506|NCT01562197|axitinib|axitinib
468507|NCT01562197|glioblastoma|glioblastoma
468508|NCT01562197|recurrent|recurrent
468509|NCT01562171|Overweight|overweight
468510|NCT01562171|Obese|obese
468511|NCT01562171|Obesity|obesity
468512|NCT01562171|Cholesterol|cholesterol
468513|NCT01562171|Hypercholesterolemia|hypercholesterolemia
468514|NCT01562171|LDL-Cholesterol|ldl-cholesterol
468515|NCT01562145|Rotator cuff tear, matrix metalloproteinase, tissue inhibitor of matrix metalloproteinase, partial-thickness tear, full-thickness tear, plasma.|rotator cuff tear, matrix metalloproteinase, tissue inhibitor of matrix metalloproteinase, partial-thickness tear, full-thickness tear, plasma.
468516|NCT01562132|cryptococcus|cryptococcus
468517|NCT01562132|HIV|hiv
468518|NCT01562119|Burns|burns
468519|NCT01562119|Wound repair|wound repair
468520|NCT01562119|Skin substitutes|skin substitutes
468521|NCT01562106|Cancer of Endometrium|cancer of endometrium
468522|NCT01562106|Cancer of the Endometrium|cancer of the endometrium
468523|NCT01562106|Carcinoma of Endometrium|carcinoma of endometrium
468524|NCT01562106|Endometrial Carcinoma|endometrial carcinoma
468525|NCT01562106|Endometrium Cancer|endometrium cancer
468526|NCT01562106|Neoplasms, Endometrial|neoplasms, endometrial
468527|NCT01562093|Adrenal Cortex Hormones|adrenal cortex hormones
468528|NCT01562093|Spirometry|spirometry
468529|NCT01562093|Administration, Intranasal|administration, intranasal
468530|NCT01562093|Nasal blockage|nasal blockage
468531|NCT01562093|Nasal sprays|nasal sprays
468532|NCT01562080|hyperlipidemia|hyperlipidemia
468533|NCT01562080|metabolic syndrome|metabolic syndrome
468534|NCT01562080|yeast red|yeast red
468535|NCT01562080|berberine|berberine
468536|NCT01562080|policosanol|policosanol
468537|NCT01562080|astaxanthin|astaxanthin
468538|NCT01562067|Cervical tumors,vascular changes,Sonographic characteristics|cervical tumors,vascular changes,sonographic characteristics
468539|NCT01562041|Cardiovascular disease|cardiovascular disease
468540|NCT01562041|Exercise Treadmill Test|exercise treadmill test
468541|NCT01562041|Ranolazine|ranolazine
468542|NCT01562041|Angina|angina
468543|NCT01562041|Myocardial ischemia|myocardial ischemia
468544|NCT01562028|non small cell lung cancer|non small cell lung cancer
468545|NCT01562028|advanced|advanced
468546|NCT01562028|non-squamous|non-squamous
468547|NCT01562028|EGFR|egfr
468548|NCT01562028|mutations|mutations
468549|NCT01562002|limbus|limbus
468550|NCT01562002|cornea|cornea
468551|NCT01562002|insufficiency syndrome|insufficiency syndrome
468552|NCT01562002|stem cell transplant|stem cell transplant
468553|NCT01561963|Apremilast|apremilast
468554|NCT01561963|drug interaction|drug interaction
468555|NCT01561963|pharmacokinetics|pharmacokinetics
468556|NCT01561911|Clinical Trial|clinical trial
468557|NCT01561911|Phase I|phase i
468558|NCT01561911|Antibodies|antibodies
468559|NCT01561911|Monoclonal|monoclonal
468560|NCT01561898|Schizophrenia|schizophrenia
468561|NCT01561898|JNS007ER|jns007er
468562|NCT01561898|Paliperidone extended-release|paliperidone extended-release
468563|NCT01561885|Clinical Pathways|clinical pathways
468564|NCT01561885|Length of Stay|length of stay
468565|NCT01561885|Patient-Centered Care|patient-centered care
468566|NCT01561885|Pragmatic Randomized Controlled Trial|pragmatic randomized controlled trial
468567|NCT01561859|Early Course Schizophrenia|early course schizophrenia
468568|NCT01561859|Cognitive Enhancement Therapy|cognitive enhancement therapy
468569|NCT01561859|Enriched Supportive Therapy|enriched supportive therapy
468570|NCT01561846|Conjugated Linoleic Acid|conjugated linoleic acid
468571|NCT01561846|LDL-cholesterol|ldl-cholesterol
468572|NCT01561846|Endocannabinoids|endocannabinoids
468573|NCT01561833|relapsed or refractory T cell lymphoma|relapsed or refractory t cell lymphoma
468574|NCT01561820|mild cognitive impairment|mild cognitive impairment
468575|NCT01561820|cognitive disorders|cognitive disorders
468576|NCT01561820|exercise|exercise
468577|NCT01561794|Ciprofloxacin|ciprofloxacin
468578|NCT01561794|Bacterial pneumonia|bacterial pneumonia
468579|NCT01561794|Community Acquired Pneumonia (CAP)|community acquired pneumonia (cap)
468580|NCT01561794|Hospital Acquired Pneumonia (HAP)|hospital acquired pneumonia (hap)
468581|NCT01561794|Secondary infection of chronic respiratory disease|secondary infection of chronic respiratory disease
468582|NCT01561794|400 mg BID/TID|400 mg bid/tid
468583|NCT01561781|Phase 1|phase 1
468584|NCT01561781|healthy volunteers|healthy volunteers
468585|NCT01561781|pharmacokinetics|pharmacokinetics
468586|NCT01561781|vandetanib|vandetanib
468587|NCT01561781|digoxin|digoxin
468588|NCT01561755|HIV associated myelopathy|hiv associated myelopathy
468589|NCT01561742|minocycline, augmentation, schizophrenia|minocycline, augmentation, schizophrenia
468590|NCT01561729|nasogastric tube|nasogastric tube
468591|NCT01561729|orogastric tube|orogastric tube
468592|NCT01561729|RightSpot pH Indicator|rightspot ph indicator
468593|NCT01561729|suction tube|suction tube
468594|NCT01561729|RightBio Metrics|rightbio metrics
468595|NCT01561729|RightLevel|rightlevel
468596|NCT01561729|RightSpot Infant|rightspot infant
468597|NCT01561729|NG Tube|ng tube
468598|NCT01561729|pH|ph
468599|NCT01561729|Gastric Acidity|gastric acidity
468600|NCT01561716|video games|video games
468601|NCT01561716|energy expenditure|energy expenditure
468602|NCT01561716|physical activity|physical activity
468603|NCT01561716|exercise physiology|exercise physiology
468604|NCT01561703|Healthcare utilization|healthcare utilization
468605|NCT01561703|Tonsillectomy|tonsillectomy
468606|NCT01561703|Adenoidectomy/Tonsillectomy|adenoidectomy/tonsillectomy
468607|NCT01561703|Antibiotics|antibiotics
468608|NCT01561677|obstructive sleep apnea|obstructive sleep apnea
468609|NCT01561677|syndrome survival|syndrome survival
468610|NCT01561677|ischemic stroke|ischemic stroke
468611|NCT01561677|continuous positive airway pressure|continuous positive airway pressure
468612|NCT01561677|handicap|handicap
468613|NCT01561664|obesity|obesity
468614|NCT01561664|insulin resistance|insulin resistance
468615|NCT01561651|cardiac surgery|cardiac surgery
468616|NCT01561651|left atrial appendage|left atrial appendage
468617|NCT01561651|atrial fibrillation|atrial fibrillation
468618|NCT01561651|stroke|stroke
468619|NCT01561651|non-CNS systemic embolism|non-cns systemic embolism
468620|NCT01561638|Pulsed|pulsed
468621|NCT01561638|radiofrequency|radiofrequency
468622|NCT01561638|single-dose|single-dose
468623|NCT01561638|shoulder pain|shoulder pain
468624|NCT01561638|Pain lasts more than one month|pain lasts more than one month
468625|NCT01561638|patients referred to the pain clinic from the shoulder clinic|patients referred to the pain clinic from the shoulder clinic
468626|NCT01561638|Failed all conservative therapies available|failed all conservative therapies available
468627|NCT01561625|COPD|copd
468628|NCT01561625|exercise training|exercise training
468629|NCT01561612|Breastfeeding|breastfeeding
468630|NCT01561612|Child Health|child health
468631|NCT01561612|Obesity|obesity
468632|NCT01561612|Blood Pressure|blood pressure
468633|NCT01561612|Asthma|asthma
468634|NCT01561612|Cognitive Development|cognitive development
468635|NCT01561612|Behavior|behavior
468636|NCT01561612|Eczema|eczema
468637|NCT01561612|Lung Function|lung function
468638|NCT01561612|Spirometry|spirometry
468639|NCT01561599|hepatocyte growth factor mimetic|hepatocyte growth factor mimetic
468640|NCT01561599|hepatocyte growth factor(HGF)|hepatocyte growth factor(hgf)
468641|NCT01561599|Delayed Graft Function (DGF)|delayed graft function (dgf)
468642|NCT01561599|Kidney transplantation|kidney transplantation
468643|NCT01561586|Cervical cancer|cervical cancer
468644|NCT01561586|Concurrent chemoradiation|concurrent chemoradiation
468645|NCT01561586|Cisplatin|cisplatin
468646|NCT01561573|Point of Care Ultrasound|point of care ultrasound
468647|NCT01561573|Emergency Ultrasound|emergency ultrasound
468648|NCT01561573|Colles Fracture|colles fracture
468649|NCT01561573|Fracture Reduction|fracture reduction
468650|NCT01561573|Bedside Ultrasound|bedside ultrasound
468651|NCT01561560|DAILIES TOTAL1|dailies total1
468652|NCT01561560|contact lenses|contact lenses
468653|NCT01561560|myopia|myopia
468654|NCT01561547|pain|pain
468655|NCT01561547|preterm neonate|preterm neonate
468656|NCT01561547|sucrose|sucrose
468657|NCT01561547|kangaroo mother care|kangaroo mother care
468658|NCT01561534|fibula flap|fibula flap
468659|NCT01561534|oral implants|oral implants
468660|NCT01561534|computer-guided|computer-guided
468661|NCT01561508|diabetes mellitus|diabetes mellitus
468662|NCT01561508|children|children
468663|NCT01561495|scheduled to receive RT either pre- or postoperatively|scheduled to receive rt either pre- or postoperatively
468664|NCT01561482|Prostate carcinoma|prostate carcinoma
468665|NCT01561482|Prostate cancer|prostate cancer
468666|NCT01561482|Prostate Specific Antigen|prostate specific antigen
468667|NCT01561482|PSA|psa
468668|NCT01561482|Metformin|metformin
468669|NCT01561482|Simvastatin|simvastatin
468670|NCT01561482|Radiation therapy|radiation therapy
468671|NCT01561482|Prostatectomy|prostatectomy
468672|NCT01561469|Linezolid|linezolid
468673|NCT01561469|Vancomycin|vancomycin
468674|NCT01561469|Ventilator-Associated Pneumonia|ventilator-associated pneumonia
468675|NCT01561469|Respiratory Tract Infections|respiratory tract infections
468676|NCT01561456|non-small-cell lung cancer|non-small-cell lung cancer
468677|NCT01561456|squamous cell carcinoma|squamous cell carcinoma
468678|NCT01561456|adenocarcinoma of the lung|adenocarcinoma of the lung
468679|NCT01561456|IGF-1 inhibitor|igf-1 inhibitor
468680|NCT01561456|docetaxel|docetaxel
468681|NCT01561456|AXL1717|axl1717
468682|NCT01561456|NSCLC|nsclc
468683|NCT01561456|SCC|scc
468684|NCT01561456|AC|ac
468685|NCT01561443|Breast cancer,|breast cancer,
468686|NCT01561443|hormone positive,|hormone positive,
468687|NCT01561430|beta-secretase inhibitor|beta-secretase inhibitor
468688|NCT01561326|cervical cancer|cervical cancer
468690|NCT01561326|Pap test|pap test
468691|NCT01561326|Medical management|medical management
468692|NCT01561326|Colposcopy|colposcopy
468693|NCT01561313|On label Humira users|on label humira users
468694|NCT01561313|Pain|pain
468695|NCT01561313|Rheumatoid Arthritis,|rheumatoid arthritis,
468696|NCT01561300|Black tea|black tea
468697|NCT01561300|Flow Mediated Dilation|flow mediated dilation
468698|NCT01561300|Vascular function|vascular function
468699|NCT01561300|India|india
468700|NCT01561261|fasciotomy|fasciotomy
468701|NCT01561261|ACS|acs
468702|NCT01561248|EHEC|ehec
468703|NCT01561248|O104:H4|o104:h4
468704|NCT01561248|German|german
468705|NCT01561248|outbreak|outbreak
468706|NCT01561248|polyethylene glycol|polyethylene glycol
468707|NCT01561248|Bowel lavage|bowel lavage
468708|NCT01561235|Protein|protein
468709|NCT01561235|Appetite|appetite
468710|NCT01561235|Satiety|satiety
468711|NCT01561235|Energi intake|energi intake
468712|NCT01561235|Appetite regulating hormones|appetite regulating hormones
468713|NCT01561235|Dose-response|dose-response
468714|NCT01561222|calcitrol|calcitrol
468715|NCT01561222|Bone mineral density|bone mineral density
468716|NCT01561222|Osteoprotegin|osteoprotegin
468717|NCT01561222|Vascular calcification|vascular calcification
468718|NCT01561209|amitryptiline|amitryptiline
468719|NCT01561209|Chronic pain|chronic pain
468720|NCT01561209|Neck pain|neck pain
468721|NCT01561196|arteria cannulation|arteria cannulation
468722|NCT01561196|Ultrasound|ultrasound
468723|NCT01561196|pain|pain
468724|NCT01561196|complications|complications
468725|NCT01561183|Vital pulp therapy|vital pulp therapy
468726|NCT01561183|Pulp cap|pulp cap
468727|NCT01561183|pulpotomy|pulpotomy
468728|NCT01561183|calcium enriched mixture|calcium enriched mixture
468729|NCT01561183|CEM cement|cem cement
468730|NCT01561183|Endodontic|endodontic
468731|NCT01561170|Electromagnetic|electromagnetic
468732|NCT01561170|Field therapy|field therapy
468733|NCT01561170|Chronically venous ulcer|chronically venous ulcer
468734|NCT01561170|Venous insufficiens|venous insufficiens
468735|NCT01561157|porphyria|porphyria
468736|NCT01561157|acute intermittent|acute intermittent
468737|NCT01561157|coproporphyria|coproporphyria
468738|NCT01561157|variegate|variegate
468739|NCT01561157|erythropoietic|erythropoietic
468740|NCT01561157|protoporphyria|protoporphyria
468741|NCT01561157|hepatoerythropoietic|hepatoerythropoietic
468742|NCT01561157|cutanea tarda|cutanea tarda
468743|NCT01561157|AIP|aip
468744|NCT01561157|HCP|hcp
468745|NCT01561157|VP|vp
468746|NCT01561157|ADP|adp
468747|NCT01561157|ALAD|alad
468748|NCT01561157|PCT|pct
468749|NCT01561157|HEP|hep
468750|NCT01561157|CEP|cep
468751|NCT01561157|EPP|epp
468752|NCT01561157|XLP|xlp
468753|NCT01561144|Defibrillators, Implantable|defibrillators, implantable
468754|NCT01561144|Cardiac arrhythmias|cardiac arrhythmias
468755|NCT01561144|Heart Disease|heart disease
468756|NCT01561131|Obesity|obesity
468757|NCT01561131|Protein intake|protein intake
468758|NCT01561131|Calcium intake|calcium intake
468759|NCT01561131|Weight loss|weight loss
468760|NCT01561131|Weight maintenance|weight maintenance
468761|NCT01561131|Blood lipid profile|blood lipid profile
468762|NCT01561131|Diet induced thermogenesis|diet induced thermogenesis
468763|NCT01561118|hemodialysis|hemodialysis
468764|NCT01561118|dialysis efficacy|dialysis efficacy
468765|NCT01561118|cardiorespiratory capacity|cardiorespiratory capacity
468766|NCT01561118|exercise capacity|exercise capacity
468767|NCT01561118|children and adolescents|children and adolescents
468768|NCT01561092|Stroke|stroke
468769|NCT01561092|RCT|rct
468770|NCT01561092|SSRI|ssri
468771|NCT01561092|Outcome|outcome
468772|NCT01561079|Buprenorphine|buprenorphine
468773|NCT01561079|Methadone|methadone
468774|NCT01561079|Fetal neurobehavior|fetal neurobehavior
468775|NCT01561079|Infant neurobehavior|infant neurobehavior
468776|NCT01561066|Fibrin glue|fibrin glue
468777|NCT01561066|Platelet|platelet
468778|NCT01561066|Autologous derivation|autologous derivation
468779|NCT01561066|Prospective randomized trial|prospective randomized trial
468780|NCT01561066|Fistulas|fistulas
468781|NCT01561053|Alzheimer's disease|alzheimer's disease
468782|NCT01561053|Amyloid Beta (AB) peptide|amyloid beta (ab) peptide
468783|NCT01561053|Albumin|albumin
468784|NCT01561053|Intravenous immunoglobulin|intravenous immunoglobulin
468785|NCT01561053|IVIG|ivig
468786|NCT01561040|Dry Eye syndrome|dry eye syndrome
468787|NCT01561040|tear film deficiency|tear film deficiency
468788|NCT01561040|Essential Fatty Acid nutritional supplements|essential fatty acid nutritional supplements
468789|NCT01561040|Omega three supplements|omega three supplements
468790|NCT01560988|Asthma|asthma
468791|NCT01560988|Borage|borage
468792|NCT01560988|Echium|echium
468793|NCT01560988|Botanical|botanical
468794|NCT01560949|Pancreatic Cancer|pancreatic cancer
468795|NCT01560949|Adenocarcinoma of the Pancreas|adenocarcinoma of the pancreas
468796|NCT01560949|High Risk Resectable|high risk resectable
468797|NCT01560949|Borderline Resectable|borderline resectable
468798|NCT01560949|Chemotherapy|chemotherapy
468799|NCT01560949|Chemoradiation therapy|chemoradiation therapy
468800|NCT01560949|Oxaliplatin|oxaliplatin
468801|NCT01560949|Eloxatin|eloxatin
468802|NCT01560949|Irinotecan|irinotecan
468803|NCT01560949|CPT-11|cpt-11
468804|NCT01560949|Camptosar|camptosar
468805|NCT01560949|5-FU|5-fu
468806|NCT01560949|5-Fluorouracil|5-fluorouracil
468807|NCT01560949|Adrucil|adrucil
468808|NCT01560949|Efudex|efudex
468809|NCT01560949|Gemcitabine|gemcitabine
468810|NCT01560949|Gemcitabine Hydrochloride|gemcitabine hydrochloride
468811|NCT01560949|Gemzar|gemzar
468812|NCT01560949|Radiation Therapy|radiation therapy
468813|NCT01560949|XRT|xrt
468814|NCT01560949|RT|rt
468815|NCT01560949|External Beam Radiation Therapy|external beam radiation therapy
468816|NCT01560936|bacterial contamination|bacterial contamination
468817|NCT01560923|hormone refractory prostate cancer|hormone refractory prostate cancer
468818|NCT01560910|with or without GERD symptoms|with or without gerd symptoms
468819|NCT01560910|presenting to gastrointestinal clinic of Maharaj Nakorn Chiangmai Hospital|presenting to gastrointestinal clinic of maharaj nakorn chiangmai hospital
468820|NCT01560910|November 2009 to November 2010|november 2009 to november 2010
468821|NCT01560910|GERD|gerd
598136|NCT01024829|HX4|hx4
468822|NCT01560910|NERD|nerd
468823|NCT01560871|Heart failure|heart failure
468824|NCT01560871|inspiratory muscle training|inspiratory muscle training
468825|NCT01560871|physical activity|physical activity
468826|NCT01560845|autologous bone marrow stem cells|autologous bone marrow stem cells
468827|NCT01560845|portal hypertension|portal hypertension
468828|NCT01560845|surgery|surgery
468829|NCT01560845|liver cirrhosis|liver cirrhosis
468830|NCT01560819|ulcerative colitis, gut microbial transplantation|ulcerative colitis, gut microbial transplantation
468831|NCT01560806|hypertension|hypertension
468832|NCT01560806|cardiovascular risk factor|cardiovascular risk factor
468833|NCT01560806|lifestyle|lifestyle
468834|NCT01560793|Influenza|influenza
468835|NCT01560793|Vaccines|vaccines
468836|NCT01560793|H5N1|h5n1
468837|NCT01560780|Coronary Artery Bypass|coronary artery bypass
468838|NCT01560780|thrombosis|thrombosis
468839|NCT01560780|prasugrel|prasugrel
468840|NCT01560767|Pain relief|pain relief
468841|NCT01560767|Arthroplasty|arthroplasty
468842|NCT01560767|periarticular knee infiltration|periarticular knee infiltration
468843|NCT01560754|Randomized|randomized
468844|NCT01560754|Placebo-controlled|placebo-controlled
468845|NCT01560754|Double-blind|double-blind
468846|NCT01560754|Multi-center|multi-center
468847|NCT01560754|Disease-modifying potential|disease-modifying potential
468848|NCT01560754|transdermal nicotine|transdermal nicotine
468849|NCT01560741|Chronic respiratory failure|chronic respiratory failure
468850|NCT01560741|Noninvasive Mechanical Ventilation|noninvasive mechanical ventilation
468851|NCT01560741|Home-care|home-care
468852|NCT01560741|Telemedicine|telemedicine
468853|NCT01560741|COPD|copd
468854|NCT01560728|Post Traumatic Stress Disorder|post traumatic stress disorder
468855|NCT01560728|Major Depressive Disorder|major depressive disorder
468856|NCT01560728|Dysthymia|dysthymia
468857|NCT01560728|Generalized Anxiety Disorder|generalized anxiety disorder
468858|NCT01560728|Social Phobia|social phobia
468859|NCT01560728|Panic Disorder|panic disorder
468860|NCT01560715|Retinitis pigmentosa|retinitis pigmentosa
468861|NCT01560715|stem cell|stem cell
468862|NCT01560715|bone marrow|bone marrow
468863|NCT01560715|retinal dysprophy|retinal dysprophy
468864|NCT01560702|autologous blood|autologous blood
468865|NCT01560702|epinephrine|epinephrine
468866|NCT01560702|endoscopy|endoscopy
468867|NCT01560702|ulcer|ulcer
468868|NCT01560702|hemostasis|hemostasis
468869|NCT01560689|bone marrow transplantation|bone marrow transplantation
468870|NCT01560689|obstructive lung disease|obstructive lung disease
468871|NCT01560689|bronchodilators|bronchodilators
468872|NCT01560689|inhaled steroids|inhaled steroids
468873|NCT01560689|late-onset pulmonary complication|late-onset pulmonary complication
468874|NCT01560676|Internet|internet
468875|NCT01560676|School based|school based
468876|NCT01560676|Obesity Prevention Program|obesity prevention program
468877|NCT01560676|Adolescents|adolescents
468878|NCT01560663|Breast Cancer|breast cancer
468879|NCT01560663|Neoadjuvant therapy|neoadjuvant therapy
468880|NCT01560663|Triple negative|triple negative
468881|NCT01560663|predictor of response|predictor of response
468882|NCT01560663|predictor of resistance|predictor of resistance
468883|NCT01560663|Continuous Renal Replacement Therapy|continuous renal replacement therapy
468884|NCT01560650|CRRT|crrt
468885|NCT01560650|cardiac surgery associated acute kidney injury|cardiac surgery associated acute kidney injury
468886|NCT01560650|Intensity|intensity
468887|NCT01560637|PAH|pah
468888|NCT01560637|PH|ph
468889|NCT01560637|FREEDOM|freedom
468890|NCT01560637|6 minute walk test|6 minute walk test
468891|NCT01560637|treprostinil|treprostinil
468892|NCT01560637|open label|open label
468893|NCT01560624|Pulmonary arterial hypertension (PAH)|pulmonary arterial hypertension (pah)
468894|NCT01560624|Pulmonary hypertension (PH)|pulmonary hypertension (ph)
468895|NCT01560624|Clinical Worsening|clinical worsening
468896|NCT01560624|Freedom|freedom
468897|NCT01560624|Freedom-EV|freedom-ev
468898|NCT01560624|Treprostinil|treprostinil
468899|NCT01560624|UT-15C|ut-15c
468900|NCT01560624|6 Minute walk test|6 minute walk test
468901|NCT01560598|GERD|gerd
468902|NCT01560598|reflux esophagitis|reflux esophagitis
468903|NCT01560598|adipokine|adipokine
468904|NCT01560598|especially|especially
468905|NCT01560598|endoscopically proven|endoscopically proven
468906|NCT01560585|Isotretinoin|isotretinoin
468907|NCT01560585|Alzheimer's disease|alzheimer's disease
468908|NCT01560585|Dementia|dementia
468909|NCT01560585|Retinoid|retinoid
468910|NCT01560572|kidney transplantation|kidney transplantation
468911|NCT01560572|immunosuppression|immunosuppression
468912|NCT01560572|steroids|steroids
468913|NCT01560572|tacrolimus OD|tacrolimus od
468914|NCT01560559|Primary esophageal achalasia|primary esophageal achalasia
468915|NCT01560559|endoscopic myotomy|endoscopic myotomy
468916|NCT01560559|high resolution manometry|high resolution manometry
468917|NCT01560520|acute ischemic stroke|acute ischemic stroke
468918|NCT01560520|accelerometer|accelerometer
468919|NCT01560481|metformin glycinate|metformin glycinate
468920|NCT01560481|pharmacokinetics|pharmacokinetics
468921|NCT01560481|pharmacodynamics|pharmacodynamics
468922|NCT01560468|Hepatitis C Virus Infection|hepatitis c virus infection
468923|NCT01560468|Liver Transplantation|liver transplantation
468924|NCT01560455|stent|stent
468925|NCT01560455|bifurcation|bifurcation
468926|NCT01560455|coronary|coronary
468927|NCT01560442|Analgesics, opioids|analgesics, opioids
468928|NCT01560442|Opiate substitution treatment|opiate substitution treatment
468929|NCT01560442|Methadone|methadone
468930|NCT01560442|Buprenorphine|buprenorphine
468931|NCT01560442|Hyperalgesia|hyperalgesia
468932|NCT01560442|Pupil|pupil
468933|NCT01560442|Pain|pain
468934|NCT01560442|Psychophysics|psychophysics
468935|NCT01560442|previous illicit drug intake, under a substitution program|previous illicit drug intake, under a substitution program
468936|NCT01560429|anesthesia and analgesia|anesthesia and analgesia
468937|NCT01560429|Epidural Anesthesia|epidural anesthesia
468938|NCT01560429|administration schedules, drug|administration schedules, drug
468939|NCT01560416|Metastatic|metastatic
468940|NCT01560416|HR positive|hr positive
468941|NCT01560416|ER positive|er positive
468942|NCT01560403|Parenteral nutrition|parenteral nutrition
468943|NCT01560403|TPN|tpn
468944|NCT01560403|HPN|hpn
468945|NCT01560403|PN|pn
468946|NCT01560403|SBS|sbs
468947|NCT01560403|Short bowel syndrome|short bowel syndrome
468948|NCT01560390|Sedation|sedation
468949|NCT01560390|ICU|icu
468950|NCT01560390|Ketamine|ketamine
468951|NCT01560390|Confusion|confusion
468952|NCT01560390|Hyperalgesia|hyperalgesia
468953|NCT01560377|Laparoscopic low anterior colon resection|laparoscopic low anterior colon resection
468954|NCT01560377|Laparoscopic left colectomy|laparoscopic left colectomy
468955|NCT01560377|Colectomy|colectomy
468956|NCT01560377|Rectal cancer|rectal cancer
468957|NCT01560377|Colon cancer|colon cancer
468958|NCT01560377|Crohn's Disease|crohn's disease
468959|NCT01560377|Polyp|polyp
468960|NCT01560377|Procidentia|procidentia
468961|NCT01560377|Diverticulitis|diverticulitis
468962|NCT01560364|Renal replacement therapy|renal replacement therapy
468963|NCT01560364|Hemofilter clotting|hemofilter clotting
468964|NCT01560364|Clotting risk factor|clotting risk factor
468965|NCT01560364|Hemofilter clotting prevention|hemofilter clotting prevention
468966|NCT01560351|Pathological gambling|pathological gambling
468967|NCT01560351|craving|craving
468968|NCT01560351|repeated Transcranial Magnetic Stimulation|repeated transcranial magnetic stimulation
468969|NCT01560351|craving cues|craving cues
468970|NCT01560338|Pharmacokinetics|pharmacokinetics
468971|NCT01560338|Midazolam|midazolam
468972|NCT01560338|Morphine|morphine
468973|NCT01560338|Cardiac Arrest|cardiac arrest
468974|NCT01560338|Hypothermia|hypothermia
468975|NCT01560325|Solid Tumor, Tubulin inhibitor|solid tumor, tubulin inhibitor
468976|NCT01560312|Renal denervation|renal denervation
468977|NCT01560312|Resistant hypertension|resistant hypertension
468978|NCT01560312|Spironolactone|spironolactone
468979|NCT01560312|Long-term Outcome|long-term outcome
468980|NCT01560299|hyperthyroidism|hyperthyroidism
468981|NCT01560299|radio-iodine|radio-iodine
468982|NCT01560299|I-131|i-131
468983|NCT01560299|methimazole|methimazole
468984|NCT01560299|graves disease|graves disease
468985|NCT01560286|PKU|pku
468986|NCT01560286|Injections|injections
468987|NCT01560286|PEG-PAL|peg-pal
468988|NCT01560286|PAL|pal
468989|NCT01560247|Stroke|stroke
468990|NCT01560247|Ischemic Stroke|ischemic stroke
468991|NCT01560247|Revascularization|revascularization
468992|NCT01560247|Mechanical thrombectomy|mechanical thrombectomy
468993|NCT01560247|Neurothrombectomy|neurothrombectomy
468994|NCT01560234|Safety|safety
468995|NCT01560234|tolerability|tolerability
468996|NCT01560234|healthy|healthy
468997|NCT01560234|pharmacokinetic|pharmacokinetic
468998|NCT01560234|pharmacodynamic|pharmacodynamic
468999|NCT01560234|inhaled|inhaled
469000|NCT01560208|infectious keratitis|infectious keratitis
469001|NCT01560208|infective keratitis|infective keratitis
469002|NCT01560208|prospective multicentre study|prospective multicentre study
469003|NCT01560208|Asia|asia
469004|NCT01560195|neutropenia|neutropenia
469005|NCT01560195|febrile neutropenia|febrile neutropenia
469006|NCT01560195|chemotherapy|chemotherapy
469007|NCT01560182|OTL-200|otl-200
469008|NCT01560182|Metachromatic Leukodystrophy|metachromatic leukodystrophy
469009|NCT01560182|Gene Therapy|gene therapy
469010|NCT01560182|MLD|mld
469011|NCT01560182|Previously GSK2696274|previously gsk2696274
469012|NCT01560169|Celiac Disease|celiac disease
469013|NCT01560169|Coeliac Disease|coeliac disease
469014|NCT01560169|Celiac Sprue|celiac sprue
469015|NCT01560169|Keilakia Disease|keilakia disease
469016|NCT01560117|AGMT|agmt
469017|NCT01560117|NHL|nhl
469018|NCT01560104|Randomized|randomized
469019|NCT01560104|metastatic|metastatic
469020|NCT01560104|ABT-888|abt-888
469021|NCT01560104|paclitaxel|paclitaxel
469022|NCT01560104|non-small cell lung cancer|non-small cell lung cancer
469023|NCT01560104|PARP|parp
469024|NCT01560104|veliparib|veliparib
469025|NCT01560104|progression free survival|progression free survival
469026|NCT01560104|carboplatin|carboplatin
469027|NCT01560091|clearance rate|clearance rate
469028|NCT01560078|Tuberculosis|tuberculosis
469029|NCT01560078|Pleural effusion|pleural effusion
469030|NCT01560078|Category 3|category 3
469031|NCT01560052|end stage kidney disease|end stage kidney disease
469032|NCT01560052|IgA nephropathy|iga nephropathy
469033|NCT01560039|Neuropathic pain|neuropathic pain
469034|NCT01560039|neurostimulation|neurostimulation
469035|NCT01560026|ovarian preservation|ovarian preservation
469036|NCT01560013|Alcohol|alcohol
469037|NCT01560013|naltrexone|naltrexone
469038|NCT01560013|cue reactivity|cue reactivity
469039|NCT01560013|PET|pet
469040|NCT01560000|The focus of this study is to determine satiety|the focus of this study is to determine satiety
469041|NCT01559987|plaque removal methods|plaque removal methods
469042|NCT01559987|oral hygiene devices|oral hygiene devices
469043|NCT01559974|Peripheral arterial disease|peripheral arterial disease
469044|NCT01559974|PAOD|paod
469045|NCT01559974|Vitamin D|vitamin d
469046|NCT01559974|Walking impairment|walking impairment
469047|NCT01559961|bladder|bladder
469048|NCT01559961|cystitis|cystitis
469049|NCT01559961|frequency|frequency
469050|NCT01559961|nocturia|nocturia
469051|NCT01559961|pain|pain
469052|NCT01559961|urgency|urgency
469053|NCT01559948|Low back pain|low back pain
469054|NCT01559948|Sacroiliac joint pain|sacroiliac joint pain
469055|NCT01559948|Lumbopelvic stabilization program|lumbopelvic stabilization program
469056|NCT01559948|Pelvic compression belt|pelvic compression belt
469057|NCT01559948|Deep abdominal muscles|deep abdominal muscles
469058|NCT01559935|Multiple Myeloma|multiple myeloma
469059|NCT01559922|Acne|acne
469060|NCT01559909|Lower limb loss|lower limb loss
469061|NCT01559909|Leg amputation|leg amputation
469062|NCT01559909|walking study|walking study
469063|NCT01559909|socket technology|socket technology
469064|NCT01559896|egg protein hydrolysate|egg protein hydrolysate
469065|NCT01559883|cancer|cancer
469066|NCT01559883|thrombosis|thrombosis
469067|NCT01559883|pulmonary embolism|pulmonary embolism
469068|NCT01559883|anticoagulation|anticoagulation
469069|NCT01559883|low molecular weight heparin|low molecular weight heparin
469070|NCT01559870|cardiac surgery|cardiac surgery
469071|NCT01559870|cytokine|cytokine
469072|NCT01559870|clinical scoring system|clinical scoring system
469073|NCT01559870|risk factor|risk factor
469074|NCT01559857|Depression|depression
469075|NCT01559857|Insulin resistance|insulin resistance
469076|NCT01559857|Mood disorder|mood disorder
469077|NCT01559844|Hepatitis|hepatitis
469078|NCT01559844|Chronic|chronic
469079|NCT01559844|hepatocellular carcinoma|hepatocellular carcinoma
469080|NCT01559844|HCC|hcc
469081|NCT01559844|transplant|transplant
469082|NCT01559831|Japanese Encephalitis|japanese encephalitis
469083|NCT01559831|IXIARO|ixiaro
469084|NCT01559831|Japanese Encephalitis Vaccine|japanese encephalitis vaccine
469085|NCT01559805|HIV|hiv
469086|NCT01559805|Viral Load|viral load
469087|NCT01559805|Risk|risk
469088|NCT01559805|Patient Compliance|patient compliance
469089|NCT01559805|Homosexuality, Male|homosexuality, male
469090|NCT01559805|Anti-Retroviral Agents|anti-retroviral agents
469091|NCT01559779|Obesity|obesity
469092|NCT01559779|Roux-en-Y gastric bypass|roux-en-y gastric bypass
469093|NCT01559779|Incretin hormones|incretin hormones
469094|NCT01559779|Beta cell function|beta cell function
469095|NCT01559766|Vitamin A|vitamin a
469096|NCT01559766|Dietary requirement|dietary requirement
469097|NCT01559766|Dietary records|dietary records
469098|NCT01559766|Deuterated retinol dilution technique|deuterated retinol dilution technique
469099|NCT01559766|Chinese children|chinese children
469100|NCT01559766|Dietary intake of vitamin A|dietary intake of vitamin a
469101|NCT01559766|Vitamin A liver reserves|vitamin a liver reserves
469102|NCT01559753|Antibiotic|antibiotic
469103|NCT01559753|treatment|treatment
469104|NCT01559753|ventilator associated pneumonia|ventilator associated pneumonia
469105|NCT01559753|duration|duration
469106|NCT01559740|regional anesthesia|regional anesthesia
469107|NCT01559740|children|children
469108|NCT01559740|postoperative pain relief|postoperative pain relief
469109|NCT01559727|heart failure|heart failure
469110|NCT01559727|diuresis|diuresis
469111|NCT01559727|prednisone|prednisone
469112|NCT01559714|Troponin|troponin
469113|NCT01559714|Exercise|exercise
469114|NCT01559714|MRI|mri
469115|NCT01559701|Safety|safety
469116|NCT01559701|PF-00345439|pf-00345439
469117|NCT01559701|Remoxy|remoxy
469118|NCT01559701|PTI-821|pti-821
469119|NCT01559675|Corticosteroids|corticosteroids
469120|NCT01559675|perioperative|perioperative
469121|NCT01559675|colorectal surgery|colorectal surgery
469122|NCT01559662|chewing gum|chewing gum
469123|NCT01559662|ileus|ileus
469124|NCT01559662|gastrointestinal function|gastrointestinal function
469125|NCT01559662|colorectal surgery|colorectal surgery
469126|NCT01559662|abdominal surgery|abdominal surgery
469127|NCT01559649|Stroke|stroke
469128|NCT01559649|Deglutition|deglutition
469129|NCT01559649|Deglutition Disorders|deglutition disorders
469130|NCT01559649|Nurse Screening|nurse screening
469131|NCT01559636|seroconversion|seroconversion
469132|NCT01559636|oral polio vaccine|oral polio vaccine
469133|NCT01559636|OPV|opv
469134|NCT01559636|poliomyelitis|poliomyelitis
469135|NCT01559636|diarrhea|diarrhea
469136|NCT01559636|seroimmunity|seroimmunity
469137|NCT01559610|cardiac surgery|cardiac surgery
469138|NCT01559610|orientation|orientation
469139|NCT01559610|nursing|nursing
469140|NCT01559597|controlled temperature chain|controlled temperature chain
469141|NCT01559597|outside the cold chain|outside the cold chain
469142|NCT01559597|vaccination|vaccination
469143|NCT01559597|prevention of mother to child transmission|prevention of mother to child transmission
469144|NCT01559584|Alopecia|alopecia
469145|NCT01559584|Areata|areata
469146|NCT01559584|Phototherapy|phototherapy
469147|NCT01559584|Phototoxic|phototoxic
469148|NCT01559584|Ultraviolet A|ultraviolet a
469149|NCT01559584|Randomized controlled trial|randomized controlled trial
469150|NCT01559584|Interferon gamma|interferon gamma
469151|NCT01559584|Transforming growth factor beta-1|transforming growth factor beta-1
469152|NCT01559584|Insulin like growth factor-1|insulin like growth factor-1
469153|NCT01559571|Retinopathy of Prematurity|retinopathy of prematurity
469154|NCT01559545|Clostridium difficile associated diarrhea|clostridium difficile associated diarrhea
469155|NCT01559545|Metronidazole|metronidazole
469156|NCT01559545|CDAD|cdad
469157|NCT01559532|Deep vein thrombosis|deep vein thrombosis
469158|NCT01559532|Thromboembolism|thromboembolism
469159|NCT01559532|Tourniquet|tourniquet
469160|NCT01559532|Knee prosthesis.|knee prosthesis.
469161|NCT01559519|TIPS|tips
469162|NCT01559519|albumin|albumin
469163|NCT01559519|hepatic encephalopathy|hepatic encephalopathy
469164|NCT01559519|hyponatremia|hyponatremia
469165|NCT01559519|hypovolemia|hypovolemia
469166|NCT01559519|cirrhosis|cirrhosis
469167|NCT01559506|CFU|cfu
469168|NCT01559506|surgery site|surgery site
469169|NCT01559493|atherosclerotic lesion assessment|atherosclerotic lesion assessment
469170|NCT01559480|Endometriosis|endometriosis
469171|NCT01559480|Desogestrel|desogestrel
469172|NCT01559480|Placebo|placebo
469173|NCT01559467|Myocardial infarction|myocardial infarction
469174|NCT01559467|Randomized Controlled Trial|randomized controlled trial
469175|NCT01559467|Magnetic Resonance Imaging|magnetic resonance imaging
469176|NCT01559467|Coronary Angiography|coronary angiography
469177|NCT01559467|Tomography, X-Ray Computed|tomography, x-ray computed
469178|NCT01559467|Mortality|mortality
469179|NCT01559467|Complications|complications
469180|NCT01559467|Quality of Life|quality of life
469181|NCT01559467|Cost-Benefit Analysis|cost-benefit analysis
469182|NCT01559454|chronic pain|chronic pain
469183|NCT01559454|opioid dependence|opioid dependence
469184|NCT01559454|methadone|methadone
469185|NCT01559454|buprenorphine|buprenorphine
469186|NCT01559454|substance use disorder|substance use disorder
469187|NCT01559441|beetroot juice|beetroot juice
469188|NCT01559441|nitrate|nitrate
469189|NCT01559441|vascular activity|vascular activity
469190|NCT01559441|postprandial state|postprandial state
469191|NCT01559428|Plant sterols|plant sterols
469192|NCT01559428|Plant stanols|plant stanols
469193|NCT01559428|Oxyphytosterols|oxyphytosterols
469194|NCT01559428|Cardiovascular Disease|cardiovascular disease
469195|NCT01559415|Adipocytes|adipocytes
469196|NCT01559389|Urge Urinary Incontinence|urge urinary incontinence
469197|NCT01559389|Vesicare|vesicare
469198|NCT01559389|Urinary Incontinence|urinary incontinence
469199|NCT01559389|Sexual function|sexual function
469200|NCT01559350|OPCAB|opcab
469201|NCT01559337|defect|defect
469202|NCT01559337|dorsal branch of the proper digital nerve|dorsal branch of the proper digital nerve
469203|NCT01559337|proper digital nerve|proper digital nerve
469204|NCT01559337|nerve transfer|nerve transfer
469205|NCT01559337|finger sensory reconstruction|finger sensory reconstruction
469206|NCT01559311|Bradycardia|bradycardia
469304|NCT01558843|Sodium Management|sodium management
469207|NCT01559298|Transcatheter aortic valve implantation|transcatheter aortic valve implantation
469208|NCT01559298|Antithrombotic treatment|antithrombotic treatment
469209|NCT01559298|Clopidogrel|clopidogrel
469210|NCT01559298|Aspirin|aspirin
469211|NCT01559298|Myocardial Infarction|myocardial infarction
469212|NCT01559298|Ischemic stroke|ischemic stroke
469213|NCT01559298|Major bleeding|major bleeding
469214|NCT01559285|epidural, local, ropivacaine|epidural, local, ropivacaine
469215|NCT01559285|epidural administration|epidural administration
469216|NCT01559285|stroke volume variability|stroke volume variability
469217|NCT01559272|Schizophrenia|schizophrenia
469218|NCT01559272|Paliperidone palmitate|paliperidone palmitate
469219|NCT01559272|R092670|r092670
469220|NCT01559272|Paliperidone|paliperidone
469221|NCT01559272|3-month formulation|3-month formulation
469222|NCT01559272|Pharmacokinetics|pharmacokinetics
469223|NCT01559259|ibuprofen|ibuprofen
469224|NCT01559259|acetaminophen|acetaminophen
469225|NCT01559259|pain|pain
469226|NCT01559259|molar extraction|molar extraction
469227|NCT01559246|Cardiac Arrhythmia Monitoring|cardiac arrhythmia monitoring
469228|NCT01559246|Holter Monitoring|holter monitoring
469229|NCT01559246|Continuous ECG monitoring|continuous ecg monitoring
469230|NCT01559246|Event monitoring|event monitoring
469231|NCT01559246|Observational|observational
469232|NCT01559207|nucleosome|nucleosome
469233|NCT01559207|plasma nucleosome concentrations|plasma nucleosome concentrations
469234|NCT01559207|free DNA|free dna
469235|NCT01559207|plasma free DNA concentrations|plasma free dna concentrations
469236|NCT01559181|Offspring of mothers with type 1 diabetes|offspring of mothers with type 1 diabetes
469237|NCT01559181|Pregnancy and programing|pregnancy and programing
469238|NCT01559181|Intrauterine hyperglycaemia|intrauterine hyperglycaemia
469239|NCT01559181|Study focuses on offspring of mothers with type 1 diabetes|study focuses on offspring of mothers with type 1 diabetes
469240|NCT01559155|proteasomes|proteasomes
469241|NCT01559155|proteasome concentration|proteasome concentration
469242|NCT01559155|disease activity|disease activity
469243|NCT01559155|proteolytic activity|proteolytic activity
469244|NCT01559155|autoantibodies|autoantibodies
469245|NCT01559155|proteasome autoantibody|proteasome autoantibody
469246|NCT01559142|Crohn Disease|crohn disease
469247|NCT01559142|infliximab|infliximab
469248|NCT01559142|azathioprine|azathioprine
469249|NCT01559103|Rheumatoid Arthritis|rheumatoid arthritis
469250|NCT01559103|Phase I|phase i
469251|NCT01559103|Biologic|biologic
469252|NCT01559090|Japan|japan
469253|NCT01559090|Phase2|phase2
469254|NCT01559090|Safety|safety
469255|NCT01559090|Tolerability|tolerability
469256|NCT01559090|Systemic Lupus Erythematosus|systemic lupus erythematosus
469257|NCT01559090|SLE, MEDI-546|sle, medi-546
469258|NCT01559077|ATTR|attr
469259|NCT01559051|COPD|copd
469260|NCT01559051|Pulmonary|pulmonary
469261|NCT01559051|Lungs|lungs
469262|NCT01559038|Assessing Effectiveness in Psoriatic Arthritis|assessing effectiveness in psoriatic arthritis
469263|NCT01559025|Type 1 diabetes|type 1 diabetes
469264|NCT01559025|Vildagliptin|vildagliptin
469265|NCT01559025|Galvus|galvus
469266|NCT01559012|Hyperemesis Gravidarum|hyperemesis gravidarum
469267|NCT01559012|treatment|treatment
469268|NCT01559012|transdermal clonidine|transdermal clonidine
469269|NCT01558986|Antibiotic prophylaxis|antibiotic prophylaxis
469270|NCT01558986|surgical site infection|surgical site infection
469271|NCT01558986|modified radical mastectomy|modified radical mastectomy
469272|NCT01558986|Prevention of surgical site infection (SSI) in patients undergoing MRM for breast cancer|prevention of surgical site infection (ssi) in patients undergoing mrm for breast cancer
469273|NCT01558960|Retinoblastoma|retinoblastoma
469274|NCT01558947|gastric cancer|gastric cancer
469275|NCT01558947|Peri-operative chemotherapy|peri-operative chemotherapy
469276|NCT01558934|lofexidine|lofexidine
469277|NCT01558934|methadone|methadone
469278|NCT01558934|interaction|interaction
469279|NCT01558934|pharmacodynamic|pharmacodynamic
469280|NCT01558934|ECG|ecg
469281|NCT01558934|QTc|qtc
469282|NCT01558921|rectal cancer|rectal cancer
469283|NCT01558921|radiotherapy|radiotherapy
469284|NCT01558921|chemotherapy|chemotherapy
469285|NCT01558921|5x5|5x5
469286|NCT01558921|capecitbine|capecitbine
469287|NCT01558921|oxaliplatin|oxaliplatin
469288|NCT01558921|CAPOX|capox
469289|NCT01558921|FOLFOX|folfox
469290|NCT01558921|folinic acid|folinic acid
469291|NCT01558921|fluorouracil|fluorouracil
469292|NCT01558908|critical limb ischemia|critical limb ischemia
469293|NCT01558895|Infrared ray heat treatment|infrared ray heat treatment
469294|NCT01558895|liver cirrhosis|liver cirrhosis
469295|NCT01558895|refractory ascites|refractory ascites
469296|NCT01558882|Essure|essure
469297|NCT01558882|Change in uterine cytokines|change in uterine cytokines
469298|NCT01558882|Change in uterine natural killer cells|change in uterine natural killer cells
469299|NCT01558882|cytokine|cytokine
469300|NCT01558882|natural killer cell|natural killer cell
469301|NCT01558856|refractory overactive bladder|refractory overactive bladder
469302|NCT01558856|neuromodulation|neuromodulation
469303|NCT01558856|sacral nerves|sacral nerves
469404|NCT01558466|INO|ino
469305|NCT01558843|Neurointensive Care|neurointensive care
469306|NCT01558843|Hyponatremia|hyponatremia
469307|NCT01558830|amiodarone|amiodarone
469308|NCT01558830|ranolazine|ranolazine
469309|NCT01558830|safety|safety
469310|NCT01558830|arrhythmia|arrhythmia
469311|NCT01558817|CPR|cpr
469312|NCT01558817|Palliative|palliative
469313|NCT01558817|Outcome|outcome
469314|NCT01558804|Streptococcus pyogenes|streptococcus pyogenes
469315|NCT01558804|Streptococcus|streptococcus
469316|NCT01558791|PTSD|ptsd
469317|NCT01558791|patient education handout|patient education handout
469318|NCT01558765|Rehabilitation|rehabilitation
469319|NCT01558765|Integrated rehabilitation programme|integrated rehabilitation programme
469320|NCT01558765|Exercise training|exercise training
469321|NCT01558765|Psycho-educational care|psycho-educational care
469322|NCT01558752|Total hip replacement|total hip replacement
469323|NCT01558752|Bone mineral density (BMD)|bone mineral density (bmd)
469324|NCT01558739|Ruxolitinib|ruxolitinib
469325|NCT01558739|INC424|inc424
469326|NCT01558739|myelofibrosis|myelofibrosis
469327|NCT01558739|PMF|pmf
469328|NCT01558739|post polycythemia myelofibrosis|post polycythemia myelofibrosis
469329|NCT01558739|PPV MF|ppv mf
469330|NCT01558739|post-essential thrombocythemia myelofibrosis|post-essential thrombocythemia myelofibrosis
469331|NCT01558739|PET-MF|pet-mf
469332|NCT01558739|Primary Myelofibrosis|primary myelofibrosis
469333|NCT01558739|Polycythemia|polycythemia
469334|NCT01558739|Thrombocythemia|thrombocythemia
469335|NCT01558739|Essential Thrombocytosis|essential thrombocytosis
469336|NCT01558739|myeloproliferative Disorders|myeloproliferative disorders
469337|NCT01558739|Bone Marrow Diseases|bone marrow diseases
469338|NCT01558739|Haematologic Diseases|haematologic diseases
469339|NCT01558739|Blood Coagulation Disorders|blood coagulation disorders
469340|NCT01558739|Blood Platelet Disorders|blood platelet disorders
469341|NCT01558739|Haemorrhagic Disorders|haemorrhagic disorders
469342|NCT01558726|Case Management|case management
469343|NCT01558726|Crack abuse/dependents|crack abuse/dependents
469344|NCT01558726|Evaluation|evaluation
469345|NCT01558726|Inpatient|inpatient
469346|NCT01558726|ASI|asi
469347|NCT01558726|Treatment retention|treatment retention
469348|NCT01558726|Abstinence|abstinence
469349|NCT01558713|parturient|parturient
469350|NCT01558700|osteoarthritis|osteoarthritis
469351|NCT01558700|pain|pain
469352|NCT01558700|brain|brain
469353|NCT01558700|gray matter|gray matter
469354|NCT01558687|Oncology|oncology
469355|NCT01558687|newly diagnosed inoperable glioblastoma|newly diagnosed inoperable glioblastoma
469356|NCT01558687|temolozomide|temolozomide
469357|NCT01558687|radiotherapy|radiotherapy
469358|NCT01558687|dynamic MRI|dynamic mri
469359|NCT01558687|Positron emission tomography|positron emission tomography
469360|NCT01558687|[18]FET tracer|[18]fet tracer
469361|NCT01558687|cilengitide|cilengitide
469362|NCT01558687|World Health Organization [WHO] Grade IV|world health organization [who] grade iv
469363|NCT01558661|axitinib (AG-013736)|axitinib (ag-013736)
469364|NCT01558661|recurrent|recurrent
469365|NCT01558661|metastatic|metastatic
469366|NCT01558661|12-004|12-004
469367|NCT01558648|Minimally Invasive Esophagectomy|minimally invasive esophagectomy
469368|NCT01558648|Open Esophagectomy|open esophagectomy
469369|NCT01558648|Quality of Life|quality of life
469370|NCT01558648|12-003|12-003
469371|NCT01558635|Atrial Fibrillation|atrial fibrillation
469372|NCT01558635|Surgical Ablation|surgical ablation
469373|NCT01558635|Maze Procedure|maze procedure
469374|NCT01558635|AF|af
469375|NCT01558622|postoperative analgesia|postoperative analgesia
469376|NCT01558622|dexketoprofen trometamol|dexketoprofen trometamol
469377|NCT01558622|tramadol hydrochloride|tramadol hydrochloride
469378|NCT01558622|pethidine|pethidine
469379|NCT01558622|laparoscopic Nissen fundoplication|laparoscopic nissen fundoplication
469380|NCT01558583|Colon|colon
469381|NCT01558583|Prostate|prostate
469382|NCT01558583|Cancer|cancer
469383|NCT01558544|Ovarian tissue cryopreservation|ovarian tissue cryopreservation
469384|NCT01558544|Ovarian tissue transplantation|ovarian tissue transplantation
469385|NCT01558544|Fertility preservation|fertility preservation
469386|NCT01558544|Risk of premature ovarian failure|risk of premature ovarian failure
469387|NCT01558531|peripheral arterial disease|peripheral arterial disease
469388|NCT01558531|drug-eluting balloon|drug-eluting balloon
469389|NCT01558531|restenosis|restenosis
469390|NCT01558518|Handheld echocardiography|handheld echocardiography
469391|NCT01558518|V-scan|v-scan
469392|NCT01558518|Handheld ultrasound|handheld ultrasound
469393|NCT01558518|Portable ultrasound|portable ultrasound
469394|NCT01558505|critical limb ischemia|critical limb ischemia
469395|NCT01558505|drug-eluting balloon|drug-eluting balloon
469396|NCT01558505|restenosis|restenosis
469397|NCT01558492|Metastatic Castrate Resistant Prostate Cancer|metastatic castrate resistant prostate cancer
469398|NCT01558492|CRPC|crpc
469399|NCT01558479|Parkinson's Disease|parkinson's disease
469400|NCT01558479|Genetics|genetics
469401|NCT01558479|Family Research|family research
469402|NCT01558479|Hereditary Neurodegenerative Diseases|hereditary neurodegenerative diseases
469403|NCT01558466|newborn|newborn
469405|NCT01558466|Sildenafil|sildenafil
469407|NCT01558440|Nutrition rehabilitation|nutrition rehabilitation
469408|NCT01558440|severe malnutrition|severe malnutrition
469409|NCT01558440|infant formula|infant formula
469410|NCT01558440|F-100|f-100
469411|NCT01558414|Cholecystectomy|cholecystectomy
469412|NCT01558414|Minimally invasive surgery|minimally invasive surgery
469413|NCT01558414|Laparoscopic surgery|laparoscopic surgery
469414|NCT01558414|Single incision surgery|single incision surgery
469415|NCT01558401|physical activity|physical activity
469416|NCT01558401|elderly|elderly
469417|NCT01558401|women|women
469418|NCT01558401|efficiency|efficiency
469419|NCT01558362|myocardial perfusion imaging|myocardial perfusion imaging
469420|NCT01558362|single photon emission tomography|single photon emission tomography
469421|NCT01558362|Coronary artery disease|coronary artery disease
469422|NCT01558362|gamma camera imaging|gamma camera imaging
469423|NCT01558362|Phase 1 clinical trial|phase 1 clinical trial
469424|NCT01558362|cyclotron|cyclotron
469425|NCT01558349|Epispot|epispot
469426|NCT01558349|CellSearch|cellsearch
469427|NCT01558349|Circulating melanoma cells|circulating melanoma cells
469428|NCT01558349|circulating cells|circulating cells
469429|NCT01558336|Schistosoma haematobium|schistosoma haematobium
469430|NCT01558336|schoolchildren|schoolchildren
469431|NCT01558336|Central Sudan|central sudan
469432|NCT01558336|Praziquantel|praziquantel
469433|NCT01558323|LCQ908, Renal Impairment, Pharmacokinetics|lcq908, renal impairment, pharmacokinetics
469434|NCT01558284|Irritable bowel syndrome|irritable bowel syndrome
469435|NCT01558284|Neu-P11|neu-p11
469436|NCT01558284|Melatonin|melatonin
469437|NCT01558284|D-IBS|d-ibs
469438|NCT01558271|GLP-1|glp-1
469439|NCT01558245|ischemic stroke; in-stent restenosis; tissue kallikrein;|ischemic stroke; in-stent restenosis; tissue kallikrein;
469440|NCT01558245|the middle cerebral artery; atherosclerotic stenosis|the middle cerebral artery; atherosclerotic stenosis
469441|NCT01558232|Stroke|stroke
469442|NCT01558232|Tibion|tibion
469443|NCT01558232|Bionics|bionics
469444|NCT01558232|Rehab|rehab
469445|NCT01558232|Therapy|therapy
469446|NCT01558232|Robotics|robotics
469447|NCT01558232|Intention|intention
469448|NCT01558219|Metastatic prostate cancer|metastatic prostate cancer
469449|NCT01558206|PTE|pte
469450|NCT01558206|Emergency bedside ultrasonography|emergency bedside ultrasonography
469451|NCT01558206|pulmonary CT Angiography|pulmonary ct angiography
469452|NCT01558206|Pulmonary Wedge infarction|pulmonary wedge infarction
469453|NCT01558206|Pulmonary Thromboembolism|pulmonary thromboembolism
469454|NCT01558193|Aggression DHA|aggression dha
469455|NCT01558193|Docosahexaenoic acid|docosahexaenoic acid
469456|NCT01558193|Impulsivity|impulsivity
469457|NCT01558193|Minerals|minerals
469458|NCT01558193|Vitamins|vitamins
469459|NCT01558167|Dose limiting toxicity of Lenalidomide|dose limiting toxicity of lenalidomide
469460|NCT01558167|Chronic lymphocytic leukemia|chronic lymphocytic leukemia
469461|NCT01558154|depression|depression
469462|NCT01558154|Chinese herb|chinese herb
469463|NCT01558154|acupuncture|acupuncture
469464|NCT01558154|Psychotherapy|psychotherapy
469465|NCT01558154|Transcranial magnetic stimulation|transcranial magnetic stimulation
469466|NCT01558141|IVF stimulation.|ivf stimulation.
469467|NCT01558141|Poor responders.|poor responders.
469468|NCT01558141|IVF patients with poor response to stimulation|ivf patients with poor response to stimulation
469469|NCT01558115|Columbia University|columbia university
469470|NCT01558115|Primary hyperparathyroidism|primary hyperparathyroidism
469471|NCT01558115|Low bone density|low bone density
469472|NCT01558115|Denosumab|denosumab
469473|NCT01558115|Prolia|prolia
469474|NCT01558102|brain aneurysm PED Pipeline|brain aneurysm ped pipeline
469475|NCT01558076|Sickle cell anemia|sickle cell anemia
469476|NCT01558076|exercise testing|exercise testing
469477|NCT01558076|cardiopulmonary disease|cardiopulmonary disease
469478|NCT01558063|Ketamine|ketamine
469479|NCT01558063|Major Depressive Disorder|major depressive disorder
469480|NCT01558063|Treatment|treatment
469481|NCT01558063|Depression|depression
469482|NCT01558037|transplant|transplant
469483|NCT01558037|solid organ transplant|solid organ transplant
469484|NCT01558037|kidney transplant|kidney transplant
469485|NCT01558037|liver transplant|liver transplant
469486|NCT01558037|pancreas transplant|pancreas transplant
469487|NCT01558037|heart transplant|heart transplant
469488|NCT01558037|CMV|cmv
469489|NCT01558037|Cytomegalovirus|cytomegalovirus
469490|NCT01558024|compression stockings|compression stockings
469491|NCT01558024|physiopathology|physiopathology
469492|NCT01558011|gastric adenocarcinoma|gastric adenocarcinoma
469493|NCT01558011|Capecitabine and oxaliplatin (XELOX)|capecitabine and oxaliplatin (xelox)
469494|NCT01558011|Docetaxel and capecitabine (TX)|docetaxel and capecitabine (tx)
469495|NCT01558011|Using genetic polymorphisms|using genetic polymorphisms
469496|NCT01558011|drug metabolism and immunohistochemical stain|drug metabolism and immunohistochemical stain
469497|NCT01558011|predict the efficacy|predict the efficacy
469498|NCT01557998|Test and linkage to care|test and linkage to care
469499|NCT01557998|Injecting drug user (IDU)|injecting drug user (idu)
469500|NCT01557998|Prevention with positives|prevention with positives
469501|NCT01557998|ART adherence|art adherence
469502|NCT01557998|point of care CD4 counts|point of care cd4 counts
469503|NCT01557998|Peer case management|peer case management
469504|NCT01557998|Conditional cash transfer|conditional cash transfer
469505|NCT01557985|children|children
469506|NCT01557985|regional anesthesia|regional anesthesia
469507|NCT01557985|postoperative pain management|postoperative pain management
469508|NCT01557985|local anesthetic solution|local anesthetic solution
469509|NCT01557985|toxicity|toxicity
469510|NCT01557933|ECT|ect
469511|NCT01557933|Bipolar Disorder|bipolar disorder
469512|NCT01557920|apnea|apnea
469513|NCT01557920|airway collapsibility|airway collapsibility
469514|NCT01557920|healthy|healthy
469515|NCT01557920|hypercapnia|hypercapnia
469516|NCT01557920|general anesthesia|general anesthesia
469517|NCT01557920|breathing-swallow coordination|breathing-swallow coordination
469518|NCT01557920|aspiration|aspiration
469519|NCT01557907|Diabetes|diabetes
469520|NCT01557907|Diabetes Mellitus|diabetes mellitus
469521|NCT01557907|Type 1 diabetes|type 1 diabetes
469522|NCT01557907|Insulin Pump users|insulin pump users
469523|NCT01557907|Intradermal insulin|intradermal insulin
469524|NCT01557894|Social anxiety disorders|social anxiety disorders
469525|NCT01557894|Social phobia|social phobia
469526|NCT01557894|Anxiety sensitivity|anxiety sensitivity
469527|NCT01557894|Irrational thinking|irrational thinking
469528|NCT01557894|Guided self-help|guided self-help
469529|NCT01557894|Internet-delivered treatment|internet-delivered treatment
469530|NCT01557855|Corus CAD|corus cad
469531|NCT01557855|ASGES|asges
469532|NCT01557855|Age/Sex/Gene Expression Score|age/sex/gene expression score
469533|NCT01557855|Gene Expression|gene expression
469534|NCT01557855|GES|ges
469535|NCT01557855|CAD|cad
469536|NCT01557855|CVD|cvd
469537|NCT01557855|CHD|chd
469538|NCT01557855|Precision Medicine|precision medicine
469539|NCT01557855|Clinical Utility|clinical utility
469540|NCT01557855|Registry|registry
469541|NCT01557855|Coronary Artery Disease|coronary artery disease
469542|NCT01557855|Coronary Heart Disease|coronary heart disease
469543|NCT01557855|Cardiovascular Disease|cardiovascular disease
469544|NCT01557855|Angina Pectoris|angina pectoris
469545|NCT01557855|Chest Pain|chest pain
469546|NCT01557855|Registry I|registry i
469547|NCT01557855|Registry-I|registry-i
469548|NCT01557842|Ischemic|ischemic
469549|NCT01557842|Ventricular Tachycardia|ventricular tachycardia
469550|NCT01557842|Implantable Cardioverter Defibrillators|implantable cardioverter defibrillators
469551|NCT01557842|Antiarrhythmic Drug Therapy|antiarrhythmic drug therapy
469552|NCT01557842|Ablation|ablation
469553|NCT01557842|Electrophysiology|electrophysiology
469554|NCT01557829|spondylolisthesis|spondylolisthesis
469555|NCT01557829|disc degeneration|disc degeneration
469556|NCT01557829|lumbar interbody fusion|lumbar interbody fusion
469557|NCT01557829|randomized controlled trial|randomized controlled trial
469558|NCT01557829|ceramic interbody spacer|ceramic interbody spacer
469559|NCT01557816|osteoarthritis|osteoarthritis
469560|NCT01557816|knee|knee
469561|NCT01557816|Naproxen|naproxen
469562|NCT01557803|Immune reconstitution inflammatory syndrome|immune reconstitution inflammatory syndrome
469563|NCT01557803|Biomarkers|biomarkers
469564|NCT01557803|HIV|hiv
469565|NCT01557803|ART|art
469566|NCT01557803|predictive factors|predictive factors
469567|NCT01557803|epidemiological pattern|epidemiological pattern
469568|NCT01557803|Gabon|gabon
469569|NCT01557790|Adult male|adult male
469570|NCT01557790|18 years or older|18 years or older
469571|NCT01557790|clinical diagnosis|clinical diagnosis
469572|NCT01557751|Total knee arthroplasty|total knee arthroplasty
469573|NCT01557751|Total knee replacement|total knee replacement
469574|NCT01557751|Genetics of pain|genetics of pain
469575|NCT01557738|Exercise|exercise
469576|NCT01557738|Blood Flow|blood flow
469577|NCT01557738|Nitric Oxide|nitric oxide
469578|NCT01557738|Aging|aging
469579|NCT01557738|Antioxidant|antioxidant
469580|NCT01557738|Flavanol|flavanol
469581|NCT01557738|Young (18-30 yrs)|young (18-30 yrs)
469582|NCT01557738|Aging (60 - 80 yrs)|aging (60 - 80 yrs)
469583|NCT01557725|Knee Replacement, Total|knee replacement, total
469584|NCT01557725|Hip Replacement, Total|hip replacement, total
469585|NCT01557725|Thromboembolism, Venous|thromboembolism, venous
469586|NCT01557725|prophylaxis|prophylaxis
469587|NCT01557725|Enhanced recovery|enhanced recovery
469588|NCT01557686|Cancer Related fatigue|cancer related fatigue
469589|NCT01557686|Quality of Life|quality of life
469590|NCT01557686|Psychosocial Intervention|psychosocial intervention
469591|NCT01557686|Rehabilitation|rehabilitation
469592|NCT01557686|Physical Fitness|physical fitness
469593|NCT01557686|Physical Activity|physical activity
469594|NCT01557686|Exercise Therapy|exercise therapy
469595|NCT01557686|Exercise|exercise
469596|NCT01557686|Hematologic|hematologic
469597|NCT01557686|Hematological|hematological
469598|NCT01557686|Leukemia, Myeloid, Acute|leukemia, myeloid, acute
469599|NCT01557686|Acute Myeloid Leukemia|acute myeloid leukemia
469705|NCT01557244|neurologic disease|neurologic disease
469600|NCT01557686|Acute Lymphoblastic Leukemia|acute lymphoblastic leukemia
469601|NCT01557686|Acute Leukemia|acute leukemia
469602|NCT01557673|Nasogastric|nasogastric
469603|NCT01557673|Small bowel water|small bowel water
469604|NCT01557673|Diarrhoea|diarrhoea
469605|NCT01557673|Mesenteric blood flow|mesenteric blood flow
469606|NCT01557673|Enteral feeding|enteral feeding
469607|NCT01557621|Immunization reminder/recall|immunization reminder/recall
469608|NCT01557621|Reminder/Recall systems|reminder/recall systems
469609|NCT01557621|Population based Recall|population based recall
469610|NCT01557621|Practice based Recall|practice based recall
599150|NCT01020695|PTSD|ptsd
469611|NCT01557608|cancer|cancer
469612|NCT01557608|chemotherapy|chemotherapy
469613|NCT01557608|photon stimulation|photon stimulation
469614|NCT01557608|neuropathy|neuropathy
469615|NCT01557608|pain|pain
469616|NCT01557582|IPAH|ipah
469617|NCT01557582|HPAH|hpah
469618|NCT01557582|APAH CTD|apah ctd
469619|NCT01557582|APAH HIV|apah hiv
469620|NCT01557582|APAH PoPH|apah poph
469621|NCT01557582|APAH Drugs/Toxins|apah drugs/toxins
469622|NCT01557582|APAH CHD repaired|apah chd repaired
469623|NCT01557582|APAH CHD unrepaired|apah chd unrepaired
469624|NCT01557569|methamphetamine|methamphetamine
469625|NCT01557569|addiction|addiction
469626|NCT01557569|relapse|relapse
469627|NCT01557569|atomoxetine|atomoxetine
469628|NCT01557556|CRH Antagonist|crh antagonist
469629|NCT01557556|Nicotine|nicotine
469630|NCT01557556|Nicotine Dependence|nicotine dependence
469631|NCT01557556|Smoking|smoking
469632|NCT01557556|Stress|stress
469633|NCT01557543|Coronary Artery Bypass Grafting|coronary artery bypass grafting
469634|NCT01557543|Coronary Artery Disease|coronary artery disease
469635|NCT01557543|Transmyocardial Revascularization|transmyocardial revascularization
469636|NCT01557543|Bone Marrow Stromal Cells|bone marrow stromal cells
469637|NCT01557517|cGVHD|cgvhd
469638|NCT01557517|Oral cGVHD|oral cgvhd
469639|NCT01557517|Topical|topical
469640|NCT01557517|Oral Rinse|oral rinse
469641|NCT01557517|Clobetasol|clobetasol
469642|NCT01557517|Oral Graft-Versus-Host Disease|oral graft-versus-host disease
469643|NCT01557517|GVHD|gvhd
469644|NCT01557491|Alopecia|alopecia
469645|NCT01557491|Coronal Incision|coronal incision
469646|NCT01557491|Scar Quality|scar quality
469647|NCT01557478|breast cancer|breast cancer
469648|NCT01557478|melatonin|melatonin
469649|NCT01557478|adjuvant therapy|adjuvant therapy
469650|NCT01557478|quality of life|quality of life
469651|NCT01557478|pain|pain
469652|NCT01557478|sleep|sleep
469653|NCT01557478|survival|survival
469654|NCT01557478|adverse events|adverse events
469655|NCT01557452|JIA|jia
469656|NCT01557426|skin|skin
469657|NCT01557426|soft tissue|soft tissue
469658|NCT01557426|infection|infection
469659|NCT01557426|cellulitis|cellulitis
469660|NCT01557426|abscess|abscess
469661|NCT01557413|Humerus|humerus
469662|NCT01557413|fracture|fracture
469663|NCT01557413|nail|nail
469664|NCT01557413|plate|plate
469665|NCT01557413|tuberosity|tuberosity
469666|NCT01557400|Duchenne muscular dystrophy|duchenne muscular dystrophy
469667|NCT01557400|Becker muscular dystrophy|becker muscular dystrophy
469668|NCT01557400|Nonsense mutation|nonsense mutation
469669|NCT01557400|Premature stop codon|premature stop codon
469671|NCT01557400|BMD|bmd
469672|NCT01557400|nmDBMD|nmdbmd
469673|NCT01557400|DBMD|dbmd
469674|NCT01557400|Ataluren|ataluren
469675|NCT01557400|PTC124|ptc124
469676|NCT01557387|Pseudopolyp|pseudopolyp
469677|NCT01557387|Inflammatory bowel disease|inflammatory bowel disease
469678|NCT01557374|Rheumatoid arthritis|rheumatoid arthritis
469679|NCT01557374|Disease activity|disease activity
469680|NCT01557374|Remission|remission
469681|NCT01557374|Lowest Effective DOse|lowest effective dose
469682|NCT01557374|Abatacept Tocilizumab|abatacept tocilizumab
469683|NCT01557374|ACR-EULAR 2010|acr-eular 2010
469684|NCT01557361|renal replacement therapy|renal replacement therapy
469685|NCT01557361|dialysis|dialysis
469686|NCT01557361|acute kidney injury|acute kidney injury
469687|NCT01557361|hemodialysis|hemodialysis
469688|NCT01557361|critical illness|critical illness
469689|NCT01557335|To evaluate adenosine diphosphate (ADP)-induced platelet aggregation|to evaluate adenosine diphosphate (adp)-induced platelet aggregation
469690|NCT01557309|traumatic rotator cuff tear|traumatic rotator cuff tear
469691|NCT01557309|arthroscopic rotator cuff repair|arthroscopic rotator cuff repair
469692|NCT01557309|age|age
469693|NCT01557309|early rotator cuff repair|early rotator cuff repair
469694|NCT01557296|Diet|diet
469695|NCT01557296|Dietary treatment|dietary treatment
469696|NCT01557296|Particle size|particle size
469697|NCT01557296|Gastroparesis|gastroparesis
469698|NCT01557296|Diabetes Mellitus|diabetes mellitus
469699|NCT01557257|single- and multiple-dose pharmacokinetics|single- and multiple-dose pharmacokinetics
469700|NCT01557257|ALO-02|alo-02
469701|NCT01557257|OxyContin|oxycontin
469702|NCT01557244|neurogenic detrusor overactivity|neurogenic detrusor overactivity
469703|NCT01557244|neurogenic bladder|neurogenic bladder
469704|NCT01557244|neuropathic bladder|neuropathic bladder
469706|NCT01557244|fesoterodine|fesoterodine
469707|NCT01557231|OA|oa
469708|NCT01557231|osteoarthritis|osteoarthritis
469709|NCT01557231|pain|pain
469710|NCT01557231|variability|variability
469711|NCT01557231|activity|activity
469712|NCT01557231|treatment|treatment
469713|NCT01557218|Dietary variety|dietary variety
469714|NCT01557218|Vegetable intake|vegetable intake
469715|NCT01557218|Fruit intake|fruit intake
469716|NCT01557205|optical coherence tomography|optical coherence tomography
599230|NCT01020331|ALS|als
469717|NCT01557205|cell imaging|cell imaging
469718|NCT01557192|Depression|depression
469719|NCT01557192|Bipolar Depression|bipolar depression
469720|NCT01557192|LFMS|lfms
469721|NCT01557192|Electromagnetic Stimulation|electromagnetic stimulation
469722|NCT01557166|OSA|osa
469723|NCT01557153|Late-life Unremitted Depression|late-life unremitted depression
469724|NCT01557140|Chagas cardiomyopathy,|chagas cardiomyopathy,
469725|NCT01557140|Renin-angiotensin system,|renin-angiotensin system,
469726|NCT01557140|Beta-blockers,|beta-blockers,
469727|NCT01557140|Enalapril,|enalapril,
469728|NCT01557140|Carvedilol,|carvedilol,
469729|NCT01557140|Renin-angiotensin system inhibitors,|renin-angiotensin system inhibitors,
469730|NCT01557140|Brain natriuretic peptide level,|brain natriuretic peptide level,
469731|NCT01557140|Left ventricular ejection fraction,|left ventricular ejection fraction,
469732|NCT01557140|Chemokines|chemokines
469733|NCT01557127|Renal cell carcinoma,|renal cell carcinoma,
469734|NCT01557127|Sorafenib|sorafenib
469735|NCT01557127|Dosing|dosing
469736|NCT01557114|unresectable Stage III or stage IV advanced malignant melanoma|unresectable stage iii or stage iv advanced malignant melanoma
469737|NCT01557088|coronary artery disease|coronary artery disease
469738|NCT01557088|coronary artery spasm|coronary artery spasm
469739|NCT01557088|small vessel coronary artery disease|small vessel coronary artery disease
469740|NCT01557075|High dose statin|high dose statin
469741|NCT01557062|Fibromyalgia|fibromyalgia
469742|NCT01557062|Hydrotherapy|hydrotherapy
469743|NCT01557062|Sleep|sleep
469744|NCT01557062|Pain|pain
469745|NCT01557062|Body Temperature|body temperature
469746|NCT01557049|chronic low back pain|chronic low back pain
469747|NCT01557049|Postural global reeducation|postural global reeducation
469748|NCT01557049|randomized|randomized
469749|NCT01557049|physical rehabilitation|physical rehabilitation
469750|NCT01557036|Brain Aneurysm|brain aneurysm
469751|NCT01556997|Hypertension|hypertension
469752|NCT01556997|Essential Hypertension|essential hypertension
469753|NCT01556984|diabetic foot|diabetic foot
469754|NCT01556984|digital subtraction angiography|digital subtraction angiography
469755|NCT01556984|endothelial function|endothelial function
469756|NCT01556984|Patients with diabetes|patients with diabetes
469757|NCT01556984|Age 40 to 70 years old|age 40 to 70 years old
469758|NCT01556984|Endothelial function are determined|endothelial function are determined
469759|NCT01556945|P. falciparum|p. falciparum
469760|NCT01556945|vaccine|vaccine
469761|NCT01556945|healthy volunteers|healthy volunteers
469762|NCT01556919|GERD|gerd
469763|NCT01556919|Esophagitis|esophagitis
469764|NCT01556893|Flap Creation|flap creation
469765|NCT01556893|Femtosecond Laser|femtosecond laser
469766|NCT01556893|corneal flap prior to LASIK procedure|corneal flap prior to lasik procedure
469767|NCT01556880|Drivers|drivers
469768|NCT01556880|Chinese|chinese
469769|NCT01556880|Short Message Service|short message service
469770|NCT01556880|Cellular Phone|cellular phone
469771|NCT01556867|Umbilical cord care|umbilical cord care
469772|NCT01556867|dry cord care|dry cord care
469773|NCT01556867|antiseptic|antiseptic
469774|NCT01556867|Omphalitis|omphalitis
469775|NCT01556867|umbilical cord drop|umbilical cord drop
469776|NCT01556867|hospitalized in maternity hospital|hospitalized in maternity hospital
469777|NCT01556854|ginkgo leaves|ginkgo leaves
469778|NCT01556854|butylphthalide|butylphthalide
469779|NCT01556854|edaravone|edaravone
469780|NCT01556854|citicoline|citicoline
469781|NCT01556854|cerebrolysin|cerebrolysin
469782|NCT01556854|piracetam|piracetam
469783|NCT01556854|Neuroprotectants|neuroprotectants
469784|NCT01556841|Randomised|randomised
469785|NCT01556841|Controlled|controlled
469786|NCT01556841|Trovax|trovax
469787|NCT01556841|MVA-5T4|mva-5t4
469788|NCT01556841|5T4|5t4
469789|NCT01556841|Immunotherapy|immunotherapy
469790|NCT01556841|Relapsed|relapsed
469791|NCT01556841|Asymptomatic|asymptomatic
469792|NCT01556841|Epithelial|epithelial
469793|NCT01556841|Ovarian|ovarian
469794|NCT01556841|Fallopian|fallopian
469795|NCT01556841|Peritoneal|peritoneal
469796|NCT01556815|Hepatocellular Carcinoma|hepatocellular carcinoma
469797|NCT01556815|Sorafenib|sorafenib
469798|NCT01556815|Transarterial Chemoembolization|transarterial chemoembolization
469799|NCT01556815|HBV|hbv
469800|NCT01556802|stroke|stroke
469801|NCT01556802|sequelaes|sequelaes
469802|NCT01556802|minocicline|minocicline
469803|NCT01556789|ONT-10|ont-10
469804|NCT01556789|MUC1|muc1
469805|NCT01556789|Vaccine|vaccine
469806|NCT01556789|Phase 1|phase 1
469807|NCT01556789|Solid Tumors|solid tumors
469808|NCT01556789|Dose escalation|dose escalation
469809|NCT01556776|CLL|cll
469810|NCT01556776|High Risk|high risk
469811|NCT01556776|Maintenance|maintenance
469812|NCT01556763|Schizophrenia|schizophrenia
469813|NCT01556763|Schizoaffective|schizoaffective
469814|NCT01556763|CNS|cns
469815|NCT01556737|isoflavone|isoflavone
469816|NCT01556737|supplement|supplement
469817|NCT01556737|daidzein|daidzein
469818|NCT01556737|genistein|genistein
469819|NCT01556737|gene expression|gene expression
469820|NCT01556724|Peripheral nerve blocks|peripheral nerve blocks
469821|NCT01556724|Ropivacaine concentrations in lumbar plexus catheters|ropivacaine concentrations in lumbar plexus catheters
469822|NCT01556724|Postoperative pain|postoperative pain
469823|NCT01556724|Total hip replacement|total hip replacement
469824|NCT01556711|Head Injury|head injury
469825|NCT01556711|Head Trauma|head trauma
469826|NCT01556711|TBI (Traumatic Brain Injury)|tbi (traumatic brain injury)
469827|NCT01556711|Emergency Department|emergency department
469828|NCT01556698|Acne Vulgaris|acne vulgaris
469829|NCT01556698|Acne|acne
469830|NCT01556672|small bowel lesions|small bowel lesions
469831|NCT01556672|Crohn's Disease|crohn's disease
469832|NCT01556672|Plaque psoriasis|plaque psoriasis
469833|NCT01556672|adalimumab|adalimumab
469834|NCT01556672|capsule endoscopy|capsule endoscopy
469835|NCT01556659|Left ventricular thrombus|left ventricular thrombus
469836|NCT01556659|Acute myocardial infarction|acute myocardial infarction
469837|NCT01556659|Anticoagulation|anticoagulation
469838|NCT01556646|Cirrhosis|cirrhosis
469839|NCT01556646|Hepatic Encephalopathy|hepatic encephalopathy
469840|NCT01556646|Hyponatremia|hyponatremia
469841|NCT01556646|Brain MRI|brain mri
469842|NCT01556646|Health-related quality of life|health-related quality of life
469843|NCT01556646|cognitive function|cognitive function
469844|NCT01556620|PtiO2|ptio2
469845|NCT01556620|NIRS|nirs
469846|NCT01556607|Respiratory Syncytial Virus Infection|respiratory syncytial virus infection
469847|NCT01556607|RSV|rsv
469848|NCT01556594|Hypoglycemia|hypoglycemia
469849|NCT01556594|Diabetes mellitus|diabetes mellitus
469850|NCT01556581|back pain|back pain
469851|NCT01556581|primary care|primary care
469852|NCT01556581|physical therapy|physical therapy
469853|NCT01556568|Noonan Syndrome, hypertrophic cardiomyopathy.|noonan syndrome, hypertrophic cardiomyopathy.
469854|NCT01556555|Sclerosing cholangitis|sclerosing cholangitis
469855|NCT01556555|Spyglass|spyglass
469856|NCT01556555|Endoscopic retrograde cholangiopancreaticography|endoscopic retrograde cholangiopancreaticography
469857|NCT01556542|peripheral arterial disease|peripheral arterial disease
469858|NCT01556542|drug-eluting balloon|drug-eluting balloon
469859|NCT01556542|restenosis|restenosis
469860|NCT01556477|MDS|mds
469861|NCT01556477|AML|aml
469862|NCT01556477|Azacitidine|azacitidine
469863|NCT01556477|Lenalidomide|lenalidomide
469864|NCT01556477|del5q|del5q
469865|NCT01556464|Obstructive sleep apnea|obstructive sleep apnea
469866|NCT01556464|CPAP|cpap
469867|NCT01556425|opioid use disorder|opioid use disorder
469868|NCT01556425|treatment|treatment
469869|NCT01556425|heroin|heroin
469870|NCT01556425|extended-release naltrexone|extended-release naltrexone
469871|NCT01556425|incentives|incentives
469872|NCT01556425|cotningency management|cotningency management
469873|NCT01556425|employment-based reinforcement|employment-based reinforcement
469874|NCT01556425|therapeutic workplace|therapeutic workplace
469875|NCT01556412|endoscopic ultrasound|endoscopic ultrasound
469876|NCT01556412|primary sclerosing cholangitis|primary sclerosing cholangitis
469877|NCT01556412|EUS|eus
469878|NCT01556412|cholestatic hepatopathy|cholestatic hepatopathy
469879|NCT01556399|Duodenal adenoma|duodenal adenoma
469880|NCT01556399|Ampullary adenoma|ampullary adenoma
469881|NCT01556386|acute lymphoblastic leukemia|acute lymphoblastic leukemia
469882|NCT01556386|single nucleotide polymorphism|single nucleotide polymorphism
469883|NCT01556373|acute systemic inflammation|acute systemic inflammation
469884|NCT01556373|arterial stiffness|arterial stiffness
469885|NCT01556373|Carotid-femoral pulse wave velocity|carotid-femoral pulse wave velocity
469886|NCT01556360|genetic hemochromatosis|genetic hemochromatosis
469887|NCT01556360|Iron overload|iron overload
469888|NCT01556360|C282 homozygosity|c282 homozygosity
469889|NCT01556347|alloantibody|alloantibody
469890|NCT01556347|immunologic|immunologic
469891|NCT01556347|memory|memory
469892|NCT01556347|heart|heart
469893|NCT01556347|transplant|transplant
469894|NCT01556347|desensitization|desensitization
469895|NCT01556334|premature ruptured membranes|premature ruptured membranes
469896|NCT01556334|azithromycin|azithromycin
469897|NCT01556334|erythromycin|erythromycin
469898|NCT01556334|latency|latency
469899|NCT01556334|antibiotics|antibiotics
469900|NCT01556321|Obesity|obesity
469901|NCT01556321|Body weight|body weight
469902|NCT01556321|Gut flora|gut flora
469903|NCT01556321|Fat absorption|fat absorption
469904|NCT01556308|Dowling Meara|dowling meara
469905|NCT01556308|Epidermolysis bullosa|epidermolysis bullosa
469906|NCT01556308|inflammation|inflammation
469907|NCT01556295|Nurses|nurses
469908|NCT01556295|Low back pain|low back pain
469909|NCT01556295|Gesture behavior|gesture behavior
469910|NCT01556295|Knowlegde|knowlegde
469911|NCT01556282|Hepatocellular Carcinoma|hepatocellular carcinoma
469912|NCT01556282|portal vein thrombosis|portal vein thrombosis
469913|NCT01556282|HCC|hcc
469914|NCT01556243|stage IA breast cancer|stage ia breast cancer
469915|NCT01556243|stage IB breast cancer|stage ib breast cancer
469916|NCT01556243|stage II breast cancer|stage ii breast cancer
469917|NCT01556243|ductal breast carcinoma in situ|ductal breast carcinoma in situ
469918|NCT01556243|lobular breast carcinoma in situ|lobular breast carcinoma in situ
469919|NCT01556230|pituitary gland|pituitary gland
469920|NCT01556230|pituitary adenoma|pituitary adenoma
469921|NCT01556230|pituitary tumor|pituitary tumor
469922|NCT01556230|hypophysis|hypophysis
469923|NCT01556230|endocrine|endocrine
469924|NCT01556230|neuroendocrine|neuroendocrine
469925|NCT01556230|hormone|hormone
469926|NCT01556217|Healthy volunteers|healthy volunteers
469927|NCT01556217|JNJ-39393406-aaa|jnj-39393406-aaa
469928|NCT01556217|Pharmacokinetics|pharmacokinetics
469929|NCT01556217|Central brain penetrance|central brain penetrance
469930|NCT01556217|Cerebral spinal fluid|cerebral spinal fluid
469931|NCT01556204|Endometriosis|endometriosis
469932|NCT01556191|lung cancer|lung cancer
469933|NCT01556191|women|women
469934|NCT01556178|Hydrocephalus|hydrocephalus
469935|NCT01556178|Survivin|survivin
469936|NCT01556178|miRNA|mirna
469937|NCT01556165|Rasagiline|rasagiline
469938|NCT01556165|Azilect|azilect
469939|NCT01556165|Parkinson´s Disease|parkinson´s disease
469940|NCT01556165|Motor fluctuations|motor fluctuations
469941|NCT01556139|Endurance|endurance
469942|NCT01556139|exercise training|exercise training
469943|NCT01556139|6-min walking test|6-min walking test
469944|NCT01556126|Coronary artery disease|coronary artery disease
469945|NCT01556126|Drug Eluting Stent|drug eluting stent
469946|NCT01556126|All comers patients|all comers patients
469947|NCT01556113|fatty liver|fatty liver
469948|NCT01556113|hypertriglyceridemia|hypertriglyceridemia
469949|NCT01556113|elevated liver enzymes|elevated liver enzymes
469950|NCT01556100|18F-DTBZ AV-133 imaging|18f-dtbz av-133 imaging
469951|NCT01556087|opioids|opioids
469952|NCT01556087|distress tolerance|distress tolerance
469953|NCT01556087|buprenorphine|buprenorphine
469954|NCT01556074|Post traumatic stress disorder|post traumatic stress disorder
469955|NCT01556074|PTSD|ptsd
469956|NCT01556074|Insomnia|insomnia
469957|NCT01556074|Sleep|sleep
469958|NCT01556074|Yoga|yoga
469959|NCT01556074|Meditation|meditation
469960|NCT01556074|Mental Health|mental health
469961|NCT01556074|Sleep Quality|sleep quality
469962|NCT01556074|Actigraphy|actigraphy
469963|NCT01556074|Sleep Diaries|sleep diaries
469964|NCT01556074|Autonomic|autonomic
469965|NCT01556074|Social Health|social health
469966|NCT01556074|Interoception|interoception
469967|NCT01556074|Attention Regulation|attention regulation
469968|NCT01556074|Emotion Regulation|emotion regulation
469969|NCT01556061|Laryngoscopy|laryngoscopy
469970|NCT01556061|Airway Management|airway management
469971|NCT01556061|Intubation|intubation
469972|NCT01556048|Behavior therapy|behavior therapy
469973|NCT01556048|Bereavement|bereavement
469974|NCT01556048|Complicated grief|complicated grief
469975|NCT01556048|Depression|depression
469976|NCT01556048|Posttraumatic Stress Disorder|posttraumatic stress disorder
469977|NCT01556035|oncodermatology|oncodermatology
469978|NCT01556035|hematology|hematology
469979|NCT01556035|cutaneous B cell lymphoma|cutaneous b cell lymphoma
469980|NCT01556035|lenalidomide|lenalidomide
469981|NCT01556022|Ischemic heart disease|ischemic heart disease
469982|NCT01556022|Coronary artery disease|coronary artery disease
469983|NCT01556022|Chronic heart failure|chronic heart failure
469984|NCT01556022|Cardiovascular disease|cardiovascular disease
469985|NCT01556022|Adult stem cells|adult stem cells
469986|NCT01556022|Adipose derived regenerative cells|adipose derived regenerative cells
469987|NCT01556009|Basal Cell Carcinoma|basal cell carcinoma
469988|NCT01556009|Photodynamic Therapy|photodynamic therapy
469989|NCT01555996|older|older
469990|NCT01555996|delirium|delirium
469991|NCT01555996|cognitive status|cognitive status
469992|NCT01555996|occupational therapy|occupational therapy
469993|NCT01555996|critically ill patients|critically ill patients
469994|NCT01555983|cannabis|cannabis
469995|NCT01555983|central neuropathic pain|central neuropathic pain
469996|NCT01555983|analgesia|analgesia
469997|NCT01555970|Obsessive-compulsive disorder|obsessive-compulsive disorder
469998|NCT01555970|Treatment|treatment
469999|NCT01555970|Glutamate|glutamate
470000|NCT01555970|N-Acetylcysteine|n-acetylcysteine
470001|NCT01555918|Pharmacokinetics|pharmacokinetics
470002|NCT01555918|Healthy volunteers|healthy volunteers
470003|NCT01555918|Isavuconazole|isavuconazole
470004|NCT01555918|BAL4815|bal4815
470005|NCT01555918|BAL8728|bal8728
470006|NCT01555918|BAL8557|bal8557
470007|NCT01555905|Respiratory Muscle Strength|respiratory muscle strength
470008|NCT01555892|EBV|ebv
470009|NCT01555892|Hodgkin's Lymphoma|hodgkin's lymphoma
470010|NCT01555892|Non-Hodgkin's Lymphoma|non-hodgkin's lymphoma
470011|NCT01555892|Lymphoma Relapse|lymphoma relapse
470012|NCT01555892|Autologous or Syngeneic Stem Cell Transplant|autologous or syngeneic stem cell transplant
470013|NCT01555892|T/NK-lymphoproliferative disease|t/nk-lymphoproliferative disease
470014|NCT01555892|LMP|lmp
470015|NCT01555892|BARF1|barf1
470016|NCT01555892|EBNA1|ebna1
470017|NCT01555879|Retrospective|retrospective
470018|NCT01555879|Database|database
470019|NCT01555879|Data warehouse|data warehouse
470020|NCT01555879|Data mining|data mining
470021|NCT01555879|Collaborative effectiveness|collaborative effectiveness
470022|NCT01555879|Comparative effectiveness|comparative effectiveness
470023|NCT01555879|Outcome based medicine|outcome based medicine
470024|NCT01555879|Evidence based medicine|evidence based medicine
470025|NCT01555866|isavuconazole|isavuconazole
470026|NCT01555866|BAL4815|bal4815
470027|NCT01555866|BAL8557|bal8557
470028|NCT01555866|BAL8728|bal8728
470029|NCT01555840|Magnetically guided capsule endoscopy (MGCE)|magnetically guided capsule endoscopy (mgce)
470030|NCT01555840|Gastroscopy|gastroscopy
470031|NCT01555827|Retina|retina
470032|NCT01555827|ALzheimer's disease|alzheimer's disease
470033|NCT01555827|neurodegenerative signs|neurodegenerative signs
470034|NCT01555814|dopamine|dopamine
470035|NCT01555814|first episode|first episode
470036|NCT01555814|reward|reward
470037|NCT01555814|cognition|cognition
470038|NCT01555814|MRI|mri
470039|NCT01555814|fMRI|fmri
470040|NCT01555814|PPI|ppi
470041|NCT01555814|P300|p300
470042|NCT01555814|P50 gating|p50 gating
470043|NCT01555814|endophenotypes|endophenotypes
470044|NCT01555801|esophageal cancer|esophageal cancer
470045|NCT01555801|early cancer|early cancer
470046|NCT01555801|ultrasonography (EUS)|ultrasonography (eus)
470047|NCT01555801|stage|stage
470048|NCT01555788|type 1 diabetes,|type 1 diabetes,
470049|NCT01555788|diaport,|diaport,
470050|NCT01555788|artificial pancreas,|artificial pancreas,
470051|NCT01555788|zone mpc algorithm,|zone mpc algorithm,
470052|NCT01555788|ap system,|ap system,
470053|NCT01555788|intraperitoneal insulin|intraperitoneal insulin
470054|NCT01555775|exercise-induced muscle damage|exercise-induced muscle damage
470055|NCT01555775|nutritional recovery|nutritional recovery
470056|NCT01555775|nutritional supplement|nutritional supplement
470057|NCT01555775|natural food|natural food
470058|NCT01555736|allergic rhinitis|allergic rhinitis
470059|NCT01555736|perennial immunotherapy|perennial immunotherapy
470060|NCT01555736|preseasonal immunotherapy|preseasonal immunotherapy
470061|NCT01555697|Schizophrenia|schizophrenia
470062|NCT01555697|prepulse inhibition|prepulse inhibition
470063|NCT01555697|neurocognition|neurocognition
470064|NCT01555697|working memory|working memory
470065|NCT01555697|memantine|memantine
470066|NCT01555697|MATRICS Consensus Cognitive Battery|matrics consensus cognitive battery
470067|NCT01555684|MS|ms
470068|NCT01555684|CCSVI|ccsvi
470069|NCT01555671|labor,|labor,
470070|NCT01555671|meperidine,|meperidine,
470071|NCT01555671|active phase,|active phase,
470072|NCT01555671|duration of labor|duration of labor
470073|NCT01555658|Long Lesions|long lesions
470074|NCT01555658|Stent Implantation|stent implantation
470075|NCT01555645|Breast cancer|breast cancer
470076|NCT01555645|Stress management|stress management
470077|NCT01555645|Stepped care|stepped care
470078|NCT01555645|Randomized|randomized
470079|NCT01555619|Left heart pacing lead|left heart pacing lead
470080|NCT01555619|Cardiac resynchronization therapy (CRT)|cardiac resynchronization therapy (crt)
470081|NCT01555619|Heart Failure|heart failure
470082|NCT01555619|Quadripolar pacing|quadripolar pacing
470083|NCT01555606|Psoriasis|psoriasis
470084|NCT01555606|Patient-reported outcome|patient-reported outcome
470085|NCT01555606|Quality of Life|quality of life
470086|NCT01555593|COPD|copd
470087|NCT01555593|FeNO|feno
470088|NCT01555593|Bronchial inflammation|bronchial inflammation
470089|NCT01555593|Small airways|small airways
470090|NCT01555593|Decubitus|decubitus
470091|NCT01555580|myasthenia gravis|myasthenia gravis
470092|NCT01555580|autoimmune|autoimmune
470093|NCT01555580|GM-CSF|gm-csf
470094|NCT01555567|ACL|acl
470095|NCT01555567|muscle|muscle
470096|NCT01555567|quadriceps|quadriceps
470097|NCT01555567|strength|strength
470098|NCT01555554|Post-traumatic stress disorder|post-traumatic stress disorder
470099|NCT01555554|Propranolol|propranolol
470100|NCT01555554|surgery|surgery
470101|NCT01555554|anesthesia|anesthesia
470102|NCT01555541|relapsed|relapsed
470103|NCT01555541|refractory|refractory
470104|NCT01555541|DLBCL|dlbcl
470105|NCT01555541|lymphoma|lymphoma
470106|NCT01555541|B-cell|b-cell
470107|NCT01555541|diffuse|diffuse
470108|NCT01555528|Growth disorders|growth disorders
470109|NCT01555528|Saizen|saizen
470110|NCT01555528|Easypod|easypod
470111|NCT01555528|Growth hormone|growth hormone
470112|NCT01555528|Pediatric subject|pediatric subject
470113|NCT01555489|Pancreatic Neoplasms|pancreatic neoplasms
470114|NCT01555489|Pancreatic Cancer cells|pancreatic cancer cells
470115|NCT01555489|Digestive System Neoplasms|digestive system neoplasms
470116|NCT01555489|Neoplasms by Site|neoplasms by site
470117|NCT01555489|Neoplasms|neoplasms
470118|NCT01555489|Endocrine Gland Neoplasms|endocrine gland neoplasms
470119|NCT01555489|Digestive System Diseases|digestive system diseases
470120|NCT01555489|Pancreatic Diseases|pancreatic diseases
470121|NCT01555489|Endocrine System Diseases|endocrine system diseases
470122|NCT01555489|Ascorbic Acid|ascorbic acid
470123|NCT01555489|Gemcitabine Vitamins|gemcitabine vitamins
470124|NCT01555489|Vitamin C|vitamin c
470125|NCT01555489|Antioxidants|antioxidants
470126|NCT01555489|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action
470127|NCT01555489|Pharmacologic Actions|pharmacologic actions
470128|NCT01555489|Protective Agents|protective agents
470129|NCT01555489|Physiological Effects of Drugs|physiological effects of drugs
470130|NCT01555489|Micronutrients|micronutrients
470131|NCT01555489|Growth Substances|growth substances
470132|NCT01555489|Erlotinib|erlotinib
470133|NCT01555489|Integrative Medicine|integrative medicine
470134|NCT01555489|Alternative Medicine|alternative medicine
470135|NCT01555489|Complementary Medicine|complementary medicine
470136|NCT01555476|Pharmacokinetics|pharmacokinetics
470137|NCT01555463|Rosacea|rosacea
470138|NCT01555450|Colorectal cancer screening|colorectal cancer screening
470139|NCT01555450|Social inequalities|social inequalities
470140|NCT01555450|Patient Navigator|patient navigator
470141|NCT01555437|capsule endoscopy scoring index|capsule endoscopy scoring index
470142|NCT01555437|Harvey-Bradshaw index|harvey-bradshaw index
470143|NCT01555437|C-reactive protein|c-reactive protein
470144|NCT01555437|serum albumin|serum albumin
470145|NCT01555437|hemoglobin|hemoglobin
470146|NCT01555424|25-hydroxyvitamin D|25-hydroxyvitamin d
470147|NCT01555424|Institutionalized seniors|institutionalized seniors
470148|NCT01555424|SF-36 survey|sf-36 survey
470149|NCT01555424|Winter|winter
470150|NCT01555411|Cardiovascular epidemiology|cardiovascular epidemiology
470151|NCT01555411|Prospective, observational cohort study|prospective, observational cohort study
470152|NCT01555411|Biomarkers|biomarkers
470153|NCT01555411|Cardio- and cerebrovascular imaging|cardio- and cerebrovascular imaging
470154|NCT01555398|Fenofibric acid|fenofibric acid
470155|NCT01555398|HIP0901|hip0901
470156|NCT01555398|food effect|food effect
470157|NCT01555385|Mental workload|mental workload
470158|NCT01555385|Multitasking|multitasking
470159|NCT01555385|Protein|protein
470160|NCT01555385|Tryptophan|tryptophan
470161|NCT01555372|unstable distal clavicular fractures (Neer 2b)|unstable distal clavicular fractures (neer 2b)
470162|NCT01555372|Study Protocol|study protocol
470163|NCT01555372|Fracture Fixation|fracture fixation
470164|NCT01555346|Down syndrome|down syndrome
470165|NCT01555346|fetal aneuploidy|fetal aneuploidy
470166|NCT01555346|trisomy|trisomy
470167|NCT01555346|noninvasive prenatal test|noninvasive prenatal test
470168|NCT01555307|total hip arthroplasty|total hip arthroplasty
470169|NCT01555307|total knee arthroplasty|total knee arthroplasty
470170|NCT01555307|balance exercises|balance exercises
470171|NCT01555307|force plate|force plate
470172|NCT01555307|berg balance scale|berg balance scale
470173|NCT01555307|timed up and go test|timed up and go test
470174|NCT01555294|(subclinical)atherosclerosis|(subclinical)atherosclerosis
470175|NCT01555294|non-invasive measurements|non-invasive measurements
470176|NCT01555294|intima-media thickness|intima-media thickness
470177|NCT01555294|flow-mediated dilation|flow-mediated dilation
470178|NCT01555294|pulse wave velocity and analysis|pulse wave velocity and analysis
470179|NCT01555294|fatal and non-fatal cardiovascular events|fatal and non-fatal cardiovascular events
470180|NCT01555294|ankle-brachial index (at rest and after exercise)|ankle-brachial index (at rest and after exercise)
470181|NCT01555294|general population|general population
470182|NCT01555294|Familial Combined Hyperlipidemia|familial combined hyperlipidemia
470183|NCT01555281|Multiple Myeloma|multiple myeloma
470184|NCT01555281|Kahler Disease|kahler disease
470185|NCT01555281|Lenalidomide|lenalidomide
470186|NCT01555281|Revlimid|revlimid
470187|NCT01555281|Nelfinavir|nelfinavir
470188|NCT01555281|Viracept|viracept
470189|NCT01555281|Dexamethasone|dexamethasone
470190|NCT01555255|malaria|malaria
470191|NCT01555255|pregnancy|pregnancy
470192|NCT01555255|placental malaria|placental malaria
470193|NCT01555255|malaria in pregnancy|malaria in pregnancy
470194|NCT01555255|birth weight|birth weight
470195|NCT01555255|anemia|anemia
470196|NCT01555242|Advanced Cancer|advanced cancer
470197|NCT01555242|Lymphoma|lymphoma
470198|NCT01555242|Refractory|refractory
470199|NCT01555229|Secretion drainage|secretion drainage
470200|NCT01555229|Ventilator-associated pneumonia|ventilator-associated pneumonia
470201|NCT01555229|Tracheal fibroscopy|tracheal fibroscopy
470202|NCT01555216|Forefoot surgery|forefoot surgery
470203|NCT01555190|myo-inositol|myo-inositol
470204|NCT01555190|folic acid|folic acid
470205|NCT01555177|Peri-operative myocardial infarction|peri-operative myocardial infarction
470206|NCT01555177|Non-ST elevation myocardial infarction|non-st elevation myocardial infarction
470207|NCT01555177|Optical coherence tomography|optical coherence tomography
470208|NCT01555151|Asthma|asthma
470209|NCT01555138|Chronic Obstructive Pulmonary Disease|chronic obstructive pulmonary disease
470210|NCT01555138|Indacaterol|indacaterol
470625|NCT01553435|Efficacy|efficacy
470211|NCT01555138|Salmeterol/fluticasone propionate|salmeterol/fluticasone propionate
470212|NCT01555125|Psoriasis|psoriasis
470213|NCT01555099|COPD, FEV1, AZD5423|copd, fev1, azd5423
470214|NCT01555086|Lymphadenectomy|lymphadenectomy
470215|NCT01555086|Prostate cancer|prostate cancer
470216|NCT01555060|hemoglobin recovery|hemoglobin recovery
470217|NCT01555060|iron recovery|iron recovery
470218|NCT01555060|iron supplements|iron supplements
470219|NCT01555034|obesity|obesity
470220|NCT01555034|movement therapy|movement therapy
470221|NCT01555034|exercise|exercise
470222|NCT01555034|behaviour|behaviour
470223|NCT01554995|LCB01-0371|lcb01-0371
470224|NCT01554982|Participation Limited|participation limited
470225|NCT01554982|Long Term|long term
470226|NCT01554982|Safety Extension|safety extension
470227|NCT01554956|Plasminogen Deficiency|plasminogen deficiency
470228|NCT01554956|Ligneous Conjunctivitis|ligneous conjunctivitis
470229|NCT01554956|Plasminogen|plasminogen
470230|NCT01554956|Ligneous Conjunctivitis in Plasminogen Deficient Patients|ligneous conjunctivitis in plasminogen deficient patients
470231|NCT01554943|CMF|cmf
470232|NCT01554943|HEC|hec
470233|NCT01554943|EC|ec
470234|NCT01554943|node positive|node positive
470235|NCT01554943|breast cancer|breast cancer
470236|NCT01554930|HFMD|hfmd
470237|NCT01554930|Traditional Chinese Medicine|traditional chinese medicine
470238|NCT01554930|Xiyanping|xiyanping
470239|NCT01554917|Rheumatoid Arthritis|rheumatoid arthritis
470240|NCT01554917|Iguratimod|iguratimod
470241|NCT01554904|Sleep Study|sleep study
470242|NCT01554904|Snoring|snoring
470243|NCT01554904|Sleep Apnea|sleep apnea
470244|NCT01554904|Muscle Laxity|muscle laxity
470245|NCT01554904|Oral Appliance|oral appliance
470246|NCT01554904|Facial Muscles|facial muscles
470247|NCT01554904|Neck Muscles|neck muscles
470248|NCT01554904|Upper Airway|upper airway
470249|NCT01554904|Muscle Strength|muscle strength
470250|NCT01554904|Dynamic Resistance|dynamic resistance
470251|NCT01554904|Oral Exercise|oral exercise
470252|NCT01554904|Facial Toning|facial toning
470253|NCT01554904|Facial Muscle Strength|facial muscle strength
470254|NCT01554904|Strap Muscles of the Neck|strap muscles of the neck
470255|NCT01554904|Apnea-Hypopnea|apnea-hypopnea
470256|NCT01554891|brain injuries, traumatic|brain injuries, traumatic
470257|NCT01554891|military personnel|military personnel
470258|NCT01554891|classification|classification
470259|NCT01554891|diagnosis|diagnosis
470260|NCT01554891|instrumentation|instrumentation
470261|NCT01554878|osteochondral defect of the knee|osteochondral defect of the knee
470262|NCT01554865|obesity|obesity
470263|NCT01554865|men|men
470264|NCT01554865|sexual function|sexual function
470265|NCT01554865|urinary tract symptoms|urinary tract symptoms
470266|NCT01554865|endothelial function|endothelial function
470267|NCT01554865|inflammation|inflammation
470268|NCT01554865|quality of life|quality of life
470269|NCT01554852|myeloma|myeloma
470270|NCT01554852|lenalidomide|lenalidomide
470271|NCT01554852|Revlimid|revlimid
470272|NCT01554852|cyclophosphamide|cyclophosphamide
470273|NCT01554852|dexamethasone|dexamethasone
470274|NCT01554852|bortezomib|bortezomib
470275|NCT01554852|Velcade|velcade
470276|NCT01554852|vorinostat|vorinostat
470277|NCT01554852|Zolinza|zolinza
470278|NCT01554852|stem cell|stem cell
470279|NCT01554852|carfilzomib|carfilzomib
470280|NCT01554852|Kyprolis|kyprolis
470281|NCT01554826|Pediatric influenza vaccine|pediatric influenza vaccine
470282|NCT01554813|Influenza Vaccine, Vaccination,|influenza vaccine, vaccination,
470283|NCT01554800|Lecithin Cholesterol Acyl Transferase|lecithin cholesterol acyl transferase
470284|NCT01554800|LCAT|lcat
470285|NCT01554800|rhLCAT|rhlcat
470286|NCT01554800|Enzyme replacement therapy|enzyme replacement therapy
470287|NCT01554800|High-Density Lipoprotein (HDL)|high-density lipoprotein (hdl)
470288|NCT01554800|Cholesterol|cholesterol
470289|NCT01554800|Cholesterol ester|cholesterol ester
470290|NCT01554800|LCAT Deficiency|lcat deficiency
470291|NCT01554787|After stroke with fatigue|after stroke with fatigue
470292|NCT01554774|COPD|copd
470293|NCT01554774|PVR|pvr
470294|NCT01554761|astigmatism|astigmatism
470295|NCT01554761|pseudophakia|pseudophakia
470296|NCT01554748|total joint arthroplasty|total joint arthroplasty
470297|NCT01554748|thumb|thumb
470298|NCT01554748|trapeziometacarpal joint|trapeziometacarpal joint
470299|NCT01554748|osteoarthritis|osteoarthritis
470300|NCT01554735|obesity|obesity
470301|NCT01554735|men|men
470302|NCT01554735|sexual function|sexual function
470303|NCT01554735|urinary tract symptoms|urinary tract symptoms
470304|NCT01554735|endothelial function|endothelial function
470305|NCT01554735|inflammation|inflammation
470306|NCT01554735|quality of life|quality of life
470307|NCT01554722|Ultrasound guidance|ultrasound guidance
470308|NCT01554722|Femoral nerve block|femoral nerve block
470309|NCT01554722|Needle placement|needle placement
470310|NCT01554722|Intraneural needle insertion|intraneural needle insertion
470311|NCT01554709|bypass|bypass
470312|NCT01554709|cannula|cannula
470313|NCT01554696|ASP015K|asp015k
470314|NCT01554696|Rheumatoid Arthritis|rheumatoid arthritis
470315|NCT01554683|Alzheimer's Disease|alzheimer's disease
470316|NCT01554683|Seizures|seizures
470317|NCT01554683|Memory|memory
470318|NCT01554683|Executive|executive
470319|NCT01554670|Arthroscopic subacromial decompression|arthroscopic subacromial decompression
470320|NCT01554670|Bipolar radiofrequency|bipolar radiofrequency
470321|NCT01554670|Tendon debridement|tendon debridement
470322|NCT01554670|Shoulder surgery|shoulder surgery
470323|NCT01554657|Pneumonia, Bacterial|pneumonia, bacterial
470324|NCT01554644|Cleansing|cleansing
470325|NCT01554644|Chronic Leg Ulcers|chronic leg ulcers
470326|NCT01554644|Diabetic Patients|diabetic patients
470327|NCT01554631|Bioequivalence|bioequivalence
470328|NCT01554631|Acarbose|acarbose
470329|NCT01554631|ODT|odt
470330|NCT01554618|exenatide|exenatide
470331|NCT01554618|type 2 diabetes|type 2 diabetes
470332|NCT01554618|GLP-1 receptor agonist|glp-1 receptor agonist
470333|NCT01554592|Heart Failure|heart failure
470334|NCT01554592|Statin withdrawal|statin withdrawal
470335|NCT01554566|honey|honey
470336|NCT01554566|diabetes|diabetes
470337|NCT01554566|lipids|lipids
470338|NCT01554566|c-peptide|c-peptide
470339|NCT01554553|Sleeve gastrectomy|sleeve gastrectomy
470340|NCT01554553|Posterior crural repair|posterior crural repair
470341|NCT01554540|Treprostinil|treprostinil
470342|NCT01554540|Scleroderma|scleroderma
470343|NCT01554540|Iontophoresis|iontophoresis
470344|NCT01554527|polysomnography|polysomnography
470345|NCT01554527|child|child
470346|NCT01554527|continuous positive airway pressure|continuous positive airway pressure
470347|NCT01554527|tonsillectomy|tonsillectomy
470348|NCT01554527|neuropsychological tests|neuropsychological tests
470349|NCT01554527|cognition|cognition
470350|NCT01554527|sleepiness|sleepiness
470351|NCT01554527|behavior|behavior
470352|NCT01554514|ADAMTS13|adamts13
470353|NCT01554514|Rituximab|rituximab
470354|NCT01554514|Thrombotic thrombocytopenic purpura|thrombotic thrombocytopenic purpura
470355|NCT01554514|TTP|ttp
470356|NCT01554514|Plasma exchange|plasma exchange
470357|NCT01554501|stress|stress
470358|NCT01554501|self-control|self-control
470359|NCT01554501|emotion regulation|emotion regulation
470360|NCT01554501|health|health
470361|NCT01554488|asthma|asthma
470362|NCT01554488|COPD|copd
470363|NCT01554488|sleep apnea, obstructive|sleep apnea, obstructive
470364|NCT01554475|herbal drugs|herbal drugs
470365|NCT01554475|dietary supplements|dietary supplements
470366|NCT01554475|drug interactions|drug interactions
470367|NCT01554462|Attention|attention
470368|NCT01554462|Cognitive control|cognitive control
470369|NCT01554462|ADHD|adhd
470370|NCT01554462|Healthy|healthy
470371|NCT01554462|EPA|epa
470372|NCT01554462|Eicosapentaenoic acid|eicosapentaenoic acid
470373|NCT01554462|DHA|dha
470374|NCT01554462|Docosahexaenoic acid|docosahexaenoic acid
470375|NCT01554462|PUFA|pufa
470376|NCT01554462|Omega-3|omega-3
470377|NCT01554449|Stroke|stroke
470378|NCT01554449|Upper arm|upper arm
470379|NCT01554449|Rehabilitation|rehabilitation
470380|NCT01554449|Motor function|motor function
470381|NCT01554449|Video games|video games
470382|NCT01554449|Virtual reality|virtual reality
470383|NCT01554449|Occupational Therapy|occupational therapy
470384|NCT01554449|Functional MRI|functional mri
470385|NCT01554436|Smoking|smoking
470386|NCT01554436|Neuropsychology|neuropsychology
470387|NCT01554436|Abstinence|abstinence
470388|NCT01554436|Prognosis|prognosis
470389|NCT01554436|Nicotine Dependence, Cigarettes, with Other Nicotine-induced Disorders|nicotine dependence, cigarettes, with other nicotine-induced disorders
470390|NCT01554423|HIV Prevention Intervention|hiv prevention intervention
470391|NCT01554410|Cervical|cervical
470392|NCT01554410|Carcinoma|carcinoma
470393|NCT01554410|Gemcitabine|gemcitabine
470394|NCT01554410|Gemzar|gemzar
470395|NCT01554410|Cisplatin|cisplatin
470396|NCT01554410|IMRT|imrt
470397|NCT01554410|Radiation|radiation
470398|NCT01554410|External Beam|external beam
470399|NCT01554410|Brachytherapy|brachytherapy
470400|NCT01554397|Cervical|cervical
470401|NCT01554397|Carcinoma|carcinoma
470402|NCT01554397|Cisplatin|cisplatin
470403|NCT01554397|IMRT|imrt
470404|NCT01554397|Radiation|radiation
470405|NCT01554397|INTERTECC|intertecc
470406|NCT01554397|International|international
470407|NCT01554397|External Beam|external beam
470408|NCT01554397|Brachytherapy|brachytherapy
470409|NCT01554397|LDR|ldr
470410|NCT01554397|HDR|hdr
470411|NCT01554397|IGRT|igrt
470412|NCT01554397|CBCT|cbct
470413|NCT01554384|Tuberculosis|tuberculosis
470414|NCT01554384|diagnosis|diagnosis
470415|NCT01554384|Xpert MTB/RIF|xpert mtb/rif
470416|NCT01554384|point-of-treatment|point-of-treatment
470417|NCT01554384|randomized controlled trial|randomized controlled trial
470418|NCT01554371|Solid tumor|solid tumor
470419|NCT01554371|Metastatic breast cancer|metastatic breast cancer
470420|NCT01554371|Unresectable or metastatic carcinoma|unresectable or metastatic carcinoma
470421|NCT01554371|Neuropathy|neuropathy
600091|NCT01016340|MCS|mcs
470422|NCT01554371|Eribulin|eribulin
470423|NCT01554371|Cyclophosphamide|cyclophosphamide
470424|NCT01554358|Gestational diabetes mellitus|gestational diabetes mellitus
470425|NCT01554358|Lifestyle intervention|lifestyle intervention
470426|NCT01554332|Motor Cortex Stimulation|motor cortex stimulation
470427|NCT01554332|Neuropathic pain|neuropathic pain
470428|NCT01554319|Antisense oligonucleotide|antisense oligonucleotide
470430|NCT01554319|Healthy subjects|healthy subjects
470432|NCT01554319|Transcription factor GATA-3|transcription factor gata-3
470433|NCT01554319|Oral inhalation|oral inhalation
470434|NCT01554280|Stricture|stricture
470435|NCT01554280|Dysphagia|dysphagia
470436|NCT01554267|Mastectomy skin flap necrosis|mastectomy skin flap necrosis
470437|NCT01554267|Breast reconstruction|breast reconstruction
470438|NCT01554267|Indocyanine Green Dye|indocyanine green dye
470439|NCT01554254|Cord blood transplant|cord blood transplant
470440|NCT01554254|hematological malignancy|hematological malignancy
470441|NCT01554254|inherited metabolic disease|inherited metabolic disease
470442|NCT01554254|Mucositis|mucositis
470443|NCT01554254|Neutrophil engraftment|neutrophil engraftment
470444|NCT01554254|Platelet recovery|platelet recovery
470445|NCT01554254|Immune reconstitution|immune reconstitution
470446|NCT01554241|vitamin D3|vitamin d3
470447|NCT01554241|D3|d3
470448|NCT01554241|cholecalciferol|cholecalciferol
470449|NCT01554241|25-OH vitamin D|25-oh vitamin d
470450|NCT01554241|elderly|elderly
470451|NCT01554241|nursing home resident|nursing home resident
470452|NCT01554215|parenting|parenting
470453|NCT01554215|child behavior|child behavior
470454|NCT01554215|attachment|attachment
470455|NCT01554202|Alzheimer's disease|alzheimer's disease
470456|NCT01554202|MCI|mci
470457|NCT01554202|genetic|genetic
470458|NCT01554202|AV45-PET|av45-pet
470459|NCT01554176|Current depressive episode|current depressive episode
470460|NCT01554176|moderate to severe|moderate to severe
470461|NCT01554163|Osteoarthritis|osteoarthritis
470462|NCT01554163|Celecoxib|celecoxib
470463|NCT01554163|Etoricoxib|etoricoxib
470464|NCT01554150|Primary Health Care|primary health care
470465|NCT01554150|Mental Health|mental health
470466|NCT01554150|Cognitive Therapy|cognitive therapy
470467|NCT01554124|Meningitis|meningitis
470468|NCT01554124|Neonates|neonates
470469|NCT01554124|Meropenem|meropenem
470470|NCT01554111|Bowel Evacuants|bowel evacuants
470471|NCT01554111|Purgatives|purgatives
470472|NCT01554098|Polyp detection|polyp detection
470473|NCT01554098|Supine|supine
470474|NCT01554098|Colonoscope withdrawal|colonoscope withdrawal
470475|NCT01554098|Patient position|patient position
470476|NCT01554098|Dynamic position change|dynamic position change
470477|NCT01554072|home-based|home-based
470478|NCT01554072|pulmonary rehabilitation|pulmonary rehabilitation
470479|NCT01554072|COPD|copd
470480|NCT01554059|Rectal cancer|rectal cancer
470481|NCT01554059|Adenocarcinoma|adenocarcinoma
470482|NCT01554059|Bevacizumab|bevacizumab
470483|NCT01554059|Chemoradiation|chemoradiation
470484|NCT01554046|Attention Deficit Hyperactivity Disorder (ADHD)|attention deficit hyperactivity disorder (adhd)
470485|NCT01554046|Methylphenidate- RITALIN IR (Immediate Release)|methylphenidate- ritalin ir (immediate release)
470486|NCT01554033|European Huntington's Disease Network|european huntington's disease network
470487|NCT01554033|Huntington patients in KOREA|huntington patients in korea
470488|NCT01554020|Blood glucose|blood glucose
470489|NCT01554020|Insulin sensitivity|insulin sensitivity
470490|NCT01554020|Oral glucose tolerance|oral glucose tolerance
470491|NCT01554007|Crohn's disease|crohn's disease
470492|NCT01553981|Interstitial lung disease|interstitial lung disease
470493|NCT01553981|Scleroderma|scleroderma
470494|NCT01553955|PRP,|prp,
470495|NCT01553955|Platelet|platelet
470496|NCT01553955|Manual|manual
470497|NCT01553942|NSCLC|nsclc
470498|NCT01553929|MCI|mci
470499|NCT01553903|Hormonal therapy|hormonal therapy
470500|NCT01553903|Breast Cancer|breast cancer
470501|NCT01553903|AEBS|aebs
470502|NCT01553903|Oxysterols|oxysterols
470503|NCT01553890|SSc= scleroderma|ssc= scleroderma
470504|NCT01553890|ICF+ informed consent form|icf+ informed consent form
470505|NCT01553890|age 18 to 85|age 18 to 85
470506|NCT01553890|healthy|healthy
470507|NCT01553838|prostate biopsy|prostate biopsy
470508|NCT01553838|MRI guided biopsy|mri guided biopsy
470509|NCT01553838|TRUS guided biopsy|trus guided biopsy
470510|NCT01553812|forced oscillation technique|forced oscillation technique
470511|NCT01553812|COPD|copd
470512|NCT01553812|elderly|elderly
470513|NCT01553812|airway resistance|airway resistance
470514|NCT01553812|airtrapping|airtrapping
470515|NCT01553786|T-cell lymphoma|t-cell lymphoma
470516|NCT01553786|CHOp|chop
470517|NCT01553786|lenalidomide|lenalidomide
470518|NCT01553773|Hyaluroic acid|hyaluroic acid
470519|NCT01553773|Estradiol|estradiol
470520|NCT01553773|Isoflavone|isoflavone
470521|NCT01553773|Skin|skin
470522|NCT01553773|Postmenopause|postmenopause
470523|NCT01553760|Cataract|cataract
470524|NCT01553760|TRI-MICS|tri-mics
470525|NCT01553760|ACM|acm
470526|NCT01553760|MICS|mics
470527|NCT01553760|phacoemulsification|phacoemulsification
470528|NCT01553747|Irritable bowel syndrome with diarrhea|irritable bowel syndrome with diarrhea
470529|NCT01553747|Irritable bowel syndrome|irritable bowel syndrome
470530|NCT01553747|Diarrhea predominant irritable bowel syndrome|diarrhea predominant irritable bowel syndrome
470531|NCT01553747|Colonic diseases|colonic diseases
470532|NCT01553747|Colonic diseases, functional|colonic diseases, functional
470533|NCT01553747|Digestive system disease|digestive system disease
470534|NCT01553747|Gastrointestinal disease|gastrointestinal disease
470535|NCT01553747|Intestinal disease|intestinal disease
470536|NCT01553747|Colonic pseudo-obstruction|colonic pseudo-obstruction
470537|NCT01553747|Diarrhea|diarrhea
470538|NCT01553747|Signs and symptoms, Digestive|signs and symptoms, digestive
470539|NCT01553734|QT prolongation|qt prolongation
470540|NCT01553734|Azithromycin|azithromycin
470541|NCT01553734|macrolide|macrolide
470542|NCT01553734|pneumonia|pneumonia
470543|NCT01553734|ECG changes|ecg changes
470544|NCT01553708|Wound healing|wound healing
470545|NCT01553708|Epithelialization|epithelialization
470546|NCT01553708|Safety|safety
470547|NCT01553695|Touble|touble
470548|NCT01553695|deficit|deficit
470549|NCT01553695|attention|attention
470550|NCT01553695|hyperactivity|hyperactivity
470551|NCT01553695|Touble deficit attention with hyperactivity|touble deficit attention with hyperactivity
470552|NCT01553682|HIV|hiv
470553|NCT01553682|STDs|stds
470554|NCT01553682|African American Females|african american females
470555|NCT01553682|Alcohol|alcohol
470556|NCT01553656|Advanced cancer|advanced cancer
470557|NCT01553656|Metastatic|metastatic
470558|NCT01553656|NSCLC|nsclc
470559|NCT01553643|Huang-Chi-Wu-Wu-Tang|huang-chi-wu-wu-tang
470560|NCT01553643|Intracranial arterial prominent stenosis|intracranial arterial prominent stenosis
470561|NCT01553630|Fractures|fractures
470562|NCT01553630|distal femur fractures|distal femur fractures
470563|NCT01553630|distal tibial fracures|distal tibial fracures
470564|NCT01553604|breast prosthesis implantation|breast prosthesis implantation
470565|NCT01553604|bandages|bandages
470566|NCT01553604|skin colonization|skin colonization
470567|NCT01553604|surgical site infection|surgical site infection
470568|NCT01553604|augmentation mammaplasty|augmentation mammaplasty
470569|NCT01553604|dressing wear time|dressing wear time
470570|NCT01553565|10 mm in diameter|10 mm in diameter
470571|NCT01553565|antithrombotic agents|antithrombotic agents
470572|NCT01553552|Schistosoma haematobium|schistosoma haematobium
470573|NCT01553552|schistosoma mansoni|schistosoma mansoni
470574|NCT01553552|Anemia|anemia
470575|NCT01553552|Underweight|underweight
470576|NCT01553552|stunting|stunting
470577|NCT01553552|Blastocystis|blastocystis
470578|NCT01553526|International|international
470579|NCT01553526|Multicenter|multicenter
470580|NCT01553526|Observational registry|observational registry
470581|NCT01553526|All-comers open label registry|all-comers open label registry
470582|NCT01553526|Orsiro Drug Eluting Stent (DES)|orsiro drug eluting stent (des)
470583|NCT01553526|Stenting|stenting
470584|NCT01553526|Treatment of Coronary Artery Disease|treatment of coronary artery disease
470585|NCT01553526|Coronary revascularization|coronary revascularization
470586|NCT01553526|Percutaneous Coronary Intervention|percutaneous coronary intervention
470587|NCT01553526|STEMI|stemi
470588|NCT01553526|NSTEMI|nstemi
470589|NCT01553526|Ischemia|ischemia
470590|NCT01553526|Angina|angina
470591|NCT01553526|Subgroups|subgroups
470592|NCT01553526|Acute Myocardial Infarction|acute myocardial infarction
470593|NCT01553526|Diabetes|diabetes
470594|NCT01553526|Small Vessels|small vessels
470595|NCT01553526|Chronic Total Occlusion (CTO)|chronic total occlusion (cto)
470596|NCT01553513|PET|pet
470597|NCT01553513|Coronary Artery Disease|coronary artery disease
470598|NCT01553513|Inflammation|inflammation
470599|NCT01553513|Plaque|plaque
470600|NCT01553513|Atherosclerosis|atherosclerosis
470601|NCT01553500|NAFLD|nafld
470602|NCT01553500|insulin resistance|insulin resistance
470603|NCT01553500|children|children
470604|NCT01553487|vibration|vibration
470605|NCT01553487|muscle strength|muscle strength
470606|NCT01553487|bone loss|bone loss
470607|NCT01553487|immobilization|immobilization
470608|NCT01553487|fracture|fracture
470609|NCT01553474|Age-Related Macular Degeneration (AMD)|age-related macular degeneration (amd)
470610|NCT01553474|Eye Diseases|eye diseases
470611|NCT01553461|Transplant|transplant
470612|NCT01553461|Umbilical Cord Blood|umbilical cord blood
470613|NCT01553461|Graft Rejection|graft rejection
470614|NCT01553461|Graft Versus Host Disease|graft versus host disease
470615|NCT01553448|disseminated neuroblastoma|disseminated neuroblastoma
470616|NCT01553448|hereditary neuroblastoma|hereditary neuroblastoma
470617|NCT01553448|localized resectable neuroblastoma|localized resectable neuroblastoma
470618|NCT01553448|localized unresectable neuroblastoma|localized unresectable neuroblastoma
470619|NCT01553448|stage 4S neuroblastoma|stage 4s neuroblastoma
470620|NCT01553435|Dextromethorphan|dextromethorphan
470621|NCT01553435|Morphine|morphine
600312|NCT01015742|ALL|all
470622|NCT01553435|Fentanyl|fentanyl
470623|NCT01553435|Opioid|opioid
470624|NCT01553435|analgesia|analgesia
470626|NCT01553422|Intrabdominal Pressure|intrabdominal pressure
470627|NCT01553422|Emergency Bedside Ultrasonography|emergency bedside ultrasonography
470628|NCT01553422|Abdominal Compartment Syndrome|abdominal compartment syndrome
470629|NCT01553409|Hypertension|hypertension
470630|NCT01553409|Ferritin|ferritin
470631|NCT01553409|Phlebotomy|phlebotomy
470632|NCT01553409|Blood donation|blood donation
470633|NCT01553383|OSA|osa
470634|NCT01553357|Plasma cell leukemia|plasma cell leukemia
470635|NCT01553357|Lenalidomide|lenalidomide
470636|NCT01553357|Dexamethasone|dexamethasone
470637|NCT01553357|Multiple myeloma|multiple myeloma
470638|NCT01553357|Bortezomib|bortezomib
470639|NCT01553357|Stem cell transplantation|stem cell transplantation
470640|NCT01553344|sclerostin|sclerostin
470641|NCT01553344|osteomalacia|osteomalacia
470642|NCT01553344|vitamin D deficiency|vitamin d deficiency
470643|NCT01553331|laparoscopic cholecystectomy|laparoscopic cholecystectomy
470644|NCT01553318|Fibromyalgia|fibromyalgia
470645|NCT01553318|FMS|fms
470646|NCT01553305|exercise programme|exercise programme
470647|NCT01553292|Respiratory distress syndrome|respiratory distress syndrome
470648|NCT01553292|Preterm infants|preterm infants
470649|NCT01553292|Vascular catheter|vascular catheter
470650|NCT01553292|Surfactant|surfactant
470651|NCT01553292|CPAP|cpap
470652|NCT01553292|ECALMIST|ecalmist
470653|NCT01553266|Diabetes Mellitus|diabetes mellitus
470654|NCT01553266|diabetes care|diabetes care
470655|NCT01553266|diabetes self-management education|diabetes self-management education
470656|NCT01553266|primary care physicians|primary care physicians
470657|NCT01553266|interprofessional collaboration|interprofessional collaboration
470658|NCT01553266|diabetes education programs|diabetes education programs
470659|NCT01553266|qualitative|qualitative
470660|NCT01553266|quantitative|quantitative
470661|NCT01553266|implementation|implementation
470662|NCT01553266|evaluation|evaluation
470663|NCT01553266|health services|health services
470664|NCT01553266|coordinated care|coordinated care
470665|NCT01553266|integrated care|integrated care
470666|NCT01553266|patient care processes|patient care processes
470667|NCT01553253|Postcholecystectomy Pain|postcholecystectomy pain
470668|NCT01553253|Chronic Postoperative Pain|chronic postoperative pain
470669|NCT01553253|Visceral Pain|visceral pain
470670|NCT01553253|Referred pain|referred pain
470671|NCT01553253|Somatic pain|somatic pain
470672|NCT01553253|Quantitative Sensory Testing|quantitative sensory testing
470673|NCT01553240|TMS|tms
470674|NCT01553240|functional MRI|functional mri
470675|NCT01553240|Supplementary motor cortex|supplementary motor cortex
470676|NCT01553240|Right Temporoparietal junction( RTPJ)|right temporoparietal junction( rtpj)
470677|NCT01553227|OSAHS: Obstructive Sleep Apnea hypopnea Syndrome|osahs: obstructive sleep apnea hypopnea syndrome
470678|NCT01553227|OHS: Obesity Hypoventilation Syndrome|ohs: obesity hypoventilation syndrome
470679|NCT01553227|Auto-trilevel ventilation|auto-trilevel ventilation
470680|NCT01553227|BiPAP ventilation|bipap ventilation
470681|NCT01553214|Neutrophils|neutrophils
470682|NCT01553214|Infection|infection
470683|NCT01553214|Granulocytapheresis|granulocytapheresis
470684|NCT01553214|Mobilization|mobilization
470685|NCT01553214|Transfusion|transfusion
470686|NCT01553214|Healthy Volunteer|healthy volunteer
470687|NCT01553214|HV|hv
470688|NCT01553201|Quality of Life|quality of life
470689|NCT01553201|Endometriosis|endometriosis
470690|NCT01553201|Botulinum Toxin A|botulinum toxin a
470691|NCT01553201|Pelvic Pain Spasm|pelvic pain spasm
470692|NCT01553201|Chronic Pelvic Pain|chronic pelvic pain
470693|NCT01553188|Anti-Angiogenesis|anti-angiogenesis
470694|NCT01553188|Ang 1|ang 1
470695|NCT01553188|Ang 2|ang 2
470696|NCT01553188|Peptide-Fc fusion protein|peptide-fc fusion protein
470697|NCT01553188|Small Molecule|small molecule
470698|NCT01553175|childhood atypical teratoid/rhabdoid tumor|childhood atypical teratoid/rhabdoid tumor
470699|NCT01553175|rhabdoid tumor of the kidney|rhabdoid tumor of the kidney
470700|NCT01553162|B-cell childhood acute lymphoblastic leukemia|b-cell childhood acute lymphoblastic leukemia
470701|NCT01553162|untreated childhood acute lymphoblastic leukemia|untreated childhood acute lymphoblastic leukemia
470702|NCT01553136|alcohol-related disorders|alcohol-related disorders
470703|NCT01553136|Cholinergic Drugs|cholinergic drugs
470704|NCT01553136|varenicline|varenicline
470705|NCT01553136|Chantix|chantix
470706|NCT01553123|Leiomyomas|leiomyomas
470707|NCT01553110|Cold|cold
470708|NCT01553110|Acute Rhinosinusitis|acute rhinosinusitis
470709|NCT01553110|Allergic Rhinitis|allergic rhinitis
470710|NCT01553097|Breast Cancer|breast cancer
470711|NCT01553097|Neurocognitive Impairment|neurocognitive impairment
470712|NCT01553097|Quality of Life|quality of life
470713|NCT01553097|Cytokines|cytokines
470714|NCT01553084|Smoking Cessation|smoking cessation
470715|NCT01553084|Smoking|smoking
470716|NCT01553084|Nicotine|nicotine
470717|NCT01553071|Malignancy, Relapsed|malignancy, relapsed
470718|NCT01553071|Chemotherapy, Intravenous|chemotherapy, intravenous
470719|NCT01553058|Psoriasis|psoriasis
470720|NCT01553058|Cardiovascular Disease|cardiovascular disease
470721|NCT01553058|FDG/PET-CT|fdg/pet-ct
470822|NCT01552551|injury|injury
470722|NCT01553058|NB-UVB Phototherapy|nb-uvb phototherapy
470723|NCT01553058|Vascular Inflammation|vascular inflammation
470724|NCT01553058|Lipid Biomarkers|lipid biomarkers
470725|NCT01553045|symptom burden|symptom burden
470726|NCT01553045|atrial fibrillation|atrial fibrillation
470727|NCT01553045|biomarkers|biomarkers
470728|NCT01553045|intracardiac pressures|intracardiac pressures
470729|NCT01553032|Immuno-(Chemo-)and Radiotherapy|immuno-(chemo-)and radiotherapy
470730|NCT01553032|Erbitux®|erbitux®
470731|NCT01553032|Skin changes in Head and neck cancer|skin changes in head and neck cancer
470732|NCT01553019|Proton radiation|proton radiation
470733|NCT01553019|Chemotherapy|chemotherapy
470734|NCT01553019|Pancreatic cancer|pancreatic cancer
470735|NCT01553019|Postoperative|postoperative
470736|NCT01553006|rhinosinusitis|rhinosinusitis
470737|NCT01553006|cefditoren pivoxil|cefditoren pivoxil
470738|NCT01552993|prematurity|prematurity
470739|NCT01552993|retinopathy|retinopathy
470740|NCT01552993|pain|pain
470741|NCT01552993|acetaminophen|acetaminophen
470742|NCT01552980|Gastric cancer|gastric cancer
470743|NCT01552980|Adenocarcinoma|adenocarcinoma
470744|NCT01552980|SOX|sox
470745|NCT01552967|Colorectal cancer|colorectal cancer
470746|NCT01552967|Adenocarcinoma|adenocarcinoma
470747|NCT01552967|XELOX|xelox
470748|NCT01552954|hypertension|hypertension
470749|NCT01552954|Chronic kidney disease|chronic kidney disease
470750|NCT01552954|albuminuria|albuminuria
470751|NCT01552954|low salt diet|low salt diet
470752|NCT01552954|Angiotensin II receptor blocker|angiotensin ii receptor blocker
470753|NCT01552941|Vagus Nerve|vagus nerve
470754|NCT01552941|Vagal Nerve Stimulation|vagal nerve stimulation
470755|NCT01552941|Rheumatoid Arthritis|rheumatoid arthritis
470756|NCT01552941|Implantable Medical Device|implantable medical device
470757|NCT01552915|ADHD|adhd
470758|NCT01552902|ADHD|adhd
470759|NCT01552863|pharmacokinetics|pharmacokinetics
470760|NCT01552863|bioavailability|bioavailability
470761|NCT01552863|oxycodone.|oxycodone.
470762|NCT01552850|pharmacokinetics|pharmacokinetics
470763|NCT01552850|relative bioavailability|relative bioavailability
470764|NCT01552850|oxycodone|oxycodone
470765|NCT01552837|Diffusion Tensor Imaging,|diffusion tensor imaging,
470766|NCT01552837|quetiapine|quetiapine
470767|NCT01552837|Bipolar Disorder|bipolar disorder
470768|NCT01552837|hippocampus|hippocampus
470769|NCT01552837|Volume Brain Morphometry|volume brain morphometry
470770|NCT01552837|Magnetic Resonance Spectroscopy|magnetic resonance spectroscopy
470771|NCT01552837|effect of quetiapine on hippocampal neurogenesis|effect of quetiapine on hippocampal neurogenesis
470772|NCT01552824|LUTO|luto
470773|NCT01552824|posterior urethral valves|posterior urethral valves
470774|NCT01552824|urethral atresia|urethral atresia
470775|NCT01552772|Safety|safety
470776|NCT01552772|Tolerability|tolerability
470777|NCT01552772|Schizophrenia|schizophrenia
470778|NCT01552772|Aripiprazole|aripiprazole
470779|NCT01552759|Appetite Hormones|appetite hormones
470780|NCT01552759|Binge Eating Disorder|binge eating disorder
470781|NCT01552759|Obesity|obesity
470782|NCT01552759|Cortisol|cortisol
470783|NCT01552759|Stress|stress
470784|NCT01552746|Postoperative shoulder pain|postoperative shoulder pain
470785|NCT01552746|Persisting postoperative pain|persisting postoperative pain
470786|NCT01552720|aorta|aorta
470787|NCT01552720|dissection|dissection
470788|NCT01552720|feature|feature
470789|NCT01552707|Spondylolisthesis|spondylolisthesis
470790|NCT01552707|Degenerative discopathy|degenerative discopathy
470791|NCT01552707|Mesenchymal Stem Cells|mesenchymal stem cells
470792|NCT01552707|Bone marrow|bone marrow
470793|NCT01552707|Tissue engineering|tissue engineering
470794|NCT01552707|Spinal fusion|spinal fusion
470795|NCT01552694|cardiometabolic complications|cardiometabolic complications
470796|NCT01552681|baminercept treatment|baminercept treatment
470797|NCT01552668|Clostridium difficile infection|clostridium difficile infection
470798|NCT01552668|fidaxomicin|fidaxomicin
470799|NCT01552655|Dual-time PET/CT|dual-time pet/ct
470800|NCT01552655|Breast cancer recurrence|breast cancer recurrence
470801|NCT01552655|Bone scintigraphy|bone scintigraphy
470802|NCT01552655|CT thorax upper abdomen|ct thorax upper abdomen
470803|NCT01552642|Comprehensive Health Enhancement Support System (CHESS)|comprehensive health enhancement support system (chess)
470804|NCT01552629|Atopic dermatitis|atopic dermatitis
470805|NCT01552629|Atopic eczema|atopic eczema
470806|NCT01552629|Skin Diseases|skin diseases
470807|NCT01552629|QGE031|qge031
470808|NCT01552603|glucose sensors|glucose sensors
470809|NCT01552603|artificial pancreas|artificial pancreas
470810|NCT01552603|Diabetes Mellitus|diabetes mellitus
470811|NCT01552577|Post-Concussion Syndrome|post-concussion syndrome
470812|NCT01552577|Concussion|concussion
470813|NCT01552577|Brain Injury|brain injury
470814|NCT01552577|TBI|tbi
470815|NCT01552577|Military Personnel|military personnel
470816|NCT01552577|Eye-tracking|eye-tracking
470817|NCT01552577|Neurocognitive Function|neurocognitive function
470818|NCT01552577|Assessment|assessment
470819|NCT01552551|Falls|falls
470820|NCT01552551|exercise|exercise
470821|NCT01552551|safety|safety
470823|NCT01552551|Older adults|older adults
470824|NCT01552538|Rheumatoid Arthritis|rheumatoid arthritis
470825|NCT01552538|Vagus Nerve|vagus nerve
470826|NCT01552538|Vagal Nerve Stimulation|vagal nerve stimulation
470827|NCT01552525|acute kidney injury|acute kidney injury
470828|NCT01552525|asymmetric dimethylarginine|asymmetric dimethylarginine
470829|NCT01552525|symmetric dimethylarginine|symmetric dimethylarginine
470830|NCT01552525|l-arginine|l-arginine
470831|NCT01552525|arterial stiffness|arterial stiffness
470832|NCT01552525|augmentation index|augmentation index
470833|NCT01552525|pulse wave velocity|pulse wave velocity
470834|NCT01552512|Stunting|stunting
470835|NCT01552512|Hidden Hunger|hidden hunger
470836|NCT01552512|Diarrhea|diarrhea
470837|NCT01552512|Vitamin A Deficiency|vitamin a deficiency
470838|NCT01552486|chiropractic|chiropractic
470839|NCT01552486|manipulation|manipulation
470840|NCT01552486|radiculopathy|radiculopathy
470841|NCT01552486|sciatica|sciatica
470842|NCT01552486|lumbar|lumbar
470843|NCT01552486|disc|disc
470844|NCT01552486|herniation|herniation
470845|NCT01552486|protrusion|protrusion
470846|NCT01552473|TBI|tbi
470847|NCT01552473|Traumatic Brain Injury|traumatic brain injury
470848|NCT01552473|combat related injury|combat related injury
470849|NCT01552473|blast injury|blast injury
470850|NCT01552473|concussion|concussion
470851|NCT01552473|sleep problems|sleep problems
470852|NCT01552473|attention problems|attention problems
470853|NCT01552473|memory problems|memory problems
470854|NCT01552473|headaches|headaches
470855|NCT01552473|dizziness|dizziness
470856|NCT01552473|OEF|oef
470857|NCT01552473|OIF|oif
470858|NCT01552473|Veterans|veterans
470859|NCT01552473|Civilian|civilian
470860|NCT01552460|Autism Spectrum Disorders|autism spectrum disorders
470861|NCT01552460|Brain Imaging|brain imaging
470862|NCT01552460|Genetics|genetics
470863|NCT01552434|Temsirolimus|temsirolimus
470864|NCT01552434|CCI-779|cci-779
470865|NCT01552434|Torisel|torisel
470866|NCT01552434|Bevacizumab|bevacizumab
470867|NCT01552434|Avastin|avastin
470868|NCT01552434|rhuMAb-VEGF|rhumab-vegf
470869|NCT01552434|Anti-VEGF Monoclonal Antibody|anti-vegf monoclonal antibody
470870|NCT01552434|Advanced Cancers|advanced cancers
470871|NCT01552434|Advanced Malignancy|advanced malignancy
470872|NCT01552434|Metastatic|metastatic
470873|NCT01552434|cancer|cancer
470874|NCT01552434|Cetuximab|cetuximab
470875|NCT01552434|C225|c225
470876|NCT01552434|Erbitux|erbitux
470877|NCT01552434|IMC-C225|imc-c225
470878|NCT01552434|Valproic Acid|valproic acid
470879|NCT01552421|Cholecystectomy|cholecystectomy
470880|NCT01552421|Natural Orifice Transluminal Endoscopic Surgery|natural orifice transluminal endoscopic surgery
470881|NCT01552421|Transvaginal cholecystectomy|transvaginal cholecystectomy
470882|NCT01552421|Postoperative outcome|postoperative outcome
470883|NCT01552408|Non Proliferative Diabetic Retinopathy|non proliferative diabetic retinopathy
470884|NCT01552408|Diabetic Retinopathy|diabetic retinopathy
470885|NCT01552408|Macular Edema|macular edema
470886|NCT01552408|Background Diabetic Retinopathy|background diabetic retinopathy
470887|NCT01552408|Pre Proliferative Diabetic Retinopathy|pre proliferative diabetic retinopathy
470888|NCT01552382|vitamin D|vitamin d
470889|NCT01552382|25-hydroxyvitamin D|25-hydroxyvitamin d
470890|NCT01552382|MACCE|macce
470891|NCT01552382|mortality|mortality
470892|NCT01552382|cardiac|cardiac
470893|NCT01552382|cerebrovascular|cerebrovascular
470894|NCT01552369|CMV|cmv
470895|NCT01552369|cytomegalovirus infections|cytomegalovirus infections
470896|NCT01552369|ganciclovir|ganciclovir
470897|NCT01552369|liver transplant|liver transplant
470898|NCT01552369|preemptive therapy|preemptive therapy
470899|NCT01552369|prophylaxis|prophylaxis
470900|NCT01552369|valganciclovir|valganciclovir
470901|NCT01552330|Primaquine|primaquine
470902|NCT01552330|Pyronaridine-artesunate|pyronaridine-artesunate
470903|NCT01552317|chronic kidney disease|chronic kidney disease
470904|NCT01552304|Obstructive sleep apnea|obstructive sleep apnea
470905|NCT01552304|Oxygen therapy|oxygen therapy
470906|NCT01552304|Surgery|surgery
470907|NCT01552304|Anesthesia|anesthesia
470908|NCT01552291|Malnourishment|malnourishment
470909|NCT01552291|Gastrointestinal tumors|gastrointestinal tumors
470910|NCT01552291|Immunocompetence|immunocompetence
470911|NCT01552265|Mild Cognitive Impairment|mild cognitive impairment
470912|NCT01552265|Alzheimer's Disease|alzheimer's disease
470913|NCT01552252|POs-Ca|pos-ca
470914|NCT01552252|calcium additives|calcium additives
470915|NCT01552252|drink|drink
470916|NCT01552239|Soft tissue sarcoma|soft tissue sarcoma
710736|NCT00588146|Liver disease with high cardiac output|liver disease with high cardiac output
470917|NCT01552239|Intensity-Modulated Radiation Therapy (IMRT)|intensity-modulated radiation therapy (imrt)
470918|NCT01552239|Tomotherapy|tomotherapy
470919|NCT01552239|Safety Margins|safety margins
470920|NCT01552239|Image-guided Radiation Therapy|image-guided radiation therapy
470921|NCT01552239|Brachytherapy|brachytherapy
470922|NCT01552239|interstitial|interstitial
470923|NCT01552200|Colorectal Cancer|colorectal cancer
470924|NCT01552200|Polyp|polyp
470925|NCT01552200|Adenoma|adenoma
470926|NCT01552200|Detection Rate|detection rate
470927|NCT01552200|Colonoscopy|colonoscopy
470928|NCT01552200|NaviAid™ G-Eye procedure|naviaid™ g-eye procedure
470929|NCT01552200|NaviAid™ G-Eye system|naviaid™ g-eye system
470930|NCT01552200|G-Eye procedure|g-eye procedure
470931|NCT01552200|G-Eye system|g-eye system
470932|NCT01552187|cardiac surgery|cardiac surgery
470933|NCT01552187|post-pericardiotomy syndrome|post-pericardiotomy syndrome
470934|NCT01552187|atrial fibrillation|atrial fibrillation
470935|NCT01552187|pericardial effusion|pericardial effusion
470936|NCT01552187|pleural effusion|pleural effusion
470937|NCT01552187|prevention|prevention
470938|NCT01552187|colchicine|colchicine
470939|NCT01552174|MGD|mgd
470940|NCT01552174|ocular surface pathologies|ocular surface pathologies
470941|NCT01552161|Angiography|angiography
470942|NCT01552161|Atherosclerosis|atherosclerosis
470943|NCT01552161|Asthma|asthma
470944|NCT01552161|Tryptase|tryptase
470945|NCT01552161|Eosinophil cationic protein|eosinophil cationic protein
470946|NCT01552135|titanium dioxide|titanium dioxide
470947|NCT01552135|nanoparticles|nanoparticles
470948|NCT01552135|skin|skin
470949|NCT01552135|penetrate|penetrate
470950|NCT01552109|symptomatic stable angina|symptomatic stable angina
470951|NCT01552109|subjects with symptomatic stable angina visiting non-interventional consulting physicians for treatment and meets the inclusion/exclusion criteria|subjects with symptomatic stable angina visiting non-interventional consulting physicians for treatment and meets the inclusion/exclusion criteria
470952|NCT01552096|Anaesthesia|anaesthesia
470953|NCT01552096|tonsillectomy|tonsillectomy
470954|NCT01552096|inflammatory response|inflammatory response
470955|NCT01552096|stress response|stress response
470956|NCT01552096|tramadol|tramadol
470957|NCT01552096|lidocaine|lidocaine
470958|NCT01552083|sleep apnea|sleep apnea
470959|NCT01552083|screening|screening
470960|NCT01552083|community pharmacy|community pharmacy
470961|NCT01552044|retina|retina
470962|NCT01552031|COPD exacerbations|copd exacerbations
470963|NCT01552031|FOT variability|fot variability
470964|NCT01551992|Sutures|sutures
470965|NCT01551992|Pelvic Organ Prolapse|pelvic organ prolapse
470966|NCT01551992|Sacrocolpopexy|sacrocolpopexy
470967|NCT01551992|Laparoscopy|laparoscopy
470968|NCT01551979|Schizophrenia|schizophrenia
470969|NCT01551979|repetitive Transcranial Magnetic Stimulation|repetitive transcranial magnetic stimulation
470970|NCT01551966|Esophageal varices|esophageal varices
470971|NCT01551966|Portal hypertension in children|portal hypertension in children
470972|NCT01551966|Wireless capsule endoscopy|wireless capsule endoscopy
470973|NCT01551953|chronic bronchitis|chronic bronchitis
470974|NCT01551953|emphysema|emphysema
470975|NCT01551953|pulmonary|pulmonary
470976|NCT01551953|COPD|copd
470977|NCT01551940|Sialorrhea|sialorrhea
470978|NCT01551940|Amyotrophic lateral sclerosis|amyotrophic lateral sclerosis
470979|NCT01551940|Botulinum toxin|botulinum toxin
470980|NCT01551927|expectations|expectations
470981|NCT01551914|Ultrasonic scissors|ultrasonic scissors
470982|NCT01551914|thyroidectomy|thyroidectomy
470983|NCT01551901|Back pain|back pain
470984|NCT01551901|Spinal fusion|spinal fusion
470985|NCT01551901|Degenerative disc disease (DDD)|degenerative disc disease (ddd)
470986|NCT01551901|Lower back pain|lower back pain
470987|NCT01551901|Fusion|fusion
470988|NCT01551888|COPD|copd
470989|NCT01551888|Chronic Obstructive Pulmonary Disease|chronic obstructive pulmonary disease
470990|NCT01551888|Chronic Bronchitis|chronic bronchitis
470991|NCT01551888|Emphysema|emphysema
470992|NCT01551888|Airflow Obstruction, Chronic|airflow obstruction, chronic
470993|NCT01551888|Chronic Airflow Obstruction|chronic airflow obstruction
470994|NCT01551888|Chronic Obstructive Airway Disease|chronic obstructive airway disease
470995|NCT01551888|Chronic Obstructive Lung Disease|chronic obstructive lung disease
470996|NCT01551875|CIMT|cimt
470997|NCT01551875|cardiovascular disease|cardiovascular disease
470998|NCT01551875|correlation with cardiovascular Risk factors|correlation with cardiovascular risk factors
470999|NCT01551862|lower body lift|lower body lift
471000|NCT01551862|body contouring surgery|body contouring surgery
471001|NCT01551862|massive weight loss|massive weight loss
471002|NCT01551836|pharmacokinetics|pharmacokinetics
471003|NCT01551836|paracetamol|paracetamol
471004|NCT01551823|Influenza Virus Vaccine (Split Virion, Inactivated)|influenza virus vaccine (split virion, inactivated)
471005|NCT01551823|Influenza|influenza
471006|NCT01551810|Influenza Virus Vaccine (Split Virion, Inactivated)|influenza virus vaccine (split virion, inactivated)
471007|NCT01551810|Influenza|influenza
471008|NCT01551784|Statin treatment|statin treatment
471009|NCT01551784|Cardiovascular disease|cardiovascular disease
471010|NCT01551784|Statin treatment induced HDL changes and the effect on cardiovascular disease|statin treatment induced hdl changes and the effect on cardiovascular disease
471011|NCT01551771|CCR3 antagonist|ccr3 antagonist
471012|NCT01551758|Exacerbation|exacerbation
471013|NCT01551758|Adult|adult
471014|NCT01551758|COPD|copd
471015|NCT01551758|Respiratory|respiratory
471016|NCT01551745|Papillary Serous Ovarian Cancer|papillary serous ovarian cancer
471017|NCT01551745|Endometrioid Ovarian Cancer|endometrioid ovarian cancer
471018|NCT01551745|Epithelial Ovarian Cancer|epithelial ovarian cancer
471019|NCT01551732|Anger|anger
471020|NCT01551732|Aggression|aggression
471021|NCT01551732|Biofeedback|biofeedback
471022|NCT01551732|Videogame|videogame
471023|NCT01551719|Bacterial infection of skin or soft tissues|bacterial infection of skin or soft tissues
471024|NCT01551706|Total antioxidant capacity|total antioxidant capacity
471025|NCT01551706|SOD|sod
471026|NCT01551706|8-OHdG|8-ohdg
471027|NCT01551706|8-isoprostane|8-isoprostane
471028|NCT01551706|oxLDL|oxldl
471029|NCT01551693|Stage III|stage iii
471030|NCT01551693|Stage IV|stage iv
471031|NCT01551693|Unresectable|unresectable
471032|NCT01551693|Metastatic|metastatic
471033|NCT01551667|S. aureus|s. aureus
471034|NCT01551654|Pain|pain
471035|NCT01551654|Colonoscopy|colonoscopy
471036|NCT01551654|TENS|tens
471037|NCT01551654|Acupuncture|acupuncture
471038|NCT01551641|Esophageal Cancer|esophageal cancer
471039|NCT01551641|Chemoradiotherapy|chemoradiotherapy
471040|NCT01551641|VEGF|vegf
471041|NCT01551641|Thalidomide|thalidomide
471042|NCT01551615|Phase 1|phase 1
471043|NCT01551615|healthy volunteers|healthy volunteers
471044|NCT01551615|pharmacokinetics|pharmacokinetics
471045|NCT01551615|vandetanib|vandetanib
471046|NCT01551615|metformin|metformin
471047|NCT01551615|AUC(0-t)|auc(0-t)
471048|NCT01551615|t1/2|t1/2
471049|NCT01551615|tmax|tmax
471050|NCT01551615|CL/F|cl/f
471051|NCT01551615|Vz/F|vz/f
471052|NCT01551615|Cmax|cmax
471053|NCT01551602|AK159|ak159
471054|NCT01551602|teriparatide acetate|teriparatide acetate
471055|NCT01551589|Esophageal squamous cell carcinoma|esophageal squamous cell carcinoma
471056|NCT01551589|Concurrent chemoradiotherapy|concurrent chemoradiotherapy
471057|NCT01551589|Clinical target volume|clinical target volume
471058|NCT01551589|Safety|safety
471059|NCT01551589|Prognosis|prognosis
471060|NCT01551550|Glaucoma Drainage Device, Tube Exposure, Amniotic Membrane|glaucoma drainage device, tube exposure, amniotic membrane
471061|NCT01551537|Healthy females|healthy females
471062|NCT01551537|Post-marketing surveillance (PMS)|post-marketing surveillance (pms)
471063|NCT01551537|Human papillomavirus vaccine|human papillomavirus vaccine
471064|NCT01551537|Sri Lanka|sri lanka
471065|NCT01551537|Cervarix|cervarix
471066|NCT01551524|Leukemia|leukemia
471067|NCT01551524|Lymphoma|lymphoma
471068|NCT01551524|C240588.448|c240588.448
471069|NCT01551524|C115.378.400|c115.378.400
471070|NCT01551511|chronic pancreatitis|chronic pancreatitis
471071|NCT01551511|abdominal pain|abdominal pain
471072|NCT01551511|visceral pain|visceral pain
471073|NCT01551511|chronic pain|chronic pain
471074|NCT01551498|Hashimoto Disease|hashimoto disease
471075|NCT01551498|Thyroiditis|thyroiditis
471076|NCT01551459|Uveal|uveal
471077|NCT01551459|Melanoma|melanoma
471078|NCT01551459|Metastatic|metastatic
471079|NCT01551459|Sunitinib|sunitinib
471080|NCT01551433|esophagectomy|esophagectomy
471081|NCT01551433|ESOPHAGUS|esophagus
471082|NCT01551433|Wipox instrument|wipox instrument
471083|NCT01551433|Tissue Oxygenation|tissue oxygenation
471084|NCT01551433|Anastomotic Leak|anastomotic leak
471085|NCT01551433|11-192|11-192
471086|NCT01551420|Amputation|amputation
471087|NCT01551420|Prosthetic Design|prosthetic design
471088|NCT01551420|Upper Extremity|upper extremity
471089|NCT01551407|Hexvix|hexvix
471090|NCT01551407|bladder cancer|bladder cancer
471091|NCT01551407|cystoscopy|cystoscopy
471092|NCT01551407|Patients with known or suspicion of bladder cancer|patients with known or suspicion of bladder cancer
471093|NCT01551394|sepsis|sepsis
471094|NCT01551394|neonates|neonates
471095|NCT01551394|meropenem|meropenem
471096|NCT01551381|Safety|safety
471097|NCT01551381|Tolerability|tolerability
471098|NCT01551381|Pharmacokinetics|pharmacokinetics
471099|NCT01551381|Pharmacodynamics|pharmacodynamics
471100|NCT01551368|male factor|male factor
471101|NCT01551368|intrauterine insemination|intrauterine insemination
471102|NCT01551368|LH surge|lh surge
471103|NCT01551368|controlled ovarian stimulation|controlled ovarian stimulation
471104|NCT01551368|clomiphene citrate|clomiphene citrate
471105|NCT01551368|letrozole|letrozole
471106|NCT01551368|human menopausal gonadotropins|human menopausal gonadotropins
471107|NCT01551355|behavioral modification|behavioral modification
471108|NCT01551355|health communication|health communication
471109|NCT01551355|prevention|prevention
471110|NCT01551342|bladder cancer|bladder cancer
471111|NCT01551342|Transitional cell carcinoma (TCC)|transitional cell carcinoma (tcc)
471112|NCT01551329|depression|depression
471113|NCT01551329|alcohol|alcohol
471114|NCT01551329|comorbidity|comorbidity
471115|NCT01551329|ketamine|ketamine
471116|NCT01551329|glutamate|glutamate
471117|NCT01551329|NMDA|nmda
471118|NCT01551316|safety|safety
471119|NCT01551316|pharmacokinetics|pharmacokinetics
471120|NCT01551316|spirometry|spirometry
471121|NCT01551290|Ulcerative colitis|ulcerative colitis
471122|NCT01551290|UC|uc
471123|NCT01551290|Remicade|remicade
471124|NCT01551290|Infliximab|infliximab
471125|NCT01551290|Chinese patients|chinese patients
471126|NCT01551290|Mayo score|mayo score
471127|NCT01551290|Mucosal healing|mucosal healing
471128|NCT01551290|Rectal bleeding|rectal bleeding
471129|NCT01551290|Inflammatory bowel disease|inflammatory bowel disease
471130|NCT01551290|IBD|ibd
471131|NCT01551238|Energy expenditure|energy expenditure
471132|NCT01551238|Sleep|sleep
471133|NCT01551238|Protein|protein
471134|NCT01551238|Carbohydrate|carbohydrate
471135|NCT01551225|Randomized controlled trial|randomized controlled trial
471136|NCT01551225|Escitalopram|escitalopram
471137|NCT01551225|Irritable bowel syndrome|irritable bowel syndrome
471138|NCT01551225|Panic disorder|panic disorder
471139|NCT01551212|Liver transplantation|liver transplantation
471140|NCT01551212|Everolimus|everolimus
471141|NCT01551212|Tacrolimus|tacrolimus
471142|NCT01551212|Renal function|renal function
471143|NCT01551186|Probiotics|probiotics
471144|NCT01551173|Dyslipidemias|dyslipidemias
471145|NCT01551173|Fluvastatin sodium|fluvastatin sodium
471146|NCT01551173|Chinese|chinese
471147|NCT01551160|Non-technical skills|non-technical skills
471148|NCT01551160|Crisis resource management|crisis resource management
471149|NCT01551160|Medical Emergency Team|medical emergency team
471150|NCT01551160|Rapid Response Team|rapid response team
471151|NCT01551147|asthma|asthma
471152|NCT01551147|ONO-6950|ono-6950
471153|NCT01551147|asthma in adult patients|asthma in adult patients
471154|NCT01551134|Gastroesophageal Reflux|gastroesophageal reflux
471155|NCT01551134|Fundoplication|fundoplication
471156|NCT01551134|Randomized Controlled Trial|randomized controlled trial
471157|NCT01551134|General Surgery|general surgery
471158|NCT01551134|Child|child
471159|NCT01551134|Laparoscopy|laparoscopy
471160|NCT01551108|Children|children
471161|NCT01551108|physical activity|physical activity
471162|NCT01551095|PEGJ|pegj
471163|NCT01551095|PEG-J|peg-j
471164|NCT01551095|percutaneous endoscopic gastrostomy|percutaneous endoscopic gastrostomy
471165|NCT01551095|feeding tube|feeding tube
471166|NCT01551095|gastroparesis|gastroparesis
471167|NCT01551095|acute pancreatitis|acute pancreatitis
471168|NCT01551095|stroke|stroke
471169|NCT01551095|respiratory failure|respiratory failure
471170|NCT01551095|GERD|gerd
471171|NCT01551095|balloon|balloon
471172|NCT01551095|self-propelled|self-propelled
471173|NCT01551043|adult patients|adult patients
471174|NCT01551043|aged 18|aged 18
471175|NCT01551043|CD19+ ALL relapsed|cd19+ all relapsed
471176|NCT01551043|after allogeneic SCT|after allogeneic sct
471177|NCT01551030|KIDNEY|kidney
471178|NCT01551030|URETER|ureter
471179|NCT01551030|URINARY BLADDER|urinary bladder
471180|NCT01551030|Buparlisib|buparlisib
471181|NCT01551030|11-060|11-060
471182|NCT01551017|total knee endoprostheses|total knee endoprostheses
471183|NCT01551017|swelling|swelling
471184|NCT01551017|mobilisation|mobilisation
471185|NCT01551004|C. diff|c. diff
471186|NCT01551004|C. difficile|c. difficile
471187|NCT01551004|Clostridium difficile|clostridium difficile
471188|NCT01551004|CRS3123|crs3123
471189|NCT01550965|Quality of Life|quality of life
471190|NCT01550965|Costs of Ulcerative Colitis|costs of ulcerative colitis
471191|NCT01550965|Health Care Utilization|health care utilization
471192|NCT01550939|Biometry of the Eye|biometry of the eye
471193|NCT01550939|Intraocular Lens Implantation|intraocular lens implantation
471194|NCT01550939|IOL|iol
471195|NCT01550926|orlistat|orlistat
471196|NCT01550926|overweight|overweight
471197|NCT01550926|bioequivalence|bioequivalence
471198|NCT01550913|Substance use|substance use
471199|NCT01550913|perinatal depression|perinatal depression
471200|NCT01550913|pregnant|pregnant
471201|NCT01550900|Colorectum|colorectum
471202|NCT01550900|Metachronous ctalColonic Neoplastic Polyps|metachronous ctalcolonic neoplastic polyps
471203|NCT01550900|Chemoprevention|chemoprevention
471204|NCT01550900|Colonic adenoma(s)|colonic adenoma(s)
471205|NCT01550900|Pre-cancerous tumor(s) on the colon|pre-cancerous tumor(s) on the colon
471206|NCT01550900|Metformin ER|metformin er
471207|NCT01550900|Extended Release|extended release
471208|NCT01550900|Placebo|placebo
471209|NCT01550900|Sugar pill|sugar pill
471210|NCT01550874|Physical Activity|physical activity
471211|NCT01550874|Epilepsy|epilepsy
471212|NCT01550874|Children|children
471213|NCT01550874|Motivation|motivation
471214|NCT01550861|infertility|infertility
471215|NCT01550861|in vitro maturation (IVM)|in vitro maturation (ivm)
471216|NCT01550861|in vitro fertilization (IVF)|in vitro fertilization (ivf)
601071|NCT01012609|POETIC|poetic
471217|NCT01550861|natural cycle|natural cycle
471218|NCT01550835|Symptomatic carotid artery stenosis|symptomatic carotid artery stenosis
471219|NCT01550822|stroke, lifestyle habits|stroke, lifestyle habits
471220|NCT01550809|T1DM|t1dm
471221|NCT01550809|CSII|csii
471222|NCT01550809|CGM|cgm
471223|NCT01550809|postprandial control|postprandial control
471224|NCT01550809|glycemic variability|glycemic variability
471225|NCT01550809|Prandial insulin dosing in Type 1 diabetes treated with continuous subcutaneous insulin infusion|prandial insulin dosing in type 1 diabetes treated with continuous subcutaneous insulin infusion
471226|NCT01550796|Tinnitus|tinnitus
471227|NCT01550796|Brain Fitness Program|brain fitness program
471228|NCT01550796|Posit Science|posit science
471229|NCT01550796|D-cycloserine|d-cycloserine
471230|NCT01550796|Cognitive Training|cognitive training
471231|NCT01550783|Cervical cancer|cervical cancer
471232|NCT01550783|Atypical squamous cells of undetermined significance|atypical squamous cells of undetermined significance
471233|NCT01550783|Stage 0 cervical cancer|stage 0 cervical cancer
471234|NCT01550783|Cervical intraepithelial neoplasia grade 1|cervical intraepithelial neoplasia grade 1
471235|NCT01550783|Cervical|cervical
471236|NCT01550783|intraepithelial neoplasia grade 2|intraepithelial neoplasia grade 2
471237|NCT01550783|Cervical intraepithelial neoplasia grade 3|cervical intraepithelial neoplasia grade 3
471238|NCT01550783|Human papillomavirus|human papillomavirus
471239|NCT01550783|HPV|hpv
471240|NCT01550744|Psoriasis|psoriasis
471241|NCT01550744|Ustekinumab|ustekinumab
471242|NCT01550744|STELARA|stelara
471243|NCT01550744|Skin disease|skin disease
471244|NCT01550744|Monoclonal|monoclonal
471245|NCT01550731|advance care planning|advance care planning
471246|NCT01550731|health communication|health communication
471247|NCT01550731|aging|aging
471248|NCT01550718|Aerobic Exercise|aerobic exercise
471249|NCT01550718|Alzheimer's Disease|alzheimer's disease
471250|NCT01550718|Burden and Stress|burden and stress
471251|NCT01550718|Caregiving Issues|caregiving issues
471252|NCT01550718|Quality of Life|quality of life
471253|NCT01550718|Early Stage Memory Loss|early stage memory loss
471254|NCT01550705|Protoporphyria|protoporphyria
471255|NCT01550705|Porphyria|porphyria
471256|NCT01550705|Porphyrins|porphyrins
471257|NCT01550666|negative symptoms|negative symptoms
471258|NCT01550653|Memory|memory
471259|NCT01550653|GLP-1|glp-1
471260|NCT01550653|Liraglutide|liraglutide
471261|NCT01550653|energy output|energy output
471262|NCT01550653|Memory facilitation|memory facilitation
471263|NCT01550653|GLP-1 analogue|glp-1 analogue
471264|NCT01550640|remifentanil|remifentanil
471265|NCT01550640|Caesarean operation|caesarean operation
471266|NCT01550640|general anaesthesia|general anaesthesia
471267|NCT01550640|hypertension|hypertension
471268|NCT01550640|newborn's adaptation|newborn's adaptation
471269|NCT01550640|pharmacogenetics|pharmacogenetics
471270|NCT01550627|preterm infants < 32 weeks of gestation|preterm infants < 32 weeks of gestation
471271|NCT01550614|Angina Pectoris|angina pectoris
471272|NCT01550614|Myocardial Ischemia|myocardial ischemia
471273|NCT01550614|Chest Pain|chest pain
471274|NCT01550614|Coronary Artery Disease|coronary artery disease
471275|NCT01550614|Heart Diseases|heart diseases
471276|NCT01550614|Cardiovascular Diseases|cardiovascular diseases
471277|NCT01550614|Myocardial Perfusion|myocardial perfusion
471278|NCT01550614|Reversible Perfusion Defect Size|reversible perfusion defect size
471279|NCT01550614|SPECT-MIBI|spect-mibi
471280|NCT01550614|Anti-Anginal Medication|anti-anginal medication
471281|NCT01550614|Quality of Life|quality of life
471282|NCT01550601|morbid obesity|morbid obesity
471283|NCT01550601|gastrectomy|gastrectomy
471284|NCT01550601|gastrinaemia|gastrinaemia
471285|NCT01550601|comorbidity|comorbidity
471286|NCT01550601|gastric antrum|gastric antrum
471287|NCT01550588|PFO|pfo
471288|NCT01550588|Stroke|stroke
471289|NCT01550549|Amyloid imaging|amyloid imaging
471290|NCT01550549|Positron Emission Tomography|positron emission tomography
471291|NCT01550549|18F-AV-45|18f-av-45
471292|NCT01550549|florbetapir F 18|florbetapir f 18
471293|NCT01550549|Diagnostic imaging|diagnostic imaging
471294|NCT01550536|basal metabolic rate|basal metabolic rate
471295|NCT01550536|resting energy expenditure|resting energy expenditure
471296|NCT01550536|menopause|menopause
471297|NCT01550536|physical activity|physical activity
471298|NCT01550536|metabolic syndrome|metabolic syndrome
471299|NCT01550523|Brain Tumor|brain tumor
471300|NCT01550510|Stage IV Colorectal cancer|stage iv colorectal cancer
471301|NCT01550510|Colorectal Neoplasms|colorectal neoplasms
471302|NCT01550510|Intestinal Neoplasms|intestinal neoplasms
471303|NCT01550510|Gastrointestinal Neoplasms|gastrointestinal neoplasms
471304|NCT01550510|Digestive System Neoplasms|digestive system neoplasms
471305|NCT01550510|Neoplasms by Site|neoplasms by site
471306|NCT01550510|Neoplasms|neoplasms
471307|NCT01550510|Digestive System Diseases|digestive system diseases
471308|NCT01550510|Gastrointestinal Diseases|gastrointestinal diseases
471309|NCT01550510|Colonic Diseases|colonic diseases
471310|NCT01550510|Intestinal Diseases|intestinal diseases
471311|NCT01550510|Rectal Diseases|rectal diseases
471312|NCT01550510|Ascorbic Acid|ascorbic acid
471313|NCT01550510|Vitamins|vitamins
471314|NCT01550510|Irinotecan|irinotecan
471315|NCT01550510|Integrative Medicine|integrative medicine
471316|NCT01550510|Complementary Medicine|complementary medicine
471317|NCT01550510|Alternative Medicine Antioxidants|alternative medicine antioxidants
471318|NCT01550510|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action
471319|NCT01550510|Pharmacologic Actions|pharmacologic actions
471320|NCT01550510|Protective Agents|protective agents
471321|NCT01550510|Physiological Effects of Drugs|physiological effects of drugs
471322|NCT01550510|Micronutrients|micronutrients
471323|NCT01550510|Growth Substances|growth substances
471324|NCT01550510|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic
471325|NCT01550510|Antineoplastic Agents|antineoplastic agents
471326|NCT01550510|Therapeutic Uses|therapeutic uses
471327|NCT01550510|Radiation-Sensitizing Agents|radiation-sensitizing agents
471328|NCT01550510|Topoisomerase I Inhibitors|topoisomerase i inhibitors
471329|NCT01550510|Topoisomerase Inhibitors|topoisomerase inhibitors
471330|NCT01550510|Enzyme Inhibitors|enzyme inhibitors
471331|NCT01550497|back pain|back pain
471332|NCT01550497|scoliosis|scoliosis
471333|NCT01550497|home exercise program|home exercise program
471334|NCT01550471|Mild asthma and allergic rhinitis|mild asthma and allergic rhinitis
471335|NCT01550458|Clinical Trial, Phase I|clinical trial, phase i
471336|NCT01550458|Human Volunteers|human volunteers
471337|NCT01550458|Healthy Volunteers|healthy volunteers
471338|NCT01550458|mibefradil|mibefradil
471339|NCT01550458|Posicor®|posicor®
471340|NCT01550445|Steroid withdrawal, Kidney transplantation|steroid withdrawal, kidney transplantation
471341|NCT01550419|Ventilator-associated pneumonia|ventilator-associated pneumonia
471342|NCT01550419|Ischemic stroke|ischemic stroke
471343|NCT01550419|Atorvastatin|atorvastatin
471344|NCT01550419|Morbidity|morbidity
471345|NCT01550419|Mortality|mortality
471346|NCT01550406|Pancreatic fistula|pancreatic fistula
471347|NCT01550406|distal Pancreatectomy|distal pancreatectomy
471348|NCT01550393|stage II Wilms tumor|stage ii wilms tumor
471349|NCT01550393|stage III Wilms tumor|stage iii wilms tumor
471350|NCT01550393|recurrent Wilms tumor and other childhood kidney tumors|recurrent wilms tumor and other childhood kidney tumors
471351|NCT01550380|Endometrial cancer|endometrial cancer
471352|NCT01550341|HIV|hiv
471353|NCT01550341|AIDS|aids
471354|NCT01550341|Opiate Addiction|opiate addiction
471355|NCT01550341|Drug Dependence|drug dependence
471356|NCT01550341|Buprenorphine|buprenorphine
471357|NCT01550328|Screening for Type 2 diabetes|screening for type 2 diabetes
471358|NCT01550315|POTS|pots
471359|NCT01550315|endothelial function|endothelial function
471360|NCT01550315|high salt vs low salt diet|high salt vs low salt diet
471361|NCT01550315|PAT protocol|pat protocol
471362|NCT01550315|Calf blood flow|calf blood flow
471363|NCT01550315|forearm mediated dilation|forearm mediated dilation
471364|NCT01550302|Superficial Cervical Plexus Block|superficial cervical plexus block
471365|NCT01550302|Thoracic Surgery|thoracic surgery
471366|NCT01550302|Thoracotomy|thoracotomy
471367|NCT01550302|Video-Assisted Thoracoscopic Surgery|video-assisted thoracoscopic surgery
471368|NCT01550289|Dengue Fever|dengue fever
471369|NCT01550289|Dengue Hemorrhagic Fever|dengue hemorrhagic fever
471370|NCT01550289|CYD Dengue Vaccine|cyd dengue vaccine
471371|NCT01550289|Dengue Virus|dengue virus
471372|NCT01550289|Flavivirus|flavivirus
471373|NCT01550276|Effectiveness|effectiveness
471374|NCT01550276|Tension-type headache|tension-type headache
471375|NCT01550276|Manual therapy|manual therapy
471376|NCT01550263|Hip Preservation|hip preservation
471377|NCT01550263|Hip Arthroscopy|hip arthroscopy
471378|NCT01550263|Hip Pain|hip pain
471379|NCT01550263|Psychological distress|psychological distress
471380|NCT01550250|Breast cancer|breast cancer
471381|NCT01550250|Arm lymphedema|arm lymphedema
471382|NCT01550250|Compression therapy|compression therapy
471383|NCT01550237|radiotherapy, image-guided|radiotherapy, image-guided
471384|NCT01550237|adverse effects|adverse effects
471385|NCT01550237|position verification|position verification
471386|NCT01550237|safety margins|safety margins
471387|NCT01550198|newborn|newborn
471388|NCT01550198|shock|shock
471389|NCT01550198|hemodynamics|hemodynamics
471390|NCT01550198|cardiac output|cardiac output
471391|NCT01550198|blood pressure|blood pressure
471392|NCT01550172|dementia caregivers|dementia caregivers
471393|NCT01550172|caregivers|caregivers
471394|NCT01550172|Alzheimer's caregivers|alzheimer's caregivers
471395|NCT01550172|caregiver sleep|caregiver sleep
471396|NCT01550172|heart disease risk|heart disease risk
471397|NCT01550172|dementia|dementia
471398|NCT01550172|Alzheimer's Disease|alzheimer's disease
471399|NCT01550159|Postoperative Cognitive Dysfunction|postoperative cognitive dysfunction
471400|NCT01550159|Cardiac Surgery|cardiac surgery
471401|NCT01550159|General Anesthesia|general anesthesia
471402|NCT01550159|Neuropsychological Tests|neuropsychological tests
471403|NCT01550146|Fractured neck of femur|fractured neck of femur
471404|NCT01550146|Dexamethasone|dexamethasone
471405|NCT01550133|Peptides|peptides
471406|NCT01550133|Hormones|hormones
471407|NCT01550133|Appetite|appetite
471408|NCT01550133|Humans|humans
471409|NCT01550133|Obese|obese
471410|NCT01550133|Beverage|beverage
471411|NCT01550133|Solid food|solid food
471412|NCT01550133|cephalic phase|cephalic phase
471413|NCT01550120|taste|taste
471414|NCT01550120|fat|fat
471415|NCT01550120|threshold|threshold
471416|NCT01550120|sensitivity|sensitivity
471417|NCT01550120|human|human
471418|NCT01550107|Sarcopenia|sarcopenia
471419|NCT01550107|Allopurinol|allopurinol
471420|NCT01550107|Xanthine Oxidase|xanthine oxidase
471421|NCT01550107|MR Spectroscopy|mr spectroscopy
471422|NCT01550094|obese|obese
471423|NCT01550094|regional anesthesia|regional anesthesia
471424|NCT01550094|anesthesia|anesthesia
471425|NCT01550094|anesthesiology|anesthesiology
471426|NCT01550094|surgery|surgery
471427|NCT01550094|foot|foot
471428|NCT01550094|foot surgery|foot surgery
471429|NCT01550094|ankle|ankle
471430|NCT01550094|ankle surgery|ankle surgery
471431|NCT01550094|orthopedics|orthopedics
471432|NCT01550094|orthopedic surgery|orthopedic surgery
471433|NCT01550094|sports medicine|sports medicine
471434|NCT01550094|sports medicine surgery|sports medicine surgery
471435|NCT01550094|Ochsner Hospital|ochsner hospital
471436|NCT01550094|Ochsner Clinic|ochsner clinic
471437|NCT01550094|New Orleans|new orleans
471438|NCT01550094|Louisiana|louisiana
471439|NCT01550094|Jefferson|jefferson
471440|NCT01550094|Soberon|soberon
471441|NCT01550081|exercise intensity|exercise intensity
471442|NCT01550081|aerobic interval training|aerobic interval training
471443|NCT01550081|cardiac rehabilitation|cardiac rehabilitation
471444|NCT01550081|group exercise|group exercise
471445|NCT01550068|Rheumatic Heart Disease|rheumatic heart disease
471446|NCT01550055|KRAS wild-type|kras wild-type
471447|NCT01550055|Metastatic Colorectal Cancer|metastatic colorectal cancer
471448|NCT01550055|CMAB009 Plus Irinotecan|cmab009 plus irinotecan
471449|NCT01550055|Phase II/III|phase ii/iii
471450|NCT01550029|Smoking|smoking
471451|NCT01550029|Tobacco|tobacco
471452|NCT01550029|Nicotine|nicotine
471453|NCT01550029|Bipolar|bipolar
471454|NCT01550016|dengue warning signs|dengue warning signs
471455|NCT01550016|latin america|latin america
471456|NCT01550016|south east asia|south east asia
471457|NCT01550016|other febrile illnesses|other febrile illnesses
471458|NCT01550016|dengue classification|dengue classification
471459|NCT01550003|Cimzia|cimzia
471460|NCT01550003|JIA|jia
471461|NCT01550003|Polyarticular|polyarticular
471462|NCT01550003|Oligoarticular|oligoarticular
471463|NCT01550003|Enthesitis-related-Arthritis|enthesitis-related-arthritis
471464|NCT01550003|Juvenile Idiopathic Arthritis|juvenile idiopathic arthritis
471465|NCT01550003|Juvenile Psoriatic Arthritis|juvenile psoriatic arthritis
471466|NCT01550003|Certolizumab Pegol|certolizumab pegol
471467|NCT01550003|PASCAL|pascal
471468|NCT01550003|CDP870|cdp870
471469|NCT01549977|Drug Therapy|drug therapy
471470|NCT01549964|Drug Therapy|drug therapy
471471|NCT01549951|Metastatic castrate resistant prostate cancer, mCRPC, orteronel, TAK-700, Phase 2, QT, QTc|metastatic castrate resistant prostate cancer, mcrpc, orteronel, tak-700, phase 2, qt, qtc
471472|NCT01549938|Vitamin D|vitamin d
471473|NCT01549938|Cholecalciferol|cholecalciferol
471474|NCT01549938|Respiratory tract infection|respiratory tract infection
471475|NCT01549912|Rotator Cuff Tears|rotator cuff tears
471476|NCT01549912|Dislocation|dislocation
471477|NCT01549912|Shoulder Dislocation|shoulder dislocation
471478|NCT01549899|Insomnia|insomnia
471479|NCT01549899|Cognitive|cognitive
471480|NCT01549899|Behavioral|behavioral
471481|NCT01549899|Therapy|therapy
471482|NCT01549899|Internet|internet
471483|NCT01549899|Depression|depression
471484|NCT01549899|Substance Use|substance use
471485|NCT01549899|Post-Tramatic Stress Disorder|post-tramatic stress disorder
471486|NCT01549886|Non-Hodgkin's Lymphoma|non-hodgkin's lymphoma
471487|NCT01549886|Zevalin|zevalin
471488|NCT01549886|Motexafin Gadolinium|motexafin gadolinium
471489|NCT01549860|Venous Insufficiency|venous insufficiency
471490|NCT01549860|Reflux|reflux
471491|NCT01549860|Lower Extremity Ulcer|lower extremity ulcer
471492|NCT01549847|Postpoliomyelitis Syndrome|postpoliomyelitis syndrome
471493|NCT01549847|Piracetam|piracetam
471494|NCT01549847|L-Carnitine|l-carnitine
471495|NCT01549808|ADL|adl
471496|NCT01549808|activities of daily living|activities of daily living
471497|NCT01549808|level of function|level of function
471498|NCT01549795|Liver transplantation|liver transplantation
471499|NCT01549795|Neoadjuvant radio- chemo-therapy|neoadjuvant radio- chemo-therapy
471500|NCT01549782|Prebiotics|prebiotics
471501|NCT01549782|Microbiota|microbiota
471502|NCT01549782|Radiotherapy|radiotherapy
471503|NCT01549782|Gynaecological Cancer|gynaecological cancer
471504|NCT01549756|stage 4 stomach cancer|stage 4 stomach cancer
471505|NCT01549756|stage 4 gastric cancer|stage 4 gastric cancer
471506|NCT01549717|Early warning score|early warning score
471507|NCT01549717|Physiological score|physiological score
471508|NCT01549717|Track and trigger score|track and trigger score
471509|NCT01549717|Scoring system|scoring system
471510|NCT01549717|Physiological model|physiological model
471511|NCT01549717|Monitoring|monitoring
471512|NCT01549717|Patient monitoring|patient monitoring
471513|NCT01549717|Wireless monitoring|wireless monitoring
471514|NCT01549717|Wearable monitor|wearable monitor
471515|NCT01549704|Total knee arthroplasty|total knee arthroplasty
471516|NCT01549704|Adductor canal blockade (ACB)|adductor canal blockade (acb)
471517|NCT01549704|High pain responders|high pain responders
471518|NCT01549704|US-guided nerve block|us-guided nerve block
471519|NCT01549691|Premedication|premedication
471520|NCT01549691|Benzodiazepine|benzodiazepine
471521|NCT01549691|Anti-anxiety agents|anti-anxiety agents
471522|NCT01549691|Anxiety|anxiety
471523|NCT01549691|Surgery|surgery
471524|NCT01549691|Adult|adult
471525|NCT01549691|Human|human
471526|NCT01549678|Plantar fasciitis|plantar fasciitis
471527|NCT01549678|foot pain|foot pain
471528|NCT01549678|insoles|insoles
471529|NCT01549678|foot function|foot function
471530|NCT01549678|electronic baropodometer|electronic baropodometer
471531|NCT01549678|plantar pressure|plantar pressure
471532|NCT01549678|gait analysis|gait analysis
471533|NCT01549665|Graft-Versus-Host Disease|graft-versus-host disease
471534|NCT01549665|GVHD|gvhd
471535|NCT01549665|Hematopoietic Stem Cell Transplantation|hematopoietic stem cell transplantation
471536|NCT01549665|Stem Cell Transplantation|stem cell transplantation
471537|NCT01549665|Allogeneic hematopoietic transplant|allogeneic hematopoietic transplant
471538|NCT01549665|Mesenchymal Stem Cells|mesenchymal stem cells
471539|NCT01549665|Unrelated Donors|unrelated donors
471540|NCT01549665|Cord Blood Stem Cell Transplantation|cord blood stem cell transplantation
471541|NCT01549639|Propofol|propofol
471542|NCT01549639|Target controlled infusion|target controlled infusion
471543|NCT01549639|General anaesthesia|general anaesthesia
471544|NCT01549626|Flaxseed|flaxseed
471545|NCT01549626|Women|women
471546|NCT01549626|Obesity|obesity
471547|NCT01549626|No smokers|no smokers
471548|NCT01549574|crizotinib|crizotinib
471549|NCT01549574|pharmacokinetics|pharmacokinetics
471550|NCT01549574|esomeprazole|esomeprazole
471551|NCT01549574|proton pump inhibitor|proton pump inhibitor
471552|NCT01549574|drug drug interaction|drug drug interaction
471553|NCT01549574|healthy volunteers|healthy volunteers
471554|NCT01549561|behavior problems|behavior problems
471555|NCT01549561|foster care|foster care
471556|NCT01549561|parent training|parent training
471557|NCT01549561|youth skills training|youth skills training
471559|NCT01549522|patients or caregivers|patients or caregivers
471560|NCT01549522|for caregivers, loved one must still be living|for caregivers, loved one must still be living
471561|NCT01549496|HCV|hcv
471562|NCT01549496|pharmacokinetics|pharmacokinetics
471563|NCT01549496|boceprevir|boceprevir
471564|NCT01549496|hypertension|hypertension
471565|NCT01549496|amlodipine|amlodipine
471566|NCT01549496|diltiazem|diltiazem
471567|NCT01549483|asthma|asthma
471568|NCT01549483|airway hyperresponsiveness|airway hyperresponsiveness
471569|NCT01549483|asymptomatic airway hyperresponsiveness|asymptomatic airway hyperresponsiveness
471570|NCT01549483|small airways|small airways
471571|NCT01549457|latent tuberculosis|latent tuberculosis
471572|NCT01549457|text message interventions|text message interventions
471573|NCT01549457|medication adherence|medication adherence
471574|NCT01549444|renin|renin
471575|NCT01549444|aldosterone|aldosterone
471576|NCT01549444|neonate|neonate
471577|NCT01549431|Multiple Myeloma|multiple myeloma
471578|NCT01549418|Gastrointestinal bleeding|gastrointestinal bleeding
471579|NCT01549418|Lower gastrointestinal bleeding (LGIB)|lower gastrointestinal bleeding (lgib)
471580|NCT01549418|Polypectomy|polypectomy
471581|NCT01549418|Large colorectal polyps|large colorectal polyps
471582|NCT01549418|ASA|asa
471583|NCT01549418|Aspirin|aspirin
471584|NCT01549418|Acetylsalicylic acid|acetylsalicylic acid
471585|NCT01549418|Colorectal Neoplasms|colorectal neoplasms
471586|NCT01549418|Intestinal Neoplasms|intestinal neoplasms
471587|NCT01549418|Gastrointestinal Neoplasms|gastrointestinal neoplasms
471588|NCT01549418|Digestive System Neoplasms|digestive system neoplasms
471589|NCT01549418|Neoplasms by Site|neoplasms by site
471590|NCT01549418|Neoplasms|neoplasms
471591|NCT01549418|Digestive System Diseases|digestive system diseases
471592|NCT01549418|Gastrointestinal Diseases|gastrointestinal diseases
471593|NCT01549418|Colonic Diseases|colonic diseases
471594|NCT01549418|Intestinal Diseases|intestinal diseases
471595|NCT01549418|Rectal Diseases|rectal diseases
471596|NCT01549405|percutanous nephrolitotomy,intercostal nerve block, Ultrasound|percutanous nephrolitotomy,intercostal nerve block, ultrasound
471597|NCT01549392|dynamic enhanced ct scan|dynamic enhanced ct scan
471598|NCT01549392|mri spectroscopy|mri spectroscopy
471599|NCT01549392|recurrent gliomas|recurrent gliomas
471600|NCT01549379|Head and neck cancer|head and neck cancer
471601|NCT01549379|Radiation|radiation
471602|NCT01549379|Chemotherapy|chemotherapy
601613|NCT01010217|MMF|mmf
471603|NCT01549379|Surgery|surgery
471604|NCT01549379|Dynamic contrast enhanced computed tomography|dynamic contrast enhanced computed tomography
471605|NCT01549340|Rhinitis|rhinitis
471606|NCT01549340|Allergen immunotherapy|allergen immunotherapy
471607|NCT01549327|Virtual Patient Navigation|virtual patient navigation
471608|NCT01549327|Randomized Clinical Trial|randomized clinical trial
471609|NCT01549327|Empowerment|empowerment
471610|NCT01549327|Cost-Effectiveness|cost-effectiveness
471611|NCT01549327|Cancer Information Preferences|cancer information preferences
471612|NCT01549314|Cystic fibrosis related bone disease|cystic fibrosis related bone disease
471613|NCT01549314|Cystic fibrosis|cystic fibrosis
471614|NCT01549314|Ivacaftor|ivacaftor
471615|NCT01549249|cone outer segment tips line|cone outer segment tips line
471616|NCT01549249|inner segment/outer segment junction line|inner segment/outer segment junction line
471617|NCT01549249|optical coherence tomography|optical coherence tomography
471618|NCT01549249|epiretinal membrane|epiretinal membrane
471619|NCT01549236|Chagas Disease|chagas disease
471620|NCT01549236|Trypanosoma Cruzi|trypanosoma cruzi
471621|NCT01549236|T.Cruzi|t.cruzi
471622|NCT01549223|Uterine Atony|uterine atony
471623|NCT01549223|Hypotension|hypotension
471624|NCT01549223|Cesarean Delivery|cesarean delivery
471625|NCT01549223|Hemorrhage|hemorrhage
471626|NCT01549223|Phenylephrine|phenylephrine
471627|NCT01549223|Ephedrine|ephedrine
471629|NCT01549210|gouty arthritis|gouty arthritis
471630|NCT01549197|PTSD|ptsd
471631|NCT01549184|secondary ITP|secondary itp
471632|NCT01549184|hydroxychloroquine|hydroxychloroquine
471633|NCT01549184|Systemic Lupus Erythematosus|systemic lupus erythematosus
471634|NCT01549171|Human ART|human art
471635|NCT01549171|Prostacyclin|prostacyclin
471636|NCT01549171|Iloprost|iloprost
471637|NCT01549171|Pregnancy|pregnancy
471638|NCT01549158|loop diuretics|loop diuretics
471639|NCT01549158|torasemide prolonged release|torasemide prolonged release
471640|NCT01549158|torasemide immediate release|torasemide immediate release
471641|NCT01549158|Sutril Neo|sutril neo
471642|NCT01549158|pharmacodynamic profile of Torasemide-PR|pharmacodynamic profile of torasemide-pr
471643|NCT01549145|Severe|severe
471644|NCT01549145|Ongoing|ongoing
471645|NCT01549145|Unilateral|unilateral
471646|NCT01549145|present for more than 6 months|present for more than 6 months
471647|NCT01549132|Clinically significant macular oedema|clinically significant macular oedema
471648|NCT01549132|Retinal Oximetry|retinal oximetry
471649|NCT01549132|Spectral imaging|spectral imaging
471650|NCT01549132|Retinal Laser therapy|retinal laser therapy
471651|NCT01549132|Intravitreal Anti-VEGF Injection therapy|intravitreal anti-vegf injection therapy
471652|NCT01549119|HIV-1|hiv-1
471653|NCT01549119|HIV|hiv
471654|NCT01549119|immunotherapy|immunotherapy
471655|NCT01549119|active immunotherapy|active immunotherapy
471656|NCT01549119|vaccine|vaccine
471657|NCT01549119|virulence|virulence
471658|NCT01549119|innate immunity|innate immunity
471659|NCT01549119|NK cells|nk cells
471660|NCT01549093|Non-small cell lung cancer|non-small cell lung cancer
471661|NCT01549093|Endostar|endostar
471662|NCT01549093|Continued Pumping into|continued pumping into
471663|NCT01549093|Gemcitabine|gemcitabine
471664|NCT01549093|Carboplatin|carboplatin
471665|NCT01549080|traditional chinese medicine and thalassemia|traditional chinese medicine and thalassemia
471666|NCT01549067|Advanced|advanced
471667|NCT01549067|Colorectal Cancer|colorectal cancer
471668|NCT01549067|Targeted chemotherapy|targeted chemotherapy
471669|NCT01549067|Surgery|surgery
471670|NCT01549067|Radiotherapy|radiotherapy
471671|NCT01549041|schizophrenia|schizophrenia
471672|NCT01549041|asenapine|asenapine
471673|NCT01549041|Once daily|once daily
471674|NCT01549041|twice daily|twice daily
471675|NCT01549015|Urea Cycle Defects|urea cycle defects
471676|NCT01549015|CPSD|cpsd
471677|NCT01549015|OTCD|otcd
471678|NCT01549015|ASSD|assd
471679|NCT01549015|ASLD|asld
471680|NCT01549002|Abscess|abscess
471681|NCT01549002|Pain|pain
471682|NCT01549002|Administration intranasal|administration intranasal
471683|NCT01549002|Infusions intravenous|infusions intravenous
471684|NCT01548989|linguistic validation of a new questionnaire|linguistic validation of a new questionnaire
471685|NCT01548976|linguistic validation of the PISQ-R questionnaire|linguistic validation of the pisq-r questionnaire
471686|NCT01548963|Tight glycemia control|tight glycemia control
471687|NCT01548963|Model Predictive Control algorithm|model predictive control algorithm
471688|NCT01548963|Cardiac surgery patients|cardiac surgery patients
471689|NCT01548950|Congenital heart disease|congenital heart disease
471690|NCT01548950|Pulmonary arterial hypertension|pulmonary arterial hypertension
471691|NCT01548950|Sildenafil|sildenafil
471692|NCT01548950|Bosentan|bosentan
471693|NCT01548950|Pediatric cardiac surgery|pediatric cardiac surgery
471694|NCT01548937|I-123 ADAM Serotonin transporter imaging|i-123 adam serotonin transporter imaging
710252|NCT00589563|adult unfavorable prognosis Hodgkin lymphoma|adult unfavorable prognosis hodgkin lymphoma
471695|NCT01548924|Patients with malignant solid tumors of any histologically confirmed, not susceptible of cure, which have received the standard treatment available|patients with malignant solid tumors of any histologically confirmed, not susceptible of cure, which have received the standard treatment available
471696|NCT01548872|HTk solution|htk solution
471697|NCT01548872|Cardioplegia|cardioplegia
471698|NCT01548872|myocardial protection|myocardial protection
471699|NCT01548872|pediatric cardiac surgery|pediatric cardiac surgery
471700|NCT01548859|Myocardial protection|myocardial protection
471701|NCT01548859|Myocardial injury|myocardial injury
471702|NCT01548859|Anaesthetic preconditioning|anaesthetic preconditioning
471703|NCT01548859|Pediatric cardiac surgery|pediatric cardiac surgery
471704|NCT01548859|Troponin I|troponin i
471705|NCT01548859|Sevoflurane|sevoflurane
471706|NCT01548859|Midazolam|midazolam
471707|NCT01548846|tomotherapy|tomotherapy
471708|NCT01548846|xerostomy|xerostomy
471709|NCT01548846|head and neck squamous cell carcinoma|head and neck squamous cell carcinoma
471710|NCT01548833|Myopia|myopia
471711|NCT01548833|Contact Lenses|contact lenses
471712|NCT01548820|Hepatitis B virus|hepatitis b virus
471713|NCT01548820|Lamivudine|lamivudine
471714|NCT01548820|Resistance to treatment|resistance to treatment
471715|NCT01548794|spinal anesthesia|spinal anesthesia
471716|NCT01548794|bupivacaine|bupivacaine
471717|NCT01548794|lidocaine|lidocaine
471718|NCT01548794|local infiltration anesthesia|local infiltration anesthesia
471719|NCT01548794|recovery|recovery
471720|NCT01548794|duration of anesthesia|duration of anesthesia
471721|NCT01548794|outpatient herniorrhaphy|outpatient herniorrhaphy
471722|NCT01548781|arm|arm
471723|NCT01548781|strength|strength
471724|NCT01548781|coordination|coordination
471725|NCT01548781|physical therapy|physical therapy
471726|NCT01548781|robotics|robotics
471727|NCT01548781|stroke|stroke
471728|NCT01548781|synergy|synergy
471729|NCT01548768|Rheumatoid Arthritis|rheumatoid arthritis
471730|NCT01548768|Cardiovascular disease|cardiovascular disease
471731|NCT01548768|Myocardium|myocardium
471732|NCT01548768|TNF-alpha inhibitors|tnf-alpha inhibitors
471733|NCT01548768|ESCAPE|escape
471734|NCT01548768|Co-morbidities|co-morbidities
471735|NCT01548768|RHYTHM|rhythm
471736|NCT01548755|Home monitoring|home monitoring
471737|NCT01548755|cardiomessenger|cardiomessenger
471738|NCT01548755|ICD|icd
471739|NCT01548742|Meditation|meditation
471740|NCT01548729|Cystic Fibrosis|cystic fibrosis
471741|NCT01548729|Diabetes Related Cystic Fibrosis|diabetes related cystic fibrosis
471742|NCT01548729|Lung transplantation|lung transplantation
471743|NCT01548729|Pancreatic islets|pancreatic islets
471744|NCT01548716|Pruritis in hemodialysis patients|pruritis in hemodialysis patients
471745|NCT01548716|25-Vitamin D in chronic kidney disease|25-vitamin d in chronic kidney disease
471746|NCT01548703|metabotropic glutamate receptors 2 and 3|metabotropic glutamate receptors 2 and 3
471747|NCT01548703|antagonist|antagonist
471748|NCT01548703|mGluR|mglur
471749|NCT01548703|ketamine|ketamine
471750|NCT01548703|BDNF|bdnf
471751|NCT01548703|Depression|depression
471752|NCT01548703|Major Depressive Disorder|major depressive disorder
471753|NCT01548703|Treatment Resistant Depression|treatment resistant depression
471754|NCT01548703|Mood Disorder|mood disorder
471755|NCT01548703|Phase 1 safety, tolerability and pharmacokinetics study|phase 1 safety, tolerability and pharmacokinetics study
471756|NCT01548690|ornithine|ornithine
471757|NCT01548690|phenylacetate|phenylacetate
471758|NCT01548690|acetaminophen toxicity|acetaminophen toxicity
471759|NCT01548690|acute liver failure|acute liver failure
471760|NCT01548690|hepatitis B|hepatitis b
471761|NCT01548690|autoimmune hepatitis|autoimmune hepatitis
471762|NCT01548690|drug-induced liver injury|drug-induced liver injury
471763|NCT01548677|Circulating Tumour Cells|circulating tumour cells
471764|NCT01548677|HER2 negative primary breast cancer|her2 negative primary breast cancer
471765|NCT01548677|HER2 positive CTC|her2 positive ctc
471766|NCT01548677|Trastuzumab|trastuzumab
471767|NCT01548664|Total knee replacement|total knee replacement
471768|NCT01548664|Outpatient|outpatient
471769|NCT01548664|Randomized controlled trial|randomized controlled trial
471770|NCT01548664|Video games|video games
471771|NCT01548638|Tobacco|tobacco
471772|NCT01548638|Smoking|smoking
471773|NCT01548638|Galantamine|galantamine
471774|NCT01548625|risk of cardiovascular events|risk of cardiovascular events
471775|NCT01548612|Schizophrenia|schizophrenia
471776|NCT01548612|Nitric oxide|nitric oxide
471777|NCT01548612|Sodium nitroprusside|sodium nitroprusside
471778|NCT01548599|HIV|hiv
471779|NCT01548599|Malnutrition|malnutrition
471780|NCT01548599|Food Security|food security
471781|NCT01548599|Kenya|kenya
471782|NCT01548586|tDCS|tdcs
471783|NCT01548586|Diaphragm|diaphragm
471784|NCT01548586|Cortical Excitability|cortical excitability
471785|NCT01548586|MEPs|meps
471786|NCT01548586|TMS|tms
471787|NCT01548573|multiple myeloma|multiple myeloma
471788|NCT01548573|POEMS (Polyneuropathy, organomegaly, endocrinopathy, monoclonal gammopathy, and skin changes)|poems (polyneuropathy, organomegaly, endocrinopathy, monoclonal gammopathy, and skin changes)
471789|NCT01548573|amyloidosis|amyloidosis
471790|NCT01548573|bone marrow transplant|bone marrow transplant
471791|NCT01548573|autologous|autologous
471792|NCT01548560|HIV Infections|hiv infections
471793|NCT01548560|Anti-HIV agents|anti-hiv agents
471794|NCT01548560|HIV-1|hiv-1
471795|NCT01548547|intravenous line|intravenous line
471796|NCT01548547|simulation education|simulation education
471797|NCT01548534|Metastatic Breast Cancer|metastatic breast cancer
471798|NCT01548534|First-Line chemotherapy|first-line chemotherapy
471799|NCT01548534|Taxane or Anthracycline|taxane or anthracycline
471800|NCT01548534|DHA|dha
471801|NCT01548534|PUFA|pufa
471802|NCT01548534|Dietary supplementation|dietary supplementation
471803|NCT01548534|First-Line Taxane or Anthracycline based chemotherapy|first-line taxane or anthracycline based chemotherapy
471804|NCT01548521|Prader-Willi, neonates, poor suckling|prader-willi, neonates, poor suckling
471805|NCT01548508|Advanced Chronic Heart Failure, physical therapy, Exercise|advanced chronic heart failure, physical therapy, exercise
471807|NCT01548495|Autoantibodies|autoantibodies
471808|NCT01548495|Erythropoietin|erythropoietin
471809|NCT01548495|Autoantibodies in MDS patients treated with EPO|autoantibodies in mds patients treated with epo
471810|NCT01548469|Mild periodontitis|mild periodontitis
471811|NCT01548469|Bio Mineral toothpaste|bio mineral toothpaste
471812|NCT01548469|Geumjin Thermal Water|geumjin thermal water
471813|NCT01548456|femur fracture|femur fracture
471814|NCT01548456|internal fixation|internal fixation
471815|NCT01548456|intramedullary nailing|intramedullary nailing
471816|NCT01548443|Wound Healing|wound healing
471817|NCT01548443|hydrocolloid|hydrocolloid
471818|NCT01548443|Wound Dressing|wound dressing
471819|NCT01548443|Medifoam H|medifoam h
471820|NCT01548443|Duoderm THIN|duoderm thin
471821|NCT01548443|Mild Acute Trauma|mild acute trauma
471822|NCT01548417|Alcohol|alcohol
471823|NCT01548417|Relapse|relapse
471824|NCT01548378|HGF|hgf
471825|NCT01548378|Gene|gene
471826|NCT01548378|Critical Limb Ischemia|critical limb ischemia
471827|NCT01548365|Nursing Services|nursing services
471828|NCT01548365|Catheterization, Central Venous|catheterization, central venous
471829|NCT01548365|Catheters Indwelling|catheters indwelling
471830|NCT01548365|Catheterization, Peripheral|catheterization, peripheral
471831|NCT01548352|Syncope|syncope
471832|NCT01548352|Unconsciousness|unconsciousness
471833|NCT01548352|Syncope, vasovagal, neurally-mediated|syncope, vasovagal, neurally-mediated
471834|NCT01548352|Syncope, cardiogenic|syncope, cardiogenic
471835|NCT01548352|Cardiac arrhythmia|cardiac arrhythmia
471836|NCT01548352|Sudden cardiac death|sudden cardiac death
471837|NCT01548352|Syncopal episode|syncopal episode
471838|NCT01548326|Vaccination Failure|vaccination failure
471839|NCT01548326|Nonresponder|nonresponder
471840|NCT01548326|Hepatitis B virus|hepatitis b virus
471841|NCT01548326|Atorvastatin|atorvastatin
471842|NCT01548326|Immunization against viral Hepatitis|immunization against viral hepatitis
471843|NCT01548313|human milk|human milk
471844|NCT01548313|nutrition|nutrition
471845|NCT01548313|breastfed child|breastfed child
471846|NCT01548313|microbiota|microbiota
471847|NCT01548313|fatty acids|fatty acids
471848|NCT01548313|intestinal microbiota|intestinal microbiota
471849|NCT01548313|probiotics|probiotics
471850|NCT01548300|cardiometabolic disease|cardiometabolic disease
471851|NCT01548287|Mild Cognitive Impairment|mild cognitive impairment
471852|NCT01548287|Mild Alzheimer's disease|mild alzheimer's disease
471853|NCT01548287|Safety|safety
471854|NCT01548287|Tolerability|tolerability
471855|NCT01548274|endothelial progenitor cells|endothelial progenitor cells
471856|NCT01548261|obtain the oral mucosal tissue from healthy donors|obtain the oral mucosal tissue from healthy donors
471857|NCT01548222|type 2 diabetes|type 2 diabetes
471858|NCT01548222|continuous glucose|continuous glucose
471859|NCT01548222|basal insulin|basal insulin
471860|NCT01548196|nephrolithotomy|nephrolithotomy
471861|NCT01548170|Pharmacokinetic|pharmacokinetic
471862|NCT01548170|Sunitinib|sunitinib
471863|NCT01548170|Ketoconazol|ketoconazol
471864|NCT01548170|interaction, Phase I|interaction, phase i
471865|NCT01548157|HCP1007|hcp1007
471866|NCT01548157|Rosuvastatin|rosuvastatin
471867|NCT01548157|Omega-3|omega-3
471868|NCT01548144|Advanced Cancers|advanced cancers
471869|NCT01548144|Advanced Malignancies|advanced malignancies
471870|NCT01548144|Crizotinib|crizotinib
471871|NCT01548144|PF-02341066|pf-02341066
471872|NCT01548144|Pazopanib|pazopanib
471873|NCT01548144|Gw786034|gw786034
471874|NCT01548144|Pemetrexed|pemetrexed
471875|NCT01548144|LY231514|ly231514
471876|NCT01548144|Alimta|alimta
471877|NCT01548144|MTA|mta
471878|NCT01548144|Multitargeted Antifolate|multitargeted antifolate
471879|NCT01548144|NSC-698037|nsc-698037
471880|NCT01548131|fear of childbirth|fear of childbirth
471881|NCT01548131|delivery mode|delivery mode
471882|NCT01548131|delivery satisfaction|delivery satisfaction
471883|NCT01548118|Human papillomavirus|human papillomavirus
471884|NCT01548118|vaccine|vaccine
471885|NCT01548118|cervical infection|cervical infection
471886|NCT01548118|cervical cancer|cervical cancer
601970|NCT01008930|Arm|arm
471887|NCT01548105|Pelvic organ prolapse|pelvic organ prolapse
471888|NCT01548105|smoking and collagen metabolism|smoking and collagen metabolism
471889|NCT01548092|Recto-vaginal fistula|recto-vaginal fistula
471890|NCT01548092|Adipose Derived Stem Cells|adipose derived stem cells
471891|NCT01548079|ursodeoxycholic acid|ursodeoxycholic acid
471892|NCT01548079|fatty liver disease|fatty liver disease
471893|NCT01548079|morbid obesity|morbid obesity
471894|NCT01548079|bariatric surgery|bariatric surgery
471895|NCT01548079|NAFLD|nafld
471896|NCT01548053|Primary care|primary care
471897|NCT01548053|Dementia|dementia
471898|NCT01548053|Knowledge translation|knowledge translation
471899|NCT01548053|Quality of care|quality of care
471900|NCT01548053|Qualitative methods|qualitative methods
471901|NCT01548053|Alzheimer's disease|alzheimer's disease
471902|NCT01548040|NMES|nmes
471903|NCT01548040|Muscle|muscle
471904|NCT01548040|strength|strength
471905|NCT01548040|TKA|tka
471906|NCT01548040|Focus to show shorter muscle recovery after Knee operation|focus to show shorter muscle recovery after knee operation
471907|NCT01548027|TAP block|tap block
471908|NCT01548027|postoperative analgesia|postoperative analgesia
471909|NCT01548014|Crohn's disease|crohn's disease
471910|NCT01548014|VSL #3|vsl #3
471911|NCT01548014|infliximab|infliximab
471912|NCT01548001|Rheumatoid Arthritis|rheumatoid arthritis
471913|NCT01548001|Iguratimod|iguratimod
471914|NCT01548001|Methotrexate|methotrexate
471915|NCT01547988|Aging|aging
471917|NCT01547988|Balance Control|balance control
471918|NCT01547988|Voluntary Step Execution Test|voluntary step execution test
471919|NCT01547988|Dual-Task|dual-task
471920|NCT01547988|Self-reported function|self-reported function
471921|NCT01547975|surgical outcomes after corneal transplantation|surgical outcomes after corneal transplantation
471922|NCT01547975|Retrospective analysis|retrospective analysis
471923|NCT01547975|corneal transplantation|corneal transplantation
471924|NCT01547949|pain|pain
471925|NCT01547949|inflammation|inflammation
471926|NCT01547949|muscle damage|muscle damage
471927|NCT01547923|Colorectal Cancer|colorectal cancer
471928|NCT01547923|DihydroPyrimidine Dehydrogenase|dihydropyrimidine dehydrogenase
471929|NCT01547923|Lethal toxicity|lethal toxicity
471930|NCT01547923|Fluoropyrimidine|fluoropyrimidine
471931|NCT01547910|fatty liver|fatty liver
471932|NCT01547910|hepatitis|hepatitis
471933|NCT01547910|insulin resistance|insulin resistance
471934|NCT01547910|unsaturated fatty acids|unsaturated fatty acids
471935|NCT01547910|NAFLD, children|nafld, children
471936|NCT01547884|T Cells|t cells
471937|NCT01547884|Immune Responses|immune responses
471938|NCT01547884|Mycobacterial Antigens|mycobacterial antigens
471939|NCT01547884|Tissue-invasive Helminth Parasites|tissue-invasive helminth parasites
471940|NCT01547884|Cytokines|cytokines
471941|NCT01547871|Natural History Study|natural history study
471942|NCT01547871|Spinal Muscular Atrophy (SMA)|spinal muscular atrophy (sma)
471943|NCT01547871|Natural History|natural history
471944|NCT01547858|Hematotoxicity|hematotoxicity
471945|NCT01547858|Formaldehyde|formaldehyde
471946|NCT01547858|Cross-Sectional Study|cross-sectional study
471947|NCT01547858|Occupational Exposure|occupational exposure
471948|NCT01547845|Disparities|disparities
471949|NCT01547845|Patient Reported Outcomes|patient reported outcomes
471950|NCT01547845|Symptoms|symptoms
471951|NCT01547845|Symptom Surveillance|symptom surveillance
471952|NCT01547832|Cholesterol|cholesterol
471953|NCT01547832|Early Onset Parkinson's Disease|early onset parkinson's disease
471954|NCT01547832|Fat Metabolism|fat metabolism
471955|NCT01547832|Insulin Resistance|insulin resistance
471956|NCT01547832|PARK2 Mutations|park2 mutations
471957|NCT01547819|TBI|tbi
471958|NCT01547819|Magnetic Resonance Imaging (MRI)|magnetic resonance imaging (mri)
471959|NCT01547819|PTSD|ptsd
471960|NCT01547819|PET Imaging|pet imaging
471961|NCT01547819|11C-Flumazenil|11c-flumazenil
471962|NCT01547806|Autologous Hematopoietic Cell Transplantation|autologous hematopoietic cell transplantation
471963|NCT01547806|Plasma Cell Myeloma|plasma cell myeloma
471964|NCT01547806|Mobilization|mobilization
471965|NCT01547806|Apheresis|apheresis
471966|NCT01547806|Plerixafor|plerixafor
471967|NCT01547793|Hemolytic Severity|hemolytic severity
471968|NCT01547793|Erythrocyte|erythrocyte
471969|NCT01547793|Sickle Cell Disease|sickle cell disease
471970|NCT01547793|SD|sd
471971|NCT01547780|MRI|mri
471972|NCT01547780|Positron Emission Tomograhy (PET)|positron emission tomograhy (pet)
471973|NCT01547780|Inflammation|inflammation
471974|NCT01547780|Microglial Activation|microglial activation
471975|NCT01547780|Traumatic Brain Injury|traumatic brain injury
471976|NCT01547780|TBI|tbi
471977|NCT01547767|Metabolism|metabolism
471978|NCT01547767|Muscle|muscle
471979|NCT01547767|Mutation|mutation
471980|NCT01547767|ISCU Myopathy|iscu myopathy
471981|NCT01547767|Myopathy|myopathy
471982|NCT01547754|Neuroinflammation|neuroinflammation
471983|NCT01547754|HIV|hiv
471984|NCT01547754|Positron Emission Tomograhy (PET)|positron emission tomograhy (pet)
471985|NCT01547754|Mild Neurocognitive Disorder|mild neurocognitive disorder
471986|NCT01547754|P-Glycoprotein|p-glycoprotein
471987|NCT01547754|Mild Cognitive Disorder|mild cognitive disorder
471988|NCT01547754|Healthy Volunteer|healthy volunteer
471989|NCT01547754|HV|hv
471990|NCT01547741|estrogen receptor-negative breast cancer|estrogen receptor-negative breast cancer
471991|NCT01547741|estrogen receptor-positive breast cancer|estrogen receptor-positive breast cancer
471992|NCT01547741|HER2-negative breast cancer|her2-negative breast cancer
471993|NCT01547741|progesterone receptor-negative breast cancer|progesterone receptor-negative breast cancer
471994|NCT01547741|progesterone receptor-positive breast cancer|progesterone receptor-positive breast cancer
471995|NCT01547741|stage IA breast cancer|stage ia breast cancer
471996|NCT01547741|stage IB breast cancer|stage ib breast cancer
471997|NCT01547741|stage II breast cancer|stage ii breast cancer
471998|NCT01547741|stage IIIA breast cancer|stage iiia breast cancer
471999|NCT01547741|stage IIIC breast cancer|stage iiic breast cancer
472000|NCT01547728|antithrombin|antithrombin
472001|NCT01547728|Heparin Resistant|heparin resistant
472002|NCT01547728|Cardiac Surgery|cardiac surgery
472003|NCT01547715|Meningococcal,|meningococcal,
472004|NCT01547715|ACWY,|acwy,
472005|NCT01547715|bacterial meningitis,|bacterial meningitis,
472006|NCT01547715|conjugate vaccine,|conjugate vaccine,
472007|NCT01547715|healthy, children,|healthy, children,
472008|NCT01547715|adolescents,|adolescents,
472009|NCT01547715|adults,|adults,
472010|NCT01547715|India|india
472011|NCT01547702|ADHD|adhd
472012|NCT01547702|attention|attention
472013|NCT01547702|inattention|inattention
472014|NCT01547702|hyperactivity|hyperactivity
472015|NCT01547702|classroom intervention|classroom intervention
472016|NCT01547702|teacher education|teacher education
472017|NCT01547702|web-based intervention|web-based intervention
472018|NCT01547663|pain scale|pain scale
472019|NCT01547663|craniotomy|craniotomy
472020|NCT01547637|Obturator nerve block|obturator nerve block
472021|NCT01547637|Regional anesthesia|regional anesthesia
472022|NCT01547637|TURBT|turbt
472023|NCT01547624|Neck|neck
472024|NCT01547624|Spine|spine
472025|NCT01547624|Muscles|muscles
472026|NCT01547624|Activity|activity
472027|NCT01547624|Coordination|coordination
472028|NCT01547611|Rehabilitation|rehabilitation
472029|NCT01547611|Cervical Spine|cervical spine
472030|NCT01547611|Radiculopathy|radiculopathy
472031|NCT01547611|Disc|disc
472032|NCT01547611|Surgery|surgery
472033|NCT01547585|Cholesterol|cholesterol
472034|NCT01547585|Cardiovascular disease|cardiovascular disease
472035|NCT01547585|Soy|soy
472036|NCT01547585|Dose-response|dose-response
472037|NCT01547572|Video education|video education
472038|NCT01547572|Enhanced recovery|enhanced recovery
472039|NCT01547572|Reducing hospital stay|reducing hospital stay
472040|NCT01547572|Improving patient satisfaction|improving patient satisfaction
472041|NCT01547533|Chagas disease|chagas disease
472042|NCT01547533|lactation|lactation
472043|NCT01547533|breastmilk|breastmilk
472044|NCT01547533|postpartum period|postpartum period
472045|NCT01547533|infants|infants
472046|NCT01547533|pediatric clinical pharmacology|pediatric clinical pharmacology
472047|NCT01547533|developmental clinical pharmacology|developmental clinical pharmacology
472048|NCT01547533|parasitology|parasitology
472049|NCT01547533|trypanosoma cruzi|trypanosoma cruzi
472050|NCT01547520|meperidine|meperidine
472051|NCT01547520|esophagogastroduodenoscopy|esophagogastroduodenoscopy
472052|NCT01547520|unsedated|unsedated
472053|NCT01547520|minimal sedation|minimal sedation
472054|NCT01547507|hemodynamics|hemodynamics
472055|NCT01547507|respiratory|respiratory
472056|NCT01547494|Migraines|migraines
472057|NCT01547494|Diet, Vegetarian|diet, vegetarian
472058|NCT01547494|Diet, Fat-Restricted|diet, fat-restricted
472059|NCT01547494|Pain|pain
472060|NCT01547468|hip fracture|hip fracture
472061|NCT01547468|elderly|elderly
472062|NCT01547468|delirium|delirium
472063|NCT01547468|broken hip|broken hip
472064|NCT01547468|hip|hip
472065|NCT01547468|surgery|surgery
472066|NCT01547468|orthopedic|orthopedic
472067|NCT01547468|orthopedic surgery|orthopedic surgery
472068|NCT01547468|pain|pain
472069|NCT01547468|anesthesia|anesthesia
472070|NCT01547468|Ochsner Clinic|ochsner clinic
472071|NCT01547468|Ochsner Hospital|ochsner hospital
472072|NCT01547468|Leslie Thomas MD|leslie thomas md
472073|NCT01547468|New Orleans|new orleans
472074|NCT01547468|Louisiana|louisiana
472075|NCT01547455|Statin|statin
472076|NCT01547455|kidney function|kidney function
472077|NCT01547455|antiinflammatory effect|antiinflammatory effect
472078|NCT01547442|aphakia|aphakia
472079|NCT01547442|secondary intraocular lens|secondary intraocular lens
472080|NCT01547442|congenital cataract|congenital cataract
472081|NCT01547442|marfan syndrome|marfan syndrome
472082|NCT01547442|pediatric cataract|pediatric cataract
472083|NCT01547442|ectopia lentis|ectopia lentis
472084|NCT01547442|subluxated lens|subluxated lens
472085|NCT01547429|aphakia|aphakia
602217|NCT01008124|PC|pc
472086|NCT01547429|secondary intraocular lens|secondary intraocular lens
472087|NCT01547416|Diaphragmatic dysfunction|diaphragmatic dysfunction
472088|NCT01547416|General anesthesia|general anesthesia
472089|NCT01547416|Epidural Anesthesia|epidural anesthesia
472090|NCT01547403|Screening for Type 2 Diabetes|screening for type 2 diabetes
472091|NCT01547390|preeclampsia|preeclampsia
472092|NCT01547390|Aspirin|aspirin
472093|NCT01547377|atherosclerosis|atherosclerosis
472094|NCT01547377|zinc and selenium status|zinc and selenium status
472095|NCT01547377|rosuvastatin|rosuvastatin
472096|NCT01547377|oxidative stress biomarkers|oxidative stress biomarkers
472097|NCT01547377|inflammation biomarkers|inflammation biomarkers
472098|NCT01547364|Caudal|caudal
472099|NCT01547364|Epidural|epidural
472100|NCT01547364|Dextrose|dextrose
472101|NCT01547364|Analgesia|analgesia
472102|NCT01547364|TRVP1|trvp1
472103|NCT01547351|Relapse in multiple sclerosis|relapse in multiple sclerosis
472104|NCT01547351|Psychometric properties of the patient self-report questionnaire|psychometric properties of the patient self-report questionnaire
472105|NCT01547351|Evaluation of ARMS questionnaire|evaluation of arms questionnaire
472106|NCT01547338|Breast|breast
472107|NCT01547338|Reconstruction|reconstruction
472108|NCT01547299|prostate cancer|prostate cancer
472109|NCT01547299|prostatectomy|prostatectomy
472110|NCT01547299|neoadjuvant|neoadjuvant
472111|NCT01547286|Asthma|asthma
472112|NCT01547286|Allergen Challenge|allergen challenge
472113|NCT01547286|Cat allergen|cat allergen
472114|NCT01547286|Dust mite allergen|dust mite allergen
472115|NCT01547286|Airway Hyper-responsiveness|airway hyper-responsiveness
472213|NCT01546844|text messages|text messages
472116|NCT01547286|Positron Emission Tomography - Computed Tomography|positron emission tomography - computed tomography
472117|NCT01547286|Nitrogen isotopes|nitrogen isotopes
472118|NCT01547286|Blood flow|blood flow
472119|NCT01547247|colonoscopy|colonoscopy
472120|NCT01547247|cap-assisted colonoscopy|cap-assisted colonoscopy
472121|NCT01547247|water immersion colonoscopy|water immersion colonoscopy
472122|NCT01547234|Multiple Sclerosis|multiple sclerosis
472123|NCT01547234|ambulation|ambulation
472124|NCT01547234|manual function|manual function
472125|NCT01547234|Fampridine|fampridine
472126|NCT01547221|otomycosis|otomycosis
472127|NCT01547221|3% boric acid|3% boric acid
472128|NCT01547221|1% clotrimazole ear drop|1% clotrimazole ear drop
472129|NCT01547208|ICD shocks|icd shocks
472130|NCT01547208|Ventricular tachycardias ablation|ventricular tachycardias ablation
472131|NCT01547208|Timing of ablation|timing of ablation
472132|NCT01547208|Electrical storm|electrical storm
472133|NCT01547208|Arrhythmic storm|arrhythmic storm
472134|NCT01547195|fibromyalgia|fibromyalgia
472135|NCT01547195|swimming|swimming
472136|NCT01547169|memory|memory
472137|NCT01547169|intranasal insulin|intranasal insulin
472138|NCT01547169|Alzheimer's disease|alzheimer's disease
472139|NCT01547156|patient decision support|patient decision support
472140|NCT01547156|telemonitoring|telemonitoring
472141|NCT01547156|self-management|self-management
472142|NCT01547156|remote patient monitoring|remote patient monitoring
472143|NCT01547156|active assistance technology|active assistance technology
472144|NCT01547156|selfcare|selfcare
472145|NCT01547143|Secondary hemophagocytic lymphohistiocytosis of adults|secondary hemophagocytic lymphohistiocytosis of adults
472146|NCT01547130|Colonoscopy|colonoscopy
472147|NCT01547130|Yoga|yoga
472148|NCT01547130|Complementary and alternative medicine|complementary and alternative medicine
472149|NCT01547130|Bowel cleansing|bowel cleansing
472150|NCT01547130|Large bowel preparation|large bowel preparation
472151|NCT01547130|Cancer screening|cancer screening
472152|NCT01547130|Colorectal cancer|colorectal cancer
472153|NCT01547117|POTS|pots
472154|NCT01547117|Orthostatic Intolerance|orthostatic intolerance
472155|NCT01547117|Orthostatic Tachycardia|orthostatic tachycardia
472156|NCT01547091|Mesenchymal Stem Cells|mesenchymal stem cells
472157|NCT01547091|Rheumatoid Arthritis|rheumatoid arthritis
472158|NCT01547065|TEE and renal resistive index|tee and renal resistive index
472159|NCT01547052|DBT, child, emotion regulation, behavior problems|dbt, child, emotion regulation, behavior problems
472160|NCT01547039|Carotid endarterectomy|carotid endarterectomy
472161|NCT01547039|Transcranial doppler|transcranial doppler
472162|NCT01547039|Micro embolic signals|micro embolic signals
472163|NCT01547039|Platelets|platelets
472164|NCT01547039|Aspirin|aspirin
472165|NCT01547026|schizophrenia|schizophrenia
472166|NCT01547026|exercise|exercise
472167|NCT01547026|sport|sport
472168|NCT01547026|weight control|weight control
472169|NCT01547026|fitness|fitness
472170|NCT01547000|Tourette Syndrome|tourette syndrome
472171|NCT01547000|Tourette Disorder|tourette disorder
472172|NCT01547000|Tics|tics
472173|NCT01547000|Motor tics|motor tics
472174|NCT01547000|Vocal tics|vocal tics
472175|NCT01547000|Intuniv|intuniv
472176|NCT01547000|Guanfacine|guanfacine
472177|NCT01547000|Medication|medication
472178|NCT01547000|Drug|drug
472179|NCT01547000|Placebo|placebo
472180|NCT01547000|Child|child
472181|NCT01547000|Children|children
472182|NCT01547000|Adolescent|adolescent
472183|NCT01546987|adenocarcinoma of the prostate|adenocarcinoma of the prostate
472184|NCT01546987|stage I prostate cancer|stage i prostate cancer
472185|NCT01546987|stage IIA prostate cancer|stage iia prostate cancer
472186|NCT01546987|stage IIB prostate cancer|stage iib prostate cancer
472187|NCT01546987|stage III prostate cancer|stage iii prostate cancer
472188|NCT01546987|stage IV prostate cancer|stage iv prostate cancer
472189|NCT01546974|Mechanical Ventilation|mechanical ventilation
472190|NCT01546974|Humidification system|humidification system
472191|NCT01546974|Patients submitted to mechanical ventilation for at least 48 hours|patients submitted to mechanical ventilation for at least 48 hours
472192|NCT01546961|Chloroquine|chloroquine
472193|NCT01546961|Uncomplicated vivax malaria|uncomplicated vivax malaria
472194|NCT01546948|Methadone|methadone
472195|NCT01546948|Hydromorphone|hydromorphone
472196|NCT01546948|Hepatobiliary surgery|hepatobiliary surgery
472197|NCT01546948|Postoperative pain|postoperative pain
472198|NCT01546935|Influenza|influenza
472199|NCT01546935|Oseltamivir|oseltamivir
472200|NCT01546935|Lower tract respiratory infection|lower tract respiratory infection
472201|NCT01546922|Hydrocortisone|hydrocortisone
472202|NCT01546922|Cognition|cognition
472203|NCT01546922|Adrenal insufficiency|adrenal insufficiency
472204|NCT01546922|Quality of Life|quality of life
472205|NCT01546922|Common Somatic Complaints|common somatic complaints
472206|NCT01546922|Cardiovascular/Metabolic Profile|cardiovascular/metabolic profile
472207|NCT01546922|Somatosensation|somatosensation
472208|NCT01546883|Atrial fibrillation|atrial fibrillation
472209|NCT01546883|MRI|mri
472210|NCT01546857|orthopedic pain|orthopedic pain
472211|NCT01546844|SMS|sms
472212|NCT01546844|text|text
472214|NCT01546844|text messaging|text messaging
472215|NCT01546844|diabetes|diabetes
472216|NCT01546844|diabetes mellitus|diabetes mellitus
472217|NCT01546844|type II diabetes|type ii diabetes
472218|NCT01546844|type II diabetes mellitus|type ii diabetes mellitus
472219|NCT01546844|type 2 diabetes|type 2 diabetes
472220|NCT01546844|type 2 diabetes mellitus|type 2 diabetes mellitus
472221|NCT01546844|Beacon|beacon
472222|NCT01546818|HIV|hiv
472223|NCT01546818|Vaccine|vaccine
472224|NCT01546818|HIV-1 infections|hiv-1 infections
472225|NCT01546805|Blepharospasm|blepharospasm
472226|NCT01546805|Hemifacial spasm|hemifacial spasm
472227|NCT01546805|Botox|botox
472228|NCT01546805|Zinc|zinc
472229|NCT01546792|exercise|exercise
472230|NCT01546792|diet|diet
472231|NCT01546792|lifestyle|lifestyle
472232|NCT01546792|sleep apnoea|sleep apnoea
472233|NCT01546792|obesity|obesity
472234|NCT01546766|Diabetes|diabetes
472235|NCT01546766|Pupillary response|pupillary response
472236|NCT01546766|Retinal disorders|retinal disorders
472237|NCT01546766|Midperipheral ischemia|midperipheral ischemia
472238|NCT01546766|Fundus photography|fundus photography
472239|NCT01546766|Optical coherence tomography|optical coherence tomography
472240|NCT01546753|Walnut hypersensitivity|walnut hypersensitivity
472241|NCT01546753|Tree nut hypersensitivity|tree nut hypersensitivity
472242|NCT01546753|Oral immunotherapy|oral immunotherapy
472243|NCT01546753|Food allergy|food allergy
472244|NCT01546753|Walnut allergy|walnut allergy
472245|NCT01546753|tree nut allergy|tree nut allergy
472246|NCT01546740|Glaucoma, Compliance, Prevalence|glaucoma, compliance, prevalence
472247|NCT01546727|Preschoolers|preschoolers
472248|NCT01546727|Obesity|obesity
472249|NCT01546727|Behavioral Treatment|behavioral treatment
472250|NCT01546675|Amputation|amputation
472251|NCT01546675|Prosthesis Design|prosthesis design
472252|NCT01546675|Biomechanics|biomechanics
472253|NCT01546662|Rhinitis|rhinitis
472254|NCT01546636|Cerebral desaturation events|cerebral desaturation events
472255|NCT01546636|Cerebral oximetry|cerebral oximetry
472256|NCT01546636|Beach chair position|beach chair position
472257|NCT01546610|Rheumatoid foot|rheumatoid foot
472258|NCT01546610|foot pain|foot pain
472259|NCT01546610|insoles|insoles
472260|NCT01546610|foot function|foot function
472261|NCT01546610|electronic baropodometer|electronic baropodometer
472262|NCT01546610|plantar pressure|plantar pressure
472263|NCT01546610|gait analysis|gait analysis
472264|NCT01546597|Metformin|metformin
472265|NCT01546597|Ranolazine|ranolazine
472266|NCT01546597|Type 2 Diabetes Mellitus|type 2 diabetes mellitus
472267|NCT01546558|Metformin|metformin
472268|NCT01546558|Ranolazine|ranolazine
472269|NCT01546558|Type 2 Diabetes Mellitus|type 2 diabetes mellitus
472270|NCT01546532|Heart failure|heart failure
472271|NCT01546532|RLX030|rlx030
472272|NCT01546532|hemodynamics|hemodynamics
472273|NCT01546532|cardiovascular diseases|cardiovascular diseases
472274|NCT01546480|Chronic postoperative pain|chronic postoperative pain
472275|NCT01546480|Postcholecystectomy pain|postcholecystectomy pain
472276|NCT01546480|Inflammation|inflammation
472277|NCT01546480|Interleukines|interleukines
472278|NCT01546467|Schizophrenia|schizophrenia
472279|NCT01546467|Schizoaffective disorder|schizoaffective disorder
472280|NCT01546467|Psychosis|psychosis
472281|NCT01546467|Early phase|early phase
472282|NCT01546467|Cognitive remediation|cognitive remediation
472283|NCT01546467|Functional outcome|functional outcome
472284|NCT01546454|Premenopausal women|premenopausal women
472285|NCT01546454|coronary heart disease|coronary heart disease
472286|NCT01546454|menstrual cycle|menstrual cycle
472287|NCT01546454|lipids|lipids
472288|NCT01546441|primary care|primary care
472289|NCT01546441|aging|aging
472290|NCT01546441|interprofessional care|interprofessional care
472291|NCT01546441|multimorbidity|multimorbidity
472292|NCT01546428|c-MET|c-met
472293|NCT01546428|Advanced solid tumor|advanced solid tumor
472294|NCT01546415|Phase 4|phase 4
472295|NCT01546415|Desferasirox|desferasirox
472296|NCT01546415|Iron Overload|iron overload
472297|NCT01546415|Aplastic Anemia|aplastic anemia
472298|NCT01546389|Malaria, vaccine, PfSPZ, challenge|malaria, vaccine, pfspz, challenge
472299|NCT01546350|infertility, recurrent pregnancy loss, miscarriage|infertility, recurrent pregnancy loss, miscarriage
472300|NCT01546337|anemia|anemia
472301|NCT01546337|non-myeloid haemopathy|non-myeloid haemopathy
472302|NCT01546337|myelodysplastic syndrome|myelodysplastic syndrome
472303|NCT01546337|Erythropoiesis stimulating agents|erythropoiesis stimulating agents
472304|NCT01546337|predictive markers|predictive markers
472305|NCT01546324|Maternal Blood|maternal blood
472306|NCT01546324|PGD|pgd
472307|NCT01546324|PGS|pgs
472308|NCT01546324|Natera|natera
472309|NCT01546324|Gene Security Network|gene security network
472310|NCT01546324|Non-invasive prenatal diagnosis|non-invasive prenatal diagnosis
472311|NCT01546311|prosthetic socket|prosthetic socket
472312|NCT01546311|residual limb volume fluctuation|residual limb volume fluctuation
472313|NCT01546311|instantaneous bladder|instantaneous bladder
472314|NCT01546298|Contact Dermatitis|contact dermatitis
472315|NCT01546285|The focus of this study is to demonstrate that DINAMAP® SuperSTATTM NIBP algorithm has been implemented correctly without performance losses to the B40 monitor|the focus of this study is to demonstrate that dinamap® superstattm nibp algorithm has been implemented correctly without performance losses to the b40 monitor
472316|NCT01546272|Subcutaneous resorbable sutures|subcutaneous resorbable sutures
472317|NCT01546272|Tolerance / effectiveness of subcutaneous suture|tolerance / effectiveness of subcutaneous suture
472318|NCT01546272|Reduced operative time and anesthesia time|reduced operative time and anesthesia time
472319|NCT01546272|Medico-economic evaluation|medico-economic evaluation
472320|NCT01546272|Accidental exposure to blood|accidental exposure to blood
472321|NCT01546259|colonoscopy|colonoscopy
472322|NCT01546259|water|water
472323|NCT01546259|female|female
472324|NCT01546259|BMI|bmi
472325|NCT01546259|unsedated|unsedated
472326|NCT01546259|low BMI female patients|low bmi female patients
472327|NCT01546259|Intubation|intubation
472328|NCT01546246|colonoscopy|colonoscopy
472329|NCT01546246|water|water
472330|NCT01546246|incomplete|incomplete
472331|NCT01546246|failed|failed
472332|NCT01546246|unsedated|unsedated
472333|NCT01546233|Lung cancer|lung cancer
472334|NCT01546233|Chemotherapy|chemotherapy
472335|NCT01546233|Multidisciplinary self care programme|multidisciplinary self care programme
472336|NCT01546233|Fatigue|fatigue
472337|NCT01546220|colonoscopy|colonoscopy
472338|NCT01546220|elder patient|elder patient
472339|NCT01546220|water|water
472340|NCT01546220|unsedated|unsedated
472341|NCT01546207|ventricular tachycardia|ventricular tachycardia
472342|NCT01546207|catheter ablation|catheter ablation
472343|NCT01546207|VT|vt
472344|NCT01546194|Informed consent|informed consent
472345|NCT01546194|Perioperative period|perioperative period
472346|NCT01546194|Morning of surgery|morning of surgery
472347|NCT01546194|Anesthesiology|anesthesiology
472348|NCT01546181|photoreceptors|photoreceptors
472349|NCT01546181|retinal pigment epithelium|retinal pigment epithelium
472350|NCT01546181|adaptive optics|adaptive optics
472351|NCT01546168|Atrial Fibrillation ablation|atrial fibrillation ablation
472352|NCT01546168|Esophageal Deviation|esophageal deviation
472353|NCT01546168|AF|af
472354|NCT01546116|adefovir|adefovir
472355|NCT01546116|lamivudine|lamivudine
472356|NCT01546116|entecavir resistance|entecavir resistance
472357|NCT01546103|Vitamin D deficiency|vitamin d deficiency
472358|NCT01546090|Alprazolam|alprazolam
472359|NCT01546090|benzodiazepines|benzodiazepines
472360|NCT01546090|Inferior alveolar nerve block|inferior alveolar nerve block
472361|NCT01546090|irreversible pulpitis|irreversible pulpitis
472362|NCT01546090|local anesthesia|local anesthesia
472363|NCT01546064|Bile duct anastomosis|bile duct anastomosis
472364|NCT01546064|Biliary complications|biliary complications
472365|NCT01546051|metabotropic glutamate receptors 2 and 3|metabotropic glutamate receptors 2 and 3
472366|NCT01546051|antagonist|antagonist
472367|NCT01546051|mGluR|mglur
472368|NCT01546051|ketamine|ketamine
472369|NCT01546051|BDNF|bdnf
472370|NCT01546051|Depression|depression
472371|NCT01546051|Major Depressive Disorder|major depressive disorder
472372|NCT01546051|Mood Disorder|mood disorder
472373|NCT01546051|Treatment Resistant Depression|treatment resistant depression
472374|NCT01546051|Phase 1 safety, tolerability and pharmacokinetics study|phase 1 safety, tolerability and pharmacokinetics study
472375|NCT01546038|Hedgehog Inhibitor|hedgehog inhibitor
472376|NCT01546038|Acute Myeloid Leukemia|acute myeloid leukemia
472377|NCT01546038|Myelodysplastic syndrome|myelodysplastic syndrome
472378|NCT01546038|Intensive chemotherapy|intensive chemotherapy
472379|NCT01546038|LDAC|ldac
472380|NCT01546038|glasdegib|glasdegib
472381|NCT01545999|Transcranial Magnetic Stimulation (TMS)|transcranial magnetic stimulation (tms)
472382|NCT01545999|Dorsolateral Prefrontal Cortex (DLPFC)|dorsolateral prefrontal cortex (dlpfc)
472383|NCT01545999|Schizophrenia|schizophrenia
472384|NCT01545999|Working Memory|working memory
472385|NCT01545999|Paired Associative Stimulation (PAS)|paired associative stimulation (pas)
472386|NCT01545999|Electroencephalography (EEG)|electroencephalography (eeg)
472387|NCT01545999|Cognition|cognition
472388|NCT01545986|Joint Replacement|joint replacement
472389|NCT01545986|Exercise|exercise
472390|NCT01545986|Power training|power training
472391|NCT01545947|Neoplasms|neoplasms
472392|NCT01545947|Pulmonary|pulmonary
472393|NCT01545947|Lung Cancer|lung cancer
472394|NCT01545947|Cancer of the Lung|cancer of the lung
472395|NCT01545947|Stage IIIB Non-Small Cell Lung Cancer|stage iiib non-small cell lung cancer
472396|NCT01545947|IV Non-Small Cell Lung Cancer|iv non-small cell lung cancer
472397|NCT01545947|Non-Small Cell Lung Cancer|non-small cell lung cancer
472398|NCT01545934|Overweight|overweight
472399|NCT01545934|Obese|obese
472400|NCT01545934|Pregnancy|pregnancy
472401|NCT01545934|Weight Gain|weight gain
472402|NCT01545921|Quality Of Life|quality of life
472403|NCT01545921|Cancer|cancer
472404|NCT01545921|End of life|end of life
472405|NCT01545921|palliative setting|palliative setting
472406|NCT01545908|Fecal transplant|fecal transplant
472407|NCT01545908|induction of remission|induction of remission
472408|NCT01545908|active ulcerative colitis|active ulcerative colitis
472409|NCT01545882|prostate|prostate
472410|NCT01545882|hormone-resistant|hormone-resistant
472411|NCT01545882|degarelix|degarelix
472412|NCT01545882|firmagon|firmagon
472413|NCT01545882|anti-androgens|anti-androgens
472414|NCT01545882|total androgen blockade|total androgen blockade
472415|NCT01545882|injection|injection
472416|NCT01545869|carbon dioxide laser|carbon dioxide laser
472417|NCT01545869|fractional resurfacing|fractional resurfacing
472418|NCT01545869|freckles|freckles
472419|NCT01545869|melanosis|melanosis
472420|NCT01545856|Parkinson's Disease|parkinson's disease
472421|NCT01545856|cardiovascular events|cardiovascular events
472422|NCT01545856|Levodopa|levodopa
472423|NCT01545843|depression|depression
472424|NCT01545843|sleep|sleep
472425|NCT01545843|treatment|treatment
472426|NCT01545830|Metabolic syndrome|metabolic syndrome
472427|NCT01545830|Insulin resistance|insulin resistance
472428|NCT01545830|Vitamin D deficiency|vitamin d deficiency
472429|NCT01545817|Renal cell carcinoma (RCC), GW786034, Everolimus, Pazopanib, renal cancer, cancer, kidney cancer, hypernephroma, Grawitz tumor, renal adenocarcinoma.|renal cell carcinoma (rcc), gw786034, everolimus, pazopanib, renal cancer, cancer, kidney cancer, hypernephroma, grawitz tumor, renal adenocarcinoma.
472430|NCT01545804|Hepatocellular carcinoma|hepatocellular carcinoma
472431|NCT01545778|Substance abuse detection|substance abuse detection
472432|NCT01545778|Opioids abuse|opioids abuse
472433|NCT01545778|Tapentadol immediate-release (IR)|tapentadol immediate-release (ir)
472434|NCT01545778|Oxycodone immediate-release (IR)|oxycodone immediate-release (ir)
472435|NCT01545765|Healthy volunteers|healthy volunteers
472436|NCT01545752|elearning|elearning
472437|NCT01545752|CD-based education|cd-based education
472438|NCT01545739|Pacemaker therapy|pacemaker therapy
472439|NCT01545739|Cardiac resynchronisation therapy (CRT)|cardiac resynchronisation therapy (crt)
472440|NCT01545726|Asthma|asthma
472441|NCT01545726|Sputum eosinophilia|sputum eosinophilia
472442|NCT01545726|CRTH2 receptor|crth2 receptor
472443|NCT01545726|PGD2 antagonist|pgd2 antagonist
472444|NCT01545713|renal|renal
472445|NCT01545713|kidney|kidney
472446|NCT01545713|transplant|transplant
472447|NCT01545713|living donor|living donor
472448|NCT01545700|dexamethasone|dexamethasone
472449|NCT01545700|hyperglycemia|hyperglycemia
472450|NCT01545700|gynecologic surgery|gynecologic surgery
472451|NCT01545687|pain|pain
472452|NCT01545687|oral complications of radiation therapy|oral complications of radiation therapy
472453|NCT01545687|weight changes|weight changes
472454|NCT01545687|recurrent squamous cell carcinoma of the hypopharynx|recurrent squamous cell carcinoma of the hypopharynx
472455|NCT01545687|recurrent squamous cell carcinoma of the larynx|recurrent squamous cell carcinoma of the larynx
472456|NCT01545687|recurrent squamous cell carcinoma of the nasopharynx|recurrent squamous cell carcinoma of the nasopharynx
472457|NCT01545687|recurrent squamous cell carcinoma of the oropharynx|recurrent squamous cell carcinoma of the oropharynx
472458|NCT01545687|recurrent verrucous carcinoma of the larynx|recurrent verrucous carcinoma of the larynx
472459|NCT01545687|stage I squamous cell carcinoma of the hypopharynx|stage i squamous cell carcinoma of the hypopharynx
472460|NCT01545687|stage I squamous cell carcinoma of the larynx|stage i squamous cell carcinoma of the larynx
472461|NCT01545687|stage I squamous cell carcinoma of the nasopharynx|stage i squamous cell carcinoma of the nasopharynx
472462|NCT01545687|stage I squamous cell carcinoma of the oropharynx|stage i squamous cell carcinoma of the oropharynx
472463|NCT01545687|stage I verrucous carcinoma of the larynx|stage i verrucous carcinoma of the larynx
472464|NCT01545687|stage II squamous cell carcinoma of the hypopharynx|stage ii squamous cell carcinoma of the hypopharynx
472465|NCT01545687|stage II squamous cell carcinoma of the larynx|stage ii squamous cell carcinoma of the larynx
472466|NCT01545687|stage II squamous cell carcinoma of the nasopharynx|stage ii squamous cell carcinoma of the nasopharynx
472467|NCT01545687|stage II squamous cell carcinoma of the oropharynx|stage ii squamous cell carcinoma of the oropharynx
472468|NCT01545687|stage II verrucous carcinoma of the larynx|stage ii verrucous carcinoma of the larynx
472469|NCT01545687|stage III squamous cell carcinoma of the hypopharynx|stage iii squamous cell carcinoma of the hypopharynx
472470|NCT01545687|stage III squamous cell carcinoma of the larynx|stage iii squamous cell carcinoma of the larynx
472471|NCT01545687|stage III squamous cell carcinoma of the nasopharynx|stage iii squamous cell carcinoma of the nasopharynx
472472|NCT01545687|stage III squamous cell carcinoma of the oropharynx|stage iii squamous cell carcinoma of the oropharynx
472473|NCT01545687|stage III verrucous carcinoma of the larynx|stage iii verrucous carcinoma of the larynx
472474|NCT01545687|stage IV squamous cell carcinoma of the hypopharynx|stage iv squamous cell carcinoma of the hypopharynx
472475|NCT01545687|stage IV squamous cell carcinoma of the nasopharynx|stage iv squamous cell carcinoma of the nasopharynx
472476|NCT01545687|stage IVA squamous cell carcinoma of the larynx|stage iva squamous cell carcinoma of the larynx
472477|NCT01545687|stage IVA squamous cell carcinoma of the oropharynx|stage iva squamous cell carcinoma of the oropharynx
472478|NCT01545687|stage IVA verrucous carcinoma of the larynx|stage iva verrucous carcinoma of the larynx
472479|NCT01545687|stage IVB squamous cell carcinoma of the larynx|stage ivb squamous cell carcinoma of the larynx
472480|NCT01545687|stage IVB squamous cell carcinoma of the oropharynx|stage ivb squamous cell carcinoma of the oropharynx
472481|NCT01545687|stage IVB verrucous carcinoma of the larynx|stage ivb verrucous carcinoma of the larynx
472482|NCT01545687|stage IVC squamous cell carcinoma of the larynx|stage ivc squamous cell carcinoma of the larynx
472575|NCT01545466|Behavioral|behavioral
472483|NCT01545687|stage IVC squamous cell carcinoma of the oropharynx|stage ivc squamous cell carcinoma of the oropharynx
472484|NCT01545687|stage IVC verrucous carcinoma of the larynx|stage ivc verrucous carcinoma of the larynx
472485|NCT01545687|stage I squamous cell carcinoma of the lip and oral cavity|stage i squamous cell carcinoma of the lip and oral cavity
472486|NCT01545687|stage I verrucous carcinoma of the oral cavity|stage i verrucous carcinoma of the oral cavity
472487|NCT01545687|stage II squamous cell carcinoma of the lip and oral cavity|stage ii squamous cell carcinoma of the lip and oral cavity
472488|NCT01545687|stage II verrucous carcinoma of the oral cavity|stage ii verrucous carcinoma of the oral cavity
472489|NCT01545687|stage III squamous cell carcinoma of the lip and oral cavity|stage iii squamous cell carcinoma of the lip and oral cavity
472490|NCT01545687|stage III verrucous carcinoma of the oral cavity|stage iii verrucous carcinoma of the oral cavity
472491|NCT01545687|stage IVA squamous cell carcinoma of the lip and oral cavity|stage iva squamous cell carcinoma of the lip and oral cavity
472492|NCT01545687|stage IVA verrucous carcinoma of the oral cavity|stage iva verrucous carcinoma of the oral cavity
472493|NCT01545687|stage IVB squamous cell carcinoma of the lip and oral cavity|stage ivb squamous cell carcinoma of the lip and oral cavity
472494|NCT01545687|stage IVB verrucous carcinoma of the oral cavity|stage ivb verrucous carcinoma of the oral cavity
472495|NCT01545687|stage IVC squamous cell carcinoma of the lip and oral cavity|stage ivc squamous cell carcinoma of the lip and oral cavity
472496|NCT01545687|stage IVC verrucous carcinoma of the oral cavity|stage ivc verrucous carcinoma of the oral cavity
472497|NCT01545687|recurrent squamous cell carcinoma of the lip and oral cavity|recurrent squamous cell carcinoma of the lip and oral cavity
472498|NCT01545687|recurrent verrucous carcinoma of the oral cavity|recurrent verrucous carcinoma of the oral cavity
472499|NCT01545674|Aneuploidy|aneuploidy
472500|NCT01545674|Non-invasive Prenatal Diagnosis|non-invasive prenatal diagnosis
472501|NCT01545674|Prenatal Blood Test|prenatal blood test
472502|NCT01545674|Prenatal Aneuploidy Screening|prenatal aneuploidy screening
472503|NCT01545674|Trisomy 13|trisomy 13
472504|NCT01545674|Trisomy 18|trisomy 18
472505|NCT01545674|Trisomy 21|trisomy 21
472506|NCT01545674|Trisomy|trisomy
472507|NCT01545674|Down Syndrome|down syndrome
472508|NCT01545674|Turner Syndrome|turner syndrome
472509|NCT01545674|Edwards Syndrome|edwards syndrome
472510|NCT01545661|Tuberculosis|tuberculosis
472511|NCT01545661|diagnosis|diagnosis
472512|NCT01545661|sputum induction|sputum induction
472513|NCT01545661|primary care|primary care
472514|NCT01545648|breast|breast
472515|NCT01545648|cancer|cancer
472516|NCT01545648|early|early
472518|NCT01545648|disseminated|disseminated
472519|NCT01545648|tumor|tumor
472520|NCT01545648|cells|cells
472521|NCT01545635|Major trauma|major trauma
472522|NCT01545635|Injury Severity Score|injury severity score
472523|NCT01545635|ISS > 15|iss > 15
472524|NCT01545635|clinical signs|clinical signs
472525|NCT01545635|risk of blood loss|risk of blood loss
472526|NCT01545635|coagulopathy|coagulopathy
472527|NCT01545635|rotational thrombelastometry|rotational thrombelastometry
472528|NCT01545635|ROTEM|rotem
472529|NCT01545609|Text messaging|text messaging
472530|NCT01545609|birth control|birth control
472531|NCT01545609|adolescents|adolescents
472532|NCT01545596|Intraoperative Monitoring|intraoperative monitoring
472533|NCT01545596|Decision Support Systems|decision support systems
472534|NCT01545596|anesthesia outcomes|anesthesia outcomes
472535|NCT01545557|Volume loss|volume loss
472536|NCT01545544|B-Cell Non Hodgkin Lymphomas|b-cell non hodgkin lymphomas
472537|NCT01545544|Hepatitis C|hepatitis c
472538|NCT01545531|glomerular filtration rate|glomerular filtration rate
472539|NCT01545531|iohexol|iohexol
472540|NCT01545531|hematopoietic cell transplant|hematopoietic cell transplant
472541|NCT01545531|kidney function|kidney function
472542|NCT01545531|gold standard measure|gold standard measure
472543|NCT01545531|cystatin C.|cystatin c.
472544|NCT01545518|Refractory epilepsy|refractory epilepsy
472545|NCT01545518|Cryptogenic epilepsy|cryptogenic epilepsy
472546|NCT01545518|Autoimmune disorders|autoimmune disorders
472547|NCT01545518|IVIG|ivig
472548|NCT01545518|Immunomodulatory therapy|immunomodulatory therapy
472549|NCT01545518|Autoantibodies|autoantibodies
472550|NCT01545492|CHIPS|chips
472551|NCT01545492|famine|famine
472552|NCT01545492|reprogramming|reprogramming
472553|NCT01545492|developmental|developmental
472554|NCT01545492|blood|blood
472555|NCT01545492|pressure|pressure
472556|NCT01545492|randomised|randomised
472557|NCT01545492|randomized|randomized
472558|NCT01545492|hypertension|hypertension
472559|NCT01545492|anthropometry|anthropometry
472560|NCT01545492|measurement|measurement
472561|NCT01545492|genetics|genetics
472562|NCT01545492|epigenetics|epigenetics
472563|NCT01545492|methylation|methylation
472564|NCT01545492|cortisol|cortisol
472565|NCT01545492|stress|stress
472566|NCT01545492|DNA|dna
472567|NCT01545492|growth|growth
472568|NCT01545492|weight|weight
472569|NCT01545492|length|length
472570|NCT01545492|height|height
472571|NCT01545479|ECA|eca
472572|NCT01545479|BOLD-MRI|bold-mri
472573|NCT01545479|kidney|kidney
472574|NCT01545466|Migraines|migraines
472576|NCT01545466|Complementary and Alternative Medicine|complementary and alternative medicine
472577|NCT01545466|Mindfulness Meditation|mindfulness meditation
472578|NCT01545466|Mindfulness Based Stress Reduction|mindfulness based stress reduction
472579|NCT01545427|Scleroderma|scleroderma
472580|NCT01545427|Randomized controled trial|randomized controled trial
472581|NCT01545427|Pilot study|pilot study
472582|NCT01545427|Gleevec (imatinib)|gleevec (imatinib)
472583|NCT01545427|Biomarkers|biomarkers
472584|NCT01545414|Self-help treatment|self-help treatment
472585|NCT01545414|Internet treatment|internet treatment
472586|NCT01545414|Cognitive Behavioral Therapy|cognitive behavioral therapy
472587|NCT01545414|Internet-based Cognitive Behavioral Therapy|internet-based cognitive behavioral therapy
472588|NCT01545401|chronic disease management|chronic disease management
472589|NCT01545401|Chronic Care Model|chronic care model
472590|NCT01545401|multifaceted intervention|multifaceted intervention
472591|NCT01545401|primary care|primary care
472592|NCT01545401|type 2 diabetes mellitus|type 2 diabetes mellitus
472593|NCT01545401|hypertension|hypertension
472594|NCT01545375|nasopharyngeal carriage|nasopharyngeal carriage
472595|NCT01545375|safety|safety
472596|NCT01545375|immunogenicity|immunogenicity
472597|NCT01545375|US|us
472598|NCT01545375|Pneumococcal vaccine|pneumococcal vaccine
472599|NCT01545375|efficacy|efficacy
472600|NCT01545375|Streptococcus pneumoniae|streptococcus pneumoniae
472601|NCT01545375|infants|infants
472602|NCT01545349|LGG|lgg
472603|NCT01545349|Immune response|immune response
472604|NCT01545349|Influenza vaccine|influenza vaccine
472605|NCT01545349|Elderly|elderly
472606|NCT01545349|Healthy|healthy
472607|NCT01545349|Microbiome|microbiome
472608|NCT01545323|Netherton syndrome|netherton syndrome
472609|NCT01545323|Gene therapy|gene therapy
472610|NCT01545323|SPINK5|spink5
472611|NCT01545297|dexmedetomidine|dexmedetomidine
472612|NCT01545297|conscious sedation|conscious sedation
472613|NCT01545297|awake craniotomy|awake craniotomy
472614|NCT01545297|brain mapping|brain mapping
472615|NCT01545284|chronic hand dermatitis|chronic hand dermatitis
472616|NCT01545284|acitretin|acitretin
472617|NCT01545284|PGA|pga
472618|NCT01545271|Xenon|xenon
472619|NCT01545271|Hypothermia|hypothermia
472620|NCT01545271|Hypoxic Ischemic Encephalopathy|hypoxic ischemic encephalopathy
472621|NCT01545271|Newborn|newborn
472622|NCT01545271|Term|term
472623|NCT01545271|Neuroprotection|neuroprotection
472624|NCT01545271|Cooling|cooling
472625|NCT01545271|HIE|hie
472626|NCT01545245|atopic asthma|atopic asthma
472627|NCT01545245|recurrent wheezing|recurrent wheezing
472628|NCT01545245|preterm infants|preterm infants
472629|NCT01545245|palivizumab|palivizumab
472630|NCT01545245|respiratory syncytial virus|respiratory syncytial virus
472631|NCT01545245|RSV|rsv
472632|NCT01545232|Massive Transfusion|massive transfusion
472633|NCT01545232|Trauma|trauma
472634|NCT01545232|Coagulopathy|coagulopathy
472635|NCT01545232|Trauma Induced Coagulopathy|trauma induced coagulopathy
472636|NCT01545232|Plasma|plasma
472637|NCT01545232|Platelets|platelets
472638|NCT01545232|Red Blood Cells|red blood cells
472639|NCT01545232|Mortality|mortality
472640|NCT01545232|Wounds and Injuries|wounds and injuries
472641|NCT01545232|Shock, Hemorrhagic|shock, hemorrhagic
472642|NCT01545232|Shock|shock
472643|NCT01545232|Pathologic Processes|pathologic processes
472644|NCT01545232|Hemorrhage|hemorrhage
472645|NCT01545232|Hemostatics|hemostatics
472646|NCT01545232|Coagulation|coagulation
472647|NCT01545232|Transfusion-related acute lung injury (TRALI)|transfusion-related acute lung injury (trali)
472648|NCT01545232|Inflammation|inflammation
472649|NCT01545193|Elderly|elderly
472650|NCT01545193|Residual neuromuscular blockade|residual neuromuscular blockade
472651|NCT01545180|Observatory|observatory
472652|NCT01545180|Heart failure|heart failure
472653|NCT01545180|Post-capillary pulmonary hypertension|post-capillary pulmonary hypertension
472654|NCT01545180|HTPcap|htpcap
472655|NCT01545167|African Americans|african americans
472656|NCT01545167|pancreatitis|pancreatitis
472657|NCT01545167|controls|controls
472658|NCT01545141|metastatic|metastatic
472659|NCT01545141|recurrent|recurrent
472660|NCT01545141|peritoneal metastasis|peritoneal metastasis
472661|NCT01545141|cytoreductive surgery|cytoreductive surgery
472662|NCT01545141|hyperthermic intraperitoneal chemoperfusion|hyperthermic intraperitoneal chemoperfusion
472663|NCT01545141|HIPEC|hipec
472664|NCT01545141|hepatic metastasis|hepatic metastasis
472665|NCT01545141|extrahepatic metastasis|extrahepatic metastasis
472666|NCT01545141|vaccine|vaccine
472667|NCT01545128|COPD|copd
472668|NCT01545128|Pulmonary rehabilitation|pulmonary rehabilitation
472669|NCT01545115|Children|children
472670|NCT01545115|Immunity|immunity
472671|NCT01545115|Sub-Saharan|sub-saharan
472672|NCT01545115|Pertussis|pertussis
472673|NCT01545115|Malaria|malaria
472674|NCT01545115|Nutrition|nutrition
472675|NCT01545115|antibodies|antibodies
472676|NCT01545011|Inspiratory muscle training|inspiratory muscle training
472677|NCT01545011|COPD|copd
472678|NCT01545011|Conventional respiratory rehabilitation|conventional respiratory rehabilitation
472679|NCT01545011|Dyspnea scale|dyspnea scale
472680|NCT01544985|pediatrics|pediatrics
472681|NCT01544985|emergency medicine|emergency medicine
472682|NCT01544985|pain|pain
472683|NCT01544985|bladder catheterization|bladder catheterization
472684|NCT01544972|Patent Ductus Arteriosus|patent ductus arteriosus
472685|NCT01544972|Paracetamol|paracetamol
472686|NCT01544972|Ibuprofen|ibuprofen
472687|NCT01544972|Serum levels|serum levels
472688|NCT01544972|Preterm infant|preterm infant
472689|NCT01544959|Narcotic|narcotic
472690|NCT01544959|Opioid|opioid
472691|NCT01544959|betablocking drug|betablocking drug
472692|NCT01544959|postoperative pain|postoperative pain
472693|NCT01544959|postoperative nausea and vomiting|postoperative nausea and vomiting
472694|NCT01544959|breast cancer|breast cancer
472695|NCT01544959|hyperalgesia|hyperalgesia
472696|NCT01544959|cancer recurrence|cancer recurrence
472697|NCT01544959|anesthesia|anesthesia
472698|NCT01544959|mastectomy|mastectomy
472699|NCT01544959|chronic postsurgical pain syndrome|chronic postsurgical pain syndrome
472700|NCT01544959|acute postoperative pain|acute postoperative pain
472701|NCT01544959|postmastectomy pain syndrome|postmastectomy pain syndrome
472702|NCT01544959|pain|pain
472703|NCT01544959|ambulatory surgery|ambulatory surgery
472704|NCT01544946|pediatrics|pediatrics
472705|NCT01544946|emergency medicine|emergency medicine
472706|NCT01544946|pain|pain
472707|NCT01544946|nasopharyngeal aspiration|nasopharyngeal aspiration
472708|NCT01544933|spinal fractures|spinal fractures
472709|NCT01544933|Thoracic vertebrae|thoracic vertebrae
472710|NCT01544933|spinal canal|spinal canal
472711|NCT01544933|kyphosis|kyphosis
472712|NCT01544907|Drug Eluting Balloon|drug eluting balloon
472713|NCT01544907|Arteriovenous fistula or graft stenosis|arteriovenous fistula or graft stenosis
472714|NCT01544894|Postmenopausal osteoporosis|postmenopausal osteoporosis
472715|NCT01544894|Compliance|compliance
472716|NCT01544894|Bone mineral density|bone mineral density
472717|NCT01544894|Bonemarkers|bonemarkers
472718|NCT01544881|Pharmacokinetics|pharmacokinetics
472719|NCT01544881|Pharmacodynamics|pharmacodynamics
472720|NCT01544881|Hyperglycemia|hyperglycemia
472721|NCT01544881|Insulin|insulin
472722|NCT01544868|Total Energy Expenditure|total energy expenditure
472723|NCT01544868|Protein Balance|protein balance
472724|NCT01544868|Burns|burns
472725|NCT01544855|Health young participants|health young participants
472726|NCT01544842|Oral lichen planus|oral lichen planus
472727|NCT01544842|Tacrolimus ointment|tacrolimus ointment
472728|NCT01544842|Triamcinolone paste|triamcinolone paste
472729|NCT01544829|theobromine|theobromine
472730|NCT01544829|heart rate|heart rate
472731|NCT01544829|blood lipids|blood lipids
472732|NCT01544803|Randomized Controlled Trial|randomized controlled trial
472733|NCT01544803|Alcohol|alcohol
472734|NCT01544803|Internet|internet
472735|NCT01544803|Screening|screening
472736|NCT01544803|Brief intervention|brief intervention
472737|NCT01544803|Personalized feedback|personalized feedback
472738|NCT01544790|Esophageal carcinoma|esophageal carcinoma
472739|NCT01544790|Esophageal cancer|esophageal cancer
472740|NCT01544790|Robotic surgery|robotic surgery
472741|NCT01544790|Esophagectomy|esophagectomy
472742|NCT01544790|Minimally invasive|minimally invasive
472743|NCT01544777|Aphakia|aphakia
472744|NCT01544777|Cataract|cataract
472745|NCT01544764|Diphtheria-Tetanus-Pertussis Vaccine|diphtheria-tetanus-pertussis vaccine
472746|NCT01544764|Measles-Mumps-Rubella Vaccine|measles-mumps-rubella vaccine
472747|NCT01544764|Meningococcal Vaccines|meningococcal vaccines
472748|NCT01544764|Hepatitis B Vaccines|hepatitis b vaccines
472749|NCT01544764|Chickenpox Vaccine|chickenpox vaccine
472750|NCT01544764|Papillomavirus Vaccines|papillomavirus vaccines
472751|NCT01544751|NAFLD|nafld
472752|NCT01544751|metformin|metformin
472753|NCT01544751|atorvastatin|atorvastatin
472754|NCT01544751|metabolic syndrome|metabolic syndrome
472755|NCT01544738|Parkinson Disease|parkinson disease
472756|NCT01544738|sensory stimulation|sensory stimulation
472757|NCT01544738|Bradykinesia|bradykinesia
472758|NCT01544725|Procedural sedation|procedural sedation
472759|NCT01544725|Ketamine-propofol|ketamine-propofol
472760|NCT01544725|Ketamine|ketamine
472761|NCT01544712|osteonecrosis|osteonecrosis
472762|NCT01544712|cell-based therapy|cell-based therapy
472763|NCT01544712|bone marrow|bone marrow
472764|NCT01544712|mesenchymal stem cell|mesenchymal stem cell
472766|NCT01544712|core decompression|core decompression
472767|NCT01544699|stroke|stroke
472768|NCT01544686|neutropenia|neutropenia
472769|NCT01544686|cancer|cancer
472770|NCT01544686|fever|fever
472771|NCT01544686|central venous catheter|central venous catheter
472772|NCT01544686|infection|infection
472773|NCT01544660|spine and hip scan|spine and hip scan
472774|NCT01544660|BMD|bmd
472775|NCT01544647|Knee osteoarthritis|knee osteoarthritis
472776|NCT01544647|spa therapy|spa therapy
472777|NCT01544647|spa modalities|spa modalities
472778|NCT01544634|Asthma|asthma
472779|NCT01544634|Propranolol|propranolol
472780|NCT01544634|Inhaled corticosteroids|inhaled corticosteroids
472781|NCT01544634|Steroid sparing agent|steroid sparing agent
472782|NCT01544634|Airway hyper-responsiveness|airway hyper-responsiveness
472783|NCT01544621|Real life smoking cessation. NON-drug NON-intervention study|real life smoking cessation. non-drug non-intervention study
472784|NCT01544608|Acute psychotic episode of Schizophrenia|acute psychotic episode of schizophrenia
472908|NCT01544088|PTSD|ptsd
472785|NCT01544595|Psoriasis, inflammatory skin disease|psoriasis, inflammatory skin disease
472786|NCT01544595|scaly patches|scaly patches
472787|NCT01544595|secukinumab (AIN457)|secukinumab (ain457)
472788|NCT01544595|Psoriasis Area and Severity Index (PASI)|psoriasis area and severity index (pasi)
472789|NCT01544595|Investigator Global Assessment (IGA) mod 2011|investigator global assessment (iga) mod 2011
472790|NCT01544582|Pegylated Interferon|pegylated interferon
472791|NCT01544582|boceprevir|boceprevir
472792|NCT01544582|telaprevir|telaprevir
472793|NCT01544569|rhabdoid tumor of the kidney|rhabdoid tumor of the kidney
472794|NCT01544556|abdominoplasty|abdominoplasty
472795|NCT01544543|COPD|copd
472796|NCT01544530|Brain-death|brain-death
472797|NCT01544530|organ donation|organ donation
472798|NCT01544517|Helicobacter pylori|helicobacter pylori
472799|NCT01544517|Concomitant therapy|concomitant therapy
472800|NCT01544517|Sequential therapy|sequential therapy
472801|NCT01544517|levofloxacin|levofloxacin
472802|NCT01544504|Radiodermatitis|radiodermatitis
472803|NCT01544504|Prevention|prevention
472804|NCT01544504|Radiotherapy|radiotherapy
472805|NCT01544504|Breast|breast
472806|NCT01544504|Radiation Dermatitis|radiation dermatitis
472807|NCT01544491|Paediatric kidney transplantation|paediatric kidney transplantation
472808|NCT01544491|Early MMF to everolimus conversion|early mmf to everolimus conversion
472809|NCT01544491|Composite efficacy (biopsy-proven acute rejection, graft loss or death)|composite efficacy (biopsy-proven acute rejection, graft loss or death)
472810|NCT01544491|Renal function|renal function
472811|NCT01544465|Parkinson's disease|parkinson's disease
472812|NCT01544465|Sleep Quality|sleep quality
472813|NCT01544465|Daytime sleepiness|daytime sleepiness
472814|NCT01544465|physical therapy|physical therapy
472815|NCT01544465|exercise|exercise
472816|NCT01544452|MR|mr
472817|NCT01544452|CT|ct
472818|NCT01544452|ultrasonography|ultrasonography
472819|NCT01544452|MR colonography|mr colonography
472820|NCT01544452|MR rectum|mr rectum
472821|NCT01544452|MR liver|mr liver
472822|NCT01544439|Temporomandibular joint disorders|temporomandibular joint disorders
472823|NCT01544439|Stress psychological|stress psychological
472824|NCT01544439|Depression|depression
472825|NCT01544439|Quality of Life|quality of life
472826|NCT01544426|Office hysteroscopy,|office hysteroscopy,
472827|NCT01544426|intrauterine insemination|intrauterine insemination
472828|NCT01544426|endometrial scrap|endometrial scrap
472829|NCT01544413|laparoscopic sentinel lymph node biopsy|laparoscopic sentinel lymph node biopsy
472830|NCT01544413|quality control study|quality control study
472831|NCT01544413|early gastric cancer|early gastric cancer
472832|NCT01544400|reverse anorexia,|reverse anorexia,
472833|NCT01544400|anorexia athletics|anorexia athletics
472834|NCT01544387|Preterm Premature Rupture Of Membranes|preterm premature rupture of membranes
472835|NCT01544387|PPROM|pprom
472836|NCT01544387|Pregnancy|pregnancy
472837|NCT01544387|Bed rest.|bed rest.
472838|NCT01544374|Breast Cancer|breast cancer
472839|NCT01544374|Treatment Disparities|treatment disparities
472840|NCT01544374|Tracking and Feedback|tracking and feedback
472841|NCT01544374|Registry|registry
472842|NCT01544374|Cancer Therapy Disparities|cancer therapy disparities
472843|NCT01544374|Adjuvant Treatment|adjuvant treatment
472844|NCT01544374|Racial Disparities|racial disparities
472845|NCT01544374|Underuse of Adjuvant Treatment|underuse of adjuvant treatment
472846|NCT01544361|Healthy subjects|healthy subjects
472847|NCT01544361|MEDI7814|medi7814
472848|NCT01544361|FTiH|ftih
472849|NCT01544348|Allergic|allergic
472850|NCT01544348|Atopic Dermatitis|atopic dermatitis
472851|NCT01544348|MEDI4212|medi4212
472852|NCT01544322|solid tumors|solid tumors
472853|NCT01544322|recurrent|recurrent
472854|NCT01544322|advanced|advanced
472855|NCT01544322|metastatic|metastatic
472856|NCT01544322|refractory|refractory
472857|NCT01544283|Shoulder Pain|shoulder pain
472858|NCT01544283|Shoulder Impingement Syndrome|shoulder impingement syndrome
472859|NCT01544270|milk protein|milk protein
472860|NCT01544270|probiotics|probiotics
472861|NCT01544270|stress|stress
472862|NCT01544270|cortisol|cortisol
472863|NCT01544270|heart beat|heart beat
472864|NCT01544257|Osteopathic manipulative treatment|osteopathic manipulative treatment
472865|NCT01544257|alternative medicine|alternative medicine
472866|NCT01544257|complementary medicine|complementary medicine
472867|NCT01544257|neonatology|neonatology
472868|NCT01544257|neonatal care|neonatal care
472869|NCT01544257|prematurity|prematurity
472870|NCT01544257|allied health care|allied health care
472871|NCT01544244|comparison of physical therapy strategies|comparison of physical therapy strategies
472872|NCT01544231|Neutrophil Gelatinase Associated Lipocalin|neutrophil gelatinase associated lipocalin
472873|NCT01544231|predicting acute kidney failure|predicting acute kidney failure
472874|NCT01544231|emergency room|emergency room
472875|NCT01544218|Alcohol related disorders|alcohol related disorders
472876|NCT01544192|Antioxidant|antioxidant
472877|NCT01544192|α−tocopherol|α−tocopherol
472878|NCT01544192|Vitamin E|vitamin e
472879|NCT01544192|Gingko Biloba|gingko biloba
472880|NCT01544192|Glaucoma|glaucoma
472881|NCT01544192|Neuroprotection|neuroprotection
472882|NCT01544192|Retina|retina
472883|NCT01544179|Non Small Cell Lung Cancer|non small cell lung cancer
472884|NCT01544179|Gefitinib|gefitinib
472885|NCT01544179|Pemetrexed|pemetrexed
472886|NCT01544179|Treatment Beyond Progression|treatment beyond progression
472887|NCT01544166|Gadolinium, Pediatrics, MRI, contrast|gadolinium, pediatrics, mri, contrast
472888|NCT01544153|Web based behavioral intervention|web based behavioral intervention
472889|NCT01544153|Adherence|adherence
472890|NCT01544153|Smoking cessation|smoking cessation
472891|NCT01544153|Social network|social network
472892|NCT01544153|Nicotine replacement therapy|nicotine replacement therapy
472893|NCT01544153|Social support|social support
472894|NCT01544140|Phase 1|phase 1
472895|NCT01544140|healthy volunteers|healthy volunteers
472896|NCT01544140|pharmacokinetics|pharmacokinetics
472897|NCT01544140|vandetanib|vandetanib
472898|NCT01544140|midazolam|midazolam
472899|NCT01544127|Veterans|veterans
472900|NCT01544127|Motivational Interviewing|motivational interviewing
472901|NCT01544127|Inpatients|inpatients
472902|NCT01544127|Suicide, Attempted|suicide, attempted
472903|NCT01544101|Rheumatoid Arthritis|rheumatoid arthritis
472904|NCT01544101|Diet, Vegetarian|diet, vegetarian
472905|NCT01544101|Diet, Fat-Restricted|diet, fat-restricted
472906|NCT01544101|Pain|pain
472907|NCT01544088|randomized controlled trial|randomized controlled trial
472909|NCT01544088|cognitive behavioral treatment|cognitive behavioral treatment
472910|NCT01544088|group treatment|group treatment
472911|NCT01544062|Cardiac surgery|cardiac surgery
472912|NCT01544062|Acute Pain|acute pain
472913|NCT01544062|Wound Hyperalgesia|wound hyperalgesia
472914|NCT01544062|Intravenous Acetaminophen|intravenous acetaminophen
472915|NCT01544062|Patient Satisfaction|patient satisfaction
472916|NCT01544049|fallopian tube removal|fallopian tube removal
472917|NCT01544049|salpingectomy|salpingectomy
472918|NCT01544049|ovarian cancer prevention|ovarian cancer prevention
472919|NCT01544036|AKI|aki
472920|NCT01544036|contrast nephropathy|contrast nephropathy
472921|NCT01544036|renal blood flow|renal blood flow
472922|NCT01544023|breast reconstruction|breast reconstruction
472923|NCT01544023|mesh|mesh
472924|NCT01544023|implant reconstruction|implant reconstruction
472925|NCT01544023|acellular dermal matrix|acellular dermal matrix
472926|NCT01544023|titanized polypropylene mesh|titanized polypropylene mesh
472927|NCT01544023|TiLOOP Bra|tiloop bra
472928|NCT01544023|TiLOOP|tiloop
472929|NCT01544023|implant based breast reconstruction|implant based breast reconstruction
472930|NCT01544010|Transtheoretical Model|transtheoretical model
472931|NCT01544010|Tailored Print Intervention|tailored print intervention
472932|NCT01544010|Population-based|population-based
472933|NCT01544010|Behavioral Intervention|behavioral intervention
472934|NCT01543984|health care workers|health care workers
472935|NCT01543984|tailored physical activity|tailored physical activity
472936|NCT01543984|prevention|prevention
472937|NCT01543984|spine|spine
472938|NCT01543984|upper body|upper body
472939|NCT01543984|pain related to Spine or Upper body|pain related to spine or upper body
472940|NCT01543971|Peripheral blood stem cell mobilization|peripheral blood stem cell mobilization
472941|NCT01543971|CD34+ count|cd34+ count
472942|NCT01543945|Postoperative Nausea and Vomiting|postoperative nausea and vomiting
472943|NCT01543945|Ambulatory|ambulatory
472944|NCT01543945|Gynecologic laparoscopy|gynecologic laparoscopy
472945|NCT01543945|Incidence of postoperative nausea and vomiting.|incidence of postoperative nausea and vomiting.
472946|NCT01543932|antiplatelet effect|antiplatelet effect
472947|NCT01543932|prasugrel|prasugrel
472948|NCT01543932|clopidogrel|clopidogrel
472949|NCT01543932|stable angina|stable angina
472950|NCT01543893|neck pain|neck pain
472951|NCT01543893|shoulder pain|shoulder pain
472952|NCT01543893|resistance training|resistance training
472953|NCT01543854|Heart failure|heart failure
472954|NCT01543854|RLX030|rlx030
472955|NCT01543854|Hemodynamics|hemodynamics
472956|NCT01543854|Cardiovascular Diseases|cardiovascular diseases
472957|NCT01543841|advanced cancer|advanced cancer
472958|NCT01543841|healthy|healthy
472959|NCT01543841|blood sample|blood sample
472960|NCT01543841|TEM|tem
472961|NCT01543841|TIE-2 expressing monocytes|tie-2 expressing monocytes
472962|NCT01543841|ANG1|ang1
472963|NCT01543841|ANG2|ang2
472964|NCT01543828|COPD|copd
472965|NCT01543828|Indacatarol|indacatarol
472966|NCT01543828|placebo|placebo
472967|NCT01543828|crossover|crossover
472968|NCT01543828|patient perception|patient perception
472969|NCT01543815|Psychological Distress|psychological distress
472970|NCT01543815|Depression|depression
472971|NCT01543815|Anxiety|anxiety
472972|NCT01543815|Well-Being Therapy|well-being therapy
472973|NCT01543815|Heart Failure|heart failure
472974|NCT01543815|Quality of Life|quality of life
472975|NCT01543815|Adherence|adherence
472976|NCT01543802|soft-tissue sarcoma|soft-tissue sarcoma
472977|NCT01543802|pazopanib|pazopanib
472978|NCT01543802|antiangiogenetic treatment|antiangiogenetic treatment
472979|NCT01543802|endothelial progenitor cells|endothelial progenitor cells
472980|NCT01543802|preoperative therapy|preoperative therapy
472981|NCT01543789|Umbilical Hernia|umbilical hernia
472982|NCT01543763|metastatic|metastatic
472983|NCT01543763|solid|solid
472984|NCT01543763|sarcoma|sarcoma
472985|NCT01543763|progression|progression
472986|NCT01543750|episodic ataxia|episodic ataxia
472987|NCT01543750|CACNA1A mutations|cacna1a mutations
472988|NCT01543724|Lithium|lithium
472989|NCT01543724|Bipolar disorder|bipolar disorder
472990|NCT01543724|Multimodal Brain Imaging|multimodal brain imaging
472991|NCT01543711|Breast cancer|breast cancer
472992|NCT01543711|persistent pain|persistent pain
472993|NCT01543711|neuropathic pain|neuropathic pain
472994|NCT01543711|lymphedema|lymphedema
472995|NCT01543698|Advanced solid tumor,|advanced solid tumor,
472996|NCT01543698|BRAF V600 mutation|braf v600 mutation
472997|NCT01543672|lung|lung
472998|NCT01543672|SBRT|sbrt
472999|NCT01543672|MLD|mld
473000|NCT01543672|toxicity|toxicity
473001|NCT01543659|89Zr-DFO-huJ591|89zr-dfo-huj591
473002|NCT01543659|prostate|prostate
473003|NCT01543659|Pet scan|pet scan
473004|NCT01543659|11-126|11-126
473005|NCT01543646|Hepatology|hepatology
473006|NCT01543646|Liver Cirrhosis|liver cirrhosis
473007|NCT01543646|Fatty Liver|fatty liver
473008|NCT01543620|kidney safety|kidney safety
473009|NCT01543620|biomarkers|biomarkers
473010|NCT01543620|serum creatinine|serum creatinine
473011|NCT01543620|BUN|bun
473012|NCT01543620|cystic fibrosis|cystic fibrosis
473013|NCT01543620|head and neck cancer|head and neck cancer
473014|NCT01543620|renal injury|renal injury
473015|NCT01543620|drug induced acute kidney injury|drug induced acute kidney injury
473016|NCT01543620|aminoglycoside|aminoglycoside
473017|NCT01543620|cisplatin|cisplatin
473018|NCT01543620|nephrotoxicity|nephrotoxicity
473019|NCT01543620|biomarker qualification|biomarker qualification
473020|NCT01543607|Bile duct|bile duct
473021|NCT01543607|Cholangiocarcinoma|cholangiocarcinoma
473022|NCT01543607|Bile duct stenosis|bile duct stenosis
473023|NCT01543607|Malignant bile duct obstruction|malignant bile duct obstruction
473024|NCT01543607|Malignant bile duct stricture|malignant bile duct stricture
473025|NCT01543607|Radiofrequency ablation|radiofrequency ablation
473026|NCT01543607|RFA|rfa
473027|NCT01543607|Endoscopic RFA catheter|endoscopic rfa catheter
473028|NCT01543607|EndoHPB|endohpb
473029|NCT01543594|Rheumatoid arthritis|rheumatoid arthritis
473030|NCT01543594|Seronegative polyarthritis|seronegative polyarthritis
603410|NCT01003171|PK|pk
473031|NCT01543594|Biologic drugs|biologic drugs
473032|NCT01543594|Safety efficacy biologics polyarthritis|safety efficacy biologics polyarthritis
473033|NCT01543581|Basal Cell Carcinoma|basal cell carcinoma
473034|NCT01543581|Treatment of Skin Cancer|treatment of skin cancer
473035|NCT01543568|Age related Macular Degeneration|age related macular degeneration
473036|NCT01543568|Recalcitrant Age Related Macular Degeneration|recalcitrant age related macular degeneration
473037|NCT01543555|myocardial infarction|myocardial infarction
473038|NCT01543555|statin|statin
473039|NCT01543555|perioperative care|perioperative care
473040|NCT01543555|peripheral vascular diseases|peripheral vascular diseases
473041|NCT01543555|anesthesiology|anesthesiology
473042|NCT01543542|1-3 brain metastases from any primary cancer|1-3 brain metastases from any primary cancer
473043|NCT01543516|Asthma|asthma
473044|NCT01543516|Sputum|sputum
473045|NCT01543516|Blood|blood
473046|NCT01543516|Inflammation|inflammation
473047|NCT01543516|adaptive immune system|adaptive immune system
473048|NCT01543516|innate immune system|innate immune system
473049|NCT01543464|Indeolamine 2,3 dioxygenase|indeolamine 2,3 dioxygenase
473050|NCT01543464|Survivin|survivin
473051|NCT01543464|Montanide|montanide
473052|NCT01543464|Imiquimod|imiquimod
473053|NCT01543464|GMCSF|gmcsf
473054|NCT01543438|ED utilization|ed utilization
473055|NCT01543438|video education|video education
473056|NCT01543438|mobile health|mobile health
473057|NCT01543438|streaming media|streaming media
473058|NCT01543438|underserved populations|underserved populations
473059|NCT01543425|Neuropathic Pain|neuropathic pain
473060|NCT01543425|Adenocorticotrophic axis|adenocorticotrophic axis
473061|NCT01543425|Psychological state|psychological state
473062|NCT01543412|FOLFIRI|folfiri
473063|NCT01543412|Metastases|metastases
473064|NCT01543412|pancreatic adenocarcinoma|pancreatic adenocarcinoma
473065|NCT01543412|locally advanced or metastatic pancreatic adenocarcinoma|locally advanced or metastatic pancreatic adenocarcinoma
473066|NCT01543399|Tibolone|tibolone
473067|NCT01543399|climacteric|climacteric
473068|NCT01543399|Doppler|doppler
473069|NCT01543399|hormone replacement therapy|hormone replacement therapy
473070|NCT01543386|Polyphenol|polyphenol
473071|NCT01543386|Curcumin|curcumin
473072|NCT01543386|Endothelium, vascular|endothelium, vascular
473073|NCT01543386|Endothelium-dependant relaxing factor|endothelium-dependant relaxing factor
473074|NCT01543386|Smoking|smoking
473075|NCT01543386|Transcriptome|transcriptome
473076|NCT01543373|Coronary artery disease|coronary artery disease
473077|NCT01543373|Optical Coherence Tomography|optical coherence tomography
473078|NCT01543373|Tissue coverage|tissue coverage
473080|NCT01543360|axillary vein|axillary vein
473081|NCT01543360|sub clavian vein|sub clavian vein
473082|NCT01543360|comparison of strategies|comparison of strategies
473083|NCT01543347|UTI|uti
473084|NCT01543347|ESBL|esbl
473085|NCT01543347|AmpC Enterobacteriaceae|ampc enterobacteriaceae
473086|NCT01543334|intensive care|intensive care
473087|NCT01543334|antibiotic levels in blood samples|antibiotic levels in blood samples
473088|NCT01543321|tetrabenazine|tetrabenazine
473089|NCT01543321|movement disorders|movement disorders
473090|NCT01543321|tardive disorders|tardive disorders
473091|NCT01543295|Non-Treponemal|non-treponemal
473092|NCT01543295|Treponemal|treponemal
473093|NCT01543282|endoscopic ultrasonography|endoscopic ultrasonography
473094|NCT01543282|fine needle aspiration cytology|fine needle aspiration cytology
473095|NCT01543282|22 gauge|22 gauge
473096|NCT01543282|25 gauge|25 gauge
473097|NCT01543269|Obesity|obesity
473098|NCT01543269|Lipid disorders|lipid disorders
473099|NCT01543256|benign biliary strictures secondary to chronic pancreatitis|benign biliary strictures secondary to chronic pancreatitis
473100|NCT01543243|postural balance|postural balance
473101|NCT01543243|strength|strength
473102|NCT01543230|Non-Inflammatory Degenerative Joint Disease|non-inflammatory degenerative joint disease
473103|NCT01543217|COPD|copd
473104|NCT01543204|plaque psoriasis|plaque psoriasis
473105|NCT01543204|etanercept|etanercept
473106|NCT01543204|adalimumab|adalimumab
473107|NCT01543191|Lung Diseases|lung diseases
473108|NCT01543191|Respiratory Tract Diseases|respiratory tract diseases
473109|NCT01543191|Fibrosis|fibrosis
473110|NCT01543178|IBS|ibs
473111|NCT01543178|IBS-D|ibs-d
473112|NCT01543178|IBS with diarrhea|ibs with diarrhea
473113|NCT01543178|Diarrhea|diarrhea
473114|NCT01543178|Irritable bowel syndrome with diarrhea|irritable bowel syndrome with diarrhea
473115|NCT01543165|Renal colic|renal colic
473116|NCT01543165|Analgesia|analgesia
473117|NCT01543165|Nefopam|nefopam
473118|NCT01543165|Ketorolac|ketorolac
473119|NCT01543152|HIV|hiv
473120|NCT01543152|autologous cell therapy|autologous cell therapy
473121|NCT01543152|cyclophosphamide|cyclophosphamide
473122|NCT01543139|Bipolar Depression|bipolar depression
473123|NCT01543139|Magnetic resonance spectroscopy|magnetic resonance spectroscopy
473124|NCT01543139|Cytidine-|cytidine-
473125|NCT01543139|Creatine-|creatine-
473126|NCT01543113|melanoma|melanoma
473127|NCT01543113|white-caucasian population|white-caucasian population
473128|NCT01543100|MGUS|mgus
473129|NCT01543074|HDAC|hdac
473130|NCT01543074|histone acetylation|histone acetylation
473131|NCT01543074|broccoli sprout extract|broccoli sprout extract
473132|NCT01543074|garlic oil|garlic oil
473133|NCT01543074|PBMCs|pbmcs
473134|NCT01543048|Human Papilloma Virus (HPV)|human papilloma virus (hpv)
473135|NCT01543048|Virological tests|virological tests
473136|NCT01543048|CIN3|cin3
473137|NCT01543048|Cervical cancer|cervical cancer
473138|NCT01543048|Conization|conization
473139|NCT01543048|within women treated by conization for a CIN3|within women treated by conization for a cin3
473140|NCT01543035|HIV infection|hiv infection
473141|NCT01543035|lipid lowering drugs|lipid lowering drugs
473142|NCT01543035|etravirine|etravirine
473143|NCT01543035|patient|patient
473144|NCT01543035|statin treatment|statin treatment
473145|NCT01543035|EFV or boosted PI antiretroviral treatment|efv or boosted pi antiretroviral treatment
473146|NCT01543009|child|child
473147|NCT01543009|venipuncture|venipuncture
473148|NCT01543009|pain|pain
473149|NCT01542983|breast cancer|breast cancer
473150|NCT01542983|bright light|bright light
473151|NCT01542983|insomnia|insomnia
473152|NCT01542983|fatigue|fatigue
473153|NCT01542970|intervention|intervention
473154|NCT01542970|lactobacillus reuteri|lactobacillus reuteri
473155|NCT01542970|omega-3 fatty acids|omega-3 fatty acids
473156|NCT01542970|pregnancy|pregnancy
473157|NCT01542970|lactation|lactation
473158|NCT01542970|allergic symptoms|allergic symptoms
473159|NCT01542970|IgE associated disease|ige associated disease
473160|NCT01542970|gastrointestinal function|gastrointestinal function
473161|NCT01542957|Major Depressive Disorder|major depressive disorder
473162|NCT01542957|Dysthymic Disorder|dysthymic disorder
473163|NCT01542957|Depression|depression
473164|NCT01542957|Cognitive Behavior Therapy|cognitive behavior therapy
473165|NCT01542957|Personal Construct Theory|personal construct theory
473166|NCT01542957|Repertory Grid Technique|repertory grid technique
473167|NCT01542957|Cognitive Conflicts|cognitive conflicts
473168|NCT01542957|Personal dilemmas|personal dilemmas
473169|NCT01542944|Acute myeloid leukemia|acute myeloid leukemia
473170|NCT01542944|Myelodysplastic syndrome|myelodysplastic syndrome
473171|NCT01542944|Stem Cell Mobilization|stem cell mobilization
473172|NCT01542944|Allogeneic Stem Cell Transplantation|allogeneic stem cell transplantation
473173|NCT01542931|Oral squamous cell carcinoma|oral squamous cell carcinoma
473174|NCT01542931|Induction chemotherapy|induction chemotherapy
473175|NCT01542931|Surgery|surgery
473176|NCT01542931|Radiotherapy|radiotherapy
473177|NCT01542918|Recurrent|recurrent
473178|NCT01542918|Refractory|refractory
473179|NCT01542918|CNS|cns
473180|NCT01542918|Intraocular|intraocular
473181|NCT01542918|Lymphoma|lymphoma
473182|NCT01542892|Sarcopenia|sarcopenia
473183|NCT01542892|Nutrition|nutrition
473184|NCT01542892|Vitamin D|vitamin d
473185|NCT01542892|Exercise|exercise
473186|NCT01542866|ranibizumab|ranibizumab
473187|NCT01542866|Age related Macular Degeneration|age related macular degeneration
473188|NCT01542866|AMD|amd
473189|NCT01542866|Health Management Tool|health management tool
473190|NCT01542866|HMT|hmt
473191|NCT01542866|Best Corrected Visual Acuity|best corrected visual acuity
473192|NCT01542866|Investigator's Clinical Judgement of Change|investigator's clinical judgement of change
473193|NCT01542866|Choroidal Neovascularization|choroidal neovascularization
473194|NCT01542866|Central Retinal Subfield Thickness|central retinal subfield thickness
473195|NCT01542866|visual function self test|visual function self test
473196|NCT01542840|surgery|surgery
473197|NCT01542840|orthopedic surgery|orthopedic surgery
473198|NCT01542840|foot surgery|foot surgery
473199|NCT01542840|leg surgery|leg surgery
473200|NCT01542840|ankle surgery|ankle surgery
473201|NCT01542840|leg|leg
473202|NCT01542840|foot|foot
473203|NCT01542840|ankle|ankle
473204|NCT01542840|anesthesia|anesthesia
473205|NCT01542840|local anesthesia|local anesthesia
473206|NCT01542840|regional anesthesia|regional anesthesia
473207|NCT01542840|Ochsner Clinic|ochsner clinic
473208|NCT01542840|Ochsner Hospital|ochsner hospital
473209|NCT01542840|New Orleans|new orleans
473210|NCT01542840|Louisiana|louisiana
473211|NCT01542840|Kristie Osteen, MD|kristie osteen, md
473212|NCT01542827|neck pain|neck pain
473213|NCT01542827|menthol|menthol
473214|NCT01542814|Screening Mammogram|screening mammogram
473215|NCT01542814|Diagnostic Mammogram|diagnostic mammogram
473216|NCT01542814|Benign|benign
473217|NCT01542814|Malignant|malignant
473218|NCT01542814|BI-RADS Categories|bi-rads categories
473219|NCT01542801|Effect of Preventive Antibiotics|effect of preventive antibiotics
473220|NCT01542788|HCV genotype 2 (GT-2)|hcv genotype 2 (gt-2)
473221|NCT01542788|HCV genotype 3 (GT-3)|hcv genotype 3 (gt-3)
473222|NCT01542788|HCV|hcv
473223|NCT01542788|Sustained Virologic Response|sustained virologic response
473224|NCT01542788|Direct Acting Antiviral|direct acting antiviral
473225|NCT01542788|Combination Therapy|combination therapy
473226|NCT01542788|Interferon intolerant|interferon intolerant
473227|NCT01542788|Interferon ineligible|interferon ineligible
473228|NCT01542788|GS-7977|gs-7977
473229|NCT01542788|Ribavirin|ribavirin
473230|NCT01542762|Deep venous thrombosis|deep venous thrombosis
473231|NCT01542762|Pulmonary Embolism|pulmonary embolism
473232|NCT01542762|Lower leg Cast immobilization|lower leg cast immobilization
473233|NCT01542749|BVA-100 Blood volume analyzer|bva-100 blood volume analyzer
473234|NCT01542749|Human serum albumin labeled with Iodine 131|human serum albumin labeled with iodine 131
473235|NCT01542723|Deep venous thrombosis|deep venous thrombosis
473236|NCT01542723|Pulmonary Embolism|pulmonary embolism
473237|NCT01542723|Arthroscopy of the knee|arthroscopy of the knee
473238|NCT01542697|magnesium sulpahate|magnesium sulpahate
473239|NCT01542697|postoperative analgesia|postoperative analgesia
473240|NCT01542684|Leukemia|leukemia
473241|NCT01542684|Myelodysplastic Syndrome|myelodysplastic syndrome
473242|NCT01542684|MDS|mds
473243|NCT01542684|Azacytidine|azacytidine
473244|NCT01542684|5-Azacytidine|5-azacytidine
473245|NCT01542684|5-AZA|5-aza
473246|NCT01542684|Vidaza|vidaza
473247|NCT01542684|5-AZC|5-azc
473248|NCT01542684|Aza-CR|aza-cr
473249|NCT01542684|Ladakamycin|ladakamycin
473250|NCT01542684|NSC-102816|nsc-102816
473251|NCT01542684|GM-CSF|gm-csf
473252|NCT01542684|Sargramostim|sargramostim
473253|NCT01542684|Leukine|leukine
473254|NCT01542671|lifestyle change|lifestyle change
473255|NCT01542671|obesity treatment|obesity treatment
473256|NCT01542671|physical activity|physical activity
473257|NCT01542671|primary care|primary care
473258|NCT01542671|quality of life|quality of life
473259|NCT01542645|Fentanyl|fentanyl
473260|NCT01542645|Methadone|methadone
473261|NCT01542645|Thoracic Surgery|thoracic surgery
473262|NCT01542632|safety and immunogenicity of dengue vaccine|safety and immunogenicity of dengue vaccine
473263|NCT01542606|PH|ph
473264|NCT01542606|SCREENING|screening
473265|NCT01542606|EARLY WARNING|early warning
473266|NCT01542606|VAGINAL HEALTH|vaginal health
473267|NCT01542606|VAGINAL SECRETION|vaginal secretion
473268|NCT01542606|VAGINAL PH|vaginal ph
473269|NCT01542580|Revision surgery|revision surgery
473270|NCT01542567|Diclofenac|diclofenac
473271|NCT01542567|BCG|bcg
473272|NCT01542567|BLADDER IRRIGATIONS|bladder irrigations
473273|NCT01542554|Diabetes mellitus|diabetes mellitus
473274|NCT01542554|Chinese|chinese
473275|NCT01542554|Glycaemic index|glycaemic index
473276|NCT01542528|ADHD|adhd
473277|NCT01542528|Executive function|executive function
473278|NCT01542528|Inhibitory control|inhibitory control
473279|NCT01542528|Computer games|computer games
473280|NCT01542528|Sports activities|sports activities
473281|NCT01542528|Good Behavior Game|good behavior game
473282|NCT01542515|Allograft|allograft
473283|NCT01542515|Arthroplasty|arthroplasty
473284|NCT01542515|Basal Joint|basal joint
473285|NCT01542515|carpometacarpal joint|carpometacarpal joint
473286|NCT01542515|Thumb|thumb
473287|NCT01542515|meniscus|meniscus
473288|NCT01542515|osteoarthritis|osteoarthritis
473289|NCT01542515|Patients with Stages I - III arthritis of the the thumb carpometacarpal joint|patients with stages i - iii arthritis of the the thumb carpometacarpal joint
473290|NCT01542502|Heart failure with preserved ejection fraction|heart failure with preserved ejection fraction
473291|NCT01542502|Diastolic heart failure|diastolic heart failure
473292|NCT01542502|Aerobic exercise performance|aerobic exercise performance
473293|NCT01542437|Non-Small Cell Lung Cancer|non-small cell lung cancer
473294|NCT01542398|community-based|community-based
473295|NCT01542398|war-affected|war-affected
473296|NCT01542398|psychosocial support|psychosocial support
473297|NCT01542398|family-focused|family-focused
473298|NCT01542398|psychological distress|psychological distress
473299|NCT01542398|adolescents|adolescents
473300|NCT01542398|Democratic Republic of Congo|democratic republic of congo
473301|NCT01542398|family functioning|family functioning
473302|NCT01542398|community functioning|community functioning
473303|NCT01542398|daily functioning|daily functioning
473304|NCT01542385|Delayed stenting|delayed stenting
473305|NCT01542385|Deferred stenting|deferred stenting
473306|NCT01542385|Late stenting|late stenting
473307|NCT01542385|postponed stenting|postponed stenting
473308|NCT01542385|Thrombectomy|thrombectomy
473309|NCT01542385|Percutaneous coronary intervention|percutaneous coronary intervention
473310|NCT01542385|PCI|pci
473311|NCT01542385|Angioplasty|angioplasty
473312|NCT01542385|STEMI|stemi
473313|NCT01542385|acute myocardial infarction|acute myocardial infarction
473314|NCT01542372|PTSD|ptsd
473315|NCT01542372|Cognitive behavioral therapy (CBT)|cognitive behavioral therapy (cbt)
473316|NCT01542372|Medication augmentation|medication augmentation
473317|NCT01542372|Treatment-resistant PTSD|treatment-resistant ptsd
473318|NCT01542372|Cambodian refugees|cambodian refugees
473319|NCT01542372|Culturally sensitive treatment|culturally sensitive treatment
473320|NCT01542359|Yoga, Hypertension|yoga, hypertension
473321|NCT01542359|Blood Pressure|blood pressure
473322|NCT01542359|Autonomic Nervous system|autonomic nervous system
473323|NCT01542346|Wound closure|wound closure
473324|NCT01542346|cosmetic outcome|cosmetic outcome
473325|NCT01542333|recurrent Wilms tumor and other childhood kidney tumors|recurrent wilms tumor and other childhood kidney tumors
473326|NCT01542333|stage I Wilms tumor|stage i wilms tumor
473327|NCT01542333|stage II Wilms tumor|stage ii wilms tumor
473328|NCT01542333|stage III Wilms tumor|stage iii wilms tumor
473329|NCT01542333|stage IV Wilms tumor|stage iv wilms tumor
473330|NCT01542333|stage V Wilms tumor|stage v wilms tumor
473331|NCT01542320|probiotic|probiotic
473332|NCT01542320|Lactobacillus reuteri DSM 17938|lactobacillus reuteri dsm 17938
473333|NCT01542320|healthy infants|healthy infants
473334|NCT01542307|migraine|migraine
473335|NCT01542307|oxygen therapy|oxygen therapy
473336|NCT01542294|gastric cancer|gastric cancer
473337|NCT01542294|S-1|s-1
473338|NCT01542294|oxaliplatin|oxaliplatin
473339|NCT01542294|adjuvant chemotherapy|adjuvant chemotherapy
473340|NCT01542281|liver resection|liver resection
473341|NCT01542281|hepatectomy|hepatectomy
473342|NCT01542281|pre-habilitation|pre-habilitation
473343|NCT01542268|pentoxifylline|pentoxifylline
473344|NCT01542268|tight junction signalling|tight junction signalling
473345|NCT01542268|intestinal epithelial barrier|intestinal epithelial barrier
473346|NCT01542268|irritable bowel syndrome|irritable bowel syndrome
473347|NCT01542255|Metronomic Therapy|metronomic therapy
473348|NCT01542255|Metastatic Melanoma|metastatic melanoma
473349|NCT01542255|Vinblastine|vinblastine
473350|NCT01542255|Cyclophosphamide|cyclophosphamide
473351|NCT01542255|Dacarbazine|dacarbazine
473352|NCT01542242|Diabetes Mellitus Type 2|diabetes mellitus type 2
473353|NCT01542242|Prader Willi Syndrome|prader willi syndrome
473354|NCT01542229|Post Traumatic Stress Disorder|post traumatic stress disorder
473355|NCT01542229|Severe Mental Illness|severe mental illness
473356|NCT01542203|doxorubicin|doxorubicin
473357|NCT01542203|cyclophosphamide|cyclophosphamide
473358|NCT01542203|Breast Cancer|breast cancer
473359|NCT01542203|BMI|bmi
473360|NCT01542190|cataract surgery|cataract surgery
473361|NCT01542190|cystoid macular edema|cystoid macular edema
473362|NCT01542190|angiography|angiography
473363|NCT01542177|hypoxia|hypoxia
473364|NCT01542177|pancreas|pancreas
473365|NCT01542177|cancer|cancer
473366|NCT01542177|pancreatic cancer|pancreatic cancer
473367|NCT01542177|18F-FAZA|18f-faza
473368|NCT01542177|18F-Fluoroazomycin Arabinoside|18f-fluoroazomycin arabinoside
473369|NCT01542177|Positron Emission Tomography|positron emission tomography
473370|NCT01542177|PET|pet
473371|NCT01542164|Calcium intake|calcium intake
473372|NCT01542164|Fat excretion|fat excretion
473373|NCT01542164|Energy excretion|energy excretion
473374|NCT01542164|Gut micro flora|gut micro flora
473375|NCT01542151|Labor, induced|labor, induced
473376|NCT01542151|Sleep|sleep
473377|NCT01542151|Fatigue|fatigue
473378|NCT01542151|Patient satisfaction|patient satisfaction
473379|NCT01542151|Circadian rhythm|circadian rhythm
473380|NCT01542138|Inflammatory hyperpigmentation, axillar pigmentation|inflammatory hyperpigmentation, axillar pigmentation
473381|NCT01542125|Patients aged 3 to 16 years presenting for|patients aged 3 to 16 years presenting for
473382|NCT01542125|removal of smooth percutaneous interosseus pins|removal of smooth percutaneous interosseus pins
473383|NCT01542125|after orthopeadic surgery|after orthopeadic surgery
473384|NCT01542112|Patient-Centered Care|patient-centered care
473385|NCT01542112|Patient Satisfaction|patient satisfaction
473386|NCT01542112|Interventional study|interventional study
473387|NCT01542112|Patient Expectations|patient expectations
473388|NCT01542112|Hospitalization|hospitalization
473389|NCT01542086|intermediate pre-test|intermediate pre-test
473390|NCT01542086|probability of significant coronary heart disease|probability of significant coronary heart disease
473391|NCT01542073|myocardial infarction|myocardial infarction
473392|NCT01542073|angiogenesis|angiogenesis
473393|NCT01542073|integrin receptor imaging|integrin receptor imaging
473394|NCT01542073|68Ga-BNOTA-PRGD2|68ga-bnota-prgd2
473395|NCT01542047|Metastatic|metastatic
473396|NCT01542047|Solid tumors|solid tumors
473397|NCT01542047|carboplatin|carboplatin
473398|NCT01542047|Paraplatin|paraplatin
473399|NCT01542047|Pazopanib|pazopanib
473400|NCT01542047|Votrient|votrient
473401|NCT01542047|Alkylating agent|alkylating agent
473402|NCT01542047|Tyrosine kinase inhibitor|tyrosine kinase inhibitor
473403|NCT01542047|Metastatic disease|metastatic disease
473404|NCT01542021|prostate|prostate
473405|NCT01542021|Degarelix|degarelix
473406|NCT01542021|injections|injections
473407|NCT01542021|radical prostatectomy|radical prostatectomy
473408|NCT01542021|11-182|11-182
473409|NCT01541995|contrast medium enhanced post mortem CT|contrast medium enhanced post mortem ct
473410|NCT01541995|virtual autopsy|virtual autopsy
473411|NCT01541995|To evaluate the value of contrast medium enhanced post-mortem CT in virtual autopsy focussing on thromboembolic and vascular conditions|to evaluate the value of contrast medium enhanced post-mortem ct in virtual autopsy focussing on thromboembolic and vascular conditions
473412|NCT01541969|Ear|ear
473413|NCT01541969|Hearing|hearing
473414|NCT01541956|type 2 diabetes;|type 2 diabetes;
473415|NCT01541956|vildagliptin;|vildagliptin;
473416|NCT01541956|metformin;|metformin;
473417|NCT01541943|Atorvastatin|atorvastatin
473418|NCT01541943|Losartan|losartan
473419|NCT01541943|Essential Hypertension|essential hypertension
473420|NCT01541943|Hyperlipidemia|hyperlipidemia
473421|NCT01541904|Ocular Allergy.|ocular allergy.
473422|NCT01541904|Seasonal Allergic Conjunctivitis|seasonal allergic conjunctivitis
473423|NCT01541904|Perennial Allergic Conjunctivitis|perennial allergic conjunctivitis
473424|NCT01541904|Conjunctivitis, Allergic|conjunctivitis, allergic
473425|NCT01541904|Ocular Antihistamines.|ocular antihistamines.
473426|NCT01541891|PRO-148|pro-148
473427|NCT01541891|Dry eye syndrome|dry eye syndrome
473428|NCT01541865|hypertension, renal denervation, uncontrolled hypertension, medication resistant hypertension|hypertension, renal denervation, uncontrolled hypertension, medication resistant hypertension
473429|NCT01541852|Vascular Inflammation|vascular inflammation
473430|NCT01541852|FDG PET-CT|fdg pet-ct
473431|NCT01541852|COPD|copd
473432|NCT01541852|Atherosclerosis|atherosclerosis
473433|NCT01541852|p38 MAP kinase inhibitor|p38 map kinase inhibitor
473434|NCT01541839|Nasal septum|nasal septum
473435|NCT01541839|Nasal surgical procedures|nasal surgical procedures
473436|NCT01541826|aronia|aronia
473437|NCT01541826|LDL cholesterol|ldl cholesterol
473438|NCT01541826|polyphenols|polyphenols
473439|NCT01541826|bioavailability|bioavailability
473440|NCT01541826|oxidative stress|oxidative stress
473441|NCT01541813|Rare iron overload|rare iron overload
473442|NCT01541813|hepcidin|hepcidin
473443|NCT01541774|Atherectomy|atherectomy
473444|NCT01541774|Atherosclerosis|atherosclerosis
473445|NCT01541774|Peripheral artery disease|peripheral artery disease
473446|NCT01541761|Obesity|obesity
473447|NCT01541761|Child|child
473448|NCT01541761|Hispanic|hispanic
473449|NCT01541761|Prevention|prevention
473450|NCT01541761|Nutrition|nutrition
473451|NCT01541761|Parenting|parenting
473452|NCT01541735|Diabetes|diabetes
473453|NCT01541735|Insulin|insulin
473454|NCT01541735|Pantoprazole|pantoprazole
473455|NCT01541722|Urea cycle disorders|urea cycle disorders
473456|NCT01541709|This is a single-center|this is a single-center
473457|NCT01541709|prospective|prospective
473458|NCT01541709|single-arm|single-arm
473459|NCT01541709|open-label phase II study|open-label phase ii study
473460|NCT01541696|zinc|zinc
473461|NCT01541696|zn|zn
473462|NCT01541696|EZP (exchangeable zinc pools)multivitamin MN|ezp (exchangeable zinc pools)multivitamin mn
473463|NCT01541683|PEG-electrolyte solution|peg-electrolyte solution
473464|NCT01541683|bowel cleansing|bowel cleansing
473465|NCT01541683|Mentholyptus drops|mentholyptus drops
473466|NCT01541683|Palatability|palatability
473467|NCT01541657|Ankle Instability|ankle instability
473468|NCT01541657|Sensorimotor Control|sensorimotor control
473469|NCT01541657|Sensory|sensory
473470|NCT01541657|Postural Control|postural control
473471|NCT01541657|Balance|balance
473472|NCT01541657|Gait|gait
473473|NCT01541644|Acupuncture Therapy|acupuncture therapy
473474|NCT01541644|bortezomib-induced peripheral neuropathy|bortezomib-induced peripheral neuropathy
473475|NCT01541631|Human Immunodeficiency Virus-1|human immunodeficiency virus-1
473476|NCT01541631|Schistosoma mansoni|schistosoma mansoni
473477|NCT01541631|Anemia|anemia
473478|NCT01541631|Immune response|immune response
473479|NCT01541631|Opportunistic infections|opportunistic infections
473480|NCT01541631|Tanzania|tanzania
473481|NCT01541618|MS|ms
473482|NCT01541618|RRMS|rrms
473483|NCT01541618|RR Multiple Sclerosis|rr multiple sclerosis
473484|NCT01541592|Insulin resistance|insulin resistance
473485|NCT01541592|Endothelial dysfunction|endothelial dysfunction
473486|NCT01541592|saturated fat|saturated fat
473487|NCT01541592|monounsaturated fat|monounsaturated fat
473488|NCT01541592|polyunsaturated fat|polyunsaturated fat
473489|NCT01541579|Perianal fistulising Crohn's disease.|perianal fistulising crohn's disease.
473490|NCT01541566|arterial hypertension|arterial hypertension
473491|NCT01541566|metabolic syndrome|metabolic syndrome
473492|NCT01541566|home blood pressure|home blood pressure
473493|NCT01541566|ambulatory blood pressure|ambulatory blood pressure
473494|NCT01541566|office blood pressure|office blood pressure
473495|NCT01541566|telemedicine|telemedicine
473496|NCT01541527|non neutralizing antibody|non neutralizing antibody
473497|NCT01541527|Epitopic profile|epitopic profile
473498|NCT01541527|Clinical relevance|clinical relevance
473499|NCT01541501|Central Corneal Thickness|central corneal thickness
473500|NCT01541501|Pachymetry|pachymetry
473501|NCT01541462|mechanical ventilation|mechanical ventilation
473502|NCT01541462|weaning|weaning
473503|NCT01541462|pressure support|pressure support
473504|NCT01541462|spontaneous breathing|spontaneous breathing
473505|NCT01541462|Long-term acute care facility|long-term acute care facility
473506|NCT01541462|mortality|mortality
473507|NCT01541449|AMD|amd
473508|NCT01541449|PLAQUENIL|plaquenil
473509|NCT01541449|CNV|cnv
473510|NCT01541436|Remote Ischemic Preconditioning|remote ischemic preconditioning
473511|NCT01541436|Nociception|nociception
473512|NCT01541436|Central Sensitization|central sensitization
473513|NCT01541436|Peripheral Sensitization|peripheral sensitization
473514|NCT01541397|Hyperphenylalaninemia|hyperphenylalaninemia
473515|NCT01541397|Phenylketonuria|phenylketonuria
473516|NCT01541397|Adults|adults
473517|NCT01541397|Bone Mineral Density|bone mineral density
473518|NCT01541384|Kidney transplant|kidney transplant
473519|NCT01541384|Adherence|adherence
473520|NCT01541384|Electronic pill bottles|electronic pill bottles
473521|NCT01541371|Schizophrenia|schizophrenia
473522|NCT01541371|Paliperidone extended-release tablets|paliperidone extended-release tablets
473523|NCT01541332|relapsed refractory|relapsed refractory
473524|NCT01541332|multiple myeloma|multiple myeloma
473525|NCT01541332|pomalidomide|pomalidomide
473526|NCT01541332|Doxil|doxil
473527|NCT01541332|dexamethasone|dexamethasone
473528|NCT01541332|Oncotherapeutics|oncotherapeutics
473529|NCT01541319|Cardiac Surgery|cardiac surgery
473530|NCT01541319|Erythrocyte Transfusion|erythrocyte transfusion
473531|NCT01541306|C-type natriuretic peptide|c-type natriuretic peptide
473532|NCT01541306|dwarfism|dwarfism
473533|NCT01541306|growth|growth
473534|NCT01541306|achondroplasia|achondroplasia
473535|NCT01541306|hypochondroplasia|hypochondroplasia
473536|NCT01541306|biomarker|biomarker
473537|NCT01541293|Abortion, Induced|abortion, induced
473538|NCT01541293|Laminaria|laminaria
473539|NCT01541293|Pain management|pain management
473540|NCT01541293|Cervical preparation|cervical preparation
473541|NCT01541293|Dilation and Evacuation|dilation and evacuation
473542|NCT01541280|Allogreffe, LAM , MDS|allogreffe, lam , mds
473543|NCT01541280|Azacitidine (VidazaÒ)|azacitidine (vidazaò)
473544|NCT01541280|Injection de lymphocytes de donneur (DLI)|injection de lymphocytes de donneur (dli)
473545|NCT01541267|aliskiren|aliskiren
473546|NCT01541267|eplerenon|eplerenon
473547|NCT01541267|telmisartan|telmisartan
473548|NCT01541267|direct renin inhibitor|direct renin inhibitor
473549|NCT01541267|ACE inhibitor|ace inhibitor
473550|NCT01541267|mineralocorticoid inhibitor|mineralocorticoid inhibitor
473551|NCT01541267|proteinuria|proteinuria
473552|NCT01541267|chronic kidney diseases|chronic kidney diseases
473553|NCT01541267|renin-angiotensin-aldosterone system|renin-angiotensin-aldosterone system
473554|NCT01541254|intracranial aneurysm|intracranial aneurysm
473555|NCT01541254|wide-neck|wide-neck
473556|NCT01541254|saccular|saccular
473557|NCT01541254|endovascular treatment|endovascular treatment
473558|NCT01541254|coil embolization|coil embolization
473559|NCT01541254|stent|stent
473560|NCT01541254|bare platinum|bare platinum
473561|NCT01541241|Intrauterine contraceptive device (IUD) is one of the most frequently used methods of birth control around the world|intrauterine contraceptive device (iud) is one of the most frequently used methods of birth control around the world
473562|NCT01541241|Uterine Hemodynamic changes|uterine hemodynamic changes
473563|NCT01541228|actinic keratosis|actinic keratosis
473564|NCT01541228|photodynamic therapy|photodynamic therapy
473565|NCT01541228|5-aminolevulinic acid|5-aminolevulinic acid
473566|NCT01541202|chronic heart failure|chronic heart failure
473567|NCT01541202|neuregulin|neuregulin
473568|NCT01541202|mortality|mortality
473569|NCT01541189|hypertension|hypertension
473570|NCT01541189|valsartan|valsartan
473571|NCT01541176|Corticotherapy|corticotherapy
473572|NCT01541176|Fibrosis|fibrosis
473573|NCT01541176|Numerical reading|numerical reading
473574|NCT01541176|18-70 years|18-70 years
473575|NCT01541176|first renal transplant was lost due to rejection|first renal transplant was lost due to rejection
473576|NCT01541176|first or second renal transplant|first or second renal transplant
473577|NCT01541163|Ischemia|ischemia
473578|NCT01541163|Brain Infarction|brain infarction
473579|NCT01541163|Acute Stroke|acute stroke
473580|NCT01541163|Heart Diseases|heart diseases
473581|NCT01541163|Myocardial Infarction|myocardial infarction
473582|NCT01541150|Pedophilia|pedophilia
473583|NCT01541150|Impaired Decision making|impaired decision making
473584|NCT01541150|Insight|insight
473585|NCT01541150|Cognitive Distorsions|cognitive distorsions
473586|NCT01541150|Impulsiveness|impulsiveness
473587|NCT01541137|thoracotomy|thoracotomy
473588|NCT01541137|pain|pain
473589|NCT01541137|NSAID|nsaid
473590|NCT01541137|PCA|pca
473591|NCT01541137|TEA|tea
473592|NCT01541137|chronic|chronic
473593|NCT01541124|cancer pain|cancer pain
473594|NCT01541124|analgesia|analgesia
473595|NCT01541124|morphine|morphine
473596|NCT01541111|Cancer pain|cancer pain
473597|NCT01541111|Magnesiun|magnesiun
473598|NCT01541085|Human Immunodeficiency Virus; HIV; Highly Active Antiretroviral Therapy; HAART; Darunavir; Ritonavir; Efavirenz; Kinetics; Immunological Recovery|human immunodeficiency virus; hiv; highly active antiretroviral therapy; haart; darunavir; ritonavir; efavirenz; kinetics; immunological recovery
473599|NCT01541072|Lymphoma, B-cell|lymphoma, b-cell
473600|NCT01541072|Lymphocyte reconstitution|lymphocyte reconstitution
473601|NCT01541072|Lymphocyte subsets|lymphocyte subsets
473602|NCT01541072|Peripheral stem cell transplantation|peripheral stem cell transplantation
473603|NCT01541072|Induction chemotherapy|induction chemotherapy
473604|NCT01541072|growth factor|growth factor
473605|NCT01541072|Granulocyte Colony-stimulating factor|granulocyte colony-stimulating factor
473606|NCT01541072|Pegfilgrastim|pegfilgrastim
473607|NCT01541072|Filgrastim|filgrastim
473608|NCT01541059|Third molar extraction|third molar extraction
473609|NCT01541059|local anesthesia|local anesthesia
473610|NCT01541059|ropivacaine|ropivacaine
473611|NCT01541046|pediatric|pediatric
473612|NCT01541046|infantile colic|infantile colic
473613|NCT01541046|probiotic treatment|probiotic treatment
473614|NCT01541033|autism|autism
473615|NCT01541033|children|children
473616|NCT01541007|Prostate Cancer|prostate cancer
473617|NCT01541007|Metastatic|metastatic
473618|NCT01541007|Castration Resistant|castration resistant
473619|NCT01540994|Neoplasms|neoplasms
473620|NCT01540994|Urogenital neoplasm|urogenital neoplasm
473621|NCT01540994|Genital neoplasms, male|genital neoplasms, male
473622|NCT01540955|Reduce Cognitive Complaints|reduce cognitive complaints
473623|NCT01540955|improve cognitive function|improve cognitive function
473624|NCT01540955|post-treatment breast cancer patients|post-treatment breast cancer patients
473625|NCT01540942|Crohn's disease|crohn's disease
473626|NCT01540942|Nutrition|nutrition
473627|NCT01540942|Bowel resection|bowel resection
473628|NCT01540942|Postoperative recurrence|postoperative recurrence
473629|NCT01540942|complication|complication
473630|NCT01540942|Active disease|active disease
473631|NCT01540929|Smallpox|smallpox
473632|NCT01540929|ACAM2000®|acam2000®
473633|NCT01540929|Smallpox vaccine|smallpox vaccine
473634|NCT01540916|acid-base equilibrium|acid-base equilibrium
473635|NCT01540916|renal system|renal system
473636|NCT01540916|urinary electrolytes|urinary electrolytes
473637|NCT01540903|Malaria Challenge|malaria challenge
473638|NCT01540903|Plasmodium falciparum|plasmodium falciparum
473639|NCT01540903|PfSPZ Challenge|pfspz challenge
473640|NCT01540903|Controlled|controlled
473641|NCT01540903|human|human
473642|NCT01540903|malaria infection|malaria infection
473643|NCT01540864|Obesity|obesity
473644|NCT01540864|Overweight|overweight
473645|NCT01540864|Body Mass Index|body mass index
473646|NCT01540851|Osteoarthritis|osteoarthritis
473647|NCT01540851|Total Knee Replacement|total knee replacement
473648|NCT01540851|total Knee Arthroplasty|total knee arthroplasty
473649|NCT01540851|Post operative recovery, TKA|post operative recovery, tka
473650|NCT01540851|Post-operative recovery TKR|post-operative recovery tkr
473651|NCT01540851|Care Navigator|care navigator
473652|NCT01540838|Bacterial meningitis|bacterial meningitis
473653|NCT01540838|infusion|infusion
473654|NCT01540838|bolus|bolus
473655|NCT01540838|paracetamol|paracetamol
473656|NCT01540812|Acute Lymphoblastic Leukemia|acute lymphoblastic leukemia
473657|NCT01540799|Migraine|migraine
473658|NCT01540799|High disability migraine|high disability migraine
473659|NCT01540799|Sphenopalatine ganglion|sphenopalatine ganglion
473660|NCT01540799|Neuromodulation|neuromodulation
473661|NCT01540799|Neurostimulation|neurostimulation
473662|NCT01540799|Autonomic nervous system|autonomic nervous system
473663|NCT01540786|OAB|oab
473664|NCT01540786|High Resolution Urodynamics|high resolution urodynamics
473665|NCT01540773|growth hormone|growth hormone
473666|NCT01540747|intrafollicular melatonin|intrafollicular melatonin
473667|NCT01540747|PCOS|pcos
473668|NCT01540747|embryos quality|embryos quality
473669|NCT01540747|oocytes quality|oocytes quality
473670|NCT01540734|paracetamol|paracetamol
473671|NCT01540734|pharmacokinetic|pharmacokinetic
473672|NCT01540721|paracetamol|paracetamol
473673|NCT01540721|pharmacokinetics|pharmacokinetics
473674|NCT01540708|Asthma|asthma
473675|NCT01540708|Respiratory|respiratory
473676|NCT01540708|COPD|copd
473677|NCT01540695|Any patient with a routine basal cell or squamous cell carcinoma|any patient with a routine basal cell or squamous cell carcinoma
473678|NCT01540695|of the skin diagnosed on frozen histology during a Mohs procedure|of the skin diagnosed on frozen histology during a mohs procedure
473679|NCT01540682|Male and female patients with HNSCC of the oral cavity, oropharynx, hypopharynx, larynx,|male and female patients with hnscc of the oral cavity, oropharynx, hypopharynx, larynx,
473680|NCT01540682|nasopharynx or paranasal sinuses that is considered appropriate|nasopharynx or paranasal sinuses that is considered appropriate
473681|NCT01540682|for definitive cetuximab-based radiation therapy.|for definitive cetuximab-based radiation therapy.
473682|NCT01540669|constipation|constipation
473683|NCT01540669|functional constipation|functional constipation
473684|NCT01540669|polydextrose|polydextrose
473685|NCT01540669|whole gut transit time|whole gut transit time
473686|NCT01540656|Stress incontinence|stress incontinence
473687|NCT01540656|Incontinence|incontinence
473688|NCT01540656|prostate cancer|prostate cancer
473689|NCT01540656|Radical Prostatectomy vibration|radical prostatectomy vibration
473690|NCT01540656|nerve stimulation|nerve stimulation
473691|NCT01540643|abdominal aortic aneurysm|abdominal aortic aneurysm
473692|NCT01540643|iliac leg graft|iliac leg graft
473693|NCT01540617|Low back pain|low back pain
473694|NCT01540617|Proprioception|proprioception
473695|NCT01540617|Postural control|postural control
473696|NCT01540617|Spine|spine
473697|NCT01540617|Variability|variability
473698|NCT01540617|MRI|mri
473699|NCT01540617|Vibration|vibration
473700|NCT01540617|Brain|brain
473701|NCT01540604|DMD|dmd
473702|NCT01540604|BMD|bmd
473703|NCT01540604|symptomatic carriers|symptomatic carriers
473704|NCT01540591|repeated implantation failure|repeated implantation failure
473705|NCT01540591|intralipid|intralipid
473706|NCT01540552|lung cancer|lung cancer
473707|NCT01540552|precancerous condition|precancerous condition
473708|NCT01540552|lung nodules|lung nodules
473709|NCT01540552|CT Scan|ct scan
473710|NCT01540500|Pharmacokinetics|pharmacokinetics
473711|NCT01540500|Drug Interaction|drug interaction
473712|NCT01540474|Interference of malaria infection|interference of malaria infection
473713|NCT01540461|HCC|hcc
473714|NCT01540435|Colorectal cancer|colorectal cancer
473715|NCT01540435|Liver metastases|liver metastases
473716|NCT01540435|Perioperative treatment|perioperative treatment
473717|NCT01540435|Liver resection|liver resection
473718|NCT01540422|vein grafts|vein grafts
473719|NCT01540422|coronary bypass|coronary bypass
473720|NCT01540422|endoscopic harvest|endoscopic harvest
473721|NCT01540422|endoscopic vein harvest|endoscopic vein harvest
473722|NCT01540409|DMD, Duchenne, Eteplirsen, dystrophy, dystrophin, exon 51|dmd, duchenne, eteplirsen, dystrophy, dystrophin, exon 51
473723|NCT01540396|Gestational Diabetes|gestational diabetes
473724|NCT01540383|Communication|communication
473725|NCT01540383|Language|language
473726|NCT01540383|Treatment|treatment
473727|NCT01540383|Intervention|intervention
473728|NCT01540383|Therapy|therapy
473729|NCT01540383|Efficacy|efficacy
473730|NCT01540383|Maintenance|maintenance
473731|NCT01540383|Recovery|recovery
473732|NCT01540383|Outcome|outcome
473733|NCT01540383|Rehabilitation|rehabilitation
473734|NCT01540383|Treatment Intensity|treatment intensity
473735|NCT01540383|Language Impairment|language impairment
473736|NCT01540383|Intensive Language Therapy|intensive language therapy
473737|NCT01540383|Functional Communication|functional communication
473738|NCT01540383|Functional Improvement|functional improvement
473739|NCT01540383|Evidence-Based Intervention|evidence-based intervention
473740|NCT01540383|High-Frequency|high-frequency
473741|NCT01540357|mindfulness-based therapy|mindfulness-based therapy
473742|NCT01540357|chronic tinnitus;|chronic tinnitus;
473743|NCT01540344|peritoneal carcinomatosis|peritoneal carcinomatosis
473744|NCT01540344|cytoreductive surgery|cytoreductive surgery
473745|NCT01540344|HIPEC|hipec
473746|NCT01540344|colorectal cancer|colorectal cancer
473747|NCT01540318|ultrasonography|ultrasonography
473748|NCT01540318|Abdominal Injuries|abdominal injuries
473749|NCT01540318|Trauma|trauma
473750|NCT01540305|Obsessive Compulsive Disorder|obsessive compulsive disorder
473751|NCT01540305|Transcranial Magnetic Stimulation|transcranial magnetic stimulation
473752|NCT01540305|Treatment|treatment
473753|NCT01540292|Crohn's disease|crohn's disease
473754|NCT01540292|Mesenchymal Stem Cell|mesenchymal stem cell
473755|NCT01540292|Cell therapy|cell therapy
473756|NCT01540292|Allogeneic|allogeneic
473950|NCT01539317|Vulvodynia|vulvodynia
473757|NCT01540292|Inflammatory disorders|inflammatory disorders
473758|NCT01540292|Autoimmune disorders|autoimmune disorders
473759|NCT01540266|physician-patient communication|physician-patient communication
473760|NCT01540266|information structuring|information structuring
473761|NCT01540266|emergency department|emergency department
473762|NCT01540240|HIV treatment|hiv treatment
473763|NCT01540240|zidovudine|zidovudine
473764|NCT01540240|dose reduction|dose reduction
473765|NCT01540240|anaemia|anaemia
473766|NCT01540240|safety and efficacy comparison|safety and efficacy comparison
473767|NCT01540227|Syphilis|syphilis
473768|NCT01540227|Penicillin|penicillin
473769|NCT01540214|Urinary Bladder, Overactive|urinary bladder, overactive
473770|NCT01540214|Pelvic Organ Prolapse|pelvic organ prolapse
473771|NCT01540214|Gynecologic Surgical Procedures|gynecologic surgical procedures
473772|NCT01540214|Urodynamics|urodynamics
473773|NCT01540201|one lung ventilation|one lung ventilation
473774|NCT01540201|gas exchange|gas exchange
473775|NCT01540201|inverse-ratio ventilation|inverse-ratio ventilation
473776|NCT01540188|Drug user|drug user
473777|NCT01540188|Family member|family member
473778|NCT01540188|Intervention|intervention
473779|NCT01540188|Community|community
473780|NCT01540188|Support|support
473781|NCT01540175|Autologous stem cell transplant|autologous stem cell transplant
473782|NCT01540175|Immune reconstitution|immune reconstitution
473783|NCT01540162|preterm newborn|preterm newborn
473784|NCT01540162|neonatology|neonatology
473785|NCT01540162|EcN|ecn
473786|NCT01540162|Nissle|nissle
473787|NCT01540162|Mutaflor|mutaflor
473788|NCT01540162|prophylaxis|prophylaxis
473789|NCT01540162|infection|infection
473790|NCT01540110|Locally Advanced or Node Positive Primary Breast Cancer|locally advanced or node positive primary breast cancer
473791|NCT01540084|Cocktail sedation|cocktail sedation
473792|NCT01540084|ERCP|ercp
473793|NCT01540071|Hormone refractory prostate cancer|hormone refractory prostate cancer
473794|NCT01540071|HRPC|hrpc
473795|NCT01540071|Androgen independent prostate cancer|androgen independent prostate cancer
473796|NCT01540071|CRPC|crpc
473797|NCT01540071|Castration and Taxane Resistant Prostate Cancer|castration and taxane resistant prostate cancer
473798|NCT01540045|Non-Small Cell Lung Cancer|non-small cell lung cancer
473799|NCT01540045|Dysgeusia|dysgeusia
473800|NCT01540045|Antineoplastic Combined Chemotherapy Protocols|antineoplastic combined chemotherapy protocols
473801|NCT01540045|Paclitaxel|paclitaxel
473802|NCT01540045|Cisplatin|cisplatin
473803|NCT01540019|anorexia|anorexia
473804|NCT01540019|Paullinia cupana|paullinia cupana
473805|NCT01540019|loss of weight|loss of weight
473806|NCT01539993|Hepatocellular carcinoma|hepatocellular carcinoma
473807|NCT01539993|Liver metastases|liver metastases
473808|NCT01539993|Cholangiocarcinoma|cholangiocarcinoma
473809|NCT01539993|Percutaneous treatments|percutaneous treatments
473810|NCT01539993|RFA|rfa
473811|NCT01539993|TACE|tace
473812|NCT01539993|DEB|deb
473813|NCT01539980|Sericin scaffold|sericin scaffold
473814|NCT01539980|Wound healing|wound healing
473815|NCT01539980|Skin graft donor|skin graft donor
473816|NCT01539967|Laparoscopic Sleeve Gastrectomy|laparoscopic sleeve gastrectomy
473817|NCT01539967|Obesity follow-up|obesity follow-up
473818|NCT01539954|Alcohol related disorders|alcohol related disorders
473819|NCT01539941|Co-occurring adolescent substance use and ADHD|co-occurring adolescent substance use and adhd
473820|NCT01539928|Dual time PET/CT|dual time pet/ct
473821|NCT01539928|glucose-6-phosphatase|glucose-6-phosphatase
473822|NCT01539915|Psoriasis|psoriasis
473823|NCT01539915|Stable plaque psoriasis|stable plaque psoriasis
473824|NCT01539915|lesions|lesions
473825|NCT01539915|TNF-alpha|tnf-alpha
473826|NCT01539915|BCT194|bct194
473827|NCT01539902|MSC for the treatment of Lupus Nephritis|msc for the treatment of lupus nephritis
473828|NCT01539876|locally advanced breast cancer patients|locally advanced breast cancer patients
473829|NCT01539850|obesity|obesity
473830|NCT01539850|gastric stimulation|gastric stimulation
473831|NCT01539850|morbid obesity|morbid obesity
473832|NCT01539837|Parkinson's disease|parkinson's disease
473833|NCT01539837|Brain Iron|brain iron
473834|NCT01539837|Iron chelation|iron chelation
473835|NCT01539837|Oxidative stress|oxidative stress
473836|NCT01539811|Foot Infections|foot infections
473837|NCT01539811|Diabetes|diabetes
473838|NCT01539811|Antibiotic|antibiotic
473839|NCT01539798|Saline solution|saline solution
473840|NCT01539798|Sodium Chloride|sodium chloride
473841|NCT01539798|Hypoalbuminemia|hypoalbuminemia
473842|NCT01539798|Weight Gain|weight gain
473843|NCT01539785|HIPEC|hipec
473844|NCT01539785|Hyperthermic|hyperthermic
473845|NCT01539785|ovarian cancer|ovarian cancer
473846|NCT01539785|recurrence|recurrence
473847|NCT01539759|Postpartum Contraception|postpartum contraception
473848|NCT01539759|Intrauterine Devices|intrauterine devices
473849|NCT01539746|Aortic stenosis|aortic stenosis
473850|NCT01539746|Transcatheter aortic valve implantation|transcatheter aortic valve implantation
473851|NCT01539746|TAVI|tavi
473852|NCT01539746|Predilation|predilation
473853|NCT01539746|Balloon valvuloplasty|balloon valvuloplasty
473854|NCT01539746|BAV|bav
473855|NCT01539746|CoreValve|corevalve
473856|NCT01539720|emergency contraception|emergency contraception
473857|NCT01539720|Ella|ella
473858|NCT01539720|Mirena IUD|mirena iud
473859|NCT01539720|post-coital contraception|post-coital contraception
473860|NCT01539720|Liletta IUD|liletta iud
473861|NCT01539707|Solifenacin succinate suspension|solifenacin succinate suspension
473862|NCT01539707|Pharmacokinetics|pharmacokinetics
473863|NCT01539707|Phase 1|phase 1
473864|NCT01539707|Neurogenic Detrusor Overactivity|neurogenic detrusor overactivity
473865|NCT01539681|Hepatocellular Carcinoma|hepatocellular carcinoma
473866|NCT01539681|Cancer, Liver|cancer, liver
473867|NCT01539681|Sorafenib|sorafenib
473868|NCT01539681|Nexavar|nexavar
473869|NCT01539668|Cervical Cancer|cervical cancer
473870|NCT01539668|HPV|hpv
473871|NCT01539668|Secondary prevention|secondary prevention
473872|NCT01539655|Phase 1|phase 1
473873|NCT01539655|healthy volunteers|healthy volunteers
473874|NCT01539655|pharmacokinetics|pharmacokinetics
473875|NCT01539655|vandetanib|vandetanib
473876|NCT01539655|omeprazole|omeprazole
473877|NCT01539655|ranitidine|ranitidine
473878|NCT01539642|In patient, post operative pain|in patient, post operative pain
473879|NCT01539642|Adult post-operative inpatients who are expected to require parenteral opioid analgesia for at least 48 hours after open abdominal surgery|adult post-operative inpatients who are expected to require parenteral opioid analgesia for at least 48 hours after open abdominal surgery
473880|NCT01539629|Heart failure|heart failure
473881|NCT01539629|Autothreshold|autothreshold
473882|NCT01539629|Pacing|pacing
473883|NCT01539629|CRT-D recipients|crt-d recipients
473884|NCT01539629|Left Ventricular evoked response signals|left ventricular evoked response signals
473885|NCT01539616|Hypertriglyceridemia|hypertriglyceridemia
473886|NCT01539616|Dyslipidemia|dyslipidemia
473887|NCT01539603|drug eluting balloon|drug eluting balloon
473888|NCT01539603|bare metal stent|bare metal stent
473889|NCT01539603|drug eluting stent|drug eluting stent
473890|NCT01539603|coronary artery disease|coronary artery disease
473891|NCT01539590|hepatocyte growth factor mimetic|hepatocyte growth factor mimetic
473892|NCT01539590|hepatocyte growth factor(HGF)|hepatocyte growth factor(hgf)
473893|NCT01539590|Myocardial Infarction|myocardial infarction
473894|NCT01539590|Acute ST Segment Elevation Myocardial Infarction (STEMI)|acute st segment elevation myocardial infarction (stemi)
473895|NCT01539590|Percutaneous Coronary Intervention (PCI)|percutaneous coronary intervention (pci)
473896|NCT01539538|Adult post-operative inpatients who|adult post-operative inpatients who
473897|NCT01539538|are expected to require parenteral|are expected to require parenteral
473898|NCT01539538|opioid analgesia for at least 48|opioid analgesia for at least 48
473899|NCT01539538|hours after open abdominal surgery|hours after open abdominal surgery
473900|NCT01539538|or hip/knee replacement surgery|or hip/knee replacement surgery
473901|NCT01539512|CLL|cll
473902|NCT01539512|CAL-101|cal-101
473903|NCT01539512|GS 1101|gs 1101
473904|NCT01539512|PI3K|pi3k
473905|NCT01539512|GS-US-312-0117|gs-us-312-0117
473906|NCT01539512|idelalisib|idelalisib
473907|NCT01539460|Axillary osmidrosis|axillary osmidrosis
473908|NCT01539460|liposuction|liposuction
473909|NCT01539460|minimally invasive surgery|minimally invasive surgery
473910|NCT01539447|Hip arthroscopy|hip arthroscopy
473911|NCT01539447|Femoroacetabular impingement|femoroacetabular impingement
473912|NCT01539447|Heterotopic ossification|heterotopic ossification
473913|NCT01539447|Heterotopic bone formation|heterotopic bone formation
473914|NCT01539434|COPD|copd
473915|NCT01539434|Behavioral intervention|behavioral intervention
473916|NCT01539434|Physical capacity|physical capacity
473917|NCT01539434|Physical activity|physical activity
473918|NCT01539421|COPD|copd
473919|NCT01539421|exercise endurance|exercise endurance
473920|NCT01539395|Relapsing Remitting|relapsing remitting
473921|NCT01539395|MS|ms
473922|NCT01539382|cardiac surgery|cardiac surgery
473923|NCT01539382|neurocognitive assessment|neurocognitive assessment
473924|NCT01539382|neurocognitive function|neurocognitive function
473925|NCT01539369|dietary intervention|dietary intervention
473926|NCT01539369|dietary fibre|dietary fibre
473927|NCT01539369|weight loss|weight loss
473928|NCT01539369|weight maintenance|weight maintenance
473929|NCT01539356|Hepcidin|hepcidin
473930|NCT01539356|Preterm Infants|preterm infants
473931|NCT01539356|Anemia|anemia
473932|NCT01539356|Sepsis|sepsis
473933|NCT01539356|Ferritin|ferritin
473934|NCT01539343|Infection|infection
473935|NCT01539343|Catheter-related bloodstream infection|catheter-related bloodstream infection
473936|NCT01539343|CRBSI|crbsi
473937|NCT01539343|Antimicrobial Lock Therapy|antimicrobial lock therapy
473938|NCT01539343|ALT|alt
473939|NCT01539343|Central Line Associated Bloodstream Infection|central line associated bloodstream infection
473940|NCT01539343|CLABSI|clabsi
473941|NCT01539343|Central Venous Catheter|central venous catheter
473942|NCT01539343|CVC|cvc
473943|NCT01539343|Quantitative blood cultures|quantitative blood cultures
473944|NCT01539343|QBC|qbc
473945|NCT01539330|voriconazole|voriconazole
473946|NCT01539330|microdialysis|microdialysis
473947|NCT01539330|sequence therapy|sequence therapy
473948|NCT01539330|pharmacokinetics|pharmacokinetics
473949|NCT01539330|Target Site Pharmacokinetics|target site pharmacokinetics
473951|NCT01539317|Dyspareunia|dyspareunia
473952|NCT01539317|Breast Cancer|breast cancer
473953|NCT01539317|Menopause|menopause
473954|NCT01539317|Vaginal dryness|vaginal dryness
473955|NCT01539317|Painful intercourse|painful intercourse
473956|NCT01539291|CLL|cll
473957|NCT01539291|CAL-101|cal-101
473958|NCT01539291|CAL 101|cal 101
473959|NCT01539291|GS-1101|gs-1101
473960|NCT01539291|GS 1101|gs 1101
473961|NCT01539291|PI3K|pi3k
473962|NCT01539291|Leukemia|leukemia
473963|NCT01539291|GS-US-312-0116|gs-us-312-0116
473964|NCT01539291|idelalisib|idelalisib
473965|NCT01539278|Sleep Apnea, Obstructive|sleep apnea, obstructive
473966|NCT01539278|Child|child
473967|NCT01539278|Tonsillectomy|tonsillectomy
473968|NCT01539278|Adenoidectomy|adenoidectomy
473969|NCT01539265|urinary calculus|urinary calculus
473970|NCT01539265|ureteral stones|ureteral stones
473971|NCT01539265|medical expulsive therapy|medical expulsive therapy
473972|NCT01539252|hemodialysis|hemodialysis
473973|NCT01539252|adequacy|adequacy
473974|NCT01539252|phosphate clearance|phosphate clearance
473975|NCT01539252|double dialyzer|double dialyzer
473976|NCT01539252|two dialyzers in parallel|two dialyzers in parallel
473977|NCT01539239|Glaucoma|glaucoma
473978|NCT01539239|POAG|poag
473979|NCT01539239|Cataract|cataract
473980|NCT01539226|HIV Infections|hiv infections
473981|NCT01539226|Anti-HIV agents|anti-hiv agents
473982|NCT01539226|HIV-1|hiv-1
473983|NCT01539213|Psoriasis|psoriasis
473984|NCT01539213|interstitial fluid|interstitial fluid
473985|NCT01539213|open flow microperfusion|open flow microperfusion
473986|NCT01539213|IL-17|il-17
473987|NCT01539213|inflammatory skin disease|inflammatory skin disease
473988|NCT01539213|scaly patches|scaly patches
473989|NCT01539213|Healthy volunteers and psoriasis patients|healthy volunteers and psoriasis patients
473990|NCT01539187|uterine fibroid RF ablation|uterine fibroid rf ablation
473991|NCT01539187|intrauterine ultrasound|intrauterine ultrasound
473992|NCT01539187|VizAblate|vizablate
473993|NCT01539161|Chagas Disease|chagas disease
473994|NCT01539161|Chagasic|chagasic
473995|NCT01539161|Reveal XT|reveal xt
473996|NCT01539161|Implantable Cardiac Monitor|implantable cardiac monitor
473997|NCT01539161|ICM|icm
473998|NCT01539148|Quality of Life|quality of life
473999|NCT01539148|Qol|qol
474000|NCT01539148|Questionnaire|questionnaire
474001|NCT01539148|Survey|survey
474002|NCT01539148|Insulin Potentiation Targeted Low Dose Chemotherapy|insulin potentiation targeted low dose chemotherapy
474003|NCT01539148|IPTLD|iptld
474004|NCT01539148|Nutritional Therapy|nutritional therapy
474005|NCT01539148|Chemotherapy|chemotherapy
474006|NCT01539148|Cancer Treatment|cancer treatment
474007|NCT01539148|Kotsanis Institute|kotsanis institute
474008|NCT01539148|The Best Answer for Cancer Foundation|the best answer for cancer foundation
474009|NCT01539148|Liberty IRB|liberty irb
474010|NCT01539148|Texas|texas
474011|NCT01539135|Aspiration, Respiratory|aspiration, respiratory
474012|NCT01539122|osteoarthritis|osteoarthritis
474013|NCT01539122|shoulder replacement|shoulder replacement
474014|NCT01539109|Incomplete Spinal Cord Injury|incomplete spinal cord injury
474015|NCT01539109|Quadriplegia|quadriplegia
474016|NCT01539109|Tetraplegia|tetraplegia
474017|NCT01539109|SCI|sci
474018|NCT01539109|Spinal Cord Disease|spinal cord disease
474019|NCT01539109|Spinal Cord Injury|spinal cord injury
474020|NCT01539109|iSCI|isci
474021|NCT01539109|Transcranial Direct Current Stimulation|transcranial direct current stimulation
474022|NCT01539109|tDCS|tdcs
474023|NCT01539109|SCI recovery|sci recovery
474024|NCT01539109|brain stimulation|brain stimulation
474025|NCT01539109|rehabilitation|rehabilitation
474026|NCT01539096|Stroke|stroke
474027|NCT01539096|Rehabilitation|rehabilitation
474028|NCT01539096|Paresis|paresis
474029|NCT01539096|Paralysis|paralysis
474030|NCT01539096|Recovery|recovery
474031|NCT01539096|tDCS|tdcs
474032|NCT01539096|Transcranial Direct Current Stimulation|transcranial direct current stimulation
474033|NCT01539096|CIMT|cimt
474034|NCT01539096|Constraint Induced Movement Therapy|constraint induced movement therapy
474035|NCT01539096|Stroke therapy|stroke therapy
474036|NCT01539096|MRI|mri
474037|NCT01539096|Hand|hand
474038|NCT01539096|CVA|cva
474039|NCT01539096|Cerebrovascular accident|cerebrovascular accident
474040|NCT01539083|Multiple Myeloma|multiple myeloma
474041|NCT01539083|Bortezomib|bortezomib
474042|NCT01539083|VELCADE|velcade
474043|NCT01539083|Consolidation therapy|consolidation therapy
474044|NCT01539083|Subcutaneous|subcutaneous
474045|NCT01539083|Thalidomide|thalidomide
474046|NCT01539083|Prednisolone|prednisolone
474047|NCT01539083|Autologous stem cell transplant (ASCT)|autologous stem cell transplant (asct)
474048|NCT01539083|VELCADE, cyclophosphamide, dexamethasone (VCD) induction therapy|velcade, cyclophosphamide, dexamethasone (vcd) induction therapy
474049|NCT01539070|Nutritional intervention|nutritional intervention
474050|NCT01539070|Childhood obesity|childhood obesity
474051|NCT01539070|Physical activity|physical activity
474052|NCT01539070|Feeding practices|feeding practices
474053|NCT01539057|Liver|liver
474054|NCT01539057|Surgery|surgery
474055|NCT01539057|hemostasis|hemostasis
474056|NCT01539057|coagulation|coagulation
474057|NCT01539057|Fibrinogen|fibrinogen
474058|NCT01539044|reversal|reversal
474059|NCT01539044|muscle relaxant|muscle relaxant
474060|NCT01539044|sugammadex|sugammadex
474061|NCT01539031|Alzheimer Disease|alzheimer disease
474062|NCT01539031|Dementia|dementia
474063|NCT01539031|Delirium|delirium
474064|NCT01539031|Amnestic|amnestic
474065|NCT01539031|Cognitive Disorders|cognitive disorders
474066|NCT01539031|Donepezil|donepezil
474067|NCT01539031|Brain Diseases|brain diseases
474068|NCT01539031|Central Nervous System Diseases|central nervous system diseases
474069|NCT01539031|Nervous System Diseases|nervous system diseases
474070|NCT01539031|Tauopathies|tauopathies
474071|NCT01539031|Neurodegenerative Diseases|neurodegenerative diseases
474072|NCT01539031|Mental Disorders|mental disorders
474073|NCT01539031|Cholinesterase Inhibitors|cholinesterase inhibitors
474074|NCT01539031|Enzy|enzy
474075|NCT01539005|Recurrence|recurrence
474076|NCT01539005|Tuberculosis|tuberculosis
474077|NCT01538992|renal denervation|renal denervation
474078|NCT01538992|heart failure|heart failure
474079|NCT01538979|Grass pollen allergy|grass pollen allergy
474080|NCT01538979|Immunotherapy|immunotherapy
474081|NCT01538979|Recombinant vaccine|recombinant vaccine
474082|NCT01538979|Rhinitis, allergic, seasonal|rhinitis, allergic, seasonal
474083|NCT01538966|acromegaly|acromegaly
474084|NCT01538966|pituitary|pituitary
474085|NCT01538966|pegvisomant|pegvisomant
474086|NCT01538966|somavert|somavert
474087|NCT01538966|lanreotide|lanreotide
474088|NCT01538966|octreotide|octreotide
474089|NCT01538953|diarrhea|diarrhea
474090|NCT01538953|handwashing|handwashing
474091|NCT01538953|point-of-use water treatment|point-of-use water treatment
474092|NCT01538953|diarrhea longitudinal prevalence|diarrhea longitudinal prevalence
474093|NCT01538940|Influenza|influenza
474094|NCT01538940|Vaccine|vaccine
474095|NCT01538940|Thailand|thailand
474096|NCT01538927|fibrin sealant|fibrin sealant
474097|NCT01538927|tissue adhesive|tissue adhesive
474098|NCT01538927|wound healing|wound healing
474099|NCT01538927|interleukin 1 beta|interleukin 1 beta
474100|NCT01538927|interleukin 8|interleukin 8
474101|NCT01538901|actinic keratoses|actinic keratoses
474102|NCT01538901|organ transplant recipients|organ transplant recipients
474103|NCT01538901|photodynamic therapy|photodynamic therapy
474104|NCT01538901|imiquimod|imiquimod
474105|NCT01538888|WHOLE BODY VIBRATION|whole body vibration
474106|NCT01538888|AGED|aged
474107|NCT01538888|VO2|vo2
474108|NCT01538888|muscle strength|muscle strength
474109|NCT01538875|Hypertension, pregnancy induced|hypertension, pregnancy induced
474110|NCT01538875|Hydralazine|hydralazine
474111|NCT01538875|Labetalol|labetalol
474112|NCT01538823|Surgery, Renal Cell Cancer|surgery, renal cell cancer
474113|NCT01538810|CT imaging|ct imaging
474114|NCT01538797|YF476|yf476
474115|NCT01538797|gastrin receptor antagonist|gastrin receptor antagonist
474116|NCT01538797|gastric pH|gastric ph
474117|NCT01538797|healthy subjects|healthy subjects
474118|NCT01538797|ranitidine|ranitidine
474119|NCT01538784|YF476|yf476
474120|NCT01538784|gastrin receptor antagonist|gastrin receptor antagonist
474121|NCT01538784|gastric pH|gastric ph
474122|NCT01538784|healthy subjects|healthy subjects
474123|NCT01538771|Myocardial infarction|myocardial infarction
474124|NCT01538771|Erythropoietin|erythropoietin
474125|NCT01538771|Myocardial reperfusion injury|myocardial reperfusion injury
474126|NCT01538758|calcifying tendinitis|calcifying tendinitis
474127|NCT01538758|rotator cuff|rotator cuff
474128|NCT01538745|Pain|pain
474129|NCT01538745|Emergency Department|emergency department
474130|NCT01538745|Morphine|morphine
474131|NCT01538745|Ketamine|ketamine
474132|NCT01538706|Hospital-based home care|hospital-based home care
474133|NCT01538706|Pediatric oncology|pediatric oncology
474134|NCT01538693|BDNF|bdnf
474135|NCT01538693|serotonin|serotonin
474136|NCT01538693|high-intensity|high-intensity
474137|NCT01538693|exercise|exercise
474138|NCT01538667|Lung|lung
474139|NCT01538667|Scintigraphy|scintigraphy
474140|NCT01538667|Pharmacokinetics|pharmacokinetics
474141|NCT01538667|Inhalation|inhalation
474142|NCT01538667|Ciprofloxacin|ciprofloxacin
474143|NCT01538654|obesity|obesity
474144|NCT01538654|PSMF ( protein sparing modified fast)|psmf ( protein sparing modified fast)
474145|NCT01538654|Enteral nutrition|enteral nutrition
474146|NCT01538654|Tube feeding|tube feeding
474147|NCT01538654|VLCD ( very low calorie diet)|vlcd ( very low calorie diet)
474148|NCT01538654|Pulmonary function tests|pulmonary function tests
474149|NCT01538654|body composition|body composition
474150|NCT01538654|FFM ( fat free mass)|ffm ( fat free mass)
474151|NCT01538654|Body fat|body fat
474152|NCT01538654|Handgripstregth|handgripstregth
474153|NCT01538628|Prostate cancer|prostate cancer
474154|NCT01538628|Spacer|spacer
474155|NCT01538615|Family meals|family meals
474156|NCT01538615|Home food environment|home food environment
474157|NCT01538615|Electronic media|electronic media
474158|NCT01538602|PCOS|pcos
474159|NCT01538602|cardiovascular disorders|cardiovascular disorders
474160|NCT01538563|ON 01910.Na|on 01910.na
474161|NCT01538563|rigosertib sodium|rigosertib sodium
474162|NCT01538563|rogosertib|rogosertib
474163|NCT01538550|cancer|cancer
474164|NCT01538550|colon|colon
474165|NCT01538550|rectum|rectum
474166|NCT01538550|adenoma|adenoma
474167|NCT01538550|screening|screening
474168|NCT01538550|iFOBT|ifobt
474169|NCT01538550|flexible sigmoidoscopy|flexible sigmoidoscopy
474170|NCT01538550|randomized trial|randomized trial
474171|NCT01538537|ON 01910.Na|on 01910.na
474172|NCT01538537|rigosertib Sodium|rigosertib sodium
474173|NCT01538537|rigosertib|rigosertib
474174|NCT01538498|PCI|pci
474175|NCT01538498|Ovarian cancer|ovarian cancer
474176|NCT01538485|Vitamin D|vitamin d
474177|NCT01538485|regulatory T cells|regulatory t cells
474178|NCT01538485|GUT|gut
474179|NCT01538472|Lymphoma|lymphoma
474180|NCT01538472|Relapse B-cell CD20+ non-Hodgkin's lymphoma|relapse b-cell cd20+ non-hodgkin's lymphoma
474181|NCT01538472|High-dose BEAM chemotherapy|high-dose beam chemotherapy
474182|NCT01538472|Y Zevalin|y zevalin
474183|NCT01538472|In Zevalin|in zevalin
474184|NCT01538472|Rituxan|rituxan
474185|NCT01538472|Rituximab|rituximab
474186|NCT01538472|BCNU|bcnu
474187|NCT01538472|1,3-bis(2-chloroethyl)-1-nitrosourea bis-chloronitrosourea|1,3-bis(2-chloroethyl)-1-nitrosourea bis-chloronitrosourea
474188|NCT01538472|Carmustine|carmustine
474189|NCT01538472|BiCNU|bicnu
474190|NCT01538472|VP-16|vp-16
474191|NCT01538472|Ara-C|ara-c
474192|NCT01538472|Cytarabine|cytarabine
474193|NCT01538472|Cytosar|cytosar
604922|NCT00997217|RIPC|ripc
474194|NCT01538472|DepoCyt|depocyt
474195|NCT01538472|Cytosine Arabinosine Hydrochloride|cytosine arabinosine hydrochloride
474196|NCT01538472|Melphalan|melphalan
474197|NCT01538472|Alkeran|alkeran
474198|NCT01538472|G-CSF|g-csf
474199|NCT01538472|Filgrastim|filgrastim
474200|NCT01538472|Neupogen|neupogen
474201|NCT01538472|Stem cell infusion|stem cell infusion
474202|NCT01538472|Autologous stem cell transplantation|autologous stem cell transplantation
474203|NCT01538459|Blood Glucose|blood glucose
474204|NCT01538459|Bupivacaine|bupivacaine
474205|NCT01538459|Interscalene Nerve Block|interscalene nerve block
474206|NCT01538459|Regional Anesthesia|regional anesthesia
474207|NCT01538459|Pain Blockade|pain blockade
474208|NCT01538459|Arthroscopic Surgery|arthroscopic surgery
474209|NCT01538459|Arthroscopic rotator cuff repair|arthroscopic rotator cuff repair
474210|NCT01538459|Dexamethasone|dexamethasone
474211|NCT01538459|Anti-Inflammatory Agents|anti-inflammatory agents
474212|NCT01538459|Therapeutic Uses|therapeutic uses
474213|NCT01538459|Physiological Effects of Drugs|physiological effects of drugs
474214|NCT01538459|Glucocorticoids|glucocorticoids
474215|NCT01538459|Anesthetics, Local|anesthetics, local
474216|NCT01538459|Anesthetics|anesthetics
474217|NCT01538459|Sensory System Agents|sensory system agents
474218|NCT01538459|Adjuvants, Anesthesia|adjuvants, anesthesia
474219|NCT01538459|Anesthesiology|anesthesiology
474220|NCT01538459|Injections|injections
474221|NCT01538459|Adult|adult
474222|NCT01538459|Analgesia/methods|analgesia/methods
474223|NCT01538459|Brachial Plexus/drug effects|brachial plexus/drug effects
474224|NCT01538459|Brachial Plexus/surgery|brachial plexus/surgery
474225|NCT01538459|Brachial Plexus/ultrasonography|brachial plexus/ultrasonography
474226|NCT01538459|Bupivacaine/administration & dosage|bupivacaine/administration & dosage
474227|NCT01538459|Dexamethasone/administration & dosage|dexamethasone/administration & dosage
474228|NCT01538459|Drug Therapy, Combination|drug therapy, combination
474229|NCT01538459|Female|female
474230|NCT01538459|Humans|humans
474231|NCT01538459|Male|male
474232|NCT01538459|Nerve Block/methods|nerve block/methods
474233|NCT01538459|Pain, Postoperative/etiology|pain, postoperative/etiology
474234|NCT01538459|Pain, Postoperative/prevention & control|pain, postoperative/prevention & control
474235|NCT01538459|Prospective Studies|prospective studies
474236|NCT01538459|Time Factors|time factors
474237|NCT01538446|Elderly|elderly
474238|NCT01538446|Acute coronary syndrome|acute coronary syndrome
474239|NCT01538446|Percutaneous coronary intervention|percutaneous coronary intervention
474240|NCT01538446|Prasugrel|prasugrel
474241|NCT01538446|Platelet function test|platelet function test
474242|NCT01538433|diagnosis|diagnosis
474243|NCT01538433|IgA nephropathy|iga nephropathy
474244|NCT01538420|Safety|safety
474245|NCT01538420|Tolerability|tolerability
474246|NCT01538420|Pharmacokinetics|pharmacokinetics
474247|NCT01538420|Pharmacodynamics|pharmacodynamics
474248|NCT01538407|Strength training|strength training
474249|NCT01538407|Biomechanics|biomechanics
474250|NCT01538407|Quadriceps|quadriceps
474251|NCT01538407|Gait|gait
474252|NCT01538394|smoking cessation|smoking cessation
474253|NCT01538394|abstinence|abstinence
474254|NCT01538394|clinical trial|clinical trial
474255|NCT01538394|varenicline|varenicline
474256|NCT01538394|nicotine|nicotine
474257|NCT01538381|Neoadjuvant targeted therapy|neoadjuvant targeted therapy
474258|NCT01538381|Preoperative targeted therapy|preoperative targeted therapy
474259|NCT01538381|Afatinib|afatinib
474260|NCT01538368|MRCP|mrcp
474261|NCT01538368|ERCP|ercp
474262|NCT01538368|EUS|eus
474263|NCT01538368|Image interpretation|image interpretation
474264|NCT01538368|MRCP findings|mrcp findings
474265|NCT01538368|endoscopic intervention(s)|endoscopic intervention(s)
474266|NCT01538355|multiple sclerosis|multiple sclerosis
474267|NCT01538355|diet|diet
474268|NCT01538355|prolonged fasting|prolonged fasting
474269|NCT01538355|caloric restriction|caloric restriction
474270|NCT01538355|ketogenic low glycemic load treatment|ketogenic low glycemic load treatment
474271|NCT01538355|health related quality of life|health related quality of life
474272|NCT01538355|ketogenic diet|ketogenic diet
474273|NCT01538355|neurodegeneration|neurodegeneration
474274|NCT01538355|neuroinflammation|neuroinflammation
474275|NCT01538329|Dyskinesia|dyskinesia
474276|NCT01538329|L-DOPA|l-dopa
474277|NCT01538329|Early introduced treatment|early introduced treatment
474278|NCT01538329|Amantadine|amantadine
474279|NCT01538316|Prostate cancer|prostate cancer
474280|NCT01538316|dietary supplements|dietary supplements
474281|NCT01538316|quercetin|quercetin
474282|NCT01538316|genistein|genistein
474283|NCT01538316|prostate-specific antigen|prostate-specific antigen
474284|NCT01538316|oxidative Status|oxidative status
474285|NCT01538303|STEMI|stemi
474286|NCT01538303|absolute flow|absolute flow
474287|NCT01538303|microvascular resistance|microvascular resistance
474288|NCT01538290|Calibration|calibration
474289|NCT01538290|Validation|validation
474290|NCT01538290|Transfer function|transfer function
474291|NCT01538290|SphygmoCor|sphygmocor
474292|NCT01538290|Arteriograph|arteriograph
474293|NCT01538277|contact force catheter|contact force catheter
474294|NCT01538277|loop recorder|loop recorder
474295|NCT01538251|ulcerative colitis|ulcerative colitis
474296|NCT01538251|propionyl-l-carnitine|propionyl-l-carnitine
474297|NCT01538225|Spasticity|spasticity
474298|NCT01538212|Alzheimer's disease|alzheimer's disease
474299|NCT01538212|retrospective|retrospective
474300|NCT01538212|Axona|axona
474301|NCT01538199|Device study|device study
474302|NCT01538199|Depression|depression
474303|NCT01538199|Major Depression|major depression
474304|NCT01538199|Major Depressive Disorder|major depressive disorder
474305|NCT01538199|MDD|mdd
474306|NCT01538199|Device for depression|device for depression
474307|NCT01538199|Alternatives to medication for depression|alternatives to medication for depression
474308|NCT01538199|Massachusetts General Hospital|massachusetts general hospital
474309|NCT01538199|Boston|boston
474310|NCT01538186|Coronary intervention|coronary intervention
474311|NCT01538186|PCI of the side branch|pci of the side branch
474312|NCT01538173|surgical side infection|surgical side infection
474313|NCT01538173|breast reduction|breast reduction
474314|NCT01538173|reduction mammaplasty|reduction mammaplasty
474315|NCT01538173|prospective trial|prospective trial
474316|NCT01538173|microcirculation|microcirculation
474317|NCT01538173|breast surgery|breast surgery
474318|NCT01538160|recombinant factor VIIa|recombinant factor viia
474319|NCT01538160|factor XI deficiency|factor xi deficiency
474320|NCT01538147|Restless Leg Syndrome|restless leg syndrome
474321|NCT01538147|Severe Preeclampsia|severe preeclampsia
474322|NCT01538134|Antibodies, anticardiolipin|antibodies, anticardiolipin
474323|NCT01538134|Antibodies, B2 Glycoprotein I|antibodies, b2 glycoprotein i
474324|NCT01538134|Lupus Anticoagulant|lupus anticoagulant
474325|NCT01538134|Fetal Growth Restriction|fetal growth restriction
474326|NCT01538121|Antibodies, anticardiolipin|antibodies, anticardiolipin
474327|NCT01538121|Antibodies, B2 Glycoprotein I|antibodies, b2 glycoprotein i
474328|NCT01538121|Lupus Anticoagulant|lupus anticoagulant
474329|NCT01538121|Severe Preeclampsia|severe preeclampsia
474330|NCT01538082|Anxiety disorders|anxiety disorders
474331|NCT01538082|Depressive disorders|depressive disorders
474332|NCT01538082|Metabolic syndrome|metabolic syndrome
474333|NCT01538082|Stress disorders|stress disorders
474334|NCT01538082|Primary care|primary care
474335|NCT01538069|Heart failure|heart failure
474336|NCT01538069|Sleep apnea syndromes|sleep apnea syndromes
474337|NCT01538069|Exercise|exercise
474338|NCT01538069|Continuous Positive Airway Pressure|continuous positive airway pressure
474339|NCT01538056|AAA|aaa
474340|NCT01538043|Cost-effectiveness analysis|cost-effectiveness analysis
474341|NCT01538043|Cost-utility analysis|cost-utility analysis
474342|NCT01538043|Osteoarthritis|osteoarthritis
474343|NCT01538043|Spa therapy|spa therapy
474344|NCT01538043|Randomized clinical trial|randomized clinical trial
474345|NCT01538043|Mechanisms of action|mechanisms of action
474346|NCT01538030|Fetal membranes, premature rupture|fetal membranes, premature rupture
474347|NCT01538030|Cesarean section|cesarean section
474348|NCT01538030|Perinatal mortality|perinatal mortality
474349|NCT01538030|Neonatal sepsis|neonatal sepsis
474350|NCT01538030|Amniotic Fluid Volume|amniotic fluid volume
474351|NCT01538004|Blood pressure determination|blood pressure determination
474352|NCT01538004|Primary health care|primary health care
474353|NCT01538004|Office visits|office visits
474354|NCT01538004|Reproducibility of results|reproducibility of results
474355|NCT01537991|radiotherapy|radiotherapy
474356|NCT01537991|non small cell lung cancer|non small cell lung cancer
474357|NCT01537991|isotoxic|isotoxic
474358|NCT01537978|spinal cord injury, video gaming, functional improvement|spinal cord injury, video gaming, functional improvement
474359|NCT01537965|hepatitis|hepatitis
474360|NCT01537965|fibrosis|fibrosis
474361|NCT01537965|elastography|elastography
474362|NCT01537952|facial paralysis, facial nerve, borreliosis, Bell's palsy|facial paralysis, facial nerve, borreliosis, bell's palsy
474363|NCT01537939|Physical Activity|physical activity
474364|NCT01537939|Walking|walking
474365|NCT01537939|Pedometer|pedometer
474366|NCT01537939|Body Composition|body composition
474367|NCT01537939|Aerobic Fitness|aerobic fitness
474368|NCT01537926|HALT|halt
474369|NCT01537926|HCM|hcm
474370|NCT01537874|Secondhand smoke|secondhand smoke
474371|NCT01537874|Pediatric disease|pediatric disease
474372|NCT01537848|EUS|eus
474373|NCT01537848|Endoscopic ultrasound|endoscopic ultrasound
474374|NCT01537848|abdominal collection|abdominal collection
474375|NCT01537848|post-operative|post-operative
474376|NCT01537848|post-surgical|post-surgical
474377|NCT01537835|healthcare|healthcare
474378|NCT01537835|worker|worker
474379|NCT01537835|uniforms|uniforms
474380|NCT01537835|bacterial|bacterial
474381|NCT01537835|contamination|contamination
474382|NCT01537822|intrauterine polyps|intrauterine polyps
474383|NCT01537822|myomas|myomas
474384|NCT01537822|residual placental tissue|residual placental tissue
474385|NCT01537809|Vitamin D|vitamin d
474386|NCT01537809|Vitamin D Deficiency|vitamin d deficiency
474387|NCT01537809|Avitaminosis|avitaminosis
474388|NCT01537809|Deficiency Diseases|deficiency diseases
474389|NCT01537809|Blood lipids|blood lipids
474390|NCT01537796|Obesity|obesity
474391|NCT01537796|Exercise|exercise
474392|NCT01537783|abscess|abscess
474393|NCT01537770|Vertebroplasty|vertebroplasty
474394|NCT01537770|Low energy osteoporotic vertebral fractures|low energy osteoporotic vertebral fractures
474395|NCT01537770|of the thoracic and/or lumbar spine|of the thoracic and/or lumbar spine
474396|NCT01537744|expansion cohort|expansion cohort
474397|NCT01537705|Medical food|medical food
474398|NCT01537705|Neuropathy|neuropathy
474399|NCT01537705|Diabetes|diabetes
474400|NCT01537705|Neuropathic Pain|neuropathic pain
474401|NCT01537679|Caregiver|caregiver
474402|NCT01537679|meditation|meditation
474403|NCT01537679|relaxation|relaxation
474404|NCT01537679|stress|stress
474405|NCT01537627|Motor activity|motor activity
474406|NCT01537627|Exercise|exercise
474407|NCT01537627|Rehabilitation|rehabilitation
474408|NCT01537601|Posterior urethral valves|posterior urethral valves
474409|NCT01537601|Febrile urinary tract infection|febrile urinary tract infection
474410|NCT01537601|Circumcision|circumcision
474411|NCT01537601|Antibioprophylaxis|antibioprophylaxis
474412|NCT01537601|Impact on family|impact on family
474413|NCT01537588|anterior cruciate ligament|anterior cruciate ligament
474414|NCT01537588|hamstring|hamstring
474415|NCT01537588|semitendinosus|semitendinosus
474416|NCT01537588|gracilis|gracilis
474417|NCT01537588|graft|graft
474418|NCT01537562|Copper IUD|copper iud
474419|NCT01537562|LNG-IUS|lng-ius
474420|NCT01537562|intrauterine contraception|intrauterine contraception
474421|NCT01537562|medical abortion|medical abortion
474422|NCT01537562|postabortion contraception|postabortion contraception
474423|NCT01537549|Progressive supranuclear palsy|progressive supranuclear palsy
474424|NCT01537549|alpha-lipoic acid|alpha-lipoic acid
474425|NCT01537549|L-acetyl carnitine|l-acetyl carnitine
474426|NCT01537549|antioxidant|antioxidant
474427|NCT01537549|magnetic resonance spectroscopy|magnetic resonance spectroscopy
474428|NCT01537549|neurodegeneration|neurodegeneration
474429|NCT01537549|glutathione|glutathione
474430|NCT01537536|Breast cancer|breast cancer
474431|NCT01537536|Neoadjuvant chemotherapy|neoadjuvant chemotherapy
474432|NCT01537536|EndoTAG-1|endotag-1
474433|NCT01537523|physical|physical
474434|NCT01537523|psychological|psychological
474435|NCT01537523|fracture hip|fracture hip
474436|NCT01537497|Phase 1|phase 1
474437|NCT01537497|Single Doses|single doses
474438|NCT01537497|Pharmacodynamics|pharmacodynamics
474439|NCT01537497|Healthy Volunteers|healthy volunteers
474440|NCT01537484|massage|massage
474441|NCT01537484|osteoarthritis|osteoarthritis
474442|NCT01537484|light touch|light touch
474443|NCT01537484|Swedish|swedish
474444|NCT01537471|PPI|ppi
474445|NCT01537471|Meclizine|meclizine
474446|NCT01537471|Startle|startle
474447|NCT01537471|Sensory processing|sensory processing
474448|NCT01537471|antihistamines|antihistamines
474449|NCT01537445|Diabetes Mellitus|diabetes mellitus
474450|NCT01537445|Pancreas|pancreas
474451|NCT01537445|Renal failure|renal failure
474452|NCT01537445|Transplantation|transplantation
474453|NCT01537432|Psoriasis, Plaque-type psoriasis|psoriasis, plaque-type psoriasis
474454|NCT01537432|Plaque|plaque
474455|NCT01537432|Secukinumab|secukinumab
474456|NCT01537432|AIN457A|ain457a
474457|NCT01537432|PASI|pasi
474458|NCT01537432|DLQI|dlqi
474459|NCT01537432|IGA|iga
474460|NCT01537419|Suicide|suicide
474461|NCT01537419|Depression|depression
474462|NCT01537419|Family Relationships|family relationships
474463|NCT01537406|BREAST IRRADIATION USING INTENSITY MODULATED RADIATION THERAPY|breast irradiation using intensity modulated radiation therapy
474465|NCT01537393|transplant|transplant
474466|NCT01537393|preservation|preservation
474467|NCT01537393|endothelial keratoplasty|endothelial keratoplasty
474468|NCT01537367|Human immunodeficiency virus|human immunodeficiency virus
474469|NCT01537367|HIV primary care|hiv primary care
474470|NCT01537328|Total knee arthroplasty|total knee arthroplasty
474471|NCT01537328|quadriceps|quadriceps
474472|NCT01537328|muscle|muscle
474473|NCT01537328|arthroplasty|arthroplasty
474474|NCT01537328|joint diseases|joint diseases
474475|NCT01537328|musculoskeletal diseases|musculoskeletal diseases
474476|NCT01537315|Kidney Failure, Chronic|kidney failure, chronic
474477|NCT01537315|Cardiovascular Disease|cardiovascular disease
474478|NCT01537315|Arteriosclerosis|arteriosclerosis
474479|NCT01537302|Chronic Total Occlusion|chronic total occlusion
474480|NCT01537302|Optimal Coherence Tomography|optimal coherence tomography
474481|NCT01537302|Lumivascular|lumivascular
474482|NCT01537289|Trauma|trauma
474483|NCT01537289|Pneumothorax|pneumothorax
474484|NCT01537276|hysterosalpingography|hysterosalpingography
474485|NCT01537276|Fluoroscopy|fluoroscopy
474486|NCT01537276|diagnostic accuracy|diagnostic accuracy
474487|NCT01537263|Aneurysmal Subarachnoid Hemorrhage|aneurysmal subarachnoid hemorrhage
474488|NCT01537263|SAB|sab
474489|NCT01537263|SAH|sah
474490|NCT01537263|Ultrasound|ultrasound
474491|NCT01537263|Perfusion imaging|perfusion imaging
474492|NCT01537250|CAP|cap
474493|NCT01537237|Atrial Fibrillation|atrial fibrillation
474494|NCT01537237|Catheter-based ablation|catheter-based ablation
474495|NCT01537237|Pulmonary vein isolation|pulmonary vein isolation
474496|NCT01537237|Electro-anatomical mapping|electro-anatomical mapping
474497|NCT01537237|Rotational angiography|rotational angiography
474498|NCT01537224|Electrophysiology|electrophysiology
474499|NCT01537224|Subthalamic nucleus|subthalamic nucleus
474500|NCT01537224|Parkinson|parkinson
474501|NCT01537211|Dysvascular|dysvascular
474502|NCT01537211|amputation|amputation
474503|NCT01537211|above knee|above knee
474504|NCT01537211|ambulation|ambulation
474505|NCT01537198|Postmarketing Drug Surveillance|postmarketing drug surveillance
474506|NCT01537172|ONO-4053 healthy subjects|ono-4053 healthy subjects
474507|NCT01537172|3 part adaptive design|3 part adaptive design
474508|NCT01537159|AML|aml
474509|NCT01537146|unicompartmental|unicompartmental
474510|NCT01537146|osteoarthritis|osteoarthritis
474511|NCT01537146|varus|varus
474512|NCT01537146|malalignment|malalignment
474513|NCT01537146|opening wedge|opening wedge
474514|NCT01537146|HTO|hto
474515|NCT01537146|high|high
474516|NCT01537146|tibia|tibia
474517|NCT01537146|osteotomy|osteotomy
474518|NCT01537094|low vitamin c|low vitamin c
474519|NCT01537094|reduced growth hormone secretion|reduced growth hormone secretion
474520|NCT01537068|Dysthymic disorder|dysthymic disorder
474521|NCT01537068|Dysthymia|dysthymia
474522|NCT01537068|Chronic non-major depression|chronic non-major depression
474523|NCT01537068|Non-major chronic depression|non-major chronic depression
474524|NCT01537068|Chronic depressive disorder|chronic depressive disorder
474525|NCT01537068|Antidepressant treatment|antidepressant treatment
474526|NCT01537055|H pylori eradication|h pylori eradication
474527|NCT01537042|Rotigotine|rotigotine
474528|NCT01537042|Neupro|neupro
474529|NCT01537042|Restless Legs Syndrome|restless legs syndrome
474530|NCT01537042|RLS|rls
474531|NCT01537042|End-Stage Renal Disease|end-stage renal disease
474532|NCT01537029|Breast cancer|breast cancer
474533|NCT01537029|Pharmacokinetics|pharmacokinetics
474534|NCT01537029|Obesity|obesity
474535|NCT01537029|Doxorubicin|doxorubicin
474536|NCT01537029|Cyclophosphamide|cyclophosphamide
474537|NCT01537029|Weight|weight
474538|NCT01536977|quality of life|quality of life
474539|NCT01536925|Behavioral Economics|behavioral economics
474540|NCT01536925|Drug self administration|drug self administration
474541|NCT01536925|Opioid|opioid
474542|NCT01536912|HIV positive|hiv positive
474543|NCT01536899|HIV positive|hiv positive
474544|NCT01536899|Medical Marijuana|medical marijuana
474545|NCT01536873|treatment experienced patients|treatment experienced patients
474546|NCT01536873|Integrase resistance|integrase resistance
474547|NCT01536834|Verruca|verruca
474548|NCT01536834|Plantar Wart|plantar wart
474549|NCT01536834|Medical Device|medical device
474550|NCT01536834|Podiatry|podiatry
474551|NCT01536834|Footcare|footcare
474552|NCT01536821|Parkinson disease|parkinson disease
474553|NCT01536821|Parkinson's Disease|parkinson's disease
474554|NCT01536821|PD|pd
474555|NCT01536821|LRRK2|lrrk2
474556|NCT01536821|genetics|genetics
474557|NCT01536821|genes|genes
474558|NCT01536808|Diabetes mellitus|diabetes mellitus
474559|NCT01536808|accelerated aging|accelerated aging
474560|NCT01536808|cellular senescence|cellular senescence
474561|NCT01536808|diabetic cardiomyopathy|diabetic cardiomyopathy
474562|NCT01536808|strain imaging|strain imaging
474563|NCT01536808|strain rate imaging,|strain rate imaging,
474564|NCT01536808|echocardiography|echocardiography
474565|NCT01536795|Ointment to treat leishmania skin lesions|ointment to treat leishmania skin lesions
474566|NCT01536782|head and neck cancer|head and neck cancer
474567|NCT01536782|chemoradiation therapy|chemoradiation therapy
474568|NCT01536782|bolus feeding|bolus feeding
474569|NCT01536782|gravity feeding|gravity feeding
474570|NCT01536782|pump feeding|pump feeding
474571|NCT01536782|optimal enteral feeding method|optimal enteral feeding method
474572|NCT01536782|To determine the optimal tube feeding method by analyzing percent weigtht loss.|to determine the optimal tube feeding method by analyzing percent weigtht loss.
474573|NCT01536782|To determine the optimal tube feeding method by analyzing tolerance of enteral feeds.|to determine the optimal tube feeding method by analyzing tolerance of enteral feeds.
474574|NCT01536782|To determine the optimal tube feeding method by analyzing percent met of estimated calories and protein.|to determine the optimal tube feeding method by analyzing percent met of estimated calories and protein.
474575|NCT01536769|Metagenomic analysis|metagenomic analysis
474576|NCT01536769|Microbiota|microbiota
474577|NCT01536756|Depressive disorder|depressive disorder
474578|NCT01536756|exercise|exercise
474579|NCT01536756|pain|pain
474580|NCT01536756|physical|physical
474581|NCT01536756|psychological|psychological
474582|NCT01536756|Chinese|chinese
474583|NCT01536756|mild to severe depressive disorders|mild to severe depressive disorders
474584|NCT01536717|atrial septal defect|atrial septal defect
474585|NCT01536717|mitral valve annuloplasty|mitral valve annuloplasty
474586|NCT01536717|aortic valve annuloplasty|aortic valve annuloplasty
474587|NCT01536717|open heart surgery|open heart surgery
474588|NCT01536717|oxycodone consumption|oxycodone consumption
474589|NCT01536717|articain|articain
474590|NCT01536717|bupivacaine|bupivacaine
474591|NCT01536717|pain after sternotomy|pain after sternotomy
474592|NCT01536717|postoperative pain|postoperative pain
474593|NCT01536717|wound infusion|wound infusion
474594|NCT01536704|nicotine lozenge|nicotine lozenge
474595|NCT01536704|nicotine|nicotine
474596|NCT01536704|nicotine replacement therapy|nicotine replacement therapy
474597|NCT01536691|ramosetron|ramosetron
474598|NCT01536691|ondansetron|ondansetron
474599|NCT01536691|aprepitant|aprepitant
474600|NCT01536691|chemotherapy induced nausea & vomiting|chemotherapy induced nausea & vomiting
474601|NCT01536587|influence of bronchodilatation with salmeterol on the autonomic nervous systems in COPD patients will be measured using MSNA.|influence of bronchodilatation with salmeterol on the autonomic nervous systems in copd patients will be measured using msna.
474602|NCT01536587|Relation of COPD and sympathetic nerve activity is to be evaluated,|relation of copd and sympathetic nerve activity is to be evaluated,
474603|NCT01536561|Tositumomab and/or Iodine I 131 Tositumomab|tositumomab and/or iodine i 131 tositumomab
474604|NCT01536561|B-cell non-Hodgkin's lymphoma|b-cell non-hodgkin's lymphoma
474605|NCT01536561|Dose-limiting toxicity|dose-limiting toxicity
474606|NCT01536561|Bexxar|bexxar
474607|NCT01536548|hemodialysis|hemodialysis
474608|NCT01536548|cannulation|cannulation
474609|NCT01536548|AV-fistula|av-fistula
474610|NCT01536548|buttonhole technique|buttonhole technique
474611|NCT01536535|Ulcerative Colitis|ulcerative colitis
474612|NCT01536535|mesalamine|mesalamine
474613|NCT01536535|corticosteroids|corticosteroids
474614|NCT01536535|PROTECT|protect
474615|NCT01536522|Asthma|asthma
474616|NCT01536522|Allergic Asthma|allergic asthma
474617|NCT01536522|Non-allergic Asthma|non-allergic asthma
474618|NCT01536496|trauma|trauma
474619|NCT01536496|hemorrhagic shock|hemorrhagic shock
474620|NCT01536496|thrombelastography|thrombelastography
474621|NCT01536496|coagulopathy|coagulopathy
474622|NCT01536496|transfusion|transfusion
474623|NCT01536496|resuscitation|resuscitation
474624|NCT01536483|Butyrate|butyrate
474625|NCT01536483|Preterms|preterms
474626|NCT01536483|Very Low Birth Weight (<1250g)|very low birth weight (<1250g)
474627|NCT01536483|Rectocolonic enemas|rectocolonic enemas
474628|NCT01536483|Digestive maturation|digestive maturation
474629|NCT01536483|Parenteral nutrition weaning|parenteral nutrition weaning
474630|NCT01536483|ECUN|ecun
474631|NCT01536483|Whole gut transit time|whole gut transit time
474632|NCT01536470|Intraoperative hemodynamic|intraoperative hemodynamic
474633|NCT01536470|Arterial pressure|arterial pressure
474634|NCT01536470|Postoperative complications|postoperative complications
474635|NCT01536470|Intraoperative fluids|intraoperative fluids
474636|NCT01536470|Noradrenaline|noradrenaline
474637|NCT01536457|asthma|asthma
474638|NCT01536457|children|children
474639|NCT01536457|gastroesophageal reflux|gastroesophageal reflux
474640|NCT01536457|retrospective|retrospective
474641|NCT01536457|data analysis|data analysis
474642|NCT01536444|Mohs surgery|mohs surgery
474643|NCT01536444|Excisional skin surgery|excisional skin surgery
474644|NCT01536444|Micrografting|micrografting
474645|NCT01536431|Diabetes|diabetes
474646|NCT01536418|Crohn's disease, chemokine receptor 9 antagonist, Crohn's Disease Activity Index|crohn's disease, chemokine receptor 9 antagonist, crohn's disease activity index
474647|NCT01536418|active treatment|active treatment
474648|NCT01536392|Cancer of the Cervix|cancer of the cervix
474649|NCT01536392|Anti-emetic therapy|anti-emetic therapy
474650|NCT01536392|Granisetron|granisetron
474651|NCT01536392|Transdermal patch|transdermal patch
474652|NCT01536392|Ondansetron|ondansetron
474653|NCT01536392|Zofran|zofran
474654|NCT01536392|Questionnaires|questionnaires
474655|NCT01536392|Surveys|surveys
474656|NCT01536392|Study Drug Diary|study drug diary
474657|NCT01536379|Infection|infection
474658|NCT01536379|Quality of Life|quality of life
474659|NCT01536366|Parkinson Disease|parkinson disease
474660|NCT01536366|BIA 9-1067|bia 9-1067
474661|NCT01536340|post discharge adverse events|post discharge adverse events
474662|NCT01536340|discontinuities in care|discontinuities in care
474663|NCT01536340|medical injury|medical injury
474664|NCT01536327|leukodystrophies|leukodystrophies
474665|NCT01536327|Metachromatic Leukodystrophy Disease|metachromatic leukodystrophy disease
474666|NCT01536314|Pre-emptive administration|pre-emptive administration
474667|NCT01536314|Post-operative administration|post-operative administration
474668|NCT01536314|Prophylaxis|prophylaxis
474669|NCT01536314|Memantine|memantine
474670|NCT01536314|Post-mastectomy/tumorectomy|post-mastectomy/tumorectomy
474671|NCT01536314|Neuropathic pain|neuropathic pain
474672|NCT01536301|oxycodone|oxycodone
474673|NCT01536301|morphine|morphine
474674|NCT01536301|hip replacement|hip replacement
474675|NCT01536301|analgesia|analgesia
474676|NCT01536301|post operative analgesia|post operative analgesia
474677|NCT01536288|acute mountain sickness|acute mountain sickness
474678|NCT01536288|AMS|ams
474679|NCT01536288|Rhodiola Crenulata|rhodiola crenulata
474680|NCT01536288|mountaineering|mountaineering
474681|NCT01536288|pulse oximetry|pulse oximetry
474682|NCT01536288|oxygen saturation|oxygen saturation
474683|NCT01536275|critical illness|critical illness
474684|NCT01536275|children|children
474685|NCT01536275|nutrition|nutrition
474686|NCT01536275|metabolism|metabolism
474687|NCT01536236|Diabetes|diabetes
474688|NCT01536236|Polyneuropathy|polyneuropathy
474689|NCT01536236|Spinal cord stimulation|spinal cord stimulation
474690|NCT01536223|Nasopharyngeal Carcinoma (NPC)|nasopharyngeal carcinoma (npc)
474691|NCT01536223|cisplatin and 5-fluorouracil (PF)|cisplatin and 5-fluorouracil (pf)
474692|NCT01536223|docetaxel,cisplatin and 5-fluorouracil(TPF)|docetaxel,cisplatin and 5-fluorouracil(tpf)
474693|NCT01536223|Neoadjuvant Chemotherapy|neoadjuvant chemotherapy
474694|NCT01536223|intensity modulated radiotherapy(IMRT)|intensity modulated radiotherapy(imrt)
474695|NCT01536210|ADHD(attention Deficit Hyperactivity Disorder)|adhd(attention deficit hyperactivity disorder)
474696|NCT01536197|obesity|obesity
474697|NCT01536197|gastric bypass|gastric bypass
474698|NCT01536197|gastric banding|gastric banding
474699|NCT01536197|sleeve gastrectomy|sleeve gastrectomy
474700|NCT01536197|weight loss|weight loss
474701|NCT01536197|taste perception|taste perception
474702|NCT01536184|Fetal Alcohol Spectrum Disorder|fetal alcohol spectrum disorder
474703|NCT01536184|FASD|fasd
474704|NCT01536171|runners|runners
474705|NCT01536171|mid-foot strike|mid-foot strike
474706|NCT01536171|fore foot strike|fore foot strike
474707|NCT01536171|metabolic costs|metabolic costs
474708|NCT01536171|trained runners (men,women) with a FM strike|trained runners (men,women) with a fm strike
474709|NCT01536171|shod running|shod running
474710|NCT01536171|barefoot running|barefoot running
474711|NCT01536158|Patent Ductus Arteriosus|patent ductus arteriosus
474712|NCT01536158|Paracetamol|paracetamol
474713|NCT01536158|Ibuprofen|ibuprofen
474714|NCT01536158|Preterm infant|preterm infant
474715|NCT01536145|IGF-1R inhibitor|igf-1r inhibitor
474716|NCT01536145|CP-751871|cp-751871
474717|NCT01536145|multiple myeloma|multiple myeloma
474718|NCT01536132|Levosimendan|levosimendan
474719|NCT01536132|chronic heart failure|chronic heart failure
474720|NCT01536132|inotropic drug|inotropic drug
474721|NCT01536119|Breastfeeding|breastfeeding
474722|NCT01536119|Coparenting|coparenting
474723|NCT01536119|Infant feeding|infant feeding
474724|NCT01536119|Fathers' support|fathers' support
474725|NCT01536119|Breastfeeding support|breastfeeding support
474726|NCT01536119|Breastfeeding support intervention|breastfeeding support intervention
474727|NCT01536119|clinical trial|clinical trial
474728|NCT01536106|Cell therapy, Bone marrow stem cells, cardiac cell therapy|cell therapy, bone marrow stem cells, cardiac cell therapy
474729|NCT01536041|asthma|asthma
474730|NCT01536041|Adult|adult
474731|NCT01536015|Rotigotine|rotigotine
474732|NCT01536015|Neupro®|neupro®
474733|NCT01536015|Levodopa|levodopa
474734|NCT01536015|Gastrointestinal Dysfunction|gastrointestinal dysfunction
474735|NCT01536002|Bariatric surgery|bariatric surgery
474736|NCT01536002|Anesthetics, intravenous|anesthetics, intravenous
474737|NCT01536002|Propofol|propofol
474738|NCT01536002|Pharmacokinetics|pharmacokinetics
474739|NCT01535989|B-cell Non Hodgkin's Lymphomas|b-cell non hodgkin's lymphomas
474740|NCT01535989|CD22 positive|cd22 positive
474741|NCT01535950|Age-related macular degeneration|age-related macular degeneration
474742|NCT01535950|intravitreal, neovascular|intravitreal, neovascular
474743|NCT01535950|anti-vascular endothelial growth factor|anti-vascular endothelial growth factor
474744|NCT01535950|wet AMD|wet amd
474745|NCT01535950|Age-related|age-related
474746|NCT01535950|Macular degeneration|macular degeneration
474848|NCT01535534|prognosis|prognosis
474747|NCT01535950|Intravitreal|intravitreal
474748|NCT01535950|Neovascular|neovascular
474749|NCT01535924|Hodgkin's Lymphoma|hodgkin's lymphoma
474750|NCT01535924|relapsed|relapsed
474751|NCT01535924|refractory|refractory
474752|NCT01535911|ketogenic diet|ketogenic diet
474753|NCT01535911|brain tumors|brain tumors
474754|NCT01535898|MRI|mri
474755|NCT01535898|MR imaging Pulse Sequence|mr imaging pulse sequence
474756|NCT01535898|High Resolution Diffusion-weighted|high resolution diffusion-weighted
474757|NCT01535898|Questionnaire|questionnaire
474758|NCT01535898|12-033|12-033
474759|NCT01535885|Cytoxic T Lymphocytes(CTL)|cytoxic t lymphocytes(ctl)
474760|NCT01535885|T-cell Depleted|t-cell depleted
474761|NCT01535885|Allogeneic Transplant|allogeneic transplant
474762|NCT01535885|Epstein Barr Virus|epstein barr virus
474763|NCT01535885|Adenovirus|adenovirus
474764|NCT01535885|Cytomegalovirus|cytomegalovirus
474765|NCT01535885|Hematopoietic progenitor cell transplantation|hematopoietic progenitor cell transplantation
474766|NCT01535846|taste|taste
474767|NCT01535846|mindful eating|mindful eating
474768|NCT01535846|intuitive eating|intuitive eating
474769|NCT01535846|attitude|attitude
474770|NCT01535846|behavior|behavior
474771|NCT01535833|robotic sacral colpopexy|robotic sacral colpopexy
474772|NCT01535833|Learning curve|learning curve
474773|NCT01535833|Pelvic Organ Prolapse|pelvic organ prolapse
474774|NCT01535833|Robotic Surgery|robotic surgery
474775|NCT01535820|Healthy volunteers|healthy volunteers
474776|NCT01535820|ORTHO EVRA|ortho evra
474777|NCT01535820|Contraceptive hormones|contraceptive hormones
474778|NCT01535820|Transdermal patch|transdermal patch
474779|NCT01535820|Progestin norelgestromin (NGMN)|progestin norelgestromin (ngmn)
474780|NCT01535820|Estrogen ethinyl estradiol (EE)|estrogen ethinyl estradiol (ee)
474781|NCT01535820|JNJ-93964|jnj-93964
474782|NCT01535820|JNJ-622206|jnj-622206
474783|NCT01535807|Atrial Fibrillation|atrial fibrillation
474784|NCT01535807|Cardiac surgery|cardiac surgery
474785|NCT01535807|Coronary Artery Bypass Graft|coronary artery bypass graft
474786|NCT01535807|CorMatrix extra cellular matrix|cormatrix extra cellular matrix
474787|NCT01535807|Heart surgery|heart surgery
474788|NCT01535807|Inflammatory Biomarkers|inflammatory biomarkers
474789|NCT01535807|Myocardial Infarction|myocardial infarction
474790|NCT01535807|identify proteomic inflammatory biomarkers|identify proteomic inflammatory biomarkers
474791|NCT01535794|HPV vaccine|hpv vaccine
474792|NCT01535794|acceptability|acceptability
474793|NCT01535794|males|males
474794|NCT01535794|men who have sex with men|men who have sex with men
474795|NCT01535781|pertrochanteric fracture|pertrochanteric fracture
474796|NCT01535781|tranexamic acid|tranexamic acid
474797|NCT01535781|postoperative blood loss|postoperative blood loss
474798|NCT01535781|blood loss|blood loss
474799|NCT01535781|hidden blood loss|hidden blood loss
474800|NCT01535781|blood transfusions|blood transfusions
474801|NCT01535755|noninvasive mechanical ventilation|noninvasive mechanical ventilation
474802|NCT01535755|ventilator weaning|ventilator weaning
474803|NCT01535742|laryngeal mask airway|laryngeal mask airway
474804|NCT01535742|children|children
474805|NCT01535742|tracheal intubation|tracheal intubation
474806|NCT01535742|fiberoptic bronchoscopy|fiberoptic bronchoscopy
474807|NCT01535690|Laser|laser
474808|NCT01535690|Clinical trial|clinical trial
474809|NCT01535690|Non-surgical periodontal therapy|non-surgical periodontal therapy
474810|NCT01535690|Periodontitis|periodontitis
474811|NCT01535690|bleeding on probing and radiographic bone loss|bleeding on probing and radiographic bone loss
474812|NCT01535690|minimum of 2 teeth with probing depth (PD) ≥ 7 mm and|minimum of 2 teeth with probing depth (pd) ≥ 7 mm and
474813|NCT01535690|2 other teeth with PD ≥ 5 mm|2 other teeth with pd ≥ 5 mm
474814|NCT01535690|mininum 16 teeth in both jaws|mininum 16 teeth in both jaws
474815|NCT01535677|Phase 1|phase 1
474816|NCT01535677|healthy volunteers|healthy volunteers
474817|NCT01535677|cross-over study|cross-over study
474818|NCT01535677|Bioavailability|bioavailability
474819|NCT01535677|Bioequivalence|bioequivalence
474820|NCT01535677|Cmax|cmax
474821|NCT01535677|tmax|tmax
474822|NCT01535677|AUC|auc
474823|NCT01535677|AUC(0-t)|auc(0-t)
474824|NCT01535677|λz|λz
474825|NCT01535677|tlast|tlast
474826|NCT01535664|Multiple Sclerosis|multiple sclerosis
474827|NCT01535664|MS|ms
474828|NCT01535625|Coronary artery disease|coronary artery disease
474829|NCT01535625|Atherosclerosis|atherosclerosis
474830|NCT01535625|CAD|cad
474831|NCT01535599|Acute Otitis Externa|acute otitis externa
474832|NCT01535586|CPAP|cpap
474833|NCT01535586|MAD|mad
474834|NCT01535586|sleep apnea|sleep apnea
474835|NCT01535586|PTSD|ptsd
474836|NCT01535573|Cocaine|cocaine
474837|NCT01535573|citalopram|citalopram
474838|NCT01535573|treatment|treatment
474839|NCT01535573|serotonin|serotonin
474840|NCT01535560|Acute otitis externa|acute otitis externa
474841|NCT01535547|isavuconazole|isavuconazole
474842|NCT01535547|tacrolimus|tacrolimus
474843|NCT01535547|Healthy Volunteers|healthy volunteers
474844|NCT01535547|BAL8557|bal8557
474845|NCT01535534|sepsis|sepsis
474846|NCT01535534|inflammation|inflammation
474847|NCT01535534|diagnosis|diagnosis
474849|NCT01535534|survival|survival
474850|NCT01535534|mortality|mortality
474851|NCT01535495|beta-antagonist|beta-antagonist
474852|NCT01535495|propranolol|propranolol
474853|NCT01535495|diabetic retinopathy|diabetic retinopathy
474854|NCT01535495|diabetes|diabetes
474855|NCT01535495|angiogenesis|angiogenesis
474856|NCT01535495|neovascularization|neovascularization
474857|NCT01535482|Cognitive therapy|cognitive therapy
474859|NCT01535482|Older men|older men
474860|NCT01535482|suicide ideation|suicide ideation
474861|NCT01535469|cryptococcal meningitis|cryptococcal meningitis
474862|NCT01535469|hiv|hiv
474863|NCT01535469|aids|aids
474864|NCT01535469|implementation science|implementation science
474865|NCT01535469|stepped wedge design|stepped wedge design
474866|NCT01535469|retention-in-care|retention-in-care
474867|NCT01535456|MDS|mds
474868|NCT01535456|AML|aml
474869|NCT01535456|5 azacitidine|5 azacitidine
474870|NCT01535456|FLT PET|flt pet
474871|NCT01535443|PRO-155|pro-155
474872|NCT01535443|Ocular NSAIDs|ocular nsaids
474873|NCT01535443|Safety and tolerability|safety and tolerability
474874|NCT01535443|Ocular Inflammation|ocular inflammation
474875|NCT01535443|Ocular Paint|ocular paint
474876|NCT01535430|brain mapping|brain mapping
474877|NCT01535430|brain tumor|brain tumor
474878|NCT01535417|Osteoarthritis|osteoarthritis
474879|NCT01535391|Chronic Myeloid Leukemia,|chronic myeloid leukemia,
474880|NCT01535391|Nilotinib,|nilotinib,
474881|NCT01535391|Philadelphia positive,|philadelphia positive,
474882|NCT01535391|BCR-ABL+|bcr-abl+
474883|NCT01535391|Early chronic phase|early chronic phase
474884|NCT01535365|muscular sprain|muscular sprain
474885|NCT01535365|acute back pain|acute back pain
474886|NCT01535365|acute neck pain|acute neck pain
474887|NCT01535365|heat treatment|heat treatment
474888|NCT01535365|cold treatment|cold treatment
474889|NCT01535339|mild Traumatic Brain Injury|mild traumatic brain injury
474890|NCT01535339|mTBI|mtbi
474891|NCT01535339|Concussion|concussion
474892|NCT01535326|colonoscopy|colonoscopy
474893|NCT01535300|Ultrasound|ultrasound
474894|NCT01535300|Minimal transverse tracheal diameter|minimal transverse tracheal diameter
474895|NCT01535300|Endotracheal tube size|endotracheal tube size
474896|NCT01535300|Paediatric age-based formulas|paediatric age-based formulas
474897|NCT01535300|Sonographic measurement of the trachea|sonographic measurement of the trachea
474898|NCT01535287|Dexmedetomidine|dexmedetomidine
474899|NCT01535287|Emergence Agitation|emergence agitation
474900|NCT01535287|Myringotomy|myringotomy
474901|NCT01535287|Children|children
474902|NCT01535287|General Anesthesia|general anesthesia
474903|NCT01535274|Cerebral oxygenation|cerebral oxygenation
474904|NCT01535274|Beach chair position|beach chair position
474905|NCT01535274|General anesthetic technique|general anesthetic technique
474906|NCT01535274|Inspired oxygen fraction|inspired oxygen fraction
474907|NCT01535274|End tidal carbon dioxide|end tidal carbon dioxide
474908|NCT01535261|Ophthalmology|ophthalmology
474909|NCT01535261|Ranibizumab|ranibizumab
474910|NCT01535261|Central Retinal Vein Occlusion|central retinal vein occlusion
474911|NCT01535248|ERCP|ercp
474912|NCT01535248|Transthoracic Echocardiography|transthoracic echocardiography
474913|NCT01535248|Air Embolus|air embolus
474914|NCT01535248|ERCP associated air embolus|ercp associated air embolus
474916|NCT01535235|Lymphoid fibrosis|lymphoid fibrosis
474917|NCT01535222|cardiac surgery|cardiac surgery
474918|NCT01535222|coronary artery bypass graft|coronary artery bypass graft
474919|NCT01535222|cardiopulmonary bypass|cardiopulmonary bypass
474920|NCT01535222|haemostasis modulator|haemostasis modulator
474921|NCT01535222|blood loss|blood loss
474922|NCT01535222|direct inhibitor of plasmin and plasma kallikrein|direct inhibitor of plasmin and plasma kallikrein
474923|NCT01535222|CABG|cabg
474924|NCT01535222|CPB|cpb
474925|NCT01535209|Stereotactic radiotherapy|stereotactic radiotherapy
474926|NCT01535209|Whole-brain radiotherapy|whole-brain radiotherapy
474927|NCT01535209|Resection cavity|resection cavity
474928|NCT01535196|vitamin D|vitamin d
474929|NCT01535196|heart failure|heart failure
474930|NCT01535183|irinotecan|irinotecan
474931|NCT01535183|brain tumor|brain tumor
474932|NCT01535183|pediatrics|pediatrics
474933|NCT01535183|salvage therapy|salvage therapy
474934|NCT01535183|chemotherapy|chemotherapy
474935|NCT01535170|lactoferrin|lactoferrin
474936|NCT01535170|selective decontamination of digestive tract|selective decontamination of digestive tract
474937|NCT01535170|antimicrobial activity|antimicrobial activity
474938|NCT01535170|prolonged mechanical ventilation|prolonged mechanical ventilation
474939|NCT01535170|respiratory care center|respiratory care center
474940|NCT01535157|Chemotherapy|chemotherapy
474941|NCT01535131|otitis media|otitis media
474942|NCT01535131|cleft palate|cleft palate
474943|NCT01535118|Allergies|allergies
474944|NCT01535118|Immunotherapy|immunotherapy
474945|NCT01535092|HCV recurrence|hcv recurrence
474946|NCT01535092|HCV reinfection|hcv reinfection
474947|NCT01535092|Liver transplantation|liver transplantation
474948|NCT01535092|Legalon SIL|legalon sil
474949|NCT01535092|silibinin|silibinin
474950|NCT01535092|viral load|viral load
474951|NCT01535079|sore throat pain|sore throat pain
474952|NCT01535079|tonsillopharyngitis|tonsillopharyngitis
474953|NCT01535079|upper respiratory tract infection|upper respiratory tract infection
474954|NCT01535066|estrogen receptor-positive breast cancer|estrogen receptor-positive breast cancer
474955|NCT01535066|progesterone receptor-positive breast cancer|progesterone receptor-positive breast cancer
474956|NCT01535066|stage IA breast cancer|stage ia breast cancer
474957|NCT01535066|stage IB breast cancer|stage ib breast cancer
474958|NCT01535066|stage II breast cancer|stage ii breast cancer
474959|NCT01535066|stage IIIA breast cancer|stage iiia breast cancer
474960|NCT01535066|stage IIIB breast cancer|stage iiib breast cancer
474961|NCT01535066|stage IIIC breast cancer|stage iiic breast cancer
474962|NCT01535066|pain|pain
474963|NCT01535040|cancer survivor|cancer survivor
474964|NCT01535040|stage I non-small cell lung cancer|stage i non-small cell lung cancer
474965|NCT01535040|stage II non-small cell lung cancer|stage ii non-small cell lung cancer
474966|NCT01535040|tobacco use disorder|tobacco use disorder
474967|NCT01535040|stage IA breast cancer|stage ia breast cancer
474968|NCT01535040|stage IB breast cancer|stage ib breast cancer
474969|NCT01535040|stage II breast cancer|stage ii breast cancer
474970|NCT01535040|stage IIIA breast cancer|stage iiia breast cancer
474971|NCT01535040|stage IIIB breast cancer|stage iiib breast cancer
474972|NCT01535040|stage IIIC breast cancer|stage iiic breast cancer
474973|NCT01535040|stage I prostate cancer|stage i prostate cancer
474974|NCT01535040|stage IIA prostate cancer|stage iia prostate cancer
474975|NCT01535040|stage IIB prostate cancer|stage iib prostate cancer
474976|NCT01535040|stage III prostate cancer|stage iii prostate cancer
474977|NCT01535040|stage I colon cancer|stage i colon cancer
474978|NCT01535040|stage IIA colon cancer|stage iia colon cancer
474979|NCT01535040|stage IIB colon cancer|stage iib colon cancer
474980|NCT01535040|stage IIC colon cancer|stage iic colon cancer
474981|NCT01535040|stage IIIA colon cancer|stage iiia colon cancer
474982|NCT01535040|stage IIIB colon cancer|stage iiib colon cancer
474983|NCT01535040|stage IIIC colon cancer|stage iiic colon cancer
474984|NCT01535040|stage I rectal cancer|stage i rectal cancer
474985|NCT01535040|stage IIA rectal cancer|stage iia rectal cancer
474986|NCT01535040|stage IIB rectal cancer|stage iib rectal cancer
474987|NCT01535040|stage IIC rectal cancer|stage iic rectal cancer
474988|NCT01535040|stage IIIA rectal cancer|stage iiia rectal cancer
474989|NCT01535040|stage IIIB rectal cancer|stage iiib rectal cancer
474990|NCT01535040|stage IIIC rectal cancer|stage iiic rectal cancer
474991|NCT01535027|teriparatide|teriparatide
474992|NCT01535027|alendronate|alendronate
474993|NCT01535027|raloxifene|raloxifene
474994|NCT01535027|bone mineral density|bone mineral density
474995|NCT01535001|Osteoarthritis, Knee|osteoarthritis, knee
474996|NCT01535001|Treatment Outcome|treatment outcome
474997|NCT01535001|Time Factors|time factors
474998|NCT01535001|Rehabilitation|rehabilitation
474999|NCT01535001|Combined Modality Therapy|combined modality therapy
475000|NCT01535001|Middle Aged|middle aged
475001|NCT01535001|Aged|aged
475002|NCT01535001|Aged, 80 and over|aged, 80 and over
475003|NCT01535001|Male|male
475004|NCT01535001|Female|female
475005|NCT01535001|Humans|humans
475006|NCT01535001|Analysis of Variance|analysis of variance
475007|NCT01534975|cardiac CT|cardiac ct
475008|NCT01534975|enhancement|enhancement
475009|NCT01534975|contrast|contrast
475010|NCT01534975|safety|safety
475011|NCT01534975|image quality|image quality
475012|NCT01534962|Atrial Fibrillation|atrial fibrillation
475013|NCT01534962|Ranolazine|ranolazine
475014|NCT01534962|Arrhythmias, Cardiac|arrhythmias, cardiac
475015|NCT01534962|Antiarrhythmic Agents|antiarrhythmic agents
475016|NCT01534962|Cardiac Electroversion|cardiac electroversion
475017|NCT01534962|Ranexa|ranexa
475018|NCT01534949|DLBCL, Biosimilar|dlbcl, biosimilar
475019|NCT01534936|schizophrenia|schizophrenia
475020|NCT01534936|atypical antipsychotics|atypical antipsychotics
475021|NCT01534936|depressive symptoms|depressive symptoms
475022|NCT01534923|Doctor-Patient Communication|doctor-patient communication
475023|NCT01534923|questionnaire|questionnaire
475024|NCT01534923|survey|survey
475025|NCT01534923|12-017|12-017
475026|NCT01534910|garlic|garlic
475027|NCT01534910|ct angiography|ct angiography
475028|NCT01534910|atherosclerosis|atherosclerosis
475029|NCT01534910|carotid IMT|carotid imt
475030|NCT01534897|thyroid cancer|thyroid cancer
475031|NCT01534897|Tall cell PTC|tall cell ptc
475032|NCT01534897|Poorly differentiated thyroid carcinoma|poorly differentiated thyroid carcinoma
475033|NCT01534897|metastatic|metastatic
475034|NCT01534884|RA, Biosimilar|ra, biosimilar
475035|NCT01534871|Cardiac rehabilitation|cardiac rehabilitation
475036|NCT01534871|Exercise|exercise
475037|NCT01534871|Systemic inflammation|systemic inflammation
475038|NCT01534871|Cardiovascular disease risk|cardiovascular disease risk
475039|NCT01534858|polyhexanide, polihexanide, PHMB, Prontosan, burns, wounds|polyhexanide, polihexanide, phmb, prontosan, burns, wounds
475040|NCT01534832|surgical smoke|surgical smoke
475041|NCT01534832|laparoscopic surgery|laparoscopic surgery
475042|NCT01534832|impaired vision|impaired vision
475043|NCT01534819|Endograft|endograft
475044|NCT01534819|Endurant|endurant
475045|NCT01534819|Heli-FX™|heli-fx™
475046|NCT01534819|EndoAnchor™|endoanchor™
475047|NCT01534819|Short neck|short neck
475048|NCT01534819|Endovascular treatment|endovascular treatment
475049|NCT01534819|Interventional treatment of aortic aneurysm|interventional treatment of aortic aneurysm
475050|NCT01534819|Abdominal aortic aneurysm|abdominal aortic aneurysm
475051|NCT01534819|AAA|aaa
475052|NCT01534819|Thoracic aortic aneurysm|thoracic aortic aneurysm
475053|NCT01534819|TAA|taa
475054|NCT01534819|Advanced disease|advanced disease
475055|NCT01534806|Migraine|migraine
475056|NCT01534793|Quality assessment|quality assessment
475057|NCT01534793|Benign Prostatic Hyperplasia|benign prostatic hyperplasia
475058|NCT01534793|Enucleation of the prostate|enucleation of the prostate
475059|NCT01534793|LUMENIS|lumenis
475060|NCT01534793|Laser|laser
475061|NCT01534793|Learning Curve|learning curve
475062|NCT01534728|Hepatitis C|hepatitis c
475063|NCT01534728|CD8 epitopes|cd8 epitopes
475064|NCT01534702|Acute Myeloid Leukemia|acute myeloid leukemia
475065|NCT01534702|chemotherapy|chemotherapy
475066|NCT01534702|clofarabine|clofarabine
475067|NCT01534676|iron|iron
475068|NCT01534676|transfusion|transfusion
475069|NCT01534676|red blood cells|red blood cells
475070|NCT01534676|sickle cell disease|sickle cell disease
475071|NCT01534676|thalassemia|thalassemia
475072|NCT01534676|blood donors|blood donors
475073|NCT01534663|Heart Failure|heart failure
475074|NCT01534663|Skeletal Muscle Function|skeletal muscle function
475075|NCT01534663|Metabolism|metabolism
475076|NCT01534663|Inflammation|inflammation
475077|NCT01534663|Glutamine|glutamine
475078|NCT01534663|Fish oil|fish oil
475079|NCT01534663|Muscle Function|muscle function
475080|NCT01534650|motion sensors|motion sensors
475081|NCT01534650|tremor|tremor
475082|NCT01534650|bradykinesia|bradykinesia
475083|NCT01534650|gait|gait
475084|NCT01534650|balance|balance
475085|NCT01534650|dyskinesia|dyskinesia
475086|NCT01534624|Induced Pluripotent Stem Cell (iPS) Cell Lines|induced pluripotent stem cell (ips) cell lines
475087|NCT01534624|Addiction|addiction
475088|NCT01534624|Addiction-Associated Human Gene Variants|addiction-associated human gene variants
475089|NCT01534624|Dopamine Transporter|dopamine transporter
475090|NCT01534598|DNA Methylation|dna methylation
475091|NCT01534598|Advanced Cancer|advanced cancer
475092|NCT01534598|Methyltransferase Inhibitor|methyltransferase inhibitor
475093|NCT01534598|Epigenetics|epigenetics
475094|NCT01534598|Gene Re-Expression|gene re-expression
475095|NCT01534598|Cancer|cancer
475096|NCT01534598|Solid Tumor|solid tumor
475097|NCT01534585|nasopharyngeal carcinoma(NPC)|nasopharyngeal carcinoma(npc)
475098|NCT01534585|Icotinib|icotinib
475099|NCT01534585|Intensity Modulation Radiation Therapy(IMRT)|intensity modulation radiation therapy(imrt)
475100|NCT01534546|neoadjuvant chemotherapy|neoadjuvant chemotherapy
475101|NCT01534546|adjuvant chemotherapy|adjuvant chemotherapy
475102|NCT01534546|DFS|dfs
475103|NCT01534546|OS|os
475104|NCT01534546|safety|safety
475105|NCT01534546|resectable locally advanced gastric carcinoma|resectable locally advanced gastric carcinoma
475106|NCT01534546|potentially resectable locally advanced gastric carcinoma|potentially resectable locally advanced gastric carcinoma
475107|NCT01534533|early atherosclerosis|early atherosclerosis
475108|NCT01534533|serum lutein|serum lutein
475109|NCT01534533|serum lycopene|serum lycopene
475110|NCT01534533|intima-media thickness|intima-media thickness
475111|NCT01534533|arterial stiffness|arterial stiffness
475112|NCT01534533|combined effect|combined effect
475113|NCT01534520|Intrauterine Device|intrauterine device
475114|NCT01534520|Pain|pain
475115|NCT01534520|Lidocaine|lidocaine
475116|NCT01534494|alcohol dependence|alcohol dependence
475117|NCT01534494|psilocybin|psilocybin
475118|NCT01534494|clinical trial|clinical trial
475119|NCT01534494|motivational enhancement therapy|motivational enhancement therapy
475120|NCT01534481|NICHD Neonatal Research Network|nichd neonatal research network
475121|NCT01534481|Extremely Low Birth Weight (ELBW)|extremely low birth weight (elbw)
475122|NCT01534481|Prematurity|prematurity
475123|NCT01534481|Neurodevelopmental Impairment|neurodevelopmental impairment
475124|NCT01534481|Donor Breast Milk|donor breast milk
475125|NCT01534481|Preterm Formula|preterm formula
475126|NCT01534455|German Breast Group|german breast group
475127|NCT01534455|GBG Forschungs GmbH|gbg forschungs gmbh
475128|NCT01534455|GBG|gbg
475129|NCT01534455|GBG 64|gbg 64
475130|NCT01534455|E-VITA|e-vita
475131|NCT01534455|Breast Cancer|breast cancer
475132|NCT01534455|Metastatic Breast Cancer|metastatic breast cancer
475133|NCT01534455|Eribulin|eribulin
475134|NCT01534455|Lapatinib|lapatinib
475135|NCT01534455|Halaven|halaven
475136|NCT01534455|Tyverb|tyverb
475137|NCT01534429|pain|pain
475138|NCT01534416|Paracervical Block|paracervical block
475139|NCT01534416|Laparoscopic Surgery|laparoscopic surgery
475140|NCT01534416|Postoperative Pain|postoperative pain
475141|NCT01534416|Bupivacaine|bupivacaine
475142|NCT01534416|Hysterectomy|hysterectomy
475143|NCT01534416|Myomectomy|myomectomy
475144|NCT01534416|Randomized Trial|randomized trial
475145|NCT01534403|Lupus|lupus
475146|NCT01534403|Monoclonal antibody|monoclonal antibody
475147|NCT01534403|B-cell immunotherapy|b-cell immunotherapy
475148|NCT01534403|Epratuzumab|epratuzumab
475149|NCT01534390|microparticles|microparticles
475150|NCT01534390|in-line microfilters|in-line microfilters
475151|NCT01534390|systemic inflammation|systemic inflammation
475152|NCT01534390|organ failure|organ failure
475153|NCT01534390|critical illness|critical illness
475154|NCT01534390|adult|adult
475155|NCT01534377|Depression|depression
475156|NCT01534377|Adolescents|adolescents
475157|NCT01534364|acute renal failure|acute renal failure
475158|NCT01534364|acute kidney injury|acute kidney injury
475159|NCT01534364|diet|diet
475160|NCT01534364|caloric restriction|caloric restriction
475161|NCT01534364|cardiac surgery|cardiac surgery
475162|NCT01534364|cardiothoracic surgery|cardiothoracic surgery
475163|NCT01534338|Sleep|sleep
475164|NCT01534338|inflammation|inflammation
475165|NCT01534338|mindfulness|mindfulness
475166|NCT01534338|meditation|meditation
475167|NCT01534338|randomized controlled trial|randomized controlled trial
475168|NCT01534312|Glycopeptides|glycopeptides
475169|NCT01534312|Dietary proteins|dietary proteins
475170|NCT01534286|Prescription Medical Food|prescription medical food
475171|NCT01534286|Theramine|theramine
475172|NCT01534286|Knee surgery|knee surgery
475173|NCT01534273|Mild Cognitive Impairment|mild cognitive impairment
475174|NCT01534247|Phase I|phase i
475175|NCT01534247|drug to drug|drug to drug
475176|NCT01534247|CAZ-AVI|caz-avi
475177|NCT01534247|Healthy volunteer|healthy volunteer
475178|NCT01534247|pharmacokinetics|pharmacokinetics
475179|NCT01534247|open label|open label
475180|NCT01534247|metronidazole|metronidazole
475181|NCT01534247|safety|safety
475182|NCT01534234|CRT-D device|crt-d device
475183|NCT01534234|Severe HF (NYHA Class III or ambulatory IV)|severe hf (nyha class iii or ambulatory iv)
475184|NCT01534234|stable, optimal drug regimen|stable, optimal drug regimen
475185|NCT01534234|sinus rhythm|sinus rhythm
475186|NCT01534221|Ischemic Heart Disease|ischemic heart disease
475187|NCT01534182|Relapsing Remitting Multiple Sclerosis (RRMS)|relapsing remitting multiple sclerosis (rrms)
475188|NCT01534182|Fingolimod|fingolimod
475189|NCT01534182|Disease Modifying Therapy (DMT)|disease modifying therapy (dmt)
475190|NCT01534182|TSQM-9|tsqm-9
475191|NCT01534169|Graves' disease|graves' disease
475192|NCT01534169|Dexamethasone|dexamethasone
475193|NCT01534169|Function of regulatory T cells|function of regulatory t cells
475194|NCT01534169|The proportion of Th1 and Th2 cells|the proportion of th1 and th2 cells
475195|NCT01534130|Chronic Fatigue Syndrome|chronic fatigue syndrome
475196|NCT01534130|Sleep Disorder, Adjustment|sleep disorder, adjustment
475197|NCT01534130|Acupuncture|acupuncture
475198|NCT01534104|fMRI|fmri
475200|NCT01534104|DSI|dsi
475201|NCT01534104|tractography|tractography
475202|NCT01534104|neurological/physical testing|neurological/physical testing
475203|NCT01534104|Motor and Language Pathways|motor and language pathways
475204|NCT01534104|resting state fMRI|resting state fmri
475205|NCT01534104|12-008|12-008
475206|NCT01534091|overweight|overweight
475207|NCT01534091|obese|obese
475208|NCT01534091|children|children
475209|NCT01534091|exercise|exercise
475210|NCT01534091|physical activity|physical activity
475211|NCT01534091|pedometer|pedometer
475212|NCT01534078|non-bulky|non-bulky
475213|NCT01534078|limited stage|limited stage
475214|NCT01534065|Hernia|hernia
475215|NCT01534065|Intervertebral Disk Displacement|intervertebral disk displacement
475216|NCT01534065|Pathological Conditions, Anatomical|pathological conditions, anatomical
475217|NCT01534065|Spinal Diseases|spinal diseases
475218|NCT01534065|Bone Diseases|bone diseases
475219|NCT01534065|Musculoskeletal Diseases|musculoskeletal diseases
475220|NCT01534052|Prostate Cancer|prostate cancer
475221|NCT01534052|Castration-Resistant Prostate Cancer (CRPC)|castration-resistant prostate cancer (crpc)
475222|NCT01534052|MDV3100|mdv3100
475223|NCT01534052|Androgen receptor signaling inhibitor|androgen receptor signaling inhibitor
475224|NCT01534013|Closed loop insulin delivery|closed loop insulin delivery
475225|NCT01534000|Cardiac CT|cardiac ct
475226|NCT01534000|Ischemic heat disease|ischemic heat disease
475227|NCT01534000|Stress test|stress test
475228|NCT01533987|Male|male
475229|NCT01533987|Overweight|overweight
475230|NCT01533987|Juice Plus|juice plus
475231|NCT01533961|neglected disease|neglected disease
475232|NCT01533961|africa|africa
475233|NCT01533961|new drug|new drug
475234|NCT01533961|oral drug|oral drug
475235|NCT01533961|parasite|parasite
475236|NCT01533896|Obesity prevention|obesity prevention
475237|NCT01533896|Primary care|primary care
475238|NCT01533896|Education|education
475239|NCT01533883|Mitral|mitral
475240|NCT01533883|Valve|valve
475241|NCT01533883|Annuloplasty|annuloplasty
475242|NCT01533883|Transatrial|transatrial
475243|NCT01533883|Transapical|transapical
475244|NCT01533883|Transfemoral|transfemoral
475245|NCT01533883|Mitral valve insufficiency|mitral valve insufficiency
475246|NCT01533870|Phase 1|phase 1
475247|NCT01533870|Healthy male and female volunteers|healthy male and female volunteers
475248|NCT01533870|Drug-drug interaction|drug-drug interaction
475249|NCT01533870|Pharmacokinetics|pharmacokinetics
475250|NCT01533870|NKTR-118|nktr-118
475251|NCT01533870|Bioavailability|bioavailability
475252|NCT01533870|Plasma AUC and Cmax|plasma auc and cmax
475253|NCT01533870|Plasma AUC0-t and t1/2λz and tmax|plasma auc0-t and t1/2λz and tmax
475254|NCT01533857|Black tea|black tea
475255|NCT01533857|phenolic acids|phenolic acids
475256|NCT01533844|CDAD|cdad
475257|NCT01533844|Neonates|neonates
475258|NCT01533844|Clostridium difficile|clostridium difficile
475259|NCT01533818|Fast breathing|fast breathing
475260|NCT01533818|Young infants|young infants
475261|NCT01533818|Management|management
475262|NCT01533818|Amoxicillin|amoxicillin
475263|NCT01533818|Placebo|placebo
475264|NCT01533805|Lumbago|lumbago
475265|NCT01533805|Exercise therapy|exercise therapy
475266|NCT01533805|Spine|spine
475267|NCT01533792|Treatment|treatment
475268|NCT01533792|pregnant women|pregnant women
475269|NCT01533792|periodontitis|periodontitis
475270|NCT01533792|dental scaling|dental scaling
475271|NCT01533792|dental plaque|dental plaque
475272|NCT01533779|children|children
475273|NCT01533779|malignancy|malignancy
475274|NCT01533779|neutrophil|neutrophil
475275|NCT01533779|neutrophil extracellular traps|neutrophil extracellular traps
475276|NCT01533779|superoxide production|superoxide production
475277|NCT01533779|hydrogen peroxide production|hydrogen peroxide production
475278|NCT01533779|chemotaxis|chemotaxis
475279|NCT01533779|myeloperoxidase|myeloperoxidase
475280|NCT01533779|immunosurveillance|immunosurveillance
475281|NCT01533779|cancer cell lines|cancer cell lines
475282|NCT01533753|hot flashes|hot flashes
475283|NCT01533753|prostate cancer|prostate cancer
475284|NCT01533727|Cytokine-Induced Killer Cell|cytokine-induced killer cell
475285|NCT01533727|NSCLC|nsclc
475286|NCT01533727|adjuvant therapy|adjuvant therapy
475287|NCT01533714|Rheumatoid Arthritis|rheumatoid arthritis
475288|NCT01533714|Monoclonal antibody|monoclonal antibody
475289|NCT01533714|Interleukin-6|interleukin-6
475290|NCT01533714|Olokizumab|olokizumab
475291|NCT01533714|CDP6038|cdp6038
475292|NCT01533701|Hypoxia|hypoxia
475293|NCT01533701|Fetal blood sampling|fetal blood sampling
475294|NCT01533701|Lactate|lactate
475295|NCT01533701|pH|ph
475296|NCT01533701|base deficit|base deficit
475297|NCT01533701|angiogenic factors|angiogenic factors
475298|NCT01533701|suspected fetal hypoxia|suspected fetal hypoxia
475299|NCT01533675|suture, tensile strength, wound care, saline, hydrogen peroxide, skin closure, wounds, wound healing, wound cleansing, antiseptics|suture, tensile strength, wound care, saline, hydrogen peroxide, skin closure, wounds, wound healing, wound cleansing, antiseptics
475300|NCT01533662|phenylephrine|phenylephrine
475301|NCT01533662|hypotension|hypotension
475302|NCT01533662|spinal anesthesia|spinal anesthesia
475303|NCT01533662|lower limb orthopedic surgery|lower limb orthopedic surgery
475304|NCT01533649|Behavioral intervention|behavioral intervention
475305|NCT01533649|Seizure self-efficacy|seizure self-efficacy
475306|NCT01533649|Psychosocial outcomes|psychosocial outcomes
475307|NCT01533649|Quality of Life in Epilepsy|quality of life in epilepsy
475308|NCT01533636|Cystic Fibrosis, Healthy|cystic fibrosis, healthy
475309|NCT01533610|Post-Traumatic Stress disorder|post-traumatic stress disorder
475310|NCT01533610|Stellate ganglion|stellate ganglion
475311|NCT01533610|cervical plexus|cervical plexus
475312|NCT01533610|local anesthesia|local anesthesia
475313|NCT01533610|anxiety|anxiety
475314|NCT01533597|Overactive bladder|overactive bladder
475315|NCT01533597|Solifenacin succinate|solifenacin succinate
475316|NCT01533597|Tamsulosin|tamsulosin
475317|NCT01533571|Guided Bone Regeneration|guided bone regeneration
475318|NCT01533571|Dental Implant|dental implant
475319|NCT01533571|Alveolar Ridge Augmentation|alveolar ridge augmentation
475320|NCT01533571|Socket graft|socket graft
475321|NCT01533558|caspofungin|caspofungin
475322|NCT01533558|pharmacokinetics|pharmacokinetics
475323|NCT01533558|invasive fungal infection|invasive fungal infection
475324|NCT01533558|candidiasis|candidiasis
475325|NCT01533558|aspergillosis|aspergillosis
475326|NCT01533558|intensive care|intensive care
475327|NCT01533545|Mepivacaine|mepivacaine
475328|NCT01533545|Epinephrine|epinephrine
475329|NCT01533545|Brachial plexus block|brachial plexus block
475330|NCT01533545|Renal insufficiency|renal insufficiency
475331|NCT01533532|Gonadotropin-Releasing Hormone (GnRH) antagonist|gonadotropin-releasing hormone (gnrh) antagonist
475332|NCT01533519|Neuropeptide Y|neuropeptide y
475333|NCT01533519|Intranasal Administration|intranasal administration
475334|NCT01533519|PTSD|ptsd
475335|NCT01533519|Trauma|trauma
475336|NCT01533506|treatment with stiripentol|treatment with stiripentol
475337|NCT01533493|ADHD|adhd
475338|NCT01533493|Executive Function|executive function
475339|NCT01533493|Namenda|namenda
475340|NCT01533493|Concerta|concerta
475341|NCT01533480|Adenovirus|adenovirus
475342|NCT01533480|Conjunctivitis|conjunctivitis
475343|NCT01533480|keratoconjunctivitis|keratoconjunctivitis
475344|NCT01533480|viral shedding|viral shedding
475441|NCT01532999|MBSR|mbsr
475345|NCT01533480|subepithelial infiltrate|subepithelial infiltrate
475346|NCT01533480|bulbar injection|bulbar injection
475347|NCT01533467|Delivery rupture|delivery rupture
475348|NCT01533467|perineal protection device|perineal protection device
475349|NCT01533467|reduce perineal tears|reduce perineal tears
475350|NCT01533454|Obesity|obesity
475351|NCT01533454|Weight loss|weight loss
475352|NCT01533454|Incentives|incentives
475353|NCT01533454|Motivation|motivation
475354|NCT01533441|anticoagulant therapy|anticoagulant therapy
475355|NCT01533441|INR|inr
475356|NCT01533441|vitamin K2|vitamin k2
475357|NCT01533441|vitamin K antagonist|vitamin k antagonist
475358|NCT01533428|Painful Diabetic Peripheral Neuropathy,|painful diabetic peripheral neuropathy,
475359|NCT01533428|Capsaicin 8% transdermal delivery system|capsaicin 8% transdermal delivery system
475360|NCT01533415|Anxiety|anxiety
475361|NCT01533415|Anxiety Disorders|anxiety disorders
475362|NCT01533402|Cognitive behavior therapy|cognitive behavior therapy
475363|NCT01533402|Internet|internet
475364|NCT01533402|Anxiety disorders|anxiety disorders
475365|NCT01533402|Children|children
606329|NCT00992459|UCD|ucd
475366|NCT01533376|Sturge Weber|sturge weber
475367|NCT01533376|SWS|sws
475368|NCT01533376|Timolol|timolol
475369|NCT01533376|Port wine mark|port wine mark
475370|NCT01533363|Hemorrhoids|hemorrhoids
475371|NCT01533363|Surgery|surgery
475372|NCT01533363|Hemorrhoidopexy|hemorrhoidopexy
475373|NCT01533363|Milligan Morgan|milligan morgan
475374|NCT01533350|Ultrasonography|ultrasonography
475375|NCT01533350|late follicle phase|late follicle phase
475376|NCT01533350|homogeneous endometrium|homogeneous endometrium
475377|NCT01533350|receptivity|receptivity
475378|NCT01533350|biochemical factor|biochemical factor
475379|NCT01533350|ultrastructure|ultrastructure
475380|NCT01533350|endometrial echo pattern|endometrial echo pattern
475381|NCT01533337|dorsal digital free flap|dorsal digital free flap
475382|NCT01533337|dorsal branch of proper digital nerve|dorsal branch of proper digital nerve
475383|NCT01533337|dorsal branch of proper digital artery|dorsal branch of proper digital artery
475384|NCT01533337|proper digital artery|proper digital artery
475385|NCT01533324|hepatocellular carcinoma|hepatocellular carcinoma
475386|NCT01533324|S-1|s-1
475387|NCT01533324|Leucovorin|leucovorin
475388|NCT01533324|fluorouracil|fluorouracil
475389|NCT01533311|nonpolypoid colorectal neoplasms(NP-CRN)|nonpolypoid colorectal neoplasms(np-crn)
475390|NCT01533311|prevalence|prevalence
475391|NCT01533311|histology|histology
475392|NCT01533285|Major depressive disorder|major depressive disorder
475393|NCT01533285|MDD|mdd
475394|NCT01533285|Psychiatry disorders|psychiatry disorders
475395|NCT01533285|Psychosocial stressor|psychosocial stressor
475396|NCT01533285|Psychosocial stress|psychosocial stress
475397|NCT01533285|Typhoid vaccination|typhoid vaccination
475398|NCT01533285|Typhoid vaccine|typhoid vaccine
475399|NCT01533272|HIV infection|hiv infection
475400|NCT01533272|Postexposure prophylaxis|postexposure prophylaxis
475401|NCT01533259|HIV-1|hiv-1
475402|NCT01533259|HIV|hiv
475403|NCT01533259|Treatment Experienced|treatment experienced
475404|NCT01533233|thoracoscopy|thoracoscopy
475405|NCT01533233|lung cancer|lung cancer
475406|NCT01533233|lobectomy|lobectomy
475407|NCT01533233|epidural anesthesia|epidural anesthesia
475408|NCT01533220|nasal and nasopharyngeal congestion|nasal and nasopharyngeal congestion
475409|NCT01533168|childhood acute lymphoblastic leukemia in remission|childhood acute lymphoblastic leukemia in remission
475410|NCT01533168|recurrent childhood acute lymphoblastic leukemia|recurrent childhood acute lymphoblastic leukemia
475411|NCT01533168|B-cell childhood acute lymphoblastic leukemia|b-cell childhood acute lymphoblastic leukemia
475412|NCT01533155|Phase 1|phase 1
475413|NCT01533155|Healthy male and female volunteers|healthy male and female volunteers
475414|NCT01533155|Drug-drug interaction|drug-drug interaction
475415|NCT01533155|Pharmacokinetics|pharmacokinetics
475416|NCT01533155|NKTR-118|nktr-118
475417|NCT01533142|lipids|lipids
475418|NCT01533129|Hypogonadism|hypogonadism
475419|NCT01533129|Endothelial dysfunction|endothelial dysfunction
475420|NCT01533129|Inflammation|inflammation
475421|NCT01533129|Insulin resistance|insulin resistance
475422|NCT01533129|Testosterone replacement therapy|testosterone replacement therapy
475423|NCT01533116|Parkinson Disease|parkinson disease
475424|NCT01533116|BIA 9-1067|bia 9-1067
475425|NCT01533077|Parkinson Disease|parkinson disease
475426|NCT01533077|BIA 9-1067|bia 9-1067
475427|NCT01533051|Chronic hepatitis B|chronic hepatitis b
475428|NCT01533051|Nucleos(t)ide analogue|nucleos(t)ide analogue
475429|NCT01533051|Antiviral treatment|antiviral treatment
475430|NCT01533051|Korea|korea
475431|NCT01533025|anterior cruciate ligament|anterior cruciate ligament
475432|NCT01533025|Achilles|achilles
475433|NCT01533025|free tendon|free tendon
475434|NCT01533025|bone-tendon|bone-tendon
475435|NCT01533025|free tendon Achilles allograft|free tendon achilles allograft
475436|NCT01533025|Achilles allograft with calcaneal bone block on its end|achilles allograft with calcaneal bone block on its end
475437|NCT01532999|Posttraumatic Stress Disorder|posttraumatic stress disorder
475438|NCT01532999|Meditation|meditation
475439|NCT01532999|Present Centered Group Therapy|present centered group therapy
475440|NCT01532999|mindfulness|mindfulness
475442|NCT01532999|complementary alternative medicine|complementary alternative medicine
475443|NCT01532986|Quality of Health Care|quality of health care
475444|NCT01532986|Nursing Care Management|nursing care management
475445|NCT01532986|Care Coordination|care coordination
475446|NCT01532986|Randomized Trials|randomized trials
475447|NCT01532960|breast cancer|breast cancer
475448|NCT01532960|peptide vaccine|peptide vaccine
475449|NCT01532960|immunotherapy|immunotherapy
475450|NCT01532934|substance use|substance use
475451|NCT01532934|psychopathy|psychopathy
475452|NCT01532934|motivational enhancement|motivational enhancement
475453|NCT01532934|criminal recidivism|criminal recidivism
475454|NCT01532908|Liver Transplantation|liver transplantation
475456|NCT01532895|Cancer pain|cancer pain
475457|NCT01532895|Hydromorphone|hydromorphone
475458|NCT01532895|Hydromorphone OROS|hydromorphone oros
475459|NCT01532895|Narcotic analgesics|narcotic analgesics
475460|NCT01532895|Opioid-naive|opioid-naive
606442|NCT00991939|ITP|itp
475461|NCT01532856|multiple myeloma|multiple myeloma
475462|NCT01532856|thalidomide|thalidomide
475463|NCT01532856|comparative|comparative
475464|NCT01532856|elderly|elderly
475465|NCT01532843|Hepatitis B|hepatitis b
475466|NCT01532843|sustained response|sustained response
475467|NCT01532843|peginterferon|peginterferon
475468|NCT01532843|nucleos(t)ide analogues|nucleos(t)ide analogues
475469|NCT01532830|vagus nerve stimulation|vagus nerve stimulation
475470|NCT01532830|vagal nerve stimulation|vagal nerve stimulation
475471|NCT01532830|nVNS|nvns
475472|NCT01532830|VNS|vns
475473|NCT01532830|migraine|migraine
475474|NCT01532830|non invasive|non invasive
475475|NCT01532830|gammacore|gammacore
475476|NCT01532804|Unresectable metastases|unresectable metastases
475477|NCT01532791|MELAS|melas
475478|NCT01532791|mitochondrial DNA mutation|mitochondrial dna mutation
475479|NCT01532791|mtDNA mutation|mtdna mutation
475480|NCT01532791|mitochondrial DNA|mitochondrial dna
475481|NCT01532791|mitochondria|mitochondria
475482|NCT01532791|m.3243A>G mutation|m.3243a>g mutation
475483|NCT01532765|Internal limiting membrane|internal limiting membrane
475484|NCT01532765|Indocyanine green dye|indocyanine green dye
475485|NCT01532739|Mild Cognitive Impairment|mild cognitive impairment
475486|NCT01532739|Aging|aging
475487|NCT01532739|Memory|memory
475488|NCT01532739|Executive Function|executive function
475489|NCT01532739|Cognitive Intervention|cognitive intervention
475490|NCT01532739|Memory Training|memory training
475491|NCT01532739|Mental Health|mental health
475492|NCT01532726|Partial-Onset Seizures|partial-onset seizures
475493|NCT01532726|Eslicarbazepine Acetate|eslicarbazepine acetate
475494|NCT01532726|ESL|esl
475495|NCT01532726|BIA 2-093|bia 2-093
475496|NCT01532726|BIAL|bial
475497|NCT01532661|TRAUMA|trauma
475498|NCT01532661|HAEMORRHAGIC|haemorrhagic
475499|NCT01532661|rVIIa|rviia
475500|NCT01532661|Complication of Trauma hemorrhage|complication of trauma hemorrhage
475501|NCT01532661|bleeding|bleeding
475502|NCT01532661|rFVIIa administration for hemorrhage after trauma|rfviia administration for hemorrhage after trauma
475503|NCT01532648|Ulcerative Colitis|ulcerative colitis
475504|NCT01532635|hematologic malignancy|hematologic malignancy
475505|NCT01532635|leukemia|leukemia
475506|NCT01532635|Acute lymphoblastic leukemia|acute lymphoblastic leukemia
475507|NCT01532635|ALL|all
475508|NCT01532635|Acute myelogenous leukemia|acute myelogenous leukemia
475509|NCT01532635|AML|aml
475510|NCT01532635|Chronic lymphocytic leukemia|chronic lymphocytic leukemia
475511|NCT01532635|CLL|cll
475512|NCT01532635|lymphoma|lymphoma
475513|NCT01532635|hodgkin's lymphoma|hodgkin's lymphoma
475514|NCT01532635|non-hodgkin's lymphoma|non-hodgkin's lymphoma
475515|NCT01532635|myeloma|myeloma
475516|NCT01532635|allogeneic stem cell transplant|allogeneic stem cell transplant
475517|NCT01532635|TJU 2-step|tju 2-step
475518|NCT01532635|Hematopoietic stem cell transplant|hematopoietic stem cell transplant
475519|NCT01532635|HSCT|hsct
475520|NCT01532635|bone marrow transplant|bone marrow transplant
475521|NCT01532635|Cyclophosphamide|cyclophosphamide
475522|NCT01532635|MMF|mmf
475523|NCT01532635|Mycophenolate Mofetil|mycophenolate mofetil
475524|NCT01532622|Blueberry|blueberry
475525|NCT01532609|Methadone maintenance therapy|methadone maintenance therapy
475526|NCT01532609|Behavioral intervention|behavioral intervention
475527|NCT01532609|Service provider|service provider
475528|NCT01532609|Drug use|drug use
475529|NCT01532570|Behcet's disease|behcet's disease
475530|NCT01532570|intestinal Behcet's disease|intestinal behcet's disease
475531|NCT01532570|neuro-Behcet's disease|neuro-behcet's disease
475532|NCT01532570|vascular Behcet's disease|vascular behcet's disease
475533|NCT01532544|Severe pneumonia|severe pneumonia
475534|NCT01532531|Collateral Meridian Therapy|collateral meridian therapy
475535|NCT01532531|Knee Osteoarthritis|knee osteoarthritis
475536|NCT01532518|Feeding intolerance|feeding intolerance
475537|NCT01532518|Infant|infant
475538|NCT01532518|tachykinin antagonist|tachykinin antagonist
475539|NCT01532518|Infant colic|infant colic
475540|NCT01532518|Nepadutant|nepadutant
475541|NCT01532505|cardiopulmonary bypass|cardiopulmonary bypass
475542|NCT01532505|Postcardiotomy vasodilatory shock|postcardiotomy vasodilatory shock
475543|NCT01532505|Microcirculation|microcirculation
475544|NCT01532505|Catecholamines|catecholamines
475545|NCT01532505|Vasopressin|vasopressin
475546|NCT01532492|Questionnaire|questionnaire
475547|NCT01532492|WORC|worc
475548|NCT01532492|Rotator cuff|rotator cuff
475549|NCT01532492|Reliability|reliability
475550|NCT01532492|Validity|validity
475551|NCT01532492|Responsiveness|responsiveness
475552|NCT01532479|Osteoradionecrosis|osteoradionecrosis
475553|NCT01532479|Xerostomia|xerostomia
475554|NCT01532466|fentanyl-induced coughing, rocuronium|fentanyl-induced coughing, rocuronium
475555|NCT01532401|Blood pressure|blood pressure
475556|NCT01532388|Randomized Controlled Trial|randomized controlled trial
475557|NCT01532388|Alcohol|alcohol
475558|NCT01532388|Drugs|drugs
475559|NCT01532388|Internet|internet
475560|NCT01532388|Screening|screening
475561|NCT01532388|Brief intervention|brief intervention
475562|NCT01532375|Kochujang,|kochujang,
475563|NCT01532375|visceral fat|visceral fat
475564|NCT01532375|population|population
475565|NCT01532349|chronic kidney disease|chronic kidney disease
475566|NCT01532349|anemia|anemia
475567|NCT01532336|adenovirus|adenovirus
475568|NCT01532336|conjunctivitis|conjunctivitis
475569|NCT01532336|pinkeye|pinkeye
475570|NCT01532323|Oral disorders|oral disorders
475571|NCT01532310|systemic lupus erythematosus|systemic lupus erythematosus
475572|NCT01532310|belimumab|belimumab
475573|NCT01532310|pregnancy|pregnancy
475574|NCT01532297|citrate dialysate|citrate dialysate
475575|NCT01532297|dialysis|dialysis
475576|NCT01532297|calcium|calcium
475577|NCT01532284|aneuploid oocytes|aneuploid oocytes
475578|NCT01532284|ICSI|icsi
475579|NCT01532284|IVF|ivf
475580|NCT01532284|Polar Body Biopsy|polar body biopsy
475581|NCT01532271|mild Traumatic Brain Injury|mild traumatic brain injury
475582|NCT01532271|mTBI|mtbi
475583|NCT01532271|Concussion|concussion
475584|NCT01532258|BMI|bmi
475585|NCT01532258|Weight loss|weight loss
475586|NCT01532258|Nutrition|nutrition
475587|NCT01532258|Diet|diet
475588|NCT01532258|Mediterranean diet|mediterranean diet
475589|NCT01532258|Online program|online program
475590|NCT01532258|web-based program|web-based program
475591|NCT01532258|Oxidative stress|oxidative stress
475592|NCT01532258|F2 isoprostanes|f2 isoprostanes
475593|NCT01532232|PLACEBO|placebo
475594|NCT01532232|VARENICLINE (CHANTIX)|varenicline (chantix)
475595|NCT01532232|Self-reported cigarettes smokers|self-reported cigarettes smokers
475596|NCT01532232|Smoking Cessation|smoking cessation
475597|NCT01532232|11-136|11-136
475598|NCT01532206|Remote ischemic preconditioning|remote ischemic preconditioning
475599|NCT01532206|inflammation|inflammation
475600|NCT01532180|Obstructive sleep apnea, neurostimulation, hypoglossal nerve|obstructive sleep apnea, neurostimulation, hypoglossal nerve
475601|NCT01532141|Parkinson Disease|parkinson disease
475602|NCT01532141|BIA 9-1067|bia 9-1067
475603|NCT01532128|Parkinson Disease|parkinson disease
475604|NCT01532128|BIA 9-1067|bia 9-1067
475605|NCT01532115|Parkinson Disease|parkinson disease
475606|NCT01532115|BIA 9-1067|bia 9-1067
475607|NCT01532102|Genital warts|genital warts
475608|NCT01532102|Anogenital warts|anogenital warts
475609|NCT01532102|HPV|hpv
475610|NCT01532102|Human papillomavirus|human papillomavirus
475611|NCT01532102|Antiviral|antiviral
475612|NCT01532076|osteoporosis|osteoporosis
475613|NCT01532076|prox. humeral fracture|prox. humeral fracture
475614|NCT01532076|geriatric trauma|geriatric trauma
475615|NCT01532076|mesenchymal stem cells|mesenchymal stem cells
475616|NCT01532063|Difficult intubation|difficult intubation
475617|NCT01532063|Intensive care units|intensive care units
475618|NCT01532063|Risk factors|risk factors
475619|NCT01532063|Incidence|incidence
475620|NCT01532063|Complications|complications
475621|NCT01532063|Intubation in Intensive Care Unit|intubation in intensive care unit
475622|NCT01532063|More than 2 attempts of intubation|more than 2 attempts of intubation
475623|NCT01532063|Intubation attempts lasting more than 10 minutes|intubation attempts lasting more than 10 minutes
475624|NCT01532050|OSAS|osas
475625|NCT01532050|American Academy of Sleep Medicine Task Force|american academy of sleep medicine task force
475626|NCT01532037|Randomised controlled trial|randomised controlled trial
475627|NCT01532037|Multiple Sclerosis|multiple sclerosis
475628|NCT01532037|Fatigue|fatigue
475629|NCT01532037|Cognitive Behavioural Therapy|cognitive behavioural therapy
475630|NCT01532037|Self Help|self help
475631|NCT01532024|Optical Imaging|optical imaging
475632|NCT01532024|Neutrophil|neutrophil
475633|NCT01532024|Elastase|elastase
475634|NCT01532024|Molecular Imaging|molecular imaging
475635|NCT01532024|Acute Lung Injury|acute lung injury
475636|NCT01532024|ARDS|ards
475637|NCT01532011|Advanced Cancers|advanced cancers
475638|NCT01532011|Solid Tumors|solid tumors
475639|NCT01532011|Erlotinib|erlotinib
475640|NCT01532011|Erlotinib Hydrochloride|erlotinib hydrochloride
475641|NCT01532011|OSI-774|osi-774
475642|NCT01532011|Tarceva|tarceva
475643|NCT01532011|Pralatrexate|pralatrexate
475644|NCT01532011|Folotyn|folotyn
475645|NCT01532011|PDX-010|pdx-010
475646|NCT01531998|Myeloma|myeloma
475647|NCT01531998|Multiple Myeloma|multiple myeloma
475648|NCT01531998|MM|mm
475649|NCT01531998|Newly diagnosed|newly diagnosed
475650|NCT01531998|Lenalidomide|lenalidomide
475651|NCT01531998|CC-5013|cc-5013
475652|NCT01531998|Revlimid|revlimid
475653|NCT01531998|Bortezomib|bortezomib
475654|NCT01531998|Velcade|velcade
475655|NCT01531998|LDP-341|ldp-341
475656|NCT01531998|MLN341|mln341
475657|NCT01531998|PS-341|ps-341
475658|NCT01531998|Siltuximab|siltuximab
475659|NCT01531998|CNTO 328|cnto 328
475660|NCT01531998|Anti-IL-6 Antibody|anti-il-6 antibody
475661|NCT01531998|Dexamethasone|dexamethasone
475662|NCT01531998|Decadron|decadron
711026|NCT00586820|Microvascular Dysfunction|microvascular dysfunction
475663|NCT01531998|M. D. Anderson Symptom Inventory Module|m. d. anderson symptom inventory module
475664|NCT01531998|MDASI-MM|mdasi-mm
475665|NCT01531998|Questionnaires|questionnaires
475666|NCT01531998|Surveys|surveys
475667|NCT01531985|Congenital Heart Disease|congenital heart disease
475668|NCT01531985|Acute Kidney Injury|acute kidney injury
475669|NCT01531985|Cardiopulmonary Bypass|cardiopulmonary bypass
475670|NCT01531985|Biomarkers|biomarkers
475671|NCT01531972|Single-photon Emission Computed Tomography|single-photon emission computed tomography
475672|NCT01531972|Healthy Volunteers|healthy volunteers
475673|NCT01531972|Tomography|tomography
475674|NCT01531959|Midodrine|midodrine
475675|NCT01531959|Hypotension|hypotension
475676|NCT01531959|Intensive care unit|intensive care unit
475677|NCT01531959|IV vasopressors|iv vasopressors
475678|NCT01531959|ICU discharge|icu discharge
475679|NCT01531946|Diffusion Tensor Imaging|diffusion tensor imaging
475680|NCT01531933|Prediabetic|prediabetic
475681|NCT01531933|Primary prevention|primary prevention
475682|NCT01531933|Type 2 diabetes mellitus|type 2 diabetes mellitus
475683|NCT01531907|GLP2|glp2
475684|NCT01531907|Obesity|obesity
475685|NCT01531907|Premenopausal|premenopausal
475686|NCT01531907|Bone|bone
475687|NCT01531907|Formation|formation
475688|NCT01531907|Resorption|resorption
475689|NCT01531894|solid tumor|solid tumor
475690|NCT01531894|GSK2110183|gsk2110183
475691|NCT01531894|hematologic malignancy|hematologic malignancy
475692|NCT01531894|AKT inhibitor|akt inhibitor
475693|NCT01531894|cancer|cancer
475694|NCT01531894|safety|safety
475695|NCT01531868|Decision making|decision making
475696|NCT01531868|Carotid stenosis|carotid stenosis
475697|NCT01531855|T1DM, Exercise|t1dm, exercise
475698|NCT01531842|Conjunctival bacterial flora|conjunctival bacterial flora
475699|NCT01531842|prophylactic topical antibiotic|prophylactic topical antibiotic
475700|NCT01531842|injection|injection
475701|NCT01531842|intravitreal injection|intravitreal injection
475702|NCT01531842|bacterial resistance|bacterial resistance
475703|NCT01531842|serial injection|serial injection
475704|NCT01531842|serial intravitreal injections|serial intravitreal injections
475705|NCT01531842|CNV|cnv
475706|NCT01531842|CRVO|crvo
475707|NCT01531842|AMD|amd
475708|NCT01531842|BRVO|brvo
475709|NCT01531829|pulmonary embolism|pulmonary embolism
475710|NCT01531829|right ventricular dysfunction|right ventricular dysfunction
475711|NCT01531829|Thrombolysis|thrombolysis
475712|NCT01531829|Heparin|heparin
475713|NCT01531816|Pediatrics,|pediatrics,
475714|NCT01531816|Critically ill Children|critically ill children
475715|NCT01531816|immobility|immobility
475716|NCT01531790|Endostar|endostar
475717|NCT01531790|Carboplatin|carboplatin
475718|NCT01531790|Pemetrexed|pemetrexed
475719|NCT01531790|NSCLC|nsclc
475720|NCT01531790|Phase I|phase i
475721|NCT01531777|Advanced Colorectal Cancer|advanced colorectal cancer
475722|NCT01531764|Metastatic breast cancer|metastatic breast cancer
475723|NCT01531764|intermediate HER2 expression|intermediate her2 expression
475724|NCT01531764|Afatinib|afatinib
475725|NCT01531751|HCO-HD|hco-hd
475726|NCT01531751|survival|survival
475727|NCT01531751|cardiac biomarkers|cardiac biomarkers
475728|NCT01531751|AL amyloidosis|al amyloidosis
475729|NCT01531751|Light Chain Amyloidosis|light chain amyloidosis
475730|NCT01531738|Taste|taste
475731|NCT01531738|bariatric surgery|bariatric surgery
475732|NCT01531738|food preferences|food preferences
475733|NCT01531738|reward|reward
475734|NCT01531738|progressive ratio task|progressive ratio task
475735|NCT01531725|Stents|stents
475736|NCT01531712|neoadjuvant treatment|neoadjuvant treatment
475737|NCT01531712|borderline resectability|borderline resectability
475738|NCT01531686|intraosseous vascular access|intraosseous vascular access
475739|NCT01531686|CT examination|ct examination
475740|NCT01531634|Borderline Personality Disorder|borderline personality disorder
475741|NCT01531634|Women|women
475742|NCT01531634|Dynamic Cognitive Intervention|dynamic cognitive intervention
475743|NCT01531634|Recovery|recovery
475744|NCT01531634|Hope Scale|hope scale
475745|NCT01531621|metastatic colorectal cancer|metastatic colorectal cancer
475746|NCT01531608|melanoma|melanoma
475747|NCT01531608|imaging|imaging
475748|NCT01531608|sentinel node|sentinel node
475749|NCT01531608|biopsy|biopsy
475750|NCT01531595|metastatic colorectal cancer|metastatic colorectal cancer
475751|NCT01531582|Angelman|angelman
475752|NCT01531582|Minocycline|minocycline
475753|NCT01531582|cognitive|cognitive
475754|NCT01531582|children|children
475755|NCT01531582|tetracycline|tetracycline
475756|NCT01531569|Flaxseed|flaxseed
475757|NCT01531569|Lignans|lignans
475758|NCT01531569|Pharmacokinetics|pharmacokinetics
475759|NCT01531543|Vacuum Assisted Closure (VAC)|vacuum assisted closure (vac)
475760|NCT01531543|Laparostomy|laparostomy
475761|NCT01531543|Severe peritonitis|severe peritonitis
475762|NCT01531530|Shigella|shigella
475763|NCT01531530|Vaccine|vaccine
475764|NCT01531530|Mucosal immunity|mucosal immunity
475765|NCT01531517|Pedyphar|pedyphar
475766|NCT01531517|Ointment|ointment
475767|NCT01531517|Healing|healing
475768|NCT01531517|Diabetic|diabetic
475769|NCT01531517|Foot Ulcer|foot ulcer
475770|NCT01531504|hysterectomies|hysterectomies
475771|NCT01531504|uterine manipulator|uterine manipulator
475772|NCT01531491|Emergence|emergence
475773|NCT01531491|Hypercapnia|hypercapnia
475774|NCT01531491|Hypocapnia|hypocapnia
475775|NCT01531491|Propofol|propofol
475776|NCT01531478|Childhood cancer|childhood cancer
475777|NCT01531478|Cancer|cancer
475778|NCT01531478|Sequels|sequels
475779|NCT01531478|Complications|complications
475780|NCT01531478|Chemotherapy|chemotherapy
475781|NCT01531478|Radiotherapy|radiotherapy
475782|NCT01531478|Surgery|surgery
475783|NCT01531465|Respiratory insufficiency|respiratory insufficiency
475784|NCT01531465|Infants|infants
475785|NCT01531465|High Flow Nasal Cannula (HFNC)|high flow nasal cannula (hfnc)
475786|NCT01531465|Nasal Continuous Positive Airway Pressure (NCPAP)|nasal continuous positive airway pressure (ncpap)
475787|NCT01531452|Stomach Neoplasms|stomach neoplasms
475788|NCT01531452|drug therapy|drug therapy
475789|NCT01531452|oxaliplatin|oxaliplatin
475790|NCT01531452|s1|s1
475791|NCT01531439|Narcotic Antagonists|narcotic antagonists
475792|NCT01531439|Naloxone infusion|naloxone infusion
475793|NCT01531439|Postoperative pruritis|postoperative pruritis
475794|NCT01531439|Patient controlled analgesia|patient controlled analgesia
475795|NCT01531439|Pediatric|pediatric
475796|NCT01531439|Children|children
475797|NCT01531426|resuscitation|resuscitation
475798|NCT01531426|hypothermia|hypothermia
475799|NCT01531426|outcome|outcome
475800|NCT01531387|Phase III|phase iii
475801|NCT01531387|Sickle cell anemia|sickle cell anemia
475802|NCT01531387|Conditional transcranial doppler velocities|conditional transcranial doppler velocities
475803|NCT01531387|Reduce risk of conversion to abnormally high transcranial doppler velocities|reduce risk of conversion to abnormally high transcranial doppler velocities
475804|NCT01531387|Pediatric patients|pediatric patients
475805|NCT01531374|Valvular Heart Disease|valvular heart disease
475806|NCT01531374|Critical Aortic Stenosis|critical aortic stenosis
475807|NCT01531374|Severe Aortic Stenosis|severe aortic stenosis
475808|NCT01531374|Extreme Risk|extreme risk
475809|NCT01531374|High Risk|high risk
475810|NCT01531374|Aortic Valve Replacement|aortic valve replacement
475811|NCT01531348|Retinitis pigmentosa|retinitis pigmentosa
475812|NCT01531348|Bone marrow-derived mesenchymal stem cells|bone marrow-derived mesenchymal stem cells
475813|NCT01531348|Intravitreal injection|intravitreal injection
475814|NCT01531335|adults|adults
475815|NCT01531322|13vPnC|13vpnc
475816|NCT01531322|Healthy subjects|healthy subjects
475817|NCT01531322|China|china
475818|NCT01531309|Liver impairment|liver impairment
475819|NCT01531309|Major Depression Disorder|major depression disorder
475820|NCT01531309|Sublingual tablet|sublingual tablet
475821|NCT01531296|MRI|mri
475822|NCT01531296|Lower Extremity Rotational|lower extremity rotational
475823|NCT01531296|Femoral Version|femoral version
475824|NCT01531296|Tibial Torsion|tibial torsion
475825|NCT01531283|unacylated ghrelin|unacylated ghrelin
475826|NCT01531283|beta cell function|beta cell function
475827|NCT01531231|heart disease|heart disease
475828|NCT01531231|unstable angina|unstable angina
475829|NCT01531231|myocardial infarction|myocardial infarction
475830|NCT01531231|behavioral|behavioral
475831|NCT01531231|cardiovascular|cardiovascular
475832|NCT01531231|emotions|emotions
475833|NCT01531218|Campylobacter|campylobacter
475834|NCT01531218|concisus|concisus
475835|NCT01531218|diarrhea|diarrhea
475836|NCT01531218|fever|fever
475837|NCT01531218|abdominal pain|abdominal pain
475838|NCT01531218|vomiting|vomiting
475839|NCT01531205|recurrent|recurrent
475840|NCT01531205|high risk|high risk
475841|NCT01531192|Lactobacillus reuteri|lactobacillus reuteri
475842|NCT01531192|Nystatin|nystatin
475843|NCT01531192|Very Low Birth Weight Infants|very low birth weight infants
475844|NCT01531192|Candida Colonization|candida colonization
475845|NCT01531166|Chronic hepatitis B|chronic hepatitis b
475846|NCT01531166|pegylated Interferon-alpha 2a|pegylated interferon-alpha 2a
475847|NCT01531166|Korean|korean
475848|NCT01531153|Cocaine use decreases, increases or stays the same|cocaine use decreases, increases or stays the same
475849|NCT01531140|colonoscopy cleansing|colonoscopy cleansing
475850|NCT01531140|PEG|peg
475851|NCT01531140|sennosides|sennosides
475852|NCT01531140|children|children
475853|NCT01531114|Diabetes mellitus|diabetes mellitus
475854|NCT01531114|antiplatelet effect|antiplatelet effect
475855|NCT01531114|prasugrel|prasugrel
475856|NCT01531114|ticagrelor|ticagrelor
475857|NCT01531114|STEMI|stemi
475858|NCT01531114|Insulin|insulin
475859|NCT01531101|Transference work|transference work
475860|NCT01531101|Psychodynamic|psychodynamic
475861|NCT01531101|Depression|depression
475862|NCT01531101|Treatment|treatment
475863|NCT01531101|Adolescent|adolescent
475864|NCT01531088|Nursing Home|nursing home
710737|NCT00588146|Diffuse pulmonary AVMs with hypoxemia|diffuse pulmonary avms with hypoxemia
475865|NCT01531075|HBV, Inflammatory bowel disease, immunosuppressor|hbv, inflammatory bowel disease, immunosuppressor
475866|NCT01531062|nigella sativa|nigella sativa
475867|NCT01531062|dyslipidemia|dyslipidemia
475868|NCT01531062|elderly|elderly
475869|NCT01531049|smoking cessation|smoking cessation
475870|NCT01531049|young adults|young adults
475871|NCT01531049|motivational counselling|motivational counselling
475872|NCT01531049|smoking|smoking
475873|NCT01531049|nicotine replacement therapy|nicotine replacement therapy
475874|NCT01531049|therapy|therapy
475875|NCT01531023|Extended-Spectrum Beta-lactamase Producing Bacteria|extended-spectrum beta-lactamase producing bacteria
475876|NCT01531010|Neonate|neonate
475877|NCT01531010|Premature|premature
475878|NCT01531010|Pressure limited ventilation|pressure limited ventilation
475879|NCT01531010|Volume ventilation|volume ventilation
475880|NCT01530997|Human Papilloma Virus|human papilloma virus
475881|NCT01530997|Oropharynx|oropharynx
475882|NCT01530997|Oropharyngeal Squamous Cell Carcinoma|oropharyngeal squamous cell carcinoma
475883|NCT01530997|Squamous Cell Carcinoma|squamous cell carcinoma
475884|NCT01530997|Radiation Therapy|radiation therapy
475885|NCT01530997|Chemotherapy|chemotherapy
475886|NCT01530997|p16|p16
475887|NCT01530984|prostate cancer|prostate cancer
475888|NCT01530984|metastatic castrate resistant prostate cancer|metastatic castrate resistant prostate cancer
475889|NCT01530984|Chemotherapy-naïve patients|chemotherapy-naïve patients
475890|NCT01530984|Anti-CTLA4 blockade|anti-ctla4 blockade
475891|NCT01530984|systemic GM-CSF|systemic gm-csf
475892|NCT01530984|Ipilimumab|ipilimumab
475893|NCT01530971|oxygen|oxygen
475894|NCT01530971|pregnancy|pregnancy
475895|NCT01530971|caesarean section|caesarean section
475896|NCT01530971|anesthetic techniques|anesthetic techniques
475897|NCT01530958|CKD|ckd
475898|NCT01530958|Automated Telephone Self Management|automated telephone self management
475899|NCT01530958|Registry|registry
475900|NCT01530958|CKD awareness|ckd awareness
475901|NCT01530958|Self efficacy|self efficacy
475902|NCT01530932|sepsis|sepsis
475903|NCT01530932|tissue oxygenation|tissue oxygenation
475904|NCT01530932|tissue perfusion|tissue perfusion
475905|NCT01530932|immune reaction|immune reaction
475906|NCT01530906|Eating disorders|eating disorders
475907|NCT01530906|Bulimia|bulimia
475908|NCT01530906|rTMS|rtms
475909|NCT01530906|Treatment|treatment
475910|NCT01530893|flavonoids|flavonoids
475911|NCT01530893|vascular function|vascular function
475912|NCT01530893|randomised controlled trial|randomised controlled trial
475913|NCT01530893|placebo controlled|placebo controlled
475914|NCT01530880|Fever reduction|fever reduction
475915|NCT01530880|Fever burden|fever burden
475916|NCT01530880|intravenous ibuprofen|intravenous ibuprofen
475917|NCT01530867|Dietary Supplements|dietary supplements
475918|NCT01530867|Physician-patient communication|physician-patient communication
475919|NCT01530867|Qualitative study|qualitative study
475920|NCT01530867|Audio recorded office visits|audio recorded office visits
475921|NCT01530854|sepsis|sepsis
475922|NCT01530854|free fatty acids|free fatty acids
475923|NCT01530854|emergency department|emergency department
475924|NCT01530841|Myotonic dystrophy type 1|myotonic dystrophy type 1
475925|NCT01530841|Home ventilation|home ventilation
475926|NCT01530841|Respiratory insufficiency|respiratory insufficiency
475927|NCT01530841|Neuromuscular|neuromuscular
475928|NCT01530828|Immunoreactive Trypsinogen|immunoreactive trypsinogen
475929|NCT01530828|Nectrotizing Enterocolitis|nectrotizing enterocolitis
475930|NCT01530828|Premature Infants|premature infants
475931|NCT01530828|Serial IRT|serial irt
475932|NCT01530802|laparoscopic myomectomy, leiomyoma, blood loss, uterine artery|laparoscopic myomectomy, leiomyoma, blood loss, uterine artery
475933|NCT01530789|Telemedecine|telemedecine
475934|NCT01530789|Telemedecine nurse|telemedecine nurse
475935|NCT01530789|Delegation of tasks|delegation of tasks
475936|NCT01530789|Type 1 diabetes|type 1 diabetes
475937|NCT01530776|Pregnancy|pregnancy
475938|NCT01530776|Postpartum|postpartum
475939|NCT01530776|Weight Retention|weight retention
475940|NCT01530776|Behavioral|behavioral
475941|NCT01530776|Electronically-mediated|electronically-mediated
475942|NCT01530763|Infections|infections
475943|NCT01530763|Pediatrics|pediatrics
475944|NCT01530763|Teflaro|teflaro
475945|NCT01530763|cephalosporin|cephalosporin
475946|NCT01530750|postoperative atrial fibrillation|postoperative atrial fibrillation
475947|NCT01530750|internal loop recorder|internal loop recorder
475948|NCT01530750|risk factors|risk factors
476048|NCT01530321|efficacy|efficacy
475949|NCT01530750|coronary artery bypass surgery|coronary artery bypass surgery
475950|NCT01530737|pediatric|pediatric
475951|NCT01530737|Antithrombin|antithrombin
475952|NCT01530737|anticoagulation efficiency|anticoagulation efficiency
475953|NCT01530737|cardiac surgery|cardiac surgery
475954|NCT01530724|abdominal obesity|abdominal obesity
475955|NCT01530698|dendritic cell vaccination|dendritic cell vaccination
475956|NCT01530698|melanoma|melanoma
475957|NCT01530698|toll like receptor ligands|toll like receptor ligands
475958|NCT01530698|mRNA electroporation|mrna electroporation
475959|NCT01530698|vaccines|vaccines
475960|NCT01530685|cinnamon|cinnamon
475961|NCT01530685|chromium|chromium
475962|NCT01530685|prediabete|prediabete
475963|NCT01530685|overweight|overweight
475964|NCT01530672|HIV|hiv
475965|NCT01530672|Syphilis|syphilis
475966|NCT01530672|Combination|combination
475967|NCT01530672|POC|poc
475968|NCT01530672|point-of-care|point-of-care
475969|NCT01530672|MBIO|mbio
475970|NCT01530659|Retinitis pigmentosa|retinitis pigmentosa
475971|NCT01530659|Usher syndrome type 2|usher syndrome type 2
475972|NCT01530659|Usher syndrome type 3|usher syndrome type 3
475973|NCT01530659|Cone photoreceptor|cone photoreceptor
475974|NCT01530659|Vision|vision
475975|NCT01530659|Blind|blind
475976|NCT01530646|obesity|obesity
475977|NCT01530646|overweight|overweight
475978|NCT01530646|muscle|muscle
475979|NCT01530646|protein|protein
475980|NCT01530646|muscle protein synthesis|muscle protein synthesis
475981|NCT01530646|muscle protein breakdown|muscle protein breakdown
475982|NCT01530646|whey|whey
475983|NCT01530646|soy|soy
475984|NCT01530646|caloric restriction|caloric restriction
475985|NCT01530620|Antimuscarinics|antimuscarinics
475986|NCT01530620|Neurogenic bladder|neurogenic bladder
475987|NCT01530620|Propiverine|propiverine
475988|NCT01530620|Urodynamics|urodynamics
475989|NCT01530607|Early Stage Breast Cancer|early stage breast cancer
475990|NCT01530607|Reduce Ovarian Failure Following Chemotherapy|reduce ovarian failure following chemotherapy
475991|NCT01530594|Untreated|untreated
475992|NCT01530594|Without intent for immediate autologous stem cell transplant|without intent for immediate autologous stem cell transplant
475993|NCT01530568|Intensive care, TB, tracheal aspirates, Gene Xpert|intensive care, tb, tracheal aspirates, gene xpert
475994|NCT01530542|bioavailability|bioavailability
475995|NCT01530542|food effect|food effect
475996|NCT01530542|oxycodone|oxycodone
475997|NCT01530542|management of acute and chronic moderate to severe pain|management of acute and chronic moderate to severe pain
475998|NCT01530529|PF-05180999|pf-05180999
475999|NCT01530529|safety|safety
476000|NCT01530529|pharmacokinetics|pharmacokinetics
476001|NCT01530529|relative bioavailability|relative bioavailability
476002|NCT01530529|Mental Disorders|mental disorders
476003|NCT01530529|Schizophrenia and Disorders with Psychotic Features|schizophrenia and disorders with psychotic features
476004|NCT01530529|Schizophrenia|schizophrenia
476005|NCT01530516|Malocclusion, Angle Class II|malocclusion, angle class ii
476006|NCT01530503|biliary tract cancer|biliary tract cancer
476007|NCT01530503|advanced disease|advanced disease
476008|NCT01530503|chemotherapy|chemotherapy
476009|NCT01530490|IVF|ivf
476010|NCT01530490|ovarian hyperstimulation syndrome|ovarian hyperstimulation syndrome
476011|NCT01530490|cabergoline|cabergoline
476012|NCT01530490|hydroxyethyl starch|hydroxyethyl starch
476013|NCT01530490|prevention|prevention
476014|NCT01530477|Bone mineral density|bone mineral density
476015|NCT01530477|weight|weight
476016|NCT01530477|body composition|body composition
476017|NCT01530477|DEXA|dexa
476018|NCT01530477|DXA|dxa
476019|NCT01530464|High altitude induced fatigue|high altitude induced fatigue
476020|NCT01530464|High altitude induced pulmonary Hypertension|high altitude induced pulmonary hypertension
476021|NCT01530451|Nocturia|nocturia
476022|NCT01530451|Obstructive sleep Apnoea|obstructive sleep apnoea
476023|NCT01530451|Desmopressin|desmopressin
476024|NCT01530438|Amyotrophic lateral sclerosis|amyotrophic lateral sclerosis
476025|NCT01530425|pediatric wheelchairs|pediatric wheelchairs
476026|NCT01530425|low-income|low-income
476027|NCT01530425|comparisons|comparisons
476028|NCT01530412|Quality of Life|quality of life
476029|NCT01530412|Free-living activity|free-living activity
476030|NCT01530412|Exacerbation|exacerbation
476031|NCT01530412|Rehabilitation|rehabilitation
476032|NCT01530386|Lacosamide|lacosamide
476033|NCT01530386|Vimpat|vimpat
476034|NCT01530373|hot flashes|hot flashes
476035|NCT01530373|breast cancer|breast cancer
476036|NCT01530373|aromatase inhibitors|aromatase inhibitors
476037|NCT01530373|solifenacin|solifenacin
476038|NCT01530373|clonidine|clonidine
476039|NCT01530373|quality of life|quality of life
476040|NCT01530347|Glucose monitoring|glucose monitoring
476041|NCT01530347|non-invasive glucometer|non-invasive glucometer
476042|NCT01530347|Self glucose monitoring|self glucose monitoring
476043|NCT01530321|cervicogenic headache|cervicogenic headache
476044|NCT01530321|spinal manipulation|spinal manipulation
476045|NCT01530321|chiropractic|chiropractic
476046|NCT01530321|randomized controlled trial|randomized controlled trial
476047|NCT01530321|dose-response|dose-response
476049|NCT01530308|Delirium|delirium
476050|NCT01530282|Respiratory Insufficiency [C08.618.846]|respiratory insufficiency [c08.618.846]
476051|NCT01530269|intermediate|intermediate
476052|NCT01530269|high|high
476053|NCT01530269|risk|risk
476054|NCT01530269|radiation|radiation
476055|NCT01530269|therapy|therapy
476056|NCT01530269|planning|planning
476057|NCT01530269|surgical|surgical
476058|NCT01530269|immunotherapy|immunotherapy
476059|NCT01530269|chemotherapy|chemotherapy
476060|NCT01530269|hormone|hormone
476061|NCT01530256|allograph|allograph
476062|NCT01530256|steroid refractory|steroid refractory
476063|NCT01530230|cesarean section|cesarean section
476064|NCT01530230|electrocardiography|electrocardiography
476065|NCT01530230|heart|heart
476066|NCT01530230|hypotension|hypotension
476067|NCT01530230|ischemia|ischemia
476068|NCT01530230|oxytocin|oxytocin
476069|NCT01530230|preeclampsia|preeclampsia
476070|NCT01530230|regional anesthesia|regional anesthesia
476071|NCT01530230|ECG changes suggestive of myocardial ischemia|ecg changes suggestive of myocardial ischemia
476072|NCT01530217|Analgesics|analgesics
476073|NCT01530217|Ibuprofen|ibuprofen
476074|NCT01530217|Inflammation|inflammation
476075|NCT01530217|Tooth Bleaching|tooth bleaching
476076|NCT01530204|knee arthritis|knee arthritis
476077|NCT01530204|knee osteoarthritis|knee osteoarthritis
476078|NCT01530204|knee pain|knee pain
476079|NCT01530204|cognitive behavioral therapy|cognitive behavioral therapy
476080|NCT01530204|physical therapy|physical therapy
476081|NCT01530204|depression prevention|depression prevention
476082|NCT01530191|depression|depression
476083|NCT01530191|anxiety|anxiety
476084|NCT01530191|pelvic organ prolapse|pelvic organ prolapse
476085|NCT01530191|POP|pop
476086|NCT01530178|Diabetes Mellitus, Type 1|diabetes mellitus, type 1
476087|NCT01530165|IFG|ifg
476088|NCT01530165|IGTT|igtt
476089|NCT01530152|Truwiev PCD laryngoscope|truwiev pcd laryngoscope
476090|NCT01530152|Macintosh laryngoscope|macintosh laryngoscope
476091|NCT01530126|periodontitis|periodontitis
476092|NCT01530113|Childhood sexual abuse|childhood sexual abuse
476093|NCT01530113|Vaginismus|vaginismus
476094|NCT01530113|Partial vaginismus|partial vaginismus
476095|NCT01530113|Labor dystocia|labor dystocia
476096|NCT01530113|Depression|depression
476097|NCT01530100|Edema|edema
476098|NCT01530100|Pain|pain
476099|NCT01530100|Lower laser therapy|lower laser therapy
476100|NCT01530100|orthognathics surgery|orthognathics surgery
476101|NCT01530087|colostomy|colostomy
476102|NCT01530087|ileostomy|ileostomy
476103|NCT01530087|irritant dermatitis|irritant dermatitis
476104|NCT01530087|two piece barrier|two piece barrier
476105|NCT01530074|Mandibular nerve|mandibular nerve
476106|NCT01530074|Mental nerve|mental nerve
476107|NCT01530074|Mandibular incisive nerve|mandibular incisive nerve
476108|NCT01530074|Local anesthesia|local anesthesia
476109|NCT01530074|None, only healthy subjects will be enrolled in this study|none, only healthy subjects will be enrolled in this study
476110|NCT01530035|cardiac|cardiac
476111|NCT01530035|vascular|vascular
476112|NCT01530035|muscular|muscular
476113|NCT01530035|adaptations|adaptations
476114|NCT01530035|soccer training|soccer training
476115|NCT01530035|strength training|strength training
476116|NCT01530022|Lacosamide|lacosamide
476117|NCT01530022|Vimpat|vimpat
476118|NCT01530022|Cognition|cognition
476119|NCT01530022|Mental Processes|mental processes
476120|NCT01530022|Adverse Effects|adverse effects
476121|NCT01530009|Antroduodenal manometry|antroduodenal manometry
476122|NCT01530009|Child|child
476123|NCT01530009|Adolescent|adolescent
476124|NCT01530009|Amoxicillin|amoxicillin
476125|NCT01530009|Gastrointestinal Motility|gastrointestinal motility
476126|NCT01529957|Volunteers|volunteers
476127|NCT01529918|Diabetes|diabetes
476128|NCT01529918|Self-screening|self-screening
476129|NCT01529918|Web-based technology|web-based technology
476130|NCT01529918|follow-up clinical care|follow-up clinical care
476131|NCT01529918|randomized control trial|randomized control trial
476132|NCT01529905|depression|depression
476133|NCT01529905|mania|mania
476134|NCT01529905|bipolar|bipolar
476135|NCT01529905|outcome|outcome
476136|NCT01529905|cognitive|cognitive
476137|NCT01529879|edentulism|edentulism
476138|NCT01529879|dental implants|dental implants
476139|NCT01529879|clinical study|clinical study
476140|NCT01529879|Nanotite Certain Tapered implant|nanotite certain tapered implant
476141|NCT01529879|randomized|randomized
476142|NCT01529879|crestal bone level|crestal bone level
476143|NCT01529866|clinical study|clinical study
476144|NCT01529866|edentulism|edentulism
476145|NCT01529866|dental implants|dental implants
476146|NCT01529866|Nanotite Certain Tapered implant|nanotite certain tapered implant
476147|NCT01529866|randomized|randomized
476148|NCT01529866|crestal bone level|crestal bone level
476149|NCT01529866|immediate loading|immediate loading
476150|NCT01529814|edentulism|edentulism
476151|NCT01529814|dental implants|dental implants
476152|NCT01529814|clinical study|clinical study
476256|NCT01529528|Efficacy|efficacy
476153|NCT01529814|Nanotite Certain Tapered implant|nanotite certain tapered implant
476154|NCT01529814|randomized|randomized
476155|NCT01529814|crestal bone level|crestal bone level
476156|NCT01529814|early loading|early loading
476157|NCT01529801|edentulism|edentulism
476158|NCT01529801|dental implants|dental implants
476159|NCT01529801|clinical study|clinical study
476160|NCT01529801|randomized|randomized
607359|NCT00988299|RMR|rmr
476161|NCT01529801|Osseotite Certain Tapered|osseotite certain tapered
476162|NCT01529801|Crestal bone level|crestal bone level
476163|NCT01529788|abobotulinum toxin lateral orbital lines|abobotulinum toxin lateral orbital lines
476164|NCT01529788|BotoxCosmetic|botoxcosmetic
476165|NCT01529788|Dysport|dysport
476166|NCT01529788|onabotulinum toxin|onabotulinum toxin
476167|NCT01529788|wrinkles|wrinkles
476168|NCT01529788|lateral orbital lines|lateral orbital lines
476169|NCT01529775|partial edentulism|partial edentulism
476170|NCT01529775|dental implants|dental implants
476171|NCT01529775|Osseotite Certain Prevail Tapered|osseotite certain prevail tapered
476172|NCT01529775|Osseotite Certain Tapered|osseotite certain tapered
476173|NCT01529775|Crestal bone level|crestal bone level
476174|NCT01529775|randomized|randomized
476175|NCT01529775|clinical study|clinical study
476176|NCT01529762|edentulism|edentulism
476177|NCT01529762|dental implants|dental implants
476178|NCT01529762|Osseotite Certain Tapered|osseotite certain tapered
476179|NCT01529762|randomized|randomized
476180|NCT01529762|clinical study|clinical study
476181|NCT01529762|partial edentulism|partial edentulism
476182|NCT01529762|immediate loading|immediate loading
476183|NCT01529762|crestal bone level|crestal bone level
476184|NCT01529736|edentulism|edentulism
476185|NCT01529736|dental implants|dental implants
476186|NCT01529736|early loading|early loading
476187|NCT01529736|crestal bone level|crestal bone level
476188|NCT01529736|high torque insertion|high torque insertion
476189|NCT01529736|low torque insertion|low torque insertion
476190|NCT01529736|randomized|randomized
476191|NCT01529736|Osseotite|osseotite
476192|NCT01529736|clinical study|clinical study
476193|NCT01529723|Stroke|stroke
476194|NCT01529723|Dysphagia screening|dysphagia screening
476195|NCT01529710|Schistosomiasis hematobium|schistosomiasis hematobium
476196|NCT01529710|Schistosomiasis mansoni|schistosomiasis mansoni
476197|NCT01529697|Asthma|asthma
476198|NCT01529697|Inhaler use|inhaler use
476199|NCT01529684|oncology patients|oncology patients
476200|NCT01529684|Metabolic profile of 906|metabolic profile of 906
476201|NCT01529684|OSI-906|osi-906
476202|NCT01529684|mass balance|mass balance
476203|NCT01529684|Pharmacokinetics of 14C-OSI-906|pharmacokinetics of 14c-osi-906
476204|NCT01529684|Cancer, solid tumors|cancer, solid tumors
476205|NCT01529684|Absorption, Metabolism, and Excretion of OSI-906|absorption, metabolism, and excretion of osi-906
476206|NCT01529658|Renal function|renal function
476207|NCT01529658|Renal hypothermia|renal hypothermia
476208|NCT01529658|Nephrology|nephrology
476209|NCT01529658|Nephrectomy|nephrectomy
476210|NCT01529658|Renal tumor|renal tumor
476211|NCT01529658|Urology|urology
476212|NCT01529658|Kidney|kidney
476213|NCT01529645|pertussis|pertussis
476214|NCT01529645|booster vaccine|booster vaccine
476215|NCT01529645|tetanus|tetanus
476216|NCT01529645|diphtheria in adults|diphtheria in adults
476217|NCT01529632|chronic obstructive pulmonary disease|chronic obstructive pulmonary disease
476218|NCT01529632|COPD|copd
476219|NCT01529632|QVA149|qva149
476220|NCT01529632|QAB149|qab149
476221|NCT01529632|NVA237|nva237
476222|NCT01529632|indacaterol|indacaterol
476223|NCT01529632|glycopyrronium bromide|glycopyrronium bromide
476224|NCT01529619|Rivastigmine|rivastigmine
476225|NCT01529619|Alzheimer's disease|alzheimer's disease
476226|NCT01529619|Transdermal patch|transdermal patch
476227|NCT01529606|dental restoration|dental restoration
476228|NCT01529606|dental caries|dental caries
476229|NCT01529606|tooth cavity|tooth cavity
476230|NCT01529593|Advanced Cancers|advanced cancers
476231|NCT01529593|Metastatic cancer|metastatic cancer
476232|NCT01529593|Tumor response|tumor response
476233|NCT01529593|Dose limiting toxicity|dose limiting toxicity
476234|NCT01529593|DLT|dlt
476235|NCT01529593|Maximum tolerated dose|maximum tolerated dose
476236|NCT01529593|MTD|mtd
476237|NCT01529593|Temsirolimus|temsirolimus
476238|NCT01529593|CCI-779|cci-779
476239|NCT01529593|Torisel|torisel
476240|NCT01529593|Metformin|metformin
476241|NCT01529580|Autism Spectrum Disorder|autism spectrum disorder
476242|NCT01529580|language|language
476243|NCT01529580|intervention|intervention
476244|NCT01529580|school-age|school-age
476245|NCT01529554|Acute Coronary Syndromes|acute coronary syndromes
476246|NCT01529554|ST-Elevation Myocardial Infarction|st-elevation myocardial infarction
476247|NCT01529554|Infarct size|infarct size
476248|NCT01529554|inflammation|inflammation
476249|NCT01529554|everolimus|everolimus
476250|NCT01529541|CWP-0403|cwp-0403
476251|NCT01529541|Sitagliptin|sitagliptin
476252|NCT01529541|Metformin|metformin
476253|NCT01529541|type 2 DM|type 2 dm
476254|NCT01529528|CWP-0403|cwp-0403
476255|NCT01529528|type 2 DM|type 2 dm
476257|NCT01529528|Safety|safety
476258|NCT01529528|Phase 3|phase 3
476259|NCT01529515|Schizophrenia|schizophrenia
476260|NCT01529515|R092670|r092670
476261|NCT01529515|Paliperidone Palmitate|paliperidone palmitate
711129|NCT00586365|prevention|prevention
607444|NCT00987987|adult|adult
476262|NCT01529515|Paliperidone palmitate 3 month formulation (PP3M)|paliperidone palmitate 3 month formulation (pp3m)
476263|NCT01529502|Blood Transfusion, Autologous|blood transfusion, autologous
476264|NCT01529502|Blood Preservation/adverse effects|blood preservation/adverse effects
476265|NCT01529502|Blood Transfusion/adverse effects|blood transfusion/adverse effects
476266|NCT01529502|Endothelium, Vascular/physiopathology|endothelium, vascular/physiopathology
476267|NCT01529502|Hemoglobins|hemoglobins
476268|NCT01529502|Nitric Oxide|nitric oxide
476269|NCT01529502|Pulmonary Hypertension|pulmonary hypertension
476270|NCT01529489|Chronic Obstructive Pulmonary Disease|chronic obstructive pulmonary disease
476271|NCT01529489|Physical training|physical training
476272|NCT01529489|Oxygen uptake kinetic|oxygen uptake kinetic
476273|NCT01529489|Heart rate kinetic|heart rate kinetic
476274|NCT01529476|Ofloxacin|ofloxacin
476275|NCT01529476|Levofloxacin|levofloxacin
476276|NCT01529476|Ofloxacin hydrochloride|ofloxacin hydrochloride
476277|NCT01529463|Congestive Heart Failure|congestive heart failure
476278|NCT01529450|basal cell carcinoma, sonidegib, smoothened inhibitor, hedgehog|basal cell carcinoma, sonidegib, smoothened inhibitor, hedgehog
476279|NCT01529437|allergy|allergy
476280|NCT01529437|immunology|immunology
476281|NCT01529437|immune tolerance|immune tolerance
476282|NCT01529437|immunotherapy|immunotherapy
476283|NCT01529424|Hypertriglyceridemia|hypertriglyceridemia
476284|NCT01529411|urothelium|urothelium
476285|NCT01529411|transitional|transitional
476286|NCT01529411|carcinoma|carcinoma
476287|NCT01529411|cancer|cancer
476288|NCT01529411|metastatic|metastatic
476289|NCT01529411|tract|tract
476290|NCT01529398|knee osteoarthritis|knee osteoarthritis
476291|NCT01529398|exercise therapy|exercise therapy
476292|NCT01529398|resistance training|resistance training
476293|NCT01529398|proprioception|proprioception
476294|NCT01529385|swollen leg|swollen leg
476295|NCT01529385|diabetes|diabetes
476296|NCT01529385|compression stockings|compression stockings
476297|NCT01529385|edema|edema
476298|NCT01529372|Hypertension|hypertension
476299|NCT01529372|Blood pressure|blood pressure
476300|NCT01529372|Renal denervation|renal denervation
476301|NCT01529359|Irritable Bowel Syndrome|irritable bowel syndrome
476302|NCT01529359|Probiotics|probiotics
476303|NCT01529346|Postoperative dental pain|postoperative dental pain
476304|NCT01529307|Biologic,|biologic,
476305|NCT01529307|solid tumors,|solid tumors,
476306|NCT01529307|Death Receptor 5 agonist,|death receptor 5 agonist,
476307|NCT01529307|caspase-8|caspase-8
476308|NCT01529294|Hepatic impairment|hepatic impairment
476309|NCT01529294|Iloperidone|iloperidone
476310|NCT01529294|ILO522D|ilo522d
476311|NCT01529294|Pharmacokinetics|pharmacokinetics
476312|NCT01529268|Nonalcoholic Fatty Liver Disease (NAFLD)|nonalcoholic fatty liver disease (nafld)
476313|NCT01529268|Cysteamine bitartrate delayed release|cysteamine bitartrate delayed release
476314|NCT01529268|Children|children
476315|NCT01529255|Chronic Hepatitis B|chronic hepatitis b
476316|NCT01529255|Compensated Chronic hepatitis B|compensated chronic hepatitis b
476317|NCT01529216|DIAMOND System|diamond system
476318|NCT01529216|T2DM|t2dm
476319|NCT01529216|Randomized study|randomized study
476320|NCT01529216|Electrical stimulation|electrical stimulation
476321|NCT01529216|Fundus|fundus
476322|NCT01529190|pregabalin|pregabalin
476323|NCT01529190|postoperative pain control|postoperative pain control
476324|NCT01529190|interleukin-6|interleukin-6
476325|NCT01529190|acute pain|acute pain
476326|NCT01529177|Metformin|metformin
476327|NCT01529177|Insulin resistance|insulin resistance
476328|NCT01529177|male infertility|male infertility
476329|NCT01529177|unexplained Oligozspermia|unexplained oligozspermia
476330|NCT01529177|Clomiphene citrate|clomiphene citrate
476331|NCT01529177|Unexplained azoospermia|unexplained azoospermia
476332|NCT01529164|endostatin|endostatin
476333|NCT01529164|chemotherapy|chemotherapy
476334|NCT01529164|antiangiogenesis agent|antiangiogenesis agent
476335|NCT01529164|colorectal cancer|colorectal cancer
476336|NCT01529151|Dizziness|dizziness
476337|NCT01529151|Vertigo|vertigo
476338|NCT01529151|Benign Paroxysmal Positional Vertigo|benign paroxysmal positional vertigo
476339|NCT01529151|Labyrinthitis|labyrinthitis
476340|NCT01529151|Osteopathic Manipulative Treatment|osteopathic manipulative treatment
476341|NCT01529151|Vestibular Rehabilitation Therapy|vestibular rehabilitation therapy
476342|NCT01529138|Cancer|cancer
476343|NCT01529112|Locally Advanced|locally advanced
476344|NCT01529112|Metastatic Non-Squamous Non-Small Cell Lung Cancer|metastatic non-squamous non-small cell lung cancer
476345|NCT01529099|Osteoarthritis|osteoarthritis
476346|NCT01529099|Knee|knee
476347|NCT01529099|Knee replacement|knee replacement
476348|NCT01529099|Knee implant|knee implant
476349|NCT01529099|Knee arthroplasty|knee arthroplasty
476350|NCT01529099|Unicompartmental|unicompartmental
476351|NCT01529099|Primary|primary
476352|NCT01529099|Partial|partial
476353|NCT01529099|Patellofemoral|patellofemoral
476354|NCT01529099|Medial|medial
476355|NCT01529099|Lateral|lateral
476356|NCT01529099|Bicompartmental|bicompartmental
476357|NCT01529099|Cemented|cemented
476358|NCT01529099|Post-traumatic arthritis of the tibio-femoral and/or patellofemoral articular surfaces|post-traumatic arthritis of the tibio-femoral and/or patellofemoral articular surfaces
476359|NCT01529099|History of Gout or pseudo-gout.|history of gout or pseudo-gout.
476360|NCT01529086|prostate cancer|prostate cancer
476361|NCT01529086|dutasteride|dutasteride
476362|NCT01529086|for cause prostate biopsy|for cause prostate biopsy
476363|NCT01529073|HIV|hiv
476364|NCT01529073|genotype 4 HCV|genotype 4 hcv
476365|NCT01529073|pegylated interferon|pegylated interferon
476366|NCT01529073|ribavirin|ribavirin
476367|NCT01529073|nitazoxanide|nitazoxanide
476368|NCT01529060|phenylbutyrate|phenylbutyrate
476369|NCT01529060|MSUD|msud
476370|NCT01529060|Buphenyl-TM|buphenyl-tm
476371|NCT01529034|Epilepsy|epilepsy
476372|NCT01529034|seizure clusters|seizure clusters
476373|NCT01529034|acute repetitive seizures|acute repetitive seizures
476374|NCT01529034|rescue treatment|rescue treatment
476375|NCT01529021|Pain management|pain management
476376|NCT01529021|vaccination|vaccination
476377|NCT01529021|immunization|immunization
476378|NCT01529021|pediatric|pediatric
476379|NCT01529021|robotics|robotics
476380|NCT01529021|human-robot interaction|human-robot interaction
476381|NCT01529008|Osteonecrosis|osteonecrosis
476382|NCT01529008|Femoral Head|femoral head
476383|NCT01529008|Hip|hip
476384|NCT01529008|Orthopedics|orthopedics
476385|NCT01529008|Bone|bone
476386|NCT01529008|Musculoskeletal Disorders|musculoskeletal disorders
476387|NCT01528995|fecal incontinence|fecal incontinence
476388|NCT01528995|anal incontinence|anal incontinence
476389|NCT01528995|obstetric sphincter injuries|obstetric sphincter injuries
476390|NCT01528995|OASIS|oasis
476391|NCT01528995|double incontinence|double incontinence
476392|NCT01528995|urinary incontinence|urinary incontinence
476393|NCT01528995|sexual function|sexual function
476394|NCT01528995|sacral nerve modulation|sacral nerve modulation
476395|NCT01528995|sacral nerve stimulation|sacral nerve stimulation
476396|NCT01528995|Interstim|interstim
476397|NCT01528995|anal bulking injections|anal bulking injections
476398|NCT01528995|Permacol|permacol
476399|NCT01528969|oral microbiota|oral microbiota
476400|NCT01528969|mutans streptococci|mutans streptococci
476401|NCT01528969|xylitol|xylitol
476402|NCT01528956|adrenocortical carcinoma|adrenocortical carcinoma
476403|NCT01528943|prostacycline, endothel integrity and abdominal surgery|prostacycline, endothel integrity and abdominal surgery
476404|NCT01528930|Lung Diseases|lung diseases
476405|NCT01528930|Anti-Infective Agents|anti-infective agents
476406|NCT01528930|Therapeutic Uses|therapeutic uses
476407|NCT01528930|Amikacin|amikacin
476408|NCT01528917|Lysosomal Storage Disease|lysosomal storage disease
476409|NCT01528917|Late Onset Lysosomal Acid Lipase (LAL) Deficiency|late onset lysosomal acid lipase (lal) deficiency
476410|NCT01528917|Acid cholesteryl ester hydrolase deficiency, type 2|acid cholesteryl ester hydrolase deficiency, type 2
476411|NCT01528917|Acid lipase disease|acid lipase disease
476412|NCT01528917|Cholesterol ester hydrolase deficiency|cholesterol ester hydrolase deficiency
476413|NCT01528917|LAL Deficiency|lal deficiency
476414|NCT01528917|LIPA Deficiency|lipa deficiency
476415|NCT01528917|Wolman disease|wolman disease
476416|NCT01528904|pregnancy|pregnancy
476417|NCT01528904|autoimmune thyroid disease|autoimmune thyroid disease
476418|NCT01528904|fetal thyroid hormones|fetal thyroid hormones
476419|NCT01528904|antithyroid antibodies|antithyroid antibodies
476420|NCT01528904|ultrasound parameters|ultrasound parameters
476421|NCT01528891|tonsillectomy|tonsillectomy
476422|NCT01528891|emergence agitation|emergence agitation
476423|NCT01528878|Liver Cancer|liver cancer
476424|NCT01528878|Hepatocellular Carcinoma|hepatocellular carcinoma
476425|NCT01528878|HCC|hcc
476426|NCT01528878|Metastatic Cancer to Liver|metastatic cancer to liver
476427|NCT01528878|Metastatic Colon Cancer|metastatic colon cancer
476428|NCT01528878|Metastatic Colo-rectal Cancer|metastatic colo-rectal cancer
476429|NCT01528878|mCRC|mcrc
476430|NCT01528878|Liver Function|liver function
476431|NCT01528878|Child-Pugh|child-pugh
476432|NCT01528865|virus|virus
476433|NCT01528865|K(HML2)[HERV-K(HML2)]|k(hml2)[herv-k(hml2)]
476434|NCT01528865|Lymphoma|lymphoma
476435|NCT01528865|Human endogenous retrovirus-K(HLM2)[HERV-K(HML2)]|human endogenous retrovirus-k(hlm2)[herv-k(hml2)]
476436|NCT01528852|neonatal Mortality|neonatal mortality
476437|NCT01528852|chlorhexidine cord care|chlorhexidine cord care
476438|NCT01528852|cord infections|cord infections
476439|NCT01528852|african settings|african settings
476440|NCT01528852|clinical trials|clinical trials
476441|NCT01528839|Bipolar disorder|bipolar disorder
476442|NCT01528839|Bipolar depression|bipolar depression
476443|NCT01528839|Thyroid abnormality|thyroid abnormality
476444|NCT01528839|mood stabilizer|mood stabilizer
476445|NCT01528839|antidepressants|antidepressants
476446|NCT01528839|currently depressed|currently depressed
476447|NCT01528826|metastatic triple-negative breast cancer|metastatic triple-negative breast cancer
476448|NCT01528826|vinorebine|vinorebine
476449|NCT01528826|oxaliplatin|oxaliplatin
476450|NCT01528813|Erbium-doped yttrium aluminium garnet laser|erbium-doped yttrium aluminium garnet laser
476451|NCT01528813|Er:YAG|er:yag
476452|NCT01528813|Amorolfine lacquer|amorolfine lacquer
476453|NCT01528813|Dermatophytes|dermatophytes
476454|NCT01528813|Subungual distal lateral onychomycosis|subungual distal lateral onychomycosis
476455|NCT01528813|Drug delivery|drug delivery
476456|NCT01528800|Vitamin K|vitamin k
476457|NCT01528800|Chronic Kidney Disease|chronic kidney disease
476458|NCT01528800|Vascular Calcification|vascular calcification
476459|NCT01528800|Hemodialysis|hemodialysis
476460|NCT01528800|Coronary Artery Calcification|coronary artery calcification
476461|NCT01528787|Intraocular pressure|intraocular pressure
476462|NCT01528787|visual field|visual field
476463|NCT01528787|Ocular hypertension or open angle glaucoma|ocular hypertension or open angle glaucoma
476464|NCT01528774|Melanoma|melanoma
476465|NCT01528774|Circulating Tumor Cells|circulating tumor cells
476466|NCT01528774|Prostate cancer|prostate cancer
476467|NCT01528774|Sarcoma|sarcoma
476468|NCT01528774|Renal Cancer|renal cancer
476469|NCT01528774|Pancreatic neuroendocrine cancer|pancreatic neuroendocrine cancer
476470|NCT01528774|Other solid tumor|other solid tumor
476471|NCT01528761|physical activity|physical activity
476472|NCT01528761|older adults|older adults
476473|NCT01528761|physical function|physical function
476474|NCT01528761|health-related quality of life|health-related quality of life
476475|NCT01528761|prosocial behavior|prosocial behavior
476476|NCT01528761|social cognitive theory|social cognitive theory
476477|NCT01528722|Emergency laparoscopic cholecystectomy|emergency laparoscopic cholecystectomy
476478|NCT01528722|Pain scores|pain scores
476479|NCT01528722|Intraperitoneal local anaesthesia|intraperitoneal local anaesthesia
476480|NCT01528722|Cholecystitis|cholecystitis
476481|NCT01528709|Statin,|statin,
476482|NCT01528709|CABG,|cabg,
476483|NCT01528709|saphenous vein graft,|saphenous vein graft,
476484|NCT01528709|graft occlusion,|graft occlusion,
476485|NCT01528709|lipids|lipids
476486|NCT01528696|Obesity|obesity
476487|NCT01528696|Cesarean Section|cesarean section
476488|NCT01528696|Wound care|wound care
476489|NCT01528657|Sick Sinus Syndrome|sick sinus syndrome
476490|NCT01528657|Ventricular pacing|ventricular pacing
476491|NCT01528657|Minimal ventricular pacing|minimal ventricular pacing
476492|NCT01528657|Ventricular pacing suppression|ventricular pacing suppression
476493|NCT01528657|Intrinsic rhythm support|intrinsic rhythm support
476494|NCT01528657|Long term AV|long term av
476495|NCT01528644|iron|iron
476496|NCT01528644|fortification|fortification
476497|NCT01528644|alginate|alginate
476498|NCT01528644|iron deficiency|iron deficiency
476499|NCT01528618|Advanced Nasopharyngeal Carcinoma|advanced nasopharyngeal carcinoma
476500|NCT01528618|treatment|treatment
476501|NCT01528605|lutein|lutein
476502|NCT01528605|zeaxanthin|zeaxanthin
476503|NCT01528605|age-related macular degeneration|age-related macular degeneration
476504|NCT01528605|supplementation|supplementation
476505|NCT01528605|macular pigment optical density|macular pigment optical density
476506|NCT01528605|visual function|visual function
476507|NCT01528605|serum concentration|serum concentration
476508|NCT01528579|Whiplash|whiplash
476509|NCT01528579|Rehabilitation|rehabilitation
476510|NCT01528579|Physiotherapy|physiotherapy
476511|NCT01528579|Exercises|exercises
476512|NCT01528566|osteoarthritis, knee|osteoarthritis, knee
476513|NCT01528566|Cognitive impairment|cognitive impairment
476514|NCT01528566|Tai Chi|tai chi
476515|NCT01528553|genu valgus|genu valgus
476516|NCT01528553|lower limb|lower limb
476517|NCT01528553|paediatric|paediatric
476518|NCT01528553|epiphysiodesis|epiphysiodesis
476519|NCT01528540|chronic pancreatitis|chronic pancreatitis
476520|NCT01528540|pregabalin|pregabalin
476521|NCT01528540|antioxidant|antioxidant
476522|NCT01528514|Myocardial infarction|myocardial infarction
476523|NCT01528514|Coronary artery bypass grafting|coronary artery bypass grafting
476524|NCT01528514|Anti-oxidant|anti-oxidant
476525|NCT01528514|Curcuminoids|curcuminoids
476526|NCT01528475|Therapeutic Hypothermia|therapeutic hypothermia
476527|NCT01528475|Cardiac arrest|cardiac arrest
476528|NCT01528462|Stroke|stroke
476529|NCT01528462|Ischemic Attack, Transient|ischemic attack, transient
476530|NCT01528462|Sleep Disorders|sleep disorders
476531|NCT01528462|Sleep Apnea Syndromes|sleep apnea syndromes
476532|NCT01528462|Restless Legs Syndrome|restless legs syndrome
476533|NCT01528462|Chronobiology Disorders|chronobiology disorders
476534|NCT01528449|babesia|babesia
476535|NCT01528449|blood donation|blood donation
476536|NCT01528449|transfusion transmitted babesiosis|transfusion transmitted babesiosis
476537|NCT01528436|Cerebral Palsy|cerebral palsy
476538|NCT01528436|Umbilical Cord Blood|umbilical cord blood
476539|NCT01528436|Rehabilitation|rehabilitation
476540|NCT01528423|XtremeCT|xtremect
476541|NCT01528423|Density|density
476542|NCT01528423|pQCT|pqct
476543|NCT01528423|Turnover|turnover
476544|NCT01528423|Bone|bone
476545|NCT01528423|short-term reproducibility|short-term reproducibility
476546|NCT01528397|defect|defect
607802|NCT00986661|hepatic|hepatic
476547|NCT01528397|dorsal branch of the proper digital nerve|dorsal branch of the proper digital nerve
476548|NCT01528397|proper digital nerve|proper digital nerve
476549|NCT01528397|second dorsal metacarpal artery|second dorsal metacarpal artery
476550|NCT01528397|pedicled nerve graft.|pedicled nerve graft.
476551|NCT01528384|Arginine|arginine
476552|NCT01528384|Arginine deiminase|arginine deiminase
476553|NCT01528384|Argininosuccinate synthetase|argininosuccinate synthetase
476554|NCT01528384|Phase 1|phase 1
476555|NCT01528384|Pediatric|pediatric
476556|NCT01528384|Failed other treatments|failed other treatments
476557|NCT01528384|Pediatric patients|pediatric patients
476558|NCT01528371|Intravenous sedation|intravenous sedation
476559|NCT01528371|Midazolam|midazolam
476560|NCT01528371|Dental treatment|dental treatment
476561|NCT01528371|White-coat hypertension|white-coat hypertension
476562|NCT01528371|STAI|stai
476563|NCT01528371|Dental patients|dental patients
476564|NCT01528371|Transient hypertension|transient hypertension
476565|NCT01528358|sepsis|sepsis
476566|NCT01528358|tissue oximetry|tissue oximetry
476567|NCT01528358|NIRS|nirs
476568|NCT01528358|VOT|vot
476569|NCT01528345|Breast Cancer|breast cancer
476570|NCT01528345|HER2-, HR+|her2-, hr+
476571|NCT01528345|post-menopausal|post-menopausal
476572|NCT01528345|Locally advanced or metastatic Breast Cancer (HER2-, HR+)|locally advanced or metastatic breast cancer (her2-, hr+)
476573|NCT01528332|Musculoskeletal pain|musculoskeletal pain
476574|NCT01528332|Back pain|back pain
476575|NCT01528332|Chronic pain|chronic pain
476576|NCT01528319|Arthroscopic Bankart repair|arthroscopic bankart repair
476577|NCT01528319|Suture anchor|suture anchor
476578|NCT01528319|Shoulder dislocation|shoulder dislocation
476579|NCT01528306|HP802-247|hp802-247
476580|NCT01528306|EB (epidermolysis bullosa)|eb (epidermolysis bullosa)
476581|NCT01528280|Shift work|shift work
476582|NCT01528280|Hepatitis A vaccination|hepatitis a vaccination
476583|NCT01528280|humoral response|humoral response
476584|NCT01528280|cellular response|cellular response
476585|NCT01528267|Emphysema, lung volume reduction, autologous blood|emphysema, lung volume reduction, autologous blood
476586|NCT01528254|Type 2 Diabetes Mellitus,|type 2 diabetes mellitus,
476587|NCT01528254|Vildagliptin,|vildagliptin,
476588|NCT01528254|Elderly Patients|elderly patients
476589|NCT01528241|ABP688|abp688
476590|NCT01528241|Tracer|tracer
476591|NCT01528241|Depression|depression
476592|NCT01528202|Sleep, circadian cycle, melatonin|sleep, circadian cycle, melatonin
476593|NCT01528189|Insulin, surgery, infection|insulin, surgery, infection
476594|NCT01528176|FGF-23, CKD, Cyp24, 24,25(OH)2D, vitamin D metabolism|fgf-23, ckd, cyp24, 24,25(oh)2d, vitamin d metabolism
476595|NCT01528163|Head and neck|head and neck
476596|NCT01528163|Squamous cell carcinoma|squamous cell carcinoma
476597|NCT01528163|Randomized|randomized
476598|NCT01528163|palliative treatment|palliative treatment
476599|NCT01528098|polyethylene glycol|polyethylene glycol
476600|NCT01528098|bisacodyl|bisacodyl
476601|NCT01528085|Philadelphia chromsome|philadelphia chromsome
476602|NCT01528085|BCR-ABL|bcr-abl
476603|NCT01528085|ALL|all
476604|NCT01528085|acute lymphoblastic leukemia|acute lymphoblastic leukemia
476605|NCT01528085|Nilotinib|nilotinib
476606|NCT01528085|Tasigna|tasigna
476607|NCT01528072|Dynesys Dynamic Stabilization System|dynesys dynamic stabilization system
476608|NCT01528072|Spondylolithesis|spondylolithesis
476609|NCT01528072|pseudoarthrosis|pseudoarthrosis
476610|NCT01528072|neurologic impairment|neurologic impairment
476611|NCT01528072|failed fusion|failed fusion
476612|NCT01528059|Diabetes|diabetes
476613|NCT01528059|Gastric cancer|gastric cancer
476614|NCT01528059|Gastric bypass|gastric bypass
476615|NCT01528046|central nervous system (CNS)|central nervous system (cns)
476616|NCT01528046|malignancy|malignancy
476617|NCT01528046|relapsed|relapsed
476618|NCT01528046|refractory|refractory
476619|NCT01528046|pediatric|pediatric
476620|NCT01528046|recurrent|recurrent
476621|NCT01528033|surgical wound|surgical wound
476622|NCT01528033|wound healing disorder|wound healing disorder
476623|NCT01528033|Wound healing impairment|wound healing impairment
476624|NCT01528033|post surgical wound healing disorder|post surgical wound healing disorder
476625|NCT01528033|abdominal wound healing impairment|abdominal wound healing impairment
476626|NCT01528033|Vacuum Assisted Closure|vacuum assisted closure
476627|NCT01528033|negative pressure wound therapy|negative pressure wound therapy
476628|NCT01528007|Pathological gambling|pathological gambling
476629|NCT01528007|Treatment intervention|treatment intervention
476630|NCT01527994|Aprepitant|aprepitant
476631|NCT01527994|Intravenous heroin dependence|intravenous heroin dependence
476632|NCT01527981|Depression|depression
476633|NCT01527981|Diabetes|diabetes
476634|NCT01527981|Adherence|adherence
476635|NCT01527981|Medication|medication
476636|NCT01527981|Glucose|glucose
476637|NCT01527981|Insulin|insulin
476638|NCT01527955|Kelee|kelee
476639|NCT01527955|Meditation|meditation
476640|NCT01527955|Stress|stress
476641|NCT01527955|Anxiety|anxiety
476642|NCT01527955|Depression|depression
476643|NCT01527955|Brain|brain
476644|NCT01527955|Mind|mind
476645|NCT01527942|Pain Management|pain management
476646|NCT01527903|propofol|propofol
476647|NCT01527903|midazolam|midazolam
476648|NCT01527903|sedation|sedation
476649|NCT01527903|ICU|icu
476650|NCT01527890|intravenous patient-controlled analgesia|intravenous patient-controlled analgesia
476651|NCT01527890|IV PCA|iv pca
476652|NCT01527877|BKM120|bkm120
476653|NCT01527877|head and neck cancer|head and neck cancer
476654|NCT01527877|squamous cell carcinoma|squamous cell carcinoma
476655|NCT01527864|NSCLC|nsclc
476656|NCT01527851|Post-bariatric surgery|post-bariatric surgery
476657|NCT01527851|Excess skin|excess skin
476658|NCT01527851|Physical fitness|physical fitness
476659|NCT01527851|Physical activity|physical activity
476660|NCT01527851|Barriers to physical activity|barriers to physical activity
476661|NCT01527851|Plastic surgery|plastic surgery
476662|NCT01527851|Quality of life|quality of life
476663|NCT01527851|Self-esteem|self-esteem
476664|NCT01527838|Hematologic malignancies|hematologic malignancies
476665|NCT01527799|Sickle cell anemia|sickle cell anemia
476666|NCT01527799|Exercise testing|exercise testing
476667|NCT01527799|Cardiopulmonary disease|cardiopulmonary disease
476668|NCT01527786|Major Depressive Disorder, Postpartum Onset|major depressive disorder, postpartum onset
476669|NCT01527773|COPD|copd
476670|NCT01527773|Cardiovascular disease|cardiovascular disease
476671|NCT01527773|Phenotypes|phenotypes
476672|NCT01527760|Essential Hypertension|essential hypertension
476673|NCT01527760|Viscum album mother tincture|viscum album mother tincture
476674|NCT01527760|one group pretest post-test study|one group pretest post-test study
476675|NCT01527747|Type 2 Diabetes|type 2 diabetes
476676|NCT01527747|Hypertriglyceridemia|hypertriglyceridemia
476677|NCT01527747|dipeptidyl peptidase-4 (DPP-4)|dipeptidyl peptidase-4 (dpp-4)
476678|NCT01527747|glucagon-like peptide-1 (glp-1)|glucagon-like peptide-1 (glp-1)
476679|NCT01527734|Comparison study|comparison study
476680|NCT01527721|keratoconus|keratoconus
476681|NCT01527721|CxL|cxl
476682|NCT01527721|CxL combined with t-PRK|cxl combined with t-prk
476683|NCT01527695|Phase IIa|phase iia
476684|NCT01527695|AZD3241|azd3241
476685|NCT01527695|microglia activation|microglia activation
476686|NCT01527695|safety|safety
476687|NCT01527695|Pharmacodynamics and pharmacokinetics analyses|pharmacodynamics and pharmacokinetics analyses
476688|NCT01527695|Parkinson patients|parkinson patients
476689|NCT01527682|Intraocular pressure|intraocular pressure
476690|NCT01527682|Latanoprost|latanoprost
476691|NCT01527682|Dorzolamide|dorzolamide
476692|NCT01527669|Red yeast rice|red yeast rice
476693|NCT01527669|lovastatin|lovastatin
476694|NCT01527669|Pharmacokinetics|pharmacokinetics
476695|NCT01527578|Healthy children|healthy children
476696|NCT01527578|Healthy adults|healthy adults
476697|NCT01527578|individuals ages 7-60|individuals ages 7-60
476698|NCT01527526|DMPA|dmpa
476699|NCT01527526|insulin resistance|insulin resistance
476700|NCT01527526|cardiovascular disease|cardiovascular disease
476701|NCT01527526|BMI|bmi
476702|NCT01527526|weight gain|weight gain
476703|NCT01527526|thrombosis|thrombosis
476704|NCT01527513|Partial Epilepsy|partial epilepsy
476705|NCT01527513|eslicarbazepine acetate|eslicarbazepine acetate
476706|NCT01527513|Children|children
476707|NCT01527500|AMD|amd
476708|NCT01527500|Age-related Macular Degeneration|age-related macular degeneration
476709|NCT01527500|geographic atrophy|geographic atrophy
476710|NCT01527500|GA|ga
476711|NCT01527500|Dry AMD|dry amd
476712|NCT01527500|Blindness|blindness
476713|NCT01527500|Drusen|drusen
476714|NCT01527500|GA lesion|ga lesion
476715|NCT01527487|breast cancer|breast cancer
476716|NCT01527487|eribulin|eribulin
476717|NCT01527487|Halaven|halaven
476718|NCT01527487|taxotere|taxotere
476719|NCT01527474|postpartum|postpartum
476720|NCT01527474|postpartum depression|postpartum depression
476721|NCT01527474|PPD|ppd
476722|NCT01527474|escitalopram|escitalopram
476723|NCT01527461|lung neoplasms|lung neoplasms
476724|NCT01527461|dogs|dogs
476725|NCT01527461|sweat|sweat
476726|NCT01527461|smell|smell
476727|NCT01527448|postpartum|postpartum
476728|NCT01527448|postpartum depression|postpartum depression
476729|NCT01527448|PPD|ppd
476730|NCT01527448|quetiapine XR|quetiapine xr
476731|NCT01527448|quetiapine|quetiapine
476732|NCT01527448|seroquel|seroquel
476733|NCT01527448|bipolar|bipolar
476734|NCT01527448|bipolar disorder|bipolar disorder
476735|NCT01527448|bipolar disorder, type II|bipolar disorder, type ii
476736|NCT01527435|Best corrected visual acuity|best corrected visual acuity
476737|NCT01527435|Slit lamp examination|slit lamp examination
476738|NCT01527435|Ophthalmoscopy with contact lens/indirect ophthalmoscope|ophthalmoscopy with contact lens/indirect ophthalmoscope
476739|NCT01527435|OCT assessment|oct assessment
476740|NCT01527435|Fundus photos, fluorescein angiogram, ICG angiogram|fundus photos, fluorescein angiogram, icg angiogram
476741|NCT01527422|Aggressive Non-Hodgkin's Lymphoma|aggressive non-hodgkin's lymphoma
476742|NCT01527409|Exercise|exercise
476743|NCT01527409|Diet|diet
476744|NCT01527409|Posttraumatic growth|posttraumatic growth
476745|NCT01527396|endometrial cancer|endometrial cancer
476746|NCT01527396|lymph node metastasis|lymph node metastasis
476747|NCT01527396|lymphadenectomy|lymphadenectomy
476748|NCT01527396|risk criteria|risk criteria
476749|NCT01527383|Shingles|shingles
476750|NCT01527357|fibrin sealant|fibrin sealant
476751|NCT01527357|thrombin|thrombin
476752|NCT01527357|fibrinogen|fibrinogen
476753|NCT01527357|hemostasis|hemostasis
476754|NCT01527344|OCT|oct
476755|NCT01527344|IVUS|ivus
476756|NCT01527344|CAV|cav
476757|NCT01527318|NLSDM|nlsdm
476758|NCT01527318|Lipid accumulation|lipid accumulation
476759|NCT01527305|Schizophrenia|schizophrenia
476760|NCT01527305|Antipsychotics|antipsychotics
476761|NCT01527305|Paliperidone Palmitate|paliperidone palmitate
476762|NCT01527305|Paliperidone|paliperidone
476763|NCT01527305|Invega|invega
476764|NCT01527305|Sustenna|sustenna
476765|NCT01527305|Psychotic disorder|psychotic disorder
476766|NCT01527305|Psychosis|psychosis
476767|NCT01527292|Vertebral Metastasis|vertebral metastasis
476768|NCT01527292|pain control|pain control
476769|NCT01527292|VAP|vap
476770|NCT01527292|SRT+VAP|srt+vap
476771|NCT01527279|atrial fibrillation|atrial fibrillation
476772|NCT01527279|paroxysmal|paroxysmal
476773|NCT01527279|cardioversion|cardioversion
476774|NCT01527279|antazoline|antazoline
476775|NCT01527266|carbohydrate|carbohydrate
476776|NCT01527266|performance|performance
476777|NCT01527266|cycling|cycling
476778|NCT01527253|Cardiometabolic risk|cardiometabolic risk
476779|NCT01527253|Metabolic syndrome|metabolic syndrome
476780|NCT01527253|Prebiotics|prebiotics
476781|NCT01527253|Legumes|legumes
476782|NCT01527253|Wholegrain cereal|wholegrain cereal
476783|NCT01527253|Functional diet|functional diet
476784|NCT01527253|Low glycemic index diet|low glycemic index diet
476785|NCT01527240|Volume of cerebral infarction|volume of cerebral infarction
476786|NCT01527240|Stroke|stroke
476787|NCT01527240|CsA|csa
476788|NCT01527240|NIHSS|nihss
476789|NCT01527227|Children of mentally ill|children of mentally ill
476790|NCT01527214|Lung cancer|lung cancer
476791|NCT01527214|early detection|early detection
476792|NCT01527214|CT scan|ct scan
476793|NCT01527214|General Practice|general practice
476794|NCT01527214|Effect of Computed Tomography scans|effect of computed tomography scans
476795|NCT01527214|Clinical medical education|clinical medical education
476796|NCT01527201|Arthroscopy|arthroscopy
476797|NCT01527201|Debridement|debridement
476799|NCT01527188|allergic rhinitis|allergic rhinitis
476800|NCT01527162|Cerebral palsy|cerebral palsy
476801|NCT01527162|orthotics|orthotics
476802|NCT01527162|solid ankle foot orthoses|solid ankle foot orthoses
476803|NCT01527123|GSK2585823, benzoic acid, hippuric acid, acne vulgaris, pharmacokinetics|gsk2585823, benzoic acid, hippuric acid, acne vulgaris, pharmacokinetics
476804|NCT01527110|zanamivir|zanamivir
476805|NCT01527110|Seasonal Influenza|seasonal influenza
476806|NCT01527110|H1N1|h1n1
476807|NCT01527110|intravenous|intravenous
476808|NCT01527110|neuraminidase inhibitor|neuraminidase inhibitor
476809|NCT01527110|Pandemic|pandemic
476810|NCT01527110|Relenza|relenza
476811|NCT01527110|Influenza B virus|influenza b virus
476812|NCT01527110|Influenza A virus|influenza a virus
476813|NCT01527097|Cardiovascular Diseases|cardiovascular diseases
476814|NCT01527097|Pharmacologic Actions|pharmacologic actions
476815|NCT01527097|Endothelial Function|endothelial function
476816|NCT01527097|Dermatology|dermatology
476817|NCT01527097|Inflammatory Disease|inflammatory disease
476818|NCT01527097|Skin Disease|skin disease
476819|NCT01527058|lung cancer|lung cancer
476820|NCT01527058|integrin receptor|integrin receptor
476821|NCT01527058|68Ga-BNOTA-PRGD2|68ga-bnota-prgd2
476822|NCT01527058|PET/CT|pet/ct
476823|NCT01527058|efficacy and safety|efficacy and safety
476824|NCT01527032|amyloidosis|amyloidosis
476825|NCT01527032|stem cell transplant|stem cell transplant
476826|NCT01527019|Acute Cystitis|acute cystitis
476827|NCT01526967|ostomy|ostomy
476828|NCT01526967|peristomal skin breakdown|peristomal skin breakdown
476829|NCT01526967|ConvaTec Moldable Skin Barriers|convatec moldable skin barriers
476830|NCT01526928|cancer|cancer
476831|NCT01526928|metastatic|metastatic
476832|NCT01526928|locally advanced|locally advanced
476833|NCT01526928|lung|lung
476834|NCT01526928|non-small cell lung cancer|non-small cell lung cancer
476835|NCT01526928|NSCLC|nsclc
476836|NCT01526928|epidermal growth factor receptor|epidermal growth factor receptor
476837|NCT01526928|EGFR|egfr
476838|NCT01526928|T790M|t790m
476839|NCT01526928|CO-1686|co-1686
476840|NCT01526928|unresectable|unresectable
476841|NCT01526928|recurrent|recurrent
476842|NCT01526928|EGFR-directed therapy|egfr-directed therapy
476843|NCT01526928|irreversible EGFR inhibitor|irreversible egfr inhibitor
476844|NCT01526928|TIGER|tiger
476845|NCT01526928|Rociletinib|rociletinib
476846|NCT01526915|PRF|prf
476847|NCT01526915|PLATELET RICH FIBRIN|platelet rich fibrin
476848|NCT01526915|BISPHOSPHONATES|bisphosphonates
476849|NCT01526902|contact lenses|contact lenses
476850|NCT01526889|Non-infectious uveitis|non-infectious uveitis
476851|NCT01526889|Panuveitis|panuveitis
476852|NCT01526889|Visual acuity|visual acuity
476853|NCT01526889|Vitreous Haze|vitreous haze
476854|NCT01526889|Inflammation of the uvea|inflammation of the uvea
476949|NCT01526486|inguinal|inguinal
476855|NCT01526889|inflammation of the middle, pigmented vascular structures of the eye, iris, ciliary body, choroid plexus|inflammation of the middle, pigmented vascular structures of the eye, iris, ciliary body, choroid plexus
476856|NCT01526876|Intracranial Pressure|intracranial pressure
476857|NCT01526876|Cerebral Perfusion Pressure|cerebral perfusion pressure
476858|NCT01526876|Clevidipine Butyrate|clevidipine butyrate
476859|NCT01526863|Allergy|allergy
476860|NCT01526863|Egg|egg
476861|NCT01526850|cGVHD|cgvhd
476862|NCT01526837|Brain tumor|brain tumor
476863|NCT01526837|GBM|gbm
476864|NCT01526837|Brain cancer|brain cancer
476865|NCT01526811|Endurant|endurant
476866|NCT01526811|Stent Graft|stent graft
476867|NCT01526811|Abdominal Aortic Aneurysm|abdominal aortic aneurysm
476868|NCT01526798|End-Stage Renal Disease (ESRD)|end-stage renal disease (esrd)
476869|NCT01526798|chronic Inflammation|chronic inflammation
476870|NCT01526798|EPO Resistance|epo resistance
476871|NCT01526798|ESA Resistance|esa resistance
476872|NCT01526798|high cut-off dialysis|high cut-off dialysis
476873|NCT01526798|hemodialysis|hemodialysis
476874|NCT01526772|Transnasal|transnasal
476875|NCT01526772|Transoral|transoral
476876|NCT01526772|Roux en Y gastric bypass|roux en y gastric bypass
476877|NCT01526772|Upper Endoscopy|upper endoscopy
476878|NCT01526772|Obesity|obesity
476879|NCT01526759|dietary fiber|dietary fiber
476880|NCT01526759|energy intake|energy intake
476881|NCT01526759|satiety|satiety
476882|NCT01526759|physicochemical properties|physicochemical properties
476883|NCT01526759|men and women|men and women
476884|NCT01526759|Healthy adults|healthy adults
476885|NCT01526746|End stage renal disease|end stage renal disease
476886|NCT01526746|ESRD|esrd
476887|NCT01526746|kidney disease|kidney disease
476888|NCT01526746|renal impairment|renal impairment
476889|NCT01526746|renal|renal
476890|NCT01526733|Type 1 Diabetes|type 1 diabetes
476891|NCT01526733|Continuous Subcutaneous Insulin Infusion (CSII)|continuous subcutaneous insulin infusion (csii)
476892|NCT01526720|Type 2 diabetes mellitus|type 2 diabetes mellitus
476893|NCT01526720|Beta cell function|beta cell function
476894|NCT01526720|Insulin sensitivity|insulin sensitivity
476895|NCT01526720|Genetics of diabetes|genetics of diabetes
476896|NCT01526707|To identify changes in FKBP51 expression with inhaled steroid treatment in asthma|to identify changes in fkbp51 expression with inhaled steroid treatment in asthma
476897|NCT01526694|relapsed or refractory multiple myeloma|relapsed or refractory multiple myeloma
476898|NCT01526681|Sensory Nerve|sensory nerve
476899|NCT01526681|Mixed Nerve|mixed nerve
476900|NCT01526681|Motor Nerve|motor nerve
476901|NCT01526681|Neurotization|neurotization
476902|NCT01526681|Nerve Injury|nerve injury
476903|NCT01526681|Peripheral Nerve Injury|peripheral nerve injury
476904|NCT01526668|Benign gynecological disease|benign gynecological disease
476905|NCT01526668|Surgery|surgery
476906|NCT01526668|Postoperative follow-up strategy|postoperative follow-up strategy
476907|NCT01526668|Pain threshold|pain threshold
476908|NCT01526668|Chronic pelvic pain|chronic pelvic pain
476909|NCT01526668|[E04.950.300.399]|[e04.950.300.399]
476910|NCT01526668|[C13.351.500]|[c13.351.500]
476911|NCT01526668|[F02.463.593.710.560]|[f02.463.593.710.560]
476912|NCT01526668|[N02.421.585.722.700]|[n02.421.585.722.700]
476913|NCT01526668|Postoperative Care|postoperative care
476914|NCT01526655|Endometrial cancer|endometrial cancer
476915|NCT01526655|Robot assisted laparoscopy|robot assisted laparoscopy
476916|NCT01526655|Abdominal hysterectomy|abdominal hysterectomy
476917|NCT01526655|Fast track program|fast track program
476918|NCT01526629|ICD|icd
476919|NCT01526629|Remote follow-up|remote follow-up
476920|NCT01526616|PCOS|pcos
476921|NCT01526616|metformin|metformin
476922|NCT01526616|spironolactone|spironolactone
476923|NCT01526616|metabolic syndrome|metabolic syndrome
476924|NCT01526616|hyperandrogenism|hyperandrogenism
476925|NCT01526603|peripheral blood stem cell transplantation|peripheral blood stem cell transplantation
476926|NCT01526603|autologous stem cell transplant|autologous stem cell transplant
476927|NCT01526577|phase1|phase1
476928|NCT01526577|healthy subjects|healthy subjects
476929|NCT01526577|antiplatelet agent|antiplatelet agent
476930|NCT01526564|Chemotherapy-induced peripheral neuropathy (CIPN)|chemotherapy-induced peripheral neuropathy (cipn)
476931|NCT01526551|Human Papillomavirus|human papillomavirus
476932|NCT01526525|tramadol|tramadol
476933|NCT01526525|ketamine|ketamine
476934|NCT01526525|parecoxib|parecoxib
476935|NCT01526525|paracetamol|paracetamol
476936|NCT01526525|numerical rating scale (NRS)|numerical rating scale (nrs)
476937|NCT01526525|McGill (SF-MPQ)|mcgill (sf-mpq)
476938|NCT01526525|electronic pressure algometer|electronic pressure algometer
476939|NCT01526525|Spielberger State Trait Anxiety Inventory STAI Y-6 item|spielberger state trait anxiety inventory stai y-6 item
476940|NCT01526512|Metronomic cyclophosphamide|metronomic cyclophosphamide
476941|NCT01526512|Metronomic capecitabine|metronomic capecitabine
476942|NCT01526512|HER2-negative breast cancer|her2-negative breast cancer
476943|NCT01526499|Metronomic cyclophosphamide|metronomic cyclophosphamide
476944|NCT01526499|metastatic breast cancer|metastatic breast cancer
476945|NCT01526499|first line|first line
476946|NCT01526499|docetaxel|docetaxel
476947|NCT01526486|melanoma|melanoma
476948|NCT01526486|urology|urology
476950|NCT01526486|lymph nodes|lymph nodes
476951|NCT01526486|groin|groin
476952|NCT01526486|lymphadenectomy|lymphadenectomy
476953|NCT01526486|groin dissection|groin dissection
476954|NCT01526486|skin cancer|skin cancer
476955|NCT01526486|penile cancer|penile cancer
476956|NCT01526486|urethral cancer|urethral cancer
476957|NCT01526486|scrotal cancer|scrotal cancer
476958|NCT01526486|Paget's disease|paget's disease
476959|NCT01526473|Alphavirus|alphavirus
476960|NCT01526473|Vaccine|vaccine
476961|NCT01526473|Immunotherapy|immunotherapy
476962|NCT01526473|HER2|her2
476963|NCT01526460|Platelet|platelet
476964|NCT01526460|Atorvastatin|atorvastatin
476965|NCT01526460|Rosuvastatin|rosuvastatin
476966|NCT01526460|Multiplate|multiplate
476967|NCT01526460|reactivity|reactivity
476968|NCT01526447|Neck Pain|neck pain
476969|NCT01526447|Craniosacral Manipulation|craniosacral manipulation
476970|NCT01526447|Complementary Therapies|complementary therapies
476971|NCT01526447|Randomized Controlled Trial|randomized controlled trial
476972|NCT01526447|Sensory Thresholds|sensory thresholds
476973|NCT01526447|Quality of Life|quality of life
476974|NCT01526434|Cimzia|cimzia
476975|NCT01526434|Non-interventional|non-interventional
476976|NCT01526434|Multicenter|multicenter
476977|NCT01526434|Postmarketing|postmarketing
476978|NCT01526434|Local|local
476979|NCT01526421|HIV|hiv
476980|NCT01526421|Antiretroviral therapy, highly active|antiretroviral therapy, highly active
476981|NCT01526408|Meniere's Disease|meniere's disease
476982|NCT01526408|Vertigo|vertigo
476983|NCT01526408|Hearing loss|hearing loss
476984|NCT01526408|Tinnitus|tinnitus
476985|NCT01526408|Anti-viral|anti-viral
476986|NCT01526408|Famciclovir|famciclovir
476987|NCT01526395|electroconvulsive therapy|electroconvulsive therapy
476988|NCT01526395|ECT|ect
476989|NCT01526395|unmodified|unmodified
476990|NCT01526395|anesthesia|anesthesia
476991|NCT01526395|propofol|propofol
476992|NCT01526382|septic shock|septic shock
476993|NCT01526382|acute respiratory distress syndrome|acute respiratory distress syndrome
476994|NCT01526382|transpulmonary thermodilution technique|transpulmonary thermodilution technique
476995|NCT01526382|mortality|mortality
476996|NCT01526369|HER2-positive metastatic breast cancer.|her2-positive metastatic breast cancer.
476997|NCT01526356|Angiofibroma|angiofibroma
476998|NCT01526356|Tuberous Sclerosis|tuberous sclerosis
476999|NCT01526356|Rapamycin|rapamycin
477000|NCT01526356|Sirolimus|sirolimus
477001|NCT01526356|mTOR|mtor
477002|NCT01526343|Patients|patients
477003|NCT01526330|Degenerative disc disease|degenerative disc disease
477004|NCT01526330|YH14618|yh14618
477005|NCT01526330|Penial 2000|penial 2000
477006|NCT01526330|Penial 2K|penial 2k
477007|NCT01526317|Drug interaction|drug interaction
477008|NCT01526317|Rosuvastatin|rosuvastatin
477009|NCT01526317|Metformin SR|metformin sr
477010|NCT01526317|Pharmacokinetic|pharmacokinetic
477011|NCT01526291|Myopia|myopia
477012|NCT01526291|Hyperopia|hyperopia
477013|NCT01526291|Astigmatism|astigmatism
477014|NCT01526291|Patient-reported outcomes|patient-reported outcomes
477015|NCT01526291|Patient satisfaction|patient satisfaction
477016|NCT01526291|Refractive Error|refractive error
477017|NCT01526291|Emmetropia|emmetropia
477018|NCT01526291|Dry eyes|dry eyes
477019|NCT01526291|glare|glare
477020|NCT01526291|halos|halos
477021|NCT01526291|patient expectations|patient expectations
477022|NCT01526278|alendronate|alendronate
477023|NCT01526278|Maxmarvil®|maxmarvil®
477024|NCT01526265|Smoking Cessation|smoking cessation
477025|NCT01526265|Work-site|work-site
477026|NCT01526265|Incentives|incentives
477027|NCT01526265|Health Behavior|health behavior
477028|NCT01526265|Smoking|smoking
477029|NCT01526252|speckle tracking echocardiography|speckle tracking echocardiography
477030|NCT01526252|database|database
477031|NCT01526239|Colorectal cancer screening|colorectal cancer screening
477032|NCT01526239|colon cancer screening|colon cancer screening
477033|NCT01526239|colonoscopy|colonoscopy
477034|NCT01526226|High flow nasal cannula|high flow nasal cannula
477035|NCT01526226|Discomfort|discomfort
477036|NCT01526200|CLM|clm
477037|NCT01526187|Public Health and Epidemiology|public health and epidemiology
477038|NCT01526187|Bacteriology|bacteriology
477039|NCT01526187|Infectious and Tropical|infectious and tropical
477040|NCT01526174|autoimmune|autoimmune
477041|NCT01526174|hearing loss|hearing loss
477042|NCT01526174|bilateral hearing loss|bilateral hearing loss
477043|NCT01526174|steroid-dependent|steroid-dependent
477044|NCT01526161|Asthma|asthma
477045|NCT01526161|Children|children
477046|NCT01526161|Therapy|therapy
477047|NCT01526161|Fluticasone|fluticasone
477048|NCT01526161|Salmeterol|salmeterol
477049|NCT01526161|Montelukast|montelukast
477050|NCT01526135|National multicentric phase III superiority trial|national multicentric phase iii superiority trial
477051|NCT01526122|Clopidogrel|clopidogrel
477052|NCT01526122|Aspirin|aspirin
477053|NCT01526122|coadministration|coadministration
477054|NCT01526109|elderly|elderly
477055|NCT01526109|quality of life|quality of life
477355|NCT01524588|Phenotype|phenotype
477056|NCT01526109|functional capacity|functional capacity
477057|NCT01526109|cognitive function|cognitive function
477058|NCT01526109|physical exercise|physical exercise
477059|NCT01526083|Male Healthy Volunteers|male healthy volunteers
477060|NCT01526057|rheumatoid arthritis|rheumatoid arthritis
477061|NCT01526057|rituximab|rituximab
477062|NCT01526057|methotrexate|methotrexate
477063|NCT01526057|anti-TNF|anti-tnf
477064|NCT01526044|hyperglycemia|hyperglycemia
477065|NCT01526044|hypoglycemia|hypoglycemia
477066|NCT01526044|insulin|insulin
477067|NCT01526044|critical illness|critical illness
477068|NCT01526044|intensive insulin therapy|intensive insulin therapy
477069|NCT01526044|continuous glucose monitoring|continuous glucose monitoring
477070|NCT01526044|CGM|cgm
477071|NCT01526044|interstitial fluid glucose|interstitial fluid glucose
477072|NCT01526044|intensive care unit|intensive care unit
477073|NCT01526044|Blood glucose|blood glucose
477074|NCT01526031|frozen shoulder|frozen shoulder
477075|NCT01526031|bee venom acupuncture|bee venom acupuncture
477076|NCT01526018|Intake|intake
477077|NCT01526018|Formula feeding|formula feeding
477078|NCT01525992|Community Pharmacy Services|community pharmacy services
477079|NCT01525992|Pharmacists|pharmacists
477080|NCT01525992|Diabetes Mellitus|diabetes mellitus
477081|NCT01525992|Diabetes Mellitus, Type 2|diabetes mellitus, type 2
477082|NCT01525992|Self Care|self care
477083|NCT01525992|Randomized Controlled Trial|randomized controlled trial
477084|NCT01525979|Stroke rehabilitation|stroke rehabilitation
477085|NCT01525979|Unilateral arm training|unilateral arm training
477086|NCT01525979|Bilateral arm training|bilateral arm training
477087|NCT01525979|Robot-assisted arm training|robot-assisted arm training
477088|NCT01525979|Kinematic analysis|kinematic analysis
477089|NCT01525979|Functional magnetic resonance image|functional magnetic resonance image
477090|NCT01525979|Motor recovery|motor recovery
477091|NCT01525979|Quality of life|quality of life
477092|NCT01525953|esophageal cancer|esophageal cancer
477093|NCT01525953|radiochemotherapy|radiochemotherapy
477094|NCT01525953|prognosis|prognosis
477095|NCT01525940|colon capsule endoscopy|colon capsule endoscopy
477096|NCT01525940|CT-colonography|ct-colonography
477097|NCT01525940|Patients|patients
477098|NCT01525940|incomplete colonoscopy|incomplete colonoscopy
477099|NCT01525927|Oropharyngeal Neoplasms|oropharyngeal neoplasms
477100|NCT01525927|Neoplasms, Oropharyngeal|neoplasms, oropharyngeal
477101|NCT01525927|Oropharynx Neoplasms|oropharynx neoplasms
477102|NCT01525914|prostate cancer|prostate cancer
477103|NCT01525914|PSA kinetics|psa kinetics
477104|NCT01525914|PSA doubling time|psa doubling time
477105|NCT01525914|active surveillance|active surveillance
477106|NCT01525901|SHANK3|shank3
477107|NCT01525901|IGF-1|igf-1
477108|NCT01525901|Autism|autism
477109|NCT01525888|Contrast induced nephropathy|contrast induced nephropathy
477110|NCT01525875|pseudoxanthoma elasticum|pseudoxanthoma elasticum
477111|NCT01525875|calcification|calcification
477112|NCT01525836|Purpura|purpura
477113|NCT01525836|Idiopathic Thrombocytopenic Purpura|idiopathic thrombocytopenic purpura
477114|NCT01525797|Liver Transplant|liver transplant
477115|NCT01525784|rtCGMS|rtcgms
477116|NCT01525784|glycemic control|glycemic control
477117|NCT01525784|type 1 diabetes mellitus|type 1 diabetes mellitus
477118|NCT01525784|youth|youth
477119|NCT01525771|Advanced Gastric cancer|advanced gastric cancer
477120|NCT01525771|Xeloda (Capecitabine)|xeloda (capecitabine)
477121|NCT01525771|Cisplatin|cisplatin
477122|NCT01525771|Taxotere (Docetaxel)|taxotere (docetaxel)
477123|NCT01525732|Achalasia, Hypertensive LES|achalasia, hypertensive les
477124|NCT01525719|cholangiocarcinoma|cholangiocarcinoma
477125|NCT01525719|RAD001|rad001
477126|NCT01525719|everolimus|everolimus
477127|NCT01525706|Endoscopic Ultrasound|endoscopic ultrasound
477128|NCT01525706|Pancreatic Mucinous Cystic Neoplasm|pancreatic mucinous cystic neoplasm
477129|NCT01525706|Fine Needle Injection|fine needle injection
477130|NCT01525706|Ethanol Ablation|ethanol ablation
477131|NCT01525706|Paclitaxel Ablation|paclitaxel ablation
477132|NCT01525693|diabetes|diabetes
477133|NCT01525693|diabetics|diabetics
477134|NCT01525693|high glucose|high glucose
477135|NCT01525693|Chinese patients|chinese patients
477136|NCT01525680|PTSD|ptsd
477137|NCT01525667|THA|tha
477138|NCT01525667|Muscle injury|muscle injury
477139|NCT01525654|Rheumatoid Arthritis|rheumatoid arthritis
477140|NCT01525654|peer support|peer support
477141|NCT01525654|self-efficacy|self-efficacy
477142|NCT01525654|medication adherence|medication adherence
477143|NCT01525602|advanced, incurable solid tumors|advanced, incurable solid tumors
477144|NCT01525589|Breast cancer|breast cancer
477145|NCT01525589|PM01183|pm01183
477146|NCT01525589|lurbinectedin|lurbinectedin
477147|NCT01525589|Pharma Mar|pharma mar
477148|NCT01525576|booster program|booster program
477149|NCT01525576|internet|internet
477150|NCT01525576|cbt|cbt
477151|NCT01525576|Study the specific effects of adding a booster program|study the specific effects of adding a booster program
477152|NCT01525563|Duphaston Study|duphaston study
477153|NCT01525550|neuroendocrine tumors|neuroendocrine tumors
477154|NCT01525550|adenoma islet cells|adenoma islet cells
477155|NCT01525550|carcinoma islet cells|carcinoma islet cells
477156|NCT01525550|pancreatic neoplasms|pancreatic neoplasms
477157|NCT01525550|angiogenesis inhibitors|angiogenesis inhibitors
477158|NCT01525550|sunitinib|sunitinib
477159|NCT01525550|neoplasms|neoplasms
477160|NCT01525550|carcinoma|carcinoma
477161|NCT01525550|adenoma|adenoma
477162|NCT01525537|Anesthesia General|anesthesia general
477163|NCT01525537|Anesthetics Inhalation|anesthetics inhalation
477164|NCT01525537|Diagnostic techniques and procedures|diagnostic techniques and procedures
477165|NCT01525524|tDCS|tdcs
477166|NCT01525524|Major Depression|major depression
477167|NCT01525524|Stroke|stroke
477168|NCT01525498|Pelvic Organ Prolapse|pelvic organ prolapse
477169|NCT01525498|Catheterization|catheterization
477170|NCT01525498|Urinary tract infection|urinary tract infection
477171|NCT01525498|Urinary retention|urinary retention
477172|NCT01525472|obesity|obesity
477173|NCT01525472|adipose tissue|adipose tissue
477174|NCT01525472|angiogenesis|angiogenesis
477175|NCT01525472|senecence|senecence
477176|NCT01525459|Glioma|glioma
477177|NCT01525459|PBMC subpopulations|pbmc subpopulations
477178|NCT01525459|Gene expression|gene expression
477179|NCT01525459|Metabolomics|metabolomics
477180|NCT01525459|Immunological status|immunological status
477181|NCT01525459|miRNA|mirna
477182|NCT01525459|Proteomics|proteomics
477183|NCT01525446|NSCLC|nsclc
477184|NCT01525446|Lung Cancer|lung cancer
477185|NCT01525394|lymphomas|lymphomas
477186|NCT01525394|Refractory solid tumors|refractory solid tumors
477187|NCT01525368|mild cognitive impairment|mild cognitive impairment
477188|NCT01525368|Alzheimer's disease|alzheimer's disease
477189|NCT01525368|cognitive intervention|cognitive intervention
477190|NCT01525368|cognitive reserve|cognitive reserve
477192|NCT01525355|ERCP|ercp
477193|NCT01525355|Intraoperative cholangiogram|intraoperative cholangiogram
477194|NCT01525355|Cholecystectomy|cholecystectomy
477195|NCT01525355|Common Bile Duct Stones|common bile duct stones
477196|NCT01525355|Strictures|strictures
477197|NCT01525355|Stenosis|stenosis
477198|NCT01525355|Duodenum|duodenum
477199|NCT01525355|Dilated Bile duct|dilated bile duct
477200|NCT01525355|Non-filling of the duodenum by contrast|non-filling of the duodenum by contrast
477201|NCT01525329|Actinic Keratosis|actinic keratosis
477202|NCT01525329|Photodynamic Therapy|photodynamic therapy
477203|NCT01525316|Late Onset Neonatal Sepsis|late onset neonatal sepsis
477204|NCT01525316|Neonates|neonates
477205|NCT01525316|Lactoferrin|lactoferrin
477206|NCT01525316|Infections|infections
477207|NCT01525316|Prevention|prevention
477208|NCT01525316|Neurodevelopment|neurodevelopment
477209|NCT01525303|headaches|headaches
477210|NCT01525303|behavioral treatment|behavioral treatment
477211|NCT01525303|physical activity|physical activity
477212|NCT01525290|wake-up stroke|wake-up stroke
477213|NCT01525290|thrombolysis|thrombolysis
477214|NCT01525290|magnetic resonance imaging (MRI)|magnetic resonance imaging (mri)
477215|NCT01525290|diffusion weighted imaging (DWI)|diffusion weighted imaging (dwi)
477216|NCT01525290|fluid attenuated inversion recovery (FLAIR)|fluid attenuated inversion recovery (flair)
477217|NCT01525264|Mammography|mammography
477218|NCT01525251|primary caregiver|primary caregiver
477219|NCT01525251|neuroblastoma|neuroblastoma
477220|NCT01525251|support group|support group
477221|NCT01525251|posttraumatic stress|posttraumatic stress
477222|NCT01525251|uncertainty|uncertainty
477223|NCT01525199|Non-Small Cell Lung Cancer,|non-small cell lung cancer,
477224|NCT01525199|Epidermal Growth Factor Receptor mutation,|epidermal growth factor receptor mutation,
477225|NCT01525199|Lung cancer,|lung cancer,
477226|NCT01525199|Lung adenocarcinoma|lung adenocarcinoma
477227|NCT01525186|Weight|weight
477228|NCT01525186|Food intakes|food intakes
477229|NCT01525186|Feeding|feeding
477230|NCT01525160|Clot structure|clot structure
477231|NCT01525160|Haemostasis|haemostasis
477232|NCT01525160|Gel point|gel point
477233|NCT01525160|Fractal dimension|fractal dimension
477234|NCT01525160|serum amyloid A|serum amyloid a
477235|NCT01525160|C-reactive protein|c-reactive protein
477236|NCT01525160|vascular cell adhesion molecule-1|vascular cell adhesion molecule-1
477237|NCT01525160|intercellular adhesion molecule-1|intercellular adhesion molecule-1
477238|NCT01525134|Tests, Diagnostic|tests, diagnostic
477239|NCT01525134|Mycobacterium tuberculosis|mycobacterium tuberculosis
477240|NCT01525134|Mycobacterium tuberculosis antigens|mycobacterium tuberculosis antigens
477241|NCT01525134|TB|tb
477242|NCT01525134|Tuberculosis|tuberculosis
477243|NCT01525134|Tuberculosis, Pulmonary|tuberculosis, pulmonary
477244|NCT01525134|Tuberculosis, Miliary|tuberculosis, miliary
477245|NCT01525134|Lipoarabinomannan|lipoarabinomannan
477246|NCT01525121|mechanical ventilation|mechanical ventilation
477247|NCT01525121|chest physiotherapy|chest physiotherapy
477248|NCT01525121|critical care|critical care
477249|NCT01525121|pneumonia|pneumonia
477250|NCT01525121|Mechanically ventilated patients with pulmonary infection.|mechanically ventilated patients with pulmonary infection.
477251|NCT01525108|Medication adherence|medication adherence
477252|NCT01525108|Blood pressure|blood pressure
477253|NCT01525108|Home-based blood pressure measurement|home-based blood pressure measurement
477254|NCT01525108|Blood Pressure Determination|blood pressure determination
477255|NCT01525108|Blood Pressure Monitors|blood pressure monitors
477256|NCT01525108|Blood Pressure Monitoring, Ambulatory|blood pressure monitoring, ambulatory
477257|NCT01525095|Candida|candida
477258|NCT01525095|Diagnostic Assay|diagnostic assay
477259|NCT01525095|Blood culture|blood culture
477260|NCT01525095|Sepsis|sepsis
477261|NCT01525095|T2 Magnetic Relaxation|t2 magnetic relaxation
477262|NCT01525056|rectal cancer|rectal cancer
477263|NCT01525056|imaging|imaging
477264|NCT01525056|PET|pet
477265|NCT01525056|MRI|mri
477266|NCT01525043|Epicondylitis|epicondylitis
477267|NCT01525004|Solid organ transplant|solid organ transplant
477268|NCT01525004|Flu vaccine|flu vaccine
477269|NCT01524965|Locking Plate|locking plate
477270|NCT01524965|Physiotherapy|physiotherapy
477271|NCT01524926|Phase 2|phase 2
477272|NCT01524926|Crizotinib|crizotinib
477273|NCT01524926|Anaplastic large cell lymphoma|anaplastic large cell lymphoma
477274|NCT01524926|Inflammatory myofibroblastic tumor|inflammatory myofibroblastic tumor
477275|NCT01524926|Papillary renal cell carcinoma type 1|papillary renal cell carcinoma type 1
477276|NCT01524926|Alveolar soft part sarcoma|alveolar soft part sarcoma
477277|NCT01524926|Clear cell sarcoma|clear cell sarcoma
477278|NCT01524926|Alveolar rhabdomyosarcoma|alveolar rhabdomyosarcoma
477279|NCT01524874|vitamin d|vitamin d
477280|NCT01524874|cholecalciferol|cholecalciferol
477281|NCT01524874|nutritional supplements|nutritional supplements
477282|NCT01524874|hypovitaminosis d|hypovitaminosis d
477283|NCT01524874|klotho|klotho
477284|NCT01524874|toll like receptor 4|toll like receptor 4
477285|NCT01524861|Tako-Tsubo|tako-tsubo
477286|NCT01524861|Sympathetic heart innervation|sympathetic heart innervation
477287|NCT01524861|MIBG|mibg
477288|NCT01524861|Alpha-lipoic acid|alpha-lipoic acid
477289|NCT01524861|L-acetyl carnitine|l-acetyl carnitine
477290|NCT01524848|Clinical trial|clinical trial
477291|NCT01524848|Investigational drugs|investigational drugs
477292|NCT01524848|Gastrointestinal stromal tumors|gastrointestinal stromal tumors
477293|NCT01524848|Pazopanib|pazopanib
477294|NCT01524835|Tissue Donors|tissue donors
477295|NCT01524835|Lung|lung
477296|NCT01524835|Transplants|transplants
477297|NCT01524835|Transplantation|transplantation
477298|NCT01524822|Military|military
477299|NCT01524822|Traumatic Brain Injury|traumatic brain injury
477300|NCT01524822|Cognitive Testing|cognitive testing
477301|NCT01524822|Neuroimaging|neuroimaging
477302|NCT01524822|Brain Function|brain function
477303|NCT01524796|Real-life|real-life
477304|NCT01524796|non-interventional|non-interventional
477305|NCT01524796|observational|observational
477306|NCT01524796|peripheral neuropathic pain|peripheral neuropathic pain
477307|NCT01524796|Lyrica|lyrica
477308|NCT01524796|pregabalin|pregabalin
477309|NCT01524783|Neuroendocrine tumor|neuroendocrine tumor
477310|NCT01524783|NET|net
477311|NCT01524783|progressive|progressive
477312|NCT01524783|advanced|advanced
477313|NCT01524783|gastrointestinal|gastrointestinal
477314|NCT01524783|GI or lung origin|gi or lung origin
477315|NCT01524783|nonfunctional|nonfunctional
477316|NCT01524783|everolimus|everolimus
477317|NCT01524783|Advanced NET of GI origin|advanced net of gi origin
477318|NCT01524783|Advanced NET of lung origin|advanced net of lung origin
477319|NCT01524744|oral lichen planus treatment pimecrolimus|oral lichen planus treatment pimecrolimus
477320|NCT01524718|radiation|radiation
477321|NCT01524718|time surgery|time surgery
477322|NCT01524705|Pilot Study|pilot study
477323|NCT01524705|Prospective Randomized Trial|prospective randomized trial
477324|NCT01524705|Comparative Effectiveness|comparative effectiveness
477325|NCT01524705|Glycemic Variability|glycemic variability
477326|NCT01524705|insulin glargine|insulin glargine
477327|NCT01524705|exenatide|exenatide
477328|NCT01524705|basal insulin|basal insulin
477329|NCT01524705|bolus insulin|bolus insulin
477330|NCT01524679|chronic hepatitis B|chronic hepatitis b
477331|NCT01524653|VTE|vte
477332|NCT01524653|DVT|dvt
477333|NCT01524653|Chemo|chemo
477334|NCT01524653|Metastatic|metastatic
477335|NCT01524653|Advanced|advanced
477336|NCT01524653|Systemic therapy|systemic therapy
477337|NCT01524653|statin|statin
477338|NCT01524653|biomarkers|biomarkers
477339|NCT01524640|oral cholera vaccine|oral cholera vaccine
608759|NCT00983320|pain|pain
477340|NCT01524640|safety and immunogenicity|safety and immunogenicity
477341|NCT01524640|bridging study|bridging study
477342|NCT01524640|ethiopia|ethiopia
477343|NCT01524627|Smokers|smokers
477344|NCT01524627|fMRI|fmri
477345|NCT01524627|varenicline|varenicline
477346|NCT01524614|continuous positive airway pressure|continuous positive airway pressure
477347|NCT01524614|nasal mask|nasal mask
477348|NCT01524614|upper airway obstruction|upper airway obstruction
477349|NCT01524601|Immunosuppression|immunosuppression
477350|NCT01524601|Everolimus|everolimus
477351|NCT01524601|rosuvastatin|rosuvastatin
477352|NCT01524601|fluvastatin|fluvastatin
477353|NCT01524601|Lipid lowering|lipid lowering
477354|NCT01524588|Genotype|genotype
477356|NCT01524588|Genotypic Variation Between Patients|genotypic variation between patients
477357|NCT01524588|Genotypic Phenotypic Relationships|genotypic phenotypic relationships
477358|NCT01524575|pancreatic cancer|pancreatic cancer
477359|NCT01524575|ERCC1|ercc1
477360|NCT01524575|oxaliplatin|oxaliplatin
477361|NCT01524575|gemcitabine|gemcitabine
477362|NCT01524562|Fibrosis|fibrosis
477363|NCT01524562|Cirrhosis|cirrhosis
477364|NCT01524562|Africa|africa
477365|NCT01524562|Schistosomiasis|schistosomiasis
477366|NCT01524562|Aflatoxin|aflatoxin
477367|NCT01524562|Liver Disease|liver disease
477368|NCT01524549|Cardiovascular|cardiovascular
477369|NCT01524549|P450s|p450s
477370|NCT01524549|Flow-Mediated Dilatation|flow-mediated dilatation
477371|NCT01524549|Brachial Artery Ultrasound|brachial artery ultrasound
477372|NCT01524549|Endothelial Cell Function|endothelial cell function
477373|NCT01524549|Healthy Volunteer|healthy volunteer
477374|NCT01524549|HV|hv
477375|NCT01524536|Hypereosinophilia|hypereosinophilia
477376|NCT01524536|Hypereosinophilic Syndrome|hypereosinophilic syndrome
477377|NCT01524536|Corticosteroids|corticosteroids
477378|NCT01524536|Therapy|therapy
477379|NCT01524536|HES|hes
477380|NCT01524523|Gene Expression|gene expression
477381|NCT01524523|Acute Pain|acute pain
477382|NCT01524523|Nitric Oxide|nitric oxide
477383|NCT01524523|Pain|pain
477384|NCT01524523|Bone Marrow|bone marrow
477385|NCT01524510|OSAS|osas
477386|NCT01524510|AHI|ahi
477387|NCT01524510|MRA|mra
477388|NCT01524510|CFD|cfd
477389|NCT01524497|losing interest and feelings of guilt|losing interest and feelings of guilt
477390|NCT01524497|poor concentration|poor concentration
477391|NCT01524497|loss of appetite|loss of appetite
477392|NCT01524497|suicide|suicide
477393|NCT01524484|Data quality|data quality
477394|NCT01524484|Anesthesia|anesthesia
477395|NCT01524484|Quality assurance|quality assurance
477396|NCT01524471|Hypertensive LES|hypertensive les
477397|NCT01524445|Bortezomib|bortezomib
477398|NCT01524445|Velcade|velcade
477399|NCT01524445|multiple myeloma|multiple myeloma
477400|NCT01524445|retrospective study, response rate, medical resource utilization|retrospective study, response rate, medical resource utilization
477401|NCT01524432|Clotrimazole|clotrimazole
477402|NCT01524432|Microcapsules|microcapsules
477403|NCT01524419|spontaneous labor|spontaneous labor
477404|NCT01524419|term|term
477405|NCT01524419|surgical|surgical
477406|NCT01524419|mechanical|mechanical
477407|NCT01524419|fetal or maternal complications|fetal or maternal complications
477408|NCT01524406|Muscle Atrophy|muscle atrophy
477409|NCT01524393|Assisted Reproductive Techniques|assisted reproductive techniques
477410|NCT01524393|Pregnancy|pregnancy
477411|NCT01524393|Pulmonary Embolism|pulmonary embolism
477412|NCT01524393|Venous Thromboembolism|venous thromboembolism
477413|NCT01524380|Schizophrenia|schizophrenia
477414|NCT01524380|clinical trial|clinical trial
477415|NCT01524380|risperidone|risperidone
477416|NCT01524380|ginkgo biloba extract|ginkgo biloba extract
477417|NCT01524380|antioxidant|antioxidant
477418|NCT01524354|depth of anesthesia|depth of anesthesia
477419|NCT01524354|valve surgery|valve surgery
477420|NCT01524341|Acute malaria|acute malaria
477421|NCT01524341|KAE609|kae609
477422|NCT01524328|Complementary and alternative medicine|complementary and alternative medicine
477423|NCT01524328|HRQoL, Inflammatory bowel disease|hrqol, inflammatory bowel disease
477424|NCT01524315|Thiamine|thiamine
477425|NCT01524315|Vitamin B1|vitamin b1
477426|NCT01524315|Thiamine Deficiency|thiamine deficiency
477427|NCT01524315|Thiamine supplementation|thiamine supplementation
477428|NCT01524315|Cardiac surgery|cardiac surgery
477429|NCT01524315|Lactic Acid|lactic acid
477430|NCT01524302|pneumonia|pneumonia
477431|NCT01524302|ceftaroline|ceftaroline
477432|NCT01524302|community-aquired|community-aquired
477433|NCT01524250|Multiple Sclerosis|multiple sclerosis
477434|NCT01524250|relapse|relapse
477435|NCT01524250|demyelination|demyelination
477436|NCT01524250|treatment|treatment
477437|NCT01524250|corticosteroids|corticosteroids
477438|NCT01524224|Metastases|metastases
477439|NCT01524224|Neoplasm|neoplasm
477440|NCT01524224|Advanced Cancer|advanced cancer
477441|NCT01524224|Metastatic Cancer|metastatic cancer
477442|NCT01524211|Aortic Aneurysms|aortic aneurysms
477443|NCT01524185|childhood trauma|childhood trauma
477444|NCT01524185|intergenerational trauma|intergenerational trauma
477445|NCT01524185|child neglect|child neglect
477446|NCT01524185|child maltreatment|child maltreatment
477447|NCT01524185|mental health|mental health
477448|NCT01524172|child trauma exposure|child trauma exposure
477449|NCT01524172|mental health|mental health
477450|NCT01524172|yoga|yoga
477451|NCT01524172|mood regulation|mood regulation
477452|NCT01524172|child maltreatment|child maltreatment
477453|NCT01524159|cardiovascular disease|cardiovascular disease
477454|NCT01524146|Unresectable Cholangiocarcinoma|unresectable cholangiocarcinoma
477455|NCT01524146|Biliary obstruction|biliary obstruction
477456|NCT01524146|Stent obstruction|stent obstruction
477457|NCT01524146|Biliary stricture|biliary stricture
479239|NCT01516827|PTSD|ptsd
477458|NCT01524146|Photodynamic therapy|photodynamic therapy
477459|NCT01524146|PDT|pdt
477460|NCT01524146|Ablation|ablation
477461|NCT01524133|combat-related PTSD|combat-related ptsd
477462|NCT01524133|Posttraumatic stress disorder|posttraumatic stress disorder
477463|NCT01524133|prolonged exposure therapy|prolonged exposure therapy
477464|NCT01524133|sertraline|sertraline
477465|NCT01524133|military|military
477466|NCT01524133|veterans|veterans
477467|NCT01524133|VA hospital|va hospital
477468|NCT01524133|mental illness|mental illness
477469|NCT01524120|Mucosal healing|mucosal healing
477470|NCT01524107|Prophylaxis Antibiotics|prophylaxis antibiotics
477471|NCT01524107|Maternal Complications|maternal complications
477472|NCT01524107|Neonatal Complications|neonatal complications
477473|NCT01524107|Cord Prolapse|cord prolapse
477474|NCT01524107|Elective Caesarian Section|elective caesarian section
477475|NCT01524107|Maternal Morbidity|maternal morbidity
477476|NCT01524107|Neonatal Morbidity|neonatal morbidity
477477|NCT01524094|colorectal cancer|colorectal cancer
477478|NCT01524094|cytoreductive surgery|cytoreductive surgery
477479|NCT01524094|intraperitoneal chemotherapy|intraperitoneal chemotherapy
477480|NCT01524094|systemic chemotherapy|systemic chemotherapy
477481|NCT01524094|Peritoneal Metastatic Disease From the Colon or Rectum|peritoneal metastatic disease from the colon or rectum
477482|NCT01524081|antibiotic prophylaxis|antibiotic prophylaxis
477483|NCT01524081|emergent surgery|emergent surgery
477484|NCT01524081|surgical site infection|surgical site infection
477485|NCT01524068|Acute Idiopathic Pulmonary Fibrosis Exacerbations|acute idiopathic pulmonary fibrosis exacerbations
477486|NCT01524068|Idiopathic Pulmonary Fibrosis|idiopathic pulmonary fibrosis
477487|NCT01524068|IPF|ipf
477488|NCT01524042|Satisfaction|satisfaction
477489|NCT01524042|colonoscopy|colonoscopy
477490|NCT01524042|double pants|double pants
477491|NCT01524042|single pants|single pants
477492|NCT01524029|Digital Breast Tomosynthesis|digital breast tomosynthesis
477493|NCT01524029|Digital Mammography|digital mammography
477494|NCT01524029|Breast cancer detection|breast cancer detection
477495|NCT01524016|Oncogenic osteomalacia|oncogenic osteomalacia
477496|NCT01524016|mesenchymal tumor|mesenchymal tumor
477497|NCT01524016|Somatostatin receptor|somatostatin receptor
477498|NCT01524016|68Ga-DOTATATE|68ga-dotatate
477499|NCT01524016|PET/CT|pet/ct
477500|NCT01524003|community based participatory research|community based participatory research
477501|NCT01523977|ALL|all
477502|NCT01523977|pediatric|pediatric
477503|NCT01523977|relapse|relapse
477504|NCT01523964|DMD|dmd
477505|NCT01523964|EIM|eim
477506|NCT01523964|Duchenne Muscular Dystrophy|duchenne muscular dystrophy
477507|NCT01523964|electrical impedance myography|electrical impedance myography
477508|NCT01523951|topical local anaesthesia|topical local anaesthesia
477509|NCT01523951|cooling|cooling
477510|NCT01523951|capsaicin 8%|capsaicin 8%
477511|NCT01523951|epidermal nerve fiber density|epidermal nerve fiber density
477512|NCT01523951|treatment pain|treatment pain
477513|NCT01523925|Functional electrical therapy|functional electrical therapy
477514|NCT01523925|Bilateral arm training|bilateral arm training
477515|NCT01523925|Constraint induced therapy|constraint induced therapy
477516|NCT01523925|Stroke rehabilitation|stroke rehabilitation
477517|NCT01523925|Clinical evaluation|clinical evaluation
477518|NCT01523925|Kinematic analysis|kinematic analysis
477519|NCT01523912|radiofrequency ablation|radiofrequency ablation
477520|NCT01523912|gastric dysplasia|gastric dysplasia
477521|NCT01523912|gastric neoplasia|gastric neoplasia
477522|NCT01523899|SSTI|ssti
477523|NCT01523899|cutaneous abscess|cutaneous abscess
477524|NCT01523899|boil|boil
477525|NCT01523847|Hodgkin Lymphoma|hodgkin lymphoma
477526|NCT01523847|Cardiopathic|cardiopathic
477527|NCT01523847|elderly|elderly
477528|NCT01523847|Myocet|myocet
477529|NCT01523834|Diffuse Large B-cell Lymphoma (DLBCL)|diffuse large b-cell lymphoma (dlbcl)
477530|NCT01523834|Panobinostat|panobinostat
477531|NCT01523834|Patients with relapsed/refractory DLBCL.|patients with relapsed/refractory dlbcl.
477532|NCT01523808|pancreatic cancer|pancreatic cancer
477533|NCT01523808|asparaginase|asparaginase
477534|NCT01523795|Energy intake|energy intake
477535|NCT01523795|Video games|video games
477536|NCT01523795|Television|television
477537|NCT01523795|Physical activity|physical activity
477538|NCT01523795|Obesity|obesity
477539|NCT01523782|Acute Lymphoblastic leukemia|acute lymphoblastic leukemia
477540|NCT01523782|Elderly patient|elderly patient
477541|NCT01523782|Asparaginase|asparaginase
477542|NCT01523769|prematurity|prematurity
477543|NCT01523769|umbilical cord milking|umbilical cord milking
477544|NCT01523769|delayed cord clamping|delayed cord clamping
477545|NCT01523769|neonatal transfusion|neonatal transfusion
477546|NCT01523730|Schizophrenia|schizophrenia
477547|NCT01523730|Nicotine|nicotine
477548|NCT01523730|Transcranial Magnetic Stimulation|transcranial magnetic stimulation
477549|NCT01523730|Cognition|cognition
477550|NCT01523730|EEG|eeg
477551|NCT01523717|procalcitonin|procalcitonin
477552|NCT01523717|decrease over 72 hours|decrease over 72 hours
477553|NCT01523717|severe sepsis|severe sepsis
477554|NCT01523717|septic shock|septic shock
477555|NCT01523691|Healthy individuals|healthy individuals
477556|NCT01523678|Ovarian Cancer|ovarian cancer
477557|NCT01523678|Endometrial Cancer|endometrial cancer
477558|NCT01523678|Endometrial Carcinoma|endometrial carcinoma
477559|NCT01523678|Uterine Cervical Cancer|uterine cervical cancer
477560|NCT01523678|Paclitaxel|paclitaxel
477561|NCT01523678|Carboplatin|carboplatin
477562|NCT01523678|Neupogen|neupogen
477563|NCT01523678|Filgrastim|filgrastim
477564|NCT01523678|Ovarian Diseases|ovarian diseases
477565|NCT01523678|Peritoneal Diseases|peritoneal diseases
477566|NCT01523678|Fallopian Tube Diseases|fallopian tube diseases
477567|NCT01523678|Endocrine System Diseases|endocrine system diseases
477568|NCT01523678|Endometrial Diseases|endometrial diseases
477569|NCT01523678|Uterine Cervical Diseases|uterine cervical diseases
477570|NCT01523678|Neoplasms|neoplasms
477571|NCT01523678|Neoplasms, Glandular and Epithelial|neoplasms, glandular and epithelial
477572|NCT01523678|Ovarian Neoplasms|ovarian neoplasms
477573|NCT01523678|Peritoneal Neoplasms|peritoneal neoplasms
477574|NCT01523678|Fallopian Tube Neoplasms|fallopian tube neoplasms
477575|NCT01523678|Neoplasms, Endometrial|neoplasms, endometrial
477576|NCT01523678|Cervical Neoplasms|cervical neoplasms
477577|NCT01523678|Genital Neoplasms, Female|genital neoplasms, female
477578|NCT01523678|Urogenital Neoplasms|urogenital neoplasms
477579|NCT01523678|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic
477580|NCT01523678|Genital Diseases, Female|genital diseases, female
477581|NCT01523639|liver injury|liver injury
477582|NCT01523639|steatosis|steatosis
477583|NCT01523639|KRAS-Wild-Type|kras-wild-type
477584|NCT01523639|metastatic colorectal cancer|metastatic colorectal cancer
477585|NCT01523639|metformin|metformin
477586|NCT01523639|placebo|placebo
477587|NCT01523639|chemotherapy|chemotherapy
477588|NCT01523626|Trauma|trauma
477589|NCT01523626|Injur*|injur*
477590|NCT01523626|Emergen*|emergen*
477591|NCT01523626|Computed Tomography|computed tomography
477592|NCT01523626|Total body|total body
477593|NCT01523626|TBCT|tbct
477594|NCT01523626|Whole body|whole body
477595|NCT01523626|WBCT|wbct
477596|NCT01523626|Full body|full body
477597|NCT01523626|Pan CT|pan ct
477598|NCT01523613|Dental caries|dental caries
477599|NCT01523613|Proximal surfaces|proximal surfaces
477600|NCT01523613|Posterior teeth|posterior teeth
477601|NCT01523613|Carious lesions|carious lesions
477602|NCT01523613|Tooth diseases|tooth diseases
477603|NCT01523613|Dental restorations|dental restorations
477604|NCT01523613|Glass-ionomer|glass-ionomer
477605|NCT01523600|whole body vibration|whole body vibration
477606|NCT01523600|physical functioning|physical functioning
477607|NCT01523600|falls|falls
477608|NCT01523600|older people|older people
477609|NCT01523600|prevention|prevention
477610|NCT01523574|oxaliplatin|oxaliplatin
477611|NCT01523574|vitamin e|vitamin e
477612|NCT01523574|neuropathy|neuropathy
477613|NCT01523574|peripheral|peripheral
477614|NCT01523574|prophylaxis|prophylaxis
477615|NCT01523561|dance|dance
477616|NCT01523561|intervention|intervention
477617|NCT01523561|adolescent|adolescent
477618|NCT01523561|girls|girls
477619|NCT01523548|Carbon Monoxide|carbon monoxide
477620|NCT01523548|Hypertension, Pulmonary|hypertension, pulmonary
477621|NCT01523522|Fecal incontinence|fecal incontinence
477622|NCT01523522|Myoblast|myoblast
477623|NCT01523522|Surgery|surgery
477624|NCT01523509|Dental Caries|dental caries
477625|NCT01523509|Radiography, Dental|radiography, dental
477626|NCT01523509|Contrast media|contrast media
477627|NCT01523509|Tooth|tooth
477628|NCT01523496|HIV|hiv
477629|NCT01523496|Vitamin D Deficiency|vitamin d deficiency
477630|NCT01523483|preterm birth|preterm birth
477631|NCT01523483|preterm labor|preterm labor
477632|NCT01523483|progesterone|progesterone
477633|NCT01523483|uterine electromyography|uterine electromyography
477634|NCT01523483|cervical length|cervical length
477635|NCT01523470|non-invasive ventilator|non-invasive ventilator
477636|NCT01523457|metastatic pancreatic cancer|metastatic pancreatic cancer
711130|NCT00586365|complication|complication
477637|NCT01523457|locally advanced pancreatic cancer|locally advanced pancreatic cancer
477638|NCT01523457|FOLFIRINOX|folfirinox
477639|NCT01523457|phase II|phase ii
477640|NCT01523457|progression free survival|progression free survival
477641|NCT01523444|Adolescents|adolescents
477642|NCT01523444|Screening|screening
477643|NCT01523444|Advice|advice
477644|NCT01523444|Referral|referral
477645|NCT01523431|Colorectal cancer|colorectal cancer
477646|NCT01523431|Irinotecan|irinotecan
477647|NCT01523431|UGT1A1 genotype|ugt1a1 genotype
477648|NCT01523431|Neutropenia|neutropenia
477649|NCT01523431|diarrhea|diarrhea
477650|NCT01523431|response|response
477651|NCT01523431|pharmacokinetic|pharmacokinetic
477652|NCT01523418|Xarelto|xarelto
477653|NCT01523418|Thromboembolism, Venous|thromboembolism, venous
477654|NCT01523418|Orthopedic surgery|orthopedic surgery
477655|NCT01523418|Factor Xa inhibitor|factor xa inhibitor
477656|NCT01523418|Observational study|observational study
477657|NCT01523405|Non Interventional Study, Type II Diabetes Mellitus, Quality of Life|non interventional study, type ii diabetes mellitus, quality of life
477658|NCT01523392|Stable Coronary Artery Disease, CAD|stable coronary artery disease, cad
477659|NCT01523379|Causalgia|causalgia
477660|NCT01523379|CRPS|crps
477661|NCT01523379|complex regional pain syndrome|complex regional pain syndrome
477662|NCT01523379|Dynastat|dynastat
477663|NCT01523379|Parecoxib|parecoxib
477664|NCT01523366|Stable Coronary Artery Disease, CAD|stable coronary artery disease, cad
477665|NCT01523353|Prehabilitation|prehabilitation
477666|NCT01523353|Exercise|exercise
477667|NCT01523353|Colorectal Cancer|colorectal cancer
477668|NCT01523353|Surgery|surgery
477669|NCT01523327|Uric acid|uric acid
477670|NCT01523314|diabetic macular edema|diabetic macular edema
477671|NCT01523314|intravitreal injection|intravitreal injection
477672|NCT01523314|dexamethasone|dexamethasone
477673|NCT01523314|Cyclodextrin|cyclodextrin
477674|NCT01523314|eye drops|eye drops
477675|NCT01523314|bevacizumab|bevacizumab
477676|NCT01523314|macular laser|macular laser
477677|NCT01523301|Rotigotine|rotigotine
477678|NCT01523301|Neupro|neupro
477679|NCT01523301|Depressive Symptom|depressive symptom
477680|NCT01523301|Idiopathic Parkinson's disease|idiopathic parkinson's disease
477681|NCT01523275|mitomycin-C|mitomycin-c
477682|NCT01523275|laryngotracheal stenosis|laryngotracheal stenosis
477683|NCT01523275|subglottic stenosis|subglottic stenosis
477684|NCT01523275|tracheal stenosis|tracheal stenosis
477685|NCT01523275|endoscopic airway surgery|endoscopic airway surgery
477686|NCT01523262|preconditioning|preconditioning
477687|NCT01523262|aortic aneurysm|aortic aneurysm
477688|NCT01523249|3D ultrasonography|3d ultrasonography
477689|NCT01523249|epidural|epidural
477690|NCT01523249|neuraxial anesthesia|neuraxial anesthesia
477691|NCT01523249|neuraxial analgesia|neuraxial analgesia
477692|NCT01523249|pregnant woman|pregnant woman
477693|NCT01523249|parturients|parturients
477694|NCT01523236|Allergic Rhinitis|allergic rhinitis
477695|NCT01523236|Bioequivalence|bioequivalence
477696|NCT01523210|spasticity|spasticity
477697|NCT01523210|Diffusor tensor imaging|diffusor tensor imaging
477698|NCT01523210|distribution|distribution
477699|NCT01523210|botulinum toxin|botulinum toxin
477700|NCT01523210|physiotherapy|physiotherapy
477701|NCT01523197|Obstructive Sleep Apnea hypopnea Syndrome|obstructive sleep apnea hypopnea syndrome
477702|NCT01523197|COPD|copd
477703|NCT01523197|overlap syndrome|overlap syndrome
477704|NCT01523197|Auto-trilevel ventilation|auto-trilevel ventilation
477705|NCT01523197|BiPAP ventilation|bipap ventilation
477706|NCT01523184|Chronic constipation (CC)|chronic constipation (cc)
477707|NCT01523184|Functional Constipation (FC)|functional constipation (fc)
477708|NCT01523184|Gastric Emptying|gastric emptying
477709|NCT01523184|Colon Transit|colon transit
477710|NCT01523184|multiple doses of YKP10811|multiple doses of ykp10811
477711|NCT01523184|gastrointestinal transit|gastrointestinal transit
477712|NCT01523184|colonic transit|colonic transit
477713|NCT01523158|Allergic Rhinitis|allergic rhinitis
477714|NCT01523158|Immunotherapy|immunotherapy
477715|NCT01523145|Atrial fibrillation|atrial fibrillation
477716|NCT01523145|Radio Frequency Ablation|radio frequency ablation
477717|NCT01523145|Rehabilitation|rehabilitation
477718|NCT01523145|Physical capacity|physical capacity
477719|NCT01523145|Quality of life|quality of life
477720|NCT01523145|Integrated rehabilitation|integrated rehabilitation
477721|NCT01523106|Crohn's disease|crohn's disease
477722|NCT01523106|carnitine|carnitine
477723|NCT01523067|Vasomera|vasomera
477724|NCT01523067|PB1046|pb1046
477725|NCT01523067|Hypertension|hypertension
477726|NCT01523054|metoprolol, acute myocardial infarction, pharmacokinetics, pharmacodynamics|metoprolol, acute myocardial infarction, pharmacokinetics, pharmacodynamics
477727|NCT01523015|Adenocarcinoma|adenocarcinoma
477728|NCT01523015|esophago-gastric cancer|esophago-gastric cancer
477729|NCT01523015|chemotherapy|chemotherapy
477730|NCT01523015|chemoradiotherapy|chemoradiotherapy
477731|NCT01523015|surgery|surgery
477732|NCT01522989|Cancer|cancer
477733|NCT01522989|Advanced|advanced
477734|NCT01522989|Refractory|refractory
477735|NCT01522950|hypertension|hypertension
477736|NCT01522950|prevention|prevention
477737|NCT01522950|endothelial function|endothelial function
477738|NCT01522924|tobacco cessation treatment|tobacco cessation treatment
477739|NCT01522924|standardized patients|standardized patients
477740|NCT01522924|dental students|dental students
477741|NCT01522924|tobacco cessation treatment education|tobacco cessation treatment education
477742|NCT01522898|Heart Failure|heart failure
477743|NCT01522898|Atrial Fibrillation|atrial fibrillation
477744|NCT01522885|Chest tube|chest tube
477745|NCT01522885|placement|placement
477746|NCT01522885|mal positioning|mal positioning
477747|NCT01522872|TH-302|th-302
477748|NCT01522872|Relapsed/Refractory Multiple Myeloma|relapsed/refractory multiple myeloma
477749|NCT01522872|Bortezomib|bortezomib
477750|NCT01522872|Phase 1/2|phase 1/2
477751|NCT01522872|Hypoxia|hypoxia
477752|NCT01522872|Myeloma|myeloma
477753|NCT01522872|Evofosfamide|evofosfamide
477754|NCT01522872|Pomalidomide|pomalidomide
477755|NCT01522872|Pimonidazole|pimonidazole
477756|NCT01522859|COPD|copd
477757|NCT01522859|Telehealth|telehealth
477758|NCT01522859|health related quality of life|health related quality of life
477759|NCT01522833|NSLCL|nslcl
477760|NCT01522833|Erlotinib|erlotinib
477761|NCT01522833|Tarceva|tarceva
477762|NCT01522807|Phase 1|phase 1
477763|NCT01522807|Single Doses|single doses
477764|NCT01522807|Biocomparison|biocomparison
477765|NCT01522807|Pharmacokinetics|pharmacokinetics
477766|NCT01522807|Healthy Volunteers|healthy volunteers
477767|NCT01522768|ESOPHAGUS|esophagus
477768|NCT01522768|STOMACH|stomach
477769|NCT01522768|Afatinib|afatinib
477770|NCT01522768|paclitaxel|paclitaxel
477771|NCT01522768|trastuzumab|trastuzumab
477772|NCT01522768|11-166|11-166
477773|NCT01522755|Pacing lead|pacing lead
477774|NCT01522755|implant|implant
477775|NCT01522755|pacemaker|pacemaker
477776|NCT01522742|psoriasis|psoriasis
477777|NCT01522742|cardiovascular disease risk|cardiovascular disease risk
477778|NCT01522742|atherosclerosis|atherosclerosis
477779|NCT01522742|etanercept (enbrel)|etanercept (enbrel)
477780|NCT01522729|Chronic pulmonary obstructive disease|chronic pulmonary obstructive disease
477781|NCT01522729|Muscle dysfunction|muscle dysfunction
477782|NCT01522729|Exercise intolerance|exercise intolerance
477783|NCT01522729|Muscle afferents|muscle afferents
477784|NCT01522729|Ventilation|ventilation
477785|NCT01522703|asthma|asthma
477786|NCT01522703|allergic rhinitis|allergic rhinitis
477787|NCT01522703|dietary interventions|dietary interventions
477788|NCT01522703|mouse allergy|mouse allergy
477789|NCT01522690|Accelerometer|accelerometer
477790|NCT01522690|gait analysis|gait analysis
477791|NCT01522690|Healthy subjects|healthy subjects
477792|NCT01522677|tumor immunology|tumor immunology
477793|NCT01522677|neoadjuvant|neoadjuvant
477794|NCT01522677|colonoscopy|colonoscopy
477795|NCT01522677|photosensitization|photosensitization
477796|NCT01522651|Atrial Fibrillation|atrial fibrillation
477797|NCT01522651|Ranolazine|ranolazine
477798|NCT01522651|Dronedarone|dronedarone
477799|NCT01522651|Dual Chamber Pacemakers|dual chamber pacemakers
477800|NCT01522625|chronic hepatitis B|chronic hepatitis b
477801|NCT01522625|hepatitis B viral DNA|hepatitis b viral dna
477802|NCT01522625|antiviral therapy|antiviral therapy
477803|NCT01522625|Tenofovir|tenofovir
477804|NCT01522612|KRAS Wild Type|kras wild type
477805|NCT01522612|Frail Elderly|frail elderly
477806|NCT01522612|QLQ-C30|qlq-c30
477807|NCT01522612|QLQ-ELD14|qlq-eld14
477808|NCT01522612|CGA|cga
477809|NCT01522612|EGFR|egfr
477810|NCT01522612|Cetuximab|cetuximab
477811|NCT01522612|5-FU|5-fu
477812|NCT01522599|ARDS: Acute Respiratory Distress Syndrome|ards: acute respiratory distress syndrome
477813|NCT01522599|LOW FLOW ECCO2-R: EXTRA-CORPOREAL CO2 REMOVAL|low flow ecco2-r: extra-corporeal co2 removal
477814|NCT01522599|VILI: Ventilator Induced Lung Injury|vili: ventilator induced lung injury
477815|NCT01522573|Cholangiocarcinoma|cholangiocarcinoma
477816|NCT01522573|Pancreatic Cancer|pancreatic cancer
477817|NCT01522573|Bile Duct Cancer|bile duct cancer
477818|NCT01522573|Biliary Stricture|biliary stricture
477819|NCT01522573|Biliary obstruction|biliary obstruction
477820|NCT01522573|Stent obstruction|stent obstruction
477821|NCT01522573|Proximal duct stricture|proximal duct stricture
477822|NCT01522573|Distal duct stricture|distal duct stricture
477823|NCT01522573|Ampullary Cancer|ampullary cancer
477824|NCT01522573|Biliary sphincter stenosis|biliary sphincter stenosis
477825|NCT01522573|Impacted stones|impacted stones
477826|NCT01522573|Chronic pancreatitis|chronic pancreatitis
477827|NCT01522573|Peri-ampullary diverticula|peri-ampullary diverticula
477828|NCT01522573|Altered anatomy|altered anatomy
477829|NCT01522573|Endoscopic ultrasound|endoscopic ultrasound
477830|NCT01522573|Endoscopic Retrograde Cholangiopancreatography|endoscopic retrograde cholangiopancreatography
477831|NCT01522573|Multicenter|multicenter
477832|NCT01522560|CA2 and CA3 residents|ca2 and ca3 residents
477833|NCT01522560|Pediatric Anesthesia|pediatric anesthesia
477834|NCT01522547|Pomalidomide|pomalidomide
711131|NCT00586365|naproxen|naproxen
609394|NCT00980681|MRA|mra
477835|NCT01522547|Sickle Cell Disease|sickle cell disease
477836|NCT01522547|Fetal Hemoglobin|fetal hemoglobin
477837|NCT01522534|injuries|injuries
477838|NCT01522534|pain|pain
477839|NCT01522534|Block, Nerve|block, nerve
477840|NCT01522534|morphine|morphine
477841|NCT01522534|Prehospital Emergency Care|prehospital emergency care
477842|NCT01522521|AK156|ak156
477843|NCT01522508|Analgesia|analgesia
477844|NCT01522508|Anesthetics|anesthetics
477845|NCT01522508|Diagnostic Techniques and Procedures|diagnostic techniques and procedures
477846|NCT01522482|fatty acids|fatty acids
477847|NCT01522482|cardiovascular disease|cardiovascular disease
477848|NCT01522482|genotype|genotype
477849|NCT01522482|apoE|apoe
477850|NCT01522469|FLT3|flt3
477851|NCT01522469|Crenolanib|crenolanib
477852|NCT01522469|Acute|acute
477853|NCT01522469|myeloid|myeloid
477854|NCT01522469|leukemia|leukemia
477855|NCT01522469|relapsed|relapsed
477856|NCT01522469|refractory|refractory
477857|NCT01522443|prostate cancer|prostate cancer
477858|NCT01522443|castration resistant prostate cancer|castration resistant prostate cancer
477859|NCT01522443|bone pain|bone pain
477860|NCT01522443|CRPC|crpc
477861|NCT01522430|Resistant hypertension|resistant hypertension
477862|NCT01522430|Renal denervation|renal denervation
477863|NCT01522430|Ambulatory blood pressure|ambulatory blood pressure
477864|NCT01522430|Renal function|renal function
477865|NCT01522430|Simplicity catheter|simplicity catheter
477866|NCT01522430|Sham procedure|sham procedure
477867|NCT01522404|Mild Cognitive Impairment|mild cognitive impairment
477868|NCT01522404|Memory Loss|memory loss
477869|NCT01522404|Alzheimer's Disease|alzheimer's disease
477870|NCT01522378|cardiac resynchronization therapy|cardiac resynchronization therapy
477871|NCT01522365|Dental implants|dental implants
477872|NCT01522365|XiVE CAD/CAM bridge|xive cad/cam bridge
477873|NCT01522352|Bioprosthesis,|bioprosthesis,
477874|NCT01522352|aortic valve replacement|aortic valve replacement
477875|NCT01522352|Magna Ease|magna ease
477876|NCT01522352|Mitroflow|mitroflow
477877|NCT01522352|Trifecta|trifecta
477878|NCT01522339|NICU|nicu
477879|NCT01522339|MRI|mri
477880|NCT01522339|Neonatal|neonatal
477881|NCT01522339|Safety|safety
477882|NCT01522339|Efficacy|efficacy
477883|NCT01522339|Cincinnati|cincinnati
477884|NCT01522326|Acute Mountain Sickness|acute mountain sickness
477885|NCT01522326|High Altitude Headache|high altitude headache
477886|NCT01522326|Lake Louise AMS Score|lake louise ams score
477887|NCT01522326|Visual Analog Scale|visual analog scale
477888|NCT01522326|Ibuprofen|ibuprofen
477889|NCT01522326|Metoclopramide|metoclopramide
477890|NCT01522326|Nepal|nepal
477891|NCT01522300|Tomosynthesis|tomosynthesis
477892|NCT01522300|breast cancer|breast cancer
477893|NCT01522300|specificity|specificity
477894|NCT01522300|sensitivity|sensitivity
477895|NCT01522300|To assess efficacy of Tomosynthesis by evaluating its sensitivity and specificity in detecting the multicentricity of mammary tumor|to assess efficacy of tomosynthesis by evaluating its sensitivity and specificity in detecting the multicentricity of mammary tumor
477896|NCT01522287|Obsessive Compulsive Disorder|obsessive compulsive disorder
477897|NCT01522287|Computer Assisted Therapy|computer assisted therapy
477898|NCT01522287|Cognitive Behavior Therapy|cognitive behavior therapy
477899|NCT01522287|Cognitive Therapy|cognitive therapy
477900|NCT01522261|Mechanical Bowel Prep|mechanical bowel prep
477901|NCT01522248|influenza vaccine|influenza vaccine
477902|NCT01522248|cytokines|cytokines
477903|NCT01522248|chemokines|chemokines
477904|NCT01522248|symptoms|symptoms
477905|NCT01522235|Autoimmune autonomic neuropathy|autoimmune autonomic neuropathy
477906|NCT01522235|Orthostatic hypotension|orthostatic hypotension
477907|NCT01522235|Dysautonomia|dysautonomia
477908|NCT01522235|Autonomic failure|autonomic failure
477909|NCT01522235|Peripheral autonomic neuropathy|peripheral autonomic neuropathy
477910|NCT01522222|cardiopulmonary bypass surgery|cardiopulmonary bypass surgery
477911|NCT01522222|CABG|cabg
477912|NCT01522222|PEEP|peep
477913|NCT01522209|CRLM|crlm
477914|NCT01522209|Primovist MRI|primovist mri
477915|NCT01522209|CEIOUS|ceious
477916|NCT01522196|SCD|scd
477917|NCT01522183|Atypical Hemolytic-Uremic Syndrome|atypical hemolytic-uremic syndrome
477918|NCT01522183|aHUS|ahus
477919|NCT01522183|Thrombotic Microangiopathy|thrombotic microangiopathy
477920|NCT01522183|TMA|tma
477921|NCT01522170|Atypical Hemolytic Uremic Syndrome|atypical hemolytic uremic syndrome
477922|NCT01522170|aHUS|ahus
477923|NCT01522170|Eculizumab|eculizumab
477924|NCT01522157|Diet|diet
477925|NCT01522157|Low-carbohydrate|low-carbohydrate
477926|NCT01522157|Postprandial|postprandial
477927|NCT01522157|Type 2 diabetes mellitus|type 2 diabetes mellitus
477928|NCT01522131|bioresorbable membrane|bioresorbable membrane
477929|NCT01522118|Prostate Cancer|prostate cancer
477930|NCT01522118|High Intensity Focused Ultrasound|high intensity focused ultrasound
477931|NCT01522118|Magnetic Resonance guided Focused Ultrasound|magnetic resonance guided focused ultrasound
477932|NCT01522118|Non-invasive therapy|non-invasive therapy
477933|NCT01522118|Focal Disease|focal disease
477934|NCT01522105|Meningitis|meningitis
477935|NCT01522105|Central Nervous System Infections|central nervous system infections
477936|NCT01522105|Pediatrics|pediatrics
477937|NCT01522105|Daptomycin|daptomycin
477938|NCT01522105|Anti-Bacterial Agents|anti-bacterial agents
477939|NCT01522105|Therapeutic Use|therapeutic use
477940|NCT01522105|Pharmacologic Actions|pharmacologic actions
477941|NCT01522092|Exacerbations|exacerbations
477942|NCT01522079|spinal muscular atrophy|spinal muscular atrophy
477943|NCT01522079|heart rate variability|heart rate variability
477944|NCT01522079|posture|posture
477945|NCT01522079|air stacking|air stacking
477946|NCT01522040|Asthma|asthma
477947|NCT01522040|Magnesium|magnesium
477948|NCT01522040|Adrenergic Receptor|adrenergic receptor
477949|NCT01522014|Joint Replacement|joint replacement
477950|NCT01522014|Health Related Quality of Life|health related quality of life
477951|NCT01522014|Functional Outcomes|functional outcomes
477952|NCT01522014|Revision Rate|revision rate
477953|NCT01522001|Acute Coronary Syndrome|acute coronary syndrome
477954|NCT01522001|Myocardial Ischemia|myocardial ischemia
477955|NCT01522001|Shared Care|shared care
477956|NCT01522001|Rehabilitation|rehabilitation
477957|NCT01522001|Community|community
479634|NCT01515059|leptin|leptin
477958|NCT01522001|Cardiac Rehabilitation|cardiac rehabilitation
477959|NCT01522001|Hospital|hospital
477960|NCT01521988|Atrial flutter|atrial flutter
477961|NCT01521988|Atrial fibrillation|atrial fibrillation
477962|NCT01521988|Catheter ablation|catheter ablation
477963|NCT01521975|HBV DNA|hbv dna
477964|NCT01521975|LdT|ldt
477965|NCT01521975|ADV|adv
477966|NCT01521975|HBeAg negative hepatitis|hbeag negative hepatitis
477967|NCT01521975|CHB|chb
477968|NCT01521949|Prostate Cancer|prostate cancer
477969|NCT01521949|Nutraceutical|nutraceutical
477970|NCT01521949|Acai Juice|acai juice
477971|NCT01521923|Certolizumab Pegol - Cimzia|certolizumab pegol - cimzia
477972|NCT01521923|Rheumatoid Arthritis|rheumatoid arthritis
477973|NCT01521910|survival|survival
477974|NCT01521910|protein restriction|protein restriction
477975|NCT01521910|diabetic nephropathy|diabetic nephropathy
477976|NCT01521910|type 1 diabetes|type 1 diabetes
477977|NCT01521910|GFR|gfr
477978|NCT01521910|ESRD|esrd
477979|NCT01521910|progressive renal disease|progressive renal disease
477980|NCT01521897|Pneumococcal Vaccine|pneumococcal vaccine
477981|NCT01521897|Prevenar|prevenar
477982|NCT01521897|7-valent|7-valent
477983|NCT01521897|Special Use-result surveillance|special use-result surveillance
477984|NCT01521871|Tissue glue|tissue glue
477985|NCT01521871|Cyanoacrylate|cyanoacrylate
477986|NCT01521871|Wound closure|wound closure
477987|NCT01521871|Living donor nephrectomy|living donor nephrectomy
477988|NCT01521871|Surgical wound closure|surgical wound closure
477989|NCT01521845|elective percutaneous coronary intervention|elective percutaneous coronary intervention
477990|NCT01521845|hs-CRP|hs-crp
477991|NCT01521845|CKMB and troponin I|ckmb and troponin i
477992|NCT01521819|AMD|amd
477993|NCT01521819|V-Ped|v-ped
477994|NCT01521819|Vascularized Pigment Epithelial Detachment|vascularized pigment epithelial detachment
477995|NCT01521819|Iray|iray
477996|NCT01521819|radiation|radiation
477997|NCT01521819|retina|retina
477998|NCT01521819|macula|macula
477999|NCT01521819|radiotherapy|radiotherapy
478000|NCT01521806|insulin sensitivity|insulin sensitivity
478001|NCT01521806|resistant starch|resistant starch
478002|NCT01521780|hepatocellular carcinoma|hepatocellular carcinoma
478003|NCT01521780|MRI|mri
478004|NCT01521780|pharmacogenomics|pharmacogenomics
478005|NCT01521780|beta-catenin|beta-catenin
478006|NCT01521767|pharmacokinetics|pharmacokinetics
478007|NCT01521767|relative bioavailability|relative bioavailability
478008|NCT01521767|tolterodine microspheres in powder blend|tolterodine microspheres in powder blend
478009|NCT01521767|Overactive Urinary Bladder|overactive urinary bladder
478010|NCT01521741|Breast Cancer|breast cancer
478011|NCT01521741|Lymphedema|lymphedema
478012|NCT01521741|symptoms|symptoms
478013|NCT01521728|ALS|als
478014|NCT01521728|Exercise|exercise
478015|NCT01521728|Resistance|resistance
478016|NCT01521728|Endurance|endurance
478017|NCT01521702|adenocarcinoma|adenocarcinoma
478018|NCT01521702|pancreatic head|pancreatic head
478019|NCT01521689|MRD negative CR|mrd negative cr
478020|NCT01521676|breast cancer|breast cancer
478021|NCT01521663|Moderate to severe idiopathic RLS|moderate to severe idiopathic rls
478022|NCT01521650|Probiotics|probiotics
478023|NCT01521650|Anaesthesia|anaesthesia
478024|NCT01521650|Intubation|intubation
478025|NCT01521650|Pathogenic bacteria|pathogenic bacteria
478026|NCT01521611|Radioimmunotherapy|radioimmunotherapy
478027|NCT01521611|Transplant|transplant
478028|NCT01521611|Bone Marrow Transplant (BMT)|bone marrow transplant (bmt)
478029|NCT01521611|yttrium|yttrium
478030|NCT01521611|indium|indium
478031|NCT01521598|Diabetic Peripheral Neuropathy|diabetic peripheral neuropathy
711132|NCT00586365|NSAIDS|nsaids
478032|NCT01521572|chronic obstructive pulmonary disease,|chronic obstructive pulmonary disease,
478033|NCT01521572|bronchial reversibility,|bronchial reversibility,
478034|NCT01521572|bronchodilator,|bronchodilator,
478035|NCT01521572|respiratory impedance,|respiratory impedance,
478036|NCT01521572|forced oscillation technique,|forced oscillation technique,
478037|NCT01521572|plethysmography,|plethysmography,
478038|NCT01521572|spirometry|spirometry
478039|NCT01521572|Diagnostic Techniques, Respiratory System|diagnostic techniques, respiratory system
478040|NCT01521546|Duchenne muscular dystrophy|duchenne muscular dystrophy
478041|NCT01521546|cardiomyopathy|cardiomyopathy
478042|NCT01521546|aldosterone antagonist|aldosterone antagonist
478043|NCT01521533|Relapsed Multiple Myeloma|relapsed multiple myeloma
478044|NCT01521533|NOX-A12|nox-a12
478045|NCT01521533|Velcade|velcade
478046|NCT01521533|Dexamethasone|dexamethasone
478047|NCT01521533|Spiegelmer|spiegelmer
478048|NCT01521533|Chemosensitization|chemosensitization
478049|NCT01521533|Stromal cell-derived factor-1 (SDF-1)|stromal cell-derived factor-1 (sdf-1)
478050|NCT01521533|CXCL12|cxcl12
478051|NCT01521520|type 1 diabetes|type 1 diabetes
478052|NCT01521520|magnetic resonance imaging|magnetic resonance imaging
478053|NCT01521520|insulitis|insulitis
478054|NCT01521520|ferumoxytol|ferumoxytol
478055|NCT01521494|Hemodialysis|hemodialysis
478056|NCT01521494|Hyperphosphatemia|hyperphosphatemia
478057|NCT01521468|Coronary artery disease|coronary artery disease
478058|NCT01521468|Diagnostic accuracy|diagnostic accuracy
478059|NCT01521468|CT coronary angiography|ct coronary angiography
478060|NCT01521468|Positron emission tomography|positron emission tomography
478061|NCT01521468|Single photon emission tomography|single photon emission tomography
478062|NCT01521468|Noninvasive techniques|noninvasive techniques
478063|NCT01521468|Cardiac catheterization|cardiac catheterization
478064|NCT01521468|Fractional flow reserve|fractional flow reserve
478065|NCT01521442|PTSD|ptsd
478066|NCT01521442|Yoga|yoga
478067|NCT01521442|Complementary and Alternative Medicine (CAM)|complementary and alternative medicine (cam)
478068|NCT01521416|Illness|illness
478069|NCT01521416|Influenza|influenza
478070|NCT01521416|Cost|cost
478071|NCT01521416|UK|uk
478072|NCT01521403|Blastocystis hominis|blastocystis hominis
478073|NCT01521403|Metronidazole|metronidazole
478074|NCT01521377|LAMA|lama
478075|NCT01521377|Respiratory|respiratory
478076|NCT01521377|COPD|copd
478077|NCT01521377|Tolerability|tolerability
478078|NCT01521377|Beta-2 Agonist|beta-2 agonist
478079|NCT01521377|Safety|safety
478080|NCT01521377|Pharmacokinetics|pharmacokinetics
478081|NCT01521377|Pharmacodynamics|pharmacodynamics
478082|NCT01521377|LABA|laba
478083|NCT01521377|Muscarinic Receptor Agonist|muscarinic receptor agonist
478084|NCT01521377|Healthy subjects|healthy subjects
478085|NCT01521377|Moxifloxacin|moxifloxacin
478086|NCT01521377|Anticholinergic|anticholinergic
478087|NCT01521377|GW642444|gw642444
478088|NCT01521377|GSK573719|gsk573719
478089|NCT01521377|QTc|qtc
478090|NCT01521364|pharmacokinetic|pharmacokinetic
478091|NCT01521364|drug-interaction|drug-interaction
478092|NCT01521364|linezolid|linezolid
478093|NCT01521364|clarithromycin|clarithromycin
478094|NCT01521364|Mycobacterium tuberculosis|mycobacterium tuberculosis
478095|NCT01521351|microwave radiometry|microwave radiometry
478096|NCT01521351|cardiovascular events|cardiovascular events
478097|NCT01521351|carotid artery disease|carotid artery disease
478098|NCT01521351|stroke|stroke
478099|NCT01521351|myocardial infarction|myocardial infarction
478100|NCT01521338|Cystic Fibrosis|cystic fibrosis
478101|NCT01521338|G551D|g551d
478102|NCT01521338|G551D Mutation|g551d mutation
478103|NCT01521312|Impaired glucose tolerance|impaired glucose tolerance
478104|NCT01521312|Saxagliptin|saxagliptin
478105|NCT01521312|Cardiovascular risk integrators|cardiovascular risk integrators
478106|NCT01521312|Vago-sympathetic activity|vago-sympathetic activity
478107|NCT01521312|Arterial stiffness|arterial stiffness
478108|NCT01521312|Endothelial function|endothelial function
478109|NCT01521299|hydroxyurea|hydroxyurea
478110|NCT01521299|S phase|s phase
478111|NCT01521299|G2 phase|g2 phase
478112|NCT01521299|pharmacokinetics|pharmacokinetics
478113|NCT01521286|Spain|spain
478114|NCT01521286|cost|cost
478115|NCT01521286|complications|complications
478116|NCT01521286|incidence|incidence
478117|NCT01521286|adults|adults
478118|NCT01521286|quality of life|quality of life
478119|NCT01521286|Herpes Zoster|herpes zoster
478120|NCT01521286|Surveillance|surveillance
478121|NCT01521273|beans|beans
478122|NCT01521273|biofortification|biofortification
478123|NCT01521273|phytic acid|phytic acid
478124|NCT01521273|iron|iron
478125|NCT01521273|iron isotopes|iron isotopes
478126|NCT01521273|different phytic acid concentrations|different phytic acid concentrations
478127|NCT01521260|dental implants|dental implants
478128|NCT01521260|microbiology|microbiology
478129|NCT01521260|chlorhexidine|chlorhexidine
478130|NCT01521247|Asthma|asthma
478131|NCT01521247|Transition program|transition program
478132|NCT01521247|Pediatric|pediatric
478133|NCT01521247|Adult|adult
478134|NCT01521208|Out-of-Hospital cardiac arrest (OHCA)|out-of-hospital cardiac arrest (ohca)
478135|NCT01521208|Chest compressions|chest compressions
478136|NCT01521208|LUCAS device|lucas device
478137|NCT01521195|pediatric|pediatric
478138|NCT01521195|ECMO|ecmo
478139|NCT01521195|extracorporeal blood flow|extracorporeal blood flow
478140|NCT01521195|VO2|vo2
478141|NCT01521182|Probiotic - dairy product - influenza vaccination - healthy elderly|probiotic - dairy product - influenza vaccination - healthy elderly
478142|NCT01521169|Plant sterol - Hypercholesterolemia - Diet - Dairy|plant sterol - hypercholesterolemia - diet - dairy
478143|NCT01521156|Plant sterols - Hypercholesterolemia - Diet - Dairy|plant sterols - hypercholesterolemia - diet - dairy
478144|NCT01521143|EOC|eoc
478145|NCT01521130|Benign Childhood Epilepsy With Centrotemporal Spikes|benign childhood epilepsy with centrotemporal spikes
478146|NCT01521130|Benign Rolandic Epilepsy|benign rolandic epilepsy
478147|NCT01521117|donepezil|donepezil
478148|NCT01521117|parkinson's disease|parkinson's disease
478149|NCT01521117|balance|balance
478150|NCT01521117|cholinesterase inhibitor|cholinesterase inhibitor
478151|NCT01521104|narrow band imaging（NBI）|narrow band imaging（nbi）
478152|NCT01521104|colorectal lesions|colorectal lesions
478153|NCT01521104|predicting histology|predicting histology
478154|NCT01521091|narrow band imaging（NBI）|narrow band imaging（nbi）
478155|NCT01521091|indigo carmine|indigo carmine
478156|NCT01521091|acetic acid|acetic acid
478157|NCT01521091|colorectal lesions|colorectal lesions
479635|NCT01515059|ghrelin|ghrelin
478158|NCT01521091|predicting histology|predicting histology
478160|NCT01521065|Wet AMD|wet amd
478161|NCT01521039|aGVHD|agvhd
478162|NCT01521039|Acute Graft-versus-Host Disease|acute graft-versus-host disease
478163|NCT01521039|allogeneic stem cell transplantation|allogeneic stem cell transplantation
478164|NCT01521039|Hematopoietic stem cell transplantation|hematopoietic stem cell transplantation
478165|NCT01521039|MicroRNA Expression|microrna expression
478166|NCT01521000|Breast Cancer|breast cancer
478167|NCT01521000|Lymphedema|lymphedema
478168|NCT01521000|Sentinel Node Biopsy|sentinel node biopsy
478169|NCT01521000|Axillary Dissection|axillary dissection
478170|NCT01520987|Parkinson Disease|parkinson disease
478171|NCT01520987|BIA 9-1067|bia 9-1067
478172|NCT01520961|Partial Hip Arthroplasty|partial hip arthroplasty
478173|NCT01520948|Parkinson disease|parkinson disease
478174|NCT01520948|Incontinence|incontinence
478175|NCT01520935|Office of National Statistics|office of national statistics
478176|NCT01520935|Burden of Disease|burden of disease
478177|NCT01520935|Influenza|influenza
478178|NCT01520935|Hospital Episode Statistics|hospital episode statistics
478179|NCT01520935|General Practitioners Research Database|general practitioners research database
478180|NCT01520922|Relapsed or Refractory Chronic Lymphocytic Leukemia|relapsed or refractory chronic lymphocytic leukemia
478181|NCT01520922|Chronic Lymphocytic Leukemia|chronic lymphocytic leukemia
478182|NCT01520922|CLL|cll
478183|NCT01520922|Cancer|cancer
478184|NCT01520922|Lymphoid leukemia|lymphoid leukemia
478185|NCT01520922|Lymphoblastic leukemia|lymphoblastic leukemia
478186|NCT01520909|immune thrombocytopenic purpura|immune thrombocytopenic purpura
478187|NCT01520909|pediatrics|pediatrics
478188|NCT01520909|chronic ITP|chronic itp
478189|NCT01520909|idiopathic thrombocytopenic purpura|idiopathic thrombocytopenic purpura
478190|NCT01520909|eltrombopag|eltrombopag
478191|NCT01520909|Chronic Immune Thrombocytopenia|chronic immune thrombocytopenia
478192|NCT01520909|platelet disorder|platelet disorder
478193|NCT01520909|thrombocytopenia|thrombocytopenia
478194|NCT01520896|Phase 1|phase 1
478195|NCT01520896|Healthy male and female volunteers|healthy male and female volunteers
478196|NCT01520896|Drug-drug interaction|drug-drug interaction
478197|NCT01520896|Pharmacokinetics|pharmacokinetics
478198|NCT01520896|NKTR-118|nktr-118
478199|NCT01520870|Dacomitinib|dacomitinib
478200|NCT01520870|PF-299804|pf-299804
478201|NCT01520870|Glioblastoma, Recurrent|glioblastoma, recurrent
478202|NCT01520870|EGFR|egfr
478203|NCT01520857|Laparoscopic inguinal hernia repair|laparoscopic inguinal hernia repair
478204|NCT01520857|TAPP|tapp
478205|NCT01520857|Spinal Anesthesia|spinal anesthesia
478206|NCT01520857|General Anesthesia|general anesthesia
478207|NCT01520805|acute myeloid leukemia|acute myeloid leukemia
478208|NCT01520805|myelodysplastic syndrome|myelodysplastic syndrome
478209|NCT01520805|refractory|refractory
478210|NCT01520805|relapsed|relapsed
478211|NCT01520805|hypomethylating agents|hypomethylating agents
478212|NCT01520792|pharmacogenetic of paracetamol|pharmacogenetic of paracetamol
478213|NCT01520792|Pain threshold|pain threshold
478214|NCT01520779|Hepatocellular cacinoma|hepatocellular cacinoma
478215|NCT01520779|Radiofrequancy ablation|radiofrequancy ablation
478216|NCT01520779|Intrahepatic recurrence|intrahepatic recurrence
478217|NCT01520766|glass fiber posts|glass fiber posts
478218|NCT01520766|titanium posts|titanium posts
478219|NCT01520766|postendodontic restoration|postendodontic restoration
478220|NCT01520766|self-adhesive resin cement|self-adhesive resin cement
478221|NCT01520740|Gold Stage III|gold stage iii
478222|NCT01520740|Gold Stage IV|gold stage iv
478223|NCT01520740|Chronic Obstructive Pulmonary Disease|chronic obstructive pulmonary disease
478224|NCT01520740|COPD|copd
478225|NCT01520740|Lung Volume Reduction Surgery|lung volume reduction surgery
478226|NCT01520740|LVRS|lvrs
478227|NCT01520740|Bronchoscopic Lung Volume Reduction|bronchoscopic lung volume reduction
478228|NCT01520740|BLVR|blvr
478229|NCT01520740|Upper Lobe Predominant|upper lobe predominant
478230|NCT01520740|ULP|ulp
478231|NCT01520740|Heterogeneous|heterogeneous
478232|NCT01520740|Homogeneous|homogeneous
478233|NCT01520727|BIA 9-1067|bia 9-1067
478234|NCT01520714|Congestive Heart Failure (CHF)|congestive heart failure (chf)
478235|NCT01520714|Cardiac Resynchronization Therapy (CRT)|cardiac resynchronization therapy (crt)
478236|NCT01520714|BiVentricular Implantable Cardioverter Defibrillator (BiVICD)|biventricular implantable cardioverter defibrillator (bivicd)
478237|NCT01520714|Fraction|fraction
478238|NCT01520701|head and neck cancer|head and neck cancer
478239|NCT01520701|Hydrotac®|hydrotac®
478240|NCT01520701|radiodermatitis|radiodermatitis
478241|NCT01520701|algia|algia
478242|NCT01520701|radiotherapy|radiotherapy
478243|NCT01520688|Mild persistent or mild intermittent asthma|mild persistent or mild intermittent asthma
478244|NCT01520675|chronic pancreatitis|chronic pancreatitis
478245|NCT01520675|randomized controlled trial|randomized controlled trial
478246|NCT01520675|endoscopic therapy|endoscopic therapy
478247|NCT01520675|surgery|surgery
478248|NCT01520675|ESWL|eswl
478249|NCT01520662|patient-centered care|patient-centered care
478250|NCT01520662|wellness|wellness
478251|NCT01520662|preventive services|preventive services
478252|NCT01520662|primary care|primary care
478253|NCT01520662|To accomplish Aim 2, we will conduct a nine-month pre-post|to accomplish aim 2, we will conduct a nine-month pre-post
478254|NCT01520662|randomized controlled trial (RCT) in four primary care|randomized controlled trial (rct) in four primary care
478255|NCT01520662|practices. The study will focus on the impact of a patient|practices. the study will focus on the impact of a patient
478256|NCT01520662|Wellness Portal on the quantity and quality of preventive|wellness portal on the quantity and quality of preventive
478257|NCT01520662|care patients receive in primary care practices.|care patients receive in primary care practices.
478258|NCT01520649|Neurogenesis|neurogenesis
478259|NCT01520649|hippocampal stem cells|hippocampal stem cells
478260|NCT01520649|depression|depression
478261|NCT01520649|stroke|stroke
478262|NCT01520636|stroke|stroke
478263|NCT01520636|early rehabilitation|early rehabilitation
478264|NCT01520636|motor recovery|motor recovery
478265|NCT01520636|functional recovery|functional recovery
478266|NCT01520623|Allogeneic haematopoietic stem cell transplantation (HSCT)|allogeneic haematopoietic stem cell transplantation (hsct)
478267|NCT01520623|Myeloablative conditioning for an haematological malignancy|myeloablative conditioning for an haematological malignancy
478268|NCT01520623|Graft-versus-host disease (GvHD)|graft-versus-host disease (gvhd)
478269|NCT01520623|Activation of complement system|activation of complement system
478270|NCT01520623|Gut GVHD|gut gvhd
478271|NCT01520610|Tako-TSUBO Cardiomyopathy|tako-tsubo cardiomyopathy
478272|NCT01520610|Stress Cardiomyopathy|stress cardiomyopathy
478273|NCT01520610|Myocardiopathies|myocardiopathies
478274|NCT01520610|Acute Coronary Syndrome|acute coronary syndrome
478275|NCT01520610|Gene|gene
478276|NCT01520597|Multicentric|multicentric
478277|NCT01520597|National|national
478278|NCT01520597|Prospective on|prospective on
478279|NCT01520597|Listeriosis|listeriosis
478280|NCT01520597|Listeria|listeria
478281|NCT01520571|Computer Assistance|computer assistance
478282|NCT01520571|Total Knee Arthroplasty|total knee arthroplasty
478283|NCT01520571|conventional|conventional
478284|NCT01520558|Acute Myeloid Leukemia|acute myeloid leukemia
478285|NCT01520558|High Risk Relapse|high risk relapse
478286|NCT01520558|Complete Remission|complete remission
478287|NCT01520558|Allogeneic Natural Killer Cells|allogeneic natural killer cells
478288|NCT01520545|Gablofen|gablofen
478289|NCT01520545|baclofen injection|baclofen injection
478290|NCT01520519|Leukemia|leukemia
478291|NCT01520519|Chronic Lymphocytic Leukemia|chronic lymphocytic leukemia
478292|NCT01520519|CLL|cll
478293|NCT01520519|Small Lymphocytic Lymphoma|small lymphocytic lymphoma
478294|NCT01520519|SLL|sll
478295|NCT01520519|Rituximab|rituximab
478296|NCT01520519|Rituxan|rituxan
478297|NCT01520519|PCI-32765|pci-32765
478298|NCT01520506|Hypertension|hypertension
478299|NCT01520506|Kidney Diseases|kidney diseases
478300|NCT01520506|Kidney Failure, Chronic|kidney failure, chronic
478301|NCT01520506|Vascular Diseases|vascular diseases
478302|NCT01520506|Cardiovascular Diseases|cardiovascular diseases
478303|NCT01520506|Urologic Diseases|urologic diseases
478304|NCT01520506|Renal Insufficiency, Chronic|renal insufficiency, chronic
478305|NCT01520506|Renal Insufficiency|renal insufficiency
478306|NCT01520493|pulmonary arterial hypertension|pulmonary arterial hypertension
478307|NCT01520493|skeletal muscle microcirculation|skeletal muscle microcirculation
478308|NCT01520493|exercise induced blood flow|exercise induced blood flow
478309|NCT01520480|survival after surgery|survival after surgery
711133|NCT00586352|Pediatric|pediatric
478310|NCT01520480|Pathological Subtrochanteric Fractures|pathological subtrochanteric fractures
478311|NCT01520467|SRS|srs
478312|NCT01520467|PWS|pws
478313|NCT01520467|pathological adrenarche|pathological adrenarche
478314|NCT01520467|aromatase inhibitor|aromatase inhibitor
478315|NCT01520467|Children|children
478316|NCT01520454|Leptin resistance|leptin resistance
478317|NCT01520454|Free fatty acids|free fatty acids
478318|NCT01520454|Lipotoxicity|lipotoxicity
478319|NCT01520441|Botulinum Toxin|botulinum toxin
478320|NCT01520441|Prostate Cancer|prostate cancer
478321|NCT01520441|BPH|bph
478322|NCT01520441|LUTS|luts
478323|NCT01520402|Genetic Determinants of Warfarin Dose Variability|genetic determinants of warfarin dose variability
478324|NCT01520389|cancer|cancer
478325|NCT01520389|solid tumors|solid tumors
478326|NCT01520389|oncology|oncology
478327|NCT01520389|Phase I|phase i
478328|NCT01520389|EGFR|egfr
478329|NCT01520389|EGF receptor (ErbB1)|egf receptor (erbb1)
478330|NCT01520389|irinotecan|irinotecan
478331|NCT01520363|Rett syndrome|rett syndrome
478332|NCT01520363|RTT|rtt
478333|NCT01520363|MECP2|mecp2
478334|NCT01520363|dextromethorphan|dextromethorphan
478335|NCT01520363|DM|dm
478336|NCT01520311|Coronary Artery Disease|coronary artery disease
478337|NCT01520311|Myocardial Ischemia|myocardial ischemia
478338|NCT01520311|Coronary Disease|coronary disease
478339|NCT01520311|Heart Diseases|heart diseases
478340|NCT01520311|Cardiovascular Diseases|cardiovascular diseases
478341|NCT01520311|Arteriosclerosis|arteriosclerosis
478342|NCT01520311|Arterial Occlusive Diseases|arterial occlusive diseases
478343|NCT01520311|Vascular Diseases|vascular diseases
478344|NCT01520311|CABG|cabg
478345|NCT01520311|SVG|svg
478346|NCT01520311|eSVS Mesh|esvs mesh
478347|NCT01520311|Bypass Grafting|bypass grafting
478348|NCT01520285|hypertension|hypertension
478349|NCT01520285|Blood pressure decrease|blood pressure decrease
478350|NCT01520285|efficacy|efficacy
478351|NCT01520272|HPV18 Immunogenicity|hpv18 immunogenicity
478352|NCT01520272|HPV16 Immunogenicity|hpv16 immunogenicity
478353|NCT01520272|Bivalent HPV16/18 Vaccine|bivalent hpv16/18 vaccine
478354|NCT01520272|Less than 3 Dosed of the Bivalent HPV Vaccine|less than 3 dosed of the bivalent hpv vaccine
478355|NCT01520272|HP Vaccine|hp vaccine
478356|NCT01520259|Gallbaldder|gallbaldder
478357|NCT01520259|Gallstones|gallstones
478358|NCT01520259|Inflammation|inflammation
478359|NCT01520259|Cholecystectomy|cholecystectomy
478360|NCT01520259|Cancer|cancer
478361|NCT01520259|Gallbaldder Cancer|gallbaldder cancer
478362|NCT01520246|adult acute lymphoblastic leukemia|adult acute lymphoblastic leukemia
478363|NCT01520246|childhood acute lymphoblastic leukemia|childhood acute lymphoblastic leukemia
478364|NCT01520246|adult T-cell leukemia/lymphoma|adult t-cell leukemia/lymphoma
478365|NCT01520233|disseminated neuroblastoma|disseminated neuroblastoma
478366|NCT01520233|localized unresectable neuroblastoma|localized unresectable neuroblastoma
478367|NCT01520233|recurrent neuroblastoma|recurrent neuroblastoma
478368|NCT01520233|regional neuroblastoma|regional neuroblastoma
478369|NCT01520233|stage 4S neuroblastoma|stage 4s neuroblastoma
478370|NCT01520194|genital warts|genital warts
478371|NCT01520194|HPV|hpv
478372|NCT01520194|psychosocial burden|psychosocial burden
478373|NCT01520194|economic burden|economic burden
478374|NCT01520194|female genital warts|female genital warts
478375|NCT01520168|Incisional hernia|incisional hernia
478376|NCT01520168|Mesh|mesh
478377|NCT01520168|Surgery|surgery
478378|NCT01520168|Composix Kugel|composix kugel
478379|NCT01520168|IPOM technique|ipom technique
478380|NCT01520155|lupus erythematosus|lupus erythematosus
478381|NCT01520155|cardiovascular risk|cardiovascular risk
478382|NCT01520142|Healthy participants|healthy participants
478383|NCT01520142|Pharmacodynamic|pharmacodynamic
478384|NCT01520142|Pharmacokinetics|pharmacokinetics
478385|NCT01520142|Intravenous Endotoxin-Induced Model|intravenous endotoxin-induced model
478386|NCT01520142|Acute Inflammation|acute inflammation
478387|NCT01520142|JNJ-26528398|jnj-26528398
478388|NCT01520142|Anti-inflammatory|anti-inflammatory
478389|NCT01520129|Bipolar Disorder|bipolar disorder
478390|NCT01520129|Bipolar NOS|bipolar nos
478391|NCT01520129|Bipolar Depression|bipolar depression
478392|NCT01520103|Metastatic breast cancer|metastatic breast cancer
478393|NCT01520103|locally advanced breast cancer|locally advanced breast cancer
478394|NCT01520103|Her2/new negative|her2/new negative
478395|NCT01520103|HER2 negative|her2 negative
478396|NCT01520090|contraception|contraception
478397|NCT01520090|family planning|family planning
478398|NCT01520090|egyptian|egyptian
478399|NCT01520090|knowledge|knowledge
478400|NCT01520077|alopecia areata|alopecia areata
478401|NCT01520077|vytorin|vytorin
478402|NCT01520077|statin|statin
478403|NCT01520077|hair growth|hair growth
478404|NCT01520064|Emphysema|emphysema
478405|NCT01520064|GOLD Stage III|gold stage iii
478406|NCT01520064|GOLD Stage IV|gold stage iv
478407|NCT01520064|AeriSeal System|aeriseal system
478408|NCT01520064|Homogeneous|homogeneous
478409|NCT01520064|Heterogeneous|heterogeneous
478410|NCT01520064|Upper Lobe Predominant|upper lobe predominant
478411|NCT01520064|ULP|ulp
478412|NCT01520064|Chronic Obstructive Pulmonary Disease|chronic obstructive pulmonary disease
478413|NCT01520064|COPD|copd
478414|NCT01520064|Lung Volume Reduction Surgery|lung volume reduction surgery
478415|NCT01520064|LVRS|lvrs
478416|NCT01520064|Bronchoscopic Lung Volume Reduction|bronchoscopic lung volume reduction
478417|NCT01520064|BLVR|blvr
478418|NCT01520051|Asthma|asthma
478419|NCT01520051|Viral|viral
478420|NCT01520051|Infection|infection
478421|NCT01520051|Inflammation|inflammation
478422|NCT01520051|Mepolizumab|mepolizumab
478423|NCT01520051|Eosinophilia|eosinophilia
478424|NCT01520025|Radiopharmaceutical|radiopharmaceutical
478425|NCT01520025|18FDG PET|18fdg pet
478426|NCT01520025|CTA|cta
478427|NCT01520025|Multi-modality imaging|multi-modality imaging
478428|NCT01520025|Metabolic Imaging of Ischemia|metabolic imaging of ischemia
478429|NCT01520025|Myocardial blood flow|myocardial blood flow
478430|NCT01520025|Myocardial blood flow reserve|myocardial blood flow reserve
478431|NCT01519999|Shared decision making|shared decision making
478432|NCT01519999|Ambulatory Care|ambulatory care
478433|NCT01519999|Patient-Centered Care|patient-centered care
478434|NCT01519999|Community-wide intervention|community-wide intervention
478435|NCT01519999|Intervention Study|intervention study
478436|NCT01519999|Longitudinal Studies|longitudinal studies
478437|NCT01519986|Vitamin D|vitamin d
478438|NCT01519986|Cholecalciferol|cholecalciferol
478439|NCT01519986|Supplementation|supplementation
478440|NCT01519986|Dietary Supplements|dietary supplements
478441|NCT01519986|Dietary Fats|dietary fats
478442|NCT01519986|25-hydroxyvitamin D|25-hydroxyvitamin d
478443|NCT01519973|Diagnostic imaging|diagnostic imaging
478444|NCT01519973|Single Photon Emission Computed Tomography|single photon emission computed tomography
479636|NCT01515046|Vitamins|vitamins
478445|NCT01519973|Positron emission tomography|positron emission tomography
478446|NCT01519973|Computed tomography|computed tomography
478447|NCT01519973|Attenuation|attenuation
478448|NCT01519973|Resolution|resolution
478449|NCT01519973|Scatter|scatter
478450|NCT01519973|Radiopharmaceutical|radiopharmaceutical
478451|NCT01519934|Ulthera® System|ulthera® system
478452|NCT01519934|Ultherapy™ Treatment|ultherapy™ treatment
478453|NCT01519934|Ulthera, Inc.|ulthera, inc.
478454|NCT01519934|Ultrasound treatment for skin tightening|ultrasound treatment for skin tightening
478455|NCT01519908|cardiac resynchronization therapy|cardiac resynchronization therapy
478456|NCT01519908|biomarkers|biomarkers
478457|NCT01519908|response|response
478458|NCT01519895|quality of life|quality of life
478459|NCT01519895|anxiety|anxiety
478460|NCT01519895|stress|stress
478461|NCT01519895|carers|carers
478462|NCT01519895|colorectal or colon cancer|colorectal or colon cancer
478463|NCT01519882|Rotigotine|rotigotine
478464|NCT01519882|Neupro|neupro
478465|NCT01519882|Polysomnography|polysomnography
478466|NCT01519882|Sleep efficiency|sleep efficiency
478467|NCT01519882|Advanced Idiopathic Parkinson's Disease|advanced idiopathic parkinson's disease
478468|NCT01519882|Sleep Disorder|sleep disorder
478469|NCT01519869|peritoneal|peritoneal
478470|NCT01519869|carcinoma|carcinoma
478471|NCT01519869|ovarian|ovarian
478472|NCT01519869|fallopian tube|fallopian tube
478473|NCT01519869|neoadjuvant chemotherapy|neoadjuvant chemotherapy
478474|NCT01519869|surgical debulking|surgical debulking
478475|NCT01519856|open|open
478476|NCT01519856|non-intervention|non-intervention
478477|NCT01519856|observational|observational
478478|NCT01519843|stroke|stroke
478479|NCT01519830|Anemia, Iron-Deficiency|anemia, iron-deficiency
478480|NCT01519830|Blood Donors|blood donors
478481|NCT01519817|Vaccine Therapy|vaccine therapy
478482|NCT01519817|Dose-Limiting Toxicity|dose-limiting toxicity
478483|NCT01519817|Maximum Tolerated Dose|maximum tolerated dose
478484|NCT01519817|Clinical Response|clinical response
478485|NCT01519817|Immune Response|immune response
478486|NCT01519817|Cancer|cancer
478487|NCT01519817|Solid Tumor|solid tumor
478488|NCT01519791|Certolizumab Pegol - Cimzia|certolizumab pegol - cimzia
478489|NCT01519791|Methotrexate|methotrexate
478490|NCT01519791|Rheumatoid Arthritis|rheumatoid arthritis
478491|NCT01519752|Tinea Pedis|tinea pedis
478492|NCT01519713|Meningitis|meningitis
478493|NCT01519713|Meningococcal Meningitis|meningococcal meningitis
478494|NCT01519713|Meningococcal Infections|meningococcal infections
478495|NCT01519713|Meningococcal conjugate Vaccine|meningococcal conjugate vaccine
478496|NCT01519713|Menactra®|menactra®
478497|NCT01519700|Filgrastim|filgrastim
478498|NCT01519700|G-CSF, neutropenia|g-csf, neutropenia
478499|NCT01519700|supportive care|supportive care
478500|NCT01519700|breast cancer|breast cancer
478501|NCT01519687|hyperuricemia|hyperuricemia
478502|NCT01519687|gout|gout
478503|NCT01519687|levotofisopam|levotofisopam
478504|NCT01519661|Tobramycin Inhalation powder|tobramycin inhalation powder
478505|NCT01519661|Cystic fibrosis|cystic fibrosis
478506|NCT01519661|Lung disease|lung disease
478507|NCT01519661|Anti-bacterial agents|anti-bacterial agents
610254|NCT00977444|knee|knee
478508|NCT01519648|Invasive fungal infection|invasive fungal infection
478509|NCT01519648|Acute leukemia (AL)|acute leukemia (al)
478510|NCT01519648|Hematopoietic stem cell transplantation|hematopoietic stem cell transplantation
478511|NCT01519648|Antifungal stewardship|antifungal stewardship
478512|NCT01519648|Neutropenia|neutropenia
478513|NCT01519648|Hematological malignancies|hematological malignancies
478514|NCT01519635|Kidney oxygenation|kidney oxygenation
478515|NCT01519635|Stage 1 or 2 hypertension|stage 1 or 2 hypertension
478516|NCT01519635|BOLD-IRM|bold-irm
478517|NCT01519622|End of life decisions|end of life decisions
478518|NCT01519622|Perception of illness|perception of illness
478519|NCT01519609|Bowel prep|bowel prep
478520|NCT01519609|Safety|safety
478521|NCT01519609|Efficacy|efficacy
478522|NCT01519583|walking|walking
478523|NCT01519583|physical activity|physical activity
478524|NCT01519583|sedentary behavior|sedentary behavior
478525|NCT01519570|Herpes Zoster vaccine|herpes zoster vaccine
478526|NCT01519570|Electronic patient portal|electronic patient portal
478527|NCT01519570|Electronic medical record|electronic medical record
478528|NCT01519570|Primary care|primary care
478529|NCT01519570|Immunizations|immunizations
478530|NCT01519544|Sleep|sleep
478531|NCT01519544|High Altitude|high altitude
478532|NCT01519544|High-altitude Sleep Disturbance|high-altitude sleep disturbance
478533|NCT01519544|Acute Mountain Sickness|acute mountain sickness
478534|NCT01519544|Difficulty Sleeping at High Altitude|difficulty sleeping at high altitude
478535|NCT01519544|Periodic Breathing|periodic breathing
478536|NCT01519544|Actigraphy|actigraphy
478537|NCT01519544|Acetazolamide|acetazolamide
478538|NCT01519544|Temazepam|temazepam
478539|NCT01519544|Groningen Sleep Quality Questionnaire survey|groningen sleep quality questionnaire survey
478540|NCT01519544|Stanford Sleepiness Scale|stanford sleepiness scale
478541|NCT01519544|Lake Louise Acute Mountain Sickness Score|lake louise acute mountain sickness score
478542|NCT01519518|ST elevation myocardial infarction|st elevation myocardial infarction
478543|NCT01519518|Primary percutaneous coronary intervention|primary percutaneous coronary intervention
478544|NCT01519518|Unfractionated heparin|unfractionated heparin
478545|NCT01519518|Bivalirudin|bivalirudin
478546|NCT01519518|primary angioplasty|primary angioplasty
478547|NCT01519505|Prevention|prevention
478548|NCT01519505|Diabetes mellitus|diabetes mellitus
478549|NCT01519505|Lifestyle changes|lifestyle changes
478550|NCT01519505|Cardiovascular risk|cardiovascular risk
478551|NCT01519505|Cost-effectiveness|cost-effectiveness
478552|NCT01519492|Skin and Subcutaneous Tissue Bacterial Infections|skin and subcutaneous tissue bacterial infections
478553|NCT01519479|Congestive Heart Failure|congestive heart failure
478554|NCT01519479|Heart Failure|heart failure
478555|NCT01519479|Palliative Care|palliative care
478556|NCT01519479|Palliative Medicine|palliative medicine
478557|NCT01519466|Diabetes|diabetes
478559|NCT01519466|Insulin calculator|insulin calculator
478560|NCT01519453|Asthma|asthma
478561|NCT01519453|Preschool|preschool
478562|NCT01519453|Health Disparities|health disparities
478563|NCT01519453|Implementation|implementation
478564|NCT01519440|unintended extension|unintended extension
478565|NCT01519440|blunt|blunt
478566|NCT01519440|sharp|sharp
478567|NCT01519440|maternal blood loss|maternal blood loss
478568|NCT01519401|PCOS|pcos
478569|NCT01519401|drospirenone ethinylestradiol|drospirenone ethinylestradiol
478570|NCT01519401|androgens|androgens
478571|NCT01519401|metabolism|metabolism
478572|NCT01519388|Neuromuscular disorder|neuromuscular disorder
478573|NCT01519388|Respiratory failure|respiratory failure
478574|NCT01519388|Swallowing|swallowing
478575|NCT01519388|Mechanical ventilation|mechanical ventilation
478576|NCT01519375|Osteoarthritis|osteoarthritis
478577|NCT01519375|Rheumatoid Arthritis|rheumatoid arthritis
478578|NCT01519375|Ankylosing Spondylitis|ankylosing spondylitis
478579|NCT01519362|Polyacrylamide hydrogel|polyacrylamide hydrogel
478580|NCT01519362|leukocytopenia|leukocytopenia
478581|NCT01519362|migration|migration
478582|NCT01519362|complication|complication
478583|NCT01519362|epicranial aponeurosis|epicranial aponeurosis
478584|NCT01519362|PAAG injection|paag injection
478585|NCT01519349|Becker muscular dystrophy|becker muscular dystrophy
478586|NCT01519349|BMD|bmd
478587|NCT01519349|muscular dystrophy|muscular dystrophy
478588|NCT01519349|inclusion body myositis|inclusion body myositis
478589|NCT01519349|IBM|ibm
478590|NCT01519349|Follistatin|follistatin
478591|NCT01519310|choline metabolism|choline metabolism
478592|NCT01519310|gut flora|gut flora
478593|NCT01519310|phosphatidylcholine|phosphatidylcholine
478594|NCT01519310|lecithin|lecithin
478595|NCT01519297|Preeclampsia|preeclampsia
478596|NCT01519297|Pregnancy Induced Hypertension|pregnancy induced hypertension
478597|NCT01519284|Parkinson Disease|parkinson disease
478598|NCT01519284|BIA 9-1067|bia 9-1067
478599|NCT01519271|Parkinson's Disease|parkinson's disease
478600|NCT01519271|Mild Cognitive Impairment|mild cognitive impairment
478601|NCT01519271|Cognition|cognition
478602|NCT01519271|Memory|memory
610376|NCT00976963|UTI|uti
478603|NCT01519271|Attention|attention
478604|NCT01519271|Exelon|exelon
478605|NCT01519271|Rivastigmine|rivastigmine
478606|NCT01519258|ARDS|ards
478607|NCT01519245|coronary artery bypass grafting|coronary artery bypass grafting
478608|NCT01519245|tranexamic acid|tranexamic acid
478609|NCT01519245|antifibrinolytic|antifibrinolytic
478610|NCT01519245|administration, topical|administration, topical
478611|NCT01519245|operative blood salvage|operative blood salvage
478612|NCT01519232|hepatocellular carcinoma|hepatocellular carcinoma
478613|NCT01519219|hepatic irradiation|hepatic irradiation
478614|NCT01519219|IC-GREEN|ic-green
478615|NCT01519206|Ulthera® System|ulthera® system
478616|NCT01519206|Ultherapy™ Treatment|ultherapy™ treatment
478617|NCT01519206|Ulthera, Inc.|ulthera, inc.
478618|NCT01519193|Aggressive Behavior|aggressive behavior
478619|NCT01519193|Appetitive Aggression|appetitive aggression
478620|NCT01519193|Post-Traumatic Stress Disorder|post-traumatic stress disorder
478621|NCT01519180|gastroparesis|gastroparesis
478622|NCT01519180|gastric emptying|gastric emptying
478623|NCT01519180|antro-duodenal manometry|antro-duodenal manometry
478624|NCT01519154|deep sedation|deep sedation
478625|NCT01519154|propofol|propofol
478626|NCT01519154|ketamine|ketamine
478627|NCT01519154|child|child
478628|NCT01519154|preschool child|preschool child
478629|NCT01519154|infant|infant
478630|NCT01519154|recovery and quality of sedation|recovery and quality of sedation
478631|NCT01519141|Human Immunodeficiency Virus|human immunodeficiency virus
478632|NCT01519141|Atherosclerosis|atherosclerosis
478633|NCT01519141|Inflammation|inflammation
478634|NCT01519141|Endothelial Function|endothelial function
478635|NCT01519141|Thrombosis|thrombosis
478636|NCT01519128|Healthy|healthy
478637|NCT01519128|TMC278|tmc278
478638|NCT01519128|TMC278IFD1001|tmc278ifd1001
478639|NCT01519128|Human immunodeficiency virus - type 1|human immunodeficiency virus - type 1
478640|NCT01519128|Pharmacokinetics|pharmacokinetics
478641|NCT01519128|Digoxin|digoxin
478642|NCT01519115|deep cervical flexors|deep cervical flexors
478643|NCT01519115|spine stabilization|spine stabilization
478644|NCT01519115|posture|posture
478645|NCT01519115|function|function
478646|NCT01519115|neck pain|neck pain
478647|NCT01519089|chronic|chronic
478648|NCT01519089|severe|severe
478649|NCT01519089|moderate|moderate
478650|NCT01519089|treatment|treatment
478651|NCT01519089|safety|safety
478652|NCT01519089|efficacy|efficacy
478653|NCT01519089|CP-690|cp-690
478654|NCT01519089|550|550
478655|NCT01519089|Plaque psoriasis|plaque psoriasis
478656|NCT01519089|Psoriasis Vulgaris|psoriasis vulgaris
478657|NCT01519089|Psoriatic Arthritis|psoriatic arthritis
478658|NCT01519089|tofacitinib|tofacitinib
478659|NCT01519089|Xeljanz|xeljanz
478660|NCT01519076|stroke|stroke
478661|NCT01519063|Alcohol|alcohol
478662|NCT01519063|Drinking|drinking
478663|NCT01519063|Drinkers|drinkers
478664|NCT01519063|Alcohol Drinking|alcohol drinking
478665|NCT01519063|Memantine|memantine
478666|NCT01519063|Naltrexone|naltrexone
478667|NCT01519063|Alcohol Dependence|alcohol dependence
478668|NCT01519063|Alcohol Abuse|alcohol abuse
478669|NCT01519063|Alcohol-Related Disorders|alcohol-related disorders
478670|NCT01519063|Ethanol|ethanol
478671|NCT01519063|Alcoholism|alcoholism
478672|NCT01519037|calcimimetic agent|calcimimetic agent
478673|NCT01519037|RAAS|raas
478674|NCT01519037|renin|renin
478675|NCT01519037|aldosterone|aldosterone
478676|NCT01519024|hypertrophy|hypertrophy
478677|NCT01519024|breast|breast
478678|NCT01519024|postural balance|postural balance
478927|NCT01518101|patient preference|patient preference
478679|NCT01519011|Myelodysplastic Syndromes|myelodysplastic syndromes
478681|NCT01519011|Chronic Myelomonocytic Leukemia|chronic myelomonocytic leukemia
478682|NCT01519011|CMML|cmml
478683|NCT01519011|Acute Myeloid Leukemia|acute myeloid leukemia
478684|NCT01519011|AML|aml
478685|NCT01519011|Vidaza|vidaza
478686|NCT01519011|oral azacitidine|oral azacitidine
478687|NCT01519011|aza|aza
478688|NCT01519011|oral aza|oral aza
478689|NCT01519011|pharmacokinetics|pharmacokinetics
478690|NCT01519011|hematology|hematology
478691|NCT01519011|myeloid disease|myeloid disease
478692|NCT01519011|PK|pk
478693|NCT01518998|Fimasartan|fimasartan
478694|NCT01518998|Amlodipine|amlodipine
478695|NCT01518998|antihypertension|antihypertension
478696|NCT01518972|Alcohol|alcohol
478697|NCT01518972|Abuse|abuse
478698|NCT01518972|Use|use
478699|NCT01518972|Disorder|disorder
478700|NCT01518972|Dependence|dependence
478701|NCT01518972|Symptoms|symptoms
478702|NCT01518972|Alcoholic|alcoholic
478703|NCT01518972|Alcoholism|alcoholism
478704|NCT01518972|Prazosin|prazosin
478705|NCT01518972|Drug|drug
478706|NCT01518972|Medicine|medicine
478707|NCT01518972|Medication|medication
478708|NCT01518972|Treatment|treatment
478709|NCT01518972|Study|study
478710|NCT01518972|Placebo|placebo
478711|NCT01518972|Medical|medical
478712|NCT01518972|Management|management
478713|NCT01518972|Craving|craving
478714|NCT01518972|Consumption|consumption
478715|NCT01518972|Binge|binge
478716|NCT01518972|Drinking|drinking
478717|NCT01518972|Drink|drink
478718|NCT01518972|Heavy|heavy
478719|NCT01518972|PTSD|ptsd
478720|NCT01518972|Trauma|trauma
478721|NCT01518972|Post|post
478722|NCT01518972|Posttraumatic|posttraumatic
478723|NCT01518946|Symptomatic Orthostatic Hypotension|symptomatic orthostatic hypotension
478724|NCT01518933|HCV recurrence|hcv recurrence
478725|NCT01518933|stable liver transplanted patients|stable liver transplanted patients
478726|NCT01518920|Age related sensorineural hearing loss|age related sensorineural hearing loss
478727|NCT01518920|PF-04958242|pf-04958242
478728|NCT01518907|cellulite|cellulite
478729|NCT01518907|Xiaflex|xiaflex
478730|NCT01518894|PF-04958242|pf-04958242
478731|NCT01518894|multiple dose|multiple dose
478732|NCT01518894|Safety|safety
478733|NCT01518894|schizophrenia|schizophrenia
478734|NCT01518842|ischemic retinopathy, stem cell,bone marrow|ischemic retinopathy, stem cell,bone marrow
478735|NCT01518829|hepatocellular carcinom|hepatocellular carcinom
478736|NCT01518829|postablation syndrom|postablation syndrom
478737|NCT01518829|procalcitonin|procalcitonin
478738|NCT01518816|antioxidant preterm labor|antioxidant preterm labor
478739|NCT01518803|Obesity|obesity
478740|NCT01518803|Adolescence|adolescence
478741|NCT01518803|Lipid metabolism|lipid metabolism
478742|NCT01518803|Mediterranean diet|mediterranean diet
478743|NCT01518803|Chylomicron|chylomicron
478744|NCT01518803|Macrophages|macrophages
478745|NCT01518790|PEG 3350|peg 3350
478746|NCT01518790|boston bowel preparation scale|boston bowel preparation scale
478747|NCT01518790|colonoscopy cleanout|colonoscopy cleanout
478748|NCT01518790|bowel preparation|bowel preparation
478749|NCT01518790|miralax|miralax
478750|NCT01518790|gatorade|gatorade
478751|NCT01518790|cleanout efficacy|cleanout efficacy
478752|NCT01518790|Focus of study is efficacy of PEG 3350 cleanout for improving diagnostic yield of colonoscopy.|focus of study is efficacy of peg 3350 cleanout for improving diagnostic yield of colonoscopy.
478753|NCT01518777|Coronary Artery Disease|coronary artery disease
478754|NCT01518725|Muscle Power|muscle power
478755|NCT01518725|Vitamin D|vitamin d
478756|NCT01518725|Vitamins|vitamins
478757|NCT01518725|Cholecalciferol|cholecalciferol
478758|NCT01518712|Healthy Volunteers|healthy volunteers
478759|NCT01518712|Bioequivalence|bioequivalence
478760|NCT01518712|Canagliflozin (JNJ-28431754)|canagliflozin (jnj-28431754)
478761|NCT01518712|Metformin IR|metformin ir
478762|NCT01518686|Norm values|norm values
478763|NCT01518686|semi-automated kinetic perimetry|semi-automated kinetic perimetry
478764|NCT01518686|isopters|isopters
478765|NCT01518686|mathematical model|mathematical model
478766|NCT01518686|luminance|luminance
478767|NCT01518686|test-retest reliability|test-retest reliability
478768|NCT01518686|deviation|deviation
478769|NCT01518686|age dependance|age dependance
478770|NCT01518686|different age groups|different age groups
478771|NCT01518686|Healthy subjects|healthy subjects
478772|NCT01518660|Resistance Training|resistance training
478773|NCT01518660|Strength Training|strength training
478774|NCT01518647|Bodily Distress Syndrome|bodily distress syndrome
478775|NCT01518647|Medically unexplained symptoms|medically unexplained symptoms
478776|NCT01518647|Functional somatic symptoms|functional somatic symptoms
478777|NCT01518647|Functional somatic syndromes|functional somatic syndromes
478778|NCT01518647|Treatment|treatment
478779|NCT01518647|Acceptance and Commitment Therapy|acceptance and commitment therapy
478780|NCT01518634|Bodily Distress Syndrome|bodily distress syndrome
478781|NCT01518634|Medically unexplained symptoms|medically unexplained symptoms
478782|NCT01518634|Functional somatic symptoms|functional somatic symptoms
478783|NCT01518634|Functional somatic syndromes|functional somatic syndromes
478784|NCT01518634|Treatment|treatment
478785|NCT01518634|Imipramine|imipramine
478786|NCT01518634|Tricyclic antidepressant|tricyclic antidepressant
478787|NCT01518608|Alfentanil|alfentanil
478788|NCT01518608|Tracheal intubation|tracheal intubation
478789|NCT01518608|Rapid sequence induction|rapid sequence induction
478790|NCT01518595|patients|patients
478791|NCT01518582|Cervicobrachial|cervicobrachial
478792|NCT01518582|neuralgia|neuralgia
478793|NCT01518582|symptomatic cervical discopathy|symptomatic cervical discopathy
478794|NCT01518569|ulinastatin|ulinastatin
478795|NCT01518569|systemic inflammation|systemic inflammation
478796|NCT01518569|cardiac surgery|cardiac surgery
478797|NCT01518569|cardiopulmonary bypass|cardiopulmonary bypass
478798|NCT01518556|Idarubicin|idarubicin
478799|NCT01518556|Remission Induction|remission induction
478800|NCT01518556|Maximum Tolerated Dose|maximum tolerated dose
478801|NCT01518556|Survival|survival
478802|NCT01518543|arthrodesis|arthrodesis
478803|NCT01518543|arthrodesis in the following joints:Ankle, 1st MTP, Metatarso - Cuneiform (1st), Navicular - Cuneiform, Talo-Navicular, Calcaneum - Cuboid;|arthrodesis in the following joints:ankle, 1st mtp, metatarso - cuneiform (1st), navicular - cuneiform, talo-navicular, calcaneum - cuboid;
478804|NCT01518530|Chronic Neck Pain, Occiflex, Computerized Mobilization|chronic neck pain, occiflex, computerized mobilization
478805|NCT01518517|acute lymphoblastic leukemia|acute lymphoblastic leukemia
478807|NCT01518517|asparaginase|asparaginase
478808|NCT01518504|Thoracic|thoracic
478809|NCT01518504|Manipulation|manipulation
478810|NCT01518504|Manual Therapy|manual therapy
478811|NCT01518504|Mobilization|mobilization
478812|NCT01518504|Shoulder|shoulder
478813|NCT01518504|Range of Motion|range of motion
478814|NCT01518452|working memory training, computerized|working memory training, computerized
478815|NCT01518452|clinical assessment|clinical assessment
478816|NCT01518452|quantitative EEG|quantitative eeg
478817|NCT01518452|child, preschool|child, preschool
478818|NCT01518439|neuromuscular|neuromuscular
478819|NCT01518439|cough|cough
478820|NCT01518439|restrictive|restrictive
478821|NCT01518426|Brain computer interface|brain computer interface
478822|NCT01518426|EEG recording|eeg recording
478823|NCT01518426|Electrodes|electrodes
478824|NCT01518413|Sora./Irino. combination therapy|sora./irino. combination therapy
478825|NCT01518400|Pediatric Cancer|pediatric cancer
478826|NCT01518400|Cancer Late Effects|cancer late effects
478827|NCT01518400|Cancer Survivor|cancer survivor
478828|NCT01518400|Cancer Survivorship|cancer survivorship
478829|NCT01518387|Hyperphosphatemia in ESRD (End Stage Renal Disease) patients on dialysis|hyperphosphatemia in esrd (end stage renal disease) patients on dialysis
478830|NCT01518374|Male or female subjects at least 18 years of age|male or female subjects at least 18 years of age
478831|NCT01518374|AD|ad
478832|NCT01518374|MCI|mci
478833|NCT01518348|Patch Test|patch test
478834|NCT01518348|Contact Dermatitis|contact dermatitis
478835|NCT01518348|Allergy|allergy
478836|NCT01518348|Children|children
478837|NCT01518348|PREA|prea
478838|NCT01518335|platelet rich plasma|platelet rich plasma
478839|NCT01518335|ankle|ankle
478840|NCT01518335|sprain|sprain
478841|NCT01518335|injection|injection
478842|NCT01518335|Platelet Rich Plasma therapy|platelet rich plasma therapy
478843|NCT01518335|focal, invasive therapy for sprains|focal, invasive therapy for sprains
478844|NCT01518322|Asthma|asthma
478845|NCT01518322|Fractional Exhaled Nitric Oxide|fractional exhaled nitric oxide
479838|NCT01514097|emergency|emergency
478846|NCT01518322|Respiratory Symptoms|respiratory symptoms
478847|NCT01518322|NIOX MINO|niox mino
478848|NCT01518322|Inhaled corticosteroids|inhaled corticosteroids
478849|NCT01518322|Nitric Oxide|nitric oxide
478850|NCT01518296|Pelvic Organ Prolapse Quantification (POPQ)|pelvic organ prolapse quantification (popq)
478851|NCT01518296|POPQ|popq
478852|NCT01518296|Urodynamic test|urodynamic test
478853|NCT01518283|Weekly cabazitaxel.|weekly cabazitaxel.
478854|NCT01518283|Advanced Hormone-refractory prostate Cancer.|advanced hormone-refractory prostate cancer.
478855|NCT01518283|Unfit patients.|unfit patients.
478856|NCT01518244|Primary open angle-glaucoma|primary open angle-glaucoma
478857|NCT01518244|Ocular hypertension|ocular hypertension
478858|NCT01518244|Pigment dispersion glaucoma|pigment dispersion glaucoma
478859|NCT01518231|stroke|stroke
478860|NCT01518231|hematopoietic stem cell transplantation|hematopoietic stem cell transplantation
478861|NCT01518218|Sickle cell disease|sickle cell disease
478862|NCT01518218|laying-on-of-hands|laying-on-of-hands
478863|NCT01518218|morbidity|morbidity
478864|NCT01518218|mortality|mortality
478865|NCT01518205|diabetic foot ulcers,|diabetic foot ulcers,
478866|NCT01518205|peripheral arterial disease,|peripheral arterial disease,
478867|NCT01518205|heparin-induced extracorporal lipid apheresis.|heparin-induced extracorporal lipid apheresis.
478868|NCT01518205|inflammatory markers|inflammatory markers
478869|NCT01518205|type 2 diabetes|type 2 diabetes
478870|NCT01518205|LDL-cholesterol|ldl-cholesterol
478871|NCT01518192|erythema migrans|erythema migrans
478872|NCT01518192|doxycycline|doxycycline
478873|NCT01518192|cefuroxime axetil|cefuroxime axetil
478874|NCT01518192|post-Lyme disease symptoms|post-lyme disease symptoms
478875|NCT01518192|background symptoms in general population|background symptoms in general population
478876|NCT01518179|Colles' Fracture|colles' fracture
478877|NCT01518179|Compression Bandages|compression bandages
478878|NCT01518179|Occupational therapy|occupational therapy
478879|NCT01518179|Rehabilitation|rehabilitation
478880|NCT01518179|Smith's fracture|smith's fracture
478881|NCT01518153|Blood and Marrow Transplantation|blood and marrow transplantation
478882|NCT01518153|Lymphoma|lymphoma
478883|NCT01518153|Myeloma|myeloma
478884|NCT01518153|Myeloproliferative Diseases|myeloproliferative diseases
478885|NCT01518153|Leukemia|leukemia
478886|NCT01518153|Myelodysplastic syndrome|myelodysplastic syndrome
478887|NCT01518153|MDS|mds
478888|NCT01518153|Hodgkin disease|hodgkin disease
478889|NCT01518153|Multiple myeloma|multiple myeloma
478890|NCT01518153|Fludarabine|fludarabine
478891|NCT01518153|Fludarabine Phosphate|fludarabine phosphate
478892|NCT01518153|Fludara|fludara
478893|NCT01518153|Melphalan|melphalan
478894|NCT01518153|Alkeran|alkeran
478895|NCT01518153|Tacrolimus|tacrolimus
478896|NCT01518153|Prograf|prograf
478897|NCT01518153|Methotrexate|methotrexate
478898|NCT01518153|G-CSF|g-csf
478899|NCT01518153|Filgrastim|filgrastim
478900|NCT01518153|NeupogenTM|neupogentm
478901|NCT01518153|Donor Lymphocyte Infusion|donor lymphocyte infusion
478902|NCT01518153|DLI|dli
478903|NCT01518153|Allogeneic Stem Cell Transplantation|allogeneic stem cell transplantation
478904|NCT01518153|Graft-vs-host disease|graft-vs-host disease
478905|NCT01518153|GvHD|gvhd
478906|NCT01518153|T-lymphocytes|t-lymphocytes
478907|NCT01518153|T-cells|t-cells
478908|NCT01518153|Alemtuzumab|alemtuzumab
478909|NCT01518153|CAMPATH-1H|campath-1h
478910|NCT01518153|Campath|campath
478911|NCT01518140|Advanced Cancers|advanced cancers
478912|NCT01518140|Locally advanced|locally advanced
478913|NCT01518140|Recurrent|recurrent
478914|NCT01518140|Metastatic disease|metastatic disease
478915|NCT01518140|Oxygen Delivery Modalities|oxygen delivery modalities
478916|NCT01518140|Shortness of breath|shortness of breath
478917|NCT01518140|Dyspnea|dyspnea
478918|NCT01518140|VapoTherm|vapotherm
478919|NCT01518140|Bilevel positive airway pressure|bilevel positive airway pressure
478920|NCT01518140|BiPAP|bipap
478921|NCT01518140|Non-rebreather mask|non-rebreather mask
478922|NCT01518127|Macular Degeneration|macular degeneration
478923|NCT01518114|Hypertrophic Cardiomyopathy|hypertrophic cardiomyopathy
478924|NCT01518114|Exercise Training|exercise training
478925|NCT01518114|Cardiac Rehabilitation|cardiac rehabilitation
478926|NCT01518114|Heart Failure|heart failure
478928|NCT01518101|vildagliptin|vildagliptin
478929|NCT01518101|liraglutide|liraglutide
478930|NCT01518075|Chronic Obstructive Pulmonary Disease|chronic obstructive pulmonary disease
478931|NCT01518075|Non invasive mechanical ventilation|non invasive mechanical ventilation
478932|NCT01518075|Breathing-swallowing interaction|breathing-swallowing interaction
478933|NCT01518075|Intensive Care Unit|intensive care unit
478934|NCT01518049|Affective Disorders, Psychotic|affective disorders, psychotic
478935|NCT01518049|Psychometrics|psychometrics
478936|NCT01518049|Biological Markers|biological markers
478937|NCT01518023|diabetes mellitus|diabetes mellitus
478938|NCT01518023|prediabetes|prediabetes
478939|NCT01518023|fasting blood glucose|fasting blood glucose
478940|NCT01518023|HbA1c|hba1c
478941|NCT01518023|Roux en Y gastric bypass|roux en y gastric bypass
478942|NCT01518023|Cancer gastrectomy|cancer gastrectomy
478943|NCT01518023|Cancer colorectal surgery|cancer colorectal surgery
478944|NCT01518010|Brain injury|brain injury
478945|NCT01518010|Cognitive rehabilitation|cognitive rehabilitation
478946|NCT01518010|Video game|video game
478947|NCT01517997|Drug coated balloons|drug coated balloons
478948|NCT01517997|Drug eluting stents|drug eluting stents
478949|NCT01517984|recipients of living-donor kidney allografts|recipients of living-donor kidney allografts
478950|NCT01517984|antithymocyte globulin (ATG) induction|antithymocyte globulin (atg) induction
478951|NCT01517984|calcineurin inhibitors (CNIs)|calcineurin inhibitors (cnis)
478952|NCT01517984|CNI withdrawal|cni withdrawal
478953|NCT01517971|stage IA non-small cell lung cancer|stage ia non-small cell lung cancer
478954|NCT01517971|stage IB non-small cell lung cancer|stage ib non-small cell lung cancer
478955|NCT01517971|adenocarcinoma of the lung|adenocarcinoma of the lung
478956|NCT01517971|squamous cell lung cancer|squamous cell lung cancer
478957|NCT01517958|Transient tachypnea of the newborn|transient tachypnea of the newborn
478958|NCT01517958|Respiratory Distress Syndrome|respiratory distress syndrome
478959|NCT01517958|Lung Ultrasound|lung ultrasound
478960|NCT01517958|Neonates|neonates
478961|NCT01517945|Survivors|survivors
478962|NCT01517945|Quality of Life|quality of life
478963|NCT01517945|Questionnaire|questionnaire
478964|NCT01517945|11-204|11-204
478965|NCT01517919|peer support|peer support
478966|NCT01517919|peer leader|peer leader
478967|NCT01517919|community health worker|community health worker
478968|NCT01517919|empowerment|empowerment
478969|NCT01517919|self-management|self-management
478970|NCT01517906|eating disorder behaviors|eating disorder behaviors
478971|NCT01517906|well being|well being
478972|NCT01517906|functional health|functional health
478973|NCT01517893|vitiligo|vitiligo
478974|NCT01517893|simvastatin|simvastatin
478975|NCT01517880|Hereditary Inclusion Body Myopathy (HIBM)|hereditary inclusion body myopathy (hibm)
478976|NCT01517880|GNE myopathies|gne myopathies
478977|NCT01517880|distal myopathy with rimmed vacuoles [DMRV]|distal myopathy with rimmed vacuoles [dmrv]
478978|NCT01517880|Nonaka disease|nonaka disease
478979|NCT01517867|preschool children behavior problems|preschool children behavior problems
478980|NCT01517867|child between 2 and 5 years old|child between 2 and 5 years old
478981|NCT01517841|peritoneal dialysis|peritoneal dialysis
478982|NCT01517841|modality choice|modality choice
478983|NCT01517841|kidney disease|kidney disease
478984|NCT01517828|Intubation|intubation
478985|NCT01517828|Delivery room|delivery room
478986|NCT01517828|Sedation|sedation
478987|NCT01517828|Analgesia|analgesia
478988|NCT01517815|Septic shock|septic shock
478989|NCT01517815|overweight|overweight
478990|NCT01517815|critically ill|critically ill
478991|NCT01517815|pharmacokinetic|pharmacokinetic
478992|NCT01517815|doripenem|doripenem
478993|NCT01517815|piperacillin-tazobactam|piperacillin-tazobactam
478994|NCT01517802|Metastatic castration-resistant prostate cancer|metastatic castration-resistant prostate cancer
478995|NCT01517802|Metastatic breast cancer|metastatic breast cancer
478996|NCT01517802|Abiraterone acetate|abiraterone acetate
478997|NCT01517802|Low-dose corticosteroid treatment|low-dose corticosteroid treatment
478998|NCT01517802|Long-term access|long-term access
478999|NCT01517789|Surgery|surgery
479000|NCT01517789|Optic Nerve and Pathway Injury|optic nerve and pathway injury
479001|NCT01517789|visual event-related potential|visual event-related potential
479002|NCT01517776|High grade glioma|high grade glioma
479003|NCT01517776|Glioblastoma multiforme|glioblastoma multiforme
479004|NCT01517776|Anaplastic astrocytoma|anaplastic astrocytoma
479005|NCT01517776|Diffuse intrinsic pontine glioma|diffuse intrinsic pontine glioma
479006|NCT01517776|Relapse|relapse
479007|NCT01517776|refractory tumour disease|refractory tumour disease
479008|NCT01517776|Relapsed or refractory high grade gliomas and diffuse intrinsic pontine gliomas|relapsed or refractory high grade gliomas and diffuse intrinsic pontine gliomas
479009|NCT01517763|Obstructive Sleep Apnea|obstructive sleep apnea
479010|NCT01517763|Humidification|humidification
479011|NCT01517763|Continuous Positive Airway Pressure|continuous positive airway pressure
479012|NCT01517763|ICON|icon
479013|NCT01517763|ThermoSmart|thermosmart
479014|NCT01517763|SensAwake|sensawake
479015|NCT01517750|Obstructive Sleep Apnea|obstructive sleep apnea
479016|NCT01517750|Humidification|humidification
479017|NCT01517750|Continuous Positive Airway Pressure|continuous positive airway pressure
479018|NCT01517750|ICON|icon
479019|NCT01517750|ThermoSmart|thermosmart
479020|NCT01517724|MM|mm
479021|NCT01517724|HDT|hdt
479022|NCT01517724|ASCT|asct
479023|NCT01517724|consolidation|consolidation
479024|NCT01517724|bortezomib|bortezomib
479025|NCT01517711|pharmacotherapy|pharmacotherapy
479026|NCT01517711|combat disorders|combat disorders
479027|NCT01517685|Eicosapentaenoic acid|eicosapentaenoic acid
479028|NCT01517685|EPA|epa
479029|NCT01517685|Docosahexaenoic acid|docosahexaenoic acid
479030|NCT01517685|DHA|dha
479031|NCT01517685|Omega 3 fat|omega 3 fat
479032|NCT01517685|alpha-linoleic acid|alpha-linoleic acid
479033|NCT01517685|ALA|ala
479034|NCT01517685|fish oil|fish oil
479035|NCT01517685|flax seed oil|flax seed oil
479036|NCT01517672|PTSD|ptsd
479037|NCT01517672|domestic violence|domestic violence
479038|NCT01517672|intimate partner violence|intimate partner violence
479039|NCT01517672|functional MRI|functional mri
479040|NCT01517672|neuroimaging|neuroimaging
479041|NCT01517659|Lipolysis|lipolysis
479042|NCT01517659|Cryolipolysis|cryolipolysis
479043|NCT01517659|Fat Reduction|fat reduction
479044|NCT01517646|Lipolysis|lipolysis
479045|NCT01517646|Cryolipolysis|cryolipolysis
479046|NCT01517646|Fat Reduction|fat reduction
479047|NCT01517633|Amniotic fluid leakage|amniotic fluid leakage
479048|NCT01517633|Urinary incontinence|urinary incontinence
479049|NCT01517581|Brown adipose tissue|brown adipose tissue
479050|NCT01517542|diet|diet
479051|NCT01517542|DASH|dash
479052|NCT01517542|Stroke|stroke
479053|NCT01517542|Nutritional counseling|nutritional counseling
479054|NCT01517529|Hepatitis C|hepatitis c
479055|NCT01517529|HCV|hcv
479056|NCT01517516|fMRI|fmri
479057|NCT01517516|resting state|resting state
479058|NCT01517516|structural MRI|structural mri
479059|NCT01517516|functional MRI|functional mri
479060|NCT01517477|Open angle|open angle
479061|NCT01517477|Glaucoma|glaucoma
479062|NCT01517477|surgery|surgery
479063|NCT01517477|Glaucoma, Open-Angle|glaucoma, open-angle
479064|NCT01517477|Ocular Hypertension|ocular hypertension
479065|NCT01517477|Eye Diseases|eye diseases
479066|NCT01517464|neoplasm|neoplasm
479067|NCT01517464|bladder cancer|bladder cancer
479068|NCT01517464|advances solid tumors|advances solid tumors
479069|NCT01517438|agitation, desflurane, children|agitation, desflurane, children
479070|NCT01517399|Oncology|oncology
479071|NCT01517399|pharmacokinetics|pharmacokinetics
479072|NCT01517399|PK interaction in advanced solid tumors with our drug and other drugs|pk interaction in advanced solid tumors with our drug and other drugs
479073|NCT01517386|paravertebral space|paravertebral space
479074|NCT01517386|needle placement|needle placement
479075|NCT01517386|tissue identification|tissue identification
479076|NCT01517386|regional|regional
479077|NCT01517373|T2DM|t2dm
479078|NCT01517373|PF-04937319|pf-04937319
479079|NCT01517373|Phase 2|phase 2
479080|NCT01517360|Schizophrenia|schizophrenia
479081|NCT01517360|Social Cognition|social cognition
479082|NCT01517360|Oxytocin|oxytocin
479083|NCT01517347|IL2|il2
479084|NCT01517347|relapse|relapse
479085|NCT01517347|GVHD|gvhd
479086|NCT01517347|survival|survival
479087|NCT01517347|allogeneic stem cell transplantation|allogeneic stem cell transplantation
479088|NCT01517347|MRD|mrd
479089|NCT01517347|CR|cr
479090|NCT01517308|HCV|hcv
479091|NCT01517308|Hepatitis|hepatitis
479092|NCT01517308|Genotype 2 or 3|genotype 2 or 3
479093|NCT01517308|Pegylated Interferon|pegylated interferon
479094|NCT01517308|Duration|duration
479095|NCT01517295|Pharmacokinetics|pharmacokinetics
479096|NCT01517295|Hydromorphone|hydromorphone
479097|NCT01517295|Hydrocodone|hydrocodone
479098|NCT01517295|APAP|apap
479099|NCT01517269|Parent education|parent education
479100|NCT01517256|Chronic pain|chronic pain
479101|NCT01517256|Primary care|primary care
479102|NCT01517256|Multidisciplinary group therapy|multidisciplinary group therapy
479103|NCT01517256|Embedded mixed-methods study|embedded mixed-methods study
479104|NCT01517243|Metastatic Renal Cell Carcinoma|metastatic renal cell carcinoma
479105|NCT01517243|sunitinib|sunitinib
479106|NCT01517243|alternating|alternating
479107|NCT01517243|temsirolimus|temsirolimus
479108|NCT01517230|Cluster-randomised trial|cluster-randomised trial
479109|NCT01517230|Comprehensive mass media campaign|comprehensive mass media campaign
479110|NCT01517230|Rural community radio|rural community radio
479111|NCT01517230|Under-five child mortality|under-five child mortality
479112|NCT01517230|Preventive and curative behaviours|preventive and curative behaviours
479113|NCT01517230|Burkina Faso|burkina faso
479114|NCT01517230|Health care seeking behavior|health care seeking behavior
479115|NCT01517230|Childbirth|childbirth
479116|NCT01517217|girdle|girdle
479117|NCT01517217|laparotomy|laparotomy
479118|NCT01517217|pulmonary function|pulmonary function
479119|NCT01517217|postoperative pain|postoperative pain
479120|NCT01517217|mobilisation|mobilisation
479121|NCT01517204|Trachway(R) intubating stylet|trachway(r) intubating stylet
479122|NCT01517204|Left sided double lumen endobronchial tube|left sided double lumen endobronchial tube
479123|NCT01517204|Efficacy|efficacy
479124|NCT01517204|Intubation complication|intubation complication
479125|NCT01517191|Influenza|influenza
479126|NCT01517191|Respiratory Infection|respiratory infection
479127|NCT01517165|Opioid Dependence|opioid dependence
479128|NCT01517165|Pioglitazone|pioglitazone
479129|NCT01517165|Buprenorphine|buprenorphine
479130|NCT01517152|Symptoms|symptoms
479131|NCT01517152|Patient-Reported Outcomes|patient-reported outcomes
479132|NCT01517152|Linguistic Validation|linguistic validation
479133|NCT01517152|Toxicity|toxicity
479134|NCT01517152|PRO-CTCAE|pro-ctcae
479135|NCT01517152|Adverse Events|adverse events
479136|NCT01517152|Translation|translation
479137|NCT01517152|Questionnaire|questionnaire
479138|NCT01517139|Diet and Nutrition|diet and nutrition
479139|NCT01517139|Pregnancy Folic Acid|pregnancy folic acid
479140|NCT01517139|In Utero Exposure|in utero exposure
479141|NCT01517139|DNA Methylation|dna methylation
479142|NCT01517139|Physical Activity|physical activity
479143|NCT01517126|Youth Suicide|youth suicide
479144|NCT01517126|Suicide Screening|suicide screening
479145|NCT01517126|Developmental Delay|developmental delay
479146|NCT01517126|Intellectual Disability|intellectual disability
479147|NCT01517126|Assessment Instrument|assessment instrument
479148|NCT01517126|Mental Retardation|mental retardation
479149|NCT01517126|Suicidal Thoughts|suicidal thoughts
479150|NCT01517126|Suicidal Behavior|suicidal behavior
479151|NCT01517113|Endothelial Dysfunction|endothelial dysfunction
479152|NCT01517113|Hepatic|hepatic
479153|NCT01517113|Adiposity|adiposity
479154|NCT01517113|Cytokines|cytokines
479155|NCT01517113|Muscle Mass|muscle mass
479156|NCT01517113|Coronary Artery Disease|coronary artery disease
479157|NCT01517113|Aging|aging
479158|NCT01517113|Inflammation|inflammation
479159|NCT01517100|Glucose|glucose
479160|NCT01517100|Insulin Secretion|insulin secretion
479161|NCT01517100|Insulin Action|insulin action
479162|NCT01517100|Endocannabinoids|endocannabinoids
479163|NCT01517100|Insulin|insulin
479164|NCT01517100|Metabolism|metabolism
479165|NCT01517087|Motor Function|motor function
479166|NCT01517087|Magnetic Resonance Spectroscopy|magnetic resonance spectroscopy
479167|NCT01517087|Transcranial Magnetic Stimulation (TMS)|transcranial magnetic stimulation (tms)
479168|NCT01517087|Diffusion Tensor Imaging|diffusion tensor imaging
479169|NCT01517087|Functional Magnetic Resonance Imaging (fMRI)|functional magnetic resonance imaging (fmri)
479170|NCT01517087|Healthy Volunteer|healthy volunteer
479171|NCT01517087|HV|hv
479172|NCT01517074|Sirolimus|sirolimus
479173|NCT01517074|Scleritis|scleritis
479174|NCT01517074|Autoimmune Scleritis|autoimmune scleritis
479175|NCT01517061|Phantom Limb Pain|phantom limb pain
479176|NCT01517061|Genetic Polymorphisms|genetic polymorphisms
479177|NCT01517061|Genetic Susceptibility|genetic susceptibility
479178|NCT01517061|Amputation|amputation
479179|NCT01517048|Body Composition|body composition
479180|NCT01517048|Obesity|obesity
479181|NCT01517048|Overweight|overweight
479182|NCT01517048|Energy Homeostasis|energy homeostasis
479183|NCT01517048|Nociception|nociception
479184|NCT01517048|Prader-Willi Syndrome|prader-willi syndrome
479185|NCT01517048|Genetic Disorder|genetic disorder
479186|NCT01517048|Healthy Volunteer|healthy volunteer
479187|NCT01517048|HV|hv
479188|NCT01517035|Peripheral Blood Stem Cell Transplantation|peripheral blood stem cell transplantation
479189|NCT01517035|Stem Cell Transplant|stem cell transplant
479190|NCT01517035|Transplant|transplant
479191|NCT01517035|Myelodyplastic Syndrome|myelodyplastic syndrome
479192|NCT01517035|MDS|mds
479193|NCT01517035|Leukemia|leukemia
479194|NCT01517022|smoking cessation|smoking cessation
479195|NCT01517022|early sputum smear conversion|early sputum smear conversion
479196|NCT01517009|Neo-adjuvant chemotherapy|neo-adjuvant chemotherapy
479197|NCT01517009|D1extra-resection|d1extra-resection
479198|NCT01516996|Neoadjuvant|neoadjuvant
479199|NCT01516996|Concurrent Chemoradiotherapy,CCRT|concurrent chemoradiotherapy,ccrt
479200|NCT01516996|Nimotuzumab|nimotuzumab
479201|NCT01516996|Locoregionally Advanced Oropharynx|locoregionally advanced oropharynx
479202|NCT01516996|Hypopharynx cancer|hypopharynx cancer
479203|NCT01516996|Randomized|randomized
479204|NCT01516996|Multicenter|multicenter
479205|NCT01516983|Safety|safety
479206|NCT01516983|EGFR-TKI|egfr-tki
479207|NCT01516983|NSCLC|nsclc
479208|NCT01516983|Icotinib|icotinib
479209|NCT01516983|WBRT|wbrt
479210|NCT01516970|Human Immunodeficiency Virus (HIV) Post exposure prophylaxis|human immunodeficiency virus (hiv) post exposure prophylaxis
479211|NCT01516970|DRV/r|drv/r
479212|NCT01516970|Occupational injury|occupational injury
479213|NCT01516970|Non-occupational exposure|non-occupational exposure
479214|NCT01516970|Prezista|prezista
479215|NCT01516970|Darunavir/r|darunavir/r
479216|NCT01516957|Psoriatic Arthritis|psoriatic arthritis
479217|NCT01516957|IL-17|il-17
479218|NCT01516957|AMG 827|amg 827
479219|NCT01516957|AMG827|amg827
479220|NCT01516957|Musculoskeletal Disease|musculoskeletal disease
479221|NCT01516957|Spondylarthropathy|spondylarthropathy
479222|NCT01516944|Tegafur，Gimeracil and Oteracil Potassium Capsules|tegafur，gimeracil and oteracil potassium capsules
479223|NCT01516944|Capecitabine|capecitabine
479224|NCT01516944|Oxaliplatin|oxaliplatin
479225|NCT01516944|perioperative Chemotherapy|perioperative chemotherapy
479226|NCT01516944|Gastric Cancer|gastric cancer
479227|NCT01516931|repetitive Transcranial Magnetic Stimulation (rTMS)|repetitive transcranial magnetic stimulation (rtms)
479228|NCT01516931|Depression|depression
479229|NCT01516931|Venlafaxine|venlafaxine
479230|NCT01516931|Relapse|relapse
479231|NCT01516879|Cholesterol|cholesterol
479232|NCT01516879|High Cholesterol|high cholesterol
479233|NCT01516879|Elevated Cholesterol|elevated cholesterol
479234|NCT01516879|Raised Cholesterol|raised cholesterol
479235|NCT01516866|Androgen receptor-directed therapy|androgen receptor-directed therapy
479236|NCT01516866|NaF PET/CT|naf pet/ct
479237|NCT01516866|antimicrotubule directed chemotherapy|antimicrotubule directed chemotherapy
479238|NCT01516840|acute symptomatic deep vein thrombosis|acute symptomatic deep vein thrombosis
479240|NCT01516827|Children and Adolescents|children and adolescents
479241|NCT01516827|Post-Traumatic Stress Disorder in Children and Adolescents|post-traumatic stress disorder in children and adolescents
479242|NCT01516814|acute symptomatic pulmonary embolism|acute symptomatic pulmonary embolism
479243|NCT01516801|Prostate Cancer Screening|prostate cancer screening
479244|NCT01516801|Pragmatic Trial|pragmatic trial
479245|NCT01516801|Health Literacy|health literacy
479246|NCT01516775|preoperative care|preoperative care
479247|NCT01516775|preoperative period|preoperative period
479248|NCT01516775|fasting|fasting
479249|NCT01516762|Radium 223|radium 223
479250|NCT01516762|Alpharadin|alpharadin
479251|NCT01516762|Prostate Cancer|prostate cancer
479252|NCT01516762|Bone metastases|bone metastases
479253|NCT01516762|Castrate resistant prostate cancer|castrate resistant prostate cancer
479254|NCT01516762|Hormone refractory prostate cancer|hormone refractory prostate cancer
479255|NCT01516749|hidradenitis suppurativa|hidradenitis suppurativa
479256|NCT01516749|anakinra|anakinra
479257|NCT01516736|Pegfilgrastim|pegfilgrastim
479258|NCT01516736|G-CSF|g-csf
479259|NCT01516736|neutropenia|neutropenia
479260|NCT01516736|breast cancer|breast cancer
479261|NCT01516736|myelosuppressive chemotherapy|myelosuppressive chemotherapy
479262|NCT01516723|drug-eluting stent|drug-eluting stent
479263|NCT01516723|chronic total occlusion|chronic total occlusion
479264|NCT01516723|hybrid sirolimus-eluting stent|hybrid sirolimus-eluting stent
479265|NCT01516723|everolimus-eluting stent|everolimus-eluting stent
479266|NCT01516710|Open liver resection|open liver resection
479267|NCT01516710|Laparoscopic liver resection|laparoscopic liver resection
479268|NCT01516710|Colorectal cancer liver metastases|colorectal cancer liver metastases
479269|NCT01516697|thoracic electric bioimpedance|thoracic electric bioimpedance
479270|NCT01516697|cardiac output monitoring|cardiac output monitoring
479271|NCT01516697|cesarean section|cesarean section
479272|NCT01516697|spinal anesthesia|spinal anesthesia
479273|NCT01516671|Subarachnoid hemorrhage|subarachnoid hemorrhage
479274|NCT01516671|Cerebral vasospasm|cerebral vasospasm
479275|NCT01516671|Neuroinflammation|neuroinflammation
479276|NCT01516671|Bilateral Bispectral Index|bilateral bispectral index
479277|NCT01516658|intracranial aneurysm|intracranial aneurysm
479278|NCT01516658|endovascular therapy|endovascular therapy
479279|NCT01516658|detachable coil|detachable coil
479280|NCT01516658|recanalization|recanalization
479281|NCT01516645|Squamous cell type tumor|squamous cell type tumor
479282|NCT01516632|Cellular Phone|cellular phone
479283|NCT01516632|Mobile Phone|mobile phone
479284|NCT01516632|Cognitive Behavior Therapy|cognitive behavior therapy
479285|NCT01516632|Technology|technology
479286|NCT01516632|Smoking cessation|smoking cessation
479287|NCT01516632|young adults|young adults
479288|NCT01516619|NHL|nhl
479289|NCT01516619|chemotherapy-induced grade-4 thrombocytopenia|chemotherapy-induced grade-4 thrombocytopenia
479290|NCT01516606|MALT|malt
479291|NCT01516606|refractory|refractory
479292|NCT01516606|relapsed|relapsed
479293|NCT01516606|extranodal|extranodal
479294|NCT01516606|relapsed or refractory extranodal marginal zone lymphoma|relapsed or refractory extranodal marginal zone lymphoma
479295|NCT01516593|HIV|hiv
479296|NCT01516593|Burkitt's lymphoma|burkitt's lymphoma
479297|NCT01516593|intensive|intensive
479298|NCT01516593|short term|short term
479299|NCT01516593|immuno-chemotherapy|immuno-chemotherapy
479300|NCT01516593|HIV-positive patients with Burkitt's lymphoma|hiv-positive patients with burkitt's lymphoma
479301|NCT01516554|Multiple Sclerosis|multiple sclerosis
479302|NCT01516554|Fatigue|fatigue
479303|NCT01516528|COPD|copd
479304|NCT01516528|exacerbation|exacerbation
479305|NCT01516528|comorbidities|comorbidities
479306|NCT01516528|lung function|lung function
479307|NCT01516528|burden|burden
479308|NCT01516528|chronic bronchitis|chronic bronchitis
479309|NCT01516528|emphysema|emphysema
479310|NCT01516528|prevalence|prevalence
479311|NCT01516528|cardiovascular disease|cardiovascular disease
479312|NCT01516515|Actinic Keratosis|actinic keratosis
479313|NCT01516515|AK|ak
479314|NCT01516502|laser therapy|laser therapy
479315|NCT01516502|myofascial pain syndrome|myofascial pain syndrome
479316|NCT01516502|acupoint|acupoint
479317|NCT01516502|trigger point|trigger point
479318|NCT01516502|range of motion|range of motion
479319|NCT01516489|screening|screening
479320|NCT01516489|colon cancer|colon cancer
479321|NCT01516489|incentives|incentives
479322|NCT01516489|behavioral economics|behavioral economics
479323|NCT01516463|burn|burn
479324|NCT01516463|partial thickness burn|partial thickness burn
479325|NCT01516463|second degree burn|second degree burn
479326|NCT01516463|minor burn|minor burn
479327|NCT01516463|scar|scar
479328|NCT01516463|Santyl|santyl
479329|NCT01516463|Bacitracin|bacitracin
479330|NCT01516463|outpatient burn center|outpatient burn center
479331|NCT01516463|scar appearance|scar appearance
479332|NCT01516463|Kansas City|kansas city
479333|NCT01516463|University of Kansas Medical Center|university of kansas medical center
479334|NCT01516463|KUMC|kumc
479335|NCT01516450|GSK1550188, belimumab, SLE, healthy, Japanese, pharmacokinetics, safety|gsk1550188, belimumab, sle, healthy, japanese, pharmacokinetics, safety
479336|NCT01516437|Chronic Obstructive Pulmonary disease (COPD)|chronic obstructive pulmonary disease (copd)
479337|NCT01516424|Blonanserin|blonanserin
479338|NCT01516411|Health Promotion|health promotion
479339|NCT01516411|Physical Activity|physical activity
479340|NCT01516411|Sedentary Time|sedentary time
479341|NCT01516411|Smartphones|smartphones
479342|NCT01516385|spinal cord injury|spinal cord injury
479343|NCT01516385|biomarkers|biomarkers
479344|NCT01516385|rehabilitation|rehabilitation
479345|NCT01516385|functional independence|functional independence
479346|NCT01516385|prognosis|prognosis
479347|NCT01516372|GEn, moxifloxacin, cardiac repolarisation, QT/QTc|gen, moxifloxacin, cardiac repolarisation, qt/qtc
479348|NCT01516346|Heart Failure|heart failure
479349|NCT01516346|Heart failure with preserved ejection fraction (HFpEF)|heart failure with preserved ejection fraction (hfpef)
479350|NCT01516346|Vasodilators|vasodilators
479351|NCT01516346|Isosorbide dinitrate|isosorbide dinitrate
479352|NCT01516346|Hydralazine|hydralazine
479353|NCT01516346|wave reflections|wave reflections
479354|NCT01516346|arterial stiffness|arterial stiffness
479355|NCT01516346|hemodynamics|hemodynamics
479356|NCT01516333|glycemic Index|glycemic index
479357|NCT01516320|Type 2 Diabetes|type 2 diabetes
479358|NCT01516320|Gastric Bypass|gastric bypass
479359|NCT01516320|Laparoscopic Banding|laparoscopic banding
479360|NCT01516320|Vertical Sleeve Gastrectomy|vertical sleeve gastrectomy
479361|NCT01516294|AMD|amd
479362|NCT01516294|PCV|pcv
479363|NCT01516294|Iray|iray
479364|NCT01516294|radiation|radiation
479365|NCT01516294|retina|retina
479366|NCT01516294|macula|macula
479367|NCT01516294|radiotherapy|radiotherapy
479368|NCT01516281|TBI|tbi
479369|NCT01516281|PD|pd
479370|NCT01516268|Cesarean Delivery|cesarean delivery
479371|NCT01516268|TAP block|tap block
479372|NCT01516268|sufentanyl|sufentanyl
479373|NCT01516268|Narcotic dosages|narcotic dosages
479374|NCT01516216|previously untreated|previously untreated
479375|NCT01516203|AZD5847|azd5847
479376|NCT01516203|dose-ranging|dose-ranging
479377|NCT01516203|Mycobacterium tuberculosis|mycobacterium tuberculosis
479378|NCT01516203|Rifafour|rifafour
479379|NCT01516203|tuberculosis|tuberculosis
479380|NCT01516190|stage I-III breast cancer|stage i-iii breast cancer
479381|NCT01516177|Kidney Transplantation|kidney transplantation
479382|NCT01516177|kidney transplant|kidney transplant
479383|NCT01516177|renal transplant|renal transplant
479384|NCT01516177|immunosuppression|immunosuppression
479385|NCT01516164|Laryngoscopy|laryngoscopy
611342|NCT00973518|AD|ad
479386|NCT01516164|Videolaryngoscopy|videolaryngoscopy
479387|NCT01516164|Ease of Intubation|ease of intubation
479388|NCT01516151|Hypertriglyceridemia|hypertriglyceridemia
479389|NCT01516138|Glucose-insulin-potassium|glucose-insulin-potassium
479390|NCT01516138|Cardiac surgery|cardiac surgery
479391|NCT01516125|healthy adult|healthy adult
479392|NCT01516125|genetic variation|genetic variation
479393|NCT01516125|botanical oils|botanical oils
479394|NCT01516125|polyunsaturated fatty acid|polyunsaturated fatty acid
479395|NCT01516125|fish oil|fish oil
479396|NCT01516125|fat metabolism|fat metabolism
479397|NCT01516125|Genetic variation of fat metabolism in healthy adults|genetic variation of fat metabolism in healthy adults
479398|NCT01516112|ICD, home monitoring, cardiomessenger, implant|icd, home monitoring, cardiomessenger, implant
479399|NCT01516099|Physical activity counselor|physical activity counselor
479400|NCT01516099|Active and healthy lifestyle|active and healthy lifestyle
479401|NCT01516099|General Practitioner|general practitioner
479402|NCT01516099|Social-cultural Organization|social-cultural organization
479403|NCT01516086|Controlled|controlled
479404|NCT01516086|uncontrolled|uncontrolled
479405|NCT01516073|partially controlled|partially controlled
479406|NCT01516073|uncontrolled|uncontrolled
479407|NCT01516047|Hepatic impairment|hepatic impairment
479408|NCT01516047|Pharmacology|pharmacology
479409|NCT01516047|Pharmacokinetics|pharmacokinetics
479410|NCT01516047|Pharmacodynamics|pharmacodynamics
479411|NCT01516047|Abiraterone acetate suspension|abiraterone acetate suspension
479412|NCT01516047|JNJ-212082|jnj-212082
479413|NCT01516034|Tattoo removal|tattoo removal
479414|NCT01516034|ultrasound|ultrasound
479415|NCT01516021|Fat ingestion|fat ingestion
479416|NCT01516021|hypothalamus|hypothalamus
479417|NCT01516021|insula|insula
479418|NCT01516021|fMRI|fmri
479419|NCT01516021|CBF|cbf
479420|NCT01516008|Hallux Valgus|hallux valgus
479421|NCT01516008|Bunionectomy|bunionectomy
479422|NCT01516008|Bunion|bunion
479423|NCT01516008|Acute pain|acute pain
479424|NCT01516008|Tapentadol|tapentadol
479425|NCT01516008|Tapentadol IR|tapentadol ir
479426|NCT01515995|Magnesium sulfate|magnesium sulfate
479427|NCT01515995|Childhood asthma|childhood asthma
479428|NCT01515995|Emergency department|emergency department
479429|NCT01515982|Alzheimer's disease|alzheimer's disease
479430|NCT01515982|Aerobic exercise|aerobic exercise
479431|NCT01515982|Physical training|physical training
479432|NCT01515982|Cognitive function|cognitive function
479433|NCT01515982|Functional capacity.|functional capacity.
479434|NCT01515956|Mucopolysaccharidosis IVA type A|mucopolysaccharidosis iva type a
479435|NCT01515956|MPS IVA Type A|mps iva type a
479436|NCT01515956|Mucopolysaccharidosis IVA|mucopolysaccharidosis iva
479437|NCT01515956|MPS IVA|mps iva
479438|NCT01515956|Morquio A Syndrome|morquio a syndrome
479439|NCT01515956|Lysosomal Storage Disorder|lysosomal storage disorder
479440|NCT01515956|LSD|lsd
479441|NCT01515956|N-acetylgalactosamine-6-sulfatase|n-acetylgalactosamine-6-sulfatase
479442|NCT01515956|N-acetylgalactosamine-6-sulfate|n-acetylgalactosamine-6-sulfate
479443|NCT01515956|sulfatase|sulfatase
479444|NCT01515956|galactose-6-sulfatase|galactose-6-sulfatase
479445|NCT01515956|GALNS|galns
479446|NCT01515956|enzyme replacement therapy|enzyme replacement therapy
479447|NCT01515956|ERT|ert
479448|NCT01515943|Convergence insufficiency|convergence insufficiency
479449|NCT01515930|Parenting|parenting
479450|NCT01515930|Parental Monitoring|parental monitoring
479451|NCT01515930|Diabetes|diabetes
479452|NCT01515930|Care|care
479453|NCT01515917|Veterans|veterans
479454|NCT01515917|Traumatic Brain Injury|traumatic brain injury
479455|NCT01515917|TBI|tbi
479456|NCT01515917|Substance Abuse|substance abuse
479457|NCT01515917|Substance Dependence|substance dependence
479458|NCT01515917|Veterans with traumatic brain injury (TBI)|veterans with traumatic brain injury (tbi)
479459|NCT01515917|Veterans with substance abuse or dependence|veterans with substance abuse or dependence
479460|NCT01515904|obesity management|obesity management
479461|NCT01515904|adolescents|adolescents
479462|NCT01515904|body mass index|body mass index
479463|NCT01515904|treatment outcomes|treatment outcomes
479464|NCT01515904|program evaluation|program evaluation
479465|NCT01515891|Parkinson Disease|parkinson disease
479466|NCT01515891|BIA 9-1067|bia 9-1067
479467|NCT01515852|stress level|stress level
479468|NCT01515852|stereotactic biopsy|stereotactic biopsy
479469|NCT01515852|brain lesion|brain lesion
479470|NCT01515852|general anesthesia|general anesthesia
479471|NCT01515852|local anesthesia|local anesthesia
479472|NCT01515839|SPECT|spect
479473|NCT01515839|Imaging|imaging
479474|NCT01515839|Football|football
479475|NCT01515839|Traumatic brain injury|traumatic brain injury
479476|NCT01515839|Regional cerebral blood flow|regional cerebral blood flow
479477|NCT01515826|Cataract surgery|cataract surgery
479478|NCT01515826|Topical therapy|topical therapy
479479|NCT01515826|Prevention of inflammation|prevention of inflammation
479480|NCT01515826|Inflammation of infection|inflammation of infection
479481|NCT01515800|estrogen receptor-positive breast cancer|estrogen receptor-positive breast cancer
479482|NCT01515800|progesterone receptor-positive breast cancer|progesterone receptor-positive breast cancer
479483|NCT01515800|stage IA breast cancer|stage ia breast cancer
479484|NCT01515800|stage IB breast cancer|stage ib breast cancer
479485|NCT01515800|stage II breast cancer|stage ii breast cancer
479486|NCT01515800|stage IIIA breast cancer|stage iiia breast cancer
479487|NCT01515787|stage IIA rectal cancer|stage iia rectal cancer
479488|NCT01515787|stage IIIA rectal cancer|stage iiia rectal cancer
479489|NCT01515787|stage IIIB rectal cancer|stage iiib rectal cancer
479490|NCT01515774|Parkinson's disease|parkinson's disease
479491|NCT01515774|Pramipexole|pramipexole
479492|NCT01515722|Medication Persistence|medication persistence
479493|NCT01515722|Compliance|compliance
479494|NCT01515722|Health Education Intervention (HEI)|health education intervention (hei)
479495|NCT01515709|Cohort Studies|cohort studies
479496|NCT01515709|Longitudinal Studies|longitudinal studies
479497|NCT01515696|VLBW infant|vlbw infant
479498|NCT01515696|Meconium|meconium
479499|NCT01515696|Enteral nutrition|enteral nutrition
479500|NCT01515696|Meconium passage|meconium passage
479501|NCT01515683|Nervousness before anesthesia|nervousness before anesthesia
479502|NCT01515670|THA|tha
479503|NCT01515670|TKA|tka
479504|NCT01515670|Fast-track|fast-track
479505|NCT01515670|Enhanced recovery|enhanced recovery
479506|NCT01515670|preoperative co-morbidity|preoperative co-morbidity
479507|NCT01515670|postoperative morbidity|postoperative morbidity
479508|NCT01515670|Arthroplasty|arthroplasty
479509|NCT01515670|Replacement|replacement
479510|NCT01515670|Hip|hip
479511|NCT01515670|Knee|knee
479512|NCT01515670|Morbidity|morbidity
479513|NCT01515644|Healthy infants|healthy infants
479514|NCT01515644|Infant formula|infant formula
479515|NCT01515644|Prebiotics|prebiotics
479516|NCT01515566|Advanced Cancer|advanced cancer
479517|NCT01515566|Dyspnea|dyspnea
479518|NCT01515566|Exercise-induced breakthrough dyspnea|exercise-induced breakthrough dyspnea
479519|NCT01515566|Shortness of breath|shortness of breath
479520|NCT01515566|Fentanyl|fentanyl
479521|NCT01515566|Sublimaze|sublimaze
479522|NCT01515566|Placebo|placebo
479523|NCT01515566|Normal saline|normal saline
479524|NCT01515566|NS|ns
479525|NCT01515566|Questionnaires|questionnaires
479526|NCT01515566|Surveys|surveys
479527|NCT01515566|Walk test|walk test
479528|NCT01515540|chronic back pain|chronic back pain
479529|NCT01515540|placebo|placebo
479530|NCT01515540|fmri|fmri
479531|NCT01515540|brain imaging|brain imaging
479532|NCT01515527|Leukemia|leukemia
479533|NCT01515527|Acute myeloid leukemia|acute myeloid leukemia
479534|NCT01515527|AML|aml
479839|NCT01514097|pediatric|pediatric
479535|NCT01515527|myelodysplastic syndrome|myelodysplastic syndrome
479536|NCT01515527|MDS|mds
479537|NCT01515527|Cytarabine|cytarabine
479538|NCT01515527|Ara-C|ara-c
479539|NCT01515527|Cytosar|cytosar
479540|NCT01515527|DepoCyt|depocyt
479541|NCT01515527|Cytosine Arabinosine Hydrochloride|cytosine arabinosine hydrochloride
479542|NCT01515527|Decitabine|decitabine
479543|NCT01515527|Dacogen|dacogen
479544|NCT01515527|Cladribine|cladribine
479545|NCT01515527|Leustatin|leustatin
479546|NCT01515527|2-CdA|2-cda
479547|NCT01515514|polyps|polyps
479548|NCT01515514|inflammatory bowel disease|inflammatory bowel disease
479549|NCT01515514|associated neoplasia|associated neoplasia
479550|NCT01515501|Constipation|constipation
479551|NCT01515501|Hirschsprung Disease|hirschsprung disease
479552|NCT01515488|Triage|triage
479553|NCT01515488|Automated|automated
479554|NCT01515488|Admitting|admitting
479555|NCT01515488|Pediatric ED|pediatric ed
479556|NCT01515475|Hyperopia|hyperopia
479557|NCT01515475|Glasses|glasses
479558|NCT01515462|Lentiviral vector|lentiviral vector
479559|NCT01515462|Gene therapy|gene therapy
479560|NCT01515462|Wiskott-Aldrich Syndrome|wiskott-aldrich syndrome
479561|NCT01515462|OTL-103|otl-103
479562|NCT01515462|Previously GSK2696275|previously gsk2696275
479563|NCT01515436|Rolandic Epilepsy|rolandic epilepsy
479564|NCT01515436|Benign Childhood Epilepsy with Centrotemporal Spikes (BCECTS)|benign childhood epilepsy with centrotemporal spikes (bcects)
479565|NCT01515436|Epilepsy|epilepsy
479566|NCT01515436|Seizures|seizures
479567|NCT01515436|Music|music
479568|NCT01515436|Mozart|mozart
479569|NCT01515436|Beethoven|beethoven
479570|NCT01515423|Schizophrenia|schizophrenia
479571|NCT01515423|R092670|r092670
479572|NCT01515423|Paliperidone Palmitate|paliperidone palmitate
479573|NCT01515423|Paliperidone palmitate 1 month formulation (PP1M)|paliperidone palmitate 1 month formulation (pp1m)
479574|NCT01515423|Paliperidone palmitate 3 month formulation (PP3M)|paliperidone palmitate 3 month formulation (pp3m)
479575|NCT01515410|Parkinson's disease|parkinson's disease
479576|NCT01515410|PD|pd
479577|NCT01515410|stage2/3Parkinson's|stage2/3parkinson's
479578|NCT01515410|Advanced Parkinson's Disease with Motor Fluctuations|advanced parkinson's disease with motor fluctuations
479579|NCT01515345|clopidogrel-nonresponder|clopidogrel-nonresponder
479580|NCT01515345|stent thrombosis|stent thrombosis
479581|NCT01515319|Obesity|obesity
479582|NCT01515319|Peptide YY|peptide yy
479583|NCT01515319|Food intake|food intake
479584|NCT01515319|Safety|safety
479585|NCT01515319|Pharmacokinetics|pharmacokinetics
479586|NCT01515306|Advanced Malignant Solid Tumors|advanced malignant solid tumors
479587|NCT01515280|chronic cough|chronic cough
479588|NCT01515267|EF|ef
479589|NCT01515267|EDV|edv
479590|NCT01515267|ESV|esv
479591|NCT01515267|Biplane|biplane
479592|NCT01515267|Echocardiography|echocardiography
479593|NCT01515254|Children|children
479594|NCT01515254|Obesity Prevention|obesity prevention
479595|NCT01515254|Child Overweight|child overweight
479596|NCT01515254|Energy Compensation|energy compensation
479597|NCT01515254|Eating Behavior|eating behavior
479598|NCT01515254|Food Intake|food intake
479599|NCT01515254|Parenting Behavior|parenting behavior
479600|NCT01515241|Heterozygous Familial Hypercholesterolemia|heterozygous familial hypercholesterolemia
479601|NCT01515241|Familial Hypercholesterolemia|familial hypercholesterolemia
479602|NCT01515241|HDL mimetic|hdl mimetic
479603|NCT01515241|ApoA-1|apoa-1
479604|NCT01515228|requiring drug eluting stents|requiring drug eluting stents
479605|NCT01515215|Major Depression Disorder|major depression disorder
479606|NCT01515215|Treatment Resistance|treatment resistance
479607|NCT01515215|repetitive Transcranial Magnetic Stimulation|repetitive transcranial magnetic stimulation
479608|NCT01515150|diverticulitis|diverticulitis
479609|NCT01515150|Out-patient management|out-patient management
479610|NCT01515150|Antibiotics|antibiotics
479611|NCT01515137|Head and Neck|head and neck
479612|NCT01515137|Locally Advanced Head and Neck Squamous Cell Carcinoma|locally advanced head and neck squamous cell carcinoma
479613|NCT01515124|Lymphedema|lymphedema
479614|NCT01515124|Strength training intervention|strength training intervention
479615|NCT01515124|Weight loss intervention|weight loss intervention
479616|NCT01515124|Breast cancer recurrence|breast cancer recurrence
479617|NCT01515124|Cost Effectiveness|cost effectiveness
479618|NCT01515111|Non-communicable diseases|non-communicable diseases
479619|NCT01515111|Preventive services|preventive services
479620|NCT01515111|Medical education|medical education
479621|NCT01515111|Guatemala|guatemala
479622|NCT01515072|Remote Ischemic Preconditioning|remote ischemic preconditioning
479623|NCT01515072|Brain death organ donors|brain death organ donors
479624|NCT01515072|Delayed graft function|delayed graft function
479625|NCT01515072|Donor management|donor management
479626|NCT01515072|Pulsatile perfusion|pulsatile perfusion
479627|NCT01515059|obesity|obesity
479628|NCT01515059|diabetes|diabetes
479629|NCT01515059|bariatric surgery|bariatric surgery
479630|NCT01515059|gastric bypass|gastric bypass
479631|NCT01515059|insulin|insulin
479632|NCT01515059|glucose|glucose
479633|NCT01515059|incretins|incretins
479637|NCT01515046|Complementary medicine|complementary medicine
479638|NCT01515046|Pancreatic cancer|pancreatic cancer
479639|NCT01515046|Ascorbate|ascorbate
479640|NCT01515046|Ascorbic Acid|ascorbic acid
479641|NCT01515046|Antioxidants|antioxidants
479642|NCT01515046|Gemcitabine|gemcitabine
479643|NCT01515046|Pharmacologic actions|pharmacologic actions
479644|NCT01515033|Coronary artery disease|coronary artery disease
479645|NCT01515033|Exercise|exercise
479646|NCT01515033|Ventilatory efficiency|ventilatory efficiency
479647|NCT01515020|bacteremia|bacteremia
479648|NCT01515020|meticillin-resistant Staphylococcus aureus|meticillin-resistant staphylococcus aureus
479649|NCT01515020|nosocomial infection|nosocomial infection
479650|NCT01515020|healthcare-associated infection|healthcare-associated infection
479651|NCT01515020|rapid molecular diagnostic test|rapid molecular diagnostic test
479652|NCT01515007|Bronchiectasis, non-CF, Ciprofloxacin, Liposome|bronchiectasis, non-cf, ciprofloxacin, liposome
479653|NCT01514981|Asthma|asthma
479654|NCT01514942|PCOS|pcos
479655|NCT01514942|Insulin resistance|insulin resistance
479656|NCT01514942|Myo-inositol|myo-inositol
479657|NCT01514942|D-chiro-inositol|d-chiro-inositol
479658|NCT01514929|Thorough QT|thorough qt
479659|NCT01514903|anti erectile dysfunction agent|anti erectile dysfunction agent
479660|NCT01514877|tumors metastatic to brain|tumors metastatic to brain
479661|NCT01514877|non-small cell lung cancer|non-small cell lung cancer
479662|NCT01514877|Icotinib|icotinib
479663|NCT01514851|Hyperphosphatemia in ESRD (End Stage Renal Disease) patients on dialysis|hyperphosphatemia in esrd (end stage renal disease) patients on dialysis
479664|NCT01514838|urine glucose|urine glucose
479665|NCT01514838|ipragliflozin|ipragliflozin
479666|NCT01514838|plasma glucose|plasma glucose
479667|NCT01514838|ASP1941|asp1941
479668|NCT01514825|YM150|ym150
479669|NCT01514825|Plasma concentration|plasma concentration
479670|NCT01514825|darexaban|darexaban
479671|NCT01514825|Healthy elderly subject|healthy elderly subject
479672|NCT01514825|Pharmacokinetics of YM150|pharmacokinetics of ym150
479673|NCT01514812|YM150|ym150
479674|NCT01514812|digoxin|digoxin
479675|NCT01514812|drug-drug interaction|drug-drug interaction
479676|NCT01514812|Plasma concentration|plasma concentration
479677|NCT01514812|darexaban|darexaban
479678|NCT01514812|Pharmacokinetics of digoxin|pharmacokinetics of digoxin
479679|NCT01514799|gastric bypass|gastric bypass
479680|NCT01514799|morbid obesity|morbid obesity
479681|NCT01514799|gut function|gut function
479682|NCT01514799|weight loss|weight loss
479683|NCT01514786|Colorectal Cancer|colorectal cancer
479684|NCT01514786|Screening|screening
479685|NCT01514786|Prevention|prevention
479686|NCT01514773|left ventricular systolic dysfunction|left ventricular systolic dysfunction
479687|NCT01514773|implantable cardioverter defibrillator|implantable cardioverter defibrillator
479688|NCT01514773|systolic heart failure|systolic heart failure
479689|NCT01514773|congestive heart failure|congestive heart failure
479690|NCT01514773|Ischemic cardiomyopathy|ischemic cardiomyopathy
479691|NCT01514773|Nonischemic cardiomyopathy|nonischemic cardiomyopathy
479692|NCT01514773|ICD|icd
479693|NCT01514773|ICD utilization|icd utilization
479694|NCT01514773|ICD implantation|icd implantation
479695|NCT01514773|defibrillator|defibrillator
479696|NCT01514773|defibrillator therapy|defibrillator therapy
479697|NCT01514773|sudden cardiac death|sudden cardiac death
479698|NCT01514760|Adolescents|adolescents
479699|NCT01514760|Mobile based applications|mobile based applications
479700|NCT01514760|Asthma action plan|asthma action plan
479701|NCT01514760|Self Efficacy|self efficacy
479702|NCT01514734|Primary open-angle glaucoma|primary open-angle glaucoma
479703|NCT01514734|Ocular hypertension|ocular hypertension
479704|NCT01514734|Pigment dispersion glaucoma|pigment dispersion glaucoma
479705|NCT01514721|Open-angle glaucoma|open-angle glaucoma
479706|NCT01514721|Ocular hypertension|ocular hypertension
479707|NCT01514721|Pigment dispersion glaucoma|pigment dispersion glaucoma
479708|NCT01514708|Influenza|influenza
479709|NCT01514708|Vaccination|vaccination
479710|NCT01514708|Vaccine|vaccine
479711|NCT01514708|Pregnancy|pregnancy
479712|NCT01514695|endoscopy|endoscopy
479713|NCT01514695|sedation|sedation
479714|NCT01514695|opioid|opioid
479715|NCT01514695|narcotic|narcotic
479716|NCT01514682|schizophrenia|schizophrenia
479717|NCT01514682|anti-inflammatory|anti-inflammatory
479718|NCT01514682|salsalate|salsalate
479719|NCT01514682|statins|statins
479720|NCT01514682|omega-3-fatty acids|omega-3-fatty acids
479721|NCT01514643|tibial plateau fracture|tibial plateau fracture
479722|NCT01514643|tibial plafond fracture|tibial plafond fracture
479723|NCT01514643|inflammatory cytokine profile|inflammatory cytokine profile
479724|NCT01514643|synovial fluid|synovial fluid
479725|NCT01514643|blood serum|blood serum
479726|NCT01514643|Post-traumatic osteoarthritis (PTOA)|post-traumatic osteoarthritis (ptoa)
479727|NCT01514617|Leiomyoma|leiomyoma
479728|NCT01514617|Diffusion weighted MRI|diffusion weighted mri
479729|NCT01514617|Perfusion MRI|perfusion mri
479730|NCT01514617|Uterine artery embolization|uterine artery embolization
479731|NCT01514617|Volumetric Response|volumetric response
479732|NCT01514617|Women with symptomatic leiomyomas|women with symptomatic leiomyomas
479733|NCT01514604|Anesthesia and analgesia|anesthesia and analgesia
479734|NCT01514604|ultrasonography|ultrasonography
479735|NCT01514604|education|education
479736|NCT01514578|safety|safety
479737|NCT01514578|tolerability|tolerability
479738|NCT01514578|TRV130A|trv130a
479739|NCT01514565|Triple negative Breast Cancer|triple negative breast cancer
479740|NCT01514565|RB|rb
479741|NCT01514565|PTEN|pten
479742|NCT01514565|Chemotherapy|chemotherapy
479743|NCT01514565|Neoadjuvant|neoadjuvant
479744|NCT01514552|Functional food|functional food
479745|NCT01514552|Strawberries|strawberries
479746|NCT01514552|Gummies|gummies
479747|NCT01514552|Smoker|smoker
479748|NCT01514552|Nonsmoker|nonsmoker
479749|NCT01514539|Human milk, Ghrelin,PYY and maternal obesity.|human milk, ghrelin,pyy and maternal obesity.
479750|NCT01514526|Adrenocortical carcinoma|adrenocortical carcinoma
479751|NCT01514461|Hyperlipoproteinemia (HLP Type I)|hyperlipoproteinemia (hlp type i)
479752|NCT01514461|Fasting Triglycerides|fasting triglycerides
479753|NCT01514448|Kidney cancer|kidney cancer
479754|NCT01514448|mRCC|mrcc
479755|NCT01514448|metastic renal cell carcinoma|metastic renal cell carcinoma
479756|NCT01514448|everolimus|everolimus
479757|NCT01514448|sunitinib|sunitinib
479758|NCT01514448|pazopanib|pazopanib
479759|NCT01514435|depression|depression
479760|NCT01514435|FDG-PET|fdg-pet
479761|NCT01514435|Electroconvulsive therapy|electroconvulsive therapy
479762|NCT01514435|glucose metabolism|glucose metabolism
479763|NCT01514422|Bipolar disorder|bipolar disorder
479764|NCT01514422|depression|depression
479765|NCT01514422|minocycline|minocycline
479766|NCT01514422|mood disorders|mood disorders
479767|NCT01514422|bipolar depression|bipolar depression
479768|NCT01514409|5-hydroxytryptophan|5-hydroxytryptophan
479769|NCT01514409|Mood|mood
479770|NCT01514409|Emotional Processing|emotional processing
479771|NCT01514409|Emotional Cognition|emotional cognition
479772|NCT01514409|Nutritional Supplement|nutritional supplement
479773|NCT01514409|Low mood|low mood
479774|NCT01514396|Pediatric|pediatric
479775|NCT01514396|Wounds|wounds
479776|NCT01514383|wounds|wounds
479777|NCT01514370|Multiple Sclerosis|multiple sclerosis
479778|NCT01514370|Relapsing|relapsing
479779|NCT01514370|Interferon beta 1a|interferon beta 1a
479780|NCT01514370|Curcumin|curcumin
479781|NCT01514344|OAL|oal
479782|NCT01514344|MALT|malt
479783|NCT01514344|conjunctiva|conjunctiva
479784|NCT01514344|indolent|indolent
479785|NCT01514344|CD20+|cd20+
479786|NCT01514331|Ventilator Induced Lung Injury|ventilator induced lung injury
479787|NCT01514331|Neonatal respiratory distress|neonatal respiratory distress
479788|NCT01514331|Mechanical ventilation|mechanical ventilation
479789|NCT01514279|Overweight|overweight
479790|NCT01514279|Obese|obese
479791|NCT01514279|Over Nutrition|over nutrition
479792|NCT01514279|Nutrition Disorders|nutrition disorders
479793|NCT01514279|Body weight|body weight
479794|NCT01514279|Signs and Symptoms|signs and symptoms
479795|NCT01514266|proven diagnosis|proven diagnosis
479796|NCT01514266|COPD|copd
479797|NCT01514266|sputum|sputum
479798|NCT01514253|glucose|glucose
479799|NCT01514253|analgesic|analgesic
479800|NCT01514253|newborns|newborns
479801|NCT01514240|mild to moderate active Crohn's disease|mild to moderate active crohn's disease
479802|NCT01514240|affecting ileum|affecting ileum
479803|NCT01514240|ileocecal region|ileocecal region
479804|NCT01514240|ascending colon|ascending colon
479805|NCT01514240|score of 180-400 on the CDAI|score of 180-400 on the cdai
479806|NCT01514214|ERCP|ercp
479807|NCT01514214|biliary stricture|biliary stricture
479808|NCT01514214|viaduct|viaduct
479809|NCT01514214|cancer|cancer
479810|NCT01514188|sarcoma|sarcoma
479811|NCT01514188|soft-tissue sarcoma|soft-tissue sarcoma
479812|NCT01514188|Metastatic,locally advanced, or unresectable soft tissue sarcoma|metastatic,locally advanced, or unresectable soft tissue sarcoma
479813|NCT01514175|Ketorolac|ketorolac
479814|NCT01514175|Caldolor|caldolor
479815|NCT01514175|Chronic Pelvic Pain|chronic pelvic pain
479816|NCT01514162|Trifecta Valve|trifecta valve
479817|NCT01514149|Type 2 Diabetes Mellitus|type 2 diabetes mellitus
479818|NCT01514149|T2DM|t2dm
479819|NCT01514149|diabetes|diabetes
479820|NCT01514149|ConjuChem|conjuchem
479821|NCT01514149|GLP-1|glp-1
479822|NCT01514149|Glucagon-like peptide-1|glucagon-like peptide-1
479823|NCT01514149|exendin-4|exendin-4
479824|NCT01514149|modified exendin-4|modified exendin-4
479825|NCT01514123|VGX-100|vgx-100
479826|NCT01514123|Bevacizumab|bevacizumab
479827|NCT01514123|VEGF-C|vegf-c
479828|NCT01514123|First-In-Human|first-in-human
479829|NCT01514123|Dose Escalation|dose escalation
479830|NCT01514123|Advanced Solid Tumors|advanced solid tumors
479831|NCT01514123|Angiogenesis Inhibitors|angiogenesis inhibitors
479832|NCT01514123|Angiogenesis Modulating Agents|angiogenesis modulating agents
479833|NCT01514123|Pharmacologic Actions|pharmacologic actions
479834|NCT01514123|Antibodies, Monoclonal|antibodies, monoclonal
479835|NCT01514123|Phase 1|phase 1
479836|NCT01514123|Oncology|oncology
479837|NCT01514123|Advanced malignancy|advanced malignancy
479840|NCT01514097|fracture|fracture
479841|NCT01514097|pain|pain
479842|NCT01514084|laceration|laceration
479843|NCT01514084|emergency|emergency
479844|NCT01514084|cosmetic outcomes|cosmetic outcomes
479845|NCT01514084|patient satisfaction|patient satisfaction
479846|NCT01514084|suture|suture
479847|NCT01514071|head injury|head injury
479848|NCT01514071|CT|ct
479849|NCT01514071|emergency|emergency
479850|NCT01514071|radiation|radiation
479851|NCT01514045|Quality of Life|quality of life
479852|NCT01514019|SLCO2B1 genotype|slco2b1 genotype
479853|NCT01514019|effect of apple juice|effect of apple juice
479854|NCT01514006|Primary hip arthroplasty|primary hip arthroplasty
479855|NCT01514006|postoperative anemia|postoperative anemia
479856|NCT01514006|functional outcomes|functional outcomes
479857|NCT01513993|CHF|chf
479858|NCT01513993|Telemonitoring|telemonitoring
479859|NCT01513980|Chronic Obstructive Pulmonary Disease|chronic obstructive pulmonary disease
479860|NCT01513980|Telemonitoring|telemonitoring
479861|NCT01513967|Alzheimer,|alzheimer,
479862|NCT01513967|dementia|dementia
479863|NCT01513954|Infertility|infertility
479864|NCT01513941|Chronic hepatitis C|chronic hepatitis c
479865|NCT01513941|Genotype 1 chronic hepatitis C|genotype 1 chronic hepatitis c
479866|NCT01513941|Treatment experienced with HCV-1/HIV-1 coinfection|treatment experienced with hcv-1/hiv-1 coinfection
479867|NCT01513941|Telaprevir|telaprevir
479868|NCT01513941|Pegylated-Interferon-alfa-2a|pegylated-interferon-alfa-2a
479869|NCT01513941|Ribavirin|ribavirin
479870|NCT01513941|HCV-1/HIV-1 coinfection|hcv-1/hiv-1 coinfection
479871|NCT01513941|Hepatitis C|hepatitis c
479872|NCT01513928|pharmacokinetics|pharmacokinetics
479873|NCT01513928|relative bioavailability|relative bioavailability
479874|NCT01513928|formulation comparison|formulation comparison
479875|NCT01513915|parents|parents
479876|NCT01513915|group cognitive behavioral intervention|group cognitive behavioral intervention
479877|NCT01513915|anxiety disorder|anxiety disorder
479878|NCT01513915|children|children
479879|NCT01513915|FRIENDS program|friends program
479880|NCT01513902|Arthritis|arthritis
611957|NCT00970905|Nausea|nausea
479881|NCT01513902|Pediatric|pediatric
479882|NCT01513902|Tofacitinib|tofacitinib
479883|NCT01513902|JIA|jia
479884|NCT01513850|Liver Transplantation|liver transplantation
479885|NCT01513850|HBV|hbv
479886|NCT01513850|HBV Recurrence|hbv recurrence
479887|NCT01513850|HBsAg Positive|hbsag positive
479888|NCT01513824|stress|stress
479889|NCT01513824|biofeed back guided treatment|biofeed back guided treatment
479890|NCT01513824|acupressure|acupressure
479891|NCT01513824|ischemic heart disease|ischemic heart disease
479892|NCT01513811|bowel preparation|bowel preparation
479893|NCT01513811|constipation|constipation
479894|NCT01513811|polyethylene glycol|polyethylene glycol
479895|NCT01513811|itopride|itopride
479896|NCT01513798|Diet Therapy|diet therapy
479897|NCT01513798|Exercise Therapy|exercise therapy
479898|NCT01513798|Insulin Resistance|insulin resistance
479899|NCT01513785|H. pylori|h. pylori
479900|NCT01513785|Dual therapy|dual therapy
479901|NCT01513785|Amoxicillin|amoxicillin
479902|NCT01513785|Rabeprazole|rabeprazole
479903|NCT01513759|Fibrinolysis|fibrinolysis
479904|NCT01513759|catheter directed fibrinolysis|catheter directed fibrinolysis
479905|NCT01513759|ultrasound accelerated fibrinolysis|ultrasound accelerated fibrinolysis
479906|NCT01513759|recombinant t-PA|recombinant t-pa
479907|NCT01513759|Activase|activase
479908|NCT01513746|Type 1 Diabetes|type 1 diabetes
479909|NCT01513746|Type 1 Diabetes Mellitus|type 1 diabetes mellitus
479910|NCT01513746|Eating Disorders|eating disorders
479911|NCT01513746|Insulin Omission|insulin omission
479912|NCT01513720|Bioequivalence|bioequivalence
479913|NCT01513720|Lamotrigine|lamotrigine
479914|NCT01513720|crossover|crossover
479915|NCT01513707|kidney transplantation|kidney transplantation
479916|NCT01513707|hemodialysis|hemodialysis
479917|NCT01513707|peritoneal dialysis|peritoneal dialysis
479918|NCT01513694|Mesenchymal Stem Cells|mesenchymal stem cells
479919|NCT01513694|Stem Cells|stem cells
479920|NCT01513694|Intervertebral disc disease|intervertebral disc disease
479921|NCT01513681|Bioequivalence|bioequivalence
479922|NCT01513681|Lamotrigine|lamotrigine
479923|NCT01513681|crossover|crossover
479924|NCT01513655|COPD|copd
479925|NCT01513655|Home NIV|home niv
479926|NCT01513655|NIV|niv
479927|NCT01513642|physiotherapy|physiotherapy
479928|NCT01513642|cardiac surgery|cardiac surgery
479929|NCT01513642|breath Stacking|breath stacking
479930|NCT01513629|Autism spectrum disorders|autism spectrum disorders
479931|NCT01513629|structural connectivity|structural connectivity
479932|NCT01513629|diffusion spectrum imaging|diffusion spectrum imaging
479933|NCT01513629|sibling|sibling
479934|NCT01513629|endophenotype|endophenotype
479935|NCT01513616|COPD|copd
479936|NCT01513616|dyspnea|dyspnea
479937|NCT01513616|exercise|exercise
479938|NCT01513616|measurement|measurement
479939|NCT01513616|respiratory physiology|respiratory physiology
479940|NCT01513577|Lumbar fusion|lumbar fusion
479941|NCT01513577|Pedicular screws|pedicular screws
479942|NCT01513577|Minimal invasive technique|minimal invasive technique
479943|NCT01513577|Randomized controlled trial|randomized controlled trial
479944|NCT01513564|Disc disease|disc disease
479945|NCT01513564|Spondylolisthesis|spondylolisthesis
479946|NCT01513551|Pneumococcal vaccines|pneumococcal vaccines
479947|NCT01513538|Pacemaker programming|pacemaker programming
479948|NCT01513538|Bradyarrhythmia|bradyarrhythmia
479949|NCT01513499|Eating behavior|eating behavior
479950|NCT01513499|Appetite|appetite
479951|NCT01513499|Oxytocin|oxytocin
479952|NCT01513499|Neuropeptide|neuropeptide
479953|NCT01513460|Chronic Obstructive Pulmonary Disease,|chronic obstructive pulmonary disease,
479954|NCT01513460|NVA 237,|nva 237,
479955|NCT01513460|glycopyrronium,|glycopyrronium,
479956|NCT01513460|COPD|copd
479957|NCT01513447|sterile water injections|sterile water injections
479958|NCT01513447|back labor|back labor
479959|NCT01513421|Infected|infected
479960|NCT01513421|Intra-abdominal|intra-abdominal
479961|NCT01513421|Collection|collection
479962|NCT01513421|Drainage|drainage
479963|NCT01513421|Percutaneous|percutaneous
479964|NCT01513408|breast cancer|breast cancer
479965|NCT01513408|CD8+|cd8+
479966|NCT01513408|Foxp3|foxp3
479967|NCT01513408|neoadjuvant chemotherapy|neoadjuvant chemotherapy
479968|NCT01513395|Cervical assessment|cervical assessment
479969|NCT01513395|Focal myometrial contractions|focal myometrial contractions
479970|NCT01513382|Pilonidal sinus|pilonidal sinus
479971|NCT01513382|Methylene blue|methylene blue
479972|NCT01513382|Histopathology|histopathology
479973|NCT01513382|Surgery|surgery
479974|NCT01513369|Diabetes|diabetes
479975|NCT01513369|iron deficiency|iron deficiency
479976|NCT01513356|breast|breast
479977|NCT01513356|cancer|cancer
479978|NCT01513356|BKM120|bkm120
479979|NCT01513317|Myelodysplastic Syndrome|myelodysplastic syndrome
479980|NCT01513317|MDS|mds
479981|NCT01513317|Blood and lymphatic diseases|blood and lymphatic diseases
479982|NCT01513317|Siltuximab|siltuximab
479983|NCT01513317|Anemic|anemic
479984|NCT01513265|reduction polypharmacy|reduction polypharmacy
479985|NCT01513265|clinical outcomes|clinical outcomes
479986|NCT01513265|pharmaceutical care|pharmaceutical care
479987|NCT01513265|clinical pharmacy|clinical pharmacy
479988|NCT01513265|geriatrics|geriatrics
479989|NCT01513265|medication review|medication review
479990|NCT01513265|potentially inappropriate drugs|potentially inappropriate drugs
479991|NCT01513252|Cognitive decline|cognitive decline
479992|NCT01513252|prevention|prevention
479993|NCT01513252|omega-3 fatty acids|omega-3 fatty acids
479994|NCT01513252|nutrition exercise|nutrition exercise
479995|NCT01513252|cognitive training|cognitive training
479996|NCT01513252|social activities|social activities
479997|NCT01513252|frailty|frailty
479998|NCT01513239|Clostridium difficile|clostridium difficile
479999|NCT01513239|Clostridium difficile infection (CDI)|clostridium difficile infection (cdi)
480000|NCT01513239|recurrent Clostridium difficile|recurrent clostridium difficile
480001|NCT01513239|vancomycin|vancomycin
480002|NCT01513239|metronidazole|metronidazole
480003|NCT01513239|monoclonal antibody|monoclonal antibody
480004|NCT01513226|cycled light|cycled light
480005|NCT01513226|dim light|dim light
480006|NCT01513226|circadian rhythm|circadian rhythm
480007|NCT01513226|actigraphy, sleep|actigraphy, sleep
480008|NCT01513226|premature infant|premature infant
480009|NCT01513213|Arterial cannulation|arterial cannulation
480010|NCT01513213|Blood gas|blood gas
480011|NCT01513213|Carbon dioxide|carbon dioxide
480012|NCT01513213|Arterial blood|arterial blood
480013|NCT01513213|Oxygen|oxygen
480014|NCT01513213|Oxygen fractions|oxygen fractions
480015|NCT01513187|Advanced renal cell carcinoma|advanced renal cell carcinoma
480016|NCT01513187|SOGUG|sogug
480017|NCT01513187|Pazopanib|pazopanib
480018|NCT01513187|Pazopanib in combination with interferon alpha 2A|pazopanib in combination with interferon alpha 2a
480019|NCT01513174|GOAL|goal
480020|NCT01513174|Lung|lung
480021|NCT01513174|Non small cell lung cancer|non small cell lung cancer
480022|NCT01513174|EGFR mutations|egfr mutations
480023|NCT01513161|pruritus|pruritus
480024|NCT01513135|HIV,|hiv,
480025|NCT01513135|HAART-treated|haart-treated
480026|NCT01513135|participants|participants
480027|NCT01513135|Tat protein,|tat protein,
480028|NCT01513135|Therapeutic immunization|therapeutic immunization
480029|NCT01513109|WT1 positive Acute Myeloid Leukemia|wt1 positive acute myeloid leukemia
480030|NCT01513109|Antigen specific cancer immunotherapeutic|antigen specific cancer immunotherapeutic
480031|NCT01513109|Ex vivo regulatory T cell depletion|ex vivo regulatory t cell depletion
480032|NCT01513109|In vivo regulatory T cell depletion|in vivo regulatory t cell depletion
480033|NCT01513096|colonoscopy|colonoscopy
480034|NCT01513096|bowel preparation|bowel preparation
480035|NCT01513096|PEG|peg
480036|NCT01513096|Prokinetics|prokinetics
480037|NCT01513070|Quick-Acting Heart Reliever|quick-acting heart reliever
480038|NCT01513070|Coronary Artery Stenosis|coronary artery stenosis
480039|NCT01513070|Coronary Heart Disease|coronary heart disease
480040|NCT01513070|Suxiao Jiuxin Pill|suxiao jiuxin pill
480041|NCT01513070|Chinese Herbal Drugs|chinese herbal drugs
480042|NCT01513070|Traditional Chinese Medicine|traditional chinese medicine
480043|NCT01513070|Chinese Medicine|chinese medicine
480044|NCT01513070|Angina Pectoris|angina pectoris
480045|NCT01513070|Isosorbide Dinitrate|isosorbide dinitrate
480046|NCT01513070|Myocardial Perfusion Imaging|myocardial perfusion imaging
480047|NCT01513070|Clinical Trial|clinical trial
480048|NCT01513057|bioequivalence|bioequivalence
480049|NCT01513057|Mycophenolate Mofetil|mycophenolate mofetil
480050|NCT01513057|crossover|crossover
480051|NCT01513044|bioequivalence|bioequivalence
480052|NCT01513044|Mycophenolate Mofetil|mycophenolate mofetil
480053|NCT01513044|crossover|crossover
480054|NCT01513031|Atrial fibrillation|atrial fibrillation
480055|NCT01513031|Anti-arrhythmic medication|anti-arrhythmic medication
480056|NCT01513031|Medication adherence|medication adherence
480057|NCT01513018|OLV|olv
480058|NCT01513018|one lung ventilation|one lung ventilation
480059|NCT01513005|Laparoscopic Sleeve Gastrectomy|laparoscopic sleeve gastrectomy
480060|NCT01513005|obesity management|obesity management
480061|NCT01512966|Diabetic Macular Edema|diabetic macular edema
480062|NCT01512966|DME|dme
480063|NCT01512966|VEGF Trap-Eye|vegf trap-eye
480064|NCT01512966|best-corrected visual acuity (BCVA)|best-corrected visual acuity (bcva)
480065|NCT01512953|PPI|ppi
480066|NCT01512953|clopidogrel|clopidogrel
480067|NCT01512953|2C19|2c19
480068|NCT01512953|Lansoprazole|lansoprazole
480069|NCT01512940|obesity|obesity
480070|NCT01512940|Laparoscopic Greater Curvature Plication|laparoscopic greater curvature plication
480071|NCT01512940|Percent Excess weight Loss|percent excess weight loss
480072|NCT01512940|comorbidities|comorbidities
480073|NCT01512940|BMI|bmi
480074|NCT01512940|Bariatric Surgery|bariatric surgery
480075|NCT01512927|electronic stethoscope|electronic stethoscope
480076|NCT01512927|arteriovenous fistula|arteriovenous fistula
480077|NCT01512927|hemodialysis,|hemodialysis,
480078|NCT01512914|Gynecologic laparoscopic surgery|gynecologic laparoscopic surgery
480079|NCT01512914|Postoperative pain|postoperative pain
480080|NCT01512914|Nebulization|nebulization
480081|NCT01512914|Ropivacaine|ropivacaine
480082|NCT01512888|SCID|scid
480083|NCT01512888|SCID-X1|scid-x1
480084|NCT01512888|X-linked SCID|x-linked scid
480085|NCT01512888|immunodeficiency|immunodeficiency
480086|NCT01512888|gene therapy|gene therapy
480087|NCT01512875|Helicobacter pylori|helicobacter pylori
480088|NCT01512875|water contamination|water contamination
480089|NCT01512875|Lima, Peru|lima, peru
480090|NCT01512862|Calcitriol|calcitriol
480091|NCT01512862|Off-label|off-label
480092|NCT01512849|TA-7284|ta-7284
480093|NCT01512849|JNJ-28431754|jnj-28431754
480094|NCT01512849|Canagliflozin|canagliflozin
480095|NCT01512849|Renal Impairment|renal impairment
480096|NCT01512849|Sodium Glucose Co-transporter2 (SGLT2) inhibitor|sodium glucose co-transporter2 (sglt2) inhibitor
480097|NCT01512836|COPD|copd
480098|NCT01512836|Case management|case management
480099|NCT01512836|CEA|cea
480100|NCT01512836|Health economy|health economy
480101|NCT01512836|Quality of Life|quality of life
480102|NCT01512823|randomised controlled trial|randomised controlled trial
480103|NCT01512823|educational intervention|educational intervention
480104|NCT01512823|occupational therapy|occupational therapy
480105|NCT01512810|Endometrial|endometrial
480106|NCT01512810|Cancer|cancer
480107|NCT01512810|Intraoperative Consultation|intraoperative consultation
480108|NCT01512797|Januvia|januvia
480109|NCT01512797|Sitagliptin|sitagliptin
480110|NCT01512797|Diabetes|diabetes
480111|NCT01512797|Gastric-Bypass|gastric-bypass
480112|NCT01512784|Quadrivalent Human Papillomavirus Vaccine (HPV) Gardasil|quadrivalent human papillomavirus vaccine (hpv) gardasil
480113|NCT01512784|HIV infection|hiv infection
480114|NCT01512784|Evaluation of quadrivalent HPV vaccine in adolescents and young adults.|evaluation of quadrivalent hpv vaccine in adolescents and young adults.
480115|NCT01512758|East Asian Patients|east asian patients
480116|NCT01512758|Advanced solid tumors|advanced solid tumors
480117|NCT01512758|Lymphomas|lymphomas
480118|NCT01512758|MLN8237|mln8237
480119|NCT01512758|Alisertib|alisertib
480120|NCT01512758|Aurora A Kinase Inhibitor|aurora a kinase inhibitor
480121|NCT01512758|Drug therapy|drug therapy
480122|NCT01512706|Human Enterovirus 71 (EV71)|human enterovirus 71 (ev71)
480123|NCT01512706|Hand, Foot and Mouth Disease|hand, foot and mouth disease
480124|NCT01512706|Inactivated Vaccine|inactivated vaccine
480125|NCT01512706|Human Diploid cell|human diploid cell
480126|NCT01512706|Safety|safety
480127|NCT01512706|Immunogenicity|immunogenicity
480128|NCT01512706|Adverse reactions associated with vaccine|adverse reactions associated with vaccine
480129|NCT01512680|Functional Insulin Thearpy|functional insulin thearpy
480130|NCT01512680|Carbs counting|carbs counting
480131|NCT01512680|Type 1 diabetes mellitus|type 1 diabetes mellitus
480132|NCT01512680|Insulin pump|insulin pump
480133|NCT01512680|Treatment by external insulin pump|treatment by external insulin pump
480134|NCT01512654|diabetes|diabetes
480135|NCT01512654|diadvisor|diadvisor
480136|NCT01512654|type 1 diabetes|type 1 diabetes
480137|NCT01512654|type 2 diabetes|type 2 diabetes
480138|NCT01512654|glucose prediction|glucose prediction
480139|NCT01512654|cgm prediction|cgm prediction
480140|NCT01512654|algorithm|algorithm
480141|NCT01512654|therapy advices|therapy advices
480142|NCT01512641|children dissociative disorders schizophrenia|children dissociative disorders schizophrenia
480143|NCT01512615|Rehabilitation|rehabilitation
480144|NCT01512615|Exercise training|exercise training
480145|NCT01512615|Psycho-educational care|psycho-educational care
480146|NCT01512602|Borderline Personality Disorder traits|borderline personality disorder traits
480147|NCT01512602|Suicide prevention|suicide prevention
480148|NCT01512602|Self-harm|self-harm
480149|NCT01512602|Dialectical Behavior Therapy|dialectical behavior therapy
480150|NCT01512602|DBT|dbt
480151|NCT01512602|Collaborative Assessment and Management of Suicidology|collaborative assessment and management of suicidology
480152|NCT01512602|CAMS|cams
480153|NCT01512589|Proton Beam Therapy|proton beam therapy
480154|NCT01512589|PBT|pbt
480155|NCT01512589|Intensity-Modulated Radiation Therapy|intensity-modulated radiation therapy
480156|NCT01512589|IMRT|imrt
480157|NCT01512589|Esophageal cancer|esophageal cancer
480158|NCT01512589|Adenocarcinoma|adenocarcinoma
480159|NCT01512589|Squamous cell carcinoma|squamous cell carcinoma
480160|NCT01512589|Cervical esophagus|cervical esophagus
480161|NCT01512589|Thoracic esophagus|thoracic esophagus
480162|NCT01512589|Gastroesophageal junction|gastroesophageal junction
480163|NCT01512589|Cardia of stomach|cardia of stomach
480164|NCT01512589|Questionnaires|questionnaires
480165|NCT01512589|Surveys|surveys
480166|NCT01512589|Symptom scores|symptom scores
480167|NCT01512589|Quality of life|quality of life
480168|NCT01512589|QOL|qol
480169|NCT01512576|whiplash|whiplash
480170|NCT01512576|chronic pain|chronic pain
480171|NCT01512576|sensitization|sensitization
480172|NCT01512576|treatment|treatment
480173|NCT01512576|acupuncture|acupuncture
480174|NCT01512576|relaxation|relaxation
480175|NCT01512563|paclitaxel|paclitaxel
480176|NCT01512563|drug eluting stent|drug eluting stent
480177|NCT01512550|Radiostereometric Analysis (RSA)|radiostereometric analysis (rsa)
480178|NCT01512550|Total hip arthroplasty (THA)|total hip arthroplasty (tha)
480179|NCT01512550|Hip anatomy|hip anatomy
480180|NCT01512550|Hip biomechanics|hip biomechanics
480181|NCT01512537|Vitamin D|vitamin d
480182|NCT01512537|UVB|uvb
480183|NCT01512537|Vitamin D supplementation|vitamin d supplementation
480184|NCT01512524|Traumatic Brain Injury|traumatic brain injury
480185|NCT01512524|Quality of Life (QoL)|quality of life (qol)
480186|NCT01512524|hypopituitarism,GH|hypopituitarism,gh
480187|NCT01512511|laparoscopic cholecystectomy|laparoscopic cholecystectomy
480188|NCT01512511|pneumoperitoneum|pneumoperitoneum
480189|NCT01512511|nitrous oxide|nitrous oxide
480190|NCT01512511|carbon dioxide|carbon dioxide
480191|NCT01512498|VV GVHD|vv gvhd
480192|NCT01512498|girls|girls
480193|NCT01512498|adolescents|adolescents
480194|NCT01512498|HSCT|hsct
480195|NCT01512485|Bioequivalence|bioequivalence
480196|NCT01512485|Clopidogrel|clopidogrel
480197|NCT01512485|crossover|crossover
480198|NCT01512472|localized prostate cancer|localized prostate cancer
480199|NCT01512472|degarelix|degarelix
480200|NCT01512472|intermittent androgen deprivation therapy|intermittent androgen deprivation therapy
480201|NCT01512459|Bioavailability|bioavailability
480202|NCT01512459|Venlafaxine|venlafaxine
480203|NCT01512459|two way crossover|two way crossover
480204|NCT01512446|Osteoporosis|osteoporosis
480205|NCT01512446|Osteoporotic fractures|osteoporotic fractures
480206|NCT01512446|Bisphosphonate|bisphosphonate
480207|NCT01512446|Pretreatment with bisphosphonates|pretreatment with bisphosphonates
480208|NCT01512433|acupuncture|acupuncture
480209|NCT01512433|methadone|methadone
480210|NCT01512407|Hepatocellular Carcinoma|hepatocellular carcinoma
480211|NCT01512407|Randomised controlled trial|randomised controlled trial
480212|NCT01512407|Transarterial chemoembolisation|transarterial chemoembolisation
480213|NCT01512394|bowel preparation|bowel preparation
480214|NCT01512381|heart failure|heart failure
480215|NCT01512381|CRT|crt
480216|NCT01512381|atrial fibrillation|atrial fibrillation
480217|NCT01512381|AV junction ablation|av junction ablation
480218|NCT01512368|Fibroblast growth factor 21 (FGF21)|fibroblast growth factor 21 (fgf21)
480219|NCT01512368|Exercise|exercise
480220|NCT01512368|Metabolic equivalents (METs)|metabolic equivalents (mets)
480221|NCT01512368|Lipolysis|lipolysis
480222|NCT01512368|Glucose|glucose
480223|NCT01512368|Free fatty acids (FFAs)|free fatty acids (ffas)
480224|NCT01512368|Epinephrine|epinephrine
480225|NCT01512342|pacing|pacing
480226|NCT01512342|activity management|activity management
480227|NCT01512342|relaxation|relaxation
480228|NCT01512342|physiotherapy|physiotherapy
480229|NCT01512342|occupational therapy|occupational therapy
480230|NCT01512342|autonomic nervous system|autonomic nervous system
480231|NCT01512329|neurology|neurology
480232|NCT01512329|physiotherapy|physiotherapy
480233|NCT01512329|physical therapy|physical therapy
480234|NCT01512329|occupational therapy|occupational therapy
480235|NCT01512329|stress management|stress management
480236|NCT01512329|activity management|activity management
480237|NCT01512329|treatment|treatment
480238|NCT01512316|Fear|fear
480239|NCT01512316|Cycloserine|cycloserine
480240|NCT01512316|Conditioning|conditioning
480241|NCT01512316|Functional neuroimaging|functional neuroimaging
480242|NCT01512316|Anxiety disorders|anxiety disorders
480243|NCT01512303|PTSD|ptsd
480244|NCT01512303|Veterans' Health|veterans' health
480245|NCT01512303|Meditation|meditation
480246|NCT01512303|MRI, Functional|mri, functional
480247|NCT01512290|Auditory verbal hallucinations|auditory verbal hallucinations
480248|NCT01512290|Transcranial Magnetic stimulation|transcranial magnetic stimulation
480249|NCT01512290|Theta Burst frequency|theta burst frequency
480250|NCT01512277|vaccines|vaccines
480251|NCT01512277|safety|safety
480252|NCT01512277|drug tolerance|drug tolerance
480253|NCT01512277|immunogenic protein|immunogenic protein
480254|NCT01512277|antibody response|antibody response
480255|NCT01512277|cytokine|cytokine
480256|NCT01512264|Aphasia|aphasia
480257|NCT01512264|Stroke|stroke
480258|NCT01512264|functional Magnetic resonance imaging|functional magnetic resonance imaging
480259|NCT01512264|fMRI|fmri
480260|NCT01512264|Language recovery after stroke|language recovery after stroke
480261|NCT01512264|constraint induced aphasia therapy|constraint induced aphasia therapy
480262|NCT01512264|CIAT|ciat
480263|NCT01512264|Repetitive transcranial magnetic stimulation|repetitive transcranial magnetic stimulation
480264|NCT01512264|rTMS|rtms
480265|NCT01512251|BKM120|bkm120
480266|NCT01512251|BRAF|braf
480267|NCT01512251|Melanoma|melanoma
480268|NCT01512251|PI3K|pi3k
480269|NCT01512238|Medicine adherence|medicine adherence
480270|NCT01512238|Drug substitution|drug substitution
480271|NCT01512238|Herb-drug interaction|herb-drug interaction
480272|NCT01512238|Herbal medicine|herbal medicine
480273|NCT01512238|Dietary supplements|dietary supplements
480274|NCT01512238|Over-the-counter products|over-the-counter products
480275|NCT01512238|On-line prescription records|on-line prescription records
480276|NCT01512238|Personal electronic medicine profile|personal electronic medicine profile
480277|NCT01512238|Intentional non-adherence|intentional non-adherence
480278|NCT01512238|Unintentional non-adherence|unintentional non-adherence
480279|NCT01512225|breastmilk|breastmilk
480280|NCT01512225|domperidone|domperidone
480281|NCT01512225|preterm|preterm
480282|NCT01512212|thyroid|thyroid
480283|NCT01512212|fine|fine
480284|NCT01512212|needle|needle
480285|NCT01512212|aspiration|aspiration
480286|NCT01512212|biopsy|biopsy
480287|NCT01512212|new|new
480288|NCT01512212|technique|technique
480289|NCT01512199|U3-1287|u3-1287
480290|NCT01512199|Trastuzumab|trastuzumab
480291|NCT01512199|Paclitaxel|paclitaxel
480292|NCT01512199|newly diagnosed HER-2 positive|newly diagnosed her-2 positive
480293|NCT01512199|breast cancer|breast cancer
480294|NCT01512199|metastatic|metastatic
480295|NCT01512186|Clear cell renal cancer|clear cell renal cancer
480296|NCT01512173|Propranolol gel|propranolol gel
480297|NCT01512173|Hemangioma|hemangioma
480298|NCT01512173|capillary neoplasm|capillary neoplasm
480299|NCT01512173|vascular tissue|vascular tissue
480300|NCT01512173|neoplasm by histologic type|neoplasm by histologic type
480301|NCT01512173|neoplasm|neoplasm
480302|NCT01512173|therapeutic uses|therapeutic uses
480303|NCT01512173|pharmacologic actions|pharmacologic actions
480304|NCT01512173|adrenergic beta-antagonists|adrenergic beta-antagonists
480305|NCT01512173|adrenergic antagonist|adrenergic antagonist
480306|NCT01512173|adrenergics agent|adrenergics agent
480307|NCT01512173|neurotransmitter agent|neurotransmitter agent
480308|NCT01512173|molecular mechanism of pharmacological action|molecular mechanism of pharmacological action
480309|NCT01512173|physiological effects of drugs|physiological effects of drugs
480310|NCT01512160|Post-surgical dental pain|post-surgical dental pain
480311|NCT01512147|SSEP measurements|ssep measurements
480312|NCT01512147|MEP measurements|mep measurements
480313|NCT01512147|Pediatric Patients|pediatric patients
480314|NCT01512147|Neurosurgery|neurosurgery
480315|NCT01512147|General Anesthesia|general anesthesia
480316|NCT01512134|Obesity|obesity
480317|NCT01512134|DBS|dbs
480318|NCT01512082|Pain|pain
480319|NCT01512082|Delayed onset muscle soreness|delayed onset muscle soreness
480320|NCT01512082|Pulsed electromagnetic field|pulsed electromagnetic field
480321|NCT01512082|Marathon|marathon
480322|NCT01512069|randomized controlled trial|randomized controlled trial
480323|NCT01512069|internet|internet
480324|NCT01512069|diet|diet
480325|NCT01512069|exercise|exercise
480326|NCT01512069|health planning|health planning
480327|NCT01512069|the TTM|the ttm
480328|NCT01512056|Influenza vaccine|influenza vaccine
480329|NCT01512056|dialysis|dialysis
480330|NCT01512056|vaccine|vaccine
480331|NCT01512056|Seroprotection|seroprotection
480332|NCT01512056|Seroresponse|seroresponse
480333|NCT01512056|Seroconversion|seroconversion
480334|NCT01512056|Safety of the vaccine|safety of the vaccine
480335|NCT01512043|Breathlessness|breathlessness
480336|NCT01512043|Symptoms|symptoms
480337|NCT01512043|Quality of life|quality of life
480338|NCT01512017|skin lesions or defects|skin lesions or defects
480339|NCT01512004|Overactive Bladder|overactive bladder
480340|NCT01512004|urgent micturition|urgent micturition
480341|NCT01512004|frequent micturition|frequent micturition
480342|NCT01512004|urge urinary incontinence|urge urinary incontinence
480343|NCT01511991|cardiac surgery|cardiac surgery
480344|NCT01511991|sevoflurane|sevoflurane
480345|NCT01511991|tissue Doppler|tissue doppler
480346|NCT01511978|Lambert-Eaton|lambert-eaton
480347|NCT01511978|Eaton-Lambert|eaton-lambert
480348|NCT01511978|myasthenia|myasthenia
480349|NCT01511978|myasthenic|myasthenic
480350|NCT01511978|LEMS|lems
480351|NCT01511978|LES|les
480352|NCT01511978|DAP|dap
480353|NCT01511978|diaminopyridine|diaminopyridine
480354|NCT01511978|3,4-diaminopyridine|3,4-diaminopyridine
480355|NCT01511978|3,4-DAP|3,4-dap
480356|NCT01511952|music therapy|music therapy
480357|NCT01511952|entrainment|entrainment
480358|NCT01511952|premature infants|premature infants
480359|NCT01511952|live music intervention|live music intervention
480360|NCT01511952|parent preferred lullabies|parent preferred lullabies
480361|NCT01511939|Knee pain|knee pain
480362|NCT01511939|Anticoagulant|anticoagulant
480363|NCT01511939|Warfarin|warfarin
480364|NCT01511939|Dabigatran|dabigatran
480365|NCT01511939|Clopidogrel|clopidogrel
480366|NCT01511939|Aspirin|aspirin
480367|NCT01511939|Topical NSAID|topical nsaid
480368|NCT01511939|Osteoarthritis|osteoarthritis
480369|NCT01511926|Vimovo™ treated patients and prescribing patterns|vimovo™ treated patients and prescribing patterns
480370|NCT01511926|Risk of gastrointestinal side effects|risk of gastrointestinal side effects
480371|NCT01511913|Unresectable or metastatic cutaneous melanoma|unresectable or metastatic cutaneous melanoma
480372|NCT01511887|Patent Ductus Arteriosus|patent ductus arteriosus
480373|NCT01511887|PDA|pda
480374|NCT01511887|Term newborns|term newborns
480375|NCT01511887|Ibuprofen|ibuprofen
480376|NCT01511874|ELIGARD|eligard
480377|NCT01511874|Prostate cancer|prostate cancer
480378|NCT01511848|Iron chelation|iron chelation
480379|NCT01511848|Iron balance|iron balance
480380|NCT01511848|Secondary iron overload|secondary iron overload
480381|NCT01511848|deferoxamine|deferoxamine
480382|NCT01511848|deferasirox|deferasirox
480383|NCT01511848|Deferiprone|deferiprone
480384|NCT01511848|1- Beta-thalassemia major patients;|1- beta-thalassemia major patients;
480385|NCT01511848|Patients with high iron stores|patients with high iron stores
480386|NCT01511848|Serum ferritin consistently > 2500 mcg/l and or increasing trend over previous 12 months|serum ferritin consistently > 2500 mcg/l and or increasing trend over previous 12 months
480387|NCT01511848|Liver iron >14 mg/g dry weight- by R2 MRI|liver iron >14 mg/g dry weight- by r2 mri
480388|NCT01511848|2- Sickle cell disease|2- sickle cell disease
480389|NCT01511848|3- Other causes of transfusional iron hemosiderosis|3- other causes of transfusional iron hemosiderosis
480390|NCT01511835|diabetes|diabetes
480391|NCT01511835|pregnancy|pregnancy
480392|NCT01511835|myo-inositol|myo-inositol
480393|NCT01511822|PCOS|pcos
480394|NCT01511822|Insulin resistance|insulin resistance
480395|NCT01511822|Hyperandrogenism|hyperandrogenism
480396|NCT01511822|Myo-inositol|myo-inositol
480397|NCT01511809|HIV-1|hiv-1
480398|NCT01511796|stroke|stroke
480399|NCT01511796|upper limb rehabilitation function|upper limb rehabilitation function
480400|NCT01511770|Bioequivalence|bioequivalence
480401|NCT01511770|Fluconazole|fluconazole
480402|NCT01511770|Crossover|crossover
480403|NCT01511757|Bioequivalence|bioequivalence
480404|NCT01511757|Fluconazole|fluconazole
480405|NCT01511757|Crossover|crossover
480406|NCT01511744|Respiratory Tract Infections; Orthomyxoviridae Infections|respiratory tract infections; orthomyxoviridae infections
480407|NCT01511731|Bioequivalence|bioequivalence
480408|NCT01511731|famotidine|famotidine
480409|NCT01511731|Crossover|crossover
480410|NCT01511718|Bioequivalence|bioequivalence
480411|NCT01511718|Ondansetron|ondansetron
480412|NCT01511718|crossover|crossover
480413|NCT01511705|Bioequivalence|bioequivalence
480414|NCT01511705|Ondansetron|ondansetron
480415|NCT01511705|crossover|crossover
480416|NCT01511679|Alcohol abuse|alcohol abuse
480417|NCT01511666|cardiac arrest|cardiac arrest
480418|NCT01511666|mechanical chest compressions|mechanical chest compressions
480419|NCT01511666|intraarrest cooling|intraarrest cooling
480420|NCT01511666|ECLS|ecls
480421|NCT01511653|screening colonoscopy|screening colonoscopy
480422|NCT01511653|colon cancer early detection|colon cancer early detection
480423|NCT01511653|rectal cancer early detection|rectal cancer early detection
480424|NCT01511653|colorectal cancer prevention|colorectal cancer prevention
480425|NCT01511653|biomarker validation|biomarker validation
480426|NCT01511640|marijuana|marijuana
480427|NCT01511640|addiction|addiction
480428|NCT01511640|treatment|treatment
480429|NCT01511640|pharmacotherapy|pharmacotherapy
480430|NCT01511640|cannabinoid|cannabinoid
480431|NCT01511614|fMRI|fmri
480432|NCT01511614|tDCS|tdcs
480433|NCT01511601|Apheresis|apheresis
480434|NCT01511601|Leukocytes|leukocytes
480435|NCT01511601|Plasma|plasma
480436|NCT01511601|Plamodium Falciparum Malaria|plamodium falciparum malaria
480437|NCT01511601|Immunology|immunology
480438|NCT01511588|Kallmann Syndrome|kallmann syndrome
480439|NCT01511588|Delayed Puberty|delayed puberty
480440|NCT01511588|GnRH Deficiency|gnrh deficiency
480441|NCT01511588|Infertility|infertility
480442|NCT01511588|Hypogonadotropic Hypogonadism|hypogonadotropic hypogonadism
480443|NCT01511588|Amenorrhea|amenorrhea
480444|NCT01511588|Hypogonadism|hypogonadism
480445|NCT01511575|childhood acute myeloid leukemia in remission|childhood acute myeloid leukemia in remission
480446|NCT01511575|childhood acute myeloid leukemia/other myeloid malignancies|childhood acute myeloid leukemia/other myeloid malignancies
480447|NCT01511575|childhood acute megakaryocytic leukemia (M7)|childhood acute megakaryocytic leukemia (m7)
480448|NCT01511562|primary central nervous system non-Hodgkin lymphoma|primary central nervous system non-hodgkin lymphoma
480449|NCT01511562|contiguous stage II adult diffuse large cell lymphoma|contiguous stage ii adult diffuse large cell lymphoma
480450|NCT01511562|noncontiguous stage II adult diffuse large cell lymphoma|noncontiguous stage ii adult diffuse large cell lymphoma
480451|NCT01511562|stage I adult diffuse large cell lymphoma|stage i adult diffuse large cell lymphoma
480452|NCT01511562|stage III adult diffuse large cell lymphoma|stage iii adult diffuse large cell lymphoma
480453|NCT01511562|stage IV adult diffuse large cell lymphoma|stage iv adult diffuse large cell lymphoma
480454|NCT01511523|Liver|liver
480455|NCT01511523|Fatty|fatty
480456|NCT01511523|Non Alcoholic|non alcoholic
480457|NCT01511523|Vitamin E|vitamin e
480458|NCT01511523|Silymarin|silymarin
480459|NCT01511523|Carnitine|carnitine
480460|NCT01511523|Supplement|supplement
480461|NCT01511523|NAFLD|nafld
480462|NCT01511510|PF-04958242|pf-04958242
480463|NCT01511510|multiple dose|multiple dose
480464|NCT01511510|safety|safety
480465|NCT01511510|schizophrenia|schizophrenia
480466|NCT01511497|Phase 1|phase 1
480467|NCT01511497|PF-04427429|pf-04427429
480468|NCT01511484|fruit|fruit
480469|NCT01511484|vegetables|vegetables
480470|NCT01511484|appearance|appearance
480471|NCT01511484|skin color|skin color
480472|NCT01511484|carotenoids|carotenoids
480473|NCT01511484|diet|diet
480474|NCT01511471|Ticagrelor|ticagrelor
480475|NCT01511471|platelet reactivity|platelet reactivity
480476|NCT01511471|clopidogrel|clopidogrel
480477|NCT01511471|haemodialysis|haemodialysis
480478|NCT01511458|Pregnancy|pregnancy
480479|NCT01511458|Fetal aneuploidy|fetal aneuploidy
480480|NCT01511458|Trisomy 21|trisomy 21
480481|NCT01511458|Down Syndrome|down syndrome
480482|NCT01511458|Prenatal screening|prenatal screening
480483|NCT01511458|Non-invasive prenatal testing|non-invasive prenatal testing
480484|NCT01511458|First trimester|first trimester
480485|NCT01511458|Combined screening|combined screening
480486|NCT01511458|Nuchal translucency|nuchal translucency
480487|NCT01511458|PAPP-A|papp-a
480488|NCT01511458|hCG|hcg
480489|NCT01511458|cell free DNA|cell free dna
480490|NCT01511458|cf DNA|cf dna
480491|NCT01511458|DNA|dna
480492|NCT01511458|Performance characteristics of non-invasive first trimester screening|performance characteristics of non-invasive first trimester screening
480493|NCT01511458|Harmony Prenatal Test|harmony prenatal test
480494|NCT01511445|Cervicobrachial pain|cervicobrachial pain
480495|NCT01511445|radicular pain|radicular pain
480496|NCT01511445|arm pain|arm pain
480497|NCT01511445|myelopathy|myelopathy
480498|NCT01511445|radiculitis|radiculitis
480499|NCT01511445|Radiating pain with or without signs of myelopathy.|radiating pain with or without signs of myelopathy.
480500|NCT01511432|Relative bioavailability|relative bioavailability
480501|NCT01511432|telaprevir formulations|telaprevir formulations
480502|NCT01511419|Influenza|influenza
480503|NCT01511419|Vaccine|vaccine
480504|NCT01511419|Pandemic|pandemic
480505|NCT01511419|H7N3|h7n3
480506|NCT01511406|Psychosis|psychosis
480507|NCT01511406|Schizophrenia|schizophrenia
480508|NCT01511406|Cognitive behavioral therapy|cognitive behavioral therapy
480509|NCT01511406|Self esteem|self esteem
480510|NCT01511406|Depression|depression
480511|NCT01511393|GLP1|glp1
480512|NCT01511393|Glucagon like peptide|glucagon like peptide
480513|NCT01511393|liraglutide|liraglutide
480514|NCT01511393|exenatide extended release|exenatide extended release
480515|NCT01511393|albiglutide|albiglutide
480516|NCT01511393|dulaglutide|dulaglutide
480517|NCT01511380|juvenile|juvenile
480518|NCT01511380|randomized trial|randomized trial
480519|NCT01511380|substance abuse|substance abuse
480520|NCT01511380|sexual risk|sexual risk
480521|NCT01511380|contingency management|contingency management
480522|NCT01511367|moderate to severe persistent reversible asthma|moderate to severe persistent reversible asthma
480523|NCT01511354|critically ill children|critically ill children
480524|NCT01511354|ICU|icu
480525|NCT01511354|24hr protein balance|24hr protein balance
480526|NCT01511354|stable isotopes|stable isotopes
480527|NCT01511354|fed state|fed state
480528|NCT01511341|Telenursing|telenursing
480529|NCT01511341|Children|children
480530|NCT01511341|Chronic Illness|chronic illness
480531|NCT01511341|Nursing|nursing
480532|NCT01511328|HPV testing|hpv testing
480533|NCT01511328|Primary screening|primary screening
480534|NCT01511328|Cervical Cancer|cervical cancer
480535|NCT01511315|Moderate to severe psoriasis|moderate to severe psoriasis
480536|NCT01511289|Radotinib|radotinib
480537|NCT01511289|CML-CP|cml-cp
480538|NCT01511289|Chronic Myeloid Leukemia, chronic phase|chronic myeloid leukemia, chronic phase
480539|NCT01511276|Breast cancer|breast cancer
480540|NCT01511276|Sex hormones|sex hormones
480541|NCT01511276|Physical activity|physical activity
480542|NCT01511263|Epigallocatechin gallate|epigallocatechin gallate
480543|NCT01511263|AL amyloidosis|al amyloidosis
480544|NCT01511250|Normal healthy adults and children|normal healthy adults and children
480545|NCT01511250|Safety and tolerability|safety and tolerability
480546|NCT01511250|Active vaccine|active vaccine
480547|NCT01511250|Placebo|placebo
480548|NCT01511250|Dengue virus vaccine|dengue virus vaccine
480549|NCT01511250|Immune response|immune response
480550|NCT01511237|HIV-1 infection|hiv-1 infection
480551|NCT01511237|Prophylaxis|prophylaxis
480552|NCT01511237|Mother-to-child transmission HIV-1|mother-to-child transmission hiv-1
480553|NCT01511237|Thailand|thailand
480554|NCT01511237|Developing Countries|developing countries
480555|NCT01511224|Bloodstream infections|bloodstream infections
480556|NCT01511224|Acinetobacter|acinetobacter
480557|NCT01511224|Drug resistant Acinetobacter baumannii bacteremia|drug resistant acinetobacter baumannii bacteremia
480558|NCT01511211|Dexamethasone|dexamethasone
480559|NCT01511211|lower limb block|lower limb block
480560|NCT01511211|ultrasound guided femoral nerve block|ultrasound guided femoral nerve block
480561|NCT01511211|ultrasound guided obturator nerve block|ultrasound guided obturator nerve block
480562|NCT01511211|ultrasound guided sciatic nerve block|ultrasound guided sciatic nerve block
480563|NCT01511211|ropivacaine|ropivacaine
480564|NCT01511211|total knee arthroplasty|total knee arthroplasty
480565|NCT01511211|Post surgical pain after total knee arthroplasty|post surgical pain after total knee arthroplasty
480566|NCT01511146|oxaliplatin|oxaliplatin
480567|NCT01511146|mitomycin|mitomycin
480568|NCT01511146|gemcitabine|gemcitabine
480569|NCT01511146|intrahepatic|intrahepatic
480570|NCT01511146|liver metastasis|liver metastasis
480571|NCT01511146|response in liver metastasis|response in liver metastasis
480572|NCT01511146|downsized to operation|downsized to operation
480573|NCT01511133|Laboratory evaluations|laboratory evaluations
480574|NCT01511133|infants|infants
480575|NCT01511133|Porcine circovirus type 1 (PCV-1)|porcine circovirus type 1 (pcv-1)
480576|NCT01511133|serologic response|serologic response
480577|NCT01511133|human rotavirus (HRV) vaccine|human rotavirus (hrv) vaccine
480578|NCT01511107|acute otitis media|acute otitis media
480579|NCT01511107|ear infection|ear infection
480580|NCT01511107|antimicrobial therapy|antimicrobial therapy
480581|NCT01511107|antimicrobial resistance|antimicrobial resistance
480582|NCT01511094|ab-interno trabeculectomy,|ab-interno trabeculectomy,
480583|NCT01511094|intraocular pressure,|intraocular pressure,
480584|NCT01511094|open angle glaucoma|open angle glaucoma
480585|NCT01511094|trabeculectomy|trabeculectomy
480586|NCT01511094|Goniocurettage|goniocurettage
480587|NCT01511094|Non-Filtering Surgery|non-filtering surgery
480588|NCT01511081|Non-small-cell lung cancer|non-small-cell lung cancer
480589|NCT01511081|NSCLC|nsclc
480590|NCT01511081|Centrally-located|centrally-located
480591|NCT01511081|Recurrent|recurrent
480592|NCT01511081|Squamous cell carcinoma|squamous cell carcinoma
480593|NCT01511081|Adenocarcinoma|adenocarcinoma
480594|NCT01511081|Large cell carcinoma|large cell carcinoma
480595|NCT01511081|Bronchioloalveolar cell carcinoma|bronchioloalveolar cell carcinoma
480596|NCT01511081|Non-small cell carcinoma not otherwise specified|non-small cell carcinoma not otherwise specified
480597|NCT01511081|Stereotactic Body Radiotherapy|stereotactic body radiotherapy
480598|NCT01511081|SBRT|sbrt
480599|NCT01511081|Stereotactic Body Proton Therapy|stereotactic body proton therapy
480600|NCT01511081|SBPT|sbpt
480601|NCT01511068|PAP|pap
480602|NCT01511055|Ovarian Cancer|ovarian cancer
480603|NCT01511016|lipid kinetics|lipid kinetics
480604|NCT01511016|fat oxidation|fat oxidation
480605|NCT01511003|calcineurin inhibitor|calcineurin inhibitor
480606|NCT01511003|Prograf|prograf
480607|NCT01511003|Rheumatoid arthritis (RA)|rheumatoid arthritis (ra)
480608|NCT01511003|Tacrolimus|tacrolimus
480609|NCT01510990|Non-small cell lung cancer|non-small cell lung cancer
480610|NCT01510990|Gefitinib|gefitinib
480611|NCT01510990|FDG-PET|fdg-pet
480612|NCT01510977|colonoscopy|colonoscopy
480613|NCT01510977|bowel preparation|bowel preparation
480614|NCT01510964|Breast cancer|breast cancer
480615|NCT01510964|Patient involvement|patient involvement
480616|NCT01510964|Question prompt-sheet|question prompt-sheet
480617|NCT01510964|Doctor-patient communication|doctor-patient communication
480618|NCT01510964|RCT|rct
480619|NCT01510951|AMGEN|amgen
480620|NCT01510951|PSORIASIS|psoriasis
480621|NCT01510951|SAFETY|safety
480622|NCT01510938|Children|children
480623|NCT01510938|Respiratory Tract Infections|respiratory tract infections
480624|NCT01510938|Prevention|prevention
480625|NCT01510886|MDD, management, Andalusia, Database, PismaEP|mdd, management, andalusia, database, pismaep
480626|NCT01510873|Health-related quality of life|health-related quality of life
480627|NCT01510873|Fatigue|fatigue
480628|NCT01510873|pITO|pito
480629|NCT01510873|Primary Immune Thrombocytopenic Purpura|primary immune thrombocytopenic purpura
480630|NCT01510834|Computerized Tailored Intervention|computerized tailored intervention
480631|NCT01510834|CTI|cti
480632|NCT01510834|Post Traumatic Stress Disorder|post traumatic stress disorder
480633|NCT01510834|PTSD|ptsd
480634|NCT01510834|Smoking|smoking
480635|NCT01510834|Anxiety|anxiety
480636|NCT01510834|Depression|depression
480637|NCT01510821|endoscopic vein harvest|endoscopic vein harvest
480638|NCT01510821|saphenous vein graft|saphenous vein graft
480639|NCT01510821|endothelial function|endothelial function
480640|NCT01510808|aggressive periodontitis orthodontic stability|aggressive periodontitis orthodontic stability
480641|NCT01510795|Kidney transplantation|kidney transplantation
480642|NCT01510795|Mineralocorticoid receptors|mineralocorticoid receptors
480643|NCT01510795|Spironolactone|spironolactone
480644|NCT01510743|open heart surgery|open heart surgery
480645|NCT01510743|lung surgery|lung surgery
480646|NCT01510743|spine surgery|spine surgery
480647|NCT01510743|hepatobiliary surgery|hepatobiliary surgery
480648|NCT01510730|gastric tumor|gastric tumor
480649|NCT01510730|Helicobacter pylori|helicobacter pylori
480650|NCT01510730|endoscopic resection|endoscopic resection
480651|NCT01510730|metachronous neoplasms|metachronous neoplasms
480652|NCT01510717|Intraocular Lens|intraocular lens
480653|NCT01510717|Monofocal|monofocal
480654|NCT01510717|Multifocal|multifocal
480655|NCT01510691|Oxygenation of the retinal vessels|oxygenation of the retinal vessels
480656|NCT01510691|vitroretinal surgery|vitroretinal surgery
480657|NCT01510678|Diet Quality|diet quality
612950|NCT00967044|NHL|nhl
480658|NCT01510665|Weight gain in pregnancy|weight gain in pregnancy
480659|NCT01510665|Metabolic and Inflammatory markers|metabolic and inflammatory markers
480660|NCT01510652|Cardiac Resynchronization therapy,|cardiac resynchronization therapy,
480661|NCT01510652|Heart Failure,|heart failure,
480662|NCT01510652|Left Ventricular Lead,|left ventricular lead,
480663|NCT01510652|Quadripolar Left ventricular Lead,|quadripolar left ventricular lead,
480664|NCT01510652|Phrenic Nerve Stimulation,|phrenic nerve stimulation,
480665|NCT01510652|Intra and post operative related complications|intra and post operative related complications
480666|NCT01510626|Multiple food allergies|multiple food allergies
480667|NCT01510613|Pomalidomide|pomalidomide
480668|NCT01510613|Dexamethasone|dexamethasone
480669|NCT01510613|treatment|treatment
480670|NCT01510613|AL amyloidosis|al amyloidosis
480671|NCT01510600|stage 4S neuroblastoma|stage 4s neuroblastoma
480672|NCT01510600|localized resectable neuroblastoma|localized resectable neuroblastoma
480673|NCT01510600|localized unresectable neuroblastoma|localized unresectable neuroblastoma
480674|NCT01510600|recurrent neuroblastoma|recurrent neuroblastoma
480675|NCT01510600|regional neuroblastoma|regional neuroblastoma
480676|NCT01510587|obesity|obesity
480677|NCT01510587|prevention|prevention
480678|NCT01510587|preteen|preteen
480679|NCT01510587|nutrition|nutrition
480680|NCT01510587|physical activity|physical activity
480681|NCT01510587|body image|body image
480682|NCT01510587|family dynamics|family dynamics
480683|NCT01510574|postpartum hemorrhage, PPH, misoprostol|postpartum hemorrhage, pph, misoprostol
480684|NCT01510561|metastatic pancreatic adenocarcinoma|metastatic pancreatic adenocarcinoma
480685|NCT01510561|pancreatic cancer|pancreatic cancer
480686|NCT01510561|metastatic pancreatic cancer|metastatic pancreatic cancer
480687|NCT01510548|Disc prolapse|disc prolapse
480688|NCT01510548|Pain|pain
480689|NCT01510548|Disability|disability
480690|NCT01510535|Osteoartritis|osteoartritis
480691|NCT01510535|Knee|knee
480692|NCT01510535|LBSA0103|lbsa0103
480693|NCT01510535|Hyruan Plus Inj.|hyruan plus inj.
480694|NCT01510522|Diabetes|diabetes
480695|NCT01510522|Glucophage|glucophage
480696|NCT01510522|Metformin|metformin
480697|NCT01510522|sachets|sachets
480698|NCT01510522|tablets|tablets
480699|NCT01510509|Drug Eluting Stent|drug eluting stent
480700|NCT01510509|Bioactive Bare Metal Stent|bioactive bare metal stent
480701|NCT01510496|Chronic pain|chronic pain
480702|NCT01510496|genetic polymorphisms|genetic polymorphisms
480703|NCT01510496|postoperative pain|postoperative pain
480704|NCT01510483|obesity prevention|obesity prevention
480705|NCT01510483|tobacco prevention|tobacco prevention
480706|NCT01510483|nutrition|nutrition
480707|NCT01510483|physical activity|physical activity
480708|NCT01510483|sedentary activity|sedentary activity
480709|NCT01510483|tobacco use|tobacco use
480710|NCT01510483|tobacco exposure|tobacco exposure
480711|NCT01510483|prevention|prevention
480712|NCT01510483|clinician intervention|clinician intervention
480713|NCT01510483|preteen|preteen
480714|NCT01510483|adolescents|adolescents
480715|NCT01510470|AstraTech Osseospeed Profile Implant|astratech osseospeed profile implant
480716|NCT01510470|Marginal bone level|marginal bone level
480717|NCT01510470|soft tissue|soft tissue
480718|NCT01510470|soft tissue responds|soft tissue responds
480719|NCT01510457|Knee Osteoarthritis|knee osteoarthritis
480720|NCT01510457|Degenerative Joint Disease|degenerative joint disease
480721|NCT01510457|Chronic Pain|chronic pain
480722|NCT01510457|Knee Pain|knee pain
480723|NCT01510418|Hemophilia|hemophilia
480724|NCT01510418|Spouse|spouse
480725|NCT01510418|Significant Other|significant other
480726|NCT01510418|Quality of Life|quality of life
480727|NCT01510405|Subjects undergoing or who have undergone thoracic surgery for presumed lung cancer.|subjects undergoing or who have undergone thoracic surgery for presumed lung cancer.
480825|NCT01510002|papillary thyroid cancer|papillary thyroid cancer
480728|NCT01510405|The following procedures are allowed: Wedge resection, lobectomy, bilobectomy, segmentectomy and pneumonectomy thoracic surgical operations are permitted.|the following procedures are allowed: wedge resection, lobectomy, bilobectomy, segmentectomy and pneumonectomy thoracic surgical operations are permitted.
480729|NCT01510392|Optical coherence tomography|optical coherence tomography
480730|NCT01510392|Glaucoma|glaucoma
480731|NCT01510392|Macula|macula
480732|NCT01510392|Keratoconus|keratoconus
480733|NCT01510392|Screening|screening
480734|NCT01510379|nausea|nausea
480735|NCT01510379|vomiting|vomiting
480736|NCT01510379|post-operative|post-operative
480737|NCT01510379|foregut surgery|foregut surgery
480738|NCT01510366|Inactivated Poliomyelitis Vaccine|inactivated poliomyelitis vaccine
480739|NCT01510366|Sabin Strains|sabin strains
480740|NCT01510366|poliomyelitis|poliomyelitis
480741|NCT01510340|adherence|adherence
480742|NCT01510340|HIV|hiv
480743|NCT01510340|antiretroviral therapy|antiretroviral therapy
480744|NCT01510340|tailored web intervention|tailored web intervention
480745|NCT01510327|drug-eluting stents|drug-eluting stents
480746|NCT01510327|DES|des
480747|NCT01510327|atherosclerotic|atherosclerotic
480748|NCT01510301|Self-report|self-report
480749|NCT01510301|Self-management|self-management
480750|NCT01510301|Hypertension|hypertension
480751|NCT01510301|Adherence|adherence
480752|NCT01510301|Cell phone|cell phone
480753|NCT01510301|Drug treatment|drug treatment
480754|NCT01510301|Medical Adherence|medical adherence
480755|NCT01510288|GVAX|gvax
480756|NCT01510288|Ipilimumab|ipilimumab
480757|NCT01510288|prostate cancer|prostate cancer
480758|NCT01510275|cardio-thoracic surgery|cardio-thoracic surgery
480759|NCT01510275|patients|patients
480760|NCT01510275|pulmonary volume|pulmonary volume
480761|NCT01510275|respiratory muscle performance|respiratory muscle performance
480762|NCT01510262|Repeat STI patients|repeat sti patients
480763|NCT01510262|HIV|hiv
480764|NCT01510262|Cost effectiveness|cost effectiveness
480765|NCT01510262|Resource scarce|resource scarce
480766|NCT01510262|Urban clinics|urban clinics
480767|NCT01510249|calcaneal spur|calcaneal spur
480768|NCT01510249|shock wave therapy|shock wave therapy
480769|NCT01510249|ultrasound therapy|ultrasound therapy
480770|NCT01510236|Adolescence|adolescence
480771|NCT01510236|Cancer|cancer
480772|NCT01510236|Depression|depression
480773|NCT01510236|Anxiety|anxiety
480774|NCT01510236|Self-help via internet|self-help via internet
480775|NCT01510223|Fats|fats
480776|NCT01510223|Macronutrients|macronutrients
480777|NCT01510223|appetite|appetite
480778|NCT01510223|gastric emptying|gastric emptying
480779|NCT01510223|Gastrointestinal transit|gastrointestinal transit
480780|NCT01510210|Atrial Fibrillation|atrial fibrillation
480781|NCT01510210|Arrhythmia|arrhythmia
480782|NCT01510210|Rhythm control|rhythm control
480783|NCT01510197|Atrial Fibrillation|atrial fibrillation
480784|NCT01510197|Arrhythmia|arrhythmia
480785|NCT01510197|Rhythm control|rhythm control
480786|NCT01510171|platelet inhibitor|platelet inhibitor
480787|NCT01510171|ST-segment elevation myocardial infarction|st-segment elevation myocardial infarction
480788|NCT01510171|stent|stent
480789|NCT01510171|prasugrel|prasugrel
480790|NCT01510171|ticagrelor|ticagrelor
480791|NCT01510145|Glaucoma|glaucoma
480792|NCT01510145|Open-angle glaucoma|open-angle glaucoma
480793|NCT01510145|Ocular hypertension|ocular hypertension
480794|NCT01510145|Hypertension|hypertension
480795|NCT01510145|Eye Diseases|eye diseases
480796|NCT01510145|Vascular Diseases|vascular diseases
480797|NCT01510145|Cardiovascular Diseases|cardiovascular diseases
480798|NCT01510145|Travoprost|travoprost
480799|NCT01510145|Antihypertensive Agents|antihypertensive agents
480800|NCT01510145|Cardiovascular Agents|cardiovascular agents
480801|NCT01510145|Therapeutic Uses|therapeutic uses
480802|NCT01510145|Pharmacologic Actions|pharmacologic actions
480803|NCT01510132|OAG|oag
480804|NCT01510132|OHT|oht
480805|NCT01510093|type 2 diabetes mellitus, endogenous insulin|type 2 diabetes mellitus, endogenous insulin
480806|NCT01510080|Computer-assisted live supervision|computer-assisted live supervision
480807|NCT01510080|"Bug-in-the-eye supervision"|"bug-in-the-eye supervision"
480808|NCT01510080|Delayed video-based supervision|delayed video-based supervision
480809|NCT01510080|Cognitive behavioral therapy supervision|cognitive behavioral therapy supervision
480810|NCT01510067|CLE|cle
480811|NCT01510067|Lupus|lupus
480812|NCT01510067|Lupus Erythematosus|lupus erythematosus
480813|NCT01510054|miRNA in endometrium|mirna in endometrium
480814|NCT01510041|Chronic obstructive pulmonary disease|chronic obstructive pulmonary disease
480815|NCT01510041|Physical therapy|physical therapy
480816|NCT01510041|Dyspnea|dyspnea
480817|NCT01510041|Inspiratory muscle training|inspiratory muscle training
480818|NCT01510041|Activities of daily living|activities of daily living
480819|NCT01510028|Intrathecal Drug Delivery Device (IDDD)|intrathecal drug delivery device (iddd)
480820|NCT01510028|Recombinant human arylsulfatase A (rhASA)|recombinant human arylsulfatase a (rhasa)
480821|NCT01510028|Metachromatic Leukodystrophy (MLD)|metachromatic leukodystrophy (mld)
480822|NCT01510015|cannabis|cannabis
480823|NCT01510015|psychostimulants|psychostimulants
480824|NCT01510015|psychosis|psychosis
480826|NCT01510002|central neck dissection|central neck dissection
480827|NCT01510002|survival|survival
480828|NCT01510002|locoregional control|locoregional control
480829|NCT01510002|morbidity|morbidity
480830|NCT01509989|Adherence|adherence
480831|NCT01509989|Compliance|compliance
480832|NCT01509989|Systemic Lupus Erythematosus|systemic lupus erythematosus
480833|NCT01509989|Hydroxychloroquine|hydroxychloroquine
480834|NCT01509989|Blood monitoring|blood monitoring
480835|NCT01509989|Flares|flares
480836|NCT01509976|Triclosan|triclosan
480837|NCT01509976|Triclocarban|triclocarban
480838|NCT01509976|Microbial flora|microbial flora
480839|NCT01509976|Obesity|obesity
480840|NCT01509963|MSKCC nomogram|mskcc nomogram
480841|NCT01509963|Tenon score|tenon score
480842|NCT01509963|metastatic SN|metastatic sn
480843|NCT01509963|low risk of metastatic non-SN|low risk of metastatic non-sn
480844|NCT01509963|additional ALND|additional alnd
480845|NCT01509937|end stage renal disease|end stage renal disease
480846|NCT01509937|maintenance hemodialysis|maintenance hemodialysis
480847|NCT01509937|dry weight|dry weight
480848|NCT01509937|bioimpedance spectroscopy analysis|bioimpedance spectroscopy analysis
480849|NCT01509937|body composition monitor|body composition monitor
480850|NCT01509937|Fresenius BCM|fresenius bcm
480851|NCT01509937|Ultrafiltration|ultrafiltration
480852|NCT01509924|Walking capacity|walking capacity
480853|NCT01509924|Mental Fatigue|mental fatigue
480854|NCT01509924|Quality of Life|quality of life
480855|NCT01509924|Cognition|cognition
480856|NCT01509924|Motor activity|motor activity
480857|NCT01509924|Exercise|exercise
480858|NCT01509872|Trauma-Focused Cognitive Behavior Therapy|trauma-focused cognitive behavior therapy
480859|NCT01509872|War-affected Children|war-affected children
480860|NCT01509872|Post-traumatic Stress Symptoms|post-traumatic stress symptoms
480861|NCT01509872|Psychosocial Distress|psychosocial distress
480862|NCT01509859|proximal femur nail|proximal femur nail
480863|NCT01509859|pfna|pfna
480864|NCT01509859|intertan|intertan
480865|NCT01509859|weight bearing|weight bearing
480866|NCT01509859|pertrochanteric fracture|pertrochanteric fracture
480867|NCT01509859|femur neck fracture|femur neck fracture
480868|NCT01509846|Shigella|shigella
480869|NCT01509846|vaccine|vaccine
480870|NCT01509846|shigellosis|shigellosis
480871|NCT01509846|dysentery|dysentery
480872|NCT01509846|whole cell|whole cell
480873|NCT01509833|ICSI Ovarian stimulation|icsi ovarian stimulation
480874|NCT01509833|hCG low dose|hcg low dose
480875|NCT01509833|Oocyte maturity|oocyte maturity
480876|NCT01509833|poor respond|poor respond
480877|NCT01509807|Ileostomy reversal|ileostomy reversal
480879|NCT01509794|Simulation|simulation
480880|NCT01509794|Affective engagement|affective engagement
480881|NCT01509794|Cognitive performance|cognitive performance
480882|NCT01509781|simple mastectomy|simple mastectomy
480883|NCT01509781|modified radical mastectomy|modified radical mastectomy
480884|NCT01509781|wound care|wound care
480885|NCT01509781|suction drain|suction drain
480886|NCT01509781|adaptive suture|adaptive suture
480887|NCT01509768|MPS IIIB|mps iiib
480888|NCT01509729|Knee|knee
480889|NCT01509729|Arthroscopy|arthroscopy
480890|NCT01509729|Lidocaine patch|lidocaine patch
480891|NCT01509729|Pain management after knee arthroscopy|pain management after knee arthroscopy
480892|NCT01509716|Predialysis|predialysis
480893|NCT01509703|COPD|copd
480894|NCT01509703|Nasal High Flow Therapy|nasal high flow therapy
480895|NCT01509703|tracheotomy stent|tracheotomy stent
480896|NCT01509703|tracheotomy|tracheotomy
480897|NCT01509690|Incident|incident
480898|NCT01509690|Hemodialysis|hemodialysis
480899|NCT01509677|Roflumilast|roflumilast
480900|NCT01509677|Chronic Obstructive Pulmonary Disease|chronic obstructive pulmonary disease
480901|NCT01509677|COPD|copd
480902|NCT01509651|antagonists neuromuscular block|antagonists neuromuscular block
480903|NCT01509651|neuromuscular block, monitoring|neuromuscular block, monitoring
480904|NCT01509651|neuromuscular function|neuromuscular function
480905|NCT01509638|Ileostomy reversal|ileostomy reversal
480906|NCT01509625|Fulvestrant|fulvestrant
480907|NCT01509625|Faslodex|faslodex
480908|NCT01509612|cancer|cancer
480909|NCT01509612|additive homeopathy|additive homeopathy
480910|NCT01509612|patients with advanced malignant tumors|patients with advanced malignant tumors
480911|NCT01509599|Venous disease|venous disease
480912|NCT01509599|Venous disorders|venous disorders
480913|NCT01509599|Venous insufficiency|venous insufficiency
480914|NCT01509599|Venous ulcers|venous ulcers
480915|NCT01509599|Cryotherapy|cryotherapy
480916|NCT01509586|smoking|smoking
480917|NCT01509586|smoking cessation|smoking cessation
480918|NCT01509586|Potentially Reduced Exposure Products (PREPs)|potentially reduced exposure products (preps)
480919|NCT01509573|prevention therapy|prevention therapy
480920|NCT01509573|depressive symptoms|depressive symptoms
480921|NCT01509573|anxiety|anxiety
480922|NCT01509573|parenting|parenting
480923|NCT01509573|family functioning|family functioning
480924|NCT01509573|resilience, psychological|resilience, psychological
480925|NCT01509573|Developing countries|developing countries
480926|NCT01509573|Rwanda|rwanda
480927|NCT01509573|HIV/AIDS|hiv/aids
480928|NCT01509534|pacemaker|pacemaker
480929|NCT01509534|implantable loop recorder|implantable loop recorder
480930|NCT01509534|syncope|syncope
480931|NCT01509521|Spectroscopy, Near-Infrared|spectroscopy, near-infrared
480932|NCT01509521|Fetal heartrate|fetal heartrate
480933|NCT01509521|Ephedrine|ephedrine
480934|NCT01509521|Phenylephrine|phenylephrine
480935|NCT01509508|HIV|hiv
480936|NCT01509508|Prevention|prevention
480937|NCT01509508|Treatment|treatment
480938|NCT01509508|South Africa|south africa
480939|NCT01509495|Heart Failure|heart failure
480940|NCT01509495|HF|hf
480941|NCT01509482|insulin resistance|insulin resistance
480942|NCT01509482|unexplained azoospermia|unexplained azoospermia
480943|NCT01509482|unexplained oligospermia|unexplained oligospermia
480944|NCT01509469|Ileal brake|ileal brake
480945|NCT01509469|Casein|casein
480946|NCT01509469|Sucrose|sucrose
480947|NCT01509469|Ileal infusion|ileal infusion
480948|NCT01509456|bone metabolism|bone metabolism
480949|NCT01509456|potassium bicarbonate|potassium bicarbonate
480950|NCT01509456|alkaline salt|alkaline salt
480951|NCT01509456|acid base balance|acid base balance
480952|NCT01509456|bed rest|bed rest
480953|NCT01509443|Asthma|asthma
480954|NCT01509443|Obesity|obesity
480955|NCT01509443|Breathing exercise|breathing exercise
480956|NCT01509417|pyloric stenosis|pyloric stenosis
480957|NCT01509404|CMV|cmv
480958|NCT01509404|cytomegalovirus|cytomegalovirus
480959|NCT01509404|transplant|transplant
480960|NCT01509378|ICD|icd
480961|NCT01509378|ATP therapy|atp therapy
480962|NCT01509378|Rescue Shock therapy|rescue shock therapy
480963|NCT01509365|cardiovascular disease|cardiovascular disease
480964|NCT01509365|maintenance dose|maintenance dose
480965|NCT01509365|clopidogrel|clopidogrel
480966|NCT01509365|overweight|overweight
480967|NCT01509365|antiplatelet agents|antiplatelet agents
480968|NCT01509352|fundoplication|fundoplication
480969|NCT01509352|gastric reflux|gastric reflux
480970|NCT01509339|Vancomycin|vancomycin
480971|NCT01509339|Inhalation|inhalation
480972|NCT01509339|Nebulization|nebulization
480973|NCT01509339|Pharmacokinetics|pharmacokinetics
480974|NCT01509326|headache|headache
480975|NCT01509326|chiropractic|chiropractic
480976|NCT01509326|manipulation|manipulation
480977|NCT01509326|acupressure|acupressure
480978|NCT01509326|self-care|self-care
480979|NCT01509313|endometrial polyps|endometrial polyps
480980|NCT01509313|uterine polyps|uterine polyps
480981|NCT01509313|morcellator|morcellator
480982|NCT01509313|hysteroscopy|hysteroscopy
480983|NCT01509300|TBI|tbi
480984|NCT01509300|Fludarabine|fludarabine
480985|NCT01509300|CD3 depletion|cd3 depletion
480986|NCT01509300|Children and adolescents|children and adolescents
480987|NCT01509300|Haploidentical hematopoietic stem cell transplantation|haploidentical hematopoietic stem cell transplantation
480988|NCT01509287|Donnai-Barrow Syndrome (DBS)|donnai-barrow syndrome (dbs)
480989|NCT01509287|metabolic testing|metabolic testing
480990|NCT01509287|genes|genes
480991|NCT01509287|genetic|genetic
480992|NCT01509274|Plantar fasciitis|plantar fasciitis
480993|NCT01509274|Plasma|plasma
480994|NCT01509274|PRP|prp
480995|NCT01509274|Heel pain|heel pain
480996|NCT01509261|Erosive Esophagitis|erosive esophagitis
480997|NCT01509261|Ilaprazole|ilaprazole
480998|NCT01509261|GERD|gerd
480999|NCT01509248|Theophylline|theophylline
481000|NCT01509235|cystic fibrosis|cystic fibrosis
481001|NCT01509235|Lung function|lung function
481002|NCT01509235|physical exercise|physical exercise
481003|NCT01509222|Health promotion|health promotion
481004|NCT01509222|Dietary Counseling|dietary counseling
481005|NCT01509209|vasomotor|vasomotor
481006|NCT01509209|pseudoephedrine|pseudoephedrine
481007|NCT01509209|levocetirizine|levocetirizine
481008|NCT01509196|Fenofibric acid|fenofibric acid
481009|NCT01509196|HIP0901|hip0901
481010|NCT01509196|Lipidilsupra|lipidilsupra
481011|NCT01509183|asthma|asthma
481012|NCT01509183|healthcare utilization costs|healthcare utilization costs
481013|NCT01509157|Type 1 diabetes|type 1 diabetes
481014|NCT01509157|Continuous Glucose Monitoring|continuous glucose monitoring
481015|NCT01509157|Nocturnal Hypoglycemia|nocturnal hypoglycemia
481016|NCT01509144|Safety of this HIV vaccine|safety of this hiv vaccine
481017|NCT01509092|traumatic macular hole|traumatic macular hole
481018|NCT01509092|vitrectomy|vitrectomy
481019|NCT01509092|observation|observation
481020|NCT01509066|vegetarian|vegetarian
481021|NCT01509066|vegan|vegan
481022|NCT01509066|low calorie|low calorie
481023|NCT01509066|infertility|infertility
481024|NCT01509066|PCOS|pcos
481025|NCT01509053|Schizophrenia|schizophrenia
481026|NCT01509040|Resuscitated from Out-of-Hospital Cardiac Arrest|resuscitated from out-of-hospital cardiac arrest
481027|NCT01509027|hemodialysis|hemodialysis
481028|NCT01509027|hyperphoshatemia|hyperphoshatemia
481029|NCT01509027|compliance|compliance
481030|NCT01509014|Statins|statins
481031|NCT01509014|Adherence|adherence
481032|NCT01509014|Pharmacists|pharmacists
483199|NCT01500174|pressure|pressure
481033|NCT01509001|type 2 diabetes|type 2 diabetes
481034|NCT01509001|metformin|metformin
481035|NCT01509001|glimepiride|glimepiride
481036|NCT01509001|glucose control|glucose control
481037|NCT01509001|vascular reactivity|vascular reactivity
481038|NCT01509001|Adverse Reaction to Other Drugs and Medicines|adverse reaction to other drugs and medicines
481039|NCT01508988|ONO-9054|ono-9054
481040|NCT01508988|adult healthy volunteers|adult healthy volunteers
481041|NCT01508988|single dose|single dose
481042|NCT01508988|phase 1|phase 1
481043|NCT01508975|satiety|satiety
481044|NCT01508975|obesity|obesity
481045|NCT01508975|food intake|food intake
481046|NCT01508962|Disease onset|disease onset
481047|NCT01508962|Disease progression|disease progression
481048|NCT01508884|intradermal|intradermal
481049|NCT01508884|influenza|influenza
481050|NCT01508884|vaccination|vaccination
481051|NCT01508845|vitamin D|vitamin d
481052|NCT01508845|vitamin D absorption|vitamin d absorption
481053|NCT01508845|vitamin D deficiency|vitamin d deficiency
481054|NCT01508819|Patients over 75|patients over 75
481055|NCT01508819|acute pathology|acute pathology
481056|NCT01508819|ICU admission|icu admission
481057|NCT01508793|Sleep|sleep
481058|NCT01508793|Obesity|obesity
481059|NCT01508793|Children|children
481060|NCT01508793|Eating behaviors|eating behaviors
481061|NCT01508793|Activity|activity
481062|NCT01508754|Continuous positive airway pressure|continuous positive airway pressure
481063|NCT01508754|Ambulatory blood pressures|ambulatory blood pressures
481064|NCT01508741|Insomnia|insomnia
481065|NCT01508741|Frequent Nocturnal Awakening|frequent nocturnal awakening
481066|NCT01508741|Irritability|irritability
481067|NCT01508741|Moody|moody
481068|NCT01508741|Moodiness|moodiness
481069|NCT01508741|Coping Ability|coping ability
481070|NCT01508741|Coping Behavior|coping behavior
481071|NCT01508741|Stress|stress
481072|NCT01508741|Feeling Overwhelmed|feeling overwhelmed
481073|NCT01508728|unoperated severe sprain of the knee with partial or total rupture of the anterior|unoperated severe sprain of the knee with partial or total rupture of the anterior
481074|NCT01508728|cruciate ligament and medial or lateral collateral ligament|cruciate ligament and medial or lateral collateral ligament
481075|NCT01508715|subacromial|subacromial
481076|NCT01508715|rotator cuff|rotator cuff
481077|NCT01508715|impingement|impingement
481078|NCT01508715|physical therapy|physical therapy
481079|NCT01508715|eccentric exercise|eccentric exercise
481080|NCT01508715|concentric exercise|concentric exercise
481081|NCT01508702|Gout|gout
481082|NCT01508689|Cereal bar|cereal bar
481083|NCT01508689|Calcium-fortified|calcium-fortified
481084|NCT01508689|Calcium intake|calcium intake
481085|NCT01508676|neuropathic pain|neuropathic pain
481086|NCT01508676|postherpetic neuralgia|postherpetic neuralgia
481087|NCT01508676|complex regional pain syndrome|complex regional pain syndrome
481088|NCT01508676|reflex sympathetic dystrophy|reflex sympathetic dystrophy
481089|NCT01508663|Coronary artery disease 75years of age or older|coronary artery disease 75years of age or older
481090|NCT01508650|heart failure|heart failure
481091|NCT01508637|air pollution|air pollution
481092|NCT01508637|vasoconstriction|vasoconstriction
481093|NCT01508637|blood pressure|blood pressure
481094|NCT01508637|diesel exhaust|diesel exhaust
481095|NCT01508624|Randomised controlled trial|randomised controlled trial
481096|NCT01508624|Pain|pain
481097|NCT01508624|Recovery|recovery
481098|NCT01508624|Office based surgery|office based surgery
481099|NCT01508611|dental caries|dental caries
481100|NCT01508611|permanent teeth|permanent teeth
481101|NCT01508611|silver diamine fluoride|silver diamine fluoride
481102|NCT01508611|tooth eruption|tooth eruption
481103|NCT01508598|Pediatric|pediatric
481104|NCT01508598|Obesity|obesity
481105|NCT01508598|Bariatric surgery|bariatric surgery
481106|NCT01508598|Cardiovascular disease|cardiovascular disease
481107|NCT01508585|Bariatric surgery|bariatric surgery
481108|NCT01508585|Cognitive Behavioral Therapy|cognitive behavioral therapy
481109|NCT01508585|Telephone based CBT|telephone based cbt
481110|NCT01508585|Obesity|obesity
481111|NCT01508572|breast cancer|breast cancer
481112|NCT01508572|VEGF|vegf
481113|NCT01508572|optical imaging|optical imaging
481114|NCT01508559|HIV|hiv
481115|NCT01508559|Neurocognitive|neurocognitive
481116|NCT01508546|breast cancer|breast cancer
481117|NCT01508546|axillary dissection|axillary dissection
481118|NCT01508533|Disease burden|disease burden
481119|NCT01508533|Rotavirus gastroenteritis|rotavirus gastroenteritis
481120|NCT01508520|early gastric cancer|early gastric cancer
481121|NCT01508520|stomach neoplasms|stomach neoplasms
481122|NCT01508520|magnifying endoscopy|magnifying endoscopy
481123|NCT01508520|narrow band imaging|narrow band imaging
481124|NCT01508507|Oral|oral
481125|NCT01508507|Cholera|cholera
481126|NCT01508507|Vaccine|vaccine
481127|NCT01508507|Herd|herd
481128|NCT01508507|Risk|risk
481129|NCT01508507|population|population
481130|NCT01508507|Matched|matched
481131|NCT01508507|Control|control
481132|NCT01508507|Case|case
481133|NCT01508507|Bias|bias
481232|NCT01508182|Bioequivalence|bioequivalence
481134|NCT01508494|modification of fMRI maps after galantamine/placebo|modification of fmri maps after galantamine/placebo
481135|NCT01508481|Vitamin D|vitamin d
481136|NCT01508481|Diabetes|diabetes
481137|NCT01508481|pancreas beta cell function|pancreas beta cell function
481138|NCT01508481|insulin resistance|insulin resistance
481139|NCT01508481|Deficiency of Vitamin D3|deficiency of vitamin d3
481140|NCT01508468|Rituximab|rituximab
481141|NCT01508468|membranous nephropathy|membranous nephropathy
481142|NCT01508468|anti-PLA2R antibody|anti-pla2r antibody
481143|NCT01508429|Postpartum hemorrhage|postpartum hemorrhage
481144|NCT01508429|PPH|pph
481145|NCT01508429|misoprostol|misoprostol
481146|NCT01508429|home deliveries|home deliveries
481147|NCT01508416|Multiple Myeloma|multiple myeloma
481148|NCT01508416|Newly diagnosed|newly diagnosed
481149|NCT01508416|Thrombin generation|thrombin generation
481150|NCT01508416|TFPI|tfpi
481151|NCT01508416|Tissue Factor pathway inhibitor|tissue factor pathway inhibitor
481152|NCT01508416|Protein S|protein s
481153|NCT01508416|Thrombosis|thrombosis
481154|NCT01508416|Chemotherapy|chemotherapy
481155|NCT01508390|prostate|prostate
481156|NCT01508377|posttraumatic stress disorder|posttraumatic stress disorder
481157|NCT01508377|internet-based psychotherapy|internet-based psychotherapy
481158|NCT01508377|cognitive restructuring|cognitive restructuring
481159|NCT01508377|exposure|exposure
481160|NCT01508364|renal cell carcinoma, first targeted therapy, observational study|renal cell carcinoma, first targeted therapy, observational study
481161|NCT01508351|Propofol|propofol
481162|NCT01508351|Induction|induction
481163|NCT01508351|Hypotension|hypotension
481164|NCT01508351|General population|general population
481165|NCT01508338|HMB beta-hydroxy-beta-methylbutyrate|hmb beta-hydroxy-beta-methylbutyrate
481166|NCT01508338|ATP (adenosine-triphosphate)|atp (adenosine-triphosphate)
481167|NCT01508338|trained athletes|trained athletes
481168|NCT01508325|Bisoprolol|bisoprolol
481169|NCT01508325|Hypertension|hypertension
481170|NCT01508325|Blood pressure|blood pressure
481171|NCT01508325|Heart rate|heart rate
481172|NCT01508312|CARBOPLATIN|carboplatin
481173|NCT01508312|ETOPOSIDE (VP-16)|etoposide (vp-16)
481174|NCT01508312|IFOSFAMIDE|ifosfamide
481175|NCT01508312|SGN-35 (BRENTUXIMAB VEDOTIN)|sgn-35 (brentuximab vedotin)
481176|NCT01508312|11-142|11-142
481177|NCT01508299|skin test|skin test
481178|NCT01508299|raw food|raw food
481179|NCT01508299|commercial extract|commercial extract
481180|NCT01508286|telaprevir|telaprevir
481181|NCT01508286|hepatitis C|hepatitis c
481182|NCT01508286|early access program|early access program
481183|NCT01508273|Breast Cancer|breast cancer
481184|NCT01508273|Breast Cancer Survivors|breast cancer survivors
481185|NCT01508273|High risk cancer survivors|high risk cancer survivors
481186|NCT01508273|Stage II to IIIC breast cancer|stage ii to iiic breast cancer
481187|NCT01508273|African American|african american
481188|NCT01508273|AA|aa
481189|NCT01508273|Hispanic|hispanic
481190|NCT01508273|Non-Hispanic White|non-hispanic white
481191|NCT01508273|Operable invasive breast carcinoma|operable invasive breast carcinoma
481192|NCT01508273|Aerobic and resistance training|aerobic and resistance training
481193|NCT01508273|Pedometer|pedometer
481194|NCT01508273|Telephone Counseling Calls|telephone counseling calls
481195|NCT01508273|Physical activity report|physical activity report
481196|NCT01508273|PAR|par
481197|NCT01508273|Functional Assessment of Cancer Therapy-Breast|functional assessment of cancer therapy-breast
481198|NCT01508273|FACT-B|fact-b
481199|NCT01508273|Health related quality of life|health related quality of life
481200|NCT01508273|HRQOL|hrqol
481201|NCT01508260|Leukemia|leukemia
481202|NCT01508260|Aquapheresis|aquapheresis
481203|NCT01508260|Ultrafiltration|ultrafiltration
481204|NCT01508260|Aquadex pump|aquadex pump
481205|NCT01508260|Severe Fluid Overload|severe fluid overload
481206|NCT01508260|Diuretic therapy|diuretic therapy
481207|NCT01508260|Dyspnea|dyspnea
481208|NCT01508260|Orthopnea|orthopnea
481209|NCT01508260|Paroxysmal nocturnal dyspnea|paroxysmal nocturnal dyspnea
481210|NCT01508260|PND|pnd
481211|NCT01508260|Peripheral edema|peripheral edema
481212|NCT01508260|Rales|rales
481213|NCT01508260|Jugular venous distension|jugular venous distension
481214|NCT01508260|JVD|jvd
481215|NCT01508260|Hypoxia|hypoxia
481216|NCT01508260|Pulmonary edema by chest X-ray|pulmonary edema by chest x-ray
481217|NCT01508260|Furosemide|furosemide
481218|NCT01508260|Lasix|lasix
481219|NCT01508247|efficacy|efficacy
481220|NCT01508247|safety|safety
481221|NCT01508247|inactivated vaccine (Vero Cell) against EV71|inactivated vaccine (vero cell) against ev71
481222|NCT01508247|EV71-associated diseases|ev71-associated diseases
481223|NCT01508221|brain metastasis|brain metastasis
481224|NCT01508208|Hypertension|hypertension
481225|NCT01508208|24 hour urine protein|24 hour urine protein
481226|NCT01508208|Protein/creatinine ratio|protein/creatinine ratio
481227|NCT01508195|Healthy Volunteers|healthy volunteers
481228|NCT01508195|Bioequivalence|bioequivalence
481229|NCT01508195|Canagliflozin (JNJ-28431754)|canagliflozin (jnj-28431754)
481230|NCT01508195|Metformin IR|metformin ir
481231|NCT01508182|Healthy Volunteers|healthy volunteers
481233|NCT01508182|Canagliflozin (JNJ-28431754)|canagliflozin (jnj-28431754)
481234|NCT01508182|Metformin IR|metformin ir
481235|NCT01508169|elderly|elderly
481236|NCT01508169|balance|balance
481237|NCT01508169|insole|insole
481238|NCT01508169|foot orthosis|foot orthosis
481239|NCT01508169|orthotics|orthotics
481240|NCT01508156|Hepatitis C|hepatitis c
481241|NCT01508156|HCV|hcv
481242|NCT01508156|treatment-naive|treatment-naive
481243|NCT01508143|Abortion|abortion
481244|NCT01508143|Pregnancy|pregnancy
481245|NCT01508143|Termination|termination
481246|NCT01508143|Misoprostol|misoprostol
481247|NCT01508117|GBM|gbm
481248|NCT01508117|brain tumor|brain tumor
481249|NCT01508104|solid tumor|solid tumor
481250|NCT01508104|glioblastoma multiforme|glioblastoma multiforme
481251|NCT01508104|GBM|gbm
481252|NCT01508104|brain tumor|brain tumor
481253|NCT01508104|neuroendocrine tumor|neuroendocrine tumor
481254|NCT01508091|Obesity|obesity
481255|NCT01508091|ageing|ageing
481256|NCT01508052|core temperature|core temperature
481257|NCT01508052|sequential compression device|sequential compression device
481258|NCT01508052|total intravenous anesthesia|total intravenous anesthesia
481259|NCT01508039|Intranasal|intranasal
481260|NCT01508039|Chitin Micro-particles|chitin micro-particles
481261|NCT01508039|Immunological Effects|immunological effects
481262|NCT01508039|Nasal mucosa|nasal mucosa
481263|NCT01508039|Cytokines|cytokines
481264|NCT01508039|Immunological Effects from Intranasal Chitin Micro-Particles|immunological effects from intranasal chitin micro-particles
481265|NCT01508026|Stage 1|stage 1
481266|NCT01508026|Stage 2|stage 2
481267|NCT01508026|Hypertension|hypertension
481268|NCT01508013|Melanoma|melanoma
481269|NCT01508013|Basal Cell Carcinoma|basal cell carcinoma
481270|NCT01508013|Squamous Cell Carcinoma|squamous cell carcinoma
481271|NCT01508000|Liver metastases|liver metastases
481272|NCT01508000|Colorectal Cancer|colorectal cancer
481273|NCT01508000|KRAS wild type|kras wild type
481274|NCT01508000|FOLFOX|folfox
481275|NCT01508000|Bevacizumab|bevacizumab
481276|NCT01508000|Panitumumab|panitumumab
481277|NCT01508000|Randomized|randomized
481278|NCT01508000|Phase II|phase ii
481279|NCT01508000|Perioperative treatment|perioperative treatment
481280|NCT01508000|Adjuvant|adjuvant
481281|NCT01508000|Neo-adjuvant|neo-adjuvant
481282|NCT01508000|Surgery|surgery
481283|NCT01508000|Progression Free Survival|progression free survival
481284|NCT01507987|Externalized Conductors, visual lead an|externalized conductors, visual lead an
481285|NCT01507974|preventive|preventive
481286|NCT01507974|antibiotic treatment|antibiotic treatment
481287|NCT01507974|urinary tract infection|urinary tract infection
481288|NCT01507974|pregnancy|pregnancy
481289|NCT01507974|puerperium|puerperium
481290|NCT01507948|Posttraumatic Stress Disorder (PTSD)|posttraumatic stress disorder (ptsd)
481291|NCT01507948|Psychotherapy|psychotherapy
481292|NCT01507948|non-medication treatment|non-medication treatment
481293|NCT01507948|Prolonged Exposure|prolonged exposure
481294|NCT01507948|Transcranial Magnetic Stimulation (TMS)|transcranial magnetic stimulation (tms)
481295|NCT01507948|Anxiety Disorders|anxiety disorders
481296|NCT01507948|emotion|emotion
481297|NCT01507948|emotion regulation|emotion regulation
481298|NCT01507948|functional MRI|functional mri
481299|NCT01507948|Affective Symptoms|affective symptoms
481300|NCT01507935|Healthy infants|healthy infants
481301|NCT01507935|Infant formula|infant formula
481302|NCT01507935|Prebiotics oligosaccharides|prebiotics oligosaccharides
481303|NCT01507935|Colonisation Resistance|colonisation resistance
481304|NCT01507935|Gut Microbiota|gut microbiota
481305|NCT01507922|Fenoverine|fenoverine
481306|NCT01507922|Irritable Bowel Syndrome|irritable bowel syndrome
481307|NCT01507922|Abdominal pain|abdominal pain
481308|NCT01507922|BSS|bss
481309|NCT01507909|EEG|eeg
481310|NCT01507909|related visual|related visual
481311|NCT01507909|and verbal cues|and verbal cues
481312|NCT01507883|Supervision|supervision
481314|NCT01507883|Resulting|resulting
481315|NCT01507870|body mass index|body mass index
481316|NCT01507857|EV71 vaccine|ev71 vaccine
481317|NCT01507857|HFMD|hfmd
481318|NCT01507857|efficacy|efficacy
481319|NCT01507857|EV71 associated disease|ev71 associated disease
481320|NCT01507844|COPD|copd
481321|NCT01507844|CPAP|cpap
481322|NCT01507844|Sham|sham
481323|NCT01507844|FEV1|fev1
481324|NCT01507844|IC|ic
481325|NCT01507844|RV/TLC|rv/tlc
481326|NCT01507818|Arthroscopic Rotator Cuff Repair|arthroscopic rotator cuff repair
481327|NCT01507818|Electromagnetic field treatment|electromagnetic field treatment
481328|NCT01507818|Pulsed Radio Frequency treatment|pulsed radio frequency treatment
481329|NCT01507818|Non-invasive|non-invasive
481330|NCT01507818|Non-thermal|non-thermal
481331|NCT01507805|Electroacupuncture|electroacupuncture
481332|NCT01507805|preconditioning|preconditioning
481333|NCT01507805|Non-cardiac surgery|non-cardiac surgery
481334|NCT01507805|Coronary heart disease|coronary heart disease
481335|NCT01507792|Cough|cough
481336|NCT01507792|Laryngismus|laryngismus
481337|NCT01507792|Bronchial spasm|bronchial spasm
482995|NCT01501045|EEG|eeg
481338|NCT01507792|Deficiency diseases|deficiency diseases
481339|NCT01507766|severe acute pancreatitis|severe acute pancreatitis
481340|NCT01507766|intra-abdominal pressure|intra-abdominal pressure
481341|NCT01507766|enteral nutrition|enteral nutrition
481342|NCT01507753|childhood bipolar disorder|childhood bipolar disorder
481343|NCT01507727|hyponatremia|hyponatremia
481344|NCT01507727|Non-hypovolemic and Non-acute hyponatremia|non-hypovolemic and non-acute hyponatremia
481345|NCT01507727|Tolvaptan|tolvaptan
481346|NCT01507714|Preventive|preventive
481347|NCT01507714|tvt-o|tvt-o
481348|NCT01507714|stress incontinence|stress incontinence
481349|NCT01507701|adolescents|adolescents
481350|NCT01507688|Stroke|stroke
481351|NCT01507688|Self-Management|self-management
481352|NCT01507688|Transient ischemic attack|transient ischemic attack
481353|NCT01507688|Self-Efficacy|self-efficacy
481354|NCT01507675|suicide|suicide
481355|NCT01507675|psychometric properties|psychometric properties
481356|NCT01507675|military|military
481357|NCT01507675|veterans|veterans
481358|NCT01507675|Interpersonal needs questionnaire|interpersonal needs questionnaire
481359|NCT01507675|Acquired capability for suicide|acquired capability for suicide
481360|NCT01507675|mental health|mental health
481361|NCT01507675|Survey of Life Principles|survey of life principles
481362|NCT01507675|Risk assessment|risk assessment
481363|NCT01507662|Bone Density|bone density
481364|NCT01507662|Absorptiometry, Photon|absorptiometry, photon
481365|NCT01507662|Osteoporosis|osteoporosis
481366|NCT01507662|Bone, Diseases, Metabolic|bone, diseases, metabolic
481367|NCT01507662|Patient Education as Topic|patient education as topic
481368|NCT01507662|Fractures, Bone/Prevention and Control|fractures, bone/prevention and control
481369|NCT01507649|postnatal depression|postnatal depression
481370|NCT01507649|quality of life|quality of life
481371|NCT01507636|apraxia|apraxia
481372|NCT01507636|occupational therapy|occupational therapy
481373|NCT01507636|multiple sclerosis|multiple sclerosis
481374|NCT01507636|manual dexterity|manual dexterity
481375|NCT01507623|NAPS|naps
481376|NCT01507623|Hypoxia|hypoxia
481377|NCT01507623|Propofol|propofol
481378|NCT01507623|capnography|capnography
481379|NCT01507623|endoscopy|endoscopy
481380|NCT01507623|Sedation|sedation
481381|NCT01507610|sumatriptan|sumatriptan
481382|NCT01507610|bioavailability|bioavailability
481383|NCT01507597|Glucagon-like peptide-1|glucagon-like peptide-1
481384|NCT01507597|Glucagon|glucagon
481385|NCT01507597|Normal physiology|normal physiology
481386|NCT01507597|T2DM|t2dm
481387|NCT01507597|T1DM|t1dm
481388|NCT01507571|Incurable cancer|incurable cancer
481389|NCT01507571|Palliative care|palliative care
481390|NCT01507571|Dignity Therapy|dignity therapy
481391|NCT01507571|Loss of dignity|loss of dignity
481392|NCT01507571|Patient Dignity Intventory|patient dignity intventory
481393|NCT01507571|Eortc QLQ-C15-PAL|eortc qlq-c15-pal
481394|NCT01507571|Structured Interview for Symptoms and Concerns|structured interview for symptoms and concerns
481395|NCT01507571|Hospital Anxiety and Depression Scale|hospital anxiety and depression scale
481396|NCT01507558|Peripheral Arterial Disease|peripheral arterial disease
481397|NCT01507558|Femoral popliteal lesions|femoral popliteal lesions
481398|NCT01507545|mCRC|mcrc
481399|NCT01507545|chemorefractory metastatic colorectal cancer|chemorefractory metastatic colorectal cancer
481400|NCT01507506|Glioblastoma|glioblastoma
481401|NCT01507506|Radiotherapy|radiotherapy
481402|NCT01507506|Intensity modulated radiation therapy (IMRT)|intensity modulated radiation therapy (imrt)
481403|NCT01507506|Magnetic resonance spectroscopic imaging (MRSI)|magnetic resonance spectroscopic imaging (mrsi)
481404|NCT01507493|gene polymorphism|gene polymorphism
481405|NCT01507493|SCN9A|scn9a
481406|NCT01507493|pain perception|pain perception
481407|NCT01507493|postoperative pain|postoperative pain
481408|NCT01507480|Hemorrhagic Hereditary Telangiectasia (HHT)|hemorrhagic hereditary telangiectasia (hht)
481409|NCT01507480|Antiangiogenic therapies|antiangiogenic therapies
481410|NCT01507480|Bevacizumab|bevacizumab
481411|NCT01507467|Head and neck carcinoma|head and neck carcinoma
481412|NCT01507467|Accelerated radiotherapy|accelerated radiotherapy
481413|NCT01507467|Hypoxic modification with Nimorazole|hypoxic modification with nimorazole
481414|NCT01507441|childhood myelodysplastic syndromes|childhood myelodysplastic syndromes
481415|NCT01507441|childhood acute myeloid leukemia/other myeloid malignancies|childhood acute myeloid leukemia/other myeloid malignancies
481416|NCT01507441|childhood acute megakaryocytic leukemia (M7)|childhood acute megakaryocytic leukemia (m7)
481417|NCT01507415|Cohort Studies|cohort studies
481418|NCT01507415|Longitudinal Studies|longitudinal studies
481419|NCT01507415|Patient Readmission|patient readmission
481420|NCT01507415|Hospitalization|hospitalization
481421|NCT01507415|Disability Evaluation|disability evaluation
481422|NCT01507376|Ovulation induction|ovulation induction
481423|NCT01507376|urinary|urinary
481424|NCT01507376|hCG|hcg
481425|NCT01507376|recombinant hCG|recombinant hcg
481426|NCT01507350|obesity related glmerulopathy|obesity related glmerulopathy
481427|NCT01507350|51 Cr-EDTA clearance|51 cr-edta clearance
481428|NCT01507350|impaired renal function|impaired renal function
481429|NCT01507350|gastric band|gastric band
481430|NCT01507350|GFR measurement|gfr measurement
481431|NCT01507350|gastric bypass|gastric bypass
481432|NCT01507350|sleeve gastrectomy|sleeve gastrectomy
481433|NCT01507298|Physical activity|physical activity
481434|NCT01507298|Accelerometry|accelerometry
481435|NCT01507298|Oesophageal pH|oesophageal ph
481436|NCT01507298|Capsule endoscopy|capsule endoscopy
481437|NCT01507259|Determine effect on cerebral vasculature|determine effect on cerebral vasculature
481438|NCT01507246|open colectomy|open colectomy
481439|NCT01507233|open colectomy|open colectomy
481440|NCT01507233|colectomy|colectomy
481441|NCT01507220|open colectomy|open colectomy
481442|NCT01507207|Dysphagia|dysphagia
481443|NCT01507207|aspiration|aspiration
481444|NCT01507207|pediatric|pediatric
481445|NCT01507207|injection laryngoplasty|injection laryngoplasty
481446|NCT01507181|suicidal ideation|suicidal ideation
481447|NCT01507181|major depression|major depression
481448|NCT01507181|treatment resistant|treatment resistant
481449|NCT01507181|ketamine|ketamine
481450|NCT01507181|glutamate|glutamate
481451|NCT01507155|Major|major
481452|NCT01507155|Depressive|depressive
481453|NCT01507155|Disorder|disorder
481454|NCT01507155|Depression|depression
481455|NCT01507155|MDD|mdd
481456|NCT01507155|Treatment Resistant|treatment resistant
481457|NCT01507155|Anxiety|anxiety
481458|NCT01507155|GAD|gad
481459|NCT01507142|saliva|saliva
481460|NCT01507142|diagnostics|diagnostics
481461|NCT01507142|HIV|hiv
481462|NCT01507142|AIDS|aids
481463|NCT01507129|dehydration|dehydration
481464|NCT01507129|plasma|plasma
481465|NCT01507129|osmolality|osmolality
481466|NCT01507129|saliva|saliva
481467|NCT01507129|urine|urine
481468|NCT01507129|biomarkers|biomarkers
481469|NCT01507129|hypertonic|hypertonic
481470|NCT01507129|isotonic|isotonic
481471|NCT01507129|hydration|hydration
481472|NCT01507103|Tecemotide (L-BLP25)|tecemotide (l-blp25)
481473|NCT01507103|Cyclophosphamide (CPA)|cyclophosphamide (cpa)
481474|NCT01507103|Mode of action|mode of action
481475|NCT01507103|Neoplasms|neoplasms
481476|NCT01507103|Neoplasms by Site|neoplasms by site
481477|NCT01507103|Carcinomas|carcinomas
481478|NCT01507103|Antineoplastic Agents|antineoplastic agents
481479|NCT01507103|Neoadjuvant|neoadjuvant
481480|NCT01507103|Radiotherapy Pharmacologic Actions|radiotherapy pharmacologic actions
481481|NCT01507103|Immunosuppressive Agents|immunosuppressive agents
481482|NCT01507103|Immunologic Function|immunologic function
481483|NCT01507103|Therapeutic Uses|therapeutic uses
481484|NCT01507103|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action
481485|NCT01507090|children for whom there is no scale to determine weight|children for whom there is no scale to determine weight
481486|NCT01507077|Obese|obese
481487|NCT01507077|Obesity|obesity
481488|NCT01507077|Overweight|overweight
481489|NCT01507064|hepatocellular carcinoma|hepatocellular carcinoma
481490|NCT01507064|sorafenib|sorafenib
481491|NCT01507064|laser ablation|laser ablation
481492|NCT01507051|Rivaroxaban|rivaroxaban
481493|NCT01507051|Xa-Factors|xa-factors
481494|NCT01507051|Warfarin|warfarin
481495|NCT01507051|Thrombosis|thrombosis
481496|NCT01507051|Embolism|embolism
481497|NCT01507038|Diabetes Mellitus|diabetes mellitus
481498|NCT01507038|YH14617|yh14617
481499|NCT01507038|Exenatide|exenatide
481500|NCT01507038|Yuhan|yuhan
481501|NCT01507025|hinge position|hinge position
481502|NCT01507025|dry eye|dry eye
481503|NCT01507012|Berry phenolics|berry phenolics
481504|NCT01507012|mood|mood
481505|NCT01507012|cognition|cognition
481506|NCT01507012|adults|adults
481507|NCT01506999|Angina Pectoris|angina pectoris
481508|NCT01506999|SNPs|snps
481509|NCT01506999|Genetic|genetic
481510|NCT01506999|Myocardial Infarction|myocardial infarction
481511|NCT01506999|Cardiovascular Risk Factors|cardiovascular risk factors
481512|NCT01506986|Ulcer bleeding|ulcer bleeding
481513|NCT01506986|Aspirin|aspirin
481514|NCT01506986|Helicobacter pylori|helicobacter pylori
481515|NCT01506986|H. pylori|h. pylori
481516|NCT01506986|Hospitalisation for ulcer bleeding|hospitalisation for ulcer bleeding
481517|NCT01506973|histologically or cytologically documented|histologically or cytologically documented
481518|NCT01506947|Hemodialysis|hemodialysis
481519|NCT01506947|Chronic kidney disease|chronic kidney disease
481520|NCT01506947|Secondary hyperparathyroidism,|secondary hyperparathyroidism,
481521|NCT01506921|racemic ketamine|racemic ketamine
481522|NCT01506921|S-ketamine|s-ketamine
481523|NCT01506921|Cerebral blood flow|cerebral blood flow
481524|NCT01506921|Magnetic resonance imaging|magnetic resonance imaging
481525|NCT01506921|arterial spin labeling|arterial spin labeling
481526|NCT01506921|healthy volunteers|healthy volunteers
481527|NCT01506908|craving|craving
481528|NCT01506895|Diabetic Macular Edema|diabetic macular edema
481529|NCT01506856|Epithelial ovarian cancer|epithelial ovarian cancer
481530|NCT01506856|Fallopian tube cancer|fallopian tube cancer
481531|NCT01506856|peritoneal cancer|peritoneal cancer
481532|NCT01506856|intraperitoneal therapy|intraperitoneal therapy
481533|NCT01506856|Carboplatin|carboplatin
481534|NCT01506856|Paclitaxel|paclitaxel
481535|NCT01506843|IgA antibody|iga antibody
481536|NCT01506843|IgE antibody|ige antibody
481537|NCT01506843|IgG1/IgG4 subclasses|igg1/igg4 subclasses
481538|NCT01506843|Mite allergy|mite allergy
481539|NCT01506843|Sublingual immunotherapy|sublingual immunotherapy
481540|NCT01506843|Saliva|saliva
481541|NCT01506830|Adhesives.|adhesives.
481542|NCT01506830|Composites.|composites.
481543|NCT01506830|Noncarious cervical lesions.|noncarious cervical lesions.
481544|NCT01506830|Clinical performance.|clinical performance.
481545|NCT01506830|Treatment|treatment
481546|NCT01506817|fibromyalgia|fibromyalgia
481547|NCT01506817|DCE-MRI|dce-mri
481548|NCT01506817|neurogenic inflammation|neurogenic inflammation
481549|NCT01506817|contrast-enhancement patterns|contrast-enhancement patterns
481550|NCT01506804|Shoulder|shoulder
481551|NCT01506804|Impingement|impingement
481552|NCT01506804|Ultrasound|ultrasound
481553|NCT01506804|injection of glucocorticosteroid|injection of glucocorticosteroid
481554|NCT01506804|exercise|exercise
481555|NCT01506791|Bioequivalence|bioequivalence
481556|NCT01506791|Desloratadine and pseudoephedrine|desloratadine and pseudoephedrine
481557|NCT01506791|crossover|crossover
481558|NCT01506778|Endometrial Sampling Procedure|endometrial sampling procedure
481559|NCT01506778|Likert Scala|likert scala
481560|NCT01506778|Pipelle|pipelle
481561|NCT01506778|Tenaculum|tenaculum
481562|NCT01506778|Visual Analog Pain Scala|visual analog pain scala
481563|NCT01506765|Schizophrenia|schizophrenia
481564|NCT01506765|glutathione|glutathione
481565|NCT01506765|NAC|nac
481566|NCT01506765|Neurological scales|neurological scales
481567|NCT01506765|Magnetic Resonance Spectroscopy (MRS)|magnetic resonance spectroscopy (mrs)
481568|NCT01506765|EEG/evoked potentials|eeg/evoked potentials
481569|NCT01506765|fibroblasts|fibroblasts
481570|NCT01506765|patients who receive NAC|patients who receive nac
481571|NCT01506765|patients who receive placebo|patients who receive placebo
481572|NCT01506752|Bioequivalence|bioequivalence
481573|NCT01506752|Healthy Subjects|healthy subjects
481574|NCT01506752|Donepezil|donepezil
481575|NCT01506739|Bioequivalence|bioequivalence
481576|NCT01506739|Healthy Subjects|healthy subjects
481577|NCT01506739|Donepezil|donepezil
481578|NCT01506726|anemia|anemia
481579|NCT01506726|unexplained anemia|unexplained anemia
481580|NCT01506726|elderly|elderly
481581|NCT01506726|geriatric|geriatric
481582|NCT01506726|older adults|older adults
481583|NCT01506726|UAE|uae
481584|NCT01506726|over 65|over 65
481585|NCT01506726|salsalate|salsalate
481586|NCT01506726|PACTTE|pactte
481587|NCT01506726|pactee|pactee
481588|NCT01506726|aging|aging
481589|NCT01506726|aged|aged
481590|NCT01506726|old|old
481591|NCT01506726|older|older
481592|NCT01506687|Colorectal cancer screening|colorectal cancer screening
481593|NCT01506687|50 years or older|50 years or older
481594|NCT01506661|Rheumatoid arthritis|rheumatoid arthritis
481595|NCT01506661|vaccination|vaccination
481596|NCT01506661|immune response|immune response
481597|NCT01506661|varicella zoster|varicella zoster
481598|NCT01506609|PARP|parp
481599|NCT01506609|TMZ|tmz
481600|NCT01506609|Temodal|temodal
481601|NCT01506609|Carboplatin|carboplatin
481602|NCT01506609|veliparib|veliparib
481603|NCT01506609|BRCA2 mutation carrier|brca2 mutation carrier
481604|NCT01506609|Breast cancer|breast cancer
481605|NCT01506609|Metastatic breast cancer|metastatic breast cancer
481606|NCT01506609|temozolomide|temozolomide
481607|NCT01506609|BRCA1 mutation carrier|brca1 mutation carrier
481608|NCT01506609|ABT-888|abt-888
481609|NCT01506609|Paclitaxel|paclitaxel
481610|NCT01506609|Recurrent breast cancer|recurrent breast cancer
481611|NCT01506609|Temodar|temodar
481612|NCT01506609|Locally recurrent|locally recurrent
481613|NCT01506596|Liposarcoma|liposarcoma
481614|NCT01506583|cough|cough
481615|NCT01506583|myalgia|myalgia
481616|NCT01506583|nasal obstruction|nasal obstruction
481617|NCT01506583|sore throat|sore throat
481618|NCT01506583|headache|headache
481619|NCT01506583|fatigue|fatigue
481620|NCT01506583|feverishness|feverishness
481621|NCT01506583|Patients who exhibit flu-like symptoms during a flu season, including cough, myalgia, nasal obstruction, sore throat, headache, fatigue, and/or feverishness.|patients who exhibit flu-like symptoms during a flu season, including cough, myalgia, nasal obstruction, sore throat, headache, fatigue, and/or feverishness.
481622|NCT01506557|vitamin D|vitamin d
481623|NCT01506557|vitamin D deficiency|vitamin d deficiency
481624|NCT01506557|breastfeeding|breastfeeding
481625|NCT01506557|body composition|body composition
481626|NCT01506557|bone mineral content|bone mineral content
481627|NCT01506544|HU|hu
481628|NCT01506544|Hydroxyurea|hydroxyurea
481629|NCT01506544|Sickle cell|sickle cell
481630|NCT01506544|Pediatric|pediatric
481631|NCT01506531|gastroschisis|gastroschisis
481632|NCT01506531|silo|silo
481633|NCT01506531|primary closure|primary closure
481634|NCT01506518|Muscular Dystrophy, Duchenne|muscular dystrophy, duchenne
481635|NCT01506518|Ultrasound|ultrasound
481636|NCT01506518|Imaging|imaging
481637|NCT01506518|Acoustic Radiation Force|acoustic radiation force
481638|NCT01506518|Double Push|double push
481639|NCT01506505|Cardiovascular prevention|cardiovascular prevention
481640|NCT01506505|Polypill|polypill
481641|NCT01506505|Combination therapy|combination therapy
481642|NCT01506492|Randomized controlled trial|randomized controlled trial
481643|NCT01506492|Depression|depression
481644|NCT01506492|Cancer|cancer
481645|NCT01506492|Psychotherapy|psychotherapy
481646|NCT01506492|Quality of life|quality of life
481647|NCT01506479|Parkinson Disease|parkinson disease
481648|NCT01506479|Basal Ganglia Disease|basal ganglia disease
481649|NCT01506479|Central Nervous System Diseases|central nervous system diseases
481650|NCT01506479|Nervous System Diseases|nervous system diseases
481651|NCT01506479|Movement Disorders|movement disorders
481652|NCT01506479|Neurodegenerative Diseases|neurodegenerative diseases
481653|NCT01506479|Brain Diseases|brain diseases
481654|NCT01506466|chemotherapy|chemotherapy
481655|NCT01506466|metabolism|metabolism
481656|NCT01506466|weight|weight
481657|NCT01506466|body composition|body composition
481658|NCT01506453|Acute Lymphoblastic Leukemia|acute lymphoblastic leukemia
481659|NCT01506453|Neuropathy|neuropathy
481660|NCT01506453|Neuropathic Pain|neuropathic pain
481661|NCT01506453|Vincristine|vincristine
481662|NCT01506453|TOTAL XVI Protocol|total xvi protocol
481663|NCT01506427|Newly Diagnosed|newly diagnosed
481664|NCT01506427|Head and Neck Cancer|head and neck cancer
481665|NCT01506427|PET Imaging|pet imaging
481666|NCT01506414|Purpura|purpura
481667|NCT01506414|Idiopathic Thrombocytopenic Purpura|idiopathic thrombocytopenic purpura
481668|NCT01506401|ARDS|ards
481669|NCT01506401|ventilator-induced lung injury|ventilator-induced lung injury
481670|NCT01506401|lung protective ventilation|lung protective ventilation
481671|NCT01506401|high frequency oscillation|high frequency oscillation
481672|NCT01506388|labour induction|labour induction
481673|NCT01506388|Foley catheter|foley catheter
481674|NCT01506388|misoprostol|misoprostol
481675|NCT01506388|isosorbide mononitrate|isosorbide mononitrate
481676|NCT01506375|seasonal allergic rhinoconjunctivitis|seasonal allergic rhinoconjunctivitis
481677|NCT01506375|grass pollen|grass pollen
481678|NCT01506375|allergen specific immunotherapy|allergen specific immunotherapy
481679|NCT01506362|Ulcerative Colitis|ulcerative colitis
481680|NCT01506362|IBD|ibd
481681|NCT01506349|celiac disease|celiac disease
481682|NCT01506349|gluten|gluten
481683|NCT01506349|fog|fog
481684|NCT01506349|attention|attention
481685|NCT01506336|GIST|gist
481686|NCT01506336|resistant|resistant
481687|NCT01506336|imatinib|imatinib
481688|NCT01506336|gastro intestinal stromal tumor resistant to imatinib|gastro intestinal stromal tumor resistant to imatinib
481689|NCT01506323|Complementary Therapy|complementary therapy
481690|NCT01506323|Stress Disorders, Post-Traumatic|stress disorders, post-traumatic
481691|NCT01506323|Veterans Health|veterans health
481692|NCT01506323|Clinical Trials, Randomized|clinical trials, randomized
481693|NCT01506323|Mindfulness|mindfulness
481694|NCT01506323|Spirituality|spirituality
481695|NCT01506323|Meditation|meditation
481696|NCT01506323|Mind-body therapy|mind-body therapy
481697|NCT01506310|gestational diabetes mellitus|gestational diabetes mellitus
481698|NCT01506310|fasting glucose|fasting glucose
481699|NCT01506310|insulin resistance|insulin resistance
481700|NCT01506310|birth-weight|birth-weight
481701|NCT01506310|Glucose values|glucose values
481702|NCT01506310|Insulin concentrations|insulin concentrations
481703|NCT01506310|Cesarean sections|cesarean sections
481704|NCT01506297|obesity|obesity
481705|NCT01506297|satiety|satiety
481706|NCT01506297|body weight management|body weight management
481707|NCT01506284|Forced oscillatory technique|forced oscillatory technique
481708|NCT01506284|Laser interferometry|laser interferometry
481709|NCT01506284|Intravenous anesthesia|intravenous anesthesia
481710|NCT01506284|Mechanical ventilation|mechanical ventilation
481711|NCT01506284|Pressure controlled ventilation|pressure controlled ventilation
481712|NCT01506284|Airways mechanical properties|airways mechanical properties
481713|NCT01506284|Respiratory system reactance|respiratory system reactance
481714|NCT01506284|Oscillatory mechanics|oscillatory mechanics
481715|NCT01506284|Atelectasis|atelectasis
481716|NCT01506271|Complicated Intra-abdominal Infections|complicated intra-abdominal infections
481717|NCT01506258|CD34+|cd34+
481718|NCT01506258|perinatal hypoxia|perinatal hypoxia
481719|NCT01506258|autologous hematopoietic stem cells|autologous hematopoietic stem cells
481720|NCT01506258|cord and placental blood|cord and placental blood
481721|NCT01506258|cerebral palsy|cerebral palsy
481722|NCT01506245|Obesity|obesity
481723|NCT01506245|Children|children
481724|NCT01506245|Behavior|behavior
481725|NCT01506245|Family|family
481726|NCT01506245|Exercise|exercise
481727|NCT01506232|ADHD|adhd
481728|NCT01506232|Pediatric Bipolar Disorder|pediatric bipolar disorder
481729|NCT01506232|Autism|autism
481730|NCT01506232|Autism Spectrum Disorders|autism spectrum disorders
481731|NCT01506232|EEG|eeg
481732|NCT01506232|Brain Flow Analyses|brain flow analyses
481733|NCT01506219|Randomized controlled trial|randomized controlled trial
481734|NCT01506219|Comprehensive geriatric care|comprehensive geriatric care
481735|NCT01506219|Activity of daily living|activity of daily living
481736|NCT01506219|Quality of life|quality of life
481737|NCT01506219|Healthcare utilization|healthcare utilization
481738|NCT01506219|Community rehabilitation unit|community rehabilitation unit
481739|NCT01506219|Medication adjustment|medication adjustment
481740|NCT01506206|Deep Brain Stimulation|deep brain stimulation
481741|NCT01506206|Impulsivity|impulsivity
481742|NCT01506193|safety|safety
481743|NCT01506193|healthy|healthy
481744|NCT01506193|conjugated|conjugated
481745|NCT01506193|immunogenicity|immunogenicity
481746|NCT01506193|children|children
481747|NCT01506193|MenC vaccine|menc vaccine
481748|NCT01506193|MMRV vaccine|mmrv vaccine
481749|NCT01506180|acute medical care|acute medical care
481750|NCT01506180|comprehensive geriatric assessment|comprehensive geriatric assessment
481751|NCT01506180|Health Services for the Aged|health services for the aged
481752|NCT01506180|Geriatric Assessment|geriatric assessment
481753|NCT01506180|Geriatrics|geriatrics
481754|NCT01506180|Aged|aged
481755|NCT01506154|bursitis/tendonitis and/or subdeltoid bursitis|bursitis/tendonitis and/or subdeltoid bursitis
481756|NCT01506141|MPS II|mps ii
481757|NCT01506141|MPS 2|mps 2
481758|NCT01506141|lysosomal storage disorder|lysosomal storage disorder
481759|NCT01506141|mps symptoms|mps symptoms
481760|NCT01506141|enlarged adenoids|enlarged adenoids
481761|NCT01506141|elaprase|elaprase
481762|NCT01506141|hunter's syndrome|hunter's syndrome
481763|NCT01506141|MPS2|mps2
481764|NCT01506141|hunters disease|hunters disease
481765|NCT01506141|hunter's disease treatment|hunter's disease treatment
481766|NCT01506141|hunter syndrome therapy|hunter syndrome therapy
481767|NCT01506141|iduronate sulfatase|iduronate sulfatase
481768|NCT01506141|mps society|mps society
481769|NCT01506141|MPSII|mpsii
481770|NCT01506141|hunter syndrome treatment|hunter syndrome treatment
481771|NCT01506141|hunter's disease|hunter's disease
481772|NCT01506141|iduronate 2 sulfatase|iduronate 2 sulfatase
481773|NCT01506141|mucopolysaccharides|mucopolysaccharides
481774|NCT01506141|mps diagnosis|mps diagnosis
481775|NCT01506141|chronic ear infection|chronic ear infection
481776|NCT01506141|hunters syndrome|hunters syndrome
481777|NCT01506141|ert treatment|ert treatment
481778|NCT01506141|lysosomal storage disease|lysosomal storage disease
481779|NCT01506141|hunter disease|hunter disease
481780|NCT01506141|enzyme replacement therapy|enzyme replacement therapy
481781|NCT01506141|idursulfase|idursulfase
481782|NCT01506141|hunter's syndrome treatment|hunter's syndrome treatment
481783|NCT01506128|HPV|hpv
481784|NCT01506128|Menstrual blood|menstrual blood
481785|NCT01506128|HPV detection using menstrual blood|hpv detection using menstrual blood
481786|NCT01506115|Hepatocellular carcinoma|hepatocellular carcinoma
481787|NCT01506115|Obstructive jaundice|obstructive jaundice
481788|NCT01506115|Photodynamic therapy|photodynamic therapy
481789|NCT01506089|IVF|ivf
481790|NCT01506089|infertility|infertility
481791|NCT01506089|PGD|pgd
481792|NCT01506089|embryo|embryo
481793|NCT01506089|temperature|temperature
481794|NCT01506089|incubator|incubator
481795|NCT01506089|CCS|ccs
481796|NCT01506089|culture|culture
481797|NCT01506089|incubator-36 degrees Celsius|incubator-36 degrees celsius
481798|NCT01506089|incubator-37 degrees Celsius|incubator-37 degrees celsius
481799|NCT01506063|Bioequivalence|bioequivalence
481800|NCT01506063|Levocetirizine|levocetirizine
481801|NCT01506063|Crossover|crossover
481802|NCT01506050|Bioequivalence|bioequivalence
481803|NCT01506050|Desloratadine|desloratadine
481804|NCT01506050|crossover|crossover
481805|NCT01506037|Bioequivalence|bioequivalence
481806|NCT01506037|Desloratadine|desloratadine
481807|NCT01506037|crossover|crossover
481808|NCT01506024|Arthroplasty, Replacement, Hip|arthroplasty, replacement, hip
481809|NCT01506024|Surgical Procedures, Operative|surgical procedures, operative
481810|NCT01506024|Surgical Procedures, Minimally Invasive|surgical procedures, minimally invasive
481811|NCT01505985|Hip fracture|hip fracture
481812|NCT01505985|SPPB|sppb
481813|NCT01505985|Functional recovery|functional recovery
481814|NCT01505972|screening colonoscopy|screening colonoscopy
481815|NCT01505972|attendance|attendance
481816|NCT01505972|response|response
481817|NCT01505972|colorectal cancer|colorectal cancer
481818|NCT01505959|Obstructive Sleep Apnea Syndrome|obstructive sleep apnea syndrome
481819|NCT01505959|Apnea|apnea
481820|NCT01505959|Sleep Apnea|sleep apnea
481821|NCT01505959|Telemedicine|telemedicine
481822|NCT01505959|CPAP compliance|cpap compliance
481823|NCT01505946|Thrombin|thrombin
481824|NCT01505946|Hemophilia|hemophilia
481825|NCT01505946|Inhibitors|inhibitors
481826|NCT01505946|Immunotolerance|immunotolerance
481827|NCT01505946|Haemostatic|haemostatic
481828|NCT01505946|FVIII|fviii
481829|NCT01505946|Epitopes|epitopes
481830|NCT01505946|Moderately severe Hemophilia A with inhibitor|moderately severe hemophilia a with inhibitor
481831|NCT01505933|upper|upper
481832|NCT01505933|airway|airway
481833|NCT01505933|dimensions|dimensions
481834|NCT01505933|propofol|propofol
481835|NCT01505933|dexmedetomidine|dexmedetomidine
481836|NCT01505907|Pharmacokinetics|pharmacokinetics
481837|NCT01505907|Safety|safety
481838|NCT01505907|Healthy Males|healthy males
481839|NCT01505855|Crohn's disease|crohn's disease
481840|NCT01505855|Pneumococcal vaccination|pneumococcal vaccination
481841|NCT01505842|Ulcerative colitis|ulcerative colitis
481842|NCT01505842|Crohn's disease|crohn's disease
481843|NCT01505842|Chromoendoscopy|chromoendoscopy
481844|NCT01505842|Dysplasia|dysplasia
481845|NCT01505842|Neoplasia|neoplasia
481846|NCT01505842|Inflammatory Bowel Disease|inflammatory bowel disease
481847|NCT01505816|Cataract|cataract
481848|NCT01505816|Vision|vision
481849|NCT01505816|Intraocular lens|intraocular lens
481850|NCT01505816|Multifocal|multifocal
481851|NCT01505816|Toric|toric
481852|NCT01505803|Type 2 diabetes mellitus|type 2 diabetes mellitus
481853|NCT01505803|Dietary supplements|dietary supplements
481854|NCT01505803|Hyperglycemia|hyperglycemia
481855|NCT01505803|Insulin resistance|insulin resistance
481856|NCT01505803|Dyslipidemia|dyslipidemia
481857|NCT01505803|Inflammation|inflammation
481858|NCT01505803|Oxidative stress|oxidative stress
481859|NCT01505803|Zinc|zinc
481860|NCT01505803|Omega 3|omega 3
481861|NCT01505777|irritable bowel syndrome without predominant diarrhea|irritable bowel syndrome without predominant diarrhea
481862|NCT01505777|Probiotics(Medirac) 10/mosapride 10mg|probiotics(medirac) 10/mosapride 10mg
481863|NCT01505777|Probiotics(Medirac) 15/mosapride 10mg|probiotics(medirac) 15/mosapride 10mg
481864|NCT01505777|Probiotics(Medirac) 15/mosapride 15mg|probiotics(medirac) 15/mosapride 15mg
481865|NCT01505777|Probiotics(Medirac) 30/mosapride 15mg|probiotics(medirac) 30/mosapride 15mg
481866|NCT01505777|Probiotics(Medirac) placebo/mosapride placebo|probiotics(medirac) placebo/mosapride placebo
481867|NCT01505764|Cachexia|cachexia
481868|NCT01505751|Outcome of cervical cancer|outcome of cervical cancer
481869|NCT01505725|Nicotine Reinforcement|nicotine reinforcement
481870|NCT01505725|Tobacco Craving|tobacco craving
481871|NCT01505725|Behavior Genetics|behavior genetics
481872|NCT01505725|Smoking|smoking
481873|NCT01505712|stage I adult Hodgkin lymphoma|stage i adult hodgkin lymphoma
481874|NCT01505712|stage II adult Hodgkin lymphoma|stage ii adult hodgkin lymphoma
481875|NCT01505712|stage III adult Hodgkin lymphoma|stage iii adult hodgkin lymphoma
481876|NCT01505712|stage IV adult Hodgkin lymphoma|stage iv adult hodgkin lymphoma
481877|NCT01505699|adult acute lymphoblastic leukemia in remission|adult acute lymphoblastic leukemia in remission
481878|NCT01505699|B-cell adult acute lymphoblastic leukemia|b-cell adult acute lymphoblastic leukemia
481879|NCT01505673|Insulin|insulin
481880|NCT01505673|Glucagon-like peptide|glucagon-like peptide
481881|NCT01505673|Liraglutide|liraglutide
481882|NCT01505673|Beta-Cell|beta-cell
481883|NCT01505673|pancreatic steatosis|pancreatic steatosis
481884|NCT01505673|hepatic steatosis|hepatic steatosis
481885|NCT01505660|Adherence|adherence
481886|NCT01505660|Depression|depression
481887|NCT01505660|Care management|care management
481888|NCT01505660|Stepped care|stepped care
481889|NCT01505660|HIV|hiv
481890|NCT01505660|Patient reported outcomes|patient reported outcomes
481891|NCT01505660|Antiretroviral medication adherence|antiretroviral medication adherence
481892|NCT01505634|Relebactam; MK-7655; Imipenem; Urinary Tract Infections; Pyelonephritis; Urologic Diseases; beta-Lactamase Inhibitors; Anti-Bacterial and Anti-Infective Agent|relebactam; mk-7655; imipenem; urinary tract infections; pyelonephritis; urologic diseases; beta-lactamase inhibitors; anti-bacterial and anti-infective agent
481893|NCT01505621|Aging|aging
481894|NCT01505621|Protein accumulation|protein accumulation
481895|NCT01505621|Protein damage|protein damage
481896|NCT01505569|autologous transplantation|autologous transplantation
481897|NCT01505569|high risk solid tumor|high risk solid tumor
481898|NCT01505569|relapsed solid tumor|relapsed solid tumor
481899|NCT01505478|Sepsis|sepsis
481900|NCT01505478|Clinical Prediction Rule|clinical prediction rule
481901|NCT01505478|Clinical Informatics|clinical informatics
481902|NCT01505478|Machine Learning|machine learning
481903|NCT01505465|Total Knee Replacement|total knee replacement
481904|NCT01505465|Pain|pain
481905|NCT01505465|Confusion|confusion
481906|NCT01505465|Sleep|sleep
481907|NCT01505439|solifenacin|solifenacin
481908|NCT01505439|bladder symptom|bladder symptom
481909|NCT01505426|ASP1941|asp1941
481910|NCT01505426|ipragliflozin|ipragliflozin
481911|NCT01505426|urine glucose|urine glucose
481912|NCT01505426|metformin|metformin
481913|NCT01505426|plasma glucose|plasma glucose
481914|NCT01505413|advanced unresectable or metastatic Pancreatic Cancer|advanced unresectable or metastatic pancreatic cancer
481915|NCT01505400|Molecular profiling|molecular profiling
481916|NCT01505400|Advanced cancer|advanced cancer
481917|NCT01505400|Breast cancer|breast cancer
481918|NCT01505400|Non-small cell lung cancer|non-small cell lung cancer
481919|NCT01505400|Colorectal cancer|colorectal cancer
481920|NCT01505400|Genitourinary cancer|genitourinary cancer
481921|NCT01505400|Pancreatobiliary gastrointestinal cancer|pancreatobiliary gastrointestinal cancer
481922|NCT01505400|Upper aerodigestive tract cancer|upper aerodigestive tract cancer
481923|NCT01505400|Gynecological cancers|gynecological cancers
481924|NCT01505400|Phase I|phase i
481925|NCT01505400|Phase I Clinical Trial Candidates|phase i clinical trial candidates
481926|NCT01505400|melanoma cancer|melanoma cancer
481927|NCT01505400|rare cancer|rare cancer
483198|NCT01500174|decubitus|decubitus
481928|NCT01505400|unknown primary cancer|unknown primary cancer
481929|NCT01505387|Weight maintenance|weight maintenance
481930|NCT01505387|Overweight|overweight
481932|NCT01505387|Weight management|weight management
481933|NCT01505374|Bilateral total knee replacement|bilateral total knee replacement
481934|NCT01505374|Femoral Nerve Block|femoral nerve block
481935|NCT01505374|Saphenous Nerve Block|saphenous nerve block
481936|NCT01505361|probiotic|probiotic
481937|NCT01505361|Lactobacillus salivarius|lactobacillus salivarius
481938|NCT01505361|mastitis|mastitis
481939|NCT01505361|prevention|prevention
481940|NCT01505361|group B streptococci|group b streptococci
481941|NCT01505361|intrapartum prophylaxis|intrapartum prophylaxis
481942|NCT01505348|feeding patterns|feeding patterns
481943|NCT01505348|aerobic exercise|aerobic exercise
481944|NCT01505348|osteoclasts|osteoclasts
481945|NCT01505335|alveolar nerve, inferior|alveolar nerve, inferior
481946|NCT01505335|ultrasound|ultrasound
481947|NCT01505335|digital radiography, dental|digital radiography, dental
481948|NCT01505335|nerve injury|nerve injury
481949|NCT01505322|daily activities|daily activities
481950|NCT01505309|Aortic Diseases|aortic diseases
481951|NCT01505309|Vascular Diseases|vascular diseases
481952|NCT01505309|Cardiovascular Diseases|cardiovascular diseases
481953|NCT01505309|Treatment Outcome|treatment outcome
481954|NCT01505309|Aorta Dissection|aorta dissection
481955|NCT01505309|Aorta Aneurysm|aorta aneurysm
481956|NCT01505309|Aorta pseudoaneurysm|aorta pseudoaneurysm
481957|NCT01505309|Endovascular aortic repair|endovascular aortic repair
481958|NCT01505296|Catheter ablation|catheter ablation
481959|NCT01505257|Delirium|delirium
481960|NCT01505257|Dementia|dementia
481961|NCT01505257|Confusion Assessment Method|confusion assessment method
481963|NCT01505231|norepinephrine|norepinephrine
481964|NCT01505231|vasopressin|vasopressin
481965|NCT01505231|cardiac surgery|cardiac surgery
481966|NCT01505218|Sedation|sedation
481967|NCT01505218|propofol|propofol
481968|NCT01505218|patient-controlled|patient-controlled
481969|NCT01505218|safety|safety
481970|NCT01505205|Gist,c-KIT,PDGFRA,DOG1,mutation|gist,c-kit,pdgfra,dog1,mutation
481971|NCT01505192|Those in Labor, Delivery and the Puerperium|those in labor, delivery and the puerperium
481972|NCT01505179|HFPEF|hfpef
481973|NCT01505179|Heart Failure|heart failure
481974|NCT01505179|HF w/ preserved EF|hf w/ preserved ef
481975|NCT01505179|Preserved EF|preserved ef
481976|NCT01505179|Preserved Ejection Fraction|preserved ejection fraction
481977|NCT01505179|Diastolic Dysfunction|diastolic dysfunction
481978|NCT01505166|colorectal carcinoma|colorectal carcinoma
481979|NCT01505166|colon cancer|colon cancer
481980|NCT01505166|liver metastases|liver metastases
481981|NCT01505153|Advanced cancer|advanced cancer
481982|NCT01505153|Metastatic cancer|metastatic cancer
481983|NCT01505153|solid tumors|solid tumors
481984|NCT01505153|Melanoma|melanoma
481985|NCT01505140|Andrology|andrology
481986|NCT01505140|Fertility|fertility
481987|NCT01505140|Reproduction|reproduction
481988|NCT01505140|Diet|diet
481989|NCT01505140|Nutritional Sciences|nutritional sciences
481990|NCT01505140|Fatty Acids|fatty acids
481991|NCT01505140|Antioxidants|antioxidants
481992|NCT01505140|Body weight changes|body weight changes
481993|NCT01505127|Drug Therapy|drug therapy
481994|NCT01505114|HIV Prevention|hiv prevention
481995|NCT01505114|PrEP|prep
481996|NCT01505114|Maraviroc|maraviroc
481997|NCT01505088|Iontophoresis|iontophoresis
481998|NCT01505088|Non-Infectious Anterior Segment Uveitis|non-infectious anterior segment uveitis
481999|NCT01505088|Ophthalmology|ophthalmology
482000|NCT01505075|prostatic neoplasms|prostatic neoplasms
482001|NCT01505075|radiotherapy|radiotherapy
482002|NCT01505075|hypofractionated|hypofractionated
482003|NCT01505075|high risk prostate cancer|high risk prostate cancer
482004|NCT01505062|Usher Syndrome Retinitis Pigmentosa|usher syndrome retinitis pigmentosa
482005|NCT01505062|Usher Syndrome associated Retinitis Pigmentosa|usher syndrome associated retinitis pigmentosa
482006|NCT01505049|immunology|immunology
482007|NCT01505049|vaccination|vaccination
482008|NCT01505049|human papillomavirus|human papillomavirus
482009|NCT01505036|Diabetes Mellitus|diabetes mellitus
482010|NCT01505036|smart-care|smart-care
482011|NCT01505036|U-health care|u-health care
482012|NCT01505010|Treatment-resistant hypertension|treatment-resistant hypertension
482013|NCT01505010|Renal denervation|renal denervation
482014|NCT01505010|Sympathetic nervous system|sympathetic nervous system
482015|NCT01504997|DaVinci|davinci
482016|NCT01504997|Robot assisted surgery|robot assisted surgery
482017|NCT01504997|Gastrectomy|gastrectomy
482018|NCT01504997|Safety|safety
482019|NCT01504997|Gastric Cancer|gastric cancer
482020|NCT01504984|Evaluation of the pharmacokinetics equivalence|evaluation of the pharmacokinetics equivalence
482021|NCT01504984|Healthy volunteers|healthy volunteers
482022|NCT01504984|Single dose over the period I and II(crossover)|single dose over the period i and ii(crossover)
482023|NCT01504984|Healthy male volunteers|healthy male volunteers
482024|NCT01504971|Gastroesophageal Reflux;|gastroesophageal reflux;
482025|NCT01504971|Endoscopy;|endoscopy;
482026|NCT01504971|Esophageal pH monitoring;|esophageal ph monitoring;
482027|NCT01504971|Narrow band imaging;|narrow band imaging;
482028|NCT01504971|Autofluorescence imaging;|autofluorescence imaging;
482029|NCT01504971|White light imaging;|white light imaging;
482030|NCT01504958|Alzheimer's disease|alzheimer's disease
482031|NCT01504958|Cognitive Training|cognitive training
482032|NCT01504958|Transcranial Magnetic Stimulation|transcranial magnetic stimulation
482033|NCT01504945|chronic coronary artery disease|chronic coronary artery disease
482034|NCT01504932|black raspberry lozenges|black raspberry lozenges
482035|NCT01504932|Appalachian|appalachian
482036|NCT01504932|Oral Cancer|oral cancer
482037|NCT01504919|Psychosocial|psychosocial
482038|NCT01504919|Behavioral intervention|behavioral intervention
482039|NCT01504919|Nicotine patch|nicotine patch
482041|NCT01504919|Mexican American|mexican american
482042|NCT01504919|Motivation and Problem Solving|motivation and problem solving
482043|NCT01504919|MAPS|maps
482044|NCT01504919|Cancer risk reduction|cancer risk reduction
482045|NCT01504919|Smoking cessation|smoking cessation
482046|NCT01504919|Overweight/obese smokers|overweight/obese smokers
482047|NCT01504919|BMI greater than or equal to 25|bmi greater than or equal to 25
482048|NCT01504919|Wellness program|wellness program
482049|NCT01504919|Questionnaires|questionnaires
482050|NCT01504919|Surveys|surveys
482051|NCT01504919|Self-help materials|self-help materials
482052|NCT01504919|Pamphlets|pamphlets
482053|NCT01504906|Phase 1|phase 1
482054|NCT01504906|Healthy male volunteers|healthy male volunteers
482055|NCT01504906|pharmacokinetics|pharmacokinetics
482056|NCT01504906|cyclosporine|cyclosporine
482057|NCT01504906|ticagrelor|ticagrelor
482058|NCT01504906|Bioavailability (plasma AUC, Cmax, plasma AUC0-t, t1/2λz, tmax)|bioavailability (plasma auc, cmax, plasma auc0-t, t1/2λz, tmax)
482059|NCT01504893|ventilation|ventilation
482060|NCT01504893|PEEP|peep
482061|NCT01504893|Acute Lung Injury|acute lung injury
482062|NCT01504893|pneumonectomy|pneumonectomy
482063|NCT01504893|ARDS|ards
482064|NCT01504880|Mitral Regurgitation|mitral regurgitation
482065|NCT01504880|Tricuspid Regurgitation|tricuspid regurgitation
482066|NCT01504880|Vena Contracta|vena contracta
482067|NCT01504867|Acute Respiratory Distress Syndrome|acute respiratory distress syndrome
482068|NCT01504867|Acute Lung Injury|acute lung injury
482069|NCT01504867|ARDS|ards
482070|NCT01504867|ALI|ali
482071|NCT01504867|aspirin|aspirin
482072|NCT01504867|prevention|prevention
482073|NCT01504854|Alzheimer's disease|alzheimer's disease
482074|NCT01504854|Dementia|dementia
482075|NCT01504854|Brain diseases|brain diseases
482076|NCT01504854|Resveratrol|resveratrol
482077|NCT01504854|Memory problems|memory problems
482078|NCT01504854|Mental disorders|mental disorders
482079|NCT01504854|Cognitive disorders|cognitive disorders
482080|NCT01504828|Energy Metabolism|energy metabolism
482081|NCT01504828|Ageing|ageing
482082|NCT01504828|left ventricle|left ventricle
482083|NCT01504828|energetics|energetics
482084|NCT01504828|function|function
482085|NCT01504815|advanced head and neck cancer|advanced head and neck cancer
482086|NCT01504815|adaptive radiotherapy|adaptive radiotherapy
482087|NCT01504815|cisplatinum|cisplatinum
482088|NCT01504802|Growth hormone|growth hormone
482089|NCT01504802|C-type natriuretic peptide|c-type natriuretic peptide
482090|NCT01504802|amino-terminal propeptide of C-type natriuretic peptide|amino-terminal propeptide of c-type natriuretic peptide
482091|NCT01504802|insulin-like growth factor-I|insulin-like growth factor-i
482092|NCT01504802|bone specific alkaline phosphatase|bone specific alkaline phosphatase
482093|NCT01504802|leptin|leptin
482094|NCT01504802|deoxypyridinoline|deoxypyridinoline
482095|NCT01504802|growth velocity|growth velocity
482096|NCT01504802|pharmacodynamic|pharmacodynamic
482097|NCT01504802|biomarker|biomarker
482098|NCT01504789|Breast Cancer|breast cancer
482099|NCT01504789|Breast Cancer Survivors|breast cancer survivors
482100|NCT01504789|Exercise|exercise
482101|NCT01504789|Hispanic|hispanic
482102|NCT01504789|Mexican-American|mexican-american
482103|NCT01504789|Puerto Rican|puerto rican
482104|NCT01504789|Culturally tailored exercise|culturally tailored exercise
482105|NCT01504789|Fitness tests|fitness tests
482106|NCT01504789|Questionnaires|questionnaires
482107|NCT01504789|Surveys|surveys
482108|NCT01504789|Culturally tailored written material|culturally tailored written material
482109|NCT01504776|MCL|mcl
482110|NCT01504776|Lymphoma|lymphoma
482111|NCT01504776|Panobinostat|panobinostat
482112|NCT01504763|Massage|massage
482113|NCT01504763|Chair massage|chair massage
482114|NCT01504763|Relaxation|relaxation
482115|NCT01504763|Nurses|nurses
482116|NCT01504750|Length of Stay [E02.760.400.480]|length of stay [e02.760.400.480]
482117|NCT01504750|Activities of Daily Living [I03.050]|activities of daily living [i03.050]
482118|NCT01504737|Exercise|exercise
482119|NCT01504737|Physical Activity|physical activity
482120|NCT01504737|Physiotherapy|physiotherapy
482121|NCT01504737|Exercise test|exercise test
482122|NCT01504737|Quality of Life|quality of life
482123|NCT01504737|Aortic Valve Replacement|aortic valve replacement
482124|NCT01504724|central macular thickness|central macular thickness
482125|NCT01504698|Manipulative treatment|manipulative treatment
482126|NCT01504698|Children|children
482127|NCT01504698|Neck pain|neck pain
482128|NCT01504698|Back pain|back pain
482129|NCT01504698|Effect|effect
482130|NCT01504698|Adolescence|adolescence
482131|NCT01504698|Advise|advise
482132|NCT01504698|Exercise|exercise
482133|NCT01504685|Morbid obesity|morbid obesity
482134|NCT01504685|Obesity surgery|obesity surgery
482135|NCT01504685|Gastric bypass|gastric bypass
482136|NCT01504685|Banded gastric bypass|banded gastric bypass
482137|NCT01504672|Drug related problems|drug related problems
482138|NCT01504659|bipolar disorder|bipolar disorder
482139|NCT01504659|treatment resistance|treatment resistance
482140|NCT01504659|depression|depression
482141|NCT01504659|ketamine|ketamine
482142|NCT01504659|intranasal|intranasal
482143|NCT01504659|child|child
482144|NCT01504646|Asthma|asthma
482145|NCT01504646|Exercise-Induced Bronchoconstriction|exercise-induced bronchoconstriction
482146|NCT01504646|lipids|lipids
482147|NCT01504646|n-3 PUFA|n-3 pufa
482148|NCT01504646|airway inflammation|airway inflammation
482149|NCT01504646|Bronchoconstriction|bronchoconstriction
482150|NCT01504633|cognitive function|cognitive function
482151|NCT01504633|omega-3 PUFA (DHA)|omega-3 pufa (dha)
482152|NCT01504633|iron|iron
482153|NCT01504633|nutrigenomics|nutrigenomics
482154|NCT01504633|under-two year old children|under-two year old children
482155|NCT01504633|Indonesia|indonesia
482156|NCT01504620|diabetes mellitus|diabetes mellitus
482157|NCT01504620|blood glucose self-assessment|blood glucose self-assessment
482158|NCT01504620|Accuracy|accuracy
482159|NCT01504620|Intra-Assay precision|intra-assay precision
482160|NCT01504620|Hematocrit interference|hematocrit interference
482161|NCT01504607|corneal endothelium|corneal endothelium
482162|NCT01504607|congenital cataract surgery|congenital cataract surgery
482163|NCT01504607|IOL implantation|iol implantation
482164|NCT01504594|Dilated cardiomyopathy|dilated cardiomyopathy
482165|NCT01504594|Idiopathic|idiopathic
482166|NCT01504594|Bone Marrow|bone marrow
482167|NCT01504594|Stem Cells|stem cells
482168|NCT01504594|CD34 +|cd34 +
482169|NCT01504594|Autologous|autologous
482170|NCT01504555|hypercortisolism, dexamethasone, alcoholism,obesity.|hypercortisolism, dexamethasone, alcoholism,obesity.
482171|NCT01504542|Immunotherapy|immunotherapy
482172|NCT01504529|Rotigotine (Neupro)|rotigotine (neupro)
482173|NCT01504529|Non-Motor Symptoms|non-motor symptoms
482174|NCT01504529|Advanced Parkinson's Disease|advanced parkinson's disease
482175|NCT01504529|Local study|local study
482176|NCT01504529|Spain|spain
482177|NCT01504529|Observational study|observational study
482178|NCT01504529|Non-interventional study|non-interventional study
482179|NCT01504529|Retrospective study|retrospective study
482180|NCT01504529|Post-marketing study|post-marketing study
482181|NCT01504529|Multicenter study|multicenter study
482182|NCT01504516|Bioequivalence|bioequivalence
482183|NCT01504516|Donepezil|donepezil
482184|NCT01504516|crossover|crossover
482185|NCT01504503|Bioequivalence|bioequivalence
482186|NCT01504503|Donepezil|donepezil
482187|NCT01504503|crossover|crossover
482188|NCT01504490|Advanced cancer|advanced cancer
482189|NCT01504477|colorectal cancer|colorectal cancer
482190|NCT01504477|relapsed|relapsed
482191|NCT01504477|refractory|refractory
482192|NCT01504477|Kras wild type|kras wild type
482193|NCT01504464|knee joint osteoarthritis mesenchymal stem cell|knee joint osteoarthritis mesenchymal stem cell
482194|NCT01504451|Atrial fibrillation|atrial fibrillation
482195|NCT01504451|Ablation|ablation
482196|NCT01504451|Implantable loop recorder|implantable loop recorder
482197|NCT01504412|Pain|pain
482198|NCT01504412|Diabetic Peripheral Neuropathy|diabetic peripheral neuropathy
482199|NCT01504399|Pituitary surgery|pituitary surgery
482200|NCT01504399|Transsphenoidal surgery|transsphenoidal surgery
482201|NCT01504399|Anterior skull base surgery|anterior skull base surgery
482202|NCT01504399|Endoscopic surgery|endoscopic surgery
482203|NCT01504399|Patient survey|patient survey
482204|NCT01504399|Nasal complications|nasal complications
482205|NCT01504373|NAVA|nava
482206|NCT01504373|neurally adjusted ventilatory support|neurally adjusted ventilatory support
482207|NCT01504373|lung injury|lung injury
482208|NCT01504373|ventilation|ventilation
482209|NCT01504373|lung volume distribution|lung volume distribution
482210|NCT01504373|oxygen cost of breathing|oxygen cost of breathing
482211|NCT01504360|sarcoma|sarcoma
482212|NCT01504360|radiation therapy|radiation therapy
482213|NCT01504360|predictive essay|predictive essay
482214|NCT01504321|Polycystic Ovary syndrome|polycystic ovary syndrome
482215|NCT01504321|PCOS|pcos
482216|NCT01504321|sympathetic nervous system|sympathetic nervous system
482217|NCT01504321|moxonidine|moxonidine
482218|NCT01504308|uterine fibroids|uterine fibroids
482219|NCT01504308|uterine leiomyomas|uterine leiomyomas
482220|NCT01504308|magnetic resonance imaging|magnetic resonance imaging
482221|NCT01504308|focused ultrasound|focused ultrasound
482222|NCT01504256|Adenocarcinoma|adenocarcinoma
482223|NCT01504256|Esophagogastric Junction|esophagogastric junction
482224|NCT01504256|Peritoneal Carcinomatosis|peritoneal carcinomatosis
482225|NCT01504256|Catumaxomab|catumaxomab
482226|NCT01504256|AIO-STO-0110|aio-sto-0110
482227|NCT01504243|CD163;|cd163;
482228|NCT01504243|SNPs;|snps;
482229|NCT01504243|prognosis;|prognosis;
482230|NCT01504243|control（normal person）|control（normal person）
482231|NCT01504230|To ascertain the mechanisms for effectively controlling balance in seniors with osteoporosis and to provide a basis for developing fall prevention programs.|to ascertain the mechanisms for effectively controlling balance in seniors with osteoporosis and to provide a basis for developing fall prevention programs.
482232|NCT01504230|To develop biomechanical models that control the entire body's center of mass (CoM) during upright quiet stance in seniors with osteoporosis.|to develop biomechanical models that control the entire body's center of mass (com) during upright quiet stance in seniors with osteoporosis.
482233|NCT01504230|To identify the mechanism to control the entire body's CoM after receiving a balance perturbation in seniors with osteoporosis.|to identify the mechanism to control the entire body's com after receiving a balance perturbation in seniors with osteoporosis.
482234|NCT01504217|Healthy older people over 65 years old|healthy older people over 65 years old
482235|NCT01504204|adherence|adherence
482236|NCT01504204|adapalene|adapalene
482237|NCT01504204|benzoyl peroxide|benzoyl peroxide
482238|NCT01504204|sample|sample
482239|NCT01504204|topical treatment|topical treatment
482240|NCT01504191|myocardial infarction|myocardial infarction
482241|NCT01504191|depression|depression
482242|NCT01504191|anxiety|anxiety
482243|NCT01504191|Internet‐based CBT|internet‐based cbt
482244|NCT01504191|genetic disposition|genetic disposition
482245|NCT01504178|Noradrenergic system and pain in Parkinson's disease|noradrenergic system and pain in parkinson's disease
482246|NCT01504165|Renal impairment|renal impairment
482247|NCT01504165|Pharmacokinetic|pharmacokinetic
482248|NCT01504165|cilengitide|cilengitide
482249|NCT01504165|subjects with mild|subjects with mild
482250|NCT01504165|moderate or severe renal impairment compared to subjects with normal renal function|moderate or severe renal impairment compared to subjects with normal renal function
482251|NCT01504152|International travel|international travel
482252|NCT01504152|cancer patients|cancer patients
482253|NCT01504152|HSCT|hsct
482254|NCT01504152|Quality of Life|quality of life
482255|NCT01504152|questionnaire|questionnaire
482256|NCT01504152|11-176|11-176
482257|NCT01504113|Target therapy|target therapy
482258|NCT01504113|Biologics|biologics
482259|NCT01504113|Psoriasis|psoriasis
482260|NCT01504113|Latent virus|latent virus
482261|NCT01504113|Human papillomaviruses|human papillomaviruses
482262|NCT01504113|Cytomegalovirus|cytomegalovirus
482263|NCT01504113|Epstein-Barr virus|epstein-barr virus
482264|NCT01504113|Tumor necrosis factor|tumor necrosis factor
482265|NCT01504087|patient in critical care|patient in critical care
482266|NCT01504074|Irvine Gass syndrome|irvine gass syndrome
482267|NCT01504074|multimodal imaging|multimodal imaging
482268|NCT01504074|SD-OCT|sd-oct
482269|NCT01504074|CME secondary to cataract surgery|cme secondary to cataract surgery
482270|NCT01504074|in vivo correlation of morphology and function|in vivo correlation of morphology and function
482271|NCT01504061|surgical|surgical
482272|NCT01504061|scars|scars
482273|NCT01504061|Mederma|mederma
482274|NCT01504048|Microscopic colitis|microscopic colitis
482275|NCT01504048|Intestinal Diseases|intestinal diseases
482276|NCT01504048|Inflammatory Bowel Diseases|inflammatory bowel diseases
482277|NCT01504035|Donor site pain|donor site pain
482278|NCT01504035|Iliac crest|iliac crest
482279|NCT01504035|Bone graft|bone graft
482280|NCT01504035|Hemostatic putty|hemostatic putty
482281|NCT01504035|lidocaine|lidocaine
482282|NCT01504035|Donor site pain following harvest of iliac crest bone grafts|donor site pain following harvest of iliac crest bone grafts
482283|NCT01504022|Hypertension|hypertension
482284|NCT01504022|self-monitoring|self-monitoring
482285|NCT01504022|internet|internet
482286|NCT01504022|lifestyle modification|lifestyle modification
482287|NCT01504009|Nervous System Disease|nervous system disease
482288|NCT01504009|Neurodegenerative Disease|neurodegenerative disease
482289|NCT01504009|Motor Neuron Disease|motor neuron disease
482290|NCT01504009|ALS|als
482291|NCT01504009|Muscle training|muscle training
482292|NCT01504009|Muscle atrophy|muscle atrophy
482293|NCT01503996|dehydration|dehydration
482294|NCT01503996|risk factor|risk factor
482295|NCT01503996|glaucoma|glaucoma
482296|NCT01503996|Controls|controls
482297|NCT01503983|Gastric Cancer with Metastasis|gastric cancer with metastasis
482298|NCT01503983|HER2-positive|her2-positive
482299|NCT01503970|chondral lesions|chondral lesions
482300|NCT01503970|knee|knee
482301|NCT01503957|Allergic rhinitis|allergic rhinitis
482302|NCT01503957|Allergen|allergen
482303|NCT01503957|Allergy|allergy
482304|NCT01503957|Dustmite|dustmite
482305|NCT01503931|alcohol dependence, functional magnetic resonance imaging, genetics, endophenotypes, dopamine,|alcohol dependence, functional magnetic resonance imaging, genetics, endophenotypes, dopamine,
482306|NCT01503931|glutamate|glutamate
482307|NCT01503918|Critical Illness|critical illness
482308|NCT01503918|Critical Care|critical care
482309|NCT01503918|Valganciclovir|valganciclovir
482310|NCT01503918|Ganciclovir|ganciclovir
482311|NCT01503918|Aciclovir|aciclovir
482312|NCT01503918|Valaciclovir|valaciclovir
482313|NCT01503918|Cytomegalovirus|cytomegalovirus
482314|NCT01503905|breast cancer|breast cancer
482315|NCT01503905|neoadjuvant chemotherapy|neoadjuvant chemotherapy
482316|NCT01503905|amenorrhea|amenorrhea
482317|NCT01503892|Small Fiber Neuropathy|small fiber neuropathy
482318|NCT01503892|Metanx Effect on Small Fiber Neuropathy|metanx effect on small fiber neuropathy
482319|NCT01503892|Metanx Effect on Diabetic Peripheral Neuropathy|metanx effect on diabetic peripheral neuropathy
482320|NCT01503879|general anaesthesia|general anaesthesia
482321|NCT01503879|invasive mechanical ventilation|invasive mechanical ventilation
482322|NCT01503879|DLCO|dlco
482324|NCT01503853|Medical Costs|medical costs
482325|NCT01503853|Health Care|health care
482326|NCT01503853|Focus Groups|focus groups
482327|NCT01503827|Whole Brain Radiotherapy|whole brain radiotherapy
482328|NCT01503827|Brain metastases|brain metastases
482329|NCT01503827|Melanoma|melanoma
482330|NCT01503827|Stage IV Metastatic Melanoma|stage iv metastatic melanoma
482331|NCT01503827|Neurocognitive function|neurocognitive function
482332|NCT01503827|Quality of life|quality of life
482333|NCT01503814|hypertension|hypertension
482334|NCT01503814|primary care|primary care
482335|NCT01503814|cardiovascular disease prevention|cardiovascular disease prevention
482336|NCT01503814|high cardiovascular risk|high cardiovascular risk
482337|NCT01503814|diuretics|diuretics
482338|NCT01503814|aspirin|aspirin
482339|NCT01503814|smoking cessation|smoking cessation
482340|NCT01503814|salt reduction|salt reduction
482341|NCT01503814|Tibet|tibet
482342|NCT01503801|Preterm neonates|preterm neonates
482343|NCT01503801|Bronchopulmonary dysplasia|bronchopulmonary dysplasia
482344|NCT01503801|Chronic lung disease|chronic lung disease
482345|NCT01503801|Inhaled nitric oxide|inhaled nitric oxide
482346|NCT01503801|Respiratory therapy|respiratory therapy
482347|NCT01503775|intracranial|intracranial
482348|NCT01503775|ruptured|ruptured
482349|NCT01503775|non-ruptured|non-ruptured
482350|NCT01503775|aneurysms|aneurysms
482351|NCT01503775|Intracranial ruptured or non-ruptured aneurysms|intracranial ruptured or non-ruptured aneurysms
482352|NCT01503762|Hand Flexor tendon Injuries|hand flexor tendon injuries
482353|NCT01503762|hand Extensor Tendon Injuries|hand extensor tendon injuries
482354|NCT01503762|Hand Joint Dislocations and subluxation|hand joint dislocations and subluxation
482355|NCT01503736|Kidney Diseases|kidney diseases
482356|NCT01503736|Kidney Failure, Chronic|kidney failure, chronic
482357|NCT01503736|Hyperphosphatemia|hyperphosphatemia
482358|NCT01503736|Urologic Diseases|urologic diseases
482359|NCT01503736|Renal Insufficiency, Chronic|renal insufficiency, chronic
482360|NCT01503736|Renal Insufficiency|renal insufficiency
482361|NCT01503736|Phosphorus Metabolism Disorders|phosphorus metabolism disorders
482362|NCT01503710|Proteinuria predict outcome|proteinuria predict outcome
482363|NCT01503710|BNP and NGAL predict outcome|bnp and ngal predict outcome
482364|NCT01503710|Pre-operative GFR and proteinuria|pre-operative gfr and proteinuria
482365|NCT01503697|Breast Cancer|breast cancer
482366|NCT01503697|High Risk|high risk
482367|NCT01503697|Imaging|imaging
482368|NCT01503697|Angiogenesis|angiogenesis
482369|NCT01503684|sepsis|sepsis
482370|NCT01503671|left ventricular diastolic function|left ventricular diastolic function
482371|NCT01503671|inflammation|inflammation
482372|NCT01503671|peritoneal dialysis|peritoneal dialysis
482373|NCT01503671|LV diastolic function changes after statin intervention|lv diastolic function changes after statin intervention
482374|NCT01503658|Clopidogrel,|clopidogrel,
482375|NCT01503658|Aspirin,|aspirin,
482376|NCT01503658|Pharmacogenomics|pharmacogenomics
482377|NCT01503645|kidney diseases|kidney diseases
482378|NCT01503645|drugs, Chinese herbal|drugs, chinese herbal
482379|NCT01503645|aristolochic acid|aristolochic acid
482380|NCT01503645|polymorphism, genetic|polymorphism, genetic
482381|NCT01503619|small cell lung cancer|small cell lung cancer
482382|NCT01503606|preterm premature rupture of membrane|preterm premature rupture of membrane
482383|NCT01503606|antibiotics|antibiotics
482384|NCT01503606|duration|duration
482385|NCT01503606|cefazolin|cefazolin
482386|NCT01503606|clarithromycin|clarithromycin
482387|NCT01503541|adult acute myeloid leukemia with 11q23 (MLL) abnormalities|adult acute myeloid leukemia with 11q23 (mll) abnormalities
482388|NCT01503541|adult acute myeloid leukemia with del(5q)|adult acute myeloid leukemia with del(5q)
482389|NCT01503541|adult acute myeloid leukemia with inv(16)(p13;q22)|adult acute myeloid leukemia with inv(16)(p13;q22)
482390|NCT01503541|adult acute myeloid leukemia with t(15;17)(q22;q12)|adult acute myeloid leukemia with t(15;17)(q22;q12)
482391|NCT01503541|adult acute myeloid leukemia with t(16;16)(p13;q22)|adult acute myeloid leukemia with t(16;16)(p13;q22)
482392|NCT01503541|adult acute myeloid leukemia with t(8;21)(q22;q22)|adult acute myeloid leukemia with t(8;21)(q22;q22)
482393|NCT01503541|adult acute myeloid leukemia|adult acute myeloid leukemia
482394|NCT01503528|arthroplasty|arthroplasty
482395|NCT01503528|wound|wound
482396|NCT01503528|catheter|catheter
482397|NCT01503528|local|local
482398|NCT01503528|anesthesia|anesthesia
482399|NCT01503528|infiltration|infiltration
482400|NCT01503528|Total Knee Arthroplasty|total knee arthroplasty
482401|NCT01503502|Myelogenous Leukemia|myelogenous leukemia
482402|NCT01503502|chronce|chronce
482403|NCT01503502|Philadelphia Chromosome Positive|philadelphia chromosome positive
482404|NCT01503502|Flumatinib|flumatinib
482406|NCT01503476|gastro esophageal reflux disease|gastro esophageal reflux disease
482407|NCT01503463|Congestive Heart Failure|congestive heart failure
482408|NCT01503463|Telemedicine|telemedicine
482409|NCT01503385|Celecoxib|celecoxib
482410|NCT01503385|phase II|phase ii
482411|NCT01503359|glutamic acid|glutamic acid
482412|NCT01503359|sarcosine|sarcosine
482413|NCT01503359|NMDA|nmda
482414|NCT01503359|schizophrenia|schizophrenia
482415|NCT01503346|Appetite Loss|appetite loss
482416|NCT01503333|exercise|exercise
482417|NCT01503333|adolescent|adolescent
482418|NCT01503333|intervention|intervention
482419|NCT01503333|female|female
482420|NCT01503333|counseling|counseling
482421|NCT01503320|To evaluate|to evaluate
482422|NCT01503320|efficacy|efficacy
482423|NCT01503320|enteral glutamine|enteral glutamine
482424|NCT01503307|prenatal chd diagnosis|prenatal chd diagnosis
482425|NCT01503307|postpartum chd diagnosis|postpartum chd diagnosis
482426|NCT01503307|parenting|parenting
482427|NCT01503307|internal working models|internal working models
482428|NCT01503294|Temporal artery thermometer|temporal artery thermometer
482429|NCT01503294|Pulmonary artery thermistor|pulmonary artery thermistor
482430|NCT01503281|Children|children
482431|NCT01503281|Physical activity|physical activity
482432|NCT01503281|Home-based treatment|home-based treatment
482433|NCT01503281|Body mass index (z-BMI)|body mass index (z-bmi)
482434|NCT01503281|Percentage body fat|percentage body fat
482435|NCT01503281|Waist circumference|waist circumference
482436|NCT01503268|Atrial fibrillation|atrial fibrillation
482437|NCT01503268|Ablation|ablation
482438|NCT01503268|Percutaneous ablation|percutaneous ablation
482439|NCT01503268|Minimally-invasive thoracoscopic ablation|minimally-invasive thoracoscopic ablation
482440|NCT01503268|Implantable loop recorder|implantable loop recorder
482441|NCT01503255|CBT|cbt
482442|NCT01503255|alcohol|alcohol
482443|NCT01503255|HIV|hiv
482444|NCT01503255|Kenya|kenya
482445|NCT01503255|paraprofessional|paraprofessional
482446|NCT01503216|randomized controlled trial|randomized controlled trial
482447|NCT01503216|vitamin D|vitamin d
482448|NCT01503216|bioavailability|bioavailability
482449|NCT01503203|Older|older
482450|NCT01503203|virtual systems|virtual systems
482451|NCT01503203|low back pain|low back pain
482452|NCT01503203|postural balance|postural balance
482453|NCT01503190|Breast Cancer|breast cancer
482454|NCT01503190|Young Women|young women
482455|NCT01503190|Pregnancy Associated Breast Cancer|pregnancy associated breast cancer
482456|NCT01503190|Pregnancy|pregnancy
482457|NCT01503190|Premenopausal Breast Cancer|premenopausal breast cancer
482458|NCT01503164|Obstructive sleep apnea|obstructive sleep apnea
482459|NCT01503164|Sleep Apnea|sleep apnea
482460|NCT01503164|Sleep-disordered breathing|sleep-disordered breathing
482461|NCT01503164|Insulin sensitivity|insulin sensitivity
482462|NCT01503164|Glucose tolerance|glucose tolerance
482463|NCT01503164|Type 2 diabetes|type 2 diabetes
482464|NCT01503151|attention bias modification treatment|attention bias modification treatment
482465|NCT01503151|interpretive bias modification|interpretive bias modification
482466|NCT01503151|cognitive bias modification|cognitive bias modification
482467|NCT01503151|attention training|attention training
482468|NCT01503151|social anxiety|social anxiety
482469|NCT01503138|Intimate Partner Violence|intimate partner violence
482470|NCT01503138|Depressive Symptoms|depressive symptoms
482471|NCT01503138|Intervention|intervention
482472|NCT01503138|Randomized Controlled Trial|randomized controlled trial
482473|NCT01503138|Mainland Chinese|mainland chinese
482474|NCT01503138|Immigrants|immigrants
482475|NCT01503138|Women|women
482476|NCT01503125|GAN|gan
482477|NCT01503125|Giant Axonal Neuropathy|giant axonal neuropathy
482478|NCT01503125|Neuromuscular Disease|neuromuscular disease
482479|NCT01503125|Natural History Study|natural history study
482480|NCT01503125|Observational Study|observational study
482481|NCT01503112|Glucagon-Like Peptide 1, DPP4 protein, Therapeutics, Hypoglycemic Agents, C-Peptide, Type 2 Diabetes Mellitus,|glucagon-like peptide 1, dpp4 protein, therapeutics, hypoglycemic agents, c-peptide, type 2 diabetes mellitus,
482482|NCT01503099|ITB|itb
482483|NCT01503099|PTB|ptb
482484|NCT01503099|CD|cd
482485|NCT01503073|stroke|stroke
482486|NCT01503060|pediatrics|pediatrics
482487|NCT01503060|Pain|pain
482488|NCT01503060|Immunization|immunization
482489|NCT01503034|Pregnant women|pregnant women
482490|NCT01503021|Soluble ferric pyrophosphate|soluble ferric pyrophosphate
482491|NCT01503021|Chronic kidney disease|chronic kidney disease
482492|NCT01503021|Chronic hemodialysis|chronic hemodialysis
482493|NCT01503021|Ferric pyrophosphate citrate|ferric pyrophosphate citrate
482494|NCT01502995|Assistive devices|assistive devices
482495|NCT01502995|Freezing of gait|freezing of gait
482496|NCT01502995|Gait disorders|gait disorders
482497|NCT01502995|Gait hesitation|gait hesitation
482498|NCT01502995|Gait ignition failure|gait ignition failure
482499|NCT01502995|Laser light|laser light
482500|NCT01502995|Parkinson's disease|parkinson's disease
482501|NCT01502995|Rolling walker|rolling walker
482502|NCT01502995|Visual Cue|visual cue
482503|NCT01502995|Walker|walker
482504|NCT01502982|DLBCL|dlbcl
482505|NCT01502982|high risk|high risk
482506|NCT01502982|young|young
482507|NCT01502969|diarrhea|diarrhea
482508|NCT01502969|fever|fever
482509|NCT01502969|nausea|nausea
482510|NCT01502969|vomit|vomit
482511|NCT01502969|irritability|irritability
482512|NCT01502956|Refractory Urinary Urge Incontinence|refractory urinary urge incontinence
482513|NCT01502956|Botox A®|botox a®
482514|NCT01502956|Interstim® Device|interstim® device
482515|NCT01502943|Complementary Therapies|complementary therapies
482516|NCT01502943|Traditional Chinese Medicine|traditional chinese medicine
482517|NCT01502943|Quality of life|quality of life
482518|NCT01502943|Seattle angina questionnaire (SAQ)|seattle angina questionnaire (saq)
482519|NCT01502943|SF-12|sf-12
482520|NCT01502943|Measure Your Medical Outcome Profile (MYMOP)|measure your medical outcome profile (mymop)
482521|NCT01502943|Phlegm and blood stasis Syndrome|phlegm and blood stasis syndrome
482522|NCT01502943|Qi deficiency and blood stasis Syndrome|qi deficiency and blood stasis syndrome
482523|NCT01502943|Invigorating Spleen to Remove Phlegm or replenish Qi|invigorating spleen to remove phlegm or replenish qi
482524|NCT01502943|Activating blood and dissolving stasis|activating blood and dissolving stasis
482525|NCT01502943|Traditional Chinese medicine SYndrome Scale (TCMsys)|traditional chinese medicine syndrome scale (tcmsys)
482526|NCT01502943|Patients Report Outcomes(PRO)|patients report outcomes(pro)
482527|NCT01502943|clinical efficacy|clinical efficacy
482528|NCT01502943|evaluative index|evaluative index
482529|NCT01502917|Brain stem glioma|brain stem glioma
482530|NCT01502917|CNS|cns
482531|NCT01502917|MAB 124I-8H9|mab 124i-8h9
482532|NCT01502917|infusion cannula|infusion cannula
482533|NCT01502917|DIPG|dipg
482534|NCT01502917|Diffuse Intrinsic Pontine Glioma|diffuse intrinsic pontine glioma
482535|NCT01502917|11-011|11-011
482536|NCT01502904|SES vs BES|ses vs bes
482537|NCT01502891|Comparative Effectiveness Research|comparative effectiveness research
482538|NCT01502891|Decision Support Techniques|decision support techniques
482539|NCT01502891|Decision Making|decision making
482540|NCT01502878|Nut allergy|nut allergy
482541|NCT01502878|Double-blind placebo-controlled (DBPC) oral nut challenge|double-blind placebo-controlled (dbpc) oral nut challenge
482542|NCT01502878|Nut oral immunotherapy (OIT)|nut oral immunotherapy (oit)
482543|NCT01502878|Nut oral desensitization|nut oral desensitization
482544|NCT01502852|OEF/OIF Veterans|oef/oif veterans
482545|NCT01502852|Traumatic Brain Injury|traumatic brain injury
482546|NCT01502852|Community Mental Health|community mental health
482547|NCT01502826|Childhood obesity|childhood obesity
482548|NCT01502826|Endothelial dysfunction|endothelial dysfunction
482549|NCT01502826|Inflammation|inflammation
482550|NCT01502826|Insulin resistance|insulin resistance
482551|NCT01502813|Neuropsychological testing|neuropsychological testing
482552|NCT01502813|Dietary supplements|dietary supplements
482553|NCT01502800|Metastatic|metastatic
482554|NCT01502800|Unresectable|unresectable
482555|NCT01502800|Recurrent advanced|recurrent advanced
482556|NCT01502787|hypertension|hypertension
482557|NCT01502787|blood pressure|blood pressure
482558|NCT01502787|blood pressure medications|blood pressure medications
482559|NCT01502787|metoprolol|metoprolol
482560|NCT01502787|nebivolol|nebivolol
482561|NCT01502787|handgrip exercise|handgrip exercise
482562|NCT01502787|lower body negative pressure|lower body negative pressure
482563|NCT01502787|angiotensin II|angiotensin ii
482564|NCT01502787|sympathetic nerve activity|sympathetic nerve activity
482565|NCT01502787|flow mediated dilation|flow mediated dilation
482566|NCT01502787|nitric oxide|nitric oxide
482567|NCT01502787|microneurography|microneurography
482568|NCT01502774|STEMI|stemi
482569|NCT01502774|cyclosporine|cyclosporine
482570|NCT01502774|reperfusion injury|reperfusion injury
482571|NCT01502761|stroke|stroke
482572|NCT01502761|Magnesium|magnesium
482573|NCT01502761|endovascular|endovascular
482574|NCT01502748|stroke|stroke
482575|NCT01502748|Magnesium|magnesium
482576|NCT01502748|Endovascular|endovascular
482577|NCT01502735|dengue|dengue
482578|NCT01502735|dengue fever|dengue fever
482579|NCT01502735|monovalent dengue vaccine|monovalent dengue vaccine
482580|NCT01502709|Single blind|single blind
482581|NCT01502709|Randomized|randomized
482582|NCT01502709|Controlled clinical trial|controlled clinical trial
482583|NCT01502696|ulcerated primary cutaneous melanoma|ulcerated primary cutaneous melanoma
482584|NCT01502696|Stage II|stage ii
482585|NCT01502696|PEG IFN alfa-2b|peg ifn alfa-2b
482586|NCT01502696|T(2-4)bN0M0|t(2-4)bn0m0
482587|NCT01502683|Stroke|stroke
482588|NCT01502683|neurocognitive dysfunction|neurocognitive dysfunction
482589|NCT01502683|cerebral embolic events|cerebral embolic events
482590|NCT01502670|Pulmonary nodules|pulmonary nodules
482591|NCT01502657|percutaneous tracheostomy|percutaneous tracheostomy
482592|NCT01502657|ultrasonography|ultrasonography
482593|NCT01502657|echography|echography
482594|NCT01502657|critical care|critical care
482595|NCT01502644|low back pain|low back pain
482596|NCT01502644|opioids|opioids
482597|NCT01502644|mood symptoms|mood symptoms
482598|NCT01502618|Adolescent Medicine Trials Network for HIV/AIDS Interventions|adolescent medicine trials network for hiv/aids interventions
482599|NCT01502618|Human Immunodeficiency Virus|human immunodeficiency virus
482600|NCT01502605|5-ALA|5-ala
482601|NCT01502605|Aminolevulinic Acid|aminolevulinic acid
482602|NCT01502605|Craniotomy|craniotomy
482603|NCT01502605|Brain Tumor|brain tumor
482604|NCT01502605|Surgical Resection|surgical resection
482605|NCT01502605|Neurosurgery|neurosurgery
482606|NCT01502592|MDX-010 (Ipilimumab)|mdx-010 (ipilimumab)
482607|NCT01502592|Cryoablation|cryoablation
482608|NCT01502592|Total mastectomy planned|total mastectomy planned
482609|NCT01502592|11-202|11-202
482610|NCT01502579|IgA nephropathy|iga nephropathy
482611|NCT01502566|educational intervention|educational intervention
482612|NCT01502566|dentals caries|dentals caries
482613|NCT01502566|population|population
482614|NCT01502566|new populational caries prevention strategies.|new populational caries prevention strategies.
482615|NCT01502553|blood pressure|blood pressure
482616|NCT01502553|heart rate|heart rate
482617|NCT01502540|pain|pain
482618|NCT01502540|craniotomy|craniotomy
482619|NCT01502527|Vulvo vaginal atrophy|vulvo vaginal atrophy
482620|NCT01502527|Femarelle|femarelle
482621|NCT01502514|CHF|chf
482622|NCT01502514|ischemia|ischemia
482623|NCT01502514|Heart Failure|heart failure
482624|NCT01502501|CHF|chf
482625|NCT01502501|Heart Failure|heart failure
482626|NCT01502501|Non-Ischemic|non-ischemic
482627|NCT01502501|nonischemic|nonischemic
482628|NCT01502501|nonischemia|nonischemia
482629|NCT01502488|Autistic|autistic
482630|NCT01502488|ASC therapy|asc therapy
482631|NCT01502488|ADSC|adsc
482632|NCT01502475|Complementary Alternative Medicine|complementary alternative medicine
482633|NCT01502475|Veteran|veteran
482634|NCT01502475|Attitudes|attitudes
482635|NCT01502475|Beliefs|beliefs
482636|NCT01502462|Clinical course and prognostic factors in patients with severe isolated TR|clinical course and prognostic factors in patients with severe isolated tr
482637|NCT01502449|telemedicine, telephonic, PTSD|telemedicine, telephonic, ptsd
482638|NCT01502436|posttraumatic stress disorder|posttraumatic stress disorder
482639|NCT01502436|traumatic brain injury|traumatic brain injury
482640|NCT01502436|Suicide Attempt|suicide attempt
482641|NCT01502436|Veterans|veterans
482642|NCT01502423|On label Humira users|on label humira users
482643|NCT01502423|Rheumatoid Arthritis|rheumatoid arthritis
482644|NCT01502423|Pain|pain
482645|NCT01502397|hepatitis B|hepatitis b
482646|NCT01502397|anti-HBc|anti-hbc
482647|NCT01502397|HBsAg|hbsag
482648|NCT01502397|rituximab|rituximab
482649|NCT01502397|occult HBV|occult hbv
482650|NCT01502384|healthy 1st degree relatives of pd patients|healthy 1st degree relatives of pd patients
482651|NCT01502371|Asthma|asthma
482652|NCT01502371|Children|children
482653|NCT01502371|Persistent|persistent
482654|NCT01502358|dengue|dengue
482655|NCT01502358|dengue fever|dengue fever
482656|NCT01502358|dengue disease|dengue disease
482657|NCT01502358|tetravalent dengue vaccine|tetravalent dengue vaccine
482658|NCT01502358|Vaxfectin®|vaxfectin®
482659|NCT01502345|HFRS|hfrs
482660|NCT01502332|Mechanical ventilation|mechanical ventilation
482661|NCT01502332|Open lung approach|open lung approach
482662|NCT01502332|Blood gases|blood gases
482663|NCT01502332|Cardiac surgery|cardiac surgery
482664|NCT01502332|Pulmonary complications|pulmonary complications
482665|NCT01502306|Smoking cessation|smoking cessation
482666|NCT01502306|Telephone|telephone
482667|NCT01502306|Self-help|self-help
482668|NCT01502306|Smoking abstinence|smoking abstinence
482669|NCT01502306|Incentives|incentives
482670|NCT01502306|Nicotine-replacement therapy|nicotine-replacement therapy
482671|NCT01502306|Medi-Cal|medi-cal
482672|NCT01502306|Medicaid|medicaid
482673|NCT01502280|extent of resection|extent of resection
482674|NCT01502280|Glioma|glioma
482675|NCT01502280|5-ALA|5-ala
482676|NCT01502280|tumor fluorescence|tumor fluorescence
482677|NCT01502280|confocal microscopy|confocal microscopy
482678|NCT01502267|Waiting list|waiting list
482679|NCT01502267|Deceased donor kidney transplantation|deceased donor kidney transplantation
482680|NCT01502267|Desensitization|desensitization
482681|NCT01502267|anti HLA antibody|anti hla antibody
482682|NCT01502254|Informed consent|informed consent
482683|NCT01502254|Cancer clinical trials|cancer clinical trials
482684|NCT01502254|Patient information|patient information
482685|NCT01502254|Knowledge|knowledge
482686|NCT01502254|Questionnaire|questionnaire
482687|NCT01502254|Patient Eligible for a Phase II or III Cancer Clinical Trial|patient eligible for a phase ii or iii cancer clinical trial
482688|NCT01502254|Scheduled Clinical Visit for Information About a Trial|scheduled clinical visit for information about a trial
482689|NCT01502241|elderly|elderly
482690|NCT01502241|brain tumors|brain tumors
482691|NCT01502241|MGMT|mgmt
482692|NCT01502241|chemotherapy|chemotherapy
482693|NCT01502241|Newly diagnosed|newly diagnosed
482694|NCT01502241|patients > 65 years|patients > 65 years
482695|NCT01502202|lung adenocarcinoma|lung adenocarcinoma
482696|NCT01502202|never smoker|never smoker
482697|NCT01502202|1st line treatment|1st line treatment
482698|NCT01502202|Intercalation administration|intercalation administration
482699|NCT01502202|Gefitinib|gefitinib
482700|NCT01502202|never smokers|never smokers
482701|NCT01502189|patient education as topic|patient education as topic
482702|NCT01502189|representational approach|representational approach
482703|NCT01502189|parents|parents
482704|NCT01502189|childhood cancer|childhood cancer
482705|NCT01502189|paediatric oncology|paediatric oncology
482706|NCT01502189|nursing|nursing
482707|NCT01502189|parents of children with cancer|parents of children with cancer
482708|NCT01502189|Stress|stress
482709|NCT01502189|Health Knowledge|health knowledge
482710|NCT01502189|Attitudes|attitudes
482711|NCT01502189|Practice|practice
482712|NCT01502176|atrial fibrillation|atrial fibrillation
482713|NCT01502176|registry|registry
482714|NCT01502163|perioperative hypothermia|perioperative hypothermia
482715|NCT01502163|prewarming|prewarming
482716|NCT01502163|forced air warming|forced air warming
482717|NCT01502163|insulation|insulation
482718|NCT01502150|Pediatric Cancer|pediatric cancer
482719|NCT01502150|Proton Radiation Therapy|proton radiation therapy
482720|NCT01502150|Proton beam radiotherapy|proton beam radiotherapy
482721|NCT01502150|PBT|pbt
482722|NCT01502150|Data Collection|data collection
482723|NCT01502150|Database|database
482724|NCT01502150|Acute and late normal tissue toxicities|acute and late normal tissue toxicities
482725|NCT01502150|Dosimetric data|dosimetric data
482726|NCT01502150|Toxicity data|toxicity data
482727|NCT01502111|decreased level of consciousness|decreased level of consciousness
482728|NCT01502111|hypoxemia|hypoxemia
482729|NCT01502111|ineffective ventilation|ineffective ventilation
482730|NCT01502111|airway obstruction|airway obstruction
482731|NCT01502111|combative or unresponsive|combative or unresponsive
482732|NCT01502111|relief of pain or distress|relief of pain or distress
482733|NCT01502111|cardiopulmonary arrest|cardiopulmonary arrest
482734|NCT01502085|multiple myeloma lenalidomide|multiple myeloma lenalidomide
482735|NCT01502072|Ribavirin|ribavirin
482736|NCT01502072|Ribavirin Aerosol|ribavirin aerosol
482737|NCT01502072|Respiratory Syncytial Virus|respiratory syncytial virus
482738|NCT01502072|RSV|rsv
482739|NCT01502072|upper respiratory tract infection|upper respiratory tract infection
482740|NCT01502072|URI|uri
482741|NCT01502072|Lower respiratory tract Infection|lower respiratory tract infection
482742|NCT01502072|LRI|lri
482743|NCT01502072|pneumonia|pneumonia
482744|NCT01502072|aerosolized ribavirin|aerosolized ribavirin
482745|NCT01502072|HSCT|hsct
482746|NCT01502072|Hematopoietic stem cell transplantation|hematopoietic stem cell transplantation
482747|NCT01502072|oral ribavirin therapy|oral ribavirin therapy
482748|NCT01502059|Pilates|pilates
482749|NCT01502059|Exercise|exercise
482750|NCT01502059|Treatment|treatment
482751|NCT01502059|Low back pain|low back pain
482752|NCT01502059|Pain|pain
482753|NCT01502059|Function|function
482754|NCT01502046|Huntington's disease, cannabinoids|huntington's disease, cannabinoids
482755|NCT01502033|Adolescent Depression|adolescent depression
482756|NCT01502033|Transcranial Magnetic Stimulation|transcranial magnetic stimulation
482757|NCT01502020|actinic keratoses|actinic keratoses
482758|NCT01502020|actinic keratosis|actinic keratosis
482759|NCT01502020|imiquimod, 3.75%|imiquimod, 3.75%
482760|NCT01502020|imiquimod|imiquimod
482761|NCT01502020|Zyclara|zyclara
482762|NCT01502020|Actinic keratoses of the face or balding scalp|actinic keratoses of the face or balding scalp
482763|NCT01502007|Activity Level|activity level
482764|NCT01502007|Overweight|overweight
482765|NCT01502007|Obesity|obesity
482766|NCT01501994|Activity level|activity level
482767|NCT01501994|Weight|weight
482768|NCT01501994|Body Fat|body fat
482769|NCT01501994|Well Being|well being
482770|NCT01501981|heart failure|heart failure
482771|NCT01501981|MR-proANP|mr-proanp
482772|NCT01501981|MR-proADM|mr-proadm
482773|NCT01501981|decompensation|decompensation
482774|NCT01501981|Copeptin|copeptin
482775|NCT01501981|CT-proET1|ct-proet1
482776|NCT01501981|NT-proBNP|nt-probnp
482777|NCT01501968|Colistin|colistin
482778|NCT01501968|ascorbic acid|ascorbic acid
482779|NCT01501968|renal toxicity|renal toxicity
482780|NCT01501955|Osteoarthritis|osteoarthritis
482781|NCT01501942|Asthma|asthma
482782|NCT01501942|Allergen induced asthma|allergen induced asthma
482783|NCT01501942|ATS Criteria (1)|ats criteria (1)
482784|NCT01501929|hypertension|hypertension
482785|NCT01501929|blood pressure|blood pressure
482786|NCT01501929|blood pressure medications|blood pressure medications
482787|NCT01501929|metoprolol|metoprolol
482788|NCT01501929|nebivolol|nebivolol
482789|NCT01501929|vascular oxidative stress|vascular oxidative stress
482790|NCT01501929|nitric oxide|nitric oxide
482791|NCT01501929|nitric oxide synthase (eNOS)|nitric oxide synthase (enos)
482792|NCT01501929|endothelium|endothelium
482793|NCT01501929|endothelial dysfunction|endothelial dysfunction
482794|NCT01501929|endothelial cell protein expression|endothelial cell protein expression
482795|NCT01501929|microvascular blood flow|microvascular blood flow
482796|NCT01501929|flow mediated dilation|flow mediated dilation
482797|NCT01501929|handgrip exercise|handgrip exercise
482798|NCT01501929|endothelial cell collection|endothelial cell collection
482799|NCT01501929|microbubbles|microbubbles
482800|NCT01501929|Definity|definity
482801|NCT01501890|Threatened Abortion|threatened abortion
482802|NCT01501890|Progesterone|progesterone
482803|NCT01501890|Subchorionic Hematoma|subchorionic hematoma
482804|NCT01501890|Pre-Eclampsia|pre-eclampsia
482805|NCT01501890|Abruptio Placentae|abruptio placentae
482806|NCT01501890|Fetal Growth Retardation|fetal growth retardation
482807|NCT01501890|Premature Birth|premature birth
482808|NCT01501877|Smoking|smoking
482809|NCT01501877|Type 2 Diabetes|type 2 diabetes
482810|NCT01501877|Smoking cessation|smoking cessation
482811|NCT01501864|HIV prevention|hiv prevention
482812|NCT01501864|HSV-2|hsv-2
482813|NCT01501864|Schooling|schooling
482814|NCT01501864|Kenya|kenya
482815|NCT01501864|Orphans|orphans
482816|NCT01501864|School support|school support
482817|NCT01501799|acne|acne
482818|NCT01501799|adapalene/benzoyl peroxide|adapalene/benzoyl peroxide
482819|NCT01501799|Epiduo|epiduo
482820|NCT01501799|Mild to severe acne vulgaris|mild to severe acne vulgaris
482821|NCT01501786|children|children
482822|NCT01501786|sedation|sedation
482823|NCT01501786|propofol|propofol
482824|NCT01501786|ketamine|ketamine
482825|NCT01501773|Acute ischemic stroke|acute ischemic stroke
482826|NCT01501747|Placebo effect|placebo effect
482827|NCT01501747|drug half life|drug half life
482828|NCT01501747|pharmacokinetics|pharmacokinetics
482829|NCT01501734|CHF|chf
482830|NCT01501734|watch-pat|watch-pat
482831|NCT01501734|embletta x|embletta x
482832|NCT01501734|endothelial function|endothelial function
482833|NCT01501721|prevention|prevention
482834|NCT01501721|workers|workers
482835|NCT01501721|clinical trials|clinical trials
482836|NCT01501721|obesity|obesity
482837|NCT01501708|caspofungin|caspofungin
482838|NCT01501708|IFI|ifi
482839|NCT01501708|allogeneic hematopoietic stem cell transplantation|allogeneic hematopoietic stem cell transplantation
482840|NCT01501695|tic disorder|tic disorder
482841|NCT01501695|pediatric|pediatric
482842|NCT01501682|ventralex|ventralex
482843|NCT01501682|ventral hernia|ventral hernia
482844|NCT01501669|irinotecan|irinotecan
482845|NCT01501669|capecitabine|capecitabine
482846|NCT01501669|metastatic breast cancer|metastatic breast cancer
482847|NCT01501643|Non invasive positive pressure ventilation|non invasive positive pressure ventilation
482848|NCT01501643|Spirometry|spirometry
482849|NCT01501643|Acute chest syndrome|acute chest syndrome
482850|NCT01501643|Sickle cell disease|sickle cell disease
482851|NCT01501643|Vaso-occlusive crisis|vaso-occlusive crisis
482852|NCT01501630|Comparison of imaging modalities|comparison of imaging modalities
482853|NCT01501630|Impact on patient management|impact on patient management
482854|NCT01501630|Optimisation of cost of the diagnostic strategy|optimisation of cost of the diagnostic strategy
482855|NCT01501617|Hair Loss|hair loss
482856|NCT01501617|Androgenetic Alopecia|androgenetic alopecia
482857|NCT01501617|Baldness|baldness
482858|NCT01501617|Male pattern baldness|male pattern baldness
482859|NCT01501617|Male pattern hair loss|male pattern hair loss
482860|NCT01501617|Hair Regrowth|hair regrowth
482861|NCT01501617|Alopecia|alopecia
482862|NCT01501617|Hair growth|hair growth
482863|NCT01501617|Regrow Hair|regrow hair
482864|NCT01501604|PIK3CA mutation|pik3ca mutation
482865|NCT01501604|Advanced solid tumors|advanced solid tumors
482866|NCT01501591|Placebo effect|placebo effect
482867|NCT01501591|placebo drug interaction|placebo drug interaction
482868|NCT01501591|placebo -controlled clinical trials|placebo -controlled clinical trials
482869|NCT01501578|Pulmonary fibrosis|pulmonary fibrosis
482870|NCT01501578|Telomerase mutation|telomerase mutation
482871|NCT01501565|Postoperative pain|postoperative pain
482872|NCT01501565|Transverse abdominal blockade|transverse abdominal blockade
482873|NCT01501565|Efficacy|efficacy
482874|NCT01501565|Safety|safety
482875|NCT01501565|Urology|urology
482876|NCT01501552|Primary health care|primary health care
482877|NCT01501552|Identification and Brief Intervention Programmes|identification and brief intervention programmes
482878|NCT01501552|Hazardous and harmful alcohol consumption|hazardous and harmful alcohol consumption
482879|NCT01501539|Hypergranulation tissue|hypergranulation tissue
482880|NCT01501539|Gastrostomy tube|gastrostomy tube
482881|NCT01501539|Hydrocolloid dressing|hydrocolloid dressing
482882|NCT01501539|Silver hydrocolloid dressing|silver hydrocolloid dressing
482883|NCT01501539|Gastrostomy tube dislodgement|gastrostomy tube dislodgement
482884|NCT01501539|Wound infection|wound infection
482885|NCT01501539|Peristomal skin breakdown|peristomal skin breakdown
482886|NCT01501526|herpes esophagitis|herpes esophagitis
482887|NCT01501526|dysphagia|dysphagia
482888|NCT01501526|vocal fold palsy|vocal fold palsy
482889|NCT01501526|immunocompetent|immunocompetent
482890|NCT01501526|husky voice|husky voice
482891|NCT01501513|colonoscopy|colonoscopy
482892|NCT01501513|bowel preparation|bowel preparation
482893|NCT01501513|endoscopy|endoscopy
482894|NCT01501500|botulinum toxin type A|botulinum toxin type a
482895|NCT01501500|hallux valgus angle|hallux valgus angle
482896|NCT01501500|foot function index|foot function index
482897|NCT01501500|VAS pain scale|vas pain scale
482898|NCT01501487|breast cancer|breast cancer
482899|NCT01501487|neo adjuvant therapy|neo adjuvant therapy
482900|NCT01501474|Confocal|confocal
482901|NCT01501474|malignant biliary stricture|malignant biliary stricture
482902|NCT01501474|Sensitivity, specificity and accuracy of CholangioFlex in malignant biliary stricture diagnosis|sensitivity, specificity and accuracy of cholangioflex in malignant biliary stricture diagnosis
482903|NCT01501474|sensitivity, specificity and accuracy of Fluorescent in situ Hybridization(FISH) in malignant biliary stricture diagnosis|sensitivity, specificity and accuracy of fluorescent in situ hybridization(fish) in malignant biliary stricture diagnosis
482904|NCT01501435|Safety|safety
482905|NCT01501435|Pharmacokinetics|pharmacokinetics
482906|NCT01501422|postmenopause|postmenopause
482907|NCT01501422|sleep quality|sleep quality
482908|NCT01501422|estrogen|estrogen
482909|NCT01501422|objective sleep quality|objective sleep quality
482910|NCT01501422|actigraph|actigraph
482911|NCT01501409|Sodium lauryl sulfate (SLS)|sodium lauryl sulfate (sls)
482912|NCT01501409|recurrent aphthous stomatitis (RAS)|recurrent aphthous stomatitis (ras)
482913|NCT01501409|dentifrice|dentifrice
482914|NCT01501409|pain|pain
482915|NCT01501370|Myeloma|myeloma
482916|NCT01501370|Biochemical relapse|biochemical relapse
482918|NCT01501357|primary molars|primary molars
482919|NCT01501357|plaque|plaque
482920|NCT01501357|toothbrushing|toothbrushing
482921|NCT01501344|osteoporosis|osteoporosis
482922|NCT01501344|postmenopausal women|postmenopausal women
482923|NCT01501344|bone remodelling|bone remodelling
482924|NCT01501344|bone turnover markers|bone turnover markers
482925|NCT01501331|Congestive Heart Failure|congestive heart failure
482926|NCT01501331|Cardiac Resynchronization Therapy|cardiac resynchronization therapy
482927|NCT01501331|Internal Cardioverter Defibrillators|internal cardioverter defibrillators
482928|NCT01501318|SBIRT|sbirt
482929|NCT01501318|brief intervention|brief intervention
482930|NCT01501318|alcohol|alcohol
482931|NCT01501318|drug abuse|drug abuse
482932|NCT01501305|influence|influence
482933|NCT01501305|carob powder|carob powder
482934|NCT01501305|probiotics|probiotics
482935|NCT01501305|duration|duration
482936|NCT01501279|pudendal nerve block|pudendal nerve block
482937|NCT01501279|postoperative pain|postoperative pain
482938|NCT01501279|bladder spasm|bladder spasm
482939|NCT01501266|postmenopausal breast cancer|postmenopausal breast cancer
482940|NCT01501266|Faslodex|faslodex
482941|NCT01501266|cohort|cohort
482942|NCT01501253|CKD-828|ckd-828
482943|NCT01501253|Hypertension|hypertension
482944|NCT01501253|Primary Hypertension|primary hypertension
482945|NCT01501253|S-Amlodipine|s-amlodipine
482946|NCT01501253|Telmisartan|telmisartan
482947|NCT01501253|Non-Responder|non-responder
482948|NCT01501240|Magnetic resonance image|magnetic resonance image
482949|NCT01501240|gadoxetic acid|gadoxetic acid
482950|NCT01501240|hepatocellular carcinoma|hepatocellular carcinoma
482951|NCT01501240|liver cirrhosis|liver cirrhosis
482952|NCT01501227|ventilator associated pneumonia|ventilator associated pneumonia
482953|NCT01501214|atosiban|atosiban
482954|NCT01501214|in vitro fertilization|in vitro fertilization
482955|NCT01501214|subfertility|subfertility
482956|NCT01501201|Obesity|obesity
482957|NCT01501201|Diabetes|diabetes
482958|NCT01501201|Bariatric Surgery|bariatric surgery
482959|NCT01501188|Chronic Venous Insufficiency|chronic venous insufficiency
482960|NCT01501188|Kinesio Taping|kinesio taping
482961|NCT01501188|Electromyography|electromyography
482962|NCT01501188|Range of ankle motion|range of ankle motion
482963|NCT01501175|superficial vein thrombosis|superficial vein thrombosis
482964|NCT01501175|Saint Etienne region|saint etienne region
482965|NCT01501162|hepatitis, alcohol|hepatitis, alcohol
482966|NCT01501149|NK/T cell lymphoma|nk/t cell lymphoma
482967|NCT01501149|chemotherapy|chemotherapy
482968|NCT01501149|clinical trial|clinical trial
482969|NCT01501149|RR|rr
482970|NCT01501149|PFS|pfs
482971|NCT01501149|OS|os
482972|NCT01501136|NK/T cell lymphoma|nk/t cell lymphoma
482973|NCT01501136|chemotherapy|chemotherapy
482974|NCT01501136|clinical trial|clinical trial
482975|NCT01501136|RR|rr
482976|NCT01501136|PFS|pfs
482977|NCT01501136|OS|os
482978|NCT01501123|Time to sedation of agitated patients|time to sedation of agitated patients
482979|NCT01501110|Euthyroid Sick Syndrome|euthyroid sick syndrome
482980|NCT01501110|low T3 syndrome|low t3 syndrome
482981|NCT01501110|deiodases|deiodases
482982|NCT01501110|oxidative stress|oxidative stress
482983|NCT01501110|ischemic heart disease|ischemic heart disease
482984|NCT01501084|functional MRI|functional mri
482985|NCT01501084|Structural MRI|structural mri
482986|NCT01501084|obesity|obesity
482987|NCT01501084|resting state networks|resting state networks
482988|NCT01501071|Laparoscopic Nissen fundoplication|laparoscopic nissen fundoplication
482989|NCT01501071|Esophageal calibration|esophageal calibration
482990|NCT01501071|Postoperative dysphagia|postoperative dysphagia
482991|NCT01501045|TMS|tms
482992|NCT01501045|CPM|cpm
482993|NCT01501045|headache|headache
482994|NCT01501045|migraine|migraine
482996|NCT01501045|psychophysics|psychophysics
482997|NCT01501032|Diabetes Type 1|diabetes type 1
482998|NCT01501032|Artificial Pancreas|artificial pancreas
482999|NCT01501006|Physicians|physicians
483000|NCT01500993|Rectal cancer|rectal cancer
483001|NCT01500993|Chemoradiotherapy|chemoradiotherapy
483002|NCT01500993|Capecitabine|capecitabine
483003|NCT01500993|phase-III trial|phase-iii trial
483004|NCT01500980|malaria|malaria
483005|NCT01500980|challenge|challenge
483006|NCT01500980|P. falciparum|p. falciparum
483007|NCT01500980|prevention|prevention
483008|NCT01500928|Insulin Pump|insulin pump
483009|NCT01500928|Glycemic Control|glycemic control
483010|NCT01500928|Type 1 Diabetes|type 1 diabetes
483011|NCT01500915|AMD|amd
483012|NCT01500915|ranibizumab|ranibizumab
483013|NCT01500915|antiVEGF|antivegf
483014|NCT01500915|regimen of injections|regimen of injections
483015|NCT01500915|anti VEGF regimen|anti vegf regimen
483016|NCT01500915|PRN|prn
483017|NCT01500915|treat and extend|treat and extend
483018|NCT01500902|Acute Coronary Syndrome (ACS)|acute coronary syndrome (acs)
483019|NCT01500902|Percutaneous Intervention (PCI)|percutaneous intervention (pci)
483020|NCT01500902|Coronary Stent (CStent)|coronary stent (cstent)
483021|NCT01500902|Percutaneous Transluminal Coronary Angioplasty (PTCA)|percutaneous transluminal coronary angioplasty (ptca)
483022|NCT01500902|stent placement|stent placement
483023|NCT01500902|balloon angioplasty|balloon angioplasty
483024|NCT01500889|Anal fissure|anal fissure
483025|NCT01500889|Advancement flap|advancement flap
483026|NCT01500889|Internal sphincterotomy|internal sphincterotomy
483027|NCT01500876|lung cancer|lung cancer
483028|NCT01500863|endometrial receptivity|endometrial receptivity
483029|NCT01500863|gene arrays|gene arrays
483030|NCT01500863|agonist triggering|agonist triggering
483031|NCT01500863|Endometrial gene expression|endometrial gene expression
483032|NCT01500863|OHSS|ohss
483033|NCT01500850|Type 2 Diabetes mellitus|type 2 diabetes mellitus
483034|NCT01500850|NPH insulin|nph insulin
483035|NCT01500850|Insulin Glargine|insulin glargine
483036|NCT01500850|cardiovascular biomarkers|cardiovascular biomarkers
483037|NCT01500850|hsCRP, adiponectin|hscrp, adiponectin
483038|NCT01500850|intact proinsulin|intact proinsulin
483039|NCT01500850|cardiovascular risk|cardiovascular risk
483040|NCT01500837|Staphylococcus aureus|staphylococcus aureus
483041|NCT01500837|osteoarticular infection|osteoarticular infection
483042|NCT01500837|clindamycin|clindamycin
483043|NCT01500837|serum concentration|serum concentration
483044|NCT01500837|orthopedic surgery|orthopedic surgery
483045|NCT01500824|Crizotinib|crizotinib
483046|NCT01500824|ALK|alk
483047|NCT01500824|NSCLC|nsclc
483048|NCT01500824|Non-Small Cell Lung Cancer|non-small cell lung cancer
483049|NCT01500824|Asian|asian
483050|NCT01500811|chondrocyte hip osteoarthritis intra articular injection|chondrocyte hip osteoarthritis intra articular injection
483051|NCT01500772|Hepatitis C|hepatitis c
483052|NCT01500772|PI treatment failure|pi treatment failure
483053|NCT01500759|chronic heart failure|chronic heart failure
483054|NCT01500759|heart failure|heart failure
483055|NCT01500759|hf|hf
483056|NCT01500759|sleep-disordered breathing|sleep-disordered breathing
483057|NCT01500759|sdb|sdb
483058|NCT01500759|nyha|nyha
483059|NCT01500759|lvef|lvef
483060|NCT01500759|cheyne stokes|cheyne stokes
483061|NCT01500759|central sleep apnoea|central sleep apnoea
483062|NCT01500759|sleep apnoea|sleep apnoea
483063|NCT01500746|chronic wound treatment|chronic wound treatment
483064|NCT01500746|pulse lavage|pulse lavage
483065|NCT01500746|serial pulse lavage|serial pulse lavage
483066|NCT01500746|wounds|wounds
483067|NCT01500746|bacterial colonization of wounds|bacterial colonization of wounds
483068|NCT01500733|Treatment|treatment
483069|NCT01500733|CLL (Chronic Lymphocytic Leukemia)|cll (chronic lymphocytic leukemia)
483070|NCT01500733|SLL (Small Lymphocytic Lymphoma)|sll (small lymphocytic lymphoma)
483071|NCT01500733|Leukemia|leukemia
483072|NCT01500733|Lymphocytic Leukemia|lymphocytic leukemia
483073|NCT01500733|Chronic Lymphocytic Leukemia|chronic lymphocytic leukemia
483074|NCT01500733|CLL|cll
483075|NCT01500733|Small Lymphocytic Leukemia|small lymphocytic leukemia
483076|NCT01500733|SLL|sll
483077|NCT01500668|Botox|botox
483078|NCT01500668|catocholamine|catocholamine
483079|NCT01500668|shock|shock
483080|NCT01500668|vasomotor|vasomotor
483081|NCT01500668|Vasopressin|vasopressin
483082|NCT01500668|botulinum toxin|botulinum toxin
483083|NCT01500655|burn|burn
483084|NCT01500655|skin graft donor site|skin graft donor site
483085|NCT01500655|analgesia for donor site|analgesia for donor site
483086|NCT01500629|Allergic Rhinitis|allergic rhinitis
483087|NCT01500629|Hayfever|hayfever
483088|NCT01500629|Pollen Allergy|pollen allergy
483089|NCT01500616|Chronic Hepatitis C Infection|chronic hepatitis c infection
483090|NCT01500616|Chronic Hepatitis C Co-Infected Patients|chronic hepatitis c co-infected patients
483091|NCT01500616|Hepatitis C|hepatitis c
483092|NCT01500616|Severe Fibrosis|severe fibrosis
483093|NCT01500616|Compensated Cirrhosis|compensated cirrhosis
483094|NCT01500616|VX-950HPC3005|vx-950hpc3005
483095|NCT01500603|post-radical prostatectomy|post-radical prostatectomy
483096|NCT01500603|stress urinary incontinence|stress urinary incontinence
483097|NCT01500603|periurethral Pro-ACT balloons|periurethral pro-act balloons
483098|NCT01500603|AdvanceXP retrourethral male sling|advancexp retrourethral male sling
483099|NCT01500590|Diabetes|diabetes
483100|NCT01500590|hypertensive|hypertensive
483101|NCT01500590|without albuminuria|without albuminuria
483102|NCT01500577|Prevention|prevention
483103|NCT01500577|Breast Cancer|breast cancer
483104|NCT01500577|Proliferation|proliferation
483105|NCT01500577|Breast Cancer Prevention|breast cancer prevention
483106|NCT01500564|Stroke|stroke
483107|NCT01500564|transcranial direct current stimulation (tDCS)|transcranial direct current stimulation (tdcs)
483108|NCT01500564|motor function|motor function
483109|NCT01500551|Arthritis|arthritis
483110|NCT01500551|Pediatric|pediatric
483111|NCT01500551|Tofacitinib|tofacitinib
483112|NCT01500551|Long-term|long-term
483113|NCT01500551|JIA|jia
483114|NCT01500551|CP-690,550|cp-690,550
483115|NCT01500551|Xeljanz|xeljanz
483116|NCT01500538|Follicular lymphoma|follicular lymphoma
483117|NCT01500538|Marginal zone lymphoma|marginal zone lymphoma
483118|NCT01500538|Mantle cell lymphoma|mantle cell lymphoma
483119|NCT01500538|thrombocytopenia|thrombocytopenia
483120|NCT01500538|eltrombopag|eltrombopag
483121|NCT01500538|vorinostat|vorinostat
483122|NCT01500538|lymphoma|lymphoma
483123|NCT01500525|asthma|asthma
483124|NCT01500525|children|children
483125|NCT01500525|accuracy of bronchodilator response|accuracy of bronchodilator response
483126|NCT01500499|adult acute myeloid leukemia|adult acute myeloid leukemia
483127|NCT01500499|childhood acute myeloid leukemia/other myeloid malignancies|childhood acute myeloid leukemia/other myeloid malignancies
483128|NCT01500447|Hypogonadotropic Hypogonadism|hypogonadotropic hypogonadism
483129|NCT01500447|Kallmann Syndrome|kallmann syndrome
483130|NCT01500447|Delayed Puberty|delayed puberty
483131|NCT01500447|Hypothalamic Amenorrhea|hypothalamic amenorrhea
483132|NCT01500447|Precocious Puberty|precocious puberty
483133|NCT01500434|drug-eluting stents|drug-eluting stents
483134|NCT01500434|DES|des
483135|NCT01500434|atherosclerotic|atherosclerotic
483136|NCT01500421|Hypothermia, Induced|hypothermia, induced
483137|NCT01500395|Aortic Diseases|aortic diseases
483138|NCT01500395|Vascular Diseases|vascular diseases
483139|NCT01500395|Cardiovascular Diseases|cardiovascular diseases
483140|NCT01500395|Treatment Outcome|treatment outcome
483141|NCT01500395|Aorta Dissection|aorta dissection
483142|NCT01500395|Aorta Aneurysm|aorta aneurysm
483143|NCT01500395|Aorta pseudoaneurysm|aorta pseudoaneurysm
483144|NCT01500395|Endovascular aortic repair|endovascular aortic repair
483145|NCT01500395|Hybrid operation|hybrid operation
483146|NCT01500395|Debranching|debranching
483147|NCT01500369|atrial fibrillation|atrial fibrillation
483148|NCT01500369|remote ischemic conditioning|remote ischemic conditioning
483149|NCT01500356|cardiovascular disease|cardiovascular disease
483150|NCT01500356|obesity|obesity
483151|NCT01500356|exercise|exercise
483152|NCT01500343|heart failure|heart failure
483153|NCT01500343|probiotics|probiotics
483154|NCT01500343|Saccharomyces boulardii|saccharomyces boulardii
483155|NCT01500343|cardio-intestinal syndrome|cardio-intestinal syndrome
483156|NCT01500343|gut|gut
483157|NCT01500343|inflammation|inflammation
483158|NCT01500317|tapentadol|tapentadol
483159|NCT01500317|oxycodone|oxycodone
483160|NCT01500317|mu-opiate|mu-opiate
483161|NCT01500317|stomach|stomach
483162|NCT01500317|small intestine|small intestine
483163|NCT01500317|colon|colon
483164|NCT01500317|motility|motility
483165|NCT01500317|nausea|nausea
483166|NCT01500317|constipation|constipation
483167|NCT01500304|Melanoma|melanoma
483168|NCT01500304|Lymph Nodes|lymph nodes
483169|NCT01500304|Lymph Node Dissection|lymph node dissection
483170|NCT01500304|Minimally invasive|minimally invasive
483171|NCT01500291|anesthesia stress|anesthesia stress
483172|NCT01500278|Certolizumab Pegol|certolizumab pegol
483173|NCT01500278|Cimzia|cimzia
483174|NCT01500278|Adalimumab|adalimumab
483175|NCT01500278|Humira|humira
483176|NCT01500278|Rheumatoid Arthritis|rheumatoid arthritis
483177|NCT01500265|hepatitis B virus|hepatitis b virus
483178|NCT01500265|early screening tools|early screening tools
483179|NCT01500265|renal proximal tubular tolerance|renal proximal tubular tolerance
483180|NCT01500252|Total Knee Replacement|total knee replacement
483181|NCT01500252|Patellar Resurfacing|patellar resurfacing
483182|NCT01500252|Health Related Quality of Life|health related quality of life
483183|NCT01500226|Rolapitant|rolapitant
483184|NCT01500226|Nausea|nausea
483185|NCT01500226|Vomiting|vomiting
483186|NCT01500226|CINV|cinv
483187|NCT01500226|Chemotherapy|chemotherapy
483188|NCT01500213|Rolapitant|rolapitant
483189|NCT01500213|Nausea|nausea
483190|NCT01500213|Vomiting|vomiting
483191|NCT01500213|CINV|cinv
483192|NCT01500213|Chemotherapy|chemotherapy
483193|NCT01500187|white spot lesions|white spot lesions
483194|NCT01500187|fixed orthodontic brackets|fixed orthodontic brackets
483195|NCT01500187|fluoride varnish|fluoride varnish
483196|NCT01500187|fluoride gel|fluoride gel
483197|NCT01500174|skin|skin
483200|NCT01500174|sore|sore
483201|NCT01500174|spinal cord injury|spinal cord injury
483202|NCT01500161|Leukemia|leukemia
483203|NCT01500161|Lymphoma|lymphoma
483204|NCT01500161|Myeloma|myeloma
483205|NCT01500161|Aplastic Anemia|aplastic anemia
483206|NCT01500161|Myelodysplasia|myelodysplasia
483208|NCT01500161|ALL|all
483209|NCT01500161|CLL|cll
483210|NCT01500161|CML|cml
483211|NCT01500148|Mitral Valve Prolapse|mitral valve prolapse
483212|NCT01500148|Mitral Valve Disease|mitral valve disease
483213|NCT01500148|Mitral Valve Regurgitation|mitral valve regurgitation
483214|NCT01500148|Mitral Valve Insufficiency|mitral valve insufficiency
483215|NCT01500148|Mitral Valve Incompetence|mitral valve incompetence
483216|NCT01500148|Percutaneous Mitral Valve Repair|percutaneous mitral valve repair
483217|NCT01500148|Posterior leaflet prolapse|posterior leaflet prolapse
483218|NCT01500148|Mitral valve degeneration|mitral valve degeneration
483219|NCT01500135|Vascular Surgery|vascular surgery
483220|NCT01500135|Secondary treatment of needle hole bleeding|secondary treatment of needle hole bleeding
483221|NCT01500135|Subjects undergoing vascular surgery and who need supportive treatment in order to control bleeding|subjects undergoing vascular surgery and who need supportive treatment in order to control bleeding
483222|NCT01500109|cleft palate surgery|cleft palate surgery
483223|NCT01500109|post-operative pain management|post-operative pain management
483224|NCT01500109|Acetaminophen|acetaminophen
483225|NCT01500096|Fatigue|fatigue
483226|NCT01500096|HIV/AIDS|hiv/aids
483227|NCT01500096|American ginseng|american ginseng
483228|NCT01500096|Panax quinquefolius|panax quinquefolius
483229|NCT01500096|Fatigue Severity Scale|fatigue severity scale
483230|NCT01500096|CD4 count|cd4 count
483231|NCT01500096|plasma HIV RNA|plasma hiv rna
483232|NCT01500096|cytokines|cytokines
483233|NCT01500096|IL-6|il-6
483234|NCT01500096|sTNFR1|stnfr1
483235|NCT01500096|sTNFR2|stnfr2
483236|NCT01500083|iNHL|inhl
483237|NCT01500083|CLL|cll
483238|NCT01500070|Peripheral Arterial Disease|peripheral arterial disease
483239|NCT01500070|Claudication|claudication
483240|NCT01500070|Drug-Eluting Stent|drug-eluting stent
483241|NCT01500070|BTK|btk
483242|NCT01500070|Everolimus|everolimus
483243|NCT01500070|CLI|cli
483244|NCT01500057|enlarged prostate|enlarged prostate
483245|NCT01500044|Radiculopathy|radiculopathy
483246|NCT01500044|Rehabilitation|rehabilitation
483247|NCT01500044|Mobilization|mobilization
483248|NCT01500044|Exercise|exercise
483249|NCT01500044|Physical Therapy|physical therapy
483250|NCT01500018|Phase I|phase i
483251|NCT01500018|healthy recreational polydrug users|healthy recreational polydrug users
483252|NCT01500018|abuse liability|abuse liability
483253|NCT01500018|TC-5214|tc-5214
483254|NCT01500018|Single dose crossover study to evaluate the abuse potential of TC-5214|single dose crossover study to evaluate the abuse potential of tc-5214
483255|NCT01499992|Shoulder rehabilitation|shoulder rehabilitation
483256|NCT01499992|Rotator cuff tear|rotator cuff tear
483257|NCT01499992|Physiotherapy|physiotherapy
483258|NCT01499992|aqua therapy|aqua therapy
483259|NCT01499992|Therapy dosage|therapy dosage
483260|NCT01499992|adjunctive aquatic physical therapy|adjunctive aquatic physical therapy
483261|NCT01499979|Ischemia-reperfusion injury|ischemia-reperfusion injury
483262|NCT01499979|In situ hypothermic perfusion|in situ hypothermic perfusion
483263|NCT01499979|In situ hypothermic preservation|in situ hypothermic preservation
483264|NCT01499966|Lateral Ankle Sprain|lateral ankle sprain
483265|NCT01499966|Plaster of Paris|plaster of paris
483266|NCT01499966|Tubigrip|tubigrip
483267|NCT01499953|superficial vein thrombosis|superficial vein thrombosis
483268|NCT01499953|thrombosis|thrombosis
483269|NCT01499953|SVT|svt
483270|NCT01499940|peripheral neuropathy|peripheral neuropathy
483271|NCT01499940|vitamin D status|vitamin d status
483272|NCT01499940|oxaliplatin|oxaliplatin
483273|NCT01499927|Early reassessment of intravenous antiinfective therapy|early reassessment of intravenous antiinfective therapy
483274|NCT01499914|vaccination H1N1|vaccination h1n1
483275|NCT01499914|cystic fibrosis|cystic fibrosis
483276|NCT01499901|deafness|deafness
483277|NCT01499901|unilateral implantation|unilateral implantation
483278|NCT01499901|bilateral|bilateral
483279|NCT01499901|auditory perception|auditory perception
483280|NCT01499888|Sickle Cell Disease|sickle cell disease
483281|NCT01499888|Subtype Hgb SS|subtype hgb ss
483282|NCT01499888|Subtype Hgb SC|subtype hgb sc
483283|NCT01499888|Subtype Hgb SB|subtype hgb sb
483284|NCT01499888|Chronic Transfusion Therapy|chronic transfusion therapy
483285|NCT01499888|Prior Stroke|prior stroke
483286|NCT01499888|Allogeneic|allogeneic
483287|NCT01499888|Stem Cell Transplantation|stem cell transplantation
483288|NCT01499888|Alemtuzumab|alemtuzumab
483289|NCT01499888|Sirolimus|sirolimus
483290|NCT01499888|Total Body Irradiation|total body irradiation
483291|NCT01499888|Hydroxyurea Intolerant|hydroxyurea intolerant
483292|NCT01499875|Pharmacokinetic|pharmacokinetic
483293|NCT01499875|Pharmacodynamic|pharmacodynamic
483294|NCT01499875|Phenoxymethylpenicillin|phenoxymethylpenicillin
483295|NCT01499875|Children|children
483296|NCT01499862|Stroke|stroke
483297|NCT01499862|Tibion|tibion
483298|NCT01499862|Bionics|bionics
483299|NCT01499862|Rehab|rehab
483300|NCT01499862|Therapy|therapy
483301|NCT01499862|Robotics|robotics
483302|NCT01499862|Intention|intention
483303|NCT01499849|Rolapitant|rolapitant
483304|NCT01499849|Nausea|nausea
483305|NCT01499849|Vomiting|vomiting
483306|NCT01499849|CINV|cinv
483307|NCT01499849|Chemotherapy|chemotherapy
483308|NCT01499823|Permeability Map|permeability map
483309|NCT01499823|High-Grade Glioma|high-grade glioma
483310|NCT01499810|Hypertension|hypertension
483311|NCT01499810|Radiofrequency Catheter Ablation|radiofrequency catheter ablation
483312|NCT01499810|Renal Artery|renal artery
483313|NCT01499810|Sympathetic Nerve Block|sympathetic nerve block
483314|NCT01499797|frailty|frailty
483315|NCT01499797|frail elders|frail elders
483316|NCT01499797|multicomponent intervention|multicomponent intervention
483317|NCT01499797|overall functioning|overall functioning
483318|NCT01499797|cost-effectiveness|cost-effectiveness
483319|NCT01499797|integrated care|integrated care
483320|NCT01499797|primary care|primary care
483321|NCT01499797|community dwelling|community dwelling
483322|NCT01499745|Idiopathic pulmonary fibrosis (IPF) patients|idiopathic pulmonary fibrosis (ipf) patients
483323|NCT01499732|Premature endothelial dysfunction|premature endothelial dysfunction
483324|NCT01499732|Early Rheumatoid Arthritis|early rheumatoid arthritis
483325|NCT01499732|established rheumatoid arthritis|established rheumatoid arthritis
483326|NCT01499732|Premature endothelial dysfunction in early rheumatoid arthritis|premature endothelial dysfunction in early rheumatoid arthritis
483327|NCT01499732|Premature endothelial dysfunction in established rheumatoid arthritis|premature endothelial dysfunction in established rheumatoid arthritis
483328|NCT01499732|Endothelial function in healthy subjects|endothelial function in healthy subjects
483329|NCT01499719|Sinusitis|sinusitis
483330|NCT01499719|Disease|disease
483331|NCT01499719|Chronic|chronic
483332|NCT01499719|Sinonasal|sinonasal
483333|NCT01499706|Motivational Interviewing|motivational interviewing
483334|NCT01499706|Telephone|telephone
483335|NCT01499706|HIV|hiv
483336|NCT01499706|AIDS|aids
483337|NCT01499706|Older Adults|older adults
483338|NCT01499693|Proton Pump Inhibitors|proton pump inhibitors
483339|NCT01499693|gastric pH|gastric ph
483340|NCT01499680|Degenerative Lumbar Conditions|degenerative lumbar conditions
483341|NCT01499667|Relapsing remitting multiple sclerosis|relapsing remitting multiple sclerosis
483342|NCT01499667|multiple sclerosis (MS)|multiple sclerosis (ms)
483343|NCT01499667|safety|safety
483344|NCT01499667|tolerability|tolerability
483345|NCT01499667|health outcomes|health outcomes
483346|NCT01499667|fingolimod|fingolimod
483347|NCT01499667|disease control|disease control
483348|NCT01499667|MRI|mri
483349|NCT01499654|SPECT MPI|spect mpi
483350|NCT01499654|Tomography, Emission-Computed, Single-Photon|tomography, emission-computed, single-photon
483351|NCT01499654|Wide Beam Reconstruction|wide beam reconstruction
483352|NCT01499641|discectomy|discectomy
483353|NCT01499641|methylprednisolone|methylprednisolone
483354|NCT01499641|randomized control trial|randomized control trial
483355|NCT01499615|adverse events|adverse events
483356|NCT01499615|adverse cardiovascular events|adverse cardiovascular events
483357|NCT01499615|early warning|early warning
483358|NCT01499602|Endometrial hyperplasia,|endometrial hyperplasia,
483359|NCT01499602|LNG-IUS,|lng-ius,
483360|NCT01499602|Progestin|progestin
483361|NCT01499589|anesthesia-controlled time|anesthesia-controlled time
483362|NCT01499589|turnover time|turnover time
483363|NCT01499576|Mass Screening|mass screening
483364|NCT01499576|Endoscopy, Gastrointestinal|endoscopy, gastrointestinal
483365|NCT01499576|Stomach Neoplasms|stomach neoplasms
483366|NCT01499576|Metaplasia|metaplasia
483367|NCT01499576|Diagnosis|diagnosis
483368|NCT01499576|Acetic acid|acetic acid
483369|NCT01499576|Chromoendoscopy|chromoendoscopy
483370|NCT01499550|transnasal high flow therapy|transnasal high flow therapy
483371|NCT01499550|COPD|copd
483372|NCT01499537|Stenosis of biliary ways|stenosis of biliary ways
483373|NCT01499524|ICP, GDM|icp, gdm
483374|NCT01499511|Hypertension|hypertension
483375|NCT01499511|Mortality|mortality
483376|NCT01499511|Morbidity|morbidity
483377|NCT01499511|Coronary Heart Disease|coronary heart disease
483378|NCT01499511|Stroke|stroke
483379|NCT01499511|Diabetes|diabetes
483380|NCT01499498|Healthy volunteers|healthy volunteers
483381|NCT01499485|Pulmonary Disease, Chronic Obstructive|pulmonary disease, chronic obstructive
483382|NCT01499485|Obesity Hypoventilation Syndrome|obesity hypoventilation syndrome
483383|NCT01499485|Alkalosis|alkalosis
483384|NCT01499485|Respiration, Artificial|respiration, artificial
483385|NCT01499485|Acetazolamide|acetazolamide
483386|NCT01499485|Intensive care|intensive care
483387|NCT01499485|Adult|adult
483388|NCT01499459|liver cirrhosis|liver cirrhosis
483389|NCT01499459|autologous mesenchymal stem cell transplantation|autologous mesenchymal stem cell transplantation
616277|NCT00954733|Co2|co2
483390|NCT01499342|Stent|stent
483391|NCT01499342|Atherosclerotic occlusive disease|atherosclerotic occlusive disease
483392|NCT01499342|Peripheral arterial disease|peripheral arterial disease
483393|NCT01499342|Superficial femoral artery|superficial femoral artery
483394|NCT01499342|SFA|sfa
483395|NCT01499329|Stent therapy|stent therapy
483396|NCT01499316|Coronary artery disease|coronary artery disease
483397|NCT01499316|Fractional flow reserve|fractional flow reserve
483398|NCT01499303|lymphoma|lymphoma
483399|NCT01499303|DLBCL|dlbcl
483400|NCT01499303|fostamatinib|fostamatinib
483401|NCT01499303|Diffuse Large B-Cell Lymphoma (DLBCL)|diffuse large b-cell lymphoma (dlbcl)
483402|NCT01499290|Ceftazidime|ceftazidime
483403|NCT01499290|Meropenem|meropenem
483404|NCT01499290|Metronidazole|metronidazole
483405|NCT01499290|Anti-Bacterial Agents|anti-bacterial agents
483406|NCT01499290|Anti-Infective Agents|anti-infective agents
483407|NCT01499290|Antiprotozoal Agents|antiprotozoal agents
483408|NCT01499290|Antiparasitic Agents|antiparasitic agents
483409|NCT01499290|cIAI, Complicated Intra-Abdominal Infection|ciai, complicated intra-abdominal infection
483410|NCT01499277|complicated skin and soft tissue infections (cSSTI)|complicated skin and soft tissue infections (cssti)
483411|NCT01499277|skin infection|skin infection
483412|NCT01499277|ceftaroline|ceftaroline
483413|NCT01499277|wound infection|wound infection
483414|NCT01499277|cellulitis|cellulitis
483415|NCT01499277|burn infection|burn infection
483416|NCT01499277|bacterial infection|bacterial infection
483417|NCT01499277|vancomycin|vancomycin
483418|NCT01499264|MySkin patch|myskin patch
483419|NCT01499251|glioblastoma|glioblastoma
483420|NCT01499238|Efficacy|efficacy
483421|NCT01499238|safety|safety
483422|NCT01499238|nasal SIMV|nasal simv
483423|NCT01499238|nasal CPAP|nasal cpap
483424|NCT01499238|infants who are >35 gestational week with wet lung|infants who are >35 gestational week with wet lung
483425|NCT01499199|cerebrospinal fluid (CSF)|cerebrospinal fluid (csf)
483426|NCT01499199|ART-naive|art-naive
483427|NCT01499199|integrase inhibitor|integrase inhibitor
483428|NCT01499199|dolutegravir|dolutegravir
483429|NCT01499199|antiretroviral therapy naive|antiretroviral therapy naive
483430|NCT01499186|Local vibration, elderly, bone, muscle, functionality|local vibration, elderly, bone, muscle, functionality
483431|NCT01499160|endocrine resistant|endocrine resistant
483432|NCT01499160|everolimus|everolimus
483433|NCT01499160|lapatinib|lapatinib
483434|NCT01499160|letrozole|letrozole
483435|NCT01499147|Acute myeloid leukemia|acute myeloid leukemia
483436|NCT01499147|First remission|first remission
483437|NCT01499147|Acute lymphocytic leukemia|acute lymphocytic leukemia
483438|NCT01499147|Acute leukemia|acute leukemia
483439|NCT01499147|Second remission|second remission
483440|NCT01499147|Early relapse|early relapse
483441|NCT01499147|Partial remission|partial remission
483442|NCT01499147|Accelerated phase|accelerated phase
483443|NCT01499147|Blast-crisis|blast-crisis
483444|NCT01499147|Chronic myelogenous leukemia|chronic myelogenous leukemia
483445|NCT01499147|Chronic phase|chronic phase
483446|NCT01499147|Recurrent malignant lymphoma|recurrent malignant lymphoma
483447|NCT01499147|Refractory malignant lymphoma|refractory malignant lymphoma
483448|NCT01499147|Hodgkin's disease|hodgkin's disease
483449|NCT01499147|Multiple myeloma.|multiple myeloma.
483450|NCT01499147|Chronic lymphocytic leukemia|chronic lymphocytic leukemia
483451|NCT01499147|Myeloproliferative disorder|myeloproliferative disorder
483452|NCT01499147|Polycythemia vera|polycythemia vera
483453|NCT01499147|Myelofibrosis|myelofibrosis
483454|NCT01499147|Severe aplastic anemia|severe aplastic anemia
483455|NCT01499108|type 2 diabetes|type 2 diabetes
483456|NCT01499108|hypertension|hypertension
483457|NCT01499108|liraglutide|liraglutide
483458|NCT01499108|kidney function|kidney function
483459|NCT01499056|osteoarthritis|osteoarthritis
483460|NCT01499056|hip joint|hip joint
483461|NCT01499056|mesenchymal stem cell|mesenchymal stem cell
483462|NCT01499043|CRPC|crpc
483463|NCT01499043|Prostate Cancer|prostate cancer
483464|NCT01499043|Bone metastasis|bone metastasis
483465|NCT01499043|Advanced Castration-Resistant Prostate Cancer (CRPC)|advanced castration-resistant prostate cancer (crpc)
483466|NCT01499017|Single Ascending Dose Study in healthy subjects|single ascending dose study in healthy subjects
483467|NCT01499004|tofacitinib|tofacitinib
483468|NCT01499004|CP-690|cp-690
483469|NCT01499004|550|550
483470|NCT01499004|relative bioavailability|relative bioavailability
483471|NCT01499004|modified release|modified release
483472|NCT01499004|Phase 1|phase 1
483473|NCT01498991|Incomplete Spinal Cord Injury|incomplete spinal cord injury
483474|NCT01498991|Rehabilitation|rehabilitation
483475|NCT01498991|AMES device|ames device
483476|NCT01498991|Lower Extremity|lower extremity
483477|NCT01498991|Gait|gait
483478|NCT01498991|Paraplegia|paraplegia
483479|NCT01498965|food allergy|food allergy
483480|NCT01498965|eczema|eczema
483481|NCT01498965|Vitamin D status|vitamin d status
483482|NCT01498965|body composition|body composition
483483|NCT01498965|obesity|obesity
483484|NCT01498965|neurodevelopmental and behavioural outcome|neurodevelopmental and behavioural outcome
483485|NCT01498952|HCC, liver cancer, hepatocellular carcinoma, MEDI-573, anti-IGF|hcc, liver cancer, hepatocellular carcinoma, medi-573, anti-igf
483486|NCT01498887|Multiple Sclerosis|multiple sclerosis
483487|NCT01498887|Relapsing Remitting Multiple Sclerosis|relapsing remitting multiple sclerosis
483488|NCT01498887|Fingolimod|fingolimod
483588|NCT01498445|Decitabine|decitabine
483489|NCT01498887|Early multiple sclerosis|early multiple sclerosis
483490|NCT01498887|Naive patients|naive patients
483491|NCT01498874|Acne|acne
483492|NCT01498874|Acne Vulgaris|acne vulgaris
483493|NCT01498835|Soft tissue sarcoma|soft tissue sarcoma
483494|NCT01498835|Radiation therapy|radiation therapy
483495|NCT01498835|Sunitinib|sunitinib
483496|NCT01498822|Levetiracetam|levetiracetam
483497|NCT01498822|Oxcarbazepine|oxcarbazepine
483498|NCT01498822|treatment failure|treatment failure
483499|NCT01498822|partial epilepsy|partial epilepsy
483500|NCT01498809|Orthostatic intolerance in people with spinal cord injury|orthostatic intolerance in people with spinal cord injury
483501|NCT01498744|Skin and Soft Tissue Abscess|skin and soft tissue abscess
483502|NCT01498744|Methicillin-resistant Staphylococcus aureus (MRSA)|methicillin-resistant staphylococcus aureus (mrsa)
483503|NCT01498744|Incision and Drainage|incision and drainage
483504|NCT01498744|Clindamycin|clindamycin
483505|NCT01498744|Trimethoprim-sulfamethoxazole|trimethoprim-sulfamethoxazole
483506|NCT01498744|Skin Infection|skin infection
483507|NCT01498731|Copeptin|copeptin
483508|NCT01498731|Troponin|troponin
483509|NCT01498731|Acute Coronary Syndrome|acute coronary syndrome
483510|NCT01498731|Rule-out of acute myocardial infarction|rule-out of acute myocardial infarction
483511|NCT01498731|Emergency Medicine|emergency medicine
483512|NCT01498718|Influenza A (H1N1)|influenza a (h1n1)
483513|NCT01498718|Influenza A (H3N2)|influenza a (h3n2)
483514|NCT01498718|Influenza B|influenza b
483515|NCT01498718|Trivalent Inactivated Vaccine (TIV)|trivalent inactivated vaccine (tiv)
483516|NCT01498718|Healthy Adults|healthy adults
483517|NCT01498705|Intraventricular Hemorrhage|intraventricular hemorrhage
483518|NCT01498705|Intracerebral Hemorrhage|intracerebral hemorrhage
483519|NCT01498705|Cerebrovascular Disorders|cerebrovascular disorders
483520|NCT01498705|Brain Diseases|brain diseases
483521|NCT01498705|Central Nervous System Diseases|central nervous system diseases
483522|NCT01498705|Nervous System Diseases|nervous system diseases
483523|NCT01498705|Vascular Diseases|vascular diseases
483524|NCT01498705|Procalcitonin Level|procalcitonin level
483525|NCT01498692|drug-eluting stents|drug-eluting stents
483526|NCT01498692|DES|des
483527|NCT01498692|atherosclerotic|atherosclerotic
483528|NCT01498640|XIAFLEX|xiaflex
483529|NCT01498640|XIAPEX|xiapex
483530|NCT01498640|Dupuytren's disease|dupuytren's disease
483531|NCT01498640|contracture|contracture
483532|NCT01498627|Autoimmune diseases (AIDs)|autoimmune diseases (aids)
483533|NCT01498627|Cervarix|cervarix
483534|NCT01498627|PGRx information system|pgrx information system
483535|NCT01498614|Diabetes mellitus|diabetes mellitus
483536|NCT01498614|depression|depression
483537|NCT01498614|anxiety|anxiety
483538|NCT01498614|negative self image|negative self image
483539|NCT01498614|alexithymia|alexithymia
483540|NCT01498614|metabolic control|metabolic control
483541|NCT01498614|diabetes complications|diabetes complications
483542|NCT01498601|oral hygiene|oral hygiene
483543|NCT01498601|tracheostomy|tracheostomy
483544|NCT01498601|deglutition disorders|deglutition disorders
483545|NCT01498601|enteral nutrition|enteral nutrition
483546|NCT01498601|brain injury|brain injury
483548|NCT01498588|Breast Neoplasms|breast neoplasms
483549|NCT01498588|Breast Cancer|breast cancer
483550|NCT01498588|Breast Tumors|breast tumors
483551|NCT01498588|Cancer of the Breast|cancer of the breast
483552|NCT01498588|Neoplasms, Breast|neoplasms, breast
483553|NCT01498588|Tumors, Breast|tumors, breast
483554|NCT01498575|Teen driving|teen driving
483555|NCT01498575|Behind the wheel practice driving|behind the wheel practice driving
483556|NCT01498575|Parent supervision|parent supervision
483557|NCT01498549|Abstinent cocaine users|abstinent cocaine users
483558|NCT01498549|cognitive testing|cognitive testing
483559|NCT01498523|Camel milk|camel milk
483560|NCT01498523|Postprandial glycaemic response|postprandial glycaemic response
483561|NCT01498523|postprandial insulinaemic response|postprandial insulinaemic response
483562|NCT01498523|Glycaemic index|glycaemic index
483563|NCT01498510|chronic pain|chronic pain
483564|NCT01498510|cognitive behavior therapy|cognitive behavior therapy
483565|NCT01498510|web-based intervention|web-based intervention
483566|NCT01498484|EBV-specific T-cell lines|ebv-specific t-cell lines
483567|NCT01498484|11-130|11-130
483568|NCT01498458|German Breast Group|german breast group
483569|NCT01498458|GBG Forschungs GmbH|gbg forschungs gmbh
483570|NCT01498458|GBG|gbg
483571|NCT01498458|GBG 62|gbg 62
483572|NCT01498458|PazoX|pazox
483573|NCT01498458|Breast Cancer|breast cancer
483574|NCT01498458|Metastatic Breast Cancer|metastatic breast cancer
483575|NCT01498458|Pazopanib|pazopanib
483576|NCT01498458|Abraxane|abraxane
483577|NCT01498458|Capecitabine|capecitabine
483578|NCT01498458|Xeloda|xeloda
483579|NCT01498445|Leukemia|leukemia
483580|NCT01498445|Chronic myelogenous leukemia|chronic myelogenous leukemia
483581|NCT01498445|Chronic myeloid leukemia|chronic myeloid leukemia
483582|NCT01498445|CML|cml
483583|NCT01498445|Accelerated phase|accelerated phase
483584|NCT01498445|Blastic phase|blastic phase
483585|NCT01498445|Dasatinib|dasatinib
483586|NCT01498445|BMS-354825|bms-354825
483587|NCT01498445|Sprycel|sprycel
483589|NCT01498445|Dacogen|dacogen
483590|NCT01498419|Tuberculosis|tuberculosis
483591|NCT01498419|Serial Sputum Colony Counts|serial sputum colony counts
483592|NCT01498419|Colony Forming Units|colony forming units
483593|NCT01498419|Time to Sputum Culture Positivity|time to sputum culture positivity
483594|NCT01498419|PA824|pa824
483595|NCT01498419|pretomanid|pretomanid
483596|NCT01498406|cutaneous lupus erythematosus|cutaneous lupus erythematosus
483597|NCT01498406|vitamin D|vitamin d
483598|NCT01498406|quality of life|quality of life
483599|NCT01498393|fungal nail|fungal nail
483600|NCT01498380|Dexmedetomidine|dexmedetomidine
483601|NCT01498380|Precedex|precedex
483602|NCT01498380|TIVA|tiva
483603|NCT01498380|Rapid bolus|rapid bolus
483604|NCT01498367|Diabetes Mellitus, Type 2|diabetes mellitus, type 2
483605|NCT01498367|Telemedicine|telemedicine
483606|NCT01498354|Transanal endoscopic microsurgery|transanal endoscopic microsurgery
483607|NCT01498354|Transanal endoscopic operations|transanal endoscopic operations
483608|NCT01498354|Rectal adenomas|rectal adenomas
483609|NCT01498354|Transanal endoscopic surgery|transanal endoscopic surgery
483610|NCT01498354|"Rectal adenocarcinomas in situ"|"rectal adenocarcinomas in situ"
483611|NCT01498341|Hypoparathyroidism|hypoparathyroidism
483612|NCT01498341|Epidemiology|epidemiology
483613|NCT01498341|Prognosis|prognosis
483614|NCT01498341|Symptoms|symptoms
483615|NCT01498328|EGFRvIII|egfrviii
483616|NCT01498328|Glioblastoma|glioblastoma
483617|NCT01498328|Rindopepimut|rindopepimut
483618|NCT01498328|CDX-110|cdx-110
483619|NCT01498328|Small cell|small cell
483620|NCT01498328|Giant cell|giant cell
483621|NCT01498328|Brain Cancer|brain cancer
483622|NCT01498328|Brain Tumor|brain tumor
483623|NCT01498328|Gliosarcoma|gliosarcoma
483624|NCT01498328|oligodendroglial|oligodendroglial
483625|NCT01498328|radiotherapy|radiotherapy
483626|NCT01498328|chemoradiation|chemoradiation
483627|NCT01498328|Tumor|tumor
483628|NCT01498328|Bevacizumab|bevacizumab
483629|NCT01498328|Relapsed|relapsed
483630|NCT01498328|Returned|returned
483631|NCT01498328|Recurrent|recurrent
483632|NCT01498328|EGFR variant III|egfr variant iii
483633|NCT01498302|childhood acute myeloid leukemia/other myeloid malignancies|childhood acute myeloid leukemia/other myeloid malignancies
483634|NCT01498289|recurrent esophageal cancer|recurrent esophageal cancer
483635|NCT01498289|stage IV esophageal cancer|stage iv esophageal cancer
483636|NCT01498289|recurrent gastric cancer|recurrent gastric cancer
483637|NCT01498289|stage IV gastric cancer|stage iv gastric cancer
483638|NCT01498289|adenocarcinoma of the gastroesophageal junction|adenocarcinoma of the gastroesophageal junction
483639|NCT01498289|stage IIIB gastric cancer|stage iiib gastric cancer
483640|NCT01498289|stage IIIC gastric cancer|stage iiic gastric cancer
483641|NCT01498289|stage IIIB esophageal cancer|stage iiib esophageal cancer
483642|NCT01498289|stage IIIC esophageal cancer|stage iiic esophageal cancer
483643|NCT01498289|adenocarcinoma of the esophagus|adenocarcinoma of the esophagus
483644|NCT01498289|adenocarcinoma of the stomach|adenocarcinoma of the stomach
483645|NCT01498276|FHH (Family Health History)|fhh (family health history)
483646|NCT01498276|Family Health History|family health history
483647|NCT01498276|Disease Risk Assessment|disease risk assessment
483648|NCT01498263|Genetic Condition|genetic condition
483649|NCT01498263|Family Network|family network
483650|NCT01498263|Social Support|social support
483651|NCT01498263|Alzheimer's Disease|alzheimer's disease
483652|NCT01498263|AD|ad
483653|NCT01498263|Family Systems|family systems
483654|NCT01498237|Photoacoustic endoscopy|photoacoustic endoscopy
483655|NCT01498224|Cataract surgery|cataract surgery
483656|NCT01498211|volunteer|volunteer
483657|NCT01498198|Rotator Cuff|rotator cuff
483658|NCT01498198|WCB|wcb
483659|NCT01498172|Non muscle invasive bladder cancer|non muscle invasive bladder cancer
483660|NCT01498159|Diabetes Mellitus|diabetes mellitus
483661|NCT01498159|Pharmacists|pharmacists
483662|NCT01498159|Community Health Aides|community health aides
483663|NCT01498146|cryptogenic stroke|cryptogenic stroke
483664|NCT01498146|atrial fibrillation|atrial fibrillation
483665|NCT01498146|longterm monitoring|longterm monitoring
483666|NCT01498146|loop recorder|loop recorder
483667|NCT01498133|Skin-to-skin contact|skin-to-skin contact
483668|NCT01498133|Decolonization|decolonization
483669|NCT01498133|MRSA|mrsa
483670|NCT01498120|Rotigotine|rotigotine
483671|NCT01498120|Restless Legs Syndrome|restless legs syndrome
483672|NCT01498120|RLS|rls
483673|NCT01498120|Long-term|long-term
483674|NCT01498120|Adolescents|adolescents
483675|NCT01498107|online intervention|online intervention
483676|NCT01498107|computerized CBT|computerized cbt
483677|NCT01498107|e-health|e-health
483678|NCT01498094|Bronchiolitis|bronchiolitis
483679|NCT01498094|High|high
483680|NCT01498094|Flow|flow
483681|NCT01498094|Oxygen|oxygen
483682|NCT01498094|Therapy|therapy
483683|NCT01498094|Nasal|nasal
483684|NCT01498094|Cannulae|cannulae
483685|NCT01498094|Prongs|prongs
483686|NCT01498081|COPD, pulmonary disease|copd, pulmonary disease
483687|NCT01498068|Genotype 1 chronic Hepatitis C|genotype 1 chronic hepatitis c
483688|NCT01498068|VX-950HPC3007|vx-950hpc3007
483689|NCT01498068|VX-950|vx-950
483690|NCT01498068|Hepatitis C|hepatitis c
483691|NCT01498068|Telaprevir|telaprevir
483692|NCT01498068|HCV|hcv
483693|NCT01498055|lung cancer|lung cancer
483694|NCT01498055|CIK cells|cik cells
483695|NCT01498055|therapy|therapy
483696|NCT01498029|Cartilage, Articular|cartilage, articular
483697|NCT01498016|acute leukemia|acute leukemia
483698|NCT01498016|allogeneic stem cell transplantation|allogeneic stem cell transplantation
483699|NCT01498016|busulfan|busulfan
483700|NCT01498003|coronary disease|coronary disease
483701|NCT01498003|stents|stents
483702|NCT01498003|thrombosis|thrombosis
483703|NCT01498003|myocardial infarction|myocardial infarction
483704|NCT01498003|prognosis|prognosis
483705|NCT01497990|Burns|burns
483706|NCT01497990|Ertapenem|ertapenem
483707|NCT01497990|Pharmacokinetics|pharmacokinetics
483708|NCT01497977|phytoestrogens|phytoestrogens
483709|NCT01497977|postmenopause|postmenopause
483710|NCT01497977|serum lipids|serum lipids
483711|NCT01497925|Arginine deiminase|arginine deiminase
483712|NCT01497925|Arginine|arginine
483713|NCT01497925|Solid tumors|solid tumors
483714|NCT01497925|Prostate cancer|prostate cancer
483715|NCT01497925|Phase 1 study|phase 1 study
483716|NCT01497899|HIV-1|hiv-1
483717|NCT01497899|HIV|hiv
483718|NCT01497899|Treatment-Naive|treatment-naive
483719|NCT01497886|Stroke|stroke
483720|NCT01497886|Children|children
483721|NCT01497886|Hip Hop Stroke|hip hop stroke
483722|NCT01497886|New York City|new york city
483723|NCT01497873|Small Cell Lung Cancer|small cell lung cancer
483724|NCT01497873|Belotecan|belotecan
483725|NCT01497873|Topotecan|topotecan
483726|NCT01497860|pediatric|pediatric
483727|NCT01497860|children|children
483728|NCT01497860|glioma|glioma
483729|NCT01497860|low-grade|low-grade
483730|NCT01497860|vinorelbine|vinorelbine
483731|NCT01497860|recurrent|recurrent
483732|NCT01497860|progressive|progressive
483733|NCT01497847|Post-Infectious Irritable Bowel Syndrome|post-infectious irritable bowel syndrome
483734|NCT01497847|PI-IBS|pi-ibs
483735|NCT01497834|Hepatitis C Virus Infection|hepatitis c virus infection
483736|NCT01497821|Amgen|amgen
483737|NCT01497821|Phase 1|phase 1
483738|NCT01497821|First in Human|first in human
483739|NCT01497821|Relapsed / Refractory Renal Cell Carcinoma (RCC)|relapsed / refractory renal cell carcinoma (rcc)
483740|NCT01497821|Kidney Cancer|kidney cancer
483741|NCT01497821|Clinical Trial|clinical trial
483742|NCT01497821|Antibody drug conjugate (ADC)|antibody drug conjugate (adc)
483743|NCT01497821|Open-label|open-label
483744|NCT01497821|Oncology|oncology
483745|NCT01497808|previously untreated|previously untreated
483746|NCT01497808|previously treated|previously treated
483747|NCT01497808|bone, lung, liver or subcutaneous involvement|bone, lung, liver or subcutaneous involvement
483748|NCT01497808|nodal involvement|nodal involvement
483749|NCT01497808|without evidence of brain involvement|without evidence of brain involvement
483750|NCT01497782|virtual reality, simulator, feedback, laparoscopy, training|virtual reality, simulator, feedback, laparoscopy, training
483751|NCT01497769|vaccine|vaccine
483752|NCT01497769|immunogenicity|immunogenicity
483753|NCT01497743|Scleroderma|scleroderma
483754|NCT01497743|gastrointestinal|gastrointestinal
483755|NCT01497743|bloating|bloating
483756|NCT01497743|reflux|reflux
483757|NCT01497730|Arthroplasty, Replacement, Knee,|arthroplasty, replacement, knee,
483758|NCT01497704|Cancer|cancer
483759|NCT01497704|Tumor|tumor
483760|NCT01497704|Oncology|oncology
483761|NCT01497704|Antiangiogenesis|antiangiogenesis
483762|NCT01497691|Asthma|asthma
483763|NCT01497691|Pediatrics|pediatrics
483764|NCT01497691|BiPAP|bipap
483765|NCT01497691|Noninvasive Positive Pressure Ventilation|noninvasive positive pressure ventilation
483766|NCT01497678|MTURR|mturr
483767|NCT01497678|ECM|ecm
483768|NCT01497678|Muscle Loss|muscle loss
483769|NCT01497678|Tendon|tendon
483770|NCT01497678|Tendon Repair|tendon repair
483771|NCT01497678|Muscle Repair|muscle repair
483772|NCT01497678|Soft Tissue Repair|soft tissue repair
483773|NCT01497678|Scaffold|scaffold
483774|NCT01497678|Extracellular Matrix|extracellular matrix
483775|NCT01497665|GRN1005|grn1005
483776|NCT01497665|ANG1005|ang1005
483777|NCT01497665|LRP-1|lrp-1
483778|NCT01497665|Targeted Therapy|targeted therapy
483779|NCT01497665|Brain Tumor|brain tumor
483780|NCT01497665|Blood Brain Barrier|blood brain barrier
483781|NCT01497665|Peptide-Drug Conjugate (PDC)|peptide-drug conjugate (pdc)
483782|NCT01497665|Brain Metastases|brain metastases
483783|NCT01497665|Paclitaxel|paclitaxel
483784|NCT01497665|Taxol|taxol
483785|NCT01497665|NSCLC|nsclc
483786|NCT01497665|Non-Small Cell Lung Cancer|non-small cell lung cancer
483787|NCT01497652|Parkinson's Disease|parkinson's disease
483788|NCT01497652|Cognition|cognition
483789|NCT01497652|Rasagiline|rasagiline
483790|NCT01497652|MoCA|moca
483791|NCT01497652|Mild Cognitive Impairment in Parkinson's Disease|mild cognitive impairment in parkinson's disease
483792|NCT01497639|dystonia|dystonia
483793|NCT01497639|pallidal stimulation|pallidal stimulation
483794|NCT01497639|deep brain stimulation|deep brain stimulation
483917|NCT01497106|Insulin resistance|insulin resistance
483795|NCT01497639|deep brain stimulation of GPi|deep brain stimulation of gpi
483797|NCT01497639|interleaving stimulation|interleaving stimulation
483798|NCT01497626|Advanced cancer|advanced cancer
483799|NCT01497626|Solid tumor|solid tumor
483800|NCT01497613|Socialization|socialization
483801|NCT01497613|Well-being|well-being
483802|NCT01497613|Quality of Life|quality of life
483803|NCT01497613|Connectivity|connectivity
483804|NCT01497548|Depression|depression
483805|NCT01497548|cancer|cancer
483806|NCT01497548|methylphenidate|methylphenidate
483807|NCT01497548|pharmacotherapy|pharmacotherapy
483808|NCT01497522|Vildagliptin|vildagliptin
483809|NCT01497522|Type 2 diabetes|type 2 diabetes
483810|NCT01497522|HbA1c|hba1c
483811|NCT01497522|Fasting plasma glucose|fasting plasma glucose
483812|NCT01497496|leukemia|leukemia
483813|NCT01497496|lymphoma|lymphoma
483814|NCT01497496|consolidative therapy|consolidative therapy
483815|NCT01497496|combination regimen|combination regimen
483816|NCT01497496|Chronic Lymphocytic Leukemia (CLL)|chronic lymphocytic leukemia (cll)
483817|NCT01497496|Small Lymphocytic Lymphoma (SLL)|small lymphocytic lymphoma (sll)
483818|NCT01497470|paclitaxel|paclitaxel
483819|NCT01497470|carboplatin|carboplatin
483820|NCT01497470|custirsen|custirsen
483821|NCT01497470|drug-drug interaction|drug-drug interaction
483822|NCT01497470|pharmacokinetics|pharmacokinetics
483823|NCT01497470|cancer|cancer
483824|NCT01497444|recurrent adult primary liver cancer|recurrent adult primary liver cancer
483825|NCT01497444|recurrent renal cell cancer|recurrent renal cell cancer
483826|NCT01497444|advanced adult primary liver cancer|advanced adult primary liver cancer
483827|NCT01497444|localized unresectable adult primary liver cancer|localized unresectable adult primary liver cancer
483828|NCT01497444|adult primary hepatocellular carcinoma|adult primary hepatocellular carcinoma
483829|NCT01497405|Gender-based Violence|gender-based violence
483831|NCT01497405|Randomized Controlled Trial|randomized controlled trial
483832|NCT01497405|Sexually Transmitted Diseases|sexually transmitted diseases
483833|NCT01497405|Substance Abuse Detection|substance abuse detection
483834|NCT01497405|Test, Treat and Retain|test, treat and retain
483835|NCT01497379|Hereditary retinal|hereditary retinal
483836|NCT01497379|degeneration outer|degeneration outer
483837|NCT01497379|retinal layers|retinal layers
483838|NCT01497379|photoreceptor rods cones|photoreceptor rods cones
483839|NCT01497379|Retinitis pigmentosa|retinitis pigmentosa
483840|NCT01497379|blindness|blindness
483841|NCT01497379|reading ability|reading ability
483842|NCT01497379|retina implant|retina implant
483843|NCT01497379|subretinal|subretinal
483844|NCT01497366|HCV genotype 2 (GT-2)|hcv genotype 2 (gt-2)
483845|NCT01497366|HCV genotype 3 (GT-3)|hcv genotype 3 (gt-3)
483846|NCT01497353|Cord clamping|cord clamping
483847|NCT01497353|newborn|newborn
483848|NCT01497353|Skin contact|skin contact
483849|NCT01497353|Placental transfusion|placental transfusion
483850|NCT01497353|Delivery room|delivery room
483851|NCT01497340|Cord clamping|cord clamping
483852|NCT01497340|newborn|newborn
483853|NCT01497340|Placental trasfusion|placental trasfusion
483854|NCT01497340|Delivery room|delivery room
483855|NCT01497327|HEPATITIS C, CHRONIC|hepatitis c, chronic
483856|NCT01497327|HCV|hcv
483857|NCT01497327|hepatic impairment|hepatic impairment
483858|NCT01497314|healthy term infants|healthy term infants
483859|NCT01497314|growth|growth
483860|NCT01497314|infant formula|infant formula
483861|NCT01497301|Diabetes|diabetes
483862|NCT01497301|Group Visit|group visit
483863|NCT01497301|Shared Medical Appointment|shared medical appointment
483864|NCT01497288|Intranasal fentanyl spray|intranasal fentanyl spray
483865|NCT01497288|Population PK|population pk
483866|NCT01497262|Multiple Sclerosis|multiple sclerosis
483867|NCT01497262|Relapsing-Remitting|relapsing-remitting
483868|NCT01497249|Dietary Fiber|dietary fiber
483869|NCT01497249|Blood glucose control|blood glucose control
483870|NCT01497249|Fermentability|fermentability
483871|NCT01497249|Tolerability|tolerability
483872|NCT01497223|Phase II|phase ii
483873|NCT01497223|Double-Blind|double-blind
483874|NCT01497223|Placebo-Controlled|placebo-controlled
483875|NCT01497223|Vulvovaginal Candidiasis|vulvovaginal candidiasis
483876|NCT01497223|Moderate to Severe|moderate to severe
483877|NCT01497223|Acute|acute
483878|NCT01497223|Treatment of Moderate to Severe Vulvovaginal Candidiasis|treatment of moderate to severe vulvovaginal candidiasis
483879|NCT01497197|Reproduction Techniques|reproduction techniques
483880|NCT01497197|Reproductive Medicine|reproductive medicine
483881|NCT01497197|Assisted Reproductive Technics|assisted reproductive technics
483882|NCT01497197|Pregnancy Rate|pregnancy rate
483883|NCT01497197|Ovulation Induction|ovulation induction
483884|NCT01497197|Ovarian Stimulation|ovarian stimulation
483885|NCT01497197|Oocytes|oocytes
483886|NCT01497197|Implantation|implantation
483887|NCT01497184|Leukemia|leukemia
483888|NCT01497184|Lymphoma|lymphoma
483889|NCT01497184|Allogeneic donor lymphocyte infusion|allogeneic donor lymphocyte infusion
483890|NCT01497184|DLI|dli
483891|NCT01497184|Hematopoietic Stem Cell Transplantation|hematopoietic stem cell transplantation
483892|NCT01497184|HSCT|hsct
483893|NCT01497184|Bone marrow transplant|bone marrow transplant
483894|NCT01497184|CD19-specific T cells|cd19-specific t cells
483895|NCT01497184|T cell infusion|t cell infusion
483896|NCT01497184|B-Lineage lymphoid malignancies|b-lineage lymphoid malignancies
483897|NCT01497184|CD19+ lymphoid malignancies|cd19+ lymphoid malignancies
483898|NCT01497184|Acute lymphoblastic leukemia|acute lymphoblastic leukemia
483899|NCT01497184|ALL|all
483900|NCT01497184|Biphenotypic leukemia CD19+ in advanced remission|biphenotypic leukemia cd19+ in advanced remission
483901|NCT01497184|Non-Hodgkin's Lymphoma|non-hodgkin's lymphoma
483902|NCT01497184|NHL|nhl
483903|NCT01497184|Diffuse large B-cell lymphoma|diffuse large b-cell lymphoma
483904|NCT01497184|Small lymphocytic lymphoma|small lymphocytic lymphoma
483905|NCT01497184|Follicular lymphoma|follicular lymphoma
483906|NCT01497184|Mantle cell lymphoma with active disease at time of transplant|mantle cell lymphoma with active disease at time of transplant
483907|NCT01497171|Cystocele|cystocele
483908|NCT01497171|Bladder prolapse|bladder prolapse
483909|NCT01497171|Anterior prolapse|anterior prolapse
483910|NCT01497171|Vaginal prolapse|vaginal prolapse
483911|NCT01497171|Uterine prolapse|uterine prolapse
483912|NCT01497171|Urinary incontinence|urinary incontinence
483913|NCT01497158|tobacco cessation|tobacco cessation
483914|NCT01497119|Moderate atopic dermatitis|moderate atopic dermatitis
483915|NCT01497119|JNJ-39758979|jnj-39758979
483916|NCT01497119|Japanese patients|japanese patients
483918|NCT01497106|Abdominal obesity|abdominal obesity
483919|NCT01497106|Calorie restriction|calorie restriction
483920|NCT01497093|Myeloma|myeloma
483921|NCT01497093|Multiple Myeloma|multiple myeloma
483922|NCT01497093|Relapsed Multiple Myeloma|relapsed multiple myeloma
483923|NCT01497093|Relapsed and Refractory Multiple Myeloma|relapsed and refractory multiple myeloma
483924|NCT01497093|Refractory Myeloma|refractory myeloma
483925|NCT01497093|Resistant Multiple Myeloma|resistant multiple myeloma
483926|NCT01497093|Treatment-resistant Multiple Myeloma|treatment-resistant multiple myeloma
483927|NCT01497093|Pomalidomide|pomalidomide
483928|NCT01497093|Lenalidomide-resistant|lenalidomide-resistant
483929|NCT01497080|distal radius fracture|distal radius fracture
483930|NCT01497080|Condition|condition
483931|NCT01497080|risk factors|risk factors
483932|NCT01497080|adverse activity transitions following DRF|adverse activity transitions following drf
483933|NCT01497080|optimal assessment approach|optimal assessment approach
483934|NCT01497067|Phakic Lens|phakic lens
483935|NCT01497067|Intraocular Lens (IOL)|intraocular lens (iol)
483936|NCT01497054|B type natriuretic peptide|b type natriuretic peptide
483937|NCT01497054|Patent Ductus Arteriosus|patent ductus arteriosus
483938|NCT01497054|Preterm infant|preterm infant
483939|NCT01497028|Co-morbid disease resolution|co-morbid disease resolution
483940|NCT01497002|AML|aml
483941|NCT01496989|HIV|hiv
483942|NCT01496989|AIDS|aids
483943|NCT01496989|HIV vaccine|hiv vaccine
483944|NCT01496989|HIV prevention|hiv prevention
483945|NCT01496976|leukemia|leukemia
483946|NCT01496976|lymphoma|lymphoma
483947|NCT01496976|consolidative therapy|consolidative therapy
483948|NCT01496976|combination regimen|combination regimen
483949|NCT01496976|CLL|cll
483950|NCT01496976|SLL|sll
483951|NCT01496963|Thalassemia|thalassemia
483952|NCT01496963|Pulmonary Arterial Hypertension|pulmonary arterial hypertension
483953|NCT01496950|migraine|migraine
483954|NCT01496924|Dysphagia|dysphagia
483955|NCT01496924|Intensive care units|intensive care units
483956|NCT01496924|Deglutition disorders|deglutition disorders
483957|NCT01496924|Rehabilitation|rehabilitation
483958|NCT01496911|Diving|diving
483959|NCT01496911|Drugs|drugs
483960|NCT01496911|Antihistamines|antihistamines
483961|NCT01496911|Performance|performance
483962|NCT01496898|Microflora|microflora
483963|NCT01496898|Vaginal|vaginal
483964|NCT01496898|Cervical|cervical
483965|NCT01496898|Uterine|uterine
483966|NCT01496898|Inflammation|inflammation
483967|NCT01496898|Cytokine|cytokine
483968|NCT01496898|Intrauterine Device|intrauterine device
483969|NCT01496898|Levonorgestrel|levonorgestrel
483970|NCT01496885|stroke|stroke
483971|NCT01496872|Newborn cranial somatic dysfunction|newborn cranial somatic dysfunction
483972|NCT01496872|Newborn observational study|newborn observational study
483973|NCT01496872|Somatic dysfunction|somatic dysfunction
483974|NCT01496872|Cranial strain pattern|cranial strain pattern
483975|NCT01496872|Osteopathy|osteopathy
483976|NCT01496859|Baska mask|baska mask
483977|NCT01496859|supraglottic airway|supraglottic airway
483978|NCT01496859|airway management|airway management
483979|NCT01496846|Articaine|articaine
483980|NCT01496846|Lidocaine|lidocaine
483981|NCT01496846|Anesthesia, Local|anesthesia, local
483982|NCT01496846|Endodontics|endodontics
483983|NCT01496846|Molar|molar
483984|NCT01496846|Dental Pulp Diseases|dental pulp diseases
483985|NCT01496833|Aortic Diseases|aortic diseases
483986|NCT01496833|Vascular Diseases|vascular diseases
483987|NCT01496833|Cardiovascular Diseases|cardiovascular diseases
483988|NCT01496833|Treatment Outcome|treatment outcome
484285|NCT01495585|Treatment|treatment
483989|NCT01496833|Aorta Dissection|aorta dissection
483990|NCT01496833|Aorta Aneurysm|aorta aneurysm
483991|NCT01496833|Aorta pseudoaneurysm|aorta pseudoaneurysm
483992|NCT01496833|Endovascular aortic repair|endovascular aortic repair
483993|NCT01496807|unresectable|unresectable
483994|NCT01496807|stage 3|stage 3
483995|NCT01496807|stage 4|stage 4
483996|NCT01496807|autoimmune|autoimmune
483997|NCT01496807|antibodies|antibodies
483998|NCT01496781|Endoscopic Hemostasis|endoscopic hemostasis
483999|NCT01496781|metallic hemoclip|metallic hemoclip
484000|NCT01496781|EndoClot Absorbable Polysaccharide Hemostat|endoclot absorbable polysaccharide hemostat
484001|NCT01496781|Colonic Polyps|colonic polyps
484002|NCT01496729|Kidney transplantation|kidney transplantation
484003|NCT01496729|Transversus abdominis plane (TAP) block|transversus abdominis plane (tap) block
484004|NCT01496716|Osteoarthritis|osteoarthritis
484005|NCT01496716|obesity|obesity
484006|NCT01496716|quality of life|quality of life
484007|NCT01496703|reasons for MMF dose reduction|reasons for mmf dose reduction
484008|NCT01496690|Anxiety-comorbidity to schizophrenia|anxiety-comorbidity to schizophrenia
484009|NCT01496690|Double-blinded randomized placebo controlled trial|double-blinded randomized placebo controlled trial
484010|NCT01496690|Pregabalin|pregabalin
484011|NCT01496677|volunteer|volunteer
484012|NCT01496651|Percutaneous coronary intervention|percutaneous coronary intervention
484013|NCT01496651|Coronary artery bypass graft operation|coronary artery bypass graft operation
484014|NCT01496651|Left Main|left main
484015|NCT01496638|PCI|pci
484016|NCT01496638|Bifurcation lesion|bifurcation lesion
484017|NCT01496625|Biological Specimens|biological specimens
484018|NCT01496625|Retinal Disease|retinal disease
484019|NCT01496625|Phenotype|phenotype
484020|NCT01496625|Phenotype-Genotype correlation|phenotype-genotype correlation
484021|NCT01496625|Age-Related Macular Degeneration (AMD)|age-related macular degeneration (amd)
484022|NCT01496625|AMD|amd
484023|NCT01496625|Diabetic Retinopathy|diabetic retinopathy
484024|NCT01496625|Healthy Volunteer|healthy volunteer
484025|NCT01496625|HV|hv
484026|NCT01496612|Epilepsy|epilepsy
484027|NCT01496612|Temporal Lobe Epilepsy|temporal lobe epilepsy
484028|NCT01496612|Serotonin 1A Receptor|serotonin 1a receptor
484029|NCT01496612|Seizures|seizures
484030|NCT01496599|Brain Imaging|brain imaging
484031|NCT01496599|Parkinson's Disease|parkinson's disease
484032|NCT01496599|Parkinsonism|parkinsonism
484033|NCT01496599|Parkinson Disease|parkinson disease
484034|NCT01496599|PD|pd
484035|NCT01496599|Healthy Volunteer|healthy volunteer
484036|NCT01496599|HV|hv
484037|NCT01496586|Fatigue|fatigue
484038|NCT01496586|Traumatic Brain Injury|traumatic brain injury
484039|NCT01496586|Motivational Incentive|motivational incentive
484040|NCT01496586|TBI|tbi
484041|NCT01496560|colonoscopy|colonoscopy
484042|NCT01496560|pain|pain
484043|NCT01496560|rectal balloon|rectal balloon
484044|NCT01496547|feasibility, effective and safety|feasibility, effective and safety
484045|NCT01496547|intensive chemotherapy|intensive chemotherapy
484046|NCT01496547|RIC regimen|ric regimen
484047|NCT01496547|refractory or relapse leukemia|refractory or relapse leukemia
484048|NCT01496547|allogeneic stem cell transplantation|allogeneic stem cell transplantation
484049|NCT01496534|advanced solid tumors|advanced solid tumors
484050|NCT01496534|bladder cancer|bladder cancer
484051|NCT01496534|gemcitabine|gemcitabine
484052|NCT01496534|cisplatin|cisplatin
484053|NCT01496534|carboplatin|carboplatin
484054|NCT01496534|solid tumors|solid tumors
484055|NCT01496521|Aspirin|aspirin
484056|NCT01496521|polyphenols|polyphenols
484057|NCT01496521|Chemoprevention|chemoprevention
484058|NCT01496508|high-frequency oscillatory ventilation|high-frequency oscillatory ventilation
484059|NCT01496508|respiratory distress syndrome|respiratory distress syndrome
484060|NCT01496508|preterm infants|preterm infants
484061|NCT01496508|neurodevelopment|neurodevelopment
484062|NCT01496508|preterm infants with severe respiratory distress syndrome|preterm infants with severe respiratory distress syndrome
484063|NCT01496482|Dry eye Syndromes|dry eye syndromes
484064|NCT01496469|Drug Therapy|drug therapy
484065|NCT01496456|Dental caries|dental caries
484066|NCT01496456|Proximal surfaces|proximal surfaces
484067|NCT01496456|Posterior teeth|posterior teeth
484068|NCT01496456|Carious lesions|carious lesions
484069|NCT01496456|Tooth diseases|tooth diseases
484070|NCT01496456|Preventive therapy|preventive therapy
484071|NCT01496443|Drug Therapy|drug therapy
484072|NCT01496430|Drug Therapy|drug therapy
484073|NCT01496430|Hypertension and Diabetes|hypertension and diabetes
484074|NCT01496417|Kidney Transplantation|kidney transplantation
484075|NCT01496417|Biopsy|biopsy
484076|NCT01496417|Belatacept|belatacept
484077|NCT01496404|Electrocautery|electrocautery
484078|NCT01496391|imaging|imaging
484079|NCT01496391|renal function|renal function
484080|NCT01496391|I-123 OIH|i-123 oih
484081|NCT01496391|Tc-99m MAG 3|tc-99m mag 3
484082|NCT01496378|Chronic Pain|chronic pain
484083|NCT01496378|Abdominal Pain|abdominal pain
484084|NCT01496378|Headache|headache
484085|NCT01496378|Adolescents|adolescents
484086|NCT01496378|Children|children
484087|NCT01496378|Parents|parents
484088|NCT01496378|Problem-Solving Skills Training|problem-solving skills training
484089|NCT01496365|Keywords: pain, diabetes, neuropathy|keywords: pain, diabetes, neuropathy
484090|NCT01496352|Surgical site infection|surgical site infection
484091|NCT01496352|Colorectal surgery|colorectal surgery
484092|NCT01496326|Osteoarthritis|osteoarthritis
484093|NCT01496326|knee pain|knee pain
484094|NCT01496313|medullary thyroid cancer|medullary thyroid cancer
484095|NCT01496313|metastatic|metastatic
484096|NCT01496313|thyroid cancer|thyroid cancer
484097|NCT01496313|carcinoma of the thyroid|carcinoma of the thyroid
484098|NCT01496313|receptor tyrosine kinase inhibitor|receptor tyrosine kinase inhibitor
484099|NCT01496313|VEGFR|vegfr
484100|NCT01496313|Unresectable locally advanced thyroid cancer|unresectable locally advanced thyroid cancer
484101|NCT01496300|Navigation OrthoPilot Hip TEP THA|navigation orthopilot hip tep tha
484102|NCT01496261|Clopidogrel|clopidogrel
484103|NCT01496261|Aspirin|aspirin
484104|NCT01496261|Combination|combination
484105|NCT01496261|Pharmacokinetics|pharmacokinetics
484106|NCT01496261|Phase 1|phase 1
484107|NCT01496248|Major depressive disorder|major depressive disorder
484108|NCT01496248|Residual symptoms|residual symptoms
484109|NCT01496248|Korean red ginseng|korean red ginseng
484110|NCT01496222|mild cognitive impairment|mild cognitive impairment
484111|NCT01496222|Montreal Cognitive Assessment test|montreal cognitive assessment test
484112|NCT01496209|Infarction|infarction
484113|NCT01496209|Myocardial Infarction|myocardial infarction
484114|NCT01496209|Ventricular Dysfunction, Left|ventricular dysfunction, left
484115|NCT01496209|Heart Disease|heart disease
484116|NCT01496209|Cardiovascular Disease|cardiovascular disease
484117|NCT01496209|Chronic Ischemia|chronic ischemia
484118|NCT01496196|hemoptisis|hemoptisis
484119|NCT01496196|bleeding|bleeding
484120|NCT01496196|tranexamic acid|tranexamic acid
484121|NCT01496157|Primary Prostate Cancer|primary prostate cancer
484122|NCT01496144|Chronic non specific low back pain|chronic non specific low back pain
484123|NCT01496144|Manual therapy|manual therapy
484124|NCT01496144|Active exercises|active exercises
484125|NCT01496144|Pain|pain
484126|NCT01496144|Disability|disability
484127|NCT01496131|Tecemotide|tecemotide
484128|NCT01496131|Prostate Cancer|prostate cancer
484129|NCT01496131|Goserelin|goserelin
484130|NCT01496131|Cyclophosphamide|cyclophosphamide
484131|NCT01496131|Radiotherapy|radiotherapy
484132|NCT01496118|Relapsed/Refractory Multiple Myeloma|relapsed/refractory multiple myeloma
484133|NCT01496118|carfilzomib|carfilzomib
484134|NCT01496118|panobinostat|panobinostat
484135|NCT01496092|Keto Acid|keto acid
484136|NCT01496092|Peritoneal dialysis|peritoneal dialysis
484137|NCT01496092|Insulin resistance|insulin resistance
484138|NCT01496079|Maternal immunization|maternal immunization
484139|NCT01496079|Infant immunization|infant immunization
484140|NCT01496079|Influenza vaccine|influenza vaccine
484141|NCT01496079|Passive transfer of immunity|passive transfer of immunity
484142|NCT01496053|Cytokine levels in blood|cytokine levels in blood
484143|NCT01496053|Calprotectin in feces|calprotectin in feces
484144|NCT01496053|Clinical symptom score.|clinical symptom score.
484145|NCT01496027|cerebral oxygenation|cerebral oxygenation
484146|NCT01496027|NIRS|nirs
484147|NCT01496027|tissue oximeters|tissue oximeters
484148|NCT01496027|near infrared spectroscopy|near infrared spectroscopy
484149|NCT01496027|newborn|newborn
484150|NCT01496014|open fracture wounds|open fracture wounds
484151|NCT01496014|infections|infections
484152|NCT01496014|tibia fractures|tibia fractures
484153|NCT01496014|antibiotic therapies in severe fractures|antibiotic therapies in severe fractures
484154|NCT01496014|All severe open fracture of the tibia bone|all severe open fracture of the tibia bone
484155|NCT01496001|Early unilateral breast cancer|early unilateral breast cancer
484156|NCT01495988|Metastatic melanoma|metastatic melanoma
484157|NCT01495988|BRAF-mutant|braf-mutant
484158|NCT01495988|Stage IV melanoma|stage iv melanoma
484159|NCT01495988|Vemurafenib|vemurafenib
484160|NCT01495988|Bevacizumab|bevacizumab
484161|NCT01495988|Cobimetinib|cobimetinib
484162|NCT01495975|Diabetes Mellitus|diabetes mellitus
484163|NCT01495975|Diabetes Mellitus, Type 2|diabetes mellitus, type 2
484164|NCT01495975|Hospitalization|hospitalization
484165|NCT01495975|Patient Discharge|patient discharge
484166|NCT01495962|Damage Control Laparotomy|damage control laparotomy
484167|NCT01495962|Open Abdomen|open abdomen
484168|NCT01495962|Botulinum Toxin A|botulinum toxin a
484169|NCT01495962|Primary Fascial Closure|primary fascial closure
484170|NCT01495949|etomidate|etomidate
484171|NCT01495949|cortisol level|cortisol level
484172|NCT01495949|inotrope|inotrope
484173|NCT01495949|cardiac patients|cardiac patients
484174|NCT01495936|One Lung Ventilation (OLV)|one lung ventilation (olv)
484175|NCT01495936|Continuous Positive Airway Pressure (CPAP)|continuous positive airway pressure (cpap)
484176|NCT01495936|Positive End Expiratory Pressure (PEEP)|positive end expiratory pressure (peep)
484177|NCT01495936|Lung recruitment maneuver|lung recruitment maneuver
484178|NCT01495936|Hypoxia|hypoxia
484179|NCT01495923|low back pain|low back pain
484180|NCT01495923|radiculopathy|radiculopathy
484181|NCT01495923|injection|injection
484286|NCT01495585|Lonafarnib|lonafarnib
484182|NCT01495910|21-hydroxylase deficiency|21-hydroxylase deficiency
484183|NCT01495910|Androstenedione|androstenedione
484184|NCT01495910|Abiraterone acetate|abiraterone acetate
484185|NCT01495910|Pharmacokinetics|pharmacokinetics
484186|NCT01495910|Pharmacodynamics|pharmacodynamics
484187|NCT01495910|Dose-finding|dose-finding
484188|NCT01495897|Dystonia|dystonia
484189|NCT01495897|Cerebellar|cerebellar
484190|NCT01495897|ocular movements|ocular movements
484192|NCT01495897|sensorimotor integration|sensorimotor integration
484193|NCT01495858|Naproxen sodium|naproxen sodium
484194|NCT01495858|Diphenhydramine|diphenhydramine
484195|NCT01495845|pharmacogenomics|pharmacogenomics
484196|NCT01495845|feasibility|feasibility
484197|NCT01495845|community pharmacy|community pharmacy
484198|NCT01495845|personalized medicine|personalized medicine
484199|NCT01495845|clopidogrel|clopidogrel
484200|NCT01495845|Plavix|plavix
484201|NCT01495832|Adult Obesity|adult obesity
484202|NCT01495832|Cardiometabolic health|cardiometabolic health
484203|NCT01495832|Pulse Foods|pulse foods
484204|NCT01495832|Beans, Peas, Lentils|beans, peas, lentils
484205|NCT01495832|Cognitive Function|cognitive function
484206|NCT01495819|Nicotine|nicotine
484207|NCT01495819|smokers|smokers
484208|NCT01495819|vitals associated with smoking|vitals associated with smoking
484209|NCT01495806|functional dyspepsia|functional dyspepsia
484210|NCT01495806|irritable bowel syndrome|irritable bowel syndrome
484211|NCT01495806|functional abdominal pain|functional abdominal pain
484212|NCT01495793|Rotigotine|rotigotine
484213|NCT01495793|Restless Legs Syndrome|restless legs syndrome
484214|NCT01495793|RLS|rls
484215|NCT01495793|Children|children
484216|NCT01495793|Adolescents|adolescents
484217|NCT01495780|Behavioral|behavioral
484218|NCT01495780|Remote monitoring|remote monitoring
484219|NCT01495767|childhood uveitis|childhood uveitis
484220|NCT01495767|health-related quality of life|health-related quality of life
484221|NCT01495767|gender|gender
484222|NCT01495754|coffee|coffee
484223|NCT01495754|overweight/obese|overweight/obese
484224|NCT01495754|appetite|appetite
484225|NCT01495754|energy intake|energy intake
484226|NCT01495754|inflammation|inflammation
484227|NCT01495754|glucose metabolism|glucose metabolism
484228|NCT01495754|randomized controlled trial|randomized controlled trial
484229|NCT01495741|Mania|mania
484230|NCT01495741|Manic|manic
484231|NCT01495741|Depressive|depressive
484232|NCT01495741|Manic Depressive|manic depressive
484233|NCT01495728|Cervical Radiculopathy|cervical radiculopathy
484234|NCT01495728|Neck Pain|neck pain
484235|NCT01495728|Manipulation|manipulation
484236|NCT01495702|HIV-1|hiv-1
484237|NCT01495702|HIV|hiv
484238|NCT01495702|Treatment Experienced|treatment experienced
484239|NCT01495689|Smoking Cessation|smoking cessation
484240|NCT01495689|respirology Out-patient setting|respirology out-patient setting
484241|NCT01495689|SmartCard|smartcard
484242|NCT01495676|Bladder cancer|bladder cancer
484243|NCT01495676|Organ-conserving strategy|organ-conserving strategy
484244|NCT01495676|Radiochemotherapy|radiochemotherapy
484245|NCT01495676|non metastatic|non metastatic
484246|NCT01495663|refractory|refractory
484247|NCT01495663|relapsed|relapsed
484248|NCT01495663|non-small cell lung cancer|non-small cell lung cancer
484249|NCT01495663|triple-negative breast cancer|triple-negative breast cancer
484250|NCT01495663|soft tissue sarcoma|soft tissue sarcoma
484251|NCT01495663|colorectal cancer|colorectal cancer
484252|NCT01495663|esophageal cancer|esophageal cancer
484253|NCT01495663|prostate cancer|prostate cancer
484254|NCT01495663|ovarian cancer|ovarian cancer
484255|NCT01495650|Comprehensive Adjuvant Care|comprehensive adjuvant care
484256|NCT01495650|Cancer-related fatigue|cancer-related fatigue
484257|NCT01495650|Therapeutic patient education|therapeutic patient education
484258|NCT01495650|Physical Activity|physical activity
484259|NCT01495650|Nutritional counselling|nutritional counselling
484260|NCT01495650|Rehabilitation|rehabilitation
484261|NCT01495637|pediatric|pediatric
484262|NCT01495637|trauma|trauma
484263|NCT01495637|critical|critical
484264|NCT01495637|GM-CSF|gm-csf
484265|NCT01495637|immune|immune
484266|NCT01495624|rotator cuff repair|rotator cuff repair
484267|NCT01495624|capsular shift|capsular shift
484268|NCT01495624|shoulder arthroplasty|shoulder arthroplasty
484269|NCT01495624|subacromial decompression|subacromial decompression
484270|NCT01495624|18 and 75 years|18 and 75 years
484271|NCT01495611|postoperative,|postoperative,
484272|NCT01495611|pediatric|pediatric
484273|NCT01495611|pharmacogenetic|pharmacogenetic
484274|NCT01495611|opioid|opioid
484275|NCT01495611|morphine|morphine
484276|NCT01495611|perioperative|perioperative
484277|NCT01495611|respiratory depression|respiratory depression
484278|NCT01495598|Human Herpesvirus-8/HHV8|human herpesvirus-8/hhv8
484279|NCT01495598|Immune Modulation|immune modulation
484280|NCT01495598|CC-4047|cc-4047
484281|NCT01495598|IMiD|imid
484282|NCT01495598|Kaposi Sarcoma|kaposi sarcoma
484283|NCT01495585|Hepatitis|hepatitis
484284|NCT01495585|Delta|delta
484287|NCT01495585|Hepatitis D|hepatitis d
484288|NCT01495572|Malignant Melanoma|malignant melanoma
484289|NCT01495572|Immunotherapy|immunotherapy
484290|NCT01495572|Cell Therapy|cell therapy
484291|NCT01495572|HLA-A2 Positive|hla-a2 positive
484292|NCT01495572|Skin Cancer|skin cancer
484293|NCT01495546|total hip arthroplasty|total hip arthroplasty
484294|NCT01495546|THA|tha
484295|NCT01495546|prosthesis type Lepine|prosthesis type lepine
484296|NCT01495520|Arrhythmias|arrhythmias
484297|NCT01495520|palpitations|palpitations
484298|NCT01495494|Nasal Strip|nasal strip
484299|NCT01495481|Supraventricular Tachycardia|supraventricular tachycardia
484300|NCT01495481|SVT|svt
484301|NCT01495481|Reentrant Tachycardia|reentrant tachycardia
484302|NCT01495481|Dexmedetomidine|dexmedetomidine
484303|NCT01495481|Adenosine|adenosine
484304|NCT01495468|pegylated somatropin|pegylated somatropin
484305|NCT01495468|PEG-rhGH|peg-rhgh
484306|NCT01495468|growth hormone|growth hormone
484307|NCT01495468|Growth Hormone Deficiency|growth hormone deficiency
484308|NCT01495468|phase III study|phase iii study
484309|NCT01495429|catheter related large vein thrombosis|catheter related large vein thrombosis
484310|NCT01495429|upper extremity deep venous thrombosis|upper extremity deep venous thrombosis
484311|NCT01495429|central venous catheters|central venous catheters
484312|NCT01495429|upper extremity catheter related large vein thrombosis|upper extremity catheter related large vein thrombosis
484313|NCT01495403|liver cirrhosis|liver cirrhosis
484314|NCT01495403|muscle cramps|muscle cramps
484315|NCT01495390|Biomarkers|biomarkers
484316|NCT01495390|Biological Markers|biological markers
484317|NCT01495390|Surrogate Markers|surrogate markers
484318|NCT01495390|Clinical Markers|clinical markers
484319|NCT01495390|Plasma|plasma
484320|NCT01495390|Cerebrospinal Fluid|cerebrospinal fluid
484321|NCT01495390|DNA|dna
484322|NCT01495390|Serum|serum
484323|NCT01495390|RNA|rna
484324|NCT01495377|swallowing difficulties|swallowing difficulties
484325|NCT01495377|remifentanil|remifentanil
484326|NCT01495377|pulmonary aspiration|pulmonary aspiration
484327|NCT01495377|scintigraphy|scintigraphy
484328|NCT01495364|STEMI|stemi
484329|NCT01495325|Firefighter|firefighter
484330|NCT01495325|Woodsmoke|woodsmoke
484331|NCT01495325|Vascular function|vascular function
484332|NCT01495325|Air Pollution|air pollution
484333|NCT01495325|Endothelial function|endothelial function
484334|NCT01495325|Thrombosis|thrombosis
484335|NCT01495312|IOP fluctuations|iop fluctuations
484336|NCT01495312|during two 24-hour periods|during two 24-hour periods
484337|NCT01495299|relationship|relationship
484338|NCT01495299|IOP fluctuations|iop fluctuations
484339|NCT01495299|glaucoma|glaucoma
484340|NCT01495299|cataract surgery|cataract surgery
484341|NCT01495299|SENSIMED Triggerfish|sensimed triggerfish
484342|NCT01495286|newborn infant|newborn infant
484343|NCT01495286|acupuncture|acupuncture
484344|NCT01495286|safety|safety
484345|NCT01495286|pain|pain
484346|NCT01495260|XALD|xald
484347|NCT01495260|AMN|amn
484348|NCT01495247|Locally advanced|locally advanced
484349|NCT01495247|metastatic|metastatic
484350|NCT01495247|breast cancer|breast cancer
484351|NCT01495247|HER2 negative|her2 negative
484352|NCT01495247|PI3K pathway|pi3k pathway
484353|NCT01495247|paclitaxel|paclitaxel
484354|NCT01495247|mTOR inhibitor|mtor inhibitor
484355|NCT01495234|Spinal degeneration|spinal degeneration
484356|NCT01495195|Acetylcholine|acetylcholine
484357|NCT01495195|Cholinesterases|cholinesterases
484358|NCT01495195|Cocaine|cocaine
484359|NCT01495195|Self-Administration|self-administration
484360|NCT01495182|Dietary fiber|dietary fiber
484361|NCT01495182|Gastrointestinal toleration|gastrointestinal toleration
484362|NCT01495182|Fecal weight|fecal weight
484363|NCT01495169|Antipsychotic|antipsychotic
484364|NCT01495169|Schizophrenia|schizophrenia
484365|NCT01495169|Bipolar disorder|bipolar disorder
484366|NCT01495169|Iloperidone|iloperidone
484367|NCT01495143|Glucose|glucose
484368|NCT01495143|Lactate pyruvate ratio|lactate pyruvate ratio
484369|NCT01495143|Glycerol|glycerol
484370|NCT01495143|Paraspinal muscle|paraspinal muscle
484371|NCT01495143|Microdialysis|microdialysis
484372|NCT01495117|surgical site infection|surgical site infection
484373|NCT01495117|chlorhexidine gluconate|chlorhexidine gluconate
484374|NCT01495117|povidone iodine|povidone iodine
484375|NCT01495091|coronary artery disease|coronary artery disease
617441|NCT00950430|PET|pet
484376|NCT01495091|cardiovascular disease|cardiovascular disease
484377|NCT01495091|exercise stress testing|exercise stress testing
484378|NCT01495091|biomarkers|biomarkers
484379|NCT01495091|NT-pro-BNP|nt-pro-bnp
484380|NCT01495078|telemonitoring|telemonitoring
484381|NCT01495078|heart failure|heart failure
484382|NCT01495065|GSK2251052, healthy volunteer, safety, tolerability, pharmacokinetics, single|gsk2251052, healthy volunteer, safety, tolerability, pharmacokinetics, single
484383|NCT01495052|naked oat (Avena nuda L.)|naked oat (avena nuda l.)
484384|NCT01495052|diabetes mellitus|diabetes mellitus
484385|NCT01495052|RCT|rct
484386|NCT01495026|Healthy male subjects|healthy male subjects
484387|NCT01495026|North-East Asian ancestry|north-east asian ancestry
484883|NCT01492751|survival|survival
484388|NCT01495026|Bioequivalence|bioequivalence
484389|NCT01495026|Food effect|food effect
484390|NCT01495026|Tamsulosin hydrochloride|tamsulosin hydrochloride
484391|NCT01495026|Cross-over design|cross-over design
484392|NCT01495026|Pilot bioequivalence|pilot bioequivalence
484393|NCT01495026|Dutasteride (GI198745)|dutasteride (gi198745)
484394|NCT01495013|non-inferiority|non-inferiority
484395|NCT01495013|glimepiride|glimepiride
484396|NCT01495013|LDL cholesterol|ldl cholesterol
484397|NCT01495013|fixed dose combination|fixed dose combination
484398|NCT01495013|atorvastatin|atorvastatin
484399|NCT01495013|Diabetes Mellitus|diabetes mellitus
484400|NCT01495000|India|india
484401|NCT01495000|dual energy x-ray absorptiometry|dual energy x-ray absorptiometry
484402|NCT01495000|bone mineral density|bone mineral density
484403|NCT01495000|denosumab|denosumab
484404|NCT01494987|Type 2 Diabetes Mellitus|type 2 diabetes mellitus
484405|NCT01494974|Glaucoma|glaucoma
484406|NCT01494974|Pediatric|pediatric
484407|NCT01494974|Ahmed|ahmed
484408|NCT01494974|Congenital|congenital
484409|NCT01494974|FP7|fp7
484410|NCT01494974|FP8|fp8
484411|NCT01494961|Partner HIV testing|partner hiv testing
484412|NCT01494961|Couple HIV counseling|couple hiv counseling
484413|NCT01494961|Couple communication on sexual and reproductive health|couple communication on sexual and reproductive health
484414|NCT01494961|HIV incidence|hiv incidence
484415|NCT01494961|Incidence of pregnancies|incidence of pregnancies
484416|NCT01494961|Disclosure|disclosure
484417|NCT01494961|Condom use|condom use
484418|NCT01494922|Skin scarring|skin scarring
484419|NCT01494922|cicatrix|cicatrix
484420|NCT01494922|hypertrophic scar|hypertrophic scar
484794|NCT01493167|casting techniques|casting techniques
484421|NCT01494922|hypertrophic scar prevention|hypertrophic scar prevention
484422|NCT01494909|protein digestion|protein digestion
484423|NCT01494909|fat absorption|fat absorption
484424|NCT01494909|gut function|gut function
484425|NCT01494909|glucose absorption|glucose absorption
484426|NCT01494909|CF|cf
484427|NCT01494909|pancreatic intake|pancreatic intake
484428|NCT01494909|feeding|feeding
484429|NCT01494896|Pulmonary Hypertension|pulmonary hypertension
484430|NCT01494896|Pulmonary Arterial Hypertension|pulmonary arterial hypertension
484431|NCT01494896|COPD|copd
484432|NCT01494896|Chronic Obstructive Pulmonary Disease|chronic obstructive pulmonary disease
484433|NCT01494896|Tyvaso|tyvaso
484434|NCT01494896|Inhaled Treprostinil Sodium|inhaled treprostinil sodium
484435|NCT01494896|Ventilation Perfusion Matching|ventilation perfusion matching
484436|NCT01494896|HO Group 1 Pulmonary Arterial Hypertension|ho group 1 pulmonary arterial hypertension
484437|NCT01494896|Concomitant Chronic Obstructive Pulmonary Disease|concomitant chronic obstructive pulmonary disease
484438|NCT01494883|Mindfulness Based Stress Reduction|mindfulness based stress reduction
484439|NCT01494883|lung cancer|lung cancer
484440|NCT01494883|psychological distress|psychological distress
484441|NCT01494883|caretakers|caretakers
484442|NCT01494870|acute coronary syndrome|acute coronary syndrome
484443|NCT01494870|percutaneous coronary intervention|percutaneous coronary intervention
484444|NCT01494870|left bundle branch block|left bundle branch block
484445|NCT01494857|Ulcerative colitis|ulcerative colitis
484446|NCT01494857|biological treatment|biological treatment
484447|NCT01494857|anti-TNF|anti-tnf
484448|NCT01494844|Patient Monitoring|patient monitoring
484449|NCT01494844|Capnography|capnography
484450|NCT01494844|Human Engineering|human engineering
484451|NCT01494818|Contact lenses|contact lenses
484452|NCT01494818|Contact lens solutions|contact lens solutions
484453|NCT01494805|Age-related Macular Degeneration|age-related macular degeneration
484454|NCT01494805|AAV|aav
484455|NCT01494805|AMD|amd
484456|NCT01494805|Wet AMD|wet amd
484457|NCT01494805|Neovascular AMD|neovascular amd
484458|NCT01494805|Gene Therapy|gene therapy
484459|NCT01494805|Ocular|ocular
484460|NCT01494805|Ocular Gene Therapy|ocular gene therapy
484461|NCT01494805|Eye diseases|eye diseases
484462|NCT01494805|Macular Degeneration|macular degeneration
484463|NCT01494805|Retinal Degeneration|retinal degeneration
484464|NCT01494805|Retinal Neovascularization|retinal neovascularization
484465|NCT01494805|Wet Macular Degeneration|wet macular degeneration
484466|NCT01494805|Retinal Diseases|retinal diseases
484467|NCT01494779|children|children
484468|NCT01494766|RLS|rls
484469|NCT01494740|H1N1|h1n1
484470|NCT01494740|Vaccine|vaccine
484471|NCT01494740|Immunogenicity|immunogenicity
484472|NCT01494740|Safety|safety
484473|NCT01494740|infants|infants
484474|NCT01494727|Safety|safety
484475|NCT01494727|Pharmacokinetics|pharmacokinetics
484476|NCT01494714|Healthy volunteers|healthy volunteers
484477|NCT01494714|JNJ 10229570-AAA|jnj 10229570-aaa
484478|NCT01494714|Skin irritation|skin irritation
484479|NCT01494714|Skin photo irritation|skin photo irritation
484480|NCT01494701|Spinal Muscular Atrophy|spinal muscular atrophy
484481|NCT01494701|SMA|sma
484482|NCT01494701|SMN|smn
484483|NCT01494701|SMNRx|smnrx
484484|NCT01494701|ISIS-SMNRx|isis-smnrx
484485|NCT01494701|ISIS-SMN Rx|isis-smn rx
484486|NCT01494701|ISIS 396443|isis 396443
484487|NCT01494701|IONIS-SMNRx|ionis-smnrx
484488|NCT01494701|IONIS-SMN Rx|ionis-smn rx
484489|NCT01494701|Spinraza|spinraza
484490|NCT01494675|procalcitonin|procalcitonin
484491|NCT01494675|duration of the antibiotic therapy|duration of the antibiotic therapy
484492|NCT01494675|sepsis|sepsis
484493|NCT01494662|HER2 Positive|her2 positive
484494|NCT01494662|BrCa|brca
484495|NCT01494649|dentinal|dentinal
484496|NCT01494649|hypersensitivity|hypersensitivity
484497|NCT01494636|Capsaicin Challenge|capsaicin challenge
484498|NCT01494636|Pharmacodynamics|pharmacodynamics
484499|NCT01494636|Safety|safety
484500|NCT01494636|Pharmacokinetics|pharmacokinetics
484501|NCT01494636|Oral GSK2339345|oral gsk2339345
484502|NCT01494636|Tolerability|tolerability
484503|NCT01494636|FTIH|ftih
484504|NCT01494636|Chronic Cough|chronic cough
484505|NCT01494623|working memory|working memory
484506|NCT01494623|schizophrenia|schizophrenia
484507|NCT01494623|cognition|cognition
484508|NCT01494623|rTMS|rtms
484509|NCT01494610|safety|safety
484510|NCT01494610|replicated cross-over design|replicated cross-over design
484511|NCT01494610|pharmacodynamics|pharmacodynamics
484512|NCT01494610|Fluticasone propionate/Salmeterol|fluticasone propionate/salmeterol
484513|NCT01494610|capsule-based inhaler|capsule-based inhaler
484514|NCT01494610|COPD|copd
484515|NCT01494610|asthma|asthma
484516|NCT01494610|multi dose dry powder inhaler|multi dose dry powder inhaler
484517|NCT01494610|bioavailability|bioavailability
484518|NCT01494610|pharmacokinetics|pharmacokinetics
484519|NCT01494597|Isavuconazole|isavuconazole
484520|NCT01494597|Cyclosporine|cyclosporine
484521|NCT01494597|Healthy Volunteers|healthy volunteers
484522|NCT01494597|BAL8557|bal8557
484523|NCT01494597|Pharmacokinetics of isavuconazole|pharmacokinetics of isavuconazole
484524|NCT01494597|Pharmacokinetics of cyclosporine|pharmacokinetics of cyclosporine
484525|NCT01494558|Overall survival|overall survival
484526|NCT01494545|DAILIES TOTAL1|dailies total1
484527|NCT01494545|Alcon|alcon
484528|NCT01494545|contact lens|contact lens
484529|NCT01494519|External ring fixation|external ring fixation
484530|NCT01494519|internal fixation|internal fixation
484531|NCT01494519|traumatic tibia fracture|traumatic tibia fracture
484532|NCT01494506|Pancreatic cancer|pancreatic cancer
484533|NCT01494506|MM-398|mm-398
484534|NCT01494506|PEP02|pep02
484535|NCT01494506|Metastatic pancreatic cancer|metastatic pancreatic cancer
484536|NCT01494506|Gemcitabine refractory pancreatic cancer|gemcitabine refractory pancreatic cancer
484537|NCT01494506|Second line pancreatic cancer treatment|second line pancreatic cancer treatment
484538|NCT01494506|Pancreatic cancer post gemcitabine therapy|pancreatic cancer post gemcitabine therapy
484539|NCT01494493|symptomatic degenerative disc disease|symptomatic degenerative disc disease
484540|NCT01494480|ALS|als
484541|NCT01494480|stem cell|stem cell
484542|NCT01494467|PPR|ppr
484543|NCT01494454|Lumbar degenerative disc disease|lumbar degenerative disc disease
484544|NCT01494441|lumbar degenerative disc disease|lumbar degenerative disc disease
484545|NCT01494428|symptomatic degenerative disc disease|symptomatic degenerative disc disease
484546|NCT01494415|Squamous Cell Lung Cancer|squamous cell lung cancer
484547|NCT01494415|radiation therapy|radiation therapy
484548|NCT01494415|chemotherapy|chemotherapy
484549|NCT01494402|Healthy volunteer, Japanese males, homo-EM|healthy volunteer, japanese males, homo-em
484550|NCT01494389|CD4+T lymphocyte subsets|cd4+t lymphocyte subsets
484551|NCT01494389|sepsis|sepsis
484552|NCT01494389|immunoparalysis|immunoparalysis
484553|NCT01494350|cutaneous leishmaniasis|cutaneous leishmaniasis
484554|NCT01494350|topical treatment|topical treatment
484555|NCT01494350|Tunisia|tunisia
484556|NCT01494337|LASER|laser
484557|NCT01494337|BPH|bph
484558|NCT01494337|Prostate surgery|prostate surgery
484559|NCT01494337|HOLEP|holep
484560|NCT01494337|Green light PVP|green light pvp
484561|NCT01494324|Liver|liver
484562|NCT01494324|Thermal Ablation|thermal ablation
484563|NCT01494324|Dynamic CT|dynamic ct
484564|NCT01494324|09-122|09-122
484565|NCT01494311|Arterial catheter|arterial catheter
484566|NCT01494311|arterial cannula|arterial cannula
484567|NCT01494311|Rapydan|rapydan
484568|NCT01494311|lidocaine/tetracaine patch|lidocaine/tetracaine patch
484569|NCT01494311|topical anaesthesia|topical anaesthesia
484570|NCT01494298|Type 2 diabetes|type 2 diabetes
484571|NCT01494298|African American|african american
484572|NCT01494298|cholesterol|cholesterol
484573|NCT01494298|lipoprotein|lipoprotein
484574|NCT01494298|apolipoprotein|apolipoprotein
484575|NCT01494285|Acne Vulgaris|acne vulgaris
484576|NCT01494285|Topical|topical
484577|NCT01494285|Foam|foam
484578|NCT01494272|caudal epidural analgesia|caudal epidural analgesia
484579|NCT01494272|elective circumcision|elective circumcision
484580|NCT01494272|elective inguinal herniorrhaphy|elective inguinal herniorrhaphy
484581|NCT01494259|immediate breast reconstruction|immediate breast reconstruction
484582|NCT01494259|pain control|pain control
484583|NCT01494259|post mastectomy pain control|post mastectomy pain control
484584|NCT01494246|Adult|adult
484585|NCT01494246|computer-assisted instruction|computer-assisted instruction
484586|NCT01494246|electronic mail|electronic mail
484587|NCT01494246|program evaluation|program evaluation
484588|NCT01494246|smoking cessation/methods|smoking cessation/methods
484589|NCT01494246|continued abstinence|continued abstinence
484590|NCT01494220|Bispectral index; anesthesia|bispectral index; anesthesia
484591|NCT01494220|liver transplantation|liver transplantation
484592|NCT01494220|independent factors|independent factors
484593|NCT01494220|outcome|outcome
484594|NCT01494220|Living donor liver transplantation|living donor liver transplantation
484595|NCT01494207|worksite|worksite
484596|NCT01494207|interventions|interventions
484597|NCT01494207|motivational interviewing|motivational interviewing
484598|NCT01494207|physical activity|physical activity
484599|NCT01494194|Mold sensitized|mold sensitized
484600|NCT01494181|obstructive sleep apnea|obstructive sleep apnea
484601|NCT01494181|vascular events|vascular events
484602|NCT01494168|Hypertension|hypertension
484603|NCT01494168|Arterial stiffness|arterial stiffness
484604|NCT01494168|Obesity|obesity
484605|NCT01494168|Bariatric surgery|bariatric surgery
484606|NCT01494155|resectable pancreatic cancer|resectable pancreatic cancer
484607|NCT01494155|pancreaticoduodenectomy|pancreaticoduodenectomy
484608|NCT01494142|Registry|registry
484609|NCT01494142|Atopic Dermatitis|atopic dermatitis
484610|NCT01494142|Eczema Herpeticum|eczema herpeticum
484611|NCT01494142|GWAS|gwas
484612|NCT01494142|Staphylococcus aureus|staphylococcus aureus
484613|NCT01494116|Pediatrics|pediatrics
484614|NCT01494116|Fluid|fluid
484615|NCT01494116|Bolus|bolus
484616|NCT01494116|Resuscitation|resuscitation
484617|NCT01494116|Shock|shock
484618|NCT01494103|Acute lymphoblastic leukemia|acute lymphoblastic leukemia
484619|NCT01494103|Myelodysplastic syndrome|myelodysplastic syndrome
484620|NCT01494103|Acute myeloid leukemia|acute myeloid leukemia
484621|NCT01494103|Chronic myelogenous leukemia|chronic myelogenous leukemia
484622|NCT01494103|Non Hodgkin lymphoma|non hodgkin lymphoma
484623|NCT01494103|Hemophagocytic lymphohistiocytosis|hemophagocytic lymphohistiocytosis
484624|NCT01494103|Familial hemophagocytic lymphohistiocytosis|familial hemophagocytic lymphohistiocytosis
484625|NCT01494103|Hemophagocytic syndrome|hemophagocytic syndrome
484626|NCT01494103|Epstein Barr virus infection|epstein barr virus infection
484627|NCT01494103|X-linked lymphoproliferative disease|x-linked lymphoproliferative disease
484628|NCT01494090|Venous thromboembolism|venous thromboembolism
484629|NCT01494090|Hip fracture|hip fracture
484630|NCT01494090|Cardiovascular events|cardiovascular events
484631|NCT01494090|Statin|statin
484632|NCT01494077|Pancreatic Cyst Fluid|pancreatic cyst fluid
484633|NCT01494077|Dilution|dilution
484634|NCT01494077|Carcinoembryonic Antigen (CEA)|carcinoembryonic antigen (cea)
484635|NCT01494051|fatty acid oxidation disorders|fatty acid oxidation disorders
484636|NCT01494025|Diabetes|diabetes
484637|NCT01494025|Pre-diabetes|pre-diabetes
484638|NCT01494025|Obese|obese
484639|NCT01493999|Clopidogrel|clopidogrel
484640|NCT01493999|prasugrel|prasugrel
484641|NCT01493999|HPR|hpr
484642|NCT01493999|loading dose|loading dose
484643|NCT01493999|maintenance dose|maintenance dose
484644|NCT01493999|stent thrombosis|stent thrombosis
484645|NCT01493999|platelet reactivity|platelet reactivity
484646|NCT01493999|Coronary intervention|coronary intervention
484647|NCT01493999|stent implantation|stent implantation
484648|NCT01493986|Ropivacaine|ropivacaine
484649|NCT01493986|Brachial plexus|brachial plexus
484650|NCT01493973|Erythropoietin|erythropoietin
484651|NCT01493973|EPO|epo
484652|NCT01493973|Friedreich|friedreich
484653|NCT01493973|Ataxia|ataxia
484654|NCT01493973|Epoetin alfa|epoetin alfa
484655|NCT01493973|VO2 max|vo2 max
484656|NCT01493973|SARA|sara
484657|NCT01493973|EQ-5D|eq-5d
484658|NCT01493973|frataxin|frataxin
484659|NCT01493960|Colitis, Ulcerative|colitis, ulcerative
484660|NCT01493960|Gastrointestinal Diseases|gastrointestinal diseases
484661|NCT01493960|Inflammatory Bowel Diseases|inflammatory bowel diseases
484662|NCT01493960|Immunomodulatory Therapy|immunomodulatory therapy
484663|NCT01493960|Glucocorticoids|glucocorticoids
484664|NCT01493960|Anti-Inflammatory Agents|anti-inflammatory agents
484665|NCT01493960|Therapeutic uses|therapeutic uses
484666|NCT01493934|metabolic syndrome|metabolic syndrome
484667|NCT01493934|type 2 diabetes mellitus|type 2 diabetes mellitus
484668|NCT01493934|insulin resistance|insulin resistance
484669|NCT01493934|Scintigraphy|scintigraphy
484670|NCT01493921|SR-T100 Clinical treatment against Actinic Keratosis|sr-t100 clinical treatment against actinic keratosis
484671|NCT01493921|Actinic keratosis skin lesion treatment with SR-T100 gel|actinic keratosis skin lesion treatment with sr-t100 gel
484672|NCT01493921|Skin lesion treatment with SR-T100 gel|skin lesion treatment with sr-t100 gel
484673|NCT01493921|SR-T100 gel treatment against skin lesion|sr-t100 gel treatment against skin lesion
484674|NCT01493921|Clinical efficacy study of SR-T100 gel|clinical efficacy study of sr-t100 gel
484675|NCT01493908|Placebo effect;|placebo effect;
484676|NCT01493908|Pain; Analgesic;|pain; analgesic;
484677|NCT01493908|Electrical shock|electrical shock
484678|NCT01493908|control in healthy volunteers|control in healthy volunteers
484679|NCT01493882|Uncontrolled Persistent Asthma, Dyspnea, Wheezing|uncontrolled persistent asthma, dyspnea, wheezing
484989|NCT01492361|Fluvastatin|fluvastatin
484680|NCT01493869|Normal healthy adult subjects|normal healthy adult subjects
484681|NCT01493869|Adult subjects with hepatic impairment|adult subjects with hepatic impairment
484682|NCT01493830|neuroblastoma|neuroblastoma
484683|NCT01493804|Near Infrared Spectroscopy|near infrared spectroscopy
484685|NCT01493804|Brain Connectivity|brain connectivity
484686|NCT01493804|Healthy Volunteer|healthy volunteer
484687|NCT01493804|HV|hv
484688|NCT01493791|CDB-2914|cdb-2914
484689|NCT01493791|Abnormal Urine Bleeding|abnormal urine bleeding
484690|NCT01493791|Abnormal Uterine Bleeding|abnormal uterine bleeding
484691|NCT01493700|heated circuit|heated circuit
484692|NCT01493700|body temperature|body temperature
484693|NCT01493674|folate|folate
484694|NCT01493674|homocysteine|homocysteine
484695|NCT01493674|cognitive function|cognitive function
484696|NCT01493674|eating disorders|eating disorders
484697|NCT01493674|depression.|depression.
484698|NCT01493661|Sleep|sleep
484699|NCT01493661|Polysomnography|polysomnography
484700|NCT01493661|Reaction Time|reaction time
484701|NCT01493661|Sleep Deprivation|sleep deprivation
484702|NCT01493661|Psychophysiology|psychophysiology
484703|NCT01493661|Chronic sleep restriction|chronic sleep restriction
484704|NCT01493661|healthy|healthy
484705|NCT01493661|without sleep complaints|without sleep complaints
484706|NCT01493648|statins|statins
484707|NCT01493648|side effects|side effects
484708|NCT01493648|muscle|muscle
484709|NCT01493648|vitamin D|vitamin d
484710|NCT01493648|biopsy|biopsy
484711|NCT01493648|strength|strength
484712|NCT01493648|fatigue|fatigue
484713|NCT01493622|Schizophrenia minocycline cognition|schizophrenia minocycline cognition
484714|NCT01493596|Safety|safety
484715|NCT01493596|Tolerability|tolerability
484716|NCT01493583|severely obese|severely obese
484717|NCT01493583|Roux-en Y gastric bypass surgery (RYGB)|roux-en y gastric bypass surgery (rygb)
484718|NCT01493583|brain activity by fMRI|brain activity by fmri
484719|NCT01493583|visual presentation of food and non-food-related pictures|visual presentation of food and non-food-related pictures
484720|NCT01493544|COPD|copd
484721|NCT01493544|smokers|smokers
484722|NCT01493544|primary care|primary care
484723|NCT01493531|Gout|gout
484724|NCT01493518|SAFETY|safety
484725|NCT01493518|ADULT|adult
484726|NCT01493518|PSORIASIS|psoriasis
484727|NCT01493518|INFLAMMATION|inflammation
484728|NCT01493505|Primary Peritoneal Cancer|primary peritoneal cancer
484729|NCT01493492|proteomics,urinary,sepsis,prognosis|proteomics,urinary,sepsis,prognosis
484730|NCT01493466|proteomics,|proteomics,
484731|NCT01493466|serum,|serum,
484732|NCT01493466|sepsis,|sepsis,
484733|NCT01493466|potential biomarkers,|potential biomarkers,
484734|NCT01493466|dynamic changes|dynamic changes
484735|NCT01493466|normal|normal
484736|NCT01493440|atosiban|atosiban
484737|NCT01493440|clinical pregnancy|clinical pregnancy
484738|NCT01493440|implantation rate|implantation rate
484739|NCT01493440|uterine contractility|uterine contractility
484740|NCT01493440|IVF-ET|ivf-et
484741|NCT01493427|Glaucoma|glaucoma
484742|NCT01493427|OAG|oag
484743|NCT01493427|OHT|oht
484744|NCT01493414|Myelofibrosis|myelofibrosis
484745|NCT01493414|Primary myelofibrosis|primary myelofibrosis
484746|NCT01493414|PMF|pmf
484747|NCT01493414|Post polycythemia myelofibrosis|post polycythemia myelofibrosis
484748|NCT01493414|PPV MF|ppv mf
484749|NCT01493414|Post-essential thrombocythemia myelofibrosis|post-essential thrombocythemia myelofibrosis
484750|NCT01493414|PET-MF|pet-mf
484751|NCT01493414|INC424|inc424
484752|NCT01493414|Ruxolitinib|ruxolitinib
484753|NCT01493375|Contamination, hip operation, knee operation|contamination, hip operation, knee operation
484754|NCT01493362|Bulimia Nervosa|bulimia nervosa
484755|NCT01493362|PET Imaging|pet imaging
484756|NCT01493362|Dopamine|dopamine
484757|NCT01493349|Colonic diverticula|colonic diverticula
484758|NCT01493349|Diverticulitis|diverticulitis
484759|NCT01493323|Psychic pain|psychic pain
484760|NCT01493323|Social exclusion|social exclusion
484761|NCT01493323|Mood disorders|mood disorders
484762|NCT01493323|Suicide, attempted|suicide, attempted
484763|NCT01493323|Magnetic Resonance Imaging, Functional|magnetic resonance imaging, functional
484764|NCT01493323|Genetic|genetic
484765|NCT01493323|Physic pain|physic pain
484766|NCT01493297|Retinyl palmitate, beta-carotene, stable isotopes, radio isotopes|retinyl palmitate, beta-carotene, stable isotopes, radio isotopes
484767|NCT01493284|aortic stenosis|aortic stenosis
484768|NCT01493284|aortic valve stenosis|aortic valve stenosis
484769|NCT01493284|valvular heart disease|valvular heart disease
484770|NCT01493284|aortic valve replacement|aortic valve replacement
484771|NCT01493284|transcatheter aortic valve implantation|transcatheter aortic valve implantation
484772|NCT01493284|TAVI|tavi
484773|NCT01493258|Diabetes|diabetes
484774|NCT01493258|Comparative Effectiveness Research|comparative effectiveness research
484775|NCT01493258|Interactive computer-assisted education|interactive computer-assisted education
484776|NCT01493258|Informatics|informatics
484777|NCT01493245|Chronic Pain|chronic pain
484778|NCT01493245|JNS020QD|jns020qd
484779|NCT01493245|Fentanyl|fentanyl
484780|NCT01493245|Opioid analgesics|opioid analgesics
484781|NCT01493232|Lingualized occlusion|lingualized occlusion
484782|NCT01493232|Complete denture occlusion|complete denture occlusion
484783|NCT01493232|Fully bilateral balanced occlusion|fully bilateral balanced occlusion
484784|NCT01493232|Patient satisfaction of complete denture|patient satisfaction of complete denture
484785|NCT01493219|Glioblastoma|glioblastoma
484786|NCT01493219|Glioblastoma Multiforme|glioblastoma multiforme
484787|NCT01493219|Astrocytoma|astrocytoma
484788|NCT01493219|Gliosarcoma|gliosarcoma
484789|NCT01493219|Glioma WHO grade IV|glioma who grade iv
484790|NCT01493206|intraoperative radiotherapy|intraoperative radiotherapy
484791|NCT01493167|cast|cast
484792|NCT01493167|splint|splint
484793|NCT01493167|circumferential casting|circumferential casting
484795|NCT01493167|fracture in extremity|fracture in extremity
484797|NCT01493154|Head and Neck Cancer|head and neck cancer
484798|NCT01493154|Vaccine|vaccine
484799|NCT01493154|Immunotherapy|immunotherapy
484800|NCT01493154|Cyclophosphamide|cyclophosphamide
484801|NCT01493154|Sexually Transmitted Diseases, Viral|sexually transmitted diseases, viral
484802|NCT01493141|MOMHR|momhr
484803|NCT01493141|THA|tha
484804|NCT01493141|Osteoarthritis|osteoarthritis
484805|NCT01493128|atrial fibrillation|atrial fibrillation
484806|NCT01493128|atrial cells|atrial cells
484807|NCT01493128|myocardial tissue|myocardial tissue
484808|NCT01493128|t-tubules|t-tubules
484809|NCT01493128|immunofluorescence|immunofluorescence
484810|NCT01493102|septic shock|septic shock
484811|NCT01493102|norepinephrine|norepinephrine
484812|NCT01493102|vasopressin|vasopressin
484813|NCT01493102|hypotension|hypotension
484814|NCT01493076|ERCP|ercp
484815|NCT01493076|Cannulation|cannulation
484816|NCT01493076|Precut|precut
484817|NCT01493076|Mini-spincterotome|mini-spincterotome
484818|NCT01493063|preterm infant|preterm infant
484819|NCT01493050|Diabetic Nephropathy|diabetic nephropathy
484820|NCT01493050|Sevelamer Carbonate|sevelamer carbonate
484821|NCT01493037|STEMI|stemi
484822|NCT01493037|PICSO|picso
484823|NCT01493037|Coronary Sinus|coronary sinus
484824|NCT01493037|Involving Left Anterior Descending Coronary Artery|involving left anterior descending coronary artery
484825|NCT01492998|Hepatitis C virus|hepatitis c virus
484826|NCT01492998|Biliary salts|biliary salts
484827|NCT01492998|Farnesoid X receptor|farnesoid x receptor
484828|NCT01492998|Guggulsterone|guggulsterone
484829|NCT01492972|Prostate|prostate
484830|NCT01492972|proton|proton
484831|NCT01492972|radiation|radiation
484832|NCT01492972|intermediate risk|intermediate risk
484833|NCT01492946|Malnutrition|malnutrition
484834|NCT01492946|Post-operative outcome|post-operative outcome
484835|NCT01492946|Phase angle|phase angle
484836|NCT01492946|MUST|must
484837|NCT01492946|Clavien Dindo classification|clavien dindo classification
484838|NCT01492946|Bioelectrical impedance analysis|bioelectrical impedance analysis
484839|NCT01492933|Ethanol|ethanol
484840|NCT01492933|Magnetic Resonance Spectroscopy|magnetic resonance spectroscopy
484841|NCT01492933|Spectroscopy|spectroscopy
484842|NCT01492933|Alcohol Use|alcohol use
484843|NCT01492907|Heterocyclic amine carcinogens|heterocyclic amine carcinogens
484844|NCT01492907|meat-borne carcinogens|meat-borne carcinogens
484845|NCT01492881|relapsed multiple myeloma|relapsed multiple myeloma
484846|NCT01492881|refractory multiple myeloma|refractory multiple myeloma
484847|NCT01492881|vorinostat|vorinostat
484848|NCT01492881|bortezomib|bortezomib
484849|NCT01492881|doxil|doxil
484850|NCT01492868|sinusitis|sinusitis
484851|NCT01492868|upper respiratory infection|upper respiratory infection
484852|NCT01492855|Meniscal lesions|meniscal lesions
484853|NCT01492855|MRI|mri
484854|NCT01492855|arthroscopic treatment|arthroscopic treatment
484855|NCT01492829|HIV prevention|hiv prevention
484856|NCT01492829|sexually transmitted infection prevention|sexually transmitted infection prevention
484857|NCT01492829|HIV knowledge|hiv knowledge
484858|NCT01492829|relationship power|relationship power
484859|NCT01492829|depression|depression
484860|NCT01492829|coping|coping
484861|NCT01492829|social support|social support
484862|NCT01492829|internally displaced persons|internally displaced persons
484863|NCT01492829|community health worker|community health worker
484864|NCT01492829|HIV/STI educational video|hiv/sti educational video
484865|NCT01492829|substance use|substance use
484866|NCT01492829|women's health|women's health
484867|NCT01492816|HIV prevention|hiv prevention
484868|NCT01492816|HIV positive communities|hiv positive communities
484869|NCT01492803|HIV infection|hiv infection
484870|NCT01492803|Probiotics|probiotics
484871|NCT01492764|Ventricular Tachyarrhythmia|ventricular tachyarrhythmia
484872|NCT01492764|Ablation|ablation
484873|NCT01492764|Electrophysiology|electrophysiology
484874|NCT01492764|Human|human
484875|NCT01492764|Mapping|mapping
484876|NCT01492751|Prostatic Neoplasms|prostatic neoplasms
484877|NCT01492751|Radiotherapy conformal|radiotherapy conformal
484878|NCT01492751|brachytherapy|brachytherapy
484879|NCT01492751|radical prostatectomy|radical prostatectomy
484880|NCT01492751|Quality of life|quality of life
484881|NCT01492751|biochemical relapse|biochemical relapse
484882|NCT01492751|biochemical failure|biochemical failure
484884|NCT01492751|Clinically localized prostate cancer|clinically localized prostate cancer
484885|NCT01492738|Acupuncture|acupuncture
484886|NCT01492738|anxiety|anxiety
484887|NCT01492738|memory|memory
484888|NCT01492712|Propofol|propofol
484889|NCT01492712|Pharmacokinetics|pharmacokinetics
484890|NCT01492712|Pharmacodynamics|pharmacodynamics
484891|NCT01492712|Infusion Pumps|infusion pumps
484892|NCT01492699|PTSD|ptsd
484893|NCT01492699|Post Traumatic Stress Disorder|post traumatic stress disorder
484894|NCT01492686|Amyotrophic Lateral Sclerosis (ALS)|amyotrophic lateral sclerosis (als)
484895|NCT01492673|Ewing's sarcoma|ewing's sarcoma
484896|NCT01492673|BEVACIZUMAB (AVASTIN)|bevacizumab (avastin)
484897|NCT01492673|CYCLOPHOSPHAMIDE (CYTOXAN)|cyclophosphamide (cytoxan)
484898|NCT01492673|TOPOTECAN|topotecan
484899|NCT01492673|11-183|11-183
484900|NCT01492673|POETIC|poetic
484901|NCT01492660|Ultrasonography|ultrasonography
484902|NCT01492660|nerve block|nerve block
484903|NCT01492660|catheters|catheters
484904|NCT01492660|needle|needle
484905|NCT01492660|anesthesia|anesthesia
484906|NCT01492647|Acne vulgaris|acne vulgaris
484907|NCT01492647|JNJ 10229570-AAA|jnj 10229570-aaa
484908|NCT01492647|Japanese patients|japanese patients
484909|NCT01492647|Topical treatment|topical treatment
484910|NCT01492634|bioimpedance|bioimpedance
484911|NCT01492634|overhydration|overhydration
484912|NCT01492634|dry weight|dry weight
484913|NCT01492621|major depression|major depression
484914|NCT01492621|DTI|dti
484915|NCT01492621|inflammatory markers|inflammatory markers
484916|NCT01492621|cognition|cognition
484917|NCT01492608|magnesium sulphate|magnesium sulphate
484918|NCT01492608|preterm birth|preterm birth
484919|NCT01492608|cerebral palsy|cerebral palsy
484920|NCT01492595|contact|contact
484921|NCT01492556|Recurrent|recurrent
484922|NCT01492556|Metastatic|metastatic
484923|NCT01492556|Breast cancer|breast cancer
484924|NCT01492543|Advanced|advanced
484925|NCT01492543|Metastatic|metastatic
484926|NCT01492543|Breast cancer|breast cancer
484927|NCT01492530|Men who have sex with Men and Women|men who have sex with men and women
484928|NCT01492530|HIV Prevention|hiv prevention
484929|NCT01492530|Behavioral Intervention|behavioral intervention
484930|NCT01492530|Condom use|condom use
484931|NCT01492530|African American MSMW|african american msmw
484932|NCT01492517|Controlled Human exposure study|controlled human exposure study
484933|NCT01492517|Air Pollution|air pollution
484934|NCT01492517|Gene expression|gene expression
484935|NCT01492517|Epigenetic|epigenetic
484936|NCT01492517|Cardiovascular|cardiovascular
484937|NCT01492491|SUPRA-HFR|supra-hfr
484938|NCT01492491|adsorpition|adsorpition
484939|NCT01492491|vitamins|vitamins
484940|NCT01492491|large toxins|large toxins
484941|NCT01492465|Type 2 diabetes|type 2 diabetes
484942|NCT01492452|guidelines for nursing|guidelines for nursing
484943|NCT01492452|anxiety|anxiety
484944|NCT01492452|cardiac surgery|cardiac surgery
484945|NCT01492452|pediatrics|pediatrics
484946|NCT01492439|Psychosis|psychosis
484947|NCT01492439|Psychosis NOS|psychosis nos
484948|NCT01492439|Schizophrenia|schizophrenia
484949|NCT01492439|Schizoaffective Disorder|schizoaffective disorder
484950|NCT01492439|Bipolar Disorder|bipolar disorder
484951|NCT01492426|Hepatitis C Virus|hepatitis c virus
484952|NCT01492413|Overweight|overweight
484953|NCT01492413|Obesity|obesity
484954|NCT01492387|community-acquired pneumonia|community-acquired pneumonia
484955|NCT01492387|healthcare-associated pneumonia|healthcare-associated pneumonia
484956|NCT01492387|antibiotic therapy|antibiotic therapy
484957|NCT01492387|Duration of therapy|duration of therapy
484958|NCT01492361|Coronary Artery Disease|coronary artery disease
484959|NCT01492361|Myocardial Ischemia|myocardial ischemia
484960|NCT01492361|Coronary Disease|coronary disease
484961|NCT01492361|Heart Diseases|heart diseases
484962|NCT01492361|Acute Coronary Syndrome|acute coronary syndrome
484963|NCT01492361|Cardiovascular Diseases|cardiovascular diseases
484964|NCT01492361|Arteriosclerosis|arteriosclerosis
484965|NCT01492361|Arterial Occlusive Diseases|arterial occlusive diseases
484966|NCT01492361|Vascular Diseases|vascular diseases
484967|NCT01492361|Angina Pectoris|angina pectoris
484968|NCT01492361|Chest Pain|chest pain
484969|NCT01492361|Anticholesteremic Agents|anticholesteremic agents
484970|NCT01492361|Hypolipidemic Agents|hypolipidemic agents
484971|NCT01492361|Lipid Regulating Agents|lipid regulating agents
484972|NCT01492361|Hypertriglyceridemia|hypertriglyceridemia
484973|NCT01492361|Omega-3 Fatty Acids|omega-3 fatty acids
484974|NCT01492361|Statin|statin
484975|NCT01492361|Triglycerides|triglycerides
484976|NCT01492361|EPA|epa
484977|NCT01492361|Docosahexaenoic Acid|docosahexaenoic acid
484978|NCT01492361|Fish|fish
484979|NCT01492361|Fatty acids|fatty acids
484980|NCT01492361|Fibrates|fibrates
484981|NCT01492361|Niacin|niacin
484982|NCT01492361|Lipids|lipids
484983|NCT01492361|Lipoprotein|lipoprotein
484984|NCT01492361|Atorvastatin|atorvastatin
484985|NCT01492361|Lovaza|lovaza
484986|NCT01492361|Simvastatin|simvastatin
484987|NCT01492361|Lovastatin|lovastatin
484988|NCT01492361|Pravastatin|pravastatin
484990|NCT01492361|Rosuvastatin|rosuvastatin
484991|NCT01492361|Trilipix|trilipix
484992|NCT01492361|Vytorin|vytorin
484993|NCT01492361|Simcor|simcor
484994|NCT01492361|Ezetimibe|ezetimibe
484995|NCT01492361|Zetia|zetia
484996|NCT01492361|Ethyl-EPA|ethyl-epa
484997|NCT01492361|Ethyl Icosapentate|ethyl icosapentate
484998|NCT01492361|Crestor|crestor
484999|NCT01492361|Zocor|zocor
485000|NCT01492361|Lipitor|lipitor
485001|NCT01492361|LDL|ldl
485002|NCT01492361|HDL|hdl
485003|NCT01492361|Cholesterol|cholesterol
485004|NCT01492361|Dyslipidemia|dyslipidemia
485005|NCT01492361|AMR101|amr101
485006|NCT01492361|Cardiovascular Disease, Unspecified|cardiovascular disease, unspecified
485007|NCT01492361|VASCEPA|vascepa
485008|NCT01492361|Icosapent Ethyl|icosapent ethyl
485009|NCT01492348|collaborative care|collaborative care
485010|NCT01492348|PTSD|ptsd
485011|NCT01492348|military|military
485012|NCT01492348|Depression|depression
485013|NCT01492348|primary care|primary care
485014|NCT01492348|care management|care management
485015|NCT01492348|stepped care|stepped care
485016|NCT01492348|telehealth|telehealth
485017|NCT01492348|OIF|oif
485018|NCT01492348|OEF|oef
485019|NCT01492348|preference-based treatment|preference-based treatment
485020|NCT01492348|cost effectiveness|cost effectiveness
485021|NCT01492348|web-based treatment|web-based treatment
485022|NCT01492348|telephonic CBT|telephonic cbt
485023|NCT01492348|evidence-based treatment|evidence-based treatment
485024|NCT01492335|Cognitive decline|cognitive decline
485025|NCT01492335|Cognitive impairment|cognitive impairment
485026|NCT01492322|Smoker|smoker
485027|NCT01492322|SPECT|spect
485028|NCT01492322|Dopamine|dopamine
485029|NCT01492322|Nicotine Sated condition|nicotine sated condition
485030|NCT01492322|Nicotine withdrawal condition|nicotine withdrawal condition
485031|NCT01492309|Major Depressive Disorder|major depressive disorder
485032|NCT01492309|Pregnancy|pregnancy
485033|NCT01492309|Brain Derived Neurotrophic Factor|brain derived neurotrophic factor
485034|NCT01492309|Transcranial Magnetic Stimulation|transcranial magnetic stimulation
485035|NCT01492283|NAFLD|nafld
485036|NCT01492283|Incretin hormones|incretin hormones
485037|NCT01492270|Prostate Cancer|prostate cancer
485038|NCT01492270|Multi parametric MRI|multi parametric mri
485039|NCT01492270|Prostate HistoScanning|prostate histoscanning
485040|NCT01492270|Transperineal prostate mapping biopsy|transperineal prostate mapping biopsy
485041|NCT01492257|shared decision making|shared decision making
485042|NCT01492257|decision aids|decision aids
485043|NCT01492257|total joint arthroplasty|total joint arthroplasty
485044|NCT01492257|osteoarthritis|osteoarthritis
485045|NCT01492244|Knee pain|knee pain
485046|NCT01492244|map|map
485047|NCT01492244|questionnaire|questionnaire
485048|NCT01492244|survey|survey
485049|NCT01492231|gastroenterology|gastroenterology
485050|NCT01492231|Endoscopy, Digestive System|endoscopy, digestive system
485051|NCT01492231|Endosonography|endosonography
485303|NCT01491217|MTD|mtd
485052|NCT01492231|Endoscopic Retrograde Cholangiopancreatography|endoscopic retrograde cholangiopancreatography
485053|NCT01492231|gastrointestinal endoscopy|gastrointestinal endoscopy
485054|NCT01492192|Angiogenesis|angiogenesis
485055|NCT01492192|PET-CT|pet-ct
485056|NCT01492192|Perfusion-CT|perfusion-ct
485057|NCT01492179|Surgery: Abdominal hysterectomy|surgery: abdominal hysterectomy
485058|NCT01492179|Anesthetics: Local|anesthetics: local
485059|NCT01492179|Postoperative: Pain|postoperative: pain
485060|NCT01492179|Drugs: Morphine|drugs: morphine
485061|NCT01492127|Hepatocellular carcinoma|hepatocellular carcinoma
485062|NCT01492127|cirrhosis|cirrhosis
485063|NCT01492127|proteasome|proteasome
485064|NCT01492127|alpha-fetoprotein|alpha-fetoprotein
485065|NCT01492114|C-reactive protein|c-reactive protein
485066|NCT01492114|Resveratrol|resveratrol
485067|NCT01492114|Redox index|redox index
485068|NCT01492088|Pediatric|pediatric
485069|NCT01492088|Lymphoma|lymphoma
485070|NCT01492088|Hodgkin|hodgkin
485071|NCT01492088|Anaplastic Large-cell|anaplastic large-cell
485072|NCT01492088|Relapsed|relapsed
485073|NCT01492088|Refractory|refractory
485074|NCT01492088|Drug therapy|drug therapy
485075|NCT01492075|Postoperative pain|postoperative pain
485076|NCT01492075|Anesthetics: Local anesthetics|anesthetics: local anesthetics
485077|NCT01492075|Surgery: Hysterectomy|surgery: hysterectomy
485078|NCT01492062|Type 1 diabetes mellitus|type 1 diabetes mellitus
485079|NCT01492062|artificial pancreas|artificial pancreas
485080|NCT01492062|closed-loop|closed-loop
485081|NCT01492049|Colorectal Neoplasms|colorectal neoplasms
485082|NCT01492049|Promoting Health Literacy|promoting health literacy
485083|NCT01492049|Patient education program|patient education program
485084|NCT01492049|Colorectal Cancer Screening|colorectal cancer screening
485085|NCT01492049|CRCS|crcs
485086|NCT01492049|Patient decision aid|patient decision aid
485087|NCT01492049|PtDA|ptda
485088|NCT01492049|Video|video
485089|NCT01492049|Questionnaires|questionnaires
485090|NCT01492049|Surveys|surveys
485091|NCT01492036|Replication-Competent Retrovirus|replication-competent retrovirus
485092|NCT01492036|RCR|rcr
485093|NCT01492036|Gene transfer therapy|gene transfer therapy
485094|NCT01492036|Registry|registry
485095|NCT01492036|Medical information database|medical information database
485096|NCT01492036|Vector or vector-treated cells|vector or vector-treated cells
485097|NCT01492036|Blood draw|blood draw
485098|NCT01492036|Computed tomography|computed tomography
485099|NCT01492036|CT|ct
485100|NCT01492036|Questionnaires|questionnaires
485101|NCT01492036|Surveys|surveys
485102|NCT01492036|Gene Transfer Research|gene transfer research
485103|NCT01492036|National Gene Vector Biorepository and Coordinating Center|national gene vector biorepository and coordinating center
485104|NCT01492036|NGVB|ngvb
485105|NCT01492023|neuropsychological|neuropsychological
485106|NCT01492023|rehabilitation|rehabilitation
485107|NCT01492023|multiple sclerosis|multiple sclerosis
485108|NCT01492023|RCT study|rct study
485109|NCT01492010|skeletal muscle|skeletal muscle
485110|NCT01492010|FSR|fsr
485111|NCT01492010|resistance exercise|resistance exercise
485112|NCT01492010|leucine|leucine
485113|NCT01492010|protein|protein
485114|NCT01491958|Leukemia|leukemia
485115|NCT01491958|AML|aml
485116|NCT01491958|ALL|all
485117|NCT01491958|MDS|mds
485118|NCT01491945|Abdominal aortic aneurysm|abdominal aortic aneurysm
485119|NCT01491945|Renal stent|renal stent
485120|NCT01491945|Juxtarenal|juxtarenal
485121|NCT01491945|Pararenal|pararenal
485122|NCT01491945|Endovascular|endovascular
485123|NCT01491932|Parkinson Disease|parkinson disease
485124|NCT01491932|L-dopa|l-dopa
485125|NCT01491932|Levodopa|levodopa
485126|NCT01491932|Dyskinesia|dyskinesia
485127|NCT01491919|High Blood Pressure|high blood pressure
485128|NCT01491919|Hypertension|hypertension
485129|NCT01491919|Renal Transplantation|renal transplantation
485130|NCT01491919|Kidney Transplantation|kidney transplantation
485131|NCT01491893|GBM|gbm
485132|NCT01491893|Brain Tumor|brain tumor
485133|NCT01491893|Poliovirus Vaccine|poliovirus vaccine
485134|NCT01491893|WHO Grade IV Malignant Glioma|who grade iv malignant glioma
485135|NCT01491880|cognitive behavior therapy|cognitive behavior therapy
485136|NCT01491880|telemedicine|telemedicine
485137|NCT01491880|rural|rural
485138|NCT01491880|Latinos|latinos
485139|NCT01491880|children|children
485140|NCT01491867|intraocular pressure|intraocular pressure
485141|NCT01491854|Long-term|long-term
485142|NCT01491854|safety|safety
485143|NCT01491854|follow-up|follow-up
485144|NCT01491854|growth hormone treatment|growth hormone treatment
485145|NCT01491854|short children|short children
485146|NCT01491854|Small for Gestational Age|small for gestational age
485147|NCT01491854|Somatropin|somatropin
485148|NCT01491828|Apnea|apnea
485149|NCT01491828|Sleep apnea|sleep apnea
485150|NCT01491828|Snoring|snoring
485151|NCT01491828|Hypoglossal nerve stimulation|hypoglossal nerve stimulation
485152|NCT01491828|Laynx stimulation|laynx stimulation
485153|NCT01491802|COPD|copd
485154|NCT01491802|Combination therapy|combination therapy
485155|NCT01491802|Anticholinergic|anticholinergic
485156|NCT01491802|Beta2-agonist|beta2-agonist
485157|NCT01491802|Exercise|exercise
485158|NCT01491802|Dyspnea|dyspnea
485159|NCT01491802|Respiratory mechanics|respiratory mechanics
485160|NCT01491789|spinal cord injury|spinal cord injury
485161|NCT01491789|Virtual sailing|virtual sailing
485162|NCT01491789|Vsail|vsail
485163|NCT01491776|Group A Streptococcus|group a streptococcus
485164|NCT01491776|Strep A|strep a
485165|NCT01491776|Rapid Test|rapid test
485166|NCT01491776|Pharyngitis|pharyngitis
485167|NCT01491750|SURGERY|surgery
485168|NCT01491750|TOTAL JOINT REPLACEMENT|total joint replacement
485169|NCT01491750|TOTAL KNEE REPLACEMENT|total knee replacement
485170|NCT01491750|GUIDED IMAGERY|guided imagery
485171|NCT01491750|COMPLEMENTARY AND ALTERNATIVE THERAPY|complementary and alternative therapy
485172|NCT01491711|Superficial basal cell carcinoma|superficial basal cell carcinoma
485173|NCT01491711|Carcinoma, Basal Cell|carcinoma, basal cell
485174|NCT01491711|Skin diseases|skin diseases
485175|NCT01491711|Connective tissue diseases|connective tissue diseases
485176|NCT01491711|Treatment|treatment
485177|NCT01491711|Drug therapy|drug therapy
485178|NCT01491711|Efficacy|efficacy
485179|NCT01491711|Photodynamic therapy|photodynamic therapy
485180|NCT01491711|Photosensitizing Agents/therapeutic use|photosensitizing agents/therapeutic use
485181|NCT01491711|Aminolevulinic acid|aminolevulinic acid
485182|NCT01491711|Methylaminolevulinate|methylaminolevulinate
485183|NCT01491711|Pain measurement|pain measurement
485184|NCT01491711|Health Care Economics and Organizations|health care economics and organizations
485185|NCT01491698|stomach|stomach
485186|NCT01491698|surgery|surgery
485187|NCT01491698|Total Gastrectomy|total gastrectomy
485188|NCT01491698|Roux-En-Y Pouch Reconstruction|roux-en-y pouch reconstruction
485189|NCT01491698|Conventional Roux-En-Y Reconstruction|conventional roux-en-y reconstruction
485190|NCT01491698|Quality of Life|quality of life
485191|NCT01491698|11-170|11-170
485192|NCT01491672|Metastatic Renal Cell Carcinoma|metastatic renal cell carcinoma
485193|NCT01491672|Second Line|second line
485194|NCT01491672|Everolimus|everolimus
485195|NCT01491672|RAD001|rad001
485196|NCT01491646|pulmonary hypertension|pulmonary hypertension
485197|NCT01491646|cardiac magnetic resonance imaging|cardiac magnetic resonance imaging
485198|NCT01491646|Characterize and quantify RV vortex flow|characterize and quantify rv vortex flow
485199|NCT01491646|Assess feasibility of cardiac MR for RVDD diagnosis|assess feasibility of cardiac mr for rvdd diagnosis
485200|NCT01491646|Biomarker information to help diagnose|biomarker information to help diagnose
485201|NCT01491633|Lung cancer|lung cancer
485203|NCT01491633|Stage IIIB|stage iiib
485204|NCT01491633|Stage IV|stage iv
485205|NCT01491620|poikiloderma of Civatte|poikiloderma of civatte
485206|NCT01491620|red dyschromia|red dyschromia
485207|NCT01491620|brown dyschromia|brown dyschromia
485208|NCT01491620|sun damage|sun damage
485209|NCT01491620|neck|neck
485210|NCT01491620|chest|chest
485211|NCT01491620|dyschromia|dyschromia
485212|NCT01491620|pigmentation disorders|pigmentation disorders
485213|NCT01491620|erythema|erythema
485214|NCT01491620|photosensitivity disorders|photosensitivity disorders
485215|NCT01491620|sun exposure|sun exposure
485216|NCT01491620|telangiectasia|telangiectasia
485217|NCT01491620|hyperpigmentation|hyperpigmentation
485218|NCT01491620|hypopigmentation|hypopigmentation
485219|NCT01491607|post-exposure prophylaxis|post-exposure prophylaxis
485220|NCT01491607|toxin neutralization assay|toxin neutralization assay
485221|NCT01491594|Metastatic sarcoma|metastatic sarcoma
485222|NCT01491594|Bone sarcoma|bone sarcoma
485223|NCT01491581|anthropometry|anthropometry
485224|NCT01491581|zinc|zinc
485225|NCT01491581|iodine|iodine
485226|NCT01491581|vitamin D|vitamin d
485227|NCT01491581|calcium|calcium
485228|NCT01491581|school children|school children
485229|NCT01491581|food supplement|food supplement
485230|NCT01491568|symptomatic degenerative disc disease at two levels|symptomatic degenerative disc disease at two levels
485231|NCT01491555|Duchenne Muscular Dystrophy|duchenne muscular dystrophy
485232|NCT01491555|DMD|dmd
485233|NCT01491555|controls|controls
485234|NCT01491555|EIM|eim
485235|NCT01491555|QUS|qus
485236|NCT01491542|Symptomatic Degenerative Disc Disease|symptomatic degenerative disc disease
485237|NCT01491529|Parkinson Disease|parkinson disease
485238|NCT01491529|L-dopa|l-dopa
485239|NCT01491529|Levodopa|levodopa
485240|NCT01491529|Dyskinesia|dyskinesia
485241|NCT01491529|Amantadine|amantadine
485242|NCT01491516|Lumbar degenerative disc disease|lumbar degenerative disc disease
485243|NCT01491503|montelukast|montelukast
485244|NCT01491503|levocetirizine|levocetirizine
485245|NCT01491503|interaction|interaction
485246|NCT01491490|Schizophrenia|schizophrenia
485247|NCT01491490|Functional psychosis|functional psychosis
485248|NCT01491490|Schizophreniform|schizophreniform
485249|NCT01491490|Acute psychosis|acute psychosis
485250|NCT01491464|symptomatic degenerative disc disease|symptomatic degenerative disc disease
485251|NCT01491451|Degenerative lumbar disc disease|degenerative lumbar disc disease
485252|NCT01491425|symptomatic degenerative disc disease|symptomatic degenerative disc disease
485253|NCT01491412|Schizophrenia|schizophrenia
485254|NCT01491412|antipsychotics|antipsychotics
485255|NCT01491412|real life treatment|real life treatment
485256|NCT01491412|non-interventional|non-interventional
485257|NCT01491386|symptomatic degenerative disc disease|symptomatic degenerative disc disease
485258|NCT01491373|Degenerative Disc Disease|degenerative disc disease
485259|NCT01491373|Symptomatic Degenerative Disc Disease|symptomatic degenerative disc disease
485260|NCT01491360|Presbyopia|presbyopia
485261|NCT01491360|sclera|sclera
485262|NCT01491360|LaserACE|laserace
485263|NCT01491347|BDNF|bdnf
485264|NCT01491347|withdrawal|withdrawal
485265|NCT01491347|alcohol|alcohol
485266|NCT01491347|psychiatry|psychiatry
485267|NCT01491334|POP|pop
485268|NCT01491334|Pelvic Floor|pelvic floor
485269|NCT01491334|Pelvic Organ Prolapse|pelvic organ prolapse
485270|NCT01491321|chronic low back pain|chronic low back pain
485271|NCT01491321|bee venom acupuncture|bee venom acupuncture
485272|NCT01491295|Lamivudine|lamivudine
485273|NCT01491295|adefovir add on treatment|adefovir add on treatment
485274|NCT01491295|tenofovir|tenofovir
485275|NCT01491295|chronic hepatitis B|chronic hepatitis b
485276|NCT01491282|human brown adipose tissue activity|human brown adipose tissue activity
485277|NCT01491282|obesity|obesity
485278|NCT01491282|energy metabolism|energy metabolism
485279|NCT01491282|adaptive thermogenesis|adaptive thermogenesis
485280|NCT01491269|chronic pain|chronic pain
485281|NCT01491269|internet delivered CBT|internet delivered cbt
485282|NCT01491269|tertiary intervention|tertiary intervention
485283|NCT01491269|mindfulness|mindfulness
485284|NCT01491269|applied relaxation|applied relaxation
485285|NCT01491269|guided self help|guided self help
485286|NCT01491256|Index of microcirculatory resistance|index of microcirculatory resistance
485287|NCT01491256|atorvastatin|atorvastatin
485288|NCT01491256|drug-eluting stent|drug-eluting stent
485289|NCT01491256|acute coronary syndrome|acute coronary syndrome
485290|NCT01491243|contrast-induced nephropathy|contrast-induced nephropathy
485291|NCT01491230|cancer|cancer
485292|NCT01491230|neutrophil extracellular traps|neutrophil extracellular traps
485293|NCT01491230|autologous hematopoietic stem cell transplantation|autologous hematopoietic stem cell transplantation
485294|NCT01491230|allogeneic hematopoietic stem cell transplantation|allogeneic hematopoietic stem cell transplantation
485295|NCT01491230|chemotaxis|chemotaxis
485296|NCT01491230|superoxide production|superoxide production
485297|NCT01491230|hydrogen peroxide production|hydrogen peroxide production
485298|NCT01491230|myeloperoxidase|myeloperoxidase
485299|NCT01491217|Oraxol®|oraxol®
485300|NCT01491217|oral paclitaxel|oral paclitaxel
485301|NCT01491217|paclitaxel|paclitaxel
485302|NCT01491217|HM30181A|hm30181a
485304|NCT01491217|DLT|dlt
485305|NCT01491217|RD|rd
485306|NCT01491191|surgical pain|surgical pain
485307|NCT01491191|chronic pain|chronic pain
485308|NCT01491191|prevention|prevention
485309|NCT01491191|palmitoylethanolamide|palmitoylethanolamide
485310|NCT01491165|umbilical cord mesenchyma stem cell|umbilical cord mesenchyma stem cell
485311|NCT01491152|Cerebral Palsy|cerebral palsy
485312|NCT01491152|Whole Body Vibration|whole body vibration
485313|NCT01491152|Infant|infant
485314|NCT01491152|Motor development|motor development
485315|NCT01491152|Physiotherapy|physiotherapy
485316|NCT01491139|Radiotherapy|radiotherapy
485317|NCT01491139|Biomarkers, pharmacological|biomarkers, pharmacological
485318|NCT01491139|Pharmacokinetics|pharmacokinetics
485319|NCT01491139|Genetic Markers|genetic markers
485320|NCT01491139|Cisplatin|cisplatin
485321|NCT01491139|Poly(ADP-ribose) Polymerases|poly(adp-ribose) polymerases
485322|NCT01491139|AZD 2281|azd 2281
485323|NCT01491139|Radiotherapy, Intensity-Modulated|radiotherapy, intensity-modulated
485324|NCT01491139|Head and Neck|head and neck
485325|NCT01491139|Chemoradiotherapy|chemoradiotherapy
485326|NCT01491139|SCC|scc
485327|NCT01491126|Gastroscopy|gastroscopy
485328|NCT01491126|Colonoscopy|colonoscopy
485329|NCT01491126|Anesthesia|anesthesia
485330|NCT01491126|Recovery|recovery
485331|NCT01491113|Levetiracetam|levetiracetam
485332|NCT01491113|Oral administration|oral administration
485333|NCT01491113|Japanese|japanese
485334|NCT01491113|Non-epileptic|non-epileptic
485335|NCT01491113|Healthy|healthy
485336|NCT01491113|Renal impaired subjects|renal impaired subjects
485337|NCT01491100|Cognition|cognition
485338|NCT01491100|Physical Activity|physical activity
485339|NCT01491100|Relapsing Remitting Multiple Sclerosis|relapsing remitting multiple sclerosis
485340|NCT01491087|Pentaxim®|pentaxim®
485341|NCT01491087|Whole-cell Pertussis vaccine|whole-cell pertussis vaccine
485342|NCT01491087|Acellular Pertussis vaccine|acellular pertussis vaccine
485343|NCT01491087|Haemophilus influenzae type b polysaccharide|haemophilus influenzae type b polysaccharide
485344|NCT01491087|Inactivated Polio vaccine|inactivated polio vaccine
485345|NCT01491087|Pentavac®|pentavac®
485346|NCT01491061|periprocedural myocardial infarction|periprocedural myocardial infarction
485347|NCT01491061|ranolazine|ranolazine
485348|NCT01491048|Hip osteoarthritis|hip osteoarthritis
485349|NCT01491048|Physiotherapy|physiotherapy
485350|NCT01491048|THA|tha
485351|NCT01491035|Children|children
485352|NCT01491035|Adolescents|adolescents
485353|NCT01491035|Pharmacokinetic|pharmacokinetic
485354|NCT01491035|Pharmacodynamic|pharmacodynamic
485355|NCT01491022|parkinson's|parkinson's
485356|NCT01491022|gait dysfunction|gait dysfunction
485357|NCT01491022|ampyra|ampyra
485358|NCT01491022|4-aminopyridine|4-aminopyridine
485359|NCT01491009|Dexmedetomidine|dexmedetomidine
485360|NCT01491009|midazolam|midazolam
485361|NCT01491009|remifentanil|remifentanil
485362|NCT01491009|mini-mental state examination|mini-mental state examination
485363|NCT01491009|monitored anaesthesia care|monitored anaesthesia care
485364|NCT01491009|cystoscopy|cystoscopy
485365|NCT01491009|sedation|sedation
485366|NCT01490996|Curcumin|curcumin
485367|NCT01490996|Colorectal cancer|colorectal cancer
485368|NCT01490996|metastases|metastases
485369|NCT01490996|FOLFOX|folfox
485370|NCT01490983|Chronic Myeloid Leukemia|chronic myeloid leukemia
485371|NCT01490983|Chronic Phase CML|chronic phase cml
485372|NCT01490970|Sarcoma Database|sarcoma database
485373|NCT01490957|HD|hd
485374|NCT01490957|NHL|nhl
485375|NCT01490931|acute pain|acute pain
485376|NCT01490931|dental pain|dental pain
485377|NCT01490931|intranasal ketorolac|intranasal ketorolac
485378|NCT01490931|dental implant surgery|dental implant surgery
485379|NCT01490918|Type-II diabetes mellitus|type-ii diabetes mellitus
485380|NCT01490918|Acarbose|acarbose
485381|NCT01490918|ACADEMIC|academic
485382|NCT01490905|Medical food|medical food
485383|NCT01490905|Theramine|theramine
485384|NCT01490905|Ibuprofen|ibuprofen
485385|NCT01490905|Amino acids|amino acids
485386|NCT01490905|Convenience Pack Kit|convenience pack kit
485387|NCT01490892|breast abnormality|breast abnormality
485388|NCT01490892|ultrasound imaging|ultrasound imaging
485389|NCT01490892|ultrasound contrast agent|ultrasound contrast agent
485390|NCT01490892|subharmonic imaging|subharmonic imaging
485391|NCT01490879|DFU|dfu
485392|NCT01490879|Diabetic Foot Ulcer|diabetic foot ulcer
485393|NCT01490879|Ulcers|ulcers
485394|NCT01490879|Foot Ulcers|foot ulcers
485395|NCT01490879|chronic wound|chronic wound
485396|NCT01490879|wounds|wounds
485397|NCT01490879|Nexagon|nexagon
485398|NCT01490879|CoDa|coda
485399|NCT01490866|Colorectal Cancer|colorectal cancer
485400|NCT01490866|Axitinib|axitinib
485401|NCT01490866|FOLFOX/Bevacizumab|folfox/bevacizumab
485402|NCT01490853|Ph pos CML|ph pos cml
485403|NCT01490853|Philadelphia positive Chronic Myeloid Leukemia|philadelphia positive chronic myeloid leukemia
485404|NCT01490840|Fatigue|fatigue
485405|NCT01490840|MS|ms
485406|NCT01490840|Multiple Sclerosis|multiple sclerosis
485407|NCT01490840|Exercise|exercise
485408|NCT01490840|Physical activity|physical activity
485409|NCT01490840|Physical training|physical training
485410|NCT01490840|Fingolimod|fingolimod
485411|NCT01490814|PAF|paf
485412|NCT01490814|two episodes within the last twelve months one episode documented|two episodes within the last twelve months one episode documented
485413|NCT01490814|Documented treatment failure of at least one antiarrhythmic|documented treatment failure of at least one antiarrhythmic
485414|NCT01490814|drug AAD Type I or III including β-blocker and AAD intolerance|drug aad type i or iii including β-blocker and aad intolerance
485415|NCT01490801|childhood Hodgkin lymphoma|childhood hodgkin lymphoma
485416|NCT01490801|childhood mixed cellularity Hodgkin lymphoma|childhood mixed cellularity hodgkin lymphoma
485417|NCT01490801|hemophagocytic lymphohistiocytosis|hemophagocytic lymphohistiocytosis
485418|NCT01490801|Epstein-Barr virus infection|epstein-barr virus infection
485419|NCT01490775|Chronic Myeloid Leukemia|chronic myeloid leukemia
485420|NCT01490762|PK|pk
485421|NCT01490762|PD|pd
485422|NCT01490749|Esophageal Cancer|esophageal cancer
485423|NCT01490749|Neoplasms, Esophageal|neoplasms, esophageal
485424|NCT01490736|Acne|acne
485425|NCT01490736|Sebum gland disease|sebum gland disease
485426|NCT01490723|Leukemia|leukemia
485427|NCT01490723|Chronic lymphocytic leukemia|chronic lymphocytic leukemia
485428|NCT01490723|Lymphoma|lymphoma
485429|NCT01490723|CD20+ lymphoid malignancies|cd20+ lymphoid malignancies
485430|NCT01490723|Diffuse large B-cell lymphoma|diffuse large b-cell lymphoma
485431|NCT01490723|Allogeneic transplantation|allogeneic transplantation
485432|NCT01490723|Rituximab|rituximab
485433|NCT01490723|Rituxan|rituxan
485434|NCT01490723|In ibritumomab|in ibritumomab
485435|NCT01490723|Y ibritumomab|y ibritumomab
485436|NCT01490723|Zevalin|zevalin
485437|NCT01490723|Fludarabine Phosphate|fludarabine phosphate
485438|NCT01490723|Fludara|fludara
485439|NCT01490723|Bendamustine Hydrochloride|bendamustine hydrochloride
485440|NCT01490723|Bendamustine HCL|bendamustine hcl
485441|NCT01490723|CEP-18083|cep-18083
485442|NCT01490723|SDX-105|sdx-105
485443|NCT01490723|Treanda|treanda
485444|NCT01490723|Stem Cell Transplantation|stem cell transplantation
485445|NCT01490723|Planar Scintigraphy|planar scintigraphy
485446|NCT01490723|Spect Scan|spect scan
485447|NCT01490723|Single Photon Emission-Computed Tomography|single photon emission-computed tomography
485448|NCT01490723|CT Scan|ct scan
485449|NCT01490723|Computed Tomography|computed tomography
485450|NCT01490723|G-CSF|g-csf
485451|NCT01490723|Filgrastim|filgrastim
485452|NCT01490723|Neupogen|neupogen
485453|NCT01490723|Thymoglobulin|thymoglobulin
485454|NCT01490723|ATG|atg
485455|NCT01490723|Antithymocyte Globulin|antithymocyte globulin
485456|NCT01490723|Methotrexate|methotrexate
485457|NCT01490723|Mycophenolate|mycophenolate
485458|NCT01490723|MMF|mmf
485459|NCT01490723|Mycophenolate Mofetil|mycophenolate mofetil
485460|NCT01490723|CellCept|cellcept
485461|NCT01490723|Tacrolimus|tacrolimus
485462|NCT01490723|Prograf|prograf
485463|NCT01490710|NAVA|nava
485464|NCT01490710|Hemodynamic|hemodynamic
485465|NCT01490710|Cardiac Index|cardiac index
485466|NCT01490710|Children with admission weight > 5kg|children with admission weight > 5kg
485467|NCT01490697|stress disorders|stress disorders
485468|NCT01490697|posttraumatic|posttraumatic
485469|NCT01490697|memory|memory
485470|NCT01490697|mifepristone|mifepristone
485471|NCT01490697|d-cycloserine|d-cycloserine
485472|NCT01490697|psychophysiology|psychophysiology
485473|NCT01490684|candidiasis|candidiasis
485474|NCT01490684|critically ill|critically ill
485475|NCT01490684|outcomes|outcomes
485476|NCT01490645|ACS patients participating in a SCP|acs patients participating in a scp
485477|NCT01490645|QoL after ACS|qol after acs
485478|NCT01490645|ASC Patients's needs|asc patients's needs
485479|NCT01490632|Moderate|moderate
485480|NCT01490632|Severe|severe
485481|NCT01490632|Plaque|plaque
485482|NCT01490632|Chronic|chronic
485483|NCT01490619|Type 1 diabetes|type 1 diabetes
485484|NCT01490619|Adolescent|adolescent
485485|NCT01490619|Resilience|resilience
485486|NCT01490619|Prevention|prevention
485487|NCT01490619|Depression|depression
485488|NCT01490593|Canadian|canadian
485489|NCT01490593|Eye|eye
485490|NCT01490593|Injury|injury
485491|NCT01490593|Registry|registry
485492|NCT01490580|Pain|pain
485493|NCT01490580|Newborn|newborn
485494|NCT01490580|Anaesthesia|anaesthesia
485495|NCT01490580|opioids|opioids
485496|NCT01490580|propofol|propofol
485497|NCT01490580|neuromuscular blocker|neuromuscular blocker
485498|NCT01490580|atropine|atropine
485499|NCT01490567|Impaired Cognition Schizophrenia|impaired cognition schizophrenia
485500|NCT01490554|Skin aging|skin aging
485501|NCT01490554|fibroblasts|fibroblasts
485502|NCT01490554|transplantation|transplantation
485503|NCT01490554|autologous|autologous
485504|NCT01490541|Gastric intestinal metaplasia|gastric intestinal metaplasia
485505|NCT01490528|Pediatric IBD|pediatric ibd
485506|NCT01490515|non-invasive,|non-invasive,
485507|NCT01490515|metabolomics,|metabolomics,
485508|NCT01490515|morphology,|morphology,
485509|NCT01490515|embryo selection,|embryo selection,
485510|NCT01490515|implantation rates|implantation rates
485511|NCT01490489|EG-VEGF|eg-vegf
485512|NCT01490489|Endocrine Gland-derived Vascular Endothelial Growth Factor|endocrine gland-derived vascular endothelial growth factor
485513|NCT01490489|Pre-eclampsia|pre-eclampsia
485514|NCT01490489|intra-uterine growth retardation|intra-uterine growth retardation
485515|NCT01490489|prognosis|prognosis
485516|NCT01490476|Neurofibromatosis Type 2 with Vestibular Schwannoma|neurofibromatosis type 2 with vestibular schwannoma
485517|NCT01490476|Vestibular Schwannoma|vestibular schwannoma
485518|NCT01490476|Peripheral Nervous System Diseases|peripheral nervous system diseases
485519|NCT01490476|Otorhinolaryngologic Diseases|otorhinolaryngologic diseases
485520|NCT01490476|Vestibulocochlear Nerve Diseases|vestibulocochlear nerve diseases
485521|NCT01490463|Treatment of|treatment of
485522|NCT01490437|Advanced urothelial carcinoma|advanced urothelial carcinoma
485523|NCT01490424|TREM-1;|trem-1;
485524|NCT01490424|SNPs;|snps;
485525|NCT01490424|prognosis|prognosis
485526|NCT01490424|control（normal person）|control（normal person）
485527|NCT01490411|Specific immunotherapy|specific immunotherapy
485529|NCT01490411|SCIT|scit
485530|NCT01490411|recombinant|recombinant
485531|NCT01490398|Hypertension|hypertension
485532|NCT01490398|Rosuvastatin|rosuvastatin
485533|NCT01490398|Coronary flow reserve|coronary flow reserve
485534|NCT01490359|human immunodeficiency virus|human immunodeficiency virus
485535|NCT01490359|randomized controlled trial|randomized controlled trial
485536|NCT01490359|intervention studies|intervention studies
485537|NCT01490359|South Africa|south africa
485538|NCT01490359|men|men
485539|NCT01490359|sexually behavior|sexually behavior
485540|NCT01490359|social cognitive theory|social cognitive theory
485541|NCT01490346|HIV 1|hiv 1
485542|NCT01490346|Pharmacokinetics|pharmacokinetics
485543|NCT01490346|Drug levels|drug levels
485544|NCT01490346|Treatment naive|treatment naive
485545|NCT01490320|Violence prevention|violence prevention
485546|NCT01490320|Media|media
485547|NCT01490320|Primary care|primary care
485548|NCT01490320|Parenting|parenting
485549|NCT01490307|parenting intervention|parenting intervention
485550|NCT01490307|Family Check-Up|family check-up
485551|NCT01490307|Anxiety Disorders|anxiety disorders
485552|NCT01490307|Depression|depression
485553|NCT01490307|Depressive Disorder|depressive disorder
485554|NCT01490307|Conduct Disorder|conduct disorder
485555|NCT01490307|Mental Disorders|mental disorders
485556|NCT01490307|Behavioral Symptoms|behavioral symptoms
485557|NCT01490307|Mood Disorders|mood disorders
485558|NCT01490307|Mental Disorders Diagnosed in Childhood|mental disorders diagnosed in childhood
485559|NCT01490307|Substance-Related Disorders|substance-related disorders
485560|NCT01490294|Cardiac MRI|cardiac mri
485561|NCT01490294|gadobutrol|gadobutrol
485562|NCT01490281|Fibromyalgia|fibromyalgia
485563|NCT01490281|exercise|exercise
485564|NCT01490281|physical activity|physical activity
485565|NCT01490281|pain|pain
485566|NCT01490268|Pharmacokinetic-pharmacodynamic modeling|pharmacokinetic-pharmacodynamic modeling
485567|NCT01490268|Patient-controlled analgesia|patient-controlled analgesia
485568|NCT01490268|Target-controlled infusion|target-controlled infusion
485569|NCT01490268|Hydromorphone|hydromorphone
485570|NCT01490268|Sufentanil|sufentanil
485571|NCT01490268|after thoracotomy|after thoracotomy
485572|NCT01490268|cardiac surgery|cardiac surgery
485573|NCT01490255|platelet reactivity|platelet reactivity
485574|NCT01490255|aspirin|aspirin
485575|NCT01490255|clopidogrel|clopidogrel
485576|NCT01490229|nutraceuticals|nutraceuticals
485577|NCT01490229|statin|statin
485578|NCT01490216|cocaine|cocaine
485579|NCT01490216|lisdexamfetamine|lisdexamfetamine
485580|NCT01490216|vyvanse|vyvanse
485581|NCT01490203|Gd-EOB-DTPA|gd-eob-dtpa
485582|NCT01490203|MRI|mri
485583|NCT01490203|Hepatectomy|hepatectomy
485584|NCT01490203|Hepatocellular Carcinoma|hepatocellular carcinoma
485585|NCT01490203|Liver Function Tests|liver function tests
485586|NCT01490177|Multiple food allergies|multiple food allergies
485587|NCT01490151|Hormone|hormone
485588|NCT01490151|Diabetes|diabetes
485589|NCT01490151|Mellitus|mellitus
485590|NCT01490151|Type 1|type 1
485591|NCT01490151|Immune|immune
485592|NCT01490151|Metabolic disorder|metabolic disorder
485593|NCT01490138|β-D-Glucan test|β-d-glucan test
485594|NCT01490138|IFI|ifi
485595|NCT01490125|COPD|copd
485596|NCT01490125|Dyspnea|dyspnea
485597|NCT01490125|QVA149|qva149
485598|NCT01490125|tiotropium|tiotropium
485599|NCT01490073|Intrauterine device|intrauterine device
485600|NCT01490073|Pain|pain
485601|NCT01490073|Contraception|contraception
485602|NCT01490073|Nitroglycerin|nitroglycerin
485603|NCT01490073|Nitric oxide donor|nitric oxide donor
485604|NCT01490073|Intrauterine device insertion|intrauterine device insertion
485605|NCT01490060|cancer|cancer
485606|NCT01490060|fosaprepitant|fosaprepitant
485607|NCT01490060|Ifosfamide-based Multi-day Chemotherapy|ifosfamide-based multi-day chemotherapy
485608|NCT01490060|Chemotherapy-induced nausea and vomiting|chemotherapy-induced nausea and vomiting
485609|NCT01490060|CINV|cinv
485610|NCT01490060|multi-day chemotherapy regimens|multi-day chemotherapy regimens
485611|NCT01490060|antiemetics|antiemetics
485612|NCT01490060|adverse effect|adverse effect
485613|NCT01490060|doxorubicin plus ifosfamide|doxorubicin plus ifosfamide
485614|NCT01490060|AI|ai
485615|NCT01490060|AI and vincristine|ai and vincristine
485616|NCT01490060|VAI|vai
485617|NCT01490060|aprepitant|aprepitant
485618|NCT01490060|prevention|prevention
485619|NCT01490060|nausea|nausea
485620|NCT01490060|vomiting|vomiting
485621|NCT01490060|emetogenic chemotherapy|emetogenic chemotherapy
485622|NCT01490034|obesity|obesity
485623|NCT01490034|energy intake|energy intake
485624|NCT01490034|appetite|appetite
485625|NCT01490034|food form|food form
485626|NCT01490034|beverage|beverage
485627|NCT01490034|learning|learning
485628|NCT01490034|dietary compensation|dietary compensation
485629|NCT01490021|Healthy young men|healthy young men
485630|NCT01489995|Food effect|food effect
485631|NCT01489995|GR181413A|gr181413a
485632|NCT01489995|AT1001|at1001
485633|NCT01489995|migalastat hydrochloride|migalastat hydrochloride
485634|NCT01489995|Lysosomal storage disorders|lysosomal storage disorders
485635|NCT01489995|Pharmacokinetics|pharmacokinetics
485636|NCT01489982|Parkinson's disease|parkinson's disease
485637|NCT01489982|insomnia|insomnia
485638|NCT01489969|sleep latency|sleep latency
485639|NCT01489969|Sleep maintenance|sleep maintenance
485640|NCT01489969|Sleep fragmentation|sleep fragmentation
485641|NCT01489969|Polysomnography|polysomnography
485642|NCT01489956|Keyhole Limpet Hemocyanin (KLH)|keyhole limpet hemocyanin (klh)
485643|NCT01489956|Immucothel|immucothel
485644|NCT01489956|Native KLH|native klh
485645|NCT01489956|Healthy volunteers|healthy volunteers
485646|NCT01489956|Oral tolerance|oral tolerance
485647|NCT01489956|Immunogenicity|immunogenicity
485648|NCT01489956|Autoimmune diseases|autoimmune diseases
485649|NCT01489930|Exercise|exercise
485650|NCT01489930|Aging|aging
485651|NCT01489930|Sarcopenia|sarcopenia
485652|NCT01489930|Mitochondria|mitochondria
485653|NCT01489917|radial artery occlusion|radial artery occlusion
485654|NCT01489917|hemostasis|hemostasis
485655|NCT01489917|coronary intervention|coronary intervention
485656|NCT01489917|radial approach|radial approach
485657|NCT01489904|drooling|drooling
485658|NCT01489904|cerebral palsy|cerebral palsy
485659|NCT01489891|Esophagogastroduodenoscopy|esophagogastroduodenoscopy
485660|NCT01489891|Lidocaine|lidocaine
485661|NCT01489891|Propofol|propofol
485662|NCT01489878|Coagulase-negative staphylococci|coagulase-negative staphylococci
485663|NCT01489878|Staphylococcus epidermidis|staphylococcus epidermidis
485664|NCT01489878|Staphylococcus aureus|staphylococcus aureus
485665|NCT01489878|Anti-bacterial agents|anti-bacterial agents
485666|NCT01489878|Drug resistance, Microbial|drug resistance, microbial
485667|NCT01489878|Methicillin resistance|methicillin resistance
485668|NCT01489878|Β-lactams|β-lactams
485669|NCT01489878|Fluoroquinolones|fluoroquinolones
485670|NCT01489878|Macrolides|macrolides
485671|NCT01489878|Synergistin|synergistin
485672|NCT01489878|General practitioners|general practitioners
485673|NCT01489878|Antibiotic selection pressure|antibiotic selection pressure
485674|NCT01489878|Ambulatory antibiotherapy|ambulatory antibiotherapy
485675|NCT01489878|Community patients|community patients
485676|NCT01489865|Pancreas cancer|pancreas cancer
485677|NCT01489865|Veliparib|veliparib
485678|NCT01489865|oxaliplatin|oxaliplatin
485679|NCT01489852|Assisted reproductive treatment|assisted reproductive treatment
485680|NCT01489852|GnRH antagonist|gnrh antagonist
485681|NCT01489852|Estrogen pre-treatment|estrogen pre-treatment
485682|NCT01489852|Ovarian stimulation|ovarian stimulation
485683|NCT01489839|periodontal disease|periodontal disease
485684|NCT01489839|biomarkers|biomarkers
485685|NCT01489839|periodontal treatment|periodontal treatment
485686|NCT01489839|clinical attachment level|clinical attachment level
485687|NCT01489826|Cancer|cancer
485688|NCT01489800|feeding|feeding
485689|NCT01489800|complications|complications
485690|NCT01489800|radical cystectomy|radical cystectomy
485691|NCT01489787|Surgery|surgery
485692|NCT01489787|Ultrasonic therapy|ultrasonic therapy
485693|NCT01489787|Liver|liver
485694|NCT01489761|long lesions|long lesions
485695|NCT01489761|drug eluting stents|drug eluting stents
485696|NCT01489735|GERD|gerd
485697|NCT01489735|GERD Q QUESTIONNAIRE|gerd q questionnaire
485698|NCT01489722|Leukemia|leukemia
485699|NCT01489722|AML|aml
485700|NCT01489722|AZD1208|azd1208
485701|NCT01489709|overactive bladder|overactive bladder
485702|NCT01489709|solifenacin|solifenacin
485703|NCT01489709|Overactive bladder questionnaire|overactive bladder questionnaire
485704|NCT01489709|Overactive Bladder Symptom Score|overactive bladder symptom score
485705|NCT01489709|satisfaction score|satisfaction score
485706|NCT01489696|Pharmacokinetics|pharmacokinetics
485707|NCT01489696|Mirabegron|mirabegron
485708|NCT01489696|Tamsulosin|tamsulosin
485709|NCT01489696|Phase 1|phase 1
485710|NCT01489683|intubating conditions|intubating conditions
485711|NCT01489683|propofol|propofol
485712|NCT01489683|remifentanil|remifentanil
485713|NCT01489683|topical lidocaine|topical lidocaine
485714|NCT01489657|Obesity|obesity
485715|NCT01489657|Bariatric Surgery|bariatric surgery
485716|NCT01489657|Sleeve Gastrectomy|sleeve gastrectomy
485717|NCT01489657|Metabolite Profiling|metabolite profiling
485718|NCT01489631|Epidural|epidural
485719|NCT01489631|Local infiltration|local infiltration
485720|NCT01489631|Knee|knee
485721|NCT01489631|Arthroplasty|arthroplasty
485722|NCT01489618|Common variable immunodeficiency|common variable immunodeficiency
485723|NCT01489618|pneumococcal vaccine|pneumococcal vaccine
485724|NCT01489618|prime boost|prime boost
485725|NCT01489605|Orotracheal intubation, videolaryngoscopy|orotracheal intubation, videolaryngoscopy
485726|NCT01489566|Hepatocellular,Carcinoma,recurrence|hepatocellular,carcinoma,recurrence
485727|NCT01489553|Egg hypersensitivity|egg hypersensitivity
485728|NCT01489553|egg allergy|egg allergy
485729|NCT01489553|egg protein allergy|egg protein allergy
485730|NCT01489540|Burn|burn
485731|NCT01489540|Depth|depth
485732|NCT01489540|Diagnosis|diagnosis
485733|NCT01489540|Laser Doppler Imaging|laser doppler imaging
485734|NCT01489527|Vaccine|vaccine
485735|NCT01489527|Placebo|placebo
485736|NCT01489527|sexually transmitted infection (STI)|sexually transmitted infection (sti)
485737|NCT01489527|HIV|hiv
485738|NCT01489527|Human Immunodeficiency|human immunodeficiency
485739|NCT01489527|Gardasil|gardasil
485740|NCT01489527|HPV|hpv
485741|NCT01489527|human papillomavirus|human papillomavirus
485742|NCT01489514|peanut allergy|peanut allergy
485743|NCT01489514|hypoallergenic peanut extracts|hypoallergenic peanut extracts
485744|NCT01489514|epicutaneous skin prick testing|epicutaneous skin prick testing
485745|NCT01489501|Caomecs, Transplantation, Limbal stem cell deficiency,|caomecs, transplantation, limbal stem cell deficiency,
485746|NCT01489488|Relative bioavailability study|relative bioavailability study
485747|NCT01489475|children|children
485748|NCT01489475|congenital heart defects|congenital heart defects
485749|NCT01489475|cardiopulmonary bypass|cardiopulmonary bypass
485750|NCT01489475|modified ultrafiltration|modified ultrafiltration
485751|NCT01489475|angiopoietins|angiopoietins
485752|NCT01489475|cytokines|cytokines
485753|NCT01489462|Arthritis|arthritis
485754|NCT01489462|Osteoarthritis|osteoarthritis
485755|NCT01489462|Strength Training|strength training
485756|NCT01489449|drug coated balloon|drug coated balloon
485757|NCT01489449|NSTEMI|nstemi
485758|NCT01489436|gallstone disease|gallstone disease
485759|NCT01489436|cholecystectomy|cholecystectomy
485760|NCT01489436|minimally invasive|minimally invasive
485761|NCT01489436|surgical|surgical
485762|NCT01489436|laparoscopic|laparoscopic
485763|NCT01489436|single port|single port
485764|NCT01489436|cytokine|cytokine
485765|NCT01489423|stage IIIC melanoma|stage iiic melanoma
485766|NCT01489423|stage IV melanoma|stage iv melanoma
485767|NCT01489423|recurrent melanoma|recurrent melanoma
485768|NCT01489397|Confocol laser endomicroscopy|confocol laser endomicroscopy
485769|NCT01489397|Feasibility of Confocol laser endomicroscopy|feasibility of confocol laser endomicroscopy
485770|NCT01489384|Rheumatoid arthritis|rheumatoid arthritis
485771|NCT01489384|DAS28|das28
485772|NCT01489358|Vaccine-Mediated Protection|vaccine-mediated protection
485773|NCT01489358|Antibody Response|antibody response
485774|NCT01489358|Chikungunya Virus|chikungunya virus
485775|NCT01489358|Immune Response|immune response
485776|NCT01489358|Healthy Volunteer|healthy volunteer
485777|NCT01489358|Humoral Inmunity|humoral inmunity
485778|NCT01489358|Virus-like Particles|virus-like particles
485779|NCT01489345|ONO-2952|ono-2952
485780|NCT01489345|Healthy adult subjects|healthy adult subjects
485781|NCT01489345|Multiple dose|multiple dose
485782|NCT01489345|Safety|safety
485783|NCT01489345|Tolerability|tolerability
485784|NCT01489345|Pharmacokinetics|pharmacokinetics
485785|NCT01489332|rectal cancer|rectal cancer
485786|NCT01489332|capecitabine|capecitabine
485787|NCT01489332|radiotherapy|radiotherapy
485788|NCT01489332|locally advanced rectal cancer|locally advanced rectal cancer
485789|NCT01489319|inflammation|inflammation
485790|NCT01489319|body composition|body composition
485791|NCT01489319|hyperandrogenism|hyperandrogenism
485792|NCT01489319|insulin resistance|insulin resistance
485793|NCT01489306|Respiratory Syncytial Virus Infection|respiratory syncytial virus infection
485794|NCT01489306|RSV|rsv
485795|NCT01489280|Temple Touch Pro|temple touch pro
485796|NCT01489280|Medisim|medisim
485797|NCT01489280|temperature|temperature
485798|NCT01489280|surgery|surgery
485799|NCT01489267|cerebellar ataxia|cerebellar ataxia
485800|NCT01489267|hereditary disease|hereditary disease
485801|NCT01489267|stem cell|stem cell
485802|NCT01489254|Multiple Sclerosis,|multiple sclerosis,
485803|NCT01489254|Relapsing-Remitting Multiple Sclerosis,|relapsing-remitting multiple sclerosis,
485804|NCT01489254|glatiramer acetate,|glatiramer acetate,
485806|NCT01489254|lesions,|lesions,
485807|NCT01489254|MS relapse rate,|ms relapse rate,
485808|NCT01489254|Copaxone|copaxone
485809|NCT01489241|Pulmonary Disease, Chronic Obstructive|pulmonary disease, chronic obstructive
485810|NCT01489241|Telemedicine|telemedicine
485811|NCT01489228|Chagas Disease|chagas disease
485812|NCT01489202|drug-eluting stent|drug-eluting stent
485813|NCT01489202|percutaneous coronary intervention|percutaneous coronary intervention
485814|NCT01489176|Stress Echocardiography|stress echocardiography
485815|NCT01489176|Real-Time Perfusion Imaging|real-time perfusion imaging
485816|NCT01489176|Regadenoson|regadenoson
485817|NCT01489176|Optison|optison
485818|NCT01489163|Gestational Diabetes|gestational diabetes
485819|NCT01489163|Weight Loss|weight loss
485820|NCT01489163|Physical Activity|physical activity
485821|NCT01489163|Pregnancy|pregnancy
485822|NCT01489163|Postpartum|postpartum
485823|NCT01489163|Intervention|intervention
485824|NCT01489150|Acute respiratory failure|acute respiratory failure
485825|NCT01489150|Hypercapnia|hypercapnia
485826|NCT01489150|Non invasive ventilation|non invasive ventilation
485827|NCT01489150|End-tidal CO2|end-tidal co2
485828|NCT01489124|Infection|infection
485829|NCT01489124|Imipenem|imipenem
485830|NCT01489124|Ventilator-Associated Pneumonia|ventilator-associated pneumonia
485831|NCT01489124|pharmacokinetic|pharmacokinetic
485832|NCT01489124|pharmacodynamic|pharmacodynamic
485833|NCT01489098|Body composition|body composition
485834|NCT01489098|Protein Metabolism|protein metabolism
485835|NCT01489085|ventilation|ventilation
485836|NCT01489085|automated|automated
485837|NCT01489033|Allergic rhinitis|allergic rhinitis
485838|NCT01489033|Phleum pratense|phleum pratense
485839|NCT01489033|Timothy grass pollen allergy|timothy grass pollen allergy
485840|NCT01489033|subcutaneous immunotherapy|subcutaneous immunotherapy
485841|NCT01489020|Allergy|allergy
485842|NCT01489020|Immunotherapy|immunotherapy
485843|NCT01489020|Allergic Rhinoconjunctivitis|allergic rhinoconjunctivitis
485844|NCT01489020|D. pteronyssinus|d. pteronyssinus
485845|NCT01489020|house dust allergy|house dust allergy
485846|NCT01489007|vegetarian|vegetarian
485847|NCT01489007|children|children
485848|NCT01489007|iron|iron
485849|NCT01489007|iron absorption|iron absorption
485850|NCT01488981|Radio Frequency Microstimulator|radio frequency microstimulator
485851|NCT01488981|Traumatic Brain Injury|traumatic brain injury
485852|NCT01488981|TBI|tbi
485853|NCT01488981|Arm Rehabilitation|arm rehabilitation
485854|NCT01488981|electrical stimulation|electrical stimulation
485855|NCT01488981|FES|fes
485856|NCT01488968|high risk prostate cancer|high risk prostate cancer
485857|NCT01488968|hypofractionated radiation treatment|hypofractionated radiation treatment
485858|NCT01488968|higher biological doses|higher biological doses
485859|NCT01488968|acceptable rectal toxicity|acceptable rectal toxicity
485860|NCT01488968|Radiation Treatment|radiation treatment
485861|NCT01488955|bacterial infection|bacterial infection
485862|NCT01488942|HIV|hiv
485863|NCT01488942|reinforcement|reinforcement
485864|NCT01488942|medication adherence|medication adherence
485865|NCT01488942|patient compliance|patient compliance
485866|NCT01488942|antiretroviral therapy, highly active|antiretroviral therapy, highly active
485867|NCT01488916|Vitamin D|vitamin d
485868|NCT01488916|Postprandial Glucose|postprandial glucose
619213|NCT00944307|HIV|hiv
485869|NCT01488916|Type 2 Diabetes|type 2 diabetes
485870|NCT01488903|genetic susceptibility|genetic susceptibility
485871|NCT01488903|obesity|obesity
485872|NCT01488903|body composition|body composition
485873|NCT01488903|the metabolic syndrome|the metabolic syndrome
485874|NCT01488903|women|women
485875|NCT01488890|Dengue fever|dengue fever
485876|NCT01488890|Dengue Hemorrhagic Fever|dengue hemorrhagic fever
485877|NCT01488890|CYD dengue vaccine|cyd dengue vaccine
485878|NCT01488890|Yellow Fever|yellow fever
485879|NCT01488890|Flavivirus|flavivirus
485880|NCT01488877|Type 2 diabetes mellitus. albuminuria.|type 2 diabetes mellitus. albuminuria.
485881|NCT01488864|Hot flashes|hot flashes
485882|NCT01488864|Vasomotor symptoms|vasomotor symptoms
485883|NCT01488864|Menopause|menopause
485884|NCT01488864|Applied Relaxation|applied relaxation
485885|NCT01488864|Health Related Quality of Life|health related quality of life
485886|NCT01488864|Salivary cortisol|salivary cortisol
485887|NCT01488851|Osteo necrosis of the Jaw|osteo necrosis of the jaw
485888|NCT01488812|Hip-fracture|hip-fracture
485889|NCT01488799|Anxiety|anxiety
485890|NCT01488799|Generalized Anxiety Disorder|generalized anxiety disorder
485891|NCT01488799|Motivational Interviewing|motivational interviewing
485892|NCT01488799|Cognitive Behavioural Therapy|cognitive behavioural therapy
485893|NCT01488799|Psychotherapy|psychotherapy
485894|NCT01488786|Assistive Technology|assistive technology
485895|NCT01488786|Non-Surgical Visual Prosthetic|non-surgical visual prosthetic
485896|NCT01488786|Sensory Substitution|sensory substitution
485897|NCT01488773|asthma|asthma
485898|NCT01488773|asthma control|asthma control
485899|NCT01488773|inhaled glucocorticosteroid|inhaled glucocorticosteroid
485900|NCT01488773|ICS|ics
485901|NCT01488773|leukotriene antagonist|leukotriene antagonist
485902|NCT01488773|LTRA|ltra
485903|NCT01488773|montelukast|montelukast
485904|NCT01488773|fluticasone|fluticasone
485905|NCT01488773|salmeterol|salmeterol
485906|NCT01488773|observational study|observational study
485907|NCT01488773|repeated measures|repeated measures
485908|NCT01488773|retrospective|retrospective
485909|NCT01488747|Omega-3 fatty acids|omega-3 fatty acids
485910|NCT01488747|Phospholipid fatty acids|phospholipid fatty acids
485911|NCT01488747|chymlomicron fatty acids|chymlomicron fatty acids
485912|NCT01488747|Bioavailability fo fish oil supplements in healthy adults|bioavailability fo fish oil supplements in healthy adults
485913|NCT01488734|Vitamin D|vitamin d
485914|NCT01488734|Mushroom|mushroom
485915|NCT01488734|Cholecalciferol|cholecalciferol
485916|NCT01488734|Prediabetes|prediabetes
485917|NCT01488734|Metabolic Syndrome|metabolic syndrome
485918|NCT01488708|Lupus|lupus
485919|NCT01488708|SLE|sle
485920|NCT01488708|Systemic Lupus Erythematosus|systemic lupus erythematosus
485921|NCT01488708|Immune System Disease|immune system disease
485922|NCT01488695|intubation|intubation
485923|NCT01488695|double lumen tube|double lumen tube
485924|NCT01488682|Head and neck cancer|head and neck cancer
485925|NCT01488682|Neck dissection|neck dissection
485926|NCT01488682|Harmonic scalpel|harmonic scalpel
485927|NCT01488669|head and neck neoplasms|head and neck neoplasms
485928|NCT01488669|neck dissection|neck dissection
485929|NCT01488669|robotics|robotics
485930|NCT01488656|Antioxidants|antioxidants
485931|NCT01488656|Dietary supplements|dietary supplements
485932|NCT01488656|Forced vital lung capacity|forced vital lung capacity
485933|NCT01488656|Exhaled nitric oxide|exhaled nitric oxide
485934|NCT01488656|Air pollution|air pollution
485935|NCT01488643|Bronchospasm|bronchospasm
485936|NCT01488643|Laparoscopic Gastrectomy|laparoscopic gastrectomy
485937|NCT01488643|Obesity|obesity
485938|NCT01488630|substance abuse|substance abuse
485939|NCT01488630|alcohol|alcohol
485940|NCT01488630|drug|drug
485941|NCT01488630|smoking|smoking
485942|NCT01488630|HIV screening|hiv screening
485943|NCT01488617|Surgery|surgery
485944|NCT01488617|Psychosocial Factors|psychosocial factors
485945|NCT01488617|Psychological Distress|psychological distress
485946|NCT01488617|Outcome Assessment (Health Care)|outcome assessment (health care)
485947|NCT01488578|Overactive Bladder|overactive bladder
485948|NCT01488578|Japanese|japanese
485949|NCT01488578|Tolterodine|tolterodine
485950|NCT01488578|Detrusitol|detrusitol
485951|NCT01488578|Detrol|detrol
485952|NCT01488578|Postmarketing commitment plan.|postmarketing commitment plan.
485953|NCT01488552|pancreatic cancer|pancreatic cancer
485954|NCT01488552|pancreatic adenocarcinoma|pancreatic adenocarcinoma
485955|NCT01488552|Stage IV pancreatic cancer|stage iv pancreatic cancer
485956|NCT01488552|pancreas|pancreas
485957|NCT01488552|pancreatic|pancreatic
485958|NCT01488539|Stress Disorders, Post-Traumatic|stress disorders, post-traumatic
485959|NCT01488539|PTSD|ptsd
485960|NCT01488539|Adult Survivors of Child Abuse|adult survivors of child abuse
485961|NCT01488539|Women|women
485962|NCT01488539|Interpersonal violence|interpersonal violence
485963|NCT01488539|psychological trauma|psychological trauma
485964|NCT01488526|Hepatitis B|hepatitis b
485965|NCT01488526|Vertical transmission|vertical transmission
485966|NCT01488526|Pregnancy|pregnancy
485967|NCT01488526|Antiviral treatment|antiviral treatment
485968|NCT01488513|ABC294640|abc294640
485969|NCT01488513|RedHill Biopharma, Ltd.|redhill biopharma, ltd.
485970|NCT01488513|ABC-101|abc-101
485971|NCT01488513|Medical University of South Carolina|medical university of south carolina
485972|NCT01488513|Apogee Biotechnology Corporation|apogee biotechnology corporation
485973|NCT01488500|Wood smoke|wood smoke
485974|NCT01488500|inflammation|inflammation
485975|NCT01488500|lung function|lung function
485976|NCT01488500|arterial stiffness|arterial stiffness
485977|NCT01488500|heart rate variability|heart rate variability
485978|NCT01488500|Respiratory and systemic inflammation following exposure to woodsmoke in healthy volunteers|respiratory and systemic inflammation following exposure to woodsmoke in healthy volunteers
485979|NCT01488487|HCC|hcc
485980|NCT01488487|Advanced Hepatocellular Carcinoma|advanced hepatocellular carcinoma
485981|NCT01488487|Metastatic Hepatocellular Carcinoma|metastatic hepatocellular carcinoma
485982|NCT01488487|Liver Cancer|liver cancer
485983|NCT01488474|regional anesthesia|regional anesthesia
485984|NCT01488474|peripheral nerve stimulation|peripheral nerve stimulation
485985|NCT01488474|diabetes|diabetes
485986|NCT01488474|diabetic neuropathy|diabetic neuropathy
485987|NCT01488461|Congenital cerebellar ataxias|congenital cerebellar ataxias
485988|NCT01488461|Genetics|genetics
485989|NCT01488461|Gene ATCAY|gene atcay
485990|NCT01488461|Gene ABC7|gene abc7
485991|NCT01488461|Cerebellar atrophy|cerebellar atrophy
485992|NCT01488448|Hypertonic saline|hypertonic saline
485993|NCT01488448|Bronchiolitis|bronchiolitis
485994|NCT01488448|Infants|infants
485995|NCT01488448|Wheezing|wheezing
485996|NCT01488448|Nebulized|nebulized
485997|NCT01488448|Bronchodilator|bronchodilator
485998|NCT01488396|Cyclosporin|cyclosporin
485999|NCT01488396|Stevens-Johnson syndrome|stevens-johnson syndrome
486000|NCT01488396|Dry eye|dry eye
486001|NCT01488383|Hyperglycemia|hyperglycemia
486002|NCT01488383|Diabetes|diabetes
486003|NCT01488383|Blood glucose|blood glucose
486004|NCT01488383|Hypertension|hypertension
486005|NCT01488383|Anti hypertensive agents|anti hypertensive agents
486006|NCT01488383|Anti hypertensive drugs|anti hypertensive drugs
486007|NCT01488383|Anti hypertensive|anti hypertensive
486008|NCT01488370|breathing tube placement|breathing tube placement
486009|NCT01488357|Breast cancer|breast cancer
486010|NCT01488357|UNC|unc
486011|NCT01488357|Lineberger|lineberger
486012|NCT01488357|Breast Reconstruction|breast reconstruction
486013|NCT01488357|Mastectomy|mastectomy
486014|NCT01488318|Cetuximab|cetuximab
486015|NCT01488318|Dasatinib|dasatinib
486016|NCT01488318|Squamous Cell|squamous cell
486017|NCT01488318|Head and Neck|head and neck
486018|NCT01488318|After Cetuximab Containing Chemoradiotherapy|after cetuximab containing chemoradiotherapy
486019|NCT01488318|Recurrent|recurrent
486020|NCT01488318|Metastatic|metastatic
486021|NCT01488305|MNP|mnp
486022|NCT01488305|AAMA program|aama program
486023|NCT01488305|Nepal|nepal
486024|NCT01488305|HFP|hfp
486025|NCT01488305|IYCF|iycf
486026|NCT01488305|BCC|bcc
486027|NCT01488292|mental health|mental health
486028|NCT01488292|social skills|social skills
486029|NCT01488279|Pre-diabetes|pre-diabetes
486030|NCT01488279|Impaired fasting glucose|impaired fasting glucose
486031|NCT01488279|Impaired glucose tolerance|impaired glucose tolerance
486032|NCT01488279|Steroid-induced hyperglycemia|steroid-induced hyperglycemia
486033|NCT01488266|depression|depression
486034|NCT01488266|depressive|depressive
486035|NCT01488266|major|major
486036|NCT01488266|aripiprazole|aripiprazole
486037|NCT01488266|switching|switching
486038|NCT01488266|augmentation|augmentation
486039|NCT01488266|antidepressant|antidepressant
486040|NCT01488253|Hematopoietic stem cell transplantation|hematopoietic stem cell transplantation
486041|NCT01488253|Graft vs Host disease|graft vs host disease
486042|NCT01488253|Prevention|prevention
486043|NCT01488253|Sirolimus|sirolimus
486044|NCT01488253|Tacrolimus|tacrolimus
486045|NCT01488240|burn|burn
486046|NCT01488240|scar|scar
486047|NCT01488240|laser|laser
486048|NCT01488227|Vitamin D status in athletes|vitamin d status in athletes
486049|NCT01488227|Vitamin D|vitamin d
486050|NCT01488227|25(OH)D|25(oh)d
486051|NCT01488227|athletes|athletes
486052|NCT01488227|body composition|body composition
486053|NCT01488227|inflammatory markers|inflammatory markers
486054|NCT01488227|illness|illness
486055|NCT01488227|injury|injury
486056|NCT01488214|Systemic Sclerosis|systemic sclerosis
486057|NCT01488214|neuropsychiatric manifestations|neuropsychiatric manifestations
486058|NCT01488214|magnetic resonance imaging|magnetic resonance imaging
486059|NCT01488201|Psoriasis|psoriasis
486060|NCT01488188|Influenza vaccine|influenza vaccine
486061|NCT01488188|nasal route|nasal route
486062|NCT01488188|sublingual route|sublingual route
486063|NCT01488188|immunogenicity|immunogenicity
486064|NCT01488188|safety|safety
486065|NCT01488175|TKA|tka
486066|NCT01488175|RSA|rsa
486067|NCT01488175|Tourniquet|tourniquet
486068|NCT01488175|Arthroplasty|arthroplasty
486069|NCT01488175|Knee|knee
486070|NCT01488149|Fentanyl|fentanyl
486071|NCT01488149|Bupivacaine|bupivacaine
486072|NCT01488149|Nalbuphine|nalbuphine
486073|NCT01488136|Type 1 diabetes|type 1 diabetes
486074|NCT01488136|Hypoglycaemia|hypoglycaemia
486075|NCT01488136|Diazoxide|diazoxide
486076|NCT01488123|Breast, Cancer, Survivorship, Integrative, Complementary|breast, cancer, survivorship, integrative, complementary
486077|NCT01488097|Enzyme replacement therapy (ERT)|enzyme replacement therapy (ert)
486078|NCT01488097|Lysosomal storage disease|lysosomal storage disease
486079|NCT01488097|Late onset lysosomal acid lipase (LAL) deficiency|late onset lysosomal acid lipase (lal) deficiency
486080|NCT01488097|Acid cholesteryl ester hydrolase deficiency, type 2|acid cholesteryl ester hydrolase deficiency, type 2
486081|NCT01488097|Acid lipase disease|acid lipase disease
486082|NCT01488097|Cholesterol ester hydrolase deficiency|cholesterol ester hydrolase deficiency
486083|NCT01488097|LAL deficiency|lal deficiency
486084|NCT01488097|LIPA enzyme deficiency|lipa enzyme deficiency
486085|NCT01488084|Saphenous vein graft patency|saphenous vein graft patency
486086|NCT01488084|Coronary artery bypass surgery|coronary artery bypass surgery
486087|NCT01488084|Coronary artery disease|coronary artery disease
486088|NCT01488071|Depression|depression
486089|NCT01488071|Multimodal antidepressant|multimodal antidepressant
486090|NCT01488045|Colonoscopy|colonoscopy
486091|NCT01488045|Propofol|propofol
486092|NCT01488045|Cancer Screening|cancer screening
486093|NCT01488006|Primary Glenohumeral Osteoarthritis|primary glenohumeral osteoarthritis
486094|NCT01488006|Total shoulder arthroplasty|total shoulder arthroplasty
486095|NCT01488006|Total shoulder replacement|total shoulder replacement
486096|NCT01488006|Osteoarthritis|osteoarthritis
486097|NCT01488006|Multicenter study|multicenter study
486098|NCT01487993|Obesity|obesity
486099|NCT01487993|Children|children
486100|NCT01487993|Adolescents|adolescents
486101|NCT01487993|Metformin|metformin
486102|NCT01487993|Insulin resistance|insulin resistance
486103|NCT01487967|Attention Deficit Hyperactivity Disorder|attention deficit hyperactivity disorder
486104|NCT01487967|ADHD|adhd
486105|NCT01487967|Preferences|preferences
486106|NCT01487967|Goals|goals
486107|NCT01487967|Decision Making|decision making
486108|NCT01487954|skin reactions secondary to radiation therapy|skin reactions secondary to radiation therapy
486109|NCT01487928|breastfed|breastfed
486110|NCT01487928|human milk cream|human milk cream
486111|NCT01487928|human milk fat|human milk fat
486112|NCT01487928|caloric supplement|caloric supplement
486113|NCT01487915|Cisplatin-unfit condition|cisplatin-unfit condition
486114|NCT01487902|Chemotherapy-naive|chemotherapy-naive
486115|NCT01487876|DNA vaccine|dna vaccine
486116|NCT01487876|HBV|hbv
486117|NCT01487876|Chronic hepatitis B (CHB)|chronic hepatitis b (chb)
486118|NCT01487876|T-cell|t-cell
486119|NCT01487863|prostate cancer|prostate cancer
486120|NCT01487863|prostate|prostate
486121|NCT01487863|androgen independent prostate cancer (AIPC)|androgen independent prostate cancer (aipc)
486122|NCT01487863|androgen-independent|androgen-independent
486123|NCT01487863|androgen independent|androgen independent
486124|NCT01487863|hormone insensitive|hormone insensitive
486125|NCT01487863|hormone-insensitive|hormone-insensitive
486126|NCT01487863|prostate specific antigen (PSA)|prostate specific antigen (psa)
486127|NCT01487863|prostatic adenocarcinoma|prostatic adenocarcinoma
486128|NCT01487863|hormone-refractory|hormone-refractory
486129|NCT01487863|hormone refractory|hormone refractory
486130|NCT01487863|hormone refractory prostate cancer (HRPC)|hormone refractory prostate cancer (hrpc)
486131|NCT01487863|immune therapy|immune therapy
486132|NCT01487863|immunotherapy|immunotherapy
486133|NCT01487863|vaccine|vaccine
486134|NCT01487863|dendritic cells|dendritic cells
486135|NCT01487863|antigen-presenting cells|antigen-presenting cells
486136|NCT01487863|antigen presenting cells|antigen presenting cells
486137|NCT01487863|cancer vaccine|cancer vaccine
486138|NCT01487863|therapeutic vaccine|therapeutic vaccine
486139|NCT01487863|therapeutic cancer vaccine|therapeutic cancer vaccine
486140|NCT01487863|recombinant|recombinant
486141|NCT01487863|biological|biological
486142|NCT01487863|biopharmaceutical|biopharmaceutical
486143|NCT01487863|biotechnology|biotechnology
486144|NCT01487863|biotech|biotech
486145|NCT01487863|castration resistant prostate cancer (CRPC)|castration resistant prostate cancer (crpc)
486146|NCT01487863|castration-resistant prostate cancer (CRPC)|castration-resistant prostate cancer (crpc)
486147|NCT01487863|castration-resistance|castration-resistance
486148|NCT01487863|sipuleucel-T|sipuleucel-t
486149|NCT01487863|abiraterone|abiraterone
486150|NCT01487863|prednisone|prednisone
486151|NCT01487863|sequence|sequence
486152|NCT01487863|sequencing|sequencing
486153|NCT01487850|wind instruments|wind instruments
486154|NCT01487850|molds|molds
486155|NCT01487850|hypersensitivity pneumonitis|hypersensitivity pneumonitis
486156|NCT01487850|fungal contamination of wind instruments|fungal contamination of wind instruments
710738|NCT00588133|antifibrinolytic, bleeding, heart|antifibrinolytic, bleeding, heart
619628|NCT00942669|SAS|sas
486157|NCT01487850|specific antibodies against molds in musicians' sera|specific antibodies against molds in musicians' sera
486158|NCT01487850|musicians|musicians
486159|NCT01487837|Fibrinogen|fibrinogen
486160|NCT01487837|Blood coagulation disorders|blood coagulation disorders
486161|NCT01487837|Postoperative bleeding|postoperative bleeding
486162|NCT01487837|Transfusions|transfusions
486163|NCT01487785|metastatic pancreatic cancer|metastatic pancreatic cancer
486164|NCT01487785|LDE225|lde225
486165|NCT01487785|gemcitabine|gemcitabine
486166|NCT01487785|locally advanced|locally advanced
486167|NCT01487785|adenocarcinoma|adenocarcinoma
486168|NCT01487746|APLA|apla
486169|NCT01487746|APS|aps
486170|NCT01487746|Stroke|stroke
486171|NCT01487746|minor anti body|minor anti body
486172|NCT01487746|major anti body|major anti body
486173|NCT01487746|APLA antibodies in Serum|apla antibodies in serum
486174|NCT01487733|metastatic squamous neck cancer with occult primary squamous cell carcinoma|metastatic squamous neck cancer with occult primary squamous cell carcinoma
486175|NCT01487733|metastatic squamous neck cancer with occult primary|metastatic squamous neck cancer with occult primary
486176|NCT01487733|recurrent metastatic squamous neck cancer with occult primary|recurrent metastatic squamous neck cancer with occult primary
486177|NCT01487733|recurrent squamous cell carcinoma of the hypopharynx|recurrent squamous cell carcinoma of the hypopharynx
486178|NCT01487733|recurrent squamous cell carcinoma of the larynx|recurrent squamous cell carcinoma of the larynx
486179|NCT01487733|recurrent squamous cell carcinoma of the lip and oral cavity|recurrent squamous cell carcinoma of the lip and oral cavity
486180|NCT01487733|recurrent squamous cell carcinoma of the nasopharynx|recurrent squamous cell carcinoma of the nasopharynx
486181|NCT01487733|recurrent squamous cell carcinoma of the oropharynx|recurrent squamous cell carcinoma of the oropharynx
486182|NCT01487733|recurrent squamous cell carcinoma of the paranasal sinus and nasal cavity|recurrent squamous cell carcinoma of the paranasal sinus and nasal cavity
486183|NCT01487733|salivary gland squamous cell carcinoma|salivary gland squamous cell carcinoma
486369|NCT01487057|cardiovascular risk|cardiovascular risk
486184|NCT01487733|stage III squamous cell carcinoma of the hypopharynx|stage iii squamous cell carcinoma of the hypopharynx
486185|NCT01487733|stage III squamous cell carcinoma of the larynx|stage iii squamous cell carcinoma of the larynx
486186|NCT01487733|stage III squamous cell carcinoma of the lip and oral cavity|stage iii squamous cell carcinoma of the lip and oral cavity
486187|NCT01487733|stage III squamous cell carcinoma of the nasopharynx|stage iii squamous cell carcinoma of the nasopharynx
486188|NCT01487733|stage III squamous cell carcinoma of the oropharynx|stage iii squamous cell carcinoma of the oropharynx
486189|NCT01487733|stage III squamous cell carcinoma of the paranasal sinus and nasal cavity|stage iii squamous cell carcinoma of the paranasal sinus and nasal cavity
486190|NCT01487733|stage IV squamous cell carcinoma of the hypopharynx|stage iv squamous cell carcinoma of the hypopharynx
486191|NCT01487733|stage IVA squamous cell carcinoma of the larynx|stage iva squamous cell carcinoma of the larynx
486192|NCT01487733|stage IVA squamous cell carcinoma of the lip and oral cavity|stage iva squamous cell carcinoma of the lip and oral cavity
486193|NCT01487733|stage IVA squamous cell carcinoma of the oropharynx|stage iva squamous cell carcinoma of the oropharynx
486194|NCT01487733|stage IVA squamous cell carcinoma of the paranasal sinus and nasal cavity|stage iva squamous cell carcinoma of the paranasal sinus and nasal cavity
486195|NCT01487733|stage IVB squamous cell carcinoma of the larynx|stage ivb squamous cell carcinoma of the larynx
486196|NCT01487733|stage IVB squamous cell carcinoma of the lip and oral cavity|stage ivb squamous cell carcinoma of the lip and oral cavity
486197|NCT01487733|stage IVB squamous cell carcinoma of the oropharynx|stage ivb squamous cell carcinoma of the oropharynx
486198|NCT01487733|stage IVB squamous cell carcinoma of the paranasal sinus and nasal cavity|stage ivb squamous cell carcinoma of the paranasal sinus and nasal cavity
486199|NCT01487733|stage IVC squamous cell carcinoma of the larynx|stage ivc squamous cell carcinoma of the larynx
486200|NCT01487733|stage IVC squamous cell carcinoma of the lip and oral cavity|stage ivc squamous cell carcinoma of the lip and oral cavity
486201|NCT01487733|stage IVC squamous cell carcinoma of the oropharynx|stage ivc squamous cell carcinoma of the oropharynx
486202|NCT01487733|stage IVC squamous cell carcinoma of the paranasal sinus and nasal cavity|stage ivc squamous cell carcinoma of the paranasal sinus and nasal cavity
486203|NCT01487733|recurrent salivary gland cancer|recurrent salivary gland cancer
486204|NCT01487733|stage III salivary gland cancer|stage iii salivary gland cancer
486205|NCT01487733|stage IVA salivary gland cancer|stage iva salivary gland cancer
486206|NCT01487733|stage IVB salivary gland cancer|stage ivb salivary gland cancer
486207|NCT01487733|stage IVC salivary gland cancer|stage ivc salivary gland cancer
486208|NCT01487720|Castration-resistant prostate cancer|castration-resistant prostate cancer
486209|NCT01487720|Docetaxel-refractory status|docetaxel-refractory status
486210|NCT01487707|pregnancy|pregnancy
486211|NCT01487707|maternal mortality|maternal mortality
486212|NCT01487707|neonatal mortality|neonatal mortality
486213|NCT01487707|community intervention|community intervention
486214|NCT01487707|voluntary health worker|voluntary health worker
486215|NCT01487707|safe birth kit|safe birth kit
486216|NCT01487707|maternal child health|maternal child health
486217|NCT01487694|back cohosh|back cohosh
486218|NCT01487694|cimicifuga racemosa|cimicifuga racemosa
486219|NCT01487694|menopausal symptoms|menopausal symptoms
486220|NCT01487694|hot flashes|hot flashes
486221|NCT01487694|Kupperman index|kupperman index
486222|NCT01487694|MENQOL|menqol
486223|NCT01487668|chronic mental disorders|chronic mental disorders
486224|NCT01487668|cardiovascular disease|cardiovascular disease
486225|NCT01487668|behavior change|behavior change
486226|NCT01487655|Open-angle glaucoma|open-angle glaucoma
486227|NCT01487655|Low tension glaucoma|low tension glaucoma
486228|NCT01487655|Color Doppler Imaging|color doppler imaging
486229|NCT01487629|Diabetic Retinopathy|diabetic retinopathy
486230|NCT01487629|Macular Edema|macular edema
486231|NCT01487629|Bevacizumab|bevacizumab
486232|NCT01487629|Ranibizumab|ranibizumab
486233|NCT01487616|Mullerian anomalies|mullerian anomalies
486234|NCT01487616|Congenital uterine malformations or anomalies|congenital uterine malformations or anomalies
486235|NCT01487616|Arcuate|arcuate
486236|NCT01487616|Septate|septate
486237|NCT01487616|Subseptate|subseptate
486238|NCT01487616|Bicornuate|bicornuate
486239|NCT01487616|Unicornuate|unicornuate
486240|NCT01487616|Didelphys|didelphys
486241|NCT01487616|T-shaped|t-shaped
486242|NCT01487603|Patients|patients
486243|NCT01487603|undiagnosed enlarged|undiagnosed enlarged
486244|NCT01487603|lymph nodes|lymph nodes
486245|NCT01487590|pregnancy|pregnancy
486246|NCT01487590|breech|breech
486247|NCT01487590|acupuncture|acupuncture
486248|NCT01487590|moxibustion|moxibustion
486249|NCT01487590|version|version
486250|NCT01487577|Allogeneic blood and marrow transplantation (BMT)|allogeneic blood and marrow transplantation (bmt)
486251|NCT01487577|Graft versus host disease|graft versus host disease
486252|NCT01487577|Mycophenolate mofetil|mycophenolate mofetil
486253|NCT01487577|Pharmacokinetics|pharmacokinetics
486254|NCT01487564|Healthy volunteers|healthy volunteers
486255|NCT01487564|Pharmacokinetics|pharmacokinetics
486256|NCT01487564|OROS Hydromorphone|oros hydromorphone
486257|NCT01487564|Hydromorphone|hydromorphone
486258|NCT01487564|Taiwan|taiwan
486259|NCT01487564|UGT2B7 Gene|ugt2b7 gene
486260|NCT01487551|Systemic sclerosis|systemic sclerosis
486261|NCT01487551|Biomarkers|biomarkers
486262|NCT01487525|symptomatic knee osteoarthritis|symptomatic knee osteoarthritis
486370|NCT01487044|DME|dme
486263|NCT01487525|partial blood flow restriction|partial blood flow restriction
486264|NCT01487525|knee extensor strength|knee extensor strength
486265|NCT01487512|Healthy Volunteers|healthy volunteers
486266|NCT01487512|Dose Proportionality|dose proportionality
486267|NCT01487512|Pharmacokinetics|pharmacokinetics
486268|NCT01487512|OROS Hydromorphone|oros hydromorphone
486269|NCT01487512|Hydromorphone|hydromorphone
486270|NCT01487512|Taiwan|taiwan
486271|NCT01487486|Polycystic Ovary Syndrome|polycystic ovary syndrome
486272|NCT01487486|PCOS|pcos
486273|NCT01487486|Follicular Fluid|follicular fluid
486274|NCT01487486|Proteomics|proteomics
486275|NCT01487486|Glyco-proteomics|glyco-proteomics
486276|NCT01487473|Meditation|meditation
486277|NCT01487473|Mindfulness|mindfulness
486278|NCT01487473|Attention|attention
486279|NCT01487473|Chronic Pain|chronic pain
486280|NCT01487473|Depression|depression
486281|NCT01487473|Anxiety|anxiety
486282|NCT01487473|Stress|stress
486283|NCT01487473|Acceptance|acceptance
486284|NCT01487473|Pain intensity|pain intensity
486285|NCT01487473|Pain disability|pain disability
486286|NCT01487460|High cholesterol levels|high cholesterol levels
486287|NCT01487460|Hyperlipidemia|hyperlipidemia
486288|NCT01487460|High-density Lipoprotein|high-density lipoprotein
486289|NCT01487460|Low-density Lipoprotein|low-density lipoprotein
486290|NCT01487460|Simvastatin|simvastatin
486291|NCT01487434|Attendance|attendance
486292|NCT01487434|Truancy|truancy
486293|NCT01487434|Student engagement|student engagement
486294|NCT01487434|Mentoring|mentoring
486295|NCT01487434|Monitoring|monitoring
486296|NCT01487434|Case management|case management
486297|NCT01487395|Alzheimer|alzheimer
486298|NCT01487395|Donepezil|donepezil
486299|NCT01487395|biomarkers|biomarkers
486300|NCT01487395|battery|battery
486301|NCT01487395|cognition|cognition
486302|NCT01487395|imaging|imaging
486303|NCT01487395|neurophysiological|neurophysiological
486304|NCT01487356|Colonoscopy|colonoscopy
486305|NCT01487356|quality assurance|quality assurance
486306|NCT01487356|withdrawal time|withdrawal time
486307|NCT01487356|polyp detection rate|polyp detection rate
486308|NCT01487343|Oral Chemotherapy|oral chemotherapy
486309|NCT01487343|capecitabine|capecitabine
486310|NCT01487343|questionnaire|questionnaire
486311|NCT01487343|breast|breast
486312|NCT01487343|gastric|gastric
486313|NCT01487343|11-194|11-194
486314|NCT01487330|aortic stenosis|aortic stenosis
486315|NCT01487330|aortic valve stenosis|aortic valve stenosis
486316|NCT01487330|valvular heart disease|valvular heart disease
486317|NCT01487330|aortic valve replacement|aortic valve replacement
486318|NCT01487330|transcatheter aortic valve implantation|transcatheter aortic valve implantation
486319|NCT01487330|TAVI|tavi
486320|NCT01487330|TAVR|tavr
486321|NCT01487317|Delirium|delirium
486322|NCT01487317|acetylcholinesterase inhibitor|acetylcholinesterase inhibitor
486323|NCT01487317|Elderly|elderly
619822|NCT00941941|Hernia|hernia
486324|NCT01487317|Emergency department|emergency department
486325|NCT01487291|Thrombophilia tests|thrombophilia tests
486326|NCT01487291|Hypofibrinolysis|hypofibrinolysis
486327|NCT01487291|Fibrinolysis|fibrinolysis
486328|NCT01487278|postpartum hemorrhage|postpartum hemorrhage
486329|NCT01487278|prevention|prevention
486330|NCT01487278|misoprostol|misoprostol
486331|NCT01487278|Uniject|uniject
486332|NCT01487278|oxytocin|oxytocin
486333|NCT01487265|Erlotinib|erlotinib
486334|NCT01487265|BKM120|bkm120
486335|NCT01487265|NSCLC|nsclc
486336|NCT01487226|Cervical cancer|cervical cancer
486337|NCT01487213|Medical abortion|medical abortion
486338|NCT01487213|Termination of pregnancy|termination of pregnancy
486339|NCT01487213|Mifepristone|mifepristone
486340|NCT01487213|Misoprostol|misoprostol
486341|NCT01487213|Urine hCG|urine hcg
486342|NCT01487213|Follow Up|follow up
486343|NCT01487213|Termination of unwanted pregnancy. Self assessment (follow up) after medical abortion|termination of unwanted pregnancy. self assessment (follow up) after medical abortion
486344|NCT01487200|Osteoarthritis|osteoarthritis
486345|NCT01487200|Knee|knee
486346|NCT01487200|Steroid|steroid
486347|NCT01487200|intra-articular|intra-articular
486348|NCT01487200|injection|injection
486349|NCT01487187|Cord-milking|cord-milking
486350|NCT01487187|hemodynamic|hemodynamic
486351|NCT01487187|preterm infants|preterm infants
486352|NCT01487161|osteoarthritis|osteoarthritis
486353|NCT01487161|knee|knee
486354|NCT01487161|pain|pain
486355|NCT01487161|corticosteroid|corticosteroid
486356|NCT01487161|intra-articular|intra-articular
486357|NCT01487161|injection|injection
486358|NCT01487135|Thorough QT (TQT)|thorough qt (tqt)
486359|NCT01487135|EVP-6124|evp-6124
486360|NCT01487122|Diathermy|diathermy
486361|NCT01487122|Neck Pain|neck pain
486362|NCT01487109|Type 2 diabetes|type 2 diabetes
486363|NCT01487109|chronic kidney disease|chronic kidney disease
486364|NCT01487083|schizophrenia|schizophrenia
486365|NCT01487083|LY2140023|ly2140023
486366|NCT01487083|pomaglumetad methionil|pomaglumetad methionil
486367|NCT01487057|thyroid cancer|thyroid cancer
486368|NCT01487057|dislipidemia|dislipidemia
486371|NCT01487031|Autologous Stem Cell Transplantation|autologous stem cell transplantation
486372|NCT01487031|multiple myeloma|multiple myeloma
486373|NCT01487031|non-Hodgkin|non-hodgkin
486374|NCT01487031|Hodgkin lymphoma|hodgkin lymphoma
486375|NCT01487031|Music Therapy|music therapy
486376|NCT01487031|Nausea|nausea
486377|NCT01487031|Pain|pain
486378|NCT01487018|Zygomatic Fractures|zygomatic fractures
486379|NCT01487018|Surgery, Computer-Assisted|surgery, computer-assisted
486380|NCT01487018|Facial Asymmetry|facial asymmetry
486381|NCT01487005|ozone|ozone
486382|NCT01487005|air pollution|air pollution
486383|NCT01487005|vascular function|vascular function
486384|NCT01487005|cardiac function|cardiac function
486385|NCT01487005|inflammation|inflammation
486386|NCT01486953|respiratory resistance|respiratory resistance
486387|NCT01486953|lung compliance|lung compliance
486388|NCT01486953|desflurane|desflurane
486389|NCT01486953|sevoflurane|sevoflurane
486390|NCT01486836|Cardiac disease (ICD indication)|cardiac disease (icd indication)
486391|NCT01486810|cocaine|cocaine
486392|NCT01486810|lisdexamfetamine|lisdexamfetamine
486393|NCT01486797|Relapsed Chronic Lymphocytic Leukemia (CLL)|relapsed chronic lymphocytic leukemia (cll)
486394|NCT01486797|NOX-A12|nox-a12
486395|NCT01486797|Bendamustine|bendamustine
486396|NCT01486797|Rituximab|rituximab
486397|NCT01486797|Spiegelmer|spiegelmer
486398|NCT01486797|Chemosensitization|chemosensitization
486399|NCT01486797|Stromal cell-derived factor-1 (SDF-1)|stromal cell-derived factor-1 (sdf-1)
486400|NCT01486797|CXCL12|cxcl12
486401|NCT01486784|equal to or greater than age 60 years|equal to or greater than age 60 years
486402|NCT01486784|non-M3 AML|non-m3 aml
486403|NCT01486784|relapsed disease|relapsed disease
486404|NCT01486784|primary refractory disease|primary refractory disease
486405|NCT01486784|not appropriate or willing candidates for aggressive therapy|not appropriate or willing candidates for aggressive therapy
486407|NCT01486771|Proliferative Diabetic Retinopathy|proliferative diabetic retinopathy
486408|NCT01486732|Cerebral Palsy|cerebral palsy
486409|NCT01486732|Umbilical Cord Blood|umbilical cord blood
486410|NCT01486732|FLT-PET|flt-pet
486411|NCT01486719|Finger pulp reconstruction|finger pulp reconstruction
486412|NCT01486719|dorsal branch|dorsal branch
486413|NCT01486719|proper digital nerve|proper digital nerve
486414|NCT01486719|palmar arterial arch|palmar arterial arch
486415|NCT01486719|dorsal digital island flap|dorsal digital island flap
486416|NCT01486706|Overactive Bladder|overactive bladder
486417|NCT01486706|Gabapentin|gabapentin
486418|NCT01486706|Quality of Life|quality of life
486419|NCT01486706|Urodynamic|urodynamic
486420|NCT01486706|safety|safety
486421|NCT01486706|Efficacy|efficacy
486422|NCT01486693|cytomegalovirus|cytomegalovirus
486423|NCT01486693|uveitis|uveitis
486424|NCT01486680|Gastric bypass|gastric bypass
486425|NCT01486680|Silastic ring gastric bypass|silastic ring gastric bypass
486426|NCT01486680|Roux-en-Y gastric bypass|roux-en-y gastric bypass
486427|NCT01486680|Sleeve gastrectomy|sleeve gastrectomy
486428|NCT01486680|Body composition analysis|body composition analysis
486429|NCT01486667|focus of study instead|focus of study instead
486430|NCT01486654|Cortical stimulation|cortical stimulation
486431|NCT01486654|Ischemic Stroke|ischemic stroke
486432|NCT01486654|Aphasia|aphasia
486433|NCT01486654|Speech and Language Rehabilitation|speech and language rehabilitation
486434|NCT01486641|femoral neck fracture|femoral neck fracture
486435|NCT01486641|arthroplasty|arthroplasty
486436|NCT01486641|surgical approach|surgical approach
486437|NCT01486641|anterolateral|anterolateral
486438|NCT01486641|posterolateral|posterolateral
486439|NCT01486615|premedication|premedication
486440|NCT01486615|premedicants|premedicants
486441|NCT01486615|preoperative anxiety|preoperative anxiety
486442|NCT01486615|melatonin|melatonin
486443|NCT01486615|alprazolam|alprazolam
486444|NCT01486602|stage IIIA non-small cell lung cancer|stage iiia non-small cell lung cancer
486445|NCT01486602|stage IIIB non-small cell lung cancer|stage iiib non-small cell lung cancer
486446|NCT01486589|emergency care|emergency care
486447|NCT01486589|cardiac autonomic function|cardiac autonomic function
486448|NCT01486589|deceleration capacity|deceleration capacity
486449|NCT01486537|samples|samples
486450|NCT01486537|children|children
486451|NCT01486537|the age group 3-13 years|the age group 3-13 years
486452|NCT01486524|pharmacogenomic biomarker|pharmacogenomic biomarker
486453|NCT01486524|predictive marker|predictive marker
486454|NCT01486524|prospective-retrospective|prospective-retrospective
486455|NCT01486524|propensity score|propensity score
486456|NCT01486524|matched-patients trial|matched-patients trial
486457|NCT01486511|Liver disease|liver disease
486458|NCT01486511|Pulmonary embolism|pulmonary embolism
486459|NCT01486511|Thrombophilia|thrombophilia
486460|NCT01486511|Death|death
486461|NCT01486485|renal replacement therapy|renal replacement therapy
486462|NCT01486472|Adjuvant chemotherapy|adjuvant chemotherapy
486463|NCT01486446|IEM|iem
486464|NCT01486446|EM|em
486465|NCT01486446|Erythromelalgia|erythromelalgia
486466|NCT01486446|Erythermalgia|erythermalgia
486467|NCT01486446|Red neuralgia|red neuralgia
486468|NCT01486446|Peripheral Vascular Disease|peripheral vascular disease
486469|NCT01486446|Vascular Disease|vascular disease
486470|NCT01486446|Cardiovascular Disease|cardiovascular disease
486471|NCT01486433|eicosapentaenoic acid|eicosapentaenoic acid
486472|NCT01486433|docosapentaenoic acid|docosapentaenoic acid
486473|NCT01486433|arachidonic acid|arachidonic acid
486474|NCT01486433|hypertriglyceridemia|hypertriglyceridemia
486475|NCT01486433|simvastatin|simvastatin
486476|NCT01486420|Quinell grade|quinell grade
486477|NCT01486420|Open surgery|open surgery
486478|NCT01486420|corticosteroid injections|corticosteroid injections
486479|NCT01486420|randomized controlled trial|randomized controlled trial
486480|NCT01486420|Trigger finger|trigger finger
486481|NCT01486407|Airway management|airway management
486482|NCT01486355|Mortality|mortality
486483|NCT01486355|Morbidity|morbidity
486484|NCT01486355|Hospitalisations/consultations|hospitalisations/consultations
486485|NCT01486355|Growth|growth
486486|NCT01486355|Measles infection|measles infection
486487|NCT01486329|Pancreatic cancer|pancreatic cancer
486488|NCT01486329|Cancer vaccine|cancer vaccine
486489|NCT01486329|Gemcitabine|gemcitabine
486490|NCT01486329|Inoperable|inoperable
486491|NCT01486329|Gemcitabine chemotherapy|gemcitabine chemotherapy
486492|NCT01486329|Locally advanced|locally advanced
486493|NCT01486303|Facial Cosmetic acupuncture|facial cosmetic acupuncture
486494|NCT01486303|Skin Rejuvenation|skin rejuvenation
486495|NCT01486303|Skin Aging|skin aging
486496|NCT01486290|Intervention|intervention
486497|NCT01486290|Cost Effective|cost effective
486498|NCT01486290|Elderly|elderly
486499|NCT01486290|Glycemic Control|glycemic control
486500|NCT01486277|Lymphoma, T-Cell, Cutaneous|lymphoma, t-cell, cutaneous
486501|NCT01486277|T-cell lymphoma|t-cell lymphoma
486502|NCT01486277|Lymphoma|lymphoma
486503|NCT01486277|Histone Deacetylase Inhibitor|histone deacetylase inhibitor
486504|NCT01486277|JNJ-26481585|jnj-26481585
486505|NCT01486238|Diabetic Macular Edema|diabetic macular edema
486506|NCT01486212|Ischemia-reperfusion injury|ischemia-reperfusion injury
486507|NCT01486212|Oxidative markers|oxidative markers
486508|NCT01486212|Inflammatory markers|inflammatory markers
486509|NCT01486199|cystic fibrosis|cystic fibrosis
486510|NCT01486199|mucociliary clearance|mucociliary clearance
486511|NCT01486199|airway surface liquid|airway surface liquid
486512|NCT01486199|nuclear medicine|nuclear medicine
486513|NCT01486186|Pulmonary Disease, Chronic Obstructive|pulmonary disease, chronic obstructive
486514|NCT01486186|Double-Blind Method|double-blind method
486515|NCT01486186|Medicine, Chinese Traditional|medicine, chinese traditional
486516|NCT01486186|Humans|humans
486517|NCT01486186|Treatment Outcome|treatment outcome
486518|NCT01486173|PUFA|pufa
486519|NCT01486173|Iron|iron
486520|NCT01486173|Neurological development|neurological development
486521|NCT01486173|Premature infant|premature infant
486522|NCT01486147|Food labeling|food labeling
486523|NCT01486147|Nutrition|nutrition
486524|NCT01486147|Memory|memory
486525|NCT01486147|Diet|diet
486526|NCT01486134|Hepatocellular carcinoma|hepatocellular carcinoma
486527|NCT01486134|Radiofrequency ablation|radiofrequency ablation
486528|NCT01486134|Multipolar mode|multipolar mode
486529|NCT01486134|Recurrence|recurrence
486530|NCT01486134|Cirrhosis|cirrhosis
486531|NCT01486134|MR temperature monitoring|mr temperature monitoring
486532|NCT01486134|large tumor|large tumor
486533|NCT01486121|Surgery|surgery
486534|NCT01486121|Critical illness|critical illness
486535|NCT01486121|Mechanical ventilation|mechanical ventilation
486536|NCT01486121|Organ dysfunction syndrome|organ dysfunction syndrome
486537|NCT01486121|Intensive Care Units Sedation|intensive care units sedation
486538|NCT01486121|Analgesia|analgesia
486539|NCT01486121|Treatment protocol|treatment protocol
486540|NCT01486121|Nursing protocol|nursing protocol
486541|NCT01486121|Outcome|outcome
486542|NCT01486121|Pain|pain
486543|NCT01486121|Neurological disorders|neurological disorders
486544|NCT01486121|Delirium|delirium
486545|NCT01486121|Muscular weakness|muscular weakness
486546|NCT01486121|Psychological disorders|psychological disorders
486547|NCT01486121|Anxiety|anxiety
486548|NCT01486121|Depression|depression
486549|NCT01486121|Stress disorders|stress disorders
486550|NCT01486121|Post-Traumatic|post-traumatic
486551|NCT01486108|tonic, burst and placebo stimulation|tonic, burst and placebo stimulation
486552|NCT01486082|OCA 10|oca 10
486553|NCT01486082|Antibiogram|antibiogram
486554|NCT01486082|Eradication|eradication
486555|NCT01486069|Dentofacial Deformity|dentofacial deformity
486556|NCT01486069|Orthognathic Surgery|orthognathic surgery
486557|NCT01486069|Mandible|mandible
486558|NCT01486069|Orthognathic Surgical Procedures|orthognathic surgical procedures
486559|NCT01486056|epilepsy|epilepsy
486561|NCT01486056|device placement|device placement
486562|NCT01486043|Induction chemotherapy|induction chemotherapy
486563|NCT01486043|Transient hyperglycemia|transient hyperglycemia
486564|NCT01486043|Metformin|metformin
486565|NCT01486043|Acute lymphoblastic leukemia|acute lymphoblastic leukemia
486566|NCT01486043|Insulin resistance|insulin resistance
486567|NCT01486043|Hyperglycemia|hyperglycemia
486568|NCT01486043|Insulin|insulin
486569|NCT01486030|Atherosclerosis|atherosclerosis
486570|NCT01486030|Corus CAD|corus cad
486571|NCT01486030|Age/Sex/Gene Expression Score|age/sex/gene expression score
486572|NCT01486030|ASGES|asges
486573|NCT01486030|Gene Expression|gene expression
486574|NCT01486030|GES|ges
486575|NCT01486030|CAD|cad
486576|NCT01486030|CVD|cvd
486577|NCT01486030|CHD|chd
486578|NCT01486030|Precision Medicine|precision medicine
486579|NCT01486030|Exercise Stress Test|exercise stress test
486580|NCT01486030|Coronary Artery Disease|coronary artery disease
486581|NCT01486030|Angina Pectoris|angina pectoris
486582|NCT01486030|Chest Pain|chest pain
486583|NCT01486030|Cardiovascular Disease|cardiovascular disease
486584|NCT01486030|Coronary Heart Disease|coronary heart disease
486585|NCT01486030|EXERCISE|exercise
486586|NCT01486017|ASP015K|asp015k
486587|NCT01486017|healthy subjects|healthy subjects
486588|NCT01486017|bioavailability|bioavailability
486589|NCT01486017|rheumatoid arthritis|rheumatoid arthritis
486590|NCT01486017|psoriasis|psoriasis
486591|NCT01486017|transplantation|transplantation
486592|NCT01486004|Hepatitis C Virus|hepatitis c virus
486593|NCT01486004|TMC435|tmc435
486594|NCT01486004|TMC435-TiDP16-C124|tmc435-tidp16-c124
486595|NCT01486004|TMC435-C124|tmc435-c124
486596|NCT01486004|HCV|hcv
486597|NCT01486004|Hepatitis C|hepatitis c
486598|NCT01486004|Hep C|hep c
486599|NCT01486004|Healthy participants|healthy participants
486600|NCT01485991|Hepatitis C|hepatitis c
486601|NCT01485991|TMC435HPC3001|tmc435hpc3001
486602|NCT01485991|TMC435|tmc435
486603|NCT01485991|Hepatitis C Virus (HCV)|hepatitis c virus (hcv)
486604|NCT01485991|HEP C|hep c
486605|NCT01485991|Genotype 1|genotype 1
486606|NCT01485991|Treatment experienced|treatment experienced
486607|NCT01485991|Null responders|null responders
486608|NCT01485991|Partial responders|partial responders
486609|NCT01485978|Alport Syndrome|alport syndrome
486610|NCT01485978|chronic kidney disease|chronic kidney disease
486611|NCT01485978|renal fibrosis|renal fibrosis
486612|NCT01485978|nephroprotection|nephroprotection
486613|NCT01485978|pediatric study|pediatric study
486614|NCT01485965|Huntington Disease|huntington disease
486615|NCT01485965|Basal Ganglia Diseases|basal ganglia diseases
486616|NCT01485965|Brain Diseases|brain diseases
486617|NCT01485965|Central Nervous System Diseases|central nervous system diseases
486618|NCT01485965|Nervous System Diseases|nervous system diseases
486619|NCT01485965|Dementia|dementia
486620|NCT01485965|Chorea|chorea
486621|NCT01485965|Dyskinesias|dyskinesias
486622|NCT01485965|Movement Disorders|movement disorders
710739|NCT00588120|Hyperoxaluria|hyperoxaluria
486623|NCT01485965|Heredodegenerative Disorders, Nervous System|heredodegenerative disorders, nervous system
486624|NCT01485965|Neurodegenerative Diseases|neurodegenerative diseases
486625|NCT01485965|Genetic Diseases, Inborn|genetic diseases, inborn
486626|NCT01485965|Cognition Disorders|cognition disorders
486627|NCT01485965|Mental Disorders|mental disorders
486628|NCT01485952|Huntington Disease|huntington disease
486629|NCT01485952|Basal Ganglia Diseases|basal ganglia diseases
486630|NCT01485952|Brain Diseases|brain diseases
486631|NCT01485952|Central Nervous System Diseases|central nervous system diseases
486632|NCT01485952|Nervous System Diseases|nervous system diseases
486633|NCT01485952|Dementia|dementia
486634|NCT01485952|Chorea|chorea
486635|NCT01485952|Dyskinesias|dyskinesias
486636|NCT01485952|Movement Disorders|movement disorders
486637|NCT01485952|Heredodegenerative Disorders, Nervous System|heredodegenerative disorders, nervous system
486638|NCT01485952|Neurodegenerative Diseases|neurodegenerative diseases
486639|NCT01485952|Genetic Diseases, Inborn|genetic diseases, inborn
486640|NCT01485952|Cognition Disorders|cognition disorders
486641|NCT01485952|Mental Disorders|mental disorders
486642|NCT01485939|lidocaine patch|lidocaine patch
486643|NCT01485939|laparoscopic cholecystectomy|laparoscopic cholecystectomy
486644|NCT01485913|Education|education
486645|NCT01485913|Diabetes|diabetes
486646|NCT01485913|Prevention complications|prevention complications
486647|NCT01485913|Prevention of complications of diabetes|prevention of complications of diabetes
486648|NCT01485887|Venlafaxine ER|venlafaxine er
486649|NCT01485887|long-term extension|long-term extension
486650|NCT01485887|Japan|japan
486651|NCT01485874|BIBF 1120|bibf 1120
486652|NCT01485835|Multiple Myeloma|multiple myeloma
486653|NCT01485835|Bortezomib|bortezomib
486654|NCT01485835|Velcade|velcade
486655|NCT01485835|Ganetespib|ganetespib
486656|NCT01485822|Glaucoma|glaucoma
486657|NCT01485822|Travatan|travatan
486658|NCT01485822|Trabeculectomy|trabeculectomy
486659|NCT01485796|PIDD|pidd
486660|NCT01485783|Hypertension|hypertension
486661|NCT01485757|patients|patients
486662|NCT01485744|metastatic|metastatic
486663|NCT01485744|untreated|untreated
486664|NCT01485744|advanced|advanced
486665|NCT01485731|Cervical|cervical
486666|NCT01485731|Cancer|cancer
486667|NCT01485731|Uterine Cervix|uterine cervix
486668|NCT01485731|Squamous Cell|squamous cell
486669|NCT01485731|Adenocarcinoma|adenocarcinoma
486670|NCT01485718|Obesity|obesity
486671|NCT01485718|Overweight|overweight
486672|NCT01485718|Weight loss|weight loss
486673|NCT01485705|severe bacterial infection|severe bacterial infection
486674|NCT01485692|Violence|violence
486675|NCT01485692|Aggression|aggression
486676|NCT01485692|Psychiatric emergencies|psychiatric emergencies
486677|NCT01485692|Psychomotor agitation|psychomotor agitation
486678|NCT01485692|Violent patient|violent patient
486679|NCT01485679|18 fluoro deoxy glucose positrons emission tomography combined with computed tomography,|18 fluoro deoxy glucose positrons emission tomography combined with computed tomography,
486680|NCT01485679|Patients with intraductal papillary mucinous tumor of the pancreas|patients with intraductal papillary mucinous tumor of the pancreas
486681|NCT01485679|intraductal papillary mucinous|intraductal papillary mucinous
486682|NCT01485679|pancreas|pancreas
486683|NCT01485666|Thoratec|thoratec
486684|NCT01485666|HeartMate II|heartmate ii
486685|NCT01485666|heart-assist devices|heart-assist devices
486686|NCT01485666|driveline or percutaneous lead management|driveline or percutaneous lead management
486687|NCT01485666|HeartMate II Percutaneous Lead Management|heartmate ii percutaneous lead management
486688|NCT01485653|Brachial Plexus|brachial plexus
486689|NCT01485653|Mepivacaine|mepivacaine
486690|NCT01485653|Ultrasound|ultrasound
486691|NCT01485653|Axillary|axillary
486692|NCT01485653|Block|block
486693|NCT01485640|Schizophrenia|schizophrenia
486694|NCT01485640|bipolar disorder|bipolar disorder
486695|NCT01485640|Lurasidone|lurasidone
486696|NCT01485640|Latuda|latuda
486697|NCT01485627|Cancer|cancer
486698|NCT01485627|Communication|communication
486699|NCT01485627|prognosis|prognosis
486700|NCT01485575|Chromovitrectomy|chromovitrectomy
486701|NCT01485575|Indocyanine green|indocyanine green
486702|NCT01485575|ICG|icg
486703|NCT01485575|Brilliant Blue G|brilliant blue g
486704|NCT01485575|BBG|bbg
486705|NCT01485575|Trypan blue|trypan blue
486706|NCT01485575|TB|tb
486707|NCT01485575|Internal limiting membrane|internal limiting membrane
486708|NCT01485575|ILM|ilm
486709|NCT01485562|postpartum haemorrhage|postpartum haemorrhage
486710|NCT01485562|misoprostol|misoprostol
486711|NCT01485562|treatment|treatment
486712|NCT01485562|prophylaxis|prophylaxis
486713|NCT01485562|home births|home births
486714|NCT01485549|Multiple system atrophy (MSA)|multiple system atrophy (msa)
486715|NCT01485549|alpha-synucleinopathies|alpha-synucleinopathies
486716|NCT01485549|biological markers|biological markers
486717|NCT01485549|cerebrospinal fluid|cerebrospinal fluid
486718|NCT01485549|plasma|plasma
486719|NCT01485536|Lymphoma|lymphoma
486720|NCT01485536|Relapsed/refractory lymphoma|relapsed/refractory lymphoma
486721|NCT01485536|AUY922|auy922
486722|NCT01485523|Allergic rhinitis|allergic rhinitis
486723|NCT01485523|Nasal provocation test|nasal provocation test
486724|NCT01485510|Maltreatment|maltreatment
486725|NCT01485510|Infant Mental Health|infant mental health
486726|NCT01485510|Infant mental health in maltreated children|infant mental health in maltreated children
486727|NCT01485497|APNEA|apnea
486728|NCT01485471|Middle Ear Infection|middle ear infection
486729|NCT01485458|Incomplete spinal cord injury|incomplete spinal cord injury
486730|NCT01485458|Cervical canal stenosis|cervical canal stenosis
486731|NCT01485458|Ossification of the posterior longitudinal ligament|ossification of the posterior longitudinal ligament
486732|NCT01485458|Surgery|surgery
486733|NCT01485458|Decompression|decompression
486734|NCT01485445|bioequivalence|bioequivalence
486735|NCT01485445|pharmacokinetics|pharmacokinetics
486736|NCT01485445|Fluticasone Furoate|fluticasone furoate
486737|NCT01485445|Vilanterol|vilanterol
486738|NCT01485432|Renal transplant surgery|renal transplant surgery
486739|NCT01485432|hemodynamic management|hemodynamic management
486740|NCT01485432|PiCCO|picco
486741|NCT01485432|delayed graft function|delayed graft function
486742|NCT01485419|Sex hormones|sex hormones
486743|NCT01485419|Testosterone|testosterone
486744|NCT01485419|Estradiol|estradiol
486745|NCT01485406|Haemophilus influenzae|haemophilus influenzae
486746|NCT01485406|Safety|safety
486747|NCT01485406|Pneumococcal vaccine|pneumococcal vaccine
486748|NCT01485406|Streptococcus pneumoniae|streptococcus pneumoniae
486749|NCT01485406|Immunogenicity|immunogenicity
486750|NCT01485406|Toddlers|toddlers
486751|NCT01485380|Dexmedetomidine|dexmedetomidine
486752|NCT01485380|Sleep|sleep
486753|NCT01485380|MRI-PET|mri-pet
486754|NCT01485380|EEG|eeg
486755|NCT01485367|Senile Purpura|senile purpura
486756|NCT01485367|Adapalene 0.3%|adapalene 0.3%
486757|NCT01485354|Stroke|stroke
486758|NCT01485354|Rehabilitation|rehabilitation
486759|NCT01485341|gluten sensitivity|gluten sensitivity
486760|NCT01485328|Dyspepsia|dyspepsia
486761|NCT01485328|Flatulence|flatulence
486762|NCT01485328|Aerophagia|aerophagia
486763|NCT01485328|Constipation|constipation
486764|NCT01485302|mild to moderate Alzheimer's Disease|mild to moderate alzheimer's disease
486765|NCT01485276|Parkinson's Disease|parkinson's disease
486766|NCT01485276|Deep Brain Stimulation|deep brain stimulation
486767|NCT01485276|Gait|gait
486768|NCT01485276|Electrophysiology|electrophysiology
486769|NCT01485276|Parkinson Disease|parkinson disease
486770|NCT01485276|PD|pd
486977|NCT01484496|Belimumab|belimumab
486771|NCT01485263|Deep Brain Stimulation|deep brain stimulation
486772|NCT01485263|OCD|ocd
486773|NCT01485250|Healthy Volunteers|healthy volunteers
486774|NCT01485250|Motivations|motivations
486775|NCT01485250|Decision Making|decision making
486776|NCT01485250|Motivation|motivation
486777|NCT01485224|Hereditary hemorrhagic telangiectasia|hereditary hemorrhagic telangiectasia
486778|NCT01485224|Epistaxis|epistaxis
486779|NCT01485224|Thalidomide|thalidomide
486780|NCT01485211|progressive keratoconus|progressive keratoconus
486781|NCT01485211|thin corneas|thin corneas
486782|NCT01485211|cross-linking|cross-linking
486783|NCT01485211|hypo-osmolar riboflavin|hypo-osmolar riboflavin
486784|NCT01485198|osteoarthritis|osteoarthritis
486785|NCT01485198|knee|knee
486786|NCT01485198|stem cell therapy|stem cell therapy
486787|NCT01485198|bone marrow|bone marrow
486788|NCT01485198|G-CSF|g-csf
486789|NCT01485185|Donepezil|donepezil
486790|NCT01485185|allodynia|allodynia
486791|NCT01485185|Gabapentin|gabapentin
486792|NCT01485185|Sural nerve stimulation|sural nerve stimulation
486793|NCT01485185|Electrical hyperalgesia|electrical hyperalgesia
486794|NCT01485159|prevalence|prevalence
486795|NCT01485159|COPD|copd
486796|NCT01485159|emphysema|emphysema
486797|NCT01485159|co-morbidities|co-morbidities
486798|NCT01485159|ischemic heart disease|ischemic heart disease
486799|NCT01485159|chronic bronchitis|chronic bronchitis
486800|NCT01485159|spirometry|spirometry
486802|NCT01485133|colonoscopy|colonoscopy
486803|NCT01485133|water|water
486804|NCT01485133|surgery|surgery
486805|NCT01485133|unsedated|unsedated
486806|NCT01485120|Blood pressure (low, normal, high)|blood pressure (low, normal, high)
486807|NCT01485107|Ulthera® System|ulthera® system
486808|NCT01485107|Ultherapy™ treatment|ultherapy™ treatment
486809|NCT01485107|Ulthera, Inc.|ulthera, inc.
486810|NCT01485107|Ultrasound treatment for skin tightening|ultrasound treatment for skin tightening
486811|NCT01485094|neuralgia|neuralgia
486812|NCT01485094|postherpetic|postherpetic
486813|NCT01485081|Bifurcation|bifurcation
486814|NCT01485081|Drug-eluting balloon|drug-eluting balloon
486815|NCT01485081|Paclitaxel-eluting balloon|paclitaxel-eluting balloon
486816|NCT01485081|Angioplasty|angioplasty
486817|NCT01485081|Coronary artery disease|coronary artery disease
486818|NCT01485081|Coronary artery stenosis|coronary artery stenosis
486819|NCT01485068|Restenosis|restenosis
486820|NCT01485068|Paclitaxel-eluting balloon|paclitaxel-eluting balloon
486821|NCT01485068|Angioplasty|angioplasty
486822|NCT01485068|Coronary artery disease|coronary artery disease
486823|NCT01485068|Coronary artery stenosis|coronary artery stenosis
486824|NCT01485055|aGVHD|agvhd
486825|NCT01485055|GVHD|gvhd
486826|NCT01485055|Graft versus host disease|graft versus host disease
486827|NCT01485055|Acute graft versus host disease|acute graft versus host disease
486828|NCT01485055|Steroid refractory graft versus host disease|steroid refractory graft versus host disease
486829|NCT01485055|Bone marrow transplant|bone marrow transplant
486830|NCT01485055|BMT|bmt
486831|NCT01485055|HSCT|hsct
486832|NCT01485055|infliximab|infliximab
486833|NCT01485055|basiliximab|basiliximab
486834|NCT01485055|Monoclonal antibody treatment|monoclonal antibody treatment
486835|NCT01485042|Phase 1|phase 1
486836|NCT01485042|pazopanib|pazopanib
486837|NCT01485042|TH-302|th-302
486838|NCT01485042|advanced solid tumors|advanced solid tumors
486839|NCT01485016|epilepsy|epilepsy
486840|NCT01485016|ECG|ecg
486841|NCT01485016|accelerometer|accelerometer
486842|NCT01484990|Parkinson's Disease|parkinson's disease
486843|NCT01484990|levodopa|levodopa
486844|NCT01484990|carbidopa|carbidopa
486845|NCT01484990|Duodopa|duodopa
486846|NCT01484990|intestinal gel|intestinal gel
486847|NCT01484977|Lacosamide|lacosamide
486848|NCT01484977|Epilepsy|epilepsy
486849|NCT01484977|Levetiracetam|levetiracetam
486850|NCT01484977|Sodium Channel Blockers|sodium channel blockers
486851|NCT01484964|ASP015K|asp015k
486852|NCT01484964|healthy subjects|healthy subjects
486853|NCT01484964|bioavailability|bioavailability
486854|NCT01484964|food effect|food effect
486855|NCT01484964|rheumatoid arthritis|rheumatoid arthritis
486856|NCT01484964|psoriasis|psoriasis
486857|NCT01484964|transplantation|transplantation
486858|NCT01484951|Open-angle glaucoma|open-angle glaucoma
486859|NCT01484951|Ocular hypertension|ocular hypertension
486860|NCT01484951|Pigment dispersion glaucoma|pigment dispersion glaucoma
486861|NCT01484938|Soft contact lenses|soft contact lenses
486862|NCT01484938|Multi-purpose solution|multi-purpose solution
486863|NCT01484938|Corneal staining|corneal staining
486864|NCT01484925|Barrett's esophagus|barrett's esophagus
486865|NCT01484912|Green tea polyphenols|green tea polyphenols
486866|NCT01484912|Chronic Stable Angina|chronic stable angina
486867|NCT01484899|Pulmonary arterial Hypertension|pulmonary arterial hypertension
486868|NCT01484899|Chronic thromboembolic pulmonary hypertension|chronic thromboembolic pulmonary hypertension
486869|NCT01484899|smoking|smoking
486870|NCT01484886|Hemoglobin|hemoglobin
486871|NCT01484886|Congenital heart disease|congenital heart disease
486872|NCT01484886|Cardiac surgery|cardiac surgery
486873|NCT01484886|Red blood cell transfusion|red blood cell transfusion
486874|NCT01484886|Number of red blood cell transfusions|number of red blood cell transfusions
486875|NCT01484873|Exenatide|exenatide
486876|NCT01484873|Byetta|byetta
486877|NCT01484873|Hypothalamic Obesity|hypothalamic obesity
486878|NCT01484873|Obesity|obesity
486879|NCT01484873|Craniopharyngioma|craniopharyngioma
486880|NCT01484860|AUY922|auy922
486881|NCT01484860|Pancreas|pancreas
486882|NCT01484860|Pancreatic cancer|pancreatic cancer
486883|NCT01484860|Adenocarcinoma of the pancreas|adenocarcinoma of the pancreas
486884|NCT01484860|Cancer of the pancreas|cancer of the pancreas
486885|NCT01484860|Metastatic|metastatic
486886|NCT01484860|Advanced|advanced
486887|NCT01484860|Advanced disease|advanced disease
486888|NCT01484860|Prior systemic anticancer therapy|prior systemic anticancer therapy
486889|NCT01484847|advanced|advanced
486890|NCT01484847|PF-00299804|pf-00299804
486891|NCT01484847|head and neck|head and neck
486892|NCT01484847|pharmacokinetic|pharmacokinetic
486893|NCT01484847|squamous cell carcinoma|squamous cell carcinoma
486894|NCT01484847|gastrojejunostomy|gastrojejunostomy
486895|NCT01484847|feeding tube|feeding tube
486896|NCT01484834|Physical Activity|physical activity
486897|NCT01484834|Occupational Health|occupational health
486898|NCT01484834|Quality of Life|quality of life
486899|NCT01484834|Health Promotion|health promotion
486900|NCT01484821|Sarcopenia|sarcopenia
486901|NCT01484821|ARFI|arfi
486902|NCT01484821|DEXA|dexa
486903|NCT01484821|Cancer|cancer
486904|NCT01484808|PSA Density|psa density
486905|NCT01484808|Prostate Cancer|prostate cancer
486906|NCT01484808|Prostate Biopsy|prostate biopsy
486907|NCT01484808|PSA|psa
486908|NCT01484795|noninvasive ventilation|noninvasive ventilation
486909|NCT01484795|autonomic nervous system|autonomic nervous system
486910|NCT01484782|Hypertension|hypertension
486911|NCT01484782|Telephone Care Management|telephone care management
486912|NCT01484782|Blood pressure|blood pressure
486913|NCT01484782|Medication adherence|medication adherence
486914|NCT01484782|Interactive Voice Response (IVR)|interactive voice response (ivr)
486915|NCT01484782|Cloud computing|cloud computing
486916|NCT01484756|respiratory infection|respiratory infection
486917|NCT01484756|independent elderly|independent elderly
486918|NCT01484756|zinc|zinc
486919|NCT01484756|vitamins|vitamins
486920|NCT01484743|recurrence|recurrence
486921|NCT01484743|readmission|readmission
486922|NCT01484743|reoperation|reoperation
486923|NCT01484743|mortality|mortality
486924|NCT01484743|morbidity|morbidity
486925|NCT01484704|Carcinoma ductale mammae|carcinoma ductale mammae
486926|NCT01484678|Duchenne Muscular Dystrophy|duchenne muscular dystrophy
486927|NCT01484678|Magnetic Resonance Imaging|magnetic resonance imaging
486928|NCT01484678|Magnetic Resonance Spectroscopy|magnetic resonance spectroscopy
486929|NCT01484678|Muscle|muscle
486930|NCT01484665|PSA screening|psa screening
486931|NCT01484665|Decision aids|decision aids
486932|NCT01484652|Moderate Post-Operative Pain|moderate post-operative pain
486933|NCT01484652|Severe Post-Operative Pain|severe post-operative pain
486934|NCT01484652|Bunionectomy|bunionectomy
486935|NCT01484639|transfusion|transfusion
486936|NCT01484639|cardiac surgery|cardiac surgery
486937|NCT01484626|Relapsed Multiple Myeloma|relapsed multiple myeloma
486938|NCT01484626|Refractory Multiple Myeloma|refractory multiple myeloma
486939|NCT01484626|Bendamustine|bendamustine
486940|NCT01484626|Bortezomib|bortezomib
486941|NCT01484626|Lenalidomide|lenalidomide
486942|NCT01484626|Dexamethasone|dexamethasone
486943|NCT01484626|Treanda|treanda
486944|NCT01484626|Velcade|velcade
486945|NCT01484626|Revlimid|revlimid
486946|NCT01484613|Hear Failure|hear failure
486947|NCT01484613|Cardiac resynchronization|cardiac resynchronization
486948|NCT01484613|CRT-D|crt-d
486949|NCT01484613|quadripolar|quadripolar
486950|NCT01484600|Volunteers|volunteers
486951|NCT01484587|Moderate to Severe Plaque-Type Psoriasis|moderate to severe plaque-type psoriasis
486952|NCT01484587|Psoriasis|psoriasis
486953|NCT01484587|Plaque-type psoriasis|plaque-type psoriasis
486954|NCT01484587|CNTO 1959|cnto 1959
486955|NCT01484587|Japanese participants|japanese participants
486956|NCT01484574|Critical limb ischemia|critical limb ischemia
486957|NCT01484574|Buerger's disease|buerger's disease
486958|NCT01484574|Critical limb ischemia due to Buerger's disease|critical limb ischemia due to buerger's disease
486959|NCT01484561|Phase 1|phase 1
486960|NCT01484522|Influenza|influenza
486961|NCT01484522|Perinatal|perinatal
486962|NCT01484522|immunogenicity|immunogenicity
486963|NCT01484522|Monovalent vaccine|monovalent vaccine
486964|NCT01484522|Children|children
486965|NCT01484522|Youth|youth
486966|NCT01484522|H1N1|h1n1
486967|NCT01484522|Adolescent|adolescent
486968|NCT01484522|Flu|flu
486969|NCT01484509|walking impairment|walking impairment
486970|NCT01484509|claudication|claudication
486971|NCT01484509|treadmill|treadmill
486972|NCT01484509|questionnaire|questionnaire
486973|NCT01484496|Subcutaneous|subcutaneous
486974|NCT01484496|Lupus|lupus
486975|NCT01484496|Systemic Lupus Erythematosus|systemic lupus erythematosus
486976|NCT01484496|SLE|sle
486978|NCT01484496|Autoimmune Disease|autoimmune disease
486979|NCT01484496|Antibodies|antibodies
486980|NCT01484470|Stem cell transplantation|stem cell transplantation
486981|NCT01484470|Stem Cell expansion|stem cell expansion
486982|NCT01484470|Elderly|elderly
486983|NCT01484457|Diabetes Mellitus|diabetes mellitus
486984|NCT01484457|Closed Loop|closed loop
486985|NCT01484457|Artificial Pancreas|artificial pancreas
486986|NCT01484418|Chronic Low Back Pain|chronic low back pain
486987|NCT01484418|Cognitive Behavioural Therapy|cognitive behavioural therapy
486988|NCT01484418|Exposure|exposure
486989|NCT01484418|Fear avoidance|fear avoidance
486990|NCT01484418|Cognitive Behavioural Therapy in chronic low back pain|cognitive behavioural therapy in chronic low back pain
486991|NCT01484418|Exposure in vivo in chronic low back pain|exposure in vivo in chronic low back pain
486992|NCT01484405|surgical approach for total hip arthroplasty|surgical approach for total hip arthroplasty
486993|NCT01484392|open angle glaucoma|open angle glaucoma
486994|NCT01484392|compliance|compliance
486995|NCT01484392|adherence|adherence
486996|NCT01484379|Primary Hyperparathyroidism|primary hyperparathyroidism
486997|NCT01484379|multigland disease|multigland disease
486998|NCT01484379|neck exploration|neck exploration
486999|NCT01484379|elderly|elderly
487000|NCT01484366|fractures of both radius and ulna|fractures of both radius and ulna
487001|NCT01484353|Diabetes|diabetes
487002|NCT01484340|smoking|smoking
487003|NCT01484340|administration, cutaneous|administration, cutaneous
487004|NCT01484327|Heart Failure|heart failure
487005|NCT01484327|Acute Myocardial Infarction|acute myocardial infarction
487006|NCT01484327|LVEF|lvef
487007|NCT01484314|Relapsed|relapsed
487008|NCT01484301|Chronic pain|chronic pain
487009|NCT01484301|Opioids|opioids
487010|NCT01484301|Tolerability|tolerability
487011|NCT01484275|High-risk smoldering multiple myeloma|high-risk smoldering multiple myeloma
487012|NCT01484275|Multiple myeloma|multiple myeloma
487013|NCT01484275|Siltuximab|siltuximab
487014|NCT01484249|embolic|embolic
487015|NCT01484249|filters|filters
487016|NCT01484249|brachiocephalic|brachiocephalic
487017|NCT01484249|neurovasculature|neurovasculature
487018|NCT01484249|debris|debris
487019|NCT01484236|Lymphangioleiomyomatosis|lymphangioleiomyomatosis
487020|NCT01484223|Primary Health Care|primary health care
487021|NCT01484223|Somatization symptoms|somatization symptoms
487022|NCT01484223|Cognitive Behavioral Therapy|cognitive behavioral therapy
487023|NCT01484223|Nursing intervention|nursing intervention
487024|NCT01484197|Asthma|asthma
487025|NCT01484197|Indacaterol|indacaterol
487026|NCT01484197|QAB149|qab149
487027|NCT01484184|Completely paralyzed|completely paralyzed
487028|NCT01484184|Chronically injured|chronically injured
487029|NCT01484184|Central Pattern Generator|central pattern generator
487030|NCT01484184|Locomotion|locomotion
487031|NCT01484184|Secondary complications|secondary complications
487032|NCT01484184|Activity-based training|activity-based training
487033|NCT01484184|Treadmill training|treadmill training
487034|NCT01484184|Spinal cord injury|spinal cord injury
487035|NCT01484184|Paraplegia|paraplegia
487036|NCT01484184|Tetraplegia|tetraplegia
487037|NCT01484171|Acute Myeloid Leukemia|acute myeloid leukemia
487038|NCT01484171|idarubicin|idarubicin
487039|NCT01484171|Microtransplantation|microtransplantation
487040|NCT01484158|Myocardial Infarction|myocardial infarction
487041|NCT01484145|Onychomycosis|onychomycosis
487042|NCT01484145|Nail fungus|nail fungus
487043|NCT01484145|Tinea Unguium|tinea unguium
487044|NCT01484132|Dental Caries|dental caries
487045|NCT01484132|Dental Restorative Materials|dental restorative materials
487046|NCT01484132|Dental Composite|dental composite
487047|NCT01484132|Bisphenol-A|bisphenol-a
487048|NCT01484119|seasonal allergic rhinitis|seasonal allergic rhinitis
487049|NCT01484093|CYCLOPHOSPHAMIDE (CYTOXAN)|cyclophosphamide (cytoxan)
487050|NCT01484093|CYTARABINE (ARA-C)|cytarabine (ara-c)
487051|NCT01484093|DOXORUBICIN/ADRIAMYCIN|doxorubicin/adriamycin
487052|NCT01484093|PREDNISONE|prednisone
487053|NCT01484093|RITUXIMAB|rituximab
487054|NCT01484093|TOSITUMOMAB (BEXXAR)|tositumomab (bexxar)
487055|NCT01484093|Iodine|iodine
487056|NCT01484093|VINCRISTIN|vincristin
487057|NCT01484093|Lymphoma|lymphoma
487058|NCT01484093|Chemo-Radioimmunotherapy|chemo-radioimmunotherapy
487059|NCT01484093|Autologous Transplantation|autologous transplantation
487060|NCT01484093|Untreated|untreated
487061|NCT01484093|11-095|11-095
487062|NCT01484067|Herpes Simplex Virus|herpes simplex virus
487063|NCT01484041|Breast cancer|breast cancer
487064|NCT01484041|postmenopausal|postmenopausal
487065|NCT01484002|Hip replacement|hip replacement
487066|NCT01484002|Crosslinked and conventional polyethylene|crosslinked and conventional polyethylene
487067|NCT01484002|Oxidation|oxidation
487068|NCT01484002|Crosslink density|crosslink density
487069|NCT01484002|Outcome|outcome
487070|NCT01483989|Dry Eye|dry eye
487071|NCT01483989|Epithelial changes|epithelial changes
487072|NCT01483950|Dyslipidemia|dyslipidemia
487073|NCT01483950|Statins|statins
487074|NCT01483950|Total Cholesterol|total cholesterol
487075|NCT01483950|Low density lipoprotein (LDL) cholesterol|low density lipoprotein (ldl) cholesterol
487076|NCT01483950|High density lipoprotein (HDL) cholesterol|high density lipoprotein (hdl) cholesterol
487077|NCT01483937|Keywords provided by BalanceSense, LLC:|keywords provided by balancesense, llc:
487078|NCT01483937|Physical Therapy|physical therapy
487079|NCT01483937|Rehabilitation|rehabilitation
487080|NCT01483937|Disequilibrium|disequilibrium
487081|NCT01483937|Balance dysfunction or disorder|balance dysfunction or disorder
487082|NCT01483937|Vestibular|vestibular
487083|NCT01483937|Mild Traumatic Brain Injury (mTBI)|mild traumatic brain injury (mtbi)
487084|NCT01483937|Vibrotactile|vibrotactile
487085|NCT01483924|Mild to Moderate Chronic Plaque Psoriasis|mild to moderate chronic plaque psoriasis
487086|NCT01483898|critical limb ischemia|critical limb ischemia
487087|NCT01483898|REVIVE|revive
487088|NCT01483898|peripheral vascular disease|peripheral vascular disease
487090|NCT01483898|PAD|pad
487091|NCT01483898|MSC|msc
487092|NCT01483898|stem cells|stem cells
487093|NCT01483898|cell therapy|cell therapy
487094|NCT01483872|salvage infected hemodialysis catheters|salvage infected hemodialysis catheters
487095|NCT01483872|novel catheter lock solution|novel catheter lock solution
487096|NCT01483846|Neuropathic Pain|neuropathic pain
487097|NCT01483846|Capsaicin Induced Pain|capsaicin induced pain
487098|NCT01483807|speech|speech
487099|NCT01483807|speech therapy|speech therapy
487100|NCT01483807|apraxia of speech|apraxia of speech
487101|NCT01483794|genital warts|genital warts
487102|NCT01483781|Diabetes Mellitus, Type 2|diabetes mellitus, type 2
487103|NCT01483781|Plasma Volume|plasma volume
487104|NCT01483781|Canagliflozin|canagliflozin
487105|NCT01483781|Metformin|metformin
487106|NCT01483781|Hemoglobin A1c|hemoglobin a1c
487107|NCT01483781|Hypertension|hypertension
487108|NCT01483781|Angiotensin-Converting Enzyme Inhibitors (ACEIs)|angiotensin-converting enzyme inhibitors (aceis)
487109|NCT01483781|Angiotensin Receptor Blockers (ARBs)|angiotensin receptor blockers (arbs)
487110|NCT01483781|Pharmacodynamics|pharmacodynamics
487111|NCT01483781|Pharmacokinetics|pharmacokinetics
487112|NCT01483768|Sleeve gastrectomy|sleeve gastrectomy
487113|NCT01483768|Obesity surgery|obesity surgery
487114|NCT01483768|Iron deficiency|iron deficiency
487115|NCT01483768|HEPCIDINE|hepcidine
487116|NCT01483755|Myocardial infarction|myocardial infarction
487117|NCT01483755|Postconditioning|postconditioning
487118|NCT01483690|Relapse|relapse
487119|NCT01483690|Lymphoblastic|lymphoblastic
487120|NCT01483690|Leukemia|leukemia
487121|NCT01483690|Decitabine|decitabine
487122|NCT01483690|Vorinostat|vorinostat
487123|NCT01483690|Refractory|refractory
487124|NCT01483690|Acute|acute
487125|NCT01483690|Childhood|childhood
487126|NCT01483690|Pediatric|pediatric
487127|NCT01483690|ALL|all
487128|NCT01483677|Laparoscopy|laparoscopy
487129|NCT01483677|video games|video games
487130|NCT01483677|Nintendo Wii|nintendo wii
487131|NCT01483677|Playstation|playstation
487132|NCT01483664|patient outcomes|patient outcomes
487133|NCT01483664|Survivorship|survivorship
487134|NCT01483664|Communication Skills|communication skills
487135|NCT01483664|Communication strategies|communication strategies
487136|NCT01483664|Physicians communication|physicians communication
487137|NCT01483664|11-180|11-180
487138|NCT01483651|diabetes|diabetes
487139|NCT01483651|glucagon|glucagon
487140|NCT01483651|insulin|insulin
487141|NCT01483651|dideuterated glucose|dideuterated glucose
487142|NCT01483638|duration of disease response|duration of disease response
487143|NCT01483638|axitinib|axitinib
487144|NCT01483612|Body Weight|body weight
487145|NCT01483612|Female|female
487146|NCT01483612|Infertility, Female/therapy|infertility, female/therapy
487147|NCT01483612|Infertility, Female/physiopathology|infertility, female/physiopathology
487148|NCT01483612|Obesity/physiopathology|obesity/physiopathology
487149|NCT01483612|Polycystic ovary syndrome|polycystic ovary syndrome
487150|NCT01483612|Pregnancy|pregnancy
487151|NCT01483612|Pregnancy Outcome|pregnancy outcome
487152|NCT01483612|Weight Loss|weight loss
487153|NCT01483599|Moderate to Severe Plaque-Type Psoriasis|moderate to severe plaque-type psoriasis
487154|NCT01483599|Psoriasis|psoriasis
487155|NCT01483599|Plaque-type psoriasis|plaque-type psoriasis
487156|NCT01483599|CNTO 1959|cnto 1959
487157|NCT01483599|adalimumab|adalimumab
487158|NCT01483573|low back pain|low back pain
487159|NCT01483573|straight leg raise|straight leg raise
487160|NCT01483560|REMOVAL|removal
487161|NCT01483560|metformin|metformin
487162|NCT01483560|carotid IMT|carotid imt
487163|NCT01483560|LDL Cholesterol|ldl cholesterol
487164|NCT01483560|endothelial function|endothelial function
487165|NCT01483560|retinopathy|retinopathy
487166|NCT01483560|HbA1c|hba1c
487167|NCT01483534|Chronic Obstructive Pulmonary Disease|chronic obstructive pulmonary disease
487168|NCT01483534|Pulmonary|pulmonary
487169|NCT01483534|Intervention|intervention
487170|NCT01483534|Device|device
487171|NCT01483534|Denervation|denervation
487172|NCT01483534|Lung|lung
487173|NCT01483534|Holaira, Inc.|holaira, inc.
487174|NCT01483534|Innovative Pulmonary Solutions, Inc.|innovative pulmonary solutions, inc.
487175|NCT01483521|Randomized|randomized
487176|NCT01483521|Home visitation|home visitation
487177|NCT01483521|Externalizing disorder|externalizing disorder
487178|NCT01483521|Parenting stress|parenting stress
487179|NCT01483521|Childhood externalizing disorders|childhood externalizing disorders
487180|NCT01483521|Positional defiant|positional defiant
487181|NCT01483508|flavanols|flavanols
487182|NCT01483508|procyanidins|procyanidins
487183|NCT01483508|absorption|absorption
487184|NCT01483508|cocoa polyphenols|cocoa polyphenols
487185|NCT01483508|Flavanol and procyanidin absorption in healthy volunteers|flavanol and procyanidin absorption in healthy volunteers
487186|NCT01483482|clavicle fractures|clavicle fractures
487187|NCT01483482|midshaft clavicle fractures|midshaft clavicle fractures
487188|NCT01483482|conservative treatment|conservative treatment
487189|NCT01483482|surgical treatment|surgical treatment
487190|NCT01483482|functional outcome|functional outcome
487191|NCT01483482|clinical assessment|clinical assessment
487192|NCT01483482|adults|adults
487193|NCT01483456|Accidental falls|accidental falls
487194|NCT01483456|safety management|safety management
487195|NCT01483456|aged|aged
487196|NCT01483456|inpatient|inpatient
487197|NCT01483456|stepped wedge design|stepped wedge design
487198|NCT01483443|oophrectomy|oophrectomy
487199|NCT01483443|survival|survival
487200|NCT01483430|Blood pressure|blood pressure
487201|NCT01483430|Korea red ginseng|korea red ginseng
487202|NCT01483430|Ambulatory blood pressure|ambulatory blood pressure
487203|NCT01483430|Pulse wave velocity|pulse wave velocity
487204|NCT01483417|SILS|sils
487205|NCT01483417|Laparoscopic hysterectomy|laparoscopic hysterectomy
487206|NCT01483417|Cosmetic outcome|cosmetic outcome
487207|NCT01483417|Pain|pain
487208|NCT01483404|microcirculation|microcirculation
487209|NCT01483404|caput femoris|caput femoris
487210|NCT01483391|Bipolar disorder|bipolar disorder
487211|NCT01483391|Major depressive disorder|major depressive disorder
487212|NCT01483391|Mania|mania
487213|NCT01483391|Depression|depression
487214|NCT01483391|Cyclothymic Disorder|cyclothymic disorder
487215|NCT01483313|Anesthestics|anesthestics
487216|NCT01483313|Minor surgery|minor surgery
487217|NCT01483313|Wechsler Intelligence Scale for Children|wechsler intelligence scale for children
487218|NCT01483313|Cognitiion|cognitiion
487219|NCT01483300|breast cancer|breast cancer
487220|NCT01483300|gemcitabine|gemcitabine
487221|NCT01483300|lobaplatin|lobaplatin
487222|NCT01483300|cisplatin|cisplatin
487223|NCT01483287|Gastrointestinal Symptoms|gastrointestinal symptoms
487224|NCT01483287|Bloating|bloating
487225|NCT01483287|Distention|distention
487226|NCT01483274|AML|aml
487227|NCT01483274|vaccine|vaccine
487228|NCT01483261|Trauma-Focused Cognitive Behavior Therapy|trauma-focused cognitive behavior therapy
487229|NCT01483261|Sexually Exploited Girls|sexually exploited girls
487230|NCT01483261|Post-traumatic Stress Symptoms|post-traumatic stress symptoms
487231|NCT01483261|Psychosocial Distress|psychosocial distress
487232|NCT01483248|Menstrual blood|menstrual blood
487233|NCT01483248|Mesenchymal stem cell|mesenchymal stem cell
487234|NCT01483248|Liver cirrhosis|liver cirrhosis
487235|NCT01483235|cardiac rehabilitation|cardiac rehabilitation
487236|NCT01483235|prevention|prevention
487237|NCT01483235|exercise capacity|exercise capacity
487238|NCT01483222|Low Back Pain|low back pain
487239|NCT01483222|Braces|braces
487240|NCT01483222|Prevention|prevention
487241|NCT01483209|Digital ischemia|digital ischemia
487242|NCT01483209|Vasopressor|vasopressor
487243|NCT01483183|Atrial fibrillation|atrial fibrillation
487244|NCT01483183|Paroxysmal Atrial fibrillation|paroxysmal atrial fibrillation
487245|NCT01483183|Persistent Atrial fibrillation|persistent atrial fibrillation
487246|NCT01483183|A-fib|a-fib
487247|NCT01483144|Familial Adenomatous Polyposis|familial adenomatous polyposis
487248|NCT01483144|Eflornithine|eflornithine
487249|NCT01483144|Sulindac|sulindac
487250|NCT01483118|PCOS|pcos
487251|NCT01483118|Insulin resistance|insulin resistance
487252|NCT01483118|Cinnamon extract|cinnamon extract
487253|NCT01483118|Irregular menstrual cycles|irregular menstrual cycles
487254|NCT01483118|Ovarian cysts|ovarian cysts
487255|NCT01483105|VCUG|vcug
487256|NCT01483105|Child|child
487257|NCT01483105|Hypnosis|hypnosis
487258|NCT01483105|Relaxation|relaxation
487259|NCT01483105|Voiding cystourethrography|voiding cystourethrography
487260|NCT01483079|donor human milk products|donor human milk products
487261|NCT01483079|post-discharge|post-discharge
487262|NCT01483079|growth|growth
487263|NCT01483079|development|development
487264|NCT01483053|Major depressive disorder|major depressive disorder
487265|NCT01483053|Sympathetic nervous system activation|sympathetic nervous system activation
487266|NCT01483053|Cardiovascular risk factors|cardiovascular risk factors
487267|NCT01483053|Agomelatine|agomelatine
487268|NCT01483053|Escitalopram|escitalopram
487269|NCT01483040|wide angle view colonoscopy|wide angle view colonoscopy
487270|NCT01483040|PeerScope B System™|peerscope b system™
487271|NCT01483014|Gastrointestinal,|gastrointestinal,
487272|NCT01483014|stromal,|stromal,
487273|NCT01483014|neoadjuvant,|neoadjuvant,
487274|NCT01483014|imatinib,|imatinib,
487275|NCT01483014|mesylate,|mesylate,
487276|NCT01483014|pre-operatory|pre-operatory
487277|NCT01483001|Cancer Stem Cells|cancer stem cells
487278|NCT01483001|Chemo-Sensitivity Assay|chemo-sensitivity assay
487279|NCT01483001|Cancer Treatment|cancer treatment
487280|NCT01482988|prevalence of the Dectin-1 polymorphism (Tyr238X)|prevalence of the dectin-1 polymorphism (tyr238x)
487281|NCT01482975|tobacco|tobacco
487282|NCT01482975|alcohol|alcohol
487283|NCT01482975|diet|diet
487284|NCT01482975|exercise|exercise
487285|NCT01482962|Drug Therapy|drug therapy
487286|NCT01482949|RCC|rcc
487287|NCT01482949|Kidney Cancer|kidney cancer
487288|NCT01482949|Renal Cancer|renal cancer
487289|NCT01482949|Arcelis|arcelis
487290|NCT01482923|Tobacco Use Assessment|tobacco use assessment
487291|NCT01482923|smoke tobacco|smoke tobacco
487292|NCT01482923|quit smoking|quit smoking
487293|NCT01482923|tobacco cessation|tobacco cessation
487294|NCT01482923|HIV/AIDS|hiv/aids
487295|NCT01482923|Community-Based Service Organizations|community-based service organizations
487296|NCT01482923|11-173|11-173
487297|NCT01482923|Low-Income Persons Living with HIV/AIDS|low-income persons living with hiv/aids
487298|NCT01482897|Discal sciatica, infiltrations|discal sciatica, infiltrations
487299|NCT01482897|Subjects|subjects
487300|NCT01482897|evolving|evolving
487301|NCT01482884|tralokinumab|tralokinumab
487302|NCT01482884|inflammatory bowel disease|inflammatory bowel disease
487303|NCT01482884|moderate to severe ulcerative colitis|moderate to severe ulcerative colitis
487304|NCT01482871|Diabetic Macular Edema|diabetic macular edema
487305|NCT01482832|Randomized trial|randomized trial
487306|NCT01482832|Postpartum depression|postpartum depression
487307|NCT01482832|Adolescent pregnancy|adolescent pregnancy
487308|NCT01482832|Interpersonal psychotherapy|interpersonal psychotherapy
487309|NCT01482806|Depression|depression
487310|NCT01482806|Anxiety|anxiety
487311|NCT01482806|Primary care|primary care
487312|NCT01482806|Cognitive Behavioral Therapy|cognitive behavioral therapy
487313|NCT01482806|Internet|internet
487314|NCT01482806|Support groups|support groups
487315|NCT01482806|Technology assisted|technology assisted
487316|NCT01482741|Quality of Life|quality of life
487317|NCT01482741|Focus groups|focus groups
621068|NCT00936819|MRI|mri
487318|NCT01482741|Risks of Ionizing Radiation|risks of ionizing radiation
487319|NCT01482741|Risk of medical imaging|risk of medical imaging
487320|NCT01482741|11-185|11-185
487321|NCT01482715|gBRCA ovarian cancer|gbrca ovarian cancer
487322|NCT01482715|platinum sensitive|platinum sensitive
487323|NCT01482715|PARP Inhibitor|parp inhibitor
487324|NCT01482715|Rucaparib|rucaparib
487325|NCT01482715|CO-338|co-338
487326|NCT01482715|PF 01367338|pf 01367338
487327|NCT01482715|AG 14699|ag 14699
487328|NCT01482715|BRCA1|brca1
487329|NCT01482715|BRCA2|brca2
487330|NCT01482715|platinum sensitive ovarian cancer|platinum sensitive ovarian cancer
487331|NCT01482715|platinum sensitive gBRCA ovarian cancer|platinum sensitive gbrca ovarian cancer
487332|NCT01482715|gynecological cancer|gynecological cancer
487333|NCT01482715|relapsed disease|relapsed disease
487334|NCT01482715|homologous recombination deficiency|homologous recombination deficiency
487335|NCT01482715|HRD|hrd
487336|NCT01482702|breast cancer survivor|breast cancer survivor
487337|NCT01482702|weight loss|weight loss
487338|NCT01482702|postmenopausal|postmenopausal
487339|NCT01482702|Weight loss for overweight postmenopausal breast cancer survivors|weight loss for overweight postmenopausal breast cancer survivors
487340|NCT01482689|Bioavailability|bioavailability
487341|NCT01482689|Vitamin D metabolism|vitamin d metabolism
487342|NCT01482689|Bone turnover|bone turnover
487343|NCT01482663|Hand eczema|hand eczema
487344|NCT01482663|Hand dermatitis|hand dermatitis
487345|NCT01482663|Chronic hand eczema|chronic hand eczema
487346|NCT01482663|Chronic hand dermatitis|chronic hand dermatitis
487347|NCT01482663|Contact dermatitis|contact dermatitis
487348|NCT01482663|Skin disease|skin disease
487349|NCT01482663|Self-management|self-management
487350|NCT01482650|Baska mask|baska mask
487351|NCT01482650|LMA|lma
487352|NCT01482650|laryngeal mask airway|laryngeal mask airway
487353|NCT01482650|supraglottic airway device|supraglottic airway device
487354|NCT01482624|hyaluronan|hyaluronan
487355|NCT01482624|hyaluronic acid|hyaluronic acid
487356|NCT01482611|Hepatitis C Virus|hepatitis c virus
487357|NCT01482611|JNJ-47910382|jnj-47910382
487358|NCT01482611|47910382HPC1001|47910382hpc1001
487359|NCT01482611|HCV|hcv
487360|NCT01482611|Hepatitis C|hepatitis c
487361|NCT01482611|Hep C|hep c
487362|NCT01482611|Healthy participants|healthy participants
487363|NCT01482611|Japanese|japanese
487364|NCT01482611|Caucasians|caucasians
487365|NCT01482598|Heart Failure|heart failure
487366|NCT01482598|Cardiac Resynchronization Therapy|cardiac resynchronization therapy
487367|NCT01482598|Remote Care|remote care
487368|NCT01482598|Disease Management|disease management
487369|NCT01482585|lung adenocarcinoma|lung adenocarcinoma
487370|NCT01482585|prognosis|prognosis
487371|NCT01482585|tumor aggressiveness|tumor aggressiveness
487372|NCT01482585|imaging biomarker|imaging biomarker
487373|NCT01482585|genetic biomarker|genetic biomarker
487374|NCT01482572|biopsy|biopsy
487375|NCT01482572|needle aspiration|needle aspiration
487376|NCT01482572|mutational analysis|mutational analysis
487377|NCT01482559|Dopamine|dopamine
487378|NCT01482559|Intraventricular haemorrhage|intraventricular haemorrhage
487379|NCT01482559|Periventricular Leukomalacia|periventricular leukomalacia
487380|NCT01482559|Neurodisability|neurodisability
487381|NCT01482559|Infant|infant
487382|NCT01482546|colonoscopy|colonoscopy
487383|NCT01482546|trainees|trainees
487384|NCT01482546|water|water
487385|NCT01482546|adenoma detection rate|adenoma detection rate
487386|NCT01482546|cecal intubation rate|cecal intubation rate
487387|NCT01482494|Myopathies|myopathies
487388|NCT01482494|Pompe disease|pompe disease
487389|NCT01482494|Polymyositis|polymyositis
487390|NCT01482494|Respiratory Insufficiency|respiratory insufficiency
487391|NCT01482481|Patient Care Planning|patient care planning
487392|NCT01482481|Type 2 Diabetes Mellitus|type 2 diabetes mellitus
487393|NCT01482481|Cardiovascular Risk Factors|cardiovascular risk factors
487394|NCT01482481|Primary Health Care|primary health care
487395|NCT01482481|Spain|spain
487396|NCT01482455|Insulin resistance|insulin resistance
487397|NCT01482455|vascular impairment|vascular impairment
487398|NCT01482455|diabetes|diabetes
487399|NCT01482442|Liver, HCC|liver, hcc
487400|NCT01482442|Liver, interventional procedures|liver, interventional procedures
487401|NCT01482442|Liver, randomized studies|liver, randomized studies
487402|NCT01482442|Liver, targeted therapy|liver, targeted therapy
487403|NCT01482442|Liver, RADIOEMBOLIZATION|liver, radioembolization
487404|NCT01482429|ventilator weaning|ventilator weaning
487405|NCT01482429|protocol|protocol
487406|NCT01482416|hormone replacement therapy|hormone replacement therapy
487407|NCT01482416|Doppler velocimetry|doppler velocimetry
487408|NCT01482416|Flow-mediated dilation|flow-mediated dilation
487409|NCT01482416|menopause|menopause
487410|NCT01482364|HOTMAN System|hotman system
487411|NCT01482364|Hemodynamic integrated management|hemodynamic integrated management
487412|NCT01482351|apnea|apnea
487413|NCT01482351|cognition|cognition
487414|NCT01482351|memory|memory
487415|NCT01482351|function|function
487416|NCT01482351|amnestic mild cognitive impairment|amnestic mild cognitive impairment
487417|NCT01482351|older adults|older adults
487418|NCT01482351|Alzheimer's Disease|alzheimer's disease
487419|NCT01482338|PMS|pms
487420|NCT01482338|Low-dose combine contraceptives pills|low-dose combine contraceptives pills
487421|NCT01482338|COC|coc
487422|NCT01482299|pS6 Ser 240/4|ps6 ser 240/4
487423|NCT01482299|RAD001 (everolimus)|rad001 (everolimus)
487424|NCT01482299|second-line treatment|second-line treatment
487425|NCT01482299|advanced gastric cancer|advanced gastric cancer
487426|NCT01482286|Exercise|exercise
487427|NCT01482286|Diet|diet
487428|NCT01482286|Insulin resistance|insulin resistance
487429|NCT01482286|Weight|weight
487430|NCT01482273|catheter-directed thrombolysis|catheter-directed thrombolysis
487431|NCT01482273|ilio-femoral deep vein thrombosis|ilio-femoral deep vein thrombosis
487432|NCT01482273|Postthrombotic syndrome|postthrombotic syndrome
487433|NCT01482273|Phlebographic scores|phlebographic scores
487434|NCT01482273|Phlebography|phlebography
487435|NCT01482273|Catheters|catheters
487436|NCT01482234|physical activity|physical activity
487437|NCT01482234|exercise|exercise
487438|NCT01482234|walking|walking
487439|NCT01482234|pedometers|pedometers
487440|NCT01482234|goal setting|goal setting
487441|NCT01482234|text messages|text messages
487442|NCT01482234|motivation|motivation
487443|NCT01482234|intrinsic motivation|intrinsic motivation
487444|NCT01482234|extrinsic motivation|extrinsic motivation
487445|NCT01482234|self determination theory|self determination theory
487446|NCT01482234|prompts|prompts
487447|NCT01482221|Major Depressive Disorder|major depressive disorder
487448|NCT01482221|MDD|mdd
487449|NCT01482221|Inadequate Response to Antidepressant Therapy|inadequate response to antidepressant therapy
487450|NCT01482221|Channel blocker of the NMDA class of glutamate receptors|channel blocker of the nmda class of glutamate receptors
487451|NCT01482208|Dehydration|dehydration
487452|NCT01482208|Hydration|hydration
487453|NCT01482208|Muscle composition|muscle composition
487454|NCT01482208|Diarrhea|diarrhea
487455|NCT01482208|Pediatrics|pediatrics
487456|NCT01482208|Neonatology|neonatology
487457|NCT01482208|Ultrasound|ultrasound
487458|NCT01482195|Retinal Disease|retinal disease
487459|NCT01482182|Non-small cell lung cancer|non-small cell lung cancer
487460|NCT01482182|Diffusion-weighted MRI|diffusion-weighted mri
487461|NCT01482182|18F-FDG PET|18f-fdg pet
487462|NCT01482182|Treatment response|treatment response
487463|NCT01482182|Prognosis|prognosis
487464|NCT01482169|Left heart catheterization|left heart catheterization
487465|NCT01482169|Fractional flow reserve|fractional flow reserve
487466|NCT01482169|Adenoscan®|adenoscan®
487467|NCT01482169|Regadenoson|regadenoson
487468|NCT01482156|Advanced solid tumors|advanced solid tumors
487469|NCT01482156|Metastatic renal cell carcinoma (mRCC)|metastatic renal cell carcinoma (mrcc)
487470|NCT01482156|ER+/HER2-Metastatic breast cancer (MBC)|er+/her2-metastatic breast cancer (mbc)
487471|NCT01482156|Dose finding study|dose finding study
487472|NCT01482156|mTOR|mtor
487473|NCT01482156|Pl3K|pl3k
487474|NCT01482156|BEZ235|bez235
487475|NCT01482156|RAD001|rad001
487476|NCT01482156|Everolimus|everolimus
487477|NCT01482156|Afinitor®|afinitor®
487478|NCT01482156|ER+/HER2- metastatic breast cancer|er+/her2- metastatic breast cancer
487479|NCT01482143|Fragile X Syndrome|fragile x syndrome
487480|NCT01482143|pharmacokinetics|pharmacokinetics
487481|NCT01482143|safety and tolerability|safety and tolerability
487482|NCT01482130|Exercise|exercise
487483|NCT01482130|osteoporosis|osteoporosis
487484|NCT01482130|prevention|prevention
487485|NCT01482117|CYP2C19|cyp2c19
487486|NCT01482117|CYP3A5|cyp3a5
487487|NCT01482117|Clopidogrel|clopidogrel
487488|NCT01482117|Cilostazol|cilostazol
487489|NCT01482117|Healthy|healthy
487490|NCT01482104|Photochemotherapy|photochemotherapy
487491|NCT01482104|methyl 5-aminolevulinate|methyl 5-aminolevulinate
487492|NCT01482091|fentanyl|fentanyl
487493|NCT01482091|intranasal|intranasal
487494|NCT01482091|sickle cell|sickle cell
487495|NCT01482091|vasoocclusive crisis|vasoocclusive crisis
487496|NCT01482091|pain crisis|pain crisis
487497|NCT01482091|pediatrics|pediatrics
487498|NCT01482078|Magnesium Sulphate|magnesium sulphate
487499|NCT01482078|Neuroprotection|neuroprotection
487500|NCT01482078|Neuraxial Anesthesia|neuraxial anesthesia
487501|NCT01482078|Sedation|sedation
487502|NCT01482078|Respiratory function|respiratory function
487503|NCT01482078|Cesarean Section|cesarean section
487504|NCT01482078|Obstetrical Anesthesia|obstetrical anesthesia
487505|NCT01482065|Non Alcoholic Fatty Liver Disease|non alcoholic fatty liver disease
487506|NCT01482065|NAFLD|nafld
487507|NCT01482065|Continuous Positive Airway Pressure|continuous positive airway pressure
487508|NCT01482065|CPAP|cpap
487509|NCT01482065|CPAP Therapy|cpap therapy
487510|NCT01482065|Apnea Hypopnea Index|apnea hypopnea index
487511|NCT01482065|Non alcoholic steatohepatitis|non alcoholic steatohepatitis
487512|NCT01482065|NASH|nash
487513|NCT01482065|OSA|osa
487514|NCT01482065|Obstructive Sleep Apnea|obstructive sleep apnea
487515|NCT01482065|AHI|ahi
487516|NCT01482052|Central Nervous System Infections|central nervous system infections
487517|NCT01482052|Meningitis|meningitis
487518|NCT01482052|toxoid|toxoid
487519|NCT01482052|Meningococcal vaccine|meningococcal vaccine
487520|NCT01482052|conjugate vaccines|conjugate vaccines
487521|NCT01482039|short cervix|short cervix
487522|NCT01482039|cervical shortening|cervical shortening
487523|NCT01482039|preterm birth|preterm birth
487524|NCT01482026|Epilepsy|epilepsy
487525|NCT01482026|Attention deficit|attention deficit
487526|NCT01482026|ADHD rating scale IV|adhd rating scale iv
487527|NCT01482000|Pulmonary Disease, Chronic Obstructive|pulmonary disease, chronic obstructive
487528|NCT01482000|Adult|adult
487529|NCT01482000|therapeutic use|therapeutic use
487530|NCT01482000|Humans|humans
487531|NCT01482000|Treatment Outcome|treatment outcome
487532|NCT01482000|daoyin therapy|daoyin therapy
487533|NCT01481987|Microperimetry|microperimetry
487534|NCT01481987|OCT|oct
487535|NCT01481987|idiopathic epiretinal membrane|idiopathic epiretinal membrane
487536|NCT01481974|liver transplantation|liver transplantation
487537|NCT01481974|treprostinil|treprostinil
487538|NCT01481961|Alzheimer's disease|alzheimer's disease
487539|NCT01481961|rTMS|rtms
487540|NCT01481961|cognition|cognition
487541|NCT01481948|physical activity|physical activity
487542|NCT01481948|fruit and vegetable|fruit and vegetable
487543|NCT01481948|water|water
487544|NCT01481948|girls|girls
487545|NCT01481948|African American|african american
487546|NCT01481948|online|online
487547|NCT01481935|Antibiotic resistant bacteria|antibiotic resistant bacteria
487548|NCT01481935|Colonization|colonization
487549|NCT01481935|Hospital cleaning|hospital cleaning
487550|NCT01481935|Environmental cleaning|environmental cleaning
487551|NCT01481935|Infection Control|infection control
487552|NCT01481922|Lumbar puncture|lumbar puncture
487553|NCT01481922|Flow rate|flow rate
487554|NCT01481922|Backache|backache
487555|NCT01481922|Pain|pain
487556|NCT01481922|Undifferentiated headache|undifferentiated headache
487557|NCT01481922|Post-lumbar puncture headache|post-lumbar puncture headache
487558|NCT01481909|Assessment of wheal and flare development|assessment of wheal and flare development
487559|NCT01481909|Assessment of life quality|assessment of life quality
487560|NCT01481896|Hip replacement|hip replacement
487561|NCT01481896|Metal-on-metal bearings|metal-on-metal bearings
487562|NCT01481896|Osteolysis|osteolysis
487563|NCT01481896|Metal ion levels|metal ion levels
487564|NCT01481896|Outcome|outcome
487565|NCT01481883|Schizophrenia|schizophrenia
487566|NCT01481883|Mental Illness|mental illness
487567|NCT01481883|SERM|serm
487568|NCT01481883|Raloxifene|raloxifene
487569|NCT01481870|renal cell carcinoma|renal cell carcinoma
487570|NCT01481870|sorafenib|sorafenib
487571|NCT01481870|sunitinib|sunitinib
487572|NCT01481870|crossover|crossover
487573|NCT01481844|sequential therapy|sequential therapy
487574|NCT01481844|second line treatment|second line treatment
487575|NCT01481844|H pylori|h pylori
488678|NCT01477476|Diabetes|diabetes
487576|NCT01481792|Keratorefractive Surgical Procedures|keratorefractive surgical procedures
487577|NCT01481766|child development|child development
487578|NCT01481766|screening|screening
487579|NCT01481766|Non-anemic iron deficiency|non-anemic iron deficiency
487580|NCT01481766|primary care pediatrics|primary care pediatrics
487581|NCT01481766|prevention and health promotion|prevention and health promotion
487582|NCT01481740|spinal induced hypotension|spinal induced hypotension
487583|NCT01481740|nausea and vomiting|nausea and vomiting
487584|NCT01481740|cesarean delivery|cesarean delivery
487585|NCT01481727|acute exacerbation of COPD number|acute exacerbation of copd number
487586|NCT01481727|acute exacerbation of COPD severity|acute exacerbation of copd severity
487587|NCT01481714|Sodium picosulphate|sodium picosulphate
487588|NCT01481714|Split-dose|split-dose
487589|NCT01481714|Bowel cleansing|bowel cleansing
487590|NCT01481714|colonoscopy|colonoscopy
487591|NCT01481714|Degree of bowel cleansing during colonoscopy|degree of bowel cleansing during colonoscopy
487592|NCT01481701|ovarian carcinoma|ovarian carcinoma
487593|NCT01481701|Bordet|bordet
487594|NCT01481701|relapse|relapse
487595|NCT01481688|Dialysis adequacy|dialysis adequacy
487596|NCT01481688|Urea clearance|urea clearance
487597|NCT01481688|Phosphate clearance|phosphate clearance
487598|NCT01481688|Beta 2 microglobulin clearance|beta 2 microglobulin clearance
487599|NCT01481688|Intradialytic exercise|intradialytic exercise
487600|NCT01481688|Haemodialysis patients|haemodialysis patients
487601|NCT01481675|biliopancreatic diversion|biliopancreatic diversion
487602|NCT01481675|sleeve gastrectomy|sleeve gastrectomy
487603|NCT01481675|diabetes mellitus|diabetes mellitus
487604|NCT01481675|weight loss|weight loss
487605|NCT01481675|ghrelin|ghrelin
487607|NCT01481675|GLP-1|glp-1
487608|NCT01481662|SUSAC's Syndrome|susac's syndrome
487609|NCT01481662|encephalopathy|encephalopathy
487610|NCT01481662|hearing loss|hearing loss
487611|NCT01481662|retinal artery branch occlusions|retinal artery branch occlusions
487612|NCT01481662|Diffusion tensor MRI|diffusion tensor mri
487613|NCT01481649|hepatitis B|hepatitis b
487614|NCT01481649|anti-HBc|anti-hbc
487615|NCT01481649|HBsAg|hbsag
487616|NCT01481649|HSCT|hsct
487617|NCT01481649|recipients|recipients
487618|NCT01481636|Obstructive sleep apnea|obstructive sleep apnea
487619|NCT01481636|correlation|correlation
487620|NCT01481636|AHI|ahi
487621|NCT01481636|symptoms|symptoms
487622|NCT01481636|mechanisms|mechanisms
487623|NCT01481623|Diabetes|diabetes
487624|NCT01481623|neonatal|neonatal
487625|NCT01481623|consanguinity|consanguinity
487626|NCT01481623|monogenic|monogenic
487627|NCT01481623|metabolism|metabolism
487628|NCT01481610|Kidney Failure, Chronic|kidney failure, chronic
487629|NCT01481610|Arthralgia|arthralgia
487630|NCT01481610|NSAID|nsaid
487631|NCT01481610|Diclofenac|diclofenac
487632|NCT01481610|Lumiracoxib|lumiracoxib
487633|NCT01481610|Safety|safety
487634|NCT01481597|deuteporfin|deuteporfin
487635|NCT01481597|safety|safety
487636|NCT01481597|tolerability|tolerability
487637|NCT01481597|pharmacokinetics|pharmacokinetics
487638|NCT01481597|healthy volunteers|healthy volunteers
487639|NCT01481584|Dietary protein|dietary protein
487640|NCT01481584|Canola protein|canola protein
487641|NCT01481584|Protein metabolism|protein metabolism
487642|NCT01481584|Protein-enriched drinks|protein-enriched drinks
487643|NCT01481584|Nitrogen balance|nitrogen balance
487644|NCT01481571|Media for vitrification/warming of human oocytes|media for vitrification/warming of human oocytes
487645|NCT01481558|Apathy|apathy
487646|NCT01481558|Alzheimer's Disease|alzheimer's disease
487647|NCT01481558|Dementia|dementia
487648|NCT01481545|locally advanced|locally advanced
487649|NCT01481545|high risk|high risk
487650|NCT01481545|preoperative therapy|preoperative therapy
487651|NCT01481532|Antineoplastic agent|antineoplastic agent
487652|NCT01481519|Conjunctivitis|conjunctivitis
487653|NCT01481519|Ocular diseases|ocular diseases
487654|NCT01481519|Artificial tears|artificial tears
487655|NCT01481493|rheumatoid arthritis|rheumatoid arthritis
487656|NCT01481480|shoulder|shoulder
487657|NCT01481480|rotator cuff|rotator cuff
487658|NCT01481480|tendon transfer|tendon transfer
487659|NCT01481480|arthroscopic repair|arthroscopic repair
487660|NCT01481467|influenza vaccination|influenza vaccination
487661|NCT01481467|intervention mapping|intervention mapping
487662|NCT01481467|hospital care|hospital care
487663|NCT01481467|respiratory infections|respiratory infections
487664|NCT01481467|vaccination|vaccination
487665|NCT01481454|Influenza|influenza
487666|NCT01481454|Quadrivalent Inactivated Influenza Vaccine|quadrivalent inactivated influenza vaccine
487667|NCT01481454|Trivalent Inactivated Influenza Vaccine|trivalent inactivated influenza vaccine
487668|NCT01481441|Contrast Enhanced Ultrasound (CEUS)|contrast enhanced ultrasound (ceus)
487669|NCT01481441|Prostate cancer|prostate cancer
487670|NCT01481441|Quantification|quantification
487671|NCT01481441|Prostate biopsies|prostate biopsies
487672|NCT01481441|Transrectal ultrasound (TRUS)|transrectal ultrasound (trus)
487673|NCT01481441|Microbubbles|microbubbles
487674|NCT01481428|High risk behavior|high risk behavior
487675|NCT01481428|Drug court clients|drug court clients
487676|NCT01481428|Substance abuse|substance abuse
487677|NCT01481428|HIV intervention|hiv intervention
487678|NCT01481428|Treatment Court Clients|treatment court clients
487679|NCT01481415|left atrial|left atrial
487680|NCT01481415|three-dimensional echocardioraphy|three-dimensional echocardioraphy
487681|NCT01481415|left atrial function|left atrial function
487682|NCT01481402|Heart failure|heart failure
487683|NCT01481402|Liothyronine|liothyronine
487684|NCT01481402|Low T3 syndrome|low t3 syndrome
487685|NCT01481389|Blood lipids|blood lipids
487686|NCT01481389|risk factor for cardiovascular diseases|risk factor for cardiovascular diseases
487687|NCT01481376|Parietex™ ProGrip™|parietex™ progrip™
487688|NCT01481376|Laparoscopic Transabdominal preperitoneal|laparoscopic transabdominal preperitoneal
487689|NCT01481376|TAPP|tapp
487690|NCT01481376|Inguinal hernia repair|inguinal hernia repair
487691|NCT01481363|dementia|dementia
487692|NCT01481363|communication|communication
487693|NCT01481363|carers|carers
487694|NCT01481363|caregivers|caregivers
487695|NCT01481363|psychosocial support systems|psychosocial support systems
487696|NCT01481363|education|education
487697|NCT01481337|colon|colon
487698|NCT01481337|endoscopy|endoscopy
487699|NCT01481337|resection|resection
487700|NCT01481324|Clubfoot|clubfoot
487701|NCT01481324|Compliance|compliance
487702|NCT01481324|Brace wear|brace wear
487703|NCT01481285|Bioelectrical Impedance Measurement|bioelectrical impedance measurement
487704|NCT01481285|Adults|adults
487705|NCT01481272|Salvage therapy in DLBCL|salvage therapy in dlbcl
487706|NCT01481259|Nonsquamous non-small cell lung cancer|nonsquamous non-small cell lung cancer
487707|NCT01481259|Maintenance therapy|maintenance therapy
487708|NCT01481259|Immunotherapy|immunotherapy
487709|NCT01481259|Autologous cytokine-induced killer cell|autologous cytokine-induced killer cell
487710|NCT01481259|Pemetrexed|pemetrexed
487711|NCT01481246|neurorehabilitation|neurorehabilitation
487712|NCT01481246|cognition|cognition
487713|NCT01481246|aging|aging
487714|NCT01481246|MCI|mci
487715|NCT01481246|cognitive decline|cognitive decline
487716|NCT01481233|oral colchicine|oral colchicine
487717|NCT01481233|castrate-resistant prostate cancer|castrate-resistant prostate cancer
487718|NCT01481233|failed taxotere based chemotherapy|failed taxotere based chemotherapy
487719|NCT01481220|Myelodysplastic syndrome|myelodysplastic syndrome
487720|NCT01481220|azacitidine|azacitidine
487721|NCT01481220|Eltrombopag|eltrombopag
487722|NCT01481220|Thrombopoietin-receptor agonist|thrombopoietin-receptor agonist
487723|NCT01481220|Thrombocytopenia|thrombocytopenia
487724|NCT01481220|Transfusion dependency|transfusion dependency
487725|NCT01481220|Safety study|safety study
487726|NCT01481207|magnetic resonance spectroscopy|magnetic resonance spectroscopy
487727|NCT01481207|magnetic resonance imaging|magnetic resonance imaging
487728|NCT01481194|Multiple Myeloma|multiple myeloma
487729|NCT01481181|zinc water diarrhoea growth preschool children|zinc water diarrhoea growth preschool children
487730|NCT01481155|actinic keratosis|actinic keratosis
487731|NCT01481155|field cancerisation|field cancerisation
487732|NCT01481116|Drug Therapy|drug therapy
487733|NCT01481103|Over the counter medication|over the counter medication
487734|NCT01481103|Acupuncture|acupuncture
487735|NCT01481090|Infertility|infertility
487736|NCT01481090|acupuncture|acupuncture
487737|NCT01481090|frozen embryos|frozen embryos
487738|NCT01481090|endometrium|endometrium
487739|NCT01481090|TCM|tcm
487740|NCT01481064|Patient centredness|patient centredness
487741|NCT01481064|Quality of life|quality of life
487742|NCT01481064|Multifaceted approach|multifaceted approach
487743|NCT01481064|Fertility care|fertility care
487744|NCT01481038|early detection|early detection
487745|NCT01481038|CRBSI|crbsi
487746|NCT01481025|Climacteric|climacteric
487747|NCT01481025|Depression|depression
487748|NCT01481025|Herbal treatment|herbal treatment
487749|NCT01481012|Heart transplantation|heart transplantation
487750|NCT01481012|Coronary artery bypass graft (CABG) surgery|coronary artery bypass graft (cabg) surgery
487751|NCT01481012|Left ventricular assist device implantation surgeries|left ventricular assist device implantation surgeries
487752|NCT01480999|Laparotomy|laparotomy
487753|NCT01480999|Open Surgery|open surgery
487754|NCT01480999|Laparoscopy|laparoscopy
487755|NCT01480999|Robotic surgery|robotic surgery
487756|NCT01480960|lung transplantation|lung transplantation
487757|NCT01480960|whole body vibration|whole body vibration
487758|NCT01480960|exercise training|exercise training
487759|NCT01480960|pulmonary rehabilitation|pulmonary rehabilitation
487760|NCT01480947|probiotics|probiotics
487761|NCT01480947|pediatric|pediatric
487762|NCT01480947|salmonella|salmonella
487763|NCT01480947|rotavirus|rotavirus
487764|NCT01480947|gastroenteritis|gastroenteritis
487765|NCT01480934|Diabetes,posterior capsule opacification,case control study|diabetes,posterior capsule opacification,case control study
487766|NCT01480921|heart failure|heart failure
487767|NCT01480921|health related quality of life|health related quality of life
487768|NCT01480921|exercise capacity|exercise capacity
487769|NCT01480921|home based exercise training|home based exercise training
487770|NCT01480921|supervised exercise training|supervised exercise training
487771|NCT01480908|Right bundle branch block|right bundle branch block
487772|NCT01480908|Ventricular septal defect|ventricular septal defect
487773|NCT01480908|Echocardiography|echocardiography
487774|NCT01480908|MRI|mri
487775|NCT01480908|Exercise testing|exercise testing
487776|NCT01480895|Diabetes Mellitus Type 2|diabetes mellitus type 2
487777|NCT01480895|Gestational Diabetes Mellitus|gestational diabetes mellitus
487778|NCT01480895|Glucose Intolerance|glucose intolerance
487779|NCT01480895|Physical exercise|physical exercise
487780|NCT01480895|Nutritional Habits|nutritional habits
487781|NCT01480895|Dyslipidemia|dyslipidemia
487782|NCT01480882|Manual percussion|manual percussion
487783|NCT01480882|Mechanical percussion|mechanical percussion
487784|NCT01480882|Chronic bronchiectasis|chronic bronchiectasis
487785|NCT01480882|Chronic Obstructive Pulmonary Disease|chronic obstructive pulmonary disease
487786|NCT01480882|Wet sputum weight|wet sputum weight
487787|NCT01480882|Dry sputum weight|dry sputum weight
487788|NCT01480869|Breast cancer|breast cancer
487789|NCT01480869|Vitamin D supplementation|vitamin d supplementation
487790|NCT01480869|in neoadjuvant|in neoadjuvant
487791|NCT01480869|adjuvant setting|adjuvant setting
487792|NCT01480843|simplification|simplification
487793|NCT01480843|glargine|glargine
487794|NCT01480843|elderly|elderly
487795|NCT01480830|Quality|quality
487796|NCT01480830|indicators|indicators
487797|NCT01480804|Barriers|barriers
487798|NCT01480804|Intervention|intervention
487799|NCT01480804|Elderly|elderly
487800|NCT01480804|glycemic control|glycemic control
487801|NCT01480791|resistance arteries|resistance arteries
487802|NCT01480791|endothelial dysfunction|endothelial dysfunction
487803|NCT01480791|aortic stiffness|aortic stiffness
487922|NCT01480362|Amputation wound|amputation wound
487804|NCT01480778|hormonal response, levonorgestrel, ethinyl estradiol|hormonal response, levonorgestrel, ethinyl estradiol
710740|NCT00588120|Unknown Hyperoxaluria|unknown hyperoxaluria
487805|NCT01480752|In the patients with symptomatic Irreversible Pulpitis|in the patients with symptomatic irreversible pulpitis
487806|NCT01480739|Phase 1, AZD5069, safety and tolerability, healthy volunteer,|phase 1, azd5069, safety and tolerability, healthy volunteer,
487807|NCT01480713|HIV-1|hiv-1
487808|NCT01480713|protease inhibitors|protease inhibitors
487809|NCT01480713|integrase inhibitors|integrase inhibitors
487810|NCT01480713|raltegravir|raltegravir
487811|NCT01480713|viral replication|viral replication
487812|NCT01480713|treatment intensification|treatment intensification
487813|NCT01480713|viral pathogenesis|viral pathogenesis
487814|NCT01480713|immune activation|immune activation
487815|NCT01480700|eggs|eggs
487816|NCT01480700|Optical Macular Pigment|optical macular pigment
487817|NCT01480700|Age Macular Degeneration|age macular degeneration
487818|NCT01480700|study for the Age Macular Degeneration prevention|study for the age macular degeneration prevention
487819|NCT01480687|Hypertension|hypertension
487820|NCT01480687|Endothelial dysfunction|endothelial dysfunction
487821|NCT01480687|Vascular stiffness|vascular stiffness
487822|NCT01480661|Pulmonary Disease, Chronic Obstructive|pulmonary disease, chronic obstructive
487823|NCT01480661|Computed Tomography scan|computed tomography scan
487824|NCT01480661|Functional Respiratory Imaging|functional respiratory imaging
487825|NCT01480661|Roflumilast|roflumilast
487826|NCT01480661|Health Related Quality of Life|health related quality of life
487827|NCT01480635|Incomplete Colonoscopy|incomplete colonoscopy
487828|NCT01480635|Efficacy of PillCam Colon2|efficacy of pillcam colon2
487829|NCT01480622|healthy subjects|healthy subjects
487830|NCT01480622|Tenofovir disoproxil fumarate|tenofovir disoproxil fumarate
487831|NCT01480622|hepatitis|hepatitis
487832|NCT01480622|pharmacokinetics|pharmacokinetics
487833|NCT01480583|GRN1005|grn1005
487834|NCT01480583|ANG1005|ang1005
487835|NCT01480583|Peptide-Drug Conjugate (PDC)|peptide-drug conjugate (pdc)
487836|NCT01480583|LRP-1|lrp-1
487837|NCT01480583|Targeted Therapy|targeted therapy
487838|NCT01480583|Breast Cancer|breast cancer
487839|NCT01480583|Brain Metastases|brain metastases
487840|NCT01480583|Brain Tumor|brain tumor
487841|NCT01480583|Blood Brain Barrier|blood brain barrier
487842|NCT01480583|Trastuzumab|trastuzumab
487843|NCT01480583|Herceptin|herceptin
487844|NCT01480583|Paclitaxel|paclitaxel
487845|NCT01480583|Taxol|taxol
487846|NCT01480583|Breast cancer with brain metastases|breast cancer with brain metastases
487847|NCT01480557|cataract|cataract
487848|NCT01480557|phacoemulsification|phacoemulsification
487849|NCT01480557|liquefaction|liquefaction
487850|NCT01480557|torsional ip|torsional ip
487851|NCT01480557|endothelial cell count|endothelial cell count
487852|NCT01480557|central corneal edema|central corneal edema
487853|NCT01480557|central corneal sensitivity|central corneal sensitivity
487854|NCT01480544|Institutional Deliveries|institutional deliveries
487855|NCT01480544|Maternal Health|maternal health
487856|NCT01480544|Infant Health|infant health
487857|NCT01480544|Private Medical Providers|private medical providers
487858|NCT01480544|Provider Incentives|provider incentives
487859|NCT01480544|Randomized Control Trial|randomized control trial
487860|NCT01480531|aorta|aorta
487861|NCT01480531|aneurysm|aneurysm
487862|NCT01480531|dissection|dissection
487959|NCT01480219|heart/lung transplant|heart/lung transplant
487863|NCT01480518|localized Ewing sarcoma/peripheral primitive neuroectodermal tumor|localized ewing sarcoma/peripheral primitive neuroectodermal tumor
487864|NCT01480505|Retinal detachment|retinal detachment
487865|NCT01480505|high myopia|high myopia
487866|NCT01480505|macular hole|macular hole
487867|NCT01480505|axial length|axial length
487868|NCT01480505|Scleral buckling|scleral buckling
487869|NCT01480505|Vitrectomy|vitrectomy
487870|NCT01480505|Visual acuity|visual acuity
487871|NCT01480505|fundus examination results|fundus examination results
487872|NCT01480492|HBV|hbv
487873|NCT01480492|Immune|immune
487874|NCT01480492|antiviral therapy|antiviral therapy
487875|NCT01480479|EGFRvIII|egfrviii
487876|NCT01480479|Glioblastoma|glioblastoma
487877|NCT01480479|Small cell|small cell
487878|NCT01480479|Giant cell|giant cell
487879|NCT01480479|Gliosarcoma|gliosarcoma
487880|NCT01480479|oligodendroglial|oligodendroglial
487881|NCT01480479|Brain Cancer|brain cancer
487882|NCT01480479|Brain Tumor|brain tumor
487883|NCT01480479|radiotherapy|radiotherapy
487884|NCT01480479|chemoradiation|chemoradiation
487885|NCT01480479|Tumor|tumor
487886|NCT01480479|temozolomide|temozolomide
487887|NCT01480479|EGFR variant III|egfr variant iii
487888|NCT01480466|Overweight|overweight
487889|NCT01480466|Obesity|obesity
487890|NCT01480466|Body mass index|body mass index
487891|NCT01480466|Weight|weight
487892|NCT01480466|Primary care|primary care
487893|NCT01480453|Osteoarthritis|osteoarthritis
487894|NCT01480453|Rheumatoid arthritis|rheumatoid arthritis
487895|NCT01480453|Post-traumatic arthritis|post-traumatic arthritis
487896|NCT01480453|Ununited humeral head fracture|ununited humeral head fracture
487897|NCT01480453|Irreducible 3- and 4-part proximal humeral fractures|irreducible 3- and 4-part proximal humeral fractures
487898|NCT01480453|Avascular necrosis|avascular necrosis
487899|NCT01480440|Reverse Total Shoulder Arthroplasty|reverse total shoulder arthroplasty
487900|NCT01480440|Reverse TSA|reverse tsa
487901|NCT01480440|Osteoarthritis|osteoarthritis
487902|NCT01480440|Rheumatoid Arthritis|rheumatoid arthritis
487903|NCT01480440|Post-traumatic arthritis|post-traumatic arthritis
487904|NCT01480440|Ununited humeral head fracture|ununited humeral head fracture
487905|NCT01480440|Irreducible 3-and 4-part proximal humeral fractures|irreducible 3-and 4-part proximal humeral fractures
487906|NCT01480440|Avascular necrosis|avascular necrosis
487907|NCT01480440|Gross rotator cuff deficiency|gross rotator cuff deficiency
487908|NCT01480440|Failed total shoulder arthroplasty (glenoid & humeral components require revision)|failed total shoulder arthroplasty (glenoid & humeral components require revision)
487909|NCT01480427|Children aged 0-12 years|children aged 0-12 years
487910|NCT01480427|IgE mediated food allergy|ige mediated food allergy
487911|NCT01480414|bone marrow mono nuclear stem cell ischemic ulcer|bone marrow mono nuclear stem cell ischemic ulcer
487912|NCT01480401|Patients with stable heart failure|patients with stable heart failure
487913|NCT01480388|Rheumatoid arthritis|rheumatoid arthritis
487914|NCT01480388|Swollen and tender joints|swollen and tender joints
487915|NCT01480388|Dose range finding study|dose range finding study
487916|NCT01480388|Concurrent treatment with methotrexate|concurrent treatment with methotrexate
487917|NCT01480375|prostate cancer detection|prostate cancer detection
487918|NCT01480375|prostate biopsy|prostate biopsy
487919|NCT01480375|3d navigation|3d navigation
487920|NCT01480375|trans rectal ultrasound|trans rectal ultrasound
487921|NCT01480362|Diabetic foot wound|diabetic foot wound
487923|NCT01480362|Chronic wound|chronic wound
487924|NCT01480349|Post-Hemorrhagic Hydrocephalus|post-hemorrhagic hydrocephalus
487925|NCT01480349|Intraventricular Hemorrhage|intraventricular hemorrhage
487926|NCT01480349|Low Birth Weight Premature Infants|low birth weight premature infants
487927|NCT01480336|Arrhythmia|arrhythmia
487928|NCT01480323|Malignant melanoma|malignant melanoma
487929|NCT01480297|Pain|pain
487930|NCT01480297|Neuropathy|neuropathy
487931|NCT01480297|Diabetes type 1|diabetes type 1
487932|NCT01480284|Tenofovir Disoproxil Fumarate|tenofovir disoproxil fumarate
487933|NCT01480284|Chronic Hepatitis B|chronic hepatitis b
487934|NCT01480271|Allergic Rhinitis|allergic rhinitis
487935|NCT01480271|Healthy Volunteers|healthy volunteers
487936|NCT01480271|Single Dose Escalation|single dose escalation
487937|NCT01480271|TLR7 agonist|tlr7 agonist
487938|NCT01480271|First Time in Human Study|first time in human study
487939|NCT01480258|combination vaccine|combination vaccine
487940|NCT01480258|diphtheria|diphtheria
487941|NCT01480258|pertussis|pertussis
487942|NCT01480258|tetanus|tetanus
487943|NCT01480258|hepatitis B|hepatitis b
487944|NCT01480258|Hep B|hep b
487945|NCT01480258|Haemophilus influenzae b|haemophilus influenzae b
487946|NCT01480258|Hib|hib
487947|NCT01480258|polio|polio
487948|NCT01480258|poliovirus|poliovirus
487949|NCT01480245|968|968
487950|NCT01480245|Duchenne|duchenne
487951|NCT01480245|DMD|dmd
487952|NCT01480245|drisapersen|drisapersen
487953|NCT01480219|voriconazole|voriconazole
487954|NCT01480219|non-melanoma skin cancer|non-melanoma skin cancer
487955|NCT01480219|confounding|confounding
487956|NCT01480219|statistical adjustment|statistical adjustment
487957|NCT01480219|risk adjustment|risk adjustment
487958|NCT01480219|lung transplant|lung transplant
487960|NCT01480219|immunosuppression|immunosuppression
487961|NCT01480193|Tinnitus|tinnitus
487962|NCT01480167|VCF|vcf
487963|NCT01480167|Osteoporosis|osteoporosis
487964|NCT01480167|Minimally Invasive|minimally invasive
487965|NCT01480167|Non-operative management|non-operative management
487966|NCT01480167|Medical Management|medical management
487967|NCT01480128|Single-port|single-port
487968|NCT01480128|Laparoscopy|laparoscopy
487969|NCT01480128|colectomy|colectomy
487970|NCT01480128|Single port|single port
487971|NCT01480128|colon cancer|colon cancer
487972|NCT01480128|minimally invasive surgery|minimally invasive surgery
487973|NCT01480115|antral follicle count|antral follicle count
487974|NCT01480115|automated antral follicle count|automated antral follicle count
487975|NCT01480115|ovarian reserve|ovarian reserve
487976|NCT01480102|Percutaneous nephrolithotomy|percutaneous nephrolithotomy
487977|NCT01480102|Paravertebral block|paravertebral block
487978|NCT01480102|bupivacaine|bupivacaine
487979|NCT01480089|Surgical Pain Management|surgical pain management
487980|NCT01480089|Robotic surgery|robotic surgery
487981|NCT01480089|Ropivacaine|ropivacaine
487982|NCT01480076|Quality of Life|quality of life
487983|NCT01480076|Multiple Sclerosis|multiple sclerosis
487984|NCT01480050|adult giant cell glioblastoma|adult giant cell glioblastoma
487985|NCT01480050|adult glioblastoma|adult glioblastoma
487986|NCT01480050|adult anaplastic astrocytoma|adult anaplastic astrocytoma
487987|NCT01480050|adult anaplastic ependymoma|adult anaplastic ependymoma
487988|NCT01480050|adult anaplastic oligodendroglioma|adult anaplastic oligodendroglioma
487989|NCT01480050|adult mixed glioma|adult mixed glioma
487990|NCT01480050|recurrent adult brain tumor|recurrent adult brain tumor
487991|NCT01480024|healthy women|healthy women
487992|NCT01480024|oocytes|oocytes
487993|NCT01480024|in vitro fertilization|in vitro fertilization
487994|NCT01480024|pregnancy|pregnancy
487995|NCT01480024|childbearing-age|childbearing-age
487996|NCT01480011|Lactobacillus CD2 lozenges|lactobacillus cd2 lozenges
487997|NCT01480011|high-dose chemotherapy induced|high-dose chemotherapy induced
487998|NCT01480011|hematopoietic stem cell transplantation|hematopoietic stem cell transplantation
487999|NCT01479998|smoking cessation|smoking cessation
488000|NCT01479998|NRT nicotine replacement therapy|nrt nicotine replacement therapy
488001|NCT01479998|CBT cognitive behavioral therapy|cbt cognitive behavioral therapy
488002|NCT01479998|contingency management|contingency management
488003|NCT01479972|Tuberculosis|tuberculosis
488004|NCT01479972|Vaccine|vaccine
488005|NCT01479972|Live vaccine|live vaccine
488006|NCT01479972|rBCG|rbcg
488007|NCT01479959|Tracheostomy|tracheostomy
488008|NCT01479959|positive end expiratory pressure|positive end expiratory pressure
488009|NCT01479959|speech|speech
488010|NCT01479959|respiratory failure|respiratory failure
488011|NCT01479959|ventilation|ventilation
488012|NCT01479959|neuromuscular disorders|neuromuscular disorders
488013|NCT01479933|vitamin D|vitamin d
488014|NCT01479933|cholecalciferol|cholecalciferol
488015|NCT01479933|supplementation|supplementation
488016|NCT01479933|prediabetic state|prediabetic state
488017|NCT01479933|obesity|obesity
488018|NCT01479933|glucose metabolism|glucose metabolism
488019|NCT01479933|gene expression|gene expression
488020|NCT01479933|transcriptomics|transcriptomics
488021|NCT01479933|epigenomics|epigenomics
488022|NCT01479933|immunological function|immunological function
488023|NCT01479933|insulin sensitivity|insulin sensitivity
488024|NCT01479933|peripheral mononuclear cells|peripheral mononuclear cells
488025|NCT01479920|Depressive Disorder|depressive disorder
488026|NCT01479920|Depressive Symptoms|depressive symptoms
488027|NCT01479920|Depressive Syndrome|depressive syndrome
488028|NCT01479920|Emotional Depression|emotional depression
488029|NCT01479881|Hepatitis C Virus|hepatitis c virus
488030|NCT01479881|TMC435|tmc435
488031|NCT01479881|TMC435-TiDP16-C120|tmc435-tidp16-c120
488032|NCT01479881|TMC435-C120|tmc435-c120
488033|NCT01479881|HCV|hcv
488034|NCT01479881|Hepatitis C|hepatitis c
488035|NCT01479881|Hep C|hep c
488036|NCT01479881|Healthy participants|healthy participants
488037|NCT01479868|Hepatitis C virus genotype-1|hepatitis c virus genotype-1
488038|NCT01479868|Human immunodeficiency virus-type 1|human immunodeficiency virus-type 1
488039|NCT01479868|HCV-1|hcv-1
488040|NCT01479868|HIV-1|hiv-1
488041|NCT01479868|TMC435|tmc435
488042|NCT01479868|Pegylated interferon alpha-2a|pegylated interferon alpha-2a
488043|NCT01479868|PegIFNα-2a|pegifnα-2a
488044|NCT01479868|Pegasys|pegasys
488045|NCT01479868|Ribavirin|ribavirin
488046|NCT01479868|RBV|rbv
488047|NCT01479868|Copegus|copegus
488048|NCT01479855|Mild Cognitive Impairment (MCI)|mild cognitive impairment (mci)
488049|NCT01479855|Alzheimers disease|alzheimers disease
488050|NCT01479855|Vitamines|vitamines
488051|NCT01479855|Nutrients|nutrients
488052|NCT01479829|Bipolar depression|bipolar depression
488053|NCT01479829|Celecoxib|celecoxib
488054|NCT01479829|Escitalopram|escitalopram
488055|NCT01479829|Inflammation|inflammation
488056|NCT01479816|continence|continence
488057|NCT01479816|index|index
488058|NCT01479790|Visante AS-OCT|visante as-oct
488059|NCT01479790|Cirrus AS-OCT|cirrus as-oct
488060|NCT01479790|Thermography|thermography
488061|NCT01479790|Tear evaporation|tear evaporation
488062|NCT01479790|Tear evaporimetry|tear evaporimetry
488063|NCT01479777|Spinal Cord Injury|spinal cord injury
488064|NCT01479777|Functional electrical stimulation|functional electrical stimulation
488065|NCT01479777|Rehabilitation|rehabilitation
488066|NCT01479751|Rocuronium|rocuronium
488067|NCT01479751|magnesium|magnesium
488068|NCT01479751|priming|priming
488069|NCT01479751|ketamine|ketamine
488070|NCT01479751|intubation|intubation
488071|NCT01479738|arthroplasty|arthroplasty
488072|NCT01479738|graft|graft
488073|NCT01479738|capitate|capitate
488074|NCT01479738|artery|artery
488075|NCT01479725|interstitial cystitis|interstitial cystitis
488076|NCT01479712|Irrigation|irrigation
488077|NCT01479712|Cesarean Section|cesarean section
488078|NCT01479712|Nausea|nausea
488079|NCT01479712|Infection|infection
488080|NCT01479699|Olive leaf extract|olive leaf extract
488081|NCT01479699|Polyphenols|polyphenols
488082|NCT01479699|Vascular function|vascular function
488083|NCT01479699|Bioavailability|bioavailability
488084|NCT01479699|Cytokines|cytokines
488085|NCT01479686|GLIOMA|glioma
488086|NCT01479686|NEURONAVIGATION|neuronavigation
488087|NCT01479686|INTERVENTIONAL MRI|interventional mri
488088|NCT01479673|Enteral Nutrition|enteral nutrition
488089|NCT01479673|Parenteral Nutrition|parenteral nutrition
488090|NCT01479673|Indirect Calorimetry|indirect calorimetry
488091|NCT01479673|Intravenous Feeding|intravenous feeding
488092|NCT01479660|Probiotics|probiotics
488093|NCT01479660|ulcerative colitis|ulcerative colitis
488094|NCT01479660|inflammatory bowel disease|inflammatory bowel disease
621997|NCT00933374|RAD001|rad001
488097|NCT01479621|Dose Ranging|dose ranging
488098|NCT01479621|Fluticasone Propionate|fluticasone propionate
488099|NCT01479621|Dry Powder Inhaler (DPI)|dry powder inhaler (dpi)
488100|NCT01479621|Non-steroidal|non-steroidal
488101|NCT01479621|Asthma|asthma
488102|NCT01479595|Asthma|asthma
488103|NCT01479595|Interleukin|interleukin
488104|NCT01479595|QBX258|qbx258
488105|NCT01479595|QAX576|qax576
488106|NCT01479595|VAK694|vak694
488107|NCT01479582|Adult and Pediatric|adult and pediatric
488108|NCT01479582|Unlicensed Cord Blood Unit IND|unlicensed cord blood unit ind
488109|NCT01479582|NMDP|nmdp
488110|NCT01479582|Transplant|transplant
488111|NCT01479582|Hematologic Malignancies|hematologic malignancies
488112|NCT01479582|Leukemia|leukemia
488113|NCT01479582|Multiple Myeloma|multiple myeloma
488114|NCT01479582|Non-Hodgkin Lymphoma|non-hodgkin lymphoma
488115|NCT01479582|CML|cml
488116|NCT01479582|Chronic Myelogenous Leukemia|chronic myelogenous leukemia
488117|NCT01479582|Myelodyplastic Syndrome|myelodyplastic syndrome
488118|NCT01479582|MDS|mds
488119|NCT01479582|Thalassemia|thalassemia
488120|NCT01479582|Lysosomal Storage Diseases|lysosomal storage diseases
488121|NCT01479569|MRI Catheterization|mri catheterization
488122|NCT01479569|Pericardiocentesis|pericardiocentesis
488123|NCT01479569|MRI Safety|mri safety
488124|NCT01479569|Cardiac Magnetic Resonance Imaging|cardiac magnetic resonance imaging
488125|NCT01479556|Pregabalin|pregabalin
488126|NCT01479556|Neuropathic pain|neuropathic pain
488127|NCT01479556|At-level neuropathic pain|at-level neuropathic pain
488128|NCT01479556|Non-evoked neuropathic pain|non-evoked neuropathic pain
488129|NCT01479556|Evoked neuropathic pain|evoked neuropathic pain
488130|NCT01479556|Sub-acute spinal cord injury|sub-acute spinal cord injury
488131|NCT01479543|Probiotic|probiotic
488132|NCT01479543|Immunity|immunity
488133|NCT01479543|Gastrointestinal symptoms|gastrointestinal symptoms
488134|NCT01479530|Rasagiline|rasagiline
488135|NCT01479530|Azilect|azilect
488136|NCT01479530|Parkinson´s Disease|parkinson´s disease
488137|NCT01479530|Motor fluctuations|motor fluctuations
488138|NCT01479517|operative|operative
488139|NCT01479517|dental procedure|dental procedure
488140|NCT01479504|Nasopharyngeal Carcinoma|nasopharyngeal carcinoma
488141|NCT01479504|neoadjuvant chemotherapy|neoadjuvant chemotherapy
488142|NCT01479504|concurrent chemoradiotherapy|concurrent chemoradiotherapy
488143|NCT01479504|Nedaplatin|nedaplatin
488144|NCT01479491|Japan|japan
488145|NCT01479491|Retrospective|retrospective
488146|NCT01479491|Observational|observational
488147|NCT01479491|Epidemiological study|epidemiological study
488148|NCT01479491|Children aged < 12 months|children aged < 12 months
488149|NCT01479491|Intussusception|intussusception
488150|NCT01479465|GSI|gsi
488151|NCT01479465|Gilead|gilead
488152|NCT01479465|Gilead Sciences|gilead sciences
488153|NCT01479465|GS-6624|gs-6624
488154|NCT01479465|Colorectal Cancer|colorectal cancer
488155|NCT01479465|KRAS|kras
488156|NCT01479465|Oncology|oncology
488157|NCT01479465|monoclonal antibody|monoclonal antibody
488158|NCT01479452|obesity|obesity
488159|NCT01479452|bariatric surgery|bariatric surgery
488160|NCT01479452|weight loss|weight loss
488161|NCT01479426|Erectile dysfunction|erectile dysfunction
488162|NCT01479426|Korean Red Ginseng|korean red ginseng
488163|NCT01479426|IIEF(International Index of Erectile Function)|iief(international index of erectile function)
488164|NCT01479426|MSHQ(Male Sexual Health Questionnaire,)|mshq(male sexual health questionnaire,)
488165|NCT01479413|Schizophrenia|schizophrenia
488166|NCT01479413|Oxidative stress|oxidative stress
488167|NCT01479413|Mitochondria|mitochondria
488168|NCT01479400|antipsychotic|antipsychotic
488169|NCT01479400|schizophrenia|schizophrenia
488170|NCT01479400|infant development|infant development
488171|NCT01479387|Zevalin|zevalin
488172|NCT01479387|CD20+|cd20+
488173|NCT01479387|Non-Hodgkin's lymphoma|non-hodgkin's lymphoma
488174|NCT01479387|Mantle cell lymphoma|mantle cell lymphoma
488175|NCT01479374|Allergic Conjunctivitis|allergic conjunctivitis
488176|NCT01479374|Ocular Allergy|ocular allergy
488177|NCT01479361|Atovaquone|atovaquone
488178|NCT01479361|Drug Interaction|drug interaction
488179|NCT01479361|Pharmacokinetics|pharmacokinetics
488180|NCT01479361|Efavirenz|efavirenz
488181|NCT01479361|Atazanavir-Ritonavir|atazanavir-ritonavir
488182|NCT01479361|HIV|hiv
488183|NCT01479348|Imaging|imaging
488184|NCT01479348|Radiopharmaceutical|radiopharmaceutical
488185|NCT01479348|Safety|safety
488186|NCT01479348|Dosimetry|dosimetry
488187|NCT01479348|Drug Distribution|drug distribution
488188|NCT01479348|Cancer|cancer
488189|NCT01479322|Intima-media thickness|intima-media thickness
488190|NCT01479322|Ghrelin|ghrelin
488191|NCT01479322|Prader-Willi syndrome|prader-willi syndrome
488192|NCT01479283|Infection|infection
488193|NCT01479283|Bone Neoplasms|bone neoplasms
488194|NCT01479283|Prosthesis|prosthesis
488195|NCT01479283|Anti-Bacterial Agents|anti-bacterial agents
488196|NCT01479283|Randomized|randomized
488197|NCT01479270|recovery|recovery
488198|NCT01479270|postoperative|postoperative
488199|NCT01479270|pain|pain
488200|NCT01479270|laparoscopy|laparoscopy
488201|NCT01479270|hysterectomy|hysterectomy
488202|NCT01479270|ropivacaine|ropivacaine
488203|NCT01479270|TAP block|tap block
488204|NCT01479270|local anesthesia|local anesthesia
488205|NCT01479257|Cancer|cancer
488206|NCT01479257|Risk factors|risk factors
488207|NCT01479257|Latinos|latinos
488208|NCT01479257|Hispanic Americans|hispanic americans
488209|NCT01479257|Hispanics|hispanics
488210|NCT01479257|Latino resident|latino resident
488211|NCT01479257|Houston metropolitan area|houston metropolitan area
488212|NCT01479257|Spanish speaking|spanish speaking
488213|NCT01479257|Cancer risk behaviors|cancer risk behaviors
488214|NCT01479257|Questionnaires|questionnaires
488215|NCT01479257|Surveys|surveys
488216|NCT01479257|Accelerometer|accelerometer
488217|NCT01479244|HER2|her2
488218|NCT01479244|low or intermediate|low or intermediate
488219|NCT01479244|breast cancer|breast cancer
488220|NCT01479244|node-positive tumors|node-positive tumors
488221|NCT01479231|GERD|gerd
488222|NCT01479231|Eosinophilic esophagitis|eosinophilic esophagitis
488223|NCT01479231|Proton pump inhibitor|proton pump inhibitor
488224|NCT01479231|dysphagia|dysphagia
488225|NCT01479205|specific immunotherapy|specific immunotherapy
488226|NCT01479205|bronchial allergen provocation|bronchial allergen provocation
488227|NCT01479205|specific IgE|specific ige
488228|NCT01479205|specific IgG|specific igg
488229|NCT01479205|specific IgG4|specific igg4
488230|NCT01479205|SIT|sit
488231|NCT01479192|breast|breast
488232|NCT01479192|cancer|cancer
488233|NCT01479192|prevention|prevention
488234|NCT01479192|fenretinide|fenretinide
488235|NCT01479179|Breast Cancer|breast cancer
488236|NCT01479179|Metastatic Breast Cancer|metastatic breast cancer
488237|NCT01479179|HER-2-overexpressing breast cancer|her-2-overexpressing breast cancer
488238|NCT01479179|Human epidermal growth factor receptor|human epidermal growth factor receptor
488239|NCT01479179|AMG 479|amg 479
488240|NCT01479179|Trastuzumab|trastuzumab
488241|NCT01479179|Herceptin|herceptin
488242|NCT01479166|cystic fibrosis|cystic fibrosis
488243|NCT01479166|HRCT|hrct
488244|NCT01479166|Sputum|sputum
488245|NCT01479166|Blood|blood
488246|NCT01479166|Inflammation|inflammation
488247|NCT01479166|adaptive immune system|adaptive immune system
488248|NCT01479166|innate immune system|innate immune system
488249|NCT01479153|Central venous catheterization|central venous catheterization
488250|NCT01479153|Major complications|major complications
488251|NCT01479153|Internal Jugular|internal jugular
488252|NCT01479153|Femoral|femoral
488253|NCT01479153|Subclavian|subclavian
488254|NCT01479140|myocardial infarction|myocardial infarction
488255|NCT01479140|dissection|dissection
488256|NCT01479140|coronary Fibromuscular Dysplasia|coronary fibromuscular dysplasia
488257|NCT01479140|coronary ectasia|coronary ectasia
488258|NCT01479140|atherosclerotic Coronary Artery Disease|atherosclerotic coronary artery disease
488259|NCT01479140|coronary vasculitis|coronary vasculitis
488260|NCT01479140|coronary embolism|coronary embolism
488261|NCT01479140|congenital coronary anomaly|congenital coronary anomaly
488262|NCT01479127|Levodopa-carbidopa intestinal gel|levodopa-carbidopa intestinal gel
488263|NCT01479127|Advanced Parkinson's disease|advanced parkinson's disease
488264|NCT01479127|Severe motor fluctuations|severe motor fluctuations
488265|NCT01479127|Dyskinesia|dyskinesia
488676|NCT01477502|prevention|prevention
488266|NCT01479101|neo adjuvant, breast cancer|neo adjuvant, breast cancer
488267|NCT01479088|Cinacalcet|cinacalcet
488268|NCT01479088|PK|pk
488269|NCT01479088|Secondary Hyperparathyroidism|secondary hyperparathyroidism
488270|NCT01479088|Paediatric|paediatric
488271|NCT01479088|Chronic Kidney Disease|chronic kidney disease
488272|NCT01479088|Dialysis|dialysis
488273|NCT01479075|central insulin|central insulin
488274|NCT01479075|insulin resistance|insulin resistance
488275|NCT01479075|energy metabolism|energy metabolism
488276|NCT01479062|behavior change|behavior change
488277|NCT01479062|pre-diabetes|pre-diabetes
488278|NCT01479062|prevention|prevention
488279|NCT01479062|diabetes prevention|diabetes prevention
488280|NCT01479062|Hemoglobin A1c|hemoglobin a1c
488281|NCT01479062|glucose|glucose
488282|NCT01479062|physical activity|physical activity
488283|NCT01479062|nutrition|nutrition
488284|NCT01479062|email|email
488285|NCT01479062|web|web
488286|NCT01479062|obesity|obesity
488287|NCT01479049|congenital heart disease|congenital heart disease
488288|NCT01479049|cardiac surgery|cardiac surgery
488289|NCT01479049|cardiopulmonary bypass|cardiopulmonary bypass
488290|NCT01479049|cardioplegia|cardioplegia
488291|NCT01479036|breast cancer|breast cancer
488292|NCT01479036|neoadjuvant chemotherapy|neoadjuvant chemotherapy
488293|NCT01479036|recombinant human endostatin (endostar)|recombinant human endostatin (endostar)
488294|NCT01479036|docetaxel|docetaxel
488295|NCT01479036|epirubicin|epirubicin
488296|NCT01478984|NSTEMI|nstemi
488297|NCT01478984|PCI|pci
622232|NCT00932269|Polio|polio
488298|NCT01478984|onestage|onestage
488299|NCT01478984|multistaged|multistaged
488300|NCT01478971|Anemia|anemia
488301|NCT01478971|Chronic Renal Failure|chronic renal failure
488302|NCT01478971|CRF|crf
488303|NCT01478971|Chronic Kidney Disease|chronic kidney disease
488304|NCT01478971|CKD|ckd
488305|NCT01478971|Erythropoietin|erythropoietin
488306|NCT01478971|Hematide|hematide
488307|NCT01478971|Peginesatide|peginesatide
488308|NCT01478971|Hemoglobin|hemoglobin
488310|NCT01478971|Red Blood Cell|red blood cell
488311|NCT01478971|Red Blood Cell Production|red blood cell production
488312|NCT01478971|Dialysis|dialysis
488313|NCT01478958|fatty acids|fatty acids
488314|NCT01478958|cardiovascular disease|cardiovascular disease
488315|NCT01478958|vascular function|vascular function
488316|NCT01478958|microparticles|microparticles
488317|NCT01478945|vitiligo|vitiligo
488318|NCT01478945|early vitiligo|early vitiligo
488319|NCT01478945|focal vitiligo|focal vitiligo
488320|NCT01478932|dyspnea|dyspnea
488321|NCT01478932|diaphragmatic breathing|diaphragmatic breathing
488322|NCT01478932|Heart failure|heart failure
488323|NCT01478919|Endoscopic Mucosal Resection|endoscopic mucosal resection
488324|NCT01478919|Laterally Spreading Tumor|laterally spreading tumor
488325|NCT01478919|Local Residual Neoplasia|local residual neoplasia
488326|NCT01478919|Colonoscopy|colonoscopy
488327|NCT01478919|Therapy|therapy
488328|NCT01478893|nicotine vaccine|nicotine vaccine
488329|NCT01478893|smoking vaccine|smoking vaccine
488330|NCT01478893|smoking cessation|smoking cessation
488331|NCT01478893|SEL-068|sel-068
488332|NCT01478867|celiac disease|celiac disease
488333|NCT01478867|gluten-free diet|gluten-free diet
488334|NCT01478867|gluten peptides|gluten peptides
488335|NCT01478867|feces|feces
488336|NCT01478841|insulin resistance|insulin resistance
488337|NCT01478841|type 2 diabetes (T2D)|type 2 diabetes (t2d)
488338|NCT01478841|cardiovascular complications|cardiovascular complications
488339|NCT01478841|polyphenolic compounds derived from red grape marc extracts|polyphenolic compounds derived from red grape marc extracts
488340|NCT01478841|oxidative stress|oxidative stress
488341|NCT01478802|Mechanical Ventilation|mechanical ventilation
488342|NCT01478802|High frequency oscillation|high frequency oscillation
488343|NCT01478802|Acute Respiratory Distress syndrome|acute respiratory distress syndrome
488344|NCT01478776|ASP|asp
488345|NCT01478776|LCN2|lcn2
488346|NCT01478776|RBP4|rbp4
488347|NCT01478776|C5L2|c5l2
488348|NCT01478763|PDRP|pdrp
488349|NCT01478763|vitreous|vitreous
488350|NCT01478763|protein|protein
488351|NCT01478763|vitrectomy|vitrectomy
488352|NCT01478750|obesity|obesity
488353|NCT01478750|fat|fat
488354|NCT01478750|appetite|appetite
488355|NCT01478750|digestion|digestion
488356|NCT01478737|PDRP|pdrp
488357|NCT01478737|vitreous hemorrhage|vitreous hemorrhage
488358|NCT01478737|vitrectomy|vitrectomy
488359|NCT01478698|peritoneal dialysis|peritoneal dialysis
488360|NCT01478698|peritoneal dialysis, continuous ambulatory|peritoneal dialysis, continuous ambulatory
488361|NCT01478698|peritonitis|peritonitis
488362|NCT01478685|Relapsed or Refractory Solid Tumors|relapsed or refractory solid tumors
488363|NCT01478672|Promotion health|promotion health
488364|NCT01478659|Diet|diet
488365|NCT01478659|Fiber|fiber
488366|NCT01478659|Adult|adult
488367|NCT01478659|Fructooligosaccharide|fructooligosaccharide
488368|NCT01478646|breathing therapy|breathing therapy
488369|NCT01478646|reflective breathing therapy|reflective breathing therapy
488370|NCT01478646|COPD|copd
488677|NCT01477476|DKA|dka
488371|NCT01478646|chronic obstructive pulmonary disease|chronic obstructive pulmonary disease
488372|NCT01478633|Alzheimer's disease|alzheimer's disease
488373|NCT01478633|Dementia|dementia
488374|NCT01478633|Galantamine|galantamine
488375|NCT01478633|Donepezil|donepezil
488376|NCT01478607|Painful Diabetic Peripheral Neuropathy|painful diabetic peripheral neuropathy
488377|NCT01478607|Qutenza|qutenza
488378|NCT01478594|metastatic colorectal cancer|metastatic colorectal cancer
488379|NCT01478594|Avastin|avastin
488380|NCT01478594|bevacizumab|bevacizumab
488381|NCT01478594|tivozanib|tivozanib
488382|NCT01478594|mFOLFOX6|mfolfox6
488383|NCT01478594|BATON-CRC|baton-crc
488384|NCT01478594|AV951|av951
488385|NCT01478594|ASP4130|asp4130
488386|NCT01478581|PCI-32765|pci-32765
488387|NCT01478581|Multiple Myeloma|multiple myeloma
488388|NCT01478581|Relapsed Refractory Multiple Myeloma|relapsed refractory multiple myeloma
488389|NCT01478581|Bruton's Tyrosine Kinase|bruton's tyrosine kinase
488390|NCT01478568|Pharmacokinetics|pharmacokinetics
488391|NCT01478568|Mirabegron|mirabegron
488392|NCT01478568|Phase 1|phase 1
488393|NCT01478555|Dry Eye|dry eye
488394|NCT01478542|DLBCL|dlbcl
488395|NCT01478542|Liposomal Vincristine (Marqibo)|liposomal vincristine (marqibo)
488396|NCT01478542|Optimised Rituximab|optimised rituximab
488397|NCT01478542|Toxicity|toxicity
488398|NCT01478542|Elderly Patients|elderly patients
488399|NCT01478542|FDG-PET|fdg-pet
488400|NCT01478542|Bulky Disease|bulky disease
488401|NCT01478542|Radiation|radiation
488402|NCT01478542|age >60 years|age >60 years
488403|NCT01478542|First line Therapy|first line therapy
488404|NCT01478542|Vitamin D|vitamin d
488405|NCT01478529|Pharmacokinetics|pharmacokinetics
488406|NCT01478529|Mirabegron|mirabegron
488407|NCT01478529|Phase 1|phase 1
488408|NCT01478516|autologous plasmin|autologous plasmin
488409|NCT01478516|macular edema|macular edema
488410|NCT01478516|vitreous|vitreous
488411|NCT01478503|Pharmacokinetics|pharmacokinetics
488412|NCT01478503|Mirabegron|mirabegron
488413|NCT01478503|Phase 1|phase 1
488414|NCT01478503|Dose-Escalation|dose-escalation
488415|NCT01478490|Pharmacokinetics,|pharmacokinetics,
488416|NCT01478490|Mirabegron|mirabegron
488417|NCT01478490|Metoprolol|metoprolol
488418|NCT01478490|CYP2D6|cyp2d6
488419|NCT01478490|Phase 1|phase 1
488420|NCT01478477|Breast Cancer|breast cancer
488421|NCT01478451|DOMS|doms
488422|NCT01478438|Unifocal|unifocal
488423|NCT01478438|20mm in diameter|20mm in diameter
488424|NCT01478438|measures|measures
488425|NCT01478438|5mm away from the skin and chest|5mm away from the skin and chest
488426|NCT01478425|Prevention|prevention
488427|NCT01478425|Pollen|pollen
488428|NCT01478425|Allergy|allergy
488429|NCT01478425|Rhinitis|rhinitis
488430|NCT01478412|Prostate cancer|prostate cancer
488431|NCT01478412|Low risk|low risk
488432|NCT01478412|Intermediate risk|intermediate risk
488433|NCT01478412|T1|t1
488434|NCT01478412|T2a|t2a
488435|NCT01478412|T2b|t2b
488436|NCT01478412|Gleason 6|gleason 6
488437|NCT01478412|Gleason 7|gleason 7
488438|NCT01478412|PSA 10|psa 10
488439|NCT01478412|PSA 20|psa 20
488440|NCT01478373|GIST|gist
488441|NCT01478373|Dovitinib|dovitinib
488442|NCT01478360|Asthma|asthma
488443|NCT01478360|Secukinumab|secukinumab
488444|NCT01478360|Therapeutic Uses|therapeutic uses
488445|NCT01478360|Respiratory|respiratory
488446|NCT01478360|Lung|lung
488447|NCT01478360|Pulmonary|pulmonary
488448|NCT01478360|inhaled|inhaled
488449|NCT01478360|corticosteroids|corticosteroids
488450|NCT01478347|Neisseria, Meningitis, Group B, Vaccine, At-risk, Adults|neisseria, meningitis, group b, vaccine, at-risk, adults
488451|NCT01478334|High intensity exercise|high intensity exercise
488452|NCT01478334|cardiovascular risk factors|cardiovascular risk factors
488453|NCT01478321|Information Not Provided|information not provided
488454|NCT01478308|prostate|prostate
488455|NCT01478308|castration resistant|castration resistant
488456|NCT01478308|hormone resistant|hormone resistant
488457|NCT01478308|CRPC|crpc
488458|NCT01478295|Nursing intervention|nursing intervention
488459|NCT01478295|Primary Health care|primary health care
488460|NCT01478295|caregiver|caregiver
488461|NCT01478295|strain|strain
488462|NCT01478282|dabigatran|dabigatran
488463|NCT01478282|rivaroxaban|rivaroxaban
488464|NCT01478282|oral anticoagulants|oral anticoagulants
488465|NCT01478282|coagulation|coagulation
488466|NCT01478282|bleeding|bleeding
488467|NCT01478282|plasma concentrates|plasma concentrates
488468|NCT01478269|Aggressive B-cell lymphoma|aggressive b-cell lymphoma
488469|NCT01478269|R-CHOP|r-chop
488470|NCT01478256|blepharitis|blepharitis
488471|NCT01478256|topical erythromycin|topical erythromycin
488472|NCT01478256|topical besifloxocin|topical besifloxocin
488473|NCT01478243|Keloid|keloid
488474|NCT01478230|Pharmacokinetics|pharmacokinetics
488475|NCT01478217|lung ultrasonography|lung ultrasonography
488476|NCT01478217|pressure-volume loops|pressure-volume loops
488477|NCT01478217|ARDS|ards
488478|NCT01478204|Alzheimer's disease|alzheimer's disease
488479|NCT01478204|Sleep quality|sleep quality
488480|NCT01478204|Anticholinesterase drugs|anticholinesterase drugs
488481|NCT01478191|Hodgkin's Lymphoma|hodgkin's lymphoma
488482|NCT01478191|Ifosfamide, Gemcitabine and Vinorelbine (IGEV)|ifosfamide, gemcitabine and vinorelbine (igev)
488483|NCT01478191|High Dose Chemotherapy (HDCT)|high dose chemotherapy (hdct)
488484|NCT01478191|Autologous Hematopoietic Stem Cells Transplantation (AHSCT)|autologous hematopoietic stem cells transplantation (ahsct)
488485|NCT01478178|Glioma|glioma
488486|NCT01478178|Glioblastoma|glioblastoma
488487|NCT01478178|Glioblastoma multiforme|glioblastoma multiforme
488488|NCT01478178|GBM|gbm
488489|NCT01478178|brain tumor|brain tumor
488490|NCT01478178|brain cancer|brain cancer
488491|NCT01478178|recurrent brain tumor|recurrent brain tumor
488492|NCT01478178|recurrent brain cancer|recurrent brain cancer
488493|NCT01478178|refractory brain tumor|refractory brain tumor
488494|NCT01478178|refractory brain cancer|refractory brain cancer
488495|NCT01478178|recurrent GBM|recurrent gbm
488496|NCT01478178|refractory GBM|refractory gbm
488497|NCT01478178|recurrent glioma|recurrent glioma
488498|NCT01478178|refractory glioma|refractory glioma
488499|NCT01478178|recurrent glioblastoma|recurrent glioblastoma
488500|NCT01478178|refractory glioblastoma|refractory glioblastoma
488501|NCT01478178|recurrent glioblastoma multiforme|recurrent glioblastoma multiforme
488502|NCT01478178|refractory glioblastoma multiforme|refractory glioblastoma multiforme
622482|NCT00931164|AHC|ahc
488503|NCT01478178|failed temodar|failed temodar
488504|NCT01478178|failed temozolomide|failed temozolomide
488505|NCT01478178|temodar refractory|temodar refractory
488506|NCT01478178|temozolomide refractory|temozolomide refractory
488507|NCT01478178|failed avastin|failed avastin
488508|NCT01478178|avastin refractory|avastin refractory
488509|NCT01478178|failed bevacizumab|failed bevacizumab
488510|NCT01478178|bevacizumab refractory|bevacizumab refractory
488511|NCT01478178|avastin failure|avastin failure
488512|NCT01478178|bevacizumab failure|bevacizumab failure
488513|NCT01478178|temodar failure|temodar failure
488514|NCT01478178|temozolomide failure|temozolomide failure
488515|NCT01478165|Palonosetron|palonosetron
488516|NCT01478165|PONV(postoperative nausea and vomiting)|ponv(postoperative nausea and vomiting)
488517|NCT01478165|TIVA(Total intravenous anesthesia)|tiva(total intravenous anesthesia)
488518|NCT01478152|Asthma|asthma
488519|NCT01478152|Ectoin|ectoin
488520|NCT01478152|Ectoine|ectoine
488521|NCT01478152|FeNO|feno
488522|NCT01478152|Metacholin|metacholin
488523|NCT01478152|sRaw|sraw
488524|NCT01478139|anorectal fistula|anorectal fistula
488525|NCT01478139|acellular dermal matrix|acellular dermal matrix
488526|NCT01478139|ligation of intersphincteric fistula tract|ligation of intersphincteric fistula tract
488527|NCT01478139|ligation of intersphincteric fistula tract and plug|ligation of intersphincteric fistula tract and plug
488528|NCT01478139|complications of treatment|complications of treatment
488529|NCT01478139|recurrence|recurrence
488530|NCT01478113|Major Depressive Disorder|major depressive disorder
488531|NCT01478113|Therapy|therapy
488532|NCT01478113|Medication study|medication study
488533|NCT01478113|Depression|depression
488534|NCT01478113|Therapy study|therapy study
488535|NCT01478100|Coronary artery disease|coronary artery disease
488536|NCT01478100|CT|ct
488537|NCT01478100|Computational flow dynamics|computational flow dynamics
488538|NCT01478074|Acute Myeloid Leukemia|acute myeloid leukemia
488539|NCT01478074|Relapsed leukemia|relapsed leukemia
488540|NCT01478074|Refractory leukemia|refractory leukemia
488541|NCT01478074|Natural Killer Cells|natural killer cells
488542|NCT01478074|Adoptive immunotherapy|adoptive immunotherapy
488543|NCT01478074|NK cell infusion|nk cell infusion
488544|NCT01478074|Haploidentical|haploidentical
488545|NCT01478074|KIR mismatch|kir mismatch
488546|NCT01478074|Fludarabine|fludarabine
488547|NCT01478074|Cytarabine|cytarabine
488548|NCT01478074|Ara-C|ara-c
488549|NCT01478074|ALT-801|alt-801
488550|NCT01478048|Relapsed/Refractory Multiple Myeloma|relapsed/refractory multiple myeloma
488551|NCT01478035|Phenytoin prophylaxis|phenytoin prophylaxis
488552|NCT01478035|Pneumococcal meningitis|pneumococcal meningitis
488553|NCT01478035|Randomized|randomized
488554|NCT01478035|Placebo-controlled|placebo-controlled
488555|NCT01478035|Double blind|double blind
488556|NCT01478035|Patient 50 years or older|patient 50 years or older
488557|NCT01478022|DMD|dmd
488558|NCT01478022|Duchenne|duchenne
488559|NCT01478022|Muscular Dystrophy|muscular dystrophy
488560|NCT01477996|intravitreal therapy|intravitreal therapy
488561|NCT01477996|pain scales|pain scales
488562|NCT01477996|gauge|gauge
488563|NCT01477996|Pain Scores|pain scores
488564|NCT01477996|Visual Analog Scale|visual analog scale
488565|NCT01477983|atrial fibrillation|atrial fibrillation
488566|NCT01477983|catheter ablation|catheter ablation
488567|NCT01477983|adenosine triphosphate|adenosine triphosphate
488568|NCT01477983|antiarrhythmic drugs|antiarrhythmic drugs
488569|NCT01477970|GnRH antagonists|gnrh antagonists
488570|NCT01477970|OHSS|ohss
488571|NCT01477970|ovarian stimulation|ovarian stimulation
488572|NCT01477957|weight loss after bariatric surgery|weight loss after bariatric surgery
488573|NCT01477957|Insulin sensitivity|insulin sensitivity
488574|NCT01477957|insulin resistance|insulin resistance
488575|NCT01477944|Statins pattern of use|statins pattern of use
488576|NCT01477944|Hypercholesterolemic patients|hypercholesterolemic patients
488578|NCT01477931|Bupropion hydrochloride extended release|bupropion hydrochloride extended release
488579|NCT01477931|Wellbutrin XL|wellbutrin xl
488580|NCT01477931|Major Depressive Disorder with Atypical Features|major depressive disorder with atypical features
488581|NCT01477918|prevalence|prevalence
488582|NCT01477918|Korea|korea
488583|NCT01477905|priming|priming
488584|NCT01477905|remifentanil|remifentanil
488585|NCT01477905|target-controlled infusion|target-controlled infusion
488586|NCT01477840|Misoprostol|misoprostol
488587|NCT01477840|Oxytocin|oxytocin
488588|NCT01477840|Cesarean Delivery|cesarean delivery
488589|NCT01477840|Blood Loss|blood loss
488590|NCT01477814|colorectal cancer|colorectal cancer
488591|NCT01477814|screening|screening
488592|NCT01477814|colonoscopy|colonoscopy
488593|NCT01477814|fecal immunochemical test|fecal immunochemical test
488594|NCT01477814|clinical guidelines|clinical guidelines
488595|NCT01477788|pelvic mass|pelvic mass
488596|NCT01477788|ovarian mass|ovarian mass
488597|NCT01477788|ultrasound|ultrasound
488598|NCT01477788|serum markers|serum markers
488599|NCT01477788|ovarian malignancy|ovarian malignancy
622613|NCT00930644|PN|pn
488600|NCT01477775|myocardial infarction|myocardial infarction
488601|NCT01477775|coronary stent|coronary stent
488602|NCT01477775|Oral P2Y12 receptor blocker|oral p2y12 receptor blocker
488603|NCT01477775|Platelet reactivity units (PRU)|platelet reactivity units (pru)
488604|NCT01477762|startle response|startle response
488605|NCT01477762|fear conditioning|fear conditioning
488606|NCT01477762|PTSD|ptsd
488607|NCT01477749|prostate cancer|prostate cancer
488608|NCT01477749|prostate|prostate
488609|NCT01477749|immune therapy|immune therapy
488610|NCT01477749|immunotherapy|immunotherapy
488611|NCT01477749|vaccine|vaccine
488612|NCT01477749|dendritic cells|dendritic cells
488613|NCT01477749|antigen-presenting cells|antigen-presenting cells
488614|NCT01477749|antigen presenting cells|antigen presenting cells
488615|NCT01477749|cancer vaccine|cancer vaccine
488616|NCT01477749|PSA|psa
488617|NCT01477749|prostatic adenocarcinoma|prostatic adenocarcinoma
488618|NCT01477736|Neurogenic bladder|neurogenic bladder
488619|NCT01477736|Urodynamic|urodynamic
488620|NCT01477736|Quality of life|quality of life
488621|NCT01477710|Mechanical ventilation|mechanical ventilation
488622|NCT01477710|Tidal volume|tidal volume
488623|NCT01477710|Respiratory rate|respiratory rate
488624|NCT01477697|Trauma|trauma
488625|NCT01477671|Dengue|dengue
488626|NCT01477671|Dengue Fever|dengue fever
488627|NCT01477671|Dengue Hemorrhagic Fever|dengue hemorrhagic fever
488628|NCT01477658|Congenital Complete Atrioventricular Heart Block|congenital complete atrioventricular heart block
488629|NCT01477658|Pacemaker|pacemaker
488630|NCT01477658|Cardiac pacing|cardiac pacing
488631|NCT01477658|Children|children
488632|NCT01477658|Heart failure|heart failure
488633|NCT01477658|Ventricular dyssynchrony|ventricular dyssynchrony
488634|NCT01477658|Echocardiography|echocardiography
488635|NCT01477658|Quality of life|quality of life
488636|NCT01477658|Six-minute walk test|six-minute walk test
488637|NCT01477658|Young adults|young adults
488638|NCT01477619|Pharmacokinetics|pharmacokinetics
488639|NCT01477606|Acute myeloid leukemia|acute myeloid leukemia
488640|NCT01477606|FLT3-ITD|flt3-itd
488641|NCT01477606|midostaurin (PKC412)|midostaurin (pkc412)
488642|NCT01477593|circumcision, chinese children, pain|circumcision, chinese children, pain
488643|NCT01477554|Women|women
488644|NCT01477554|Maternal morbidity|maternal morbidity
488645|NCT01477554|Maternal mortality|maternal mortality
488646|NCT01477554|Perinatal mortality|perinatal mortality
488647|NCT01477554|Perinatal morbidity|perinatal morbidity
488648|NCT01477554|Training|training
488649|NCT01477554|Obstetric Emergency|obstetric emergency
488650|NCT01477554|Medical team|medical team
488651|NCT01477554|Simulation|simulation
488652|NCT01477541|Prenatal care|prenatal care
488653|NCT01477541|Maternal mortality|maternal mortality
488654|NCT01477541|Perinatal mortality|perinatal mortality
488655|NCT01477541|Perinatal|perinatal
488656|NCT01477541|Puerperium|puerperium
488657|NCT01477541|Puerperium care|puerperium care
488658|NCT01477541|Midwives|midwives
488659|NCT01477541|Midwife|midwife
488660|NCT01477541|Obstetric|obstetric
488661|NCT01477541|Nurse|nurse
488662|NCT01477541|Integration|integration
488663|NCT01477541|Alternative personnel|alternative personnel
488664|NCT01477541|Skilled attendant|skilled attendant
488665|NCT01477541|Birth attendant|birth attendant
488666|NCT01477541|Delivery|delivery
488667|NCT01477541|Delivery services|delivery services
488668|NCT01477541|Best practices|best practices
488669|NCT01477541|Rural|rural
488670|NCT01477528|HeartMate II|heartmate ii
488671|NCT01477528|Anticoagulation|anticoagulation
488672|NCT01477528|Thoratec Corporation|thoratec corporation
488673|NCT01477502|urinary tract infection|urinary tract infection
488674|NCT01477502|spinal cord injury|spinal cord injury
488675|NCT01477502|homeopathy|homeopathy
488679|NCT01477476|Type I Diabetes|type i diabetes
488680|NCT01477463|quality of life|quality of life
488681|NCT01477450|Hypobaric hypoxemia|hypobaric hypoxemia
488682|NCT01477450|Altitude|altitude
488684|NCT01477450|oxygen concentrator|oxygen concentrator
488685|NCT01477437|teens|teens
488686|NCT01477437|adolescents|adolescents
488687|NCT01477437|Internet intervention|internet intervention
488688|NCT01477437|Hemophilia|hemophilia
488689|NCT01477424|Drug-drug interaction|drug-drug interaction
488690|NCT01477424|Pharmacokinetics|pharmacokinetics
488691|NCT01477424|PA21|pa21
488692|NCT01477411|Drug-drug interaction|drug-drug interaction
488693|NCT01477411|Pharmacokinetics|pharmacokinetics
488694|NCT01477411|PA21|pa21
488695|NCT01477385|dental caries|dental caries
488696|NCT01477385|primary teeth|primary teeth
488697|NCT01477385|permanent teeth|permanent teeth
488698|NCT01477385|silver diamine fluoride|silver diamine fluoride
488699|NCT01477372|Pregnancy|pregnancy
488700|NCT01477372|Exercise|exercise
488701|NCT01477372|Excessive weight gain|excessive weight gain
488702|NCT01477372|Outcomes|outcomes
488703|NCT01477372|Urinary incontinence|urinary incontinence
488704|NCT01477359|Sarcoidosis|sarcoidosis
488705|NCT01477333|Tyvaso|tyvaso
488706|NCT01477333|UT-15C SR|ut-15c sr
488707|NCT01477333|PAH|pah
488708|NCT01477320|Enteral Nutrition|enteral nutrition
488709|NCT01477320|Stress Ulcer Prophylaxis|stress ulcer prophylaxis
488710|NCT01477320|Critically Ill Patients|critically ill patients
488711|NCT01477320|Overt and significant GI bleeding|overt and significant gi bleeding
488712|NCT01477320|Stress gastropathy|stress gastropathy
488713|NCT01477320|Clostridium Difficile pseudomembranous colitis|clostridium difficile pseudomembranous colitis
488714|NCT01477320|Vital AF|vital af
488715|NCT01477320|Small peptide fish oil structured lipids|small peptide fish oil structured lipids
488716|NCT01477320|Fructose oligosaccharide|fructose oligosaccharide
488717|NCT01477307|obesity|obesity
488718|NCT01477307|non-alcoholic fatty liver disease|non-alcoholic fatty liver disease
488719|NCT01477294|Total|total
488720|NCT01477294|Intra and Extracellular Water|intra and extracellular water
488721|NCT01477294|Energy Expenditure, Physical Activity|energy expenditure, physical activity
488722|NCT01477294|Body Composition|body composition
488723|NCT01477294|Dilution Techniques|dilution techniques
488724|NCT01477281|chronic venous insufficiency|chronic venous insufficiency
488725|NCT01477281|Daflon|daflon
488726|NCT01477281|Venaflon|venaflon
488727|NCT01477268|antidepressants|antidepressants
488728|NCT01477268|depression|depression
488729|NCT01477268|zoloft|zoloft
488730|NCT01477268|psychiatry|psychiatry
488731|NCT01477268|psychology|psychology
488732|NCT01477255|daily assessment|daily assessment
488733|NCT01477255|electronic diary|electronic diary
488734|NCT01477255|coping strategies|coping strategies
488735|NCT01477255|resiliency of cancer patients|resiliency of cancer patients
488736|NCT01477255|psychology|psychology
488737|NCT01477242|vomiting|vomiting
488738|NCT01477242|anti-emetics|anti-emetics
488739|NCT01477242|ketamine|ketamine
488740|NCT01477242|sedation|sedation
488741|NCT01477229|Rectal cancer|rectal cancer
488742|NCT01477229|Quality of Life|quality of life
488743|NCT01477229|Abdominoperineal Resection|abdominoperineal resection
488744|NCT01477229|Anterior Resection|anterior resection
488745|NCT01477229|Palliative cancer treatment|palliative cancer treatment
488746|NCT01477229|Radio chemotherapy|radio chemotherapy
488747|NCT01477216|Glycemic index|glycemic index
488748|NCT01477216|Glycemic responses|glycemic responses
488749|NCT01477216|Insulin responses|insulin responses
488750|NCT01477216|Insulinemic index|insulinemic index
488751|NCT01477216|Carbohydrates|carbohydrates
488752|NCT01477216|Methodology|methodology
488753|NCT01477216|Glucose metabolism|glucose metabolism
488754|NCT01477177|Barrett's esophagus dysplasia|barrett's esophagus dysplasia
488755|NCT01477164|Exercise|exercise
488756|NCT01477164|Aging|aging
488757|NCT01477164|Sarcopenia|sarcopenia
488758|NCT01477164|Muscle function|muscle function
488759|NCT01477151|isoflurane|isoflurane
488760|NCT01477151|sevoflurane|sevoflurane
488761|NCT01477151|troponin|troponin
488762|NCT01477151|anesthesia|anesthesia
488763|NCT01477151|cardioprotection|cardioprotection
488764|NCT01477151|preconditioning|preconditioning
488765|NCT01477151|cardiac surgery|cardiac surgery
488766|NCT01477151|cardiac anesthesia|cardiac anesthesia
488767|NCT01477138|Sick Sinus Syndrome|sick sinus syndrome
488768|NCT01477138|Cardiac Pacing, Artificial|cardiac pacing, artificial
488769|NCT01477138|Cardiac Resynchronization Therapy|cardiac resynchronization therapy
488770|NCT01477138|Pacemaker, Artificial|pacemaker, artificial
488771|NCT01477138|SSS|sss
488772|NCT01477125|adhd|adhd
488773|NCT01477125|adults|adults
488774|NCT01477125|working memory|working memory
488775|NCT01477125|training|training
488776|NCT01477125|RCT|rct
488777|NCT01477112|Type 2 diabetes|type 2 diabetes
488778|NCT01477112|β-carotene|β-carotene
488779|NCT01477112|Oxidative balance|oxidative balance
488780|NCT01477112|Oxidants|oxidants
488781|NCT01477112|Antioxidants|antioxidants
488782|NCT01477086|Sarcopenia|sarcopenia
488783|NCT01477086|Hip fracture|hip fracture
488784|NCT01477086|Frailty|frailty
488785|NCT01477073|in-vitro fertilization|in-vitro fertilization
488786|NCT01477073|reproductive disorder|reproductive disorder
488787|NCT01477034|Vitamin D deficiency|vitamin d deficiency
488788|NCT01477034|Obesity|obesity
488789|NCT01477034|Inflammation|inflammation
488790|NCT01477034|Low-grade, chronic inflammation|low-grade, chronic inflammation
488791|NCT01477034|Adipose tissue inflammation|adipose tissue inflammation
488792|NCT01477034|Diabetes|diabetes
488793|NCT01477034|Type 2 diabetes mellitus|type 2 diabetes mellitus
488794|NCT01477034|Insulin resistance|insulin resistance
488795|NCT01477034|Intestinal permeability|intestinal permeability
488796|NCT01477008|Knee|knee
488797|NCT01477008|Cartilage repair|cartilage repair
488798|NCT01477008|Cartilage regeneration|cartilage regeneration
488799|NCT01477008|Chondral|chondral
488800|NCT01477008|Osteochondral|osteochondral
488801|NCT01477008|Biphasic scaffold|biphasic scaffold
488802|NCT01477008|Medical device|medical device
488803|NCT01477008|Autologous|autologous
488804|NCT01477008|Synthetic|synthetic
488805|NCT01477008|Medial condyle|medial condyle
488806|NCT01477008|Lateral condyle|lateral condyle
488807|NCT01477008|Trochlea|trochlea
488808|NCT01476995|Cardiovascular system|cardiovascular system
488809|NCT01476995|gastrointestinal system|gastrointestinal system
488810|NCT01476995|kidneys|kidneys
488811|NCT01476995|liver|liver
488812|NCT01476995|lungs|lungs
488813|NCT01476969|Ischemia reperfusion injury|ischemia reperfusion injury
488814|NCT01476969|Cardiopulmonary bypass|cardiopulmonary bypass
488815|NCT01476969|Remote Ischemic Postconditioning|remote ischemic postconditioning
488816|NCT01476969|Other Functional Disturbances Following Cardiac Surgery|other functional disturbances following cardiac surgery
488817|NCT01476930|migraine|migraine
488818|NCT01476930|prophylactic treatment|prophylactic treatment
488820|NCT01476930|serkangabin|serkangabin
488821|NCT01476904|Asthma|asthma
488822|NCT01476904|Bronchial Asthma|bronchial asthma
488823|NCT01476904|Shortness of breath|shortness of breath
488824|NCT01476891|MBSR|mbsr
488825|NCT01476891|Cancer|cancer
488826|NCT01476891|Online|online
488827|NCT01476891|Mindfulness Meditation|mindfulness meditation
488828|NCT01476891|Randomized Waitlist Controlled Trial|randomized waitlist controlled trial
488829|NCT01476878|Radiosurgery|radiosurgery
488830|NCT01476878|Frameless radiosurgery|frameless radiosurgery
488831|NCT01476878|Accuracy|accuracy
488832|NCT01476800|Drugs, Investigational|drugs, investigational
488833|NCT01476800|pharmacokinetics|pharmacokinetics
488834|NCT01476800|Urinary Bladder, Overactive|urinary bladder, overactive
488835|NCT01476800|YM178|ym178
488836|NCT01476800|Mirabegron|mirabegron
488837|NCT01476787|Follicular lymphoma|follicular lymphoma
488838|NCT01476787|Non-Hodgkins Follicular Lymphoma|non-hodgkins follicular lymphoma
488839|NCT01476787|treatment for Follicular Lymphoma|treatment for follicular lymphoma
488840|NCT01476787|rituximab treatment|rituximab treatment
488841|NCT01476787|rituximab and lenalidomide treatment|rituximab and lenalidomide treatment
488842|NCT01476761|Surgical tissue resection|surgical tissue resection
488843|NCT01476761|Tissue dissection|tissue dissection
488844|NCT01476761|Tissue transection|tissue transection
488845|NCT01476761|Anastomosis of gastrointestina tissue|anastomosis of gastrointestina tissue
488846|NCT01476722|Silicone Hydrogel|silicone hydrogel
488847|NCT01476722|Soft Contact Lenses|soft contact lenses
488848|NCT01476722|Multi-Purpose Solution|multi-purpose solution
488849|NCT01476709|Puncture; Instrument|puncture; instrument
488850|NCT01476709|Optics and Photonics|optics and photonics
488851|NCT01476709|Pain|pain
488852|NCT01476696|Sickle cell disease|sickle cell disease
488853|NCT01476696|pediatrics|pediatrics
488854|NCT01476696|SCD|scd
488855|NCT01476696|children|children
488856|NCT01476696|child|child
488857|NCT01476696|kids|kids
488858|NCT01476696|pain crisis|pain crisis
488859|NCT01476696|sickle cell anemia|sickle cell anemia
488860|NCT01476696|sickle cell pain|sickle cell pain
488861|NCT01476683|Antidiarrheals|antidiarrheals
488862|NCT01476670|Posterior fossa brain tumor|posterior fossa brain tumor
488863|NCT01476670|Cerebral blood flow|cerebral blood flow
488864|NCT01476670|Cerebral autoregulation|cerebral autoregulation
488865|NCT01476670|Carbon dioxide reactivity|carbon dioxide reactivity
488866|NCT01476670|Transcranial Doppler|transcranial doppler
488867|NCT01476657|Phase 1|phase 1
488868|NCT01476644|Health related quality of life|health related quality of life
488869|NCT01476644|Clinical measures of vision|clinical measures of vision
488870|NCT01476618|Provider Perspectives|provider perspectives
488871|NCT01476618|Barriers|barriers
488872|NCT01476618|OIF/OEF Veterans|oif/oef veterans
488873|NCT01476605|prolotherapy|prolotherapy
488874|NCT01476605|Platelet rich plasma|platelet rich plasma
488875|NCT01476605|tennis elbow|tennis elbow
488876|NCT01476605|lateral epicondylosis|lateral epicondylosis
488877|NCT01476592|gastrointestinal neuroendocrine tumor|gastrointestinal neuroendocrine tumor
488878|NCT01476579|Coronary CT|coronary ct
488879|NCT01476579|Sensitivity|sensitivity
488880|NCT01476579|Specificity|specificity
488881|NCT01476579|Radiation|radiation
488882|NCT01476579|Tomography, X-Ray Computed|tomography, x-ray computed
488883|NCT01476579|Coronary angiography|coronary angiography
488884|NCT01476566|aged|aged
488885|NCT01476566|family practice|family practice
488886|NCT01476553|gastric cancer|gastric cancer
488887|NCT01476553|extensive intraperitoneal lavage|extensive intraperitoneal lavage
488888|NCT01476553|EIPL|eipl
488889|NCT01476553|intraperitoneal tumor cells|intraperitoneal tumor cells
488890|NCT01476553|peritoneal carcinomatosis|peritoneal carcinomatosis
488891|NCT01476514|Hyperekplexia|hyperekplexia
488892|NCT01476514|Pain modulation|pain modulation
488893|NCT01476514|Glycine receptors|glycine receptors
488894|NCT01476514|Hyperalgesia|hyperalgesia
488895|NCT01476514|Spinal inhibitory interneurons|spinal inhibitory interneurons
488896|NCT01476501|vitamin D|vitamin d
488897|NCT01476501|bone health|bone health
488898|NCT01476501|diabetes|diabetes
488899|NCT01476501|nephropathy|nephropathy
488900|NCT01476462|Acute lymphoblastic leukemia|acute lymphoblastic leukemia
488901|NCT01476462|Ponte-di-Legno consortium|ponte-di-legno consortium
488902|NCT01476462|Second cancer|second cancer
488903|NCT01476462|Survival|survival
488904|NCT01476449|Diabetic Macular Edema|diabetic macular edema
488905|NCT01476449|Diabetic Retinal Swelling|diabetic retinal swelling
488906|NCT01476449|DIabetic Eye Disease|diabetic eye disease
488907|NCT01476436|Cardio vascular risk factors|cardio vascular risk factors
488908|NCT01476423|Glanzmann's Thrombasthenia|glanzmann's thrombasthenia
488909|NCT01476397|full-term|full-term
488910|NCT01476397|formula-fed infants|formula-fed infants
488911|NCT01476384|Glucose|glucose
488912|NCT01476384|insulin|insulin
488913|NCT01476384|Glycocalyx|glycocalyx
488914|NCT01476384|Muscle|muscle
488915|NCT01476384|Vascularisation|vascularisation
488916|NCT01476384|young|young
488917|NCT01476384|elderly|elderly
488918|NCT01476371|Group treatment|group treatment
488919|NCT01476371|Mindfulness|mindfulness
488920|NCT01476371|Minor mental disorders|minor mental disorders
488921|NCT01476371|Inflammation|inflammation
488922|NCT01476332|eyes|eyes
488923|NCT01476332|cis-urocanic acid|cis-urocanic acid
488924|NCT01476332|safety|safety
488925|NCT01476332|tolerability|tolerability
488926|NCT01476332|pharmacokinetics|pharmacokinetics
488927|NCT01476306|feasibility|feasibility
488928|NCT01476306|effectiveness|effectiveness
488929|NCT01476306|Parkinson disease care|parkinson disease care
488930|NCT01476306|care via telemedicine|care via telemedicine
488931|NCT01476293|Infiltration|infiltration
488932|NCT01476293|Extravasation|extravasation
488933|NCT01476293|Leaking|leaking
488934|NCT01476293|PIV Infiltration|piv infiltration
488935|NCT01476293|IV Infiltration|iv infiltration
488936|NCT01476293|Optical Detection of Infiltration|optical detection of infiltration
488937|NCT01476293|Optical Monitoring|optical monitoring
488938|NCT01476280|antiemetics|antiemetics
488939|NCT01476280|ramosetron|ramosetron
488940|NCT01476280|palonosetron|palonosetron
488941|NCT01476280|PONV(postoperative nausea and vomiting)|ponv(postoperative nausea and vomiting)
488942|NCT01476254|Postoperative pulmonary complications|postoperative pulmonary complications
488943|NCT01476254|Laparoscopic surgery|laparoscopic surgery
488944|NCT01476215|paracetamol|paracetamol
488945|NCT01476202|craving, provoked craving, smoking cessation, nicotine replacement therapy, NRT|craving, provoked craving, smoking cessation, nicotine replacement therapy, nrt
488946|NCT01476189|pharmacokinetic|pharmacokinetic
488947|NCT01476189|paracetamol|paracetamol
488948|NCT01476189|Healthy volunteer|healthy volunteer
488949|NCT01476189|steady state|steady state
488950|NCT01476176|Bioequivalence|bioequivalence
488951|NCT01476176|Pharmacokinetics|pharmacokinetics
488952|NCT01476176|Healthy volunteers|healthy volunteers
488953|NCT01476176|paracetamol|paracetamol
488954|NCT01476176|caffeine|caffeine
488955|NCT01476163|AT1001|at1001
488956|NCT01476163|Lysosomal storage disease|lysosomal storage disease
488957|NCT01476163|Lysosomal Storage Disorder|lysosomal storage disorder
488958|NCT01476163|migalastat|migalastat
488959|NCT01476163|Fabry disease|fabry disease
488960|NCT01476163|Fabry|fabry
488961|NCT01476163|Amicus|amicus
488962|NCT01476137|oncology|oncology
488963|NCT01476137|solid tumors|solid tumors
488964|NCT01476137|multiple myeloma|multiple myeloma
488965|NCT01476137|AKT inhibitor|akt inhibitor
488966|NCT01476137|MEK inhibitor|mek inhibitor
488967|NCT01476111|tumor antigens|tumor antigens
488968|NCT01476111|observational|observational
488969|NCT01476111|breast cancer|breast cancer
488970|NCT01476111|biomarkers|biomarkers
488971|NCT01476111|Neoadjuvant|neoadjuvant
488972|NCT01476059|Treatment compliance|treatment compliance
488973|NCT01476059|Pediatric|pediatric
488974|NCT01476059|Asthma|asthma
488975|NCT01476046|Acute Lung Injury (ALI)|acute lung injury (ali)
488976|NCT01476046|Acute Respiratory Distress Syndrome (ARDS)|acute respiratory distress syndrome (ards)
488977|NCT01476033|Oxidative stress|oxidative stress
488978|NCT01476033|inflammation|inflammation
488979|NCT01476033|blood flow|blood flow
488980|NCT01476020|Drug eluting stent|drug eluting stent
488981|NCT01476020|Dual antiplatelet therapy|dual antiplatelet therapy
488982|NCT01476020|bleeding|bleeding
488983|NCT01476020|stent thrombosis|stent thrombosis
488984|NCT01476020|follow-up of the drug eluting stent|follow-up of the drug eluting stent
488985|NCT01476007|primary health care|primary health care
488986|NCT01476007|Vitamin B 12 Deficiency|vitamin b 12 deficiency
488988|NCT01475981|single dose|single dose
488989|NCT01475942|elderly|elderly
488990|NCT01475942|probiotic|probiotic
488991|NCT01475942|bowel function|bowel function
488992|NCT01475942|pathogen|pathogen
488993|NCT01475942|constipation|constipation
488994|NCT01475942|diarrhoea|diarrhoea
488995|NCT01475942|Subclinical levels|subclinical levels
488996|NCT01475929|irritable bowel syndrome|irritable bowel syndrome
488997|NCT01475929|probiotic|probiotic
488998|NCT01475916|Asthma|asthma
488999|NCT01475916|Educational program|educational program
489000|NCT01475916|Quality of life|quality of life
489001|NCT01475916|School-aged children|school-aged children
489002|NCT01475903|Obesity|obesity
489003|NCT01475903|Sleeve gastrectomy|sleeve gastrectomy
489004|NCT01475903|Nutritional impact|nutritional impact
489005|NCT01475903|Vitamin deficiency|vitamin deficiency
489006|NCT01475890|HIV/AIDS|hiv/aids
489007|NCT01475890|Nutrition|nutrition
489008|NCT01475877|bromfenac|bromfenac
489009|NCT01475877|nepafenac|nepafenac
489010|NCT01475877|PRK|prk
489011|NCT01475877|epithelial healing,|epithelial healing,
489012|NCT01475864|Choledocholithiasis|choledocholithiasis
489013|NCT01475864|metal stents|metal stents
489014|NCT01475864|biliary duct stent|biliary duct stent
489015|NCT01475851|Tenofovir disoproxil fumarate, compensated chronic hepatitis B|tenofovir disoproxil fumarate, compensated chronic hepatitis b
489016|NCT01475838|HIV-1|hiv-1
489017|NCT01475838|HIV|hiv
489018|NCT01475838|Treatment Experienced|treatment experienced
489019|NCT01475812|COPD|copd
489020|NCT01475812|activities of daily living|activities of daily living
489021|NCT01475812|pulmonary hyperinflation|pulmonary hyperinflation
489022|NCT01475812|exercise|exercise
489023|NCT01475786|nerve pain|nerve pain
489024|NCT01475786|diabetic nerve pain|diabetic nerve pain
489025|NCT01475786|throbbing|throbbing
489026|NCT01475786|burning|burning
489027|NCT01475786|painful feet|painful feet
489028|NCT01475786|tingling|tingling
489029|NCT01475786|numbness|numbness
489030|NCT01475773|self-esteem|self-esteem
489031|NCT01475773|personality|personality
489032|NCT01475773|quality of life|quality of life
489033|NCT01475773|malocclusion|malocclusion
489034|NCT01475773|orthodontics|orthodontics
489035|NCT01475760|chronic kidney disease|chronic kidney disease
489036|NCT01475760|serum phosphorus|serum phosphorus
489037|NCT01475760|salivary phosphorus|salivary phosphorus
489038|NCT01475760|FGF23|fgf23
489039|NCT01475734|glucose clamp|glucose clamp
489040|NCT01475734|hypoglycemia|hypoglycemia
489041|NCT01475721|ADVAIR|advair
489042|NCT01475721|Asthma|asthma
489043|NCT01475721|safety|safety
489044|NCT01475721|FLOVENT|flovent
489045|NCT01475708|Lyme borreliosis|lyme borreliosis
489046|NCT01475708|Erythema migrans|erythema migrans
489047|NCT01475708|Doxycycline|doxycycline
489048|NCT01475708|Subjective symptoms|subjective symptoms
489049|NCT01475708|Outcome|outcome
489050|NCT01475695|Mass balance|mass balance
489051|NCT01475695|intravenous|intravenous
489052|NCT01475695|GSK2251052|gsk2251052
489053|NCT01475695|Healthy volunteer|healthy volunteer
489054|NCT01475695|Antimicrobial|antimicrobial
489055|NCT01475695|Radiolabel|radiolabel
489056|NCT01475682|Obstructive sleep apnea|obstructive sleep apnea
489057|NCT01475682|cardiometabolic complications|cardiometabolic complications
489058|NCT01475682|Effects of CPAP treatment|effects of cpap treatment
489059|NCT01475643|Pediatric cataract|pediatric cataract
489060|NCT01475630|temporomandibular joint|temporomandibular joint
489061|NCT01475630|rehabilitation medicine|rehabilitation medicine
489062|NCT01475630|joint diseases|joint diseases
489063|NCT01475630|physical therapy|physical therapy
489064|NCT01475604|Pulsed Radio Frequency, Electromagnetic Field therapy|pulsed radio frequency, electromagnetic field therapy
489065|NCT01475591|persistent neuromusculoskeletal pain|persistent neuromusculoskeletal pain
489066|NCT01475591|neck|neck
489067|NCT01475591|shoulder|shoulder
489068|NCT01475591|back-area|back-area
489069|NCT01475591|risk|risk
489070|NCT01475591|longlasting|longlasting
489071|NCT01475591|pain syndrome|pain syndrome
489072|NCT01475578|Vascular Dementia|vascular dementia
489073|NCT01475565|polycystic ovary syndrome (PCOS)|polycystic ovary syndrome (pcos)
489074|NCT01475565|insulin sensitivity|insulin sensitivity
489075|NCT01475565|insulin resistance|insulin resistance
489076|NCT01475565|gestational diabetes|gestational diabetes
489077|NCT01475565|pregnancy|pregnancy
489078|NCT01475565|estrogen|estrogen
489079|NCT01475565|glucose intolerance|glucose intolerance
489080|NCT01475565|obesity|obesity
489081|NCT01475565|ovulatory disorder|ovulatory disorder
489082|NCT01475565|racial differences|racial differences
489083|NCT01475565|hyperandrogenism|hyperandrogenism
489084|NCT01475552|platelet reactivity|platelet reactivity
489085|NCT01475552|platelet function assay|platelet function assay
489086|NCT01475552|abciximab|abciximab
489087|NCT01475552|tailored therapy|tailored therapy
489088|NCT01475539|Polio|polio
489089|NCT01475539|Poliovirus|poliovirus
489090|NCT01475539|Oral poliovirus vaccine|oral poliovirus vaccine
489091|NCT01475539|IMOVAX Polio®|imovax polio®
489092|NCT01475526|grocery store|grocery store
489093|NCT01475526|nutrition|nutrition
489094|NCT01475526|Latino|latino
489095|NCT01475526|Hispanic|hispanic
489096|NCT01475513|oral contraceptive|oral contraceptive
489097|NCT01475513|birth control pill|birth control pill
489098|NCT01475513|women|women
489099|NCT01475513|healthy volunteer|healthy volunteer
489100|NCT01475513|insulin sensitivity|insulin sensitivity
489101|NCT01475513|insulin resistance|insulin resistance
489102|NCT01475513|cardiovascular risk factors|cardiovascular risk factors
489103|NCT01475513|endothelial function|endothelial function
489104|NCT01475513|estrogen metabolism|estrogen metabolism
489105|NCT01475513|racial difference|racial difference
489106|NCT01475513|glucose intolerance|glucose intolerance
489107|NCT01475474|incontinence|incontinence
489108|NCT01475474|bowel|bowel
489109|NCT01475474|movement|movement
489110|NCT01475474|fecal|fecal
489111|NCT01475474|anal|anal
489112|NCT01475474|diarrhea|diarrhea
489113|NCT01475474|stool|stool
489114|NCT01475474|rectal|rectal
489115|NCT01475474|feces|feces
489116|NCT01475474|uncontrolled|uncontrolled
489117|NCT01475474|loose|loose
489118|NCT01475474|leakage|leakage
489119|NCT01475474|rectum|rectum
489120|NCT01475474|BM|bm
489121|NCT01475474|watery|watery
489122|NCT01475474|urgent|urgent
489123|NCT01475474|flatulence|flatulence
489124|NCT01475474|gas|gas
489125|NCT01475461|Phase 2|phase 2
489126|NCT01475461|type 2 diabetes mellitus|type 2 diabetes mellitus
489127|NCT01475461|PF-04937319|pf-04937319
489128|NCT01475448|biomechanics|biomechanics
489129|NCT01475448|motor control|motor control
489130|NCT01475448|movement|movement
489131|NCT01475448|walking|walking
489132|NCT01475448|running|running
489133|NCT01475448|sedentarism|sedentarism
489134|NCT01475448|joint moment|joint moment
489135|NCT01475409|anti-TNF|anti-tnf
489136|NCT01475409|tuberculosis|tuberculosis
489137|NCT01475409|QuantiFERON-TB Gold In-Tube|quantiferon-tb gold in-tube
489138|NCT01475409|tuberculin skin test|tuberculin skin test
489139|NCT01475409|rheumatoid arthritis|rheumatoid arthritis
489140|NCT01475409|spondyloarthritis|spondyloarthritis
489141|NCT01475396|exercise|exercise
489142|NCT01475396|physical activity|physical activity
489143|NCT01475396|cognition|cognition
489144|NCT01475396|brain|brain
489145|NCT01475396|aging|aging
489146|NCT01475396|BDNF|bdnf
489147|NCT01475383|Tourette's Syndrome in adults|tourette's syndrome in adults
489148|NCT01475383|Safety and Efficacy|safety and efficacy
489149|NCT01475383|Randomized|randomized
489150|NCT01475383|Placebo Control|placebo control
489151|NCT01475383|Cross-over|cross-over
489152|NCT01475370|Acute myeloid leukemia|acute myeloid leukemia
489153|NCT01475370|WT1|wt1
489154|NCT01475357|congenital heart defects|congenital heart defects
489155|NCT01475357|growth failure|growth failure
489156|NCT01475344|Trauma patient with major bleeding|trauma patient with major bleeding
489157|NCT01475331|pancreatic cyst|pancreatic cyst
489158|NCT01475331|chemotherapy|chemotherapy
489159|NCT01475331|ethanol|ethanol
489160|NCT01475331|ablation|ablation
489161|NCT01475318|complete abortion rate|complete abortion rate
489162|NCT01475318|side effects|side effects
489163|NCT01475318|induction-to-abortion interval|induction-to-abortion interval
489164|NCT01475305|Respiratory Syncytial Virus (RSV)|respiratory syncytial virus (rsv)
489165|NCT01475305|Healthy adults|healthy adults
489166|NCT01475305|MEDI-557|medi-557
489167|NCT01475305|Intranasal challenge|intranasal challenge
489168|NCT01475305|Human model|human model
489169|NCT01475292|COPD|copd
489170|NCT01475279|Warfarin|warfarin
489171|NCT01475279|Dantonic|dantonic
489172|NCT01475279|Pharmacodynamics|pharmacodynamics
489173|NCT01475279|Pharmacokinetics|pharmacokinetics
489174|NCT01475279|Interaction|interaction
489175|NCT01475266|Bladder Cancer|bladder cancer
489176|NCT01475266|NMIBC|nmibc
489177|NCT01475266|TURBT|turbt
489178|NCT01475266|Apaziquone|apaziquone
489179|NCT01475266|EOquin|eoquin
489180|NCT01475266|Immediate instillation|immediate instillation
489181|NCT01475240|HIV|hiv
489182|NCT01475227|HIV|hiv
489183|NCT01475227|Bilirubin|bilirubin
489184|NCT01475214|potassium bicarbonate|potassium bicarbonate
489185|NCT01475214|urinary N-telopeptide|urinary n-telopeptide
489186|NCT01475214|urinary nitrogen|urinary nitrogen
489187|NCT01475214|net acid excretion|net acid excretion
489188|NCT01475201|Type 2 diabetes|type 2 diabetes
489189|NCT01475201|Hypertension|hypertension
489190|NCT01475201|Primary Care|primary care
489191|NCT01475201|Physical Activity|physical activity
489192|NCT01475201|Behavioural Intervention|behavioural intervention
489193|NCT01475201|Pedometer|pedometer
489194|NCT01475201|Accelerometer|accelerometer
489195|NCT01475201|Arterial Stiffness|arterial stiffness
489196|NCT01475201|Carotid femoral pulse wave velocity|carotid femoral pulse wave velocity
489197|NCT01475201|Vascular disease risk|vascular disease risk
489198|NCT01475201|Vascular disease prevention|vascular disease prevention
489199|NCT01475201|Intervention|intervention
489200|NCT01475188|specific subcutaneous immunotherapy|specific subcutaneous immunotherapy
489201|NCT01475188|seasonal allergic rhinitis|seasonal allergic rhinitis
489202|NCT01475188|regulatory lymphocytes|regulatory lymphocytes
489203|NCT01475188|signal transduction|signal transduction
489204|NCT01475188|histamine receptor|histamine receptor
489205|NCT01475162|acute Graft versus Host Disease (aGVHD)|acute graft versus host disease (agvhd)
489206|NCT01475162|steroid refractory acute Graft versus Host Disease (aGVHD)|steroid refractory acute graft versus host disease (agvhd)
489207|NCT01475162|chronic Graft versus Host Disease (cGVHD)|chronic graft versus host disease (cgvhd)
489208|NCT01475162|corticosteroids|corticosteroids
489209|NCT01475162|allogeneic hematopoietic stem cell transplantation|allogeneic hematopoietic stem cell transplantation
489210|NCT01475149|Antiphospholipid syndrome|antiphospholipid syndrome
489211|NCT01475149|Antiphospholipid antibodies|antiphospholipid antibodies
489212|NCT01475149|Systemic lupus erythematosus|systemic lupus erythematosus
489213|NCT01475149|Annexin A5 and Annexin A5 resistance assay|annexin a5 and annexin a5 resistance assay
489214|NCT01475123|Nicorandil|nicorandil
489215|NCT01475123|Randomized control study|randomized control study
489216|NCT01475123|Hemodialysis|hemodialysis
489217|NCT01475123|Coronary Artery Disease|coronary artery disease
489218|NCT01475110|Imatinib|imatinib
489219|NCT01475110|Chronic Myeloid Leukaemia|chronic myeloid leukaemia
489220|NCT01475110|Nilotinib|nilotinib
489221|NCT01475110|Adult patients|adult patients
489222|NCT01475110|Imatinib resistant|imatinib resistant
489223|NCT01475097|AE - Adverse event|ae - adverse event
489224|NCT01475097|Arteriography|arteriography
489225|NCT01475097|IA - Intra-arterial|ia - intra-arterial
489226|NCT01475097|IOCM - Iso-Osmolar Contrast Medium|iocm - iso-osmolar contrast medium
489227|NCT01475097|LOCM - Low-Osmolar Contrast Medium|locm - low-osmolar contrast medium
489228|NCT01475097|Patient Comfort|patient comfort
489229|NCT01475097|Body Image Disturbance|body image disturbance
489230|NCT01475097|Patient|patient
489231|NCT01475084|Flex-rigid pleuroscopy|flex-rigid pleuroscopy
489232|NCT01475084|cryobiopsy|cryobiopsy
489233|NCT01475084|pleural biopsy|pleural biopsy
489234|NCT01475084|pleural effusion|pleural effusion
489235|NCT01475084|safety|safety
489236|NCT01475084|thoracoscopy|thoracoscopy
489237|NCT01475045|COPD|copd
489238|NCT01475032|Asthma|asthma
489239|NCT01475032|children|children
489240|NCT01475032|chronic treatment|chronic treatment
489241|NCT01475019|Obesity|obesity
489242|NCT01475019|Polycystic Ovaries Syndrome|polycystic ovaries syndrome
489243|NCT01475019|Orlistat|orlistat
489244|NCT01475019|Sibutramine|sibutramine
489245|NCT01475019|Androgen levels|androgen levels
489246|NCT01475019|Insulin resistance|insulin resistance
489247|NCT01475006|Epidermal Growth Factor Receptor Variant III|epidermal growth factor receptor variant iii
489248|NCT01475006|EGFRvIII|egfrviii
489249|NCT01475006|Glioma|glioma
489250|NCT01475006|Anaplastic Astrocytomas|anaplastic astrocytomas
489251|NCT01475006|Glioblastoma Multiforme|glioblastoma multiforme
489252|NCT01475006|Antibody drug conjugate|antibody drug conjugate
489253|NCT01475006|brain tumor|brain tumor
489254|NCT01474980|Congenital Myasthenic Syndrome|congenital myasthenic syndrome
489255|NCT01474980|Pregnancy|pregnancy
489256|NCT01474980|Outcome|outcome
489257|NCT01474967|polycystic ovary syndrome|polycystic ovary syndrome
489258|NCT01474967|lipid profile|lipid profile
489259|NCT01474967|metformin|metformin
489260|NCT01474954|HIV|hiv
489261|NCT01474954|Antiretroviral Medication|antiretroviral medication
489262|NCT01474954|Cardiovascular Disease Risk|cardiovascular disease risk
489263|NCT01474941|Multiple Dose Study Overweight Healthy Subjects Body Weight Modified-Release Formulation|multiple dose study overweight healthy subjects body weight modified-release formulation
489264|NCT01474928|Asthma|asthma
489265|NCT01474928|Community-based participatory research|community-based participatory research
489266|NCT01474928|Educational intervention|educational intervention
489267|NCT01474928|Ethno-cultural community|ethno-cultural community
489268|NCT01474928|Video recording|video recording
489269|NCT01474928|Patient education handout|patient education handout
489270|NCT01474915|Neurosurgery|neurosurgery
489271|NCT01474902|pediatric|pediatric
489272|NCT01474902|asymptotic venous thrombosis|asymptotic venous thrombosis
489273|NCT01474902|Enoxaparin|enoxaparin
489274|NCT01474902|pediatric cardiac surgery|pediatric cardiac surgery
489275|NCT01474889|Hypoglycemia, Unawareness, RT-CGM, Type 1 Diabetes|hypoglycemia, unawareness, rt-cgm, type 1 diabetes
489276|NCT01474876|Post-marketing observational study (PMOS) Protocol|post-marketing observational study (pmos) protocol
489277|NCT01474876|Effectiveness of Adalimumab (HUMIRA®)|effectiveness of adalimumab (humira®)
489278|NCT01474876|Psoriatic Arthritis|psoriatic arthritis
489279|NCT01474876|Ankylosing Spondylitis|ankylosing spondylitis
489280|NCT01474850|mechanical ventilation|mechanical ventilation
489281|NCT01474850|pressure control ventilation|pressure control ventilation
489282|NCT01474850|lung recruitment|lung recruitment
489283|NCT01474850|positive end expiratory pressure|positive end expiratory pressure
489284|NCT01474850|opto-electronic plethysmography|opto-electronic plethysmography
489285|NCT01474850|chest wall volume variation|chest wall volume variation
489286|NCT01474850|intravenous anesthesia|intravenous anesthesia
489287|NCT01474837|depressive disorders|depressive disorders
489288|NCT01474837|exercise therapy|exercise therapy
489289|NCT01474824|Cardiac output|cardiac output
489290|NCT01474824|Stroke volume|stroke volume
489291|NCT01474811|Hepatitis|hepatitis
489292|NCT01474811|Hepatitis C|hepatitis c
489293|NCT01474811|HCV-TARGET|hcv-target
489294|NCT01474811|HCV|hcv
489295|NCT01474811|Observational Study|observational study
489296|NCT01474798|Acne Vulgaris|acne vulgaris
623476|NCT00927238|DDD|ddd
489297|NCT01474785|Obesity|obesity
489298|NCT01474785|Bariatric surgery|bariatric surgery
489299|NCT01474785|Nashville, Tennessee|nashville, tennessee
489300|NCT01474772|Diabetic Peripheral Neuropathy|diabetic peripheral neuropathy
489301|NCT01474772|Pain on Walking|pain on walking
489302|NCT01474772|Pregabalin|pregabalin
489303|NCT01474746|Fragile X Syndrome|fragile x syndrome
489304|NCT01474746|Pediatrics|pediatrics
489305|NCT01474746|sertraline|sertraline
489306|NCT01474746|autism|autism
489307|NCT01474733|resident education|resident education
489308|NCT01474733|health literacy|health literacy
489309|NCT01474733|curriculum|curriculum
489310|NCT01474720|Systemic Lupus Erythematosus|systemic lupus erythematosus
489311|NCT01474720|Lupus|lupus
489312|NCT01474720|SLE|sle
489313|NCT01474720|Zostavax|zostavax
489314|NCT01474720|shingles|shingles
489315|NCT01474707|COPD|copd
489316|NCT01474707|Educational materials|educational materials
489317|NCT01474707|Cultural background|cultural background
489318|NCT01474707|Instructional videos|instructional videos
489319|NCT01474707|Patient education handouts|patient education handouts
489320|NCT01474707|Lung age|lung age
489321|NCT01474694|prospective study|prospective study
489322|NCT01474694|multicenter trial|multicenter trial
489323|NCT01474694|analysis, computer assisted image|analysis, computer assisted image
489324|NCT01474694|CE marked|ce marked
489325|NCT01474694|medical devices|medical devices
489326|NCT01474694|catheter ablation|catheter ablation
489327|NCT01474681|hematologic malignancies|hematologic malignancies
489328|NCT01474681|leukemia|leukemia
489329|NCT01474681|lymphoma|lymphoma
489330|NCT01474655|epiretinal membrane|epiretinal membrane
489331|NCT01474655|visual acuity|visual acuity
489332|NCT01474655|metamorphopsia|metamorphopsia
489333|NCT01474655|thickness of retinal layers|thickness of retinal layers
489334|NCT01474655|spectral domain optical coherence tomography|spectral domain optical coherence tomography
489335|NCT01474642|Advanced or recurrent esophageal squamous cell carcinoma|advanced or recurrent esophageal squamous cell carcinoma
489336|NCT01474642|Randomizes phase II trial|randomizes phase ii trial
489337|NCT01474642|Capecitabine|capecitabine
489338|NCT01474642|Cisplatin|cisplatin
489339|NCT01474642|Genexol|genexol
489340|NCT01474629|oxidative stress|oxidative stress
489341|NCT01474629|inflammation|inflammation
489342|NCT01474629|endotoxemia|endotoxemia
489343|NCT01474629|strenuous exercise|strenuous exercise
489344|NCT01474616|Aging|aging
489345|NCT01474616|Health Services|health services
489346|NCT01474616|Knowledge Translation|knowledge translation
489347|NCT01474616|Long-Term Care Facilities|long-term care facilities
489348|NCT01474616|Mobility|mobility
489349|NCT01474616|Psychosocial And Health Behaviours|psychosocial and health behaviours
489350|NCT01474603|observational study|observational study
489351|NCT01474577|stress test|stress test
489352|NCT01474577|cardiac issues|cardiac issues
489353|NCT01474577|Rb-82 PET Myocardial Perfusion Imaging|rb-82 pet myocardial perfusion imaging
489354|NCT01474577|11-150|11-150
489355|NCT01474577|one or more 82Rb myocardial perfusion stress tests|one or more 82rb myocardial perfusion stress tests
489356|NCT01474564|Blood draw|blood draw
489357|NCT01474564|pancreas|pancreas
489358|NCT01474564|Tumorigenic Cells|tumorigenic cells
489359|NCT01474564|11-141|11-141
489360|NCT01474551|Vemurafenib|vemurafenib
489361|NCT01474551|skin cancer|skin cancer
489362|NCT01474551|Stage IV|stage iv
489363|NCT01474551|advanced stage III|advanced stage iii
489364|NCT01474551|11-091|11-091
489365|NCT01474538|diabetes|diabetes
489366|NCT01474538|type 2 diabetes|type 2 diabetes
489367|NCT01474538|insulin pump|insulin pump
489368|NCT01474538|continuous subcutaneous insulin infusion|continuous subcutaneous insulin infusion
489369|NCT01474538|CSII|csii
489370|NCT01474538|A1C|a1c
489371|NCT01474486|thiamin|thiamin
489372|NCT01474486|pyridoxine|pyridoxine
489373|NCT01474486|vitamin D|vitamin d
489374|NCT01474486|zinc|zinc
489375|NCT01474486|congestive heart failure (CHF)|congestive heart failure (chf)
489376|NCT01474486|ischemic cardiomyopathy|ischemic cardiomyopathy
489377|NCT01474486|nutritional injury|nutritional injury
489378|NCT01474486|quality of life|quality of life
489379|NCT01474473|CACIPLIQ20|cacipliq20
489380|NCT01474473|Matrix Therapy|matrix therapy
489381|NCT01474473|Diabetic foot|diabetic foot
489382|NCT01474460|warfarin|warfarin
489383|NCT01474460|phytonadione|phytonadione
489384|NCT01474460|INR|inr
489385|NCT01474447|low back pain|low back pain
489386|NCT01474434|coronary artery disease,|coronary artery disease,
489387|NCT01474434|LCQ908,|lcq908,
489388|NCT01474434|hyperlipidemia,|hyperlipidemia,
489389|NCT01474434|hypertriglyceridemia,|hypertriglyceridemia,
489390|NCT01474434|pradigastat|pradigastat
489391|NCT01474421|Parkinson's disease|parkinson's disease
489392|NCT01474421|Dyskinesia|dyskinesia
489393|NCT01474421|Movement disorders|movement disorders
489394|NCT01474421|L-dopa|l-dopa
489395|NCT01474408|Coronary artery bypass|coronary artery bypass
489396|NCT01474408|Exercise therapy|exercise therapy
489397|NCT01474408|Revascularization (PCI)|revascularization (pci)
489398|NCT01474395|schizophrenia|schizophrenia
489399|NCT01474395|cognitive remediation|cognitive remediation
489400|NCT01474395|NMDA|nmda
489401|NCT01474382|OraVerse|oraverse
489402|NCT01474382|Safety|safety
489403|NCT01474382|Efficacy|efficacy
489404|NCT01474382|Pediatric|pediatric
489405|NCT01474382|Reversal of dental anesthesia|reversal of dental anesthesia
489406|NCT01474369|Drug Therapy|drug therapy
489407|NCT01474356|brachytherapy|brachytherapy
489408|NCT01474356|interstitial hyperthermia|interstitial hyperthermia
489409|NCT01474356|cervical cancer|cervical cancer
489410|NCT01474356|side effects|side effects
489411|NCT01474356|Locally advanced cervical cancer patients|locally advanced cervical cancer patients
489412|NCT01474343|Neurodegenerative Diseases|neurodegenerative diseases
489413|NCT01474343|Nervous System Diseases|nervous system diseases
489414|NCT01474343|Genetic Diseases, Inborn|genetic diseases, inborn
489415|NCT01474343|Metabolic Diseases|metabolic diseases
489416|NCT01474343|Gene Therapy|gene therapy
489417|NCT01474343|Adenovirus Associated Vector|adenovirus associated vector
489418|NCT01474330|Pomalidomide|pomalidomide
489419|NCT01474330|safety|safety
489420|NCT01474330|tolerability|tolerability
489421|NCT01474330|pharmacokinetics|pharmacokinetics
489422|NCT01474304|craniotomy|craniotomy
489423|NCT01474304|tumor resection|tumor resection
489424|NCT01474304|aneurysm|aneurysm
489425|NCT01474304|revascularization|revascularization
489426|NCT01474304|opioid|opioid
489427|NCT01474304|nausea|nausea
489428|NCT01474304|vomiting|vomiting
489429|NCT01474304|acetaminophen|acetaminophen
489430|NCT01474265|smoking cessation|smoking cessation
489431|NCT01474265|varenicline|varenicline
489432|NCT01474265|sympathovagal balance|sympathovagal balance
489433|NCT01474265|quit attempts|quit attempts
489434|NCT01474265|MSNA|msna
489435|NCT01474226|lysine|lysine
489436|NCT01474226|rice|rice
489437|NCT01474226|bioavailability|bioavailability
489438|NCT01474213|dexmedetomidine|dexmedetomidine
489439|NCT01474213|remifentanil|remifentanil
489440|NCT01474213|awake nasotracheal fibreoptic intubation|awake nasotracheal fibreoptic intubation
489441|NCT01474213|oral maxillofacial surgery|oral maxillofacial surgery
489442|NCT01474213|difficult airway|difficult airway
489443|NCT01474213|adult|adult
489444|NCT01474200|Ultrafiltration|ultrafiltration
489445|NCT01474200|Aquapheresis|aquapheresis
489446|NCT01474200|Diuretics|diuretics
489447|NCT01474200|Loop Diuretics|loop diuretics
489448|NCT01474200|Aquadex Flexflow System|aquadex flexflow system
489449|NCT01474200|Gambro UF Solutions|gambro uf solutions
489450|NCT01474187|Neoadjuvant chemotherapy|neoadjuvant chemotherapy
489451|NCT01474187|rectal cancer|rectal cancer
489452|NCT01474187|phase I study|phase i study
489453|NCT01474187|irinotecan|irinotecan
489454|NCT01474148|paraplegia|paraplegia
489455|NCT01474148|tetraplegia|tetraplegia
489456|NCT01474148|Spinal cord injured|spinal cord injured
489457|NCT01474148|FES|fes
489458|NCT01474135|Glaucoma|glaucoma
489459|NCT01474135|Ocular Hypertension|ocular hypertension
489460|NCT01474122|digital ulcers|digital ulcers
489461|NCT01474122|systemic sclerosis|systemic sclerosis
489462|NCT01474109|systemic sclerosis|systemic sclerosis
489463|NCT01474109|digital ulcers|digital ulcers
489464|NCT01474096|clinical practice guideline-primary health care|clinical practice guideline-primary health care
489465|NCT01474083|Type 2 diabetes mellitus|type 2 diabetes mellitus
489466|NCT01474083|pharmacokinetics|pharmacokinetics
489467|NCT01474083|pharmacodynamics|pharmacodynamics
489468|NCT01474070|Glaucoma|glaucoma
489469|NCT01474070|Goldmann Tonometry|goldmann tonometry
489470|NCT01474070|Dynamic Contour Tonometry|dynamic contour tonometry
489471|NCT01474057|PTSD|ptsd
489472|NCT01474057|combat trauma|combat trauma
489473|NCT01474057|telemedicine|telemedicine
489474|NCT01474057|primary care interventions|primary care interventions
489475|NCT01474057|CBT|cbt
489476|NCT01474057|self-managed treatment|self-managed treatment
489477|NCT01474057|web-based intervention|web-based intervention
489478|NCT01474057|internet treatment|internet treatment
489479|NCT01474031|total hip arthroplasty|total hip arthroplasty
489480|NCT01474031|biomechanics|biomechanics
489481|NCT01474031|direct anterior approach|direct anterior approach
489482|NCT01474005|laryngectomy|laryngectomy
489483|NCT01474005|artificial larynx|artificial larynx
489484|NCT01474005|breathing|breathing
489485|NCT01474005|swallowing|swallowing
489486|NCT01474005|upper airway|upper airway
489487|NCT01473979|cardiac surgery|cardiac surgery
489488|NCT01473979|poststernotomy wound infections|poststernotomy wound infections
489489|NCT01473979|delayed secondary closure of sternum|delayed secondary closure of sternum
489490|NCT01473927|Inflammatory bowel diseases|inflammatory bowel diseases
489491|NCT01473927|Crohn disease|crohn disease
489492|NCT01473927|Ficolin-2|ficolin-2
489493|NCT01473927|C-Reactive Protein|c-reactive protein
489494|NCT01473927|Calprotectin|calprotectin
489495|NCT01473927|Inflammatory markers|inflammatory markers
489497|NCT01473901|BKM120|bkm120
489498|NCT01473901|temozolomide|temozolomide
489499|NCT01473901|glioblastoma multiforme|glioblastoma multiforme
489500|NCT01473901|GBM|gbm
489501|NCT01473901|Newly diagnosed|newly diagnosed
489502|NCT01473888|T89(Dantonic®)|t89(dantonic®)
489503|NCT01473888|Cooperstown 5+1 cocktail probes|cooperstown 5+1 cocktail probes
489504|NCT01473888|CYP450|cyp450
489505|NCT01473875|LIPA|lipa
489506|NCT01473875|Wolman Disease|wolman disease
489507|NCT01473875|Wolman Phenotype|wolman phenotype
489508|NCT01473875|Acid Lipase Deficiency|acid lipase deficiency
489509|NCT01473875|Acid Cholesteryl Hydrolase|acid cholesteryl hydrolase
489510|NCT01473875|Acid Lipase Disease Deficiency, type 2|acid lipase disease deficiency, type 2
489511|NCT01473875|Cholesteryl Ester Storage Disease (CESD)|cholesteryl ester storage disease (cesd)
489512|NCT01473875|Cholesteryl Ester Hydrolase Deficiency|cholesteryl ester hydrolase deficiency
489513|NCT01473875|Early Onset LAL-Deficiency (Wolman Disease)|early onset lal-deficiency (wolman disease)
489514|NCT01473875|LAL Deficiency|lal deficiency
489515|NCT01473875|Late Onset Lysosomal Acid Lipase Deficiency (CESD)|late onset lysosomal acid lipase deficiency (cesd)
489516|NCT01473875|Wolman Disease (early onset LAL Deficiency)|wolman disease (early onset lal deficiency)
489517|NCT01473875|Related Disorders:|related disorders:
489518|NCT01473875|Non-alcoholic Fatty Liver Disease (NAFLD)|non-alcoholic fatty liver disease (nafld)
489519|NCT01473875|Non-alcoholic Steatohepatitis (NASH)|non-alcoholic steatohepatitis (nash)
489520|NCT01473875|Alcoholic Liver Disease|alcoholic liver disease
489521|NCT01473875|Cryptogenic Cirrhosis|cryptogenic cirrhosis
489522|NCT01473875|Niemann-Pick Disease (NPD) Type C|niemann-pick disease (npd) type c
489523|NCT01473875|Chanarin Dorfman Syndrome|chanarin dorfman syndrome
489524|NCT01473862|adolescent|adolescent
489525|NCT01473862|bereavement|bereavement
489526|NCT01473862|cancer|cancer
489527|NCT01473862|coping skills|coping skills
489528|NCT01473849|Cytomegalovirus|cytomegalovirus
489529|NCT01473849|Liver transplantation|liver transplantation
489530|NCT01473849|Hepatitis C virus|hepatitis c virus
489531|NCT01473849|Patients who underwent first liver transplantation due to hepatopathy caused by HCV,confirmed by detection of HCV RNA previously to transplantation|patients who underwent first liver transplantation due to hepatopathy caused by hcv,confirmed by detection of hcv rna previously to transplantation
489532|NCT01473836|Metronidazole|metronidazole
489533|NCT01473836|intra-abdominal infection|intra-abdominal infection
489534|NCT01473836|pelvic inflammatory disease|pelvic inflammatory disease
489535|NCT01473836|anaerobe|anaerobe
489536|NCT01473823|food allergy|food allergy
489537|NCT01473823|eczema|eczema
489538|NCT01473823|sensitisation|sensitisation
489539|NCT01473823|omega-3 long chain polyunsaturated fatty acids|omega-3 long chain polyunsaturated fatty acids
489540|NCT01473823|prevention|prevention
489541|NCT01473823|asthma|asthma
489542|NCT01473810|HIV|hiv
489543|NCT01473810|vaccination|vaccination
489544|NCT01473810|T cells|t cells
489545|NCT01473810|mucosal immunity|mucosal immunity
489546|NCT01473810|safety|safety
489547|NCT01473810|nasal administration|nasal administration
489548|NCT01473810|DTH skin test|dth skin test
489549|NCT01473771|Suicide|suicide
489550|NCT01473771|Suicide, Attempted|suicide, attempted
489551|NCT01473758|COPD|copd
489552|NCT01473758|Chronic obstructive pulmonary disease|chronic obstructive pulmonary disease
489553|NCT01473758|Roflumilast|roflumilast
489554|NCT01473745|Alar Base Suture; Nasolabial Change; 3D stereogrammetry|alar base suture; nasolabial change; 3d stereogrammetry
489555|NCT01473732|CNI toxicity|cni toxicity
489556|NCT01473732|CAI|cai
489557|NCT01473719|alcohol use|alcohol use
489558|NCT01473719|marijuana use|marijuana use
489559|NCT01473719|STI|sti
489560|NCT01473706|Malnutrition|malnutrition
489561|NCT01473706|Nutrition status|nutrition status
489562|NCT01473706|Elderly|elderly
489563|NCT01473706|Nutrition screening|nutrition screening
489564|NCT01473693|Quality of Life|quality of life
489565|NCT01473693|Lung cancer|lung cancer
489566|NCT01473693|MRI|mri
489567|NCT01473693|Surgery|surgery
489568|NCT01473693|induction chemotherapy|induction chemotherapy
489569|NCT01473693|11-145|11-145
489570|NCT01473680|minority breast cancer patients|minority breast cancer patients
489571|NCT01473680|EEG|eeg
489572|NCT01473680|Evaluation|evaluation
489573|NCT01473680|Questionnaires|questionnaires
489574|NCT01473680|11-139|11-139
489575|NCT01473641|Etonogestrel|etonogestrel
489576|NCT01473641|Contraceptive implant|contraceptive implant
489577|NCT01473641|Safety|safety
489578|NCT01473628|early stage follicular lymphoma|early stage follicular lymphoma
489579|NCT01473628|indolent non-Hodgkin's lymphomas|indolent non-hodgkin's lymphomas
489580|NCT01473628|Lymphoma|lymphoma
489581|NCT01473628|Follicular Lymphoma|follicular lymphoma
489582|NCT01473628|FL|fl
489583|NCT01473628|Rituximab|rituximab
489584|NCT01473628|Rituxan|rituxan
489585|NCT01473628|Radiation|radiation
489586|NCT01473628|Radiation Therapy|radiation therapy
489587|NCT01473628|XRT|xrt
489588|NCT01473576|type II diabetes|type ii diabetes
489589|NCT01473576|protein synthesis|protein synthesis
489590|NCT01473576|nitrate|nitrate
489591|NCT01473576|elderly|elderly
489592|NCT01473550|Mental Health|mental health
489593|NCT01473550|Smart Technology|smart technology
489594|NCT01473550|Mood disorder|mood disorder
489595|NCT01473550|Psychotic disorder|psychotic disorder
489596|NCT01473537|dental caries/prevention and control|dental caries/prevention and control
489597|NCT01473537|oral health|oral health
489598|NCT01473537|cariostatic agents|cariostatic agents
489599|NCT01473524|Primary Biliary Cholangitis|primary biliary cholangitis
489600|NCT01473524|Primary Biliary Cirrhosis|primary biliary cirrhosis
489601|NCT01473524|PBC|pbc
489602|NCT01473524|Cirrhosis|cirrhosis
489603|NCT01473524|Liver|liver
489604|NCT01473511|Behavioural intervention|behavioural intervention
489605|NCT01473511|Distance intervention|distance intervention
489606|NCT01473511|Parenting intervention|parenting intervention
489607|NCT01473498|Sepsis|sepsis
489608|NCT01473498|Acute kidney injury|acute kidney injury
489609|NCT01473498|Mean arterial pressure|mean arterial pressure
489610|NCT01473498|Catecholamines|catecholamines
489611|NCT01473498|Renal doppler|renal doppler
489612|NCT01473485|Brain Tumor|brain tumor
489613|NCT01473485|Glioma|glioma
489614|NCT01473485|Brain Cancer|brain cancer
489615|NCT01473485|Metastatic Brain Cancer|metastatic brain cancer
489616|NCT01473472|Prophylaxis|prophylaxis
489617|NCT01473472|HIV infection|hiv infection
489618|NCT01473472|tenofovir|tenofovir
489619|NCT01473472|emtricitabine|emtricitabine
489620|NCT01473472|men who have sex with men|men who have sex with men
489621|NCT01473459|best fertility protocol|best fertility protocol
489622|NCT01473459|(BMI > 30)|(bmi > 30)
489623|NCT01473459|women|women
489624|NCT01473459|PCOS|pcos
489625|NCT01473446|Goal directed fluid therapy|goal directed fluid therapy
489626|NCT01473446|perioperative fluid therapy|perioperative fluid therapy
489627|NCT01473446|LiDCOrapid|lidcorapid
489628|NCT01473446|Postoperative outcome|postoperative outcome
489629|NCT01473446|Open abdominal surgery|open abdominal surgery
489630|NCT01473433|Regenerative medicine|regenerative medicine
489631|NCT01473433|Myocardial infarction|myocardial infarction
489632|NCT01473394|Major depressive disorder|major depressive disorder
489633|NCT01473394|Depression|depression
489634|NCT01473381|Major Depressive Disorder|major depressive disorder
489635|NCT01473381|Depression|depression
489636|NCT01473368|human Gut Microbiota|human gut microbiota
489637|NCT01473368|gut microbiota|gut microbiota
489638|NCT01473368|gut microbiome|gut microbiome
489639|NCT01473368|probiotic|probiotic
489640|NCT01473368|antibiotic|antibiotic
489641|NCT01473368|antibiotic-associated diarrhea|antibiotic-associated diarrhea
489642|NCT01473368|intestinal bacterial overgrowth|intestinal bacterial overgrowth
489643|NCT01473342|Healthy survivorship|healthy survivorship
489644|NCT01473342|Smartphones|smartphones
489645|NCT01473342|Treatment|treatment
489646|NCT01473329|diabetes care|diabetes care
489647|NCT01473329|diabetes education|diabetes education
489648|NCT01473329|diabetes control|diabetes control
489649|NCT01473303|stage IV pancreatic cancer|stage iv pancreatic cancer
489650|NCT01473303|duct cell adenocarcinoma of the pancreas|duct cell adenocarcinoma of the pancreas
489651|NCT01473290|diarrhea|diarrhea
489652|NCT01473290|constipation, impaction, and bowel obstruction|constipation, impaction, and bowel obstruction
489653|NCT01473290|gastrointestinal complications|gastrointestinal complications
489654|NCT01473290|fatigue|fatigue
489655|NCT01473290|psychosocial effects of cancer and its treatment|psychosocial effects of cancer and its treatment
489656|NCT01473290|cognitive/functional effects|cognitive/functional effects
489657|NCT01473290|unspecified adult solid tumor, protocol specific|unspecified adult solid tumor, protocol specific
489658|NCT01473277|Hemiplegic shoulder pain|hemiplegic shoulder pain
489659|NCT01473277|Botulinum toxin type A (BT-A)|botulinum toxin type a (bt-a)
489660|NCT01473277|Steroid|steroid
489661|NCT01473277|Intra-articular injection|intra-articular injection
489662|NCT01473277|Pain score of 45 or greater on a 0-100 mm VAS|pain score of 45 or greater on a 0-100 mm vas
489663|NCT01473277|Duration of HSP for at least one month|duration of hsp for at least one month
489664|NCT01473277|Pain refractoriness to conventional treatment|pain refractoriness to conventional treatment
489665|NCT01473264|CC10|cc10
489666|NCT01473264|BPD|bpd
489667|NCT01473264|Bronchopulmonary dysplasia|bronchopulmonary dysplasia
489668|NCT01473264|premature infants|premature infants
489669|NCT01473264|neonates|neonates
489670|NCT01473264|pulmonary inflammation|pulmonary inflammation
489671|NCT01473264|lung function|lung function
489672|NCT01473264|RDS|rds
489673|NCT01473238|Desktop computer|desktop computer
489674|NCT01473238|Mobile|mobile
489675|NCT01473238|iPad|ipad
489676|NCT01473238|Evaluation|evaluation
489677|NCT01473238|User experience|user experience
489678|NCT01473238|Benefits|benefits
489679|NCT01473238|Cost analysis|cost analysis
489680|NCT01473199|focal defect|focal defect
489681|NCT01473199|focal lesion|focal lesion
489682|NCT01473199|chondral lesion|chondral lesion
489683|NCT01473199|osteochondral lesion|osteochondral lesion
489684|NCT01473186|morbid obesity|morbid obesity
623964|NCT00925249|IGRA|igra
489685|NCT01473186|endometrial pathology|endometrial pathology
489686|NCT01473186|menstrual irregularities|menstrual irregularities
489687|NCT01473173|Safety|safety
489688|NCT01473173|Tolerability|tolerability
489689|NCT01473173|Pharmacokinetics|pharmacokinetics
489690|NCT01473173|Pharmacodynamics|pharmacodynamics
489691|NCT01473147|GLP-1 analogue|glp-1 analogue
489692|NCT01473147|CSII|csii
489693|NCT01473147|insulin|insulin
489694|NCT01473147|type 2 diabetes mellitus|type 2 diabetes mellitus
489695|NCT01473121|Hepatocellular carcinoma|hepatocellular carcinoma
489696|NCT01473121|Registry|registry
489697|NCT01473121|Turkey|turkey
489698|NCT01473108|Healthy volunteers, proof-of-concept trial, PK and PD|healthy volunteers, proof-of-concept trial, pk and pd
489700|NCT01473095|ARQ 092|arq 092
489701|NCT01473095|Targeted therapy|targeted therapy
489702|NCT01473095|Molecular therapy|molecular therapy
489703|NCT01473095|Biomarker|biomarker
489704|NCT01473095|Phase 1|phase 1
489705|NCT01473095|Phase I|phase i
489706|NCT01473095|Endometrial cancer|endometrial cancer
489707|NCT01473095|Lymphoma|lymphoma
489708|NCT01473095|AKT pathway|akt pathway
489709|NCT01473095|AKT signaling|akt signaling
489710|NCT01473095|AKT inhibitor|akt inhibitor
489711|NCT01473095|AKT pan inhibitor|akt pan inhibitor
489712|NCT01473095|AKT1|akt1
489713|NCT01473095|AKT2|akt2
489714|NCT01473095|AKT3|akt3
489715|NCT01473095|AKT1 mutation|akt1 mutation
489716|NCT01473095|AKT1-E17K|akt1-e17k
489717|NCT01473095|AKT1-E17K mutation|akt1-e17k mutation
489718|NCT01473095|AKT 2 inhibitor|akt 2 inhibitor
489719|NCT01473095|AKT 3 inhibitor|akt 3 inhibitor
489720|NCT01473095|AKT 3 amplification|akt 3 amplification
489721|NCT01473095|PI3K AKT mTOR signalling pathway|pi3k akt mtor signalling pathway
489722|NCT01473095|mTOR inhibitor|mtor inhibitor
489723|NCT01473095|PI3K inhibitor|pi3k inhibitor
489724|NCT01473095|Clinical oncology|clinical oncology
489725|NCT01473095|Tumor|tumor
489726|NCT01473095|Tumour|tumour
489727|NCT01473095|PIK3CA H1047R mutation|pik3ca h1047r mutation
489728|NCT01473069|JTK-853|jtk-853
489729|NCT01473069|Healthy subjects|healthy subjects
489730|NCT01473056|Hepatitis C|hepatitis c
489731|NCT01473056|JTK-853|jtk-853
489732|NCT01473043|Axitinib|axitinib
489733|NCT01473043|metastatic renal cell carcinoma|metastatic renal cell carcinoma
489734|NCT01473030|Benign prostate|benign prostate
489735|NCT01473030|serum DHT|serum dht
489736|NCT01473030|Dutasteride|dutasteride
489737|NCT01473030|PSA|psa
489738|NCT01473030|Avodart|avodart
489739|NCT01473004|Sir-spheres|sir-spheres
489740|NCT01473004|Liver Metastases|liver metastases
489741|NCT01473004|Selective internal radiation|selective internal radiation
489742|NCT01473004|Yttrium-90|yttrium-90
489743|NCT01473004|Uveal|uveal
489744|NCT01473004|Melanoma|melanoma
489745|NCT01473004|Ocular melanoma|ocular melanoma
489746|NCT01472991|ADHD|adhd
489747|NCT01472978|C. difficile|c. difficile
489748|NCT01472965|central line|central line
489749|NCT01472965|adolescents|adolescents
489750|NCT01472965|children|children
489751|NCT01472965|bloodstream infection|bloodstream infection
489752|NCT01472965|antibiotic lock therapy|antibiotic lock therapy
489753|NCT01472965|catheter lock therapy|catheter lock therapy
489754|NCT01472965|ethanol lock therapy|ethanol lock therapy
489755|NCT01472952|sepsis|sepsis
489756|NCT01472952|immune cells|immune cells
489757|NCT01472952|immune reaction|immune reaction
489758|NCT01472952|trauma|trauma
489759|NCT01472952|Immune activation|immune activation
489760|NCT01472926|acute ischaemic stroke|acute ischaemic stroke
489761|NCT01472926|stroke|stroke
489762|NCT01472926|thrombolysis|thrombolysis
489763|NCT01472926|thrombolytic drug therapy|thrombolytic drug therapy
489764|NCT01472926|CT perfusion|ct perfusion
489765|NCT01472926|CT angiography|ct angiography
489766|NCT01472926|brain imaging|brain imaging
489767|NCT01472913|Prospective randomised double-blind study|prospective randomised double-blind study
489768|NCT01472913|Fibrin sealant|fibrin sealant
489769|NCT01472913|Bilateral simultaneous total knee arthroplasty|bilateral simultaneous total knee arthroplasty
489770|NCT01472913|Blood loss|blood loss
489771|NCT01472913|Postoperative pain|postoperative pain
489772|NCT01472913|Complications|complications
489773|NCT01472900|acne vulgaris|acne vulgaris
489774|NCT01472874|Wilson Disease|wilson disease
489775|NCT01472874|Trientine|trientine
489776|NCT01472874|One Daily Dosage|one daily dosage
489777|NCT01472861|coculture|coculture
489778|NCT01472861|endometrial biopsy|endometrial biopsy
489779|NCT01472861|IVF poor responders|ivf poor responders
489780|NCT01472835|sedation|sedation
489781|NCT01472835|sensitivity|sensitivity
489782|NCT01472835|specificity|specificity
489783|NCT01472835|validity|validity
489784|NCT01472835|diagnostic injection|diagnostic injection
489785|NCT01472822|Omija|omija
489786|NCT01472822|knee osteoarthritis|knee osteoarthritis
489787|NCT01472809|ZYGK1|zygk1
489788|NCT01472809|Cadila|cadila
489789|NCT01472809|Zydus|zydus
489790|NCT01472809|ZRC|zrc
489791|NCT01472809|Zydus Research Center|zydus research center
489792|NCT01472809|Phase 1|phase 1
489793|NCT01472809|Diabetes|diabetes
489794|NCT01472796|African American|african american
489795|NCT01472796|Vitamin D deficient|vitamin d deficient
489796|NCT01472783|BRCA1 mutation|brca1 mutation
489797|NCT01472783|BRCA2 mutation|brca2 mutation
489798|NCT01472783|Ovarian cancer|ovarian cancer
489799|NCT01472783|PARP inhibitor|parp inhibitor
489800|NCT01472770|Colorectal cancer|colorectal cancer
489801|NCT01472770|Metastatic|metastatic
489802|NCT01472770|Treatment resistant|treatment resistant
489803|NCT01472744|Executive function|executive function
489804|NCT01472744|Aging|aging
489805|NCT01472744|Physical activity|physical activity
489806|NCT01472731|GC1008|gc1008
489807|NCT01472731|PET imaging|pet imaging
489808|NCT01472731|primary brain tumors|primary brain tumors
489809|NCT01472731|recurrent high grade glioma's|recurrent high grade glioma's
489810|NCT01472705|drug-eluting coronary stent|drug-eluting coronary stent
489811|NCT01472705|percutaneous coronary intervention|percutaneous coronary intervention
489812|NCT01472692|Prehypertension|prehypertension
489813|NCT01472692|Gout|gout
489814|NCT01472692|Puls Wave Velocity|puls wave velocity
489815|NCT01472692|Hypertension|hypertension
489816|NCT01472692|24 hour blood pressure|24 hour blood pressure
489817|NCT01472679|fat mass|fat mass
489818|NCT01472679|fat free mass|fat free mass
489819|NCT01472679|body mass index|body mass index
489820|NCT01472666|Medium chain fatty acids|medium chain fatty acids
489821|NCT01472666|Saturated fatty acids|saturated fatty acids
489822|NCT01472666|Whey protein|whey protein
489823|NCT01472666|Casein protein|casein protein
489824|NCT01472666|Metabolic syndrome|metabolic syndrome
489825|NCT01472666|Type 2 diabetes|type 2 diabetes
489826|NCT01472666|Cardiovascular disease|cardiovascular disease
489827|NCT01472666|Dairy products|dairy products
489828|NCT01472666|Dietary intervention|dietary intervention
489829|NCT01472653|Head and neck Cancer|head and neck cancer
489830|NCT01472653|Radiochemotherapy|radiochemotherapy
489831|NCT01472653|Radioimmunotherapy|radioimmunotherapy
489832|NCT01472653|Skin rush|skin rush
489833|NCT01472653|locoregional control|locoregional control
489834|NCT01472653|Survival|survival
489835|NCT01472653|Toxicity|toxicity
489836|NCT01472640|CHF, Diabetes; Liraglutid, Ecco|chf, diabetes; liraglutid, ecco
489837|NCT01472627|MM|mm
489838|NCT01472627|Bortezomib|bortezomib
489839|NCT01472627|Velcade|velcade
489840|NCT01472614|Type-2 diabetes mellitus|type-2 diabetes mellitus
489841|NCT01472614|Add-on therapy|add-on therapy
489842|NCT01472575|rotavirus|rotavirus
489843|NCT01472575|gastroenteritis|gastroenteritis
489844|NCT01472575|vaccination|vaccination
489845|NCT01472575|hospitalisation|hospitalisation
489846|NCT01472562|mantle cell lymphoma|mantle cell lymphoma
489847|NCT01472549|Preoperative|preoperative
489848|NCT01472549|Antiseptics|antiseptics
489849|NCT01472549|Comparative|comparative
489850|NCT01472549|Cost|cost
489851|NCT01472549|Effectiveness|effectiveness
489852|NCT01472536|Influenza|influenza
489853|NCT01472536|Non pharmaceutical intervention|non pharmaceutical intervention
489854|NCT01472536|Sequestration|sequestration
489855|NCT01472536|Social network|social network
489856|NCT01472510|Diabetic|diabetic
489857|NCT01472510|Macular|macular
489858|NCT01472510|Edema|edema
489859|NCT01472510|Ranibizumab|ranibizumab
489860|NCT01472510|anti-VEGF|anti-vegf
489861|NCT01472497|hypertension|hypertension
489862|NCT01472497|insulin resistance|insulin resistance
489863|NCT01472497|oral glucose tolerance test|oral glucose tolerance test
489864|NCT01472497|AGE|age
489865|NCT01472497|inflammatory cytokine|inflammatory cytokine
489866|NCT01472484|beans|beans
489867|NCT01472484|lpa mutant|lpa mutant
489868|NCT01472484|polyphenols|polyphenols
489869|NCT01472484|phytic acid|phytic acid
489870|NCT01472484|stable iron isotopes|stable iron isotopes
489871|NCT01472471|Childhood Asthma|childhood asthma
489872|NCT01472471|Oxidative stress|oxidative stress
489873|NCT01472471|Urinary 8-isoprostane|urinary 8-isoprostane
489874|NCT01472458|Cardiac arrest|cardiac arrest
489875|NCT01472458|Hypothermia|hypothermia
489876|NCT01472458|Post Cardiac Arrest Care|post cardiac arrest care
489877|NCT01472458|Survivors of cardiac arrest|survivors of cardiac arrest
489878|NCT01472445|Vitamin D|vitamin d
489879|NCT01472445|Obesity|obesity
489880|NCT01472432|type 2 diabetes|type 2 diabetes
489881|NCT01472432|healing|healing
489882|NCT01472432|foot ulcers|foot ulcers
489883|NCT01472432|vildagliptin|vildagliptin
489884|NCT01472419|metastatic esophageal squamous cell carcinoma|metastatic esophageal squamous cell carcinoma
489885|NCT01472419|Fluoropyrimidine/platinum-based first-line chemotherapy|fluoropyrimidine/platinum-based first-line chemotherapy
489886|NCT01472419|prognosis|prognosis
489887|NCT01472406|type 1 diabetes mellitus|type 1 diabetes mellitus
489888|NCT01472406|closed-loop artificial pancreas|closed-loop artificial pancreas
489889|NCT01472393|creatine supplementation|creatine supplementation
489890|NCT01472393|bone mass|bone mass
489891|NCT01472393|postmenopausal women|postmenopausal women
489892|NCT01472393|muscle function|muscle function
489893|NCT01472393|bone markers|bone markers
489894|NCT01472354|HIV|hiv
489895|NCT01472354|Hepatitis C|hepatitis c
489896|NCT01472354|Decision-Making|decision-making
489897|NCT01472354|chronic|chronic
489898|NCT01472328|Oxidative stress|oxidative stress
489899|NCT01472328|Insulin resistance|insulin resistance
489900|NCT01472315|sleep apnea|sleep apnea
489901|NCT01472315|women|women
489902|NCT01472315|postmenopause|postmenopause
489903|NCT01472315|hormone treatment|hormone treatment
489904|NCT01472289|CLI|cli
489905|NCT01472289|Peripheral arterial disease|peripheral arterial disease
489906|NCT01472276|Behaviour change|behaviour change
489907|NCT01472276|Weight loss|weight loss
489908|NCT01472276|Cardiovascular risk|cardiovascular risk
489909|NCT01472276|Diet|diet
489910|NCT01472276|Physical activity|physical activity
489911|NCT01472276|Overweight|overweight
489912|NCT01472276|Obesity|obesity
489913|NCT01472276|Internet|internet
489914|NCT01472263|HTLV-1|htlv-1
489915|NCT01472263|tropical spastic paraparesis|tropical spastic paraparesis
489916|NCT01472263|Immune System Diseases|immune system diseases
489917|NCT01472263|Physical disability|physical disability
489918|NCT01472263|pentoxifylline|pentoxifylline
489919|NCT01472250|Advanced Gastric Cancer|advanced gastric cancer
489920|NCT01472250|chemotherapy|chemotherapy
489921|NCT01472250|quality of life|quality of life
489922|NCT01472250|treatment expense|treatment expense
489923|NCT01472250|patients accepted first-line chemotherapy|patients accepted first-line chemotherapy
489924|NCT01472224|Transcranial ultrasound|transcranial ultrasound
489925|NCT01472224|Haematoma expansion|haematoma expansion
489926|NCT01472198|GSI|gsi
489927|NCT01472198|Gilead|gilead
489928|NCT01472198|Gilead Sciences|gilead sciences
489929|NCT01472198|Pancreatic Cancer|pancreatic cancer
489930|NCT01472198|PC|pc
489931|NCT01472198|Gemcitabine|gemcitabine
489932|NCT01472198|Phase 2|phase 2
489933|NCT01472198|Phase II|phase ii
489934|NCT01472198|GS-6624|gs-6624
489935|NCT01472198|Oncology|oncology
489936|NCT01472198|Monoclonal Antibody|monoclonal antibody
489937|NCT01472185|Type 2 Diabetes Mellitus|type 2 diabetes mellitus
489938|NCT01472172|Flex-rigid pleuroscopy|flex-rigid pleuroscopy
489939|NCT01472172|cryobiopsy|cryobiopsy
489940|NCT01472172|pleural biopsy|pleural biopsy
489941|NCT01472172|pleural effusion|pleural effusion
489942|NCT01472172|safety|safety
489943|NCT01472172|thoracoscopy|thoracoscopy
489944|NCT01472146|Neoadjuvant therapy|neoadjuvant therapy
489945|NCT01472146|Breast cancer HER2 positive|breast cancer her2 positive
489946|NCT01472146|zolendronic acid|zolendronic acid
489947|NCT01472133|Respiration Rate|respiration rate
489948|NCT01472133|ECG|ecg
489949|NCT01472133|Pulse oximetry|pulse oximetry
489950|NCT01472133|Photoplethysmograph|photoplethysmograph
489951|NCT01472133|PPG|ppg
489952|NCT01472133|Physiology|physiology
489953|NCT01472107|Pregnancy|pregnancy
489954|NCT01472107|APL female patients|apl female patients
489955|NCT01472068|Incontinence|incontinence
489956|NCT01472068|NMES|nmes
489957|NCT01472055|Hematopoietic stem cell transplantation with fludarabine based conditioning|hematopoietic stem cell transplantation with fludarabine based conditioning
489958|NCT01472042|Traumatic Brain Injury|traumatic brain injury
489959|NCT01472042|Sport Concussion|sport concussion
489960|NCT01472042|Head Injury|head injury
489961|NCT01472042|Sports Injury|sports injury
489962|NCT01472029|Adenocarcinoma|adenocarcinoma
489963|NCT01472029|Gastroesophageal junction|gastroesophageal junction
489964|NCT01472029|Stomach|stomach
489965|NCT01472029|HER2|her2
489966|NCT01472016|c-Met overexpression|c-met overexpression
489967|NCT01472016|MET amplification|met amplification
489968|NCT01472016|Neoplasms|neoplasms
489969|NCT01472016|h224G11|h224g11
489970|NCT01471990|PACAP38|pacap38
489971|NCT01471990|MMA|mma
489972|NCT01471990|migraine|migraine
489973|NCT01471990|angiography|angiography
489974|NCT01471990|VIP|vip
489975|NCT01471990|vasodilatation|vasodilatation
489976|NCT01471912|Macular Holes|macular holes
489977|NCT01471912|spectral domain optical coherence tomography|spectral domain optical coherence tomography
489978|NCT01471912|elongation of foveal tissue|elongation of foveal tissue
489979|NCT01471912|M-score|m-score
489980|NCT01471873|Posterior corneal surface elevation|posterior corneal surface elevation
489981|NCT01471873|Pentacam-Scheimpflung imaging|pentacam-scheimpflung imaging
489982|NCT01471873|variability|variability
489983|NCT01471873|progressive keratoconus|progressive keratoconus
489984|NCT01471873|corneal cross-linking|corneal cross-linking
489985|NCT01471847|Locally advanced|locally advanced
489986|NCT01471847|metastatic|metastatic
489987|NCT01471847|breast cancer|breast cancer
489988|NCT01471847|HER2 positive|her2 positive
489989|NCT01471847|PI3K|pi3k
489990|NCT01471847|mTOR|mtor
489991|NCT01471847|trastuzumab|trastuzumab
489992|NCT01471847|targeted therapy|targeted therapy
489993|NCT01471847|LABC|labc
489994|NCT01471847|MBC|mbc
489995|NCT01471782|ALL|all
489996|NCT01471782|relapsed, refractory B-precursor ALL|relapsed, refractory b-precursor all
489997|NCT01471782|Leukemia|leukemia
489998|NCT01471782|Leukemia, Lymphoid|leukemia, lymphoid
489999|NCT01471782|Precursor Cell Lymphoblastic Leukemia|precursor cell lymphoblastic leukemia
490000|NCT01471782|Neoplasms by Histologic Type|neoplasms by histologic type
490001|NCT01471782|Neoplasms|neoplasms
490002|NCT01471782|Lymphoproliferative Disorders|lymphoproliferative disorders
490003|NCT01471782|Lymphatic Diseases|lymphatic diseases
490004|NCT01471782|Immunoproliferative Disorders|immunoproliferative disorders
490005|NCT01471782|Antibodies, Bispecific|antibodies, bispecific
490006|NCT01471769|pediatric|pediatric
490007|NCT01471769|pain|pain
490008|NCT01471756|sessile neoplasms|sessile neoplasms
490009|NCT01471756|flat neoplasms|flat neoplasms
490010|NCT01471756|gastric cancer|gastric cancer
490011|NCT01471743|nutrition|nutrition
490012|NCT01471743|surgery|surgery
490013|NCT01471743|immune|immune
490014|NCT01471730|Transfusions|transfusions
490015|NCT01471730|Fresh Frozen Plasma|fresh frozen plasma
490016|NCT01471730|Fibrinogen|fibrinogen
490017|NCT01471730|Prothrombin complex|prothrombin complex
490018|NCT01471717|PK|pk
490019|NCT01471717|pharmacokinetics|pharmacokinetics
490020|NCT01471717|INX08189|inx08189
490021|NCT01471717|Victrelis|victrelis
490022|NCT01471717|Inhibitex|inhibitex
490023|NCT01471704|Pharmacokinetics|pharmacokinetics
490024|NCT01471704|PK|pk
490025|NCT01471704|INX08189|inx08189
490026|NCT01471704|Verapamil|verapamil
490027|NCT01471704|Inhibitex|inhibitex
490028|NCT01471678|Cross-over design|cross-over design
490029|NCT01471678|Pilot bioequivalence|pilot bioequivalence
490030|NCT01471678|North east Asian ancestry|north east asian ancestry
490031|NCT01471678|GI198745|gi198745
490032|NCT01471678|Tamsulosin hydrochloride|tamsulosin hydrochloride
490033|NCT01471678|healthy male subjects|healthy male subjects
490034|NCT01471678|Bioequivalence|bioequivalence
490035|NCT01471678|Dutasteride|dutasteride
490036|NCT01471561|Osmolarity|osmolarity
490037|NCT01471561|Cataract|cataract
490038|NCT01471561|Dry Eye|dry eye
490039|NCT01471548|tumor|tumor
490040|NCT01471548|cancer|cancer
490041|NCT01471548|phase1|phase1
490042|NCT01471548|TKI258|tki258
490043|NCT01471418|TMJ|tmj
490044|NCT01471418|orofacial pain|orofacial pain
490045|NCT01471418|synovitis|synovitis
490046|NCT01471418|arthroscopy|arthroscopy
490047|NCT01471379|Irritable Bowel Syndrome|irritable bowel syndrome
490048|NCT01471379|IBS|ibs
490049|NCT01471379|Savella|savella
490050|NCT01471379|Milnacipran|milnacipran
490051|NCT01471379|Abdominal Pain|abdominal pain
490052|NCT01471366|Hyperlipidemias|hyperlipidemias
490053|NCT01471366|Dyslipidemias|dyslipidemias
490054|NCT01471366|Fatty Acids, Omega-3|fatty acids, omega-3
490055|NCT01471366|Fish Oils|fish oils
490056|NCT01471353|Metastatic|metastatic
490057|NCT01471353|Colon Cancer|colon cancer
490058|NCT01471353|Rectal Cancer|rectal cancer
490059|NCT01471652|myalgic encephalopathy|myalgic encephalopathy
490060|NCT01471652|chronic fatigue syndrome|chronic fatigue syndrome
490061|NCT01471652|post viral infection|post viral infection
490062|NCT01471652|fatigue|fatigue
490063|NCT01471652|muscle pain|muscle pain
490064|NCT01471652|unrefreshing sleep|unrefreshing sleep
490065|NCT01471652|fuzzy thought|fuzzy thought
490066|NCT01471652|poor memory|poor memory
490067|NCT01471652|forgetfulness|forgetfulness
490068|NCT01471639|18 years and older,|18 years and older,
490069|NCT01471639|previously healthy|previously healthy
490070|NCT01471639|men and nonpregnant women|men and nonpregnant women
490071|NCT01471639|emergency department|emergency department
490072|NCT01471626|sleep apnea|sleep apnea
490073|NCT01471626|polysomnography|polysomnography
490074|NCT01471626|telemedicine|telemedicine
490075|NCT01471613|spinal cord injury|spinal cord injury
490076|NCT01471613|umbilical cord blood cell|umbilical cord blood cell
490077|NCT01471613|cell transplant|cell transplant
490078|NCT01471613|lithium carbonate|lithium carbonate
490079|NCT01471600|upper gastrointestinal endoscopy|upper gastrointestinal endoscopy
490080|NCT01471600|general anesthesia|general anesthesia
490081|NCT01471535|chronic hepatitis B|chronic hepatitis b
490082|NCT01471509|Glycemic Index|glycemic index
490083|NCT01471509|LoBAG Diet|lobag diet
490084|NCT01471509|Insulin|insulin
490085|NCT01471509|Glucagon|glucagon
490086|NCT01471496|duodenal ulcer|duodenal ulcer
490087|NCT01471496|upper gastrointestinal system bleeding|upper gastrointestinal system bleeding
490088|NCT01471496|injection therapy|injection therapy
490089|NCT01471483|Geriatric Assessment|geriatric assessment
490090|NCT01471483|Quality of Life|quality of life
490091|NCT01471483|11-164|11-164
490092|NCT01471483|Fallopian Tubes|fallopian tubes
490093|NCT01471470|Advanced gastric cancer|advanced gastric cancer
490094|NCT01471470|Neoadjuvant|neoadjuvant
490095|NCT01471470|Bevacizumab|bevacizumab
490096|NCT01471457|bacterial|bacterial
490097|NCT01471457|vaginosis|vaginosis
490099|NCT01471457|discharge|discharge
490100|NCT01471444|Blood And Marrow Transplantation|blood and marrow transplantation
490101|NCT01471444|Leukemia|leukemia
490102|NCT01471444|Allogeneic hematopoietic stem cell transplantation|allogeneic hematopoietic stem cell transplantation
490103|NCT01471444|Acute myeloid leukemia|acute myeloid leukemia
490104|NCT01471444|AML|aml
490105|NCT01471444|Myelodysplastic syndrome|myelodysplastic syndrome
490106|NCT01471444|MDS|mds
490107|NCT01471444|Progression free survival|progression free survival
490108|NCT01471444|Rate of engraftment|rate of engraftment
490109|NCT01471444|Toxicity|toxicity
490110|NCT01471444|Relapse rate|relapse rate
490111|NCT01471444|Graft-vs-host disease|graft-vs-host disease
490112|NCT01471444|GvHD|gvhd
490113|NCT01471444|Progression-free survival|progression-free survival
490114|NCT01471444|PFS|pfs
490115|NCT01471444|Overall survival|overall survival
490116|NCT01471444|OS|os
490117|NCT01471444|Fludarabine|fludarabine
490118|NCT01471444|Fludarabine Phosphate|fludarabine phosphate
490119|NCT01471444|Fludara|fludara
490120|NCT01471444|Clofarabine|clofarabine
490121|NCT01471444|Clofarex|clofarex
490122|NCT01471444|Clolar|clolar
490123|NCT01471444|Busulfan|busulfan
490124|NCT01471444|Busulfex|busulfex
490125|NCT01471444|Myleran|myleran
490126|NCT01471444|Thymoglobulin|thymoglobulin
490127|NCT01471444|ATG|atg
490128|NCT01471444|Antithymocyte Globulin|antithymocyte globulin
490129|NCT01471444|Methotrexate|methotrexate
490130|NCT01471444|Tacrolimus|tacrolimus
490131|NCT01471444|Prograf|prograf
490132|NCT01471392|Identigene|identigene
490133|NCT01471392|STD Test|std test
490134|NCT01471392|Chlamydia|chlamydia
490135|NCT01471392|Gonorrhoeae|gonorrhoeae
490136|NCT01471392|APTIMA|aptima
490137|NCT01471392|Sexually Transmitted Disease|sexually transmitted disease
490138|NCT01471301|systemic lupus erythematosus|systemic lupus erythematosus
490139|NCT01471301|rheumatoid arthritis|rheumatoid arthritis
490140|NCT01471288|well differentiated thyroid cancer|well differentiated thyroid cancer
490141|NCT01471288|Carum Carvi|carum carvi
490142|NCT01471288|Normal controls|normal controls
490143|NCT01471275|type 2 diabetes|type 2 diabetes
490144|NCT01471275|obesity|obesity
490145|NCT01471275|hypertriglyceridemia|hypertriglyceridemia
490146|NCT01471262|Complications|complications
490147|NCT01471262|Mortality|mortality
490148|NCT01471262|Liver|liver
490149|NCT01471262|Failure|failure
490150|NCT01471249|esophageal stenting|esophageal stenting
490151|NCT01471249|palliative|palliative
490152|NCT01471249|dysphagia|dysphagia
490153|NCT01471236|cartilage|cartilage
490154|NCT01471236|bone|bone
490155|NCT01471184|Allergic Rhinitis|allergic rhinitis
490156|NCT01471184|Conjunctivitis|conjunctivitis
490157|NCT01471184|Bitop|bitop
490158|NCT01471184|Eye|eye
490159|NCT01471184|Eye Drops|eye drops
490160|NCT01471184|Nasal Spray|nasal spray
490161|NCT01471184|Total Nasal Symptom Score|total nasal symptom score
490162|NCT01471184|Total Ocular Symptom Score|total ocular symptom score
490163|NCT01471184|AUC|auc
490164|NCT01471171|COPD|copd
490165|NCT01471171|Antimuscarinic|antimuscarinic
490166|NCT01471158|Primary open-angle glaucoma|primary open-angle glaucoma
490167|NCT01471158|ocular hypertension|ocular hypertension
490168|NCT01471158|pigment dispersion glaucoma|pigment dispersion glaucoma
490169|NCT01471145|opioid dependence|opioid dependence
490170|NCT01471145|heroin dependence|heroin dependence
490171|NCT01471145|extended release depot naltrexone|extended release depot naltrexone
490172|NCT01471145|functional Magnetic Resonance Imaging|functional magnetic resonance imaging
490173|NCT01471145|dopamine transporter|dopamine transporter
490174|NCT01471145|Single Photon Emission Computed Tomography|single photon emission computed tomography
490175|NCT01471119|sublingual immunotherapy|sublingual immunotherapy
490176|NCT01471119|atopic dermatitis|atopic dermatitis
490177|NCT01471119|Dermatophagoides Farinae Drops|dermatophagoides farinae drops
490178|NCT01471106|Breast Cancer|breast cancer
490179|NCT01471106|Estrogen Receptor Negative Breast Cancer|estrogen receptor negative breast cancer
490180|NCT01471106|Biomarker studies|biomarker studies
490181|NCT01471106|Ki-67|ki-67
490182|NCT01471106|Dasatinib|dasatinib
490183|NCT01471106|BMS-354825|bms-354825
490184|NCT01471106|Sprycel|sprycel
490185|NCT01471080|laparoscopic hepatectomy|laparoscopic hepatectomy
490186|NCT01471080|radio-frequency ablation|radio-frequency ablation
490187|NCT01471080|giant cavernous hemangiomas|giant cavernous hemangiomas
490188|NCT01471080|liver|liver
490189|NCT01471067|Blood And Marrow Transplantation|blood and marrow transplantation
490190|NCT01471067|Leukemia|leukemia
490191|NCT01471067|Lymphoma|lymphoma
490192|NCT01471067|Pediatrics|pediatrics
490193|NCT01471067|Cord blood transplant|cord blood transplant
490194|NCT01471067|Cord Blood Fucosylation|cord blood fucosylation
490195|NCT01471067|Hematologic Malignancies|hematologic malignancies
490196|NCT01471067|Acute Myelogenous Leukemia|acute myelogenous leukemia
490197|NCT01471067|AML|aml
490198|NCT01471067|Myelodysplastic Syndrome|myelodysplastic syndrome
490199|NCT01471067|MDS|mds
490200|NCT01471067|High-risk cytogenetics|high-risk cytogenetics
490201|NCT01471067|Secondary leukemia from prior chemotherapy|secondary leukemia from prior chemotherapy
490202|NCT01471067|Langerhan's cell histiocytosis|langerhan's cell histiocytosis
490203|NCT01471067|Acute Lymphoblastic Leukemia|acute lymphoblastic leukemia
490204|NCT01471067|ALL|all
490205|NCT01471067|complete remission|complete remission
490206|NCT01471067|Philadelphia chromosome|philadelphia chromosome
490207|NCT01471067|translocation 4;11|translocation 4;11
490208|NCT01471067|Hypodiploidy|hypodiploidy
490209|NCT01471067|Chronic Myeloid Leukemia|chronic myeloid leukemia
490210|NCT01471067|CML|cml
490211|NCT01471067|Non-Hodgkin's Lymphoma|non-hodgkin's lymphoma
490212|NCT01471067|NHL|nhl
490213|NCT01471067|Hodgkin's Disease|hodgkin's disease
490214|NCT01471067|HD|hd
490215|NCT01471067|Chronic Lymphocytic Leukemia|chronic lymphocytic leukemia
490216|NCT01471067|CLL|cll
490217|NCT01471067|Melphalan|melphalan
490218|NCT01471067|Alkeran|alkeran
490219|NCT01471067|Thiotepa|thiotepa
490220|NCT01471067|Fludarabine|fludarabine
490221|NCT01471067|Fludarabine Phosphate|fludarabine phosphate
490222|NCT01471067|Fludara|fludara
490223|NCT01471067|Mycophenolate Mofetil|mycophenolate mofetil
490224|NCT01471067|MMF|mmf
490225|NCT01471067|CellCept|cellcept
490226|NCT01471067|Tacrolimus|tacrolimus
490227|NCT01471067|Prograf|prograf
490228|NCT01471067|Rituximab|rituximab
490229|NCT01471067|Rituxan|rituxan
490230|NCT01471067|ATG|atg
490231|NCT01471067|Antithymocyte Globulin|antithymocyte globulin
490232|NCT01471067|Thymoglobulin|thymoglobulin
490233|NCT01471054|Plaque radiotherapy|plaque radiotherapy
490234|NCT01471054|Brachytherapy|brachytherapy
490235|NCT01471054|Macular edema|macular edema
490236|NCT01471054|Cystoid macular edema|cystoid macular edema
490237|NCT01471054|Uveal melanoma|uveal melanoma
490238|NCT01471054|Radiation maculopathy|radiation maculopathy
490239|NCT01471054|Radiation retinopathy|radiation retinopathy
490240|NCT01471054|Ozurdex|ozurdex
490241|NCT01471054|Dexamethasone intravitreal implant|dexamethasone intravitreal implant
490242|NCT01471041|End Stage Renal Disease|end stage renal disease
490243|NCT01471041|Hemodialysis|hemodialysis
490244|NCT01471041|AV fistula|av fistula
490245|NCT01471041|Kidney failure|kidney failure
490246|NCT01471028|Acute alcoholic hepatitis|acute alcoholic hepatitis
490247|NCT01471028|alcoholic|alcoholic
490248|NCT01471028|hepatitis|hepatitis
490249|NCT01471028|liver|liver
490250|NCT01471015|Hypoxic Ischemic Encephalopathy|hypoxic ischemic encephalopathy
490251|NCT01471015|Cooling Therapy|cooling therapy
490252|NCT01471015|HIE|hie
490253|NCT01470989|gouty arthritis|gouty arthritis
490254|NCT01470976|Goal-directed therapy|goal-directed therapy
490255|NCT01470976|Hemodynamic optimization|hemodynamic optimization
490256|NCT01470976|Cardiac surgery|cardiac surgery
490257|NCT01470963|Referral|referral
490258|NCT01470963|Quality of Health Care|quality of health care
490259|NCT01470950|Functional Electrical Stimulation|functional electrical stimulation
490260|NCT01470950|Signalling Pathways|signalling pathways
490261|NCT01470937|diabetes acarbose alphaglucosidase prevention|diabetes acarbose alphaglucosidase prevention
490262|NCT01470924|acute lymphoblastic leukemia|acute lymphoblastic leukemia
490263|NCT01470924|relapse|relapse
490264|NCT01470924|salvage|salvage
490265|NCT01470924|prognostic|prognostic
490266|NCT01470911|Antisense oligonucleotide|antisense oligonucleotide
490267|NCT01470911|Asthma|asthma
490268|NCT01470911|Healthy subjects|healthy subjects
490269|NCT01470911|Phase 1|phase 1
490270|NCT01470911|Transcription factor GATA-3|transcription factor gata-3
490271|NCT01470911|Oral inhalation|oral inhalation
490272|NCT01470898|bispectral index monitoring|bispectral index monitoring
490273|NCT01470898|extubation|extubation
490274|NCT01470898|analgesia|analgesia
490275|NCT01470898|abdominal surgery|abdominal surgery
490276|NCT01470885|glucose|glucose
490277|NCT01470885|prognosis|prognosis
490278|NCT01470885|glycated hemoglobin|glycated hemoglobin
490279|NCT01470859|De Novo parkinson's disease|de novo parkinson's disease
490280|NCT01470859|initial treatment|initial treatment
490281|NCT01470859|pramipexole|pramipexole
490282|NCT01470859|Levodopa|levodopa
490283|NCT01470859|Parkinson's disease-related spatial covariance pattern|parkinson's disease-related spatial covariance pattern
490284|NCT01470846|epidural analgesia|epidural analgesia
490285|NCT01470846|morphin analgesia|morphin analgesia
490286|NCT01470846|laparotomy|laparotomy
490287|NCT01470833|Achilles tendon|achilles tendon
490288|NCT01470833|rupture|rupture
490289|NCT01470833|non-operative|non-operative
490290|NCT01470833|treatment|treatment
490291|NCT01470820|Neonates|neonates
490292|NCT01470820|Hyperbilirubinemia|hyperbilirubinemia
490293|NCT01470820|Phototherapy|phototherapy
490294|NCT01470820|Light irradiance|light irradiance
490295|NCT01470820|Saturation point|saturation point
490296|NCT01470807|Artificial Pancreas|artificial pancreas
490297|NCT01470807|Insulin Pump|insulin pump
490298|NCT01470807|Continuous Glucose Monitor|continuous glucose monitor
490299|NCT01470807|Closed Loop|closed loop
490300|NCT01470794|GBM|gbm
490301|NCT01470794|HGG|hgg
490302|NCT01470794|High grade glioma|high grade glioma
490303|NCT01470794|Malignant glioma|malignant glioma
490304|NCT01470794|Grade III glioma|grade iii glioma
490305|NCT01470794|Grad IV glioma|grad iv glioma
490306|NCT01470794|glioma|glioma
490307|NCT01470794|glioblastoma|glioblastoma
490308|NCT01470794|Grade IV astrocytoma|grade iv astrocytoma
490309|NCT01470794|brain cancer|brain cancer
490310|NCT01470794|recurrent glioblastoma|recurrent glioblastoma
490311|NCT01470794|AA|aa
490312|NCT01470794|AOD|aod
490313|NCT01470794|anaplastic astrocytoma|anaplastic astrocytoma
490314|NCT01470794|Anaplastic oligodendroglioma|anaplastic oligodendroglioma
490315|NCT01470794|Anaplastic oligoastrocytoma|anaplastic oligoastrocytoma
490316|NCT01470781|Bipolar Disorder|bipolar disorder
490317|NCT01470781|Psychosis|psychosis
490318|NCT01470781|Cognition|cognition
490319|NCT01470781|Cognitive Remediation|cognitive remediation
490320|NCT01470755|Pediatrics|pediatrics
490321|NCT01470755|Bronchial wheeze|bronchial wheeze
490322|NCT01470755|bronchodilator|bronchodilator
490323|NCT01470755|lung function|lung function
490324|NCT01470755|airway resistance|airway resistance
490325|NCT01470729|Spinocerebellar ataxia, energy metabolism, NMR spectroscopy|spinocerebellar ataxia, energy metabolism, nmr spectroscopy
490326|NCT01470716|EGFR mutation|egfr mutation
490327|NCT01470716|NSCLC|nsclc
490328|NCT01470703|Acute Respiratory Distress Syndrome,|acute respiratory distress syndrome,
490329|NCT01470703|ECMO, Extracorporeal Membrane Oxygenation|ecmo, extracorporeal membrane oxygenation
490330|NCT01470703|Randomized controlled trial|randomized controlled trial
490331|NCT01470703|Positive-Pressure ventilation|positive-pressure ventilation
490332|NCT01470703|Survival Rate|survival rate
490333|NCT01470690|HVC infection|hvc infection
490334|NCT01470690|gastric acid-related disorders|gastric acid-related disorders
490335|NCT01470690|proton pump inhibitor|proton pump inhibitor
490336|NCT01470690|interaction|interaction
490337|NCT01470690|pharmacokinetics|pharmacokinetics
490338|NCT01470690|boceprevir|boceprevir
490339|NCT01470690|omeprazole|omeprazole
490340|NCT01470677|lymph cyst|lymph cyst
490341|NCT01470677|lymphocele|lymphocele
490342|NCT01470677|fibrin|fibrin
490343|NCT01470677|collagen|collagen
490344|NCT01470677|prevention|prevention
490345|NCT01470677|cancer|cancer
490346|NCT01470651|HCV+|hcv+
490347|NCT01470651|HCV treatment|hcv treatment
490348|NCT01470651|Fatigue|fatigue
490349|NCT01470651|patients starting alpha interferon/ribavirin treatment|patients starting alpha interferon/ribavirin treatment
490350|NCT01470638|Flt3-L|flt3-l
490351|NCT01470638|CSF|csf
490352|NCT01470625|Dying|dying
490353|NCT01470625|Patients|patients
490354|NCT01470625|Hospice|hospice
490355|NCT01470625|Liverpool Care Pathways|liverpool care pathways
490356|NCT01470612|Ulcerative colitis|ulcerative colitis
490357|NCT01470612|open-label|open-label
490358|NCT01470612|long term treatment|long term treatment
490359|NCT01470586|Colorectal cancer|colorectal cancer
490360|NCT01470586|Surgical resection|surgical resection
490361|NCT01470586|Oxidative Stress Markers|oxidative stress markers
490362|NCT01470586|Controls|controls
490363|NCT01470560|Mindfulness|mindfulness
490364|NCT01470560|Mindfulness-Based Stress Reduction|mindfulness-based stress reduction
490365|NCT01470560|Meditation|meditation
490366|NCT01470560|Yoga|yoga
490367|NCT01470547|Liver Cirrhosis|liver cirrhosis
490368|NCT01470547|Portal Vein Thrombosis|portal vein thrombosis
490369|NCT01470547|Cirrhosis Complications|cirrhosis complications
490370|NCT01470547|Registry|registry
490371|NCT01470547|Italian|italian
490372|NCT01470534|Dietary supplement|dietary supplement
490373|NCT01470534|Carbohydrate loading|carbohydrate loading
490374|NCT01470534|Insulin resistance|insulin resistance
490375|NCT01470534|Surgery|surgery
490376|NCT01470521|Multiple sclerosis|multiple sclerosis
490377|NCT01470521|Hookworm larvae|hookworm larvae
490378|NCT01470521|Necator americanus|necator americanus
490379|NCT01470521|Treg cells|treg cells
490380|NCT01470508|Bulimia|bulimia
490381|NCT01470508|Binge-Eating Disorder|binge-eating disorder
490382|NCT01470508|Eating Disorders|eating disorders
490383|NCT01470482|Total knee|total knee
490384|NCT01470482|Tourniquet|tourniquet
490385|NCT01470482|Blood loss|blood loss
490386|NCT01470482|pain|pain
490387|NCT01470482|range of motion|range of motion
490388|NCT01470391|Adductor-Canal-Blockade|adductor-canal-blockade
490389|NCT01470391|Femoral Nerve Block|femoral nerve block
490390|NCT01470391|Postoperative Pain|postoperative pain
490391|NCT01470391|Total Knee Arthroplasty|total knee arthroplasty
490392|NCT01470378|Lymphedema|lymphedema
490393|NCT01470378|Magnetic Resonance Imaging|magnetic resonance imaging
490394|NCT01470378|Plastic Surgery|plastic surgery
490395|NCT01470352|migraine|migraine
490396|NCT01470352|pain|pain
490397|NCT01470352|CPM|cpm
490398|NCT01470352|offset analgesia|offset analgesia
490399|NCT01470352|fMRI|fmri
490400|NCT01470339|endogenous pain modulation|endogenous pain modulation
490401|NCT01470339|migraine|migraine
624875|NCT00921947|M2e|m2e
490402|NCT01470339|fMRI|fmri
490403|NCT01470339|duloxetine|duloxetine
490404|NCT01470339|preventive migraine treatment|preventive migraine treatment
490405|NCT01470326|Osteoporosis|osteoporosis
490406|NCT01470326|Post menopausal women|post menopausal women
490407|NCT01470326|SERM|serm
490408|NCT01470326|Japanese|japanese
490409|NCT01470326|Viviant|viviant
490410|NCT01470326|Regulatory Post Marketing Commitment Plan|regulatory post marketing commitment plan
490411|NCT01470326|Long term treatment|long term treatment
490412|NCT01470313|Safety and tolerability|safety and tolerability
490413|NCT01470313|cutaneous lupus erythematosus|cutaneous lupus erythematosus
490414|NCT01470313|efficacy|efficacy
490415|NCT01470287|Infants,|infants,
490416|NCT01470287|Immunogenicity,|immunogenicity,
490417|NCT01470287|Safety|safety
490418|NCT01470274|Blood volume|blood volume
490419|NCT01470274|CO-rebreathing|co-rebreathing
490420|NCT01470274|COPD|copd
490421|NCT01470274|CVD|cvd
490422|NCT01470261|methylphenidate|methylphenidate
490423|NCT01470261|ritalin|ritalin
490424|NCT01470261|Attention Deficit Disorder|attention deficit disorder
490425|NCT01470248|Lung Cancer|lung cancer
490426|NCT01470248|Carcinoma, small cell|carcinoma, small cell
490427|NCT01470248|Trisenox|trisenox
490428|NCT01470248|Arsenic trioxide|arsenic trioxide
490429|NCT01470248|phase II trial|phase ii trial
490430|NCT01470235|screening|screening
490431|NCT01470235|genetic|genetic
490432|NCT01470235|cancer|cancer
490433|NCT01470222|Worksite|worksite
490434|NCT01470222|group weight loss|group weight loss
490435|NCT01470222|behavioral components|behavioral components
490436|NCT01470209|lung cancer with activated mTOR/PI3K pathway|lung cancer with activated mtor/pi3k pathway
490437|NCT01470209|alterations in PIK3CA, NF1, TSC1/TSC2, mTOR, KRAS, LKB1, PTEN|alterations in pik3ca, nf1, tsc1/tsc2, mtor, kras, lkb1, pten
490438|NCT01470196|WM|wm
490439|NCT01470196|untreated|untreated
490440|NCT01470196|symptomatic|symptomatic
490441|NCT01470183|Lupus Nephritis|lupus nephritis
490442|NCT01470170|Sedative bronchoscope|sedative bronchoscope
490443|NCT01470170|Alfentanil doses|alfentanil doses
490444|NCT01470170|Propofol|propofol
490445|NCT01470170|Targeted controlled infusion|targeted controlled infusion
490446|NCT01470170|Hypoxemia|hypoxemia
490447|NCT01470131|multiple myeloma|multiple myeloma
490448|NCT01470131|relapse|relapse
490449|NCT01470131|second line therapy|second line therapy
490450|NCT01470131|bortezomib|bortezomib
490451|NCT01470131|dexamethasone|dexamethasone
490452|NCT01470105|questionnaire|questionnaire
490453|NCT01470105|11-121|11-121
490454|NCT01470092|Menopause|menopause
490455|NCT01470092|Depression|depression
490456|NCT01470066|peripheral T cell lymphomas|peripheral t cell lymphomas
490457|NCT01470066|interim PET/CT|interim pet/ct
490458|NCT01470066|prognosis|prognosis
490459|NCT01470066|Positron-emission tomography/Computerized tomography|positron-emission tomography/computerized tomography
490460|NCT01470053|mometasone furoate|mometasone furoate
490461|NCT01470053|azelastine HCl|azelastine hcl
490462|NCT01470053|perennial allergic rhinitis|perennial allergic rhinitis
490463|NCT01470040|traumatic brain injury|traumatic brain injury
490464|NCT01470040|chronic subdural hematoma|chronic subdural hematoma
490465|NCT01470040|aspirin|aspirin
490466|NCT01470040|antiplatelet therapy|antiplatelet therapy
490467|NCT01470027|magnetic resonance spectroscopy|magnetic resonance spectroscopy
490468|NCT01470027|N-acetylcysteine|n-acetylcysteine
490469|NCT01470027|antioxidant|antioxidant
490470|NCT01470027|glutathione|glutathione
490471|NCT01470014|isolated left ventricular non-compaction|isolated left ventricular non-compaction
490472|NCT01470014|cardiac computed tomography|cardiac computed tomography
490473|NCT01470014|cardiac magnet resonance imaging|cardiac magnet resonance imaging
490474|NCT01470014|echocardiography|echocardiography
490475|NCT01469975|cancer|cancer
490476|NCT01469975|relapse or refractory|relapse or refractory
490477|NCT01469962|morbid obesity|morbid obesity
490478|NCT01469962|bariatric surgery|bariatric surgery
490479|NCT01469962|NASH|nash
490480|NCT01469962|Liver fibrosis|liver fibrosis
490481|NCT01469962|Fibrotest|fibrotest
490482|NCT01469949|Improvement of the accuracy of Lumbar repositioning|improvement of the accuracy of lumbar repositioning
490483|NCT01469936|Fibromyalgia|fibromyalgia
490484|NCT01469936|Irritable Bowel Syndrome|irritable bowel syndrome
490485|NCT01469923|Phase 1|phase 1
490486|NCT01469923|obese|obese
490487|NCT01469923|healthy male volunteers|healthy male volunteers
490488|NCT01469923|multiple doses|multiple doses
490489|NCT01469923|dose escalation|dose escalation
490490|NCT01469923|pharmacokinetics|pharmacokinetics
490491|NCT01469923|pharmakodynamics|pharmakodynamics
490492|NCT01469897|JIA|jia
490493|NCT01469897|Juvenile Idiopathic Arthritis|juvenile idiopathic arthritis
490494|NCT01469897|Cost of Care|cost of care
490495|NCT01469897|Quality of Life|quality of life
490496|NCT01469897|QOL|qol
490497|NCT01469884|Renal allograft recipients|renal allograft recipients
490498|NCT01469884|Hepatitis C virus (HCV)|hepatitis c virus (hcv)
625058|NCT00921206|M2e|m2e
490499|NCT01469884|Certican|certican
490500|NCT01469884|Calcineurin inhibitor(tacrolimus or cyclosporin)|calcineurin inhibitor(tacrolimus or cyclosporin)
490501|NCT01469871|Dressing|dressing
490502|NCT01469871|Blisters|blisters
490503|NCT01469871|Silicone|silicone
490504|NCT01469845|hospital admissions|hospital admissions
490505|NCT01469845|acute bronchiolitis|acute bronchiolitis
490506|NCT01469845|under one year old|under one year old
490507|NCT01469845|requiring oxygen therapy|requiring oxygen therapy
490508|NCT01469832|fundus flavimaculatus|fundus flavimaculatus
490509|NCT01469832|Retinal Diseases|retinal diseases
490510|NCT01469832|Macular Degeneration|macular degeneration
490511|NCT01469832|SMD|smd
490512|NCT01469832|juvenile macular dystrophy|juvenile macular dystrophy
490513|NCT01469819|chronic constipation|chronic constipation
490514|NCT01469819|constipation|constipation
490515|NCT01469819|idiopathic constipation|idiopathic constipation
490516|NCT01469819|SmartPill|smartpill
490517|NCT01469819|Wireless Motility Capsule|wireless motility capsule
490518|NCT01469819|lubiprostone (Amitiza)|lubiprostone (amitiza)
490519|NCT01469819|small intestinal bacterial overgrowth|small intestinal bacterial overgrowth
490520|NCT01469780|Pain|pain
490521|NCT01469780|Health behavior change|health behavior change
490522|NCT01469780|Coronary angioplasty|coronary angioplasty
490523|NCT01469780|Cardiovascular disease|cardiovascular disease
490524|NCT01469780|Outcomes|outcomes
490525|NCT01469780|Morbidity|morbidity
490526|NCT01469780|Mortality|mortality
490527|NCT01469767|eczema|eczema
490528|NCT01469767|itch|itch
490529|NCT01469767|scratching|scratching
490530|NCT01469767|actigraphy|actigraphy
490531|NCT01469767|adherence|adherence
490532|NCT01469754|lymphoma|lymphoma
490533|NCT01469754|survivors|survivors
490534|NCT01469754|posttraumatic growth|posttraumatic growth
490535|NCT01469754|posttraumatic stress|posttraumatic stress
490536|NCT01469754|longitudinal|longitudinal
490537|NCT01469728|VATS|vats
490538|NCT01469728|awake thoracic surgery|awake thoracic surgery
490539|NCT01469728|pleurodesis|pleurodesis
490540|NCT01469728|talc|talc
490541|NCT01469728|TEA|tea
490542|NCT01469728|epidural anesthesia|epidural anesthesia
490543|NCT01469728|Video-Assisted|video-assisted
490544|NCT01469728|Anesthesia Epidural|anesthesia epidural
490545|NCT01469715|Continuous Glucose Monitor|continuous glucose monitor
490546|NCT01469702|cat-scratch disease|cat-scratch disease
490547|NCT01469702|Bartonella henselae|bartonella henselae
490548|NCT01469702|corticosteroids|corticosteroids
490549|NCT01469702|treatment|treatment
490550|NCT01469689|People|people
490551|NCT01469689|living|living
490552|NCT01469689|community|community
490553|NCT01469676|Coronary Artery Bypass Surgery|coronary artery bypass surgery
490554|NCT01469676|Cardiopulmonary Bypass|cardiopulmonary bypass
490555|NCT01469676|Leukocyte Reduction Filtrations|leukocyte reduction filtrations
490556|NCT01469676|Pulmonary Function|pulmonary function
490557|NCT01469676|Systemic Inflammatory Response|systemic inflammatory response
490558|NCT01469663|Borderline Personality Disorder|borderline personality disorder
490559|NCT01469663|Major Depression|major depression
490560|NCT01469663|Electroencephalogram|electroencephalogram
490561|NCT01469663|N2|n2
490562|NCT01469663|Error Related Negativity|error related negativity
490563|NCT01469663|Emotional Processing|emotional processing
490564|NCT01469663|Levels of Emotional Awareness|levels of emotional awareness
490565|NCT01469650|vitamin D3|vitamin d3
490566|NCT01469650|prematurity|prematurity
490567|NCT01469650|parathyroid hormone|parathyroid hormone
490568|NCT01469650|25(OH)D|25(oh)d
490569|NCT01469650|NICU hospitalization|nicu hospitalization
490570|NCT01469624|Contrast Induced Nephropathy|contrast induced nephropathy
490571|NCT01469624|Pentoxifylline|pentoxifylline
490572|NCT01469624|PCI|pci
490573|NCT01469611|advanced/metastatic colorectal carcinoma|advanced/metastatic colorectal carcinoma
490574|NCT01469585|continuous oral contraceptives|continuous oral contraceptives
490575|NCT01469585|MMP expression|mmp expression
490576|NCT01469572|Neuroendocrine hepatic tumors|neuroendocrine hepatic tumors
490577|NCT01469572|Liver cancer|liver cancer
490578|NCT01469572|Metastatic liver cancer|metastatic liver cancer
490579|NCT01469559|Insulin|insulin
490580|NCT01469559|Diabetic neuropathy|diabetic neuropathy
490581|NCT01469559|Intranasal administration|intranasal administration
490582|NCT01469559|Pilot project|pilot project
490583|NCT01469546|Squamous Cell Carcinoma of the Head and Neck|squamous cell carcinoma of the head and neck
490584|NCT01469533|Spine|spine
490585|NCT01469533|Manipulation|manipulation
490586|NCT01469533|Pain Threshold|pain threshold
490587|NCT01469533|Electromyography.|electromyography.
490588|NCT01469520|HIV|hiv
490589|NCT01469520|AIDS|aids
490590|NCT01469520|Treatment|treatment
490591|NCT01469494|DIEP flap|diep flap
490592|NCT01469494|SIEA flap|siea flap
490593|NCT01469494|breast reconstruction|breast reconstruction
490594|NCT01469494|objective isokinetic abdominal strength testing|objective isokinetic abdominal strength testing
490595|NCT01469494|fat necrosis|fat necrosis
490596|NCT01469494|flap loss|flap loss
490597|NCT01469494|seroma rate|seroma rate
490598|NCT01469494|abdominal wound breakdown|abdominal wound breakdown
490599|NCT01469494|Breast-Q|breast-q
490600|NCT01469494|abdominal wall outcome questionnaire|abdominal wall outcome questionnaire
490601|NCT01469481|diabetes mellitus|diabetes mellitus
490602|NCT01469481|ADME|adme
490603|NCT01469455|Local metastatic melanoma|local metastatic melanoma
490604|NCT01469455|relapsed cutaneous/subcutaneous tumors|relapsed cutaneous/subcutaneous tumors
490605|NCT01469455|melanoma-in-transit|melanoma-in-transit
490606|NCT01469442|Biliary fistula|biliary fistula
490607|NCT01469442|prevention|prevention
490608|NCT01469442|hepatectomy|hepatectomy
490609|NCT01469442|external stent|external stent
490610|NCT01469442|Hepatectomy of more 2 segments|hepatectomy of more 2 segments
490611|NCT01469442|Not emergency or laparoscopy surgery|not emergency or laparoscopy surgery
490612|NCT01469429|oral cancer|oral cancer
490613|NCT01469416|rosuvastatin|rosuvastatin
490614|NCT01469416|clopidogrel|clopidogrel
490615|NCT01469416|pharmacokinetics|pharmacokinetics
490616|NCT01469416|drug interaction|drug interaction
490617|NCT01469416|healthy volunteer|healthy volunteer
490618|NCT01469416|drug transporter|drug transporter
490619|NCT01469403|Osteoarthritis, knee|osteoarthritis, knee
490620|NCT01469403|Obesity|obesity
490621|NCT01469403|Weight Loss|weight loss
490622|NCT01469403|Arthroplasty|arthroplasty
490623|NCT01469377|Major depressive disorder|major depressive disorder
490624|NCT01469377|Depression|depression
490625|NCT01469364|Lung Transplant|lung transplant
490626|NCT01469364|Lung Transplant Recipient|lung transplant recipient
490627|NCT01469351|Alzheimers disease|alzheimers disease
490628|NCT01469325|Repetitive Transcranial Magnetic Stimulation|repetitive transcranial magnetic stimulation
490629|NCT01469325|Depression|depression
490630|NCT01469325|left prefrontal|left prefrontal
490631|NCT01469312|Low Biologically Available Glucose Diet (LoBAG diet)|low biologically available glucose diet (lobag diet)
490632|NCT01469312|Diabetes|diabetes
490633|NCT01469312|Glycemic Index|glycemic index
490634|NCT01469299|Ligament Balance, Total Knee Arthroplasty, Intra-operative Sensors|ligament balance, total knee arthroplasty, intra-operative sensors
490635|NCT01469286|delayed gastric emptying|delayed gastric emptying
490636|NCT01469286|nausea|nausea
490637|NCT01469286|vomiting|vomiting
490638|NCT01469286|abdominal discomfort|abdominal discomfort
490639|NCT01469273|Diarrhea|diarrhea
490640|NCT01469273|EcN|ecn
490641|NCT01469273|E. coli strain Nissle 1917|e. coli strain nissle 1917
490642|NCT01469273|Gastrointestinal infection|gastrointestinal infection
490643|NCT01469273|Infant|infant
490644|NCT01469273|Newborn|newborn
490645|NCT01469273|Probiotic drug|probiotic drug
490646|NCT01469273|Prevention|prevention
490647|NCT01469273|Prophylaxis|prophylaxis
490648|NCT01469260|Overweight|overweight
490649|NCT01469260|Obesity|obesity
490650|NCT01469260|Pregnancy|pregnancy
490651|NCT01469260|Weight gain|weight gain
490652|NCT01469260|Pedometer|pedometer
490653|NCT01469260|Exercise|exercise
490654|NCT01469247|Brain cancer|brain cancer
490655|NCT01469247|Recurrent or progressive brainstem glioma|recurrent or progressive brainstem glioma
490656|NCT01469247|Diffuse Intrinsic Pontine Glioma|diffuse intrinsic pontine glioma
490657|NCT01469247|DIPG|dipg
490658|NCT01469247|Reirradiation|reirradiation
490659|NCT01469247|ReRT|rert
490660|NCT01469247|Photon radiation therapy|photon radiation therapy
490661|NCT01469247|XRT|xrt
490662|NCT01469221|Bladder Cancer|bladder cancer
490663|NCT01469221|Non-Muscle Invasive Bladder Cancer|non-muscle invasive bladder cancer
490664|NCT01469221|NMIBC|nmibc
490665|NCT01469221|Apaziquone|apaziquone
490666|NCT01469221|EOquin|eoquin
490667|NCT01469221|GU Cancer|gu cancer
490668|NCT01469221|TURBT|turbt
490669|NCT01469208|Gastroschisis|gastroschisis
490670|NCT01469208|NICU inpatients|nicu inpatients
490671|NCT01469208|Post surgical repair|post surgical repair
490672|NCT01469208|Music Therapy|music therapy
490673|NCT01469195|lead rectangle|lead rectangle
490674|NCT01469195|radiation exposure|radiation exposure
490675|NCT01469195|operators|operators
490676|NCT01469195|radial approach|radial approach
490677|NCT01469195|coronary procedures|coronary procedures
490678|NCT01469195|percutaneous coronary intervention|percutaneous coronary intervention
490679|NCT01469182|Immunology|immunology
490680|NCT01469169|Iloprost|iloprost
490681|NCT01469169|Inhalation|inhalation
490682|NCT01469169|Pulmonary Hypertension|pulmonary hypertension
490683|NCT01469169|Pulmonary Artery Hypertension|pulmonary artery hypertension
490684|NCT01469169|Japanese Patients|japanese patients
490685|NCT01469156|polypoidal choroidal vasculopathy|polypoidal choroidal vasculopathy
490686|NCT01469156|choroidal neovascularization|choroidal neovascularization
490687|NCT01469156|ranibizumab|ranibizumab
490688|NCT01469156|Lucentis|lucentis
490689|NCT01469130|MEK, Advanced solid tumor|mek, advanced solid tumor
490690|NCT01469117|Developmental disabilities|developmental disabilities
490691|NCT01469117|Enteral Nutrition|enteral nutrition
490692|NCT01469117|Tube feeding|tube feeding
490693|NCT01469117|Nutrition support|nutrition support
490694|NCT01469104|Diabetes|diabetes
490695|NCT01469091|Acute admittance|acute admittance
490696|NCT01469091|Current smoker|current smoker
490697|NCT01469078|Chronic Kidney Disease|chronic kidney disease
490698|NCT01469078|CKD stage 5|ckd stage 5
490699|NCT01469078|Iron deficiency|iron deficiency
490700|NCT01469065|inpatient|inpatient
490701|NCT01469065|diabetes|diabetes
490702|NCT01469065|phase 1|phase 1
490703|NCT01469039|Alkermes|alkermes
490704|NCT01469039|schizophrenia|schizophrenia
490705|NCT01469039|ALKS 9072|alks 9072
490706|NCT01469039|ALKS 9070|alks 9070
490707|NCT01469039|aripiprazole lauroxil|aripiprazole lauroxil
490708|NCT01468948|Essential Tremor|essential tremor
490709|NCT01468948|Tremor|tremor
490710|NCT01468948|Octanol|octanol
490711|NCT01468948|Octanoic Acid|octanoic acid
490712|NCT01468935|Uterus|uterus
490713|NCT01468935|Endometrium|endometrium
490714|NCT01468935|Bone Marrow Transplant|bone marrow transplant
490715|NCT01468935|Gynecology|gynecology
490716|NCT01468935|Healthy Volunteer|healthy volunteer
490717|NCT01468935|HV|hv
490718|NCT01468935|Stem Cell Transplant|stem cell transplant
490719|NCT01468935|Endometriosis|endometriosis
490720|NCT01468922|Pazopanib|pazopanib
490721|NCT01468922|Tivantinib|tivantinib
490722|NCT01468922|MET Inhibitor|met inhibitor
490723|NCT01468922|Advanced Cancer|advanced cancer
490724|NCT01468922|Anti-Angiogenesis|anti-angiogenesis
490725|NCT01468922|Cancer|cancer
490726|NCT01468922|Solid Tumor|solid tumor
490727|NCT01468922|Sarcoma|sarcoma
490728|NCT01468883|Breast Cancer|breast cancer
490729|NCT01468883|Surgery|surgery
490730|NCT01468883|Radiation|radiation
490731|NCT01468857|Clinical Stress Markers|clinical stress markers
490732|NCT01468857|Chronic Stress|chronic stress
490733|NCT01468857|Allogeneic Hematopoietic Stem Cell Transplant|allogeneic hematopoietic stem cell transplant
490734|NCT01468857|HSCT Caregivers|hsct caregivers
490735|NCT01468857|Cancer Caregivers|cancer caregivers
490736|NCT01468857|Stress|stress
490737|NCT01468857|Family Caregivers|family caregivers
490738|NCT01468844|Central Retinal Vein Occlusion|central retinal vein occlusion
490739|NCT01468844|Minocycline|minocycline
490740|NCT01468844|Retinal Vein Occlusion|retinal vein occlusion
490741|NCT01468844|CRVO|crvo
490742|NCT01468831|Branch Retinal Vein Occlusion|branch retinal vein occlusion
490743|NCT01468831|Minocycline|minocycline
490744|NCT01468831|Macular Edema|macular edema
490745|NCT01468831|Retinal Vein Occlusion|retinal vein occlusion
490746|NCT01468831|BRVO|brvo
490747|NCT01468818|Metastatic Melanoma|metastatic melanoma
490748|NCT01468818|Adoptive Cell Therapy|adoptive cell therapy
490749|NCT01468818|Skin Cancer|skin cancer
490750|NCT01468805|Environmental Intervention|environmental intervention
490751|NCT01468805|Indoor Allergens|indoor allergens
490752|NCT01468805|Cockroach|cockroach
490753|NCT01468805|Health Disparities|health disparities
490754|NCT01468805|Multi-Center|multi-center
490755|NCT01468805|Asthma|asthma
490756|NCT01468805|Environment|environment
490757|NCT01468792|systemic sclerosis|systemic sclerosis
490758|NCT01468792|pulmonary arterial hypertension|pulmonary arterial hypertension
490759|NCT01468779|Periampullary cancer|periampullary cancer
490760|NCT01468779|Surgery|surgery
490761|NCT01468779|Dietary supplementation|dietary supplementation
490762|NCT01468779|Nutritional assessment|nutritional assessment
490763|NCT01468753|Conception in HIV Discordant Couples|conception in hiv discordant couples
490764|NCT01468753|Reproduction in HIV Discordant Couples|reproduction in hiv discordant couples
490765|NCT01468753|Vaginal Insemination|vaginal insemination
490766|NCT01468727|dental caries|dental caries
490767|NCT01468727|mutans streptococci|mutans streptococci
490768|NCT01468727|lactobacilli|lactobacilli
490769|NCT01468727|bacterial transmission|bacterial transmission
490770|NCT01468727|bacterial colonization|bacterial colonization
490771|NCT01468714|Drug Interaction|drug interaction
490772|NCT01468714|pharmacokinetics|pharmacokinetics
490773|NCT01468714|ketoconazole|ketoconazole
490774|NCT01468714|CYP3A|cyp3a
490775|NCT01468688|Imatinib mesylate|imatinib mesylate
490776|NCT01468688|BKM120|bkm120
490777|NCT01468688|GIST|gist
490778|NCT01468649|Breast Cancer|breast cancer
490779|NCT01468649|Sentinel Lymph Node Mapping|sentinel lymph node mapping
490780|NCT01468649|Intraoperative Imaging|intraoperative imaging
490781|NCT01468636|Warts|warts
490782|NCT01468636|HPV|hpv
490783|NCT01468636|Zinc|zinc
490784|NCT01468623|Colorectal cancer, metastatic|colorectal cancer, metastatic
490785|NCT01468623|FOLFOX6|folfox6
490786|NCT01468623|5-FU|5-fu
490787|NCT01468623|First line|first line
490788|NCT01468623|bevacizumab|bevacizumab
490789|NCT01468610|depression|depression
490790|NCT01468610|cognition|cognition
490791|NCT01468610|occupational functioning|occupational functioning
490792|NCT01468610|productivity|productivity
490793|NCT01468610|neuropsychology|neuropsychology
490794|NCT01468610|desvenlafaxine|desvenlafaxine
490795|NCT01468610|antidepressants|antidepressants
490796|NCT01468597|Emergent|emergent
490797|NCT01468597|Cardiac surgery|cardiac surgery
490798|NCT01468597|On-pump|on-pump
490799|NCT01468597|Platelet function|platelet function
490800|NCT01468584|Genotype 2|genotype 2
490801|NCT01468571|Potassium Sparing Diuretics|potassium sparing diuretics
490802|NCT01468571|Right-sided heart failure|right-sided heart failure
490803|NCT01468571|Edema|edema
490904|NCT01468233|acne|acne
490905|NCT01468220|tissue metabolism|tissue metabolism
490804|NCT01468558|Drug Drug Interaction Study in Normal Healthy Volunteers|drug drug interaction study in normal healthy volunteers
490805|NCT01468545|Education|education
490806|NCT01468545|Ventavis|ventavis
490807|NCT01468545|Adherence|adherence
490808|NCT01468545|PAH|pah
490809|NCT01468545|Pulmonary artery hypertension|pulmonary artery hypertension
490810|NCT01468519|Diabetes mellitus, type 2|diabetes mellitus, type 2
490811|NCT01468519|Erectile dysfunction|erectile dysfunction
490812|NCT01468519|continuous subcutaneous insulin infusion|continuous subcutaneous insulin infusion
490813|NCT01468519|CSII|csii
490814|NCT01468519|insulin|insulin
490815|NCT01468506|Chronic Kidney Disease|chronic kidney disease
490816|NCT01468506|arteriovenous fistula|arteriovenous fistula
490817|NCT01468493|FSGS|fsgs
490818|NCT01468493|suPAR|supar
490819|NCT01468480|direct pulp capping|direct pulp capping
490820|NCT01468480|MTA|mta
490821|NCT01468480|Single visit pulp cap|single visit pulp cap
490822|NCT01468480|Multical|multical
490823|NCT01468467|AC220|ac220
490824|NCT01468467|Acute Myeloid Leukemia (AML)|acute myeloid leukemia (aml)
490825|NCT01468467|Transplantation|transplantation
490826|NCT01468467|Stem Cell Transplantation|stem cell transplantation
490827|NCT01468467|Allogeneic Transplantation|allogeneic transplantation
490828|NCT01468467|FMS-like tyrosine kinase (FLT3)|fms-like tyrosine kinase (flt3)
490829|NCT01468467|FMS-like tyrosine kinase (FLT3) Inhibitor|fms-like tyrosine kinase (flt3) inhibitor
490830|NCT01468467|Kinase|kinase
490831|NCT01468467|Kinase Inhibitor|kinase inhibitor
490832|NCT01468467|Pharmacokinetics|pharmacokinetics
490833|NCT01468467|ASP2689|asp2689
490834|NCT01468467|quizartinib|quizartinib
490835|NCT01468454|Congenital Hyperinsulinism (CHI)|congenital hyperinsulinism (chi)
490836|NCT01468454|hyperinsulinism|hyperinsulinism
490837|NCT01468454|Persistent Hyperinsulinemic Hypoglycemia of Infancy (PHHI)|persistent hyperinsulinemic hypoglycemia of infancy (phhi)
490838|NCT01468454|CHI|chi
490839|NCT01468454|PHHI|phhi
490840|NCT01468454|Pancreatectomy|pancreatectomy
490841|NCT01468454|18F-DOPA|18f-dopa
490842|NCT01468454|PET/CT scan|pet/ct scan
490843|NCT01468441|ovarian stimulation|ovarian stimulation
490844|NCT01468441|GnRH agonist|gnrh agonist
490845|NCT01468441|GnRH antagonist|gnrh antagonist
490846|NCT01468441|hCG microdose|hcg microdose
490847|NCT01468441|ICSI|icsi
490848|NCT01468415|Methylprednisolone|methylprednisolone
490849|NCT01468415|trans sacral block|trans sacral block
490850|NCT01468415|phenol|phenol
490851|NCT01468402|Leiomyoma|leiomyoma
490852|NCT01468402|uterine artery embolization|uterine artery embolization
490853|NCT01468402|magnetic resonance imaging|magnetic resonance imaging
490854|NCT01468389|Gastric Cancer|gastric cancer
490855|NCT01468389|capecitabine|capecitabine
490856|NCT01468389|maintenance treatment|maintenance treatment
490857|NCT01468376|impaired glucose tolerance|impaired glucose tolerance
490858|NCT01468376|pre-diabetes|pre-diabetes
490859|NCT01468363|Dry weight|dry weight
490860|NCT01468363|Body composition monitor|body composition monitor
490861|NCT01468363|Hemodialysis|hemodialysis
490862|NCT01468363|Zonguldak|zonguldak
490863|NCT01468337|Central Serous Chorioretinopathy|central serous chorioretinopathy
490864|NCT01468337|Interferon-Gamma (IFN-Gamma)|interferon-gamma (ifn-gamma)
490865|NCT01468337|Jakstat|jakstat
490866|NCT01468337|Retinal Eye Disease|retinal eye disease
490867|NCT01468337|Macular Eye Disease|macular eye disease
490868|NCT01468337|CSC|csc
490869|NCT01468324|Brain|brain
490870|NCT01468324|Angiogenesis|angiogenesis
490871|NCT01468324|Radiotherapy|radiotherapy
490872|NCT01468324|Malignant|malignant
490873|NCT01468324|Tumor|tumor
490874|NCT01468324|Glioma|glioma
490875|NCT01468324|Glioblastoma Multiforme|glioblastoma multiforme
490876|NCT01468324|Brain Tumor|brain tumor
490877|NCT01468311|Immunotherapy|immunotherapy
490878|NCT01468311|Resistant Hodgkins Lymphoma|resistant hodgkins lymphoma
490879|NCT01468311|Auto Stem Cell Transplant|auto stem cell transplant
490880|NCT01468311|Combination Chemo and Radiolabeled Monoclonal Antibody|combination chemo and radiolabeled monoclonal antibody
490881|NCT01468311|Hodgkin Lymphoma|hodgkin lymphoma
490882|NCT01468298|back pain|back pain
490883|NCT01468298|physical therapy|physical therapy
490884|NCT01468298|spine|spine
490885|NCT01468298|rehabilitation|rehabilitation
490886|NCT01468298|exercise|exercise
490887|NCT01468285|interventional,placebo controlled|interventional,placebo controlled
490888|NCT01468272|asthma children NEXT DPI LABA ICS inhalation|asthma children next dpi laba ics inhalation
490889|NCT01468246|Breast Cancer|breast cancer
490890|NCT01468246|Cohort|cohort
490891|NCT01468246|Young Women|young women
490892|NCT01468246|Survivorship|survivorship
490893|NCT01468246|Fertility|fertility
490894|NCT01468233|placebo controlled|placebo controlled
490895|NCT01468233|double blind|double blind
490896|NCT01468233|adalimumab|adalimumab
490897|NCT01468233|TNF|tnf
490898|NCT01468233|psoriasis|psoriasis
490899|NCT01468233|HS|hs
490900|NCT01468233|PIONEER II|pioneer ii
490901|NCT01468233|hidradenitis suppurativa|hidradenitis suppurativa
490902|NCT01468233|acne inversa|acne inversa
490903|NCT01468233|boil|boil
490906|NCT01468220|skeletal muscle|skeletal muscle
490907|NCT01468220|adipose tissue|adipose tissue
490908|NCT01468220|HIF|hif
490909|NCT01468207|acne|acne
490910|NCT01468207|psoriasis|psoriasis
490911|NCT01468207|hidradenitis suppurativa|hidradenitis suppurativa
490912|NCT01468207|TNF|tnf
490913|NCT01468207|HS|hs
490914|NCT01468207|PIONEER I|pioneer i
490915|NCT01468207|acne inversa|acne inversa
490916|NCT01468207|boil|boil
490917|NCT01468207|placebo controlled|placebo controlled
490918|NCT01468207|Double blind|double blind
490919|NCT01468207|adalimumab|adalimumab
490920|NCT01468194|AMS|ams
490921|NCT01468194|HAPE|hape
490922|NCT01468194|high altitude|high altitude
490923|NCT01468194|oxygen|oxygen
490924|NCT01468194|saturation|saturation
490925|NCT01468194|mountain|mountain
490926|NCT01468194|climbing|climbing
490927|NCT01468194|breathing|breathing
490928|NCT01468181|Type 2 diabetes mellitus|type 2 diabetes mellitus
490929|NCT01468181|Oral antihyperglycemic medications|oral antihyperglycemic medications
490930|NCT01468181|Long-Term Safety|long-term safety
490931|NCT01468181|GLP 1|glp 1
490932|NCT01468181|Glucagon like peptide 1|glucagon like peptide 1
490933|NCT01468155|PVA|pva
490934|NCT01468155|peri procedural bleeding complications|peri procedural bleeding complications
490935|NCT01468116|Type 2 diabetes|type 2 diabetes
490936|NCT01468116|Gastric bypass surgery|gastric bypass surgery
490937|NCT01468116|Obesity|obesity
490938|NCT01468116|Mitochondrial function|mitochondrial function
490939|NCT01468103|intraocular pressure|intraocular pressure
490940|NCT01468103|Peripheral anterior synechiae|peripheral anterior synechiae
490941|NCT01468090|Inflammatory bowel disease|inflammatory bowel disease
490942|NCT01468090|Crohn's disease|crohn's disease
490943|NCT01468090|Ulcerative colitis|ulcerative colitis
490944|NCT01468090|Disease course|disease course
490945|NCT01468090|Phenotype|phenotype
490946|NCT01468090|Biological treatment|biological treatment
490947|NCT01468064|Central Nervous System Diseases|central nervous system diseases
490948|NCT01468064|Stroke|stroke
490949|NCT01468064|Infarction, Middle Cerebral Artery|infarction, middle cerebral artery
490950|NCT01468064|Cerebral Infarction|cerebral infarction
490951|NCT01468064|Cerebrovascular Accident|cerebrovascular accident
490952|NCT01468064|Stem Cell Transplantation|stem cell transplantation
490953|NCT01468064|Mesenchymal Stem Cell Transplantation|mesenchymal stem cell transplantation
490954|NCT01468064|Bone marrow stromal cells|bone marrow stromal cells
490955|NCT01468064|Mesenchymal Stem Cells|mesenchymal stem cells
490956|NCT01468064|Endothelial progenitor cells|endothelial progenitor cells
490957|NCT01468064|Adult Stem Cells|adult stem cells
490958|NCT01468064|Cell Therapy|cell therapy
490959|NCT01468051|predialysed|predialysed
490960|NCT01468051|chronic|chronic
490961|NCT01468051|renal failure patients|renal failure patients
490962|NCT01468025|NSAIDs|nsaids
490963|NCT01468025|Theramine|theramine
490964|NCT01468025|naproxen|naproxen
490965|NCT01468025|Low back pain|low back pain
490966|NCT01468025|amino acids|amino acids
490967|NCT01468025|CRP|crp
490968|NCT01468025|Medical Food|medical food
490969|NCT01468012|cocaine dependence|cocaine dependence
490970|NCT01468012|levodopa|levodopa
490971|NCT01468012|carbidopa|carbidopa
490972|NCT01468012|entacapone|entacapone
490973|NCT01467999|cannabis dependence|cannabis dependence
490974|NCT01467999|marijuana dependence|marijuana dependence
490975|NCT01467999|guanfacine|guanfacine
490976|NCT01467986|neuroblastoma|neuroblastoma
490977|NCT01467986|molecular targeted therapy|molecular targeted therapy
490978|NCT01467986|protein kinase inhibitor|protein kinase inhibitor
490979|NCT01467986|mTOR Inhibitor|mtor inhibitor
490980|NCT01467986|cytostatic topoisomerase-I-inhibitor|cytostatic topoisomerase-i-inhibitor
490981|NCT01467986|temozolomide|temozolomide
490982|NCT01467986|irinotecan|irinotecan
490983|NCT01467986|dasatinib|dasatinib
490984|NCT01467986|rapamycin|rapamycin
490985|NCT01467973|Heart Failure|heart failure
490986|NCT01467973|Heart Failure, Diastolic|heart failure, diastolic
490987|NCT01467973|Heart Failure, Systolic|heart failure, systolic
490988|NCT01467973|Middle-East|middle-east
490989|NCT01467908|Diagnosed vegetative state after stroke or traumatic brain injury|diagnosed vegetative state after stroke or traumatic brain injury
490990|NCT01467869|abnormal semen|abnormal semen
490991|NCT01467869|assisted conception|assisted conception
490992|NCT01467856|Tetraplegia|tetraplegia
490993|NCT01467843|Cognitive Behavioral Therapy|cognitive behavioral therapy
490994|NCT01467843|Mindfulness Based Stress Reduction|mindfulness based stress reduction
490995|NCT01467830|absorbable sutures efficacy|absorbable sutures efficacy
490996|NCT01467830|reducing Adverse effect to be caused from surgery|reducing adverse effect to be caused from surgery
490997|NCT01467830|Inguinal Hernia repair with mesh|inguinal hernia repair with mesh
490998|NCT01467817|body mass|body mass
490999|NCT01467817|abdominal fat|abdominal fat
491000|NCT01467817|whole body lean mass|whole body lean mass
491001|NCT01467817|insulin resistance|insulin resistance
491002|NCT01467817|caloric intake|caloric intake
491003|NCT01467817|expenditure|expenditure
491004|NCT01467817|endurance|endurance
491005|NCT01467817|Strength|strength
491006|NCT01467817|TC:HDL ratio|tc:hdl ratio
491007|NCT01467817|LDL:HDL ratio|ldl:hdl ratio
491008|NCT01467817|area under the TG response curve|area under the tg response curve
491009|NCT01467817|feeding challenge|feeding challenge
491010|NCT01467817|fasting and post-prandial whole body fat oxidation|fasting and post-prandial whole body fat oxidation
491011|NCT01467817|HRQoL|hrqol
491012|NCT01467804|efficacy,|efficacy,
491013|NCT01467804|safety,|safety,
491014|NCT01467804|JWXYJN|jwxyjn
491015|NCT01467791|ambrisentan|ambrisentan
491016|NCT01467791|Bosentan|bosentan
491017|NCT01467791|Iloprost|iloprost
491018|NCT01467778|skin|skin
491019|NCT01467752|reconstruction|reconstruction
491020|NCT01467752|metacarpophalangeal joint|metacarpophalangeal joint
491021|NCT01467752|bone graft|bone graft
491022|NCT01467752|MCP joint|mcp joint
491023|NCT01467726|Alzheimer's disease|alzheimer's disease
491024|NCT01467726|Elderly|elderly
491025|NCT01467713|Drug Therapy|drug therapy
491026|NCT01467700|Drug Therapy|drug therapy
491027|NCT01467674|Diabetes mellitus|diabetes mellitus
491028|NCT01467674|Chronic periodontitis|chronic periodontitis
491029|NCT01467674|Malondialdehyde|malondialdehyde
491030|NCT01467674|Glutathione peroxidase|glutathione peroxidase
491031|NCT01467674|Paraoxonase|paraoxonase
491032|NCT01467648|Infection|infection
491033|NCT01467648|Doripenem|doripenem
491034|NCT01467648|Ventilator-Associated Pneumonia|ventilator-associated pneumonia
491035|NCT01467648|pharmacokinetic|pharmacokinetic
491036|NCT01467648|pharmacodynamic|pharmacodynamic
491037|NCT01467635|Endobronchial ultrasound|endobronchial ultrasound
491038|NCT01467635|Transbronchial needle aspiration|transbronchial needle aspiration
491039|NCT01467635|Transbronchial biopsy forceps|transbronchial biopsy forceps
491040|NCT01467635|Mediastinal lymphadenopathy|mediastinal lymphadenopathy
491041|NCT01467635|Hilar lymphadenopathy|hilar lymphadenopathy
491042|NCT01467622|chest tube drainage|chest tube drainage
491043|NCT01467622|pulmonary air leak|pulmonary air leak
491044|NCT01467622|lung resection|lung resection
491045|NCT01467609|Pillcam colon capsule endoscopy|pillcam colon capsule endoscopy
491046|NCT01467609|conventional colonoscopy|conventional colonoscopy
491047|NCT01467609|ulcerative colitis|ulcerative colitis
491048|NCT01467609|endoscopic manifestation|endoscopic manifestation
491049|NCT01467609|colonoscopy|colonoscopy
491050|NCT01467596|Ultrasound|ultrasound
491051|NCT01467596|Brachial block|brachial block
491052|NCT01467596|Levobupivacaine|levobupivacaine
491053|NCT01467596|Minimum|minimum
491054|NCT01467596|Volume|volume
491055|NCT01467596|Minimum volume of Levobupivacaine 0,5%|minimum volume of levobupivacaine 0,5%
491056|NCT01467583|Fondaparinux|fondaparinux
491057|NCT01467583|Renal Failure|renal failure
491058|NCT01467583|Critically Ill|critically ill
491059|NCT01467570|diarrhea|diarrhea
491060|NCT01467557|adverse events|adverse events
491061|NCT01467544|Tai Chi|tai chi
491062|NCT01467531|HIV, GSK1265744, GSK1349572, dolutegravir, rilpivirine, drug interaction, pharmacokinetics|hiv, gsk1265744, gsk1349572, dolutegravir, rilpivirine, drug interaction, pharmacokinetics
491063|NCT01467518|methadone|methadone
491064|NCT01467518|Opiate-dependent|opiate-dependent
491065|NCT01467492|VX-950, Incivek|vx-950, incivek
491066|NCT01467466|renal|renal
491067|NCT01467466|cardiovascular|cardiovascular
491068|NCT01467466|kidney|kidney
491069|NCT01467466|heart|heart
491070|NCT01467466|clinical trial|clinical trial
491071|NCT01467466|double-blind|double-blind
491072|NCT01467466|multi-site trial|multi-site trial
491073|NCT01467466|randomized|randomized
491074|NCT01467466|drug treatment|drug treatment
491075|NCT01467466|IV solutions|iv solutions
491076|NCT01467466|antioxidant|antioxidant
491077|NCT01467440|Glaucoma and Ocular Hypertension|glaucoma and ocular hypertension
491078|NCT01467388|patients with glaucoma or ocular hypertension|patients with glaucoma or ocular hypertension
491079|NCT01467362|xerosis|xerosis
491080|NCT01467362|dry skin|dry skin
491081|NCT01467362|dermatitis|dermatitis
491082|NCT01467362|pruritus|pruritus
491083|NCT01467362|eczema|eczema
491084|NCT01467362|emollient|emollient
491085|NCT01467362|corticosteroid|corticosteroid
491086|NCT01467349|Raltegravir|raltegravir
491087|NCT01467349|efficacy|efficacy
491088|NCT01467349|safety|safety
491089|NCT01467349|raltegravir-containing regimens|raltegravir-containing regimens
491090|NCT01467349|HIV urban clinic setting|hiv urban clinic setting
491091|NCT01467310|GSK1120212|gsk1120212
491093|NCT01467310|Triple Negative Breast Cancer|triple negative breast cancer
491094|NCT01467310|Surgical Resection|surgical resection
491095|NCT01467297|Chronic bronchitis|chronic bronchitis
491096|NCT01467297|exacerbations|exacerbations
491097|NCT01467297|treatment|treatment
491098|NCT01467297|ceftidoren|ceftidoren
491099|NCT01467297|levofloxacin|levofloxacin
491100|NCT01467297|inflammation|inflammation
491101|NCT01467284|Obesity|obesity
491102|NCT01467284|Workplace|workplace
491103|NCT01467284|Intervention|intervention
491104|NCT01467284|Diet|diet
491105|NCT01467284|Exercise|exercise
491106|NCT01467245|Thoracoscopy|thoracoscopy
491663|NCT01465256|Bleeding|bleeding
491107|NCT01467245|congenital diaphragmatic hernia|congenital diaphragmatic hernia
491108|NCT01467245|oesophageal atresia|oesophageal atresia
491109|NCT01467245|hypercapnia|hypercapnia
491110|NCT01467245|acidosis|acidosis
491111|NCT01467245|cerebral oxygenation|cerebral oxygenation
491112|NCT01467245|neonates|neonates
491113|NCT01467219|early|early
491114|NCT01467219|high risk|high risk
491115|NCT01467206|Stroke|stroke
491116|NCT01467206|Physiotherapy|physiotherapy
491117|NCT01467206|Motor training|motor training
491118|NCT01467206|Rehabilitation|rehabilitation
491119|NCT01467180|septeX|septex
491120|NCT01467180|CVVH|cvvh
491121|NCT01467180|CVHD|cvhd
491122|NCT01467180|myoglobin|myoglobin
491123|NCT01467167|Anesthesia|anesthesia
491124|NCT01467167|Smart Pilot View|smart pilot view
491125|NCT01467167|Pain control|pain control
491126|NCT01467167|Recovery|recovery
491127|NCT01467128|Elderly|elderly
491128|NCT01467128|Hospital|hospital
491129|NCT01467128|Adverse Drug|adverse drug
491130|NCT01467128|Pharmacist|pharmacist
491131|NCT01467128|Prevention|prevention
491132|NCT01467115|loco regionally advanced|loco regionally advanced
491133|NCT01467115|head and neck cancer|head and neck cancer
491134|NCT01467115|chemotherapy|chemotherapy
491135|NCT01467115|radiation|radiation
491136|NCT01467102|chronic post surgical pain|chronic post surgical pain
491137|NCT01467102|Pain|pain
491138|NCT01467102|Risk factors of chronic post surgical pain|risk factors of chronic post surgical pain
491139|NCT01467102|predictive risk factors|predictive risk factors
491140|NCT01467102|chronic post-surgical pain (CPSP)|chronic post-surgical pain (cpsp)
491141|NCT01467102|international level|international level
491142|NCT01467102|epidemiology of CPSP|epidemiology of cpsp
491143|NCT01467102|Europe|europe
491144|NCT01467102|observational|observational
491145|NCT01467102|prospective|prospective
491146|NCT01467089|Schizophrenia|schizophrenia
491147|NCT01467089|Extrapyramidal symptoms|extrapyramidal symptoms
491148|NCT01467089|Tardive dyskinesia|tardive dyskinesia
491149|NCT01467089|Two Way Video Assessment|two way video assessment
491150|NCT01467063|Type I Diabetes|type i diabetes
491151|NCT01467063|Insulin Resistance|insulin resistance
491152|NCT01467063|Glutamine|glutamine
491153|NCT01467063|Amino Acids|amino acids
491154|NCT01467063|Glucagon like peptide 1|glucagon like peptide 1
491155|NCT01467063|Glutathione|glutathione
491156|NCT01467063|Citrulline|citrulline
491157|NCT01467063|Arginine|arginine
491158|NCT01467063|Nitric Oxide|nitric oxide
491159|NCT01467050|Adverse drug event|adverse drug event
491160|NCT01467050|Adverse drug reaction|adverse drug reaction
491161|NCT01467050|Inappropriate prescribing|inappropriate prescribing
491162|NCT01467050|Elderly|elderly
491163|NCT01467050|Hospital-acquired|hospital-acquired
491164|NCT01467037|Rotavirus|rotavirus
491165|NCT01467037|Gastroenteritis|gastroenteritis
491166|NCT01467037|Vaccination|vaccination
491167|NCT01467037|Pediatrics|pediatrics
491168|NCT01467024|HTLV|htlv
491169|NCT01467024|Confirmatory|confirmatory
491170|NCT01467024|Supplemental|supplemental
491171|NCT01467024|Blot|blot
491172|NCT01467024|HTLV-I|htlv-i
491173|NCT01467024|HTLV-II|htlv-ii
491174|NCT01467011|Myfortic|myfortic
491175|NCT01467011|Mycophenolic acid|mycophenolic acid
491176|NCT01467011|Prograf|prograf
491177|NCT01467011|Tacrolimus|tacrolimus
491178|NCT01467011|Liver transplantation|liver transplantation
491179|NCT01466972|Advanced|advanced
491180|NCT01466972|Breast|breast
491181|NCT01466972|Cancer|cancer
491182|NCT01466972|Hormone Resistance|hormone resistance
491183|NCT01466972|Pazopanib|pazopanib
491184|NCT01466972|anastrozole|anastrozole
491185|NCT01466972|arimidex|arimidex
491186|NCT01466972|letrozole|letrozole
491187|NCT01466972|femara|femara
491188|NCT01466959|hemodialysis|hemodialysis
491189|NCT01466959|dialysate|dialysate
491190|NCT01466959|acetate based dialysate|acetate based dialysate
491191|NCT01466959|citrasate dialysate|citrasate dialysate
491192|NCT01466959|heparin anticoagulation|heparin anticoagulation
491193|NCT01466959|hemodynamic stability|hemodynamic stability
491194|NCT01466946|lung cancer|lung cancer
491195|NCT01466946|Hispanic/Latino patients|hispanic/latino patients
491196|NCT01466946|interviews|interviews
491197|NCT01466946|11-109|11-109
491198|NCT01466933|parenting intervention|parenting intervention
491199|NCT01466933|child development|child development
491200|NCT01466933|low and middle income countries|low and middle income countries
491201|NCT01466920|Total knee arthroplasty|total knee arthroplasty
491202|NCT01466907|complication|complication
491203|NCT01466907|depression|depression
491204|NCT01466907|follow-up|follow-up
491205|NCT01466907|intervention|intervention
491206|NCT01466907|nurse-led|nurse-led
491207|NCT01466907|outcome|outcome
491208|NCT01466907|secondary prevention|secondary prevention
491209|NCT01466907|stroke|stroke
491210|NCT01466894|Nonalcoholic fatty liver disease|nonalcoholic fatty liver disease
491211|NCT01466894|NAFLD|nafld
491212|NCT01466894|Fatty liver|fatty liver
491213|NCT01466894|NASH|nash
491214|NCT01466868|Diffuse Large B cell Lymphoma|diffuse large b cell lymphoma
491215|NCT01466868|AKT|akt
491216|NCT01466868|MK 2206|mk 2206
491217|NCT01466868|objective response rate|objective response rate
491218|NCT01466868|progression free survival|progression free survival
491219|NCT01466868|overall survival|overall survival
491220|NCT01466868|safety|safety
491221|NCT01466855|Retinoblastoma|retinoblastoma
491222|NCT01466829|sternotomy|sternotomy
491223|NCT01466829|parathyroid hormone|parathyroid hormone
491224|NCT01466829|bone healing|bone healing
491225|NCT01466816|Lipid metabolism|lipid metabolism
491226|NCT01466803|Buprenorphine|buprenorphine
491227|NCT01466803|Vorikonazole|vorikonazole
491228|NCT01466803|Interactions|interactions
491229|NCT01466803|Pharmacokinetics|pharmacokinetics
491230|NCT01466803|Pharmacodynamics|pharmacodynamics
491231|NCT01466803|Voriconazole|voriconazole
491232|NCT01466790|Hepatitis C|hepatitis c
491233|NCT01466790|TMC435|tmc435
491234|NCT01466790|PSI-7977|psi-7977
491235|NCT01466790|GS7977|gs7977
491236|NCT01466790|Ribavirin|ribavirin
491237|NCT01466790|HCV|hcv
491238|NCT01466790|Hep C|hep c
491239|NCT01466790|Genotype 1|genotype 1
491240|NCT01466777|Endometrium cancer|endometrium cancer
491241|NCT01466777|Robotic-assisted laparoscopy|robotic-assisted laparoscopy
491242|NCT01466777|Traditional laparoscopy|traditional laparoscopy
491243|NCT01466777|Laparoscopic surgery|laparoscopic surgery
491244|NCT01466777|Treatment|treatment
491245|NCT01466777|Operation time|operation time
491246|NCT01466777|Bleeding|bleeding
491247|NCT01466777|Complications|complications
491248|NCT01466777|Conversions|conversions
491249|NCT01466777|Pelvic lymph node|pelvic lymph node
491250|NCT01466764|biomarkers|biomarkers
491251|NCT01466751|Computerized neurobehavioral intervention|computerized neurobehavioral intervention
491252|NCT01466738|Healthy volunteer|healthy volunteer
491253|NCT01466738|Rhinovirus|rhinovirus
491254|NCT01466738|Cold virus|cold virus
491255|NCT01466738|HRV-16|hrv-16
491256|NCT01466725|Lupus|lupus
491257|NCT01466725|Discoid Lupus|discoid lupus
491258|NCT01466725|DLE|dle
491259|NCT01466725|Cutaneous Lupus|cutaneous lupus
491260|NCT01466686|Recurrent Glioblastoma Multiforme|recurrent glioblastoma multiforme
491261|NCT01466686|Recurrent Anaplastic Astrocytoma|recurrent anaplastic astrocytoma
491262|NCT01466686|Surgery|surgery
491263|NCT01466686|Adjuvant Radiation|adjuvant radiation
491264|NCT01466686|Adjuvant Temozolomide|adjuvant temozolomide
491265|NCT01466673|Acne Vulgaris|acne vulgaris
491266|NCT01466673|Ethinyl estradiol|ethinyl estradiol
491267|NCT01466673|Norgestimate|norgestimate
491268|NCT01466673|Desogestrel|desogestrel
491269|NCT01466673|Tricilest|tricilest
491270|NCT01466673|Oilezz|oilezz
491271|NCT01466647|NSCLC|nsclc
491272|NCT01466621|cardiac resynchronization therapy|cardiac resynchronization therapy
491273|NCT01466621|heart failure|heart failure
491274|NCT01466621|mortality|mortality
491275|NCT01466608|OATP1B1|oatp1b1
491276|NCT01466608|Rosuvastatin|rosuvastatin
491277|NCT01466608|lipidomics|lipidomics
491278|NCT01466608|pharmacodynamics|pharmacodynamics
491279|NCT01466582|HIV-1-infection|hiv-1-infection
491280|NCT01466582|comorbidity|comorbidity
491281|NCT01466582|ageing|ageing
491282|NCT01466569|Advanced Solid Tumor|advanced solid tumor
491283|NCT01466569|Gastric Cancer|gastric cancer
491284|NCT01466569|Oncology|oncology
491285|NCT01466569|monoclonal Antibody|monoclonal antibody
491286|NCT01466543|Vascular dementia|vascular dementia
491287|NCT01466543|Subcortical vascular dementia|subcortical vascular dementia
491288|NCT01466543|Phosphodiesterase 5|phosphodiesterase 5
491289|NCT01466543|Udenafil|udenafil
491290|NCT01466530|Full term pregnancy > 36 weeks|full term pregnancy > 36 weeks
491291|NCT01466530|Cesarean delivery|cesarean delivery
491292|NCT01466530|General anesthesia|general anesthesia
491293|NCT01466517|Relative Bioavailability Study|relative bioavailability study
491294|NCT01466517|Ibuprofen|ibuprofen
491295|NCT01466517|Alivium|alivium
491296|NCT01466504|P63|p63
491297|NCT01466504|Sorafenib|sorafenib
491298|NCT01466504|Regorafenib|regorafenib
491299|NCT01466504|rash|rash
491300|NCT01466504|skin toxicity|skin toxicity
491301|NCT01466504|RCC|rcc
491302|NCT01466504|HCC|hcc
491303|NCT01466504|colorectal carcinoma|colorectal carcinoma
710741|NCT00588120|Enteric Hyperoxaluria|enteric hyperoxaluria
491304|NCT01466491|Pain during first-trimester surgical abortion|pain during first-trimester surgical abortion
491305|NCT01466465|Vitamin D|vitamin d
491306|NCT01466465|SIT|sit
491307|NCT01466465|Grass pollen|grass pollen
491308|NCT01466465|allergic rhinoconjunctivitis|allergic rhinoconjunctivitis
491309|NCT01466439|rTMS|rtms
491310|NCT01466439|P50|p50
491311|NCT01466439|inhibitory|inhibitory
491312|NCT01466439|facilitatory|facilitatory
491313|NCT01466439|physiological process|physiological process
491314|NCT01466439|brain changes|brain changes
491315|NCT01466426|Venous thromboembolic disease|venous thromboembolic disease
491316|NCT01466426|Deep veinous thrombosis|deep veinous thrombosis
491317|NCT01466426|Pulmonary embolism|pulmonary embolism
491318|NCT01466413|Intrinsic Aging of Skin|intrinsic aging of skin
491319|NCT01466400|health benefits of infant formula|health benefits of infant formula
491320|NCT01466387|Adults|adults
491321|NCT01466387|international travel vaccination|international travel vaccination
491322|NCT01466387|Meningococcal disease|meningococcal disease
491323|NCT01466387|meningococcal meningitis|meningococcal meningitis
491324|NCT01466387|typhoid|typhoid
491325|NCT01466387|yellow fever|yellow fever
491326|NCT01466387|rabies|rabies
491327|NCT01466387|Japanese encephalitis|japanese encephalitis
491328|NCT01466361|Nicotine|nicotine
491329|NCT01466361|Nicotine craving|nicotine craving
491330|NCT01466348|Paracetomol|paracetomol
491331|NCT01466348|Caffeine|caffeine
491332|NCT01466348|Common cold|common cold
491333|NCT01466322|Healthy volunteers|healthy volunteers
491334|NCT01466322|GSK2018682|gsk2018682
491335|NCT01466322|Pharmacokinetics|pharmacokinetics
491336|NCT01466322|Relapsing Remitting Multiple Sclerosis|relapsing remitting multiple sclerosis
491337|NCT01466322|Pharmacodynamics|pharmacodynamics
491338|NCT01466309|AHI|ahi
491339|NCT01466309|ESS|ess
491340|NCT01466309|VAS|vas
491341|NCT01466309|FOSQ|fosq
491342|NCT01466309|SF-36|sf-36
491343|NCT01466296|CERBRAL PALSY|cerbral palsy
491344|NCT01466296|Poststroke/CVA Paresis|poststroke/cva paresis
491345|NCT01466296|REHABILITATION|rehabilitation
491346|NCT01466296|WALKING|walking
491347|NCT01466296|PERUTURBATION|peruturbation
491348|NCT01466283|childhood rhabdomyosarcoma|childhood rhabdomyosarcoma
491349|NCT01466270|fatigue|fatigue
491350|NCT01466270|sleep disorders|sleep disorders
491351|NCT01466270|depression|depression
491352|NCT01466270|anxiety disorder|anxiety disorder
491353|NCT01466270|cognitive/functional effects|cognitive/functional effects
491354|NCT01466270|breast cancer|breast cancer
491355|NCT01466270|cancer survivor|cancer survivor
491356|NCT01466257|metastatic squamous neck cancer with occult primary squamous cell carcinoma|metastatic squamous neck cancer with occult primary squamous cell carcinoma
491357|NCT01466257|recurrent metastatic squamous neck cancer with occult primary|recurrent metastatic squamous neck cancer with occult primary
491358|NCT01466257|recurrent squamous cell carcinoma of the hypopharynx|recurrent squamous cell carcinoma of the hypopharynx
491359|NCT01466257|recurrent squamous cell carcinoma of the larynx|recurrent squamous cell carcinoma of the larynx
491360|NCT01466257|recurrent squamous cell carcinoma of the lip and oral cavity|recurrent squamous cell carcinoma of the lip and oral cavity
491361|NCT01466257|recurrent squamous cell carcinoma of the oropharynx|recurrent squamous cell carcinoma of the oropharynx
491362|NCT01466257|recurrent squamous cell carcinoma of the paranasal sinus and nasal cavity|recurrent squamous cell carcinoma of the paranasal sinus and nasal cavity
491363|NCT01466257|stage III squamous cell carcinoma of the hypopharynx|stage iii squamous cell carcinoma of the hypopharynx
491364|NCT01466257|stage III squamous cell carcinoma of the larynx|stage iii squamous cell carcinoma of the larynx
491365|NCT01466257|stage III squamous cell carcinoma of the lip and oral cavity|stage iii squamous cell carcinoma of the lip and oral cavity
491366|NCT01466257|stage III squamous cell carcinoma of the oropharynx|stage iii squamous cell carcinoma of the oropharynx
491367|NCT01466257|stage III squamous cell carcinoma of the paranasal sinus and nasal cavity|stage iii squamous cell carcinoma of the paranasal sinus and nasal cavity
491368|NCT01466257|stage IV squamous cell carcinoma of the hypopharynx|stage iv squamous cell carcinoma of the hypopharynx
491369|NCT01466257|stage IVA squamous cell carcinoma of the larynx|stage iva squamous cell carcinoma of the larynx
491370|NCT01466257|stage IVA squamous cell carcinoma of the lip and oral cavity|stage iva squamous cell carcinoma of the lip and oral cavity
491371|NCT01466257|stage IVA squamous cell carcinoma of the oropharynx|stage iva squamous cell carcinoma of the oropharynx
491372|NCT01466257|stage IVA squamous cell carcinoma of the paranasal sinus and nasal cavity|stage iva squamous cell carcinoma of the paranasal sinus and nasal cavity
491373|NCT01466257|stage IVB squamous cell carcinoma of the larynx|stage ivb squamous cell carcinoma of the larynx
491374|NCT01466257|stage IVB squamous cell carcinoma of the lip and oral cavity|stage ivb squamous cell carcinoma of the lip and oral cavity
491375|NCT01466257|stage IVB squamous cell carcinoma of the oropharynx|stage ivb squamous cell carcinoma of the oropharynx
491376|NCT01466257|stage IVB squamous cell carcinoma of the paranasal sinus and nasal cavity|stage ivb squamous cell carcinoma of the paranasal sinus and nasal cavity
491377|NCT01466257|stage IVC squamous cell carcinoma of the larynx|stage ivc squamous cell carcinoma of the larynx
491378|NCT01466257|stage IVC squamous cell carcinoma of the lip and oral cavity|stage ivc squamous cell carcinoma of the lip and oral cavity
710742|NCT00588120|Oxaluric|oxaluric
626056|NCT00917345|PRA|pra
491379|NCT01466257|stage IVC squamous cell carcinoma of the oropharynx|stage ivc squamous cell carcinoma of the oropharynx
491380|NCT01466257|stage IVC squamous cell carcinoma of the paranasal sinus and nasal cavity|stage ivc squamous cell carcinoma of the paranasal sinus and nasal cavity
491381|NCT01466257|untreated metastatic squamous neck cancer with occult primary|untreated metastatic squamous neck cancer with occult primary
491382|NCT01466244|metastatic squamous neck cancer with occult primary squamous cell carcinoma|metastatic squamous neck cancer with occult primary squamous cell carcinoma
491383|NCT01466244|recurrent metastatic squamous neck cancer with occult primary|recurrent metastatic squamous neck cancer with occult primary
491384|NCT01466244|recurrent squamous cell carcinoma of the hypopharynx|recurrent squamous cell carcinoma of the hypopharynx
491385|NCT01466244|recurrent squamous cell carcinoma of the larynx|recurrent squamous cell carcinoma of the larynx
491386|NCT01466244|recurrent squamous cell carcinoma of the lip and oral cavity|recurrent squamous cell carcinoma of the lip and oral cavity
491387|NCT01466244|recurrent squamous cell carcinoma of the oropharynx|recurrent squamous cell carcinoma of the oropharynx
491388|NCT01466244|recurrent squamous cell carcinoma of the paranasal sinus and nasal cavity|recurrent squamous cell carcinoma of the paranasal sinus and nasal cavity
491389|NCT01466244|stage III squamous cell carcinoma of the hypopharynx|stage iii squamous cell carcinoma of the hypopharynx
491390|NCT01466244|stage III squamous cell carcinoma of the larynx|stage iii squamous cell carcinoma of the larynx
491391|NCT01466244|stage III squamous cell carcinoma of the lip and oral cavity|stage iii squamous cell carcinoma of the lip and oral cavity
491392|NCT01466244|stage III squamous cell carcinoma of the oropharynx|stage iii squamous cell carcinoma of the oropharynx
491393|NCT01466244|stage III squamous cell carcinoma of the paranasal sinus and nasal cavity|stage iii squamous cell carcinoma of the paranasal sinus and nasal cavity
491394|NCT01466244|stage IVA squamous cell carcinoma of the larynx|stage iva squamous cell carcinoma of the larynx
491395|NCT01466244|stage IVA squamous cell carcinoma of the lip and oral cavity|stage iva squamous cell carcinoma of the lip and oral cavity
491396|NCT01466244|stage IVA squamous cell carcinoma of the oropharynx|stage iva squamous cell carcinoma of the oropharynx
491397|NCT01466244|stage IVA squamous cell carcinoma of the paranasal sinus and nasal cavity|stage iva squamous cell carcinoma of the paranasal sinus and nasal cavity
491398|NCT01466244|stage IVB squamous cell carcinoma of the larynx|stage ivb squamous cell carcinoma of the larynx
491399|NCT01466244|stage IVB squamous cell carcinoma of the lip and oral cavity|stage ivb squamous cell carcinoma of the lip and oral cavity
491400|NCT01466244|stage IVB squamous cell carcinoma of the oropharynx|stage ivb squamous cell carcinoma of the oropharynx
491401|NCT01466244|stage IVB squamous cell carcinoma of the paranasal sinus and nasal cavity|stage ivb squamous cell carcinoma of the paranasal sinus and nasal cavity
491402|NCT01466244|stage IVC squamous cell carcinoma of the larynx|stage ivc squamous cell carcinoma of the larynx
491403|NCT01466244|stage IVC squamous cell carcinoma of the lip and oral cavity|stage ivc squamous cell carcinoma of the lip and oral cavity
491404|NCT01466244|stage IVC squamous cell carcinoma of the oropharynx|stage ivc squamous cell carcinoma of the oropharynx
491405|NCT01466244|stage IVC squamous cell carcinoma of the paranasal sinus and nasal cavity|stage ivc squamous cell carcinoma of the paranasal sinus and nasal cavity
491406|NCT01466244|untreated metastatic squamous neck cancer with occult primary|untreated metastatic squamous neck cancer with occult primary
491407|NCT01466231|refractory germ cell cancer|refractory germ cell cancer
491408|NCT01466231|everolimus|everolimus
491409|NCT01466218|pulmonary function abnormalities|pulmonary function abnormalities
491410|NCT01466218|pulmonary disease|pulmonary disease
491411|NCT01466218|cardiac disease|cardiac disease
491412|NCT01466218|cardiopulmonary disease|cardiopulmonary disease
491413|NCT01466218|obstructive sleep apnea|obstructive sleep apnea
491414|NCT01466218|OSA|osa
491415|NCT01466218|cardiovascular disease|cardiovascular disease
491416|NCT01466218|CVD|cvd
491417|NCT01466218|particulate matter|particulate matter
491418|NCT01466205|schizotypal personality disorder|schizotypal personality disorder
491419|NCT01466205|cognitive impairment|cognitive impairment
491420|NCT01466205|working memory|working memory
491421|NCT01466192|Genotype 2|genotype 2
491422|NCT01466179|B-ALL|b-all
491423|NCT01466179|relapsed ALL|relapsed all
491424|NCT01466179|refractory ALL|refractory all
491425|NCT01466179|adult ALL|adult all
491426|NCT01466179|Leukemia|leukemia
491427|NCT01466179|Leukemia, Lymphoid|leukemia, lymphoid
491428|NCT01466179|precursor cell lymphoblastic leukemia-lymphoma|precursor cell lymphoblastic leukemia-lymphoma
491429|NCT01466179|Lymphatic diseases|lymphatic diseases
491430|NCT01466179|Lymphoproliferative disorders|lymphoproliferative disorders
491431|NCT01466179|bispecific antibody|bispecific antibody
491432|NCT01466179|anti-CD19|anti-cd19
491433|NCT01466179|Immunotherapeutic treatment|immunotherapeutic treatment
491434|NCT01466179|immunoproliferative disorders|immunoproliferative disorders
491435|NCT01466153|Chronic lymphocytic leukemia; leukemia; B-Cell malignancy; anti-CD19; monoclonal antibody; CLL; Refractory; Relapse; Non-Hodgkin's Lymphoma|chronic lymphocytic leukemia; leukemia; b-cell malignancy; anti-cd19; monoclonal antibody; cll; refractory; relapse; non-hodgkin's lymphoma
491436|NCT01466140|Patient Satisfaction|patient satisfaction
491437|NCT01466140|Request for help|request for help
491438|NCT01466140|General practice|general practice
491439|NCT01466127|Effect of oxytocin on learning|effect of oxytocin on learning
491440|NCT01466114|multiple sclerosis|multiple sclerosis
491441|NCT01466114|MS|ms
491442|NCT01466114|relapsing remitting multiple sclerosis|relapsing remitting multiple sclerosis
491444|NCT01466114|secondary progressive multiple sclerosis|secondary progressive multiple sclerosis
491445|NCT01466114|SPMS|spms
491446|NCT01466114|primary progressive multiple sclerosis|primary progressive multiple sclerosis
491447|NCT01466114|estrogen|estrogen
491448|NCT01466114|estriol|estriol
491449|NCT01466101|Hysterectomy|hysterectomy
491450|NCT01466101|Pain|pain
491451|NCT01466101|Pregabalin|pregabalin
491452|NCT01466088|Alzheimer's Disease|alzheimer's disease
491453|NCT01466088|AD|ad
491454|NCT01466088|Dementia|dementia
491455|NCT01466062|Immunocompromised medical conditions|immunocompromised medical conditions
491456|NCT01466062|Respiratory Syncytial Virus Infection|respiratory syncytial virus infection
491457|NCT01466062|Infant|infant
491458|NCT01466062|Newborn|newborn
491459|NCT01466062|Young children|young children
491460|NCT01466049|Ovarian Cancer|ovarian cancer
491461|NCT01466049|Adnexal Mass|adnexal mass
491462|NCT01466049|Pelvic Mass|pelvic mass
491463|NCT01466036|metastatic|metastatic
491664|NCT01465243|Efficacy|efficacy
491464|NCT01466023|thyroid metabolism during pregnancy|thyroid metabolism during pregnancy
491465|NCT01466023|impact on neonate|impact on neonate
491466|NCT01466010|osteoma, osteoid|osteoma, osteoid
491467|NCT01466010|surgical procedures, operative|surgical procedures, operative
491468|NCT01466010|bone neoplasms|bone neoplasms
491469|NCT01465997|Lacosamide|lacosamide
491470|NCT01465984|Paracetamol|paracetamol
491471|NCT01465984|Morphine sulfates|morphine sulfates
491472|NCT01465984|Acute pain|acute pain
491473|NCT01465971|high|high
491474|NCT01465971|altitude|altitude
491475|NCT01465971|acute|acute
491476|NCT01465971|mountain|mountain
491477|NCT01465971|sickness|sickness
491478|NCT01465971|sleep|sleep
491479|NCT01465971|disorder|disorder
491480|NCT01465971|periodic|periodic
491481|NCT01465971|breathing|breathing
491482|NCT01465971|hyperventilation|hyperventilation
491483|NCT01465971|apnea|apnea
491484|NCT01465945|TEM for rectal lesions|tem for rectal lesions
491485|NCT01465945|Sutured defect|sutured defect
491486|NCT01465945|Unsutured defect|unsutured defect
491487|NCT01465932|Nursing staff|nursing staff
491488|NCT01465932|Physical Therapy (Specialty)|physical therapy (specialty)
491489|NCT01465919|depression|depression
491490|NCT01465919|interferon|interferon
491491|NCT01465919|chronic hepatitis C|chronic hepatitis c
491492|NCT01465919|mirtazapine|mirtazapine
491493|NCT01465906|COPD|copd
491494|NCT01465893|vitamin d|vitamin d
491495|NCT01465880|Smoking research study|smoking research study
491496|NCT01465867|Selenium|selenium
491497|NCT01465867|Pregnancy|pregnancy
491498|NCT01465867|Auto-immune thyroiditis|auto-immune thyroiditis
491499|NCT01465867|Post-partum thyroiditis|post-partum thyroiditis
491500|NCT01465867|Miscarriage|miscarriage
491501|NCT01465867|Pre-eclampsia|pre-eclampsia
491502|NCT01465867|Implantation and Pregnancy rate|implantation and pregnancy rate
491503|NCT01465867|Infertility|infertility
491504|NCT01465854|lung cancer|lung cancer
491505|NCT01465854|smoking|smoking
491506|NCT01465854|molecular epidemiology|molecular epidemiology
491507|NCT01465854|genetic polymorphism|genetic polymorphism
491508|NCT01465854|risk factors|risk factors
491509|NCT01465854|never smokers|never smokers
491510|NCT01465854|histologically/cytologically confirmed|histologically/cytologically confirmed
491511|NCT01465841|intracranial aneurysms|intracranial aneurysms
491512|NCT01465841|Peripheral aneurysms|peripheral aneurysms
491513|NCT01465841|acute treatment|acute treatment
491514|NCT01465841|PC 400 System|pc 400 system
491515|NCT01465841|packing density|packing density
491516|NCT01465828|antiplatelet effect|antiplatelet effect
491517|NCT01465828|prasugrel|prasugrel
491518|NCT01465828|clopidogrel|clopidogrel
491519|NCT01465828|ACS|acs
491520|NCT01465802|non-small cell lung cancer|non-small cell lung cancer
491521|NCT01465802|advanced|advanced
491522|NCT01465802|previously treated|previously treated
491523|NCT01465776|SCC of the oral cavity|scc of the oral cavity
491524|NCT01465776|black raspberries|black raspberries
491525|NCT01465763|tofacitinib|tofacitinib
491526|NCT01465763|CP-690|cp-690
491527|NCT01465763|550|550
491528|NCT01465763|Moderate to severe ulcerative colitis|moderate to severe ulcerative colitis
491529|NCT01465763|phase 3 clinical trial|phase 3 clinical trial
491530|NCT01465763|Mayo score|mayo score
491531|NCT01465737|epidemiology|epidemiology
491532|NCT01465737|uterine cancer|uterine cancer
491533|NCT01465737|Taiwan|taiwan
491534|NCT01465724|Insulin resistance|insulin resistance
491535|NCT01465724|Insulin sensitivity|insulin sensitivity
491536|NCT01465724|HOMA-IR|homa-ir
491537|NCT01465724|blood pressure|blood pressure
491538|NCT01465724|Renal denervation|renal denervation
491539|NCT01465724|renal sympathetic denervation|renal sympathetic denervation
491540|NCT01465724|renal ablation|renal ablation
491541|NCT01465711|Peritonitis|peritonitis
491542|NCT01465711|Sepsis|sepsis
491543|NCT01465711|General Surgery|general surgery
491544|NCT01465711|Intensive Care Units|intensive care units
491545|NCT01465711|Sensitivity and Specificity|sensitivity and specificity
491546|NCT01465698|exercise|exercise
491547|NCT01465698|counseling|counseling
491548|NCT01465698|movement control|movement control
491549|NCT01465698|fear avoidance|fear avoidance
491550|NCT01465685|MDMA|mdma
491551|NCT01465685|pharmacokinetics|pharmacokinetics
491552|NCT01465685|pharmacodynamics|pharmacodynamics
491553|NCT01465685|emotions|emotions
491554|NCT01465685|Mechanism of action of MDMA|mechanism of action of mdma
491555|NCT01465685|Interaction study|interaction study
491556|NCT01465685|Effect of MDMA and methylphenidate on emotions|effect of mdma and methylphenidate on emotions
491557|NCT01465672|copeptin|copeptin
491558|NCT01465672|SIADH|siadh
491559|NCT01465672|Diabetes insipidus|diabetes insipidus
491560|NCT01465672|transphenoidal pituitary adenoma resection|transphenoidal pituitary adenoma resection
491561|NCT01465672|pituitary adenoma|pituitary adenoma
491562|NCT01465672|tumors close to pituitary gland|tumors close to pituitary gland
491563|NCT01465672|tumors close to hypothalamus|tumors close to hypothalamus
491564|NCT01465646|levothyroxine|levothyroxine
491565|NCT01465646|bioavailability|bioavailability
491566|NCT01465633|bioavailability|bioavailability
491567|NCT01465633|levothyroxine|levothyroxine
491568|NCT01465620|Peripheral Nervous System Diseases|peripheral nervous system diseases
491569|NCT01465620|Diabetic Polyneuropathy|diabetic polyneuropathy
491570|NCT01465620|Metabolic Syndrome X|metabolic syndrome x
491571|NCT01465607|Condom use|condom use
491572|NCT01465594|Pain Measurement|pain measurement
491573|NCT01465581|incontinence|incontinence
491574|NCT01465581|dysfunctional voiding|dysfunctional voiding
491575|NCT01465581|neurogenic bladder disturbance|neurogenic bladder disturbance
491576|NCT01465581|filum terminale|filum terminale
491577|NCT01465581|spinal cord tethering|spinal cord tethering
491578|NCT01465581|conus|conus
491579|NCT01465568|osteoporosis|osteoporosis
491580|NCT01465568|denosumab|denosumab
491581|NCT01465568|RANKL|rankl
491582|NCT01465568|glucocorticoids|glucocorticoids
491583|NCT01465555|Clinical Alert|clinical alert
491584|NCT01465555|Cognitive Behavioral Intervention|cognitive behavioral intervention
491585|NCT01465555|Web-based|web-based
491586|NCT01465555|Substance Abuse Treatment|substance abuse treatment
491587|NCT01465542|Acetaminophen Toxicity|acetaminophen toxicity
491588|NCT01465542|Acetaminophen Overdose|acetaminophen overdose
491589|NCT01465542|N-acetylcysteine|n-acetylcysteine
491590|NCT01465542|Liver Toxicity|liver toxicity
491591|NCT01465503|bleeding|bleeding
491592|NCT01465503|percutaneous coronary intervention|percutaneous coronary intervention
491593|NCT01465503|heparin|heparin
491594|NCT01465503|bivalirudin|bivalirudin
491595|NCT01465490|Monitoring|monitoring
491596|NCT01465490|Feedback|feedback
491597|NCT01465490|Substance Abuse Treatment|substance abuse treatment
491598|NCT01465477|Fibromyalgia|fibromyalgia
491599|NCT01465477|Influenza vaccination|influenza vaccination
491600|NCT01465451|colorectal cancer|colorectal cancer
491601|NCT01465451|curative resection|curative resection
491602|NCT01465451|intra-operative chemotherapy|intra-operative chemotherapy
491603|NCT01465451|5-fluorouracil|5-fluorouracil
491604|NCT01465451|chemotherapy|chemotherapy
491605|NCT01465425|extracolonic findings|extracolonic findings
491606|NCT01465425|ECFs|ecfs
491607|NCT01465425|CT colonography|ct colonography
491608|NCT01465425|computed tomography colonography|computed tomography colonography
491609|NCT01465425|National CT Colonography Trial|national ct colonography trial
491610|NCT01465425|ACRIN 6664|acrin 6664
491611|NCT01465412|Parkinson disease|parkinson disease
491612|NCT01465373|In-Vitro Fertilization|in-vitro fertilization
491613|NCT01465373|Donor Egg IVF|donor egg ivf
491614|NCT01465360|Alzheimer's disease|alzheimer's disease
491615|NCT01465360|AD|ad
491616|NCT01465360|Non AD dementia|non ad dementia
491617|NCT01465360|Mild Cognitive Impairment|mild cognitive impairment
491618|NCT01465360|MCI|mci
491619|NCT01465360|Vascular dementia|vascular dementia
491620|NCT01465360|Fronto-temporal dementia|fronto-temporal dementia
491621|NCT01465360|Primary progressive aphasia|primary progressive aphasia
491622|NCT01465360|Parkinson's Disease dementia|parkinson's disease dementia
491623|NCT01465360|Mixed dementia|mixed dementia
491624|NCT01465360|Blood signature|blood signature
491625|NCT01465360|Diagnosis|diagnosis
491626|NCT01465360|AclarusDx|aclarusdx
491627|NCT01465360|Alzheimer's Disease and other non-AD dementia|alzheimer's disease and other non-ad dementia
491628|NCT01465360|Exonhit|exonhit
491629|NCT01465347|Primary brain tumor|primary brain tumor
491630|NCT01465347|Glioblastoma|glioblastoma
491631|NCT01465347|Glioma|glioma
491632|NCT01465347|GBM|gbm
491633|NCT01465347|Radiation therapy|radiation therapy
491634|NCT01465334|17p Deletion CLL|17p deletion cll
491635|NCT01465308|head and neck cancer|head and neck cancer
491636|NCT01465308|radiotherapy induced xerostomia|radiotherapy induced xerostomia
491637|NCT01465308|radiotherapy induced oral mucositis|radiotherapy induced oral mucositis
491638|NCT01465308|RCT|rct
491639|NCT01465308|symptom management|symptom management
491640|NCT01465295|Scoliosis|scoliosis
491641|NCT01465295|Adolescent Idiopathic Scoliosis (AIS)|adolescent idiopathic scoliosis (ais)
491642|NCT01465295|Scoliosis treatment|scoliosis treatment
491643|NCT01465295|Fusionless spinal surgery|fusionless spinal surgery
491644|NCT01465295|Vertebral stapling|vertebral stapling
491645|NCT01465295|Spinal stapling|spinal stapling
491646|NCT01465295|Non-fusion|non-fusion
491647|NCT01465295|Spinal curvature|spinal curvature
491648|NCT01465295|Curvature of the spine|curvature of the spine
491649|NCT01465295|Spinal bracing alternative|spinal bracing alternative
491650|NCT01465295|HemiBridge|hemibridge
491651|NCT01465295|SpineForm|spineform
491652|NCT01465295|Dr. Eric Wall|dr. eric wall
491653|NCT01465295|Dr. George Thompson|dr. george thompson
491654|NCT01465295|Spinal clip|spinal clip
491655|NCT01465295|Cincinnati Children's Hospital Medical Center|cincinnati children's hospital medical center
491656|NCT01465295|University Hospitals Case Medical Center, Rainbow Babies|university hospitals case medical center, rainbow babies
491657|NCT01465282|psoriasis vulgaris|psoriasis vulgaris
491658|NCT01465282|topical ointment|topical ointment
491659|NCT01465269|TBI|tbi
491660|NCT01465269|Social Competence|social competence
491661|NCT01465256|Aspirin|aspirin
491662|NCT01465256|Colon polypectomy|colon polypectomy
491665|NCT01465243|Safety|safety
491666|NCT01465243|EGFR-TKI|egfr-tki
491667|NCT01465243|phase IV|phase iv
491668|NCT01465243|NSCLC|nsclc
491669|NCT01465243|Dose escalation|dose escalation
491670|NCT01465230|chronic lymphocytic leukemia|chronic lymphocytic leukemia
491671|NCT01465230|maintenance therapy|maintenance therapy
491672|NCT01465217|medication adherence|medication adherence
491673|NCT01465217|African Americans|african americans
491674|NCT01465204|Behavior Change|behavior change
491675|NCT01465204|Hygiene & Sanitation Marketing|hygiene & sanitation marketing
491676|NCT01465191|cesarean|cesarean
491677|NCT01465191|postoperative|postoperative
491678|NCT01465191|morphine|morphine
491679|NCT01465191|genetics|genetics
491680|NCT01465191|opioid|opioid
491681|NCT01465178|hypovitaminosis D|hypovitaminosis d
491682|NCT01465178|vitamin D insufficiency|vitamin d insufficiency
491683|NCT01465178|low vitamin D|low vitamin d
491684|NCT01465165|Depression|depression
491685|NCT01465165|Positron emission tomography|positron emission tomography
491686|NCT01465165|Magnetic resonance spectroscopy|magnetic resonance spectroscopy
491687|NCT01465165|glucose metabolism|glucose metabolism
491688|NCT01465165|ATP|atp
491689|NCT01465165|phosphocreatine|phosphocreatine
491690|NCT01465113|Barrett's Esophagus|barrett's esophagus
491691|NCT01465113|Vitamin D3|vitamin d3
491692|NCT01465113|cholecalciferol|cholecalciferol
491693|NCT01465113|15-Prostaglandin Dehydrogenase Expression|15-prostaglandin dehydrogenase expression
491694|NCT01465113|metformin|metformin
491695|NCT01465100|phenylketonuria|phenylketonuria
491696|NCT01465100|hepatocyte|hepatocyte
491697|NCT01465087|Multiple Sclerosis|multiple sclerosis
491698|NCT01465087|Breath|breath
491699|NCT01465087|Diagnosis|diagnosis
491700|NCT01465087|Discrimination MS/healthy subj. via exhaled breath samples|discrimination ms/healthy subj. via exhaled breath samples
491701|NCT01465087|Discrimination MS/other neurological and autoimmune diseases|discrimination ms/other neurological and autoimmune diseases
491702|NCT01465074|nicotine|nicotine
491703|NCT01465074|memory|memory
491704|NCT01465074|plasticity|plasticity
491705|NCT01465074|TMS|tms
491706|NCT01465074|Paired Associative Stimulation|paired associative stimulation
491707|NCT01465061|Online social network|online social network
491708|NCT01465061|Psoriasis|psoriasis
491709|NCT01465061|Filipino|filipino
491710|NCT01465048|Malaria|malaria
491711|NCT01465048|Protozoan Infections|protozoan infections
491712|NCT01465048|Parasitic Diseases|parasitic diseases
491713|NCT01465048|Malaria Challenge|malaria challenge
491714|NCT01465022|Breastfeeding rates|breastfeeding rates
491715|NCT01465022|Contraceptive continuation|contraceptive continuation
491716|NCT01465022|Birth control pills|birth control pills
491717|NCT01465022|Lactation|lactation
491718|NCT01465009|Sore Throat|sore throat
491719|NCT01464996|non-carious cervical lesions|non-carious cervical lesions
491720|NCT01464996|bonded restorations|bonded restorations
491721|NCT01464996|composites|composites
491722|NCT01464996|adhesives|adhesives
491723|NCT01464970|DIEP perfusion|diep perfusion
491724|NCT01464970|Zone IV|zone iv
491725|NCT01464970|Free Flap|free flap
491726|NCT01464970|Breast Cancer Reconstruction|breast cancer reconstruction
491727|NCT01464970|Perfusion of Zone IV of DIEP flaps|perfusion of zone iv of diep flaps
491728|NCT01464957|skin cancer prevention|skin cancer prevention
491729|NCT01464957|precaution adoption process model|precaution adoption process model
491730|NCT01464957|semi-tailored newsletter|semi-tailored newsletter
491731|NCT01464957|pediatric|pediatric
491732|NCT01464957|behavioral intervention|behavioral intervention
491733|NCT01464944|Upper Respiratory Tract Infections|upper respiratory tract infections
491734|NCT01464918|gastric cancer|gastric cancer
491735|NCT01464918|colon cancer|colon cancer
626594|NCT00915252|AML|aml
491736|NCT01464918|endoscopic submucosal dissection|endoscopic submucosal dissection
491737|NCT01464905|RRMS|rrms
491738|NCT01464892|Imagery rescripting|imagery rescripting
491739|NCT01464892|Imagery rescripting and reprocessing therapy|imagery rescripting and reprocessing therapy
491740|NCT01464892|Skills Training in affective and interpersonal regulation|skills training in affective and interpersonal regulation
491741|NCT01464892|Post-traumatic Stress Disorder|post-traumatic stress disorder
491742|NCT01464892|Childhood abuse|childhood abuse
491743|NCT01464892|Childhood sexual abuse|childhood sexual abuse
491744|NCT01464840|Pregnancy|pregnancy
491745|NCT01464840|Cesarean section|cesarean section
491746|NCT01464840|Antibiotic|antibiotic
491747|NCT01464827|Hepatitis C Genotype 1|hepatitis c genotype 1
491748|NCT01464827|Hepatitis C|hepatitis c
491749|NCT01464827|Interferon-Free|interferon-free
491750|NCT01464827|HCV|hcv
491751|NCT01464827|Chronic Hepatitis C|chronic hepatitis c
491752|NCT01464814|probiotic|probiotic
491753|NCT01464814|fish oil|fish oil
491754|NCT01464814|digestion|digestion
491755|NCT01464814|viability|viability
491756|NCT01464801|Non-alcoholic Fatty Liver Disease|non-alcoholic fatty liver disease
491757|NCT01464801|Non-alcoholic Steatohepatitis|non-alcoholic steatohepatitis
491758|NCT01464801|Resveratrol|resveratrol
491759|NCT01464801|Human study|human study
491760|NCT01464788|stroke|stroke
491761|NCT01464788|Argatroban|argatroban
491762|NCT01464788|thrombin-inhibition|thrombin-inhibition
491763|NCT01464788|thrombolysis|thrombolysis
491764|NCT01464788|anticoagulation|anticoagulation
491765|NCT01464775|Endometriosis|endometriosis
491766|NCT01464775|Laparoscopy|laparoscopy
491767|NCT01464775|Narrow Band Imaging|narrow band imaging
491768|NCT01464762|Tuberculosis|tuberculosis
491769|NCT01464762|TMC207TBC3001|tmc207tbc3001
491770|NCT01464762|TMC207|tmc207
491771|NCT01464762|Early access|early access
491772|NCT01464762|TB|tb
491773|NCT01464762|Drug resistant|drug resistant
491774|NCT01464762|Multi drug-resistant|multi drug-resistant
491775|NCT01464762|Extensively drug-resistant|extensively drug-resistant
491776|NCT01464749|multiple sclerosis|multiple sclerosis
491777|NCT01464749|gait rehabilitation|gait rehabilitation
491778|NCT01464736|aerobic exercise|aerobic exercise
491779|NCT01464736|noninvasive ventilation|noninvasive ventilation
491780|NCT01464736|functionality|functionality
491781|NCT01464697|hot flushes/hot flashes|hot flushes/hot flashes
491782|NCT01464697|night sweats|night sweats
491783|NCT01464697|sleep problems|sleep problems
491784|NCT01464697|negative mood|negative mood
491785|NCT01464697|anxiety|anxiety
491786|NCT01464697|perimenopause|perimenopause
491787|NCT01464697|progesterone|progesterone
491788|NCT01464697|vasomotor symptoms|vasomotor symptoms
491789|NCT01464697|premenopause|premenopause
491790|NCT01464671|Coronary Artery Disease|coronary artery disease
491791|NCT01464671|Stable Angina|stable angina
491792|NCT01464671|Percutaneous Coronary Intervention|percutaneous coronary intervention
491793|NCT01464658|panniculitis|panniculitis
491794|NCT01464658|panniculectomy|panniculectomy
491795|NCT01464632|medial knee replacement|medial knee replacement
491796|NCT01464619|Parenting|parenting
491797|NCT01464619|Early Child Development|early child development
491798|NCT01464606|pleuropulmonary blastoma|pleuropulmonary blastoma
491799|NCT01464606|pediatric|pediatric
491800|NCT01464606|lung cysts|lung cysts
491801|NCT01464593|Colorectal Liver Metastasis|colorectal liver metastasis
491802|NCT01464593|Colon Cancer|colon cancer
491803|NCT01464593|Liver Cancer|liver cancer
491804|NCT01464593|Liver Metastasis|liver metastasis
491805|NCT01464593|Liver metastases|liver metastases
491806|NCT01464567|Weaning|weaning
491807|NCT01464567|Chronic Obstructive Pulmonary Disease|chronic obstructive pulmonary disease
491808|NCT01464567|Spontaneous Breathing Trial|spontaneous breathing trial
491809|NCT01464554|adolescents|adolescents
491810|NCT01464554|alcohol|alcohol
491811|NCT01464554|drugs|drugs
491812|NCT01464554|delinquency|delinquency
491813|NCT01464554|intervention|intervention
491814|NCT01464541|Orbit|orbit
491815|NCT01464541|Fracture|fracture
491816|NCT01464541|measurement|measurement
491817|NCT01464541|CT|ct
491818|NCT01464541|intraoperative|intraoperative
491819|NCT01464528|hysteroscopy|hysteroscopy
491820|NCT01464528|postoperative complications|postoperative complications
491821|NCT01464528|adhesions|adhesions
491822|NCT01464528|hyaluronic gel|hyaluronic gel
491823|NCT01464528|prevention|prevention
491824|NCT01464515|Mild Cognitive Impairment, So Stated|mild cognitive impairment, so stated
491825|NCT01464515|Deep Transcranial Magnetic Stimulation|deep transcranial magnetic stimulation
491826|NCT01464502|Heart failure|heart failure
491827|NCT01464502|Cardiac resynchronisation therapy|cardiac resynchronisation therapy
491828|NCT01464502|Acute haemodynamic response|acute haemodynamic response
491829|NCT01464502|Responder|responder
491830|NCT01464489|Intubation time|intubation time
491831|NCT01464489|Atropine|atropine
491832|NCT01464489|Propofol anesthesia|propofol anesthesia
491833|NCT01464463|Depression|depression
626690|NCT00914901|Asthma|asthma
491834|NCT01464463|Exercise|exercise
491835|NCT01464463|Psychoneuroimmunology|psychoneuroimmunology
491836|NCT01464463|Cognitive Behavioral Therapy|cognitive behavioral therapy
491837|NCT01464463|CBASP|cbasp
491838|NCT01464450|Pharmacokinetics|pharmacokinetics
491839|NCT01464450|Bioavailability|bioavailability
491840|NCT01464450|Healthy Participants|healthy participants
491841|NCT01464437|diabetes|diabetes
491842|NCT01464437|mellitus|mellitus
491843|NCT01464437|metformin|metformin
491844|NCT01464424|Glaucoma|glaucoma
491845|NCT01464424|Ocular Hypertension|ocular hypertension
491846|NCT01464424|Open-Angle Glaucoma|open-angle glaucoma
491847|NCT01464424|Intraocular Pressure|intraocular pressure
491848|NCT01464411|chronic myelogenous leukemia|chronic myelogenous leukemia
491849|NCT01464411|chronic phase|chronic phase
491850|NCT01464411|Phase II|phase ii
491851|NCT01464411|dasatinib|dasatinib
491852|NCT01464398|Polycystic Ovary Syndrome|polycystic ovary syndrome
491853|NCT01464398|stress|stress
491854|NCT01464398|mindfulness|mindfulness
491855|NCT01464398|meditation|meditation
491856|NCT01464398|health education|health education
491857|NCT01464398|women|women
491858|NCT01464398|overweight|overweight
491859|NCT01464398|obesity|obesity
491860|NCT01464372|Urinary Incontinence, Urge|urinary incontinence, urge
491861|NCT01464372|Peripheral Nerve Stimulation|peripheral nerve stimulation
491862|NCT01464359|umbilical cord blood transplant|umbilical cord blood transplant
491863|NCT01464346|diabetes|diabetes
491864|NCT01464346|glucose sensor|glucose sensor
491866|NCT01464333|Crohn's Disease|crohn's disease
491867|NCT01464320|Safety|safety
491868|NCT01464320|Type 2 diabetes|type 2 diabetes
491869|NCT01464320|Kidney disease|kidney disease
491870|NCT01464294|CAD/CAM|cad/cam
491871|NCT01464294|crowns|crowns
491872|NCT01464294|onlays|onlays
491873|NCT01464294|composite block|composite block
491874|NCT01464294|milled restorations|milled restorations
491875|NCT01464281|nucleoside|nucleoside
491876|NCT01464281|peginterferon alfa-2a|peginterferon alfa-2a
491877|NCT01464268|Keratoconus|keratoconus
491878|NCT01464268|Corneal Ectasia|corneal ectasia
491879|NCT01464268|Collagen Crosslinking|collagen crosslinking
491880|NCT01464268|Riboflavin|riboflavin
491881|NCT01464255|contact lenses|contact lenses
491882|NCT01464242|Cutaneous Leishmaniasis|cutaneous leishmaniasis
491883|NCT01464242|pentoxifylline|pentoxifylline
491884|NCT01464242|immunomodulation|immunomodulation
491885|NCT01464216|Functional Magnetic Resonance Imaging|functional magnetic resonance imaging
491886|NCT01464216|Prostate cancer|prostate cancer
491887|NCT01464216|FACBC PET|facbc pet
491888|NCT01464216|Hypoxia imaging|hypoxia imaging
491889|NCT01464203|Computed tomographic coronary angiography|computed tomographic coronary angiography
491890|NCT01464203|multi-slice CT|multi-slice ct
491891|NCT01464203|angina|angina
491892|NCT01464203|cost-effectiveness|cost-effectiveness
491893|NCT01464190|PA21|pa21
491894|NCT01464190|Phosphate Binder|phosphate binder
491895|NCT01464177|malignant glioma|malignant glioma
491896|NCT01464177|glioblastoma|glioblastoma
491897|NCT01464177|radiotherapy|radiotherapy
491898|NCT01464177|randomized|randomized
491899|NCT01464164|Diamond Blackfan anemia|diamond blackfan anemia
491900|NCT01464164|DBA|dba
491901|NCT01464164|Blackfan Diamond anemia|blackfan diamond anemia
491902|NCT01464164|Congenital pure red cell aplasia|congenital pure red cell aplasia
491903|NCT01464164|Aase-Smith II Syndrome|aase-smith ii syndrome
491904|NCT01464164|Aase Syndrome|aase syndrome
491905|NCT01464164|Anemia, Congenital Pure Red Cell|anemia, congenital pure red cell
491906|NCT01464164|Aplasia, Congenital Pure Red Cell|aplasia, congenital pure red cell
491907|NCT01464164|BDA|bda
491908|NCT01464164|Congenital Hypoplastic Anemia|congenital hypoplastic anemia
491909|NCT01464164|Erythrogenesis Imperfecta|erythrogenesis imperfecta
491910|NCT01464164|Hypoplastic Congenital Anemia|hypoplastic congenital anemia
491911|NCT01464164|Inherited Erythroblastopenia|inherited erythroblastopenia
491912|NCT01464164|pure red cell aplasia|pure red cell aplasia
491913|NCT01464164|bone marrow failure syndrome|bone marrow failure syndrome
491914|NCT01464151|IBD|ibd
491915|NCT01464151|colitis|colitis
491916|NCT01464151|dysplasia|dysplasia
491917|NCT01464151|colorectal cancer|colorectal cancer
491918|NCT01464138|Malaria|malaria
491919|NCT01464125|Malaria|malaria
491920|NCT01464125|Plasmodium falciparum|plasmodium falciparum
491921|NCT01464125|acute uncomplicated|acute uncomplicated
491922|NCT01464112|Multiple myeloma that has relapsed or is progressive following prior therapy|multiple myeloma that has relapsed or is progressive following prior therapy
491923|NCT01464112|Relapsed Multiple Myeloma|relapsed multiple myeloma
491924|NCT01464112|JNJ 26481585|jnj 26481585
491925|NCT01464112|VELCADE|velcade
491926|NCT01464112|Bortezomib|bortezomib
491927|NCT01464112|Dexamethasone|dexamethasone
491928|NCT01464086|patients with Li Fraumeni syndrome|patients with li fraumeni syndrome
491929|NCT01464073|NIDDM|niddm
491930|NCT01464073|obesity|obesity
491931|NCT01464073|lifestyle intervention|lifestyle intervention
491932|NCT01464073|physical exercise|physical exercise
491933|NCT01464073|diet|diet
491934|NCT01464073|LIPOXmax|lipoxmax
491935|NCT01464073|FATmax|fatmax
491936|NCT01464073|fat oxydation rate|fat oxydation rate
491937|NCT01464060|Helicobacter pylori|helicobacter pylori
491938|NCT01464060|Quadruple therapy|quadruple therapy
491939|NCT01464060|Clarithromycin resistance|clarithromycin resistance
491940|NCT01464021|Study|study
491941|NCT01464021|prospective|prospective
491942|NCT01464021|Rheumatoid|rheumatoid
491943|NCT01464021|Observational study|observational study
491944|NCT01464021|Arthritis|arthritis
491945|NCT01464021|Adalimumab|adalimumab
491946|NCT01463995|severe neurological diseases|severe neurological diseases
491947|NCT01463995|neurological intensive care unit|neurological intensive care unit
491948|NCT01463995|prediction|prediction
491949|NCT01463995|long-term outcome|long-term outcome
491950|NCT01463995|biomarkers|biomarkers
491951|NCT01463995|prediction of long-term outcome|prediction of long-term outcome
491952|NCT01463982|Advanced solid cancer|advanced solid cancer
491953|NCT01463969|PCOS and PTX3 levels|pcos and ptx3 levels
491954|NCT01463956|Boceprevir|boceprevir
491955|NCT01463956|HCV infection|hcv infection
491956|NCT01463956|Antiviral therapy|antiviral therapy
491957|NCT01463956|Liver transplantation|liver transplantation
491958|NCT01463930|Total Knee Replacement|total knee replacement
491959|NCT01463930|Expectations|expectations
491960|NCT01463930|Audiovisual videodisc|audiovisual videodisc
491961|NCT01463917|Coronary Artery Bypass|coronary artery bypass
491962|NCT01463917|Off-Pump|off-pump
491963|NCT01463917|Saline Solution|saline solution
491964|NCT01463917|Hypertonic|hypertonic
491965|NCT01463904|Morbid obesity|morbid obesity
491966|NCT01463904|duodenal switch|duodenal switch
491967|NCT01463904|diabetes|diabetes
491968|NCT01463904|decrease in cardiac risk|decrease in cardiac risk
491969|NCT01463904|remission of T2DM|remission of t2dm
491970|NCT01463891|Eribulin Mesylate|eribulin mesylate
491971|NCT01463891|inoperable or recurrent breast cancer|inoperable or recurrent breast cancer
491972|NCT01463878|glycemic control|glycemic control
491973|NCT01463878|glycemic variability|glycemic variability
491974|NCT01463878|mean blood glucose level|mean blood glucose level
491975|NCT01463852|vincristine|vincristine
491976|NCT01463852|JNK|jnk
491977|NCT01463852|phosphorylation|phosphorylation
491978|NCT01463852|cll|cll
491979|NCT01463852|vinca alkaloid|vinca alkaloid
491980|NCT01463852|apoptosis|apoptosis
491981|NCT01463839|sleep disorder|sleep disorder
491982|NCT01463839|malocclusion|malocclusion
491983|NCT01463839|children|children
491984|NCT01463826|bruxism|bruxism
491985|NCT01463826|children|children
491986|NCT01463826|oral breathing|oral breathing
491987|NCT01463826|dental caries|dental caries
491988|NCT01463813|bone density conservation agents|bone density conservation agents
491989|NCT01463813|cancer|cancer
491990|NCT01463813|cardiovascular disease|cardiovascular disease
491991|NCT01463813|cholecalciferol|cholecalciferol
491992|NCT01463813|diabetes mellitus, type 2|diabetes mellitus, type 2
491993|NCT01463813|dietary supplements|dietary supplements
491994|NCT01463813|primary prevention|primary prevention
491995|NCT01463813|vitamin D|vitamin d
491996|NCT01463800|Heart Defects, congenital|heart defects, congenital
491997|NCT01463787|Infertility|infertility
491998|NCT01463787|varicocelectomy|varicocelectomy
491999|NCT01463787|microsurgery|microsurgery
492000|NCT01463787|Chinese men|chinese men
492001|NCT01463787|pregnancy rate|pregnancy rate
492002|NCT01463774|Healthy Volunteers|healthy volunteers
492003|NCT01463774|Bioequivalence|bioequivalence
492004|NCT01463774|Canagliflozin (JNJ-28431754)|canagliflozin (jnj-28431754)
492005|NCT01463774|Metformin|metformin
492006|NCT01463761|High-level athlete|high-level athlete
492007|NCT01463761|ANS activity|ans activity
492008|NCT01463761|Overtraining|overtraining
492009|NCT01463735|Cirrhotic patients|cirrhotic patients
492010|NCT01463722|Respiratory distress syndrome|respiratory distress syndrome
492011|NCT01463722|Lung maturity|lung maturity
492012|NCT01463722|lamellar body|lamellar body
492013|NCT01463709|basal cell carcinoma|basal cell carcinoma
492014|NCT01463709|Basal Cell Nevus Syndrome|basal cell nevus syndrome
492015|NCT01463709|Electric Field|electric field
492016|NCT01463709|Nanosecond pulse|nanosecond pulse
492017|NCT01463670|LENALIDOMIDE (CC-5013)|lenalidomide (cc-5013)
492018|NCT01463670|BONE MARROW|bone marrow
492019|NCT01463670|11-107|11-107
492020|NCT01463657|Aging|aging
492021|NCT01463644|Mepolizumab|mepolizumab
492022|NCT01463644|COPD|copd
492023|NCT01463644|eosinophilic bronchitis|eosinophilic bronchitis
492024|NCT01463644|exacerbation|exacerbation
492025|NCT01463644|anti-interleukin 5 (IL5)|anti-interleukin 5 (il5)
492026|NCT01463605|radiotherapy|radiotherapy
492027|NCT01463605|targeted therapy|targeted therapy
492028|NCT01463605|esophageal cancer|esophageal cancer
492029|NCT01463605|older|older
492030|NCT01463592|Renessans|renessans
492031|NCT01463592|HCV|hcv
492032|NCT01463579|Intensive Care Unit|intensive care unit
626923|NCT00913861|comfort|comfort
492033|NCT01463579|Critical Illness|critical illness
492034|NCT01463579|Rehabilitation|rehabilitation
492035|NCT01463579|Exercise Programme|exercise programme
492036|NCT01463566|arthritis|arthritis
492037|NCT01463553|primary spontaneous pneumothorax|primary spontaneous pneumothorax
492038|NCT01463553|VATS|vats
492039|NCT01463553|pleurodesis|pleurodesis
492040|NCT01463553|recurrence rate|recurrence rate
492041|NCT01463540|Enteral nutrition|enteral nutrition
492042|NCT01463540|Gastrostomy, adverse effects|gastrostomy, adverse effects
492043|NCT01463540|Gastrostomy, nursing|gastrostomy, nursing
492044|NCT01463540|Endoscopy,gastrointestinal|endoscopy,gastrointestinal
492045|NCT01463540|Surgical wound infection|surgical wound infection
492046|NCT01463527|Hypoventilation during sedation|hypoventilation during sedation
492047|NCT01463527|Hypoxia associated with hypoventilation|hypoxia associated with hypoventilation
492048|NCT01463514|Pulmonary Hypertension,|pulmonary hypertension,
492049|NCT01463514|NIRS,|nirs,
492050|NCT01463514|Near-infrared spectroscopy,|near-infrared spectroscopy,
492051|NCT01463514|cerebral tissue oxygenation,|cerebral tissue oxygenation,
492052|NCT01463514|cerebral blood flow|cerebral blood flow
492053|NCT01463501|Esophageal cancer|esophageal cancer
492054|NCT01463501|Resectable|resectable
492055|NCT01463501|Neoadjuvant chemoradiotherapy|neoadjuvant chemoradiotherapy
492056|NCT01463501|Adjuvant chemoradiotherapy|adjuvant chemoradiotherapy
492057|NCT01463475|MSC|msc
492058|NCT01463475|Allogeneic|allogeneic
492059|NCT01463475|Bone marrow cells|bone marrow cells
492060|NCT01463475|Healthy subject donors|healthy subject donors
492061|NCT01463475|Collection of MSC from bone marrow aspirate|collection of msc from bone marrow aspirate
492062|NCT01463475|Bronchiolitis obliterans syndrome (BOS)|bronchiolitis obliterans syndrome (bos)
492063|NCT01463449|Obesity|obesity
492064|NCT01463449|Soluble-CD163|soluble-cd163
492065|NCT01463449|Macrophage|macrophage
492066|NCT01463449|Inflammation|inflammation
492067|NCT01463436|endothelial function|endothelial function
492068|NCT01463436|postmenopausal|postmenopausal
492069|NCT01463436|soy isoflavone supplementation|soy isoflavone supplementation
492070|NCT01463436|osteoporosis|osteoporosis
492071|NCT01463384|Magnetic Resonance Imaging|magnetic resonance imaging
492072|NCT01463384|Magnetic Resonance Spectroscopy|magnetic resonance spectroscopy
492073|NCT01463384|Neuroinflammation|neuroinflammation
492074|NCT01463384|Mild Cognitive Impairment|mild cognitive impairment
492075|NCT01463384|Alzheimer's Disease|alzheimer's disease
492076|NCT01463384|Minocycline|minocycline
492077|NCT01463371|Bronchiectasis|bronchiectasis
492078|NCT01463371|Oxidative stress markers|oxidative stress markers
492079|NCT01463371|Airway inflammation|airway inflammation
492080|NCT01463358|Syncope|syncope
492081|NCT01463358|Bifascicular block|bifascicular block
492082|NCT01463358|Bradycardia pacing|bradycardia pacing
492083|NCT01463345|Blood conservation|blood conservation
492084|NCT01463345|Transfusion|transfusion
492085|NCT01463345|Hemoglobin trigger|hemoglobin trigger
492086|NCT01463345|Transfusion trigger|transfusion trigger
492087|NCT01463345|Cardiac surgery|cardiac surgery
492088|NCT01463345|Transfusion triggers post cardiac surgery|transfusion triggers post cardiac surgery
492089|NCT01463332|Propofol|propofol
492090|NCT01463332|Pain|pain
492091|NCT01463332|Dexmedetomidine|dexmedetomidine
492092|NCT01463319|colonoscopy|colonoscopy
492093|NCT01463319|warm water method|warm water method
492094|NCT01463319|hydrocolonoscopy|hydrocolonoscopy
492095|NCT01463319|unsedated colonoscopy|unsedated colonoscopy
492096|NCT01463306|safety|safety
492097|NCT01463306|partial onset seizures|partial onset seizures
492098|NCT01463306|primary generalized tonic-clonic seizures|primary generalized tonic-clonic seizures
492099|NCT01463306|pregabalin|pregabalin
492100|NCT01463306|pediatric|pediatric
492101|NCT01463306|adult|adult
492102|NCT01463306|open-label|open-label
492103|NCT01463306|long term|long term
492104|NCT01463293|constipation|constipation
492105|NCT01463293|probiotic|probiotic
492106|NCT01463293|functional constipation|functional constipation
492107|NCT01463293|IBS-C|ibs-c
492108|NCT01463280|Platelets|platelets
492109|NCT01463280|Inhibition|inhibition
492110|NCT01463280|Lidocaine|lidocaine
492111|NCT01463280|Thromboembolism|thromboembolism
492112|NCT01463280|Prevention|prevention
492113|NCT01463280|Lidocaine effects on platelets|lidocaine effects on platelets
492114|NCT01463267|Heart Failure|heart failure
492115|NCT01463254|Femplant|femplant
492116|NCT01463254|AE adverse event|ae adverse event
492117|NCT01463254|AIDS acquired immunodeficiency syndrome|aids acquired immunodeficiency syndrome
492118|NCT01463254|ALT (SGPT) alanine aminotransferase|alt (sgpt) alanine aminotransferase
492119|NCT01463254|ART antiretroviral therapy|art antiretroviral therapy
492120|NCT01463254|AST (SGOT) aspartate aminotransferase|ast (sgot) aspartate aminotransferase
492121|NCT01463254|DCF data collection forms|dcf data collection forms
492122|NCT01463254|DMC Data Monitoring Committee|dmc data monitoring committee
492123|NCT01463254|FDA (U.S.) Food and Drug Administration|fda (u.s.) food and drug administration
710743|NCT00588120|High Oxalate|high oxalate
492124|NCT01463254|GCP Good Clinical Practice guidelines|gcp good clinical practice guidelines
492125|NCT01463254|HB sAg Hepatitis B surface antigen|hb sag hepatitis b surface antigen
492126|NCT01463254|ICH International Conference of Harmonisation|ich international conference of harmonisation
492127|NCT01463254|IND Investigational New Drug Application|ind investigational new drug application
492128|NCT01463254|IRB Institutional Review Board|irb institutional review board
492129|NCT01463254|IU international units|iu international units
492130|NCT01463254|mg milligram(s)|mg milligram(s)
492131|NCT01463254|mm3 cubic millimeter(s)|mm3 cubic millimeter(s)
492132|NCT01463254|PCR polymerase chain reaction|pcr polymerase chain reaction
492133|NCT01463254|SAE serious adverse event|sae serious adverse event
492134|NCT01463254|µg microgram|µg microgram
492135|NCT01463254|ULN upper limit of the normal range|uln upper limit of the normal range
492136|NCT01463254|WB Western Blot|wb western blot
492137|NCT01463228|Healthy Volunteers|healthy volunteers
492138|NCT01463228|Bioequivalence|bioequivalence
492139|NCT01463228|Canagliflozin (JNJ-28431754)|canagliflozin (jnj-28431754)
492140|NCT01463228|Metformin IR|metformin ir
492141|NCT01463215|Ambroxol|ambroxol
492142|NCT01463215|Type I Gaucher Disease|type i gaucher disease
492143|NCT01463202|Postpartum contraception|postpartum contraception
492144|NCT01463202|Contraceptive continuation|contraceptive continuation
492145|NCT01463202|Breastfeeding|breastfeeding
492146|NCT01463202|Postpartum depression|postpartum depression
492147|NCT01463202|Progestins|progestins
492148|NCT01463189|arthritis|arthritis
492149|NCT01463189|self management|self management
492150|NCT01463176|Music Therapy|music therapy
492151|NCT01463176|Child Psychology|child psychology
492152|NCT01463176|Vaccination|vaccination
492153|NCT01463163|Platelet reactivity|platelet reactivity
492154|NCT01463163|Ticagrelor|ticagrelor
492155|NCT01463163|Prasugrel|prasugrel
492156|NCT01463150|Platelet reactivity|platelet reactivity
492157|NCT01463150|Clopidogrel|clopidogrel
492158|NCT01463150|Prasugrel|prasugrel
492159|NCT01463137|social phobia|social phobia
492160|NCT01463137|anxiety|anxiety
492161|NCT01463124|School Nurse|school nurse
492162|NCT01463124|Overweight|overweight
492163|NCT01463124|Obesity|obesity
492164|NCT01463124|Counseling|counseling
492165|NCT01463124|Intervention|intervention
492166|NCT01463124|Exercise|exercise
492167|NCT01463111|Bipolar|bipolar
492168|NCT01463111|Manic depression|manic depression
492169|NCT01463111|Mood stabilizer|mood stabilizer
492170|NCT01463111|Decision|decision
492171|NCT01463111|Neuroeconomics|neuroeconomics
492172|NCT01463059|Rheumatoid Arthritis|rheumatoid arthritis
492173|NCT01463059|Monoclonal Antibody|monoclonal antibody
492174|NCT01463059|Interleukin-6|interleukin-6
492175|NCT01463059|Olokizumab|olokizumab
492176|NCT01463059|CDP6038|cdp6038
492177|NCT01463046|leukemia|leukemia
492179|NCT01463046|AMS|ams
492180|NCT01463046|panobinostat|panobinostat
492181|NCT01463046|cytarabine|cytarabine
492182|NCT01463046|daunorubicin|daunorubicin
492183|NCT01463046|HDAC|hdac
492184|NCT01463033|Post-Traumatic epilepsy|post-traumatic epilepsy
492185|NCT01463033|Traumatic brain injury|traumatic brain injury
492186|NCT01463033|Epilepsy prevention|epilepsy prevention
492187|NCT01463033|Levetiracetam|levetiracetam
492188|NCT01463020|Depression|depression
492189|NCT01463020|Smartphone|smartphone
492190|NCT01463020|Behavioural activation|behavioural activation
492191|NCT01463020|Mindfulness|mindfulness
492192|NCT01463007|invasive ductal cancer|invasive ductal cancer
492193|NCT01463007|tubular breast cancer|tubular breast cancer
492194|NCT01463007|breast cancer|breast cancer
492195|NCT01463007|colloid|colloid
492196|NCT01463007|ER positive|er positive
492197|NCT01463007|radiation|radiation
492198|NCT01462994|Patients with GIST treated with standard therapy harboring activating mutations of CKIT and PDGFRA|patients with gist treated with standard therapy harboring activating mutations of ckit and pdgfra
492199|NCT01462968|Heparin treatment during cardiac surgery|heparin treatment during cardiac surgery
492200|NCT01462968|Heparin reversal after cardiac surgery|heparin reversal after cardiac surgery
492201|NCT01462968|Thrombin generation|thrombin generation
492202|NCT01462968|Endogenous Thrombin potential|endogenous thrombin potential
492203|NCT01462942|COPD|copd
492204|NCT01462942|Bronchitis|bronchitis
492205|NCT01462942|Chronic|chronic
492206|NCT01462942|Emphysema|emphysema
492207|NCT01462929|COPD|copd
492208|NCT01462929|antimuscarinic|antimuscarinic
492209|NCT01462916|honey|honey
492210|NCT01462916|mucositis|mucositis
492211|NCT01462916|bee products|bee products
492213|NCT01462903|NPC|npc
492214|NCT01462903|hepatocellular carcinoma|hepatocellular carcinoma
492215|NCT01462903|immunotherapy|immunotherapy
492216|NCT01462890|Ovarian Carcinoma|ovarian carcinoma
492217|NCT01462890|Bevacizumab|bevacizumab
492218|NCT01462890|Paclitaxel|paclitaxel
492219|NCT01462890|Carboplatin|carboplatin
492220|NCT01462877|Lipid Regulating Agents|lipid regulating agents
492221|NCT01462877|Drug Therapy|drug therapy
492222|NCT01462877|cardiovascular diseases|cardiovascular diseases
710744|NCT00588120|Oxalate|oxalate
492223|NCT01462877|hypertriglyceridemia|hypertriglyceridemia
492224|NCT01462877|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors
492225|NCT01462877|fenofibrate|fenofibrate
492226|NCT01462877|Dyslipidemias|dyslipidemias
492227|NCT01462877|Combination|combination
492228|NCT01462864|Polycystic Ovary Syndrome|polycystic ovary syndrome
492229|NCT01462864|Lifestyle|lifestyle
492230|NCT01462864|Structured Education|structured education
492231|NCT01462864|Walking Activity|walking activity
492232|NCT01462864|Exercise|exercise
492233|NCT01462864|Overweight|overweight
492234|NCT01462864|Impaired Glucose Regulation|impaired glucose regulation
492235|NCT01462864|Diabetes Prevention|diabetes prevention
492236|NCT01462851|healthy volunteer|healthy volunteer
492237|NCT01462851|safety|safety
492238|NCT01462851|pharmacokinetic|pharmacokinetic
492239|NCT01462851|pharmacodynamic|pharmacodynamic
492240|NCT01462838|advanced HPV-|advanced hpv-
492241|NCT01462838|p16INK4a-positive|p16ink4a-positive
492242|NCT01462838|cervical|cervical
492243|NCT01462838|vulvar,|vulvar,
492244|NCT01462838|vaginal|vaginal
492245|NCT01462838|penile|penile
492246|NCT01462838|anal|anal
492247|NCT01462838|head|head
492248|NCT01462838|neck|neck
492249|NCT01462825|Inflammation|inflammation
492250|NCT01462825|cytokines|cytokines
492251|NCT01462825|chemotaxis|chemotaxis
492252|NCT01462825|tomatoes|tomatoes
492253|NCT01462825|cardiovascular disease|cardiovascular disease
492254|NCT01462812|Migraine|migraine
492255|NCT01462812|Headache|headache
492256|NCT01462812|Sumatriptan|sumatriptan
492257|NCT01462799|PBL|pbl
492258|NCT01462799|patient education|patient education
492259|NCT01462799|coronary heart disease|coronary heart disease
492260|NCT01462799|empowerment|empowerment
492261|NCT01462799|self-efficacy|self-efficacy
492262|NCT01462799|self-care|self-care
492359|NCT01462331|Short chain fatty acids|short chain fatty acids
492360|NCT01462331|Blood glucose|blood glucose
492664|NCT01460953|training|training
492263|NCT01462799|Focus on to determine the long term effectiveness of PBL in patient education by comparison of standardized homesent information in patients with CHD.|focus on to determine the long term effectiveness of pbl in patient education by comparison of standardized homesent information in patients with chd.
492264|NCT01462799|Further focus is on patients' self-care goals, beliefs, self-efficacy and empowerment to make lifestyle changes.|further focus is on patients' self-care goals, beliefs, self-efficacy and empowerment to make lifestyle changes.
492265|NCT01462773|malignant|malignant
492266|NCT01462773|melanoma|melanoma
492267|NCT01462708|Parkinson Disease|parkinson disease
492268|NCT01462708|Molecular NeuroImaging|molecular neuroimaging
492269|NCT01462682|focus group study|focus group study
492270|NCT01462682|sleep deprivation|sleep deprivation
492271|NCT01462682|surgery|surgery
492272|NCT01462669|Ezogabine|ezogabine
492273|NCT01462669|Pharmacokinetics|pharmacokinetics
492274|NCT01462669|Retigabine|retigabine
492275|NCT01462656|anti-epileptic drug|anti-epileptic drug
492276|NCT01462656|ezogabine|ezogabine
492277|NCT01462656|AED polytherapy|aed polytherapy
492278|NCT01462656|epilepsy|epilepsy
492279|NCT01462656|AED monotherapy|aed monotherapy
492280|NCT01462656|retigabine|retigabine
492281|NCT01462656|urinary retention|urinary retention
492282|NCT01462643|Psoriasis Plaque Test|psoriasis plaque test
492283|NCT01462643|topical|topical
492284|NCT01462643|ointment|ointment
492285|NCT01462591|wave reflection|wave reflection
492286|NCT01462591|augmentation Index|augmentation index
492287|NCT01462591|heart rate variability|heart rate variability
492288|NCT01462591|wasted left ventricular energy|wasted left ventricular energy
492289|NCT01462578|Neoplasms benign, malignant and unspecified|neoplasms benign, malignant and unspecified
492290|NCT01462578|Acute myeloid leukemia|acute myeloid leukemia
492291|NCT01462578|AML|aml
492292|NCT01462578|Myelodysplastic syndrome|myelodysplastic syndrome
492293|NCT01462578|MDS|mds
492294|NCT01462565|flolan|flolan
492295|NCT01462565|pulmonary arterial hypertension|pulmonary arterial hypertension
492296|NCT01462565|thermo stable formulation|thermo stable formulation
492297|NCT01462565|epoprostenol sodium|epoprostenol sodium
492298|NCT01462565|modified sterile diluent|modified sterile diluent
492299|NCT01462552|liver function testing|liver function testing
492300|NCT01462552|Breast cancer|breast cancer
492301|NCT01462552|lapatanib|lapatanib
492302|NCT01462513|Colon carcinoma|colon carcinoma
492303|NCT01462513|Rectum carcinoma|rectum carcinoma
492304|NCT01462513|Liver metastases|liver metastases
492305|NCT01462500|Miltefosine|miltefosine
492306|NCT01462500|pharmacokinetics|pharmacokinetics
492307|NCT01462500|cutaneous leishmaniasis|cutaneous leishmaniasis
492308|NCT01462487|Pregnancy safety|pregnancy safety
492309|NCT01462487|zanamivir|zanamivir
492310|NCT01462487|influenza|influenza
492311|NCT01462474|Concurrent Chemoradiotherapy|concurrent chemoradiotherapy
492312|NCT01462461|Phantom Limb|phantom limb
492313|NCT01462461|Amputation, Traumatic|amputation, traumatic
492314|NCT01462461|Electromyography|electromyography
492315|NCT01462461|Visual Analog Pain Scale|visual analog pain scale
492316|NCT01462448|Phantom Limb|phantom limb
492317|NCT01462448|Genetic Variation|genetic variation
492318|NCT01462448|DNA Sequence Analysis|dna sequence analysis
492319|NCT01462448|Amputation, Traumatic|amputation, traumatic
492320|NCT01462448|Single Nucleotide Polymorphism|single nucleotide polymorphism
492321|NCT01462448|Visual Analog Pain Scale|visual analog pain scale
492322|NCT01462448|Brain-Derived Neurotrophic Factor|brain-derived neurotrophic factor
492323|NCT01462448|Inflammatory Antibody|inflammatory antibody
492324|NCT01462448|Peripheral Nerve Damage|peripheral nerve damage
492325|NCT01462422|Postpartum hemorrhage|postpartum hemorrhage
492326|NCT01462422|Prevention|prevention
492327|NCT01462422|Misoprostol|misoprostol
492328|NCT01462422|Developing countries|developing countries
492329|NCT01462422|Nurse midwife|nurse midwife
492330|NCT01462409|obstructive sleep apnea|obstructive sleep apnea
492331|NCT01462409|humidification|humidification
492332|NCT01462409|mask|mask
492333|NCT01462409|heated tubing|heated tubing
492334|NCT01462396|Neuroblastoma|neuroblastoma
492335|NCT01462396|Relapsed|relapsed
492336|NCT01462396|Refractory|refractory
492337|NCT01462383|Advanced Cancer|advanced cancer
492338|NCT01462383|Malignancy|malignancy
492339|NCT01462383|Cardiac complications|cardiac complications
492340|NCT01462383|Electrocardiograms|electrocardiograms
492341|NCT01462383|ECG|ecg
492342|NCT01462383|Chart Review|chart review
492343|NCT01462383|Data Review|data review
492344|NCT01462383|Data Analysis|data analysis
492345|NCT01462383|Phase I|phase i
492346|NCT01462383|Clinical Research Study|clinical research study
492347|NCT01462357|Human papillomavirus|human papillomavirus
492348|NCT01462357|Safety|safety
492349|NCT01462357|HPV vaccine|hpv vaccine
492350|NCT01462357|Immune response|immune response
492351|NCT01462344|pediatric|pediatric
492352|NCT01462344|ADVAIR|advair
492353|NCT01462344|FLOVENT|flovent
492354|NCT01462344|asthma|asthma
492355|NCT01462331|Isomaltooligosaccharide|isomaltooligosaccharide
492356|NCT01462331|Human Consumption|human consumption
492357|NCT01462331|Dose tolerance|dose tolerance
492358|NCT01462331|Prebiotic|prebiotic
492361|NCT01462331|Dose tolerance and prebiotic effect|dose tolerance and prebiotic effect
492362|NCT01462318|Pre-filled syringe|pre-filled syringe
492363|NCT01462318|Pharmacokinetic|pharmacokinetic
492364|NCT01462318|Daclizumab High Yield Process|daclizumab high yield process
492365|NCT01462318|immunogenicity|immunogenicity
492366|NCT01462305|SAD|sad
492367|NCT01462305|Seasonal Affective Disorder|seasonal affective disorder
492368|NCT01462305|Winter Blues|winter blues
492369|NCT01462305|Seasonal Depression|seasonal depression
492370|NCT01462292|968|968
492371|NCT01462292|Duchenne Muscular Dystrophy|duchenne muscular dystrophy
492372|NCT01462292|GSK2402968|gsk2402968
492373|NCT01462292|DMD|dmd
492374|NCT01462292|Duchenne|duchenne
492375|NCT01462292|GSK|gsk
492376|NCT01462279|acute respiratory failure|acute respiratory failure
492377|NCT01462279|thiamine|thiamine
492378|NCT01462279|oxygen consumption|oxygen consumption
492379|NCT01462279|VO2|vo2
492380|NCT01462253|Adult patients|adult patients
492381|NCT01462253|Refractory|refractory
492382|NCT01462253|Relapsed|relapsed
492383|NCT01462253|clofarabine|clofarabine
492384|NCT01462253|cyclophosphamide|cyclophosphamide
492385|NCT01462253|refractory and relapsed acute lymphoblastic leukemia|refractory and relapsed acute lymphoblastic leukemia
492386|NCT01462253|ALL|all
492387|NCT01462240|arthritis|arthritis
492388|NCT01462227|Hypoglycemia|hypoglycemia
492389|NCT01462227|Type 1 diabetes|type 1 diabetes
492390|NCT01462201|focused ultrasound|focused ultrasound
492391|NCT01462201|mechanical fat destruction|mechanical fat destruction
492392|NCT01462201|Body Sculpting|body sculpting
492393|NCT01462188|ST-segment elevation myocardial infarction|st-segment elevation myocardial infarction
492394|NCT01462188|Primary angioplasty|primary angioplasty
492395|NCT01462188|stent|stent
492396|NCT01462136|PK study|pk study
492397|NCT01462097|Chronic kidney disease|chronic kidney disease
492398|NCT01462097|Exercise|exercise
492399|NCT01462097|Aerobic capacity|aerobic capacity
492400|NCT01462097|Learning and memory|learning and memory
492401|NCT01462097|Executive function|executive function
492402|NCT01462097|Endothelial function|endothelial function
492403|NCT01462084|sleeping|sleeping
492404|NCT01462084|opioid medications|opioid medications
492405|NCT01462084|positive airway pressure|positive airway pressure
492406|NCT01462058|SPAQ|spaq
492407|NCT01462058|Sigh-SAD|sigh-sad
492408|NCT01462058|Hamilton 29|hamilton 29
492409|NCT01462058|Vitamin D3|vitamin d3
492410|NCT01462058|p25(OH)D|p25(oh)d
492411|NCT01462045|Exercise|exercise
492412|NCT01462045|Stress|stress
492413|NCT01462045|PTSD|ptsd
492414|NCT01462045|Mindfulness|mindfulness
492415|NCT01462045|Breathing|breathing
492416|NCT01462045|Cortisol|cortisol
492417|NCT01462032|Preschool Children|preschool children
492418|NCT01462032|ADHD|adhd
492419|NCT01462032|Treatment|treatment
492420|NCT01462032|Non-pharmacological|non-pharmacological
492421|NCT01462019|nipple trauma|nipple trauma
627428|NCT00911612|IBS|ibs
492422|NCT01462019|breast feeding|breast feeding
492423|NCT01462019|phototherapy|phototherapy
492424|NCT01462019|wound healing|wound healing
492425|NCT01461993|vaccine|vaccine
492426|NCT01461993|rLP2086|rlp2086
492427|NCT01461993|Gardasil|gardasil
492428|NCT01461993|HPV|hpv
492429|NCT01461993|meningitis B|meningitis b
492430|NCT01461993|N. meningitidis serogroup B|n. meningitidis serogroup b
492431|NCT01461993|adolescents|adolescents
492432|NCT01461993|single-blind|single-blind
492433|NCT01461993|Meningococcal Vaccines|meningococcal vaccines
492434|NCT01461980|vaccine|vaccine
492435|NCT01461980|rLP2086|rlp2086
492436|NCT01461980|MCV4|mcv4
492437|NCT01461980|Tdap|tdap
492438|NCT01461980|meningitis B|meningitis b
492439|NCT01461980|N. meningitidis serogroup B|n. meningitidis serogroup b
492440|NCT01461980|adolescents|adolescents
492441|NCT01461980|observer-blind|observer-blind
492442|NCT01461941|Dermatitis|dermatitis
492443|NCT01461941|Atopic|atopic
492444|NCT01461915|Pancreatic Cancer|pancreatic cancer
492445|NCT01461902|traumatic brain injury|traumatic brain injury
492446|NCT01461902|brain injury|brain injury
492447|NCT01461902|head injury|head injury
492448|NCT01461902|vasospasm|vasospasm
492449|NCT01461889|transfusion-related acute lung injury|transfusion-related acute lung injury
492450|NCT01461889|Blood Component Transfusion|blood component transfusion
492451|NCT01461889|Gastrointestinal Hemorrhage|gastrointestinal hemorrhage
492452|NCT01461889|Cirrhosis|cirrhosis
492453|NCT01461889|Fresh frozen plasma|fresh frozen plasma
492454|NCT01461837|sickle cell disease|sickle cell disease
492455|NCT01461837|stem cell transplantation|stem cell transplantation
492456|NCT01461837|haploidentical|haploidentical
492457|NCT01461824|Birth Control|birth control
492458|NCT01461824|Contraceptive Methods|contraceptive methods
492459|NCT01461824|Female Contraception|female contraception
492460|NCT01461824|Weight Gain|weight gain
492461|NCT01461824|Bone Density|bone density
492462|NCT01461811|toric|toric
492463|NCT01461811|contact lenses|contact lenses
492464|NCT01461811|daily disposable contact lenses|daily disposable contact lenses
492465|NCT01461811|astigmatism|astigmatism
492466|NCT01461811|soft contact lenses|soft contact lenses
492467|NCT01461811|contact lens comfort|contact lens comfort
492468|NCT01461798|plant stanols|plant stanols
492469|NCT01461798|lipids|lipids
492470|NCT01461798|cardiovascular disease|cardiovascular disease
492471|NCT01461785|Platelet rich plasma|platelet rich plasma
492472|NCT01461785|Dermal improvement|dermal improvement
492473|NCT01461785|Graft survival|graft survival
492474|NCT01461733|atrial fibrillation|atrial fibrillation
492475|NCT01461733|amiodarone|amiodarone
492476|NCT01461720|Bone marrow|bone marrow
492477|NCT01461720|Autologous|autologous
492478|NCT01461720|Mesenchymal stem cells|mesenchymal stem cells
492479|NCT01461720|Unilateral middle cerebral artery infarct|unilateral middle cerebral artery infarct
492480|NCT01461707|Cellular phone|cellular phone
492481|NCT01461707|exercise|exercise
492482|NCT01461707|pregnant women|pregnant women
492483|NCT01461707|obesity|obesity
492484|NCT01461707|overweight|overweight
492485|NCT01461707|physical activity|physical activity
492486|NCT01461694|Hirsutism|hirsutism
492487|NCT01461694|Laser|laser
492488|NCT01461694|Hair Reduction|hair reduction
492489|NCT01461694|IPL|ipl
492490|NCT01461694|Intense Pulsed Light|intense pulsed light
492491|NCT01461681|Palliative care|palliative care
492492|NCT01461681|Symptom management|symptom management
492493|NCT01461681|Heart failure|heart failure
492494|NCT01461668|MRSA|mrsa
492495|NCT01461668|MRSA resistant to mupirocin|mrsa resistant to mupirocin
492496|NCT01461642|Asthma|asthma
492497|NCT01461642|ICT Support|ict support
492498|NCT01461642|ACT|act
492499|NCT01461642|PEF|pef
492500|NCT01461629|cognitive impairment|cognitive impairment
492501|NCT01461629|cognitive function|cognitive function
492502|NCT01461629|hospitalization|hospitalization
492503|NCT01461629|self-management|self-management
492504|NCT01461629|cardiac disease|cardiac disease
492505|NCT01461629|heart failure|heart failure
492506|NCT01461616|Diabetes Mellitus, Type 1|diabetes mellitus, type 1
492507|NCT01461603|critical illness|critical illness
492508|NCT01461603|protein metabolism|protein metabolism
492509|NCT01461603|pharmaconutrients|pharmaconutrients
492510|NCT01461564|screening|screening
492511|NCT01461564|colonoscopy|colonoscopy
492512|NCT01461564|carbon dioxide|carbon dioxide
492513|NCT01461564|air|air
492514|NCT01461564|pain score|pain score
492515|NCT01461564|complications|complications
492516|NCT01461551|troponin I|troponin i
492517|NCT01461551|creatine kinase mb|creatine kinase mb
492518|NCT01461551|hospital days|hospital days
492519|NCT01461551|lymphocyte apoptosis|lymphocyte apoptosis
492520|NCT01461551|intensive care unit days|intensive care unit days
492521|NCT01461538|Acute Lymphoid Leukemia|acute lymphoid leukemia
492522|NCT01461538|Myelodysplastic Syndrome|myelodysplastic syndrome
492523|NCT01461538|Acute Myeloid Leukemia|acute myeloid leukemia
492524|NCT01461538|Solid Tumors|solid tumors
492525|NCT01461538|Anemia, Refractory, with Excess of Blasts|anemia, refractory, with excess of blasts
492526|NCT01461538|Antibodies, Monoclonal|antibodies, monoclonal
492527|NCT01461538|Antibody-Drug Conjugate|antibody-drug conjugate
492528|NCT01461538|Antigens, CD30|antigens, cd30
492529|NCT01461538|Drug Therapy|drug therapy
492530|NCT01461538|Hematologic Diseases|hematologic diseases
492531|NCT01461538|Immunotherapy|immunotherapy
492532|NCT01461538|Monomethyl Auristatin E|monomethyl auristatin e
492533|NCT01461525|Low Rectal Cancer|low rectal cancer
492534|NCT01461525|Sphincter preservation|sphincter preservation
492535|NCT01461525|Abdominoperineal resection|abdominoperineal resection
492536|NCT01461525|Quality of life|quality of life
492537|NCT01461525|Sexual function|sexual function
492538|NCT01461525|Urinary function|urinary function
492539|NCT01461525|Oncologic outcome|oncologic outcome
492540|NCT01461499|Hypertension|hypertension
492541|NCT01461499|Albuminuria|albuminuria
492542|NCT01461499|Direct renin inhibitor|direct renin inhibitor
492543|NCT01461499|Angiotensin receptor blocker|angiotensin receptor blocker
492544|NCT01461499|Type 2 diabetes|type 2 diabetes
492545|NCT01461486|Continuous positive airway pressure|continuous positive airway pressure
492546|NCT01461486|Oral appliance|oral appliance
492547|NCT01461486|mild Obstructive Sleep Apnea Syndrome|mild obstructive sleep apnea syndrome
492548|NCT01461473|Obstructive Sleep Apnea|obstructive sleep apnea
492549|NCT01461473|Obstructive Sleep Apnea Syndrome|obstructive sleep apnea syndrome
492550|NCT01461473|Sleep Apnea Syndrome, Obstructive|sleep apnea syndrome, obstructive
492551|NCT01461473|Syndrome, Obstructive Sleep Apnea|syndrome, obstructive sleep apnea
492552|NCT01461473|Syndrome, Sleep Apnea, Obstructive|syndrome, sleep apnea, obstructive
492553|NCT01461473|Syndrome, Upper Airway Resistance, Sleep Apnea|syndrome, upper airway resistance, sleep apnea
492554|NCT01461473|Upper Airway Resistance Sleep Apnea Syndrome|upper airway resistance sleep apnea syndrome
492555|NCT01461460|volunteer|volunteer
492556|NCT01461434|atrial fibrillation|atrial fibrillation
492557|NCT01461434|biomarkers|biomarkers
492558|NCT01461434|stroke prevention|stroke prevention
492559|NCT01461434|implantable loop recorder|implantable loop recorder
492560|NCT01461421|Obesity|obesity
492561|NCT01461421|Primary Care|primary care
492562|NCT01461421|Behavior Modification|behavior modification
492563|NCT01461408|HPV Vaccination|hpv vaccination
492564|NCT01461408|Beauty Salons|beauty salons
492565|NCT01461408|Health Education|health education
492566|NCT01461408|Sexual Health|sexual health
492567|NCT01461395|IVF|ivf
492568|NCT01461343|pulmonary hypertension, PET imaging, CT/PET|pulmonary hypertension, pet imaging, ct/pet
492569|NCT01461330|diabetes|diabetes
492570|NCT01461330|exercise|exercise
492571|NCT01461330|DASH diet|dash diet
492572|NCT01461330|ABPM|abpm
492573|NCT01461304|fatty acid oxidation|fatty acid oxidation
492574|NCT01461304|triheptanoin|triheptanoin
492575|NCT01461304|long-chain fatty acid oxidation disorders|long-chain fatty acid oxidation disorders
492576|NCT01461304|LCHADD|lchadd
492577|NCT01461304|VLCADD|vlcadd
492578|NCT01461304|CPT1|cpt1
492579|NCT01461304|CPT2|cpt2
492580|NCT01461304|TFP|tfp
492581|NCT01461304|Glycogen Storage Disorders|glycogen storage disorders
492582|NCT01461304|GSD|gsd
492583|NCT01461304|Pyruvate Carboxylase|pyruvate carboxylase
492584|NCT01461304|PC|pc
492585|NCT01461304|ACAD9|acad9
492586|NCT01461304|Barth|barth
492587|NCT01461291|Primary open-angle glaucoma|primary open-angle glaucoma
492588|NCT01461291|POAG|poag
492589|NCT01461291|Trabecular meshwork|trabecular meshwork
492590|NCT01461291|iStent inject|istent inject
492591|NCT01461278|Primary open-angle glaucoma|primary open-angle glaucoma
492592|NCT01461278|POAG|poag
492593|NCT01461278|Cataract surgery|cataract surgery
492594|NCT01461278|Suprachoroidal space|suprachoroidal space
492595|NCT01461278|Suprachoroidal stent|suprachoroidal stent
492596|NCT01461278|iStent supra|istent supra
492597|NCT01461265|Painful bone metastases|painful bone metastases
492598|NCT01461265|Bone metastases|bone metastases
492599|NCT01461265|Metastatic bone tumors|metastatic bone tumors
492600|NCT01461265|Metastatic bone pain|metastatic bone pain
492601|NCT01461265|Cryoablation|cryoablation
492602|NCT01461265|Cryotherapy|cryotherapy
492603|NCT01461265|Cryosurgery|cryosurgery
492604|NCT01461252|Painful bone metastases|painful bone metastases
492605|NCT01461252|Bone metastases|bone metastases
492606|NCT01461252|Metastatic bone tumors|metastatic bone tumors
492607|NCT01461252|Metastatic bone pain|metastatic bone pain
492608|NCT01461252|Cryoablation|cryoablation
492609|NCT01461252|Cryotherapy|cryotherapy
492610|NCT01461252|Cryosurgery|cryosurgery
492611|NCT01461252|Radiation therapy|radiation therapy
492612|NCT01461252|Radiotherapy|radiotherapy
492613|NCT01461239|survival|survival
492614|NCT01461239|debonding|debonding
492615|NCT01461239|endodontic treated teeth|endodontic treated teeth
492616|NCT01461226|overweight|overweight
492617|NCT01461226|cardiovascular risk factors|cardiovascular risk factors
492618|NCT01461226|exercise training|exercise training
710745|NCT00588120|C13|c13
492619|NCT01461226|endothelial function|endothelial function
492620|NCT01461226|endothelium|endothelium
492621|NCT01461226|endothelial progenitor cells|endothelial progenitor cells
492622|NCT01461213|Tapetoretinal degeneration, choroideraemia, X-linked|tapetoretinal degeneration, choroideraemia, x-linked
492623|NCT01461213|retinitis pigmentosa|retinitis pigmentosa
492624|NCT01461187|Exercise|exercise
492625|NCT01461187|Pregnancy|pregnancy
492626|NCT01461187|Childbirth|childbirth
492627|NCT01461187|Vaginal|vaginal
492628|NCT01461187|Cesarean section|cesarean section
492629|NCT01461174|Sleep deprivation|sleep deprivation
492630|NCT01461174|Cognitive Functions|cognitive functions
492631|NCT01461174|young male|young male
492632|NCT01461148|UICC stage III/IV MSI-H colorectal cancer|uicc stage iii/iv msi-h colorectal cancer
492633|NCT01461109|Parkinson Disease|parkinson disease
492634|NCT01461109|Alzheimer Disease|alzheimer disease
492635|NCT01461109|[18F] CFPyPB|[18f] cfpypb
492636|NCT01461109|GlyT1|glyt1
492637|NCT01461083|Parkinson Disease|parkinson disease
492638|NCT01461083|[18F]MPPF|[18f]mppf
492639|NCT01461070|Breast Cancer|breast cancer
492640|NCT01461070|Post Menopausal Estrogens|post menopausal estrogens
492641|NCT01461070|Fecal Microbes|fecal microbes
492642|NCT01461031|pain|pain
492643|NCT01461031|orthognathic|orthognathic
492644|NCT01461018|Immune globulin subcutaneous|immune globulin subcutaneous
492645|NCT01461018|SCIG|scig
492646|NCT01461018|Primary immunodeficiency|primary immunodeficiency
492647|NCT01461018|PID|pid
492648|NCT01461005|Spondylolisthesis|spondylolisthesis
492649|NCT01461005|Neurologic impairment|neurologic impairment
492650|NCT01461005|Kyphosis|kyphosis
492651|NCT01461005|Pseudarthrosis|pseudarthrosis
492652|NCT01460992|Pacemaker therapy|pacemaker therapy
492653|NCT01460992|Magnetic Resonance Imaging (MRI)|magnetic resonance imaging (mri)
492654|NCT01460992|EVIA/ENTOVIS|evia/entovis
492655|NCT01460979|Ovarian Cancer|ovarian cancer
492656|NCT01460979|Endometrial Carcinoma|endometrial carcinoma
492657|NCT01460979|Temsirolimus|temsirolimus
492658|NCT01460966|Distal protection device|distal protection device
492659|NCT01460966|Thrombus aspiration|thrombus aspiration
492660|NCT01460966|Coronary Artery Disease|coronary artery disease
492661|NCT01460966|Coronary Disease|coronary disease
492662|NCT01460966|Acute Coronary Syndrome|acute coronary syndrome
492663|NCT01460953|curriculum|curriculum
492665|NCT01460953|Medical student Knowledge|medical student knowledge
492666|NCT01460940|refractory Hodgkin's lymphoma|refractory hodgkin's lymphoma
492667|NCT01460940|panobinostat|panobinostat
492668|NCT01460940|lenalidomide|lenalidomide
492669|NCT01460914|ECP|ecp
492670|NCT01460914|CTCL|ctcl
492671|NCT01460914|Extracorporeal photopheresis|extracorporeal photopheresis
492672|NCT01460914|Cutaneous T Cell Lymphoma|cutaneous t cell lymphoma
492673|NCT01460914|GVHD|gvhd
492674|NCT01460914|Graft versus host disease|graft versus host disease
492675|NCT01460901|Neuroblastoma|neuroblastoma
492676|NCT01460901|Relapsed|relapsed
492677|NCT01460901|Refractory|refractory
492678|NCT01460875|high risk melanoma|high risk melanoma
492679|NCT01460875|lymph node disease|lymph node disease
492680|NCT01460862|Asthma|asthma
492681|NCT01460862|Omalizumab|omalizumab
492682|NCT01460849|Cystic fibrosis|cystic fibrosis
492683|NCT01460836|Cystic fibrosis|cystic fibrosis
492684|NCT01460823|Hearing loss|hearing loss
492685|NCT01460823|Cochlear Implantation|cochlear implantation
492686|NCT01460823|Image guided surgery|image guided surgery
492687|NCT01460797|Glycemic index|glycemic index
492688|NCT01460797|Caloric restriction|caloric restriction
492689|NCT01460797|Energy intake|energy intake
492690|NCT01460797|Glucose|glucose
492691|NCT01460797|Lipid Metabolism|lipid metabolism
492692|NCT01460797|Cholesterol|cholesterol
492693|NCT01460797|HDL Cholesterol|hdl cholesterol
492694|NCT01460797|LDL Cholesterol|ldl cholesterol
492695|NCT01460797|Obesity|obesity
492696|NCT01460797|Metformin|metformin
492697|NCT01460784|Metabolic dysfunction|metabolic dysfunction
492698|NCT01460784|Insulin resistance|insulin resistance
492699|NCT01460784|Brown adipose tissue|brown adipose tissue
492700|NCT01460784|Dyslipidemia|dyslipidemia
492701|NCT01460771|childhood dystonia|childhood dystonia
492702|NCT01460758|Depression|depression
492703|NCT01460758|Transcranial magnetic stimulation|transcranial magnetic stimulation
492705|NCT01460758|DLPFC|dlpfc
492706|NCT01460758|medial frontal cortex|medial frontal cortex
492707|NCT01460758|anterior cingulate complex|anterior cingulate complex
492708|NCT01460745|Erbitux|erbitux
492709|NCT01460745|CRC|crc
492710|NCT01460745|mCRC|mcrc
492711|NCT01460745|Liver|liver
492712|NCT01460745|Metastases|metastases
492713|NCT01460732|Hypertension|hypertension
492714|NCT01460732|Nocturnal BP dipping|nocturnal bp dipping
492715|NCT01460732|Home Blood pressure Monitoring|home blood pressure monitoring
492716|NCT01460732|Ambulatory Blood Pressure Monitoring|ambulatory blood pressure monitoring
492717|NCT01460706|Glioma|glioma
492718|NCT01460706|68Ga-DOTATOC|68ga-dotatoc
492719|NCT01460706|PET/CT|pet/ct
492720|NCT01460706|Somatostatin receptor|somatostatin receptor
492721|NCT01460693|Leukemia|leukemia
492722|NCT01460693|Myeloid|myeloid
492723|NCT01460693|Chronic|chronic
492724|NCT01460693|Chronic-Phase|chronic-phase
492725|NCT01460693|CML|cml
492726|NCT01460680|Fibromyalgia|fibromyalgia
492727|NCT01460680|Systemic Lupus Erythematosus|systemic lupus erythematosus
492728|NCT01460680|Omega-3 Fatty acids|omega-3 fatty acids
492729|NCT01460680|Magnesium|magnesium
492730|NCT01460667|Laparoscopic Roux-en-Y Gastric Bypass|laparoscopic roux-en-y gastric bypass
492731|NCT01460667|Post-Operative Pain|post-operative pain
492732|NCT01460667|IV Acetaminophen|iv acetaminophen
492733|NCT01460667|Post-Operative Nausea and Vomiting|post-operative nausea and vomiting
492734|NCT01460628|fatigue|fatigue
492735|NCT01460628|menopausal symptoms|menopausal symptoms
492736|NCT01460628|hot flashes|hot flashes
492737|NCT01460628|Vasomotor symptoms|vasomotor symptoms
492738|NCT01460628|perimenopause|perimenopause
492739|NCT01460628|related Quality of life|related quality of life
492740|NCT01460615|Postoperative pancreatitis|postoperative pancreatitis
492741|NCT01460615|Postoperative complications|postoperative complications
492742|NCT01460615|Delayed gastric emptying|delayed gastric emptying
492743|NCT01460615|Leakage|leakage
492744|NCT01460615|Fistula|fistula
492745|NCT01460615|Acinar cell|acinar cell
492746|NCT01460615|Risk patient|risk patient
492747|NCT01460615|Pancreaticoduodenectomy|pancreaticoduodenectomy
492748|NCT01460615|Whipple|whipple
492749|NCT01460615|Cortisone|cortisone
492750|NCT01460602|Lymphoma|lymphoma
492751|NCT01460602|Follicular|follicular
492752|NCT01460602|Marginal Zone|marginal zone
492753|NCT01460602|Mantle Cell|mantle cell
492754|NCT01460602|Velcade|velcade
492755|NCT01460602|bortezomib|bortezomib
492756|NCT01460602|Nipent|nipent
492757|NCT01460602|pentastatin|pentastatin
492758|NCT01460602|Rituxan|rituxan
492759|NCT01460602|rituximab|rituximab
492760|NCT01460602|Turturro|turturro
492761|NCT01460602|Shreveport|shreveport
492762|NCT01460589|colon cancer|colon cancer
492763|NCT01460589|Chemotherapy|chemotherapy
492764|NCT01460589|adjuvant|adjuvant
492765|NCT01460576|prematurity|prematurity
492766|NCT01460576|respiratory disease|respiratory disease
492767|NCT01460576|bronchopulmonary dysplasia|bronchopulmonary dysplasia
492768|NCT01460563|craniotomy|craniotomy
492769|NCT01460563|sodium valproate|sodium valproate
492770|NCT01460563|rocuronium|rocuronium
492771|NCT01460550|delayed gastric emptying(DGE)|delayed gastric emptying(dge)
492772|NCT01460550|pancreaticoduodenectomy(PD)|pancreaticoduodenectomy(pd)
492773|NCT01460550|randomized controlled trial(RCT)|randomized controlled trial(rct)
492774|NCT01460550|gastro- or duodeno- jejunostomy reconstruction|gastro- or duodeno- jejunostomy reconstruction
492775|NCT01460550|morbidity|morbidity
492776|NCT01460537|phase I|phase i
492777|NCT01460537|phosphatidylinositol-3 kinase inhibitor|phosphatidylinositol-3 kinase inhibitor
492778|NCT01460537|gemcitabine|gemcitabine
492779|NCT01460537|cisplatin|cisplatin
492780|NCT01460537|maximum tolerated dose|maximum tolerated dose
492781|NCT01460524|bronchiolitis|bronchiolitis
492782|NCT01460524|saline|saline
492783|NCT01460524|nebulization|nebulization
492784|NCT01460524|hypertonic|hypertonic
492785|NCT01460511|Mild bronchial asthma|mild bronchial asthma
492786|NCT01460498|Leukemia|leukemia
492787|NCT01460498|Chronic Myeloid Leukemia|chronic myeloid leukemia
492788|NCT01460498|CML|cml
492789|NCT01460498|Complete cytogenetic remission|complete cytogenetic remission
492790|NCT01460498|CCyR|ccyr
492791|NCT01460498|Minimal residual disease|minimal residual disease
492792|NCT01460498|Philadelphia chromosome (Ph)-|philadelphia chromosome (ph)-
492793|NCT01460498|BCR/ABL-positive|bcr/abl-positive
492794|NCT01460498|Tyrosine kinase inhibitor|tyrosine kinase inhibitor
492795|NCT01460498|TKI|tki
492796|NCT01460498|Azacitidine|azacitidine
492797|NCT01460498|5-Azacytidine|5-azacytidine
492798|NCT01460498|5-AZA|5-aza
492799|NCT01460498|Vidaza|vidaza
492800|NCT01460498|5-AZC|5-azc
492801|NCT01460498|AZA-CR|aza-cr
492802|NCT01460498|Ladakamycin|ladakamycin
492803|NCT01460498|NSC-102816|nsc-102816
492804|NCT01460472|NSCLC|nsclc
492805|NCT01460472|Lung cancer, small-cell|lung cancer, small-cell
492806|NCT01460472|advanced lung cancer|advanced lung cancer
492807|NCT01460472|therapeutic vaccine|therapeutic vaccine
492808|NCT01460472|anti-idiotypic vaccine|anti-idiotypic vaccine
492809|NCT01460472|1E10|1e10
492810|NCT01460459|diabetes|diabetes
492811|NCT01460459|self-monitoring of blood glucose|self-monitoring of blood glucose
492812|NCT01460459|frequency|frequency
492813|NCT01460433|HIV 1|hiv 1
492814|NCT01460433|Herpes Simplex Type 2|herpes simplex type 2
492815|NCT01460433|Treatment experienced|treatment experienced
492816|NCT01460420|Allogeneic transplantation|allogeneic transplantation
492817|NCT01460420|Hematologic malignancies|hematologic malignancies
492818|NCT01460420|Multiple myeloma|multiple myeloma
492819|NCT01460420|RIC (Reduced Intensity Conditioning)|ric (reduced intensity conditioning)
492820|NCT01460394|Healthy|healthy
492821|NCT01460394|Control|control
492822|NCT01460355|strabismus surgery|strabismus surgery
492823|NCT01460355|botulinum toxin|botulinum toxin
492824|NCT01460355|esotropia|esotropia
492825|NCT01460355|exotropia|exotropia
492826|NCT01460355|blepharoptosis|blepharoptosis
492827|NCT01460342|Prostatic hyperplasia|prostatic hyperplasia
492828|NCT01460342|Benign prostatic hyperplasia|benign prostatic hyperplasia
492829|NCT01460342|Lower urinary tract|lower urinary tract
492830|NCT01460329|intensive care units|intensive care units
492831|NCT01460329|pediatric|pediatric
492832|NCT01460329|cardiac index|cardiac index
492833|NCT01460329|Doppler Ultrasonography|doppler ultrasonography
492834|NCT01460316|Conotruncal cardiac defects|conotruncal cardiac defects
492835|NCT01460316|methylation|methylation
492836|NCT01460316|genotype|genotype
492837|NCT01460316|cobalamin|cobalamin
492838|NCT01460316|folates|folates
492839|NCT01460316|nutrition|nutrition
492840|NCT01460303|Transurethral catheterization|transurethral catheterization
492841|NCT01460303|Urinary retention|urinary retention
492842|NCT01460303|Bladder dysfunction|bladder dysfunction
492843|NCT01460303|Patient comfort|patient comfort
492844|NCT01460303|Pelvic Reconstructive Surgery|pelvic reconstructive surgery
492845|NCT01460303|Postoperative bladder dysfunction|postoperative bladder dysfunction
492846|NCT01460303|Postoperative urinary retention|postoperative urinary retention
492847|NCT01460277|hemiplegic|hemiplegic
492848|NCT01460277|balance|balance
492849|NCT01460277|hydrotherapy|hydrotherapy
492850|NCT01460264|Prospective Cohort Study|prospective cohort study
492851|NCT01460264|Respiratory Function Tests|respiratory function tests
492852|NCT01460264|Computed Tomography|computed tomography
492853|NCT01460264|Electrocardiography|electrocardiography
492854|NCT01460264|Peripheral Arterial Disease|peripheral arterial disease
492855|NCT01460251|type 1 diabetes|type 1 diabetes
492856|NCT01460251|beta cell|beta cell
492857|NCT01460251|immunomodulation|immunomodulation
492858|NCT01460251|immunointervention|immunointervention
492859|NCT01460238|Lipoprotein Lipase|lipoprotein lipase
492860|NCT01460238|Chronic Lymphocytic Leukemia|chronic lymphocytic leukemia
492861|NCT01460238|CLL|cll
492862|NCT01460225|constipation|constipation
492863|NCT01460225|chronic idiopathic constipation|chronic idiopathic constipation
492864|NCT01460225|no prior history of surgery to the colon|no prior history of surgery to the colon
492865|NCT01460225|not on any type of medication that could alter gastrointestinal motility or transit|not on any type of medication that could alter gastrointestinal motility or transit
492866|NCT01460212|Cognitive-Behavior Therapy|cognitive-behavior therapy
492867|NCT01460212|Magnetic Resonance Imaging|magnetic resonance imaging
492868|NCT01460212|major depressive disorder|major depressive disorder
492869|NCT01460186|Germ line polymorphisms|germ line polymorphisms
492870|NCT01460173|alertness test|alertness test
492871|NCT01460173|sleepiness|sleepiness
492872|NCT01460173|vigilance|vigilance
492873|NCT01460173|Sleep Apnea, Obstructive|sleep apnea, obstructive
492874|NCT01460147|Hemophilia|hemophilia
492875|NCT01460134|CD27 expressing Hematologic Malignancies|cd27 expressing hematologic malignancies
492876|NCT01460134|CD27 expressing Solid Tumors|cd27 expressing solid tumors
492877|NCT01460134|chronic lymphocytic leukemia|chronic lymphocytic leukemia
492878|NCT01460134|Burkett's lymphoma|burkett's lymphoma
492879|NCT01460134|mantle cell lymphoma|mantle cell lymphoma
492880|NCT01460134|primary lymphoma of the central nervous system|primary lymphoma of the central nervous system
492881|NCT01460134|marginal zone B cell lymphoma|marginal zone b cell lymphoma
492882|NCT01460134|solid tumor|solid tumor
492883|NCT01460134|metastatic melanoma|metastatic melanoma
492884|NCT01460134|renal (clear) cell carcinoma|renal (clear) cell carcinoma
492885|NCT01460134|hormone-refractory prostate adenocarcinoma|hormone-refractory prostate adenocarcinoma
492886|NCT01460134|ovarian cancer|ovarian cancer
492887|NCT01460134|colorectal adenocarcinoma|colorectal adenocarcinoma
492888|NCT01460134|non-small cell lung cancer|non-small cell lung cancer
492889|NCT01460121|Phobic Postural Vertigo|phobic postural vertigo
492890|NCT01460121|Visual Vertigo|visual vertigo
492891|NCT01460121|Chronic Subjective Dizziness|chronic subjective dizziness
492892|NCT01460121|Motion and Space Discomfort|motion and space discomfort
492893|NCT01460121|SpotOn|spoton
492894|NCT01460108|PLVR|plvr
492895|NCT01460108|AeriSeal|aeriseal
492896|NCT01460108|Treatment|treatment
492897|NCT01460108|Device|device
492898|NCT01460108|Breathing|breathing
492899|NCT01460108|COPD|copd
492900|NCT01460108|emphysema|emphysema
492901|NCT01460108|polymeric lung volume reduction|polymeric lung volume reduction
492902|NCT01460108|heterogeneous|heterogeneous
492903|NCT01460108|homogeneous|homogeneous
492904|NCT01460108|Chronic Obstructive Pulmonary Disease|chronic obstructive pulmonary disease
492905|NCT01460095|diabetes|diabetes
492906|NCT01460095|translational research|translational research
492907|NCT01460095|HbA1c|hba1c
492908|NCT01460095|education|education
492909|NCT01460082|chronic obstructive pulmonary disease|chronic obstructive pulmonary disease
492910|NCT01460082|acute exacerbation|acute exacerbation
492911|NCT01460082|endothelial dysfunction|endothelial dysfunction
492912|NCT01460082|flow mediated dilation|flow mediated dilation
628040|NCT00909285|TMS|tms
492913|NCT01460082|systemic inflammation|systemic inflammation
492914|NCT01460069|psoriasis|psoriasis
492915|NCT01460069|liraglutide|liraglutide
492916|NCT01460069|morbidity|morbidity
492917|NCT01460069|PASI|pasi
492918|NCT01460069|DLQI|dlqi
492919|NCT01460056|peritoneal dialysis|peritoneal dialysis
492920|NCT01460056|endotoxin-associated sterile peritonitis|endotoxin-associated sterile peritonitis
492921|NCT01460030|Hypercalcemia in patients with parathyroid carcinoma or intractable PHPT|hypercalcemia in patients with parathyroid carcinoma or intractable phpt
492922|NCT01460004|patellar tendinopathy|patellar tendinopathy
492923|NCT01460004|jumper's knee|jumper's knee
492924|NCT01459991|walnut|walnut
492925|NCT01459991|mediterranean|mediterranean
492926|NCT01459978|CUmulative SUM (CUSUM)|cumulative sum (cusum)
492927|NCT01459978|quality indicators|quality indicators
492928|NCT01459978|obstetrics|obstetrics
492929|NCT01459965|Jaundice|jaundice
492930|NCT01459965|Biliary stents|biliary stents
492931|NCT01459965|Palliation|palliation
492932|NCT01459965|Quality of Life|quality of life
492933|NCT01459965|Endoscopic Retrograde Cholangiography|endoscopic retrograde cholangiography
492934|NCT01459952|occurences of flu|occurences of flu
492935|NCT01459952|occurences of common cold|occurences of common cold
492936|NCT01459939|Osteoarthritis|osteoarthritis
492937|NCT01459926|Opioid induced constipation|opioid induced constipation
492938|NCT01459926|OIC|oic
492939|NCT01459926|Constipation|constipation
492940|NCT01459926|Opioid side effects|opioid side effects
492941|NCT01459926|Morphine induced constipation|morphine induced constipation
492942|NCT01459926|Opioid therapy|opioid therapy
492943|NCT01459913|VX-950|vx-950
492944|NCT01459913|INCIVEK|incivek
492945|NCT01459913|INCIVO|incivo
492946|NCT01459900|Treatment Resistant Hypertension|treatment resistant hypertension
492947|NCT01459887|untreated, CD20-positive|untreated, cd20-positive
492948|NCT01459874|Home Monitoring|home monitoring
492949|NCT01459874|Remote monitoring|remote monitoring
492950|NCT01459874|Telecardiology|telecardiology
492951|NCT01459874|Organizational model|organizational model
492952|NCT01459874|Patient indicated for pacemaker, ICD, CRT-P, or CRT-D|patient indicated for pacemaker, icd, crt-p, or crt-d
492953|NCT01459861|early ambulation|early ambulation
492954|NCT01459861|knee arthroplasty|knee arthroplasty
492955|NCT01459848|Salivary cortisol measured after DVD watching or block play|salivary cortisol measured after dvd watching or block play
492956|NCT01459835|TV|tv
492957|NCT01459835|Violence|violence
492958|NCT01459835|DVDs|dvds
492959|NCT01459835|Behavior|behavior
492960|NCT01459835|Preschool children|preschool children
492961|NCT01459822|sepsis|sepsis
492962|NCT01459822|miRNA|mirna
492963|NCT01459783|Caregivers|caregivers
492964|NCT01459783|Comparative Effectiveness Research|comparative effectiveness research
492965|NCT01459783|Cost Effectiveness|cost effectiveness
492966|NCT01459783|Patient Care Management|patient care management
492967|NCT01459783|Social Work|social work
492968|NCT01459770|glomerular filtration rate|glomerular filtration rate
492969|NCT01459770|albuminuria|albuminuria
492970|NCT01459770|medical therapy|medical therapy
492971|NCT01459770|hospital discharge|hospital discharge
492972|NCT01459770|hospital readmission|hospital readmission
492973|NCT01459770|CKD complications|ckd complications
492974|NCT01459770|CKD risk factors|ckd risk factors
492975|NCT01459757|Retrospective|retrospective
492976|NCT01459757|GIST|gist
492977|NCT01459757|sunitinib|sunitinib
492978|NCT01459757|mutational|mutational
492979|NCT01459744|Heart failure|heart failure
492980|NCT01459744|Palliative care|palliative care
492981|NCT01459744|Communication|communication
492982|NCT01459718|Severe cardiac iron overload|severe cardiac iron overload
492983|NCT01459718|deferasirox|deferasirox
492984|NCT01459718|β-thalassaemia|β-thalassaemia
492985|NCT01459718|cardiac dysfunction|cardiac dysfunction
492986|NCT01459705|Combat Disorders|combat disorders
492987|NCT01459705|Exposure Therapy|exposure therapy
492988|NCT01459705|Army Personnel|army personnel
492989|NCT01459692|Seizures|seizures
492990|NCT01459692|Epilepsy|epilepsy
492991|NCT01459692|Auditory Stimulation|auditory stimulation
492992|NCT01459692|Music|music
492993|NCT01459666|Scar|scar
492994|NCT01459666|Forehead|forehead
492995|NCT01459666|Skin Cancer|skin cancer
492996|NCT01459666|MOHS Surgery|mohs surgery
492997|NCT01459666|Dermatology|dermatology
492998|NCT01459653|Febrile neutropenia|febrile neutropenia
492999|NCT01459653|cancer|cancer
493000|NCT01459653|chemotherapy,|chemotherapy,
493001|NCT01459653|primary prophylaxis|primary prophylaxis
493002|NCT01459653|secondary prophylaxis|secondary prophylaxis
493003|NCT01459653|filgrastim|filgrastim
493004|NCT01459653|granulocyte colony stimulating factor|granulocyte colony stimulating factor
493005|NCT01459653|observational study|observational study
493006|NCT01459653|noninterventional study|noninterventional study
493007|NCT01459640|Osteoarthritis|osteoarthritis
493008|NCT01459640|Bone marrow|bone marrow
493009|NCT01459640|Mesenchymal stem cells|mesenchymal stem cells
628210|NCT00908479|RCT|rct
493010|NCT01459640|Autologous|autologous
493011|NCT01459640|Mild osteoarthritis|mild osteoarthritis
493012|NCT01459640|Moderate osteoarthritis|moderate osteoarthritis
493013|NCT01459627|DAPT- Dual Antiplatelet Therapy|dapt- dual antiplatelet therapy
493014|NCT01459627|STEMI|stemi
493015|NCT01459601|diabetes mellitus|diabetes mellitus
493016|NCT01459601|FBS|fbs
493017|NCT01459601|HbA1C|hba1c
493018|NCT01459601|Cabergoline|cabergoline
493019|NCT01459575|Acquired Immunodeficiency Syndrome|acquired immunodeficiency syndrome
493020|NCT01459575|antiretroviral therapy|antiretroviral therapy
493021|NCT01459575|China|china
493022|NCT01459549|hepatolithiasis|hepatolithiasis
493023|NCT01459549|sphincter of oddi laxity|sphincter of oddi laxity
493024|NCT01459549|choledochojejunostomy|choledochojejunostomy
493025|NCT01459536|Aging|aging
493026|NCT01459523|Peripheral Nerve Block|peripheral nerve block
493027|NCT01459523|Perineural Catheter|perineural catheter
493028|NCT01459523|Orthopedic Surgery|orthopedic surgery
493029|NCT01459523|Ultrasound|ultrasound
493030|NCT01459510|Violence prevention|violence prevention
493031|NCT01459510|Parenting|parenting
493032|NCT01459510|Discipline|discipline
493033|NCT01459497|non-small cell lung cancer|non-small cell lung cancer
493034|NCT01459497|Stages II or III non-small cell lung cancer|stages ii or iii non-small cell lung cancer
493035|NCT01459484|Non metastatic extremities high grade osteosarcoma|non metastatic extremities high grade osteosarcoma
493036|NCT01459458|intimate partner violence|intimate partner violence
493037|NCT01459458|gender-based violence|gender-based violence
493038|NCT01459458|domestic violence|domestic violence
493039|NCT01459458|unintended pregnancy|unintended pregnancy
493040|NCT01459445|ethinylestradiol 30µg-drospirenone|ethinylestradiol 30µg-drospirenone
493041|NCT01459445|flow-mediated dilatation|flow-mediated dilatation
493042|NCT01459445|endothelial dysfunction|endothelial dysfunction
493043|NCT01459445|hsCRP|hscrp
493044|NCT01459445|metformin|metformin
493045|NCT01459445|polycystic ovary syndrome|polycystic ovary syndrome
493046|NCT01459406|Gastrointestinal physiology|gastrointestinal physiology
493047|NCT01459406|Gastrointestinal response to sugars|gastrointestinal response to sugars
493048|NCT01459406|MRI|mri
493049|NCT01459406|gastrointestinal|gastrointestinal
493050|NCT01459406|stomach|stomach
493051|NCT01459406|small bowel|small bowel
493052|NCT01459406|colon|colon
493053|NCT01459406|glucose|glucose
493054|NCT01459406|fructose|fructose
493055|NCT01459406|fructan|fructan
493056|NCT01459406|FODMAP|fodmap
493057|NCT01459393|Actinic keratosis|actinic keratosis
493058|NCT01459393|Photodynamic therapy|photodynamic therapy
493059|NCT01459393|5-aminolevulinic acid|5-aminolevulinic acid
493060|NCT01459393|Cryotherapy|cryotherapy
493061|NCT01459367|Drug Therapy|drug therapy
493062|NCT01459341|CLI Critical limb ischemia|cli critical limb ischemia
493063|NCT01459341|PVD peripheral vascular disease|pvd peripheral vascular disease
493064|NCT01459341|NIRS near infrared spectroscopy|nirs near infrared spectroscopy
493065|NCT01459341|TCPO2 - transcutaneous oxygen pressure|tcpo2 - transcutaneous oxygen pressure
493066|NCT01459328|rectal carcinoma|rectal carcinoma
493067|NCT01459328|long course chemo-radiation|long course chemo-radiation
493068|NCT01459328|short course chemo-rdiation|short course chemo-rdiation
493069|NCT01459328|Locally Advanced Rectal Carcinoma|locally advanced rectal carcinoma
493070|NCT01459315|Healthy|healthy
493071|NCT01459315|Male|male
493072|NCT01459315|GSK1349572|gsk1349572
493073|NCT01459315|Dolutegravir|dolutegravir
493074|NCT01459315|DTG|dtg
493075|NCT01459315|Integrase|integrase
493076|NCT01459315|HIV|hiv
493077|NCT01459302|FALS|fals
493078|NCT01459302|ALS|als
493079|NCT01459302|SALS|sals
493080|NCT01459302|MND|mnd
493081|NCT01459302|SOD1|sod1
493082|NCT01459302|ALS GENES|als genes
493083|NCT01459302|PLS|pls
493084|NCT01459302|PMA|pma
493085|NCT01459302|ALS/FTD|als/ftd
493086|NCT01459302|FAMILIAL ALS|familial als
493087|NCT01459302|SPORADIC ALS|sporadic als
493088|NCT01459302|GENETICS|genetics
493089|NCT01459302|FTD|ftd
493090|NCT01459302|Miyoshi myopathy|miyoshi myopathy
493091|NCT01459276|seasonal|seasonal
493092|NCT01459276|prevention|prevention
493093|NCT01459276|influenza|influenza
493094|NCT01459276|infection|infection
493095|NCT01459276|influenza vaccine|influenza vaccine
493096|NCT01459276|vaccine|vaccine
493097|NCT01459276|influenza in humans|influenza in humans
493098|NCT01459263|GSV|gsv
493099|NCT01459263|insufficiency|insufficiency
493100|NCT01459263|ClariVein device|clarivein device
493101|NCT01459263|safety|safety
493102|NCT01459263|efficacy|efficacy
493103|NCT01459263|QOL|qol
493104|NCT01459250|AGO178C,|ago178c,
493105|NCT01459250|renal impairment,|renal impairment,
493106|NCT01459250|ESRD,|esrd,
493107|NCT01459250|pharmacokinetics|pharmacokinetics
493108|NCT01459237|Cushing's Disease|cushing's disease
493109|NCT01459237|Microadenoma|microadenoma
493110|NCT01459237|PET Imaging|pet imaging
493111|NCT01459237|Cushing Disease Tumor|cushing disease tumor
493112|NCT01459237|Pituitary Tumors|pituitary tumors
493113|NCT01459211|CLL|cll
493114|NCT01459185|Non-small cell lung cancer|non-small cell lung cancer
493115|NCT01459185|Adjuvant chemotherapy|adjuvant chemotherapy
493116|NCT01459185|oral fluoropyrimidine|oral fluoropyrimidine
493117|NCT01459185|S-1|s-1
493118|NCT01459185|Feasibility study|feasibility study
493119|NCT01459185|Surgery|surgery
493120|NCT01459172|breast cancer prevention|breast cancer prevention
493121|NCT01459159|Hematology|hematology
493122|NCT01459159|MDS|mds
493123|NCT01459159|Myelodysplastic Syndrome|myelodysplastic syndrome
493124|NCT01459159|Low risk MDS|low risk mds
493125|NCT01459159|Int-1 risk MDS|int-1 risk mds
493126|NCT01459159|Transfusion dependence|transfusion dependence
493127|NCT01459159|Telintra|telintra
493128|NCT01459159|ezatiostat|ezatiostat
493129|NCT01459159|ezatiostat hydrochloride|ezatiostat hydrochloride
493130|NCT01459159|TLK199|tlk199
493131|NCT01459159|Glutathione|glutathione
493132|NCT01459159|Glutathione analog|glutathione analog
493133|NCT01459159|Glutathione Transferase|glutathione transferase
493134|NCT01459159|Glutathione Transferase P1-1 inhibitor|glutathione transferase p1-1 inhibitor
493135|NCT01459159|GST P1-1 inhibitor|gst p1-1 inhibitor
493136|NCT01459159|Apoptosis|apoptosis
493137|NCT01459159|Differentiation|differentiation
493138|NCT01459159|Enzyme inhibitor|enzyme inhibitor
493139|NCT01459159|non-del (5q)|non-del (5q)
493140|NCT01459159|non-deletion 5q|non-deletion 5q
493141|NCT01459146|IPT|ipt
493142|NCT01459146|malaria|malaria
493143|NCT01459146|ACT|act
493144|NCT01459146|schistosomiasis|schistosomiasis
493145|NCT01459146|Hemoglobin|hemoglobin
493146|NCT01459146|Anemia|anemia
493147|NCT01459146|Sustained attention|sustained attention
493148|NCT01459146|Recall|recall
493149|NCT01459146|Schoolchildren|schoolchildren
493150|NCT01459146|Kassena-Nankana|kassena-nankana
493151|NCT01459133|investigational|investigational
493152|NCT01459133|inhaled insulin product|inhaled insulin product
493153|NCT01459120|Home-based HIV-testing|home-based hiv-testing
493154|NCT01459120|Voluntary Counseling and Testing|voluntary counseling and testing
493155|NCT01459120|Community based testing|community based testing
493156|NCT01459120|HIV/AIDS|hiv/aids
493157|NCT01459120|Lesotho|lesotho
493158|NCT01459107|Hand Transplant|hand transplant
493159|NCT01459107|Composite Tissue Allotransplantation (CTA)|composite tissue allotransplantation (cta)
493160|NCT01459107|Vascularized Composite Allotransplantation (VCA)|vascularized composite allotransplantation (vca)
493161|NCT01459107|Composite Tissue|composite tissue
493162|NCT01459107|Amputation|amputation
493163|NCT01459107|Upper limb|upper limb
493164|NCT01459107|Immunosuppression|immunosuppression
493165|NCT01459094|Healthy Volunteers|healthy volunteers
493166|NCT01459094|Oral bioavailability|oral bioavailability
493167|NCT01459094|Canagliflozin (JNJ-28431754)|canagliflozin (jnj-28431754)
493168|NCT01459094|Metformin IR|metformin ir
493169|NCT01459029|Schizophrenia|schizophrenia
493170|NCT01459029|NMDA receptor|nmda receptor
493171|NCT01459029|D-serine|d-serine
493172|NCT01459029|Recent onset|recent onset
493173|NCT01459029|Negative symptoms|negative symptoms
493174|NCT01459029|Cognition|cognition
493175|NCT01459016|Mild Cognitive Impairment|mild cognitive impairment
493176|NCT01459016|Brain Imaging Biomarkers|brain imaging biomarkers
493177|NCT01459016|Magnetic resonance imaging biomarker|magnetic resonance imaging biomarker
493178|NCT01459016|Positron Emission Tomography|positron emission tomography
493179|NCT01458977|Lípid-lowering effect|lípid-lowering effect
493180|NCT01458977|Tenofovir|tenofovir
493181|NCT01458977|Dyslipidemia|dyslipidemia
493182|NCT01458964|Fibromyalgia|fibromyalgia
493183|NCT01458951|Tofacitinib|tofacitinib
493184|NCT01458951|CP-690|cp-690
493185|NCT01458951|550|550
493186|NCT01458951|Moderate to severe ulcerative colitis|moderate to severe ulcerative colitis
493187|NCT01458951|phase 3 clinical trial|phase 3 clinical trial
493188|NCT01458951|Mayo score|mayo score
493189|NCT01458925|Colorectal cancer|colorectal cancer
493190|NCT01458925|Colonic polyps|colonic polyps
493191|NCT01458899|Phase 1|phase 1
493192|NCT01458899|healthy male|healthy male
493193|NCT01458899|nonpregnant female|nonpregnant female
493194|NCT01458899|volunteers|volunteers
493195|NCT01458899|pharmacokinetics|pharmacokinetics
493196|NCT01458899|TC 5214|tc 5214
493197|NCT01458899|The effect of food on the pharmacokinetics of TC-5214|the effect of food on the pharmacokinetics of tc-5214
493198|NCT01458873|infiltration|infiltration
493199|NCT01458873|extravasation|extravasation
493200|NCT01458847|bladder cancer|bladder cancer
493201|NCT01458847|cis-urocanic acid|cis-urocanic acid
493202|NCT01458847|primary|primary
493203|NCT01458847|recurrent|recurrent
493204|NCT01458847|non-muscle|non-muscle
493205|NCT01458834|Smoking|smoking
493206|NCT01458834|Attentional bias|attentional bias
493207|NCT01458834|Craving|craving
493208|NCT01458821|Tinnitus|tinnitus
493209|NCT01458808|salt|salt
493210|NCT01458808|inflammation|inflammation
493211|NCT01458808|hypervolemia|hypervolemia
493212|NCT01458808|diet|diet
493213|NCT01458782|Cartilage repair|cartilage repair
493214|NCT01458782|Chondrocytes|chondrocytes
493215|NCT01458782|Stemcells|stemcells
493216|NCT01458756|liver transplant patients|liver transplant patients
493217|NCT01458756|hepatic transplantation|hepatic transplantation
493218|NCT01458743|pharmacokinetics|pharmacokinetics
493219|NCT01458730|PCNSL|pcnsl
493220|NCT01458730|Immunochemotherapy|immunochemotherapy
493221|NCT01458730|Intraspinal Depocyt|intraspinal depocyt
493222|NCT01458730|Maintenance temozolomide|maintenance temozolomide
493223|NCT01458717|pancreas|pancreas
493224|NCT01458717|cancer|cancer
493225|NCT01458717|borderline resectable|borderline resectable
493226|NCT01458717|locally advanced|locally advanced
493227|NCT01458717|resectability|resectability
493228|NCT01458717|chemotherapy|chemotherapy
493229|NCT01458717|radiation|radiation
493230|NCT01458717|chemoradiation|chemoradiation
493231|NCT01458717|neoadjuvant|neoadjuvant
493232|NCT01458717|survival|survival
493233|NCT01458717|prognosis|prognosis
493234|NCT01458717|recurrence|recurrence
493235|NCT01458717|response rate|response rate
493236|NCT01458652|AST-120|ast-120
493237|NCT01458652|HDF|hdf
493238|NCT01458652|Replacement Volume described above|replacement volume described above
493239|NCT01458639|Pulmonary embolism|pulmonary embolism
493240|NCT01458639|PE|pe
493241|NCT01458626|mirtazapine|mirtazapine
493242|NCT01458626|paroxetine|paroxetine
493243|NCT01458626|major depression|major depression
493244|NCT01458626|early improvement|early improvement
493245|NCT01458613|Maroteaux-Lamy Disease|maroteaux-lamy disease
493246|NCT01458613|Biomarker|biomarker
493247|NCT01458600|ophthalmopathy|ophthalmopathy
493248|NCT01458600|prevention|prevention
493249|NCT01458600|diclofenac|diclofenac
493250|NCT01458587|Actinic keratosis|actinic keratosis
493251|NCT01458574|Janus kinase inhibitor|janus kinase inhibitor
493252|NCT01458574|JAK 3 inhibitor|jak 3 inhibitor
493253|NCT01458574|inflammatory bowel disease|inflammatory bowel disease
493254|NCT01458574|ulcerative colitis|ulcerative colitis
493255|NCT01458574|OCTAVE|octave
493256|NCT01458574|CP-690|cp-690
493257|NCT01458574|550|550
493258|NCT01458574|tofacitinib|tofacitinib
493259|NCT01458574|Xeljanz|xeljanz
493260|NCT01458561|Hemostatic agent|hemostatic agent
493261|NCT01458561|Liver surgery|liver surgery
493262|NCT01458561|Hemostasis|hemostasis
493263|NCT01458548|1st-line therapy|1st-line therapy
493264|NCT01458548|single agent rituximab|single agent rituximab
493265|NCT01458548|CHOP|chop
493266|NCT01458548|PTLD|ptld
493267|NCT01458535|Genotype 1|genotype 1
493268|NCT01458535|Genotype 2|genotype 2
493269|NCT01458535|Genotype 3|genotype 3
493270|NCT01458535|Hepatitis C Virus|hepatitis c virus
493271|NCT01458535|ABT-450/r|abt-450/r
493272|NCT01458535|Ribavirin|ribavirin
493273|NCT01458535|ABT-267|abt-267
493274|NCT01458535|Ombitasvir|ombitasvir
493275|NCT01458535|Paritaprevir|paritaprevir
493276|NCT01458522|Nonconvulsive Seizures|nonconvulsive seizures
493277|NCT01458509|Quality of Life|quality of life
493278|NCT01458509|patient outcomes|patient outcomes
493279|NCT01458509|questionaires|questionaires
493280|NCT01458509|11-101|11-101
493281|NCT01458470|huntington|huntington
493282|NCT01458470|huntingtin|huntingtin
493283|NCT01458470|memantine|memantine
493284|NCT01458470|ebixa|ebixa
493285|NCT01458470|namenda|namenda
493286|NCT01458444|Respiratory Insufficiency|respiratory insufficiency
493287|NCT01458444|Cardiothoracic Surgery|cardiothoracic surgery
493288|NCT01458444|Ventilation system|ventilation system
493289|NCT01458431|cesarean section|cesarean section
493290|NCT01458431|wound infusion|wound infusion
493291|NCT01458431|Local anesthetic levobupivacaine|local anesthetic levobupivacaine
493292|NCT01458431|Pain management|pain management
493293|NCT01458418|Eosinophil|eosinophil
493294|NCT01458418|Esophagitis|esophagitis
493295|NCT01458405|Myocardial Infarction|myocardial infarction
493296|NCT01458405|Heart Attack|heart attack
493297|NCT01458405|Stem cell|stem cell
493298|NCT01458405|Left ventricular dysfunction|left ventricular dysfunction
493299|NCT01458405|Congestive heart failure|congestive heart failure
493300|NCT01458366|Non-Hodgkin's Lymphoma|non-hodgkin's lymphoma
493301|NCT01458366|Lymphoma|lymphoma
493302|NCT01458366|B-Cell Lymphoma|b-cell lymphoma
493303|NCT01458353|Right-sided colon cancer|right-sided colon cancer
493304|NCT01458353|Ileocolonic anastomosis|ileocolonic anastomosis
493305|NCT01458353|stapled anastomosis|stapled anastomosis
493306|NCT01458353|handsewn anastomosis|handsewn anastomosis
493307|NCT01458353|peritoneal contamination|peritoneal contamination
493308|NCT01458353|microbiological spectrum|microbiological spectrum
493309|NCT01458340|Adult ADHD|adult adhd
493310|NCT01458340|Attention-Deficit/Hyperactivity Disorder|attention-deficit/hyperactivity disorder
493311|NCT01458327|MDMA|mdma
493312|NCT01458327|PTSD|ptsd
493313|NCT01458327|psychotherapy|psychotherapy
493314|NCT01458314|Physical exercise|physical exercise
493315|NCT01458314|Rehabilitation|rehabilitation
493316|NCT01458314|NIV|niv
493317|NCT01458301|Drug Therapy|drug therapy
493318|NCT01458275|Seasonal Allergic Rhinitis|seasonal allergic rhinitis
493319|NCT01458275|Ciclesonide|ciclesonide
493320|NCT01458275|Ciclesonide Nasal Aerosol|ciclesonide nasal aerosol
493321|NCT01458262|cerebral oxymetry|cerebral oxymetry
493322|NCT01458262|systemic oxymetry|systemic oxymetry
493323|NCT01458262|hepatic surgery|hepatic surgery
493324|NCT01458262|liver transplantation|liver transplantation
493325|NCT01458249|Soft Tissue Sarcoma|soft tissue sarcoma
493326|NCT01458223|spine surgery|spine surgery
493327|NCT01458223|postoperative infection|postoperative infection
493328|NCT01458223|postoperative antibiotics|postoperative antibiotics
493329|NCT01458197|Overactive Bladder|overactive bladder
493330|NCT01458197|Tarafenacin|tarafenacin
493331|NCT01458184|risk factors for complications|risk factors for complications
493332|NCT01458184|precarious medical situations|precarious medical situations
493333|NCT01458171|Immune globulin subcutaneous|immune globulin subcutaneous
493334|NCT01458171|SCIG|scig
493335|NCT01458171|Primary immunodeficiency|primary immunodeficiency
493336|NCT01458171|PID|pid
493337|NCT01458158|Gelatinases|gelatinases
493338|NCT01458158|kidney disease|kidney disease
493339|NCT01458158|diabetes mellitus type 2|diabetes mellitus type 2
493340|NCT01458132|subject follow-up|subject follow-up
493341|NCT01458132|HIV infection|hiv infection
493342|NCT01458132|registry|registry
493343|NCT01458132|seizures|seizures
493344|NCT01458132|GSK2248761|gsk2248761
493345|NCT01458119|Amicus Therapeutics|amicus therapeutics
493346|NCT01458119|AT1001|at1001
493347|NCT01458119|Galafold|galafold
493348|NCT01458119|Migalastat|migalastat
493349|NCT01458080|ENABLE|enable
493350|NCT01458080|invasive procedures|invasive procedures
493351|NCT01458080|Thrombocytopenia|thrombocytopenia
493352|NCT01458080|Thromboembolic events|thromboembolic events
493353|NCT01458080|Eltrombopag|eltrombopag
493354|NCT01458080|Hepatitis C|hepatitis c
493355|NCT01458080|HCV|hcv
493356|NCT01458054|pharmacokinetics|pharmacokinetics
493357|NCT01458054|omeprazole|omeprazole
493358|NCT01458054|ritonavir|ritonavir
493359|NCT01458054|healthy subjects|healthy subjects
493360|NCT01458054|drug interaction|drug interaction
493361|NCT01458041|Critical limb ischaemia|critical limb ischaemia
493362|NCT01458041|Iloprost|iloprost
493363|NCT01458041|Quality of life|quality of life
493364|NCT01458041|Visual analogue scale|visual analogue scale
493365|NCT01458028|BAY85-3934|bay85-3934
493366|NCT01458028|pharmacokinetics|pharmacokinetics
493367|NCT01458028|age|age
493368|NCT01458028|gender|gender
493369|NCT01458015|QST|qst
493370|NCT01458015|neuropathic pain|neuropathic pain
493371|NCT01458015|tapentadol pr|tapentadol pr
493372|NCT01458015|oxycodone|oxycodone
493373|NCT01457989|retention rate|retention rate
493374|NCT01457989|epilepsy|epilepsy
493375|NCT01457989|responder rate|responder rate
493376|NCT01457989|seizure freedom|seizure freedom
493976|NCT01455389|PK|pk
493377|NCT01457989|discontinuation rate|discontinuation rate
493378|NCT01457989|safety assessment|safety assessment
493379|NCT01457989|reduction in seizure frequency|reduction in seizure frequency
493380|NCT01457989|open-label|open-label
493381|NCT01457976|cancer|cancer
493382|NCT01457976|obesity|obesity
493383|NCT01457976|personal responsibility|personal responsibility
493384|NCT01457950|denosumab|denosumab
493385|NCT01457950|Republic of Korea|republic of korea
493386|NCT01457950|dual energy x-ray absorptiometry|dual energy x-ray absorptiometry
493387|NCT01457937|HCV|hcv
493388|NCT01457937|Menopause|menopause
493389|NCT01457937|Peg IFN|peg ifn
493390|NCT01457937|Ribavirin|ribavirin
493391|NCT01457937|Boceprevir|boceprevir
493392|NCT01457924|Relapsing Remitting Multiple Sclerosis|relapsing remitting multiple sclerosis
493393|NCT01457924|Ofatumumab|ofatumumab
493394|NCT01457898|Cardiac surgery|cardiac surgery
493395|NCT01457898|Non-invasive ventilation|non-invasive ventilation
493396|NCT01457885|AML|aml
493397|NCT01457872|Heroin addiction|heroin addiction
493398|NCT01457872|Substance use disorders|substance use disorders
493399|NCT01457872|Substitution treatment|substitution treatment
493400|NCT01457872|Syringe exchange|syringe exchange
493401|NCT01457846|gastro-oesophageal junction cancer|gastro-oesophageal junction cancer
493402|NCT01457846|gastric cancer|gastric cancer
493403|NCT01457846|lower third oesophageal cancer|lower third oesophageal cancer
493404|NCT01457846|polysomy|polysomy
493405|NCT01457846|amplification|amplification
493406|NCT01457846|FGFR|fgfr
493407|NCT01457820|Allopurinol|allopurinol
493408|NCT01457820|Angina|angina
493409|NCT01457820|Acute coronary syndrome|acute coronary syndrome
493410|NCT01457807|Phase 1|phase 1
493411|NCT01457807|Parkinson's disease|parkinson's disease
493412|NCT01457807|pharmacodynamic|pharmacodynamic
493413|NCT01457807|biomarkers|biomarkers
493414|NCT01457807|pharmacokinetics|pharmacokinetics
493415|NCT01457807|extended release formulation|extended release formulation
493416|NCT01457794|Metabolic Syndrome X|metabolic syndrome x
493417|NCT01457794|Fatty Acids, Omega-3|fatty acids, omega-3
493418|NCT01457794|Learning|learning
493419|NCT01457794|Attention|attention
493420|NCT01457794|Nutritional Status|nutritional status
493421|NCT01457794|Nutrition Assessments|nutrition assessments
493422|NCT01457794|Body Weight|body weight
493423|NCT01457794|Physical Activity|physical activity
493424|NCT01457794|Sleep|sleep
493425|NCT01457794|Child Nutrition Sciences|child nutrition sciences
493426|NCT01457781|Inhaled nitric oxide|inhaled nitric oxide
493427|NCT01457781|pulmonary arterial hypertension|pulmonary arterial hypertension
493428|NCT01457781|pulmonary hypertension|pulmonary hypertension
493429|NCT01457781|PAH|pah
493430|NCT01457768|Hepatitis C|hepatitis c
493431|NCT01457768|HCV|hcv
493432|NCT01457768|Sustained Virologic Response|sustained virologic response
493433|NCT01457768|Direct Acting Antiviral|direct acting antiviral
493434|NCT01457768|Combination Therapy|combination therapy
493435|NCT01457768|Tegobuvir|tegobuvir
493436|NCT01457768|Registry|registry
493437|NCT01457768|HCV RNA|hcv rna
493438|NCT01457768|Treatment experienced|treatment experienced
493439|NCT01457768|Treatment naive|treatment naive
493440|NCT01457768|GS 9451|gs 9451
493441|NCT01457768|GS 5885|gs 5885
493442|NCT01457768|Sequence|sequence
493443|NCT01457768|GS 5816|gs 5816
493444|NCT01457768|GS 7977|gs 7977
493445|NCT01457768|Sofosbuvir|sofosbuvir
493446|NCT01457768|Sovaldi™|sovaldi™
493447|NCT01457768|SOF|sof
493448|NCT01457768|Ledipasvir|ledipasvir
493449|NCT01457768|LDV|ldv
493450|NCT01457755|Hepatitis C|hepatitis c
493451|NCT01457755|HCV|hcv
493452|NCT01457755|Sustained Virologic Response|sustained virologic response
493453|NCT01457755|Direct Acting Antiviral|direct acting antiviral
493454|NCT01457755|Combination Therapy|combination therapy
493455|NCT01457755|Tegobuvir|tegobuvir
493456|NCT01457755|Registry|registry
493457|NCT01457755|HCV RNA|hcv rna
493458|NCT01457755|Treatment experienced|treatment experienced
493459|NCT01457755|Treatment naive|treatment naive
493460|NCT01457755|GS 9451|gs 9451
493461|NCT01457755|GS 5885|gs 5885
493462|NCT01457755|GS 7977|gs 7977
493463|NCT01457755|GS 5816|gs 5816
493464|NCT01457755|Sofosbuvir|sofosbuvir
493465|NCT01457755|Sovaldi™|sovaldi™
493466|NCT01457755|SOF|sof
493467|NCT01457755|Ledipasvir|ledipasvir
493468|NCT01457755|LDV|ldv
493469|NCT01457742|Osteoarthritis|osteoarthritis
493470|NCT01457729|ergometer|ergometer
493471|NCT01457729|training|training
493472|NCT01457729|motivation|motivation
493473|NCT01457729|telemonitoring|telemonitoring
493474|NCT01457729|sleep apnea|sleep apnea
493475|NCT01457716|Healthy volunteer study|healthy volunteer study
493476|NCT01457703|LH pulsatility|lh pulsatility
493477|NCT01457703|Obesity|obesity
493478|NCT01457703|Reproduction|reproduction
493479|NCT01457690|Vitamin E pegylated|vitamin e pegylated
493480|NCT01457690|chylomicron retention|chylomicron retention
493481|NCT01457690|Familial Hypocholesterolemia|familial hypocholesterolemia
493482|NCT01457690|Hypobetalipoproteinemias|hypobetalipoproteinemias
493483|NCT01457651|Recruitment|recruitment
493484|NCT01457651|Coronary artery bypass grafting|coronary artery bypass grafting
493485|NCT01457651|Postoperative period|postoperative period
493486|NCT01457638|nasal obstruction|nasal obstruction
493487|NCT01457638|rhinoplasty|rhinoplasty
493488|NCT01457638|turbinate surgery|turbinate surgery
493489|NCT01457638|quality of life|quality of life
493490|NCT01457638|acoustic rhinometry|acoustic rhinometry
493491|NCT01457625|fetuin A liver fat content visceral obesity mortality|fetuin a liver fat content visceral obesity mortality
493492|NCT01457612|Insulin Resistant|insulin resistant
493493|NCT01457612|Dietary Supplements|dietary supplements
493494|NCT01457612|Nutrition|nutrition
493495|NCT01457612|Antioxidant|antioxidant
493496|NCT01457612|Inflammation|inflammation
493497|NCT01457599|liver-colorectal metastases-computertomography-guided-wire-chemotherapy-complete response|liver-colorectal metastases-computertomography-guided-wire-chemotherapy-complete response
493498|NCT01457599|Feasibility, safety|feasibility, safety
493499|NCT01457586|Heart Surgery|heart surgery
493500|NCT01457586|Blood Transfusion|blood transfusion
493501|NCT01457586|Postoperative Complications|postoperative complications
493502|NCT01457560|Oral polio vaccine (OPV)|oral polio vaccine (opv)
493503|NCT01457560|DTPa-HBV-IPV/Hib vaccine|dtpa-hbv-ipv/hib vaccine
493504|NCT01457547|HEXAVACTM|hexavactm
493505|NCT01457547|InfanrixTM HEXA|infanrixtm hexa
493506|NCT01457547|DTPa-HBV-IPV-Hib|dtpa-hbv-ipv-hib
493507|NCT01457547|DTPa-HBV-IPV/Hib|dtpa-hbv-ipv/hib
493508|NCT01457521|pain|pain
493509|NCT01457521|medical abortion|medical abortion
493510|NCT01457508|combination vaccine|combination vaccine
493511|NCT01457508|DTPa-HBV-IPV|dtpa-hbv-ipv
493512|NCT01457508|Hib|hib
493513|NCT01457495|Infants|infants
493514|NCT01457495|combined vaccine|combined vaccine
493515|NCT01457495|DTPa-HBV-IPV/Hib|dtpa-hbv-ipv/hib
493516|NCT01457495|DTPa-IPV/Hib|dtpa-ipv/hib
493517|NCT01457495|safety|safety
493518|NCT01457495|Immunogenicity|immunogenicity
493519|NCT01457495|HBV|hbv
493520|NCT01457482|Fear|fear
493521|NCT01457482|Childbirth|childbirth
493522|NCT01457482|Art therapy|art therapy
493523|NCT01457482|Therapeutic conversations|therapeutic conversations
493524|NCT01457482|W-DEQ|w-deq
493525|NCT01457456|Biomarker|biomarker
493526|NCT01457456|Morquio Disease|morquio disease
493527|NCT01457443|Pompe Disease|pompe disease
493528|NCT01457443|Biomarker|biomarker
493529|NCT01457417|Cancer|cancer
493530|NCT01457417|Oncology|oncology
493531|NCT01457404|integrated cognitive behavioral therapy|integrated cognitive behavioral therapy
493532|NCT01457404|cognitive behavioral therapy|cognitive behavioral therapy
493533|NCT01457404|addiction|addiction
493534|NCT01457404|posttraumatic stress disorder (PTSD)|posttraumatic stress disorder (ptsd)
493535|NCT01457391|cognitive behavioral therapy|cognitive behavioral therapy
493536|NCT01457391|addiction|addiction
493537|NCT01457391|posttraumatic stress disorder (PTSD)|posttraumatic stress disorder (ptsd)
493538|NCT01457378|Gastrointestinal symptoms|gastrointestinal symptoms
493539|NCT01457378|healthy subjects|healthy subjects
493540|NCT01457378|IBS|ibs
493541|NCT01457378|HRQoL|hrqol
493542|NCT01457378|questionnaires|questionnaires
493543|NCT01457352|spasticity|spasticity
493544|NCT01457339|Schizophrenia|schizophrenia
493545|NCT01457326|Immersion therapy|immersion therapy
493546|NCT01457326|early weight bearing physical therapy|early weight bearing physical therapy
493547|NCT01457300|Rehabilitation outcome|rehabilitation outcome
493548|NCT01457300|Aged|aged
493549|NCT01457300|Aged, 80 and over|aged, 80 and over
493550|NCT01457300|Activities of daily living|activities of daily living
493551|NCT01457274|AMBULATORY CARE|ambulatory care
493552|NCT01457274|AWARENESS AND RECALL|awareness and recall
493553|NCT01457274|Propofol|propofol
493554|NCT01457274|Patient Safety and Satisfaction|patient safety and satisfaction
493555|NCT01457274|Colonoscopy|colonoscopy
493556|NCT01457274|Elective outpatient colonoscopy|elective outpatient colonoscopy
493557|NCT01457274|Procedural sedation|procedural sedation
493558|NCT01457261|interstitial lung disease|interstitial lung disease
493559|NCT01457261|drug deposition|drug deposition
493560|NCT01457261|lung imaging|lung imaging
493561|NCT01457261|respiratory|respiratory
493562|NCT01457248|after aortic surgery|after aortic surgery
493563|NCT01457235|Bipolar disorder|bipolar disorder
493564|NCT01457235|Cognitive Remediation|cognitive remediation
493565|NCT01457235|Cognition|cognition
493566|NCT01457235|Cognitive function|cognitive function
493567|NCT01457235|Mood disorders|mood disorders
493568|NCT01457235|Affective disorders|affective disorders
493569|NCT01457222|Mindfulness|mindfulness
493570|NCT01457222|Stress|stress
493571|NCT01457222|Cognition|cognition
493572|NCT01457222|Psychological health|psychological health
493573|NCT01457222|Primary prevention|primary prevention
493574|NCT01457209|PCOS|pcos
493575|NCT01457209|Insulin resistance|insulin resistance
493576|NCT01457209|Acupuncture|acupuncture
493577|NCT01457196|Cancer Genetics|cancer genetics
493578|NCT01457183|pulsed lavage|pulsed lavage
493579|NCT01457183|evaluate containment|evaluate containment
493580|NCT01457183|evaluate tolerability|evaluate tolerability
493581|NCT01457170|Pulmonary Hypertension|pulmonary hypertension
493582|NCT01457170|Heart Failure|heart failure
493584|NCT01457170|Haemodynamics|haemodynamics
493585|NCT01457170|pulmonary vascular resistance|pulmonary vascular resistance
493586|NCT01457170|cardiac output|cardiac output
493587|NCT01457144|Mantle cell lymphoma|mantle cell lymphoma
493588|NCT01457144|Rituximab|rituximab
493589|NCT01457144|bendamustine|bendamustine
493590|NCT01457144|Velcade|velcade
493591|NCT01457144|Dexamethasone|dexamethasone
493592|NCT01457131|Metastatic Cancer|metastatic cancer
493593|NCT01457131|Immunotherapy|immunotherapy
493594|NCT01457131|Gene Therapy|gene therapy
493595|NCT01457131|Metastatic Melanoma|metastatic melanoma
493596|NCT01457131|Metastatic Kidney Cancer|metastatic kidney cancer
493597|NCT01457118|Open Label multicenter extension study advanced solid tumors|open label multicenter extension study advanced solid tumors
493598|NCT01457105|Malignant strictures of the main biliary duct|malignant strictures of the main biliary duct
493599|NCT01457092|benign biliary strictures|benign biliary strictures
493600|NCT01457092|chronic pancreatitis|chronic pancreatitis
493601|NCT01457079|Keloid|keloid
493602|NCT01457079|Radiation Therapy|radiation therapy
493603|NCT01457079|Hypertrophic Scar|hypertrophic scar
493604|NCT01457053|Acute decompensated heart failure|acute decompensated heart failure
493605|NCT01457053|Myocardial blood flow|myocardial blood flow
493606|NCT01457053|Coronary flow reserve|coronary flow reserve
493607|NCT01457053|Ultrafiltration|ultrafiltration
493608|NCT01457053|Diuretics|diuretics
493609|NCT01457040|Acute Lymphoblastic leukemia|acute lymphoblastic leukemia
493610|NCT01457040|Hematopoietic Stem Cell Transplantation|hematopoietic stem cell transplantation
493611|NCT01457027|Influenza|influenza
493612|NCT01457027|Virus|virus
493613|NCT01457027|Vaccination|vaccination
493614|NCT01457027|Immunisation|immunisation
493615|NCT01457014|chronic pain|chronic pain
493616|NCT01457014|sleep disordered breathing|sleep disordered breathing
493617|NCT01457014|Opioids|opioids
493618|NCT01457001|chronic haemodialysis|chronic haemodialysis
493619|NCT01457001|25-OH-D vitamin|25-oh-d vitamin
493620|NCT01456975|Ascending aorta aneurism|ascending aorta aneurism
493621|NCT01456975|Aortic insufficiency|aortic insufficiency
493622|NCT01456962|Immune reconstitution|immune reconstitution
493623|NCT01456962|CD4+ T cells|cd4+ t cells
493624|NCT01456949|Atrial fibrillation (AF)|atrial fibrillation (af)
493625|NCT01456949|Paroxysmal atrial fibrillation (PAF)|paroxysmal atrial fibrillation (paf)
493626|NCT01456949|Arrythmias|arrythmias
493627|NCT01456949|Cardiac Arrythmias|cardiac arrythmias
493628|NCT01456949|Cardiac ablation|cardiac ablation
493629|NCT01456949|Cryoablation|cryoablation
493630|NCT01456936|smoking cessation|smoking cessation
493631|NCT01456936|psychiatric disease|psychiatric disease
493632|NCT01456923|DNA damaging agents|dna damaging agents
493633|NCT01456910|Physical education|physical education
493634|NCT01456910|People with mental disabilities|people with mental disabilities
493635|NCT01456910|muscular strength dynamometer|muscular strength dynamometer
493636|NCT01456910|Performance Evaluation|performance evaluation
493637|NCT01456910|Occupational health|occupational health
493638|NCT01456884|Music therapy|music therapy
493639|NCT01456884|Infants|infants
493640|NCT01456884|Children|children
493641|NCT01456884|Adolescents|adolescents
493642|NCT01456884|pediatric|pediatric
493643|NCT01456884|palliative care|palliative care
493644|NCT01456884|neurological impairment|neurological impairment
493645|NCT01456884|metabolic condition|metabolic condition
493646|NCT01456884|pain management|pain management
493647|NCT01456871|Mechanoreceptors|mechanoreceptors
493648|NCT01456871|PIP joint|pip joint
493649|NCT01456871|Ligamento-muscular reflexes|ligamento-muscular reflexes
493650|NCT01456858|Malaria Prevention Refugee Emergency|malaria prevention refugee emergency
493651|NCT01456858|Malaria, Falciparum C03.752.530.650|malaria, falciparum c03.752.530.650
493652|NCT01456845|Plasma levels|plasma levels
493653|NCT01456845|isoniazid|isoniazid
493654|NCT01456845|rifampicin|rifampicin
493655|NCT01456845|pyrazinamide|pyrazinamide
493656|NCT01456845|hepatoxicity|hepatoxicity
493657|NCT01456832|hyponatremia|hyponatremia
493658|NCT01456832|renal transplant|renal transplant
493659|NCT01456819|autologous|autologous
493660|NCT01456819|bone marrow|bone marrow
493661|NCT01456819|critical limb ischemia|critical limb ischemia
493662|NCT01456819|efficacy|efficacy
493663|NCT01456819|mesenchymal stem cells|mesenchymal stem cells
493664|NCT01456819|mononuclear cells|mononuclear cells
493665|NCT01456806|T2DM|t2dm
493666|NCT01456806|Cardiovascular risk factors|cardiovascular risk factors
493667|NCT01456806|Metabolic control|metabolic control
493668|NCT01456806|Well-being|well-being
493669|NCT01456806|Cost|cost
493670|NCT01456806|Cost-consequence|cost-consequence
493671|NCT01456793|Pregnancy prevention|pregnancy prevention
493672|NCT01456793|Pregnancy|pregnancy
493673|NCT01456793|Birth|birth
493674|NCT01456793|Contraceptive use|contraceptive use
493675|NCT01456793|Adolescents|adolescents
493676|NCT01456780|Meibomian gland dysfunction|meibomian gland dysfunction
493677|NCT01456780|Blepharitis|blepharitis
493678|NCT01456780|Dry Eye|dry eye
493679|NCT01456780|Ocular Inflammation|ocular inflammation
493682|NCT01456780|Lotemax|lotemax
493683|NCT01456780|Artificial Tear|artificial tear
493684|NCT01456754|Insulin Metabolism|insulin metabolism
493685|NCT01456754|Glucose Metabolism|glucose metabolism
493686|NCT01456754|Substrate Partitioning|substrate partitioning
493687|NCT01456754|Muscle Biopsies|muscle biopsies
493688|NCT01456754|Feeding Frequency|feeding frequency
493689|NCT01456754|Insulin|insulin
493690|NCT01456741|endobronchial needle aspiration (EBNA)|endobronchial needle aspiration (ebna)
493691|NCT01456741|transbronchial needle aspiration (TBNA)|transbronchial needle aspiration (tbna)
493692|NCT01456741|rapid on-site evaluation (ROSE)|rapid on-site evaluation (rose)
493693|NCT01456741|lung cancer|lung cancer
493694|NCT01456728|Helicobacter pylori|helicobacter pylori
493695|NCT01456728|Progastria|progastria
493696|NCT01456728|Lactobacillus reuteri|lactobacillus reuteri
493697|NCT01456728|omeprazole|omeprazole
493698|NCT01456728|triple therapy|triple therapy
493699|NCT01456728|probiotic|probiotic
493700|NCT01456715|Human Papillomavirus Vaccines|human papillomavirus vaccines
493701|NCT01456715|Immunogenicity Gardasil Cervarix|immunogenicity gardasil cervarix
493702|NCT01456715|Booster dose|booster dose
493703|NCT01456702|SVV|svv
493704|NCT01456702|hemodynamic monitoring|hemodynamic monitoring
493705|NCT01456702|goal-directed volume therapie|goal-directed volume therapie
493706|NCT01456689|Myeloma|myeloma
493707|NCT01456689|Multiple Myeloma|multiple myeloma
493708|NCT01456689|MM|mm
493709|NCT01456676|LDE225|lde225
493710|NCT01456676|nilotinib|nilotinib
493711|NCT01456676|Chronic myeloid leukemia|chronic myeloid leukemia
493712|NCT01456676|CML|cml
493713|NCT01456676|Philadelphia positive|philadelphia positive
493714|NCT01456676|Ph+|ph+
493715|NCT01456676|resistant|resistant
710253|NCT00589563|childhood favorable prognosis Hodgkin lymphoma|childhood favorable prognosis hodgkin lymphoma
710746|NCT00588120|Oxalate Diet|oxalate diet
493716|NCT01456676|Resistant Philadelphia chromosome positive chronic myeloid leukemia (Ph+ CML) in chronic phase (CP)|resistant philadelphia chromosome positive chronic myeloid leukemia (ph+ cml) in chronic phase (cp)
493717|NCT01456663|AFQ056|afq056
493718|NCT01456663|Hepatic impairment|hepatic impairment
493719|NCT01456663|Hepatic impaired|hepatic impaired
493720|NCT01456650|Type 2 diabetes|type 2 diabetes
493721|NCT01456650|ABCA1 alleles|abca1 alleles
493722|NCT01456650|Glyburide|glyburide
493723|NCT01456637|Insomnia|insomnia
493724|NCT01456637|Intervention|intervention
493725|NCT01456637|Self-help|self-help
493726|NCT01456637|Internet|internet
493727|NCT01456598|Stomach neoplasm|stomach neoplasm
493728|NCT01456598|Laparoscopy|laparoscopy
493729|NCT01456585|Histological documentation|histological documentation
493730|NCT01456585|primary adenocarcinoma of the pancreas|primary adenocarcinoma of the pancreas
493731|NCT01456585|surgically eligible|surgically eligible
493732|NCT01456585|tumor resection|tumor resection
493733|NCT01456585|curative intent|curative intent
493734|NCT01456572|glucagon-like peptide-1|glucagon-like peptide-1
493735|NCT01456572|peptide tyrosine tyrosine|peptide tyrosine tyrosine
493736|NCT01456572|ghrelin|ghrelin
493737|NCT01456572|stomach|stomach
493738|NCT01456572|small intestine|small intestine
493739|NCT01456572|gastric emptying|gastric emptying
493740|NCT01456559|Hypovolemia|hypovolemia
493741|NCT01456559|Lower body negative pressure|lower body negative pressure
493742|NCT01456559|Photoplethysmography|photoplethysmography
493743|NCT01456546|CYP2C19*17|cyp2c19*17
493744|NCT01456546|Pharmacokinetics|pharmacokinetics
493745|NCT01456546|Pharmacodynamics|pharmacodynamics
493746|NCT01456533|hyponatremia|hyponatremia
493747|NCT01456533|hypernatremia|hypernatremia
493748|NCT01456520|pharmacokinetics|pharmacokinetics
493749|NCT01456520|bioequivalence|bioequivalence
493750|NCT01456520|hydrocodone|hydrocodone
493751|NCT01456520|acetaminophen|acetaminophen
493752|NCT01456520|moderate to moderately severe pain|moderate to moderately severe pain
493753|NCT01456507|Food effect|food effect
493754|NCT01456507|bioavailability|bioavailability
493755|NCT01456507|oxycodone|oxycodone
493756|NCT01456507|sequestered Naltrexone|sequestered naltrexone
493757|NCT01456507|management of moderate to severe pain|management of moderate to severe pain
493758|NCT01456494|Obstructive Lung Disease|obstructive lung disease
493759|NCT01456494|COPD|copd
493760|NCT01456494|Asthma|asthma
493761|NCT01456494|Inhaler|inhaler
493762|NCT01456494|Metered-Dose Inhaler|metered-dose inhaler
493763|NCT01456494|Education|education
493764|NCT01456494|Hospital-based education|hospital-based education
493765|NCT01456481|reflex fainting|reflex fainting
493766|NCT01456481|vasovagal syncope|vasovagal syncope
493767|NCT01456481|midodrine|midodrine
493768|NCT01456468|Cholangitis, Sclerosing|cholangitis, sclerosing
493769|NCT01456468|Tretinoin|tretinoin
493770|NCT01456468|Ursodeoxycholic Acid|ursodeoxycholic acid
493771|NCT01456455|Central nervous system|central nervous system
493772|NCT01456455|pathological markers|pathological markers
493773|NCT01456429|invasive staging|invasive staging
493774|NCT01456429|mediastinal lymph nodes|mediastinal lymph nodes
493775|NCT01456429|endosonography|endosonography
493776|NCT01456429|surgical staging|surgical staging
493777|NCT01456429|lung cancer|lung cancer
493778|NCT01456416|RRMS|rrms
493779|NCT01456416|Multiple Sclerosis|multiple sclerosis
493780|NCT01456416|Glatiramer Acetate|glatiramer acetate
493781|NCT01456416|Autoimmune Comorbidities|autoimmune comorbidities
493782|NCT01456416|Psoriasis|psoriasis
493783|NCT01456416|Autoimmune Thyroiditis|autoimmune thyroiditis
493784|NCT01456416|Vasculitis|vasculitis
493785|NCT01456416|Rheumatoid Arthritis|rheumatoid arthritis
493787|NCT01456403|endarterectomy|endarterectomy
493788|NCT01456403|vulnerable plaque|vulnerable plaque
493789|NCT01456403|Ultrasound|ultrasound
493790|NCT01456403|MRI|mri
493791|NCT01456403|PET/CT|pet/ct
493792|NCT01456390|Open angle glaucoma|open angle glaucoma
493793|NCT01456390|Prior trabeculectomy|prior trabeculectomy
493794|NCT01456377|lumbar stenosis|lumbar stenosis
493795|NCT01456377|systemic corticosteroids|systemic corticosteroids
493796|NCT01456377|outcome|outcome
493797|NCT01456377|security|security
493798|NCT01456364|clopidogrel low response|clopidogrel low response
493799|NCT01456364|ticagrelor|ticagrelor
493800|NCT01456364|prasugrel|prasugrel
493801|NCT01456364|platelet aggregation|platelet aggregation
493802|NCT01456351|Event free survival|event free survival
493803|NCT01456351|Remission rates|remission rates
493804|NCT01456351|Toxicity|toxicity
493805|NCT01456351|Overall survival|overall survival
493806|NCT01456351|Efficiency costs|efficiency costs
493807|NCT01456351|Recurrent low grade|recurrent low grade
493808|NCT01456338|cognitive behavior therapy|cognitive behavior therapy
493809|NCT01456338|addiction|addiction
493810|NCT01456338|posttraumatic stress disorder (PTSD)|posttraumatic stress disorder (ptsd)
493811|NCT01456312|Peginterferon alfa 2a|peginterferon alfa 2a
493812|NCT01456312|Entecavir|entecavir
493813|NCT01456312|Response Guided Therapy|response guided therapy
493814|NCT01456312|Chronic Hepatitis B|chronic hepatitis b
493815|NCT01456299|laryngeal mask airway|laryngeal mask airway
493816|NCT01456299|insertion|insertion
493817|NCT01456299|sevoflurane|sevoflurane
493818|NCT01456299|remifentanil|remifentanil
493819|NCT01456273|biopsychosocial model|biopsychosocial model
493820|NCT01456273|biomedical model|biomedical model
493821|NCT01456273|functional dyspepsia|functional dyspepsia
493822|NCT01456260|Drug Therapy|drug therapy
493823|NCT01456247|Drug Therapy|drug therapy
493824|NCT01456221|Obesity|obesity
493825|NCT01456221|Insulin resistance|insulin resistance
493826|NCT01456221|Omega3 long chain polyunsaturated fatty acids|omega3 long chain polyunsaturated fatty acids
493827|NCT01456195|Drug Therapy|drug therapy
493828|NCT01456169|High Blood Pressure|high blood pressure
493829|NCT01456169|Drug Therapy|drug therapy
493830|NCT01456156|hepatocellular carcinoma|hepatocellular carcinoma
493831|NCT01456156|postoperative radiotherapy|postoperative radiotherapy
493832|NCT01456143|Squamous Cell Carcinoma|squamous cell carcinoma
493833|NCT01456143|Neoplasia|neoplasia
493834|NCT01456143|Optical imaging|optical imaging
493835|NCT01456143|Head and Neck Cancer|head and neck cancer
493836|NCT01456143|Oropharynx|oropharynx
493837|NCT01456143|Larynx|larynx
493838|NCT01456143|Oral Cavity|oral cavity
493839|NCT01456117|Drug Therapy|drug therapy
493840|NCT01456117|pharmacodynamics|pharmacodynamics
493841|NCT01456117|pharmacokinetics|pharmacokinetics
493842|NCT01456104|vaccine|vaccine
493843|NCT01456104|stage IIB|stage iib
493844|NCT01456104|stage IIC|stage iic
493845|NCT01456104|stage III|stage iii
493846|NCT01456104|stage IV (MIa)|stage iv (mia)
493847|NCT01456104|Langerhans-type dendritic cells|langerhans-type dendritic cells
493848|NCT01456104|Immune Responses|immune responses
493849|NCT01456104|10-229|10-229
493850|NCT01456091|adolescent pregnancy|adolescent pregnancy
493851|NCT01456091|adolescent birth|adolescent birth
493852|NCT01456091|rapid repeat pregnancy|rapid repeat pregnancy
493853|NCT01456091|rapid repeat birth|rapid repeat birth
493854|NCT01456091|youth development|youth development
493855|NCT01456091|Pregnancy in Adolescence|pregnancy in adolescence
493856|NCT01456078|Neuroendocrine tumor|neuroendocrine tumor
493857|NCT01456078|Liver metastases|liver metastases
493858|NCT01456078|177Lu-DOTA-TATE|177lu-dota-tate
493859|NCT01456078|Safety|safety
493860|NCT01456078|Kidney dosimetry|kidney dosimetry
493861|NCT01456078|Dose escalation|dose escalation
493862|NCT01456078|Neuroendocrine tumors, with liver metastases.|neuroendocrine tumors, with liver metastases.
493863|NCT01456026|Diabetes|diabetes
493864|NCT01456026|Advanced glycation endproducts|advanced glycation endproducts
493865|NCT01456026|Endothelium|endothelium
493866|NCT01456000|atrial fibrillation|atrial fibrillation
493867|NCT01456000|AF|af
493868|NCT01456000|PAF|paf
493869|NCT01456000|PVI|pvi
493870|NCT01456000|ablation|ablation
493871|NCT01456000|paroxysmal atrial fibrillation|paroxysmal atrial fibrillation
493872|NCT01456000|pulmonary vein isolation|pulmonary vein isolation
493873|NCT01455987|Osteochondritis dissecans|osteochondritis dissecans
493874|NCT01455987|Juvenile osteochondritis dissecans|juvenile osteochondritis dissecans
493875|NCT01455987|Knee|knee
493876|NCT01455987|Osteochondral|osteochondral
493877|NCT01455987|Outcome|outcome
493878|NCT01455974|hypertension|hypertension
493879|NCT01455974|arterial stiffness|arterial stiffness
493880|NCT01455974|left ventricular hypertrophy|left ventricular hypertrophy
493881|NCT01455961|Real life setting|real life setting
493882|NCT01455961|Bipolar Disorder|bipolar disorder
493883|NCT01455961|Registry based Data Base Audit|registry based data base audit
493884|NCT01455948|sinusitis|sinusitis
493885|NCT01455948|chronic|chronic
493886|NCT01455948|Functional endoscopic sinus surgery|functional endoscopic sinus surgery
493887|NCT01455948|balloon sinuplasty|balloon sinuplasty
493888|NCT01455844|Hypertriglyceridemia|hypertriglyceridemia
493889|NCT01455792|Biopsy|biopsy
493890|NCT01455792|MRI and ultrasound soft image fusion|mri and ultrasound soft image fusion
493891|NCT01455792|Gold standard TRUS biopsy|gold standard trus biopsy
493892|NCT01455779|Stress Urinary Incontinence|stress urinary incontinence
493893|NCT01455779|Incontinence|incontinence
493894|NCT01455779|SUI|sui
493895|NCT01455779|Renessa|renessa
493896|NCT01455766|postpneumonectomy pulmonary edema|postpneumonectomy pulmonary edema
493897|NCT01455766|extravascular lung water|extravascular lung water
493898|NCT01455753|Influenza|influenza
493899|NCT01455753|Proximity|proximity
493900|NCT01455740|Acquired Immunodeficiency Syndrome|acquired immunodeficiency syndrome
493901|NCT01455740|HIV|hiv
493902|NCT01455740|Commitment|commitment
493903|NCT01455740|Financial Incentives|financial incentives
493904|NCT01455727|Pharmaceutical care|pharmaceutical care
493905|NCT01455727|Diabetes Mellitus|diabetes mellitus
493906|NCT01455714|hypertenion|hypertenion
493907|NCT01455714|exertional dyspnoea|exertional dyspnoea
493908|NCT01455714|heart failure|heart failure
493909|NCT01455714|biomarkers|biomarkers
493910|NCT01455688|critically ill patients|critically ill patients
493911|NCT01455688|HIV infection|hiv infection
493912|NCT01455688|HAART|haart
493913|NCT01455688|mortality|mortality
493914|NCT01455675|cystic fibrosis|cystic fibrosis
493915|NCT01455662|cardiac arrest|cardiac arrest
493916|NCT01455649|Kidney|kidney
493917|NCT01455649|Transplant|transplant
493918|NCT01455649|Immunosuppression|immunosuppression
493919|NCT01455649|Everolimus|everolimus
493920|NCT01455649|Graft function|graft function
493921|NCT01455636|pediatric|pediatric
493922|NCT01455636|micronutrient powder|micronutrient powder
493923|NCT01455636|hand hygiene|hand hygiene
493924|NCT01455636|low birth weight|low birth weight
493925|NCT01455636|infant feeding|infant feeding
493926|NCT01455636|hand sanitizers|hand sanitizers
493927|NCT01455623|CMT|cmt
493928|NCT01455610|Computed tomography|computed tomography
493929|NCT01455610|Contrast enhancement|contrast enhancement
493930|NCT01455610|Pancreas|pancreas
493931|NCT01455610|Cancer|cancer
493932|NCT01455610|Resectability|resectability
493933|NCT01455597|Postmenopausal Women|postmenopausal women
493934|NCT01455597|Vaginal Dryness|vaginal dryness
493935|NCT01455597|Postmenopausal Vulvovaginal Atrophy|postmenopausal vulvovaginal atrophy
493936|NCT01455584|HM781-36B|hm781-36b
493937|NCT01455558|Pharmacokinetics|pharmacokinetics
493938|NCT01455545|Asthma|asthma
493939|NCT01455545|Degree of Control|degree of control
493940|NCT01455545|Exhaled Nitric Oxide|exhaled nitric oxide
493941|NCT01455545|Asthma Control Test|asthma control test
493942|NCT01455519|Low Back Pain|low back pain
493943|NCT01455519|Back Pain|back pain
493944|NCT01455519|Chronic back pain|chronic back pain
493945|NCT01455506|Acute Myeloid Leukemia (AML)|acute myeloid leukemia (aml)
493946|NCT01455506|Myelodysplastic Syndrome (MDS)|myelodysplastic syndrome (mds)
493947|NCT01455506|Bone Marrow Transplant|bone marrow transplant
493948|NCT01455506|Stem Cell Transplant|stem cell transplant
493949|NCT01455480|Second Degree Burn|second degree burn
493950|NCT01455480|partial thickness burns|partial thickness burns
493951|NCT01455467|Open angle glaucoma|open angle glaucoma
493952|NCT01455467|Pigmentary glaucoma|pigmentary glaucoma
493953|NCT01455467|Pseudoexfoliative glaucoma|pseudoexfoliative glaucoma
493954|NCT01455441|GLP-1|glp-1
493955|NCT01455441|Training|training
493956|NCT01455441|Exercise|exercise
493957|NCT01455441|Type 2 Diabetes|type 2 diabetes
493958|NCT01455428|Pregabalin|pregabalin
493959|NCT01455428|Postherpetic Neuralgia ( PHN )|postherpetic neuralgia ( phn )
494210|NCT01454362|electronic cigarette|electronic cigarette
493960|NCT01455402|Respiratory Syncytial Virus, Chronic Obstructive Pulmonary Disease, Congestive Heart Failure, Observational|respiratory syncytial virus, chronic obstructive pulmonary disease, congestive heart failure, observational
493961|NCT01455389|Lung Cancer|lung cancer
493962|NCT01455389|Non-small cell lung cancer|non-small cell lung cancer
493963|NCT01455389|NSCLC|nsclc
493964|NCT01455389|FUS1-nanoparticles|fus1-nanoparticles
493965|NCT01455389|DOTAP:Chol-TUSC2|dotap:chol-tusc2
493966|NCT01455389|DOTAP:Cholesterol-TUSC2 Liposome Complex|dotap:cholesterol-tusc2 liposome complex
493967|NCT01455389|Erlotinib|erlotinib
493968|NCT01455389|Erlotinib Hydrochloride|erlotinib hydrochloride
493969|NCT01455389|OSI-774|osi-774
493970|NCT01455389|Tarceva|tarceva
493971|NCT01455389|Dexamethasone|dexamethasone
493972|NCT01455389|Decadron|decadron
493973|NCT01455389|Diphenhydramine|diphenhydramine
493974|NCT01455389|Benadryl|benadryl
493975|NCT01455389|Benylin Cough SyrupPharmacokinetic|benylin cough syruppharmacokinetic
493977|NCT01455376|brain injury|brain injury
493978|NCT01455376|cognitive function|cognitive function
493979|NCT01455376|sodium lactate|sodium lactate
493980|NCT01455376|MMSE score|mmse score
493981|NCT01455350|provoked vestibulodynia|provoked vestibulodynia
493982|NCT01455350|multimodal physiotherapy|multimodal physiotherapy
493983|NCT01455350|lidocaine|lidocaine
493984|NCT01455337|severe alcoholic hepatitis|severe alcoholic hepatitis
493985|NCT01455324|prosthetic socket|prosthetic socket
493986|NCT01455324|residual limb volume fluctuation|residual limb volume fluctuation
493987|NCT01455324|conformable socket liner|conformable socket liner
493988|NCT01455311|cystic pancreatic tumors|cystic pancreatic tumors
493989|NCT01455311|cystic pancreatic lesions|cystic pancreatic lesions
493990|NCT01455311|gastrointestinal|gastrointestinal
493991|NCT01455311|GI|gi
493992|NCT01455311|EUS-FNA|eus-fna
493993|NCT01455311|EchoBrush®|echobrush®
493994|NCT01455311|cytology brush|cytology brush
493995|NCT01455311|endoscopic|endoscopic
493996|NCT01455298|Alpha-1 AT deficiency|alpha-1 at deficiency
493997|NCT01455298|liver injury|liver injury
493998|NCT01455298|Transient Elastography|transient elastography
493999|NCT01455298|FibroTest|fibrotest
494000|NCT01455285|dysmenorrhea|dysmenorrhea
494001|NCT01455285|transcutaneous electrical nerve stimulation (TENS|transcutaneous electrical nerve stimulation (tens
494002|NCT01455285|analgesia|analgesia
494003|NCT01455285|pain visual analog scale|pain visual analog scale
494004|NCT01455285|McGill pain questionnaire|mcgill pain questionnaire
494005|NCT01455259|AdCD40L|adcd40l
494006|NCT01455259|Adenoviral vector|adenoviral vector
494007|NCT01455259|CD40L|cd40l
494008|NCT01455259|CD154|cd154
494009|NCT01455259|malignant melanoma|malignant melanoma
494010|NCT01455246|Cirrhosis|cirrhosis
494011|NCT01455246|Nosocomial Spontaneous Bacterial Peritonitis|nosocomial spontaneous bacterial peritonitis
494012|NCT01455246|Ascites|ascites
494013|NCT01455246|Daptomycin|daptomycin
494014|NCT01455246|Meropenem|meropenem
494015|NCT01455246|Ceftazidime|ceftazidime
494016|NCT01455246|Nosocomial infection|nosocomial infection
494017|NCT01455246|Multi drug resistant bacteria|multi drug resistant bacteria
494018|NCT01455246|Sepsis|sepsis
494019|NCT01455246|Albumin|albumin
494020|NCT01455233|cornea|cornea
494021|NCT01455233|ocular antibiotic|ocular antibiotic
494022|NCT01455233|cataract surgery|cataract surgery
494023|NCT01455220|Multiple Sclerosis|multiple sclerosis
494024|NCT01455220|Sexual Dysfunction|sexual dysfunction
494025|NCT01455220|Quality of Life|quality of life
494026|NCT01455207|Magnetic Resonance Imaging|magnetic resonance imaging
494027|NCT01455207|Positon Emission Tomography|positon emission tomography
494028|NCT01455207|Behavior|behavior
494029|NCT01455194|ciclesonide|ciclesonide
494030|NCT01455194|asthma|asthma
494031|NCT01455181|PTH 1-84|pth 1-84
494032|NCT01455181|Hypoparathyroidism|hypoparathyroidism
494033|NCT01455181|NPSP558|npsp558
494034|NCT01455181|Parathyroid Hormone 1-84|parathyroid hormone 1-84
494035|NCT01455168|anterior capsule shrinkage|anterior capsule shrinkage
494036|NCT01455168|capsular tension ring|capsular tension ring
494037|NCT01455168|exfoliation syndrome|exfoliation syndrome
494038|NCT01455168|phacoemulsification and aspiration|phacoemulsification and aspiration
494039|NCT01455155|stroke|stroke
494040|NCT01455155|Art therapy|art therapy
494041|NCT01455155|Music therapy|music therapy
494042|NCT01455155|Creative therapy|creative therapy
494043|NCT01455155|Efficacy|efficacy
494044|NCT01455129|chronic obstructive pulmonary disease|chronic obstructive pulmonary disease
494045|NCT01455129|COPD|copd
494046|NCT01455129|COPD exacerbation|copd exacerbation
494047|NCT01455129|treatment|treatment
494048|NCT01455129|tiotropium|tiotropium
494049|NCT01455129|anticholinergic|anticholinergic
494050|NCT01455129|acute exacerbation of COPD (AECOPD)|acute exacerbation of copd (aecopd)
494051|NCT01455116|Sepsis|sepsis
494052|NCT01455116|Multi organ dysfunction syndrome|multi organ dysfunction syndrome
494053|NCT01455116|Mild Induced Hypothermia|mild induced hypothermia
494054|NCT01455077|obesity|obesity
494055|NCT01455077|sleep apnea|sleep apnea
494056|NCT01455077|portable monitoring|portable monitoring
494057|NCT01455025|Plerixafor granulocyte-colony stimulating factor|plerixafor granulocyte-colony stimulating factor
494058|NCT01455025|Chemotherapy in relapse|chemotherapy in relapse
494059|NCT01455025|Acute Myeloid Leukemia|acute myeloid leukemia
494060|NCT01455012|Rotigotine|rotigotine
494061|NCT01455012|Neupro|neupro
494062|NCT01455012|RLS|rls
494063|NCT01455012|Cardiovascular Risk|cardiovascular risk
494064|NCT01455012|Nocturnal Blood Pressure|nocturnal blood pressure
494065|NCT01454999|veteran|veteran
494066|NCT01454999|smoking|smoking
494067|NCT01454999|stage of change|stage of change
494068|NCT01454999|cell phone|cell phone
494069|NCT01454999|computerized tailored intervention|computerized tailored intervention
494070|NCT01454986|Healthy subjects|healthy subjects
494071|NCT01454973|type 2 diabetes|type 2 diabetes
494072|NCT01454973|beta cell function|beta cell function
494073|NCT01454973|meal tolerance test|meal tolerance test
494074|NCT01454973|maximum stimulation test|maximum stimulation test
494075|NCT01454973|method standardization|method standardization
494076|NCT01454973|insulin secretion|insulin secretion
494077|NCT01454960|Antibiotics|antibiotics
494078|NCT01454960|Inappropriate Prescribing|inappropriate prescribing
494079|NCT01454960|Respiratory Tract Infections|respiratory tract infections
494080|NCT01454960|Behavioral Research|behavioral research
494081|NCT01454947|Antibiotics|antibiotics
494082|NCT01454947|Inappropriate Prescribing|inappropriate prescribing
494083|NCT01454947|Respiratory Tract Infections|respiratory tract infections
494084|NCT01454947|Behavioral Research|behavioral research
494085|NCT01454921|HIV|hiv
494086|NCT01454921|Adolescent Trials Network|adolescent trials network
494087|NCT01454908|partial knee arthroplasty|partial knee arthroplasty
494088|NCT01454895|noise-induced hearing loss|noise-induced hearing loss
494089|NCT01454895|prevention|prevention
494090|NCT01454895|farmers|farmers
494091|NCT01454882|Direct calorimetry|direct calorimetry
494092|NCT01454882|Indirect calorimetry|indirect calorimetry
494093|NCT01454882|Energy Expenditure|energy expenditure
494094|NCT01454869|heparin|heparin
494095|NCT01454843|Myopia|myopia
494096|NCT01454843|Astigmatism|astigmatism
494097|NCT01454843|Aberrations|aberrations
494098|NCT01454843|Wavefront|wavefront
494099|NCT01454843|LASIK|lasik
494100|NCT01454843|Wavefront LASIK|wavefront lasik
494101|NCT01454830|Social support|social support
494102|NCT01454830|Cognition|cognition
494103|NCT01454830|Adaptation, psychological|adaptation, psychological
494104|NCT01454830|Health behavior|health behavior
494105|NCT01454830|Patient education|patient education
494106|NCT01454817|Quality of Life|quality of life
494107|NCT01454817|Implantable Cardiac Defibrillators|implantable cardiac defibrillators
494108|NCT01454817|ICDs|icds
494109|NCT01454804|Advanced Cancers|advanced cancers
494110|NCT01454804|Solid Tumors|solid tumors
494111|NCT01454804|Pazopanib|pazopanib
494112|NCT01454804|GW786034|gw786034
494113|NCT01454804|Lapatinib|lapatinib
494114|NCT01454804|Tykerb|tykerb
494115|NCT01454804|GW572016|gw572016
494116|NCT01454804|Trastuzumab|trastuzumab
494117|NCT01454804|Herceptin|herceptin
494118|NCT01454791|multiple sclerosis|multiple sclerosis
494119|NCT01454791|diclofenac|diclofenac
494120|NCT01454791|subcutaneous injection|subcutaneous injection
494121|NCT01454791|glatiramer acetate|glatiramer acetate
494122|NCT01454791|Copaxone|copaxone
494123|NCT01454778|restenosis|restenosis
494124|NCT01454778|peripheral vascular disease|peripheral vascular disease
494125|NCT01454778|lower extremity ischemia|lower extremity ischemia
494126|NCT01454778|claudication|claudication
494127|NCT01454752|malaria|malaria
494128|NCT01454752|anaemia|anaemia
494129|NCT01454752|cognition|cognition
494130|NCT01454752|intermittent preventive treatment|intermittent preventive treatment
494131|NCT01454752|children|children
494132|NCT01454752|schools|schools
494133|NCT01454752|insecticide-treated nets|insecticide-treated nets
494134|NCT01454739|rFVIIIFc|rfviiifc
494135|NCT01454739|A-LONG Extension|a-long extension
494136|NCT01454726|Dizziness|dizziness
494137|NCT01454726|Meniere's disease|meniere's disease
494138|NCT01454726|Diaoshi Jifa therapy|diaoshi jifa therapy
494139|NCT01454700|Type 1 diabetes mellitus|type 1 diabetes mellitus
494140|NCT01454700|Albuminuria|albuminuria
494141|NCT01454700|Late diabetes complications|late diabetes complications
494142|NCT01454700|CSII|csii
494143|NCT01454700|CGM|cgm
494144|NCT01454700|Glycaemic control|glycaemic control
494145|NCT01454661|Probiotics|probiotics
494146|NCT01454661|Premature infant|premature infant
494147|NCT01454661|Intestinal microbiota|intestinal microbiota
494148|NCT01454661|Intestinal immunity|intestinal immunity
494149|NCT01454661|Breastfeeding|breastfeeding
494150|NCT01454648|Traumatic Brain Injury|traumatic brain injury
494151|NCT01454648|EMS|ems
494152|NCT01454648|Out-of-Hospital|out-of-hospital
494153|NCT01454635|depression|depression
494154|NCT01454635|treatment response|treatment response
494155|NCT01454635|selective serotonin reuptake inhibitor|selective serotonin reuptake inhibitor
494156|NCT01454622|Healthy Volunteers|healthy volunteers
494157|NCT01454622|Bioequivalence|bioequivalence
494158|NCT01454622|Canagliflozin (JNJ-28431754)|canagliflozin (jnj-28431754)
494159|NCT01454622|Metformin IR|metformin ir
494160|NCT01454609|cervical plexus block|cervical plexus block
494161|NCT01454609|thyroidectomy|thyroidectomy
494162|NCT01454609|postoperative analgesia|postoperative analgesia
494163|NCT01454596|Cell Therapy|cell therapy
494164|NCT01454596|Gene Therapy|gene therapy
494165|NCT01454596|Immunotherapy|immunotherapy
494166|NCT01454596|Brain Cancer|brain cancer
494167|NCT01454596|Glioma|glioma
494168|NCT01454596|Glioblastoma|glioblastoma
494169|NCT01454583|renin inhibitor|renin inhibitor
494170|NCT01454583|ACE inhibitor|ace inhibitor
494171|NCT01454583|ARB (AT1 receptor blockers)|arb (at1 receptor blockers)
494172|NCT01454583|RAS blockade|ras blockade
494173|NCT01454570|exoskeleton walking system|exoskeleton walking system
494174|NCT01454570|paraplegia|paraplegia
494175|NCT01454570|paralysis|paralysis
494176|NCT01454557|Acquired Brain Injury|acquired brain injury
494177|NCT01454557|Heart Rate Variability (HRV)|heart rate variability (hrv)
494178|NCT01454557|Auditory Stimuli|auditory stimuli
494179|NCT01454557|Physical Activity|physical activity
494180|NCT01454518|hip arthroscopy|hip arthroscopy
494181|NCT01454518|post operative analgesia|post operative analgesia
494182|NCT01454505|Healthy subjects|healthy subjects
494183|NCT01454505|Nasal allergies|nasal allergies
494184|NCT01454505|Allergies|allergies
494185|NCT01454505|Environmental Exposure Chamber|environmental exposure chamber
494186|NCT01454505|EEC|eec
494187|NCT01454505|Ragweed|ragweed
494188|NCT01454492|Allergy rhinitis|allergy rhinitis
494189|NCT01454492|Geographic tongue|geographic tongue
494190|NCT01454479|Lapatinib|lapatinib
494191|NCT01454479|Ixabepilone|ixabepilone
494192|NCT01454479|HER-2|her-2
494193|NCT01454479|Endometrial Carcinoma|endometrial carcinoma
494194|NCT01454466|prevention|prevention
494195|NCT01454466|retinal break|retinal break
494196|NCT01454466|vitrectomy|vitrectomy
494197|NCT01454466|partial posterior hyaloidectomy|partial posterior hyaloidectomy
494198|NCT01454453|amisulpride|amisulpride
494199|NCT01454453|receptor occupancy|receptor occupancy
494200|NCT01454453|antipsychotic sensitivity|antipsychotic sensitivity
494201|NCT01454440|Coronary artery disease|coronary artery disease
494202|NCT01454440|Eptifibatide|eptifibatide
494203|NCT01454440|Percutaneous coronary intervention|percutaneous coronary intervention
494204|NCT01454440|stable coronary artery disease|stable coronary artery disease
494205|NCT01454440|percutaneous coronary intervention (PCI)|percutaneous coronary intervention (pci)
494206|NCT01454440|DES|des
494207|NCT01454375|Smoking|smoking
494208|NCT01454362|nicotine|nicotine
494209|NCT01454362|inhalator|inhalator
494211|NCT01454362|tobacco|tobacco
494212|NCT01454349|Benign prostatic hyperplasia|benign prostatic hyperplasia
494213|NCT01454349|BPH|bph
494214|NCT01454349|Enlarged prostate|enlarged prostate
494215|NCT01454349|Lower urinary tract symptoms (LUTS)|lower urinary tract symptoms (luts)
494216|NCT01454336|MSCs|mscs
494217|NCT01454336|Pioglitazon|pioglitazon
494218|NCT01454336|fibrosis|fibrosis
494219|NCT01454336|liver|liver
494220|NCT01454323|Chronic Myocardial Ischemia|chronic myocardial ischemia
494221|NCT01454323|Cell therapy|cell therapy
494222|NCT01454323|Bone marrow mononuclear cells|bone marrow mononuclear cells
494223|NCT01454310|Skin substitutes|skin substitutes
494224|NCT01454310|Split-thickness skin graft|split-thickness skin graft
494225|NCT01454310|Burn wound|burn wound
494226|NCT01454310|Scar formation|scar formation
494227|NCT01454310|Skin quality|skin quality
494228|NCT01454297|Myeloma|myeloma
494229|NCT01454297|Multiple Myeloma|multiple myeloma
494230|NCT01454297|Observational|observational
494231|NCT01454297|Longitudinal|longitudinal
494232|NCT01454271|Total Hip arthroplasty|total hip arthroplasty
494233|NCT01454271|Hip Osteoarthritis|hip osteoarthritis
494234|NCT01454271|Infection after Total Hip Arthroplasty|infection after total hip arthroplasty
494235|NCT01454245|39439335EDI1013|39439335edi1013
494236|NCT01454245|Bioavailability|bioavailability
494237|NCT01454245|Pharmacokinetics|pharmacokinetics
494238|NCT01454232|Obesity|obesity
494239|NCT01454232|adipose tissue inflammation|adipose tissue inflammation
494240|NCT01454232|Low grade systemic inflammation|low grade systemic inflammation
494241|NCT01454232|gut microbiota|gut microbiota
494242|NCT01454232|Bariatric surgery|bariatric surgery
494243|NCT01454206|cannabis abuse|cannabis abuse
494244|NCT01454206|alcohol abuse|alcohol abuse
494245|NCT01454206|substance abuse|substance abuse
494246|NCT01454180|Therapeutic targets in Pancreas|therapeutic targets in pancreas
494247|NCT01454167|vacum drains|vacum drains
494248|NCT01454167|operational wounds|operational wounds
494249|NCT01454167|infections|infections
494250|NCT01454167|seroma|seroma
494251|NCT01454167|acid base|acid base
494252|NCT01454167|glucose|glucose
494253|NCT01454167|lactate|lactate
494254|NCT01454154|TBI|tbi
494255|NCT01454154|Traumatic Brain Injury|traumatic brain injury
494256|NCT01454141|Depressed mood|depressed mood
494257|NCT01454128|exercise base rehabilitation|exercise base rehabilitation
494258|NCT01454128|heart failure|heart failure
494259|NCT01454128|periodic breathing|periodic breathing
494260|NCT01454128|aerobic fitness|aerobic fitness
494261|NCT01454089|bladder|bladder
494262|NCT01454089|urinary tract|urinary tract
494263|NCT01454089|transitional cell carcinoma|transitional cell carcinoma
494264|NCT01454089|metastatic bladder cancer|metastatic bladder cancer
494265|NCT01454089|chemotherapy|chemotherapy
494266|NCT01454076|Cmax: maximum plasma concentration|cmax: maximum plasma concentration
494267|NCT01454076|AUC0-tlast: area under the plasma concentration-time curve from time zero to the time of the last quantifiable concentration|auc0-tlast: area under the plasma concentration-time curve from time zero to the time of the last quantifiable concentration
494268|NCT01454063|cataract|cataract
494269|NCT01454063|lens replacement|lens replacement
494270|NCT01454050|ICD therapy|icd therapy
494271|NCT01454050|RV/LV Capture Control|rv/lv capture control
494272|NCT01454050|Safety and Efficacy|safety and efficacy
494273|NCT01454011|hypogonadism|hypogonadism
494274|NCT01454011|testosterone|testosterone
494275|NCT01454011|HDL cholesterol subgroups|hdl cholesterol subgroups
494276|NCT01454011|hsCRP|hscrp
494277|NCT01454011|HOMA-IR|homa-ir
494278|NCT01453972|Exercise|exercise
494279|NCT01453972|High-intensity|high-intensity
494280|NCT01453972|Interval training|interval training
494281|NCT01453959|hypertension|hypertension
494282|NCT01453959|salt sensitivity|salt sensitivity
494283|NCT01453959|fludrocortisone|fludrocortisone
494284|NCT01453946|Crohn's Disease|crohn's disease
494285|NCT01453933|Anti-HIV Agents|anti-hiv agents
494286|NCT01453933|Anti-Retroviral Agents|anti-retroviral agents
494287|NCT01453933|Antiviral Agents|antiviral agents
494288|NCT01453933|Anti-Infective Agents|anti-infective agents
494289|NCT01453933|Lopinavir/ritonavir|lopinavir/ritonavir
494290|NCT01453920|Age Related Macular Degeneration|age related macular degeneration
494291|NCT01453920|Choroidal Neovascular Membrane|choroidal neovascular membrane
494292|NCT01453894|Colorectal Cancer Screening|colorectal cancer screening
494293|NCT01453894|Fecal Occult Blood Testing|fecal occult blood testing
494294|NCT01453881|Asthma|asthma
494295|NCT01453881|pMDI|pmdi
494296|NCT01453881|Beclomethasone|beclomethasone
494297|NCT01453881|Formoterol|formoterol
494298|NCT01453881|Efficacy|efficacy
494299|NCT01453868|Multiple Sclerosis|multiple sclerosis
494300|NCT01453868|non impact aerobics|non impact aerobics
494301|NCT01453855|Open-Angle Glaucoma|open-angle glaucoma
494302|NCT01453855|Ocular Hypertension|ocular hypertension
494303|NCT01453842|Glucagon-like peptide-1|glucagon-like peptide-1
494304|NCT01453842|Glucose-dependant insulinotropic polypeptide|glucose-dependant insulinotropic polypeptide
494305|NCT01453842|Glucagon|glucagon
494306|NCT01453842|Peptide PYY|peptide pyy
494307|NCT01453842|2-oleyl glycerol|2-oleyl glycerol
494308|NCT01453816|Renal insufficiency|renal insufficiency
494309|NCT01453816|kidney failure|kidney failure
494310|NCT01453803|Liposuction|liposuction
494311|NCT01453803|ADSC|adsc
494312|NCT01453803|ASC|asc
494313|NCT01453803|stem cell|stem cell
494314|NCT01453803|Parkinson's Disease|parkinson's disease
494315|NCT01453803|Parkinson's|parkinson's
494316|NCT01453803|therapy|therapy
494317|NCT01453790|depression|depression
494318|NCT01453790|treatment|treatment
494319|NCT01453790|motivation to seek follow up|motivation to seek follow up
494320|NCT01453777|diffuse brain lesion|diffuse brain lesion
494321|NCT01453751|Diabetes|diabetes
494322|NCT01453751|Type 2 Diabetes|type 2 diabetes
494323|NCT01453738|Osteoarthritis|osteoarthritis
494324|NCT01453738|Knee|knee
494325|NCT01453738|Stem cells|stem cells
494326|NCT01453738|Mesenchymal Stem Cells|mesenchymal stem cells
494327|NCT01453712|coronary artery disease|coronary artery disease
494328|NCT01453712|coronary CT angiography|coronary ct angiography
494329|NCT01453712|radiation dose|radiation dose
494330|NCT01453712|iterative image reconstruction|iterative image reconstruction
494331|NCT01453712|detection|detection
494332|NCT01453699|Bereavement|bereavement
494333|NCT01453699|early parental death|early parental death
494334|NCT01453699|grief|grief
494335|NCT01453699|affective disorders|affective disorders
494463|NCT01453283|Ewing Sarcoma|ewing sarcoma
494336|NCT01453699|depression, depressive symptoms|depression, depressive symptoms
494337|NCT01453699|socioeconomic factors|socioeconomic factors
494338|NCT01453699|suicide|suicide
494339|NCT01453699|attempted suicide|attempted suicide
494340|NCT01453699|antidepressive agents|antidepressive agents
494341|NCT01453699|cardiovascular diseases|cardiovascular diseases
494342|NCT01453699|quality of life|quality of life
494343|NCT01453699|Long-term health effects|long-term health effects
494344|NCT01453699|Socioeconomic outcomes|socioeconomic outcomes
494345|NCT01453699|Psychosocial well-being|psychosocial well-being
494346|NCT01453686|Alopecia Areata|alopecia areata
494347|NCT01453686|Hydrocortisone|hydrocortisone
494348|NCT01453686|Clobetasol Propionate|clobetasol propionate
494349|NCT01453686|Randomized Controlled Trial|randomized controlled trial
494350|NCT01453673|knee|knee
494351|NCT01453673|Cruciate Ligament|cruciate ligament
494352|NCT01453673|Meniscus|meniscus
494353|NCT01453660|Endothelial Function|endothelial function
494354|NCT01453660|Endo-PAT2000 system|endo-pat2000 system
494355|NCT01453660|11-140|11-140
494356|NCT01453647|Fibromyalgia|fibromyalgia
494357|NCT01453647|self-efficacy|self-efficacy
494358|NCT01453647|fatigue|fatigue
494359|NCT01453647|stress|stress
494360|NCT01453647|cytokine|cytokine
494361|NCT01453634|chronic kidney disease (CKD)|chronic kidney disease (ckd)
494362|NCT01453634|secondary hyperparathyroidism (SHPT)|secondary hyperparathyroidism (shpt)
494363|NCT01453634|hemodialysis (HD)|hemodialysis (hd)
494364|NCT01453621|prediction rules|prediction rules
494365|NCT01453621|computerized clinical decision support|computerized clinical decision support
494366|NCT01453621|traumatic brain injury|traumatic brain injury
494367|NCT01453621|blunt head trauma|blunt head trauma
494368|NCT01453595|Kidney|kidney
494369|NCT01453595|renal cell carcinoma|renal cell carcinoma
494370|NCT01453595|BEZ235|bez235
494371|NCT01453595|11-080|11-080
494372|NCT01453582|Chest stuffiness of TCM|chest stuffiness of tcm
494373|NCT01453582|Qi deficiency and blood stasis of TCM|qi deficiency and blood stasis of tcm
494374|NCT01453556|Laparoscopic surgery|laparoscopic surgery
494375|NCT01453556|Right colectomy|right colectomy
494376|NCT01453556|Mechanical anastomosis|mechanical anastomosis
494377|NCT01453556|Post-operative ileum|post-operative ileum
494378|NCT01453530|Recovery|recovery
494379|NCT01453530|Street fitness|street fitness
494380|NCT01453530|Sugammadex|sugammadex
494381|NCT01453530|Alertness|alertness
494382|NCT01453530|Ambulatory surgery|ambulatory surgery
494383|NCT01453517|bariatric|bariatric
494384|NCT01453517|obesity|obesity
494385|NCT01453517|post-surgery|post-surgery
494386|NCT01453517|intervention|intervention
494387|NCT01453452|weight changes|weight changes
494388|NCT01453452|fatigue|fatigue
494389|NCT01453452|depression|depression
494390|NCT01453452|anxiety disorder|anxiety disorder
494391|NCT01453452|pain|pain
494392|NCT01453452|cognitive/functional effects|cognitive/functional effects
494393|NCT01453452|psychosocial effects of cancer and its treatment|psychosocial effects of cancer and its treatment
494394|NCT01453452|cancer survivor|cancer survivor
494395|NCT01453452|stage IA breast cancer|stage ia breast cancer
494396|NCT01453452|stage IB breast cancer|stage ib breast cancer
494397|NCT01453452|stage II breast cancer|stage ii breast cancer
494398|NCT01453452|stage IIIA breast cancer|stage iiia breast cancer
494399|NCT01453452|stage IIIB breast cancer|stage iiib breast cancer
494400|NCT01453452|stage IIIC breast cancer|stage iiic breast cancer
494401|NCT01453452|stage I colon cancer|stage i colon cancer
494402|NCT01453452|stage IIA colon cancer|stage iia colon cancer
494403|NCT01453452|stage IIB colon cancer|stage iib colon cancer
629890|NCT00901901|HCC|hcc
494404|NCT01453452|stage IIC colon cancer|stage iic colon cancer
494405|NCT01453452|stage IIIA colon cancer|stage iiia colon cancer
494406|NCT01453452|stage IIIB colon cancer|stage iiib colon cancer
494407|NCT01453452|stage IIIC colon cancer|stage iiic colon cancer
494408|NCT01453452|stage I rectal cancer|stage i rectal cancer
494409|NCT01453452|stage IIA rectal cancer|stage iia rectal cancer
494410|NCT01453452|stage IIB rectal cancer|stage iib rectal cancer
494411|NCT01453452|stage IIC rectal cancer|stage iic rectal cancer
494412|NCT01453452|stage IIIA rectal cancer|stage iiia rectal cancer
494413|NCT01453452|stage IIIB rectal cancer|stage iiib rectal cancer
494414|NCT01453452|stage IIIC rectal cancer|stage iiic rectal cancer
494415|NCT01453439|Body dysmorphic disorder|body dysmorphic disorder
494416|NCT01453439|Obsessive compulsive spectrum disorder|obsessive compulsive spectrum disorder
494417|NCT01453439|Body image|body image
494418|NCT01453439|Appearance concerns|appearance concerns
494419|NCT01453400|aspirin|aspirin
494420|NCT01453400|acetylsalicylic acid|acetylsalicylic acid
494421|NCT01453400|pharyngitis|pharyngitis
494422|NCT01453400|sore throat|sore throat
494423|NCT01453387|MEK inhibitor|mek inhibitor
494424|NCT01453387|Solid Tumor|solid tumor
494425|NCT01453387|Phase I|phase i
494426|NCT01453374|opioid dependence|opioid dependence
494427|NCT01453374|VIVITROL|vivitrol
494428|NCT01453374|criminal justice|criminal justice
494429|NCT01453361|FANG|fang
494430|NCT01453361|Melanoma|melanoma
494431|NCT01453361|Vigil|vigil
494432|NCT01453348|meningococcal|meningococcal
494433|NCT01453348|conjugate|conjugate
494434|NCT01453348|vaccine|vaccine
494435|NCT01453348|adults|adults
494436|NCT01453335|Veins|veins
494437|NCT01453335|Catheter Segments|catheter segments
494438|NCT01453335|Vascular Access|vascular access
494439|NCT01453335|VeinViewer Vision|veinviewer vision
494440|NCT01453322|Veins|veins
494441|NCT01453322|Vascular Access|vascular access
494442|NCT01453322|IV complications|iv complications
494443|NCT01453322|VeinViewer Vision|veinviewer vision
494444|NCT01453309|lumbar fusion|lumbar fusion
494445|NCT01453309|transfusion|transfusion
494446|NCT01453309|cell-saver|cell-saver
494447|NCT01453309|cost-effectiveness|cost-effectiveness
494448|NCT01453296|Asthma|asthma
494449|NCT01453296|Tolerability|tolerability
494450|NCT01453296|Safety|safety
494451|NCT01453296|Pharmacokinetics|pharmacokinetics
494452|NCT01453296|GW642444|gw642444
494453|NCT01453283|DNA Repair|dna repair
494454|NCT01453283|Nucleotide Excision Repair|nucleotide excision repair
494455|NCT01453283|Trabectedine|trabectedine
494456|NCT01453283|Phase I|phase i
494457|NCT01453283|Sarcoma|sarcoma
494458|NCT01453283|Cytotoxic|cytotoxic
494459|NCT01453283|Chemotherapy|chemotherapy
494460|NCT01453283|Solid Tumor|solid tumor
494461|NCT01453283|Malignant Tumor|malignant tumor
494462|NCT01453283|Rhabdomyosarcoma|rhabdomyosarcoma
494464|NCT01453283|Neuroblastoma|neuroblastoma
494465|NCT01453283|Wilm's Tumor|wilm's tumor
494466|NCT01453283|Hepatic Tumor|hepatic tumor
494467|NCT01453283|Brain Tumor|brain tumor
494468|NCT01453270|Sepsis|sepsis
494469|NCT01453270|Emergency medicine|emergency medicine
494470|NCT01453270|Cardiac output|cardiac output
494471|NCT01453270|Stroke volume|stroke volume
494472|NCT01453270|Lactate|lactate
494473|NCT01453257|Molecular Targets|molecular targets
494474|NCT01453257|Personalize Treatment|personalize treatment
494475|NCT01453257|Colon Cancer|colon cancer
494476|NCT01453257|Complete Response Rate|complete response rate
494477|NCT01453244|Chronic hepatitis C|chronic hepatitis c
494478|NCT01453244|Pharmacogenomics|pharmacogenomics
494479|NCT01453244|IL28B|il28b
494480|NCT01453244|ITPA|itpa
494481|NCT01453231|bariatric surgery|bariatric surgery
494482|NCT01453231|plastic surgery|plastic surgery
494483|NCT01453231|thigh|thigh
494484|NCT01453231|obesity|obesity
494485|NCT01453231|body image|body image
494486|NCT01453231|quality of life|quality of life
494487|NCT01453218|Renal insufficiency|renal insufficiency
494488|NCT01453218|Liver transplant|liver transplant
494489|NCT01453218|Acute rejection|acute rejection
494490|NCT01453218|Infections|infections
494491|NCT01453218|Hepatitis C recurrence|hepatitis c recurrence
494492|NCT01453205|Lymphoma, Non-Hodgkin's Lymphoma, Diffuse Large B-Cell Lymphoma, DLBCL, B-Cell Malignancy, anti-CD19, monoclonal antibody, second line, ASCT, Refractory|lymphoma, non-hodgkin's lymphoma, diffuse large b-cell lymphoma, dlbcl, b-cell malignancy, anti-cd19, monoclonal antibody, second line, asct, refractory
494493|NCT01453192|Raltegravir|raltegravir
494494|NCT01453192|Renal transplantation|renal transplantation
494495|NCT01453192|HIV-1|hiv-1
494496|NCT01453192|Acute renal graft rejection|acute renal graft rejection
494497|NCT01453179|actinic keratosis|actinic keratosis
494498|NCT01453179|invasive SCC|invasive scc
494499|NCT01453179|in situ SCC|in situ scc
494500|NCT01453179|histological classification|histological classification
494501|NCT01453179|histological progression|histological progression
494502|NCT01453179|clinical clearance|clinical clearance
630004|NCT00901550|MTX|mtx
494503|NCT01453179|cryotherapy|cryotherapy
494504|NCT01453153|pancreatic|pancreatic
494505|NCT01453153|Cancer|cancer
494506|NCT01453153|Stage IV|stage iv
494507|NCT01453153|untreated|untreated
494508|NCT01453127|dementia|dementia
494509|NCT01453127|parkinsonism|parkinsonism
494510|NCT01453127|mild cognitive impairment|mild cognitive impairment
494511|NCT01453127|REM sleep behavior disorder|rem sleep behavior disorder
494512|NCT01453114|Cognitive Behavioral Therapy|cognitive behavioral therapy
494513|NCT01453114|CBT|cbt
494514|NCT01453114|relapse|relapse
494515|NCT01453114|postpartum depression|postpartum depression
494516|NCT01453114|depression recurrence|depression recurrence
494517|NCT01453114|depression relapse|depression relapse
494518|NCT01453101|Multiple Myeloma|multiple myeloma
494519|NCT01453101|Transplant|transplant
494520|NCT01453088|multiple myeloma|multiple myeloma
494521|NCT01453088|transplant|transplant
494522|NCT01453075|hepatitis C|hepatitis c
494523|NCT01453075|herpes simplex type 2|herpes simplex type 2
494524|NCT01453075|veterans|veterans
494525|NCT01453062|Ofatumumab|ofatumumab
494526|NCT01453062|Chronic lymphocytic leukemia (CLL)|chronic lymphocytic leukemia (cll)
494527|NCT01453062|Arzerra|arzerra
494528|NCT01453049|rosiglitazone/glimepiride, fix dose, type 2 diabetes|rosiglitazone/glimepiride, fix dose, type 2 diabetes
494529|NCT01453036|Peptic ulcer|peptic ulcer
494530|NCT01453036|Helicobacter pylori|helicobacter pylori
494531|NCT01453036|Clarithromycin|clarithromycin
494532|NCT01453036|23S rRNA|23s rrna
494533|NCT01453036|Resistance|resistance
494534|NCT01453023|pediatric ages 5 to 11 years|pediatric ages 5 to 11 years
494535|NCT01453010|SaeboFlex|saeboflex
494536|NCT01453010|Stroke rehabilitation|stroke rehabilitation
494537|NCT01453010|Upper Limb Rehabilitation|upper limb rehabilitation
494538|NCT01453010|Acute Stroke|acute stroke
494539|NCT01452997|mosquito|mosquito
494540|NCT01452997|allergy|allergy
494541|NCT01452997|bite|bite
494542|NCT01452997|ant-inflammatory|ant-inflammatory
494543|NCT01452997|Aedes aegypti mosquito bite|aedes aegypti mosquito bite
494544|NCT01452984|Non-Melanoma skin cancer patients who have undergone or about to undergo Mohs surgery|non-melanoma skin cancer patients who have undergone or about to undergo mohs surgery
494545|NCT01452984|who are treated within the University of Pennsylvania Health System|who are treated within the university of pennsylvania health system
494546|NCT01452971|tumor susceptibility gene|tumor susceptibility gene
494547|NCT01452971|glycine N-methyltransferase (GNMT)|glycine n-methyltransferase (gnmt)
494548|NCT01452971|polycyclic aromatic hydrocarbons (PAHs)|polycyclic aromatic hydrocarbons (pahs)
494549|NCT01452971|lung cancer|lung cancer
494550|NCT01452958|Endotoxin|endotoxin
494551|NCT01452958|LPS|lps
494552|NCT01452958|TNF-α|tnf-α
494553|NCT01452958|insulin resistance|insulin resistance
494554|NCT01452958|metabolism|metabolism
494555|NCT01452932|Chronic obstructive pulmonary disease|chronic obstructive pulmonary disease
494556|NCT01452932|Dyspnea|dyspnea
494557|NCT01452932|Exercise test|exercise test
494558|NCT01452932|Endurance training|endurance training
494559|NCT01452919|schizophrenia, LY2140023, pomaglumetad methionil|schizophrenia, ly2140023, pomaglumetad methionil
494560|NCT01452906|Drug-drug interaction|drug-drug interaction
494561|NCT01452906|Pharmacokinetics|pharmacokinetics
494562|NCT01452906|PA21|pa21
494563|NCT01452906|Drug Interaction Potentiation|drug interaction potentiation
494564|NCT01452880|Remifentanil|remifentanil
494565|NCT01452880|Lithotripsy|lithotripsy
494566|NCT01452880|Conscious Sedation|conscious sedation
494567|NCT01452867|Airway|airway
494568|NCT01452867|Bag-Valve -Mask- Ventilation|bag-valve -mask- ventilation
494569|NCT01452867|Laryngeal Mask - Ventilation|laryngeal mask - ventilation
494570|NCT01452867|Laryngeal Tube - Ventilation|laryngeal tube - ventilation
494571|NCT01452854|LGG|lgg
494572|NCT01452854|Temozolomide|temozolomide
494573|NCT01452854|Temodar|temodar
494574|NCT01452854|Ovarian Aging|ovarian aging
494575|NCT01452854|Infertility|infertility
494576|NCT01452854|Chemotherapy|chemotherapy
494577|NCT01452841|grapefruit|grapefruit
494578|NCT01452841|weight loss|weight loss
494579|NCT01452841|blood pressure|blood pressure
494580|NCT01452841|lipids|lipids
494581|NCT01452841|inflammation|inflammation
494582|NCT01452828|Renal Impairment|renal impairment
494583|NCT01452815|diabetic gastroparesis|diabetic gastroparesis
494584|NCT01452815|delayed gastric emptying|delayed gastric emptying
494585|NCT01452815|gastroparesis|gastroparesis
494586|NCT01452815|diabetes mellitus, Type 1|diabetes mellitus, type 1
494587|NCT01452815|diabetes mellitus, Type 2|diabetes mellitus, type 2
494588|NCT01452802|HeartMate II|heartmate ii
494589|NCT01452802|heart-assist device|heart-assist device
494590|NCT01452802|medical management|medical management
494591|NCT01452802|optimal medical management|optimal medical management
494592|NCT01452802|Heart Failure NYHA Class IIIB/IV|heart failure nyha class iiib/iv
494593|NCT01452802|Thoratec Corporation|thoratec corporation
494594|NCT01452789|neonatal abstinence syndrome|neonatal abstinence syndrome
494595|NCT01452789|buprenorphine|buprenorphine
494596|NCT01452789|morphine|morphine
494597|NCT01452789|pharmacokinetics|pharmacokinetics
494598|NCT01452776|Drug Therapy|drug therapy
494599|NCT01452763|Drug Therapy|drug therapy
494600|NCT01452750|Drug Therapy|drug therapy
494601|NCT01452737|colonoscopy|colonoscopy
494602|NCT01452737|bowel preparation|bowel preparation
494603|NCT01452737|Golytely|golytely
494604|NCT01452724|Drug Therapy|drug therapy
494605|NCT01452711|Drug Therapy|drug therapy
494606|NCT01452698|Drug Therapy|drug therapy
494607|NCT01452685|Drug Therapy|drug therapy
494608|NCT01452672|Breast cancer|breast cancer
494609|NCT01452672|Radiotherapy|radiotherapy
494610|NCT01452672|Post-mastectomy|post-mastectomy
494611|NCT01452672|Molecular characterization|molecular characterization
494612|NCT01452659|Drug Therapy|drug therapy
494613|NCT01452646|acute myeloid leukemia|acute myeloid leukemia
494614|NCT01452646|risk-adapted therapy|risk-adapted therapy
494615|NCT01452646|MRD-directed therapy|mrd-directed therapy
494616|NCT01452646|young adults|young adults
494617|NCT01452633|pain|pain
494618|NCT01452633|laparoscopy|laparoscopy
494619|NCT01452633|reduction|reduction
494620|NCT01452620|Endovascular Abdominal Aortic Aneurysm Repair (EVAR)|endovascular abdominal aortic aneurysm repair (evar)
494621|NCT01452620|Abdominal Aortic aneurysm (AAA)|abdominal aortic aneurysm (aaa)
494622|NCT01452607|Ebselen|ebselen
494623|NCT01452581|Transfusion|transfusion
494624|NCT01452581|Red blood cells|red blood cells
494625|NCT01452581|Postoperative|postoperative
494626|NCT01452581|Dizziness|dizziness
494627|NCT01452581|Hip Arthroplasty|hip arthroplasty
494628|NCT01452568|Thromboembolic complications|thromboembolic complications
494629|NCT01452568|Bleeding complications|bleeding complications
494630|NCT01452568|Haemorrhagic complications|haemorrhagic complications
494631|NCT01452568|Anticoagulant therapy|anticoagulant therapy
494632|NCT01452568|Aspirin|aspirin
494633|NCT01452568|biological Aorta Valve|biological aorta valve
494634|NCT01452555|HIV|hiv
494635|NCT01452555|HIV Prevention|hiv prevention
494636|NCT01452555|HIV testing|hiv testing
494637|NCT01452555|HIV Rapid Test|hiv rapid test
494638|NCT01452542|Genz-112638|genz-112638
494639|NCT01452529|Pain|pain
494640|NCT01452529|Opioid|opioid
494641|NCT01452516|PLF|plf
494642|NCT01452516|lumbar fusion|lumbar fusion
494643|NCT01452516|bone graft|bone graft
494644|NCT01452516|biologics|biologics
494645|NCT01452503|AE adverse event|ae adverse event
494646|NCT01452503|AIDS acquired immunodeficiency syndrome|aids acquired immunodeficiency syndrome
494647|NCT01452503|ALT (SGPT) alanine aminotransferase|alt (sgpt) alanine aminotransferase
494648|NCT01452503|ART antiretroviral therapy|art antiretroviral therapy
494649|NCT01452503|AST (SGOT) aspartate aminotransferase|ast (sgot) aspartate aminotransferase
494650|NCT01452503|DCF data collection forms|dcf data collection forms
494651|NCT01452503|DMC Data Monitoring Committee|dmc data monitoring committee
494652|NCT01452503|FDA (U.S.) Food and Drug Administration|fda (u.s.) food and drug administration
494653|NCT01452503|GCP Good Clinical Practice guidelines|gcp good clinical practice guidelines
494654|NCT01452503|HB sAg Hepatitis B surface antigen|hb sag hepatitis b surface antigen
494655|NCT01452503|ICH International Conference of Harmonization|ich international conference of harmonization
494656|NCT01452503|IND Investigational New Drug Application|ind investigational new drug application
494657|NCT01452503|IRB Institutional Review Board|irb institutional review board
494658|NCT01452503|IU International units|iu international units
494659|NCT01452503|mg milligram(s)|mg milligram(s)
494660|NCT01452503|mm3 cubic millimeter(s)|mm3 cubic millimeter(s)
494661|NCT01452503|PCR polymerase chain reaction|pcr polymerase chain reaction
494662|NCT01452503|SAE serious adverse event|sae serious adverse event
494663|NCT01452503|µg microgram|µg microgram
494664|NCT01452503|ULN upper limit of the normal range|uln upper limit of the normal range
494665|NCT01452503|WB Western Blot|wb western blot
494666|NCT01452490|Onychomycosis|onychomycosis
494667|NCT01452490|Toenail Fungus|toenail fungus
494668|NCT01452477|Polycystic Ovary Syndrome|polycystic ovary syndrome
494669|NCT01452477|Cryptotanshinone|cryptotanshinone
494670|NCT01452464|observational|observational
494671|NCT01452464|serogroup A, B, Y, W|serogroup a, b, y, w
494672|NCT01452464|meningococcal meningitis|meningococcal meningitis
494673|NCT01452464|meningococcal vaccines|meningococcal vaccines
494674|NCT01452464|safety|safety
494675|NCT01452464|MenACYW-CRM|menacyw-crm
494676|NCT01452464|post-marketing|post-marketing
494677|NCT01452464|adolescents|adolescents
494678|NCT01452438|observational|observational
494679|NCT01452438|serogroup A, B, Y, W|serogroup a, b, y, w
494680|NCT01452438|meningococcal meningitis|meningococcal meningitis
494681|NCT01452438|meningococcal vaccines|meningococcal vaccines
494682|NCT01452438|safety|safety
494683|NCT01452438|MenACYW-CRM|menacyw-crm
494684|NCT01452438|post-marketing|post-marketing
494685|NCT01452438|children|children
494686|NCT01452425|Human volunteers|human volunteers
494687|NCT01452412|Alkali|alkali
494688|NCT01452412|Sodium bicarbonate|sodium bicarbonate
494689|NCT01452412|Kidney disease|kidney disease
494690|NCT01452412|Acidosis|acidosis
494691|NCT01452386|Constipation|constipation
494692|NCT01452386|Stimulation Treatment|stimulation treatment
494693|NCT01452373|Hot flush(es)|hot flush(es)
494694|NCT01452373|Hot flash(es)|hot flash(es)
494695|NCT01452373|Vasomotor symptoms|vasomotor symptoms
494696|NCT01452373|Dehydroepiandrosterone (DHEA)|dehydroepiandrosterone (dhea)
494697|NCT01452373|Prasterone|prasterone
494698|NCT01452373|Acolbifene|acolbifene
494699|NCT01452373|Selective estrogen receptor modulator (SERM)|selective estrogen receptor modulator (serm)
494700|NCT01452373|Antiestrogen|antiestrogen
494701|NCT01452373|Menopause|menopause
494702|NCT01452373|Postmenopausal women|postmenopausal women
494703|NCT01452360|chronic kidney disease|chronic kidney disease
494704|NCT01452321|Transcranial Magnetic Stimulation;|transcranial magnetic stimulation;
494705|NCT01452321|Postpartum Depression;|postpartum depression;
494706|NCT01452321|Clinical Performance;|clinical performance;
494707|NCT01452321|Cognitive Performance;|cognitive performance;
494708|NCT01452321|Social Performance|social performance
494709|NCT01452308|Gilead|gilead
494710|NCT01452308|Gilead Sciences|gilead sciences
494711|NCT01452308|GSI|gsi
494712|NCT01452308|Liver Fibrosis|liver fibrosis
494713|NCT01452308|Liver|liver
494714|NCT01452308|Fibrosis|fibrosis
494715|NCT01452295|liver|liver
494716|NCT01452295|liver failure|liver failure
494717|NCT01452295|acute liver failure|acute liver failure
494718|NCT01452295|ELAD|elad
494719|NCT01452295|alcoholic hepatitis|alcoholic hepatitis
494720|NCT01452295|acute on chronic hepatitis|acute on chronic hepatitis
494721|NCT01452282|Ankle Brachial Index|ankle brachial index
494722|NCT01452282|Perioperative care|perioperative care
494723|NCT01452282|General Surgery|general surgery
494724|NCT01452282|Acute Coronary Syndromes|acute coronary syndromes
494725|NCT01452282|Cardiovascular Complications|cardiovascular complications
494726|NCT01452243|Vitamin D|vitamin d
494727|NCT01452243|Calcium|calcium
494728|NCT01452243|Elderly|elderly
494729|NCT01452230|Bariatric Surgery Candidate|bariatric surgery candidate
494730|NCT01452230|Severely obese|severely obese
494731|NCT01452230|Bariatric surgery|bariatric surgery
494732|NCT01452230|Physical activity|physical activity
494733|NCT01452230|Physical fitness|physical fitness
494734|NCT01452230|Comorbidities|comorbidities
494735|NCT01452230|Quality of life|quality of life
494736|NCT01452230|Surgical complications|surgical complications
494737|NCT01452217|Pancreas|pancreas
494738|NCT01452217|Chronic pancreatitis|chronic pancreatitis
494739|NCT01452217|Perfusion|perfusion
494740|NCT01452217|Blood flow|blood flow
494741|NCT01452217|Magnetic resonance imaging|magnetic resonance imaging
494742|NCT01452204|PEMF|pemf
494743|NCT01452204|magneto|magneto
494744|NCT01452204|shoulder|shoulder
494745|NCT01452204|impingement|impingement
494746|NCT01452191|Cluster Randomised Controlled Trial|cluster randomised controlled trial
494747|NCT01452191|Community Health Services|community health services
494748|NCT01452191|prevention & control|prevention & control
494749|NCT01452191|Accidents, Home|accidents, home
494750|NCT01452191|Child Health Services|child health services
494751|NCT01452178|Cardiovascular diseases|cardiovascular diseases
494752|NCT01452178|Glucometabolic disorders|glucometabolic disorders
494753|NCT01452178|Type-D personality|type-d personality
494754|NCT01452165|Cardiovascular diseases|cardiovascular diseases
494755|NCT01452165|Hypertrophy, Left ventricle|hypertrophy, left ventricle
494756|NCT01452165|Echocardiography|echocardiography
494757|NCT01452165|Prognosis|prognosis
494758|NCT01452152|Pharmacogenomics|pharmacogenomics
494759|NCT01452152|Platelet Aggregation Inhibitors|platelet aggregation inhibitors
494760|NCT01452139|STEMI|stemi
494761|NCT01452139|Pharmacogenetics|pharmacogenetics
494762|NCT01452139|Prasugrel|prasugrel
494763|NCT01452139|Clopidogrel|clopidogrel
494764|NCT01452139|Percutaneous Coronary Intervention|percutaneous coronary intervention
494765|NCT01452113|Diabetes Mellitus|diabetes mellitus
494766|NCT01452113|DPP-IV protein|dpp-iv protein
494767|NCT01452113|Glucagon-Like Peptide 1|glucagon-like peptide 1
494768|NCT01452113|autonomic neuropathy|autonomic neuropathy
494769|NCT01452100|embolism|embolism
494770|NCT01452100|cholesterol cristal|cholesterol cristal
494771|NCT01452100|creatinine|creatinine
494772|NCT01452100|renal insufficiency|renal insufficiency
494773|NCT01452100|prednisone|prednisone
494774|NCT01452100|systemic atheroembolism|systemic atheroembolism
494775|NCT01452087|insulin sensitivity|insulin sensitivity
494776|NCT01452087|exercise|exercise
494777|NCT01452074|Insulin Sensitivity|insulin sensitivity
494778|NCT01452074|Exercise Training|exercise training
494779|NCT01452074|Weight Loss|weight loss
494780|NCT01452074|Fat Metabolism|fat metabolism
494781|NCT01452061|Autism Spectrum Disorder|autism spectrum disorder
494782|NCT01452061|Attention Deficit/Hyperactivity Disorder|attention deficit/hyperactivity disorder
494783|NCT01452061|Developmental Delay|developmental delay
494784|NCT01452048|insulin sensitivity|insulin sensitivity
494785|NCT01452048|fatty acid metabolism|fatty acid metabolism
494786|NCT01452035|insulin sensitivity|insulin sensitivity
494787|NCT01452035|fatty acid metabolism|fatty acid metabolism
494788|NCT01452035|exercise|exercise
494789|NCT01452022|inductigraft|inductigraft
494790|NCT01452022|osteoinductive|osteoinductive
494791|NCT01452022|synthetic bone graft|synthetic bone graft
494792|NCT01452022|posterolateral lumbar fusion|posterolateral lumbar fusion
494793|NCT01452022|post market|post market
494794|NCT01452022|lumbar spinal stenosis|lumbar spinal stenosis
494795|NCT01452009|open angle glaucoma|open angle glaucoma
494796|NCT01452009|ocular hypertension|ocular hypertension
494797|NCT01451996|direct-to-consumer advertising|direct-to-consumer advertising
494798|NCT01451983|Autism|autism
494799|NCT01451983|PTEN|pten
494800|NCT01451983|macrocephaly|macrocephaly
494801|NCT01451970|high fat diet treatment|high fat diet treatment
494802|NCT01451970|insulin sensitivity|insulin sensitivity
494803|NCT01451957|exercise|exercise
494804|NCT01451957|fatty acid metabolism|fatty acid metabolism
494805|NCT01451957|insulin sensitivity|insulin sensitivity
494806|NCT01451944|Asthma|asthma
494807|NCT01451944|Home Health Nursing|home health nursing
494808|NCT01451944|Patient education|patient education
494809|NCT01451931|kidney stone|kidney stone
494810|NCT01451931|urolithiasis|urolithiasis
494811|NCT01451931|urinary tract infection|urinary tract infection
494812|NCT01451931|ultrasound|ultrasound
494813|NCT01451931|computed tomography|computed tomography
494814|NCT01451931|safety|safety
494815|NCT01451931|cost|cost
494816|NCT01451931|accuracy|accuracy
494817|NCT01451918|Dyslipidaemia|dyslipidaemia
494818|NCT01451918|Insulin resistance|insulin resistance
494819|NCT01451918|Type 2 Diabetes|type 2 diabetes
494820|NCT01451892|Obesity|obesity
494821|NCT01451892|dance|dance
494822|NCT01451892|gait|gait
494823|NCT01451892|balance|balance
494824|NCT01451892|posture|posture
494825|NCT01451892|dance therapy|dance therapy
494826|NCT01451879|Pompe Disease|pompe disease
494827|NCT01451879|Infusion Associated Reaction|infusion associated reaction
494828|NCT01451879|Immune-modulation regimen|immune-modulation regimen
494829|NCT01451866|resistance training|resistance training
494830|NCT01451866|Healthy People Programs|healthy people programs
494831|NCT01451853|Lung Cancer|lung cancer
494832|NCT01451853|Head and Neck Cancer|head and neck cancer
494833|NCT01451853|Hearing Loss|hearing loss
494834|NCT01451853|Ototoxicity|ototoxicity
494835|NCT01451853|Tinnitus|tinnitus
494836|NCT01451853|Deafness|deafness
494837|NCT01451853|SPI-1005|spi-1005
494838|NCT01451853|Cisplatin|cisplatin
494839|NCT01451853|Carboplatin|carboplatin
494840|NCT01451853|Ebselen|ebselen
494841|NCT01451827|Kidney Disease|kidney disease
494842|NCT01451827|Polycystic Kidney Disease|polycystic kidney disease
494843|NCT01451827|Autosomal Dominant Polycystic Kidney Disease|autosomal dominant polycystic kidney disease
494844|NCT01451827|PKD|pkd
494845|NCT01451827|ADPKD|adpkd
494846|NCT01451814|smoking cessation|smoking cessation
494847|NCT01451801|Hepatitis B|hepatitis b
494848|NCT01451801|non responders|non responders
494849|NCT01451801|cellular immune response|cellular immune response
494850|NCT01451801|cytokines|cytokines
494851|NCT01451801|predictors|predictors
494852|NCT01451801|HBsAg|hbsag
494853|NCT01451788|RCT|rct
494854|NCT01451788|Gelatin matrix|gelatin matrix
494855|NCT01451788|thrombin|thrombin
494856|NCT01451788|idiopathic scoliosis|idiopathic scoliosis
494857|NCT01451788|Surgery|surgery
494858|NCT01451762|pain|pain
494859|NCT01451762|anesthesia|anesthesia
494860|NCT01451762|surgery|surgery
494861|NCT01451762|postoperative|postoperative
494862|NCT01451749|Mild cognitive impairment|mild cognitive impairment
494863|NCT01451736|First-episode Schizophrenia|first-episode schizophrenia
494864|NCT01451736|Schizoaffective Disorder, Depressed Type (recent-onset)|schizoaffective disorder, depressed type (recent-onset)
494865|NCT01451736|Schizophreniform Disorder|schizophreniform disorder
494866|NCT01451736|oral risperidone|oral risperidone
494867|NCT01451736|long-acting injectable paliperidone palmitate|long-acting injectable paliperidone palmitate
494868|NCT01451736|functional outcome|functional outcome
494869|NCT01451723|Multiple Sclerosis|multiple sclerosis
494870|NCT01451723|Polyphenon E|polyphenon e
494871|NCT01451723|Green tea|green tea
494873|NCT01451723|Epigallocatechin-galleate|epigallocatechin-galleate
494874|NCT01451723|Placebo|placebo
494875|NCT01451723|Randomized controlled trial|randomized controlled trial
494876|NCT01451710|enough steroids|enough steroids
494877|NCT01451710|MCD|mcd
494878|NCT01451710|efficacy|efficacy
494879|NCT01451684|pregnancy|pregnancy
494880|NCT01451684|fetus|fetus
494881|NCT01451684|euploid|euploid
494882|NCT01451671|fetal|fetal
494883|NCT01451671|aneuploidy|aneuploidy
494884|NCT01451671|non-invasive|non-invasive
494885|NCT01451671|prenatal|prenatal
494886|NCT01451671|cell free DNA|cell free dna
494887|NCT01451658|Variceal bleeding|variceal bleeding
494888|NCT01451658|portal hypertension|portal hypertension
494889|NCT01451658|hepatocellular carcinoma|hepatocellular carcinoma
494890|NCT01451658|endoscopic variceal ligation|endoscopic variceal ligation
494891|NCT01451658|non-selective beta-blocker|non-selective beta-blocker
494892|NCT01451658|rebleeding|rebleeding
494893|NCT01451645|Gout|gout
494894|NCT01451632|Metastatic Colorectal cancer|metastatic colorectal cancer
494895|NCT01451632|Kras wild-type|kras wild-type
494896|NCT01451632|Squamous cell head and neck cancer|squamous cell head and neck cancer
494897|NCT01451632|Non-small cell lung cancer|non-small cell lung cancer
494898|NCT01451632|Triple negative breast cancer|triple negative breast cancer
494899|NCT01451632|EGFR|egfr
494900|NCT01451632|ErbB3|erbb3
494901|NCT01451632|MM-121|mm-121
494902|NCT01451632|Cetuximab|cetuximab
494903|NCT01451632|Irinotecan|irinotecan
494904|NCT01451606|Chronic Pelvic Pain (CPP)|chronic pelvic pain (cpp)
494905|NCT01451606|Pelvic Pain|pelvic pain
494906|NCT01451593|Optic neuritis|optic neuritis
494907|NCT01451593|Multiple sclerosis|multiple sclerosis
494908|NCT01451593|Retinal nerve fibre layer|retinal nerve fibre layer
494909|NCT01451593|Axonal loss|axonal loss
494910|NCT01451593|Neuroprotection|neuroprotection
494911|NCT01451593|Phenytoin|phenytoin
494912|NCT01451593|MRI|mri
494913|NCT01451593|Optical coherence tomography|optical coherence tomography
494914|NCT01451593|Sodium Channel Blockers|sodium channel blockers
494915|NCT01451580|Phase II|phase ii
494916|NCT01451580|Metastatic Breast Cancer|metastatic breast cancer
494917|NCT01451567|Nurses, Workload, Musculoskeletal System, Intervention|nurses, workload, musculoskeletal system, intervention
494918|NCT01451554|weight|weight
494919|NCT01451554|body mass index|body mass index
494920|NCT01451554|obesity|obesity
494921|NCT01451554|portion control plate|portion control plate
494922|NCT01451554|diet|diet
494923|NCT01451554|exercise|exercise
494924|NCT01451528|Umbilical Cord Blood|umbilical cord blood
494925|NCT01451528|Allogeneic|allogeneic
494926|NCT01451528|Traumatic Brain Injury|traumatic brain injury
494927|NCT01451515|Lymphoblastic lymphoma|lymphoblastic lymphoma
494928|NCT01451502|umbilical cord blood|umbilical cord blood
494929|NCT01451489|FSGS|fsgs
494930|NCT01451489|FK506|fk506
494931|NCT01451489|CTX|ctx
494932|NCT01451476|Ageing|ageing
494933|NCT01451463|Huntington's Disease|huntington's disease
494934|NCT01451463|Chorea|chorea
494935|NCT01451463|Gait|gait
494936|NCT01451463|Balance|balance
494937|NCT01451450|Peanut Allergy|peanut allergy
494938|NCT01451411|Serum Sodium|serum sodium
494939|NCT01451411|Euvolemia|euvolemia
494940|NCT01451411|Hypervolemia|hypervolemia
494941|NCT01451411|Vaprisol®|vaprisol®
494942|NCT01451411|Conivaptan|conivaptan
494943|NCT01451411|YM087|ym087
494944|NCT01451372|Diabetes|diabetes
494945|NCT01451372|CGM|cgm
494946|NCT01451372|CSII|csii
494947|NCT01451346|Pilot study|pilot study
494948|NCT01451333|HIV|hiv
494949|NCT01451333|Efavirenz|efavirenz
494950|NCT01451333|Central Nervous System (CNS)|central nervous system (cns)
494951|NCT01451333|Lumbar puncture|lumbar puncture
494952|NCT01451333|Dose reduction|dose reduction
494953|NCT01451320|Prosthetic valve|prosthetic valve
494954|NCT01451320|thrombosis|thrombosis
494955|NCT01451320|TROIA|troia
494956|NCT01451320|tPA|tpa
494957|NCT01451320|TEE|tee
494958|NCT01451307|Congenital abnormalities|congenital abnormalities
494959|NCT01451307|Digestive system abnormalities|digestive system abnormalities
494960|NCT01451307|Neonatal surgery|neonatal surgery
494961|NCT01451307|Neonatal anesthesia|neonatal anesthesia
494962|NCT01451307|Bayley Scales of Infant Development II|bayley scales of infant development ii
494963|NCT01451294|Cerebral autoregulation|cerebral autoregulation
494964|NCT01451281|Ultrasonography|ultrasonography
494965|NCT01451281|Muscular Dystrophy|muscular dystrophy
494966|NCT01451281|Neuromuscular Disease|neuromuscular disease
494967|NCT01451281|Oligonucleotide|oligonucleotide
494968|NCT01451281|Magnetic Resonance Imaging (MRI)|magnetic resonance imaging (mri)
494969|NCT01451281|Duchenne Muscular Dystrophy|duchenne muscular dystrophy
494971|NCT01451268|60 to 150 Days After Allogeneic Stem Cell Transplantation|60 to 150 days after allogeneic stem cell transplantation
494972|NCT01451268|High Risk MDS|high risk mds
494973|NCT01451268|MDS|mds
494974|NCT01451268|AML|aml
494975|NCT01451255|pulsatility|pulsatility
494976|NCT01451255|normal subjects|normal subjects
494977|NCT01451255|mild pulmonary hypertension|mild pulmonary hypertension
494978|NCT01451255|exercise-associated pulmonary hypertension|exercise-associated pulmonary hypertension
494979|NCT01451242|Heart Rate Variability|heart rate variability
494980|NCT01451242|Acquired Brain Injury|acquired brain injury
494981|NCT01451242|Physical Activity|physical activity
494982|NCT01451229|pharmacokinetics|pharmacokinetics
494983|NCT01451229|pharmacodynamics|pharmacodynamics
494984|NCT01451216|Acquired brain injury|acquired brain injury
494985|NCT01451216|Balance control|balance control
494986|NCT01451216|Functional reach|functional reach
494987|NCT01451203|Cimzia|cimzia
494988|NCT01451203|Early RA|early ra
494989|NCT01451203|Certolizumab Pegol|certolizumab pegol
494990|NCT01451190|Androgenetic Alopecia|androgenetic alopecia
494991|NCT01451190|Male Pattern Baldness|male pattern baldness
494992|NCT01451190|Female Pattern Baldness|female pattern baldness
494993|NCT01451190|Hair Loss|hair loss
494994|NCT01451190|Baldness|baldness
494995|NCT01451177|Androgenetic Alopecia|androgenetic alopecia
630591|NCT00900159|MWT|mwt
494996|NCT01451177|Male Pattern Baldness|male pattern baldness
494997|NCT01451177|Female Pattern Baldness|female pattern baldness
494998|NCT01451177|Hair Loss|hair loss
494999|NCT01451177|Baldness|baldness
495000|NCT01451151|Androgenetic Alopecia|androgenetic alopecia
495001|NCT01451151|Male Pattern Baldness|male pattern baldness
495002|NCT01451151|Female Pattern Baldness|female pattern baldness
495003|NCT01451151|Hair Loss|hair loss
495004|NCT01451151|Baldness|baldness
495005|NCT01451138|Androgenetic Alopecia|androgenetic alopecia
495006|NCT01451138|Male Pattern Baldness|male pattern baldness
495007|NCT01451138|Female Pattern Baldness|female pattern baldness
495008|NCT01451138|Hair Loss|hair loss
495009|NCT01451138|Baldness|baldness
495010|NCT01451125|Androgenetic Alopecia|androgenetic alopecia
495011|NCT01451125|Male Pattern Baldness|male pattern baldness
495012|NCT01451125|Female Pattern Baldness|female pattern baldness
495013|NCT01451125|Hair Loss Baldness|hair loss baldness
495014|NCT01451112|Androgenetic Alopecia|androgenetic alopecia
495015|NCT01451112|Male Pattern Baldness|male pattern baldness
495016|NCT01451112|Female Pattern Baldness|female pattern baldness
495017|NCT01451112|Hair Loss|hair loss
495018|NCT01451112|Baldness|baldness
495019|NCT01451099|Androgenetic Alopecia|androgenetic alopecia
495020|NCT01451099|Male Pattern Baldness|male pattern baldness
495021|NCT01451099|Female Pattern Baldness|female pattern baldness
495022|NCT01451099|Hair Loss|hair loss
495023|NCT01451099|Baldness|baldness
495024|NCT01451086|Safety|safety
495025|NCT01451086|Immunogenicity|immunogenicity
495026|NCT01451086|Pneumococcal vaccine|pneumococcal vaccine
495027|NCT01451073|Androgenetic Alopecia|androgenetic alopecia
495028|NCT01451073|Male Pattern Baldness|male pattern baldness
495029|NCT01451073|Female Pattern Baldness|female pattern baldness
495030|NCT01451073|Hair Loss|hair loss
495031|NCT01451073|Baldness|baldness
495032|NCT01451060|vasopressors|vasopressors
495033|NCT01451060|cesarean anesthesia|cesarean anesthesia
495034|NCT01451060|hypotension|hypotension
495035|NCT01451047|Androgenetic Alopecia|androgenetic alopecia
495036|NCT01451047|Male Pattern Baldness|male pattern baldness
495037|NCT01451047|Female Pattern Baldness|female pattern baldness
495038|NCT01451047|Hair Loss|hair loss
495039|NCT01451047|Baldness|baldness
495040|NCT01451034|WHYX lesion|whyx lesion
495041|NCT01451034|endoscopic resection|endoscopic resection
495042|NCT01451034|complete resection|complete resection
495043|NCT01451034|complete resection rate|complete resection rate
495044|NCT01451034|endoscopic feature|endoscopic feature
495045|NCT01451034|Average size discrepancy|average size discrepancy
495046|NCT01451021|Androgenetic Alopecia|androgenetic alopecia
495047|NCT01451021|Male Pattern Baldness|male pattern baldness
495048|NCT01451021|Female Pattern Baldness|female pattern baldness
495049|NCT01451021|Hair Loss|hair loss
495050|NCT01451021|Baldness|baldness
495051|NCT01451008|Anastomosis|anastomosis
495052|NCT01451008|Compression|compression
495053|NCT01451008|Colon|colon
495054|NCT01450995|Migraine|migraine
495055|NCT01450995|Headache, Migraine|headache, migraine
495056|NCT01450982|Rheumatoid Arthritis|rheumatoid arthritis
495057|NCT01450982|JNJ-38518168|jnj-38518168
495058|NCT01450982|Methotrexate|methotrexate
495059|NCT01450969|Operator Comfort Assessment|operator comfort assessment
495060|NCT01450969|Radiation protection|radiation protection
495061|NCT01450969|Measurement of Radiation Exposure|measurement of radiation exposure
495062|NCT01450969|Endovascular Interventional Radiology|endovascular interventional radiology
495063|NCT01450956|congenital heart diseases|congenital heart diseases
495064|NCT01450956|cardiopulmonary bypass|cardiopulmonary bypass
495065|NCT01450956|Pediatric|pediatric
495066|NCT01450956|sevoflurane|sevoflurane
495067|NCT01450943|Diabetic Foot Ulcer|diabetic foot ulcer
495068|NCT01450943|Chronic wounds|chronic wounds
495069|NCT01450943|Chronic ulcers|chronic ulcers
495070|NCT01450943|Oasis|oasis
495071|NCT01450943|Dermagraft|dermagraft
495072|NCT01450943|Adaptic|adaptic
495073|NCT01450930|Adrenal insufficiency|adrenal insufficiency
495074|NCT01450930|Addison's disease|addison's disease
495075|NCT01450891|Alzheimer's disease|alzheimer's disease
495076|NCT01450891|Diagnosis|diagnosis
495077|NCT01450891|Costs|costs
495078|NCT01450891|Benefits|benefits
495079|NCT01450891|subjective and/or objective memory complaints|subjective and/or objective memory complaints
495080|NCT01450878|high dose of EPO|high dose of epo
495081|NCT01450878|transplant kidney|transplant kidney
495082|NCT01450878|cadaveric organ donor|cadaveric organ donor
495083|NCT01450878|mono-organ (kidney) retrieval|mono-organ (kidney) retrieval
495084|NCT01450878|patient|patient
495085|NCT01450878|kidney graft|kidney graft
495086|NCT01450865|neuropathy|neuropathy
495087|NCT01450865|axonal excitability|axonal excitability
495088|NCT01450865|myelinated nerve|myelinated nerve
495089|NCT01450865|human|human
495090|NCT01450865|ectopic discharge|ectopic discharge
495091|NCT01450865|flupirtine|flupirtine
495092|NCT01450852|Melanocortin Receptor|melanocortin receptor
495093|NCT01450852|Monocyte|monocyte
495094|NCT01450852|Resistance Training|resistance training
495095|NCT01450852|Inflammation|inflammation
495096|NCT01450852|Markers of Inflammation|markers of inflammation
495097|NCT01450839|Transdermal Administration|transdermal administration
495098|NCT01450839|Japanese|japanese
495099|NCT01450839|elderly|elderly
495100|NCT01450839|male|male
495101|NCT01450839|volunteers|volunteers
495102|NCT01450826|Chemotherapy induced nausea and vomiting|chemotherapy induced nausea and vomiting
495103|NCT01450826|CINV|cinv
495104|NCT01450826|Glioma|glioma
495105|NCT01450826|Temozolomide|temozolomide
495106|NCT01450826|Temodar|temodar
495107|NCT01450826|Aprepitant|aprepitant
495108|NCT01450826|Emend|emend
495109|NCT01450826|Ondansetron|ondansetron
495110|NCT01450826|Zofran|zofran
495111|NCT01450826|Pro00031206|pro00031206
495112|NCT01450826|Affronti|affronti
495113|NCT01450826|Peters|peters
495114|NCT01450826|Duke|duke
495115|NCT01450826|Preston Robert Tisch Brain Tumor Center|preston robert tisch brain tumor center
495116|NCT01450800|urinary tract infection|urinary tract infection
495117|NCT01450800|gynecologic surgery|gynecologic surgery
495118|NCT01450800|post-operative complications|post-operative complications
495119|NCT01450800|nitrofurantoin|nitrofurantoin
495120|NCT01450787|dry eyes|dry eyes
495121|NCT01450787|diabetes|diabetes
495122|NCT01450748|sodium alginate|sodium alginate
495123|NCT01450748|laryngopharyngeal reflux|laryngopharyngeal reflux
495124|NCT01450748|combined impedance-pH monitoring|combined impedance-ph monitoring
495125|NCT01450722|Chronic lower limb ischemia|chronic lower limb ischemia
495126|NCT01450722|claudication|claudication
495127|NCT01450722|chronic critical ischemia|chronic critical ischemia
495128|NCT01450709|Probiotics|probiotics
495129|NCT01450709|Kibow Biotics|kibow biotics
495130|NCT01450709|Dialysis|dialysis
495131|NCT01450709|Gut based uremic toxin removal|gut based uremic toxin removal
495132|NCT01450670|Probiotics|probiotics
495133|NCT01450670|Kibow Biotics|kibow biotics
495134|NCT01450670|Dialysis|dialysis
495135|NCT01450670|Gut based uremic toxin removal|gut based uremic toxin removal
495136|NCT01450657|Chronic Kidney failure stage three and four|chronic kidney failure stage three and four
495137|NCT01450657|Probiotics|probiotics
495138|NCT01450657|Kibow Biotics|kibow biotics
495139|NCT01450657|Dialysis|dialysis
495140|NCT01450657|Gut based uremic toxin removal|gut based uremic toxin removal
495141|NCT01450644|Advanced|advanced
495142|NCT01450644|Progressive|progressive
495143|NCT01450644|Idiopathic Fibrotic Interstitial Lung Disease|idiopathic fibrotic interstitial lung disease
495144|NCT01450644|Palliative Care|palliative care
495145|NCT01450644|Randomised|randomised
495146|NCT01450644|Controlled|controlled
495147|NCT01450631|surgical site infection|surgical site infection
495148|NCT01450631|nosocomial infection|nosocomial infection
495149|NCT01450631|post-operative complication|post-operative complication
495150|NCT01450631|surgical incision risk|surgical incision risk
495151|NCT01450631|surgical incision infection|surgical incision infection
495152|NCT01450631|negative pressure wound therapy|negative pressure wound therapy
495153|NCT01450631|wound management|wound management
495154|NCT01450631|cesarean section surgery|cesarean section surgery
495155|NCT01450631|wound dehiscence|wound dehiscence
495156|NCT01450631|wound infection|wound infection
495157|NCT01450631|surgical closure|surgical closure
495158|NCT01450631|wound disruption|wound disruption
495159|NCT01450631|subcutaneous approximation|subcutaneous approximation
495160|NCT01450631|wound separation|wound separation
495161|NCT01450631|seroma|seroma
495162|NCT01450631|hematoma|hematoma
495163|NCT01450631|subcutaneous closure|subcutaneous closure
495164|NCT01450631|obesity|obesity
495165|NCT01450631|cesarean|cesarean
495166|NCT01450631|incision|incision
495167|NCT01450631|massive obesity|massive obesity
495168|NCT01450631|obese|obese
495169|NCT01450631|pregnancy|pregnancy
495170|NCT01450631|cesarean delivery|cesarean delivery
495171|NCT01450631|superobesity|superobesity
495172|NCT01450631|wound complication|wound complication
495173|NCT01450592|Carbohydrate, Dietary|carbohydrate, dietary
495174|NCT01450579|Recombinant Influenza HA vaccine|recombinant influenza ha vaccine
495175|NCT01450579|Immunogenicity of ASP7373|immunogenicity of asp7373
495176|NCT01450566|ureteroscopy (URS)|ureteroscopy (urs)
495177|NCT01450566|ureteral stent placement|ureteral stent placement
495178|NCT01450566|Ureteral Calculi|ureteral calculi
495179|NCT01450566|Renal Calculi|renal calculi
495180|NCT01450553|Tissue Collection|tissue collection
495181|NCT01450553|Lung Cancer|lung cancer
495182|NCT01450553|Non-Small Cell Lung Cancer|non-small cell lung cancer
495183|NCT01450553|Early Stage Lung Cancer|early stage lung cancer
495184|NCT01450527|Etiology and outcomes of ARDS|etiology and outcomes of ards
495185|NCT01450488|primary progressive multiple sclerosis|primary progressive multiple sclerosis
495186|NCT01450488|relapse-free secondary progressive multiple sclerosis|relapse-free secondary progressive multiple sclerosis
495187|NCT01450449|GBM, fractionation, short course, standard course|gbm, fractionation, short course, standard course
495188|NCT01450423|Epilepsy|epilepsy
495189|NCT01450423|Physical activity|physical activity
495190|NCT01450423|Cardio exercise|cardio exercise
495191|NCT01450423|Physical fitness|physical fitness
495192|NCT01450423|Cognitive function|cognitive function
495193|NCT01450410|Dyslipemia, HDL composition|dyslipemia, hdl composition
495194|NCT01450397|Dupuytren's Contracture|dupuytren's contracture
495195|NCT01450384|protocol specific|protocol specific
495196|NCT01450371|Autonomic Nervous System|autonomic nervous system
495197|NCT01450371|Neuromodulation|neuromodulation
495198|NCT01450371|Blood flow control|blood flow control
495199|NCT01450371|Exercise|exercise
495200|NCT01450358|Sepsis|sepsis
495201|NCT01450358|Real time PCR|real time pcr
495202|NCT01450358|Blood culture|blood culture
495203|NCT01450358|Bacteremia diagnosis|bacteremia diagnosis
495204|NCT01450358|Fungemia diagnosis|fungemia diagnosis
495205|NCT01450345|Clinical diagnosis of inguinal hernia|clinical diagnosis of inguinal hernia
495206|NCT01450345|Patient undergo operation under daycare basis|patient undergo operation under daycare basis
495207|NCT01450345|ASA I-II|asa i-ii
495208|NCT01450345|Written consent|written consent
495209|NCT01450332|ACL|acl
495210|NCT01450332|arthroscopy|arthroscopy
495211|NCT01450332|ligament|ligament
495212|NCT01450332|rupture|rupture
495213|NCT01450332|reconstruction|reconstruction
495214|NCT01450332|ACLR|aclr
495215|NCT01450332|accelerated rehabilitation program|accelerated rehabilitation program
495216|NCT01450319|K-RAS|k-ras
495217|NCT01450319|FcγRII/IIIa genotypes|fcγrii/iiia genotypes
495218|NCT01450319|CRC|crc
495219|NCT01450319|Colorectal cancer|colorectal cancer
495220|NCT01450293|Immune response|immune response
495221|NCT01450267|Cystic Fibrosis|cystic fibrosis
495222|NCT01450267|Glutathione|glutathione
495223|NCT01450254|Hip Osteoarthritis|hip osteoarthritis
495224|NCT01450254|Gait Patterns|gait patterns
495225|NCT01450254|Neuromuscular retraining|neuromuscular retraining
495226|NCT01450241|Febrile neutropenia|febrile neutropenia
495227|NCT01450241|Unexplained fever|unexplained fever
495228|NCT01450241|Duration|duration
495229|NCT01450241|Short-term antibiotic treatment|short-term antibiotic treatment
495230|NCT01450228|primary insomnia|primary insomnia
495231|NCT01450215|Relapsed and refractory Multiple Myeloma|relapsed and refractory multiple myeloma
495232|NCT01450202|Carbon dioxide insufflation|carbon dioxide insufflation
495233|NCT01450202|Colonoscopy|colonoscopy
495234|NCT01450202|Esophagogastroduodenoscopy|esophagogastroduodenoscopy
495235|NCT01450202|Bowel insufflation|bowel insufflation
495236|NCT01450202|Postprocedure pain|postprocedure pain
495237|NCT01450202|Pain Due to Certain Specified Procedures|pain due to certain specified procedures
495238|NCT01450189|Acute HIV|acute hiv
495239|NCT01450189|Transmission Prevention|transmission prevention
495240|NCT01450189|Randomized Pilot study|randomized pilot study
495241|NCT01450176|eye|eye
495242|NCT01450176|itching|itching
495243|NCT01450176|allergies|allergies
495244|NCT01450163|Neuropathic pain|neuropathic pain
495245|NCT01450163|prevention|prevention
495246|NCT01450163|prophylaxis|prophylaxis
495247|NCT01450163|chemotherapy|chemotherapy
495248|NCT01450163|neuropathy|neuropathy
495249|NCT01450163|Oxaliplatin|oxaliplatin
495250|NCT01450163|pregabalin|pregabalin
495251|NCT01450150|Major Depression|major depression
495252|NCT01450150|Transcranial Direct Current Stimulation|transcranial direct current stimulation
495253|NCT01450150|Randomized, Sham-Controlled Trial|randomized, sham-controlled trial
495254|NCT01450150|tDCS|tdcs
495255|NCT01450137|Giant Cell Arteritis|giant cell arteritis
495256|NCT01450137|Tocilizumab|tocilizumab
495257|NCT01450137|Antibodies, Monoclonal|antibodies, monoclonal
495258|NCT01450137|Glucocorticoids|glucocorticoids
495259|NCT01450111|Lacosamide|lacosamide
495260|NCT01450059|Human Immunodeficiency Virus|human immunodeficiency virus
495261|NCT01450059|Microchimerism|microchimerism
495262|NCT01450059|Maternal-Fetal Exchange|maternal-fetal exchange
495263|NCT01450059|Gestation|gestation
495264|NCT01450059|HiV-vertical transmission|hiv-vertical transmission
495265|NCT01450046|pancreas|pancreas
495266|NCT01450046|gastrointestinal|gastrointestinal
495267|NCT01450046|GI|gi
495268|NCT01450046|prevention|prevention
495269|NCT01450046|vitamin E|vitamin e
495270|NCT01450033|kidney|kidney
495271|NCT01450033|renal|renal
495272|NCT01450033|transplant|transplant
495273|NCT01450033|transplantation|transplantation
495274|NCT01450033|adolescent|adolescent
495275|NCT01450033|pediatric|pediatric
495276|NCT01450033|mentor|mentor
495277|NCT01450033|mentoring|mentoring
495278|NCT01450033|medication|medication
495279|NCT01450033|adherence|adherence
495280|NCT01450033|immunosuppressant|immunosuppressant
495281|NCT01450033|heart|heart
495282|NCT01450033|liver|liver
495283|NCT01450020|cancer survivor|cancer survivor
495284|NCT01450007|Pain blockade|pain blockade
495285|NCT01450007|Ropivacaine|ropivacaine
495286|NCT01450007|Dexamethasone|dexamethasone
495287|NCT01449994|knee|knee
495288|NCT01449994|hip|hip
495289|NCT01449994|ankle|ankle
495290|NCT01449994|foot|foot
495291|NCT01449994|pain|pain
495292|NCT01449994|lower limb|lower limb
495293|NCT01449994|activator|activator
495294|NCT01449994|instrumental|instrumental
495295|NCT01449994|chiropractic|chiropractic
495296|NCT01449994|Painful functional conditions of the lower extremity|painful functional conditions of the lower extremity
495297|NCT01449981|Adolescents|adolescents
495298|NCT01449981|Alcohol Abuse|alcohol abuse
495299|NCT01449981|Alcohol Dependence|alcohol dependence
495300|NCT01449981|Drug Abuse|drug abuse
495301|NCT01449981|Drug Dependence|drug dependence
495302|NCT01449981|Substance Use Disorder|substance use disorder
495303|NCT01449981|Alcoholics Anonymous|alcoholics anonymous
495304|NCT01449981|Motivational Enhancement Therapy|motivational enhancement therapy
495305|NCT01449981|Cognitive Behavioral Therapy|cognitive behavioral therapy
495306|NCT01449955|PTSD|ptsd
495307|NCT01449942|Nasopharyngeal carcinoma|nasopharyngeal carcinoma
495308|NCT01449942|EBV|ebv
495309|NCT01449942|LMP1|lmp1
495310|NCT01449929|ritonavir|ritonavir
495311|NCT01449929|HIV|hiv
495312|NCT01449929|HAART|haart
495313|NCT01449929|darunavir|darunavir
495314|NCT01449929|antiretroviral|antiretroviral
495315|NCT01449929|dolutegravir|dolutegravir
495316|NCT01449929|GSK1349572|gsk1349572
495317|NCT01449916|Sepsis|sepsis
495318|NCT01449916|Severe Sepsis|severe sepsis
495319|NCT01449916|Protocol|protocol
495320|NCT01449916|Zambia|zambia
495321|NCT01449890|follow up care|follow up care
495322|NCT01449890|e-mail|e-mail
495323|NCT01449890|effectiveness|effectiveness
495324|NCT01449890|depressive disorders|depressive disorders
495325|NCT01449877|Ocular Toxoplasmosis|ocular toxoplasmosis
495326|NCT01449877|Retinochoroiditis|retinochoroiditis
495327|NCT01449877|Prophylaxis|prophylaxis
495328|NCT01449864|upper GI malignancies|upper gi malignancies
495329|NCT01449864|concurrent chemoradiation with continuous infusion 5-Fluorouracil chemotherapy|concurrent chemoradiation with continuous infusion 5-fluorouracil chemotherapy
495330|NCT01449825|hepatic safety|hepatic safety
495331|NCT01449825|prescriber compliance|prescriber compliance
495332|NCT01449825|pazopanib|pazopanib
495333|NCT01449825|epidemiology|epidemiology
495334|NCT01449812|combination vaccine|combination vaccine
495335|NCT01449812|booster vaccination|booster vaccination
495336|NCT01449786|Mal d 1, Bet v 1, sublingual immunotherapy,|mal d 1, bet v 1, sublingual immunotherapy,
495337|NCT01449760|Ankle sprain|ankle sprain
495338|NCT01449760|Balance|balance
495339|NCT01449760|Gait|gait
495340|NCT01449747|Type 2 diabetes mellitus|type 2 diabetes mellitus
495341|NCT01449747|Dipeptidyl peptidase IV inhibitors|dipeptidyl peptidase iv inhibitors
495342|NCT01449747|Glucagon-like peptide 1|glucagon-like peptide 1
495343|NCT01449721|Sepsis|sepsis
495344|NCT01449721|Multiple organ failure|multiple organ failure
495345|NCT01449721|Resuscitation|resuscitation
495346|NCT01449708|Bariatric Surgery|bariatric surgery
495347|NCT01449708|TIVA|tiva
495348|NCT01449708|PONV|ponv
495349|NCT01449708|non-opioid|non-opioid
495350|NCT01449708|OSA|osa
495351|NCT01449695|PAD|pad
495352|NCT01449695|CVA|cva
495353|NCT01449695|ACS|acs
495354|NCT01449682|BRVO|brvo
495355|NCT01449682|CRVO|crvo
495356|NCT01449682|Macular Edema|macular edema
495357|NCT01449682|Anti-VEGF|anti-vegf
495358|NCT01449682|Ozurdex|ozurdex
495359|NCT01449669|pharmacokinetics|pharmacokinetics
495360|NCT01449669|cefazolin|cefazolin
495361|NCT01449669|microdialysis sampling|microdialysis sampling
495362|NCT01449669|interstitial fluid|interstitial fluid
495363|NCT01449669|skeletal muscle|skeletal muscle
495364|NCT01449669|plasma|plasma
495365|NCT01449669|children|children
495366|NCT01449643|Obesity|obesity
495367|NCT01449643|Diaphragm|diaphragm
495368|NCT01449643|Inspiratory muscular training|inspiratory muscular training
495369|NCT01449617|Carotid stenosis|carotid stenosis
495370|NCT01449617|Aspirin plus Clopidogrel|aspirin plus clopidogrel
495371|NCT01449617|Residual platelet reactivity|residual platelet reactivity
495372|NCT01449604|Stereotactic radiotherapy|stereotactic radiotherapy
495373|NCT01449604|SRS|srs
495374|NCT01449604|SRT|srt
495375|NCT01449604|vestibular schwannoma|vestibular schwannoma
495376|NCT01449591|BFH772|bfh772
495377|NCT01449591|rosacea|rosacea
495378|NCT01449591|erythemato-telangiectatic rosacea|erythemato-telangiectatic rosacea
495379|NCT01449565|methamphetamine|methamphetamine
495380|NCT01449565|high-risk sexual behavior|high-risk sexual behavior
495381|NCT01449565|HIV prevention|hiv prevention
495382|NCT01449539|Hyperbaric oxygen|hyperbaric oxygen
495383|NCT01449539|mobilize|mobilize
495384|NCT01449539|stem cells|stem cells
495385|NCT01449539|growth factor|growth factor
495386|NCT01449526|contact lens|contact lens
495387|NCT01449500|Dyspeptic H.pylori-infection|dyspeptic h.pylori-infection
495388|NCT01449487|Experimental pain|experimental pain
495390|NCT01449487|Rectum|rectum
495391|NCT01449448|pain relief|pain relief
495392|NCT01449448|Hypermobility, Joint|hypermobility, joint
495393|NCT01449448|increased strength|increased strength
495394|NCT01449448|increased patient satisfaction|increased patient satisfaction
495395|NCT01449435|Asthma|asthma
495396|NCT01449435|children|children
495397|NCT01449435|predictors of exacerbation|predictors of exacerbation
495398|NCT01449435|Methacholine challenge|methacholine challenge
495399|NCT01449435|Pulmonary function testing|pulmonary function testing
495400|NCT01449409|Uncontrolled asthma|uncontrolled asthma
495401|NCT01449409|Asthma risk|asthma risk
495402|NCT01449409|Asthma impairment|asthma impairment
495403|NCT01449409|Real time asthma outreach program|real time asthma outreach program
495404|NCT01449396|acupuncture|acupuncture
495405|NCT01449396|in vitro fertilization|in vitro fertilization
495406|NCT01449396|embryo transfer|embryo transfer
495407|NCT01449383|cross over|cross over
495408|NCT01449383|dietary intervention|dietary intervention
495409|NCT01449383|fibre|fibre
495410|NCT01449383|red meat|red meat
495411|NCT01449383|microbiota|microbiota
495412|NCT01449370|INK1117|ink1117
495413|NCT01449370|PIK3CA|pik3ca
495414|NCT01449370|KINASE|kinase
495415|NCT01449370|TUMOR|tumor
495416|NCT01449370|CANCER|cancer
495417|NCT01449370|Locally advanced or metastatic solid tumors|locally advanced or metastatic solid tumors
495418|NCT01449370|not eligible for standard of care therapy|not eligible for standard of care therapy
495419|NCT01449357|NSCLC|nsclc
495420|NCT01449357|Zalutumumab|zalutumumab
495421|NCT01449357|Efficacy|efficacy
495422|NCT01449357|Safety|safety
495423|NCT01449344|relapsed|relapsed
495424|NCT01449344|refractory|refractory
495425|NCT01449318|Pain|pain
495426|NCT01449318|quantitative sensory testing|quantitative sensory testing
495427|NCT01449292|PLVR|plvr
495428|NCT01449292|ELVR|elvr
495429|NCT01449292|AeriSeal System|aeriseal system
495430|NCT01449292|foam sealant|foam sealant
495431|NCT01449292|emphysematous lung sealant|emphysematous lung sealant
495432|NCT01449292|ELS|els
495433|NCT01449292|COPD|copd
495434|NCT01449292|emphysema|emphysema
495435|NCT01449292|polymeric lung volume reduction|polymeric lung volume reduction
495436|NCT01449292|heterogeneous|heterogeneous
495437|NCT01449292|Respiratory Tract Diseases|respiratory tract diseases
495438|NCT01449292|Lung Diseases|lung diseases
495439|NCT01449292|Chronic Obstructive Pulmonary Disease|chronic obstructive pulmonary disease
495440|NCT01449266|Dotarem|dotarem
495441|NCT01449266|Dialyses|dialyses
495442|NCT01449266|Dialysed|dialysed
495443|NCT01449266|Safety|safety
495444|NCT01449266|Safety and dialysability of Dotarem in dialysed patients|safety and dialysability of dotarem in dialysed patients
495445|NCT01449240|Hunter syndrome|hunter syndrome
495446|NCT01449240|Mucopolysaccharidosis II|mucopolysaccharidosis ii
495447|NCT01449240|Iduronate 2-Sulfatase Deficiency|iduronate 2-sulfatase deficiency
495448|NCT01449240|Lumbar puncture|lumbar puncture
495449|NCT01449240|Cerebrospinal fluid (CSF)|cerebrospinal fluid (csf)
495450|NCT01449240|Pediatric|pediatric
495451|NCT01449240|Adult|adult
495452|NCT01449240|Biomarkers|biomarkers
495453|NCT01449227|adhesive capsulitis|adhesive capsulitis
495454|NCT01449227|hip|hip
495455|NCT01449214|Thoracic epidural|thoracic epidural
495456|NCT01449214|Epidural anesthesia|epidural anesthesia
495457|NCT01449214|Ultrasound|ultrasound
495458|NCT01449214|Palpation|palpation
495459|NCT01449214|Thoracic spine|thoracic spine
495460|NCT01449201|PF-00299804, head and neck cancer, squamous cell carcinoma|pf-00299804, head and neck cancer, squamous cell carcinoma
495461|NCT01449188|ondansetron|ondansetron
495462|NCT01449188|moxifloxacin|moxifloxacin
495463|NCT01449188|Zofran|zofran
495464|NCT01449188|thorough QT study|thorough qt study
495465|NCT01449188|IV|iv
495466|NCT01449175|AeriSeal|aeriseal
495467|NCT01449175|treatment|treatment
495468|NCT01449175|device|device
495469|NCT01449175|breathing|breathing
495470|NCT01449175|COPD|copd
495471|NCT01449175|emphysema|emphysema
495472|NCT01449175|polymeric lung volume reduction (PLVR)|polymeric lung volume reduction (plvr)
495473|NCT01449175|biologic lung volume reduction (BLVR)|biologic lung volume reduction (blvr)
495474|NCT01449175|heterogeneous|heterogeneous
495475|NCT01449175|homogeneous|homogeneous
495476|NCT01449175|Respiratory Tract Diseases|respiratory tract diseases
495477|NCT01449175|Lung Diseases|lung diseases
495478|NCT01449175|Pulmonary Disease, Chronic Obstructive|pulmonary disease, chronic obstructive
495479|NCT01449162|severe persistent asthma|severe persistent asthma
495480|NCT01449162|tyrosine kinase inhibitor|tyrosine kinase inhibitor
495481|NCT01449149|Age 18 or greater|age 18 or greater
495482|NCT01449149|No prior radiation|no prior radiation
495483|NCT01449136|Antibacterial agents|antibacterial agents
495484|NCT01449136|Deciduous Teeth|deciduous teeth
495485|NCT01449136|Clinical Trial|clinical trial
495486|NCT01449123|Asthma|asthma
495487|NCT01449123|mannitol challenge test|mannitol challenge test
495488|NCT01449123|Sweden|sweden
495489|NCT01449123|primary care|primary care
495490|NCT01449110|Primary prevention|primary prevention
495491|NCT01449110|Secondary prevention|secondary prevention
495492|NCT01449110|Resveratrol|resveratrol
495493|NCT01449110|Grape|grape
495494|NCT01449110|Cardiovascular|cardiovascular
495495|NCT01449110|Nutraceutical|nutraceutical
495496|NCT01449110|Food complement|food complement
495497|NCT01449097|Adductor-Canal-blockade,|adductor-canal-blockade,
495498|NCT01449097|human volunteers,|human volunteers,
710747|NCT00588107|Cancer|cancer
495499|NCT01449097|US-guided nerve block|us-guided nerve block
495500|NCT01449097|femoral nerve block|femoral nerve block
495501|NCT01449084|Pancreatic duct stenting|pancreatic duct stenting
495502|NCT01449084|Post-endoscopic pancreatitis|post-endoscopic pancreatitis
495503|NCT01449071|Lupus|lupus
495504|NCT01449071|Monoclonal antibody|monoclonal antibody
495505|NCT01449071|B-cell immunotherapy|b-cell immunotherapy
495506|NCT01449071|Epratuzumab|epratuzumab
495507|NCT01449058|Advanced solid tumor,|advanced solid tumor,
495508|NCT01449058|AML|aml
495509|NCT01449058|high risk and very high risk MDS|high risk and very high risk mds
495510|NCT01449058|dose escalation,|dose escalation,
495511|NCT01449058|RAS/BRAF mutation,|ras/braf mutation,
495512|NCT01449058|PI3K inhibitor,|pi3k inhibitor,
495513|NCT01449058|MEK inhibitor,|mek inhibitor,
495514|NCT01449058|BYL719,|byl719,
495515|NCT01449058|MEK162|mek162
495516|NCT01449045|IPTc|iptc
495517|NCT01449045|Community Case Management|community case management
495518|NCT01449045|Home Management for malaria|home management for malaria
495519|NCT01449032|Patients|patients
495520|NCT01449019|GLP-1|glp-1
495521|NCT01449019|Exendin(9-39)|exendin(9-39)
495522|NCT01449019|Insulin|insulin
495523|NCT01449019|Glucagon|glucagon
495524|NCT01449019|T2DM|t2dm
495525|NCT01449019|incretin effect|incretin effect
495526|NCT01449019|human physiology|human physiology
495527|NCT01449006|HIV|hiv
495528|NCT01449006|HAND|hand
495529|NCT01449006|Maraviroc|maraviroc
495530|NCT01449006|Neurocognitive|neurocognitive
495531|NCT01449006|Neurology|neurology
495532|NCT01449006|Human Immunodeficiency Virus|human immunodeficiency virus
495533|NCT01449006|HIV Associated Neurocognitive Disorders|hiv associated neurocognitive disorders
495534|NCT01448980|massage|massage
495535|NCT01448980|stroke spasticity|stroke spasticity
495536|NCT01448928|Zevalin|zevalin
495537|NCT01448928|CD20+|cd20+
495538|NCT01448928|Non-Hodgkin's Lymphoma|non-hodgkin's lymphoma
495539|NCT01448928|Mantle Cell Lymphoma|mantle cell lymphoma
495540|NCT01448915|HIV|hiv
495541|NCT01448915|Human immunodeficiency virus|human immunodeficiency virus
495542|NCT01448915|Acquired Immune Deficiency Syndrome Virus|acquired immune deficiency syndrome virus
495543|NCT01448915|AIDS virus|aids virus
495544|NCT01448915|Immunodeficiency Virus, Human|immunodeficiency virus, human
495545|NCT01448915|Virus, Human Immunodeficiency|virus, human immunodeficiency
495546|NCT01448915|Hepatitis C|hepatitis c
495547|NCT01448915|Hepatitis C, chronic|hepatitis c, chronic
495548|NCT01448915|Hepatitis C virus|hepatitis c virus
495549|NCT01448915|Hepatitis C antibodies|hepatitis c antibodies
495550|NCT01448915|Hepatitis C antigens|hepatitis c antigens
495551|NCT01448902|Allergic rhinitis|allergic rhinitis
495552|NCT01448902|CRTH2|crth2
495553|NCT01448889|contrast induced nephropathy|contrast induced nephropathy
495554|NCT01448889|oxigen|oxigen
495555|NCT01448889|coronary angiography|coronary angiography
495556|NCT01448876|Chlamydia trachomatis|chlamydia trachomatis
495557|NCT01448876|anorectal|anorectal
495558|NCT01448876|cervicovaginal|cervicovaginal
495559|NCT01448876|MSM|msm
495560|NCT01448876|women|women
495561|NCT01448876|treatment|treatment
495562|NCT01448876|RNA|rna
495563|NCT01448876|bacterial load|bacterial load
495564|NCT01448876|sexual behaviour|sexual behaviour
495565|NCT01448876|Azythromycin treated|azythromycin treated
495566|NCT01448850|Chronic Obstructive Pulmonary Disease (COPD)|chronic obstructive pulmonary disease (copd)
495567|NCT01448850|MEDI8968|medi8968
495568|NCT01448824|Low High-density Lipoprotein (HDL)|low high-density lipoprotein (hdl)
495569|NCT01448824|Cholesterol (HDL-C)|cholesterol (hdl-c)
495570|NCT01448798|radical prostatectomy|radical prostatectomy
495571|NCT01448798|robotic surgery|robotic surgery
495572|NCT01448798|erectile dysfunction|erectile dysfunction
495573|NCT01448798|continence|continence
495574|NCT01448785|obesity|obesity
495575|NCT01448785|gastric stimulation|gastric stimulation
495576|NCT01448785|morbid obesity|morbid obesity
495577|NCT01448772|Dronabinol|dronabinol
495578|NCT01448772|fasting|fasting
495678|NCT01448330|aspinin|aspinin
495679|NCT01448330|combination|combination
495579|NCT01448759|Patients receiving docetaxel or paclitaxel. All tumors.|patients receiving docetaxel or paclitaxel. all tumors.
495580|NCT01448746|gastric cancer|gastric cancer
495581|NCT01448746|VTE|vte
495582|NCT01448746|incidence|incidence
495583|NCT01448733|acne vulgaris|acne vulgaris
495584|NCT01448720|Schizophrenia|schizophrenia
495585|NCT01448720|Paliperidone palmitate|paliperidone palmitate
495586|NCT01448720|Long-acting injectable antipsychotic medication|long-acting injectable antipsychotic medication
495587|NCT01448707|Darunavir (DRV)|darunavir (drv)
495588|NCT01448707|TMC114|tmc114
495589|NCT01448707|Prezista|prezista
495590|NCT01448707|HIV|hiv
495591|NCT01448707|virologic response|virologic response
495592|NCT01448707|neurocognitive function|neurocognitive function
495593|NCT01448694|Hemorrhage|hemorrhage
495594|NCT01448681|Intracranial Hypertension|intracranial hypertension
495595|NCT01448681|Elevated ICP (Intracranial Pressure)|elevated icp (intracranial pressure)
495596|NCT01448668|pancreatic cancer|pancreatic cancer
495597|NCT01448668|mistletoe|mistletoe
495598|NCT01448668|supportive treatment|supportive treatment
495599|NCT01448668|long-term study|long-term study
495600|NCT01448668|non-interventional cohort study|non-interventional cohort study
495601|NCT01448668|controlled study with parallel groups|controlled study with parallel groups
495602|NCT01448655|colorectal cancer|colorectal cancer
495603|NCT01448655|mistletoe|mistletoe
495604|NCT01448655|supportive treatment|supportive treatment
495605|NCT01448655|long-term study|long-term study
495606|NCT01448655|non-interventional cohort study|non-interventional cohort study
495607|NCT01448655|controlled study with parallel groups|controlled study with parallel groups
495608|NCT01448603|Ragweed allergy|ragweed allergy
495609|NCT01448603|ToleroMune ragweed|toleromune ragweed
495610|NCT01448603|immunotherapy|immunotherapy
495611|NCT01448590|post dural puncture headache|post dural puncture headache
495612|NCT01448590|accidental dural puncture|accidental dural puncture
495613|NCT01448590|PDPH|pdph
495614|NCT01448590|ADP|adp
495615|NCT01448590|spinal catheter|spinal catheter
495616|NCT01448590|epidural catheter|epidural catheter
495617|NCT01448590|intrathecal catheter|intrathecal catheter
495618|NCT01448590|dural puncture|dural puncture
495619|NCT01448590|systemic review|systemic review
495620|NCT01448564|Chronic Obstructive Pulmonary Disease|chronic obstructive pulmonary disease
495621|NCT01448564|Fatigue|fatigue
495622|NCT01448564|laser therapy|laser therapy
495623|NCT01448551|Obesity|obesity
495624|NCT01448551|Treatment|treatment
495625|NCT01448551|Adolescents|adolescents
495626|NCT01448551|Text Messages|text messages
495627|NCT01448551|Mobile phones|mobile phones
495628|NCT01448551|Multidisciplinary|multidisciplinary
495629|NCT01448538|Medication Non-Adherence|medication non-adherence
495630|NCT01448538|Medication Persistence|medication persistence
495631|NCT01448538|wet macular degeneration|wet macular degeneration
495632|NCT01448512|HIV|hiv
495633|NCT01448512|Pregnancy|pregnancy
495634|NCT01448512|Prevention|prevention
495635|NCT01448512|Couples|couples
495636|NCT01448499|schizophrenia|schizophrenia
495637|NCT01448499|clozapine|clozapine
495638|NCT01448499|amisulpride|amisulpride
495639|NCT01448499|combination|combination
495640|NCT01448499|treatment resistant|treatment resistant
495641|NCT01448486|HIV|hiv
495642|NCT01448486|HAND|hand
495643|NCT01448486|Human Immunodeficiency Virus|human immunodeficiency virus
495644|NCT01448486|Raltegravir|raltegravir
495645|NCT01448486|HIV Associated Neurocognitive Disorders|hiv associated neurocognitive disorders
495646|NCT01448486|Neuro-HAART|neuro-haart
495647|NCT01448486|Neurocognitive|neurocognitive
495648|NCT01448486|Neurology|neurology
495649|NCT01448473|Head trauma|head trauma
495650|NCT01448473|Children|children
495651|NCT01448473|Radiography|radiography
495652|NCT01448434|Osteoarthritis|osteoarthritis
495653|NCT01448434|Knee|knee
495654|NCT01448434|Stem cell|stem cell
495655|NCT01448434|MSC|msc
495656|NCT01448421|TAVR|tavr
495657|NCT01448408|Forme Fruste Keratoconus|forme fruste keratoconus
495658|NCT01448408|Corneal Biomechanical properties|corneal biomechanical properties
495659|NCT01448408|Anterior Segment Parameters|anterior segment parameters
495660|NCT01448408|Diagnostic Capacity|diagnostic capacity
495661|NCT01448395|Mass Balance|mass balance
495662|NCT01448395|Metabolite Identification and Profiling|metabolite identification and profiling
495663|NCT01448395|Metabolite profile and Identification of [14C]NXL104|metabolite profile and identification of [14c]nxl104
495664|NCT01448395|Mass Balance Recovery|mass balance recovery
495665|NCT01448369|meibomian gland dysfunction|meibomian gland dysfunction
495666|NCT01448369|hot compress|hot compress
495667|NCT01448369|eyelid warming|eyelid warming
495668|NCT01448369|meibum|meibum
495669|NCT01448356|Controlled adverse chamber|controlled adverse chamber
495670|NCT01448356|tear film stability|tear film stability
495671|NCT01448356|tear film evaporation|tear film evaporation
495672|NCT01448356|tear film break up time|tear film break up time
495673|NCT01448356|humidity|humidity
495674|NCT01448356|temperature|temperature
495675|NCT01448343|transfusion|transfusion
495676|NCT01448343|potassium|potassium
495677|NCT01448330|clopidogrel|clopidogrel
495680|NCT01448291|Contraception|contraception
495681|NCT01448291|Nuvaring|nuvaring
495682|NCT01448291|Vaginal inflammation|vaginal inflammation
495683|NCT01448291|Bacterial vaginosis|bacterial vaginosis
495684|NCT01448291|Nugent score|nugent score
495685|NCT01448278|Anterior cruciate ligament|anterior cruciate ligament
495686|NCT01448278|Arthroscopy|arthroscopy
495687|NCT01448278|Incomplete bone tunnels|incomplete bone tunnels
495688|NCT01448278|Anterior cruciate ligament reconstruction|anterior cruciate ligament reconstruction
495689|NCT01448265|atrial fibrillation|atrial fibrillation
495690|NCT01448265|catheter ablation|catheter ablation
495691|NCT01448265|circular mapping catheter|circular mapping catheter
495692|NCT01448265|cryoballoon|cryoballoon
495693|NCT01448252|T cell vaccination|t cell vaccination
495694|NCT01448252|Immunotherapy|immunotherapy
495695|NCT01448252|Tolerance|tolerance
495696|NCT01448252|safety|safety
495697|NCT01448252|clinical efficacy|clinical efficacy
495698|NCT01448213|DMEK|dmek
495699|NCT01448213|Rejection|rejection
495700|NCT01448213|Corticosteroid|corticosteroid
495701|NCT01448200|hepatitis C|hepatitis c
495702|NCT01448200|NS5A inhibitor|ns5a inhibitor
495703|NCT01448200|Phase 1|phase 1
495704|NCT01448200|genotype-1|genotype-1
495705|NCT01448200|genotype-2|genotype-2
495706|NCT01448200|genotype-3|genotype-3
495707|NCT01448187|Lung cancer, France|lung cancer, france
495708|NCT01448174|salusin-alpha|salusin-alpha
495709|NCT01448174|atorvastatin|atorvastatin
495710|NCT01448174|CD36|cd36
495711|NCT01448174|Hemodialysis|hemodialysis
495712|NCT01448161|Pediatric|pediatric
495713|NCT01448161|Adult|adult
495715|NCT01448148|Mild cognitive impairment|mild cognitive impairment
495716|NCT01448122|Prevention of pigmentation|prevention of pigmentation
495717|NCT01448109|Sepsis|sepsis
495718|NCT01448109|Corticosteroid|corticosteroid
495719|NCT01448096|primary breast diffuse large B cell lymphoma|primary breast diffuse large b cell lymphoma
495720|NCT01448096|rituximab|rituximab
495721|NCT01448096|prophylactic intrathecal chemotherapy|prophylactic intrathecal chemotherapy
495722|NCT01448096|CNS recurrence|cns recurrence
495723|NCT01448083|I-131 MIBG therapy|i-131 mibg therapy
495724|NCT01448083|whole body I-123 MIBG scintigraphy|whole body i-123 mibg scintigraphy
495725|NCT01448057|Paracetamol|paracetamol
495726|NCT01448057|dimethindene maleate|dimethindene maleate
495727|NCT01448057|phenylephrine hydrochloride|phenylephrine hydrochloride
495728|NCT01448057|cold and flu symptoms|cold and flu symptoms
495729|NCT01448044|hepatitis C virus|hepatitis c virus
495730|NCT01448031|Acetyl Salicylic Acid|acetyl salicylic acid
495731|NCT01448031|Bioavailability|bioavailability
495732|NCT01448031|Healthy Volunteers|healthy volunteers
495733|NCT01448005|Coronary Artery Bypass Grafting|coronary artery bypass grafting
495734|NCT01448005|Resuscitation|resuscitation
495735|NCT01448005|Sudden Cardiac Death|sudden cardiac death
495736|NCT01448005|Ventricular Dysfunction|ventricular dysfunction
495737|NCT01447992|Artificial Pancreas|artificial pancreas
495738|NCT01447992|Insulin Pump|insulin pump
495739|NCT01447992|Continuous Glucose Monitor|continuous glucose monitor
495740|NCT01447992|Closed Loop|closed loop
495741|NCT01447979|Artificial Pancreas|artificial pancreas
495742|NCT01447979|Insulin Pump|insulin pump
495743|NCT01447979|Continuous Glucose Monitor|continuous glucose monitor
495744|NCT01447979|Closed Loop|closed loop
495745|NCT01447966|OCD|ocd
495746|NCT01447966|Obsessive Compulsive Disorder|obsessive compulsive disorder
495747|NCT01447966|Child|child
495748|NCT01447966|Pediatric|pediatric
495749|NCT01447966|CBT|cbt
495750|NCT01447966|Therapy|therapy
495751|NCT01447966|ERP|erp
495752|NCT01447966|Exposure Response Prevention|exposure response prevention
495753|NCT01447966|Preschool|preschool
495754|NCT01447966|Cognitive Behavioral|cognitive behavioral
495755|NCT01447953|Activity|activity
495756|NCT01447953|disability|disability
495757|NCT01447953|life-role|life-role
495758|NCT01447953|multimodal rehabilitation|multimodal rehabilitation
495759|NCT01447953|primary health care|primary health care
495760|NCT01447953|persistent pain|persistent pain
495761|NCT01447953|randomized controlled trial|randomized controlled trial
495762|NCT01447953|Musculoskeletal back pain|musculoskeletal back pain
495763|NCT01447940|Telemedicine|telemedicine
495764|NCT01447940|Type 1 diabetes|type 1 diabetes
495765|NCT01447940|economic cost of Type 1 diabetes|economic cost of type 1 diabetes
495766|NCT01447940|ePortal Meos|eportal meos
495767|NCT01447914|c-Met Inhibitor ARQ-197|c-met inhibitor arq-197
495768|NCT01447914|tivantinib|tivantinib
495769|NCT01447914|multiple myeloma|multiple myeloma
495770|NCT01447914|plasma cell proliferative disorder|plasma cell proliferative disorder
495771|NCT01447914|Hypercalcemia|hypercalcemia
495772|NCT01447914|hematologic malignancy|hematologic malignancy
495773|NCT01447914|plasma cell dyscrasia|plasma cell dyscrasia
495774|NCT01447914|cast nephropathy|cast nephropathy
495775|NCT01447914|amyloidosis|amyloidosis
495776|NCT01447914|osteolysis|osteolysis
495777|NCT01447914|Renal insufficiency|renal insufficiency
495778|NCT01447914|Anemia|anemia
495779|NCT01447914|Bone lytic lesions|bone lytic lesions
495780|NCT01447914|severe osteopenia|severe osteopenia
495781|NCT01447914|pathologic fractures|pathologic fractures
495782|NCT01447914|biopsy-proven plasmacytoma|biopsy-proven plasmacytoma
495783|NCT01447901|Hyperlipoproteinemia Type I|hyperlipoproteinemia type i
495784|NCT01447888|Spine surgery|spine surgery
495785|NCT01447888|Chronic pain|chronic pain
495786|NCT01447888|Opioid tolerant|opioid tolerant
495787|NCT01447888|Pain management in spine surgery patients|pain management in spine surgery patients
495788|NCT01447862|recent-onset|recent-onset
495789|NCT01447849|Chronic Constipation|chronic constipation
495790|NCT01447836|indocyanine green|indocyanine green
495791|NCT01447836|sepsis|sepsis
495792|NCT01447836|liver injury|liver injury
495793|NCT01447836|abdominal perfusion pressure|abdominal perfusion pressure
495794|NCT01447823|Oesophageal bolus obstruction|oesophageal bolus obstruction
495795|NCT01447823|Gastroscopy|gastroscopy
495796|NCT01447823|phmetry|phmetry
495797|NCT01447810|Constraint-Induced Movement therapy|constraint-induced movement therapy
495798|NCT01447810|Pediatric|pediatric
495799|NCT01447810|Hemiplegia|hemiplegia
495800|NCT01447810|Brain Tumor|brain tumor
495801|NCT01447810|Rehabilitation|rehabilitation
495802|NCT01447797|Irbesartan|irbesartan
495803|NCT01447797|Atorvastatin|atorvastatin
495804|NCT01447797|combination|combination
495805|NCT01447784|HDM allergy|hdm allergy
495806|NCT01447784|Rhinoconunctivitis|rhinoconunctivitis
495807|NCT01447784|Environmental Exposure Chamber|environmental exposure chamber
495808|NCT01447784|Immunotherapy|immunotherapy
495809|NCT01447784|ToleroMune HDM|toleromune hdm
495810|NCT01447771|Decision making|decision making
495811|NCT01447771|Decisional aide|decisional aide
495812|NCT01447745|Visceral obesity|visceral obesity
495813|NCT01447745|Cardiometabolic risk|cardiometabolic risk
495814|NCT01447745|Atherosclerosis|atherosclerosis
495815|NCT01447745|Ectopic fat|ectopic fat
495816|NCT01447745|Carotid plaque|carotid plaque
495817|NCT01447745|Magnetic resonance imaging (MRI)|magnetic resonance imaging (mri)
495818|NCT01447745|Computed tomography (CT)|computed tomography (ct)
495819|NCT01447732|Monoclonal antibody (Mab)|monoclonal antibody (mab)
495820|NCT01447732|Antibody dependent cellular cytotoxicity (ADCC)|antibody dependent cellular cytotoxicity (adcc)
495821|NCT01447732|Complement-dependent toxicity (CDC)|complement-dependent toxicity (cdc)
495822|NCT01447732|Non-fucosylated immunoglobulin G|non-fucosylated immunoglobulin g
495823|NCT01447706|Ovarian Cancer|ovarian cancer
495824|NCT01447706|Platinum-resistant|platinum-resistant
495825|NCT01447706|Platinum-refractory|platinum-refractory
495826|NCT01447706|Fallopian tube cancer|fallopian tube cancer
495827|NCT01447706|Peritoneal Cancer|peritoneal cancer
495828|NCT01447706|Paclitaxel|paclitaxel
495829|NCT01447706|ErbB3|erbb3
495830|NCT01447706|Phase II|phase ii
495831|NCT01447706|locally advanced/metastatic or recurrent|locally advanced/metastatic or recurrent
495832|NCT01447693|uremia|uremia
495833|NCT01447693|pruritus|pruritus
495834|NCT01447693|oliva-omega 3|oliva-omega 3
495835|NCT01447680|HIV infection|hiv infection
495836|NCT01447680|HCV infection|hcv infection
495837|NCT01447680|SMARTube|smartube
495838|NCT01447680|SMARTplasma|smartplasma
495839|NCT01447667|Hepatic fibrosis|hepatic fibrosis
495840|NCT01447667|Magnetic resonance elastography|magnetic resonance elastography
495841|NCT01447667|Hepatocellular carcinoma|hepatocellular carcinoma
495842|NCT01447667|Recurrence|recurrence
495843|NCT01447654|Hypertrophic cardiomyopathy|hypertrophic cardiomyopathy
495844|NCT01447654|Hypertrophic obstructive cardiomyopathy|hypertrophic obstructive cardiomyopathy
495845|NCT01447654|Hypertrophy|hypertrophy
495846|NCT01447654|Losartan|losartan
495847|NCT01447654|Angiotensin II receptor antagonist|angiotensin ii receptor antagonist
495848|NCT01447641|Cluster Headache|cluster headache
495849|NCT01447641|Trigeminal Autonomic Cephalalgias|trigeminal autonomic cephalalgias
495850|NCT01447641|Sleep|sleep
495851|NCT01447641|Circadian Rhythms|circadian rhythms
495852|NCT01447628|Idiopathic pulmonary arterial hypertension (IPAH)|idiopathic pulmonary arterial hypertension (ipah)
495853|NCT01447628|Iron deficiency|iron deficiency
495854|NCT01447615|Orphaned children and youth|orphaned children and youth
495855|NCT01447615|Economic empowerment|economic empowerment
495856|NCT01447615|Uganda|uganda
495857|NCT01447615|HIV/AIDS|hiv/aids
495858|NCT01447615|Sub-Saharan Africa|sub-saharan africa
495859|NCT01447602|Major Depressive Disorder (MDD)|major depressive disorder (mdd)
495860|NCT01447602|Dysthymia|dysthymia
495861|NCT01447602|Depressive Disorder Not Otherwise Specified (DDNOS)|depressive disorder not otherwise specified (ddnos)
495862|NCT01447589|Radiosensitiser|radiosensitiser
495863|NCT01447563|Bioequivalence|bioequivalence
495864|NCT01447563|Bioavailability|bioavailability
495865|NCT01447550|Bosentan|bosentan
495866|NCT01447550|Buerguer disease|buerguer disease
495867|NCT01447537|Cirrhosis|cirrhosis
495868|NCT01447537|Exercise|exercise
495869|NCT01447537|Relaxation|relaxation
495870|NCT01447537|Muscle mass|muscle mass
495871|NCT01447537|Effort tolerance|effort tolerance
495872|NCT01447511|Drug Interactions|drug interactions
495873|NCT01447511|Warfarin|warfarin
495874|NCT01447511|Genetics|genetics
495875|NCT01447511|CYP2C9|cyp2c9
495876|NCT01447511|Healthy Volunteers|healthy volunteers
495877|NCT01447485|Hypertension, chronic kidney disease|hypertension, chronic kidney disease
495878|NCT01447485|nephrotic syndrome|nephrotic syndrome
495879|NCT01447485|pharmacokinetics|pharmacokinetics
495881|NCT01447472|pharmacokinetics,|pharmacokinetics,
495882|NCT01447472|pharmacodynamics,|pharmacodynamics,
495883|NCT01447472|CYP2D6, COMT,|cyp2d6, comt,
495884|NCT01447472|SERT, 5-HTTLPR, gender,|sert, 5-httlpr, gender,
495885|NCT01447472|dextromethorphan,|dextromethorphan,
495886|NCT01447472|caffeine.|caffeine.
495887|NCT01447459|Asthma|asthma
495888|NCT01447459|Asthma Education|asthma education
495889|NCT01447433|Calcium Carbonate|calcium carbonate
495890|NCT01447433|Vitamin D|vitamin d
495891|NCT01447433|Body weight|body weight
495892|NCT01447433|Body fat|body fat
495893|NCT01447433|Metabolic parameters|metabolic parameters
495894|NCT01447433|Energy restriction|energy restriction
495895|NCT01447433|Very-low calcium consumers|very-low calcium consumers
495896|NCT01447433|Obesity|obesity
495897|NCT01447433|Overweight|overweight
631400|NCT00899431|CLL|cll
495898|NCT01447407|Staphylococcal infections|staphylococcal infections
495899|NCT01447407|Yeast infections|yeast infections
495900|NCT01447407|Candidiasis|candidiasis
495901|NCT01447368|chronic kidney disease|chronic kidney disease
495902|NCT01447368|peritoneal dialysis|peritoneal dialysis
495903|NCT01447368|secondary hyperparathyroidism|secondary hyperparathyroidism
495904|NCT01447368|parathyroidectomy|parathyroidectomy
495905|NCT01447368|vascular calcification|vascular calcification
495906|NCT01447368|cinacalcet|cinacalcet
495907|NCT01447329|pain|pain
495908|NCT01447329|acupuncture|acupuncture
495909|NCT01447329|knee|knee
495910|NCT01447329|debridement|debridement
495911|NCT01447329|surgery|surgery
495912|NCT01447329|arthroscopic knee surgery debridement|arthroscopic knee surgery debridement
495913|NCT01447316|body composition|body composition
495914|NCT01447316|gait|gait
495915|NCT01447316|quality of life|quality of life
495916|NCT01447316|Patients|patients
495917|NCT01447316|undergoing|undergoing
495918|NCT01447316|bariatric surgery.|bariatric surgery.
495919|NCT01447303|knee|knee
495920|NCT01447303|osteoarthritis|osteoarthritis
495921|NCT01447303|hyaluronic acid|hyaluronic acid
495922|NCT01447303|viscosupplementation|viscosupplementation
495923|NCT01447290|preeclampsia|preeclampsia
495924|NCT01447290|protein|protein
495925|NCT01447290|creatinine|creatinine
495926|NCT01447290|protein:creatinine ratio|protein:creatinine ratio
495927|NCT01447277|ACL reconstruction|acl reconstruction
495928|NCT01447277|Femoral Block|femoral block
495929|NCT01447277|Sciatic Block|sciatic block
495930|NCT01447264|Rheumatoid arthritis|rheumatoid arthritis
495931|NCT01447264|Muscle strength|muscle strength
495932|NCT01447264|Body composition|body composition
495933|NCT01447264|Physical activity|physical activity
495934|NCT01447264|Water exercises|water exercises
495935|NCT01447264|Hydrotherapy|hydrotherapy
495936|NCT01447264|Randomized controlled clinical trial|randomized controlled clinical trial
495937|NCT01447251|Obstructive Sleep Apnea|obstructive sleep apnea
495938|NCT01447251|Diabetes Mellitus type 2|diabetes mellitus type 2
495939|NCT01447251|DM2|dm2
495940|NCT01447251|OSA|osa
495941|NCT01447251|CPAP|cpap
495942|NCT01447251|continuous positive airway pressure|continuous positive airway pressure
495943|NCT01447238|pancreatic cysts|pancreatic cysts
495944|NCT01447238|EUS/FNA|eus/fna
495945|NCT01447238|Needle-based Confocal Laser Endomicroscopy (nCLE)|needle-based confocal laser endomicroscopy (ncle)
495946|NCT01447238|fiber optic imaging|fiber optic imaging
495947|NCT01447238|EUS/FNA of pancreatic cysts|eus/fna of pancreatic cysts
495948|NCT01447225|Advanced-stage|advanced-stage
495949|NCT01447225|Solid Tumors|solid tumors
495950|NCT01447225|MM-121|mm-121
495951|NCT01447225|Carboplatin|carboplatin
495952|NCT01447225|Pemetrexed|pemetrexed
495953|NCT01447225|Gemcitabine|gemcitabine
495954|NCT01447225|Cabazitaxel|cabazitaxel
495955|NCT01447225|ErbB3|erbb3
495956|NCT01447225|Phase I|phase i
495957|NCT01447225|Cancer|cancer
495958|NCT01447212|Opioid Dependence|opioid dependence
495959|NCT01447212|Long-term Opioid Injectors|long-term opioid injectors
495960|NCT01447212|Opioid Substitution Treatment|opioid substitution treatment
495961|NCT01447212|Hydromorphone|hydromorphone
495962|NCT01447212|Diamorphine|diamorphine
495963|NCT01447212|Diacetylmorphine|diacetylmorphine
495964|NCT01447199|Bladder cancer|bladder cancer
495965|NCT01447199|Colorectal cancer|colorectal cancer
495966|NCT01447199|Endometrial cancer|endometrial cancer
495967|NCT01447199|Kidney cancer|kidney cancer
495968|NCT01447199|Skin cancer|skin cancer
495969|NCT01447199|Uterus cancer|uterus cancer
495970|NCT01447199|Molecular Predisposition|molecular predisposition
495971|NCT01447199|Hereditary Nonpolyposis Colon Cancer|hereditary nonpolyposis colon cancer
495972|NCT01447199|HNPCC|hnpcc
495973|NCT01447199|Molecular genetic testing|molecular genetic testing
495974|NCT01447199|Gene mutations|gene mutations
495975|NCT01447199|Mutation analyses|mutation analyses
495976|NCT01447199|Genetic polymorphisms|genetic polymorphisms
495977|NCT01447199|Family history of cancer|family history of cancer
495978|NCT01447199|Early age of cancer onset|early age of cancer onset
495979|NCT01447199|Little/no personal or family history of cancer|little/no personal or family history of cancer
495980|NCT01447199|Spouses|spouses
495981|NCT01447199|Questionnaires|questionnaires
495982|NCT01447199|Blood sample|blood sample
495983|NCT01447199|Saliva Sample|saliva sample
495984|NCT01447186|Prostate cancer screening|prostate cancer screening
495985|NCT01447186|Prostate Cancer|prostate cancer
495986|NCT01447186|Patient Decision Aid|patient decision aid
495987|NCT01447186|Spanish Speaking Men|spanish speaking men
495988|NCT01447186|Spanish-language slide set|spanish-language slide set
495989|NCT01447186|Focus group|focus group
495990|NCT01447186|Interview|interview
495991|NCT01447186|Survey|survey
495992|NCT01447173|Asthma|asthma
495993|NCT01447173|Pulmonary Function Test|pulmonary function test
495994|NCT01447173|Vitamin D|vitamin d
495995|NCT01447160|facet joint|facet joint
495996|NCT01447160|back pain|back pain
495997|NCT01447160|osteoarthritis|osteoarthritis
495998|NCT01447160|infiltration|infiltration
495999|NCT01447108|Trigeminal Neuralgia|trigeminal neuralgia
496000|NCT01447108|Tic Douloureux|tic douloureux
496001|NCT01447108|Low Intensity Low Frequency Surface Acoustic Wave Ultrasound|low intensity low frequency surface acoustic wave ultrasound
496002|NCT01447095|Subarachnoid hemorrhage|subarachnoid hemorrhage
496003|NCT01447095|vasospasm|vasospasm
496004|NCT01447095|prostacyclin|prostacyclin
496005|NCT01447082|atypical|atypical
496006|NCT01447082|antipsychotics|antipsychotics
496007|NCT01447082|quetiapine|quetiapine
496008|NCT01447069|heart failure stage 3|heart failure stage 3
496009|NCT01447069|beta 2 agonist|beta 2 agonist
496010|NCT01447069|N-terminal pro-brain natriuretic peptide|n-terminal pro-brain natriuretic peptide
496011|NCT01447069|ejection fraction <35%|ejection fraction <35%
496012|NCT01447056|Hodgkin lymphoma|hodgkin lymphoma
496013|NCT01447056|Non-Hodgkin lymphoma|non-hodgkin lymphoma
496014|NCT01447056|Lymphoproliferative disorder|lymphoproliferative disorder
496015|NCT01447056|Nasopharyngeal carcinoma|nasopharyngeal carcinoma
496016|NCT01447056|Leiomyosarcoma|leiomyosarcoma
496017|NCT01447056|EBV Cytotoxic T Lymphocytes|ebv cytotoxic t lymphocytes
496018|NCT01447043|retrospective studies|retrospective studies
496019|NCT01447030|Biliary strictur|biliary strictur
496020|NCT01447030|Hepatojejunostomy|hepatojejunostomy
496021|NCT01447030|Iatrogenic major bile duct injury|iatrogenic major bile duct injury
496022|NCT01446991|prostate neoplasm|prostate neoplasm
496023|NCT01446991|brachytherapy|brachytherapy
496024|NCT01446991|androgen ablation|androgen ablation
496025|NCT01446991|benign prostatic hypertrophy|benign prostatic hypertrophy
496026|NCT01446991|prostate size reduction|prostate size reduction
496027|NCT01446991|localized prostate cancer with prostate volume > 40 cc|localized prostate cancer with prostate volume > 40 cc
496028|NCT01446978|hepatitis A vaccine|hepatitis a vaccine
496029|NCT01446978|TNF-alfa inhibitory drugs|tnf-alfa inhibitory drugs
496030|NCT01446978|Rheumatoid arthritis|rheumatoid arthritis
496031|NCT01446978|methotrexate|methotrexate
496032|NCT01446965|myocardial infarction, acute|myocardial infarction, acute
496033|NCT01446965|myocardial infarction|myocardial infarction
496034|NCT01446965|ventricular dysfunction|ventricular dysfunction
496035|NCT01446965|death, sudden, cardiac|death, sudden, cardiac
496036|NCT01446965|death, sudden|death, sudden
496037|NCT01446965|death|death
496038|NCT01446965|ventricular tachycardia|ventricular tachycardia
496039|NCT01446965|ventricular fibrillation|ventricular fibrillation
496040|NCT01446965|defibrillation, electric|defibrillation, electric
496041|NCT01446965|cardioversion, electric|cardioversion, electric
496042|NCT01446965|electric countershock|electric countershock
496043|NCT01446965|defibrillators, external|defibrillators, external
496044|NCT01446952|prevention|prevention
496045|NCT01446952|pancreas|pancreas
496046|NCT01446939|MRI|mri
496047|NCT01446939|Parkinson's disease|parkinson's disease
496048|NCT01446939|Essential tremor|essential tremor
496049|NCT01446939|Ultrasonography|ultrasonography
496050|NCT01446939|Diagnosis|diagnosis
496051|NCT01446926|Pneumonia|pneumonia
496052|NCT01446926|Pneumococcal Infections|pneumococcal infections
496053|NCT01446926|Streptococcus pneumoniae Infections|streptococcus pneumoniae infections
496054|NCT01446926|Pneumococcal vaccines|pneumococcal vaccines
496055|NCT01446913|Sleep Apnea|sleep apnea
496056|NCT01446913|CPAP adherence|cpap adherence
496057|NCT01446913|behavioral adherence|behavioral adherence
496058|NCT01446913|stroke|stroke
496059|NCT01446900|Rituximab|rituximab
496060|NCT01446900|Cladribine|cladribine
496061|NCT01446900|Chronic Lymphocytic Leukaemia|chronic lymphocytic leukaemia
496062|NCT01446900|Small Lymphocytic Lymphoma|small lymphocytic lymphoma
496063|NCT01446887|Deep Vein Thrombosis|deep vein thrombosis
496064|NCT01446887|total hip arthroplasty|total hip arthroplasty
496065|NCT01446887|prophylactic anticoagulation|prophylactic anticoagulation
496066|NCT01446887|randomized study|randomized study
496067|NCT01446874|Incidence of post-operative pneumonia in patients undergoing surgery for primary lung cancer or primary esophageal cancer|incidence of post-operative pneumonia in patients undergoing surgery for primary lung cancer or primary esophageal cancer
496068|NCT01446861|Cystic fibrosis|cystic fibrosis
496069|NCT01446861|Pancreas|pancreas
496070|NCT01446861|Exocrine function|exocrine function
496071|NCT01446861|Ultrasound|ultrasound
496072|NCT01446861|Contrast ultrasound|contrast ultrasound
496073|NCT01446848|iron deficiency|iron deficiency
496074|NCT01446848|pulmonary hypertension|pulmonary hypertension
496075|NCT01446848|iron supplements|iron supplements
496076|NCT01446848|ferrous sulfate|ferrous sulfate
496077|NCT01446822|urinary bladder neoplasm|urinary bladder neoplasm
496078|NCT01446822|bipolar transurethral resection|bipolar transurethral resection
496079|NCT01446822|monopolar transurethral resection|monopolar transurethral resection
496080|NCT01446822|obturator nerve|obturator nerve
496081|NCT01446796|Ventricular assist device|ventricular assist device
496082|NCT01446783|COL5A1|col5a1
496083|NCT01446783|Collagen disorders|collagen disorders
496084|NCT01446783|IGF-I|igf-i
496085|NCT01446783|Collagen synthesis|collagen synthesis
496086|NCT01446757|quality of life|quality of life
710748|NCT00588107|Smoker|smoker
496087|NCT01446757|feeling of security|feeling of security
496088|NCT01446757|costs|costs
496089|NCT01446757|multiprofessional team|multiprofessional team
496090|NCT01446757|geriatric competence|geriatric competence
496091|NCT01446731|Prostate cancer|prostate cancer
496092|NCT01446718|quadrivalent vaccine|quadrivalent vaccine
496093|NCT01446718|Human Papillomavirus|human papillomavirus
496094|NCT01446692|Major depressive disorder|major depressive disorder
496095|NCT01446692|primary care|primary care
496096|NCT01446692|real-world evidence|real-world evidence
496097|NCT01446692|database|database
496098|NCT01446679|Lipitor|lipitor
496099|NCT01446679|HMG-CoA reductase inhibitor|hmg-coa reductase inhibitor
496100|NCT01446666|hepatocellular carcinoma|hepatocellular carcinoma
496101|NCT01446666|surveillance|surveillance
496102|NCT01446666|gadoxetic acid|gadoxetic acid
496104|NCT01446653|Fetal Alcohol Spectrum Disorders|fetal alcohol spectrum disorders
496105|NCT01446653|FASDs|fasds
496106|NCT01446653|AEP risk|aep risk
496107|NCT01446653|binge drinking|binge drinking
496108|NCT01446653|ineffective contraception|ineffective contraception
496109|NCT01446627|Absorbable vicryl subcuticular staples|absorbable vicryl subcuticular staples
496110|NCT01446627|metal staples|metal staples
496111|NCT01446627|wound healing|wound healing
496112|NCT01446627|cesarean section|cesarean section
496113|NCT01446601|Apnea|apnea
496114|NCT01446601|OSA|osa
496115|NCT01446601|Sleep Apnea Syndromes|sleep apnea syndromes
496116|NCT01446601|Sleep Apnea, Obstructive|sleep apnea, obstructive
496117|NCT01446601|Hypoglossal Nerve Stimulation|hypoglossal nerve stimulation
496118|NCT01446601|Sleep Disorders|sleep disorders
496119|NCT01446601|Tongue|tongue
496120|NCT01446536|Quality|quality
496121|NCT01446536|Improvement|improvement
496122|NCT01446523|endotoxins HE|endotoxins he
496123|NCT01446510|VTE|vte
496124|NCT01446510|DVT|dvt
496125|NCT01446510|PE|pe
496126|NCT01446510|Risk assessment|risk assessment
496127|NCT01446510|risk score|risk score
496128|NCT01446510|risk analysis|risk analysis
496129|NCT01446510|Venous thromboembolism risk|venous thromboembolism risk
496130|NCT01446497|Normal tension glaucoma|normal tension glaucoma
496131|NCT01446497|Antiglaucoma ophthalmic solution|antiglaucoma ophthalmic solution
496132|NCT01446497|Brimonidine|brimonidine
496133|NCT01446497|Timolol|timolol
496134|NCT01446497|Combination drugs|combination drugs
496135|NCT01446484|Renal transplantation|renal transplantation
496136|NCT01446484|Kidney transplantation|kidney transplantation
496137|NCT01446484|CD4+CD25+CD127lowFoxP3+ T Regulatory Cells|cd4+cd25+cd127lowfoxp3+ t regulatory cells
496138|NCT01446484|T reg|t reg
496139|NCT01446484|Campath|campath
496140|NCT01446471|Bedside Ultrasound|bedside ultrasound
496141|NCT01446471|Point of care ultrasound|point of care ultrasound
496142|NCT01446471|cardiac arrest|cardiac arrest
496143|NCT01446458|Cancer of Pancreas|cancer of pancreas
496144|NCT01446458|Cancer of the Pancreas|cancer of the pancreas
496145|NCT01446458|Neoplasms, Pancreatic|neoplasms, pancreatic
496146|NCT01446458|Pancreas Cancer|pancreas cancer
496147|NCT01446458|Pancreas Neoplasms|pancreas neoplasms
496148|NCT01446458|Entry Term Pancreatic Cancer|entry term pancreatic cancer
496149|NCT01446445|Cytomegalovirus|cytomegalovirus
496150|NCT01446445|renal transplant|renal transplant
496151|NCT01446432|Dupuytren's Contracture|dupuytren's contracture
496152|NCT01446419|chronic axial low back pain|chronic axial low back pain
496153|NCT01446419|vertebrogenic pain|vertebrogenic pain
496154|NCT01446419|Radio frequency ablation|radio frequency ablation
496155|NCT01446406|Bipolar disorder|bipolar disorder
496156|NCT01446406|Electronic daily monitoring|electronic daily monitoring
496157|NCT01446406|Affective episodes|affective episodes
496158|NCT01446354|Blood component transfusion|blood component transfusion
496159|NCT01446354|Hypothermic|hypothermic
496160|NCT01446341|Ankle sprain|ankle sprain
496161|NCT01446341|Functional rehabilitation|functional rehabilitation
496162|NCT01446341|Immobilization|immobilization
496163|NCT01446328|Antipsychotic Drugs|antipsychotic drugs
496164|NCT01446328|Randomized Controlled Trial|randomized controlled trial
496165|NCT01446328|Treatment Effectiveness|treatment effectiveness
496166|NCT01446328|Translational Research|translational research
496167|NCT01446315|asthma|asthma
496168|NCT01446315|asthma care system|asthma care system
496169|NCT01446315|effectiveness|effectiveness
496170|NCT01446315|primary care|primary care
496171|NCT01446315|practice based research network|practice based research network
496172|NCT01446302|Dialysis|dialysis
496173|NCT01446302|Protein-energy wasting|protein-energy wasting
496174|NCT01446302|Insulin-Like Growth Factor I|insulin-like growth factor i
496175|NCT01446302|Insulin-Like Growth Factor Binding Protein 1|insulin-like growth factor binding protein 1
496176|NCT01446302|Inflammation|inflammation
496177|NCT01446289|Group B streptococcus|group b streptococcus
496178|NCT01446289|GBS|gbs
496179|NCT01446289|Vaccine|vaccine
496180|NCT01446289|Prevention of group B streptococcus infection|prevention of group b streptococcus infection
496181|NCT01446276|Obesity|obesity
496182|NCT01446276|Resveratrol|resveratrol
496183|NCT01446276|Nonalcoholic fatty liver disease|nonalcoholic fatty liver disease
496184|NCT01446276|Insulin sensitivity|insulin sensitivity
496185|NCT01446276|Lipid turnover|lipid turnover
496186|NCT01446276|Liver fat content|liver fat content
496187|NCT01446263|Radial access|radial access
496188|NCT01446263|Femoral access|femoral access
496189|NCT01446263|Coronary angiography|coronary angiography
496190|NCT01446263|Coronary artery bypass graft|coronary artery bypass graft
496191|NCT01446250|Chronic hepatitis C|chronic hepatitis c
496192|NCT01446250|Cyclophilin inhibitor|cyclophilin inhibitor
496193|NCT01446224|adverse events|adverse events
496194|NCT01446224|pazopanib|pazopanib
496195|NCT01446224|Torsades des Pointes|torsades des pointes
496196|NCT01446224|renal cell carcinoma|renal cell carcinoma
496197|NCT01446224|anti-VEGF agents|anti-vegf agents
496198|NCT01446224|observational data|observational data
496199|NCT01446224|cardiac ischemia|cardiac ischemia
496200|NCT01446211|gusperimus|gusperimus
496201|NCT01446211|Wegeners granulomatosis|wegeners granulomatosis
496202|NCT01446211|relapse|relapse
496203|NCT01446198|HPV|hpv
496204|NCT01446185|HR+, N- or pN1(mi), Her2- breast cancer adjuvant population|hr+, n- or pn1(mi), her2- breast cancer adjuvant population
496205|NCT01446185|Early Breast cancer|early breast cancer
496206|NCT01446185|Gene Expression|gene expression
496207|NCT01446185|Node-Negative|node-negative
496208|NCT01446185|treatment options|treatment options
496209|NCT01446185|Hormone receptor positive|hormone receptor positive
496210|NCT01446172|Long term outcome|long term outcome
496211|NCT01446159|MEDI-573, breast cancer, metastatic, aromatase inhibitor, anti-IGF|medi-573, breast cancer, metastatic, aromatase inhibitor, anti-igf
496212|NCT01446146|Posttraumatic Stress Disorder|posttraumatic stress disorder
496213|NCT01446146|PTSD Treatment|ptsd treatment
496214|NCT01446146|Decision making|decision making
496215|NCT01446146|Veterans|veterans
496216|NCT01446133|Leukemia|leukemia
496217|NCT01446133|Lymphoma|lymphoma
496218|NCT01446133|Chronic Lymphocytic Leukemia|chronic lymphocytic leukemia
496220|NCT01446133|Small Lymphocytic Lymphoma|small lymphocytic lymphoma
496221|NCT01446133|SLL|sll
496222|NCT01446133|Initial Treatment|initial treatment
496223|NCT01446133|Subsequent Therapy|subsequent therapy
496224|NCT01446133|Rituximab|rituximab
496225|NCT01446133|Rituxan|rituxan
496226|NCT01446133|Lenalidomide|lenalidomide
496227|NCT01446133|CC-5013|cc-5013
496228|NCT01446133|Revlimid|revlimid
496229|NCT01446120|this is phase one study. The study population are healthy volunteers.|this is phase one study. the study population are healthy volunteers.
496230|NCT01446107|tooth decay|tooth decay
496231|NCT01446107|fluoride|fluoride
496232|NCT01446107|sealant|sealant
496233|NCT01446107|prevention|prevention
496234|NCT01446094|Coronary artery disease|coronary artery disease
496235|NCT01446081|chemotherapy|chemotherapy
496236|NCT01446081|exercise|exercise
496237|NCT01446081|quality of life|quality of life
496238|NCT01446081|cancer-related fatigue|cancer-related fatigue
496239|NCT01446081|elderly|elderly
496240|NCT01446081|physical fitness|physical fitness
496241|NCT01446055|Peripheral arterial disease|peripheral arterial disease
496242|NCT01446055|Buerger's disease|buerger's disease
496243|NCT01446055|atherosclerotic arterial occlusion|atherosclerotic arterial occlusion
496244|NCT01446055|bone marrow mononuclear cell|bone marrow mononuclear cell
496245|NCT01446055|chronic limb ischemia|chronic limb ischemia
496246|NCT01446029|Telemonitoring|telemonitoring
496247|NCT01446029|Chronic Kidney Disease|chronic kidney disease
496248|NCT01446016|Breast Cancer|breast cancer
496249|NCT01446016|Breast Tumors|breast tumors
496250|NCT01446016|Cancer of Breast|cancer of breast
496251|NCT01446016|Cancer of the Breast|cancer of the breast
496252|NCT01446016|Human Mammary Carcinoma|human mammary carcinoma
496253|NCT01446016|Mammary Carcinoma, Human|mammary carcinoma, human
496254|NCT01446016|Mammary Neoplasm, Human|mammary neoplasm, human
496255|NCT01446016|Mammary Neoplasms, Human|mammary neoplasms, human
496256|NCT01446016|Neoplasms, Breast|neoplasms, breast
496257|NCT01446016|Tumors, Breast|tumors, breast
496258|NCT01446016|Chloroquine|chloroquine
496259|NCT01446016|Paclitaxel|paclitaxel
496260|NCT01446016|Taxol|taxol
496261|NCT01446016|Ixabepilone|ixabepilone
496262|NCT01446016|Abraxane|abraxane
496263|NCT01446016|Metastatic Breast Cancer|metastatic breast cancer
496264|NCT01446016|Advanced Breast Cancer|advanced breast cancer
496265|NCT01446016|Anthracycline|anthracycline
496266|NCT01445990|free tissue flaps|free tissue flaps
496267|NCT01445990|lactic acid|lactic acid
496268|NCT01445990|glucose|glucose
496269|NCT01445990|thrombosis|thrombosis
496270|NCT01445990|diagnostic test|diagnostic test
496271|NCT01445990|Pedicle postoperative complications diagnosis|pedicle postoperative complications diagnosis
496272|NCT01445977|Sonitus Medical|sonitus medical
496273|NCT01445977|SoundBite|soundbite
496274|NCT01445977|Single Sided Deafness|single sided deafness
496275|NCT01445977|Conductive Hearing Loss|conductive hearing loss
496276|NCT01445977|Unilateral Hearing Loss|unilateral hearing loss
496277|NCT01445964|SLCO2B1 genotype|slco2b1 genotype
496278|NCT01445964|effect of apple juice|effect of apple juice
496279|NCT01445886|Nail Psoriasis|nail psoriasis
496280|NCT01445886|Indigo Naturalis|indigo naturalis
496281|NCT01445886|Indirubin|indirubin
496282|NCT01445886|Calcipotriol|calcipotriol
496283|NCT01445886|Nail Psoriasis Severity Index|nail psoriasis severity index
496284|NCT01445873|Pulmonary arterial hypertension|pulmonary arterial hypertension
496285|NCT01445873|sitaxentan sodium|sitaxentan sodium
496286|NCT01445873|Thelin|thelin
496287|NCT01445860|DDI|ddi
496288|NCT01445860|pharmacokinetics|pharmacokinetics
496289|NCT01445847|Laryngospasm|laryngospasm
496290|NCT01445847|Lidocaine|lidocaine
496291|NCT01445834|outcome of pelvic floor muscle physiotherapy|outcome of pelvic floor muscle physiotherapy
496292|NCT01445834|female|female
496293|NCT01445834|stress urinary incontinence|stress urinary incontinence
496294|NCT01445834|urgency urinary incontinence|urgency urinary incontinence
496295|NCT01445834|mixed urinary incontinence|mixed urinary incontinence
496296|NCT01445821|Autologous Stem Cell Transplantation|autologous stem cell transplantation
496297|NCT01445808|psychodynamic psychotherapy|psychodynamic psychotherapy
496298|NCT01445808|coronary heart disease|coronary heart disease
496299|NCT01445808|physical activity|physical activity
496300|NCT01445808|secondary prevention|secondary prevention
496301|NCT01445795|Inhibitex|inhibitex
496302|NCT01445795|Chronic Hepatitis|chronic hepatitis
496303|NCT01445795|Hepatitis C Virus|hepatitis c virus
496304|NCT01445782|Safety|safety
496305|NCT01445782|tolerability|tolerability
496306|NCT01445782|healthy|healthy
496307|NCT01445782|inhaled|inhaled
496308|NCT01445769|Myelofibrosis|myelofibrosis
496309|NCT01445769|Primary Myelofibrosis|primary myelofibrosis
496310|NCT01445769|PMF|pmf
496311|NCT01445769|Post-Polycythemia Vera Myelofibrosis|post-polycythemia vera myelofibrosis
496312|NCT01445769|PPV-MF|ppv-mf
496313|NCT01445769|Post-Essential Thrombocythemia Myelofibrosis|post-essential thrombocythemia myelofibrosis
496314|NCT01445769|PET-MF|pet-mf
496315|NCT01445769|Open label|open label
496316|NCT01445769|Ruxolitinib|ruxolitinib
496317|NCT01445769|18424|18424
496318|NCT01445769|Jak inhibitor|jak inhibitor
496319|NCT01445756|Intrauterine Device|intrauterine device
496320|NCT01445743|Tdap Vaccine|tdap vaccine
496321|NCT01445743|Pregnant woman|pregnant woman
496322|NCT01445743|Pertussis|pertussis
496323|NCT01445730|fructose|fructose
496324|NCT01445730|hypertriglyceridemia|hypertriglyceridemia
496325|NCT01445730|postprandial lipids|postprandial lipids
496326|NCT01445730|de novo lipogenesis|de novo lipogenesis
496327|NCT01445730|stable isotopes|stable isotopes
496328|NCT01445717|GBS, Streptococcus, .|gbs, streptococcus, .
496329|NCT01445717|Group B|group b
496330|NCT01445704|Weight loss|weight loss
496331|NCT01445704|Probiotics|probiotics
496332|NCT01445704|Gastric Bypass|gastric bypass
496333|NCT01445691|Benign Neoplasms, Brain|benign neoplasms, brain
496334|NCT01445691|Brain Cancer|brain cancer
496335|NCT01445691|Brain Neoplasms, Benign|brain neoplasms, benign
496336|NCT01445691|Brain Neoplasms, Malignant|brain neoplasms, malignant
496337|NCT01445691|Brain Tumor, Primary|brain tumor, primary
496338|NCT01445691|Brain Tumor, Recurrent|brain tumor, recurrent
496339|NCT01445691|Brain Tumors|brain tumors
496340|NCT01445691|Intracranial Neoplasms|intracranial neoplasms
496341|NCT01445691|Neoplasms, Brain|neoplasms, brain
496342|NCT01445691|Neoplasms, Intracranial|neoplasms, intracranial
496343|NCT01445691|Primary Brain Neoplasms|primary brain neoplasms
496344|NCT01445691|Primary Malignant Brain Neoplasms|primary malignant brain neoplasms
496345|NCT01445691|Primary Malignant Brain Tumors|primary malignant brain tumors
496346|NCT01445691|Gliomas|gliomas
496347|NCT01445691|Glioblastoma|glioblastoma
496348|NCT01445691|Surgery|surgery
496349|NCT01445691|5-ALA|5-ala
496350|NCT01445691|Aminolevulinic acid|aminolevulinic acid
496351|NCT01445691|Fluorescence|fluorescence
496352|NCT01445678|cIAI|ciai
496353|NCT01445639|dexmedetomidine|dexmedetomidine
496354|NCT01445639|sedation|sedation
496355|NCT01445639|neurosurgery|neurosurgery
496356|NCT01445639|postoperative care|postoperative care
496357|NCT01445613|Carotid|carotid
496358|NCT01445613|Stent|stent
496359|NCT01445613|Carotid Endarterectomy|carotid endarterectomy
496360|NCT01445600|Impetigo|impetigo
496361|NCT01445600|secondarily-infected traumatic lesions|secondarily-infected traumatic lesions
496362|NCT01445600|retapamulin|retapamulin
496363|NCT01445587|bortezomib|bortezomib
496364|NCT01445587|AKT inhibitor|akt inhibitor
496365|NCT01445587|multiple myeloma|multiple myeloma
496366|NCT01445587|GSK2110183|gsk2110183
496367|NCT01445587|hematologic malignancies|hematologic malignancies
496368|NCT01445561|Interleukin-2|interleukin-2
496369|NCT01445561|IL-2|il-2
496370|NCT01445561|Stem Cells|stem cells
496371|NCT01445561|Regulatory T Cells (T regs)|regulatory t cells (t regs)
496372|NCT01445561|Natural Killer Cells (NK cells)|natural killer cells (nk cells)
496373|NCT01445561|Healthy Volunteer|healthy volunteer
496374|NCT01445561|HV|hv
496375|NCT01445548|Age-Related Macular Degeneration (AMD)|age-related macular degeneration (amd)
496376|NCT01445548|Geographic Atrophy|geographic atrophy
496377|NCT01445548|Bilateral Geographic Atrophy|bilateral geographic atrophy
496378|NCT01445548|Sirolimus|sirolimus
496379|NCT01445548|Age Related Macular Degeneration|age related macular degeneration
496380|NCT01445548|AMD|amd
496381|NCT01445535|CD2 Positive|cd2 positive
496382|NCT01445535|Toxicity|toxicity
496383|NCT01445535|EBV Lymphoma|ebv lymphoma
496384|NCT01445535|Chemotherapy Naive|chemotherapy naive
496385|NCT01445535|Maximum Tolerated Dose|maximum tolerated dose
496386|NCT01445535|Lymphoma|lymphoma
496387|NCT01445535|T-Cell Lymphoma|t-cell lymphoma
496388|NCT01445535|NK T-Cell Lymphoma|nk t-cell lymphoma
496389|NCT01445522|PARP Inhibitor|parp inhibitor
496390|NCT01445522|DNA Damage|dna damage
496391|NCT01445522|Chemotherapy|chemotherapy
496392|NCT01445522|Advanced Cancer|advanced cancer
496393|NCT01445522|DNA Repair|dna repair
496394|NCT01445509|Angiogenesis|angiogenesis
496395|NCT01445509|VEGF|vegf
496396|NCT01445509|SRC|src
496397|NCT01445509|Targeted Therapy|targeted therapy
496398|NCT01445509|Cancer|cancer
496399|NCT01445509|Solid Tumor|solid tumor
496400|NCT01445483|Cancer|cancer
496401|NCT01445483|Radiation|radiation
496402|NCT01445483|Brain|brain
496403|NCT01445483|Neuropsychological Outcome|neuropsychological outcome
496404|NCT01445483|Metastasis|metastasis
496405|NCT01445483|Brain Metastasis|brain metastasis
496406|NCT01445444|Habit Reversal Training|habit reversal training
496407|NCT01445444|Hair Pulling|hair pulling
496408|NCT01445444|Children|children
496409|NCT01445444|Trich|trich
496410|NCT01445444|cognitive behavioral therapy|cognitive behavioral therapy
496411|NCT01445444|TTM|ttm
496412|NCT01445444|psychotherapy|psychotherapy
496413|NCT01445418|Genetic|genetic
496414|NCT01445418|BRCA|brca
496415|NCT01445418|Ovarian Cancer, sporadic epithelial ovarian cancer|ovarian cancer, sporadic epithelial ovarian cancer
496416|NCT01445418|Breast Cancer, triple negative breast cancer|breast cancer, triple negative breast cancer
496417|NCT01445418|Metastatic|metastatic
496418|NCT01445418|Breast Cancer|breast cancer
496419|NCT01445418|Ovarian Cancer|ovarian cancer
496420|NCT01445405|Proteasome|proteasome
496421|NCT01445405|Bortezomib|bortezomib
496422|NCT01445405|NF-kappaB|nf-kappab
496423|NCT01445405|Cetuximab|cetuximab
496424|NCT01445405|Epidermal Growth Factor|epidermal growth factor
496425|NCT01445405|Head and Neck Cancer|head and neck cancer
496426|NCT01445405|Squamous Cell Carcinoma|squamous cell carcinoma
496427|NCT01445405|Oral Cancer|oral cancer
496428|NCT01445392|Recombinant Immunotoxin|recombinant immunotoxin
496429|NCT01445392|Monoclonal Antibody|monoclonal antibody
496430|NCT01445392|Pseudomonas Exotoxin|pseudomonas exotoxin
496431|NCT01445392|Targeted Therapy|targeted therapy
496432|NCT01445392|Pleural Mesothelioma|pleural mesothelioma
496433|NCT01445392|Mesothelioma|mesothelioma
496434|NCT01445392|Epithelial Pleural Mesothelioma|epithelial pleural mesothelioma
496435|NCT01445379|Solid Tumor|solid tumor
496436|NCT01445379|Monoclonal Antibody|monoclonal antibody
496437|NCT01445379|Pediatrics|pediatrics
496438|NCT01445379|Pharmacokinetics|pharmacokinetics
496439|NCT01445379|Immunotherapy|immunotherapy
496440|NCT01445379|Sarcoma|sarcoma
496441|NCT01445379|Lymphoma|lymphoma
496442|NCT01445379|Neuroblastoma|neuroblastoma
496443|NCT01445340|Topical Depsi|topical depsi
496444|NCT01445340|Cutaneous T Cell Lymphoma|cutaneous t cell lymphoma
496445|NCT01445340|CTCL|ctcl
496446|NCT01445340|Mycosis Fungoides|mycosis fungoides
496447|NCT01445327|Blood|blood
496448|NCT01445327|Urine|urine
496449|NCT01445327|Stool|stool
496450|NCT01445327|Tumor Marker|tumor marker
496451|NCT01445327|Radiation Therapy|radiation therapy
496452|NCT01445327|Gastrointestinal Cancer|gastrointestinal cancer
496453|NCT01445327|Esophageal Cancer|esophageal cancer
496454|NCT01445327|Stomach|stomach
496455|NCT01445327|Pancreatic Cancer|pancreatic cancer
496456|NCT01445314|Stored Data|stored data
496457|NCT01445314|Neurobehavioral|neurobehavioral
496458|NCT01445314|Behavior|behavior
496459|NCT01445314|Quality of Life|quality of life
496460|NCT01445301|twice daily|twice daily
496461|NCT01445301|once daily|once daily
496462|NCT01445301|CLDM 1%-BPO 3% gel|cldm 1%-bpo 3% gel
496463|NCT01445301|Clindamycin (CLDM)|clindamycin (cldm)
496464|NCT01445301|benzoyl peroxide (BPO)|benzoyl peroxide (bpo)
496465|NCT01445301|inflammatory lesion|inflammatory lesion
496466|NCT01445301|non-inflammatory lesion|non-inflammatory lesion
496467|NCT01445301|acne vulgaris|acne vulgaris
496468|NCT01445288|Neurotoxicity|neurotoxicity
496469|NCT01445288|Brain Tumor|brain tumor
496470|NCT01445288|Children|children
496471|NCT01445288|Angiogenesis|angiogenesis
496472|NCT01445288|Imaging|imaging
496473|NCT01445288|Central Nervous System Tumor|central nervous system tumor
496474|NCT01445288|CNS Tumor|cns tumor
496475|NCT01445249|regional anaesthetic techniques|regional anaesthetic techniques
496476|NCT01445249|surgery orthopaedic|surgery orthopaedic
496477|NCT01445236|Operational tolerance|operational tolerance
496478|NCT01445236|Biomarkers|biomarkers
496479|NCT01445236|Liver Transplantation|liver transplantation
496480|NCT01445223|HIV|hiv
496481|NCT01445223|Antiretroviral therapy|antiretroviral therapy
496482|NCT01445223|efavirenz|efavirenz
496483|NCT01445223|lopinavir|lopinavir
496484|NCT01445223|atazanavir|atazanavir
496485|NCT01445223|randomised controlled clinical trial|randomised controlled clinical trial
496486|NCT01445210|Postoperative pain|postoperative pain
496487|NCT01445210|Major ankle surgery|major ankle surgery
496488|NCT01445210|Continuous nerve block|continuous nerve block
496489|NCT01445210|Saphenous nerve|saphenous nerve
496490|NCT01445210|Ropivacaine|ropivacaine
496491|NCT01445171|Aortic Valve Replacement|aortic valve replacement
496492|NCT01445158|ShopTalk|shoptalk
496493|NCT01445158|Comprehension|comprehension
496494|NCT01445158|Donors|donors
496495|NCT01445158|Education|education
496496|NCT01445158|Stem Cell Transplant|stem cell transplant
496497|NCT01445158|Sibling Donor|sibling donor
496498|NCT01445145|End-of-Life|end-of-life
496499|NCT01445145|Advance Directive|advance directive
496500|NCT01445145|Pediatric Cancer|pediatric cancer
496501|NCT01445145|Adolescents|adolescents
496502|NCT01445145|Young Adults|young adults
496503|NCT01445132|Adoptive Immunotherapy|adoptive immunotherapy
496504|NCT01445132|Tumor Infiltrating Lymphocytes|tumor infiltrating lymphocytes
496505|NCT01445132|Refractory Tumor|refractory tumor
496506|NCT01445132|Resection|resection
496507|NCT01445132|B-Cell Malignancies|b-cell malignancies
496508|NCT01445132|Chronic Lymphocytic Leukemia|chronic lymphocytic leukemia
496509|NCT01445132|BCL|bcl
496510|NCT01445132|B-Cell Lymphoid Malignancy|b-cell lymphoid malignancy
496511|NCT01445119|Brain|brain
496512|NCT01445119|Tumor|tumor
496513|NCT01445119|Radiation|radiation
496514|NCT01445119|Antiangiogenesis|antiangiogenesis
496515|NCT01445119|Chemotherapy|chemotherapy
496516|NCT01445119|Brain Tumor|brain tumor
496517|NCT01445119|Glioma|glioma
496518|NCT01445106|HIV Protease Inhibitor|hiv protease inhibitor
496519|NCT01445106|Drug Repositioning|drug repositioning
496520|NCT01445106|Akt/Mtor Inhibitor|akt/mtor inhibitor
496521|NCT01445106|Targeted Therapy|targeted therapy
496522|NCT01445106|Off - Label Drugs|off - label drugs
496523|NCT01445106|Nelfinavir|nelfinavir
496524|NCT01445106|Protease Inhibitor|protease inhibitor
496525|NCT01445106|Solid Tumor|solid tumor
496526|NCT01445106|Phase I|phase i
496527|NCT01445106|Malignant Tumor|malignant tumor
496528|NCT01445054|111 Indium Trastuzumab Imaging|111 indium trastuzumab imaging
496529|NCT01445054|PET|pet
496530|NCT01445054|Optimal Scanning Strategy|optimal scanning strategy
496531|NCT01445054|Breast Cancer|breast cancer
496532|NCT01445041|Hypoplastic Left Heart Syndrome|hypoplastic left heart syndrome
496533|NCT01445041|Autologous Umbilical Cord Blood|autologous umbilical cord blood
496534|NCT01445041|Newborn Infants|newborn infants
496535|NCT01445015|adolescents|adolescents
496536|NCT01445002|grass pollen allergy|grass pollen allergy
496537|NCT01445002|immunotherapy|immunotherapy
496538|NCT01445002|recombinant vaccine|recombinant vaccine
496539|NCT01444989|"Sun spots"|"sun spots"
496540|NCT01444989|"Pre-cancerous skin lesion"|"pre-cancerous skin lesion"
496541|NCT01444976|age range of 18-83|age range of 18-83
496542|NCT01444924|Pain control|pain control
496543|NCT01444924|Gynecologic Oncology|gynecologic oncology
496544|NCT01444924|Surgery|surgery
496545|NCT01444911|Sexual Dysfunction|sexual dysfunction
496546|NCT01444911|Gynecologic cancer|gynecologic cancer
496547|NCT01444911|Cancer survivor|cancer survivor
496548|NCT01444911|Vaginal dilator|vaginal dilator
496549|NCT01444898|Prader-Willi Syndrome|prader-willi syndrome
496550|NCT01444898|Obesity|obesity
496551|NCT01444898|Weight|weight
496552|NCT01444898|Exenatide|exenatide
496553|NCT01444898|Byetta|byetta
496554|NCT01444898|Pediatrics|pediatrics
496555|NCT01444898|Adolescents|adolescents
496556|NCT01444885|Variant angina|variant angina
496557|NCT01444885|Cilostazol|cilostazol
496558|NCT01444846|Temporary Auditory Threshold Shift|temporary auditory threshold shift
496559|NCT01444846|Hearing Loss|hearing loss
496560|NCT01444846|Deafness|deafness
496561|NCT01444846|SPI-1005|spi-1005
496562|NCT01444846|Ebselen|ebselen
496563|NCT01444833|hypertension|hypertension
496564|NCT01444833|obesity|obesity
496565|NCT01444833|metabolism|metabolism
496566|NCT01444833|angiotensin|angiotensin
496567|NCT01444820|radiation therapy|radiation therapy
496568|NCT01444820|hypofractionation|hypofractionation
496569|NCT01444820|hormonal therapy|hormonal therapy
496570|NCT01444820|high risk adenocarcinoma of the prostate|high risk adenocarcinoma of the prostate
496571|NCT01444807|sorafenib|sorafenib
496572|NCT01444807|metastatic renal cell carcinoma|metastatic renal cell carcinoma
496573|NCT01444807|metastasectomy|metastasectomy
496574|NCT01444794|Lower limb spasticity|lower limb spasticity
496575|NCT01444781|Diphtheria|diphtheria
496576|NCT01444781|Tetanus|tetanus
496577|NCT01444781|Whooping Cough|whooping cough
496578|NCT01444781|Hepatitis B|hepatitis b
496579|NCT01444781|Poliomyelitis|poliomyelitis
496580|NCT01444781|Pediatric combined vaccine|pediatric combined vaccine
496581|NCT01444781|Invasive Hib infections|invasive hib infections
496582|NCT01444768|Alert Systems, Medication|alert systems, medication
496583|NCT01444768|Computerized Physician Order Entry System|computerized physician order entry system
496584|NCT01444768|CPOE|cpoe
496585|NCT01444768|Medication Alert Systems|medication alert systems
496586|NCT01444768|Medical Order Entry Systems|medical order entry systems
710749|NCT00588107|Web based intervention|web based intervention
496587|NCT01444755|Locally advanced gastric cancer|locally advanced gastric cancer
496588|NCT01444755|neoadjuvant chemotherapy|neoadjuvant chemotherapy
496589|NCT01444742|Leukemia|leukemia
496590|NCT01444742|Myeloproliferative Diseases|myeloproliferative diseases
496591|NCT01444742|Myelodysplastic Syndrome|myelodysplastic syndrome
496592|NCT01444742|(MDS)|(mds)
496593|NCT01444742|Relapsing|relapsing
496594|NCT01444742|Refractory|refractory
496595|NCT01444742|Clofarabine|clofarabine
496596|NCT01444742|Clofarex|clofarex
496597|NCT01444742|Clolar|clolar
496598|NCT01444742|Cytarabine|cytarabine
496599|NCT01444742|Ara-C|ara-c
496600|NCT01444742|Cytosar|cytosar
496601|NCT01444742|DepoCyt|depocyt
496602|NCT01444742|Cytosine Arabinosine Hydrochloride|cytosine arabinosine hydrochloride
496603|NCT01444729|'Dupuytren's contracture'|'dupuytren's contracture'
496604|NCT01444729|'xiapex'|'xiapex'
496605|NCT01444729|'surgery'|'surgery'
496606|NCT01444703|Thoracic surgery|thoracic surgery
496607|NCT01444703|double-lumen endotracheal tube|double-lumen endotracheal tube
496608|NCT01444703|intubation|intubation
496609|NCT01444703|extubation|extubation
496610|NCT01444703|sore throat|sore throat
496611|NCT01444703|prevention of post-extubation sore throat|prevention of post-extubation sore throat
496612|NCT01444690|Antiretroviral therapy|antiretroviral therapy
496613|NCT01444690|Acquired Immunodeficiency Syndrome/complications*|acquired immunodeficiency syndrome/complications*
496614|NCT01444690|Anti-HIV Agents/adverse effects|anti-hiv agents/adverse effects
496615|NCT01444677|Safety|safety
496616|NCT01444677|Tolerability|tolerability
496617|NCT01444677|Pharmacokinetic|pharmacokinetic
496618|NCT01444651|Tadalafil|tadalafil
496619|NCT01444651|Phosphodiesterase 5 Inhibitors|phosphodiesterase 5 inhibitors
496620|NCT01444651|Cyclic Guanylyl Monophosphate Pathway|cyclic guanylyl monophosphate pathway
496621|NCT01444651|Pharmacologic Actions|pharmacologic actions
496622|NCT01444651|Vasodilator Agents|vasodilator agents
496623|NCT01444651|Cardiovascular Agents|cardiovascular agents
496624|NCT01444651|Obesity|obesity
496625|NCT01444651|Glycemic Traits|glycemic traits
496626|NCT01444651|Insulin Resistance|insulin resistance
496627|NCT01444651|Glucose Metabolism|glucose metabolism
496628|NCT01444638|pregnancy|pregnancy
496629|NCT01444638|Caesarian|caesarian
496630|NCT01444638|section|section
496631|NCT01444638|spinal|spinal
496632|NCT01444625|UV radiation|uv radiation
496633|NCT01444625|photoprotection|photoprotection
496634|NCT01444625|flavanols rich chocolate|flavanols rich chocolate
496635|NCT01444612|cancer surgery|cancer surgery
496636|NCT01444612|venous thromboembolism|venous thromboembolism
496637|NCT01444612|hospitalization|hospitalization
496638|NCT01444612|anticoagulants|anticoagulants
496639|NCT01444612|costs and cost analysis|costs and cost analysis
496640|NCT01444612|thromboprophylaxis|thromboprophylaxis
496641|NCT01444599|coronary atherosclerosis|coronary atherosclerosis
496642|NCT01444599|virtual histology intravascular ultrasound|virtual histology intravascular ultrasound
496643|NCT01444599|fractional flow reserve|fractional flow reserve
496644|NCT01444586|non-interventional|non-interventional
496645|NCT01444586|Xarelto|xarelto
496646|NCT01444586|knee replacement|knee replacement
496647|NCT01444586|hip replecement|hip replecement
496648|NCT01444586|Russia|russia
496649|NCT01444573|Rate control|rate control
496650|NCT01444573|ILR|ilr
496651|NCT01444547|esophageal cancer|esophageal cancer
496652|NCT01444547|paclitaxel|paclitaxel
496653|NCT01444547|cisplatin|cisplatin
496654|NCT01444534|mobile phone application|mobile phone application
496655|NCT01444534|diabetes type 1|diabetes type 1
496656|NCT01444534|self-management|self-management
496657|NCT01444534|telemedicin|telemedicin
496658|NCT01444521|advanced gastric cancer|advanced gastric cancer
496659|NCT01444521|irinotecan|irinotecan
496660|NCT01444521|cisplatin|cisplatin
496661|NCT01444495|rectal cancer|rectal cancer
496662|NCT01444495|radiotherapy|radiotherapy
496663|NCT01444495|overall survival|overall survival
496664|NCT01444495|recurrence rate|recurrence rate
496665|NCT01444495|downstaging|downstaging
496666|NCT01444469|Asthma exacerbations|asthma exacerbations
496667|NCT01444469|Respiratory disease|respiratory disease
496668|NCT01444469|Viral infection|viral infection
496669|NCT01444469|Macrolide/ketolide antibiotics|macrolide/ketolide antibiotics
496670|NCT01444469|Mycoplasma pneumoniae (M. pneumoniae)|mycoplasma pneumoniae (m. pneumoniae)
496671|NCT01444469|Chlamydophila pneumoniae (C. pneumoniae)|chlamydophila pneumoniae (c. pneumoniae)
496672|NCT01444456|Breast Cancer|breast cancer
496673|NCT01444456|Lung Cancer|lung cancer
496674|NCT01444456|Ovarian Cancer|ovarian cancer
496675|NCT01444456|Prostate Cancer|prostate cancer
496676|NCT01444456|Colorectal Cancer|colorectal cancer
496677|NCT01444456|Aranesp|aranesp
496678|NCT01444456|Chemotherapy induced anaemia|chemotherapy induced anaemia
496679|NCT01444456|Chemotherapy|chemotherapy
496680|NCT01444456|Bladder Cancer|bladder cancer
496681|NCT01444456|Endometrial Cancer|endometrial cancer
496682|NCT01444456|Renal Cancer|renal cancer
496683|NCT01444456|Pancreatic Cancer|pancreatic cancer
496684|NCT01444456|Esophageal Cancer|esophageal cancer
496685|NCT01444456|Gastric Cancer|gastric cancer
496686|NCT01444443|Type 1 diabetes|type 1 diabetes
496687|NCT01444443|Glucose control|glucose control
496688|NCT01444443|Closed-loop|closed-loop
496689|NCT01444443|Insulin pump|insulin pump
496690|NCT01444443|Glucose sensor|glucose sensor
496691|NCT01444430|Symbicort pMDI|symbicort pmdi
496692|NCT01444430|Asthma|asthma
496693|NCT01444430|safety|safety
496694|NCT01444430|budesonide|budesonide
496695|NCT01444417|Immune (Idiopathic) Thrombocytopenic Purpura|immune (idiopathic) thrombocytopenic purpura
496696|NCT01444417|Pediatric Immune (Idiopathic) Thrombocytopenic Purpura|pediatric immune (idiopathic) thrombocytopenic purpura
496697|NCT01444417|Immune Thrombocytopenia|immune thrombocytopenia
496698|NCT01444404|Solid Tumors|solid tumors
496699|NCT01444404|Phase 1|phase 1
496700|NCT01444404|Clinical Trial|clinical trial
496701|NCT01444391|Tympanostomy tube placement|tympanostomy tube placement
496702|NCT01444391|iontophoresis|iontophoresis
496703|NCT01444378|Atherosclerosis|atherosclerosis
496704|NCT01444378|Claudication|claudication
496705|NCT01444378|Peripheral Arterial Occlusive Disease|peripheral arterial occlusive disease
496706|NCT01444378|Stent|stent
496707|NCT01444365|Osteoarthritis of the knee|osteoarthritis of the knee
496708|NCT01444352|Pneumococcal infections|pneumococcal infections
496709|NCT01444352|Streptococcus pneumoniae Infections|streptococcus pneumoniae infections
496710|NCT01444352|Pneumococcal Vaccines|pneumococcal vaccines
496711|NCT01444339|Pneumococcal Infections|pneumococcal infections
496712|NCT01444339|Streptococcus Pneumoniae Infections|streptococcus pneumoniae infections
496713|NCT01444339|Pneumococcal Vaccine|pneumococcal vaccine
496714|NCT01444326|Keywords;|keywords;
496715|NCT01444326|Cardiovascular disease|cardiovascular disease
496716|NCT01444326|Dairy|dairy
496717|NCT01444326|Inflammation|inflammation
496718|NCT01444326|Blood lipids|blood lipids
496719|NCT01444300|multiple sclerosis|multiple sclerosis
496720|NCT01444300|postural balance|postural balance
496721|NCT01444300|gait|gait
496722|NCT01444300|fatigue|fatigue
496723|NCT01444261|iron deficiency|iron deficiency
496724|NCT01444261|anemia|anemia
496725|NCT01444248|Amaryl MEX|amaryl mex
496726|NCT01444235|CAD, ACVB|cad, acvb
496727|NCT01444222|Myocardial contractility|myocardial contractility
496728|NCT01444222|Quantification of regurgitant flow|quantification of regurgitant flow
496729|NCT01444222|exercise capacity|exercise capacity
496730|NCT01444209|pituitary gland|pituitary gland
496731|NCT01444196|ACU|acu
496732|NCT01444196|acquired cold urticaria|acquired cold urticaria
496733|NCT01444183|Epilepsy|epilepsy
496734|NCT01444183|seizures|seizures
496735|NCT01444183|stress reduction|stress reduction
496736|NCT01444170|eccentric exercise|eccentric exercise
496737|NCT01444170|exercise induce muscle damage|exercise induce muscle damage
496738|NCT01444170|isometric strength|isometric strength
496739|NCT01444170|range of motion|range of motion
496740|NCT01444170|self report symptoms|self report symptoms
496741|NCT01444170|mechanical pain threshold|mechanical pain threshold
496742|NCT01444144|Ankle|ankle
496743|NCT01444144|Fracture|fracture
496744|NCT01444144|Elderly|elderly
496745|NCT01444144|At-risk Population|at-risk population
496746|NCT01444144|Ankle Fracture in at-risk elderly population|ankle fracture in at-risk elderly population
496747|NCT01444131|Smoking|smoking
496748|NCT01444131|Smoking cessation|smoking cessation
496749|NCT01444131|Pharmaceutical aids|pharmaceutical aids
496750|NCT01444105|Open angle glaucoma|open angle glaucoma
496751|NCT01444105|Pseudoexfoliative glaucoma|pseudoexfoliative glaucoma
496752|NCT01444079|Liver transplantation|liver transplantation
496753|NCT01444079|Rejection|rejection
496754|NCT01444079|Tolerance|tolerance
496755|NCT01444040|Open angle glaucoma|open angle glaucoma
496756|NCT01444040|POAG|poag
496757|NCT01444040|Ocular hypertension|ocular hypertension
496758|NCT01444040|Pseudoexfoliative glaucoma|pseudoexfoliative glaucoma
496759|NCT01444040|Naïve to treatment|naïve to treatment
496760|NCT01444014|YF476|yf476
496761|NCT01444014|netazepide|netazepide
496762|NCT01444014|hypergastrinaemia|hypergastrinaemia
496763|NCT01444014|gastric carcinoids|gastric carcinoids
496764|NCT01444001|Pneumococcal Infections|pneumococcal infections
496765|NCT01444001|Pneumococcal Vaccines|pneumococcal vaccines
496766|NCT01444001|pneumococcal protein|pneumococcal protein
496767|NCT01443988|Open angle glaucoma|open angle glaucoma
496768|NCT01443988|POAG|poag
496769|NCT01443988|Ocular hypertension|ocular hypertension
496770|NCT01443988|Pseudoexfoliative glaucoma|pseudoexfoliative glaucoma
496771|NCT01443988|Naïve to treatment|naïve to treatment
496772|NCT01443975|Total Hip Arthroplasty|total hip arthroplasty
496773|NCT01443975|Osteoarthritis|osteoarthritis
496774|NCT01443962|laparoscopic cholecystectomy|laparoscopic cholecystectomy
496775|NCT01443962|PEEP|peep
496776|NCT01443962|rSO2|rso2
496777|NCT01443949|fMRI|fmri
496778|NCT01443949|Reward|reward
496779|NCT01443949|Adolescents|adolescents
496780|NCT01443949|Impulse Control|impulse control
496781|NCT01443949|Cabergoline|cabergoline
496782|NCT01443936|Influenza Vaccine|influenza vaccine
496783|NCT01443936|H5N1 Influenza|h5n1 influenza
496784|NCT01443936|Normal Volunteer|normal volunteer
496785|NCT01443936|Adenovirus|adenovirus
496786|NCT01443936|Live Virus Vaccine|live virus vaccine
496787|NCT01443936|Healthy Volunteer|healthy volunteer
496788|NCT01443936|HV|hv
496789|NCT01443923|Hepatitis|hepatitis
496790|NCT01443923|Immunological Response|immunological response
496791|NCT01443923|Virological Response|virological response
496792|NCT01443923|Resistance Mutations|resistance mutations
496793|NCT01443923|Viral Kinetics|viral kinetics
496794|NCT01443923|Hepatitis C|hepatitis c
496795|NCT01443923|HCV|hcv
496796|NCT01443910|Body Weight|body weight
496797|NCT01443910|Healthy Volunteer|healthy volunteer
496798|NCT01443897|Vitamin D|vitamin d
496799|NCT01443871|Volunteer|volunteer
496800|NCT01443858|Smoking Cessation|smoking cessation
496801|NCT01443858|Cigarette Smoking|cigarette smoking
496802|NCT01443858|Meclizine|meclizine
496803|NCT01443858|Nicotine Patch|nicotine patch
496804|NCT01443845|COPD|copd
496805|NCT01443845|Exacerbations|exacerbations
496806|NCT01443845|Roflumilast|roflumilast
496807|NCT01443845|Daliresp|daliresp
496808|NCT01443832|ferrous sulfate|ferrous sulfate
496809|NCT01443832|iron absorption|iron absorption
496810|NCT01443832|Beninese women|beninese women
496811|NCT01443832|fonio|fonio
496812|NCT01443819|Radiculopathy|radiculopathy
496813|NCT01443819|Transforaminal|transforaminal
496814|NCT01443819|Disc Protrusion|disc protrusion
496815|NCT01443806|oseltamivir metabolism|oseltamivir metabolism
496816|NCT01443806|Carboxylesterase 1|carboxylesterase 1
496817|NCT01443780|Selenium|selenium
496818|NCT01443780|Q10|q10
496819|NCT01443780|dietary supplement|dietary supplement
496820|NCT01443780|elderly population|elderly population
496821|NCT01443780|intervention|intervention
496822|NCT01443780|All-cause mortality|all-cause mortality
496823|NCT01443780|cardiac function|cardiac function
496824|NCT01443767|Cardiac Output|cardiac output
496825|NCT01443767|esCCO|escco
496826|NCT01443767|Pulse Wave Transit Time|pulse wave transit time
496827|NCT01443767|PiCCO|picco
496828|NCT01443767|Pulse Contour Analysis|pulse contour analysis
496829|NCT01443767|Non-invasive Monitoring|non-invasive monitoring
496830|NCT01443767|Partial Liver Resection|partial liver resection
496831|NCT01443741|FIT Therapy|fit therapy
496832|NCT01443741|Diabetes mellitus|diabetes mellitus
496833|NCT01443741|Insulin pump|insulin pump
496834|NCT01443741|Pediatric|pediatric
496835|NCT01443728|sickle cell disease|sickle cell disease
496836|NCT01443728|acute chest syndrome|acute chest syndrome
496837|NCT01443728|respiratory complications|respiratory complications
496838|NCT01443728|vitamin D|vitamin d
496839|NCT01443715|MDD|mdd
496840|NCT01443715|Dysthymia|dysthymia
496841|NCT01443715|Depressive Disorder Not Otherwise Specified (DDNOS)|depressive disorder not otherwise specified (ddnos)
496842|NCT01443702|Kidney Calculi|kidney calculi
496843|NCT01443702|Iranian traditional medicine|iranian traditional medicine
496844|NCT01443702|Lapis judaicus|lapis judaicus
496845|NCT01443689|Extensive Burn|extensive burn
496846|NCT01443689|Human Cord Blood Mononuclear Cells|human cord blood mononuclear cells
496847|NCT01443689|Human Umbilical Cord Mesenchymal Stem Cells|human umbilical cord mesenchymal stem cells
496848|NCT01443637|Coronary Artery Disease|coronary artery disease
496849|NCT01443637|CAD|cad
496850|NCT01443637|Atherosclerosis|atherosclerosis
496851|NCT01443637|Myocardial Infarction|myocardial infarction
496852|NCT01443637|MI|mi
496853|NCT01443637|CONFIRM|confirm
496854|NCT01443637|Coronary Computed Tomographic Angiography|coronary computed tomographic angiography
496855|NCT01443637|CCTA|ccta
496856|NCT01443624|iron|iron
496857|NCT01443624|critical illness|critical illness
496858|NCT01443624|oxidative stress|oxidative stress
496859|NCT01443611|Infants|infants
496860|NCT01443598|Pulmonary arterial hypertension,|pulmonary arterial hypertension,
496861|NCT01443598|Interstitial lung disease at HRCT|interstitial lung disease at hrct
496862|NCT01443585|Progressive Addition Lens|progressive addition lens
496863|NCT01443585|Multifocal|multifocal
496864|NCT01443585|Presbyopia|presbyopia
496865|NCT01443572|Kasai operation under general anesthesia|kasai operation under general anesthesia
496866|NCT01443559|Xenogenic|xenogenic
496867|NCT01443546|oocyte donor|oocyte donor
496868|NCT01443546|oocyte recipient|oocyte recipient
497261|NCT01441947|metastatic|metastatic
496869|NCT01443546|ovulation trigger|ovulation trigger
496870|NCT01443533|Contraception|contraception
496871|NCT01443533|Contraception behavior|contraception behavior
496872|NCT01443533|Postnatal care|postnatal care
496873|NCT01443533|Health education|health education
496874|NCT01443533|Randomized controlled trial|randomized controlled trial
496875|NCT01443520|Pharmacokinetics|pharmacokinetics
496876|NCT01443520|Pharmacodynamics|pharmacodynamics
496877|NCT01443507|aerobic capacity|aerobic capacity
496878|NCT01443507|maximal oxygen uptake|maximal oxygen uptake
496879|NCT01443507|aerobic endurance|aerobic endurance
496880|NCT01443507|work economy|work economy
496881|NCT01443507|lactate threshold|lactate threshold
496882|NCT01443507|endurance training|endurance training
496883|NCT01443507|exercise intensity|exercise intensity
496884|NCT01443494|septic shock|septic shock
496885|NCT01443494|microcirculation|microcirculation
496886|NCT01443494|norepinephrine|norepinephrine
496887|NCT01443494|fluid|fluid
496888|NCT01443481|solid tumors|solid tumors
496889|NCT01443481|hepatic impairment|hepatic impairment
496890|NCT01443481|Child-Pugh classification|child-pugh classification
496891|NCT01443481|pharmacokinetics|pharmacokinetics
496892|NCT01443481|PK|pk
496893|NCT01443481|RECIST 1.1|recist 1.1
496894|NCT01443468|Tp53|tp53
496895|NCT01443468|Cancer|cancer
496896|NCT01443468|Hereditary|hereditary
496897|NCT01443468|Genetic Testing|genetic testing
496898|NCT01443468|Screening|screening
496899|NCT01443455|menopause|menopause
496900|NCT01443455|sedentary|sedentary
496901|NCT01443455|overweight|overweight
496902|NCT01443442|Conjunctivitis|conjunctivitis
496903|NCT01443442|Allergic|allergic
496904|NCT01443442|Bepotastine besilate|bepotastine besilate
496905|NCT01443442|Loteprednol etabonate|loteprednol etabonate
496906|NCT01443429|TRK-100STP|trk-100stp
496907|NCT01443429|PK|pk
496908|NCT01443429|beraprost sodium|beraprost sodium
496909|NCT01443429|Japanese males and females|japanese males and females
496910|NCT01443429|Subjects with mild/moderate/severe patients|subjects with mild/moderate/severe patients
496911|NCT01443429|renal impairment|renal impairment
496912|NCT01443416|pneumococcal conjugate vaccine|pneumococcal conjugate vaccine
496913|NCT01443416|invasive pneumococcal disease|invasive pneumococcal disease
496914|NCT01443416|vaccination|vaccination
496915|NCT01443416|children|children
496916|NCT01443403|Opioid Therapy|opioid therapy
496917|NCT01443403|Non-Malignant Chronic Pain|non-malignant chronic pain
496918|NCT01443403|Opioid-Induced Constipation|opioid-induced constipation
496919|NCT01443390|Whole genome sequencing|whole genome sequencing
496920|NCT01443390|Advanced Refractory Cancer|advanced refractory cancer
496921|NCT01443377|Neorec|neorec
496922|NCT01443377|rectal cancer|rectal cancer
496923|NCT01443377|KRAS|kras
496924|NCT01443377|Panitumumab|panitumumab
496925|NCT01443377|neoadjuvant|neoadjuvant
496926|NCT01443377|Radiochemotherapy|radiochemotherapy
496927|NCT01443377|antibody|antibody
496928|NCT01443377|locally advanced KRAS wild type rectal cancer|locally advanced kras wild type rectal cancer
496929|NCT01443364|Certolizumab pegol - Cimzia|certolizumab pegol - cimzia
496930|NCT01443364|Rheumatoid Arthritis|rheumatoid arthritis
496931|NCT01443364|Power Doppler Ultrasonography|power doppler ultrasonography
496932|NCT01443364|Italy|italy
496933|NCT01443364|Moderate-severe Rheumatoid Arthritis|moderate-severe rheumatoid arthritis
496934|NCT01443351|ITP|itp
496935|NCT01443351|romiplostim|romiplostim
496936|NCT01443351|eltrombopag|eltrombopag
496937|NCT01443351|bone marrow fibrosis|bone marrow fibrosis
496938|NCT01443351|long-term safety|long-term safety
496939|NCT01443338|Triptergium wilfordii|triptergium wilfordii
496940|NCT01443338|Acitretin|acitretin
496941|NCT01443338|psoriasis vulgaris|psoriasis vulgaris
496942|NCT01443325|Persistent Postherniorrhaphy inguinal Pain|persistent postherniorrhaphy inguinal pain
496943|NCT01443312|Beta globin gene|beta globin gene
496944|NCT01443312|Alfa globin gene|alfa globin gene
496945|NCT01443312|xmn1 polymorphism|xmn1 polymorphism
496946|NCT01443273|Newborns|newborns
496947|NCT01443260|oncolytic virus|oncolytic virus
496948|NCT01443260|oncolytic|oncolytic
496949|NCT01443260|GL-ONC1|gl-onc1
496950|NCT01443260|Vaccinia|vaccinia
496951|NCT01443260|Vaccinia virus|vaccinia virus
496952|NCT01443260|Genelux|genelux
496953|NCT01443260|Genelux GmbH|genelux gmbh
496954|NCT01443260|peritoneal|peritoneal
496955|NCT01443260|peritoneal carcinomatosis|peritoneal carcinomatosis
496956|NCT01443260|cancer|cancer
496957|NCT01443260|abdominal cancer|abdominal cancer
496958|NCT01443260|imaging|imaging
496959|NCT01443234|Depression|depression
496960|NCT01443234|Cognitive Bias|cognitive bias
496961|NCT01443234|Internet|internet
496962|NCT01443221|mitiglinide|mitiglinide
496963|NCT01443221|metformin|metformin
496964|NCT01443221|Pharmacokinetics|pharmacokinetics
496965|NCT01443221|Safety|safety
496966|NCT01443208|pharmacokinetics|pharmacokinetics
496967|NCT01443208|safety|safety
496968|NCT01443208|desvenlafaxine|desvenlafaxine
496969|NCT01443208|Korean healthy subjects|korean healthy subjects
496970|NCT01443169|Pharmacokinetic|pharmacokinetic
496971|NCT01443169|relative oral bioavailability|relative oral bioavailability
496972|NCT01443169|pregabalin|pregabalin
496973|NCT01443156|Diet|diet
496974|NCT01443156|Sleep deficiency|sleep deficiency
496975|NCT01443156|Cancer|cancer
496976|NCT01443156|Obesity|obesity
496977|NCT01443156|Diabetes|diabetes
496978|NCT01443156|Shift work|shift work
496979|NCT01443156|Work schedule|work schedule
496980|NCT01443156|Cardiovascular disease|cardiovascular disease
496981|NCT01443156|Body composition|body composition
496982|NCT01443156|Body mass index|body mass index
496983|NCT01443156|Body fat percentage|body fat percentage
496984|NCT01443143|Diabetes|diabetes
496985|NCT01443143|Obesity|obesity
496986|NCT01443143|Glycemic|glycemic
496987|NCT01443143|Portion-control|portion-control
496988|NCT01443143|Commercial diet|commercial diet
496989|NCT01443130|malaria,Malawi,pregnancy|malaria,malawi,pregnancy
496990|NCT01443104|coronary artery disease|coronary artery disease
496991|NCT01443104|drug-eluting stents|drug-eluting stents
496992|NCT01443104|polymers|polymers
496993|NCT01443091|very low birth weight infants|very low birth weight infants
496994|NCT01443091|VLBW infants|vlbw infants
496995|NCT01443091|colostrum|colostrum
496996|NCT01443078|Carboplatin|carboplatin
496997|NCT01443078|Cisplatin|cisplatin
496998|NCT01443078|Pemetrexed (Altima)|pemetrexed (altima)
496999|NCT01443078|Taxotere (Docetaxel)|taxotere (docetaxel)
497000|NCT01443078|Vinorelbine Tartrate (Navelbine)|vinorelbine tartrate (navelbine)
497001|NCT01443078|Stage IB-III|stage ib-iii
497002|NCT01443078|non squamous|non squamous
497003|NCT01443078|non-small cell lung cancer|non-small cell lung cancer
497004|NCT01443078|11-106|11-106
497005|NCT01443065|Adenocarcinoma|adenocarcinoma
497006|NCT01443065|Locally advanced (non operable) or metastatic|locally advanced (non operable) or metastatic
497007|NCT01443065|First line treatment|first line treatment
497008|NCT01443052|Gait stability|gait stability
497009|NCT01443052|Spatiotemporal parameters|spatiotemporal parameters
497010|NCT01443052|Walking|walking
497011|NCT01443052|Elderly people|elderly people
497012|NCT01443052|Stroke|stroke
497013|NCT01443052|Fallers|fallers
497014|NCT01443039|drug metabolizing enzymes and drug transporter|drug metabolizing enzymes and drug transporter
497015|NCT01443039|Roux-en Y-Gastric Bypass|roux-en y-gastric bypass
497016|NCT01443039|Obesity|obesity
497017|NCT01443039|Drug Availability|drug availability
497018|NCT01443039|BMI over 35kg/m² and comorbidities or >40kg/m²|bmi over 35kg/m² and comorbidities or >40kg/m²
497019|NCT01443026|Intraepithelial Prostatic Neoplasia|intraepithelial prostatic neoplasia
497020|NCT01443026|Prostatic neoplasms|prostatic neoplasms
497021|NCT01443026|Male urogenital disease|male urogenital disease
497022|NCT01443026|Prostate|prostate
497023|NCT01443013|Tolerance|tolerance
497024|NCT01443013|Renal Transplantation|renal transplantation
497025|NCT01443013|Chronic allograft nephropathy|chronic allograft nephropathy
497026|NCT01443000|Observational study|observational study
497027|NCT01443000|IOIS|iois
497028|NCT01443000|Orbital Pseudotumor|orbital pseudotumor
497029|NCT01443000|Outcome|outcome
497030|NCT01443000|Treatment|treatment
497031|NCT01442987|Irbesartan|irbesartan
497032|NCT01442987|Atorvastatin|atorvastatin
497033|NCT01442987|Hypertension|hypertension
497034|NCT01442987|Hyperlipidemia|hyperlipidemia
497035|NCT01442974|nab-paclitaxel|nab-paclitaxel
497036|NCT01442974|neoadjuvant treatment|neoadjuvant treatment
497037|NCT01442974|SPARC|sparc
497038|NCT01442974|Pancreatic Cancer|pancreatic cancer
497039|NCT01442961|pain, postoperative|pain, postoperative
497040|NCT01442961|hysterectomy, vaginal|hysterectomy, vaginal
497041|NCT01442961|surgery, gynecological|surgery, gynecological
497042|NCT01442948|-CD16+ monocytes|-cd16+ monocytes
497043|NCT01442935|Adenocarcinoma|adenocarcinoma
497044|NCT01442935|Non-resectable hepatic metastases|non-resectable hepatic metastases
497045|NCT01442935|First-line treatment|first-line treatment
497046|NCT01442922|L3-L4|l3-l4
497047|NCT01442922|L4-L5|l4-l5
497048|NCT01442922|L5-S1|l5-s1
497049|NCT01442922|Human Meniscus Allograft|human meniscus allograft
497050|NCT01442922|Nucleus pulposus|nucleus pulposus
497051|NCT01442922|Minimally invasive surgery|minimally invasive surgery
497052|NCT01442922|Degeneration of L3-L4 Intervertebral Disc|degeneration of l3-l4 intervertebral disc
497053|NCT01442922|Degeneration of L4-L5 Intervertebral Disc|degeneration of l4-l5 intervertebral disc
497054|NCT01442922|Degeneration of L5-S1 Intervertebral Disc|degeneration of l5-s1 intervertebral disc
497055|NCT01442909|lung cancer|lung cancer
497056|NCT01442909|docetaxel|docetaxel
497057|NCT01442909|pemetrexed|pemetrexed
497058|NCT01442883|Treatment Resistant|treatment resistant
497059|NCT01442857|Magnetic Resonance Imaging|magnetic resonance imaging
497060|NCT01442857|Nerve Net|nerve net
497061|NCT01442857|Brachial Plexus|brachial plexus
497062|NCT01442857|Nerve block|nerve block
497063|NCT01442844|Mohs|mohs
497064|NCT01442844|Scalp|scalp
497065|NCT01442831|metabolic profile of TR-700 in plasma urine|metabolic profile of tr-700 in plasma urine
497066|NCT01442818|vaginal reconstructive surgery|vaginal reconstructive surgery
497067|NCT01442805|Cognitive Behavior Therapy|cognitive behavior therapy
497663|NCT01440452|MS|ms
497068|NCT01442805|Virtual Reality Exposure Therapy|virtual reality exposure therapy
497069|NCT01442805|Psychophysiological Measures|psychophysiological measures
497070|NCT01442805|Driving Phobia|driving phobia
497071|NCT01442805|Flying Phobia|flying phobia
497072|NCT01442792|Angioplasty, Balloon, Coronary|angioplasty, balloon, coronary
497073|NCT01442779|Idiopathic Pulmonary Fibrosis|idiopathic pulmonary fibrosis
497074|NCT01442779|Interferon alpha|interferon alpha
497075|NCT01442766|cholinesterase inhibitor|cholinesterase inhibitor
497076|NCT01442766|donepezil|donepezil
497077|NCT01442766|motor|motor
497078|NCT01442766|stroke|stroke
497079|NCT01442753|Spanish speaking|spanish speaking
497080|NCT01442740|Functional Endoscopic Sinus Surgery|functional endoscopic sinus surgery
497081|NCT01442740|Reverse Trendelenburg Position|reverse trendelenburg position
497082|NCT01442727|arsenical melanosis|arsenical melanosis
497083|NCT01442727|arsenical melanoses|arsenical melanoses
632520|NCT00897715|CKD|ckd
497084|NCT01442727|arsenical keratosis|arsenical keratosis
497085|NCT01442727|arsenical keratoses|arsenical keratoses
497086|NCT01442727|arsenical cancer|arsenical cancer
497087|NCT01442727|arsenic cancers|arsenic cancers
497088|NCT01442727|arsenic|arsenic
497089|NCT01442727|arsenicosis|arsenicosis
497090|NCT01442727|arsenic exposure|arsenic exposure
497091|NCT01442727|arsenic toxicity|arsenic toxicity
497092|NCT01442727|arsenic poisoning|arsenic poisoning
497093|NCT01442727|drinking water|drinking water
497094|NCT01442727|selenium|selenium
497095|NCT01442727|selenite|selenite
497096|NCT01442727|sodium selenite|sodium selenite
497097|NCT01442675|Meningitis|meningitis
497098|NCT01442675|Meningococcal Infection|meningococcal infection
497099|NCT01442675|Menactra®|menactra®
497100|NCT01442662|Metastatic or relapsed uterine or soft tissue leiomyosarcoma|metastatic or relapsed uterine or soft tissue leiomyosarcoma
497101|NCT01442649|Adenocarcinoma|adenocarcinoma
497102|NCT01442649|Metastatic|metastatic
497103|NCT01442649|Second-line treatment|second-line treatment
497104|NCT01442649|Progressive disease after first-line treatment with bevacizumab|progressive disease after first-line treatment with bevacizumab
497105|NCT01442649|Non-mutated (wild-type) KRAS.|non-mutated (wild-type) kras.
497106|NCT01442623|Vestibular Rehabilitation|vestibular rehabilitation
497107|NCT01442623|Balance|balance
497108|NCT01442623|Virtual Reality|virtual reality
497109|NCT01442623|Gait|gait
497110|NCT01442623|Dizziness|dizziness
497111|NCT01442610|Rasagiline|rasagiline
497112|NCT01442610|Sleep disorder|sleep disorder
497113|NCT01442610|Parkinson's disease|parkinson's disease
497114|NCT01442610|Sleep Disturbances in patients with parkinsons's disease|sleep disturbances in patients with parkinsons's disease
497115|NCT01442597|cognitive behavior therapy|cognitive behavior therapy
497116|NCT01442597|computer assisted instruction|computer assisted instruction
497117|NCT01442597|drug abuse therapy|drug abuse therapy
497118|NCT01442597|educational resource design and development|educational resource design and development
497119|NCT01442584|ovary|ovary
497120|NCT01442584|cortex|cortex
497121|NCT01442584|transplantation|transplantation
497122|NCT01442571|Adult Men and Women, who underwent arthroscopy of the knee with cartilage injury of ICRS grade 2 or higher|adult men and women, who underwent arthroscopy of the knee with cartilage injury of icrs grade 2 or higher
497123|NCT01442558|relief|relief
497124|NCT01442558|Intra-operative|intra-operative
497125|NCT01442545|Rheumatoid Arthritis|rheumatoid arthritis
497126|NCT01442545|JNJ-39758979|jnj-39758979
497127|NCT01442545|Methotrexate|methotrexate
497128|NCT01442532|Healthy male volunteer|healthy male volunteer
497129|NCT01442532|JNJ-38518168|jnj-38518168
497130|NCT01442532|Midazolam|midazolam
497131|NCT01442519|non-muscle invasive urothelial bladder cancer|non-muscle invasive urothelial bladder cancer
497132|NCT01442519|intravesical therapy|intravesical therapy
497133|NCT01442519|BCG|bcg
497134|NCT01442519|mitomycin|mitomycin
497135|NCT01442519|electromotive drug administration|electromotive drug administration
497136|NCT01442519|Bladder Cancer Stage 0, Without Cancer in Situ|bladder cancer stage 0, without cancer in situ
497137|NCT01442506|acetic acid|acetic acid
497138|NCT01442506|virtual chromoendosopy|virtual chromoendosopy
497139|NCT01442493|Methadone Treatment|methadone treatment
497140|NCT01442493|Opiate dependence|opiate dependence
497141|NCT01442493|Services research|services research
497142|NCT01442480|air pollution|air pollution
497143|NCT01442480|fatty acid supplementation|fatty acid supplementation
497144|NCT01442467|mitral annular calcification|mitral annular calcification
497145|NCT01442467|MAC|mac
497146|NCT01442467|left atrial pressure|left atrial pressure
497147|NCT01442467|LAP|lap
497148|NCT01442467|left ventricular end diastolic pressure|left ventricular end diastolic pressure
497149|NCT01442467|LVEDP|lvedp
497150|NCT01442467|Echocardiogram|echocardiogram
497151|NCT01442454|chronic pancreatitis|chronic pancreatitis
497152|NCT01442441|chronic pancreatitis|chronic pancreatitis
497153|NCT01442428|TB|tb
497154|NCT01442428|AIDS|aids
497155|NCT01442428|HIV|hiv
497156|NCT01442428|IRIS|iris
497157|NCT01442428|immune reconstitution inflammatory syndrome|immune reconstitution inflammatory syndrome
497158|NCT01442428|anti-inflammatory|anti-inflammatory
497159|NCT01442428|treatment|treatment
497262|NCT01441921|pistachio intake|pistachio intake
497160|NCT01442376|Prevention of Chemotherapy-Induced Nausea and Vomiting|prevention of chemotherapy-induced nausea and vomiting
497161|NCT01442376|Palonosetron|palonosetron
497162|NCT01442376|Ondansetron|ondansetron
497163|NCT01442376|Pediatric|pediatric
497164|NCT01442363|Crohn's disease|crohn's disease
497165|NCT01442363|perianal|perianal
497166|NCT01442363|inflammatory bowel disease|inflammatory bowel disease
497167|NCT01442363|fistula|fistula
497168|NCT01442350|Fabry disease|fabry disease
497169|NCT01442350|annexin 5|annexin 5
497170|NCT01442350|miosin|miosin
497171|NCT01442350|sarcoma|sarcoma
497172|NCT01442350|alfa-galactosidase|alfa-galactosidase
497173|NCT01442350|fibrosis|fibrosis
497174|NCT01442350|apoptosis|apoptosis
497175|NCT01442350|biomarkers|biomarkers
497176|NCT01442350|NT-proBNP|nt-probnp
497177|NCT01442337|de novo kidney transplant|de novo kidney transplant
497178|NCT01442337|kidney transplant|kidney transplant
497179|NCT01442337|ASP8597|asp8597
497180|NCT01442337|diannexin|diannexin
497181|NCT01442337|ischemia-reperfusion injury|ischemia-reperfusion injury
497182|NCT01442324|Laparotomic surgery|laparotomic surgery
497183|NCT01442324|Laparoscopic surgery|laparoscopic surgery
497184|NCT01442324|Percutaneos tumour ablation|percutaneos tumour ablation
497185|NCT01442324|Irreversible electroporation (IRE)|irreversible electroporation (ire)
497186|NCT01442311|Hepatitis C Virus|hepatitis c virus
497187|NCT01442311|Chronic Hepatitis C|chronic hepatitis c
497188|NCT01442311|Methadone|methadone
497189|NCT01442311|Injection Drug User|injection drug user
497190|NCT01442311|Adherence|adherence
497191|NCT01442311|Directly Observed Treatment|directly observed treatment
497192|NCT01442298|bloodless field|bloodless field
497193|NCT01442298|cuff pressure|cuff pressure
497194|NCT01442298|limb occlusion pressure|limb occlusion pressure
497195|NCT01442259|Renal impairment,|renal impairment,
497196|NCT01442259|pharmacokinetics,|pharmacokinetics,
497197|NCT01442259|safety|safety
497198|NCT01442246|Benefit of|benefit of
497199|NCT01442246|adjuvant|adjuvant
497200|NCT01442246|treatment|treatment
497201|NCT01442246|prostatectomy|prostatectomy
497202|NCT01442233|multiple sclerosis|multiple sclerosis
497203|NCT01442233|plasma exchange|plasma exchange
497204|NCT01442207|Premature Birth|premature birth
497205|NCT01442207|Placenta Previa|placenta previa
497206|NCT01442194|Multiple sclerosis|multiple sclerosis
497207|NCT01442194|fingolimod|fingolimod
497208|NCT01442194|observational study|observational study
497209|NCT01442168|Uncomplicated Falciparum Malaria|uncomplicated falciparum malaria
497210|NCT01442168|Plasmodium falciparum|plasmodium falciparum
497211|NCT01442168|Antimalarial treatment|antimalarial treatment
497212|NCT01442168|Sevuparin/DF02|sevuparin/df02
497213|NCT01442168|Adjuvant therapy|adjuvant therapy
497214|NCT01442168|Malanil|malanil
497215|NCT01442168|Peripheral blood parasitemia|peripheral blood parasitemia
497216|NCT01442168|Rosette formation|rosette formation
497217|NCT01442168|Maximum tolerated dose|maximum tolerated dose
497218|NCT01442155|Colorectal cancer|colorectal cancer
497219|NCT01442155|Adjuvant setting|adjuvant setting
497220|NCT01442155|Capecitabine|capecitabine
497221|NCT01442155|Oxaliplatin|oxaliplatin
497222|NCT01442142|obesity|obesity
497223|NCT01442142|pediatric|pediatric
497224|NCT01442142|childhood|childhood
497225|NCT01442142|overweight|overweight
497226|NCT01442129|Heart Failure|heart failure
497227|NCT01442129|Left Ventricular Assist Device|left ventricular assist device
497228|NCT01442129|Heart Transplantation|heart transplantation
497229|NCT01442129|Cardiomyopathy|cardiomyopathy
497230|NCT01442129|Destination Therapy|destination therapy
497231|NCT01442129|Cell Therapy|cell therapy
497232|NCT01442064|CNV|cnv
497233|NCT01442064|Lucentis|lucentis
497234|NCT01442064|AMD|amd
497235|NCT01442064|Age-related macular degeneration|age-related macular degeneration
497236|NCT01442064|RVO|rvo
497237|NCT01442064|Macular edema secondary to retinal vein occlusion|macular edema secondary to retinal vein occlusion
497238|NCT01442051|Acute Normovolemic Hemodilution|acute normovolemic hemodilution
497239|NCT01442051|Cytoreductive Surgery|cytoreductive surgery
497240|NCT01442051|laparotomy|laparotomy
497241|NCT01442051|11-149|11-149
497242|NCT01442051|advanced primary epithelial ovarian cancer|advanced primary epithelial ovarian cancer
497243|NCT01442025|Crohn's Disease|crohn's disease
497244|NCT01442025|IFX trough level|ifx trough level
497245|NCT01442012|PONV|ponv
497246|NCT01442012|ACUPUNCTURE|acupuncture
497247|NCT01441999|Rigid rods|rigid rods
497248|NCT01441999|less rigid rods|less rigid rods
497249|NCT01441999|prevent kyphosis|prevent kyphosis
497250|NCT01441999|long constructs|long constructs
497251|NCT01441986|dextromethorphan|dextromethorphan
497252|NCT01441986|amantadine|amantadine
497253|NCT01441986|blood glucose lowering effect|blood glucose lowering effect
497254|NCT01441986|oral glucose tolerance test|oral glucose tolerance test
497255|NCT01441960|Succinylcholine|succinylcholine
497256|NCT01441960|Rocuronium|rocuronium
497257|NCT01441960|ECT|ect
497258|NCT01441947|ER+|er+
497259|NCT01441947|PR+|pr+
497260|NCT01441947|Human Epidermal Growth Factor Receptor (HER) 2 negative|human epidermal growth factor receptor (her) 2 negative
497263|NCT01441921|insulin resistance|insulin resistance
497264|NCT01441921|type 2 diabetes mellitus|type 2 diabetes mellitus
497265|NCT01441908|Cardiovascular|cardiovascular
497266|NCT01441908|Multi-analyte|multi-analyte
497268|NCT01441908|Dyslipidemia|dyslipidemia
497269|NCT01441895|Refractive Cataract Extraction|refractive cataract extraction
497270|NCT01441895|Femtosecond laser|femtosecond laser
497271|NCT01441895|arcuate relaxing incisions|arcuate relaxing incisions
497272|NCT01441895|Dry Eye post cataract refraction|dry eye post cataract refraction
497273|NCT01441869|Phase 1, Healthy male volunteers, pharmacokinetics, saxagliptin/ metformin , Diabex|phase 1, healthy male volunteers, pharmacokinetics, saxagliptin/ metformin , diabex
497274|NCT01441856|Open|open
497275|NCT01441856|Laparoscopic|laparoscopic
497276|NCT01441856|Hemihepatectomy|hemihepatectomy
497277|NCT01441856|Hepatectomy|hepatectomy
497278|NCT01441856|Enhanced Recovery After Surgery|enhanced recovery after surgery
497279|NCT01441856|Functional recovery|functional recovery
497280|NCT01441843|quality of life|quality of life
497281|NCT01441843|lorazepam|lorazepam
497282|NCT01441843|anxiety|anxiety
497283|NCT01441843|premedication|premedication
497284|NCT01441843|surgery|surgery
497285|NCT01441843|Adult patients|adult patients
497286|NCT01441843|Ambulatory Surgical Procedures|ambulatory surgical procedures
497287|NCT01441843|Postoperative Period|postoperative period
497288|NCT01441830|shoulder|shoulder
497289|NCT01441830|subacromial|subacromial
497290|NCT01441830|impingement|impingement
497291|NCT01441830|tendinopathy|tendinopathy
497292|NCT01441830|rESWT|reswt
497293|NCT01441830|shock wave|shock wave
497294|NCT01441830|ESWT|eswt
497295|NCT01441830|RSWT|rswt
497296|NCT01441791|PEEP|peep
497297|NCT01441791|Positive end-expiratory pressure|positive end-expiratory pressure
497298|NCT01441791|Recruitment maneuver|recruitment maneuver
497299|NCT01441791|Open lung approach|open lung approach
497300|NCT01441791|Post-operative complications|post-operative complications
497301|NCT01441791|Open abdominal surgery|open abdominal surgery
497302|NCT01441778|nasal irrigation|nasal irrigation
497303|NCT01441778|allergic rhinitis|allergic rhinitis
497304|NCT01441778|children|children
497305|NCT01441765|Kidney|kidney
497306|NCT01441765|Metastatic|metastatic
497307|NCT01441765|Stage IV|stage iv
497308|NCT01441726|Advanced dementia|advanced dementia
497309|NCT01441726|Quality|quality
497310|NCT01441726|Terminal care|terminal care
497311|NCT01441713|Hormone treatment|hormone treatment
497312|NCT01441713|castration|castration
497313|NCT01441713|Orchiectomy|orchiectomy
497314|NCT01441713|treatment frequency|treatment frequency
497315|NCT01441713|treatment satisfaction|treatment satisfaction
497316|NCT01441713|side effects|side effects
497317|NCT01441700|Prone emergence|prone emergence
497318|NCT01441700|supine emergence|supine emergence
497319|NCT01441700|coughing|coughing
497320|NCT01441700|haemodynamic stimulation|haemodynamic stimulation
497321|NCT01441700|lumbar surgery|lumbar surgery
497322|NCT01441687|Health status unknown|health status unknown
497323|NCT01441687|healthy,no evidence of disease|healthy,no evidence of disease
497324|NCT01441674|Occupational Therapy|occupational therapy
497325|NCT01441661|Sunitinib|sunitinib
497326|NCT01441661|kidney diseases|kidney diseases
497327|NCT01441661|urogenital neoplasms|urogenital neoplasms
497328|NCT01441661|kidney cancer|kidney cancer
497329|NCT01441648|conjunctival injection|conjunctival injection
497330|NCT01441648|conjunctival papillary hypertrophy|conjunctival papillary hypertrophy
497331|NCT01441648|pannus formation|pannus formation
497332|NCT01441648|corneal epitheliopathy|corneal epitheliopathy
497333|NCT01441648|Schirmer test|schirmer test
497334|NCT01441648|Impression cytology|impression cytology
497335|NCT01441648|confocal microscopy|confocal microscopy
497336|NCT01441648|Scanning electronmicroscopy (SEM)|scanning electronmicroscopy (sem)
497337|NCT01441648|bacterial adhesion determination|bacterial adhesion determination
497338|NCT01441635|Elagolix|elagolix
497339|NCT01441635|Uterine Fibroids|uterine fibroids
497340|NCT01441635|Elagolix sodium|elagolix sodium
497341|NCT01441635|Leiomyomata|leiomyomata
497342|NCT01441635|Heavy Uterine Bleeding|heavy uterine bleeding
497343|NCT01441635|Menorrhagia|menorrhagia
497344|NCT01441635|ABT-620|abt-620
497345|NCT01441622|Continuous Positive Airway Pressure (CPAP)|continuous positive airway pressure (cpap)
497347|NCT01441622|Home-monitoring|home-monitoring
497348|NCT01441609|Th9 cells|th9 cells
497349|NCT01441609|IL9|il9
497350|NCT01441609|non/poor responsiveness to hepatitis B|non/poor responsiveness to hepatitis b
497351|NCT01441609|collect blood samples after vaccination|collect blood samples after vaccination
497352|NCT01441583|pacemaker, CRT-P, auto threshold|pacemaker, crt-p, auto threshold
497353|NCT01441570|kidney|kidney
497354|NCT01441570|transplant|transplant
497355|NCT01441570|hypertension|hypertension
497356|NCT01441570|nebivolol|nebivolol
497357|NCT01441570|metoprolol|metoprolol
497358|NCT01441570|bystolic|bystolic
497359|NCT01441570|toprol|toprol
497360|NCT01441557|mechanical ventilation|mechanical ventilation
497361|NCT01441544|active video games|active video games
497362|NCT01441544|Energy expenditure|energy expenditure
497363|NCT01441531|narcotic use|narcotic use
497364|NCT01441531|Other Acute Pain|other acute pain
497365|NCT01441492|Distal pancreatectomy|distal pancreatectomy
497366|NCT01441492|Pancreas resection|pancreas resection
497367|NCT01441466|bronchiolitis|bronchiolitis
497368|NCT01441466|RSV|rsv
497369|NCT01441453|Hepatocellular carcinoma|hepatocellular carcinoma
497370|NCT01441453|Cirrhosis|cirrhosis
497371|NCT01441453|Liver resection|liver resection
497372|NCT01441453|FibroScan|fibroscan
497373|NCT01441440|venlafaxine ER|venlafaxine er
497374|NCT01441440|Major depressive disorder|major depressive disorder
497375|NCT01441440|Japan|japan
497376|NCT01441440|placebo-controlled|placebo-controlled
497377|NCT01441427|feeding intolerance|feeding intolerance
497378|NCT01441427|recombinant growth factors|recombinant growth factors
497379|NCT01441427|G-CSF|g-csf
497380|NCT01441427|EPO|epo
497381|NCT01441427|necrotizing enterocolitis|necrotizing enterocolitis
497382|NCT01441414|CVX-060|cvx-060
497383|NCT01441414|PF-04856884|pf-04856884
497384|NCT01441414|AG-013736|ag-013736
497385|NCT01441414|axitinib|axitinib
497386|NCT01441414|mRCC|mrcc
497387|NCT01441414|metastatic renal cell cancer|metastatic renal cell cancer
497388|NCT01441414|second line|second line
497389|NCT01441414|anti-angiogenic|anti-angiogenic
497390|NCT01441414|Ang-2|ang-2
497391|NCT01441401|Gabapentin|gabapentin
497392|NCT01441401|Epilepsies|epilepsies
497393|NCT01441401|safety|safety
497394|NCT01441388|Phase 1b|phase 1b
497395|NCT01441388|crizotinib|crizotinib
497396|NCT01441388|sunitinib|sunitinib
497397|NCT01441388|axitinib|axitinib
497398|NCT01441388|sorafenib|sorafenib
497399|NCT01441388|bevacizumab|bevacizumab
497400|NCT01441388|cMET inhibitor|cmet inhibitor
497401|NCT01441388|VEGF inhibitor|vegf inhibitor
497402|NCT01441388|crizotinib combination|crizotinib combination
497403|NCT01441375|Sickle cell anemia|sickle cell anemia
497404|NCT01441362|during double-lumen|during double-lumen
497405|NCT01441362|tube intubation|tube intubation
497406|NCT01441349|Simvastatin|simvastatin
497407|NCT01441349|SCLC|sclc
497408|NCT01441349|Extensive Disease|extensive disease
497409|NCT01441323|Obesity|obesity
497410|NCT01441323|Type 2 Diabetes|type 2 diabetes
497411|NCT01441323|Cardiovascular Risk|cardiovascular risk
497412|NCT01441323|Cancer|cancer
497413|NCT01441323|African American|african american
497414|NCT01441323|Adolescents|adolescents
497415|NCT01441323|Strength Training|strength training
497416|NCT01441323|Nutrition|nutrition
497417|NCT01441310|Gastric cancer|gastric cancer
497418|NCT01441310|Sentinel node navigation surgery|sentinel node navigation surgery
497419|NCT01441310|Dual method|dual method
497420|NCT01441310|Recurrence|recurrence
497421|NCT01441297|recurrent small cell lung cancer|recurrent small cell lung cancer
497422|NCT01441284|pramipexole|pramipexole
497423|NCT01441284|essential tremor|essential tremor
497424|NCT01441284|cross-over|cross-over
497425|NCT01441245|acute heart failure|acute heart failure
497426|NCT01441245|diuretics|diuretics
497427|NCT01441245|BNP|bnp
497428|NCT01441245|Renal function|renal function
497429|NCT01441245|acute decompensated Heart Failure,|acute decompensated heart failure,
497430|NCT01441245|volume overload|volume overload
497431|NCT01441206|rifampin|rifampin
497432|NCT01441206|infants|infants
497433|NCT01441193|HIV|hiv
497434|NCT01441193|preventive vaccine|preventive vaccine
497435|NCT01441193|Tat|tat
497436|NCT01441193|Env|env
497437|NCT01441180|Direct Acting Antiviral|direct acting antiviral
497438|NCT01441180|Liver|liver
497439|NCT01441180|Hepatitis C|hepatitis c
497440|NCT01441180|HCV|hcv
497441|NCT01441167|Healthy Subjects|healthy subjects
497442|NCT01441167|Immunogenicity|immunogenicity
497443|NCT01441167|Vaccine-Mediated Protection|vaccine-mediated protection
497444|NCT01441167|Sporozoites|sporozoites
497445|NCT01441167|Parasitemia|parasitemia
497446|NCT01441167|Healthy Volunteer|healthy volunteer
497447|NCT01441167|HV|hv
497448|NCT01441154|Hypothyroidism|hypothyroidism
497449|NCT01441154|Thyroid Cancer|thyroid cancer
497450|NCT01441154|Triiodothyronine (T3)|triiodothyronine (t3)
497451|NCT01441154|Energy Expenditure|energy expenditure
497452|NCT01441154|Thyroid Hormone|thyroid hormone
497453|NCT01441141|GCH1|gch1
497454|NCT01441141|Pain Sensitivity|pain sensitivity
497455|NCT01441141|Quantitative Sensory Testing (QST)|quantitative sensory testing (qst)
497456|NCT01441141|Genetic Variation|genetic variation
497457|NCT01441141|Sickle Cell Anemia|sickle cell anemia
497458|NCT01441128|Lung Neoplasms|lung neoplasms
497459|NCT01441128|Epithelial-Mesenchymal Transition Factor (c-Met)|epithelial-mesenchymal transition factor (c-met)
497460|NCT01441128|Tyrosine Kinase Inhibitor|tyrosine kinase inhibitor
497461|NCT01441128|Hepatocyte Growth Factor Receptor|hepatocyte growth factor receptor
497462|NCT01441128|Epidermal Growth Factor Receptor|epidermal growth factor receptor
497463|NCT01441128|Non Small Cell Lung Cancer|non small cell lung cancer
497464|NCT01441128|NSCLC|nsclc
497465|NCT01441115|Metastasis|metastasis
497466|NCT01441115|Cancer|cancer
497467|NCT01441115|Radiation Therapy|radiation therapy
497468|NCT01441115|Locally Advanced|locally advanced
497469|NCT01441115|Palliation|palliation
497470|NCT01441115|Metastatic Cancer|metastatic cancer
497471|NCT01441102|Diabetic Macular Edema|diabetic macular edema
497472|NCT01441102|Microglia|microglia
497473|NCT01441102|Dextromethorphan|dextromethorphan
497474|NCT01441089|Pharmacogenetics|pharmacogenetics
497475|NCT01441089|Pharmacokinetics|pharmacokinetics
497476|NCT01441089|Pharmacodynamics|pharmacodynamics
497477|NCT01441089|Clinical Outcome|clinical outcome
497478|NCT01441089|Drug Metabolism and Transport|drug metabolism and transport
497479|NCT01441089|Cancer|cancer
497480|NCT01441076|Behcet's Disease|behcet's disease
497481|NCT01441076|Aphthous Ulcer|aphthous ulcer
497482|NCT01441076|Uveitis|uveitis
497483|NCT01441076|IL-1|il-1
497484|NCT01441076|Autoinflammation|autoinflammation
497485|NCT01441076|BD|bd
497486|NCT01441063|Kaposi Sarcoma Herpesvirus|kaposi sarcoma herpesvirus
497487|NCT01441063|Human Immunodeficiency Virus|human immunodeficiency virus
497488|NCT01441063|Tocilizumab|tocilizumab
497489|NCT01441063|Multicentric Castleman Disease|multicentric castleman disease
497490|NCT01441063|Interleukin-6|interleukin-6
497491|NCT01441063|Castleman Disease|castleman disease
497492|NCT01441037|Aplastic Anemia|aplastic anemia
497493|NCT01441037|Androgen|androgen
497494|NCT01441037|Telomeres|telomeres
497495|NCT01441037|Sex hormone|sex hormone
497496|NCT01441037|Pulmonary fibrosis|pulmonary fibrosis
497497|NCT01441037|Liver cirrhosis|liver cirrhosis
497498|NCT01441024|Immunocompromised|immunocompromised
497499|NCT01441024|Respiratory Tract Disease|respiratory tract disease
497500|NCT01441024|Viral Shedding|viral shedding
497501|NCT01441024|Fever|fever
497502|NCT01441024|Pharmacokinetics|pharmacokinetics
497503|NCT01441024|Parainfluenza Infection|parainfluenza infection
497504|NCT01441024|Flu|flu
497505|NCT01441011|weight loss|weight loss
497506|NCT01441011|breast cancer|breast cancer
497507|NCT01441011|obesity|obesity
497508|NCT01441011|overweight|overweight
497509|NCT01441011|rural women|rural women
497510|NCT01441011|community based|community based
497511|NCT01441011|Secondary Prevention|secondary prevention
497512|NCT01440985|Tooth Staining|tooth staining
497513|NCT01440972|knee osteoarthritis|knee osteoarthritis
497514|NCT01440972|symptomatic knee osteoarthritis|symptomatic knee osteoarthritis
497515|NCT01440972|isotonic leg-press strength|isotonic leg-press strength
497516|NCT01440972|isokinetic knee extensor strength|isokinetic knee extensor strength
497517|NCT01440972|quadriceps volume|quadriceps volume
497518|NCT01440959|This is a single-center|this is a single-center
497519|NCT01440959|prospective|prospective
497520|NCT01440959|single-arm|single-arm
497521|NCT01440959|open-label phase II study|open-label phase ii study
497522|NCT01440933|sugammadex|sugammadex
497523|NCT01440933|rocuronium|rocuronium
497524|NCT01440933|magnesiumsulphate|magnesiumsulphate
497525|NCT01440933|neuromuscular monitoring|neuromuscular monitoring
497526|NCT01440920|Acute myeloid leukemia|acute myeloid leukemia
497527|NCT01440920|WT1|wt1
497528|NCT01440907|Health Information Technology|health information technology
497529|NCT01440907|Health Records, Personal|health records, personal
497530|NCT01440907|Hospital Information Systems|hospital information systems
497531|NCT01440907|Patient Access to Records|patient access to records
497532|NCT01440907|Medical Records|medical records
497533|NCT01440907|Medical Record Systems, Computerized|medical record systems, computerized
497534|NCT01440894|weight|weight
497535|NCT01440894|body fat|body fat
497536|NCT01440894|total body water|total body water
497537|NCT01440894|bone mass|bone mass
497538|NCT01440894|muscle mass|muscle mass
497539|NCT01440881|renal failure|renal failure
497540|NCT01440881|cardiopulmonary bypass|cardiopulmonary bypass
497541|NCT01440868|Respiratory Distress Syndrome, Newborn|respiratory distress syndrome, newborn
497542|NCT01440868|Delivery Rooms|delivery rooms
497543|NCT01440868|Resuscitation|resuscitation
497544|NCT01440868|Premature Birth|premature birth
497545|NCT01440868|Infant, Newborn|infant, newborn
497546|NCT01440868|Respiration, Artificial|respiration, artificial
497547|NCT01440855|Survivorship|survivorship
497548|NCT01440855|cancer control|cancer control
497549|NCT01440855|psychosocial interventions|psychosocial interventions
497550|NCT01440855|Facing Forward|facing forward
497551|NCT01440842|Stress hyperglycaemia|stress hyperglycaemia
497552|NCT01440829|Transjugular Intrahepatic Portosystemic Shunt|transjugular intrahepatic portosystemic shunt
497553|NCT01440829|TIPS|tips
497554|NCT01440829|Liver Cirrhosis|liver cirrhosis
497555|NCT01440829|LOLA|lola
497556|NCT01440829|L-ornithine-L-aspartate|l-ornithine-l-aspartate
497557|NCT01440829|Refractory Ascites|refractory ascites
497558|NCT01440803|osteoporosis|osteoporosis
497559|NCT01440803|premenopausal|premenopausal
497560|NCT01440803|forteo|forteo
497561|NCT01440803|idiopathic|idiopathic
497562|NCT01440803|Idiopathic Osteoporosis in Premenopausal Women|idiopathic osteoporosis in premenopausal women
497563|NCT01440777|Insomnia|insomnia
497564|NCT01440777|Sleep|sleep
497565|NCT01440777|Stress|stress
497566|NCT01440777|Online program|online program
497567|NCT01440777|Web-based program|web-based program
497568|NCT01440777|Cognitive Behavioral Therapy for Insomnia (CBT-i)|cognitive behavioral therapy for insomnia (cbt-i)
497569|NCT01440764|dyspnea|dyspnea
497570|NCT01440764|Laboratory model of dyspnea in healthy subjects|laboratory model of dyspnea in healthy subjects
497571|NCT01440751|ologen collagen matrix|ologen collagen matrix
497572|NCT01440751|mitomycin-C|mitomycin-c
497573|NCT01440751|trabeculectomy|trabeculectomy
497574|NCT01440751|glaucoma|glaucoma
497575|NCT01440751|filtering surgery|filtering surgery
497576|NCT01440738|general population|general population
497577|NCT01440725|muscle|muscle
497578|NCT01440725|injuries|injuries
497579|NCT01440725|platelet-rich plasma|platelet-rich plasma
497580|NCT01440725|autologous|autologous
497581|NCT01440725|haematoma|haematoma
497582|NCT01440712|Gastrografin|gastrografin
633008|NCT00896272|XXY|xxy
497583|NCT01440712|Postoperative ileus|postoperative ileus
497584|NCT01440712|Colo-rectal surgery|colo-rectal surgery
497585|NCT01440712|Effects on morbidity and mortality of postoperative ileus|effects on morbidity and mortality of postoperative ileus
497586|NCT01440699|Crohn's fistula|crohn's fistula
497587|NCT01440686|Pharmacokinetics|pharmacokinetics
497588|NCT01440686|Pharmacodynamics|pharmacodynamics
497589|NCT01440686|Safety|safety
497590|NCT01440686|Male|male
497591|NCT01440673|Postoperative Nausea and Vomiting|postoperative nausea and vomiting
497592|NCT01440647|Respiration, Artificial|respiration, artificial
497593|NCT01440647|Infant, Premature|infant, premature
497594|NCT01440647|Bronchopulmonary Dysplasia|bronchopulmonary dysplasia
497595|NCT01440647|Continuous Positive Airway Pressure|continuous positive airway pressure
497596|NCT01440647|Non-Invasive Positive-Pressure Ventilation|non-invasive positive-pressure ventilation
497721|NCT01440244|mediastinoscopy|mediastinoscopy
497597|NCT01440647|Intermittent Positive-Pressure Ventilation|intermittent positive-pressure ventilation
497598|NCT01440647|High-Frequency Ventilation|high-frequency ventilation
497599|NCT01440634|Peripheral arterial disease|peripheral arterial disease
497600|NCT01440634|Community Medicine|community medicine
497601|NCT01440634|Exercise Test|exercise test
497602|NCT01440634|Exercise Therapy|exercise therapy
497603|NCT01440621|Cancer related fatigue|cancer related fatigue
497604|NCT01440621|Quality of life|quality of life
497605|NCT01440621|Modafinil|modafinil
497606|NCT01440621|Radiation therapy|radiation therapy
497607|NCT01440621|Radiotherapy|radiotherapy
497608|NCT01440582|Myeloma|myeloma
497609|NCT01440582|Multiple Myeloma|multiple myeloma
497610|NCT01440582|MM|mm
497611|NCT01440582|Newly diagnosed|newly diagnosed
497612|NCT01440582|Transplant eligible|transplant eligible
497613|NCT01440582|Panobinostat|panobinostat
497614|NCT01440582|LBH589B|lbh589b
497615|NCT01440582|Bortezomib|bortezomib
497616|NCT01440582|Velcade|velcade
497617|NCT01440582|LDP-341|ldp-341
497618|NCT01440582|MLN341|mln341
497619|NCT01440582|PS-341|ps-341
497620|NCT01440582|Lenalidomide|lenalidomide
497621|NCT01440582|CC-5013|cc-5013
497622|NCT01440582|Revlimid|revlimid
497623|NCT01440582|Dexamethasone|dexamethasone
497624|NCT01440582|Decadron|decadron
497625|NCT01440582|Symptom questionnaire|symptom questionnaire
497626|NCT01440582|Survey|survey
497627|NCT01440569|HIV-1|hiv-1
497628|NCT01440569|HIV|hiv
497629|NCT01440569|Treatment Naïve|treatment naïve
497630|NCT01440569|Treatment Experienced|treatment experienced
497631|NCT01440556|Allogeneic bone marrow transplantation|allogeneic bone marrow transplantation
497632|NCT01440556|Multiple myeloma|multiple myeloma
497633|NCT01440543|colonoscopy|colonoscopy
497634|NCT01440543|water immersion|water immersion
497635|NCT01440543|CO2 insufflation|co2 insufflation
497636|NCT01440543|patients referred for diagnostic outpatient colonoscopy|patients referred for diagnostic outpatient colonoscopy
497637|NCT01440543|(screening, surveillance, symptoms)|(screening, surveillance, symptoms)
497638|NCT01440543|patient discomfort associated with diagnostic colonoscopy|patient discomfort associated with diagnostic colonoscopy
497639|NCT01440530|Diabetes Internet Education|diabetes internet education
497640|NCT01440530|Diabetes Education|diabetes education
497641|NCT01440530|Diabetes Self-Care|diabetes self-care
497642|NCT01440530|Diabetes Self-Management|diabetes self-management
497643|NCT01440530|Diabetes Behavior Intervention|diabetes behavior intervention
497644|NCT01440517|CE-MRI - Contrast-enhanced magnetic resonance imaging|ce-mri - contrast-enhanced magnetic resonance imaging
497645|NCT01440517|DM - Diabetes mellitus|dm - diabetes mellitus
497646|NCT01440517|EKG - Echocardiography|ekg - echocardiography
497647|NCT01440517|HFPEF - Heart failure preserved left ventricular ejection fraction|hfpef - heart failure preserved left ventricular ejection fraction
497648|NCT01440517|LVEF - Left Ventricular Ejection Fraction|lvef - left ventricular ejection fraction
497649|NCT01440504|Cancer|cancer
497650|NCT01440504|Ovarian|ovarian
497651|NCT01440504|chemotherapy|chemotherapy
497652|NCT01440504|BH3-mimetic|bh3-mimetic
497653|NCT01440504|platin|platin
497654|NCT01440504|ex-vivo|ex-vivo
497655|NCT01440491|low back pain|low back pain
497656|NCT01440491|exercise|exercise
497657|NCT01440491|booklet|booklet
497658|NCT01440465|chemotherapy|chemotherapy
497659|NCT01440465|cancer|cancer
497660|NCT01440465|nausea|nausea
497661|NCT01440465|vomiting|vomiting
497662|NCT01440452|TM|tm
497664|NCT01440452|Spinal Cord Injury|spinal cord injury
497665|NCT01440452|Functional electrical stimulation|functional electrical stimulation
497666|NCT01440452|Rehabilitation|rehabilitation
497667|NCT01440452|Growth factors|growth factors
497668|NCT01440452|Cytokines|cytokines
497669|NCT01440439|insulin glargine|insulin glargine
497670|NCT01440439|insulin detemir|insulin detemir
497671|NCT01440439|hypoglycaemia|hypoglycaemia
497672|NCT01440439|metabolism|metabolism
497673|NCT01440439|Exercise|exercise
497674|NCT01440426|gingival recession|gingival recession
497675|NCT01440426|root coverage|root coverage
497676|NCT01440426|periodontal surgery|periodontal surgery
497677|NCT01440426|collagen matrix|collagen matrix
497678|NCT01440426|mucograft|mucograft
497679|NCT01440426|multiple exposed teeth|multiple exposed teeth
497680|NCT01440413|anti-tumor immune response|anti-tumor immune response
497681|NCT01440413|neo-adjuvant chemotherapy|neo-adjuvant chemotherapy
497682|NCT01440413|relapse|relapse
497683|NCT01440413|long term survival|long term survival
497684|NCT01440413|histo-pathological response|histo-pathological response
497685|NCT01440413|tumor cell death|tumor cell death
497686|NCT01440413|tumor associated antigens|tumor associated antigens
497687|NCT01440413|Calreticulin|calreticulin
497688|NCT01440413|Localized breast cancer|localized breast cancer
497689|NCT01440400|Ultrasound|ultrasound
497690|NCT01440400|Spinal anesthesia|spinal anesthesia
497691|NCT01440400|Cesarean section|cesarean section
497692|NCT01440387|Influenza|influenza
497693|NCT01440387|Phase III|phase iii
497694|NCT01440387|Seasonal influenza|seasonal influenza
497695|NCT01440374|acute myeloid leukemia (AML)|acute myeloid leukemia (aml)
497696|NCT01440374|acute myelogenous leukemia (AML)|acute myelogenous leukemia (aml)
497697|NCT01440374|acute non lymphocytic leukemia (ANLL)|acute non lymphocytic leukemia (anll)
497698|NCT01440374|myeloproliferative disease (MDS)|myeloproliferative disease (mds)
497699|NCT01440374|myelodysplastic syndrome ( secondary acute myeloid leukemia)|myelodysplastic syndrome ( secondary acute myeloid leukemia)
497700|NCT01440374|refractory acute myeloid leukemia|refractory acute myeloid leukemia
497701|NCT01440348|Achilles allograft|achilles allograft
497702|NCT01440348|cruciate ligament|cruciate ligament
497703|NCT01440348|reconstruction|reconstruction
497704|NCT01440335|Fenoterol|fenoterol
497705|NCT01440335|Pharmacodynamics|pharmacodynamics
497706|NCT01440335|Pharmacokinetics|pharmacokinetics
497707|NCT01440335|Safety|safety
497708|NCT01440335|Beta Adrenergic Agonist|beta adrenergic agonist
497709|NCT01440322|Myopia|myopia
497710|NCT01440322|Contact lenses|contact lenses
497711|NCT01440309|biliary cirrhosis|biliary cirrhosis
497712|NCT01440283|Neuroblastoma|neuroblastoma
497713|NCT01440283|Radiation Therapy|radiation therapy
497714|NCT01440270|Oral cancer|oral cancer
497715|NCT01440270|Oropharyngeal cancer|oropharyngeal cancer
497716|NCT01440270|Induction chemotherapy|induction chemotherapy
497717|NCT01440270|Targeted chemotherapy|targeted chemotherapy
497718|NCT01440270|Surgery|surgery
497719|NCT01440270|Radiotherapy|radiotherapy
497720|NCT01440270|Effects of Chemotherapy|effects of chemotherapy
497722|NCT01440244|pleural evaluation|pleural evaluation
497723|NCT01440244|pleural biopsy|pleural biopsy
497724|NCT01440244|pleurodesis|pleurodesis
497725|NCT01440231|Rheumatology|rheumatology
497726|NCT01440231|Double-Blind|double-blind
497727|NCT01440231|Placebo-Controlled|placebo-controlled
497728|NCT01440231|Multidose|multidose
497729|NCT01440231|Dose-Response|dose-response
497730|NCT01440231|Phase II|phase ii
497731|NCT01440231|Systemic Lupus Erythematosus|systemic lupus erythematosus
497732|NCT01440231|SLE|sle
497733|NCT01440231|Atacicept|atacicept
497734|NCT01440218|Idiopathic diseases|idiopathic diseases
497735|NCT01440218|family member of the affected individual|family member of the affected individual
497736|NCT01440218|unknown etiology|unknown etiology
497737|NCT01440205|Flu Shot|flu shot
497738|NCT01440192|Sarcoidosis|sarcoidosis
497739|NCT01440192|Stem cells|stem cells
497740|NCT01440192|PDA001|pda001
497741|NCT01440192|Celgene|celgene
497742|NCT01440192|Human Placenta-Derived cells|human placenta-derived cells
497743|NCT01440192|Cenplacel-L|cenplacel-l
497744|NCT01440166|Human healthy volunteers|human healthy volunteers
497745|NCT01440153|Dance|dance
497746|NCT01440153|Injury|injury
497747|NCT01440153|Physical condition|physical condition
497748|NCT01440153|Exercise|exercise
497749|NCT01440114|emergence agitation|emergence agitation
497750|NCT01440114|pediatric patient|pediatric patient
497751|NCT01440114|fentanyl|fentanyl
497752|NCT01440114|incidence of emergence agitation|incidence of emergence agitation
497753|NCT01440114|severity of emergence agitation|severity of emergence agitation
497754|NCT01440114|adverse outcome from intervention|adverse outcome from intervention
497755|NCT01440088|TH-302|th-302
497756|NCT01440088|TH-CR-406|th-cr-406
497757|NCT01440088|SARC021|sarc021
497758|NCT01440088|Locally Advanced Soft Tissue Sarcoma|locally advanced soft tissue sarcoma
497759|NCT01440088|Metastatic Soft Tissue Sarcoma|metastatic soft tissue sarcoma
497760|NCT01440088|Sarcoma|sarcoma
497761|NCT01440088|Doxorubicin|doxorubicin
497762|NCT01440088|Evofosfamide|evofosfamide
497763|NCT01440075|Kawasaki disease|kawasaki disease
497764|NCT01440049|patients with MI- on top of treatment add Eplerenone - assess LVEF and BP|patients with mi- on top of treatment add eplerenone - assess lvef and bp
497765|NCT01440036|carotid artery|carotid artery
497766|NCT01440036|Atherosclerotic plaque|atherosclerotic plaque
497767|NCT01440036|paraoxygenase 1 PON1|paraoxygenase 1 pon1
497768|NCT01440036|Patients undergoing carotid artery endarterectomy CEA for carotid artery stenosis|patients undergoing carotid artery endarterectomy cea for carotid artery stenosis
497769|NCT01440023|tic disorder|tic disorder
497770|NCT01440023|tourette syndrome|tourette syndrome
497771|NCT01440023|habit reversal|habit reversal
497772|NCT01440023|response inhibition|response inhibition
497773|NCT01440023|cognitive retraining|cognitive retraining
497774|NCT01440010|IORT|iort
497775|NCT01440010|Boost|boost
497776|NCT01440010|Breast cancer|breast cancer
497777|NCT01440010|Local recurrence|local recurrence
497778|NCT01440010|Toxicity|toxicity
497779|NCT01440010|LENT SOMA|lent soma
497780|NCT01440010|TARGIT|targit
497781|NCT01440010|Quality Control Registry|quality control registry
497782|NCT01439997|Nocturnal polyuria|nocturnal polyuria
497783|NCT01439984|PE|pe
497784|NCT01439984|IELT|ielt
497785|NCT01439984|DCIT|dcit
497786|NCT01439971|Phase 1|phase 1
497787|NCT01439971|Safety|safety
497788|NCT01439971|Pharmacokinetic|pharmacokinetic
497789|NCT01439971|Pharmacodynamic|pharmacodynamic
497790|NCT01439958|Inhalation|inhalation
497791|NCT01439958|Lung Transplantation|lung transplantation
497792|NCT01439958|Cyclosporine|cyclosporine
497793|NCT01439945|hot flashes|hot flashes
497794|NCT01439945|cancer survivor|cancer survivor
497795|NCT01439945|breast cancer|breast cancer
497796|NCT01439932|plantar fasciitis|plantar fasciitis
497797|NCT01439932|heel pain|heel pain
497798|NCT01439932|manual treatment|manual treatment
497799|NCT01439932|dorsi flexion|dorsi flexion
497800|NCT01439906|Degenerative scoliosis|degenerative scoliosis
497801|NCT01439906|Pain|pain
497802|NCT01439906|Deformity correction|deformity correction
497803|NCT01439906|Instrumented arthrodesis|instrumented arthrodesis
497804|NCT01439893|Chronic heart failure|chronic heart failure
497805|NCT01439893|rhNRG-1|rhnrg-1
497806|NCT01439893|Cardiac remodeling|cardiac remodeling
497807|NCT01439880|High cholesterol|high cholesterol
497808|NCT01439880|Raised cholesterol|raised cholesterol
497809|NCT01439880|Cholesterol|cholesterol
497810|NCT01439880|Elevated Cholesterol|elevated cholesterol
497811|NCT01439867|Dialysis|dialysis
497812|NCT01439867|Sensipar|sensipar
497813|NCT01439867|Mimpara|mimpara
497814|NCT01439867|Hemodialysis|hemodialysis
497815|NCT01439867|Peritoneal Dialysis|peritoneal dialysis
497816|NCT01439867|Renal|renal
497817|NCT01439867|Parathyroid hormone|parathyroid hormone
497818|NCT01439867|Pediatric|pediatric
497819|NCT01439854|Insulin sensitivity|insulin sensitivity
497820|NCT01439854|Mitochondrial function|mitochondrial function
497821|NCT01439854|Glucose toxicity|glucose toxicity
497822|NCT01439854|Glucosuria|glucosuria
497823|NCT01439841|HIV|hiv
497824|NCT01439841|microbial translocation|microbial translocation
497825|NCT01439841|immune activation|immune activation
497826|NCT01439841|probiotics|probiotics
497827|NCT01439828|Cannabis|cannabis
497828|NCT01439828|N-Acetylcystein|n-acetylcystein
497829|NCT01439828|Dependence|dependence
497830|NCT01439828|Abuse|abuse
497831|NCT01439828|Craving|craving
497832|NCT01439828|Genetic|genetic
497833|NCT01439802|Postpartum IUD|postpartum iud
497834|NCT01439802|Cesarean Delivery|cesarean delivery
497835|NCT01439802|6 months postpartum|6 months postpartum
497836|NCT01439802|satisfaction|satisfaction
497837|NCT01439789|Chronic Heart Failure|chronic heart failure
497838|NCT01439789|rhNRG-1|rhnrg-1
497839|NCT01439789|NT-proBNP|nt-probnp
497840|NCT01439776|chronic hepatitis C|chronic hepatitis c
497841|NCT01439776|SVR|svr
497842|NCT01439776|Vit D|vit d
497843|NCT01439776|Peginterferon alfa 2a|peginterferon alfa 2a
497844|NCT01439776|Ribavirin|ribavirin
497845|NCT01439763|Bullies|bullies
497846|NCT01439763|Bully victims|bully victims
497847|NCT01439763|Psychiatric symptoms|psychiatric symptoms
497848|NCT01439750|mantle cell lymphoma|mantle cell lymphoma
497849|NCT01439750|lymphoma|lymphoma
497850|NCT01439737|Asthma|asthma
497851|NCT01439737|metabolomics|metabolomics
497852|NCT01439737|exhaled breath condensate|exhaled breath condensate
497853|NCT01439724|Oral mucositis|oral mucositis
497854|NCT01439724|Low Level Laser Therapy|low level laser therapy
497855|NCT01439724|Head and neck cancer|head and neck cancer
497856|NCT01439711|ductal breast carcinoma in situ|ductal breast carcinoma in situ
497857|NCT01439711|estrogen receptor-positive breast cancer|estrogen receptor-positive breast cancer
497858|NCT01439698|Cholangiocarcinoma|cholangiocarcinoma
497859|NCT01439698|Pancreatic Cancer|pancreatic cancer
497860|NCT01439698|Bile Duct Cancer|bile duct cancer
497861|NCT01439698|Biliary Stricture|biliary stricture
497862|NCT01439698|Bile duct obstruction|bile duct obstruction
497863|NCT01439698|ENDOHPB|endohpb
497864|NCT01439698|Radio Frequency Ablation|radio frequency ablation
497865|NCT01439698|RFA|rfa
497866|NCT01439698|ERCP|ercp
497867|NCT01439698|Endoscopic Retrograde Cholangiopancreatography|endoscopic retrograde cholangiopancreatography
497868|NCT01439698|Registry|registry
497869|NCT01439698|Multicenter|multicenter
497870|NCT01439685|Cholangiocarcinoma|cholangiocarcinoma
497871|NCT01439685|PDT|pdt
497872|NCT01439685|Photodynamic Therapy|photodynamic therapy
497873|NCT01439685|Bile Duct|bile duct
497874|NCT01439685|Bile Duct Obstruction|bile duct obstruction
497875|NCT01439685|Jaundice|jaundice
497876|NCT01439685|Biliary Stent|biliary stent
497877|NCT01439685|ERCP|ercp
497878|NCT01439685|Obstructive Jaundice|obstructive jaundice
497879|NCT01439672|Type 1 Diabetes Mellitus|type 1 diabetes mellitus
497880|NCT01439659|Ovarian Cancer|ovarian cancer
497881|NCT01439659|Epithelial ovarian cancer|epithelial ovarian cancer
497882|NCT01439659|First clinical remission|first clinical remission
497883|NCT01439659|Nutritional Supplements|nutritional supplements
497884|NCT01439659|Juice Plus +|juice plus +
497885|NCT01439659|Juice Plus + Complete|juice plus + complete
497886|NCT01439659|Dietary counseling|dietary counseling
497887|NCT01439646|empirical|empirical
497888|NCT01439646|ICU|icu
497889|NCT01439646|high risk patient|high risk patient
497890|NCT01439633|Barrett's Esophagus|barrett's esophagus
497891|NCT01439633|Esophagus|esophagus
497892|NCT01439633|OCT|oct
497893|NCT01439633|Imaging|imaging
497894|NCT01439620|Biliary Stricture|biliary stricture
497895|NCT01439620|OCT|oct
497896|NCT01439620|Imaging|imaging
497897|NCT01439607|Gaucher disease|gaucher disease
497898|NCT01439594|Barrett's Esophagus|barrett's esophagus
497899|NCT01439594|Esophagus|esophagus
497900|NCT01439594|OCT|oct
497901|NCT01439594|Imaging|imaging
497902|NCT01439594|Radiofrequency Ablation|radiofrequency ablation
497903|NCT01439594|BARRX|barrx
497904|NCT01439581|patients|patients
497905|NCT01439581|susceptible to|susceptible to
497906|NCT01439581|hospital|hospital
497907|NCT01439581|acquired pressure|acquired pressure
497908|NCT01439568|Cancer|cancer
497909|NCT01439568|Lung|lung
497910|NCT01439568|Metastasis|metastasis
497911|NCT01439555|Early Alzheimer|early alzheimer
497912|NCT01439555|Mild Cognitive Impairment|mild cognitive impairment
497913|NCT01439555|Drug treatment|drug treatment
497914|NCT01439555|Cerebral blood flow|cerebral blood flow
497915|NCT01439555|Endothelial facilitation|endothelial facilitation
497916|NCT01439555|Cognitive improvement|cognitive improvement
497917|NCT01439542|High risk prostate cancer|high risk prostate cancer
497918|NCT01439529|Cardiac|cardiac
497919|NCT01439529|Resynchronization|resynchronization
497920|NCT01439529|Therapy|therapy
497921|NCT01439477|exercise|exercise
497922|NCT01439477|healthy eating|healthy eating
497923|NCT01439477|heart disease|heart disease
497924|NCT01439477|prevention & control|prevention & control
497925|NCT01439477|Middle aged|middle aged
497926|NCT01439477|Women|women
497927|NCT01439477|Health promotion|health promotion
497928|NCT01439451|Balance control|balance control
497929|NCT01439451|Aging|aging
497930|NCT01439451|Balance reactions|balance reactions
497931|NCT01439451|Perturbation|perturbation
497932|NCT01439451|above seventy years old|above seventy years old
497933|NCT01439425|psoriasis|psoriasis
497934|NCT01439425|obesity|obesity
497935|NCT01439425|body mass index|body mass index
497936|NCT01439425|disease remission|disease remission
497937|NCT01439425|diet|diet
497938|NCT01439412|Low back pain|low back pain
497939|NCT01439412|Acupuncture|acupuncture
497940|NCT01439412|General practice|general practice
497941|NCT01439399|postoperative pain|postoperative pain
497942|NCT01439399|postoperative care|postoperative care
497943|NCT01439399|intravenous lidocaine|intravenous lidocaine
497944|NCT01439399|intravenous ketamine|intravenous ketamine
497945|NCT01439399|morphine consumption|morphine consumption
497946|NCT01439373|chronic hepatitis C|chronic hepatitis c
497947|NCT01439373|NS5A inhibitor|ns5a inhibitor
497948|NCT01439373|ribavirin|ribavirin
497949|NCT01439373|pegylated interferon|pegylated interferon
497950|NCT01439373|GSK2336805|gsk2336805
497951|NCT01439360|Vaccine|vaccine
497952|NCT01439360|Seasonal Flu|seasonal flu
497953|NCT01439360|Efficacy|efficacy
497954|NCT01439360|Children|children
497955|NCT01439347|Marqibo|marqibo
497956|NCT01439347|HALLMARQ|hallmarq
497957|NCT01439347|leukemia|leukemia
497958|NCT01439347|front-line|front-line
497959|NCT01439347|ALL|all
497960|NCT01439347|acute lymphoblastic leukemia|acute lymphoblastic leukemia
497961|NCT01439334|Brief|brief
497962|NCT01439334|Online|online
497963|NCT01439334|Image|image
497964|NCT01439334|Interactive|interactive
497965|NCT01439334|Young Adult|young adult
497966|NCT01439334|Primary Care|primary care
497967|NCT01439321|treatment satisfaction|treatment satisfaction
497968|NCT01439321|romiplostim|romiplostim
497969|NCT01439321|eltrombopag|eltrombopag
497970|NCT01439321|chronic immune thrombocytopenic pupura|chronic immune thrombocytopenic pupura
497971|NCT01439308|NAR|nar
497972|NCT01439308|Capsaicin challenge|capsaicin challenge
497973|NCT01439295|Ascorbyl peroxide|ascorbyl peroxide
497974|NCT01439295|Bronchopulmonary dysplasia|bronchopulmonary dysplasia
497975|NCT01439295|Redox status|redox status
497976|NCT01439295|Necrotising entercolitis|necrotising entercolitis
497977|NCT01439295|Retinopathy of prematurity|retinopathy of prematurity
497978|NCT01439295|Patent ductus arteriosus|patent ductus arteriosus
497979|NCT01439295|Intraventricular hemorrhage|intraventricular hemorrhage
710750|NCT00588107|Partnership for Health|partnership for health
497980|NCT01439295|Periventricular leucomalacia|periventricular leucomalacia
497981|NCT01439282|Estrogen Receptor-Positive Early Stage Breast Cancer|estrogen receptor-positive early stage breast cancer
497982|NCT01439269|Separation stress|separation stress
497983|NCT01439269|Family Nurture|family nurture
497984|NCT01439269|Maternal Confidence|maternal confidence
497985|NCT01439269|Maternal Competence|maternal competence
497986|NCT01439269|Calming Cycle|calming cycle
497987|NCT01439269|Kangaroo Care|kangaroo care
497988|NCT01439269|Infant Neurodevelopment|infant neurodevelopment
497989|NCT01439269|Infant Psychological Development|infant psychological development
497990|NCT01439269|Post-partum depression|post-partum depression
497991|NCT01439269|Mother-infant Co-regulation|mother-infant co-regulation
497992|NCT01439243|Bioequivalence|bioequivalence
497993|NCT01439243|Healthy Subjects|healthy subjects
497994|NCT01439243|Donepezil|donepezil
497995|NCT01439230|Bioequivalence|bioequivalence
497996|NCT01439230|Healthy Subjects|healthy subjects
497997|NCT01439230|Donepezil|donepezil
497998|NCT01439217|Acute lymphoblastic leukemia|acute lymphoblastic leukemia
497999|NCT01439217|Survivor|survivor
498000|NCT01439217|Sibling control|sibling control
498001|NCT01439191|HER2-Overexpressed|her2-overexpressed
498002|NCT01439165|Adacel vaccine|adacel vaccine
498003|NCT01439165|Tetanus|tetanus
498004|NCT01439165|Diphtheria|diphtheria
498005|NCT01439165|whooping cough|whooping cough
498006|NCT01439152|Oncology|oncology
498007|NCT01439152|Solid tumors|solid tumors
498008|NCT01439152|Antibody drug conjugate (ADC)|antibody drug conjugate (adc)
498009|NCT01439152|Treatment Emergent Adverse Events|treatment emergent adverse events
498010|NCT01439152|Mesothelin|mesothelin
498011|NCT01439139|Osteoporosis|osteoporosis
498012|NCT01439139|ultrasound|ultrasound
498013|NCT01439139|sonometer|sonometer
498014|NCT01439139|DXA|dxa
498015|NCT01439126|Attention Deficit Hyperactivity Disorder|attention deficit hyperactivity disorder
498016|NCT01439113|Ultrasound, Difficult access|ultrasound, difficult access
498017|NCT01439100|Parkinson's disease|parkinson's disease
498018|NCT01439100|severe pain|severe pain
498019|NCT01439100|OXN PR|oxn pr
498020|NCT01439100|randomised|randomised
498021|NCT01439087|Colonic Polyps|colonic polyps
498022|NCT01439087|OCT|oct
498023|NCT01439087|Imaging|imaging
498024|NCT01439087|Colon|colon
498025|NCT01439087|Polyp|polyp
498026|NCT01439074|Burn injuries|burn injuries
498027|NCT01439074|Mepilex Ag|mepilex ag
498028|NCT01439074|SSD Ag|ssd ag
498029|NCT01439074|Partial thickness|partial thickness
498030|NCT01439061|Growth disorders|growth disorders
498031|NCT01439061|Saizen|saizen
498032|NCT01439061|Easypod|easypod
498033|NCT01439061|Growth hormone|growth hormone
498034|NCT01439061|Pediatric subject|pediatric subject
498035|NCT01439048|Placenta|placenta
498036|NCT01439048|Cord Blood|cord blood
498037|NCT01439048|PAH|pah
498038|NCT01439048|Environmental Markers|environmental markers
498039|NCT01439048|Toll-Like Receptors|toll-like receptors
498040|NCT01439035|Celiac Disease|celiac disease
498041|NCT01439035|Duodenal|duodenal
498042|NCT01439035|OCT|oct
498043|NCT01439035|Imaging|imaging
498044|NCT01439022|Parkinson's Disease|parkinson's disease
498045|NCT01439022|Exercise|exercise
498046|NCT01439022|Treatment Outcome|treatment outcome
498047|NCT01439022|Patient Adherence|patient adherence
498048|NCT01439009|Heart failure|heart failure
498049|NCT01439009|Volume overload|volume overload
498050|NCT01439009|Tolvaptan|tolvaptan
498051|NCT01439009|loop diuretics|loop diuretics
498052|NCT01438996|Typhoid fever|typhoid fever
498053|NCT01438996|Glycoconjugate vaccine|glycoconjugate vaccine
498054|NCT01438996|Vi polysaccharide|vi polysaccharide
498055|NCT01438996|Immunogenicity|immunogenicity
498056|NCT01438957|Dexmedetomidine|dexmedetomidine
498057|NCT01438957|Sedation|sedation
498058|NCT01438957|Non-intubation|non-intubation
498059|NCT01438957|epidural anesthesia|epidural anesthesia
498060|NCT01438957|spinal anesthesia|spinal anesthesia
498061|NCT01438944|NRT|nrt
498062|NCT01438944|Patch|patch
498063|NCT01438944|smoking|smoking
498064|NCT01438944|addiction|addiction
498065|NCT01438931|Dexmedetomidine|dexmedetomidine
498066|NCT01438931|Sedation|sedation
498067|NCT01438931|Non-intubation|non-intubation
498068|NCT01438931|local anesthesia|local anesthesia
498069|NCT01438918|Knee|knee
498070|NCT01438918|Osteoarthritis|osteoarthritis
498071|NCT01438918|X-ray|x-ray
498072|NCT01438918|Joint Space Narrowing|joint space narrowing
498073|NCT01438905|Ankle Sprain|ankle sprain
498074|NCT01438905|Chronic Ankle Instability|chronic ankle instability
498075|NCT01438905|Ankle Mobilization|ankle mobilization
498366|NCT01437748|Tiotropium|tiotropium
498076|NCT01438905|Talocrural Joint Mobilization|talocrural joint mobilization
498077|NCT01438905|Cortical Muscle Activation|cortical muscle activation
498078|NCT01438905|Spinal Muscle Activation|spinal muscle activation
498079|NCT01438892|rheumatoid arthritis|rheumatoid arthritis
498080|NCT01438892|therapy compliance|therapy compliance
498081|NCT01438879|CSF|csf
498082|NCT01438879|PCR|pcr
498083|NCT01438879|lymphocytic herpesvirus|lymphocytic herpesvirus
498084|NCT01438879|CNS|cns
498085|NCT01438866|Dental caries|dental caries
498086|NCT01438866|Fissure sealant|fissure sealant
498087|NCT01438866|Fluoride varnish|fluoride varnish
498088|NCT01438866|Primary molar|primary molar
498089|NCT01438853|Sepsis|sepsis
498090|NCT01438853|Acute Lung Injury|acute lung injury
498091|NCT01438853|Acute Respiratory Distress Syndrome|acute respiratory distress syndrome
498092|NCT01438853|ALI/ARDS|ali/ards
498093|NCT01438853|Lung Disease|lung disease
498094|NCT01438840|Chronic Immune Thrombocytopenia|chronic immune thrombocytopenia
498095|NCT01438788|Bethlem myopathy|bethlem myopathy
498096|NCT01438788|Ullrich congenital muscular dystrophy|ullrich congenital muscular dystrophy
498097|NCT01438788|Low protein diet|low protein diet
498098|NCT01438788|Autophagy|autophagy
498099|NCT01438788|Pilot clinical trial|pilot clinical trial
498100|NCT01438775|Benign prostatic hyperplasia|benign prostatic hyperplasia
498101|NCT01438775|BPH|bph
498102|NCT01438775|Enlarged prostate|enlarged prostate
498103|NCT01438775|Lower urinary tract symptoms|lower urinary tract symptoms
498104|NCT01438775|LUTS|luts
498105|NCT01438775|LUTS secondary to BPH|luts secondary to bph
498106|NCT01438775|LUTS/BPH|luts/bph
498107|NCT01438775|Benign prostatic obstruction|benign prostatic obstruction
498109|NCT01438775|Bladder outlet obstruction|bladder outlet obstruction
498110|NCT01438775|BOO|boo
498111|NCT01438762|Anterior Knee Pain|anterior knee pain
498112|NCT01438736|Focus:|focus:
498113|NCT01438736|preceding|preceding
498114|NCT01438736|desogestrel predicts|desogestrel predicts
498115|NCT01438736|pattern of following|pattern of following
498116|NCT01438736|etonogestrel implant|etonogestrel implant
498117|NCT01438723|ischemia reperfusion injury|ischemia reperfusion injury
498118|NCT01438723|CABG|cabg
498119|NCT01438723|metformin|metformin
498120|NCT01438723|Hs-troponin-I|hs-troponin-i
498121|NCT01438697|sleep|sleep
498122|NCT01438697|insomnia|insomnia
498123|NCT01438697|internet|internet
498124|NCT01438697|CBT|cbt
498125|NCT01438684|chronic vegetative state|chronic vegetative state
498126|NCT01438684|functional MRI|functional mri
498127|NCT01438671|WiiFit|wiifit
498128|NCT01438671|Standing Balance|standing balance
498129|NCT01438671|Neurological Population|neurological population
498130|NCT01438658|uveal melanoma|uveal melanoma
498131|NCT01438658|metastatic uveal melanoma|metastatic uveal melanoma
498132|NCT01438645|Colonoscopy|colonoscopy
498133|NCT01438645|Colon cancer screening|colon cancer screening
498134|NCT01438632|Insulin action|insulin action
498135|NCT01438632|Jet injector|jet injector
498136|NCT01438632|Diabetes Mellitus|diabetes mellitus
498137|NCT01438632|Pharmacodynamics|pharmacodynamics
498138|NCT01438632|Pharmacokinetics|pharmacokinetics
498139|NCT01438632|Insulin analogs|insulin analogs
498140|NCT01438632|Insulin aspart|insulin aspart
498141|NCT01438619|sodium|sodium
498142|NCT01438619|blood pressure|blood pressure
498143|NCT01438619|pulse wave velocity|pulse wave velocity
498144|NCT01438619|random digit dialling|random digit dialling
498145|NCT01438593|Stroke|stroke
498146|NCT01438593|Brain disease|brain disease
498147|NCT01438593|Ischemia|ischemia
498148|NCT01438593|Cerebral infraction|cerebral infraction
498149|NCT01438593|Cord Blood|cord blood
498150|NCT01438580|atrial ﬁbrillation|atrial ﬁbrillation
498151|NCT01438580|stroke|stroke
498152|NCT01438580|warfarin|warfarin
498153|NCT01438580|aspirin|aspirin
498154|NCT01438567|oxycodone naloxone combination|oxycodone naloxone combination
498155|NCT01438567|severe chronic and non-malignant pain|severe chronic and non-malignant pain
498156|NCT01438567|Malignant and non-malignant pain that requires around-the clock opioid therapy|malignant and non-malignant pain that requires around-the clock opioid therapy
498157|NCT01438567|Opioid related constipation|opioid related constipation
498158|NCT01438541|No skin breakdown|no skin breakdown
498159|NCT01438541|Prevention|prevention
498160|NCT01438541|protection of the skin|protection of the skin
498161|NCT01438528|Growth disorders|growth disorders
498162|NCT01438528|Saizen|saizen
498163|NCT01438528|Easypod|easypod
498164|NCT01438528|Growth hormone|growth hormone
498165|NCT01438528|Pediatric subject|pediatric subject
498166|NCT01438515|MRSA|mrsa
498167|NCT01438515|doxycycline|doxycycline
498168|NCT01438515|rifampin|rifampin
498169|NCT01438515|mupirocin|mupirocin
498170|NCT01438515|chlorhexidine gluconate|chlorhexidine gluconate
498171|NCT01438515|decolonization|decolonization
498172|NCT01438515|methicillin-resistant staphylococcus aureus|methicillin-resistant staphylococcus aureus
498173|NCT01438502|cardiac surgery|cardiac surgery
498174|NCT01438502|cardio-pulmonary-bypass|cardio-pulmonary-bypass
498175|NCT01438489|MEDI-546|medi-546
498176|NCT01438489|Anifrolumab|anifrolumab
498177|NCT01438489|Systemic Lupus Erythematosus|systemic lupus erythematosus
498178|NCT01438476|Liver Cancer|liver cancer
498179|NCT01438476|Pancreatic Cancer|pancreatic cancer
498180|NCT01438476|Thoracic epidural analgesia|thoracic epidural analgesia
498181|NCT01438476|TEA|tea
498182|NCT01438476|Intravenous patient-controlled analgesia|intravenous patient-controlled analgesia
498183|NCT01438476|IVPCA|ivpca
498184|NCT01438476|Pain control|pain control
498185|NCT01438476|Quality of life|quality of life
498186|NCT01438476|QOL|qol
498187|NCT01438476|Surgical resection|surgical resection
498188|NCT01438463|non-seasonal allergy|non-seasonal allergy
498189|NCT01438463|house dust mite|house dust mite
498190|NCT01438463|immunotherapy|immunotherapy
498191|NCT01438463|dose response|dose response
498192|NCT01438450|Thalidomide|thalidomide
498193|NCT01438450|Capecitabine|capecitabine
498194|NCT01438450|Advanced hepatocellular carcinoma|advanced hepatocellular carcinoma
498195|NCT01438450|Therapy|therapy
498196|NCT01438450|Supportive care|supportive care
498197|NCT01438437|Hepatocellular carcinoma|hepatocellular carcinoma
498198|NCT01438437|Radiofrequency ablation|radiofrequency ablation
498199|NCT01438437|Percutaneous acetic acid ablation|percutaneous acetic acid ablation
498200|NCT01438437|Tumour response|tumour response
498201|NCT01438411|Cholic Acid|cholic acid
498202|NCT01438411|Inborn Error|inborn error
498203|NCT01438411|Bile Acid Metabolism|bile acid metabolism
498204|NCT01438411|Inborn Error of Bile Acid Synthesis|inborn error of bile acid synthesis
498205|NCT01438398|Submucosal endoscopic myotomy|submucosal endoscopic myotomy
498206|NCT01438398|Per Oral Endoscopic Myotomy|per oral endoscopic myotomy
498207|NCT01438398|Natural Orifice Transluminal Endoscopic Surgery|natural orifice transluminal endoscopic surgery
498208|NCT01438385|Pancreatico-biliary|pancreatico-biliary
498209|NCT01438385|Biliary|biliary
498210|NCT01438385|Bile Duct|bile duct
498211|NCT01438385|Gastrointestinal disorder|gastrointestinal disorder
498212|NCT01438385|Esophageal disorder|esophageal disorder
498213|NCT01438372|Iron Deficiency Anemia|iron deficiency anemia
498214|NCT01438372|Inflammatory Bowel Disease|inflammatory bowel disease
498215|NCT01438372|Children|children
498216|NCT01438359|Drug-drug interaction|drug-drug interaction
498217|NCT01438359|Pharmacokinetics|pharmacokinetics
498218|NCT01438359|PA21|pa21
498219|NCT01438359|Drug Interaction Potentiation|drug interaction potentiation
498220|NCT01438346|Substance Abuse|substance abuse
498221|NCT01438346|Substance Addiction|substance addiction
498222|NCT01438346|Substance Dependence|substance dependence
498223|NCT01438346|Treatment program|treatment program
498224|NCT01438333|Chronic Peridodontitis|chronic peridodontitis
498225|NCT01438333|probiotics|probiotics
498226|NCT01438333|lactobacillus brevis|lactobacillus brevis
498227|NCT01438333|full mouth disinfection|full mouth disinfection
498228|NCT01438320|Treatment naive|treatment naive
498229|NCT01438320|Contraindications to standard therapies|contraindications to standard therapies
498230|NCT01438320|Alternative hepatitis C therapy|alternative hepatitis c therapy
498231|NCT01438307|Non-small cell lung cancer|non-small cell lung cancer
498232|NCT01438307|Cabazitaxel-XRP6258|cabazitaxel-xrp6258
498233|NCT01438307|P-glycoprotein|p-glycoprotein
498234|NCT01438307|taxane|taxane
498235|NCT01438307|Advanced NSCLC|advanced nsclc
498236|NCT01438294|Asthma|asthma
498237|NCT01438294|childhood|childhood
498238|NCT01438294|exercise|exercise
498239|NCT01438281|ocular pain|ocular pain
498240|NCT01438281|dry eye|dry eye
498241|NCT01438281|siRNA|sirna
498242|NCT01438242|Major|major
498243|NCT01438242|Depressive|depressive
498244|NCT01438242|Disorder|disorder
498245|NCT01438242|Depression|depression
498246|NCT01438242|Treatment Resistant|treatment resistant
498247|NCT01438229|Catheter-based renal artery ablation|catheter-based renal artery ablation
498248|NCT01438229|Hypertension|hypertension
498249|NCT01438229|Resistant to Conventional Therapy|resistant to conventional therapy
498250|NCT01438216|Pharmacokinetics|pharmacokinetics
498251|NCT01438216|Intensive Care|intensive care
498252|NCT01438216|Candidemia|candidemia
498253|NCT01438216|Invasive candidiasis|invasive candidiasis
498254|NCT01438216|Anidulafungin|anidulafungin
498255|NCT01438203|manipulation|manipulation
498256|NCT01438203|mobilization|mobilization
498257|NCT01438203|low back pain|low back pain
498258|NCT01438203|treatment|treatment
498259|NCT01438177|myeloma|myeloma
498260|NCT01438177|multiple myeloma|multiple myeloma
498261|NCT01438177|relapsed myeloma|relapsed myeloma
498262|NCT01438177|refractory myeloma|refractory myeloma
498263|NCT01438164|FDG-PET|fdg-pet
498264|NCT01438164|cancer|cancer
498265|NCT01438164|staging|staging
498266|NCT01438164|Evaluate the cost impact in the evaluation of oncologic patients.|evaluate the cost impact in the evaluation of oncologic patients.
498267|NCT01438151|Crohn's disease|crohn's disease
498268|NCT01438151|Remicade|remicade
498269|NCT01438151|infliximab|infliximab
498270|NCT01438138|childhood acute myeloid leukemia in remission|childhood acute myeloid leukemia in remission
498271|NCT01438138|recurrent childhood acute myeloid leukemia|recurrent childhood acute myeloid leukemia
498367|NCT01437748|Indacaterol|indacaterol
498368|NCT01437748|COPD|copd
498369|NCT01437735|Asthma|asthma
498272|NCT01438138|untreated childhood acute myeloid leukemia and other myeloid malignancies|untreated childhood acute myeloid leukemia and other myeloid malignancies
710751|NCT00588107|Cancer Survivors|cancer survivors
633881|NCT00892632|ERCP|ercp
498273|NCT01438138|childhood acute basophilic leukemia|childhood acute basophilic leukemia
498274|NCT01438138|childhood acute eosinophilic leukemia|childhood acute eosinophilic leukemia
498275|NCT01438138|childhood acute erythroleukemia (M6)|childhood acute erythroleukemia (m6)
498276|NCT01438138|childhood acute megakaryocytic leukemia (M7)|childhood acute megakaryocytic leukemia (m7)
498277|NCT01438138|childhood acute monoblastic leukemia (M5a)|childhood acute monoblastic leukemia (m5a)
498278|NCT01438138|childhood acute monocytic leukemia (M5b)|childhood acute monocytic leukemia (m5b)
498279|NCT01438138|childhood acute myeloblastic leukemia with maturation (M2)|childhood acute myeloblastic leukemia with maturation (m2)
498280|NCT01438138|childhood acute myeloblastic leukemia without maturation (M1)|childhood acute myeloblastic leukemia without maturation (m1)
498281|NCT01438138|childhood acute myelomonocytic leukemia (M4)|childhood acute myelomonocytic leukemia (m4)
498282|NCT01438138|childhood acute minimally differentiated myeloid leukemia (M0)|childhood acute minimally differentiated myeloid leukemia (m0)
498283|NCT01438112|cancer|cancer
498284|NCT01438112|bladder cancer|bladder cancer
498285|NCT01438112|transitional cell|transitional cell
498286|NCT01438112|virus|virus
498287|NCT01438112|oncolytic|oncolytic
498288|NCT01438112|GM-CSF|gm-csf
498289|NCT01438112|adenovirus|adenovirus
498290|NCT01438112|intravesical|intravesical
498291|NCT01438112|neoadjuvant|neoadjuvant
498292|NCT01438112|cystectomy|cystectomy
498293|NCT01438112|gene therapy|gene therapy
498294|NCT01438112|oncolytic virus|oncolytic virus
498295|NCT01438112|carcinoma in situ|carcinoma in situ
498296|NCT01438112|carcinoma in situ concurrent with papillary tumors|carcinoma in situ concurrent with papillary tumors
498297|NCT01438099|epidural analgesia|epidural analgesia
498298|NCT01438099|ultrasound|ultrasound
498299|NCT01438099|labor analgesia|labor analgesia
498300|NCT01438099|labor|labor
498301|NCT01438086|Heart Failure|heart failure
498302|NCT01438086|Myocardial Infarction|myocardial infarction
498303|NCT01438047|Port Wine Stain|port wine stain
498304|NCT01438021|unspecified adult solid tumor, protocol specific|unspecified adult solid tumor, protocol specific
498305|NCT01438008|Sucrose|sucrose
498306|NCT01438008|Pain|pain
498307|NCT01437995|Asthma|asthma
498308|NCT01437995|Step down therapy|step down therapy
498309|NCT01437995|Inhaled corticosteroids|inhaled corticosteroids
498310|NCT01437995|Long-acting beta agonists|long-acting beta agonists
498311|NCT01437995|Fluticasone Salmeterol|fluticasone salmeterol
498312|NCT01437982|post-operative inflammation|post-operative inflammation
498313|NCT01437982|conjunctivitis|conjunctivitis
498314|NCT01437982|safety|safety
498315|NCT01437982|Seasonal allergic conjunctivitis|seasonal allergic conjunctivitis
498316|NCT01437982|Giant papillary conjunctivitis|giant papillary conjunctivitis
498317|NCT01437969|Possible association|possible association
498318|NCT01437969|between severity|between severity
498319|NCT01437969|IL28B genetic variants|il28b genetic variants
498320|NCT01437969|patients|patients
498321|NCT01437969|different HCV genotypes|different hcv genotypes
498322|NCT01437956|Calcineurin|calcineurin
498323|NCT01437956|Bronchiolitis|bronchiolitis
498324|NCT01437956|Epithelial lung injury|epithelial lung injury
498325|NCT01437956|Rhinovirus|rhinovirus
498326|NCT01437956|Respiratory Syncytial Virus|respiratory syncytial virus
498327|NCT01437956|Asthma|asthma
498328|NCT01437943|Transplant|transplant
498329|NCT01437943|Failure|failure
498330|NCT01437943|Kidney|kidney
498331|NCT01437930|n-3 LC-PUFA|n-3 lc-pufa
498332|NCT01437930|hypertriglyceridemic|hypertriglyceridemic
498333|NCT01437930|human|human
498335|NCT01437917|glycemic index|glycemic index
498336|NCT01437904|Renal Calculi|renal calculi
498337|NCT01437904|Percutaneous nephrolithotomy (PCNL)|percutaneous nephrolithotomy (pcnl)
498338|NCT01437891|PTSD|ptsd
498339|NCT01437891|Military veteran|military veteran
498340|NCT01437891|Gulf War|gulf war
498341|NCT01437891|Fibromyalgia|fibromyalgia
498342|NCT01437891|Gulf War Syndrome|gulf war syndrome
498343|NCT01437878|PH|ph
498344|NCT01437878|COPD|copd
498345|NCT01437865|MRI|mri
498346|NCT01437865|lymph node metastases|lymph node metastases
498347|NCT01437865|breast cancer|breast cancer
498348|NCT01437865|gadofosveset|gadofosveset
498349|NCT01437839|Food effect study|food effect study
498350|NCT01437839|Pharmacokinetics|pharmacokinetics
498351|NCT01437839|Apixaban|apixaban
498352|NCT01437826|chemoprevention|chemoprevention
498353|NCT01437826|colorectal cancer|colorectal cancer
498354|NCT01437826|metachronous adenoma|metachronous adenoma
498355|NCT01437826|randomized trial|randomized trial
498356|NCT01437813|DM2|dm2
498357|NCT01437813|glimepiride|glimepiride
498358|NCT01437813|metformin extended release|metformin extended release
498359|NCT01437800|DM2|dm2
498360|NCT01437800|glimepiride|glimepiride
498361|NCT01437800|metformin extended release|metformin extended release
498362|NCT01437774|Acute ischemic stroke|acute ischemic stroke
498363|NCT01437748|Small Airways|small airways
498364|NCT01437748|Closing volume|closing volume
498365|NCT01437748|Closing Capacity|closing capacity
498370|NCT01437735|QAW039|qaw039
498371|NCT01437722|BV|bv
498372|NCT01437722|Bacterial vaginosis|bacterial vaginosis
498373|NCT01437722|recurrent|recurrent
498374|NCT01437722|SPL7013 Gel|spl7013 gel
498375|NCT01437722|VivaGel|vivagel
498376|NCT01437709|Bendamustine HCL|bendamustine hcl
498377|NCT01437709|Ofatumumab (GSK 1841157)|ofatumumab (gsk 1841157)
498378|NCT01437709|Immunotherapy|immunotherapy
498379|NCT01437709|Chemoimmunotherapy|chemoimmunotherapy
498380|NCT01437709|11-050|11-050
498381|NCT01437696|Aging|aging
498382|NCT01437696|Vitamin D|vitamin d
498383|NCT01437696|Bone health|bone health
498384|NCT01437696|Inflammation|inflammation
498385|NCT01437696|Men|men
498386|NCT01437683|Craniocerebral Trauma|craniocerebral trauma
498387|NCT01437683|Quality of life|quality of life
498388|NCT01437683|Long term outcome|long term outcome
498389|NCT01437683|Activities of Daily Living|activities of daily living
498390|NCT01437683|Cognitive Deficiency|cognitive deficiency
498391|NCT01437683|Health Care Quality, Access, and Evaluation|health care quality, access, and evaluation
498392|NCT01437644|Cerebral Palsy|cerebral palsy
498393|NCT01437644|Hip displacement|hip displacement
498394|NCT01437644|Hip surgery|hip surgery
498395|NCT01437644|Post-operative pain|post-operative pain
498396|NCT01437644|Botulinum Toxin|botulinum toxin
498397|NCT01437631|colon polyp|colon polyp
498398|NCT01437631|endoscopic polypectomy|endoscopic polypectomy
498399|NCT01437631|postpolypectomy bleeding|postpolypectomy bleeding
498400|NCT01437631|prophylactic clip application|prophylactic clip application
498401|NCT01437605|Resected|resected
498402|NCT01437605|Skin|skin
498403|NCT01437605|Stage IV|stage iv
498404|NCT01437579|interstitial cystitis|interstitial cystitis
498405|NCT01437579|bladder pain syndrome|bladder pain syndrome
498406|NCT01437579|intratrigonal injection|intratrigonal injection
498407|NCT01437579|botulinum toxin|botulinum toxin
498408|NCT01437553|IVUS|ivus
498409|NCT01437553|iMAP|imap
498410|NCT01437553|Catheterization|catheterization
498411|NCT01437553|Acute Coronary Syndrome|acute coronary syndrome
498412|NCT01437540|COPD|copd
498413|NCT01437540|Chronic Obstructive Pulmonary Disease|chronic obstructive pulmonary disease
498414|NCT01437540|Chronic Bronchitis|chronic bronchitis
498415|NCT01437540|Emphysema|emphysema
498416|NCT01437540|Airflow Obstruction, Chronic|airflow obstruction, chronic
498417|NCT01437540|Chronic Airflow Obstruction|chronic airflow obstruction
498418|NCT01437540|Chronic Obstructive Airway Disease|chronic obstructive airway disease
498419|NCT01437540|Chronic Obstructive Lung Disease|chronic obstructive lung disease
498420|NCT01437527|anorexia nervosa|anorexia nervosa
498421|NCT01437527|CMME-TCA Unit|cmme-tca unit
498422|NCT01437527|Centre Hospitalier Sainte Anne|centre hospitalier sainte anne
498423|NCT01437514|rectal cancer|rectal cancer
498424|NCT01437514|Endosonography|endosonography
498425|NCT01437514|preoperative short-course radiotherapy|preoperative short-course radiotherapy
498426|NCT01437514|preoperative adjuvant therapy|preoperative adjuvant therapy
498427|NCT01437514|neoadjuvant therapy|neoadjuvant therapy
498428|NCT01437514|short-term high-dose preoperative radiotherapy|short-term high-dose preoperative radiotherapy
498429|NCT01437514|total mesorectal excision|total mesorectal excision
498430|NCT01437514|circumferential resection margin|circumferential resection margin
498431|NCT01437514|local recurrence|local recurrence
498432|NCT01437514|overall survival|overall survival
498433|NCT01437514|metastasis|metastasis
498434|NCT01437514|complication|complication
498435|NCT01437501|glucoraphanin|glucoraphanin
498436|NCT01437501|sulforaphane|sulforaphane
498437|NCT01437501|pharmacokinetics|pharmacokinetics
498438|NCT01437501|pharmacodynamics|pharmacodynamics
498439|NCT01437501|broccoli sprout|broccoli sprout
498440|NCT01437501|carcinogens, environment|carcinogens, environment
498441|NCT01437488|Urothelial carcinoma|urothelial carcinoma
498442|NCT01437488|Urothelial cancer|urothelial cancer
498443|NCT01437475|HBV|hbv
498444|NCT01437475|HIV|hiv
498445|NCT01437475|Immunization|immunization
498446|NCT01437475|HBV Immunization rate among HIV positive individuals|hbv immunization rate among hiv positive individuals
498447|NCT01437462|Pain, Postoperative|pain, postoperative
498448|NCT01437462|Anesthetics, intravenous|anesthetics, intravenous
498449|NCT01437462|Anesthetics, inhalation|anesthetics, inhalation
498450|NCT01437462|Otherwise healthy adults undergoing general anesthesia for gynecological disease.|otherwise healthy adults undergoing general anesthesia for gynecological disease.
498451|NCT01437449|Quality of Life|quality of life
498452|NCT01437436|otitis media|otitis media
498453|NCT01437436|obesity|obesity
498454|NCT01437436|ventilation tube|ventilation tube
498455|NCT01437423|Diphtheria|diphtheria
498456|NCT01437423|Tetanus|tetanus
498457|NCT01437423|Pertussis|pertussis
498458|NCT01437423|Poliomyelitis|poliomyelitis
498459|NCT01437423|TETRAXIM™|tetraxim™
498460|NCT01437397|COPD|copd
498461|NCT01437397|Chronic Obstructive Pulmonary Disease|chronic obstructive pulmonary disease
498462|NCT01437397|Chronic Bronchitis|chronic bronchitis
498463|NCT01437397|Emphysema|emphysema
498464|NCT01437397|Airflow Obstruction, Chronic|airflow obstruction, chronic
498465|NCT01437397|Chronic Airflow Obstruction|chronic airflow obstruction
498466|NCT01437397|Chronic Obstructive Airway Disease|chronic obstructive airway disease
498467|NCT01437397|Chronic Obstructive Lung Disease|chronic obstructive lung disease
498468|NCT01437371|Heart failure|heart failure
498469|NCT01437371|Aged and over 80|aged and over 80
498470|NCT01437371|clinical trial|clinical trial
498471|NCT01437371|quality of life|quality of life
498472|NCT01437358|Epidural catheter|epidural catheter
498473|NCT01437358|Epidural analgesia|epidural analgesia
498474|NCT01437358|Intensive care unit|intensive care unit
498475|NCT01437358|Safety|safety
498476|NCT01437306|lofexidine|lofexidine
498477|NCT01437306|food effect|food effect
498478|NCT01437306|pharmacokinetics|pharmacokinetics
498479|NCT01437306|healthy volunteer|healthy volunteer
498480|NCT01437293|cocaine|cocaine
498481|NCT01437280|Tumors|tumors
498482|NCT01437280|Solid Tumors|solid tumors
498483|NCT01437254|99mTc Pertechnetate|99mtc pertechnetate
498484|NCT01437254|thyroidectomy|thyroidectomy
498485|NCT01437241|HIV-infection|hiv-infection
498486|NCT01437241|Etravirine|etravirine
498487|NCT01437241|Treatment|treatment
498488|NCT01437241|Non-nucleoside reverse-transcriptase inhibitor|non-nucleoside reverse-transcriptase inhibitor
498489|NCT01437215|aneurysm|aneurysm
498490|NCT01437215|renal stent|renal stent
498491|NCT01437215|juxtarenal|juxtarenal
498492|NCT01437215|pararenal|pararenal
498493|NCT01437202|imatinib|imatinib
498494|NCT01437202|drug resistance|drug resistance
498495|NCT01437202|pharmacogenetics|pharmacogenetics
498496|NCT01437189|Parkinson's disease|parkinson's disease
498497|NCT01437189|depression|depression
498498|NCT01437189|sertraline|sertraline
498499|NCT01437189|intervention|intervention
498500|NCT01437176|surgery|surgery
498501|NCT01437176|fixation|fixation
498502|NCT01437176|intramedullary nail|intramedullary nail
498503|NCT01437150|surgery|surgery
498504|NCT01437150|fixation|fixation
498505|NCT01437150|bone plate|bone plate
498506|NCT01437137|elective surgery of short duration (less than 2 hr) undergoing general anesthesia using supraglottic airway|elective surgery of short duration (less than 2 hr) undergoing general anesthesia using supraglottic airway
498507|NCT01437111|Osteoporosis|osteoporosis
498508|NCT01437111|Postmenopausal|postmenopausal
498509|NCT01437098|Valvular Heart Disease|valvular heart disease
498510|NCT01437098|Severe Aortic Stenosis|severe aortic stenosis
498511|NCT01437098|Aortic Valve Replacement|aortic valve replacement
498512|NCT01437085|Needle deflection|needle deflection
498513|NCT01437085|Prostate Deformation|prostate deformation
498514|NCT01437085|Prostate Brachytherapy|prostate brachytherapy
498515|NCT01437085|Needles|needles
498516|NCT01437046|Alcohol drinking|alcohol drinking
498517|NCT01437046|Alcohol craving|alcohol craving
498518|NCT01437033|Breath Tests|breath tests
498519|NCT01437033|Human Volunteers|human volunteers
498520|NCT01437033|Pilot Study|pilot study
498521|NCT01437033|Breath Test|breath test
498522|NCT01437020|IL-10|il-10
498523|NCT01437020|Leishmaniasis|leishmaniasis
498524|NCT01437020|Immunotherapy|immunotherapy
498525|NCT01437007|SNALP|snalp
498526|NCT01437007|Regional Therapy|regional therapy
498527|NCT01437007|Stage IV Disease|stage iv disease
498528|NCT01437007|Adenocarcinoma|adenocarcinoma
498529|NCT01437007|Unresectable|unresectable
498530|NCT01437007|Liver Metastases|liver metastases
498531|NCT01437007|Colorectal Cancer|colorectal cancer
498532|NCT01437007|Stomach Cancer|stomach cancer
498533|NCT01437007|Gastric Cancer|gastric cancer
498534|NCT01437007|Breast Cancer|breast cancer
498535|NCT01437007|Ovarian Cancer|ovarian cancer
498536|NCT01437007|Pancreatic Cancer|pancreatic cancer
498537|NCT01437007|Liver Cancer|liver cancer
498538|NCT01436994|thyrotoxic|thyrotoxic
498539|NCT01436994|thyrotoxicosis|thyrotoxicosis
498540|NCT01436994|paediatric|paediatric
498541|NCT01436994|endocrinology|endocrinology
498542|NCT01436994|block and replace|block and replace
498543|NCT01436994|dose titration|dose titration
498544|NCT01436994|carbimazole|carbimazole
498545|NCT01436981|papaverine|papaverine
498546|NCT01436981|pharmacokinetic|pharmacokinetic
498547|NCT01436981|CABG|cabg
498548|NCT01436981|Injury of Internal Mammary Artery|injury of internal mammary artery
498549|NCT01436981|Complications Due to Coronary Artery Bypass Graft|complications due to coronary artery bypass graft
498550|NCT01436968|immunotherapy, cytotoxicity, tumor vaccine, prostate cancer, radiotherapy|immunotherapy, cytotoxicity, tumor vaccine, prostate cancer, radiotherapy
498551|NCT01436929|silymarin|silymarin
498552|NCT01436929|hepatotoxicity|hepatotoxicity
498553|NCT01436929|tuberculosis|tuberculosis
498554|NCT01436929|HREZ|hrez
498555|NCT01436916|prediabetes|prediabetes
498556|NCT01436916|oral cholecalciferol|oral cholecalciferol
498557|NCT01436903|menorrhagia|menorrhagia
498558|NCT01436903|dysfunctional uterine bleeding|dysfunctional uterine bleeding
498559|NCT01436903|endometrial ablation|endometrial ablation
498560|NCT01436903|cavatermTM|cavatermtm
498561|NCT01436903|probe|probe
498562|NCT01436890|Chronic Persistent Asthma|chronic persistent asthma
710752|NCT00588094|Lymphoma|lymphoma
498564|NCT01436877|bladder neck obstruction|bladder neck obstruction
498668|NCT01436435|atherectomy|atherectomy
498565|NCT01436877|Bladder neck obstruction secondary to BPH|bladder neck obstruction secondary to bph
498566|NCT01436864|Recombinant Human VEGF Receptor-Fc Fusion Protein (KH902|recombinant human vegf receptor-fc fusion protein (kh902
498568|NCT01436864|age-related macular degeneration (AMD)|age-related macular degeneration (amd)
498569|NCT01436864|choroidal neovascularization (CNV)|choroidal neovascularization (cnv)
498570|NCT01436864|intravitreal injection|intravitreal injection
498571|NCT01436864|best corrected visual acuity (BCVA)|best corrected visual acuity (bcva)
498572|NCT01436864|central retinal thickness|central retinal thickness
498573|NCT01436851|rhinitis|rhinitis
498574|NCT01436851|allergy|allergy
498575|NCT01436851|occupational|occupational
498576|NCT01436851|storage mites|storage mites
498577|NCT01436851|nasal lavage|nasal lavage
498578|NCT01436851|challenge test|challenge test
498579|NCT01436851|ECP|ecp
498580|NCT01436851|alfa2Macroglobuline|alfa2macroglobuline
498581|NCT01436838|Relapsing-Remitting Multiple Sclerosis|relapsing-remitting multiple sclerosis
498582|NCT01436838|Secondary Progressive Multiple Sclerosis|secondary progressive multiple sclerosis
498583|NCT01436825|Haemophilia A|haemophilia a
498584|NCT01436825|Factor VIII|factor viii
498585|NCT01436825|Pharmacokinetic|pharmacokinetic
498586|NCT01436825|Computer Tool validation|computer tool validation
498587|NCT01436812|cerebral oxymetry|cerebral oxymetry
498588|NCT01436812|laparoscopy|laparoscopy
498589|NCT01436812|PEEP|peep
498590|NCT01436799|propofol|propofol
498591|NCT01436799|desflurane|desflurane
498592|NCT01436799|cerebrovascular circulation|cerebrovascular circulation
498593|NCT01436799|sitting|sitting
498594|NCT01436786|cytokines|cytokines
498595|NCT01436786|Guided imagery|guided imagery
498596|NCT01436760|IBS|ibs
498597|NCT01436747|Kidney transplantation|kidney transplantation
498598|NCT01436747|Proteinuria|proteinuria
498599|NCT01436747|Albuminuria|albuminuria
498600|NCT01436747|Vitamin D|vitamin d
498601|NCT01436747|Paricalcitol|paricalcitol
498602|NCT01436721|Effectiveness|effectiveness
498603|NCT01436721|Device success|device success
498604|NCT01436721|Hepatectomy|hepatectomy
498605|NCT01436708|pelvic organ prolapse|pelvic organ prolapse
498606|NCT01436708|urinary symptoms|urinary symptoms
498607|NCT01436708|sexual function|sexual function
498608|NCT01436695|seizure early detection|seizure early detection
498609|NCT01436682|Nerve Blocks|nerve blocks
498610|NCT01436656|BRAF mutant,|braf mutant,
498611|NCT01436656|BRAF mutated,|braf mutated,
498612|NCT01436656|melanoma,|melanoma,
498613|NCT01436656|metastatic,|metastatic,
498614|NCT01436656|advanced,|advanced,
498615|NCT01436656|RAF kinase inhibitor|raf kinase inhibitor
498616|NCT01436656|BRAF V600 mutation|braf v600 mutation
498617|NCT01436643|Depression|depression
498618|NCT01436643|Multiple Sclerosis|multiple sclerosis
498619|NCT01436643|Fingolimod|fingolimod
498620|NCT01436643|Venlafaxine|venlafaxine
498621|NCT01436643|Fluoxetine|fluoxetine
498622|NCT01436630|Exercise Tolerance|exercise tolerance
498623|NCT01436630|Step Test|step test
498624|NCT01436630|Stroke|stroke
498625|NCT01436630|Walking|walking
498626|NCT01436617|cancer|cancer
498627|NCT01436617|colon|colon
498628|NCT01436617|Head and neck|head and neck
498629|NCT01436617|cetuximab|cetuximab
498630|NCT01436617|anti-cetuximab dosage|anti-cetuximab dosage
498631|NCT01436604|cardiac MRI|cardiac mri
498632|NCT01436604|Cancer|cancer
498633|NCT01436604|Breast|breast
498634|NCT01436604|Herceptin|herceptin
498635|NCT01436604|LV dysfunction|lv dysfunction
498636|NCT01436591|Cancer|cancer
498637|NCT01436591|Breast|breast
498638|NCT01436591|18FDG|18fdg
498639|NCT01436591|Axillary|axillary
498640|NCT01436591|Positron Emission Tomography|positron emission tomography
498641|NCT01436552|MCI|mci
498642|NCT01436552|Depression|depression
498643|NCT01436552|Alzheimer|alzheimer
498644|NCT01436552|Life events|life events
498645|NCT01436526|Bioequivalence|bioequivalence
498646|NCT01436513|bioequivalence|bioequivalence
498647|NCT01436513|menometrorrhagia|menometrorrhagia
498648|NCT01436513|climacteric disturbance|climacteric disturbance
498649|NCT01436513|Estrogen Replacement Therapy|estrogen replacement therapy
498650|NCT01436513|Estrogens Conjugated|estrogens conjugated
498651|NCT01436500|Hepatorenal Syndrome|hepatorenal syndrome
498652|NCT01436500|HRS|hrs
498653|NCT01436500|ifetroban|ifetroban
498654|NCT01436487|ischemic stroke|ischemic stroke
498655|NCT01436487|adult stem cells|adult stem cells
498656|NCT01436474|Varenicline|varenicline
498657|NCT01436474|Chantix|chantix
498658|NCT01436474|Chronic Pain|chronic pain
498659|NCT01436474|Opioid dependence|opioid dependence
498660|NCT01436448|efficacy|efficacy
498661|NCT01436448|Lactobacillus Rhamnosus|lactobacillus rhamnosus
498662|NCT01436448|glucose intolerance|glucose intolerance
498663|NCT01436448|feasibility|feasibility
498664|NCT01436448|compliance and safety|compliance and safety
498665|NCT01436448|reducing glucose intolerance during and after pregnancy|reducing glucose intolerance during and after pregnancy
498666|NCT01436435|PAD|pad
498667|NCT01436435|peripheral artery disease|peripheral artery disease
498669|NCT01436422|Dengue Virus|dengue virus
498670|NCT01436422|Dengue Fever|dengue fever
498671|NCT01436422|Dengue Vaccine|dengue vaccine
498672|NCT01436422|Dengue Hemorrhagic Fever|dengue hemorrhagic fever
498673|NCT01436422|Dengue Shock Syndrome|dengue shock syndrome
498674|NCT01436409|vaginal touch|vaginal touch
498675|NCT01436409|deliveries assisted|deliveries assisted
498676|NCT01436409|echography|echography
498677|NCT01436409|assisted delivery|assisted delivery
498678|NCT01436396|Dengue|dengue
498679|NCT01436396|Dengue Hemorrhagic Fever|dengue hemorrhagic fever
498680|NCT01436396|CYD Dengue Vaccines|cyd dengue vaccines
498681|NCT01436396|Yellow Fever|yellow fever
498682|NCT01436396|Stamaril®|stamaril®
498683|NCT01436396|Flavivirus Infections|flavivirus infections
498684|NCT01436383|high altitude|high altitude
498685|NCT01436383|hypobaric hypoxia|hypobaric hypoxia
498686|NCT01436383|metabolomics|metabolomics
498687|NCT01436383|oxidative stress|oxidative stress
498688|NCT01436383|acute mountain sickness|acute mountain sickness
498689|NCT01436370|influenza, rheumatoid arthritis, TNF-alpha-inhibitor, Fluzone®, Fluzone® High Dose|influenza, rheumatoid arthritis, tnf-alpha-inhibitor, fluzone®, fluzone® high dose
498690|NCT01436357|AdCh3NSmut1|adch3nsmut1
498691|NCT01436357|Hepatitis C|hepatitis c
498692|NCT01436357|MVA-NSmut|mva-nsmut
498693|NCT01436357|vaccine|vaccine
498694|NCT01436344|esophageal electrocardiography|esophageal electrocardiography
498695|NCT01436344|electrocardiography|electrocardiography
498696|NCT01436344|atrial electrogram|atrial electrogram
498697|NCT01436344|atrial function, left|atrial function, left
498698|NCT01436331|First episode psychosis|first episode psychosis
498699|NCT01436331|Early Psychosis|early psychosis
498700|NCT01436331|Cognitive Behavioural therapy|cognitive behavioural therapy
498701|NCT01436331|Psychosocial Intervention|psychosocial intervention
498702|NCT01436331|Assertive Community treatment|assertive community treatment
498703|NCT01436331|Family Intervention|family intervention
498704|NCT01436331|Mental Disorders|mental disorders
498705|NCT01436331|Psychotic Disorders|psychotic disorders
498706|NCT01436331|Schizophrenia and Disorders with Psychotic Features|schizophrenia and disorders with psychotic features
498707|NCT01436331|Affective Disorders, Psychotic|affective disorders, psychotic
498708|NCT01436318|Healthy Kids|healthy kids
498709|NCT01436318|Respiratory|respiratory
498710|NCT01436318|Volunteers|volunteers
498711|NCT01436305|immunosuppressive (IS) regimens|immunosuppressive (is) regimens
498712|NCT01436305|long-term graft function|long-term graft function
498713|NCT01436305|CNI (calcineurin Inhibitor )-free IS regimen|cni (calcineurin inhibitor )-free is regimen
498714|NCT01436305|CNI (calcineurin Inhibitor ) IS regimen|cni (calcineurin inhibitor ) is regimen
498715|NCT01436305|corticosteroids|corticosteroids
498716|NCT01436292|Hypoalbuminemia|hypoalbuminemia
498717|NCT01436292|Burns|burns
498718|NCT01436292|Albumin|albumin
498719|NCT01436292|Organ dysfunction|organ dysfunction
498720|NCT01436292|Outcome|outcome
498721|NCT01436240|Patient-Reported Outcomes|patient-reported outcomes
498722|NCT01436240|Common Terminology Criteria for Adverse Events|common terminology criteria for adverse events
498723|NCT01436240|PRO-CTCAE|pro-ctcae
498724|NCT01436240|Native Spanish Speaking|native spanish speaking
498725|NCT01436240|Spanish Translation|spanish translation
498726|NCT01436240|Cognitive Interview|cognitive interview
498727|NCT01436240|Questionnaire|questionnaire
498728|NCT01436240|11-133|11-133
498729|NCT01436240|Adverse Events|adverse events
498730|NCT01436240|chemotherapy|chemotherapy
498731|NCT01436240|radiation therapy|radiation therapy
498732|NCT01436240|treatment in previous 6 months|treatment in previous 6 months
498733|NCT01436227|Von Hippel-Lindau Syndrome|von hippel-lindau syndrome
498734|NCT01436227|VHL|vhl
498735|NCT01436227|Von Hippel-Lindau related lesion|von hippel-lindau related lesion
498736|NCT01436227|Pazopanib|pazopanib
498737|NCT01436227|GW786034|gw786034
498738|NCT01436188|Biological Markers|biological markers
498739|NCT01436188|Healthy Volunteer|healthy volunteer
498740|NCT01436188|Alzheimer's Disease (AD)|alzheimer's disease (ad)
498741|NCT01436188|Mild Cognitive Impairment (MCI)|mild cognitive impairment (mci)
498742|NCT01436188|Cerebrospinal fluid (CSF)|cerebrospinal fluid (csf)
498743|NCT01436188|CSF proteins|csf proteins
498744|NCT01436136|Cardiovascular disease|cardiovascular disease
498745|NCT01436136|HIV|hiv
498746|NCT01436136|Antiretroviral treatment|antiretroviral treatment
498747|NCT01436136|team interventions|team interventions
498748|NCT01436136|Framingham risk score|framingham risk score
498749|NCT01436123|Plasmonic Photothermal Therapy|plasmonic photothermal therapy
498750|NCT01436123|Nanoparticles|nanoparticles
498751|NCT01436123|Stem cells|stem cells
498752|NCT01436123|Atherosclerosis|atherosclerosis
498753|NCT01436123|Bioengineering|bioengineering
498754|NCT01436123|Biodegradable stenting|biodegradable stenting
498755|NCT01436123|Repair disease|repair disease
498756|NCT01436097|Healthy Eating|healthy eating
498757|NCT01436097|Health Behavior|health behavior
498758|NCT01436097|Incentive|incentive
498759|NCT01436097|Work-site|work-site
498760|NCT01436084|Leukemia|leukemia
634491|NCT00890656|ALL|all
498761|NCT01436084|Myelodysplastic syndrome|myelodysplastic syndrome
498762|NCT01436084|MDS|mds
498763|NCT01436084|SB1518|sb1518
498764|NCT01436058|side effect|side effect
498765|NCT01436058|mesenchymal stem cell|mesenchymal stem cell
498766|NCT01436058|ankle|ankle
498767|NCT01436058|osteoarthritis|osteoarthritis
498768|NCT01436045|Memory|memory
498769|NCT01436045|Insulin glulisine|insulin glulisine
498770|NCT01436045|Alzheimer's Disease|alzheimer's disease
498771|NCT01436019|Juvenile idiopathic arthritis|juvenile idiopathic arthritis
498772|NCT01436019|Rheumatic diseases|rheumatic diseases
498773|NCT01436019|Antibodies|antibodies
498774|NCT01436019|Biological therapy|biological therapy
498775|NCT01436006|MDCT|mdct
498776|NCT01436006|radiation|radiation
498777|NCT01436006|dose|dose
498778|NCT01435993|Multiple Sclerosis, Secondary-Progressive with relapses|multiple sclerosis, secondary-progressive with relapses
498779|NCT01435980|type 2 diabetes|type 2 diabetes
498780|NCT01435980|Gastric Bypass|gastric bypass
498781|NCT01435980|GLP-1|glp-1
498782|NCT01435980|adiponectin|adiponectin
498783|NCT01435967|Rotarix™|rotarix™
498784|NCT01435967|Observational|observational
498785|NCT01435967|ecological|ecological
498786|NCT01435954|benign prostatic hyperplasia|benign prostatic hyperplasia
498787|NCT01435954|surgery|surgery
498788|NCT01435954|5-alpha-reductase inhibitor|5-alpha-reductase inhibitor
498789|NCT01435954|enlarged prostate|enlarged prostate
498790|NCT01435954|acute urinary retention|acute urinary retention
498791|NCT01435941|mailed survey|mailed survey
498792|NCT01435941|non-steroidal anti-inflammatory drug|non-steroidal anti-inflammatory drug
498793|NCT01435941|migraine disorders|migraine disorders
498794|NCT01435941|headache|headache
498795|NCT01435928|Schizophrenia|schizophrenia
498796|NCT01435928|Lurasidone|lurasidone
498797|NCT01435928|Latuda|latuda
498798|NCT01435902|exercise-induced bronchospasm|exercise-induced bronchospasm
498799|NCT01435902|Activity/Exercise induced bronchospasm|activity/exercise induced bronchospasm
498800|NCT01435902|asthma|asthma
498801|NCT01435889|Acute respiratory distress syndrome|acute respiratory distress syndrome
498802|NCT01435889|Children|children
498803|NCT01435889|Long term respiratory sequelae|long term respiratory sequelae
498804|NCT01435889|Pulmonary function tests|pulmonary function tests
498805|NCT01435889|Computed tomography, lung|computed tomography, lung
498806|NCT01435850|hip arthroplasty|hip arthroplasty
498807|NCT01435850|primary stability|primary stability
498808|NCT01435850|secondary stability|secondary stability
498809|NCT01435850|EBRA|ebra
498810|NCT01435837|Voice|voice
498811|NCT01435837|aerodynamics|aerodynamics
498812|NCT01435837|acoustics|acoustics
498813|NCT01435824|healthy adult volunteers|healthy adult volunteers
498814|NCT01435824|comparative bioavailability|comparative bioavailability
498815|NCT01435824|amoxicillin|amoxicillin
498816|NCT01435824|breast milk|breast milk
498817|NCT01435824|Amoxicillin Bioavailability in breast milk|amoxicillin bioavailability in breast milk
498818|NCT01435811|Norovirus|norovirus
498819|NCT01435798|chronic pain|chronic pain
498820|NCT01435798|central neuropathic pain|central neuropathic pain
498821|NCT01435798|spinal cord injury|spinal cord injury
498822|NCT01435798|dextromethorphan|dextromethorphan
498823|NCT01435798|lidocaine|lidocaine
498824|NCT01435798|combination therapy|combination therapy
498825|NCT01435798|analgesia|analgesia
498826|NCT01435785|PKPD|pkpd
498827|NCT01435785|Propofol|propofol
498828|NCT01435785|TCI|tci
498829|NCT01435785|Elderly patients|elderly patients
498830|NCT01435746|liver transplantation|liver transplantation
498831|NCT01435746|intensive care|intensive care
498832|NCT01435746|red blood cell transfusion|red blood cell transfusion
498833|NCT01435733|ASD|asd
498834|NCT01435733|Divorce|divorce
498835|NCT01435720|Multiple myeloma|multiple myeloma
498836|NCT01435720|B cell lymphoma|b cell lymphoma
498837|NCT01435720|Hematologic disease|hematologic disease
498838|NCT01435720|Blood protein disorder|blood protein disorder
498839|NCT01435720|Neoplasm, plasma cell|neoplasm, plasma cell
498840|NCT01435720|Mantle Cell Lymphoma|mantle cell lymphoma
498841|NCT01435720|Diffuse Large B Cell Lymphoma|diffuse large b cell lymphoma
498842|NCT01435720|Plasma Cell Leukemia|plasma cell leukemia
498843|NCT01435720|B cell malignancy|b cell malignancy
498844|NCT01435707|epidural steroid injection|epidural steroid injection
498845|NCT01435707|triamcinolone|triamcinolone
498846|NCT01435707|fasting blood glucose|fasting blood glucose
498847|NCT01435707|diabetes mellitus|diabetes mellitus
498848|NCT01435694|multiple sclerosis|multiple sclerosis
498849|NCT01435694|gait rehabilitation|gait rehabilitation
498850|NCT01435681|DYT-1|dyt-1
498851|NCT01435681|DYT1|dyt1
498852|NCT01435681|DYT 1|dyt 1
498853|NCT01435681|dystonia|dystonia
498854|NCT01435681|DBS|dbs
498855|NCT01435681|deep brain stimulation|deep brain stimulation
498856|NCT01435681|TMS|tms
498857|NCT01435681|transcranial magnetic stimulation|transcranial magnetic stimulation
498858|NCT01435668|alcohol|alcohol
498859|NCT01435668|hazardous or harmful drinking|hazardous or harmful drinking
498860|NCT01435668|emergency department (ED)|emergency department (ed)
498861|NCT01435616|diabetes mellitus|diabetes mellitus
498862|NCT01435616|type 2 diabetes mellitus|type 2 diabetes mellitus
498863|NCT01435616|insulin naive|insulin naive
498864|NCT01435616|insulin treatment|insulin treatment
498865|NCT01435603|Prevention & Control|prevention & control
498866|NCT01435603|Hyperglycemia|hyperglycemia
498867|NCT01435603|Obesity|obesity
498868|NCT01435603|Diabetes Mellitus|diabetes mellitus
498869|NCT01435603|Cost Benefit Analysis|cost benefit analysis
498870|NCT01435577|Bunionectomy|bunionectomy
498871|NCT01435577|Postsurgical Pain|postsurgical pain
498872|NCT01435577|Acute Pain|acute pain
498873|NCT01435564|Mobile phone|mobile phone
498874|NCT01435564|Sedentary lifestyle|sedentary lifestyle
498875|NCT01435564|Physical activity|physical activity
498876|NCT01435564|Prevention|prevention
498877|NCT01435564|Health Promotion|health promotion
498878|NCT01435564|Exercise|exercise
498879|NCT01435564|eHealth|ehealth
498880|NCT01435564|Electronic diary|electronic diary
498881|NCT01435551|Alzheimer|alzheimer
498882|NCT01435551|Dementia|dementia
498883|NCT01435538|interprofessional teamwork|interprofessional teamwork
498884|NCT01435538|care pathways|care pathways
498885|NCT01435538|team communication|team communication
498886|NCT01435538|team coordination|team coordination
498887|NCT01435538|Chronic Obstructive Pulmonary Disease Teams|chronic obstructive pulmonary disease teams
498888|NCT01435538|Proximal Femur Fracture Teams|proximal femur fracture teams
498889|NCT01435525|triple therapy|triple therapy
498890|NCT01435525|Helicobacter pylori|helicobacter pylori
498891|NCT01435525|eradication|eradication
498892|NCT01435525|Nexium|nexium
498893|NCT01435512|PTSD|ptsd
498895|NCT01435512|Intimate Partner Violence|intimate partner violence
498896|NCT01435512|Treatment|treatment
498897|NCT01435499|immunotherapy|immunotherapy
498898|NCT01435499|vaccine|vaccine
498899|NCT01435499|GVAX|gvax
498900|NCT01435499|GM-CSF|gm-csf
498901|NCT01435486|caffeine|caffeine
498902|NCT01435486|apnea|apnea
498903|NCT01435486|bronchiolitis|bronchiolitis
498904|NCT01435473|pediatrics|pediatrics
498905|NCT01435473|thrombosis|thrombosis
498906|NCT01435473|thromboembolic complications|thromboembolic complications
498907|NCT01435473|pediatric cardiac surgery|pediatric cardiac surgery
498908|NCT01435460|ocular allergy|ocular allergy
498909|NCT01435447|efficacy|efficacy
498910|NCT01435447|safety|safety
498911|NCT01435447|conditioning|conditioning
498912|NCT01435447|fludarabine|fludarabine
498913|NCT01435447|busulfan|busulfan
498914|NCT01435447|cyclophosphamide|cyclophosphamide
498915|NCT01435447|adult|adult
498916|NCT01435434|subjects sustaining Non union/delayed fractures and requiring surgical intervention for treatment|subjects sustaining non union/delayed fractures and requiring surgical intervention for treatment
498917|NCT01435408|STEMI|stemi
498918|NCT01435408|Ischemic postconditioning|ischemic postconditioning
498919|NCT01435408|Deferred stenting|deferred stenting
498920|NCT01435408|Primary PCI|primary pci
498921|NCT01435382|PF-04950615|pf-04950615
498922|NCT01435382|RN316|rn316
498923|NCT01435356|Urinary Bladder neoplasms|urinary bladder neoplasms
498924|NCT01435356|Lymphoproliferative Disorders|lymphoproliferative disorders
498925|NCT01435356|Immune System Diseases|immune system diseases
498926|NCT01435356|Cystectomy|cystectomy
498927|NCT01435356|Adjuvants, Immunologic|adjuvants, immunologic
498928|NCT01435356|Immunologic Factors|immunologic factors
498929|NCT01435330|Safety|safety
498930|NCT01435330|BVS857|bvs857
498931|NCT01435330|insulin resistance|insulin resistance
498932|NCT01435317|Acoustic CR®-neuromodulation|acoustic cr®-neuromodulation
498933|NCT01435317|ANM T30 CR®-System|anm t30 cr®-system
498934|NCT01435278|Weight maintenance|weight maintenance
498935|NCT01435278|BMI|bmi
498936|NCT01435278|Body weight|body weight
498937|NCT01435278|Overweight|overweight
498938|NCT01435278|Obesity|obesity
498939|NCT01435278|Satiety|satiety
498940|NCT01435265|Psoriasis|psoriasis
498941|NCT01435265|Dermatology|dermatology
498942|NCT01435265|Phase IV|phase iv
498943|NCT01435265|Nurse Education|nurse education
498944|NCT01435265|Adalimumab|adalimumab
498945|NCT01435265|Humira|humira
498946|NCT01435226|Hepatitis C|hepatitis c
498947|NCT01435226|HCV|hcv
498948|NCT01435226|Rapid Virologic Response|rapid virologic response
498949|NCT01435226|Sustained Virologic Response|sustained virologic response
498950|NCT01435226|Direct Acting Antiviral|direct acting antiviral
498951|NCT01435226|Combination Therapy|combination therapy
498952|NCT01435226|Tegobuvir|tegobuvir
498953|NCT01435226|Treatment Experienced|treatment experienced
498954|NCT01435226|HCV RNA|hcv rna
498955|NCT01435226|Polymerase inhibitor|polymerase inhibitor
498956|NCT01435226|Protease inhibitor|protease inhibitor
498957|NCT01435226|Interferon intolerant|interferon intolerant
498958|NCT01435226|Interferon ineligible|interferon ineligible
498959|NCT01435226|GS-9190|gs-9190
498960|NCT01435226|GS-9451|gs-9451
498961|NCT01435226|GS-5885|gs-5885
498962|NCT01435226|Chronic Genotype 1a or 1b|chronic genotype 1a or 1b
498963|NCT01435213|alpha2-adrenoceptor|alpha2-adrenoceptor
498964|NCT01435213|receptor occupancy|receptor occupancy
498965|NCT01435213|positron emission tomography|positron emission tomography
498966|NCT01435213|[11C]ORM-13070|[11c]orm-13070
498967|NCT01435213|striatum|striatum
498968|NCT01435213|brain|brain
498969|NCT01435213|noradrenaline|noradrenaline
498970|NCT01435213|norepinephrine|norepinephrine
498971|NCT01435213|endogenous|endogenous
498972|NCT01435213|binding|binding
498973|NCT01435213|Validation studies|validation studies
498974|NCT01435200|Intravenous iron|intravenous iron
498975|NCT01435200|gynecologic cancer blood transfusion|gynecologic cancer blood transfusion
498976|NCT01435174|ranolazine|ranolazine
498977|NCT01435174|end-stage renal disease|end-stage renal disease
498978|NCT01435174|pharmacokinetics|pharmacokinetics
498979|NCT01435174|cardiovascular disease|cardiovascular disease
498980|NCT01435161|paroxysmal atrial fibrillation, hypertension|paroxysmal atrial fibrillation, hypertension
498981|NCT01435148|Deep Brain Stimulation|deep brain stimulation
498982|NCT01435148|Treatment Resistant Depression|treatment resistant depression
498983|NCT01435122|progressive advanced carcinoid tumors|progressive advanced carcinoid tumors
498984|NCT01435122|advanced|advanced
498985|NCT01435122|unresectable|unresectable
498986|NCT01435122|metastatic|metastatic
498987|NCT01435122|cancerous tumors|cancerous tumors
498988|NCT01435122|neuroendocrine|neuroendocrine
498989|NCT01435122|digestive tract|digestive tract
498990|NCT01435122|lungs|lungs
498991|NCT01435122|renal|renal
498992|NCT01435122|ovarian|ovarian
498993|NCT01435122|thymic|thymic
498994|NCT01435122|hepatic|hepatic
498995|NCT01435109|Osteoarthritis|osteoarthritis
498996|NCT01435109|Exercise|exercise
498997|NCT01435109|Diet|diet
498998|NCT01435109|Coping Skills|coping skills
498999|NCT01435109|Education, Medical|education, medical
499000|NCT01435083|Nocturia|nocturia
499001|NCT01435070|Colles' fracture|colles' fracture
499002|NCT01435070|Radius fracture|radius fracture
499003|NCT01435070|grip strength|grip strength
499004|NCT01435070|pinch strength|pinch strength
499005|NCT01435070|range of movement|range of movement
499006|NCT01435070|PRWE|prwe
499007|NCT01435070|DASH|dash
499008|NCT01435070|EQ-5D|eq-5d
499009|NCT01435070|Kirschner wire|kirschner wire
499010|NCT01435070|Volar locking plate|volar locking plate
499011|NCT01435057|Abdominal Obesity|abdominal obesity
499012|NCT01435057|training|training
499013|NCT01435057|fat|fat
499014|NCT01435057|insulin|insulin
499015|NCT01435057|glucose|glucose
499016|NCT01435057|diet|diet
499017|NCT01435044|Hepatitis C|hepatitis c
499018|NCT01435044|Chronic|chronic
499019|NCT01435044|HCV|hcv
499020|NCT01435031|Angioplasty|angioplasty
499021|NCT01435031|Chronic Total Occlusion (CTO)|chronic total occlusion (cto)
499022|NCT01435031|Chronic total coronary occlusions|chronic total coronary occlusions
499023|NCT01435031|Coronary Artery Disease (CAD)|coronary artery disease (cad)
499024|NCT01435031|Coronary artery stenosis|coronary artery stenosis
499025|NCT01435031|Total coronary occlusion|total coronary occlusion
499026|NCT01435005|Prevention and control|prevention and control
499027|NCT01435005|Exercise|exercise
499028|NCT01435005|Sedentary lifestyle|sedentary lifestyle
499029|NCT01435005|Biological markers|biological markers
499030|NCT01434966|Lumbopelvic Manipulation|lumbopelvic manipulation
499031|NCT01434966|Lumbosacral Manipulation|lumbosacral manipulation
499032|NCT01434966|Sacroiliac Manipulation|sacroiliac manipulation
499033|NCT01434966|TENS Spine|tens spine
499034|NCT01434966|TENS Knee|tens knee
499035|NCT01434966|Knee Pain|knee pain
499036|NCT01434966|Chronic Knee Pain|chronic knee pain
499037|NCT01434953|Prehypertension|prehypertension
499038|NCT01434953|Blood pressure screening|blood pressure screening
499039|NCT01434953|White coat effect|white coat effect
499040|NCT01434940|Alzheimer disease|alzheimer disease
499041|NCT01434940|Depression|depression
499042|NCT01434940|Differential diagnosis|differential diagnosis
499043|NCT01434940|Eye movement|eye movement
499044|NCT01434914|Ulcus cruris|ulcus cruris
499045|NCT01434914|chronic wounds|chronic wounds
499046|NCT01434914|octenisept®|octenisept®
499047|NCT01434901|Diabetes|diabetes
499048|NCT01434901|Blood Sugar|blood sugar
499049|NCT01434901|Xenin-25|xenin-25
499050|NCT01434901|GIP|gip
499051|NCT01434901|Muscarinic|muscarinic
499052|NCT01434888|pharmacokinetics|pharmacokinetics
499053|NCT01434862|Type 1 Diabetes Mellitus|type 1 diabetes mellitus
499054|NCT01434849|infantile hemangioma|infantile hemangioma
499055|NCT01434849|very low birth weight infants|very low birth weight infants
499056|NCT01434849|premature infants|premature infants
499057|NCT01434836|Anti-depressant effects|anti-depressant effects
499058|NCT01434823|nocturnal staffing|nocturnal staffing
499059|NCT01434823|intensivist staffing|intensivist staffing
499060|NCT01434823|intensivist coverage|intensivist coverage
499061|NCT01434823|ICU patient-centered outcomes|icu patient-centered outcomes
499062|NCT01434823|ICU resource utilization|icu resource utilization
499063|NCT01434823|patients admitted to the medical intensive care unit|patients admitted to the medical intensive care unit
499064|NCT01434823|Sleep Deprivation|sleep deprivation
499065|NCT01434823|Inattention|inattention
499066|NCT01434823|Work Hours|work hours
499067|NCT01434810|Hyperbilirubinemia, Neonatal|hyperbilirubinemia, neonatal
499068|NCT01434797|Infection|infection
499069|NCT01434797|Permanent central venous catheter|permanent central venous catheter
499070|NCT01434797|Device Related|device related
499071|NCT01434784|lung cancer|lung cancer
499072|NCT01434784|quality of life|quality of life
499073|NCT01434758|Mycobacterium tuberculosis|mycobacterium tuberculosis
499074|NCT01434758|Culture yield|culture yield
499076|NCT01434745|Cholesterol Supplementation|cholesterol supplementation
499077|NCT01434745|Simvastatin|simvastatin
499078|NCT01434732|Superior vena cava flow|superior vena cava flow
499079|NCT01434732|umbilical cord milking|umbilical cord milking
499080|NCT01434732|hemodynamics|hemodynamics
499081|NCT01434732|systemic blood flow|systemic blood flow
499082|NCT01434719|Streptococcus suis|streptococcus suis
499083|NCT01434719|Sepsis|sepsis
499084|NCT01434719|Porcine Respiratory and Reproductive System virus|porcine respiratory and reproductive system virus
499085|NCT01434719|Pig disease|pig disease
499086|NCT01434719|Epidemiology|epidemiology
499087|NCT01434706|HIV|hiv
499088|NCT01434706|acute infection|acute infection
499089|NCT01434706|primary infection|primary infection
499090|NCT01434706|seroconverters|seroconverters
499091|NCT01434693|T. suis ova|t. suis ova
499092|NCT01434693|Crohn's disease|crohn's disease
499093|NCT01434680|Meningococcal disease|meningococcal disease
499094|NCT01434680|vaccines|vaccines
499095|NCT01434680|toddlers|toddlers
499096|NCT01434680|prevention|prevention
499097|NCT01434680|Meningitis|meningitis
499098|NCT01434667|Mild Cognitive Impairment (MCI)|mild cognitive impairment (mci)
499099|NCT01434667|Alzheimer's disease (AD)|alzheimer's disease (ad)
499100|NCT01434667|APOE|apoe
499101|NCT01434667|genetics|genetics
499102|NCT01434667|risk assessment|risk assessment
499103|NCT01434667|education|education
499104|NCT01434667|genetic counseling|genetic counseling
499105|NCT01434667|Mild Cognitive Impairment, So Stated|mild cognitive impairment, so stated
499106|NCT01434654|HAND|hand
499107|NCT01434654|HIV|hiv
499108|NCT01434654|Neurology|neurology
499109|NCT01434654|Neurocognitive|neurocognitive
499110|NCT01434654|Neuro-HAART|neuro-haart
499111|NCT01434654|HIV Associated Neurocognitive Disorders (HAND)|hiv associated neurocognitive disorders (hand)
499112|NCT01434641|myocardial perfusion SPECT|myocardial perfusion spect
499113|NCT01434641|wide beam reconstruction|wide beam reconstruction
499114|NCT01434641|Tc-99m sestamibi|tc-99m sestamibi
499115|NCT01434628|Male Circumcision|male circumcision
499116|NCT01434628|HIV Prevention|hiv prevention
499117|NCT01434628|HIV Infections|hiv infections
499118|NCT01434615|Cardiac Resynchronization Therapy|cardiac resynchronization therapy
499119|NCT01434615|Moderate to advanced|moderate to advanced
499120|NCT01434615|patients|patients
499121|NCT01434615|current consensus guidelines|current consensus guidelines
499122|NCT01434602|Chemotherapy|chemotherapy
499123|NCT01434602|Brain Tumor|brain tumor
499124|NCT01434602|Glioblastoma|glioblastoma
499125|NCT01434602|Anaplastic Glioma|anaplastic glioma
499126|NCT01434589|internet addiction|internet addiction
499127|NCT01434589|computer game addiction|computer game addiction
499128|NCT01434589|STICA|stica
499129|NCT01434589|short-term treatment|short-term treatment
499130|NCT01434589|psychotherapy|psychotherapy
499131|NCT01434589|internet and computer game addiction|internet and computer game addiction
499132|NCT01434563|HIV|hiv
499133|NCT01434563|neurocognitive disorder|neurocognitive disorder
499134|NCT01434563|primary care|primary care
499135|NCT01434563|HIV negative|hiv negative
499136|NCT01434563|HAND|hand
499137|NCT01434563|CNS|cns
499138|NCT01434550|pancreas|pancreas
499139|NCT01434550|pancreatic cancer|pancreatic cancer
499140|NCT01434550|SBRT|sbrt
499141|NCT01434550|stereotactic body radiation|stereotactic body radiation
499142|NCT01434550|radiation therapy|radiation therapy
499143|NCT01434550|unresectable|unresectable
499144|NCT01434550|non-metastatic|non-metastatic
499145|NCT01434550|tissue, blood, research imaging|tissue, blood, research imaging
499146|NCT01434550|TBRI|tbri
499147|NCT01434537|pediatric anesthesia|pediatric anesthesia
499148|NCT01434537|venepuncture|venepuncture
499149|NCT01434537|peripheral venous access|peripheral venous access
499150|NCT01434511|hemophilia A|hemophilia a
499151|NCT01434511|haemophilia A|haemophilia a
499152|NCT01434511|blood coagulation disorders|blood coagulation disorders
499153|NCT01434511|hemorrhagic disorders|hemorrhagic disorders
499154|NCT01434511|coagulation protein disorder|coagulation protein disorder
499155|NCT01434511|hematologic diseases|hematologic diseases
499156|NCT01434511|congenital hemophilia A|congenital hemophilia a
499157|NCT01434498|Hepatitis C|hepatitis c
499158|NCT01434498|HCV|hcv
499159|NCT01434498|Rapid Virologic Response|rapid virologic response
499160|NCT01434498|Sustained Virologic Response|sustained virologic response
710753|NCT00588094|ASCT|asct
634924|NCT00889226|PWV|pwv
499161|NCT01434498|Direct Acting Antiviral|direct acting antiviral
499162|NCT01434498|Combination Therapy|combination therapy
499163|NCT01434498|Tegobuvir|tegobuvir
499164|NCT01434498|Treatment naïve|treatment naïve
499165|NCT01434498|HCV RNA|hcv rna
499166|NCT01434498|Polymerase inhibitor|polymerase inhibitor
499167|NCT01434498|Protease inhibitor|protease inhibitor
499168|NCT01434498|Interferon intolerant|interferon intolerant
499169|NCT01434498|Interferon ineligible|interferon ineligible
499170|NCT01434498|GS-9190|gs-9190
499171|NCT01434498|GS-9451|gs-9451
499172|NCT01434498|GS-5885|gs-5885
499173|NCT01434485|gastric ulcer, duodenal ulcer, anastomotic ulcer, reflux oesophagitis, non-erosive reflux disease, Zollinger-Ellison syndrome, Nexium|gastric ulcer, duodenal ulcer, anastomotic ulcer, reflux oesophagitis, non-erosive reflux disease, zollinger-ellison syndrome, nexium
499174|NCT01434459|Pancreatic neoplasms|pancreatic neoplasms
499175|NCT01434459|Cholangiocarcinoma|cholangiocarcinoma
499176|NCT01434420|triple negative breast cancer|triple negative breast cancer
499177|NCT01434407|Advanced glycation endproducts|advanced glycation endproducts
499178|NCT01434407|Satiety|satiety
499179|NCT01434407|Obesity|obesity
499180|NCT01434407|Inflammation|inflammation
499181|NCT01434407|Insulin resistance|insulin resistance
499182|NCT01434394|Oral cancer|oral cancer
499183|NCT01434394|Oropharyngeal cancer|oropharyngeal cancer
499184|NCT01434394|Induction chemotherapy|induction chemotherapy
499185|NCT01434394|Targeted chemotherapy|targeted chemotherapy
499186|NCT01434394|Surgery|surgery
499187|NCT01434394|Radiotherapy|radiotherapy
499188|NCT01434381|Recombinant|recombinant
499189|NCT01434381|Proteins|proteins
499190|NCT01434381|Antigen|antigen
499191|NCT01434381|Membrane|membrane
499192|NCT01434381|Assay|assay
499193|NCT01434381|Malaria|malaria
499194|NCT01434368|Functional Magnetic Resonance Imaging (fMRI)|functional magnetic resonance imaging (fmri)
499195|NCT01434368|Normal Development|normal development
499196|NCT01434368|Puberty|puberty
499197|NCT01434368|Brain Function|brain function
499198|NCT01434368|Gonadal Steroids|gonadal steroids
499199|NCT01434368|Brain Structure|brain structure
499200|NCT01434368|Healthy Volunteer|healthy volunteer
499201|NCT01434368|HV|hv
499202|NCT01434342|stage IA non-small cell lung cancer|stage ia non-small cell lung cancer
499203|NCT01434342|stage IB non-small cell lung cancer|stage ib non-small cell lung cancer
499204|NCT01434342|stage IIA non-small cell lung cancer|stage iia non-small cell lung cancer
499205|NCT01434342|stage IIB non-small cell lung cancer|stage iib non-small cell lung cancer
499206|NCT01434342|stage IIIA non-small cell lung cancer|stage iiia non-small cell lung cancer
499207|NCT01434342|stage IIIB non-small cell lung cancer|stage iiib non-small cell lung cancer
499208|NCT01434342|limited stage small cell lung cancer|limited stage small cell lung cancer
499209|NCT01434342|tobacco use disorder|tobacco use disorder
499210|NCT01434342|Breast Cancer|breast cancer
499211|NCT01434342|Cervical Cancer|cervical cancer
499212|NCT01434342|head & neck cancer|head & neck cancer
499213|NCT01434342|Prostate Cancer|prostate cancer
499214|NCT01434342|All histologies|all histologies
499215|NCT01434329|untreated adult acute myeloid leukemia|untreated adult acute myeloid leukemia
499216|NCT01434290|radiation toxicity|radiation toxicity
499217|NCT01434290|sexual dysfunction|sexual dysfunction
499218|NCT01434290|psychosocial effects of cancer and its treatment|psychosocial effects of cancer and its treatment
499219|NCT01434290|adenocarcinoma of the prostate|adenocarcinoma of the prostate
499220|NCT01434290|stage I prostate cancer|stage i prostate cancer
499221|NCT01434290|stage IIA prostate cancer|stage iia prostate cancer
499222|NCT01434277|Preservative|preservative
499223|NCT01434277|Eye Drops|eye drops
499224|NCT01434264|rehabilitation|rehabilitation
499225|NCT01434251|Hypotension|hypotension
499226|NCT01434251|premature infants|premature infants
499227|NCT01434251|near infrared spectroscopy|near infrared spectroscopy
499228|NCT01434238|infant feeding|infant feeding
499229|NCT01434238|HIV|hiv
499230|NCT01434238|growth|growth
499231|NCT01434238|anemia|anemia
499232|NCT01434225|Neonatal seizures|neonatal seizures
499233|NCT01434225|Hypoxic Ischemic Encephalopathy|hypoxic ischemic encephalopathy
499234|NCT01434225|Electroencephalography|electroencephalography
499235|NCT01434225|Bumetanide|bumetanide
499236|NCT01434212|HCV dynamics|hcv dynamics
499237|NCT01434212|Mathematical model|mathematical model
499238|NCT01434212|Interferon|interferon
499239|NCT01434212|Predict|predict
499240|NCT01434212|Hepatitis C Virus|hepatitis c virus
499241|NCT01434199|magnetic endoscope imaging|magnetic endoscope imaging
499242|NCT01434199|colonoscopy|colonoscopy
499243|NCT01434199|caecal intubation|caecal intubation
499244|NCT01434173|Liver Diseases|liver diseases
499245|NCT01434173|Anti-Bacterial Agents|anti-bacterial agents
499246|NCT01434173|Fluoroquinolones|fluoroquinolones
499247|NCT01434173|Amoxicillin|amoxicillin
499248|NCT01434173|Amoxicillin-Potassium Clavulanate Combination|amoxicillin-potassium clavulanate combination
499249|NCT01434173|Clarithromycin|clarithromycin
499250|NCT01434173|Doxycycline|doxycycline
499251|NCT01434173|Cefuroxime|cefuroxime
635054|NCT00888589|MBI|mbi
499252|NCT01434173|Case-Control Studies|case-control studies
499253|NCT01434173|Retrospective Studies|retrospective studies
499254|NCT01434173|Cohort Studies|cohort studies
499255|NCT01434173|Epidemiologic Research Design|epidemiologic research design
499256|NCT01434173|Epidemiologic Studies|epidemiologic studies
499257|NCT01434173|HealthCore Integrated Research Database (non-MESH)|healthcore integrated research database (non-mesh)
499258|NCT01434173|United States|united states
499259|NCT01434173|Human|human
499260|NCT01434173|Insurance Claim Review|insurance claim review
499261|NCT01434160|Intrauterine|intrauterine
499262|NCT01434160|contraception|contraception
499263|NCT01434160|adolescent|adolescent
499264|NCT01434147|locally advanced rectal cancer|locally advanced rectal cancer
499265|NCT01434147|preoperative induction chemotherapy chemoradiotherapy|preoperative induction chemotherapy chemoradiotherapy
499266|NCT01434134|Anthracyclines|anthracyclines
499267|NCT01434134|Trastuzumab|trastuzumab
499268|NCT01434108|cirrhosis, gastrointestinal bleeding|cirrhosis, gastrointestinal bleeding
499269|NCT01434095|microperimetry|microperimetry
499270|NCT01434095|fixation point|fixation point
499271|NCT01434095|retinal sensitivity|retinal sensitivity
499272|NCT01434095|photodynamic therapy|photodynamic therapy
499273|NCT01434095|chronic central serous chorioretinopathy|chronic central serous chorioretinopathy
499274|NCT01434082|sleep|sleep
499275|NCT01434082|school-age children|school-age children
499276|NCT01434082|Children with and without arthritis|children with and without arthritis
499277|NCT01434069|colon|colon
499278|NCT01434069|rectum|rectum
499279|NCT01434069|small bowel|small bowel
499280|NCT01434069|pancreas|pancreas
499281|NCT01434069|gastric|gastric
499282|NCT01434069|esophageal|esophageal
499283|NCT01434069|metastatic|metastatic
499284|NCT01434069|unresectable|unresectable
499285|NCT01434069|GI|gi
499286|NCT01434069|combination therapy|combination therapy
499287|NCT01434069|dose escalation|dose escalation
499288|NCT01434069|solid tumor|solid tumor
499289|NCT01434056|Liver disease|liver disease
499290|NCT01434056|Hepatic encephalopathy|hepatic encephalopathy
499291|NCT01434056|MELD|meld
499292|NCT01434056|Liver transplantation|liver transplantation
499293|NCT01434043|Cardiac CT perfusion|cardiac ct perfusion
499294|NCT01434043|Positron emission tomography perfusion|positron emission tomography perfusion
499295|NCT01434043|Quantitative perfusion|quantitative perfusion
499296|NCT01434017|PONV|ponv
499297|NCT01434017|Dexamethasone|dexamethasone
499298|NCT01434017|Droperidol|droperidol
499299|NCT01434017|Ondansetron|ondansetron
499300|NCT01434017|Tonsillectomy|tonsillectomy
499301|NCT01434004|prostate cancer|prostate cancer
499302|NCT01433965|Bone marrow transplantation|bone marrow transplantation
499303|NCT01433965|Maintenance lenalidomide|maintenance lenalidomide
499304|NCT01433939|colonoscopy|colonoscopy
499305|NCT01433939|position changes|position changes
499306|NCT01433939|patient comfort|patient comfort
499307|NCT01433926|Breast cancer.|breast cancer.
499308|NCT01433926|Trastuzumab.|trastuzumab.
499309|NCT01433926|Complete remission.|complete remission.
499310|NCT01433900|glaucoma|glaucoma
499311|NCT01433900|intraocular pressure|intraocular pressure
499312|NCT01433900|ocular surface|ocular surface
499313|NCT01433900|benzalkonium chloride|benzalkonium chloride
499314|NCT01433887|Peginterferon alfa-2a|peginterferon alfa-2a
499315|NCT01433887|ribavirin|ribavirin
499316|NCT01433874|Shoulder pain|shoulder pain
499317|NCT01433874|Upper abdominal pain|upper abdominal pain
499318|NCT01433874|Laparoscopic surgery|laparoscopic surgery
499319|NCT01433874|Abdominal fullness|abdominal fullness
499320|NCT01433861|gastric cancer|gastric cancer
499321|NCT01433861|proximal gastrectomy|proximal gastrectomy
499322|NCT01433861|total gastrectomy|total gastrectomy
499323|NCT01433861|laparoscopy|laparoscopy
499324|NCT01433861|reflux esophagitis|reflux esophagitis
499325|NCT01433861|double tract reconstruction|double tract reconstruction
499326|NCT01433835|Cytomegalovirus|cytomegalovirus
499327|NCT01433835|Antiviral|antiviral
499328|NCT01433835|Safety|safety
499329|NCT01433835|Healthy|healthy
499330|NCT01433809|thyroid cancer|thyroid cancer
499331|NCT01433809|thyroid neoplasm|thyroid neoplasm
499332|NCT01433809|thyroid adenoma|thyroid adenoma
499333|NCT01433796|antiretroviral therapy|antiretroviral therapy
499334|NCT01433796|tuberculosis|tuberculosis
499335|NCT01433796|health centres|health centres
499336|NCT01433796|Ethiopia|ethiopia
499337|NCT01433757|dystonia|dystonia
499338|NCT01433757|DYT-1|dyt-1
499339|NCT01433757|AMPICILLIN|ampicillin
499340|NCT01433744|C-Reactive protein|c-reactive protein
499341|NCT01433744|risk|risk
499342|NCT01433731|CTCL|ctcl
499343|NCT01433731|Cutaneous T-Cell Lymphoma|cutaneous t-cell lymphoma
499344|NCT01433718|Effectivness|effectivness
499345|NCT01433718|Neuromuscular Training|neuromuscular training
499346|NCT01433718|Resistance Training|resistance training
499347|NCT01433718|Modification|modification
499348|NCT01433718|Anterior Cruciate Ligament Risk Factors|anterior cruciate ligament risk factors
635180|NCT00888030|outcome|outcome
499349|NCT01433718|Drop-Jump|drop-jump
499350|NCT01433718|Knee Separation|knee separation
499351|NCT01433718|Resistance training program|resistance training program
499352|NCT01433705|heart|heart
499353|NCT01433705|perfusion|perfusion
499354|NCT01433705|glucose|glucose
499355|NCT01433692|Addictions|addictions
499356|NCT01433692|Adolescents|adolescents
499357|NCT01433692|Primary Health Care|primary health care
499358|NCT01433692|Brief Intervention|brief intervention
499359|NCT01433679|Health Behavior|health behavior
499360|NCT01433679|Exercise|exercise
499361|NCT01433679|Adolescent Behavior|adolescent behavior
499362|NCT01433679|Motivation|motivation
499363|NCT01433679|Biological Markers|biological markers
499364|NCT01433653|Comorbid|comorbid
499365|NCT01433653|Complicated|complicated
499366|NCT01433640|image on multi-modalities|image on multi-modalities
499367|NCT01433640|visualize cancer lesions|visualize cancer lesions
499368|NCT01433640|highly suspicious lesions|highly suspicious lesions
499369|NCT01433627|acute coronary syndromes|acute coronary syndromes
499370|NCT01433627|myocardial infarction|myocardial infarction
499371|NCT01433627|access site|access site
499372|NCT01433627|bivalirudin|bivalirudin
499373|NCT01433627|bleedings|bleedings
499374|NCT01433601|Adherence|adherence
499375|NCT01433601|Peer support|peer support
499376|NCT01433601|Treatment failure|treatment failure
499377|NCT01433588|Managing infant pain|managing infant pain
499378|NCT01433588|27 - 36+6 weeks gestation|27 - 36+6 weeks gestation
499379|NCT01433588|Preterm infants|preterm infants
499380|NCT01433562|breast cancer|breast cancer
499381|NCT01433562|neoadjuvant therapy|neoadjuvant therapy
499382|NCT01433562|Stage II/III|stage ii/iii
499383|NCT01433536|cranial trauma with or without high velocity fracture to inferior limb|cranial trauma with or without high velocity fracture to inferior limb
499384|NCT01433536|spinal trauma with or without high velocity fracture to inferior limb|spinal trauma with or without high velocity fracture to inferior limb
499385|NCT01433536|high velocity fracture to inferior limb|high velocity fracture to inferior limb
499386|NCT01433523|HDM|hdm
499387|NCT01433523|AIT|ait
499388|NCT01433523|asthma|asthma
499389|NCT01433523|asthma exacerbation|asthma exacerbation
499390|NCT01433523|House dust mite induced asthma|house dust mite induced asthma
499391|NCT01433510|Allergic|allergic
499392|NCT01433510|Rhinoconjunctivitis|rhinoconjunctivitis
499393|NCT01433510|Immunotherapy|immunotherapy
499394|NCT01433497|multiple sclerosis|multiple sclerosis
499395|NCT01433497|primary progressive|primary progressive
499396|NCT01433497|relapse-free|relapse-free
499397|NCT01433497|secondary progressive|secondary progressive
499398|NCT01433484|cardiovascular disease|cardiovascular disease
499399|NCT01433484|coronary heart disease|coronary heart disease
499400|NCT01433484|obesity|obesity
499401|NCT01433484|weight loss|weight loss
499402|NCT01433484|genomics|genomics
499403|NCT01433471|Ulcerative Colitis|ulcerative colitis
499404|NCT01433471|Trichuris Suis Ova|trichuris suis ova
499405|NCT01433471|Inflammatory Bowel Disease|inflammatory bowel disease
499406|NCT01433471|Mucus|mucus
499407|NCT01433458|Hepatic impairment|hepatic impairment
499408|NCT01433458|healthy volunteers|healthy volunteers
499409|NCT01433458|RLX030|rlx030
499410|NCT01433458|pharmacokinetics|pharmacokinetics
499411|NCT01433445|Myelofibrosis|myelofibrosis
499412|NCT01433445|Panobinostat|panobinostat
499413|NCT01433445|Ruxolitinib|ruxolitinib
499414|NCT01433445|MF|mf
499415|NCT01433445|PMF|pmf
499416|NCT01433445|PPV|ppv
499417|NCT01433445|PPV-MF|ppv-mf
499418|NCT01433445|PET|pet
499419|NCT01433445|PET-MF|pet-mf
499420|NCT01433445|JAK2|jak2
499421|NCT01433445|DACi|daci
499422|NCT01433432|Crohn's Disease|crohn's disease
499423|NCT01433419|Drug Therapy|drug therapy
499424|NCT01433406|Drug Therapy|drug therapy
499425|NCT01433393|Drug Therapy|drug therapy
499426|NCT01433380|Phase 1|phase 1
499427|NCT01433380|Single Doses|single doses
499428|NCT01433380|Pharmacodynamics|pharmacodynamics
499429|NCT01433380|Healthy Volunteers|healthy volunteers
499430|NCT01433367|total disc replacement|total disc replacement
499431|NCT01433367|cervical disc disease|cervical disc disease
499432|NCT01433354|Fragile X Syndrome|fragile x syndrome
499433|NCT01433354|Martin-Bell Syndrome|martin-bell syndrome
499434|NCT01433354|Genetic Diseases|genetic diseases
499435|NCT01433354|X-Linked|x-linked
499436|NCT01433354|Escalante's syndrome|escalante's syndrome
499437|NCT01433341|Normal young athletes|normal young athletes
499438|NCT01433328|Remodulin|remodulin
499439|NCT01433328|Treprostinil|treprostinil
499440|NCT01433315|sleep deprivation|sleep deprivation
499441|NCT01433315|sleep restriction|sleep restriction
499442|NCT01433302|Breast cancer|breast cancer
499443|NCT01433302|Genitourinary cancer|genitourinary cancer
499444|NCT01433302|Gynecological cancer|gynecological cancer
499445|NCT01433302|Malignant Female Reproductive System Neoplasm|malignant female reproductive system neoplasm
499446|NCT01433302|Melanoma|melanoma
499447|NCT01433302|Sarcoma|sarcoma
499448|NCT01433302|Inflammatory Response|inflammatory response
499449|NCT01433302|Inflammatory proteins|inflammatory proteins
499450|NCT01433302|Tissue Fibrosis|tissue fibrosis
499451|NCT01433302|Lymphatico-venous Bypass Surgery|lymphatico-venous bypass surgery
499452|NCT01433302|Punch biopsy|punch biopsy
499453|NCT01433302|Lab collections|lab collections
499454|NCT01433302|Th2 immune phenotype|th2 immune phenotype
499455|NCT01433302|Lymphedema|lymphedema
499456|NCT01433289|HIV|hiv
499457|NCT01433289|safety|safety
499458|NCT01433289|toxicity|toxicity
499459|NCT01433289|pharmacokinetics|pharmacokinetics
499460|NCT01433289|Polyphenon E|polyphenon e
499461|NCT01433289|EGCG|egcg
499462|NCT01433289|green tea|green tea
499463|NCT01433289|CD4|cd4
499464|NCT01433289|viral load|viral load
499465|NCT01433276|Fluid resuscitation|fluid resuscitation
499466|NCT01433276|hemorrhagic shock|hemorrhagic shock
499467|NCT01433276|Totilac|totilac
499468|NCT01433276|Ringer's|ringer's
499469|NCT01433276|trauma|trauma
499470|NCT01433263|Wasting syndrome|wasting syndrome
499471|NCT01433263|emaciation|emaciation
499472|NCT01433263|lung cancer|lung cancer
499473|NCT01433263|adenocarcinoma|adenocarcinoma
499474|NCT01433263|pancreatic cancer|pancreatic cancer
499475|NCT01433250|Multiple Sclerosis,|multiple sclerosis,
499476|NCT01433250|demyelinating autoimmune diseases,|demyelinating autoimmune diseases,
499477|NCT01433250|interleukin-17,|interleukin-17,
499478|NCT01433250|monoclonal human antibody|monoclonal human antibody
499479|NCT01433237|embryonal childhood rhabdomyosarcoma|embryonal childhood rhabdomyosarcoma
499480|NCT01433237|adult rhabdomyosarcoma|adult rhabdomyosarcoma
499481|NCT01433237|alveolar childhood rhabdomyosarcoma|alveolar childhood rhabdomyosarcoma
499482|NCT01433237|adult soft tissue sarcoma|adult soft tissue sarcoma
499483|NCT01433237|childhood rhabdomyosarcoma|childhood rhabdomyosarcoma
499484|NCT01433224|recurrent childhood malignant germ cell tumor|recurrent childhood malignant germ cell tumor
499485|NCT01433224|recurrent extragonadal germ cell tumor|recurrent extragonadal germ cell tumor
499486|NCT01433224|recurrent malignant testicular germ cell tumor|recurrent malignant testicular germ cell tumor
499487|NCT01433224|recurrent ovarian germ cell tumor|recurrent ovarian germ cell tumor
499488|NCT01433185|PMTCT|pmtct
499489|NCT01433185|SMS|sms
499490|NCT01433185|HIV Infections|hiv infections
499491|NCT01433185|Acquired Immunodeficiency Syndrome|acquired immunodeficiency syndrome
499492|NCT01433185|Prevention & Control|prevention & control
499493|NCT01433185|Patient Compliance|patient compliance
499494|NCT01433185|Cellular Phone|cellular phone
499495|NCT01433185|Randomized Controlled Trial|randomized controlled trial
499496|NCT01433172|stage IV|stage iv
499497|NCT01433172|adenocarcinoma|adenocarcinoma
499498|NCT01433172|vaccine therapy|vaccine therapy
499499|NCT01433172|immunology|immunology
499500|NCT01433172|tumor vaccine|tumor vaccine
499501|NCT01433172|colony stimulating factor(CSF)|colony stimulating factor(csf)
499502|NCT01433172|granulocyte-macrophage colony-stimulating factor (GM-CSF)|granulocyte-macrophage colony-stimulating factor (gm-csf)
499503|NCT01433172|CC chemokine ligand 21 (CCL21)|cc chemokine ligand 21 (ccl21)
499504|NCT01433172|Chemokine [C-C motif] ligand 21 (CCL21)|chemokine [c-c motif] ligand 21 (ccl21)
499505|NCT01433172|human leukocyte antigen serotype (HLA)|human leukocyte antigen serotype (hla)
499506|NCT01433159|Pressure Ulcers|pressure ulcers
499507|NCT01433159|Spinal Cord Injury|spinal cord injury
499508|NCT01433159|Healthpoint|healthpoint
499509|NCT01433159|Xenaderm|xenaderm
499510|NCT01433159|011-101|011-101
499511|NCT01433146|Temperament|temperament
499512|NCT01433146|Anxiety|anxiety
499513|NCT01433146|Depression|depression
499514|NCT01433146|Colorectal Cancer|colorectal cancer
499515|NCT01433120|Obesity|obesity
499516|NCT01433120|Insulin resistance|insulin resistance
499517|NCT01433120|Microbiota|microbiota
499518|NCT01433120|Probiotic|probiotic
499519|NCT01433120|Prebiotic|prebiotic
499520|NCT01433107|Tinea pedis|tinea pedis
499521|NCT01433107|Terbinafine film forming solution|terbinafine film forming solution
499522|NCT01433094|Adherence|adherence
499523|NCT01433094|Psychoeducation|psychoeducation
499524|NCT01433094|Pharmacotherapy|pharmacotherapy
499525|NCT01433094|Schizophrenia|schizophrenia
499526|NCT01433094|Family support|family support
499527|NCT01433068|Adult Soft Tissue Sarcoma of the extremities and Trunk wall|adult soft tissue sarcoma of the extremities and trunk wall
499528|NCT01433055|Schizophrenia|schizophrenia
499529|NCT01433055|Cognitive Symptoms|cognitive symptoms
499530|NCT01433055|Clozapine|clozapine
499531|NCT01433042|small bowel disease|small bowel disease
499532|NCT01433029|Surgical Procedure|surgical procedure
499533|NCT01433029|Assessment|assessment
499534|NCT01433029|Cardiothoracic Surgery|cardiothoracic surgery
499535|NCT01433029|Coronary artery bypass|coronary artery bypass
499536|NCT01433029|CAB|cab
499537|NCT01433029|Video recordings|video recordings
499538|NCT01433029|Global rating scale|global rating scale
499539|NCT01433029|GRS|grs
499540|NCT01433029|Cardiothoracic surgeon|cardiothoracic surgeon
499541|NCT01433029|Surgical trainees|surgical trainees
499542|NCT01433016|HCC Hepatocellular carcinoma|hcc hepatocellular carcinoma
499543|NCT01433016|OBT Octanoate Breath Test|obt octanoate breath test
499544|NCT01433003|Thrombotic thrombocytopenia purpura|thrombotic thrombocytopenia purpura
499545|NCT01433003|hemolytic uremic syndrome|hemolytic uremic syndrome
499546|NCT01433003|plasma exchange|plasma exchange
499547|NCT01433003|Improve treatment response|improve treatment response
499548|NCT01433003|TTP/HUS|ttp/hus
499549|NCT01432990|SCI|sci
499550|NCT01432990|gait|gait
499551|NCT01432990|rehabilitation|rehabilitation
499552|NCT01432990|robotic|robotic
499553|NCT01432964|Orbital Fractures|orbital fractures
499554|NCT01432964|Fracture Fixation|fracture fixation
499555|NCT01432964|Blow-out Fractures|blow-out fractures
499556|NCT01432964|Surgical Mesh|surgical mesh
499557|NCT01432964|Titanium|titanium
499558|NCT01432964|Computer-assisted Image Processing|computer-assisted image processing
499559|NCT01432925|Buruli ulcer|buruli ulcer
499560|NCT01432925|Mycobacterium ulcerans|mycobacterium ulcerans
499561|NCT01432925|Streptomycin|streptomycin
499562|NCT01432925|Rifampicin|rifampicin
499563|NCT01432925|Functional limitations|functional limitations
499564|NCT01432925|surgery|surgery
499565|NCT01432925|Bénin|bénin
499566|NCT01432899|Neurophysiology|neurophysiology
499567|NCT01432899|Hemidystonia|hemidystonia
499568|NCT01432899|Childhood-onset|childhood-onset
499569|NCT01432899|Motion Analysis|motion analysis
499570|NCT01432899|Neuroimaging|neuroimaging
499571|NCT01432899|Childhood Onset Hemidystonia|childhood onset hemidystonia
499572|NCT01432899|Healthy Volunteer|healthy volunteer
499573|NCT01432899|HV|hv
499574|NCT01432886|Breast Cancer|breast cancer
499575|NCT01432873|BMT|bmt
499576|NCT01432873|HSCT|hsct
499577|NCT01432860|Skin Self Examination|skin self examination
499578|NCT01432847|Best Disease|best disease
499579|NCT01432847|Late-Onset Retinal Degeneration (L-ORD)|late-onset retinal degeneration (l-ord)
499580|NCT01432847|Age-Related Macular Degeneration (AMD)|age-related macular degeneration (amd)
499581|NCT01432847|Induced Pluripotent Stem Cell (iPS) Cell Lines|induced pluripotent stem cell (ips) cell lines
499582|NCT01432847|Retinal Degeneration|retinal degeneration
499583|NCT01432847|Age-Related Macular Degeneration|age-related macular degeneration
499584|NCT01432847|AMD|amd
499585|NCT01432834|non-anterior astigmatism correction|non-anterior astigmatism correction
499586|NCT01432834|Allegretto Wave excimer laser|allegretto wave excimer laser
499587|NCT01432834|wavefront optimized ablation profile (WFO)|wavefront optimized ablation profile (wfo)
499588|NCT01432834|LASIK|lasik
499589|NCT01432834|PRK|prk
499590|NCT01432821|Epilepsy,|epilepsy,
499591|NCT01432821|dopamine|dopamine
499592|NCT01432821|yawning,|yawning,
499593|NCT01432821|blinking eyelids,|blinking eyelids,
499594|NCT01432821|electroencephalography|electroencephalography
499595|NCT01432795|chronic venous insufficiency|chronic venous insufficiency
499596|NCT01432795|post-thrombotic syndrome|post-thrombotic syndrome
499597|NCT01432795|medical compression therapy|medical compression therapy
499598|NCT01432795|compression stocking|compression stocking
499599|NCT01432795|gliding aid|gliding aid
499600|NCT01432795|stocking butler|stocking butler
499601|NCT01432795|adherence to treatment|adherence to treatment
499602|NCT01432782|Weight loss|weight loss
499603|NCT01432782|Dysphagia|dysphagia
499604|NCT01432782|Esophageal hypermotility|esophageal hypermotility
499605|NCT01432782|Chest Pain|chest pain
499606|NCT01432769|enteral nutrition|enteral nutrition
499607|NCT01432769|malnutrition|malnutrition
499608|NCT01432769|cardiac surgery|cardiac surgery
499609|NCT01432756|HIV|hiv
499610|NCT01432743|3D mapping|3d mapping
499611|NCT01432743|Image integration|image integration
499612|NCT01432743|Atrial fibrillation|atrial fibrillation
499613|NCT01432743|Catheter Ablation|catheter ablation
499614|NCT01432704|MS|ms
499615|NCT01432704|vitamin D|vitamin d
499616|NCT01432704|environment|environment
499617|NCT01432691|Hip-fracture|hip-fracture
499618|NCT01432691|RSA|rsa
499619|NCT01432678|vitamin D|vitamin d
499620|NCT01432678|asthma|asthma
499621|NCT01432665|HSDD|hsdd
499622|NCT01432639|Myocardial infarction|myocardial infarction
499623|NCT01432639|Autonomic function|autonomic function
499624|NCT01432639|Arterial Stiffness|arterial stiffness
499625|NCT01432639|Endothelial function|endothelial function
499626|NCT01432639|Inflammation|inflammation
499627|NCT01432639|Rehabilitation program|rehabilitation program
499628|NCT01432639|Exercise|exercise
499629|NCT01432626|stress induced cardiomyopathy|stress induced cardiomyopathy
499630|NCT01432626|broken heart syndrome|broken heart syndrome
499631|NCT01432626|Takotsubo cardiomyopathy|takotsubo cardiomyopathy
499632|NCT01432626|transient apical ballooning syndrome|transient apical ballooning syndrome
499633|NCT01432626|apical ballooning cardiomyopathy|apical ballooning cardiomyopathy
499634|NCT01432626|stress cardiomyopathy|stress cardiomyopathy
499635|NCT01432626|non-ischemic cardiomyopathy|non-ischemic cardiomyopathy
499636|NCT01432613|Myositis|myositis
499637|NCT01432613|Magnetic Resonance Imaging|magnetic resonance imaging
499638|NCT01432613|Muscle biopsy|muscle biopsy
499639|NCT01432613|Sensitivity and Specificity|sensitivity and specificity
499640|NCT01432600|Multiple Myeloma|multiple myeloma
499641|NCT01432600|Relapsed|relapsed
499642|NCT01432600|Refractory|refractory
499643|NCT01432600|Corticosteroids|corticosteroids
499644|NCT01432587|Amyloidosis|amyloidosis
499645|NCT01432587|Transthyretin|transthyretin
499646|NCT01432587|Neuropathies|neuropathies
499647|NCT01432587|Diflunisal|diflunisal
499648|NCT01432587|Familial|familial
499649|NCT01432574|HPV|hpv
499650|NCT01432561|Lysosomal Storage Diseases|lysosomal storage diseases
499651|NCT01432561|Metabolic Diseases|metabolic diseases
499652|NCT01432561|Metabolism, Inborn Errors|metabolism, inborn errors
499653|NCT01432548|Ischemic|ischemic
499654|NCT01432548|preconditioning|preconditioning
499655|NCT01432548|liver|liver
499656|NCT01432548|resection|resection
499657|NCT01432522|Intranasal epinephrine|intranasal epinephrine
499658|NCT01432522|Plasma epinephrine level|plasma epinephrine level
499659|NCT01432509|Pre-diabetes|pre-diabetes
499660|NCT01432509|Type 2 diabetes|type 2 diabetes
499661|NCT01432509|Biomarkers|biomarkers
499662|NCT01432509|Cohort|cohort
499663|NCT01432509|Diabetes Risk Score|diabetes risk score
499664|NCT01432509|Diabetes Mellitus, Type 2|diabetes mellitus, type 2
499665|NCT01432509|Glucose Intolerance|glucose intolerance
499666|NCT01432509|Prediabetic State|prediabetic state
499667|NCT01432509|Glucose Metabolism Disorders|glucose metabolism disorders
499668|NCT01432509|Metabolic Diseases|metabolic diseases
499669|NCT01432509|Endocrine System Diseases|endocrine system diseases
499670|NCT01432509|Hyperglycemia|hyperglycemia
499671|NCT01432496|Laparoscopic|laparoscopic
499672|NCT01432496|Colectomy|colectomy
499673|NCT01432496|Nebulization|nebulization
499674|NCT01432496|Ropivacaine|ropivacaine
499675|NCT01432483|Cancer|cancer
499676|NCT01432483|ONTAK|ontak
499677|NCT01432483|Denileukin diftitox|denileukin diftitox
499678|NCT01432483|persistent or recurrent disease|persistent or recurrent disease
499679|NCT01432483|requiring continued delivery of essential cancer therapy|requiring continued delivery of essential cancer therapy
499680|NCT01432470|vaginal atrophy|vaginal atrophy
499681|NCT01432444|Schizophrenia|schizophrenia
499682|NCT01432418|rehabilitation|rehabilitation
499683|NCT01432418|wheelchairs|wheelchairs
499684|NCT01432418|safety|safety
499685|NCT01432418|disability evaluation|disability evaluation
499686|NCT01432418|motor skills|motor skills
499687|NCT01432405|Diabetes|diabetes
499688|NCT01432392|gastroesophageal reflux disease|gastroesophageal reflux disease
499689|NCT01432392|GERD questionnaire|gerd questionnaire
499690|NCT01432392|primary care setting|primary care setting
499691|NCT01432340|Influenza|influenza
499692|NCT01432340|Influenza vaccine|influenza vaccine
499693|NCT01432340|Influenza vaccine effectiveness study|influenza vaccine effectiveness study
499694|NCT01432327|motor activity|motor activity
499695|NCT01432327|randomized controlled trial|randomized controlled trial
499696|NCT01432327|feedback|feedback
499697|NCT01432314|patient's survival|patient's survival
499698|NCT01432314|tumor response|tumor response
499699|NCT01432314|safety|safety
499700|NCT01432301|fluorouracil overdose|fluorouracil overdose
499701|NCT01432301|fluorouracil toxicity|fluorouracil toxicity
499702|NCT01432301|capecitabine overdose|capecitabine overdose
499703|NCT01432301|capecitabine toxicity|capecitabine toxicity
499704|NCT01432275|Diabetes|diabetes
499705|NCT01432275|SMBG|smbg
499706|NCT01432275|Insulin calculator|insulin calculator
499707|NCT01432262|prevention of pneumococcal diseases|prevention of pneumococcal diseases
499708|NCT01432249|pediatric psoriasis|pediatric psoriasis
499709|NCT01432249|enbrel|enbrel
499710|NCT01432249|safety|safety
499711|NCT01432249|efficacy|efficacy
499712|NCT01432236|Pregabalin|pregabalin
499713|NCT01432236|Lyrica|lyrica
499714|NCT01432236|depression|depression
499715|NCT01432223|Trastuzumab|trastuzumab
499716|NCT01432223|Neoadjuvant chemotherapy|neoadjuvant chemotherapy
499717|NCT01432223|Primary chemotherapy|primary chemotherapy
499718|NCT01432210|post-prandial absorption|post-prandial absorption
499719|NCT01432210|provitamin A carotenoids|provitamin a carotenoids
499720|NCT01432210|vitamin A|vitamin a
499721|NCT01432210|avocado|avocado
499722|NCT01432210|tomato|tomato
499723|NCT01432210|carrot|carrot
499724|NCT01432197|HRQOL|hrqol
499725|NCT01432197|Occupational therapy|occupational therapy
499726|NCT01432197|ADL intervention|adl intervention
499727|NCT01432197|Cancer patients|cancer patients
499728|NCT01432184|cerebral|cerebral
499729|NCT01432184|hypoxia|hypoxia
499730|NCT01432158|Invasive pneumococcal disease|invasive pneumococcal disease
499731|NCT01432145|BRCA defective|brca defective
499732|NCT01432132|Head and Neck Cancer|head and neck cancer
499733|NCT01432132|Body Image Adaptation|body image adaptation
499734|NCT01432132|Post surgical body image|post surgical body image
499735|NCT01432132|Audio-recorded interview|audio-recorded interview
499736|NCT01432132|Questionnaire|questionnaire
499737|NCT01432132|Survey|survey
499738|NCT01432119|Advanced Cancers|advanced cancers
499739|NCT01432119|Advanced Malignancies|advanced malignancies
499740|NCT01432119|Liver Metastases|liver metastases
499741|NCT01432119|SIR-Spheres|sir-spheres
499742|NCT01432119|Selective internal radiation|selective internal radiation
499743|NCT01432119|Yttrium-90|yttrium-90
499744|NCT01432119|Cetuximab|cetuximab
499745|NCT01432119|C225|c225
499746|NCT01432119|Erbitux|erbitux
499747|NCT01432119|Erlotinib|erlotinib
499748|NCT01432119|Erlotinib Hydrochloride|erlotinib hydrochloride
499749|NCT01432119|Tarceva|tarceva
499750|NCT01432119|OSI-774|osi-774
499751|NCT01432106|Hypertension|hypertension
499752|NCT01432106|Metabolic Syndrome|metabolic syndrome
499753|NCT01432106|African American|african american
499754|NCT01432093|liver transplant|liver transplant
499755|NCT01432093|high blood sugars|high blood sugars
499756|NCT01432093|hospital hyperglycemia|hospital hyperglycemia
499757|NCT01432093|post-transplant hyperglycemia|post-transplant hyperglycemia
499758|NCT01432093|post liver transplant|post liver transplant
500952|NCT01427400|Botox|botox
499759|NCT01432093|post liver-kidney transplant|post liver-kidney transplant
499760|NCT01432080|Pulmonary disease, chronic obstructive|pulmonary disease, chronic obstructive
499761|NCT01432080|Viral respiratory tract infections|viral respiratory tract infections
499762|NCT01432080|Respiratory syncytial viruses|respiratory syncytial viruses
499763|NCT01432080|Influenza virus A|influenza virus a
499764|NCT01432080|Influenza virus B|influenza virus b
499765|NCT01432080|Transplantation, Allogeneic|transplantation, allogeneic
499766|NCT01432067|cancer|cancer
499767|NCT01432067|geriatry|geriatry
499768|NCT01432067|curative care|curative care
499769|NCT01432067|physical activity|physical activity
499770|NCT01432054|Human Tissue Repository|human tissue repository
499771|NCT01432041|Injury prevention|injury prevention
499772|NCT01432041|smoke alarms|smoke alarms
499773|NCT01432041|car seats|car seats
499774|NCT01432015|aprepitant|aprepitant
499775|NCT01432015|fosaprepitant|fosaprepitant
499776|NCT01432015|gynecologic cancer|gynecologic cancer
499777|NCT01432015|emesis|emesis
499778|NCT01432002|breast carcinoma|breast carcinoma
499780|NCT01432002|PET/CT|pet/ct
499781|NCT01432002|PET/IRM|pet/irm
499782|NCT01431950|fluticasone furoate|fluticasone furoate
499783|NCT01431937|Pharmacodynamics|pharmacodynamics
499784|NCT01431937|Pharmacokinetics|pharmacokinetics
499785|NCT01431924|outcomes|outcomes
499786|NCT01431924|observational|observational
499787|NCT01431924|retrospective|retrospective
499788|NCT01431924|database|database
499789|NCT01431924|asthma|asthma
499790|NCT01431898|HCV RNA|hcv rna
499791|NCT01431898|Polymerase inhibitor|polymerase inhibitor
499792|NCT01431898|Treatment naïve and Treatment experienced|treatment naïve and treatment experienced
499793|NCT01431898|GS-9669|gs-9669
499794|NCT01431898|Hepatitis C|hepatitis c
499795|NCT01431898|HCV|hcv
499796|NCT01431885|fibronectin|fibronectin
499797|NCT01431885|cervical length|cervical length
499798|NCT01431872|Aromatase Inhibitors|aromatase inhibitors
499799|NCT01431859|pollen|pollen
499800|NCT01431859|allergy|allergy
499801|NCT01431859|food|food
499802|NCT01431859|immunotherapy|immunotherapy
499803|NCT01431833|Hepatic Impairment|hepatic impairment
499804|NCT01431833|Matched control subjects|matched control subjects
499805|NCT01431820|Onychomycosis|onychomycosis
499806|NCT01431820|Toenail Fungus|toenail fungus
499807|NCT01431820|luliconazole|luliconazole
499808|NCT01431820|Antifungal|antifungal
499809|NCT01431820|Topical|topical
499810|NCT01431794|Pancreatic ductal adenocarcinoma (PDA)Neoplasms|pancreatic ductal adenocarcinoma (pda)neoplasms
499811|NCT01431794|LDE225|lde225
499812|NCT01431794|nab-paclitaxel|nab-paclitaxel
499813|NCT01431794|abraxane|abraxane
499814|NCT01431794|gemcitabine|gemcitabine
499815|NCT01431794|neoadjuvant|neoadjuvant
499816|NCT01431794|cytotoxic|cytotoxic
499817|NCT01431794|hedgehog inhibitor|hedgehog inhibitor
499818|NCT01431794|stromal cells|stromal cells
499819|NCT01431794|resectable PDA|resectable pda
499820|NCT01431794|Pancreatic Diseases|pancreatic diseases
499821|NCT01431794|Carcinoma|carcinoma
499822|NCT01431794|Sonidegib|sonidegib
499823|NCT01431768|Influenza|influenza
499824|NCT01431768|Human|human
499825|NCT01431768|Orthomyxoviridae infections|orthomyxoviridae infections
499826|NCT01431768|RNA Virus Infections|rna virus infections
499827|NCT01431768|Virus Diseases|virus diseases
499828|NCT01431768|Respiratory Tract infections|respiratory tract infections
499829|NCT01431768|Respiratory Tract Diseases|respiratory tract diseases
499830|NCT01431742|buccal soluble film|buccal soluble film
499831|NCT01431742|Pain|pain
499832|NCT01431742|Back Pain|back pain
499833|NCT01431742|Low Back Pain|low back pain
499834|NCT01431742|Buprenorphine|buprenorphine
499835|NCT01431742|Analgesics, Opioid|analgesics, opioid
499836|NCT01431742|Analgesics|analgesics
499837|NCT01431703|narrow band imaging|narrow band imaging
499838|NCT01431703|learning curve|learning curve
499839|NCT01431703|colorectal|colorectal
499840|NCT01431703|differential diagnosis|differential diagnosis
499841|NCT01431703|with colorectal lesion|with colorectal lesion
499842|NCT01431703|NBI with magnification|nbi with magnification
499843|NCT01431690|Eicosapentaenoic Acid|eicosapentaenoic acid
499844|NCT01431690|Docosahexaenoic Acid|docosahexaenoic acid
499845|NCT01431690|Warfarin|warfarin
499846|NCT01431690|Hypertriglyceridemia|hypertriglyceridemia
499847|NCT01431690|Omega-3 free fatty acids|omega-3 free fatty acids
499848|NCT01431690|Omega-3 ethyl ester acids|omega-3 ethyl ester acids
499849|NCT01431690|Epanova|epanova
499850|NCT01431690|Lovaza|lovaza
499851|NCT01431690|pharmacokinetics|pharmacokinetics
499852|NCT01431690|low-fat meal|low-fat meal
499853|NCT01431677|Muscle|muscle
499854|NCT01431677|Biopsy|biopsy
499855|NCT01431677|Energetics|energetics
499856|NCT01431677|Sarcopenia|sarcopenia
499857|NCT01431677|Frailty|frailty
499858|NCT01431664|recurrent childhood acute lymphoblastic leukemia|recurrent childhood acute lymphoblastic leukemia
499859|NCT01431664|recurrent childhood acute myeloid leukemia|recurrent childhood acute myeloid leukemia
499860|NCT01431664|acute leukemias of ambiguous lineage|acute leukemias of ambiguous lineage
500953|NCT01427387|ASP0456|asp0456
499861|NCT01431664|acute undifferentiated leukemia|acute undifferentiated leukemia
499862|NCT01431664|secondary acute myeloid leukemia|secondary acute myeloid leukemia
499863|NCT01431651|Food and beverages|food and beverages
499864|NCT01431651|Food|food
499865|NCT01431651|Dietary supplements|dietary supplements
499866|NCT01431638|Gout|gout
499867|NCT01431638|arthritis|arthritis
499868|NCT01431638|gout flare|gout flare
499869|NCT01431638|acute gout|acute gout
499870|NCT01431638|gouty|gouty
499871|NCT01431638|rheumatic disease|rheumatic disease
499872|NCT01431638|uric acid|uric acid
499873|NCT01431638|podagra|podagra
499874|NCT01431625|COPD|copd
499875|NCT01431625|Exercise Training|exercise training
499876|NCT01431612|Pharmacokinetics, kidney;|pharmacokinetics, kidney;
499877|NCT01431612|Receptors, adrenergic;|receptors, adrenergic;
499878|NCT01431612|Fluids, i.v.;|fluids, i.v.;
499879|NCT01431612|Sympathetic nervous system, esmolol;|sympathetic nervous system, esmolol;
499880|NCT01431612|Sympathetic nervous system, phenylephrine|sympathetic nervous system, phenylephrine
499881|NCT01431599|Locally advanced rectal cancer|locally advanced rectal cancer
499882|NCT01431586|JDTic|jdtic
499883|NCT01431586|cocaine dependence|cocaine dependence
499884|NCT01431586|kappa-opioid antagonist|kappa-opioid antagonist
499885|NCT01431573|Depression|depression
499886|NCT01431560|ankle|ankle
499887|NCT01431560|metallic|metallic
499888|NCT01431560|biodegradable|biodegradable
499889|NCT01431560|Freedom|freedom
499890|NCT01431508|Hypertension|hypertension
499891|NCT01431495|platelet agregation|platelet agregation
499892|NCT01431495|clopidogrel|clopidogrel
499893|NCT01431495|major adverse cardiac events (MACE)|major adverse cardiac events (mace)
499894|NCT01431482|skin symptoms|skin symptoms
499895|NCT01431456|Prevention|prevention
499896|NCT01431456|venous thromboembolism after knee arthroplasty|venous thromboembolism after knee arthroplasty
499897|NCT01431443|Randomized double blind trial|randomized double blind trial
499898|NCT01431443|Cocoa flavonoids|cocoa flavonoids
499899|NCT01431443|Endothelial function|endothelial function
499900|NCT01431443|Blood pressure|blood pressure
499901|NCT01431443|Pregnant women|pregnant women
499902|NCT01431443|Preeclampsia|preeclampsia
499903|NCT01431443|Uterine artery flow|uterine artery flow
499904|NCT01431443|Pulsatility index|pulsatility index
499905|NCT01431430|Vitamine D|vitamine d
499906|NCT01431430|renal transplantation|renal transplantation
499907|NCT01431430|diabetes mellitus|diabetes mellitus
499908|NCT01431430|cancer|cancer
499909|NCT01431430|cardiovascular complications|cardiovascular complications
499910|NCT01431417|Shoulder|shoulder
499911|NCT01431417|Outcome treatment|outcome treatment
499912|NCT01431417|Validation Studies as topic|validation studies as topic
499913|NCT01431417|Biomechanics|biomechanics
499914|NCT01431417|Shoulder, Joint Instability|shoulder, joint instability
499915|NCT01431391|Immune therapy|immune therapy
499916|NCT01431391|Cancer vaccine|cancer vaccine
499917|NCT01431391|Therapeutic vaccine|therapeutic vaccine
499918|NCT01431391|Therapeutic cancer vaccine|therapeutic cancer vaccine
499919|NCT01431391|Vaccine|vaccine
499920|NCT01431391|Dendritic cells|dendritic cells
499921|NCT01431391|PSA|psa
499922|NCT01431391|Androgen deprivation therapy|androgen deprivation therapy
499923|NCT01431391|Prostatic Neoplasms|prostatic neoplasms
499924|NCT01431391|Genital Neoplasms, Male|genital neoplasms, male
499925|NCT01431391|Urogenital Neoplasms|urogenital neoplasms
499926|NCT01431391|Neoplasms|neoplasms
499927|NCT01431391|Prostatic Diseases|prostatic diseases
499928|NCT01431391|Androgens|androgens
499929|NCT01431391|Hormones|hormones
499930|NCT01431391|Adenocarcinoma|adenocarcinoma
499931|NCT01431391|Carcinoma|carcinoma
499932|NCT01431391|Neoplasms, Glandular and Epithelial|neoplasms, glandular and epithelial
499933|NCT01431391|Immunology|immunology
499934|NCT01431391|Hormone therapy|hormone therapy
499935|NCT01431391|Immunotherapy|immunotherapy
499936|NCT01431391|Luteinizing hormone-releasing hormone (LHRH)|luteinizing hormone-releasing hormone (lhrh)
499937|NCT01431378|CT scan|ct scan
499938|NCT01431378|CNS|cns
499939|NCT01431378|Thorax|thorax
499940|NCT01431378|Abdomen|abdomen
499941|NCT01431378|staging of a known or suspected lung cancer|staging of a known or suspected lung cancer
499942|NCT01431378|suspected urolithiasis|suspected urolithiasis
499943|NCT01431378|known or suspected focal liver lesion|known or suspected focal liver lesion
499944|NCT01431365|exercise|exercise
499945|NCT01431365|topography|topography
499946|NCT01431365|cravings|cravings
499947|NCT01431365|smoking behaviour|smoking behaviour
499948|NCT01431352|Polycystic ovary syndrome|polycystic ovary syndrome
499949|NCT01431352|Randomized controlled trial|randomized controlled trial
499950|NCT01431352|Chinese herbal medicine|chinese herbal medicine
499951|NCT01431352|Chinese herbal medicine granules|chinese herbal medicine granules
499952|NCT01431352|Letrozole|letrozole
499953|NCT01431352|Live birth|live birth
499954|NCT01431326|adenovirus|adenovirus
499955|NCT01431326|anaesthetic|anaesthetic
499956|NCT01431326|anesthesia|anesthesia
499957|NCT01431326|anticoagulant|anticoagulant
499958|NCT01431326|anti-epileptic|anti-epileptic
499959|NCT01431326|anti-inflammatory|anti-inflammatory
499960|NCT01431326|antimicrobial|antimicrobial
499961|NCT01431326|anti-psychotic|anti-psychotic
499962|NCT01431326|antiviral|antiviral
499963|NCT01431326|anxiety|anxiety
499964|NCT01431326|anxiolysis|anxiolysis
499965|NCT01431326|anxiolytic|anxiolytic
499966|NCT01431326|autism|autism
499967|NCT01431326|autistic disorder|autistic disorder
499968|NCT01431326|benzodiazepine|benzodiazepine
499969|NCT01431326|bipolar disorder|bipolar disorder
499970|NCT01431326|convulsions|convulsions
499971|NCT01431326|epilepsy|epilepsy
499972|NCT01431326|headaches|headaches
499973|NCT01431326|herpes simplex virus|herpes simplex virus
499974|NCT01431326|herpes simplex virus (HSV)|herpes simplex virus (hsv)
499975|NCT01431326|hypertension|hypertension
499976|NCT01431326|infantile hemangioma|infantile hemangioma
499977|NCT01431326|infection|infection
499978|NCT01431326|inflammation|inflammation
499979|NCT01431326|influenza|influenza
499980|NCT01431326|lower respiratory tract infection (LRTI)|lower respiratory tract infection (lrti)
499981|NCT01431326|meningitis|meningitis
499982|NCT01431326|migraines|migraines
499983|NCT01431326|muscle spasms|muscle spasms
499984|NCT01431326|pain|pain
499985|NCT01431326|pneumonia|pneumonia
499986|NCT01431326|prophylaxis|prophylaxis
499987|NCT01431326|retinitis|retinitis
499988|NCT01431326|schizophrenia|schizophrenia
499989|NCT01431326|sedation|sedation
499990|NCT01431326|sedative|sedative
499991|NCT01431326|seizures|seizures
499992|NCT01431326|septicemia|septicemia
499993|NCT01431326|swelling|swelling
499994|NCT01431326|urinary tract infection|urinary tract infection
499995|NCT01431326|urinary tract infection (UTI)|urinary tract infection (uti)
499996|NCT01431326|withdrawal|withdrawal
499997|NCT01431326|empiric therapy|empiric therapy
499998|NCT01431326|staphylococci|staphylococci
499999|NCT01431326|Fibrinolytic Bleeding|fibrinolytic bleeding
500000|NCT01431326|pulmonary arterial hypertension|pulmonary arterial hypertension
500001|NCT01431326|CMV retinitis|cmv retinitis
500002|NCT01431326|control of serum phosphorus|control of serum phosphorus
500003|NCT01431326|Hyperaldosteronism|hyperaldosteronism
500004|NCT01431326|hypokalemia|hypokalemia
500005|NCT01431326|heart failure|heart failure
500006|NCT01431326|hemophilia|hemophilia
500007|NCT01431326|Heavy Menstrual Bleeding|heavy menstrual bleeding
500008|NCT01431326|insomnia|insomnia
500009|NCT01431313|pulmonary hypertension|pulmonary hypertension
500010|NCT01431313|heart failure|heart failure
500011|NCT01431300|central veins|central veins
500012|NCT01431300|thorax|thorax
500013|NCT01431300|superior vena cava|superior vena cava
500014|NCT01431300|Central vein imaging|central vein imaging
500015|NCT01431261|Chronic neck pain|chronic neck pain
500016|NCT01431261|Whiplash|whiplash
500017|NCT01431261|Whiplash Associated Disorders|whiplash associated disorders
500018|NCT01431261|Chronic Pain|chronic pain
500019|NCT01431261|Neck exercises|neck exercises
500020|NCT01431261|Training|training
500021|NCT01431261|Pacing|pacing
500022|NCT01431261|Patient Education|patient education
500023|NCT01431261|Pain Management|pain management
500024|NCT01431261|Whiplash Injuries|whiplash injuries
500025|NCT01431261|Musculoskeletal|musculoskeletal
500026|NCT01431248|Preterm Premature Rupture of Membranes|preterm premature rupture of membranes
500027|NCT01431248|Erythromycin|erythromycin
500028|NCT01431248|Azithromycin|azithromycin
500029|NCT01431235|ADHD|adhd
500030|NCT01431235|SUD|sud
500031|NCT01431235|cognitive behavioral therapy|cognitive behavioral therapy
500032|NCT01431222|severe mitral regurgitation|severe mitral regurgitation
500033|NCT01431222|interventional mitral valve reconstruction|interventional mitral valve reconstruction
500034|NCT01431222|inoperable|inoperable
500035|NCT01431222|EuroSCORE|euroscore
500036|NCT01431222|STS Risk Score|sts risk score
500037|NCT01431222|MitraClip|mitraclip
500038|NCT01431222|fluoroscopy|fluoroscopy
500039|NCT01431222|echocardiography|echocardiography
636030|NCT00884832|FI|fi
500040|NCT01431222|percutaneous treatment of mitral regurgitation|percutaneous treatment of mitral regurgitation
500041|NCT01431196|breast cancer|breast cancer
500042|NCT01431196|neoadjuvant chemotherapy|neoadjuvant chemotherapy
500043|NCT01431196|autologous dendritic cell vaccination|autologous dendritic cell vaccination
500044|NCT01431183|influenza|influenza
500045|NCT01431183|vaccine|vaccine
500046|NCT01431183|reminder / recall|reminder / recall
500047|NCT01431183|immunization registry|immunization registry
500048|NCT01431183|immunization information systems|immunization information systems
500049|NCT01431157|Sleep Apnea Syndrome|sleep apnea syndrome
500050|NCT01431157|Heart Failure|heart failure
500051|NCT01431157|Oxygen Inhalation Therapy|oxygen inhalation therapy
500052|NCT01431144|soft tissue thickness|soft tissue thickness
500053|NCT01431144|dental implant|dental implant
500054|NCT01431144|soft tissue recession|soft tissue recession
500055|NCT01431144|implant exposure|implant exposure
500056|NCT01431131|graft placement|graft placement
500057|NCT01431131|bone resorption|bone resorption
500058|NCT01431118|iron metabolism|iron metabolism
500059|NCT01431118|hepcidin|hepcidin
500060|NCT01431118|dragon boating|dragon boating
500061|NCT01431118|sport-specific stress|sport-specific stress
500062|NCT01431118|iron|iron
500063|NCT01431118|anaemia|anaemia
500064|NCT01431118|sport|sport
500065|NCT01431105|Kawasaki disease|kawasaki disease
500066|NCT01431079|HPV|hpv
500067|NCT01431079|College men|college men
500068|NCT01431079|HPV vaccine|hpv vaccine
500069|NCT01431079|Health belief model|health belief model
500070|NCT01431079|HPV vaccine acceptance|hpv vaccine acceptance
500071|NCT01431053|exemestane|exemestane
500072|NCT01431053|aspirin|aspirin
500073|NCT01431053|quality of life|quality of life
500074|NCT01431040|Bowel Prep|bowel prep
500075|NCT01431040|No bowel prep|no bowel prep
500076|NCT01431040|Vaginal reconstructive or obliterative surgery|vaginal reconstructive or obliterative surgery
500077|NCT01431027|Heart Failure|heart failure
500078|NCT01431027|Diastolic Heart Failure|diastolic heart failure
500079|NCT01431027|Heart Failure with Normal Ejection Fraction|heart failure with normal ejection fraction
500080|NCT01431014|orthognathic surgery|orthognathic surgery
500081|NCT01431014|steroid|steroid
500082|NCT01431014|swelling|swelling
500083|NCT01431014|3-dimensional photogrammetry|3-dimensional photogrammetry
500084|NCT01431001|Depression|depression
500085|NCT01431001|MDD|mdd
500086|NCT01431001|Transcranial Magnetic Stimulation|transcranial magnetic stimulation
500087|NCT01431001|Depressive Disorder|depressive disorder
500088|NCT01431001|TMS|tms
500089|NCT01430988|Head Injuries|head injuries
500090|NCT01430988|Head Trauma|head trauma
500091|NCT01430988|TBI (Traumatic Brain Injury)|tbi (traumatic brain injury)
500092|NCT01430988|Emergency Department|emergency department
500093|NCT01430988|Accident & Emergency|accident & emergency
500094|NCT01430975|Radiation Exposure|radiation exposure
500095|NCT01430975|Rubidium 82|rubidium 82
500096|NCT01430975|Strontium 82|strontium 82
500097|NCT01430975|Strontium 85|strontium 85
500098|NCT01430962|EBUS|ebus
500099|NCT01430962|mediastinal lymph nodes|mediastinal lymph nodes
500100|NCT01430962|mediastinal masses|mediastinal masses
500101|NCT01430962|anesthesia|anesthesia
500102|NCT01430962|moderate sedation|moderate sedation
500103|NCT01430949|Paroxysmal Atrial Fibrillation|paroxysmal atrial fibrillation
500104|NCT01430949|Catheter Ablation|catheter ablation
500105|NCT01430949|Pulmonary Vein Isolation|pulmonary vein isolation
500106|NCT01430949|Radio Frequency Ablation|radio frequency ablation
500107|NCT01430936|Vascular Diseases|vascular diseases
500108|NCT01430936|Hypertension|hypertension
500109|NCT01430936|Chronic Kidney Disease|chronic kidney disease
500110|NCT01430936|COPD|copd
500111|NCT01430923|Refrigeration free latanoprost|refrigeration free latanoprost
500112|NCT01430910|Phase 1|phase 1
500113|NCT01430910|open label|open label
500114|NCT01430910|ceftazidime|ceftazidime
500115|NCT01430910|pharmacokinetics|pharmacokinetics
500116|NCT01430910|urinary tract infection|urinary tract infection
500117|NCT01430910|intra-abdominal infection|intra-abdominal infection
500118|NCT01430897|d-TGA|d-tga
500119|NCT01430897|dextro Transposition of the great arteries|dextro transposition of the great arteries
500120|NCT01430897|systemic right ventricle|systemic right ventricle
500121|NCT01430897|right ventricular failure|right ventricular failure
500122|NCT01430897|Atrial switch procedure|atrial switch procedure
500123|NCT01430884|coronary aspirate blood|coronary aspirate blood
500124|NCT01430884|particular debris / microemboli|particular debris / microemboli
500125|NCT01430884|distal occlusion device|distal occlusion device
500126|NCT01430858|Fracture|fracture
500127|NCT01430858|Anabolic|anabolic
500128|NCT01430858|Vibration|vibration
500129|NCT01430858|Strain Gauge|strain gauge
500130|NCT01430858|Focus - Osteoporosis|focus - osteoporosis
500132|NCT01430845|CP|cp
500133|NCT01430845|MR|mr
500134|NCT01430845|PDD|pdd
500135|NCT01430845|ASD|asd
500136|NCT01430845|BSID|bsid
500137|NCT01430832|PTSD|ptsd
500138|NCT01430832|Preterm|preterm
500139|NCT01430832|Premature|premature
500140|NCT01430832|VLBW|vlbw
500141|NCT01430819|Influenza|influenza
500142|NCT01430819|Influenza Virus Vaccine|influenza virus vaccine
500143|NCT01430819|Fluzone® 2011-2012 Formulation|fluzone® 2011-2012 formulation
500144|NCT01430819|Fluzone® High-Dose 2011-2012 Formulation|fluzone® high-dose 2011-2012 formulation
500145|NCT01430819|Trivalent Inactivated Influenza Vaccine|trivalent inactivated influenza vaccine
500146|NCT01430780|Coronary artery disease|coronary artery disease
500147|NCT01430780|nitrate|nitrate
500148|NCT01430780|endothelium|endothelium
500149|NCT01430767|adherence|adherence
500150|NCT01430754|Blindness|blindness
500151|NCT01430754|Eye Diseases|eye diseases
500152|NCT01430754|Nap Disorders|nap disorders
500153|NCT01430754|Circadian Rhythm Disorders|circadian rhythm disorders
500154|NCT01430754|Sleep Disorders|sleep disorders
500155|NCT01430754|Circadian Rhythm Sleep Disorders|circadian rhythm sleep disorders
500156|NCT01430754|Dyssomnias|dyssomnias
500157|NCT01430754|Nervous System Diseases|nervous system diseases
500158|NCT01430741|Implementation Science|implementation science
500159|NCT01430741|Supportive Housing|supportive housing
500160|NCT01430741|Co-occurring disorders|co-occurring disorders
500161|NCT01430741|Cluster randomized controlled trial|cluster randomized controlled trial
500162|NCT01430741|Hybrid implementation-effectiveness trial|hybrid implementation-effectiveness trial
500163|NCT01430715|active video game|active video game
500164|NCT01430715|video gaming|video gaming
500165|NCT01430715|accelerometery|accelerometery
500166|NCT01430715|MVPA|mvpa
500167|NCT01430715|outdoor play|outdoor play
500168|NCT01430715|children|children
500169|NCT01430715|unstructured|unstructured
500170|NCT01430715|energy expenditure|energy expenditure
500171|NCT01430689|Influenza|influenza
500172|NCT01430689|Pregnancy|pregnancy
500173|NCT01430689|Neonates|neonates
500174|NCT01430676|Incisional hernia|incisional hernia
500175|NCT01430676|recurrence|recurrence
500176|NCT01430676|longterm|longterm
500177|NCT01430663|aspergillosis|aspergillosis
500178|NCT01430663|bronchoalveolar lavage|bronchoalveolar lavage
500179|NCT01430663|galactomannan|galactomannan
500180|NCT01430663|pcr|pcr
500181|NCT01430663|hematological patients|hematological patients
500182|NCT01430650|Oral estrogens|oral estrogens
500183|NCT01430650|transdermal estrogens|transdermal estrogens
500184|NCT01430650|endometrial priming|endometrial priming
500185|NCT01430637|childhood desmoplastic small round cell tumor|childhood desmoplastic small round cell tumor
500186|NCT01430637|metastatic childhood soft tissue sarcoma|metastatic childhood soft tissue sarcoma
500187|NCT01430637|nonmetastatic childhood soft tissue sarcoma|nonmetastatic childhood soft tissue sarcoma
500188|NCT01430637|recurrent childhood soft tissue sarcoma|recurrent childhood soft tissue sarcoma
500189|NCT01430637|recurrent adult soft tissue sarcoma|recurrent adult soft tissue sarcoma
500190|NCT01430637|stage I adult soft tissue sarcoma|stage i adult soft tissue sarcoma
500191|NCT01430637|stage II adult soft tissue sarcoma|stage ii adult soft tissue sarcoma
500192|NCT01430637|stage III adult soft tissue sarcoma|stage iii adult soft tissue sarcoma
500193|NCT01430637|stage IV adult soft tissue sarcoma|stage iv adult soft tissue sarcoma
500194|NCT01430637|adult desmoplastic small round cell tumor|adult desmoplastic small round cell tumor
500195|NCT01430624|Rape|rape
500196|NCT01430624|Secondary prevention|secondary prevention
500197|NCT01430624|Intervention|intervention
500198|NCT01430611|Meningitis|meningitis
500199|NCT01430611|Neisseria meningitidis|neisseria meningitidis
500200|NCT01430611|Meningo A+C®|meningo a+c®
500201|NCT01430611|Meng Ling Kang®|meng ling kang®
500202|NCT01430598|Full Thickness Rotator Cuff Tear and Acromial Spur|full thickness rotator cuff tear and acromial spur
500203|NCT01430585|Ki-67|ki-67
500204|NCT01430585|postmenopausal early breast cancer|postmenopausal early breast cancer
500205|NCT01430585|ER positive/HER2 negative early breast cancer|er positive/her2 negative early breast cancer
500206|NCT01430572|Advanced Cancers|advanced cancers
500207|NCT01430572|Solid Tumors|solid tumors
500208|NCT01430572|PI3KCA Mutation Positive/PTEN|pi3kca mutation positive/pten
500209|NCT01430572|Refractory to standard therapy|refractory to standard therapy
500210|NCT01430572|Relapsed after standard therapy|relapsed after standard therapy
500211|NCT01430572|Pazopanib|pazopanib
500212|NCT01430572|GW786034|gw786034
500213|NCT01430572|Everolimus|everolimus
500214|NCT01430572|Afinitor|afinitor
500215|NCT01430572|RAD001|rad001
500216|NCT01430559|Validation of the WOMAC in Chinese subjects with osteoarthritis of the knee|validation of the womac in chinese subjects with osteoarthritis of the knee
500217|NCT01430546|Relapsed and Refractory Multiple Myeloma|relapsed and refractory multiple myeloma
500218|NCT01430533|dermal sensitization potential|dermal sensitization potential
500219|NCT01430507|Anti-inflammatory drugs, DMARD|anti-inflammatory drugs, dmard
500220|NCT01430481|rosehip|rosehip
500221|NCT01430481|osteoarthritis|osteoarthritis
500222|NCT01430481|pain|pain
500223|NCT01430481|knee|knee
500224|NCT01430481|RCT|rct
500225|NCT01430468|Glenoid component position|glenoid component position
500226|NCT01430468|patient specific instruments|patient specific instruments
500227|NCT01430455|Major Depressive Episode|major depressive episode
500228|NCT01430455|Depression NOS|depression nos
500229|NCT01430455|Bipolar Disorder|bipolar disorder
500230|NCT01430455|Bipolar Disorder I|bipolar disorder i
500231|NCT01430455|Bipolar Disorder II|bipolar disorder ii
500232|NCT01430455|Bipolar Depression|bipolar depression
500233|NCT01430455|Major Depression|major depression
500234|NCT01430416|Uveal melanoma|uveal melanoma
500235|NCT01430416|phase 1|phase 1
500236|NCT01430416|AEB071|aeb071
500237|NCT01430416|Metastatic|metastatic
500238|NCT01430403|persistent allergic asthma|persistent allergic asthma
500239|NCT01430403|asthma exacerbations reduction|asthma exacerbations reduction
500240|NCT01430403|Xolair® (omalizumab)|xolair® (omalizumab)
500241|NCT01430403|Flovent® Diskus® (fluticasone)|flovent® diskus® (fluticasone)
500242|NCT01430403|placebo|placebo
500243|NCT01430403|inhaled corticosteroid therapy|inhaled corticosteroid therapy
500244|NCT01430403|anti-immunoglobulin E therapy|anti-immunoglobulin e therapy
500245|NCT01430403|anti-IgE therapy|anti-ige therapy
500246|NCT01430390|In Vitro Expanded Allogeneic Epstein-Barr Virus Specific Cytotoxic|in vitro expanded allogeneic epstein-barr virus specific cytotoxic
500247|NCT01430390|T-Lymphocytes (EBV-CTLs)|t-lymphocytes (ebv-ctls)
500248|NCT01430390|CD19 specific T-cells|cd19 specific t-cells
500249|NCT01430390|11-038|11-038
500250|NCT01430377|periprocedural myonecrosis|periprocedural myonecrosis
500251|NCT01430377|procedure time|procedure time
500252|NCT01430377|fluoroscopy time|fluoroscopy time
500253|NCT01430364|coronary bifurcation stenosis|coronary bifurcation stenosis
500254|NCT01430364|dedicated bifurcation stent|dedicated bifurcation stent
500255|NCT01430364|sirolymus|sirolymus
500256|NCT01430364|PTS|pts
500257|NCT01430364|BiOSS Lym|bioss lym
500258|NCT01430325|Hyperbaric oxygen|hyperbaric oxygen
500259|NCT01430312|dermal irritative potential|dermal irritative potential
500260|NCT01430286|Caregivers|caregivers
500261|NCT01430286|Alzheimer Disease|alzheimer disease
500262|NCT01430286|Psychological stress|psychological stress
500263|NCT01430286|Psychological adaptation|psychological adaptation
500264|NCT01430286|Self-efficacy|self-efficacy
500265|NCT01430286|Randomized controlled trial|randomized controlled trial
500266|NCT01430273|Antiplatelet therapy|antiplatelet therapy
500267|NCT01430273|Surgery|surgery
500268|NCT01430273|Bleeding|bleeding
500269|NCT01430273|Platelet aggregation|platelet aggregation
500270|NCT01430260|efficacy|efficacy
500271|NCT01430260|ciclesonide|ciclesonide
500272|NCT01430260|levocetirizine|levocetirizine
500273|NCT01430260|allergic rhinitis|allergic rhinitis
500274|NCT01430247|amblyopia|amblyopia
500275|NCT01430247|amblyogenic factors|amblyogenic factors
500276|NCT01430247|screening|screening
500277|NCT01430247|preschool children|preschool children
500278|NCT01430247|visual acuity|visual acuity
500279|NCT01430247|prevalence|prevalence
500280|NCT01430234|Chronic pancreatitis|chronic pancreatitis
500281|NCT01430234|Exocrine insufficiency|exocrine insufficiency
500282|NCT01430234|Pancreatic enzyme replacement therapy|pancreatic enzyme replacement therapy
500283|NCT01430234|Self-administration|self-administration
500284|NCT01430221|prediabetes|prediabetes
500285|NCT01430221|severity of depressive symptoms|severity of depressive symptoms
500286|NCT01430221|mindfulness|mindfulness
500287|NCT01430221|personalized health planning|personalized health planning
500288|NCT01430221|cardiometabolic diseases prevention|cardiometabolic diseases prevention
500289|NCT01430208|endometrial pathology|endometrial pathology
500290|NCT01430195|vitiligo|vitiligo
500291|NCT01430195|depigmentation|depigmentation
500292|NCT01430195|phototherapy|phototherapy
500293|NCT01430195|non-segmental vitiligo|non-segmental vitiligo
500294|NCT01430182|Adult|adult
500295|NCT01430182|Female|female
500296|NCT01430182|Humans|humans
500297|NCT01430182|Intraoperative Care/methods|intraoperative care/methods
500298|NCT01430182|Male|male
500299|NCT01430182|Methadone/administration & dosage|methadone/administration & dosage
500300|NCT01430182|Analgesics/therapeutic use|analgesics/therapeutic use
500301|NCT01430182|Methadone/therapeutic use|methadone/therapeutic use
500302|NCT01430182|Morphine/therapeutic use|morphine/therapeutic use
500303|NCT01430182|Middle Aged|middle aged
500304|NCT01430182|Pain Measurement/drug effects|pain measurement/drug effects
500305|NCT01430182|Pain Measurement/methods|pain measurement/methods
500306|NCT01430182|Pain, Postoperative/prevention & control|pain, postoperative/prevention & control
500307|NCT01430182|Prospective Studies|prospective studies
500308|NCT01430182|Double-Blind Method|double-blind method
500309|NCT01430182|Tibial Fractures/surgery|tibial fractures/surgery
500310|NCT01430182|Young Adult|young adult
500311|NCT01430182|Orthopedics|orthopedics
500312|NCT01430169|Xiaflex|xiaflex
500313|NCT01430169|Xiapex|xiapex
500314|NCT01430169|Collagenase clostridium histolyticum|collagenase clostridium histolyticum
500315|NCT01430156|Renal Transplantation|renal transplantation
500316|NCT01430156|Ischemia-reperfusion injury|ischemia-reperfusion injury
500317|NCT01430156|Heme-oxygenase 1|heme-oxygenase 1
500318|NCT01430156|Heme arginate|heme arginate
500319|NCT01430143|Exercise|exercise
500320|NCT01430130|scar|scar
500321|NCT01430130|incision|incision
500322|NCT01430130|wound healing|wound healing
500323|NCT01430130|scarring|scarring
500324|NCT01430130|scar revision|scar revision
500325|NCT01430117|Immunotherapy|immunotherapy
500326|NCT01430117|Skin prick test|skin prick test
500327|NCT01430117|Standardization|standardization
500328|NCT01430117|Poa pratensis|poa pratensis
500329|NCT01430078|ASP015K|asp015k
500330|NCT01430078|Healthy subjects|healthy subjects
500331|NCT01430078|Pharmacokinetics of ASP015K|pharmacokinetics of asp015k
500332|NCT01430065|transplant|transplant
500333|NCT01430065|ASP015K|asp015k
500334|NCT01430065|tacrolimus|tacrolimus
500335|NCT01430065|Prograf|prograf
500336|NCT01430065|healthy volunteers|healthy volunteers
500337|NCT01430039|Crohn's disease|crohn's disease
500338|NCT01430039|ulcerative colitis|ulcerative colitis
500339|NCT01430039|Syndecan-1|syndecan-1
500340|NCT01430026|chronic sinusitis|chronic sinusitis
500341|NCT01430026|gentamicin nasal irrigation|gentamicin nasal irrigation
500342|NCT01429987|Chronic Idiopathic Constipation|chronic idiopathic constipation
500343|NCT01429987|Constipation|constipation
500344|NCT01429987|Sign and Symptoms: Digestive|sign and symptoms: digestive
500345|NCT01429974|amniotic fluid|amniotic fluid
500346|NCT01429974|post term pregnancies|post term pregnancies
500347|NCT01429948|Stroke, Ischemic|stroke, ischemic
500348|NCT01429948|Patent foramen ovale|patent foramen ovale
500349|NCT01429948|Magnetic resonance imaging|magnetic resonance imaging
500350|NCT01429948|Paradoxical embolism|paradoxical embolism
500351|NCT01429948|Transcranial Doppler|transcranial doppler
500352|NCT01429948|Silent cerebral infarct|silent cerebral infarct
500353|NCT01429935|dental pain model|dental pain model
500354|NCT01429935|Ginger powder|ginger powder
500355|NCT01429935|CRP|crp
500356|NCT01429909|Functional magnetic resonance imaging|functional magnetic resonance imaging
500358|NCT01429909|cortex and basal ganglia|cortex and basal ganglia
500359|NCT01429909|Parkinson's disease|parkinson's disease
500360|NCT01429896|peanut allergy|peanut allergy
500361|NCT01429896|food allergy|food allergy
500362|NCT01429896|thresholds|thresholds
500363|NCT01429896|anaphylaxis|anaphylaxis
500364|NCT01429896|food labelling|food labelling
500365|NCT01429896|food challenges|food challenges
500366|NCT01429896|peanut challenges|peanut challenges
500367|NCT01429857|Troponin concentration in heart failure|troponin concentration in heart failure
500368|NCT01429844|Calcineurin inhibitors|calcineurin inhibitors
500369|NCT01429844|Bronchiolitis obliterans|bronchiolitis obliterans
500370|NCT01429844|Lung transplantation|lung transplantation
500371|NCT01429844|Cyclosporine|cyclosporine
500372|NCT01429844|Tacrolimus|tacrolimus
500373|NCT01429844|Mycophenolate|mycophenolate
500374|NCT01429844|Steroids|steroids
500375|NCT01429844|Chronic rejection|chronic rejection
500376|NCT01429844|Acute rejection|acute rejection
500377|NCT01429844|Obliterative bronchiolitis|obliterative bronchiolitis
500378|NCT01429818|Endothelial dysfunction|endothelial dysfunction
500379|NCT01429818|Diabetes mellitus|diabetes mellitus
500380|NCT01429818|glimepiride|glimepiride
500381|NCT01429818|metformin|metformin
500382|NCT01429805|Hip arthroscopy|hip arthroscopy
500383|NCT01429779|General surgery|general surgery
500384|NCT01429766|Breath holding times|breath holding times
500385|NCT01429766|Phases of respiration|phases of respiration
500386|NCT01429766|Radiotherapy|radiotherapy
500387|NCT01429753|Cardiac resychronisation therapy|cardiac resychronisation therapy
500388|NCT01429753|Heart failure|heart failure
500389|NCT01429753|Imaging guided LV lead placement|imaging guided lv lead placement
500390|NCT01429740|PF 05180999|pf 05180999
500391|NCT01429740|safety|safety
500392|NCT01429740|pharmacokinetics|pharmacokinetics
500393|NCT01429727|Spontaneous coronary artery dissection|spontaneous coronary artery dissection
500394|NCT01429727|SCAD|scad
500395|NCT01429727|coronary artery disease|coronary artery disease
500396|NCT01429727|myocardial infarction|myocardial infarction
500397|NCT01429727|coronary dissection|coronary dissection
500398|NCT01429714|Elastic Compression Stockings|elastic compression stockings
500399|NCT01429714|Deep Venous Thrombosis|deep venous thrombosis
500400|NCT01429714|Post Thrombotic Syndrome|post thrombotic syndrome
500401|NCT01429701|Dermatitis|dermatitis
500402|NCT01429701|Dermatitis, Atopic|dermatitis, atopic
500403|NCT01429662|postmenopause|postmenopause
500404|NCT01429662|hypertension|hypertension
500405|NCT01429662|relaxation|relaxation
500406|NCT01429662|SBP 140-159 mmHg|sbp 140-159 mmhg
500407|NCT01429662|DBP 90-99 mmHg|dbp 90-99 mmhg
500408|NCT01429662|stage 1 or mild hypertension|stage 1 or mild hypertension
500409|NCT01429649|pure pulmonary ground glass opacity|pure pulmonary ground glass opacity
500410|NCT01429636|perimenopause|perimenopause
500411|NCT01429636|postmenopause|postmenopause
500412|NCT01429636|vasomotor symptoms|vasomotor symptoms
500413|NCT01429636|relaxation|relaxation
500414|NCT01429623|Mild Cognitive Impairment|mild cognitive impairment
500415|NCT01429623|Early Stage Dementia|early stage dementia
500416|NCT01429623|Conversion to Alzheimer's disease|conversion to alzheimer's disease
500417|NCT01429623|Memory Impairment|memory impairment
500418|NCT01429610|acute lymphoblastic leukemia|acute lymphoblastic leukemia
500419|NCT01429610|rituximab|rituximab
500420|NCT01429610|VPDL|vpdl
500421|NCT01429610|CD20|cd20
500422|NCT01429597|Cerebrovascular Accident|cerebrovascular accident
500423|NCT01429597|Cerebrovascular Accident, Acute|cerebrovascular accident, acute
500424|NCT01429597|Fabry Disease|fabry disease
500425|NCT01429597|Fabry´s Disease|fabry´s disease
500426|NCT01429597|Anderson-Fabry Disease|anderson-fabry disease
500427|NCT01429597|CVA (Cerebrovascular Accident)|cva (cerebrovascular accident)
500428|NCT01429597|Stroke, Acute|stroke, acute
500429|NCT01429597|Cerebral Stroke|cerebral stroke
500430|NCT01429584|bupivacaine concentration|bupivacaine concentration
500431|NCT01429584|interscalene nerve block|interscalene nerve block
500432|NCT01429584|diaphragm function|diaphragm function
500433|NCT01429584|diaphragm weakness|diaphragm weakness
500434|NCT01429558|treatment resistant obsessive-compulsive disorder|treatment resistant obsessive-compulsive disorder
500435|NCT01429545|Tocolysis|tocolysis
500436|NCT01429545|atosiban|atosiban
500437|NCT01429545|nifedipine|nifedipine
500438|NCT01429545|combination|combination
500439|NCT01429532|Cataract|cataract
500440|NCT01429519|chronic wound|chronic wound
500441|NCT01429519|ulcerated wound|ulcerated wound
500442|NCT01429519|venous insufficiency|venous insufficiency
500443|NCT01429519|lymphatic insufficiency|lymphatic insufficiency
500444|NCT01429519|neuropathic wound|neuropathic wound
500445|NCT01429519|diabetic ulcer|diabetic ulcer
500446|NCT01429519|post- operative|post- operative
500447|NCT01429519|post-traumatic chronic wound|post-traumatic chronic wound
500448|NCT01429506|Sleeve gastrectomy|sleeve gastrectomy
500449|NCT01429506|Intensive medical management|intensive medical management
500450|NCT01429480|Analgesia, postoperative|analgesia, postoperative
500451|NCT01429467|Glucose Variability|glucose variability
500452|NCT01429467|Continuous Glucose Monitoring|continuous glucose monitoring
500453|NCT01429467|Hypoxia-inducible Factor (HIF)|hypoxia-inducible factor (hif)
500454|NCT01429467|Vascular Endothelial Growth Factor (VEGF)|vascular endothelial growth factor (vegf)
500455|NCT01429467|Erythropoietin|erythropoietin
500456|NCT01429467|Cortisol|cortisol
500457|NCT01429454|Prodromal|prodromal
500458|NCT01429454|Schizophrenia|schizophrenia
500459|NCT01429454|Psychosis|psychosis
500460|NCT01429454|Omega|omega
500461|NCT01429428|Cellulitis|cellulitis
500462|NCT01429428|Skin ultra-sound images|skin ultra-sound images
500463|NCT01429428|Treatment|treatment
500464|NCT01429428|Infra-red light|infra-red light
500465|NCT01429415|pediatric|pediatric
500466|NCT01429415|Acute Asthma|acute asthma
500467|NCT01429415|Inhaled Magnesium|inhaled magnesium
500468|NCT01429402|Botulinum toxin A.|botulinum toxin a.
500469|NCT01429402|Cleft lip scar|cleft lip scar
500470|NCT01429389|Down syndrome|down syndrome
500471|NCT01429389|fetal aneuploidy|fetal aneuploidy
500472|NCT01429389|trisomy|trisomy
500473|NCT01429389|noninvasive screening test|noninvasive screening test
500474|NCT01429376|Chronic heart failure|chronic heart failure
500475|NCT01429376|Pulmonary function abnormalities/impairment|pulmonary function abnormalities/impairment
500476|NCT01429376|Restriction|restriction
500477|NCT01429376|Airway obstruction|airway obstruction
500478|NCT01429376|Diffusion impairment|diffusion impairment
500479|NCT01429376|Pulmonary function tests|pulmonary function tests
500480|NCT01429376|Chronic obstructive pulmonary disease (COPD)|chronic obstructive pulmonary disease (copd)
500481|NCT01429376|Prevalence|prevalence
500482|NCT01429376|Overdiagnosis|overdiagnosis
500483|NCT01429376|Underdiagnosis|underdiagnosis
500484|NCT01429376|Systemic inflammation|systemic inflammation
500485|NCT01429376|Diagnostic Errors|diagnostic errors
500486|NCT01429363|contained herniated lumbar discs|contained herniated lumbar discs
500487|NCT01429363|TDD|tdd
500488|NCT01429363|Case series|case series
500489|NCT01429363|RCT|rct
500490|NCT01429350|ischemic stroke|ischemic stroke
500491|NCT01429350|acute intervention|acute intervention
500492|NCT01429350|thrombolysis|thrombolysis
500493|NCT01429350|rtPA|rtpa
500494|NCT01429350|internal carotid artery|internal carotid artery
500495|NCT01429350|middle cerebral artery|middle cerebral artery
500496|NCT01429350|mechanical thrombectomy|mechanical thrombectomy
500497|NCT01429350|Penumbra System|penumbra system
500498|NCT01429350|clot length|clot length
500499|NCT01429350|mRS|mrs
500500|NCT01429350|NIHSS|nihss
500501|NCT01429337|Pharmacokinetics|pharmacokinetics
500502|NCT01429337|Hepatic impaired patients|hepatic impaired patients
500503|NCT01429337|Healthy volunteers|healthy volunteers
500504|NCT01429337|Varying degrees of hepatic impairment|varying degrees of hepatic impairment
500505|NCT01429324|Near infrared spectroscopy|near infrared spectroscopy
500506|NCT01429324|neuromonitoring|neuromonitoring
500507|NCT01429324|aortic arch surgery|aortic arch surgery
500508|NCT01429311|Atopic Dermatitis|atopic dermatitis
500509|NCT01429311|Eczema herpeticum|eczema herpeticum
500510|NCT01429311|Interferon gamma|interferon gamma
500511|NCT01429311|IFNγ|ifnγ
500512|NCT01429298|Acute|acute
500513|NCT01429298|Pain|pain
500514|NCT01429298|Emergency Department|emergency department
500515|NCT01429298|Hydromorphone|hydromorphone
500516|NCT01429298|Protocol|protocol
500517|NCT01429285|Pain|pain
500518|NCT01429285|Hydromorphone|hydromorphone
500519|NCT01429285|Acute|acute
500520|NCT01429285|Emergency Department|emergency department
500521|NCT01429272|Bipolar Disorder|bipolar disorder
500522|NCT01429272|Minocycline|minocycline
500523|NCT01429259|Cystic Fibrosis|cystic fibrosis
500524|NCT01429259|Acute Pulmonary Exacerbations|acute pulmonary exacerbations
500525|NCT01429259|Pseudomonas aeruginosa|pseudomonas aeruginosa
500526|NCT01429246|Hypertension|hypertension
500527|NCT01429246|Diet Therapy|diet therapy
500528|NCT01429246|Sodium Chloride, Dietary|sodium chloride, dietary
500529|NCT01429246|Tibet|tibet
500530|NCT01429246|Aged|aged
500531|NCT01429233|Observational|observational
500532|NCT01429233|Colombia|colombia
500533|NCT01429220|deep brain stimulation|deep brain stimulation
500534|NCT01429220|monopolar review|monopolar review
500535|NCT01429220|motion sensors|motion sensors
500536|NCT01429220|tremor|tremor
500537|NCT01429220|bradykinesia|bradykinesia
500538|NCT01429207|levodopa|levodopa
500539|NCT01429207|tremor|tremor
500540|NCT01429207|bradykinesia|bradykinesia
500541|NCT01429207|motion sensors|motion sensors
500542|NCT01429194|Weight Loss|weight loss
500543|NCT01429194|Trans-oral Endoscopic Procedure|trans-oral endoscopic procedure
500544|NCT01429194|Gastric Plication|gastric plication
500545|NCT01429181|Peripheral Neuropathic Pain|peripheral neuropathic pain
500546|NCT01429155|End stage liver disease|end stage liver disease
500547|NCT01429155|Living donor liver transplantation|living donor liver transplantation
500548|NCT01429155|Hepatitis C|hepatitis c
500549|NCT01429155|Interleukin 28B|interleukin 28b
500550|NCT01429129|Smoking|smoking
500551|NCT01429129|Nicotine|nicotine
500552|NCT01429129|Nicotine Replacement Therapy|nicotine replacement therapy
500553|NCT01429129|Nicotine Patch|nicotine patch
500554|NCT01429129|Nicoderm|nicoderm
500555|NCT01429129|Mass Distribution|mass distribution
500556|NCT01429129|Tobacco Control|tobacco control
500557|NCT01429129|Randomized Controlled Trial|randomized controlled trial
500558|NCT01429116|Blindness|blindness
500559|NCT01429116|Eye Diseases|eye diseases
500560|NCT01429116|Nap Disorders|nap disorders
500561|NCT01429116|Circadian Rhythm Disorders|circadian rhythm disorders
500562|NCT01429116|Sleep Disorders|sleep disorders
500563|NCT01429116|Circadian Rhythm Sleep Disorders|circadian rhythm sleep disorders
500564|NCT01429116|Dyssomnias|dyssomnias
500565|NCT01429116|Nervous System Diseases|nervous system diseases
500566|NCT01429090|Pharmacokinetics|pharmacokinetics
500567|NCT01429090|Accommodation, Ocular|accommodation, ocular
500568|NCT01429090|Reflex, Pupillary|reflex, pupillary
500569|NCT01429090|Salivation|salivation
500570|NCT01429077|Levodopa|levodopa
500571|NCT01429077|Ischemic Stroke|ischemic stroke
500572|NCT01429077|Aphasia|aphasia
500573|NCT01429077|Speech Rehabilitation|speech rehabilitation
500574|NCT01429051|Break through pain|break through pain
500575|NCT01429051|BTP|btp
500576|NCT01429051|Cancer|cancer
500577|NCT01429051|Intranasal Fentanyl Spray|intranasal fentanyl spray
500578|NCT01429051|INFS|infs
500579|NCT01429051|cancer patients|cancer patients
500580|NCT01429038|end-stage|end-stage
500581|NCT01429038|liver diseases|liver diseases
500582|NCT01429038|cirrhosis|cirrhosis
500583|NCT01429038|cancer|cancer
500584|NCT01429038|fulminant hepatic failure|fulminant hepatic failure
500585|NCT01429038|metabolic hepatic diseases|metabolic hepatic diseases
500586|NCT01429038|congenital hepatic diseases|congenital hepatic diseases
500587|NCT01429038|renal diseases|renal diseases
500588|NCT01429025|recurrent grade 1 follicular lymphoma|recurrent grade 1 follicular lymphoma
500589|NCT01429025|recurrent grade 2 follicular lymphoma|recurrent grade 2 follicular lymphoma
500590|NCT01429025|recurrent marginal zone lymphoma|recurrent marginal zone lymphoma
500591|NCT01429025|recurrent small lymphocytic lymphoma|recurrent small lymphocytic lymphoma
500592|NCT01429025|extranodal marginal zone B-cell lymphoma of mucosa-associated lymphoid tissue|extranodal marginal zone b-cell lymphoma of mucosa-associated lymphoid tissue
500593|NCT01429025|Waldenström macroglobulinemia|waldenström macroglobulinemia
500594|NCT01429025|nodal marginal zone B-cell lymphoma|nodal marginal zone b-cell lymphoma
500595|NCT01429025|splenic marginal zone lymphoma|splenic marginal zone lymphoma
500596|NCT01429012|bone|bone
500597|NCT01429012|nonunion fracture|nonunion fracture
500598|NCT01429012|atrophic nonunion fracture|atrophic nonunion fracture
500599|NCT01429012|callus|callus
500600|NCT01429012|mesenchymal stem cells|mesenchymal stem cells
500601|NCT01429012|cell therapy|cell therapy
500602|NCT01429012|autologous|autologous
500603|NCT01429012|indium|indium
500604|NCT01429012|Pet-scan|pet-scan
500605|NCT01428999|probiotics|probiotics
500606|NCT01428999|gastrointestinal function|gastrointestinal function
500607|NCT01428999|intestinal bacteria flora|intestinal bacteria flora
500608|NCT01428986|maraviroc|maraviroc
500609|NCT01428986|osteoclasts|osteoclasts
500610|NCT01428986|Receptors, CCR5|receptors, ccr5
500611|NCT01428986|Chemokine CCL5|chemokine ccl5
500612|NCT01428973|Allogeneic hematopoeitic cell transplantation|allogeneic hematopoeitic cell transplantation
500613|NCT01428973|Graft-Versus-Host Disease|graft-versus-host disease
500614|NCT01428973|Prophylaxis|prophylaxis
500615|NCT01428973|Reduced-intensity conditioning|reduced-intensity conditioning
500616|NCT01428973|Immunosuppressive regimen|immunosuppressive regimen
500617|NCT01428973|HLA-matched donor|hla-matched donor
500618|NCT01428973|Progression free survival|progression free survival
500619|NCT01428973|Overall survival|overall survival
500620|NCT01428960|Palm mid fraction|palm mid fraction
500621|NCT01428960|Shea butter|shea butter
500622|NCT01428960|sn-1, sn-3 fatty acids|sn-1, sn-3 fatty acids
500623|NCT01428960|Cholesterol|cholesterol
500624|NCT01428960|Postprandial lipemia,|postprandial lipemia,
500625|NCT01428960|Inflammatory markers|inflammatory markers
500626|NCT01428960|Satiety|satiety
500627|NCT01428960|Gut hormone|gut hormone
500628|NCT01428960|Insulin|insulin
500629|NCT01428921|Long-term efficacy|long-term efficacy
500630|NCT01428921|Education programme|education programme
500631|NCT01428921|Adherence|adherence
500632|NCT01428921|OSA|osa
500633|NCT01428921|CPAP|cpap
500634|NCT01428908|immunogenicity|immunogenicity
500635|NCT01428908|safety|safety
500636|NCT01428908|group A, C polysaccharide meningitis|group a, c polysaccharide meningitis
500637|NCT01428908|type b haemophilus Influenza|type b haemophilus influenza
500638|NCT01428908|conjugate vaccine|conjugate vaccine
500639|NCT01428895|Bone Metastases|bone metastases
500640|NCT01428895|Femoral Metastases|femoral metastases
500641|NCT01428882|Propofol|propofol
500642|NCT01428882|Midazolam|midazolam
501244|NCT01426230|PHN|phn
500643|NCT01428882|Moderate sedation|moderate sedation
500644|NCT01428882|Deep sedation|deep sedation
500645|NCT01428882|Colonoscopy|colonoscopy
500646|NCT01428869|Statins|statins
500647|NCT01428869|acetylsalicylic acid|acetylsalicylic acid
500648|NCT01428869|dutasteride|dutasteride
500649|NCT01428869|Prostate Cancer|prostate cancer
500650|NCT01428869|Lower urinary tract symptoms|lower urinary tract symptoms
500651|NCT01428869|prevention|prevention
500652|NCT01428869|drug interactions|drug interactions
500653|NCT01428843|Inflammatory Bowel Disease|inflammatory bowel disease
500654|NCT01428843|Anemia|anemia
500655|NCT01428843|Anti-TNF alpha theray|anti-tnf alpha theray
500656|NCT01428843|Ferrisat perfusion|ferrisat perfusion
500657|NCT01428830|fistula|fistula
500658|NCT01428830|catheter|catheter
500659|NCT01428830|surgery|surgery
500660|NCT01428830|obstetrics|obstetrics
500661|NCT01428830|gynecology|gynecology
500662|NCT01428830|urology|urology
500663|NCT01428817|pregnancy|pregnancy
500664|NCT01428817|postpartum hemorrhage|postpartum hemorrhage
500665|NCT01428817|Cesarean delivery|cesarean delivery
500666|NCT01428817|carbetocin|carbetocin
500667|NCT01428804|Resistant Major Depression|resistant major depression
500668|NCT01428804|Mood disorders|mood disorders
500669|NCT01428804|tDCS|tdcs
500670|NCT01428791|Geriatrics|geriatrics
500671|NCT01428791|Older adults|older adults
500672|NCT01428791|Health Disparities|health disparities
500673|NCT01428791|Health Services for the Aged|health services for the aged
500674|NCT01428791|Interdisciplinary Health Team|interdisciplinary health team
500675|NCT01428791|Depressive symptoms|depressive symptoms
500676|NCT01428791|Metabolic Syndrome X|metabolic syndrome x
500677|NCT01428791|Overweight|overweight
500678|NCT01428791|Obesity|obesity
500679|NCT01428791|Hypertension|hypertension
500680|NCT01428791|Hyperglycemia|hyperglycemia
500681|NCT01428791|Dyslipidemias|dyslipidemias
500682|NCT01428778|Marathon running|marathon running
500683|NCT01428778|Brain MRI|brain mri
500684|NCT01428778|ECG recording|ecg recording
500685|NCT01428778|Blood tests|blood tests
500686|NCT01428752|colonoscopy|colonoscopy
500687|NCT01428752|colorectal neoplasms|colorectal neoplasms
500688|NCT01428752|screening|screening
500689|NCT01428752|family history|family history
500690|NCT01428739|cancer|cancer
500692|NCT01428739|Treatment response|treatment response
500693|NCT01428726|NT-KO-003|nt-ko-003
500694|NCT01428726|RRMS|rrms
500695|NCT01428726|efficacy|efficacy
500696|NCT01428726|safety|safety
500697|NCT01428726|Phase IIa|phase iia
500698|NCT01428713|menorrhagia|menorrhagia
500699|NCT01428713|oral contraceptives|oral contraceptives
500700|NCT01428713|oral tranexamic acid|oral tranexamic acid
500701|NCT01428687|Weight loss|weight loss
500702|NCT01428687|Sleep duration|sleep duration
500703|NCT01428674|Interpersonal mindful compassion|interpersonal mindful compassion
500704|NCT01428674|Loving kindness meditation|loving kindness meditation
500705|NCT01428674|Autonomic Nervous System|autonomic nervous system
500706|NCT01428674|Heart rate variability|heart rate variability
500707|NCT01428674|Respiratory rate|respiratory rate
500708|NCT01428674|Relaxation|relaxation
500709|NCT01428661|tasimelteon|tasimelteon
500710|NCT01428661|Major Depressive Disorder|major depressive disorder
500711|NCT01428661|MDD|mdd
500712|NCT01428661|depression|depression
500713|NCT01428648|Parkinson|parkinson
500714|NCT01428648|ballroom dancing|ballroom dancing
500715|NCT01428609|Amalgam|amalgam
500716|NCT01428609|Mercury|mercury
500717|NCT01428609|Endodontics|endodontics
500718|NCT01428609|Apicoectomy|apicoectomy
500719|NCT01428596|HIV-1|hiv-1
500720|NCT01428596|therapeutic vaccine|therapeutic vaccine
500721|NCT01428596|immunotherapy|immunotherapy
500722|NCT01428596|AIDS|aids
500723|NCT01428583|Chronic noncancer pain|chronic noncancer pain
500724|NCT01428583|oxycodone|oxycodone
500725|NCT01428583|naltrexone|naltrexone
500726|NCT01428570|sleep apnea, obstructive|sleep apnea, obstructive
500727|NCT01428570|intubation|intubation
500728|NCT01428557|Heart Failure|heart failure
500729|NCT01428557|Epidemiology|epidemiology
500730|NCT01428557|Evidence-Based Practice|evidence-based practice
500731|NCT01428492|AKT Inhibitor|akt inhibitor
500732|NCT01428492|hematologic malignancies|hematologic malignancies
500733|NCT01428492|GSK2110183|gsk2110183
500734|NCT01428492|bortezomib|bortezomib
500735|NCT01428492|multiple myeloma|multiple myeloma
500736|NCT01428492|dexamethasone|dexamethasone
500737|NCT01428453|Alzheimer's disease|alzheimer's disease
500738|NCT01428427|Gemcitabine|gemcitabine
500739|NCT01428427|MEK inhibitor|mek inhibitor
500740|NCT01428427|GSK1120212|gsk1120212
500741|NCT01428414|HER2|her2
500742|NCT01428414|Breast cancer|breast cancer
500743|NCT01428414|neoadjuvant chemotherapy|neoadjuvant chemotherapy
500744|NCT01428414|efficacy|efficacy
500745|NCT01428414|safety|safety
500746|NCT01428401|Complementary therapies|complementary therapies
500747|NCT01428401|Acute hemorrhagic stroke|acute hemorrhagic stroke
500748|NCT01428388|macular edema|macular edema
500749|NCT01428388|vein occlusion|vein occlusion
500750|NCT01428388|bevacizumab|bevacizumab
500751|NCT01428388|ranibizumab|ranibizumab
500752|NCT01428388|vascular endothelial growth factor|vascular endothelial growth factor
500753|NCT01428375|intravenous paracetamol|intravenous paracetamol
500754|NCT01428375|intrapartum analgesia|intrapartum analgesia
500755|NCT01428375|labor pain|labor pain
500756|NCT01428375|intrapartum pains|intrapartum pains
500757|NCT01428362|donepezil|donepezil
500758|NCT01428362|VI-1121|vi-1121
500759|NCT01428349|Incarcerated offenders|incarcerated offenders
500760|NCT01428349|emotionally reactive|emotionally reactive
500761|NCT01428349|emotionally stable|emotionally stable
500762|NCT01428349|psychopathy|psychopathy
500763|NCT01428310|dietary supplement|dietary supplement
500764|NCT01428310|nutraceutical|nutraceutical
500765|NCT01428297|Atopic dermatitis|atopic dermatitis
500766|NCT01428297|Eczema|eczema
500767|NCT01428297|Skin Diseases, Eczematous|skin diseases, eczematous
500768|NCT01428297|Netherton syndrome|netherton syndrome
500769|NCT01428297|Skin Diseases, Genetic|skin diseases, genetic
500770|NCT01428297|BPR277|bpr277
500771|NCT01428284|Healthy Volunteers|healthy volunteers
500772|NCT01428284|Canagliflozin (JNJ-28431754)|canagliflozin (jnj-28431754)
500773|NCT01428284|Pharmacokinetic|pharmacokinetic
500774|NCT01428284|Probenecid|probenecid
500775|NCT01428258|Diet therapy|diet therapy
500776|NCT01428258|Low phenylalanine diet|low phenylalanine diet
500777|NCT01428258|Attention|attention
500778|NCT01428258|Executive function|executive function
500779|NCT01428232|Breastfeeding|breastfeeding
500780|NCT01428232|Baby Friendly Hospital Initiative|baby friendly hospital initiative
500781|NCT01428232|Well-child clinics|well-child clinics
500782|NCT01428219|Prostate|prostate
500783|NCT01428219|Cancer|cancer
500784|NCT01428219|Metastatic|metastatic
500785|NCT01428206|palliative care|palliative care
500786|NCT01428206|nursing homes|nursing homes
500787|NCT01428206|Liverpool care pathway|liverpool care pathway
500788|NCT01428193|PCOS|pcos
500789|NCT01428193|hyperandrogenemia|hyperandrogenemia
500790|NCT01428180|preterm neonates|preterm neonates
500791|NCT01428180|hemodynamically relevant patent ductus arteriosus|hemodynamically relevant patent ductus arteriosus
500792|NCT01428167|Thyroid cancer|thyroid cancer
500793|NCT01428167|Hashimotos thyroiditis|hashimotos thyroiditis
500794|NCT01428167|Thyroidectomy|thyroidectomy
500795|NCT01428167|Anti-inflammatory factors|anti-inflammatory factors
500796|NCT01428154|paediatric|paediatric
500797|NCT01428154|dialysis|dialysis
500798|NCT01428154|CKD|ckd
500799|NCT01428154|pediatric|pediatric
500800|NCT01428141|Cancer|cancer
500801|NCT01428141|Gastrointestinal Cancer|gastrointestinal cancer
500802|NCT01428115|monoclonal|monoclonal
500803|NCT01428115|anxiety|anxiety
500804|NCT01428115|antibodies|antibodies
500805|NCT01428115|adalimumab|adalimumab
500806|NCT01428115|severe crohn's disease|severe crohn's disease
500807|NCT01428115|quality of life|quality of life
500808|NCT01428115|biological products|biological products
500809|NCT01428102|Thromboelastography|thromboelastography
500810|NCT01428102|TEG|teg
500811|NCT01428102|Coagulation|coagulation
500812|NCT01428102|RapidTEG|rapidteg
500813|NCT01428102|Kaolin|kaolin
500814|NCT01428089|hyperandrogenemia|hyperandrogenemia
500815|NCT01428076|Varicose Veins|varicose veins
637053|NCT00880334|TCC|tcc
500816|NCT01428076|SFJ Reflux|sfj reflux
500817|NCT01428050|whipple|whipple
500818|NCT01428050|hypertonic saline|hypertonic saline
500819|NCT01428050|pancreaticoduodenectomy|pancreaticoduodenectomy
500820|NCT01428050|fluid restriction|fluid restriction
500821|NCT01428050|resuscitation strategy|resuscitation strategy
500822|NCT01428037|Vaginal Misoprostol|vaginal misoprostol
500823|NCT01428037|Cervical Ripening|cervical ripening
500824|NCT01428037|Labor Induced|labor induced
500825|NCT01428024|efficacy|efficacy
500826|NCT01428024|safety|safety
500827|NCT01428024|Restylane|restylane
500828|NCT01428024|Lip products|lip products
500829|NCT01428024|injection techniques|injection techniques
500830|NCT01428011|Hypertension|hypertension
500831|NCT01428011|Patient-Provider Communication|patient-provider communication
500832|NCT01428011|Medication Adherence|medication adherence
500833|NCT01428011|Race Concordance|race concordance
500834|NCT01427998|diabetes|diabetes
500835|NCT01427998|blood glucose|blood glucose
500836|NCT01427998|olive leaf extract|olive leaf extract
500837|NCT01427946|KRAS mutant|kras mutant
500838|NCT01427946|Non-Small Cell Lung Cancer|non-small cell lung cancer
500839|NCT01427946|NSCLC|nsclc
500840|NCT01427933|Breast Cancer|breast cancer
500841|NCT01427907|Serum phosphorus levels|serum phosphorus levels
500842|NCT01427894|Prematurity|prematurity
500843|NCT01427894|Music|music
500844|NCT01427894|Kangaroo Care|kangaroo care
500845|NCT01427894|Bonding Mother infant|bonding mother infant
500846|NCT01427868|LB80380|lb80380
500847|NCT01427868|bioequivalence|bioequivalence
500848|NCT01427855|Dietary Protein|dietary protein
500849|NCT01427855|Red Meat|red meat
500850|NCT01427855|White Meat|white meat
500851|NCT01427855|Vegetable Protein|vegetable protein
500852|NCT01427855|Saturated Fat|saturated fat
500853|NCT01427855|LDL Subclasses|ldl subclasses
500854|NCT01427855|Cholesterol|cholesterol
500855|NCT01427855|Atherogenic Dyslipidemia|atherogenic dyslipidemia
500856|NCT01427842|Trough concentration|trough concentration
500857|NCT01427842|Vancomycin|vancomycin
500858|NCT01427842|Pharmacokinetics|pharmacokinetics
500859|NCT01427829|pilot|pilot
500986|NCT01427283|Low back pain|low back pain
500860|NCT01427829|randomized controlled trial|randomized controlled trial
500861|NCT01427829|RCT|rct
500862|NCT01427829|computer|computer
500863|NCT01427829|screening|screening
500864|NCT01427829|community heath center|community heath center
500865|NCT01427829|psychosocial|psychosocial
500866|NCT01427829|immigrant|immigrant
500867|NCT01427816|Dry eye syndromes|dry eye syndromes
500868|NCT01427816|Corneal diseases|corneal diseases
500869|NCT01427816|Conjunctival diseases|conjunctival diseases
500870|NCT01427803|Actual Use Trial|actual use trial
500871|NCT01427764|Dentin sensitivity|dentin sensitivity
500872|NCT01427764|Dental scaling|dental scaling
500873|NCT01427764|Ultrasonic|ultrasonic
500874|NCT01427764|manual and ultrasonic instrumentation|manual and ultrasonic instrumentation
500875|NCT01427725|Digestive System Diseases|digestive system diseases
500876|NCT01427725|Therapeutic Uses|therapeutic uses
500877|NCT01427725|Pancreatectomy|pancreatectomy
500878|NCT01427725|Gastrointestinal Agents|gastrointestinal agents
500879|NCT01427725|Pancreatic Diseases|pancreatic diseases
500880|NCT01427725|Pancrelipase|pancrelipase
500881|NCT01427725|Exocrine Pancreatic Insufficiency|exocrine pancreatic insufficiency
500882|NCT01427712|Digestive System Diseases|digestive system diseases
500883|NCT01427712|Cystic Fibrosis|cystic fibrosis
500884|NCT01427712|Therapeutic Uses|therapeutic uses
500885|NCT01427712|Gastrointestinal Agents|gastrointestinal agents
500886|NCT01427712|Pancreatic Diseases|pancreatic diseases
500887|NCT01427712|Pancrelipase|pancrelipase
500888|NCT01427712|Exocrine Pancreatic Insufficiency|exocrine pancreatic insufficiency
500889|NCT01427673|Chronic Obstructive Pulmonary Disease|chronic obstructive pulmonary disease
500890|NCT01427673|Obstructive Sleep Apnea|obstructive sleep apnea
500891|NCT01427673|Overlap Syndrome|overlap syndrome
500892|NCT01427673|COPD|copd
500893|NCT01427673|OSA|osa
500894|NCT01427660|Diabetes|diabetes
500895|NCT01427660|Decision Aid|decision aid
500896|NCT01427660|AntiHyperglycemic Medication|antihyperglycemic medication
500897|NCT01427660|Tailored health information|tailored health information
500898|NCT01427660|Medication information|medication information
500899|NCT01427647|Laparoscopy|laparoscopy
500900|NCT01427647|Anesthesia, Epidural|anesthesia, epidural
500901|NCT01427634|Heart Failure|heart failure
500902|NCT01427634|Ventricular Assist Device|ventricular assist device
500903|NCT01427634|Palliative Care|palliative care
500904|NCT01427595|hyperandrogenemia|hyperandrogenemia
500905|NCT01427569|Diabetes|diabetes
500906|NCT01427569|Chronic wound|chronic wound
500907|NCT01427556|Food intake|food intake
500908|NCT01427556|Breakfast eating|breakfast eating
500909|NCT01427543|behavioral intervention|behavioral intervention
500910|NCT01427543|HIV risk reduction|hiv risk reduction
500911|NCT01427543|African Americans|african americans
500912|NCT01427543|incarceration|incarceration
637150|NCT00880048|placebo|placebo
500913|NCT01427543|bisexual|bisexual
500914|NCT01427543|reduce risk behaviors|reduce risk behaviors
500915|NCT01427530|brain activity|brain activity
500916|NCT01427530|implanted with DBS electrodes|implanted with dbs electrodes
500917|NCT01427517|Parkinson's disease|parkinson's disease
500918|NCT01427517|Gaucher's disease|gaucher's disease
500919|NCT01427517|Control|control
500920|NCT01427504|HCV|hcv
500921|NCT01427504|HIV|hiv
500922|NCT01427478|Head and neck squamous cell carcinoma|head and neck squamous cell carcinoma
500923|NCT01427478|Post operative radio-chemotherapy|post operative radio-chemotherapy
500924|NCT01427478|Randomisation|randomisation
500925|NCT01427478|Maintenance treatment|maintenance treatment
500926|NCT01427478|Afatinib|afatinib
500927|NCT01427465|Brief|brief
500928|NCT01427465|Image|image
500929|NCT01427465|Intervention|intervention
500930|NCT01427465|Adolescents|adolescents
500931|NCT01427465|School|school
500932|NCT01427452|Live Donor|live donor
500933|NCT01427452|Kidney Donation|kidney donation
500934|NCT01427452|Living Donation|living donation
500935|NCT01427452|Live Donor Kidney Transplantation|live donor kidney transplantation
500936|NCT01427452|Donor Nephrectomy|donor nephrectomy
500937|NCT01427439|MDD|mdd
500938|NCT01427439|Non-interventional study|non-interventional study
500939|NCT01427439|Observational study|observational study
500940|NCT01427426|Health|health
500941|NCT01427426|Vitality|vitality
500942|NCT01427426|Well-being|well-being
500943|NCT01427426|Nutritional Supplement|nutritional supplement
500944|NCT01427426|Phytonutrient|phytonutrient
500945|NCT01427426|Greens|greens
500946|NCT01427413|blastocoele fluid|blastocoele fluid
500947|NCT01427413|mass spectrometry|mass spectrometry
500948|NCT01427413|metabolomics|metabolomics
500949|NCT01427400|Breast expander|breast expander
500950|NCT01427400|Breast reconstruction|breast reconstruction
500951|NCT01427400|Implants|implants
500954|NCT01427387|Pharmacokinetics|pharmacokinetics
500955|NCT01427387|safety|safety
500956|NCT01427387|tolerability|tolerability
500957|NCT01427387|food effect|food effect
500958|NCT01427374|hemodialysis|hemodialysis
500959|NCT01427374|peritoneal dialysis|peritoneal dialysis
500960|NCT01427374|chronic kidney disease|chronic kidney disease
500961|NCT01427374|cardiovascular risk factors|cardiovascular risk factors
500962|NCT01427374|cardiac imaging|cardiac imaging
500963|NCT01427374|dialysis|dialysis
500964|NCT01427374|parathyroid hormone|parathyroid hormone
500965|NCT01427374|vitamin D|vitamin d
500966|NCT01427374|coronary artery calcification|coronary artery calcification
500967|NCT01427374|left ventricular hypertrophy|left ventricular hypertrophy
500968|NCT01427374|genetic predisposition|genetic predisposition
500969|NCT01427374|biochemical markers|biochemical markers
500970|NCT01427374|infection|infection
500971|NCT01427374|pharmacogenomics|pharmacogenomics
500972|NCT01427335|OHSS|ohss
500973|NCT01427335|ICSI|icsi
500974|NCT01427335|calcium injection|calcium injection
500975|NCT01427322|lapatinib|lapatinib
500976|NCT01427322|radiation therapy|radiation therapy
500977|NCT01427322|metastases|metastases
500978|NCT01427309|Influenza|influenza
500979|NCT01427309|Trivalent Inactivated Influenza Vaccine|trivalent inactivated influenza vaccine
500980|NCT01427309|High-Dose Trivalent Inactivated Influenza Vaccine|high-dose trivalent inactivated influenza vaccine
500981|NCT01427309|Fluzone® High-Dose|fluzone® high-dose
500982|NCT01427309|Influenza vaccines|influenza vaccines
500983|NCT01427296|Colon Cleansing|colon cleansing
500984|NCT01427296|Bowel Prep|bowel prep
500985|NCT01427296|Colonoscopy|colonoscopy
500987|NCT01427283|Chronic pain|chronic pain
500988|NCT01427283|Opioid|opioid
500989|NCT01427283|Constipation|constipation
500990|NCT01427283|Moderate to severe|moderate to severe
500991|NCT01427270|Low back pain|low back pain
500992|NCT01427270|Chronic pain|chronic pain
500993|NCT01427270|Opioid|opioid
500994|NCT01427270|Constipation|constipation
500995|NCT01427270|Moderate to severe chronic low back pain|moderate to severe chronic low back pain
500996|NCT01427244|HER2+|her2+
500997|NCT01427244|Histologic confirmation|histologic confirmation
500998|NCT01427244|measurable disease|measurable disease
500999|NCT01427244|HER2 positive|her2 positive
501000|NCT01427244|HER2 overexpression|her2 overexpression
501001|NCT01427244|persistent vulvar Paget's disease|persistent vulvar paget's disease
501002|NCT01427244|recurrent vulvar Paget's disease|recurrent vulvar paget's disease
501003|NCT01427231|Cognitive performance|cognitive performance
501004|NCT01427231|Attention|attention
501005|NCT01427231|Memory|memory
501006|NCT01427231|Glucose|glucose
501007|NCT01427231|Sacharose|sacharose
501008|NCT01427231|Elderly|elderly
501009|NCT01427231|Memory complaints|memory complaints
501010|NCT01427218|pharmacist|pharmacist
501011|NCT01427218|medication therapy management|medication therapy management
501012|NCT01427218|evidence based medicine|evidence based medicine
501013|NCT01427205|Head and Neck Squamous Cell Carcinoma|head and neck squamous cell carcinoma
501014|NCT01427205|HNSCC|hnscc
501015|NCT01427205|recurrent|recurrent
501016|NCT01427205|metastatic|metastatic
501017|NCT01427205|oral cavity|oral cavity
501018|NCT01427205|Cetuximab|cetuximab
501019|NCT01427205|C225|c225
501020|NCT01427205|Erbitux|erbitux
501021|NCT01427205|IMC-C225|imc-c225
501022|NCT01427205|OSI-906|osi-906
501023|NCT01427205|Placebo|placebo
501024|NCT01427205|sugar pill|sugar pill
501025|NCT01427205|oropharynx|oropharynx
501026|NCT01427205|larynx|larynx
501027|NCT01427205|hypopharynx|hypopharynx
501028|NCT01427192|Breathing-Related Sleep Disorder|breathing-related sleep disorder
501029|NCT01427192|Pulmonary Hypertension|pulmonary hypertension
501030|NCT01427179|Spontaneous coronary artery dissection|spontaneous coronary artery dissection
501031|NCT01427179|SCAD|scad
501032|NCT01427166|Breast Cancer|breast cancer
501033|NCT01427166|Cording|cording
501034|NCT01427166|Lymphedema|lymphedema
501035|NCT01427166|upper extremity cording|upper extremity cording
501036|NCT01427166|following treatment|following treatment
501037|NCT01427153|knee osteoarthritis|knee osteoarthritis
501038|NCT01427153|physical therapy|physical therapy
501039|NCT01427153|corticosteroid|corticosteroid
501040|NCT01427153|treatment|treatment
501041|NCT01427140|Liver fat|liver fat
501042|NCT01427140|Polyunsaturated fatty acids (PUFA)|polyunsaturated fatty acids (pufa)
501043|NCT01427140|Saturated fatty acids (SFA)|saturated fatty acids (sfa)
501044|NCT01427140|Weight gain|weight gain
501045|NCT01427140|Overfeed|overfeed
501046|NCT01427140|Dietary fatty acids|dietary fatty acids
501047|NCT01427140|Palm oil|palm oil
501048|NCT01427140|Sunflower oil|sunflower oil
501049|NCT01427114|extranodal marginal zone lymphoma|extranodal marginal zone lymphoma
501050|NCT01427114|ocular adnexal lymphoma|ocular adnexal lymphoma
501051|NCT01427114|mucosa associated lymphoid tissue|mucosa associated lymphoid tissue
501052|NCT01427114|cyclophosphamide|cyclophosphamide
501053|NCT01427114|vincristine|vincristine
501054|NCT01427114|prednisolone|prednisolone
501055|NCT01427101|Pseudomyxoma Peritonei|pseudomyxoma peritonei
501056|NCT01427101|Cytoreductive surgery|cytoreductive surgery
501057|NCT01427101|Debulking surgery|debulking surgery
501058|NCT01427101|Intraperitoneal chemotherapy|intraperitoneal chemotherapy
501059|NCT01427088|rTMS-induced cumulative pattern of sBDNF|rtms-induced cumulative pattern of sbdnf
501060|NCT01427075|Magnetic Resonance Imaging|magnetic resonance imaging
501061|NCT01427075|Sleep Apnea, Obstructive|sleep apnea, obstructive
501062|NCT01427075|Pharyngeal Muscles|pharyngeal muscles
501063|NCT01427062|parkinson's disease|parkinson's disease
501064|NCT01427062|balance|balance
501065|NCT01427062|anticipatory postural adjustment|anticipatory postural adjustment
501066|NCT01427062|componsatory postural adjustment|componsatory postural adjustment
501067|NCT01427062|falls|falls
501068|NCT01427049|renal denervation|renal denervation
501069|NCT01427049|renal sympathetic denervation|renal sympathetic denervation
501070|NCT01427049|renal ablation|renal ablation
501071|NCT01427049|resistant hypertension|resistant hypertension
501072|NCT01427049|hypertension|hypertension
501073|NCT01427049|renal oxygenation|renal oxygenation
501074|NCT01427049|renal perfusion|renal perfusion
501075|NCT01427023|APTIMA Trichomonas vaginalis Assay|aptima trichomonas vaginalis assay
501076|NCT01427023|APTIMA|aptima
501077|NCT01427023|trichomonas|trichomonas
501078|NCT01427023|trichomonas vaginalis|trichomonas vaginalis
501079|NCT01426997|Major Depressive Disorder|major depressive disorder
501080|NCT01426997|Depression|depression
501081|NCT01426971|Migraine|migraine
501082|NCT01426945|alveolar childhood rhabdomyosarcoma|alveolar childhood rhabdomyosarcoma
501083|NCT01426945|previously treated childhood rhabdomyosarcoma|previously treated childhood rhabdomyosarcoma
501084|NCT01426945|previously untreated childhood rhabdomyosarcoma|previously untreated childhood rhabdomyosarcoma
501085|NCT01426945|recurrent childhood rhabdomyosarcoma|recurrent childhood rhabdomyosarcoma
501086|NCT01426945|embryonal childhood rhabdomyosarcoma|embryonal childhood rhabdomyosarcoma
501087|NCT01426932|Vestibular Function Tests|vestibular function tests
501088|NCT01426932|Caloric Test|caloric test
501089|NCT01426932|Electronystagmography|electronystagmography
501090|NCT01426932|Prediction|prediction
501091|NCT01426919|Traumatic Brain Injury|traumatic brain injury
501092|NCT01426919|Head Injury|head injury
501093|NCT01426893|Respiratory disease|respiratory disease
501094|NCT01426893|COPD|copd
501095|NCT01426880|GBG|gbg
501096|NCT01426880|German Breast Group|german breast group
501097|NCT01426880|neo-adjuvant|neo-adjuvant
501098|NCT01426880|GBG Forschungs GmbH|gbg forschungs gmbh
501099|NCT01426880|Tubular breast cancer stage II|tubular breast cancer stage ii
501100|NCT01426880|Mucinous breast cancer stage II|mucinous breast cancer stage ii
501101|NCT01426880|Invasive ductal breast cancer|invasive ductal breast cancer
501102|NCT01426880|Tubular breast cancer stage III|tubular breast cancer stage iii
501103|NCT01426880|HER-2 positive breast cancer|her-2 positive breast cancer
501104|NCT01426880|Inflammatory breast cancer stage IV|inflammatory breast cancer stage iv
501105|NCT01426880|Inflammatory breast cancer|inflammatory breast cancer
501106|NCT01426867|Open-Angle Glaucoma|open-angle glaucoma
501107|NCT01426867|Ocular Hypertension|ocular hypertension
501108|NCT01426867|Intraocular Pressure|intraocular pressure
501109|NCT01426867|Brinzolamide|brinzolamide
501110|NCT01426867|Brimonidine|brimonidine
501111|NCT01426854|Cataract Surgery|cataract surgery
501112|NCT01426854|Anti-ocular Inflammation|anti-ocular inflammation
501113|NCT01426854|Anti-ocular Pain|anti-ocular pain
501114|NCT01426841|Small cell lung cancer|small cell lung cancer
501115|NCT01426841|Adaptive radiotherapy|adaptive radiotherapy
501116|NCT01426841|Thoracic radiotherapy|thoracic radiotherapy
501117|NCT01426828|adult|adult
501118|NCT01426828|symptomatic multiple myeloma|symptomatic multiple myeloma
501119|NCT01426828|myeloma|myeloma
501120|NCT01426828|diagnosis within 12 months of initiation of systemic therapy|diagnosis within 12 months of initiation of systemic therapy
501121|NCT01426815|Peripheral spondylarthritis according to ASAS- criteria|peripheral spondylarthritis according to asas- criteria
501122|NCT01426802|metformin|metformin
501123|NCT01426802|vildagliptin|vildagliptin
501124|NCT01426802|T2DM|t2dm
501125|NCT01426789|Rheumatoid Arthritis|rheumatoid arthritis
501126|NCT01426789|IgG1K monoclonal antibody|igg1k monoclonal antibody
501127|NCT01426789|Interleukin-17A neutralizing|interleukin-17a neutralizing
501128|NCT01426776|Cheyne-Stokes respiration|cheyne-stokes respiration
501129|NCT01426776|Heart valve disease|heart valve disease
501130|NCT01426776|Central Sleep Apnea|central sleep apnea
501131|NCT01426763|HAE|hae
501132|NCT01426763|C1 esterase inhibitor|c1 esterase inhibitor
501133|NCT01426763|C1 INH|c1 inh
501134|NCT01426763|Subcutaneous|subcutaneous
501135|NCT01426763|hyaluronidase|hyaluronidase
501136|NCT01426763|rHuPH20|rhuph20
501137|NCT01426750|Nutritional support.|nutritional support.
501138|NCT01426750|Cancer.|cancer.
501139|NCT01426750|Malnutrition.|malnutrition.
501140|NCT01426750|Child.|child.
501141|NCT01426750|Adolescent|adolescent
501142|NCT01426724|Vitamin D|vitamin d
501143|NCT01426724|Chronic Kidney Disease|chronic kidney disease
501144|NCT01426724|Hyperparathyroidism|hyperparathyroidism
501145|NCT01426724|Renal Blood Flow|renal blood flow
501146|NCT01426724|Proteinuria|proteinuria
501147|NCT01426724|Inflammation|inflammation
501148|NCT01426724|Renin Angiotensin System|renin angiotensin system
501149|NCT01426698|delayed cord clamping|delayed cord clamping
501150|NCT01426698|developmental delay|developmental delay
501151|NCT01426685|sudden death|sudden death
501152|NCT01426685|coronary artery disease|coronary artery disease
501153|NCT01426685|diabetes|diabetes
501154|NCT01426672|Strabismic deviation less than 12 prism diopeters|strabismic deviation less than 12 prism diopeters
501155|NCT01426659|language|language
501156|NCT01426659|constraints|constraints
501157|NCT01426659|premature|premature
501158|NCT01426659|phonology|phonology
501159|NCT01426659|implied|implied
501160|NCT01426659|early development (< 5 years)|early development (< 5 years)
501161|NCT01426646|gastric cancer|gastric cancer
501162|NCT01426646|S-1|s-1
501163|NCT01426646|cisplatin|cisplatin
501164|NCT01426646|adjuvant chemotherapy|adjuvant chemotherapy
501165|NCT01426633|L-sarcomas|l-sarcomas
501166|NCT01426620|NSCLC|nsclc
501167|NCT01426620|blueberry|blueberry
501168|NCT01426620|salvage therapy|salvage therapy
501169|NCT01426620|docetaxel|docetaxel
501170|NCT01426620|non-small cell lung cancer|non-small cell lung cancer
501171|NCT01426620|second-line|second-line
501172|NCT01426620|polyphenol|polyphenol
501173|NCT01426594|Observational|observational
501174|NCT01426594|Colombia|colombia
501175|NCT01426594|Metpure XL|metpure xl
501176|NCT01426581|Asthma|asthma
501177|NCT01426581|Chronic Obstructive Pulmonary Disease (COPD)|chronic obstructive pulmonary disease (copd)
501178|NCT01426581|Pulmonary Disease, Chronic Obstructive|pulmonary disease, chronic obstructive
501179|NCT01426581|Lung Disease, Obstructive|lung disease, obstructive
501180|NCT01426581|Self-management|self-management
501181|NCT01426581|Health Literacy|health literacy
501182|NCT01426568|Multi-Convergent Therapy|multi-convergent therapy
501183|NCT01426568|Mindfulness Meditation|mindfulness meditation
501184|NCT01426568|Functional Abdominal Symptoms|functional abdominal symptoms
501185|NCT01426568|Irritable Bowel Syndrome|irritable bowel syndrome
501186|NCT01426568|Inflammatory Bowel Disease|inflammatory bowel disease
501187|NCT01426568|Psychological Stress|psychological stress
501188|NCT01426555|Disorder of Bone Density and Structure, Unspecified|disorder of bone density and structure, unspecified
501189|NCT01426555|Weakening of the bone structure|weakening of the bone structure
501190|NCT01426542|brain injury|brain injury
501191|NCT01426542|stroke|stroke
501192|NCT01426542|cerebral palsy|cerebral palsy
501193|NCT01426542|seizures|seizures
501194|NCT01426516|Treatment Resistant|treatment resistant
501195|NCT01426516|Depression|depression
501196|NCT01426477|Ventral hernia|ventral hernia
501197|NCT01426477|Abdominal wall hernia|abdominal wall hernia
501198|NCT01426477|Incisional hernia|incisional hernia
501199|NCT01426477|Biologic mesh|biologic mesh
501200|NCT01426477|Veritas Collagen Matrix|veritas collagen matrix
501201|NCT01426477|Veritas|veritas
501202|NCT01426464|Glaucoma|glaucoma
501203|NCT01426464|Xalatan|xalatan
501204|NCT01426464|Transdermal|transdermal
501205|NCT01426451|Dramatherapy|dramatherapy
501206|NCT01426451|Group tutoring activities|group tutoring activities
501207|NCT01426451|Impairment|impairment
501208|NCT01426451|Emotional and behavioural problems|emotional and behavioural problems
501209|NCT01426451|Learning difficulties|learning difficulties
501210|NCT01426425|Cardiac cryoablation|cardiac cryoablation
501211|NCT01426425|AVNRT|avnrt
501212|NCT01426425|heart disease|heart disease
501213|NCT01426425|tachycardia|tachycardia
501214|NCT01426425|AtrioVentricular Nodal Reentrant Tachycardia|atrioventricular nodal reentrant tachycardia
501215|NCT01426425|Supraventricular tachycardia|supraventricular tachycardia
501216|NCT01426425|SVT|svt
501217|NCT01426360|dentifrice|dentifrice
501218|NCT01426360|potassium nitrate|potassium nitrate
501219|NCT01426360|strontium chloride|strontium chloride
501220|NCT01426347|Rheumatoid Arthritis|rheumatoid arthritis
501221|NCT01426347|Vitamin D deficiency|vitamin d deficiency
501222|NCT01426347|Disability|disability
501223|NCT01426321|Cardiac resynchronization therapy|cardiac resynchronization therapy
501224|NCT01426321|Echocardiography|echocardiography
501225|NCT01426321|Cardiac computed tomography|cardiac computed tomography
501226|NCT01426295|hematologic disease candidates for autologous or allogeneic bone marrow|hematologic disease candidates for autologous or allogeneic bone marrow
501227|NCT01426282|Out-patient Compliance|out-patient compliance
501228|NCT01426282|Nurse, Heath Education|nurse, heath education
501229|NCT01426282|Cardiovascular Diseases|cardiovascular diseases
501230|NCT01426282|Treatment and Prevention|treatment and prevention
501231|NCT01426256|vitamin D|vitamin d
501232|NCT01426256|cholecalciferol|cholecalciferol
501233|NCT01426256|cystic fibrosis|cystic fibrosis
501234|NCT01426256|respiratory tract infection|respiratory tract infection
501235|NCT01426256|immunity|immunity
501236|NCT01426256|intervention studies|intervention studies
501237|NCT01426256|inflammation|inflammation
501238|NCT01426256|dietary supplements|dietary supplements
501239|NCT01426256|alpha-Defensins|alpha-defensins
501240|NCT01426256|Cytokines|cytokines
501241|NCT01426256|mortality|mortality
501242|NCT01426256|biological markers|biological markers
501243|NCT01426256|Biomedical Research|biomedical research
501245|NCT01426230|Post Herpetic Neuralgia|post herpetic neuralgia
501246|NCT01426230|Shingles|shingles
501247|NCT01426230|HZ roster|hz roster
501248|NCT01426217|IV contamination|iv contamination
501249|NCT01426217|intravenous contamination|intravenous contamination
501250|NCT01426217|stopcock contamination|stopcock contamination
501251|NCT01426217|surgical site infection|surgical site infection
501252|NCT01426204|Hepatitis C|hepatitis c
501253|NCT01426204|Retreatment|retreatment
501254|NCT01426204|Failures|failures
501255|NCT01426204|Infergen|infergen
501256|NCT01426204|Interferon Alfacon-1|interferon alfacon-1
501257|NCT01426191|Cefotaxime sulbactam sodium|cefotaxime sulbactam sodium
501258|NCT01426191|Phase IV clinical studies|phase iv clinical studies
501259|NCT01426191|Respiratory and urinary tract infections|respiratory and urinary tract infections
501260|NCT01426178|Respiratory Insufficiency|respiratory insufficiency
501261|NCT01426178|Respiration, Artificial|respiration, artificial
501262|NCT01426178|Intermittent Positive-Pressure Ventilation|intermittent positive-pressure ventilation
501263|NCT01426178|Neurally Adjusted Ventilatory Assist|neurally adjusted ventilatory assist
501264|NCT01426178|Non Invasive Ventilation|non invasive ventilation
501265|NCT01426165|hypomagnesemia|hypomagnesemia
501266|NCT01426165|magnesium|magnesium
501267|NCT01426165|magnesium sulfate|magnesium sulfate
501268|NCT01426152|IVF|ivf
501269|NCT01426152|progesterone|progesterone
501270|NCT01426152|ovulation induction|ovulation induction
501271|NCT01426152|pregnancy rates|pregnancy rates
501272|NCT01426152|Female Infertility Due to Nonimplantation|female infertility due to nonimplantation
501273|NCT01426126|urothelial carcinoma|urothelial carcinoma
501274|NCT01426126|gemcitabine|gemcitabine
501275|NCT01426126|platinum|platinum
501276|NCT01426126|refractory|refractory
501277|NCT01426126|salvage chemotherapy|salvage chemotherapy
501278|NCT01426100|CKD-828|ckd-828
501279|NCT01426100|Hypertension|hypertension
501280|NCT01426100|Primary Hypertension|primary hypertension
501281|NCT01426100|S-Amlodipine|s-amlodipine
501282|NCT01426100|Telmisartan|telmisartan
501283|NCT01426100|Amlodipine|amlodipine
501284|NCT01426100|Non-Responder|non-responder
501285|NCT01426061|Complementary and alternative medicine|complementary and alternative medicine
501286|NCT01426061|Reflexology|reflexology
501287|NCT01426061|Homeopathy|homeopathy
501288|NCT01426061|Asthma|asthma
501289|NCT01426061|Randomized controlled trial|randomized controlled trial
501290|NCT01426035|SUPERFICIAL VARICOSE VEINS|superficial varicose veins
501291|NCT01426022|alcohol|alcohol
501292|NCT01426022|mood|mood
501293|NCT01426022|postprandial|postprandial
501294|NCT01426009|COPD|copd
501295|NCT01425996|HCC|hcc
501296|NCT01425996|PVTT|pvtt
501297|NCT01425983|stress|stress
501298|NCT01425983|lability and irritative disturbances|lability and irritative disturbances
501299|NCT01425983|dietary supplement|dietary supplement
501300|NCT01425983|amino acid composition|amino acid composition
501301|NCT01425983|psychological neurological questionnaire (PNF)|psychological neurological questionnaire (pnf)
501302|NCT01425970|Inhibitex|inhibitex
501303|NCT01425970|Chronic Hepatitis|chronic hepatitis
501304|NCT01425970|Hepatitis C Virus|hepatitis c virus
501305|NCT01425957|MEMORY and COGNITIVE IMPAIRMENT|memory and cognitive impairment
501306|NCT01425957|ALZHEIMER DISEASE CONVERSION|alzheimer disease conversion
501307|NCT01425957|Amyloid beta-Peptides|amyloid beta-peptides
501308|NCT01425944|Sturge Weber Syndrome|sturge weber syndrome
501309|NCT01425944|Biomarkers|biomarkers
501310|NCT01425944|DNA arrays|dna arrays
501311|NCT01425944|brain vessel malformations|brain vessel malformations
501312|NCT01425918|Autism Spectrum Disorder|autism spectrum disorder
501313|NCT01425918|language|language
501314|NCT01425918|social|social
501315|NCT01425918|toddlers|toddlers
501316|NCT01425905|Female|female
501317|NCT01425905|Depression|depression
501318|NCT01425905|Obesity|obesity
501319|NCT01425905|Insulin Resistance|insulin resistance
501320|NCT01425905|Adolescents|adolescents
501321|NCT01425905|Overweight|overweight
501322|NCT01425905|Type 2 Diabetes Risk|type 2 diabetes risk
501323|NCT01425905|Mood|mood
501324|NCT01425892|Salivary Gland|salivary gland
501325|NCT01425892|Pathogenesis|pathogenesis
501326|NCT01425892|Sj(SqrRoot)(Delta)gren s Syndrome|sj(sqrroot)(delta)gren s syndrome
501327|NCT01425892|Sjogren Syndrome|sjogren syndrome
501328|NCT01425866|Diabetes Mellitus|diabetes mellitus
501329|NCT01425866|Diabetes Mellitus, Type 2|diabetes mellitus, type 2
501330|NCT01425866|Structured self-management education|structured self-management education
501331|NCT01425866|Therapeutic patient education|therapeutic patient education
501332|NCT01425866|Lifestyle changes|lifestyle changes
501333|NCT01425866|Self-management Blood glucose|self-management blood glucose
501334|NCT01425866|Empowerment|empowerment
501335|NCT01425866|Adult learning|adult learning
501336|NCT01425866|Socio-constructivism|socio-constructivism
501337|NCT01425866|Health management network|health management network
501338|NCT01425866|Reunion island|reunion island
501339|NCT01425840|Lidocaine,|lidocaine,
501340|NCT01425840|liposome encapsulation,|liposome encapsulation,
501341|NCT01425840|topical anesthesia,|topical anesthesia,
501342|NCT01425840|palatal mucosa|palatal mucosa
501343|NCT01425827|duloxetine|duloxetine
501344|NCT01425827|osteoarthritis|osteoarthritis
501345|NCT01425827|pain|pain
501346|NCT01425827|function|function
501347|NCT01425814|COPD|copd
501348|NCT01425801|COPD|copd
501349|NCT01425788|Grass pollen induced allergic rhinoconjunctivitis|grass pollen induced allergic rhinoconjunctivitis
501350|NCT01425775|SLE|sle
501351|NCT01425775|disease activity markers|disease activity markers
501352|NCT01425775|vitamin D|vitamin d
501353|NCT01425749|melanoma|melanoma
501354|NCT01425749|MAGE-A3|mage-a3
501355|NCT01425749|immunotherapy|immunotherapy
501356|NCT01425749|adjuvant|adjuvant
501357|NCT01425749|skin cancer|skin cancer
501358|NCT01425749|skin diseases|skin diseases
501359|NCT01425749|immunology|immunology
501360|NCT01425736|Nimotuzumab|nimotuzumab
501361|NCT01425736|Chemotherapy|chemotherapy
501362|NCT01425736|Head and Neck Squamous Cell Carcinoma|head and neck squamous cell carcinoma
501363|NCT01425723|B-LONG|b-long
501364|NCT01425723|B-YOND|b-yond
501365|NCT01425723|B-LONG Extension|b-long extension
501366|NCT01425723|rFIXFc|rfixfc
501367|NCT01425723|Severe Hemophilia B|severe hemophilia b
501368|NCT01425710|Pheochromocytoma|pheochromocytoma
501369|NCT01425710|Adrenalectomy|adrenalectomy
501370|NCT01425710|Cardiac output|cardiac output
501371|NCT01425710|Fluid managment|fluid managment
501372|NCT01425710|Esopagheal doppler sonography|esopagheal doppler sonography
501373|NCT01425697|Adult Cardiac surgery|adult cardiac surgery
501374|NCT01425697|Surgery site infections|surgery site infections
501376|NCT01425684|Smoking|smoking
501377|NCT01425684|Schizophrenia|schizophrenia
501378|NCT01425671|Schizophrenia|schizophrenia
501379|NCT01425671|Family|family
501380|NCT01425671|Psychosis|psychosis
501381|NCT01425658|Fentanyl|fentanyl
501382|NCT01425658|clonidine|clonidine
501383|NCT01425658|intrathcal|intrathcal
501384|NCT01425658|bupivacaine|bupivacaine
501385|NCT01425645|gestational diabetes|gestational diabetes
501386|NCT01425645|GDM|gdm
501387|NCT01425645|prevention|prevention
501388|NCT01425632|TAU-284|tau-284
501389|NCT01425632|Bepotastine besilate|bepotastine besilate
501390|NCT01425632|Histamine H1 receptor antagonists|histamine h1 receptor antagonists
501391|NCT01425619|Anxiety Disorder due to Allergy Skin Testing|anxiety disorder due to allergy skin testing
501392|NCT01425580|Congestive Heart Failure|congestive heart failure
501393|NCT01425580|Type 2 Diabetes Mellitus|type 2 diabetes mellitus
501394|NCT01425580|GLP-1|glp-1
501395|NCT01425580|Liraglutide|liraglutide
501396|NCT01425567|cholestasis|cholestasis
501397|NCT01425567|parenteral nutrition|parenteral nutrition
711134|NCT00586352|Crohn's disease|crohn's disease
501398|NCT01425554|Vascular malformations in the internal jugular veins|vascular malformations in the internal jugular veins
501399|NCT01425515|hypertension|hypertension
501400|NCT01425515|genomics|genomics
501401|NCT01425502|High risk prescribing|high risk prescribing
501402|NCT01425502|Primary care|primary care
501403|NCT01425502|Non-steroidal anti-inflammatory drugs|non-steroidal anti-inflammatory drugs
501404|NCT01425502|Anti-platelet agents|anti-platelet agents
501405|NCT01425502|Stepped wedge design|stepped wedge design
501406|NCT01425502|Cluster randomised controlled trial|cluster randomised controlled trial
501407|NCT01425502|United Kingdom|united kingdom
501408|NCT01425489|Krabbe Disease|krabbe disease
501409|NCT01425489|Biomarker|biomarker
501410|NCT01425476|breast|breast
501411|NCT01425476|high risk women|high risk women
501412|NCT01425476|biomarkers|biomarkers
501413|NCT01425476|vitamin D|vitamin d
501414|NCT01425463|Ferrous (II) Glycine Sulphate Complex|ferrous (ii) glycine sulphate complex
501415|NCT01425463|Polyferose|polyferose
501416|NCT01425463|Ferro Sanol duodenal|ferro sanol duodenal
501417|NCT01425463|Niferex|niferex
501418|NCT01425463|Iron Deficiency Anemia|iron deficiency anemia
501419|NCT01425437|Keloid|keloid
501420|NCT01425424|Vitamin D|vitamin d
501421|NCT01425424|Prediabetes|prediabetes
501422|NCT01425424|Prehypertension|prehypertension
501423|NCT01425411|hypertension|hypertension
501424|NCT01425411|left ventricular hypertrophy|left ventricular hypertrophy
501425|NCT01425411|angiotensin receptor blocker|angiotensin receptor blocker
501426|NCT01425411|midwall mechanics|midwall mechanics
501427|NCT01425411|tissue Doppler imaging|tissue doppler imaging
501428|NCT01425411|Hypertension with left ventricular hypertrophy|hypertension with left ventricular hypertrophy
501429|NCT01425385|liver failure|liver failure
501430|NCT01425385|liver transplantation|liver transplantation
501431|NCT01425372|vaccine|vaccine
501432|NCT01425372|pneumococcal conjugate vaccine|pneumococcal conjugate vaccine
501433|NCT01425372|immune responses|immune responses
501434|NCT01425372|primary immunisation|primary immunisation
501435|NCT01425372|Vaccine responses to primary immunisation in the UK|vaccine responses to primary immunisation in the uk
501436|NCT01425359|Chronic angina|chronic angina
501437|NCT01425359|Angina pectoris|angina pectoris
501438|NCT01425359|Coronary artery disease|coronary artery disease
501439|NCT01425359|Type 2 Diabetes Mellitus|type 2 diabetes mellitus
501440|NCT01425346|Ophthalmic, healthy eye, fluorescence, lens|ophthalmic, healthy eye, fluorescence, lens
501639|NCT01424618|Donor eggs|donor eggs
501441|NCT01425333|Ovarian endometriomas|ovarian endometriomas
501442|NCT01425333|Laparoscopy|laparoscopy
501443|NCT01425333|Cystectomy|cystectomy
501444|NCT01425333|Ablation|ablation
501445|NCT01425307|Phase III|phase iii
501446|NCT01425307|Sickle cell anemia|sickle cell anemia
501447|NCT01425307|Abnormally high Transcranial Doppler velocities.|abnormally high transcranial doppler velocities.
501448|NCT01425307|Reduce risk of primary stroke|reduce risk of primary stroke
501449|NCT01425307|Pediatric patients|pediatric patients
501450|NCT01425307|Chelation therapy|chelation therapy
501451|NCT01425294|Chinese post-menopausal women|chinese post-menopausal women
501452|NCT01425294|oestrogen receptor-positive locally advanced|oestrogen receptor-positive locally advanced
501453|NCT01425294|metastatic breast cancer|metastatic breast cancer
501454|NCT01425294|fulvestrant 250 mg|fulvestrant 250 mg
501455|NCT01425294|failure to adjuvant anti-oestrogen therapy|failure to adjuvant anti-oestrogen therapy
501456|NCT01425281|Bioabsorbable|bioabsorbable
501457|NCT01425281|Coronary scaffold|coronary scaffold
501458|NCT01425281|Coronary Stent|coronary stent
501459|NCT01425281|Everolimus|everolimus
501460|NCT01425281|Drug eluting stents|drug eluting stents
501461|NCT01425281|Angioplasty|angioplasty
501462|NCT01425281|Coronary artery disease|coronary artery disease
501463|NCT01425281|Total coronary occlusion|total coronary occlusion
501464|NCT01425281|Coronary artery restenosis|coronary artery restenosis
501465|NCT01425281|Stent thrombosis|stent thrombosis
501466|NCT01425281|Myocardial ischemia|myocardial ischemia
501467|NCT01425281|Coronary artery stenosis|coronary artery stenosis
501468|NCT01425268|Tissue Expansion|tissue expansion
501469|NCT01425268|Tissue Expander|tissue expander
501470|NCT01425268|Breast Tissue Expansion|breast tissue expansion
501471|NCT01425268|Breast Tissue Expander|breast tissue expander
501472|NCT01425268|Breast Reconstruction|breast reconstruction
501473|NCT01425268|Two Stage Breast Reconstruction|two stage breast reconstruction
501474|NCT01425268|2 Stage Breast Reconstruction|2 stage breast reconstruction
501475|NCT01425255|Type 1 diabetes|type 1 diabetes
501476|NCT01425255|Sleep quality|sleep quality
501477|NCT01425255|Parents|parents
501478|NCT01425242|inflammation|inflammation
501479|NCT01425242|aneurysm|aneurysm
501480|NCT01425242|hypertension|hypertension
501481|NCT01425242|aliskiren|aliskiren
501482|NCT01425229|steady state|steady state
501483|NCT01425229|bosentan|bosentan
501484|NCT01425229|clarithromycin|clarithromycin
501485|NCT01425216|Keloid|keloid
501486|NCT01425216|Patient who have extensive or massive keloids|patient who have extensive or massive keloids
501487|NCT01425177|Retained CBD Stones|retained cbd stones
501488|NCT01425177|Recurrent CBD Stones|recurrent cbd stones
501489|NCT01425164|hemodialysis|hemodialysis
501490|NCT01425164|coronary heart disease|coronary heart disease
501491|NCT01425164|angina|angina
501492|NCT01425164|betablocker|betablocker
501493|NCT01425164|carvedilol|carvedilol
501494|NCT01425164|ivabradine|ivabradine
501495|NCT01425138|psoriasis|psoriasis
501496|NCT01425138|systematic review|systematic review
501497|NCT01425138|meta-analyses|meta-analyses
501498|NCT01425125|nonedematous hyponatremia|nonedematous hyponatremia
501499|NCT01425125|fractional urate excretion|fractional urate excretion
501500|NCT01425112|trabeculectomy|trabeculectomy
501501|NCT01425112|bevacizumab|bevacizumab
501502|NCT01425112|anti-VEGF|anti-vegf
501503|NCT01425112|Efficacy|efficacy
501504|NCT01425086|Incubator,|incubator,
501505|NCT01425086|hypothermia,|hypothermia,
501506|NCT01425086|preterm,|preterm,
501507|NCT01425086|low-birthweight infants,|low-birthweight infants,
501508|NCT01425086|embrace device,|embrace device,
501509|NCT01425086|phase change materials|phase change materials
501511|NCT01425073|HIV|hiv
501512|NCT01425073|Co-Infections|co-infections
501513|NCT01425073|Malaria|malaria
501514|NCT01425073|Pneumonia|pneumonia
501515|NCT01425073|Diarrhea|diarrhea
501516|NCT01425060|Contraception|contraception
501517|NCT01425060|Unintended pregnancy|unintended pregnancy
501518|NCT01425060|HIV|hiv
501519|NCT01425060|HIV Risk|hiv risk
501520|NCT01425060|Sexually Transmitted Infections|sexually transmitted infections
501521|NCT01425060|Women|women
501522|NCT01425060|Pregnancy|pregnancy
501523|NCT01425060|Neonatal Health|neonatal health
501524|NCT01425060|Drug Use|drug use
501525|NCT01425060|Drug Treatment|drug treatment
501526|NCT01425060|Opioids|opioids
501527|NCT01425047|mangosteen|mangosteen
501528|NCT01425047|xanthones|xanthones
501529|NCT01425047|dietary supplement|dietary supplement
501530|NCT01425047|botanical supplement|botanical supplement
501531|NCT01425047|bioavailability|bioavailability
501532|NCT01425047|Determine bioavailability of mangosteen xanthones in adults|determine bioavailability of mangosteen xanthones in adults
501533|NCT01425034|Cast|cast
501534|NCT01425034|motion|motion
501535|NCT01425034|thumb CMC arthritis|thumb cmc arthritis
501536|NCT01425034|Collateral Ligament of Metacarpophalangeal Joint|collateral ligament of metacarpophalangeal joint
501537|NCT01424995|trigger thumb|trigger thumb
501538|NCT01424995|flexor pollicis longus tendon of the thumb|flexor pollicis longus tendon of the thumb
501539|NCT01424995|stenosis tenosynovitis|stenosis tenosynovitis
501540|NCT01424969|rotator cuff repair|rotator cuff repair
501541|NCT01424969|arthroscopic|arthroscopic
501542|NCT01424969|platelet-rich plasma|platelet-rich plasma
501543|NCT01424969|platelet-rich fibrin matrix|platelet-rich fibrin matrix
501544|NCT01424969|outcomes|outcomes
501545|NCT01424969|tendon healing|tendon healing
501546|NCT01424969|magnetic resonance imaging|magnetic resonance imaging
501548|NCT01424956|breast cancer|breast cancer
501549|NCT01424956|breast screening|breast screening
501550|NCT01424956|breast cancer screening|breast cancer screening
501551|NCT01424956|ultrasound|ultrasound
501552|NCT01424956|ultrasonography|ultrasonography
501553|NCT01424956|mammogram|mammogram
501554|NCT01424956|mammography|mammography
501555|NCT01424956|breast density|breast density
501556|NCT01424956|dense breasts|dense breasts
501557|NCT01424956|early detection|early detection
501558|NCT01424956|somo v|somo v
501559|NCT01424956|somo•v|somo•v
501560|NCT01424956|U-Systems|u-systems
501561|NCT01424956|Automated Breast Ultrasound|automated breast ultrasound
501562|NCT01424956|Ultrasonography, Mammary|ultrasonography, mammary
501563|NCT01424956|Breast Neoplasms|breast neoplasms
501564|NCT01424956|Breast Density > 50% (BI-RADS III & IV)|breast density > 50% (bi-rads iii & iv)
501565|NCT01424943|prevention|prevention
501566|NCT01424943|evidence-based parenting intervention|evidence-based parenting intervention
501567|NCT01424943|children|children
501568|NCT01424943|disabilities|disabilities
501569|NCT01424943|IDEA Part C|idea part c
501570|NCT01424943|Stepping Stones Triple P|stepping stones triple p
501571|NCT01424930|Metastatic castration-resistant prostate cancer|metastatic castration-resistant prostate cancer
501572|NCT01424930|CRPC|crpc
501573|NCT01424930|Abiraterone Acetate|abiraterone acetate
501574|NCT01424930|Prednisone|prednisone
501575|NCT01424930|Food Safety|food safety
501576|NCT01424917|Cardiac Allograft Vasculopathy|cardiac allograft vasculopathy
501577|NCT01424904|Ergogenic aid|ergogenic aid
501578|NCT01424904|Exercise endurance|exercise endurance
501579|NCT01424904|High performance|high performance
501580|NCT01424904|Time trial performance|time trial performance
501581|NCT01424904|Glutathione|glutathione
501582|NCT01424878|Molecular Analysis of Medullary Thyroid Carcinoma Tissues|molecular analysis of medullary thyroid carcinoma tissues
501583|NCT01424865|HER2-positive breast cancer|her2-positive breast cancer
501584|NCT01424865|stage II breast cancer|stage ii breast cancer
501585|NCT01424865|stage IIIA breast cancer|stage iiia breast cancer
501586|NCT01424852|Probiotics|probiotics
638064|NCT00876499|PBT|pbt
501587|NCT01424852|Caries|caries
501588|NCT01424852|Oral flora|oral flora
501589|NCT01424839|SIOP CNS GCT II|siop cns gct ii
501590|NCT01424839|Patients with the primary disease of an Intracranial Germ Cell Tumors|patients with the primary disease of an intracranial germ cell tumors
501591|NCT01424826|Healthy volunteers|healthy volunteers
501592|NCT01424813|Asthma|asthma
501593|NCT01424813|dry powder inhaler|dry powder inhaler
501594|NCT01424813|short-acting beta2-agonist|short-acting beta2-agonist
501595|NCT01424813|SABA|saba
501596|NCT01424813|bronchoconstriction|bronchoconstriction
501597|NCT01424813|bronchodilation|bronchodilation
501598|NCT01424813|bronchodilator|bronchodilator
501599|NCT01424813|metered dose inhaler|metered dose inhaler
501600|NCT01424774|Radiation Exposure|radiation exposure
501601|NCT01424774|Rubidium 82|rubidium 82
501602|NCT01424774|Strontium 82|strontium 82
501603|NCT01424774|Strontium 85|strontium 85
501604|NCT01424748|Noni juice|noni juice
501605|NCT01424748|Safety|safety
501606|NCT01424735|Best corrected Visual Acuity|best corrected visual acuity
501607|NCT01424735|Pupillary Reaction|pupillary reaction
501608|NCT01424735|Colour vision|colour vision
501609|NCT01424735|Disc edema|disc edema
501610|NCT01424722|ICD Indicated patients|icd indicated patients
501611|NCT01424722|documented CAD|documented cad
501612|NCT01424709|Chemotherapy|chemotherapy
501613|NCT01424709|Individual therapy|individual therapy
501614|NCT01424709|RRM1|rrm1
501615|NCT01424709|BRCA1|brca1
501616|NCT01424696|growth measures|growth measures
501617|NCT01424696|nutritional status|nutritional status
501618|NCT01424696|pulmonary infection|pulmonary infection
501619|NCT01424696|inflammatory markers|inflammatory markers
501620|NCT01424696|pancreatic enzyme replacement therapy|pancreatic enzyme replacement therapy
501621|NCT01424683|Qol|qol
501622|NCT01424683|Quality of life|quality of life
501623|NCT01424683|VAS|vas
501624|NCT01424683|Visual Analogue Scale|visual analogue scale
501625|NCT01424683|CABG|cabg
501626|NCT01424683|Coronary Artery Bypass Graft|coronary artery bypass graft
501627|NCT01424683|Qol conversion|qol conversion
501628|NCT01424683|post hoc HTA|post hoc hta
501629|NCT01424670|Multidrug-resistant tuberculosis|multidrug-resistant tuberculosis
501630|NCT01424657|MRCP|mrcp
501631|NCT01424657|ERCP|ercp
501632|NCT01424657|BILIARY OBSTRUCTION|biliary obstruction
501633|NCT01424657|EFFECTIVENESS|effectiveness
501634|NCT01424644|meningitis|meningitis
501635|NCT01424644|human papillomavirus|human papillomavirus
501636|NCT01424644|tetanus|tetanus
501637|NCT01424644|diptheria|diptheria
501638|NCT01424644|pertussis|pertussis
501640|NCT01424618|Donor oocytes|donor oocytes
501641|NCT01424618|Pregnancy|pregnancy
501642|NCT01424618|Embryo Implantation|embryo implantation
501643|NCT01424618|Infertility|infertility
501644|NCT01424618|IVF|ivf
501645|NCT01424605|left-sided double lumen bronchial tube|left-sided double lumen bronchial tube
501646|NCT01424605|GlideScope videolaryngoscope|glidescope videolaryngoscope
501647|NCT01424605|direct laryngoscope|direct laryngoscope
501648|NCT01424592|Portable sleep apnea testing|portable sleep apnea testing
501649|NCT01424592|Positive airway pressure therapy|positive airway pressure therapy
501650|NCT01424592|Polysomnography|polysomnography
501651|NCT01424566|Cancer pain|cancer pain
501652|NCT01424566|Opioid therapy|opioid therapy
501653|NCT01424566|Inadequate analgesia|inadequate analgesia
501654|NCT01424566|Optimized chronic opioid therapy|optimized chronic opioid therapy
501655|NCT01424553|Low birthweight|low birthweight
501656|NCT01424553|Bronchopulmonary dysplasia|bronchopulmonary dysplasia
501657|NCT01424553|Lung development|lung development
501658|NCT01424553|Airway obstruction|airway obstruction
501659|NCT01424553|Asthma|asthma
501660|NCT01424527|Chronic Obstructive Pulmonary Disease(COPD)|chronic obstructive pulmonary disease(copd)
501661|NCT01424527|COPD Assessment Test(CAT)|copd assessment test(cat)
501662|NCT01424501|Tuberculosis vaccine|tuberculosis vaccine
501663|NCT01424501|HIV-negative|hiv-negative
501664|NCT01424501|tuberculosis treatment|tuberculosis treatment
501665|NCT01424488|sugammadex|sugammadex
501666|NCT01424488|reversal|reversal
501667|NCT01424488|pipecuronium-induced neuromuscular blockade|pipecuronium-induced neuromuscular blockade
501668|NCT01424462|healthy volunteers|healthy volunteers
501669|NCT01424462|firategrast|firategrast
501670|NCT01424462|Pharmacokinetics|pharmacokinetics
501671|NCT01424462|modified release|modified release
501672|NCT01424436|CSF sampling|csf sampling
501673|NCT01424436|Alzheimer's disease|alzheimer's disease
501674|NCT01424436|Amyloid beta levels|amyloid beta levels
501675|NCT01424423|Safety|safety
501676|NCT01424423|GSK1223249|gsk1223249
501677|NCT01424423|Pharmacokinetics|pharmacokinetics
501678|NCT01424423|Single dose escalation|single dose escalation
501679|NCT01424423|anti-GSK1223249 antibodies|anti-gsk1223249 antibodies
501680|NCT01424423|Multiple Sclerosis|multiple sclerosis
501681|NCT01424410|paediatric schistosomiasis morbidity immunology|paediatric schistosomiasis morbidity immunology
501682|NCT01424384|healthy volunteers|healthy volunteers
501683|NCT01424384|Anxiety Disorder|anxiety disorder
501684|NCT01424384|neuropsychological tests|neuropsychological tests
501685|NCT01424345|Kidney Transplantation|kidney transplantation
501686|NCT01424345|Immunosuppression|immunosuppression
501687|NCT01424345|Immune monitoring|immune monitoring
501688|NCT01424332|Pharmacodynamics|pharmacodynamics
501689|NCT01424332|pharmacokinetics|pharmacokinetics
501690|NCT01424332|darexaban|darexaban
501691|NCT01424332|Acetyl Salicylic Acid|acetyl salicylic acid
501692|NCT01424332|darexaban glucuronide|darexaban glucuronide
501693|NCT01424332|YM150|ym150
501694|NCT01424332|YM-222714|ym-222714
501695|NCT01424332|Phase 1|phase 1
501696|NCT01424319|Endothelin Receptor Antagonists|endothelin receptor antagonists
501697|NCT01424319|Proteinuria|proteinuria
501698|NCT01424306|Inflammation|inflammation
501699|NCT01424306|Intestinal permeability|intestinal permeability
501700|NCT01424306|Type 2 diabetes mellitus|type 2 diabetes mellitus
501701|NCT01424306|Cardiovascular disease|cardiovascular disease
501702|NCT01424306|Obesity|obesity
501703|NCT01424306|Sweetened beverages|sweetened beverages
501704|NCT01424306|Sugar|sugar
501705|NCT01424306|Fructose|fructose
501706|NCT01424306|Glucose|glucose
501707|NCT01424306|High-fructose corn syrup|high-fructose corn syrup
501708|NCT01424293|Rectal Cancer|rectal cancer
501709|NCT01424293|Colon Cancer|colon cancer
501710|NCT01424293|Diverticulitis|diverticulitis
501711|NCT01424293|Anastamosis|anastamosis
501712|NCT01424293|colectomy|colectomy
501713|NCT01424293|low anterior resection|low anterior resection
501714|NCT01424267|low profile|low profile
501715|NCT01424267|endovascular graft|endovascular graft
501716|NCT01424267|endovascular procedure|endovascular procedure
501717|NCT01424267|aortic aneurysm, abdominal aortic aneurysm|aortic aneurysm, abdominal aortic aneurysm
501718|NCT01424254|Gastrointestinal Bleeding of Obscure Origin|gastrointestinal bleeding of obscure origin
501719|NCT01424241|Sandostatin LAR|sandostatin lar
501720|NCT01424228|Long term|long term
501721|NCT01424228|Constipation|constipation
501722|NCT01424228|Digestive signs and symptoms|digestive signs and symptoms
501723|NCT01424202|Post extubation failure|post extubation failure
501724|NCT01424202|Mechanical Insufflation-Exsufflation|mechanical insufflation-exsufflation
501725|NCT01424202|Noninvasive Ventilation|noninvasive ventilation
501726|NCT01424202|Weaning|weaning
501727|NCT01424189|Cataract surgery|cataract surgery
501728|NCT01424189|Intraocular lens|intraocular lens
501729|NCT01424150|Postoperative fluid|postoperative fluid
501730|NCT01424150|surgery|surgery
501731|NCT01424150|anaesthesia|anaesthesia
501732|NCT01424150|fluid|fluid
501733|NCT01424150|mortality|mortality
501734|NCT01424150|morbidity|morbidity
501735|NCT01424111|Biomarkers|biomarkers
501736|NCT01424111|Depression|depression
501737|NCT01424111|Major Depressive Disorder|major depressive disorder
501738|NCT01424111|Escitalopram|escitalopram
501739|NCT01424072|stress psychological|stress psychological
501740|NCT01424072|coping behavior|coping behavior
501741|NCT01424059|fear|fear
501742|NCT01424059|labor|labor
501743|NCT01424059|induction|induction
501744|NCT01424059|amniotomy|amniotomy
501745|NCT01424059|WEDQ-B|wedq-b
501746|NCT01424059|parous|parous
501747|NCT01424059|cesarean section|cesarean section
501748|NCT01424046|type 1 diabetes|type 1 diabetes
501749|NCT01424046|basal insulin|basal insulin
501750|NCT01424046|developing world|developing world
501751|NCT01424046|comparative effectiveness|comparative effectiveness
501752|NCT01424033|Interstitial lung disease|interstitial lung disease
501753|NCT01424033|Connective tissue disease|connective tissue disease
501754|NCT01424033|Scleroderma|scleroderma
501755|NCT01424033|Rheumatoid arthritis|rheumatoid arthritis
501756|NCT01424033|Sjogren's syndrome|sjogren's syndrome
501757|NCT01424033|Mixed connective tissue disease|mixed connective tissue disease
501758|NCT01424033|Dermatomyositis|dermatomyositis
501759|NCT01424033|Polymyositis|polymyositis
501760|NCT01424033|Systemic lupus erythematosis|systemic lupus erythematosis
501761|NCT01424020|Questionnaire|questionnaire
501762|NCT01424020|peripheral artery disease|peripheral artery disease
501763|NCT01424020|execise|execise
501764|NCT01424007|Obese|obese
501765|NCT01424007|Women|women
501766|NCT01424007|Weight loss|weight loss
501767|NCT01424007|Exercise|exercise
501768|NCT01424007|Physical activity|physical activity
501769|NCT01424007|Diet|diet
501770|NCT01424007|Female|female
501771|NCT01423994|syncope|syncope
501772|NCT01423994|fainting|fainting
501773|NCT01423994|implantable loop recorder|implantable loop recorder
501774|NCT01423994|pacemaker|pacemaker
501775|NCT01423994|heart block|heart block
501776|NCT01423994|bifascicular heart block|bifascicular heart block
501777|NCT01423981|Keloid|keloid
501778|NCT01423981|Scar|scar
501779|NCT01423981|hypertrophic scar|hypertrophic scar
501780|NCT01423981|familial keloid|familial keloid
501781|NCT01423968|Sepsis|sepsis
501782|NCT01423968|Inflammation|inflammation
501783|NCT01423968|Lipopolysaccharide|lipopolysaccharide
501784|NCT01423968|Muscle protein turnover|muscle protein turnover
501785|NCT01423968|Insulin resistance|insulin resistance
501786|NCT01423955|Erythropoietin|erythropoietin
501787|NCT01423955|Erythropoetin|erythropoetin
501788|NCT01423955|Cardiac surgery|cardiac surgery
501789|NCT01423955|Ischemia|ischemia
501790|NCT01423955|Reperfusion|reperfusion
501791|NCT01423955|Renal function|renal function
501792|NCT01423955|Cystatin C|cystatin c
501793|NCT01423955|Creatinine|creatinine
501794|NCT01423955|Safety|safety
501795|NCT01423929|Oxygen|oxygen
501796|NCT01423929|Myocardial infarction|myocardial infarction
501797|NCT01423929|Ambulance|ambulance
501798|NCT01423929|Percutaneous coronary intervention|percutaneous coronary intervention
501799|NCT01423929|Cardiac magnetic resonance imaging|cardiac magnetic resonance imaging
501800|NCT01423916|Schizophrenia|schizophrenia
501801|NCT01423916|QTc Interval|qtc interval
501802|NCT01423903|Phase I|phase i
501803|NCT01423903|STAT-3 inhibitor|stat-3 inhibitor
501804|NCT01423903|solid tumors|solid tumors
501805|NCT01423890|Breast Cancer|breast cancer
501806|NCT01423890|Oncotype DX|oncotype dx
501807|NCT01423890|Adjuvant! Online|adjuvant! online
501808|NCT01423890|Decisional Conflict Scale|decisional conflict scale
501809|NCT01423877|bariatric surgery|bariatric surgery
501810|NCT01423877|diabetes|diabetes
501811|NCT01423877|sleeve gastrectomy|sleeve gastrectomy
501812|NCT01423877|gastric bypass|gastric bypass
501813|NCT01423877|gastric banding|gastric banding
501814|NCT01423864|Acute Respiratory Distress Syndrome|acute respiratory distress syndrome
501815|NCT01423864|Multi-organ Dysfunction Syndrome|multi-organ dysfunction syndrome
501816|NCT01423864|Extracorporeal Membrane Oxygenation|extracorporeal membrane oxygenation
501817|NCT01423851|Keywords provided by NS Pharma, Inc.:|keywords provided by ns pharma, inc.:
501818|NCT01423851|JAK2 kinase inhibitor|jak2 kinase inhibitor
501819|NCT01423851|NS-018|ns-018
501820|NCT01423851|Myeloproliferative Neoplasms|myeloproliferative neoplasms
501821|NCT01423851|Primary Myelofibrosis|primary myelofibrosis
501822|NCT01423851|post-Polycythemia Vera Myelofibrosis|post-polycythemia vera myelofibrosis
501823|NCT01423851|post-Essential Thrombocythemia Myelofibrosis|post-essential thrombocythemia myelofibrosis
501824|NCT01423851|Additional relevant MeSH terms:|additional relevant mesh terms:
501825|NCT01423851|Bone Marrow Diseases|bone marrow diseases
501826|NCT01423851|Hematologic Diseases|hematologic diseases
501827|NCT01423851|Polycythemia Vera|polycythemia vera
501828|NCT01423851|Thrombocythemia, Essential|thrombocythemia, essential
501829|NCT01423851|PMF|pmf
501830|NCT01423851|post-PV MF|post-pv mf
501831|NCT01423851|post-ET MF|post-et mf
501832|NCT01423838|Overactive bladder|overactive bladder
501833|NCT01423838|Solifenacin|solifenacin
501834|NCT01423838|Oxybutynin|oxybutynin
501835|NCT01423812|HIV|hiv
501836|NCT01423812|treatment-experienced|treatment-experienced
501837|NCT01423812|protease inhibitor|protease inhibitor
501838|NCT01423812|adherence|adherence
501839|NCT01423812|lipids|lipids
501840|NCT01423799|Quality of life|quality of life
501841|NCT01423799|Cancer|cancer
501842|NCT01423799|Immunonutrition|immunonutrition
501843|NCT01423760|Vaccine|vaccine
501844|NCT01423760|Stimuvax|stimuvax
501845|NCT01423760|Tecemotide|tecemotide
501846|NCT01423760|L-BLP25|l-blp25
501847|NCT01423760|Non-Small Cell Lung Carcinoma|non-small cell lung carcinoma
501848|NCT01423760|Multiple Myeloma|multiple myeloma
501849|NCT01423747|ALL|all
501850|NCT01423747|HSCT|hsct
501851|NCT01423747|children|children
501852|NCT01423747|adolescents|adolescents
501853|NCT01423734|ADRENAL GLAND|adrenal gland
501854|NCT01423734|MRI|mri
501855|NCT01423734|11-122|11-122
501856|NCT01423708|Liver Transplantation|liver transplantation
501857|NCT01423708|Graft Rejection|graft rejection
501858|NCT01423708|Graft Survival|graft survival
501859|NCT01423708|Transplantation Immunology|transplantation immunology
501860|NCT01423708|Anti-Rejection Therapy|anti-rejection therapy
501861|NCT01423708|Immunosuppression|immunosuppression
501862|NCT01423708|Organ Transplantation|organ transplantation
501863|NCT01423708|Host vs Graft Reaction|host vs graft reaction
501864|NCT01423708|Gastroenterology|gastroenterology
501865|NCT01423708|Hepatology|hepatology
501866|NCT01423669|Psychotic Disorders|psychotic disorders
501867|NCT01423643|HIV|hiv
501868|NCT01423643|Human immunodeficiency virus|human immunodeficiency virus
501869|NCT01423643|Acquired Immune Deficiency Syndrome Virus|acquired immune deficiency syndrome virus
501870|NCT01423643|AIDS Virus|aids virus
501871|NCT01423643|Immunodeficiency Virus, Human|immunodeficiency virus, human
501872|NCT01423643|Virus, Human Immunodeficiency|virus, human immunodeficiency
501873|NCT01423643|Hepatitis C|hepatitis c
501874|NCT01423643|Hepatitis C, chronic|hepatitis c, chronic
501875|NCT01423643|Hepatitis C virus|hepatitis c virus
501876|NCT01423643|Hepatitis C antibodies|hepatitis c antibodies
501877|NCT01423643|Hepatitis C antigens|hepatitis c antigens
501878|NCT01423630|fatty liver|fatty liver
501879|NCT01423630|probiotics|probiotics
501880|NCT01423630|Lactobacillus|lactobacillus
501881|NCT01423630|fruit|fruit
501882|NCT01423630|fibre|fibre
501883|NCT01423630|dietary intervention|dietary intervention
501884|NCT01423630|obesity|obesity
501885|NCT01423617|overweight|overweight
501886|NCT01423617|weight loss|weight loss
501887|NCT01423617|body fat|body fat
501888|NCT01423617|waist circumference|waist circumference
501889|NCT01423617|satiety|satiety
501890|NCT01423617|appetite|appetite
501891|NCT01423604|Metastatic pancreatic cancer|metastatic pancreatic cancer
501892|NCT01423591|Infliximab|infliximab
501893|NCT01423591|polymyalgia rheumatica|polymyalgia rheumatica
501894|NCT01423591|refractory|refractory
501895|NCT01423591|double blind|double blind
501896|NCT01423591|placebo controlled|placebo controlled
501897|NCT01423591|trial|trial
501898|NCT01423578|craving|craving
501899|NCT01423578|mood|mood
501900|NCT01423578|cue reactivity|cue reactivity
501901|NCT01423578|smoking behavior|smoking behavior
501902|NCT01423578|quit smoking|quit smoking
501903|NCT01423578|prevention|prevention
501904|NCT01423578|Hatha yoga|hatha yoga
501905|NCT01423578|cardiovascular exercise|cardiovascular exercise
501906|NCT01423565|Deep Brain Stimulation|deep brain stimulation
501907|NCT01423565|Parkinson's Disease|parkinson's disease
501908|NCT01423565|Subthalamic Nucleus|subthalamic nucleus
501909|NCT01423565|Constant Current|constant current
501910|NCT01423552|Heart transplantation|heart transplantation
501911|NCT01423552|Immunosuppression|immunosuppression
501912|NCT01423552|Pharmacokinetics|pharmacokinetics
501913|NCT01423552|Pharmacogenetics|pharmacogenetics
501914|NCT01423513|ankle tape|ankle tape
501915|NCT01423513|Hoffmann reflex|hoffmann reflex
501916|NCT01423513|Balance|balance
501917|NCT01423500|ALL|all
501918|NCT01423500|HSCT|hsct
501919|NCT01423500|children|children
501920|NCT01423500|adolescents|adolescents
501921|NCT01423487|Metformin|metformin
501922|NCT01423487|Risperidone|risperidone
501923|NCT01423487|Prevention|prevention
501924|NCT01423487|weight gain|weight gain
501925|NCT01423487|Amenorrhea|amenorrhea
501926|NCT01423474|Radiotherapy|radiotherapy
501927|NCT01423474|Hypofractionation|hypofractionation
501928|NCT01423448|Depression|depression
501929|NCT01423448|mental health|mental health
501930|NCT01423448|wellbeing|wellbeing
501931|NCT01423448|online bulletin board|online bulletin board
501932|NCT01423448|online support group|online support group
501933|NCT01423435|TRK-100STP|trk-100stp
501934|NCT01423435|PK|pk
501935|NCT01423435|beraprost sodium|beraprost sodium
501936|NCT01423422|Exercise stress test|exercise stress test
501937|NCT01423422|Effort Angina|effort angina
501938|NCT01423422|Exercise induced angina|exercise induced angina
501939|NCT01423409|visual analog pain scale|visual analog pain scale
501940|NCT01423409|Deaf persons|deaf persons
501941|NCT01423409|clinical trial|clinical trial
501942|NCT01423409|multicentric|multicentric
501943|NCT01423396|Alzheimer's disease|alzheimer's disease
501944|NCT01423396|cardiovascular risk factors|cardiovascular risk factors
501945|NCT01423383|Keloid|keloid
501946|NCT01423370|Erectile Dysfunction|erectile dysfunction
501947|NCT01423370|YHD1023|yhd1023
501948|NCT01423370|YCD190|ycd190
501949|NCT01423370|Cialis|cialis
501950|NCT01423370|Yuhan|yuhan
501951|NCT01423357|HIV prevention|hiv prevention
501952|NCT01423357|condom distribution|condom distribution
501953|NCT01423357|youth peer education|youth peer education
501954|NCT01423357|high risk places|high risk places
501955|NCT01423357|condom use|condom use
501956|NCT01423357|prevention through increased condom use|prevention through increased condom use
501957|NCT01423344|multiple myeloma|multiple myeloma
501958|NCT01423344|Free light chains|free light chains
501959|NCT01423331|Postpartum depression|postpartum depression
501960|NCT01423331|maternal mental health|maternal mental health
501961|NCT01423305|Asthma|asthma
501962|NCT01423266|High Protein Diet in heart failure|high protein diet in heart failure
501963|NCT01423266|obesity and heart failure|obesity and heart failure
501964|NCT01423266|Weight management in Heart failure|weight management in heart failure
501965|NCT01423266|heart failure, diabetes and obesity|heart failure, diabetes and obesity
501966|NCT01423253|Depression|depression
501967|NCT01423253|Lurasidone|lurasidone
501968|NCT01423253|Latuda|latuda
501969|NCT01423240|Depression|depression
501970|NCT01423240|Lurasidone|lurasidone
501971|NCT01423240|Latuda|latuda
501972|NCT01423227|COPD|copd
501973|NCT01423227|exercise|exercise
501974|NCT01423227|rehabilitation|rehabilitation
501975|NCT01423227|dyspnea|dyspnea
501976|NCT01423227|quality of life|quality of life
501977|NCT01423227|economic evaluation|economic evaluation
501978|NCT01423214|rectal cancer|rectal cancer
501979|NCT01423214|robot|robot
501980|NCT01423214|laparoscopy|laparoscopy
501981|NCT01423214|total mesorectal excision|total mesorectal excision
501982|NCT01423214|robotic surgery|robotic surgery
501983|NCT01423201|TIA|tia
501984|NCT01423201|triage|triage
501985|NCT01423201|Lp-PLA2|lp-pla2
501986|NCT01423201|Proteomic|proteomic
501987|NCT01423201|Genomic|genomic
501988|NCT01423188|ApolipoproteinA1|apolipoproteina1
501989|NCT01423188|HDL-C|hdl-c
501990|NCT01423188|Atherosclerosis|atherosclerosis
501991|NCT01423175|high risk acute myeloid leukemia|high risk acute myeloid leukemia
501992|NCT01423175|advanced myelodysplastic syndrome|advanced myelodysplastic syndrome
501993|NCT01423175|allogenic stem cell transplantation|allogenic stem cell transplantation
501994|NCT01423175|clofarabine|clofarabine
501995|NCT01423162|Iron absorption|iron absorption
501996|NCT01423162|Oats|oats
501997|NCT01423162|fortified oat beverages|fortified oat beverages
501998|NCT01423149|subfoveal choroidal neovascularization|subfoveal choroidal neovascularization
501999|NCT01423149|pathologic myopia|pathologic myopia
502000|NCT01423136|Patients undergoing non-cardiac Surgery|patients undergoing non-cardiac surgery
502001|NCT01423123|Paclitaxel|paclitaxel
502002|NCT01423123|Trastuzumab|trastuzumab
502003|NCT01423123|Neratinib|neratinib
502004|NCT01423123|Breast Cancer|breast cancer
502005|NCT01423123|HER2-positive|her2-positive
502006|NCT01423110|sporadic Inclusion Body Myositis|sporadic inclusion body myositis
502007|NCT01423097|osteoarthritis symptoms|osteoarthritis symptoms
502008|NCT01423084|Meningococcal Meningitis|meningococcal meningitis
502009|NCT01423084|prevention, vaccination|prevention, vaccination
502010|NCT01423084|adolescents|adolescents
502011|NCT01423071|Pulmonary Hypertension|pulmonary hypertension
502012|NCT01423071|Chronic obstructive pulmonary disease|chronic obstructive pulmonary disease
502013|NCT01423071|Prevalence|prevalence
502014|NCT01423071|Quality of life|quality of life
502015|NCT01423045|Chronic kidney disease|chronic kidney disease
502016|NCT01423045|Urine osmolarity|urine osmolarity
502017|NCT01423045|Glomerular filtration rate|glomerular filtration rate
502018|NCT01423032|relapsed|relapsed
502019|NCT01423019|Weight Loss|weight loss
502020|NCT01423019|Body Composition|body composition
502021|NCT01423019|Fat Free Mass|fat free mass
502022|NCT01423019|Bone Mineral Density|bone mineral density
502023|NCT01423019|Adipose Tissue|adipose tissue
502024|NCT01423019|Dual-Energy X-Ray Absorptiometry|dual-energy x-ray absorptiometry
502025|NCT01423019|Body Fat|body fat
502026|NCT01423019|Eating and appetite control|eating and appetite control
502027|NCT01423019|Basal Metabolic Rate|basal metabolic rate
502028|NCT01423006|Pilot|pilot
502029|NCT01423006|Ablation|ablation
502030|NCT01423006|Low Risk|low risk
502031|NCT01423006|Radio Frequency|radio frequency
502032|NCT01423006|RFA|rfa
502033|NCT01423006|minimally invasive|minimally invasive
502034|NCT01423006|prostate gland|prostate gland
502035|NCT01422993|Oxaliplatin Induced|oxaliplatin induced
502036|NCT01422993|Peripheral Neuropathy|peripheral neuropathy
502037|NCT01422993|Strength|strength
502038|NCT01422993|Balance|balance
502039|NCT01422993|Training Program|training program
502040|NCT01422993|Colon|colon
502041|NCT01422993|Rectal|rectal
502042|NCT01422980|dairy product|dairy product
502043|NCT01422980|upper gastric discomfort|upper gastric discomfort
502044|NCT01422980|adult|adult
502150|NCT01422486|Apoptosis|apoptosis
502045|NCT01422967|Osteoarthritis|osteoarthritis
502046|NCT01422967|Sleep|sleep
502047|NCT01422967|muscle strength|muscle strength
502048|NCT01422967|balance|balance
502049|NCT01422928|Radiotherapy|radiotherapy
502050|NCT01422928|Acupuncture|acupuncture
502051|NCT01422928|Immune System|immune system
502052|NCT01422915|Sorbent|sorbent
502053|NCT01422915|Resin|resin
502054|NCT01422915|EPP|epp
502055|NCT01422915|Cutaneous porphyria|cutaneous porphyria
502056|NCT01422915|Adult|adult
502057|NCT01422915|over age 21|over age 21
502058|NCT01422915|without intercurrent illness|without intercurrent illness
502059|NCT01422915|not pregnant|not pregnant
502060|NCT01422915|willing to participate|willing to participate
502061|NCT01422902|Schizophrenia|schizophrenia
502062|NCT01422902|Cognitive deficits|cognitive deficits
502063|NCT01422902|Cognitive remediation|cognitive remediation
502064|NCT01422902|Software|software
502065|NCT01422902|Brain Plasticity|brain plasticity
502066|NCT01422889|Atherosclerosis|atherosclerosis
502067|NCT01422889|Coronary Artery Disease|coronary artery disease
502068|NCT01422863|weight loss|weight loss
502069|NCT01422863|exercise|exercise
502070|NCT01422863|diet|diet
502071|NCT01422863|sleep apnea|sleep apnea
502072|NCT01422863|aging|aging
502073|NCT01422850|hormone-refractory prostate cancer|hormone-refractory prostate cancer
502074|NCT01422850|Immunotherapy|immunotherapy
502075|NCT01422837|opioid|opioid
502076|NCT01422837|dependence|dependence
502077|NCT01422837|VIVITROL|vivitrol
502078|NCT01422811|Public health|public health
502079|NCT01422811|Policy|policy
502080|NCT01422811|Training|training
502081|NCT01422785|Acne Vulgaris|acne vulgaris
502082|NCT01422720|Epilepsy|epilepsy
502083|NCT01422720|ESL|esl
502084|NCT01422720|Eslicarbazepine Acetate|eslicarbazepine acetate
502085|NCT01422720|BIAL|bial
502086|NCT01422720|BIA|bia
502087|NCT01422720|Partial-onset Seizures|partial-onset seizures
502088|NCT01422694|Sacroiliitis|sacroiliitis
502089|NCT01422694|Ankylosing Spondylitis|ankylosing spondylitis
502090|NCT01422694|Spondyloarthritis|spondyloarthritis
502091|NCT01422694|HLA-B27|hla-b27
502092|NCT01422694|Enthesitis-Related Arthritis|enthesitis-related arthritis
502093|NCT01422681|COPD|copd
502094|NCT01422668|Glycemic index|glycemic index
502095|NCT01422668|Dates|dates
502096|NCT01422668|Diabetes|diabetes
502097|NCT01422668|Coffee|coffee
502098|NCT01422629|Breast Fibroadenoma|breast fibroadenoma
502099|NCT01422629|High Intensity Focused Ultrasound|high intensity focused ultrasound
502100|NCT01422616|Ischemic stroke|ischemic stroke
502101|NCT01422616|High blood pressure|high blood pressure
502102|NCT01422616|Thrombolysis|thrombolysis
502103|NCT01422616|Antihypertensive drugs|antihypertensive drugs
502104|NCT01422616|Disability|disability
502105|NCT01422616|Clinical trial|clinical trial
502106|NCT01422603|High risk|high risk
502107|NCT01422603|AML|aml
502108|NCT01422603|MDS|mds
502109|NCT01422590|sitagliptin|sitagliptin
502110|NCT01422590|mitiglinide|mitiglinide
502111|NCT01422590|type 2 diabetes mellitus|type 2 diabetes mellitus
502112|NCT01422590|Pharmacodynamics|pharmacodynamics
502113|NCT01422590|Safety|safety
502114|NCT01422551|stress management intervention|stress management intervention
502115|NCT01422551|breast cancer|breast cancer
502116|NCT01422551|quality of life|quality of life
502117|NCT01422551|psychosocial adaptation|psychosocial adaptation
502118|NCT01422538|Ulthera® System|ulthera® system
502119|NCT01422538|Ultherapy™ treatment|ultherapy™ treatment
502120|NCT01422538|Ulthera, Inc.|ulthera, inc.
502121|NCT01422538|Ultrasound treatment for skin tightening|ultrasound treatment for skin tightening
502122|NCT01422538|Skin laxity on the face and neck.|skin laxity on the face and neck.
502123|NCT01422512|seasonal influenza|seasonal influenza
502124|NCT01422512|vaccine|vaccine
502125|NCT01422499|pediatric oncology|pediatric oncology
502126|NCT01422499|relapsed solid tumor|relapsed solid tumor
502127|NCT01422499|lymphoma|lymphoma
502128|NCT01422499|leukemia|leukemia
502129|NCT01422499|vorinostat|vorinostat
502130|NCT01422486|Hematology|hematology
502131|NCT01422486|MDS|mds
502132|NCT01422486|Myelodysplastic Syndrome|myelodysplastic syndrome
502133|NCT01422486|Low risk MDS|low risk mds
502134|NCT01422486|Intermediate-1 risk MDS|intermediate-1 risk mds
502135|NCT01422486|Int-1 risk MDS|int-1 risk mds
502136|NCT01422486|Transfusion dependence|transfusion dependence
502137|NCT01422486|Lenalidomide refractory|lenalidomide refractory
502138|NCT01422486|Revlimid refractory|revlimid refractory
502139|NCT01422486|Lenalidomide resistant|lenalidomide resistant
502140|NCT01422486|Revlimid resistant|revlimid resistant
502141|NCT01422486|Telintra|telintra
502142|NCT01422486|ezatiostat|ezatiostat
502143|NCT01422486|ezatiostat hydrochloride|ezatiostat hydrochloride
502144|NCT01422486|TLK199|tlk199
502145|NCT01422486|Glutathione|glutathione
502146|NCT01422486|Glutathione analog|glutathione analog
502147|NCT01422486|Glutathione Transferase|glutathione transferase
502148|NCT01422486|Glutathione Transferase P1-1 inhibitor|glutathione transferase p1-1 inhibitor
502149|NCT01422486|GST P1-1 inhibitor|gst p1-1 inhibitor
502151|NCT01422486|Differentiation|differentiation
502152|NCT01422486|Enzyme inhibitor|enzyme inhibitor
502153|NCT01422473|Hemorrhoids|hemorrhoids
502154|NCT01422473|Rectal Diseases|rectal diseases
502155|NCT01422473|Intestinal Diseases|intestinal diseases
502156|NCT01422473|Gastrointestinal Diseases|gastrointestinal diseases
502157|NCT01422473|Digestive System Diseases|digestive system diseases
502158|NCT01422460|Osteoarthritis|osteoarthritis
502159|NCT01422460|PRP|prp
502160|NCT01422460|PRGF|prgf
502161|NCT01422447|mental health education|mental health education
502162|NCT01422447|community-based|community-based
502163|NCT01422434|A national|a national
502164|NCT01422434|multi-centre|multi-centre
502165|NCT01422434|prospective|prospective
502166|NCT01422434|randomised|randomised
502167|NCT01422434|double-blind|double-blind
502168|NCT01422434|active-controlled|active-controlled
502169|NCT01422434|3-arm|3-arm
502170|NCT01422434|parallel group|parallel group
502171|NCT01422434|4 week study|4 week study
502172|NCT01422421|type 2 diabetes|type 2 diabetes
502173|NCT01422421|coronary artery disease|coronary artery disease
502174|NCT01422421|hypertension|hypertension
502175|NCT01422421|dyslipidemia|dyslipidemia
502176|NCT01422395|Vitrification|vitrification
502177|NCT01422395|Egg Freezing|egg freezing
502178|NCT01422395|Oocyte Cryopreservation|oocyte cryopreservation
502179|NCT01422382|Healthy Volunteers|healthy volunteers
502180|NCT01422369|Healthy Volunteers|healthy volunteers
502181|NCT01422356|cohort study|cohort study
502182|NCT01422356|men who have sex with men|men who have sex with men
502183|NCT01422343|peripheral arterial disease|peripheral arterial disease
502184|NCT01422343|cell-derived microparticles|cell-derived microparticles
502185|NCT01422343|immunity, innate|immunity, innate
502186|NCT01422343|blood coagulation|blood coagulation
502187|NCT01422330|Human Immunodeficiency Virus (HIV) infection|human immunodeficiency virus (hiv) infection
502188|NCT01422330|TMC125IFD3002|tmc125ifd3002
502189|NCT01422330|TMC125|tmc125
502190|NCT01422330|Intelence|intelence
502191|NCT01422330|HIV|hiv
502192|NCT01422317|n-3 fatty acids|n-3 fatty acids
638803|NCT00873444|Hip|hip
502193|NCT01422317|randomized double-blind study|randomized double-blind study
502194|NCT01422317|coronary events|coronary events
502195|NCT01422317|serum lipids|serum lipids
502196|NCT01422317|antithrombotic effects of omega-3 fatty acids|antithrombotic effects of omega-3 fatty acids
502197|NCT01422317|anti-inflammatory effects of omega-3 fatty acids|anti-inflammatory effects of omega-3 fatty acids
502198|NCT01422317|prognostic biomarkers in myocardial infarction (MI)-patients|prognostic biomarkers in myocardial infarction (mi)-patients
502199|NCT01422291|Low back pain|low back pain
502200|NCT01422291|paracetamol|paracetamol
502201|NCT01422291|dexketoprofen|dexketoprofen
502202|NCT01422291|morphine|morphine
502203|NCT01422252|Falls Elderly persons|falls elderly persons
502204|NCT01422252|Isolated At risk for falls|isolated at risk for falls
502205|NCT01422252|Fall detection device|fall detection device
502206|NCT01422252|Precocious detection Vigi'Fall®|precocious detection vigi'fall®
502207|NCT01422239|smoking|smoking
502208|NCT01422239|treatment|treatment
502209|NCT01422239|perceived risks|perceived risks
502210|NCT01422226|IUD|iud
502211|NCT01422226|contraception|contraception
502212|NCT01422226|nulliparous|nulliparous
502213|NCT01422226|women|women
502214|NCT01422213|MDD|mdd
502215|NCT01422213|Cognitive dysfunction|cognitive dysfunction
502216|NCT01422200|DMD|dmd
502217|NCT01422200|SMA|sma
502218|NCT01422200|CMD|cmd
502219|NCT01422200|flu vaccine|flu vaccine
502220|NCT01422187|enzyme replacement therapy|enzyme replacement therapy
502221|NCT01422174|Primary prevention|primary prevention
502222|NCT01422174|Latin America|latin america
502223|NCT01422174|Sudden death|sudden death
502224|NCT01422174|Myocardial infarction|myocardial infarction
502225|NCT01422174|Ejection Fraction|ejection fraction
502226|NCT01422174|ICD|icd
502227|NCT01422161|Rehabilitation|rehabilitation
502228|NCT01422161|Fingers|fingers
502229|NCT01422161|Grasp|grasp
502230|NCT01422161|Hand|hand
502231|NCT01422161|Strength|strength
502232|NCT01422161|Brain Infraction|brain infraction
502233|NCT01422161|Pathology|pathology
502234|NCT01422161|Physiopathology|physiopathology
502235|NCT01422161|Functional Laterality|functional laterality
502236|NCT01422161|Neuronal Plasticity|neuronal plasticity
502237|NCT01422161|Psychomotor Performance|psychomotor performance
502238|NCT01422161|Biomechanics|biomechanics
502239|NCT01422161|Touch|touch
502240|NCT01422161|Weight-Bearing|weight-bearing
502241|NCT01422148|cardiac surgery|cardiac surgery
502242|NCT01422148|atrial fibrillation|atrial fibrillation
502243|NCT01422148|minocycline|minocycline
502244|NCT01422148|amiodarone|amiodarone
502245|NCT01422135|PK and safety|pk and safety
502246|NCT01422135|Pharmacokinetic profile (PK) and safety|pharmacokinetic profile (pk) and safety
502247|NCT01422122|vitamin D|vitamin d
502248|NCT01422122|pregnancy|pregnancy
502249|NCT01422122|periodontal health|periodontal health
502250|NCT01422122|biomarkers|biomarkers
502251|NCT01422109|YH14659|yh14659
502252|NCT01422109|Aspirin|aspirin
502253|NCT01422109|Clopidogrel|clopidogrel
502254|NCT01422109|Yuhan|yuhan
502255|NCT01422070|mortality|mortality
502256|NCT01422070|intensive care|intensive care
502257|NCT01422070|critical care|critical care
502258|NCT01422070|intermediate care|intermediate care
502259|NCT01422057|diabetes|diabetes
502260|NCT01422057|coronary artery disease|coronary artery disease
502261|NCT01422057|ischemic heart disease|ischemic heart disease
502262|NCT01422057|autonomic function|autonomic function
502263|NCT01422057|heart rate turbulence|heart rate turbulence
502264|NCT01422057|deceleration capacity|deceleration capacity
502265|NCT01422057|severe autonomic failure|severe autonomic failure
502266|NCT01422044|aortic stenosis|aortic stenosis
502267|NCT01422044|autonomic function|autonomic function
502268|NCT01422031|Primary care|primary care
502269|NCT01422031|Family doctor|family doctor
502270|NCT01422031|Consultation|consultation
502271|NCT01422031|utilization|utilization
502272|NCT01422031|Non-drug managements|non-drug managements
502273|NCT01422031|Patient enablement index|patient enablement index
502274|NCT01422018|clinically significant macular edema|clinically significant macular edema
502275|NCT01422018|diabetic macular edema|diabetic macular edema
502276|NCT01422018|focal edema|focal edema
502277|NCT01422018|focal laser photocoagulation|focal laser photocoagulation
502278|NCT01422018|hard exudates|hard exudates
502279|NCT01422018|intravitreal bevacizumab|intravitreal bevacizumab
502280|NCT01422005|Rehabilitation|rehabilitation
502281|NCT01422005|Fingers|fingers
502282|NCT01422005|Grasp|grasp
502283|NCT01422005|Hand|hand
502284|NCT01422005|Strength|strength
502285|NCT01422005|Brain Infraction|brain infraction
502286|NCT01422005|Hand Function|hand function
502287|NCT01422005|Post Stroke|post stroke
502288|NCT01422005|Neural mechanisms|neural mechanisms
502289|NCT01422005|Motor Control|motor control
502290|NCT01422005|Motor Function|motor function
502291|NCT01421992|randomized|randomized
502292|NCT01421992|double-blind|double-blind
502293|NCT01421992|crossover|crossover
502294|NCT01421992|methylphenidate|methylphenidate
502295|NCT01421992|excessive daytime sleepiness|excessive daytime sleepiness
502296|NCT01421966|chronic ulcers|chronic ulcers
502297|NCT01421966|diabetic foot ulcers|diabetic foot ulcers
502298|NCT01421953|Positron Emission Tomography|positron emission tomography
502299|NCT01421953|Computed Tomography|computed tomography
502300|NCT01421953|Lung cancer|lung cancer
502301|NCT01421940|Udenafil|udenafil
502302|NCT01421940|rectal cancer|rectal cancer
502303|NCT01421940|penile rehabilitation|penile rehabilitation
502304|NCT01421940|total mesorectal excision|total mesorectal excision
502305|NCT01421927|lenalidomide|lenalidomide
502306|NCT01421914|Ultrasound|ultrasound
502307|NCT01421914|Axillary block|axillary block
502308|NCT01421914|Bupivacaine|bupivacaine
502309|NCT01421914|Minimum|minimum
502310|NCT01421914|Volume|volume
502311|NCT01421914|Minimum volume of bupivacaine 0,5%|minimum volume of bupivacaine 0,5%
502312|NCT01421901|Acute appendicitis|acute appendicitis
502313|NCT01421901|Surgery|surgery
502314|NCT01421901|Antibiotics|antibiotics
502315|NCT01421901|comparison surgery and antibiotics|comparison surgery and antibiotics
502316|NCT01421901|resolutions of symptoms|resolutions of symptoms
502317|NCT01421888|Immunity|immunity
502318|NCT01421888|Urea Cycle Disorder|urea cycle disorder
502319|NCT01421888|Nutrition|nutrition
502320|NCT01421888|Vaccination|vaccination
502321|NCT01421888|Influenza|influenza
502322|NCT01421875|adult acute myeloid leukemia with 11q23 (MLL) abnormalities|adult acute myeloid leukemia with 11q23 (mll) abnormalities
502323|NCT01421875|adult acute myeloid leukemia with del(5q)|adult acute myeloid leukemia with del(5q)
502324|NCT01421875|adult acute myeloid leukemia with inv(16)(p13;q22)|adult acute myeloid leukemia with inv(16)(p13;q22)
502325|NCT01421875|adult acute myeloid leukemia with t(16;16)(p13;q22)|adult acute myeloid leukemia with t(16;16)(p13;q22)
502326|NCT01421875|adult acute myeloid leukemia with t(8;21)(q22;q22)|adult acute myeloid leukemia with t(8;21)(q22;q22)
502327|NCT01421875|untreated adult acute myeloid leukemia|untreated adult acute myeloid leukemia
502328|NCT01421875|adult acute myeloblastic leukemia without maturation (M1)|adult acute myeloblastic leukemia without maturation (m1)
502329|NCT01421875|adult acute myeloblastic leukemia with maturation (M2)|adult acute myeloblastic leukemia with maturation (m2)
502330|NCT01421875|adult acute myelomonocytic leukemia (M4)|adult acute myelomonocytic leukemia (m4)
502331|NCT01421875|adult acute monoblastic leukemia (M5a)|adult acute monoblastic leukemia (m5a)
502332|NCT01421875|adult acute monocytic leukemia (M5b)|adult acute monocytic leukemia (m5b)
502333|NCT01421875|adult erythroleukemia (M6a)|adult erythroleukemia (m6a)
502334|NCT01421875|adult pure erythroid leukemia (M6b)|adult pure erythroid leukemia (m6b)
502335|NCT01421875|adult acute megakaryoblastic leukemia (M7)|adult acute megakaryoblastic leukemia (m7)
502336|NCT01421875|adult acute minimally differentiated myeloid leukemia (M0)|adult acute minimally differentiated myeloid leukemia (m0)
502337|NCT01421862|adult acute basophilic leukemia|adult acute basophilic leukemia
502338|NCT01421862|adult acute eosinophilic leukemia|adult acute eosinophilic leukemia
502339|NCT01421862|adult erythroleukemia (M6a)|adult erythroleukemia (m6a)
502340|NCT01421862|adult pure erythroid leukemia (M6b)|adult pure erythroid leukemia (m6b)
502341|NCT01421862|adult acute minimally differentiated myeloid leukemia (M0)|adult acute minimally differentiated myeloid leukemia (m0)
502342|NCT01421862|adult acute monoblastic leukemia (M5a)|adult acute monoblastic leukemia (m5a)
502343|NCT01421862|adult acute monocytic leukemia (M5b)|adult acute monocytic leukemia (m5b)
502344|NCT01421862|adult acute myeloblastic leukemia with maturation (M2)|adult acute myeloblastic leukemia with maturation (m2)
502345|NCT01421862|adult acute myelomonocytic leukemia (M4)|adult acute myelomonocytic leukemia (m4)
502346|NCT01421862|adult acute myeloid leukemia with 11q23 (MLL) abnormalities|adult acute myeloid leukemia with 11q23 (mll) abnormalities
502347|NCT01421862|adult acute myeloid leukemia with del(5q)|adult acute myeloid leukemia with del(5q)
502348|NCT01421862|adult acute myeloid leukemia with inv(16)(p13;q22)|adult acute myeloid leukemia with inv(16)(p13;q22)
502349|NCT01421862|adult acute myeloid leukemia with t(16;16)(p13;q22)|adult acute myeloid leukemia with t(16;16)(p13;q22)
502350|NCT01421862|adult acute myeloid leukemia with t(8;21)(q22;q22)|adult acute myeloid leukemia with t(8;21)(q22;q22)
502351|NCT01421862|untreated adult acute myeloid leukemia|untreated adult acute myeloid leukemia
502352|NCT01421862|adult acute myeloblastic leukemia without maturation (M1)|adult acute myeloblastic leukemia without maturation (m1)
502353|NCT01421862|adult acute megakaryoblastic leukemia (M7)|adult acute megakaryoblastic leukemia (m7)
502354|NCT01421849|single implant denture|single implant denture
502355|NCT01421849|Elderly with an unstable mandibular denture|elderly with an unstable mandibular denture
502356|NCT01421836|stent patency|stent patency
502357|NCT01421836|EUS guided insertion|eus guided insertion
502358|NCT01421836|ERCP guided insertion|ercp guided insertion
502359|NCT01421823|Fecal Incontinence|fecal incontinence
502360|NCT01421823|Alpha agonist|alpha agonist
502361|NCT01421732|Dengue fever|dengue fever
502362|NCT01421732|severe dengue fever|severe dengue fever
502363|NCT01421732|NS1 detection assay|ns1 detection assay
502364|NCT01421732|Prognosis|prognosis
502365|NCT01421732|Diagnosis|diagnosis
502366|NCT01421719|Parkinson's Disease|parkinson's disease
502367|NCT01421719|Neurogenic Bladder|neurogenic bladder
639023|NCT00872612|BAL|bal
502368|NCT01421719|Urinary Incontinence|urinary incontinence
502369|NCT01421719|botulinum toxin|botulinum toxin
502370|NCT01421719|cystoscopy|cystoscopy
502371|NCT01421719|Effect of Other Parasympatholytics [Anticholinergics and Antimuscarinics] and Spasmolytics|effect of other parasympatholytics [anticholinergics and antimuscarinics] and spasmolytics
502372|NCT01421706|clarithromycin|clarithromycin
502373|NCT01421706|sibutramine|sibutramine
502374|NCT01421706|clopidogrel|clopidogrel
502375|NCT01421693|Gatifloxacin|gatifloxacin
502376|NCT01421693|Ceftriaxone|ceftriaxone
502377|NCT01421693|Enteric fever|enteric fever
502378|NCT01421693|Typhoid fever|typhoid fever
502379|NCT01421667|Lymphoma, Large B-Cell, Diffuse|lymphoma, large b-cell, diffuse
502380|NCT01421667|Antigens, CD30|antigens, cd30
502381|NCT01421667|Antibody-Drug Conjugate|antibody-drug conjugate
502382|NCT01421667|Antibodies, Monoclonal|antibodies, monoclonal
502383|NCT01421667|Lymphoma, Non-Hodgkin|lymphoma, non-hodgkin
502384|NCT01421667|Monomethyl auristatin E|monomethyl auristatin e
502385|NCT01421667|Drug Therapy|drug therapy
502386|NCT01421667|Immunotherapy|immunotherapy
502387|NCT01421667|Hematologic Diseases|hematologic diseases
502388|NCT01421667|Lymphoma|lymphoma
502389|NCT01421667|Lymphoma, B-Cell|lymphoma, b-cell
502390|NCT01421667|Lymphoma, T-Cell|lymphoma, t-cell
502391|NCT01421654|OSA|osa
502392|NCT01421654|Sleep Apnea|sleep apnea
502393|NCT01421654|PAP|pap
502394|NCT01421654|positive airway pressure|positive airway pressure
502395|NCT01421641|Tenaculum|tenaculum
502396|NCT01421641|Pain|pain
502397|NCT01421641|Lidocaine|lidocaine
502398|NCT01421628|older adults|older adults
502399|NCT01421628|exercise|exercise
502400|NCT01421628|stretching|stretching
502401|NCT01421628|mobility|mobility
502402|NCT01421615|Bacterial vaginosis|bacterial vaginosis
502403|NCT01421615|Probiotics|probiotics
502404|NCT01421615|Lactobacilli|lactobacilli
502405|NCT01421615|Pregnancy outcome|pregnancy outcome
502406|NCT01421615|Randomized controlled trial|randomized controlled trial
502407|NCT01421602|Inguinal Hernia|inguinal hernia
502408|NCT01421602|Self-fixating mesh|self-fixating mesh
502409|NCT01421602|Progrip|progrip
502410|NCT01421602|Hernia Recurrence|hernia recurrence
502411|NCT01421602|Mesh, Surgical|mesh, surgical
502412|NCT01421602|Recurrence|recurrence
502413|NCT01421589|Growth hormone|growth hormone
502414|NCT01421589|GH|gh
502415|NCT01421589|Obesity|obesity
502416|NCT01421589|Mitochondrial function|mitochondrial function
502417|NCT01421589|reduced growth hormone secretion|reduced growth hormone secretion
502418|NCT01421550|umbilical|umbilical
502419|NCT01421550|hernia|hernia
502420|NCT01421550|cirrhosis|cirrhosis
502421|NCT01421550|ascites|ascites
502422|NCT01421550|conservative|conservative
502423|NCT01421550|surgery|surgery
502424|NCT01421550|optimal management|optimal management
502425|NCT01421537|Thromboprophylaxis|thromboprophylaxis
502426|NCT01421537|enoxaparin|enoxaparin
502427|NCT01421524|Neoplasm|neoplasm
502428|NCT01421524|Malignancy|malignancy
502429|NCT01421524|Carcinoma|carcinoma
502430|NCT01421524|Lymphoma|lymphoma
502431|NCT01421524|Multiple Myeloma|multiple myeloma
502432|NCT01421524|DNA-PK inhibitor|dna-pk inhibitor
502433|NCT01421524|Advanced Solid Tumors|advanced solid tumors
502434|NCT01421524|Glioblastoma multiforme|glioblastoma multiforme
502435|NCT01421524|Hepatocellular Carcinoma|hepatocellular carcinoma
502436|NCT01421524|Diffuse large B-cell lymphoma|diffuse large b-cell lymphoma
502437|NCT01421524|Mantel Cell Lymphoma|mantel cell lymphoma
502438|NCT01421524|Advanced unresectable Solid Tumors|advanced unresectable solid tumors
502439|NCT01421524|Primary CNS Lymphoma|primary cns lymphoma
502441|NCT01421511|Tedizolid Phosphate|tedizolid phosphate
502442|NCT01421511|TR-701|tr-701
502443|NCT01421511|Acute Bacterial Skin and Skin Structure Infections|acute bacterial skin and skin structure infections
502444|NCT01421498|ophthalmic delivery|ophthalmic delivery
502445|NCT01421498|Dry Eye|dry eye
502446|NCT01421472|Breast Cancer|breast cancer
502447|NCT01421472|Neoadjuvant|neoadjuvant
502448|NCT01421472|Her2 negative|her2 negative
502449|NCT01421472|Her2 non-overexpressing|her2 non-overexpressing
502450|NCT01421472|Estrogen Receptor Positive|estrogen receptor positive
502451|NCT01421472|Triple Negative|triple negative
502452|NCT01421472|MM-121|mm-121
502453|NCT01421472|Paclitaxel|paclitaxel
502454|NCT01421459|Diabetes|diabetes
502455|NCT01421459|Type 2 Diabetes|type 2 diabetes
502456|NCT01421446|Neuropsychology|neuropsychology
502457|NCT01421433|Clonixin|clonixin
502458|NCT01421433|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal
502459|NCT01421433|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors
502460|NCT01421433|Lysine|lysine
502461|NCT01421433|L-Lysine|l-lysine
502462|NCT01421433|Lysine Acetate|lysine acetate
502463|NCT01421433|Lysine Hydrochloride|lysine hydrochloride
502464|NCT01421433|Amitriptyline|amitriptyline
502465|NCT01421420|Alzheimer's|alzheimer's
502466|NCT01421420|Dementia|dementia
502467|NCT01421420|Mild Cognitive Impairment|mild cognitive impairment
502468|NCT01421407|Secondary hyperparathyroidism|secondary hyperparathyroidism
502469|NCT01421407|End stage renal disease|end stage renal disease
502470|NCT01421407|Parathyroid hyperplasia|parathyroid hyperplasia
502471|NCT01421407|High Intensity Focused Ultrasound|high intensity focused ultrasound
502472|NCT01421394|spinal cord injury(SCI)|spinal cord injury(sci)
502473|NCT01421394|diffusion tensor imaging(DTI)|diffusion tensor imaging(dti)
502474|NCT01421394|tractography|tractography
502475|NCT01421381|leber's hereditary optic neuropathy|leber's hereditary optic neuropathy
502476|NCT01421381|idebenone|idebenone
502477|NCT01421342|Mood Disorder|mood disorder
502478|NCT01421342|Depression|depression
502479|NCT01421342|Depressive Disorder|depressive disorder
502480|NCT01421342|Depressive Disorder, Major|depressive disorder, major
502481|NCT01421342|Bupropion|bupropion
502482|NCT01421342|Aripiprazole|aripiprazole
502483|NCT01421342|Remission|remission
502484|NCT01421342|Relapse|relapse
502485|NCT01421342|Cost-Effectiveness|cost-effectiveness
502486|NCT01421342|Atypical Antipsychotic|atypical antipsychotic
502487|NCT01421342|Antidepressant|antidepressant
502488|NCT01421342|Augmentation|augmentation
502489|NCT01421342|Veterans|veterans
502490|NCT01421342|Mental Health|mental health
502491|NCT01421316|Patients treated with whole brain radiotherapy in the setting of brain metastases|patients treated with whole brain radiotherapy in the setting of brain metastases
502492|NCT01421316|Patients treated with whole brain radiotherapy in the prophylactic treatment for small cell lung cancer (extended disease).|patients treated with whole brain radiotherapy in the prophylactic treatment for small cell lung cancer (extended disease).
502493|NCT01421290|Cartilage lesions in the knee joint|cartilage lesions in the knee joint
502494|NCT01421264|concussion|concussion
502495|NCT01421264|gabapentin|gabapentin
502496|NCT01421264|neurontin|neurontin
502497|NCT01421264|insomnia|insomnia
502498|NCT01421251|H1N1|h1n1
502500|NCT01421251|Influenza|influenza
502501|NCT01421251|Vaccine|vaccine
502502|NCT01421251|Manitoba|manitoba
502503|NCT01421251|Canada|canada
502504|NCT01421251|Safety|safety
502505|NCT01421238|Decision Making|decision making
502506|NCT01421238|Premature infant|premature infant
502507|NCT01421238|Informed consent|informed consent
502508|NCT01421238|Prematurity|prematurity
502509|NCT01421238|Framing|framing
502510|NCT01421238|Negotiation Model|negotiation model
502511|NCT01421225|Closed Loop Insulin Delivery|closed loop insulin delivery
502512|NCT01421225|Diabetes|diabetes
502513|NCT01421225|Type 1 Diabetes|type 1 diabetes
502514|NCT01421225|Artificial pancreas|artificial pancreas
502515|NCT01421212|Liver Transplantation|liver transplantation
502516|NCT01421212|Liver Disease|liver disease
502517|NCT01421212|Hepatitis B|hepatitis b
502518|NCT01421212|Hepatitis B Infection|hepatitis b infection
502519|NCT01421212|Hepatitis B Associated Liver Disease|hepatitis b associated liver disease
502520|NCT01421212|HBV|hbv
502521|NCT01421199|Otitis Media with Effusion|otitis media with effusion
502522|NCT01421199|Middle Ear Effusion|middle ear effusion
502523|NCT01421186|Multiple Myeloma|multiple myeloma
502524|NCT01421186|MOR03087 (MOR202)|mor03087 (mor202)
502525|NCT01421186|Lenalidomide|lenalidomide
502526|NCT01421186|Pomalidomide|pomalidomide
502527|NCT01421186|CD38|cd38
502528|NCT01421173|Lymphoma|lymphoma
502529|NCT01421173|Lymphoid malignancies|lymphoid malignancies
502530|NCT01421173|Relapsed|relapsed
502531|NCT01421173|Refractory|refractory
502532|NCT01421173|Autologous hematopoietic cell support|autologous hematopoietic cell support
502533|NCT01421173|Stem cell infusion|stem cell infusion
502534|NCT01421173|Hodgkin's lymphoma|hodgkin's lymphoma
502535|NCT01421173|non-Hodgkin's lymphoma|non-hodgkin's lymphoma
502536|NCT01421173|Vorinostat|vorinostat
502537|NCT01421173|SAHA|saha
502538|NCT01421173|Suberoylanilide Hydroxamic Acid|suberoylanilide hydroxamic acid
502539|NCT01421173|MSK-390|msk-390
502540|NCT01421173|Zolinza|zolinza
502541|NCT01421173|Busulfan|busulfan
502542|NCT01421173|Busulfex|busulfex
502543|NCT01421173|Myleran|myleran
502544|NCT01421173|Gemcitabine|gemcitabine
502545|NCT01421173|Gemcitabine Hydrochloride|gemcitabine hydrochloride
502546|NCT01421173|Gemzar|gemzar
502547|NCT01421173|Melphalan|melphalan
502548|NCT01421173|Alkeran|alkeran
502549|NCT01421173|Rituximab|rituximab
502550|NCT01421173|Rituxan|rituxan
502551|NCT01421173|Dexamethasone|dexamethasone
502552|NCT01421173|Decadron|decadron
502553|NCT01421173|G-CSF|g-csf
502554|NCT01421173|Filgrastim|filgrastim
502555|NCT01421173|NeupogenTM|neupogentm
502556|NCT01421173|Palifermin|palifermin
502557|NCT01421173|Kepivance|kepivance
502558|NCT01421160|Chronic|chronic
502559|NCT01421160|Inflammatory|inflammatory
502560|NCT01421160|Joint|joint
502561|NCT01421160|Pain|pain
502562|NCT01421147|Diabetes|diabetes
502563|NCT01421147|Type 1 Diabetes|type 1 diabetes
502564|NCT01421147|Diabetes Mellitus|diabetes mellitus
502565|NCT01421134|depression|depression
502566|NCT01421134|Lurasidone|lurasidone
502567|NCT01421134|Latuda|latuda
502568|NCT01421108|oral health|oral health
502569|NCT01421108|dental brushing|dental brushing
502570|NCT01421108|dental flossing|dental flossing
502571|NCT01421095|Fertility|fertility
502572|NCT01421095|adolescent|adolescent
502573|NCT01421095|young adult|young adult
502574|NCT01421095|cancer survivors|cancer survivors
502575|NCT01421082|LVRS (Lung Volume Reduction Surgery)|lvrs (lung volume reduction surgery)
502576|NCT01421082|LVRC (Lung Volume Reduction Coil)|lvrc (lung volume reduction coil)
502577|NCT01421082|Emphysema|emphysema
502578|NCT01421082|coil|coil
502579|NCT01421082|RePneu|repneu
502580|NCT01421069|Use of etanercept to treat pediatric subjects with extended oligoarticular JIA|use of etanercept to treat pediatric subjects with extended oligoarticular jia
502581|NCT01421069|enthestitis related arthritis (ERA)|enthestitis related arthritis (era)
502582|NCT01421069|or psoriatic arthritis (PsA).|or psoriatic arthritis (psa).
502583|NCT01421043|bioequivalence study|bioequivalence study
502584|NCT01421043|triazolam|triazolam
502585|NCT01421043|liquid oral drops|liquid oral drops
502586|NCT01421043|tablet|tablet
502587|NCT01421030|quality of life|quality of life
502588|NCT01421030|congenital heart disease|congenital heart disease
502589|NCT01421030|open heart surgery|open heart surgery
502590|NCT01421030|percutaneous pulmonary valve implantation|percutaneous pulmonary valve implantation
502591|NCT01421030|costs|costs
502592|NCT01421017|radiation therapy|radiation therapy
502593|NCT01421017|combination therapy|combination therapy
502594|NCT01421017|immunotherapy|immunotherapy
502595|NCT01421017|immune response modifier|immune response modifier
502596|NCT01421017|immunostimulatory|immunostimulatory
502597|NCT01421017|immunomodulator|immunomodulator
502598|NCT01421004|cancer|cancer
502599|NCT01421004|tumors|tumors
502600|NCT01421004|phase I|phase i
502601|NCT01421004|crossover|crossover
502602|NCT01421004|bioequivalence|bioequivalence
502603|NCT01420965|Anti PD-1 Monoclonal Antibody|anti pd-1 monoclonal antibody
502604|NCT01420965|Vaccine|vaccine
502605|NCT01420965|Autologous Cellular Immunotherapy|autologous cellular immunotherapy
502606|NCT01420965|Prostate Cancer|prostate cancer
502607|NCT01420952|Positron Emission Tomograhy (PET)|positron emission tomograhy (pet)
502608|NCT01420952|Metabolic Glutamate Receptors|metabolic glutamate receptors
502609|NCT01420952|Brain|brain
502610|NCT01420939|TBI|tbi
502611|NCT01420939|Brain|brain
502612|NCT01420939|Traumatic Brain Injury|traumatic brain injury
502613|NCT01420939|Biomarkers|biomarkers
502614|NCT01420939|Healthy Volunteer|healthy volunteer
502615|NCT01420939|HV|hv
502616|NCT01420913|To evaluate the pharmacokinetic characteristics of Lyrica, YHD1119 A,B,C|to evaluate the pharmacokinetic characteristics of lyrica, yhd1119 a,b,c
502617|NCT01420887|CPM|cpm
502618|NCT01420887|elbow joint surgery|elbow joint surgery
502619|NCT01420887|continuous passive motion|continuous passive motion
502620|NCT01420887|Recovery after surgery to restore elbow motion|recovery after surgery to restore elbow motion
502621|NCT01420861|castrate resistant|castrate resistant
502622|NCT01420848|stress disorders|stress disorders
502623|NCT01420848|anxiety disorders|anxiety disorders
502624|NCT01420835|Stress|stress
502625|NCT01420835|Quality of life|quality of life
502626|NCT01420796|Parkinson's disease|parkinson's disease
502627|NCT01420796|dysphagia|dysphagia
502628|NCT01420796|swallowing treatment|swallowing treatment
502629|NCT01420757|operation time|operation time
502630|NCT01420757|length of hospital stay|length of hospital stay
502631|NCT01420744|Endotracheal ventilation|endotracheal ventilation
502632|NCT01420744|Bacterial pneumonia|bacterial pneumonia
502633|NCT01420731|sexual life, back pain|sexual life, back pain
502634|NCT01420718|partial pulpotomy|partial pulpotomy
502635|NCT01420718|Cvek pulpotomy|cvek pulpotomy
502636|NCT01420718|MTA|mta
502637|NCT01420718|iRootBP|irootbp
502638|NCT01420718|dentin bridge|dentin bridge
502639|NCT01420705|Bacille Calmette-Guérin|bacille calmette-guérin
502640|NCT01420705|DTP|dtp
502641|NCT01420705|Vaccination|vaccination
502642|NCT01420705|Allergy|allergy
502643|NCT01420705|Atopy|atopy
502644|NCT01420705|Guinea-Bissau|guinea-bissau
502645|NCT01420692|Tip 2 DM|tip 2 dm
502646|NCT01420692|Endothelium|endothelium
502647|NCT01420692|Gliclazide|gliclazide
502648|NCT01420692|Insulin detemir|insulin detemir
502649|NCT01420679|Lymphoproliferative Disorders|lymphoproliferative disorders
502650|NCT01420679|Lymphoma|lymphoma
502651|NCT01420679|Non-Hodgkin's Lymphoma|non-hodgkin's lymphoma
502652|NCT01420679|T-cell Lymphoma|t-cell lymphoma
502653|NCT01420640|Fibromyalgia|fibromyalgia
502654|NCT01420640|Tai Chi|tai chi
502655|NCT01420640|mind-body exercise|mind-body exercise
502656|NCT01420640|aerobic exercise|aerobic exercise
502657|NCT01420640|exercise|exercise
502658|NCT01420640|pain|pain
502659|NCT01420614|radial access|radial access
502660|NCT01420614|primary angioplasty|primary angioplasty
502661|NCT01420614|trial|trial
502662|NCT01420614|randomization|randomization
502663|NCT01420614|outcome|outcome
502664|NCT01420588|Oncologic Investigations|oncologic investigations
502665|NCT01420588|Gastric Diseases|gastric diseases
502666|NCT01420588|Gastric Cancer|gastric cancer
502667|NCT01420588|Gastric Ulcer|gastric ulcer
502668|NCT01420588|Breath Analysis|breath analysis
502669|NCT01420588|Volatile Biomarkers|volatile biomarkers
502670|NCT01420588|Nanosensors Array|nanosensors array
502671|NCT01420588|Discriminant Factor Analysis|discriminant factor analysis
502672|NCT01420588|GC-MS|gc-ms
502673|NCT01420588|Breath Tests|breath tests
502674|NCT01420575|Schizophrenia|schizophrenia
502675|NCT01420575|Schizoaffective Disorder|schizoaffective disorder
502676|NCT01420575|Shared Decision|shared decision
502677|NCT01420575|Decision Aid|decision aid
502678|NCT01420575|Antipsychotic|antipsychotic
502679|NCT01420575|Weight Gain|weight gain
502680|NCT01420575|Olanzapine|olanzapine
502681|NCT01420575|Lexapro|lexapro
502682|NCT01420575|Perphenazine|perphenazine
502683|NCT01420562|allogeneic HSCT|allogeneic hsct
502684|NCT01420562|posaconazole|posaconazole
502685|NCT01420562|prophylaxis|prophylaxis
502686|NCT01420562|mucositis|mucositis
502687|NCT01420562|pharmacokinetics|pharmacokinetics
502688|NCT01420549|Hypercholesterolemia|hypercholesterolemia
502689|NCT01420549|Dyslipidemia|dyslipidemia
502690|NCT01420536|Bilateral Balanced Occlusion|bilateral balanced occlusion
502691|NCT01420536|Canine Guidance|canine guidance
502692|NCT01420536|Complete Denture|complete denture
502693|NCT01420536|Denture Retention|denture retention
502694|NCT01420536|Dental Occlusion|dental occlusion
502695|NCT01420536|Edentulous|edentulous
502696|NCT01420536|Edentulism|edentulism
502697|NCT01420536|Mandibular movement|mandibular movement
502698|NCT01420536|Mastication|mastication
502699|NCT01420536|Patient Acceptance of Health Care|patient acceptance of health care
502700|NCT01420536|Patient Satisfaction|patient satisfaction
502701|NCT01420523|HIV|hiv
502702|NCT01420523|Lipohypertrophy|lipohypertrophy
502703|NCT01420510|Patients satisfaction|patients satisfaction
502704|NCT01420510|Side effects|side effects
502705|NCT01420497|methylprednisolone|methylprednisolone
502706|NCT01420497|intra articular infiltration|intra articular infiltration
502707|NCT01420497|glycemia|glycemia
502708|NCT01420497|epidural infiltration|epidural infiltration
502709|NCT01420497|diabetes|diabetes
502710|NCT01420484|CNAP|cnap
502711|NCT01420484|continuous non-invasive arterial pressure|continuous non-invasive arterial pressure
502712|NCT01420484|IAP|iap
502713|NCT01420484|blood pressure|blood pressure
502714|NCT01420484|analgosedation|analgosedation
502715|NCT01420484|high-risk patients|high-risk patients
502716|NCT01420484|rapid-pacing|rapid-pacing
502717|NCT01420471|Endoscopic Sinus Surgery|endoscopic sinus surgery
502718|NCT01420471|Triamcinolone|triamcinolone
502719|NCT01420471|Merocel Middle Meatus Spacers|merocel middle meatus spacers
502720|NCT01420458|bioequivalence|bioequivalence
502721|NCT01420432|Ankylosing Spondylitis|ankylosing spondylitis
502722|NCT01420432|Umbilical Cord/placenta-Derived MSC|umbilical cord/placenta-derived msc
502723|NCT01420432|Transplantation|transplantation
502724|NCT01420419|nipple pain|nipple pain
502725|NCT01420419|breastfeeding|breastfeeding
502726|NCT01420419|nipple damage|nipple damage
502727|NCT01420419|lanolin|lanolin
502728|NCT01420419|clinical trial|clinical trial
502729|NCT01420406|lactation|lactation
502730|NCT01420406|cryptoxanthin|cryptoxanthin
502731|NCT01420406|beta-carotene|beta-carotene
502732|NCT01420406|vitamin A|vitamin a
502733|NCT01420393|Heart Failure|heart failure
502734|NCT01420393|Atrial Fibrillation|atrial fibrillation
502735|NCT01420393|Catheter Ablation|catheter ablation
502736|NCT01420393|Anti-arrhythmic Medications|anti-arrhythmic medications
502737|NCT01420393|Cardiovascular Mortality|cardiovascular mortality
502738|NCT01420367|Paediatric|paediatric
502739|NCT01420367|Simple|simple
502740|NCT01420367|Non-perforated|non-perforated
502741|NCT01420354|Metabolic stones|metabolic stones
502742|NCT01420354|kidney stones|kidney stones
502743|NCT01420354|renal calculi|renal calculi
502744|NCT01420354|metabolic evaluation|metabolic evaluation
502745|NCT01420341|Meliodosis|meliodosis
502746|NCT01420341|Co-trimoxazole|co-trimoxazole
502747|NCT01420341|Relapse|relapse
502748|NCT01420315|vitamin D|vitamin d
502749|NCT01420315|deficiency|deficiency
502750|NCT01420315|alzheimer's disease|alzheimer's disease
502751|NCT01420302|critical illness|critical illness
502752|NCT01420302|intensive care|intensive care
502753|NCT01420302|insulin|insulin
502754|NCT01420302|glucose|glucose
502755|NCT01420302|algorithm|algorithm
502756|NCT01420302|blood glucose control|blood glucose control
502757|NCT01420289|Ischemic ulcers|ischemic ulcers
502758|NCT01420289|PAD|pad
502759|NCT01420289|Intermittent Claudication Pain|intermittent claudication pain
502760|NCT01420276|Female sexual function|female sexual function
502761|NCT01420263|premature infant|premature infant
502762|NCT01420263|feeding|feeding
502763|NCT01420263|residuals|residuals
502764|NCT01420263|fresh feeds|fresh feeds
502765|NCT01420263|full feeds|full feeds
502766|NCT01420263|digestive system|digestive system
502767|NCT01420250|Prostate cancer|prostate cancer
502768|NCT01420250|Adenocarcinoma of the prostate|adenocarcinoma of the prostate
502769|NCT01420237|Noninflammatory joint disease of the hip.|noninflammatory joint disease of the hip.
502770|NCT01420224|Air travel|air travel
502771|NCT01420224|Aircraft cabin hypoxia|aircraft cabin hypoxia
502772|NCT01420224|Pulmonary artery pressure|pulmonary artery pressure
502773|NCT01420224|Hypoxic pulmonary vasoconstriction|hypoxic pulmonary vasoconstriction
502774|NCT01420224|Pulmonary hypertension|pulmonary hypertension
502775|NCT01420211|pharmacokinetics|pharmacokinetics
502776|NCT01420211|MRI|mri
502777|NCT01420211|liver|liver
502778|NCT01420211|drug transporter|drug transporter
502779|NCT01420211|Gd-EOB-DTPA|gd-eob-dtpa
502780|NCT01420198|Diabetes type 2|diabetes type 2
502781|NCT01420198|Lifestyle intervention|lifestyle intervention
502782|NCT01420198|QALY|qaly
502783|NCT01420198|Ethnic group|ethnic group
502784|NCT01420198|Impaired glucose tolerance|impaired glucose tolerance
502785|NCT01420198|Impaired fasting glucose|impaired fasting glucose
502786|NCT01420185|estrogen receptor-positive breast cancer|estrogen receptor-positive breast cancer
502787|NCT01420185|stage II breast cancer|stage ii breast cancer
502788|NCT01420185|stage IIIA breast cancer|stage iiia breast cancer
502789|NCT01420159|Pain|pain
502790|NCT01420159|Trauma|trauma
502791|NCT01420159|Analgesia|analgesia
502792|NCT01420133|Corticosteroids|corticosteroids
502793|NCT01420133|Diet low in sugar and salt|diet low in sugar and salt
502794|NCT01420133|Dermatological disease|dermatological disease
502795|NCT01420133|Corticosteroids Allergy|corticosteroids allergy
502796|NCT01420133|3 Months|3 months
502797|NCT01420120|Biodegradable stent, PAD|biodegradable stent, pad
502798|NCT01420107|Infant, Premature|infant, premature
502799|NCT01420107|Delivery Rooms|delivery rooms
502800|NCT01420107|Video Recording|video recording
502801|NCT01420107|Outcome Assessment (Health Care)|outcome assessment (health care)
502802|NCT01420094|Drugs, Investigational|drugs, investigational
502803|NCT01420094|Acetylsalicylic Acid|acetylsalicylic acid
502804|NCT01420094|Aspirin|aspirin
502805|NCT01420094|dental pain|dental pain
502806|NCT01420081|uterine neoplasms|uterine neoplasms
502807|NCT01420081|endometrial|endometrial
502808|NCT01420081|uterine|uterine
502809|NCT01420081|cancer|cancer
502810|NCT01420081|PI3K|pi3k
502811|NCT01420081|mTOR|mtor
502812|NCT01420081|PI3K/mTOR|pi3k/mtor
502813|NCT01420081|recurrent|recurrent
502814|NCT01420081|metastatic|metastatic
502815|NCT01420068|Pediatric|pediatric
502816|NCT01420068|hypertension|hypertension
502817|NCT01420068|aliskiren|aliskiren
502818|NCT01420055|Multiple sclerosis|multiple sclerosis
502819|NCT01420055|Fingolimod|fingolimod
502820|NCT01420055|Coping|coping
502821|NCT01420055|Anxiety|anxiety
502822|NCT01420055|France|france
502823|NCT01420055|Treatment Satisfaction Questionnaire for Medication-9 items (TSQM 9)|treatment satisfaction questionnaire for medication-9 items (tsqm 9)
502824|NCT01420055|Active|active
502825|NCT01420029|Low birth weight neonates|low birth weight neonates
502826|NCT01420029|Neurodevelopmental outcome|neurodevelopmental outcome
502827|NCT01420029|Thyroid dysfunction|thyroid dysfunction
502828|NCT01420029|Extrauterine growth|extrauterine growth
502829|NCT01420029|Plasticizers|plasticizers
502830|NCT01420016|Cardiovascular risk|cardiovascular risk
502831|NCT01420016|Clinical Decision Support|clinical decision support
502832|NCT01420016|Electronic Health Records|electronic health records
502833|NCT01420016|Primary Care|primary care
502834|NCT01420016|Quality of Care|quality of care
502835|NCT01420003|Allergen Challenge|allergen challenge
502836|NCT01420003|B cell activation|b cell activation
502837|NCT01420003|M1 prime related biomarkers|m1 prime related biomarkers
502838|NCT01419977|sickle cell disease|sickle cell disease
502839|NCT01419977|vaso-occlusive crisis|vaso-occlusive crisis
502840|NCT01419977|anticoagulation|anticoagulation
502841|NCT01419964|Vitiligo|vitiligo
502842|NCT01419964|Macular depigmentation|macular depigmentation
502843|NCT01419964|Stachytarpheta cayensensis|stachytarpheta cayensensis
502844|NCT01419951|Behavioral treatment|behavioral treatment
502845|NCT01419951|Preschool aged children|preschool aged children
502846|NCT01419951|Obesity|obesity
502847|NCT01419938|Light therapy|light therapy
502848|NCT01419938|circadian rhythm|circadian rhythm
502849|NCT01419938|CBT|cbt
502850|NCT01419925|influenza vaccine|influenza vaccine
502851|NCT01419925|peptide|peptide
502852|NCT01419925|universal|universal
502853|NCT01419925|prime|prime
502854|NCT01419925|boost|boost
502855|NCT01419925|TIV|tiv
502856|NCT01419925|HAI|hai
502857|NCT01419925|Hemagglutination Inhibition|hemagglutination inhibition
502858|NCT01419925|elderly|elderly
502859|NCT01419899|Brief intervention|brief intervention
502860|NCT01419899|Rapid testing|rapid testing
502861|NCT01419873|Hyperglycaemia|hyperglycaemia
502862|NCT01419873|Very low birthweight infants|very low birthweight infants
502863|NCT01419873|Insulin|insulin
502864|NCT01419860|Microcirculation|microcirculation
502865|NCT01419860|Colon|colon
502866|NCT01419860|Anastomosis|anastomosis
502868|NCT01419860|Gastro surgery|gastro surgery
711135|NCT00586352|Ulcerative colitis|ulcerative colitis
639640|NCT00870350|FHA|fha
502869|NCT01419860|benign colon diseases requiring resection|benign colon diseases requiring resection
502870|NCT01419834|CNS|cns
502871|NCT01419834|Brain|brain
502872|NCT01419834|MAB 3F8|mab 3f8
502873|NCT01419834|Hu3F8|hu3f8
502874|NCT01419834|11-009|11-009
502875|NCT01419821|Vitamin D|vitamin d
502876|NCT01419821|Bone densitometry|bone densitometry
502877|NCT01419821|Vitamin D supplementation|vitamin d supplementation
502878|NCT01419821|Growth|growth
502879|NCT01419808|Scaphoid|scaphoid
502880|NCT01419808|Non-Union|non-union
502881|NCT01419808|Proximal pole|proximal pole
502882|NCT01419808|Bone Graft|bone graft
502883|NCT01419808|Vascularized|vascularized
502884|NCT01419808|Non-Vascularized|non-vascularized
502885|NCT01419808|PREE|pree
502886|NCT01419782|bone|bone
502887|NCT01419782|osteocyte|osteocyte
502888|NCT01419782|rest muscle electrical activity|rest muscle electrical activity
502889|NCT01419782|whole-body vibration|whole-body vibration
502890|NCT01419782|sclerostin|sclerostin
502891|NCT01419769|symptomatic pancreatic pseudocyst|symptomatic pancreatic pseudocyst
502892|NCT01419769|pancreatic pseudocyst|pancreatic pseudocyst
502893|NCT01419769|transluminal drainage|transluminal drainage
502894|NCT01419769|minimally invasive|minimally invasive
502895|NCT01419769|Nitinol stent|nitinol stent
502896|NCT01419769|transmural endoscopic drainage|transmural endoscopic drainage
502897|NCT01419769|catheter based|catheter based
502898|NCT01419743|Vitamin D deficiency|vitamin d deficiency
502899|NCT01419743|Supplementation|supplementation
502900|NCT01419743|Infertility|infertility
502901|NCT01419743|Clinical pregnancy rates|clinical pregnancy rates
502902|NCT01419717|cancer|cancer
502903|NCT01419717|bone metastases|bone metastases
502904|NCT01419717|breast cancer|breast cancer
502905|NCT01419717|prostate cancer|prostate cancer
502906|NCT01419704|other hemoglobinopathies|other hemoglobinopathies
502907|NCT01419704|chimerism|chimerism
502908|NCT01419704|sickle cell|sickle cell
502909|NCT01419704|thalassemia|thalassemia
502910|NCT01419704|Marrow/Enriched Hematopoetic Stem Cell Transplant|marrow/enriched hematopoetic stem cell transplant
502911|NCT01419691|auranofin|auranofin
502912|NCT01419691|chronic lymphocytic leukemia|chronic lymphocytic leukemia
502913|NCT01419691|relapsed|relapsed
502914|NCT01419691|refractory|refractory
502915|NCT01419691|CLL|cll
502916|NCT01419691|SLL|sll
502917|NCT01419691|PLL|pll
502918|NCT01419678|posaconazole|posaconazole
502919|NCT01419678|PK blood sampling|pk blood sampling
502920|NCT01419665|Follicular Lymphoma|follicular lymphoma
502921|NCT01419665|Biosimilar|biosimilar
502922|NCT01419665|GP13-301|gp13-301
502923|NCT01419665|rituximab|rituximab
502924|NCT01419665|Antibodies|antibodies
502925|NCT01419665|CD20|cd20
502926|NCT01419652|percutaneous coronary intervention|percutaneous coronary intervention
502927|NCT01419639|Neurofibromatosis Type II|neurofibromatosis type ii
502928|NCT01419639|cranial nerve schwannomas|cranial nerve schwannomas
502929|NCT01419639|meningiomas|meningiomas
502930|NCT01419639|ependymomas|ependymomas
502931|NCT01419613|healthy lifestyle|healthy lifestyle
502932|NCT01419613|physical activity|physical activity
502933|NCT01419613|behavior|behavior
502934|NCT01419613|motivational|motivational
502935|NCT01419613|interview|interview
502936|NCT01419613|breast cancer survivor|breast cancer survivor
502937|NCT01419600|Phase 1|phase 1
502938|NCT01419600|healthy volunteers|healthy volunteers
502939|NCT01419600|safety|safety
502940|NCT01419600|tolerability|tolerability
502941|NCT01419600|pharmacokinetics|pharmacokinetics
502942|NCT01419600|single ascending dose study|single ascending dose study
502943|NCT01419587|Carcinoma, Non-Small-Cell Lung|carcinoma, non-small-cell lung
502944|NCT01419587|Non small cell lung cancer|non small cell lung cancer
502945|NCT01419587|NSCLC|nsclc
502946|NCT01419587|Ketogenic Diet|ketogenic diet
502947|NCT01419587|radiotherapy|radiotherapy
502948|NCT01419587|paclitaxel|paclitaxel
502949|NCT01419587|carboplatin|carboplatin
502950|NCT01419574|Carotid Artery Plaque|carotid artery plaque
502951|NCT01419574|Contrast Agents|contrast agents
502952|NCT01419574|Vasa Vasorum|vasa vasorum
502953|NCT01419574|MRI|mri
502954|NCT01419574|Intraplaque Hemorrhage|intraplaque hemorrhage
502955|NCT01419574|Solid Tumor|solid tumor
502956|NCT01419574|Metastatic Solid Tumor|metastatic solid tumor
502957|NCT01419561|KSHV|kshv
502958|NCT01419561|KICS|kics
502959|NCT01419561|HIV|hiv
502960|NCT01419561|Cytokines|cytokines
502961|NCT01419561|HHV-8|hhv-8
502962|NCT01419561|KSHV Inflammatory Cytokine Syndrome|kshv inflammatory cytokine syndrome
502963|NCT01419561|Kaposi Sarcoma Heres Virus|kaposi sarcoma heres virus
502964|NCT01419548|ABT-888|abt-888
502965|NCT01419548|Liver Dysfunction|liver dysfunction
502966|NCT01419548|Kidney Dysfunction|kidney dysfunction
502967|NCT01419548|PARP Inhibitor|parp inhibitor
502968|NCT01419548|Pharmacokinetics|pharmacokinetics
502969|NCT01419548|Cancer|cancer
502970|NCT01419535|Metabolism|metabolism
502971|NCT01419535|Cortisol|cortisol
502972|NCT01419535|Hypercortisolism|hypercortisolism
502973|NCT01419535|Glucose Intolerance|glucose intolerance
502974|NCT01419522|Traumatic Brain Injury|traumatic brain injury
502975|NCT01419522|Walking Impairment|walking impairment
502976|NCT01419522|Gait Training|gait training
502977|NCT01419522|TBI|tbi
502978|NCT01419509|alveolar childhood rhabdomyosarcoma|alveolar childhood rhabdomyosarcoma
502979|NCT01419509|embryonal childhood rhabdomyosarcoma|embryonal childhood rhabdomyosarcoma
502980|NCT01419509|embryonal-botryoid childhood rhabdomyosarcoma|embryonal-botryoid childhood rhabdomyosarcoma
502981|NCT01419509|mixed childhood rhabdomyosarcoma|mixed childhood rhabdomyosarcoma
502982|NCT01419509|pleomorphic childhood rhabdomyosarcoma|pleomorphic childhood rhabdomyosarcoma
502983|NCT01419509|previously untreated childhood rhabdomyosarcoma|previously untreated childhood rhabdomyosarcoma
502984|NCT01419509|nonmetastatic childhood soft tissue sarcoma|nonmetastatic childhood soft tissue sarcoma
502985|NCT01419496|recurrent adult acute myeloid leukemia|recurrent adult acute myeloid leukemia
502986|NCT01419496|recurrent childhood acute myeloid leukemia|recurrent childhood acute myeloid leukemia
502987|NCT01419496|adult acute myeloid leukemia with 11q23 (MLL) abnormalities|adult acute myeloid leukemia with 11q23 (mll) abnormalities
502988|NCT01419496|adult acute myeloid leukemia with inv(16)(p13;q22)|adult acute myeloid leukemia with inv(16)(p13;q22)
502989|NCT01419496|adult acute myeloid leukemia with t(15;17)(q22;q12)|adult acute myeloid leukemia with t(15;17)(q22;q12)
502990|NCT01419496|adult acute myeloid leukemia with t(16;16)(p13;q22)|adult acute myeloid leukemia with t(16;16)(p13;q22)
502991|NCT01419496|adult acute myeloid leukemia with t(8;21)(q22;q22)|adult acute myeloid leukemia with t(8;21)(q22;q22)
502992|NCT01419496|adult acute myeloid leukemia with del(5q)|adult acute myeloid leukemia with del(5q)
502993|NCT01419483|Pancreatic neoplasms|pancreatic neoplasms
502994|NCT01419483|Pancreatic cancer|pancreatic cancer
502995|NCT01419483|Ketogenic Diet|ketogenic diet
502996|NCT01419483|radiotherapy|radiotherapy
502997|NCT01419483|gemcitabine|gemcitabine
502998|NCT01419457|Healthy|healthy
502999|NCT01419457|hepatic impairment|hepatic impairment
503000|NCT01419457|T-705a|t-705a
503001|NCT01419457|Favipiravir|favipiravir
503002|NCT01419444|Voice|voice
503003|NCT01419444|Muscle Tension Dysphonia|muscle tension dysphonia
503004|NCT01419444|Hyperfunction|hyperfunction
503005|NCT01419444|Treatment|treatment
503006|NCT01419431|Colon cancer|colon cancer
503007|NCT01419418|Peripheral Arterial Disease (PAD)|peripheral arterial disease (pad)
503008|NCT01419418|Qualitative analysis|qualitative analysis
503009|NCT01419418|Patients' perspective|patients' perspective
503010|NCT01419405|analgesia|analgesia
503011|NCT01419405|acute experimental pain|acute experimental pain
503012|NCT01419405|cold pressor test|cold pressor test
503013|NCT01419405|pregabalin|pregabalin
503014|NCT01419405|remifentanil|remifentanil
503015|NCT01419392|sildenafil citrate|sildenafil citrate
503016|NCT01419392|Doppler Ultrasonography|doppler ultrasonography
503017|NCT01419392|nitric oxide|nitric oxide
503018|NCT01419392|total antioxidant capacity|total antioxidant capacity
503019|NCT01419379|COPD exacerbation rate|copd exacerbation rate
503020|NCT01419353|Infertility, IVF, Estrogen|infertility, ivf, estrogen
503021|NCT01419327|Fosrenol|fosrenol
503022|NCT01419327|Hyperphosphatemia|hyperphosphatemia
503023|NCT01419327|Hemodialysis|hemodialysis
503024|NCT01419314|Physical Therapy|physical therapy
503025|NCT01419314|Splint|splint
503026|NCT01419314|Sleep|sleep
503027|NCT01419314|Pain|pain
503028|NCT01419314|6 min walk|6 min walk
503029|NCT01419314|forward reach|forward reach
503030|NCT01419314|Function|function
503031|NCT01419301|multiple sclerosis|multiple sclerosis
503032|NCT01419301|glatiramer acetate|glatiramer acetate
503033|NCT01419301|stress reduction|stress reduction
503034|NCT01419301|medication adherence|medication adherence
503035|NCT01419288|Amputees|amputees
503036|NCT01419262|Vitamin D|vitamin d
503037|NCT01419262|Randomized Controlled Trial|randomized controlled trial
503038|NCT01419262|Child, Preschool|child, preschool
503039|NCT01419262|Dietary Supplements|dietary supplements
503040|NCT01419262|Respiratory Tract Infections|respiratory tract infections
503041|NCT01419262|Asthma|asthma
503042|NCT01419249|Growth Hormone Deficiency|growth hormone deficiency
503043|NCT01419249|Turner syndrome|turner syndrome
503044|NCT01419249|Pharmacogenetics|pharmacogenetics
503045|NCT01419249|Recombinant Human Growth Hormone therapy|recombinant human growth hormone therapy
503046|NCT01419236|Ejaculatory Dysfunction|ejaculatory dysfunction
503047|NCT01419236|Orgasmic Dysfunction|orgasmic dysfunction
503048|NCT01419236|Sexual Dysfunction|sexual dysfunction
503049|NCT01419236|Climax Dysfunction|climax dysfunction
503050|NCT01419236|Erectile Dysfunction|erectile dysfunction
503051|NCT01419236|Impotence|impotence
503052|NCT01419236|Hypogonadism|hypogonadism
503053|NCT01419236|Low testosterone|low testosterone
503054|NCT01419236|Low t|low t
503055|NCT01419223|Qualitative research|qualitative research
503056|NCT01419223|Health Knowledge, Attitudes, Practice|health knowledge, attitudes, practice
503057|NCT01419223|Refusal to Participate|refusal to participate
503058|NCT01419210|Complementary Medicine|complementary medicine
503059|NCT01419210|Traditional Medicine|traditional medicine
503060|NCT01419184|Complicated Skin and Skin Structure Infections (cSSSI)|complicated skin and skin structure infections (csssi)
503061|NCT01419184|Methicillin-resistant Staphylococcus aureus (MRSA)|methicillin-resistant staphylococcus aureus (mrsa)
503062|NCT01419184|Daptomycin|daptomycin
503063|NCT01419184|Vancomycin|vancomycin
503064|NCT01419184|Antibiotics|antibiotics
503065|NCT01419158|Alpha-1 antitrypsin|alpha-1 antitrypsin
503066|NCT01419158|Alpha-1 antitrypsin deficiency|alpha-1 antitrypsin deficiency
503067|NCT01419158|Chronic obstructive pulmonary disease|chronic obstructive pulmonary disease
503068|NCT01419145|cachexia|cachexia
503069|NCT01419145|neoplasms|neoplasms
503070|NCT01419145|complications|complications
503071|NCT01419145|combined modality therapy|combined modality therapy
503072|NCT01419145|exercise therapy|exercise therapy
503073|NCT01419145|diet therapy|diet therapy
503074|NCT01419145|anti-inflammatory agents|anti-inflammatory agents
503075|NCT01419132|furosemide|furosemide
503076|NCT01419132|hypertonic saline solution|hypertonic saline solution
503077|NCT01419132|troponin I|troponin i
503078|NCT01419119|vitamin D insufficiency|vitamin d insufficiency
503079|NCT01419119|Cholecalciferol|cholecalciferol
503080|NCT01419119|D3|d3
503081|NCT01419119|Parathyroid Hormone|parathyroid hormone
503082|NCT01419119|25-hydroxyvitamin D3|25-hydroxyvitamin d3
503083|NCT01419119|RDA, recommended daily intake (nutrition policy)|rda, recommended daily intake (nutrition policy)
503084|NCT01419119|Vitamin D|vitamin d
503085|NCT01419119|Hypovitaminosis-D|hypovitaminosis-d
503086|NCT01419119|Pharmacologic treatment|pharmacologic treatment
503087|NCT01419106|Hypotension|hypotension
503088|NCT01419106|Emergency care|emergency care
503089|NCT01419106|Point of care Ultrasound|point of care ultrasound
503090|NCT01419106|Shock|shock
503091|NCT01419093|Physical Activity|physical activity
503092|NCT01419093|Exercise|exercise
503093|NCT01419080|Peripheral Arterial Disease|peripheral arterial disease
503094|NCT01419080|Quality of Life|quality of life
503095|NCT01419080|Quality of Care|quality of care
503096|NCT01419067|Proton Therapy|proton therapy
503097|NCT01419067|Radical resection|radical resection
503098|NCT01419041|renal impairment|renal impairment
503099|NCT01419041|crizotinib|crizotinib
503100|NCT01419041|pharmacokinetics|pharmacokinetics
503101|NCT01419028|Hypophosphatasia|hypophosphatasia
503102|NCT01419028|HPP|hpp
503103|NCT01419028|Bone disease|bone disease
503104|NCT01419028|Soft bones|soft bones
503105|NCT01419028|Low alkaline phosphatase|low alkaline phosphatase
503106|NCT01419028|Genetic metabolic disorder|genetic metabolic disorder
503107|NCT01419028|Alkaline phosphatase|alkaline phosphatase
503234|NCT01418313|MRI|mri
503108|NCT01419028|Tissue non-specific alkaline phosphatase|tissue non-specific alkaline phosphatase
503109|NCT01419028|Rickets|rickets
503110|NCT01419028|Osteomalacia|osteomalacia
503111|NCT01419015|SAPIEN XT Valve (20mm)|sapien xt valve (20mm)
503112|NCT01419015|Cardiovascular Disease|cardiovascular disease
503113|NCT01419015|Valvular Heart Disease|valvular heart disease
503114|NCT01419015|Aortic Stenosis|aortic stenosis
503115|NCT01419015|Heart Valve Therapy|heart valve therapy
503116|NCT01419015|Transcatheter|transcatheter
503117|NCT01419015|Transfemoral|transfemoral
503118|NCT01419015|Efficacy endpoints|efficacy endpoints
503119|NCT01419015|Indexed Aortic Valve Area|indexed aortic valve area
503120|NCT01419015|NYHA|nyha
503121|NCT01419002|Pancreatic Cancer|pancreatic cancer
503122|NCT01419002|Adenocarcinoma|adenocarcinoma
503123|NCT01419002|Neoadjuvant Radiotherapy|neoadjuvant radiotherapy
503124|NCT01418976|physical therapy techniques|physical therapy techniques
503125|NCT01418976|brain injuries, traumatic|brain injuries, traumatic
503126|NCT01418976|walking|walking
503127|NCT01418976|gait|gait
503128|NCT01418976|postural balance|postural balance
503129|NCT01418950|Prematurity Counseling for pregnant women and their family|prematurity counseling for pregnant women and their family
503130|NCT01418937|HPV vaccine|hpv vaccine
503912|NCT01415453|RP|rp
503131|NCT01418937|serious adverse events (SAEs)|serious adverse events (saes)
503132|NCT01418937|medically significant conditions|medically significant conditions
503133|NCT01418937|cervical neoplasia|cervical neoplasia
503134|NCT01418924|sclerostin|sclerostin
503135|NCT01418924|estradiol|estradiol
503136|NCT01418924|progesterone|progesterone
503137|NCT01418924|testosteron|testosteron
503138|NCT01418924|sex hormones|sex hormones
503139|NCT01418898|Iron deficiency anemia|iron deficiency anemia
503141|NCT01418898|zinc|zinc
503142|NCT01418898|vitamin A|vitamin a
503143|NCT01418898|vitamin C|vitamin c
503144|NCT01418898|oats|oats
503145|NCT01418885|subcortical ischemic vascular disease|subcortical ischemic vascular disease
503146|NCT01418872|Obesity|obesity
503147|NCT01418872|Cardiovascular Diseases Prevention|cardiovascular diseases prevention
503148|NCT01418872|Paediatrics|paediatrics
503149|NCT01418859|cervical cancer|cervical cancer
503150|NCT01418859|postoperation|postoperation
503151|NCT01418859|chemotherapy|chemotherapy
503152|NCT01418859|radiotherapy|radiotherapy
711136|NCT00586339|HPV|hpv
503153|NCT01418846|voriconazole|voriconazole
503154|NCT01418846|saliva|saliva
503155|NCT01418846|pharmacokinetics|pharmacokinetics
503156|NCT01418833|voriconazole|voriconazole
503157|NCT01418833|therapeutic drug monitoring|therapeutic drug monitoring
503158|NCT01418833|plasma levels|plasma levels
503159|NCT01418833|dose adjustment|dose adjustment
503160|NCT01418820|hemianopia|hemianopia
503161|NCT01418820|visual field defect|visual field defect
503162|NCT01418820|stroke|stroke
503163|NCT01418820|non-invasive brain stimulation|non-invasive brain stimulation
503164|NCT01418820|alternating current stimulation|alternating current stimulation
503165|NCT01418794|Acute Coronary Syndromes|acute coronary syndromes
503166|NCT01418794|Drug eluting stent|drug eluting stent
503167|NCT01418794|Diffused lesion|diffused lesion
503168|NCT01418781|gout|gout
503169|NCT01418781|cost|cost
503170|NCT01418781|utilization|utilization
503171|NCT01418768|COPD|copd
503172|NCT01418768|CAT|cat
503173|NCT01418768|Rehabilitation|rehabilitation
503174|NCT01418768|chronic obstructive pulmonary disease GOLD III/IV|chronic obstructive pulmonary disease gold iii/iv
503175|NCT01418755|Platelet-Rich Plasma|platelet-rich plasma
503176|NCT01418755|Knee|knee
503177|NCT01418755|Tibiofemoral Chondromalacia|tibiofemoral chondromalacia
503178|NCT01418755|Injection|injection
503179|NCT01418742|skin toxicity|skin toxicity
503180|NCT01418716|Disease Management|disease management
503181|NCT01418716|Quality Improvement|quality improvement
503182|NCT01418716|Cooperative Behavior (collaboration)|cooperative behavior (collaboration)
503183|NCT01418677|Unspecified Advance Solid Tumor, Protocol Specific|unspecified advance solid tumor, protocol specific
503184|NCT01418664|vitamin D|vitamin d
503185|NCT01418664|adverse pregnancy outcome|adverse pregnancy outcome
503186|NCT01418664|Pakistan|pakistan
503187|NCT01418638|Major Depressive Disorder|major depressive disorder
503188|NCT01418638|Antidepressants|antidepressants
503189|NCT01418573|glucose, insulin, post prandial|glucose, insulin, post prandial
503190|NCT01418560|renal artery|renal artery
503191|NCT01418560|sympathetic nerves|sympathetic nerves
503192|NCT01418560|modification|modification
503193|NCT01418560|chronic renal failure|chronic renal failure
503194|NCT01418521|Cardiac surgery|cardiac surgery
503195|NCT01418521|Balanced 3rd generation Hydroxyethyl starch|balanced 3rd generation hydroxyethyl starch
503196|NCT01418521|Tetraspan|tetraspan
503197|NCT01418521|Ringer-albumin|ringer-albumin
503198|NCT01418469|COPD|copd
503199|NCT01418469|protein metabolism|protein metabolism
503200|NCT01418469|branched-chain amino acid metabolism|branched-chain amino acid metabolism
503201|NCT01418469|exercise|exercise
503202|NCT01418469|protein feeding|protein feeding
503203|NCT01418456|diabetes|diabetes
503204|NCT01418456|antibiotics|antibiotics
503205|NCT01418456|clean foot ulcers|clean foot ulcers
503206|NCT01418404|Stroke|stroke
503207|NCT01418404|Effects of TS in U/E motor recovery|effects of ts in u/e motor recovery
503208|NCT01418404|Brain mapping|brain mapping
503209|NCT01418404|Kinematics analysis|kinematics analysis
503210|NCT01418391|minimal laparotomy|minimal laparotomy
503211|NCT01418391|TAP block|tap block
503212|NCT01418391|morphine consumption|morphine consumption
503213|NCT01418391|post-operative analgesia|post-operative analgesia
503214|NCT01418378|Sigma|sigma
503215|NCT01418378|cruciate|cruciate
503216|NCT01418378|retaining|retaining
503217|NCT01418378|fixed|fixed
503218|NCT01418378|primary|primary
503219|NCT01418378|total|total
503220|NCT01418378|knee|knee
503221|NCT01418378|arthroplasty|arthroplasty
503222|NCT01418378|cemented|cemented
503223|NCT01418378|osteoarthritis|osteoarthritis
503224|NCT01418352|Tourette's Disorder|tourette's disorder
503225|NCT01418352|tic disorders|tic disorders
503226|NCT01418339|Tourette's Disorder|tourette's disorder
503227|NCT01418339|tic disorders|tic disorders
503228|NCT01418326|Cancer - breast|cancer - breast
503229|NCT01418326|colo-rectal|colo-rectal
503230|NCT01418326|skin|skin
503231|NCT01418313|Atherosclerosis|atherosclerosis
503232|NCT01418313|Non-invasive imaging|non-invasive imaging
503233|NCT01418313|Magnetic Resonance Imaging|magnetic resonance imaging
503235|NCT01418313|Positron Emission Tomography|positron emission tomography
503236|NCT01418313|PET/CT|pet/ct
503237|NCT01418313|PET/MRI|pet/mri
503238|NCT01418313|Inflammation|inflammation
503239|NCT01418313|Neovascularization|neovascularization
503240|NCT01418261|uncontrolled hypertension|uncontrolled hypertension
503241|NCT01418261|renal denervation|renal denervation
503242|NCT01418248|cardiac catheterization|cardiac catheterization
503243|NCT01418248|echocardiography|echocardiography
503244|NCT01418235|HIV Infections|hiv infections
503245|NCT01418235|Acquired Immunodeficiency Syndrome|acquired immunodeficiency syndrome
503246|NCT01418235|Lentivirus Infections|lentivirus infections
503247|NCT01418235|Retroviridae Infections|retroviridae infections
503248|NCT01418235|RNA Virus Infections|rna virus infections
503249|NCT01418235|Virus Diseases|virus diseases
503250|NCT01418235|Sexually Transmitted Diseases, Viral|sexually transmitted diseases, viral
711239|NCT00585897|Diabetes|diabetes
503251|NCT01418235|Sexually Transmitted Diseases|sexually transmitted diseases
503252|NCT01418235|Immunologic Deficiency Syndromes|immunologic deficiency syndromes
503253|NCT01418235|Immune System Diseases|immune system diseases
503254|NCT01418235|Slow Virus Diseases|slow virus diseases
503255|NCT01418209|Menopause|menopause
503256|NCT01418209|Vasomotor|vasomotor
503257|NCT01418209|Symptoms|symptoms
503258|NCT01418209|Estradiol|estradiol
503259|NCT01418209|Venlafaxine|venlafaxine
503260|NCT01418196|TMAO|tmao
503261|NCT01418196|Children|children
503262|NCT01418196|Dietary choline|dietary choline
503263|NCT01418196|Cardiovascular disease risk|cardiovascular disease risk
503264|NCT01418196|Atherogenic dyslipidemia|atherogenic dyslipidemia
503265|NCT01418183|Orthognathic surgery|orthognathic surgery
503266|NCT01418183|Pain control|pain control
503267|NCT01418183|Trigeminal nerve|trigeminal nerve
503268|NCT01418183|Levobupivacaine|levobupivacaine
503269|NCT01418170|myofascial pain syndrome|myofascial pain syndrome
503270|NCT01418170|myofascial trigger points|myofascial trigger points
503271|NCT01418170|spinal manipulative therapy|spinal manipulative therapy
503272|NCT01418170|algometer|algometer
503273|NCT01418170|pressure pain thresholds|pressure pain thresholds
503274|NCT01418157|Acute mountain sickness|acute mountain sickness
503275|NCT01418157|Rapid ascent|rapid ascent
503276|NCT01418157|High altitude headache|high altitude headache
503277|NCT01418157|Mountain Medicine Society Nepal|mountain medicine society nepal
503278|NCT01418131|Proctitis|proctitis
503279|NCT01418131|resistant|resistant
503280|NCT01418131|ulcerative colitis|ulcerative colitis
503281|NCT01418131|inflammatory bowel disease|inflammatory bowel disease
503282|NCT01418118|noradrenaline|noradrenaline
503283|NCT01418118|norepinephrine|norepinephrine
503284|NCT01418118|epinephrine|epinephrine
503285|NCT01418118|adrenaline|adrenaline
503286|NCT01418118|dobutamine|dobutamine
503287|NCT01418118|dopexamine|dopexamine
503288|NCT01418118|inotrope|inotrope
503289|NCT01418118|pressor|pressor
503290|NCT01418118|sympathomimetic|sympathomimetic
503291|NCT01418118|free flap|free flap
503292|NCT01418118|transplantation|transplantation
503293|NCT01418118|free tissue transfer|free tissue transfer
503294|NCT01418118|microsurgery|microsurgery
503295|NCT01418118|survival|survival
503296|NCT01418105|spine injuries|spine injuries
503297|NCT01418105|brain lesions|brain lesions
503298|NCT01418105|dysphagia|dysphagia
503299|NCT01418079|Spectroscopy, near infrared|spectroscopy, near infrared
503300|NCT01418079|cerebral oxygenation|cerebral oxygenation
503301|NCT01418027|NAFLD|nafld
503302|NCT01418027|exercise|exercise
503303|NCT01418027|hepatic triglycerides|hepatic triglycerides
503304|NCT01418001|GEMCITABINE|gemcitabine
503305|NCT01418001|GW786034 (PAZOPANIB)|gw786034 (pazopanib)
503306|NCT01418001|TAXOTERE (DOCETAXEL)|taxotere (docetaxel)
503307|NCT01418001|11-104|11-104
503308|NCT01417988|TB|tb
503309|NCT01417975|exercise|exercise
503310|NCT01417975|smoking satisfaction|smoking satisfaction
503311|NCT01417975|topography|topography
503312|NCT01417975|cravings|cravings
503313|NCT01417962|Autopsy|autopsy
503314|NCT01417962|MRI|mri
503315|NCT01417962|Stillbirths|stillbirths
503316|NCT01417962|Neonatal death|neonatal death
503317|NCT01417962|Sudden Infant death|sudden infant death
503318|NCT01417923|chronic musculo-skeletal pain|chronic musculo-skeletal pain
503319|NCT01417923|therapeutic&serology effects of vitamin D|therapeutic&serology effects of vitamin d
503320|NCT01417923|CRP, IL-6, IL-8, TNF and prostaglandin E2|crp, il-6, il-8, tnf and prostaglandin e2
503321|NCT01417923|patients suffering from chronic musculo-skeletal pain|patients suffering from chronic musculo-skeletal pain
503322|NCT01417884|molecular cardiology|molecular cardiology
503323|NCT01417884|molecular epidemiology|molecular epidemiology
503324|NCT01417884|platelets|platelets
503325|NCT01417884|cardiovascular disease|cardiovascular disease
503326|NCT01417858|intra-ocular pressure|intra-ocular pressure
503327|NCT01417858|iridectomy|iridectomy
503328|NCT01417858|gonioscopy|gonioscopy
503329|NCT01417858|ocular tonometry|ocular tonometry
503330|NCT01417832|Dental caries|dental caries
503331|NCT01417832|Proximal surfaces|proximal surfaces
503332|NCT01417832|Preventive therapy|preventive therapy
503333|NCT01417832|Dental radiography|dental radiography
503334|NCT01417832|Treatment efficacy|treatment efficacy
503335|NCT01417832|Young adults|young adults
503336|NCT01417806|small cell lung cancer|small cell lung cancer
503337|NCT01417806|somatostatin|somatostatin
503338|NCT01417806|topotecan|topotecan
503339|NCT01417793|Smoking cessation rate|smoking cessation rate
503340|NCT01417767|myelodysplastic syndromes|myelodysplastic syndromes
503341|NCT01417767|Decitabine|decitabine
503342|NCT01417767|homoharringtonine|homoharringtonine
503343|NCT01417767|cytarabine|cytarabine
503344|NCT01417767|G-CSF|g-csf
503345|NCT01417754|toremifene|toremifene
503346|NCT01417728|endomicroscopy|endomicroscopy
503347|NCT01417728|inflammatory bowel disease|inflammatory bowel disease
503348|NCT01417728|mucosal healing|mucosal healing
503349|NCT01417728|infliximab|infliximab
503350|NCT01417689|glaucoma|glaucoma
503351|NCT01417689|randomized controlled trial|randomized controlled trial
503352|NCT01417689|eye drops|eye drops
503353|NCT01417689|instillation|instillation
503354|NCT01417689|compliance|compliance
503355|NCT01417676|prostate cancer|prostate cancer
503356|NCT01417676|locally advanced|locally advanced
503357|NCT01417676|lymph node positive|lymph node positive
503358|NCT01417676|radiation therapy|radiation therapy
503359|NCT01417676|morbidity|morbidity
503360|NCT01417676|early morbidity|early morbidity
503361|NCT01417676|late morbidity|late morbidity
503362|NCT01417663|Aging|aging
503363|NCT01417663|Cardiovascular disease|cardiovascular disease
503364|NCT01417663|Endothelial function|endothelial function
503365|NCT01417663|Physical activity|physical activity
503366|NCT01417663|Advanced Glycation Endproducts|advanced glycation endproducts
503367|NCT01417663|AGE crosslink breakers|age crosslink breakers
503368|NCT01417650|temporomandibular disorder|temporomandibular disorder
503369|NCT01417650|laser therapy|laser therapy
503370|NCT01417650|osteoarthritis|osteoarthritis
503371|NCT01417637|TMD|tmd
503372|NCT01417637|myofacial pain syndrome|myofacial pain syndrome
503373|NCT01417637|low level laser therapy|low level laser therapy
503374|NCT01417637|LLLT|lllt
503375|NCT01417624|Heart Failure|heart failure
503376|NCT01417624|Cardiac Resynchronisation Therapy|cardiac resynchronisation therapy
503377|NCT01417611|screening colonoscopy|screening colonoscopy
503378|NCT01417598|Balance|balance
503379|NCT01417598|Gait|gait
503380|NCT01417598|Physical activity|physical activity
503381|NCT01417585|Activities of daily living|activities of daily living
503382|NCT01417585|Caregiver burden|caregiver burden
503383|NCT01417585|Client centered|client centered
503384|NCT01417585|Life satisfaction|life satisfaction
503385|NCT01417585|Participation|participation
503386|NCT01417585|Patient satisfaction|patient satisfaction
503387|NCT01417585|Rehabilitation|rehabilitation
503388|NCT01417585|Self rated impact of stroke|self rated impact of stroke
503389|NCT01417585|Stroke|stroke
503390|NCT01417546|Dose-Limiting Toxicity|dose-limiting toxicity
503391|NCT01417546|Maximum Tolerated Dose|maximum tolerated dose
503392|NCT01417546|Immune Response|immune response
503393|NCT01417546|Pharmacokinetics|pharmacokinetics
503394|NCT01417546|Dose Escalation|dose escalation
503395|NCT01417546|Cancer|cancer
503396|NCT01417546|Metastatic Solid Tumor|metastatic solid tumor
503397|NCT01417546|Solid Tumor|solid tumor
503398|NCT01417533|Hereditary Inclusion Body Myopathy|hereditary inclusion body myopathy
503399|NCT01417533|HIBM|hibm
503400|NCT01417520|ECD|ecd
503401|NCT01417520|Erdheim-Chester Disease|erdheim-chester disease
503402|NCT01417494|adenocarcinoma of the colon|adenocarcinoma of the colon
503403|NCT01417494|stage IVA colon cancer|stage iva colon cancer
503404|NCT01417494|stage IVB colon cancer|stage ivb colon cancer
503405|NCT01417494|adenocarcinoma of the rectum|adenocarcinoma of the rectum
503406|NCT01417494|stage IVA rectal cancer|stage iva rectal cancer
503407|NCT01417494|stage IVB rectal cancer|stage ivb rectal cancer
503408|NCT01417481|cystic fibrosis|cystic fibrosis
503409|NCT01417481|glycine|glycine
503410|NCT01417481|airway inflammation|airway inflammation
503411|NCT01417468|Cognitive Rehabilitation|cognitive rehabilitation
503412|NCT01417468|Learning Styles|learning styles
503413|NCT01417468|Learning Modes|learning modes
503414|NCT01417468|Learning Modalities|learning modalities
503415|NCT01417468|Multiple Intelligences|multiple intelligences
503416|NCT01417468|Educational Intervention|educational intervention
503417|NCT01417468|Instructional Design|instructional design
503418|NCT01417455|Rheumatoid arthritis|rheumatoid arthritis
503419|NCT01417455|Ankylosing spondylitis|ankylosing spondylitis
503420|NCT01417455|Osteoclasts|osteoclasts
503421|NCT01417455|TNF antagonists|tnf antagonists
503422|NCT01417442|papillary thyroid carcinoma|papillary thyroid carcinoma
503423|NCT01417442|BRAF V600E|braf v600e
503424|NCT01417442|poor prognosis|poor prognosis
503425|NCT01417442|aggressive|aggressive
503426|NCT01417429|galantamine|galantamine
503427|NCT01417429|subjective nicotine|subjective nicotine
503428|NCT01417429|tobacco withdrawal symptoms|tobacco withdrawal symptoms
503429|NCT01417429|nicotine|nicotine
504321|NCT01413594|HABIT|habit
503430|NCT01417390|Nasopharyngeal Carcinoma|nasopharyngeal carcinoma
503431|NCT01417364|Sarcopenia|sarcopenia
503432|NCT01417364|Aging muscle|aging muscle
503433|NCT01417364|Testosterone administration|testosterone administration
503434|NCT01417364|Bone metabolism|bone metabolism
503435|NCT01417351|pregnancy|pregnancy
503436|NCT01417351|immune function|immune function
503437|NCT01417338|Hypertension,pulmonary|hypertension,pulmonary
503438|NCT01417338|Mortality|mortality
503439|NCT01417338|Risk factors|risk factors
503440|NCT01417312|Multiple sclerosis|multiple sclerosis
503441|NCT01417312|Green tea extract|green tea extract
503442|NCT01417312|Metabolism|metabolism
503443|NCT01417299|chronic vegetative state|chronic vegetative state
503444|NCT01417299|RPh201|rph201
503445|NCT01417299|functional MRI|functional mri
503446|NCT01417273|Multiple sclerosis|multiple sclerosis
711240|NCT00585897|Obesity|obesity
503447|NCT01417273|immune system|immune system
503448|NCT01417273|vitamin A|vitamin a
503449|NCT01417273|(MSFC)Multiple Sclerosis Functional Composite|(msfc)multiple sclerosis functional composite
503450|NCT01417273|(EDSS)Expanded Disability Status Scale|(edss)expanded disability status scale
503451|NCT01417273|(MRI)Magnetic resonance imaging|(mri)magnetic resonance imaging
503452|NCT01417247|renal artery|renal artery
503453|NCT01417247|sympathetic nerves|sympathetic nerves
503454|NCT01417247|modification|modification
503455|NCT01417247|metabolic syndrome|metabolic syndrome
503456|NCT01417221|renal artery|renal artery
503457|NCT01417221|sympathetic nerves|sympathetic nerves
503458|NCT01417221|modification|modification
503459|NCT01417221|essential hypertension|essential hypertension
503460|NCT01417221|primary hypertension|primary hypertension
503461|NCT01417195|Assisted Reproductive Technology|assisted reproductive technology
503462|NCT01417182|Patients with Advanced Prostate Cancer|patients with advanced prostate cancer
503463|NCT01417143|dovitinib|dovitinib
503464|NCT01417130|Naproxen|naproxen
503465|NCT01417130|Celecoxib|celecoxib
503466|NCT01417130|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal
503467|NCT01417117|Intracerebral Hemorrhage|intracerebral hemorrhage
503468|NCT01417117|Ischemic Stroke|ischemic stroke
503469|NCT01417117|Diffusion Weight Imaging Abnormalities|diffusion weight imaging abnormalities
503470|NCT01417117|Neurologic Outcome|neurologic outcome
503471|NCT01417104|plaque|plaque
503472|NCT01417104|magnetic resonance imaging (MRI)|magnetic resonance imaging (mri)
503473|NCT01417104|high blood pressure|high blood pressure
503474|NCT01417104|MI|mi
503475|NCT01417104|heart attack|heart attack
503476|NCT01417104|CVA|cva
503477|NCT01417104|stroke|stroke
503478|NCT01417104|PAD|pad
503479|NCT01417091|Brittle bone disease|brittle bone disease
503480|NCT01417091|inherited|inherited
503481|NCT01417091|connective tissue disorder|connective tissue disorder
503482|NCT01417091|fracture|fracture
503483|NCT01417065|Cancer|cancer
503731|NCT01416038|fallopian tube|fallopian tube
503484|NCT01417065|mTOR inhibitor Temsirolimus|mtor inhibitor temsirolimus
503485|NCT01417065|Torisel|torisel
503486|NCT01417065|CCI-779|cci-779
503487|NCT01417065|pharmacodynamic targets|pharmacodynamic targets
503488|NCT01417026|Autism Spectrum Disorders|autism spectrum disorders
503489|NCT01417026|Oxytocin|oxytocin
503490|NCT01417026|Clinical Trial|clinical trial
503491|NCT01417026|Computer-based Intervention|computer-based intervention
503492|NCT01417026|Social Perception|social perception
503493|NCT01417026|Social Motivation|social motivation
503494|NCT01417026|Social Cognition|social cognition
503495|NCT01417013|Dry eye or lubricant eye drops|dry eye or lubricant eye drops
503496|NCT01417000|Cancer|cancer
503497|NCT01417000|Cancer vaccine|cancer vaccine
503498|NCT01417000|Listeria monocytogenes|listeria monocytogenes
503499|NCT01417000|Listeria-based vaccines|listeria-based vaccines
503500|NCT01417000|GVAX|gvax
503501|NCT01417000|Cyclophosphamide|cyclophosphamide
503502|NCT01417000|Cytoxan|cytoxan
503503|NCT01417000|T regulatory cells|t regulatory cells
503504|NCT01417000|Heterologous Prime-Boost|heterologous prime-boost
503505|NCT01417000|Immunotherapy|immunotherapy
503506|NCT01417000|Mesothelin|mesothelin
503507|NCT01417000|Pancreatic cancer|pancreatic cancer
503508|NCT01416974|19-28Z RETROVIRUS|19-28z retrovirus
503509|NCT01416974|CYCLOPHOSPHAMIDE (CYTOXAN)|cyclophosphamide (cytoxan)
503510|NCT01416974|autologous T cells|autologous t cells
503511|NCT01416974|Leukapheresis|leukapheresis
503512|NCT01416974|11-048|11-048
503513|NCT01416961|Squamous Cell|squamous cell
503514|NCT01416961|Non-squamous cell|non-squamous cell
503515|NCT01416948|Cognitive Complaints, TBI, PTSD|cognitive complaints, tbi, ptsd
503516|NCT01416935|Atrial Fibrillation|atrial fibrillation
503517|NCT01416935|Anti-Arrhythmic Medication|anti-arrhythmic medication
503518|NCT01416909|Medication-induced|medication-induced
503519|NCT01416909|Constipation in Cancer|constipation in cancer
503520|NCT01416896|End stage Renal Disease|end stage renal disease
503521|NCT01416896|Hemodialysis|hemodialysis
503522|NCT01416896|Oxidative Stress|oxidative stress
503523|NCT01416896|Inflammation|inflammation
503524|NCT01416883|oral mucosal absorption|oral mucosal absorption
503525|NCT01416883|pharmacokinetics|pharmacokinetics
503526|NCT01416883|safety|safety
503527|NCT01416883|bicalutamide|bicalutamide
503528|NCT01416883|Japanese|japanese
503529|NCT01416883|healthy subject|healthy subject
503530|NCT01416870|Bioequivalence|bioequivalence
503531|NCT01416870|pharmacokinetics|pharmacokinetics
503533|NCT01416870|bicalutamide|bicalutamide
503534|NCT01416870|Casodex|casodex
503535|NCT01416870|Japanese|japanese
503536|NCT01416870|healthy subject|healthy subject
503537|NCT01416857|Medicare|medicare
503538|NCT01416844|Metastatic melanoma|metastatic melanoma
503539|NCT01416844|anti-OX40|anti-ox40
503540|NCT01416844|Immunostimulatory|immunostimulatory
503541|NCT01416831|metastatic melanoma|metastatic melanoma
503542|NCT01416831|IL-2|il-2
503543|NCT01416831|Interleukin 2|interleukin 2
503544|NCT01416831|Radiation|radiation
503545|NCT01416831|Stereotactic Body Radiation Treatment|stereotactic body radiation treatment
503546|NCT01416831|SBRT|sbrt
503547|NCT01416831|Immunotherapy|immunotherapy
503548|NCT01416818|Depression;|depression;
503549|NCT01416818|Parkinson's disease;|parkinson's disease;
503550|NCT01416818|antidepressant|antidepressant
503551|NCT01416805|childhood anxiety disorders|childhood anxiety disorders
503552|NCT01416805|cognitive behavioral therapy|cognitive behavioral therapy
503553|NCT01416805|CBT|cbt
503554|NCT01416805|Generalized Anxiety Disorder|generalized anxiety disorder
503555|NCT01416805|Social Phobia|social phobia
503556|NCT01416805|Separation Anxiety Disorder|separation anxiety disorder
503557|NCT01416805|Psychotherapy|psychotherapy
503558|NCT01416805|Counseling|counseling
503559|NCT01416805|Social Anxiety Disorder|social anxiety disorder
503560|NCT01416779|Writing Intervention|writing intervention
503561|NCT01416779|Bereaved Caregivers|bereaved caregivers
503562|NCT01416779|Older Adults|older adults
503563|NCT01416779|hope|hope
503564|NCT01416779|inventory of daily widowed life|inventory of daily widowed life
503565|NCT01416766|Blood Pressure Monitors|blood pressure monitors
503566|NCT01416766|Medical Informatics|medical informatics
503567|NCT01416766|Disease Management|disease management
503568|NCT01416766|Comparative Effectiveness Research|comparative effectiveness research
503569|NCT01416753|hemodialysis|hemodialysis
503570|NCT01416753|blood volume monitoring|blood volume monitoring
503571|NCT01416740|Indirect magnetic resonance arthrogram|indirect magnetic resonance arthrogram
503572|NCT01416740|Direct magnetic resonance arthrogram|direct magnetic resonance arthrogram
503573|NCT01416740|Diagnostic tests for shoulder pain|diagnostic tests for shoulder pain
503574|NCT01416727|Patient Simulation|patient simulation
503575|NCT01416727|Education, Medical, Graduate|education, medical, graduate
503576|NCT01416727|Internship and Residency|internship and residency
503577|NCT01416727|Psychiatry|psychiatry
503578|NCT01416701|COPD|copd
503579|NCT01416701|Vitamin D|vitamin d
503580|NCT01416701|Pulmonary rehabilitation|pulmonary rehabilitation
503581|NCT01416688|therapy-related toxicity|therapy-related toxicity
503582|NCT01416688|dermatologic complications|dermatologic complications
503583|NCT01416688|stage I colon cancer|stage i colon cancer
503584|NCT01416688|stage IIA colon cancer|stage iia colon cancer
503585|NCT01416688|stage IIB colon cancer|stage iib colon cancer
503586|NCT01416688|stage IIC colon cancer|stage iic colon cancer
503587|NCT01416688|stage IIIA colon cancer|stage iiia colon cancer
503588|NCT01416688|stage IIIB colon cancer|stage iiib colon cancer
503589|NCT01416688|stage IIIC colon cancer|stage iiic colon cancer
503590|NCT01416688|stage IVA colon cancer|stage iva colon cancer
503591|NCT01416688|stage IVB colon cancer|stage ivb colon cancer
503592|NCT01416688|stage I rectal cancer|stage i rectal cancer
503593|NCT01416688|stage IIA rectal cancer|stage iia rectal cancer
503594|NCT01416688|stage IIB rectal cancer|stage iib rectal cancer
503595|NCT01416688|stage IIC rectal cancer|stage iic rectal cancer
503596|NCT01416688|stage IIIA rectal cancer|stage iiia rectal cancer
503597|NCT01416688|stage IIIB rectal cancer|stage iiib rectal cancer
503598|NCT01416688|stage IIIC rectal cancer|stage iiic rectal cancer
503599|NCT01416688|stage IVA rectal cancer|stage iva rectal cancer
503600|NCT01416688|stage IVB rectal cancer|stage ivb rectal cancer
503601|NCT01416688|stage IA non-small cell lung cancer|stage ia non-small cell lung cancer
503602|NCT01416688|stage IB non-small cell lung cancer|stage ib non-small cell lung cancer
503603|NCT01416688|stage IIA non-small cell lung cancer|stage iia non-small cell lung cancer
503604|NCT01416688|stage IIB non-small cell lung cancer|stage iib non-small cell lung cancer
503605|NCT01416688|stage IIIA non-small cell lung cancer|stage iiia non-small cell lung cancer
503606|NCT01416688|stage IIIB non-small cell lung cancer|stage iiib non-small cell lung cancer
503607|NCT01416688|stage IV non-small cell lung cancer|stage iv non-small cell lung cancer
503608|NCT01416688|extensive stage small cell lung cancer|extensive stage small cell lung cancer
503609|NCT01416688|limited stage small cell lung cancer|limited stage small cell lung cancer
503610|NCT01416688|recurrent small cell lung cancer|recurrent small cell lung cancer
503611|NCT01416688|recurrent colon cancer|recurrent colon cancer
503612|NCT01416688|recurrent rectal cancer|recurrent rectal cancer
503613|NCT01416688|recurrent non-small cell lung cancer|recurrent non-small cell lung cancer
503614|NCT01416662|adenocarcinoma of the pancreas|adenocarcinoma of the pancreas
503615|NCT01416662|stage IA pancreatic cancer|stage ia pancreatic cancer
503616|NCT01416662|stage IB pancreatic cancer|stage ib pancreatic cancer
503617|NCT01416662|stage IIA pancreatic cancer|stage iia pancreatic cancer
503618|NCT01416623|Advanced solid cancer|advanced solid cancer
503619|NCT01416623|Henatinib|henatinib
503620|NCT01416623|phase I|phase i
503621|NCT01416597|Influenza|influenza
503622|NCT01416597|Systematic review|systematic review
503623|NCT01416597|Meta-analysis|meta-analysis
503624|NCT01416597|Mismatched strains|mismatched strains
503625|NCT01416597|Cross-protection|cross-protection
503626|NCT01416571|H5N1|h5n1
503627|NCT01416571|Influenza vaccine|influenza vaccine
503628|NCT01416571|influenza infection|influenza infection
503629|NCT01416571|GSK1557484A|gsk1557484a
503630|NCT01416558|German Breast Group|german breast group
503631|NCT01416558|GBG Forschungs GmbH|gbg forschungs gmbh
503633|NCT01416558|GBG 65|gbg 65
503634|NCT01416558|Tiffany|tiffany
503635|NCT01416558|Breast Cancer|breast cancer
503636|NCT01416558|Metastatic Breast Cancer|metastatic breast cancer
503637|NCT01416558|Nab-Paclitaxel|nab-paclitaxel
503638|NCT01416558|Abraxane|abraxane
503639|NCT01416558|Taxane Failure|taxane failure
503640|NCT01416545|Primary Prevention|primary prevention
503641|NCT01416545|Cardiovascular disease|cardiovascular disease
503642|NCT01416545|Child|child
503643|NCT01416545|Behavior modification|behavior modification
503644|NCT01416545|Activities, Educational|activities, educational
503645|NCT01416532|coronary Atheroslcerosis|coronary atheroslcerosis
503646|NCT01416532|Computed Tomography|computed tomography
503647|NCT01416519|Continuous Positive Airway Pressure|continuous positive airway pressure
503648|NCT01416519|Cough|cough
503649|NCT01416519|Oxygen Inhalation Therapy|oxygen inhalation therapy
503650|NCT01416506|Pneumonia, surveillance|pneumonia, surveillance
503651|NCT01416493|acute rheumatoid arthritis|acute rheumatoid arthritis
503652|NCT01416480|Theobromine|theobromine
503653|NCT01416480|cough|cough
503654|NCT01416480|acute bronchitis|acute bronchitis
503655|NCT01416467|lysosomal storage disease|lysosomal storage disease
503656|NCT01416467|AAV vector|aav vector
503657|NCT01416467|gene transfer|gene transfer
503658|NCT01416467|disease characterization|disease characterization
503659|NCT01416441|Tourette's Disorder|tourette's disorder
503660|NCT01416441|tic disorders|tic disorders
503661|NCT01416428|multiple myeloma|multiple myeloma
503662|NCT01416428|waldenstrom macroglobulinemia|waldenstrom macroglobulinemia
503663|NCT01416415|Glaucoma, Open-Angle|glaucoma, open-angle
503664|NCT01416415|Ophthalmic Solutions, Eye drops|ophthalmic solutions, eye drops
503665|NCT01416415|Instructional Films and Videos|instructional films and videos
503666|NCT01416402|Hyperuricemia|hyperuricemia
503667|NCT01416402|gout|gout
503668|NCT01416402|serum uric acid|serum uric acid
503669|NCT01416389|Locally|locally
503670|NCT01416389|Recurrent|recurrent
503671|NCT01416389|Breast|breast
503672|NCT01416389|Cancer|cancer
503673|NCT01416363|firategrast|firategrast
503674|NCT01416363|pharmacokinetics, modified release, firategrast,|pharmacokinetics, modified release, firategrast,
503675|NCT01416363|simulated gastro-retentive|simulated gastro-retentive
503676|NCT01416363|pharmacokinetics|pharmacokinetics
503677|NCT01416363|healthy volunteers, simulated gastro-retentive|healthy volunteers, simulated gastro-retentive
503678|NCT01416363|healthy volunteers|healthy volunteers
503679|NCT01416363|modified release|modified release
503680|NCT01416324|pharmacodynamics|pharmacodynamics
503681|NCT01416324|first time in human|first time in human
503682|NCT01416324|pharmacokinetics|pharmacokinetics
503683|NCT01416298|Acute Kidney Injury|acute kidney injury
503684|NCT01416298|Critically ill children|critically ill children
503685|NCT01416298|Biomarkers|biomarkers
503686|NCT01416298|NGAL|ngal
503687|NCT01416298|Fluid Overload|fluid overload
503688|NCT01416298|Continuous Renal Replacement Therapy (CRRT)|continuous renal replacement therapy (crrt)
503689|NCT01416285|Congestive heart failure (CHF)|congestive heart failure (chf)
503690|NCT01416285|CHF education|chf education
503691|NCT01416285|self-care training|self-care training
503692|NCT01416285|CHF center|chf center
503693|NCT01416259|QTc Prolongation|qtc prolongation
503694|NCT01416246|Stem cell Infusions|stem cell infusions
503695|NCT01416246|Autologous Stem Cell Transplant|autologous stem cell transplant
503696|NCT01416246|11-105|11-105
503697|NCT01416233|autologous|autologous
503699|NCT01416233|orbit|orbit
503700|NCT01416233|atrophy|atrophy
503701|NCT01416233|cannula|cannula
503702|NCT01416220|depression|depression
503703|NCT01416220|bipolar disorder|bipolar disorder
503704|NCT01416220|manic depressive illness|manic depressive illness
503705|NCT01416194|Osteoporosis|osteoporosis
503706|NCT01416181|Natalizumab|natalizumab
503707|NCT01416181|secondary|secondary
503708|NCT01416181|multiple sclerosis|multiple sclerosis
503709|NCT01416181|MS|ms
503710|NCT01416181|SPMS|spms
503711|NCT01416181|Tysabri|tysabri
503712|NCT01416168|Colon|colon
503713|NCT01416168|Geriatric|geriatric
503714|NCT01416168|McCorkle Model|mccorkle model
503715|NCT01416168|Questionnaire|questionnaire
503716|NCT01416116|Tramadol|tramadol
503717|NCT01416116|QUTENZA|qutenza
503718|NCT01416116|Pre-treatment|pre-treatment
503719|NCT01416116|Tolerability|tolerability
503720|NCT01416090|syndactyly|syndactyly
503721|NCT01416077|fluid|fluid
503722|NCT01416077|goal-directed|goal-directed
503723|NCT01416077|FloTrac|flotrac
503724|NCT01416077|pulse contour analysis|pulse contour analysis
503725|NCT01416077|postoperative complications|postoperative complications
503726|NCT01416077|anesthesia|anesthesia
503727|NCT01416077|esophagus|esophagus
503728|NCT01416038|vaccine|vaccine
503729|NCT01416038|immunotherapy|immunotherapy
503730|NCT01416038|ovarian|ovarian
503732|NCT01416038|peritoneal|peritoneal
503733|NCT01416038|cancer|cancer
503734|NCT01416038|tumor|tumor
503735|NCT01416038|Phase 1|phase 1
503736|NCT01416038|Phase I|phase i
503737|NCT01416038|combination therapy|combination therapy
503738|NCT01416025|Voriconazole|voriconazole
503739|NCT01416025|Therapeutic drug monitoring|therapeutic drug monitoring
503740|NCT01416025|Hematopoietic stem cell transplant|hematopoietic stem cell transplant
503741|NCT01416025|Hematologic malignancy|hematologic malignancy
503742|NCT01416025|Invasive mould infection|invasive mould infection
503743|NCT01415999|anthracycline|anthracycline
503744|NCT01415999|cardiac function|cardiac function
503745|NCT01415999|echocardiography|echocardiography
503746|NCT01415999|biomarkers|biomarkers
503747|NCT01415986|Advanced head and neck cancer|advanced head and neck cancer
503748|NCT01415986|Squamous cell carcinoma|squamous cell carcinoma
503749|NCT01415986|SCC|scc
503750|NCT01415986|HNSCC|hnscc
503751|NCT01415973|beef|beef
503752|NCT01415973|protein|protein
503753|NCT01415973|synergy|synergy
503754|NCT01415973|intact beef constituents|intact beef constituents
503755|NCT01415973|protein constituent|protein constituent
503756|NCT01415973|Nutrient Synergy|nutrient synergy
503757|NCT01415960|Prostate Cancer|prostate cancer
503758|NCT01415960|androgen deprivation therapy.|androgen deprivation therapy.
503759|NCT01415960|Leuprolide Acetate Depot Formulation|leuprolide acetate depot formulation
503760|NCT01415960|Pharmacokinetics|pharmacokinetics
503761|NCT01415960|testosterone|testosterone
503762|NCT01415960|serum luteinizing hormone|serum luteinizing hormone
503763|NCT01415960|follicle-stimulating hormone|follicle-stimulating hormone
503764|NCT01415960|prostate-specific antigen|prostate-specific antigen
503765|NCT01415947|Heart disease|heart disease
503766|NCT01415947|Device|device
503767|NCT01415947|Mitral valve|mitral valve
503768|NCT01415947|leaflet prolapse|leaflet prolapse
503769|NCT01415947|Heart valve disease|heart valve disease
503770|NCT01415947|Cardiovascular disease|cardiovascular disease
503771|NCT01415947|Neochordae|neochordae
503772|NCT01415921|heart failure|heart failure
503773|NCT01415921|autonomic function|autonomic function
503774|NCT01415921|sympathovagal balance|sympathovagal balance
503775|NCT01415921|cholinesterase inhibitors|cholinesterase inhibitors
503776|NCT01415921|pharmacology|pharmacology
503777|NCT01415908|advanced degenerative disease of the lumbosacral spine|advanced degenerative disease of the lumbosacral spine
503778|NCT01415908|lumbosacral spine|lumbosacral spine
503779|NCT01415908|radiculopathy|radiculopathy
503780|NCT01415908|degenerative instability|degenerative instability
503781|NCT01415908|spondylolisthesis|spondylolisthesis
503782|NCT01415908|retrolisthesis|retrolisthesis
503783|NCT01415908|lateral listhesis|lateral listhesis
503784|NCT01415908|spinal stenosis|spinal stenosis
503785|NCT01415908|disc herniation|disc herniation
503786|NCT01415908|INFUSE Bone Graft|infuse bone graft
503787|NCT01415908|CD HORIZON Spinal System|cd horizon spinal system
503788|NCT01415908|CAPSTONE Spinal System|capstone spinal system
503789|NCT01415895|back pain|back pain
503790|NCT01415895|cervical pain|cervical pain
503791|NCT01415895|neuropathic pain|neuropathic pain
503792|NCT01415895|radicular pain|radicular pain
503793|NCT01415869|Ventricular Assist Device|ventricular assist device
503794|NCT01415869|Gastrointestinal Bleeding|gastrointestinal bleeding
503795|NCT01415869|VAD|vad
503796|NCT01415856|pulsed electromagnetic fields device|pulsed electromagnetic fields device
503797|NCT01415856|Torino II|torino ii
503798|NCT01415856|postoperative knee pain|postoperative knee pain
503799|NCT01415856|knee replacement|knee replacement
503800|NCT01415830|Anti-Scorpion venom serum|anti-scorpion venom serum
503801|NCT01415830|venom|venom
503802|NCT01415830|efficacy|efficacy
503803|NCT01415830|safety|safety
503804|NCT01415830|children|children
503805|NCT01415817|Quality Improvement|quality improvement
503806|NCT01415817|Adenoma Detection Rate|adenoma detection rate
503807|NCT01415817|Polyp detection rate|polyp detection rate
503808|NCT01415817|Colonoscopy|colonoscopy
503809|NCT01415817|Training|training
503810|NCT01415817|Colorectal cancer screening|colorectal cancer screening
503811|NCT01415804|Dissection|dissection
503812|NCT01415804|Aorta|aorta
503813|NCT01415804|Surgery|surgery
503814|NCT01415791|oral mucosal absorption|oral mucosal absorption
503815|NCT01415791|pharmacokinetics|pharmacokinetics
503816|NCT01415791|safety|safety
503817|NCT01415791|bicalutamide|bicalutamide
503818|NCT01415791|Japanese|japanese
503819|NCT01415791|healthy subject|healthy subject
503820|NCT01415778|Bioequivalence|bioequivalence
503821|NCT01415778|pharmacokinetics|pharmacokinetics
503822|NCT01415778|safety|safety
503823|NCT01415778|bicalutamide|bicalutamide
503824|NCT01415778|Casodex|casodex
503825|NCT01415778|Japanese|japanese
503826|NCT01415778|healthy subject|healthy subject
503827|NCT01415765|Germinal Center Like B-Cell (GCB) DLBCL|germinal center like b-cell (gcb) dlbcl
503828|NCT01415765|Activated B-Cell Like (ABC) DLBCL|activated b-cell like (abc) dlbcl
503829|NCT01415765|NF-KappaB Pathway|nf-kappab pathway
503830|NCT01415765|Drug Resistance|drug resistance
503831|NCT01415765|Nedd-8 Activating Enzyme Inhibitor|nedd-8 activating enzyme inhibitor
640937|NCT00865332|PET|pet
503832|NCT01415765|Diffuse Large B-Cell Lymphoma|diffuse large b-cell lymphoma
503833|NCT01415765|Lymphoma|lymphoma
503834|NCT01415752|neurotoxicity|neurotoxicity
503835|NCT01415752|therapy-related toxicity|therapy-related toxicity
503836|NCT01415752|contiguous stage II mantle cell lymphoma|contiguous stage ii mantle cell lymphoma
503837|NCT01415752|noncontiguous stage II mantle cell lymphoma|noncontiguous stage ii mantle cell lymphoma
503838|NCT01415752|stage I mantle cell lymphoma|stage i mantle cell lymphoma
503839|NCT01415752|stage III mantle cell lymphoma|stage iii mantle cell lymphoma
503840|NCT01415752|stage IV mantle cell lymphoma|stage iv mantle cell lymphoma
503841|NCT01415739|stage IA non-small cell lung cancer|stage ia non-small cell lung cancer
503842|NCT01415739|stage IB non-small cell lung cancer|stage ib non-small cell lung cancer
503843|NCT01415739|adenocarcinoma of the lung|adenocarcinoma of the lung
503844|NCT01415739|squamous cell lung cancer|squamous cell lung cancer
503845|NCT01415726|Cord blood stem cells|cord blood stem cells
503846|NCT01415726|inflammation|inflammation
503847|NCT01415726|type 2 diabetes|type 2 diabetes
503848|NCT01415726|stem cell educator|stem cell educator
503849|NCT01415726|autoimmunity|autoimmunity
503850|NCT01415726|immune modulation|immune modulation
503851|NCT01415713|enroll the 80 patients in this trial|enroll the 80 patients in this trial
503852|NCT01415700|feet STEPPAGE of central neurological origin|feet steppage of central neurological origin
503853|NCT01415700|implanted functional electrical stimulation|implanted functional electrical stimulation
503854|NCT01415700|feet orthosis|feet orthosis
503855|NCT01415687|preoperative care|preoperative care
503856|NCT01415687|colonoscopy|colonoscopy
503857|NCT01415687|cathartics|cathartics
503858|NCT01415674|Squamous cell carcinoma of the head and neck|squamous cell carcinoma of the head and neck
503859|NCT01415674|pre operative treatment|pre operative treatment
503860|NCT01415674|Afatinib|afatinib
503861|NCT01415674|BIBW2992|bibw2992
503862|NCT01415674|Biological markers|biological markers
503863|NCT01415648|with surgical indication|with surgical indication
503864|NCT01415648|Cerebral oximetry|cerebral oximetry
503865|NCT01415648|carotid endarterectomy|carotid endarterectomy
503866|NCT01415648|MRI|mri
503867|NCT01415648|ischemic lesion|ischemic lesion
503868|NCT01415648|cost/effectiveness analysis|cost/effectiveness analysis
503869|NCT01415648|Neurocognitive Outcome|neurocognitive outcome
503870|NCT01415648|protein S-100B|protein s-100b
503871|NCT01415635|Nutritional risk, Hospital food, Nutritional Intervention|nutritional risk, hospital food, nutritional intervention
503872|NCT01415622|plasma therapy|plasma therapy
503873|NCT01415622|ulcus cruris|ulcus cruris
503874|NCT01415609|Gastrointestinal neoplasia|gastrointestinal neoplasia
503875|NCT01415609|Submucosal resection|submucosal resection
503876|NCT01415570|Protein-energy wasting (PEW)|protein-energy wasting (pew)
503877|NCT01415570|racial disparities|racial disparities
503878|NCT01415570|hemodialysis|hemodialysis
503879|NCT01415570|survival paradoxes|survival paradoxes
503880|NCT01415570|Stage 5|stage 5
503881|NCT01415557|micronutrient|micronutrient
503882|NCT01415557|healthy children|healthy children
503883|NCT01415557|vitamins|vitamins
503884|NCT01415557|minerals|minerals
503885|NCT01415557|cognition|cognition
503886|NCT01415557|physical performance|physical performance
503887|NCT01415557|iron|iron
503888|NCT01415557|Micronutrient status|micronutrient status
503889|NCT01415557|Cognitive Performance|cognitive performance
503890|NCT01415544|Diabetes|diabetes
503891|NCT01415531|Stage 1|stage 1
503892|NCT01415531|Stage 2|stage 2
503893|NCT01415531|Hypertension|hypertension
503894|NCT01415518|Severe chronic obstructive pulmonary disease (COPD) patients|severe chronic obstructive pulmonary disease (copd) patients
503895|NCT01415505|Stage 1|stage 1
503896|NCT01415505|Stage 2|stage 2
503897|NCT01415505|Hypertension|hypertension
503898|NCT01415505|1 year open label safety study|1 year open label safety study
503899|NCT01415492|Exercise|exercise
503900|NCT01415492|Physical activity|physical activity
503901|NCT01415492|Cigarette Smoking|cigarette smoking
503902|NCT01415492|Smoking cessation|smoking cessation
503903|NCT01415492|Multi Vitamin intake|multi vitamin intake
503904|NCT01415492|Vegetable consumption|vegetable consumption
503905|NCT01415492|Fruit consumption|fruit consumption
503906|NCT01415492|Meat consumption|meat consumption
503907|NCT01415479|Colon cancer|colon cancer
503908|NCT01415479|Screening|screening
503909|NCT01415479|Decision-making|decision-making
503910|NCT01415453|retinitis pigmentosa|retinitis pigmentosa
503911|NCT01415453|acoustic radiation force ultrasound|acoustic radiation force ultrasound
503913|NCT01415453|visual field loss|visual field loss
503914|NCT01415453|Photoreceptor|photoreceptor
503915|NCT01415453|Vision loss|vision loss
503916|NCT01415453|retina|retina
503917|NCT01415453|progressive vision loss|progressive vision loss
503918|NCT01415453|ultrasound|ultrasound
503919|NCT01415440|ADHD|adhd
503920|NCT01415440|Vyvanse|vyvanse
503921|NCT01415440|stimulant medication|stimulant medication
503922|NCT01415440|ADD|add
503923|NCT01415427|Mucopolysaccharidosis IV type A|mucopolysaccharidosis iv type a
503924|NCT01415427|MPS IV Type A|mps iv type a
503925|NCT01415427|Mucopolysaccharidosis IVA|mucopolysaccharidosis iva
503926|NCT01415427|MPS IVA|mps iva
503927|NCT01415427|Morquio A Syndrome|morquio a syndrome
503928|NCT01415427|Lysosomal Storage Disorder|lysosomal storage disorder
503929|NCT01415427|LSD|lsd
503930|NCT01415427|N-acetylgalactosamine-6-sulfatase|n-acetylgalactosamine-6-sulfatase
503931|NCT01415427|N-acetylgalactosamine-6-sulfate sulfatase|n-acetylgalactosamine-6-sulfate sulfatase
503932|NCT01415427|galactose-6-sulfatase|galactose-6-sulfatase
503933|NCT01415427|GALNS|galns
503934|NCT01415427|enzyme replacement therapy|enzyme replacement therapy
503935|NCT01415427|ERT|ert
503936|NCT01415414|Image quality|image quality
503937|NCT01415414|CNR|cnr
503938|NCT01415414|SNR|snr
503939|NCT01415414|Abdominal|abdominal
503940|NCT01415414|Pelvic|pelvic
503941|NCT01415401|Glaucoma|glaucoma
503942|NCT01415401|Ocular hypertension|ocular hypertension
503943|NCT01415401|Intraocular pressure (IOP)|intraocular pressure (iop)
503944|NCT01415401|Open angle glaucoma|open angle glaucoma
503945|NCT01415401|Pigment dispersion glaucoma|pigment dispersion glaucoma
503946|NCT01415401|Pigmentary|pigmentary
503947|NCT01415388|Maintenance of normal blood triglyceride levels|maintenance of normal blood triglyceride levels
503948|NCT01415375|prostate-specific antigen (146-154)|prostate-specific antigen (146-154)
503949|NCT01415375|prostate-specific antigen (154-163)|prostate-specific antigen (154-163)
503950|NCT01415362|transcranial direct current stimulation|transcranial direct current stimulation
503951|NCT01415362|electroencephalography|electroencephalography
503952|NCT01415323|Emergency services, psychiatric|emergency services, psychiatric
503953|NCT01415323|Psychomotor agitation|psychomotor agitation
503954|NCT01415323|Suicide|suicide
503955|NCT01415323|Violence|violence
503956|NCT01415310|Geriatric Psychiatry|geriatric psychiatry
503957|NCT01415310|Quality register|quality register
503958|NCT01415310|Quality improvement|quality improvement
503959|NCT01415310|Quality control|quality control
503960|NCT01415310|Research elderly patients with psychiatric disorders|research elderly patients with psychiatric disorders
503961|NCT01415297|Phase 1|phase 1
503962|NCT01415297|advanced solid tumors|advanced solid tumors
503963|NCT01415284|Obstetric anesthesia|obstetric anesthesia
503964|NCT01415284|Spinal anesthesia|spinal anesthesia
503965|NCT01415284|Hypotension|hypotension
503966|NCT01415284|Fluid therapy|fluid therapy
503967|NCT01415284|Cesarean section|cesarean section
503968|NCT01415284|phenylephrine|phenylephrine
503969|NCT01415284|cardiac output|cardiac output
503970|NCT01415271|diabetes|diabetes
503971|NCT01415271|A1c|a1c
503972|NCT01415271|internet|internet
503973|NCT01415271|long term care|long term care
503974|NCT01415258|cancer|cancer
503975|NCT01415258|vulnerability|vulnerability
503976|NCT01415258|frail|frail
503977|NCT01415232|Obesity|obesity
503978|NCT01415232|Ultrasound|ultrasound
503979|NCT01415219|rehabilitation|rehabilitation
503980|NCT01415219|exercise|exercise
503981|NCT01415219|efficacy|efficacy
503982|NCT01415219|functional status|functional status
503983|NCT01415206|Behavioral changes|behavioral changes
503984|NCT01415206|Multiple risks|multiple risks
503985|NCT01415180|sepsis|sepsis
503986|NCT01415180|health related quality of life|health related quality of life
503987|NCT01415180|functional status|functional status
503988|NCT01415180|chronic comorbid conditions|chronic comorbid conditions
503989|NCT01415180|organ dysfunction|organ dysfunction
503990|NCT01415154|TMS|tms
503991|NCT01415154|Major Depressive Disorder|major depressive disorder
503992|NCT01415154|NeuroStar TMS|neurostar tms
503993|NCT01415141|genotype 1|genotype 1
503994|NCT01415141|IL28B CC polymorphism|il28b cc polymorphism
503995|NCT01415141|telaprevir|telaprevir
503996|NCT01415141|peginterferon|peginterferon
503997|NCT01415141|ribavirin|ribavirin
503998|NCT01415115|diabetes|diabetes
503999|NCT01415115|hypertension|hypertension
504000|NCT01415089|Cancer|cancer
504001|NCT01415089|Quality of life|quality of life
504002|NCT01415089|Family caregiver|family caregiver
504003|NCT01415089|Stress and coping|stress and coping
504004|NCT01415089|Web-based intervention|web-based intervention
504005|NCT01415089|Communication|communication
504006|NCT01415063|Hepatocellular Carcinoma|hepatocellular carcinoma
504007|NCT01415063|RFA|rfa
504008|NCT01415063|TACE|tace
504009|NCT01415050|Osteoporosis|osteoporosis
504010|NCT01415050|Menopause|menopause
504011|NCT01415050|Raloxifane|raloxifane
504012|NCT01415050|Alendronate|alendronate
504013|NCT01415037|Annular Array Ultrasound|annular array ultrasound
504014|NCT01415037|Ultrasound Exam|ultrasound exam
504015|NCT01415037|Posterior Vitreous Detachment|posterior vitreous detachment
504016|NCT01415037|PVD|pvd
504017|NCT01415037|Diabetic Retinopathy|diabetic retinopathy
504018|NCT01415024|CRT|crt
504019|NCT01415024|Dual LV|dual lv
504020|NCT01415024|Triple Ventricle stimulation|triple ventricle stimulation
504021|NCT01415024|two leftventricular leads|two leftventricular leads
504022|NCT01415024|Av VV optimization|av vv optimization
504023|NCT01415024|Lv dp/dt measurement|lv dp/dt measurement
504024|NCT01415011|Afatinib (BIBW2992)|afatinib (bibw2992)
504025|NCT01415011|EGFR Mutation|egfr mutation
504026|NCT01415011|Non Small Cell Lung Cancer|non small cell lung cancer
504027|NCT01415011|Poor performance status|poor performance status
504028|NCT01415011|Elderly|elderly
504029|NCT01414985|Batten Disease|batten disease
504030|NCT01414972|Atherosclerosis|atherosclerosis
504031|NCT01414972|Coronary Artery Disease|coronary artery disease
504032|NCT01414972|Vitamin A|vitamin a
504033|NCT01414972|CD4-Positive T-Lymphocytes|cd4-positive t-lymphocytes
504034|NCT01414972|gene expression|gene expression
504035|NCT01414959|intensive care patient|intensive care patient
504036|NCT01414959|intubation|intubation
504037|NCT01414959|(please change wording as you like!)|(please change wording as you like!)
504038|NCT01414920|Drug Therapy|drug therapy
504039|NCT01414907|Drinking Behavior|drinking behavior
504040|NCT01414907|Harm Reduction|harm reduction
504041|NCT01414907|Tobacco Use Cessation|tobacco use cessation
504042|NCT01414907|Smoking Cessation|smoking cessation
504043|NCT01414907|Rehabilitation|rehabilitation
504044|NCT01414907|Health Promotion|health promotion
504045|NCT01414907|Nutrition Therapy|nutrition therapy
504046|NCT01414907|Feeding Behavior|feeding behavior
504047|NCT01414907|Exercise|exercise
504048|NCT01414881|ApoB (Apolipoprotein B)|apob (apolipoprotein b)
504049|NCT01414881|LDL (low density lipoprotein)|ldl (low density lipoprotein)
504050|NCT01414881|mipomersen|mipomersen
504051|NCT01414868|Leukotriene|leukotriene
504052|NCT01414868|leukotriene receptor antagonist|leukotriene receptor antagonist
504053|NCT01414868|bronchial provocation test|bronchial provocation test
504054|NCT01414868|therapeutic outcome|therapeutic outcome
504055|NCT01414829|Peptic disease|peptic disease
504056|NCT01414829|Helicobacter pylori|helicobacter pylori
504057|NCT01414829|Different methods|different methods
504058|NCT01414816|Multiple Sclerosis|multiple sclerosis
504059|NCT01414816|Clinical Isolated Syndrome (CIS)|clinical isolated syndrome (cis)
504060|NCT01414803|rosuvastatin, fenofibrate, creatine kinase, alanine aminotransferase|rosuvastatin, fenofibrate, creatine kinase, alanine aminotransferase
504061|NCT01414790|human acellular dermal matrix|human acellular dermal matrix
504062|NCT01414790|parotid tumor|parotid tumor
504063|NCT01414790|total parotidectomy|total parotidectomy
504064|NCT01414777|c-section|c-section
504065|NCT01414777|Hypotension after spinal anesthesia for C-section|hypotension after spinal anesthesia for c-section
504066|NCT01414764|rotator cuff tendon repair surgery|rotator cuff tendon repair surgery
504067|NCT01414764|supraspinatus tendon repair|supraspinatus tendon repair
504068|NCT01414751|Risk communication|risk communication
504069|NCT01414751|Shared decision making|shared decision making
504070|NCT01414751|Cardiovascular diseases|cardiovascular diseases
504071|NCT01414751|Hypercholesterolemia|hypercholesterolemia
504072|NCT01414751|Prevention|prevention
504073|NCT01414725|Multiple Sclerosis|multiple sclerosis
504074|NCT01414725|Mobility|mobility
504075|NCT01414725|Balance|balance
504076|NCT01414725|Core Stability|core stability
504077|NCT01414725|Physiotherapy|physiotherapy
504078|NCT01414712|Low- and Intermediate-Risk Prostate Cancer|low- and intermediate-risk prostate cancer
504079|NCT01414699|dietary variety|dietary variety
504080|NCT01414699|course sequence|course sequence
504081|NCT01414699|preschool|preschool
504082|NCT01414699|child feeding|child feeding
504083|NCT01414673|IUI|iui
504084|NCT01414673|HCG|hcg
504085|NCT01414673|Spontaneous LH|spontaneous lh
504086|NCT01414673|pregnancy|pregnancy
504087|NCT01414660|interleukin 7|interleukin 7
504088|NCT01414660|transplantation|transplantation
504089|NCT01414660|liver|liver
504090|NCT01414660|kidney|kidney
504091|NCT01414660|islet|islet
504092|NCT01414660|diabetes|diabetes
504093|NCT01414647|Bilberry|bilberry
504094|NCT01414647|Vaccinium myrtillus|vaccinium myrtillus
504095|NCT01414647|Metabolic syndrome|metabolic syndrome
504096|NCT01414647|Glucose metabolism|glucose metabolism
504097|NCT01414647|Lipid metabolism|lipid metabolism
504098|NCT01414647|Inflammation|inflammation
504099|NCT01414647|Gene expression|gene expression
504100|NCT01414621|CABG|cabg
504101|NCT01414595|adenocarcinoma of the lung|adenocarcinoma of the lung
504102|NCT01414595|adenosquamous cell lung cancer|adenosquamous cell lung cancer
504103|NCT01414595|non-small cell lung cancer|non-small cell lung cancer
504104|NCT01414595|squamous cell lung cancer|squamous cell lung cancer
504105|NCT01414582|tDCS|tdcs
504106|NCT01414582|Stroke|stroke
504107|NCT01414582|Functional MRI|functional mri
504108|NCT01414582|Motor Learning|motor learning
504109|NCT01414543|violence|violence
504110|NCT01414517|Prebiotics|prebiotics
504111|NCT01414517|Acute Intestinal Injury|acute intestinal injury
504619|NCT01412567|HBV DNA|hbv dna
504112|NCT01414517|Chronic radiation enteritis|chronic radiation enteritis
504113|NCT01414504|pneumococcal,|pneumococcal,
504114|NCT01414504|pneumococcal polysaccharide vaccine,|pneumococcal polysaccharide vaccine,
504115|NCT01414504|challenge dose,|challenge dose,
504116|NCT01414504|hyporesponsiveness,|hyporesponsiveness,
504117|NCT01414504|Papua New Guinea|papua new guinea
504118|NCT01414478|emesis|emesis
504119|NCT01414478|nausea|nausea
504120|NCT01414465|Fatty acids|fatty acids
504121|NCT01414465|orlistat|orlistat
504122|NCT01414465|lipase|lipase
504123|NCT01414465|BMC (Body Mass Index) between 30 to 40 kg/m2|bmc (body mass index) between 30 to 40 kg/m2
504124|NCT01414465|Women|women
504125|NCT01414465|18 to 45 years|18 to 45 years
504126|NCT01414465|Premenopausal stage|premenopausal stage
504127|NCT01414452|Myocardial Infarction|myocardial infarction
504128|NCT01414452|Reperfusion injury|reperfusion injury
504129|NCT01414452|Adiponectin|adiponectin
504130|NCT01414452|endothelial progenitor cells|endothelial progenitor cells
504131|NCT01414413|HIV|hiv
504132|NCT01414413|AIDS|aids
504133|NCT01414413|Antiretroviral therapy|antiretroviral therapy
504134|NCT01414413|Community-based study|community-based study
504135|NCT01414413|Cluster-randomised trial|cluster-randomised trial
504136|NCT01414413|HIV testing|hiv testing
504137|NCT01414413|Africa|africa
504138|NCT01414400|Bacteremia|bacteremia
504139|NCT01414400|Spyglass|spyglass
504140|NCT01414400|Cholangioscopy|cholangioscopy
504141|NCT01414387|carotid stenosis|carotid stenosis
504142|NCT01414387|cerebral embolization|cerebral embolization
504143|NCT01414387|stents|stents
504144|NCT01414387|stroke|stroke
504145|NCT01414374|iron|iron
504146|NCT01414374|anemia|anemia
504147|NCT01414374|herbal medicine|herbal medicine
504148|NCT01414374|phytotherapy|phytotherapy
504149|NCT01414374|Centella asiatica|centella asiatica
504150|NCT01414374|Hibiscus sabdariffa|hibiscus sabdariffa
504151|NCT01414361|Coronary artery stenosis|coronary artery stenosis
504152|NCT01414361|Fractional flow reserve|fractional flow reserve
504153|NCT01414361|Intravascular ultrasonography|intravascular ultrasonography
504154|NCT01414348|participation|participation
504155|NCT01414348|activities of daily living|activities of daily living
504156|NCT01414348|brain injuries|brain injuries
504157|NCT01414348|executive function|executive function
504158|NCT01414335|amino acids|amino acids
504159|NCT01414335|immune system|immune system
504160|NCT01414335|vitamins|vitamins
504161|NCT01414335|chronic infection|chronic infection
504162|NCT01414335|common cold|common cold
504163|NCT01414335|ear|ear
504164|NCT01414335|nose|nose
504165|NCT01414335|throat|throat
504166|NCT01414309|Heart Failure|heart failure
504167|NCT01414309|Central Sleep Apnea|central sleep apnea
504168|NCT01414309|Sleep Disordered Breathing|sleep disordered breathing
504169|NCT01414309|Cardiac Dysfunction|cardiac dysfunction
504170|NCT01414257|Rheumatrex|rheumatrex
504171|NCT01414257|High Dose|high dose
504172|NCT01414244|Irritable Bowel Syndrome|irritable bowel syndrome
504173|NCT01414244|Glutamine|glutamine
504174|NCT01414244|Intestinal Permeability|intestinal permeability
504175|NCT01414231|AML|aml
504176|NCT01414231|acute myeloid leukaemia|acute myeloid leukaemia
504177|NCT01414231|low vs intermediate dose AraC|low vs intermediate dose arac
504178|NCT01414231|CR rate|cr rate
504179|NCT01414231|patients <60 years|patients <60 years
504180|NCT01414218|elderly|elderly
504181|NCT01414218|humor|humor
504182|NCT01414218|general well being|general well being
504183|NCT01414218|psychological distress|psychological distress
504184|NCT01414218|health quality of life|health quality of life
504185|NCT01414179|nutrition|nutrition
504186|NCT01414179|environnement|environnement
504187|NCT01414179|cardiovascular pathology|cardiovascular pathology
504188|NCT01414153|choroidal neovascularization|choroidal neovascularization
504189|NCT01414153|age-related macular degeneration|age-related macular degeneration
504190|NCT01414153|iSONEP|isonep
504191|NCT01414153|sonepcizumab|sonepcizumab
504192|NCT01414153|Lucentis|lucentis
504193|NCT01414153|ranibizumab|ranibizumab
504194|NCT01414153|Avastin|avastin
504195|NCT01414153|bevacizumab|bevacizumab
504196|NCT01414153|Eylea|eylea
504197|NCT01414153|aflibercept|aflibercept
504198|NCT01414140|Mirena, contraception|mirena, contraception
504199|NCT01414114|Clinical Trial, Phase 2|clinical trial, phase 2
504200|NCT01414114|Renal Dialysis|renal dialysis
504201|NCT01414114|Secondary Hyperparathyroidism|secondary hyperparathyroidism
504202|NCT01414114|Chronic kidney disease-mineral and bone disorder|chronic kidney disease-mineral and bone disorder
504203|NCT01414114|Parathyroid hormone|parathyroid hormone
504204|NCT01414101|Rheumatoid Arthritis|rheumatoid arthritis
504205|NCT01414088|Nephrology|nephrology
504206|NCT01414088|ENaC|enac
504207|NCT01414088|NCC|ncc
504208|NCT01414088|NKCC|nkcc
504209|NCT01414088|Sodium channels|sodium channels
504210|NCT01414088|renal biomarkers|renal biomarkers
504211|NCT01414075|Kidney|kidney
504212|NCT01414075|ESRD|esrd
504213|NCT01414075|Renal|renal
504214|NCT01414075|End-Stage Renal Disease|end-stage renal disease
504215|NCT01414075|Anemia|anemia
504216|NCT01414075|Oral anemia treatment|oral anemia treatment
504217|NCT01414075|Hemoglobin levels|hemoglobin levels
504218|NCT01414075|Hemodialysis|hemodialysis
504219|NCT01414075|Peritoneal|peritoneal
504220|NCT01414075|HD|hd
641392|NCT00863265|Diet|diet
504221|NCT01414075|PD|pd
504222|NCT01414075|Hb|hb
504223|NCT01414075|Erythropoietin|erythropoietin
504224|NCT01414075|Blood count|blood count
504225|NCT01414062|Breast Cancer|breast cancer
504226|NCT01414062|Healthy meals|healthy meals
504227|NCT01414062|Cocinar|cocinar
504228|NCT01414062|Dietary|dietary
504229|NCT01414062|Dietary Intervention|dietary intervention
504230|NCT01414062|fruits and vegetables|fruits and vegetables
504231|NCT01414062|Cancer survivor|cancer survivor
504232|NCT01414062|Nutrition|nutrition
504233|NCT01414049|CABG|cabg
504234|NCT01414049|Off-pump CABG|off-pump cabg
504235|NCT01414049|Beating heart|beating heart
504236|NCT01414049|Graft patency|graft patency
504237|NCT01414049|Computed tomography angiography|computed tomography angiography
504238|NCT01414049|Angiographic evaluation of coronary graft patency|angiographic evaluation of coronary graft patency
504239|NCT01414036|cigarette smoking|cigarette smoking
504240|NCT01414036|patient navigation|patient navigation
504241|NCT01414036|primary care|primary care
504242|NCT01414023|High OCI-R scores|high oci-r scores
504243|NCT01414010|healthy volunteers|healthy volunteers
504244|NCT01414010|gut microbiota|gut microbiota
504245|NCT01414010|gut microbiome|gut microbiome
504246|NCT01414010|prebiotic|prebiotic
504247|NCT01414010|probiotic|probiotic
504248|NCT01414010|antibiotic|antibiotic
504249|NCT01414010|antibiotic-associated diarrhea|antibiotic-associated diarrhea
504250|NCT01414010|intestinal bacterial overgrowth|intestinal bacterial overgrowth
504251|NCT01413984|Trauma|trauma
504252|NCT01413984|incarceration|incarceration
504253|NCT01413984|treatment|treatment
504254|NCT01413984|substance abuse|substance abuse
504255|NCT01413958|Nasal Decongestants|nasal decongestants
504256|NCT01413958|Rhinitis, Allergic, Seasonal|rhinitis, allergic, seasonal
504257|NCT01413958|Rhinitis|rhinitis
504258|NCT01413958|Nose Conditions|nose conditions
504259|NCT01413958|Respiratory Tract Diseases|respiratory tract diseases
504260|NCT01413958|Phenylephrine|phenylephrine
504261|NCT01413945|Ileocecal valve|ileocecal valve
504262|NCT01413945|Irritable bowel syndrome|irritable bowel syndrome
504263|NCT01413945|small bowel bacteria|small bowel bacteria
504264|NCT01413867|hemorrhoids|hemorrhoids
504265|NCT01413867|circular staplers|circular staplers
504266|NCT01413867|mucosal resection|mucosal resection
504267|NCT01413867|hemostatic suture|hemostatic suture
504268|NCT01413841|PCI|pci
504269|NCT01413841|oxygen|oxygen
504270|NCT01413828|breast cancer|breast cancer
504271|NCT01413828|adjuvant chemotherapy|adjuvant chemotherapy
504272|NCT01413828|trastuzumab|trastuzumab
504273|NCT01413828|anthracycline|anthracycline
504274|NCT01413815|peri-operative|peri-operative
504275|NCT01413815|cardiovascular risk|cardiovascular risk
504276|NCT01413815|oral supplementation|oral supplementation
504277|NCT01413815|amino acid L-arginine|amino acid l-arginine
504278|NCT01413802|Thyroid surgery|thyroid surgery
504279|NCT01413763|Actinic keratosis|actinic keratosis
504280|NCT01413763|Atrial ectopy|atrial ectopy
504281|NCT01413724|Administered analgesic therapy|administered analgesic therapy
504282|NCT01413711|IS|is
504283|NCT01413711|Pharmacokinetics|pharmacokinetics
504284|NCT01413711|Area under the curve|area under the curve
504285|NCT01413711|Maximum plasma concentration|maximum plasma concentration
504286|NCT01413711|Time to maximum concentration|time to maximum concentration
504287|NCT01413685|tacrolimus|tacrolimus
504288|NCT01413685|calcineurin|calcineurin
504289|NCT01413685|pharmacodynamic|pharmacodynamic
504290|NCT01413685|TDM|tdm
504291|NCT01413685|pharmacokinetics|pharmacokinetics
504292|NCT01413672|ostomy|ostomy
504293|NCT01413672|colostomy|colostomy
504294|NCT01413672|ileostomy|ileostomy
504295|NCT01413672|barrier|barrier
504296|NCT01413672|irritation|irritation
504297|NCT01413659|Colorectal surgery|colorectal surgery
504298|NCT01413659|Surgical site infection|surgical site infection
504299|NCT01413659|Symbiotic|symbiotic
504300|NCT01413646|obesity|obesity
504301|NCT01413646|walnuts|walnuts
504302|NCT01413646|endothelial function|endothelial function
504303|NCT01413620|Vitamin E|vitamin e
504304|NCT01413620|Burn|burn
504305|NCT01413620|Oxidation|oxidation
504306|NCT01413620|Lung Dysfunction|lung dysfunction
504307|NCT01413620|Fatty Liver|fatty liver
504308|NCT01413620|Lipid Peroxidation|lipid peroxidation
504309|NCT01413607|nephrectomy|nephrectomy
504310|NCT01413607|self retaining sutures|self retaining sutures
504311|NCT01413607|laparoscopy|laparoscopy
504312|NCT01413594|cerebral palsy|cerebral palsy
504313|NCT01413594|constraint-induced therapy|constraint-induced therapy
504314|NCT01413594|constraint-induced movement therapy|constraint-induced movement therapy
504315|NCT01413594|CP|cp
504316|NCT01413594|hemiplegia|hemiplegia
504317|NCT01413594|hand|hand
504318|NCT01413594|forced use|forced use
504319|NCT01413594|motor control|motor control
504320|NCT01413594|children|children
504322|NCT01413594|Hand-arm bimanual intensive therapy|hand-arm bimanual intensive therapy
504323|NCT01413594|bilateral training|bilateral training
504324|NCT01413594|bimanual training|bimanual training
504325|NCT01413594|functional therapy|functional therapy
504326|NCT01413594|physical therapy|physical therapy
504327|NCT01413594|occupational therapy|occupational therapy
504328|NCT01413594|intensive|intensive
504329|NCT01413594|pediatric|pediatric
504330|NCT01413594|development|development
504331|NCT01413594|upper extremity|upper extremity
504332|NCT01413594|hemiplegic|hemiplegic
504333|NCT01413594|childhood stroke|childhood stroke
504334|NCT01413581|rhBSSL|rhbssl
504335|NCT01413581|preterm infants|preterm infants
504336|NCT01413581|Swedish Orphan Biovitrum|swedish orphan biovitrum
504337|NCT01413581|growth velocity|growth velocity
504338|NCT01413581|Prevention of growth restriction|prevention of growth restriction
504339|NCT01413555|blood culture|blood culture
504340|NCT01413555|emergency department|emergency department
504341|NCT01413555|quality improvement|quality improvement
504342|NCT01413542|DPPIV inhibitors|dppiv inhibitors
504343|NCT01413542|ACE inhibitors|ace inhibitors
504344|NCT01413542|Bradykinin|bradykinin
504345|NCT01413542|glucagon-like peptide (GLP-1)|glucagon-like peptide (glp-1)
504346|NCT01413542|BNP|bnp
504347|NCT01413542|diabetes|diabetes
504348|NCT01413542|hypertension|hypertension
504349|NCT01413529|HIV infected persons with co-occurring drug use|hiv infected persons with co-occurring drug use
504350|NCT01413516|Varenicline|varenicline
504351|NCT01413516|Placebo|placebo
504352|NCT01413516|Inpatient|inpatient
504353|NCT01413503|Pheochromocytoma|pheochromocytoma
504354|NCT01413503|Paraganglioma|paraganglioma
504355|NCT01413503|MIBG|mibg
504356|NCT01413503|131I-MIBG|131i-mibg
504357|NCT01413503|Resistant|resistant
504358|NCT01413503|Relapsed|relapsed
504359|NCT01413503|Treatment|treatment
504360|NCT01413503|UCSF|ucsf
504361|NCT01413503|Pediatric|pediatric
504362|NCT01413503|Adult|adult
504363|NCT01413503|Oncology|oncology
504364|NCT01413490|hepatitis C virus|hepatitis c virus
504365|NCT01413490|Interferon|interferon
504366|NCT01413490|rimantadine|rimantadine
504367|NCT01413490|liver|liver
504368|NCT01413477|Allergic contact dermatitis|allergic contact dermatitis
504369|NCT01413477|Nickel allergy|nickel allergy
504370|NCT01413477|Desensitization therapy|desensitization therapy
504371|NCT01413464|Renal Transplant|renal transplant
504372|NCT01413464|Venous Thrombosis|venous thrombosis
504373|NCT01413464|Deep Vein Thrombosis|deep vein thrombosis
504374|NCT01413464|Prophylaxis|prophylaxis
504375|NCT01413464|Bleeding|bleeding
504376|NCT01413451|Monoclonal IgG Antibody|monoclonal igg antibody
504377|NCT01413451|Biodistribution|biodistribution
504378|NCT01413451|Pharmacokinetics|pharmacokinetics
504379|NCT01413451|HACA|haca
504380|NCT01413451|Safety|safety
504381|NCT01413451|Mesothelioma|mesothelioma
504382|NCT01413451|Ovarian Cancer|ovarian cancer
504383|NCT01413451|Pancreatic Duct Cancer|pancreatic duct cancer
504384|NCT01413451|Non-Small Cell Lung Cancer|non-small cell lung cancer
504385|NCT01413438|Bevacizumab|bevacizumab
504386|NCT01413438|Quality of Life|quality of life
504387|NCT01413438|Glioblastoma Multiforme|glioblastoma multiforme
504388|NCT01413438|Neurosurgery|neurosurgery
504389|NCT01413438|Glioblastoma|glioblastoma
504391|NCT01413438|Brain Tumor|brain tumor
504392|NCT01413425|Smith-Lemli-Opitz Syndrome|smith-lemli-opitz syndrome
504393|NCT01413425|Cholesterol|cholesterol
504394|NCT01413425|SLOS|slos
504395|NCT01413412|Ventral Hernia|ventral hernia
504396|NCT01413412|Postoperative Pain|postoperative pain
504397|NCT01413412|Ventral Hernia Pain Questionnaire|ventral hernia pain questionnaire
504398|NCT01413412|Postoperative Abdominal wall and muscle function|postoperative abdominal wall and muscle function
504399|NCT01413412|Biodex|biodex
504400|NCT01413386|paclitaxel|paclitaxel
504401|NCT01413386|drug eluting stent|drug eluting stent
504402|NCT01413373|cephalometry|cephalometry
504403|NCT01413373|three-dimensional|three-dimensional
504404|NCT01413373|CT scan|ct scan
504405|NCT01413373|lateral radiography|lateral radiography
504406|NCT01413373|facial symmetry|facial symmetry
504407|NCT01413373|maxillomandibular dysmorphoses|maxillomandibular dysmorphoses
504408|NCT01413334|Coronary artery disease|coronary artery disease
504409|NCT01413334|CT|ct
504410|NCT01413321|Brain Injuries|brain injuries
504411|NCT01413321|Post Traumatic Encephalopathy|post traumatic encephalopathy
504412|NCT01413321|TBI (Traumatic Brain Injury)|tbi (traumatic brain injury)
504413|NCT01413321|Cerebral Stroke|cerebral stroke
504414|NCT01413321|Vascular Accidents, Brain|vascular accidents, brain
504415|NCT01413321|Cerebrovascular Apoplexy|cerebrovascular apoplexy
504416|NCT01413321|Cerebrovascular Accident|cerebrovascular accident
504417|NCT01413321|hemiparesis|hemiparesis
504418|NCT01413308|Fontan|fontan
504419|NCT01413308|lung function test|lung function test
504420|NCT01413308|nitric oxide production|nitric oxide production
504421|NCT01413308|NYHA class 1-2 without acute or chronic specified lung disease|nyha class 1-2 without acute or chronic specified lung disease
504422|NCT01413295|Colorectal Neoplasms|colorectal neoplasms
504423|NCT01413295|Dendritic Cells|dendritic cells
504424|NCT01413282|Acute coronary syndrome|acute coronary syndrome
504425|NCT01413269|breast cancer patients|breast cancer patients
504426|NCT01413269|breast conservation surgery|breast conservation surgery
504427|NCT01413269|hypofractionated radiotherapy|hypofractionated radiotherapy
504428|NCT01413243|Multipe sclerosis, Trichuris suis ova|multipe sclerosis, trichuris suis ova
504429|NCT01413230|Systemic lupus erythematosus|systemic lupus erythematosus
504430|NCT01413230|vitamin D supplementation|vitamin d supplementation
504431|NCT01413230|regulatory T cells|regulatory t cells
504432|NCT01413230|Th17 cells|th17 cells
504433|NCT01413204|TA-7284|ta-7284
504434|NCT01413204|JNJ-28431754|jnj-28431754
504435|NCT01413204|Canagliflozin|canagliflozin
504436|NCT01413204|Sodium Glucose Co-transporter (SGLT2 inhibitor)|sodium glucose co-transporter (sglt2 inhibitor)
504437|NCT01413178|Myeloma|myeloma
504438|NCT01413178|Multiple Myeloma|multiple myeloma
504439|NCT01413178|Light chain Multiple Myeloma|light chain multiple myeloma
504440|NCT01413178|MM|mm
504441|NCT01413178|Autologous Hematopoietic Stem Cell Transplantation|autologous hematopoietic stem cell transplantation
504442|NCT01413178|Busulfan|busulfan
504443|NCT01413178|Busulfex|busulfex
504444|NCT01413178|Myleran|myleran
504445|NCT01413178|Melphalan|melphalan
504446|NCT01413178|Alkeran|alkeran
504447|NCT01413178|G-CSF|g-csf
504448|NCT01413178|Filgrastim|filgrastim
504449|NCT01413178|NeupogenTM|neupogentm
504450|NCT01413178|Questionnaire|questionnaire
504451|NCT01413178|Survey|survey
504452|NCT01413178|Quality of Life|quality of life
504453|NCT01413178|QOL|qol
504454|NCT01413152|men having sex with men|men having sex with men
504455|NCT01413139|peripheral Vascular Disease|peripheral vascular disease
504456|NCT01413139|claudication|claudication
504457|NCT01413139|rest pain|rest pain
504458|NCT01413126|Peanut|peanut
504459|NCT01413126|Blood glucose|blood glucose
504460|NCT01413126|Insulin|insulin
504461|NCT01413126|Non-esterified free fatty acids|non-esterified free fatty acids
504462|NCT01413126|Glucagon-like peptide-1|glucagon-like peptide-1
504463|NCT01413126|Peptide YY|peptide yy
504464|NCT01413126|Cholecystokinin|cholecystokinin
504465|NCT01413126|Appetitive|appetitive
504466|NCT01413126|Food intake|food intake
504467|NCT01413087|Pancreatic cancer|pancreatic cancer
504468|NCT01413087|Gemcitabine|gemcitabine
504469|NCT01413087|BC-819|bc-819
504470|NCT01413087|Adenocarcinoma|adenocarcinoma
504471|NCT01413087|Resectable|resectable
504472|NCT01413087|H19 gene|h19 gene
504473|NCT01413087|DTA-H19|dta-h19
504474|NCT01413087|BioCancell|biocancell
504475|NCT01413087|inodiftagene vixteplasmid|inodiftagene vixteplasmid
504476|NCT01413074|End Stage Renal Disease|end stage renal disease
504477|NCT01413074|ESRD|esrd
504478|NCT01413074|Peritoneal Dialysis|peritoneal dialysis
504479|NCT01413074|PD|pd
504480|NCT01413074|Hemodialysis|hemodialysis
504481|NCT01413074|HD|hd
504482|NCT01413061|Other Hindfoot Conditions requiring Subtalar Arthrodesis|other hindfoot conditions requiring subtalar arthrodesis
504483|NCT01413061|Post-traumatic Arthritis|post-traumatic arthritis
504484|NCT01413048|Essential Hypertension|essential hypertension
504485|NCT01413048|Hypertension|hypertension
504486|NCT01413035|Diabetes|diabetes
504487|NCT01413035|Diabetes Medicines: Oral Hypoglycemic Drugs and Insulins.|diabetes medicines: oral hypoglycemic drugs and insulins.
504488|NCT01413035|Umbilical Cord/placenta-Derived MSC|umbilical cord/placenta-derived msc
504489|NCT01413035|Transplantation|transplantation
504490|NCT01413009|delirium|delirium
504491|NCT01413009|ICU|icu
504492|NCT01413009|spontaneous awakening trials|spontaneous awakening trials
504493|NCT01413009|spontaneous breathing trials|spontaneous breathing trials
504494|NCT01413009|early mobility|early mobility
504495|NCT01412970|hemodynamic monitoring|hemodynamic monitoring
504496|NCT01412970|volume responsiveness|volume responsiveness
504497|NCT01412970|electrical impedance tomography|electrical impedance tomography
504498|NCT01412957|Best Supportive Care|best supportive care
504499|NCT01412957|Panitumumab|panitumumab
504500|NCT01412957|Chemorefractory|chemorefractory
504501|NCT01412957|Wild-type KRAS|wild-type kras
504502|NCT01412957|Overall Survival|overall survival
504503|NCT01412957|Phase 3|phase 3
504504|NCT01412944|Psoriasis|psoriasis
504505|NCT01412944|plaque|plaque
504506|NCT01412944|inflammatory skin disease|inflammatory skin disease
504507|NCT01412944|scaly patches|scaly patches
504508|NCT01412944|AIN457|ain457
504509|NCT01412944|secukinumab|secukinumab
504510|NCT01412944|Moderate to severe|moderate to severe
504511|NCT01412918|Tinnitus|tinnitus
504512|NCT01412918|Inhibitor Device|inhibitor device
504513|NCT01412918|SCN9 gene|scn9 gene
504514|NCT01412918|Ringing in the ears|ringing in the ears
504515|NCT01412918|Milwaukee|milwaukee
504516|NCT01412918|Medical College of Wisconsin|medical college of wisconsin
504517|NCT01412905|screening|screening
504518|NCT01412905|diabetic retinopathy|diabetic retinopathy
504519|NCT01412892|Neurofibromatosis type 1|neurofibromatosis type 1
504520|NCT01412892|Everolimus|everolimus
504521|NCT01412892|Plexiform neurofibromas|plexiform neurofibromas
504522|NCT01412892|Rapamycin|rapamycin
504523|NCT01412879|contiguous stage II mantle cell lymphoma|contiguous stage ii mantle cell lymphoma
504524|NCT01412879|noncontiguous stage II mantle cell lymphoma|noncontiguous stage ii mantle cell lymphoma
504525|NCT01412879|stage III mantle cell lymphoma|stage iii mantle cell lymphoma
504526|NCT01412879|stage IV mantle cell lymphoma|stage iv mantle cell lymphoma
504527|NCT01412866|schizophrenia|schizophrenia
504528|NCT01412866|severe mental illness|severe mental illness
504529|NCT01412866|nicotine|nicotine
504530|NCT01412866|smoking|smoking
504531|NCT01412866|motivation|motivation
504532|NCT01412866|electronic decision support system|electronic decision support system
504533|NCT01412866|motivational interviewing|motivational interviewing
504534|NCT01412853|localized|localized
504535|NCT01412840|Ureterolithiasis|ureterolithiasis
504536|NCT01412840|Pain|pain
504537|NCT01412840|Complementary|complementary
504538|NCT01412840|RCT|rct
504539|NCT01412827|Single-photon emission computed tomography|single-photon emission computed tomography
504540|NCT01412827|myocardial perfusion imaging|myocardial perfusion imaging
504541|NCT01412827|rest/stress|rest/stress
504542|NCT01412827|treadmill|treadmill
504543|NCT01412827|persantine|persantine
504544|NCT01412827|half-dose|half-dose
504545|NCT01412827|radiotracer|radiotracer
504546|NCT01412827|tetrofosmin|tetrofosmin
504547|NCT01412827|Thallium|thallium
504548|NCT01412827|cadmium zinc telluride|cadmium zinc telluride
504549|NCT01412827|diagnostic|diagnostic
504550|NCT01412827|prognostic|prognostic
504551|NCT01412814|Total knee arthroplasty|total knee arthroplasty
504552|NCT01412814|Total knee replacement|total knee replacement
504553|NCT01412814|End-stage knee osteoarthritis|end-stage knee osteoarthritis
504554|NCT01412814|Gait patterns|gait patterns
504555|NCT01412814|Neuromuscular education|neuromuscular education
504556|NCT01412801|Group B streptococcus|group b streptococcus
504557|NCT01412801|GBS|gbs
504558|NCT01412801|Vaccine|vaccine
504559|NCT01412801|Prevention of group B streptococcus infection|prevention of group b streptococcus infection
504560|NCT01412788|breast cancer|breast cancer
504561|NCT01412788|Breast Conserving Surgery|breast conserving surgery
504562|NCT01412788|Peri-areolar Incision|peri-areolar incision
504563|NCT01412775|stress|stress
504564|NCT01412775|burnout|burnout
504565|NCT01412775|exhaustion|exhaustion
504566|NCT01412762|Surgery|surgery
504567|NCT01412762|interview|interview
504568|NCT01412762|11-087|11-087
504569|NCT01412749|registry|registry
504570|NCT01412749|database|database
504571|NCT01412749|eHNS|ehns
504572|NCT01412749|Endoscopic Head and Neck Surgery|endoscopic head and neck surgery
504573|NCT01412749|Transoral Endoscopic Surgery Trial|transoral endoscopic surgery trial
504574|NCT01412749|TEST|test
504575|NCT01412749|melanoma|melanoma
504576|NCT01412749|head and neck surgery|head and neck surgery
504577|NCT01412723|Iron Deficiency|iron deficiency
504578|NCT01412723|Child, Preschool|child, preschool
504579|NCT01412723|Dietary Iron|dietary iron
504580|NCT01412723|Ferrous sulfate|ferrous sulfate
504581|NCT01412723|Bis-glycino iron II|bis-glycino iron ii
504582|NCT01412710|Type 2 Diabetes|type 2 diabetes
504583|NCT01412710|Cholecalciferol|cholecalciferol
504584|NCT01412710|Vitamin D|vitamin d
504585|NCT01412710|Insulin resistance|insulin resistance
504586|NCT01412710|Cardiovascular disease risk|cardiovascular disease risk
504587|NCT01412710|Minorities|minorities
504588|NCT01412697|Rural youth|rural youth
504589|NCT01412697|Theory-based intervention|theory-based intervention
504590|NCT01412697|Randomized by schools|randomized by schools
504591|NCT01412697|Fruit and vegetable intake|fruit and vegetable intake
504592|NCT01412697|Health classes|health classes
504593|NCT01412671|Nexavar|nexavar
504594|NCT01412671|unresectable or advanced renal cell carcinoma|unresectable or advanced renal cell carcinoma
504595|NCT01412645|Obesity|obesity
504596|NCT01412645|Inflammation|inflammation
504597|NCT01412645|Metabolic Syndrome|metabolic syndrome
504598|NCT01412645|Insulin sensitivity|insulin sensitivity
504599|NCT01412645|Osteoporosis|osteoporosis
504600|NCT01412645|Bone turnover|bone turnover
504601|NCT01412645|Ectopic fat accumulation|ectopic fat accumulation
504602|NCT01412645|Resveratrol|resveratrol
504603|NCT01412619|Neurological Outcome|neurological outcome
504604|NCT01412619|Intraoperative intracerebral Oxygen level|intraoperative intracerebral oxygen level
504605|NCT01412619|Mean arterial blood pressure|mean arterial blood pressure
504606|NCT01412619|Central venous blood pressure|central venous blood pressure
504607|NCT01412619|Cardiac output|cardiac output
504608|NCT01412619|Serum Lactate|serum lactate
504609|NCT01412619|Venous oxygen saturation|venous oxygen saturation
504610|NCT01412619|Fluid balance|fluid balance
504611|NCT01412606|Unexplained infertility-endometrial scratching|unexplained infertility-endometrial scratching
504612|NCT01412606|effect of endometrial biopsy (scratching) on clinical pregnancy rates in women with unexplained infertility|effect of endometrial biopsy (scratching) on clinical pregnancy rates in women with unexplained infertility
504613|NCT01412567|Hepatitis B|hepatitis b
504614|NCT01412567|HBsAg|hbsag
504615|NCT01412567|Antenatal|antenatal
641921|NCT00861133|ECG|ecg
504616|NCT01412567|Pregnancy|pregnancy
504617|NCT01412567|Vertical transmission|vertical transmission
504618|NCT01412567|Placenta|placenta
504620|NCT01412554|Insulin resistance|insulin resistance
504621|NCT01412554|Diabetes mellitus|diabetes mellitus
504622|NCT01412554|Adipositas|adipositas
504623|NCT01412541|Arms|arms
504624|NCT01412541|Experimental|experimental
504625|NCT01412541|Drug Coated Angioplasty Balloon|drug coated angioplasty balloon
504626|NCT01412541|Active Comparator|active comparator
504627|NCT01412541|Standard Angioplasty Balloon|standard angioplasty balloon
504628|NCT01412515|mTOR inhibitors|mtor inhibitors
504629|NCT01412502|Tissue Donors|tissue donors
504630|NCT01412502|Tissue and Organ Procurement|tissue and organ procurement
504631|NCT01412502|Brain death|brain death
504632|NCT01412502|Withdrawal of life support|withdrawal of life support
504633|NCT01412489|Uterine synechiae|uterine synechiae
504634|NCT01412489|HyalobarrierR Gel Endo|hyalobarrierr gel endo
504635|NCT01412489|Operative hysteroscopy|operative hysteroscopy
504636|NCT01412489|submucous myoma|submucous myoma
504637|NCT01412450|symptomatic popliteal artery stenosis or occlusion|symptomatic popliteal artery stenosis or occlusion
504638|NCT01412437|PKU|pku
504639|NCT01412437|MRI|mri
504640|NCT01412437|neurocognition|neurocognition
504641|NCT01412437|sapropterin dihydrochloride|sapropterin dihydrochloride
504642|NCT01412424|acromegaly|acromegaly
504643|NCT01412424|IGF-1|igf-1
504644|NCT01412424|growth hormone|growth hormone
504645|NCT01412424|Octreolin|octreolin
504646|NCT01412424|octreotide|octreotide
504647|NCT01412424|somatostatin analog|somatostatin analog
504648|NCT01412411|Anemia|anemia
504649|NCT01412411|Growth|growth
504650|NCT01412411|Infants|infants
504651|NCT01412411|Focus of the study is to assess the level of anemia and growth indicators among the infants|focus of the study is to assess the level of anemia and growth indicators among the infants
504652|NCT01412398|Fosrenol|fosrenol
504653|NCT01412398|Hyperphosphatemia|hyperphosphatemia
504654|NCT01412398|Continuous Cyclic Peritoneal Dialysis|continuous cyclic peritoneal dialysis
504655|NCT01412372|Irritable Bowel Syndrome|irritable bowel syndrome
504656|NCT01412372|Diarrhea|diarrhea
504657|NCT01412372|Mesalamine|mesalamine
504658|NCT01412372|Gastroenteritis|gastroenteritis
504659|NCT01412372|abdominal pain|abdominal pain
504660|NCT01412372|hypersensitivity|hypersensitivity
504661|NCT01412359|TPN Cholestasis|tpn cholestasis
504662|NCT01412346|human|human
504663|NCT01412346|clinical trial|clinical trial
504664|NCT01412346|dietary intervention study|dietary intervention study
504665|NCT01412346|blood pressure|blood pressure
504666|NCT01412346|cardiovascular biomarkers|cardiovascular biomarkers
504667|NCT01412346|nutritional biomarkers|nutritional biomarkers
504668|NCT01412346|gene expression|gene expression
504669|NCT01412307|Hodgkin Lymphoma|hodgkin lymphoma
504670|NCT01412307|Lenalidomide|lenalidomide
504671|NCT01412307|Bendamustine|bendamustine
504672|NCT01412307|Salvage therapy|salvage therapy
504673|NCT01412307|Palliation|palliation
504674|NCT01412294|gastric cancer|gastric cancer
504675|NCT01412294|recurrent gastric cancer|recurrent gastric cancer
504676|NCT01412294|adenocarcinoma of the stomach|adenocarcinoma of the stomach
504677|NCT01412294|capecitabine|capecitabine
504678|NCT01412294|xp|xp
504679|NCT01412281|Influenza|influenza
504680|NCT01412281|Virus|virus
504681|NCT01412281|Vaccination|vaccination
504682|NCT01412281|Immunisation|immunisation
504683|NCT01412268|Obesity|obesity
504684|NCT01412268|Bariatric surgery|bariatric surgery
504685|NCT01412268|Behavioral changes|behavioral changes
504686|NCT01412268|Eating habits|eating habits
504687|NCT01412268|Eating addiction|eating addiction
504688|NCT01412242|Deep vein thrombosis|deep vein thrombosis
504689|NCT01412242|Ultrasonography|ultrasonography
504690|NCT01412242|Pulmonary embolism|pulmonary embolism
504691|NCT01412242|D-dimer|d-dimer
504692|NCT01412242|Pre-test probability|pre-test probability
504693|NCT01412229|Head and neck cancer|head and neck cancer
504694|NCT01412229|Phase II|phase ii
504695|NCT01412229|Locally advanced|locally advanced
504696|NCT01412229|Squamous Cell|squamous cell
504697|NCT01412229|Carboplatin|carboplatin
504698|NCT01412229|Nab-paclitaxel|nab-paclitaxel
504699|NCT01412229|Abraxane|abraxane
504700|NCT01412229|Cetuximab|cetuximab
504701|NCT01412229|Induction|induction
504702|NCT01412229|Chemotherapy|chemotherapy
504703|NCT01412216|Sedentarism|sedentarism
504704|NCT01412216|Physical inactivity|physical inactivity
504705|NCT01412216|Fish oil|fish oil
504706|NCT01412216|Omega-3 fatty acids|omega-3 fatty acids
504707|NCT01412216|Endothelial dysfunction|endothelial dysfunction
504708|NCT01412216|Insulin resistance|insulin resistance
504709|NCT01412216|Metabolic syndrome|metabolic syndrome
504710|NCT01412216|peripheral arterial disease|peripheral arterial disease
504711|NCT01412203|Physical activity|physical activity
504712|NCT01412203|Healthy weight|healthy weight
504713|NCT01412203|Healthy eating|healthy eating
504714|NCT01412203|Physical fitness|physical fitness
504715|NCT01412203|Children|children
504716|NCT01412203|School based|school based
504717|NCT01412203|Community based|community based
504718|NCT01412203|Obesity|obesity
504719|NCT01412203|Health promotion|health promotion
504720|NCT01412203|Socio-ecological|socio-ecological
504721|NCT01412203|Environment based|environment based
504722|NCT01412190|Skin rejuvenation|skin rejuvenation
504723|NCT01412177|Meniere's Disease|meniere's disease
504725|NCT01412177|Definitive vertigo|definitive vertigo
504726|NCT01412177|Vertigo episodes|vertigo episodes
504727|NCT01412177|Vertigo frequency|vertigo frequency
504728|NCT01412177|Tinnitus|tinnitus
504729|NCT01412177|Hearing loss|hearing loss
504730|NCT01412177|Aural fullness|aural fullness
504731|NCT01412164|DES|des
504732|NCT01412164|CAD|cad
504733|NCT01412164|FIREHAWK|firehawk
504734|NCT01412164|MicroPort|microport
504735|NCT01412164|PCI|pci
504736|NCT01412151|Symptomatic|symptomatic
504737|NCT01412151|Huntington's Disease|huntington's disease
504738|NCT01412151|HD|hd
504739|NCT01412125|Biomarkers|biomarkers
504740|NCT01412125|Genetic polymorphism|genetic polymorphism
504741|NCT01412125|Neuroimaging markers|neuroimaging markers
504742|NCT01412125|Neuropsychology|neuropsychology
504743|NCT01412099|Exercise|exercise
504744|NCT01412099|Fast Foods|fast foods
504745|NCT01412099|Fruits|fruits
504746|NCT01412099|Vegetables|vegetables
504747|NCT01412099|Beverages|beverages
504748|NCT01412099|Non-traditional college students|non-traditional college students
504749|NCT01412099|Motivational Interviewing|motivational interviewing
504750|NCT01412099|Peer Counselors|peer counselors
504751|NCT01412099|Cancer Prevention|cancer prevention
504752|NCT01412073|caesarean section, intrapartum haemorrhage|caesarean section, intrapartum haemorrhage
504753|NCT01412060|Schizophrenia|schizophrenia
504754|NCT01412060|Schizophrenic disorder|schizophrenic disorder
504755|NCT01412047|Paroxysmal Nocturnal Hemoglobinuria|paroxysmal nocturnal hemoglobinuria
504756|NCT01412047|PNH|pnh
504757|NCT01412047|Human Anti-Human Antibody|human anti-human antibody
504758|NCT01412047|HAHA|haha
504759|NCT01412047|Soliris|soliris
504760|NCT01412047|eculizumab|eculizumab
504761|NCT01412034|Homozygous Familial Hypercholesterolemia|homozygous familial hypercholesterolemia
504762|NCT01412034|Familial Hypercholesterolemia|familial hypercholesterolemia
504763|NCT01412034|HDL mimetic|hdl mimetic
504764|NCT01412034|ApoA-1|apoa-1
504765|NCT01412021|Arthritis, Juvenile Rheumatoid|arthritis, juvenile rheumatoid
504766|NCT01412008|MRI|mri
504767|NCT01412008|Magnetic Resonance Imaging|magnetic resonance imaging
504768|NCT01412008|Botox|botox
504769|NCT01412008|botulinum toxin|botulinum toxin
504770|NCT01412008|neurological|neurological
504771|NCT01412008|stroke|stroke
504772|NCT01412008|spasticity|spasticity
504773|NCT01412008|muscle stiffness|muscle stiffness
504774|NCT01412008|diffusion|diffusion
504775|NCT01412008|Weill Cornell|weill cornell
504776|NCT01412008|New York Presbyterian Hospital|new york presbyterian hospital
504777|NCT01412008|O'Dell|o'dell
504778|NCT01411995|intrauterine device|intrauterine device
504779|NCT01411995|pain|pain
504780|NCT01411995|lidocaine gel|lidocaine gel
504781|NCT01411982|PACAP (pituitary adenylate cyclase-activating polypeptide)|pacap (pituitary adenylate cyclase-activating polypeptide)
504782|NCT01411982|Nephrotic syndrome|nephrotic syndrome
504783|NCT01411982|Thrombosis|thrombosis
504784|NCT01411982|Platelets|platelets
504785|NCT01411969|external nasal dilator strip|external nasal dilator strip
504786|NCT01411969|nasal valve|nasal valve
504787|NCT01411969|acoustic rhinometry|acoustic rhinometry
504788|NCT01411956|Health Behavior Theory|health behavior theory
504789|NCT01411956|Patient Education|patient education
504790|NCT01411956|Hypertension|hypertension
504791|NCT01411956|Health beliefs related to hypertension and hypertension treatment|health beliefs related to hypertension and hypertension treatment
504792|NCT01411943|Epigenetics|epigenetics
504793|NCT01411943|Inflammatory|inflammatory
504794|NCT01411943|Psychoneurologic Symptoms|psychoneurologic symptoms
504795|NCT01411943|Cognitive Dysfunction|cognitive dysfunction
504796|NCT01411943|Pain|pain
504797|NCT01411943|Fatigue|fatigue
504798|NCT01411943|Sleep Disturbance|sleep disturbance
504799|NCT01411943|Depression|depression
504800|NCT01411943|Depressive Symptoms|depressive symptoms
504801|NCT01411943|Anxiety|anxiety
504802|NCT01411943|Breast Cancer|breast cancer
504803|NCT01411930|Insulin resistance|insulin resistance
504804|NCT01411930|Antipsychotics|antipsychotics
504805|NCT01411930|Olanzapine|olanzapine
504806|NCT01411930|Aripiprazole|aripiprazole
504807|NCT01411917|surgical stomas|surgical stomas
504808|NCT01411917|Nerve block|nerve block
504809|NCT01411904|Leukemia|leukemia
504810|NCT01411904|magnetic needle|magnetic needle
504811|NCT01411904|magnetic nanoparticles|magnetic nanoparticles
504812|NCT01411904|CD34|cd34
504813|NCT01411891|Arthroplasty|arthroplasty
504814|NCT01411891|Infection Control|infection control
504815|NCT01411878|Teen Pregnancy Prevention|teen pregnancy prevention
711341|NCT00585195|ROS1 rearrangements|ros1 rearrangements
642135|NCT00860236|CBT|cbt
504816|NCT01411865|Pragmatic randomized controlled trial|pragmatic randomized controlled trial
504817|NCT01411865|Cardiovascular risk reduction|cardiovascular risk reduction
504818|NCT01411865|Knowledge translation|knowledge translation
504819|NCT01411865|Clinical practice guidelines|clinical practice guidelines
504820|NCT01411865|Administrative databases|administrative databases
504821|NCT01411852|fluid volume resuscitation|fluid volume resuscitation
504822|NCT01411852|trauma|trauma
504823|NCT01411852|hemorrhagic shock|hemorrhagic shock
504824|NCT01411839|Depression|depression
504825|NCT01411839|Latinos|latinos
504826|NCT01411839|Adherence|adherence
504827|NCT01411839|Cognitive-Behavioral Therapy|cognitive-behavioral therapy
504828|NCT01411839|HIV/AIDS|hiv/aids
504829|NCT01411826|Colon cancer screening|colon cancer screening
504830|NCT01411787|Breast cancer|breast cancer
504831|NCT01411787|neoadjuvant chemotherapy|neoadjuvant chemotherapy
504832|NCT01411787|exercise|exercise
504833|NCT01411787|Ki-67|ki-67
504834|NCT01411774|Obsessive-compulsive disorder|obsessive-compulsive disorder
504835|NCT01411774|OCD|ocd
504836|NCT01411761|indirect hyperbilirubinemia|indirect hyperbilirubinemia
504837|NCT01411761|very low birth weight infants|very low birth weight infants
504838|NCT01411722|Electrical Activity of Diaphragm|electrical activity of diaphragm
504839|NCT01411722|Weaning outcome|weaning outcome
504840|NCT01411722|NAVA|nava
504841|NCT01411683|Cost estimates|cost estimates
504842|NCT01411683|Complete Denture|complete denture
504843|NCT01411683|Dental Economics|dental economics
504844|NCT01411683|Dental Implants|dental implants
504845|NCT01411683|Dental Prosthesis, Implant-Supported|dental prosthesis, implant-supported
504846|NCT01411683|Denture Retention|denture retention
504847|NCT01411683|Edentulous|edentulous
504848|NCT01411683|Edentulism|edentulism
504849|NCT01411683|Mini dental implant|mini dental implant
504850|NCT01411683|Oral Health-Related Quality of Life|oral health-related quality of life
504851|NCT01411683|Overdenture|overdenture
504852|NCT01411683|Patient Acceptance of Health Care|patient acceptance of health care
504853|NCT01411683|Quality of Health Care|quality of health care
504854|NCT01411683|Quality of Life|quality of life
504855|NCT01411683|Patient Satisfaction|patient satisfaction
504856|NCT01411670|Human Protein C|human protein c
504857|NCT01411670|Activated protein C|activated protein c
504858|NCT01411670|Microcirculation|microcirculation
504859|NCT01411670|Septic Shock|septic shock
504860|NCT01411670|Sepsis|sepsis
504861|NCT01411644|POF|pof
504862|NCT01411644|IOF|iof
504863|NCT01411644|Poor response|poor response
504864|NCT01411644|early menopause|early menopause
504865|NCT01411644|Primary amenorrhea|primary amenorrhea
504866|NCT01411631|Polyphenols|polyphenols
504867|NCT01411631|Cognition|cognition
504868|NCT01411631|Cognitive function|cognitive function
504869|NCT01411631|Driving performance|driving performance
504870|NCT01411631|Stress|stress
504871|NCT01411618|Antiplaque agents|antiplaque agents
504872|NCT01411618|chemical plaque control|chemical plaque control
504873|NCT01411618|oral hygiene|oral hygiene
504874|NCT01411618|essential oils|essential oils
504875|NCT01411618|alcohol|alcohol
504876|NCT01411618|mouthwash|mouthwash
504877|NCT01411605|Obesity|obesity
504878|NCT01411605|Adolescent|adolescent
504879|NCT01411605|Exercise training|exercise training
504880|NCT01411605|Exercise tolerance|exercise tolerance
504881|NCT01411592|All-Ceramic|all-ceramic
504882|NCT01411592|Resin-bonded Fixed Dental Protheses|resin-bonded fixed dental protheses
504883|NCT01411592|Single Retainer|single retainer
504884|NCT01411592|Randomized Clinical Trial|randomized clinical trial
504885|NCT01411592|Resin Bond|resin bond
504886|NCT01411592|Bonding System|bonding system
504887|NCT01411579|liver|liver
504888|NCT01411579|metastases|metastases
504889|NCT01411579|hepatocarcinoma|hepatocarcinoma
504890|NCT01411579|MR|mr
504891|NCT01411579|DWI|dwi
504892|NCT01411579|chemotherapy|chemotherapy
504893|NCT01411566|KLIPS|klips
504894|NCT01411553|ICU|icu
504895|NCT01411553|Telemetry|telemetry
504896|NCT01411553|ECG lead wire monitoring|ecg lead wire monitoring
504897|NCT01411553|Infection|infection
504898|NCT01411553|Nuisance alarms|nuisance alarms
504899|NCT01411540|Body composition|body composition
504900|NCT01411540|Health markers|health markers
504901|NCT01411540|Diet|diet
504902|NCT01411527|Hormones|hormones
504903|NCT01411527|Endocrine Disrupters|endocrine disrupters
504904|NCT01411527|Polymorphism, Genetic|polymorphism, genetic
504905|NCT01411514|Relapsing remittent multipse sclerosis|relapsing remittent multipse sclerosis
504906|NCT01411514|Secondary progressive multiple sclerosis|secondary progressive multiple sclerosis
504907|NCT01411514|Clinically isolated syndrome|clinically isolated syndrome
504908|NCT01411514|Primary progressive multiple sclerosis|primary progressive multiple sclerosis
504909|NCT01411501|Acupuncture|acupuncture
504910|NCT01411501|Functional constipation|functional constipation
504911|NCT01411488|Focus: anal erosion|focus: anal erosion
504912|NCT01411449|Primovist|primovist
504913|NCT01411449|MRI agent|mri agent
504914|NCT01411436|Nexavar|nexavar
504915|NCT01411436|unresectable hepatocellular carcinoma|unresectable hepatocellular carcinoma
504916|NCT01411423|Nexavar|nexavar
504917|NCT01411423|Unresectable or advanced renal cell carcinoma|unresectable or advanced renal cell carcinoma
504918|NCT01411410|phase I|phase i
504919|NCT01411410|phosphatidylinositol 3΄-kinase (PI3K)|phosphatidylinositol 3΄-kinase (pi3k)
504920|NCT01411410|paclitaxel|paclitaxel
504921|NCT01411410|Maximum tolerated Dose|maximum tolerated dose
504922|NCT01411397|Infection|infection
504923|NCT01411397|Prosthesis|prosthesis
504924|NCT01411397|Recurrence|recurrence
504925|NCT01411397|Strangulation|strangulation
504926|NCT01411384|Keratoconus (KC)|keratoconus (kc)
504927|NCT01411384|Corneal collagen cross-linking (CXL)|corneal collagen cross-linking (cxl)
504928|NCT01411384|Corneal hysteresis (CH)|corneal hysteresis (ch)
504929|NCT01411384|Corneal resistance factor (CRF)|corneal resistance factor (crf)
504930|NCT01411384|Ocular Response Analyzer (ORA)|ocular response analyzer (ora)
504931|NCT01411371|Atrial fibrillation|atrial fibrillation
504932|NCT01411371|Heart failure|heart failure
504933|NCT01411371|Catheter ablation|catheter ablation
504934|NCT01411358|influenza|influenza
504935|NCT01411358|vaccine|vaccine
504936|NCT01411358|immunogenicity|immunogenicity
504937|NCT01411345|Prostate Cancer|prostate cancer
504938|NCT01411345|Prostate Adenocarcinoma|prostate adenocarcinoma
504939|NCT01411332|Prostate Cancer|prostate cancer
504940|NCT01411332|Prostate Adenocarcinoma|prostate adenocarcinoma
504941|NCT01411319|Prostate Cancer|prostate cancer
504942|NCT01411319|Prostate Adenocarcinoma|prostate adenocarcinoma
504943|NCT01411293|cardiovascular disease|cardiovascular disease
504944|NCT01411293|oxidative stress|oxidative stress
504945|NCT01411293|dairy consumption|dairy consumption
504946|NCT01411293|metabolic syndrome|metabolic syndrome
504947|NCT01411293|obesity|obesity
504948|NCT01411293|endothelial function|endothelial function
504949|NCT01411267|Relapse|relapse
504950|NCT01411267|Lymphoblastic|lymphoblastic
504951|NCT01411267|Leukemia|leukemia
504952|NCT01411267|AC220|ac220
504953|NCT01411267|Refractory|refractory
504954|NCT01411267|Myelogenous|myelogenous
504955|NCT01411267|Acute|acute
504956|NCT01411267|Childhood|childhood
504957|NCT01411267|Pediatric|pediatric
504958|NCT01411267|ALL|all
504959|NCT01411267|AML|aml
504960|NCT01411254|DME|dme
504961|NCT01411241|Dengue|dengue
504962|NCT01411241|Dengue Hemorrhagic Fever|dengue hemorrhagic fever
504963|NCT01411241|CYD Dengue Vaccines|cyd dengue vaccines
504964|NCT01411241|Pentaxim™|pentaxim™
504965|NCT01411228|Gaucher disease|gaucher disease
504966|NCT01411228|pediatrics|pediatrics
504967|NCT01411215|Rheumatoid arthritis|rheumatoid arthritis
504968|NCT01411215|ankylosing spondylitis|ankylosing spondylitis
504969|NCT01411215|observational study|observational study
504970|NCT01411202|Malignant Pleural Effusion|malignant pleural effusion
504971|NCT01411202|Doxycycline|doxycycline
504972|NCT01411202|Pleurodesis|pleurodesis
504973|NCT01411202|Pleurx catheter|pleurx catheter
504974|NCT01411189|therapeutic upper gastrointestinal endoscopy|therapeutic upper gastrointestinal endoscopy
504975|NCT01411189|percutaneous endoscopic gastrostomy|percutaneous endoscopic gastrostomy
504976|NCT01411189|endoscopic mucosal resection|endoscopic mucosal resection
504977|NCT01411189|endoscopic submucosal dissection|endoscopic submucosal dissection
504978|NCT01411189|PEG|peg
504979|NCT01411189|EMR|emr
504980|NCT01411189|ESD|esd
504981|NCT01411189|endoscopic hemostasis|endoscopic hemostasis
504982|NCT01411176|upper gastrointestinal endoscopy|upper gastrointestinal endoscopy
504983|NCT01411176|suspected gastric cancer|suspected gastric cancer
504984|NCT01411163|Premanifest|premanifest
504985|NCT01411163|At-Risk|at-risk
504986|NCT01411163|Huntington's Disease|huntington's disease
504987|NCT01411163|HD|hd
504988|NCT01411150|Premanifest|premanifest
504989|NCT01411150|At-Risk|at-risk
504990|NCT01411150|Huntington's Disease|huntington's disease
504991|NCT01411150|HD|hd
504992|NCT01411124|gabapentin|gabapentin
504993|NCT01411124|restless leg syndrome|restless leg syndrome
504994|NCT01411111|Drug-drug interaction|drug-drug interaction
504995|NCT01411111|rosuvastatin|rosuvastatin
504996|NCT01411111|asthma|asthma
504997|NCT01411111|FLAP inhibitor|flap inhibitor
504998|NCT01411085|Schizophrenia|schizophrenia
504999|NCT01411085|Alcoholism|alcoholism
505000|NCT01411085|Dual Diagnosis|dual diagnosis
505001|NCT01411085|Desipramine|desipramine
505002|NCT01411085|Risperidone|risperidone
505003|NCT01411072|Biomarker directed adjuvant chemotherapy|biomarker directed adjuvant chemotherapy
505004|NCT01411072|resected pancreas cancer|resected pancreas cancer
505005|NCT01411059|yoga biomechanics seniors|yoga biomechanics seniors
505006|NCT01411046|Glucocorticoid|glucocorticoid
505007|NCT01411046|polymorphism|polymorphism
505008|NCT01411046|Glucocorticoid receptor gene|glucocorticoid receptor gene
505009|NCT01411046|rheumatoid arthritis|rheumatoid arthritis
505010|NCT01411046|adrenal insufficiency|adrenal insufficiency
505011|NCT01411046|prednisolone treatment|prednisolone treatment
505012|NCT01411007|Nicotine|nicotine
505013|NCT01411007|Cigarettes|cigarettes
505014|NCT01411007|Smoker|smoker
505015|NCT01411007|realtime fMRI|realtime fmri
505016|NCT01411007|brain imaging|brain imaging
505017|NCT01411007|imaging|imaging
505018|NCT01410994|glomerular filtration rate|glomerular filtration rate
505019|NCT01410955|probiotics|probiotics
505020|NCT01410955|diarrhoea|diarrhoea
505021|NCT01410955|prevention|prevention
505022|NCT01410955|colon cancer|colon cancer
505023|NCT01410955|irinotecan|irinotecan
505024|NCT01410942|Prostate Cancer|prostate cancer
505025|NCT01410942|Multimodal Therapy|multimodal therapy
505026|NCT01410942|MMT|mmt
505027|NCT01410942|Fatigue|fatigue
505028|NCT01410942|Cognitive Behavioral Therapy|cognitive behavioral therapy
505029|NCT01410942|CBT|cbt
505030|NCT01410942|Radiation therapy|radiation therapy
505031|NCT01410942|Radiotherapy|radiotherapy
505032|NCT01410942|RT|rt
505033|NCT01410942|Functional Assessment of Chronic Illness Therapy - Fatigue|functional assessment of chronic illness therapy - fatigue
505034|NCT01410942|FACIT-F|facit-f
505035|NCT01410942|Androgen deprivation therapy|androgen deprivation therapy
505036|NCT01410942|Methylphenidate|methylphenidate
505037|NCT01410942|Methylphenidate Hydrochloride|methylphenidate hydrochloride
505038|NCT01410942|Ritalin|ritalin
505039|NCT01410942|Concerta|concerta
505040|NCT01410942|Placebo|placebo
505041|NCT01410942|Sugar Pill|sugar pill
505042|NCT01410929|multiple myeloma|multiple myeloma
505043|NCT01410929|VCF|vcf
505044|NCT01410929|Vertebral Compression Fracture|vertebral compression fracture
505045|NCT01410929|Spine|spine
505046|NCT01410929|Kyphoplasty|kyphoplasty
505047|NCT01410929|Back pain|back pain
505048|NCT01410929|Cancer|cancer
505049|NCT01410916|STEC-HUS|stec-hus
505050|NCT01410916|Shiga-like toxin-producing Escherichia Coli Hemolytic-Uremic Syndrome|shiga-like toxin-producing escherichia coli hemolytic-uremic syndrome
505051|NCT01410916|uncontrolled complement activation|uncontrolled complement activation
505052|NCT01410864|cerebrospinal fluid leaks|cerebrospinal fluid leaks
505053|NCT01410864|dural opening|dural opening
505054|NCT01410864|dural sealing|dural sealing
505055|NCT01410838|Obesity|obesity
505056|NCT01410838|Food preferences|food preferences
505057|NCT01410838|Eating Behavior|eating behavior
505058|NCT01410825|WAS|was
505059|NCT01410825|Wiskott|wiskott
505060|NCT01410825|Gene Transfer|gene transfer
505061|NCT01410825|Gene Therapy|gene therapy
505062|NCT01410812|Interest in exercising more|interest in exercising more
505063|NCT01410799|Growth Hormone Releasing Hormone|growth hormone releasing hormone
505064|NCT01410799|Growth Hormone Insufficiency|growth hormone insufficiency
505065|NCT01410799|Aging|aging
505066|NCT01410799|Growth Hormone|growth hormone
505067|NCT01410799|Physiologic Effects of Drugs|physiologic effects of drugs
505068|NCT01410799|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists
505069|NCT01410799|Hormones|hormones
505070|NCT01410760|Imaging study|imaging study
505071|NCT01410760|Perfusion Computerised Tomography|perfusion computerised tomography
505072|NCT01410747|long-term treatment|long-term treatment
505073|NCT01410747|tacrolimus|tacrolimus
505074|NCT01410747|renal failure|renal failure
505075|NCT01410734|cholecystectomy|cholecystectomy
505076|NCT01410734|chronic right upper quadrant pain|chronic right upper quadrant pain
505077|NCT01410721|TBI|tbi
505078|NCT01410721|PTSD|ptsd
505079|NCT01410721|Veterans|veterans
505080|NCT01410708|Human Breast Cancer Tissue|human breast cancer tissue
505081|NCT01410708|Dasatinin|dasatinin
505082|NCT01410695|Rheumatoid Arthritis|rheumatoid arthritis
505083|NCT01410695|RA|ra
505084|NCT01410695|masitinib|masitinib
505085|NCT01410695|DMARD|dmard
505086|NCT01410695|methotrexate|methotrexate
505087|NCT01410682|oral hygiene|oral hygiene
505088|NCT01410682|ventilator-associated pneumonia|ventilator-associated pneumonia
505089|NCT01410682|infection control|infection control
505090|NCT01410682|intensive care|intensive care
505091|NCT01410682|pediatric nursing|pediatric nursing
505092|NCT01410682|pediatrics|pediatrics
505093|NCT01410669|Self-efficacy|self-efficacy
505094|NCT01410669|Intimate partner violence|intimate partner violence
505095|NCT01410669|Randomized clinical trial|randomized clinical trial
505096|NCT01410669|Depression|depression
505097|NCT01410656|Survivors|survivors
505098|NCT01410643|puberty|puberty
505099|NCT01410643|body composition|body composition
505100|NCT01410643|metabolism|metabolism
505101|NCT01410643|obesity|obesity
505102|NCT01410643|optimization of body composition|optimization of body composition
505103|NCT01410643|pubertal transition|pubertal transition
505104|NCT01410604|Metformin|metformin
505105|NCT01410604|Obesity|obesity
505106|NCT01410604|Insulin resistance|insulin resistance
505107|NCT01410604|Interleukin six|interleukin six
505108|NCT01410604|Adiponectin|adiponectin
505109|NCT01410604|High sensitivity C reactive protein.|high sensitivity c reactive protein.
505110|NCT01410604|Tumour Necrosis Factor alpha|tumour necrosis factor alpha
505111|NCT01410591|transjugular intrahepatic portosystemic shunt|transjugular intrahepatic portosystemic shunt
505112|NCT01410591|TIPS|tips
505113|NCT01410591|liver cirrhosis|liver cirrhosis
505114|NCT01410591|variceal bleeding|variceal bleeding
505115|NCT01410591|8- or 10-mm covered stent|8- or 10-mm covered stent
505116|NCT01410578|sTRE-1|stre-1
505117|NCT01410578|PCT|pct
505118|NCT01410578|CRP|crp
505119|NCT01410578|sepsis|sepsis
505120|NCT01410578|bacteremia|bacteremia
505121|NCT01410578|FUO|fuo
505122|NCT01410578|diagnosis|diagnosis
505123|NCT01410578|prognosis|prognosis
505124|NCT01410565|Bladder Cancer|bladder cancer
505125|NCT01410565|Non-Muscle Invasive Bladder Cancer|non-muscle invasive bladder cancer
505126|NCT01410565|NMIBC|nmibc
505127|NCT01410565|Apaziquone|apaziquone
505128|NCT01410565|EOquin|eoquin
505129|NCT01410565|GU Cancer|gu cancer
505130|NCT01410565|TURBT|turbt
505131|NCT01410552|Primary prevention|primary prevention
505132|NCT01410552|Secondary prevention|secondary prevention
505133|NCT01410539|Stent Thrombosis|stent thrombosis
505134|NCT01410539|Percutaneous Coronary Intervention|percutaneous coronary intervention
505135|NCT01410539|Bare Metal Stent|bare metal stent
505136|NCT01410539|Drug Eluting Stent|drug eluting stent
505137|NCT01410539|Residual Platelet Reactivity|residual platelet reactivity
505138|NCT01410539|Optical Coherence Tomography|optical coherence tomography
505139|NCT01410539|OCT|oct
505140|NCT01410526|VAC|vac
505141|NCT01410526|Severe abdominal sepsis|severe abdominal sepsis
505142|NCT01410526|Peritoneal immune reaction|peritoneal immune reaction
505143|NCT01410526|Peritonitis|peritonitis
505144|NCT01410526|Immune peritoneal reaction when abdominal sepsis is treated with VAC|immune peritoneal reaction when abdominal sepsis is treated with vac
505145|NCT01410500|multiple myeloma|multiple myeloma
505146|NCT01410487|pulmonary circulation|pulmonary circulation
505147|NCT01410474|Meningococcal|meningococcal
505148|NCT01410474|ACWY|acwy
505149|NCT01410474|bacterial meningitis|bacterial meningitis
505150|NCT01410474|conjugate vaccine|conjugate vaccine
505151|NCT01410474|healthy|healthy
505152|NCT01410474|children|children
505153|NCT01410474|adolescents|adolescents
505154|NCT01410474|Taiwan|taiwan
505155|NCT01410461|painful bladder|painful bladder
505156|NCT01410461|physical therapy|physical therapy
505157|NCT01410461|levator ani|levator ani
505158|NCT01410448|Immunosuppression|immunosuppression
505159|NCT01410448|Kidney transplantation|kidney transplantation
505160|NCT01410448|everolimus|everolimus
505161|NCT01410448|safety|safety
505162|NCT01410422|COPD|copd
505163|NCT01410422|Bronchiectasis|bronchiectasis
505164|NCT01410422|Metabolomics|metabolomics
505165|NCT01410409|Osteoarthritis, Knee|osteoarthritis, knee
505166|NCT01410409|Treatment Outcome|treatment outcome
505167|NCT01410409|Time Factors|time factors
505168|NCT01410409|Arthroplasty, Replacement|arthroplasty, replacement
505169|NCT01410409|Rehabilitation|rehabilitation
505170|NCT01410409|Combined Modality Therapy|combined modality therapy
505171|NCT01410409|Middle Aged|middle aged
505172|NCT01410409|Aged|aged
505173|NCT01410409|Aged, 80 and over|aged, 80 and over
505174|NCT01410409|Male|male
505175|NCT01410409|Female|female
505176|NCT01410409|Humans|humans
505177|NCT01410409|Analysis of Variance|analysis of variance
505178|NCT01410396|Atrial Fibrillation|atrial fibrillation
505179|NCT01410396|Stroke|stroke
505180|NCT01410383|hypercholesterolemia,|hypercholesterolemia,
505181|NCT01410383|dyslipidemia,|dyslipidemia,
505182|NCT01410383|thyroid,|thyroid,
505183|NCT01410383|safety,|safety,
505184|NCT01410383|Heterozygous Familial Hypercholesterolaemia|heterozygous familial hypercholesterolaemia
505185|NCT01410383|coronary artery disease|coronary artery disease
505186|NCT01410370|Endostar|endostar
505187|NCT01410370|Radiotherapy|radiotherapy
505188|NCT01410370|Brain Metastases|brain metastases
505189|NCT01410357|serious mental illness|serious mental illness
505190|NCT01410357|diabetes|diabetes
505191|NCT01410344|HIV|hiv
505192|NCT01410344|ALL|all
505193|NCT01410344|AML|aml
505194|NCT01410344|MDS|mds
505195|NCT01410344|Non-Hodgkin Lymphoma|non-hodgkin lymphoma
505196|NCT01410331|CLI|cli
505197|NCT01410331|peripheral vascular disease|peripheral vascular disease
505198|NCT01410331|PVD|pvd
505199|NCT01410331|PAD|pad
505200|NCT01410331|SDF-1|sdf-1
505201|NCT01410318|Atherosclerosis|atherosclerosis
505202|NCT01410318|PESA|pesa
505203|NCT01410318|Subclinical|subclinical
505204|NCT01410318|Cardiovascular diseases|cardiovascular diseases
505205|NCT01410318|Coronary disease|coronary disease
505206|NCT01410318|Heart diseases|heart diseases
505207|NCT01410318|Heart Failure|heart failure
505208|NCT01410318|Myocardial Infarction|myocardial infarction
505209|NCT01410318|Stroke|stroke
505210|NCT01410318|Arteriosclerosis|arteriosclerosis
505211|NCT01410305|Vitamin D Deficiency|vitamin d deficiency
505212|NCT01410305|HIV+ Children|hiv+ children
505213|NCT01410305|HIV+ Young Adults|hiv+ young adults
505214|NCT01410292|fiber|fiber
505215|NCT01410292|glycemic index|glycemic index
505216|NCT01410292|glycemic response|glycemic response
505217|NCT01410292|diabetes|diabetes
505218|NCT01410292|ghrelin|ghrelin
505219|NCT01410279|pulmonary hypertension|pulmonary hypertension
505220|NCT01410279|inspiratory muscle training|inspiratory muscle training
505221|NCT01410279|inspiratory muscle weakness|inspiratory muscle weakness
505222|NCT01410279|pulmonary functional|pulmonary functional
505223|NCT01410279|functional capacity|functional capacity
505224|NCT01410279|quality of life|quality of life
505225|NCT01410266|medical abortion|medical abortion
505226|NCT01410266|first trimester|first trimester
505227|NCT01410266|follow-up|follow-up
505228|NCT01410266|pregnancy test|pregnancy test
505229|NCT01410214|NSCLC|nsclc
505230|NCT01410214|EGFR Mutation Positive|egfr mutation positive
505231|NCT01410214|complete resection|complete resection
505232|NCT01410214|Erlotinib Versus NVB/Cisplatin as Adjuvant treatment|erlotinib versus nvb/cisplatin as adjuvant treatment
505233|NCT01410201|Epiretinal Membrane|epiretinal membrane
505234|NCT01410201|Macular Edema|macular edema
505235|NCT01410201|Dexamethasone Intravitreal Implant (Ozurdex)|dexamethasone intravitreal implant (ozurdex)
505236|NCT01410201|Pars Plana Vitrectomy|pars plana vitrectomy
505237|NCT01410188|open-angle glaucoma|open-angle glaucoma
505238|NCT01410188|glaucoma|glaucoma
505239|NCT01410188|ocular hypertension|ocular hypertension
505240|NCT01410188|intraocular pressure|intraocular pressure
505242|NCT01410162|Kidney/Pancreas|kidney/pancreas
505243|NCT01410162|Transplant|transplant
505244|NCT01410162|conversion|conversion
505245|NCT01410162|bioequivalence|bioequivalence
505246|NCT01410162|Mycophenolate Acid|mycophenolate acid
505247|NCT01410149|PAV (proportional assist ventilation); sleep; polysomnography; mechanical ventilation|pav (proportional assist ventilation); sleep; polysomnography; mechanical ventilation
505248|NCT01410136|Knee|knee
505249|NCT01410136|Femur|femur
505250|NCT01410136|Articular cartilage|articular cartilage
505251|NCT01410136|Lesions|lesions
505252|NCT01410136|Defects|defects
505253|NCT01410136|Osteochondral graft|osteochondral graft
505254|NCT01410136|Cartilage treatments|cartilage treatments
505255|NCT01410136|Osteochondritis Dissecans|osteochondritis dissecans
505256|NCT01410136|OCD|ocd
505257|NCT01410110|Substance Abuse|substance abuse
505258|NCT01410110|Substance Dependence|substance dependence
505259|NCT01410110|Cognitive Impairment|cognitive impairment
505260|NCT01410084|vitamin D|vitamin d
505261|NCT01410084|falls|falls
505262|NCT01410084|deficiency|deficiency
505263|NCT01410084|insufficiency|insufficiency
505264|NCT01410071|Sphincter of Oddi Dysfunction|sphincter of oddi dysfunction
505265|NCT01410058|HIV|hiv
505266|NCT01410058|antiretroviral drug interaction|antiretroviral drug interaction
505267|NCT01410058|herbal medicine|herbal medicine
505268|NCT01410058|pharmacokinetics|pharmacokinetics
505269|NCT01410058|herbal pharmacology|herbal pharmacology
505270|NCT01410045|Turner syndrome|turner syndrome
505271|NCT01410045|infertility|infertility
505272|NCT01410045|ovarian insufficiency|ovarian insufficiency
505273|NCT01410045|ovarian cryopreservation|ovarian cryopreservation
505274|NCT01410032|clavicle|clavicle
505275|NCT01410032|clavicular|clavicular
505276|NCT01410032|fracture|fracture
505277|NCT01410032|midshaft|midshaft
505278|NCT01410032|plate|plate
505279|NCT01410032|ESIN|esin
505280|NCT01410032|intramedullary|intramedullary
505281|NCT01410032|flexible|flexible
505282|NCT01410032|nailing|nailing
505283|NCT01410019|X-linked Severe Combined Immunodeficiency (SCID-X1)|x-linked severe combined immunodeficiency (scid-x1)
505284|NCT01410019|severe infection|severe infection
505285|NCT01410019|gene therapy|gene therapy
505286|NCT01410019|HLA identical family donor|hla identical family donor
505287|NCT01410019|without HLA identical unrelated donor|without hla identical unrelated donor
505288|NCT01410006|NF1|nf1
505289|NCT01410006|neurofibromatosis|neurofibromatosis
505290|NCT01410006|NF|nf
505291|NCT01409993|BMI greater than 25|bmi greater than 25
505292|NCT01409993|Elevated fasting blood sugar (100-125mg/dL)|elevated fasting blood sugar (100-125mg/dl)
505293|NCT01409980|delta phalanx|delta phalanx
505294|NCT01409980|thumb reconstructed|thumb reconstructed
505295|NCT01409980|triphalangeal thumbs|triphalangeal thumbs
505296|NCT01409967|Anemia|anemia
505297|NCT01409967|Transfusion|transfusion
505298|NCT01409967|Biological markers|biological markers
505299|NCT01409954|Fusion|fusion
505300|NCT01409954|Spine|spine
505301|NCT01409954|Decompression|decompression
505302|NCT01409954|Pseudarthrosis|pseudarthrosis
505303|NCT01409954|bone harvest|bone harvest
505304|NCT01409954|Instrumented posterolateral fusion|instrumented posterolateral fusion
505305|NCT01409941|cerebral oxygen saturation,|cerebral oxygen saturation,
505306|NCT01409941|NTproBNP|ntprobnp
505307|NCT01409941|hsTNT|hstnt
505308|NCT01409941|GDF-15|gdf-15
505309|NCT01409928|obesity|obesity
505310|NCT01409928|adolescent|adolescent
505311|NCT01409928|pediatric|pediatric
505312|NCT01409928|weight loss|weight loss
505313|NCT01409928|bariatric surgery|bariatric surgery
505314|NCT01409928|gastric banding|gastric banding
505315|NCT01409915|Alzheimer's disease|alzheimer's disease
505316|NCT01409915|neuropsychological assessment|neuropsychological assessment
642756|NCT00857376|obesity|obesity
505317|NCT01409915|Granulocyte-Macrophage Colony-Stimulating Factor|granulocyte-macrophage colony-stimulating factor
505318|NCT01409915|Leukine|leukine
505319|NCT01409876|histoscanning|histoscanning
505320|NCT01409876|brachytherapy|brachytherapy
505321|NCT01409863|post surgical or post traumatic scar on face or scalp|post surgical or post traumatic scar on face or scalp
505322|NCT01409837|Oligospermia|oligospermia
505323|NCT01409837|Male infertility|male infertility
505324|NCT01409837|Lisinopril|lisinopril
505325|NCT01409824|clinical decision support system|clinical decision support system
505326|NCT01409824|performance based incentives|performance based incentives
505327|NCT01409824|quality of maternal health care services|quality of maternal health care services
505328|NCT01409798|Hyperparathyroidism|hyperparathyroidism
505329|NCT01409798|Hypercalcemia|hypercalcemia
505330|NCT01409785|supraglottic airway devices in children|supraglottic airway devices in children
505331|NCT01409759|Perforators|perforators
505332|NCT01409759|Interposition plasty|interposition plasty
505333|NCT01409759|Contracture release|contracture release
505334|NCT01409746|twin|twin
505335|NCT01409746|brain development|brain development
505336|NCT01409746|MRI|mri
505337|NCT01409720|bony metastases|bony metastases
505338|NCT01409720|physical exercise|physical exercise
505339|NCT01409694|Alzheimer Disease|alzheimer disease
505340|NCT01409694|Vitamin D|vitamin d
505341|NCT01409694|Cholecalciferol|cholecalciferol
505342|NCT01409694|Memantine|memantine
505343|NCT01409694|Cognition Disorders|cognition disorders
505344|NCT01409655|AIDS, HIV, Adherence, Compliance, Contingency management|aids, hiv, adherence, compliance, contingency management
505345|NCT01409616|Pharmacodynamics|pharmacodynamics
505346|NCT01409616|darexaban|darexaban
505347|NCT01409616|Acetyl Salicylic Acid|acetyl salicylic acid
505348|NCT01409616|clopidogrel|clopidogrel
505349|NCT01409616|YM150|ym150
505350|NCT01409616|Phase 1|phase 1
505351|NCT01409603|Pharmacodynamics|pharmacodynamics
505352|NCT01409603|darexaban|darexaban
505353|NCT01409603|naproxen|naproxen
505354|NCT01409603|YM150|ym150
505355|NCT01409603|Phase 1|phase 1
505356|NCT01409590|Schizophrenia|schizophrenia
505357|NCT01409590|weight gain|weight gain
505358|NCT01409590|atypical neuroleptics|atypical neuroleptics
505359|NCT01409577|Coronary stenosis|coronary stenosis
505360|NCT01409577|stent|stent
505361|NCT01409577|fractional flow reserve|fractional flow reserve
505362|NCT01409564|Alzheimer's dementia|alzheimer's dementia
505363|NCT01409564|Cilostazol|cilostazol
505364|NCT01409551|Pleural effusion|pleural effusion
505365|NCT01409551|VATS|vats
505366|NCT01409551|hyperthermia|hyperthermia
505367|NCT01409551|thoracostomy|thoracostomy
505368|NCT01409551|pleurodesis|pleurodesis
505369|NCT01409512|Heart rate variability, anti cholinergic medication|heart rate variability, anti cholinergic medication
505370|NCT01409499|hepatocellular carcinoma, treatments, survival|hepatocellular carcinoma, treatments, survival
505371|NCT01409486|Pompe disease|pompe disease
505372|NCT01409486|Alpha glucosidase|alpha glucosidase
505373|NCT01409486|Newborn screening|newborn screening
505374|NCT01409486|Tandem Mass Spectrometry (LC-MS-MS)|tandem mass spectrometry (lc-ms-ms)
505375|NCT01409486|The study aims:|the study aims:
505376|NCT01409486|To establish the control mean values of alpha glucosidase activity in Dry blood spots of Newborn babies from Israel.|to establish the control mean values of alpha glucosidase activity in dry blood spots of newborn babies from israel.
505377|NCT01409486|To include the alpha glucosidase assay in the newborn screening program in Israel|to include the alpha glucosidase assay in the newborn screening program in israel
505378|NCT01409473|Prostate cancer|prostate cancer
505379|NCT01409473|Stereotactic body radiotherapy|stereotactic body radiotherapy
505380|NCT01409473|Radiosurgery|radiosurgery
505381|NCT01409473|Intensity-modulated radiotherapy|intensity-modulated radiotherapy
505382|NCT01409473|SBRT|sbrt
505383|NCT01409473|IMRT|imrt
505384|NCT01409473|Early-stage prostate cancer|early-stage prostate cancer
505385|NCT01409473|Low-risk prostate cancer|low-risk prostate cancer
505386|NCT01409473|Intermediate-risk prostate cancer|intermediate-risk prostate cancer
505387|NCT01409473|Intraprostatic lesions|intraprostatic lesions
505388|NCT01409473|IPL|ipl
505389|NCT01409421|adherence|adherence
505390|NCT01409421|glaucoma|glaucoma
505391|NCT01409421|motivational interviewing|motivational interviewing
505392|NCT01409408|Hypertension|hypertension
505393|NCT01409408|Diabetes Mellitus|diabetes mellitus
505394|NCT01409408|Vascular stiffness|vascular stiffness
505395|NCT01409408|Endothelial function|endothelial function
505396|NCT01409395|Drug drug interaction|drug drug interaction
505397|NCT01409382|neonatal hypoglycemia|neonatal hypoglycemia
505398|NCT01409382|pregnancy|pregnancy
505399|NCT01409382|physical activity|physical activity
505400|NCT01409382|sedentary lifestyle|sedentary lifestyle
505401|NCT01409382|high-glycemic index diet|high-glycemic index diet
505402|NCT01409382|take-home baby|take-home baby
505403|NCT01409382|recurrent miscarriages|recurrent miscarriages
505404|NCT01409382|preterm delivery|preterm delivery
505405|NCT01409356|Obesity|obesity
505406|NCT01409356|Portal hypertension|portal hypertension
505407|NCT01409356|Cirrhosis|cirrhosis
505408|NCT01409356|Diet|diet
505409|NCT01409356|Exercise|exercise
505410|NCT01409343|advanced solid cancers|advanced solid cancers
505411|NCT01409343|metastatic solid cancers|metastatic solid cancers
505412|NCT01409330|insulin sensitivity|insulin sensitivity
505413|NCT01409330|type 2 diabetes|type 2 diabetes
505414|NCT01409330|diet intervention|diet intervention
505415|NCT01409317|Major Depression|major depression
505416|NCT01409317|Functional Magnetic Resonance Imaging|functional magnetic resonance imaging
505417|NCT01409317|Deep Transcranial Magnetic Stimulation|deep transcranial magnetic stimulation
505418|NCT01409317|Repetitive Transcranial Magnetic Stimulation|repetitive transcranial magnetic stimulation
505419|NCT01409317|rTMS|rtms
505420|NCT01409317|DTMS|dtms
505421|NCT01409317|fMRI|fmri
505422|NCT01409317|Randomized, Sham-Controlled Trial|randomized, sham-controlled trial
505423|NCT01409304|Major depression|major depression
505424|NCT01409304|Deep Transcranial Magnetic Stimulation|deep transcranial magnetic stimulation
505425|NCT01409304|Naturalistic Trial|naturalistic trial
505426|NCT01409304|DTMS|dtms
505427|NCT01409291|low socioeconomic status|low socioeconomic status
505428|NCT01409291|stress|stress
505429|NCT01409291|women|women
505430|NCT01409291|children|children
505431|NCT01409291|cortisol|cortisol
505432|NCT01409265|stroke rehabilitation|stroke rehabilitation
505433|NCT01409265|perceptual deficits|perceptual deficits
505434|NCT01409252|Stroke|stroke
505435|NCT01409252|intracerebral hemorrhage|intracerebral hemorrhage
505436|NCT01409252|surgery|surgery
505437|NCT01409239|hospital|hospital
505438|NCT01409239|diabetes|diabetes
505439|NCT01409239|glycemic variability|glycemic variability
505440|NCT01409239|autonomic tone|autonomic tone
505441|NCT01409226|high-risk of breast cancer|high-risk of breast cancer
505442|NCT01409226|BRCA1 mutation carrier|brca1 mutation carrier
505443|NCT01409226|BRCA2 mutation carrier|brca2 mutation carrier
505444|NCT01409226|diagnostic|diagnostic
505446|NCT01409226|BI-RADS 4|bi-rads 4
505447|NCT01409226|mammographically occult|mammographically occult
505448|NCT01409187|Melanoma|melanoma
505449|NCT01409187|Metastatic Melanoma|metastatic melanoma
505450|NCT01409187|Cytotoxic Drugs|cytotoxic drugs
505451|NCT01409187|IPI-Biotherapy|ipi-biotherapy
505452|NCT01409187|Ipilimumab|ipilimumab
505453|NCT01409187|Yervoy|yervoy
505454|NCT01409187|BMS-734016|bms-734016
505455|NCT01409187|MDX010|mdx010
505456|NCT01409187|Interferon|interferon
505457|NCT01409187|IFN Alpha-2b|ifn alpha-2b
505458|NCT01409187|Intron A|intron a
505459|NCT01409187|Interferon Apha-2b|interferon apha-2b
505460|NCT01409187|Interleukin-2|interleukin-2
505461|NCT01409187|IL-2|il-2
505462|NCT01409187|Aldesleukin|aldesleukin
505463|NCT01409187|Proleukin|proleukin
505464|NCT01409174|Melanoma|melanoma
505465|NCT01409174|Metastatic|metastatic
505466|NCT01409174|IPI-Biochemotherapy|ipi-biochemotherapy
505467|NCT01409174|Chemonaive|chemonaive
505468|NCT01409174|Advanced stage IV|advanced stage iv
505469|NCT01409174|Unresectable stage III melanoma|unresectable stage iii melanoma
505470|NCT01409174|1.0 cm or larger|1.0 cm or larger
505471|NCT01409174|Ipilimumab|ipilimumab
505472|NCT01409174|Yervoy|yervoy
505473|NCT01409174|BMS-734016|bms-734016
505474|NCT01409174|MDX010|mdx010
505475|NCT01409174|Interferon Alpha-2b|interferon alpha-2b
505476|NCT01409174|Intron A|intron a
505477|NCT01409174|Temozolomide|temozolomide
505478|NCT01409174|Temodar|temodar
505479|NCT01409174|Cisplatin|cisplatin
505480|NCT01409174|Platinol-AQ|platinol-aq
505481|NCT01409174|Platinol|platinol
505482|NCT01409174|CDDP|cddp
505483|NCT01409174|Interleukin-2|interleukin-2
505484|NCT01409174|IL-2|il-2
505485|NCT01409174|Aldesleukin|aldesleukin
505486|NCT01409174|Proleukin|proleukin
505487|NCT01409148|Radioimmunoimaging|radioimmunoimaging
505488|NCT01409148|AL Amyloidosis|al amyloidosis
505489|NCT01409148|PET/CT|pet/ct
505490|NCT01409135|Nectin 4 protein, humans|nectin 4 protein, humans
505491|NCT01409135|Cancer|cancer
505492|NCT01409135|Pharmacokinetics of AGS-22M6E|pharmacokinetics of ags-22m6e
505493|NCT01409135|Pharmacokinetics of ASG-22CE|pharmacokinetics of asg-22ce
505494|NCT01409135|Safety|safety
505495|NCT01409135|Clinical Trial, Phase 1|clinical trial, phase 1
505496|NCT01409135|ASG-22ME|asg-22me
505497|NCT01409135|AGS-22M6E|ags-22m6e
505498|NCT01409135|ASG-22CE|asg-22ce
505499|NCT01409135|ASG-22C3|asg-22c3
505500|NCT01409122|vasodilator|vasodilator
505501|NCT01409122|nitric oxide|nitric oxide
505502|NCT01409122|sodium nitrite|sodium nitrite
505503|NCT01409122|sildenafil|sildenafil
505504|NCT01409122|PDE-5|pde-5
505505|NCT01409122|pulmonary hypertension|pulmonary hypertension
505506|NCT01409122|pulmonary arterial hypertension|pulmonary arterial hypertension
505507|NCT01409109|Schizophrenia|schizophrenia
505508|NCT01409109|Schizoaffective|schizoaffective
505509|NCT01409109|Neuroimaging|neuroimaging
505510|NCT01409109|Magnetic Resonance Imaging (MRI)|magnetic resonance imaging (mri)
505511|NCT01409109|Functional Magnetic Resonance Imaging (fMRI)|functional magnetic resonance imaging (fmri)
505512|NCT01409109|Spectroscopy|spectroscopy
505513|NCT01409083|infiltration|infiltration
505514|NCT01409083|extravasation|extravasation
505515|NCT01409083|end-tidal carbon dioxide|end-tidal carbon dioxide
505516|NCT01409083|sodium bicarbonate|sodium bicarbonate
505517|NCT01409070|MDS|mds
505518|NCT01409057|Inflammation parameters|inflammation parameters
505519|NCT01409057|Various blood values|various blood values
505520|NCT01409057|Clinical Outcome|clinical outcome
505521|NCT01409057|Residence in ICU/ Hospital|residence in icu/ hospital
505522|NCT01409057|SAPS-Score|saps-score
505523|NCT01409057|SOFA-Score|sofa-score
505524|NCT01409057|Duration of artificial respiration|duration of artificial respiration
505525|NCT01409044|Patient-Controlled Analgesia (PCA)|patient-controlled analgesia (pca)
505526|NCT01409044|Music Listening|music listening
505527|NCT01409044|Opioids|opioids
505528|NCT01409044|Post Surgical Intensive Care Patient|post surgical intensive care patient
505529|NCT01409044|Patient-Controlled Analgesia|patient-controlled analgesia
505530|NCT01409031|newborns|newborns
505531|NCT01409031|respiratory failure|respiratory failure
505532|NCT01409031|pulmonary hypertension|pulmonary hypertension
505533|NCT01409031|treatment|treatment
505534|NCT01409018|pediatric|pediatric
505535|NCT01409018|cancer|cancer
505536|NCT01409018|invasive fungal disease|invasive fungal disease
505537|NCT01409018|antifungal agent|antifungal agent
505538|NCT01408992|Hearing screening|hearing screening
505539|NCT01408992|Questionnaire|questionnaire
505540|NCT01408992|Hearing disability|hearing disability
505541|NCT01408979|Severe preeclampsia|severe preeclampsia
505542|NCT01408979|magnesium sulfate|magnesium sulfate
505543|NCT01408979|anticonvulsivant|anticonvulsivant
505544|NCT01408966|Dark chocolate|dark chocolate
505545|NCT01408966|Catechins|catechins
505546|NCT01408966|Intrahepatic endothelial dysfunction|intrahepatic endothelial dysfunction
505547|NCT01408966|Cirrhosis|cirrhosis
505548|NCT01408966|Portal Hypertension|portal hypertension
505549|NCT01408953|Keloid|keloid
505550|NCT01408927|Thienopyridine resistance|thienopyridine resistance
505551|NCT01408927|Aspirin resistance|aspirin resistance
505552|NCT01408927|Platelet reactivity|platelet reactivity
505553|NCT01408901|peripheral arterial disease|peripheral arterial disease
505554|NCT01408901|granulocyte macrophage colony stimulating factor|granulocyte macrophage colony stimulating factor
505555|NCT01408901|PAD|pad
505556|NCT01408901|GM-CSF|gm-csf
505557|NCT01408901|sargramostim|sargramostim
505558|NCT01408901|leukine|leukine
505559|NCT01408901|treadmill exercise|treadmill exercise
505560|NCT01408875|Chronic Heart Failure|chronic heart failure
505561|NCT01408875|Cardiac rehabilitation|cardiac rehabilitation
505562|NCT01408875|Exercise training|exercise training
505563|NCT01408875|Peak VO2|peak vo2
505564|NCT01408875|Electrical myostimulation|electrical myostimulation
505565|NCT01408862|GLP1|glp1
505566|NCT01408862|GIP|gip
505567|NCT01408862|platelets|platelets
505568|NCT01408862|human|human
505569|NCT01408862|aggregation|aggregation
505570|NCT01408849|Endoscopy|endoscopy
505571|NCT01408849|Herbal medicine|herbal medicine
505572|NCT01408849|Phytotherapy|phytotherapy
505573|NCT01408836|Vasculitis|vasculitis
505574|NCT01408836|ANCA|anca
505575|NCT01408836|Therapy|therapy
505576|NCT01408836|Plasma exchange|plasma exchange
505577|NCT01408836|Immunosuppression|immunosuppression
505578|NCT01408823|Pediatrics|pediatrics
505579|NCT01408823|Scoliosis|scoliosis
505580|NCT01408823|Pharmacokinetics|pharmacokinetics
505581|NCT01408823|Hemorrhage|hemorrhage
505582|NCT01408823|Orthopedic Surgery|orthopedic surgery
505583|NCT01408810|infliximab|infliximab
505584|NCT01408810|ulcerative colitis|ulcerative colitis
505585|NCT01408810|histologic remission|histologic remission
505586|NCT01408797|clonal deletion|clonal deletion
505587|NCT01408797|kidney transplantation|kidney transplantation
505588|NCT01408784|calories|calories
505589|NCT01408784|counting|counting
505590|NCT01408784|obesity|obesity
505591|NCT01408784|overweight|overweight
505592|NCT01408784|categories|categories
505593|NCT01408784|calorie|calorie
505594|NCT01408784|method|method
505595|NCT01408784|counting calories|counting calories
505596|NCT01408784|lose weight|lose weight
505597|NCT01408784|diet|diet
505598|NCT01408784|energy balance|energy balance
505599|NCT01408784|energy intake|energy intake
505600|NCT01408784|24 hours recall|24 hours recall
505601|NCT01408784|food intake|food intake
505602|NCT01408771|Urodynamics|urodynamics
505603|NCT01408771|Overactive Bladder|overactive bladder
505604|NCT01408745|medical device|medical device
505605|NCT01408745|sternal closure|sternal closure
505606|NCT01408745|sternotomy|sternotomy
505607|NCT01408745|dehiscence|dehiscence
505608|NCT01408745|sternal wound healing|sternal wound healing
505609|NCT01408745|randomized trial|randomized trial
505610|NCT01408745|steel wire|steel wire
505611|NCT01408732|Epistaxis|epistaxis
711342|NCT00585195|c-Met exon 14 deletion|c-met exon 14 deletion
505612|NCT01408732|Hereditary Hemorrhagic Telangiectasia|hereditary hemorrhagic telangiectasia
505613|NCT01408732|HHT|hht
505614|NCT01408732|Sclerotherapy|sclerotherapy
505615|NCT01408732|Epistaxis (nosebleeds) due to Hereditary Hemorrhagic Telangiectasia|epistaxis (nosebleeds) due to hereditary hemorrhagic telangiectasia
505616|NCT01408719|Beta-Glucan|beta-glucan
505617|NCT01408719|Barley|barley
505618|NCT01408719|Molecular Weight|molecular weight
505619|NCT01408719|Viscosity|viscosity
505620|NCT01408719|Cholesterol|cholesterol
505621|NCT01408719|Stable isotope|stable isotope
505622|NCT01408719|Gene-nutrient interaction|gene-nutrient interaction
505623|NCT01408719|Gut microbiota|gut microbiota
505624|NCT01408693|hip fracture|hip fracture
505625|NCT01408693|hemiarthroplasty|hemiarthroplasty
505626|NCT01408693|endoprosthesis|endoprosthesis
505627|NCT01408693|elderly|elderly
505628|NCT01408693|minimally invasive surgery|minimally invasive surgery
505629|NCT01408693|anterior approach|anterior approach
505630|NCT01408693|geriatric patients|geriatric patients
505631|NCT01408680|End-stage Renal Disease|end-stage renal disease
505632|NCT01408680|Hemodialysis|hemodialysis
505633|NCT01408680|Cardiovascular Disease|cardiovascular disease
505634|NCT01408680|Antioxidants|antioxidants
505635|NCT01408680|Atherosclerosis|atherosclerosis
505636|NCT01408680|Coenzyme Q10|coenzyme q10
505637|NCT01408667|insulin sensitivity|insulin sensitivity
505638|NCT01408667|cardiometabolic risk|cardiometabolic risk
505639|NCT01408667|hyperinsulinemic euglycemic clamp|hyperinsulinemic euglycemic clamp
505640|NCT01408654|Suicidal Ideation|suicidal ideation
505641|NCT01408654|Loneliness|loneliness
505642|NCT01408654|Social Support|social support
505643|NCT01408654|Voluntary Workers|voluntary workers
505644|NCT01408654|Friends/Companions|friends/companions
505645|NCT01408654|Prevention|prevention
505646|NCT01408654|Aged|aged
505647|NCT01408641|topiramate|topiramate
505648|NCT01408641|PTSD|ptsd
505649|NCT01408641|drinking|drinking
505650|NCT01408641|alcohol|alcohol
505651|NCT01408602|Rheumatoid Arthritis|rheumatoid arthritis
505652|NCT01408589|alcohol|alcohol
505653|NCT01408589|craving|craving
505654|NCT01408589|mood|mood
505655|NCT01408589|optimum dose of atomoxetine|optimum dose of atomoxetine
505656|NCT01408576|Lupus|lupus
505657|NCT01408576|Monoclonal antibody|monoclonal antibody
505658|NCT01408576|B-Cell immunotherapy|b-cell immunotherapy
505659|NCT01408576|Epratuzumab|epratuzumab
505661|NCT01408563|lymphoma|lymphoma
505662|NCT01408563|leukemia|leukemia
505663|NCT01408563|myelodysplastic disorder|myelodysplastic disorder
505664|NCT01408563|aplastic anemia|aplastic anemia
505665|NCT01408550|IVIG in pemphigoid|ivig in pemphigoid
505666|NCT01408550|Patients with bullous pemphigoid unresponsive to corticosteroids|patients with bullous pemphigoid unresponsive to corticosteroids
505667|NCT01408537|inactivated Japanese encephalitis vaccine|inactivated japanese encephalitis vaccine
505668|NCT01408537|vero cell|vero cell
505669|NCT01408537|children|children
505670|NCT01408537|immunogenicity|immunogenicity
505671|NCT01408537|safety|safety
505672|NCT01408524|Hypertension|hypertension
505673|NCT01408524|emergence|emergence
505674|NCT01408524|craniotomy|craniotomy
505675|NCT01408524|Hypertension during the emergence after craniotomy|hypertension during the emergence after craniotomy
505676|NCT01408498|Testosterone|testosterone
505677|NCT01408498|Social psychology|social psychology
505678|NCT01408498|Human behavior|human behavior
505679|NCT01408459|Prostate cancer prevention|prostate cancer prevention
505680|NCT01408446|Hypertension|hypertension
505681|NCT01408446|Menthol|menthol
505682|NCT01408446|Metabolism|metabolism
505683|NCT01408433|embryo transfer|embryo transfer
505684|NCT01408433|in-vitro fertilization (IVF)|in-vitro fertilization (ivf)
505685|NCT01408433|pre-implantation diagnosis (PGD)|pre-implantation diagnosis (pgd)
505686|NCT01408433|infertility|infertility
505687|NCT01408433|single embryo transfer|single embryo transfer
505688|NCT01408433|two embryo transfer|two embryo transfer
505689|NCT01408433|double embryo transfer|double embryo transfer
505690|NCT01408420|Renal insufficiency|renal insufficiency
505691|NCT01408420|Acute Kidney Injury|acute kidney injury
505692|NCT01408420|Postoperative|postoperative
505693|NCT01408420|Extracorporeal Circulation|extracorporeal circulation
505694|NCT01408420|Heart surgery|heart surgery
505695|NCT01408407|Patients with anal canal, low rectal or gynecological cancer|patients with anal canal, low rectal or gynecological cancer
505696|NCT01408394|safety|safety
505697|NCT01408394|pharmacokinetics|pharmacokinetics
505698|NCT01408394|controlled release|controlled release
505699|NCT01408394|formulation|formulation
505700|NCT01408381|Critical Limb Ischemia (CLI)|critical limb ischemia (cli)
505701|NCT01408381|Cell Therapy|cell therapy
505702|NCT01408381|Bone marrow mononuclear cells|bone marrow mononuclear cells
505703|NCT01408368|Graves' disease|graves' disease
505704|NCT01408368|total thyroidectomy|total thyroidectomy
505705|NCT01408368|bilateral subtotal thyroidectomy|bilateral subtotal thyroidectomy
505706|NCT01408368|Graves' ophthalmopathy|graves' ophthalmopathy
505707|NCT01408368|morbidity rate|morbidity rate
505708|NCT01408342|Alemtuzumab|alemtuzumab
505709|NCT01408342|Rituximab|rituximab
505710|NCT01408342|Aplastic anemia|aplastic anemia
505711|NCT01408342|cyclosporine|cyclosporine
505712|NCT01408316|Healthy Volunteer|healthy volunteer
505713|NCT01408316|PX-866|px-866
505714|NCT01408316|PI3K Inhibitor|pi3k inhibitor
505715|NCT01408303|dyslipidemia|dyslipidemia
505716|NCT01408303|hyperlipidemia|hyperlipidemia
505717|NCT01408303|cardiovascular risk|cardiovascular risk
505718|NCT01408290|seasonal|seasonal
505719|NCT01408290|prevention|prevention
505720|NCT01408290|influenza|influenza
505721|NCT01408290|infection|infection
505722|NCT01408290|influenza vaccine|influenza vaccine
505723|NCT01408290|vaccine|vaccine
505724|NCT01408290|influenza in humans|influenza in humans
505725|NCT01408277|Diabetic Foot Ulcers|diabetic foot ulcers
505726|NCT01408277|Diabetic Foot Wounds|diabetic foot wounds
505727|NCT01408238|Immunotherapy|immunotherapy
505728|NCT01408238|Skin prick test|skin prick test
505729|NCT01408238|Standardization|standardization
505730|NCT01408238|Secale cereale|secale cereale
505731|NCT01408225|MGUS|mgus
505732|NCT01408225|Multiple Myeloma|multiple myeloma
505733|NCT01408225|Tissue Bank|tissue bank
505734|NCT01408199|Lenalidomide|lenalidomide
505735|NCT01408199|Refractory Cutaneous Lupus|refractory cutaneous lupus
505736|NCT01408186|aspirin|aspirin
505737|NCT01408186|PPI|ppi
505738|NCT01408186|H2RA|h2ra
505739|NCT01408173|caffeine|caffeine
505740|NCT01408173|apnea|apnea
505741|NCT01408173|prematurity|prematurity
505742|NCT01408147|Postpartum weight retention|postpartum weight retention
505743|NCT01408147|Low income women|low income women
505744|NCT01408147|WIC|wic
505745|NCT01408147|Online|online
505746|NCT01408134|Inter-reader variability of myocardial viability imaging|inter-reader variability of myocardial viability imaging
505747|NCT01408121|Platelet reactivity|platelet reactivity
505748|NCT01408121|Genotyping|genotyping
505749|NCT01408108|Hiatal hernia|hiatal hernia
505750|NCT01408108|Gastro-oesophageal reflux disease|gastro-oesophageal reflux disease
505751|NCT01408108|Laparoscopic hiatal repair|laparoscopic hiatal repair
505752|NCT01408108|Laparoscopic anti-reflux surgery|laparoscopic anti-reflux surgery
505753|NCT01408108|Partially absorbable lightweight mesh|partially absorbable lightweight mesh
505754|NCT01408095|diabetes|diabetes
505755|NCT01408095|glimepiride|glimepiride
505756|NCT01408095|diabetes type II|diabetes type ii
505757|NCT01408095|diabetes type 2|diabetes type 2
505758|NCT01408095|Type 2 diabetes|type 2 diabetes
505759|NCT01408095|diabetes mellitus|diabetes mellitus
505760|NCT01408069|headache|headache
505761|NCT01408069|migraine|migraine
505762|NCT01408056|Hemangioma|hemangioma
505763|NCT01408056|Infantile Hemangioma|infantile hemangioma
505764|NCT01408056|Ulcerated Hemangioma|ulcerated hemangioma
505766|NCT01408056|Beta blocker|beta blocker
505767|NCT01408056|Vascular anomaly|vascular anomaly
505768|NCT01408030|epistaxis|epistaxis
505769|NCT01408030|HHT|hht
505770|NCT01408030|bevacizumab|bevacizumab
505771|NCT01408030|tranexamic acid|tranexamic acid
505772|NCT01408030|nosebleed|nosebleed
505773|NCT01408030|estrogen|estrogen
505774|NCT01408004|Renal carcinoma|renal carcinoma
505775|NCT01408004|Resistance|resistance
505776|NCT01408004|Reversible|reversible
505777|NCT01408004|Translational|translational
505778|NCT01407991|Enteral tube placement|enteral tube placement
505779|NCT01407978|Influenza|influenza
505780|NCT01407978|Pandemic vaccine|pandemic vaccine
505781|NCT01407978|Seasonal vaccine|seasonal vaccine
505782|NCT01407978|Prevention|prevention
505783|NCT01407978|Influenza vaccine|influenza vaccine
505784|NCT01407978|Influenza in humans|influenza in humans
505785|NCT01407978|Pandemic influenza in humans|pandemic influenza in humans
505786|NCT01407978|Influenza vaccine for children|influenza vaccine for children
505787|NCT01407978|Influenza vaccine for adolescents|influenza vaccine for adolescents
505788|NCT01407978|Seasonal vaccine for children|seasonal vaccine for children
505789|NCT01407978|Seasonal vaccine for adolescents|seasonal vaccine for adolescents
505790|NCT01407965|obesity|obesity
505791|NCT01407965|pharmacokinetic|pharmacokinetic
505792|NCT01407965|ertapenem|ertapenem
505793|NCT01407965|meropenem|meropenem
505794|NCT01407952|treatment trial|treatment trial
505795|NCT01407952|cerebral aneurysm|cerebral aneurysm
505796|NCT01407952|randomized|randomized
505797|NCT01407952|coils|coils
505798|NCT01407952|endovascular|endovascular
505799|NCT01407952|HEAT|heat
505800|NCT01407952|bare platinum|bare platinum
505801|NCT01407952|Hydrogel|hydrogel
505802|NCT01407952|Hydrocoil|hydrocoil
505803|NCT01407939|Bitter Taste|bitter taste
505804|NCT01407939|Bitter Blockers|bitter blockers
505805|NCT01407939|Pediatric Medications|pediatric medications
505806|NCT01407939|Sensory methodology|sensory methodology
505807|NCT01407939|Children|children
505808|NCT01407926|Depression|depression
505809|NCT01407926|Aging|aging
505810|NCT01407926|Clinical Effectiveness|clinical effectiveness
505811|NCT01407926|Home Care|home care
505812|NCT01407926|Nurse-Led|nurse-led
505813|NCT01407900|CD NP|cd np
505814|NCT01407900|dual receptor|dual receptor
505815|NCT01407900|NPR A|npr a
505816|NCT01407900|NPR B|npr b
505817|NCT01407900|Adult, aged over 45|adult, aged over 45
505818|NCT01407887|children|children
505819|NCT01407874|Gout|gout
505820|NCT01407874|Hyperuricemia|hyperuricemia
505821|NCT01407874|Arthritis|arthritis
505822|NCT01407874|Joint Disease|joint disease
505823|NCT01407874|Allopurinol|allopurinol
505824|NCT01407874|Renal Insufficiency|renal insufficiency
505825|NCT01407835|Immunotherapy|immunotherapy
505826|NCT01407835|Skin prick test|skin prick test
505827|NCT01407835|Standardization|standardization
505828|NCT01407835|Dactylis glomerata|dactylis glomerata
505829|NCT01407822|Lung cancer|lung cancer
505830|NCT01407822|IIIA-N2|iiia-n2
505831|NCT01407822|Neo-adjuvant treatment|neo-adjuvant treatment
505832|NCT01407822|EGFR mutations|egfr mutations
505833|NCT01407822|Tyrosine kinase inhibitor|tyrosine kinase inhibitor
505834|NCT01407796|lung inflammation|lung inflammation
506104|NCT01406860|Migraines|migraines
505835|NCT01407796|positron emission tomography (PET)|positron emission tomography (pet)
505836|NCT01407796|fluorodeoxyglucose (FDG)|fluorodeoxyglucose (fdg)
505837|NCT01407796|inducible nitric oxide synthase (iNOS)|inducible nitric oxide synthase (inos)
505838|NCT01407796|lung anti-inflammatory therapy|lung anti-inflammatory therapy
505839|NCT01407783|Post-partum depression|post-partum depression
505840|NCT01407783|Low-income mothers|low-income mothers
505841|NCT01407783|home nurse visitation|home nurse visitation
505842|NCT01407770|radiation toxicity|radiation toxicity
505843|NCT01407770|skin reactions secondary to radiation therapy|skin reactions secondary to radiation therapy
505844|NCT01407770|pain|pain
505845|NCT01407770|fatigue|fatigue
505846|NCT01407770|psychosocial effects of cancer and its treatment|psychosocial effects of cancer and its treatment
505847|NCT01407770|depression|depression
505848|NCT01407770|cognitive/functional effects|cognitive/functional effects
505849|NCT01407770|stage IA breast cancer|stage ia breast cancer
505850|NCT01407770|stage IB breast cancer|stage ib breast cancer
505851|NCT01407770|stage II breast cancer|stage ii breast cancer
505852|NCT01407770|stage IIIA breast cancer|stage iiia breast cancer
505853|NCT01407770|ductal breast carcinoma in situ|ductal breast carcinoma in situ
505854|NCT01407757|adult acute myeloid leukemia with 11q23 (MLL) abnormalities|adult acute myeloid leukemia with 11q23 (mll) abnormalities
505855|NCT01407757|adult acute myeloid leukemia with del(5q)|adult acute myeloid leukemia with del(5q)
505856|NCT01407757|adult acute myeloid leukemia with inv(16)(p13;q22)|adult acute myeloid leukemia with inv(16)(p13;q22)
505857|NCT01407757|adult acute myeloid leukemia with t(16;16)(p13;q22)|adult acute myeloid leukemia with t(16;16)(p13;q22)
505858|NCT01407757|adult acute myeloid leukemia with t(8;21)(q22;q22)|adult acute myeloid leukemia with t(8;21)(q22;q22)
505859|NCT01407757|untreated adult acute myeloid leukemia|untreated adult acute myeloid leukemia
505860|NCT01407757|untreated childhood acute myeloid leukemia and other myeloid malignancies|untreated childhood acute myeloid leukemia and other myeloid malignancies
505861|NCT01407757|adult acute basophilic leukemia|adult acute basophilic leukemia
505862|NCT01407757|childhood acute basophilic leukemia|childhood acute basophilic leukemia
505863|NCT01407757|adult acute eosinophilic leukemia|adult acute eosinophilic leukemia
505864|NCT01407757|childhood acute eosinophilic leukemia|childhood acute eosinophilic leukemia
505865|NCT01407757|adult acute myeloblastic leukemia without maturation (M1)|adult acute myeloblastic leukemia without maturation (m1)
505866|NCT01407757|childhood acute myeloblastic leukemia without maturation (M1)|childhood acute myeloblastic leukemia without maturation (m1)
505867|NCT01407757|adult acute minimally differentiated myeloid leukemia (M0)|adult acute minimally differentiated myeloid leukemia (m0)
505868|NCT01407757|childhood acute minimally differentiated myeloid leukemia (M0)|childhood acute minimally differentiated myeloid leukemia (m0)
505869|NCT01407757|adult acute myeloblastic leukemia with maturation (M2)|adult acute myeloblastic leukemia with maturation (m2)
505870|NCT01407757|childhood acute myeloblastic leukemia with maturation (M2)|childhood acute myeloblastic leukemia with maturation (m2)
505871|NCT01407757|adult acute myelomonocytic leukemia (M4)|adult acute myelomonocytic leukemia (m4)
505872|NCT01407757|childhood acute myelomonocytic leukemia (M4)|childhood acute myelomonocytic leukemia (m4)
505873|NCT01407757|adult acute monoblastic leukemia (M5a)|adult acute monoblastic leukemia (m5a)
505874|NCT01407757|adult acute monocytic leukemia (M5b)|adult acute monocytic leukemia (m5b)
505875|NCT01407757|childhood acute monoblastic leukemia (M5a)|childhood acute monoblastic leukemia (m5a)
505876|NCT01407757|childhood acute monocytic leukemia (M5b)|childhood acute monocytic leukemia (m5b)
505877|NCT01407757|adult erythroleukemia (M6a)|adult erythroleukemia (m6a)
505878|NCT01407757|adult pure erythroid leukemia (M6b)|adult pure erythroid leukemia (m6b)
505879|NCT01407757|childhood acute erythroleukemia (M6)|childhood acute erythroleukemia (m6)
505880|NCT01407757|adult acute megakaryoblastic leukemia (M7)|adult acute megakaryoblastic leukemia (m7)
505881|NCT01407757|childhood acute megakaryocytic leukemia (M7)|childhood acute megakaryocytic leukemia (m7)
505882|NCT01407757|recurrent adult acute myeloid leukemia|recurrent adult acute myeloid leukemia
505883|NCT01407757|recurrent childhood acute myeloid leukemia|recurrent childhood acute myeloid leukemia
505884|NCT01407731|disseminated neuroblastoma|disseminated neuroblastoma
505885|NCT01407731|localized resectable neuroblastoma|localized resectable neuroblastoma
505886|NCT01407731|localized unresectable neuroblastoma|localized unresectable neuroblastoma
505887|NCT01407731|stage 4S neuroblastoma|stage 4s neuroblastoma
505888|NCT01407718|Knee pain|knee pain
505889|NCT01407718|tibial nailing|tibial nailing
505890|NCT01407705|spinal cord injury with traumatic event|spinal cord injury with traumatic event
505891|NCT01407692|menstrual cycle|menstrual cycle
505892|NCT01407692|estrogen|estrogen
505893|NCT01407679|cutaneous lupus erythematosus|cutaneous lupus erythematosus
505894|NCT01407679|discoid lupus erythematosus|discoid lupus erythematosus
505895|NCT01407679|subacute cutaneous lupus erythematosus|subacute cutaneous lupus erythematosus
505896|NCT01407679|lupus erythematosus tumidus|lupus erythematosus tumidus
505897|NCT01407666|paravertebral block|paravertebral block
505898|NCT01407666|epidural block|epidural block
505899|NCT01407666|pain management|pain management
505900|NCT01407666|liver resection|liver resection
505901|NCT01407666|comparison|comparison
505902|NCT01407653|Low back pain|low back pain
505903|NCT01407653|virtual reality|virtual reality
505904|NCT01407640|Insulin allergy|insulin allergy
505905|NCT01407640|adverse drug reaction|adverse drug reaction
505906|NCT01407640|diabetes|diabetes
506518|NCT01405157|tablets|tablets
505907|NCT01407640|type 1 hypersensitivity|type 1 hypersensitivity
505908|NCT01407640|immediate hypersensitivity|immediate hypersensitivity
505909|NCT01407640|type 4 hypersensitivity|type 4 hypersensitivity
505910|NCT01407640|insulin analogs|insulin analogs
505911|NCT01407640|intradermal testing|intradermal testing
505912|NCT01407640|insulin antibody|insulin antibody
505913|NCT01407640|mast cell|mast cell
505914|NCT01407640|CD+ TCELL|cd+ tcell
505916|NCT01407627|fructose|fructose
505917|NCT01407627|dextrose|dextrose
505918|NCT01407627|renin angiotensin system|renin angiotensin system
505919|NCT01407627|kidney|kidney
505920|NCT01407627|renal hemodynamics|renal hemodynamics
505921|NCT01407614|Subarachnoid hemorrhage|subarachnoid hemorrhage
505922|NCT01407614|delayed cerebral ischemia|delayed cerebral ischemia
505923|NCT01407614|external lumbar drainage|external lumbar drainage
505924|NCT01407614|vasospasm|vasospasm
505925|NCT01407601|vitamin K|vitamin k
505926|NCT01407601|MK-7|mk-7
505927|NCT01407601|Hemodialysis|hemodialysis
505928|NCT01407601|vascular calcification|vascular calcification
505929|NCT01407601|Matrix Gla protein|matrix gla protein
505930|NCT01407601|Osteocalcin|osteocalcin
505931|NCT01407588|Atrial fibrillation|atrial fibrillation
505932|NCT01407588|Ablation|ablation
505933|NCT01407575|Buprenorphine|buprenorphine
505934|NCT01407575|Receptors, opioid|receptors, opioid
505935|NCT01407575|Receptors, opioid, kappa|receptors, opioid, kappa
505936|NCT01407536|Stroke|stroke
505937|NCT01407536|Thermal Stimulation|thermal stimulation
505938|NCT01407536|Upper Extremity|upper extremity
505939|NCT01407536|Motor Recovery|motor recovery
505940|NCT01407536|Transcranial Magnetic Stimulation|transcranial magnetic stimulation
505941|NCT01407523|Levetiracetam|levetiracetam
505942|NCT01407523|Infusion|infusion
505943|NCT01407523|Epilepsy|epilepsy
505944|NCT01407523|Partial Onset Seizures|partial onset seizures
505945|NCT01407497|HIV|hiv
505946|NCT01407497|Vaccine|vaccine
505947|NCT01407497|DNA|dna
505948|NCT01407497|Prevention|prevention
505949|NCT01407484|Infertility|infertility
505950|NCT01407484|Assisted reproductive technology|assisted reproductive technology
505951|NCT01407484|Double blind therapeutical trial|double blind therapeutical trial
505952|NCT01407484|Multicentric study|multicentric study
505953|NCT01407484|Prospective randomized study|prospective randomized study
505954|NCT01407471|aldosterone|aldosterone
505955|NCT01407471|clobetasol|clobetasol
505956|NCT01407471|atrophy|atrophy
505957|NCT01407471|skin|skin
505958|NCT01407471|epidermis|epidermis
505959|NCT01407471|wound healing|wound healing
505960|NCT01407471|mineral corticoid receptor|mineral corticoid receptor
505961|NCT01407471|spironolactone|spironolactone
505962|NCT01407445|Menopause|menopause
505963|NCT01407445|Sexual dysfunction|sexual dysfunction
505964|NCT01407445|Tribulus|tribulus
505965|NCT01407445|Sexuality|sexuality
505966|NCT01407445|Phytotherapeutic Drugs|phytotherapeutic drugs
505967|NCT01407432|Male infertility|male infertility
505968|NCT01407432|folic acid|folic acid
505969|NCT01407432|in VITRO fertilization|in vitro fertilization
505970|NCT01407432|sperm parameters|sperm parameters
505971|NCT01407432|MTHFR genotype|mthfr genotype
505972|NCT01407419|Rheumatoid Arthritis|rheumatoid arthritis
505973|NCT01407393|overweight|overweight
505974|NCT01407393|obesity|obesity
505975|NCT01407393|weight loss|weight loss
505976|NCT01407393|body fat|body fat
505977|NCT01407393|waste cirumference|waste cirumference
505978|NCT01407393|satiety|satiety
505979|NCT01407393|appetite|appetite
505980|NCT01407380|Advanced malignancies|advanced malignancies
505981|NCT01407380|solid tumors|solid tumors
505982|NCT01407380|cancer|cancer
505983|NCT01407367|patient safety|patient safety
505984|NCT01407367|chronic kidney disease|chronic kidney disease
505985|NCT01407367|medical errors|medical errors
505986|NCT01407354|robotic weight support|robotic weight support
505987|NCT01407354|aquatic exercise|aquatic exercise
505988|NCT01407354|incomplete motor spinal cord injury|incomplete motor spinal cord injury
505989|NCT01407354|ASIA C and D|asia c and d
505990|NCT01407328|shoulder arthroscopic surgery|shoulder arthroscopic surgery
505991|NCT01407328|respiratory discomfort|respiratory discomfort
505992|NCT01407328|airway obstruction|airway obstruction
505993|NCT01407328|restrictive pathology|restrictive pathology
505994|NCT01407328|diaphragm palsy|diaphragm palsy
505995|NCT01407315|Continuous subcutaneous glucose monitoring|continuous subcutaneous glucose monitoring
505996|NCT01407315|Type 1 Diabetes|type 1 diabetes
505997|NCT01407302|Laryngeal mask airway|laryngeal mask airway
505998|NCT01407302|internal jugular vein cannulation|internal jugular vein cannulation
505999|NCT01407263|radical prostatectomy|radical prostatectomy
506000|NCT01407263|anastomotic suturing|anastomotic suturing
506001|NCT01407263|lymph node dissection|lymph node dissection
506002|NCT01407263|11-096|11-096
506003|NCT01407237|HIV-infection|hiv-infection
506004|NCT01407237|renin|renin
506005|NCT01407237|aldosterone|aldosterone
506006|NCT01407237|visceral fat|visceral fat
506007|NCT01407224|Exclusive Breastfeeding|exclusive breastfeeding
506008|NCT01407224|Skin to skin contact|skin to skin contact
506009|NCT01407224|Cord Clumping|cord clumping
506010|NCT01407224|Prelactial feeding|prelactial feeding
506011|NCT01407211|multiple sclerosis|multiple sclerosis
506012|NCT01407211|Myelin Oligodendrocyte Glycoprotein(MOG)|myelin oligodendrocyte glycoprotein(mog)
506013|NCT01407211|Vitamin A|vitamin a
506014|NCT01407211|CD4-Positive T-Lymphocytes|cd4-positive t-lymphocytes
506015|NCT01407211|gene expression|gene expression
506016|NCT01407211|Th1 Cells|th1 cells
506017|NCT01407211|Th2 Cells|th2 cells
506018|NCT01407198|High Risk Chordoma|high risk chordoma
506019|NCT01407185|heart failure|heart failure
506020|NCT01407185|quality of life|quality of life
506021|NCT01407185|fall prevention|fall prevention
506022|NCT01407185|endurance|endurance
506023|NCT01407185|resistive training|resistive training
506024|NCT01407172|PAD|pad
506025|NCT01407172|Peripheral arterial disease|peripheral arterial disease
506026|NCT01407172|Hydrogen Sulfide|hydrogen sulfide
506027|NCT01407172|Gasotransmitter|gasotransmitter
506028|NCT01407159|type b dissection|type b dissection
506029|NCT01407159|thoracic stentgraft|thoracic stentgraft
506030|NCT01407159|aortic stent|aortic stent
506031|NCT01407159|clinical and technical success|clinical and technical success
506032|NCT01407159|safety and feasibility of E-XL aortic stent|safety and feasibility of e-xl aortic stent
506033|NCT01407146|acute myocardial infarction|acute myocardial infarction
506034|NCT01407146|care-seeking behavior|care-seeking behavior
506035|NCT01407146|acute coronary syndrome|acute coronary syndrome
506036|NCT01407146|care-seeking delay|care-seeking delay
506037|NCT01407146|cardiac delay|cardiac delay
506038|NCT01407146|prehospital delay|prehospital delay
506039|NCT01407146|acute myocardial infarction & PTSD|acute myocardial infarction & ptsd
506040|NCT01407146|help seeking behaviors|help seeking behaviors
506041|NCT01407146|seeking treatment|seeking treatment
506042|NCT01407146|cardiac patients|cardiac patients
506043|NCT01407146|decision time|decision time
506044|NCT01407133|Neuro-otology|neuro-otology
506045|NCT01407133|Chronic tinnitus|chronic tinnitus
506046|NCT01407133|Sensory disability|sensory disability
506047|NCT01407133|Repetitive transcranial magnetic stimulation|repetitive transcranial magnetic stimulation
506048|NCT01407133|Dose escalation|dose escalation
506049|NCT01407120|Prevention|prevention
506050|NCT01407120|Divorce|divorce
506051|NCT01407107|nitroglycerin|nitroglycerin
506052|NCT01407107|5-flourouracil|5-flourouracil
506053|NCT01407107|radiation therapy|radiation therapy
506054|NCT01407107|neo-adjuvant treatment|neo-adjuvant treatment
506055|NCT01407094|Depression, Major Depressive Disorder, Mood Disorder|depression, major depressive disorder, mood disorder
506056|NCT01407081|cognitive rehabilitation|cognitive rehabilitation
506057|NCT01407081|SMART goals|smart goals
506058|NCT01407081|telehealth|telehealth
506059|NCT01407055|Coronary Artery Bypass Graft Surgery (CABG)|coronary artery bypass graft surgery (cabg)
506060|NCT01407055|Patients' Expectations|patients' expectations
506061|NCT01407055|Coronary Heart Disease|coronary heart disease
506062|NCT01407055|Illness Perception Intervention|illness perception intervention
506063|NCT01407055|Randomized Controlled Trial|randomized controlled trial
506064|NCT01407042|unicondylar knee arthroplasty|unicondylar knee arthroplasty
506065|NCT01407042|mobile-bearing|mobile-bearing
506066|NCT01407042|patellofemoral pain|patellofemoral pain
506067|NCT01407016|metronidazole infusion|metronidazole infusion
506068|NCT01407003|T2DM, blood glucose, OGTT, LIK066|t2dm, blood glucose, ogtt, lik066
506069|NCT01406990|aspirin resistance|aspirin resistance
506070|NCT01406990|hyporesponsive|hyporesponsive
506071|NCT01406990|CAD|cad
506072|NCT01406990|women|women
506073|NCT01406977|Hypophosphatasia|hypophosphatasia
506074|NCT01406977|HPP|hpp
506075|NCT01406977|Rathbun's disease|rathbun's disease
506076|NCT01406964|Chlamidia Antibody test, Hysterosalpyngography, Tubal disease|chlamidia antibody test, hysterosalpyngography, tubal disease
506077|NCT01406951|sTREM-1|strem-1
506078|NCT01406951|PCT|pct
506079|NCT01406951|CPIS|cpis
506080|NCT01406951|VAP|vap
506081|NCT01406951|EVC|evc
506082|NCT01406951|diagnosis|diagnosis
506083|NCT01406951|prognosis|prognosis
506084|NCT01406938|Psoriasis|psoriasis
506085|NCT01406938|plaque|plaque
506086|NCT01406938|inflammatory skin disease|inflammatory skin disease
506087|NCT01406938|scaly patches|scaly patches
506088|NCT01406938|AIN457|ain457
506089|NCT01406938|secukinumab|secukinumab
506090|NCT01406938|Moderate to Severe Plaque-type Psoriasis|moderate to severe plaque-type psoriasis
506091|NCT01406912|Stroke Rehabilitation|stroke rehabilitation
506092|NCT01406912|Ischemic Stroke|ischemic stroke
506093|NCT01406912|Virtual Reality|virtual reality
506094|NCT01406912|Nintendo Wii|nintendo wii
506095|NCT01406912|Recreational Activity|recreational activity
506096|NCT01406912|Motor Function|motor function
506097|NCT01406886|Modifiable environmental|modifiable environmental
506098|NCT01406886|behavioral factors|behavioral factors
506099|NCT01406873|Myotonic Dystrophy|myotonic dystrophy
506100|NCT01406873|Myotonic Dystrophy Type 1 (DM1)|myotonic dystrophy type 1 (dm1)
506101|NCT01406873|Muscular Dystrophy|muscular dystrophy
506102|NCT01406873|Mexiletine|mexiletine
506103|NCT01406860|Headaches|headaches
506105|NCT01406860|Tension headaches|tension headaches
506106|NCT01406860|Cluster headaches|cluster headaches
506107|NCT01406847|Spinal Manipulation|spinal manipulation
506108|NCT01406847|Body-based intervention|body-based intervention
506109|NCT01406847|Experimental pain|experimental pain
506110|NCT01406834|PTSD|ptsd
506111|NCT01406834|Veterans|veterans
506112|NCT01406834|Killing|killing
506113|NCT01406834|Military|military
506115|NCT01406821|platelet-rich-plasma|platelet-rich-plasma
506116|NCT01406821|platelet|platelet
506117|NCT01406821|tendinosis|tendinosis
506118|NCT01406821|tendinitis|tendinitis
506119|NCT01406821|tendonitis|tendonitis
506120|NCT01406821|tendinopathy|tendinopathy
506121|NCT01406821|enthesopathy|enthesopathy
506122|NCT01406821|muscle|muscle
506123|NCT01406821|sport|sport
506124|NCT01406821|tendon|tendon
506125|NCT01406821|patella|patella
506126|NCT01406821|patellar tendon|patellar tendon
506127|NCT01406808|genetic|genetic
506128|NCT01406808|atherosclerosis|atherosclerosis
506129|NCT01406808|myocardial infarction|myocardial infarction
506130|NCT01406808|risk|risk
506131|NCT01406808|preventive cardiology|preventive cardiology
506132|NCT01406795|Post Thrombotic Syndrome|post thrombotic syndrome
506133|NCT01406795|Venous Stasis|venous stasis
506134|NCT01406795|Venous Occlusions|venous occlusions
506135|NCT01406795|Venous Stenosis|venous stenosis
506136|NCT01406782|stage III grade 1 follicular lymphoma|stage iii grade 1 follicular lymphoma
506137|NCT01406782|stage III grade 2 follicular lymphoma|stage iii grade 2 follicular lymphoma
506138|NCT01406782|stage IV grade 1 follicular lymphoma|stage iv grade 1 follicular lymphoma
506139|NCT01406782|stage IV grade 2 follicular lymphoma|stage iv grade 2 follicular lymphoma
506140|NCT01406743|Spine and pelvis parameters|spine and pelvis parameters
506141|NCT01406743|Sagittal balance|sagittal balance
506142|NCT01406743|Database|database
506143|NCT01406730|running exercise|running exercise
506144|NCT01406730|cardiac hypertrophy|cardiac hypertrophy
506145|NCT01406730|blood|blood
506146|NCT01406730|maximum oxygen uptake|maximum oxygen uptake
506147|NCT01406730|intervention|intervention
506148|NCT01406730|untrained|untrained
506149|NCT01406730|males|males
506150|NCT01406717|SPIL1033|spil1033
506151|NCT01406717|type 2 diabetes mellitus|type 2 diabetes mellitus
506152|NCT01406691|sleep|sleep
506153|NCT01406691|delayed sleep phase disorder|delayed sleep phase disorder
506154|NCT01406691|circadian|circadian
506155|NCT01406691|teen|teen
506156|NCT01406691|adolescent|adolescent
506157|NCT01406678|remote ischemic preconditioning|remote ischemic preconditioning
506158|NCT01406678|coronary artery bypass grafting|coronary artery bypass grafting
506159|NCT01406678|myocardial injury|myocardial injury
506160|NCT01406665|diabetes|diabetes
506161|NCT01406665|impaired glucose tolerance|impaired glucose tolerance
506162|NCT01406652|septic bursitis|septic bursitis
506163|NCT01406652|bursectomy|bursectomy
506164|NCT01406652|primary closure|primary closure
506165|NCT01406639|Hereditary Hemorrhagic Telangiectasia (HHT)|hereditary hemorrhagic telangiectasia (hht)
506166|NCT01406639|Nosebleeds|nosebleeds
506167|NCT01406639|Ranibizumab|ranibizumab
506168|NCT01406639|Lucentis|lucentis
506169|NCT01406626|HIV|hiv
506170|NCT01406626|AIDS|aids
506171|NCT01406626|Health navigation|health navigation
506172|NCT01406626|Viral load|viral load
506173|NCT01406626|Corrections|corrections
506174|NCT01406613|Observational|observational
506175|NCT01406613|Bone Density|bone density
506176|NCT01406613|alendronate|alendronate
506177|NCT01406613|ibandronate|ibandronate
506178|NCT01406613|risedronate|risedronate
506179|NCT01406613|postmenopausal|postmenopausal
506180|NCT01406613|osteoporosis|osteoporosis
506181|NCT01406600|recombinant hCG|recombinant hcg
506182|NCT01406600|poor responder|poor responder
506183|NCT01406600|oocyte maturity|oocyte maturity
506184|NCT01406587|Burning|burning
506185|NCT01406587|Dysuria|dysuria
506186|NCT01406587|Frequency|frequency
506187|NCT01406587|Pain|pain
506188|NCT01406587|Uncomplicated Urinary Tract Infection|uncomplicated urinary tract infection
506189|NCT01406587|Uncomplicated UTI|uncomplicated uti
506190|NCT01406587|Urinary Tract Infection|urinary tract infection
506191|NCT01406587|UTI|uti
506192|NCT01406587|Burning during urination associated with uncomplicated urinary tract infection|burning during urination associated with uncomplicated urinary tract infection
506193|NCT01406587|Urination frequency associated with uncomplicated urinary tract infection|urination frequency associated with uncomplicated urinary tract infection
506194|NCT01406587|Pain associated with uncomplicated urinary tract infection|pain associated with uncomplicated urinary tract infection
506195|NCT01406574|Hepatocellular carcinoma|hepatocellular carcinoma
506196|NCT01406561|Meniscectomy|meniscectomy
506197|NCT01406561|Knee Pain|knee pain
506198|NCT01406561|Postoperative Pain|postoperative pain
506199|NCT01406548|Osteopenia|osteopenia
506200|NCT01406548|osteoporosis|osteoporosis
506201|NCT01406548|low bone mineral density|low bone mineral density
506202|NCT01406535|Phosphodiesterase 5 inhibition|phosphodiesterase 5 inhibition
506203|NCT01406535|myocardial perfusion|myocardial perfusion
506204|NCT01406535|angiogenesis|angiogenesis
506205|NCT01406535|coronary artery disease|coronary artery disease
506206|NCT01406535|therapy refractory|therapy refractory
506207|NCT01406522|Acetylcholine|acetylcholine
506208|NCT01406522|Cholinesterases|cholinesterases
506209|NCT01406522|Cocaine|cocaine
506210|NCT01406522|Self-Administration|self-administration
506211|NCT01406509|Safety|safety
506212|NCT01406509|Conjugate vaccine|conjugate vaccine
506213|NCT01406496|Insulin bolus|insulin bolus
506214|NCT01406496|glucose excursions|glucose excursions
506215|NCT01406496|post-prandial|post-prandial
506216|NCT01406496|timing|timing
506217|NCT01406496|meal content|meal content
506218|NCT01406483|Platelet reactivity|platelet reactivity
506219|NCT01406483|CABG|cabg
506220|NCT01406483|Perioperative and in hospital bleeding|perioperative and in hospital bleeding
506221|NCT01406470|IGIV|igiv
506222|NCT01406470|Primary Immune Deficiency|primary immune deficiency
506223|NCT01406470|Immunoglobulin G|immunoglobulin g
506224|NCT01406457|Subarachnoid Hemorrhage|subarachnoid hemorrhage
506225|NCT01406444|Anorexia Nervosa|anorexia nervosa
506226|NCT01406444|Osteopenia|osteopenia
506227|NCT01406444|Osteoporosis|osteoporosis
506228|NCT01406444|Bone density|bone density
506229|NCT01406431|pitavastatin|pitavastatin
506230|NCT01406431|Livalo|livalo
506231|NCT01406418|Influenza|influenza
506232|NCT01406418|Virus|virus
506233|NCT01406418|Monoclonal|monoclonal
506234|NCT01406418|Antibody|antibody
506235|NCT01406418|Immunization|immunization
506236|NCT01406418|Treatment|treatment
506237|NCT01406405|Degenerative disc disease|degenerative disc disease
506238|NCT01406405|spinal stenosis|spinal stenosis
506239|NCT01406405|herniated disc|herniated disc
506240|NCT01406392|Misoprostol|misoprostol
506241|NCT01406392|Sublingual|sublingual
506242|NCT01406392|Induced|induced
506243|NCT01406392|Labor|labor
506244|NCT01406366|Pediatric oral health|pediatric oral health
506245|NCT01406366|Bright Futures|bright futures
506246|NCT01406366|Health promotion|health promotion
506247|NCT01406353|Mitral Stenosis|mitral stenosis
506248|NCT01406353|Mitral Valvuloplasty|mitral valvuloplasty
506249|NCT01406314|Phase 1|phase 1
506250|NCT01406314|Patient|patient
506251|NCT01406314|Systemic Amyloidosis|systemic amyloidosis
506252|NCT01406314|Amyloidosis|amyloidosis
506253|NCT01406301|prescribing information|prescribing information
506254|NCT01406288|hemolytic-uremic syndrome|hemolytic-uremic syndrome
506255|NCT01406288|shiga-toxin-producing E. Coli|shiga-toxin-producing e. coli
506256|NCT01406262|albiglutide|albiglutide
506257|NCT01406262|QT interval|qt interval
506258|NCT01406262|cardiac repolarization|cardiac repolarization
506259|NCT01406262|ECG study|ecg study
506260|NCT01406249|unresectable gastric cancer|unresectable gastric cancer
506261|NCT01406249|recurrent gastric cancer|recurrent gastric cancer
506262|NCT01406249|StageIV gastric cancer|stageiv gastric cancer
506263|NCT01406249|adenocarcinoma of the stomach|adenocarcinoma of the stomach
506264|NCT01406249|XP|xp
506265|NCT01406249|SP|sp
506266|NCT01406236|Female|female
506267|NCT01406236|urgent or elective percutaneous coronary intervention|urgent or elective percutaneous coronary intervention
506268|NCT01406236|PCI|pci
506269|NCT01406236|diagnostic angiography|diagnostic angiography
506270|NCT01406223|Nicotine addiction|nicotine addiction
506271|NCT01406223|Cigarette smoking|cigarette smoking
506272|NCT01406223|Smoking cessation|smoking cessation
506273|NCT01406223|Zyban|zyban
506274|NCT01406223|Chantix|chantix
506275|NCT01406223|Nicotine patches|nicotine patches
506276|NCT01406223|varenicline|varenicline
506277|NCT01406223|bupropion|bupropion
506278|NCT01406223|fMRI|fmri
506279|NCT01406210|Lung Transplant|lung transplant
506280|NCT01406210|REflux Surgery|reflux surgery
506281|NCT01406210|Gastroesophageal Reflux Disease (GERD)|gastroesophageal reflux disease (gerd)
506282|NCT01406210|Fundoplication|fundoplication
506283|NCT01406197|Progesterone|progesterone
506284|NCT01406197|Progestins|progestins
506285|NCT01406197|Preterm labor|preterm labor
506286|NCT01406197|Premature birth|premature birth
506287|NCT01406197|Uterine electromyography|uterine electromyography
506288|NCT01406197|Uterine contractility|uterine contractility
506289|NCT01406184|Child Abuse|child abuse
506290|NCT01406184|Child Neglect|child neglect
506291|NCT01406184|Child Hospital Emergency Room Presentations|child hospital emergency room presentations
506292|NCT01406184|Child Well-Care Compliance|child well-care compliance
506293|NCT01406184|Child Immunization Compliance|child immunization compliance
506294|NCT01406171|Isavuconazole|isavuconazole
506295|NCT01406171|ASP9766|asp9766
506296|NCT01406171|BAL8557|bal8557
506297|NCT01406171|Midazolam|midazolam
506298|NCT01406171|Healthy volunteers|healthy volunteers
506299|NCT01406158|Solifenacin succinate|solifenacin succinate
506300|NCT01406158|VESIcare|vesicare
506301|NCT01406158|Healthy Volunteers|healthy volunteers
506302|NCT01406158|YM905|ym905
506303|NCT01406145|ASP0777|asp0777
506304|NCT01406145|Alzheimer's Disease|alzheimer's disease
506305|NCT01406132|ASP015K|asp015k
506306|NCT01406132|Healthy volunteers|healthy volunteers
506519|NCT01405157|fasting|fasting
506307|NCT01406106|Hypercholesterolemia|hypercholesterolemia
506308|NCT01406106|Lipids|lipids
506309|NCT01406106|Cardiovascular disease|cardiovascular disease
506310|NCT01406106|Risks factors|risks factors
506311|NCT01406106|Primary Care|primary care
506312|NCT01406093|Candidemia|candidemia
506313|NCT01406093|Early-onset|early-onset
506314|NCT01406093|Late-onset|late-onset
506315|NCT01406093|Health-care associated|health-care associated
506316|NCT01406093|Nosocomial|nosocomial
506317|NCT01406080|Photoaging|photoaging
506318|NCT01406080|Photodamage|photodamage
506319|NCT01406080|Adapalene|adapalene
506320|NCT01406080|Differin|differin
506321|NCT01406067|social skills training,|social skills training,
506322|NCT01406067|social competence training,|social competence training,
506323|NCT01406067|Oppositional Defiant Disorder|oppositional defiant disorder
506324|NCT01406067|peer related aggressive behavior|peer related aggressive behavior
506325|NCT01406067|randomized controlled trial|randomized controlled trial
506326|NCT01406054|athletes|athletes
506327|NCT01406054|injury prevention|injury prevention
506328|NCT01406054|neuromuscular training|neuromuscular training
506329|NCT01406054|public school|public school
506330|NCT01406054|physical education|physical education
506331|NCT01406054|knee|knee
506332|NCT01406054|sports|sports
506333|NCT01406054|ACL|acl
506334|NCT01406054|KIPP|kipp
506335|NCT01406041|Fluid and electrolyte imbalance|fluid and electrolyte imbalance
506336|NCT01406041|Hyponatremia|hyponatremia
506337|NCT01406041|Hypernatremia|hypernatremia
506338|NCT01406041|Electrolytes disorder|electrolytes disorder
506339|NCT01406028|IVF|ivf
506340|NCT01406028|Stress|stress
506341|NCT01406028|Infertility|infertility
506342|NCT01406015|Obesity|obesity
506343|NCT01406015|Insulin resistance|insulin resistance
506344|NCT01406015|Mineralocorticoid receptor|mineralocorticoid receptor
506345|NCT01406002|Pharmacokinetics|pharmacokinetics
506346|NCT01406002|darexaban|darexaban
506347|NCT01406002|YM150|ym150
506348|NCT01406002|rifampicin|rifampicin
506349|NCT01406002|Phase 1|phase 1
506350|NCT01405989|Pharmacokinetics|pharmacokinetics
506351|NCT01405989|darexaban|darexaban
506352|NCT01405989|ketoconazole|ketoconazole
506353|NCT01405989|Phase 1|phase 1
506354|NCT01405976|sleep apneas|sleep apneas
506355|NCT01405976|noninvasive ventilation|noninvasive ventilation
506356|NCT01405976|CPAP|cpap
506357|NCT01405963|Amgen|amgen
506358|NCT01405963|AMG 157|amg 157
506359|NCT01405963|Asthma|asthma
506360|NCT01405898|hypertension|hypertension
506361|NCT01405898|nitrite|nitrite
506362|NCT01405898|blood pressure|blood pressure
506363|NCT01405898|endothelial function|endothelial function
506364|NCT01405885|Universal Influenza|universal influenza
506365|NCT01405885|Intradermal DNA vaccine|intradermal dna vaccine
506366|NCT01405885|Electroporation|electroporation
506367|NCT01405885|H1 and H5|h1 and h5
506368|NCT01405885|DNA Vaccination|dna vaccination
506369|NCT01405885|Influenza|influenza
506370|NCT01405885|INO-3510|ino-3510
506371|NCT01405859|Tourette|tourette
506372|NCT01405859|tic|tic
506373|NCT01405859|Tourette's|tourette's
506374|NCT01405859|Tourette syndrome|tourette syndrome
506375|NCT01405859|Tourette's syndrome|tourette's syndrome
506376|NCT01405807|Vasculitis|vasculitis
506377|NCT01405807|ANCA|anca
506378|NCT01405807|Refractory|refractory
506379|NCT01405742|Hemophilia|hemophilia
506380|NCT01405742|Prophylaxis|prophylaxis
506381|NCT01405742|Recombinant factor VIII|recombinant factor viii
506382|NCT01405716|Mindfulness|mindfulness
506383|NCT01405716|Back Pain|back pain
506384|NCT01405716|Older adults|older adults
506385|NCT01405703|Clavicle Fractures|clavicle fractures
506386|NCT01405703|Numbness|numbness
506387|NCT01405703|Percutaneous plate fixation|percutaneous plate fixation
506388|NCT01405703|open plate fixation|open plate fixation
506389|NCT01405703|incision related numbness|incision related numbness
506390|NCT01405703|union rates|union rates
506391|NCT01405703|subjective|subjective
506392|NCT01405703|questionnaire based outcomes|questionnaire based outcomes
506393|NCT01405703|Diaphyseal|diaphyseal
506394|NCT01405690|CAD|cad
506395|NCT01405690|CTCA|ctca
506396|NCT01405690|multidetector computer tomography (MDCT)|multidetector computer tomography (mdct)
506397|NCT01405677|Hepatitis A|hepatitis a
506398|NCT01405677|Vaccination|vaccination
506399|NCT01405677|Immunisation|immunisation
506400|NCT01405651|ONO-6950|ono-6950
506401|NCT01405651|Healthy adult subjects|healthy adult subjects
506402|NCT01405625|Asthma|asthma
506403|NCT01405625|Health literacy|health literacy
506404|NCT01405625|Parent knowledge of appropriate action plan steps|parent knowledge of appropriate action plan steps
506405|NCT01405599|Ulimorelin|ulimorelin
506406|NCT01405599|Hepatic Impairment|hepatic impairment
506407|NCT01405586|elderly|elderly
506408|NCT01405586|chemotherapy|chemotherapy
506409|NCT01405573|Child Pugh B|child pugh b
506410|NCT01405573|first line|first line
506411|NCT01405547|Gestational Diabetes|gestational diabetes
506412|NCT01405547|Gestational Hyperglycemia|gestational hyperglycemia
506520|NCT01405144|Photoaging|photoaging
506413|NCT01405547|Gestational Insulinemia|gestational insulinemia
506414|NCT01405547|Maternal Obesity|maternal obesity
506415|NCT01405547|Human Milk|human milk
506416|NCT01405547|Lactogenesis|lactogenesis
506417|NCT01405547|Obstetrics|obstetrics
506418|NCT01405547|Nutrition|nutrition
506419|NCT01405547|Infant Growth|infant growth
506420|NCT01405534|Catheterization, Central Venous|catheterization, central venous
506421|NCT01405521|typhoid vaccine M01ZH09|typhoid vaccine m01zh09
506422|NCT01405521|Ty21a typhoid vaccine|ty21a typhoid vaccine
506423|NCT01405508|N01258|n01258
506424|NCT01405508|Brivaracetam|brivaracetam
506425|NCT01405508|Epilepsy|epilepsy
506426|NCT01405508|IV|iv
506427|NCT01405508|intravenous|intravenous
506428|NCT01405495|Posttraumatic Stress Disorder|posttraumatic stress disorder
506429|NCT01405495|Working Memory|working memory
506430|NCT01405495|Attentional Bias|attentional bias
506431|NCT01405495|Connectivity|connectivity
506432|NCT01405495|Structural Neuroimaging|structural neuroimaging
506433|NCT01405495|Functional Neuroimaging|functional neuroimaging
506434|NCT01405495|Diffusion Tensor Imaging|diffusion tensor imaging
506435|NCT01405495|Arterial Spin Labelling|arterial spin labelling
506436|NCT01405495|Cortisol|cortisol
506437|NCT01405495|Psychophysiology|psychophysiology
506438|NCT01405495|Early development of|early development of
506439|NCT01405482|Botulinum Toxin Type A|botulinum toxin type a
506440|NCT01405482|Thoracic Outlet Syndrome|thoracic outlet syndrome
506441|NCT01405469|Achalasia|achalasia
506442|NCT01405469|Heller myotomy|heller myotomy
506443|NCT01405469|Dysphagia|dysphagia
506444|NCT01405469|Peroral Endoscopic Myotomy|peroral endoscopic myotomy
506445|NCT01405456|HIV-infection|hiv-infection
506446|NCT01405456|eplerenone|eplerenone
506447|NCT01405456|aldosterone|aldosterone
506448|NCT01405456|visceral fat|visceral fat
506449|NCT01405456|lipodystrophy|lipodystrophy
506450|NCT01405443|Simulator training|simulator training
506451|NCT01405443|Flexible endoscopy|flexible endoscopy
506452|NCT01405443|Gastrointestinal endoscopy|gastrointestinal endoscopy
506453|NCT01405443|Colonoscopy|colonoscopy
506454|NCT01405443|Training|training
506455|NCT01405443|Performance|performance
506456|NCT01405417|Achalasia|achalasia
506457|NCT01405417|Heller myotomy|heller myotomy
506458|NCT01405417|Dysphagia|dysphagia
506459|NCT01405417|Peroral Endoscopic Myotomy|peroral endoscopic myotomy
506460|NCT01405404|parenting childcare discounts child behavior|parenting childcare discounts child behavior
506461|NCT01405404|No Intervention Control|no intervention control
506462|NCT01405404|Intervention no childcare discount|intervention no childcare discount
506463|NCT01405404|Intervention with childcare discount|intervention with childcare discount
506464|NCT01405391|Pharma Mar|pharma mar
506465|NCT01405391|PM01183|pm01183
506466|NCT01405391|Non-Colorectal Cancer (non-CRC)|non-colorectal cancer (non-crc)
506467|NCT01405391|Dose finding phase I|dose finding phase i
506468|NCT01405365|Periodontitis|periodontitis
506469|NCT01405365|Periodontal diseases|periodontal diseases
506470|NCT01405365|Obesity|obesity
506471|NCT01405365|Metronidazole|metronidazole
506472|NCT01405365|Prognosis|prognosis
506473|NCT01405365|Probing depth|probing depth
506474|NCT01405365|Periodontal attachment loss|periodontal attachment loss
506475|NCT01405352|obesity|obesity
506476|NCT01405352|vitamin A|vitamin a
506477|NCT01405352|immune system|immune system
506478|NCT01405326|rheumatoid arthritis|rheumatoid arthritis
506479|NCT01405326|biological therapy|biological therapy
506480|NCT01405326|adalimumab|adalimumab
506481|NCT01405326|ability to work|ability to work
506482|NCT01405326|sick leaves|sick leaves
506483|NCT01405287|stent|stent
506484|NCT01405287|drug eluting stent|drug eluting stent
506485|NCT01405287|healing|healing
506486|NCT01405287|endothelium|endothelium
506487|NCT01405287|DES|des
506488|NCT01405287|OCT|oct
506489|NCT01405287|MI|mi
506490|NCT01405287|ACS|acs
506491|NCT01405248|Butylphthalide|butylphthalide
506492|NCT01405235|Paclitaxel/Topotecan|paclitaxel/topotecan
506493|NCT01405235|Cisplatin/Topotecan|cisplatin/topotecan
506494|NCT01405222|exacerbation|exacerbation
506495|NCT01405222|COPD|copd
506496|NCT01405222|Cough|cough
506497|NCT01405209|EKG|ekg
506498|NCT01405209|AF|af
506499|NCT01405209|biosignals|biosignals
506500|NCT01405196|double-blind|double-blind
506501|NCT01405196|placebo-controlled|placebo-controlled
506502|NCT01405196|multicenter|multicenter
506503|NCT01405196|dose-ranging|dose-ranging
506504|NCT01405196|efficacy|efficacy
506505|NCT01405196|safety|safety
506506|NCT01405196|lupus.|lupus.
506507|NCT01405183|Hepatitis C|hepatitis c
506508|NCT01405183|Renal Cell Carcinoma|renal cell carcinoma
506509|NCT01405183|Colorectal Cancer|colorectal cancer
506510|NCT01405170|bioequivalence study|bioequivalence study
506511|NCT01405170|methylprednisolone|methylprednisolone
506512|NCT01405170|suspension|suspension
506513|NCT01405170|tablets|tablets
506514|NCT01405170|fed|fed
506515|NCT01405157|bioequivalence study|bioequivalence study
506516|NCT01405157|methylprednisolone|methylprednisolone
506517|NCT01405157|suspension|suspension
506521|NCT01405144|Actinic keratosis|actinic keratosis
506522|NCT01405144|5-fluoruracil|5-fluoruracil
506523|NCT01405144|Carcinogenesis|carcinogenesis
506524|NCT01405131|bioequivalence study|bioequivalence study
506525|NCT01405131|methylprednisolone|methylprednisolone
506526|NCT01405131|suspension|suspension
506527|NCT01405131|tablets|tablets
506528|NCT01405118|Drug-Drug Interaction Healthy Volunteers CP-690|drug-drug interaction healthy volunteers cp-690
506529|NCT01405118|550 Metformin|550 metformin
506530|NCT01405092|volume|volume
506531|NCT01405092|acute kidney injury|acute kidney injury
506532|NCT01405092|continuous renal replacement|continuous renal replacement
506533|NCT01405079|Lung cancer|lung cancer
506534|NCT01405079|II-IIIA(N1-N2)|ii-iiia(n1-n2)
506535|NCT01405079|Adjuvant treatment|adjuvant treatment
506536|NCT01405079|EGFR mutations|egfr mutations
506537|NCT01405079|Tyrosine kinase inhibitor|tyrosine kinase inhibitor
506538|NCT01405066|Computed Tomography (CT)|computed tomography (ct)
506539|NCT01405066|Ionizing radiation|ionizing radiation
506540|NCT01405066|Advanced medical imaging|advanced medical imaging
506541|NCT01405066|Radiation Dose Audit Reports|radiation dose audit reports
506542|NCT01405053|Central Nervous System|central nervous system
506543|NCT01405040|Cardiac|cardiac
506544|NCT01405040|Output|output
506545|NCT01405040|Preload|preload
506546|NCT01405040|Lung|lung
506547|NCT01405040|Water|water
506548|NCT01405027|HCV|hcv
506549|NCT01405027|Genotype1|genotype1
506550|NCT01405027|Naive|naive
506551|NCT01405027|Partial responder|partial responder
506552|NCT01405027|Relapser|relapser
506553|NCT01405014|Hold Me Tight|hold me tight
506554|NCT01405014|Emotionally Focused Therapy|emotionally focused therapy
506555|NCT01405014|Relationship enhancement|relationship enhancement
506556|NCT01405014|Couples counseling|couples counseling
506557|NCT01405014|Marital therapy|marital therapy
506558|NCT01405014|Acquired brain injury|acquired brain injury
506559|NCT01405014|Traumatic brain injury|traumatic brain injury
506560|NCT01405014|Stroke|stroke
506561|NCT01405001|Emergencies|emergencies
506562|NCT01405001|War|war
506563|NCT01405001|Intubation, Intratracheal|intubation, intratracheal
506564|NCT01404988|Heart Failure|heart failure
506565|NCT01404988|Telemedicine|telemedicine
506566|NCT01404988|Medication Adherence|medication adherence
506567|NCT01404975|Delirium|delirium
506568|NCT01404975|PVB|pvb
506569|NCT01404975|PCA|pca
506570|NCT01404975|Opioid|opioid
506571|NCT01404975|Aortic Valve replacement|aortic valve replacement
506572|NCT01404962|Haemophilus influenza type b|haemophilus influenza type b
506573|NCT01404962|children|children
506574|NCT01404962|Korea|korea
506575|NCT01404962|vaccine|vaccine
506576|NCT01404962|Prevention of haemophilus influenza type b|prevention of haemophilus influenza type b
506577|NCT01404949|Tretinoin|tretinoin
506578|NCT01404949|all-trans retinoic acid|all-trans retinoic acid
506579|NCT01404949|ATRA|atra
506580|NCT01404949|Vesanoid|vesanoid
506581|NCT01404949|Arsenic Trioxide|arsenic trioxide
506582|NCT01404949|ATO|ato
506583|NCT01404949|Trisenox|trisenox
506584|NCT01404949|11-040|11-040
506585|NCT01404936|Lymphoma|lymphoma
506586|NCT01404936|Hodgkin's Disease|hodgkin's disease
506587|NCT01404936|Stage III and IV|stage iii and iv
506588|NCT01404936|Adriamycin|adriamycin
506589|NCT01404936|Doxorubicin|doxorubicin
506590|NCT01404936|Rubex|rubex
506591|NCT01404936|Bleomycin|bleomycin
506592|NCT01404936|Bleomycin Sulfate|bleomycin sulfate
506593|NCT01404936|BLM|blm
506594|NCT01404936|Dacarbazine|dacarbazine
644334|NCT00851201|obesity|obesity
506595|NCT01404936|DTIC-DOME|dtic-dome
506596|NCT01404936|Interferon-2A|interferon-2a
506597|NCT01404936|Interferon-Alfa-2a|interferon-alfa-2a
506598|NCT01404936|Roferon-A|roferon-a
506599|NCT01404936|Velban|velban
506600|NCT01404936|Vinblastine|vinblastine
506601|NCT01404910|Pregnancy|pregnancy
506602|NCT01404910|Preeclampsia|preeclampsia
506603|NCT01404910|Pre-term|pre-term
506604|NCT01404910|sFlt-1|sflt-1
506605|NCT01404910|Apheresis|apheresis
506606|NCT01404910|Hypertension|hypertension
506607|NCT01404910|Proteinuria|proteinuria
506608|NCT01404910|VEGF|vegf
506609|NCT01404897|carbohydrate|carbohydrate
506610|NCT01404897|DASH diet|dash diet
506611|NCT01404897|blood pressure|blood pressure
506612|NCT01404897|cholesterol|cholesterol
506613|NCT01404884|myopia|myopia
506614|NCT01404884|astigmatism|astigmatism
506615|NCT01404884|presbyopia|presbyopia
506616|NCT01404884|SUPRACOR|supracor
506617|NCT01404884|multifocal|multifocal
506618|NCT01404871|OCD|ocd
506619|NCT01404871|pharmacogenetics|pharmacogenetics
506620|NCT01404871|cortical inhibition|cortical inhibition
506621|NCT01404871|genetics|genetics
506622|NCT01404858|IVF|ivf
506623|NCT01404858|Lifestyle habits|lifestyle habits
506624|NCT01404845|exudative AMD|exudative amd
506625|NCT01404845|dietary supplements|dietary supplements
506626|NCT01404845|macular pigment|macular pigment
506627|NCT01404845|lutein|lutein
506628|NCT01404845|zeaxanthin|zeaxanthin
506629|NCT01404845|Nutrof total|nutrof total
506630|NCT01404845|in one eye|in one eye
506631|NCT01404832|Gastroesophageal reflux|gastroesophageal reflux
506632|NCT01404832|Proton pump inhibitor|proton pump inhibitor
506633|NCT01404832|Eosinophilic esophagitis|eosinophilic esophagitis
506634|NCT01404793|Liver Transplantation|liver transplantation
506635|NCT01404793|Solid Phase Micro Extraction|solid phase micro extraction
506636|NCT01404793|Rocuronium|rocuronium
506637|NCT01404793|Metabolomics|metabolomics
506638|NCT01404793|Pharmacokinetics|pharmacokinetics
506639|NCT01404793|Clinical Marker|clinical marker
506640|NCT01404780|Double lumen ET intubation|double lumen et intubation
506641|NCT01404780|Laryngoscope|laryngoscope
506642|NCT01404780|Lung Surgery|lung surgery
506643|NCT01404767|Vascular surgery|vascular surgery
506644|NCT01404767|esmolol|esmolol
506645|NCT01404767|hemodynamic control|hemodynamic control
506646|NCT01404754|MDMA|mdma
506647|NCT01404754|mood|mood
506648|NCT01404754|subjective effects|subjective effects
506649|NCT01404754|interpersonal closeness|interpersonal closeness
506650|NCT01404741|MDS|mds
506651|NCT01404741|CMML|cmml
506652|NCT01404741|allogeneic stem cell transplantation|allogeneic stem cell transplantation
506653|NCT01404741|5-azacytidine|5-azacytidine
506654|NCT01404728|Vaginal length|vaginal length
506655|NCT01404728|Sexual dysfunction|sexual dysfunction
506656|NCT01404715|Drug drug interaction|drug drug interaction
506657|NCT01404702|Neuroblastoma|neuroblastoma
506658|NCT01404702|Pediatrics|pediatrics
506659|NCT01404702|Refractory|refractory
506660|NCT01404702|Immunotherapy|immunotherapy
506661|NCT01404702|Biological therapy|biological therapy
506662|NCT01404702|Lymphocytes|lymphocytes
506663|NCT01404702|Cancer|cancer
506664|NCT01404702|Bisphosphonate|bisphosphonate
506665|NCT01404689|dexmedetomidine|dexmedetomidine
506666|NCT01404689|midazolam|midazolam
506667|NCT01404689|ERCP|ercp
506668|NCT01404689|cholangiopancreatography|cholangiopancreatography
506669|NCT01404689|sedation|sedation
506670|NCT01404689|propofol|propofol
506671|NCT01404676|Glucose variability|glucose variability
506672|NCT01404676|Oxidative stress|oxidative stress
506673|NCT01404676|Endothelial cell function|endothelial cell function
506674|NCT01404663|bone marrow CD133 transplantation side effects|bone marrow cd133 transplantation side effects
506675|NCT01404663|side effects|side effects
506676|NCT01404650|GIST|gist
506677|NCT01404650|Refractory|refractory
506678|NCT01404650|Gastrointestinal|gastrointestinal
506679|NCT01404650|Stromal|stromal
506680|NCT01404650|Tumor|tumor
506681|NCT01404611|with tubes|with tubes
506682|NCT01404559|Amputee|amputee
506683|NCT01404559|Transtibial|transtibial
506684|NCT01404559|Military|military
506685|NCT01404559|Gait|gait
506686|NCT01404559|Rehabilitation|rehabilitation
506687|NCT01404546|stroke smoking cessation cost-free pharmacotherapy|stroke smoking cessation cost-free pharmacotherapy
506688|NCT01404533|NTBI|ntbi
506689|NCT01404533|Iron|iron
506690|NCT01404533|Absorption|absorption
506691|NCT01404520|#14 Cancer Related fatigue|#14 cancer related fatigue
506692|NCT01404520|#13 Quality of Life|#13 quality of life
506693|NCT01404520|"#12 Psychosocial Intervention[ti/ab]"|"#12 psychosocial intervention[ti/ab]"
506694|NCT01404520|#11 Rehabilitation[tw]|#11 rehabilitation[tw]
506695|NCT01404520|"#10 Physical Fitness[tw]"|"#10 physical fitness[tw]"
506696|NCT01404520|"#9 Physical Activity[tw]"|"#9 physical activity[tw]"
506697|NCT01404520|"#8 Exercise Therapy[tw]"|"#8 exercise therapy[tw]"
506698|NCT01404520|#7 Exercise[tw]|#7 exercise[tw]
506699|NCT01404520|#6 Hematologic[tw]|#6 hematologic[tw]
506700|NCT01404520|#5 Hematological[tw]|#5 hematological[tw]
506701|NCT01404520|#4 Leukemia, Myeloid, Acute[mh]|#4 leukemia, myeloid, acute[mh]
506702|NCT01404520|"#3 Acute Myeloid Leukemia[tw]"|"#3 acute myeloid leukemia[tw]"
506703|NCT01404520|"#2 Acute Lymphoblastic Leukemia[tw]"|"#2 acute lymphoblastic leukemia[tw]"
506704|NCT01404520|"#1 Acute Leukemia[tw]"|"#1 acute leukemia[tw]"
506705|NCT01404507|Acute Myocardial Infarction|acute myocardial infarction
506706|NCT01404494|Haptic Skills|haptic skills
506707|NCT01404494|Computer Assisted Interface|computer assisted interface
506708|NCT01404494|TBI|tbi
506709|NCT01404494|Traumatic Brain Injury|traumatic brain injury
506710|NCT01404481|Urinary retention|urinary retention
506711|NCT01404481|CISC|cisc
506712|NCT01404481|Single use|single use
506713|NCT01404481|Re use|re use
506714|NCT01404442|midazolam|midazolam
506715|NCT01404442|ketamine|ketamine
506716|NCT01404442|intrathecal|intrathecal
506717|NCT01404442|pain|pain
506718|NCT01404429|Rheumatoid arthritis|rheumatoid arthritis
506719|NCT01404429|Active|active
506720|NCT01404390|Phase I|phase i
506721|NCT01404390|Japanese|japanese
506722|NCT01404377|breast surgery : postoperative pain; ropivacaine|breast surgery : postoperative pain; ropivacaine
506723|NCT01404364|Triamcinolone|triamcinolone
506724|NCT01404364|Chlorpromazine|chlorpromazine
506725|NCT01404364|Refractory glaucoma|refractory glaucoma
506726|NCT01404364|Blind painful eye|blind painful eye
506727|NCT01404351|Reduction mammaplasty|reduction mammaplasty
506728|NCT01404351|Breast reduction|breast reduction
506729|NCT01404351|PlasmaBlade|plasmablade
506730|NCT01404351|PEAK|peak
506731|NCT01404325|Lung transplantation|lung transplantation
506732|NCT01404325|everolimus|everolimus
506733|NCT01404325|kidney function|kidney function
506734|NCT01404325|renal function|renal function
506735|NCT01404299|Frailty,|frailty,
506736|NCT01404299|nutritional supplementation,|nutritional supplementation,
506737|NCT01404299|functional status|functional status
506738|NCT01404260|chemotherapy|chemotherapy
506739|NCT01404260|maintenance therapy|maintenance therapy
506740|NCT01404260|gefitinib|gefitinib
506741|NCT01404247|retina|retina
506742|NCT01404247|optic nerve|optic nerve
506743|NCT01404247|fovea|fovea
506744|NCT01404247|Eyes|eyes
506745|NCT01404247|Neonates|neonates
506746|NCT01404234|Cystic fibrosis|cystic fibrosis
506747|NCT01404234|CF|cf
506748|NCT01404234|PA|pa
506749|NCT01404234|Pseudomonas aeruginosa|pseudomonas aeruginosa
506750|NCT01404234|AZLI|azli
506751|NCT01404234|aztreonam|aztreonam
506752|NCT01404234|Chronic Pseudomonas aeruginosa|chronic pseudomonas aeruginosa
506753|NCT01404195|Nutritional supplement|nutritional supplement
506754|NCT01404195|CaHMB|cahmb
506755|NCT01404195|Barthel index|barthel index
506756|NCT01404195|Frailty|frailty
506757|NCT01404182|seasonal|seasonal
506758|NCT01404182|prevention|prevention
506759|NCT01404182|influenza|influenza
506760|NCT01404182|infection|infection
506761|NCT01404182|influenza vaccine|influenza vaccine
506762|NCT01404182|vaccine|vaccine
506763|NCT01404182|influenza in humans|influenza in humans
506764|NCT01404169|Alzheimer Disease|alzheimer disease
506765|NCT01404169|Dementia|dementia
506766|NCT01404169|Delirium|delirium
506767|NCT01404169|Amnestic|amnestic
506768|NCT01404169|Cognitive Disorders|cognitive disorders
506769|NCT01404169|Donepezil|donepezil
506770|NCT01404169|Brain Diseases|brain diseases
506771|NCT01404169|Central Nervous System Diseases|central nervous system diseases
506772|NCT01404169|Nervous System Diseases|nervous system diseases
506773|NCT01404169|Tauopathies|tauopathies
506774|NCT01404169|Neurodegenerative Diseases|neurodegenerative diseases
506775|NCT01404169|Mental Disorders|mental disorders
506776|NCT01404169|Cholinesterase Inhibitors|cholinesterase inhibitors
506777|NCT01404169|Enzy|enzy
506778|NCT01404156|Esophageal cancer|esophageal cancer
506779|NCT01404156|Neoadjuvant|neoadjuvant
506780|NCT01404156|Chemotherapy|chemotherapy
506781|NCT01404156|Chemoradiation|chemoradiation
506782|NCT01404156|Surgery|surgery
506783|NCT01404156|Esophagectomy|esophagectomy
506784|NCT01404156|Adenocarcinoma|adenocarcinoma
506785|NCT01404156|Gastroesophageal|gastroesophageal
506786|NCT01404130|isotretinoin|isotretinoin
506787|NCT01404130|hippocampus|hippocampus
506788|NCT01404130|memory|memory
506789|NCT01404130|learning|learning
506790|NCT01404130|CANTAB|cantab
506791|NCT01404065|transcranial direct current stimulation|transcranial direct current stimulation
506792|NCT01404052|transcranial direct current stimulation|transcranial direct current stimulation
506793|NCT01404052|transcranial ultrasound|transcranial ultrasound
506794|NCT01404039|learning|learning
506795|NCT01404039|pain perception|pain perception
506796|NCT01404026|Transcranial Direct Current Stimulation|transcranial direct current stimulation
506797|NCT01404013|Montelukast|montelukast
506798|NCT01404013|Cough variant asthma|cough variant asthma
506799|NCT01404013|Inhaled Corticosteroid|inhaled corticosteroid
506800|NCT01403987|Education|education
506801|NCT01403987|Ascites|ascites
506802|NCT01403987|Liver|liver
506803|NCT01403987|Guidelines|guidelines
506804|NCT01403922|Phase I, Randomised, Placebo-Controlled, Double-Blind,Hypertensive Patients, Blood Pressure, Calcium Channel Blockers, Beta Blockers, ACE Inhibitors|phase i, randomised, placebo-controlled, double-blind,hypertensive patients, blood pressure, calcium channel blockers, beta blockers, ace inhibitors
506805|NCT01403922|Scientific terminology: To determine if treatment with TC5214 alone or in combination with Anti-Hypertensive Medications has an effect on sitting blood pressure|scientific terminology: to determine if treatment with tc5214 alone or in combination with anti-hypertensive medications has an effect on sitting blood pressure
506806|NCT01403922|Laymen terminology: Hypertension|laymen terminology: hypertension
506807|NCT01403896|Hematopoietic Stem Cell Transplantation|hematopoietic stem cell transplantation
506808|NCT01403896|Plerixafor|plerixafor
506809|NCT01403896|Healthy Donors|healthy donors
506810|NCT01403896|Stem Cell Graft|stem cell graft
506811|NCT01403883|Rectal cancer|rectal cancer
506812|NCT01403883|Temporary stoma|temporary stoma
506813|NCT01403883|Psychological disorders|psychological disorders
506814|NCT01403870|Low Back Pain|low back pain
506815|NCT01403857|Acceptability|acceptability
506816|NCT01403857|liking|liking
506817|NCT01403844|resonance Raman spectroscopy|resonance raman spectroscopy
506818|NCT01403844|Dietary Guidelines|dietary guidelines
506819|NCT01403844|fruits|fruits
506820|NCT01403844|biomarkers|biomarkers
506821|NCT01403844|carotenoids|carotenoids
506822|NCT01403844|MyPlate|myplate
506823|NCT01403844|vegetables|vegetables
506824|NCT01403818|ASP1941|asp1941
506825|NCT01403818|ipragliflozin|ipragliflozin
506826|NCT01403818|Mitiglinide calcium hydrate|mitiglinide calcium hydrate
506827|NCT01403818|Drug-Drug interaction|drug-drug interaction
506828|NCT01403818|Pharmacokinetics|pharmacokinetics
506829|NCT01403805|Oral care|oral care
506830|NCT01403805|Vaccine|vaccine
506831|NCT01403805|Pneumonia|pneumonia
506832|NCT01403805|Elderly|elderly
506833|NCT01403805|Prevention|prevention
506834|NCT01403805|Primary care|primary care
506835|NCT01403792|Human Immunodeficiency Virus|human immunodeficiency virus
506836|NCT01403792|Neutralising monoclonal antibody|neutralising monoclonal antibody
506837|NCT01403779|Intensity-Modulated Radiation Therapy (IMRT)|intensity-modulated radiation therapy (imrt)
506838|NCT01403779|Breast cancer|breast cancer
506839|NCT01403779|Hypofractionation|hypofractionation
506840|NCT01403766|pediatric|pediatric
506841|NCT01403766|kidney|kidney
506842|NCT01403766|transplant|transplant
506844|NCT01403766|creatinine|creatinine
506845|NCT01403766|cystatin C|cystatin c
506846|NCT01403766|iohexol|iohexol
506847|NCT01403753|Obesity|obesity
506848|NCT01403753|Child|child
506849|NCT01403753|Dietary Habits|dietary habits
506850|NCT01403740|acquired haemophilia|acquired haemophilia
506851|NCT01403740|factor VIII|factor viii
506852|NCT01403727|Biopsy of liver tumors|biopsy of liver tumors
506853|NCT01403714|acute heart failure|acute heart failure
506854|NCT01403701|physical therapy|physical therapy
506855|NCT01403701|pelvic prolapse|pelvic prolapse
506856|NCT01403701|incontinence|incontinence
506857|NCT01403701|quality of life|quality of life
506858|NCT01403688|fertility high risk, controlled ovarian stimulation, breast cancer|fertility high risk, controlled ovarian stimulation, breast cancer
506859|NCT01403675|women with cancer whose ovarian tissue has been collected and stored in liquid nitrogen before cancer therapy (surgery, chemotherapy, radiotherapy),|women with cancer whose ovarian tissue has been collected and stored in liquid nitrogen before cancer therapy (surgery, chemotherapy, radiotherapy),
506860|NCT01403675|who are in remission (no recurrence of disease for 5 years),|who are in remission (no recurrence of disease for 5 years),
506861|NCT01403675|who are in normal organ function and have no contraindication for surgery or pregnancy, and|who are in normal organ function and have no contraindication for surgery or pregnancy, and
506862|NCT01403675|who wish to restore ovarian function using stored ovarian tissue.|who wish to restore ovarian function using stored ovarian tissue.
506863|NCT01403662|bipolar disorder|bipolar disorder
506864|NCT01403662|depression|depression
506865|NCT01403662|major depression|major depression
506866|NCT01403662|bipolar I depression|bipolar i depression
506867|NCT01403662|bipolar II depression|bipolar ii depression
506868|NCT01403662|bipolar I disorder|bipolar i disorder
506869|NCT01403662|bipolar II disorder|bipolar ii disorder
506870|NCT01403662|minocycline|minocycline
506871|NCT01403662|minocin|minocin
506872|NCT01403623|Hypothermia|hypothermia
506873|NCT01403623|Newborn|newborn
506874|NCT01403623|Resuscitation|resuscitation
506875|NCT01403623|Plastic bag|plastic bag
506876|NCT01403610|TH-302|th-302
506877|NCT01403610|Bevacizumab|bevacizumab
506878|NCT01403610|Phase 2|phase 2
506879|NCT01403610|Glioma|glioma
506880|NCT01403610|High Grade Glioma|high grade glioma
506881|NCT01403610|CNS|cns
506882|NCT01403597|Skin wrinkling|skin wrinkling
506883|NCT01403597|Skin aging|skin aging
506884|NCT01403597|Skin pigmentation|skin pigmentation
506885|NCT01403545|Safety|safety
506886|NCT01403545|Tolerability|tolerability
506887|NCT01403545|Pharmacokinetics|pharmacokinetics
506888|NCT01403545|Liposomal Curcumin|liposomal curcumin
506889|NCT01403532|Hypogonadotropic Hypogonadism|hypogonadotropic hypogonadism
506890|NCT01403532|Kallmann Syndrome|kallmann syndrome
506891|NCT01403532|LH|lh
506892|NCT01403532|FSH|fsh
506893|NCT01403506|kidney transplantation|kidney transplantation
506894|NCT01403506|N-Acetyl Cysteine|n-acetyl cysteine
506895|NCT01403506|living donor|living donor
506896|NCT01403506|delayed graft function|delayed graft function
506897|NCT01403493|Irritable bowel syndrome|irritable bowel syndrome
506898|NCT01403493|Patient education|patient education
506899|NCT01403480|Basal Cell Carcinoma|basal cell carcinoma
506900|NCT01403467|Bronchial disease|bronchial disease
506901|NCT01403467|asthma|asthma
506902|NCT01403467|continuous positive airway pressure (CPAP)|continuous positive airway pressure (cpap)
506903|NCT01403467|Bronchoconstriction|bronchoconstriction
506904|NCT01403454|chronic kidney disease|chronic kidney disease
506905|NCT01403454|web-based application|web-based application
506906|NCT01403454|dialysis education|dialysis education
506907|NCT01403441|Refractory Bipolar Depression|refractory bipolar depression
506908|NCT01403428|Asthma|asthma
506909|NCT01403428|non invasive ventilation|non invasive ventilation
506910|NCT01403428|pediatrics|pediatrics
506911|NCT01403428|noninvasive positive pressure ventilation (NPPV)|noninvasive positive pressure ventilation (nppv)
506912|NCT01403402|Congenital Muscular Dystrophy|congenital muscular dystrophy
506913|NCT01403402|Congenital Myopathy|congenital myopathy
506914|NCT01403402|Neuromuscular Diseases|neuromuscular diseases
506915|NCT01403402|Musculoskeletal Diseases|musculoskeletal diseases
506916|NCT01403389|Kidney Transplant|kidney transplant
506917|NCT01403389|Delayed Graft Function|delayed graft function
506918|NCT01403350|Malaria|malaria
506919|NCT01403350|Fever|fever
506920|NCT01403350|Acute febrile illness|acute febrile illness
506921|NCT01403350|Pneumonia|pneumonia
506922|NCT01403350|Community health worker|community health worker
506923|NCT01403350|Rapid diagnostic test|rapid diagnostic test
506924|NCT01403337|peripheral arterial disease|peripheral arterial disease
506925|NCT01403337|myocardial infarction|myocardial infarction
506926|NCT01403324|metastatic or locally advanced differentiated thyroid cancer|metastatic or locally advanced differentiated thyroid cancer
506927|NCT01403324|planned for a therapeutic activity of 131I after thyroid hormone withdrawal|planned for a therapeutic activity of 131i after thyroid hormone withdrawal
506928|NCT01403311|Anaplastic astrocytoma|anaplastic astrocytoma
506929|NCT01403311|Astrocytoma|astrocytoma
506930|NCT01403311|Brain stem glioma|brain stem glioma
506931|NCT01403311|Ependymoma|ependymoma
506932|NCT01403311|Glioblastoma|glioblastoma
506933|NCT01403311|Glioblastoma multiforme|glioblastoma multiforme
506934|NCT01403311|Gliosarcoma|gliosarcoma
506935|NCT01403311|oligodendroglioma|oligodendroglioma
506936|NCT01403311|Medulloblastoma|medulloblastoma
506937|NCT01403311|Mixed astrocytoma-ependymoma|mixed astrocytoma-ependymoma
506938|NCT01403311|ALA|ala
506939|NCT01403298|Adolescent|adolescent
506940|NCT01403298|HIV|hiv
506941|NCT01403298|AIDS|aids
506942|NCT01403298|Sexual risk|sexual risk
506943|NCT01403298|Family|family
506944|NCT01403298|Prevention|prevention
506945|NCT01403298|Juvenile Drug Court|juvenile drug court
506946|NCT01403298|Juvenile Justice|juvenile justice
506947|NCT01403298|Drug Use|drug use
506948|NCT01403298|Marijuana|marijuana
506949|NCT01403285|Glioblastoma|glioblastoma
506950|NCT01403285|stable disease|stable disease
506951|NCT01403272|pressure ulcers|pressure ulcers
506952|NCT01403272|stage 1|stage 1
506953|NCT01403272|stage 2|stage 2
506954|NCT01403272|stage 3|stage 3
506955|NCT01403272|stage 4|stage 4
506956|NCT01403272|wounds|wounds
506957|NCT01403272|sores|sores
506958|NCT01403272|infection|infection
506959|NCT01403272|bioburden|bioburden
506960|NCT01403272|bacterial contamination|bacterial contamination
506961|NCT01403272|bed linen|bed linen
506962|NCT01403272|sheets|sheets
506963|NCT01403272|underpad|underpad
506964|NCT01403272|skin assessment|skin assessment
506965|NCT01403272|microclimate|microclimate
506966|NCT01403272|shear|shear
506967|NCT01403272|friction|friction
506968|NCT01403272|moisture|moisture
506969|NCT01403272|fabrics|fabrics
506970|NCT01403272|long term care|long term care
506971|NCT01403272|nursing home|nursing home
506972|NCT01403272|decubitus ulcer|decubitus ulcer
506973|NCT01403272|bed ridden|bed ridden
506974|NCT01403272|anti-microbial|anti-microbial
506975|NCT01403259|Nasopharyngeal carcinoma|nasopharyngeal carcinoma
506976|NCT01403259|S-1|s-1
506977|NCT01403259|Oxaliplatin|oxaliplatin
506978|NCT01403246|CLL|cll
506979|NCT01403246|Lenalidomide|lenalidomide
506980|NCT01403246|Chlorambucil|chlorambucil
506981|NCT01403246|No previous treatment|no previous treatment
506982|NCT01403233|Pharmacokinetics|pharmacokinetics
506983|NCT01403233|Safety|safety
506984|NCT01403207|Sex differences|sex differences
506985|NCT01403207|knee joint|knee joint
506986|NCT01403207|inflammatory mediators|inflammatory mediators
506987|NCT01403207|Vitamin D|vitamin d
506988|NCT01403207|osteoarthritis|osteoarthritis
506989|NCT01403194|Sleep Disordered Breathing|sleep disordered breathing
506990|NCT01403194|CPAP|cpap
506991|NCT01403194|BiPAP|bipap
506992|NCT01403194|Cardiovascular risk markers|cardiovascular risk markers
506993|NCT01403181|HCV|hcv
506994|NCT01403181|T cells|t cells
506995|NCT01403181|cytokines|cytokines
506996|NCT01403181|cytotoxicity|cytotoxicity
506997|NCT01403181|proliferation|proliferation
506998|NCT01403168|Osteopathy|osteopathy
506999|NCT01403168|Breast cancer|breast cancer
507000|NCT01403168|Pain|pain
507001|NCT01403155|H5N1|h5n1
507002|NCT01403155|Avian Influenza|avian influenza
507003|NCT01403155|DNA Vaccine|dna vaccine
507126|NCT01402570|rehabilitation|rehabilitation
507004|NCT01403155|Intradermal (ID) Injection|intradermal (id) injection
507005|NCT01403155|Electroporation|electroporation
507006|NCT01403155|Healthy Adults|healthy adults
507007|NCT01403142|heart transplant|heart transplant
507008|NCT01403142|vasculopathy|vasculopathy
507009|NCT01403129|keratoconus|keratoconus
507010|NCT01403129|keratoconus-suspect|keratoconus-suspect
507011|NCT01403129|ultrasound exam|ultrasound exam
507012|NCT01403129|acoustic radiation force ultrasound exam|acoustic radiation force ultrasound exam
507013|NCT01403116|testosterone|testosterone
507014|NCT01403116|male hypogonadism|male hypogonadism
507015|NCT01403116|low testosterone|low testosterone
507016|NCT01403090|Pulmonary Embolism|pulmonary embolism
507017|NCT01403090|Deep Vein Thrombosis|deep vein thrombosis
507018|NCT01403090|Venous Thromboembolism|venous thromboembolism
507019|NCT01403090|Central Line Catheter|central line catheter
507020|NCT01403090|Vena Cava Filters|vena cava filters
507021|NCT01403077|Superficial femoral artery|superficial femoral artery
507022|NCT01403077|Peripheral arterial disease|peripheral arterial disease
507023|NCT01403077|Atherosclerosis|atherosclerosis
507024|NCT01403077|Intermittent Claudication|intermittent claudication
507025|NCT01403077|Vascular Diseases|vascular diseases
507121|NCT01402583|Menopause|menopause
507026|NCT01403077|Cardiovascular Diseases|cardiovascular diseases
507027|NCT01403064|Oral mucositis; head and neck cancer; chemotherapy; radiotherapy|oral mucositis; head and neck cancer; chemotherapy; radiotherapy
507028|NCT01403038|healthy volunteers|healthy volunteers
507029|NCT01403038|elagolix|elagolix
507030|NCT01403038|endometriosis|endometriosis
507031|NCT01403038|ovarian reserve|ovarian reserve
507032|NCT01403038|gonadotropin-releasing hormone antagonist|gonadotropin-releasing hormone antagonist
507033|NCT01403038|ovulation|ovulation
507034|NCT01403038|ovarian activity|ovarian activity
507035|NCT01403012|To identify clinical and metabolomic markers that underlie variability in response to systemic therapy in psoriasis|to identify clinical and metabolomic markers that underlie variability in response to systemic therapy in psoriasis
507036|NCT01403012|To identify metabolomic signatures associated with psoriasis|to identify metabolomic signatures associated with psoriasis
507037|NCT01403012|To identify possible treatment-specific metabolomic signatures|to identify possible treatment-specific metabolomic signatures
507038|NCT01402999|Growth disorders|growth disorders
507039|NCT01402999|Saizen|saizen
507040|NCT01402999|Easypod|easypod
507041|NCT01402999|Growth hormone|growth hormone
507042|NCT01402999|Pediatric subject|pediatric subject
507043|NCT01402986|Asthma|asthma
507044|NCT01402986|Tralokinumab|tralokinumab
507045|NCT01402986|CAT-354|cat-354
507046|NCT01402960|High-Definition Transcranial Direct Current Stimulation|high-definition transcranial direct current stimulation
507047|NCT01402908|Hepatocellular Carcinoma|hepatocellular carcinoma
507048|NCT01402908|PI-88|pi-88
507049|NCT01402908|Phase III|phase iii
507050|NCT01402908|Adjuvant Therapy|adjuvant therapy
507051|NCT01402908|Hepatoma|hepatoma
507052|NCT01402908|Liver Cancer|liver cancer
507053|NCT01402895|Nerve conduction|nerve conduction
507054|NCT01402895|H-reflex, mobilizations|h-reflex, mobilizations
507055|NCT01402895|with neurodynamic component|with neurodynamic component
507056|NCT01402882|traumatic brain injury|traumatic brain injury
507057|NCT01402882|tranexamic acid|tranexamic acid
507058|NCT01402882|antifibrinolytic|antifibrinolytic
507059|NCT01402882|randomised|randomised
507060|NCT01402882|clinical trial|clinical trial
507061|NCT01402869|Methemoglobin|methemoglobin
507062|NCT01402869|Methemoglobinemia|methemoglobinemia
507063|NCT01402869|Prilocaine|prilocaine
507064|NCT01402869|Lidocaine|lidocaine
507065|NCT01402856|Prevention|prevention
507066|NCT01402856|Adolescent|adolescent
507067|NCT01402856|Trauma|trauma
507068|NCT01402856|Driving|driving
507069|NCT01402843|phase III combination study|phase iii combination study
507070|NCT01402830|cancer|cancer
507071|NCT01402830|depression|depression
507072|NCT01402830|pain|pain
507074|NCT01402817|plexiform neurofibromas|plexiform neurofibromas
507075|NCT01402817|Sunitinib|sunitinib
507076|NCT01402817|Sutent®|sutent®
507077|NCT01402739|PoC|poc
507078|NCT01402739|ROTEM|rotem
507079|NCT01402739|Multiplate|multiplate
507080|NCT01402739|transfusion|transfusion
507081|NCT01402739|cardiac surgery|cardiac surgery
507082|NCT01402739|drainage blood loss|drainage blood loss
507083|NCT01402739|chest tube output|chest tube output
507084|NCT01402726|renal artery|renal artery
507085|NCT01402726|sympathetic nerves|sympathetic nerves
507086|NCT01402726|modification|modification
507087|NCT01402726|heart failure|heart failure
507088|NCT01402700|Peripheral arterial disease|peripheral arterial disease
507089|NCT01402700|claudication|claudication
507090|NCT01402700|stent|stent
507091|NCT01402700|VISI-Pro|visi-pro
507092|NCT01402700|Iliac artery|iliac artery
507093|NCT01402687|Stem Cell Transplant|stem cell transplant
507094|NCT01402687|Mucositis|mucositis
507095|NCT01402674|Obesity treatment|obesity treatment
507096|NCT01402674|Phentermine|phentermine
507097|NCT01402674|Withholding treatment|withholding treatment
507098|NCT01402674|Phentermine dependence|phentermine dependence
507099|NCT01402661|rheumatoid arthritis|rheumatoid arthritis
507100|NCT01402661|psoriatic arthritis|psoriatic arthritis
507101|NCT01402661|disease registry|disease registry
507102|NCT01402648|Non adenomatous mucosa|non adenomatous mucosa
507103|NCT01402648|Estrogen Receptor beta and apoptosis|estrogen receptor beta and apoptosis
507104|NCT01402648|Adenoma recurrence|adenoma recurrence
507105|NCT01402648|Screening colonoscopy every 3-5 years|screening colonoscopy every 3-5 years
507106|NCT01402648|patients at intermediate risk for CRC|patients at intermediate risk for crc
507107|NCT01402635|crowding|crowding
507108|NCT01402635|Point-of-Care Systems|point-of-care systems
507109|NCT01402635|emergency medicine|emergency medicine
507110|NCT01402609|Continuity of care|continuity of care
507111|NCT01402609|Patient safety|patient safety
507112|NCT01402609|Communication between acute and community care providers|communication between acute and community care providers
507113|NCT01402596|Deep Sedation|deep sedation
507114|NCT01402596|Pediatrics|pediatrics
507115|NCT01402596|Emergency Hospital Services|emergency hospital services
507116|NCT01402596|Midazolam|midazolam
507117|NCT01402596|Chloral hydrate|chloral hydrate
507118|NCT01402596|Randomized controlled trial|randomized controlled trial
507119|NCT01402583|Hepatitis C|hepatitis c
507120|NCT01402583|Gender|gender
507122|NCT01402583|Sustained viral response|sustained viral response
507123|NCT01402583|Cytokines|cytokines
507124|NCT01402570|disability|disability
507125|NCT01402570|polio|polio
507127|NCT01402570|wellness|wellness
507128|NCT01402557|Obesity|obesity
507129|NCT01402557|Body Weight Changes|body weight changes
507130|NCT01402557|Internet|internet
507131|NCT01402544|AMD|amd
507132|NCT01402544|Choroidal neovascularization|choroidal neovascularization
507133|NCT01402544|Ranibizumab|ranibizumab
507134|NCT01402544|Age-related Macular Degeneration|age-related macular degeneration
507135|NCT01402544|Genome|genome
507136|NCT01402531|Hereditary hemorrhagic telangiectasia (HHT)|hereditary hemorrhagic telangiectasia (hht)
507137|NCT01402531|nosebleed|nosebleed
507138|NCT01402531|Bevacizumab|bevacizumab
507139|NCT01402531|Avastin|avastin
507140|NCT01402518|achalasia|achalasia
507141|NCT01402518|myotomy|myotomy
507142|NCT01402518|endoscopic myotomy|endoscopic myotomy
507143|NCT01402518|difficulty swallowing|difficulty swallowing
507144|NCT01402505|obesity|obesity
507145|NCT01402505|sleeve gastrectomy|sleeve gastrectomy
507146|NCT01402505|transvaginal NOTES|transvaginal notes
507147|NCT01402492|Cocaine-Related disorders|cocaine-related disorders
507148|NCT01402492|Cocaine|cocaine
507149|NCT01402492|Substance-Related disorders|substance-related disorders
507150|NCT01402492|Opioid abuse|opioid abuse
507151|NCT01402492|Opioid dependence|opioid dependence
507152|NCT01402492|abuse|abuse
507153|NCT01402492|addiction|addiction
507154|NCT01402492|treatment|treatment
507155|NCT01402492|buprenorphine|buprenorphine
507156|NCT01402492|naltrexone|naltrexone
507157|NCT01402492|Suboxone|suboxone
507158|NCT01402492|Vivitrol|vivitrol
507159|NCT01402479|migraine,|migraine,
507160|NCT01402479|ramipril,|ramipril,
507161|NCT01402479|hypertension|hypertension
507162|NCT01402466|Drug users|drug users
507163|NCT01402466|criminal justice|criminal justice
507164|NCT01402466|HIV care|hiv care
507165|NCT01402466|HAART|haart
507166|NCT01402466|incarceration|incarceration
507167|NCT01402453|Incentives|incentives
507168|NCT01402453|Social psychology|social psychology
507169|NCT01402453|Randomized trial|randomized trial
507170|NCT01402453|Hypertension|hypertension
507171|NCT01402453|Intervention|intervention
507172|NCT01402453|Pilot Study|pilot study
507173|NCT01402440|Diffuse Large B-Cell Lymphoma,|diffuse large b-cell lymphoma,
507174|NCT01402440|Phase 1,|phase 1,
507175|NCT01402440|CD79 Mutation|cd79 mutation
507176|NCT01402427|Coronary Artery Disease|coronary artery disease
507177|NCT01402427|Coronary Angiography|coronary angiography
507178|NCT01402427|Percutaneous Coronary Intervention|percutaneous coronary intervention
507179|NCT01402427|Transradial|transradial
507180|NCT01402427|Radial Artery Spasm|radial artery spasm
507181|NCT01402427|Verapamil|verapamil
507182|NCT01402427|Adverse Effects|adverse effects
507183|NCT01402414|atopic dermatitis|atopic dermatitis
507184|NCT01402414|NB-UVB|nb-uvb
507185|NCT01402414|phototherapy|phototherapy
507186|NCT01402414|balneophototherapy|balneophototherapy
507187|NCT01402414|Bath-PUVA|bath-puva
507188|NCT01402414|SCORAD index|scorad index
507189|NCT01402401|HER2+,|her2+,
507190|NCT01402401|Gastric Cancer,|gastric cancer,
507191|NCT01402401|HSP90,|hsp90,
507192|NCT01402401|2nd-line,|2nd-line,
507193|NCT01402401|Trastuzumab|trastuzumab
507194|NCT01402375|Pain Management|pain management
507195|NCT01402375|Emergency Medicine|emergency medicine
507196|NCT01402375|Extremity Injuries|extremity injuries
507197|NCT01402362|Ethiopians|ethiopians
507198|NCT01402362|Diabetes Mellitus|diabetes mellitus
507199|NCT01402362|Glucose tolerance|glucose tolerance
507200|NCT01402362|Israel|israel
507201|NCT01402362|Included in the year 2000 study|included in the year 2000 study
507202|NCT01402349|Chronic rhinosinusitis, SNOT 22, Quality of life|chronic rhinosinusitis, snot 22, quality of life
507203|NCT01402336|Polycystic ovary syndrome|polycystic ovary syndrome
507204|NCT01402336|ovulation induction|ovulation induction
507205|NCT01402336|In vitro fertilization-embryo transfer|in vitro fertilization-embryo transfer
507206|NCT01402310|Onset of labor|onset of labor
507207|NCT01402310|Bishop score|bishop score
507208|NCT01402310|Cervical length|cervical length
507209|NCT01402310|Multiple proteins|multiple proteins
507210|NCT01402310|Cervicovaginal fluid|cervicovaginal fluid
507211|NCT01402297|apocynin|apocynin
507212|NCT01402297|COPD|copd
507213|NCT01402284|Novel Drug Combinations|novel drug combinations
507214|NCT01402284|Protease Inhibitors|protease inhibitors
507215|NCT01402284|Decreased Peripheral Neuropathy|decreased peripheral neuropathy
507216|NCT01402284|Auto Stem Cell Transplant|auto stem cell transplant
507217|NCT01402284|Multiple Myeloma|multiple myeloma
507218|NCT01402271|recurrent ovarian epithelial cancer|recurrent ovarian epithelial cancer
507219|NCT01402271|recurrent fallopian tube cancer|recurrent fallopian tube cancer
507220|NCT01402271|recurrent primary peritoneal cavity cancer|recurrent primary peritoneal cavity cancer
507221|NCT01402245|pneumonia|pneumonia
507222|NCT01402245|pneumococcal polysaccharide vaccine|pneumococcal polysaccharide vaccine
507223|NCT01402245|pneumococcal conjugate vaccine|pneumococcal conjugate vaccine
507224|NCT01402232|contrast-induced nephropathy|contrast-induced nephropathy
507225|NCT01402232|contrast medium|contrast medium
507226|NCT01402232|creatinine clearance|creatinine clearance
507227|NCT01402232|coronary angiography|coronary angiography
507228|NCT01402232|diabetes|diabetes
507229|NCT01402232|chronic kidney disease|chronic kidney disease
507230|NCT01402232|predictive|predictive
507231|NCT01402219|contrast-induced nephropathy|contrast-induced nephropathy
507232|NCT01402219|contrast medium|contrast medium
507233|NCT01402219|creatinine clearance|creatinine clearance
507234|NCT01402219|coronary angiography|coronary angiography
507235|NCT01402219|chronic kidney disease|chronic kidney disease
507236|NCT01402206|Depression|depression
507237|NCT01402206|Intervention|intervention
507238|NCT01402206|Primary health care|primary health care
507239|NCT01402193|Breast Cancer|breast cancer
507240|NCT01402193|Timing of Radiotherapy|timing of radiotherapy
507241|NCT01402193|TGF-beta1|tgf-beta1
507242|NCT01402180|Esophageal squamous cell carcinoma|esophageal squamous cell carcinoma
507243|NCT01402180|lymph nodes recurrence|lymph nodes recurrence
507244|NCT01402180|chemoradiation|chemoradiation
507245|NCT01402180|Nimotuzumab|nimotuzumab
507246|NCT01402141|Chungkookjang|chungkookjang
507247|NCT01402141|histamine|histamine
507248|NCT01402141|skin reaction|skin reaction
507250|NCT01402128|Soluble fiber|soluble fiber
507251|NCT01402128|Polycan|polycan
507252|NCT01402128|Overweight|overweight
507253|NCT01402128|LDL-C(Low Density Lipoprotein-cholesterol)|ldl-c(low density lipoprotein-cholesterol)
507254|NCT01402115|Polycan|polycan
507255|NCT01402115|Bone metabolism|bone metabolism
507256|NCT01402115|Osteocalcin|osteocalcin
507257|NCT01402115|Deoxypyridinoline|deoxypyridinoline
507258|NCT01402102|Aged garlic|aged garlic
507259|NCT01402102|Hyperlipidemic|hyperlipidemic
507260|NCT01402102|LDL|ldl
507261|NCT01402102|HDL|hdl
507262|NCT01402102|Triglyceride|triglyceride
507263|NCT01402089|phenotyping|phenotyping
507264|NCT01402089|cytochrome p450|cytochrome p450
507265|NCT01402089|erlotinib|erlotinib
507266|NCT01402089|sunitinib|sunitinib
507267|NCT01402089|lung cancer|lung cancer
507268|NCT01402089|renal-cell cancer|renal-cell cancer
507269|NCT01402089|gastrointestinal stromal tumor|gastrointestinal stromal tumor
507270|NCT01402076|Pharmacokinetics|pharmacokinetics
507271|NCT01402076|Drug Interaction|drug interaction
507272|NCT01402063|Brain Tumors|brain tumors
507273|NCT01402063|Glioblastoma Multiforme|glioblastoma multiforme
507274|NCT01402063|GBM|gbm
507275|NCT01402050|Time from the start of the induction to delivery|time from the start of the induction to delivery
507276|NCT01402037|type 1 diabetes|type 1 diabetes
507277|NCT01402037|Prevention|prevention
507278|NCT01402037|First degree relatives|first degree relatives
507279|NCT01402037|High risk for type 1 diabetes|high risk for type 1 diabetes
507280|NCT01402011|Prolotherapy|prolotherapy
507281|NCT01402011|regenerative injection therapy|regenerative injection therapy
507282|NCT01402011|dextrose injections|dextrose injections
507283|NCT01401998|cystic kidney disease|cystic kidney disease
507284|NCT01401998|polycystic kidney disease|polycystic kidney disease
507285|NCT01401998|congenital hepatic fibrosis|congenital hepatic fibrosis
507286|NCT01401998|genetic disease|genetic disease
507287|NCT01401985|Opioid induced constipation|opioid induced constipation
507288|NCT01401985|OIC|oic
507289|NCT01401985|Constipation|constipation
507290|NCT01401985|Opioid side effects|opioid side effects
507291|NCT01401985|morphine induced constipation|morphine induced constipation
507292|NCT01401972|prostate|prostate
507293|NCT01401972|cancer|cancer
507294|NCT01401972|ultrasound|ultrasound
507295|NCT01401972|spectroscopy|spectroscopy
507296|NCT01401959|Metastatic Breast Cancer|metastatic breast cancer
507297|NCT01401959|Adjuvant|adjuvant
507298|NCT01401959|Residual Disease|residual disease
507299|NCT01401959|eribulin|eribulin
507300|NCT01401959|Trastuzumab|trastuzumab
507301|NCT01401920|internal jugular vein cannulation|internal jugular vein cannulation
507302|NCT01401920|cross-sectional area|cross-sectional area
507303|NCT01401920|passive leg elevation|passive leg elevation
507304|NCT01401920|trendelenburg position|trendelenburg position
507305|NCT01401920|open heart surgery|open heart surgery
507306|NCT01401907|Palliative care|palliative care
507307|NCT01401907|Lung|lung
507308|NCT01401907|Gastric|gastric
507309|NCT01401907|Liver|liver
507310|NCT01401907|Pancreatic|pancreatic
507311|NCT01401907|Esophageal|esophageal
507312|NCT01401907|Caregiver|caregiver
507313|NCT01401894|advanced cancer|advanced cancer
507314|NCT01401868|solid tumor|solid tumor
507315|NCT01401868|recurrent|recurrent
507316|NCT01401868|advanced|advanced
507317|NCT01401868|metastatic|metastatic
507318|NCT01401855|Diagnosis|diagnosis
507319|NCT01401855|Fine Needle Aspiration Biopsy|fine needle aspiration biopsy
507320|NCT01401842|low back muscular strength and endurance|low back muscular strength and endurance
507321|NCT01401829|endometrial cancer|endometrial cancer
507322|NCT01401829|aerobic walking|aerobic walking
507323|NCT01401829|stretching/flexibility exercises|stretching/flexibility exercises
507324|NCT01401829|quality of life|quality of life
507325|NCT01401816|Adolescents|adolescents
507326|NCT01401816|Sexually Active|sexually active
507327|NCT01401816|Unprotected Sex|unprotected sex
507328|NCT01401816|Emergency Contraception|emergency contraception
507329|NCT01401803|periorbital|periorbital
507330|NCT01401803|glabella|glabella
507331|NCT01401803|ptosis|ptosis
507332|NCT01401803|eyelid|eyelid
507333|NCT01401803|brow|brow
507334|NCT01401790|Children|children
507335|NCT01401790|Adolescents|adolescents
507336|NCT01401790|Telehomecare|telehomecare
507337|NCT01401777|Kidney Tumors, Cryoablation, Biopsy|kidney tumors, cryoablation, biopsy
507338|NCT01401751|Type 1 Diabetes Mellitus|type 1 diabetes mellitus
507339|NCT01401751|Artificial Pancreas|artificial pancreas
507340|NCT01401738|Shoulder Arthroscopic Surgery|shoulder arthroscopic surgery
507341|NCT01401725|venous thromboembolism|venous thromboembolism
507342|NCT01401725|thromboprophylaxis|thromboprophylaxis
507343|NCT01401725|anticoagulants|anticoagulants
507344|NCT01401725|hospitalized medical patients|hospitalized medical patients
507345|NCT01401725|electronic order sets|electronic order sets
507346|NCT01401725|decision support|decision support
507347|NCT01401725|knowledge translation|knowledge translation
507348|NCT01401725|patient safety|patient safety
507349|NCT01401712|ON-Q|on-q
507350|NCT01401712|epidural|epidural
507351|NCT01401712|analgesia|analgesia
507352|NCT01401699|Barrett's|barrett's
507353|NCT01401699|esophagus|esophagus
507355|NCT01401699|imaging|imaging
507356|NCT01401673|Chronic Cough|chronic cough
507357|NCT01401673|Indantadol|indantadol
507358|NCT01401660|low back pain|low back pain
507359|NCT01401647|cardiac arrest|cardiac arrest
507360|NCT01401647|cardiopulmonary resuscitation|cardiopulmonary resuscitation
507361|NCT01401647|ventricular fibrillation|ventricular fibrillation
507362|NCT01401647|pulseless ventricular tachycardia|pulseless ventricular tachycardia
507363|NCT01401647|Non-traumatic Out of Hospital Cardiac Arrest (OOHCA)|non-traumatic out of hospital cardiac arrest (oohca)
507364|NCT01401634|Hyperglycemia Hydration|hyperglycemia hydration
507365|NCT01401621|behavioral economics|behavioral economics
507366|NCT01401621|nudge|nudge
507367|NCT01401621|scratch off|scratch off
507368|NCT01401621|blood pressure check|blood pressure check
507369|NCT01401621|cholesterol test|cholesterol test
507370|NCT01401608|VT|vt
507371|NCT01401608|ventricular tachycardia|ventricular tachycardia
507372|NCT01401608|ablation|ablation
507373|NCT01401608|magnetic navigation|magnetic navigation
507374|NCT01401608|robotic|robotic
507375|NCT01401582|health care|health care
507376|NCT01401582|dementia care|dementia care
507377|NCT01401582|caregiver support|caregiver support
507378|NCT01401582|epidemiological study|epidemiological study
507379|NCT01401569|Exercise,|exercise,
507380|NCT01401569|counseling,|counseling,
507381|NCT01401569|smoking cessation,|smoking cessation,
507382|NCT01401569|depressive disorders|depressive disorders
645346|NCT00847106|CD25|cd25
507383|NCT01401556|osteoporosis|osteoporosis
507384|NCT01401556|fracture|fracture
507385|NCT01401556|treatment|treatment
507386|NCT01401556|guidelines|guidelines
507387|NCT01401556|quality|quality
507388|NCT01401543|testosterone|testosterone
507389|NCT01401543|energy|energy
507390|NCT01401543|libido|libido
507391|NCT01401543|erectile function|erectile function
507392|NCT01401543|weak muscles|weak muscles
507393|NCT01401530|Neoplasms|neoplasms
507394|NCT01401530|Neoplasms by Histologic Type|neoplasms by histologic type
507395|NCT01401530|Lymphoma|lymphoma
507396|NCT01401530|Non-Hodgkin|non-hodgkin
507397|NCT01401530|T- Cell|t- cell
507398|NCT01401530|Lymphatic Diseases|lymphatic diseases
507399|NCT01401530|Lymphoproliferative Disorders|lymphoproliferative disorders
507400|NCT01401530|lmmune System Diseases|lmmune system diseases
507401|NCT01401530|lmmunoproliferative Disorders|lmmunoproliferative disorders
507402|NCT01401504|Anti-cancer|anti-cancer
507403|NCT01401504|ASP3026|asp3026
507404|NCT01401504|Anaplastic Lymphoma Kinase (ALK)|anaplastic lymphoma kinase (alk)
507405|NCT01401491|schizophrenia|schizophrenia
507406|NCT01401491|clozapine|clozapine
507407|NCT01401491|fluvoxamine|fluvoxamine
507408|NCT01401491|metabolic syndrome|metabolic syndrome
507409|NCT01401478|Secondary Hyperparathyroidism|secondary hyperparathyroidism
507410|NCT01401478|Chronic Renal Insufficiency|chronic renal insufficiency
507411|NCT01401465|perennial allergic rhinitis|perennial allergic rhinitis
507412|NCT01401465|PAR|par
507413|NCT01401452|Monoclonals|monoclonals
507414|NCT01401452|Moderate to severe plaque psoriasis|moderate to severe plaque psoriasis
507415|NCT01401452|Psoriasis Area & Severity Index (PASI)|psoriasis area & severity index (pasi)
507416|NCT01401452|Adalimumab|adalimumab
507417|NCT01401452|Biological disease modifying anti-rheumatic drugs (BDMARD)|biological disease modifying anti-rheumatic drugs (bdmard)
507418|NCT01401452|Co-morbidities|co-morbidities
507419|NCT01401452|Antibodies|antibodies
507420|NCT01401452|Disease Life Quality Index (DLQI)|disease life quality index (dlqi)
507421|NCT01401439|cystic fibrosis|cystic fibrosis
507422|NCT01401439|body mass index|body mass index
507423|NCT01401439|fat free mass|fat free mass
507424|NCT01401439|Children with cystic fibrosis|children with cystic fibrosis
507425|NCT01401426|overweight|overweight
507426|NCT01401426|Obesity, Morbid|obesity, morbid
507427|NCT01401374|Vitiligo Vulgaris|vitiligo vulgaris
507428|NCT01401374|Autoimmunity|autoimmunity
507429|NCT01401374|Thyroid Disease|thyroid disease
507430|NCT01401296|Depression|depression
507431|NCT01401296|Online-Therapy|online-therapy
507432|NCT01401296|Deprexis|deprexis
507433|NCT01401296|Self-help|self-help
507434|NCT01401257|PXT3003|pxt3003
507435|NCT01401257|Charcot-Marie-Tooth Disease|charcot-marie-tooth disease
507436|NCT01401257|Hereditary Motor and Sensory Neuropathies|hereditary motor and sensory neuropathies
507437|NCT01401231|depression|depression
507438|NCT01401231|pregnancy|pregnancy
507439|NCT01401218|thoracic aortic surgery|thoracic aortic surgery
507440|NCT01401218|acute kidney injury|acute kidney injury
507441|NCT01401205|shoulder arthroscopic surgery|shoulder arthroscopic surgery
507442|NCT01401205|dyspnea|dyspnea
507443|NCT01401205|airway diameter|airway diameter
507444|NCT01401192|thymidylate synthase|thymidylate synthase
507445|NCT01401179|Preterm Premature Rupture of Fetal Membranes|preterm premature rupture of fetal membranes
507446|NCT01401179|antibiotic therapy|antibiotic therapy
507447|NCT01401140|Coronary Artery Bypass|coronary artery bypass
507448|NCT01401140|Coronary Artery Surgery|coronary artery surgery
507449|NCT01401140|Coronary Artery Bypass Graft|coronary artery bypass graft
507450|NCT01401140|Coronary Revascularization|coronary revascularization
507451|NCT01401140|Cardiac microdialysis|cardiac microdialysis
507452|NCT01401140|Custodiol|custodiol
507453|NCT01401140|St Thomas|st thomas
507454|NCT01401140|Cardioplegic solutions|cardioplegic solutions
507455|NCT01401127|Type 1 Diabetes Mellitus|type 1 diabetes mellitus
507456|NCT01401127|Exercise|exercise
507457|NCT01401127|Continuous Subcutaneous Insulin Infusion|continuous subcutaneous insulin infusion
507458|NCT01401127|CSII|csii
507459|NCT01401127|Insulin Pump Therapy|insulin pump therapy
507460|NCT01401114|Wellnara|wellnara
507461|NCT01401114|Postmenopausal osteoporosis|postmenopausal osteoporosis
507462|NCT01401101|mental health|mental health
507463|NCT01401101|PTSD|ptsd
507464|NCT01401101|primary care|primary care
507465|NCT01401101|quality improvement|quality improvement
507466|NCT01401101|collaborative care|collaborative care
507467|NCT01401088|patient with refractory glaucoma|patient with refractory glaucoma
507468|NCT01401075|Quality of Life|quality of life
507469|NCT01401075|QoL|qol
507470|NCT01401075|EORTC QLQ-C30|eortc qlq-c30
507471|NCT01401075|EORTC QLQ-STO22|eortc qlq-sto22
507472|NCT01401075|5-FU|5-fu
507473|NCT01401075|Viscum album|viscum album
507474|NCT01401062|metastatic breast cancer|metastatic breast cancer
507475|NCT01401062|TGF-beta|tgf-beta
507476|NCT01401062|fresolimumab|fresolimumab
507477|NCT01401062|monoclonal antibody|monoclonal antibody
507478|NCT01401062|radiation therapy|radiation therapy
507479|NCT01401062|abscopal response|abscopal response
507480|NCT01401049|Fospropofol|fospropofol
507481|NCT01401049|Propofol|propofol
507482|NCT01401049|Colonoscopy|colonoscopy
507483|NCT01401049|Lusedra|lusedra
507484|NCT01401036|acute myocardial infarction|acute myocardial infarction
507485|NCT01401036|stents|stents
507486|NCT01401036|angioplasty|angioplasty
507487|NCT01401036|thrombosis|thrombosis
507488|NCT01401010|neutropenia|neutropenia
507489|NCT01401010|doripenem|doripenem
507490|NCT01400997|Growth disorders|growth disorders
507491|NCT01400997|Saizen|saizen
507492|NCT01400997|Easypod|easypod
507493|NCT01400997|Growth hormone|growth hormone
507494|NCT01400997|Pediatric subject|pediatric subject
507495|NCT01400984|Growth disorders|growth disorders
507496|NCT01400984|Saizen|saizen
507497|NCT01400984|Easypod|easypod
507498|NCT01400984|Growth hormone|growth hormone
507499|NCT01400984|Pediatric subject|pediatric subject
507500|NCT01400971|Diabetes|diabetes
507501|NCT01400971|Insulin|insulin
507502|NCT01400971|Progression|progression
507503|NCT01400971|Patient Reported Measures|patient reported measures
507504|NCT01400971|Adherence|adherence
507505|NCT01400971|Heterogeneity|heterogeneity
507506|NCT01400971|Hypoglycemia|hypoglycemia
507507|NCT01400958|fatigue|fatigue
507508|NCT01400958|external beam radiation|external beam radiation
507509|NCT01400958|EBRT|ebrt
507510|NCT01400958|radiation therapy|radiation therapy
507511|NCT01400958|placebo|placebo
507512|NCT01400958|cognitive function|cognitive function
507514|NCT01400958|Temozolomide|temozolomide
507515|NCT01400945|GERD|gerd
507516|NCT01400945|endoscopy|endoscopy
507517|NCT01400945|LA grade|la grade
507518|NCT01400945|heartburn|heartburn
507519|NCT01400932|inflammatory lesion|inflammatory lesion
507520|NCT01400932|Benzoyl peroxide (BPO)|benzoyl peroxide (bpo)
507521|NCT01400932|once daily|once daily
507522|NCT01400932|acne vulgaris|acne vulgaris
507523|NCT01400932|vehicle gel|vehicle gel
507524|NCT01400932|clindamycin (CLDM) 1%-BPO 3% gel|clindamycin (cldm) 1%-bpo 3% gel
507525|NCT01400932|non-inflammatory lesion|non-inflammatory lesion
507526|NCT01400919|Peripheral arterial disease|peripheral arterial disease
507527|NCT01400919|claudication|claudication
507528|NCT01400919|stent|stent
507529|NCT01400919|EverFlex|everflex
507530|NCT01400919|GPS|gps
507531|NCT01400919|Iliac Artery|iliac artery
507532|NCT01400893|Acute Renal Failure|acute renal failure
507533|NCT01400893|Acute kidney injury|acute kidney injury
507534|NCT01400893|Acute tubular necrosis|acute tubular necrosis
507535|NCT01400893|Continuous Renal Replacement Therapy|continuous renal replacement therapy
507536|NCT01400893|Severe sepsis|severe sepsis
507537|NCT01400893|Selective cytopheretic device|selective cytopheretic device
507538|NCT01400880|Maternal Fetal Monitoring|maternal fetal monitoring
507539|NCT01400867|Infections|infections
507540|NCT01400867|Pediatrics|pediatrics
507541|NCT01400867|Teflaro|teflaro
507542|NCT01400867|cephalosporin|cephalosporin
507543|NCT01400854|breakthrough cancer pain|breakthrough cancer pain
507544|NCT01400841|Aortic Insufficiency, Aortic Regurgitation, Aortic Valve Repair|aortic insufficiency, aortic regurgitation, aortic valve repair
507545|NCT01400815|smoking|smoking
507546|NCT01400815|smoking cessation|smoking cessation
507547|NCT01400815|quitting smoking|quitting smoking
507548|NCT01400776|Postmenopausal Women, Vaginal Dryness|postmenopausal women, vaginal dryness
507549|NCT01400763|focus of study|focus of study
507550|NCT01400750|cystic fibrosis- P aeruginosa- eradication-child|cystic fibrosis- p aeruginosa- eradication-child
507551|NCT01400737|ibuprofen|ibuprofen
507552|NCT01400737|prophylaxis|prophylaxis
507553|NCT01400737|VELBW|velbw
507554|NCT01400724|menopause|menopause
507555|NCT01400724|metabolic syndrome|metabolic syndrome
507556|NCT01400724|myo-inositol|myo-inositol
507557|NCT01400724|insulin resistance|insulin resistance
507558|NCT01400724|cocoa polyphenols|cocoa polyphenols
507559|NCT01400724|isoflavones|isoflavones
507560|NCT01400711|Fast-tract surgery, Enhanced recovery after surgery, multimodal surgery.|fast-tract surgery, enhanced recovery after surgery, multimodal surgery.
507561|NCT01400698|Intra-uterine growth retardation (IUGR)|intra-uterine growth retardation (iugr)
507562|NCT01400698|Saizen|saizen
507563|NCT01400698|Recombinant human growth hormone (r-hGH)|recombinant human growth hormone (r-hgh)
507564|NCT01400698|Final height|final height
507565|NCT01400698|Bone age|bone age
507566|NCT01400698|SGA (Small for Gestational Age)|sga (small for gestational age)
507567|NCT01400685|CLL|cll
507568|NCT01400685|Leukemia|leukemia
507569|NCT01400685|Untreated|untreated
507570|NCT01400685|B-CLL|b-cll
507571|NCT01400685|SLL|sll
507572|NCT01400672|Diffuse intrinsic pontine glioma|diffuse intrinsic pontine glioma
507573|NCT01400659|CSII|csii
507574|NCT01400659|prandial insulin requirements|prandial insulin requirements
507575|NCT01400659|bolus calculation|bolus calculation
507576|NCT01400659|dual-wave bolus|dual-wave bolus
507577|NCT01400646|Rivaroxaban|rivaroxaban
507578|NCT01400646|JNJ-39039039|jnj-39039039
645593|NCT00846092|NIR|nir
507579|NCT01400646|BAY59-7939|bay59-7939
507580|NCT01400646|Warfarin|warfarin
507581|NCT01400646|Transition|transition
507582|NCT01400633|Myelodysplastic Syndrome|myelodysplastic syndrome
507583|NCT01400633|Dacogen|dacogen
507584|NCT01400633|decitabine|decitabine
507585|NCT01400633|epigenetic therapy|epigenetic therapy
507586|NCT01400633|hypomethylating agent|hypomethylating agent
507587|NCT01400620|oral mucositis|oral mucositis
507588|NCT01400620|chemoradiation|chemoradiation
507589|NCT01400620|head and neck cancer|head and neck cancer
507590|NCT01400607|cartilage|cartilage
507591|NCT01400607|knee surgery|knee surgery
507592|NCT01400607|cartilage injury|cartilage injury
507593|NCT01400607|knee pain|knee pain
507594|NCT01400607|cartilage repair|cartilage repair
507595|NCT01400607|cartilage damage|cartilage damage
507596|NCT01400607|cartilage lesion|cartilage lesion
507597|NCT01400607|cartilage defect|cartilage defect
507598|NCT01400607|articular cartilage lesion|articular cartilage lesion
507599|NCT01400607|articular cartilage defect|articular cartilage defect
507600|NCT01400607|juvenile|juvenile
507601|NCT01400607|cells|cells
507602|NCT01400607|ISTO Technologies|isto technologies
507603|NCT01400607|Neocartilage|neocartilage
507604|NCT01400607|RevaFlex|revaflex
507605|NCT01400594|Onychomycosis|onychomycosis
507606|NCT01400555|Prostate Cancer|prostate cancer
507607|NCT01400555|Metastatic Castration-Resistant Prostate Cancer|metastatic castration-resistant prostate cancer
507608|NCT01400555|Abiraterone Acetate|abiraterone acetate
507609|NCT01400555|Docetaxel|docetaxel
507610|NCT01400555|Prednisone|prednisone
507611|NCT01400555|Dexamethasone|dexamethasone
507612|NCT01400542|Early Onset Alzheimer Disease|early onset alzheimer disease
507613|NCT01400542|Alzheimer Disease|alzheimer disease
507614|NCT01400542|Sleep Apnea Syndromes|sleep apnea syndromes
507615|NCT01400542|Obstructive Sleep Apnea Syndromes|obstructive sleep apnea syndromes
507616|NCT01400542|Cognitive functions|cognitive functions
507617|NCT01400542|Continuous Positive Airway Pressure (CPAP) treatment|continuous positive airway pressure (cpap) treatment
507618|NCT01400529|Osteoarthritis|osteoarthritis
507619|NCT01400529|knee|knee
507620|NCT01400529|hip|hip
507621|NCT01400529|population based|population based
507622|NCT01400516|Rheumatoid Arthritis|rheumatoid arthritis
507623|NCT01400516|Bone erosion|bone erosion
507624|NCT01400516|Osteopenia|osteopenia
507625|NCT01400503|Multicentric Castleman's Disease|multicentric castleman's disease
507626|NCT01400503|Multicentric|multicentric
507627|NCT01400503|Castleman|castleman
507628|NCT01400503|Siltuximab|siltuximab
507629|NCT01400503|Long term safety|long term safety
507630|NCT01400477|Drug Trial|drug trial
507631|NCT01400477|Smoking|smoking
507632|NCT01400477|Smoking Cessation|smoking cessation
507633|NCT01400477|Cognition|cognition
507634|NCT01400477|Mental Focus|mental focus
507635|NCT01400464|Giant Cell Arteritis|giant cell arteritis
507636|NCT01400464|prednisone|prednisone
507637|NCT01400464|pharmacokinetics|pharmacokinetics
507638|NCT01400438|Herceptin|herceptin
507639|NCT01400438|Breast cancer|breast cancer
507640|NCT01400438|Quality of life|quality of life
507641|NCT01400438|fatigue|fatigue
507642|NCT01400399|AJCC DCIS or T1- T2, N0|ajcc dcis or t1- t2, n0
507643|NCT01400373|Hypothermia, induced|hypothermia, induced
507644|NCT01400373|Intra-arrest cooling|intra-arrest cooling
507645|NCT01400373|Cardiac arrest|cardiac arrest
507646|NCT01400373|Prehospital emergency care|prehospital emergency care
507647|NCT01400373|Emergency Medical Services|emergency medical services
507648|NCT01400360|cerebral vasospasm|cerebral vasospasm
507649|NCT01400360|subarachnoid hemorrhage|subarachnoid hemorrhage
507650|NCT01400360|transluminal balloon angioplasty|transluminal balloon angioplasty
507651|NCT01400360|intraarterial treatment|intraarterial treatment
507652|NCT01400347|Motor activity, lower extremity, physical exercise|motor activity, lower extremity, physical exercise
507653|NCT01400334|Ischemic Cardiomyopathy|ischemic cardiomyopathy
507654|NCT01400334|Sudden Cardiac Death|sudden cardiac death
507655|NCT01400334|Positron Emission Tomography|positron emission tomography
507656|NCT01400334|Hibernating Myocardium|hibernating myocardium
507657|NCT01400334|Denervated Myocardium|denervated myocardium
507658|NCT01400321|dental implant|dental implant
507659|NCT01400321|soft tissue maintenance|soft tissue maintenance
507660|NCT01400321|bone remodelling|bone remodelling
507661|NCT01400321|inclined atrophy|inclined atrophy
507662|NCT01400308|Methicillin Resistant Staphylococcus Aureus colonization.|methicillin resistant staphylococcus aureus colonization.
507663|NCT01400308|Methicillin Resistant Staphylococcus Aureus infection.|methicillin resistant staphylococcus aureus infection.
507664|NCT01400295|contrast-induced nephropathy|contrast-induced nephropathy
507665|NCT01400295|contrast medium|contrast medium
507666|NCT01400295|creatinine clearance|creatinine clearance
507667|NCT01400295|coronary angiography|coronary angiography
507668|NCT01400295|diabetes|diabetes
507669|NCT01400295|chronic kidney disease|chronic kidney disease
507670|NCT01400269|PACE|pace
507671|NCT01400256|diagnostic|diagnostic
507672|NCT01400243|Marijuana|marijuana
507673|NCT01400243|Drug withdrawal symptoms|drug withdrawal symptoms
507674|NCT01400243|Nicotine|nicotine
507675|NCT01400230|computed tomography|computed tomography
507676|NCT01400230|intravascular ultrasound|intravascular ultrasound
507677|NCT01400230|coronary stenosis|coronary stenosis
507678|NCT01400230|fractional flow reserve|fractional flow reserve
507679|NCT01400217|Primary Care|primary care
507680|NCT01400217|Particle size|particle size
507681|NCT01400217|beclomethasone dipropionate|beclomethasone dipropionate
507682|NCT01400217|Asthma Management|asthma management
507683|NCT01400217|Maintenance Therapy|maintenance therapy
507684|NCT01400217|Metered-Dose Inhaler|metered-dose inhaler
507685|NCT01400204|hangover|hangover
507686|NCT01400204|next day effects|next day effects
507687|NCT01400204|MDMA|mdma
507688|NCT01400204|Alcohol|alcohol
507689|NCT01400191|Metformin|metformin
507690|NCT01400191|Hypoglycemic Agents|hypoglycemic agents
507691|NCT01400191|Diabetes Mellitus, Type 2|diabetes mellitus, type 2
507692|NCT01400191|Gluconeogenesis|gluconeogenesis
507693|NCT01400191|Pharmacodynamics|pharmacodynamics
507694|NCT01400191|Pharmacogenetics|pharmacogenetics
507695|NCT01400178|cochlear implant|cochlear implant
507696|NCT01400178|children|children
507697|NCT01400178|follow up|follow up
507698|NCT01400178|results|results
507699|NCT01400165|Therapeutic Equivalency|therapeutic equivalency
507700|NCT01400165|Human Experimentation|human experimentation
507701|NCT01400165|Bioequivalence|bioequivalence
507702|NCT01400165|Brand name|brand name
507703|NCT01400165|Generic|generic
507704|NCT01400165|Healthy volunteers|healthy volunteers
507705|NCT01400152|Hypothermia, body temperature regulation,thermal comfort, active warming, passive warming, prehospital trauma care|hypothermia, body temperature regulation,thermal comfort, active warming, passive warming, prehospital trauma care
507706|NCT01400139|Pain|pain
507707|NCT01400139|Nonmalignant pain|nonmalignant pain
507708|NCT01400139|Nonneuropathic Pain|nonneuropathic pain
507709|NCT01400139|Opioid|opioid
507710|NCT01400126|Ultrapure water,hemodialysis, CRP, blood pressure|ultrapure water,hemodialysis, crp, blood pressure
507711|NCT01400113|Acute Agitation|acute agitation
507712|NCT01400113|schizophrenia|schizophrenia
507713|NCT01400113|bipolar|bipolar
507714|NCT01400113|psychosis|psychosis
507715|NCT01400113|panss-ec|panss-ec
507716|NCT01400100|octreotide|octreotide
507717|NCT01400100|intraarterial|intraarterial
507718|NCT01400100|pancreatic hardness|pancreatic hardness
507820|NCT01399567|depression|depression
507719|NCT01400100|pancreatoduodenectomy|pancreatoduodenectomy
507720|NCT01400100|durometer|durometer
507721|NCT01400100|dynamometer|dynamometer
507722|NCT01400087|colonoscopy|colonoscopy
507723|NCT01400087|Lower Gastrointestinal Tract|lower gastrointestinal tract
507724|NCT01400087|Cecal intubation|cecal intubation
507725|NCT01400087|Cap-attached colonoscopy|cap-attached colonoscopy
507726|NCT01400087|Trainee|trainee
507727|NCT01400061|obesity, etiology, pathogenesis, treatment|obesity, etiology, pathogenesis, treatment
507728|NCT01400035|acute cerebral infarction, Vinpocetine|acute cerebral infarction, vinpocetine
507729|NCT01400022|lichen|lichen
507730|NCT01400022|sclerosus|sclerosus
507731|NCT01400022|genital|genital
507732|NCT01400022|vulvar|vulvar
507733|NCT01400022|UVA1|uva1
507734|NCT01400009|Statin|statin
507735|NCT01400009|HMG COA Reductase Inhibitor|hmg coa reductase inhibitor
507736|NCT01400009|myalgia|myalgia
507737|NCT01400009|vitamin D|vitamin d
507738|NCT01399996|probiotic|probiotic
507739|NCT01399996|microbiota|microbiota
507740|NCT01399996|transit time|transit time
507741|NCT01399996|immunity|immunity
507742|NCT01399996|immune function|immune function
507743|NCT01399996|constipation|constipation
507744|NCT01399996|bowel function|bowel function
507745|NCT01399983|six minute walk|six minute walk
507746|NCT01399970|Mobile Teledermatology|mobile teledermatology
507747|NCT01399970|Telemedicine|telemedicine
507748|NCT01399970|Acne|acne
507749|NCT01399957|Multiple Sclerosis|multiple sclerosis
507750|NCT01399957|Dalfampridine-ER|dalfampridine-er
507751|NCT01399957|Walking speed|walking speed
507752|NCT01399944|bitter taste|bitter taste
507753|NCT01399944|psychophysics|psychophysics
507754|NCT01399944|genetics|genetics
507755|NCT01399944|epigenetics|epigenetics
507756|NCT01399944|bitterness sensitivity|bitterness sensitivity
507757|NCT01399931|Early stage|early stage
507758|NCT01399918|Kidney|kidney
507759|NCT01399918|Everolimus|everolimus
507760|NCT01399918|Bevacizumab|bevacizumab
507761|NCT01399918|10-226|10-226
507762|NCT01399918|non-clear cell histology|non-clear cell histology
507763|NCT01399918|Advanced|advanced
507764|NCT01399905|Parkinson's disease|parkinson's disease
507765|NCT01399905|Levodopa|levodopa
507766|NCT01399905|Carbidopa|carbidopa
507767|NCT01399905|Blood brain barrier|blood brain barrier
507768|NCT01399879|Surface potential|surface potential
507769|NCT01399879|Electrical|electrical
507770|NCT01399879|Motion stabilization|motion stabilization
507771|NCT01399866|D-cycloserine|d-cycloserine
507772|NCT01399866|Smoking cues|smoking cues
507773|NCT01399866|Cognitive remediation|cognitive remediation
507774|NCT01399866|physiologic reactivity|physiologic reactivity
507775|NCT01399866|craving|craving
507776|NCT01399853|immunogenicity|immunogenicity
507777|NCT01399853|safety|safety
507778|NCT01399853|inactivated EV71 vaccine|inactivated ev71 vaccine
507779|NCT01399801|Cardiac Resynchronization Therapy|cardiac resynchronization therapy
507780|NCT01399801|medically refractory heart failure patients|medically refractory heart failure patients
507781|NCT01399788|Bioequivalence|bioequivalence
507782|NCT01399788|Healthy Volunteers|healthy volunteers
507783|NCT01399775|Atrophy of Edentulous Alveolar Ridge|atrophy of edentulous alveolar ridge
507784|NCT01399775|Dental Prosthesis, Implant-Supported|dental prosthesis, implant-supported
507785|NCT01399775|Dental Implants, Single-Tooth|dental implants, single-tooth
507786|NCT01399762|stroke, acute|stroke, acute
507787|NCT01399762|mechanical recanalization|mechanical recanalization
507788|NCT01399762|interventional neuroradiology|interventional neuroradiology
507789|NCT01399762|clinical registry|clinical registry
507790|NCT01399749|Cartilage|cartilage
507791|NCT01399749|Articular|articular
507792|NCT01399749|Femoral|femoral
507793|NCT01399749|Knee|knee
507794|NCT01399749|Chondrocytes|chondrocytes
507795|NCT01399749|Adipose tissue-derived mesenchymal stem cells|adipose tissue-derived mesenchymal stem cells
507796|NCT01399736|PCI FFR STEMI MVD|pci ffr stemi mvd
507797|NCT01399736|FFR guided PCI in acute STEMI patients with MVD|ffr guided pci in acute stemi patients with mvd
507798|NCT01399723|Severe pneumonia|severe pneumonia
507799|NCT01399710|colorectal cancer|colorectal cancer
507800|NCT01399710|CT colonography|ct colonography
507801|NCT01399710|CAD|cad
507802|NCT01399671|depression|depression
507803|NCT01399671|vestibular|vestibular
507804|NCT01399658|Brachytherapy|brachytherapy
507805|NCT01399658|Gynecological cancer|gynecological cancer
507806|NCT01399645|Randomized trial|randomized trial
507807|NCT01399645|Open label|open label
507808|NCT01399645|Pilot study|pilot study
507809|NCT01399645|Single center|single center
507810|NCT01399606|Excessive Daytime Sleepiness (EDS)|excessive daytime sleepiness (eds)
507811|NCT01399606|Narcolepsy|narcolepsy
507812|NCT01399593|Antibody Mediated Rejection|antibody mediated rejection
507813|NCT01399593|AMR|amr
507814|NCT01399593|Acute Humoral Rejection|acute humoral rejection
507815|NCT01399593|AHR|ahr
507816|NCT01399593|Living Donor|living donor
507817|NCT01399593|Kidney Transplant|kidney transplant
507818|NCT01399580|endothelin receptor antagonists|endothelin receptor antagonists
507819|NCT01399567|pain|pain
507821|NCT01399567|nursing homes|nursing homes
507822|NCT01399567|diffusion of innovations|diffusion of innovations
507823|NCT01399567|clinical trial|clinical trial
507824|NCT01399541|Symptoms|symptoms
507825|NCT01399541|Symptoms cluster|symptoms cluster
507826|NCT01399541|Fatigue|fatigue
507827|NCT01399541|Depression|depression
507828|NCT01399541|Sleeplessness|sleeplessness
507829|NCT01399541|Social support|social support
507830|NCT01399541|Stigma|stigma
507831|NCT01399515|Retinitis pigmentosa|retinitis pigmentosa
507832|NCT01399515|Valproic acid|valproic acid
507833|NCT01399502|Depression|depression
507834|NCT01399502|Self Care|self care
507835|NCT01399489|Aerobic exercise|aerobic exercise
507836|NCT01399489|Moderate intensity|moderate intensity
507837|NCT01399489|Ambulatory blood pressure|ambulatory blood pressure
507838|NCT01399489|Post exercise hypotension|post exercise hypotension
507839|NCT01399476|Achalasia|achalasia
507840|NCT01399463|Drug Eluting Stent, Drug Eluting Balloon, Fractional Flow Reserve, DES, DEB, FFR|drug eluting stent, drug eluting balloon, fractional flow reserve, des, deb, ffr
507841|NCT01399450|Schizophrenia, depressive symptom, paliperidone|schizophrenia, depressive symptom, paliperidone
507842|NCT01399437|Default Network|default network
507843|NCT01399437|Schizophrenia|schizophrenia
507844|NCT01399437|fMRI|fmri
507845|NCT01399437|Spatial Attention|spatial attention
507846|NCT01399437|Sentinel Function|sentinel function
507847|NCT01399424|Shigellosis|shigellosis
507848|NCT01399424|Safety and Immunogenicity|safety and immunogenicity
507849|NCT01399424|Conjugate Vaccine|conjugate vaccine
507850|NCT01399424|Shigella|shigella
507851|NCT01399424|Vaccine|vaccine
507852|NCT01399411|Self-Reported|self-reported
507853|NCT01399411|Farming|farming
507854|NCT01399411|Agriculture|agriculture
507855|NCT01399411|Disease Validation|disease validation
507856|NCT01399411|Autoimmune Disorders|autoimmune disorders
507857|NCT01399398|Brain Scan|brain scan
507858|NCT01399398|Kinetic Analysis|kinetic analysis
507859|NCT01399398|Healthy Subjects|healthy subjects
507860|NCT01399398|Healthy Volunteer|healthy volunteer
507861|NCT01399398|HV|hv
507862|NCT01399385|Arteriosclerosis|arteriosclerosis
507863|NCT01399385|Arteriosclerosis, Narrowing of Vessels|arteriosclerosis, narrowing of vessels
507864|NCT01399385|Endothelial Dysfunction|endothelial dysfunction
507865|NCT01399385|Hardening of the arteries|hardening of the arteries
507866|NCT01399385|Noninvasive Plaque Imaging|noninvasive plaque imaging
645979|NCT00844454|PEI|pei
507867|NCT01399385|Cardiovascular Disease|cardiovascular disease
507868|NCT01399385|Heart Disease|heart disease
507869|NCT01399385|Healthy Volunteer|healthy volunteer
507870|NCT01399385|HV|hv
507871|NCT01399372|neurotoxicity|neurotoxicity
507872|NCT01399372|chemotherapeutic agent toxicity|chemotherapeutic agent toxicity
507873|NCT01399372|radiation toxicity|radiation toxicity
507874|NCT01399372|cognitive/functional effects|cognitive/functional effects
507875|NCT01399372|primary central nervous system non-Hodgkin lymphoma|primary central nervous system non-hodgkin lymphoma
507876|NCT01399359|breast cancer|breast cancer
507877|NCT01399346|Insulin aspart|insulin aspart
507878|NCT01399346|Type 1 diabetes|type 1 diabetes
507879|NCT01399346|Glucose clamp|glucose clamp
507880|NCT01399346|Pharmacodynamics|pharmacodynamics
507881|NCT01399346|Pharmacokinetics|pharmacokinetics
507882|NCT01399346|Rapid Acting Insulin Analog|rapid acting insulin analog
507883|NCT01399333|PDCAAS|pdcaas
507884|NCT01399333|Bariatric patient|bariatric patient
507885|NCT01399320|Pilonidal disease|pilonidal disease
507886|NCT01399320|Excision|excision
507887|NCT01399320|cyanoacrylate|cyanoacrylate
507888|NCT01399307|Stem|stem
507889|NCT01399307|Cell|cell
507890|NCT01399307|Antria|antria
507891|NCT01399307|Adipose|adipose
507892|NCT01399307|Stromal|stromal
507893|NCT01399307|Vascular|vascular
507894|NCT01399307|Fraction|fraction
507895|NCT01399307|Shahram|shahram
507896|NCT01399307|Shah|shah
507897|NCT01399307|Rahimian|rahimian
507898|NCT01399294|Palliative Care|palliative care
507899|NCT01399294|Advanced Cancer|advanced cancer
507900|NCT01399294|Constipation|constipation
507901|NCT01399294|Traditional Chinese Medicine|traditional chinese medicine
507902|NCT01399294|Syndrome Distribution|syndrome distribution
507903|NCT01399281|juvenile idiopathic arthritis, biologics, methotrexate|juvenile idiopathic arthritis, biologics, methotrexate
507904|NCT01399268|Bilateral total knee replacement|bilateral total knee replacement
507905|NCT01399268|cytokine|cytokine
507906|NCT01399268|desmosine|desmosine
507907|NCT01399242|Disorder Related to Renal Transplantation|disorder related to renal transplantation
507908|NCT01399203|contrast-induced nephropathy|contrast-induced nephropathy
507909|NCT01399203|contrast medium|contrast medium
507910|NCT01399203|creatinine clearance|creatinine clearance
507911|NCT01399203|percutaneous coronary intervention|percutaneous coronary intervention
507912|NCT01399164|Vitamin B-12|vitamin b-12
507913|NCT01399151|Vitamin D|vitamin d
507914|NCT01399151|Immune function|immune function
507915|NCT01399138|Pre-diabetes|pre-diabetes
507916|NCT01399138|Metabolic syndrome|metabolic syndrome
507917|NCT01399138|Diabetes|diabetes
507918|NCT01399138|Hypertension|hypertension
507919|NCT01399138|Blueberries|blueberries
507920|NCT01399138|Anthocyanins|anthocyanins
507921|NCT01399138|Insulin sensitivity|insulin sensitivity
507922|NCT01399138|Insulin resistance|insulin resistance
507923|NCT01399125|Alzheimer's|alzheimer's
507924|NCT01399125|Rivastigmine|rivastigmine
507925|NCT01399125|Patch|patch
507926|NCT01399125|Dementia|dementia
507927|NCT01399112|Smoking Cessation|smoking cessation
507928|NCT01399112|First episode psychosis|first episode psychosis
507929|NCT01399112|Electronic Decision Support System|electronic decision support system
507930|NCT01399099|scar|scar
507931|NCT01399099|incision|incision
507932|NCT01399099|wound healing|wound healing
507933|NCT01399099|scarring|scarring
507934|NCT01399099|post-surgical|post-surgical
507935|NCT01399086|Cancer|cancer
507936|NCT01399086|Breast|breast
507937|NCT01399086|Metastatic|metastatic
507938|NCT01399086|Hormonotherapy|hormonotherapy
507939|NCT01399073|stroke|stroke
507940|NCT01399073|neglect|neglect
507941|NCT01399073|hemianopsia|hemianopsia
507942|NCT01399073|virtual reality|virtual reality
507943|NCT01399060|Cough|cough
507944|NCT01399060|tobacco smoke exposure|tobacco smoke exposure
507945|NCT01399047|Batten Disease|batten disease
507946|NCT01399034|Epigenomics|epigenomics
507947|NCT01399034|DNA methylation|dna methylation
507948|NCT01399034|MicroRNA|microrna
507949|NCT01399034|Periodontitis|periodontitis
507950|NCT01399034|Inflammation|inflammation
507951|NCT01399034|Obesity|obesity
507952|NCT01399021|Parotidectomy|parotidectomy
507953|NCT01399021|Drain removal|drain removal
507954|NCT01399021|Timing|timing
507955|NCT01399021|Hematoma|hematoma
507956|NCT01399021|Surgical wound infection|surgical wound infection
507957|NCT01399008|Hyperuricemia|hyperuricemia
507958|NCT01398995|Type 1 Diabetes|type 1 diabetes
507959|NCT01398995|Exercise|exercise
507960|NCT01398995|continuous subcutaneous insulin infusion|continuous subcutaneous insulin infusion
507961|NCT01398969|Randomized|randomized
507962|NCT01398969|Double Blind|double blind
507963|NCT01398969|Fecal Transplant|fecal transplant
507964|NCT01398969|Recurrent|recurrent
507965|NCT01398969|Clostridium difficile infection|clostridium difficile infection
507966|NCT01398969|CDI|cdi
507967|NCT01398969|HBT|hbt
507968|NCT01398969|Diarrhea|diarrhea
507969|NCT01398969|Frozen HBT|frozen hbt
507970|NCT01398969|Thawed HBT|thawed hbt
507971|NCT01398969|Fecal Enema|fecal enema
507972|NCT01398956|Levetiracetam|levetiracetam
507973|NCT01398956|Epilepsy|epilepsy
507974|NCT01398956|Generalized tonic-clonic seizures|generalized tonic-clonic seizures
507975|NCT01398943|flow-mediated dilation|flow-mediated dilation
507976|NCT01398943|arterial stiffness|arterial stiffness
507977|NCT01398943|intima-media thickness|intima-media thickness
507978|NCT01398943|pulse wave velocity|pulse wave velocity
507979|NCT01398943|dual energy x-ray absorptiometry|dual energy x-ray absorptiometry
507980|NCT01398943|inflammatory markers|inflammatory markers
507981|NCT01398943|blood lipids|blood lipids
507982|NCT01398943|tetrahydrobiopterin|tetrahydrobiopterin
507983|NCT01398943|body mass index|body mass index
507984|NCT01398943|hemoglobin A1c|hemoglobin a1c
507985|NCT01398943|complete blood count|complete blood count
507986|NCT01398943|oxidative stress biomarkers|oxidative stress biomarkers
507987|NCT01398943|pulmonary function test|pulmonary function test
507988|NCT01398943|lung|lung
507989|NCT01398943|COPD|copd
507990|NCT01398930|acupuncture; knee osteoarthritis; adjunctive therapy; chronic pain; algometer; etoricoxib.|acupuncture; knee osteoarthritis; adjunctive therapy; chronic pain; algometer; etoricoxib.
507991|NCT01398917|psc|psc
507992|NCT01398917|dominant stricture|dominant stricture
507993|NCT01398904|BDD|bdd
507994|NCT01398878|Medical education, graduate|medical education, graduate
507995|NCT01398878|Patient care|patient care
507996|NCT01398878|Outcome assessment (Health care)|outcome assessment (health care)
507997|NCT01398878|Work schedule tolerance|work schedule tolerance
507998|NCT01398865|BDD|bdd
507999|NCT01398826|Type 1 Diabetes|type 1 diabetes
508000|NCT01398826|Exercise|exercise
508001|NCT01398826|Continuous glucose monitoring|continuous glucose monitoring
508002|NCT01398813|HED|hed
508003|NCT01398813|XLHED|xlhed
508004|NCT01398774|Pseudohypoparathyroidism|pseudohypoparathyroidism
508005|NCT01398774|Albright Hereditary Osteodystrophy|albright hereditary osteodystrophy
508006|NCT01398761|Continuity of patient care|continuity of patient care
508007|NCT01398761|Workflow|workflow
508008|NCT01398761|Quality of signout|quality of signout
508009|NCT01398761|Web based|web based
508010|NCT01398761|Handoffs|handoffs
508011|NCT01398761|Multi disciplinary|multi disciplinary
508012|NCT01398761|Written signout|written signout
508013|NCT01398761|Information science|information science
508014|NCT01398748|Parkinson's disease|parkinson's disease
508015|NCT01398748|Neuroprotection|neuroprotection
508016|NCT01398748|Glutathione|glutathione
508017|NCT01398748|Intranasal|intranasal
508018|NCT01398722|cardiac surgery|cardiac surgery
508019|NCT01398722|prognosis|prognosis
508020|NCT01398722|intensive insulin therapy|intensive insulin therapy
508021|NCT01398709|Cardiopulmonary Bypass|cardiopulmonary bypass
508022|NCT01398709|Prognosis|prognosis
508023|NCT01398709|Cardiac Surgery|cardiac surgery
508024|NCT01398709|Rewarming Rate|rewarming rate
508025|NCT01398696|Patient Information Leaflets|patient information leaflets
508026|NCT01398696|primary care|primary care
508027|NCT01398696|patient behaviour|patient behaviour
508028|NCT01398696|pharyngitis|pharyngitis
508029|NCT01398696|gastroenteritis|gastroenteritis
508030|NCT01398670|Type I Diabetes|type i diabetes
508031|NCT01398670|Wockhardt's Insulin analogue Lispro|wockhardt's insulin analogue lispro
508032|NCT01398670|Humalog®|humalog®
508033|NCT01398670|Humalog Mix|humalog mix
508034|NCT01398670|Wockhardt|wockhardt
508035|NCT01398670|Biosimilar|biosimilar
508036|NCT01398670|Phase 3|phase 3
508037|NCT01398657|localized|localized
508038|NCT01398657|High risk|high risk
508039|NCT01398657|Prostate Cancer|prostate cancer
508040|NCT01398657|Randomized|randomized
508041|NCT01398657|Cryotherapy|cryotherapy
508042|NCT01398657|Cryoablation|cryoablation
508043|NCT01398657|Adjuvant|adjuvant
508044|NCT01398657|Androgen Deprivation Therapy|androgen deprivation therapy
508045|NCT01398657|Hormone therapy|hormone therapy
508047|NCT01398644|Phlebotomy|phlebotomy
508048|NCT01398644|Therapeutic erythrocytapheresis|therapeutic erythrocytapheresis
508049|NCT01398644|Hereditary Hemochromatosis|hereditary hemochromatosis
508050|NCT01398644|maintenance therapy|maintenance therapy
508051|NCT01398631|Risk scores|risk scores
508052|NCT01398631|ACS|acs
508053|NCT01398631|HEART-score|heart-score
508054|NCT01398618|latent tuberculosis infection|latent tuberculosis infection
508055|NCT01398618|tuberculosis|tuberculosis
508056|NCT01398618|interferon-gamma release assay|interferon-gamma release assay
508057|NCT01398618|preventive therapy|preventive therapy
508058|NCT01398618|9-month isoniazid|9-month isoniazid
508059|NCT01398618|4-month rifampin|4-month rifampin
508060|NCT01398605|Postmenopausal women|postmenopausal women
508061|NCT01398605|Physical activity|physical activity
508062|NCT01398605|Cardiovascular risks|cardiovascular risks
508063|NCT01398605|Cardiac function|cardiac function
508064|NCT01398605|Dose-response|dose-response
508065|NCT01398592|Diabetes mellitus Type two|diabetes mellitus type two
508066|NCT01398592|T2DM|t2dm
508067|NCT01398592|vildagliptin|vildagliptin
508068|NCT01398592|sitagliptin|sitagliptin
508069|NCT01398592|FPG|fpg
508070|NCT01398592|DPP-4|dpp-4
508071|NCT01398579|intestinal metaplasia|intestinal metaplasia
508072|NCT01398579|dysplasia|dysplasia
508073|NCT01398579|probe-based confocal endomicroscopy|probe-based confocal endomicroscopy
508074|NCT01398566|TBI|tbi
508075|NCT01398566|concussion|concussion
508076|NCT01398566|brain injury|brain injury
508077|NCT01398553|stroke|stroke
508078|NCT01398553|tbi|tbi
508079|NCT01398553|rehabilitation|rehabilitation
508080|NCT01398553|upper limb|upper limb
508081|NCT01398527|Long-Term Care|long-term care
508082|NCT01398527|Vitamin D|vitamin d
508083|NCT01398501|AML|aml
508084|NCT01398501|FLT3-ITD|flt3-itd
508085|NCT01398501|Stem cell transplant|stem cell transplant
508086|NCT01398488|Trough levels|trough levels
508087|NCT01398488|Education|education
508088|NCT01398488|Adherence|adherence
508089|NCT01398449|thoracic esophageal squamous cell carcinoma|thoracic esophageal squamous cell carcinoma
508090|NCT01398449|esophagectomy|esophagectomy
508091|NCT01398449|elective nodal irradiation|elective nodal irradiation
508092|NCT01398449|adjuvant chemotherapy|adjuvant chemotherapy
508093|NCT01398436|Central venous saturation|central venous saturation
508094|NCT01398436|Mixed venous saturation|mixed venous saturation
508095|NCT01398436|Right atrium|right atrium
508096|NCT01398436|Central Venous Catheter position|central venous catheter position
508097|NCT01398423|Hypertension|hypertension
508098|NCT01398423|Diabetes mellitis|diabetes mellitis
508099|NCT01398423|Nephropathy|nephropathy
508100|NCT01398423|Albuminuria|albuminuria
508101|NCT01398410|Rabeprazole|rabeprazole
508102|NCT01398410|proton pump inhibitor|proton pump inhibitor
508103|NCT01398410|Acetylsalicylic Acid|acetylsalicylic acid
508104|NCT01398410|Aspirin|aspirin
508105|NCT01398410|Gastric Ulcer|gastric ulcer
508106|NCT01398410|Duodenal Ulcer|duodenal ulcer
508107|NCT01398397|HED|hed
508108|NCT01398397|XLHED|xlhed
508109|NCT01398397|X-linked Hypohidrotic Ectodermal Dysplasia (XLHED)|x-linked hypohidrotic ectodermal dysplasia (xlhed)
508110|NCT01398384|ST Elevation MI|st elevation mi
508111|NCT01398384|STEMI|stemi
508112|NCT01398371|Heart failure|heart failure
508113|NCT01398371|Digoxin withdrawal|digoxin withdrawal
508114|NCT01398358|obesity|obesity
508115|NCT01398358|prevention|prevention
508116|NCT01398358|children|children
508117|NCT01398319|prevention|prevention
508118|NCT01398319|alcohol abuse|alcohol abuse
508119|NCT01398306|Angiogenesis Inhibitors|angiogenesis inhibitors
508120|NCT01398306|Neoplasms, Glandular and Epithelial|neoplasms, glandular and epithelial
508121|NCT01398306|Neoplasms by Histologic Type|neoplasms by histologic type
508122|NCT01398306|Neoplasms|neoplasms
508123|NCT01398306|Adenocarcinoma|adenocarcinoma
508124|NCT01398306|Kidney Neoplasms|kidney neoplasms
508125|NCT01398306|Urologic Neoplasms|urologic neoplasms
508126|NCT01398306|Urogenital Neoplasms|urogenital neoplasms
508127|NCT01398306|Neoplasms by Site|neoplasms by site
508128|NCT01398306|Kidney Diseases|kidney diseases
508129|NCT01398306|Angiogenesis Inducing Agents|angiogenesis inducing agents
508130|NCT01398306|Biological Markers|biological markers
508131|NCT01398280|Rosacea|rosacea
508132|NCT01398280|Dermatology|dermatology
508133|NCT01398280|UCSD|ucsd
508134|NCT01398280|Skin disease|skin disease
508135|NCT01398254|ST-Elevation Myocardial Infarction|st-elevation myocardial infarction
508136|NCT01398254|Mortality|mortality
508137|NCT01398228|Quality of care|quality of care
508138|NCT01398228|Acute Coronary Syndromes (ACS)|acute coronary syndromes (acs)
508139|NCT01398215|umbilical hernia|umbilical hernia
508140|NCT01398215|ventral hernia|ventral hernia
508141|NCT01398202|Vitamin D status|vitamin d status
508142|NCT01398202|25-hydroxyvitamin D|25-hydroxyvitamin d
508143|NCT01398202|Vitamin D3|vitamin d3
508144|NCT01398202|RCT|rct
508145|NCT01398202|Bio-efficacy|bio-efficacy
508146|NCT01398189|clozapine|clozapine
508147|NCT01398189|PET|pet
508148|NCT01398189|schizophrenia|schizophrenia
508149|NCT01398189|schizoaffective disorder|schizoaffective disorder
508150|NCT01398176|gamma delta T cell|gamma delta t cell
508151|NCT01398176|proliferation|proliferation
508152|NCT01398163|probiotics|probiotics
508153|NCT01398163|digestive well-being|digestive well-being
508154|NCT01398163|fMRI|fmri
508155|NCT01398163|brain-gut axis|brain-gut axis
508156|NCT01398150|gamma delta T cell|gamma delta t cell
508157|NCT01398150|proliferation|proliferation
508158|NCT01398150|cytokine secretion|cytokine secretion
508159|NCT01398150|immune function|immune function
508160|NCT01398150|antioxidant status|antioxidant status
508161|NCT01398137|Ragweed allergy|ragweed allergy
508162|NCT01398124|early stage non-small cell lung cancer|early stage non-small cell lung cancer
508163|NCT01398124|non-small cell lung cancer|non-small cell lung cancer
508164|NCT01398085|Papillary thyroid carcinoma|papillary thyroid carcinoma
508165|NCT01398085|Follicular thyroid carcinoma|follicular thyroid carcinoma
508166|NCT01398085|Hurthle cell carcinoma of the thyroid|hurthle cell carcinoma of the thyroid
508167|NCT01398085|Iodine Radioisotopes|iodine radioisotopes
508168|NCT01398059|Sedentary Behavior|sedentary behavior
508169|NCT01398059|Cardiometabolic Risk|cardiometabolic risk
508170|NCT01398059|Pediatrics|pediatrics
508171|NCT01398046|dasatinib|dasatinib
508172|NCT01398046|betaine|betaine
508173|NCT01398046|betaine hydrochloride|betaine hydrochloride
508174|NCT01398046|pharmacokinetics|pharmacokinetics
508175|NCT01398046|healthy volunteer|healthy volunteer
508176|NCT01398033|infrapopliteal arteries|infrapopliteal arteries
508177|NCT01398033|In-stent stenosis|in-stent stenosis
508178|NCT01398033|long lesions|long lesions
508179|NCT01398033|drug-coated balloon|drug-coated balloon
508180|NCT01398020|Bowel Preparation|bowel preparation
508181|NCT01398020|Patient comfort|patient comfort
508182|NCT01398020|Bi-Peglyte|bi-peglyte
508183|NCT01397994|Nicorandil therapy in patients of chronic stable angina|nicorandil therapy in patients of chronic stable angina
508184|NCT01397968|partial onset seizures|partial onset seizures
508185|NCT01397968|treatment resistant|treatment resistant
508186|NCT01397968|partial epilepsy|partial epilepsy
508187|NCT01397955|Julina|julina
508188|NCT01397955|Postmenopausal osteoporosis|postmenopausal osteoporosis
508189|NCT01397942|Diet intervention|diet intervention
508190|NCT01397942|Type 2 diabetes|type 2 diabetes
508191|NCT01397942|Vegetables|vegetables
508192|NCT01397942|Phytochemicals|phytochemicals
508193|NCT01397916|CLL|cll
508194|NCT01397916|IDO|ido
508195|NCT01397903|antidepressant therapy, inadequate control, add-on therapy|antidepressant therapy, inadequate control, add-on therapy
508196|NCT01397890|Severe chronic obstructive pulmonary disease (COPD) patients|severe chronic obstructive pulmonary disease (copd) patients
508197|NCT01397877|endometrial cancer|endometrial cancer
508198|NCT01397877|BKM|bkm
508199|NCT01397877|monotherapy|monotherapy
508200|NCT01397877|metastatic|metastatic
508201|NCT01397877|initial treatment|initial treatment
508202|NCT01397864|Hereditary Angioedema|hereditary angioedema
508203|NCT01397864|HAE|hae
508204|NCT01397864|Angioedema|angioedema
508205|NCT01397864|Recombinant C1 Inhibitor|recombinant c1 inhibitor
508206|NCT01397864|rhC1INH|rhc1inh
508207|NCT01397864|registry|registry
508208|NCT01397838|Osteopenia|osteopenia
508209|NCT01397812|Rejection of the Heart Transplant|rejection of the heart transplant
508210|NCT01397812|Heart Transplant Rejection, an immune-mediated allograft injury|heart transplant rejection, an immune-mediated allograft injury
508211|NCT01397812|Non-cellular or humoral rejection in cardiac transplant recipients|non-cellular or humoral rejection in cardiac transplant recipients
508212|NCT01397812|Right ventricular endomyocardial biopsy to detect Heart transplant rejection|right ventricular endomyocardial biopsy to detect heart transplant rejection
508213|NCT01397799|Acute Myelogenous Leukemia|acute myelogenous leukemia
508214|NCT01397799|AML|aml
508215|NCT01397799|Refractory|refractory
508216|NCT01397799|Elderly|elderly
508217|NCT01397773|Hemodialysis|hemodialysis
508218|NCT01397773|peritoneal dialysis|peritoneal dialysis
508219|NCT01397773|chronic kidney disease|chronic kidney disease
508220|NCT01397773|inflammation|inflammation
508221|NCT01397773|carotis intima media thickness|carotis intima media thickness
508222|NCT01397760|DIFFICULT TO CONTROL ASTHMA|difficult to control asthma
508223|NCT01397760|OMALIZUMABE|omalizumabe
508224|NCT01397747|Cancer|cancer
508225|NCT01397747|Colorectal Cancer|colorectal cancer
508226|NCT01397747|Neoplasm|neoplasm
508227|NCT01397747|Colorectal Neoplasm|colorectal neoplasm
508228|NCT01397747|Intestinal Neoplasms|intestinal neoplasms
508229|NCT01397747|Gastrointestinal Neoplasms|gastrointestinal neoplasms
508230|NCT01397747|Digestive System Neoplasms|digestive system neoplasms
508231|NCT01397747|Neoplasms by Site|neoplasms by site
508232|NCT01397747|Neoplasms|neoplasms
508233|NCT01397747|Digestive System Diseases|digestive system diseases
508234|NCT01397747|Gastrointestinal Diseases|gastrointestinal diseases
508235|NCT01397747|Colonic Diseases|colonic diseases
508236|NCT01397747|Intestinal Diseases|intestinal diseases
508237|NCT01397747|Rectal Diseases|rectal diseases
508238|NCT01397734|CML|cml
508239|NCT01397734|Chronic myelogenous leukemia|chronic myelogenous leukemia
508240|NCT01397734|Chronic Myeloid leukemia|chronic myeloid leukemia
508241|NCT01397734|Arsenic|arsenic
508242|NCT01397734|Arsenic trioxide|arsenic trioxide
508243|NCT01397734|Imatinib|imatinib
508244|NCT01397734|Dasatinib|dasatinib
508245|NCT01397734|Nilotinib|nilotinib
508246|NCT01397734|TKI|tki
508247|NCT01397734|Tyrosine kinase inhibitor|tyrosine kinase inhibitor
508248|NCT01397721|Chronic Obstructive Pulmonary Disease (COPD)|chronic obstructive pulmonary disease (copd)
508249|NCT01397721|pulmonary vasculature|pulmonary vasculature
508250|NCT01397721|pulmonary hypertension|pulmonary hypertension
508251|NCT01397721|atherosclerosis|atherosclerosis
508252|NCT01397721|smokers|smokers
508253|NCT01397721|emphysema|emphysema
508254|NCT01397708|Melanoma|melanoma
508255|NCT01397708|Unresectable|unresectable
508256|NCT01397682|Comprehensive Geriatric Assessment|comprehensive geriatric assessment
508257|NCT01397682|Frail elderly|frail elderly
508258|NCT01397682|Italy/epidemiology|italy/epidemiology
508259|NCT01397682|Geriatric Health Service|geriatric health service
508260|NCT01397682|Polypharmacy|polypharmacy
508261|NCT01397682|Biological Markers|biological markers
508262|NCT01397682|Epidemiologic Research Design|epidemiologic research design
508263|NCT01397656|cardiac arrest|cardiac arrest
508265|NCT01397656|resuscitation|resuscitation
508266|NCT01397656|fatigue|fatigue
508267|NCT01397656|quality|quality
508268|NCT01397565|Cholecystectomy|cholecystectomy
508269|NCT01397565|Laparoscopy|laparoscopy
508270|NCT01397565|Minilaparoscopic surgery|minilaparoscopic surgery
508271|NCT01397565|Post-operative pain|post-operative pain
508272|NCT01397565|Recovery time|recovery time
508273|NCT01397526|Congenital heart disease|congenital heart disease
508274|NCT01397526|Cardiopulmonary bypass|cardiopulmonary bypass
508275|NCT01397526|Capillary leak|capillary leak
508276|NCT01397526|Colloid osmotic pressure|colloid osmotic pressure
508277|NCT01397526|Children|children
508278|NCT01397513|Fibrin network structure|fibrin network structure
508279|NCT01397513|Aspirin treatment|aspirin treatment
508280|NCT01397513|Platelet microparticles|platelet microparticles
508281|NCT01397487|morphometric parameters, embryo biopsy|morphometric parameters, embryo biopsy
508282|NCT01397474|peripheral perfusion|peripheral perfusion
508283|NCT01397474|critically ill patients|critically ill patients
508284|NCT01397474|fluid administration|fluid administration
508285|NCT01397448|Rabeprazole|rabeprazole
508286|NCT01397448|proton pump inhibitor|proton pump inhibitor
508287|NCT01397448|Acetylsalicylic Acid|acetylsalicylic acid
508288|NCT01397448|Aspirin|aspirin
508289|NCT01397448|Gastric Ulcer|gastric ulcer
508290|NCT01397448|Duodenal Ulcer|duodenal ulcer
508291|NCT01397435|Lysosomal diseases|lysosomal diseases
508292|NCT01397435|Magnetic resonance Spectroscopy|magnetic resonance spectroscopy
508293|NCT01397435|MRI|mri
508294|NCT01397422|Levodopa-induced dyskinesia|levodopa-induced dyskinesia
508295|NCT01397422|Parkinsonism|parkinsonism
508296|NCT01397370|Safety|safety
508297|NCT01397370|Tolerability|tolerability
508298|NCT01397370|Pharmacokinetics|pharmacokinetics
508299|NCT01397370|Pharmacodynamics|pharmacodynamics
508300|NCT01397357|Cardiac magnetic resonance|cardiac magnetic resonance
508301|NCT01397357|Myocardial Ischemia|myocardial ischemia
508302|NCT01397357|Coronary Artery Disease|coronary artery disease
508303|NCT01397357|suspected Myocardial Ischemia|suspected myocardial ischemia
508304|NCT01397344|People in the outpatient waiting room|people in the outpatient waiting room
508305|NCT01397331|inhalational anesthesia|inhalational anesthesia
508306|NCT01397331|intravenous anesthesia|intravenous anesthesia
508307|NCT01397331|cardiac surgery|cardiac surgery
508308|NCT01397318|TaiChi Exercise|taichi exercise
508309|NCT01397318|pregnant women|pregnant women
508310|NCT01397305|5,10-methylenetetrahydrofolate|5,10-methylenetetrahydrofolate
508311|NCT01397305|neoadjuvant therapy|neoadjuvant therapy
508312|NCT01397305|pemetrexed|pemetrexed
508313|NCT01397305|Neoplasms|neoplasms
508314|NCT01397305|Rectal Neoplasms|rectal neoplasms
508315|NCT01397305|Colorectal Neoplasms|colorectal neoplasms
508316|NCT01397305|Intestinal Neoplasms|intestinal neoplasms
508317|NCT01397305|Gastrointestinal Neoplasms|gastrointestinal neoplasms
508318|NCT01397305|Digestive System Neoplasms|digestive system neoplasms
508319|NCT01397305|Neoplasms by Site|neoplasms by site
508320|NCT01397305|Rectal Diseases|rectal diseases
508321|NCT01397305|Digestive System Diseases|digestive system diseases
508322|NCT01397305|Gastrointestinal Diseases|gastrointestinal diseases
508323|NCT01397305|Intestinal Diseases|intestinal diseases
508324|NCT01397305|Pharmacologic Actions|pharmacologic actions
508325|NCT01397305|Therapeutic Uses|therapeutic uses
508326|NCT01397305|Antineoplastic Agents|antineoplastic agents
508327|NCT01397305|Enzyme Inhibitors|enzyme inhibitors
508328|NCT01397305|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action
508329|NCT01397305|Folic Acid Antagonists|folic acid antagonists
508330|NCT01397305|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic
508331|NCT01397305|Antimetabolites|antimetabolites
508332|NCT01397292|Bronchoscopy|bronchoscopy
508333|NCT01397292|Interventional Pulmonary|interventional pulmonary
508334|NCT01397292|Pleuroscopy|pleuroscopy
508335|NCT01397292|Tracheostomy|tracheostomy
508336|NCT01397279|type 2 diabetes|type 2 diabetes
508337|NCT01397279|insulin sensitivity|insulin sensitivity
508338|NCT01397279|hyperinsulinemic euglycemic clamp|hyperinsulinemic euglycemic clamp
508339|NCT01397266|Transcranial Magnetic Stimulation|transcranial magnetic stimulation
508340|NCT01397266|Cocaine|cocaine
508341|NCT01397266|impulsivity|impulsivity
508342|NCT01397266|rating scale|rating scale
508343|NCT01397253|Automated Communication Tools|automated communication tools
508344|NCT01397253|Medication errors|medication errors
508345|NCT01397253|PCP communication|pcp communication
508346|NCT01397227|Malaria|malaria
508347|NCT01397227|Plasmodium falciparum|plasmodium falciparum
508348|NCT01397227|Vaccination|vaccination
508349|NCT01397227|Prophylaxis|prophylaxis
508350|NCT01397227|Adenovirus|adenovirus
508351|NCT01397188|PiCCO|picco
508352|NCT01397175|Coronary artery disease|coronary artery disease
508353|NCT01397175|Percutaneous coronary intervention|percutaneous coronary intervention
508354|NCT01397175|Drug-eluting stent|drug-eluting stent
508355|NCT01397149|Chronic lymphocytic leukemia|chronic lymphocytic leukemia
508356|NCT01397149|Thrombocytopenia|thrombocytopenia
508357|NCT01397149|Alkylating agents|alkylating agents
508358|NCT01397149|Purine derivatives|purine derivatives
508359|NCT01397149|TPO receptor agonist|tpo receptor agonist
508360|NCT01397136|Human embryo|human embryo
508361|NCT01397136|Culture media|culture media
508362|NCT01397136|Cell-free DNA|cell-free dna
508363|NCT01397136|In vitro fertilization|in vitro fertilization
508364|NCT01397136|Infertility|infertility
508365|NCT01397123|BMI z-score|bmi z-score
508366|NCT01397123|children|children
508367|NCT01397123|overweight|overweight
508368|NCT01397123|school-based intervention|school-based intervention
508369|NCT01397123|trained teachers|trained teachers
508370|NCT01397123|fruit|fruit
508371|NCT01397123|vegetables|vegetables
508372|NCT01397123|Low nutrition energy dense foods|low nutrition energy dense foods
508373|NCT01397084|esomeprazole 20mg|esomeprazole 20mg
508374|NCT01397084|heartburn|heartburn
508375|NCT01397084|rabeprazole 10mg|rabeprazole 10mg
508376|NCT01397084|reflux esophagitis|reflux esophagitis
508377|NCT01397084|Phase IV|phase iv
508378|NCT01397071|Avocado, antioxidant|avocado, antioxidant
508379|NCT01397045|Lung|lung
508380|NCT01397045|Nodule|nodule
508381|NCT01397045|Rehabilitation|rehabilitation
508382|NCT01397045|VATS|vats
508383|NCT01397045|Thoracotomy|thoracotomy
508384|NCT01397032|attention bias modification treatment|attention bias modification treatment
508385|NCT01397032|cognitive bias modification|cognitive bias modification
508386|NCT01397032|attention training|attention training
508387|NCT01397032|social anxiety|social anxiety
508388|NCT01397019|Pancreatic cancer|pancreatic cancer
508389|NCT01397019|Chemotherapy|chemotherapy
508390|NCT01397019|Chemoradiotherapy|chemoradiotherapy
508391|NCT01397006|Fibromyalgia|fibromyalgia
508392|NCT01397006|pregabalin|pregabalin
508393|NCT01397006|Lyrica|lyrica
508394|NCT01396980|hemodialysis|hemodialysis
508395|NCT01396980|intensive care|intensive care
508396|NCT01396980|microcirculation|microcirculation
508397|NCT01396967|capsulorhexis|capsulorhexis
508398|NCT01396954|Liver cirrhosis|liver cirrhosis
508399|NCT01396954|Diabetes mellitus|diabetes mellitus
508400|NCT01396954|Hepatogenous diabetes|hepatogenous diabetes
508401|NCT01396954|Oral glucose tolerance test|oral glucose tolerance test
508402|NCT01396954|Insulin resistance.|insulin resistance.
508403|NCT01396941|Diabetes|diabetes
508404|NCT01396928|Low rectal adenocarcinoma|low rectal adenocarcinoma
508405|NCT01396915|Skeletal muscle lipid content|skeletal muscle lipid content
508406|NCT01396915|whole muscle volume|whole muscle volume
508407|NCT01396915|fasting glucose|fasting glucose
508408|NCT01396915|insulin|insulin
508409|NCT01396915|blood urea nitrogen|blood urea nitrogen
508410|NCT01396889|Upper Respiratory Tract Infections|upper respiratory tract infections
508411|NCT01396889|Echinacea|echinacea
508412|NCT01396889|viral infections|viral infections
508413|NCT01396876|Medical clown|medical clown
508414|NCT01396876|Pediatric emergency medicine|pediatric emergency medicine
508515|NCT01396499|ALL|all
508415|NCT01396876|Emergency procedures|emergency procedures
508416|NCT01396863|Renal dialysis|renal dialysis
508417|NCT01396863|Hemodiafiltration|hemodiafiltration
508418|NCT01396863|Hemodialysis|hemodialysis
508419|NCT01396863|MRI|mri
508420|NCT01396850|Psychotic Patients|psychotic patients
508421|NCT01396837|Diabetic Foot Ulcer|diabetic foot ulcer
508422|NCT01396837|Diabetic Ulcer|diabetic ulcer
508423|NCT01396837|Diabetic Wound|diabetic wound
508424|NCT01396837|Chronic Ulcer|chronic ulcer
508425|NCT01396837|Chronic Wound|chronic wound
508426|NCT01396837|Neuropathic Diabetic Foot Ulcer|neuropathic diabetic foot ulcer
508427|NCT01396837|Neuropathic DFU|neuropathic dfu
508428|NCT01396837|DFU|dfu
508429|NCT01396824|Malnutrition|malnutrition
508430|NCT01396824|Undernutrition|undernutrition
508431|NCT01396824|Nutrition Assessment|nutrition assessment
508432|NCT01396824|Nutritional Assessment|nutritional assessment
508433|NCT01396824|Nutritional Index|nutritional index
508434|NCT01396824|Prognostic Nutritional Index|prognostic nutritional index
508435|NCT01396824|Prognostic Nutritional Index (PNI)|prognostic nutritional index (pni)
508436|NCT01396824|Nutritional Status|nutritional status
508437|NCT01396824|Prognosis|prognosis
508438|NCT01396824|Heart Failure|heart failure
508439|NCT01396824|Cardiovascular Diseases|cardiovascular diseases
508440|NCT01396824|Body Composition|body composition
508441|NCT01396824|Body Weights and Measures|body weights and measures
508442|NCT01396811|Tinea Pedis|tinea pedis
508443|NCT01396811|Antifungal|antifungal
508444|NCT01396798|serious infections|serious infections
508445|NCT01396798|meningitis|meningitis
508446|NCT01396785|Tinea Pedis|tinea pedis
508447|NCT01396785|Antifungal|antifungal
508448|NCT01396772|prediabetes|prediabetes
508449|NCT01396772|diabetes prevention|diabetes prevention
508450|NCT01396772|adults|adults
508451|NCT01396772|lifestyle intervention|lifestyle intervention
508452|NCT01396772|Social Cognitive Theory|social cognitive theory
646746|NCT00841256|SIT|sit
508453|NCT01396772|dietary intake|dietary intake
508454|NCT01396772|physical activity|physical activity
508455|NCT01396759|Bubble CPAP|bubble cpap
508456|NCT01396759|Humidified high flow|humidified high flow
508457|NCT01396759|Hypoxaemia|hypoxaemia
508458|NCT01396759|Nasal prong|nasal prong
508459|NCT01396759|Severe pneumonia|severe pneumonia
508460|NCT01396733|thyroid|thyroid
508461|NCT01396733|cancer|cancer
508462|NCT01396733|redifferentiation|redifferentiation
508463|NCT01396733|lipoic acid|lipoic acid
508464|NCT01396707|HER2|her2
508465|NCT01396707|Trastuzumab|trastuzumab
508466|NCT01396707|XELOX|xelox
508467|NCT01396707|PHASE 2|phase 2
508468|NCT01396681|resected pancreatic cancer|resected pancreatic cancer
508469|NCT01396668|locally advanced|locally advanced
508470|NCT01396655|breast cancer|breast cancer
508471|NCT01396655|neoadjuvant chemotherapy|neoadjuvant chemotherapy
508472|NCT01396655|molecular marker|molecular marker
508473|NCT01396655|FDG PET|fdg pet
508474|NCT01396655|locally advanced breast cancer|locally advanced breast cancer
508475|NCT01396642|Topical Emollient Therapy|topical emollient therapy
508476|NCT01396642|Emollient|emollient
508477|NCT01396642|Preterm|preterm
508478|NCT01396642|Hospital Acquired Infection|hospital acquired infection
508479|NCT01396629|cartridge IOL|cartridge iol
508480|NCT01396603|Optical Frequency Domain Imaging|optical frequency domain imaging
508481|NCT01396603|Optical Coherence Tomography|optical coherence tomography
508482|NCT01396603|Optical biopsy|optical biopsy
508483|NCT01396603|Comprehensive Microscopy|comprehensive microscopy
508484|NCT01396590|Central Nervous System|central nervous system
508485|NCT01396577|Central Nervous System|central nervous system
508486|NCT01396564|Type 2 diabetes|type 2 diabetes
508487|NCT01396564|Resistin|resistin
508488|NCT01396564|Inflammation|inflammation
508489|NCT01396564|Insulin Resistance|insulin resistance
508490|NCT01396551|Anchored Beacon Transponder|anchored beacon transponder
508491|NCT01396551|Anchored Transponder|anchored transponder
508492|NCT01396551|Lung cancer|lung cancer
508493|NCT01396551|Calypso system|calypso system
508494|NCT01396551|Realtime tracking|realtime tracking
508495|NCT01396538|anti-HBc alone ；occult HBV infection|anti-hbc alone ；occult hbv infection
508496|NCT01396525|Atherosclerosis|atherosclerosis
508497|NCT01396525|Peripheral artery disease|peripheral artery disease
508498|NCT01396525|Peripheral vascular disease|peripheral vascular disease
508499|NCT01396525|PAD|pad
508500|NCT01396525|Claudication|claudication
508501|NCT01396525|Peripheral Arterial Occlusive Disease|peripheral arterial occlusive disease
508502|NCT01396525|Stent|stent
508503|NCT01396525|PAOD|paod
508504|NCT01396525|PVD|pvd
508505|NCT01396512|Japanese Encephalitis|japanese encephalitis
508506|NCT01396512|Japanese Encephalitis Virus Disease|japanese encephalitis virus disease
508507|NCT01396512|IMOJEV™|imojev™
508508|NCT01396512|CD.JEVAX™|cd.jevax™
508509|NCT01396499|Leukemia|leukemia
508510|NCT01396499|Acute leukemias|acute leukemias
508511|NCT01396499|Relapsed/refractory leukemias|relapsed/refractory leukemias
508512|NCT01396499|Acute myelogenous leukemia|acute myelogenous leukemia
508513|NCT01396499|AML|aml
508514|NCT01396499|Acute lymphoblastic leukemia|acute lymphoblastic leukemia
508516|NCT01396499|BKM120|bkm120
508517|NCT01396486|Omega-3 Fatty Acids|omega-3 fatty acids
508518|NCT01396486|Fish Oil|fish oil
508519|NCT01396486|Inositol|inositol
508520|NCT01396486|Natural supplements|natural supplements
508521|NCT01396486|Bipolar Spectrum Disorders|bipolar spectrum disorders
508522|NCT01396486|Mania|mania
508523|NCT01396486|Depression|depression
508524|NCT01396486|Children|children
508525|NCT01396473|afterschool|afterschool
508526|NCT01396473|accelerometers|accelerometers
508527|NCT01396473|plate waste|plate waste
508528|NCT01396473|policy|policy
508529|NCT01396473|environment|environment
508530|NCT01396460|respiratory quotient|respiratory quotient
508531|NCT01396460|fat oxidation|fat oxidation
508532|NCT01396460|morbid obesity|morbid obesity
508533|NCT01396460|bariatric|bariatric
508534|NCT01396460|Bariatric Surgery|bariatric surgery
508535|NCT01396447|Bipolar I disorder|bipolar i disorder
508536|NCT01396447|Bipolar depression|bipolar depression
508537|NCT01396447|Depression|depression
508538|NCT01396447|Bipolar disorder|bipolar disorder
508539|NCT01396395|Nicorandil|nicorandil
508540|NCT01396395|Stable angina|stable angina
508541|NCT01396382|neuroendocrine|neuroendocrine
508542|NCT01396382|neuroendocrine carcinoma|neuroendocrine carcinoma
508543|NCT01396382|neuroendocrine tumor|neuroendocrine tumor
508544|NCT01396382|carcinoid|carcinoid
508545|NCT01396382|carcinoid tumor|carcinoid tumor
508546|NCT01396382|islet cell tumor|islet cell tumor
508547|NCT01396382|APUDoma|apudoma
508548|NCT01396382|Gallium|gallium
508549|NCT01396382|PET Scan|pet scan
508550|NCT01396343|Pediatric Multiple Sclerosis|pediatric multiple sclerosis
508551|NCT01396343|Relapsing Remitting Multiple Sclerosis|relapsing remitting multiple sclerosis
508552|NCT01396343|Clinically Isolated Syndrome|clinically isolated syndrome
646832|NCT00840931|MDS|mds
508553|NCT01396343|Demyelinating Disease|demyelinating disease
508554|NCT01396317|PMR|pmr
508555|NCT01396317|POLYMYALGIA RHEUMATICA|polymyalgia rheumatica
508556|NCT01396317|Tocilizumab|tocilizumab
508557|NCT01396317|Hospital for Special Surgery|hospital for special surgery
508558|NCT01396317|HSS|hss
508559|NCT01396317|Robert Spiera|robert spiera
508560|NCT01396304|leg ulcer|leg ulcer
508561|NCT01396304|infection|infection
508562|NCT01396304|closure|closure
508563|NCT01396304|wound dressings|wound dressings
508564|NCT01396239|DMD|dmd
508565|NCT01396226|Atrial refractoriness|atrial refractoriness
508566|NCT01396226|cardiac electrophysiology|cardiac electrophysiology
508567|NCT01396226|IKACh|ikach
508568|NCT01396213|larazotide acetate|larazotide acetate
508569|NCT01396187|Type 2 diabetes|type 2 diabetes
508570|NCT01396187|safety|safety
508571|NCT01396187|multiple dose|multiple dose
508572|NCT01396187|intravenous|intravenous
508573|NCT01396174|breast cancer|breast cancer
508574|NCT01396174|breast tumor|breast tumor
508575|NCT01396161|Phase 1|phase 1
508576|NCT01396161|Multiple Doses|multiple doses
508577|NCT01396161|Safety|safety
508578|NCT01396161|Pharmacokinetics|pharmacokinetics
508579|NCT01396161|Pharmacodynamics|pharmacodynamics
508580|NCT01396161|Healthy Volunteers|healthy volunteers
508581|NCT01396161|Type 2 Diabetic Patients|type 2 diabetic patients
508582|NCT01396148|Children and young adults with GIST|children and young adults with gist
508583|NCT01396148|sunitinib malate|sunitinib malate
508584|NCT01396148|pharmacokinetics|pharmacokinetics
508585|NCT01396148|tumor response|tumor response
508586|NCT01396148|overall survival|overall survival
508587|NCT01396148|tumor KIT mutation status|tumor kit mutation status
508588|NCT01396135|Phase 1|phase 1
508589|NCT01396135|Pharmacokinetics|pharmacokinetics
508590|NCT01396135|Healthy|healthy
508591|NCT01396135|Japanese|japanese
508592|NCT01396135|Non-smokers|non-smokers
508593|NCT01396135|Major Depressive Disorder|major depressive disorder
508594|NCT01396135|CP-601|cp-601
508595|NCT01396135|927|927
508596|NCT01396096|Bariatric Surgery|bariatric surgery
508597|NCT01396083|Visual impairment|visual impairment
508598|NCT01396083|macular edema|macular edema
508599|NCT01396083|Central retinal vein occlusion|central retinal vein occlusion
508600|NCT01396083|Dexamethasone implant|dexamethasone implant
508601|NCT01396083|Ranibizumab|ranibizumab
508602|NCT01396057|Visual impairment|visual impairment
508603|NCT01396057|macular edema|macular edema
508604|NCT01396057|branch retinal vein occlusion|branch retinal vein occlusion
508605|NCT01396057|Dexamethasone implant|dexamethasone implant
508606|NCT01396057|Ranibizumab|ranibizumab
508607|NCT01396044|Quality improvement|quality improvement
508608|NCT01396044|Checklist|checklist
508609|NCT01396044|Critical care|critical care
508610|NCT01396044|Anti-bacterial agents|anti-bacterial agents
508611|NCT01396044|Mechanical ventilation|mechanical ventilation
508612|NCT01395966|with tubes|with tubes
508613|NCT01395953|Buspirone|buspirone
508614|NCT01395953|Buspar|buspar
508615|NCT01395953|Autism Spectrum Disorders|autism spectrum disorders
508616|NCT01395953|Pervasive Developmental Disorders|pervasive developmental disorders
508617|NCT01395953|Children|children
508618|NCT01395953|Adolescents|adolescents
508619|NCT01395953|Anxiety|anxiety
508620|NCT01395940|Gonadotropin-Releasing Hormone (GnRH) antagonist|gonadotropin-releasing hormone (gnrh) antagonist
508621|NCT01395927|Canagliflozin|canagliflozin
508622|NCT01395927|Rifampin|rifampin
508623|NCT01395927|Pharmacokinetics|pharmacokinetics
508624|NCT01395901|Prevention of Postoperative Nausea and Vomiting|prevention of postoperative nausea and vomiting
508625|NCT01395901|Palonosetron|palonosetron
508626|NCT01395901|Ondansetron|ondansetron
508627|NCT01395901|Pediatric|pediatric
508628|NCT01395836|Coronary Artery Bypass Grafting|coronary artery bypass grafting
508629|NCT01395836|Cardiology|cardiology
508630|NCT01395836|Cardiac Electrophysiology|cardiac electrophysiology
508631|NCT01395836|Cardiac Surgery|cardiac surgery
508632|NCT01395784|Oxycodone|oxycodone
508633|NCT01395784|Opioid abuse|opioid abuse
508634|NCT01395771|Effect|effect
508635|NCT01395771|Phone call|phone call
508636|NCT01395771|Intervention|intervention
508637|NCT01395771|Promote|promote
508638|NCT01395771|HAART adherence|haart adherence
508639|NCT01395758|KRAS mutation|kras mutation
508640|NCT01395758|metastatic NSCLC|metastatic nsclc
508641|NCT01395745|SLE|sle
508642|NCT01395745|Lupus|lupus
508643|NCT01395745|Lupus Erythematosus, Systemic|lupus erythematosus, systemic
508644|NCT01395745|Autoimmune Diseases|autoimmune diseases
508645|NCT01395745|A-623|a-623
508646|NCT01395745|Blisibimod|blisibimod
508647|NCT01395719|renal transplantation|renal transplantation
508648|NCT01395719|glomerular filtration rate|glomerular filtration rate
508649|NCT01395719|remote ischemic preconditioning|remote ischemic preconditioning
508650|NCT01395719|remote ischemic conditioning|remote ischemic conditioning
508651|NCT01395706|Malignant Neoplasm of Breast|malignant neoplasm of breast
508652|NCT01395706|Sentinel lymph node detection|sentinel lymph node detection
508653|NCT01395706|ICG fluorescence technique|icg fluorescence technique
508654|NCT01395706|Population of male and female patients with mamma carcinoma|population of male and female patients with mamma carcinoma
508655|NCT01395680|cancer adolescent|cancer adolescent
508656|NCT01395680|resilience|resilience
508657|NCT01395641|Aromatic Amino Acid Decarboxylase|aromatic amino acid decarboxylase
508658|NCT01395641|AADC|aadc
508659|NCT01395641|DDC|ddc
508660|NCT01395641|Gene Therapy|gene therapy
508661|NCT01395641|AAV2-AADC|aav2-aadc
508662|NCT01395641|Viral Vector|viral vector
508663|NCT01395641|Gene Transfer|gene transfer
508664|NCT01395641|Aromatic L-Amino Acid Decarboxylase Deficiency|aromatic l-amino acid decarboxylase deficiency
508665|NCT01395628|chronic phase chronic myelogenous leukemia|chronic phase chronic myelogenous leukemia
508666|NCT01395628|childhood acute promyelocytic leukemia (M3)|childhood acute promyelocytic leukemia (m3)
508667|NCT01395628|childhood acute myeloid leukemia/other myeloid malignancies|childhood acute myeloid leukemia/other myeloid malignancies
508668|NCT01395628|adult acute myeloid leukemia with t(8;21)(q22;q22)|adult acute myeloid leukemia with t(8;21)(q22;q22)
508669|NCT01395628|adult acute myeloid leukemia with del(5q)|adult acute myeloid leukemia with del(5q)
508670|NCT01395628|adult acute promyelocytic leukemia (M3)|adult acute promyelocytic leukemia (m3)
508671|NCT01395589|allergy|allergy
508672|NCT01395589|clinical trial|clinical trial
508673|NCT01395589|exacerbation|exacerbation
508674|NCT01395589|pediatrics|pediatrics
508675|NCT01395576|Genu recurvatum|genu recurvatum
508676|NCT01395576|Knee hyper extension|knee hyper extension
508677|NCT01395576|Orthosis|orthosis
508678|NCT01395576|Gait analysis|gait analysis
508679|NCT01395576|Post stroke|post stroke
508680|NCT01395524|Non-Cancer-Related Pain|non-cancer-related pain
508681|NCT01395524|Opioid-Induced Constipation.|opioid-induced constipation.
508682|NCT01395511|whiplash associated disorder,|whiplash associated disorder,
508683|NCT01395511|Intractable Traumatic Cervical Syndrome,|intractable traumatic cervical syndrome,
508684|NCT01395511|Acupuncture,|acupuncture,
508685|NCT01395511|Randomized controlled trial|randomized controlled trial
508686|NCT01395498|CMV|cmv
508687|NCT01395498|PCP|pcp
508688|NCT01395498|bronchoalveolar lavage|bronchoalveolar lavage
508689|NCT01395485|Amgen|amgen
508690|NCT01395485|Adolescent|adolescent
508691|NCT01395485|Single Dose|single dose
508692|NCT01395485|Safety|safety
508693|NCT01395485|Pharmacokinetics|pharmacokinetics
508694|NCT01395472|TBI|tbi
508695|NCT01395472|Acute physical exercise|acute physical exercise
508696|NCT01395472|Cognitive functions|cognitive functions
508697|NCT01395472|Mood|mood
508698|NCT01395459|screening|screening
508699|NCT01395459|cancer prevention|cancer prevention
508700|NCT01395459|IVR|ivr
508701|NCT01395433|Assessing the bioequivalence of escitalopram dosage forms|assessing the bioequivalence of escitalopram dosage forms
508702|NCT01395420|Phase 1|phase 1
508703|NCT01395420|open label|open label
508704|NCT01395420|healthy male and female (post menopausal) volunteers|healthy male and female (post menopausal) volunteers
508705|NCT01395420|Pharmacokinetics|pharmacokinetics
508706|NCT01395420|CAZ104|caz104
508707|NCT01395420|Avibactam|avibactam
508708|NCT01395420|Ceftazidime|ceftazidime
508709|NCT01395420|open label, at least 2 different regimens, concentration of investigational product (IP), CAZ104, Avibactam, Ceftazidime, Cmax, tmax|open label, at least 2 different regimens, concentration of investigational product (ip), caz104, avibactam, ceftazidime, cmax, tmax
508710|NCT01395407|Brain|brain
508711|NCT01395407|Neoplasm|neoplasm
508712|NCT01395407|Neoplasm Metastasis|neoplasm metastasis
508713|NCT01395407|Radiosurgery|radiosurgery
508714|NCT01395394|Phenylketonuria|phenylketonuria
508716|NCT01395394|tetrahydrobiopterin|tetrahydrobiopterin
508717|NCT01395394|sapropterin dihydrochloride|sapropterin dihydrochloride
508718|NCT01395394|BH4|bh4
508719|NCT01395394|Kuvan|kuvan
508720|NCT01395394|Oxidative stress|oxidative stress
508721|NCT01395368|subjective|subjective
508722|NCT01395368|unilateral|unilateral
508723|NCT01395368|bilateral|bilateral
508724|NCT01395368|non-pulsatile|non-pulsatile
508725|NCT01395368|6 month's duration or longer|6 month's duration or longer
508726|NCT01395355|binge eating|binge eating
508727|NCT01395355|loss of control eating|loss of control eating
508728|NCT01395355|eating in the absence of hunger|eating in the absence of hunger
508729|NCT01395355|emotional eating|emotional eating
508730|NCT01395342|Pregnant women|pregnant women
508731|NCT01395342|Pre-eclampsia|pre-eclampsia
508732|NCT01395342|Exercise|exercise
508733|NCT01395342|Hypertension, Pregnancy-Induced|hypertension, pregnancy-induced
508734|NCT01395342|Parturition|parturition
508735|NCT01395303|infarction|infarction
508736|NCT01395303|stroke|stroke
508737|NCT01395303|diabetes|diabetes
508738|NCT01395303|fracture|fracture
508739|NCT01395303|aortic stenosis|aortic stenosis
508740|NCT01395303|cancer|cancer
508741|NCT01395303|death|death
508742|NCT01395303|vitamin D|vitamin d
508743|NCT01395303|androgens|androgens
508744|NCT01395303|thyroid hormones|thyroid hormones
508745|NCT01395290|staphylococcus aureus|staphylococcus aureus
508746|NCT01395290|vitamin D|vitamin d
508747|NCT01395277|Nitric Oxide|nitric oxide
508748|NCT01395277|Vascular Function|vascular function
508749|NCT01395277|Aging|aging
508750|NCT01395277|Blood Pressure|blood pressure
508751|NCT01395277|Arterial Stiffness|arterial stiffness
508752|NCT01395277|Cardiovascular Disease|cardiovascular disease
508753|NCT01395277|Cerebral Blood Flow|cerebral blood flow
508754|NCT01395251|rheumatoid arthritis|rheumatoid arthritis
508755|NCT01395251|diagnosis|diagnosis
508756|NCT01395251|sensitivity|sensitivity
508757|NCT01395251|glucocorticoids|glucocorticoids
508758|NCT01395238|fathers|fathers
508759|NCT01395238|parenting|parenting
508760|NCT01395238|high-risk|high-risk
508761|NCT01395238|child maltreatment|child maltreatment
508762|NCT01395238|prevention|prevention
508763|NCT01395225|Fat Emulsifying|fat emulsifying
508764|NCT01395225|Radical Cystectomy|radical cystectomy
508765|NCT01395225|Pelvic Lymph Node Dissection|pelvic lymph node dissection
508766|NCT01395225|Pathological Lymph Node Processing|pathological lymph node processing
508767|NCT01395225|Bladder Cancer|bladder cancer
508768|NCT01395225|Transitional Cell Carcinoma|transitional cell carcinoma
508769|NCT01395225|Urothelial Cell Carcinoma|urothelial cell carcinoma
508770|NCT01395212|Cell-based cardiac regenerative therapy|cell-based cardiac regenerative therapy
508771|NCT01395212|Intramyocardial injections|intramyocardial injections
508772|NCT01395212|NOGA procedure|noga procedure
508773|NCT01395212|Acute myocardial infarction|acute myocardial infarction
508774|NCT01395199|Magnetic resonance imaging|magnetic resonance imaging
508775|NCT01395199|Thalassemia|thalassemia
508776|NCT01395199|Iron overload|iron overload
508777|NCT01395186|varicocele|varicocele
508778|NCT01395186|pain|pain
508779|NCT01395173|detection|detection
508780|NCT01395160|Attention deficit hyperactivity disorder|attention deficit hyperactivity disorder
508781|NCT01395160|ADHD|adhd
508782|NCT01395160|Bipolar Disorder|bipolar disorder
508783|NCT01395160|Electrophysiological|electrophysiological
508784|NCT01395160|EEG|eeg
508785|NCT01395160|ERP|erp
508786|NCT01395160|Attention|attention
508787|NCT01395160|Motivation|motivation
508788|NCT01395160|Mood instability|mood instability
508789|NCT01395147|Drug Therapy|drug therapy
508790|NCT01395134|External branch of the superior laryngeal nerve,|external branch of the superior laryngeal nerve,
508791|NCT01395134|Recurrent laryngeal nerve,|recurrent laryngeal nerve,
508792|NCT01395134|Intraoperative neuromonitoring,|intraoperative neuromonitoring,
508793|NCT01395134|Thyroid surgery|thyroid surgery
508794|NCT01395121|c-KIT mutation|c-kit mutation
508795|NCT01395121|advanced disease|advanced disease
508796|NCT01395121|tyrosine kinase inhibitors|tyrosine kinase inhibitors
508797|NCT01395095|cardiac rehabilitation|cardiac rehabilitation
508798|NCT01395095|risk factor|risk factor
508799|NCT01395095|lifestyle|lifestyle
508800|NCT01395082|Myocarditis|myocarditis
508801|NCT01395082|Pericarditis|pericarditis
508802|NCT01395082|Vaccinia virus|vaccinia virus
508803|NCT01395082|ACAM2000®|acam2000®
508804|NCT01395082|Smallpox vaccine|smallpox vaccine
508805|NCT01395069|Post-cataract surgery|post-cataract surgery
508806|NCT01395069|macular edema|macular edema
508807|NCT01395056|breast neoplasm|breast neoplasm
508808|NCT01395056|Neoplasm Metastasis|neoplasm metastasis
508809|NCT01395056|Drug Therapy|drug therapy
508810|NCT01395043|Transversus Abdominis Plane catheter|transversus abdominis plane catheter
508811|NCT01395043|TAP catheter|tap catheter
508812|NCT01395017|Pancreatic cancer|pancreatic cancer
508813|NCT01395017|Dasatinib|dasatinib
508814|NCT01395017|chemotherapy|chemotherapy
508815|NCT01395017|Locally advanced|locally advanced
508816|NCT01394991|Epoetin alfa (EPREX, ERYPO)|epoetin alfa (eprex, erypo)
508817|NCT01394978|Pleural air leak|pleural air leak
508818|NCT01394978|Pulmonary resection|pulmonary resection
508819|NCT01394978|Open thoracotomy|open thoracotomy
508820|NCT01394965|ECG|ecg
508821|NCT01394965|Mapping|mapping
508822|NCT01394965|ecg mapping|ecg mapping
508823|NCT01394965|arrythmias|arrythmias
508824|NCT01394952|Cardiovascular disease|cardiovascular disease
508825|NCT01394952|Diabetes Mellitus|diabetes mellitus
508826|NCT01394952|Dulaglutide|dulaglutide
508827|NCT01394939|Vaccinia|vaccinia
508828|NCT01394939|Vaccinia Virus|vaccinia virus
508829|NCT01394939|JX-594|jx-594
508830|NCT01394939|Jennerex|jennerex
508831|NCT01394939|Colorectal Carcinoma|colorectal carcinoma
508832|NCT01394939|Colorectal cancer|colorectal cancer
508833|NCT01394939|Colon Cancer|colon cancer
508834|NCT01394939|Rectal Cancer|rectal cancer
508835|NCT01394939|oncolytic virus|oncolytic virus
508836|NCT01394939|viral therapy|viral therapy
508837|NCT01394939|RAS mutant|ras mutant
508838|NCT01394939|Erbitux failure|erbitux failure
508839|NCT01394939|Oxaliplatin failure|oxaliplatin failure
508840|NCT01394939|FOLFOX failure|folfox failure
508841|NCT01394939|FOLFIRI failure|folfiri failure
508842|NCT01394939|Irinotecan failure|irinotecan failure
508843|NCT01394939|Pexa-Vec|pexa-vec
508844|NCT01394926|CE-U/S - Contrast-Enhanced U/S|ce-u/s - contrast-enhanced u/s
508845|NCT01394926|U/S - Ultrasound|u/s - ultrasound
647190|NCT00839319|hCG|hcg
508846|NCT01394926|Assess effectiveness|assess effectiveness
508847|NCT01394900|HIV|hiv
508848|NCT01394900|sexually transmitted infection|sexually transmitted infection
508849|NCT01394900|STI|sti
508850|NCT01394900|men who have sex with men|men who have sex with men
508851|NCT01394900|MSM|msm
508852|NCT01394900|couples|couples
508853|NCT01394900|African American|african american
508854|NCT01394900|Black|black
508855|NCT01394887|Metformin, inflammation|metformin, inflammation
508856|NCT01394887|resistin|resistin
508857|NCT01394887|impaired glucose tolerance|impaired glucose tolerance
508858|NCT01394887|children|children
508859|NCT01394874|osteoarthritis|osteoarthritis
508860|NCT01394874|exercise|exercise
508861|NCT01394861|Endoscopic Submucosal Dissection|endoscopic submucosal dissection
508862|NCT01394861|ESD|esd
508863|NCT01394861|EMR|emr
508864|NCT01394861|Early Gastric Cancer|early gastric cancer
508865|NCT01394861|Flexible Endoscopic Robotic System|flexible endoscopic robotic system
508866|NCT01394861|Master Slave Robot|master slave robot
508867|NCT01394861|Ease & Safety of ESD by Flexible Master Slave Robotic System|ease & safety of esd by flexible master slave robotic system
508868|NCT01394835|Patient after lung transplantation|patient after lung transplantation
508869|NCT01394809|osteoporosis|osteoporosis
508870|NCT01394809|wrist fracture|wrist fracture
508871|NCT01394809|mental practice|mental practice
508872|NCT01394809|mirror therapy|mirror therapy
508873|NCT01394809|immobilization|immobilization
508874|NCT01394809|elderly|elderly
508875|NCT01394783|Endotracheal intubation, Teaching, Videolaryngoscope|endotracheal intubation, teaching, videolaryngoscope
508876|NCT01394770|hypertension|hypertension
508877|NCT01394770|dialysis|dialysis
508878|NCT01394770|aliskiren|aliskiren
508879|NCT01394770|amlodipine|amlodipine
508881|NCT01394744|metal|metal
508882|NCT01394744|ion|ion
508883|NCT01394744|cytokine|cytokine
508884|NCT01394744|hip arthroplasty|hip arthroplasty
508885|NCT01394744|blood|blood
508886|NCT01394744|Assessment|assessment
508887|NCT01394744|cytokine profile|cytokine profile
508888|NCT01394718|analgesic adjunct|analgesic adjunct
508889|NCT01394718|acetaminophen|acetaminophen
508890|NCT01394718|spine fusion surgery|spine fusion surgery
508891|NCT01394718|opiate reduction|opiate reduction
508892|NCT01394718|pain management after elective surgical operation|pain management after elective surgical operation
508893|NCT01394705|patients at increased risk for atherosclerosis|patients at increased risk for atherosclerosis
508894|NCT01394692|intraoperative MRI|intraoperative mri
508895|NCT01394692|glioma surgery|glioma surgery
508896|NCT01394692|extent of resection|extent of resection
508897|NCT01394679|Lung Cancer|lung cancer
508898|NCT01394679|Recurrent Lung Cancer no treatment within 3 months|recurrent lung cancer no treatment within 3 months
508899|NCT01394653|YM060|ym060
508900|NCT01394653|ramosetron|ramosetron
508901|NCT01394653|orally-disintegrating tablet|orally-disintegrating tablet
508902|NCT01394653|OD tablet|od tablet
508903|NCT01394653|bioequivalence|bioequivalence
508904|NCT01394614|Cataplexy|cataplexy
508905|NCT01394614|MSLT|mslt
508906|NCT01394614|Hypocretin|hypocretin
508907|NCT01394614|HLA typing|hla typing
508908|NCT01394614|Polysomnography|polysomnography
508909|NCT01394614|A/H1N1 vaccine|a/h1n1 vaccine
508910|NCT01394601|Antipsychotics|antipsychotics
508911|NCT01394601|schizophrenia|schizophrenia
508912|NCT01394601|acute inpatient|acute inpatient
508913|NCT01394588|Cardiac Surgery|cardiac surgery
508914|NCT01394588|Perioperative Glucose Control|perioperative glucose control
508915|NCT01394575|breast cancer|breast cancer
508916|NCT01394575|radiotherapy|radiotherapy
508917|NCT01394575|simultaneous integrated boost|simultaneous integrated boost
508918|NCT01394575|tumor bed|tumor bed
508919|NCT01394575|IMRT|imrt
508920|NCT01394536|Post-operative|post-operative
508921|NCT01394536|post-op|post-op
508922|NCT01394536|nausea|nausea
508923|NCT01394536|vomiting|vomiting
508924|NCT01394510|insulin secretion|insulin secretion
508925|NCT01394510|beta-cell function|beta-cell function
508926|NCT01394510|oxidative stress|oxidative stress
508927|NCT01394510|type 2 diabetes|type 2 diabetes
508928|NCT01394497|Liver Transplantation|liver transplantation
508929|NCT01394497|Graft Survival|graft survival
508930|NCT01394497|Graft Rejection|graft rejection
508931|NCT01394497|Primary Graft Dysfunction|primary graft dysfunction
508932|NCT01394497|Tissue and Organ Harvesting|tissue and organ harvesting
508933|NCT01394497|Tissue and Organ Procurement|tissue and organ procurement
508934|NCT01394497|Tissue Donors|tissue donors
508935|NCT01394497|Cold Ischemia|cold ischemia
508936|NCT01394471|schizophrenia|schizophrenia
508937|NCT01394471|schizoaffective disorder|schizoaffective disorder
508938|NCT01394471|oxytocin|oxytocin
508939|NCT01394471|OT|ot
508940|NCT01394471|social cognition|social cognition
508941|NCT01394471|social functioning|social functioning
508942|NCT01394471|paranoia|paranoia
508943|NCT01394471|psychosis|psychosis
508944|NCT01394471|psychotic symptoms|psychotic symptoms
508945|NCT01394471|social deficits|social deficits
508946|NCT01394471|intranasal administration|intranasal administration
508947|NCT01394458|catheter related infection|catheter related infection
508948|NCT01394458|bacteremia|bacteremia
508949|NCT01394458|hemodialysis|hemodialysis
508950|NCT01394432|Endocardial Stem Cells Injection|endocardial stem cells injection
508951|NCT01394432|Percutaneous Coronary Intervention|percutaneous coronary intervention
508952|NCT01394393|obesity treatment|obesity treatment
508953|NCT01394393|evidence based intervention|evidence based intervention
508954|NCT01394393|cognitive behavioral treatment|cognitive behavioral treatment
508955|NCT01394393|virtual reality environments|virtual reality environments
508956|NCT01394380|sugar|sugar
508957|NCT01394380|sweetened beverages|sweetened beverages
508958|NCT01394380|hepatic steatosis|hepatic steatosis
508959|NCT01394380|visceral obesity|visceral obesity
508960|NCT01394380|metabolic syndrome|metabolic syndrome
508961|NCT01394367|respiratory therapy|respiratory therapy
508962|NCT01394367|exercise therapy|exercise therapy
508963|NCT01394367|oxygen uptake|oxygen uptake
508964|NCT01394367|quality of life|quality of life
508965|NCT01394367|right ventricular function|right ventricular function
508966|NCT01394367|severe pulmonary hypertension|severe pulmonary hypertension
508967|NCT01394354|Multiple Myeloma relapsed refractory|multiple myeloma relapsed refractory
508968|NCT01394341|Liraglutide|liraglutide
508969|NCT01394341|Uremia|uremia
508970|NCT01394341|Dialysis|dialysis
508971|NCT01394341|Type 2 diabetes mellitus|type 2 diabetes mellitus
508972|NCT01394341|Safety|safety
508973|NCT01394341|Efficacy|efficacy
508974|NCT01394328|Delirium|delirium
508975|NCT01394328|Dementia|dementia
508976|NCT01394328|Confusion Assessment Method|confusion assessment method
508977|NCT01394328|Elderly|elderly
508978|NCT01394315|diffuse optical tomography|diffuse optical tomography
508979|NCT01394315|response|response
508980|NCT01394315|neoadjuvant chemotherapy|neoadjuvant chemotherapy
508981|NCT01394315|breast cancer|breast cancer
508982|NCT01394302|Trigger Finger|trigger finger
508983|NCT01394289|Standardization|standardization
508984|NCT01394289|Immunotherapy|immunotherapy
508985|NCT01394289|Skin prick test|skin prick test
508986|NCT01394263|prostate cancer|prostate cancer
508987|NCT01394263|PSA|psa
508988|NCT01394263|testosterone suppression|testosterone suppression
508989|NCT01394250|Pain|pain
508990|NCT01394250|Anxiety|anxiety
508991|NCT01394250|IV Cannulation|iv cannulation
508992|NCT01394250|Topical Lidocaine|topical lidocaine
508993|NCT01394250|Buzzy|buzzy
508994|NCT01394250|Face, Legs, Activity, Crying, Consolability (FLACC) scale|face, legs, activity, crying, consolability (flacc) scale
508995|NCT01394250|Faces Pain Scale Revised (FPS-R)|faces pain scale revised (fps-r)
508996|NCT01394250|Child Rating of Anxiety Scale|child rating of anxiety scale
508997|NCT01394224|Healthy volunteers|healthy volunteers
508998|NCT01394224|Japanese|japanese
508999|NCT01394198|Osteopathic Manipulative Medicine (OMM)|osteopathic manipulative medicine (omm)
509000|NCT01394198|Neuromuscular Medicine (NMM)|neuromuscular medicine (nmm)
509001|NCT01394198|Somatic Dysfunction|somatic dysfunction
509002|NCT01394198|Correlational Study|correlational study
509003|NCT01394198|Endoscopy|endoscopy
509004|NCT01394185|marijuana|marijuana
509005|NCT01394185|dronabinol|dronabinol
509006|NCT01394185|pharmacotherapy|pharmacotherapy
509007|NCT01394172|Tidal Volume|tidal volume
509008|NCT01394172|Pediatric|pediatric
509009|NCT01394172|Difficult airway|difficult airway
509010|NCT01394172|Ventilation|ventilation
509011|NCT01394172|Airway management|airway management
509012|NCT01394159|passes required to establish diagnosis|passes required to establish diagnosis
509013|NCT01394146|phosphorus-based food additives|phosphorus-based food additives
509014|NCT01394146|phosphorus metabolism|phosphorus metabolism
509015|NCT01394133|HIV Infected Women|hiv infected women
509016|NCT01394120|Pancreas cancer|pancreas cancer
509017|NCT01394120|Targeted Therapy|targeted therapy
509018|NCT01394107|Thromboprophylaxis|thromboprophylaxis
509019|NCT01394107|Effect of LMWH on coagulation|effect of lmwh on coagulation
509020|NCT01394107|Pregnancy|pregnancy
509021|NCT01394107|Neuraxial anesthesia|neuraxial anesthesia
509022|NCT01394107|Spinal haematoma|spinal haematoma
509023|NCT01394094|Gum chewing|gum chewing
509024|NCT01394094|Bowel function|bowel function
509025|NCT01394094|benign gynecologic surgery|benign gynecologic surgery
509026|NCT01394081|Veterans|veterans
509027|NCT01394081|Health Care Utilization|health care utilization
509028|NCT01394081|Rural Health|rural health
509029|NCT01394081|Patient Navigation|patient navigation
509030|NCT01394081|Motivational Interviewing|motivational interviewing
509031|NCT01394068|Selenium level|selenium level
509032|NCT01394068|Various blood values|various blood values
509033|NCT01394068|Duration of artificial respiration|duration of artificial respiration
509034|NCT01394068|Residence in ICU/ Hospital|residence in icu/ hospital
509035|NCT01394068|SOFA-Score|sofa-score
509036|NCT01394068|SAPS-Score|saps-score
509037|NCT01394055|Diabetes Mellitus Type 1 and 2|diabetes mellitus type 1 and 2
509038|NCT01394055|Delayed Gastric Emptying|delayed gastric emptying
647462|NCT00838435|PKU|pku
509039|NCT01394055|Gastroparesis|gastroparesis
509040|NCT01394055|Gastrointestinal Motility Disorder|gastrointestinal motility disorder
509041|NCT01394042|Biopsy proven primary prostate cancer|biopsy proven primary prostate cancer
509042|NCT01394029|iron overload|iron overload
509043|NCT01394029|iron chelation|iron chelation
509044|NCT01394029|deferasirox|deferasirox
509045|NCT01394029|observational|observational
509046|NCT01394003|Advanced cancer|advanced cancer
509047|NCT01393977|Spinal Cord Injuries|spinal cord injuries
509048|NCT01393977|Stem Cell Transplantation|stem cell transplantation
509049|NCT01393977|Rehabilitation|rehabilitation
509050|NCT01393951|Recombinant Influenza hemagglutinin vaccine|recombinant influenza hemagglutinin vaccine
509051|NCT01393938|Mullerian Duct Anomaly|mullerian duct anomaly
509052|NCT01393938|3-dimensional Ultrasound|3-dimensional ultrasound
509053|NCT01393938|Magnetic Resonance Imaging|magnetic resonance imaging
509054|NCT01393912|crenolanib|crenolanib
509055|NCT01393912|radiation therapy|radiation therapy
509056|NCT01393912|malignant brain tumors|malignant brain tumors
509057|NCT01393912|pediatric|pediatric
509058|NCT01393899|tofacitinib|tofacitinib
509059|NCT01393899|Xeljanz|xeljanz
509060|NCT01393899|CP-690,550|cp-690,550
509061|NCT01393899|maintenance therapy|maintenance therapy
509062|NCT01393886|Obesity Surgery|obesity surgery
509063|NCT01393873|Obesity|obesity
509064|NCT01393873|Type 2 DM|type 2 dm
509065|NCT01393860|Diabetes|diabetes
509066|NCT01393860|aliskiren|aliskiren
509067|NCT01393860|hypertension|hypertension
509068|NCT01393860|renal impairment|renal impairment
509069|NCT01393847|Sickle Cell|sickle cell
509070|NCT01393847|Pain|pain
509071|NCT01393847|Genetics|genetics
509072|NCT01393847|Sickle Cell Disease|sickle cell disease
509073|NCT01393847|Healthy Volunteer|healthy volunteer
509074|NCT01393847|HV|hv
509075|NCT01393834|Delayed cord clamping|delayed cord clamping
509076|NCT01393834|Umbilical cord|umbilical cord
509077|NCT01393834|Preterm|preterm
509078|NCT01393834|Cord milking|cord milking
509079|NCT01393808|Type 2 diabetes|type 2 diabetes
509080|NCT01393808|Paricalcitol|paricalcitol
509081|NCT01393808|Proteinuria|proteinuria
509082|NCT01393808|Sodium intake|sodium intake
509083|NCT01393795|Pulmonary Hypertension|pulmonary hypertension
509084|NCT01393795|Pain|pain
509085|NCT01393782|high output shock|high output shock
509086|NCT01393782|distributive shock|distributive shock
509087|NCT01393782|warm shock|warm shock
509088|NCT01393782|septic shock|septic shock
509089|NCT01393782|pressor|pressor
509090|NCT01393782|angiotensin|angiotensin
509091|NCT01393782|ATII|atii
509092|NCT01393782|vasopressor|vasopressor
509093|NCT01393769|Retinoblastoma|retinoblastoma
509094|NCT01393769|RTB|rtb
509095|NCT01393769|Ocular tumour|ocular tumour
509096|NCT01393769|Melfalan|melfalan
509097|NCT01393769|Enucleation|enucleation
509098|NCT01393769|Tumor of the eye|tumor of the eye
509099|NCT01393769|Eye|eye
509100|NCT01393769|Ocular cancer|ocular cancer
509101|NCT01393769|Ocular chemotherapy|ocular chemotherapy
509102|NCT01393769|Ophthalmic artery|ophthalmic artery
509103|NCT01393769|Intra-arterial chemotherapy|intra-arterial chemotherapy
509104|NCT01393743|Central Nervous System|central nervous system
509105|NCT01393730|prostate|prostate
509106|NCT01393730|metastatic|metastatic
509107|NCT01393730|castrate resistant|castrate resistant
509108|NCT01393704|myomectomy|myomectomy
509109|NCT01393704|vasopressin|vasopressin
509110|NCT01393704|blood loss|blood loss
509111|NCT01393691|nighttime fears|nighttime fears
509112|NCT01393691|anxiety|anxiety
509113|NCT01393691|sleep|sleep
509114|NCT01393691|actigraphy|actigraphy
509115|NCT01393691|intervention|intervention
509116|NCT01393652|Pharmacokinetics Safety Tolerability Pharmacodynamics|pharmacokinetics safety tolerability pharmacodynamics
509117|NCT01393639|treatment of rheumatoid arthritis|treatment of rheumatoid arthritis
509118|NCT01393639|treatment of RA|treatment of ra
509119|NCT01393639|patients on methotrexate for rheumatoid arthritis|patients on methotrexate for rheumatoid arthritis
509120|NCT01393639|prednisone for rheumatoid arthritis|prednisone for rheumatoid arthritis
509121|NCT01393587|Oxidative Stress|oxidative stress
509122|NCT01393587|Laproscopy|laproscopy
509123|NCT01393561|Rhinitis|rhinitis
509124|NCT01393561|Common cold|common cold
509125|NCT01393561|Nasal symptoms|nasal symptoms
509126|NCT01393561|Children|children
509127|NCT01393548|Rhinitis|rhinitis
509128|NCT01393548|common cold|common cold
509129|NCT01393548|nasal symptoms|nasal symptoms
509130|NCT01393548|children|children
509131|NCT01393535|Adiponectin|adiponectin
509132|NCT01393535|Prognosis|prognosis
509133|NCT01393535|Cardiac Surgery|cardiac surgery
509134|NCT01393522|headache|headache
509135|NCT01393522|migraine|migraine
509136|NCT01393509|PU-H71|pu-h71
509137|NCT01393509|Solid Tumor|solid tumor
509138|NCT01393509|Lymphoma|lymphoma
509139|NCT01393509|11-041|11-041
710254|NCT00589563|childhood unfavorable prognosis Hodgkin lymphoma|childhood unfavorable prognosis hodgkin lymphoma
509140|NCT01393509|incurable, locally advanced or metastatic solid tumor malignancy or lymphoma|incurable, locally advanced or metastatic solid tumor malignancy or lymphoma
509141|NCT01393496|prematurity|prematurity
509142|NCT01393496|anemia|anemia
509143|NCT01393496|transfusion|transfusion
509144|NCT01393483|esophagectomy|esophagectomy
509145|NCT01393483|endoscopy|endoscopy
509146|NCT01393483|biopsy|biopsy
509147|NCT01393483|Tissue mesothelin|tissue mesothelin
509148|NCT01393483|Serum mesothelin|serum mesothelin
509149|NCT01393483|11-037|11-037
509150|NCT01393470|HPV|hpv
509151|NCT01393470|Vaccine|vaccine
509152|NCT01393470|long-term efficacy|long-term efficacy
509153|NCT01393470|registry-based study|registry-based study
509154|NCT01393470|Evaluation of long-term HPV vaccine efficacy: a population-based, registry-based cohort study in Finland.|evaluation of long-term hpv vaccine efficacy: a population-based, registry-based cohort study in finland.
509155|NCT01393457|cocaine|cocaine
509156|NCT01393457|cognition|cognition
509157|NCT01393457|medication|medication
509158|NCT01393457|treatment|treatment
509159|NCT01393444|Electrocorticography|electrocorticography
509160|NCT01393444|Tetraplegia|tetraplegia
509161|NCT01393444|Spinal cord injury|spinal cord injury
509162|NCT01393444|Brainstem stroke|brainstem stroke
509163|NCT01393444|Neuroprosthetic|neuroprosthetic
509164|NCT01393444|Brain-computer interface|brain-computer interface
509165|NCT01393444|Direct brain interface|direct brain interface
509166|NCT01393444|Neural activity|neural activity
509167|NCT01393444|Motor cortex|motor cortex
509168|NCT01393431|Exhaled breath condensate pH|exhaled breath condensate ph
509169|NCT01393431|Predictive value of pH|predictive value of ph
509170|NCT01393418|Erythropoietin|erythropoietin
509171|NCT01393418|Cardiac Surgery|cardiac surgery
509172|NCT01393418|Renal Biomarker|renal biomarker
509173|NCT01393418|Acute Kidney Injury|acute kidney injury
509174|NCT01393418|Hypothermic Circulatory Arrest|hypothermic circulatory arrest
509175|NCT01393392|smoking cessation|smoking cessation
509176|NCT01393392|methadone treatment|methadone treatment
509177|NCT01393392|nicotine addiction|nicotine addiction
509178|NCT01393392|drug treatment|drug treatment
509179|NCT01393392|drug addiction|drug addiction
509180|NCT01393392|tobacco dependence|tobacco dependence
509181|NCT01393327|physical training|physical training
509182|NCT01393327|remaining post-operative pulmonary vascular changes|remaining post-operative pulmonary vascular changes
509183|NCT01393327|right ventricular pump function|right ventricular pump function
509184|NCT01393327|PEA|pea
509185|NCT01393301|Nicotine dependence|nicotine dependence
509186|NCT01393301|Smoking, cessation|smoking, cessation
509187|NCT01393301|Quitting|quitting
509188|NCT01393301|Anxiety symptoms|anxiety symptoms
509189|NCT01393301|Cognitive-behavioral therapy|cognitive-behavioral therapy
509190|NCT01393275|diabetes|diabetes
509191|NCT01393275|exercise|exercise
509192|NCT01393275|intervention|intervention
509193|NCT01393275|rehabilitation|rehabilitation
509194|NCT01393275|metabolic rate|metabolic rate
509195|NCT01393275|sport|sport
509196|NCT01393249|Acute Lymphoblastic Leukemia|acute lymphoblastic leukemia
509197|NCT01393249|Pediatric|pediatric
509198|NCT01393249|Asparaginase|asparaginase
509199|NCT01393249|Pancreatitis|pancreatitis
509200|NCT01393223|Interstitial Cystitis|interstitial cystitis
509201|NCT01393223|Painful Bladder Syndrome|painful bladder syndrome
509202|NCT01393223|Bladder Pain Syndrome|bladder pain syndrome
509203|NCT01393223|Liposome|liposome
509204|NCT01393223|LP-08|lp-08
509205|NCT01393210|insulin sensitivity|insulin sensitivity
509206|NCT01393210|adipose tissue|adipose tissue
509207|NCT01393210|inflammation|inflammation
509208|NCT01393197|HCC|hcc
509209|NCT01393197|TACE|tace
509210|NCT01393184|Target therapy|target therapy
509211|NCT01393171|Anterior Vaginal Prolapse|anterior vaginal prolapse
509212|NCT01393171|Cystocele|cystocele
509213|NCT01393171|Pelvic Organ Prolapse|pelvic organ prolapse
509318|NCT01392794|ramosetron|ramosetron
509214|NCT01393145|Chronic obstructive pulmonary disease (COPD)|chronic obstructive pulmonary disease (copd)
509215|NCT01393145|salmeterol|salmeterol
509216|NCT01393145|fluticasone|fluticasone
509217|NCT01393145|formoterol|formoterol
509218|NCT01393145|FEV1|fev1
509219|NCT01393145|Moderate-to-severe|moderate-to-severe
509220|NCT01393132|Dry Eye|dry eye
509221|NCT01393132|Sjogren's Syndrome|sjogren's syndrome
509222|NCT01393132|Graft vs. Host Disease|graft vs. host disease
509223|NCT01393132|Rheumatoid arthritis|rheumatoid arthritis
509224|NCT01393132|Systemic lupus erythematosus|systemic lupus erythematosus
509225|NCT01393132|Scleroderma|scleroderma
509226|NCT01393106|HL|hl
509227|NCT01393106|idelalisib|idelalisib
509228|NCT01393106|CAL-101|cal-101
509229|NCT01393106|GS-1101|gs-1101
509230|NCT01393106|PI3K|pi3k
509231|NCT01393093|HCC|hcc
509232|NCT01393093|TACE|tace
509233|NCT01393080|nimotuzumab|nimotuzumab
509234|NCT01393080|non-small cell lung cancer|non-small cell lung cancer
509235|NCT01393080|chemotherapy|chemotherapy
509236|NCT01393067|cSEMS|csems
509237|NCT01393067|NEPS|neps
509238|NCT01393067|ERCP|ercp
509239|NCT01393067|biliary stricture|biliary stricture
509240|NCT01393067|biliary stenosis|biliary stenosis
509241|NCT01393067|liver transplantation|liver transplantation
509242|NCT01393054|Nigella sativa seed extract|nigella sativa seed extract
509243|NCT01393054|hypertension|hypertension
509244|NCT01393054|elderly|elderly
509245|NCT01393028|coronary artery disease|coronary artery disease
509246|NCT01393028|angina pectoris|angina pectoris
509247|NCT01393028|Stable chest pain complaints|stable chest pain complaints
509248|NCT01393015|automatic|automatic
509249|NCT01393015|automation|automation
509250|NCT01393015|oxygen|oxygen
509251|NCT01393015|weaning|weaning
509252|NCT01393015|COPD|copd
509253|NCT01393015|exacerbation|exacerbation
509254|NCT01393002|intensive care|intensive care
509255|NCT01393002|candidemia|candidemia
509256|NCT01393002|fungal infection|fungal infection
509257|NCT01392976|cancer|cancer
509258|NCT01392976|advanced|advanced
509259|NCT01392976|solid|solid
509260|NCT01392976|tumor|tumor
509261|NCT01392976|gemcitabine|gemcitabine
509262|NCT01392976|human equilibrative nucleoside transporter-1 (hENT1)|human equilibrative nucleoside transporter-1 (hent1)
509263|NCT01392976|CO-1.01|co-1.01
509264|NCT01392976|CO-101|co-101
509265|NCT01392976|CO101|co101
509266|NCT01392963|botox|botox
509267|NCT01392963|depression|depression
509268|NCT01392950|silicone hydrogel contact lenses for daily wear|silicone hydrogel contact lenses for daily wear
509269|NCT01392937|AIOL|aiol
509270|NCT01392937|multipurpose solution|multipurpose solution
509271|NCT01392937|silicone hydrogel lenses|silicone hydrogel lenses
509272|NCT01392937|The safety and efficacy of the All-in-One Light multipurpose care regimen by comparison with the Aquify care regimen|the safety and efficacy of the all-in-one light multipurpose care regimen by comparison with the aquify care regimen
509273|NCT01392911|Dose Ranging|dose ranging
509274|NCT01392911|Extended Early Bactericidal Activity|extended early bactericidal activity
509275|NCT01392911|Maximum tolerable dose|maximum tolerable dose
509276|NCT01392911|Pharmacokinetics|pharmacokinetics
509277|NCT01392911|Pulmonary Tuberculosis|pulmonary tuberculosis
509278|NCT01392911|Rifampicin|rifampicin
509279|NCT01392911|Rifafour|rifafour
509280|NCT01392911|Safety|safety
509281|NCT01392911|Tolerability|tolerability
509282|NCT01392911|Max Tolerable Dose|max tolerable dose
509283|NCT01392898|liraglutide|liraglutide
509284|NCT01392898|insulin|insulin
509285|NCT01392898|type 2 diabetes mellitus|type 2 diabetes mellitus
509286|NCT01392885|Schizophrenia|schizophrenia
509287|NCT01392885|Schizoaffective Disorder|schizoaffective disorder
509288|NCT01392885|Brain Health|brain health
509289|NCT01392885|Exercise|exercise
509290|NCT01392885|Mental Health|mental health
509291|NCT01392885|Poor memory|poor memory
509292|NCT01392872|Immunosuppressant|immunosuppressant
509293|NCT01392872|Quality of life|quality of life
509294|NCT01392872|Cognitive function|cognitive function
509295|NCT01392872|Relapsing Multiple Sclerosis|relapsing multiple sclerosis
509296|NCT01392846|Coronary artery disease requiring drug eluting stents|coronary artery disease requiring drug eluting stents
509297|NCT01392833|iga nephropathy|iga nephropathy
509298|NCT01392833|chronic kidney disease|chronic kidney disease
509299|NCT01392833|proteinuria|proteinuria
509300|NCT01392833|steroids|steroids
509301|NCT01392833|azathioprine|azathioprine
509302|NCT01392820|Phase I|phase i
509303|NCT01392820|Japan|japan
509304|NCT01392820|Elderly|elderly
509305|NCT01392820|PK|pk
509306|NCT01392820|SAD|sad
509307|NCT01392820|MAD|mad
509308|NCT01392807|Phase 1|phase 1
509309|NCT01392807|volunteers with hepatic impairment|volunteers with hepatic impairment
509310|NCT01392807|pharmacokinetics|pharmacokinetics
509311|NCT01392807|NKTR-118|nktr-118
509312|NCT01392807|Child-Pugh scale|child-pugh scale
509313|NCT01392807|AUC|auc
509314|NCT01392807|Cmax|cmax
509315|NCT01392807|tmax|tmax
509316|NCT01392807|t1/2|t1/2
509317|NCT01392794|YM060|ym060
509319|NCT01392794|orally-disintegrating tablet|orally-disintegrating tablet
509320|NCT01392794|OD tablet|od tablet
509321|NCT01392794|bioequivalence|bioequivalence
509322|NCT01392781|PCOS|pcos
509323|NCT01392781|hsC-RP|hsc-rp
509324|NCT01392781|Lp-PLA2|lp-pla2
509325|NCT01392781|cardiovascular risk|cardiovascular risk
509326|NCT01392768|Epilepsy|epilepsy
509327|NCT01392768|Partial|partial
509328|NCT01392768|Seizures|seizures
509329|NCT01392768|Adjunctive|adjunctive
509330|NCT01392690|No condition|no condition
509331|NCT01392690|Primary prevention|primary prevention
509332|NCT01392690|Anxiety|anxiety
509333|NCT01392677|dapagliflozin|dapagliflozin
509334|NCT01392677|diabetes|diabetes
509335|NCT01392677|hyperglycaemia|hyperglycaemia
509336|NCT01392651|Urinary stress incontinence|urinary stress incontinence
509337|NCT01392651|TVT|tvt
509338|NCT01392638|Sildenafil|sildenafil
509339|NCT01392638|Nitric oxide synthase|nitric oxide synthase
509340|NCT01392638|Polymorphism|polymorphism
509341|NCT01392638|Hemodynamics|hemodynamics
711343|NCT00585195|c-Met exon 14 skipping|c-met exon 14 skipping
509342|NCT01392625|Non ischemic dilated cardiomyopathy|non ischemic dilated cardiomyopathy
509343|NCT01392625|Dilated cardiomyopathy|dilated cardiomyopathy
509344|NCT01392625|Heart failure|heart failure
509345|NCT01392625|Cardiac Stem Cell Transplantation|cardiac stem cell transplantation
509346|NCT01392625|Stem Cells|stem cells
509347|NCT01392612|thrombosis|thrombosis
509348|NCT01392612|hypertension|hypertension
509349|NCT01392612|gender|gender
509350|NCT01392612|endothelium|endothelium
509351|NCT01392599|CRPS Type II|crps type ii
509352|NCT01392599|Pain|pain
509353|NCT01392599|Surgery|surgery
509354|NCT01392599|Regional Subcutaneous Venous Sympathectomy(RSVS)|regional subcutaneous venous sympathectomy(rsvs)
509355|NCT01392599|Sudeck|sudeck
509356|NCT01392599|Reflex sympathetic dystrophy (RSD)|reflex sympathetic dystrophy (rsd)
509357|NCT01392599|Causalgia|causalgia
509358|NCT01392599|Algodystrophy|algodystrophy
509359|NCT01392586|survival|survival
509360|NCT01392586|systemic therapy|systemic therapy
509361|NCT01392586|upfront surgery|upfront surgery
509362|NCT01392534|Hypertension|hypertension
509363|NCT01392534|Telmisartan|telmisartan
509364|NCT01392534|Hydrochlorothiazide|hydrochlorothiazide
509365|NCT01392534|Potassium|potassium
509366|NCT01392534|Glucose metabolism|glucose metabolism
509367|NCT01392534|Lipid metabolism|lipid metabolism
509368|NCT01392521|Safety|safety
509369|NCT01392521|Tolerability|tolerability
509370|NCT01392521|Pharmacokinetics|pharmacokinetics
509371|NCT01392495|Pulmonary arterial hypertension|pulmonary arterial hypertension
509372|NCT01392495|imatinib|imatinib
509373|NCT01392495|6MWD|6mwd
509374|NCT01392482|Schizophrenia|schizophrenia
509375|NCT01392482|Bipolar Disorder|bipolar disorder
509376|NCT01392469|Pulmonary arterial hypertension|pulmonary arterial hypertension
509377|NCT01392469|pulmonary vascular resistance|pulmonary vascular resistance
509378|NCT01392469|imatinib|imatinib
509379|NCT01392469|bosentan|bosentan
509380|NCT01392469|sildenafil|sildenafil
509381|NCT01392456|OHIP-EDENT, VALIDATION, OVERDENTURE, ROMANIAN|ohip-edent, validation, overdenture, romanian
509382|NCT01392443|Primary Myelofibrosis (MF)|primary myelofibrosis (mf)
509383|NCT01392443|Post-Polycythemia Vera (PV) MF|post-polycythemia vera (pv) mf
509384|NCT01392443|Post-Essential Thrombocythemia (ET) MF|post-essential thrombocythemia (et) mf
509385|NCT01392443|post-PV MF|post-pv mf
509386|NCT01392443|post-ET MF|post-et mf
509387|NCT01392443|INC424|inc424
509388|NCT01392443|Ruxolitinib|ruxolitinib
509389|NCT01392443|Myelofibrosis|myelofibrosis
509390|NCT01392443|MF|mf
509391|NCT01392430|Primary prophylaxis|primary prophylaxis
509392|NCT01392430|Secondary prophylaxis|secondary prophylaxis
509393|NCT01392430|Discontinuation|discontinuation
509394|NCT01392391|Stroke|stroke
509395|NCT01392391|Exercise|exercise
509396|NCT01392391|Protein synthesis|protein synthesis
509397|NCT01392391|Protein breakdown|protein breakdown
509398|NCT01392391|Muscle atrophy|muscle atrophy
509399|NCT01392391|Muscle phenotype|muscle phenotype
509400|NCT01392391|Inflammation|inflammation
509401|NCT01392391|Insulin resistance|insulin resistance
509402|NCT01392391|Fitness|fitness
509403|NCT01392378|Prevenar 13|prevenar 13
509404|NCT01392378|13vPnC|13vpnc
509405|NCT01392378|Antipyretic medication|antipyretic medication
509406|NCT01392378|Healthy subjects|healthy subjects
509407|NCT01392365|Crohn's disease|crohn's disease
509408|NCT01392365|Intestinal tuberculosis|intestinal tuberculosis
509409|NCT01392365|Diagnosis, Differential|diagnosis, differential
509410|NCT01392352|pazopanib|pazopanib
509411|NCT01392352|hypertension|hypertension
509412|NCT01392352|forearm blood flow|forearm blood flow
509413|NCT01392339|Obstructive Sleep Apnea|obstructive sleep apnea
509414|NCT01392339|CPAP|cpap
509415|NCT01392339|hypoxia|hypoxia
509416|NCT01392339|sleep|sleep
509417|NCT01392339|translational science|translational science
509418|NCT01392339|gene expression|gene expression
509419|NCT01392326|Psoriatic arthritis|psoriatic arthritis
509420|NCT01392326|PsA|psa
509421|NCT01392326|ACR|acr
509422|NCT01392326|CASPAR|caspar
509629|NCT01391624|chocolate|chocolate
509423|NCT01392313|carnitine, kidney|carnitine, kidney
509424|NCT01392287|Geriatric|geriatric
509425|NCT01392287|Older adults|older adults
509426|NCT01392287|Major Depressive Disorder|major depressive disorder
509427|NCT01392287|Magnetic Resonance Spectroscopy|magnetic resonance spectroscopy
509428|NCT01392287|memantine hydrochloride|memantine hydrochloride
509429|NCT01392287|N-Acetylaspartylglutamate|n-acetylaspartylglutamate
509430|NCT01392287|NAAG|naag
509431|NCT01392287|Cognitive impairment|cognitive impairment
509432|NCT01392248|EEG|eeg
509433|NCT01392248|breast cancer surgery|breast cancer surgery
509434|NCT01392248|prediction|prediction
509435|NCT01392248|acute postoperative pain|acute postoperative pain
509436|NCT01392248|chronic pain|chronic pain
509437|NCT01392235|Recurrent and/or Metastatic Nasopharyngeal Carcinoma (NPC)|recurrent and/or metastatic nasopharyngeal carcinoma (npc)
509438|NCT01392222|focus group|focus group
509439|NCT01392222|11-108|11-108
509440|NCT01392209|BEVACIZUMAB|bevacizumab
509441|NCT01392209|HYPOFRACTIONATED STEREOTACTIC RADIOTHERAPY|hypofractionated stereotactic radiotherapy
509442|NCT01392209|Brain|brain
509443|NCT01392209|CNS|cns
509444|NCT01392209|anti-VEGF antibody|anti-vegf antibody
509445|NCT01392209|11-057|11-057
509446|NCT01392196|Renal Impairment|renal impairment
509447|NCT01392183|Kidney cancer|kidney cancer
509448|NCT01392183|Renal Cell Carcinoma|renal cell carcinoma
509449|NCT01392183|Poor-Risk Clear-Cell Renal Cell Carcinoma|poor-risk clear-cell renal cell carcinoma
509450|NCT01392183|RCC|rcc
509451|NCT01392183|Metastatic|metastatic
509452|NCT01392183|Locally advanced|locally advanced
509453|NCT01392183|Complete response|complete response
509454|NCT01392183|CR|cr
509455|NCT01392183|Partial Response|partial response
509456|NCT01392183|PR|pr
509457|NCT01392183|Overall survival|overall survival
509458|NCT01392183|OS|os
509459|NCT01392183|Time to progression|time to progression
509460|NCT01392183|TTP|ttp
509461|NCT01392183|Pazopanib|pazopanib
509462|NCT01392183|GW786034|gw786034
509463|NCT01392183|Temsirolimus|temsirolimus
509464|NCT01392183|CCI-779|cci-779
509465|NCT01392183|Torisel|torisel
509466|NCT01392183|Benadryl|benadryl
509467|NCT01392183|Diphenhydramine|diphenhydramine
509468|NCT01392183|TemPa|tempa
509469|NCT01392170|Leukemia|leukemia
509470|NCT01392170|Chronic Myeloid Leukemia|chronic myeloid leukemia
509471|NCT01392170|CML|cml
509472|NCT01392170|Tyrosine Kinase Inhibitors|tyrosine kinase inhibitors
509473|NCT01392170|TKI|tki
509474|NCT01392170|Complete cytogenetic remission|complete cytogenetic remission
509475|NCT01392170|CCyR|ccyr
509476|NCT01392170|Minimal residual disease|minimal residual disease
509477|NCT01392170|MRD|mrd
509478|NCT01392170|PEG-IFNa-2a|peg-ifna-2a
509479|NCT01392170|Pegasys|pegasys
509480|NCT01392170|Peginterferon Alpha-2a|peginterferon alpha-2a
509481|NCT01392170|Philadelphia chromosome (Ph)-positive|philadelphia chromosome (ph)-positive
509482|NCT01392170|BCR-ABL1-positive|bcr-abl1-positive
509483|NCT01392144|Radiation pneumonitis|radiation pneumonitis
509484|NCT01392144|RP|rp
509485|NCT01392144|Nitric oxide|nitric oxide
509486|NCT01392144|NO|no
509487|NCT01392144|Thoracic|thoracic
509488|NCT01392144|Esophagus cancer|esophagus cancer
509489|NCT01392144|Lung cancer|lung cancer
509490|NCT01392144|Radiation therapy|radiation therapy
509491|NCT01392144|radiotherapy|radiotherapy
509492|NCT01392144|RT|rt
509493|NCT01392144|XRT|xrt
509494|NCT01392144|Airway|airway
509495|NCT01392144|Alveolar|alveolar
509496|NCT01392144|Nitric oxide breath analyzer|nitric oxide breath analyzer
509497|NCT01392144|Questionnaires|questionnaires
509498|NCT01392131|Oncoxin|oncoxin
509499|NCT01392131|Safety of Oncoxin|safety of oncoxin
509500|NCT01392131|Therapeutic efficacy of Oncoxin|therapeutic efficacy of oncoxin
509501|NCT01392131|Improvement of quality of life with Oncoxin|improvement of quality of life with oncoxin
509502|NCT01392131|Survival benefit with Oncoxin|survival benefit with oncoxin
509503|NCT01392105|Mesenchymal stem cells|mesenchymal stem cells
509504|NCT01392105|Myocardial infarction|myocardial infarction
509505|NCT01392105|Left ventricular dysfunction|left ventricular dysfunction
509506|NCT01392092|Contingency Management|contingency management
509507|NCT01392092|Drug Self-Administration|drug self-administration
509508|NCT01392079|CLL|cll
509509|NCT01392079|17p deletion|17p deletion
509510|NCT01392079|refractory to fludarabine|refractory to fludarabine
509511|NCT01392079|subcutaneous alemtuzumab|subcutaneous alemtuzumab
509642|NCT01391585|adherence|adherence
509512|NCT01392079|CLL with 17p- or refractory to fludarabine|cll with 17p- or refractory to fludarabine
509513|NCT01392066|breast neoplasms|breast neoplasms
509514|NCT01392066|spouses/partners|spouses/partners
509515|NCT01392066|couples|couples
509516|NCT01392066|interpersonal relations|interpersonal relations
509517|NCT01392066|psychosocial adjustment|psychosocial adjustment
509518|NCT01392066|psychological adaptation|psychological adaptation
509519|NCT01392066|depression|depression
509520|NCT01392066|quality of life|quality of life
509521|NCT01392066|dyadic coping|dyadic coping
509522|NCT01392066|coping behavior|coping behavior
509523|NCT01392066|cohort|cohort
509524|NCT01392066|questionnaire|questionnaire
509525|NCT01392053|labor|labor
509526|NCT01392053|pain|pain
509527|NCT01392053|massage|massage
509528|NCT01392027|Pancreatic Cancer|pancreatic cancer
509529|NCT01392027|Chronic Pancreatitis|chronic pancreatitis
509530|NCT01392027|Diseases of the pancreas|diseases of the pancreas
509531|NCT01392014|malaria|malaria
509532|NCT01392014|DHP|dhp
509533|NCT01392014|PQ|pq
509534|NCT01392014|gametocytes|gametocytes
509535|NCT01391975|arteriovenous fistula|arteriovenous fistula
509536|NCT01391975|surveillance|surveillance
509537|NCT01391975|arterial stenosis|arterial stenosis
509538|NCT01391975|venous stenosis|venous stenosis
509539|NCT01391962|Pharmacodynamics|pharmacodynamics
509540|NCT01391962|VEGF Inhibitor|vegf inhibitor
509541|NCT01391962|Alveolar Soft Part Sarcoma|alveolar soft part sarcoma
509542|NCT01391962|Anti-Angiogenesis|anti-angiogenesis
509543|NCT01391962|Gene Expression Profiling|gene expression profiling
509544|NCT01391949|disability|disability
509545|NCT01391949|walking|walking
509546|NCT01391949|feedback|feedback
509547|NCT01391949|exercise|exercise
509548|NCT01391923|Lipolysis|lipolysis
509549|NCT01391923|Cryolipolysis|cryolipolysis
509550|NCT01391923|Fat Reduction|fat reduction
509551|NCT01391910|rhinosinusitis|rhinosinusitis
509552|NCT01391897|somatoform disorders|somatoform disorders
509553|NCT01391897|PTSD|ptsd
509554|NCT01391897|epigenetics|epigenetics
509555|NCT01391897|psychotherapy|psychotherapy
509556|NCT01391897|psychosomatics|psychosomatics
509557|NCT01391884|Incretin hormones|incretin hormones
509558|NCT01391884|GLP-1|glp-1
509559|NCT01391884|GIP|gip
509560|NCT01391884|Uremia|uremia
509561|NCT01391884|Dialysis|dialysis
509562|NCT01391858|Pregabalin|pregabalin
509563|NCT01391858|Postoperative pain|postoperative pain
509564|NCT01391858|Mastectomy|mastectomy
509565|NCT01391845|progesterone|progesterone
509566|NCT01391845|glycodelin-A|glycodelin-a
509567|NCT01391845|ulipristal acetate|ulipristal acetate
509568|NCT01391832|rTMS|rtms
509569|NCT01391832|PTSD|ptsd
509570|NCT01391832|Post Traumatic Stress Disorder|post traumatic stress disorder
509571|NCT01391832|repetitive transcranial magnetic stimulation|repetitive transcranial magnetic stimulation
509572|NCT01391832|combat related PTSD|combat related ptsd
509573|NCT01391832|OEF|oef
509574|NCT01391832|OIF|oif
509575|NCT01391832|Veterans|veterans
509576|NCT01391832|operation enduring freedom|operation enduring freedom
509577|NCT01391832|operation iraqi freedom|operation iraqi freedom
509578|NCT01391832|CPT|cpt
509579|NCT01391832|cognitive processing therapy|cognitive processing therapy
509580|NCT01391819|Brazil|brazil
509581|NCT01391819|Incidence|incidence
509582|NCT01391819|Dengue virus|dengue virus
509583|NCT01391819|Dengue|dengue
509584|NCT01391819|Dengue infection|dengue infection
509585|NCT01391806|Breast cancer|breast cancer
509586|NCT01391806|Preoperative breast MRI|preoperative breast mri
509587|NCT01391806|Breast-conserving surgery|breast-conserving surgery
509588|NCT01391806|Mastectomy|mastectomy
509589|NCT01391806|Prospective study|prospective study
509590|NCT01391793|Renal scarring|renal scarring
509591|NCT01391793|Dexamethasone|dexamethasone
509592|NCT01391793|Child|child
509593|NCT01391793|Corticosteroids|corticosteroids
509594|NCT01391793|Pediatric|pediatric
509595|NCT01391793|Urinary tract infection|urinary tract infection
509596|NCT01391793|Escherichia Coli Urinary Tract Infection|escherichia coli urinary tract infection
509597|NCT01391780|pelvic floor evaluation,|pelvic floor evaluation,
509598|NCT01391780|women,|women,
509599|NCT01391780|stress urinary incontinence;|stress urinary incontinence;
509600|NCT01391780|urgency urinary incontinence.|urgency urinary incontinence.
509601|NCT01391767|Ridge Preservation|ridge preservation
509602|NCT01391767|Dental Implant|dental implant
509603|NCT01391767|Histology|histology
509604|NCT01391754|child abuse|child abuse
509605|NCT01391741|Parkinson´s Disease|parkinson´s disease
509606|NCT01391741|Walking|walking
509607|NCT01391741|Exercise|exercise
509608|NCT01391741|Automaticity|automaticity
509609|NCT01391741|Dual Task|dual task
509610|NCT01391741|Visual Cues|visual cues
509611|NCT01391741|Cueing|cueing
509612|NCT01391741|Neuroplasticity|neuroplasticity
509613|NCT01391741|Gait analysis|gait analysis
509614|NCT01391715|Gastroesophageal reflux disease|gastroesophageal reflux disease
509615|NCT01391715|Proton pump inhibitor|proton pump inhibitor
509616|NCT01391715|standard dose|standard dose
509617|NCT01391715|Double dose|double dose
509618|NCT01391676|glaucoma|glaucoma
509619|NCT01391676|trabeculectomy|trabeculectomy
509620|NCT01391676|filtering bleb|filtering bleb
509621|NCT01391676|spectral domain optical coherence tomography|spectral domain optical coherence tomography
509622|NCT01391663|Drug Therapy|drug therapy
509623|NCT01391650|ACL|acl
509624|NCT01391650|double-bundle|double-bundle
509625|NCT01391650|navigation system|navigation system
509626|NCT01391637|Long term follow-up|long term follow-up
509627|NCT01391637|HuCNS-SC cells|hucns-sc cells
509628|NCT01391637|human central nervous system stem cells|human central nervous system stem cells
509631|NCT01391624|addiction|addiction
509632|NCT01391624|compulsion|compulsion
509633|NCT01391598|fibromyalgia|fibromyalgia
509634|NCT01391598|intravenous lidocaine|intravenous lidocaine
509635|NCT01391598|substance P|substance p
509636|NCT01391598|interleukins|interleukins
509637|NCT01391585|Text|text
509638|NCT01391585|SMS|sms
509639|NCT01391585|diabetes|diabetes
509640|NCT01391585|self-monitoring|self-monitoring
509641|NCT01391585|self-management|self-management
509643|NCT01391572|thoracic esophageal squamous cell carcinoma|thoracic esophageal squamous cell carcinoma
509644|NCT01391572|esophagectomy|esophagectomy
509645|NCT01391572|radiation|radiation
509646|NCT01391572|tumor bed|tumor bed
509647|NCT01391572|elective nodal irradiation|elective nodal irradiation
509648|NCT01391559|breathing difficulty|breathing difficulty
509649|NCT01391520|Acute Kidney Injury|acute kidney injury
509650|NCT01391520|Contrast-Induced Nephropathy|contrast-induced nephropathy
509651|NCT01391520|Labile Iron|labile iron
509652|NCT01391520|Iron Chelation|iron chelation
509653|NCT01391520|Deferiprone|deferiprone
509654|NCT01391507|Anti-beta1-receptor autoantibodies|anti-beta1-receptor autoantibodies
509655|NCT01391507|COR-1|cor-1
509656|NCT01391507|Heart failure|heart failure
509657|NCT01391494|Human Enterovirus 71 (EV71)|human enterovirus 71 (ev71)
509658|NCT01391494|Hand, Foot and Mouth Disease|hand, foot and mouth disease
509659|NCT01391494|Inactivated Vaccine|inactivated vaccine
509660|NCT01391494|Human Diploid cell|human diploid cell
509661|NCT01391494|Safety|safety
509662|NCT01391494|Immunogenicity|immunogenicity
509663|NCT01391494|Adverse reactions associated with vaccine|adverse reactions associated with vaccine
509664|NCT01391481|Perfluorocarbon|perfluorocarbon
509665|NCT01391481|Acute Respiratory Distress Syndrome|acute respiratory distress syndrome
509666|NCT01391481|Acute lung injury|acute lung injury
509667|NCT01391455|Inguinal hernia repair|inguinal hernia repair
509668|NCT01391455|Mesh|mesh
509669|NCT01391455|Groin pain|groin pain
509670|NCT01391455|Testicular pain|testicular pain
509671|NCT01391442|follow up of troop,|follow up of troop,
509672|NCT01391442|MRI, Echocardiography, Functional indices|mri, echocardiography, functional indices
509673|NCT01391416|Hyperhomocysteinemia|hyperhomocysteinemia
509674|NCT01391416|Chronic kidney disease|chronic kidney disease
509675|NCT01391403|Schizophrenia|schizophrenia
509676|NCT01391403|Risperidone|risperidone
509677|NCT01391403|Artemisinin|artemisinin
509678|NCT01391403|Toxoplasma|toxoplasma
509679|NCT01391403|Immune|immune
509680|NCT01391390|Tardive Dyskinesia|tardive dyskinesia
509681|NCT01391390|Schizophrenia|schizophrenia
509682|NCT01391390|Melatonin|melatonin
509683|NCT01391390|Oxidative Stress|oxidative stress
509684|NCT01391390|Antioxidant|antioxidant
509685|NCT01391377|HDL|hdl
509686|NCT01391377|High density Lipoprotein|high density lipoprotein
509687|NCT01391377|Peripheral arterial disease|peripheral arterial disease
509688|NCT01391377|Tredaptive|tredaptive
509689|NCT01391377|Niacin|niacin
509690|NCT01391377|Laropiprant|laropiprant
509691|NCT01391377|Plaque|plaque
509692|NCT01391377|Atherosclerosis|atherosclerosis
509693|NCT01391377|Lipid content|lipid content
509694|NCT01391351|carcinoma of the ovary, the fallopian tube or peritoneal serous-type advanced stage|carcinoma of the ovary, the fallopian tube or peritoneal serous-type advanced stage
509695|NCT01391351|chemotherapy with Taxol and Carboplatin|chemotherapy with taxol and carboplatin
509696|NCT01391351|predictors of therapeutic response|predictors of therapeutic response
509697|NCT01391351|serum miRNA|serum mirna
509698|NCT01391351|identification of polymorphisms or SNPs (Single Nucleotide Polymorphism)|identification of polymorphisms or snps (single nucleotide polymorphism)
509699|NCT01391338|Prostatitis|prostatitis
509700|NCT01391338|Chronic|chronic
509701|NCT01391338|Pelvic Pain|pelvic pain
509702|NCT01391338|NIH-CPSI|nih-cpsi
509703|NCT01391338|Pain domain score in NIH-CPSI|pain domain score in nih-cpsi
509704|NCT01391260|Locally Advanced NSCLC|locally advanced nsclc
509705|NCT01391260|EGFR Mutation Positive|egfr mutation positive
509706|NCT01391260|Radiotherapy combined Gefitinib|radiotherapy combined gefitinib
509707|NCT01391247|open angle glaucoma|open angle glaucoma
509708|NCT01391247|low tension glaucoma|low tension glaucoma
509709|NCT01391247|oximetry|oximetry
509710|NCT01391234|Metastatic bone disease|metastatic bone disease
509711|NCT01391234|Bone metastases|bone metastases
509712|NCT01391234|Radiation therapy|radiation therapy
509713|NCT01391234|TomoTherapy|tomotherapy
509714|NCT01391221|Depression|depression
509715|NCT01391221|Inflammation|inflammation
509716|NCT01391221|Cognition|cognition
509717|NCT01391221|Pain|pain
509718|NCT01391221|Allostatic load|allostatic load
509719|NCT01391208|Barrett's Esophagus with High Grade Dysplasia|barrett's esophagus with high grade dysplasia
509720|NCT01391208|Esophageal adenocarcinoma|esophageal adenocarcinoma
509721|NCT01391195|low level laser therapy|low level laser therapy
509722|NCT01391195|muscle performance|muscle performance
509723|NCT01391195|fatigue index|fatigue index
509724|NCT01391195|endurance training|endurance training
509725|NCT01391195|ventilatory threshold|ventilatory threshold
509726|NCT01391195|VO2Max|vo2max
509727|NCT01391195|VO2Peak|vo2peak
509728|NCT01391182|Epsilon Aminocaproic Acid|epsilon aminocaproic acid
509729|NCT01391182|blood loss|blood loss
509730|NCT01391182|total hip arthroplasty|total hip arthroplasty
509731|NCT01391182|reduction in blood transfusions|reduction in blood transfusions
509732|NCT01391182|Amicar|amicar
509733|NCT01391156|minoxidil|minoxidil
509734|NCT01391156|finasteride|finasteride
509735|NCT01391156|topical|topical
509736|NCT01391156|lotion|lotion
509737|NCT01391156|male pattern hair loss|male pattern hair loss
509738|NCT01391156|androgenetic alopecia|androgenetic alopecia
509739|NCT01391143|Prostate cancer|prostate cancer
509740|NCT01391143|Melanoma|melanoma
509741|NCT01391143|Renal cell carcinoma|renal cell carcinoma
509742|NCT01391143|Triple-negative breast cancer|triple-negative breast cancer
509743|NCT01391143|Head and neck cancer|head and neck cancer
509744|NCT01391143|Bladder cancer|bladder cancer
509745|NCT01391143|Non-small cell lung cancer|non-small cell lung cancer
509746|NCT01391143|Squamous cell carcinoma|squamous cell carcinoma
509747|NCT01391130|Cancer|cancer
509748|NCT01391130|Tumor|tumor
509749|NCT01391130|Metastasis|metastasis
509750|NCT01391117|TMC649128|tmc649128
509751|NCT01391117|HCV|hcv
509752|NCT01391117|TMC649128HPC1002|tmc649128hpc1002
509753|NCT01391117|Hepatitis C|hepatitis c
509754|NCT01391117|Hep C|hep c
509755|NCT01391104|Pulmonary Hypertension|pulmonary hypertension
509756|NCT01391104|Pulmonary Arterial Hypertension|pulmonary arterial hypertension
509757|NCT01391104|Exercise|exercise
509758|NCT01391104|Six-minute walk test|six-minute walk test
509759|NCT01391104|sildenafil|sildenafil
509760|NCT01391078|glaucoma|glaucoma
509761|NCT01391078|IOP|iop
509762|NCT01391078|Sensimed Triggerfish|sensimed triggerfish
509763|NCT01391078|Goldmann Applanation Tonometry|goldmann applanation tonometry
509764|NCT01391078|fluctuation|fluctuation
509765|NCT01391078|comparison|comparison
509766|NCT01391065|Diffusion Weighted MRI|diffusion weighted mri
509767|NCT01391065|FLT PET|flt pet
509768|NCT01391065|F-Miso PET|f-miso pet
509769|NCT01391065|Image Guided Brachytherapy|image guided brachytherapy
509770|NCT01391065|Cervix|cervix
509771|NCT01391065|Postoperative Residual Disease/Postoperative recurrences|postoperative residual disease/postoperative recurrences
509772|NCT01391052|Intrauterine system|intrauterine system
509773|NCT01391052|reproductive age|reproductive age
509774|NCT01391052|menstrual bleeding|menstrual bleeding
509775|NCT01391039|Ductal Carcinoma In-situ|ductal carcinoma in-situ
509776|NCT01391039|Contrast Ultrasound|contrast ultrasound
509777|NCT01391039|Microinvasion|microinvasion
509778|NCT01391039|Elastography|elastography
509779|NCT01391026|Medical informatics|medical informatics
509780|NCT01391026|Health services accessibility|health services accessibility
509781|NCT01391013|Human immunodeficiency virus 1|human immunodeficiency virus 1
509782|NCT01391013|Acquired immunodeficiency syndrome|acquired immunodeficiency syndrome
509783|NCT01391013|Immunologic deficiency syndrome|immunologic deficiency syndrome
509784|NCT01391013|Darunavir/ritonavir|darunavir/ritonavir
509785|NCT01391013|Darunavir|darunavir
509786|NCT01391013|Ritonavir|ritonavir
509787|NCT01391013|Nucleoside reverse transcriptase inhibitors (NRTIs)|nucleoside reverse transcriptase inhibitors (nrtis)
509788|NCT01391013|Prezista|prezista
509789|NCT01391000|rotator cuff surgery|rotator cuff surgery
509790|NCT01391000|pain|pain
509791|NCT01391000|exercise therapy|exercise therapy
509792|NCT01390974|ACS|acs
509793|NCT01390974|PCI|pci
509794|NCT01390974|thienopyridines|thienopyridines
509795|NCT01390974|prasugrel therapy|prasugrel therapy
509796|NCT01390974|clopidogrel therapy|clopidogrel therapy
509797|NCT01390961|Allergic conjunctivitis|allergic conjunctivitis
509798|NCT01390935|guideline adherence|guideline adherence
509799|NCT01390935|systolic heart failure|systolic heart failure
509800|NCT01390909|epilepsy|epilepsy
509801|NCT01390909|anti-epileptic drug|anti-epileptic drug
509802|NCT01390909|polytherapy|polytherapy
509803|NCT01390909|adherence|adherence
509804|NCT01390909|Medicaid|medicaid
509805|NCT01390870|Enlarged prostate, 5-alpha-reductase inhibitor, alpha-blocker, adherence|enlarged prostate, 5-alpha-reductase inhibitor, alpha-blocker, adherence
509806|NCT01390818|MEK inhibitor (Pimasertib)|mek inhibitor (pimasertib)
509807|NCT01390818|PI3K/mTOR Inhibitor|pi3k/mtor inhibitor
509808|NCT01390818|Solid Tumor|solid tumor
509809|NCT01390818|Phase I|phase i
509810|NCT01390766|Antirejection|antirejection
509811|NCT01390740|Transthoracic echocardiography|transthoracic echocardiography
509812|NCT01390727|hypertension|hypertension
509813|NCT01390727|device-guided breathing|device-guided breathing
509814|NCT01390727|autonomic function|autonomic function
509815|NCT01390727|Resperate|resperate
509816|NCT01390714|Proton Pump Inhibitors|proton pump inhibitors
509817|NCT01390714|Gastroesophageal Reflux Disease|gastroesophageal reflux disease
509818|NCT01390714|pharmacokinetics|pharmacokinetics
509819|NCT01390714|pharmacodynamics|pharmacodynamics
509820|NCT01390701|randomized|randomized
509821|NCT01390701|cross-over|cross-over
509822|NCT01390701|transcutaneous electrical nerve stimulation|transcutaneous electrical nerve stimulation
509823|NCT01390701|felodipin|felodipin
509824|NCT01390701|hypertension|hypertension
509825|NCT01390701|blood pressure|blood pressure
509826|NCT01390701|treatment|treatment
509827|NCT01390688|Brain-derived Neurotrophic factor|brain-derived neurotrophic factor
509828|NCT01390688|Low-grade inflammation|low-grade inflammation
509829|NCT01390688|Cognitive dysfunction|cognitive dysfunction
509830|NCT01390662|serum 25-hydroxyvitamin d,vitamin D supplement, depression,|serum 25-hydroxyvitamin d,vitamin d supplement, depression,
509831|NCT01390662|parathyroid hormone|parathyroid hormone
509832|NCT01390649|ITP|itp
509833|NCT01390636|Continuous Glucose Monitoring|continuous glucose monitoring
509834|NCT01390636|Type 1 Diabetes and an Eating Disorder|type 1 diabetes and an eating disorder
509835|NCT01390636|Eating Disorder Only|eating disorder only
509836|NCT01390623|Acute Uncomplicated Pyelonephritis|acute uncomplicated pyelonephritis
509837|NCT01390623|Short-term antibiotic|short-term antibiotic
509838|NCT01390623|Ceftriaxone|ceftriaxone
509839|NCT01390623|Cefixime|cefixime
509840|NCT01390623|Women|women
509841|NCT01390623|Efficacy|efficacy
509842|NCT01390610|Continuous Glucose Monitoring|continuous glucose monitoring
509843|NCT01390610|Self Monitored Blood Glucose|self monitored blood glucose
509844|NCT01390610|Type 2 Diabetes|type 2 diabetes
509845|NCT01390597|peripheral T-cell lymphoma|peripheral t-cell lymphoma
509846|NCT01390597|stage I adult T-cell leukemia/lymphoma|stage i adult t-cell leukemia/lymphoma
509847|NCT01390597|stage II adult T-cell leukemia/lymphoma|stage ii adult t-cell leukemia/lymphoma
509848|NCT01390597|stage III adult T-cell leukemia/lymphoma|stage iii adult t-cell leukemia/lymphoma
509849|NCT01390597|stage IV adult T-cell leukemia/lymphoma|stage iv adult t-cell leukemia/lymphoma
509850|NCT01390597|anaplastic large cell lymphoma|anaplastic large cell lymphoma
509851|NCT01390584|stage I adult Hodgkin lymphoma|stage i adult hodgkin lymphoma
509852|NCT01390584|stage II adult Hodgkin lymphoma|stage ii adult hodgkin lymphoma
509853|NCT01390584|adult favorable prognosis Hodgkin lymphoma|adult favorable prognosis hodgkin lymphoma
509854|NCT01390584|adult mixed cellularity Hodgkin lymphoma|adult mixed cellularity hodgkin lymphoma
509855|NCT01390584|adult nodular sclerosis Hodgkin lymphoma|adult nodular sclerosis hodgkin lymphoma
509856|NCT01390584|adult lymphocyte depletion Hodgkin lymphoma|adult lymphocyte depletion hodgkin lymphoma
509857|NCT01390584|adult unfavorable prognosis Hodgkin lymphoma|adult unfavorable prognosis hodgkin lymphoma
509858|NCT01390571|adult glioblastoma|adult glioblastoma
509859|NCT01390571|adult giant cell glioblastoma|adult giant cell glioblastoma
509860|NCT01390571|adult gliosarcoma|adult gliosarcoma
509861|NCT01390571|recurrent adult brain tumor|recurrent adult brain tumor
509862|NCT01390558|Down Syndrome|down syndrome
509863|NCT01390558|Orthotics|orthotics
509864|NCT01390558|Gait Analysis|gait analysis
509865|NCT01390545|Rheumatoid arthritis|rheumatoid arthritis
509866|NCT01390545|anti-CD20 antibody|anti-cd20 antibody
509867|NCT01390545|subcutaneous|subcutaneous
509868|NCT01390532|Left Ventricular Dyssynchrony|left ventricular dyssynchrony
509869|NCT01390532|Gated blood-pool|gated blood-pool
509870|NCT01390532|D-SPECT|d-spect
509871|NCT01390532|Pharmacological stress|pharmacological stress
509872|NCT01390532|NYHA III/IV|nyha iii/iv
509873|NCT01390532|LVEF < 35 %|lvef < 35 %
509874|NCT01390532|QRS > 120 ms|qrs > 120 ms
509875|NCT01390532|optimal medical treatment|optimal medical treatment
509876|NCT01390532|cardiac resynchronization therapy|cardiac resynchronization therapy
509877|NCT01390519|mRCC,|mrcc,
509878|NCT01390519|observational,|observational,
509879|NCT01390519|Afinitor,|afinitor,
509880|NCT01390519|everolimus,|everolimus,
509881|NCT01390519|2.line|2.line
509882|NCT01390506|cardiac arrest|cardiac arrest
509883|NCT01390506|resuscitation|resuscitation
509884|NCT01390506|neurological outcome|neurological outcome
509885|NCT01390493|neurofeedback, alpha, anorexia nervosa|neurofeedback, alpha, anorexia nervosa
509886|NCT01390480|vitamin D|vitamin d
509887|NCT01390480|Autoimmune disease|autoimmune disease
509888|NCT01390480|diabetes|diabetes
509889|NCT01390467|Paracetamol|paracetamol
509890|NCT01390467|Cognitive impact|cognitive impact
509891|NCT01390441|Rheumatoid arthritis|rheumatoid arthritis
509892|NCT01390441|RA|ra
509893|NCT01390441|Rituximab|rituximab
509894|NCT01390441|Rituxan|rituxan
509895|NCT01390441|MabThera|mabthera
509896|NCT01390441|Methotrexate|methotrexate
509897|NCT01390441|Rheumatrex|rheumatrex
509898|NCT01390441|Trexall|trexall
509899|NCT01390441|MK-8808|mk-8808
509900|NCT01390402|Alloreactive haploidentical NK cells|alloreactive haploidentical nk cells
509901|NCT01390402|Natural killer cells|natural killer cells
509902|NCT01390402|Stem Cell Transplantation|stem cell transplantation
509903|NCT01390402|Immune cells|immune cells
509904|NCT01390402|Chronic myelogenous leukemia|chronic myelogenous leukemia
509905|NCT01390402|CML|cml
509906|NCT01390402|Human leukocyte antigen|human leukocyte antigen
509907|NCT01390402|HLA|hla
509908|NCT01390402|Graft-vs-host disease|graft-vs-host disease
509909|NCT01390402|GVHD|gvhd
509910|NCT01390402|Antithymocyte globulin|antithymocyte globulin
509911|NCT01390402|ATG|atg
509912|NCT01390402|Thymoglobulin|thymoglobulin
509913|NCT01390402|Interleukin-2|interleukin-2
509914|NCT01390402|IL-2|il-2
509915|NCT01390402|Aldesleukin|aldesleukin
509916|NCT01390402|Proleukin|proleukin
509917|NCT01390402|Fludarabine|fludarabine
509918|NCT01390402|Fludarabine phosphate|fludarabine phosphate
509920|NCT01390402|Tacrolimus|tacrolimus
509921|NCT01390402|Prograf|prograf
509922|NCT01390402|Busulfan|busulfan
509923|NCT01390402|Busulfex|busulfex
509924|NCT01390402|Myleran|myleran
509925|NCT01390402|Methotrexate|methotrexate
509926|NCT01390389|Geriatric bipolar depression|geriatric bipolar depression
509927|NCT01390389|MR Spectroscopy|mr spectroscopy
509928|NCT01390389|Coenzyme Q10|coenzyme q10
509929|NCT01390389|Mitochondrial Dysfunction|mitochondrial dysfunction
509930|NCT01390376|Schizophrenia|schizophrenia
509931|NCT01390376|NMDA|nmda
509932|NCT01390376|DAAOI|daaoi
509933|NCT01390376|Clozapine resistant schizophrenia|clozapine resistant schizophrenia
509934|NCT01390363|immunization|immunization
509935|NCT01390363|reminder systems|reminder systems
509936|NCT01390350|Schnitzler syndrome|schnitzler syndrome
509937|NCT01390350|autoinflammatory syndrome|autoinflammatory syndrome
509938|NCT01390337|AC220|ac220
509939|NCT01390337|Acute Myeloid Leukemia (AML)|acute myeloid leukemia (aml)
509940|NCT01390337|De Novo Acute Myeloid Leukemia (AML)|de novo acute myeloid leukemia (aml)
509941|NCT01390337|Newly diagnosed Acute Myeloid Leukemia (AML)|newly diagnosed acute myeloid leukemia (aml)
509942|NCT01390337|FMS-like tyrosine kinase (FLT3)|fms-like tyrosine kinase (flt3)
509943|NCT01390337|FMS-like tyrosine kinase (FLT3) Inhibitor|fms-like tyrosine kinase (flt3) inhibitor
509944|NCT01390337|Kinase|kinase
509945|NCT01390337|Kinase Inhibitor|kinase inhibitor
509946|NCT01390337|Pharmacokinetics|pharmacokinetics
509947|NCT01390337|ASP2689|asp2689
509948|NCT01390337|quizartinib|quizartinib
509949|NCT01390324|Migraine|migraine
509950|NCT01390324|Naratriptan|naratriptan
509951|NCT01390324|Naproxen|naproxen
509952|NCT01390298|chronic pain after knee replacement surgery|chronic pain after knee replacement surgery
509953|NCT01390272|Hypertension|hypertension
509954|NCT01390272|Telephone|telephone
509955|NCT01390272|Disease Management|disease management
509956|NCT01390272|Veterans|veterans
509957|NCT01390272|Pharmacists|pharmacists
509958|NCT01390272|Nurses|nurses
509959|NCT01390246|Pregnancy|pregnancy
509960|NCT01390246|Tobacco use disorder|tobacco use disorder
509961|NCT01390246|Smoking cessation|smoking cessation
509962|NCT01390246|Bupropion SR|bupropion sr
509963|NCT01390246|Zyban|zyban
509964|NCT01390233|Labor, obstetric|labor, obstetric
509965|NCT01390233|Labor, induced|labor, induced
509966|NCT01390220|Epilepsy|epilepsy
509967|NCT01390220|seizure clusters|seizure clusters
509968|NCT01390220|acute repetitive seizures|acute repetitive seizures
509969|NCT01390220|rescue treatment|rescue treatment
509970|NCT01390220|ARTEMIS|artemis
509971|NCT01390207|hCG triggering|hcg triggering
509972|NCT01390207|pregnancy|pregnancy
509973|NCT01390207|GnRH antagonist|gnrh antagonist
509974|NCT01390194|liver disease|liver disease
509975|NCT01390194|hepatocellular carcinoma|hepatocellular carcinoma
509976|NCT01390155|Electrocardiography|electrocardiography
509977|NCT01390155|Coronary Artery Disease|coronary artery disease
509978|NCT01390155|Atrial Fibrillation|atrial fibrillation
509979|NCT01390155|Heart Atria|heart atria
509980|NCT01390155|Coronary Circulation|coronary circulation
509981|NCT01390155|Ischemia|ischemia
509982|NCT01390116|gamma delta T cell|gamma delta t cell
509983|NCT01390116|natural killer cell|natural killer cell
509984|NCT01390116|proliferation|proliferation
509985|NCT01390116|cytokine secretion|cytokine secretion
509986|NCT01390116|Improvement in immune cell function in healthy humans|improvement in immune cell function in healthy humans
509987|NCT01390103|hip pain|hip pain
509988|NCT01390090|piriformis muscle|piriformis muscle
509989|NCT01390077|homogentisic acid|homogentisic acid
509990|NCT01390051|birth weight|birth weight
509991|NCT01390051|thrombosis|thrombosis
509992|NCT01390051|anticoagulant therapy|anticoagulant therapy
509993|NCT01390025|Influenza|influenza
509994|NCT01390025|Monoclonal antibody|monoclonal antibody
509995|NCT01389973|Diseases [C] - Digestive System Diseases [C06]|diseases [c] - digestive system diseases [c06]
509996|NCT01389973|primary biliary cirrhosis|primary biliary cirrhosis
509997|NCT01389973|ursodeoxycholic acid (UDCA)|ursodeoxycholic acid (udca)
509998|NCT01389973|STELARA|stelara
509999|NCT01389973|ustekinumab|ustekinumab
510000|NCT01389947|mesenteric ischemia|mesenteric ischemia
510001|NCT01389947|extracorporeal circulation|extracorporeal circulation
510002|NCT01389947|microcirculation|microcirculation
510003|NCT01389947|cardiac surgery|cardiac surgery
510004|NCT01389947|IFABP|ifabp
510005|NCT01389947|citrullinemia|citrullinemia
510006|NCT01389947|glycocalyx|glycocalyx
510007|NCT01389947|vascular occlusion test|vascular occlusion test
510008|NCT01389947|NIRS probe on thenar eminence|nirs probe on thenar eminence
510009|NCT01389934|levo-bupicaine|levo-bupicaine
510010|NCT01389934|Radical|radical
510011|NCT01389934|Mastectomy|mastectomy
510012|NCT01389921|lower urinary tract|lower urinary tract
510013|NCT01389921|sensory evoked potential|sensory evoked potential
510014|NCT01389921|contact heat evoked potential stimulation|contact heat evoked potential stimulation
510015|NCT01389921|electroencephalogram|electroencephalogram
510016|NCT01389921|cortical processing|cortical processing
510017|NCT01389921|bladder sensations|bladder sensations
510018|NCT01389921|lower urinary tract dysfunction|lower urinary tract dysfunction
510019|NCT01389921|overactive bladder|overactive bladder
510020|NCT01389895|Lupus|lupus
510021|NCT01389895|Cutaneous lupus|cutaneous lupus
510022|NCT01389882|mechanical ventilation|mechanical ventilation
510023|NCT01389882|diaphragm electrical activity|diaphragm electrical activity
510024|NCT01389882|pressure support|pressure support
510025|NCT01389869|Emotional tears|emotional tears
510026|NCT01389869|Postprandial plasma|postprandial plasma
510027|NCT01389869|Chemosignal|chemosignal
510028|NCT01389869|Obesity|obesity
510029|NCT01389869|Appetite|appetite
510030|NCT01389869|Food intake|food intake
510031|NCT01389856|Persistent pulmonary hypertension, newborn|persistent pulmonary hypertension, newborn
510032|NCT01389856|PPHN|pphn
510033|NCT01389843|Heart failure|heart failure
510034|NCT01389843|Registry|registry
510035|NCT01389843|Cohort|cohort
510036|NCT01389843|Heart Disease|heart disease
510037|NCT01389843|Cardiovascular Diseases|cardiovascular diseases
510038|NCT01389830|End of Life|end of life
510039|NCT01389830|EOL|eol
510040|NCT01389830|Latinos|latinos
510041|NCT01389830|Hispanic American|hispanic american
510042|NCT01389830|Medicare beneficiaries|medicare beneficiaries
510043|NCT01389830|stage III diagnosis|stage iii diagnosis
510044|NCT01389830|Breast cancer|breast cancer
510045|NCT01389830|Colorectal cancer|colorectal cancer
510046|NCT01389830|Prostate cancer|prostate cancer
510047|NCT01389830|Lung cancer|lung cancer
510048|NCT01389830|Cancer Prevention and Treatment Demonstration|cancer prevention and treatment demonstration
510049|NCT01389830|CPTD|cptd
510050|NCT01389804|transplant, pediatric|transplant, pediatric
510051|NCT01389791|muscle relaxation|muscle relaxation
510052|NCT01389791|magnesium sulfate|magnesium sulfate
510053|NCT01389791|rocuronium|rocuronium
510054|NCT01389739|continuity of care|continuity of care
510055|NCT01389739|interprofessional collaboration|interprofessional collaboration
510056|NCT01389726|custodial grandparents|custodial grandparents
510057|NCT01389726|kinship caregivers|kinship caregivers
510058|NCT01389726|grandparents raising grandchildren|grandparents raising grandchildren
510059|NCT01389726|grandmothers|grandmothers
510060|NCT01389726|grandchildren|grandchildren
510061|NCT01389726|psychological well-being|psychological well-being
510062|NCT01389713|ovarian reserve|ovarian reserve
510063|NCT01389713|ovarian stimulation|ovarian stimulation
510064|NCT01389713|clomifene citrate|clomifene citrate
510065|NCT01389713|high doses Follicle Stimulating Hormone (FSH)|high doses follicle stimulating hormone (fsh)
510066|NCT01389687|Poliomyelitis|poliomyelitis
510067|NCT01389687|Inactivated polio vaccine|inactivated polio vaccine
510068|NCT01389687|Polio|polio
510069|NCT01389687|Poliovirus|poliovirus
510070|NCT01389674|coronary stenosis|coronary stenosis
510071|NCT01389674|Angina pectoris|angina pectoris
510072|NCT01389674|left ventricular wall motion abnormalities|left ventricular wall motion abnormalities
510073|NCT01389661|Maxillary bone cysts|maxillary bone cysts
510074|NCT01389661|Cell therapy|cell therapy
510075|NCT01389661|Mesenchymal stem cells|mesenchymal stem cells
510076|NCT01389661|Autologous serum scaffold|autologous serum scaffold
510077|NCT01389648|adult|adult
510078|NCT01389635|Abdominoplasty|abdominoplasty
510079|NCT01389635|Epidural|epidural
510080|NCT01389622|Acupuncture|acupuncture
510081|NCT01389622|smoking cessation|smoking cessation
510082|NCT01389609|Bioequivalence|bioequivalence
510083|NCT01389609|Orally-disintegrating Tablet|orally-disintegrating tablet
510084|NCT01389596|safety|safety
510085|NCT01389596|efficacy|efficacy
510086|NCT01389596|partial onset seizures|partial onset seizures
510087|NCT01389596|pediatric|pediatric
510088|NCT01389596|pregabalin|pregabalin
510089|NCT01389596|placebo-controlled|placebo-controlled
510090|NCT01389596|double-blind|double-blind
510091|NCT01389583|GIST(Gastrointestinal stromal tumor)|gist(gastrointestinal stromal tumor)
510092|NCT01389583|HSP(Heat Shock Protein)|hsp(heat shock protein)
510093|NCT01389583|Biomarker|biomarker
510094|NCT01389557|malaria|malaria
510095|NCT01389557|DHP|dhp
510096|NCT01389557|PQ|pq
510097|NCT01389557|MST|mst
510098|NCT01389518|Symptomatic treatment|symptomatic treatment
510099|NCT01389518|Common Cold|common cold
510100|NCT01389518|flu syndrome|flu syndrome
510101|NCT01389505|Proliferative Diabetic Retinopathy|proliferative diabetic retinopathy
510102|NCT01389505|Bevacizumab|bevacizumab
510103|NCT01389505|Panretinal Photocoagulation|panretinal photocoagulation
510104|NCT01389492|meat|meat
510105|NCT01389492|LDL|ldl
510106|NCT01389492|MDA|mda
510107|NCT01389466|Avian influenza|avian influenza
510108|NCT01389453|umbilical cord mesenchyma stem cell transplantation|umbilical cord mesenchyma stem cell transplantation
510109|NCT01389440|Resectable pancreatic adenocarcinoma|resectable pancreatic adenocarcinoma
510110|NCT01389440|Gemcitabine|gemcitabine
510111|NCT01389440|Erlotinib|erlotinib
510112|NCT01389440|Radiotherapy|radiotherapy
510113|NCT01389440|Neoadjuvant treatment|neoadjuvant treatment
510114|NCT01389414|cholangiocarcinoma|cholangiocarcinoma
510115|NCT01389414|biliary|biliary
510116|NCT01389414|gallbladder|gallbladder
510117|NCT01389414|intrahepatic|intrahepatic
510118|NCT01389414|extrahepatic|extrahepatic
510119|NCT01389401|Larynx|larynx
510120|NCT01389401|GERD|gerd
510121|NCT01389401|saliva|saliva
510122|NCT01389401|epidermal growth factor|epidermal growth factor
510123|NCT01389388|Carotid plaques|carotid plaques
510124|NCT01389388|inflammatory joint disease|inflammatory joint disease
510125|NCT01389388|statins|statins
510126|NCT01389388|inflammation|inflammation
510127|NCT01389388|lipoprotein components|lipoprotein components
510128|NCT01389375|Closure Device|closure device
510129|NCT01389375|Coronary Angiography|coronary angiography
510130|NCT01389362|Diabetes|diabetes
510131|NCT01389362|foot ulcer|foot ulcer
510132|NCT01389362|Chinese herbal medicine|chinese herbal medicine
510133|NCT01389349|tonsillectomy|tonsillectomy
510134|NCT01389349|adenotonsillectomy|adenotonsillectomy
510135|NCT01389349|acupuncture|acupuncture
510136|NCT01389349|children|children
510137|NCT01389349|postoperative pain|postoperative pain
510138|NCT01389349|postoperative nausea|postoperative nausea
510139|NCT01389336|Fibromyalgia Syndrome|fibromyalgia syndrome
510140|NCT01389336|Fibromyalgia|fibromyalgia
510141|NCT01389336|Ayurveda|ayurveda
510142|NCT01389336|Traditional Indian Medicine|traditional indian medicine
510143|NCT01389336|CAM|cam
510144|NCT01389336|Pain|pain
510145|NCT01389336|Chronic Widespread Pain|chronic widespread pain
510146|NCT01389297|alcohol dependence intervention|alcohol dependence intervention
510147|NCT01389297|Internet delivered intervention|internet delivered intervention
510148|NCT01389297|alcohol dependence treatment|alcohol dependence treatment
510149|NCT01389297|Internet delivered treatment|internet delivered treatment
510150|NCT01389284|Naproxen Sodium,|naproxen sodium,
510151|NCT01389284|dental pain|dental pain
510152|NCT01389271|Pulmonary hypertension|pulmonary hypertension
510153|NCT01389271|Inhaled iloprost|inhaled iloprost
510154|NCT01389271|Efficacy|efficacy
510155|NCT01389271|Safety|safety
510156|NCT01389271|Tolerability|tolerability
510157|NCT01389271|Survival|survival
510158|NCT01389271|NYHA class III and IV|nyha class iii and iv
510159|NCT01389219|Post partum|post partum
510160|NCT01389219|Neonate|neonate
510161|NCT01389219|community health care workers|community health care workers
510162|NCT01389193|ibudilast|ibudilast
510163|NCT01389193|migraine|migraine
510164|NCT01389193|glial cell|glial cell
510165|NCT01389154|diagnostic yield|diagnostic yield
510166|NCT01389154|Electromagnetic Tip Tracked|electromagnetic tip tracked
510167|NCT01389154|peripheral lung lesion|peripheral lung lesion
510168|NCT01389141|ovary|ovary
510169|NCT01389141|follicle|follicle
510170|NCT01389141|hormones|hormones
510171|NCT01389141|bone|bone
510172|NCT01389141|muscle|muscle
510173|NCT01389128|labor|labor
510174|NCT01389128|pain|pain
510175|NCT01389128|massage|massage
510176|NCT01389128|natural birth|natural birth
510177|NCT01389115|liver cirrhosis|liver cirrhosis
510178|NCT01389115|oxidative stress|oxidative stress
510179|NCT01389115|liver transplant|liver transplant
510180|NCT01389102|Postmenopause|postmenopause
510181|NCT01389102|Hot Flashes|hot flashes
510182|NCT01389102|Estradiol|estradiol
510183|NCT01389102|Polyestradiol phosphate|polyestradiol phosphate
510184|NCT01389102|Estradiol valerate|estradiol valerate
510185|NCT01389102|Estradiol 3-benzoate|estradiol 3-benzoate
510186|NCT01389102|Estradiol 17 beta-cypionate|estradiol 17 beta-cypionate
510187|NCT01389102|Estrogens|estrogens
510188|NCT01389102|Hormones|hormones
510189|NCT01389102|Hormones, Hormone Substitutes|hormones, hormone substitutes
510190|NCT01389102|Hormone Antagonists|hormone antagonists
510191|NCT01389089|edema reduction|edema reduction
510192|NCT01389089|ice|ice
510193|NCT01389089|multi-layer compression bandage|multi-layer compression bandage
510194|NCT01389089|A-V Impulse compression|a-v impulse compression
510195|NCT01389089|ankle|ankle
510196|NCT01389076|Previously Untreated, Advanced-Stage, Follicular Lymphoma|previously untreated, advanced-stage, follicular lymphoma
510197|NCT01389063|endothelial function|endothelial function
510198|NCT01389063|CCR5 receptor|ccr5 receptor
510199|NCT01389063|Maraviroc|maraviroc
510200|NCT01389063|Abacavir|abacavir
510201|NCT01389063|Flow Mediated Dilatation|flow mediated dilatation
510202|NCT01389063|EndoPAT|endopat
510203|NCT01389037|African American|african american
510204|NCT01389037|High blood pressure|high blood pressure
510205|NCT01389024|sickle cell disease|sickle cell disease
510206|NCT01389024|stroke|stroke
510207|NCT01389024|silent cerebral infarct|silent cerebral infarct
510208|NCT01389024|children|children
510209|NCT01389011|PI|pi
510210|NCT01389011|PVI|pvi
510211|NCT01389011|Interscalene block|interscalene block
510212|NCT01388998|fluid management|fluid management
510213|NCT01388998|fluid therapy|fluid therapy
510214|NCT01388998|dPP|dpp
510215|NCT01388998|difference in pulse pressure|difference in pulse pressure
510216|NCT01388998|PVI|pvi
510217|NCT01388998|pleth variability index|pleth variability index
510218|NCT01388998|external pressure applied on the caval vein|external pressure applied on the caval vein
510219|NCT01388985|Rabies|rabies
510220|NCT01388985|Vaccination|vaccination
510221|NCT01388985|Boostability|boostability
510222|NCT01388972|Community nutritional environment|community nutritional environment
510223|NCT01388972|Physical activity|physical activity
510224|NCT01388946|acute postoperative pain|acute postoperative pain
510225|NCT01388946|late pain|late pain
510226|NCT01388946|chronic pain|chronic pain
510227|NCT01388946|wound irrigation with local anesthetic|wound irrigation with local anesthetic
510228|NCT01388933|Crohn's Disease|crohn's disease
510230|NCT01388933|herbal|herbal
510231|NCT01388933|Kampo|kampo
510232|NCT01388933|inflammatory bowel disease|inflammatory bowel disease
510233|NCT01388933|Adult ages 18 to 75|adult ages 18 to 75
510234|NCT01388933|Male and female subjects|male and female subjects
510235|NCT01388920|COPD|copd
510236|NCT01388920|Muscle wasting|muscle wasting
510237|NCT01388907|myomectomy|myomectomy
510238|NCT01388907|adhesion prevention|adhesion prevention
510239|NCT01388907|pregnancy rate|pregnancy rate
510240|NCT01388881|reading difficulties|reading difficulties
510241|NCT01388868|infusion dose|infusion dose
510242|NCT01388868|vecuronium|vecuronium
510243|NCT01388868|motor evoked potential|motor evoked potential
510244|NCT01388868|neuromuscular blocking agent|neuromuscular blocking agent
510245|NCT01388855|Heart Failure|heart failure
510246|NCT01388855|Vitamin D|vitamin d
510247|NCT01388855|Pain|pain
510248|NCT01388855|Pilot Study|pilot study
510249|NCT01388855|RCT|rct
510250|NCT01388842|severe malaria|severe malaria
510251|NCT01388842|children|children
510252|NCT01388842|adjunctive treatment|adjunctive treatment
510253|NCT01388829|formulation comparison|formulation comparison
510254|NCT01388816|Randomized|randomized
510255|NCT01388816|Double-Blind|double-blind
510256|NCT01388816|Placebo Controlled|placebo controlled
510257|NCT01388816|Parallel Arm|parallel arm
510258|NCT01388816|Type II Hyperlipidemia|type ii hyperlipidemia
510259|NCT01388816|Cholesteryl Ester Transferase Protein Inhibitor|cholesteryl ester transferase protein inhibitor
510260|NCT01388816|CETP Inhibitor|cetp inhibitor
510261|NCT01388803|bronchial blocker|bronchial blocker
510262|NCT01388803|VATS|vats
510263|NCT01388790|Gastric Cancer|gastric cancer
510264|NCT01388790|Cetuximab|cetuximab
510265|NCT01388790|EMD271786|emd271786
510266|NCT01388790|TS-1|ts-1
510267|NCT01388790|Cisplatin|cisplatin
510268|NCT01388777|Breast Cancer|breast cancer
510269|NCT01388777|Breast Carcinoma|breast carcinoma
510270|NCT01388777|Cryoablation|cryoablation
510271|NCT01388777|The Visica 2™ Treatment System|the visica 2™ treatment system
510272|NCT01388777|Unifocal primary invasive ductal breast carcinoma|unifocal primary invasive ductal breast carcinoma
510273|NCT01388777|Cryoprobe|cryoprobe
510274|NCT01388764|L-arginine supplement study|l-arginine supplement study
510275|NCT01388751|Mallet Finger splinting|mallet finger splinting
510276|NCT01388738|Navigation Brain Stimulation (NEXSTIM)|navigation brain stimulation (nexstim)
510277|NCT01388738|cerebroprotective drug effectiveness|cerebroprotective drug effectiveness
510278|NCT01388738|acute ischemic stroke|acute ischemic stroke
510279|NCT01388725|sTREM-1|strem-1
510280|NCT01388725|sCD163|scd163
510281|NCT01388725|PCT|pct
510282|NCT01388725|CRP|crp
510283|NCT01388725|WBC count|wbc count
510284|NCT01388725|SOFA score|sofa score
510285|NCT01388725|SIRS|sirs
510286|NCT01388725|sepsis|sepsis
510287|NCT01388725|severity|severity
510288|NCT01388725|prognosis|prognosis
510289|NCT01388712|Probiotics|probiotics
510290|NCT01388712|constipation|constipation
510291|NCT01388712|children|children
510292|NCT01388699|Migraine with aura|migraine with aura
510293|NCT01388686|sepsis|sepsis
510294|NCT01388686|catheter|catheter
510295|NCT01388686|blood stream infection|blood stream infection
510296|NCT01388686|blood culture|blood culture
510297|NCT01388673|prior RYGB procedure|prior rygb procedure
510298|NCT01388673|regained weight over time|regained weight over time
510299|NCT01388673|dilated pouch and/or stoma|dilated pouch and/or stoma
510300|NCT01388660|Healthy|healthy
510301|NCT01388660|Platelet Aggregation Inhibitors|platelet aggregation inhibitors
510302|NCT01388660|Pharmacokinetics|pharmacokinetics
510303|NCT01388647|Neoadjuvant Treatment|neoadjuvant treatment
510304|NCT01388647|HER-2 Positive Breast Cancer|her-2 positive breast cancer
510305|NCT01388634|Length of hospital stay|length of hospital stay
510306|NCT01388634|readmission|readmission
510307|NCT01388634|ventral hernia|ventral hernia
510308|NCT01388621|ovarian cancer|ovarian cancer
510309|NCT01388621|fallopian cancer|fallopian cancer
510310|NCT01388621|recurrent|recurrent
510311|NCT01388621|platinum-sensitive|platinum-sensitive
510312|NCT01388621|KRAS-Wildtype|kras-wildtype
510313|NCT01388608|rheumatoid arthritis|rheumatoid arthritis
510314|NCT01388608|etanercept|etanercept
510315|NCT01388608|step activity measure|step activity measure
510316|NCT01388582|contraceptives|contraceptives
510317|NCT01388582|hormonal|hormonal
510318|NCT01388582|breastfeeding|breastfeeding
510319|NCT01388582|infant weight|infant weight
510320|NCT01388569|stage IV melanoma|stage iv melanoma
510321|NCT01388556|exercise|exercise
510322|NCT01388556|Parkinson disease|parkinson disease
510323|NCT01388556|motor symptoms|motor symptoms
510324|NCT01388556|gait|gait
510325|NCT01388556|balance|balance
510326|NCT01388543|Pharmacokinetics|pharmacokinetics
510327|NCT01388543|Clinical Pharmacology|clinical pharmacology
510328|NCT01388543|Pharmacogenomics|pharmacogenomics
510329|NCT01388543|HIV|hiv
510330|NCT01388517|Pityriasis alba|pityriasis alba
510331|NCT01388517|Tacrolimus|tacrolimus
510332|NCT01388517|Calcitriol|calcitriol
649029|NCT00831701|ureter|ureter
510333|NCT01388517|Petrolatum|petrolatum
510334|NCT01388491|Contraception|contraception
510335|NCT01388491|Hemostasis|hemostasis
510336|NCT01388491|Blood Coagulation|blood coagulation
510337|NCT01388478|Safety|safety
510338|NCT01388478|Tolerability|tolerability
510339|NCT01388478|R(+)Pramipexole|r(+)pramipexole
510340|NCT01388478|Alzheimer's|alzheimer's
510341|NCT01388465|Adherence|adherence
510342|NCT01388465|Intervention|intervention
510343|NCT01388452|HIV|hiv
510344|NCT01388452|routine HIV testing|routine hiv testing
510345|NCT01388452|provider-initiated HIV testing and counseling|provider-initiated hiv testing and counseling
510346|NCT01388452|early infant diagnosis|early infant diagnosis
510347|NCT01388452|Africa South of the Sahara|africa south of the sahara
510348|NCT01388439|oseltamivir|oseltamivir
510349|NCT01388439|influenza|influenza
510350|NCT01388439|neonate|neonate
510351|NCT01388439|premature|premature
510352|NCT01388439|pharmacokinetics|pharmacokinetics
510353|NCT01388413|neurogenic bladder|neurogenic bladder
510354|NCT01388413|urinary tract infection|urinary tract infection
510355|NCT01388400|stroke|stroke
510356|NCT01388400|rehabilitation|rehabilitation
510357|NCT01388400|virtual reality|virtual reality
510358|NCT01388400|upper limb|upper limb
510359|NCT01388387|pharmacogenetics|pharmacogenetics
510360|NCT01388387|pharmacokinetics|pharmacokinetics
510361|NCT01388387|tacrolimus|tacrolimus
510362|NCT01388387|genetic polymorphism|genetic polymorphism
510363|NCT01388387|CYP3A5|cyp3a5
510364|NCT01388387|liver transplantation|liver transplantation
510365|NCT01388374|Delivery of Health Care|delivery of health care
510366|NCT01388374|Nurse Practitioners|nurse practitioners
510367|NCT01388374|Out of Hours Medical Care|out of hours medical care
510368|NCT01388374|Primary Health Care|primary health care
510369|NCT01388374|Emergency Medical Services|emergency medical services
510370|NCT01388348|benign prostatic hyperplasia (BPH)|benign prostatic hyperplasia (bph)
510371|NCT01388348|acoustic vibration|acoustic vibration
510372|NCT01388322|Pregnancy|pregnancy
510373|NCT01388322|Preeclampsia|preeclampsia
510374|NCT01388322|Placental insufficiency|placental insufficiency
510375|NCT01388283|prognostic marker|prognostic marker
510376|NCT01388270|Hemodialysis|hemodialysis
510377|NCT01388270|Anticoagulation|anticoagulation
510378|NCT01388270|Clotting|clotting
510379|NCT01388270|Coagulation|coagulation
510380|NCT01388270|dalteparin|dalteparin
510381|NCT01388270|Clotting in the extracorporeal system during HD|clotting in the extracorporeal system during hd
510382|NCT01388270|Antithrombogenic property of Evodial HD filter|antithrombogenic property of evodial hd filter
510383|NCT01388270|Anticoagulation during HD|anticoagulation during hd
510384|NCT01388257|Crohn Disease|crohn disease
510385|NCT01388257|Anoperineal fistula|anoperineal fistula
510386|NCT01388257|Anal fistula|anal fistula
510387|NCT01388257|Proctology|proctology
510388|NCT01388257|Drainage|drainage
510389|NCT01388257|Colorectal Surgery|colorectal surgery
510390|NCT01388257|Fistulotomy|fistulotomy
510391|NCT01388257|Plug|plug
510392|NCT01388257|Advancement flap|advancement flap
510393|NCT01388257|Glue|glue
510394|NCT01388257|Anti Tumor Necrosis Factor-alpha|anti tumor necrosis factor-alpha
510395|NCT01388257|Adalimumab|adalimumab
510396|NCT01388244|Screening|screening
510397|NCT01388244|Risk Assessment|risk assessment
510398|NCT01388244|Fractures|fractures
510399|NCT01388244|Absorptiometry, Photon|absorptiometry, photon
510400|NCT01388244|Fracture prevention|fracture prevention
510401|NCT01388244|Women|women
510402|NCT01388244|Patient prespective|patient prespective
510403|NCT01388231|social phobia, cognitive-behavioral therapy, treatment|social phobia, cognitive-behavioral therapy, treatment
510404|NCT01388218|Physical Activity|physical activity
510405|NCT01388218|Patient Reported Outcome (PRO)|patient reported outcome (pro)
510406|NCT01388218|Chronic obstructive pulmonary disease (COPD)|chronic obstructive pulmonary disease (copd)
510407|NCT01388218|Innovative Medicines Initiative - Joint Undertaking (IMI-JU)|innovative medicines initiative - joint undertaking (imi-ju)
510408|NCT01388205|Myopia|myopia
510409|NCT01388205|Outdoor activity|outdoor activity
510410|NCT01388205|Physical activity|physical activity
510411|NCT01388205|Randomized Controlled Trial|randomized controlled trial
510412|NCT01388205|Pedometer|pedometer
510413|NCT01388205|Behavior modification|behavior modification
510414|NCT01388205|Obesity|obesity
510415|NCT01388192|Pancreaticoduodenectomy|pancreaticoduodenectomy
510416|NCT01388192|diabetes|diabetes
510417|NCT01388192|sugar metabolism|sugar metabolism
510418|NCT01388179|Autism|autism
510419|NCT01388179|TMS|tms
510519|NCT01387724|disseminated neuroblastoma|disseminated neuroblastoma
510420|NCT01388153|Bioequivalence, acarbose, ODT|bioequivalence, acarbose, odt
510421|NCT01388140|dissociation|dissociation
510422|NCT01388140|psychosis|psychosis
510423|NCT01388140|trauma|trauma
510424|NCT01388140|parenting|parenting
510425|NCT01388140|executive functions|executive functions
510426|NCT01388114|Procalcitonin Measurement|procalcitonin measurement
649228|NCT00830856|HIV|hiv
510427|NCT01388101|LECT2|lect2
510428|NCT01388088|Hypertension|hypertension
510429|NCT01388088|Potassium|potassium
510430|NCT01388088|Blood-pressure|blood-pressure
510431|NCT01388075|induction|induction
510432|NCT01388075|CYP2C9|cyp2c9
510433|NCT01388075|Genetic variability|genetic variability
510434|NCT01388075|Expression|expression
510435|NCT01388062|influenza virus|influenza virus
510436|NCT01388049|EV71|ev71
510437|NCT01388036|heart rate|heart rate
510438|NCT01388023|SmellX|smellx
510439|NCT01388023|malodor|malodor
510440|NCT01388023|halitosis|halitosis
510441|NCT01388023|herbal formulation|herbal formulation
510442|NCT01388023|natural medicinals|natural medicinals
510443|NCT01388023|slow release delivery system|slow release delivery system
510444|NCT01388023|gingivitis|gingivitis
510445|NCT01388023|Bad Breath|bad breath
510446|NCT01388010|probiotics|probiotics
510447|NCT01388010|gastrointestinal well being|gastrointestinal well being
510448|NCT01388010|digestive symptoms|digestive symptoms
510449|NCT01388010|healthy population|healthy population
510450|NCT01387997|HPV|hpv
510451|NCT01387984|Type 2 diabetes mellitus|type 2 diabetes mellitus
510452|NCT01387984|Diabetic complications|diabetic complications
510453|NCT01387984|YKL-40|ykl-40
510454|NCT01387971|impression cytology|impression cytology
510455|NCT01387971|ocular surface disorders|ocular surface disorders
510456|NCT01387971|ocular surface cells' variation|ocular surface cells' variation
510457|NCT01387971|Limbal insufficiency|limbal insufficiency
510458|NCT01387958|Hepatitis C virus|hepatitis c virus
510459|NCT01387958|Chronically infected|chronically infected
510460|NCT01387958|treatment naive|treatment naive
510461|NCT01387958|non responders to prior therapy|non responders to prior therapy
510462|NCT01387945|Home blood pressure monitoring|home blood pressure monitoring
510463|NCT01387945|Patient activation|patient activation
510464|NCT01387945|Patient-centered care|patient-centered care
510465|NCT01387945|Community Health Aides|community health aides
510466|NCT01387945|Primary Health Care|primary health care
510467|NCT01387932|Hepatocellular carcinoma|hepatocellular carcinoma
510468|NCT01387932|TACE|tace
510469|NCT01387932|HepaSphere Microspheres|hepasphere microspheres
510470|NCT01387932|QuadraSphere Microspheres|quadrasphere microspheres
510471|NCT01387932|Doxorubicin|doxorubicin
510472|NCT01387919|Set time points during 48 hours of fasting|set time points during 48 hours of fasting
510473|NCT01387906|mild|mild
510474|NCT01387906|moderate|moderate
510475|NCT01387893|Benign Prostatic Hyperplasia|benign prostatic hyperplasia
510476|NCT01387893|BPH|bph
510477|NCT01387893|Lower Urinary Tract Symptoms|lower urinary tract symptoms
510478|NCT01387893|LUTS|luts
510479|NCT01387893|Self-Administered Maneuver|self-administered maneuver
510480|NCT01387893|Symptomatic Relief|symptomatic relief
510481|NCT01387893|Digital Repetitive Infrapubic Pressure maneuver|digital repetitive infrapubic pressure maneuver
510482|NCT01387880|Metastatic colorectal cancer|metastatic colorectal cancer
510483|NCT01387880|Third line therapy|third line therapy
510484|NCT01387880|Fourth line therapy|fourth line therapy
510485|NCT01387880|KRAS mutation status|kras mutation status
510486|NCT01387880|Cetuximab|cetuximab
510487|NCT01387880|Everolimus|everolimus
510488|NCT01387880|Irinotecan|irinotecan
510489|NCT01387867|Exercise|exercise
510490|NCT01387867|Hip osteoarthritis|hip osteoarthritis
510491|NCT01387867|Randomized controlled trial|randomized controlled trial
510492|NCT01387841|yoga|yoga
510493|NCT01387841|chemotherapy|chemotherapy
510494|NCT01387841|nausea|nausea
510495|NCT01387841|vomiting|vomiting
510496|NCT01387828|Splenic artery|splenic artery
510497|NCT01387828|Aneurysm|aneurysm
510498|NCT01387828|laparoscopic|laparoscopic
510499|NCT01387828|Vascular reconstruction|vascular reconstruction
510500|NCT01387828|Splenectomy|splenectomy
510501|NCT01387815|Effectiveness|effectiveness
510502|NCT01387815|Psoriasis|psoriasis
510503|NCT01387815|Observational|observational
510504|NCT01387815|Prospective|prospective
510505|NCT01387815|Adalimumab|adalimumab
510506|NCT01387815|Traditional Systemic Agents|traditional systemic agents
510507|NCT01387815|Topical Agents|topical agents
510508|NCT01387815|Comparative|comparative
510509|NCT01387802|Assessing Effectiveness in Ankylosing Spondylitis|assessing effectiveness in ankylosing spondylitis
510510|NCT01387789|Product Surveillance|product surveillance
510511|NCT01387789|Postmarketing|postmarketing
510512|NCT01387750|Acute Pain|acute pain
510513|NCT01387750|Musculoskeletal Pain|musculoskeletal pain
510514|NCT01387750|Topical Analgesic|topical analgesic
510515|NCT01387737|TA-7284|ta-7284
510516|NCT01387737|JNJ-28431754|jnj-28431754
510517|NCT01387737|Canagliflozin|canagliflozin
510518|NCT01387737|Sodium Glucose Co-Transporter (SGLT2 inhibitor)|sodium glucose co-transporter (sglt2 inhibitor)
510622|NCT01387360|Presbyopia|presbyopia
510520|NCT01387724|localized resectable neuroblastoma|localized resectable neuroblastoma
510521|NCT01387724|localized unresectable neuroblastoma|localized unresectable neuroblastoma
510522|NCT01387724|regional neuroblastoma|regional neuroblastoma
510523|NCT01387724|stage 4S neuroblastoma|stage 4s neuroblastoma
510524|NCT01387672|postmenopausal|postmenopausal
510525|NCT01387672|osteoporosis|osteoporosis
510526|NCT01387672|bone turnover|bone turnover
510527|NCT01387672|nitrate|nitrate
510528|NCT01387672|headache|headache
510529|NCT01387659|Myfortic|myfortic
510530|NCT01387659|Simulect|simulect
510531|NCT01387659|Steroids|steroids
510532|NCT01387659|Diabetes|diabetes
510533|NCT01387659|Transplant|transplant
510534|NCT01387659|Gastric emptying|gastric emptying
510535|NCT01387659|Gastric motility|gastric motility
510536|NCT01387646|STI, abuse, substance use, unintended pregnancy|sti, abuse, substance use, unintended pregnancy
510537|NCT01387633|Nursing care|nursing care
510538|NCT01387633|Diabetes mellitus|diabetes mellitus
510539|NCT01387633|Health Education|health education
510540|NCT01387633|Patient compliance|patient compliance
510541|NCT01387633|Social support|social support
510542|NCT01387633|Self-efficacy|self-efficacy
510543|NCT01387633|Adaptation strategy|adaptation strategy
510544|NCT01387620|Phacoemulsification|phacoemulsification
510545|NCT01387620|Corneal Edema|corneal edema
510546|NCT01387620|Corneal Endothelium|corneal endothelium
510547|NCT01387620|Viscoelastic Substances|viscoelastic substances
510548|NCT01387607|Pregabalin|pregabalin
510549|NCT01387607|fibromyalgia|fibromyalgia
510550|NCT01387594|Crohn's disease lumbar puncture anti-MAdCAM monoclonal antibody PF-00547659 Ulcerative Colitis|crohn's disease lumbar puncture anti-madcam monoclonal antibody pf-00547659 ulcerative colitis
510551|NCT01387555|liver cancer|liver cancer
510552|NCT01387555|liver tumor|liver tumor
510553|NCT01387555|advanced hcc|advanced hcc
510554|NCT01387555|hepatocellular cancer|hepatocellular cancer
510555|NCT01387555|Jennerex|jennerex
510556|NCT01387555|HCC|hcc
510557|NCT01387555|sorafenib|sorafenib
510558|NCT01387555|sorafenib failure|sorafenib failure
510559|NCT01387555|sorafenib intolerant|sorafenib intolerant
510560|NCT01387555|Nexavar|nexavar
510561|NCT01387555|Nexavar failure|nexavar failure
510562|NCT01387555|JX594|jx594
510563|NCT01387555|oncolytic virus|oncolytic virus
510564|NCT01387555|vaccinia|vaccinia
510565|NCT01387555|viral therapy|viral therapy
510566|NCT01387555|JX|jx
510567|NCT01387555|Biotherapeutics|biotherapeutics
510568|NCT01387555|HEP018|hep018
510569|NCT01387555|traverse|traverse
510570|NCT01387555|biologic|biologic
510571|NCT01387555|Pexa-Vec|pexa-vec
510572|NCT01387542|Schizophrenia|schizophrenia
510573|NCT01387542|Paliperidone Extended Release (ER)|paliperidone extended release (er)
510574|NCT01387542|INVEGA|invega
510575|NCT01387529|Reference Values|reference values
510576|NCT01387516|nicotine|nicotine
510577|NCT01387516|juveniles|juveniles
510578|NCT01387516|detention|detention
510579|NCT01387503|Hepatocellular Carcinoma|hepatocellular carcinoma
510580|NCT01387503|Liver Transplantation|liver transplantation
510581|NCT01387503|Downstaging|downstaging
510582|NCT01387503|Trans-arterial chemoembolization (TACE)|trans-arterial chemoembolization (tace)
510583|NCT01387503|Radiofrequency ablation (RFA)|radiofrequency ablation (rfa)
510584|NCT01387503|Liver resection|liver resection
510585|NCT01387503|Sorafenib|sorafenib
510586|NCT01387490|Mild Traumatic Brain Injury|mild traumatic brain injury
510587|NCT01387490|Telephone counseling|telephone counseling
510588|NCT01387477|hypoglycemia|hypoglycemia
510589|NCT01387477|lactate|lactate
510590|NCT01387477|glucose|glucose
510591|NCT01387477|ICU|icu
510592|NCT01387464|bromfenac concentrations|bromfenac concentrations
510593|NCT01387464|ISV-303|isv-303
510594|NCT01387464|Bromday|bromday
510595|NCT01387451|Brown adipose tissue|brown adipose tissue
510596|NCT01387451|Different regions|different regions
510597|NCT01387451|Chinese adults|chinese adults
510598|NCT01387438|Brown Adipose Tissue|brown adipose tissue
510599|NCT01387438|Cross sectional study|cross sectional study
510600|NCT01387438|Chinese Adults|chinese adults
510601|NCT01387438|Factor|factor
510602|NCT01387425|Smoking cessation of diabetic smoker|smoking cessation of diabetic smoker
510603|NCT01387412|genital warts|genital warts
510604|NCT01387412|HIV|hiv
510605|NCT01387412|MSM|msm
510606|NCT01387412|Peru|peru
510607|NCT01387412|HPV|hpv
510608|NCT01387399|ovarian cancer|ovarian cancer
510609|NCT01387399|recurrence|recurrence
510610|NCT01387399|platinum-sensitive recurrent ovarian cancer|platinum-sensitive recurrent ovarian cancer
510611|NCT01387399|HIPEC|hipec
510612|NCT01387399|intraperitoneal chemotherapy|intraperitoneal chemotherapy
510613|NCT01387399|hyperthermic intraperitoneal chemoperfusion|hyperthermic intraperitoneal chemoperfusion
510614|NCT01387399|cisplatin|cisplatin
510615|NCT01387373|breast cancer|breast cancer
510616|NCT01387373|metastatic|metastatic
510617|NCT01387373|liver metastases|liver metastases
510618|NCT01387373|intrahepatic|intrahepatic
510619|NCT01387373|chemotherapy|chemotherapy
510620|NCT01387360|Myopia|myopia
510621|NCT01387360|Hyperopia|hyperopia
510623|NCT01387360|Pseudophakia|pseudophakia
510624|NCT01387360|LASIK|lasik
510625|NCT01387347|Thymosin beta 4|thymosin beta 4
510626|NCT01387347|Dry eye syndrome|dry eye syndrome
510627|NCT01387347|Dry eye|dry eye
510628|NCT01387334|resistive exercise|resistive exercise
510629|NCT01387334|Resistance Exercise Training Program|resistance exercise training program
510630|NCT01387334|Rubber Bands|rubber bands
510631|NCT01387334|Glycemic Control|glycemic control
510632|NCT01387334|Type 2 Diabetes Mellitus|type 2 diabetes mellitus
510633|NCT01387321|Pi3K|pi3k
510634|NCT01387321|Advanced solid tumor|advanced solid tumor
510635|NCT01387308|Phase 1|phase 1
510636|NCT01387308|Healthy male volunteers|healthy male volunteers
510637|NCT01387308|pharmacokinetics|pharmacokinetics
510638|NCT01387308|fostamatinib|fostamatinib
510639|NCT01387308|Scientific Terminology: Bioavailability, R406 plasma AUC and C_maxR406 plasma AUC0-t, t1/2λz and t_max|scientific terminology: bioavailability, r406 plasma auc and c_maxr406 plasma auc0-t, t1/2λz and t_max
510640|NCT01387308|Laymen Terminology: Amount of R406 in blood|laymen terminology: amount of r406 in blood
510641|NCT01387295|breast cancer|breast cancer
510642|NCT01387295|liver metastases|liver metastases
510643|NCT01387295|intrahepatic chemotherapy|intrahepatic chemotherapy
510644|NCT01387256|abortion|abortion
510645|NCT01387256|mifepristone|mifepristone
510646|NCT01387256|misoprostol|misoprostol
510647|NCT01387256|with gestations > 63 days LMP|with gestations > 63 days lmp
510648|NCT01387243|behavior modification|behavior modification
510649|NCT01387243|overweight|overweight
510650|NCT01387243|orlistat|orlistat
510651|NCT01387230|chronic obstructive pulmonary disease|chronic obstructive pulmonary disease
510652|NCT01387230|long acting muscarinic antagonist|long acting muscarinic antagonist
510653|NCT01387217|GSK2018682|gsk2018682
510654|NCT01387217|First Time in Human|first time in human
510655|NCT01387217|Healthy Volunteer|healthy volunteer
510656|NCT01387204|MEK inhibitor|mek inhibitor
510657|NCT01387204|elimination|elimination
510658|NCT01387204|Phase 1|phase 1
510659|NCT01387204|GSK1120212|gsk1120212
510660|NCT01387204|cancer|cancer
510661|NCT01387204|Pharmacokinetics|pharmacokinetics
510662|NCT01387204|oncology|oncology
510663|NCT01387204|radiolabeled ADME|radiolabeled adme
510664|NCT01387178|chronic obstructive pulmonary disease|chronic obstructive pulmonary disease
510665|NCT01387178|cost and cost analysis|cost and cost analysis
510666|NCT01387178|bronchodilators|bronchodilators
510667|NCT01387178|healthcare utilization|healthcare utilization
510668|NCT01387178|fluticasone propionate/salmeterol|fluticasone propionate/salmeterol
510669|NCT01387178|tiotropium|tiotropium
510670|NCT01387165|Latin America|latin america
510671|NCT01387165|diabetes complications|diabetes complications
510672|NCT01387165|patient compliance|patient compliance
510673|NCT01387165|Diabetes mellitus, type 2|diabetes mellitus, type 2
510674|NCT01387165|health services accessibility|health services accessibility
510675|NCT01387152|chest pain|chest pain
510676|NCT01387152|myocardial perfusion scintigraphy|myocardial perfusion scintigraphy
510677|NCT01387152|nuclear stress testing|nuclear stress testing
510678|NCT01387152|low radiation dose|low radiation dose
510679|NCT01387139|Ketamine|ketamine
510680|NCT01387139|Propofol|propofol
510681|NCT01387139|Procedural Sedation and Analgesia|procedural sedation and analgesia
510682|NCT01387113|stroke|stroke
510683|NCT01387113|tPA|tpa
510684|NCT01387113|Thrombolysis|thrombolysis
510685|NCT01387113|rt-PA|rt-pa
510686|NCT01387113|Ischemic|ischemic
510687|NCT01387113|CTP|ctp
510688|NCT01387113|Imaging|imaging
510689|NCT01387113|CT Perfusion Imaging|ct perfusion imaging
510690|NCT01387113|Perfusion|perfusion
510691|NCT01387113|CTA|cta
510692|NCT01387113|CT Angiography|ct angiography
510693|NCT01387113|Acute ischemic stroke|acute ischemic stroke
510694|NCT01387113|Acute stroke therapy|acute stroke therapy
510695|NCT01387113|(AIS)|(ais)
510696|NCT01387100|supportive employment|supportive employment
510697|NCT01387100|vocational rehabilitation|vocational rehabilitation
510698|NCT01387087|ASP015K|asp015k
510699|NCT01387087|Healthy subjects|healthy subjects
510700|NCT01387087|Pharmacodynamics|pharmacodynamics
510701|NCT01387087|Maximum tolerated dose|maximum tolerated dose
510702|NCT01387061|liver resection|liver resection
510703|NCT01387061|hepatic resection|hepatic resection
510704|NCT01387061|intraoperative ultrasound|intraoperative ultrasound
510705|NCT01387048|acne vulgaris|acne vulgaris
510706|NCT01387048|late-type acne|late-type acne
510707|NCT01387048|Skinoren|skinoren
510708|NCT01387048|maintenance|maintenance
510709|NCT01387022|Antiretroviral treatment|antiretroviral treatment
510710|NCT01387022|Tenofovir|tenofovir
510711|NCT01387022|Drug resistance|drug resistance
510712|NCT01387022|Treatment outcome|treatment outcome
510713|NCT01386983|Enlarged prostate, 5-alpha-reductase inhibitor, alpha-blocker, acute urinary retention, surgery, early, costs|enlarged prostate, 5-alpha-reductase inhibitor, alpha-blocker, acute urinary retention, surgery, early, costs
510714|NCT01386983|benign prostatic hyperplasia|benign prostatic hyperplasia
510715|NCT01386970|Pharmacokinetics|pharmacokinetics
510716|NCT01386970|antiretroviral therapy|antiretroviral therapy
510717|NCT01386970|nucleoside analogs|nucleoside analogs
510718|NCT01386970|mitochondrial toxicity|mitochondrial toxicity
510719|NCT01386970|clinical pharmacology|clinical pharmacology
510720|NCT01386970|cellular pharmacology|cellular pharmacology
510721|NCT01386970|pharmacogenetics|pharmacogenetics
510722|NCT01386957|Nephrotic Syndrome|nephrotic syndrome
510723|NCT01386957|Steroid treatment|steroid treatment
510724|NCT01386957|Proteinuria|proteinuria
510725|NCT01386957|Child|child
510726|NCT01386944|Rotigotine|rotigotine
510727|NCT01386944|Neupro®|neupro®
510728|NCT01386944|Augmentation|augmentation
510729|NCT01386944|Restless Legs Syndrome|restless legs syndrome
510730|NCT01386944|Moderate to severe|moderate to severe
510731|NCT01386944|idiopathic|idiopathic
510732|NCT01386944|adults|adults
510733|NCT01386931|Biopsy, Fine-Needle|biopsy, fine-needle
510734|NCT01386931|Endoscopic Ultrasonography|endoscopic ultrasonography
510735|NCT01386931|cytopathology|cytopathology
510736|NCT01386918|Hallucinations|hallucinations
510737|NCT01386918|Schizophrenia|schizophrenia
510738|NCT01386905|Obesity|obesity
510739|NCT01386879|suction|suction
510740|NCT01386879|aspiration|aspiration
510741|NCT01386879|general anesthesia|general anesthesia
510742|NCT01386879|intubation|intubation
510743|NCT01386879|endotracheal tube|endotracheal tube
510744|NCT01386879|respiratory complications|respiratory complications
510745|NCT01386866|AMG 706|amg 706
510746|NCT01386866|Motesanib|motesanib
510747|NCT01386866|Amgen|amgen
510748|NCT01386866|Phase 1|phase 1
510749|NCT01386853|Hyperlipidemia|hyperlipidemia
510750|NCT01386853|Pitavastatin|pitavastatin
510751|NCT01386853|Atorvastatin|atorvastatin
510752|NCT01386840|Efficacy of Treatment|efficacy of treatment
510753|NCT01386840|Severe|severe
510754|NCT01386840|home treatment|home treatment
510755|NCT01386840|treatment at hospital|treatment at hospital
510756|NCT01386827|Ixiaro|ixiaro
510757|NCT01386827|japanese encephalitis vaccine|japanese encephalitis vaccine
510758|NCT01386827|booster|booster
510759|NCT01386801|Diabetes|diabetes
510760|NCT01386801|Controls|controls
510761|NCT01386801|Biospecimen|biospecimen
510762|NCT01386788|Smoke, cyanide, closed space fires|smoke, cyanide, closed space fires
510763|NCT01386775|X-Linked Hypohidrotic Ectodermal Dysplasia|x-linked hypohidrotic ectodermal dysplasia
510764|NCT01386775|XLHED|xlhed
510765|NCT01386775|Hypohidrotic Ectodermal Dysplasia|hypohidrotic ectodermal dysplasia
510766|NCT01386775|HED|hed
510767|NCT01386762|paralysis|paralysis
510768|NCT01386762|paraplegia|paraplegia
510769|NCT01386762|obesity|obesity
510770|NCT01386749|Vibration treatment|vibration treatment
510771|NCT01386749|Fracture healing|fracture healing
510772|NCT01386749|Muscular function|muscular function
510773|NCT01386736|insulin resistance|insulin resistance
510774|NCT01386736|obesity|obesity
510775|NCT01386736|adolescence|adolescence
510776|NCT01386736|vitamin D supplementation|vitamin d supplementation
510777|NCT01386723|eltrombopag|eltrombopag
510778|NCT01386723|promacta|promacta
510779|NCT01386723|immune thrombocytopenia (ITP)|immune thrombocytopenia (itp)
510780|NCT01386710|GBM|gbm
510781|NCT01386710|AA|aa
510782|NCT01386710|AO|ao
510783|NCT01386710|Brain|brain
510784|NCT01386710|Tumors|tumors
510785|NCT01386710|Malignant|malignant
510786|NCT01386710|Glioblastoma|glioblastoma
510787|NCT01386710|Multiforme|multiforme
510788|NCT01386710|Anaplastic|anaplastic
510789|NCT01386710|Astrocytoma|astrocytoma
510790|NCT01386684|Prostate Cancer|prostate cancer
510791|NCT01386671|Type 2 Diabetes|type 2 diabetes
510792|NCT01386671|metformin glycinate|metformin glycinate
510793|NCT01386671|metabolic control|metabolic control
510794|NCT01386658|Efficacy|efficacy
510795|NCT01386658|Hereditary angioedema|hereditary angioedema
510796|NCT01386658|HAE|hae
510797|NCT01386658|Pediatric|pediatric
510798|NCT01386658|Children|children
510799|NCT01386658|Pharmacokinetics|pharmacokinetics
510800|NCT01386658|Safety|safety
510801|NCT01386658|Firazyr|firazyr
510802|NCT01386658|icatibant|icatibant
510803|NCT01386645|impaired glucose tolerance|impaired glucose tolerance
510804|NCT01386645|prediabetes|prediabetes
510805|NCT01386645|dietary glycemic index|dietary glycemic index
510806|NCT01386645|beta-cell function|beta-cell function
510807|NCT01386645|insulin secretion|insulin secretion
510808|NCT01386645|oxidative stress|oxidative stress
510809|NCT01386645|glycemic variability|glycemic variability
510810|NCT01386632|Stage III-IV Squamous Cell Carcinoma|stage iii-iv squamous cell carcinoma
510811|NCT01386593|Cytochrome|cytochrome
510812|NCT01386593|Phenotyping|phenotyping
510813|NCT01386593|Pharmacokinetics|pharmacokinetics
510814|NCT01386580|Brain Neoplasms|brain neoplasms
510815|NCT01386580|Neoplasm Metastasis|neoplasm metastasis
510816|NCT01386580|Neoplasms|neoplasms
510817|NCT01386580|Central Nervous System Neoplasms|central nervous system neoplasms
510818|NCT01386580|Nervous System Neoplasms|nervous system neoplasms
510819|NCT01386580|Neoplasms by Site|neoplasms by site
510820|NCT01386580|Brain Diseases|brain diseases
510821|NCT01386580|Central Nervous System Diseases|central nervous system diseases
510822|NCT01386580|Nervous System Diseases|nervous system diseases
510823|NCT01386580|Neoplastic Processes|neoplastic processes
510824|NCT01386580|Pathologic Processes|pathologic processes
510825|NCT01386567|hypogonadism|hypogonadism
510826|NCT01386567|low testosterone|low testosterone
510827|NCT01386567|low T|low t
510828|NCT01386554|H.P. Acthar Gel|h.p. acthar gel
510829|NCT01386554|Acthar|acthar
510830|NCT01386554|nephrotic syndrome|nephrotic syndrome
510831|NCT01386554|idiopathic membranous nephropathy|idiopathic membranous nephropathy
510832|NCT01386554|proteinuria|proteinuria
510833|NCT01386515|Adaptation|adaptation
510834|NCT01386515|Duchenne Muscular Dystrophy|duchenne muscular dystrophy
510835|NCT01386515|Communication about Duchenne Muscular Dystrophy|communication about duchenne muscular dystrophy
510836|NCT01386515|Sibling|sibling
510837|NCT01386502|Solid Tumors|solid tumors
510838|NCT01386502|Monoclonal Antibody|monoclonal antibody
510839|NCT01386502|Peptide Vaccine|peptide vaccine
510840|NCT01386502|Toxicity|toxicity
510841|NCT01386502|PD-1 ligand|pd-1 ligand
510842|NCT01386502|Solid Tumor|solid tumor
510843|NCT01386502|Breast Cancer|breast cancer
510844|NCT01386502|Ovarian Cancer|ovarian cancer
510845|NCT01386502|Pancreatic Cancer|pancreatic cancer
510846|NCT01386502|Colon Cancer|colon cancer
510847|NCT01386502|Sarcoma|sarcoma
510848|NCT01386489|HIV-uninfected|hiv-uninfected
510849|NCT01386489|Mucosal Immunity|mucosal immunity
510850|NCT01386489|Kinetics|kinetics
510851|NCT01386489|Cytokines|cytokines
510852|NCT01386489|Chemokines|chemokines
510853|NCT01386489|Healthy Volunteer|healthy volunteer
510855|NCT01386476|5-HT1A Receptors|5-ht1a receptors
510856|NCT01386476|Blood Brain Barrier|blood brain barrier
510857|NCT01386476|Drug Resistance|drug resistance
510858|NCT01386476|Healthy Volunteer|healthy volunteer
510859|NCT01386476|HV|hv
510860|NCT01386437|Autoimmune Polyendocrinopathy Candidiasis Ectodermal Dystrophy (APECED)|autoimmune polyendocrinopathy candidiasis ectodermal dystrophy (apeced)
510861|NCT01386437|Fungal Infections|fungal infections
510862|NCT01386437|Molds|molds
510863|NCT01386437|Autoimmune Polyendocrinpathy Syndrome (APS) Type 1|autoimmune polyendocrinpathy syndrome (aps) type 1
510864|NCT01386437|Mucocutaneous Fungal Infection|mucocutaneous fungal infection
510865|NCT01386437|Invasive Fungal Infection|invasive fungal infection
510866|NCT01386424|Future|future
510867|NCT01386424|Influenza|influenza
510868|NCT01386424|Flu|flu
510869|NCT01386424|Observation|observation
510870|NCT01386424|Vaccine|vaccine
510871|NCT01386424|Healthy Volunteer|healthy volunteer
510872|NCT01386424|HV|hv
510873|NCT01386411|Genetic testing|genetic testing
510874|NCT01386411|BRCA testing|brca testing
510875|NCT01386411|Ashkenazi descent|ashkenazi descent
510876|NCT01386411|11-086|11-086
510877|NCT01386398|stage II mycosis fungoides/Sezary syndrome|stage ii mycosis fungoides/sezary syndrome
510878|NCT01386398|stage III mycosis fungoides/Sezary syndrome|stage iii mycosis fungoides/sezary syndrome
510879|NCT01386398|stage IV mycosis fungoides/Sezary syndrome|stage iv mycosis fungoides/sezary syndrome
510880|NCT01386398|stage II cutaneous T-cell non-Hodgkin lymphoma|stage ii cutaneous t-cell non-hodgkin lymphoma
510881|NCT01386398|stage III cutaneous T-cell non-Hodgkin lymphoma|stage iii cutaneous t-cell non-hodgkin lymphoma
510882|NCT01386398|stage IV cutaneous T-cell non-Hodgkin lymphoma|stage iv cutaneous t-cell non-hodgkin lymphoma
510883|NCT01386398|recurrent mycosis fungoides/Sezary syndrome|recurrent mycosis fungoides/sezary syndrome
510884|NCT01386398|recurrent cutaneous T-cell non-Hodgkin lymphoma|recurrent cutaneous t-cell non-hodgkin lymphoma
510885|NCT01386372|Hyponatremia|hyponatremia
510886|NCT01386372|Vasopressin|vasopressin
510887|NCT01386372|Tolvaptan|tolvaptan
510888|NCT01386372|SIADH|siadh
510889|NCT01386346|gastroesophageal junction|gastroesophageal junction
510890|NCT01386346|GEJ|gej
510891|NCT01386346|esophageal|esophageal
510892|NCT01386346|esophagus|esophagus
510893|NCT01386333|Frontotemporal Dementia|frontotemporal dementia
510894|NCT01386333|oxytocin|oxytocin
510895|NCT01386333|Pick's disease|pick's disease
510896|NCT01386320|anaesthetic techniques, regional; surgery orthopaedic|anaesthetic techniques, regional; surgery orthopaedic
510897|NCT01386307|Pain|pain
510898|NCT01386307|Hospitalization|hospitalization
510899|NCT01386281|Julina|julina
510900|NCT01386281|Postmenopausal osteoporosis|postmenopausal osteoporosis
510901|NCT01386268|Kogenate FS|kogenate fs
510902|NCT01386268|Hemophilia A|hemophilia a
510903|NCT01386255|GERD|gerd
510904|NCT01386242|Colorectal Cancer|colorectal cancer
510905|NCT01386242|Novaferon|novaferon
510906|NCT01386229|hemodynamic stability|hemodynamic stability
510907|NCT01386229|etomidate|etomidate
510908|NCT01386229|ketamine|ketamine
510909|NCT01386229|coronary artery bypass surgery after induction of anesthesia, hemodynamic stability|coronary artery bypass surgery after induction of anesthesia, hemodynamic stability
510910|NCT01386216|Critical limb ischemia|critical limb ischemia
510911|NCT01386216|Peripheral vascular disease|peripheral vascular disease
510912|NCT01386216|platelet-rich plasma|platelet-rich plasma
510913|NCT01386203|lung cancer|lung cancer
510914|NCT01386203|biomarkers|biomarkers
510915|NCT01386203|breath|breath
510916|NCT01386203|early detection|early detection
711344|NCT00585195|c-Met exon 14 alterations|c-met exon 14 alterations
510917|NCT01386190|preterm infant, body composition, exercise|preterm infant, body composition, exercise
510919|NCT01386177|doxazosin|doxazosin
510920|NCT01386177|norepinephrine|norepinephrine
510921|NCT01386177|alpha1- receptor|alpha1- receptor
510922|NCT01386177|ecstasy|ecstasy
510923|NCT01386177|stimulants|stimulants
510924|NCT01386151|Moderate asthmatic, uncontrolled|moderate asthmatic, uncontrolled
510925|NCT01386138|HIV|hiv
510926|NCT01386138|HIV Risk|hiv risk
510927|NCT01386138|Sexually Transmitted Infections|sexually transmitted infections
510928|NCT01386138|Women|women
510929|NCT01386138|Pregnancy|pregnancy
510930|NCT01386138|Neonatal Health|neonatal health
510931|NCT01386138|Drug Use|drug use
510932|NCT01386138|Drug Treatment|drug treatment
510933|NCT01386138|Gender-specific Treatment|gender-specific treatment
510934|NCT01386138|Methamphetamine|methamphetamine
510935|NCT01386138|Opioids|opioids
510936|NCT01386138|Cocaine|cocaine
510937|NCT01386138|Injection Drugs|injection drugs
510938|NCT01386138|Stimulants|stimulants
510939|NCT01386138|Alcohol|alcohol
510940|NCT01386138|Mandrax|mandrax
510941|NCT01386138|Marijuana|marijuana
510942|NCT01386138|Nicotine|nicotine
510943|NCT01386086|Aripiprazole|aripiprazole
510944|NCT01386086|adjunctive therapy|adjunctive therapy
510945|NCT01386086|mood stabilizers|mood stabilizers
510946|NCT01386086|major depressive disorder|major depressive disorder
510947|NCT01386086|postpartum|postpartum
510948|NCT01386086|Augmentation therapy|augmentation therapy
510949|NCT01386086|resistant|resistant
510950|NCT01386060|Stress|stress
510951|NCT01386060|Mindfulness|mindfulness
510952|NCT01386060|Meditation|meditation
510953|NCT01386047|Clinical Prediction Rules|clinical prediction rules
510954|NCT01386047|Electronic Health Records|electronic health records
510955|NCT01386047|Walsh Clinical Prediction Rule|walsh clinical prediction rule
510956|NCT01386047|Heckerling Clinical Prediction Rule|heckerling clinical prediction rule
510957|NCT01386034|Nutrition, protein metabolism, stable isotopes, mass spectrometry, intestinal failure|nutrition, protein metabolism, stable isotopes, mass spectrometry, intestinal failure
510958|NCT01386021|allograft|allograft
510959|NCT01386021|coronary|coronary
510960|NCT01386021|patency|patency
510961|NCT01386021|morbidity|morbidity
510962|NCT01385969|overinflation of LMAs|overinflation of lmas
510963|NCT01385956|metastatic|metastatic
510964|NCT01385956|locally advanced|locally advanced
510965|NCT01385956|combination therapy|combination therapy
510966|NCT01385956|dose escalation|dose escalation
510967|NCT01385956|epithelial cancer|epithelial cancer
510968|NCT01385956|adenocarcinoma|adenocarcinoma
510969|NCT01385956|exocrine pancreas|exocrine pancreas
510970|NCT01385943|Reflectance Confocal Microscopy|reflectance confocal microscopy
510971|NCT01385943|Dermoscopy|dermoscopy
510972|NCT01385943|Clinical Photos|clinical photos
510973|NCT01385943|Telemedicine|telemedicine
510974|NCT01385930|Overweight|overweight
510975|NCT01385930|Obesity|obesity
510976|NCT01385930|lifestyle counseling|lifestyle counseling
510977|NCT01385917|Duchenne Muscular Dystrophy|duchenne muscular dystrophy
510978|NCT01385917|strength and function tests|strength and function tests
510979|NCT01385917|MRI|mri
510980|NCT01385878|Microcoaxial phacoemulsification, 1.8mm, 2.2mm|microcoaxial phacoemulsification, 1.8mm, 2.2mm
510981|NCT01385852|CME|cme
510982|NCT01385852|OCT|oct
510983|NCT01385852|Optical coherence tomography|optical coherence tomography
510984|NCT01385852|macular thickness|macular thickness
510985|NCT01385839|Alopecia|alopecia
510986|NCT01385839|Hair transplantation|hair transplantation
510987|NCT01385839|Needle irritation|needle irritation
510988|NCT01385839|Medical needling|medical needling
510989|NCT01385826|Uveitis|uveitis
510990|NCT01385826|Juvenile arthritis|juvenile arthritis
510991|NCT01385826|Anti-tumor necrosis factor alpha monoclonal antibody|anti-tumor necrosis factor alpha monoclonal antibody
510992|NCT01385826|treatment|treatment
510993|NCT01385813|pre-eclampsia|pre-eclampsia
510994|NCT01385813|inflammatory markers|inflammatory markers
510995|NCT01385813|serological biobank|serological biobank
510996|NCT01385813|To assess whether the inflammatory markers could be useful|to assess whether the inflammatory markers could be useful
510997|NCT01385813|in order to identify pregnant women at risk to|in order to identify pregnant women at risk to
510998|NCT01385813|develop preeclampsia|develop preeclampsia
510999|NCT01385800|Grass allergy|grass allergy
511000|NCT01385800|Rhinoconjunctivitis|rhinoconjunctivitis
511001|NCT01385800|Environmental Exposure Unit|environmental exposure unit
511002|NCT01385800|Immunotherapy|immunotherapy
511003|NCT01385800|ToleroMune Grass|toleromune grass
511004|NCT01385787|Pediatric (ages 0-21 years)|pediatric (ages 0-21 years)
511005|NCT01385787|myeloablative HCT|myeloablative hct
511006|NCT01385787|PBMTC sites|pbmtc sites
511007|NCT01385774|Intermittent Claudication|intermittent claudication
511008|NCT01385774|Percutaneous Transluminal Angioplasty|percutaneous transluminal angioplasty
511009|NCT01385774|Supervised Exercise Therapy|supervised exercise therapy
511010|NCT01385774|Peripheral Arterial Disease|peripheral arterial disease
511011|NCT01385761|Supraglottic airway devices|supraglottic airway devices
511012|NCT01385735|Parkinson Disease|parkinson disease
511013|NCT01385735|Emotion|emotion
511014|NCT01385735|mood|mood
511015|NCT01385735|executive function|executive function
511016|NCT01385709|Lithium|lithium
511017|NCT01385709|Sertraline|sertraline
511018|NCT01385683|Healthy volunteer|healthy volunteer
511019|NCT01385683|Pharmacokinetic|pharmacokinetic
511020|NCT01385683|pharmacodynamic|pharmacodynamic
511021|NCT01385683|Polymorphism, Genetic|polymorphism, genetic
511022|NCT01385670|Patent Foramen Ovale|patent foramen ovale
511023|NCT01385670|PFO|pfo
511024|NCT01385644|Mesenchymal stem cells|mesenchymal stem cells
511025|NCT01385644|Idiopathic pulmonary fibrosis|idiopathic pulmonary fibrosis
511026|NCT01385631|ST-Segment Elevation Myocardial Infarction|st-segment elevation myocardial infarction
511027|NCT01385631|Intravascular ultrasound|intravascular ultrasound
511028|NCT01385631|IVUS|ivus
511029|NCT01385631|Optical coherence tomography|optical coherence tomography
511030|NCT01385631|OCT|oct
511031|NCT01385631|Ezetimibe|ezetimibe
511032|NCT01385631|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors
511033|NCT01385631|Atorvastatin|atorvastatin
511034|NCT01385631|Randomized trial|randomized trial
511035|NCT01385631|Hypolipidemic Agents|hypolipidemic agents
511036|NCT01385631|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action
511037|NCT01385631|Pharmacologic Actions|pharmacologic actions
511038|NCT01385631|Enzyme Inhibitors|enzyme inhibitors
511039|NCT01385631|Lipid Regulating Agents|lipid regulating agents
511040|NCT01385631|Therapeutic Uses|therapeutic uses
511041|NCT01385592|Parkinson Disease|parkinson disease
511042|NCT01385592|L-dopa|l-dopa
511043|NCT01385592|Levodopa|levodopa
511044|NCT01385592|Dyskinesia|dyskinesia
511045|NCT01385592|Anti-Dyskinesia Agents|anti-dyskinesia agents
511046|NCT01385579|colorectal cancer screening|colorectal cancer screening
511047|NCT01385579|fecal occult blood testing (FOBT)|fecal occult blood testing (fobt)
511048|NCT01385579|vulnerable populations|vulnerable populations
511049|NCT01385579|community health center|community health center
511050|NCT01385540|Tinnitus, fMRI, task-based fMRI, attention network|tinnitus, fmri, task-based fmri, attention network
511051|NCT01385488|lymphedema|lymphedema
511052|NCT01385488|breast cancer|breast cancer
511053|NCT01385488|self care|self care
511054|NCT01385488|bioelectrical impedance|bioelectrical impedance
511055|NCT01385488|monitoring|monitoring
511056|NCT01385475|Resistance Training|resistance training
511057|NCT01385475|Physical Function|physical function
511058|NCT01385475|Older Adults|older adults
511059|NCT01385449|nerve block|nerve block
511060|NCT01385449|shoulder surgery|shoulder surgery
511061|NCT01385449|physical therapy|physical therapy
511062|NCT01385436|human papillomavirus (HPV)|human papillomavirus (hpv)
511063|NCT01385436|cervical cancer|cervical cancer
511064|NCT01385436|high grade cervical squamous intraepithelial lesion (HSIL)|high grade cervical squamous intraepithelial lesion (hsil)
511065|NCT01385423|acute myelogenous leukemia|acute myelogenous leukemia
511066|NCT01385423|natural killer cells|natural killer cells
511067|NCT01385423|haploidentical donor|haploidentical donor
511068|NCT01385410|breastfeeding exclusively|breastfeeding exclusively
511069|NCT01385397|Health system organization|health system organization
511070|NCT01385345|Vitamin D deficiency|vitamin d deficiency
511071|NCT01385345|Insulin resistance|insulin resistance
511072|NCT01385332|Metaphase II|metaphase ii
511073|NCT01385332|Ovarian stimulation|ovarian stimulation
511074|NCT01385332|Egg donors|egg donors
511075|NCT01385319|Bare metal stent|bare metal stent
511076|NCT01385319|zotarolimus eluting stent|zotarolimus eluting stent
511077|NCT01385319|triple anti-thrombotic therapy|triple anti-thrombotic therapy
511078|NCT01385319|high bleeding riskduration of dual anti-platelet therapy|high bleeding riskduration of dual anti-platelet therapy
511079|NCT01385293|BKM120|bkm120
511080|NCT01385293|prostate cancer|prostate cancer
511081|NCT01385293|metastatic castrate-resistant prostate cancer (mCRPC)|metastatic castrate-resistant prostate cancer (mcrpc)
511082|NCT01385254|very low birthweight|very low birthweight
511083|NCT01385254|premature|premature
511084|NCT01385254|sibling adjustment|sibling adjustment
511085|NCT01385254|preterm|preterm
511086|NCT01385241|Human Immunodeficiency Virus (HIV)|human immunodeficiency virus (hiv)
511087|NCT01385241|Stigma|stigma
511088|NCT01385241|Safe disclosure of seropositive status|safe disclosure of seropositive status
511089|NCT01385241|HIV positive women|hiv positive women
511090|NCT01385241|Self-efficacy|self-efficacy
511091|NCT01385228|prostate cancer|prostate cancer
511092|NCT01385228|metastatic|metastatic
511093|NCT01385228|pazopanib|pazopanib
511094|NCT01385228|docetaxel|docetaxel
511095|NCT01385228|metastatic prostate cancer|metastatic prostate cancer
511096|NCT01385215|Vaccination|vaccination
511097|NCT01385215|Mucosal Immunity|mucosal immunity
511098|NCT01385215|Nasal Immunization|nasal immunization
511099|NCT01385202|Atrial Fibrillation|atrial fibrillation
511100|NCT01385202|Paroxysmal Atrial Fibrillation|paroxysmal atrial fibrillation
511101|NCT01385189|Human Hookworm Vaccine Initiative|human hookworm vaccine initiative
511102|NCT01385189|HHVI|hhvi
511103|NCT01385189|Human Hookworm|human hookworm
511104|NCT01385189|Hookworm|hookworm
511105|NCT01385189|Hookworm Disease|hookworm disease
511106|NCT01385189|N. americanus|n. americanus
511782|NCT01382095|Diarrhea|diarrhea
511107|NCT01385189|Soil-transmitted helminth infection|soil-transmitted helminth infection
511108|NCT01385189|Intestinal blood loss|intestinal blood loss
511109|NCT01385189|Iron deficiency anemia|iron deficiency anemia
511110|NCT01385176|Heart failure|heart failure
511111|NCT01385176|Congestive heart failure|congestive heart failure
511112|NCT01385176|New York Heart Association Class II-III|new york heart association class ii-iii
511113|NCT01385176|Vagal therapy|vagal therapy
511114|NCT01385176|Vagal nerve stimulation|vagal nerve stimulation
511115|NCT01385163|mental health|mental health
511116|NCT01385163|gender-based violence|gender-based violence
511117|NCT01385163|Africa|africa
511118|NCT01385150|adult acute myeloid leukemia with 11q23 (MLL) abnormalities|adult acute myeloid leukemia with 11q23 (mll) abnormalities
511119|NCT01385150|adult acute myeloid leukemia with inv(16)(p13;q22)|adult acute myeloid leukemia with inv(16)(p13;q22)
511120|NCT01385150|adult acute myeloid leukemia with t(16;16)(p13;q22)|adult acute myeloid leukemia with t(16;16)(p13;q22)
511121|NCT01385150|adult acute myeloid leukemia with t(8;21)(q22;q22)|adult acute myeloid leukemia with t(8;21)(q22;q22)
511122|NCT01385150|untreated adult acute myeloid leukemia|untreated adult acute myeloid leukemia
511123|NCT01385150|adult acute basophilic leukemia|adult acute basophilic leukemia
511124|NCT01385150|adult acute eosinophilic leukemia|adult acute eosinophilic leukemia
511125|NCT01385150|adult erythroleukemia (M6a)|adult erythroleukemia (m6a)
511126|NCT01385150|adult pure erythroid leukemia (M6b)|adult pure erythroid leukemia (m6b)
511127|NCT01385150|adult acute minimally differentiated myeloid leukemia (M0)|adult acute minimally differentiated myeloid leukemia (m0)
511128|NCT01385150|adult acute monoblastic leukemia (M5a)|adult acute monoblastic leukemia (m5a)
511129|NCT01385150|adult acute monocytic leukemia (M5b)|adult acute monocytic leukemia (m5b)
511130|NCT01385150|adult acute myeloblastic leukemia with maturation (M2)|adult acute myeloblastic leukemia with maturation (m2)
511255|NCT01384604|Phenotype|phenotype
511131|NCT01385150|adult acute myeloblastic leukemia without maturation (M1)|adult acute myeloblastic leukemia without maturation (m1)
511132|NCT01385150|adult acute myelomonocytic leukemia (M4)|adult acute myelomonocytic leukemia (m4)
511133|NCT01385137|estrogen receptor-positive breast cancer|estrogen receptor-positive breast cancer
511134|NCT01385137|progesterone receptor-positive breast cancer|progesterone receptor-positive breast cancer
511135|NCT01385137|stage I breast cancer|stage i breast cancer
511136|NCT01385137|stage II breast cancer|stage ii breast cancer
511137|NCT01385137|stage IIIA breast cancer|stage iiia breast cancer
511138|NCT01385137|pain|pain
511139|NCT01385137|arthralgia|arthralgia
511140|NCT01385124|Cannabidiol|cannabidiol
511141|NCT01385124|GVHD|gvhd
511142|NCT01385124|Allogeneic transplantation|allogeneic transplantation
511143|NCT01385124|Prophylaxis|prophylaxis
511144|NCT01385111|endobronchial ultrasound|endobronchial ultrasound
511145|NCT01385111|endoscopic ultrasound|endoscopic ultrasound
511146|NCT01385111|EBUS-TBNA|ebus-tbna
511147|NCT01385111|EUS-FNA|eus-fna
511148|NCT01385111|EUS-B-FNA|eus-b-fna
511149|NCT01385111|lung cancer|lung cancer
511150|NCT01385111|staging|staging
511151|NCT01385098|Vitamin D|vitamin d
511152|NCT01385098|Bariatric surgery|bariatric surgery
511153|NCT01385098|Roux-en Y surgery|roux-en y surgery
511154|NCT01385098|Gastric sleeve surgery|gastric sleeve surgery
511155|NCT01385098|Parathyroid Hormone|parathyroid hormone
511156|NCT01385085|Vitamin D|vitamin d
511157|NCT01385085|Sunlight|sunlight
511158|NCT01385085|Deficiency|deficiency
511159|NCT01385072|acute leukemia|acute leukemia
511160|NCT01385072|relapse|relapse
511161|NCT01385072|induction failure|induction failure
511162|NCT01385072|allogeneic transplantation|allogeneic transplantation
511163|NCT01385072|graft versus leukemia effect|graft versus leukemia effect
511164|NCT01385046|physical inactivity|physical inactivity
511165|NCT01385046|poor diet|poor diet
511166|NCT01385020|Red yeast rice|red yeast rice
511167|NCT01385020|Gemfibrozil|gemfibrozil
511168|NCT01385020|Drug-drug interaction|drug-drug interaction
511169|NCT01385020|Pharmacokinetics|pharmacokinetics
511170|NCT01385007|Rural|rural
511171|NCT01385007|Veterans|veterans
511172|NCT01385007|Dementia|dementia
511173|NCT01385007|Pain|pain
511174|NCT01385007|Aggression|aggression
511175|NCT01385007|residence in a VA designated rural area|residence in a va designated rural area
511176|NCT01385007|presence of a caregiver|presence of a caregiver
511177|NCT01384994|Colorectal Cancer|colorectal cancer
511178|NCT01384994|PARLIM|parlim
511179|NCT01384994|KRAS Wildtype|kras wildtype
511180|NCT01384994|Liver metastases|liver metastases
511181|NCT01384981|chronic obstructive pulmonary rehabilitation|chronic obstructive pulmonary rehabilitation
511182|NCT01384981|COPD|copd
511183|NCT01384981|non invasive ventilation|non invasive ventilation
511185|NCT01384981|exercise capacity|exercise capacity
511186|NCT01384981|pulmonary rehabilitation|pulmonary rehabilitation
511187|NCT01384968|nitrite|nitrite
511188|NCT01384968|exercise|exercise
511189|NCT01384968|cycling|cycling
511190|NCT01384955|scoliosis|scoliosis
511191|NCT01384955|physical therapy|physical therapy
511192|NCT01384955|long term outcome|long term outcome
511193|NCT01384955|pulmonary function|pulmonary function
511194|NCT01384955|physical fitness|physical fitness
511195|NCT01384955|health related quality of life|health related quality of life
511196|NCT01384955|psychopathology|psychopathology
511197|NCT01384942|Bereavement|bereavement
511198|NCT01384942|Grief|grief
511199|NCT01384942|Mourning|mourning
511200|NCT01384942|Loss|loss
511201|NCT01384942|Death|death
511202|NCT01384942|Meaning|meaning
511203|NCT01384942|Group|group
511204|NCT01384942|Counseling|counseling
511205|NCT01384942|Psychotherapy|psychotherapy
511206|NCT01384942|Uncomplicated|uncomplicated
511207|NCT01384942|Support|support
511208|NCT01384916|depression|depression
511209|NCT01384916|yoga|yoga
511210|NCT01384916|health education|health education
511211|NCT01384916|antidepressant|antidepressant
511212|NCT01384877|Pain|pain
511213|NCT01384877|Cancer|cancer
511214|NCT01384877|Lidocaine|lidocaine
511215|NCT01384877|Sodium Channel Blockers|sodium channel blockers
511216|NCT01384864|barrett's esophagus|barrett's esophagus
511217|NCT01384864|intraepithelial neoplasia|intraepithelial neoplasia
511218|NCT01384864|cross polarized reflectance examination|cross polarized reflectance examination
511219|NCT01384864|vital-dye enhanced fluorescence examination|vital-dye enhanced fluorescence examination
511220|NCT01384838|breast cancer|breast cancer
511221|NCT01384838|physical activity|physical activity
511222|NCT01384838|sports|sports
511223|NCT01384838|exercise|exercise
511224|NCT01384825|Multiple Sclerosis|multiple sclerosis
511225|NCT01384825|Other Neurodegenerative Diseases|other neurodegenerative diseases
511226|NCT01384825|Chronic CerebroSpinal Venous Insufficiency|chronic cerebrospinal venous insufficiency
511227|NCT01384825|Prevalence|prevalence
511228|NCT01384825|Case-control|case-control
511229|NCT01384773|Keratoconus|keratoconus
511230|NCT01384773|Ectasia|ectasia
511231|NCT01384773|UVA light|uva light
511232|NCT01384773|riboflavin|riboflavin
511233|NCT01384773|post-LASIK (laser in situ keratomileusis)|post-lasik (laser in situ keratomileusis)
511234|NCT01384773|pellucid marginal degeneration|pellucid marginal degeneration
511235|NCT01384773|irregular astigmatism|irregular astigmatism
511236|NCT01384721|Computed Tomography Coronary Angiography|computed tomography coronary angiography
511237|NCT01384721|Coronary Artery Disease|coronary artery disease
511238|NCT01384721|Prevalence Of Disease|prevalence of disease
511239|NCT01384721|Prognosis|prognosis
511240|NCT01384721|Risk Stratification|risk stratification
511241|NCT01384708|squamous cell cancer|squamous cell cancer
511242|NCT01384708|squamous cell neoplasia|squamous cell neoplasia
511243|NCT01384695|Barrett's esophagus|barrett's esophagus
511244|NCT01384695|confocal microendoscopy|confocal microendoscopy
511245|NCT01384617|distal pancreatectomy|distal pancreatectomy
511246|NCT01384617|pancreatic fistula|pancreatic fistula
511247|NCT01384617|pancreaticojejunostomy|pancreaticojejunostomy
511248|NCT01384617|Roux-en-Y anastomosis|roux-en-y anastomosis
511249|NCT01384617|stapling closure|stapling closure
511250|NCT01384604|Schizophrenia|schizophrenia
511251|NCT01384604|Schizoaffective disorder|schizoaffective disorder
511252|NCT01384604|Bipolar disorder|bipolar disorder
511253|NCT01384604|Psychosis|psychosis
511254|NCT01384604|Genetics|genetics
511256|NCT01384591|oxidative stress|oxidative stress
511257|NCT01384591|blood flow|blood flow
511258|NCT01384591|antioxidant|antioxidant
511259|NCT01384591|muscle|muscle
511260|NCT01384591|elderly|elderly
511261|NCT01384552|normal weight|normal weight
511262|NCT01384552|overweight|overweight
511263|NCT01384552|dietary restraint|dietary restraint
511264|NCT01384552|package unit size|package unit size
511265|NCT01384552|food intake|food intake
511266|NCT01384539|chronic kidney disease|chronic kidney disease
511267|NCT01384539|vitamin D deficiency|vitamin d deficiency
511268|NCT01384526|hormone therapy|hormone therapy
511269|NCT01384526|ovarian aging|ovarian aging
511270|NCT01384526|ovarian reserve|ovarian reserve
511271|NCT01384526|fertility|fertility
511272|NCT01384526|breast cancer|breast cancer
511273|NCT01384513|Allogeneic HSCT|allogeneic hsct
511274|NCT01384513|Hematopoietic stem cell transplantation|hematopoietic stem cell transplantation
511275|NCT01384487|Viewing and axial cross sectional imaging of ocular|viewing and axial cross sectional imaging of ocular
511276|NCT01384487|structures, including the anterior chamber|structures, including the anterior chamber
511277|NCT01384474|Crew Resource Management|crew resource management
511278|NCT01384474|Surgical safety checklist|surgical safety checklist
511279|NCT01384474|Postoperative complications|postoperative complications
511280|NCT01384448|stress echocardiography|stress echocardiography
511281|NCT01384448|coronary ct angiography|coronary ct angiography
511282|NCT01384435|Spinocerebellar degeneration (SCD)|spinocerebellar degeneration (scd)
511283|NCT01384435|Thyrotropin-Releasing Hormone (TRH)|thyrotropin-releasing hormone (trh)
511284|NCT01384422|methotrexate-refractory|methotrexate-refractory
511285|NCT01384383|Chronic Hepatitis C|chronic hepatitis c
511286|NCT01384383|IL28B CC Genotype|il28b cc genotype
511287|NCT01384383|Treatment naive|treatment naive
511288|NCT01384383|Peginterferon α-2a (PEG)|peginterferon α-2a (peg)
511289|NCT01384383|Genotype 1a/b|genotype 1a/b
511290|NCT01384383|GS 9451|gs 9451
511291|NCT01384383|GS 5885|gs 5885
511292|NCT01384383|Ribavirin (RBV)|ribavirin (rbv)
511293|NCT01384383|HCV NS5A inhibitor|hcv ns5a inhibitor
511783|NCT01382095|Vaccine|vaccine
511294|NCT01384383|HCV NS3 protease inhibitor|hcv ns3 protease inhibitor
511295|NCT01384357|lymphadenopathy|lymphadenopathy
511296|NCT01384357|needle biopsy|needle biopsy
511297|NCT01384357|sonography|sonography
511298|NCT01384331|Implanon users|implanon users
511299|NCT01384331|Frequent bleeding|frequent bleeding
511300|NCT01384331|Prolonged bleeding|prolonged bleeding
511301|NCT01384331|Comparison of treatments|comparison of treatments
511302|NCT01384331|Placebo controlled|placebo controlled
511303|NCT01384331|Randomly allocated tretment|randomly allocated tretment
511304|NCT01384292|Cancer-Related Pain|cancer-related pain
511305|NCT01384292|Opioid-Induced Constipation|opioid-induced constipation
511307|NCT01384279|metformin|metformin
511308|NCT01384279|topiramate|topiramate
511309|NCT01384279|obesity|obesity
511310|NCT01384279|metabolic syndrome|metabolic syndrome
511311|NCT01384266|Intraocular Inflammation following routine Cataract Surgery|intraocular inflammation following routine cataract surgery
511312|NCT01384253|HER2+|her2+
511313|NCT01384253|HER-2 positive|her-2 positive
511314|NCT01384253|intraperitoneal|intraperitoneal
511315|NCT01384253|intra-abdominal|intra-abdominal
511316|NCT01384253|Lead 212|lead 212
511317|NCT01384253|Radio Immunotherapy|radio immunotherapy
511318|NCT01384253|Alpha particle|alpha particle
511319|NCT01384253|Antibodies|antibodies
511320|NCT01384253|Immunoglobulins|immunoglobulins
511321|NCT01384253|Antibodies, Monoclonal|antibodies, monoclonal
511322|NCT01384253|Immunologic Factors|immunologic factors
511323|NCT01384253|Physiological Effects of Drugs|physiological effects of drugs
511324|NCT01384253|Pharmacologic Actions|pharmacologic actions
511325|NCT01384253|RIT|rit
511326|NCT01384240|colon polyps|colon polyps
511327|NCT01384240|colonic dysplasia|colonic dysplasia
511328|NCT01384240|anal dysplasia|anal dysplasia
511329|NCT01384240|microendoscopy|microendoscopy
511330|NCT01384227|Barrett's esophagus|barrett's esophagus
511331|NCT01384227|in vivo imaging|in vivo imaging
511332|NCT01384227|image guide microscope|image guide microscope
511333|NCT01384201|intestinal metaplasia, gastric cancer|intestinal metaplasia, gastric cancer
511334|NCT01384175|Epidural Analgesia|epidural analgesia
511335|NCT01384175|OPCAB|opcab
511336|NCT01384175|PCEA|pcea
511337|NCT01384162|ALS|als
511338|NCT01384162|VEGF165|vegf165
511339|NCT01384162|Safety|safety
511340|NCT01384162|Intracerebroventricular|intracerebroventricular
511341|NCT01384162|Infusion|infusion
511342|NCT01384162|Implantable|implantable
511343|NCT01384149|intra ocular pressure|intra ocular pressure
511344|NCT01384149|open angle glaucoma|open angle glaucoma
511345|NCT01384149|selective laser trabeculoplasty|selective laser trabeculoplasty
511346|NCT01384149|external laser treatment|external laser treatment
511347|NCT01384123|stable pulmonary sarcoidosis with no change in medication during the last 3 months/|stable pulmonary sarcoidosis with no change in medication during the last 3 months/
511348|NCT01384110|Amylase|amylase
511349|NCT01384110|Glucosidase|glucosidase
511350|NCT01384110|Glycemic response|glycemic response
511351|NCT01384110|Sucrose|sucrose
511352|NCT01384110|Seaweed|seaweed
511353|NCT01384097|haemodynamic|haemodynamic
511354|NCT01384097|goal-directed therapy|goal-directed therapy
511355|NCT01384097|surgery|surgery
511356|NCT01384097|anaesthesia|anaesthesia
511357|NCT01384084|pelvic organ prolapse|pelvic organ prolapse
511358|NCT01384084|urinary incontinence|urinary incontinence
511359|NCT01384084|sacropexy|sacropexy
511360|NCT01384084|sling|sling
511361|NCT01384071|Low back pain|low back pain
511362|NCT01384071|Unstable shoes|unstable shoes
511363|NCT01384071|Gait|gait
511364|NCT01384071|Balance|balance
511365|NCT01384058|atherogenic lipoprotein|atherogenic lipoprotein
511366|NCT01384058|cardiovascular disease|cardiovascular disease
511367|NCT01384058|coronary artery disease|coronary artery disease
511368|NCT01384058|type 2 diabetes|type 2 diabetes
511369|NCT01384058|small, dense LDL|small, dense ldl
511370|NCT01384045|Type II Diabetes|type ii diabetes
511371|NCT01384045|Diabetes|diabetes
511372|NCT01384032|CVD, LDL-C, apoE, SFA, DHA|cvd, ldl-c, apoe, sfa, dha
511373|NCT01384019|ST-elevation myocardial infarction|st-elevation myocardial infarction
511374|NCT01384019|percutaneous coronary intervention|percutaneous coronary intervention
511375|NCT01384019|cardiac magnetic resonance imaging|cardiac magnetic resonance imaging
511376|NCT01384019|microvascular occlusion|microvascular occlusion
511377|NCT01384019|myocardial salvage|myocardial salvage
511378|NCT01384006|Pancreas transplantation|pancreas transplantation
511379|NCT01384006|extended donor criteria|extended donor criteria
511380|NCT01384006|organ survival|organ survival
511381|NCT01383993|Open-Label|open-label
511382|NCT01383993|Pharmacokinetics|pharmacokinetics
511383|NCT01383993|Intravenous to oral switch|intravenous to oral switch
511384|NCT01383993|Safety|safety
511385|NCT01383993|Voriconazole|voriconazole
511386|NCT01383993|Immunocompromise|immunocompromise
650353|NCT00826553|GABA|gaba
511387|NCT01383993|Children|children
511388|NCT01383993|High Risk For Systemic Fungal Infection|high risk for systemic fungal infection
511389|NCT01383980|Enteral Nutrition|enteral nutrition
511390|NCT01383980|Enteral Feeding|enteral feeding
511391|NCT01383980|nasogastric tubes|nasogastric tubes
511392|NCT01383980|gastrostomy tubes|gastrostomy tubes
511393|NCT01383980|jejunostomy tubes|jejunostomy tubes
511394|NCT01383954|Knee osteoarthritis|knee osteoarthritis
511395|NCT01383941|asthma|asthma
511396|NCT01383941|rhinitis|rhinitis
511397|NCT01383941|difficult-to-treat asthmatic|difficult-to-treat asthmatic
511398|NCT01383941|phenotypes|phenotypes
511399|NCT01383889|Physical exercise|physical exercise
511400|NCT01383889|Pregnancy|pregnancy
511401|NCT01383889|Fetal well being|fetal well being
511402|NCT01383876|cervical|cervical
511403|NCT01383876|laminectomy|laminectomy
511404|NCT01383876|fusion|fusion
511405|NCT01383876|neurological compression|neurological compression
511406|NCT01383876|spondylosis|spondylosis
511407|NCT01383850|preterm infants|preterm infants
511408|NCT01383850|nasal continuous positive airway pressure|nasal continuous positive airway pressure
511409|NCT01383850|heliox|heliox
511410|NCT01383850|bronchopulmonary dysplasia.|bronchopulmonary dysplasia.
511411|NCT01383837|HIV/STI|hiv/sti
511412|NCT01383837|Prevention|prevention
511413|NCT01383837|Adolescents|adolescents
511414|NCT01383837|Substance Use Disorders|substance use disorders
511415|NCT01383837|Family-based intervention|family-based intervention
511416|NCT01383824|Hip Replacement|hip replacement
511417|NCT01383824|Femoral Component|femoral component
511418|NCT01383811|Treatment Resistant Depression|treatment resistant depression
511419|NCT01383811|Exercise|exercise
511420|NCT01383798|iron deficiency, physical performance, female athletes|iron deficiency, physical performance, female athletes
511421|NCT01383785|Primary PTCA|primary ptca
511422|NCT01383785|Thrombus Aspiration Catheter|thrombus aspiration catheter
511423|NCT01383785|Intracoronary Abciximab|intracoronary abciximab
511424|NCT01383772|Proliferative diabetic retinopathy|proliferative diabetic retinopathy
511425|NCT01383772|Pan retinal photocoagulation|pan retinal photocoagulation
511426|NCT01383772|Multi-spot Photocoagulator|multi-spot photocoagulator
511427|NCT01383772|Visual field tests|visual field tests
511428|NCT01383759|BORTEZOMIB (VELCADE)|bortezomib (velcade)
511429|NCT01383759|CYCLOPHOSPHAMIDE (CYTOXAN)|cyclophosphamide (cytoxan)
511430|NCT01383759|DEXAMETHASONE|dexamethasone
511431|NCT01383759|MELPHALAN|melphalan
511432|NCT01383759|11-061|11-061
511433|NCT01383746|Cholangiocarcinoma|cholangiocarcinoma
511434|NCT01383746|RADIOEMBOLIZATION|radioembolization
511435|NCT01383746|tumor response|tumor response
511436|NCT01383746|progression-free survival|progression-free survival
511437|NCT01383746|safety|safety
511438|NCT01383746|second-line therapy|second-line therapy
511439|NCT01383720|Aortic Valve Stenosis|aortic valve stenosis
511440|NCT01383720|Transcatheter Aortic Valve Replacement|transcatheter aortic valve replacement
511441|NCT01383655|wheezy bronchitis|wheezy bronchitis
511442|NCT01383655|asthma|asthma
511443|NCT01383655|rhinovirus|rhinovirus
511444|NCT01383655|magnesium|magnesium
511445|NCT01383629|Vitrectomy|vitrectomy
511446|NCT01383629|Local anaesthesia|local anaesthesia
511447|NCT01383629|Counselling|counselling
511448|NCT01383629|Fear|fear
511449|NCT01383629|Visual perception|visual perception
511450|NCT01383616|osteoporosis|osteoporosis
511451|NCT01383616|vertebral compression fractures|vertebral compression fractures
511452|NCT01383603|Cat Allergy|cat allergy
511453|NCT01383603|Rhinoconjunctivitis|rhinoconjunctivitis
511454|NCT01383603|Immunotherapy|immunotherapy
511455|NCT01383603|Cat-PAD|cat-pad
511456|NCT01383590|Cat allergy|cat allergy
511457|NCT01383590|Rhinoconjunctivitis|rhinoconjunctivitis
511458|NCT01383590|Immunotherapy|immunotherapy
511459|NCT01383590|Cat-PAD|cat-pad
511460|NCT01383577|Hemorrhoids|hemorrhoids
511461|NCT01383577|Ligation|ligation
511462|NCT01383577|Pain|pain
511463|NCT01383577|Morbidity|morbidity
511464|NCT01383577|Patient Satisfaction|patient satisfaction
511465|NCT01383577|Cost-Benefit Analysis|cost-benefit analysis
511466|NCT01383551|Depression|depression
511467|NCT01383551|Marital relationship|marital relationship
511468|NCT01383551|Parental competence|parental competence
511469|NCT01383538|pancreas|pancreas
511470|NCT01383538|cancer|cancer
511471|NCT01383538|adenocarcinoma|adenocarcinoma
511472|NCT01383538|Oxaliplatin|oxaliplatin
511473|NCT01383538|Leucovorin|leucovorin
511474|NCT01383538|Irinotecan|irinotecan
511475|NCT01383538|5-FU|5-fu
511476|NCT01383538|IPI-926|ipi-926
511477|NCT01383525|SLT, LTP, DSLT|slt, ltp, dslt
511478|NCT01383525|non contact|non contact
511479|NCT01383525|Trabeculoplasty|trabeculoplasty
511480|NCT01383525|Laser|laser
511481|NCT01383525|intraocular pressure|intraocular pressure
511482|NCT01383512|stroke|stroke
511483|NCT01383512|rehabilitation|rehabilitation
511484|NCT01383512|robotics|robotics
511485|NCT01383512|motor control|motor control
511486|NCT01383512|upper limb|upper limb
511487|NCT01383486|Self Selection Tria|self selection tria
511488|NCT01383473|cancer therapy|cancer therapy
511489|NCT01383473|school attendance|school attendance
511490|NCT01383473|cancer diagnosis|cancer diagnosis
511491|NCT01383473|perception|perception
511492|NCT01383460|Acute-on-chronic liver failure|acute-on-chronic liver failure
511493|NCT01383460|ACLF|aclf
511494|NCT01383460|cirrhosis|cirrhosis
511495|NCT01383460|acute hepatitis|acute hepatitis
511496|NCT01383421|Rheumatoid Arthritis|rheumatoid arthritis
511497|NCT01383421|Patient Support Program|patient support program
511498|NCT01383421|adalimumab|adalimumab
511499|NCT01383408|breath sample analysis|breath sample analysis
511500|NCT01383408|exhalation analysis|exhalation analysis
511501|NCT01383408|volatile organic compounds|volatile organic compounds
511502|NCT01383408|screening|screening
511503|NCT01383408|lung cancer|lung cancer
511504|NCT01383408|breast cancer|breast cancer
511505|NCT01383408|ovarian cancer|ovarian cancer
511506|NCT01383408|canine scent detection|canine scent detection
511507|NCT01383382|Heart Diseases|heart diseases
511508|NCT01383382|Cardiovascular Diseases|cardiovascular diseases
511509|NCT01383382|Acute Myocardial Infarction|acute myocardial infarction
511510|NCT01383382|Decision Making|decision making
511511|NCT01383382|Percutaneous Coronary Intervention|percutaneous coronary intervention
511512|NCT01383382|Informed Consent|informed consent
511513|NCT01383382|Quality of Care|quality of care
511514|NCT01383330|megesterol|megesterol
511515|NCT01383317|Remote Ischemic Preconditioning|remote ischemic preconditioning
511516|NCT01383317|Acute Pain|acute pain
511517|NCT01383304|Platelet aggregation|platelet aggregation
511518|NCT01383304|Aspirin|aspirin
511519|NCT01383304|Drug resistance|drug resistance
511520|NCT01383304|Thromboxane B2|thromboxane b2
511521|NCT01383304|Pharmacologic Actions|pharmacologic actions
511522|NCT01383304|Platelet Aggregation Inhibitors|platelet aggregation inhibitors
511523|NCT01383291|pelvic floor prolapse|pelvic floor prolapse
511524|NCT01383291|prolift|prolift
511525|NCT01383291|IVS|ivs
511526|NCT01383291|Surgery|surgery
511527|NCT01383278|tobacco|tobacco
511528|NCT01383278|smoking|smoking
511529|NCT01383278|smoking cessation|smoking cessation
511530|NCT01383265|screening colonoscopy|screening colonoscopy
511531|NCT01383265|adenoma|adenoma
511532|NCT01383265|water method|water method
511533|NCT01383252|water method|water method
511534|NCT01383252|air method|air method
511535|NCT01383252|unsedated colonoscopy|unsedated colonoscopy
511536|NCT01383252|adenoma detection|adenoma detection
511537|NCT01383239|Rotator Cuff Tear Repair|rotator cuff tear repair
511538|NCT01383239|Rotator Cuff Tear Repair and postoperative treatment|rotator cuff tear repair and postoperative treatment
511539|NCT01383226|endosonography|endosonography
511540|NCT01383226|enlarged thoracic lymph adenopathies|enlarged thoracic lymph adenopathies
511541|NCT01383226|non-cancer patient|non-cancer patient
511542|NCT01383213|Acute Respiratory Failure|acute respiratory failure
511543|NCT01383213|Pneumonia|pneumonia
511544|NCT01383213|Continuous Positive Airway Pressure|continuous positive airway pressure
511545|NCT01383200|efficacy|efficacy
511546|NCT01383200|comfort|comfort
511547|NCT01383187|Deep Burn Trauma|deep burn trauma
511548|NCT01383187|Dermo-Epidermal Graft|dermo-epidermal graft
511549|NCT01383187|Platelet Rich Plasma Concentrate (PRP)|platelet rich plasma concentrate (prp)
511550|NCT01383187|Vancouver Scar Score|vancouver scar score
511551|NCT01383187|Scarring|scarring
511552|NCT01383187|Hypertrophic Scarring|hypertrophic scarring
511553|NCT01383174|Breast cancer|breast cancer
511554|NCT01383174|Latinas|latinas
511555|NCT01383174|Peer support counselor|peer support counselor
511556|NCT01383174|Spanish speaking|spanish speaking
511557|NCT01383174|Community based|community based
511558|NCT01383161|Curcumin|curcumin
511559|NCT01383161|Turmeric|turmeric
511560|NCT01383161|Memory|memory
511561|NCT01383161|Cognitive Impairment|cognitive impairment
511562|NCT01383161|Brain Imaging|brain imaging
511563|NCT01383161|Supplement|supplement
511564|NCT01383148|NSCLC|nsclc
511565|NCT01383135|Healthy volunteers|healthy volunteers
511566|NCT01383122|Pulsed electromagnetic field device|pulsed electromagnetic field device
511567|NCT01383122|Cesarean section|cesarean section
511568|NCT01383109|Mass Balance|mass balance
511569|NCT01383109|Accelerated Mass Spectrometry (AMS)|accelerated mass spectrometry (ams)
511570|NCT01383109|microdose|microdose
511571|NCT01383109|Focus of the study: ADME|focus of the study: adme
511572|NCT01383096|OZ439|oz439
511573|NCT01383096|Bioavailability|bioavailability
511574|NCT01383096|Food Effect|food effect
511575|NCT01383083|Pulmonary arterial hypertension|pulmonary arterial hypertension
511576|NCT01383083|Congenital heart disease|congenital heart disease
511577|NCT01383083|Eisenmenger physiology|eisenmenger physiology
511578|NCT01383070|Timely initiation of breast feeding|timely initiation of breast feeding
511579|NCT01383070|Exclusive breast feeding|exclusive breast feeding
511580|NCT01383070|Timely introduction of complimentary feeding|timely introduction of complimentary feeding
511581|NCT01383070|Breast Feeding, Exclusive|breast feeding, exclusive
511582|NCT01383070|Childbirth and the Puerperium|childbirth and the puerperium
511583|NCT01383044|Carvedilol|carvedilol
511584|NCT01383044|Banding ligation with Carvedilol|banding ligation with carvedilol
511585|NCT01383044|the efficacy & safety of combining EVL and carvedilol in prevention of first variceal bleeding|the efficacy & safety of combining evl and carvedilol in prevention of first variceal bleeding
511586|NCT01383031|laparoscopic cholecystectomy|laparoscopic cholecystectomy
511587|NCT01383031|single site|single site
511588|NCT01383031|randomized controlled trail|randomized controlled trail
511589|NCT01383018|Erectile Dysfunction (ED)|erectile dysfunction (ed)
511590|NCT01383018|Penile Implant|penile implant
511591|NCT01383018|Impotence|impotence
511592|NCT01383018|Penile Prosthesis|penile prosthesis
511593|NCT01383018|Registry|registry
511594|NCT01383005|Treatment satisfaction|treatment satisfaction
511595|NCT01383005|Adherence to treatment|adherence to treatment
511596|NCT01382992|Carcinoma, Non-Small-Cell Lung|carcinoma, non-small-cell lung
511597|NCT01382992|erbB-1|erbb-1
511598|NCT01382979|Alcohol misuse prevention|alcohol misuse prevention
511599|NCT01382979|College students|college students
511600|NCT01382979|Intervention and control|intervention and control
511601|NCT01382966|sclerostin|sclerostin
511602|NCT01382966|arteriovenous fistula thrombosis|arteriovenous fistula thrombosis
511603|NCT01382966|carpal tunnel syndrome|carpal tunnel syndrome
511604|NCT01382966|echocardiography|echocardiography
511605|NCT01382953|Holter Monitor, Ambulatory Electrocardiography Monitoring|holter monitor, ambulatory electrocardiography monitoring
511606|NCT01382888|Haemodialysis|haemodialysis
511607|NCT01382888|Arteriovenous fistula|arteriovenous fistula
511608|NCT01382888|Severe chronic kidney disease|severe chronic kidney disease
511609|NCT01382888|Newly constructed primary arteriovenous fistulas in patients planned for haemodialysis|newly constructed primary arteriovenous fistulas in patients planned for haemodialysis
511610|NCT01382875|Multi-disciplinary management program|multi-disciplinary management program
511611|NCT01382875|Conventional care program|conventional care program
511612|NCT01382875|Balance Ability|balance ability
511613|NCT01382875|Quality of Life|quality of life
511614|NCT01382862|acute ischemic stroke|acute ischemic stroke
511615|NCT01382862|thrombolysis|thrombolysis
511616|NCT01382862|prehospital|prehospital
511617|NCT01382862|emergency medicine|emergency medicine
511618|NCT01382862|suspected acute stroke|suspected acute stroke
511619|NCT01382862|telemedicine|telemedicine
511620|NCT01382849|amyloid|amyloid
511621|NCT01382849|cerebral amyloid angiopathy|cerebral amyloid angiopathy
511622|NCT01382849|hemorrhages|hemorrhages
511623|NCT01382849|cerebral spot sign|cerebral spot sign
511624|NCT01382810|dry eye signs and symptoms|dry eye signs and symptoms
511625|NCT01382771|low back pain|low back pain
511626|NCT01382771|zygapophysial joint pain|zygapophysial joint pain
511627|NCT01382771|medial branch block|medial branch block
511628|NCT01382771|> 6 months duration|> 6 months duration
511629|NCT01382771|non-radicular|non-radicular
511630|NCT01382758|Near Infrared Spectroscopy (NIRS)|near infrared spectroscopy (nirs)
511631|NCT01382758|Acute kidney injury (AKI)|acute kidney injury (aki)
511632|NCT01382732|Pre-eclampsia|pre-eclampsia
511633|NCT01382732|Postpartum hemorrhage|postpartum hemorrhage
511634|NCT01382732|Carbetocin|carbetocin
511635|NCT01382732|Oxytocin|oxytocin
511636|NCT01382719|FSAD|fsad
511637|NCT01382719|HSDD|hsdd
511638|NCT01382719|female sexual dysfunction|female sexual dysfunction
511639|NCT01382719|FSD|fsd
511640|NCT01382719|Female Sexual Arousal Disorder|female sexual arousal disorder
511641|NCT01382719|Hypoactive Sexual Desire Disorder|hypoactive sexual desire disorder
511642|NCT01382693|Behavioral symptoms|behavioral symptoms
511643|NCT01382693|Long-term care|long-term care
511644|NCT01382667|mucositis|mucositis
511645|NCT01382667|dyspepsia|dyspepsia
511646|NCT01382667|chemotherapy|chemotherapy
511647|NCT01382667|GLP-2|glp-2
511648|NCT01382667|questionnaire|questionnaire
511649|NCT01382641|Cataract surgery|cataract surgery
511650|NCT01382628|Diabetes|diabetes
511651|NCT01382628|Ulcers|ulcers
511652|NCT01382628|Equinus Deformity|equinus deformity
511653|NCT01382628|Amputation|amputation
511654|NCT01382628|Achilles Tendon|achilles tendon
511655|NCT01382628|Limb Loss|limb loss
511656|NCT01382615|Multiple Myeloma|multiple myeloma
511657|NCT01382602|Urinary Incontinence, Stress|urinary incontinence, stress
511658|NCT01382602|Tissue Therapy (Cell Therapy)|tissue therapy (cell therapy)
511659|NCT01382602|Transplantation, Autologous|transplantation, autologous
511660|NCT01382589|vitiligo|vitiligo
511661|NCT01382589|depigmentation|depigmentation
511662|NCT01382589|phototherapy|phototherapy
511663|NCT01382589|non-segmental vitiligo|non-segmental vitiligo
511664|NCT01382576|polycystic ovary syndrome|polycystic ovary syndrome
511665|NCT01382576|chitotriosidase activity|chitotriosidase activity
511666|NCT01382563|Eosinophilic Gastrointestinal Disorders|eosinophilic gastrointestinal disorders
511667|NCT01382563|EGID|egid
511668|NCT01382563|Eosinophilic Esophagitis|eosinophilic esophagitis
511669|NCT01382563|Registry|registry
511670|NCT01382563|Eosinophils|eosinophils
511671|NCT01382563|Eosinophilia|eosinophilia
511672|NCT01382563|Eosinophilic enteropathy|eosinophilic enteropathy
511673|NCT01382563|Eosinophilic enteritis|eosinophilic enteritis
511674|NCT01382563|Eosinophilic gastritis|eosinophilic gastritis
511675|NCT01382563|Eosinophilic gastroenteritis|eosinophilic gastroenteritis
511676|NCT01382563|Eosinophilic gastroenteropathy|eosinophilic gastroenteropathy
511677|NCT01382550|antithrombin|antithrombin
511678|NCT01382550|venous thrombosis|venous thrombosis
511679|NCT01382550|thrombosis risk factors|thrombosis risk factors
511680|NCT01382550|thrombophilia|thrombophilia
511681|NCT01382537|Neck|neck
511682|NCT01382537|Chronic|chronic
511683|NCT01382537|Musculoskeletal|musculoskeletal
511684|NCT01382537|Shoulder|shoulder
511685|NCT01382524|PIV therapy|piv therapy
511686|NCT01382498|Endothelin-1 high sensitivity CRP|endothelin-1 high sensitivity crp
511687|NCT01382485|non union|non union
511688|NCT01382485|bone defect|bone defect
511689|NCT01382485|tibia non union|tibia non union
511690|NCT01382485|femur non union|femur non union
511691|NCT01382485|bone graft|bone graft
511692|NCT01382472|STEMI|stemi
511693|NCT01382472|PPCI|ppci
511694|NCT01382472|Statins|statins
511695|NCT01382472|Infarct size|infarct size
511696|NCT01382459|children|children
511697|NCT01382446|Trauma|trauma
511698|NCT01382446|Mechanical Ventilation|mechanical ventilation
511699|NCT01382446|Ventilator Associated Pneumonia|ventilator associated pneumonia
511700|NCT01382446|Oral Care|oral care
511701|NCT01382433|Chronic Cannabis Users|chronic cannabis users
511702|NCT01382433|negative symptoms|negative symptoms
511703|NCT01382433|cognitive electrophysiology functions|cognitive electrophysiology functions
511704|NCT01382420|subclinical cushing syndrome|subclinical cushing syndrome
511705|NCT01382420|hypercortisolism|hypercortisolism
511706|NCT01382420|adrenal incidentaloma|adrenal incidentaloma
511707|NCT01382420|adrenalectomy|adrenalectomy
511708|NCT01382407|skin rash reaction|skin rash reaction
511709|NCT01382407|ERBITUX® (cetuximab)|erbitux® (cetuximab)
511710|NCT01382407|acne|acne
511711|NCT01382394|Sepsis|sepsis
511712|NCT01382394|heart failure|heart failure
511713|NCT01382394|BNP|bnp
511714|NCT01382394|IL-6|il-6
511715|NCT01382394|Procalcitonin|procalcitonin
511716|NCT01382394|Prognosis|prognosis
511717|NCT01382368|Post Pneumonectomy Patients|post pneumonectomy patients
511718|NCT01382368|IPF|ipf
511719|NCT01382368|COPD|copd
511720|NCT01382355|Kidney transplant|kidney transplant
511721|NCT01382355|Kidney/Pancreas transplant|kidney/pancreas transplant
511722|NCT01382355|Antibody|antibody
511723|NCT01382355|Monitoring|monitoring
511724|NCT01382342|Parkinson's disease|parkinson's disease
511725|NCT01382342|cognition|cognition
511726|NCT01382342|executive function|executive function
511727|NCT01382342|rasagiline|rasagiline
511728|NCT01382329|Prophylaxis of influenza infection caused by a pandemic influenza virus (H5N1)|prophylaxis of influenza infection caused by a pandemic influenza virus (h5n1)
511729|NCT01382316|12-step facilitation|12-step facilitation
511730|NCT01382316|Alcoholics Anonymous|alcoholics anonymous
511731|NCT01382316|Narcotics Anonymous|narcotics anonymous
511732|NCT01382316|AA|aa
511733|NCT01382316|Self-help|self-help
511734|NCT01382303|Type 2 Diabetes|type 2 diabetes
511735|NCT01382303|pentoxifylline|pentoxifylline
511736|NCT01382303|proteinuria|proteinuria
511737|NCT01382290|MRI|mri
511738|NCT01382290|Spine|spine
511739|NCT01382290|Diffusion|diffusion
511740|NCT01382264|Poorly controlled diabetes Type 2|poorly controlled diabetes type 2
511741|NCT01382264|Computer Assisted Decision Support|computer assisted decision support
511742|NCT01382264|Primary Care Providers|primary care providers
511743|NCT01382251|Activities of Daily Living|activities of daily living
511744|NCT01382251|Caregivers|caregivers
511745|NCT01382251|Ambulatory Surgical Procedures|ambulatory surgical procedures
511746|NCT01382238|dolutegravir|dolutegravir
511747|NCT01382238|pediatric|pediatric
511748|NCT01382238|granule formulation|granule formulation
511749|NCT01382238|GSK1349572|gsk1349572
511750|NCT01382238|HIV|hiv
511751|NCT01382225|Dry eyes|dry eyes
511752|NCT01382225|Ocular discomfort|ocular discomfort
511753|NCT01382212|Evaluate safety through the evaluation of the incidence of hypercalcemia in pediatric subjects|evaluate safety through the evaluation of the incidence of hypercalcemia in pediatric subjects
511754|NCT01382199|Antibiotic Associated Diarrhea in Adult Patients|antibiotic associated diarrhea in adult patients
511755|NCT01382186|Qualitative|qualitative
511756|NCT01382186|User, Computer Interface|user, computer interface
511757|NCT01382186|quantitative|quantitative
511758|NCT01382186|survey|survey
511759|NCT01382186|telemedicine|telemedicine
511760|NCT01382173|Knee injury|knee injury
511761|NCT01382173|Osteoarthritis|osteoarthritis
511762|NCT01382173|Anterior Cruciate Ligament injury|anterior cruciate ligament injury
511763|NCT01382173|Patellar dislocation|patellar dislocation
511764|NCT01382160|Rheumatoid arthritis|rheumatoid arthritis
511765|NCT01382160|adalimumab|adalimumab
511766|NCT01382160|pharmacokinetic-pharmacodynamic relationship|pharmacokinetic-pharmacodynamic relationship
511767|NCT01382160|immunogenicity|immunogenicity
511768|NCT01382160|Fc gamma receptors polymorphisms|fc gamma receptors polymorphisms
511769|NCT01382134|Platelet dysfunction|platelet dysfunction
511770|NCT01382134|Hemodilution|hemodilution
511771|NCT01382134|Mild hypothermia|mild hypothermia
511772|NCT01382134|NSAID|nsaid
511773|NCT01382134|Desmopressin|desmopressin
511774|NCT01382121|Peer modeling|peer modeling
511775|NCT01382121|Observational learning|observational learning
511776|NCT01382121|Obesity|obesity
511777|NCT01382121|Adolescents|adolescents
511778|NCT01382121|Maximum ventilatory oxygen|maximum ventilatory oxygen
511779|NCT01382121|Aerobic fitness|aerobic fitness
511780|NCT01382121|Health behaviour|health behaviour
511781|NCT01382095|ETEC|etec
511784|NCT01382082|cognitive function|cognitive function
511785|NCT01382082|memory|memory
511786|NCT01382082|attention|attention
511787|NCT01382082|breast cancer|breast cancer
511788|NCT01382082|lymphoma|lymphoma
511789|NCT01382069|androgen|androgen
511790|NCT01382069|male contraception|male contraception
511791|NCT01382069|dimethandrolone|dimethandrolone
511792|NCT01382069|healthy men|healthy men
511793|NCT01382056|Peripheral Artery Disease|peripheral artery disease
511794|NCT01382056|Pulses|pulses
511795|NCT01382056|Beans|beans
511796|NCT01382056|PAD|pad
511797|NCT01382043|percutaneous coronary angioplasty|percutaneous coronary angioplasty
511798|NCT01382043|zotarolimus-eluting stent|zotarolimus-eluting stent
511799|NCT01382043|sirolimus-eluting stent|sirolimus-eluting stent
511800|NCT01382043|biodegradable polymer|biodegradable polymer
511801|NCT01382043|biocompatible polymer|biocompatible polymer
511802|NCT01382030|Soft tissue sarcoma|soft tissue sarcoma
511803|NCT01382030|High-risk|high-risk
511804|NCT01382030|Neoadjuvant|neoadjuvant
511805|NCT01382030|Adjuvant|adjuvant
511806|NCT01382030|Chemotherapy|chemotherapy
511807|NCT01382030|Radiotherapy|radiotherapy
511808|NCT01382017|lacosamide|lacosamide
511809|NCT01382017|carbamazepine|carbamazepine
511810|NCT01382017|placebo|placebo
511811|NCT01382017|transcranial magnetic stimulation|transcranial magnetic stimulation
511812|NCT01382017|TMS|tms
511813|NCT01382017|motor cortex|motor cortex
511814|NCT01382017|sodium channel|sodium channel
511815|NCT01382017|inhibition|inhibition
511816|NCT01382017|threshold|threshold
511817|NCT01382004|Neglected diseases|neglected diseases
511818|NCT01382004|Children|children
511819|NCT01381991|Gastroesophageal Reflux Disease|gastroesophageal reflux disease
511820|NCT01381991|Reflux esophagitis|reflux esophagitis
511821|NCT01381991|i-scan|i-scan
511822|NCT01381978|Nutritional status of scholars|nutritional status of scholars
511823|NCT01381978|Risk factors of obesity|risk factors of obesity
511824|NCT01381978|Socioeconomical status|socioeconomical status
511825|NCT01381978|Physical activity habits|physical activity habits
511826|NCT01381965|spectral-domain optical coherence tomography|spectral-domain optical coherence tomography
511827|NCT01381965|idiopathic macular hole|idiopathic macular hole
511828|NCT01381965|cone outer segment tips line|cone outer segment tips line
511829|NCT01381965|vitrectomy|vitrectomy
511830|NCT01381952|X-ray|x-ray
511831|NCT01381952|Image processing|image processing
511832|NCT01381952|Neuro angiography|neuro angiography
511833|NCT01381952|Radiation exposure|radiation exposure
511834|NCT01381939|Intrahepatic Cholestasis of Pregnancy|intrahepatic cholestasis of pregnancy
511835|NCT01381939|Induction of labor|induction of labor
511836|NCT01381939|Pregnancy|pregnancy
511837|NCT01381939|Caesarian section|caesarian section
511838|NCT01381939|Pruritus|pruritus
511839|NCT01381939|IUFD|iufd
511840|NCT01381926|Type 2 diabetes|type 2 diabetes
511841|NCT01381926|exenatide|exenatide
511842|NCT01381926|Byetta|byetta
511843|NCT01381913|Gastric cancer|gastric cancer
511844|NCT01381913|Chemoradiotherapy|chemoradiotherapy
511845|NCT01381913|Adjacent tissue invasion|adjacent tissue invasion
511846|NCT01381913|Feasibility trial|feasibility trial
511847|NCT01381900|Canagliflozin|canagliflozin
511848|NCT01381900|Placebo|placebo
511849|NCT01381900|Type 2 diabetes mellitus|type 2 diabetes mellitus
511850|NCT01381887|Canagliflozin|canagliflozin
511851|NCT01381887|Placebo|placebo
511852|NCT01381887|Type 2 diabetes mellitus|type 2 diabetes mellitus
511853|NCT01381874|Breast cancer|breast cancer
511854|NCT01381874|Abiraterone|abiraterone
511855|NCT01381874|Postmenopausal|postmenopausal
511856|NCT01381874|Metastatic|metastatic
511857|NCT01381848|Doripenem|doripenem
511858|NCT01381848|DORIPED1003|doriped1003
511859|NCT01381848|Intravenous|intravenous
511860|NCT01381848|Infection|infection
511861|NCT01381848|Colonization|colonization
511862|NCT01381848|Prophylaxis|prophylaxis
511863|NCT01381848|Pediatric|pediatric
511864|NCT01381848|Antibiotic|antibiotic
511865|NCT01381848|Pharmacokinetics|pharmacokinetics
511866|NCT01381835|TMC435-TiDP16-C126|tmc435-tidp16-c126
511867|NCT01381835|TMC435-C126|tmc435-c126
511868|NCT01381835|TMC435|tmc435
511869|NCT01381835|HCV|hcv
511870|NCT01381835|Hepatitis C|hepatitis c
511871|NCT01381835|Hep C|hep c
711345|NCT00585182|Obesity|obesity
650981|NCT00824265|Safety|safety
511872|NCT01381835|severe renal impairement|severe renal impairement
511873|NCT01381822|TH-302|th-302
511874|NCT01381822|Advanced Renal Cell Carcinoma|advanced renal cell carcinoma
511875|NCT01381822|RCC|rcc
511876|NCT01381822|Gastrointestinal Stromal Tumors|gastrointestinal stromal tumors
511877|NCT01381822|GIST|gist
511878|NCT01381822|Phase 1|phase 1
511879|NCT01381822|Sunitinib|sunitinib
511880|NCT01381822|Pancreatic Neuroendocrine Tumors|pancreatic neuroendocrine tumors
511881|NCT01381822|PNET|pnet
511882|NCT01381809|Myelodysplastic Syndromes|myelodysplastic syndromes
511883|NCT01381809|Myeloproliferative Disorders|myeloproliferative disorders
511884|NCT01381809|Bone Marrow disease|bone marrow disease
511885|NCT01381809|Anemia|anemia
511886|NCT01381809|Epoetin Alfa|epoetin alfa
511887|NCT01381809|Eprex|eprex
511888|NCT01381809|Erypo|erypo
511889|NCT01381809|Erythropoiesis-stimulating agent|erythropoiesis-stimulating agent
511890|NCT01381783|topical anaesthesia|topical anaesthesia
511891|NCT01381783|Phacoemulsification|phacoemulsification
511892|NCT01381770|muscular lesions grade 2|muscular lesions grade 2
511893|NCT01381770|muscular lesions grade 3|muscular lesions grade 3
511894|NCT01381757|Extensively Drug-Resistant Tuberculosis|extensively drug-resistant tuberculosis
511895|NCT01381757|First-Line Antituberculous Drugs|first-line antituberculous drugs
511896|NCT01381757|Second-Line Antituberculous Drugs|second-line antituberculous drugs
511897|NCT01381757|Middlebrook Culture|middlebrook culture
511898|NCT01381757|Agar Proportion Method|agar proportion method
511899|NCT01381744|Yersinia pestis, vaccine, plague, Flagellin/F1/V, Parent Protocol of 15-0104|yersinia pestis, vaccine, plague, flagellin/f1/v, parent protocol of 15-0104
511900|NCT01381731|post PRK wound healing|post prk wound healing
511901|NCT01381718|childhood brain tumor|childhood brain tumor
511902|NCT01381718|neurotoxicity|neurotoxicity
511903|NCT01381718|fatigue|fatigue
511904|NCT01381718|cognitive/functional effects|cognitive/functional effects
511905|NCT01381718|psychosocial effects of cancer and its treatment|psychosocial effects of cancer and its treatment
511906|NCT01381705|recurrent grade 1 follicular lymphoma|recurrent grade 1 follicular lymphoma
511907|NCT01381705|recurrent grade 2 follicular lymphoma|recurrent grade 2 follicular lymphoma
511908|NCT01381653|sexual risk|sexual risk
511909|NCT01381653|substance use|substance use
511910|NCT01381653|HIV prevention|hiv prevention
511911|NCT01381653|intervention acceptability and feasibility|intervention acceptability and feasibility
511912|NCT01381653|young men who have sex with men|young men who have sex with men
511913|NCT01381640|paracetamol|paracetamol
511914|NCT01381640|healthy volunteer|healthy volunteer
511915|NCT01381640|pharmacoscintography|pharmacoscintography
511916|NCT01381627|EBUS-TBNA|ebus-tbna
511917|NCT01381627|Dexmedetomidine|dexmedetomidine
511918|NCT01381627|Precedex|precedex
511919|NCT01381627|Remifentanil|remifentanil
511920|NCT01381627|Ultiva|ultiva
511921|NCT01381627|Monitored Anesthesia Care|monitored anesthesia care
511922|NCT01381627|Sedation|sedation
511923|NCT01381627|Bronchoscopy|bronchoscopy
511924|NCT01381627|Lung cancer|lung cancer
511925|NCT01381627|Mediastinal node|mediastinal node
511926|NCT01381627|Cancer staging|cancer staging
511927|NCT01381627|Anesthesia|anesthesia
511928|NCT01381627|Remote location|remote location
511929|NCT01381614|retrospective database analysis|retrospective database analysis
511930|NCT01381614|economic burden|economic burden
511931|NCT01381601|retrospective database analysis|retrospective database analysis
511932|NCT01381601|economic burden|economic burden
511933|NCT01381575|HPV infection|hpv infection
511934|NCT01381575|Human Papillomavirus|human papillomavirus
511935|NCT01381575|Cervical cancer|cervical cancer
511936|NCT01381575|HPV-16|hpv-16
511937|NCT01381575|HPV-18|hpv-18
511938|NCT01381575|vaccine|vaccine
511939|NCT01381562|intra-abdominal infection|intra-abdominal infection
511940|NCT01381562|belly|belly
511941|NCT01381562|Gram-negative pathogen|gram-negative pathogen
511942|NCT01381562|abscess|abscess
511943|NCT01381562|peritonitis|peritonitis
511944|NCT01381549|Gram-negative|gram-negative
511945|NCT01381549|uropathogens|uropathogens
511946|NCT01381549|complicated lower urinary tract infection|complicated lower urinary tract infection
511947|NCT01381549|pyelonephritis|pyelonephritis
511948|NCT01381536|Anti Blys Antibody|anti blys antibody
511949|NCT01381523|resource utilization|resource utilization
511950|NCT01381523|naproxen sodium|naproxen sodium
511951|NCT01381523|cost and cost analysis|cost and cost analysis
511952|NCT01381523|triptan|triptan
511953|NCT01381523|migraine|migraine
511954|NCT01381510|Benign prostatic hyperplasia|benign prostatic hyperplasia
511955|NCT01381510|Adherence|adherence
511956|NCT01381510|Acute urinary retention|acute urinary retention
511957|NCT01381510|Enlarged prostate|enlarged prostate
511958|NCT01381510|5-alpha reductase inhibitor|5-alpha reductase inhibitor
511959|NCT01381510|Surgery|surgery
511960|NCT01381510|Cost and cost analysis|cost and cost analysis
511961|NCT01381497|presenteeism|presenteeism
511962|NCT01381497|migraine disorders|migraine disorders
511963|NCT01381497|work productivity|work productivity
511964|NCT01381497|triptan|triptan
511965|NCT01381497|sumatriptan and naproxen sodium|sumatriptan and naproxen sodium
511966|NCT01381497|absenteeism|absenteeism
511967|NCT01381484|Periorbital wrinkles|periorbital wrinkles
511968|NCT01381484|Efficacy and safety|efficacy and safety
511969|NCT01381432|Antirejection|antirejection
511970|NCT01381419|pharmacokinetics|pharmacokinetics
511971|NCT01381419|safety|safety
511972|NCT01381419|positron emission tomography (PET)|positron emission tomography (pet)
511973|NCT01381419|single ascending dose|single ascending dose
511974|NCT01381393|osteoporosis|osteoporosis
511975|NCT01381393|ibandronate|ibandronate
511976|NCT01381380|myofascial pain|myofascial pain
511977|NCT01381380|trigger point injection|trigger point injection
511978|NCT01381380|manual therapy|manual therapy
511979|NCT01381367|Chronic obstructive pulmonary disease|chronic obstructive pulmonary disease
511980|NCT01381367|Inhaled corticosteroid|inhaled corticosteroid
511981|NCT01381367|Pneumococcal vaccine|pneumococcal vaccine
511982|NCT01381367|Acute exacerbation|acute exacerbation
511983|NCT01381367|High-dose daily inhaled corticosteroid usage|high-dose daily inhaled corticosteroid usage
511984|NCT01381367|Efficacy of the PPSV23 pneumococcal vaccine|efficacy of the ppsv23 pneumococcal vaccine
511985|NCT01381354|Secondary Progressive Multiple Sclerosis, primary progressive multiple sclerosis|secondary progressive multiple sclerosis, primary progressive multiple sclerosis
511986|NCT01381328|HIV-1 infected patients|hiv-1 infected patients
511987|NCT01381328|RALTEGRAVIR regimen|raltegravir regimen
511988|NCT01381328|genotypic evaluations|genotypic evaluations
511989|NCT01381328|phenotypic evaluations|phenotypic evaluations
511990|NCT01381315|Sentinel lymph node biopsy|sentinel lymph node biopsy
511991|NCT01381315|Axillary lymph node dissection|axillary lymph node dissection
511992|NCT01381315|Prevention of lymphedema|prevention of lymphedema
511993|NCT01381302|Severity of disease|severity of disease
511994|NCT01381276|Vitamin A|vitamin a
511995|NCT01381250|Pathological gambling according to DSM and having gambled at least once the past month.|pathological gambling according to dsm and having gambled at least once the past month.
511996|NCT01381250|Being atleast 18 years old|being atleast 18 years old
511998|NCT01381237|Postural|postural
511999|NCT01381237|Rehabilitation|rehabilitation
512000|NCT01381237|Therapy|therapy
512001|NCT01381237|computer-assisted|computer-assisted
512002|NCT01381237|Video Games|video games
512003|NCT01381237|Center of Pressure|center of pressure
512004|NCT01381224|low back pain|low back pain
512005|NCT01381224|lumbar|lumbar
512006|NCT01381224|injection|injection
512007|NCT01381224|lumbar pain|lumbar pain
512008|NCT01381211|Intermediate stage hepatocellular carcinoma|intermediate stage hepatocellular carcinoma
512009|NCT01381198|cerebral palsy|cerebral palsy
512010|NCT01381198|distal rectus femoris transfer|distal rectus femoris transfer
512011|NCT01381198|stiff knee gait pattern|stiff knee gait pattern
512012|NCT01381198|gait analysis|gait analysis
512013|NCT01381198|single event multilevel surgery|single event multilevel surgery
512014|NCT01381198|randomized trial|randomized trial
512015|NCT01381198|crouch gait|crouch gait
512016|NCT01381185|myocardial infarction|myocardial infarction
512017|NCT01381185|percutaneous coronary intervention (PCI)|percutaneous coronary intervention (pci)
512018|NCT01381185|high platelet reactivity (HPR)|high platelet reactivity (hpr)
512019|NCT01381172|Heart Failure|heart failure
512020|NCT01381172|Congestive Heart Failure|congestive heart failure
512021|NCT01381172|Chronic heart disease|chronic heart disease
512022|NCT01381172|Cardiac contractility modulation|cardiac contractility modulation
512023|NCT01381172|CCM|ccm
512024|NCT01381172|CHF|chf
512025|NCT01381159|Adherence|adherence
512026|NCT01381159|Asthma Control|asthma control
512027|NCT01381159|Asthma Quality Of Life|asthma quality of life
512028|NCT01381159|Motivational Communication|motivational communication
512029|NCT01381159|Motivational Interviewing|motivational interviewing
512030|NCT01381146|criminal behavior|criminal behavior
512031|NCT01381146|substance abuse|substance abuse
512032|NCT01381146|HIV risk behavior|hiv risk behavior
512033|NCT01381146|criminogenic thinking|criminogenic thinking
512034|NCT01381146|shame|shame
512035|NCT01381146|guilt|guilt
512036|NCT01381146|empathy|empathy
512037|NCT01381146|jail inmates|jail inmates
512038|NCT01381146|restorative justice|restorative justice
512039|NCT01381146|Crime|crime
512040|NCT01381133|Substance abuse|substance abuse
512041|NCT01381133|Adolescent outpatient treatment|adolescent outpatient treatment
512042|NCT01381133|Continuing care|continuing care
512043|NCT01381133|Outcomes|outcomes
512044|NCT01381120|Flank Pain|flank pain
512045|NCT01381120|Lower Urinary Tract Symptoms|lower urinary tract symptoms
512046|NCT01381120|LUTS|luts
512047|NCT01381120|Urgency|urgency
512048|NCT01381120|Nocturia|nocturia
512049|NCT01381120|Frequency|frequency
512050|NCT01381120|Ureteroscopy|ureteroscopy
512051|NCT01381120|Kidney Stones|kidney stones
512052|NCT01381120|Stent|stent
512053|NCT01381120|Incontinence|incontinence
512054|NCT01381120|VESIcare|vesicare
512055|NCT01381120|Ureter|ureter
512056|NCT01381120|Urinary Bladder, Overactive|urinary bladder, overactive
512057|NCT01381120|OAB|oab
512058|NCT01381120|Overactive Bladder Syndrome|overactive bladder syndrome
512059|NCT01381094|anemia|anemia
512060|NCT01381094|chronic kidney disease|chronic kidney disease
512061|NCT01381094|CKD|ckd
512062|NCT01381094|chronic renal insufficiency|chronic renal insufficiency
512063|NCT01381094|renal impairment|renal impairment
512064|NCT01381094|erythropoietin|erythropoietin
512065|NCT01381094|safety|safety
512066|NCT01381094|efficacy|efficacy
512067|NCT01381094|tolerability|tolerability
512068|NCT01381094|pharmacokinetics|pharmacokinetics
512069|NCT01381081|knee osteoarthritis|knee osteoarthritis
512070|NCT01381081|comparing platelet-rich plasma|comparing platelet-rich plasma
512071|NCT01381081|intra-articular knee injections|intra-articular knee injections
512072|NCT01381068|ventilation|ventilation
512073|NCT01381068|end tidal carbon dioxide|end tidal carbon dioxide
512074|NCT01381068|hypercapnia|hypercapnia
512075|NCT01381068|hypocapnia|hypocapnia
512076|NCT01381068|positive pressure ventilation|positive pressure ventilation
512077|NCT01381068|neonates|neonates
512078|NCT01381068|delivery room resuscitation|delivery room resuscitation
512079|NCT01381055|Cutaneous leishmaniasis|cutaneous leishmaniasis
512080|NCT01381055|Pentoxifylline|pentoxifylline
512081|NCT01381055|Meglumine antimoniate|meglumine antimoniate
512082|NCT01381055|L. braziliensis|l. braziliensis
512083|NCT01381042|Brown Adipose Tissue|brown adipose tissue
512084|NCT01381042|Incidence|incidence
512086|NCT01381042|Human|human
512087|NCT01381016|LH pulsatility|lh pulsatility
512088|NCT01381016|Obesity|obesity
512089|NCT01381016|Reproduction|reproduction
512090|NCT01381003|Chronic Granulomatous Disease|chronic granulomatous disease
512091|NCT01381003|Gene therapy|gene therapy
512092|NCT01381003|X-CGD|x-cgd
512093|NCT01381003|NADPH-oxidase|nadph-oxidase
512094|NCT01381003|gp91-phox|gp91-phox
512095|NCT01380977|crime|crime
512096|NCT01380977|substance abuse|substance abuse
512097|NCT01380977|HIV risk|hiv risk
512098|NCT01380977|criminogenic thinking|criminogenic thinking
512099|NCT01380977|shame|shame
512100|NCT01380977|guilt|guilt
512101|NCT01380977|restorative justice|restorative justice
512102|NCT01380977|victim impact group|victim impact group
512103|NCT01380964|Duchenne Muscular Dystrophy|duchenne muscular dystrophy
512104|NCT01380964|biomarkers|biomarkers
512105|NCT01380964|transcriptomics|transcriptomics
512106|NCT01380964|mironics|mironics
512107|NCT01380964|proteomics|proteomics
512108|NCT01380951|liver cirrhosis|liver cirrhosis
512109|NCT01380951|chronic hepatitis B|chronic hepatitis b
512110|NCT01380951|antiviral therapy|antiviral therapy
512111|NCT01380951|telbivudine|telbivudine
512112|NCT01380938|genotypes 2 and 3|genotypes 2 and 3
512113|NCT01380938|combination treatment|combination treatment
512114|NCT01380938|individualized treatment|individualized treatment
512115|NCT01380912|breast cancer|breast cancer
512116|NCT01380912|mastectomy|mastectomy
512117|NCT01380912|methylprednisoloneacetate|methylprednisoloneacetate
512118|NCT01380912|seroma|seroma
512119|NCT01380912|numbers of punctures|numbers of punctures
512120|NCT01380899|Parkinson Disease|parkinson disease
512121|NCT01380899|Parkinsonian Disorders|parkinsonian disorders
512122|NCT01380899|Lewy Bodies|lewy bodies
512123|NCT01380899|alpha-Synuclein|alpha-synuclein
512124|NCT01380860|mesh|mesh
512125|NCT01380860|hernia|hernia
512126|NCT01380847|Kidney Transplantation|kidney transplantation
512127|NCT01380847|Allograft|allograft
512128|NCT01380847|Kidney failure|kidney failure
512129|NCT01380847|Chronic allograft nephropathy|chronic allograft nephropathy
512130|NCT01380847|Monitoring|monitoring
512131|NCT01380847|Urine|urine
512132|NCT01380834|paravertebral nerve blocks|paravertebral nerve blocks
512133|NCT01380834|laparoscopic cholecystectomy|laparoscopic cholecystectomy
512134|NCT01380821|clinical indication for myocardial SPECT|clinical indication for myocardial spect
512135|NCT01380821|suspected or known coronary artery disease|suspected or known coronary artery disease
512136|NCT01380795|non-small cell lung cancer carcinoma|non-small cell lung cancer carcinoma
512137|NCT01380795|circulating tumor cells|circulating tumor cells
512138|NCT01380795|EGFR|egfr
512139|NCT01380795|K-ras|k-ras
512140|NCT01380782|brain tumor|brain tumor
512141|NCT01380782|recurrent disease|recurrent disease
512142|NCT01380756|Amgen|amgen
512143|NCT01380756|Phase 1|phase 1
512144|NCT01380756|Clinical Trial|clinical trial
512145|NCT01380756|Aurora kinase inhibitor|aurora kinase inhibitor
512146|NCT01380756|Open label|open label
512147|NCT01380756|Oncology|oncology
512148|NCT01380756|Hematology|hematology
512149|NCT01380743|Amicus Therapeutics|amicus therapeutics
512150|NCT01380743|duvoglustat|duvoglustat
512151|NCT01380743|AT2220|at2220
512152|NCT01380743|alpha-glucosidase|alpha-glucosidase
512153|NCT01380743|alglucosidase alfa|alglucosidase alfa
512154|NCT01380730|Hypercholesterolemia|hypercholesterolemia
512155|NCT01380730|Proprotein convertase subtilisin/kexin type 9 (PCSK9)|proprotein convertase subtilisin/kexin type 9 (pcsk9)
512156|NCT01380704|Depression|depression
512157|NCT01380678|bevacizumab|bevacizumab
512158|NCT01380678|pterygium|pterygium
512159|NCT01380678|treatment|treatment
512160|NCT01380678|elevation|elevation
512161|NCT01380665|Prevena|prevena
651322|NCT00823290|HCC|hcc
512162|NCT01380665|Incision|incision
512163|NCT01380665|Management|management
512164|NCT01380665|System|system
512165|NCT01380665|total|total
512166|NCT01380665|knee|knee
512167|NCT01380665|hip|hip
512168|NCT01380665|replacement|replacement
512169|NCT01380665|Surgery|surgery
512170|NCT01380665|Negative|negative
512171|NCT01380665|Pressure|pressure
512172|NCT01380665|dressing|dressing
512173|NCT01380665|KCI|kci
512174|NCT01380652|COPD III/IV|copd iii/iv
512175|NCT01380652|Activity Monitoring|activity monitoring
512176|NCT01380652|SenseWear|sensewear
512177|NCT01380652|Vibration training|vibration training
512178|NCT01380652|Galileo|galileo
512179|NCT01380652|Pulmonary rehabilitation|pulmonary rehabilitation
512180|NCT01380639|COPD III/IV|copd iii/iv
512181|NCT01380639|6-Minutes-Walking-Distance|6-minutes-walking-distance
512182|NCT01380639|Vibration training|vibration training
512183|NCT01380639|Galileo|galileo
512184|NCT01380639|Pulmonary rehabilitation|pulmonary rehabilitation
512185|NCT01380626|alpha-1-antitrypsin-deficiency|alpha-1-antitrypsin-deficiency
512186|NCT01380626|COPD|copd
512187|NCT01380626|exercise training|exercise training
512188|NCT01380626|muscle biopsy|muscle biopsy
512190|NCT01380613|depression|depression
512191|NCT01380613|drug use,|drug use,
512192|NCT01380613|risk reduction|risk reduction
512193|NCT01380600|Vaccinia|vaccinia
512194|NCT01380600|Vaccinia Virus|vaccinia virus
512195|NCT01380600|JX-594|jx-594
512196|NCT01380600|Jennerex|jennerex
512197|NCT01380600|Colorectal Carcinoma|colorectal carcinoma
512198|NCT01380600|Colorectal cancer|colorectal cancer
512199|NCT01380600|Colon Cancer|colon cancer
512200|NCT01380600|Rectal Cancer|rectal cancer
512201|NCT01380600|Pexa-Vec|pexa-vec
512202|NCT01380587|ALL|all
512203|NCT01380587|XCL1|xcl1
512204|NCT01380587|Cytokines|cytokines
512205|NCT01380587|Prognosis|prognosis
512206|NCT01380574|atrial fibrillation|atrial fibrillation
512207|NCT01380574|cardioversion|cardioversion
512208|NCT01380574|stroke|stroke
512209|NCT01380574|thromboembolism|thromboembolism
512210|NCT01380561|asimadoline|asimadoline
512211|NCT01380561|pharmacokinetic|pharmacokinetic
512212|NCT01380561|excretion of 14C-derived radioactivity|excretion of 14c-derived radioactivity
512213|NCT01380561|metabolite profile|metabolite profile
512214|NCT01380561|14C-asimadoline|14c-asimadoline
512215|NCT01380561|metabolites|metabolites
512216|NCT01380561|single and multiple oral doses|single and multiple oral doses
512217|NCT01380535|Extracorporeal photopheresis therapy|extracorporeal photopheresis therapy
512218|NCT01380535|Methoxsalen|methoxsalen
512219|NCT01380535|cGVHD|cgvhd
512220|NCT01380535|hematopoietic stem cell transplantation|hematopoietic stem cell transplantation
512221|NCT01380522|Bioequivalence, single-dose, fed|bioequivalence, single-dose, fed
512222|NCT01380509|Bioequivalence, single-dose, fasting|bioequivalence, single-dose, fasting
512223|NCT01380496|bioequivalence|bioequivalence
512224|NCT01380496|doxycycline monohydrate|doxycycline monohydrate
512225|NCT01380496|fed|fed
512226|NCT01380483|bioequivalence|bioequivalence
512227|NCT01380483|doxycycline monohydrate|doxycycline monohydrate
512228|NCT01380483|fasting|fasting
512229|NCT01380470|Chronic Obstructive Pulmonary Disease|chronic obstructive pulmonary disease
512230|NCT01380470|Diagnosis differential|diagnosis differential
512231|NCT01380470|Dyspnea/classification|dyspnea/classification
512232|NCT01380470|Dyspnea/etiology|dyspnea/etiology
512233|NCT01380457|bioequivalence|bioequivalence
512234|NCT01380457|dronabinol|dronabinol
512235|NCT01380457|fasting|fasting
512236|NCT01380444|Intertrochanteric fracture|intertrochanteric fracture
512237|NCT01380444|Gamma3 intramedullary nail|gamma3 intramedullary nail
512238|NCT01380444|Sliding hip screw|sliding hip screw
512239|NCT01380431|bioequivalence, lisinopril, fed|bioequivalence, lisinopril, fed
512240|NCT01380418|Obesity|obesity
512241|NCT01380405|Inhalators|inhalators
512242|NCT01380405|Education|education
512243|NCT01380405|Primary care|primary care
512244|NCT01380392|Liver cancer|liver cancer
512245|NCT01380392|Uncertainty|uncertainty
512246|NCT01380392|Personality|personality
512247|NCT01380392|coping strategies|coping strategies
512248|NCT01380379|physical violence|physical violence
512249|NCT01380379|sexual violence|sexual violence
512250|NCT01380366|Malabsorption|malabsorption
512251|NCT01380353|Women undergoing total mastectomy|women undergoing total mastectomy
512252|NCT01380353|Breast cancer prevention|breast cancer prevention
512253|NCT01380340|Seniors|seniors
512254|NCT01380340|Driving|driving
512255|NCT01380340|Group work|group work
512256|NCT01380327|cockroach|cockroach
512257|NCT01380327|immunotherapy|immunotherapy
512258|NCT01380327|sublingual immunotherapy (SLIT)|sublingual immunotherapy (slit)
512259|NCT01380327|inner city asthma|inner city asthma
512260|NCT01380314|leishmaniasis|leishmaniasis
512261|NCT01380314|cutaneois leishmaniasis|cutaneois leishmaniasis
512262|NCT01380314|miltefosine|miltefosine
512263|NCT01380314|oral therapy|oral therapy
512264|NCT01380314|treatment|treatment
512265|NCT01380314|imiquimod|imiquimod
512266|NCT01380301|Leishmaniasis|leishmaniasis
512267|NCT01380301|Miltefosine|miltefosine
512268|NCT01380301|Antimony|antimony
512269|NCT01380301|Therapy|therapy
512270|NCT01380288|Alzheimer's disease|alzheimer's disease
512271|NCT01380288|rivastigmine patch|rivastigmine patch
512272|NCT01380288|white matter change|white matter change
512273|NCT01380275|recurrent, refractory, bone, soft tissue, sarcomas|recurrent, refractory, bone, soft tissue, sarcomas
512274|NCT01380262|Colorectal Cancer|colorectal cancer
512275|NCT01380262|Skin Rash|skin rash
512276|NCT01380262|Pre-emptive treatment|pre-emptive treatment
512277|NCT01380262|Doxycycline|doxycycline
512278|NCT01380262|Anti-EGFR antibody|anti-egfr antibody
512279|NCT01380262|Cetuximab|cetuximab
512280|NCT01380262|Panitumumab|panitumumab
512281|NCT01380249|Phase I|phase i
512282|NCT01380249|Phase I multiple doses|phase i multiple doses
512283|NCT01380249|PDM08|pdm08
512284|NCT01380249|Cancer Treatment|cancer treatment
512285|NCT01380249|Pharmacokinetics and Pharmacodynamics|pharmacokinetics and pharmacodynamics
512286|NCT01380249|Advanced Solid Tumors|advanced solid tumors
512287|NCT01380249|Prodimed|prodimed
512288|NCT01380210|Carbon dioxide intoxication|carbon dioxide intoxication
512289|NCT01380210|Diffusion weighted images(DWI)|diffusion weighted images(dwi)
512290|NCT01380197|pain|pain
512291|NCT01380197|sickle cell|sickle cell
512292|NCT01380197|nubain|nubain
512293|NCT01380197|morphine|morphine
512294|NCT01380197|acute chest|acute chest
512295|NCT01380197|side effects|side effects
512296|NCT01380184|Relapsed cancer|relapsed cancer
512297|NCT01380158|pessary|pessary
512298|NCT01380158|preterm birth|preterm birth
512299|NCT01380158|short cervix|short cervix
512300|NCT01380158|cervical incompetence|cervical incompetence
512301|NCT01380145|multiple myeloma|multiple myeloma
512302|NCT01380145|MAGE-A3|mage-a3
512303|NCT01380145|autologous stem cell transplant|autologous stem cell transplant
512304|NCT01380132|Fecal incontinence|fecal incontinence
512305|NCT01380132|Treatment|treatment
512306|NCT01380132|Surgery|surgery
512307|NCT01380119|sputum conversion|sputum conversion
512308|NCT01380119|liver biochemistry|liver biochemistry
512309|NCT01380119|weight loss|weight loss
512310|NCT01380119|quality of life|quality of life
512311|NCT01380106|Multiple myeloma|multiple myeloma
512312|NCT01380106|Relapsed|relapsed
512313|NCT01380106|Revlimid|revlimid
512314|NCT01380093|abuse potential|abuse potential
512315|NCT01380093|abuse liability|abuse liability
512316|NCT01380093|recreational opioid use|recreational opioid use
512317|NCT01380093|morphine|morphine
512318|NCT01380067|Inguinal hernia|inguinal hernia
512319|NCT01380067|Lateral umbilicus ligament|lateral umbilicus ligament
512320|NCT01380067|Recurrence|recurrence
512321|NCT01380054|Pulmonary Hypertension|pulmonary hypertension
512322|NCT01380054|Quality of life|quality of life
512323|NCT01380054|Coping|coping
512324|NCT01380054|Depression|depression
512325|NCT01380054|Anxiety|anxiety
512326|NCT01380054|Social support|social support
512327|NCT01380054|Control beliefs|control beliefs
512328|NCT01380041|Multiple sclerosisCerebrospinal fluidBiomarkerCytokineArray|multiple sclerosiscerebrospinal fluidbiomarkercytokinearray
512329|NCT01380028|chronic subdural hematomas|chronic subdural hematomas
512330|NCT01380028|corticosteroid|corticosteroid
512331|NCT01380028|treatment|treatment
512332|NCT01380028|neurosurgery|neurosurgery
512333|NCT01380028|recurrence, adjuvant|recurrence, adjuvant
512334|NCT01380015|osteoarthritis|osteoarthritis
512335|NCT01380015|spearmint|spearmint
512336|NCT01380015|rosmarinic acid|rosmarinic acid
512337|NCT01380002|care needs|care needs
512338|NCT01379976|lung|lung
512339|NCT01379976|cancer|cancer
512340|NCT01379976|non small cell lung cancer|non small cell lung cancer
512341|NCT01379976|Advanced or metastatic non small cell lung cancer|advanced or metastatic non small cell lung cancer
512342|NCT01379937|influenza|influenza
512343|NCT01379937|H5N1|h5n1
512344|NCT01379937|vaccine|vaccine
512345|NCT01379937|children|children
512346|NCT01379911|Satiety|satiety
512347|NCT01379911|Food intake|food intake
512348|NCT01379911|Yogurt|yogurt
512349|NCT01379898|Pheochromocytoma|pheochromocytoma
512350|NCT01379898|Doxazosin|doxazosin
512351|NCT01379898|Phenoxybenzamine|phenoxybenzamine
512352|NCT01379885|Pain|pain
512353|NCT01379885|immunization|immunization
512354|NCT01379885|distraction|distraction
512355|NCT01379885|hypnosis|hypnosis
512356|NCT01379885|injections|injections
512357|NCT01379885|anxiety|anxiety
512358|NCT01379872|Prostate|prostate
512359|NCT01379872|Head and Neck|head and neck
512360|NCT01379872|Anal|anal
512361|NCT01379846|Immunostimulation|immunostimulation
512362|NCT01379846|Haemophilus b conjugate vaccine|haemophilus b conjugate vaccine
512364|NCT01379833|Chronic Inflammatory Demyelinating Polyneuropathy|chronic inflammatory demyelinating polyneuropathy
512365|NCT01379833|Neurotrophic corneal ulcer|neurotrophic corneal ulcer
512366|NCT01379820|NEONATAL RESPIRATORY FAILURE|neonatal respiratory failure
512367|NCT01379820|OROTRACHEAL cpap|orotracheal cpap
512368|NCT01379820|NASAL cpap|nasal cpap
512369|NCT01379820|MECHANICAL VENTILATION|mechanical ventilation
512370|NCT01379820|PNEUMOTHORAX|pneumothorax
512371|NCT01379820|COMPENSATION BAG|compensation bag
512372|NCT01379781|prevention|prevention
512373|NCT01379781|postpartum depression|postpartum depression
512374|NCT01379755|stability|stability
512375|NCT01379755|single-radius|single-radius
512376|NCT01379755|multi-radius|multi-radius
512377|NCT01379755|total knee arthroplasty|total knee arthroplasty
512378|NCT01379742|prostate cancer|prostate cancer
512379|NCT01379742|prostate brachytherapy|prostate brachytherapy
512380|NCT01379729|Type 1 Diabetes|type 1 diabetes
512381|NCT01379729|Transplantation|transplantation
512382|NCT01379729|Beta Cells|beta cells
512383|NCT01379729|Encapsulation|encapsulation
512384|NCT01379703|HIV-1 infected patients|hiv-1 infected patients
512385|NCT01379703|Protease inhibitor|protease inhibitor
512386|NCT01379703|Kaletra®|kaletra®
512387|NCT01379690|HbA1c|hba1c
512388|NCT01379677|Coronary Artery Disease|coronary artery disease
512389|NCT01379677|Myocardial perfusion imaging|myocardial perfusion imaging
512390|NCT01379677|Rubidium|rubidium
512391|NCT01379677|Technetium|technetium
512392|NCT01379664|Sevoflurane|sevoflurane
512393|NCT01379664|Isoflurane|isoflurane
512394|NCT01379664|volatile anesthetic|volatile anesthetic
512395|NCT01379664|duration of hospitalization|duration of hospitalization
512396|NCT01379651|Egg allergy,specific oral tolerance induction|egg allergy,specific oral tolerance induction
512397|NCT01379638|cardiopulmonary bypass|cardiopulmonary bypass
512398|NCT01379638|cardiac output|cardiac output
512399|NCT01379638|flow rate|flow rate
512400|NCT01379638|lactate|lactate
512401|NCT01379625|fatty acid oxidation|fatty acid oxidation
512402|NCT01379625|triheptanoin|triheptanoin
512403|NCT01379625|long-chain fatty acid oxidation disorders|long-chain fatty acid oxidation disorders
512404|NCT01379625|LCHADD|lchadd
512405|NCT01379625|VLCADD|vlcadd
512406|NCT01379625|CPT2|cpt2
512407|NCT01379625|TFP|tfp
512408|NCT01379612|Ultrasound elastography|ultrasound elastography
512409|NCT01379612|Rectal cancer|rectal cancer
512410|NCT01379612|Preoperative chemoradiation|preoperative chemoradiation
512411|NCT01379599|cocaine|cocaine
512412|NCT01379599|heroin|heroin
512413|NCT01379599|STIs|stis
512414|NCT01379599|HIV|hiv
512415|NCT01379599|brief motivational intervention|brief motivational intervention
512416|NCT01379599|voluntary testing and counseling|voluntary testing and counseling
512417|NCT01379586|ONO-4053|ono-4053
512418|NCT01379586|Healthy adult subjects|healthy adult subjects
512419|NCT01379586|First time in humans|first time in humans
512420|NCT01379573|hydroxychloroquine|hydroxychloroquine
512421|NCT01379573|Plaquenil|plaquenil
512422|NCT01379573|congenital heart block|congenital heart block
512423|NCT01379573|neonatal lupus|neonatal lupus
512424|NCT01379573|systemic lupus erythematosus|systemic lupus erythematosus
512425|NCT01379573|Sjogren's syndrome|sjogren's syndrome
512426|NCT01379573|autoantibodies|autoantibodies
512427|NCT01379573|SSA/Ro|ssa/ro
512428|NCT01379573|SSB/La|ssb/la
512429|NCT01379573|autoimmunity|autoimmunity
512430|NCT01379573|pregnancy|pregnancy
512431|NCT01379573|immunoglobulin|immunoglobulin
512432|NCT01379547|Procalcitonin|procalcitonin
512433|NCT01379547|sepsis|sepsis
512434|NCT01379547|ICU|icu
512435|NCT01379547|antibiotic|antibiotic
512436|NCT01379547|antibiotic duration|antibiotic duration
512437|NCT01379547|Antibiotic treatment duration|antibiotic treatment duration
512438|NCT01379534|Solid tumors,|solid tumors,
512439|NCT01379534|advanced endometrial cancer,|advanced endometrial cancer,
512440|NCT01379534|Endometrial Cancer,|endometrial cancer,
512441|NCT01379534|Second-line treatment,|second-line treatment,
512442|NCT01379534|VEGF,|vegf,
512443|NCT01379534|Neoplasms,|neoplasms,
512444|NCT01379534|Endometrial Neoplasms,|endometrial neoplasms,
512445|NCT01379534|Uterine Neoplasms,|uterine neoplasms,
512446|NCT01379534|Female Genital Neoplasms,|female genital neoplasms,
512447|NCT01379534|Cancer,|cancer,
512448|NCT01379534|Carcinoma,|carcinoma,
512449|NCT01379534|Uterine Diseases,|uterine diseases,
512450|NCT01379534|Female Genital Diseases,|female genital diseases,
512451|NCT01379534|Tumors,|tumors,
512452|NCT01379534|Oral Administration,|oral administration,
512453|NCT01379534|Capsules,|capsules,
512454|NCT01379534|Tablets,|tablets,
512455|NCT01379534|CHIR258,|chir258,
512456|NCT01379534|CHIR-258,|chir-258,
512457|NCT01379534|CHIR 258,|chir 258,
512458|NCT01379534|TKI258,|tki258,
512459|NCT01379534|TKI-258,|tki-258,
512460|NCT01379534|TKI 258|tki 258
512461|NCT01379521|Localised|localised
512462|NCT01379521|unresectable|unresectable
512463|NCT01379521|chemoembolization|chemoembolization
512464|NCT01379495|burns|burns
512465|NCT01379495|rehabilitation|rehabilitation
512466|NCT01379482|Peritoneal carcinomatosis from gastric cancer|peritoneal carcinomatosis from gastric cancer
512467|NCT01379469|Carbamazepine (Tegretol) use|carbamazepine (tegretol) use
512468|NCT01379469|severe liver disease|severe liver disease
512469|NCT01379469|alpha-1-antitrypsin deficiency|alpha-1-antitrypsin deficiency
512470|NCT01379443|Children|children
512471|NCT01379443|Rehabilitation|rehabilitation
512472|NCT01379443|Family Functioning|family functioning
512473|NCT01379443|Mental Health|mental health
512474|NCT01379443|Costs|costs
512475|NCT01379443|Integration|integration
512476|NCT01379430|Vaccine|vaccine
512477|NCT01379430|Immune response|immune response
512478|NCT01379417|Prematurity|prematurity
512479|NCT01379417|Nutrition|nutrition
512480|NCT01379417|Growth|growth
512481|NCT01379404|sepsis, fluid status, BIA, CVP|sepsis, fluid status, bia, cvp
512482|NCT01379391|Allogeneic Hematopoietic Stem Cell Transplantation|allogeneic hematopoietic stem cell transplantation
512483|NCT01379391|Platelet Engraftment|platelet engraftment
512484|NCT01379391|TPO|tpo
512485|NCT01379365|wrinkle rhytid aging|wrinkle rhytid aging
512486|NCT01379352|liver transplantation|liver transplantation
512487|NCT01379352|vecuronium|vecuronium
512488|NCT01379339|Cabazitaxel|cabazitaxel
512693|NCT01378572|mapping|mapping
512489|NCT01379339|Cabazitaxel and Cisplatin|cabazitaxel and cisplatin
512490|NCT01379339|Phase I|phase i
512491|NCT01379339|PF Induction Chemotherapy|pf induction chemotherapy
512492|NCT01379339|Squamous Cell Carcinoma|squamous cell carcinoma
512493|NCT01379339|Head and Neck|head and neck
512494|NCT01379339|Sanofi-Aventis Oncology|sanofi-aventis oncology
512495|NCT01379339|Locally Advanced|locally advanced
512496|NCT01379313|laparoscopic gynecologic surgery|laparoscopic gynecologic surgery
512497|NCT01379313|gas exchange|gas exchange
512498|NCT01379313|inspiratory time|inspiratory time
512499|NCT01379313|expiratory time|expiratory time
512500|NCT01379313|I:E ratio|i:e ratio
512501|NCT01379300|Hemophilia B|hemophilia b
512502|NCT01379287|Iso-Fludelone|iso-fludelone
512503|NCT01379287|KOS-1803|kos-1803
512504|NCT01379287|Dose-Escalation|dose-escalation
512505|NCT01379287|10-202|10-202
512506|NCT01379274|MDS|mds
512507|NCT01379274|Low risk disease|low risk disease
512508|NCT01379274|IPSS|ipss
512509|NCT01379261|STEMI|stemi
512510|NCT01379261|primary PCI|primary pci
512511|NCT01379261|Hypothermia|hypothermia
512512|NCT01379261|Endovascular cooling|endovascular cooling
512513|NCT01379261|Cardiac MRI|cardiac mri
512514|NCT01379235|independent 65 years old and above|independent 65 years old and above
512516|NCT01379222|Abdominal Aortic Aneurysm|abdominal aortic aneurysm
512517|NCT01379222|EVAR|evar
512518|NCT01379222|Endovascular aneurysm repair|endovascular aneurysm repair
512519|NCT01379209|AHSCT|ahsct
512520|NCT01379209|Bone Marrow Transplant|bone marrow transplant
512521|NCT01379209|Leukemia|leukemia
512522|NCT01379209|myelodysplastic syndrome|myelodysplastic syndrome
512523|NCT01379209|hematological malignancies|hematological malignancies
512524|NCT01379209|Graft-versus-host-disease|graft-versus-host-disease
512525|NCT01379209|GvHD|gvhd
512526|NCT01379209|Hematopoietic Stem Cell Transplantation|hematopoietic stem cell transplantation
512527|NCT01379209|Stem Cell|stem cell
512528|NCT01379209|Transplantation|transplantation
512529|NCT01379196|Graves Orbitopathy|graves orbitopathy
512530|NCT01379196|Macrolide antibiotics|macrolide antibiotics
512531|NCT01379196|Inflammation|inflammation
512532|NCT01379196|Clinical Activity Score|clinical activity score
512533|NCT01379183|Healthy|healthy
512534|NCT01379183|Men|men
512535|NCT01379183|Women|women
512536|NCT01379183|No known gastrointestinal disease|no known gastrointestinal disease
512537|NCT01379183|Aged between 18-70 years|aged between 18-70 years
512538|NCT01379170|brown adipose tissue|brown adipose tissue
512539|NCT01379170|mitochondrial dysfunction|mitochondrial dysfunction
512540|NCT01379170|insulin resistance|insulin resistance
512541|NCT01379157|Patients with ventilator-associated pneumonia|patients with ventilator-associated pneumonia
512542|NCT01379131|Manifestation|manifestation
512543|NCT01379131|Coronary Heart Disease|coronary heart disease
512544|NCT01379131|Myocardial infarction|myocardial infarction
512545|NCT01379131|Angina pectoris|angina pectoris
512546|NCT01379131|Unheralded|unheralded
512547|NCT01379131|General Practice Research Database|general practice research database
512548|NCT01379131|Myocardial Ischaemia National Audit Project|myocardial ischaemia national audit project
512549|NCT01379131|CALIBER|caliber
512550|NCT01379118|Total knee replacement|total knee replacement
512551|NCT01379105|Electromyography|electromyography
512552|NCT01379105|Muscle Stretching Exercises|muscle stretching exercises
512553|NCT01379105|Neuromuscular agents|neuromuscular agents
512554|NCT01379105|Sedentary Lifestyle|sedentary lifestyle
512555|NCT01379092|Radiography|radiography
512556|NCT01379092|Breast Specimen Imaging|breast specimen imaging
512557|NCT01379066|Mycobacterium tuberculosis|mycobacterium tuberculosis
512558|NCT01379066|Pulmonary tuberculosis|pulmonary tuberculosis
512559|NCT01379066|Electronic nose|electronic nose
512560|NCT01379066|Gas chromatography|gas chromatography
512561|NCT01379053|Staphylococcus aureus|staphylococcus aureus
512562|NCT01379053|Methicillin-resistant staphylococcus aureus|methicillin-resistant staphylococcus aureus
512563|NCT01379053|Nosocomial disease|nosocomial disease
512564|NCT01379053|Electronic nose|electronic nose
512565|NCT01379053|Gas chromatography|gas chromatography
512566|NCT01379040|Cystic Fibrosis|cystic fibrosis
512567|NCT01379040|Pseudomonas aeruginosa|pseudomonas aeruginosa
512568|NCT01379040|Volatile Organic Compounds|volatile organic compounds
512569|NCT01379040|Electronic nose|electronic nose
512570|NCT01379040|Gas Chromatography|gas chromatography
512571|NCT01379027|Depression|depression
512572|NCT01379027|Website intervention|website intervention
512573|NCT01379027|CBT|cbt
512574|NCT01379014|Decisional conflict|decisional conflict
512575|NCT01379014|Disclosure|disclosure
512576|NCT01379014|Mental Health history|mental health history
512577|NCT01379014|Mental health service users|mental health service users
512578|NCT01379014|Decision Aid Tool|decision aid tool
512579|NCT01379014|Vocational Specialists|vocational specialists
512580|NCT01379001|cholinergic function|cholinergic function
512581|NCT01379001|aging|aging
512582|NCT01379001|pharmacologic MRI|pharmacologic mri
512583|NCT01378949|pain score|pain score
512584|NCT01378936|criminal behavior|criminal behavior
512585|NCT01378936|substance abuse|substance abuse
512586|NCT01378936|HIV risk behavior|hiv risk behavior
512587|NCT01378936|criminogenic thinking|criminogenic thinking
512588|NCT01378936|shame|shame
512589|NCT01378936|guilt|guilt
512590|NCT01378936|empathy|empathy
512591|NCT01378936|jail inmates|jail inmates
512592|NCT01378936|restorative justice|restorative justice
512593|NCT01378936|crime|crime
512594|NCT01378923|Mindfulness|mindfulness
512595|NCT01378923|Values|values
512596|NCT01378923|Jail Inmates|jail inmates
512597|NCT01378923|Impulsivity|impulsivity
512598|NCT01378923|Substance Abuse|substance abuse
512599|NCT01378923|HIV risk behavior|hiv risk behavior
512600|NCT01378923|Anxiety|anxiety
512601|NCT01378923|Depression|depression
512602|NCT01378923|Criminogenic Thinking|criminogenic thinking
512603|NCT01378910|HIV|hiv
512604|NCT01378910|TROPISM|tropism
512605|NCT01378910|PBMC|pbmc
512606|NCT01378910|GENOTYPE|genotype
512607|NCT01378910|454 SEQUENCING|454 sequencing
512608|NCT01378897|bariatric surgery|bariatric surgery
512609|NCT01378897|gastric bypass surgery|gastric bypass surgery
512610|NCT01378884|Gastroparesis|gastroparesis
512611|NCT01378884|Domperidone|domperidone
512612|NCT01378884|Motilium|motilium
512613|NCT01378871|T Cell|t cell
512614|NCT01378871|T-Cell|t-cell
512615|NCT01378871|Leukemia|leukemia
512616|NCT01378871|Lymphoma|lymphoma
512617|NCT01378871|Leukemia/Lymphoma|leukemia/lymphoma
512618|NCT01378871|ATL|atl
512619|NCT01378858|Smoking|smoking
512620|NCT01378858|Substance-Related Disorders|substance-related disorders
512621|NCT01378858|medication adherence|medication adherence
512622|NCT01378858|Methadone|methadone
512623|NCT01378845|Morbus Raynaud|morbus raynaud
512624|NCT01378845|Ulcera Hands, Toes|ulcera hands, toes
512625|NCT01378845|Vasospastic disorder|vasospastic disorder
512626|NCT01378845|Raynaud's phenomenon|raynaud's phenomenon
512627|NCT01378832|Intra-abdominal abscess|intra-abdominal abscess
512628|NCT01378832|wound infection|wound infection
512629|NCT01378832|colorectal surgery|colorectal surgery
512630|NCT01378819|laparoscopic cholecystectomy|laparoscopic cholecystectomy
512631|NCT01378819|Postoperative pain|postoperative pain
512632|NCT01378806|overweight|overweight
512633|NCT01378806|obesity|obesity
512634|NCT01378806|adults|adults
512635|NCT01378806|children|children
512636|NCT01378793|Acupressure|acupressure
512637|NCT01378793|Insomnia|insomnia
512638|NCT01378793|Sleep Disorders|sleep disorders
512639|NCT01378780|Stroke|stroke
512640|NCT01378780|hypertension|hypertension
512641|NCT01378780|diet|diet
512642|NCT01378780|sodium|sodium
512643|NCT01378780|physical activity|physical activity
512644|NCT01378767|Dietary restriction|dietary restriction
512645|NCT01378767|oxidative stress|oxidative stress
512646|NCT01378767|fasting|fasting
512647|NCT01378754|hydrodilation|hydrodilation
512648|NCT01378754|general anesthetic|general anesthetic
512649|NCT01378741|delirium|delirium
512650|NCT01378741|cardiac surgery|cardiac surgery
512651|NCT01378741|postoperative sedation|postoperative sedation
512652|NCT01378728|Optical imaging|optical imaging
512653|NCT01378728|Fluorescence imaging|fluorescence imaging
512654|NCT01378728|Chronic and acute wounds|chronic and acute wounds
512655|NCT01378728|Wound bacteria|wound bacteria
512656|NCT01378728|Bacterial biofilms|bacterial biofilms
512657|NCT01378728|Pathogenic bacteria|pathogenic bacteria
512658|NCT01378728|Microorganisms|microorganisms
512659|NCT01378728|Wound infection|wound infection
512660|NCT01378728|Wound healing|wound healing
512661|NCT01378728|Treatment response assessment|treatment response assessment
512662|NCT01378715|coronary artery disease|coronary artery disease
512663|NCT01378715|percutaneous coronary intervention|percutaneous coronary intervention
512664|NCT01378715|statins|statins
512665|NCT01378715|periprocedural myocardial infarction|periprocedural myocardial infarction
512666|NCT01378702|Mistletoe|mistletoe
512667|NCT01378702|Anthroposophical medicine|anthroposophical medicine
512668|NCT01378663|Congenital cardiac surgery|congenital cardiac surgery
512669|NCT01378663|Postoperative pain management|postoperative pain management
512670|NCT01378650|Tinnitus|tinnitus
512671|NCT01378650|Medication therapy management|medication therapy management
512672|NCT01378650|Cilostazol|cilostazol
512673|NCT01378650|Antiplatelet agents|antiplatelet agents
512674|NCT01378637|Leg|leg
512675|NCT01378637|Robotic device|robotic device
512676|NCT01378637|AMES|ames
512677|NCT01378637|Stroke|stroke
512678|NCT01378637|Cerebrovascular Accident|cerebrovascular accident
512679|NCT01378637|Rehabilitation|rehabilitation
512680|NCT01378611|intractable childhood epilepsy|intractable childhood epilepsy
512681|NCT01378611|VNS|vns
512682|NCT01378611|immune system|immune system
512683|NCT01378598|erlotinib|erlotinib
512684|NCT01378598|educational intervention|educational intervention
512685|NCT01378598|direct care nurse|direct care nurse
512686|NCT01378585|DLBS1033|dlbs1033
512687|NCT01378585|safety|safety
512688|NCT01378585|fibrinolytic|fibrinolytic
512689|NCT01378585|fibrinogenolytic|fibrinogenolytic
512690|NCT01378585|antiplatelet|antiplatelet
512691|NCT01378572|ICD|icd
512692|NCT01378572|sudden cardiac death|sudden cardiac death
512694|NCT01378559|Penis prosthesis|penis prosthesis
512695|NCT01378559|Titan|titan
512696|NCT01378559|Satisfaction|satisfaction
512697|NCT01378559|Complications|complications
512698|NCT01378533|triple-negative breast cancer|triple-negative breast cancer
512699|NCT01378533|dose-dense|dose-dense
512700|NCT01378533|epirubicin and cyclophosphamide followed by paclitaxel（AC-T）|epirubicin and cyclophosphamide followed by paclitaxel（ac-t）
512701|NCT01378533|paclitaxel plus carboplatin（PC）|paclitaxel plus carboplatin（pc）
512702|NCT01378533|3 years DFS|3 years dfs
512703|NCT01378533|the tolerance|the tolerance
512704|NCT01378520|breathlessness|breathlessness
512705|NCT01378520|resistive load breathing|resistive load breathing
512706|NCT01378520|beta-endorphins|beta-endorphins
512707|NCT01378507|endoscopic submucosal dissection|endoscopic submucosal dissection
512708|NCT01378507|gastrointestinal neoplasm|gastrointestinal neoplasm
512709|NCT01378494|osteoporosis|osteoporosis
512710|NCT01378494|bone|bone
512711|NCT01378494|HIV|hiv
512712|NCT01378494|antiretrovirals|antiretrovirals
512713|NCT01378494|inflammation|inflammation
512714|NCT01378455|handwriting|handwriting
512715|NCT01378455|cerebral palsy|cerebral palsy
512716|NCT01378455|visual perception|visual perception
512717|NCT01378455|sensory function|sensory function
512718|NCT01378455|motor function|motor function
512719|NCT01378455|computerized handwriting programs|computerized handwriting programs
512720|NCT01378442|Cerebral palsy|cerebral palsy
512721|NCT01378442|bone density|bone density
512722|NCT01378442|bone strength|bone strength
512723|NCT01378429|Perennial Allergic Rhinitis|perennial allergic rhinitis
512724|NCT01378429|PAR|par
512725|NCT01378416|Acute myelogenous leukemia|acute myelogenous leukemia
512726|NCT01378416|myelodysplastic Syndrome|myelodysplastic syndrome
512727|NCT01378416|cancer|cancer
512728|NCT01378403|Schizophrenia|schizophrenia
512729|NCT01378403|Cognitive deficites|cognitive deficites
512730|NCT01378403|Degraded objects|degraded objects
512731|NCT01378403|Magnocellular pathway|magnocellular pathway
512732|NCT01378390|Complex perianal fistula|complex perianal fistula
512733|NCT01378390|Crohn disease|crohn disease
512734|NCT01378390|Adipose-derived stem cells|adipose-derived stem cells
512735|NCT01378390|Liposuction|liposuction
512736|NCT01378377|MEK inhibitor|mek inhibitor
512737|NCT01378377|Temsirolimus|temsirolimus
512738|NCT01378377|Neoplasms|neoplasms
512739|NCT01378377|Phase I|phase i
512740|NCT01378377|Pimasertib|pimasertib
512741|NCT01378338|GERD|gerd
512742|NCT01378338|Comparison between ERD and NERD|comparison between erd and nerd
512743|NCT01378338|Rate of complete resolution|rate of complete resolution
512744|NCT01378338|rate of recurrence|rate of recurrence
512745|NCT01378338|QOL|qol
512746|NCT01378338|To investigate the frequency and related risk factors of recurrence, and quality of life in patients with GERD after treatment with PPI|to investigate the frequency and related risk factors of recurrence, and quality of life in patients with gerd after treatment with ppi
512747|NCT01378338|The aim of this study is to investigate the frequency and related risk factors of recurrence, and quality of life in patients with GERD after treatment with PPI|the aim of this study is to investigate the frequency and related risk factors of recurrence, and quality of life in patients with gerd after treatment with ppi
512748|NCT01378325|spinal|spinal
512749|NCT01378325|cesarean delivery|cesarean delivery
512750|NCT01378325|phenylephrine|phenylephrine
512751|NCT01378325|hypotension|hypotension
512752|NCT01378312|vaccine|vaccine
512753|NCT01378312|TB|tb
512754|NCT01378312|tuberculosis|tuberculosis
512755|NCT01378299|testosterone|testosterone
512756|NCT01378273|neuroprotection|neuroprotection
512757|NCT01378273|erythropoietin|erythropoietin
512758|NCT01378273|Epo|epo
512759|NCT01378273|ELGANs|elgans
512760|NCT01378273|preterm|preterm
512761|NCT01378273|neonate|neonate
512762|NCT01378260|Peripheral Arterial Disease|peripheral arterial disease
512763|NCT01378260|Claudication|claudication
512764|NCT01378260|Comparative Effectiveness Research|comparative effectiveness research
512765|NCT01378260|PAD Study|pad study
512766|NCT01378260|PAD|pad
512767|NCT01378260|atherosclerosis|atherosclerosis
512768|NCT01378260|Intermittent claudication|intermittent claudication
512769|NCT01378260|leg pain|leg pain
512770|NCT01378247|Heart Failure|heart failure
512771|NCT01378247|Family Nursing|family nursing
512772|NCT01378247|Health-Related Quality of Life|health-related quality of life
512773|NCT01378247|Heart Failure Clinic|heart failure clinic
512774|NCT01378221|vitamin D|vitamin d
512775|NCT01378221|cardiac surgery|cardiac surgery
512776|NCT01378221|inflammation|inflammation
512777|NCT01378221|immune system|immune system
512778|NCT01378221|age|age
512779|NCT01378208|Intermittent fasting|intermittent fasting
512780|NCT01378208|Meal frequency|meal frequency
512781|NCT01378208|body composition|body composition
512782|NCT01378208|cognitive function|cognitive function
512783|NCT01378208|glucose metabolism|glucose metabolism
512784|NCT01378195|Alzheimer's Disease|alzheimer's disease
512785|NCT01378195|Dementia|dementia
512786|NCT01378195|caregiving|caregiving
512787|NCT01378195|caregiver|caregiver
512788|NCT01378195|coping|coping
512789|NCT01378195|coping with caregiving|coping with caregiving
512790|NCT01378195|stress|stress
512791|NCT01378182|Transplantation,Stem Cell|transplantation,stem cell
512792|NCT01378182|Wilson's Disease|wilson's disease
512793|NCT01378169|SIRS|sirs
512794|NCT01378169|Sepsis|sepsis
512795|NCT01378169|Severe Sepsis|severe sepsis
512796|NCT01378169|Septic Shock|septic shock
512797|NCT01378169|Inflammatory processes|inflammatory processes
512798|NCT01378169|Cytokines|cytokines
512799|NCT01378169|HLA-DR|hla-dr
512800|NCT01378169|HLA type II|hla type ii
512801|NCT01378169|Chemokines|chemokines
512802|NCT01378169|TLR expression|tlr expression
512803|NCT01378169|mRNA expression in whole blood|mrna expression in whole blood
512804|NCT01378169|Bacterial DNA detection|bacterial dna detection
512805|NCT01378169|Prognosis factors|prognosis factors
512806|NCT01378169|Infection|infection
512807|NCT01378169|Diagnosis|diagnosis
512808|NCT01378156|Therapy for HIV Infection|therapy for hiv infection
512809|NCT01378156|Suppressive ART with no failures|suppressive art with no failures
512810|NCT01378156|Treatment interruption|treatment interruption
512811|NCT01378143|Colorectal Cancer|colorectal cancer
512812|NCT01378143|Pentamidine bis(2-hydroxyethanesulfonate)|pentamidine bis(2-hydroxyethanesulfonate)
512813|NCT01378143|OCZ103-OS|ocz103-os
512814|NCT01378143|Standard of Care|standard of care
512815|NCT01378130|CCS|ccs
512816|NCT01378130|CSC|csc
512817|NCT01378130|Subretinal Fluid|subretinal fluid
512818|NCT01378130|multimodal imaging|multimodal imaging
512819|NCT01378117|diabetes|diabetes
512820|NCT01378117|non critical care setting|non critical care setting
512821|NCT01378117|hyperglycemia|hyperglycemia
512822|NCT01378117|treatment|treatment
512823|NCT01378117|oral antidiabetic agents|oral antidiabetic agents
512824|NCT01378117|subcutaneous insulin|subcutaneous insulin
512825|NCT01378104|reducing dose of peginterferon|reducing dose of peginterferon
512826|NCT01378104|chronic hepatitis c|chronic hepatitis c
512827|NCT01378104|Koreans|koreans
512828|NCT01378104|IL28B polymorphism|il28b polymorphism
512829|NCT01378091|Androgen Independent Prostate Cancer|androgen independent prostate cancer
512830|NCT01378078|schizophrenia|schizophrenia
512831|NCT01378078|negative syndrome|negative syndrome
512832|NCT01378078|PANSS|panss
512833|NCT01378065|POP|pop
512834|NCT01378065|pelvic organ prolapse|pelvic organ prolapse
512835|NCT01378065|anterior prolapse|anterior prolapse
512836|NCT01378065|posterior prolapse|posterior prolapse
512837|NCT01378065|vaginal prolapse|vaginal prolapse
512838|NCT01378065|vaginal floor reconstruction|vaginal floor reconstruction
512839|NCT01378039|COPD|copd
512840|NCT01378039|Asthma|asthma
512841|NCT01378039|Pathophysiology|pathophysiology
512842|NCT01378039|Genetics|genetics
512843|NCT01378039|Phenotype|phenotype
512844|NCT01378039|Treatment response|treatment response
512845|NCT01378026|Amyotrophic Lateral Sclerosis|amyotrophic lateral sclerosis
512846|NCT01378026|G72|g72
512847|NCT01378026|SNP|snp
512848|NCT01378013|Metabonomics|metabonomics
512849|NCT01378013|Systems biology|systems biology
512850|NCT01378013|Intelligent knife|intelligent knife
512851|NCT01378013|Colorectal cancer|colorectal cancer
512852|NCT01378013|NMR|nmr
512853|NCT01378013|Mass spectrometry|mass spectrometry
512854|NCT01377974|Leishmaniasis|leishmaniasis
512855|NCT01377974|Mucocutaneous Leishmaniasis|mucocutaneous leishmaniasis
512856|NCT01377974|Therapeutics|therapeutics
512857|NCT01377974|meglumine antimoniate|meglumine antimoniate
512858|NCT01377974|miltefosine|miltefosine
512859|NCT01377948|Anger|anger
512860|NCT01377948|Aggression|aggression
512861|NCT01377948|CBT|cbt
512862|NCT01377948|Videogame|videogame
512863|NCT01377948|biofeedback|biofeedback
512864|NCT01377909|chronic hepatitis C, interferon|chronic hepatitis c, interferon
512865|NCT01377883|Needle, Anxiety, Pain, Clowns|needle, anxiety, pain, clowns
512866|NCT01377870|multiple sclerosis mesenchymal stem cell intravenous injection|multiple sclerosis mesenchymal stem cell intravenous injection
512867|NCT01377844|Diabetes mellitus|diabetes mellitus
512868|NCT01377818|COPD|copd
512869|NCT01377818|Exercise trainig|exercise trainig
512870|NCT01377805|Multiple Sclerosis hydrocephalus|multiple sclerosis hydrocephalus
512871|NCT01377792|hypertonic saline|hypertonic saline
512872|NCT01377792|cystic fibrosis|cystic fibrosis
512873|NCT01377792|pulmonary inflammation|pulmonary inflammation
512874|NCT01377792|pulmonary exacerbation|pulmonary exacerbation
512875|NCT01377779|Oxiplex/AP gel|oxiplex/ap gel
512876|NCT01377779|Prevention of Asherman's syndrome|prevention of asherman's syndrome
512877|NCT01377779|Intra uterine adhesions|intra uterine adhesions
512878|NCT01377766|Bell's palsy|bell's palsy
512879|NCT01377766|psychological stress|psychological stress
512880|NCT01377766|personality factors|personality factors
512881|NCT01377766|psychological factors|psychological factors
512882|NCT01377753|Toxicity|toxicity
512883|NCT01377753|Thermal Ablation/Damage|thermal ablation/damage
512884|NCT01377753|Localized Prostate Cancer|localized prostate cancer
512885|NCT01377753|Laser Ablation|laser ablation
512886|NCT01377753|PSA Levels|psa levels
512887|NCT01377753|Prostate Cancer|prostate cancer
512888|NCT01377740|Lipolysis|lipolysis
512889|NCT01377740|Cryolipolysis|cryolipolysis
512890|NCT01377740|Fat Reduction|fat reduction
512891|NCT01377701|pituitary adenomas|pituitary adenomas
512892|NCT01377701|recovery of vision|recovery of vision
512893|NCT01377701|trans-sphenoidal surgery|trans-sphenoidal surgery
512894|NCT01377688|DKD|dkd
512895|NCT01377636|Isoproterenol|isoproterenol
512896|NCT01377636|Bispectral index (BIS)|bispectral index (bis)
512897|NCT01377636|electrophysiology studies (EPS)|electrophysiology studies (eps)
512898|NCT01377623|Spinal fusion|spinal fusion
512899|NCT01377623|Inflammatory response|inflammatory response
512900|NCT01377623|Inflammatory markers|inflammatory markers
512901|NCT01377623|Dexmedetomidine|dexmedetomidine
512902|NCT01377610|Outpatient detoxification|outpatient detoxification
512903|NCT01377610|Opioid dependence|opioid dependence
512904|NCT01377610|Naltrexone|naltrexone
512905|NCT01377610|Vivitrol|vivitrol
512906|NCT01377610|Buprenorphine|buprenorphine
512907|NCT01377597|retinal vein occlusion|retinal vein occlusion
512908|NCT01377597|branch retinal vein occlusion|branch retinal vein occlusion
512909|NCT01377597|central retinal vein occlusion|central retinal vein occlusion
512910|NCT01377597|visual impairment|visual impairment
512911|NCT01377597|macular edema|macular edema
512912|NCT01377597|ranibizumab|ranibizumab
512913|NCT01377584|Continuous Positive Airway Pressure|continuous positive airway pressure
512914|NCT01377584|Patient Compliance|patient compliance
512915|NCT01377584|Intervention Studies|intervention studies
512916|NCT01377584|Spouses|spouses
512917|NCT01377571|diarrhea|diarrhea
512918|NCT01377571|fever|fever
512919|NCT01377571|nausea|nausea
512920|NCT01377571|vomit|vomit
512921|NCT01377571|irritability|irritability
512922|NCT01377558|aerobic training|aerobic training
512923|NCT01377558|resistance training|resistance training
512924|NCT01377558|combination of aerobic and resistance training|combination of aerobic and resistance training
512925|NCT01377558|diabetes|diabetes
512926|NCT01377558|type 2 diabetes|type 2 diabetes
512927|NCT01377558|HbA1c|hba1c
512928|NCT01377558|endothelial dysfunction|endothelial dysfunction
512929|NCT01377558|inflammation markers|inflammation markers
512930|NCT01377558|Parodontitis|parodontitis
512931|NCT01377558|Exercise intervention|exercise intervention
512932|NCT01377558|training|training
512933|NCT01377545|Infraclavicular|infraclavicular
512934|NCT01377545|Nerve Block|nerve block
512935|NCT01377545|Needle|needle
512936|NCT01377545|Perineural Catheter|perineural catheter
512937|NCT01377545|Volunteer|volunteer
512938|NCT01377545|Upper Extremity Nerve Block|upper extremity nerve block
512939|NCT01377545|Sensation|sensation
512940|NCT01377545|Strength|strength
512941|NCT01377532|Pheochromocytoma|pheochromocytoma
512942|NCT01377532|Paraganglioma|paraganglioma
512943|NCT01377532|MIBG|mibg
512944|NCT01377532|131I-MIBG|131i-mibg
512945|NCT01377532|Resistant|resistant
512946|NCT01377532|Relapsed|relapsed
512947|NCT01377532|Treatment|treatment
512948|NCT01377532|UCSF|ucsf
512949|NCT01377532|Pediatric|pediatric
512950|NCT01377532|Adult|adult
512951|NCT01377532|Oncology|oncology
512952|NCT01377519|Fibroids|fibroids
512953|NCT01377519|Uterine|uterine
512954|NCT01377519|Focused Ultrasound|focused ultrasound
512955|NCT01377519|Magnetic Resonance focused ultrasound|magnetic resonance focused ultrasound
512956|NCT01377519|HIFU|hifu
512957|NCT01377519|NOninvasive|noninvasive
512958|NCT01377519|Treatment|treatment
512959|NCT01377506|behavioral weight control|behavioral weight control
512960|NCT01377506|lifestyle intervention|lifestyle intervention
512961|NCT01377506|memory training|memory training
512962|NCT01377506|cognitive training|cognitive training
512963|NCT01377506|community-based|community-based
512964|NCT01377493|chewing-gum|chewing-gum
512965|NCT01377493|enamel subsurface lesion|enamel subsurface lesion
512966|NCT01377493|calcium additives|calcium additives
512967|NCT01377493|fluoride|fluoride
512968|NCT01377493|in situ|in situ
512969|NCT01377467|Osteoporosis|osteoporosis
512970|NCT01377467|Osteopenia|osteopenia
512971|NCT01377467|Denosumab|denosumab
512972|NCT01377467|Transplantation|transplantation
512973|NCT01377467|Kidney|kidney
512974|NCT01377454|mTBI|mtbi
512975|NCT01377454|concussion|concussion
512976|NCT01377454|mild Traumatic Brain Injury|mild traumatic brain injury
512977|NCT01377454|balance|balance
512978|NCT01377454|sensors|sensors
512979|NCT01377441|Ibuprofen|ibuprofen
512980|NCT01377441|Cytokines|cytokines
512981|NCT01377441|Recovery|recovery
512982|NCT01377441|IV ibuprofen|iv ibuprofen
512983|NCT01377441|major surgery|major surgery
512984|NCT01377428|COPD|copd
512985|NCT01377428|Indacaterol|indacaterol
512986|NCT01377428|Formoterol|formoterol
512987|NCT01377415|arthroscopy|arthroscopy
512988|NCT01377415|shoulder surgery|shoulder surgery
512989|NCT01377415|subacromial|subacromial
512990|NCT01377415|continuous bupivacaine|continuous bupivacaine
512991|NCT01377389|Prostate cancer|prostate cancer
512992|NCT01377389|Castrate sensitive prostate carcinoma|castrate sensitive prostate carcinoma
512993|NCT01377389|Metastatic prostate carcinoma|metastatic prostate carcinoma
513292|NCT01376232|Anaemia|anaemia
512994|NCT01377389|Androgen depravation therapy|androgen depravation therapy
512996|NCT01377389|Prostate-specific antigen|prostate-specific antigen
512997|NCT01377389|PSA|psa
512998|NCT01377389|Ipilimumab|ipilimumab
512999|NCT01377389|Yervoy|yervoy
513000|NCT01377389|BMS-734016|bms-734016
513001|NCT01377389|MDX010|mdx010
513002|NCT01377389|Leuprolide|leuprolide
513003|NCT01377389|Lupron Depot|lupron depot
513004|NCT01377389|Leuprolide Acetate|leuprolide acetate
513005|NCT01377389|Goserelin|goserelin
513006|NCT01377389|Zoladex|zoladex
513007|NCT01377389|Degarelix|degarelix
513008|NCT01377389|Firmagon|firmagon
513009|NCT01377363|metastatic breast cancer|metastatic breast cancer
513010|NCT01377363|primary breast cancer|primary breast cancer
513011|NCT01377350|Heart failure|heart failure
513012|NCT01377350|monitoring|monitoring
513013|NCT01377337|cardiac arrest|cardiac arrest
513014|NCT01377337|cardiopulmonary resuscitation|cardiopulmonary resuscitation
513015|NCT01377337|(sodium) bicarbonate|(sodium) bicarbonate
513016|NCT01377337|return of spontaneous circulation|return of spontaneous circulation
513017|NCT01377337|outcome|outcome
513018|NCT01377324|Breast cancer|breast cancer
513019|NCT01377324|Fulvestrant|fulvestrant
513020|NCT01377324|FES|fes
513021|NCT01377324|PET|pet
513022|NCT01377324|Positron|positron
513023|NCT01377324|Emission|emission
513024|NCT01377324|Tomography|tomography
513025|NCT01377324|Fluoroestradiol|fluoroestradiol
513026|NCT01377324|FES-PET|fes-pet
513027|NCT01377324|Molecular Imaging|molecular imaging
513028|NCT01377324|Estrogen Receptor|estrogen receptor
513029|NCT01377311|limbal stem cell|limbal stem cell
513030|NCT01377311|amniotic membrane|amniotic membrane
513031|NCT01377311|ex vivo expansion of autologous limbal stem cell|ex vivo expansion of autologous limbal stem cell
513032|NCT01377311|unilateral limbal stem cell insufficiency|unilateral limbal stem cell insufficiency
513033|NCT01377285|chronic kidney disease|chronic kidney disease
513034|NCT01377285|pentoxifylline|pentoxifylline
513035|NCT01377285|angiotensin receptor blockers(ARB)|angiotensin receptor blockers(arb)
513036|NCT01377272|HIV/AIDS|hiv/aids
513037|NCT01377272|spatial epidemiology|spatial epidemiology
513038|NCT01377272|geographic information system|geographic information system
513039|NCT01377272|HIV-infection/Aids|hiv-infection/aids
513040|NCT01377259|changes|changes
513041|NCT01377259|tissue|tissue
513042|NCT01377259|oxygenation|oxygenation
513043|NCT01377259|saturation|saturation
513044|NCT01377259|between|between
513045|NCT01377259|upper|upper
513046|NCT01377259|lower|lower
513047|NCT01377259|extremities|extremities
513048|NCT01377259|patients|patients
513049|NCT01377259|Adverse Effect|adverse effect
513050|NCT01377259|Spinal and Epidural|spinal and epidural
513051|NCT01377246|Somatostatin.|somatostatin.
513052|NCT01377246|Polycystic kidney disease.|polycystic kidney disease.
513053|NCT01377246|Renal insufficiency.|renal insufficiency.
513054|NCT01377233|Schizophrenia|schizophrenia
513055|NCT01377233|Antipsychotic|antipsychotic
513056|NCT01377233|Zicronapine|zicronapine
513057|NCT01377233|Lu 31-310|lu 31-310
513058|NCT01377220|Hepatocellular carcinoma|hepatocellular carcinoma
513059|NCT01377220|Positron Emission Tomography/computed tomography (PET-CT)|positron emission tomography/computed tomography (pet-ct)
513060|NCT01377220|11C-Choline|11c-choline
513061|NCT01377220|alpha fetoprotein|alpha fetoprotein
513062|NCT01377220|Dynamic magnetic resonance imaging|dynamic magnetic resonance imaging
513063|NCT01377220|Abdomen computed tomography|abdomen computed tomography
513064|NCT01377220|Tumoral liver biopsy|tumoral liver biopsy
513065|NCT01377207|ST segment Elevation Myocardial Infarction|st segment elevation myocardial infarction
513066|NCT01377207|Optical Coherence Tomography|optical coherence tomography
513067|NCT01377207|Percutaneous Coronary Intervention|percutaneous coronary intervention
513068|NCT01377207|Thrombus hystopathology|thrombus hystopathology
513069|NCT01377207|Gender differences|gender differences
513070|NCT01377194|Depression|depression
513071|NCT01377194|Major Depressive Disorder|major depressive disorder
513072|NCT01377181|Inguinal hernia|inguinal hernia
513073|NCT01377181|Laparoscope|laparoscope
513074|NCT01377181|Lateral us ligament|lateral us ligament
513075|NCT01377181|Recurrence|recurrence
513076|NCT01377181|Pediatric|pediatric
513077|NCT01377181|unilateral inguinal hernia|unilateral inguinal hernia
513078|NCT01377155|basal insulin|basal insulin
513079|NCT01377155|hypoglycemia|hypoglycemia
513080|NCT01377155|diabetes mellitus type two|diabetes mellitus type two
513081|NCT01377142|Uterovaginal prolapse|uterovaginal prolapse
513082|NCT01377142|hysteropexy|hysteropexy
513083|NCT01377142|mesh|mesh
513084|NCT01377129|Residual Rotational Laxity|residual rotational laxity
513085|NCT01377103|heart failure|heart failure
513086|NCT01377103|hypogonadism|hypogonadism
513087|NCT01377103|testosterone|testosterone
513088|NCT01377077|vitiligo|vitiligo
513089|NCT01377077|piebaldism|piebaldism
513090|NCT01377077|punchgrafting|punchgrafting
513091|NCT01377077|minigrafting|minigrafting
513092|NCT01377077|stable for at least 12 months|stable for at least 12 months
513093|NCT01377064|HIV|hiv
513094|NCT01377064|physical activity|physical activity
513095|NCT01377064|cardiovascular disease risk|cardiovascular disease risk
513096|NCT01377051|COPD|copd
513097|NCT01377051|Inspiratory capacity|inspiratory capacity
513098|NCT01377051|Residual volume|residual volume
513099|NCT01377051|Total lung resistance|total lung resistance
513100|NCT01377051|Arterial Oxygen|arterial oxygen
513101|NCT01377038|Osteoarthritis|osteoarthritis
513102|NCT01377038|Chronic pain|chronic pain
513103|NCT01377038|Central pain|central pain
513104|NCT01377012|Rheumatoid Arthritis|rheumatoid arthritis
513105|NCT01377012|RA|ra
513106|NCT01377012|ACR|acr
513107|NCT01377012|inflammatory joints|inflammatory joints
513108|NCT01376999|Sterility|sterility
513109|NCT01376999|FSH-r|fsh-r
513110|NCT01376999|intrauterine insemination|intrauterine insemination
513111|NCT01376999|unexplained sterility|unexplained sterility
513112|NCT01376973|stress, temporomandibular disorders.|stress, temporomandibular disorders.
513113|NCT01376960|forefoot surgery|forefoot surgery
513114|NCT01376960|Ankle Block|ankle block
513115|NCT01376960|Popliteal Fossa Block|popliteal fossa block
513116|NCT01376947|IUD device insertion|iud device insertion
513117|NCT01376947|Nulliparous|nulliparous
513118|NCT01376947|Multiparous|multiparous
513119|NCT01376947|Pain|pain
513120|NCT01376934|hysteroscopy|hysteroscopy
513121|NCT01376934|saline solution|saline solution
513122|NCT01376934|carbon dioxide|carbon dioxide
513123|NCT01376934|compare two techniques in office hysteroscopy co2 and saline solution|compare two techniques in office hysteroscopy co2 and saline solution
513124|NCT01376921|Growth disorders|growth disorders
513125|NCT01376921|Saizen|saizen
513126|NCT01376921|Easypod|easypod
513127|NCT01376921|Growth hormone|growth hormone
513128|NCT01376921|Pediatric subject|pediatric subject
513129|NCT01376908|Phenylketonuria (PKU)|phenylketonuria (pku)
513130|NCT01376908|Kuvan® (Sapropterin)|kuvan® (sapropterin)
513131|NCT01376908|Phe-restricted diet|phe-restricted diet
513132|NCT01376908|Paediatric <4 years old|paediatric <4 years old
513133|NCT01376908|responders to BH4|responders to bh4
513134|NCT01376908|Phe tolerance|phe tolerance
513135|NCT01376895|Black MSM/W|black msm/w
513136|NCT01376895|HIV|hiv
513137|NCT01376882|Caffeine|caffeine
513138|NCT01376882|Withdrawal|withdrawal
513139|NCT01376882|Cognitive function|cognitive function
513140|NCT01376882|Mood|mood
513141|NCT01376882|Cerebral haemodynamics|cerebral haemodynamics
513142|NCT01376869|Hops|hops
513143|NCT01376869|Mood|mood
513144|NCT01376869|Cognitive Function|cognitive function
513145|NCT01376869|Bioavailability|bioavailability
513146|NCT01376869|Satiety|satiety
513147|NCT01376869|Blood Pressure|blood pressure
513148|NCT01376869|Heart rate|heart rate
513149|NCT01376856|mediastinal lymph node with false positive FDG PET/CT results in lung cancer staging|mediastinal lymph node with false positive fdg pet/ct results in lung cancer staging
513150|NCT01376843|latent tuberculosis in health care workers|latent tuberculosis in health care workers
513151|NCT01376830|COPD|copd
513152|NCT01376830|Exacerbations|exacerbations
513153|NCT01376830|Viruses|viruses
513154|NCT01376817|Severe acute pancreatitis|severe acute pancreatitis
513155|NCT01376817|total parenteral nutrition|total parenteral nutrition
513156|NCT01376817|fat emulsions|fat emulsions
513157|NCT01376817|omega 3 fatty acids|omega 3 fatty acids
513158|NCT01376791|Periodontal disease|periodontal disease
513159|NCT01376791|Atherosclerosis|atherosclerosis
513160|NCT01376791|Oral Pathogens|oral pathogens
513161|NCT01376791|Native Americans|native americans
513162|NCT01376791|Inflammatory cytokines|inflammatory cytokines
513163|NCT01376791|Microbial metagenomics|microbial metagenomics
513164|NCT01376778|Perinatology|perinatology
513165|NCT01376778|Cytomegalovirus immune globulin|cytomegalovirus immune globulin
513166|NCT01376778|Cytogam|cytogam
513167|NCT01376778|CMVIG infusions|cmvig infusions
513168|NCT01376765|SARS, coronavirus, vaccine, adjuvant, Alhydrogel®, severe acute respiratory syndrome|sars, coronavirus, vaccine, adjuvant, alhydrogel®, severe acute respiratory syndrome
513169|NCT01376739|Magnevist|magnevist
513170|NCT01376739|MR angiography|mr angiography
513171|NCT01376713|Melanoma|melanoma
513172|NCT01376687|Osteopathic Medicine|osteopathic medicine
513173|NCT01376687|Cervical Spine|cervical spine
513174|NCT01376687|Kinetics|kinetics
513175|NCT01376674|localised|localised
513176|NCT01376674|prostate cancer|prostate cancer
513177|NCT01376674|radiotherapy|radiotherapy
513178|NCT01376674|immunology|immunology
513179|NCT01376661|Prostate Cancer|prostate cancer
513180|NCT01376661|Active Surveillance|active surveillance
513181|NCT01376661|Low risk prostate cancer|low risk prostate cancer
513182|NCT01376635|Chronic Kidney Disease|chronic kidney disease
513183|NCT01376635|Autonomic Dysfunction|autonomic dysfunction
513184|NCT01376609|Stroke|stroke
513185|NCT01376609|Ischaemic Stroke|ischaemic stroke
513186|NCT01376609|Cerebral Infarction|cerebral infarction
513187|NCT01376609|Cerebrovascular Disorders|cerebrovascular disorders
513188|NCT01376609|Brain Diseases|brain diseases
513189|NCT01376609|Nervous System Diseases|nervous system diseases
513190|NCT01376609|Vascular Diseases|vascular diseases
513191|NCT01376609|Brain Infarction|brain infarction
513192|NCT01376609|Brain Ischemia|brain ischemia
513193|NCT01376609|mismatch|mismatch
513194|NCT01376609|PWI/DWI mismatch|pwi/dwi mismatch
513195|NCT01376609|ischaemic penumbra|ischaemic penumbra
513196|NCT01376609|image analysis|image analysis
513197|NCT01376596|Remission|remission
513198|NCT01376596|Psychosocial Functioning|psychosocial functioning
513199|NCT01376596|Symptoms reduction|symptoms reduction
513200|NCT01376583|Breast cancer|breast cancer
513201|NCT01376583|Exercise|exercise
513202|NCT01376583|Myokines|myokines
513203|NCT01376583|AMPK|ampk
513205|NCT01376570|Opiate dependence|opiate dependence
513206|NCT01376570|Opiate replacement therapy|opiate replacement therapy
513207|NCT01376570|Cocaine-related disorders|cocaine-related disorders
513208|NCT01376570|Risk Reduction Behavior|risk reduction behavior
513209|NCT01376570|Medication Adherence|medication adherence
513210|NCT01376570|Motivation|motivation
513211|NCT01376557|diabetes mellitus|diabetes mellitus
513212|NCT01376544|Neonate|neonate
513213|NCT01376544|Weaning|weaning
513214|NCT01376544|Assist control ventilation|assist control ventilation
513215|NCT01376544|Pressure support ventilation|pressure support ventilation
513216|NCT01376531|acute renal failure|acute renal failure
513217|NCT01376531|cerebrovascular autoregulation|cerebrovascular autoregulation
513218|NCT01376531|transcranial Doppler|transcranial doppler
513219|NCT01376531|continuous veno-venous hemodialysis|continuous veno-venous hemodialysis
513220|NCT01376518|acute respiratory distress syndrome|acute respiratory distress syndrome
513221|NCT01376518|acute lung injury|acute lung injury
513222|NCT01376518|cerebrovascular autoregulation|cerebrovascular autoregulation
513223|NCT01376518|transcranial Doppler|transcranial doppler
513224|NCT01376518|ventilation|ventilation
513225|NCT01376505|Vaccine Therapy|vaccine therapy
513226|NCT01376492|Schizophrenia|schizophrenia
513227|NCT01376492|Sleep disturbances|sleep disturbances
513228|NCT01376492|Quality of sleep|quality of sleep
513229|NCT01376492|Functioning level|functioning level
513230|NCT01376492|Antipsychotic therapy.|antipsychotic therapy.
513231|NCT01376479|HFMD|hfmd
513232|NCT01376479|EV71|ev71
513233|NCT01376479|Enterovirus|enterovirus
513234|NCT01376479|INV21|inv21
513235|NCT01376479|Encephalitis|encephalitis
513236|NCT01376466|acute appendicitis|acute appendicitis
513237|NCT01376466|diagnosis|diagnosis
513238|NCT01376466|computed tomography|computed tomography
513239|NCT01376453|External Radiation Therapy|external radiation therapy
513240|NCT01376453|Locally Advanced Rectal|locally advanced rectal
513241|NCT01376453|Adenocarcinoma|adenocarcinoma
513242|NCT01376440|three or more loss stools in 24 hours|three or more loss stools in 24 hours
513243|NCT01376414|dyspepsia|dyspepsia
513244|NCT01376414|abdominal|abdominal
513245|NCT01376414|pain|pain
513246|NCT01376414|helicobacter|helicobacter
513247|NCT01376414|pylori|pylori
513248|NCT01376414|[C06.405.748.398]|[c06.405.748.398]
513249|NCT01376414|[C06.405.748.586]|[c06.405.748.586]
513250|NCT01376414|[C06.405.748.586.698]|[c06.405.748.586.698]
513251|NCT01376414|[C06.405.748.586.849]|[c06.405.748.586.849]
513252|NCT01376388|Chronic Obstructive Pulmonary Disease (COPD)|chronic obstructive pulmonary disease (copd)
513253|NCT01376388|Pharmacogenetics|pharmacogenetics
513254|NCT01376388|GSK573719/GW642444|gsk573719/gw642444
513255|NCT01376375|Acupuncture|acupuncture
513256|NCT01376375|Low Back Pain|low back pain
513257|NCT01376362|Cystoid Macular Edema|cystoid macular edema
513258|NCT01376362|Intermediate Uveitis|intermediate uveitis
513259|NCT01376362|Uveitis|uveitis
513260|NCT01376362|OCT|oct
513261|NCT01376362|Interferon-Gamma (IFN-Gamma)|interferon-gamma (ifn-gamma)
513262|NCT01376349|depression|depression
513263|NCT01376349|anxiety disorder|anxiety disorder
513264|NCT01376349|cognitive/functional effects|cognitive/functional effects
513265|NCT01376349|sexual dysfunction|sexual dysfunction
513266|NCT01376349|cancer survivor|cancer survivor
513267|NCT01376349|breast cancer|breast cancer
513268|NCT01376349|cervical cancer|cervical cancer
513269|NCT01376349|fallopian tube cancer|fallopian tube cancer
513270|NCT01376349|uterine sarcoma|uterine sarcoma
513271|NCT01376349|vaginal cancer|vaginal cancer
513272|NCT01376349|vulvar cancer|vulvar cancer
513273|NCT01376349|ovarian epithelial cancer|ovarian epithelial cancer
513274|NCT01376349|ovarian germ cell tumor|ovarian germ cell tumor
513275|NCT01376349|ovarian sarcoma|ovarian sarcoma
513276|NCT01376349|ovarian stromal cancer|ovarian stromal cancer
513277|NCT01376349|primary peritoneal cavity cancer|primary peritoneal cavity cancer
513278|NCT01376349|endometrial cancer|endometrial cancer
513279|NCT01376336|environmental health|environmental health
513280|NCT01376336|diarrhea|diarrhea
513281|NCT01376336|water|water
513282|NCT01376336|HIV|hiv
513283|NCT01376323|Safety|safety
513284|NCT01376323|Dose Ranging|dose ranging
513285|NCT01376323|Efficacy|efficacy
513286|NCT01376258|benign prostatic hyperplasia|benign prostatic hyperplasia
513287|NCT01376258|acute urinary retention|acute urinary retention
513288|NCT01376258|adherence|adherence
513289|NCT01376258|5-alpha reductase inhibitor|5-alpha reductase inhibitor
513290|NCT01376258|enlarged prostate|enlarged prostate
513291|NCT01376258|surgery|surgery
513293|NCT01376232|Drug- Drug Interaction|drug- drug interaction
513294|NCT01376219|GINA|gina
513295|NCT01376219|direct / indirect costs|direct / indirect costs
513296|NCT01376219|exacerbations|exacerbations
513297|NCT01376219|European|european
513298|NCT01376219|asthma control|asthma control
513299|NCT01376219|Asthma Control Test (TM - QualityMetric Incorporated)|asthma control test (tm - qualitymetric incorporated)
513300|NCT01376102|osteoporosis|osteoporosis
513301|NCT01376102|ibandronate|ibandronate
513302|NCT01376089|Safety|safety
513303|NCT01376076|schizophrenia|schizophrenia
513304|NCT01376076|QTc|qtc
513305|NCT01376076|cardiac repolarization|cardiac repolarization
513306|NCT01376050|venous stasis ulcer|venous stasis ulcer
513307|NCT01376050|leg ulcer|leg ulcer
513308|NCT01376037|upper arm|upper arm
513309|NCT01376037|body contouring|body contouring
513310|NCT01376037|body shaping|body shaping
513311|NCT01376024|Carpometacarpal arthritis|carpometacarpal arthritis
513312|NCT01376024|Basal joint arthritis|basal joint arthritis
513313|NCT01376024|CMC arthritis|cmc arthritis
513314|NCT01376024|Osteoarthritis|osteoarthritis
513315|NCT01376011|quercetin|quercetin
513316|NCT01376011|brain blood flow|brain blood flow
513317|NCT01376011|aging|aging
513318|NCT01376011|memory|memory
513319|NCT01375998|YAZ|yaz
513320|NCT01375998|Dysmenorrhea|dysmenorrhea
513321|NCT01375972|biliary cancer|biliary cancer
513322|NCT01375972|systemic chemotherapy|systemic chemotherapy
513323|NCT01375972|S-1|s-1
513324|NCT01375972|gemcitabine|gemcitabine
513325|NCT01375972|cisplatin|cisplatin
513326|NCT01375959|resveratrol|resveratrol
513327|NCT01375959|glucose intolerance|glucose intolerance
513328|NCT01375959|insulin resistance|insulin resistance
513329|NCT01375959|endothelial function|endothelial function
513330|NCT01375946|Pharmacokinetic Profile (PK) and Safety|pharmacokinetic profile (pk) and safety
513331|NCT01375946|PK analysis of EE and LNG|pk analysis of ee and lng
513332|NCT01375933|Smoking|smoking
513333|NCT01375933|NicVAX|nicvax
513334|NCT01375933|Smoking vaccine|smoking vaccine
513335|NCT01375920|Depression|depression
513336|NCT01375920|Antiglucocorticoid|antiglucocorticoid
513337|NCT01375920|Anti-depressants|anti-depressants
513338|NCT01375907|blood cell counts|blood cell counts
513339|NCT01375907|BUN|bun
513340|NCT01375907|ALT|alt
513341|NCT01375907|AST|ast
513342|NCT01375907|diarrhea|diarrhea
513343|NCT01375907|fever|fever
513344|NCT01375907|vomit|vomit
513345|NCT01375907|nausea|nausea
513346|NCT01375907|loss of appetite|loss of appetite
513347|NCT01375907|irritability|irritability
513348|NCT01375881|HIV|hiv
513349|NCT01375881|darunavir|darunavir
513350|NCT01375881|ritonavir|ritonavir
513351|NCT01375881|Prezista|prezista
513352|NCT01375881|naive|naive
513353|NCT01375881|experienced|experienced
513354|NCT01375868|HPV|hpv
513355|NCT01375868|recurrent respiratory papillomatosis|recurrent respiratory papillomatosis
513356|NCT01375868|antibodies|antibodies
513357|NCT01375855|Late stent malapposition|late stent malapposition
513358|NCT01375855|stent thrombosis|stent thrombosis
513359|NCT01375855|IVUS|ivus
513360|NCT01375855|non-polimeric stent|non-polimeric stent
513361|NCT01375816|adenocarcinoma of the colon|adenocarcinoma of the colon
513362|NCT01375816|recurrent colon cancer|recurrent colon cancer
513363|NCT01375816|stage IV colon cancer|stage iv colon cancer
513364|NCT01375816|adenocarcinoma of the rectum|adenocarcinoma of the rectum
513365|NCT01375816|recurrent rectal cancer|recurrent rectal cancer
513366|NCT01375816|stage IV rectal cancer|stage iv rectal cancer
513367|NCT01375803|dietary fiber|dietary fiber
513368|NCT01375803|fiber|fiber
513369|NCT01375803|insulin sensitivity|insulin sensitivity
513370|NCT01375803|insulin resistance|insulin resistance
513371|NCT01375803|glucose metabolism|glucose metabolism
513372|NCT01375790|whole-body vibration|whole-body vibration
513373|NCT01375790|older people|older people
513374|NCT01375790|exercise|exercise
513375|NCT01375790|body balance|body balance
513376|NCT01375790|muscle performance|muscle performance
513377|NCT01375790|falls|falls
513378|NCT01375790|physiotherapy|physiotherapy
513379|NCT01375777|High cholesterol|high cholesterol
513380|NCT01375777|Proprotein convertase subtilisin/kexin type 9 (PCSK9)|proprotein convertase subtilisin/kexin type 9 (pcsk9)
513381|NCT01375777|Treatment for high cholesterol|treatment for high cholesterol
513382|NCT01375777|Lowering cholesterol|lowering cholesterol
513383|NCT01375777|Lowering high cholesterol|lowering high cholesterol
513384|NCT01375777|Hypercholesterolemia|hypercholesterolemia
513385|NCT01375764|Proprotein convertase subtilisin/kexin type 9 (PCSK9)|proprotein convertase subtilisin/kexin type 9 (pcsk9)
513386|NCT01375764|Cholesterol|cholesterol
513387|NCT01375764|High Cholesterol|high cholesterol
513388|NCT01375764|Raised Cholesterol|raised cholesterol
513389|NCT01375764|Elevated Cholesterol|elevated cholesterol
513390|NCT01375764|Statin intolerant|statin intolerant
513391|NCT01375764|Hypercholesterolemia|hypercholesterolemia
513392|NCT01375751|Heterozygous Familial Hypercholesterolemia|heterozygous familial hypercholesterolemia
513498|NCT01375335|Inotropes|inotropes
513499|NCT01375335|Stunning|stunning
513393|NCT01375751|Proprotein convertase subtilisin/kexin type 9 (PCSK9)|proprotein convertase subtilisin/kexin type 9 (pcsk9)
513394|NCT01375738|Early gastric cancer|early gastric cancer
513395|NCT01375712|Hard or lumpy stools|hard or lumpy stools
513396|NCT01375712|Stool consistency|stool consistency
513397|NCT01375712|Stool frequency|stool frequency
513398|NCT01375712|Constipation related symptoms|constipation related symptoms
513399|NCT01375712|Constipation related quality of life|constipation related quality of life
513400|NCT01375699|Breast cancer|breast cancer
513401|NCT01375699|Gastrointestinal cancer|gastrointestinal cancer
513402|NCT01375699|Genitourinary cancer|genitourinary cancer
513403|NCT01375699|Sarcoma|sarcoma
513404|NCT01375699|Gynecologic cancer|gynecologic cancer
513405|NCT01375686|Diabetes|diabetes
513406|NCT01375673|Exercise|exercise
513407|NCT01375673|Heart Failure|heart failure
513408|NCT01375673|Mixed Effects Modeling|mixed effects modeling
513409|NCT01375660|Vitamin D|vitamin d
513410|NCT01375660|Glucose intolerance|glucose intolerance
513411|NCT01375660|African American men|african american men
513412|NCT01375647|Oral Vaccines|oral vaccines
513413|NCT01375647|Vaccine Responsiveness|vaccine responsiveness
513414|NCT01375647|Tropical Enteropathy|tropical enteropathy
513415|NCT01375634|Intubation|intubation
513416|NCT01375634|Gastrointestinal|gastrointestinal
513417|NCT01375621|Farming|farming
513418|NCT01375621|Antibiotic Resistant|antibiotic resistant
513419|NCT01375621|Bacteria|bacteria
513420|NCT01375608|Neutropenia|neutropenia
513421|NCT01375608|Hemaglobin|hemaglobin
513422|NCT01375608|Coagulation Disorders|coagulation disorders
513423|NCT01375608|Thrombocytosis|thrombocytosis
513424|NCT01375608|Red Blood Cells|red blood cells
513425|NCT01375608|Sickle Cell Disease|sickle cell disease
513426|NCT01375595|Working Memory|working memory
513427|NCT01375595|Repetitive TMS (rTMS)|repetitive tms (rtms)
513428|NCT01375595|Language|language
513429|NCT01375595|Healthy Volunteer|healthy volunteer
513431|NCT01375582|Dry Eye|dry eye
513432|NCT01375582|tear film|tear film
513433|NCT01375582|lipid|lipid
513434|NCT01375582|tear volume|tear volume
513435|NCT01375582|environmental chamber|environmental chamber
513436|NCT01375582|thermal imaging|thermal imaging
513437|NCT01375569|CD105|cd105
513438|NCT01375569|Monoclonal Antibody|monoclonal antibody
513439|NCT01375569|Anti-Angiogenic|anti-angiogenic
513440|NCT01375569|Chimeric|chimeric
513441|NCT01375569|Apoptosis|apoptosis
513442|NCT01375569|Liver Cancer|liver cancer
513443|NCT01375556|Alcohol Clamp|alcohol clamp
513444|NCT01375556|Pharmacogenetics|pharmacogenetics
513445|NCT01375556|Family History of Alcoholism|family history of alcoholism
513446|NCT01375556|Pharmacodynamics|pharmacodynamics
513447|NCT01375556|Healthy Volunteer|healthy volunteer
513448|NCT01375556|HV|hv
513449|NCT01375543|Whole Exome|whole exome
513450|NCT01375543|Whole Genome|whole genome
513451|NCT01375543|Rare Disorders|rare disorders
513452|NCT01375543|Genetic Disorders|genetic disorders
513453|NCT01375530|Prevention|prevention
513454|NCT01375530|Vaccine|vaccine
513455|NCT01375530|Immunity|immunity
513456|NCT01375530|Evaluate|evaluate
513457|NCT01375530|Screen|screen
513458|NCT01375530|Healthy Volunteer|healthy volunteer
513459|NCT01375530|HV|hv
513460|NCT01375504|Obesity|obesity
513461|NCT01375504|Body Mass Index|body mass index
513462|NCT01375504|Mindfulness Training|mindfulness training
513463|NCT01375504|Attention and Interpretation Therapy|attention and interpretation therapy
513464|NCT01375491|doxycycline|doxycycline
513465|NCT01375491|insulin resistance|insulin resistance
513466|NCT01375491|obesity|obesity
513467|NCT01375491|inflammation|inflammation
513468|NCT01375439|Pregnancy|pregnancy
513469|NCT01375439|vulvovaginitis|vulvovaginitis
513470|NCT01375439|uterine cervicitis|uterine cervicitis
513471|NCT01375439|pregnancy outcome|pregnancy outcome
513472|NCT01375426|Non-severe pneumonia|non-severe pneumonia
513473|NCT01375426|Treatment failure|treatment failure
513474|NCT01375426|Double dose amoxicillin|double dose amoxicillin
513475|NCT01375426|Children|children
513476|NCT01375413|Parkinson's disease|parkinson's disease
513477|NCT01375413|Gait|gait
513478|NCT01375413|Rehabilitation|rehabilitation
513479|NCT01375413|Cognition|cognition
513480|NCT01375413|Freezing of gait|freezing of gait
513481|NCT01375400|aspirin|aspirin
513482|NCT01375400|platelet|platelet
513483|NCT01375387|Vimpat|vimpat
513484|NCT01375387|Pharmacokinetics|pharmacokinetics
513485|NCT01375387|Healthy Japanese male|healthy japanese male
513486|NCT01375387|Healthy Chinese male|healthy chinese male
513487|NCT01375374|Vimpat|vimpat
513488|NCT01375374|Partial seizures|partial seizures
513489|NCT01375374|Carbamazepine|carbamazepine
513490|NCT01375374|Hormone levels|hormone levels
513491|NCT01375374|Lipid levels|lipid levels
513492|NCT01375374|Lacosamide|lacosamide
513493|NCT01375361|albuterol|albuterol
513494|NCT01375348|Cognitive function|cognitive function
513495|NCT01375348|Experimental pain|experimental pain
513496|NCT01375335|Postoperative|postoperative
513497|NCT01375335|Dobutamine|dobutamine
513500|NCT01375335|Heart failure|heart failure
513501|NCT01375309|probiotics|probiotics
513502|NCT01375309|preterm infants|preterm infants
513503|NCT01375309|enteral feeding|enteral feeding
513504|NCT01375309|Bifidobacterium on enteral feeding|bifidobacterium on enteral feeding
513505|NCT01375270|diabetes|diabetes
513506|NCT01375270|incretin|incretin
513507|NCT01375270|beta-cell function|beta-cell function
513508|NCT01375270|glucolipotoxicity|glucolipotoxicity
513509|NCT01375270|glucagon-like peptide 1|glucagon-like peptide 1
513510|NCT01375270|glucose-dependent insulinotropic polypeptide|glucose-dependent insulinotropic polypeptide
513511|NCT01375244|bioequivalence|bioequivalence
513512|NCT01375244|lisinopril|lisinopril
513513|NCT01375244|fasting|fasting
513514|NCT01375205|atopic dermatitis|atopic dermatitis
513515|NCT01375205|skin care|skin care
513516|NCT01375179|Inflammatory Bowel disease|inflammatory bowel disease
513517|NCT01375179|Ulcerative colitis|ulcerative colitis
513518|NCT01375153|BNP administration|bnp administration
513519|NCT01375153|appetite|appetite
513520|NCT01375153|ghrelin|ghrelin
513521|NCT01375153|PYY|pyy
513522|NCT01375140|Myeloproliferative Diseases|myeloproliferative diseases
513523|NCT01375140|Myelofibrosis|myelofibrosis
513524|NCT01375140|Post essential thrombocythemia/polycythemia vera|post essential thrombocythemia/polycythemia vera
513525|NCT01375140|Ruxolitinib|ruxolitinib
513526|NCT01375140|INCB018424|incb018424
513527|NCT01375140|Lenalidomide|lenalidomide
513528|NCT01375140|CC-5013|cc-5013
513529|NCT01375140|Revlimid|revlimid
513530|NCT01375140|Prednisone|prednisone
513531|NCT01375140|Interactive Voice Response System|interactive voice response system
513532|NCT01375140|IVR|ivr
513533|NCT01375127|Observational|observational
513534|NCT01375127|clinical follow-up data|clinical follow-up data
513535|NCT01375114|Advanced Cancers|advanced cancers
513536|NCT01375114|Solid Tumors|solid tumors
513537|NCT01375114|Cancer related fatigue|cancer related fatigue
513538|NCT01375114|CRF|crf
513539|NCT01375114|Panax ginseng|panax ginseng
513540|NCT01375114|Placebo|placebo
513541|NCT01375114|Sugar pill|sugar pill
513542|NCT01375114|Functional Assessment of Chronic Illness Therapy-Fatigue|functional assessment of chronic illness therapy-fatigue
513543|NCT01375114|FACIT-F|facit-f
513544|NCT01375114|Quality of life|quality of life
513545|NCT01375114|QOL|qol
513546|NCT01375114|FACT-G|fact-g
513547|NCT01375114|Hospital Anxiety and Depression Inventory|hospital anxiety and depression inventory
513548|NCT01375114|Neurocognitive function|neurocognitive function
513549|NCT01375114|SDMT|sdmt
513550|NCT01375114|Global Symptom Evaluation|global symptom evaluation
513551|NCT01375114|GSE|gse
513552|NCT01375101|lichen planus|lichen planus
513553|NCT01375101|quercetin|quercetin
513554|NCT01375088|propolis|propolis
513555|NCT01375088|mucositis|mucositis
513556|NCT01375088|radiotherapy|radiotherapy
513557|NCT01375088|cancer|cancer
513558|NCT01375049|Cystic fibrosis|cystic fibrosis
513559|NCT01375049|CF|cf
513560|NCT01375049|PA|pa
513561|NCT01375049|Pseudomonas aeruginosa|pseudomonas aeruginosa
513562|NCT01375049|AZLI|azli
513563|NCT01375049|aztreonam|aztreonam
513564|NCT01375036|Cystic fibrosis|cystic fibrosis
513565|NCT01375036|PA|pa
513566|NCT01375036|Pseudomonas aeruginosa|pseudomonas aeruginosa
513567|NCT01375036|CF|cf
513568|NCT01375036|aztreonam|aztreonam
653061|NCT00816855|NPC|npc
513569|NCT01375023|Allogenic Haematopoietic Cell Transplantation|allogenic haematopoietic cell transplantation
513570|NCT01375023|Total Lymphoid Irradiation|total lymphoid irradiation
513571|NCT01375023|Anti-Thymocyte Globulin|anti-thymocyte globulin
513572|NCT01375023|Triple Negative Breast Cancer|triple negative breast cancer
513573|NCT01375010|HIV|hiv
513574|NCT01375010|Postmenopausal women|postmenopausal women
513575|NCT01375010|Vitamin D|vitamin d
513576|NCT01374984|smallpox|smallpox
513577|NCT01374984|vaccination|vaccination
513578|NCT01374984|complications|complications
513579|NCT01374971|Rheumatoid Arthritis|rheumatoid arthritis
513580|NCT01374971|Cimzia|cimzia
513581|NCT01374971|Certolizumab Pegol|certolizumab pegol
513582|NCT01374971|Arthroscopic Synovial biopsy|arthroscopic synovial biopsy
513583|NCT01374971|Office Based Procedure|office based procedure
513584|NCT01374971|Biologic|biologic
513585|NCT01374971|Tumor Necrosis Factor (TNF)|tumor necrosis factor (tnf)
513586|NCT01374971|Anti-TNF|anti-tnf
513587|NCT01374932|Asthma|asthma
513588|NCT01374932|Obstructive Sleep Apnea Syndrome|obstructive sleep apnea syndrome
513589|NCT01374919|Intravenous iron|intravenous iron
513590|NCT01374919|ferumoxytol|ferumoxytol
513591|NCT01374919|iron deficiency anemia|iron deficiency anemia
513592|NCT01374919|Treatment of iron deficiency|treatment of iron deficiency
513593|NCT01374919|Intolerance of or ineffectiveness of oral iron|intolerance of or ineffectiveness of oral iron
513594|NCT01374906|SOM230|som230
513595|NCT01374906|Cushing's Disease|cushing's disease
513596|NCT01374906|Mean Urinary Free Cortisol|mean urinary free cortisol
513597|NCT01374906|Pasireotide|pasireotide
513598|NCT01374906|Pasireotide LAR|pasireotide lar
513599|NCT01374906|Pasireotide long-acting release|pasireotide long-acting release
513600|NCT01374906|secondary hypercortisolism|secondary hypercortisolism
513601|NCT01374906|secondary hypercorticism|secondary hypercorticism
513602|NCT01374906|Itsenko-Cushing disease|itsenko-cushing disease
513603|NCT01374906|increased secretion of adrenocorticotropic hormone (ACTH)|increased secretion of adrenocorticotropic hormone (acth)
513604|NCT01374906|hyperpituitarism|hyperpituitarism
513605|NCT01374893|Function, hospitalization, elderly|function, hospitalization, elderly
513606|NCT01374880|Heart failure|heart failure
513607|NCT01374880|Dyspnea|dyspnea
513608|NCT01374880|Heart disease|heart disease
513609|NCT01374880|Pulmonary disease|pulmonary disease
513610|NCT01374880|Natriuretic peptide|natriuretic peptide
513611|NCT01374880|Rehabilitation|rehabilitation
513612|NCT01374867|Cardiogenic shock|cardiogenic shock
513613|NCT01374867|Myocardial infarction|myocardial infarction
513614|NCT01374867|Low-output syndrome|low-output syndrome
513615|NCT01374867|Prognosis|prognosis
513616|NCT01374867|Biomarkers|biomarkers
513617|NCT01374867|Pathophysiology|pathophysiology
513618|NCT01374854|type 1 diabetes mellitus|type 1 diabetes mellitus
513619|NCT01374854|umbilical mesenchymal stem cell|umbilical mesenchymal stem cell
513620|NCT01374854|mononuclear cell|mononuclear cell
513621|NCT01374841|Hematopoietic Stem Cell Transplantation|hematopoietic stem cell transplantation
513622|NCT01374841|High-Risk Hematologic Neoplasms|high-risk hematologic neoplasms
513623|NCT01374841|Haploidentical Donors|haploidentical donors
513624|NCT01374841|Cyclophosphamide|cyclophosphamide
513625|NCT01374828|Toradol|toradol
513626|NCT01374828|Ketorolac|ketorolac
513627|NCT01374828|Normal saline|normal saline
513628|NCT01374828|Laparoscopic|laparoscopic
513629|NCT01374828|Postoperative pain control|postoperative pain control
513630|NCT01374828|Incisional analgesia|incisional analgesia
513631|NCT01374815|Children's diet quality|children's diet quality
513632|NCT01374815|Health-related social problems|health-related social problems
513633|NCT01374763|Naloxone|naloxone
513634|NCT01374763|Oxycodone|oxycodone
513635|NCT01374763|Constipation|constipation
513636|NCT01374763|Pain, postoperative|pain, postoperative
513637|NCT01374763|Physiological effects of drugs|physiological effects of drugs
513638|NCT01374763|Analgesics, Opioid|analgesics, opioid
513639|NCT01374724|Tobacco Use|tobacco use
513640|NCT01374724|Relapse Prevention|relapse prevention
513641|NCT01374724|Military|military
513642|NCT01374724|Smokeless Tobacco Use|smokeless tobacco use
513643|NCT01374724|Dual Use|dual use
513644|NCT01374711|Endotoxin|endotoxin
513645|NCT01374711|Inflammation|inflammation
513646|NCT01374711|Sepsis|sepsis
513647|NCT01374711|GM-CSF|gm-csf
513648|NCT01374711|IFN-y|ifn-y
513650|NCT01374698|Aspirin|aspirin
513651|NCT01374698|Reload|reload
513652|NCT01374685|BRCA1|brca1
513653|NCT01374685|BRCA2|brca2
513654|NCT01374685|Breast Cancer|breast cancer
513655|NCT01374685|African American|african american
513656|NCT01374685|Women|women
513657|NCT01374659|124-I PET|124-i pet
513658|NCT01374659|FDG-PET|fdg-pet
513659|NCT01374659|PET/CT|pet/ct
513660|NCT01374659|recurrence|recurrence
513661|NCT01374659|differentiated thyroid carcinoma|differentiated thyroid carcinoma
513662|NCT01374659|diagnostic value|diagnostic value
513663|NCT01374646|Childhood Obesity|childhood obesity
513664|NCT01374646|Group Treatment|group treatment
653160|NCT00816582|PET/CT|pet/ct
513665|NCT01374646|Community-based Programs|community-based programs
513666|NCT01374633|Sevoflurane|sevoflurane
513667|NCT01374633|Brain injury|brain injury
513668|NCT01374633|Intra cranial pressure|intra cranial pressure
513669|NCT01374633|Sedation|sedation
513670|NCT01374633|Brain injury with initial Glasgow score less than 9|brain injury with initial glasgow score less than 9
513671|NCT01374620|Cancer|cancer
513672|NCT01374607|acute coronary syndrome|acute coronary syndrome
513673|NCT01374607|myocardial ischemia|myocardial ischemia
513674|NCT01374607|high-sensitivity cardiac troponin T|high-sensitivity cardiac troponin t
513675|NCT01374581|retreatment|retreatment
513676|NCT01374581|artemisinin-based combination|artemisinin-based combination
513677|NCT01374581|malaria|malaria
513678|NCT01374581|resistant|resistant
513679|NCT01374568|Type 2 diabetes|type 2 diabetes
513680|NCT01374568|sitagliptin|sitagliptin
513681|NCT01374568|Januvia|januvia
513682|NCT01374555|Coronary artery disease|coronary artery disease
513683|NCT01374542|Bronchoscopy|bronchoscopy
513684|NCT01374542|Thoracoscopy|thoracoscopy
513685|NCT01374516|Dengue Virus|dengue virus
513686|NCT01374516|Dengue fever|dengue fever
513687|NCT01374516|Dengue Hemorrhagic Fever|dengue hemorrhagic fever
513688|NCT01374516|CYD dengue vaccine|cyd dengue vaccine
513689|NCT01374516|Flavivirus|flavivirus
513690|NCT01374516|Dengue Disease|dengue disease
513691|NCT01374490|HIV +|hiv +
513692|NCT01374490|HIV positive|hiv positive
513693|NCT01374490|HIV associated diarrhea|hiv associated diarrhea
513694|NCT01374490|AIDS|aids
513695|NCT01374490|Diarrhea|diarrhea
513696|NCT01374477|Preeclampsia in Adolescence|preeclampsia in adolescence
513697|NCT01374477|Adolescent|adolescent
513698|NCT01374477|Primipaternity|primipaternity
513699|NCT01374464|Interscalene brachial plexus nerve block|interscalene brachial plexus nerve block
513700|NCT01374464|Nerve block|nerve block
513701|NCT01374451|Pancreatic|pancreatic
513702|NCT01374451|Neuroendocrine tumors|neuroendocrine tumors
513703|NCT01374451|PNET|pnet
513704|NCT01374451|Pasireotide|pasireotide
513705|NCT01374451|Everolimus|everolimus
513706|NCT01374451|Advanced progressive pancreatic neuroendocrine tumor|advanced progressive pancreatic neuroendocrine tumor
513707|NCT01374438|Alzheimer's disease|alzheimer's disease
513708|NCT01374438|cognitive function|cognitive function
513709|NCT01374438|brain glucose utilization|brain glucose utilization
513710|NCT01374438|FDG-PET|fdg-pet
513711|NCT01374399|allogeneic stem cell transplantation|allogeneic stem cell transplantation
513712|NCT01374399|exercise|exercise
513713|NCT01374399|survival|survival
513714|NCT01374399|fatigue|fatigue
513715|NCT01374399|quality of life|quality of life
513716|NCT01374399|cancer|cancer
513717|NCT01374399|physical performance|physical performance
513718|NCT01374386|adolescent obesity|adolescent obesity
513719|NCT01374373|Chemotherapy|chemotherapy
513720|NCT01374373|Anemia|anemia
513721|NCT01374373|Epoetin alfa|epoetin alfa
513722|NCT01374373|Erythropoiesis stimulating agent (ESA)|erythropoiesis stimulating agent (esa)
513724|NCT01374360|Paroxysmal Nocturnal hemoglobinuria|paroxysmal nocturnal hemoglobinuria
513725|NCT01374360|Soliris|soliris
513726|NCT01374360|Eculizumab|eculizumab
513727|NCT01374308|NASVAC|nasvac
513728|NCT01374308|Pegylated Interferon-2b|pegylated interferon-2b
513729|NCT01374308|CHB|chb
513730|NCT01374269|NSAIDS (Nonsteroidal anti-inflammatory drugs)|nsaids (nonsteroidal anti-inflammatory drugs)
513731|NCT01374269|Exercise|exercise
513732|NCT01374269|Physiotherapy|physiotherapy
513733|NCT01374269|Subacute Low Back Pain|subacute low back pain
513734|NCT01374269|Pain|pain
513735|NCT01374269|Visual Analogue Scale|visual analogue scale
513736|NCT01374269|oswesrty|oswesrty
513737|NCT01374269|Roland Morris|roland morris
513738|NCT01374269|SF-36|sf-36
513739|NCT01374269|Quality of life|quality of life
513740|NCT01374256|carbapenem|carbapenem
513741|NCT01374256|sulbactam|sulbactam
513742|NCT01374256|Acinetobacter baumannii|acinetobacter baumannii
513743|NCT01374230|clinical outcomes|clinical outcomes
513744|NCT01374230|radiographic outcomes|radiographic outcomes
513745|NCT01374230|total knee arthroplasty|total knee arthroplasty
513746|NCT01374230|survivorship|survivorship
513747|NCT01374204|Epilepsy|epilepsy
513748|NCT01374204|Stigma|stigma
513749|NCT01374191|botox|botox
513750|NCT01374191|neuroma pain|neuroma pain
513751|NCT01374191|pain|pain
513752|NCT01374191|chronic pain|chronic pain
513753|NCT01374191|botulinum toxin|botulinum toxin
513754|NCT01374191|botulinum toxin A|botulinum toxin a
513755|NCT01374191|botox and pain|botox and pain
513756|NCT01374191|botox and neuroma|botox and neuroma
513757|NCT01374191|botox treatment|botox treatment
513758|NCT01374191|onabotulinum|onabotulinum
513759|NCT01374191|onabotulinum toxin|onabotulinum toxin
513760|NCT01374191|onabotulinum toxin type A|onabotulinum toxin type a
513761|NCT01374165|SCD|scd
513762|NCT01374152|stroke|stroke
513763|NCT01374152|upper extremity|upper extremity
513764|NCT01374152|rehabilitation|rehabilitation
513765|NCT01374152|perfetti|perfetti
513766|NCT01374139|Bosutinib|bosutinib
513767|NCT01374139|Bioequivalence and Food Effect Studies|bioequivalence and food effect studies
513768|NCT01374113|safinamide|safinamide
513769|NCT01374113|pharmacokinetics|pharmacokinetics
513770|NCT01374113|renal impairment|renal impairment
513771|NCT01374113|Moderate and Severe Renal Impairment|moderate and severe renal impairment
513772|NCT01374100|Qigong|qigong
513773|NCT01374100|Complementary Medicine|complementary medicine
513774|NCT01374100|Exercise|exercise
513775|NCT01374100|Traditional Chinese Medicine|traditional chinese medicine
513776|NCT01374100|Meditation|meditation
513777|NCT01374100|Standard Exercise|standard exercise
513778|NCT01374100|Chemotherapy|chemotherapy
513779|NCT01374100|Advanced cancer|advanced cancer
513780|NCT01374100|Quality of Life|quality of life
513781|NCT01374100|Functional Assessment of Cancer Therapy|functional assessment of cancer therapy
513782|NCT01374100|Hospital Anxiety and Depression Scale|hospital anxiety and depression scale
513783|NCT01374100|Anxiety|anxiety
513784|NCT01374100|Depression|depression
513785|NCT01374100|Cancer Nutrition-Rehabilitation Program|cancer nutrition-rehabilitation program
513786|NCT01374100|Edmonton Symptom Assessment Scale|edmonton symptom assessment scale
513787|NCT01374100|Simmonds Functional Assessment|simmonds functional assessment
513788|NCT01374087|Recurrent Prostate Carcinoma|recurrent prostate carcinoma
513789|NCT01374087|Brachytherapy|brachytherapy
513790|NCT01374087|Triptorelin|triptorelin
513791|NCT01374087|Hormone Therapy|hormone therapy
513792|NCT01374074|Barrett's Esophagus (BE)|barrett's esophagus (be)
513793|NCT01374074|Intestinal metaplasia|intestinal metaplasia
513794|NCT01374074|Gastroesophageal reflux disease (GERD)|gastroesophageal reflux disease (gerd)
513795|NCT01374074|Racial Disparity|racial disparity
513796|NCT01374061|Emergency intubation|emergency intubation
513797|NCT01374061|Glide scope Ranger|glide scope ranger
513798|NCT01374061|Pre hospital|pre hospital
513799|NCT01374035|Health Service|health service
513800|NCT01374035|Coordination|coordination
513801|NCT01374035|Referral letters|referral letters
513802|NCT01374035|Mental Health|mental health
513803|NCT01374035|Adults|adults
513804|NCT01374022|Respiratory Distress Syndrome, Adult|respiratory distress syndrome, adult
513805|NCT01374022|Randomized Controlled Trial|randomized controlled trial
513806|NCT01374022|Respiration, Artificial|respiration, artificial
513807|NCT01373996|Invasive blood pressure monitoring|invasive blood pressure monitoring
513808|NCT01373996|Intensive care unit|intensive care unit
513809|NCT01373996|Wireless Technology|wireless technology
513810|NCT01373983|Neuropathic pain|neuropathic pain
513811|NCT01373983|Intrathecal analgesia|intrathecal analgesia
513812|NCT01373983|Ziconotide|ziconotide
513813|NCT01373983|Bolus|bolus
513814|NCT01373983|trauma|trauma
513815|NCT01373983|central|central
513816|NCT01373983|severe|severe
513817|NCT01373983|chronic|chronic
513818|NCT01373970|Functional Dyspepsia|functional dyspepsia
513819|NCT01373970|Protonpump inhibitor|protonpump inhibitor
513820|NCT01373970|Rebound Acid HyperSecretion|rebound acid hypersecretion
513821|NCT01373957|Acute Coronary Syndrome|acute coronary syndrome
513822|NCT01373957|antithrombotic management|antithrombotic management
513823|NCT01373957|STEMI|stemi
513824|NCT01373957|NSTE-ACS|nste-acs
513825|NCT01373944|MPI|mpi
513826|NCT01373944|SPECT|spect
513827|NCT01373944|Stress-Only|stress-only
513828|NCT01373944|Spectrum Dynamics Camera|spectrum dynamics camera
513829|NCT01373944|Anger|anger
513830|NCT01373918|cholestasis|cholestasis
513831|NCT01373918|neonates|neonates
513832|NCT01373918|parenteral nutrition|parenteral nutrition
513833|NCT01373918|gastrointestinal disorders|gastrointestinal disorders
513834|NCT01373905|ARDS|ards
513835|NCT01373905|PEEP|peep
513836|NCT01373905|Recruitment maneuver|recruitment maneuver
513837|NCT01373879|Vaccine|vaccine
513838|NCT01373879|Immune response|immune response
513839|NCT01373866|Repetitive Transcranial Magnetic Stimulation|repetitive transcranial magnetic stimulation
513840|NCT01373866|Neuronavigation|neuronavigation
513841|NCT01373866|Functional Magnetic Resonance Imaging|functional magnetic resonance imaging
513842|NCT01373866|Diffusion Tensor Imaging|diffusion tensor imaging
513843|NCT01373853|Lens Fragmentation|lens fragmentation
513844|NCT01373853|Cataract|cataract
513845|NCT01373853|Phacoemulsification|phacoemulsification
513846|NCT01373853|Femtosecond Laser|femtosecond laser
513847|NCT01373840|focal|focal
513848|NCT01373840|dystonia|dystonia
513849|NCT01373840|dopamine|dopamine
513850|NCT01373840|receptor|receptor
513851|NCT01373827|VASER|vaser
513852|NCT01373827|VASERShape|vasershape
513853|NCT01373827|MC1|mc1
513854|NCT01373827|ultrasound|ultrasound
513855|NCT01373801|Postpartum women, after surgical repair of vaginal and cervical lacerations|postpartum women, after surgical repair of vaginal and cervical lacerations
513856|NCT01373775|Heart failure|heart failure
513857|NCT01373775|Revisit|revisit
513858|NCT01373775|Emergency room|emergency room
513859|NCT01373762|Adherence|adherence
513860|NCT01373762|Motivation|motivation
513861|NCT01373762|Health-related fitness|health-related fitness
513862|NCT01373762|Exercise videogames|exercise videogames
513863|NCT01373762|Physical Activity|physical activity
513864|NCT01373749|PPHN|pphn
513865|NCT01373749|NO inhalation|no inhalation
513866|NCT01373749|Sildenafil|sildenafil
513867|NCT01373749|Treatment|treatment
513868|NCT01373749|Safety|safety
513869|NCT01373723|Uterine Cervical Neoplasms|uterine cervical neoplasms
513870|NCT01373723|cancer screening|cancer screening
513871|NCT01373723|Costs and Cost Analysis|costs and cost analysis
513872|NCT01373723|cost-effectiveness analysis|cost-effectiveness analysis
513873|NCT01373723|Clinical Trial|clinical trial
513874|NCT01373723|Primary Health Care|primary health care
513875|NCT01373710|Adverse Reaction to Trastuzumab Administered by intrathecal|adverse reaction to trastuzumab administered by intrathecal
513876|NCT01373697|Ibuprofen|ibuprofen
513877|NCT01373697|muscle pain|muscle pain
513878|NCT01373697|sprains|sprains
513879|NCT01373697|contusions|contusions
513880|NCT01373697|tendonitis|tendonitis
513881|NCT01373684|Chronic hepatitis B|chronic hepatitis b
513882|NCT01373684|HBeAg-negative|hbeag-negative
513883|NCT01373671|Mammography|mammography
513884|NCT01373671|Screening|screening
513885|NCT01373671|Diagnostic|diagnostic
513886|NCT01373632|significant stenosis (>70% of lumen stenosis)|significant stenosis (>70% of lumen stenosis)
513887|NCT01373632|epicardial coronary arteries|epicardial coronary arteries
513888|NCT01373632|clinical ischemic|clinical ischemic
513889|NCT01373619|Heart failure with normal ejection fraction|heart failure with normal ejection fraction
513890|NCT01373619|hemodialysis patients|hemodialysis patients
513891|NCT01373619|ivabradine|ivabradine
513892|NCT01373619|Echocardiography|echocardiography
513893|NCT01373619|NYHA class|nyha class
513894|NCT01373619|6-minutes walking test|6-minutes walking test
513895|NCT01373593|persistent postherniorrhaphy pain|persistent postherniorrhaphy pain
513896|NCT01373580|presbyopia|presbyopia
513897|NCT01373580|LASIK|lasik
513898|NCT01373580|loss of accommodation|loss of accommodation
513899|NCT01373580|Emmetrope|emmetrope
513900|NCT01373567|Plaque Psoriasis|plaque psoriasis
513901|NCT01373528|Sinonasal Budesonide|sinonasal budesonide
513902|NCT01373528|Endoscopic sinus surgery|endoscopic sinus surgery
513903|NCT01373528|Hypothalamic-Pituitary-Adrenal Axis Function|hypothalamic-pituitary-adrenal axis function
513904|NCT01373515|DCOne|dcone
513905|NCT01373515|DCP-001|dcp-001
513906|NCT01373515|Second complete remission of AML|second complete remission of aml
513907|NCT01373515|Relapse AML|relapse aml
513908|NCT01373489|type 2 diabetes|type 2 diabetes
513909|NCT01373489|nurse case management|nurse case management
513910|NCT01373489|telemedicine|telemedicine
513911|NCT01373476|Diabetic Retinopathy|diabetic retinopathy
513912|NCT01373476|Traditional Chinese medicine|traditional chinese medicine
513913|NCT01373476|Diabetic Eye Problems|diabetic eye problems
513914|NCT01373476|Retinal Disorders|retinal disorders
513915|NCT01373463|resectable|resectable
513916|NCT01373437|Ultrasonography|ultrasonography
513917|NCT01373437|US|us
513918|NCT01373437|Confirming|confirming
513919|NCT01373437|Confirmation|confirmation
513920|NCT01373437|Proper|proper
513921|NCT01373437|Position|position
513922|NCT01373437|Endotracheal tube|endotracheal tube
513923|NCT01373437|ETT|ett
513924|NCT01373437|Emergency department|emergency department
513925|NCT01373437|ED|ed
513926|NCT01373437|Applicability|applicability
513927|NCT01373437|Accuracy|accuracy
513928|NCT01373424|Observational study|observational study
513929|NCT01373424|Cross-sectional and Prospective study|cross-sectional and prospective study
513930|NCT01373424|Cohort and case-control study|cohort and case-control study
513931|NCT01373411|CABG|cabg
513932|NCT01373411|Ticagrelor|ticagrelor
513933|NCT01373411|Coronary Artery Bypass Surgery|coronary artery bypass surgery
513934|NCT01373398|bladder cancer|bladder cancer
513935|NCT01373398|EO9|eo9
513936|NCT01373398|Apaziquone|apaziquone
513937|NCT01373385|pediatric urology|pediatric urology
513938|NCT01373385|vesicoureteral reflux|vesicoureteral reflux
513939|NCT01373385|ureteral reimplant|ureteral reimplant
513940|NCT01373385|Deflux|deflux
513941|NCT01373372|functional dyspepsia|functional dyspepsia
513942|NCT01373372|GI|gi
513943|NCT01373359|Misoprostol, oxytocin, postpartum blood loss, hemoglobin|misoprostol, oxytocin, postpartum blood loss, hemoglobin
513944|NCT01373346|type II diabetes|type ii diabetes
513945|NCT01373346|Gastric cancer|gastric cancer
513946|NCT01373346|Long limb Roux-en Y|long limb roux-en y
513947|NCT01373320|Smoking cessation|smoking cessation
513948|NCT01373320|Cancer screening|cancer screening
513949|NCT01373320|Appalachia|appalachia
513950|NCT01373320|Group-randomized trial|group-randomized trial
513951|NCT01373320|Faith-placed|faith-placed
513952|NCT01373307|Overweight|overweight
513953|NCT01373307|obesity|obesity
513954|NCT01373307|Appalachian|appalachian
513955|NCT01373307|intergenerational|intergenerational
513956|NCT01373307|families|families
513957|NCT01373307|energy balance|energy balance
513958|NCT01373307|group-randomized trial|group-randomized trial
513959|NCT01373294|non-muscle-invasive|non-muscle-invasive
513960|NCT01373294|transitional cell|transitional cell
513961|NCT01373294|oral lenalidomide|oral lenalidomide
513962|NCT01373294|intravesical|intravesical
513963|NCT01373281|Dengue|dengue
513964|NCT01373281|Dengue fever|dengue fever
513965|NCT01373281|Dengue Hemorrhagic Fever|dengue hemorrhagic fever
513966|NCT01373281|CYD dengue vaccine|cyd dengue vaccine
513967|NCT01373281|Flavivirus|flavivirus
513968|NCT01373255|Placenta accreta|placenta accreta
513969|NCT01373255|Internal iliac artery catheterization|internal iliac artery catheterization
513970|NCT01373255|Post partum bleeding|post partum bleeding
513971|NCT01373229|Chronic Lymphocytic Leukemia|chronic lymphocytic leukemia
513972|NCT01373229|CLL|cll
513973|NCT01373203|Acute Lung Injury(ALI)|acute lung injury(ali)
513974|NCT01373190|epilepsy|epilepsy
513975|NCT01373190|thermography|thermography
513976|NCT01373164|Neoplasms|neoplasms
513977|NCT01373164|Neoplasm Metastasis|neoplasm metastasis
513978|NCT01373164|Pancreatic Cancer|pancreatic cancer
513979|NCT01373138|Bioequivalence|bioequivalence
513980|NCT01373138|Desloratadine and pseudoephedrine|desloratadine and pseudoephedrine
513981|NCT01373138|crossover|crossover
513982|NCT01373125|Barrett's Esophagus|barrett's esophagus
513983|NCT01373125|Intestinal metaplasia|intestinal metaplasia
513984|NCT01373125|Gastroesophageal reflux disease (GERD)|gastroesophageal reflux disease (gerd)
513985|NCT01373125|Neosquamous epithelium|neosquamous epithelium
513986|NCT01373125|Radiofrequency ablation (RFA)|radiofrequency ablation (rfa)
513987|NCT01373112|arthroplasty|arthroplasty
513988|NCT01373112|knee replacement|knee replacement
513989|NCT01373112|Osteoarthritis|osteoarthritis
513990|NCT01373112|knee Infection|knee infection
513991|NCT01373112|Prosthetic Joint Infection|prosthetic joint infection
513992|NCT01373112|Complications; Arthroplasty, Infection or Inflammation|complications; arthroplasty, infection or inflammation
513993|NCT01373112|Complications; Arthroplasty|complications; arthroplasty
513994|NCT01373099|arthroplasty|arthroplasty
513995|NCT01373099|hip replacement|hip replacement
513996|NCT01373099|Osteoarthritis|osteoarthritis
513997|NCT01373099|knee Infection|knee infection
513998|NCT01373099|Prosthetic Joint Infection|prosthetic joint infection
513999|NCT01373099|Complications; Arthroplasty, Infection or Inflammation|complications; arthroplasty, infection or inflammation
514000|NCT01373099|Complications; Arthroplasty|complications; arthroplasty
514001|NCT01373086|Hypertension,|hypertension,
514002|NCT01373086|mild hypertension,|mild hypertension,
514003|NCT01373086|moderate hypertension,|moderate hypertension,
514004|NCT01373086|high blood pressure,|high blood pressure,
514005|NCT01373086|uncomplicated hypertension.|uncomplicated hypertension.
514006|NCT01373060|ASP1941|asp1941
514007|NCT01373060|ipragliflozin|ipragliflozin
514008|NCT01373060|plasma glucose|plasma glucose
514009|NCT01373060|urine glucose|urine glucose
514010|NCT01373047|liver metastases|liver metastases
514011|NCT01373047|immunotherapy|immunotherapy
514012|NCT01373047|regional therapy|regional therapy
514013|NCT01373047|T cells|t cells
514014|NCT01373008|Inhaled steroids|inhaled steroids
514015|NCT01373008|bronchopulmonary dysplasia|bronchopulmonary dysplasia
514016|NCT01373008|Infants with moderate to severe BPD|infants with moderate to severe bpd
514017|NCT01372995|critical care|critical care
514018|NCT01372995|nosocomial infection|nosocomial infection
514019|NCT01372995|antiAntimicrobial peptide expression|antiantimicrobial peptide expression
514020|NCT01372995|LL-37|ll-37
514021|NCT01372995|hBD-2|hbd-2
514022|NCT01372995|cathelicidin|cathelicidin
514023|NCT01372995|microbial peptide|microbial peptide
514150|NCT01372332|on-road car driving|on-road car driving
514024|NCT01372956|LDL-C, cholesterol, risk factor|ldl-c, cholesterol, risk factor
514025|NCT01372943|Clostridium difficile|clostridium difficile
514026|NCT01372943|recurrent|recurrent
514027|NCT01372943|infection|infection
514028|NCT01372930|Etanercept|etanercept
514029|NCT01372930|acute ST segment elevated myocardial infarction|acute st segment elevated myocardial infarction
514030|NCT01372930|percutaneous coronary intervention|percutaneous coronary intervention
514031|NCT01372930|myocardial reperfusion injury|myocardial reperfusion injury
514032|NCT01372904|Cisplatin|cisplatin
514033|NCT01372904|Hearing loss|hearing loss
514034|NCT01372904|Ototoxicity|ototoxicity
514035|NCT01372904|Intratympanic injection|intratympanic injection
514036|NCT01372904|Dexamethasone|dexamethasone
514037|NCT01372904|Steroids|steroids
514038|NCT01372904|Prevention|prevention
514039|NCT01372891|Contrast Induced Nephropathy|contrast induced nephropathy
514040|NCT01372891|percutaneous coronary interventions|percutaneous coronary interventions
514041|NCT01372878|Polyps|polyps
514042|NCT01372878|Capsule endoscopy|capsule endoscopy
514043|NCT01372878|Colonoscopy|colonoscopy
514044|NCT01372852|Diabetes mellitus|diabetes mellitus
514045|NCT01372839|Myocardial Infarction|myocardial infarction
514046|NCT01372839|Unstable Angina|unstable angina
514047|NCT01372826|Phase 1|phase 1
514048|NCT01372826|Pharmacokinetics|pharmacokinetics
514049|NCT01372826|NKTR-118|nktr-118
514050|NCT01372826|renal impairment|renal impairment
514051|NCT01372826|parallel study|parallel study
514052|NCT01372826|QTcF Interval|qtcf interval
514053|NCT01372826|AUC(0-t)|auc(0-t)
514054|NCT01372826|Cmax|cmax
514055|NCT01372826|tmax|tmax
514056|NCT01372813|Advanced Clear Cell Renal Cell Carcinoma|advanced clear cell renal cell carcinoma
514057|NCT01372813|Cancer|cancer
514058|NCT01372813|Renal|renal
514059|NCT01372813|Renal Cell Carcinoma|renal cell carcinoma
514060|NCT01372813|Kidney Cancer|kidney cancer
514061|NCT01372800|adiponectin|adiponectin
514062|NCT01372800|cardiovascular diseases|cardiovascular diseases
514063|NCT01372800|cerebrovascular diseases|cerebrovascular diseases
514064|NCT01372774|neurotoxicity|neurotoxicity
514065|NCT01372774|radiation toxicity|radiation toxicity
514066|NCT01372774|cognitive/functional effects|cognitive/functional effects
514067|NCT01372774|tumors metastatic to brain|tumors metastatic to brain
514068|NCT01372774|unspecified adult solid tumor, protocol specific|unspecified adult solid tumor, protocol specific
514069|NCT01372761|Obese|obese
514070|NCT01372761|Obesity|obesity
514071|NCT01372761|Overweight|overweight
514072|NCT01372748|cardiac arrest|cardiac arrest
514073|NCT01372748|cardiopulmonary resuscitation|cardiopulmonary resuscitation
514074|NCT01372735|pancreatic cancer|pancreatic cancer
514075|NCT01372735|intensity-modulated radiation therapy|intensity-modulated radiation therapy
514076|NCT01372735|intraoperative radiation therapy|intraoperative radiation therapy
514077|NCT01372722|treatment resistant|treatment resistant
514078|NCT01372709|abdominal|abdominal
514079|NCT01372709|aortic|aortic
514080|NCT01372709|aneurysm|aneurysm
514081|NCT01372683|Appetite|appetite
514082|NCT01372683|Satiety|satiety
514083|NCT01372683|Subjective energy|subjective energy
514084|NCT01372683|Oats|oats
514085|NCT01372670|Treating meal related anxiety|treating meal related anxiety
514086|NCT01372657|cataract|cataract
514087|NCT01372657|refraction|refraction
514089|NCT01372657|calculation|calculation
514090|NCT01372657|formula|formula
514091|NCT01372631|Reduction mammoplasty|reduction mammoplasty
514092|NCT01372631|mastectomy|mastectomy
514093|NCT01372631|partial mastectomy|partial mastectomy
514094|NCT01372631|lumpectomy|lumpectomy
514591|NCT01370408|Etoposide|etoposide
514095|NCT01372631|breast conserving surgery|breast conserving surgery
514096|NCT01372631|breast cancer|breast cancer
514097|NCT01372605|Depression|depression
514098|NCT01372605|HIV|hiv
514099|NCT01372605|Adherence|adherence
514100|NCT01372605|Collaborative care|collaborative care
514101|NCT01372605|Measurement-Based Care|measurement-based care
514102|NCT01372553|Primary care|primary care
514103|NCT01372553|Family History|family history
514104|NCT01372553|Risk Stratification|risk stratification
514105|NCT01372553|Cancer|cancer
514106|NCT01372553|Thrombosis|thrombosis
514107|NCT01372527|medical informatics|medical informatics
514108|NCT01372527|health IT|health it
514109|NCT01372527|primary care|primary care
514110|NCT01372527|screening|screening
514111|NCT01372527|cervical cancer|cervical cancer
514112|NCT01372527|colorectal cancer|colorectal cancer
514113|NCT01372527|breast cancer|breast cancer
514114|NCT01372527|mammography|mammography
514115|NCT01372527|colonoscopy|colonoscopy
514116|NCT01372527|pap smear|pap smear
514117|NCT01372514|Thromboembolism|thromboembolism
514118|NCT01372514|Venous Thromboembolism|venous thromboembolism
514119|NCT01372514|Pulmonary Embolism|pulmonary embolism
514120|NCT01372501|Obesity|obesity
514121|NCT01372488|Suture self removal|suture self removal
514122|NCT01372488|non-absorbable sutures|non-absorbable sutures
514123|NCT01372475|Osteoarthritis|osteoarthritis
514124|NCT01372475|Knee|knee
514125|NCT01372475|Hyaluronan|hyaluronan
514126|NCT01372475|Hyaluronic Acid|hyaluronic acid
514127|NCT01372475|Viscoelastic|viscoelastic
514128|NCT01372475|Hydrogel|hydrogel
514129|NCT01372462|COPD|copd
514130|NCT01372462|Ventilator|ventilator
514131|NCT01372462|Constant work rate|constant work rate
514132|NCT01372449|Autism|autism
514133|NCT01372449|Psychopharmacology|psychopharmacology
514134|NCT01372449|Clinical Trial|clinical trial
514135|NCT01372449|Children|children
514136|NCT01372436|dental decay|dental decay
514137|NCT01372436|DMFT|dmft
514138|NCT01372436|Individual Caries Risk|individual caries risk
514139|NCT01372436|Risk factors|risk factors
514140|NCT01372410|Long acting muscarinic antagonist|long acting muscarinic antagonist
514141|NCT01372410|Tiotropium|tiotropium
514142|NCT01372410|Chronic Bronchitis|chronic bronchitis
514143|NCT01372410|Emphysema|emphysema
514144|NCT01372410|Chronic Obstructive Pulmonary Disease|chronic obstructive pulmonary disease
514145|NCT01372371|Vancomycin, Gentamycin|vancomycin, gentamycin
514146|NCT01372371|Local Powder Antibiotic's Efficacy in Controlling Post Surgical Infection|local powder antibiotic's efficacy in controlling post surgical infection
514147|NCT01372332|homonymous hemianopia|homonymous hemianopia
514148|NCT01372332|quality of life (QoL)|quality of life (qol)
514149|NCT01372332|visual exploration|visual exploration
514151|NCT01372332|driving simulator|driving simulator
514152|NCT01372332|useful field of view (UFOV)|useful field of view (ufov)
514153|NCT01372332|modified field of view (MAFOV)|modified field of view (mafov)
514154|NCT01372319|glaucoma|glaucoma
653764|NCT00814528|AK|ak
514155|NCT01372319|binocular visual field loss|binocular visual field loss
514156|NCT01372319|semi-automated kinetic perimetry (SKP)|semi-automated kinetic perimetry (skp)
514157|NCT01372319|quality of life (QoL)|quality of life (qol)
514158|NCT01372319|visual exploration|visual exploration
514159|NCT01372319|on-road car driving|on-road car driving
514160|NCT01372319|driving simulator|driving simulator
514161|NCT01372293|PCOS|pcos
514162|NCT01372293|oral contraceptive pill|oral contraceptive pill
514163|NCT01372293|polymorphisms|polymorphisms
514164|NCT01372267|Cognitive Behavioral Therapy|cognitive behavioral therapy
514165|NCT01372267|Chronic Pain|chronic pain
514166|NCT01372267|Substance Use Disorders|substance use disorders
514167|NCT01372267|Psychoeducational control group|psychoeducational control group
514168|NCT01372254|Cigarette Smoking|cigarette smoking
514169|NCT01372254|Drug Use|drug use
514170|NCT01372254|Depressed Mood|depressed mood
514171|NCT01372241|Papanicolaou test|papanicolaou test
514172|NCT01372241|Cervical cancer screening|cervical cancer screening
514173|NCT01372241|Randomized controlled trial|randomized controlled trial
514174|NCT01372241|Faith-placed|faith-placed
514175|NCT01372241|Appalachia|appalachia
514176|NCT01372228|hematopoietic stem cell Tx, chimerism, leukodystrophy|hematopoietic stem cell tx, chimerism, leukodystrophy
514177|NCT01372215|Breast mass|breast mass
514178|NCT01372215|Breast lesion|breast lesion
514179|NCT01372202|Operable|operable
514180|NCT01372202|Based on CHFR Methylation Status|based on chfr methylation status
514181|NCT01372202|Diagnostic Biopsies|diagnostic biopsies
514182|NCT01372189|molecular imaging|molecular imaging
514183|NCT01372189|epidermal growth factor receptor|epidermal growth factor receptor
514184|NCT01372189|colorectal neoplasia|colorectal neoplasia
514185|NCT01372189|confocal laser endomicroscopy|confocal laser endomicroscopy
514186|NCT01372176|Intensive care unit|intensive care unit
514187|NCT01372176|Critical illness|critical illness
514188|NCT01372176|Mortality|mortality
514189|NCT01372176|Reduced quality of life|reduced quality of life
514190|NCT01372176|Loss of lean body mass|loss of lean body mass
514191|NCT01372176|Loss of physical function|loss of physical function
514192|NCT01372176|Optimised nutritional support|optimised nutritional support
514193|NCT01372176|Early initiation of nutrition|early initiation of nutrition
514194|NCT01372176|Indirect calorimetry|indirect calorimetry
514195|NCT01372163|Phase 1|phase 1
514196|NCT01372163|Multiple Ascending Doses|multiple ascending doses
514197|NCT01372163|Safety|safety
514198|NCT01372163|Pharmacokinetics|pharmacokinetics
514199|NCT01372163|Healthy Volunteers|healthy volunteers
514200|NCT01372163|Type 2 Diabetic Patients|type 2 diabetic patients
514201|NCT01372150|major depressive disorder|major depressive disorder
514202|NCT01372150|MDD|mdd
514203|NCT01372150|depression|depression
514204|NCT01372137|NOX-H94|nox-h94
514205|NCT01372137|Hepcidin|hepcidin
514206|NCT01372137|Anemia|anemia
514207|NCT01372137|Inflammation|inflammation
514208|NCT01372124|Renal impairment|renal impairment
514209|NCT01372124|NOX-E36|nox-e36
514210|NCT01372111|Stg III or IVa Squamous Cell Carcinoma.|stg iii or iva squamous cell carcinoma.
514211|NCT01372111|Advanced|advanced
514212|NCT01372098|Domestic Violence|domestic violence
514213|NCT01372098|Spouse Abuse|spouse abuse
514214|NCT01372072|chronic respiratory hypercapnic failure|chronic respiratory hypercapnic failure
514215|NCT01372046|technology transfer|technology transfer
514216|NCT01372046|skill development|skill development
514217|NCT01372046|organizational change|organizational change
514218|NCT01372033|drug treatment|drug treatment
514219|NCT01372033|substance abuse|substance abuse
514220|NCT01372033|offenders|offenders
514221|NCT01372033|high risk|high risk
514222|NCT01372020|Varicose ulcer|varicose ulcer
514223|NCT01372020|wound healing|wound healing
514224|NCT01372020|electrical stimulation|electrical stimulation
514225|NCT01372007|Rectal carcinoma|rectal carcinoma
514226|NCT01371994|Radical Robotic Arm|radical robotic arm
514227|NCT01371994|Vesicare|vesicare
514228|NCT01371994|Post Prostatectomy Incontinence|post prostatectomy incontinence
514229|NCT01371994|YM905|ym905
514230|NCT01371968|Alfentanil|alfentanil
514231|NCT01371968|optimal dose|optimal dose
514232|NCT01371968|laryngeal mask airway|laryngeal mask airway
514233|NCT01371955|diabetic nephropathy|diabetic nephropathy
514234|NCT01371955|CYBA|cyba
514235|NCT01371955|p22phox|p22phox
514236|NCT01371955|RAGE|rage
514237|NCT01371955|12LOX|12lox
514238|NCT01371955|genetic|genetic
514239|NCT01371955|Type 1 Diabetes Mellitus with Diabetic Dermatitis|type 1 diabetes mellitus with diabetic dermatitis
514240|NCT01371955|caucasian|caucasian
514241|NCT01371955|more than twenty years of diabetes duration|more than twenty years of diabetes duration
514242|NCT01371955|older than 18 years|older than 18 years
514243|NCT01371955|no nephropathy other than diabetic nephropathy|no nephropathy other than diabetic nephropathy
514244|NCT01371942|Colorectal cancer(CRC)|colorectal cancer(crc)
514245|NCT01371916|tuberculous meningitis|tuberculous meningitis
514246|NCT01371916|early secretory antigenic target 6|early secretory antigenic target 6
514247|NCT01371916|diagnosis|diagnosis
514248|NCT01371903|morphine|morphine
514249|NCT01371903|fentanyl|fentanyl
514250|NCT01371903|dilaudid|dilaudid
514251|NCT01371903|opioid|opioid
514252|NCT01371903|capnography|capnography
514253|NCT01371890|hemodialysis|hemodialysis
514254|NCT01371890|end-stage renal disease|end-stage renal disease
514255|NCT01371890|hypertension|hypertension
514256|NCT01371877|urticaria|urticaria
514257|NCT01371877|angioedema|angioedema
514258|NCT01371877|hive|hive
514259|NCT01371877|swelling|swelling
514260|NCT01371864|Congenital cardiac disease|congenital cardiac disease
514261|NCT01371864|Teamwork|teamwork
514262|NCT01371864|Communication|communication
514263|NCT01371864|Peri-operative|peri-operative
514264|NCT01371838|Community-Acquired Bacterial Pneumonia|community-acquired bacterial pneumonia
514265|NCT01371825|LIPA|lipa
514266|NCT01371825|Wolman Disease|wolman disease
514267|NCT01371825|Wolman Phenotype|wolman phenotype
514268|NCT01371825|Acid Lipase Deficiency|acid lipase deficiency
514269|NCT01371825|Acid Cholesteryl Hydrolase|acid cholesteryl hydrolase
514270|NCT01371825|Acid Lipase Disease Deficiency, type 2|acid lipase disease deficiency, type 2
514271|NCT01371825|Cholesteryl Ester Storage Disease (CESD)|cholesteryl ester storage disease (cesd)
514272|NCT01371825|Cholesteryl Ester Hydrolase Deficiency|cholesteryl ester hydrolase deficiency
514273|NCT01371825|Early Onset Lysosomal Acid Lipase Deficiency (Wolman Disease)|early onset lysosomal acid lipase deficiency (wolman disease)
514274|NCT01371825|LAL Deficiency|lal deficiency
514275|NCT01371825|Late Onset Lysosomal Acid Lipase Deficiency (CESD)|late onset lysosomal acid lipase deficiency (cesd)
514276|NCT01371825|Wolman Disease (early onset LAL Deficiency)|wolman disease (early onset lal deficiency)
514277|NCT01371825|Related Disorders:|related disorders:
514278|NCT01371825|Non-alcoholic Fatty Liver Disease (NAFLD)|non-alcoholic fatty liver disease (nafld)
514279|NCT01371825|Non-alcoholic Steatohepatitis (NASH)|non-alcoholic steatohepatitis (nash)
514280|NCT01371825|Alcoholic Liver Disease|alcoholic liver disease
514281|NCT01371825|Cryptogenic Cirrhosis|cryptogenic cirrhosis
514282|NCT01371825|Niemann-Pick Disease (NPD) Type C|niemann-pick disease (npd) type c
514283|NCT01371825|Chanarin Dorfman Syndrome|chanarin dorfman syndrome
514284|NCT01371799|Schizophrenia|schizophrenia
514285|NCT01371786|Ciclesonide|ciclesonide
514286|NCT01371786|Allergic Rhinitis|allergic rhinitis
514287|NCT01371760|Multiple sclerosis|multiple sclerosis
514288|NCT01371760|Chronic cerebrospinal venous insufficiency|chronic cerebrospinal venous insufficiency
514289|NCT01371760|Percutaneous Transluminal Angioplasty (PTA)|percutaneous transluminal angioplasty (pta)
514290|NCT01371760|Internal jugular vein|internal jugular vein
514291|NCT01371760|Azygous vein|azygous vein
514292|NCT01371747|Hyperkalemia|hyperkalemia
514293|NCT01371747|Chronic Kidney Disease|chronic kidney disease
514294|NCT01371747|Treatment of Hyperkalemia|treatment of hyperkalemia
514295|NCT01371747|Hypertension|hypertension
514296|NCT01371747|Diabetic Nephropathy|diabetic nephropathy
514297|NCT01371734|Major Depressive Disorder|major depressive disorder
514299|NCT01371734|Depression|depression
514300|NCT01371721|Major Depressive Disorder|major depressive disorder
514301|NCT01371721|MDD|mdd
514302|NCT01371721|Depression|depression
514303|NCT01371708|Major Depressive Disorder|major depressive disorder
514304|NCT01371708|MDD|mdd
514305|NCT01371708|Depression|depression
514306|NCT01371695|IGF-II levels|igf-ii levels
514307|NCT01371669|Pulmonary arterial hypertension|pulmonary arterial hypertension
514308|NCT01371669|Chronic post embolic disease|chronic post embolic disease
514309|NCT01371669|Sleep hypoxemia|sleep hypoxemia
514310|NCT01371669|polysomnography|polysomnography
514311|NCT01371669|sleep apnea|sleep apnea
514312|NCT01371669|periodic respiration|periodic respiration
514313|NCT01371617|IPI-926|ipi-926
514314|NCT01371617|926|926
514315|NCT01371617|Myelofibrosis|myelofibrosis
514316|NCT01371617|Hedgehog|hedgehog
514317|NCT01371617|Infinity Pharmaceuticals|infinity pharmaceuticals
514318|NCT01371617|Post Essential thrombocythemia|post essential thrombocythemia
514319|NCT01371617|Post Polycythemia vera|post polycythemia vera
514320|NCT01371604|Hepatitis C|hepatitis c
514321|NCT01371604|HCV|hcv
514322|NCT01371604|treatment-naive|treatment-naive
514323|NCT01371591|Bleeding|bleeding
514324|NCT01371591|gastrointestinal|gastrointestinal
514325|NCT01371591|hemorrhage|hemorrhage
514326|NCT01371591|ulcer|ulcer
514327|NCT01371591|varix|varix
514328|NCT01371591|varices|varices
514329|NCT01371591|ulcers|ulcers
514330|NCT01371591|GI|gi
514331|NCT01371591|stomach|stomach
514332|NCT01371591|esophagus|esophagus
514333|NCT01371591|duodenum|duodenum
514334|NCT01371591|melena|melena
514335|NCT01371591|hematemesis|hematemesis
514336|NCT01371591|coffee-ground|coffee-ground
514337|NCT01371578|Hepatitis C|hepatitis c
514338|NCT01371578|HCV|hcv
514339|NCT01371578|Rapid Virologic Response|rapid virologic response
514340|NCT01371578|Sustained Virologic Response|sustained virologic response
514341|NCT01371578|Direct Acting Antiviral|direct acting antiviral
514342|NCT01371578|Combination Therapy HCV RNA|combination therapy hcv rna
514343|NCT01371578|Polymerase inhibitor|polymerase inhibitor
514344|NCT01371578|Protease inhibitor|protease inhibitor
514345|NCT01371578|Treatment naïve|treatment naïve
514346|NCT01371578|GS-5885|gs-5885
514347|NCT01371578|GS-9190|gs-9190
514348|NCT01371578|Tegobuvir|tegobuvir
514349|NCT01371578|GS-9451|gs-9451
514350|NCT01371565|Cushing's Disease|cushing's disease
514351|NCT01371565|Cushing's Syndrome|cushing's syndrome
514352|NCT01371565|Cushings|cushings
514353|NCT01371565|Pituitary|pituitary
514354|NCT01371565|Ectopic ACTH secretion|ectopic acth secretion
514355|NCT01371539|Myopia|myopia
514356|NCT01371539|Presbyopia|presbyopia
514357|NCT01371513|Serum prostate specific antigen|serum prostate specific antigen
514358|NCT01371422|Paravertebral nerve blockade|paravertebral nerve blockade
514359|NCT01371422|Percutaneous nephrolithotomy/nephrolithotripsy|percutaneous nephrolithotomy/nephrolithotripsy
514360|NCT01371422|opioids|opioids
514361|NCT01371422|pain|pain
514362|NCT01371409|Stroke|stroke
514363|NCT01371409|TMS|tms
514364|NCT01371409|Paired Pulse|paired pulse
514365|NCT01371409|EEG|eeg
514366|NCT01371409|Motor Learning|motor learning
514367|NCT01371396|Metabolic syndrome|metabolic syndrome
514368|NCT01371396|Non-alcoholic fatty liver disease|non-alcoholic fatty liver disease
514369|NCT01371396|Obesity Metabolism|obesity metabolism
514370|NCT01371396|Stable isotopes|stable isotopes
514371|NCT01371396|Dietary weight loss|dietary weight loss
514372|NCT01371370|low intensity resistance exercise training|low intensity resistance exercise training
514373|NCT01371370|hypocaloric diet|hypocaloric diet
514374|NCT01371370|prehypertension|prehypertension
514375|NCT01371370|hypertension|hypertension
514376|NCT01371370|obesity|obesity
514377|NCT01371370|arterial function|arterial function
514378|NCT01371370|arterial stiffness|arterial stiffness
514379|NCT01371370|pulse wave velocity|pulse wave velocity
514380|NCT01371370|autonomic function|autonomic function
514381|NCT01371370|endothelial function|endothelial function
514382|NCT01371370|adipocytokines|adipocytokines
514383|NCT01371357|Remethylation|remethylation
514384|NCT01371357|Human Subjects|human subjects
514385|NCT01371357|Clinical Trial|clinical trial
514386|NCT01371357|B-vitamin|b-vitamin
514387|NCT01371357|Creatine|creatine
514388|NCT01371344|Liver Transplantation|liver transplantation
514389|NCT01371344|Kidney Transplantation|kidney transplantation
514592|NCT01370408|Carboplatin|carboplatin
514390|NCT01371344|Heart Transplantation|heart transplantation
514391|NCT01371344|Pharmacokinetics|pharmacokinetics
514392|NCT01371331|Kidney Transplantation|kidney transplantation
514393|NCT01371331|Pharmacokinetics|pharmacokinetics
514394|NCT01371331|Heart Transplantation|heart transplantation
514395|NCT01371331|Liver Transplantation|liver transplantation
514396|NCT01371318|diabetic foot ulcer|diabetic foot ulcer
514397|NCT01371318|amputation|amputation
514398|NCT01371318|wounds|wounds
514399|NCT01371318|diabetic foot|diabetic foot
514400|NCT01371318|diabetes complications|diabetes complications
514401|NCT01371292|Physical activity|physical activity
514402|NCT01371292|Transformational leadership|transformational leadership
514403|NCT01371292|Physical education|physical education
514404|NCT01371266|Glucose intolerance|glucose intolerance
514405|NCT01371266|Insulin resistance|insulin resistance
514406|NCT01371266|Insulin|insulin
514407|NCT01371266|metabolic syndrome|metabolic syndrome
514408|NCT01371266|honey|honey
514409|NCT01371266|Inflammation|inflammation
514410|NCT01371266|oxidative stress|oxidative stress
514411|NCT01371253|Nintendo wii|nintendo wii
514412|NCT01371253|postural balance|postural balance
514413|NCT01371253|muscle strength|muscle strength
514414|NCT01371253|elderly|elderly
514415|NCT01371240|pancreas cancer|pancreas cancer
514417|NCT01371240|CT scan|ct scan
514418|NCT01371227|Multiple myeloma|multiple myeloma
514419|NCT01371227|Relapsed or refractory multiple myeloma|relapsed or refractory multiple myeloma
514420|NCT01371227|JNS002|jns002
514421|NCT01371227|Bortezomib|bortezomib
514422|NCT01371214|exercise|exercise
514423|NCT01371214|exercise movement techniques|exercise movement techniques
514424|NCT01371214|activities of daily living|activities of daily living
514425|NCT01371175|HIV|hiv
514426|NCT01371123|serum aluminum|serum aluminum
514427|NCT01371123|parenteral nutrition|parenteral nutrition
514428|NCT01371123|children|children
514429|NCT01371110|OCD|ocd
514430|NCT01371110|Obsessive-Compulsive Disorder|obsessive-compulsive disorder
514431|NCT01371110|ketamine|ketamine
514432|NCT01371110|treatment|treatment
514433|NCT01371097|Barthel Index|barthel index
514434|NCT01371097|elderly hospitalised patients|elderly hospitalised patients
514435|NCT01371097|progressive resistance training|progressive resistance training
514436|NCT01371071|Clinically isolated syndrome (CIS)|clinically isolated syndrome (cis)
514437|NCT01371071|Multiple sclerosis (MS)|multiple sclerosis (ms)
514438|NCT01371071|Immunomodulatory therapy|immunomodulatory therapy
514439|NCT01371071|Prognostic markers|prognostic markers
514440|NCT01371071|MRI|mri
514441|NCT01371071|OCT|oct
514442|NCT01371058|high on-treatment platelet reactivity|high on-treatment platelet reactivity
514443|NCT01371058|percutaneous coronary intervention|percutaneous coronary intervention
514444|NCT01371058|stent thrombosis|stent thrombosis
514445|NCT01371045|Acromegaly|acromegaly
514446|NCT01371045|Growth Hormone|growth hormone
514447|NCT01371045|Carcinoid Syndrome|carcinoid syndrome
514448|NCT01371045|Somatostatin|somatostatin
514449|NCT01371019|Preterm Birth, Proteomics|preterm birth, proteomics
514450|NCT01370993|Hypoxemia|hypoxemia
514451|NCT01370993|Model|model
514452|NCT01370993|Bronchoscopes|bronchoscopes
514453|NCT01370993|Monitored anesthesia care|monitored anesthesia care
514454|NCT01370980|Medication Adherence|medication adherence
514455|NCT01370980|Patient Compliance|patient compliance
514456|NCT01370980|Patient Acceptance of Health Care|patient acceptance of health care
514457|NCT01370980|Administration, Oral|administration, oral
514458|NCT01370980|Cancer|cancer
514459|NCT01370980|Letrozol|letrozol
514460|NCT01370980|Exemestan|exemestan
514461|NCT01370980|Imatinib|imatinib
514462|NCT01370980|Sunitinib|sunitinib
514463|NCT01370980|Nilotinib|nilotinib
514464|NCT01370980|Everolimus|everolimus
514465|NCT01370980|Deferasirox|deferasirox
514466|NCT01370967|infant|infant
514467|NCT01370967|term birth|term birth
514468|NCT01370967|human milk|human milk
514469|NCT01370967|infant formula|infant formula
514470|NCT01370967|breast feeding|breast feeding
514471|NCT01370967|bottle feeding|bottle feeding
514472|NCT01370967|gastrointestinal tract|gastrointestinal tract
514473|NCT01370967|quality of life|quality of life
514474|NCT01370967|infant development|infant development
514475|NCT01370954|CerefolinNAC|cerefolinnac
514476|NCT01370954|early memory loss|early memory loss
514477|NCT01370954|pre-alzheimer's disease|pre-alzheimer's disease
514478|NCT01370954|cognitive function|cognitive function
514479|NCT01370954|folic acid|folic acid
514480|NCT01370954|folate|folate
514481|NCT01370954|L-methylfolate|l-methylfolate
514482|NCT01370954|vitamin B12|vitamin b12
514483|NCT01370954|methylcobalamin|methylcobalamin
514484|NCT01370954|N-acetylcysteine|n-acetylcysteine
514485|NCT01370954|NAC|nac
514486|NCT01370954|oxidative stress|oxidative stress
514487|NCT01370954|memory deficit|memory deficit
514488|NCT01370954|antioxidant|antioxidant
514489|NCT01370941|Chymosin|chymosin
514490|NCT01370941|24H urine calcium excretion|24h urine calcium excretion
514491|NCT01370941|Calcium absorption|calcium absorption
514492|NCT01370941|Intestinal Absorption of Calcium|intestinal absorption of calcium
514493|NCT01370928|Colonoscopy performance|colonoscopy performance
514494|NCT01370928|Pain|pain
514495|NCT01370928|Discomfort|discomfort
514496|NCT01370928|Screening|screening
514497|NCT01370928|Colorectal cancer|colorectal cancer
514498|NCT01370928|Colorectal cancer screening, diagnostics of adenomas|colorectal cancer screening, diagnostics of adenomas
514499|NCT01370915|postoperative pain, nasal septum surgery, pregabalin|postoperative pain, nasal septum surgery, pregabalin
514500|NCT01370876|Oxaliplatin|oxaliplatin
514501|NCT01370876|Head and Neck cancer|head and neck cancer
514502|NCT01370863|GERD|gerd
514503|NCT01370863|Gastroesophageal reflux disease|gastroesophageal reflux disease
514504|NCT01370863|SPD557|spd557
514505|NCT01370863|Proton pump inhibitors|proton pump inhibitors
514506|NCT01370850|Retina pathology|retina pathology
514507|NCT01370824|Diagnosis|diagnosis
514508|NCT01370824|Clinical|clinical
514509|NCT01370824|Punch biopsy|punch biopsy
514510|NCT01370824|Surgical excision|surgical excision
514511|NCT01370824|Histology|histology
514512|NCT01370824|Histopathology|histopathology
514513|NCT01370824|Observed agreement|observed agreement
514514|NCT01370824|Diagnostic value|diagnostic value
514515|NCT01370824|Accuracy|accuracy
514516|NCT01370824|Interobserver variability|interobserver variability
514517|NCT01370824|Intraobserver variability|intraobserver variability
514518|NCT01370811|oxybutynin|oxybutynin
514519|NCT01370811|clonidine|clonidine
514520|NCT01370811|OC Oral Solution|oc oral solution
514521|NCT01370811|sialorrhoea|sialorrhoea
514522|NCT01370811|Parkinson's disease|parkinson's disease
514523|NCT01370798|Severe hypospadias|severe hypospadias
514524|NCT01370798|local oestrogen|local oestrogen
514525|NCT01370798|promestriene|promestriene
514526|NCT01370798|Onlay-tube-onlay urethroplasty|onlay-tube-onlay urethroplasty
514527|NCT01370798|post-operative complications|post-operative complications
514528|NCT01370798|fistula dehiscence|fistula dehiscence
514529|NCT01370772|B CLL|b cll
514530|NCT01370772|Fist line treatment|fist line treatment
514531|NCT01370759|bowel prep|bowel prep
514532|NCT01370759|PillCam|pillcam
514533|NCT01370733|TMS,|tms,
514534|NCT01370733|MDD,|mdd,
514535|NCT01370733|Depression,|depression,
514536|NCT01370733|sTMS,|stms,
514537|NCT01370733|NEST,|nest,
514538|NCT01370733|NeoSync,|neosync,
514539|NCT01370733|EEG,|eeg,
514540|NCT01370733|synchronous,|synchronous,
514541|NCT01370733|non-invasive neuromodulation,|non-invasive neuromodulation,
514542|NCT01370733|transcranial magnetic stimulation,|transcranial magnetic stimulation,
514543|NCT01370733|antidepressant,|antidepressant,
514544|NCT01370720|IBS|ibs
514545|NCT01370720|mast cell activation|mast cell activation
514546|NCT01370720|low grade inflammation|low grade inflammation
514547|NCT01370720|visceral hyperalgesia|visceral hyperalgesia
514548|NCT01370668|functional remediation|functional remediation
514549|NCT01370668|psychoeducation|psychoeducation
514550|NCT01370668|neurocognition|neurocognition
514551|NCT01370629|atrial fibrillation|atrial fibrillation
514552|NCT01370629|cardioversion|cardioversion
514553|NCT01370616|Infection|infection
514554|NCT01370616|Diabetes complications|diabetes complications
514555|NCT01370616|Diabetes wound infection|diabetes wound infection
514556|NCT01370616|Soft tissue infection|soft tissue infection
514557|NCT01370616|Osteomyelitis|osteomyelitis
514558|NCT01370616|Diabetes mellitus|diabetes mellitus
514559|NCT01370577|Predictors for asthma control|predictors for asthma control
514560|NCT01370577|Asthma Exacerbation rate|asthma exacerbation rate
514561|NCT01370577|Mean frequency of PFT|mean frequency of pft
514562|NCT01370577|sputum assessments|sputum assessments
514563|NCT01370577|refill adherence(%)|refill adherence(%)
514564|NCT01370577|prescription persistence|prescription persistence
514565|NCT01370564|Heart failure|heart failure
514566|NCT01370564|Cardiac filling pressure|cardiac filling pressure
514567|NCT01370538|Heartburn|heartburn
514568|NCT01370525|Heartburn|heartburn
514569|NCT01370486|Lennox-Gastaut syndrome|lennox-gastaut syndrome
514570|NCT01370486|Epileptic encephalopathy|epileptic encephalopathy
514571|NCT01370486|Melatonin|melatonin
514572|NCT01370486|Tonic seizures|tonic seizures
514573|NCT01370486|Interictal discharges|interictal discharges
514574|NCT01370486|Quality of sleep|quality of sleep
514575|NCT01370473|Hyponatremia|hyponatremia
514576|NCT01370460|Tranexamic Acid|tranexamic acid
514577|NCT01370460|Blood transfusion|blood transfusion
514578|NCT01370460|Total knee arthroplasty|total knee arthroplasty
514579|NCT01370447|Leigh syndrome|leigh syndrome
514580|NCT01370447|MELAS|melas
514581|NCT01370447|Kearns-Sayre|kearns-sayre
514582|NCT01370447|Alper's|alper's
514583|NCT01370447|Inherited mitochondrial disease|inherited mitochondrial disease
514584|NCT01370447|Friedreich's ataxia|friedreich's ataxia
514585|NCT01370447|POLG1 deficiency|polg1 deficiency
514586|NCT01370434|MM|mm
514587|NCT01370408|Autologous stem cell transplant|autologous stem cell transplant
514588|NCT01370408|BEAM|beam
514589|NCT01370408|Oral busulfan|oral busulfan
514590|NCT01370408|Cyclophosphamide|cyclophosphamide
514593|NCT01370408|melphalan|melphalan
514594|NCT01370395|geriatrics|geriatrics
514595|NCT01370395|troponin|troponin
514596|NCT01370395|electrocardiography|electrocardiography
514597|NCT01370395|diagnosis|diagnosis
514598|NCT01370395|myocardial infarction|myocardial infarction
514599|NCT01370382|geriatrics|geriatrics
514600|NCT01370382|troponin|troponin
514601|NCT01370382|electrocardiography|electrocardiography
514602|NCT01370382|diagnosis|diagnosis
514603|NCT01370382|myocardial infarction|myocardial infarction
514604|NCT01370356|smoking reduction|smoking reduction
514605|NCT01370356|smoking cessation|smoking cessation
514606|NCT01370330|Neuroblastoma|neuroblastoma
514607|NCT01370330|MIBG|mibg
514608|NCT01370330|131I-MIBG|131i-mibg
514609|NCT01370330|Resistant|resistant
514610|NCT01370330|Relapsed|relapsed
514611|NCT01370330|Treatment|treatment
514612|NCT01370330|University of California, San Francisco|university of california, san francisco
514613|NCT01370330|Pediatric|pediatric
514614|NCT01370330|Oncology|oncology
514615|NCT01370304|repetitive Transcranial Magnetic Stimulation (rTMS)|repetitive transcranial magnetic stimulation (rtms)
514616|NCT01370304|Depression|depression
514617|NCT01370304|Venlafaxine|venlafaxine
514618|NCT01370304|fMRI|fmri
514619|NCT01370291|rTMS|rtms
514620|NCT01370291|Risperidone|risperidone
514621|NCT01370278|Central airway obstruction|central airway obstruction
514622|NCT01370278|lumen obstruction|lumen obstruction
514623|NCT01370278|Sodium bicarbonate|sodium bicarbonate
514624|NCT01370278|Baking soda|baking soda
514625|NCT01370278|Normal saline|normal saline
514626|NCT01370278|Salt water|salt water
514627|NCT01370278|Airway stents|airway stents
514628|NCT01370278|Bronchoscopy|bronchoscopy
514629|NCT01370278|mucus obstruction|mucus obstruction
514630|NCT01370265|Regadenoson (Lexiscan)|regadenoson (lexiscan)
514631|NCT01370265|PET N-13 ammonia imaging|pet n-13 ammonia imaging
514632|NCT01370265|Myocardial Blood Flow (MBF)|myocardial blood flow (mbf)
514633|NCT01370265|Regadenoson Stress|regadenoson stress
514634|NCT01370252|ankle arthrodesis|ankle arthrodesis
514635|NCT01370252|pain|pain
514636|NCT01370252|arthroscopic technique|arthroscopic technique
514637|NCT01370252|ankle osteoarthritis|ankle osteoarthritis
514638|NCT01370239|monoclonal antibody|monoclonal antibody
514639|NCT01370239|Lewis|lewis
514640|NCT01370239|breast cancer|breast cancer
514641|NCT01370213|non-myeloablative haploidentical transplant|non-myeloablative haploidentical transplant
514642|NCT01370213|hematopoietic cell transplant|hematopoietic cell transplant
514643|NCT01370213|natural killer cells|natural killer cells
514644|NCT01370213|adoptive cellular therapy|adoptive cellular therapy
514645|NCT01370200|citrate|citrate
514646|NCT01370200|anticoagulation|anticoagulation
514647|NCT01370200|plasma exchange|plasma exchange
514648|NCT01370200|efficacy|efficacy
514649|NCT01370187|Bronchiolitis|bronchiolitis
514650|NCT01370187|Postbronchiolitis wheezing|postbronchiolitis wheezing
514651|NCT01370187|Montelukast|montelukast
514652|NCT01370174|Falls|falls
514653|NCT01370174|Balance|balance
514654|NCT01370174|Protective Stepping|protective stepping
514655|NCT01370174|Lateral Balance|lateral balance
514656|NCT01370174|Elderly|elderly
514657|NCT01370161|transjugular intrahepatic portosystemic shunt|transjugular intrahepatic portosystemic shunt
514658|NCT01370161|TIPS|tips
514659|NCT01370161|variceal bleeding|variceal bleeding
514660|NCT01370161|liver cirrhosis|liver cirrhosis
514661|NCT01370161|hepatitis B|hepatitis b
514662|NCT01370148|Pharmacokinetics|pharmacokinetics
514663|NCT01370148|Protein Binding|protein binding
514664|NCT01370148|Conivaptan|conivaptan
514665|NCT01370148|Vaprisol|vaprisol
514666|NCT01370148|Liver Disease|liver disease
514667|NCT01370148|YM087|ym087
514668|NCT01370135|neovascular glaucoma|neovascular glaucoma
514669|NCT01370135|rubeosis|rubeosis
514670|NCT01370135|anterior chamber|anterior chamber
514671|NCT01370135|intraocular|intraocular
514672|NCT01370135|intravitreal injections|intravitreal injections
514673|NCT01370135|Lucentis|lucentis
514674|NCT01370135|Ranibizumab|ranibizumab
514675|NCT01370135|short ans longterm effects|short ans longterm effects
514676|NCT01370135|best corrected visual acuity|best corrected visual acuity
514677|NCT01370135|gonioscopy|gonioscopy
514678|NCT01370135|BCVA|bcva
514679|NCT01370135|quality of life|quality of life
514680|NCT01370122|Women over the age of 20|women over the age of 20
514681|NCT01370083|Dysphagia|dysphagia
514682|NCT01370083|Viscosity|viscosity
514683|NCT01370083|Tongue|tongue
514684|NCT01370083|Pressure|pressure
514685|NCT01370057|Adolescent Idiopathic Scoliosis|adolescent idiopathic scoliosis
514686|NCT01370057|Scoliosis|scoliosis
514688|NCT01370057|Brace|brace
514689|NCT01370057|TLSO|tlso
514690|NCT01370044|Febrile Seizure|febrile seizure
514691|NCT01370044|Carbon Dioxide|carbon dioxide
514692|NCT01370044|Carbogen|carbogen
514693|NCT01370044|Respiratory Alkalosis|respiratory alkalosis
514694|NCT01370031|Asthma|asthma
514695|NCT01370031|PK|pk
514696|NCT01370031|Adults|adults
514697|NCT01370018|CD4 counts|cd4 counts
514895|NCT01369342|Crohn's|crohn's
514698|NCT01369992|Metastatic Cancer|metastatic cancer
514699|NCT01369979|Lumped constant|lumped constant
514701|NCT01369979|PET|pet
514702|NCT01369966|Smoking Cessation|smoking cessation
514703|NCT01369966|Schizophrenic Smokers|schizophrenic smokers
514704|NCT01369966|fMRI|fmri
514705|NCT01369966|Neural Circuits|neural circuits
514706|NCT01369953|Civic Ideals/Social Norms|civic ideals/social norms
514707|NCT01369953|Genetic Counseling|genetic counseling
514708|NCT01369953|Genetic Disorders|genetic disorders
514709|NCT01369953|Genetic Testing|genetic testing
514710|NCT01369953|Whole Genome Sequencing|whole genome sequencing
514711|NCT01369940|Growth Discordancy|growth discordancy
514712|NCT01369940|Fetal Growth|fetal growth
514713|NCT01369940|Twin Growth|twin growth
514714|NCT01369927|Shigellosis|shigellosis
514715|NCT01369927|Safety and Immunogenicity|safety and immunogenicity
514716|NCT01369927|Conjugate Vaccine|conjugate vaccine
514717|NCT01369914|Graft-Versus-Host Disease|graft-versus-host disease
514718|NCT01369914|Natural History Study|natural history study
514719|NCT01369914|Hematopoietic Stem Cell Transplant|hematopoietic stem cell transplant
514720|NCT01369914|GVHD|gvhd
514721|NCT01369901|Exercise|exercise
514722|NCT01369901|Spinal Bulbar Muscular Atrophy|spinal bulbar muscular atrophy
514723|NCT01369901|Spinal and Bulbar Muscular Atrophy|spinal and bulbar muscular atrophy
514724|NCT01369901|SBMA|sbma
514725|NCT01369901|Motor Neuron Disease|motor neuron disease
514726|NCT01369888|Immunotherapy|immunotherapy
514727|NCT01369888|Cell Therapy|cell therapy
514728|NCT01369888|IL-15 Cytokine|il-15 cytokine
514729|NCT01369888|Melanoma|melanoma
514730|NCT01369888|Metastatic Melanoma|metastatic melanoma
514731|NCT01369888|Skin Cancer|skin cancer
514732|NCT01369875|Immunotherapy|immunotherapy
514733|NCT01369875|Cell Therapy|cell therapy
514734|NCT01369875|Metastatic Cancer|metastatic cancer
514735|NCT01369875|Melanoma|melanoma
514736|NCT01369875|Metastatic Melanoma|metastatic melanoma
514737|NCT01369875|Skin Cancer|skin cancer
514738|NCT01369862|live attenuated flu vaccines|live attenuated flu vaccines
514739|NCT01369862|influenza A (H1N1)|influenza a (h1n1)
514740|NCT01369862|intranasal application|intranasal application
514741|NCT01369862|replication-deficient influenza virus|replication-deficient influenza virus
514742|NCT01369836|Tafamidis|tafamidis
514743|NCT01369836|Pharmacokinetics|pharmacokinetics
514744|NCT01369836|TTR stabilization|ttr stabilization
514745|NCT01369823|HbA1c|hba1c
514746|NCT01369823|Paradigm 522/722 Infusion Pump|paradigm 522/722 infusion pump
654573|NCT00811577|VAS|vas
514747|NCT01369823|Transmitter (MMT-7703WW)|transmitter (mmt-7703ww)
514748|NCT01369823|Sensor MMT-7002 (i.e. Glucose Sensor)|sensor mmt-7002 (i.e. glucose sensor)
514749|NCT01369823|Levels of HbA1c at enrollment higher than 7|levels of hba1c at enrollment higher than 7
514750|NCT01369810|Epidemiological|epidemiological
514751|NCT01369810|asthma|asthma
514752|NCT01369810|COPD|copd
514753|NCT01369810|reimbursement|reimbursement
514754|NCT01369810|switch|switch
514755|NCT01369810|outcomes associated with the change in reimbursement|outcomes associated with the change in reimbursement
514756|NCT01369797|UPSAV|upsav
514757|NCT01369797|autonomy|autonomy
514758|NCT01369797|the elderly of 75 years and older|the elderly of 75 years and older
514759|NCT01369784|Diffuse large B-cell Lymphoma|diffuse large b-cell lymphoma
514760|NCT01369784|R-IPI|r-ipi
514761|NCT01369771|Confocal microscopic findings|confocal microscopic findings
514762|NCT01369771|Ocular Hypertension|ocular hypertension
514763|NCT01369771|Open-Angle Glaucoma|open-angle glaucoma
514764|NCT01369771|Preservative-free eye drops|preservative-free eye drops
514765|NCT01369758|morcellator|morcellator
514766|NCT01369758|hysteroscope|hysteroscope
514767|NCT01369758|myomectomy|myomectomy
514768|NCT01369758|polypectomy|polypectomy
514769|NCT01369758|uterine fibroids|uterine fibroids
514770|NCT01369758|uterine polyps|uterine polyps
514771|NCT01369745|Rheumatoid Arthritis|rheumatoid arthritis
514772|NCT01369745|Moderate to severe|moderate to severe
514773|NCT01369719|Thalassemia|thalassemia
514774|NCT01369719|Iron overload|iron overload
514775|NCT01369719|transfusion|transfusion
514776|NCT01369719|osveral|osveral
514777|NCT01369719|desferal|desferal
514778|NCT01369706|electromagnetic interference|electromagnetic interference
514779|NCT01369706|hand-held metal detector|hand-held metal detector
514780|NCT01369706|pacemaker|pacemaker
514781|NCT01369706|cardioverter-defibrillator|cardioverter-defibrillator
514782|NCT01369693|smokeless tobacco|smokeless tobacco
514783|NCT01369693|Nicotine|nicotine
514784|NCT01369693|Cadmium|cadmium
514785|NCT01369693|lead|lead
514786|NCT01369693|Tobacco Specific Nitrosamines|tobacco specific nitrosamines
514787|NCT01369680|Ketamine|ketamine
514788|NCT01369680|Chronic pain|chronic pain
514789|NCT01369680|Children|children
514790|NCT01369680|Oral pain medication|oral pain medication
514791|NCT01369654|hysterectomy with Bilateral Salpingo Oophorectomy|hysterectomy with bilateral salpingo oophorectomy
514792|NCT01369654|Oophorectomy|oophorectomy
514793|NCT01369654|Gynecologic condition|gynecologic condition
514794|NCT01369641|cisplatin|cisplatin
514795|NCT01369641|STS|sts
514796|NCT01369641|sodium thiosulfate|sodium thiosulfate
514797|NCT01369641|Adults|adults
514798|NCT01369641|dose range of 80-120mg/m2|dose range of 80-120mg/m2
514799|NCT01369628|Open label|open label
514800|NCT01369628|Dose Escalating|dose escalating
514801|NCT01369628|Phase Ib|phase ib
514802|NCT01369615|Malignant pain|malignant pain
514803|NCT01369615|Nonmalignant pain|nonmalignant pain
514804|NCT01369615|Pain|pain
514805|NCT01369615|Pediatric|pediatric
514806|NCT01369615|Opioid|opioid
514807|NCT01369615|Moderate to severe|moderate to severe
514808|NCT01369589|Xerostomia|xerostomia
514809|NCT01369589|dry mouth|dry mouth
514810|NCT01369589|Sjogren's Syndrome|sjogren's syndrome
514811|NCT01369563|rhinitis|rhinitis
514812|NCT01369563|ciclesonide|ciclesonide
514813|NCT01369563|intermittent rhinitis|intermittent rhinitis
514814|NCT01369563|persistent rhinitis|persistent rhinitis
514815|NCT01369524|fluid responsiveness|fluid responsiveness
514816|NCT01369524|microcirculation|microcirculation
514817|NCT01369524|Intensive Care|intensive care
514818|NCT01369511|Disuse Atrophy|disuse atrophy
514819|NCT01369511|Muscle|muscle
514820|NCT01369511|Strength|strength
514821|NCT01369511|Arthroplasty|arthroplasty
514822|NCT01369511|Hip|hip
514823|NCT01369511|Joint Replacement|joint replacement
514824|NCT01369498|Hematology|hematology
514825|NCT01369498|Myelofibrosis|myelofibrosis
514826|NCT01369498|Thrombocythemia Myelofibrosis|thrombocythemia myelofibrosis
514827|NCT01369498|Bone Marrow Diseases|bone marrow diseases
514828|NCT01369498|Hematologic Diseases|hematologic diseases
514829|NCT01369498|Blood Diseases|blood diseases
514830|NCT01369498|Leukemia|leukemia
514831|NCT01369498|Blood Disorders|blood disorders
514832|NCT01369485|Urinary Incontinence|urinary incontinence
514833|NCT01369485|Overactive Bladder|overactive bladder
514834|NCT01369485|Frequency|frequency
514835|NCT01369485|Urgency|urgency
514836|NCT01369459|Comorbid|comorbid
514837|NCT01369459|ADHD|adhd
514838|NCT01369459|SUD|sud
514839|NCT01369459|ASU|asu
514840|NCT01369446|In vitro fertilization|in vitro fertilization
514841|NCT01369446|Assisted reproduction|assisted reproduction
514842|NCT01369446|Noninvasive imaging of embryos|noninvasive imaging of embryos
514843|NCT01369446|Time lapse imaging of embryos|time lapse imaging of embryos
514844|NCT01369446|Traditional morphological grading of embryos|traditional morphological grading of embryos
654606|NCT00811421|HIV|hiv
514845|NCT01369446|Prediction of blastocysts|prediction of blastocysts
514846|NCT01369433|tivozanib|tivozanib
514847|NCT01369420|locoregional cancer therapy|locoregional cancer therapy
514848|NCT01369420|pancreatic cancer|pancreatic cancer
514849|NCT01369420|unresectable pancreatic cancer|unresectable pancreatic cancer
514850|NCT01369420|pancreatic adenocarcinoma|pancreatic adenocarcinoma
514851|NCT01369420|locally advanced, unresectable pancreatic cancer|locally advanced, unresectable pancreatic cancer
514852|NCT01369420|pancreatic cancer tumor ablation|pancreatic cancer tumor ablation
514853|NCT01369420|NanoKnife tumor ablation for pancreatic cancer|nanoknife tumor ablation for pancreatic cancer
514854|NCT01369420|NanoKnife LEDC system tumor ablation|nanoknife ledc system tumor ablation
514855|NCT01369420|Non thermal ablation|non thermal ablation
514856|NCT01369420|Irreversible electroporation for pancreatic cancer treatment|irreversible electroporation for pancreatic cancer treatment
514857|NCT01369420|IRE for unresectable pancreatic cancer|ire for unresectable pancreatic cancer
514858|NCT01369407|Heart failure|heart failure
514859|NCT01369407|HF|hf
514860|NCT01369407|Heart Diseases|heart diseases
514861|NCT01369407|Cardiovascular Diseases|cardiovascular diseases
514862|NCT01369407|Heart Failure NYHA class III|heart failure nyha class iii
514863|NCT01369407|Advanced heart failure|advanced heart failure
514864|NCT01369407|Systolic Heart Failure|systolic heart failure
514865|NCT01369394|Measles|measles
514866|NCT01369394|Mumps|mumps
514867|NCT01369394|Rubella|rubella
514868|NCT01369394|MMR|mmr
514869|NCT01369394|Prevention|prevention
514870|NCT01369394|Tailoring|tailoring
514871|NCT01369394|Persuasive communication|persuasive communication
514872|NCT01369394|Children|children
514873|NCT01369381|Cervical spine|cervical spine
514874|NCT01369381|Endotracheal intubation|endotracheal intubation
514875|NCT01369381|Laryngoscope|laryngoscope
514876|NCT01369381|Biomechanics|biomechanics
514877|NCT01369368|Acute myeloid leukemia|acute myeloid leukemia
514878|NCT01369368|Allogeneic stem cell transplantation|allogeneic stem cell transplantation
514879|NCT01369368|Relapse|relapse
514880|NCT01369368|Disease stabilization, survival|disease stabilization, survival
514881|NCT01369355|Ustekinumab|ustekinumab
514882|NCT01369355|Stelara, Moderately to severely active Crohn's Disease|stelara, moderately to severely active crohn's disease
514883|NCT01369355|IBD, Crohn's|ibd, crohn's
514884|NCT01369355|UNITI|uniti
514885|NCT01369355|colitis|colitis
514886|NCT01369355|IL-12|il-12
514887|NCT01369355|IL-23|il-23
514888|NCT01369342|ustekinumab|ustekinumab
514889|NCT01369342|moderately to severely active Crohn's Disease|moderately to severely active crohn's disease
514890|NCT01369342|Stelara|stelara
514891|NCT01369342|IBD|ibd
514892|NCT01369342|colitis|colitis
514893|NCT01369342|crohn|crohn
514894|NCT01369342|UNITI|uniti
514896|NCT01369329|ustekinumab|ustekinumab
514897|NCT01369329|moderately to severely active Crohn's Disease|moderately to severely active crohn's disease
514898|NCT01369329|tumor necrosis factor, Stelara|tumor necrosis factor, stelara
514899|NCT01369329|Crohn|crohn
514900|NCT01369329|Crohn's|crohn's
514901|NCT01369329|IBD|ibd
514902|NCT01369329|UNITI|uniti
514903|NCT01369303|HIV|hiv
514904|NCT01369290|Depression|depression
514905|NCT01369290|Antidepressant Medication|antidepressant medication
514906|NCT01369290|CBT|cbt
514907|NCT01369277|PF-04991532|pf-04991532
514908|NCT01369277|safety and tolerability|safety and tolerability
514909|NCT01369277|PK|pk
514910|NCT01369277|Japanese and Western population|japanese and western population
514911|NCT01369264|Repetitive Transcranial Magnetic Stimulation (rTMS)|repetitive transcranial magnetic stimulation (rtms)
514912|NCT01369264|Electroencephalography (EEG)|electroencephalography (eeg)
514913|NCT01369264|Magnetic Resonance Imaging|magnetic resonance imaging
514914|NCT01369264|Quantitative EEG (QEEG)|quantitative eeg (qeeg)
514915|NCT01369238|bee venom acupuncture|bee venom acupuncture
514916|NCT01369238|east west collaborative medicine|east west collaborative medicine
514917|NCT01369238|whiplash associated disorder|whiplash associated disorder
514918|NCT01369225|Randomized|randomized
514919|NCT01369225|Safety Study|safety study
514920|NCT01369225|Open Label|open label
514921|NCT01369199|Hepatitis B|hepatitis b
514922|NCT01369199|Immune-tolerant hepatitis B|immune-tolerant hepatitis b
514923|NCT01369199|HBV|hbv
514924|NCT01369173|Healthy|healthy
514925|NCT01369147|SICU|sicu
514926|NCT01369147|calories|calories
514927|NCT01369147|TPN|tpn
514928|NCT01369147|tube feeding|tube feeding
514929|NCT01369147|Optimum Energy Dose in SICU|optimum energy dose in sicu
514930|NCT01369134|self-etch adhesive|self-etch adhesive
514931|NCT01369134|selective enamel etching|selective enamel etching
514932|NCT01369134|Adper Easy Bond|adper easy bond
514933|NCT01369134|Supreme Ultra|supreme ultra
514934|NCT01369134|Molar and premolar teeth|molar and premolar teeth
514935|NCT01369134|Adult|adult
514936|NCT01369134|Class I and II cavities|class i and ii cavities
514937|NCT01369121|peritumoral brain edema|peritumoral brain edema
514938|NCT01369121|edema|edema
514939|NCT01369121|malignant brain tumor|malignant brain tumor
514940|NCT01369121|brain tumor|brain tumor
514941|NCT01369121|dexamethasone|dexamethasone
514942|NCT01369121|Decadron|decadron
514943|NCT01369108|small Class I|small class i
514944|NCT01369108|molar and premolar|molar and premolar
514945|NCT01369108|low stress flowable composite|low stress flowable composite
514946|NCT01369108|adult|adult
514947|NCT01369108|Restoration|restoration
514948|NCT01369108|small caries lesions|small caries lesions
514949|NCT01369082|islet allograft function|islet allograft function
514950|NCT01369082|c-peptide production|c-peptide production
514951|NCT01369082|maintenance immunosuppressive medications|maintenance immunosuppressive medications
514952|NCT01369069|stroke|stroke
514953|NCT01369069|diabetes|diabetes
514954|NCT01369069|hyperglycemia|hyperglycemia
514955|NCT01369056|antiretroviral therapy, highly active|antiretroviral therapy, highly active
514956|NCT01369056|treatment adherence|treatment adherence
514957|NCT01369043|Vitamin E|vitamin e
514958|NCT01369043|Vitamin C|vitamin c
514959|NCT01369043|Exercise|exercise
514960|NCT01369043|Antioxidant|antioxidant
514961|NCT01369030|L-methylfolate|l-methylfolate
514962|NCT01369030|Deplin|deplin
514963|NCT01369030|depression|depression
514964|NCT01369030|antidepressant|antidepressant
514965|NCT01369030|combination therapy|combination therapy
514966|NCT01369030|augmentation|augmentation
514967|NCT01369030|folate|folate
514968|NCT01369030|folic acid|folic acid
514969|NCT01369030|homocysteine|homocysteine
514970|NCT01369030|methionine|methionine
514971|NCT01369030|MTHFR genotype|mthfr genotype
514972|NCT01369030|C677T mutation|c677t mutation
514973|NCT01369030|vitamin B6|vitamin b6
514974|NCT01369030|vitamin B12|vitamin b12
514975|NCT01369017|healthy volunteer|healthy volunteer
514976|NCT01369017|endotoxin|endotoxin
514977|NCT01369004|self-weighing|self-weighing
514978|NCT01369004|self-monitoring|self-monitoring
514979|NCT01369004|weight loss|weight loss
514980|NCT01369004|obesity|obesity
514981|NCT01368991|Coronary Artery Bypass Grafts|coronary artery bypass grafts
514982|NCT01368991|Sternal Closure|sternal closure
514983|NCT01368991|Biologic Bone cement|biologic bone cement
514984|NCT01368978|TIDM|tidm
514985|NCT01368952|Obstructive Sleep Apnea|obstructive sleep apnea
514986|NCT01368952|Prone positioning|prone positioning
514987|NCT01368952|Positional Treatment|positional treatment
514988|NCT01368952|Hypoxemia|hypoxemia
514989|NCT01368939|breast imaging|breast imaging
514990|NCT01368939|MBI|mbi
514991|NCT01368939|dose reduction|dose reduction
514992|NCT01368939|Tc-99m|tc-99m
514993|NCT01368939|imaging|imaging
514994|NCT01368939|cardiac|cardiac
514995|NCT01368900|Ultherapy™ Treatment|ultherapy™ treatment
514996|NCT01368900|Ulthera, Inc.|ulthera, inc.
514997|NCT01368900|Ultrasound treatment for skin tightening|ultrasound treatment for skin tightening
514998|NCT01368887|psoriasis|psoriasis
514999|NCT01368887|scalp psoriasis|scalp psoriasis
515000|NCT01368861|infant|infant
515001|NCT01368861|immunizations|immunizations
515002|NCT01368861|pain|pain
515003|NCT01368861|pain management|pain management
515004|NCT01368861|vaccines|vaccines
515005|NCT01368861|analgesia|analgesia
515006|NCT01368848|AGMT|agmt
515007|NCT01368848|NSCLC|nsclc
515008|NCT01368848|non-small cell lung cancer|non-small cell lung cancer
515009|NCT01368848|bevacizumab|bevacizumab
515010|NCT01368848|Avastin|avastin
515011|NCT01368848|Cisplatin|cisplatin
515012|NCT01368848|Docetaxel|docetaxel
515013|NCT01368848|Taxotere|taxotere
515014|NCT01368848|Inoperable|inoperable
515015|NCT01368848|stages IIIB and IV|stages iiib and iv
515016|NCT01368809|Ambulatory surgery|ambulatory surgery
515017|NCT01368809|Pain management|pain management
515018|NCT01368809|Perioperative outcomes|perioperative outcomes
515019|NCT01368809|Fentanyl|fentanyl
515020|NCT01368809|Coughing during insertion of an LMA|coughing during insertion of an lma
515021|NCT01368809|Ambulatory surgery procedures|ambulatory surgery procedures
515022|NCT01368796|Vaccine|vaccine
515023|NCT01368796|Influenza vaccine|influenza vaccine
515024|NCT01368796|Adjuvanted Influenza vaccine|adjuvanted influenza vaccine
515025|NCT01368796|Intradermal Influenza vaccine|intradermal influenza vaccine
515026|NCT01368796|Seniors|seniors
515027|NCT01368796|Acceptability of vaccines|acceptability of vaccines
515028|NCT01368796|Influenza|influenza
515029|NCT01368757|Chronic myelomonocytic leukemia|chronic myelomonocytic leukemia
515030|NCT01368757|CMML|cmml
515031|NCT01368757|Lenalidomide|lenalidomide
515032|NCT01368757|Revlimid|revlimid
515033|NCT01368744|Breast Neoplasms|breast neoplasms
515034|NCT01368744|Breast Diseases|breast diseases
515035|NCT01368705|Infants|infants
515036|NCT01368705|Nitrogen Balance|nitrogen balance
515037|NCT01368705|Cardiothoracic surgery|cardiothoracic surgery
515038|NCT01368705|Congenital heart disease|congenital heart disease
515039|NCT01368705|Malnutrition|malnutrition
515040|NCT01368692|subclavian vein catheterization success rate|subclavian vein catheterization success rate
515041|NCT01368679|Aortic Aneurysm, Abdominal|aortic aneurysm, abdominal
515042|NCT01368679|Abdominal Aortic|abdominal aortic
515043|NCT01368666|Aortic valve replacement|aortic valve replacement
515044|NCT01368666|Aortic stenosis|aortic stenosis
515045|NCT01368666|Biological valve|biological valve
515046|NCT01368666|Sutureless valve|sutureless valve
515047|NCT01368666|Stented valve|stented valve
515048|NCT01368666|Aortic Valve Disease|aortic valve disease
515049|NCT01368653|Tobacco|tobacco
515050|NCT01368653|Smoking|smoking
515051|NCT01368653|Smoking Cessation|smoking cessation
515052|NCT01368653|Tobacco Dependence|tobacco dependence
515053|NCT01368653|Tobacco Use|tobacco use
515054|NCT01368653|Nicotine Dependence|nicotine dependence
515055|NCT01368627|Coronary Artery Disease|coronary artery disease
515056|NCT01368627|Restenosis|restenosis
515057|NCT01368627|Stent thrombosis|stent thrombosis
515058|NCT01368627|Coronary stents|coronary stents
515059|NCT01368627|Angioplasty|angioplasty
515060|NCT01368627|Drug Eluting Stents(DES)|drug eluting stents(des)
515062|NCT01368601|Lung Cancer|lung cancer
515063|NCT01368601|CPAP|cpap
515064|NCT01368601|PPC|ppc
515065|NCT01368601|lobectomy|lobectomy
515066|NCT01368601|One-lung ventilation|one-lung ventilation
515067|NCT01368588|adenocarcinoma of the prostate|adenocarcinoma of the prostate
515068|NCT01368588|stage I prostate cancer|stage i prostate cancer
515069|NCT01368588|stage IIA prostate cancer|stage iia prostate cancer
515070|NCT01368588|stage IIB prostate cancer|stage iib prostate cancer
515071|NCT01368588|stage III prostate cancer|stage iii prostate cancer
515072|NCT01368575|Ischemic|ischemic
515073|NCT01368575|Mitral|mitral
515074|NCT01368575|Valve|valve
515075|NCT01368575|Insufficiency|insufficiency
515076|NCT01368575|SVR|svr
515077|NCT01368549|Metanx|metanx
515078|NCT01368549|diabetes|diabetes
515079|NCT01368549|neuropathy|neuropathy
515080|NCT01368549|folic acid|folic acid
515081|NCT01368549|folate|folate
515082|NCT01368549|L-methylfolate|l-methylfolate
515083|NCT01368549|vitamin B6|vitamin b6
515084|NCT01368549|Pyridoxal 5'-phosphate|pyridoxal 5'-phosphate
515085|NCT01368549|vitamin B12|vitamin b12
515086|NCT01368549|methylcobalamin|methylcobalamin
515087|NCT01368549|DPN|dpn
515088|NCT01368536|High blood pressure|high blood pressure
515089|NCT01368536|diabetes|diabetes
515090|NCT01368523|Chronic Myelogenous Leukemia|chronic myelogenous leukemia
515091|NCT01368523|chronic phase|chronic phase
515092|NCT01368523|accelerated phase|accelerated phase
515093|NCT01368523|blastic phase|blastic phase
515094|NCT01368523|nilotinib|nilotinib
515095|NCT01368510|obsessive-compulsive disorder (OCD)|obsessive-compulsive disorder (ocd)
515096|NCT01368510|cognitive-behavioral therapy (CBT)|cognitive-behavioral therapy (cbt)
515097|NCT01368510|magnetic resonance spectroscopy (MRS)|magnetic resonance spectroscopy (mrs)
515098|NCT01368510|glutamate|glutamate
515099|NCT01368510|cingulate gyrus|cingulate gyrus
515100|NCT01368497|Hepatitis B|hepatitis b
515101|NCT01368497|HBV|hbv
515102|NCT01368471|STEMI|stemi
515103|NCT01368471|myocardial infarction|myocardial infarction
515104|NCT01368471|stent|stent
515105|NCT01368432|TBI|tbi
515106|NCT01368432|Depression|depression
515107|NCT01368432|Mood|mood
515108|NCT01368432|Behavior|behavior
515109|NCT01368419|Endostar|endostar
515110|NCT01368419|Radiotherapy|radiotherapy
515111|NCT01368419|Esophageal Cancer|esophageal cancer
515112|NCT01368406|schizophrenia|schizophrenia
515113|NCT01368406|weight gain|weight gain
515114|NCT01368406|intervention|intervention
515115|NCT01368380|Breast cancer|breast cancer
515116|NCT01368380|Partners|partners
515117|NCT01368380|Couples|couples
515118|NCT01368380|Attachment|attachment
515119|NCT01368380|Intervention|intervention
515120|NCT01368367|Burns|burns
515121|NCT01368354|Community Led Total Sanitation|community led total sanitation
515122|NCT01368354|Open Defecation|open defecation
515123|NCT01368354|Cysticercosis|cysticercosis
515124|NCT01368354|Soil transmitted helminths|soil transmitted helminths
515125|NCT01368354|Zambia|zambia
515126|NCT01368341|Antibiotics|antibiotics
515127|NCT01368341|General Practice|general practice
515128|NCT01368341|Erythema migrans|erythema migrans
515129|NCT01368341|Borrelia|borrelia
515130|NCT01368341|Ticks|ticks
515131|NCT01368328|Type 2 Diabetes|type 2 diabetes
515132|NCT01368328|Chromium|chromium
515133|NCT01368328|Insulin resistance|insulin resistance
515134|NCT01368302|attention bias modification treatment|attention bias modification treatment
515135|NCT01368302|cognitive bias modification|cognitive bias modification
515136|NCT01368302|attention training|attention training
515137|NCT01368302|anxiety|anxiety
515138|NCT01368276|Melanoma|melanoma
515139|NCT01368276|Stage IIIb, IIIc and IV Disease|stage iiib, iiic and iv disease
515140|NCT01368276|oncolytic|oncolytic
515141|NCT01368276|OncoVex|oncovex
515142|NCT01368276|OncoVEX^GM-CSF|oncovex^gm-csf
515143|NCT01368250|Aortic|aortic
515144|NCT01368250|Stenosis|stenosis
515145|NCT01368250|Valve|valve
515146|NCT01368250|VARC|varc
515147|NCT01368250|Transcatheter|transcatheter
515148|NCT01368250|Minimal-invasive|minimal-invasive
515149|NCT01368237|Computed tomography|computed tomography
515150|NCT01368237|Myocardial perfusion|myocardial perfusion
515151|NCT01368237|Coronary heart disease|coronary heart disease
515152|NCT01368224|Skin sensitivity|skin sensitivity
515153|NCT01368224|Trans-epidermal water loss|trans-epidermal water loss
515154|NCT01368224|Clinical score|clinical score
515155|NCT01368224|skin moisturization factors|skin moisturization factors
515156|NCT01368224|serum immune-regulatory cytokine|serum immune-regulatory cytokine
515157|NCT01368224|Evaluation of intestinal flora composition|evaluation of intestinal flora composition
515158|NCT01368211|Mirasol|mirasol
515159|NCT01368211|Thrombocytopenic|thrombocytopenic
515160|NCT01368211|Pathogen reduction|pathogen reduction
515161|NCT01368211|Platelets|platelets
515162|NCT01368211|Thromboelastography|thromboelastography
515163|NCT01368211|CCI|cci
515164|NCT01368211|Corrected Count Increment|corrected count increment
515165|NCT01368198|Ocular Emulsion|ocular emulsion
515166|NCT01368198|OPTIVE™ Lubricant|optive™ lubricant
515167|NCT01368198|Tear Film Break Up Time|tear film break up time
515168|NCT01368185|Essential hypertension Uric acid Retrospective Hyzaar|essential hypertension uric acid retrospective hyzaar
515169|NCT01368172|spinal cord injury|spinal cord injury
515170|NCT01368172|physical activity|physical activity
515171|NCT01368172|physical fitness|physical fitness
515172|NCT01368133|acromegaly|acromegaly
515173|NCT01368133|pituitary tumor|pituitary tumor
515174|NCT01368107|IL-7|il-7
515175|NCT01368107|metastatic breast cancer patients|metastatic breast cancer patients
515176|NCT01368107|lymphopenia|lymphopenia
515177|NCT01368094|Pancreaticoduodenectomy|pancreaticoduodenectomy
515178|NCT01368094|Drainage|drainage
515179|NCT01368094|Surgical site infection|surgical site infection
515180|NCT01368068|Perimenopause|perimenopause
515181|NCT01368068|Depression|depression
515182|NCT01368055|Proton Radiation, Prostate Cancer|proton radiation, prostate cancer
515183|NCT01368042|Quality of Life changes|quality of life changes
515184|NCT01368042|Secondary Hyperparathyroidism|secondary hyperparathyroidism
515185|NCT01368042|Chronic Kidney Disease|chronic kidney disease
515186|NCT01368042|Hemodialysis|hemodialysis
515187|NCT01368042|Paricalcitol intravenous treatment|paricalcitol intravenous treatment
515188|NCT01368029|LGG|lgg
515189|NCT01368029|Immune response|immune response
515190|NCT01368029|Influenza vaccine|influenza vaccine
515191|NCT01368029|Elderly|elderly
515192|NCT01368029|Healthy|healthy
515193|NCT01368029|Microbiome|microbiome
515194|NCT01368016|Smoking Cessation|smoking cessation
515195|NCT01368016|Nicotine Pharmacodynamics|nicotine pharmacodynamics
515196|NCT01368003|Castration resistant prostate cancer|castration resistant prostate cancer
515197|NCT01367990|alopecia|alopecia
515198|NCT01367990|hair loss|hair loss
515199|NCT01367990|prevention|prevention
515200|NCT01367990|radiotherapy|radiotherapy
515201|NCT01367990|head & neck cancer|head & neck cancer
515202|NCT01367990|radiodermatitis|radiodermatitis
515507|NCT01366651|Intravenous|intravenous
515203|NCT01367990|radiation dermatitis|radiation dermatitis
515204|NCT01367990|radiation-induced alopecia|radiation-induced alopecia
515205|NCT01367977|Ehlers Danlos Syndrome|ehlers danlos syndrome
515206|NCT01367977|External Communicating Hydrocephalus|external communicating hydrocephalus
515207|NCT01367977|Dysautonomia|dysautonomia
515208|NCT01367977|Postural orthostatic tachycardia syndrome|postural orthostatic tachycardia syndrome
515209|NCT01367977|Chronic cerebrospinal venous insufficiency|chronic cerebrospinal venous insufficiency
515210|NCT01367964|Hypsarrhythmia|hypsarrhythmia
515211|NCT01367964|Spasms, Infantile|spasms, infantile
515212|NCT01367964|West Syndrome|west syndrome
515213|NCT01367951|unstable chest injury|unstable chest injury
515214|NCT01367951|flail chest|flail chest
515215|NCT01367951|chest wall injury|chest wall injury
515216|NCT01367951|rib fracture|rib fracture
515217|NCT01367938|Osteoarthritis|osteoarthritis
515218|NCT01367938|Total Knee Replacement|total knee replacement
515219|NCT01367938|Total Knee Arthroplasty|total knee arthroplasty
515220|NCT01367938|TKA|tka
515221|NCT01367938|Knee|knee
515222|NCT01367925|Osteoarthritis|osteoarthritis
515223|NCT01367925|Total Knee Replacement|total knee replacement
515224|NCT01367925|TKA|tka
515225|NCT01367925|Knee|knee
515226|NCT01367925|PS|ps
515227|NCT01367925|CS|cs
515228|NCT01367912|Luteal phase support|luteal phase support
515229|NCT01367912|estradiol supplementation|estradiol supplementation
515230|NCT01367912|IVF/ICSI|ivf/icsi
515231|NCT01367912|clinical pregnancy rate|clinical pregnancy rate
515232|NCT01367899|Safety|safety
515233|NCT01367899|Efficacy|efficacy
515234|NCT01367886|Urine proteomics|urine proteomics
515235|NCT01367886|overactive bladder|overactive bladder
515236|NCT01367860|spine surgery|spine surgery
515237|NCT01367860|low back pain|low back pain
515238|NCT01367860|herniated disk|herniated disk
515239|NCT01367847|Parenting|parenting
515240|NCT01367847|Parent-Child Relations|parent-child relations
515241|NCT01367847|Child Behavior|child behavior
515242|NCT01367834|Turner Syndrome|turner syndrome
515243|NCT01367834|growth hormone|growth hormone
515244|NCT01367834|brain development|brain development
655070|NCT00809679|Pain|pain
515245|NCT01367821|Obstructive jaundice|obstructive jaundice
515246|NCT01367821|ERCP|ercp
515247|NCT01367821|Immune dysfunction|immune dysfunction
515248|NCT01367821|Endotoxin tolerance|endotoxin tolerance
515249|NCT01367821|Quorum sensing|quorum sensing
515250|NCT01367808|Buprenorphine|buprenorphine
515251|NCT01367808|Vorikonazole|vorikonazole
515252|NCT01367808|Posakonazole|posakonazole
515253|NCT01367808|Interactions|interactions
515254|NCT01367795|palliation|palliation
515255|NCT01367795|quality of life|quality of life
515256|NCT01367795|surgery|surgery
515257|NCT01367795|surgery; palliative|surgery; palliative
515258|NCT01367795|lifestyle|lifestyle
515259|NCT01367782|UPDRS|updrs
515260|NCT01367769|Deep vein thrombosis|deep vein thrombosis
515261|NCT01367769|superficial thrombophlebitis|superficial thrombophlebitis
515262|NCT01367769|contrast ultrasound|contrast ultrasound
515263|NCT01367743|myocardial infarction|myocardial infarction
515264|NCT01367743|epinephrine|epinephrine
515265|NCT01367743|norepinephrine|norepinephrine
515266|NCT01367743|cardiac output|cardiac output
515267|NCT01367730|osteopenia and osteoporosis|osteopenia and osteoporosis
515268|NCT01367717|Creatine|creatine
515269|NCT01367717|Creatinine|creatinine
515270|NCT01367717|Serum Creatinine|serum creatinine
515271|NCT01367717|Urine Creatinine|urine creatinine
515272|NCT01367717|Creatine Monohydrate|creatine monohydrate
515273|NCT01367717|Creatine Ethyl Ester|creatine ethyl ester
515274|NCT01367717|Acute Kidney Injury|acute kidney injury
515275|NCT01367717|Renal|renal
515276|NCT01367717|Kidney|kidney
515277|NCT01367704|gender-based violence|gender-based violence
515278|NCT01367704|intimate partner violence|intimate partner violence
515279|NCT01367704|relationship abuse|relationship abuse
515280|NCT01367704|sexual harassment|sexual harassment
515281|NCT01367704|sexual violence|sexual violence
515282|NCT01367691|CRT|crt
515283|NCT01367691|heart failure|heart failure
515284|NCT01367691|CMR|cmr
515285|NCT01367691|safety|safety
515286|NCT01367639|BRCA 1/2 Carriers|brca 1/2 carriers
515287|NCT01367639|IBSR|ibsr
515288|NCT01367639|The Work|the work
515289|NCT01367639|Randomized clinical trial|randomized clinical trial
515290|NCT01367613|Advanced medical illness|advanced medical illness
515291|NCT01367600|Advanced medical illness|advanced medical illness
515292|NCT01367574|Opioid-induced bowel dysfunction|opioid-induced bowel dysfunction
515293|NCT01367444|Stargardt's Disease|stargardt's disease
515294|NCT01367431|Xanthohumol|xanthohumol
515295|NCT01367431|Metabolic syndrome|metabolic syndrome
515296|NCT01367418|Analgesia: Thoracic epidural, patient controlled|analgesia: thoracic epidural, patient controlled
515297|NCT01367418|Surgery: Radical retropubic prostatectomy|surgery: radical retropubic prostatectomy
515298|NCT01367418|Immune system|immune system
515299|NCT01367418|Inflammation|inflammation
515300|NCT01367405|Surgical decompression|surgical decompression
515301|NCT01367405|conservative treatment|conservative treatment
515401|NCT01367093|QUALITY OF LIFE|quality of life
515302|NCT01367405|incomplete spinal cord lesion|incomplete spinal cord lesion
515303|NCT01367405|recovery|recovery
515304|NCT01367379|Physician|physician
515305|NCT01367379|duty loading|duty loading
515306|NCT01367379|stress response|stress response
515307|NCT01367379|Physician with different amount of duty area|physician with different amount of duty area
515308|NCT01367366|malignant mediastinal lymphadenopathy|malignant mediastinal lymphadenopathy
515309|NCT01367366|positron emission tomography|positron emission tomography
515310|NCT01367366|endobronchial ultrasound|endobronchial ultrasound
515311|NCT01367366|transbronchial needle aspiration|transbronchial needle aspiration
515312|NCT01367327|Exercise|exercise
515313|NCT01367288|locally advanced breast cancer|locally advanced breast cancer
515314|NCT01367288|neoadjuvant chemotherapy|neoadjuvant chemotherapy
515315|NCT01367288|HER2-negative breast cancer|her2-negative breast cancer
515316|NCT01367288|stage IIb breast cancer|stage iib breast cancer
515317|NCT01367288|stage IIIa breast cancer|stage iiia breast cancer
515318|NCT01367288|Zoledronic acid|zoledronic acid
515319|NCT01367288|bisphosphonate|bisphosphonate
515320|NCT01367288|zometa|zometa
515321|NCT01367288|therapeutic response|therapeutic response
515322|NCT01367288|VEGF serum|vegf serum
515323|NCT01367288|tumors markers|tumors markers
515324|NCT01367288|neoangiogenesis|neoangiogenesis
515325|NCT01367288|apoptosis|apoptosis
515326|NCT01367288|proliferation|proliferation
515327|NCT01367288|disseminated tumors cells|disseminated tumors cells
515328|NCT01367288|gamma-delta T cells activation|gamma-delta t cells activation
515329|NCT01367275|colon|colon
515330|NCT01367275|Colorectum|colorectum
515331|NCT01367275|Colorectal Cancer|colorectal cancer
515332|NCT01367275|Plasma FGF|plasma fgf
515333|NCT01367275|Colorectal adenocarcinoma|colorectal adenocarcinoma
515334|NCT01367275|Bevacizumab|bevacizumab
515335|NCT01367275|Brivanib|brivanib
515336|NCT01367275|BMS-582664|bms-582664
515337|NCT01367275|Irinotecan|irinotecan
515338|NCT01367275|CPT-11|cpt-11
515339|NCT01367275|Camptosar|camptosar
515340|NCT01367275|Fibroblast Growth Factor|fibroblast growth factor
515341|NCT01367275|bFGF|bfgf
515342|NCT01367275|tyrosine kinase receptors|tyrosine kinase receptors
515343|NCT01367275|vascular endothelial growth factor receptors|vascular endothelial growth factor receptors
515344|NCT01367275|VEGFR|vegfr
515345|NCT01367275|fibroblast growth factor receptors|fibroblast growth factor receptors
515346|NCT01367275|FGFR|fgfr
515347|NCT01367262|Absorption|absorption
515348|NCT01367262|Distribution|distribution
515349|NCT01367262|Metabolism|metabolism
515350|NCT01367262|Excretion|excretion
515351|NCT01367249|cataract surgery|cataract surgery
515352|NCT01367236|HIV|hiv
515353|NCT01367223|inflammatory response|inflammatory response
515354|NCT01367223|parenteral nutrition|parenteral nutrition
515355|NCT01367223|glutamine|glutamine
515356|NCT01367223|amino acid|amino acid
515357|NCT01367223|pediatric|pediatric
515358|NCT01367223|intensive care|intensive care
515359|NCT01367223|systemic infection|systemic infection
515360|NCT01367223|abdominal surgery|abdominal surgery
515361|NCT01367223|polytraumatised|polytraumatised
515362|NCT01367223|mortality|mortality
515363|NCT01367223|mean stay in the intensive care unit|mean stay in the intensive care unit
515364|NCT01367223|occurrence of infections|occurrence of infections
515365|NCT01367210|HIV|hiv
515366|NCT01367210|AIDS|aids
515367|NCT01367210|Highly Active AntiRetroviral Therapy|highly active antiretroviral therapy
515368|NCT01367210|Simplification|simplification
515369|NCT01367210|Maraviroc|maraviroc
515370|NCT01367210|Darunavir|darunavir
515371|NCT01367210|Treatment experienced|treatment experienced
515372|NCT01367210|Tropism|tropism
515373|NCT01367197|exercise training|exercise training
515374|NCT01367197|atrial fibrillation|atrial fibrillation
515375|NCT01367184|VTE|vte
515376|NCT01367184|Inferior vena cava|inferior vena cava
515377|NCT01367184|Venous thrombo-embolism|venous thrombo-embolism
515378|NCT01367184|Outcome data|outcome data
515379|NCT01367184|IVC Filters|ivc filters
515380|NCT01367158|Meningococcal disease|meningococcal disease
515381|NCT01367158|vaccines|vaccines
515382|NCT01367158|adolescents|adolescents
515383|NCT01367158|prevention|prevention
515384|NCT01367158|Meningitis|meningitis
515385|NCT01367145|OMEGA-3 polyunsaturated fatty-acids|omega-3 polyunsaturated fatty-acids
515386|NCT01367145|Peripheral Arterial Disease|peripheral arterial disease
515387|NCT01367145|Endothelial Function|endothelial function
515388|NCT01367145|Inflammation|inflammation
515389|NCT01367145|Platelet Function|platelet function
515390|NCT01367132|ultrasound|ultrasound
515391|NCT01367132|first trimester|first trimester
515392|NCT01367132|umbilical cord|umbilical cord
515393|NCT01367119|Depression|depression
515394|NCT01367119|Electroconvulsive therapy|electroconvulsive therapy
515395|NCT01367119|Ketamine|ketamine
515396|NCT01367119|Methohexital|methohexital
515397|NCT01367106|offspring of 21-hydroxylase enzyme block|offspring of 21-hydroxylase enzyme block
515398|NCT01367093|BIOLOGICAL MARKERS|biological markers
515399|NCT01367093|INTENSIVE CARE UNIT|intensive care unit
515400|NCT01367093|MORTALITY|mortality
515402|NCT01367093|CARDIOVASCULAR|cardiovascular
515403|NCT01367080|depression|depression
515404|NCT01367067|claustrophobia|claustrophobia
515405|NCT01367067|magnetic resonance imaging|magnetic resonance imaging
515407|NCT01367067|anxiety|anxiety
515408|NCT01367067|anxious patients|anxious patients
515409|NCT01367067|phobic disorders|phobic disorders
515410|NCT01367067|anxiety disorders|anxiety disorders
515411|NCT01367067|mental disorders|mental disorders
515412|NCT01367054|Metformine|metformine
515413|NCT01367054|adverse events|adverse events
515414|NCT01367054|bioequivalence|bioequivalence
515415|NCT01367041|bone|bone
515416|NCT01367041|muscle electrical activity|muscle electrical activity
515417|NCT01367041|whole-body vibration|whole-body vibration
515418|NCT01367028|HER2-positive early breast cancer|her2-positive early breast cancer
515419|NCT01367015|Preterm|preterm
515420|NCT01367015|SGA|sga
515421|NCT01367015|AREDF|aredf
515422|NCT01367015|Early feeding|early feeding
515423|NCT01367015|Late feeding|late feeding
515424|NCT01367015|Feed intolerance|feed intolerance
515425|NCT01367015|Necrotizing enterocolitis|necrotizing enterocolitis
515426|NCT01367015|Days to achieve Full Feeds defined as 150 mL/kg|days to achieve full feeds defined as 150 ml/kg
515427|NCT01367002|Uterine serous papillary carcinoma|uterine serous papillary carcinoma
515428|NCT01367002|Type II endometrial cancer|type ii endometrial cancer
515429|NCT01367002|HER2/neu|her2/neu
515430|NCT01367002|Paclitaxel, Carboplatin, Trastuzumab|paclitaxel, carboplatin, trastuzumab
515431|NCT01366989|Total Ankle Arthroplasty|total ankle arthroplasty
515432|NCT01366976|oxidative stress|oxidative stress
515433|NCT01366976|cardiopulmonary bypass|cardiopulmonary bypass
515434|NCT01366976|acetaminophen|acetaminophen
515435|NCT01366976|hemolysis|hemolysis
515436|NCT01366963|postural tachycardia syndrome|postural tachycardia syndrome
515437|NCT01366963|brain fog|brain fog
515438|NCT01366963|cognitive dysfunction|cognitive dysfunction
515439|NCT01366937|vitamin B12|vitamin b12
515440|NCT01366937|egg|egg
515441|NCT01366937|14C|14c
515442|NCT01366937|fecal excretion|fecal excretion
515443|NCT01366924|protein turnover|protein turnover
515444|NCT01366924|whole body protein turnover|whole body protein turnover
515445|NCT01366924|essential amino acids|essential amino acids
515446|NCT01366924|leucine|leucine
515447|NCT01366911|stem cells|stem cells
515448|NCT01366911|QCT testing|qct testing
515449|NCT01366911|Bone density findings|bone density findings
515450|NCT01366911|mesenchymal stem cells|mesenchymal stem cells
515451|NCT01366885|Autism|autism
515452|NCT01366885|Pregnancy|pregnancy
515453|NCT01366885|Newborn siblings|newborn siblings
515454|NCT01366872|ankle|ankle
515455|NCT01366872|arthritis|arthritis
515456|NCT01366872|total ankle arthroplasty|total ankle arthroplasty
515457|NCT01366872|Agility LP,|agility lp,
515458|NCT01366859|Autism|autism
515459|NCT01366859|Children|children
515460|NCT01366859|Behavior|behavior
515461|NCT01366859|Glutathione|glutathione
515462|NCT01366859|Whey Protein|whey protein
515463|NCT01366859|Immunocal|immunocal
515464|NCT01366859|Antioxidant|antioxidant
515465|NCT01366846|Peanut|peanut
515466|NCT01366833|Dysphagia|dysphagia
515467|NCT01366833|Esophagus|esophagus
515468|NCT01366833|Cancer|cancer
515469|NCT01366833|Esophageal Cancer|esophageal cancer
515470|NCT01366794|Gut hormones|gut hormones
515471|NCT01366794|Insulin secretion|insulin secretion
515472|NCT01366781|Gut hormones|gut hormones
515473|NCT01366781|Insulin secretion|insulin secretion
515474|NCT01366768|Gut hormones|gut hormones
515475|NCT01366768|Insulin secretion|insulin secretion
515476|NCT01366768|Normal physiology|normal physiology
515477|NCT01366729|hemiplegia|hemiplegia
515478|NCT01366729|walking|walking
515479|NCT01366729|canes|canes
515480|NCT01366729|TheraTogs|theratogs
515481|NCT01366729|EMG|emg
515482|NCT01366729|balance|balance
515483|NCT01366729|Timed up and go|timed up and go
515484|NCT01366716|Contingency Management|contingency management
515485|NCT01366716|Cash|cash
515486|NCT01366716|Substance Abuse|substance abuse
515487|NCT01366716|Ethics|ethics
515488|NCT01366703|heart failure|heart failure
515489|NCT01366703|implantable loop recorder|implantable loop recorder
515490|NCT01366690|HIV|hiv
515491|NCT01366690|community health workers|community health workers
515492|NCT01366690|randomized trial|randomized trial
515493|NCT01366690|task shifting|task shifting
515494|NCT01366690|Uganda|uganda
515495|NCT01366690|retention|retention
515496|NCT01366690|operations research|operations research
515497|NCT01366690|implementation research|implementation research
515498|NCT01366664|Premature Ejaculation|premature ejaculation
515499|NCT01366664|Selective Serotonin Reuptake Inhibitor|selective serotonin reuptake inhibitor
515500|NCT01366664|Dapoxetine|dapoxetine
515501|NCT01366664|PRILIGY|priligy
515502|NCT01366664|Terazosin|terazosin
515503|NCT01366664|Pharmacodynamic|pharmacodynamic
515504|NCT01366664|Pharmacokinetic|pharmacokinetic
515505|NCT01366651|Doripenem|doripenem
515506|NCT01366651|DORIPED1002|doriped1002
515508|NCT01366651|Pediatric|pediatric
515509|NCT01366651|Antibiotic|antibiotic
515510|NCT01366651|Meningitis|meningitis
515511|NCT01366638|Hepatitis C, Chronic|hepatitis c, chronic
515512|NCT01366638|TMC435|tmc435
515513|NCT01366638|Hepatitis C|hepatitis c
515514|NCT01366638|Hepatitis C virus|hepatitis c virus
515515|NCT01366638|Interferon Alfa-2b|interferon alfa-2b
515516|NCT01366638|Ribavirin|ribavirin
515517|NCT01366638|Viral ribonucleic acid|viral ribonucleic acid
515518|NCT01366625|hypertension, resistant|hypertension, resistant
515519|NCT01366625|obstructive sleep apnea|obstructive sleep apnea
515520|NCT01366625|renal denervation|renal denervation
515521|NCT01366625|continuous positive airway pressure therapy|continuous positive airway pressure therapy
515522|NCT01366612|Allogeneic Stem Cell Transplant|allogeneic stem cell transplant
515523|NCT01366612|AML|aml
515524|NCT01366612|CML|cml
515525|NCT01366612|MDS|mds
515526|NCT01366599|highly emetogenic chemotherapy|highly emetogenic chemotherapy
515527|NCT01366599|HEC|hec
515528|NCT01366599|moderately emetogenic chemotherapy|moderately emetogenic chemotherapy
515529|NCT01366599|MEC|mec
515530|NCT01366573|Pharmacokinetics|pharmacokinetics
515531|NCT01366573|mu-opioid receptors|mu-opioid receptors
515532|NCT01366573|Addiction|addiction
515533|NCT01366573|Pharmacodynamics|pharmacodynamics
515534|NCT01366573|Alcohol|alcohol
515535|NCT01366547|Bioavailability|bioavailability
515536|NCT01366547|Lamivudine|lamivudine
515537|NCT01366547|Dolutegravir|dolutegravir
515538|NCT01366547|integrase|integrase
515539|NCT01366547|Abacavir|abacavir
515540|NCT01366534|safety|safety
515541|NCT01366534|Vaccine|vaccine
515542|NCT01366534|Phase 1/2|phase 1/2
515543|NCT01366534|immunogenicity|immunogenicity
515544|NCT01366534|Malaria|malaria
515545|NCT01366534|efficacy|efficacy
515546|NCT01366534|sporozoite challenge|sporozoite challenge
515547|NCT01366495|Seek|seek
515548|NCT01366495|Test|test
515549|NCT01366495|Treat|treat
515550|NCT01366482|Peripheral arterial disease,|peripheral arterial disease,
515551|NCT01366482|claudication,|claudication,
515552|NCT01366482|atherectomy,|atherectomy,
515553|NCT01366482|plaque excision,|plaque excision,
515554|NCT01366482|drug-coated balloon|drug-coated balloon
515555|NCT01366482|drug-eluting balloon|drug-eluting balloon
515556|NCT01366469|coronary artery bypass grafting|coronary artery bypass grafting
515557|NCT01366469|coronary artery disease|coronary artery disease
515558|NCT01366469|chronic obstructive pulmonary disease|chronic obstructive pulmonary disease
515559|NCT01366456|Temperature Change|temperature change
515560|NCT01366456|Moxibustion|moxibustion
515561|NCT01366456|Warming effect|warming effect
515562|NCT01366443|ROM PLUS|rom plus
515563|NCT01366443|conventional clinical tests of rupture of membranes (ROM)|conventional clinical tests of rupture of membranes (rom)
515564|NCT01366443|speculum exam|speculum exam
515565|NCT01366443|visualization of leakage|visualization of leakage
515566|NCT01366443|pooling of amniotic fluid in the posterior fornix|pooling of amniotic fluid in the posterior fornix
515567|NCT01366443|nitrazine testing|nitrazine testing
515568|NCT01366443|ferning|ferning
515569|NCT01366430|BPPV(benign paroxysmal positional vertigo)|bppv(benign paroxysmal positional vertigo)
515570|NCT01366430|HC-BPPV(BPPV involving the horizontal semicircular canal)|hc-bppv(bppv involving the horizontal semicircular canal)
515571|NCT01366430|Nystagmus|nystagmus
515572|NCT01366430|Treatment outcome|treatment outcome
515573|NCT01366430|Horizontal Canal Benign Paroxysmal Positional Vertigo|horizontal canal benign paroxysmal positional vertigo
515574|NCT01366404|FFR|ffr
515575|NCT01366391|polycystic ovary syndrome|polycystic ovary syndrome
515576|NCT01366391|metformin|metformin
515577|NCT01366391|pharmacokinetic|pharmacokinetic
515578|NCT01366313|paracetamol|paracetamol
515579|NCT01366313|morphine|morphine
515580|NCT01366313|median effective dose|median effective dose
515581|NCT01366313|pain|pain
515582|NCT01366287|Relative bioavailability|relative bioavailability
515583|NCT01366287|food effect|food effect
515584|NCT01366287|tablet|tablet
515585|NCT01366287|suspension|suspension
515586|NCT01366287|single dose|single dose
515587|NCT01366287|crossover|crossover
515588|NCT01366287|healthy subjects|healthy subjects
515589|NCT01366274|Trauma|trauma
515590|NCT01366261|Flex-rigid pleuroscopy|flex-rigid pleuroscopy
515591|NCT01366261|pleural biopsy|pleural biopsy
515592|NCT01366261|pleural effusion|pleural effusion
515593|NCT01366261|safety|safety
515594|NCT01366261|thoracoscopy|thoracoscopy
515595|NCT01366222|asthma|asthma
515596|NCT01366209|Pirfenidone|pirfenidone
515597|NCT01366209|ASCEND|ascend
515598|NCT01366209|IPF|ipf
515599|NCT01366209|FVC|fvc
515600|NCT01366196|Orthopedic Procedures|orthopedic procedures
515601|NCT01366196|Spinal Fusions|spinal fusions
515602|NCT01366196|Pregabalin|pregabalin
515603|NCT01366196|Gamma-Aminobutyric Acid|gamma-aminobutyric acid
515604|NCT01366196|Analgesics|analgesics
515605|NCT01366196|Sensory System Agents|sensory system agents
515606|NCT01366196|Peripheral Nervous System Agents|peripheral nervous system agents
515607|NCT01366196|Physiological Effects of Drugs|physiological effects of drugs
515608|NCT01366196|Pharmacologic Actions|pharmacologic actions
515609|NCT01366196|Central Nervous System Agents|central nervous system agents
515610|NCT01366196|Therapeutic Uses|therapeutic uses
515611|NCT01366196|Anticonvulsants|anticonvulsants
515612|NCT01366196|GABA Agents|gaba agents
515613|NCT01366196|Neurotransmitter Agents|neurotransmitter agents
515614|NCT01366196|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action
515615|NCT01366170|childhood anaplastic large cell lymphoma|childhood anaplastic large cell lymphoma
515616|NCT01366157|childhood favorable prognosis Hodgkin lymphoma|childhood favorable prognosis hodgkin lymphoma
515617|NCT01366157|stage I childhood Hodgkin lymphoma|stage i childhood hodgkin lymphoma
515618|NCT01366157|stage II childhood Hodgkin lymphoma|stage ii childhood hodgkin lymphoma
515619|NCT01366157|stage III childhood Hodgkin lymphoma|stage iii childhood hodgkin lymphoma
515620|NCT01366157|stage IV childhood Hodgkin lymphoma|stage iv childhood hodgkin lymphoma
515621|NCT01366157|childhood lymphocyte depletion Hodgkin lymphoma|childhood lymphocyte depletion hodgkin lymphoma
515622|NCT01366157|childhood lymphocyte predominant Hodgkin lymphoma|childhood lymphocyte predominant hodgkin lymphoma
515623|NCT01366157|childhood mixed cellularity Hodgkin lymphoma|childhood mixed cellularity hodgkin lymphoma
515624|NCT01366157|childhood nodular lymphocyte predominant Hodgkin lymphoma|childhood nodular lymphocyte predominant hodgkin lymphoma
515625|NCT01366157|childhood nodular sclerosis Hodgkin lymphoma|childhood nodular sclerosis hodgkin lymphoma
515626|NCT01366118|Rectal cancer, Chemoradiotherapy, target therapy|rectal cancer, chemoradiotherapy, target therapy
515627|NCT01366105|Wound healing|wound healing
515628|NCT01366105|Negative Pressure Wound Therapy|negative pressure wound therapy
515629|NCT01366105|V.A.C.|v.a.c.
515630|NCT01366105|Incision|incision
515631|NCT01366092|stem cell transplant|stem cell transplant
515632|NCT01366092|GVHD|gvhd
515633|NCT01366092|bone marrow transplant|bone marrow transplant
515634|NCT01366092|cord blood transplant|cord blood transplant
515635|NCT01366092|regulatory T cell|regulatory t cell
515636|NCT01366092|interleukin|interleukin
515637|NCT01366066|Stress incontinence|stress incontinence
515638|NCT01366066|urge incontinence|urge incontinence
515639|NCT01366066|overactive bladder syndrome|overactive bladder syndrome
515640|NCT01366066|vibration|vibration
515641|NCT01366066|nerve stimulation|nerve stimulation
515642|NCT01366053|Prostate Cancer|prostate cancer
515643|NCT01366053|Androgen Deprivation Therapy|androgen deprivation therapy
515644|NCT01366053|Agonist|agonist
515645|NCT01366053|Antagonist|antagonist
515646|NCT01366053|PSA Failure|psa failure
515647|NCT01366053|PSA Rise|psa rise
515648|NCT01366040|Patient Satisfaction|patient satisfaction
515649|NCT01366040|Multiple Sclerosis|multiple sclerosis
515650|NCT01366040|Autoinjector|autoinjector
515651|NCT01366040|Avonex|avonex
515652|NCT01366027|pseudobulbar affect|pseudobulbar affect
515653|NCT01366014|osteoarthritis|osteoarthritis
515654|NCT01366014|knee|knee
515655|NCT01366014|pain|pain
515656|NCT01366014|NSAID|nsaid
515657|NCT01366001|Opioid|opioid
515658|NCT01366001|Cocaine|cocaine
515659|NCT01366001|Dependence|dependence
515660|NCT01366001|Abuse|abuse
515661|NCT01366001|Intravenous|intravenous
515662|NCT01366001|Buprenorphine|buprenorphine
515663|NCT01365988|fMRI|fmri
515664|NCT01365988|Risk-Taking|risk-taking
515665|NCT01365988|Decision-Making|decision-making
515666|NCT01365988|Memory|memory
515667|NCT01365988|Resting-State Functional Connectivity|resting-state functional connectivity
515668|NCT01365975|Cohort Study|cohort study
515669|NCT01365975|Folic Acid Peri-Conception|folic acid peri-conception
515670|NCT01365975|Pediatric Leukemia|pediatric leukemia
515671|NCT01365975|Pediatric Cancer|pediatric cancer
515672|NCT01365962|alveolar childhood rhabdomyosarcoma|alveolar childhood rhabdomyosarcoma
515673|NCT01365962|embryonal childhood rhabdomyosarcoma|embryonal childhood rhabdomyosarcoma
515674|NCT01365962|previously treated childhood rhabdomyosarcoma|previously treated childhood rhabdomyosarcoma
515675|NCT01365962|previously untreated childhood rhabdomyosarcoma|previously untreated childhood rhabdomyosarcoma
515676|NCT01365962|recurrent childhood rhabdomyosarcoma|recurrent childhood rhabdomyosarcoma
515677|NCT01365949|Ewing sarcoma/peripheral primitive neuroectodermal tumor (PNET)|ewing sarcoma/peripheral primitive neuroectodermal tumor (pnet)
515678|NCT01365936|IVF|ivf
515679|NCT01365936|ICSI|icsi
515680|NCT01365936|OHSS|ohss
515681|NCT01365936|PCOS|pcos
515682|NCT01365936|recFSH|recfsh
515683|NCT01365936|HMG|hmg
515684|NCT01365897|Modafinil|modafinil
515685|NCT01365897|Memory|memory
515686|NCT01365897|Executive Functions|executive functions
515687|NCT01365897|Memory, Short-Term|memory, short-term
515688|NCT01365897|Attention|attention
515689|NCT01365897|University Students|university students
515690|NCT01365897|Stroop Effect|stroop effect
515691|NCT01365897|Digit Span|digit span
515692|NCT01365897|Backwards Digit Span|backwards digit span
515693|NCT01365897|Biber Cognitive Estimation Test|biber cognitive estimation test
515694|NCT01365871|prostate biopsy|prostate biopsy
515695|NCT01365871|pain|pain
515696|NCT01365845|Proton Radiation|proton radiation
515697|NCT01365845|Breast Cancer|breast cancer
515698|NCT01365819|Crystal meth dependence|crystal meth dependence
515699|NCT01365819|crystal meth|crystal meth
515700|NCT01365819|methamphetamine dependence|methamphetamine dependence
515701|NCT01365819|substance abuse|substance abuse
515702|NCT01365806|heart transplantation|heart transplantation
515703|NCT01365806|allograft rejection|allograft rejection
515704|NCT01365806|QT interval|qt interval
515705|NCT01365806|electrocardiogram (ECG)|electrocardiogram (ecg)
515706|NCT01365793|cerebral edema|cerebral edema
515707|NCT01365793|diabetic ketoacidosis|diabetic ketoacidosis
515708|NCT01365793|pediatric diabetes|pediatric diabetes
515709|NCT01365793|fluid therapy|fluid therapy
515710|NCT01365780|microcirculation, O2c|microcirculation, o2c
515711|NCT01365767|Crohn disease|crohn disease
515712|NCT01365767|Ultrasonography, contrast enhanced|ultrasonography, contrast enhanced
515713|NCT01365767|Elasticity Imaging Techniques|elasticity imaging techniques
515714|NCT01365767|Small intestine|small intestine
515715|NCT01365767|Magnetic Resonance Imaging|magnetic resonance imaging
515716|NCT01365767|CDAI|cdai
515717|NCT01365767|Calprotectin|calprotectin
515718|NCT01365767|IBD|ibd
515719|NCT01365767|Sonography|sonography
515720|NCT01365754|Lumbar degenerative disease|lumbar degenerative disease
515721|NCT01365741|PCI|pci
515722|NCT01365741|STEMI|stemi
515723|NCT01365741|Interventions|interventions
515724|NCT01365741|Heart disease|heart disease
515725|NCT01365741|Thrombocytic inhibition|thrombocytic inhibition
515726|NCT01365741|Cross-over study|cross-over study
515727|NCT01365741|Percutaneous coronary intervention|percutaneous coronary intervention
515728|NCT01365728|Femtosecond Laser|femtosecond laser
515729|NCT01365728|FS60|fs60
515730|NCT01365728|iFS|ifs
515731|NCT01365728|Intralase|intralase
515732|NCT01365728|Wavefront-guided LASIK|wavefront-guided lasik
515733|NCT01365728|IntraLASIK|intralasik
515734|NCT01365728|LASIK|lasik
515735|NCT01365728|Myopia|myopia
515736|NCT01365728|Nearsightedness|nearsightedness
515737|NCT01365715|Preoperative embolization|preoperative embolization
515738|NCT01365715|Transcatheter arterial embolization|transcatheter arterial embolization
515739|NCT01365715|Therapeutic angiography|therapeutic angiography
515740|NCT01365715|Embolization|embolization
515741|NCT01365715|Surgical blood loss|surgical blood loss
515742|NCT01365715|Spinal metastases|spinal metastases
515743|NCT01365715|Spinal neoplasms|spinal neoplasms
515744|NCT01365715|Vertebral metastases|vertebral metastases
515745|NCT01365715|metastatic spine surgery|metastatic spine surgery
515746|NCT01365715|Spinal surgery|spinal surgery
515747|NCT01365702|COPD|copd
515748|NCT01365702|tiotropium|tiotropium
515749|NCT01365702|tuberculous destroyed lung|tuberculous destroyed lung
515750|NCT01365676|Edema|edema
515751|NCT01365676|Depression|depression
515752|NCT01365676|Hot Flashes|hot flashes
515753|NCT01365676|Anxiety|anxiety
515754|NCT01365676|Irritability|irritability
515755|NCT01365676|PMS|pms
515756|NCT01365663|Hypercholesterolemia|hypercholesterolemia
515757|NCT01365663|LDL|ldl
515758|NCT01365663|HDL|hdl
515759|NCT01365663|apoB|apob
515760|NCT01365663|hyperlipidemia|hyperlipidemia
515761|NCT01365663|LNA-oligonucleotide|lna-oligonucleotide
515762|NCT01365637|safety|safety
515763|NCT01365637|tolerability|tolerability
515764|NCT01365637|pharmacokinetics|pharmacokinetics
515765|NCT01365637|PF-05089771|pf-05089771
515766|NCT01365598|malaria|malaria
515767|NCT01365598|uncomplicated malaria|uncomplicated malaria
515768|NCT01365598|gametocytocidal drug|gametocytocidal drug
515769|NCT01365598|gametocytocidal|gametocytocidal
515770|NCT01365598|gametocyte|gametocyte
515771|NCT01365598|primaquine|primaquine
515772|NCT01365598|transmission blocking|transmission blocking
515773|NCT01365598|malaria transmission|malaria transmission
515774|NCT01365598|sexual parasite|sexual parasite
515775|NCT01365598|sexual stage|sexual stage
515776|NCT01365598|Uganda|uganda
515777|NCT01365598|Africa|africa
515778|NCT01365585|Pulmonary arterial hypertension|pulmonary arterial hypertension
515779|NCT01365585|sildenafil citrate|sildenafil citrate
515780|NCT01365585|Revatio|revatio
515781|NCT01365572|Drug-eluting stent|drug-eluting stent
515782|NCT01365559|multiple myeloma|multiple myeloma
515783|NCT01365559|carfilzomib|carfilzomib
515784|NCT01365559|relapsed|relapsed
515785|NCT01365559|refractory|refractory
515786|NCT01365559|bortezomib|bortezomib
515787|NCT01365559|Oncotherapeutics|oncotherapeutics
515788|NCT01365533|Airway Inflammation|airway inflammation
515789|NCT01365533|Roflumilast|roflumilast
515790|NCT01365494|Rabies|rabies
515791|NCT01365494|rabies vaccines|rabies vaccines
515792|NCT01365494|post-exposure prophylaxis|post-exposure prophylaxis
515793|NCT01365481|Hypertension, pediatric|hypertension, pediatric
515794|NCT01365481|Hypertension with or without chronic kidney disease|hypertension with or without chronic kidney disease
515795|NCT01365468|RAD001,|rad001,
515796|NCT01365468|Everolimus,|everolimus,
515797|NCT01365468|Plexiform Neurofibroma,|plexiform neurofibroma,
515798|NCT01365468|Neurofibromatosis Type 1|neurofibromatosis type 1
515799|NCT01365455|Psoriasis|psoriasis
515800|NCT01365455|plaque|plaque
515801|NCT01365455|plaque-type psoriasis|plaque-type psoriasis
515802|NCT01365455|IL-17 blocker|il-17 blocker
515803|NCT01365455|subcutaneous|subcutaneous
515804|NCT01365455|psoriatic arthritis|psoriatic arthritis
515805|NCT01365455|injection|injection
515806|NCT01365455|AIN457|ain457
515807|NCT01365455|AIN457A|ain457a
515808|NCT01365455|secukinumab|secukinumab
515809|NCT01365442|Cholera|cholera
515810|NCT01365442|Vaccination|vaccination
515811|NCT01365442|Oral cholera vaccine|oral cholera vaccine
515812|NCT01365442|Mass vaccination|mass vaccination
515813|NCT01365442|Oral whole cell cholera vaccine|oral whole cell cholera vaccine
515814|NCT01365429|Lung Transplant, Transplantation Lung|lung transplant, transplantation lung
515815|NCT01365416|diabetes|diabetes
515816|NCT01365416|diabetes remission|diabetes remission
515817|NCT01365416|obesity|obesity
515818|NCT01365416|bariatric surgery|bariatric surgery
515819|NCT01365416|gene expression|gene expression
515820|NCT01365416|genetic variation|genetic variation
515821|NCT01365416|metabolomics|metabolomics
515822|NCT01365416|metabonomics|metabonomics
515823|NCT01365416|epigenetic variation|epigenetic variation
515824|NCT01365416|mutations|mutations
515825|NCT01365390|prospective|prospective
515826|NCT01365390|Incidence|incidence
515827|NCT01365390|otitis|otitis
515828|NCT01365390|observational|observational
515829|NCT01365390|Epidemiological|epidemiological
515830|NCT01365390|retrospective|retrospective
515831|NCT01365377|Anxiety|anxiety
515832|NCT01365377|Depression|depression
515833|NCT01365377|Post-traumatic stress disorders|post-traumatic stress disorders
515834|NCT01365377|Quality of life|quality of life
515835|NCT01365377|Family|family
515836|NCT01365377|ICU|icu
515837|NCT01365364|PLM|plm
515838|NCT01365364|dopamine|dopamine
515839|NCT01365364|physical exercise|physical exercise
515840|NCT01365338|schizophrenia fMRI cognition working memory ASL|schizophrenia fmri cognition working memory asl
515841|NCT01365312|Central line associated infection|central line associated infection
515842|NCT01365312|PICC associated infection|picc associated infection
515843|NCT01365312|Neonatal central line associated sepsis|neonatal central line associated sepsis
515844|NCT01365312|Central line colonization|central line colonization
515845|NCT01365312|Ethanol Lock|ethanol lock
515846|NCT01365286|asthma, chronic obstructive pulmonary disease, COPD, ivabradine, heart rate|asthma, chronic obstructive pulmonary disease, copd, ivabradine, heart rate
515847|NCT01365273|Split thickness skin grafts|split thickness skin grafts
515848|NCT01365273|Mepitel One|mepitel one
515849|NCT01365273|Bridal Veil and staples|bridal veil and staples
515850|NCT01365273|Pain|pain
515851|NCT01365247|Co-morbid substance disorders and PTSD|co-morbid substance disorders and ptsd
515852|NCT01365247|Trauma|trauma
515853|NCT01365247|Alcohol and other drug use disorders|alcohol and other drug use disorders
515854|NCT01365247|Treatment outcome|treatment outcome
515855|NCT01365247|Post-Traumatic Stress Disorder (PTSD)|post-traumatic stress disorder (ptsd)
515856|NCT01365247|Co-morbid Alcohol and other drug use disorders (AOD)|co-morbid alcohol and other drug use disorders (aod)
515857|NCT01365247|Behavioral Treatment|behavioral treatment
515858|NCT01365221|Acute Coronary Syndrome|acute coronary syndrome
515859|NCT01365221|Clopidogrel|clopidogrel
515860|NCT01365221|Prasugrel|prasugrel
515861|NCT01365195|opioid|opioid
515862|NCT01365195|Fentanyl|fentanyl
515863|NCT01365195|Anesthetic adjuvant|anesthetic adjuvant
515864|NCT01365195|Pain management|pain management
515865|NCT01365195|Perioperative outcomes|perioperative outcomes
515866|NCT01365195|Constipation|constipation
515867|NCT01365195|Ileus|ileus
515868|NCT01365195|Colorectal|colorectal
515869|NCT01365182|prostate cancer|prostate cancer
515870|NCT01365182|urinary incontinence|urinary incontinence
515871|NCT01365182|pelvic floor muscle exercise|pelvic floor muscle exercise
515872|NCT01365182|self-management|self-management
515873|NCT01365182|behavioral intervention|behavioral intervention
515874|NCT01365182|quality of life|quality of life
515875|NCT01365156|locally advanced cervical cancer|locally advanced cervical cancer
515876|NCT01365156|pretherapeutic para-aortic surgical staging|pretherapeutic para-aortic surgical staging
515877|NCT01365156|radiologic staging|radiologic staging
515878|NCT01365156|pretherapeutic surgical staging|pretherapeutic surgical staging
515879|NCT01365156|para-aortic metastatic disease|para-aortic metastatic disease
515880|NCT01365130|esophageal cancer|esophageal cancer
515881|NCT01365130|gastroesophageal cancer|gastroesophageal cancer
515882|NCT01365130|gastric cancer|gastric cancer
515883|NCT01365104|brain blood flow|brain blood flow
515884|NCT01365104|stroke|stroke
515885|NCT01365104|cerebrovascular|cerebrovascular
515886|NCT01365104|aging|aging
515887|NCT01365104|cerebrovascular hemodynamics|cerebrovascular hemodynamics
515888|NCT01365078|n-3 polyunsaturated fatty acids|n-3 polyunsaturated fatty acids
515889|NCT01365078|Stearidonic acid|stearidonic acid
515890|NCT01365078|Lipid metabolism|lipid metabolism
515891|NCT01365078|Serum triacylglycerol|serum triacylglycerol
515892|NCT01365052|Maximum Use Safety Trial|maximum use safety trial
515893|NCT01365039|contact lens|contact lens
515894|NCT01365026|Healthy Lifestyle|healthy lifestyle
515895|NCT01365026|Health promotion|health promotion
515896|NCT01365026|Counselling|counselling
515897|NCT01365026|Action Plan|action plan
515898|NCT01365026|Primary Health Care|primary health care
515899|NCT01365013|Lifestyle|lifestyle
515900|NCT01365013|Prediabetic State|prediabetic state
515901|NCT01365013|Patient Education|patient education
515902|NCT01365013|Primary Health Care|primary health care
515903|NCT01365000|Phase 1|phase 1
515904|NCT01365000|Pharmacokinetics|pharmacokinetics
515905|NCT01365000|NKTR-118|nktr-118
515906|NCT01365000|fasting or fed state|fasting or fed state
515907|NCT01365000|cross-over study|cross-over study
515908|NCT01365000|AUC(0-t)|auc(0-t)
515909|NCT01365000|Cmax|cmax
515910|NCT01365000|tmax|tmax
515911|NCT01365000|QTcF Interval|qtcf interval
515912|NCT01364987|transplant|transplant
515913|NCT01364987|ASP015K|asp015k
515914|NCT01364987|healthy subjects|healthy subjects
515915|NCT01364974|ASP015K|asp015k
515916|NCT01364974|Healthy subjects|healthy subjects
515917|NCT01364961|Resveratrol|resveratrol
515918|NCT01364961|FMD|fmd
515919|NCT01364961|PWV|pwv
515920|NCT01364961|HDL-cholesterol|hdl-cholesterol
515921|NCT01364961|Macrovasculature|macrovasculature
515922|NCT01364961|Microvasculature|microvasculature
515923|NCT01364948|Preterm|preterm
515924|NCT01364948|VLBW|vlbw
515925|NCT01364948|Coconut Oil application|coconut oil application
515926|NCT01364948|Trans epidermal water loss|trans epidermal water loss
515927|NCT01364948|Weight gain|weight gain
515928|NCT01364909|Sepsis|sepsis
515929|NCT01364909|Severe sepsis|severe sepsis
515930|NCT01364909|Septic shock|septic shock
515931|NCT01364909|Septicaemia|septicaemia
515932|NCT01364909|Bacteremia|bacteremia
515933|NCT01364896|Non-corticosteroid immunosuppressive agent|non-corticosteroid immunosuppressive agent
515934|NCT01364883|Vaccine|vaccine
515935|NCT01364883|Immune response|immune response
515936|NCT01364870|Knee OA|knee oa
515937|NCT01364870|TENS|tens
515938|NCT01364870|Total knee replacement|total knee replacement
515939|NCT01364870|Knee arthroplasty|knee arthroplasty
515940|NCT01364870|total unilateral knee replacement|total unilateral knee replacement
515941|NCT01364857|port wine stain of a limb|port wine stain of a limb
515942|NCT01364831|sleep time|sleep time
515943|NCT01364831|athletic performance|athletic performance
515944|NCT01364792|schizophrenia|schizophrenia
515945|NCT01364792|treatment|treatment
515946|NCT01364792|inflammation|inflammation
515947|NCT01364792|neuroinflammation|neuroinflammation
515948|NCT01364792|hippocampal|hippocampal
515949|NCT01364779|aspirin|aspirin
515950|NCT01364779|Chronic kidney disease|chronic kidney disease
515951|NCT01364753|Memory|memory
515952|NCT01364753|Aviation|aviation
515953|NCT01364714|ICU acquired weakness|icu acquired weakness
515954|NCT01364701|Erectile dysfunction|erectile dysfunction
515955|NCT01364701|combination therapy|combination therapy
515956|NCT01364701|Sildenafil|sildenafil
515957|NCT01364701|tadalafil|tadalafil
515958|NCT01364701|PDE5i|pde5i
515959|NCT01364701|No Conditions|no conditions
515960|NCT01364688|coronary calcification|coronary calcification
515961|NCT01364688|vascular calcification|vascular calcification
515962|NCT01364688|active vitamin D|active vitamin d
515963|NCT01364688|alfacalcidol|alfacalcidol
515964|NCT01364675|Impaired fasting glucose|impaired fasting glucose
515965|NCT01364675|Impaired glucose tolerance|impaired glucose tolerance
515966|NCT01364675|Pre-diabetes|pre-diabetes
515967|NCT01364675|Pre-hypertensives|pre-hypertensives
515968|NCT01364675|Cardiovascular events|cardiovascular events
515969|NCT01364662|Impulsive Aggression|impulsive aggression
515970|NCT01364662|Attention Deficit Hyperactivity Disorder|attention deficit hyperactivity disorder
515971|NCT01364662|ADHD|adhd
515972|NCT01364649|Sexual Dysfunction, Physiological|sexual dysfunction, physiological
515973|NCT01364649|Depressive Disorder, Major|depressive disorder, major
515974|NCT01364649|Depression|depression
515975|NCT01364649|Antidepressive Agents|antidepressive agents
515976|NCT01364649|Drug Therapy|drug therapy
515977|NCT01364636|1-Heart Failure|1-heart failure
515978|NCT01364636|2-Acute Heart Failure|2-acute heart failure
515979|NCT01364636|3-Acute Decompensated Heart Failure|3-acute decompensated heart failure
515980|NCT01364636|4-Worsening Renal Function|4-worsening renal function
515981|NCT01364636|5-Acute Kidney Injury|5-acute kidney injury
515982|NCT01364636|6-Cardiorenal Syndrome|6-cardiorenal syndrome
515983|NCT01364623|testosterone|testosterone
515984|NCT01364623|pharmacokinetics|pharmacokinetics
515985|NCT01364610|diagnosis|diagnosis
515986|NCT01364610|pH measurement|ph measurement
515987|NCT01364610|catheter|catheter
515988|NCT01364610|wireless|wireless
515989|NCT01364597|Brivaracetam|brivaracetam
515990|NCT01364597|Epilepsy|epilepsy
515991|NCT01364597|Child|child
515992|NCT01364597|Infant|infant
515993|NCT01364597|Adolescents|adolescents
515994|NCT01364597|Partial onset seizures|partial onset seizures
515995|NCT01364571|Staphylococcus aureus|staphylococcus aureus
515996|NCT01364571|vaccine|vaccine
515997|NCT01364571|staphylococcal infection|staphylococcal infection
515998|NCT01364532|transulnar arterial access|transulnar arterial access
515999|NCT01364532|transradial arterial access|transradial arterial access
516000|NCT01364532|percutaneous coronary intervention|percutaneous coronary intervention
516001|NCT01364519|COPD|copd
516002|NCT01364506|Cardiovascular capacity|cardiovascular capacity
516003|NCT01364506|Water exercise|water exercise
516004|NCT01364506|Hydrokinetic Therapy|hydrokinetic therapy
516005|NCT01364506|Pregnancy|pregnancy
516006|NCT01364506|Perinatal outcomes|perinatal outcomes
516007|NCT01364493|HER2-positive|her2-positive
516008|NCT01364493|adenocarcinoma of the stomach or gastro-esophageal junction|adenocarcinoma of the stomach or gastro-esophageal junction
516009|NCT01364493|Inoperable|inoperable
516010|NCT01364493|locally advanced|locally advanced
516011|NCT01364493|recurrent|recurrent
516012|NCT01364493|metastatic|metastatic
516013|NCT01364480|Tetraplegia|tetraplegia
516014|NCT01364480|Spinal cord injury|spinal cord injury
516015|NCT01364480|Brainstem or spinal stroke|brainstem or spinal stroke
516016|NCT01364480|Neuroprosthetic|neuroprosthetic
516017|NCT01364480|Brain-machine interface|brain-machine interface
516018|NCT01364480|Brain-computer interface|brain-computer interface
516019|NCT01364480|Neural activity|neural activity
516020|NCT01364454|Colorectal Cancer Screening|colorectal cancer screening
516021|NCT01364454|Faecal Occult Blood test|faecal occult blood test
516022|NCT01364454|General Practitioners Involvement|general practitioners involvement
516023|NCT01364454|Patient's Participation|patient's participation
516024|NCT01364454|Reminder|reminder
516025|NCT01364441|ONO-2950|ono-2950
516026|NCT01364441|healthy adult subjects|healthy adult subjects
516027|NCT01364441|first in human|first in human
516028|NCT01364441|safety|safety
516029|NCT01364441|tolerability|tolerability
516030|NCT01364441|pharmacokinetics|pharmacokinetics
516031|NCT01364415|MTD|mtd
516032|NCT01364415|pasireotide|pasireotide
516033|NCT01364415|LAR|lar
516034|NCT01364415|NETs|nets
516035|NCT01364415|advanced neuroendocrine tumors|advanced neuroendocrine tumors
516036|NCT01364402|scheduled for PCI|scheduled for pci
516037|NCT01364389|Polymyalgia Rheumatica|polymyalgia rheumatica
516038|NCT01364389|Inflammatory Disease|inflammatory disease
516039|NCT01364389|Rheumatic Disease|rheumatic disease
516040|NCT01364376|Gastric Cancer|gastric cancer
516041|NCT01364363|Transplant|transplant
516042|NCT01364363|Allogeneic|allogeneic
516043|NCT01364363|Allogeneic transplant|allogeneic transplant
516044|NCT01364363|Unrelated donor transplant|unrelated donor transplant
516045|NCT01364363|MUD|mud
516046|NCT01364363|HSCT|hsct
516047|NCT01364363|Stem cell transplant|stem cell transplant
516048|NCT01364350|type 2 diabetes mellitus|type 2 diabetes mellitus
516049|NCT01364350|pediatrics|pediatrics
516050|NCT01364350|post-intervention study|post-intervention study
516051|NCT01364350|metformin|metformin
516052|NCT01364350|complications|complications
516053|NCT01364337|Hypertension|hypertension
516054|NCT01364324|tuberculosis|tuberculosis
516055|NCT01364324|pharmacokinetics|pharmacokinetics
516056|NCT01364324|first-line drugs|first-line drugs
516057|NCT01364324|gastrectomy|gastrectomy
516058|NCT01364311|Dry Eye Syndromes|dry eye syndromes
516059|NCT01364311|Dietary Supplements|dietary supplements
516060|NCT01364311|Vitamac® Tag and Nacht capsules|vitamac® tag and nacht capsules
516061|NCT01364311|Lutein|lutein
516062|NCT01364311|Vitamin C|vitamin c
516063|NCT01364311|Zinc|zinc
516064|NCT01364311|ginkgo biloba|ginkgo biloba
516065|NCT01364311|Flavinoids|flavinoids
516066|NCT01364311|Fishoil|fishoil
516067|NCT01364311|Zeaxanthin|zeaxanthin
516068|NCT01364311|Vitamin E|vitamin e
516069|NCT01364311|Copper|copper
516070|NCT01364311|Selen|selen
516071|NCT01364311|Alpha Lipon acid|alpha lipon acid
516072|NCT01364311|Break up time (BUT)|break up time (but)
516073|NCT01364311|Improvement of subjective symptoms of dry eye syndrome|improvement of subjective symptoms of dry eye syndrome
516074|NCT01364311|Visual Acuity|visual acuity
516075|NCT01364311|Tear film osmolarity|tear film osmolarity
516076|NCT01364311|OSI (Objective Scattering Index)|osi (objective scattering index)
516077|NCT01364311|Schirmer I test|schirmer i test
516078|NCT01364311|Staining of the cornea with fluorescein|staining of the cornea with fluorescein
516079|NCT01364311|Impression cytology|impression cytology
516080|NCT01364311|Tear cytokines/chemokines|tear cytokines/chemokines
516081|NCT01364311|Data from patient diary how often Hylo-Comod® eye drops were used|data from patient diary how often hylo-comod® eye drops were used
516082|NCT01364298|Gabapentin/B complex|gabapentin/b complex
516083|NCT01364298|Pregabalin|pregabalin
516084|NCT01364298|Pain|pain
516085|NCT01364298|Neuropathic|neuropathic
516086|NCT01364298|Gavindo|gavindo
516087|NCT01364298|Lyrica|lyrica
516088|NCT01364259|tic douloureux|tic douloureux
516089|NCT01364246|Progressive Multiple Sclerosis|progressive multiple sclerosis
516090|NCT01364246|neuromyelitis optica|neuromyelitis optica
516091|NCT01364246|Umbilical Cord Mesenchymal Stem Cell|umbilical cord mesenchymal stem cell
516092|NCT01364220|Additional relevant MeSH terms|additional relevant mesh terms
516093|NCT01364220|Stroke|stroke
516094|NCT01364220|Cerebral Infarction|cerebral infarction
516095|NCT01364220|Cerebrovascular Disorders|cerebrovascular disorders
516096|NCT01364220|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors
516097|NCT01364220|Magnetic Resonance Imaging|magnetic resonance imaging
516098|NCT01364220|Recurrence|recurrence
516099|NCT01364194|Post operative pain|post operative pain
516100|NCT01364194|Total knee replacement|total knee replacement
516101|NCT01364194|Total knee arthroplasty|total knee arthroplasty
516102|NCT01364194|Bupivacaine|bupivacaine
516103|NCT01364194|Periarticular injection|periarticular injection
516104|NCT01364194|Placebo|placebo
516105|NCT01364194|Morphine consumption|morphine consumption
516106|NCT01364181|Udenafil|udenafil
516107|NCT01364181|Chronic obstructive pulmonary disease|chronic obstructive pulmonary disease
516108|NCT01364181|pulmonary hypertension|pulmonary hypertension
516109|NCT01364181|Phosphodiesterase 5 inhibitors|phosphodiesterase 5 inhibitors
516110|NCT01364181|Exercise|exercise
516111|NCT01364181|Dyspnea|dyspnea
516112|NCT01364129|Diabetes|diabetes
516113|NCT01364129|Diabetic Retinopathy Screening|diabetic retinopathy screening
516114|NCT01364129|Ophthalmic Telemedicine|ophthalmic telemedicine
516115|NCT01364129|Comparative Effectiveness Research|comparative effectiveness research
516116|NCT01364116|Pulse CO-Oximetry™|pulse co-oximetry™
516117|NCT01364116|children|children
516118|NCT01364116|noninvasive|noninvasive
516119|NCT01364103|pulse pressure variation|pulse pressure variation
516120|NCT01364103|systolic pressure variation|systolic pressure variation
516121|NCT01364103|central venous pressure|central venous pressure
516122|NCT01364103|aortic blood flow velocity variation|aortic blood flow velocity variation
516123|NCT01364103|pleth variability index|pleth variability index
516124|NCT01364090|hepatitis C|hepatitis c
516125|NCT01364090|treatment|treatment
516126|NCT01364090|injection drug users or receiving opiate substitution therapy|injection drug users or receiving opiate substitution therapy
516127|NCT01364077|Heart rate|heart rate
516128|NCT01364077|Dialysis|dialysis
516129|NCT01364077|ESRD|esrd
516130|NCT01364077|ivabradine|ivabradine
516131|NCT01363973|oropharyngeal dysphagia|oropharyngeal dysphagia
516132|NCT01363973|post-stroke|post-stroke
516133|NCT01363960|Incidence|incidence
516134|NCT01363960|neonatal care|neonatal care
516135|NCT01363960|retinopathy of prematurity|retinopathy of prematurity
516136|NCT01363960|risk factors|risk factors
516137|NCT01363934|Erythropoietin|erythropoietin
516138|NCT01363934|EPO-hFC|epo-hfc
516139|NCT01363921|CKD5|ckd5
516140|NCT01363921|dialysis|dialysis
516141|NCT01363921|high porous membranes|high porous membranes
516142|NCT01363921|micro-inflammation|micro-inflammation
516143|NCT01363908|Beta-Thalassemia|beta-thalassemia
516144|NCT01363908|Sickle Cell Anemia|sickle cell anemia
516145|NCT01363908|Transfusional iron overload|transfusional iron overload
516146|NCT01363908|Iron Overload|iron overload
516147|NCT01363908|Iron Chelation|iron chelation
516148|NCT01363895|atrial fibrillation|atrial fibrillation
516149|NCT01363895|catheter ablation|catheter ablation
516150|NCT01363895|percutaneous closure of LAA|percutaneous closure of laa
516151|NCT01363895|intervention|intervention
516152|NCT01363882|Amyotrophic Lateral Sclerosis|amyotrophic lateral sclerosis
516153|NCT01363882|Noninvasive Ventilation|noninvasive ventilation
516154|NCT01363882|Respiratory Dysfunction|respiratory dysfunction
516155|NCT01363882|Positive Pressure Ventilation|positive pressure ventilation
516156|NCT01363869|hyperuricemia|hyperuricemia
516157|NCT01363869|gout|gout
516158|NCT01363869|uric acid|uric acid
516159|NCT01363869|xanthine oxidase inhibitor|xanthine oxidase inhibitor
516160|NCT01363869|green tea|green tea
516161|NCT01363869|catechins|catechins
516162|NCT01363869|antioxidant|antioxidant
516163|NCT01363856|first ever stroke|first ever stroke
516164|NCT01363843|neoadjuvant|neoadjuvant
516165|NCT01363843|chemo/radiation|chemo/radiation
516166|NCT01363843|rectal cancer|rectal cancer
516167|NCT01363843|rectum cancer|rectum cancer
516168|NCT01363843|colon cancer|colon cancer
516169|NCT01363843|colorectal cancer|colorectal cancer
516170|NCT01363830|Disc|disc
516171|NCT01363830|lumbar|lumbar
516172|NCT01363830|herniation|herniation
516173|NCT01363804|AV-951|av-951
516174|NCT01363804|Tivozanib|tivozanib
516175|NCT01363804|Healthy Subjects|healthy subjects
516176|NCT01363804|rifampin|rifampin
516177|NCT01363804|Pharmacokinetics|pharmacokinetics
516178|NCT01363791|Systematic review and meta-analysis|systematic review and meta-analysis
516179|NCT01363791|Evidence-based medicine (EBM)|evidence-based medicine (ebm)
516180|NCT01363791|Evidence-based nutrition (EBN)|evidence-based nutrition (ebn)
516181|NCT01363791|Clinical practice guidelines|clinical practice guidelines
516182|NCT01363791|Clinical trials|clinical trials
516183|NCT01363791|Dietary sugars|dietary sugars
516184|NCT01363791|Fructose|fructose
516185|NCT01363791|High fructose corn syrup|high fructose corn syrup
516186|NCT01363791|Fruit|fruit
516187|NCT01363791|Isocaloric|isocaloric
516188|NCT01363791|Hypercaloric|hypercaloric
516189|NCT01363791|Cardiometabolic risk factors|cardiometabolic risk factors
516190|NCT01363791|Triglycerides|triglycerides
516191|NCT01363791|Cholesterol|cholesterol
516192|NCT01363791|Glycemic control|glycemic control
516193|NCT01363791|Insulin resistance|insulin resistance
516194|NCT01363791|Body weight|body weight
516195|NCT01363791|Uric acid|uric acid
516196|NCT01363791|Blood pressure|blood pressure
516197|NCT01363791|Fatty liver|fatty liver
516198|NCT01363791|Fasting|fasting
516199|NCT01363791|Postprandial|postprandial
516200|NCT01363778|AV-951|av-951
516201|NCT01363778|Tivozanib|tivozanib
516202|NCT01363778|Healthy Subjects|healthy subjects
516203|NCT01363778|ketoconazole|ketoconazole
516204|NCT01363778|Pharmacokinetics|pharmacokinetics
516205|NCT01363765|diagnosis|diagnosis
516206|NCT01363765|polymerase chain reaction|polymerase chain reaction
516207|NCT01363765|sputum smear|sputum smear
516208|NCT01363765|stepped-wedge design|stepped-wedge design
516209|NCT01363765|cost-effectiveness|cost-effectiveness
516210|NCT01363765|Xpert MTB/Rif|xpert mtb/rif
516211|NCT01363752|Kidney|kidney
516212|NCT01363752|Kidney Failure, Acute|kidney failure, acute
516213|NCT01363752|Astagraf XL|astagraf xl
516214|NCT01363752|Immunosuppression|immunosuppression
516215|NCT01363752|Advagraf|advagraf
516216|NCT01363752|Tacrolimus|tacrolimus
516217|NCT01363752|Transplant|transplant
516218|NCT01363739|VEGF polymorphism Bevacizumab|vegf polymorphism bevacizumab
516219|NCT01363726|surveillance Rotavirus Gastroenteritis Children|surveillance rotavirus gastroenteritis children
516220|NCT01363726|< 5 years of age|< 5 years of age
516221|NCT01363726|southern Israel|southern israel
516222|NCT01363726|Signed informed concent|signed informed concent
516223|NCT01363674|Growth disorders|growth disorders
516224|NCT01363674|Saizen|saizen
516225|NCT01363674|Easypod|easypod
516226|NCT01363674|Growth hormone|growth hormone
516227|NCT01363674|Pediatric subject|pediatric subject
516228|NCT01363661|angina pectoris|angina pectoris
516229|NCT01363661|atherosclerosis|atherosclerosis
516230|NCT01363661|endothelial dysfunction|endothelial dysfunction
516231|NCT01363648|VCI-HS|vci-hs
516232|NCT01363648|stroke|stroke
516233|NCT01363648|choline alphoscerate|choline alphoscerate
516234|NCT01363635|severe sepsis/septic shock|severe sepsis/septic shock
516235|NCT01363635|organ failure|organ failure
516237|NCT01363635|PMI|pmi
516238|NCT01363635|ALI|ali
516239|NCT01363635|Stroke|stroke
516240|NCT01363635|ICU death|icu death
516241|NCT01363622|Vaspin|vaspin
516242|NCT01363622|LGA|lga
516243|NCT01363622|SGA|sga
516244|NCT01363622|Insulin|insulin
516245|NCT01363622|Blood glucose|blood glucose
516246|NCT01363596|Infertility|infertility
516247|NCT01363596|Fertility|fertility
516248|NCT01363596|Reproductive Medicine|reproductive medicine
516249|NCT01363596|Pregnancy|pregnancy
516250|NCT01363596|Conception|conception
516251|NCT01363596|Miscarriage|miscarriage
516252|NCT01363596|Ovulation Detection|ovulation detection
516253|NCT01363596|Cervical Mucus|cervical mucus
516254|NCT01363596|IVF Alternative|ivf alternative
516255|NCT01363583|traumatic brain injury|traumatic brain injury
516256|NCT01363570|Macular Degeneration|macular degeneration
516257|NCT01363570|Age related macular degeneration|age related macular degeneration
516258|NCT01363570|Macula Risk|macula risk
516259|NCT01363570|Genetic test|genetic test
516260|NCT01363570|Anti-inflammatory|anti-inflammatory
516261|NCT01363570|Anti-vascular endothelial growth factor (Anti-VEGF)|anti-vascular endothelial growth factor (anti-vegf)
516262|NCT01363570|Lucentis|lucentis
516263|NCT01363570|Ranibizumab|ranibizumab
516264|NCT01363570|Vision loss|vision loss
516265|NCT01363557|Randomized|randomized
516266|NCT01363557|Brain Radiation Therapy|brain radiation therapy
516267|NCT01363557|Lung Cancer|lung cancer
516268|NCT01363557|Brain Metastasis|brain metastasis
516269|NCT01363557|Gefitinib|gefitinib
516270|NCT01363544|ADHD|adhd
516271|NCT01363544|neurofeedback|neurofeedback
516272|NCT01363544|exercise|exercise
516273|NCT01363544|neurophysiology|neurophysiology
516274|NCT01363531|Prescription|prescription
516275|NCT01363531|Antibiotic|antibiotic
516276|NCT01363531|Acute respiratory infections|acute respiratory infections
516277|NCT01363531|Satisfaction|satisfaction
516278|NCT01363531|Perception|perception
516279|NCT01363531|Pharyngitis and/or acute tonsillitis|pharyngitis and/or acute tonsillitis
516280|NCT01363531|Rhinosinusitis|rhinosinusitis
516281|NCT01363531|Acute bronchitis|acute bronchitis
516282|NCT01363531|Acute exacerbation of chronic obstructive pulmonary disease (mild to moderate)|acute exacerbation of chronic obstructive pulmonary disease (mild to moderate)
516283|NCT01363518|humerus|humerus
516284|NCT01363518|fracture|fracture
516285|NCT01363518|operative treatment|operative treatment
516286|NCT01363518|non-operative treatment|non-operative treatment
516287|NCT01363492|agalsidase alfa|agalsidase alfa
516288|NCT01363492|Replagal|replagal
516289|NCT01363492|Enzyme Replacement Therapy|enzyme replacement therapy
516290|NCT01363440|Diabetic Macular Edema|diabetic macular edema
516291|NCT01363440|Diabetic Retinopathy|diabetic retinopathy
516292|NCT01363414|Dry eye|dry eye
516293|NCT01363414|Ocular aberration|ocular aberration
516294|NCT01363401|Amyotrophic lateral sclerosis|amyotrophic lateral sclerosis
516295|NCT01363401|ALS|als
516296|NCT01363401|Motor neuron disease|motor neuron disease
516297|NCT01363401|MND|mnd
516298|NCT01363401|HYNR-CS inj|hynr-cs inj
516299|NCT01363401|Autologous bone marrow derived stem cell|autologous bone marrow derived stem cell
516300|NCT01363401|Intrathecal injection|intrathecal injection
516301|NCT01363375|Plantar fascia|plantar fascia
516302|NCT01363375|Plantar fasciitis|plantar fasciitis
516303|NCT01363375|Foot orthosis|foot orthosis
516304|NCT01363375|Finite element analysis|finite element analysis
516305|NCT01363375|Gait analysis|gait analysis
516306|NCT01363375|Plantar pressure measurement|plantar pressure measurement
516307|NCT01363362|Selective Laser Trabeculoplasty|selective laser trabeculoplasty
516308|NCT01363362|pulsatile ocular blood flow|pulsatile ocular blood flow
516309|NCT01363336|Adalat|adalat
516310|NCT01363336|Hypertension|hypertension
516311|NCT01363336|Diabetes|diabetes
516312|NCT01363336|Chronic kidney disease|chronic kidney disease
516313|NCT01363297|Relapsed/Refractory Acute Lymphocytic Leukemia (ALL)|relapsed/refractory acute lymphocytic leukemia (all)
516314|NCT01363258|Elderly|elderly
516315|NCT01363258|Dementia|dementia
516316|NCT01363258|Care-resistant behavior|care-resistant behavior
516317|NCT01363258|Oral health|oral health
516318|NCT01363258|Long-term care|long-term care
516319|NCT01363245|cost effectiveness|cost effectiveness
516320|NCT01363245|behavioral health counseling|behavioral health counseling
516321|NCT01363232|BKM120|bkm120
516322|NCT01363232|MEK162|mek162
516323|NCT01363232|RAS RAF mutations|ras raf mutations
516324|NCT01363232|triple negative breast cancer|triple negative breast cancer
516325|NCT01363232|pancreatic cancer, ovarian cancer|pancreatic cancer, ovarian cancer
516326|NCT01363232|NSCLC progressed on EGFR TKI|nsclc progressed on egfr tki
516327|NCT01363232|PI3K inhibitor|pi3k inhibitor
516328|NCT01363232|MEK inhibitor|mek inhibitor
516329|NCT01363206|Melanoma|melanoma
516330|NCT01363206|GM-CSF|gm-csf
516331|NCT01363206|Ipilimumab|ipilimumab
516332|NCT01363206|Immunologic Response|immunologic response
516333|NCT01363193|Weight-based heparin dosing|weight-based heparin dosing
516334|NCT01363193|Obesity|obesity
516335|NCT01363193|Body Mass Index|body mass index
516336|NCT01363193|Venous thromboembolism|venous thromboembolism
516337|NCT01363193|Atrial fibrillation|atrial fibrillation
516338|NCT01363193|Lean body weight|lean body weight
516339|NCT01363193|Unfractionated heparin|unfractionated heparin
516340|NCT01363193|heparin|heparin
516341|NCT01363167|vitamin D|vitamin d
516342|NCT01363167|preterm infants|preterm infants
516343|NCT01363167|calcium|calcium
516344|NCT01363167|bone|bone
516345|NCT01363167|parathyroid hormone|parathyroid hormone
516346|NCT01363154|Children's Health|children's health
516347|NCT01363154|Pediatrics|pediatrics
516348|NCT01363154|Epilepsy|epilepsy
516349|NCT01363154|Photoparoxysmal|photoparoxysmal
516350|NCT01363154|Photosensitive|photosensitive
516351|NCT01363154|Music|music
516352|NCT01363154|Mozart|mozart
516353|NCT01363154|K-448|k-448
516354|NCT01363141|Cardiovascular Diseases|cardiovascular diseases
516355|NCT01363141|Type 2 Diabetes Mellitus|type 2 diabetes mellitus
516356|NCT01363141|Abdominal Fat|abdominal fat
516357|NCT01363141|Atherogenic Dyslipidemia|atherogenic dyslipidemia
516358|NCT01363141|Hypertension|hypertension
516359|NCT01363141|Hyperglycemia|hyperglycemia
516360|NCT01363141|Insulin Resistance|insulin resistance
516361|NCT01363141|Thrombosis state|thrombosis state
516362|NCT01363115|Body Weight|body weight
516363|NCT01363115|Dietary Supplement|dietary supplement
516364|NCT01363115|Calcium|calcium
516365|NCT01363115|Vitamin D|vitamin d
516366|NCT01363102|Muscle strength|muscle strength
516367|NCT01363102|functional mobility|functional mobility
516368|NCT01363102|outcome|outcome
516369|NCT01363102|intensive care unit|intensive care unit
516370|NCT01363102|quality of life|quality of life
516371|NCT01363037|HIV infections|hiv infections
516372|NCT01363037|Anti-HIV agents|anti-hiv agents
516373|NCT01363037|HIV-1|hiv-1
516374|NCT01363024|Solid Cancers|solid cancers
516375|NCT01363011|HIV-1|hiv-1
516376|NCT01363011|Treatment Naive|treatment naive
516377|NCT01363011|Treatment Experienced|treatment experienced
516378|NCT01362998|fentanyl, morphine, duramorph, Cesarean section, epidural|fentanyl, morphine, duramorph, cesarean section, epidural
516379|NCT01362959|Delirium|delirium
516380|NCT01362959|Psychomotor Agitation|psychomotor agitation
516381|NCT01362959|Substance Withdrawal Syndrome|substance withdrawal syndrome
516382|NCT01362959|Nicotine replacement therapy|nicotine replacement therapy
516383|NCT01362946|Conduct problems|conduct problems
516384|NCT01362946|callous-unemotional traits|callous-unemotional traits
516385|NCT01362946|disruptive behavior disorders|disruptive behavior disorders
516386|NCT01362933|PE|pe
516387|NCT01362933|DVT|dvt
516388|NCT01362933|SVT|svt
516389|NCT01362933|LMWH|lmwh
516390|NCT01362933|VKA|vka
516391|NCT01362933|international Venous Thromboembolism Recommendations|international venous thromboembolism recommendations
516392|NCT01362920|Sepsis|sepsis
516393|NCT01362920|Septic shock|septic shock
516394|NCT01362920|Procalcitonin|procalcitonin
516395|NCT01362920|PCT|pct
516396|NCT01362881|Early|early
516397|NCT01362881|Onset|onset
516398|NCT01362881|Scoliosis|scoliosis
516399|NCT01362868|Glaucoma|glaucoma
516400|NCT01362868|Triggerfish|triggerfish
516401|NCT01362868|Water drinking test|water drinking test
516402|NCT01362855|Advance Care Planning|advance care planning
516403|NCT01362855|End of life|end of life
516404|NCT01362855|Knowledge translation|knowledge translation
516405|NCT01362855|Goals of care|goals of care
516406|NCT01362855|Advance directive|advance directive
516407|NCT01362855|Lining will|lining will
516408|NCT01362842|Lung Cancer|lung cancer
516409|NCT01362842|Symptom distress|symptom distress
516410|NCT01362842|Post-operation|post-operation
516411|NCT01362842|Anxiety|anxiety
516412|NCT01362842|Depression|depression
516413|NCT01362842|Uncertainty|uncertainty
516414|NCT01362842|Fear of recurrence|fear of recurrence
516415|NCT01362842|Self-efficacy|self-efficacy
516416|NCT01362842|Needs|needs
516417|NCT01362803|Maximum Tolerated Dose|maximum tolerated dose
516418|NCT01362803|Pharmacokinetics|pharmacokinetics
516419|NCT01362803|Pharmacodynamics|pharmacodynamics
516420|NCT01362803|Response Rate|response rate
516421|NCT01362803|pain, quality of life and physical functioning|pain, quality of life and physical functioning
516422|NCT01362803|Neurofibromatosis Type 1|neurofibromatosis type 1
516423|NCT01362803|NF1|nf1
516424|NCT01362803|Plexiform Neurofibroma|plexiform neurofibroma
516425|NCT01362790|Immune Therapy|immune therapy
516426|NCT01362790|Immunotoxin|immunotoxin
516427|NCT01362790|T-Cell Depletion|t-cell depletion
516428|NCT01362790|Mesothelioma|mesothelioma
516429|NCT01362777|Obstructive Sleep Apnea/Hypopnea Syndrome|obstructive sleep apnea/hypopnea syndrome
516430|NCT01362777|Exercise training program|exercise training program
516431|NCT01362777|Inflammation|inflammation
516432|NCT01362777|Oxidative Stress|oxidative stress
516433|NCT01362777|Resistance to insulin|resistance to insulin
516434|NCT01362764|Abiraterone Acetate|abiraterone acetate
516435|NCT01362764|ZYTIGA|zytiga
516436|NCT01362738|Long-standing persistent atrial fibrillation|long-standing persistent atrial fibrillation
516437|NCT01362725|spinal cord stimulation|spinal cord stimulation
516438|NCT01362725|systolic heart failure|systolic heart failure
516439|NCT01362712|breast cancer|breast cancer
516440|NCT01362712|radiotherapy|radiotherapy
516441|NCT01362712|chemoradiotherapy|chemoradiotherapy
516442|NCT01362712|radiation|radiation
516443|NCT01362712|chemoradiation|chemoradiation
516444|NCT01362712|[F-18]|[f-18]
516445|NCT01362699|Alcoholism|alcoholism
516446|NCT01362699|Alcohol-Related Disorders|alcohol-related disorders
516447|NCT01362699|Substance-Related Disorders|substance-related disorders
516448|NCT01362699|Mental Disorders|mental disorders
516449|NCT01362699|Alcohol Dependence|alcohol dependence
516450|NCT01362699|JNJ-31001074|jnj-31001074
516451|NCT01362699|Bavisant|bavisant
516452|NCT01362686|diagnosis of Alzheimer's disease|diagnosis of alzheimer's disease
516453|NCT01362686|medication adherence|medication adherence
516454|NCT01362673|Phase 1|phase 1
516455|NCT01362673|Pharmacokinetics|pharmacokinetics
516456|NCT01362673|food effect|food effect
516457|NCT01362673|Healthy Japanese|healthy japanese
516458|NCT01362673|rheumatoid arthritis|rheumatoid arthritis
516459|NCT01362660|post-natal monitoring|post-natal monitoring
516460|NCT01362660|exposure in utero|exposure in utero
516461|NCT01362647|Muscle Relaxation|muscle relaxation
516462|NCT01362634|HIV/AIDS|hiv/aids
516463|NCT01362634|substance use|substance use
516464|NCT01362634|club drugs|club drugs
516465|NCT01362634|sexual risk|sexual risk
516466|NCT01362621|Allergic asthma|allergic asthma
516467|NCT01362621|Pediatrics|pediatrics
516468|NCT01362621|Exacerbations|exacerbations
516469|NCT01362621|Perennial aeroallergens|perennial aeroallergens
516470|NCT01362621|Inhaled corticosteroids|inhaled corticosteroids
516471|NCT01362608|Gout|gout
516472|NCT01362608|Inflammatory gout|inflammatory gout
516473|NCT01362608|acute gout|acute gout
516474|NCT01362595|leucine administration|leucine administration
516475|NCT01362595|red blood cell transfusion|red blood cell transfusion
516476|NCT01362595|Diamond Blackfan anemia|diamond blackfan anemia
516477|NCT01362582|Pancreatic cancer|pancreatic cancer
516478|NCT01362582|progression under chemotherapy|progression under chemotherapy
516479|NCT01362582|parenteral nutrition|parenteral nutrition
516480|NCT01362582|pancreatic adenocarcinoma|pancreatic adenocarcinoma
516481|NCT01362582|chemotherapy|chemotherapy
516482|NCT01362569|endotoxin|endotoxin
516483|NCT01362569|neutrophil function|neutrophil function
516484|NCT01362569|albumin function|albumin function
516485|NCT01362543|PTSD|ptsd
516486|NCT01362543|Depression|depression
516487|NCT01362543|Refugees|refugees
516488|NCT01362543|Trauma|trauma
516489|NCT01362517|Vaccination|vaccination
516490|NCT01362517|Immunisation|immunisation
516491|NCT01362517|Virus|virus
516492|NCT01362517|Diphtheria|diphtheria
516493|NCT01362517|Pertussis|pertussis
516494|NCT01362517|Tetanus|tetanus
516495|NCT01362517|Hepatitis B|hepatitis b
516496|NCT01362517|Haemophilus Influenzae|haemophilus influenzae
516497|NCT01362517|Immunity|immunity
516498|NCT01362504|Pro-adrenomedullin|pro-adrenomedullin
516499|NCT01362504|Neonatal sepsis|neonatal sepsis
516500|NCT01362504|Prognosis|prognosis
516501|NCT01362504|Sepsis marker|sepsis marker
516502|NCT01362504|Clinical sepsis|clinical sepsis
516503|NCT01362504|Proven sepsis|proven sepsis
516504|NCT01362491|Headache|headache
516611|NCT01362153|Golimumab|golimumab
516505|NCT01362478|schizophrenia|schizophrenia
516506|NCT01362478|gene promoter|gene promoter
516507|NCT01362478|methylation|methylation
516508|NCT01362478|endophenotype|endophenotype
516509|NCT01362478|epigenetic|epigenetic
516510|NCT01362452|Leukemia|leukemia
516511|NCT01362452|Lymphoma|lymphoma
516512|NCT01362452|CD19-specific T cells|cd19-specific t cells
516513|NCT01362452|Umbilical cord blood transplantation|umbilical cord blood transplantation
516514|NCT01362452|B-Lineage Lymphoid Malignancies|b-lineage lymphoid malignancies
516515|NCT01362452|B-cell leukemia|b-cell leukemia
516516|NCT01362452|Acute Lymphoblastic Leukemia|acute lymphoblastic leukemia
516517|NCT01362452|ALL|all
516518|NCT01362452|Biphenotypic Leukemia|biphenotypic leukemia
516519|NCT01362452|Non-Hodgkin's Lymphoma|non-hodgkin's lymphoma
516520|NCT01362452|NHL|nhl
516521|NCT01362452|Small Lymphocytic Lymphoma|small lymphocytic lymphoma
516522|NCT01362452|SLL|sll
516523|NCT01362452|Chronic Lymphocytic Leukemia|chronic lymphocytic leukemia
516524|NCT01362452|CLL|cll
516525|NCT01362452|White blood cells|white blood cells
516526|NCT01362452|T cells|t cells
516527|NCT01362452|Melphalan|melphalan
516528|NCT01362452|Alkeran|alkeran
516529|NCT01362452|Thiotepa|thiotepa
516530|NCT01362452|Fludarabine|fludarabine
516531|NCT01362452|Fludarabine Phosphate|fludarabine phosphate
516532|NCT01362452|Fludara|fludara
516533|NCT01362452|ATG|atg
516534|NCT01362452|Antithymocyte Globulin|antithymocyte globulin
516535|NCT01362452|Thymoglobulin|thymoglobulin
516536|NCT01362452|Rituxan|rituxan
516537|NCT01362452|Rituximab|rituximab
516538|NCT01362452|Cyclophosphamide|cyclophosphamide
516539|NCT01362452|Cytoxan|cytoxan
516540|NCT01362452|Neosar|neosar
516541|NCT01362439|Schizophrenia|schizophrenia
516542|NCT01362439|Paliperidone|paliperidone
516543|NCT01362426|schizophrenia|schizophrenia
516544|NCT01362426|paliperidone palmitate|paliperidone palmitate
516545|NCT01362426|INVEGA SUSTENNA|invega sustenna
516546|NCT01362426|registries|registries
516547|NCT01362426|quality of healthcare|quality of healthcare
516548|NCT01362413|pseudarthrosis|pseudarthrosis
516549|NCT01362413|mineralization|mineralization
516550|NCT01362413|platelet-rich-plasma|platelet-rich-plasma
516551|NCT01362413|serum|serum
516552|NCT01362400|LUNG NEOPLASMS|lung neoplasms
516553|NCT01362400|LARGE CELL CARCINOMA|large cell carcinoma
516554|NCT01362400|SQUAMOUS CELL CARCINOMA|squamous cell carcinoma
516555|NCT01362387|Medical abortion|medical abortion
516556|NCT01362387|abortion follow-up|abortion follow-up
516557|NCT01362361|Second line colorectal cancer|second line colorectal cancer
516558|NCT01362348|Age-related Macular Degeneration|age-related macular degeneration
516559|NCT01362322|dTpa|dtpa
516560|NCT01362322|Boostrix|boostrix
516561|NCT01362309|Alcohol|alcohol
516562|NCT01362309|Cues|cues
516563|NCT01362309|Extinction|extinction
516564|NCT01362309|D-Cycloserine|d-cycloserine
516565|NCT01362296|NRAS|nras
516566|NCT01362296|docetaxel|docetaxel
516567|NCT01362296|NSCLC|nsclc
516568|NCT01362296|GSK1120212|gsk1120212
516569|NCT01362296|MEK inhibitor|mek inhibitor
516570|NCT01362296|targeted therapy|targeted therapy
516571|NCT01362296|KRAS|kras
516572|NCT01362296|BRAF|braf
516573|NCT01362270|Anxiolytics|anxiolytics
516574|NCT01362270|Sedatives|sedatives
516575|NCT01362270|Acupuncture Therapy|acupuncture therapy
516576|NCT01362244|Quality of Life|quality of life
516577|NCT01362244|Intranasal Steroids|intranasal steroids
516578|NCT01362244|Severe Nasal Polyposis|severe nasal polyposis
516579|NCT01362244|Polyp Relapse|polyp relapse
516580|NCT01362244|Endoscopic Polyp Score|endoscopic polyp score
516581|NCT01362244|Surgery|surgery
516582|NCT01362231|Fibrosis|fibrosis
516583|NCT01362231|Pulmonary Fibrosis|pulmonary fibrosis
516584|NCT01362231|Lung Diseases|lung diseases
516585|NCT01362231|Interstitial|interstitial
516586|NCT01362205|Severe Alcohol Withdrawal Delirium Tremens|severe alcohol withdrawal delirium tremens
516587|NCT01362192|Telangiectasis|telangiectasis
516588|NCT01362192|Spider Veins|spider veins
516589|NCT01362192|Excel V|excel v
516590|NCT01362192|Cutera|cutera
516591|NCT01362192|Laser|laser
516592|NCT01362192|Leg Veins|leg veins
516593|NCT01362192|Venulectasia|venulectasia
516594|NCT01362192|Lower Extremity veins|lower extremity veins
516595|NCT01362192|Laser light|laser light
516596|NCT01362192|KTP|ktp
516597|NCT01362192|532nm|532nm
516598|NCT01362179|malignant myeloid hematologic disorders|malignant myeloid hematologic disorders
516599|NCT01362179|filgrastim|filgrastim
516600|NCT01362179|long term incidence|long term incidence
516601|NCT01362179|donors who received and in those who did not receive filgrastim.|donors who received and in those who did not receive filgrastim.
516602|NCT01362166|Chinese medicine|chinese medicine
516603|NCT01362166|channel|channel
516604|NCT01362166|acupuncture|acupuncture
516605|NCT01362166|ZuSanLi|zusanli
516606|NCT01362166|XianGu|xiangu
516607|NCT01362166|frequency response|frequency response
516608|NCT01362166|resonance|resonance
516609|NCT01362166|male volunteer|male volunteer
516610|NCT01362166|aged within 20-35 years old|aged within 20-35 years old
516613|NCT01362153|Rheumatoid Arthritis|rheumatoid arthritis
516614|NCT01362153|PK|pk
516615|NCT01362153|PD|pd
516616|NCT01362140|Randomized|randomized
516617|NCT01362140|Darbepoetin alfa|darbepoetin alfa
516618|NCT01362140|Myelodysplastic Syndromes|myelodysplastic syndromes
516619|NCT01362140|Placebo-controlled|placebo-controlled
516620|NCT01362140|low risk MDS|low risk mds
516621|NCT01362140|intermediate-1 risk MDS|intermediate-1 risk mds
516622|NCT01362140|International Prognostic Scoring System|international prognostic scoring system
516623|NCT01362127|Histologically confirmed squamos cell carcinoma or adenocarcinoma of the esophagus and gastric cardia.Suitable for surgery.|histologically confirmed squamos cell carcinoma or adenocarcinoma of the esophagus and gastric cardia.suitable for surgery.
516624|NCT01362114|Hwa-byung|hwa-byung
516625|NCT01362114|Sihogayonggolmoryeo-tang|sihogayonggolmoryeo-tang
516626|NCT01362114|Anxiety|anxiety
516627|NCT01362101|cue reactivity|cue reactivity
516628|NCT01362101|physiologic activation|physiologic activation
516629|NCT01362101|craving|craving
516630|NCT01362101|smoking cues|smoking cues
516631|NCT01362101|Behavioral therapy|behavioral therapy
516632|NCT01362088|microcirculation|microcirculation
516633|NCT01362088|intensive care|intensive care
516634|NCT01362088|ultrafiltration|ultrafiltration
516635|NCT01362088|CVVH|cvvh
516636|NCT01362075|Shoulder Arthroplasty|shoulder arthroplasty
516637|NCT01362075|Local infiltration analgesia|local infiltration analgesia
516638|NCT01362049|Stabilization exercise|stabilization exercise
516639|NCT01362049|Physical therapy|physical therapy
516640|NCT01362049|Rehabilitation|rehabilitation
516641|NCT01362049|Movement System Impairment exercise|movement system impairment exercise
516642|NCT01362010|Acne|acne
516643|NCT01362010|Acne Vulgaris|acne vulgaris
516644|NCT01362010|Topical|topical
516645|NCT01362010|Minocycline|minocycline
516646|NCT01362010|Foam|foam
516647|NCT01362010|Phase II|phase ii
516648|NCT01361997|Antiseptics|antiseptics
516649|NCT01361997|Hemoculture contamination|hemoculture contamination
516650|NCT01361997|Anti-infecting agents, local|anti-infecting agents, local
516651|NCT01361984|Chronic Obstructive Pulmonary Disease|chronic obstructive pulmonary disease
516652|NCT01361984|COPD|copd
516653|NCT01361984|Emphysema|emphysema
516654|NCT01361984|Chronic Bronchitis|chronic bronchitis
516655|NCT01361984|Brovana|brovana
516656|NCT01361984|Serevent|serevent
516657|NCT01361971|Insulin resistance|insulin resistance
516658|NCT01361971|Inflammation|inflammation
516659|NCT01361971|Hypoxia|hypoxia
516660|NCT01361945|ER+|er+
516661|NCT01361945|HER2+|her2+
516662|NCT01361945|Breast|breast
516663|NCT01361919|compressions|compressions
516664|NCT01361919|quality|quality
516665|NCT01361919|teaching method|teaching method
516666|NCT01361919|feedback|feedback
516667|NCT01361919|CPR performance|cpr performance
516668|NCT01361919|Cardiopulmonary resuscitation (CPR)|cardiopulmonary resuscitation (cpr)
516669|NCT01361906|Musculoskeletal and Neural Physiological Phenomena|musculoskeletal and neural physiological phenomena
516670|NCT01361906|Postural Balance|postural balance
516671|NCT01361906|Eye/hand coordination|eye/hand coordination
516672|NCT01361893|SIDS|sids
516673|NCT01361893|African American|african american
516674|NCT01361893|Infants|infants
516675|NCT01361893|Disparity|disparity
516676|NCT01361880|African American|african american
516677|NCT01361880|Anticipatory Guidance|anticipatory guidance
516678|NCT01361880|Health Promotion|health promotion
516679|NCT01361880|Infant Mortality|infant mortality
516680|NCT01361880|Injury Prevention|injury prevention
516681|NCT01361880|Nurses|nurses
516682|NCT01361880|Parent Education|parent education
516683|NCT01361880|sudden Infant Death Syndrome|sudden infant death syndrome
516684|NCT01361867|motor adaptation|motor adaptation
516685|NCT01361867|lower extremity motor learning|lower extremity motor learning
516686|NCT01361854|polysomnography|polysomnography
516687|NCT01361854|portable monitoring|portable monitoring
516688|NCT01361854|sleep|sleep
516689|NCT01361854|sleep disordered breathing|sleep disordered breathing
516690|NCT01361854|home based polysomnography|home based polysomnography
516691|NCT01361841|Latanoprost|latanoprost
516692|NCT01361841|bimatoprost|bimatoprost
516693|NCT01361841|travoprost|travoprost
516694|NCT01361841|non responders|non responders
516695|NCT01361828|Bevacizumab|bevacizumab
516696|NCT01361828|VEP|vep
516697|NCT01361828|ERG|erg
516698|NCT01361828|Optic nerve and retinal functions following intravitreal bevacizumab|optic nerve and retinal functions following intravitreal bevacizumab
516699|NCT01361815|Depression|depression
516700|NCT01361815|MDD|mdd
516701|NCT01361815|SSRIs|ssris
516702|NCT01361815|TMS|tms
516703|NCT01361789|Arthroscopic reconstruction|arthroscopic reconstruction
516704|NCT01361789|Anterior crucial ligament|anterior crucial ligament
516705|NCT01361789|Coxib|coxib
516706|NCT01361789|Dexamethasone|dexamethasone
516707|NCT01361776|immune response|immune response
516708|NCT01361776|TBE-vaccine|tbe-vaccine
516709|NCT01361776|elderly|elderly
516710|NCT01361776|additional doses|additional doses
516711|NCT01361763|Dabigatran|dabigatran
516712|NCT01361763|Microbleeds|microbleeds
516713|NCT01361763|Microthrombi|microthrombi
516714|NCT01361763|CADASIL|cadasil
516715|NCT01361763|Small Vessel Disease|small vessel disease
516716|NCT01361737|Preeclampsia|preeclampsia
516717|NCT01361737|serological bio-bank|serological bio-bank
516718|NCT01361737|adiponectin|adiponectin
516719|NCT01361737|suPAR|supar
516720|NCT01361724|Parkinson's disease|parkinson's disease
516721|NCT01361724|PD|pd
516722|NCT01361724|Exercise|exercise
516723|NCT01361724|Balance|balance
516724|NCT01361724|Mobility|mobility
516725|NCT01361698|recovery|recovery
516726|NCT01361698|illness management|illness management
516727|NCT01361698|rehabilitation|rehabilitation
516728|NCT01361698|mental illness|mental illness
516729|NCT01361698|psychosocial intervention|psychosocial intervention
516730|NCT01361698|Clinical recovery (increase in functioning, decrease in symptoms)|clinical recovery (increase in functioning, decrease in symptoms)
516731|NCT01361698|Personal recovery (Hope, optimism, living a fulfilling life)|personal recovery (hope, optimism, living a fulfilling life)
516732|NCT01361659|anginal complaints|anginal complaints
516733|NCT01361659|Lithotripsy|lithotripsy
516734|NCT01361659|no option patients|no option patients
516735|NCT01361633|d-cycloserine|d-cycloserine
516736|NCT01361633|geriatric|geriatric
656863|NCT00802503|human|human
516737|NCT01361633|neuropsychology|neuropsychology
516738|NCT01361633|cognition|cognition
516739|NCT01361633|cognitive-enhancer|cognitive-enhancer
516740|NCT01361633|aging|aging
516741|NCT01361633|neuropsychological functioning|neuropsychological functioning
516742|NCT01361620|genomic markers|genomic markers
516743|NCT01361620|aspirin resistance|aspirin resistance
516744|NCT01361607|Cancer pain|cancer pain
516745|NCT01361607|Opioid therapy|opioid therapy
516746|NCT01361607|Inadequate analgesia|inadequate analgesia
516747|NCT01361607|Optimized chronic opioid therapy|optimized chronic opioid therapy
516748|NCT01361594|Diabetes|diabetes
516749|NCT01361594|Coronary Artery Bypass Surgery|coronary artery bypass surgery
516750|NCT01361594|Glycemic control|glycemic control
516751|NCT01361594|Insulin infusion|insulin infusion
516752|NCT01361581|Acute renal failure|acute renal failure
516753|NCT01361581|Anticoagulation|anticoagulation
516754|NCT01361581|Citrate|citrate
516755|NCT01361581|Haemodiafiltration|haemodiafiltration
516756|NCT01361581|Haemofiltration|haemofiltration
516757|NCT01361581|Renal replacement therapy|renal replacement therapy
516758|NCT01361568|pain|pain
516759|NCT01361568|acute pain|acute pain
516760|NCT01361568|visceral pain|visceral pain
516761|NCT01361568|kappa agonist|kappa agonist
516762|NCT01361568|opioid analgesics|opioid analgesics
516763|NCT01361568|peripheral nervous system agents|peripheral nervous system agents
516764|NCT01361568|physiological effects of drugs|physiological effects of drugs
516765|NCT01361568|surgery|surgery
516766|NCT01361568|hysterectomy|hysterectomy
516767|NCT01361568|post-operative|post-operative
516768|NCT01361568|post-operative complications|post-operative complications
516769|NCT01361542|TNF|tnf
516770|NCT01361542|BMD|bmd
516771|NCT01361542|Ankylosing spondylitis|ankylosing spondylitis
516772|NCT01361542|bone health|bone health
516773|NCT01361542|Anti TNF therapy|anti tnf therapy
516774|NCT01361542|Disease activity|disease activity
516775|NCT01361529|dose escalation|dose escalation
516776|NCT01361516|Urolithiasis|urolithiasis
516777|NCT01361516|ESWL|eswl
516778|NCT01361516|Stone Fragmentation efficacy|stone fragmentation efficacy
516779|NCT01361516|Sedation|sedation
516780|NCT01361516|General Anaesthesia|general anaesthesia
516781|NCT01361503|Autism Spectrum Disorders|autism spectrum disorders
516782|NCT01361503|Pervasive Developmental Disorders|pervasive developmental disorders
516783|NCT01361503|Asperger's Syndrome|asperger's syndrome
516784|NCT01361503|Adolescents|adolescents
516785|NCT01361503|Magnetic Resonance Spectroscopy|magnetic resonance spectroscopy
516786|NCT01361503|Diffusion Tensor Imaging|diffusion tensor imaging
516787|NCT01361477|General surgical ICU|general surgical icu
516788|NCT01361477|ICU Siamitra|icu siamitra
516789|NCT01361477|ICU Salad-Samung|icu salad-samung
516790|NCT01361477|Data registry|data registry
516791|NCT01361477|ICU refusal|icu refusal
516792|NCT01361477|ICU complications|icu complications
516793|NCT01361477|ICU resource utilization|icu resource utilization
516794|NCT01361477|Adverse events|adverse events
516795|NCT01361477|ICU readmission|icu readmission
516796|NCT01361451|parasternal electromyogram|parasternal electromyogram
516797|NCT01361451|neural respiratory drive|neural respiratory drive
516798|NCT01361451|chronic obstructive pulmonary disease|chronic obstructive pulmonary disease
516799|NCT01361451|respiratory physiology|respiratory physiology
516800|NCT01361451|Acute exacerbation|acute exacerbation
516801|NCT01361425|hypertension|hypertension
516802|NCT01361425|ultrasonography|ultrasonography
516803|NCT01361425|preeclampsia|preeclampsia
516804|NCT01361425|clinical trials|clinical trials
516805|NCT01361425|treatment|treatment
516806|NCT01361425|methyldopa|methyldopa
516807|NCT01361412|ragweed allergy|ragweed allergy
516808|NCT01361412|immunotherapy|immunotherapy
516809|NCT01361399|Sore Throat|sore throat
516810|NCT01361386|Long-term follow up|long-term follow up
516811|NCT01361386|Antithrombotic management patterns|antithrombotic management patterns
516812|NCT01361386|Acute Coronary Syndrome|acute coronary syndrome
516814|NCT01361386|quality of life|quality of life
516815|NCT01361347|milk allergy|milk allergy
516816|NCT01361347|desensitization|desensitization
516817|NCT01361347|anaphylaxis|anaphylaxis
516818|NCT01361347|school-age|school-age
516819|NCT01361334|(other than AML M3)|(other than aml m3)
516820|NCT01361321|follow up|follow up
516821|NCT01361321|Guided bone regeneration|guided bone regeneration
516822|NCT01361321|Micro computerized tomography|micro computerized tomography
516823|NCT01361321|histological examination|histological examination
516824|NCT01361308|Menopause|menopause
516825|NCT01361308|Vasomotor Symptoms|vasomotor symptoms
516826|NCT01361308|Hot Flashes Perimenopause|hot flashes perimenopause
516827|NCT01361308|Climacteric Symptoms|climacteric symptoms
516828|NCT01361308|Mesafem|mesafem
516829|NCT01361308|Low-Dose Mesylate salt of Paroxetine (LDMP)|low-dose mesylate salt of paroxetine (ldmp)
516830|NCT01361295|Atrial fibrillation|atrial fibrillation
516831|NCT01361295|cerebral embolism|cerebral embolism
516832|NCT01361295|catheter ablation|catheter ablation
516833|NCT01361282|Total Corneal Power|total corneal power
516834|NCT01361282|Optical Coherence Tomography|optical coherence tomography
516835|NCT01361282|Descemet Stripping Endothelial Keratoplasty|descemet stripping endothelial keratoplasty
516836|NCT01361256|Macular Degeneration|macular degeneration
516837|NCT01361256|Visual Impairment|visual impairment
516838|NCT01361256|Implantable Telescope|implantable telescope
516839|NCT01361243|Pediatric Overweight|pediatric overweight
516840|NCT01361243|Pediatric Obesity|pediatric obesity
516841|NCT01361217|Fluoxetine|fluoxetine
516842|NCT01361217|CYP3A4|cyp3a4
516843|NCT01361217|CYP2D6|cyp2d6
516844|NCT01361217|CYP2C19|cyp2c19
516845|NCT01361217|Drug-Drug Interaction|drug-drug interaction
516846|NCT01361217|Multi-CYP Inhibition|multi-cyp inhibition
516847|NCT01361204|stress|stress
516848|NCT01361204|students|students
516849|NCT01361204|pharmacy practice|pharmacy practice
516850|NCT01361204|theanine|theanine
516851|NCT01361204|pharmacy training|pharmacy training
516852|NCT01361191|DLBCL|dlbcl
516853|NCT01361191|PET|pet
516854|NCT01361191|IPI|ipi
516855|NCT01361191|R-MegaCHOP|r-megachop
516856|NCT01361191|Autologous stem cell transplantation|autologous stem cell transplantation
516857|NCT01361165|Pediatric|pediatric
516858|NCT01361165|Data Analysis|data analysis
516859|NCT01361152|total knee arthroplasty|total knee arthroplasty
516860|NCT01361152|fixed-bearing|fixed-bearing
516861|NCT01361152|mobile-bearing|mobile-bearing
516862|NCT01361152|long-term|long-term
516863|NCT01361139|Chronic obstructive lung disease|chronic obstructive lung disease
516864|NCT01361139|Interstitial lung disease|interstitial lung disease
516865|NCT01361139|Asthma|asthma
516866|NCT01361139|Sarcoidosis|sarcoidosis
516867|NCT01361139|Pulmonary hypertension|pulmonary hypertension
516868|NCT01361139|Ultrasound|ultrasound
516869|NCT01361139|Doppler|doppler
516870|NCT01361139|Lung disease diagnosis|lung disease diagnosis
516871|NCT01361113|Renal Cell Carcinoma|renal cell carcinoma
516872|NCT01361113|RCC|rcc
516873|NCT01361113|Votrient|votrient
516874|NCT01361113|Pazopanib|pazopanib
516875|NCT01361113|Nephrectomy|nephrectomy
516876|NCT01361113|Neoadjuvant|neoadjuvant
516877|NCT01361113|Phase II|phase ii
516878|NCT01361113|LCCC 1028|lccc 1028
516879|NCT01361113|Lineberger Comprehensive Cancer Center|lineberger comprehensive cancer center
516880|NCT01361100|Otolaryngology|otolaryngology
516881|NCT01361087|TGF-B blood levels Atenolol vs, Losartan Study, NIH, NIHLB and NMF|tgf-b blood levels atenolol vs, losartan study, nih, nihlb and nmf
516882|NCT01361074|Virtual reality|virtual reality
516883|NCT01361074|Augmented reality|augmented reality
516884|NCT01361074|In vivo exposure|in vivo exposure
516885|NCT01361074|One session treatment|one session treatment
516886|NCT01361074|ICT|ict
516887|NCT01361074|Efficacy|efficacy
516888|NCT01361074|Specific phobia|specific phobia
516889|NCT01361074|Anxiety disorders|anxiety disorders
516890|NCT01361061|liver cirrhosis|liver cirrhosis
516891|NCT01361061|screening|screening
516892|NCT01361061|hepatocellular carcinoma|hepatocellular carcinoma
516893|NCT01361061|liver cancer markers: AFP, AFP-L3% and DCP|liver cancer markers: afp, afp-l3% and dcp
516894|NCT01361048|trichomonas|trichomonas
516895|NCT01361035|health literacy|health literacy
516896|NCT01361035|cancer screening|cancer screening
516897|NCT01361035|doctor-patient communication|doctor-patient communication
516898|NCT01361035|standardized patient|standardized patient
516899|NCT01361035|continuing medical education|continuing medical education
516900|NCT01360996|PCOS|pcos
516901|NCT01360970|hepatitis A vaccine|hepatitis a vaccine
516902|NCT01360970|TNF-alfa inhibitory drugs|tnf-alfa inhibitory drugs
516903|NCT01360970|Rheumatoid arthritis|rheumatoid arthritis
516904|NCT01360970|methotrexate|methotrexate
516905|NCT01360957|Obesity|obesity
516906|NCT01360944|PPT, topical, psoriasis|ppt, topical, psoriasis
516907|NCT01360931|Lung cancer|lung cancer
516908|NCT01360931|Chronic obstructive pulmonary disease|chronic obstructive pulmonary disease
516909|NCT01360905|PTL|ptl
516910|NCT01360905|Multiples|multiples
516911|NCT01360892|Hepatitis B virus|hepatitis b virus
516912|NCT01360892|Hepatitis C virus|hepatitis c virus
516913|NCT01360892|Chronic hepatitis|chronic hepatitis
516914|NCT01360892|Liver chlorosis|liver chlorosis
516915|NCT01360892|Liver stiffness|liver stiffness
516916|NCT01360892|Liver fibrosis|liver fibrosis
516917|NCT01360879|Hepatitis B virus|hepatitis b virus
516918|NCT01360879|Hepatitis C virus|hepatitis c virus
516919|NCT01360879|Chronic hepatitis|chronic hepatitis
516920|NCT01360879|Liver cirrhosis|liver cirrhosis
516921|NCT01360879|Liver stiffness|liver stiffness
516922|NCT01360879|Liver fibrosis|liver fibrosis
516923|NCT01360866|OPC-34712|opc-34712
516924|NCT01360866|brexpiprazole|brexpiprazole
516925|NCT01360866|Major Depressive Disorder|major depressive disorder
516926|NCT01360866|Adjunctive Treatment|adjunctive treatment
516927|NCT01360853|pancreatic cancer|pancreatic cancer
516928|NCT01360853|gemcitabine|gemcitabine
516929|NCT01360853|ON 01910.Na|on 01910.na
516930|NCT01360853|rigosertib sodium|rigosertib sodium
516931|NCT01360840|Asymptomatic|asymptomatic
516932|NCT01360840|mildly symptomatic|mildly symptomatic
516933|NCT01360840|metastatic castrate-resistant prostate cancer|metastatic castrate-resistant prostate cancer
516934|NCT01360840|mCRPC|mcrpc
516935|NCT01360827|Safety|safety
516936|NCT01360827|tolerability|tolerability
516937|NCT01360827|maximum tolerated dose of EMD 1201081|maximum tolerated dose of emd 1201081
516938|NCT01360827|TLR9 agonists|tlr9 agonists
516939|NCT01360827|squamous cell carcinoma of the head and neck|squamous cell carcinoma of the head and neck
516940|NCT01360827|First line subjects|first line subjects
516941|NCT01360827|recurrent/metastatic|recurrent/metastatic
516942|NCT01360788|chronic obstructive pulmonary disease|chronic obstructive pulmonary disease
516943|NCT01360788|lung function|lung function
516944|NCT01360788|symptoms|symptoms
516945|NCT01360788|activity-related dyspnea|activity-related dyspnea
516946|NCT01360788|quadriceps muscle function|quadriceps muscle function
516947|NCT01360788|exercise capacity|exercise capacity
516948|NCT01360788|physical activity in daily life|physical activity in daily life
516949|NCT01360788|muscle biopsy|muscle biopsy
516950|NCT01360788|systemic inflammation|systemic inflammation
516951|NCT01360788|GOLD stage I|gold stage i
516952|NCT01360788|pulmonary function|pulmonary function
516953|NCT01360775|Nutritional status|nutritional status
516954|NCT01360775|Dependent patients|dependent patients
516955|NCT01360775|Nutritional educational intervention|nutritional educational intervention
516956|NCT01360775|Caregivers|caregivers
516957|NCT01360775|Clinical assay|clinical assay
516958|NCT01360762|Secondary prophylaxis|secondary prophylaxis
516959|NCT01360762|Visceral leishmaniasis|visceral leishmaniasis
516960|NCT01360762|Relapses|relapses
516961|NCT01360762|HIV co-infection|hiv co-infection
516962|NCT01360762|Pentamidine|pentamidine
516963|NCT01360762|Ethiopia|ethiopia
516964|NCT01360749|Pain management|pain management
516965|NCT01360749|Lidocaine|lidocaine
516966|NCT01360736|Suicide Prevention|suicide prevention
516967|NCT01360736|Suicide Attempt|suicide attempt
516968|NCT01360736|Suicide Ideation|suicide ideation
516969|NCT01360736|Randomized Controlled Trial|randomized controlled trial
516970|NCT01360736|Safety Planning|safety planning
516971|NCT01360710|male age 18-30 years old|male age 18-30 years old
516972|NCT01360710|presence of central obesity|presence of central obesity
516973|NCT01360710|no history of cardiovascular disease, depression|no history of cardiovascular disease, depression
516974|NCT01360710|not on any medication|not on any medication
516975|NCT01360697|Diabetes|diabetes
516976|NCT01360697|Structured care|structured care
516977|NCT01360671|PPHN|pphn
516978|NCT01360671|persistent pulmonary hypertension of the newborn|persistent pulmonary hypertension of the newborn
516979|NCT01360671|sildenafil|sildenafil
516980|NCT01360671|iv|iv
516981|NCT01360658|Intravenous immunoglobulins|intravenous immunoglobulins
516982|NCT01360658|Solar urticaria|solar urticaria
516983|NCT01360658|Minimal urticaria dose|minimal urticaria dose
516984|NCT01360658|Quality of life|quality of life
516985|NCT01360658|Safety|safety
516986|NCT01360645|OPC-34712|opc-34712
516987|NCT01360645|brexpiprazole|brexpiprazole
516988|NCT01360645|Major Depressive Disorder|major depressive disorder
516989|NCT01360645|Adjunctive Treatment|adjunctive treatment
516990|NCT01360632|OPC-34712|opc-34712
516991|NCT01360632|brexpiprazole|brexpiprazole
516992|NCT01360632|Major Depressive Disorder|major depressive disorder
516993|NCT01360632|Adjunctive Treatment|adjunctive treatment
516994|NCT01360619|To demonstrate that multifunction Keito is as effective, as safe and accurate as the predicate K014009 on its body fat measurement.|to demonstrate that multifunction keito is as effective, as safe and accurate as the predicate k014009 on its body fat measurement.
516995|NCT01360606|Liver|liver
516996|NCT01360606|Mets|mets
516997|NCT01360593|Pancreas|pancreas
516998|NCT01360567|green tea|green tea
516999|NCT01360567|EGCG|egcg
517000|NCT01360567|type 2 diabetes|type 2 diabetes
517001|NCT01360567|hyperlipidemia|hyperlipidemia
517002|NCT01360554|comparative study of PF-00299804 and Erlotinib|comparative study of pf-00299804 and erlotinib
517003|NCT01360554|Double-Blind Phase 3 trial of TKI|double-blind phase 3 trial of tki
517004|NCT01360541|Barrett oesophagus|barrett oesophagus
517005|NCT01360541|Low grade dysplasia|low grade dysplasia
517006|NCT01360541|Radiofrequency ablation|radiofrequency ablation
517007|NCT01360528|Folic acid replacement|folic acid replacement
517008|NCT01360528|Folic acid|folic acid
517009|NCT01360528|Preterm neonate|preterm neonate
517010|NCT01360515|esophagoscope|esophagoscope
517011|NCT01360515|esophageal disease|esophageal disease
517012|NCT01360515|gastroesophageal reflux|gastroesophageal reflux
517013|NCT01360515|esophageal varices|esophageal varices
517014|NCT01360502|capsule endoscopy|capsule endoscopy
517015|NCT01360502|cardiac pacemaker|cardiac pacemaker
517016|NCT01360502|implantable cardiac defibrillator|implantable cardiac defibrillator
517017|NCT01360476|hypertension|hypertension
517018|NCT01360476|left ventricular hypertrophy|left ventricular hypertrophy
517019|NCT01360476|Vitamin D|vitamin d
517020|NCT01360476|African-Americans|african-americans
517021|NCT01360463|drug abuse counseling|drug abuse counseling
517022|NCT01360463|HIV risk reduction counseling|hiv risk reduction counseling
517023|NCT01360463|HIV infection|hiv infection
517024|NCT01360463|injection drug users|injection drug users
517025|NCT01360463|AIDS|aids
517026|NCT01360450|opioid withdrawal|opioid withdrawal
517027|NCT01360450|Neonatal Pain, Agitation, and Sedation Scale (NPASS)|neonatal pain, agitation, and sedation scale (npass)
517028|NCT01360450|duraclon|duraclon
517029|NCT01360437|coronary angioplasty|coronary angioplasty
517030|NCT01360437|clopidogrel hyporesponsiveness|clopidogrel hyporesponsiveness
517031|NCT01360437|prasugrel|prasugrel
517032|NCT01360437|ticagrelor|ticagrelor
517033|NCT01360437|CAD|cad
517034|NCT01360437|ACS|acs
517035|NCT01360424|osteoporosis|osteoporosis
517036|NCT01360424|teriparatide|teriparatide
517037|NCT01360424|bone turnover|bone turnover
517038|NCT01360424|New forms of inherited low-turnover osteoporosis|new forms of inherited low-turnover osteoporosis
517039|NCT01360411|elastography|elastography
517040|NCT01360411|strain ratio|strain ratio
517041|NCT01360411|pancreas|pancreas
517042|NCT01360411|GI wall lesions|gi wall lesions
517043|NCT01360411|lymph nodes|lymph nodes
517044|NCT01360398|pathogen|pathogen
517160|NCT01360047|epidemiology|epidemiology
517045|NCT01360398|Chronic Obstructive Pulmonary Disease|chronic obstructive pulmonary disease
517046|NCT01360398|Acute Exacerbations of Chronic Obstructive Pulmonary Disease|acute exacerbations of chronic obstructive pulmonary disease
517047|NCT01360398|COPD|copd
517048|NCT01360398|respiratory|respiratory
517049|NCT01360398|AECOPD|aecopd
517050|NCT01360398|exacerbation|exacerbation
517051|NCT01360385|Central retinal rein occlusion|central retinal rein occlusion
517052|NCT01360385|Retinal oximetry|retinal oximetry
517053|NCT01360385|Oxymap Retinal Oximeter|oxymap retinal oximeter
517054|NCT01360385|Visual acuity|visual acuity
517055|NCT01360385|Central retinal thickness|central retinal thickness
517056|NCT01360372|Hydrogen breath test value and gastric residual volume measurements|hydrogen breath test value and gastric residual volume measurements
517057|NCT01360372|Tube feeding tolerance while taking a stable dose of opiate|tube feeding tolerance while taking a stable dose of opiate
517058|NCT01360359|low back pain|low back pain
517059|NCT01360359|core stabilization|core stabilization
517060|NCT01360359|trunk muscle exercises|trunk muscle exercises
517061|NCT01360359|physical therapy|physical therapy
517062|NCT01360359|RCT|rct
517063|NCT01360346|Enteral Sedation|enteral sedation
517064|NCT01360346|Intravenous Sedation|intravenous sedation
517065|NCT01360346|Critically ill ICU patient|critically ill icu patient
517066|NCT01360346|Conscious Sedation|conscious sedation
517067|NCT01360346|Deep Sedation|deep sedation
517068|NCT01360346|RASS|rass
517069|NCT01360346|CAM-ICU|cam-icu
517070|NCT01360346|VNR|vnr
517071|NCT01360346|BPS|bps
517072|NCT01360346|Propofol|propofol
517073|NCT01360346|Midazolam|midazolam
517074|NCT01360346|Hydroxyzine|hydroxyzine
517075|NCT01360346|Lorazepam|lorazepam
517076|NCT01360346|Melatonin|melatonin
517077|NCT01360333|Dehydration|dehydration
517078|NCT01360333|Hydration|hydration
517079|NCT01360320|Green tea|green tea
517080|NCT01360320|polyphenol|polyphenol
517081|NCT01360320|catechin|catechin
517082|NCT01360320|EGCG|egcg
517083|NCT01360320|Epigallocatechin gallate|epigallocatechin gallate
517084|NCT01360320|colorectal adenoma|colorectal adenoma
517085|NCT01360320|adenoma prevention|adenoma prevention
517086|NCT01360320|colon cancer prevention|colon cancer prevention
517087|NCT01360307|psychometric validation|psychometric validation
517088|NCT01360307|major depressive disorder|major depressive disorder
517089|NCT01360307|patient-reported outcome|patient-reported outcome
517090|NCT01360294|Asthma|asthma
517091|NCT01360294|Small airways disease|small airways disease
517092|NCT01360294|Questionnaire|questionnaire
517093|NCT01360281|Quadriceps strength|quadriceps strength
517094|NCT01360281|osteoarthritis rehabilitation|osteoarthritis rehabilitation
517095|NCT01360281|NMES|nmes
517096|NCT01360255|Hepatocellular Carcinoma|hepatocellular carcinoma
517097|NCT01360255|transarterial chemoembolisation|transarterial chemoembolisation
517098|NCT01360255|liver cancer markers: AFP, AFP-L3% and DCP|liver cancer markers: afp, afp-l3% and dcp
517099|NCT01360242|Acute STEMI|acute stemi
517100|NCT01360242|Thrombus aspiration|thrombus aspiration
517101|NCT01360242|Angioplasty|angioplasty
517102|NCT01360242|Primary Percutaneous Coronary Intervention|primary percutaneous coronary intervention
517103|NCT01360229|Parkinsons Disease|parkinsons disease
517105|NCT01360216|Long-acting reversible contraception|long-acting reversible contraception
517106|NCT01360216|Intrauterine contraception|intrauterine contraception
517107|NCT01360216|Intrauterine devices|intrauterine devices
517108|NCT01360216|Single-rod implant|single-rod implant
517109|NCT01360216|Hormonal contraception|hormonal contraception
517110|NCT01360190|MDD|mdd
517111|NCT01360190|major depressive disorder|major depressive disorder
517112|NCT01360190|QEEG|qeeg
517113|NCT01360190|electroencephalograph|electroencephalograph
517114|NCT01360190|fluoxtine|fluoxtine
517115|NCT01360190|placebo|placebo
517116|NCT01360164|Human Umbilical Cord Mesenchymal Stem Cells|human umbilical cord mesenchymal stem cells
517117|NCT01360151|VEGF (Vascular endothelial growth factor)|vegf (vascular endothelial growth factor)
517118|NCT01360125|adult acute basophilic leukemia|adult acute basophilic leukemia
517119|NCT01360125|adult acute eosinophilic leukemia|adult acute eosinophilic leukemia
517120|NCT01360125|adult acute erythroid leukemia (M6)|adult acute erythroid leukemia (m6)
517121|NCT01360125|adult acute megakaryoblastic leukemia (M7)|adult acute megakaryoblastic leukemia (m7)
517122|NCT01360125|adult acute minimally differentiated myeloid leukemia (M0)|adult acute minimally differentiated myeloid leukemia (m0)
517123|NCT01360125|adult acute monoblastic leukemia (M5a)|adult acute monoblastic leukemia (m5a)
517124|NCT01360125|adult acute monocytic leukemia (M5b)|adult acute monocytic leukemia (m5b)
517125|NCT01360125|adult acute myeloblastic leukemia with maturation (M2)|adult acute myeloblastic leukemia with maturation (m2)
517126|NCT01360125|adult acute myeloblastic leukemia without maturation (M1)|adult acute myeloblastic leukemia without maturation (m1)
517127|NCT01360125|adult acute myeloid leukemia in remission|adult acute myeloid leukemia in remission
517128|NCT01360125|adult acute myeloid leukemia with 11q23 (MLL) abnormalities|adult acute myeloid leukemia with 11q23 (mll) abnormalities
517129|NCT01360125|adult acute myeloid leukemia with del(5q)|adult acute myeloid leukemia with del(5q)
517130|NCT01360125|adult acute myeloid leukemia with inv(16)(p13;q22)|adult acute myeloid leukemia with inv(16)(p13;q22)
517131|NCT01360125|adult acute myeloid leukemia with t(16;16)(p13;q22)|adult acute myeloid leukemia with t(16;16)(p13;q22)
517132|NCT01360125|adult acute myeloid leukemia with t(8;21)(q22;q22)|adult acute myeloid leukemia with t(8;21)(q22;q22)
517133|NCT01360125|adult acute myelomonocytic leukemia (M4)|adult acute myelomonocytic leukemia (m4)
517134|NCT01360112|Mosquito|mosquito
517135|NCT01360112|Membrane|membrane
517136|NCT01360112|Feeding|feeding
517137|NCT01360112|Parasites|parasites
517138|NCT01360112|Infection|infection
517139|NCT01360112|Malaria|malaria
517140|NCT01360099|Atypical Hip Fracture|atypical hip fracture
517141|NCT01360099|Biosphosphonates|biosphosphonates
517142|NCT01360099|Subtrochanteric Hip Fracture|subtrochanteric hip fracture
517143|NCT01360099|Osteoporosis|osteoporosis
517144|NCT01360086|adenocarcinoma of the gastroesophageal junction|adenocarcinoma of the gastroesophageal junction
517145|NCT01360086|adenocarcinoma of the stomach|adenocarcinoma of the stomach
517146|NCT01360086|stage IB gastric cancer|stage ib gastric cancer
517147|NCT01360086|stage IIA gastric cancer|stage iia gastric cancer
517148|NCT01360086|stage IIB gastric cancer|stage iib gastric cancer
517149|NCT01360086|stage IIIA gastric cancer|stage iiia gastric cancer
517150|NCT01360086|stage IIIB gastric cancer|stage iiib gastric cancer
517151|NCT01360086|stage IIIC gastric cancer|stage iiic gastric cancer
517152|NCT01360073|MI|mi
517153|NCT01360073|low dose aspirin|low dose aspirin
517154|NCT01360073|PPI|ppi
517155|NCT01360073|epidemiology|epidemiology
517156|NCT01360073|Nonfatal MI and coronary death|nonfatal mi and coronary death
517157|NCT01360047|MI|mi
517158|NCT01360047|low dose aspirin|low dose aspirin
517159|NCT01360047|PPI|ppi
517161|NCT01360034|Obstetric labor, premature|obstetric labor, premature
517162|NCT01360034|Short cervix|short cervix
517163|NCT01360034|Nifedipine|nifedipine
517164|NCT01360034|Indomethacin|indomethacin
517165|NCT01360008|Cardiac arrhythmia|cardiac arrhythmia
517166|NCT01360008|Catheter ablation|catheter ablation
517167|NCT01360008|Cohort Study|cohort study
517168|NCT01360008|cryoballoon|cryoballoon
517169|NCT01360008|radiofrequency|radiofrequency
517170|NCT01359995|cytomegalovirus endotheliitis|cytomegalovirus endotheliitis
517171|NCT01359982|Advanced Solid Tumors|advanced solid tumors
517172|NCT01359982|Lymphomas|lymphomas
517173|NCT01359982|Safety|safety
517174|NCT01359982|Blood flow|blood flow
517175|NCT01359982|Nitric oxide|nitric oxide
517176|NCT01359982|Cancer|cancer
517177|NCT01359982|Dynamic contrast enhanced MRI (DCE-MRI)|dynamic contrast enhanced mri (dce-mri)
517178|NCT01359982|Contrast Enhanced Ultrasound (CEUS)|contrast enhanced ultrasound (ceus)
517179|NCT01359969|Hereditary Angioedema|hereditary angioedema
517180|NCT01359969|HAE|hae
517181|NCT01359969|Angioedema|angioedema
517182|NCT01359969|Recombinant C1 Inhibitor|recombinant c1 inhibitor
517183|NCT01359969|rhC1INH|rhc1inh
517184|NCT01359969|Pediatrics|pediatrics
517185|NCT01359943|Rheumatoid Arthritis|rheumatoid arthritis
517186|NCT01359943|RA|ra
517187|NCT01359943|secukinumab|secukinumab
517188|NCT01359943|AIN457|ain457
517189|NCT01359943|inflammatory joints|inflammatory joints
517190|NCT01359943|American College of Rheumatology|american college of rheumatology
517191|NCT01359943|ACR|acr
517192|NCT01359904|dialysate glucose|dialysate glucose
517193|NCT01359904|glycemic control|glycemic control
517194|NCT01359904|hypoglycemic episodes|hypoglycemic episodes
517195|NCT01359878|Postpartum haemorrhage|postpartum haemorrhage
517196|NCT01359878|Postpartum bleeding|postpartum bleeding
517197|NCT01359878|Postnatal bleeding|postnatal bleeding
517198|NCT01359878|Fibrinogen concentrate|fibrinogen concentrate
517199|NCT01359878|Transfusion|transfusion
517200|NCT01359878|Haemostatis|haemostatis
517201|NCT01359878|Thrombelastography|thrombelastography
517202|NCT01359865|Total hip arthroplasty|total hip arthroplasty
517203|NCT01359865|lumbar plexus block|lumbar plexus block
517204|NCT01359865|spinal anesthesia|spinal anesthesia
517205|NCT01359865|range of motion|range of motion
517206|NCT01359865|Anesthetic Technique|anesthetic technique
517207|NCT01359865|Post-operative Pain Scores|post-operative pain scores
517208|NCT01359852|JNJ-42491293|jnj-42491293
517209|NCT01359852|JNJ-40411813|jnj-40411813
517210|NCT01359852|Metabotropic glutamate subtype 2 receptor (mGlu2R)|metabotropic glutamate subtype 2 receptor (mglu2r)
517211|NCT01359852|Positive allosteric modulator (PAM)|positive allosteric modulator (pam)
517212|NCT01359852|positron emission tomography (PET)|positron emission tomography (pet)
517213|NCT01359826|Systemic Lupus Erythematosus|systemic lupus erythematosus
517214|NCT01359826|Widespread Pain|widespread pain
517215|NCT01359826|Fibromyalgia|fibromyalgia
517216|NCT01359826|Fatigue|fatigue
517217|NCT01359826|Pain|pain
517218|NCT01359826|Quality of Life|quality of life
517219|NCT01359800|HIV|hiv
517220|NCT01359800|HAART|haart
517221|NCT01359774|Energy|energy
517222|NCT01359774|Metabolism|metabolism
517223|NCT01359774|Spectroscopy|spectroscopy
517224|NCT01359761|Suicide|suicide
517225|NCT01359761|Cognitive Therapy|cognitive therapy
517226|NCT01359761|Inpatient|inpatient
517227|NCT01359761|Military|military
517228|NCT01359748|Non Invasive Blood Pressure measurement study.|non invasive blood pressure measurement study.
517229|NCT01359735|Wound|wound
517230|NCT01359735|non-melanoma skin cancer|non-melanoma skin cancer
517231|NCT01359735|Mohs micrographic surgery|mohs micrographic surgery
517232|NCT01359735|Head or neck|head or neck
517233|NCT01359722|N-acetylcysteine|n-acetylcysteine
517234|NCT01359722|Myocardial Revascularization|myocardial revascularization
517235|NCT01359722|Acute Renal Failure|acute renal failure
517236|NCT01359722|Oxidative Stress|oxidative stress
517237|NCT01359696|solid cancers|solid cancers
517238|NCT01359670|Duchenne|duchenne
517239|NCT01359670|muscular dystrophy|muscular dystrophy
517240|NCT01359670|tadalafil|tadalafil
517241|NCT01359670|sildenafil|sildenafil
517242|NCT01359670|muscle ischemia|muscle ischemia
517243|NCT01359670|exercise|exercise
517244|NCT01359657|Relapsed|relapsed
517245|NCT01359657|Refractory|refractory
517246|NCT01359631|Chronic Cluster Headache|chronic cluster headache
517247|NCT01359618|Phase I|phase i
517248|NCT01359618|Safety|safety
517249|NCT01359618|tolerability|tolerability
517250|NCT01359618|healthy|healthy
517251|NCT01359618|major depressive disorder|major depressive disorder
517252|NCT01359618|thorough QT|thorough qt
517253|NCT01359618|maximum tolerated dose|maximum tolerated dose
517254|NCT01359618|elimination|elimination
517255|NCT01359618|heart electrical signal|heart electrical signal
517256|NCT01359605|ADME|adme
517257|NCT01359605|Healthy volunteers|healthy volunteers
517258|NCT01359592|stage I adult diffuse large cell lymphoma|stage i adult diffuse large cell lymphoma
517259|NCT01359592|contiguous stage II adult diffuse large cell lymphoma|contiguous stage ii adult diffuse large cell lymphoma
517260|NCT01359592|noncontiguous stage II adult diffuse large cell lymphoma|noncontiguous stage ii adult diffuse large cell lymphoma
517261|NCT01359592|stage III adult diffuse large cell lymphoma|stage iii adult diffuse large cell lymphoma
517262|NCT01359592|stage IV adult diffuse large cell lymphoma|stage iv adult diffuse large cell lymphoma
517263|NCT01359579|renal impairment|renal impairment
517264|NCT01359579|phase 1|phase 1
517265|NCT01359579|healthy volunteers|healthy volunteers
517266|NCT01359540|Total Hip Arthroplasty|total hip arthroplasty
517267|NCT01359540|Bone Loss|bone loss
517268|NCT01359540|Femoral Remodeling|femoral remodeling
517269|NCT01359540|Bone mineral density|bone mineral density
517270|NCT01359540|THA|tha
517271|NCT01359540|DXA|dxa
517272|NCT01359540|DEXA|dexa
517273|NCT01359540|Dual Energy X-Ray Absorptiometry|dual energy x-ray absorptiometry
517274|NCT01359527|Total Hip Replacement|total hip replacement
517275|NCT01359527|Hip Resurfacing|hip resurfacing
517276|NCT01359527|Femoral Remodeling|femoral remodeling
517277|NCT01359527|Bone Loss|bone loss
517278|NCT01359527|Bone Mineral Density|bone mineral density
517279|NCT01359527|BMD|bmd
517280|NCT01359527|DXA|dxa
517281|NCT01359527|DEXA|dexa
517282|NCT01359527|THA|tha
517283|NCT01359501|patients receiving chemotherapy|patients receiving chemotherapy
517284|NCT01359488|Growth Hormone Deficiency|growth hormone deficiency
517285|NCT01359488|rhGH|rhgh
517286|NCT01359488|hGH|hgh
517287|NCT01359488|Versartis|versartis
517288|NCT01359488|AGHD|aghd
517289|NCT01359488|Hormones|hormones
517290|NCT01359488|Hormone substitute|hormone substitute
517291|NCT01359488|Endocrin System disease|endocrin system disease
517292|NCT01359488|Bone disease|bone disease
517293|NCT01359488|Bone disease, developmental|bone disease, developmental
517294|NCT01359488|Bone diseases|bone diseases
517295|NCT01359488|Musculoskeletal diseases|musculoskeletal diseases
517296|NCT01359488|Bone diseases, endocrine|bone diseases, endocrine
517297|NCT01359488|Metabolism diseases|metabolism diseases
517298|NCT01359488|Hypopituitarism|hypopituitarism
517299|NCT01359488|Pituitary disease|pituitary disease
517300|NCT01359488|Hypothalmic disease|hypothalmic disease
517301|NCT01359488|Brain disease|brain disease
657581|NCT00799773|TTP|ttp
517302|NCT01359488|Growth Hormone Releasing Hormone|growth hormone releasing hormone
517303|NCT01359488|Hormone replacement therapy|hormone replacement therapy
517304|NCT01359488|IGF-I|igf-i
517305|NCT01359488|IGFBP-3|igfbp-3
517306|NCT01359475|Acetal crowns|acetal crowns
517307|NCT01359475|Primary molars|primary molars
517308|NCT01359475|The retention of acetal crowns in primary dentition|the retention of acetal crowns in primary dentition
517309|NCT01359475|Color changes of acetal crowns|color changes of acetal crowns
517310|NCT01359462|hepatic cirrhosis patients with ascites|hepatic cirrhosis patients with ascites
517311|NCT01359449|Meningitis|meningitis
517312|NCT01359449|Meningococcal Infection|meningococcal infection
517313|NCT01359449|Menactra®|menactra®
517314|NCT01359449|MenC|menc
517315|NCT01359410|Pancreas adenocarcinoma|pancreas adenocarcinoma
517316|NCT01359410|Precancerous lesions of the pancreas (mucinous cystic neoplasms, IPMN)|precancerous lesions of the pancreas (mucinous cystic neoplasms, ipmn)
517317|NCT01359410|Pancreas neuroendocrine cancer|pancreas neuroendocrine cancer
517318|NCT01359397|Adenoca. stomach/gastr. Junct.|adenoca. stomach/gastr. junct.
517319|NCT01359384|severe primary immune deficieny|severe primary immune deficieny
517320|NCT01359371|Smoking Cessation|smoking cessation
517321|NCT01359371|Telephone|telephone
517322|NCT01359371|Hospital Volunteers|hospital volunteers
517323|NCT01359358|MRSA|mrsa
517324|NCT01359358|MLST|mlst
517325|NCT01359358|PFGE|pfge
517326|NCT01359358|Resistance|resistance
517327|NCT01359358|isolated from colonization|isolated from colonization
517328|NCT01359345|NSF|nsf
517329|NCT01359345|ESRD|esrd
517330|NCT01359345|MRA|mra
517331|NCT01359345|MRI|mri
517332|NCT01359345|occurrence of NSF|occurrence of nsf
517333|NCT01359345|Use of Gadollinum|use of gadollinum
517334|NCT01359332|Convulsive status EPILEPTICUS|convulsive status epilepticus
517335|NCT01359332|hypothermia therapy|hypothermia therapy
517336|NCT01359332|(defined as continuous SEIZURING for longer than 5 min or three seizures|(defined as continuous seizuring for longer than 5 min or three seizures
517337|NCT01359332|not separated by recovery of normal consciousness|not separated by recovery of normal consciousness
517338|NCT01359332|or of the level of consciousness present before the|or of the level of consciousness present before the
517339|NCT01359332|seizures)|seizures)
517340|NCT01359319|Phase 1 Safety and Pharmacokinetic Study|phase 1 safety and pharmacokinetic study
517341|NCT01359306|Acute myocardial infarction|acute myocardial infarction
517342|NCT01359306|Right ventricular infarction|right ventricular infarction
517343|NCT01359306|Cardiovascular Magnetic Resonance|cardiovascular magnetic resonance
517344|NCT01359306|Prognosis|prognosis
517345|NCT01359280|HIV|hiv
517346|NCT01359280|AIDS|aids
517347|NCT01359280|Medication|medication
517348|NCT01359280|Adherence|adherence
517349|NCT01359241|dysglycemia|dysglycemia
517350|NCT01359241|diabetes|diabetes
517351|NCT01359241|closed loop insulin delivery|closed loop insulin delivery
517352|NCT01359228|Rosacea|rosacea
517353|NCT01359202|Stroke|stroke
517354|NCT01359202|ICH|ich
517355|NCT01359202|Intracerebral hemorrhage|intracerebral hemorrhage
517356|NCT01359202|acute stroke|acute stroke
517357|NCT01359202|rfVIIa|rfviia
517358|NCT01359202|Niastase|niastase
517359|NCT01359189|Suspected Primary Prostate Cancer|suspected primary prostate cancer
517360|NCT01359163|bioequivalence study|bioequivalence study
517361|NCT01359163|marketed vs reformulation tablets|marketed vs reformulation tablets
517362|NCT01359163|Femulen|femulen
517363|NCT01359137|Behavior|behavior
517364|NCT01359137|Drug users|drug users
517365|NCT01359137|Criminal Justice|criminal justice
517366|NCT01359137|Probation|probation
517367|NCT01359124|Osteoarthritis, Knee|osteoarthritis, knee
517368|NCT01359124|Exercise Therapies|exercise therapies
517369|NCT01359111|Intradermal injections|intradermal injections
517370|NCT01359111|Vaccination|vaccination
517371|NCT01359098|swimmer's ear|swimmer's ear
517372|NCT01359098|ear drops|ear drops
517373|NCT01359098|ear foam|ear foam
517374|NCT01359098|otic foam|otic foam
517375|NCT01359098|ear infection|ear infection
517376|NCT01359098|ear pain|ear pain
517377|NCT01359098|ear inflammation|ear inflammation
517378|NCT01359085|To compare postoperative pain relief by pregabalin versus ISBPB following arthroscopic rotator cuff repair|to compare postoperative pain relief by pregabalin versus isbpb following arthroscopic rotator cuff repair
517776|NCT01357265|vaccine|vaccine
517379|NCT01359085|To compare postoperative opioid consumption and opioid related AEs|to compare postoperative opioid consumption and opioid related aes
517380|NCT01359085|To compare patients recovery profile and patients satisfaction|to compare patients recovery profile and patients satisfaction
517381|NCT01359072|coping|coping
517382|NCT01359072|psychological distress|psychological distress
517383|NCT01359072|self-administered intervention|self-administered intervention
517384|NCT01359059|assess the beneficial effects of PGL administered either pre or post surgery|assess the beneficial effects of pgl administered either pre or post surgery
517385|NCT01359059|assess the satisfaction rate in the orthopedic oncologic patients|assess the satisfaction rate in the orthopedic oncologic patients
517386|NCT01359046|CAUTI|cauti
517387|NCT01359046|UTI|uti
517388|NCT01359033|Myocardial Infarction|myocardial infarction
517389|NCT01359033|UK|uk
517390|NCT01359033|Sweden|sweden
517391|NCT01359033|National audit registry|national audit registry
517392|NCT01359033|MINAP|minap
517393|NCT01359033|RIKS-HIA|riks-hia
517394|NCT01359020|Fever|fever
517395|NCT01359020|Ibuprofen|ibuprofen
517396|NCT01359020|Acetaminophen|acetaminophen
517397|NCT01359020|Dipyrone|dipyrone
517398|NCT01359007|Locally advanced unresectable adenocarcinoma of pancreas|locally advanced unresectable adenocarcinoma of pancreas
517399|NCT01359007|Borderline resectable adenocarcinoma of pancreas|borderline resectable adenocarcinoma of pancreas
517400|NCT01358994|metformin|metformin
517401|NCT01358994|type 2 diabetes|type 2 diabetes
517402|NCT01358994|e-GFR|e-gfr
517403|NCT01358994|creatinine|creatinine
517404|NCT01358994|lactic acidosis|lactic acidosis
517405|NCT01358955|mild cognitive impairment|mild cognitive impairment
517406|NCT01358955|cognitive therapy|cognitive therapy
517407|NCT01358955|prevention|prevention
517408|NCT01358916|antimicrobial resistance|antimicrobial resistance
517409|NCT01358916|antibiotic prescription|antibiotic prescription
517410|NCT01358916|primary health care|primary health care
517411|NCT01358916|cluster-randomized trial|cluster-randomized trial
517412|NCT01358890|over weight|over weight
517413|NCT01358890|obesity|obesity
517414|NCT01358838|Patients with either hypertrophic or atrophic scars|patients with either hypertrophic or atrophic scars
517415|NCT01358838|Efficacy of ablative 10600nm fractional laser therapy|efficacy of ablative 10600nm fractional laser therapy
517416|NCT01358838|Laser therapy compared to no treatment of (part of) the scar|laser therapy compared to no treatment of (part of) the scar
517417|NCT01358825|Infanrix-IPV/Hib|infanrix-ipv/hib
517418|NCT01358825|Long-term follow up|long-term follow up
517419|NCT01358825|Persistence|persistence
517420|NCT01358825|Infanrix hexa|infanrix hexa
517421|NCT01358812|RAS Wild-Type|ras wild-type
517422|NCT01358812|BRAF Wild-Type|braf wild-type
517423|NCT01358799|Chlamydia trachomatis|chlamydia trachomatis
517424|NCT01358799|APTIMA Assay for Chlamydia trachomatis|aptima assay for chlamydia trachomatis
517425|NCT01358786|Quilting suture|quilting suture
517426|NCT01358786|seroma|seroma
517427|NCT01358786|Procedure|procedure
517428|NCT01358786|Surgery|surgery
517429|NCT01358773|Obesity|obesity
517430|NCT01358773|Therapy|therapy
517431|NCT01358773|Interdisciplinary|interdisciplinary
517432|NCT01358760|Vulvar/vaginal atrophy|vulvar/vaginal atrophy
517433|NCT01358760|Atrophic Vaginitis|atrophic vaginitis
517434|NCT01358760|Dehydroepiandrosterone|dehydroepiandrosterone
517435|NCT01358760|DHEA|dhea
517436|NCT01358760|Prasterone|prasterone
517437|NCT01358760|Vaginorm|vaginorm
517438|NCT01358760|Menopause|menopause
517439|NCT01358760|Intrarosa|intrarosa
517440|NCT01358734|AML|aml
517441|NCT01358734|elderly|elderly
517442|NCT01358734|acute myelogenous leukemia|acute myelogenous leukemia
517443|NCT01358734|vidaza|vidaza
517444|NCT01358734|azacitidine|azacitidine
517445|NCT01358734|elderly AML|elderly aml
517446|NCT01358734|revlimid|revlimid
517447|NCT01358734|lenalidomide|lenalidomide
517448|NCT01358695|Lateral Canthal Lines|lateral canthal lines
517449|NCT01358695|Crow's Feet|crow's feet
517450|NCT01358669|Denosumab|denosumab
517451|NCT01358669|Total Hip Arthroplasty|total hip arthroplasty
517452|NCT01358643|OEF/OIF|oef/oif
517453|NCT01358643|Physical Activity|physical activity
517454|NCT01358643|Preferences|preferences
517455|NCT01358630|Periodontitis|periodontitis
517456|NCT01358630|Vascular disease|vascular disease
517457|NCT01358630|Proinflammatory cytokines|proinflammatory cytokines
517458|NCT01358604|localized resectable neuroblastoma|localized resectable neuroblastoma
517459|NCT01358604|recurrent neuroblastoma|recurrent neuroblastoma
517460|NCT01358604|regional neuroblastoma|regional neuroblastoma
517461|NCT01358604|stage 4S neuroblastoma|stage 4s neuroblastoma
517462|NCT01358604|localized unresectable neuroblastoma|localized unresectable neuroblastoma
517463|NCT01358578|Psoriasis,|psoriasis,
517464|NCT01358578|inflammatory skin disease,|inflammatory skin disease,
517465|NCT01358578|scaly patches|scaly patches
517466|NCT01358578|Psoriasis|psoriasis
517467|NCT01358578|inflammatory skin disease|inflammatory skin disease
517468|NCT01358552|Neevo|neevo
517469|NCT01358552|Neevo DHA|neevo dha
517470|NCT01358552|L-methylfolate|l-methylfolate
517471|NCT01358552|anemia during pregnancy|anemia during pregnancy
517472|NCT01358552|folic acid|folic acid
517473|NCT01358552|vitamin B12|vitamin b12
517474|NCT01358552|prenatal vitamins|prenatal vitamins
517475|NCT01358552|hemoglobin|hemoglobin
517476|NCT01358552|iron deficiency|iron deficiency
517477|NCT01358552|Pregnancy|pregnancy
517478|NCT01358539|palliation|palliation
517479|NCT01358539|pain education|pain education
517480|NCT01358526|Low back pain|low back pain
517481|NCT01358526|Chronic pain|chronic pain
517482|NCT01358526|Opioid|opioid
517483|NCT01358526|Moderate to severe chronic low back pain|moderate to severe chronic low back pain
517484|NCT01358513|Positron Emission Tomography|positron emission tomography
517485|NCT01358513|Inflammation|inflammation
657828|NCT00798811|infant|infant
517486|NCT01358513|Calcification|calcification
517487|NCT01358500|opioid dependence|opioid dependence
517488|NCT01358500|tolerant|tolerant
517489|NCT01358500|dependent|dependent
517490|NCT01358487|Major depression|major depression
517491|NCT01358487|Cognitive Behavioral preventive intervention|cognitive behavioral preventive intervention
517492|NCT01358487|Mood Management|mood management
517493|NCT01358487|Self-help|self-help
517494|NCT01358487|Internet|internet
517495|NCT01358474|Parkinson disease|parkinson disease
517496|NCT01358474|idiopathic rapid eye movement sleep disorder|idiopathic rapid eye movement sleep disorder
517497|NCT01358474|Gaucher disease|gaucher disease
517498|NCT01358474|healthy volunteer|healthy volunteer
517499|NCT01358448|Treatment of childhood obesity|treatment of childhood obesity
517500|NCT01358422|Prospective observational study|prospective observational study
517501|NCT01358422|major adverse cardiac events (MACE)|major adverse cardiac events (mace)
517502|NCT01358422|clinically significant bleeding events|clinically significant bleeding events
517503|NCT01358422|Dual anti-platelet therapy|dual anti-platelet therapy
517504|NCT01358422|aspirin alone therapy|aspirin alone therapy
517505|NCT01358422|non-cardiac surgery|non-cardiac surgery
517506|NCT01358422|percutaneous coronary intervention (PCI)|percutaneous coronary intervention (pci)
517507|NCT01358422|placement of a bare metal or drug eluting stent|placement of a bare metal or drug eluting stent
517508|NCT01358422|OBTAIN|obtain
517509|NCT01358422|Simon Howell|simon howell
517510|NCT01358422|ESA|esa
517511|NCT01358422|European Society of Anaesthesiology|european society of anaesthesiology
517512|NCT01358409|steatosis|steatosis
517513|NCT01358409|MR spectroscopy|mr spectroscopy
517514|NCT01358409|Nebivolol|nebivolol
517515|NCT01358409|cardiac MRI|cardiac mri
517516|NCT01358396|Diabetic Macular Edema, Glycemic Control|diabetic macular edema, glycemic control
517517|NCT01358383|Juvenile Idiopathic Arthritis|juvenile idiopathic arthritis
517518|NCT01358383|Pharmacokinetics|pharmacokinetics
517519|NCT01358383|VIMOVO|vimovo
517520|NCT01358383|fasting state|fasting state
517521|NCT01358383|Amount of VIMOVO in the blood|amount of vimovo in the blood
517522|NCT01358383|taken on empty stomach|taken on empty stomach
517523|NCT01358370|LAL Deficiency|lal deficiency
517524|NCT01358370|LIPA|lipa
517525|NCT01358370|Wolman disease|wolman disease
517526|NCT01358370|Wolman Phenotype|wolman phenotype
517527|NCT01358370|Early Onset LAL Deficiency|early onset lal deficiency
517528|NCT01358370|Acid Lipase Deficiency|acid lipase deficiency
517529|NCT01358357|Lurasidone|lurasidone
517530|NCT01358357|Latuda|latuda
517531|NCT01358357|Bipolar I|bipolar i
517532|NCT01358318|obesity|obesity
517533|NCT01358318|satiety|satiety
517534|NCT01358318|soy protein|soy protein
517535|NCT01358318|soy fiber|soy fiber
517536|NCT01358318|control appetite|control appetite
517537|NCT01358318|reduce food intake|reduce food intake
517538|NCT01358305|muscle|muscle
517539|NCT01358305|synthesis|synthesis
517540|NCT01358305|mTOR|mtor
517541|NCT01358305|antioxidant|antioxidant
517542|NCT01358305|inflammatory markers|inflammatory markers
517543|NCT01358305|soy protein|soy protein
517544|NCT01358305|whey|whey
517545|NCT01358305|casein|casein
517546|NCT01358292|Intramedullary tibia nailing|intramedullary tibia nailing
517547|NCT01358292|Anterior Knee Pain|anterior knee pain
517548|NCT01358292|Nail positioning|nail positioning
517549|NCT01358253|Rituximab|rituximab
517550|NCT01358253|HyperCVAD|hypercvad
517551|NCT01358240|Econazole Nitrate|econazole nitrate
517552|NCT01358240|Foam|foam
517553|NCT01358240|Quinnova|quinnova
517554|NCT01358240|Tinea Pedis|tinea pedis
517555|NCT01358214|Sub-urethral Sling|sub-urethral sling
517556|NCT01358214|Treatment Outcome|treatment outcome
517557|NCT01358214|Quality of Life|quality of life
517558|NCT01358201|Acute Lymphoblastic Leukemia|acute lymphoblastic leukemia
517559|NCT01358188|Gaucher disease|gaucher disease
517560|NCT01358188|immunity|immunity
517561|NCT01358188|inflammation|inflammation
517562|NCT01358188|macrophage activation|macrophage activation
517563|NCT01358175|Ankylosing spondylitis|ankylosing spondylitis
517565|NCT01358175|ASAS|asas
517566|NCT01358175|inflammatory back pain|inflammatory back pain
517567|NCT01358162|Tuberculosis|tuberculosis
517568|NCT01358136|Thyroidectomy|thyroidectomy
517569|NCT01358136|Mitochondria|mitochondria
517570|NCT01358123|liver cirrhosis|liver cirrhosis
517571|NCT01358123|portal hypertension|portal hypertension
517572|NCT01358123|survival|survival
517573|NCT01358123|von willebrand factor|von willebrand factor
517574|NCT01358123|hepatic venous pressure gradient|hepatic venous pressure gradient
517575|NCT01358110|palliative care|palliative care
517576|NCT01358110|cancer|cancer
517577|NCT01358110|emergency medicine|emergency medicine
517578|NCT01358110|end- of- life care|end- of- life care
517579|NCT01358097|Head and neck cancer|head and neck cancer
517580|NCT01358097|Oropharyngeal cancer|oropharyngeal cancer
517581|NCT01358097|Human papillomavirus|human papillomavirus
657969|NCT00798265|HV|hv
517582|NCT01358097|Squamous cell carcinoma|squamous cell carcinoma
517583|NCT01358097|Radiation treatment|radiation treatment
517584|NCT01358097|Chemotherapy|chemotherapy
517585|NCT01358097|Induction chemotherapy|induction chemotherapy
517586|NCT01358097|Immune status|immune status
517587|NCT01358097|Immune monitoring|immune monitoring
517588|NCT01358097|head and neck robotic surgery|head and neck robotic surgery
517589|NCT01358084|Malignant Pleural Mesothelioma|malignant pleural mesothelioma
517590|NCT01358084|MPM|mpm
517591|NCT01358084|Maintenance treatment|maintenance treatment
517592|NCT01358084|NGR-hTNF|ngr-htnf
517593|NCT01358071|NGR-hTNF|ngr-htnf
517594|NCT01358071|Pegylated liposomal doxorubicin|pegylated liposomal doxorubicin
517595|NCT01358071|Doxorubicin|doxorubicin
517596|NCT01358071|Platinum-resistant|platinum-resistant
517597|NCT01358071|Progression or recurrence Ovarian Cancer|progression or recurrence ovarian cancer
517598|NCT01358071|Ovarian Cancer|ovarian cancer
517599|NCT01358071|Advanced or metastatic|advanced or metastatic
517600|NCT01358058|Brain tumors|brain tumors
517601|NCT01358058|Radiation|radiation
517602|NCT01358058|Proton|proton
517603|NCT01358058|Gliomas|gliomas
517604|NCT01358045|Topical|topical
517605|NCT01358045|Diclofenac|diclofenac
517606|NCT01358045|Vitamin D3|vitamin d3
517607|NCT01358032|Fear of falling|fear of falling
517608|NCT01358032|Cognitive behavioral therapy|cognitive behavioral therapy
517609|NCT01358032|Randomized controlled trial|randomized controlled trial
517610|NCT01358032|Frailty|frailty
517611|NCT01358032|Accidental Falls|accidental falls
517612|NCT01358006|JNJ-40411813|jnj-40411813
517613|NCT01358006|Positron Emission Tomography (PET)|positron emission tomography (pet)
517614|NCT01358006|Serotonin-2A (5-HT2A) receptor antagonist|serotonin-2a (5-ht2a) receptor antagonist
517615|NCT01358006|Male Volunteers|male volunteers
517616|NCT01357993|Methylphenidate hydrochloride|methylphenidate hydrochloride
517617|NCT01357993|Concerta|concerta
517618|NCT01357993|Adults|adults
517619|NCT01357993|Attention-Deficit / Hyperactivity Disorder|attention-deficit / hyperactivity disorder
517620|NCT01357993|ADHD|adhd
517621|NCT01357993|Long term safety|long term safety
517622|NCT01357980|Detrusor Muscle Overactivity|detrusor muscle overactivity
517623|NCT01357954|Postural control|postural control
517624|NCT01357954|Targeted Training|targeted training
517625|NCT01357954|Gross motor function|gross motor function
517626|NCT01357954|Cerebral palsy|cerebral palsy
517627|NCT01357941|venous thromboembolism|venous thromboembolism
517628|NCT01357941|thromboembolism|thromboembolism
517629|NCT01357941|deep vein thrombosis|deep vein thrombosis
517630|NCT01357941|pulmonary embolism|pulmonary embolism
517631|NCT01357941|thromboprophylaxis|thromboprophylaxis
517632|NCT01357941|thrombosis|thrombosis
517633|NCT01357941|embolism and thrombosis|embolism and thrombosis
517634|NCT01357941|cardiovascular diseases|cardiovascular diseases
517635|NCT01357941|venous thrombosis|venous thrombosis
517636|NCT01357941|vascular diseases|vascular diseases
517637|NCT01357941|anticoagulants|anticoagulants
517638|NCT01357941|hematologic agents|hematologic agents
517639|NCT01357941|cardiovascular agents|cardiovascular agents
517640|NCT01357941|enoxaparin|enoxaparin
517641|NCT01357941|dalteparin|dalteparin
517642|NCT01357941|tinzaparin|tinzaparin
517643|NCT01357941|pregnancy complications|pregnancy complications
517644|NCT01357928|TEG|teg
517645|NCT01357928|Thromboelastography|thromboelastography
517646|NCT01357928|Coagulation|coagulation
517647|NCT01357915|Cytomegalovirus|cytomegalovirus
517648|NCT01357915|Vaccine|vaccine
517649|NCT01357889|pharmacokinetics|pharmacokinetics
517650|NCT01357889|pharmacodynamics|pharmacodynamics
517651|NCT01357889|GSK716155|gsk716155
517652|NCT01357889|albiglutide|albiglutide
517653|NCT01357863|Lapatinib|lapatinib
517654|NCT01357863|Observational Study|observational study
517655|NCT01357863|Trastuzumab|trastuzumab
517656|NCT01357863|Brazil|brazil
517657|NCT01357863|Metastatic Breast Cancer|metastatic breast cancer
517658|NCT01357837|Osteoarthritis, knee|osteoarthritis, knee
517659|NCT01357837|Analgesia|analgesia
517660|NCT01357837|Pain|pain
517661|NCT01357837|Painful|painful
517662|NCT01357824|Intubation|intubation
517663|NCT01357824|Sellick´s maneuver|sellick´s maneuver
517664|NCT01357824|aspiration|aspiration
517665|NCT01357824|[E05.497.578]|[e05.497.578]
517666|NCT01357811|Genz-112638|genz-112638
517667|NCT01357811|digoxin|digoxin
517668|NCT01357798|Headache|headache
517669|NCT01357798|Allodynia|allodynia
517670|NCT01357798|Botulinum Toxin Type A|botulinum toxin type a
517671|NCT01357785|Periodontal ligament stem cells|periodontal ligament stem cells
517672|NCT01357785|Periodontal regeneration|periodontal regeneration
517673|NCT01357785|Clinical trial|clinical trial
517674|NCT01357785|Deep intraosseous defects|deep intraosseous defects
517675|NCT01357746|Pulmonary arterial blood pressure doppler|pulmonary arterial blood pressure doppler
517676|NCT01357733|Diffuse, Large B-Cell, Lymphoma|diffuse, large b-cell, lymphoma
517677|NCT01357733|18F Fluorodeoxyglucose|18f fluorodeoxyglucose
517678|NCT01357733|Radionuclide-Emission Computed Tomography|radionuclide-emission computed tomography
517679|NCT01357720|Vaccination|vaccination
517680|NCT01357720|Immunisation|immunisation
517681|NCT01357720|Virus|virus
517682|NCT01357720|Diphtheria|diphtheria
517683|NCT01357720|Pertussis|pertussis
517684|NCT01357720|Tetanus|tetanus
517685|NCT01357720|Hepatitis B|hepatitis b
517686|NCT01357720|Haemophilus Influenzae|haemophilus influenzae
517687|NCT01357720|Immunity|immunity
517688|NCT01357694|psychotherapy|psychotherapy
517689|NCT01357694|depression|depression
517690|NCT01357694|anxiety|anxiety
517691|NCT01357694|surgical patients|surgical patients
517692|NCT01357681|Huntington Disease|huntington disease
517693|NCT01357681|Cognition|cognition
517694|NCT01357681|Motor|motor
517695|NCT01357681|Behaviour|behaviour
517696|NCT01357681|Functional Capacity|functional capacity
517697|NCT01357681|Quality of Life|quality of life
517698|NCT01357681|Biomarker|biomarker
517699|NCT01357681|MRI|mri
517700|NCT01357681|Huntingtin|huntingtin
517701|NCT01357681|EGCG|egcg
517702|NCT01357655|Myelogenous|myelogenous
517703|NCT01357655|Chronic|chronic
517704|NCT01357655|BCR-ABL Positive|bcr-abl positive
517705|NCT01357642|asthma|asthma
517706|NCT01357642|bronchial asthma|bronchial asthma
517707|NCT01357642|shortness of breath|shortness of breath
517708|NCT01357629|Vaccination follow-up|vaccination follow-up
517709|NCT01357616|Glaucoma|glaucoma
517710|NCT01357616|Open-angle glaucoma|open-angle glaucoma
517711|NCT01357616|Ocular hypertension|ocular hypertension
517712|NCT01357616|OAG|oag
517713|NCT01357616|OH|oh
517714|NCT01357590|aneurysm, penetrating ulcer, descending thoracic aorta|aneurysm, penetrating ulcer, descending thoracic aorta
517715|NCT01357577|PTSD|ptsd
517716|NCT01357577|Substance Use Disorders|substance use disorders
517717|NCT01357564|dementia|dementia
517718|NCT01357564|caregivers|caregivers
517719|NCT01357564|tailored activity|tailored activity
517720|NCT01357564|neuropsychiatric symptoms|neuropsychiatric symptoms
517721|NCT01357564|behavioral symptoms|behavioral symptoms
517722|NCT01357551|obesity|obesity
517723|NCT01357551|intervention studies|intervention studies
517724|NCT01357551|patient adherence|patient adherence
517725|NCT01357538|Bibrocathol|bibrocathol
517726|NCT01357538|eye ointment|eye ointment
517727|NCT01357538|blepharitis|blepharitis
517728|NCT01357538|eye lid|eye lid
517729|NCT01357525|Pancreas|pancreas
517730|NCT01357525|Resected|resected
517731|NCT01357512|prostate cancer diagnosis|prostate cancer diagnosis
517732|NCT01357512|magnetic resonance imaging|magnetic resonance imaging
517733|NCT01357512|prostate biopsy|prostate biopsy
517734|NCT01357486|Hepatocellular Carcinoma|hepatocellular carcinoma
517735|NCT01357486|CHILD B|child b
517736|NCT01357486|palliative management|palliative management
517737|NCT01357486|Sorafenib|sorafenib
517738|NCT01357486|Pravastatin|pravastatin
517739|NCT01357473|hormonal values|hormonal values
517740|NCT01357473|menstruations|menstruations
517741|NCT01357473|pregnancy|pregnancy
517742|NCT01357473|antagonist|antagonist
517743|NCT01357460|Emphysema|emphysema
517744|NCT01357460|alpha1 antitrypsin deficiency|alpha1 antitrypsin deficiency
517745|NCT01357460|endoscopic lung volume reduction|endoscopic lung volume reduction
517746|NCT01357447|Sjogren's syndrome|sjogren's syndrome
517747|NCT01357447|Cough|cough
517748|NCT01357408|without an indication for ICD or CRT|without an indication for icd or crt
517749|NCT01357408|left ventricular function greater than or equal to 40%|left ventricular function greater than or equal to 40%
517750|NCT01357395|Small Cell Lung Carcinoma|small cell lung carcinoma
517751|NCT01357382|low fat diet|low fat diet
517752|NCT01357382|low carbohydrate diet|low carbohydrate diet
517753|NCT01357369|bacteria infections|bacteria infections
517754|NCT01357343|Low back pain|low back pain
517755|NCT01357343|Chiropractic|chiropractic
517756|NCT01357343|Acupuncture|acupuncture
517757|NCT01357343|Integrated care|integrated care
517758|NCT01357330|locally advanced or metastatic|locally advanced or metastatic
517759|NCT01357317|Kidney disease|kidney disease
517760|NCT01357317|Hyperphosphatemia|hyperphosphatemia
517761|NCT01357317|Parathyroid hormone|parathyroid hormone
517762|NCT01357304|Group treatment|group treatment
517763|NCT01357304|Physical activity referral|physical activity referral
517764|NCT01357304|Type 2 diabetes|type 2 diabetes
517765|NCT01357304|Hypertension|hypertension
517766|NCT01357291|Behavior|behavior
517767|NCT01357291|Drug users|drug users
517768|NCT01357291|Inmates|inmates
517769|NCT01357278|osteoporosis|osteoporosis
517770|NCT01357278|exercise|exercise
517771|NCT01357278|intervention|intervention
517772|NCT01357278|rehabilitation|rehabilitation
517773|NCT01357278|bone mineral density|bone mineral density
517774|NCT01357278|muscle strength|muscle strength
517775|NCT01357265|Seasonal Influenza|seasonal influenza
517777|NCT01357252|Diabetes mellitus|diabetes mellitus
517778|NCT01357252|vildagliptin|vildagliptin
517779|NCT01357239|Fragile X Syndrome|fragile x syndrome
517780|NCT01357239|Martin-Bell Syndrome|martin-bell syndrome
517781|NCT01357239|Genetic Diseases|genetic diseases
517782|NCT01357239|X-Linked|x-linked
517783|NCT01357239|Escalante's syndrome|escalante's syndrome
517784|NCT01357226|measurement in two environments|measurement in two environments
517785|NCT01357213|Botulism, Clostridium|botulism, clostridium
517786|NCT01357187|Lumbar pathology|lumbar pathology
517787|NCT01357187|requiring elective lumbar interbody fusion|requiring elective lumbar interbody fusion
517788|NCT01357096|intervention|intervention
517789|NCT01357096|CABG or PTCA|cabg or ptca
517790|NCT01357083|Melatonin|melatonin
517791|NCT01357083|Periodicity|periodicity
517792|NCT01357083|Depressive disorder, major|depressive disorder, major
517793|NCT01357083|Serum|serum
517794|NCT01357083|Depression|depression
517795|NCT01357070|white blood cell|white blood cell
517796|NCT01357070|broccoli|broccoli
517797|NCT01357070|P38 Map Kinase|p38 map kinase
517798|NCT01357057|Medical records|medical records
517799|NCT01357057|Outcome scale|outcome scale
517800|NCT01357057|Biological biomarkers|biological biomarkers
517801|NCT01357044|Semen quality|semen quality
517802|NCT01357044|Plant extracts|plant extracts
517803|NCT01357031|Amitriptyline|amitriptyline
517804|NCT01357031|Placebo|placebo
517805|NCT01357031|Melatonin|melatonin
517806|NCT01357031|Migraine|migraine
517807|NCT01357031|Headache|headache
517808|NCT01357031|Drug therapy|drug therapy
517809|NCT01357031|Preventive treatment of migraine|preventive treatment of migraine
517810|NCT01357018|Ankylosing spondylitis|ankylosing spondylitis
517811|NCT01357018|Disease activity|disease activity
517812|NCT01357018|EQ-5D|eq-5d
517813|NCT01357018|Quality of life|quality of life
517814|NCT01357018|Rheumatoid arthritis|rheumatoid arthritis
517815|NCT01356992|non-inferiority phase III study|non-inferiority phase iii study
517816|NCT01356992|Low-Molecular Weight Heparin|low-molecular weight heparin
517817|NCT01356992|Versa® (enoxaparin - Eurofarma)|versa® (enoxaparin - eurofarma)
517818|NCT01356992|Clexane® (enoxaparin - Sanofi-Aventis)|clexane® (enoxaparin - sanofi-aventis)
517819|NCT01356992|Acute coronary syndrome without ST-segment elevation|acute coronary syndrome without st-segment elevation
517820|NCT01356979|Medical thoracoscopy|medical thoracoscopy
517821|NCT01356979|Pleural effusion|pleural effusion
517822|NCT01356979|Malignant pleural diseases|malignant pleural diseases
517823|NCT01356979|Tuberculous pleuritis|tuberculous pleuritis
517824|NCT01356979|Fibrinous pleuritis|fibrinous pleuritis
517825|NCT01356953|Aerobic Exercise|aerobic exercise
517826|NCT01356953|Blood Pressure|blood pressure
517827|NCT01356940|Ambulation|ambulation
517828|NCT01356927|long acting reversible contraception|long acting reversible contraception
517829|NCT01356927|medical abortion|medical abortion
517830|NCT01356927|DMPA|dmpa
517831|NCT01356927|etonogestrel implant|etonogestrel implant
517832|NCT01356927|Implanon|implanon
517833|NCT01356927|contraceptive continuation|contraceptive continuation
517834|NCT01356875|myelodysplastic syndrome|myelodysplastic syndrome
517835|NCT01356875|Transfusion|transfusion
517836|NCT01356875|Hydralazine|hydralazine
517837|NCT01356875|valproic acid|valproic acid
517838|NCT01356862|mastectomy|mastectomy
517839|NCT01356862|axillary node dissection|axillary node dissection
517840|NCT01356862|adjuvant or neoadjuvant|adjuvant or neoadjuvant
517841|NCT01356849|Endothelin Receptor Antagonists|endothelin receptor antagonists
517842|NCT01356849|Proteinuria|proteinuria
517843|NCT01356836|Coronary collateral development|coronary collateral development
517844|NCT01356836|monocyte subsets|monocyte subsets
517845|NCT01356836|collateralization|collateralization
517846|NCT01356823|Human Papilloma Virus 16|human papilloma virus 16
517847|NCT01356823|Human Papilloma Virus 18|human papilloma virus 18
517848|NCT01356823|vaccine|vaccine
517849|NCT01356823|Cervical Intraepithelial Neoplasia|cervical intraepithelial neoplasia
517850|NCT01356823|cervical Cancer|cervical cancer
517851|NCT01356810|Delirium|delirium
517852|NCT01356810|Primary Prevention|primary prevention
517853|NCT01356810|Elderly|elderly
517854|NCT01356797|knee arthroscopy|knee arthroscopy
517855|NCT01356797|hyperbaric bupivacaine|hyperbaric bupivacaine
517856|NCT01356797|hypobaric levobupivacaine plus fentanyl|hypobaric levobupivacaine plus fentanyl
517857|NCT01356784|Sick-listed|sick-listed
517858|NCT01356784|Tailored physical activity|tailored physical activity
517859|NCT01356784|Patient education|patient education
517860|NCT01356784|Returning to work|returning to work
517861|NCT01356784|DK-Sønderborg Municipality|dk-sønderborg municipality
517862|NCT01356784|columna|columna
517863|NCT01356784|upper body|upper body
517864|NCT01356771|Risk Assessment|risk assessment
517865|NCT01356771|Intervention|intervention
517866|NCT01356745|premixed nitrous oxide and oxygen|premixed nitrous oxide and oxygen
517867|NCT01356745|acute pain|acute pain
517868|NCT01356745|prehospital setting|prehospital setting
517869|NCT01356732|mechanical ventilation|mechanical ventilation
517870|NCT01356732|Midazolam|midazolam
517871|NCT01356732|Ramsay|ramsay
517872|NCT01356732|Sufentanil|sufentanil
517873|NCT01356719|Tracheostomy|tracheostomy
517874|NCT01356719|adverse effects|adverse effects
517875|NCT01356719|Critical Care|critical care
517876|NCT01356719|standards|standards
517877|NCT01356719|safety|safety
517878|NCT01356706|liver metastases|liver metastases
517879|NCT01356706|colorectal cancer|colorectal cancer
517880|NCT01356706|surgery|surgery
517881|NCT01356706|prognosis|prognosis
517882|NCT01356693|Cough|cough
517883|NCT01356693|Common cold|common cold
517884|NCT01356693|Child|child
517885|NCT01356693|Adolescent|adolescent
517886|NCT01356680|Hodgkin Lymphoma|hodgkin lymphoma
517887|NCT01356680|intermediate stage|intermediate stage
517888|NCT01356680|PET|pet
517889|NCT01356667|American Indians|american indians
517890|NCT01356667|Native Americans|native americans
517891|NCT01356667|substance abuse|substance abuse
517892|NCT01356667|culture|culture
517893|NCT01356654|Stroke|stroke
517894|NCT01356654|TDCS|tdcs
517895|NCT01356654|Gait|gait
517896|NCT01356654|Balance|balance
517897|NCT01356654|loss of postural balance|loss of postural balance
517898|NCT01356641|Antibiotic treatment|antibiotic treatment
517899|NCT01356641|Non perforated appendicitis|non perforated appendicitis
517900|NCT01356641|Children|children
517901|NCT01356628|Advanced Hepatocellular Carcinoma|advanced hepatocellular carcinoma
517902|NCT01356628|HCC|hcc
517903|NCT01356628|Liver Cancer|liver cancer
517904|NCT01356628|PD-0332991|pd-0332991
517905|NCT01356615|anticoagulation|anticoagulation
517906|NCT01356615|hemodialysis|hemodialysis
517907|NCT01356615|heparin|heparin
517908|NCT01356615|lipids|lipids
517909|NCT01356615|low molecular weight heparins|low molecular weight heparins
517910|NCT01356602|Gout|gout
517911|NCT01356602|arthritis|arthritis
517912|NCT01356602|gout flare|gout flare
517913|NCT01356602|acute gout|acute gout
517914|NCT01356602|gouty|gouty
517915|NCT01356602|rheumatic disease|rheumatic disease
517916|NCT01356602|uric acid|uric acid
517917|NCT01356563|hemodialysis|hemodialysis
517918|NCT01356563|pharmacist|pharmacist
517919|NCT01356563|medication-related problems|medication-related problems
517920|NCT01356563|compliance|compliance
517921|NCT01356511|Purpura, Thrombocytopenic, Idiopathic|purpura, thrombocytopenic, idiopathic
517922|NCT01356498|gout|gout
517923|NCT01356498|chronic gout|chronic gout
517924|NCT01356485|Sickle cell anemia|sickle cell anemia
517925|NCT01356485|Sickle cell disease|sickle cell disease
517926|NCT01356485|Sickling crisis|sickling crisis
517927|NCT01356485|Vaso-occlusive crisis|vaso-occlusive crisis
517928|NCT01356485|Carboxyhemoglobin|carboxyhemoglobin
517929|NCT01356485|Oxygen therapeutic|oxygen therapeutic
517930|NCT01356485|Hemoglobin solutions|hemoglobin solutions
517931|NCT01356485|Pegylated hemoglobin|pegylated hemoglobin
517932|NCT01356472|Methicillin-resistant Staphylococcus aureus|methicillin-resistant staphylococcus aureus
517933|NCT01356472|Pneumonia, Ventilator-Associated|pneumonia, ventilator-associated
517934|NCT01356472|linezolid|linezolid
517935|NCT01356472|imipenem/cilastatin|imipenem/cilastatin
517936|NCT01356459|Pressure ulcers|pressure ulcers
517937|NCT01356459|ICU|icu
517938|NCT01356459|Prevention|prevention
517939|NCT01356446|safety|safety
517940|NCT01356446|team|team
517941|NCT01356446|team performance|team performance
517942|NCT01356446|surgery|surgery
517943|NCT01356446|outcome|outcome
517944|NCT01356433|dialysis,inflammation,vitamin C|dialysis,inflammation,vitamin c
517945|NCT01356420|SLOS|slos
517946|NCT01356394|Obesity|obesity
517947|NCT01356394|Metabolic Syndrome|metabolic syndrome
517948|NCT01356394|Microalbuminuria|microalbuminuria
517949|NCT01356394|Chronic Kidney Disease|chronic kidney disease
517950|NCT01356381|Diabetes mellitus|diabetes mellitus
517951|NCT01356381|vildagliptin|vildagliptin
517952|NCT01356368|Lung cancer|lung cancer
517953|NCT01356355|Stent discomfort|stent discomfort
517954|NCT01356355|Herbmed plus|herbmed plus
517955|NCT01356355|Tolterodine|tolterodine
517956|NCT01356342|Influenza|influenza
517957|NCT01356342|Vaccine|vaccine
517958|NCT01356342|Immunogenicity|immunogenicity
517959|NCT01356329|Gynecologic malignancy ,major surgery|gynecologic malignancy ,major surgery
517960|NCT01356316|Influenza|influenza
517961|NCT01356316|Vaccine|vaccine
517962|NCT01356316|Immunogenicity|immunogenicity
517963|NCT01356303|Lung cancer|lung cancer
517964|NCT01356290|Medulloblastoma|medulloblastoma
517965|NCT01356290|Relapse|relapse
517966|NCT01356290|Children|children
517967|NCT01356290|antiangiogenic|antiangiogenic
517968|NCT01356290|metronomic|metronomic
517969|NCT01356290|intrathecal|intrathecal
517970|NCT01356277|renal|renal
517971|NCT01356277|allograft|allograft
517972|NCT01356277|immunosuppressive|immunosuppressive
517973|NCT01356277|immunosuppression|immunosuppression
517974|NCT01356277|adherence|adherence
517975|NCT01356277|medication|medication
517976|NCT01356277|compliance|compliance
517977|NCT01356264|colorectal cancer|colorectal cancer
517978|NCT01356264|colorectal surgery|colorectal surgery
517979|NCT01356264|prehabilitation|prehabilitation
517980|NCT01356264|surgical recovery|surgical recovery
517981|NCT01356264|exercise|exercise
517982|NCT01356264|referred for scheduled resection|referred for scheduled resection
517983|NCT01356251|Quality of life|quality of life
517984|NCT01356251|support group|support group
517985|NCT01356251|questionnaires|questionnaires
517986|NCT01356251|Internet-based support group|internet-based support group
517987|NCT01356251|11-066|11-066
517988|NCT01356225|pain following dental impaction surgery|pain following dental impaction surgery
517989|NCT01356199|Gonalgia|gonalgia
517990|NCT01356199|Quality of Life|quality of life
517991|NCT01356199|Dietary supplement|dietary supplement
517992|NCT01356199|Nutrition|nutrition
517993|NCT01356186|Suicide|suicide
517994|NCT01356186|Cognitive Therapy|cognitive therapy
517995|NCT01356186|Inpatient|inpatient
517996|NCT01356186|Military|military
517997|NCT01356173|solid cancers|solid cancers
517998|NCT01356160|Hepatitis C|hepatitis c
518000|NCT01356160|Rapid Virologic Response|rapid virologic response
518001|NCT01356160|Sustained Virologic Response|sustained virologic response
518002|NCT01356160|Direct Acting Antiviral|direct acting antiviral
518003|NCT01356160|Combination Therapy HCV RNA|combination therapy hcv rna
518004|NCT01356160|Protease inhibitor|protease inhibitor
518005|NCT01356160|Treatment naïve|treatment naïve
518006|NCT01356160|GS-5885|gs-5885
518007|NCT01356160|GS-9451|gs-9451
518008|NCT01356147|ventilator associated pulmonary infections|ventilator associated pulmonary infections
518009|NCT01356134|multiple sclerosis|multiple sclerosis
518010|NCT01356134|ehlers danlos syndrome|ehlers danlos syndrome
518011|NCT01356134|CCSVI|ccsvi
518012|NCT01356134|chronic cerebrospinal venous insufficiency|chronic cerebrospinal venous insufficiency
518013|NCT01356134|fundus|fundus
518014|NCT01356134|retina|retina
518015|NCT01356108|Conduit|conduit
518016|NCT01356108|Pulmonic|pulmonic
518017|NCT01356108|Stenosis|stenosis
518018|NCT01356108|Regurgitation|regurgitation
518019|NCT01356108|Dysfunctional|dysfunctional
518020|NCT01356095|Tuberculosis|tuberculosis
518021|NCT01356095|Treatment Adherence|treatment adherence
518022|NCT01356095|knowledge translation|knowledge translation
518023|NCT01356095|Educational outreach|educational outreach
518024|NCT01356069|BPD|bpd
518025|NCT01356069|MHS|mhs
518026|NCT01356069|heavy users|heavy users
518027|NCT01356069|sequential psychotherapy|sequential psychotherapy
518028|NCT01356004|severe resistant|severe resistant
518029|NCT01355991|Spinal Cord Injury|spinal cord injury
518030|NCT01355991|Tetraplegia|tetraplegia
518031|NCT01355991|Pulmonary Function|pulmonary function
518032|NCT01355991|Bronchodilator|bronchodilator
518033|NCT01355965|completed standard first line therapy|completed standard first line therapy
518034|NCT01355965|platinum based double regimen|platinum based double regimen
518035|NCT01355965|Progressive Disease|progressive disease
518167|NCT01355536|Hirsutism|hirsutism
518036|NCT01355965|chosen not to pursue primary standard of care therapy|chosen not to pursue primary standard of care therapy
518037|NCT01355952|Obesity|obesity
518038|NCT01355952|Weight Loss|weight loss
518039|NCT01355952|Schizophrenia|schizophrenia
518040|NCT01355952|Alpha Lipoic Acid|alpha lipoic acid
518041|NCT01355939|Hernia|hernia
518042|NCT01355939|Adhesiolysis|adhesiolysis
518043|NCT01355939|Adhesions|adhesions
518044|NCT01355939|Intraperitoneal Mesh|intraperitoneal mesh
518045|NCT01355939|Abdominal Re-exploration|abdominal re-exploration
518046|NCT01355939|Mesh|mesh
518047|NCT01355939|Barrier-Coated Mesh|barrier-coated mesh
518048|NCT01355939|Non-Barrier-Coated Mesh|non-barrier-coated mesh
518049|NCT01355939|Laparoscopic Approach|laparoscopic approach
518050|NCT01355939|Open Approach|open approach
518051|NCT01355939|Abdominal Re-Exploration Surgery|abdominal re-exploration surgery
518052|NCT01355926|Flexible Fiber-based CO2 Laser|flexible fiber-based co2 laser
518053|NCT01355926|Monopolar Cautery|monopolar cautery
518054|NCT01355926|Oral Cavity Lesions|oral cavity lesions
518055|NCT01355926|Quality of life|quality of life
518056|NCT01355926|Assessing Pain|assessing pain
518057|NCT01355926|11-034|11-034
518058|NCT01355913|Myelodysplastic syndromes (MDS)|myelodysplastic syndromes (mds)
518059|NCT01355913|chromosmal aberrations|chromosmal aberrations
518060|NCT01355913|cytogenetics|cytogenetics
518061|NCT01355913|Fluorescence in situ hybridization (FISH)|fluorescence in situ hybridization (fish)
518062|NCT01355913|CD34+ cells|cd34+ cells
518063|NCT01355913|peripheral blood|peripheral blood
518064|NCT01355900|Total knee arthroplasty|total knee arthroplasty
518065|NCT01355900|Tourniquet|tourniquet
518066|NCT01355900|Blood loss|blood loss
518067|NCT01355900|Volume loading test|volume loading test
518068|NCT01355887|blood loss|blood loss
518069|NCT01355887|hepatectomy|hepatectomy
518070|NCT01355887|prospective study|prospective study
518071|NCT01355887|PTC|ptc
518072|NCT01355874|Internal Symptomatic Hemorrhoids|internal symptomatic hemorrhoids
518073|NCT01355861|sarcopenia|sarcopenia
518074|NCT01355861|aging|aging
518075|NCT01355861|rehabilitation|rehabilitation
518076|NCT01355861|exercise|exercise
518077|NCT01355848|Suicide|suicide
518078|NCT01355848|Brief Intervention|brief intervention
518079|NCT01355848|Youth|youth
518080|NCT01355848|Acute Medical Setting|acute medical setting
518081|NCT01355848|Readiness to Change|readiness to change
518082|NCT01355848|Suicidality|suicidality
518083|NCT01355835|Parkinson's disease|parkinson's disease
518084|NCT01355835|gait|gait
518085|NCT01355835|deep brain stimulation|deep brain stimulation
518086|NCT01355835|substantia nigra pars reticulata|substantia nigra pars reticulata
518087|NCT01355835|subthalamic nucleus|subthalamic nucleus
518088|NCT01355822|abortion|abortion
518089|NCT01355822|perinatal death|perinatal death
518090|NCT01355822|IUGR|iugr
518091|NCT01355822|preterm birth|preterm birth
518092|NCT01355822|placental abruption|placental abruption
518093|NCT01355822|preeclampsia|preeclampsia
518094|NCT01355809|Six-Minute Walk Test|six-minute walk test
518095|NCT01355757|shoulder arthroscopy|shoulder arthroscopy
518096|NCT01355757|24-week follow-up|24-week follow-up
518097|NCT01355757|quality of life|quality of life
518098|NCT01355757|rehabilitation achievement|rehabilitation achievement
518099|NCT01355757|rotator cuff repair|rotator cuff repair
518100|NCT01355744|humans|humans
518101|NCT01355744|insect bites|insect bites
518102|NCT01355731|Registered Nurse|registered nurse
518103|NCT01355731|Behaviors|behaviors
518104|NCT01355731|Attitudes|attitudes
518105|NCT01355692|DME|dme
518106|NCT01355692|Laser|laser
518107|NCT01355692|Selective laser therapy|selective laser therapy
518108|NCT01355692|photocoagulation|photocoagulation
518109|NCT01355666|pressure ulcers|pressure ulcers
518110|NCT01355666|stage 1|stage 1
518111|NCT01355666|stage 2|stage 2
518112|NCT01355666|stage 3|stage 3
518113|NCT01355666|stage 4|stage 4
518114|NCT01355666|wounds|wounds
518115|NCT01355666|sores|sores
518116|NCT01355666|infection|infection
518117|NCT01355666|bioburden|bioburden
518118|NCT01355666|bacterial contamination|bacterial contamination
518119|NCT01355666|bed linen|bed linen
518120|NCT01355666|sheets|sheets
518121|NCT01355666|underpad|underpad
518122|NCT01355666|skin assessment|skin assessment
518123|NCT01355666|microclimate|microclimate
518124|NCT01355666|shear|shear
518125|NCT01355666|friction|friction
518126|NCT01355666|moisture|moisture
518127|NCT01355666|fabrics|fabrics
518128|NCT01355666|long term care|long term care
518129|NCT01355666|nursing home|nursing home
518130|NCT01355666|decubitus ulcer|decubitus ulcer
518131|NCT01355666|bed ridden|bed ridden
518132|NCT01355666|anti-microbial|anti-microbial
518133|NCT01355653|heat|heat
518134|NCT01355653|device|device
518135|NCT01355653|safety|safety
518136|NCT01355653|performance|performance
518137|NCT01355653|heatwrap|heatwrap
518138|NCT01355653|elderly|elderly
518139|NCT01355653|overweight|overweight
518140|NCT01355640|heel lance|heel lance
518141|NCT01355640|pain|pain
518142|NCT01355640|newborn|newborn
518143|NCT01355627|CSF leaks|csf leaks
518144|NCT01355627|Skull base surgery|skull base surgery
518145|NCT01355627|pseudomeningocele|pseudomeningocele
518146|NCT01355627|TachoSil®|tachosil®
518147|NCT01355627|Prevention|prevention
518148|NCT01355627|post-operative|post-operative
518149|NCT01355614|Crohn's Disease|crohn's disease
518150|NCT01355614|Fistula|fistula
518151|NCT01355575|Microbiota|microbiota
518152|NCT01355575|Insulin resistance|insulin resistance
518153|NCT01355575|Bacterial endotoxin|bacterial endotoxin
518154|NCT01355575|Hepatic triglyceride|hepatic triglyceride
518155|NCT01355575|Inflammation|inflammation
518156|NCT01355549|Shoulder pain|shoulder pain
518157|NCT01355549|Rotator cuff disease|rotator cuff disease
518158|NCT01355549|Spinal cord injuries|spinal cord injuries
518159|NCT01355549|Platelet-rich plasma therapy|platelet-rich plasma therapy
518160|NCT01355549|Rehabilitation|rehabilitation
518161|NCT01355536|Preterm birth|preterm birth
518162|NCT01355536|Preterm labour|preterm labour
518163|NCT01355536|Polycystic Ovary Syndrome|polycystic ovary syndrome
518164|NCT01355536|PCOS|pcos
518165|NCT01355536|Diabetes Mellitus|diabetes mellitus
518166|NCT01355536|Hyperandrogenism|hyperandrogenism
518168|NCT01355536|Ovarian cysts|ovarian cysts
518169|NCT01355536|Anti Muller Hormone|anti muller hormone
518170|NCT01355536|Hypertension|hypertension
518171|NCT01355523|Breast cancer surgery|breast cancer surgery
518172|NCT01355523|Melatonin|melatonin
518173|NCT01355523|Depression|depression
518174|NCT01355523|Anxiety|anxiety
518175|NCT01355523|Sleep disturbances|sleep disturbances
518176|NCT01355523|Cognitive function|cognitive function
518177|NCT01355471|rosacea|rosacea
518178|NCT01355458|rosacea|rosacea
518179|NCT01355419|Obstructive sleep apnea|obstructive sleep apnea
518180|NCT01355419|CPAP|cpap
518181|NCT01355419|actigraphy|actigraphy
518182|NCT01355419|sleep|sleep
518183|NCT01355419|physical activity|physical activity
518184|NCT01355406|FlexStent|flexstent
518185|NCT01355406|Superficial Femoral Artery or SFA|superficial femoral artery or sfa
518186|NCT01355406|Self Expanding Stent|self expanding stent
518187|NCT01355406|Stent|stent
518188|NCT01355406|Bare Metal Stent|bare metal stent
518189|NCT01355393|Breast Cancer|breast cancer
518190|NCT01355393|HER2+|her2+
518191|NCT01355393|Vaccine|vaccine
518192|NCT01355393|Stage II|stage ii
518193|NCT01355393|Stage III|stage iii
518194|NCT01355393|Stage IV|stage iv
518195|NCT01355380|Pulmonary arterial hypertension|pulmonary arterial hypertension
518196|NCT01355380|Inhaled iloprost|inhaled iloprost
518197|NCT01355380|Quality of life|quality of life
518198|NCT01355367|BAYA1040 CR|baya1040 cr
518199|NCT01355367|Nifedipine|nifedipine
518200|NCT01355367|Essential hypertension|essential hypertension
518201|NCT01355367|Japanese Patients|japanese patients
518202|NCT01355367|Phase III|phase iii
518203|NCT01355367|Extension study|extension study
518204|NCT01355354|Phase 1|phase 1
518205|NCT01355354|healthy volunteers|healthy volunteers
518206|NCT01355354|pharmacokinetics|pharmacokinetics
518207|NCT01355354|Rheumatoid arthritis|rheumatoid arthritis
518208|NCT01355354|RA, Fostamatinib|ra, fostamatinib
518209|NCT01355354|Digoxin, drug-drug interaction|digoxin, drug-drug interaction
518210|NCT01355354|Scientific terminology: Rheumatoid arthritis|scientific terminology: rheumatoid arthritis
518211|NCT01355354|Fostamatinib|fostamatinib
518212|NCT01355354|Digoxin|digoxin
518213|NCT01355354|drug-drug interaction|drug-drug interaction
518214|NCT01355354|Laymen terminology: Rheumatoid arthritis|laymen terminology: rheumatoid arthritis
518215|NCT01355354|Amount of Digoxin in blood|amount of digoxin in blood
518216|NCT01355341|RENAL CALCULI HERBMED PLUS|renal calculi herbmed plus
518217|NCT01355328|light|light
518218|NCT01355315|EECP|eecp
518219|NCT01355315|ischemic cardiomyopathy|ischemic cardiomyopathy
518220|NCT01355315|endothelin-1|endothelin-1
518221|NCT01355315|ischemia coronary artery diseases|ischemia coronary artery diseases
518222|NCT01355315|congestive heart failure not amenable to standard procedures|congestive heart failure not amenable to standard procedures
518223|NCT01355302|Cancer|cancer
518224|NCT01355302|Solid Tumors|solid tumors
518225|NCT01355302|Gastric|gastric
518226|NCT01355302|Phase I|phase i
518227|NCT01355302|Phase II|phase ii
518228|NCT01355289|Chronic Hepatitis C related|chronic hepatitis c related
518229|NCT01355276|Cinitapride|cinitapride
518230|NCT01355276|efficacy|efficacy
518231|NCT01355276|safety|safety
518232|NCT01355276|mild to moderate functional dyspepsia|mild to moderate functional dyspepsia
518233|NCT01355263|vitamin a|vitamin a
518234|NCT01355263|preschool children|preschool children
518235|NCT01355263|iron metabolic homeostasis|iron metabolic homeostasis
518236|NCT01355263|supplementation effect|supplementation effect
518237|NCT01355237|Complementary and alternative medicine (CAM)|complementary and alternative medicine (cam)
518238|NCT01355224|obesity|obesity
518239|NCT01355224|genetics|genetics
518240|NCT01355224|risk assessment|risk assessment
518241|NCT01355224|health behaviors|health behaviors
518242|NCT01355224|randomized controlled trial|randomized controlled trial
518243|NCT01355211|Altered Mental Status|altered mental status
518244|NCT01355211|non-convulsive seizure|non-convulsive seizure
518245|NCT01355211|status epilepticus|status epilepticus
518246|NCT01355211|electroencephalography|electroencephalography
518247|NCT01355185|Seed movement|seed movement
518248|NCT01355185|implants|implants
518249|NCT01355185|prostate brachytherapy|prostate brachytherapy
518250|NCT01355185|localized|localized
518251|NCT01355172|Influenza|influenza
518252|NCT01355172|Vaccine|vaccine
518253|NCT01355172|Immunogenicity|immunogenicity
518254|NCT01355159|Pregnancy|pregnancy
518255|NCT01355159|Folic Acid supplementation|folic acid supplementation
518256|NCT01355159|Preeclampsia|preeclampsia
518257|NCT01355146|Patients with proven Fabry's Disease|patients with proven fabry's disease
518258|NCT01355133|Urinary incontinence|urinary incontinence
518259|NCT01355133|Myoblasts|myoblasts
518260|NCT01355133|Muscle derived cells|muscle derived cells
518261|NCT01355133|Stem cells|stem cells
518262|NCT01355120|advanced ocular melanoma|advanced ocular melanoma
518263|NCT01355107|selenium level measurement|selenium level measurement
518264|NCT01355094|temporary abdomen closure|temporary abdomen closure
518265|NCT01355094|peritoneal vacuum therapy|peritoneal vacuum therapy
518266|NCT01355094|open abdomen|open abdomen
518267|NCT01355094|abdominal compartment syndrome|abdominal compartment syndrome
518268|NCT01355094|intra-abdominal sepsis|intra-abdominal sepsis
518269|NCT01355094|intra-abdominal hypertension|intra-abdominal hypertension
518270|NCT01355094|critical care|critical care
518271|NCT01355081|Drug Therapy|drug therapy
518272|NCT01355068|phenytoin|phenytoin
518273|NCT01355068|chewable tablets|chewable tablets
518274|NCT01355068|dilantin|dilantin
518275|NCT01355068|epanutin|epanutin
518276|NCT01355068|infatabs|infatabs
518277|NCT01355068|bioequivalence|bioequivalence
518278|NCT01355068|Partial seizure|partial seizure
518279|NCT01355068|Tonic-clonic seizure|tonic-clonic seizure
518280|NCT01355029|Stroke caregivers|stroke caregivers
518281|NCT01355029|Family Caregivers|family caregivers
518282|NCT01355029|Stroke|stroke
518284|NCT01354977|Diabetes Mellitus, Type 2|diabetes mellitus, type 2
518285|NCT01354977|Glucose Metabolism Disorders|glucose metabolism disorders
518286|NCT01354977|Metabolic Diseases|metabolic diseases
518287|NCT01354977|Diabetes Mellitus|diabetes mellitus
518288|NCT01354977|Endocrin System Diseases|endocrin system diseases
518289|NCT01354977|Resveratrol|resveratrol
518290|NCT01354977|Therapeutic Uses|therapeutic uses
518291|NCT01354964|Glucose Metabolism Disorders|glucose metabolism disorders
518292|NCT01354964|Insulin Resistance|insulin resistance
518293|NCT01354964|Endocrine System|endocrine system
518294|NCT01354964|Vitamin D|vitamin d
518295|NCT01354951|Focal Brachytherapy|focal brachytherapy
518296|NCT01354951|Endorectal coil MRI|endorectal coil mri
518297|NCT01354951|Quality of Life|quality of life
518298|NCT01354951|11-056|11-056
518299|NCT01354938|Bronchitis|bronchitis
518300|NCT01354925|Diabetes type 2|diabetes type 2
518301|NCT01354925|Fasting|fasting
518302|NCT01354925|Ramadan|ramadan
518303|NCT01354925|Insulin analogues|insulin analogues
518304|NCT01354912|mycobacterial infection|mycobacterial infection
518305|NCT01354912|culture|culture
518306|NCT01354912|ct scan|ct scan
518307|NCT01354886|in-vitro fertilization|in-vitro fertilization
518308|NCT01354886|reproductive disorder|reproductive disorder
518309|NCT01354873|Colonoscopy|colonoscopy
518310|NCT01354873|Colon Polyps|colon polyps
518311|NCT01354860|knee osteoarthritis|knee osteoarthritis
518312|NCT01354847|extracorporeal circulation|extracorporeal circulation
518313|NCT01354847|platelet dysfunction|platelet dysfunction
518314|NCT01354847|Multiplate electrode aggregometry analyses|multiplate electrode aggregometry analyses
518315|NCT01354847|Multiplate|multiplate
518316|NCT01354821|Aorta|aorta
518317|NCT01354821|Aneurysm|aneurysm
518318|NCT01354821|endovascular|endovascular
518319|NCT01354821|stent-graft|stent-graft
518320|NCT01354808|Cilostazol|cilostazol
518321|NCT01354808|Platelet|platelet
518322|NCT01354808|Inflammation|inflammation
518323|NCT01354808|Myonecrosis|myonecrosis
518324|NCT01354795|EUS FNA|eus fna
518325|NCT01354795|stylet|stylet
518326|NCT01354795|suction|suction
518327|NCT01354782|Pharmacokinetic|pharmacokinetic
518328|NCT01354782|Roflumilast|roflumilast
518329|NCT01354756|sleep apnea|sleep apnea
518330|NCT01354756|polysomnography|polysomnography
518331|NCT01354756|obesity|obesity
518332|NCT01354756|bariatric surgery|bariatric surgery
518333|NCT01354743|atrophy|atrophy
518334|NCT01354743|rhytids|rhytids
518335|NCT01354743|glabellar|glabellar
518336|NCT01354743|periorbital|periorbital
518337|NCT01354730|incidence|incidence
518338|NCT01354730|nature|nature
518339|NCT01354730|seriousness|seriousness
518340|NCT01354730|ADRs|adrs
518341|NCT01354730|vaccination|vaccination
518342|NCT01354704|deep veinous thrombosis|deep veinous thrombosis
518343|NCT01354704|enoxaparin|enoxaparin
518344|NCT01354691|Alzheimer's Disease|alzheimer's disease
518345|NCT01354691|Dementia|dementia
518346|NCT01354691|Memory Loss|memory loss
518347|NCT01354691|Cognitive Impairment|cognitive impairment
518348|NCT01354691|Brain Diseases|brain diseases
518349|NCT01354691|Central Nervous System Diseases|central nervous system diseases
518350|NCT01354691|Nervous System Diseases|nervous system diseases
518351|NCT01354691|Neurodegenerative Diseases|neurodegenerative diseases
518352|NCT01354691|Delirium, Dementia, Amnestic, Cognitive Disorders|delirium, dementia, amnestic, cognitive disorders
518353|NCT01354691|Mental Disorders|mental disorders
518354|NCT01354691|Depression|depression
518355|NCT01354691|Anxiety|anxiety
518356|NCT01354678|heart failure|heart failure
518357|NCT01354678|bone marrow mononuclear cells|bone marrow mononuclear cells
518358|NCT01354665|Multiple sclerosis|multiple sclerosis
518359|NCT01354665|Interferon beta-1b|interferon beta-1b
518360|NCT01354665|Fatigue|fatigue
518361|NCT01354665|Depression|depression
518362|NCT01354652|lactic acidosis|lactic acidosis
518363|NCT01354652|entecavir|entecavir
518364|NCT01354652|lamivudine|lamivudine
518365|NCT01354626|Hepatic fat accumulation|hepatic fat accumulation
518366|NCT01354626|Dietary protein|dietary protein
518367|NCT01354626|NAFLD|nafld
518368|NCT01354600|Obesity|obesity
518369|NCT01354600|Appetite|appetite
518370|NCT01354600|Hormones|hormones
518371|NCT01354600|Exercise|exercise
518372|NCT01354600|Body Weight|body weight
518373|NCT01354587|immunodeficiency|immunodeficiency
518374|NCT01354574|energy metabolism|energy metabolism
518375|NCT01354574|lipids|lipids
518376|NCT01354574|lipoproteins|lipoproteins
518377|NCT01354574|satiety|satiety
518378|NCT01354574|glycemic load|glycemic load
518379|NCT01354574|insulin|insulin
518380|NCT01354561|respiratory physiotherapy|respiratory physiotherapy
518381|NCT01354561|cardiac autonomic modulation|cardiac autonomic modulation
518382|NCT01354561|paediatric patients|paediatric patients
518383|NCT01354548|Trismus|trismus
518384|NCT01354548|Cancer|cancer
518385|NCT01354548|Radiotherapy|radiotherapy
518386|NCT01354548|Quality of life|quality of life
518387|NCT01354535|periprosthetic|periprosthetic
518388|NCT01354535|femur fractures|femur fractures
518389|NCT01354535|Vancouver B1|vancouver b1
518390|NCT01354509|Normothermia|normothermia
518391|NCT01354509|fever control|fever control
518392|NCT01354509|Outcome study|outcome study
518393|NCT01354496|Healthy Volunteers|healthy volunteers
518394|NCT01354496|Bioavailability|bioavailability
518395|NCT01354483|spinal cord injury|spinal cord injury
518396|NCT01354483|umbilical cord blood mononuclear cell|umbilical cord blood mononuclear cell
518397|NCT01354483|lithium carbonate|lithium carbonate
518398|NCT01354470|Meth|meth
518399|NCT01354470|Methamphetamine Addiction|methamphetamine addiction
518400|NCT01354470|Methamphetamine Treatment|methamphetamine treatment
518401|NCT01354470|Modafinil|modafinil
518402|NCT01354457|Patient with relapsing or refractory CD22+B-acute lymphoblastic leukemia (ALL)|patient with relapsing or refractory cd22+b-acute lymphoblastic leukemia (all)
518403|NCT01354444|Memory problems|memory problems
518404|NCT01354444|Alzheimer's Disease|alzheimer's disease
518405|NCT01354431|Advanced/Metastatic|advanced/metastatic
518406|NCT01354431|clear cell component|clear cell component
518407|NCT01354392|Relapsed or refractory|relapsed or refractory
518408|NCT01354392|Large B-Cell|large b-cell
518409|NCT01354392|Diffuse|diffuse
518410|NCT01354340|Cholesterol|cholesterol
518411|NCT01354340|LDL-cholesterol|ldl-cholesterol
518412|NCT01354340|Coronary artery disease|coronary artery disease
518413|NCT01354340|Red yeast rice|red yeast rice
518414|NCT01354340|Plants extract|plants extract
518415|NCT01354340|Cholesterol excess|cholesterol excess
518416|NCT01354340|Delivery of Health Care|delivery of health care
518417|NCT01354327|Delivery of Health Care|delivery of health care
518418|NCT01354327|Cholesterol|cholesterol
518419|NCT01354327|LDL-cholesterol|ldl-cholesterol
518420|NCT01354327|Coronary artery disease|coronary artery disease
518421|NCT01354327|Red yeast rice|red yeast rice
518422|NCT01354327|Plants extract|plants extract
518423|NCT01354327|Cholesterol excess|cholesterol excess
518424|NCT01354314|HIV|hiv
518425|NCT01354314|Neurocognitive impairment|neurocognitive impairment
518426|NCT01354314|Memory|memory
518427|NCT01354314|Dementia|dementia
518428|NCT01354314|CSF marker|csf marker
518429|NCT01354314|Functional assessment|functional assessment
518430|NCT01354314|MRS|mrs
518431|NCT01354314|Magnetic resonance spectroscopy|magnetic resonance spectroscopy
518432|NCT01354314|Arterial spin labeling|arterial spin labeling
518433|NCT01354314|SSRI|ssri
518434|NCT01354301|kidney transplantation|kidney transplantation
518435|NCT01354301|thymoglobulin|thymoglobulin
518436|NCT01354301|everolimus|everolimus
518437|NCT01354288|Diabetes|diabetes
518438|NCT01354288|Children|children
518439|NCT01354288|Disease management|disease management
518440|NCT01354288|Ketosis|ketosis
518441|NCT01354288|Hypoglycemia|hypoglycemia
518442|NCT01354288|Parents|parents
518443|NCT01354288|Education|education
518444|NCT01354275|PCOS|pcos
518445|NCT01354275|IVF/ICSI|ivf/icsi
518446|NCT01354275|Clinical Pregnancy rates|clinical pregnancy rates
518447|NCT01354275|GnRH Antagonist|gnrh antagonist
518448|NCT01354275|GnRH Agonist|gnrh agonist
518449|NCT01354262|Diabetes|diabetes
518450|NCT01354262|Vitamin D deficiency|vitamin d deficiency
518451|NCT01354262|Hemoglobin A1c|hemoglobin a1c
518452|NCT01354249|preoperative fasting|preoperative fasting
518453|NCT01354249|insulin resistance|insulin resistance
518454|NCT01354249|carbohydrates|carbohydrates
518455|NCT01354249|whey protein|whey protein
518456|NCT01354249|inflammatory response|inflammatory response
518457|NCT01354223|silicone hydrogel contact lens|silicone hydrogel contact lens
518458|NCT01354223|SHCL|shcl
518459|NCT01354223|stenfilcon A|stenfilcon a
518460|NCT01354223|ocufilcon B|ocufilcon b
518461|NCT01354223|daily disposable|daily disposable
518462|NCT01354223|substantial equivalence|substantial equivalence
518463|NCT01354223|CooperVision ClearSight™ 1 Day SCL|coopervision clearsight™ 1 day scl
518464|NCT01354210|Patient Adherence|patient adherence
518465|NCT01354210|HIV|hiv
518466|NCT01354197|Adverse events|adverse events
518467|NCT01354197|Mortality|mortality
518468|NCT01354197|Readmission|readmission
518469|NCT01354197|Surgical intensive care unit|surgical intensive care unit
518470|NCT01354171|active surveillance|active surveillance
518471|NCT01354171|low risk prostate cancer|low risk prostate cancer
518472|NCT01354132|schizophrenia|schizophrenia
518473|NCT01354132|schizoaffective|schizoaffective
518474|NCT01354132|schizophreniform|schizophreniform
518475|NCT01354132|early schizophrenia spectrum psychosis|early schizophrenia spectrum psychosis
518476|NCT01354106|Skin condition after wear|skin condition after wear
518477|NCT01354093|MacTel|mactel
518478|NCT01354093|Macular telangiectasia type 2|macular telangiectasia type 2
518479|NCT01354080|constipation|constipation
518480|NCT01354080|massage|massage
518481|NCT01354080|tensegrity|tensegrity
518482|NCT01354067|Pulmonary Disease, Chronic Obstructive|pulmonary disease, chronic obstructive
518483|NCT01354067|Lung Diseases, Obstructive|lung diseases, obstructive
518484|NCT01354067|Single Limb|single limb
518485|NCT01354067|Elastic Resistance|elastic resistance
518486|NCT01354067|Resistance Training|resistance training
518487|NCT01354067|Minor Muscle Mass|minor muscle mass
518488|NCT01354067|Local muscle training|local muscle training
518489|NCT01354054|Knee OA|knee oa
518490|NCT01354054|TENS|tens
518491|NCT01354041|fear and health worries about cancer recurrence|fear and health worries about cancer recurrence
518492|NCT01354028|premature infant|premature infant
518493|NCT01354028|massage therapy|massage therapy
518494|NCT01354028|sleep induction|sleep induction
518495|NCT01354028|relaxation|relaxation
518496|NCT01354015|Diabetes|diabetes
518497|NCT01354015|Technology|technology
518498|NCT01354002|human biological samples|human biological samples
518499|NCT01354002|tissue banking|tissue banking
518500|NCT01353989|hepatitis A|hepatitis a
518501|NCT01353989|vaccination|vaccination
518502|NCT01353989|elderly|elderly
518503|NCT01353989|protection to hepatitis A after vaccination|protection to hepatitis a after vaccination
518504|NCT01353976|Econazole Nitrate|econazole nitrate
518505|NCT01353976|Foam|foam
518506|NCT01353976|Quinnova|quinnova
518507|NCT01353976|Tinea Pedis|tinea pedis
518508|NCT01353950|Costimulatory molecules|costimulatory molecules
518509|NCT01353950|Cystic Fibrosis|cystic fibrosis
518510|NCT01353950|Biomarkers|biomarkers
518511|NCT01353937|wound healing|wound healing
518512|NCT01353924|Allergy|allergy
518513|NCT01353924|Vaccine|vaccine
518514|NCT01353924|rBet v 1|rbet v 1
518515|NCT01353924|Prevention|prevention
518516|NCT01353885|Primary Osteoarthritis, Hip|primary osteoarthritis, hip
518517|NCT01353885|Total Hip Arthroplasty|total hip arthroplasty
518518|NCT01353885|Anterior Approach|anterior approach
518519|NCT01353885|Posterior Approach|posterior approach
518520|NCT01353885|Anterolateral Approach|anterolateral approach
518521|NCT01353885|Cohort Study|cohort study
518522|NCT01353885|Outcomes, Complication Rate|outcomes, complication rate
518523|NCT01353885|Outcomes, Quality of Life|outcomes, quality of life
518524|NCT01353872|Fatigue|fatigue
518525|NCT01353872|Tennis|tennis
518526|NCT01353872|Nutrition|nutrition
518527|NCT01353872|Tournament simulation|tournament simulation
518528|NCT01353872|Delivery of Health Care|delivery of health care
518529|NCT01353846|oocyte donation program|oocyte donation program
518530|NCT01353846|natural cycle|natural cycle
518531|NCT01353846|hormone replacement therapy|hormone replacement therapy
518532|NCT01353820|Midly hypercholesterolemic subjects|midly hypercholesterolemic subjects
518533|NCT01353820|Probiotic|probiotic
518534|NCT01353820|Cholesterol lowering|cholesterol lowering
518535|NCT01353820|Dairy|dairy
518536|NCT01353807|Fish oil|fish oil
518537|NCT01353807|Pregnancy|pregnancy
518538|NCT01353807|RCT|rct
518539|NCT01353807|Birth weight|birth weight
518540|NCT01353807|Gestational age|gestational age
518541|NCT01353807|Asthma and allergies|asthma and allergies
518542|NCT01353807|Metabolic syndrome|metabolic syndrome
518543|NCT01353807|Obesity|obesity
518544|NCT01353794|SORAFENIB|sorafenib
518545|NCT01353794|RENAL CELL CARCINOMA|renal cell carcinoma
518546|NCT01353794|TYROSINE KINASE INHIBITOR|tyrosine kinase inhibitor
518547|NCT01353794|OBSERVATIONAL STUDY|observational study
518548|NCT01353781|Phase 1|phase 1
518549|NCT01353781|advanced solid tumor|advanced solid tumor
518550|NCT01353781|AKT|akt
518551|NCT01353781|Ascending|ascending
518552|NCT01353781|Japanese|japanese
518553|NCT01353768|Influenza|influenza
518554|NCT01353755|specific immunotherapy|specific immunotherapy
518555|NCT01353755|SIT|sit
518556|NCT01353729|12-lead ECG|12-lead ecg
518557|NCT01353729|cardiac repolarization|cardiac repolarization
518558|NCT01353729|QTc|qtc
518559|NCT01353729|influenza|influenza
518560|NCT01353729|GR121167|gr121167
518561|NCT01353729|zanamivir|zanamivir
518562|NCT01353703|Infanrix hexa™|infanrix hexa™
518563|NCT01353703|Primary vaccination|primary vaccination
518564|NCT01353703|India|india
518565|NCT01353703|combination vaccine|combination vaccine
518566|NCT01353703|infants|infants
518567|NCT01353690|Cell Therapy|cell therapy
518568|NCT01353690|Heart Failure|heart failure
518569|NCT01353690|Heart Disease|heart disease
518570|NCT01353690|Myocardial Infarction|myocardial infarction
518571|NCT01353690|Myocardial Ischemia|myocardial ischemia
518572|NCT01353690|Autologous|autologous
518573|NCT01353690|Muscle-derived Cell|muscle-derived cell
518574|NCT01353677|Hematopoietic stem cell transplantation|hematopoietic stem cell transplantation
518575|NCT01353677|QOL|qol
518576|NCT01353664|rollover protocol|rollover protocol
518577|NCT01353664|romidepsin|romidepsin
518578|NCT01353664|Gloucester Pharmaceuticals|gloucester pharmaceuticals
518579|NCT01353664|Celgene Corporation|celgene corporation
518580|NCT01353664|continuing treatment|continuing treatment
518581|NCT01353638|Peritoneal dialysis|peritoneal dialysis
518582|NCT01353638|Alanyl-Glutamine-Dipeptide|alanyl-glutamine-dipeptide
518583|NCT01353638|Heat shock protein|heat shock protein
518584|NCT01353638|Peritoneal cells|peritoneal cells
518585|NCT01353638|functional maintenance of the peritoneal membrane|functional maintenance of the peritoneal membrane
518586|NCT01353625|Neoplasm|neoplasm
518587|NCT01353625|Malignancy|malignancy
518588|NCT01353625|Carcinoma|carcinoma
518589|NCT01353625|Lymphoma|lymphoma
518590|NCT01353625|Leukemia|leukemia
518591|NCT01353625|Multiple myeloma|multiple myeloma
518592|NCT01353625|mTOR kinase inhibitor|mtor kinase inhibitor
518593|NCT01353625|Castration-resistant prostate cancer|castration-resistant prostate cancer
518594|NCT01353625|Hormone-resistant prostate cancer|hormone-resistant prostate cancer
518889|NCT01352429|adult|adult
518595|NCT01353625|Diffuse Large B-cell lymphoma|diffuse large b-cell lymphoma
518596|NCT01353599|Spinal Cord Injury|spinal cord injury
518597|NCT01353599|Tetraplegia|tetraplegia
518598|NCT01353599|Pulmonary Function|pulmonary function
518599|NCT01353573|Brain Neoplasms|brain neoplasms
518600|NCT01353573|Neoplasm Metastasis|neoplasm metastasis
518601|NCT01353573|Neoplasms|neoplasms
518602|NCT01353560|integrative medicine|integrative medicine
518603|NCT01353560|barriers to utilization|barriers to utilization
518604|NCT01353560|communication|communication
518605|NCT01353534|Immunogenicity and Safety|immunogenicity and safety
518606|NCT01353521|complex renal cysts|complex renal cysts
518607|NCT01353521|Contrast enhanced ultrasound|contrast enhanced ultrasound
518608|NCT01353508|Sodium excretion,|sodium excretion,
518609|NCT01353508|LCZ696|lcz696
518610|NCT01353495|Diabetic Foot Ulcers|diabetic foot ulcers
518611|NCT01353482|mesothelioma|mesothelioma
518612|NCT01353482|vorinostat|vorinostat
518613|NCT01353456|Ambulation|ambulation
518614|NCT01353456|Side effects|side effects
518615|NCT01353456|Serum sCD40L|serum scd40l
518616|NCT01353456|Bowel function|bowel function
518617|NCT01353456|Postoperative pain|postoperative pain
518618|NCT01353443|Abdominal Aortic Aneurysm|abdominal aortic aneurysm
518619|NCT01353443|AAA|aaa
518620|NCT01353430|IBMPFD - Inclusion Body Myopathy associated with|ibmpfd - inclusion body myopathy associated with
518621|NCT01353430|Paget's disease of bone and Frontotemporal Dementia|paget's disease of bone and frontotemporal dementia
518622|NCT01353430|VCP gene - Valosin-containing protein gene|vcp gene - valosin-containing protein gene
518623|NCT01353417|Grafting, kidney|grafting, kidney
518624|NCT01353417|Transplantation, kidney|transplantation, kidney
518625|NCT01353391|Diabetes|diabetes
518626|NCT01353391|MiTy|mity
518627|NCT01353391|Metformin in Women|metformin in women
518628|NCT01353391|Type 2 Diabetes Pregnancy|type 2 diabetes pregnancy
518629|NCT01353378|dexmedetomidine|dexmedetomidine
518630|NCT01353378|emergence delirium|emergence delirium
518631|NCT01353378|sevoflurane anesthesia|sevoflurane anesthesia
518632|NCT01353378|preschool children|preschool children
518633|NCT01353378|oral maxillofacial surgery|oral maxillofacial surgery
518634|NCT01353352|Evaluation|evaluation
518635|NCT01353352|C-Spine|c-spine
518636|NCT01353352|Nursing|nursing
518637|NCT01353352|Clinical Decision Rule|clinical decision rule
518638|NCT01353339|Kidney Transplant|kidney transplant
518639|NCT01353339|BK Polyomavirus Infection|bk polyomavirus infection
518640|NCT01353326|non-inflammatory degenerative joint disease|non-inflammatory degenerative joint disease
518641|NCT01353326|hip resurfacing|hip resurfacing
518642|NCT01353326|bone mineral density|bone mineral density
518643|NCT01353326|cemented|cemented
518644|NCT01353326|cementless|cementless
518645|NCT01353313|NICHD Neonatal Research Network|nichd neonatal research network
518646|NCT01353313|Extremely Low Birth Weight (ELBW)|extremely low birth weight (elbw)
518647|NCT01353313|Very Low Birth Weight (VLBW)|very low birth weight (vlbw)
518648|NCT01353313|Prematurity|prematurity
518649|NCT01353313|Mechanical ventilation|mechanical ventilation
518650|NCT01353313|Intubation|intubation
518651|NCT01353313|Neurodevelopmental impairment|neurodevelopmental impairment
518652|NCT01353300|embryonal childhood rhabdomyosarcoma|embryonal childhood rhabdomyosarcoma
518653|NCT01353300|cystic nephroma|cystic nephroma
518654|NCT01353300|neuroblastoma|neuroblastoma
518655|NCT01353300|childhood medulloblastoma|childhood medulloblastoma
518656|NCT01353300|childhood hepatoblastoma|childhood hepatoblastoma
518657|NCT01353300|stromal predominant Wilms tumor|stromal predominant wilms tumor
518658|NCT01353300|hereditary Wilms tumor|hereditary wilms tumor
518659|NCT01353300|pleuropulmonary blastoma|pleuropulmonary blastoma
518660|NCT01353287|Transcatheter Aortic Valve Intervention (TAVI)|transcatheter aortic valve intervention (tavi)
518661|NCT01353287|Live case transmission|live case transmission
518662|NCT01353261|Platelet reactivity|platelet reactivity
518663|NCT01353248|Hepatitis C|hepatitis c
518664|NCT01353248|HCV|hcv
518665|NCT01353248|Rapid Virologic Response|rapid virologic response
518666|NCT01353248|Sustained Virologic Response|sustained virologic response
518667|NCT01353248|Direct Acting Antiviral|direct acting antiviral
518668|NCT01353248|Combination Therapy|combination therapy
518669|NCT01353248|HCV RNA|hcv rna
518670|NCT01353248|Polymerase inhibitor|polymerase inhibitor
518671|NCT01353248|Protease inhibitor|protease inhibitor
518672|NCT01353248|Treatment naïve|treatment naïve
518673|NCT01353248|GS-5885|gs-5885
518674|NCT01353248|GS-9451|gs-9451
518675|NCT01353248|Tegobuvir|tegobuvir
518676|NCT01353235|COPD|copd
518677|NCT01353235|acute respiratory failure|acute respiratory failure
518678|NCT01353235|mechanical ventilation|mechanical ventilation
518679|NCT01353235|non invasive ventilation|non invasive ventilation
518680|NCT01353235|steroids|steroids
518681|NCT01353222|Bladder cancer|bladder cancer
518682|NCT01353222|Renal pelvis cancer|renal pelvis cancer
518683|NCT01353222|Ureteral cancer|ureteral cancer
518684|NCT01353222|Urethral cancer|urethral cancer
518685|NCT01353222|Bladder|bladder
518686|NCT01353222|Renal pelvis|renal pelvis
518687|NCT01353222|Ureter|ureter
518688|NCT01353222|Urethra|urethra
518689|NCT01353222|Immune therapy|immune therapy
518690|NCT01353222|Immunotherapy|immunotherapy
518691|NCT01353222|Vaccine|vaccine
518692|NCT01353222|Dendritic cells|dendritic cells
518693|NCT01353222|Antigen-presenting cells|antigen-presenting cells
518694|NCT01353222|Antigen presenting cells|antigen presenting cells
518695|NCT01353222|Cancer vaccine|cancer vaccine
518696|NCT01353222|Urothelial carcinoma|urothelial carcinoma
518697|NCT01353222|Urothelial neoplasms|urothelial neoplasms
518698|NCT01353222|Neoplasms by site|neoplasms by site
518699|NCT01353222|Neoplasms|neoplasms
518700|NCT01353196|carotid|carotid
518701|NCT01353196|atherosclerosis|atherosclerosis
518702|NCT01353196|cognitive function|cognitive function
518703|NCT01353183|biopsies, enteric nervous system, biomarker|biopsies, enteric nervous system, biomarker
518704|NCT01353170|Serum calcium|serum calcium
518705|NCT01353170|Dialysate|dialysate
518706|NCT01353170|Mass balance|mass balance
518707|NCT01353170|Blood pressure|blood pressure
518708|NCT01353157|cytokine|cytokine
518709|NCT01353157|cardiac surgery|cardiac surgery
518710|NCT01353157|clinical scoring system|clinical scoring system
518711|NCT01353144|aspirin|aspirin
518712|NCT01353144|peptic ulcer|peptic ulcer
518713|NCT01353131|electrocardiogram|electrocardiogram
518714|NCT01353131|cardiac magnetic resonance|cardiac magnetic resonance
518715|NCT01353131|heart failure|heart failure
518716|NCT01353131|sudden cardiac death|sudden cardiac death
518717|NCT01353131|ECG scoring|ecg scoring
518718|NCT01353131|Delayed enhancement|delayed enhancement
518719|NCT01353118|diabetes|diabetes
518720|NCT01353118|bariatric surgery|bariatric surgery
518721|NCT01353118|Roux-en-y gastric bypass|roux-en-y gastric bypass
518722|NCT01353118|retinopathy|retinopathy
518723|NCT01353118|neuropathy|neuropathy
518724|NCT01353118|nephropathy|nephropathy
518725|NCT01353105|cystic fibrosis|cystic fibrosis
518726|NCT01353105|chronic obstructive pulmonary disease|chronic obstructive pulmonary disease
518727|NCT01353105|pulmonary fibrosis|pulmonary fibrosis
518728|NCT01353092|Randomized Controlled Trial|randomized controlled trial
518729|NCT01353092|Major depression|major depression
518730|NCT01353092|Hamilton|hamilton
518731|NCT01353092|PEMF|pemf
518732|NCT01353066|Type 2 Diabetes Mellitus|type 2 diabetes mellitus
518733|NCT01353066|BMI 30.0-34.9 kg/m2|bmi 30.0-34.9 kg/m2
518734|NCT01353053|Immunosuppression|immunosuppression
518735|NCT01353053|Cytomegalovirus|cytomegalovirus
518736|NCT01353053|Renal Transplant|renal transplant
518737|NCT01353053|Atrophy/interstitial|atrophy/interstitial
518738|NCT01353053|Conversion of tacrolimus everolimus|conversion of tacrolimus everolimus
518739|NCT01353014|Nutrigenomics|nutrigenomics
518740|NCT01353014|Diet|diet
518741|NCT01353014|Nutrition|nutrition
518742|NCT01353001|Intervention Studies|intervention studies
518743|NCT01353001|Magnetic Resonance Imaging|magnetic resonance imaging
518744|NCT01353001|C-Reactive Protein|c-reactive protein
518745|NCT01352988|C17.300.475|c17.300.475
518746|NCT01352988|C17.800.480|c17.800.480
518747|NCT01352975|Age Related Macular Degeneration (AMD)|age related macular degeneration (amd)
518748|NCT01352975|Dark Adaptation|dark adaptation
518749|NCT01352975|Age Related Macular Degeneration|age related macular degeneration
518751|NCT01352962|Dose Limiting Toxicity|dose limiting toxicity
518752|NCT01352962|Urethra Cancer|urethra cancer
518753|NCT01352962|Carcinoma of the Bladder|carcinoma of the bladder
518754|NCT01352962|Cancer of the Renal Pelvis|cancer of the renal pelvis
518755|NCT01352962|Ureter Cancer|ureter cancer
518756|NCT01352962|Urethral Cancer|urethral cancer
518757|NCT01352962|Solid Tumor|solid tumor
518758|NCT01352962|Pancreatic Cancer|pancreatic cancer
518759|NCT01352962|Ovarian Cancer|ovarian cancer
518760|NCT01352962|Non-Small Cell Lung Cancer|non-small cell lung cancer
518761|NCT01352949|Anthropometry|anthropometry
518762|NCT01352949|Stereophotogrammetry|stereophotogrammetry
518763|NCT01352949|Torso|torso
518764|NCT01352936|nephrotoxicity|nephrotoxicity
518765|NCT01352936|hospital cost|hospital cost
518766|NCT01352936|Staphylococcus aureus|staphylococcus aureus
518767|NCT01352936|bacteremia|bacteremia
518768|NCT01352936|vancomycin|vancomycin
518769|NCT01352936|teicoplanin|teicoplanin
518770|NCT01352923|PEAR1 gene|pear1 gene
518771|NCT01352923|whether and how PEAR 1 modulate intracellular signaling pathways relevant for platelet function|whether and how pear 1 modulate intracellular signaling pathways relevant for platelet function
518772|NCT01352897|Cholesterol|cholesterol
518773|NCT01352897|rosuvastatin|rosuvastatin
518774|NCT01352897|retrospective|retrospective
518775|NCT01352884|Cancer|cancer
518776|NCT01352884|Carcinoma|carcinoma
518777|NCT01352884|Tumor|tumor
518778|NCT01352884|Solid tumor|solid tumor
518779|NCT01352884|Metastatic|metastatic
518780|NCT01352884|Melanoma|melanoma
518781|NCT01352871|Immunity, Innate|immunity, innate
518782|NCT01352871|Attention|attention
518783|NCT01352871|Concentration|concentration
518784|NCT01352858|Arthritis|arthritis
518785|NCT01352858|RA|ra
518786|NCT01352858|Auto-immune disorders|auto-immune disorders
518787|NCT01352832|Chronic NSAID use|chronic nsaid use
518788|NCT01352806|accuracy of identifying intralaminar space|accuracy of identifying intralaminar space
518789|NCT01352793|phase 3 safety study|phase 3 safety study
518790|NCT01352793|5700 healthy subjects|5700 healthy subjects
518791|NCT01352793|3 vaccine doses at month 0|3 vaccine doses at month 0
518792|NCT01352793|2|2
518793|NCT01352793|and 6|and 6
518794|NCT01352793|control HAV/saline/HAV|control hav/saline/hav
518795|NCT01352780|motivational interviewing|motivational interviewing
518796|NCT01352780|psoriasis|psoriasis
518797|NCT01352780|self management|self management
518798|NCT01352767|insulin injection|insulin injection
518799|NCT01352754|Hip fracture|hip fracture
518800|NCT01352754|Troponin T|troponin t
518801|NCT01352754|myocardial infarction|myocardial infarction
518802|NCT01352741|low back pain|low back pain
518803|NCT01352741|neuropathic|neuropathic
518804|NCT01352741|pain assessment|pain assessment
518805|NCT01352741|centrally acting tapentadol pregabalin|centrally acting tapentadol pregabalin
518806|NCT01352741|severe chronic|severe chronic
518807|NCT01352728|Unresectable|unresectable
518808|NCT01352689|CKD-828|ckd-828
518809|NCT01352689|Hypertension|hypertension
518810|NCT01352689|Primary Hypertension|primary hypertension
518811|NCT01352689|Healthy Volunteer|healthy volunteer
518812|NCT01352689|S-Amlodipine|s-amlodipine
518813|NCT01352689|Telmisartan|telmisartan
518814|NCT01352689|Amlodipine|amlodipine
518815|NCT01352689|Pharmacokinetic|pharmacokinetic
518816|NCT01352689|Phase 1|phase 1
518817|NCT01352676|renal colic|renal colic
518818|NCT01352676|flank pain|flank pain
518819|NCT01352676|back pain|back pain
518820|NCT01352663|Type I Diabetes|type i diabetes
518821|NCT01352663|Wockhardt|wockhardt
518822|NCT01352663|Insulin Analogue|insulin analogue
518823|NCT01352650|leukemia|leukemia
518824|NCT01352637|Traumatic Event|traumatic event
518825|NCT01352637|Trauma Survivor|trauma survivor
518826|NCT01352637|Exposure Therapy|exposure therapy
518827|NCT01352637|PTSD DCS|ptsd dcs
518828|NCT01352637|Virtual Reality Exposure|virtual reality exposure
518829|NCT01352637|Veteran|veteran
518830|NCT01352637|Combat-related PTSD|combat-related ptsd
518831|NCT01352611|Tactile Defensiveness|tactile defensiveness
518832|NCT01352611|Autistic Disorder|autistic disorder
518833|NCT01352598|prostate cancer|prostate cancer
518834|NCT01352598|stereotactic radiotherapy|stereotactic radiotherapy
518835|NCT01352572|Antidepressant Response|antidepressant response
518836|NCT01352572|Signal Transduction|signal transduction
518837|NCT01352572|Lymphocyte|lymphocyte
518838|NCT01352572|Biomarkers|biomarkers
518839|NCT01352572|Depressed Patients|depressed patients
518840|NCT01352572|Antidepressant Drug Adverse Reaction|antidepressant drug adverse reaction
518841|NCT01352559|Pharmacogenomics|pharmacogenomics
518842|NCT01352559|Prediction of Antidepressant Response|prediction of antidepressant response
518843|NCT01352559|Depressed Patients|depressed patients
518844|NCT01352559|biomarkers|biomarkers
518845|NCT01352559|phenotype|phenotype
518846|NCT01352559|Antidepressant Response|antidepressant response
518847|NCT01352559|Adverse Reaction to Drug|adverse reaction to drug
518848|NCT01352546|vaginismus|vaginismus
518849|NCT01352546|painful sex|painful sex
518850|NCT01352546|painful intercourse|painful intercourse
518851|NCT01352546|dyspareunia|dyspareunia
518852|NCT01352546|inability to have intercourse|inability to have intercourse
518853|NCT01352546|inability to consummate marriage|inability to consummate marriage
518854|NCT01352546|vaginal spasm|vaginal spasm
518855|NCT01352546|"hitting a wall"|"hitting a wall"
518856|NCT01352546|pain during sex|pain during sex
518857|NCT01352546|pain during intercourse|pain during intercourse
518858|NCT01352546|burning with intercourse|burning with intercourse
518859|NCT01352520|systemic therapy|systemic therapy
518860|NCT01352520|cutaneous anaplastic large T cell lymphoma|cutaneous anaplastic large t cell lymphoma
518861|NCT01352520|ALCL|alcl
518862|NCT01352520|lymphomatoid papulosis|lymphomatoid papulosis
518863|NCT01352520|LyP|lyp
518864|NCT01352520|mycosis fungoides|mycosis fungoides
518865|NCT01352520|MF|mf
518866|NCT01352520|SGN-35 (brentuximab vedotin)|sgn-35 (brentuximab vedotin)
518867|NCT01352520|skin lymphomas|skin lymphomas
518868|NCT01352520|CD30-positive lymphoproliferative disorders|cd30-positive lymphoproliferative disorders
518869|NCT01352520|tumor lymphocytes|tumor lymphocytes
518870|NCT01352520|cutaneous lymphomas|cutaneous lymphomas
518871|NCT01352520|CD30+ expression|cd30+ expression
518872|NCT01352520|Hematologic Disorder|hematologic disorder
518873|NCT01352520|Lymphoma|lymphoma
518874|NCT01352494|locally advanced breast cancer|locally advanced breast cancer
518875|NCT01352494|docetaxel|docetaxel
518876|NCT01352494|gemcitabine|gemcitabine
518877|NCT01352481|Speech sound development|speech sound development
518878|NCT01352468|ADHD|adhd
518879|NCT01352468|cognitive training|cognitive training
518880|NCT01352455|Hemodialysis|hemodialysis
518881|NCT01352455|Pediatric|pediatric
518882|NCT01352455|Outcomes|outcomes
518883|NCT01352455|Comparative Effectiveness|comparative effectiveness
518884|NCT01352455|End Stage Renal Disease|end stage renal disease
518885|NCT01352442|Presbyopia|presbyopia
518886|NCT01352442|Accommodation|accommodation
518887|NCT01352442|Near visual acuity|near visual acuity
518888|NCT01352442|LASIK|lasik
518890|NCT01352429|histologically confirmed|histologically confirmed
518891|NCT01352416|Suppress Atrial Fibrillation|suppress atrial fibrillation
518892|NCT01352416|heart bypass surgery|heart bypass surgery
518893|NCT01352416|heart valve surgery|heart valve surgery
518894|NCT01352403|obesity|obesity
518895|NCT01352403|bariatric surgery|bariatric surgery
518896|NCT01352403|gastric bypass|gastric bypass
518897|NCT01352403|life style intervention|life style intervention
518898|NCT01352403|cardiac function|cardiac function
518899|NCT01352390|behavioral economics|behavioral economics
518900|NCT01352390|nudge|nudge
518901|NCT01352390|artwork|artwork
518902|NCT01352390|Pap smear|pap smear
518903|NCT01352390|Blood pressure check|blood pressure check
518904|NCT01352390|Cholesterol test|cholesterol test
518905|NCT01352390|Fasting plasma glucose test|fasting plasma glucose test
518906|NCT01352364|Physiotherapy.|physiotherapy.
518907|NCT01352364|Deafness.|deafness.
518908|NCT01352364|Postural balance.|postural balance.
518909|NCT01352364|Motor skills.|motor skills.
518910|NCT01352351|Breast feeding Exclusive|breast feeding exclusive
518911|NCT01352351|Initiation of breastfeeding|initiation of breastfeeding
518912|NCT01352338|REPEAT|repeat
518913|NCT01352338|multiple myeloma|multiple myeloma
518914|NCT01352338|revlimid|revlimid
518915|NCT01352338|lenalidomide|lenalidomide
518916|NCT01352338|cyclophosphamide|cyclophosphamide
518917|NCT01352338|endoxan|endoxan
518918|NCT01352338|prednisone|prednisone
518919|NCT01352338|lenalidomide refractory|lenalidomide refractory
518920|NCT01352312|Chronic Lymphocytic Leukemia|chronic lymphocytic leukemia
518921|NCT01352312|Non-Hodgkin's Lymphoma|non-hodgkin's lymphoma
518922|NCT01352312|B-cell|b-cell
518923|NCT01352312|leukemia|leukemia
518924|NCT01352312|lymphoma|lymphoma
518925|NCT01352312|bendamustine|bendamustine
518926|NCT01352312|pentostatin|pentostatin
518927|NCT01352312|ofatumumab|ofatumumab
518928|NCT01352312|NHL|nhl
518929|NCT01352312|CLL|cll
518930|NCT01352299|Macintosh laryngoscope blade|macintosh laryngoscope blade
518931|NCT01352299|MacCoy laryngoscope blade|maccoy laryngoscope blade
518932|NCT01352299|Miller laryngoscope blade|miller laryngoscope blade
518933|NCT01352299|TrueView laryngoscope|trueview laryngoscope
518934|NCT01352286|Multiple myeloma|multiple myeloma
518935|NCT01352286|Received initial treatment previously|received initial treatment previously
518936|NCT01352286|Autologous stem cell transplantation|autologous stem cell transplantation
518937|NCT01352273|advanced Solid tumors|advanced solid tumors
518938|NCT01352273|harboring RAS|harboring ras
518939|NCT01352273|harboring BRAFV600E|harboring brafv600e
518940|NCT01352260|Near Infrared Spectroscopy|near infrared spectroscopy
518941|NCT01352260|Neuromonitoring|neuromonitoring
518942|NCT01352260|Aortic Arch Replacement|aortic arch replacement
518943|NCT01352221|iron deficiency|iron deficiency
518944|NCT01352221|anaemia|anaemia
518945|NCT01352221|inflammatory bowel disease|inflammatory bowel disease
518946|NCT01352221|Crohn's Disease|crohn's disease
518947|NCT01352208|ASP9521|asp9521
518948|NCT01352208|Castrate Resistant Prostate Cancer|castrate resistant prostate cancer
518949|NCT01352208|Phase 1/2|phase 1/2
518950|NCT01352195|Forever Free|forever free
518951|NCT01352143|Neonates|neonates
518952|NCT01352130|Postoperative nausea and vomiting|postoperative nausea and vomiting
518953|NCT01352130|Ondansetron|ondansetron
518954|NCT01352130|Granisetron|granisetron
518955|NCT01352130|QTc interval|qtc interval
518956|NCT01352104|Externalizing Problem Behaviour in Preschoolers|externalizing problem behaviour in preschoolers
518957|NCT01352091|breast cancer|breast cancer
518958|NCT01352091|adjuvant endocrine therapy|adjuvant endocrine therapy
518959|NCT01352091|AI|ai
518960|NCT01352091|Zoladex|zoladex
518961|NCT01352078|Non healing ulcer|non healing ulcer
518962|NCT01352078|Wound|wound
518963|NCT01352078|Hidradenitis suppurativa|hidradenitis suppurativa
518964|NCT01352078|Acne Inversa|acne inversa
518965|NCT01352078|Hidradenitis|hidradenitis
518966|NCT01352065|Pharmacokinetics|pharmacokinetics
518967|NCT01352065|Exercise performance|exercise performance
518968|NCT01352065|Athletes|athletes
518969|NCT01352052|chronic widespread pain|chronic widespread pain
518970|NCT01352052|fibromyalgia|fibromyalgia
518971|NCT01352052|outcome assessment|outcome assessment
518972|NCT01352052|functional ability|functional ability
518973|NCT01352052|AMPS|amps
518974|NCT01352052|rehabilitation|rehabilitation
518975|NCT01352039|Heparin Sodium|heparin sodium
518976|NCT01352039|Thromboprophylaxis|thromboprophylaxis
518977|NCT01352039|Hip Fracture Surgery.|hip fracture surgery.
518978|NCT01352013|Fibromyalgia|fibromyalgia
518979|NCT01352013|Omega-3|omega-3
518980|NCT01352013|Chronic Pain|chronic pain
518981|NCT01352013|Fatigue|fatigue
518982|NCT01352013|Mood|mood
518983|NCT01352013|docosahexaenoic acid (DHA)|docosahexaenoic acid (dha)
518984|NCT01352013|eicosapentaenoic acid (EPA)|eicosapentaenoic acid (epa)
518985|NCT01352000|self help|self help
518986|NCT01352000|smoking cessation|smoking cessation
518987|NCT01352000|cancer prevention|cancer prevention
518988|NCT01351987|Benign Prostatic Hyperplasia|benign prostatic hyperplasia
518989|NCT01351974|breast cancer|breast cancer
518990|NCT01351974|sentinel lymph node biopsy|sentinel lymph node biopsy
518991|NCT01351974|axillary recurrence|axillary recurrence
518992|NCT01351961|Hypertension|hypertension
518993|NCT01351961|Cognitive function|cognitive function
518994|NCT01351948|Immune response|immune response
518995|NCT01351935|non-hodgkin's lymphoma|non-hodgkin's lymphoma
518996|NCT01351935|lymphoma|lymphoma
518997|NCT01351935|leukemia|leukemia
518998|NCT01351935|chronic lymphocytic leukemia|chronic lymphocytic leukemia
518999|NCT01351935|b-cell malignancies|b-cell malignancies
519000|NCT01351935|Btk inhibitor|btk inhibitor
519001|NCT01351935|Phase 1b|phase 1b
519002|NCT01351935|Avila Therapeutics|avila therapeutics
519003|NCT01351935|Waldenstrom Macroglobulinemia|waldenstrom macroglobulinemia
519004|NCT01351883|immunomodulating diet|immunomodulating diet
519005|NCT01351883|postoperative infection|postoperative infection
519006|NCT01351857|Type 1 Diabetes|type 1 diabetes
519007|NCT01351857|17 to 20 years of age|17 to 20 years of age
519008|NCT01351844|Aromatase inhibitor|aromatase inhibitor
519009|NCT01351844|Arthralgia Syndrome|arthralgia syndrome
519010|NCT01351844|Exercise|exercise
519011|NCT01351831|Arthroplasty, Replacement, Knee|arthroplasty, replacement, knee
519012|NCT01351831|Resistance training|resistance training
519013|NCT01351831|Physical Therapy Modalities|physical therapy modalities
519014|NCT01351831|Randomized Controlled Trial|randomized controlled trial
519015|NCT01351805|vitamin D|vitamin d
519016|NCT01351805|omega-3 fatty acid|omega-3 fatty acid
519017|NCT01351805|fish oil|fish oil
519018|NCT01351805|prevention|prevention
519019|NCT01351805|trial|trial
519020|NCT01351805|autoimmune disease|autoimmune disease
519021|NCT01351805|rheumatoid arthritis|rheumatoid arthritis
519022|NCT01351805|psoriasis|psoriasis
519023|NCT01351805|systemic inflammation|systemic inflammation
519024|NCT01351805|Interleukin-6|interleukin-6
519025|NCT01351805|C-reactive peptide|c-reactive peptide
519026|NCT01351805|tumor necrosis factor|tumor necrosis factor
519027|NCT01351805|osteoarthritis|osteoarthritis
519028|NCT01351779|Intraocular pressure|intraocular pressure
519029|NCT01351779|Contact lens sensor|contact lens sensor
519030|NCT01351779|Optic disc hemorrhage|optic disc hemorrhage
519031|NCT01351766|Behavioral Activation|behavioral activation
519032|NCT01351753|Obesity|obesity
519033|NCT01351753|Metabolic Syndrome X|metabolic syndrome x
519034|NCT01351753|Hypertension|hypertension
519035|NCT01351753|Dyslipidemia|dyslipidemia
519036|NCT01351753|Impaired glucose tolerance|impaired glucose tolerance
519037|NCT01351740|HIV|hiv
519038|NCT01351740|Anti-HIV Agents|anti-hiv agents
519039|NCT01351740|HIV Protease Inhibitors|hiv protease inhibitors
519040|NCT01351727|seniors|seniors
519041|NCT01351727|seizures|seizures
519042|NCT01351727|epilepsy|epilepsy
519043|NCT01351727|quality of life|quality of life
519044|NCT01351714|D3 resection|d3 resection
519045|NCT01351714|right colectomy|right colectomy
519046|NCT01351714|MDCT angiography|mdct angiography
519047|NCT01351714|lymphadenectomy|lymphadenectomy
519048|NCT01351714|safe|safe
519049|NCT01351714|right colon|right colon
519050|NCT01351714|preoperative|preoperative
519051|NCT01351701|Diabetic foot|diabetic foot
519052|NCT01351701|Bacteriological epidemiology|bacteriological epidemiology
519053|NCT01351701|Wagner's Grading|wagner's grading
519054|NCT01351701|eastern India|eastern india
519055|NCT01351688|Phase 1|phase 1
519056|NCT01351688|Metastatic|metastatic
519057|NCT01351688|Castration resistant|castration resistant
519058|NCT01351688|Prostate cancer|prostate cancer
519059|NCT01351688|Androgen receptor|androgen receptor
519060|NCT01351688|Down regulation|down regulation
519061|NCT01351688|Japanese|japanese
519062|NCT01351675|Chronic kidney disease|chronic kidney disease
519063|NCT01351675|Type 2 diabetes|type 2 diabetes
519064|NCT01351675|Diabetic nephropathy|diabetic nephropathy
519065|NCT01351662|Lupus|lupus
519066|NCT01351662|stress|stress
519067|NCT01351649|exercise|exercise
519068|NCT01351649|adolescent|adolescent
519069|NCT01351649|intervention|intervention
519070|NCT01351649|female|female
519071|NCT01351649|counseling|counseling
519072|NCT01351636|chronic kidney disease|chronic kidney disease
519073|NCT01351636|hypertension|hypertension
519074|NCT01351623|PR-171 (CARFILZOMIB)|pr-171 (carfilzomib)
519075|NCT01351623|Chemotherapy|chemotherapy
519076|NCT01351623|10-228|10-228
519077|NCT01351610|Critical Limb Ischemia|critical limb ischemia
519078|NCT01351610|Peripheral Arterial Occlusive Disease|peripheral arterial occlusive disease
519079|NCT01351610|Peripheral Artery Disease|peripheral artery disease
519080|NCT01351610|Peripheral Vascular Disease|peripheral vascular disease
519081|NCT01351610|Stem Cell Therapy|stem cell therapy
519082|NCT01351610|Mesenchymal Stem Cells|mesenchymal stem cells
519083|NCT01351597|recurrent breast cancer|recurrent breast cancer
519084|NCT01351597|metastatic breast cancer|metastatic breast cancer
519085|NCT01351597|docetaxel|docetaxel
519086|NCT01351597|oxaliplatin|oxaliplatin
519087|NCT01351584|Breast Cancer|breast cancer
519088|NCT01351584|Advanced Breast Cancer|advanced breast cancer
519089|NCT01351584|Epidemiology|epidemiology
519090|NCT01351584|Registry|registry
519091|NCT01351584|Health Services Research|health services research
519092|NCT01351584|Germany|germany
519093|NCT01351584|Palliative Treatment|palliative treatment
519094|NCT01351584|Adjuvant Drug Therapy|adjuvant drug therapy
519095|NCT01351584|Nutrition Assessment|nutrition assessment
519096|NCT01351584|Physical Activity|physical activity
519097|NCT01351519|Glioma|glioma
519098|NCT01351519|Glioblastoma|glioblastoma
519099|NCT01351519|Glioblastoma Multiforme|glioblastoma multiforme
519100|NCT01351519|Astrocytoma|astrocytoma
519101|NCT01351519|Brain Tumor|brain tumor
519102|NCT01351506|Body weight|body weight
519103|NCT01351506|Body mass index|body mass index
519104|NCT01351506|Weight change|weight change
519105|NCT01351506|ICU outcomes|icu outcomes
519106|NCT01351493|pressure sore|pressure sore
519107|NCT01351493|nitric oxide|nitric oxide
519108|NCT01351480|Auto-immune Disease|auto-immune disease
519109|NCT01351480|Arthritis|arthritis
519110|NCT01351480|Rheumatoid Arthritis|rheumatoid arthritis
519111|NCT01351467|Parkinson's|parkinson's
519112|NCT01351467|genetic|genetic
519113|NCT01351467|online|online
519114|NCT01351467|GWAS|gwas
519115|NCT01351467|genome wide association|genome wide association
519116|NCT01351454|Depression|depression
519117|NCT01351454|Substance Use|substance use
519118|NCT01351454|HIV Medication Adherence|hiv medication adherence
519119|NCT01351454|Behavioral Activation|behavioral activation
519120|NCT01351441|Geriatric|geriatric
519121|NCT01351441|Pharmacoeconomics|pharmacoeconomics
519122|NCT01351441|Health Literacy|health literacy
519123|NCT01351441|Adherence|adherence
519124|NCT01351428|Non invasive cardiac output monitor|non invasive cardiac output monitor
519125|NCT01351428|NICOM|nicom
519126|NCT01351428|Hypertension|hypertension
519127|NCT01351428|Pregnancy|pregnancy
519128|NCT01351428|Pre-Eclampsia|pre-eclampsia
519129|NCT01351402|Massage|massage
519130|NCT01351402|Rest|rest
519131|NCT01351389|Brief|brief
519132|NCT01351389|Alcohol|alcohol
519133|NCT01351389|Intervention|intervention
519134|NCT01351389|Sex|sex
519135|NCT01351389|Risk|risk
519136|NCT01351376|Lymphedema, Low Level Laser, Breast Cancer|lymphedema, low level laser, breast cancer
519137|NCT01351363|Arthroscopic shoulder surgery|arthroscopic shoulder surgery
519138|NCT01351363|Pain threshold|pain threshold
519139|NCT01351350|Solid tumor, mTORC1/2 inhibitors, HER2|solid tumor, mtorc1/2 inhibitors, her2
519140|NCT01351337|Diffusion tensor imaging, Glioma, Intraoperative monitoring, Pyramidal tract, Subcortical|diffusion tensor imaging, glioma, intraoperative monitoring, pyramidal tract, subcortical
519141|NCT01351337|stimulation, Tractography|stimulation, tractography
519142|NCT01351324|Endothelial function|endothelial function
519143|NCT01351324|Non-esterified fatty acids|non-esterified fatty acids
519144|NCT01351324|Insulin sensitivity|insulin sensitivity
519145|NCT01351311|treatment|treatment
519146|NCT01351311|exercise|exercise
519147|NCT01351311|resistance training|resistance training
519148|NCT01351311|swiss ball|swiss ball
519149|NCT01351311|functional capacity|functional capacity
519150|NCT01351259|Mechanical ventilation|mechanical ventilation
519151|NCT01351259|Intubation|intubation
519152|NCT01351259|Cuff pressure|cuff pressure
519153|NCT01351259|Microaspiration|microaspiration
519154|NCT01351246|Program Evaluation|program evaluation
519155|NCT01351246|ADHD|adhd
519156|NCT01351233|Cataract|cataract
519157|NCT01351220|CRC screening|crc screening
519158|NCT01351220|Prevention and early detection of CRC|prevention and early detection of crc
519159|NCT01351220|Filipino|filipino
519160|NCT01351220|Dissemination|dissemination
519161|NCT01351194|Hepatocellular Carcinoma|hepatocellular carcinoma
519162|NCT01351194|RFA|rfa
519163|NCT01351194|HR|hr
519164|NCT01351181|Diabetes|diabetes
519165|NCT01351168|Parkinson's disease|parkinson's disease
519166|NCT01351168|zolpidem|zolpidem
519167|NCT01351155|acute respiratory failure|acute respiratory failure
519168|NCT01351155|noninvasive ventilation|noninvasive ventilation
519169|NCT01351129|formulation comparison|formulation comparison
519170|NCT01351116|brachytherapy|brachytherapy
519171|NCT01351116|external beam radiation|external beam radiation
519172|NCT01351116|high dose rate intraluminal brachytherapy|high dose rate intraluminal brachytherapy
519173|NCT01351116|lung cancer|lung cancer
519174|NCT01351116|quality of life|quality of life
519175|NCT01351116|radiation treatment|radiation treatment
519176|NCT01351116|bronchus|bronchus
519177|NCT01351103|LGK974|lgk974
519178|NCT01351103|pancreatic adenocarcinoma|pancreatic adenocarcinoma
519179|NCT01351103|BRAF mutant colorectal cancer|braf mutant colorectal cancer
519180|NCT01351103|RNF43 mutation|rnf43 mutation
519181|NCT01351103|RSPO fusion|rspo fusion
519182|NCT01351103|melanoma|melanoma
519183|NCT01351103|triple negative breast cancer|triple negative breast cancer
519184|NCT01351103|PDR001|pdr001
519185|NCT01351103|immunotherapy|immunotherapy
519186|NCT01351103|head and neck scc|head and neck scc
519187|NCT01351103|cervical scc|cervical scc
519188|NCT01351103|esophageal scc|esophageal scc
519189|NCT01351103|lung scc|lung scc
519190|NCT01351077|Developmental Delay|developmental delay
519191|NCT01351064|ADHD|adhd
519192|NCT01351012|Canola oil|canola oil
519193|NCT01351012|High oleic canola oil|high oleic canola oil
519194|NCT01351012|Flax oil|flax oil
519195|NCT01351012|ALA|ala
519196|NCT01351012|DHA|dha
519197|NCT01351012|Metabolic syndrome|metabolic syndrome
519198|NCT01351012|Cardiovascular disease|cardiovascular disease
519199|NCT01351012|Endothelial function|endothelial function
519200|NCT01351012|FADS1|fads1
519201|NCT01351012|Gut microbiome|gut microbiome
519202|NCT01351012|Body composition|body composition
519203|NCT01351012|Psychosocial status|psychosocial status
519204|NCT01351012|Cholesterol|cholesterol
519205|NCT01351012|Lipids|lipids
519206|NCT01351012|Lipoproteins|lipoproteins
519207|NCT01351012|Inflammation|inflammation
519208|NCT01351012|Lipid peroxidation|lipid peroxidation
519209|NCT01350999|Drug Therapy|drug therapy
519210|NCT01350986|Controlled Clinical Trials, Randomized|controlled clinical trials, randomized
519211|NCT01350973|Drug Therapy|drug therapy
519212|NCT01350960|hypercholesterolemia|hypercholesterolemia
519213|NCT01350960|hyperlipidemia|hyperlipidemia
519214|NCT01350960|LDL|ldl
519215|NCT01350960|HDL|hdl
519216|NCT01350960|PCSK9|pcsk9
519217|NCT01350960|LNA-oligonucleotide|lna-oligonucleotide
519218|NCT01350947|Chronic Myelomonocytic Leukemia|chronic myelomonocytic leukemia
519219|NCT01350947|CMML|cmml
519220|NCT01350921|phase 1|phase 1
519221|NCT01350921|ticagrelor|ticagrelor
519222|NCT01350921|venlafaxine|venlafaxine
519223|NCT01350895|Polycystic ovarian syndrome (PCOS)|polycystic ovarian syndrome (pcos)
519224|NCT01350882|kidney transplantation|kidney transplantation
519225|NCT01350882|acute humoral rejection|acute humoral rejection
519226|NCT01350882|rituximab|rituximab
519227|NCT01350856|Uncomplicated P. falciparum malaria|uncomplicated p. falciparum malaria
519228|NCT01350843|Men|men
519229|NCT01350843|Orange Juice|orange juice
519230|NCT01350843|Cholesterol|cholesterol
519231|NCT01350843|Obesity|obesity
519232|NCT01350830|inguinal hernia|inguinal hernia
519233|NCT01350830|groin hernia|groin hernia
519234|NCT01350830|chronic pain|chronic pain
519235|NCT01350830|mesh repair|mesh repair
519236|NCT01350804|Rheumatoid Arthritis|rheumatoid arthritis
519237|NCT01350804|RA|ra
519238|NCT01350804|ACR|acr
519239|NCT01350804|inflammatory joints|inflammatory joints
519240|NCT01350778|Coronary artery disease requiring drug eluting stents|coronary artery disease requiring drug eluting stents
519241|NCT01350765|Birth asphyxia|birth asphyxia
519242|NCT01350765|Low birth weight|low birth weight
519243|NCT01350765|neonatal sepsis|neonatal sepsis
519244|NCT01350765|mortality|mortality
519245|NCT01350765|community based interventions|community based interventions
519246|NCT01350752|cost effectiveness|cost effectiveness
519247|NCT01350752|provider knowledge|provider knowledge
519248|NCT01350752|schools|schools
519249|NCT01350726|Cirrhosis|cirrhosis
519250|NCT01350726|Hepatic Carcinoma|hepatic carcinoma
519251|NCT01350713|skin|skin
519252|NCT01350713|burn|burn
519253|NCT01350713|povidone iodine|povidone iodine
519254|NCT01350713|cold water|cold water
519255|NCT01350700|QOL|qol
519256|NCT01350687|Calcium Phosphore|calcium phosphore
519257|NCT01350687|Renagel|renagel
519258|NCT01350674|mediastinal tuberculosis|mediastinal tuberculosis
519259|NCT01350674|endoscopy|endoscopy
519260|NCT01350674|EBUS|ebus
519261|NCT01350674|tuberculous lymphadenopathy|tuberculous lymphadenopathy
519262|NCT01350674|endobronchial ultrasound|endobronchial ultrasound
519263|NCT01350661|Asthma|asthma
519264|NCT01350661|Questionnaires|questionnaires
519265|NCT01350648|Viral Hepatitis|viral hepatitis
519266|NCT01350648|Acquired Immunodeficiency Syndrome (AIDS)|acquired immunodeficiency syndrome (aids)
519267|NCT01350648|Hepatocellular Carcinoma|hepatocellular carcinoma
519268|NCT01350648|HIV-HCV Co-Infection|hiv-hcv co-infection
519269|NCT01350648|Liver Neoplasms|liver neoplasms
519270|NCT01350635|Specific Immunotherapy|specific immunotherapy
519271|NCT01350635|Grass pollen vaccine|grass pollen vaccine
519272|NCT01350635|Allergy|allergy
519273|NCT01350635|Grass Pollen Allergy|grass pollen allergy
519274|NCT01350622|pain management|pain management
519275|NCT01350609|essential hypertension, blood pressure, nifedipine, candesartan, FDC|essential hypertension, blood pressure, nifedipine, candesartan, fdc
519276|NCT01350596|Bioequivalence Study|bioequivalence study
519277|NCT01350596|Ibuprofen|ibuprofen
519278|NCT01350596|Alivium|alivium
519279|NCT01350583|tumor related pain|tumor related pain
519280|NCT01350570|acupuncture|acupuncture
519281|NCT01350570|loperamide|loperamide
519282|NCT01350570|functional diarrhea|functional diarrhea
519283|NCT01350570|IBS|ibs
519284|NCT01350557|Elderly|elderly
519285|NCT01350557|Hip fracture|hip fracture
519286|NCT01350557|Intervention program|intervention program
519287|NCT01350544|HIV|hiv
519288|NCT01350544|Adherence|adherence
519289|NCT01350544|African American/Black|african american/black
519290|NCT01350544|Disparities|disparities
519291|NCT01350531|Obesity|obesity
519292|NCT01350531|African American adolescents|african american adolescents
519293|NCT01350531|Motivation|motivation
519294|NCT01350518|Intra-Abdominal Fat|intra-abdominal fat
519394|NCT01350167|Screening|screening
519295|NCT01350518|Metabolic Syndrome|metabolic syndrome
519296|NCT01350518|Hepatic steatosis|hepatic steatosis
519297|NCT01350505|Postural Balance|postural balance
519298|NCT01350505|Sleep Initiation and Maintenance Disorders|sleep initiation and maintenance disorders
519300|NCT01350492|brain imaging|brain imaging
519301|NCT01350492|exercise|exercise
519302|NCT01350479|Cross infection|cross infection
519303|NCT01350479|Long term care|long term care
519304|NCT01350466|Chronic rhinosinusitis|chronic rhinosinusitis
519305|NCT01350453|CIT|cit
519306|NCT01350453|Stroke|stroke
519307|NCT01350427|leucine supplementation|leucine supplementation
519308|NCT01350427|BCCA supplementation|bcca supplementation
519309|NCT01350427|resistance exercise-induced muscle remodeling|resistance exercise-induced muscle remodeling
519310|NCT01350401|Melanoma|melanoma
519311|NCT01350401|Cell Therapy|cell therapy
519312|NCT01350401|T Cell Therapy|t cell therapy
519313|NCT01350401|NY-ESO-1|ny-eso-1
519314|NCT01350401|Immuno-oncology|immuno-oncology
519315|NCT01350401|Metastatic|metastatic
519316|NCT01350401|Previously treated|previously treated
519317|NCT01350401|T Cell Receptor|t cell receptor
519318|NCT01350388|Chronic Kidney Disease|chronic kidney disease
519319|NCT01350388|Diabetes|diabetes
519320|NCT01350388|Febuxostat|febuxostat
519321|NCT01350388|Inflammation|inflammation
519322|NCT01350388|Hyperuricemia|hyperuricemia
519323|NCT01350362|tideglusib|tideglusib
519324|NCT01350362|Alzheimer|alzheimer
519325|NCT01350362|NP-12|np-12
519326|NCT01350362|NP031112|np031112
519327|NCT01350362|ARGO|argo
519328|NCT01350362|Noscira|noscira
519329|NCT01350349|Depression|depression
519330|NCT01350349|Dementia|dementia
519331|NCT01350349|Geriatrics|geriatrics
519332|NCT01350310|Heart failure|heart failure
519333|NCT01350310|Dilated cardiomyopathy|dilated cardiomyopathy
519334|NCT01350310|Stem cells|stem cells
519335|NCT01350297|tetraplegia|tetraplegia
519336|NCT01350297|reinnervation|reinnervation
519337|NCT01350297|phrenic nerve|phrenic nerve
519338|NCT01350284|Antioxidants|antioxidants
519339|NCT01350284|Glucose Intolerance prevention and control|glucose intolerance prevention and control
519340|NCT01350284|Diabetes Mellitus prevention and control|diabetes mellitus prevention and control
519341|NCT01350271|Hookworm|hookworm
519342|NCT01350271|Necator americanus|necator americanus
519343|NCT01350271|Mebendazole|mebendazole
519344|NCT01350258|allogeneic HSCT|allogeneic hsct
519345|NCT01350258|Hematopoietic stem cell transplantation|hematopoietic stem cell transplantation
519346|NCT01350245|Acute Myeloid Leukemia|acute myeloid leukemia
519347|NCT01350245|Myelodysplastic Syndromes|myelodysplastic syndromes
519348|NCT01350245|Biphenotypic Leukemia|biphenotypic leukemia
519349|NCT01350245|Acute Lymphocytic Leukemia|acute lymphocytic leukemia
519350|NCT01350245|Chronic Myeloid Leukemia|chronic myeloid leukemia
519351|NCT01350245|Chronic Lymphocytic Leukemia|chronic lymphocytic leukemia
519352|NCT01350245|Plasma Cell Neoplasms|plasma cell neoplasms
519353|NCT01350245|Lymphoma|lymphoma
519354|NCT01350245|Hodgkin's Disease|hodgkin's disease
519355|NCT01350245|Aplastic Anemia|aplastic anemia
519356|NCT01350245|Hematopoietic stem cell transplant (HSCT)|hematopoietic stem cell transplant (hsct)
519357|NCT01350245|myeloablative haploidentical HSCT|myeloablative haploidentical hsct
519358|NCT01350245|graft versus host disease (GVHD)|graft versus host disease (gvhd)
519359|NCT01350232|sickle cell|sickle cell
519360|NCT01350232|SS disease|ss disease
519361|NCT01350232|SC disease|sc disease
519362|NCT01350232|S-thalassemia|s-thalassemia
519363|NCT01350232|transplant|transplant
519364|NCT01350232|bone marrow transplant|bone marrow transplant
519365|NCT01350232|stem cell transplant|stem cell transplant
519366|NCT01350232|matched sibling|matched sibling
519367|NCT01350232|haploidentical|haploidentical
519368|NCT01350232|hemoglobinopathy|hemoglobinopathy
519369|NCT01350232|anemia|anemia
519370|NCT01350232|desensitization|desensitization
519371|NCT01350219|Cord blood stem cells|cord blood stem cells
519372|NCT01350219|Immune modulation|immune modulation
519373|NCT01350219|Stem cell educator|stem cell educator
519374|NCT01350219|Autoimmunity|autoimmunity
519375|NCT01350219|Islet beta cell regeneration|islet beta cell regeneration
519376|NCT01350219|Type 1 diabetes|type 1 diabetes
519377|NCT01350206|Carcinoma,Hepatocellular|carcinoma,hepatocellular
519378|NCT01350206|Liver Neoplasms|liver neoplasms
519379|NCT01350206|Therapeutic|therapeutic
519380|NCT01350206|Chemoembolization,|chemoembolization,
519381|NCT01350206|TACE|tace
519382|NCT01350206|hepatic resection|hepatic resection
519383|NCT01350193|Manuka Honey|manuka honey
519384|NCT01350193|Irrigation|irrigation
519385|NCT01350193|Endoscopic Sinus Surgery|endoscopic sinus surgery
519386|NCT01350180|biochemical failure|biochemical failure
519387|NCT01350180|hormonal therapy|hormonal therapy
519388|NCT01350167|Hepatocellular Carcinoma|hepatocellular carcinoma
519389|NCT01350167|Liver Cancer|liver cancer
519390|NCT01350167|Ultrasound|ultrasound
519391|NCT01350167|Computed Tomography|computed tomography
519392|NCT01350167|Alpha fetoprotein|alpha fetoprotein
519393|NCT01350167|Cirrhosis|cirrhosis
519395|NCT01350167|Advanced Liver Disease|advanced liver disease
519396|NCT01350154|clinical trial|clinical trial
519397|NCT01350154|sildenafil|sildenafil
519398|NCT01350154|revatio|revatio
519399|NCT01350154|muscular dystrophy|muscular dystrophy
519400|NCT01350154|adult|adult
519401|NCT01350154|nNOS|nnos
519402|NCT01350141|Hypercholesterolemia|hypercholesterolemia
519403|NCT01350141|dyslipidemia|dyslipidemia
519404|NCT01350141|high cholesterol|high cholesterol
519405|NCT01350141|LDL|ldl
519406|NCT01350141|antibody|antibody
519407|NCT01350141|PCSK9|pcsk9
519408|NCT01350141|PF-04950615|pf-04950615
519409|NCT01350141|RN316|rn316
519410|NCT01350128|COPD|copd
519411|NCT01350115|Basal Cell Carcinoma|basal cell carcinoma
519412|NCT01350115|Gorlin Syndrome,|gorlin syndrome,
519413|NCT01350115|Gorlin-Goltz Syndrome,|gorlin-goltz syndrome,
519414|NCT01350115|Basal Cell Nevus Syndrome,|basal cell nevus syndrome,
519415|NCT01350115|Nevoid Basal Cell Carcinoma Syndrome,|nevoid basal cell carcinoma syndrome,
519416|NCT01350115|Basal Cell Carcinoma Nevus Syndrome|basal cell carcinoma nevus syndrome
519417|NCT01350115|Smo inhibitor,|smo inhibitor,
519418|NCT01350115|Hedgehog pathway inhibitor|hedgehog pathway inhibitor
519419|NCT01350115|BCCs|bccs
519420|NCT01350102|Adult|adult
519421|NCT01350089|energy drinks|energy drinks
519422|NCT01350089|alcohol intoxication|alcohol intoxication
519423|NCT01350076|intraoperative fluid|intraoperative fluid
519424|NCT01350076|pediatric|pediatric
519425|NCT01350076|goal directed therapy|goal directed therapy
519426|NCT01350076|pediatric with major abdominal surgery|pediatric with major abdominal surgery
519427|NCT01350076|ASA less than or equal to 3|asa less than or equal to 3
519428|NCT01350076|Duration of surgery less than 2 hours|duration of surgery less than 2 hours
519429|NCT01350076|Body weight more than or equal to 15 kg|body weight more than or equal to 15 kg
519430|NCT01350063|water|water
519431|NCT01350063|tubewell|tubewell
519432|NCT01350063|diarrhea|diarrhea
519433|NCT01350063|chlorination|chlorination
519434|NCT01350063|safe storage|safe storage
519435|NCT01350050|topical pharyngeal anesthesia|topical pharyngeal anesthesia
519436|NCT01350050|articaine|articaine
519437|NCT01350037|patient-controlled sedation|patient-controlled sedation
519438|NCT01350037|propofol|propofol
519439|NCT01350037|alfentanil|alfentanil
519440|NCT01350037|remifentanil|remifentanil
519441|NCT01350037|endoscopic retrograde cholangiopancreatography|endoscopic retrograde cholangiopancreatography
519442|NCT01350024|Conjunctival Mullerectomy|conjunctival mullerectomy
519443|NCT01350024|Blepharoptosis|blepharoptosis
519444|NCT01350024|Ptosis surgery|ptosis surgery
519445|NCT01350024|Pain Control|pain control
519446|NCT01350011|Nicotine Replacement Therapy|nicotine replacement therapy
519447|NCT01350011|Buprenorphine|buprenorphine
519448|NCT01350011|Varenicline|varenicline
519449|NCT01350011|Smoking Cessation|smoking cessation
519450|NCT01350011|Addiction|addiction
519451|NCT01350011|The Innovative System (IS) Treatment|the innovative system (is) treatment
519452|NCT01350011|The Standard Treatment Control (STC)|the standard treatment control (stc)
519453|NCT01349985|Naltrexone|naltrexone
519454|NCT01349985|problem drinking|problem drinking
519455|NCT01349985|medication adherence|medication adherence
519456|NCT01349985|adherence|adherence
519457|NCT01349985|smartphone|smartphone
519458|NCT01349920|biological markers|biological markers
519459|NCT01349920|endoscopy|endoscopy
519460|NCT01349920|gastrointestinal|gastrointestinal
519461|NCT01349881|Eflornithine/sulindac prevention trial|eflornithine/sulindac prevention trial
519462|NCT01349868|COPD|copd
519463|NCT01349829|Hepatitis A|hepatitis a
519464|NCT01349829|Vaccination|vaccination
519465|NCT01349829|Immunity|immunity
519466|NCT01349816|COPD|copd
519467|NCT01349803|COPD|copd
519468|NCT01349790|ITP|itp
519469|NCT01349790|Primary immune thrombocytopenia|primary immune thrombocytopenia
519470|NCT01349777|antiplatelet therapy post drug eluting stents|antiplatelet therapy post drug eluting stents
519471|NCT01349764|vitamin D replacement|vitamin d replacement
519472|NCT01349764|Urolithiasis|urolithiasis
519473|NCT01349764|deficiency|deficiency
519474|NCT01349764|insufficiency|insufficiency
519475|NCT01349751|abdominal incision|abdominal incision
519476|NCT01349751|hyperbaric|hyperbaric
519477|NCT01349751|isobaric|isobaric
519478|NCT01349751|levobupivacaine|levobupivacaine
519479|NCT01349751|spinal anaesthesia|spinal anaesthesia
519480|NCT01349725|Safety|safety
519481|NCT01349699|endotoxemia|endotoxemia
519482|NCT01349699|inflammation|inflammation
519483|NCT01349699|iron|iron
519484|NCT01349699|iron chelation|iron chelation
519485|NCT01349699|cytokines|cytokines
519486|NCT01349686|Food|food
519487|NCT01349686|Fluids|fluids
519488|NCT01349686|Labor|labor
519489|NCT01349673|Open-label|open-label
519490|NCT01349673|Proctitis|proctitis
519491|NCT01349673|Proctosigmoiditis|proctosigmoiditis
519492|NCT01349673|Ulcerative|ulcerative
519493|NCT01349673|Salix|salix
519494|NCT01349673|Budesonide foam|budesonide foam
519495|NCT01349673|Budesonide|budesonide
519496|NCT01349673|Rectal|rectal
519497|NCT01349673|Gastrointestinal|gastrointestinal
519499|NCT01349673|UC|uc
519500|NCT01349673|UP|up
519501|NCT01349673|UPS|ups
519502|NCT01349673|Additional relevant MeSH terms:|additional relevant mesh terms:
519503|NCT01349673|Proctocolitis|proctocolitis
519504|NCT01349673|Ulcer|ulcer
519505|NCT01349673|Colitis, Ulcerative|colitis, ulcerative
519506|NCT01349673|Gastroenteritis|gastroenteritis
519507|NCT01349673|Gastrointestinal Diseases|gastrointestinal diseases
519508|NCT01349673|Digestive System Diseases|digestive system diseases
519509|NCT01349673|Rectal Diseases|rectal diseases
519510|NCT01349673|Intestinal Diseases|intestinal diseases
519511|NCT01349673|Colonic Diseases|colonic diseases
519512|NCT01349673|Sigmoid Diseases|sigmoid diseases
519513|NCT01349673|Pathologic Processes|pathologic processes
519514|NCT01349673|Inflammatory Bowel Diseases|inflammatory bowel diseases
519515|NCT01349673|Bronchodilator Agents|bronchodilator agents
519516|NCT01349673|Autonomic Agents|autonomic agents
519517|NCT01349673|Peripheral Nervous System Agents|peripheral nervous system agents
519518|NCT01349673|Physiological Effects of Drugs|physiological effects of drugs
519519|NCT01349673|Pharmacologic Actions|pharmacologic actions
519520|NCT01349673|Anti-Asthmatic Agents|anti-asthmatic agents
519521|NCT01349673|Respiratory System Agents|respiratory system agents
519522|NCT01349673|Therapeutic Uses|therapeutic uses
519523|NCT01349673|Glucocorticoids|glucocorticoids
519524|NCT01349673|Hormones|hormones
519525|NCT01349673|Hormones, Hormone Substitutes and Hormone Antagonists|hormones, hormone substitutes and hormone antagonists
519526|NCT01349673|Anti-inflammatory Agents|anti-inflammatory agents
519527|NCT01349660|Glioblastoma multiforme|glioblastoma multiforme
519528|NCT01349660|GBM|gbm
519529|NCT01349660|Bevacizumab|bevacizumab
519530|NCT01349660|PI3K Pathway|pi3k pathway
519531|NCT01349660|BKM120|bkm120
519532|NCT01349647|FUCOSYL-GM1-KLH|fucosyl-gm1-klh
519533|NCT01349647|GLOBO H-KLH CONJUGATE|globo h-klh conjugate
519534|NCT01349647|OPT-821|opt-821
519535|NCT01349647|POLYSIALIC ACID - KLH|polysialic acid - klh
519536|NCT01349647|Vaccine|vaccine
519537|NCT01349647|08-095|08-095
519538|NCT01349634|iodine|iodine
519539|NCT01349634|goiter|goiter
519540|NCT01349634|cretinism|cretinism
519541|NCT01349634|child nutrition|child nutrition
519542|NCT01349634|cognition|cognition
519543|NCT01349621|Abnormal Pap results|abnormal pap results
519544|NCT01349621|Colposcopy|colposcopy
519545|NCT01349608|Chronic Obstructive Pulmonary Disease|chronic obstructive pulmonary disease
519546|NCT01349608|Motivational Interviewing|motivational interviewing
519547|NCT01349608|Health Coaching|health coaching
519548|NCT01349608|Physical Activity|physical activity
519549|NCT01349582|flow diversion|flow diversion
519550|NCT01349582|endovascular treatment|endovascular treatment
519551|NCT01349582|symptomatic aneurysm|symptomatic aneurysm
519552|NCT01349582|cavernous carotid aneurysm|cavernous carotid aneurysm
519553|NCT01349582|ophthalmic aneurysm|ophthalmic aneurysm
519554|NCT01349582|vertebral aneurysm|vertebral aneurysm
519555|NCT01349556|cancer|cancer
519556|NCT01349556|chemotherapy|chemotherapy
519557|NCT01349556|EGFR inhibitors|egfr inhibitors
519558|NCT01349556|tretinoin|tretinoin
519559|NCT01349556|EGFRi drug rash|egfri drug rash
519560|NCT01349543|Respiratory syncytial virus|respiratory syncytial virus
519562|NCT01349543|Immunology|immunology
519563|NCT01349543|Viral infection|viral infection
519564|NCT01349543|Bronchiolitis|bronchiolitis
519565|NCT01349543|Viral challenge|viral challenge
519566|NCT01349543|Viral lung disease|viral lung disease
519567|NCT01349530|Usual medical care|usual medical care
519568|NCT01349530|Anticoagulation by VKAs: COUMADINE® & PREVISCAN®|anticoagulation by vkas: coumadine® & previscan®
519569|NCT01349530|Anticoagulation clinic care, CREATIF|anticoagulation clinic care, creatif
519570|NCT01349517|health-related quality of life(HRQL)|health-related quality of life(hrql)
519571|NCT01349517|Esophageal Cancer|esophageal cancer
519572|NCT01349491|Atrial Fibrillation|atrial fibrillation
519573|NCT01349491|Ranolazine|ranolazine
519574|NCT01349478|paraplegia|paraplegia
519575|NCT01349478|tetraplegia|tetraplegia
519576|NCT01349478|passive gait training|passive gait training
519577|NCT01349478|O2 consumption|o2 consumption
519578|NCT01349478|exercise capacity|exercise capacity
519579|NCT01349478|CVD risk factors|cvd risk factors
519580|NCT01349478|spasticity|spasticity
519581|NCT01349478|pain|pain
660463|NCT00788099|Aplidin|aplidin
519582|NCT01349478|bladder, bowel|bladder, bowel
519583|NCT01349478|well being|well being
519584|NCT01349465|Hepatitis C|hepatitis c
519585|NCT01349465|Hepatitis|hepatitis
519586|NCT01349465|TMC435|tmc435
519587|NCT01349465|Liver disease|liver disease
519588|NCT01349465|Virus Infection|virus infection
519589|NCT01349452|Conjunctivitis, Viral|conjunctivitis, viral
519590|NCT01349452|Adenoviridae Infections|adenoviridae infections
519591|NCT01349452|Ganciclovir|ganciclovir
519592|NCT01349452|Adenovirus Keratoconjunctivitis|adenovirus keratoconjunctivitis
519593|NCT01349452|Treatment of viral conjunctivitis|treatment of viral conjunctivitis
519594|NCT01349426|Lung resection|lung resection
519595|NCT01349426|Parenchymal pneumostasis, haemostasis|parenchymal pneumostasis, haemostasis
519596|NCT01349426|Fissure closure|fissure closure
519597|NCT01349426|Automatic staplers,LigaSure, Force Triad Generator|automatic staplers,ligasure, force triad generator
519598|NCT01349426|Bipolar fusion|bipolar fusion
519599|NCT01349426|Procedure cost|procedure cost
519600|NCT01349413|Functional dyspepsia|functional dyspepsia
519601|NCT01349413|symptom response|symptom response
519602|NCT01349413|postprandial fullness|postprandial fullness
519603|NCT01349413|gastroesophageal reflux disease|gastroesophageal reflux disease
519604|NCT01349413|acid suppression|acid suppression
519605|NCT01349400|asymptomatic|asymptomatic
519606|NCT01349400|minimally symptomatic|minimally symptomatic
519607|NCT01349348|Tolvaptan treatment to ascites and hepatic cirrhosis|tolvaptan treatment to ascites and hepatic cirrhosis
519608|NCT01349322|stage IA breast cancer|stage ia breast cancer
519609|NCT01349322|stage IB breast cancer|stage ib breast cancer
519610|NCT01349322|stage II breast cancer|stage ii breast cancer
519611|NCT01349322|estrogen receptor-negative breast cancer|estrogen receptor-negative breast cancer
519612|NCT01349322|estrogen receptor-positive breast cancer|estrogen receptor-positive breast cancer
519613|NCT01349322|progesterone receptor-negative breast cancer|progesterone receptor-negative breast cancer
519614|NCT01349322|progesterone receptor-positive breast cancer|progesterone receptor-positive breast cancer
519615|NCT01349322|ductal breast carcinoma in situ|ductal breast carcinoma in situ
519616|NCT01349309|Prophylactic Swallowing Exercises|prophylactic swallowing exercises
519617|NCT01349309|Head and Neck Cancer|head and neck cancer
519618|NCT01349309|Dysphagia|dysphagia
519619|NCT01349296|Solid Tumors|solid tumors
519620|NCT01349283|Hepatitis B Vaccine|hepatitis b vaccine
519621|NCT01349283|Hepatitis B Virus|hepatitis b virus
519622|NCT01349283|Antigen|antigen
519623|NCT01349283|Antibody|antibody
519624|NCT01349283|Vaccination|vaccination
519625|NCT01349270|chronic inflammatory demyelinating polyneuropathy|chronic inflammatory demyelinating polyneuropathy
519626|NCT01349270|immunoglobulin|immunoglobulin
519627|NCT01349270|prednisone|prednisone
519628|NCT01349257|Asthmatic patients|asthmatic patients
519629|NCT01349244|hydronephrosis|hydronephrosis
519630|NCT01349244|CT|ct
519631|NCT01349244|POC US|poc us
519632|NCT01349231|obsessive-compulsive disorder|obsessive-compulsive disorder
519633|NCT01349231|ketamine|ketamine
519634|NCT01349231|glutamate|glutamate
519635|NCT01349218|Potassium|potassium
519636|NCT01349218|Infants|infants
519637|NCT01349218|Heel Stick|heel stick
519638|NCT01349218|Less than or equal to 6 months of age|less than or equal to 6 months of age
519639|NCT01349218|IV catheter blood samples|iv catheter blood samples
519640|NCT01349218|perioperatively|perioperatively
519641|NCT01349218|elective surgical procedures|elective surgical procedures
519642|NCT01349205|OSA|osa
519643|NCT01349205|Caffeine|caffeine
519644|NCT01349205|Tonsillectomy|tonsillectomy
519645|NCT01349205|Adenoidectomy|adenoidectomy
519646|NCT01349205|Sleep Study|sleep study
519647|NCT01349192|MRSA|mrsa
519648|NCT01349192|Cystic Fibrosis|cystic fibrosis
519649|NCT01349192|Early Infection|early infection
519650|NCT01349192|Treatment|treatment
519651|NCT01349179|Hip|hip
519652|NCT01349179|Arthroplasty|arthroplasty
519653|NCT01349179|Metal on metal|metal on metal
519654|NCT01349179|operated on 2002|operated on 2002
519655|NCT01349166|Obesity|obesity
519656|NCT01349166|Type 2 diabetes|type 2 diabetes
519657|NCT01349166|glucose intolerance|glucose intolerance
519658|NCT01349166|Physical Activity|physical activity
519659|NCT01349166|Inflammation|inflammation
519660|NCT01349166|HPA axis|hpa axis
519661|NCT01349166|Cytokines|cytokines
519662|NCT01349153|Physical Activity|physical activity
519663|NCT01349153|Young Adults|young adults
519664|NCT01349153|Cancer Survivors|cancer survivors
519665|NCT01349127|Vitamin D|vitamin d
519666|NCT01349127|Cholecalciferol|cholecalciferol
519667|NCT01349127|Nutrient requirements|nutrient requirements
519668|NCT01349127|Randomised Controlled Trial|randomised controlled trial
519669|NCT01349127|Lactation|lactation
519670|NCT01349127|pregnancy|pregnancy
519671|NCT01349127|Cord blood|cord blood
519672|NCT01349127|Human milk|human milk
519673|NCT01349127|serum 25-hydroxyvitamin D|serum 25-hydroxyvitamin d
519674|NCT01349127|deficiency|deficiency
519675|NCT01349127|insufficiency|insufficiency
519676|NCT01349127|nutrition|nutrition
519677|NCT01349114|aliskiren|aliskiren
519678|NCT01349114|endothelial function|endothelial function
519679|NCT01349114|hypertension|hypertension
519680|NCT01349101|hematopoietic stem cell transplantation|hematopoietic stem cell transplantation
519681|NCT01349101|HSCT|hsct
519682|NCT01349101|allogeneic marrow transplantation|allogeneic marrow transplantation
519683|NCT01349101|cyclophosphamide|cyclophosphamide
519684|NCT01349101|graft-versus-host disease|graft-versus-host disease
519685|NCT01349101|GVHD|gvhd
519686|NCT01349088|breast cancer|breast cancer
519687|NCT01349088|metastatic breast cancer|metastatic breast cancer
519688|NCT01349088|stage IV breast cancer|stage iv breast cancer
519689|NCT01349088|motesanib|motesanib
519690|NCT01349088|ixabepilone|ixabepilone
519691|NCT01349088|capecitabine|capecitabine
519692|NCT01349075|Unresectable|unresectable
519693|NCT01349075|Hepatocellular Carcinoma|hepatocellular carcinoma
519694|NCT01349075|TheraSphere|therasphere
519695|NCT01349075|Yttrium-90|yttrium-90
519696|NCT01349062|Prolonged Viral Suppression|prolonged viral suppression
519697|NCT01349062|HIV Infections|hiv infections
519698|NCT01349049|AML|aml
519699|NCT01349049|relapsed|relapsed
519700|NCT01349049|refractory|refractory
519701|NCT01349036|GBM|gbm
519702|NCT01349036|Glioblastoma|glioblastoma
519703|NCT01349036|brain cancer|brain cancer
519704|NCT01349023|energy content|energy content
519705|NCT01349023|energy density|energy density
519706|NCT01349023|energy intake|energy intake
519707|NCT01349023|pre-portioned entrees|pre-portioned entrees
519708|NCT01349010|hyperlipidemia|hyperlipidemia
519709|NCT01348997|cancer|cancer
519710|NCT01348997|cancer survivors|cancer survivors
519711|NCT01348997|internet|internet
519712|NCT01348997|depression|depression
519713|NCT01348997|anxiety|anxiety
519714|NCT01348984|postoperative|postoperative
519715|NCT01348984|pain score|pain score
519716|NCT01348984|morphine consumption|morphine consumption
519717|NCT01348971|sodium nitrate|sodium nitrate
519718|NCT01348971|coronary artery bypass surgery|coronary artery bypass surgery
519719|NCT01348971|ischemia-reperfusion|ischemia-reperfusion
519720|NCT01348971|myocardial injury|myocardial injury
519721|NCT01348958|Patello femoral|patello femoral
519722|NCT01348958|osteoarthritis|osteoarthritis
519723|NCT01348958|arthroplasty|arthroplasty
519724|NCT01348945|Partial tear ACL|partial tear acl
519725|NCT01348945|Stump preserved ACL surgery|stump preserved acl surgery
519726|NCT01348932|asthma|asthma
519727|NCT01348932|Chitinase 3-like 1 (CHI3L1)|chitinase 3-like 1 (chi3l1)
519728|NCT01348932|YKL-40|ykl-40
519729|NCT01348932|single nucleotide polymorphism(SNP)|single nucleotide polymorphism(snp)
519730|NCT01348932|Real time PCR|real time pcr
519731|NCT01348932|gene|gene
519732|NCT01348919|Cancer|cancer
519733|NCT01348919|Multiple myeloma|multiple myeloma
519734|NCT01348919|CEP-18770|cep-18770
519735|NCT01348919|Lenalidomide|lenalidomide
519736|NCT01348919|Dexamethasone|dexamethasone
519737|NCT01348906|cardiopulmonary bypass|cardiopulmonary bypass
519738|NCT01348893|Mental health|mental health
519739|NCT01348893|Education|education
519740|NCT01348893|Mind Body Therapies|mind body therapies
519741|NCT01348880|drug-drug interaction|drug-drug interaction
519742|NCT01348867|Diabetes|diabetes
519743|NCT01348867|Structured Care|structured care
519744|NCT01348854|astigmatism|astigmatism
519745|NCT01348841|community wound care|community wound care
519746|NCT01348841|systematic wound team referral|systematic wound team referral
519747|NCT01348841|Advanced in-home nurse wound training|advanced in-home nurse wound training
519748|NCT01348828|Abdominal Aortic Aneurysm|abdominal aortic aneurysm
519749|NCT01348828|Fenestrated|fenestrated
519750|NCT01348828|Renal Stent|renal stent
519751|NCT01348828|Juxtarenal|juxtarenal
519752|NCT01348828|Pararenal|pararenal
519753|NCT01348828|Endologix|endologix
519754|NCT01348828|Renal|renal
519755|NCT01348802|Knowledge Translation|knowledge translation
519756|NCT01348802|Push-out Evidence|push-out evidence
519757|NCT01348802|Technology-Based Knowledge Translation|technology-based knowledge translation
519758|NCT01348802|Pain|pain
519759|NCT01348802|Interdisciplinary|interdisciplinary
519760|NCT01348802|Physician|physician
519761|NCT01348802|Rehabilitation|rehabilitation
519762|NCT01348802|Nursing|nursing
519763|NCT01348802|Knowledge Uptake|knowledge uptake
519764|NCT01348789|Hair removal|hair removal
519765|NCT01348789|Hair Clearance|hair clearance
519766|NCT01348789|Epilation|epilation
519767|NCT01348776|hair reduction|hair reduction
519768|NCT01348776|hair removal|hair removal
519769|NCT01348776|hair clearance|hair clearance
519770|NCT01348763|HIV|hiv
519771|NCT01348750|PTSD|ptsd
519772|NCT01348750|Healing Touch|healing touch
519773|NCT01348750|Guided Imagery|guided imagery
519774|NCT01348750|Military|military
519775|NCT01348750|Complementary Medicine|complementary medicine
519776|NCT01348737|Phase 1|phase 1
519777|NCT01348737|healthy volunteers|healthy volunteers
519778|NCT01348737|double-blind|double-blind
519779|NCT01348737|placebo-controlled|placebo-controlled
519780|NCT01348737|AZD3839|azd3839
519781|NCT01348737|pharmacokinetics|pharmacokinetics
519782|NCT01348737|Alzheimer's Disease|alzheimer's disease
519783|NCT01348724|Radioactive carbon|radioactive carbon
519784|NCT01348724|Absorption|absorption
519785|NCT01348724|Distribution|distribution
519786|NCT01348724|Metabolism|metabolism
519787|NCT01348724|Excretion|excretion
519788|NCT01348724|Healthy Volunteers|healthy volunteers
519789|NCT01348711|Pre-eclampsia|pre-eclampsia
519790|NCT01348698|Adrenal Cancer|adrenal cancer
519791|NCT01348698|Pheochromocytoma|pheochromocytoma
519792|NCT01348698|Functioning Tumor|functioning tumor
519793|NCT01348698|Nonfunctioning Tumor|nonfunctioning tumor
519794|NCT01348698|Gene Expression|gene expression
519795|NCT01348698|Adrenal Tumor|adrenal tumor
519796|NCT01348672|Age related macular degeneration|age related macular degeneration
519797|NCT01348672|Glaucoma|glaucoma
519798|NCT01348672|Diabetic retinopathy|diabetic retinopathy
519799|NCT01348672|Retinal oxygen saturation|retinal oxygen saturation
519800|NCT01348672|Blood flow|blood flow
519801|NCT01348672|Vascular function|vascular function
519802|NCT01348672|High resolution imaging|high resolution imaging
519803|NCT01348659|Hypertonic saline|hypertonic saline
519804|NCT01348659|Extracellular fluid|extracellular fluid
519805|NCT01348659|cardiopulmonary bypass|cardiopulmonary bypass
519806|NCT01348646|Smoking|smoking
519807|NCT01348646|Adolescence|adolescence
519808|NCT01348646|Brief intervention|brief intervention
519809|NCT01348633|Doppler SD-OCT Blood Flow Technology|doppler sd-oct blood flow technology
519810|NCT01348633|Retinal and choroidal blood flow|retinal and choroidal blood flow
519811|NCT01348633|Canon Laser Blood Flowmeter|canon laser blood flowmeter
519812|NCT01348620|single port cholecystectomy|single port cholecystectomy
519813|NCT01348607|psychosocial effects of cancer and its treatment|psychosocial effects of cancer and its treatment
519814|NCT01348607|sleep disorders|sleep disorders
519815|NCT01348607|fatigue|fatigue
519816|NCT01348607|childhood craniopharyngioma|childhood craniopharyngioma
519817|NCT01348594|Vitamin D|vitamin d
519818|NCT01348594|In vitro Fertilization|in vitro fertilization
519819|NCT01348581|Adult|adult
519820|NCT01348581|Aged|aged
519821|NCT01348581|Aged, 80 and over|aged, 80 and over
519822|NCT01348581|Bandages|bandages
519823|NCT01348581|Biological Dressings|biological dressings
519824|NCT01348581|Chronic Disease|chronic disease
519825|NCT01348581|Collagen|collagen
519826|NCT01348581|Epithelium|epithelium
519827|NCT01348581|Extracellular Matrix|extracellular matrix
519828|NCT01348581|Fibroblasts|fibroblasts
519829|NCT01348581|Granulation Tissue|granulation tissue
519830|NCT01348581|Humans|humans
519831|NCT01348581|Leg Ulcer|leg ulcer
519832|NCT01348581|Middle Aged|middle aged
519833|NCT01348581|Prospective Studies|prospective studies
519834|NCT01348581|Soft Tissue Injuries|soft tissue injuries
519835|NCT01348581|Treatment Outcome|treatment outcome
519836|NCT01348581|Varicose Ulcer|varicose ulcer
519837|NCT01348581|Wound Healing|wound healing
519838|NCT01348581|Wounds and Injuries|wounds and injuries
519839|NCT01348555|COPD|copd
519840|NCT01348542|Chronic Insomnia|chronic insomnia
519841|NCT01348542|Short Sleep Duration|short sleep duration
519842|NCT01348542|Trazodone|trazodone
519843|NCT01348542|Cognitive Behavioral Therapy|cognitive behavioral therapy
519844|NCT01348542|Efficacy|efficacy
519845|NCT01348529|OCD|ocd
519846|NCT01348529|CBT|cbt
519847|NCT01348529|Reducing OCD symptoms|reducing ocd symptoms
519848|NCT01348516|HIV|hiv
519849|NCT01348490|PMF|pmf
519850|NCT01348490|PPV-MF|ppv-mf
519851|NCT01348490|PET-MF|pet-mf
519852|NCT01348477|inguinal|inguinal
519853|NCT01348477|hernia|hernia
519854|NCT01348477|pain|pain
519855|NCT01348477|inguinodynia|inguinodynia
519856|NCT01348477|mesh|mesh
519857|NCT01348464|appendectomy|appendectomy
519858|NCT01348464|appendicitis|appendicitis
519859|NCT01348464|laparoscopic surgery|laparoscopic surgery
519860|NCT01348451|Human spinal cord derived neural stem cell transplantation|human spinal cord derived neural stem cell transplantation
519861|NCT01348451|ALS|als
519862|NCT01348438|high risk|high risk
519863|NCT01348438|surgical valve replacement|surgical valve replacement
519864|NCT01348425|PAD|pad
519865|NCT01348412|non resectable metastases|non resectable metastases
519866|NCT01348412|liver of colic or rectal origin|liver of colic or rectal origin
519867|NCT01348412|after failure of the conventional treatments|after failure of the conventional treatments
519868|NCT01348399|Coronary artery disease requiring drug eluting stents|coronary artery disease requiring drug eluting stents
519869|NCT01348386|Potassium hydroxide.|potassium hydroxide.
519870|NCT01348386|Molluscum Contagiosum|molluscum contagiosum
519871|NCT01348373|drug eluting stents|drug eluting stents
519872|NCT01348334|Sling surgery|sling surgery
519873|NCT01348334|synthetic meshes|synthetic meshes
519874|NCT01348334|ultrapromesh®|ultrapromesh®
519875|NCT01348334|mix mesh|mix mesh
519876|NCT01348334|incontinence|incontinence
710255|NCT00589563|cutaneous B-cell non-Hodgkin lymphoma|cutaneous b-cell non-hodgkin lymphoma
710256|NCT00589563|recurrent adult Hodgkin lymphoma|recurrent adult hodgkin lymphoma
519877|NCT01348334|The Ultrapromesh® synthetic sling procedures have lower complications incidence and higher success rates than the other synthetic slings in 3-year follow-up.|the ultrapromesh® synthetic sling procedures have lower complications incidence and higher success rates than the other synthetic slings in 3-year follow-up.
519878|NCT01348308|Late diagnosed HIV-1 infected patients|late diagnosed hiv-1 infected patients
519879|NCT01348308|AIDS-defining events|aids-defining events
519880|NCT01348308|Immune restoration|immune restoration
519881|NCT01348295|Mechanical ventilation|mechanical ventilation
519882|NCT01348295|Children|children
519883|NCT01348295|Neonates|neonates
519884|NCT01348295|Pediatric intensive care|pediatric intensive care
519885|NCT01348282|Neurocognitive Impairment|neurocognitive impairment
519886|NCT01348282|Controlled Randomized Trial|controlled randomized trial
519887|NCT01348282|Coadjunctive Treatments|coadjunctive treatments
519888|NCT01348282|Lithium; Rivastigmine|lithium; rivastigmine
519889|NCT01348282|Antiretroviral Therapy|antiretroviral therapy
519890|NCT01348282|HIV Infection|hiv infection
519891|NCT01348269|bone marrow edema|bone marrow edema
519892|NCT01348269|Aclasta|aclasta
519893|NCT01348256|colorectal carcinoma|colorectal carcinoma
519894|NCT01348256|resectable hepatic metastasis|resectable hepatic metastasis
519895|NCT01348256|adjuvant treatment|adjuvant treatment
519896|NCT01348256|dendritic cells|dendritic cells
519897|NCT01348230|Premature prolonged rupture of membranes|premature prolonged rupture of membranes
519898|NCT01348230|Premature labor|premature labor
519899|NCT01348230|Uromodulin|uromodulin
519900|NCT01348230|Glycosylation|glycosylation
519901|NCT01348217|unoperated cancers|unoperated cancers
519902|NCT01348217|oesophagus|oesophagus
519903|NCT01348217|radiochemotherapy|radiochemotherapy
519904|NCT01348217|with and without increased doses|with and without increased doses
519905|NCT01348204|Cystic Fibrosis|cystic fibrosis
519906|NCT01348191|Thyrotrophin|thyrotrophin
519907|NCT01348191|Pregnancy|pregnancy
519908|NCT01348191|Human myometrium|human myometrium
519909|NCT01348191|Relaxation|relaxation
519910|NCT01348191|Contractility|contractility
519911|NCT01348152|Gastric Emptying|gastric emptying
519912|NCT01348139|Asthma|asthma
519913|NCT01348139|patients|patients
519914|NCT01348139|lung function|lung function
519915|NCT01348126|Advanced non-small cell lung cancer|advanced non-small cell lung cancer
519916|NCT01348126|NSCLC|nsclc
519917|NCT01348126|Lung cancer|lung cancer
519918|NCT01348113|Alcohol Use Disorders Identification Test|alcohol use disorders identification test
519919|NCT01348113|alcohol dependence|alcohol dependence
519920|NCT01348113|Alcohol problem|alcohol problem
519921|NCT01348100|Schizophrenia|schizophrenia
519922|NCT01348100|Iloperidone|iloperidone
519923|NCT01348100|Depot|depot
519924|NCT01348100|Injection|injection
519925|NCT01348087|Fragile X Syndrome|fragile x syndrome
519926|NCT01348087|Martin-Bell Syndrome|martin-bell syndrome
519927|NCT01348087|Genetic Diseases|genetic diseases
519928|NCT01348087|X-Linked|x-linked
519929|NCT01348087|Escalante's syndrome|escalante's syndrome
519930|NCT01348074|warfarin|warfarin
519931|NCT01348074|surgery|surgery
519932|NCT01348074|management|management
519933|NCT01348074|thromboembolism|thromboembolism
519934|NCT01348074|bleeding|bleeding
519935|NCT01348061|Alzheimers Disease|alzheimers disease
519936|NCT01348061|Progressive Supranuclear Palsy|progressive supranuclear palsy
519937|NCT01348061|CSF|csf
519938|NCT01348061|Cerebrospinal Fluid|cerebrospinal fluid
519939|NCT01348061|Biomarker|biomarker
519940|NCT01348061|Heavy Water|heavy water
519941|NCT01348061|Cargo proteins|cargo proteins
519942|NCT01348048|palliative care|palliative care
519943|NCT01348048|end-of-life care|end-of-life care
519944|NCT01348048|randomized clinical trial|randomized clinical trial
519945|NCT01348048|quality of life|quality of life
519946|NCT01348048|needs assessment|needs assessment
519947|NCT01348048|patient satisfaction|patient satisfaction
519948|NCT01348048|cost-effectiveness|cost-effectiveness
519949|NCT01348048|Screening|screening
519950|NCT01348035|Autosomal Dominant Polycystic Kidney Disease.|autosomal dominant polycystic kidney disease.
519951|NCT01348035|Arginine vasopressin|arginine vasopressin
519952|NCT01348035|Total Kidney Volume|total kidney volume
519953|NCT01348035|Glomerular Filtration Rate|glomerular filtration rate
519954|NCT01348009|Gastric cancer|gastric cancer
519955|NCT01348009|First-line therapy|first-line therapy
519956|NCT01348009|Tesetaxel|tesetaxel
519957|NCT01348009|Taxane|taxane
519958|NCT01348009|Capecitabine|capecitabine
519959|NCT01348009|Oral fluoropyrimidine|oral fluoropyrimidine
519960|NCT01348009|Cisplatin|cisplatin
519961|NCT01348009|Platinum|platinum
519962|NCT01347996|AML|aml
519963|NCT01347996|Leukemia|leukemia
519964|NCT01347996|Acute Myeloid Leukemia|acute myeloid leukemia
519965|NCT01347996|Minimal Residual Disease|minimal residual disease
519966|NCT01347996|Ceplene|ceplene
519967|NCT01347996|Histamine|histamine
519968|NCT01347996|interleukin 2|interleukin 2
519969|NCT01347983|RA|ra
519970|NCT01347970|childhood cancer survivor|childhood cancer survivor
519971|NCT01347970|CHF|chf
660900|NCT00786773|PPI|ppi
519972|NCT01347970|risk of congestive heart failure|risk of congestive heart failure
519973|NCT01347944|MORE|more
519974|NCT01347944|Monitoring Revlimid|monitoring revlimid
519975|NCT01347944|Myelodysplastic Syndrome|myelodysplastic syndrome
519976|NCT01347944|Transfusion-dependent anemia|transfusion-dependent anemia
519977|NCT01347944|5q deletion|5q deletion
519978|NCT01347944|lenalidomide|lenalidomide
519979|NCT01347918|Fluorine MRI, small intestinal transit and motor activity|fluorine mri, small intestinal transit and motor activity
519980|NCT01347892|Talar injury|talar injury
519981|NCT01347892|ankle|ankle
519982|NCT01347892|lesion|lesion
519983|NCT01347892|defect|defect
519984|NCT01347892|cartilage repair|cartilage repair
519985|NCT01347879|Acne vulgaris|acne vulgaris
519986|NCT01347879|PDT|pdt
519987|NCT01347866|Advanced metastatic cancer (solid tumors)|advanced metastatic cancer (solid tumors)
519988|NCT01347866|PI3K|pi3k
519989|NCT01347866|mTOR|mtor
519990|NCT01347866|MEK|mek
519991|NCT01347840|Obesity Gastric Bypass Roux en Y|obesity gastric bypass roux en y
519992|NCT01347827|Coronary artery bypass surgery|coronary artery bypass surgery
519993|NCT01347827|Oximetry|oximetry
519994|NCT01347827|Brain metabolism|brain metabolism
519995|NCT01347814|Domperidone|domperidone
519996|NCT01347814|gastric emptying|gastric emptying
519997|NCT01347814|obesity|obesity
519998|NCT01347814|diabetes mellitus|diabetes mellitus
519999|NCT01347814|Domperidone/pharmacology|domperidone/pharmacology
520000|NCT01347814|Pharmacologic Actions|pharmacologic actions
520001|NCT01347814|Physiological Effects of Drugs|physiological effects of drugs
520002|NCT01347814|Gastrointestinal Agents|gastrointestinal agents
520003|NCT01347814|Humans|humans
520004|NCT01347801|GLP-1|glp-1
520005|NCT01347801|Inflammation|inflammation
520006|NCT01347801|Glucose|glucose
520007|NCT01347788|Prostate cancer|prostate cancer
520008|NCT01347788|Castration Resistant|castration resistant
520009|NCT01347788|Bone Metastases|bone metastases
520010|NCT01347775|Renal failure|renal failure
520011|NCT01347775|Respiratory muscles|respiratory muscles
520012|NCT01347775|Resistance training|resistance training
520013|NCT01347762|cannabis dependence|cannabis dependence
520014|NCT01347762|marijuana dependence|marijuana dependence
520015|NCT01347762|cannabis use disorders|cannabis use disorders
520016|NCT01347762|cannabis withdrawal|cannabis withdrawal
520017|NCT01347762|nabilone|nabilone
520018|NCT01347749|Meditation|meditation
520019|NCT01347749|Mindfulness|mindfulness
520020|NCT01347749|Compassion|compassion
520021|NCT01347749|Group Psychotherapy|group psychotherapy
520022|NCT01347749|Emotional Regulation|emotional regulation
520023|NCT01347749|fMRI|fmri
520024|NCT01347710|Coronary Artery Disease.|coronary artery disease.
520025|NCT01347710|Positron Emission Tomography Myocardial Perfusion Imaging.|positron emission tomography myocardial perfusion imaging.
520026|NCT01347710|Single Positron Emission Computed Tomography.|single positron emission computed tomography.
520027|NCT01347710|Flurpiridaz F18 Injection.|flurpiridaz f18 injection.
520028|NCT01347697|rectal neoplasms|rectal neoplasms
520029|NCT01347697|reconstructive surgical procedure|reconstructive surgical procedure
520030|NCT01347697|bioprosthesis|bioprosthesis
520031|NCT01347697|surgical flaps|surgical flaps
520032|NCT01347697|locomotion|locomotion
520033|NCT01347697|lesser pelvis|lesser pelvis
520034|NCT01347684|headache|headache
520035|NCT01347684|elavil|elavil
520036|NCT01347684|splints|splints
520037|NCT01347684|physical therapy|physical therapy
520038|NCT01347684|behavioral therapy|behavioral therapy
520039|NCT01347671|analgesia|analgesia
520040|NCT01347671|analgesics|analgesics
520041|NCT01347671|pain|pain
520042|NCT01347671|chronic pain|chronic pain
520043|NCT01347671|neuropathic pain|neuropathic pain
520044|NCT01347658|etravirine|etravirine
520045|NCT01347658|Echinacea purpurea|echinacea purpurea
520046|NCT01347658|interaction|interaction
520047|NCT01347645|locally advanced|locally advanced
520048|NCT01347645|metastatic colon|metastatic colon
520049|NCT01347645|rectal cancer|rectal cancer
520050|NCT01347632|Bacterial Vaginosis|bacterial vaginosis
520051|NCT01347632|Vaginal discharge|vaginal discharge
520052|NCT01347632|Vaginal infections|vaginal infections
520053|NCT01347619|Comparative Effectiveness Research Summary Guide (CERSG)|comparative effectiveness research summary guide (cersg)
520054|NCT01347619|anti-psychotic use|anti-psychotic use
520055|NCT01347619|Nursing Home|nursing home
520056|NCT01347619|Long-term care|long-term care
520310|NCT01346748|vasospasm prevention|vasospasm prevention
520057|NCT01347619|Qualitative assessment of influences on CERSG adoption in NH|qualitative assessment of influences on cersg adoption in nh
520058|NCT01347619|Development of toolkit of CERSG-based products for NHs|development of toolkit of cersg-based products for nhs
520059|NCT01347619|Evaluation of 3 implementation strategies of the toolkit|evaluation of 3 implementation strategies of the toolkit
520060|NCT01347606|thyroid|thyroid
520061|NCT01347606|secure|secure
520062|NCT01347606|surgery|surgery
520063|NCT01347606|methylene|methylene
520064|NCT01347606|blue|blue
520065|NCT01347593|ceftizoxime|ceftizoxime
520066|NCT01347593|Cesarean|cesarean
520067|NCT01347593|post caesarean febrile morbidity|post caesarean febrile morbidity
520068|NCT01347580|Heart attack|heart attack
520069|NCT01347580|heart disease|heart disease
520070|NCT01347580|cardiovascular disease|cardiovascular disease
520071|NCT01347580|stroke|stroke
520072|NCT01347580|reperfusion|reperfusion
520073|NCT01347580|pre hospital settings|pre hospital settings
520074|NCT01347580|ticagrelor|ticagrelor
520075|NCT01347580|Percutaneous Coronary Intervention|percutaneous coronary intervention
520076|NCT01347567|Fingerstick BNP test|fingerstick bnp test
520077|NCT01347567|Home Health Management System|home health management system
520078|NCT01347567|Acute Decompensated Heart Failure|acute decompensated heart failure
520079|NCT01347567|Hospital Readmission|hospital readmission
520080|NCT01347567|Prevention|prevention
520081|NCT01347554|drug-eluting stent|drug-eluting stent
520082|NCT01347554|everolimus|everolimus
520083|NCT01347554|zotarolimus|zotarolimus
520084|NCT01347554|myocardial ischemia|myocardial ischemia
520085|NCT01347554|cardiovascular diseases|cardiovascular diseases
520086|NCT01347554|MACE|mace
520087|NCT01347554|safety|safety
520088|NCT01347541|PTSD|ptsd
520089|NCT01347528|Medication adherence|medication adherence
520090|NCT01347528|Heart failure|heart failure
520091|NCT01347528|Telemonitoring|telemonitoring
520092|NCT01347528|Determinants of adherence|determinants of adherence
520093|NCT01347515|Phenol-enriched olive oil|phenol-enriched olive oil
520094|NCT01347515|bioavailability|bioavailability
520095|NCT01347515|bioactivity|bioactivity
520096|NCT01347489|gender|gender
520097|NCT01347476|prostate-specific antigen|prostate-specific antigen
520098|NCT01347476|radical prostatectomy|radical prostatectomy
520099|NCT01347450|Flavonoids|flavonoids
520100|NCT01347450|cacao|cacao
520101|NCT01347450|lipid peroxidation|lipid peroxidation
520102|NCT01347450|plasma|plasma
520103|NCT01347437|HIV|hiv
520104|NCT01347437|antiretroviral medication|antiretroviral medication
520105|NCT01347437|adherence|adherence
520106|NCT01347437|adolescent|adolescent
520107|NCT01347424|NSCLC|nsclc
520108|NCT01347424|NPC|npc
520109|NCT01347398|Sleep apnoea|sleep apnoea
520110|NCT01347398|Diagnosis|diagnosis
520111|NCT01347398|Blood pressure|blood pressure
520112|NCT01347398|Body mass index|body mass index
520113|NCT01347398|Breath analysis|breath analysis
520114|NCT01347385|Fibroids|fibroids
520115|NCT01347385|Laparoscopic myomectomy|laparoscopic myomectomy
520116|NCT01347385|Barbed suture|barbed suture
520117|NCT01347372|peer support|peer support
520118|NCT01347372|peer mentoring|peer mentoring
520119|NCT01347372|peer counselling|peer counselling
520120|NCT01347372|arthritis|arthritis
520121|NCT01347372|chronic disease|chronic disease
520122|NCT01347372|inflammatory arthritis|inflammatory arthritis
520123|NCT01347372|early inflammatory arthritis|early inflammatory arthritis
520124|NCT01347372|rheumatoid arthritis|rheumatoid arthritis
520125|NCT01347359|Peer support|peer support
520126|NCT01347359|Peer mentoring|peer mentoring
520127|NCT01347359|Peer counselling|peer counselling
520128|NCT01347359|Arthritis|arthritis
520129|NCT01347359|Inflammatory arthritis|inflammatory arthritis
520130|NCT01347359|Early inflammatory arthritis|early inflammatory arthritis
520131|NCT01347359|Rheumatoid arthritis|rheumatoid arthritis
520132|NCT01347359|Chronic disease|chronic disease
520133|NCT01347346|Wiskott-Aldrich Syndrome|wiskott-aldrich syndrome
520134|NCT01347346|Primary immune deficiency|primary immune deficiency
520135|NCT01347346|ex vivo gene therapy|ex vivo gene therapy
520136|NCT01347346|hematopoietic stem cells|hematopoietic stem cells
520137|NCT01347333|liver metastases|liver metastases
520138|NCT01347333|stereotactic radiotherapy|stereotactic radiotherapy
520139|NCT01347320|Prostate cancer|prostate cancer
520140|NCT01347320|preoperative staging|preoperative staging
520141|NCT01347320|MRI|mri
520142|NCT01347320|Free surgical margins|free surgical margins
520143|NCT01347307|stereotactic radiotherapy|stereotactic radiotherapy
520144|NCT01347307|spinal metastases|spinal metastases
520145|NCT01347307|vertebral metastases|vertebral metastases
520146|NCT01347307|benign spinal tumors|benign spinal tumors
520147|NCT01347281|Cancer of the Head and Neck|cancer of the head and neck
520148|NCT01347281|[18F]HX4|[18f]hx4
520149|NCT01347281|hypoxia|hypoxia
520150|NCT01347281|PET|pet
520151|NCT01347281|phase II trial|phase ii trial
520152|NCT01347268|coasting|coasting
520153|NCT01347268|withdrawing GnRH agonist|withdrawing gnrh agonist
520154|NCT01347268|GnRH antagonist|gnrh antagonist
520155|NCT01347268|IVF|ivf
520156|NCT01347242|Wiskott-Aldrich Syndrome|wiskott-aldrich syndrome
520157|NCT01347242|Primary immune deficiency|primary immune deficiency
520158|NCT01347242|ex vivo gene therapy|ex vivo gene therapy
520159|NCT01347242|hematopoietic stem cells|hematopoietic stem cells
520160|NCT01347229|Glaucoma|glaucoma
520161|NCT01347229|Triggerfish|triggerfish
520162|NCT01347229|body position|body position
520163|NCT01347216|Drug treatment|drug treatment
661117|NCT00786019|Women|women
520164|NCT01347216|Treatment pathways|treatment pathways
520165|NCT01347216|Clinical routine|clinical routine
520166|NCT01347216|Registry|registry
520167|NCT01347216|Treatment outcomes|treatment outcomes
520168|NCT01347216|Endothelin receptor antagonist|endothelin receptor antagonist
520169|NCT01347216|Phosphodiesterase-V inhibitor|phosphodiesterase-v inhibitor
520170|NCT01347216|Prostanoid|prostanoid
520171|NCT01347216|Sildenafil|sildenafil
520172|NCT01347216|Bosentan|bosentan
520173|NCT01347216|Macitentan|macitentan
520174|NCT01347216|Sitaxentan|sitaxentan
520175|NCT01347216|Ambrisentan|ambrisentan
520176|NCT01347216|Imatinib|imatinib
520177|NCT01347216|Epoprostenol|epoprostenol
520178|NCT01347216|Treprostinil|treprostinil
520179|NCT01347216|Iloprost|iloprost
520180|NCT01347216|Infusion pump|infusion pump
520181|NCT01347216|Riociguat|riociguat
520552|NCT01345721|Boost|boost
520182|NCT01347216|soluble guanylate cyclase stimulator|soluble guanylate cyclase stimulator
520183|NCT01347216|Quality of life|quality of life
520184|NCT01347216|Patient-related outcomes|patient-related outcomes
520185|NCT01347216|Economic model|economic model
520186|NCT01347216|Adverse event|adverse event
520188|NCT01347216|Combination therapy|combination therapy
520189|NCT01347216|Internet|internet
520190|NCT01347216|Europe|europe
520191|NCT01347216|Australia|australia
520192|NCT01347216|Japan|japan
520193|NCT01347216|Eisenmenger|eisenmenger
520194|NCT01347216|Adults|adults
520195|NCT01347216|Children|children
520196|NCT01347216|Selexipag|selexipag
520197|NCT01347216|Baltic states|baltic states
520198|NCT01347203|phase I|phase i
520199|NCT01347203|healthy volunteers|healthy volunteers
520200|NCT01347203|crossover study|crossover study
520201|NCT01347203|pharmacokinetics|pharmacokinetics
520202|NCT01347203|pharmacodynamics|pharmacodynamics
520203|NCT01347190|Cystic Fibrosis|cystic fibrosis
520204|NCT01347164|bisexual|bisexual
520205|NCT01347164|HIV prevention|hiv prevention
520206|NCT01347151|Glide scope|glide scope
520207|NCT01347151|Pentax|pentax
520208|NCT01347151|C spine movement|c spine movement
520209|NCT01347138|Screening|screening
520210|NCT01347138|depression|depression
520211|NCT01347138|case management|case management
520212|NCT01347125|DHF (diastolic heart failure)|dhf (diastolic heart failure)
520213|NCT01347125|HFNEF (heart failure with normal ejection fraction|hfnef (heart failure with normal ejection fraction
520214|NCT01347112|smoking|smoking
520215|NCT01347112|tobacco dependence|tobacco dependence
520216|NCT01347112|alcohol dependence|alcohol dependence
520217|NCT01347099|CBT|cbt
520218|NCT01347099|OCD|ocd
520219|NCT01347099|Internet|internet
520220|NCT01347099|Reduce symptom burden|reduce symptom burden
520221|NCT01347073|Urea Cycle Disorder|urea cycle disorder
520222|NCT01347073|UCD|ucd
520223|NCT01347073|GT4P|gt4p
520224|NCT01347073|Buphenyl|buphenyl
520225|NCT01347073|hyperammonemia|hyperammonemia
520226|NCT01347073|sodium phenylbutyrate|sodium phenylbutyrate
520227|NCT01347060|Asthma|asthma
520228|NCT01347060|treatment|treatment
520229|NCT01347060|Advair and inhaled corticosteroids|advair and inhaled corticosteroids
520230|NCT01347060|Medicare|medicare
520231|NCT01347060|Outcomes|outcomes
520232|NCT01347060|costs|costs
520233|NCT01347047|Amyloidosis|amyloidosis
520234|NCT01347047|Known or Suspected|known or suspected
520235|NCT01347034|radiation|radiation
520236|NCT01347034|neoadjuvant|neoadjuvant
520237|NCT01347034|intratumoral|intratumoral
520238|NCT01347034|autologous|autologous
520239|NCT01347034|dendritic cells|dendritic cells
520240|NCT01347021|vaginal colpopexy sacrospinous|vaginal colpopexy sacrospinous
520241|NCT01347021|vaginal colpopexy uterosacral|vaginal colpopexy uterosacral
520242|NCT01347008|Sildenafil|sildenafil
520243|NCT01347008|Endothelial Progenitor Cells|endothelial progenitor cells
520244|NCT01347008|Laser Doppler Imaging|laser doppler imaging
520245|NCT01346982|Darunavir|darunavir
520246|NCT01346982|Silimarine|silimarine
520247|NCT01346982|interaction|interaction
520248|NCT01346969|Skin scarring|skin scarring
520249|NCT01346969|cicatrix|cicatrix
520250|NCT01346969|breast scar|breast scar
520251|NCT01346956|Cigarette|cigarette
520252|NCT01346956|Smoking|smoking
520253|NCT01346956|Cardiovascular Effects|cardiovascular effects
520254|NCT01346956|2D Echocardiography|2d echocardiography
520255|NCT01346956|Doppler|doppler
520256|NCT01346943|Abdominal Aortic Aneurysms, AAA|abdominal aortic aneurysms, aaa
520257|NCT01346930|Idiopathic pulmonary fibrosis|idiopathic pulmonary fibrosis
520258|NCT01346930|IPF|ipf
520259|NCT01346930|pulmonary fibrosis|pulmonary fibrosis
520260|NCT01346917|Colorectal cancer|colorectal cancer
520261|NCT01346917|Laparoscopic surgery|laparoscopic surgery
520262|NCT01346917|Postoperative ileus|postoperative ileus
520263|NCT01346917|Lidocaine|lidocaine
520264|NCT01346917|Early oral feeding|early oral feeding
520265|NCT01346878|Ultra deep sequencing|ultra deep sequencing
520266|NCT01346878|Virological failure|virological failure
520267|NCT01346878|Salvage antiretroviral therapy|salvage antiretroviral therapy
520268|NCT01346865|triple anti-platelet therapy|triple anti-platelet therapy
520269|NCT01346865|dual antiplatelet therapy|dual antiplatelet therapy
520270|NCT01346865|DES|des
520271|NCT01346865|Coronary Artery Disease|coronary artery disease
520272|NCT01346852|pediatrics|pediatrics
520273|NCT01346852|Medicaid|medicaid
520274|NCT01346852|asthma|asthma
520275|NCT01346852|outcomes|outcomes
520276|NCT01346852|asthma medication ratio|asthma medication ratio
520277|NCT01346839|Diagnostic delay|diagnostic delay
520278|NCT01346839|Prevention|prevention
520279|NCT01346839|Diagnostic errors|diagnostic errors
520280|NCT01346826|Crohn's disease|crohn's disease
520281|NCT01346826|Ulcerative colitis|ulcerative colitis
520282|NCT01346826|Infliximab|infliximab
520283|NCT01346826|Infusion reaction|infusion reaction
520284|NCT01346813|Newborns|newborns
520285|NCT01346813|Premature|premature
520286|NCT01346813|Pain|pain
520287|NCT01346813|Pain assessment|pain assessment
520288|NCT01346813|Painful Procedures|painful procedures
520289|NCT01346813|Stressful Procedures|stressful procedures
520290|NCT01346813|Endotracheal Intubation|endotracheal intubation
520291|NCT01346813|Analgesia|analgesia
520292|NCT01346813|Sedation|sedation
520293|NCT01346813|Longterm effects of pain|longterm effects of pain
520294|NCT01346813|Epidemiology|epidemiology
520295|NCT01346787|carfilzomib|carfilzomib
520296|NCT01346787|dexamethasone|dexamethasone
520297|NCT01346787|cyclophosphamide|cyclophosphamide
520298|NCT01346787|multiple myeloma|multiple myeloma
520299|NCT01346787|newly diagnosed|newly diagnosed
520300|NCT01346774|cystitis|cystitis
520301|NCT01346774|pyelonephritis|pyelonephritis
520302|NCT01346774|bladder infection|bladder infection
520303|NCT01346774|kidney infection|kidney infection
520304|NCT01346761|Genetic Counseling|genetic counseling
520305|NCT01346761|Genetic Counseling Interventions|genetic counseling interventions
520306|NCT01346761|Genetic Testing|genetic testing
520307|NCT01346761|BRCA1 gene|brca1 gene
520308|NCT01346761|BRCA2 gene|brca2 gene
520309|NCT01346761|Risk Communication|risk communication
520311|NCT01346735|Ventilator associated pneumonia|ventilator associated pneumonia
520312|NCT01346735|Catheter related blood stream infection|catheter related blood stream infection
520313|NCT01346735|Catheter associated urinary tract infection|catheter associated urinary tract infection
520314|NCT01346735|ICU-related infections (VAP, CAUTI and CRBSI)|icu-related infections (vap, cauti and crbsi)
520315|NCT01346735|India|india
520316|NCT01346709|Operative surgical procedures|operative surgical procedures
520317|NCT01346709|Postoperative pulmonary complications (PPC)|postoperative pulmonary complications (ppc)
520318|NCT01346709|Epidemiological Study|epidemiological study
520319|NCT01346709|ARISCAT score|ariscat score
520320|NCT01346709|Risk Score|risk score
520321|NCT01346709|Europe|europe
520322|NCT01346709|PERISCOPE|periscope
520323|NCT01346709|observational study|observational study
520324|NCT01346709|Mild respiratory failure|mild respiratory failure
520325|NCT01346709|Severe respiratory failure|severe respiratory failure
520326|NCT01346709|acute lung injury (ALI)|acute lung injury (ali)
520327|NCT01346709|Acute respiratory distress syndrome (ARDS)|acute respiratory distress syndrome (ards)
520328|NCT01346709|Suspected pulmonary infection|suspected pulmonary infection
520329|NCT01346709|Pulmonary infiltrate|pulmonary infiltrate
520330|NCT01346709|Pleural effusion|pleural effusion
520331|NCT01346709|Atelectasis|atelectasis
520332|NCT01346709|Pneumothorax|pneumothorax
520333|NCT01346709|Bronchospasm|bronchospasm
520334|NCT01346709|Aspiration Pneumonitis|aspiration pneumonitis
520335|NCT01346709|Cardiopulmonary edema|cardiopulmonary edema
520336|NCT01346709|Prospective Evaluation|prospective evaluation
520337|NCT01346709|nonobstetric in-hospital surgical procedure|nonobstetric in-hospital surgical procedure
520338|NCT01346709|general or regional anaesthesia|general or regional anaesthesia
520339|NCT01346709|continued 7-day period recruitment|continued 7-day period recruitment
520340|NCT01346670|Red yeast rice|red yeast rice
520341|NCT01346670|Lovastatin|lovastatin
520342|NCT01346670|Bioavailability|bioavailability
520343|NCT01346657|Nifidipine|nifidipine
520344|NCT01346657|red yeast rice|red yeast rice
520345|NCT01346657|drug-drug interaction|drug-drug interaction
520346|NCT01346644|Probiotic|probiotic
520347|NCT01346644|infant nutrition|infant nutrition
520348|NCT01346644|safety|safety
520349|NCT01346644|infections|infections
520350|NCT01346618|bone age|bone age
520351|NCT01346618|children|children
520352|NCT01346618|x-ray|x-ray
520353|NCT01346618|ultrasound|ultrasound
520354|NCT01346618|ultrasound based method|ultrasound based method
520355|NCT01346618|safe|safe
520356|NCT01346618|valid|valid
520357|NCT01346618|reproducable|reproducable
520358|NCT01346605|Cardiac CT, heart disease|cardiac ct, heart disease
520359|NCT01346592|Adjuvanted Trivalent Subunit Influenza Vaccine|adjuvanted trivalent subunit influenza vaccine
520360|NCT01346592|vaccine|vaccine
520361|NCT01346592|influenza|influenza
520362|NCT01346592|adjuvant|adjuvant
520363|NCT01346592|MF-59|mf-59
520364|NCT01346592|pediatric|pediatric
520365|NCT01346579|stage IA breast cancer|stage ia breast cancer
520366|NCT01346579|stage IB breast cancer|stage ib breast cancer
520367|NCT01346579|estrogen receptor-positive breast cancer|estrogen receptor-positive breast cancer
520368|NCT01346566|Cionni Ring|cionni ring
520369|NCT01346566|In-the-bag IOL|in-the-bag iol
520370|NCT01346566|Subluxated lenses|subluxated lenses
520371|NCT01346566|Intraoperative Performance|intraoperative performance
520372|NCT01346566|Postoperative Outcome|postoperative outcome
520373|NCT01346553|Chronic Venous Insufficiency (CVI)|chronic venous insufficiency (cvi)
520374|NCT01346527|diabetes|diabetes
520375|NCT01346527|pregnancy|pregnancy
520376|NCT01346527|left ventricular dysfunction|left ventricular dysfunction
520377|NCT01346527|neonatal|neonatal
520378|NCT01346527|lipid|lipid
520379|NCT01346527|lipotoxicity|lipotoxicity
520380|NCT01346527|neurodevelopment|neurodevelopment
520381|NCT01346514|Homeless Persons|homeless persons
520382|NCT01346514|Housing|housing
520383|NCT01346514|Case Management|case management
520384|NCT01346514|Veterans|veterans
520385|NCT01346514|Substance Related Disorders|substance related disorders
520386|NCT01346514|Mental Disorders|mental disorders
520387|NCT01346514|Social Adjustment|social adjustment
520388|NCT01346501|Rheumatoid arthritis|rheumatoid arthritis
520389|NCT01346488|Rheumatoid arthritis|rheumatoid arthritis
520390|NCT01346449|Obesity|obesity
520391|NCT01346423|Sick leave|sick leave
520392|NCT01346423|musculoskeletal pain|musculoskeletal pain
520393|NCT01346423|return to work|return to work
520394|NCT01346423|multidisciplinary intervention|multidisciplinary intervention
520395|NCT01346423|randomised controlled trial|randomised controlled trial
520396|NCT01346410|pancreatic cancer|pancreatic cancer
520397|NCT01346397|rejection|rejection
520398|NCT01346397|survival|survival
520399|NCT01346397|alemtuzumab|alemtuzumab
520400|NCT01346397|cyclosporine|cyclosporine
520401|NCT01346397|tacrolimus|tacrolimus
520402|NCT01346384|intracuff pressure|intracuff pressure
520403|NCT01346384|laryngeal tube|laryngeal tube
520404|NCT01346384|nitrous oxide|nitrous oxide
520405|NCT01346371|Allergic|allergic
520406|NCT01346371|conjunctivitis|conjunctivitis
520407|NCT01346371|Allergic conjunctivitis|allergic conjunctivitis
520408|NCT01346358|Advanced Solid Tumors|advanced solid tumors
520409|NCT01346345|Recession|recession
520410|NCT01346319|dose escalating|dose escalating
520411|NCT01346293|Tetanus|tetanus
520412|NCT01346293|Diphtheria|diphtheria
520413|NCT01346293|Pertussis|pertussis
520414|NCT01346293|DTap-IPV|dtap-ipv
520415|NCT01346293|DAPTACEL®|daptacel®
520416|NCT01346293|VARIVAX®|varivax®
520417|NCT01346280|Adherence to Evidence-Based Guidelines|adherence to evidence-based guidelines
520418|NCT01346280|Multidisciplinary Care|multidisciplinary care
520419|NCT01346280|Patient Experiences|patient experiences
520420|NCT01346280|Quality of Care Outcomes|quality of care outcomes
520421|NCT01346267|nausea and vomiting|nausea and vomiting
520422|NCT01346267|unspecified childhood solid tumor|unspecified childhood solid tumor
520423|NCT01346267|childhood central nervous system embryonal tumor|childhood central nervous system embryonal tumor
520424|NCT01346267|childhood central nervous system germ cell tumor|childhood central nervous system germ cell tumor
520425|NCT01346267|childhood central nervous system germinoma|childhood central nervous system germinoma
520426|NCT01346267|childhood central nervous system mixed germ cell tumor|childhood central nervous system mixed germ cell tumor
520427|NCT01346267|childhood central nervous system teratoma|childhood central nervous system teratoma
520428|NCT01346267|childhood central nervous system yolk sac tumor|childhood central nervous system yolk sac tumor
520429|NCT01346267|childhood mixed glioma|childhood mixed glioma
520430|NCT01346267|childhood oligodendroglioma|childhood oligodendroglioma
520431|NCT01346267|untreated childhood brain stem glioma|untreated childhood brain stem glioma
520432|NCT01346267|untreated childhood visual pathway and hypothalamic glioma|untreated childhood visual pathway and hypothalamic glioma
520433|NCT01346267|untreated childhood visual pathway glioma|untreated childhood visual pathway glioma
520434|NCT01346267|childhood high-grade cerebellar astrocytoma|childhood high-grade cerebellar astrocytoma
520435|NCT01346267|childhood high-grade cerebral astrocytoma|childhood high-grade cerebral astrocytoma
520436|NCT01346267|childhood low-grade cerebellar astrocytoma|childhood low-grade cerebellar astrocytoma
520437|NCT01346267|childhood low-grade cerebral astrocytoma|childhood low-grade cerebral astrocytoma
520438|NCT01346267|untreated childhood cerebellar astrocytoma|untreated childhood cerebellar astrocytoma
520439|NCT01346267|untreated childhood cerebral astrocytoma|untreated childhood cerebral astrocytoma
520440|NCT01346267|untreated childhood subependymal giant cell astrocytoma|untreated childhood subependymal giant cell astrocytoma
520441|NCT01346267|childhood ependymoblastoma|childhood ependymoblastoma
520442|NCT01346267|untreated childhood medulloblastoma|untreated childhood medulloblastoma
520443|NCT01346267|untreated childhood pineoblastoma|untreated childhood pineoblastoma
520444|NCT01346267|childhood choroid plexus tumor|childhood choroid plexus tumor
520445|NCT01346267|childhood craniopharyngioma|childhood craniopharyngioma
520446|NCT01346267|childhood supratentorial ependymoma|childhood supratentorial ependymoma
710754|NCT00588094|B-cell non-Hodgkin's lymphoma|b-cell non-hodgkin's lymphoma
520447|NCT01346267|childhood supratentorial primitive neuroectodermal tumor|childhood supratentorial primitive neuroectodermal tumor
520448|NCT01346267|childhood medulloepithelioma|childhood medulloepithelioma
520449|NCT01346267|childhood infratentorial ependymoma|childhood infratentorial ependymoma
520450|NCT01346267|newly diagnosed childhood ependymoma|newly diagnosed childhood ependymoma
520451|NCT01346267|childhood meningioma|childhood meningioma
520452|NCT01346254|after|after
520453|NCT01346241|Panic|panic
520454|NCT01346241|Anxiety|anxiety
520455|NCT01346228|Panic|panic
520456|NCT01346228|Panic Disorder|panic disorder
520457|NCT01346228|Anxiety|anxiety
520458|NCT01346215|heparin|heparin
520459|NCT01346215|renal insufficiency, chronic|renal insufficiency, chronic
520460|NCT01346215|extracorporeal dialysis|extracorporeal dialysis
520461|NCT01346215|fibrinolytic agents|fibrinolytic agents
520462|NCT01346215|anticoagulants|anticoagulants
520463|NCT01346215|aPTT|aptt
520464|NCT01346202|multi-modal pain therapy, chronic pain|multi-modal pain therapy, chronic pain
520465|NCT01346189|Cardiovascular Disease|cardiovascular disease
520466|NCT01346163|Schizophrenia|schizophrenia
520467|NCT01346163|Cognitive Impairment|cognitive impairment
520468|NCT01346163|Electrophysiology|electrophysiology
520469|NCT01346163|H3 receptor antagonist|h3 receptor antagonist
520470|NCT01346137|ovulation|ovulation
520471|NCT01346137|unruptured luteinized follicle|unruptured luteinized follicle
520472|NCT01346137|meloxicam|meloxicam
520473|NCT01346124|radiation|radiation
520474|NCT01346124|IMRT|imrt
520475|NCT01346124|IMPT|impt
520476|NCT01346098|diabetes|diabetes
520477|NCT01346098|islet transplantation|islet transplantation
520478|NCT01346098|pancreas|pancreas
520690|NCT01345175|11-045|11-045
520479|NCT01346098|pancreatectomy|pancreatectomy
520480|NCT01346085|islet transplantation|islet transplantation
520481|NCT01346085|brittle diabetes|brittle diabetes
520482|NCT01346085|type 1 diabetes|type 1 diabetes
520483|NCT01346072|tolvaptan|tolvaptan
520484|NCT01346072|copeptin|copeptin
520485|NCT01346072|heart failure|heart failure
520486|NCT01346072|vasopressin antagonist|vasopressin antagonist
520487|NCT01346059|Clostridium|clostridium
520488|NCT01346059|Colitis|colitis
520489|NCT01346059|Intracolonic vancomycin|intracolonic vancomycin
520490|NCT01346059|psuedomembranous colitis|psuedomembranous colitis
520491|NCT01346046|Type 2 Diabetes|type 2 diabetes
520492|NCT01346046|Adults 18 years and older|adults 18 years and older
520493|NCT01346046|Taking Control of Your Diabetes Health Fair|taking control of your diabetes health fair
520494|NCT01346033|Type 2 Diabetes|type 2 diabetes
520495|NCT01346033|Adults 18 years and older|adults 18 years and older
520496|NCT01346033|Taking Control of Your Diabetes Health Fair|taking control of your diabetes health fair
520497|NCT01345968|anemia|anemia
520498|NCT01345968|transfusion|transfusion
520499|NCT01345968|intravenous ferric carboxymaltose|intravenous ferric carboxymaltose
520500|NCT01345929|cUTI|cuti
520501|NCT01345890|swallowing|swallowing
520502|NCT01345890|stroke|stroke
520503|NCT01345890|aspiration|aspiration
520504|NCT01345890|human|human
520505|NCT01345890|electrical stimulation|electrical stimulation
520506|NCT01345890|post stroke dysphagia|post stroke dysphagia
520507|NCT01345877|burn injury|burn injury
520508|NCT01345877|cold pressor test|cold pressor test
520509|NCT01345877|gender|gender
520510|NCT01345877|pain|pain
520511|NCT01345877|pain sensitivity|pain sensitivity
520512|NCT01345877|pain prediction|pain prediction
520513|NCT01345877|psychometrics|psychometrics
520514|NCT01345877|quantitative sensory testing|quantitative sensory testing
520515|NCT01345864|attention cognition memory problem solving scopolamine challenge|attention cognition memory problem solving scopolamine challenge
520516|NCT01345825|osteoarthrosis|osteoarthrosis
520517|NCT01345825|unicompartmental knee replacement|unicompartmental knee replacement
520518|NCT01345825|knee|knee
520519|NCT01345825|resistance training|resistance training
520520|NCT01345825|Muscle power|muscle power
520521|NCT01345825|gait analysis|gait analysis
520522|NCT01345825|gait|gait
520523|NCT01345825|physiotherapy|physiotherapy
520524|NCT01345825|Gyro sensor|gyro sensor
520525|NCT01345812|ART|art
520526|NCT01345812|IVF|ivf
520527|NCT01345812|Timelapse|timelapse
520528|NCT01345799|Crohn's Disease Activity Index|crohn's disease activity index
520529|NCT01345799|Crohn's Disease|crohn's disease
520530|NCT01345799|Inflammatory Bowel Disease|inflammatory bowel disease
520531|NCT01345760|Basal Cell Carcinoma|basal cell carcinoma
520532|NCT01345760|Squamous Cell Carcinoma|squamous cell carcinoma
520533|NCT01345760|Actinic Keratosis|actinic keratosis
520534|NCT01345760|microRNA|microrna
520535|NCT01345760|Dicer|dicer
520536|NCT01345760|Drosha|drosha
520537|NCT01345760|RISC|risc
520538|NCT01345760|microprocessor complex|microprocessor complex
520539|NCT01345760|Argonaute|argonaute
520540|NCT01345760|DGCR8|dgcr8
520541|NCT01345760|TARBP|tarbp
520542|NCT01345747|laryngeal tube suction|laryngeal tube suction
520543|NCT01345747|gynecology|gynecology
520544|NCT01345747|laparoscopic surgery|laparoscopic surgery
520545|NCT01345721|Meningococcal|meningococcal
520546|NCT01345721|ACWY|acwy
520547|NCT01345721|Conjugate Vaccine|conjugate vaccine
520548|NCT01345721|Meningitis|meningitis
520549|NCT01345721|Toddlers|toddlers
520550|NCT01345721|Children|children
520551|NCT01345721|Persistence|persistence
520553|NCT01345708|Low dose rituximab|low dose rituximab
520554|NCT01345708|WAIHA|waiha
520555|NCT01345708|CHD|chd
520556|NCT01345695|Childhood diarrhea|childhood diarrhea
520557|NCT01345695|childhood pneumonia|childhood pneumonia
520558|NCT01345695|telemedicine|telemedicine
520559|NCT01345695|cluster|cluster
520560|NCT01345695|treatment-control trial|treatment-control trial
520561|NCT01345656|Chronic Heart Failure|chronic heart failure
520562|NCT01345643|Transfusion|transfusion
520563|NCT01345643|Hemoglobin level|hemoglobin level
520564|NCT01345630|Double-blind|double-blind
520565|NCT01345630|comparative|comparative
520566|NCT01345630|trial|trial
520567|NCT01345630|maraviroc|maraviroc
520568|NCT01345630|versus|versus
520569|NCT01345630|emtricitabine/tenofovir|emtricitabine/tenofovir
520570|NCT01345630|both with darunavir/ritonavir|both with darunavir/ritonavir
520571|NCT01345630|antiretroviral-naive|antiretroviral-naive
520572|NCT01345630|Ccr5 tropic|ccr5 tropic
520573|NCT01345630|Hiv 1|hiv 1
520574|NCT01345630|patients.|patients.
520575|NCT01345591|BTI|bti
520576|NCT01345591|Craniomaxillofacial (CMF) Battle-injured (BI)|craniomaxillofacial (cmf) battle-injured (bi)
520577|NCT01345591|Facial Trauma|facial trauma
520578|NCT01345591|Fat Grafts|fat grafts
520579|NCT01345591|Autogenous Fat Transfers (AFT)|autogenous fat transfers (aft)
520580|NCT01345591|Wounded warriors|wounded warriors
520581|NCT01345578|Urea Cycle Disorders|urea cycle disorders
520691|NCT01345162|Herniotomy|herniotomy
520582|NCT01345578|Carbamoyl-Phosphate Synthase I Deficiency Disease|carbamoyl-phosphate synthase i deficiency disease
520583|NCT01345578|Citrullinemia|citrullinemia
520584|NCT01345578|Ornithine Carbamoyltransferase Deficiency Disease|ornithine carbamoyltransferase deficiency disease
520585|NCT01345578|Crigler-Najjar Syndrome|crigler-najjar syndrome
520586|NCT01345565|fulminant hepatic failure|fulminant hepatic failure
520587|NCT01345552|Oligo mets|oligo mets
520588|NCT01345552|Oligometastatic disease|oligometastatic disease
520589|NCT01345539|Oligo mets|oligo mets
520590|NCT01345539|Oligometastatic disease|oligometastatic disease
520591|NCT01345513|Genomic Analysis|genomic analysis
520592|NCT01345513|Sequencing|sequencing
520593|NCT01345513|Genetic|genetic
520594|NCT01345513|Biopsy|biopsy
520595|NCT01345513|Solid tumors|solid tumors
520596|NCT01345500|Overweight|overweight
520597|NCT01345500|Obese|obese
520598|NCT01345500|Type 2 Diabetic|type 2 diabetic
520599|NCT01345500|Diabetes|diabetes
520600|NCT01345500|Weight loss|weight loss
520601|NCT01345500|Physical activity|physical activity
520602|NCT01345500|Diet|diet
520603|NCT01345500|Prepackaged meals|prepackaged meals
520604|NCT01345487|appetite|appetite
520605|NCT01345487|protein|protein
520606|NCT01345487|legumes|legumes
520607|NCT01345487|meat|meat
520608|NCT01345448|Glaucoma|glaucoma
520609|NCT01345448|Brimonidine|brimonidine
520610|NCT01345448|Transdermal|transdermal
520611|NCT01345435|telemonitoring|telemonitoring
520612|NCT01345435|usual care|usual care
520613|NCT01345435|telemedicine|telemedicine
520614|NCT01345435|telehealth|telehealth
520615|NCT01345435|home care|home care
520616|NCT01345435|Health Care Quality|health care quality
520617|NCT01345435|Access|access
520618|NCT01345435|Evaluation|evaluation
520619|NCT01345409|Musculoskeletal pain|musculoskeletal pain
520620|NCT01345409|Chronic pain|chronic pain
520621|NCT01345409|Acupuncture|acupuncture
520622|NCT01345409|Chiropractic|chiropractic
520623|NCT01345396|Asthma|asthma
520624|NCT01345396|Health education|health education
520625|NCT01345396|Pregnancy|pregnancy
520626|NCT01345383|smoking|smoking
520627|NCT01345383|bronchoscopy|bronchoscopy
520628|NCT01345383|cough|cough
520629|NCT01345370|Glioblastoma|glioblastoma
520630|NCT01345357|Solid tumors|solid tumors
520631|NCT01345357|mantle cell lymphoma|mantle cell lymphoma
520632|NCT01345357|Gemcitabine|gemcitabine
520633|NCT01345357|Cisplatin|cisplatin
520634|NCT01345357|Cancer|cancer
520635|NCT01345357|Neoplasms|neoplasms
520636|NCT01345357|Antineoplastic agents|antineoplastic agents
520637|NCT01345318|Crohn's Disease|crohn's disease
520638|NCT01345318|safety|safety
520639|NCT01345318|efficacy|efficacy
520640|NCT01345318|pharmacokinetics|pharmacokinetics
520641|NCT01345318|pharmacodynamics|pharmacodynamics
520642|NCT01345318|Crohn's Disease Activity Index (CDAI)|crohn's disease activity index (cdai)
520643|NCT01345305|Sturge-Weber Syndrome|sturge-weber syndrome
520644|NCT01345305|Biomarkers|biomarkers
520645|NCT01345305|Quantitative EEG|quantitative eeg
520646|NCT01345305|Transcranial Doppler Ultrasound|transcranial doppler ultrasound
520647|NCT01345305|Medical Rehabilitation Scales|medical rehabilitation scales
520648|NCT01345305|Optical Coherence Tomography|optical coherence tomography
520649|NCT01345266|Pharyngometry|pharyngometry
520650|NCT01345266|Novel Dry Powder Inhaler|novel dry powder inhaler
520651|NCT01345266|HRCT|hrct
520652|NCT01345266|Inhalation Profiles|inhalation profiles
520653|NCT01345253|SLEDAI|sledai
520654|NCT01345253|Asia|asia
520655|NCT01345253|placebo|placebo
520656|NCT01345253|BLys|blys
520657|NCT01345253|PGA|pga
520658|NCT01345253|BILAG|bilag
520659|NCT01345253|systemic lupus erythematosus|systemic lupus erythematosus
520660|NCT01345253|SELENA|selena
520661|NCT01345253|Lupus|lupus
520662|NCT01345253|SRI|sri
520663|NCT01345253|efficacy|efficacy
520664|NCT01345253|B cell|b cell
520665|NCT01345253|SLE Flare Index|sle flare index
520666|NCT01345253|belimumab|belimumab
520667|NCT01345253|safety|safety
520668|NCT01345253|phase III|phase iii
520669|NCT01345253|B lymphocyte|b lymphocyte
520670|NCT01345240|Africa|africa
520671|NCT01345240|Plasmodium falciparum|plasmodium falciparum
520672|NCT01345240|Malaria vaccine|malaria vaccine
520673|NCT01345240|hepatitis B|hepatitis b
520674|NCT01345240|EPI|epi
520675|NCT01345227|Type 1 diabetes|type 1 diabetes
520676|NCT01345227|islet transplantation|islet transplantation
520677|NCT01345227|autotransplantation|autotransplantation
520678|NCT01345214|ONO-7746|ono-7746
520679|NCT01345214|Chemotherapy Induced Thrombocytopenia|chemotherapy induced thrombocytopenia
520680|NCT01345214|Thrombocytopenia|thrombocytopenia
520681|NCT01345201|Phase 1|phase 1
520682|NCT01345201|dose escalation|dose escalation
520683|NCT01345201|histologically confirmed|histologically confirmed
520684|NCT01345201|malignancy metastatic|malignancy metastatic
520685|NCT01345175|rectal|rectal
520686|NCT01345175|colon|colon
520687|NCT01345175|PLACEBO|placebo
520688|NCT01345175|RIFAXIMIN|rifaximin
520689|NCT01345175|metronidazole|metronidazole
520692|NCT01345149|Obesity|obesity
520693|NCT01345149|Pregnancy|pregnancy
520694|NCT01345149|Intervention|intervention
520695|NCT01345149|Diet|diet
520696|NCT01345149|Physical activity|physical activity
520697|NCT01345136|Neurofibromatosis Type 2|neurofibromatosis type 2
520698|NCT01345136|Vestibular schwannoma|vestibular schwannoma
520699|NCT01345136|Hearing|hearing
520700|NCT01345110|dementia|dementia
520701|NCT01345110|mild cognitive impairment|mild cognitive impairment
520702|NCT01345110|prevalence|prevalence
520703|NCT01345110|incidence|incidence
520704|NCT01345110|elderly|elderly
520705|NCT01345110|longitudinal study|longitudinal study
520706|NCT01345110|population study|population study
520707|NCT01345097|short, metaphyseal-fitting femoral stem|short, metaphyseal-fitting femoral stem
520708|NCT01345097|cementless anatomical femoral stem|cementless anatomical femoral stem
520709|NCT01345097|young patient|young patient
520710|NCT01345097|elderly patient|elderly patient
520711|NCT01345071|Rheumatoid Arthritis|rheumatoid arthritis
520712|NCT01345071|Pregnancy|pregnancy
520713|NCT01345071|Anti-TNF|anti-tnf
520714|NCT01345071|Preconceptional counselling|preconceptional counselling
520715|NCT01345071|Disease activity|disease activity
520716|NCT01345058|Epilepsy|epilepsy
520717|NCT01345058|antiepileptic drug|antiepileptic drug
520718|NCT01345058|polytherapy|polytherapy
520719|NCT01345045|Diabetic Asymmetric Polyneuropathy|diabetic asymmetric polyneuropathy
520720|NCT01345045|Symmetric Diabetic Proximal Motor Neuropathy|symmetric diabetic proximal motor neuropathy
520721|NCT01345045|Diabetic Mononeuropathy Simplex,|diabetic mononeuropathy simplex,
520722|NCT01345045|Diabetic Autonomic Neuropathy,|diabetic autonomic neuropathy,
520723|NCT01345045|Diabetic Amyotrophy|diabetic amyotrophy
520724|NCT01345045|Mononeuropathy|mononeuropathy
520725|NCT01345045|Diabetic Neuropathy|diabetic neuropathy
520726|NCT01345045|Asymmetric Diabetic Proximal Motor Neuropathy|asymmetric diabetic proximal motor neuropathy
520727|NCT01345045|Diabetic Polyneuropathy|diabetic polyneuropathy
520728|NCT01345045|Painful|painful
520729|NCT01345045|Diabetic Mononeuropathy|diabetic mononeuropathy
520730|NCT01345045|Neuralgia|neuralgia
520731|NCT01345019|zoledronic acid|zoledronic acid
520732|NCT01345019|hematologic malignancies|hematologic malignancies
520734|NCT01345019|skeletal-related event|skeletal-related event
520735|NCT01345019|blood cancer|blood cancer
520736|NCT01345019|lytic bone lesions|lytic bone lesions
520737|NCT01345019|bone metastases|bone metastases
520738|NCT01345019|myeloma|myeloma
520739|NCT01345019|fractures|fractures
520740|NCT01345019|spinal cord compression|spinal cord compression
520741|NCT01345019|radiation to bone|radiation to bone
520742|NCT01345019|surgery to bone|surgery to bone
520743|NCT01345019|bisphosphonates|bisphosphonates
520744|NCT01345019|Neoplasms, Plasma Cell|neoplasms, plasma cell
520745|NCT01345019|Paraproteinemias|paraproteinemias
520746|NCT01345019|Neoplasms|neoplasms
520747|NCT01345019|Neoplasm Metastasis|neoplasm metastasis
520748|NCT01345019|Bone Neoplasms|bone neoplasms
520749|NCT01345019|Bone Marrow Diseases|bone marrow diseases
520750|NCT01345019|Blood Protein Disorders|blood protein disorders
520751|NCT01345019|Hematologic Diseases|hematologic diseases
520752|NCT01345019|multiple myeloma|multiple myeloma
520753|NCT01345019|denosumab|denosumab
520754|NCT01345019|Neoplastic Processes|neoplastic processes
520755|NCT01345019|Bone Diseases|bone diseases
520756|NCT01345019|Diphosphonates|diphosphonates
520757|NCT01345019|Bone Density Conservation Agents|bone density conservation agents
520758|NCT01345006|juvenile macular dystrophy|juvenile macular dystrophy
520760|NCT01345006|fundus flavimaculatus|fundus flavimaculatus
520761|NCT01344993|Dry AMD|dry amd
520762|NCT01344993|Geographic atrophy|geographic atrophy
520763|NCT01344941|Vaccine response|vaccine response
520764|NCT01344941|Human Lymphocytes|human lymphocytes
520765|NCT01344915|Patella|patella
520766|NCT01344915|Knee|knee
520767|NCT01344915|Brace|brace
520768|NCT01344876|multiple myeloma [MM]|multiple myeloma [mm]
520769|NCT01344876|non-Hodgkin lymphoma [NHL]|non-hodgkin lymphoma [nhl]
520770|NCT01344876|acute myeloid leukemia [AML]|acute myeloid leukemia [aml]
520771|NCT01344876|acute lymphoid leukemia [ALL]|acute lymphoid leukemia [all]
520772|NCT01344876|chronic myeloid leukemia [CML]|chronic myeloid leukemia [cml]
520773|NCT01344824|recurrent non-small cell lung cancer|recurrent non-small cell lung cancer
520774|NCT01344824|stage IIIB non-small cell lung cancer|stage iiib non-small cell lung cancer
520775|NCT01344824|stage IV non-small cell lung cancer|stage iv non-small cell lung cancer
520776|NCT01344824|adenocarcinoma of the lung|adenocarcinoma of the lung
520777|NCT01344824|bronchoalveolar cell lung cancer|bronchoalveolar cell lung cancer
520778|NCT01344824|large cell lung cancer|large cell lung cancer
520779|NCT01344811|telemonitoring|telemonitoring
520780|NCT01344811|usual care|usual care
520781|NCT01344811|telehealth|telehealth
520782|NCT01344811|home care|home care
520783|NCT01344811|Health Care Quality|health care quality
520784|NCT01344811|Access|access
520785|NCT01344811|Evaluation|evaluation
520786|NCT01344798|limb girdle muscular dystrophy type 2C|limb girdle muscular dystrophy type 2c
520787|NCT01344798|gamma-sarcoglycanopathy|gamma-sarcoglycanopathy
520788|NCT01344798|gene therapy|gene therapy
520789|NCT01344798|AAV vector|aav vector
520790|NCT01344798|neuromuscular disease|neuromuscular disease
520791|NCT01344798|orphan disease|orphan disease
520792|NCT01344785|Intertrochanteric Fractures|intertrochanteric fractures
520793|NCT01344785|Intramedullary nailing|intramedullary nailing
520794|NCT01344785|Hip function|hip function
520795|NCT01344785|Pain|pain
520796|NCT01344772|femoral neck fracture|femoral neck fracture
520797|NCT01344772|total hip arthroplasty|total hip arthroplasty
520798|NCT01344772|internal fixation|internal fixation
520799|NCT01344759|Obstructive Sleep Apnea|obstructive sleep apnea
520800|NCT01344759|MRI|mri
520801|NCT01344759|Pediatrics|pediatrics
520802|NCT01344759|Dexmedetomidine|dexmedetomidine
520803|NCT01344759|Propofol|propofol
520804|NCT01344759|Anesthesia|anesthesia
520805|NCT01344746|sleep-disordered breathing|sleep-disordered breathing
520806|NCT01344733|Major Depressive Disorder|major depressive disorder
520807|NCT01344733|MDD|mdd
520808|NCT01344720|Low Back Pain|low back pain
520809|NCT01344720|Etoricoxib|etoricoxib
520810|NCT01344720|Oxycodone|oxycodone
520811|NCT01344707|Hematologic Malignancies|hematologic malignancies
520812|NCT01344707|Acute Myeloid Leukemia (AML)|acute myeloid leukemia (aml)
520813|NCT01344707|Acute Lymphocytic Leukemia (ALL)|acute lymphocytic leukemia (all)
520814|NCT01344707|Chronic Lymphocytic Leukemia (CLL)|chronic lymphocytic leukemia (cll)
520815|NCT01344707|Multiple Myeloma (MM)|multiple myeloma (mm)
520816|NCT01344707|Myelodysplastic Syndrome (MDS)|myelodysplastic syndrome (mds)
520817|NCT01344707|Malignant Lymphomas|malignant lymphomas
520818|NCT01344707|Histone Deacetylase (HDAC)|histone deacetylase (hdac)
520819|NCT01344707|4SC-202|4sc-202
520820|NCT01344707|Phase I|phase i
520821|NCT01344694|Epicardial fat|epicardial fat
520822|NCT01344694|Visceral fat|visceral fat
520823|NCT01344694|atherosclerosis|atherosclerosis
520824|NCT01344694|coronary computed tomography angiography|coronary computed tomography angiography
520825|NCT01344694|Carotid Doppler ultrasound|carotid doppler ultrasound
520826|NCT01344668|Diabetes|diabetes
520827|NCT01344642|HIV|hiv
520828|NCT01344642|RNA|rna
520829|NCT01344616|computer-based behavioral support|computer-based behavioral support
520830|NCT01344603|cardiac surgery|cardiac surgery
520831|NCT01344603|cardiac anesthesia|cardiac anesthesia
520832|NCT01344603|epidural|epidural
520833|NCT01344590|central line associated blood stream infections|central line associated blood stream infections
520834|NCT01344577|Buccal Plate Augmentation technique|buccal plate augmentation technique
520835|NCT01344577|socket preservation|socket preservation
520836|NCT01344577|porcine biomaterial|porcine biomaterial
520837|NCT01344564|Prostate cancer|prostate cancer
520838|NCT01344564|Hormone therapy|hormone therapy
520839|NCT01344564|Testosterone measures|testosterone measures
520840|NCT01344538|ginger|ginger
520841|NCT01344538|Zingiber officinale|zingiber officinale
520842|NCT01344538|Cancer Risk Reductive|cancer risk reductive
520843|NCT01344538|Eicosanoids|eicosanoids
520844|NCT01344538|Colorectal Cancer|colorectal cancer
520845|NCT01344538|Inflammation|inflammation
520846|NCT01344525|obesity therapy|obesity therapy
520847|NCT01344525|metabolic syndrome|metabolic syndrome
520848|NCT01344525|gastrointestinal tract|gastrointestinal tract
662015|NCT00782353|HCV|hcv
520849|NCT01344525|microbiota|microbiota
520850|NCT01344525|metabolomics|metabolomics
520851|NCT01344525|micronutrients|micronutrients
520852|NCT01344525|outcome|outcome
520853|NCT01344525|sustainability|sustainability
520854|NCT01344512|Pharmacokinetic|pharmacokinetic
520855|NCT01344512|Population|population
520856|NCT01344512|Children|children
520857|NCT01344512|Ceftazidime|ceftazidime
520858|NCT01344512|Ciprofloxacin|ciprofloxacin
520859|NCT01344512|Voriconazole|voriconazole
520860|NCT01344512|Pediatric|pediatric
520861|NCT01344499|women|women
520862|NCT01344499|laparoscopic subtotal hysterectomy|laparoscopic subtotal hysterectomy
520863|NCT01344486|women undergoing laparoscopic surgery|women undergoing laparoscopic surgery
520864|NCT01344473|Remineralisation|remineralisation
520865|NCT01344473|White Spot Lesions|white spot lesions
520866|NCT01344473|Orthodontic treatment|orthodontic treatment
520867|NCT01344473|Tooth Mousse creme|tooth mousse creme
520868|NCT01344473|Casein Phosphopeptide|casein phosphopeptide
520869|NCT01344460|magnetic resonance angiography (MRA) of the renal arteries|magnetic resonance angiography (mra) of the renal arteries
520870|NCT01344447|Supra-aortic vascular disease|supra-aortic vascular disease
520871|NCT01344447|MRA|mra
520872|NCT01344447|CTA|cta
520873|NCT01344447|Males and females aged 18 years or older|males and females aged 18 years or older
520874|NCT01344447|Stroke|stroke
520875|NCT01344447|Transient Ischemic Attack (TIA)|transient ischemic attack (tia)
520876|NCT01344421|Movement capture system|movement capture system
520877|NCT01344421|Movement analysis|movement analysis
520878|NCT01344421|Hip dysplasia|hip dysplasia
520879|NCT01344421|Hip pain|hip pain
520880|NCT01344421|Quality of life|quality of life
520881|NCT01344421|Physical function|physical function
520882|NCT01344408|Dizziness|dizziness
520883|NCT01344408|rehabilitation|rehabilitation
520884|NCT01344408|geriatric|geriatric
520885|NCT01344408|IT-technology|it-technology
520886|NCT01344382|Adolescent|adolescent
520887|NCT01344382|Parent|parent
520888|NCT01344382|Substance Abuse|substance abuse
520889|NCT01344382|Parent Training|parent training
520890|NCT01344382|Community Reinforcement and Family Training|community reinforcement and family training
520891|NCT01344382|CRAFT|craft
520892|NCT01344382|Community Reinforcement Approach|community reinforcement approach
520893|NCT01344382|Addiction|addiction
520894|NCT01344382|Family Intervention|family intervention
520895|NCT01344369|Healthy Subjects|healthy subjects
520896|NCT01344369|Bioequivalence|bioequivalence
520897|NCT01344356|stereotactic radiosurgery|stereotactic radiosurgery
520898|NCT01344356|head and neck tumors|head and neck tumors
520899|NCT01344356|squamous cell carcinoma of head and neck|squamous cell carcinoma of head and neck
520900|NCT01344330|Colon cancer|colon cancer
520901|NCT01344330|Prevention|prevention
520902|NCT01344330|Cruciferous vegetables|cruciferous vegetables
520903|NCT01344330|Histone status|histone status
520904|NCT01344304|aprepitant therapy|aprepitant therapy
520905|NCT01344304|fosaprepitant therapy|fosaprepitant therapy
520906|NCT01344304|5HT3-receptor antagonist|5ht3-receptor antagonist
520907|NCT01344304|dexamethasone|dexamethasone
520908|NCT01344304|colorectal cancer|colorectal cancer
520909|NCT01344304|FOLFOX|folfox
520910|NCT01344304|XELOX|xelox
520911|NCT01344304|SOX|sox
520912|NCT01344291|hyperprolactinoma|hyperprolactinoma
520913|NCT01344291|turmeric|turmeric
520914|NCT01344291|amenorrhea|amenorrhea
520915|NCT01344265|B-type natriuretic peptide|b-type natriuretic peptide
520916|NCT01344265|global end diastolic volume|global end diastolic volume
520917|NCT01344239|aortic aneurysm|aortic aneurysm
520918|NCT01344239|ischemia/reperfusion|ischemia/reperfusion
520919|NCT01344239|preconditioning|preconditioning
520920|NCT01344239|pulmonary injury|pulmonary injury
520921|NCT01344239|intestinal injury|intestinal injury
520922|NCT01344226|steroid responder|steroid responder
520923|NCT01344213|Pregabalin|pregabalin
520924|NCT01344213|Celecoxib|celecoxib
520925|NCT01344213|Intrathecal morphine|intrathecal morphine
520926|NCT01344213|Total knee arthroplasty|total knee arthroplasty
520927|NCT01344200|Pharmacokinetics|pharmacokinetics
520928|NCT01344200|Celecoxib|celecoxib
520929|NCT01344200|Pediatric|pediatric
520930|NCT01344200|Peds QL|peds ql
520931|NCT01344200|CYP2C9|cyp2c9
520932|NCT01344174|Acute-on-chronic liver failure|acute-on-chronic liver failure
520933|NCT01344174|HBV|hbv
520934|NCT01344174|Dexamethasone|dexamethasone
520935|NCT01344174|Prognosis|prognosis
520936|NCT01344161|Vitamin D|vitamin d
520937|NCT01344161|Metabolic profile|metabolic profile
520938|NCT01344161|Overweight|overweight
520939|NCT01344161|Obesity|obesity
520940|NCT01344148|Anti- TB|anti- tb
520941|NCT01344148|HAART|haart
520942|NCT01344148|choice of the right moment|choice of the right moment
520943|NCT01344135|Pulmonary Disease, Chronic Obstructive|pulmonary disease, chronic obstructive
520944|NCT01344135|Muscular Atrophy|muscular atrophy
520945|NCT01344135|Nutritional rehabilitation|nutritional rehabilitation
520946|NCT01344135|Counselling|counselling
520947|NCT01344096|Gaucher disease|gaucher disease
520948|NCT01344096|Thrombocytopathy|thrombocytopathy
520949|NCT01344096|Imiglucerase|imiglucerase
520950|NCT01344070|innovator formulations|innovator formulations
520951|NCT01344070|generic formulations|generic formulations
520952|NCT01344070|bioequivalence|bioequivalence
520953|NCT01344070|interchangeability|interchangeability
520954|NCT01344070|inter-patch variation|inter-patch variation
520955|NCT01344070|quality of generic drug formulations on the market|quality of generic drug formulations on the market
520956|NCT01344070|Interchangeability between marketed generic formulations|interchangeability between marketed generic formulations
520957|NCT01344070|prevalence of large intrasubject variability despite average bioequivalence|prevalence of large intrasubject variability despite average bioequivalence
520958|NCT01344070|Causes of large intrasubject variability|causes of large intrasubject variability
520959|NCT01344057|Seasonal Influenza, vaccine|seasonal influenza, vaccine
520960|NCT01344044|Brain-Computer Interface|brain-computer interface
520961|NCT01344018|adult angiosarcoma|adult angiosarcoma
520962|NCT01344018|adult fibrosarcoma|adult fibrosarcoma
520963|NCT01344018|adult leiomyosarcoma|adult leiomyosarcoma
520964|NCT01344018|adult liposarcoma|adult liposarcoma
520965|NCT01344018|adult malignant fibrous histiocytoma|adult malignant fibrous histiocytoma
520966|NCT01344018|adult malignant mesenchymoma|adult malignant mesenchymoma
520967|NCT01344018|stage I adult soft tissue sarcoma|stage i adult soft tissue sarcoma
520968|NCT01344018|stage II adult soft tissue sarcoma|stage ii adult soft tissue sarcoma
520969|NCT01344018|stage III adult soft tissue sarcoma|stage iii adult soft tissue sarcoma
520970|NCT01344005|non-small cell lung cancer|non-small cell lung cancer
520971|NCT01344005|small cell lung cancer|small cell lung cancer
520972|NCT01344005|tobacco use disorder|tobacco use disorder
520973|NCT01343992|Embryo transfer|embryo transfer
520974|NCT01343992|Implantation rate|implantation rate
520975|NCT01343992|Pregnancy rate|pregnancy rate
520976|NCT01343992|bedrest|bedrest
520977|NCT01343992|neutral|neutral
520978|NCT01343992|benevolent|benevolent
520979|NCT01343992|deterious|deterious
520980|NCT01343992|implantation|implantation
520981|NCT01343992|gestation rates|gestation rates
520982|NCT01343953|severe aplastic anemia|severe aplastic anemia
520983|NCT01343953|cord blood transplantation|cord blood transplantation
520984|NCT01343940|RCT|rct
520985|NCT01343940|randomized block repeated measures design|randomized block repeated measures design
520986|NCT01343940|efficacy trial|efficacy trial
520987|NCT01343940|high risk population|high risk population
520988|NCT01343927|Chronic low back pain|chronic low back pain
520989|NCT01343927|Community health center|community health center
520990|NCT01343927|Yoga|yoga
520991|NCT01343927|Physical therapy|physical therapy
520992|NCT01343927|Minority populations|minority populations
520993|NCT01343927|Health education|health education
520994|NCT01343862|moderate traumatic brain injury|moderate traumatic brain injury
520995|NCT01343862|brain contusion|brain contusion
520996|NCT01343849|breast cancer|breast cancer
520997|NCT01343849|auto antibodies|auto antibodies
520998|NCT01343836|autologous tenocytes|autologous tenocytes
520999|NCT01343836|cell therapy|cell therapy
521000|NCT01343836|eccentric exercises|eccentric exercises
521001|NCT01343810|Mindfulness-Based Stress Reduction|mindfulness-based stress reduction
521002|NCT01343810|Meditation|meditation
521003|NCT01343810|Psychological stress|psychological stress
521004|NCT01343810|Sleep quality|sleep quality
521005|NCT01343810|Cardiovascular disease|cardiovascular disease
521006|NCT01343810|Inflammation|inflammation
521007|NCT01343797|Glycemic index|glycemic index
521008|NCT01343797|Insulinemic index|insulinemic index
521009|NCT01343797|Fructo-oligosaccharide syrup|fructo-oligosaccharide syrup
521010|NCT01343797|Fructose syrup|fructose syrup
521011|NCT01343797|Aged between eighteen and fifty years old|aged between eighteen and fifty years old
521012|NCT01343797|BMI between nineteen and twenty five kg/m²|bmi between nineteen and twenty five kg/m²
521013|NCT01343797|Non diabetic or pre-diabetic|non diabetic or pre-diabetic
521014|NCT01343797|Without liver, renal or gastro-intestinal disorder|without liver, renal or gastro-intestinal disorder
521015|NCT01343797|Non-smoker|non-smoker
521016|NCT01343784|Voiding trial|voiding trial
521017|NCT01343784|sling|sling
521018|NCT01343784|post-operative assessment|post-operative assessment
521019|NCT01343784|urinary retention|urinary retention
521020|NCT01343771|Anorexia Nervosa (AN)|anorexia nervosa (an)
521021|NCT01343771|bone density|bone density
521022|NCT01343771|DHEA|dhea
521023|NCT01343771|estrogen therapy|estrogen therapy
521024|NCT01343771|eating disorder|eating disorder
521025|NCT01343693|DDD|ddd
521026|NCT01343693|Deformity|deformity
521027|NCT01343693|Tumor|tumor
521028|NCT01343693|Fracture|fracture
521029|NCT01343693|Cervical|cervical
521030|NCT01343667|GORE Neuro Protection System|gore neuro protection system
521031|NCT01343667|GORE Flow Reversal System|gore flow reversal system
521032|NCT01343667|carotid artery stenosis|carotid artery stenosis
521033|NCT01343667|embolic protection device|embolic protection device
521034|NCT01343667|reverse flow|reverse flow
521035|NCT01343667|proximal occlusion device|proximal occlusion device
521036|NCT01343667|GNPS|gnps
521037|NCT01343667|Parodi|parodi
521038|NCT01343667|EMPiRE|empire
521039|NCT01343667|distal embolization|distal embolization
521040|NCT01343667|minimizing risks of CAS|minimizing risks of cas
521041|NCT01343667|PAES|paes
521042|NCT01343667|embolic filter|embolic filter
521043|NCT01343654|HIV medication adherence|hiv medication adherence
521044|NCT01343654|drug use|drug use
521045|NCT01343654|rural|rural
521046|NCT01343654|nonadherence to HIV medications|nonadherence to hiv medications
521047|NCT01343641|Kidney Disease|kidney disease
521048|NCT01343641|Chronic Kidney Disease|chronic kidney disease
521049|NCT01343641|Growth Hormone|growth hormone
521050|NCT01343628|Alcohol, atomoxetine, Strattera, alcohol dependence, alcoholism|alcohol, atomoxetine, strattera, alcohol dependence, alcoholism
521051|NCT01343602|stroke|stroke
521052|NCT01343602|Constraint Induced Movement Therapy|constraint induced movement therapy
521053|NCT01343602|participation|participation
521054|NCT01343602|Physical Therapy|physical therapy
521055|NCT01343602|Occupational Therapy|occupational therapy
521056|NCT01343563|Depression|depression
521057|NCT01343563|Major Depressive Disorder (MDD)|major depressive disorder (mdd)
521058|NCT01343563|EEG|eeg
521059|NCT01343563|Trigeminal Nerve Stimulation|trigeminal nerve stimulation
521060|NCT01343550|Borderline Personality Disorder|borderline personality disorder
521061|NCT01343550|Borderline Personality|borderline personality
521062|NCT01343550|Borderline|borderline
521063|NCT01343537|Brain Bleed|brain bleed
521064|NCT01343537|SAH|sah
521065|NCT01343537|Vasospasm|vasospasm
521066|NCT01343524|cystic fibrosis|cystic fibrosis
521067|NCT01343524|spirometry|spirometry
521068|NCT01343524|PFT's|pft's
521069|NCT01343524|pulmonary function test|pulmonary function test
521070|NCT01343511|Autism|autism
521071|NCT01343511|human cord blood mononuclear cells|human cord blood mononuclear cells
521072|NCT01343511|human umbilical cord mesenchymal stem cells|human umbilical cord mesenchymal stem cells
521073|NCT01343498|Solid Tumor Malignancy|solid tumor malignancy
521074|NCT01343498|Advanced Solid Tumors|advanced solid tumors
521075|NCT01343498|BEZ235|bez235
521076|NCT01343498|mTOR Inhibitor|mtor inhibitor
521077|NCT01343485|Human papillomavirus (HPV) vaccine|human papillomavirus (hpv) vaccine
521078|NCT01343485|Gardasil vaccine|gardasil vaccine
521079|NCT01343472|Behavior|behavior
521080|NCT01343472|Drug users|drug users
521081|NCT01343459|Hypofractionated Whole breast irradiation|hypofractionated whole breast irradiation
521082|NCT01343459|Hypofractionated Whole breast irradiation long term results|hypofractionated whole breast irradiation long term results
521083|NCT01343459|Breast conserving therapy|breast conserving therapy
521084|NCT01343459|IORT with electrons in breast cancer|iort with electrons in breast cancer
521085|NCT01343459|IOERT as anticipated Boost|ioert as anticipated boost
521086|NCT01343459|IOERT and hypofractionated whole breast irradiation|ioert and hypofractionated whole breast irradiation
521087|NCT01343446|Sleep impairment, Coping Style, Diabetes Mellitus|sleep impairment, coping style, diabetes mellitus
521088|NCT01343433|Delirium|delirium
521089|NCT01343433|Intensive Care Unit Syndrome|intensive care unit syndrome
521090|NCT01343433|Bright light therapy|bright light therapy
521091|NCT01343433|Intensive Care Unit|intensive care unit
521092|NCT01343420|Skin tests|skin tests
521093|NCT01343420|Dog Hair|dog hair
521094|NCT01343420|Allergy Extract|allergy extract
521095|NCT01343394|Autologous|autologous
521096|NCT01343394|Stem Cells|stem cells
521097|NCT01343394|Hearing Loss|hearing loss
521098|NCT01343394|Children|children
521099|NCT01343381|Heparin|heparin
521100|NCT01343381|Coronary artery bypass graft surgery|coronary artery bypass graft surgery
521101|NCT01343381|Anti-coagulation efficacy|anti-coagulation efficacy
521102|NCT01343368|Post-menarchal|post-menarchal
521103|NCT01343355|Tropical Spastic Paraparesis|tropical spastic paraparesis
521104|NCT01343355|HAM|ham
521105|NCT01343355|TSP|tsp
521106|NCT01343342|omega-3|omega-3
521107|NCT01343342|PUFA|pufa
521108|NCT01343342|fatty acids|fatty acids
521109|NCT01343342|cardiovascular disease|cardiovascular disease
521110|NCT01343342|gene expression|gene expression
521111|NCT01343329|Traumatic Brain Injury|traumatic brain injury
521112|NCT01343329|Dysautonomia|dysautonomia
521113|NCT01343329|Brain Injury|brain injury
521114|NCT01343329|Sympathetic hyperactivity|sympathetic hyperactivity
521115|NCT01343316|Enteral Feeds|enteral feeds
521116|NCT01343316|Supplemental Feeds|supplemental feeds
521117|NCT01343316|Transpyloric Tube|transpyloric tube
521118|NCT01343316|Nasogastric Tube|nasogastric tube
521119|NCT01343303|Osteoarthritis, knee|osteoarthritis, knee
521120|NCT01343303|knee pain|knee pain
521121|NCT01343303|pain measurement|pain measurement
521122|NCT01343290|Canagliflozin (JNJ-28431754)|canagliflozin (jnj-28431754)
521123|NCT01343290|Pharmacokinetic|pharmacokinetic
521124|NCT01343290|Oral Bioavailability|oral bioavailability
521125|NCT01343290|Food effect|food effect
521126|NCT01343277|Advanced Liposarcoma or Leiomyosarcoma|advanced liposarcoma or leiomyosarcoma
521127|NCT01343277|Trabectedin|trabectedin
521128|NCT01343277|Yondelis|yondelis
521129|NCT01343277|Dacarbazine|dacarbazine
521130|NCT01343277|Anthracycline|anthracycline
521131|NCT01343277|L-sarcoma|l-sarcoma
521132|NCT01343264|Radical Pleurectomy|radical pleurectomy
521133|NCT01343264|Pleurectomy/decortication|pleurectomy/decortication
521134|NCT01343264|Cisplatin|cisplatin
521135|NCT01343264|Pemetrexed|pemetrexed
521136|NCT01343264|Radiation|radiation
521137|NCT01343251|dialysis|dialysis
521138|NCT01343251|HeRO graft|hero graft
521139|NCT01343251|catheter|catheter
521140|NCT01343251|chronic renal failure|chronic renal failure
521141|NCT01343251|end stage renal disease|end stage renal disease
521142|NCT01343251|renal insufficiency|renal insufficiency
521143|NCT01343238|obesity|obesity
521144|NCT01343238|diet|diet
521145|NCT01343238|exercise|exercise
521146|NCT01343225|African american vitamin d bone density|african american vitamin d bone density
521147|NCT01343225|African American male or female treatment naive|african american male or female treatment naive
521148|NCT01343212|hepatocellular carcinoma|hepatocellular carcinoma
521149|NCT01343212|stiffness|stiffness
521150|NCT01343186|Peginterferon|peginterferon
521151|NCT01343186|Healthy subject|healthy subject
521152|NCT01343186|Pharmacokinetics|pharmacokinetics
521153|NCT01343186|Pharmacodynamics|pharmacodynamics
521154|NCT01343186|Safety|safety
521155|NCT01343173|Leukemia|leukemia
521156|NCT01343173|Adult Chronic|adult chronic
521157|NCT01343173|Myeloid|myeloid
521158|NCT01343147|Hyperthermia|hyperthermia
521159|NCT01343147|Microwave diathermy|microwave diathermy
521160|NCT01343147|Hot packs|hot packs
521161|NCT01343147|Pain|pain
521162|NCT01343147|Physical function|physical function
521163|NCT01343134|Retina|retina
521164|NCT01343134|Rhegmatogenous retinal detachment|rhegmatogenous retinal detachment
521165|NCT01343134|Macular detachment|macular detachment
521166|NCT01343134|Spectral domain OCT|spectral domain oct
521167|NCT01343134|Microperimetry|microperimetry
521168|NCT01343121|Radiotherapy|radiotherapy
521169|NCT01343121|GemX Chemoradiotherapy|gemx chemoradiotherapy
521170|NCT01343121|Bladder Cancer|bladder cancer
521171|NCT01343108|Emotional Labor|emotional labor
521172|NCT01343108|Burnout|burnout
521173|NCT01343108|Job Satisfaction|job satisfaction
521174|NCT01343108|Emotional Intelligence|emotional intelligence
521175|NCT01343108|Job stress|job stress
521176|NCT01343108|Job involvement|job involvement
521177|NCT01343095|ICU Delirium|icu delirium
521178|NCT01343095|Delirium|delirium
521179|NCT01343095|Sleep Quality|sleep quality
521180|NCT01343095|Sleep Efficiency|sleep efficiency
521181|NCT01343095|ICU Noise|icu noise
521182|NCT01343095|Noise Reduction|noise reduction
521183|NCT01343095|Earplugs|earplugs
521184|NCT01343095|Noise Canceling Headphones|noise canceling headphones
521185|NCT01343069|safety|safety
521186|NCT01343069|team|team
521187|NCT01343069|team performance|team performance
521188|NCT01343069|surgery|surgery
521189|NCT01343069|outcome|outcome
521190|NCT01343056|Diabetes Self Management Education (DSME)|diabetes self management education (dsme)
521191|NCT01343056|Diabetes|diabetes
521192|NCT01343056|Self Management Support (SMS)|self management support (sms)
521193|NCT01343043|T Cell Receptor|t cell receptor
521194|NCT01343043|Sarcoma|sarcoma
521195|NCT01343043|Cell Therapy|cell therapy
521196|NCT01343043|T Cell Therapy|t cell therapy
521197|NCT01343043|Previously treated|previously treated
521198|NCT01343043|NY-ESO-1|ny-eso-1
521199|NCT01343043|Metastatic|metastatic
521200|NCT01343043|Immuno-oncology|immuno-oncology
521201|NCT01343017|Anaesthesia|anaesthesia
521202|NCT01343017|Pulmonary gas exchange|pulmonary gas exchange
521203|NCT01343017|Functional residual capacity|functional residual capacity
521204|NCT01343017|Cardiac output|cardiac output
521205|NCT01343017|Sevoflurane|sevoflurane
521206|NCT01343004|BA058|ba058
521207|NCT01343004|abaloparatide|abaloparatide
521208|NCT01343004|Abaloparatide-SC|abaloparatide-sc
521209|NCT01343004|osteoporosis|osteoporosis
521210|NCT01343004|postmenopausal|postmenopausal
521211|NCT01343004|bone loss|bone loss
521212|NCT01343004|ACTIVE|active
521213|NCT01343004|fracture|fracture
521214|NCT01342991|Haemorrhoids|haemorrhoids
521215|NCT01342991|Haemorrhoidectomy|haemorrhoidectomy
521216|NCT01342991|Laser Haemorrhoidectomy|laser haemorrhoidectomy
521217|NCT01342991|Milligan-Morgan Haemorrhoidectomy|milligan-morgan haemorrhoidectomy
521218|NCT01342991|Open Haemorrhoidectomy|open haemorrhoidectomy
521219|NCT01342978|HPV|hpv
521220|NCT01342978|HNSCC|hnscc
521221|NCT01342952|pulmonary arterial hypertension|pulmonary arterial hypertension
521222|NCT01342952|pediatrics|pediatrics
521223|NCT01342939|Monogenetic diabetes|monogenetic diabetes
521224|NCT01342939|Diabetes mellitus|diabetes mellitus
521225|NCT01342926|age-related macular degeneration|age-related macular degeneration
521226|NCT01342926|geographic atrophy|geographic atrophy
521227|NCT01342926|dry AMD|dry amd
521228|NCT01342900|tissue oxygenation|tissue oxygenation
521229|NCT01342900|higk risk surgery|higk risk surgery
521230|NCT01342900|high risk patient|high risk patient
521231|NCT01342900|postoperative complications|postoperative complications
521232|NCT01342874|inositol|inositol
521233|NCT01342874|gestational diabetes mellitus|gestational diabetes mellitus
521234|NCT01342874|obstetric adverse outcomes|obstetric adverse outcomes
521235|NCT01342861|protein supplementation|protein supplementation
521236|NCT01342861|caloric intake|caloric intake
521237|NCT01342861|breakfast|breakfast
521238|NCT01342861|transthyretin (prealbumin)|transthyretin (prealbumin)
521239|NCT01342861|albumin|albumin
521240|NCT01342861|Length of stay|length of stay
521241|NCT01342848|NSTE-ACS|nste-acs
521242|NCT01342848|PCI|pci
521243|NCT01342848|Thrombus Aspiration|thrombus aspiration
521244|NCT01342848|IVUS|ivus
521245|NCT01342848|Periprocedural Myocardial Infarction|periprocedural myocardial infarction
521246|NCT01342835|propofol|propofol
521247|NCT01342835|sevoflurane|sevoflurane
521248|NCT01342835|postoperative pain|postoperative pain
521249|NCT01342835|children|children
521250|NCT01342822|Heart disease|heart disease
521251|NCT01342822|Coronary Revascularization|coronary revascularization
521252|NCT01342809|Depression|depression
521253|NCT01342809|Hopelessness|hopelessness
521254|NCT01342809|Suicidal ideation|suicidal ideation
521255|NCT01342796|Cell mediated immunity|cell mediated immunity
521256|NCT01342796|cell mediated immune response|cell mediated immune response
521257|NCT01342796|Children|children
521258|NCT01342796|adjuvanted|adjuvanted
521259|NCT01342783|metastatic childhood soft tissue sarcoma|metastatic childhood soft tissue sarcoma
521260|NCT01342783|nonmetastatic childhood soft tissue sarcoma|nonmetastatic childhood soft tissue sarcoma
521261|NCT01342783|recurrent childhood soft tissue sarcoma|recurrent childhood soft tissue sarcoma
521262|NCT01342783|previously treated childhood rhabdomyosarcoma|previously treated childhood rhabdomyosarcoma
521263|NCT01342783|previously untreated childhood rhabdomyosarcoma|previously untreated childhood rhabdomyosarcoma
521264|NCT01342783|recurrent childhood rhabdomyosarcoma|recurrent childhood rhabdomyosarcoma
521265|NCT01342744|Cardiovascular risk factors|cardiovascular risk factors
521266|NCT01342731|Tigecycline|tigecycline
521267|NCT01342731|A.baumannii|a.baumannii
521268|NCT01342731|Drug safety|drug safety
521269|NCT01342718|Irritable bowel syndrome|irritable bowel syndrome
521270|NCT01342718|Herbal medicine|herbal medicine
521271|NCT01342718|Probiotics|probiotics
521577|NCT01341171|tamoxifen|tamoxifen
521272|NCT01342679|chronic myeloid leukemia|chronic myeloid leukemia
521273|NCT01342679|dasatinib|dasatinib
521274|NCT01342679|complete molecular response|complete molecular response
521275|NCT01342666|High density lipoprotein cholesterol|high density lipoprotein cholesterol
521276|NCT01342666|Tomato|tomato
521277|NCT01342666|Lycopene|lycopene
521278|NCT01342666|Hypoalphalipoproteinemia|hypoalphalipoproteinemia
521279|NCT01342666|Dyslipidemia|dyslipidemia
521280|NCT01342653|Peritoneal|peritoneal
521281|NCT01342653|Carcinomatosis|carcinomatosis
521282|NCT01342653|Gastric|gastric
521283|NCT01342653|Cancer|cancer
521284|NCT01342653|NIPS|nips
521285|NCT01342653|HIPEC|hipec
521286|NCT01342627|Renal Carcinoma|renal carcinoma
521287|NCT01342627|Metastatic|metastatic
521288|NCT01342627|Sorafenib|sorafenib
521289|NCT01342627|Elderly|elderly
521290|NCT01342614|Hypertension|hypertension
521291|NCT01342614|Insulin Resistance|insulin resistance
521292|NCT01342614|Hyperinsulinemia|hyperinsulinemia
521293|NCT01342614|Metformin|metformin
521294|NCT01342614|Fosinopril|fosinopril
521295|NCT01342588|Pedicle screws|pedicle screws
521296|NCT01342588|safety|safety
521297|NCT01342575|ACDF|acdf
521298|NCT01342549|Alcohol Use Disorders|alcohol use disorders
521299|NCT01342549|Traumatic Brain Injury|traumatic brain injury
521300|NCT01342549|Mood and Anxiety Disorders|mood and anxiety disorders
521301|NCT01342536|Depression|depression
521302|NCT01342523|Smoking Cessation|smoking cessation
521303|NCT01342523|Smoking|smoking
521304|NCT01342523|Nicotine|nicotine
521305|NCT01342510|Intravenous Anesthesia|intravenous anesthesia
521306|NCT01342510|General Anesthesia|general anesthesia
521307|NCT01342497|diabetic foot ulcer|diabetic foot ulcer
521308|NCT01342471|Physical activity intervention|physical activity intervention
521309|NCT01342471|walking|walking
521310|NCT01342471|TV|tv
521311|NCT01342471|sedentary|sedentary
521312|NCT01342458|Knee osteoarthritis|knee osteoarthritis
521313|NCT01342458|Shoes|shoes
521314|NCT01342458|Gait|gait
521315|NCT01342458|Biomechanics|biomechanics
521316|NCT01342432|low back pain|low back pain
521317|NCT01342432|balance reeducation|balance reeducation
521318|NCT01342432|pain|pain
521319|NCT01342432|function|function
521320|NCT01342367|Prostate cancer|prostate cancer
521321|NCT01342367|Quality of Life|quality of life
521322|NCT01342354|Pancreatic Cancer|pancreatic cancer
521323|NCT01342354|Stereotactic Radiation|stereotactic radiation
521324|NCT01342328|Sleep disruption|sleep disruption
521325|NCT01342328|Sleep hygiene|sleep hygiene
521326|NCT01342328|Sedative agents and sleep|sedative agents and sleep
521327|NCT01342328|Electroencephalography|electroencephalography
521328|NCT01342328|REM sleep|rem sleep
521329|NCT01342328|Magnetoencephalography|magnetoencephalography
521330|NCT01342315|Tinea Cruris, antifungal|tinea cruris, antifungal
521331|NCT01342302|Breast Cancer|breast cancer
521332|NCT01342302|Couples|couples
521333|NCT01342302|Distress|distress
521334|NCT01342302|Online Support|online support
521335|NCT01342302|e-health|e-health
521336|NCT01342302|Intervention|intervention
521337|NCT01342302|Relationships|relationships
521338|NCT01342289|Nonmyeloablative|nonmyeloablative
521339|NCT01342289|Allogeneic|allogeneic
521340|NCT01342289|Bone Marrow Transplant (BMT)|bone marrow transplant (bmt)
521341|NCT01342289|Tacrolimus|tacrolimus
521342|NCT01342289|Cyclophosphamide|cyclophosphamide
521343|NCT01342276|Heart failure|heart failure
521344|NCT01342276|Self-management|self-management
521345|NCT01342276|Telehealth|telehealth
521346|NCT01342276|Internet|internet
521347|NCT01342263|Chronic disease management|chronic disease management
521348|NCT01342263|Ischemic heart disease|ischemic heart disease
521349|NCT01342263|Heart failure|heart failure
521350|NCT01342263|Chronic kidney disease|chronic kidney disease
521351|NCT01342263|Diabetes|diabetes
521352|NCT01342263|Chronic obstructive pulmonary disease|chronic obstructive pulmonary disease
521353|NCT01342263|Telehealth|telehealth
521354|NCT01342263|Internet|internet
521355|NCT01342250|Decompensated Liver Cirrhosis|decompensated liver cirrhosis
521356|NCT01342250|Umbilical Cord Mesenchymal Stem Cells|umbilical cord mesenchymal stem cells
521357|NCT01342237|Brain tumors|brain tumors
521358|NCT01342237|Stem cell transplantation|stem cell transplantation
521359|NCT01342237|topotecan|topotecan
521360|NCT01342237|thiotepa|thiotepa
521361|NCT01342237|carboplatin|carboplatin
521362|NCT01342237|melphalan|melphalan
521363|NCT01342237|etoposide|etoposide
521364|NCT01342224|pancreatic|pancreatic
521365|NCT01342224|cancer|cancer
521366|NCT01342224|adenocarcinoma|adenocarcinoma
521367|NCT01342224|vaccine|vaccine
521368|NCT01342211|PF-04950615|pf-04950615
521369|NCT01342211|RN316|rn316
521370|NCT01342198|pregabalin|pregabalin
521371|NCT01342198|pharmacokinetics|pharmacokinetics
521372|NCT01342198|bioavailability|bioavailability
521373|NCT01342198|bioequivalence|bioequivalence
521374|NCT01342185|Medical ozone therapy|medical ozone therapy
521375|NCT01342185|chronic hepatitis B|chronic hepatitis b
521376|NCT01342172|Bladder Cancer|bladder cancer
521377|NCT01342172|Urothelial Cancer|urothelial cancer
521378|NCT01342172|Chemotherapy|chemotherapy
521379|NCT01342172|First-line|first-line
521380|NCT01342172|Metastatic|metastatic
521381|NCT01342159|bevacizumab, diabetic macular edema, triamcinolone|bevacizumab, diabetic macular edema, triamcinolone
521382|NCT01342146|pegylated Somatropin|pegylated somatropin
521383|NCT01342146|PEG-GH|peg-gh
521384|NCT01342146|Growth hormone|growth hormone
521385|NCT01342146|PEG-rhGH|peg-rhgh
521386|NCT01342146|Growth hormone deficiency (GHD)|growth hormone deficiency (ghd)
521387|NCT01342146|Phase 2 study|phase 2 study
521388|NCT01342120|atypical antipsychotics|atypical antipsychotics
521389|NCT01342120|quetiapine|quetiapine
521390|NCT01342107|Contact Lenses|contact lenses
521391|NCT01342107|Contact Lens Care|contact lens care
521392|NCT01342107|Multi-Purpose Solution Wettability|multi-purpose solution wettability
521393|NCT01342107|Myopia|myopia
521394|NCT01342094|Primary open angle glaucoma or ocular hypertension|primary open angle glaucoma or ocular hypertension
521395|NCT01342081|Primary open angle glaucoma or ocular hypertension|primary open angle glaucoma or ocular hypertension
521396|NCT01342068|Thoracic outlet syndrome|thoracic outlet syndrome
521397|NCT01342068|Osteopathic medicine|osteopathic medicine
521398|NCT01342068|Osteopathic Manual Manipulations|osteopathic manual manipulations
521399|NCT01342068|OMT|omt
521400|NCT01342068|Wright's Test|wright's test
521401|NCT01342068|Adson's Test|adson's test
521402|NCT01342068|Halstead's Maneuver|halstead's maneuver
521403|NCT01342068|TOS|tos
521404|NCT01342068|Vascular Sonography|vascular sonography
521405|NCT01342042|diabetes|diabetes
521406|NCT01342042|rRE-4|rre-4
521407|NCT01342042|exenatide|exenatide
521408|NCT01342042|metformin|metformin
521409|NCT01342042|CSPC ZhongQi|cspc zhongqi
521410|NCT01342029|Microvascular Coronary Dysfunction (MCD)|microvascular coronary dysfunction (mcd)
521411|NCT01342016|prograf|prograf
521412|NCT01342016|nephritis|nephritis
521413|NCT01342016|leflunomide|leflunomide
521414|NCT01342016|immunosuppressant|immunosuppressant
521415|NCT01342003|HCV infection|hcv infection
521416|NCT01342003|genotype 1a|genotype 1a
521417|NCT01342003|genotype 1 b|genotype 1 b
521418|NCT01341990|Contact Lenses|contact lenses
521419|NCT01341990|Contact Lens Care|contact lens care
521420|NCT01341990|Multi-Purpose Solution|multi-purpose solution
521421|NCT01341977|Contact Lenses|contact lenses
521422|NCT01341977|Contact Lens Care|contact lens care
521423|NCT01341977|Multi-Purpose Solution|multi-purpose solution
521424|NCT01341964|Clopidogrel|clopidogrel
521425|NCT01341964|Aspirin|aspirin
521426|NCT01341964|Interaction|interaction
521427|NCT01341951|liver failure, Acute|liver failure, acute
521428|NCT01341938|Smokeless Tobacco Use|smokeless tobacco use
710755|NCT00588094|Cancer|cancer
662696|NCT00779402|vaccine|vaccine
521429|NCT01341925|childhood depression|childhood depression
521430|NCT01341899|Type 1 diabetes|type 1 diabetes
521431|NCT01341899|stem cell|stem cell
521432|NCT01341899|C-peptide|c-peptide
521433|NCT01341899|Immune function|immune function
521434|NCT01341886|differentiated thyroid cancer|differentiated thyroid cancer
521435|NCT01341886|THS suppression|ths suppression
521436|NCT01341886|metformin|metformin
521437|NCT01341834|Nasopharyngeal carcinoma, antiangiogenesis, HDACi, mTOR, Phase Ib|nasopharyngeal carcinoma, antiangiogenesis, hdaci, mtor, phase ib
521438|NCT01341821|Leadership Style|leadership style
521439|NCT01341821|Team Climate|team climate
521440|NCT01341808|Crohn's disease|crohn's disease
521441|NCT01341808|Ulcerative colitis|ulcerative colitis
521442|NCT01341808|Hepatitis A|hepatitis a
521443|NCT01341808|vaccine|vaccine
521444|NCT01341795|Newly diagnosed type 2 diabetes patients|newly diagnosed type 2 diabetes patients
521445|NCT01341782|Secondary hyperparathyroidism|secondary hyperparathyroidism
521446|NCT01341782|Paricalcitol|paricalcitol
521447|NCT01341782|Hemodialysis|hemodialysis
521448|NCT01341782|Maxacalcitol|maxacalcitol
521449|NCT01341756|Gastric Cancer|gastric cancer
521450|NCT01341756|Radiotherapy|radiotherapy
521451|NCT01341756|palliation|palliation
521452|NCT01341756|bleeding|bleeding
521453|NCT01341756|pain|pain
521454|NCT01341756|obstruction|obstruction
521455|NCT01341743|chronic hepatitis B|chronic hepatitis b
521456|NCT01341743|inadequate response|inadequate response
521457|NCT01341743|NUC therapy|nuc therapy
521458|NCT01341730|Atherosclerosis|atherosclerosis
521459|NCT01341730|Pioglitazone|pioglitazone
521460|NCT01341730|Atorvastatin|atorvastatin
521461|NCT01341730|PET CT|pet ct
521462|NCT01341717|Diabetes Mellitus, Type 2|diabetes mellitus, type 2
521463|NCT01341717|Sitagliptin|sitagliptin
521464|NCT01341717|Insulin|insulin
521465|NCT01341704|malaria|malaria
521466|NCT01341704|vaccine|vaccine
521467|NCT01341704|clinical trials|clinical trials
521468|NCT01341704|proof of concept|proof of concept
521469|NCT01341704|efficacy|efficacy
521470|NCT01341691|chronic kidney disease|chronic kidney disease
521471|NCT01341691|K2CG chewing gum|k2cg chewing gum
521472|NCT01341691|phosphorus|phosphorus
521473|NCT01341691|saliva|saliva
521474|NCT01341678|chronic kidney disease|chronic kidney disease
521475|NCT01341678|phosphorus|phosphorus
521476|NCT01341678|circadian rhythm|circadian rhythm
521477|NCT01341678|saliva|saliva
521478|NCT01341665|hyponatremia|hyponatremia
521479|NCT01341665|SIADH|siadh
521480|NCT01341665|copeptin|copeptin
521481|NCT01341639|combination vaccine|combination vaccine
521482|NCT01341639|diphtheria|diphtheria
521483|NCT01341639|pertussis|pertussis
521484|NCT01341639|tetanus|tetanus
521485|NCT01341639|hepatitis B|hepatitis b
521486|NCT01341639|Hep B|hep b
521487|NCT01341639|Haemophilus influenzae b|haemophilus influenzae b
521488|NCT01341639|Hib|hib
521489|NCT01341639|polio|polio
521490|NCT01341639|poliovirus|poliovirus
521491|NCT01341626|delinquency|delinquency
521492|NCT01341626|drug use|drug use
521493|NCT01341626|HIV risk behavior|hiv risk behavior
521494|NCT01341626|economic costs|economic costs
521495|NCT01341600|Clopidogrel|clopidogrel
521496|NCT01341600|Pharmacogenetics|pharmacogenetics
521497|NCT01341600|Platelets|platelets
521498|NCT01341600|Healthy Subjects|healthy subjects
521499|NCT01341587|SMBG (self monitoring of blood glucose)|smbg (self monitoring of blood glucose)
521500|NCT01341587|diabetes|diabetes
521501|NCT01341587|mobile technology|mobile technology
521502|NCT01341574|spatial neglect|spatial neglect
521503|NCT01341574|stroke|stroke
521504|NCT01341548|Nasal|nasal
521505|NCT01341548|Cluster Headache|cluster headache
521506|NCT01341548|Episodic Cluster|episodic cluster
521507|NCT01341548|Headache|headache
521508|NCT01341548|Phase 3|phase 3
521509|NCT01341548|Civamide|civamide
521510|NCT01341548|TRPV-1 Receptor|trpv-1 receptor
521511|NCT01341509|Surgical Treatment of Insertional Achilles Tendinopathy|surgical treatment of insertional achilles tendinopathy
521512|NCT01341496|Metastatic Cancer|metastatic cancer
521513|NCT01341496|Cancer Vaccine|cancer vaccine
521514|NCT01341496|Immunotherapy|immunotherapy
521515|NCT01341496|Chest Metastases|chest metastases
521516|NCT01341496|Sarcoma|sarcoma
521517|NCT01341496|Melanoma|melanoma
521518|NCT01341483|erectile dysfunction|erectile dysfunction
521519|NCT01341483|internal pudendal artery|internal pudendal artery
521520|NCT01341483|erection|erection
521521|NCT01341483|coronary artery disease|coronary artery disease
521522|NCT01341483|peripheral atherosclerotic disease|peripheral atherosclerotic disease
521523|NCT01341431|Parkinson disease|parkinson disease
521524|NCT01341431|Bee venom|bee venom
521525|NCT01341431|Motor fluctuations|motor fluctuations
521526|NCT01341431|Disease progression|disease progression
521527|NCT01341418|tibia|tibia
521528|NCT01341418|suprapatellar|suprapatellar
521529|NCT01341392|Drug-Drug interaction between the CKD-501 and Amlodipine|drug-drug interaction between the ckd-501 and amlodipine
521530|NCT01341379|Ureagenesis|ureagenesis
521531|NCT01341379|Urea cycle|urea cycle
521532|NCT01341379|Inborn errors of metabolism|inborn errors of metabolism
521533|NCT01341366|Laparoscopic surgery|laparoscopic surgery
521534|NCT01341340|Stent|stent
521535|NCT01341340|Infrapopliteal|infrapopliteal
521536|NCT01341340|Tibial|tibial
521537|NCT01341340|Limb Salvage|limb salvage
521538|NCT01341327|Left Main|left main
521539|NCT01341314|joint pain|joint pain
521540|NCT01341314|stiffness|stiffness
521541|NCT01341301|allogeneic stem cell transplant|allogeneic stem cell transplant
521542|NCT01341301|TJU 2 Step|tju 2 step
521543|NCT01341301|HSCT|hsct
521544|NCT01341301|Hematopoietic stem cell transplantation|hematopoietic stem cell transplantation
521545|NCT01341288|prostate cancer|prostate cancer
521546|NCT01341288|EUCLIDIAN|euclidian
521547|NCT01341288|Endo-Uro Computed Lattice for Intratumoral Delivery, Implantation, Ablation with Nanosensing|endo-uro computed lattice for intratumoral delivery, implantation, ablation with nanosensing
521548|NCT01341288|robot|robot
521549|NCT01341288|brachytherapy|brachytherapy
521550|NCT01341288|seed implantation|seed implantation
521551|NCT01341275|hepatitis B vaccine|hepatitis b vaccine
521552|NCT01341275|duration of protection|duration of protection
521553|NCT01341275|adolescent immunization|adolescent immunization
521554|NCT01341275|anamnestic response|anamnestic response
521555|NCT01341275|booster dose|booster dose
521556|NCT01341275|Immunity to hepatitis B as measured by anti-HBSAg titers|immunity to hepatitis b as measured by anti-hbsag titers
521557|NCT01341262|autologous stem cell transplantation|autologous stem cell transplantation
521558|NCT01341262|thalidomide|thalidomide
521559|NCT01341262|induction therapy|induction therapy
521560|NCT01341236|VLBW|vlbw
521561|NCT01341236|IUGR|iugr
521562|NCT01341236|NIRS|nirs
521563|NCT01341236|enteral nutrition|enteral nutrition
521564|NCT01341236|superior mesenteric artery doppler|superior mesenteric artery doppler
521565|NCT01341210|Patients Satisfaction|patients satisfaction
521566|NCT01341210|Decision Making|decision making
521567|NCT01341210|Informed Consent|informed consent
521568|NCT01341197|Fecal immunochemical test|fecal immunochemical test
521569|NCT01341197|Guaiac fecal occult blood test|guaiac fecal occult blood test
521570|NCT01341197|Helicobacter pylori stool antigen test|helicobacter pylori stool antigen test
521571|NCT01341197|Mass screening|mass screening
521572|NCT01341197|Bidirectional endoscopy|bidirectional endoscopy
521573|NCT01341184|rifabutin|rifabutin
521574|NCT01341184|rifampin|rifampin
521575|NCT01341184|TMC207|tmc207
521576|NCT01341184|tuberculosis|tuberculosis
521578|NCT01341171|aromatase inhibitors|aromatase inhibitors
521579|NCT01341171|breast cancer|breast cancer
521580|NCT01341171|platelets|platelets
521581|NCT01341158|Malignatn Melanoma|malignatn melanoma
521582|NCT01341145|hypertension|hypertension
521583|NCT01341145|aerobic exercise|aerobic exercise
521584|NCT01341145|relaxation|relaxation
521585|NCT01341145|functional magnetic resonance imaging (fMRI)|functional magnetic resonance imaging (fmri)
521586|NCT01341145|magnetic resonance spectroscopy (MRS)|magnetic resonance spectroscopy (mrs)
521587|NCT01341145|brain health|brain health
521589|NCT01341132|Hepatocellular Carcinoma|hepatocellular carcinoma
521591|NCT01341132|Liver|liver
521592|NCT01341106|chronic hepatitis B|chronic hepatitis b
521593|NCT01341106|liver fibrosis|liver fibrosis
521594|NCT01341106|treatment with Entecavir|treatment with entecavir
521595|NCT01341080|Balance|balance
521596|NCT01341080|Postural impairment|postural impairment
521597|NCT01341080|Falls|falls
521598|NCT01341080|Parkinson Disease|parkinson disease
521599|NCT01341054|mucositis|mucositis
521600|NCT01341054|chamomilla|chamomilla
521601|NCT01341054|therapeutics|therapeutics
521602|NCT01341028|weight loss|weight loss
521603|NCT01341028|appetite|appetite
521604|NCT01341028|ghrelin|ghrelin
521605|NCT01341028|PYY|pyy
521606|NCT01341028|GLP-1|glp-1
521607|NCT01341028|insulin|insulin
521608|NCT01341028|laparoscopic|laparoscopic
521609|NCT01341028|Roux-en-Y gastric bypass|roux-en-y gastric bypass
521610|NCT01341028|gastric fundus resection|gastric fundus resection
521611|NCT01341002|Postoperative Care|postoperative care
521612|NCT01341002|red blood cell transfusion|red blood cell transfusion
521613|NCT01341002|venous oxygen saturation|venous oxygen saturation
521614|NCT01340989|women undergoing laparoscopic surgery for: hysterectomy, colpopexy, endometriosis, adhesions or myomas|women undergoing laparoscopic surgery for: hysterectomy, colpopexy, endometriosis, adhesions or myomas
521615|NCT01340976|Cancer Related Anemia|cancer related anemia
521616|NCT01340963|Chagas heart disease|chagas heart disease
521617|NCT01340963|ventricular tachycardia|ventricular tachycardia
521618|NCT01340963|atrial fibrillation|atrial fibrillation
521619|NCT01340963|stroke|stroke
521620|NCT01340963|cardiac death|cardiac death
521621|NCT01340963|signal averaged electrocardiogram|signal averaged electrocardiogram
521622|NCT01340950|Prevention|prevention
521623|NCT01340950|Anti-Retroviral Agents|anti-retroviral agents
521624|NCT01340950|Neuropsychological Tests|neuropsychological tests
521625|NCT01340937|Diphtheria|diphtheria
521626|NCT01340937|Tetanus|tetanus
521627|NCT01340937|Whooping Cough (pertussis)|whooping cough (pertussis)
521628|NCT01340937|Poliomyelitis|poliomyelitis
521629|NCT01340937|Hepatitis B infection|hepatitis b infection
521630|NCT01340937|Haemophilus influenzae type b infection|haemophilus influenzae type b infection
521631|NCT01340924|Gestational diabetes|gestational diabetes
521632|NCT01340924|Type 2 diabetes|type 2 diabetes
521633|NCT01340898|meningococcal conjugate vaccine|meningococcal conjugate vaccine
521634|NCT01340898|serogroups A,C, W-135 or Y|serogroups a,c, w-135 or y
521635|NCT01340898|meningococcal diseases|meningococcal diseases
521636|NCT01340898|Immunogenicity|immunogenicity
521637|NCT01340898|Neisseria meningitidis|neisseria meningitidis
521638|NCT01340898|co-administration|co-administration
521639|NCT01340898|routine vaccines|routine vaccines
521640|NCT01340885|attention|attention
521641|NCT01340885|mild cognitive impairment|mild cognitive impairment
521642|NCT01340885|dementia|dementia
521643|NCT01340872|iron deficiency|iron deficiency
521644|NCT01340872|anaemia|anaemia
521645|NCT01340872|inflammatory bowel disease|inflammatory bowel disease
521646|NCT01340872|ulcerative colitis|ulcerative colitis
521647|NCT01340859|Suicide|suicide
521648|NCT01340859|Cognitive Therapy|cognitive therapy
521649|NCT01340859|Inpatient|inpatient
521650|NCT01340859|Military|military
521651|NCT01340846|gemfibrozil|gemfibrozil
521652|NCT01340846|BRAF|braf
521653|NCT01340846|Drug Interactions|drug interactions
521654|NCT01340846|GSK2118436|gsk2118436
521655|NCT01340846|warfarin|warfarin
521656|NCT01340846|ketoconazole|ketoconazole
521657|NCT01340846|BRAF inhibitor|braf inhibitor
521658|NCT01340846|oncology|oncology
521659|NCT01340846|BRAF positive tumor|braf positive tumor
521660|NCT01340833|GSK2118436|gsk2118436
521661|NCT01340833|BRAF inhibitor|braf inhibitor
521662|NCT01340833|BRAF-mutation positive tumor|braf-mutation positive tumor
521663|NCT01340833|Oncology|oncology
521664|NCT01340833|absolute bioavailability|absolute bioavailability
521665|NCT01340833|microtracer|microtracer
521666|NCT01340781|inpatients|inpatients
521667|NCT01340781|medical|medical
521668|NCT01340781|polysomnogram|polysomnogram
521669|NCT01340781|questionnaires|questionnaires
521670|NCT01340768|Glucose metabolism disorders Metabolic diseases Peptidase inhibitors|glucose metabolism disorders metabolic diseases peptidase inhibitors
521671|NCT01340755|Rectal cancer|rectal cancer
521672|NCT01340742|Remote ischemic preconditioning|remote ischemic preconditioning
521673|NCT01340742|Abdominal surgery|abdominal surgery
521674|NCT01340742|Perioperative complications|perioperative complications
521675|NCT01340729|melanoma|melanoma
521676|NCT01340729|TPI 287|tpi 287
521677|NCT01340729|tumor recurrence|tumor recurrence
521678|NCT01340729|tumor progression|tumor progression
521679|NCT01340729|novel taxane analog|novel taxane analog
521680|NCT01340703|optic disc pit|optic disc pit
521681|NCT01340703|retinal detachment|retinal detachment
521682|NCT01340703|retinoschisis|retinoschisis
521683|NCT01340703|vitrectomy|vitrectomy
521684|NCT01340703|posterior vitreous detachment|posterior vitreous detachment
521685|NCT01340690|ADHD|adhd
521686|NCT01340690|children|children
521687|NCT01340690|adolescents|adolescents
521688|NCT01340690|Polyunsaturated Fatty Acids|polyunsaturated fatty acids
521689|NCT01340690|ADHDRS - IV|adhdrs - iv
521690|NCT01340677|Canagliflozin (JNJ-28431754)|canagliflozin (jnj-28431754)
521691|NCT01340677|Pharmacokinetic|pharmacokinetic
521692|NCT01340677|Dose proportionality|dose proportionality
521693|NCT01340664|Canagliflozin|canagliflozin
521694|NCT01340664|Placebo|placebo
521695|NCT01340664|Metformin|metformin
521696|NCT01340664|Hemoglobin A1c|hemoglobin a1c
521697|NCT01340664|Type 2 diabetes mellitus|type 2 diabetes mellitus
521698|NCT01340651|myelofibrosis|myelofibrosis
521699|NCT01340651|myeloproliferative neoplasms|myeloproliferative neoplasms
521700|NCT01340651|PMF|pmf
521701|NCT01340651|PET-MF|pet-mf
521702|NCT01340651|PPV-MF|ppv-mf
521703|NCT01340638|Seal pressure|seal pressure
521704|NCT01340638|Cookgas|cookgas
521705|NCT01340638|AirQ|airq
521706|NCT01340638|LMA|lma
521707|NCT01340638|supraglottic device|supraglottic device
521708|NCT01340625|Healthy Subjects|healthy subjects
521709|NCT01340612|large aneurysm|large aneurysm
521710|NCT01340612|wide-necked aneurysm|wide-necked aneurysm
521711|NCT01340612|recurring aneurysm|recurring aneurysm
521712|NCT01340586|PHARMACOKINETIC|pharmacokinetic
521713|NCT01340586|NOS|nos
521714|NCT01340573|Chronic Hepatitis C|chronic hepatitis c
521715|NCT01340573|pegylated interferon|pegylated interferon
521716|NCT01340573|PegIntron Pen|pegintron pen
521717|NCT01340573|Ribavirin|ribavirin
521718|NCT01340560|Endometrium, local injury, implantation, pregnancy, in vitro fertilization|endometrium, local injury, implantation, pregnancy, in vitro fertilization
521719|NCT01340547|Phase I|phase i
521720|NCT01340547|Safety|safety
521721|NCT01340547|PK|pk
521722|NCT01340547|ECG QTc|ecg qtc
521723|NCT01340547|Efficacy|efficacy
521724|NCT01340547|Palifosfamide-tris|palifosfamide-tris
521725|NCT01340547|non-randomized|non-randomized
521726|NCT01340534|Surgical wound infection|surgical wound infection
521727|NCT01340534|Oxygen|oxygen
521728|NCT01340534|Cesarean|cesarean
521729|NCT01340521|Pituitary Hormone Response|pituitary hormone response
521730|NCT01340521|Clomiphene Citrate|clomiphene citrate
521731|NCT01340521|Follicle Stimulating Hormone|follicle stimulating hormone
521732|NCT01340521|Luteinizing Hormone|luteinizing hormone
521733|NCT01340508|Pathological complete response|pathological complete response
521734|NCT01340508|Intensity modulated radiotherapy|intensity modulated radiotherapy
521735|NCT01340508|Rectal cancer|rectal cancer
521736|NCT01340495|Breast Cancer|breast cancer
521737|NCT01340495|Mastectomy|mastectomy
521738|NCT01340482|XLH|xlh
521739|NCT01340469|nosocomial infections|nosocomial infections
521740|NCT01340469|necrotizing enterocolitis|necrotizing enterocolitis
521741|NCT01340469|preterm infants|preterm infants
521742|NCT01340469|ver low birth weight|ver low birth weight
521743|NCT01340469|probiotics|probiotics
521744|NCT01340456|4beta-OHcholesterol|4beta-ohcholesterol
521745|NCT01340456|Midazolam|midazolam
521746|NCT01340456|CYP3A4|cyp3a4
521747|NCT01340456|Enzyme induction|enzyme induction
521748|NCT01340456|Drug metabolism|drug metabolism
521749|NCT01340430|her2 positive breast cancer|her2 positive breast cancer
521750|NCT01340430|her2 positive non operable breast cancer|her2 positive non operable breast cancer
521751|NCT01340430|her2 positive locally advanced breast cancer|her2 positive locally advanced breast cancer
521752|NCT01340430|neoadjuvant trastuzumab|neoadjuvant trastuzumab
521753|NCT01340430|pathologic complete response|pathologic complete response
521754|NCT01340417|melatonin|melatonin
521755|NCT01340417|preterm|preterm
521756|NCT01340417|deficiency|deficiency
521757|NCT01340417|neuroprotection|neuroprotection
521758|NCT01340391|cast, radius fracture|cast, radius fracture
521759|NCT01340378|neonatal surgery|neonatal surgery
521760|NCT01340378|Blalock-Taussig shunt|blalock-taussig shunt
521761|NCT01340339|Jaundice|jaundice
521762|NCT01340339|Hyperbilirubinemia|hyperbilirubinemia
521763|NCT01340339|Phototherapy and Super-LED Fluorescent lamps|phototherapy and super-led fluorescent lamps
521764|NCT01340326|Post myocardial infarction ventricular remodeling|post myocardial infarction ventricular remodeling
521765|NCT01340326|valsartan|valsartan
521766|NCT01340313|caudal block, children, ultrasound, urological surgery|caudal block, children, ultrasound, urological surgery
521767|NCT01340300|Colorectal|colorectal
521768|NCT01340300|Breast|breast
521769|NCT01340300|Insulin|insulin
521770|NCT01340300|Exercise|exercise
521771|NCT01340287|Plant sterol|plant sterol
521772|NCT01340287|Hypercholesterolemia|hypercholesterolemia
521773|NCT01340287|diet|diet
521774|NCT01340287|dairy|dairy
521775|NCT01340287|isoprostanes|isoprostanes
521776|NCT01340287|Midly hypercholesterolemic subjects|midly hypercholesterolemic subjects
521777|NCT01340274|Community Reinforcement and Family Training|community reinforcement and family training
521778|NCT01340274|Concerned Significant Others|concerned significant others
521779|NCT01340274|Identified Problem Gambler|identified problem gambler
521780|NCT01340274|Therapeutics|therapeutics
521781|NCT01340261|Pediatric|pediatric
521782|NCT01340261|Chronic Pain|chronic pain
521783|NCT01340248|food effect|food effect
521784|NCT01340248|pharmacokinetics|pharmacokinetics
521785|NCT01340248|healthy male volunteers|healthy male volunteers
521786|NCT01340222|Preterm labour|preterm labour
521787|NCT01340222|monocyte|monocyte
521788|NCT01340222|lymphocyte|lymphocyte
521790|NCT01340222|Treg Lymphocytes|treg lymphocytes
521791|NCT01340222|biologic markers|biologic markers
521792|NCT01340222|immunology|immunology
521793|NCT01340222|HLA-DR|hla-dr
521794|NCT01340222|Th17|th17
521795|NCT01340183|Phase I|phase i
521796|NCT01340183|safety|safety
521797|NCT01340183|tolerability|tolerability
521798|NCT01340183|pharmacokinetics|pharmacokinetics
521799|NCT01340183|AZD5099|azd5099
521800|NCT01340183|volunteers|volunteers
521801|NCT01340183|safety of the drug AZD5099|safety of the drug azd5099
521802|NCT01340183|blood and urine levels of AZD5099|blood and urine levels of azd5099
521803|NCT01340183|single intravenous doses|single intravenous doses
521804|NCT01340183|healthy volunteers|healthy volunteers
521805|NCT01340157|Fexinidazole|fexinidazole
521806|NCT01340157|Phase I|phase i
521807|NCT01340157|Bioavailability study|bioavailability study
521808|NCT01340157|Food effect|food effect
521809|NCT01340157|Human African Trypanosomiasis|human african trypanosomiasis
521810|NCT01340144|total knee replacement|total knee replacement
521811|NCT01340144|patellar crepitus|patellar crepitus
521812|NCT01340144|Replacement of knee joint|replacement of knee joint
521813|NCT01340131|CKD-828|ckd-828
521814|NCT01340131|Hypertension|hypertension
521815|NCT01340131|Primary Hypertension|primary hypertension
521816|NCT01340131|Healthy Volunteer|healthy volunteer
521817|NCT01340131|S-Amlodipine|s-amlodipine
521818|NCT01340131|Telmisartan|telmisartan
521819|NCT01340131|Amlodipine|amlodipine
521820|NCT01340131|Pharmacokinetic|pharmacokinetic
521821|NCT01340131|Phase 1|phase 1
521822|NCT01340118|Asthma|asthma
521823|NCT01340118|FEF25-75|fef25-75
521824|NCT01340118|exhaled nitric oxide|exhaled nitric oxide
663235|NCT00776737|HV|hv
521825|NCT01340118|inhaled corticosteroid|inhaled corticosteroid
521826|NCT01340118|children|children
521827|NCT01340105|Microwave ablation|microwave ablation
521828|NCT01340105|Radiofrequency ablation|radiofrequency ablation
521829|NCT01340105|Randomised controlled trial|randomised controlled trial
521830|NCT01340092|Family Navigator|family navigator
521831|NCT01340092|Autistic Disorder|autistic disorder
521832|NCT01340092|Early Intervention|early intervention
521833|NCT01340092|Developmental Disabilities|developmental disabilities
521834|NCT01340092|Child Development Disorders|child development disorders
521835|NCT01340079|diabetes mellitus, non-insulin dependent|diabetes mellitus, non-insulin dependent
521836|NCT01340066|urinary incontinence|urinary incontinence
521837|NCT01340066|stress incontinence|stress incontinence
521838|NCT01340066|urge incontinence|urge incontinence
521839|NCT01340066|mixed incontinence|mixed incontinence
521840|NCT01340040|Phase I|phase i
521841|NCT01340040|cancer|cancer
521842|NCT01340040|solid tumours|solid tumours
521843|NCT01340040|advanced solid malignancies|advanced solid malignancies
521844|NCT01340040|dose escalation|dose escalation
521845|NCT01340040|Insulin like growth factor|insulin like growth factor
521846|NCT01340040|Japanese|japanese
521847|NCT01340027|Urinary incontinence|urinary incontinence
521848|NCT01340027|Overactive bladder (OAB)|overactive bladder (oab)
521849|NCT01340027|Micturition|micturition
521850|NCT01340027|Frequency|frequency
521851|NCT01340027|YM178|ym178
521852|NCT01340027|Urgency incontinence|urgency incontinence
521853|NCT01340027|Urgency|urgency
521854|NCT01340014|Glaucoma|glaucoma
521855|NCT01340014|Intraocular pressure|intraocular pressure
521856|NCT01340014|Tonometry, ocular|tonometry, ocular
521857|NCT01340001|Dementia with Lewy bodies|dementia with lewy bodies
521858|NCT01340001|Nucleus basalis of Meynert|nucleus basalis of meynert
521859|NCT01340001|Deep brain stimulation|deep brain stimulation
521860|NCT01339988|Stem-cells|stem-cells
521861|NCT01339988|Transplantation|transplantation
521862|NCT01339988|Busulfex|busulfex
521863|NCT01339988|Cyclophosphamide|cyclophosphamide
521864|NCT01339988|Total-Body-Ittadiation|total-body-ittadiation
521865|NCT01339975|Renal Cell Carcinoma|renal cell carcinoma
521866|NCT01339975|Nephrectomy|nephrectomy
521867|NCT01339975|Antiangiogenics|antiangiogenics
521868|NCT01339975|Chemokines|chemokines
521869|NCT01339975|Prognostic value|prognostic value
521870|NCT01339975|Carcinoma|carcinoma
521871|NCT01339975|Carcinoma, Renal Cell|carcinoma, renal cell
521872|NCT01339975|Kidney Neoplasms|kidney neoplasms
521873|NCT01339975|Kidney Diseases|kidney diseases
521874|NCT01339975|Neoplasms, Glandular and Epithelial|neoplasms, glandular and epithelial
521875|NCT01339975|Neoplasms by Histologic Type|neoplasms by histologic type
521876|NCT01339975|Neoplasms|neoplasms
521877|NCT01339975|Adenocarcinoma|adenocarcinoma
521878|NCT01339975|Urologic Neoplasms|urologic neoplasms
521879|NCT01339975|Urogenital Neoplasms|urogenital neoplasms
521880|NCT01339975|Neoplasms by Site|neoplasms by site
521881|NCT01339975|Urologic Diseases|urologic diseases
521882|NCT01339975|Adjuvants, Immunologic|adjuvants, immunologic
521883|NCT01339975|Physiological Effects of Drugs|physiological effects of drugs
521884|NCT01339975|Pharmacologic Actions|pharmacologic actions
521885|NCT01339975|Biomarkers|biomarkers
521886|NCT01339975|Targeted therapies|targeted therapies
521887|NCT01339975|Surgery|surgery
521888|NCT01339962|Metastatic renal cell carcinoma|metastatic renal cell carcinoma
521889|NCT01339949|AMD|amd
521890|NCT01339949|wet AMD|wet amd
521891|NCT01339949|Macular Degeneration|macular degeneration
521892|NCT01339949|wet Age-related Macular Degeneration|wet age-related macular degeneration
521893|NCT01339949|Age-Related Macular Degeneration|age-related macular degeneration
521894|NCT01339949|IRay|iray
521895|NCT01339949|radiation|radiation
521896|NCT01339949|Oraya|oraya
521897|NCT01339949|Oraya Therapeutics, Inc|oraya therapeutics, inc
521898|NCT01339949|Low-voltage stereotactic radiosurgery|low-voltage stereotactic radiosurgery
521899|NCT01339949|radiosurgery|radiosurgery
521900|NCT01339949|x-ray|x-ray
521901|NCT01339949|Lucentis|lucentis
521902|NCT01339949|external beam radiation|external beam radiation
521903|NCT01339923|Meningococcal disease|meningococcal disease
521904|NCT01339923|Vaccines|vaccines
521905|NCT01339923|intercalated administration|intercalated administration
521906|NCT01339910|Acute Myelogenous Leukemia|acute myelogenous leukemia
521907|NCT01339910|Myelodysplastic Syndrome|myelodysplastic syndrome
521908|NCT01339897|N6022, GSNORi|n6022, gsnori
521909|NCT01339884|Friedreich ataxia|friedreich ataxia
521910|NCT01339884|Resveratrol|resveratrol
521911|NCT01339884|Frataxin|frataxin
521912|NCT01339884|Cardiomyopathy|cardiomyopathy
521913|NCT01339884|Oxidative stress|oxidative stress
521914|NCT01339871|Pazopanib|pazopanib
521915|NCT01339871|Vorinostat|vorinostat
521916|NCT01339871|Advanced Malignancies|advanced malignancies
521917|NCT01339845|Cholera vaccine|cholera vaccine
521918|NCT01339845|Behaviour change intervention|behaviour change intervention
663306|NCT00776373|ALL|all
521919|NCT01339845|Cost effectiveness and cost-benefit|cost effectiveness and cost-benefit
521920|NCT01339845|Prevention of cholera|prevention of cholera
521921|NCT01339845|Control of Cholera|control of cholera
521922|NCT01339845|Vaccination|vaccination
521923|NCT01339806|mTBI|mtbi
521924|NCT01339806|Concussion|concussion
521925|NCT01339793|corporate social responsibility|corporate social responsibility
521926|NCT01339793|social identity theory|social identity theory
521927|NCT01339793|stakeholder theory|stakeholder theory
521928|NCT01339793|organizational commitment|organizational commitment
521929|NCT01339793|organizational performance|organizational performance
521930|NCT01339767|Autism|autism
521931|NCT01339767|Language Acquisition|language acquisition
521932|NCT01339767|Language Development|language development
521933|NCT01339767|Toddlers|toddlers
521934|NCT01339754|recurrent pancreatic cancer|recurrent pancreatic cancer
521935|NCT01339754|stage IV pancreatic cancer|stage iv pancreatic cancer
521936|NCT01339754|adenocarcinoma of the pancreas|adenocarcinoma of the pancreas
521937|NCT01339741|Psoriasis Vulgaris|psoriasis vulgaris
521938|NCT01339741|Vitamin D Deficiency|vitamin d deficiency
521939|NCT01339741|Vitamin D Insufficiency|vitamin d insufficiency
521940|NCT01339741|Vitamin D Supplement|vitamin d supplement
521941|NCT01339741|Psoriasis Area and Severity Index (PASI Score)|psoriasis area and severity index (pasi score)
521942|NCT01339741|Dermatologic Life Qualify Index (DLQI)|dermatologic life qualify index (dlqi)
521943|NCT01339715|Ryodoraku|ryodoraku
521944|NCT01339715|Heart Rate Variability|heart rate variability
521945|NCT01339715|Traditional medicine|traditional medicine
521946|NCT01339715|Autonomic Nervous System|autonomic nervous system
521947|NCT01339715|Acupuncture|acupuncture
521948|NCT01339715|Far Infrared Ray|far infrared ray
521949|NCT01339715|CV12 Acupoint|cv12 acupoint
521950|NCT01339702|Traumatic Brain Injury|traumatic brain injury
521951|NCT01339702|TBI|tbi
521952|NCT01339702|Head Trauma|head trauma
521953|NCT01339702|Acute Traumatic Brain Injury|acute traumatic brain injury
521954|NCT01339702|Trauma, Brain|trauma, brain
521955|NCT01339689|PTSD|ptsd
521956|NCT01339689|Posttraumatic Stress Disorder|posttraumatic stress disorder
521957|NCT01339689|pharmacotherapy|pharmacotherapy
521958|NCT01339689|ganaxolone|ganaxolone
521959|NCT01339676|Vitamin D|vitamin d
521960|NCT01339676|Multiple Sclerosis|multiple sclerosis
521961|NCT01339676|MRI|mri
521962|NCT01339676|Randomised Trial|randomised trial
521963|NCT01339676|Finland|finland
521964|NCT01339650|Solid Tumor|solid tumor
521965|NCT01339650|BRCA 1 and BRCA 2 Mutations|brca 1 and brca 2 mutations
521966|NCT01339650|Breast Cancer 1|breast cancer 1
521967|NCT01339650|Breast Cancer 2|breast cancer 2
521968|NCT01339650|High Grade Serous Ovarian, Fallopian Tube, or Primary Peritoneal Cancers|high grade serous ovarian, fallopian tube, or primary peritoneal cancers
521969|NCT01339650|Solid Tumors|solid tumors
521970|NCT01339637|Impaired Glucose Tolerance|impaired glucose tolerance
521971|NCT01339637|Diabetes Risk Factors|diabetes risk factors
521972|NCT01339637|Dark Skin|dark skin
521973|NCT01339624|analgesia|analgesia
521974|NCT01339624|renal colic|renal colic
521975|NCT01339624|ketorolac|ketorolac
521976|NCT01339624|nasal fentanyl|nasal fentanyl
521977|NCT01339624|morphine.|morphine.
521978|NCT01339624|treatment of acute renal colic|treatment of acute renal colic
521979|NCT01339611|quality of life|quality of life
521980|NCT01339611|medical adherence|medical adherence
521981|NCT01339611|warfarin|warfarin
521982|NCT01339611|Health education|health education
521983|NCT01339572|autologous transplantation|autologous transplantation
521984|NCT01339572|peripheral stem cell mobilization|peripheral stem cell mobilization
521985|NCT01339559|Epilepsy|epilepsy
521986|NCT01339559|Brivaracetam|brivaracetam
521987|NCT01339559|Partial Onset Seizures|partial onset seizures
521988|NCT01339559|Adjunctive treatment|adjunctive treatment
521989|NCT01339546|ecologic|ecologic
521990|NCT01339546|cross sectional|cross sectional
521991|NCT01339546|trend analysis|trend analysis
521992|NCT01339533|ALI|ali
521993|NCT01339533|ARDS|ards
521994|NCT01339481|Orencia|orencia
521995|NCT01339481|Abatacept|abatacept
521996|NCT01339481|Rheumatoid Arthritis|rheumatoid arthritis
521997|NCT01339481|Infusion|infusion
521998|NCT01339468|advagraf|advagraf
521999|NCT01339468|prograf|prograf
522000|NCT01339468|living donor liver transplantation|living donor liver transplantation
522001|NCT01339468|FK506|fk506
522002|NCT01339468|Immunosuppressant|immunosuppressant
522003|NCT01339455|Neuromyelitis Optica|neuromyelitis optica
522004|NCT01339455|NMO|nmo
522005|NCT01339455|Devic's Disease|devic's disease
522006|NCT01339455|Stem Cell Transplant|stem cell transplant
522007|NCT01339429|wound|wound
522008|NCT01339429|negative pressure wound therapy|negative pressure wound therapy
522009|NCT01339429|non-powered negative pressure wound therapy|non-powered negative pressure wound therapy
522010|NCT01339390|Obesity|obesity
522011|NCT01339390|Veteran|veteran
522012|NCT01339390|Self Care|self care
522013|NCT01339390|Patient Education|patient education
522014|NCT01339390|Peer Group|peer group
522015|NCT01339377|Ozone|ozone
522016|NCT01339377|Oxygen|oxygen
522017|NCT01339377|Oxygen-Ozone|oxygen-ozone
522018|NCT01339377|AO-1000|ao-1000
522019|NCT01339377|ActiveO|activeo
522020|NCT01339377|Herniated Disc|herniated disc
522021|NCT01339377|Disc|disc
522022|NCT01339377|Lumbar|lumbar
522023|NCT01339351|breast cancer|breast cancer
522024|NCT01339351|social connection|social connection
522025|NCT01339325|Laparo-endoscopic single site cholecystectomy|laparo-endoscopic single site cholecystectomy
522026|NCT01339325|Quality of Life|quality of life
522027|NCT01339325|Postoperative Pain|postoperative pain
522028|NCT01339325|Cosmetics|cosmetics
522029|NCT01339325|Complication|complication
522030|NCT01339312|Rabies|rabies
522031|NCT01339312|Rabies virus|rabies virus
522032|NCT01339312|Purified Vero Rabies Vaccine - Serum Free|purified vero rabies vaccine - serum free
522033|NCT01339299|COS|cos
522034|NCT01339299|ART|art
522035|NCT01339299|Infertility|infertility
522036|NCT01339273|TAP block|tap block
522037|NCT01339273|Laparoscopic hemicolectomy|laparoscopic hemicolectomy
522038|NCT01339273|Laparoscopic anterior resection|laparoscopic anterior resection
522039|NCT01339273|laparoscopic colonic resection|laparoscopic colonic resection
522040|NCT01339247|Bioequivalence|bioequivalence
522041|NCT01339247|Paroxetine reference/test|paroxetine reference/test
522042|NCT01339247|healthy volunteers|healthy volunteers
522043|NCT01339247|Fed condition|fed condition
522044|NCT01339234|treadmill exercise|treadmill exercise
522045|NCT01339234|rehabilitation|rehabilitation
522046|NCT01339234|progressive multiple sclerosis|progressive multiple sclerosis
522047|NCT01339234|functional ability|functional ability
522048|NCT01339234|quality of life|quality of life
522049|NCT01339234|fatigue|fatigue
522050|NCT01339221|Observational|observational
522051|NCT01339221|Rotarix™|rotarix™
522052|NCT01339221|post-marketing|post-marketing
522053|NCT01339208|Type 2 Diabetes|type 2 diabetes
522054|NCT01339195|Dementia|dementia
522055|NCT01339195|Alzheimer disease|alzheimer disease
522057|NCT01339195|cognitive impairment|cognitive impairment
522058|NCT01339182|somatropin|somatropin
522059|NCT01339182|PK|pk
522060|NCT01339182|PD|pd
522061|NCT01339182|male|male
522062|NCT01339182|pharmacokinetics|pharmacokinetics
522063|NCT01339182|pharmacodynamics|pharmacodynamics
522064|NCT01339182|safety|safety
522065|NCT01339169|YF476|yf476
522066|NCT01339169|Hypergastrinaemia|hypergastrinaemia
522067|NCT01339169|netazepide|netazepide
522068|NCT01339169|gastric carcinoids|gastric carcinoids
522069|NCT01339156|Safety|safety
522070|NCT01339156|Tolerability|tolerability
522071|NCT01339156|Food Effect|food effect
522072|NCT01339156|Pharmacokinetics|pharmacokinetics
522073|NCT01339143|Vildagliptin|vildagliptin
522074|NCT01339130|Alzheimer disease|alzheimer disease
522075|NCT01339130|Stroke|stroke
522669|NCT01336816|nicotine|nicotine
522076|NCT01339130|Frontotemporal Lobar Degeneration|frontotemporal lobar degeneration
522077|NCT01339130|Lewy Body Dementia|lewy body dementia
522078|NCT01339130|Huntington Disease|huntington disease
522079|NCT01339130|mild cognitive impairment|mild cognitive impairment
522080|NCT01339130|vascular injury|vascular injury
522081|NCT01339130|Parkinson's disease|parkinson's disease
522082|NCT01339117|irritable bowel syndrome|irritable bowel syndrome
522083|NCT01339117|children|children
522084|NCT01339117|chronic abdominal pain|chronic abdominal pain
522085|NCT01339117|recurrent abdominal pain|recurrent abdominal pain
522086|NCT01339104|Cardiovascular safety|cardiovascular safety
522087|NCT01339078|Biliary strictures|biliary strictures
522088|NCT01339078|liver transplantation|liver transplantation
522089|NCT01339065|ketamine|ketamine
522090|NCT01339065|inflammatory|inflammatory
522091|NCT01339065|pro inflammatory|pro inflammatory
522092|NCT01339065|pro inflammatory markers IL-6 and IL-1beta|pro inflammatory markers il-6 and il-1beta
522093|NCT01339052|BKM120|bkm120
522094|NCT01339052|Brain tumor|brain tumor
522095|NCT01339039|AMD3100|amd3100
522096|NCT01339039|plerixafor|plerixafor
522097|NCT01339039|Mozobil|mozobil
522098|NCT01339039|bevacizumab|bevacizumab
522099|NCT01339026|Acute coronary syndrome|acute coronary syndrome
522100|NCT01339026|Platelet reactivity|platelet reactivity
522101|NCT01339026|Clopidogrel|clopidogrel
522102|NCT01339026|Percutaneous coronary intervention|percutaneous coronary intervention
522103|NCT01339013|Quantification|quantification
522104|NCT01339013|ventilatory requirements|ventilatory requirements
522105|NCT01339013|charcoal filter|charcoal filter
522106|NCT01339000|Colorectal Cancer|colorectal cancer
522107|NCT01339000|Breast Cancer|breast cancer
522108|NCT01339000|Immunization|immunization
522109|NCT01339000|Immunocompromised Host|immunocompromised host
522110|NCT01339000|Bladder Cancer|bladder cancer
522111|NCT01339000|Colon Cancer|colon cancer
522112|NCT01338987|FLT|flt
522113|NCT01338987|Leuprolide|leuprolide
522114|NCT01338987|Thymic Renewal|thymic renewal
522115|NCT01338987|Stem Cell Transplant|stem cell transplant
522116|NCT01338987|Acute Lymphocytic Leukemia|acute lymphocytic leukemia
522117|NCT01338987|Acute Myelogenous Leukemia|acute myelogenous leukemia
522118|NCT01338987|Myelodysplastic Syndrome|myelodysplastic syndrome
522119|NCT01338974|adult acute myeloid leukemia with 11q23 (MLL) abnormalities|adult acute myeloid leukemia with 11q23 (mll) abnormalities
522120|NCT01338974|adult acute myeloid leukemia with del(5q)|adult acute myeloid leukemia with del(5q)
522121|NCT01338974|adult acute myeloid leukemia with inv(16)(p13;q22)|adult acute myeloid leukemia with inv(16)(p13;q22)
522122|NCT01338974|adult acute myeloid leukemia with t(16;16)(p13;q22)|adult acute myeloid leukemia with t(16;16)(p13;q22)
522123|NCT01338974|adult acute myeloid leukemia with t(8;21)(q22;q22)|adult acute myeloid leukemia with t(8;21)(q22;q22)
522124|NCT01338974|recurrent adult acute myeloid leukemia|recurrent adult acute myeloid leukemia
522125|NCT01338974|untreated adult acute myeloid leukemia|untreated adult acute myeloid leukemia
522126|NCT01338974|adult acute minimally differentiated myeloid leukemia (M0)|adult acute minimally differentiated myeloid leukemia (m0)
522127|NCT01338974|adult acute myeloblastic leukemia without maturation (M1)|adult acute myeloblastic leukemia without maturation (m1)
522128|NCT01338974|adult acute myeloblastic leukemia with maturation (M2)|adult acute myeloblastic leukemia with maturation (m2)
522129|NCT01338974|adult acute myelomonocytic leukemia (M4)|adult acute myelomonocytic leukemia (m4)
522130|NCT01338974|adult acute monoblastic leukemia (M5a)|adult acute monoblastic leukemia (m5a)
522131|NCT01338974|adult acute monocytic leukemia (M5b)|adult acute monocytic leukemia (m5b)
522132|NCT01338974|adult erythroleukemia (M6a)|adult erythroleukemia (m6a)
522133|NCT01338974|adult pure erythroid leukemia (M6b)|adult pure erythroid leukemia (m6b)
522134|NCT01338974|adult acute megakaryoblastic leukemia (M7)|adult acute megakaryoblastic leukemia (m7)
522135|NCT01338961|Cardiopulmonary Bypass|cardiopulmonary bypass
522136|NCT01338961|Hypothermia|hypothermia
522137|NCT01338961|Normothermia|normothermia
522138|NCT01338961|Troponin I|troponin i
522139|NCT01338961|Bleeding|bleeding
522140|NCT01338935|CW 002|cw 002
522141|NCT01338935|Phase I trial|phase i trial
522142|NCT01338935|safety|safety
522143|NCT01338935|efficacy|efficacy
522144|NCT01338935|pharmacokinetics|pharmacokinetics
522145|NCT01338935|estimated dose|estimated dose
522146|NCT01338935|Neuromuscular Blocking Agents|neuromuscular blocking agents
522147|NCT01338935|Treatment Effectiveness|treatment effectiveness
522148|NCT01338935|Drug Antagonism|drug antagonism
522149|NCT01338909|prasugrel|prasugrel
522150|NCT01338909|clopidogrel|clopidogrel
522151|NCT01338909|primary percutaneous coronary intervention|primary percutaneous coronary intervention
522152|NCT01338909|high platelet reactivity|high platelet reactivity
522153|NCT01338896|Rotigotine|rotigotine
522154|NCT01338896|Neupro|neupro
522155|NCT01338883|HIV-1 Infection|hiv-1 infection
522156|NCT01338883|CCR5-tropic|ccr5-tropic
522157|NCT01338883|Anti-retroviral naive|anti-retroviral naive
522158|NCT01338870|Phase 2|phase 2
522159|NCT01338870|safety and efficacy study with PF-04991532|safety and efficacy study with pf-04991532
522160|NCT01338870|Type 2 diabetes|type 2 diabetes
522161|NCT01338857|neurofibromatosis1 (NF1)|neurofibromatosis1 (nf1)
522162|NCT01338857|Recurrent or progressive optic pathway gliomas (OPG)|recurrent or progressive optic pathway gliomas (opg)
522163|NCT01338857|Recurrent or progressive low-grade glioma|recurrent or progressive low-grade glioma
522164|NCT01338857|sorafenib|sorafenib
522165|NCT01338857|low-grade astrocytoma|low-grade astrocytoma
522166|NCT01338844|Poor oocyte quality|poor oocyte quality
522167|NCT01338844|IVF failure|ivf failure
522168|NCT01338831|prostate cancer,|prostate cancer,
522169|NCT01338831|breast cancer,|breast cancer,
522170|NCT01338831|prolactin,|prolactin,
522171|NCT01338831|prolactin receptor|prolactin receptor
522172|NCT01338831|uterine leiomyoma|uterine leiomyoma
522173|NCT01338818|Attention Deficit /Hyperactivity Disorder,|attention deficit /hyperactivity disorder,
522174|NCT01338818|hyperactivity|hyperactivity
522175|NCT01338805|Partial onset seizure|partial onset seizure
522176|NCT01338805|seizure frequency|seizure frequency
522177|NCT01338805|nervous system diseases|nervous system diseases
522178|NCT01338805|central nervous system diseases|central nervous system diseases
522180|NCT01338805|brain diseases|brain diseases
522181|NCT01338805|neurologic manifestations|neurologic manifestations
522182|NCT01338805|adjunctive treatment|adjunctive treatment
522183|NCT01338805|AEDs|aeds
522184|NCT01338805|antiepileptic drug|antiepileptic drug
522185|NCT01338779|Tolerance|tolerance
522186|NCT01338779|Renal|renal
522187|NCT01338779|Allograft|allograft
522188|NCT01338779|B Cell Signature|b cell signature
522189|NCT01338766|spondylolisthesis|spondylolisthesis
522190|NCT01338766|lumbar spinal stenosis|lumbar spinal stenosis
522191|NCT01338753|breast|breast
522192|NCT01338753|cancer|cancer
522193|NCT01338753|Pharmacogenomics|pharmacogenomics
522194|NCT01338753|bevacizumab|bevacizumab
522195|NCT01338740|Chrohn's disease|chrohn's disease
522196|NCT01338740|Moderate to severely active Crohn's disease patients|moderate to severely active crohn's disease patients
522197|NCT01338714|HBV carrier|hbv carrier
522198|NCT01338714|HBV DNA title|hbv dna title
522199|NCT01338714|Chinese Medicine|chinese medicine
522200|NCT01338714|Liver function|liver function
522201|NCT01338714|RHD-1|rhd-1
522202|NCT01338701|TBI|tbi
522203|NCT01338701|Headaches|headaches
522204|NCT01338701|Military|military
522205|NCT01338701|Acupuncture|acupuncture
522206|NCT01338701|Walter Reed Army Medical Center|walter reed army medical center
522207|NCT01338701|Fort Belvoir Community Hospital|fort belvoir community hospital
522208|NCT01338675|Chronic granulomatous disease|chronic granulomatous disease
522209|NCT01338675|Hematopoietic Stem Cell Transplantation|hematopoietic stem cell transplantation
522210|NCT01338662|Parkinson`s disease|parkinson`s disease
522211|NCT01338649|Parkinson's disease|parkinson's disease
522212|NCT01338649|Daytime somnolence|daytime somnolence
522213|NCT01338649|Sleepiness|sleepiness
522214|NCT01338649|Light therapy|light therapy
522215|NCT01338636|Exercise-induced pulmonary arterial hypertension (EIPAH)|exercise-induced pulmonary arterial hypertension (eipah)
522216|NCT01338636|Pulmonary arterial hypertension (PAH)|pulmonary arterial hypertension (pah)
522217|NCT01338636|ambrisentan|ambrisentan
522218|NCT01338636|Advanced cardiopulmonary exercise test (CPET)|advanced cardiopulmonary exercise test (cpet)
522219|NCT01338623|bioequivalence|bioequivalence
522220|NCT01338623|tansulosine|tansulosine
522221|NCT01338610|Ocular discomfort|ocular discomfort
522222|NCT01338597|thyroidectomy|thyroidectomy
522223|NCT01338597|invasiveness|invasiveness
522224|NCT01338584|Pelvic floor muscle training|pelvic floor muscle training
522225|NCT01338584|Post prostatectomy|post prostatectomy
522226|NCT01338584|Early regaining of urinary continence|early regaining of urinary continence
522227|NCT01338584|Positive improvement in quality of life|positive improvement in quality of life
522228|NCT01338571|stool fatty acid|stool fatty acid
522229|NCT01338532|Hip osteoarthritis|hip osteoarthritis
522230|NCT01338532|Exercise|exercise
522231|NCT01338532|Patient Education|patient education
522232|NCT01338532|Total Hip Replacement|total hip replacement
522233|NCT01338506|Military|military
522234|NCT01338506|Posttraumatic Stress Disorder|posttraumatic stress disorder
522235|NCT01338506|PTSD|ptsd
522236|NCT01338506|PostTraumatic Stress Disorders|posttraumatic stress disorders
522237|NCT01338506|Combat|combat
522238|NCT01338506|Psychological Treatment|psychological treatment
522239|NCT01338506|Psychotherapy|psychotherapy
522240|NCT01338506|Trauma|trauma
522241|NCT01338506|Posttraumatic Stress|posttraumatic stress
522242|NCT01338506|Prolonged Exposure|prolonged exposure
522243|NCT01338506|Exposure therapy|exposure therapy
522244|NCT01338506|Behavior Therapy|behavior therapy
522245|NCT01338506|Cognitive Behavior Therapy|cognitive behavior therapy
522246|NCT01338506|Stress Disorders|stress disorders
522247|NCT01338506|Drug Abuse|drug abuse
522248|NCT01338506|Drug Dependence|drug dependence
522249|NCT01338506|Alcohol Abuse|alcohol abuse
522250|NCT01338506|Alcohol Dependence|alcohol dependence
522251|NCT01338506|Substance Use Disorders|substance use disorders
522252|NCT01338506|Alcoholism|alcoholism
522253|NCT01338480|trauma|trauma
522254|NCT01338480|surgery|surgery
522255|NCT01338480|informed consent|informed consent
522256|NCT01338467|Glaucoma|glaucoma
522257|NCT01338467|Refractory glaucoma|refractory glaucoma
522258|NCT01338467|Cyclocoagulation|cyclocoagulation
522259|NCT01338467|High Intensity Focused Ultrasound|high intensity focused ultrasound
522260|NCT01338441|Drug induced QT prolongation|drug induced qt prolongation
522261|NCT01338428|rape|rape
522262|NCT01338428|sexual assault|sexual assault
522263|NCT01338428|intervention|intervention
522264|NCT01338428|female university students|female university students
522265|NCT01338415|pediatric|pediatric
522266|NCT01338415|pulmonary arterial hypertension|pulmonary arterial hypertension
522267|NCT01338415|bosentan|bosentan
522268|NCT01338415|Tracleer|tracleer
522269|NCT01338363|acid suppressing drugs|acid suppressing drugs
522270|NCT01338363|pharmacoepidemiology|pharmacoepidemiology
522271|NCT01338363|children|children
522272|NCT01338350|safety|safety
522273|NCT01338350|tolerability|tolerability
522274|NCT01338350|pharmacokinetics|pharmacokinetics
522275|NCT01338350|pharmacodynamics|pharmacodynamics
522276|NCT01338350|AZD5423|azd5423
522277|NCT01338350|Japanese|japanese
522278|NCT01338337|Low risk International Prognostic Scoring System (IPSS) (0 or Int-1)|low risk international prognostic scoring system (ipss) (0 or int-1)
522279|NCT01338337|Patients who have not responded to previous treatment with erythropoietin (EPO)|patients who have not responded to previous treatment with erythropoietin (epo)
522280|NCT01338337|Eastern Cooperative Oncology Group (ECOG) score ≤ 3|eastern cooperative oncology group (ecog) score ≤ 3
522281|NCT01338324|Biomarker|biomarker
522282|NCT01338324|Pharmacokinetics|pharmacokinetics
522283|NCT01338324|Villous|villous
522284|NCT01338324|Simvastatin|simvastatin
522285|NCT01338324|Celiac disease|celiac disease
522286|NCT01338298|Schizophrenia|schizophrenia
522287|NCT01338298|Symptomatic Hyperprolactinemia|symptomatic hyperprolactinemia
522288|NCT01338298|Hormone|hormone
522289|NCT01338298|Menstrual|menstrual
522290|NCT01338285|Industry Hygiene|industry hygiene
522291|NCT01338285|Molecular Epidemiology|molecular epidemiology
522292|NCT01338285|Cancer Susceptability|cancer susceptability
522293|NCT01338285|Genotoxocity|genotoxocity
522294|NCT01338285|FISH|fish
522295|NCT01338142|postmenopausal|postmenopausal
663821|NCT00774319|TPF|tpf
522297|NCT01338142|absorption|absorption
522298|NCT01338142|calcium|calcium
522299|NCT01338142|amorphous calcium|amorphous calcium
522300|NCT01338129|vitamin c|vitamin c
522301|NCT01338129|ascorbic acid|ascorbic acid
522302|NCT01338129|ankle fracture|ankle fracture
522303|NCT01338129|crps|crps
522304|NCT01338129|rds|rds
522305|NCT01338129|crps prevention|crps prevention
522306|NCT01338116|computerized decision support system|computerized decision support system
522307|NCT01338116|PCR|pcr
522308|NCT01338116|antibiotic treatment|antibiotic treatment
522309|NCT01338103|Pemphigus|pemphigus
522310|NCT01338103|Rituximab|rituximab
522311|NCT01338103|Cylex|cylex
522312|NCT01338090|VEGF imaging|vegf imaging
522313|NCT01338090|neuroendocrine tumors|neuroendocrine tumors
522314|NCT01338090|biomarker|biomarker
522315|NCT01338090|mTOR inhibition|mtor inhibition
522316|NCT01338077|Alginate|alginate
522317|NCT01338077|Gastroesophageal reflux disease|gastroesophageal reflux disease
522318|NCT01338064|Silicosis|silicosis
522319|NCT01338051|Community based participatory research|community based participatory research
522320|NCT01338025|HIV|hiv
522321|NCT01338025|Bridging|bridging
522322|NCT01338025|Strategy|strategy
522323|NCT01338012|metastatic castrate resistant prostate cancer|metastatic castrate resistant prostate cancer
522324|NCT01338012|prostate cancer|prostate cancer
522325|NCT01338012|prostate|prostate
522326|NCT01338012|immune therapy|immune therapy
522327|NCT01338012|immunotherapy|immunotherapy
522328|NCT01338012|vaccine|vaccine
522329|NCT01338012|dendritic cells|dendritic cells
522330|NCT01338012|antigen-presenting cells|antigen-presenting cells
522331|NCT01338012|antigen presenting cells|antigen presenting cells
522332|NCT01338012|cancer vaccine|cancer vaccine
522333|NCT01338012|prostatic adenocarcinoma|prostatic adenocarcinoma
522334|NCT01338012|Sipuleucel-T|sipuleucel-t
522335|NCT01338012|castration resistant prostate cancer (CRPC)|castration resistant prostate cancer (crpc)
522336|NCT01338012|booster|booster
522337|NCT01338012|retreatment|retreatment
522338|NCT01338012|immune memory|immune memory
522339|NCT01338012|immune response|immune response
522340|NCT01337986|Multiple Sclerosis|multiple sclerosis
522341|NCT01337986|Optic Neuritis|optic neuritis
522342|NCT01337986|Ampyra|ampyra
522343|NCT01337986|Dalfampridine|dalfampridine
522344|NCT01337986|Fampridine|fampridine
522345|NCT01337986|Remote Optic Neuritis|remote optic neuritis
522346|NCT01337986|Contrast Sensitivity|contrast sensitivity
522347|NCT01337986|Treatment|treatment
522348|NCT01337973|violence|violence
522349|NCT01337973|aggression|aggression
522350|NCT01337973|Substance-Related Disorders|substance-related disorders
522351|NCT01337973|Alcohol-Related Disorders|alcohol-related disorders
522352|NCT01337973|Drug-Related Disorders|drug-related disorders
522353|NCT01337960|Stroke|stroke
522354|NCT01337960|Robotics|robotics
522355|NCT01337960|Neurorehabilitation|neurorehabilitation
522356|NCT01337947|Type 1 diabetes|type 1 diabetes
522357|NCT01337947|adolescents|adolescents
522358|NCT01337947|exercise|exercise
522359|NCT01337947|vascular function|vascular function
522360|NCT01337934|Septic shock|septic shock
522361|NCT01337934|Sepsis|sepsis
522362|NCT01337934|Albumin|albumin
522363|NCT01337934|Lactated Ringer|lactated ringer
522364|NCT01337908|depression|depression
522365|NCT01337908|quality of life|quality of life
522366|NCT01337908|disability|disability
522367|NCT01337895|Dairy|dairy
522368|NCT01337895|obesity|obesity
522369|NCT01337895|overweight|overweight
522370|NCT01337895|weight loss|weight loss
522371|NCT01337895|adults|adults
522372|NCT01337882|Air Pollution|air pollution
522373|NCT01337882|Diesel exhaust|diesel exhaust
522374|NCT01337882|Biodiesel exhaust|biodiesel exhaust
522375|NCT01337882|Vascular function|vascular function
522376|NCT01337882|Fibrinolysis|fibrinolysis
522377|NCT01337882|Acute vascular and endothelial responses|acute vascular and endothelial responses
522378|NCT01337869|Bascom Procedure, Limberg, Pilonidal Disease|bascom procedure, limberg, pilonidal disease
522379|NCT01337856|time-effectiveness|time-effectiveness
522380|NCT01337856|hand hygiene protocols|hand hygiene protocols
522381|NCT01337843|Chronic low back pain|chronic low back pain
522382|NCT01337843|cognitive behavioral pain management|cognitive behavioral pain management
522383|NCT01337843|coping|coping
522384|NCT01337843|mindfulness|mindfulness
522385|NCT01337843|physical activity|physical activity
522386|NCT01337843|Back Pain Lower Back Chronic|back pain lower back chronic
522387|NCT01337830|smoking|smoking
522388|NCT01337830|smokeless|smokeless
522389|NCT01337830|aversion|aversion
522390|NCT01337830|nicotine|nicotine
522391|NCT01337830|nicotine replacement|nicotine replacement
522392|NCT01337817|smoking|smoking
522393|NCT01337817|smokeless|smokeless
522394|NCT01337817|aversion|aversion
522395|NCT01337817|nicotine|nicotine
522396|NCT01337817|nicotine replacement|nicotine replacement
522397|NCT01337791|chronic hepatitis B|chronic hepatitis b
522398|NCT01337791|hepatitis B virus|hepatitis b virus
522399|NCT01337791|perinatal transmission|perinatal transmission
522400|NCT01337791|Telbivudine|telbivudine
522401|NCT01337778|gender based violence|gender based violence
522402|NCT01337778|maternal and child health|maternal and child health
522403|NCT01337778|women|women
522404|NCT01337778|India|india
522405|NCT01337765|BEZ235,|bez235,
522406|NCT01337765|MEK162|mek162
522407|NCT01337765|RAS RAF mutations,|ras raf mutations,
522408|NCT01337765|triple negative breast cancer|triple negative breast cancer
522409|NCT01337765|pancreatic cancer,|pancreatic cancer,
522410|NCT01337765|NSCLC progressed on EGFR TKI|nsclc progressed on egfr tki
522411|NCT01337765|PI3K/mTOR inhibitor,|pi3k/mtor inhibitor,
522412|NCT01337765|MEK inhibitor|mek inhibitor
522413|NCT01337765|Advanced and selected solid tumors|advanced and selected solid tumors
522414|NCT01337752|multiple myeloma|multiple myeloma
522415|NCT01337752|renal insufficiency|renal insufficiency
522416|NCT01337752|untreated multiple myeloma|untreated multiple myeloma
522417|NCT01337739|Hysteroscopic Surgery|hysteroscopic surgery
522418|NCT01337739|Dexmedetomidine|dexmedetomidine
522419|NCT01337739|Sedation|sedation
522420|NCT01337739|Opioids|opioids
522421|NCT01337726|Depression|depression
522422|NCT01337726|Heart Failure|heart failure
522423|NCT01337726|Chronic Obstructive Pulmonary Disease|chronic obstructive pulmonary disease
522424|NCT01337726|Quality of Life|quality of life
522425|NCT01337726|Functional Impairment|functional impairment
522426|NCT01337713|Anxiety, GAD, Massage|anxiety, gad, massage
522427|NCT01337700|ASD|asd
522428|NCT01337700|Autism|autism
522429|NCT01337700|Autism Spectrum Disorder|autism spectrum disorder
522430|NCT01337700|Asperger Syndrome|asperger syndrome
522431|NCT01337700|Asperger|asperger
522432|NCT01337700|PDD|pdd
522433|NCT01337700|PDD-NOS|pdd-nos
522434|NCT01337687|Autism|autism
522435|NCT01337687|Autism Spectrum Disorders|autism spectrum disorders
522436|NCT01337687|Oxytocin|oxytocin
522437|NCT01337687|Hollander|hollander
522438|NCT01337687|ASD|asd
522439|NCT01337687|Asperger Syndrome|asperger syndrome
522440|NCT01337687|Asperger|asperger
522441|NCT01337661|Chronic Obstructive Pulmonary Disease|chronic obstructive pulmonary disease
522442|NCT01337661|COPD|copd
522443|NCT01337661|Acute Exacerbation of COPD|acute exacerbation of copd
522444|NCT01337661|AECOPD|aecopd
522445|NCT01337648|Fecal biomarkers|fecal biomarkers
522446|NCT01337648|Radiation biodosimetry|radiation biodosimetry
522447|NCT01337648|Total-body irradiation (TBI)|total-body irradiation (tbi)
522448|NCT01337648|Hematopoietic stem cell transplantation|hematopoietic stem cell transplantation
522449|NCT01337648|Gene expression profiles|gene expression profiles
522450|NCT01337648|Fecal metabolites|fecal metabolites
522451|NCT01337609|Depression|depression
522452|NCT01337609|Irritable Bowel Syndrome|irritable bowel syndrome
522453|NCT01337609|Probiotic|probiotic
522454|NCT01337609|Bacillus Coagulans|bacillus coagulans
522455|NCT01337596|pain|pain
522456|NCT01337596|neuropathic pain|neuropathic pain
522457|NCT01337596|headaches|headaches
522458|NCT01337583|HIV Infections|hiv infections
522459|NCT01337583|Anti-HIV agents|anti-hiv agents
522460|NCT01337583|HIV-1|hiv-1
522461|NCT01337570|HIV Infections|hiv infections
522462|NCT01337570|Anti-HIV agents|anti-hiv agents
522463|NCT01337570|HIV-1|hiv-1
522464|NCT01337557|Allergic conjunctivitis|allergic conjunctivitis
522465|NCT01337544|HAPLOIDENTICAL STEM CELL TRANSPLANTATION|haploidentical stem cell transplantation
522466|NCT01337544|NK CELL|nk cell
522467|NCT01337544|IL-15|il-15
522468|NCT01337531|Ovarian Response in PCOS|ovarian response in pcos
522469|NCT01337531|pregnancy rate in PCOS|pregnancy rate in pcos
522470|NCT01337531|miscarriage rate in PCOS|miscarriage rate in pcos
522471|NCT01337518|Prostate Specific Antigen|prostate specific antigen
522472|NCT01337518|Castration Resistant Prostate Cancer|castration resistant prostate cancer
522473|NCT01337518|Adenocarcinoma|adenocarcinoma
522474|NCT01337518|Androgen Receptor|androgen receptor
522475|NCT01337518|Metastases|metastases
522476|NCT01337505|INNO-206|inno-206
522477|NCT01337505|Phase 1|phase 1
522478|NCT01337505|DOXO-EMCH|doxo-emch
522479|NCT01337505|Advanced solid tumors|advanced solid tumors
522480|NCT01337492|Hepatocellular Carcinoma|hepatocellular carcinoma
522481|NCT01337492|Orthotopic Liver Transplant|orthotopic liver transplant
522482|NCT01337466|Phase I|phase i
522483|NCT01337466|FIAU|fiau
522484|NCT01337466|Fialuridine|fialuridine
522485|NCT01337466|Biodistribution|biodistribution
522486|NCT01337466|Dosimetry|dosimetry
522487|NCT01337466|Prosthetic|prosthetic
522488|NCT01337466|Joint|joint
522489|NCT01337466|Infection|infection
522490|NCT01337466|PET-CT|pet-ct
522491|NCT01337453|botulinum toxin|botulinum toxin
522492|NCT01337453|flu like symptoms|flu like symptoms
522493|NCT01337453|frequency of FLS|frequency of fls
522494|NCT01337453|Botox|botox
522495|NCT01337440|Ursodeoxycholic Acid|ursodeoxycholic acid
522496|NCT01337440|sitagliptin|sitagliptin
522497|NCT01337440|bile acids|bile acids
522498|NCT01337440|GLP-1|glp-1
522499|NCT01337427|multiple sclerosis|multiple sclerosis
522500|NCT01337427|relapsing|relapsing
664018|NCT00773552|OAB|oab
522501|NCT01337427|MS|ms
522502|NCT01337427|injectable|injectable
522503|NCT01337427|subcutaneous|subcutaneous
522504|NCT01337427|SC|sc
522505|NCT01337427|PEGylated|pegylated
522506|NCT01337427|interferon|interferon
522507|NCT01337427|PEG|peg
522508|NCT01337427|OCT|oct
522509|NCT01337427|Optical Coherence Tomography|optical coherence tomography
522510|NCT01337414|age-related macular degeneration|age-related macular degeneration
522511|NCT01337414|screening|screening
522512|NCT01337414|monitoring|monitoring
522513|NCT01337414|diagnosis|diagnosis
522514|NCT01337414|dry or non-neovascular age-related macular degeneration (high risk, intermediate, geographic atrophy or AREDS grade 3/4 AMD)|dry or non-neovascular age-related macular degeneration (high risk, intermediate, geographic atrophy or areds grade 3/4 amd)
522515|NCT01337401|Cediranib|cediranib
522516|NCT01337401|ASPS|asps
522517|NCT01337401|Sarcoma|sarcoma
522518|NCT01337362|Diabetes|diabetes
522519|NCT01337362|Hypoglycaemia|hypoglycaemia
522520|NCT01337362|EEG|eeg
522521|NCT01337362|Thermography|thermography
522522|NCT01337362|Hypoglycaemia-associated autonomic failure|hypoglycaemia-associated autonomic failure
522523|NCT01337362|QTc interval|qtc interval
522524|NCT01337362|Hypoglycemic alarm device|hypoglycemic alarm device
522525|NCT01337362|Hormone response|hormone response
522526|NCT01337349|Pentoxifylline|pentoxifylline
522527|NCT01337349|Chronic Congestive Heart Failure|chronic congestive heart failure
522528|NCT01337349|Left Systolic Function|left systolic function
522529|NCT01337349|Biomarkers|biomarkers
522530|NCT01337323|allergic rhinitis, allergies, concomitant medications, allergy symptoms|allergic rhinitis, allergies, concomitant medications, allergy symptoms
522531|NCT01337310|Advanced solid tumors|advanced solid tumors
522532|NCT01337297|crack cocaine|crack cocaine
522533|NCT01337297|addiction|addiction
522534|NCT01337297|tDCS|tdcs
522535|NCT01337297|ERP|erp
522536|NCT01337297|P300|p300
522537|NCT01337297|attention|attention
522538|NCT01337297|inhibitory control|inhibitory control
522539|NCT01337297|working memory|working memory
522540|NCT01337271|artificial, ventilation|artificial, ventilation
522541|NCT01337271|mechanical ventilation|mechanical ventilation
522542|NCT01337271|weaning|weaning
522543|NCT01337258|cost effectiveness|cost effectiveness
522544|NCT01337258|dutasteride|dutasteride
522545|NCT01337258|elevated risk population|elevated risk population
522546|NCT01337258|Prostate cancer|prostate cancer
522547|NCT01337258|prevention|prevention
522548|NCT01337245|Envenomation|envenomation
522549|NCT01337245|Coral Snake|coral snake
522550|NCT01337245|Antivenom|antivenom
522551|NCT01337245|Micrurus fulvius|micrurus fulvius
522552|NCT01337232|language development disorders|language development disorders
522553|NCT01337232|learning disorders|learning disorders
522554|NCT01337232|sentences|sentences
522556|NCT01337232|school-age|school-age
522557|NCT01337232|language|language
522558|NCT01337219|cystic fibrosis|cystic fibrosis
522559|NCT01337219|bioequivalence|bioequivalence
522560|NCT01337219|pharmacokinetic|pharmacokinetic
522561|NCT01337219|sputum|sputum
522562|NCT01337219|plasma|plasma
522563|NCT01337206|Esophageal Stenosis|esophageal stenosis
522564|NCT01337206|Esopageal Strictures|esopageal strictures
522565|NCT01337206|Esophageal Dysphagia|esophageal dysphagia
522566|NCT01337193|stress urinary incontinence|stress urinary incontinence
522567|NCT01337193|exercise|exercise
522568|NCT01337193|pelvic floor muscles|pelvic floor muscles
522569|NCT01337193|biofeedback|biofeedback
522570|NCT01337193|rehabilitative ultrasound imaging|rehabilitative ultrasound imaging
522571|NCT01337180|lung function|lung function
522572|NCT01337180|respiratory symptoms|respiratory symptoms
522573|NCT01337180|dust|dust
522574|NCT01337180|inflammation|inflammation
522575|NCT01337180|prospective|prospective
522576|NCT01337167|Diphtheria|diphtheria
522577|NCT01337167|Tetanus|tetanus
522578|NCT01337167|Whooping Cough (pertussis)|whooping cough (pertussis)
522579|NCT01337167|Poliomyelitis|poliomyelitis
522580|NCT01337167|Hepatitis B infection|hepatitis b infection
522581|NCT01337167|Haemophilus influenzae type b infection|haemophilus influenzae type b infection
522582|NCT01337154|NSCLC|nsclc
522583|NCT01337154|non-small cell lung cancer|non-small cell lung cancer
522584|NCT01337154|tamibarotene|tamibarotene
522585|NCT01337141|Telemedicine|telemedicine
522586|NCT01337141|Type 1 diabetes|type 1 diabetes
522587|NCT01337141|Metabolic control optimisation|metabolic control optimisation
522588|NCT01337141|Health care costs|health care costs
522589|NCT01337141|Intervention study|intervention study
522590|NCT01337141|Access to internet|access to internet
522591|NCT01337115|Postoperative pain|postoperative pain
522592|NCT01337115|Knee arthroplasty|knee arthroplasty
522593|NCT01337115|Peripheral nerve blocks|peripheral nerve blocks
522594|NCT01337115|Sciatic nerve block|sciatic nerve block
522595|NCT01337115|Femoral nerve block|femoral nerve block
522596|NCT01337102|Lung Cancer|lung cancer
522597|NCT01337102|Stage 3b|stage 3b
522598|NCT01337102|Stage 4|stage 4
522599|NCT01337102|First Line Chemotherapy Treatment|first line chemotherapy treatment
522600|NCT01337102|Quality Of Life|quality of life
522601|NCT01337102|Palliative Care|palliative care
522602|NCT01337102|Randomized|randomized
522603|NCT01337102|Lung Cancer Scale|lung cancer scale
522604|NCT01337089|Cancer pain|cancer pain
522605|NCT01337089|Opioid therapy|opioid therapy
522606|NCT01337089|Inadequate analgesia|inadequate analgesia
522607|NCT01337089|Optimized chronic opioid therapy|optimized chronic opioid therapy
522608|NCT01337063|Adverse drug events|adverse drug events
522609|NCT01337050|Hepatocellular Carcinoma|hepatocellular carcinoma
522610|NCT01337050|Advanced/Metastatic solid tumors|advanced/metastatic solid tumors
522611|NCT01337037|video-assisted thoracic surgery|video-assisted thoracic surgery
522612|NCT01337037|Lung cancer|lung cancer
522613|NCT01337037|lobectomy|lobectomy
522614|NCT01337024|HRV|hrv
522615|NCT01337024|NDO|ndo
522616|NCT01337024|BoNT/A,|bont/a,
522617|NCT01337024|adverse effects|adverse effects
522618|NCT01337011|Chronic Ischemic Cardiomyopathy|chronic ischemic cardiomyopathy
522619|NCT01336998|necrotizing enterocolitis|necrotizing enterocolitis
522620|NCT01336998|arginine supplementation|arginine supplementation
522621|NCT01336998|calprotectin|calprotectin
522622|NCT01336985|Chemoembolization|chemoembolization
522623|NCT01336985|Hepatic Metastases|hepatic metastases
522624|NCT01336985|Irinotecan|irinotecan
522625|NCT01336985|Drug Eluding Beads|drug eluding beads
522626|NCT01336985|Colorectal Cancer|colorectal cancer
522627|NCT01336985|Liver Cancer|liver cancer
522628|NCT01336985|Hepatic Cancer|hepatic cancer
522629|NCT01336985|Melanoma|melanoma
522630|NCT01336959|Acute Kidney Injury|acute kidney injury
522631|NCT01336959|Cardiopulmonary Bypass|cardiopulmonary bypass
522632|NCT01336959|CABG|cabg
522633|NCT01336959|Cardiac Surgery|cardiac surgery
522634|NCT01336946|lifestyle|lifestyle
522635|NCT01336946|mental disorder|mental disorder
522636|NCT01336907|CNV|cnv
522637|NCT01336907|AMD|amd
522638|NCT01336907|Wet-treated CNV|wet-treated cnv
522639|NCT01336894|stage IA non-small cell lung cancer|stage ia non-small cell lung cancer
522640|NCT01336894|stage IB non-small cell lung cancer|stage ib non-small cell lung cancer
522641|NCT01336855|HIV|hiv
522642|NCT01336855|Observational|observational
522643|NCT01336855|Pathogenesis|pathogenesis
522644|NCT01336855|Immunology|immunology
522645|NCT01336855|Virology|virology
522646|NCT01336855|Control|control
522647|NCT01336855|Healthy control|healthy control
522648|NCT01336855|Men who have sex with men|men who have sex with men
522649|NCT01336842|panobinostat|panobinostat
522650|NCT01336842|cisplatin|cisplatin
522651|NCT01336842|pemetrexed|pemetrexed
522652|NCT01336842|dose escalation|dose escalation
522653|NCT01336829|Hepatitis C|hepatitis c
522654|NCT01336829|HIV|hiv
522655|NCT01336829|TMC125IFD1001|tmc125ifd1001
522656|NCT01336829|TMC125|tmc125
522657|NCT01336829|Intelence|intelence
522658|NCT01336829|etravirine|etravirine
522659|NCT01336829|ETR|etr
522660|NCT01336829|TMC278|tmc278
522661|NCT01336829|telaprevir|telaprevir
522662|NCT01336829|TVR|tvr
522663|NCT01336829|VX-950|vx-950
522664|NCT01336829|healthy volunteers|healthy volunteers
522665|NCT01336829|crossover|crossover
522666|NCT01336816|smoking|smoking
522667|NCT01336816|smokeless|smokeless
522668|NCT01336816|aversion|aversion
522670|NCT01336816|nicotine replacement|nicotine replacement
522671|NCT01336790|Lymphatic disease|lymphatic disease
522672|NCT01336790|Lymphedema|lymphedema
522673|NCT01336790|Lymphangiomatosis|lymphangiomatosis
522674|NCT01336790|Lymphangiectasia|lymphangiectasia
522675|NCT01336790|Protein-losing enteropathy|protein-losing enteropathy
522676|NCT01336790|Vascular Anomalies|vascular anomalies
522677|NCT01336777|obesity|obesity
522678|NCT01336777|adipocyte differentiation|adipocyte differentiation
522679|NCT01336777|inflammation|inflammation
522680|NCT01336777|insulin resistance|insulin resistance
522681|NCT01336777|visceral fat|visceral fat
522682|NCT01336777|regional fat depots|regional fat depots
522683|NCT01336764|driving distress|driving distress
522684|NCT01336764|veterans|veterans
522685|NCT01336764|OEF/OIF|oef/oif
522686|NCT01336738|Phase 2|phase 2
522687|NCT01336738|safety and efficacy study with PF-04991532|safety and efficacy study with pf-04991532
522688|NCT01336738|Type 2 diabetes|type 2 diabetes
522689|NCT01336725|Morbid obesity|morbid obesity
522690|NCT01336725|Patient education|patient education
522692|NCT01336712|CLL|cll
522693|NCT01336712|AML|aml
522694|NCT01336712|ALL|all
522695|NCT01336712|MDS|mds
522696|NCT01336712|HD|hd
522697|NCT01336712|NHL|nhl
522698|NCT01336712|MFB|mfb
522699|NCT01336712|P.vera|p.vera
522700|NCT01336712|Essential Thrombocytosis|essential thrombocytosis
522701|NCT01336699|Shigella sonnei|shigella sonnei
522702|NCT01336699|shigellosis|shigellosis
522703|NCT01336699|vaccine|vaccine
522704|NCT01336699|WRSs2|wrss2
522705|NCT01336699|WRSs3|wrss3
522706|NCT01336673|Glucophage XR|glucophage xr
522707|NCT01336673|Tolerability|tolerability
522708|NCT01336660|Effectiveness|effectiveness
522709|NCT01336660|New Antivenom|new antivenom
522710|NCT01336660|North Africa and Middle East Scorpio Envenomation|north africa and middle east scorpio envenomation
522711|NCT01336634|BRAF V600E|braf v600e
522712|NCT01336634|trametinib|trametinib
522713|NCT01336634|dabrafenib|dabrafenib
522714|NCT01336634|GSK2118436|gsk2118436
522715|NCT01336634|GSK1120212|gsk1120212
522716|NCT01336634|Oncology|oncology
522717|NCT01336634|Non-Small Cell Lung Cancer|non-small cell lung cancer
522718|NCT01336621|Partial-onset seizures|partial-onset seizures
522719|NCT01336621|retigabine IR|retigabine ir
522720|NCT01336621|Open Label Extension|open label extension
522721|NCT01336621|GW582892|gw582892
522722|NCT01336621|Epilepsy|epilepsy
522723|NCT01336595|total knee arthroplasty|total knee arthroplasty
522724|NCT01336595|oxidized zirconium|oxidized zirconium
522725|NCT01336595|genesis II|genesis ii
522726|NCT01336595|femoral component|femoral component
522727|NCT01336595|cobalt chrome|cobalt chrome
522728|NCT01336582|suitable candidate|suitable candidate
522729|NCT01336582|single agent docetaxel therapy|single agent docetaxel therapy
522730|NCT01336582|Advanced Solid Tumor|advanced solid tumor
522731|NCT01336569|Primary Open-Angle Glaucoma|primary open-angle glaucoma
522732|NCT01336569|Ocular Hypertension|ocular hypertension
522733|NCT01336569|Pigment Dispersion Glaucoma|pigment dispersion glaucoma
522734|NCT01336569|IOP|iop
522735|NCT01336556|Oral appliance|oral appliance
522736|NCT01336556|Continuous positive airway pressure|continuous positive airway pressure
522737|NCT01336556|Obstructive Sleep Apnea Syndrome|obstructive sleep apnea syndrome
522738|NCT01336556|Snore|snore
522739|NCT01336543|Non small cell lung cancer|non small cell lung cancer
522740|NCT01336543|Inoperable Stage III|inoperable stage iii
522741|NCT01336543|Inoperable|inoperable
522742|NCT01336543|Stage III|stage iii
522743|NCT01336530|Oesophageal pain|oesophageal pain
522744|NCT01336530|Radiotherapy|radiotherapy
522745|NCT01336530|Combined radio-chemotherapy|combined radio-chemotherapy
522746|NCT01336530|Oesophageal symptoms|oesophageal symptoms
522747|NCT01336517|Stroke|stroke
522748|NCT01336517|Hemiplegia|hemiplegia
522749|NCT01336517|AFO|afo
522750|NCT01336517|Gait|gait
522751|NCT01336478|NK|nk
522752|NCT01336478|natural killer|natural killer
522753|NCT01336478|immunotherapy|immunotherapy
522754|NCT01336478|leukemia|leukemia
522755|NCT01336478|hematological malignancies|hematological malignancies
522756|NCT01336478|stem cell transplantation|stem cell transplantation
522757|NCT01336478|adoptive therapy|adoptive therapy
522758|NCT01336439|Bruxism|bruxism
522759|NCT01336439|Polysomnography|polysomnography
522760|NCT01336439|Botulinum toxin type A|botulinum toxin type a
522761|NCT01336439|Masseter muscle|masseter muscle
522762|NCT01336439|Temporal muscle|temporal muscle
522763|NCT01336426|Peripheral Artery Disease|peripheral artery disease
522764|NCT01336426|PAD|pad
522765|NCT01336413|brain injuries, traumatic|brain injuries, traumatic
522766|NCT01336413|pregnenolone|pregnenolone
522767|NCT01336413|Veteran|veteran
522768|NCT01336413|OEF/OIF|oef/oif
522769|NCT01336413|neurosteroid|neurosteroid
522770|NCT01336413|allopregnanolone|allopregnanolone
522771|NCT01336400|Single cell haplotyping|single cell haplotyping
522772|NCT01336400|Preimplantation genetic diagnosis|preimplantation genetic diagnosis
522773|NCT01336361|Palliative Care|palliative care
522774|NCT01336361|Physical Therapy|physical therapy
522775|NCT01336361|Functionally Dependent Elderly|functionally dependent elderly
522776|NCT01336348|Prasugrel|prasugrel
522777|NCT01336348|Tirofiban|tirofiban
522778|NCT01336348|Clopidogrel|clopidogrel
522779|NCT01336348|glycoprotein IIa/IIIa inhibitors|glycoprotein iia/iiia inhibitors
522780|NCT01336348|P2Y12 blockers|p2y12 blockers
522781|NCT01336335|sleep apnea, obstructive|sleep apnea, obstructive
522782|NCT01336335|sympathetic nerve activity|sympathetic nerve activity
522783|NCT01336335|treatment|treatment
522784|NCT01336322|beta-cell function|beta-cell function
522785|NCT01336322|insulin resistance|insulin resistance
522787|NCT01336283|COPD|copd
522788|NCT01336283|Exercise Training|exercise training
522789|NCT01336270|Melanoma|melanoma
522790|NCT01336270|NK cells|nk cells
522791|NCT01336270|T lymphocytes|t lymphocytes
522792|NCT01336270|macrophages|macrophages
522793|NCT01336257|Decision Support Techniques|decision support techniques
522794|NCT01336257|Electronic Health Records|electronic health records
522795|NCT01336257|Reminder Systems|reminder systems
522796|NCT01336257|Early Detection of Cancer|early detection of cancer
522797|NCT01336257|Mammography|mammography
522798|NCT01336257|Women|women
522799|NCT01336244|Safety|safety
522800|NCT01336244|Tolerability|tolerability
522801|NCT01336244|Pharmacokinetics|pharmacokinetics
522802|NCT01336231|quality of life|quality of life
522803|NCT01336231|cognitive functions|cognitive functions
522804|NCT01336231|antiangiogenic agents|antiangiogenic agents
522805|NCT01336231|kidney cancer|kidney cancer
522806|NCT01336231|metastatic|metastatic
522807|NCT01336218|Phase 1|phase 1
522808|NCT01336218|healthy volunteers|healthy volunteers
522809|NCT01336218|Rheumatoid arthritis|rheumatoid arthritis
522810|NCT01336218|RA|ra
522811|NCT01336218|Fostamatinib|fostamatinib
522812|NCT01336218|Rifampicin|rifampicin
522813|NCT01336218|drug-drug interaction|drug-drug interaction
522814|NCT01336218|Pharmacokinetics|pharmacokinetics
522815|NCT01336218|Amount of Rifampicin in blood|amount of rifampicin in blood
522816|NCT01336205|Non-Cancer-Related Pain|non-cancer-related pain
522817|NCT01336205|Opioid-Induced Constipation|opioid-induced constipation
522818|NCT01336192|Advanced NSCLC|advanced nsclc
522819|NCT01336192|Maintenance therapy|maintenance therapy
522820|NCT01336192|Gemcitabine|gemcitabine
522821|NCT01336179|gingivitis|gingivitis
522822|NCT01336179|dental plaque|dental plaque
522823|NCT01336179|oral hygiene|oral hygiene
522824|NCT01336179|toothbrush|toothbrush
522825|NCT01336179|chewing sticks|chewing sticks
522826|NCT01336166|H1N1|h1n1
522827|NCT01336166|Vaccine|vaccine
522828|NCT01336166|Immunogenicity|immunogenicity
522829|NCT01336166|Safety|safety
522830|NCT01336153|Safety|safety
522831|NCT01336153|Efficacy|efficacy
522832|NCT01336153|MLC601|mlc601
522833|NCT01336153|motor recovery|motor recovery
522834|NCT01336140|regadenoson|regadenoson
522835|NCT01336140|chronic kidney disease|chronic kidney disease
522836|NCT01336140|renal failure|renal failure
522837|NCT01336140|lexiscan|lexiscan
522838|NCT01336140|aminophylline|aminophylline
522839|NCT01336140|SPECT|spect
522840|NCT01336140|Myocardial Perfusion Imaging|myocardial perfusion imaging
522841|NCT01336140|pharmacologic stress test|pharmacologic stress test
522842|NCT01336140|Patients with stage IV or V chronic kidney disease being assessed with nuclear stress testing of the heart using the stress agent regadenoson (Lexiscan ®)|patients with stage iv or v chronic kidney disease being assessed with nuclear stress testing of the heart using the stress agent regadenoson (lexiscan ®)
522843|NCT01336127|Occupational Therapy|occupational therapy
522844|NCT01336127|Parkinson's Disease|parkinson's disease
522845|NCT01336127|Effectiveness|effectiveness
522846|NCT01336127|RCT|rct
522847|NCT01336127|Activities of daily living|activities of daily living
522848|NCT01336127|Participation|participation
522849|NCT01336127|Caregiver's Burden|caregiver's burden
522850|NCT01336127|Economic evaluation|economic evaluation
522851|NCT01336101|PAD|pad
522852|NCT01336101|SFA|sfa
522853|NCT01336088|dyskinesia|dyskinesia
522854|NCT01336088|Parkinson's disease|parkinson's disease
522855|NCT01336075|Percutaneous radiofrequency catheter ablation|percutaneous radiofrequency catheter ablation
522856|NCT01336075|Mini invasive thoracoscopic radiofrequency ablation|mini invasive thoracoscopic radiofrequency ablation
522857|NCT01336062|advanced|advanced
522858|NCT01336062|resistant to prior chemotherapy|resistant to prior chemotherapy
522859|NCT01336010|Hepatitis C|hepatitis c
522860|NCT01336010|Acute Hepatitis C|acute hepatitis c
522861|NCT01336010|Early chronic Hepatitis C|early chronic hepatitis c
522862|NCT01335997|Low-density lipoprotein|low-density lipoprotein
522863|NCT01335997|LDL|ldl
522864|NCT01335997|High-density lipoprotein|high-density lipoprotein
522865|NCT01335997|HDL|hdl
522866|NCT01335997|Niacin|niacin
522867|NCT01335997|Lipid modifying therapy|lipid modifying therapy
522868|NCT01335997|Cholesterol|cholesterol
522869|NCT01335997|High cholesterol|high cholesterol
522870|NCT01335997|Triglycerides|triglycerides
522871|NCT01335984|telemonitoring|telemonitoring
522872|NCT01335984|usual care|usual care
522873|NCT01335984|telemedicine|telemedicine
522874|NCT01335984|telehealth|telehealth
522875|NCT01335984|home care|home care
522876|NCT01335984|Health Care Quality|health care quality
522877|NCT01335984|Access|access
522878|NCT01335984|Evaluation|evaluation
522879|NCT01335971|COPD|copd
522880|NCT01335971|Nrf2|nrf2
522881|NCT01335971|Sulforaphane|sulforaphane
522882|NCT01335945|Cryoablation|cryoablation
522883|NCT01335945|Cryotherapy|cryotherapy
522884|NCT01335945|Cryosurgery|cryosurgery
522885|NCT01335945|Pancreas|pancreas
522886|NCT01335945|Pancreatic Cancer|pancreatic cancer
522887|NCT01335945|Celiac Plexus|celiac plexus
522888|NCT01335945|Pain|pain
522889|NCT01335945|Abdominal pain|abdominal pain
522890|NCT01335932|Acute Lung Injury|acute lung injury
522891|NCT01335932|Acute Respiratory Distress Syndrome|acute respiratory distress syndrome
522892|NCT01335932|Respiratory Failure|respiratory failure
522893|NCT01335932|Cytomegalovirus seropositive|cytomegalovirus seropositive
522894|NCT01335932|Infection|infection
522895|NCT01335932|Intravenous Ganciclovir|intravenous ganciclovir
522896|NCT01335932|Non-immunocompromised|non-immunocompromised
522897|NCT01335932|Valganciclovir|valganciclovir
522898|NCT01335919|Hemoglobin|hemoglobin
522899|NCT01335919|Monitoring, Physiologic|monitoring, physiologic
522900|NCT01335919|Blood Gas Monitoring, Transcutaneous|blood gas monitoring, transcutaneous
522901|NCT01335906|Cancer Screening Tests|cancer screening tests
522902|NCT01335906|Early Diagnosis of Cancer|early diagnosis of cancer
522903|NCT01335906|Mammography|mammography
522904|NCT01335906|Informed Consent|informed consent
522905|NCT01335906|Consent Forms|consent forms
522906|NCT01335893|Imaging|imaging
664547|NCT00771394|BPH|bph
522907|NCT01335893|Indocyanine Green|indocyanine green
522908|NCT01335893|Lung Cancer|lung cancer
522909|NCT01335893|Lung Neoplasms|lung neoplasms
522910|NCT01335893|Preliminary Study|preliminary study
522911|NCT01335880|Obesity|obesity
522912|NCT01335880|Heart Disease|heart disease
522913|NCT01335880|Seniors|seniors
522914|NCT01335880|Elderly|elderly
522915|NCT01335880|Chronic Disease|chronic disease
522916|NCT01335880|Prevention|prevention
522917|NCT01335854|Apnea-hypopnea index|apnea-hypopnea index
522918|NCT01335854|Continuous positive airway pressure|continuous positive airway pressure
522919|NCT01335854|CPAP adherence|cpap adherence
522920|NCT01335828|Echography|echography
522921|NCT01335828|Elastography|elastography
522922|NCT01335828|Thyroid nodules|thyroid nodules
522923|NCT01335828|Needles punction|needles punction
522924|NCT01335828|Thyroid surgery|thyroid surgery
522925|NCT01335828|Patients with thyroids nodules|patients with thyroids nodules
522926|NCT01335802|Abortion, Spontaneous|abortion, spontaneous
522927|NCT01335802|Pre-eclampsia|pre-eclampsia
522928|NCT01335802|Gestational hypertension|gestational hypertension
522929|NCT01335802|Pregnancy Complications|pregnancy complications
522930|NCT01335802|Subclinical hypothyroidism|subclinical hypothyroidism
522931|NCT01335802|Thyroperoxidase antibodies (TPOab)|thyroperoxidase antibodies (tpoab)
522932|NCT01335802|Mitochondrial dysfunction|mitochondrial dysfunction
522933|NCT01335789|marijuana|marijuana
522934|NCT01335789|substance abuse|substance abuse
522935|NCT01335789|drug abuse|drug abuse
522936|NCT01335789|marijuana dependence|marijuana dependence
522937|NCT01335789|drug addiction|drug addiction
522938|NCT01335776|Mindfulness-Based Stress Reduction|mindfulness-based stress reduction
522939|NCT01335776|Cognitive Behavior Therapy|cognitive behavior therapy
522940|NCT01335776|Actigraphy|actigraphy
522941|NCT01335776|Noninferiority|noninferiority
522942|NCT01335776|MBSR|mbsr
522943|NCT01335776|CBT-I|cbt-i
522944|NCT01335763|HbA1c|hba1c
522945|NCT01335763|Multicentre before-after design|multicentre before-after design
522946|NCT01335763|Glycemic control|glycemic control
522947|NCT01335763|Community pharmacists|community pharmacists
522948|NCT01335750|corneal staining|corneal staining
522949|NCT01335698|Pediatric|pediatric
522950|NCT01335685|Drug Therapy|drug therapy
522951|NCT01335672|Myocardial infarction|myocardial infarction
522952|NCT01335672|chronic obstructive pulmonary disease|chronic obstructive pulmonary disease
522953|NCT01335672|General Practice Research Database|general practice research database
522954|NCT01335672|Myocardial Ischaemia National Audit Project|myocardial ischaemia national audit project
522955|NCT01335672|CALIBER|caliber
522956|NCT01335659|FFR|ffr
522957|NCT01335659|IVUS|ivus
522958|NCT01335659|QCA|qca
522959|NCT01335633|MS|ms
522960|NCT01335633|Neuropsychological tests|neuropsychological tests
522961|NCT01335620|HIV|hiv
522962|NCT01335620|Pharmatokinetic|pharmatokinetic
522963|NCT01335620|60 years old|60 years old
522964|NCT01335620|Raltegravir|raltegravir
522965|NCT01335607|HCV|hcv
522966|NCT01335607|Hepatitis C Virus|hepatitis c virus
522967|NCT01335594|Sleep apnea, obstructive|sleep apnea, obstructive
522968|NCT01335594|Deglutition Disorders|deglutition disorders
522969|NCT01335594|Manometry|manometry
522970|NCT01335594|Endoscopy|endoscopy
522971|NCT01335568|Hepatocyte|hepatocyte
522972|NCT01335568|Scaffold|scaffold
522973|NCT01335568|Matrix|matrix
522974|NCT01335568|Liver cirrhosis|liver cirrhosis
522975|NCT01335568|Liver insufficiency|liver insufficiency
522976|NCT01335529|HCV infection|hcv infection
522977|NCT01335529|HIV-1 infection|hiv-1 infection
522978|NCT01335503|gluten|gluten
522979|NCT01335451|AZD5213|azd5213
522980|NCT01335451|safety|safety
522981|NCT01335451|pharmacokinetics|pharmacokinetics
522982|NCT01335451|single dose|single dose
522983|NCT01335451|repeated dose|repeated dose
522984|NCT01335451|young|young
522985|NCT01335451|elderly|elderly
522986|NCT01335451|Japanese|japanese
522987|NCT01335451|healthy subject|healthy subject
522988|NCT01335438|total knee arthroplasty|total knee arthroplasty
522989|NCT01335438|cemented|cemented
522990|NCT01335438|cementless|cementless
522991|NCT01335438|fixation|fixation
522992|NCT01335438|posterior stabilized|posterior stabilized
522993|NCT01335438|cruciate retaining|cruciate retaining
522994|NCT01335425|Language problems|language problems
522995|NCT01335425|childhood epilepsy|childhood epilepsy
522996|NCT01335425|bening (rolandic) epilepsy (of childhood) with centro temporal spikes|bening (rolandic) epilepsy (of childhood) with centro temporal spikes
522997|NCT01335425|brain maturation|brain maturation
522998|NCT01335425|structral connectivity|structral connectivity
522999|NCT01335425|functional connectivity|functional connectivity
523000|NCT01335399|Newly Diagnosed|newly diagnosed
523001|NCT01335399|Previously Untreated|previously untreated
523002|NCT01335373|Vaginal candidiasis|vaginal candidiasis
523003|NCT01335373|Bacterial vaginosis (also known as non-specific, or Gardnerellosis, or anaerobic vaginosis)|bacterial vaginosis (also known as non-specific, or gardnerellosis, or anaerobic vaginosis)
523004|NCT01335373|Trichomonal vaginitis|trichomonal vaginitis
523005|NCT01335373|Vaginitis due to mixed infection|vaginitis due to mixed infection
523006|NCT01335360|nevirapine|nevirapine
523007|NCT01335360|pharmacokinetics|pharmacokinetics
523008|NCT01335347|Influenza|influenza
523009|NCT01335347|pandemic|pandemic
523010|NCT01335347|avian influenza|avian influenza
523011|NCT01335347|H5N1|h5n1
523012|NCT01335347|flu|flu
523013|NCT01335334|Effectiveness|effectiveness
523014|NCT01335334|eradication|eradication
523015|NCT01335334|Asymptomatic|asymptomatic
523016|NCT01335321|viscosupplementation|viscosupplementation
523017|NCT01335321|intra-articular injection|intra-articular injection
523018|NCT01335321|hyaluronic acid|hyaluronic acid
523019|NCT01335321|osteoarthritis|osteoarthritis
523020|NCT01335321|knee|knee
523021|NCT01335308|Pediatric Obesity|pediatric obesity
523022|NCT01335308|Motivational Interviewing|motivational interviewing
523023|NCT01335308|Overweight|overweight
523024|NCT01335308|Behavior Change|behavior change
523025|NCT01335295|Flavocoxid|flavocoxid
523026|NCT01335295|Duchenne muscular dystrophy|duchenne muscular dystrophy
523027|NCT01335295|pilot study|pilot study
523028|NCT01335256|Phase I, dose escalation, kinase inhibitor, cyclin-dependent kinase inhibitor, target therapy, small molecule|phase i, dose escalation, kinase inhibitor, cyclin-dependent kinase inhibitor, target therapy, small molecule
523029|NCT01335243|Orthopedic Procedures|orthopedic procedures
523030|NCT01335243|Spine|spine
523031|NCT01335243|Interbody fusion|interbody fusion
523032|NCT01335243|Arthrodesis|arthrodesis
523033|NCT01335243|Lumbar Vertebrae|lumbar vertebrae
523034|NCT01335243|CT Scan|ct scan
523035|NCT01335243|Spine balance|spine balance
523036|NCT01335243|Instrumented fusion|instrumented fusion
523037|NCT01335243|Posterior fusion|posterior fusion
523038|NCT01335243|Degenerative spine|degenerative spine
523039|NCT01335243|painful|painful
523040|NCT01335230|HIV|hiv
523041|NCT01335230|HCV|hcv
523042|NCT01335230|Hepatitis C|hepatitis c
523043|NCT01335230|HIV and Hepatitis C coinfection|hiv and hepatitis c coinfection
523044|NCT01335230|HIV/HCV|hiv/hcv
523045|NCT01335217|Depression|depression
523046|NCT01335217|Major Depressive Disorder (MDD)|major depressive disorder (mdd)
523047|NCT01335217|Trigeminal Nerve Stimulation|trigeminal nerve stimulation
523048|NCT01335217|Post Traumatic Stress Disorder|post traumatic stress disorder
523049|NCT01335204|Castration-resistant prostate cancer|castration-resistant prostate cancer
523050|NCT01335204|Prostate Cancer|prostate cancer
523051|NCT01335204|JEVTANA|jevtana
523052|NCT01335204|Cabazitaxel|cabazitaxel
523053|NCT01335204|Bavituximab|bavituximab
523054|NCT01335191|HIV|hiv
523055|NCT01335191|vaccine|vaccine
523056|NCT01335191|lipopeptide|lipopeptide
523057|NCT01335191|Tat|tat
523058|NCT01335191|TUTI-16|tuti-16
523059|NCT01335191|THYMON|thymon
523060|NCT01335178|Tobacco smoke exposure|tobacco smoke exposure
523061|NCT01335178|Secondhand smoke exposure|secondhand smoke exposure
523062|NCT01335178|Passive smoking|passive smoking
523063|NCT01335178|Child health|child health
523064|NCT01335178|Prevention|prevention
523065|NCT01335178|Tobacco control|tobacco control
523066|NCT01335178|Motivational Interviewing|motivational interviewing
523067|NCT01335178|Air quality|air quality
523068|NCT01335178|Pilot Study|pilot study
523069|NCT01335165|PNH|pnh
523070|NCT01335152|stress|stress
523071|NCT01335152|depression|depression
523072|NCT01335152|anxiety|anxiety
523073|NCT01335152|web|web
523074|NCT01335152|internet|internet
523075|NCT01335152|coping|coping
523262|NCT01334307|RePneu|repneu
523076|NCT01335139|sublingual immunotherapy|sublingual immunotherapy
523077|NCT01335139|subcutaneous immunotherapy|subcutaneous immunotherapy
523078|NCT01335126|Artificial tears|artificial tears
523079|NCT01335100|Functional outcome|functional outcome
523080|NCT01335100|Quality of life|quality of life
523081|NCT01335100|Global Positioning System (GPS)|global positioning system (gps)
523082|NCT01335100|Advanced tracking technologies|advanced tracking technologies
523083|NCT01335100|Time-space activity.|time-space activity.
523084|NCT01335100|walking speed|walking speed
523085|NCT01335100|distances|distances
523086|NCT01335100|number of walking events and destinations|number of walking events and destinations
523087|NCT01335087|sleep apnea|sleep apnea
523088|NCT01335087|secondary prevention|secondary prevention
523089|NCT01335087|cardiovascular endpoint|cardiovascular endpoint
523090|NCT01335061|Hemophilia B|hemophilia b
523091|NCT01335061|on-demand|on-demand
523092|NCT01335061|prophylaxis|prophylaxis
523093|NCT01335061|nonacog alfa|nonacog alfa
523094|NCT01335061|BeneFIX|benefix
523095|NCT01335061|FIX|fix
523096|NCT01335048|Clopidogrel|clopidogrel
523097|NCT01335048|Statins|statins
523098|NCT01335048|Platelet reactivity|platelet reactivity
523099|NCT01335048|Point-of-care platelet function test|point-of-care platelet function test
523100|NCT01335035|Iron metabolism,|iron metabolism,
523101|NCT01335035|Allogenetic Hematopoietic Stem Cell Transplant,|allogenetic hematopoietic stem cell transplant,
523102|NCT01335035|haematological diseases|haematological diseases
523103|NCT01335009|melanoma|melanoma
523104|NCT01335009|malignant|malignant
523105|NCT01335009|metastatic|metastatic
523106|NCT01334983|cancer|cancer
523107|NCT01334983|function|function
523108|NCT01334983|fatigue|fatigue
523109|NCT01334983|late stage|late stage
523110|NCT01334983|metastases|metastases
523111|NCT01334983|quality of life|quality of life
523112|NCT01334983|functional decline in cancer|functional decline in cancer
523113|NCT01334944|Pain|pain
523114|NCT01334944|Fever|fever
523115|NCT01334931|Exposure to Ionizing Radiation|exposure to ionizing radiation
523116|NCT01334931|Occupational Exposure to Radiation|occupational exposure to radiation
523117|NCT01334918|pharmacologic stress|pharmacologic stress
523118|NCT01334918|Coronary Artery Disease (CAD)|coronary artery disease (cad)
523119|NCT01334918|regadenoson|regadenoson
523120|NCT01334918|ischemia|ischemia
523121|NCT01334905|Overactive Bladder|overactive bladder
523122|NCT01334905|Urinary incontinence|urinary incontinence
523123|NCT01334905|YM178|ym178
523124|NCT01334905|mirabegron|mirabegron
523125|NCT01334905|Food effect|food effect
523126|NCT01334879|radiation|radiation
523127|NCT01334879|retinopathy|retinopathy
523128|NCT01334879|anti-VEGF|anti-vegf
523129|NCT01334879|eye|eye
523130|NCT01334866|Minimally invasive coronary surgery|minimally invasive coronary surgery
523131|NCT01334866|Coronary artery bypass grafting|coronary artery bypass grafting
523132|NCT01334866|MICS CABG|mics cabg
523133|NCT01334840|Cardiovascular risk|cardiovascular risk
523134|NCT01334840|Cholecystokinin|cholecystokinin
523135|NCT01334840|Gallbladder emptying|gallbladder emptying
523136|NCT01334840|Lipid absorption|lipid absorption
523137|NCT01334840|Postprandial triacylglycerols|postprandial triacylglycerols
523138|NCT01334840|Sodium-bicarbonated mineral water|sodium-bicarbonated mineral water
523139|NCT01334827|topical microbicide|topical microbicide
523140|NCT01334827|primary prevention|primary prevention
523141|NCT01334827|HIV|hiv
523142|NCT01334827|AIDS|aids
523143|NCT01334827|drug delivery systems|drug delivery systems
523144|NCT01334801|aortic stenosis|aortic stenosis
523145|NCT01334801|von Willebrand factor|von willebrand factor
523146|NCT01334801|mitral valve replacement|mitral valve replacement
523147|NCT01334801|aortic valve replacement|aortic valve replacement
523148|NCT01334801|prosthetic valve dysfunction|prosthetic valve dysfunction
523149|NCT01334801|brain natriuretic peptide|brain natriuretic peptide
523150|NCT01334801|mitral valve regurgitation|mitral valve regurgitation
523151|NCT01334801|aortic valve regurgitation|aortic valve regurgitation
523152|NCT01334801|hypertrophic cardiomyopathy|hypertrophic cardiomyopathy
523153|NCT01334801|tricuspid insufficiency|tricuspid insufficiency
523154|NCT01334788|sleep deprivation|sleep deprivation
523155|NCT01334788|sleep restriction|sleep restriction
523156|NCT01334775|Inguinal hernia|inguinal hernia
523157|NCT01334775|Postoperative pain|postoperative pain
523158|NCT01334775|Surgical mesh|surgical mesh
523159|NCT01334762|minimal to mild endometriosis|minimal to mild endometriosis
523160|NCT01334762|letrozole|letrozole
523161|NCT01334762|clomiphene citrate|clomiphene citrate
523162|NCT01334762|IUI|iui
523163|NCT01334749|Stroke|stroke
523164|NCT01334749|Dementia|dementia
523165|NCT01334749|Dementia, Vascular|dementia, vascular
523166|NCT01334749|Alzheimer's Disease|alzheimer's disease
523167|NCT01334749|Intracranial Hemorrhage|intracranial hemorrhage
523168|NCT01334749|Brain Ischemia|brain ischemia
523169|NCT01334736|smoking cessation|smoking cessation
523170|NCT01334736|contingency management|contingency management
523171|NCT01334736|spirometry|spirometry
523172|NCT01334736|lung age|lung age
523263|NCT01334294|CNV|cnv
523264|NCT01334294|AMD|amd
523173|NCT01334723|Benign prostatic hyperplasia, enlarged prostate, 5-alpha-reductase inhibitor, adherence, surgery, acute urinary retention|benign prostatic hyperplasia, enlarged prostate, 5-alpha-reductase inhibitor, adherence, surgery, acute urinary retention
523174|NCT01334710|Liver cancer|liver cancer
523175|NCT01334697|Cardiotrophin-1|cardiotrophin-1
523176|NCT01334697|CT-1|ct-1
523177|NCT01334684|Type 2 Diabetes Mellitus|type 2 diabetes mellitus
523178|NCT01334684|Metformin Efficacy|metformin efficacy
523179|NCT01334684|Gene Expression Profiles|gene expression profiles
523180|NCT01334684|Personalized Medicine|personalized medicine
523181|NCT01334671|ST-elevation myocardial infarction(STEMI)|st-elevation myocardial infarction(stemi)
523182|NCT01334671|emergency percutaneous coronary intervention(PCI)|emergency percutaneous coronary intervention(pci)
523183|NCT01334671|lipitor or Atorvastatin|lipitor or atorvastatin
523184|NCT01334658|Corneal endothelium|corneal endothelium
523185|NCT01334658|Cataract surgery|cataract surgery
523186|NCT01334658|Irrigation solutions intraocular|irrigation solutions intraocular
523187|NCT01334658|Phacoemulsification|phacoemulsification
523188|NCT01334645|Copeptin|copeptin
523189|NCT01334645|Troponin|troponin
523190|NCT01334645|Diagnosis|diagnosis
523191|NCT01334645|Chest pain|chest pain
523192|NCT01334645|Acute Coronary Syndrome|acute coronary syndrome
523193|NCT01334645|Acute Myocardial Infarction|acute myocardial infarction
523194|NCT01334645|Unstable Angina|unstable angina
523195|NCT01334632|Electrophysiological study|electrophysiological study
523196|NCT01334632|Nerve block|nerve block
523197|NCT01334632|Analgesia, patient-controlled|analgesia, patient-controlled
523198|NCT01334632|Shoulder surgery|shoulder surgery
523199|NCT01334619|Anesthetic techniques,regional|anesthetic techniques,regional
523200|NCT01334619|Drug delivery,volume|drug delivery,volume
523201|NCT01334619|Anesthetic, local: ropivacaine|anesthetic, local: ropivacaine
523202|NCT01334606|diabetes|diabetes
523203|NCT01334606|pen needle|pen needle
523204|NCT01334606|basal insulin|basal insulin
523205|NCT01334606|long-acting insulin|long-acting insulin
523206|NCT01334554|African American|african american
523207|NCT01334554|Women|women
523208|NCT01334554|Metabolic Syndrome|metabolic syndrome
523209|NCT01334554|Endothelial function|endothelial function
523210|NCT01334554|Sildenafil citrate|sildenafil citrate
523211|NCT01334528|Deployment Acquired Mild Traumatic Brain Injury|deployment acquired mild traumatic brain injury
523212|NCT01334528|Persistent Post-Concussive Symptoms|persistent post-concussive symptoms
523213|NCT01334528|Repeated measures|repeated measures
523214|NCT01334502|contiguous stage II adult diffuse large cell lymphoma|contiguous stage ii adult diffuse large cell lymphoma
523215|NCT01334502|noncontiguous stage II adult diffuse large cell lymphoma|noncontiguous stage ii adult diffuse large cell lymphoma
523216|NCT01334502|stage III adult diffuse large cell lymphoma|stage iii adult diffuse large cell lymphoma
523217|NCT01334502|stage IV adult diffuse large cell lymphoma|stage iv adult diffuse large cell lymphoma
523218|NCT01334489|Monochorionic pregnancy|monochorionic pregnancy
523219|NCT01334489|Twin to twin transfusion syndrome|twin to twin transfusion syndrome
523220|NCT01334489|Cervical pessary|cervical pessary
523221|NCT01334489|Cervical lenght|cervical lenght
523222|NCT01334476|Data Repository|data repository
523223|NCT01334476|Facilitate Recruitment of Participants for Ongoing and Future Research|facilitate recruitment of participants for ongoing and future research
523224|NCT01334450|Improvement of ADAS-COG|improvement of adas-cog
523225|NCT01334437|blood test|blood test
523226|NCT01334437|ovarian cancer|ovarian cancer
523227|NCT01334437|Associated Auto Antibodies|associated auto antibodies
523228|NCT01334424|Robot assisted laparoscopic radical prostatectomy|robot assisted laparoscopic radical prostatectomy
523229|NCT01334424|Hypoperfusion reperfusion injury,|hypoperfusion reperfusion injury,
523230|NCT01334424|Propofol|propofol
523231|NCT01334424|oxidative stress|oxidative stress
523232|NCT01334398|Traumatic Brain Injury|traumatic brain injury
523233|NCT01334372|suicide|suicide
523234|NCT01334372|veterans|veterans
523235|NCT01334372|assessment|assessment
523236|NCT01334372|CAMS|cams
523237|NCT01334359|physical activity|physical activity
523238|NCT01334359|fitness|fitness
523239|NCT01334359|brain health|brain health
523240|NCT01334359|cognition|cognition
523241|NCT01334359|scholastic achievement|scholastic achievement
523242|NCT01334359|preadolescent children|preadolescent children
523243|NCT01334346|Running|running
523244|NCT01334346|Footwear|footwear
523245|NCT01334346|Injury incidence|injury incidence
523246|NCT01334346|injury risk|injury risk
523247|NCT01334346|pain|pain
523248|NCT01334333|kidney transplant|kidney transplant
523249|NCT01334333|tacrolimus|tacrolimus
523250|NCT01334333|medication adherence|medication adherence
523251|NCT01334333|depression|depression
523252|NCT01334333|neuropsychological|neuropsychological
523253|NCT01334333|cognition|cognition
523254|NCT01334333|Self-efficacy|self-efficacy
523255|NCT01334333|everyday problem solving|everyday problem solving
523256|NCT01334320|oral squamous cell carcinoma|oral squamous cell carcinoma
523257|NCT01334320|elective neck dissection|elective neck dissection
523258|NCT01334320|"watchful waiting"|"watchful waiting"
523259|NCT01334320|survival benefit|survival benefit
523260|NCT01334320|recurrence rate|recurrence rate
523261|NCT01334307|Emphysema|emphysema
523265|NCT01334281|Panel Reactive Antibody (PRA)|panel reactive antibody (pra)
523266|NCT01334281|Sensitization|sensitization
523267|NCT01334281|Organ Transplant|organ transplant
523268|NCT01334268|In-stent Late Lumen Loss (LLL)|in-stent late lumen loss (lll)
523269|NCT01334268|TARGET VESSEL FAILURE (TVF)|target vessel failure (tvf)
523270|NCT01334268|MYOCARDIAL INFARCTION (MI)|myocardial infarction (mi)
523271|NCT01334268|TARGET VESSEL REVASCULARIZATION (TVR)|target vessel revascularization (tvr)
523272|NCT01334268|TARGET LESION REVASCULARIZATION (TLR)|target lesion revascularization (tlr)
523273|NCT01334268|TARGET LESION FAILURE (TLF)|target lesion failure (tlf)
523274|NCT01334268|STENT THROMBOSIS|stent thrombosis
523275|NCT01334268|RESTENOTIC LESION|restenotic lesion
523276|NCT01334268|PERCUTANEOUS CORONARY INTERVENTION (PCI)|percutaneous coronary intervention (pci)
523277|NCT01334268|REAL-WORLD|real-world
523278|NCT01334268|THE RANDOMIZED CONTROLLED TRIAL|the randomized controlled trial
523279|NCT01334255|Pigment epithelial detachment|pigment epithelial detachment
523280|NCT01334255|Exudative age-related macular degeneration|exudative age-related macular degeneration
523281|NCT01334255|Polypoidal choroidal vasculopathy|polypoidal choroidal vasculopathy
523282|NCT01334242|Pharmacodynamics|pharmacodynamics
523283|NCT01334229|sitagliptin|sitagliptin
523284|NCT01334229|diabetes|diabetes
523285|NCT01334229|apolipoprotein B48 and B100|apolipoprotein b48 and b100
523286|NCT01334216|smoking|smoking
523287|NCT01334216|quitting|quitting
523288|NCT01334216|tobacco|tobacco
523289|NCT01334216|Parental|parental
523290|NCT01334203|Chronic angina|chronic angina
523291|NCT01334203|Angina pectoris|angina pectoris
523292|NCT01334203|Coronary artery disease|coronary artery disease
523293|NCT01334203|Type 2 Diabetes Mellitus|type 2 diabetes mellitus
523294|NCT01334203|ETT|ett
523295|NCT01334190|AE adverse event|ae adverse event
523296|NCT01334190|AIDS acquired immunodeficiency syndrome|aids acquired immunodeficiency syndrome
523297|NCT01334190|ALT (SGPT) alanine aminotransferase|alt (sgpt) alanine aminotransferase
523298|NCT01334190|ART antiretroviral therapy|art antiretroviral therapy
523424|NCT01333657|blood|blood
523299|NCT01334190|AST (SGOT) aspartate aminotransferase|ast (sgot) aspartate aminotransferase
523300|NCT01334190|DCF data collection forms|dcf data collection forms
523301|NCT01334190|DMC Data Monitoring Committee|dmc data monitoring committee
523302|NCT01334190|FDA (U.S.) Food and Drug Administration|fda (u.s.) food and drug administration
523303|NCT01334190|GCP Good Clinical Practice guidelines|gcp good clinical practice guidelines
523304|NCT01334190|HB sAg Hepatitis B surface antigen|hb sag hepatitis b surface antigen
523305|NCT01334190|ICH International Conference of Harmonisation|ich international conference of harmonisation
523306|NCT01334190|IND Investigational New Drug Application|ind investigational new drug application
523307|NCT01334190|IRB Institutional Review Board|irb institutional review board
523308|NCT01334190|IU international units|iu international units
523309|NCT01334190|mg milligram(s)|mg milligram(s)
523310|NCT01334190|mm3 cubic millimeter(s)|mm3 cubic millimeter(s)
523311|NCT01334190|PCR polymerase chain reaction|pcr polymerase chain reaction
523312|NCT01334190|SAE serious adverse event|sae serious adverse event
523313|NCT01334190|µg microgram|µg microgram
523314|NCT01334190|ULN upper limit of the normal range|uln upper limit of the normal range
523315|NCT01334190|WB Western Blot|wb western blot
523316|NCT01334190|post-marketing monitoring|post-marketing monitoring
523317|NCT01334190|safety|safety
523318|NCT01334190|efficacy|efficacy
523319|NCT01334190|acceptability|acceptability
523320|NCT01334164|substance use disorder|substance use disorder
523321|NCT01334164|offenders|offenders
523322|NCT01334164|reentry|reentry
523323|NCT01334164|HIV risk behavior|hiv risk behavior
523324|NCT01334164|recidivism|recidivism
523325|NCT01334138|hypertension|hypertension
523326|NCT01334138|sodium|sodium
523327|NCT01334138|diet|diet
523328|NCT01334125|Double Diabetes|double diabetes
523329|NCT01334125|Type 1 diabetes|type 1 diabetes
523330|NCT01334125|Type 2 diabetes|type 2 diabetes
523331|NCT01334125|Obesity|obesity
523332|NCT01334125|Acanthosis nigricans|acanthosis nigricans
523333|NCT01334125|Diabetes associated autoantibodies|diabetes associated autoantibodies
523334|NCT01334112|Hepatocellular Carcinoma|hepatocellular carcinoma
523335|NCT01334112|Advanced Hepatocellular Carcinoma|advanced hepatocellular carcinoma
523336|NCT01334112|Liver Cancer|liver cancer
523337|NCT01334112|Axitinib|axitinib
523338|NCT01334112|AG-013736|ag-013736
523339|NCT01334086|AML|aml
523340|NCT01334073|Phase I|phase i
523341|NCT01334073|Axitinib|axitinib
523342|NCT01334073|Everolimus|everolimus
523343|NCT01334073|Maximum tolerated dose (MTD)|maximum tolerated dose (mtd)
523344|NCT01334073|solid tumor|solid tumor
523345|NCT01334073|Renal cell cancer (RCC)|renal cell cancer (rcc)
523346|NCT01334073|Pharmacokinetics (PK/PD)|pharmacokinetics (pk/pd)
523347|NCT01334008|Circulating tumor DNA|circulating tumor dna
523348|NCT01334008|Choroidal Melanoma|choroidal melanoma
523349|NCT01333995|Peer counselling|peer counselling
523350|NCT01333995|Infant|infant
523351|NCT01333995|Intervention|intervention
523352|NCT01333995|breastfeeding|breastfeeding
523353|NCT01333995|complementary feeding|complementary feeding
523354|NCT01333995|stunting|stunting
523355|NCT01333982|Neonatal Sepsis|neonatal sepsis
523356|NCT01333982|Evaluation|evaluation
523357|NCT01333982|Bangladesh|bangladesh
523359|NCT01333982|Wrapping|wrapping
523360|NCT01333982|Bathing|bathing
523361|NCT01333943|Total Knee Replacement|total knee replacement
523362|NCT01333943|Regional Anesthesia|regional anesthesia
523363|NCT01333943|Quadriceps|quadriceps
523364|NCT01333943|Muscle Strength|muscle strength
523365|NCT01333943|Muscle Strength Dynamometer|muscle strength dynamometer
523366|NCT01333943|Quadriceps muscle strength after regional anesthesia for TKA|quadriceps muscle strength after regional anesthesia for tka
523367|NCT01333930|immunological effects|immunological effects
523368|NCT01333930|Active O2|active o2
523369|NCT01333930|strenuous exercise|strenuous exercise
523370|NCT01333930|procedures|procedures
523371|NCT01333930|pharmacodynamic parameters|pharmacodynamic parameters
523372|NCT01333930|blood sampling scheme|blood sampling scheme
523373|NCT01333917|Curcumin|curcumin
523374|NCT01333917|Colorectal Cancer|colorectal cancer
523375|NCT01333917|GWAS|gwas
523376|NCT01333865|Memantine|memantine
523377|NCT01333865|Namenda|namenda
523378|NCT01333865|Autism Spectrum Disorders|autism spectrum disorders
523379|NCT01333865|Pervasive Developmental Disorders|pervasive developmental disorders
523380|NCT01333865|Adults|adults
523381|NCT01333852|head and neck cancer|head and neck cancer
523382|NCT01333852|paclitaxel|paclitaxel
523383|NCT01333852|metformin|metformin
665126|NCT00769561|Pain|pain
523384|NCT01333852|squamous cell carcinoma|squamous cell carcinoma
523385|NCT01333839|CABG surgery|cabg surgery
523386|NCT01333839|exercise intervention|exercise intervention
523387|NCT01333839|insulin sensitivity|insulin sensitivity
523388|NCT01333839|muscle mass|muscle mass
523389|NCT01333813|immune response|immune response
523390|NCT01333813|Engerix-B™Kinder|engerix-b™kinder
523391|NCT01333813|Persistence|persistence
523392|NCT01333813|challenge dose|challenge dose
523393|NCT01333787|dietary fiber|dietary fiber
523394|NCT01333787|clinical trial|clinical trial
523395|NCT01333787|constipation|constipation
523396|NCT01333787|children|children
523397|NCT01333774|Diabetes|diabetes
523398|NCT01333774|Acarbose|acarbose
523399|NCT01333774|Diet|diet
523400|NCT01333774|Compliance|compliance
523401|NCT01333774|Advising|advising
523402|NCT01333761|right to left cardiac shunt finding|right to left cardiac shunt finding
523403|NCT01333748|breast cancer|breast cancer
523404|NCT01333748|ovarian cancer|ovarian cancer
523405|NCT01333748|BRCA 1 and BRCA 2|brca 1 and brca 2
523406|NCT01333735|cognitive functions|cognitive functions
523407|NCT01333735|quality of life|quality of life
523408|NCT01333735|breast cancer|breast cancer
523409|NCT01333735|chemotherapy|chemotherapy
523410|NCT01333735|ages patients|ages patients
523411|NCT01333709|locally advanced rectal carcinoma|locally advanced rectal carcinoma
523412|NCT01333709|Tailored treatment strategy|tailored treatment strategy
523413|NCT01333709|MRI volumetry|mri volumetry
523414|NCT01333709|Early tumor response|early tumor response
523415|NCT01333696|Squamous cell carcinoma of head and neck|squamous cell carcinoma of head and neck
523416|NCT01333696|Pemetrexed|pemetrexed
523417|NCT01333683|tinnitus|tinnitus
523418|NCT01333683|hearing loss|hearing loss
523419|NCT01333683|arterial hypertension|arterial hypertension
523420|NCT01333683|ototoxicity|ototoxicity
523421|NCT01333657|sTREM-1|strem-1
523422|NCT01333657|sepsis|sepsis
523423|NCT01333657|SIRS|sirs
523425|NCT01333657|urine|urine
523426|NCT01333657|diagnosis|diagnosis
523427|NCT01333657|prognosis|prognosis
523428|NCT01333644|HIV Infection|hiv infection
523429|NCT01333644|Endothelial function|endothelial function
523430|NCT01333644|Cardiovascular Disease|cardiovascular disease
523431|NCT01333644|Inflammation|inflammation
523432|NCT01333644|Antiretroviral medication|antiretroviral medication
523433|NCT01333644|Treatment naive|treatment naive
523434|NCT01333644|Treatment experienced|treatment experienced
523435|NCT01333631|Locally advanced unresectable pancreatic cancer|locally advanced unresectable pancreatic cancer
523436|NCT01333618|Filter Tilt|filter tilt
523437|NCT01333618|Preventional efficiency|preventional efficiency
523438|NCT01333618|Günther Tulip filter|günther tulip filter
523439|NCT01333618|Transfemoral Approach|transfemoral approach
523440|NCT01333605|Hodgkin lymphoma|hodgkin lymphoma
523441|NCT01333605|Chemotherapy|chemotherapy
523442|NCT01333605|IGEV|igev
523443|NCT01333605|Autologous stem cell transplantation|autologous stem cell transplantation
523444|NCT01333592|Type 2 diabetes|type 2 diabetes
523445|NCT01333592|HbA1c|hba1c
523446|NCT01333592|Long-term study|long-term study
523447|NCT01333553|birthmark|birthmark
523448|NCT01333540|constipation|constipation
523449|NCT01333540|opioid induced|opioid induced
523450|NCT01333514|diabetes|diabetes
523451|NCT01333514|prandial|prandial
523452|NCT01333514|insulin|insulin
523453|NCT01333514|aspart|aspart
523454|NCT01333514|carbohydrate|carbohydrate
523455|NCT01333514|inpatient|inpatient
523456|NCT01333514|novolog|novolog
523457|NCT01333501|Multiple sclerosis|multiple sclerosis
523458|NCT01333501|cognitive symptoms|cognitive symptoms
523459|NCT01333501|relapsing-remitting multiple sclerosis (RRMS)|relapsing-remitting multiple sclerosis (rrms)
523460|NCT01333501|fingolimod|fingolimod
523461|NCT01333501|Magnetic resonance imaging (MRI)|magnetic resonance imaging (mri)
523462|NCT01333488|Traumatic|traumatic
523463|NCT01333488|Brain|brain
523464|NCT01333488|Injury|injury
523465|NCT01333475|Targeted Therapy|targeted therapy
523466|NCT01333475|KRAS Mutation|kras mutation
523467|NCT01333475|Metastatic Colorectal Cancer|metastatic colorectal cancer
523468|NCT01333475|Colorectal Cancer|colorectal cancer
523469|NCT01333449|Decitabine|decitabine
523470|NCT01333449|MDS, myelodysplastic syndrome|mds, myelodysplastic syndrome
523471|NCT01333449|prospective open label, phaseII|prospective open label, phaseii
523472|NCT01333449|Allogeneic Hematopoietic cell transplant|allogeneic hematopoietic cell transplant
523473|NCT01333423|Breast Cancer|breast cancer
523474|NCT01333423|Metastatic Triple Negative|metastatic triple negative
523475|NCT01333423|ER/PR/HER2 negative|er/pr/her2 negative
523476|NCT01333423|Locally advanced|locally advanced
523477|NCT01333423|Stage IV|stage iv
523478|NCT01333423|Metastatic|metastatic
523479|NCT01333423|Seliciclib|seliciclib
523480|NCT01333423|Liposomal Doxorubicin|liposomal doxorubicin
523481|NCT01333423|Doxil|doxil
523482|NCT01333423|Doxorubicin Hydrochloride (Liposomal)|doxorubicin hydrochloride (liposomal)
523483|NCT01333410|vitiligo|vitiligo
523484|NCT01333410|tacrolimus|tacrolimus
523485|NCT01333410|mometasone furoate|mometasone furoate
523486|NCT01333371|Distal Radius|distal radius
523487|NCT01333371|Volar locked plating|volar locked plating
523488|NCT01333371|Cost Effectiveness|cost effectiveness
523489|NCT01333371|Randomization|randomization
523490|NCT01333371|Outcomes|outcomes
523491|NCT01333358|Relapsing|relapsing
523492|NCT01333358|remitting|remitting
523493|NCT01333345|Cataract replacement surgery|cataract replacement surgery
523494|NCT01333345|implantation|implantation
523495|NCT01333345|EC-3 IOL|ec-3 iol
523496|NCT01333332|Pancreas|pancreas
523497|NCT01333332|Radiation|radiation
523498|NCT01333319|liver transplantation|liver transplantation
523499|NCT01333319|acute kidney injury|acute kidney injury
523500|NCT01333306|tDCS|tdcs
523501|NCT01333306|cognitive training|cognitive training
523502|NCT01333293|mastocytosis|mastocytosis
523503|NCT01333293|omalizumab|omalizumab
523504|NCT01333267|Endocrine System Diseases|endocrine system diseases
523505|NCT01333267|MusculoSkeletal System Disease|musculoskeletal system disease
523506|NCT01333267|Hormones|hormones
523507|NCT01333267|Postmenopausal Women|postmenopausal women
523508|NCT01333267|Bone metabolism|bone metabolism
523509|NCT01333267|Physiologic Properties|physiologic properties
523510|NCT01333267|African-Americans|african-americans
523511|NCT01333254|urinary tract infections|urinary tract infections
523512|NCT01333254|urinary catheterisation|urinary catheterisation
523513|NCT01333241|Hispanic/Latina Americans|hispanic/latina americans
523514|NCT01333241|Cardiovascular diseases|cardiovascular diseases
523515|NCT01333241|Obesity|obesity
523516|NCT01333241|Intervention|intervention
523517|NCT01333215|Suicide, Attempted|suicide, attempted
523518|NCT01333215|Cognitive Symptoms|cognitive symptoms
523519|NCT01333202|Fresh lime|fresh lime
523520|NCT01333202|nicotine gum|nicotine gum
523521|NCT01333202|smoking cessation|smoking cessation
523522|NCT01333202|craving|craving
523523|NCT01333189|total knee arthroplasty|total knee arthroplasty
523524|NCT01333189|osteoarthritis|osteoarthritis
523525|NCT01333189|biomechanics|biomechanics
523526|NCT01333189|gait|gait
523527|NCT01333176|Type 2 Diabetes|type 2 diabetes
523528|NCT01333176|Hb A1c screening for diabetes in aboriginals|hb a1c screening for diabetes in aboriginals
523529|NCT01333150|Temporomandibular disorders|temporomandibular disorders
523530|NCT01333150|Orofacial pain|orofacial pain
523531|NCT01333137|Triple negative breast cancer|triple negative breast cancer
523532|NCT01333124|Preoperative chemoradiotherapy with Gemcitabine|preoperative chemoradiotherapy with gemcitabine
523533|NCT01333098|anxiety|anxiety
523534|NCT01333098|older adult|older adult
523535|NCT01333098|memory|memory
523536|NCT01333098|cognitive|cognitive
523537|NCT01333098|Saint Louis|saint louis
523538|NCT01333098|treatment|treatment
523539|NCT01333098|cognitive impariment|cognitive impariment
523540|NCT01333085|stage IV squamous cell carcinoma of the hypopharynx|stage iv squamous cell carcinoma of the hypopharynx
523541|NCT01333085|stage IV squamous cell carcinoma of the larynx|stage iv squamous cell carcinoma of the larynx
523542|NCT01333085|stage IV verrucous carcinoma of the larynx|stage iv verrucous carcinoma of the larynx
523543|NCT01333085|stage IV squamous cell carcinoma of the lip and oral cavity|stage iv squamous cell carcinoma of the lip and oral cavity
523544|NCT01333085|stage IV verrucous carcinoma of the oral cavity|stage iv verrucous carcinoma of the oral cavity
523545|NCT01333085|stage IV squamous cell carcinoma of the oropharynx|stage iv squamous cell carcinoma of the oropharynx
523546|NCT01333085|tongue cancer|tongue cancer
523547|NCT01333072|Autistic Disorder|autistic disorder
523548|NCT01333059|Sedation|sedation
523549|NCT01333059|Cycling|cycling
523550|NCT01333059|Pediatric|pediatric
523551|NCT01333046|Hodgkin Lymphoma|hodgkin lymphoma
523552|NCT01333046|Non-Hodgkin Lymphoma|non-hodgkin lymphoma
523553|NCT01333046|CTL|ctl
523554|NCT01333033|adenocarcinoma of the gastroesophageal junction|adenocarcinoma of the gastroesophageal junction
523555|NCT01333033|adenocarcinoma of the esophagus|adenocarcinoma of the esophagus
523556|NCT01333033|stage IB esophageal cancer|stage ib esophageal cancer
523557|NCT01333033|stage IIA esophageal cancer|stage iia esophageal cancer
523558|NCT01333033|stage IIB esophageal cancer|stage iib esophageal cancer
523559|NCT01333033|stage IIIA esophageal cancer|stage iiia esophageal cancer
523560|NCT01333033|stage IIIB esophageal cancer|stage iiib esophageal cancer
523561|NCT01333033|stage IIIC esophageal cancer|stage iiic esophageal cancer
523562|NCT01333020|emulsion|emulsion
523563|NCT01333020|protein|protein
523564|NCT01333020|cross-linking|cross-linking
523565|NCT01333020|gastric emptying|gastric emptying
523566|NCT01332955|Hepatitis C, Chronic|hepatitis c, chronic
523567|NCT01332955|HIV Infection|hiv infection
523568|NCT01332955|Telaprevir|telaprevir
523569|NCT01332955|Peginterferon alfa-2a|peginterferon alfa-2a
523570|NCT01332955|Ribavirin|ribavirin
523571|NCT01332955|Pharmacokinetic|pharmacokinetic
523572|NCT01332955|Pharmacogenetic|pharmacogenetic
523573|NCT01332955|Previous peginterferon-ribavirin regimen failure|previous peginterferon-ribavirin regimen failure
523574|NCT01332942|Anemia|anemia
523575|NCT01332929|brain radiation therapy|brain radiation therapy
523576|NCT01332929|Bevacizumab|bevacizumab
523577|NCT01332929|brain metastasis|brain metastasis
523578|NCT01332929|solid tumor|solid tumor
523579|NCT01332916|No metastatic breast cancer|no metastatic breast cancer
523580|NCT01332916|cognitive troubles|cognitive troubles
523581|NCT01332916|adjuvant chemotherapy|adjuvant chemotherapy
523582|NCT01332890|Drug interaction|drug interaction
523583|NCT01332890|revaprazan|revaprazan
523584|NCT01332890|Itopride HCI|itopride hci
523585|NCT01332877|Obesity|obesity
523586|NCT01332877|Weight loss|weight loss
523587|NCT01332877|Ghrelin|ghrelin
523588|NCT01332877|Satiety|satiety
523589|NCT01332877|Hunger|hunger
523590|NCT01332864|headache|headache
523591|NCT01332864|migraine|migraine
523592|NCT01332864|cephalgia|cephalgia
523593|NCT01332864|osteopathic manipulative treatment|osteopathic manipulative treatment
523594|NCT01332851|child welfare|child welfare
523595|NCT01332851|child protective services|child protective services
523596|NCT01332851|child abuse|child abuse
523597|NCT01332851|child neglect|child neglect
523598|NCT01332851|infant|infant
523599|NCT01332851|parenting|parenting
523600|NCT01332825|olfaction|olfaction
523601|NCT01332825|smell dysfunction|smell dysfunction
523602|NCT01332812|Dexamethasone|dexamethasone
523603|NCT01332812|Postoperative cognitive dysfunction|postoperative cognitive dysfunction
523604|NCT01332812|General Anesthesia|general anesthesia
523605|NCT01332812|neuropsychological tests|neuropsychological tests
523606|NCT01332799|cardiovascular disease|cardiovascular disease
523607|NCT01332799|kidney transplantation|kidney transplantation
523608|NCT01332786|AML|aml
523609|NCT01332760|ergonomics|ergonomics
523610|NCT01332760|workplace|workplace
523611|NCT01332760|occupational|occupational
523612|NCT01332760|tool|tool
523613|NCT01332760|dental|dental
523614|NCT01332760|dentist|dentist
523615|NCT01332747|TC|tc
523616|NCT01332747|TG|tg
523617|NCT01332747|HDL|hdl
523618|NCT01332747|LDL|ldl
523619|NCT01332747|VLDL|vldl
523620|NCT01332734|microcirculation|microcirculation
523621|NCT01332734|SDF|sdf
523622|NCT01332734|magnesium sulfate|magnesium sulfate
523623|NCT01332721|TRC105|trc105
523624|NCT01332721|CD105|cd105
523625|NCT01332721|Endoglin|endoglin
523626|NCT01332721|Solid Tumors|solid tumors
523627|NCT01332721|Avastin|avastin
523628|NCT01332721|Bevacizumab|bevacizumab
523629|NCT01332708|high complex carbohydrates|high complex carbohydrates
523630|NCT01332708|hypocaloric diet|hypocaloric diet
523631|NCT01332708|cholinergic status|cholinergic status
523632|NCT01332708|overweight|overweight
523633|NCT01332708|obese|obese
523634|NCT01332695|tremor|tremor
523635|NCT01332695|WHIGET|whiget
523636|NCT01332695|Fahn Tolosa Marin Scale|fahn tolosa marin scale
523637|NCT01332682|head and neck cancer|head and neck cancer
523638|NCT01332682|resistance training|resistance training
523639|NCT01332682|nutrition counseling|nutrition counseling
523640|NCT01332682|pharyngeal or laryngeal cancer|pharyngeal or laryngeal cancer
523641|NCT01332669|hepatocellular carcinoma|hepatocellular carcinoma
523642|NCT01332669|chemoembolization|chemoembolization
523643|NCT01332669|drug eluting beads|drug eluting beads
523644|NCT01332669|HCC|hcc
523645|NCT01332669|Liver cancer|liver cancer
523646|NCT01332669|Korea|korea
523647|NCT01332643|Preimplantation Genetic Diagnosis|preimplantation genetic diagnosis
523648|NCT01332643|recurrent pregnancy loss|recurrent pregnancy loss
523649|NCT01332643|infertility|infertility
523650|NCT01332643|genetic screening|genetic screening
523651|NCT01332643|trisomy 21|trisomy 21
523652|NCT01332643|Down syndrome|down syndrome
523653|NCT01332630|Breast cancer|breast cancer
523654|NCT01332630|Brain metastases|brain metastases
523655|NCT01332630|TPI 287|tpi 287
523656|NCT01332630|Computed Tomography|computed tomography
523657|NCT01332630|CT|ct
523658|NCT01332630|Magnetic Resonance Imaging|magnetic resonance imaging
523659|NCT01332630|MRI|mri
523660|NCT01332617|Multiple Myeloma|multiple myeloma
523661|NCT01332617|Simvastatin|simvastatin
523662|NCT01332617|Zoledronic|zoledronic
523663|NCT01332617|Bortezomib|bortezomib
523664|NCT01332617|Bendamustine|bendamustine
523665|NCT01332617|Methylprednisolone|methylprednisolone
523666|NCT01332591|STEMI, primary PCI, non-infarct, non-culprit lesion, CABG|stemi, primary pci, non-infarct, non-culprit lesion, cabg
523667|NCT01332565|GSK1349572|gsk1349572
523668|NCT01332565|pharmacokinetics|pharmacokinetics
523669|NCT01332565|Japanese|japanese
523670|NCT01332565|HIV|hiv
523671|NCT01332552|pharmacokinetics|pharmacokinetics
523672|NCT01332552|First administration to human|first administration to human
523673|NCT01332552|antiviral activity|antiviral activity
523674|NCT01332552|safety|safety
523675|NCT01332552|hepatitis C|hepatitis c
523677|NCT01332526|inflammation|inflammation
523678|NCT01332526|lipid metabolism|lipid metabolism
523679|NCT01332526|hyperuricemia|hyperuricemia
523680|NCT01332526|Agents Affecting Uric Acid Metabolism|agents affecting uric acid metabolism
523681|NCT01332513|Healthy Volunteers|healthy volunteers
523682|NCT01332500|Triptans|triptans
523683|NCT01332500|Migraine|migraine
523684|NCT01332487|5-alpha-reductase inhibitor|5-alpha-reductase inhibitor
523685|NCT01332487|prostate surgery|prostate surgery
523686|NCT01332487|alpha-blocker|alpha-blocker
523687|NCT01332487|enlarged prostate|enlarged prostate
523688|NCT01332487|acute urinary retention|acute urinary retention
523689|NCT01332487|Benign prostatic hyperplasia|benign prostatic hyperplasia
523690|NCT01332474|Botox|botox
523691|NCT01332474|JCP|jcp
523692|NCT01332448|Xenical|xenical
523693|NCT01332448|Alli|alli
523694|NCT01332448|safety|safety
523695|NCT01332448|meta-analysis|meta-analysis
523696|NCT01332448|liver-function test|liver-function test
523697|NCT01332448|Roche|roche
523698|NCT01332448|orlistat|orlistat
523699|NCT01332435|Enlarged prostate, 5-alpha-reductase inhibitor, alpha-blocker, early, costs|enlarged prostate, 5-alpha-reductase inhibitor, alpha-blocker, early, costs
523700|NCT01332370|Retrospective|retrospective
523701|NCT01332370|Type 2 Diabetes|type 2 diabetes
523702|NCT01332370|Cost Analysis|cost analysis
523703|NCT01332370|Rosiglitazone|rosiglitazone
523704|NCT01332370|Sitagliptin|sitagliptin
523705|NCT01332357|fluticasone/propionate salmeterol combination|fluticasone/propionate salmeterol combination
523706|NCT01332357|hospitalization|hospitalization
523707|NCT01332357|emergency department|emergency department
523708|NCT01332357|asthma|asthma
523709|NCT01332344|fluticasone propionate/salmeterol combination|fluticasone propionate/salmeterol combination
523710|NCT01332344|Asthma|asthma
523711|NCT01332344|inhaled corticosteroids|inhaled corticosteroids
523712|NCT01332344|outcomes|outcomes
523713|NCT01332331|pulmonary arterial hypertension|pulmonary arterial hypertension
523714|NCT01332331|pediatric|pediatric
523715|NCT01332292|inhalation profiles|inhalation profiles
523716|NCT01332292|pharmacokinetics|pharmacokinetics
523717|NCT01332292|pharyngometry|pharyngometry
523718|NCT01332292|asthma|asthma
523719|NCT01332292|pediatric subjects|pediatric subjects
523720|NCT01332292|GW685698|gw685698
523721|NCT01332292|Fluticasone furoate|fluticasone furoate
523722|NCT01332292|safety|safety
523723|NCT01332266|Cancer|cancer
523724|NCT01332266|head and neck|head and neck
523725|NCT01332266|squamous cell carcinoma of the head and neck|squamous cell carcinoma of the head and neck
523726|NCT01332266|phase I|phase i
523727|NCT01332266|phase II|phase ii
523728|NCT01332253|Tonsillectomy, Pediatric|tonsillectomy, pediatric
523729|NCT01332240|staging|staging
523730|NCT01332240|endosonography|endosonography
523731|NCT01332240|lung cancer|lung cancer
523732|NCT01332240|stage III|stage iii
523733|NCT01332214|Phase 1|phase 1
523734|NCT01332214|healthy male volunteers|healthy male volunteers
523735|NCT01332214|dose escalation|dose escalation
523736|NCT01332214|pharmacokinetics|pharmacokinetics
523737|NCT01332214|Single Ascending Dose|single ascending dose
523738|NCT01332214|AZD2820 Cmax|azd2820 cmax
523739|NCT01332214|tmax|tmax
523740|NCT01332214|t1/2λz|t1/2λz
523741|NCT01332201|Advagraf|advagraf
523742|NCT01332201|Heart|heart
523743|NCT01332201|Lung|lung
523744|NCT01332201|Pancreas|pancreas
523745|NCT01332201|Transplant|transplant
523746|NCT01332201|Immunosuppression|immunosuppression
523747|NCT01332201|Pharmacokinetics|pharmacokinetics
523748|NCT01332162|Hypertrophic Obstructive Cardiomyopathy (HOCM)|hypertrophic obstructive cardiomyopathy (hocm)
523749|NCT01332162|Pacing|pacing
523750|NCT01332149|Diabetic Neuropathies|diabetic neuropathies
523751|NCT01332149|Pain|pain
523752|NCT01332149|Efficacy of pregabalin|efficacy of pregabalin
523753|NCT01332149|Placebo controlled|placebo controlled
523754|NCT01332110|Footwear|footwear
523755|NCT01332110|Motion Analysis|motion analysis
523756|NCT01332110|Running Injury|running injury
523757|NCT01332097|Chronic Obstructive Pulmonary Disease|chronic obstructive pulmonary disease
523758|NCT01332097|Exacerbation|exacerbation
523969|NCT01331213|colon|colon
523759|NCT01332097|Pulmonary Inflammation|pulmonary inflammation
523760|NCT01332084|SOTI|soti
523761|NCT01332084|tolerance|tolerance
523762|NCT01332084|desensitization|desensitization
523763|NCT01332084|challenge test|challenge test
523764|NCT01332084|HA wheat cereals|ha wheat cereals
523765|NCT01332071|Metformin|metformin
523766|NCT01332071|Rosiglitazone|rosiglitazone
523767|NCT01332071|Healthy volunteers|healthy volunteers
523768|NCT01332071|Avandamet|avandamet
523769|NCT01332071|Fed conditions|fed conditions
523770|NCT01332071|Bioequivalence|bioequivalence
523771|NCT01332058|Peripheral arterial disease|peripheral arterial disease
523772|NCT01332058|Walking|walking
523773|NCT01332058|Motivational Interviewing|motivational interviewing
523774|NCT01332032|cost effectiveness|cost effectiveness
523775|NCT01332032|screening mammography|screening mammography
523776|NCT01332032|repeat mammography|repeat mammography
523777|NCT01332032|telephone counseling|telephone counseling
523778|NCT01332032|computerized reminders|computerized reminders
523779|NCT01332032|compliance|compliance
523780|NCT01332019|Subcutaneous|subcutaneous
523781|NCT01332019|Extension|extension
523782|NCT01332019|Interferon|interferon
523783|NCT01332019|MS|ms
523784|NCT01332019|PEGylated|pegylated
523785|NCT01332019|Injectable|injectable
523786|NCT01332019|SC|sc
523787|NCT01332019|PEG|peg
523788|NCT01332019|peginterferon beta-1a|peginterferon beta-1a
523789|NCT01332019|Relapsing|relapsing
523790|NCT01331993|Phase 1|phase 1
523791|NCT01331993|crossover|crossover
523792|NCT01331993|bioequivalence|bioequivalence
523793|NCT01331993|naproxen|naproxen
523794|NCT01331993|esomeprazole|esomeprazole
523795|NCT01331993|vimovo|vimovo
523796|NCT01331993|healthy volunteers|healthy volunteers
523797|NCT01331980|cystic fibrosis|cystic fibrosis
523798|NCT01331980|bone|bone
523799|NCT01331967|pioglitazone|pioglitazone
523800|NCT01331967|optical coherence tomography|optical coherence tomography
523801|NCT01331967|microRNA|microrna
523802|NCT01331967|neointima|neointima
523803|NCT01331967|major adverse cardiovascular event|major adverse cardiovascular event
523804|NCT01331941|AMG 386|amg 386
523805|NCT01331941|Pharmacokinetic|pharmacokinetic
523806|NCT01331941|Renal Impairment|renal impairment
523807|NCT01331928|Sequential chemotherapy, gastric cancer|sequential chemotherapy, gastric cancer
523808|NCT01331915|Metastatic Melanoma|metastatic melanoma
523809|NCT01331915|Safety|safety
523810|NCT01331915|Theravac vaccine|theravac vaccine
523811|NCT01331915|HLA-A2 typing|hla-a2 typing
523812|NCT01331915|Tyrosinase.A2 gene expression|tyrosinase.a2 gene expression
523813|NCT01331902|Adenosine|adenosine
523814|NCT01331902|Nicorandil|nicorandil
523815|NCT01331902|Fractional Flow Reserve|fractional flow reserve
523816|NCT01331902|Maximal Hyperemia|maximal hyperemia
523817|NCT01331889|transfusion|transfusion
523818|NCT01331889|liver transplantation|liver transplantation
523819|NCT01331889|potassium|potassium
523820|NCT01331876|Cognitive and Behavioral Therapy|cognitive and behavioral therapy
523821|NCT01331863|Bronchial disease|bronchial disease
523822|NCT01331863|Lung cancer surgery|lung cancer surgery
523823|NCT01331863|Aorta/aortic Allograft|aorta/aortic allograft
523824|NCT01331863|homograft|homograft
523825|NCT01331863|Tracheal disease|tracheal disease
523826|NCT01331863|Benign|benign
523827|NCT01331863|Malignant|malignant
523828|NCT01331824|Bladder Cancer|bladder cancer
523829|NCT01331824|Urothelial Cancer|urothelial cancer
523830|NCT01331824|Chemotherapy|chemotherapy
523831|NCT01331824|Second-line|second-line
523832|NCT01331824|Metastatic|metastatic
523833|NCT01331811|HIV|hiv
523834|NCT01331811|Tuberculosis|tuberculosis
523835|NCT01331811|Diagnosis|diagnosis
523836|NCT01331811|Pediatrics|pediatrics
523837|NCT01331811|Asia|asia
523838|NCT01331811|Africa|africa
523839|NCT01331798|Abdominoplasty|abdominoplasty
523840|NCT01331785|paracentesis|paracentesis
523841|NCT01331785|ascites|ascites
523842|NCT01331785|hypotension|hypotension
523843|NCT01331772|Breast cancer|breast cancer
523844|NCT01331772|Adapted Physical activity|adapted physical activity
523845|NCT01331772|Nutrition|nutrition
523846|NCT01331772|Assessment|assessment
523847|NCT01331772|Patient education|patient education
523848|NCT01331759|Burnout|burnout
523849|NCT01331759|Subthreshold Disorder|subthreshold disorder
523850|NCT01331707|drug-eluting stent|drug-eluting stent
523851|NCT01331707|Zotarolimus|zotarolimus
523852|NCT01331707|Everolimus|everolimus
523853|NCT01331707|all comers population|all comers population
523854|NCT01331707|target vessel failure|target vessel failure
523855|NCT01331707|coronary artery disease|coronary artery disease
523856|NCT01331681|Diabetic Macular Edema (DME)|diabetic macular edema (dme)
523857|NCT01331681|VEGF Trap-Eye|vegf trap-eye
523858|NCT01331681|Best-corrected visual acuity (BCVA)|best-corrected visual acuity (bcva)
523859|NCT01331642|Gaucher Disease|gaucher disease
523860|NCT01331642|Biomarker|biomarker
523861|NCT01331629|breast cancer|breast cancer
523862|NCT01331629|fatigue|fatigue
523863|NCT01331629|quality of life|quality of life
523864|NCT01331629|art-therapie|art-therapie
523865|NCT01331629|adjuvant radiotherapy|adjuvant radiotherapy
523866|NCT01331616|Prospective study|prospective study
523867|NCT01331616|Glioblastoma|glioblastoma
523868|NCT01331616|Avastin|avastin
523869|NCT01331616|Visual Evoked Potential|visual evoked potential
523870|NCT01331616|Optic neuropathy|optic neuropathy
523871|NCT01331616|Chemo-radiotherapy|chemo-radiotherapy
523872|NCT01331603|MDS|mds
523873|NCT01331603|primary myelofibrosis|primary myelofibrosis
523874|NCT01331603|low+high risk MDS patients|low+high risk mds patients
523875|NCT01331603|patients|patients
523876|NCT01331577|Healthy|healthy
523877|NCT01331577|Primary Prevention|primary prevention
523878|NCT01331577|Stress|stress
523879|NCT01331577|Kinesiology|kinesiology
523880|NCT01331577|cognitive behavioural therapy|cognitive behavioural therapy
523881|NCT01331577|Prevention|prevention
523882|NCT01331564|Pregnancy|pregnancy
523883|NCT01331564|Postpartum|postpartum
523884|NCT01331564|Weight gain|weight gain
523885|NCT01331564|Weight retention|weight retention
523886|NCT01331564|Behavior|behavior
523887|NCT01331564|Electronic Media|electronic media
523888|NCT01331564|Randomized Clinical Trial|randomized clinical trial
523889|NCT01331551|Inflammatory Bowel disease|inflammatory bowel disease
523890|NCT01331538|temporomandibular dysfunction|temporomandibular dysfunction
523891|NCT01331538|posture|posture
523892|NCT01331525|Small cell lung cancer|small cell lung cancer
523893|NCT01331525|Chemotherapy|chemotherapy
523894|NCT01331525|Immunotherapy|immunotherapy
523895|NCT01331525|CTLA-4|ctla-4
523896|NCT01331525|Ipilimumab|ipilimumab
523897|NCT01331512|Clinical Geriatrics|clinical geriatrics
523898|NCT01331512|Biomechanics|biomechanics
523899|NCT01331512|Epidemiology|epidemiology
523900|NCT01331512|Decline in Ambulation|decline in ambulation
523901|NCT01331499|Blood loss|blood loss
523902|NCT01331499|transfusions|transfusions
523903|NCT01331499|instrumented spinal fusion|instrumented spinal fusion
523904|NCT01331486|Prehypertension|prehypertension
523905|NCT01331486|Mild hypertension|mild hypertension
523906|NCT01331486|Flow mediated dilation|flow mediated dilation
523907|NCT01331486|Hawthorn|hawthorn
523908|NCT01331473|Carotid Artery|carotid artery
523909|NCT01331473|Stenting|stenting
523910|NCT01331473|CAS|cas
523911|NCT01331473|proximal protection|proximal protection
523912|NCT01331460|HIV|hiv
523913|NCT01331460|HIV risk|hiv risk
523914|NCT01331460|Sexually Transmitted Diseases|sexually transmitted diseases
523915|NCT01331460|Drug Use|drug use
523916|NCT01331460|Women|women
523917|NCT01331460|Drug Treatment|drug treatment
523918|NCT01331460|opioids|opioids
523919|NCT01331460|injection drug use|injection drug use
523920|NCT01331460|stimulants|stimulants
523921|NCT01331460|gender-specific treatment|gender-specific treatment
523922|NCT01331395|Infertility|infertility
523923|NCT01331395|IVF|ivf
523924|NCT01331395|Acupuncture|acupuncture
523925|NCT01331382|Resveratrol|resveratrol
523926|NCT01331382|Piperine|piperine
523927|NCT01331382|Cerebral blood flow|cerebral blood flow
523928|NCT01331382|Near- infrared spectroscopy|near- infrared spectroscopy
523929|NCT01331382|Bioavailability|bioavailability
523930|NCT01331369|adherence|adherence
523931|NCT01331369|compliance|compliance
523932|NCT01331369|persistence|persistence
523933|NCT01331369|drop out|drop out
523934|NCT01331369|abandon|abandon
523935|NCT01331356|Chronic proctalgia|chronic proctalgia
523936|NCT01331356|Botulinum toxin type A|botulinum toxin type a
523937|NCT01331356|Ganglion Impar|ganglion impar
523938|NCT01331356|Perineal pain|perineal pain
523939|NCT01331356|Pudendal neuralgia|pudendal neuralgia
523940|NCT01331356|Refractory chronic proctalgia|refractory chronic proctalgia
523941|NCT01331343|Diabetes|diabetes
523942|NCT01331343|Glycemic Control|glycemic control
523943|NCT01331343|Continuous Glucose Monitoring|continuous glucose monitoring
523944|NCT01331330|Depressive Disorder|depressive disorder
523945|NCT01331330|Unipolar|unipolar
523946|NCT01331330|Implantable Stimulation Electrodes|implantable stimulation electrodes
523947|NCT01331317|Cardiovascular disease and mortality|cardiovascular disease and mortality
523948|NCT01331317|Plasma NTproBNP|plasma ntprobnp
523949|NCT01331317|UAER|uaer
523950|NCT01331304|Bipolar disorder|bipolar disorder
523951|NCT01331304|Comparative effectiveness trial|comparative effectiveness trial
523952|NCT01331304|Lithium|lithium
523953|NCT01331304|Quetiapine|quetiapine
523954|NCT01331291|bosutinib|bosutinib
523955|NCT01331291|SKI-606|ski-606
523956|NCT01331278|total joint replacement|total joint replacement
523957|NCT01331278|knee|knee
523958|NCT01331265|perceived lactose intolerance|perceived lactose intolerance
523959|NCT01331265|calcium/dairy consumption|calcium/dairy consumption
523960|NCT01331265|specific health outcomes|specific health outcomes
523961|NCT01331239|Cushing Disease|cushing disease
523962|NCT01331239|LCI699|lci699
523963|NCT01331239|Pituitary Gland|pituitary gland
523964|NCT01331239|Adrenocorticotropic Hormone|adrenocorticotropic hormone
523965|NCT01331213|Pregabalin|pregabalin
523966|NCT01331213|Irritable Bowel Syndrome|irritable bowel syndrome
523967|NCT01331213|motor|motor
523968|NCT01331213|sensation|sensation
523970|NCT01331213|human|human
523971|NCT01331200|ischemic stroke|ischemic stroke
523972|NCT01331200|tissue plasminogen activator|tissue plasminogen activator
523973|NCT01331200|early mobilization|early mobilization
523974|NCT01331200|patient safety|patient safety
523975|NCT01331200|length of stay|length of stay
523976|NCT01331187|Echocardiography|echocardiography
523977|NCT01331187|Heart failure|heart failure
523978|NCT01331187|Ultrasonography|ultrasonography
523979|NCT01331187|pocket-size device|pocket-size device
523980|NCT01331187|Aorta|aorta
523981|NCT01331187|Education|education
523982|NCT01331174|knee|knee
523983|NCT01331174|osteoarthritis|osteoarthritis
523984|NCT01331174|physical therapy|physical therapy
523985|NCT01331174|pulsed short wave|pulsed short wave
523986|NCT01331161|shingles vaccine|shingles vaccine
523987|NCT01331161|immune responses|immune responses
523988|NCT01331148|sickle cell disease|sickle cell disease
523989|NCT01331148|vitamin D|vitamin d
523990|NCT01331148|pediatrics|pediatrics
523991|NCT01331148|pain|pain
523992|NCT01331135|pediatrics|pediatrics
523993|NCT01331135|sirolimus|sirolimus
523994|NCT01331135|relapse|relapse
523995|NCT01331109|Fibromyalgia|fibromyalgia
523996|NCT01331109|Pediatric Fibromyalgia|pediatric fibromyalgia
523997|NCT01331109|Adolescent Fibromyalgia|adolescent fibromyalgia
523998|NCT01331109|milnacipran|milnacipran
523999|NCT01331109|Savella|savella
524000|NCT01331109|loss of therapeutic response|loss of therapeutic response
524001|NCT01331109|Forest Research Institute|forest research institute
524002|NCT01331109|Pain|pain
524003|NCT01331109|Fatigue|fatigue
524004|NCT01331109|Serotonin Norepinephrine Reuptake Inhibitors|serotonin norepinephrine reuptake inhibitors
524005|NCT01331096|thyroid gland resection surgery|thyroid gland resection surgery
524006|NCT01331096|total intravenous anesthesia|total intravenous anesthesia
524007|NCT01331070|Chronic obstructive pulmonary disease (COPD)|chronic obstructive pulmonary disease (copd)
524008|NCT01331057|Bilingualism|bilingualism
524009|NCT01331057|Language|language
524010|NCT01331057|Evaluation transcultural|evaluation transcultural
524011|NCT01331057|Intra Familial Relationship|intra familial relationship
524012|NCT01331057|Transmissions mother|transmissions mother
524013|NCT01331057|Tongue french|tongue french
524014|NCT01331057|Language tamil|language tamil
524015|NCT01331057|Language arabic|language arabic
524016|NCT01331057|Language soninke|language soninke
524017|NCT01331057|Language cultural|language cultural
524018|NCT01331057|Affiliations crossbreeding|affiliations crossbreeding
524019|NCT01331044|RUTF|rutf
524020|NCT01331044|Severe Acute Malnutrition|severe acute malnutrition
524021|NCT01331044|Children|children
524022|NCT01331044|Body composition|body composition
524023|NCT01331044|Microbiota|microbiota
524024|NCT01331044|Short Chain Fatty Acid|short chain fatty acid
524025|NCT01331044|Acceptability of RUTF|acceptability of rutf
524026|NCT01331044|Edema free 15 percent weight gain|edema free 15 percent weight gain
524027|NCT01331044|Changes in body composition|changes in body composition
524028|NCT01331044|Gut microbiota|gut microbiota
524029|NCT01331044|Genome wide association|genome wide association
524030|NCT01331031|temporomandibular disorder|temporomandibular disorder
524031|NCT01331031|adolescents|adolescents
524032|NCT01331005|Macular Edema|macular edema
524033|NCT01331005|Non steroidal anti-inflammatories|non steroidal anti-inflammatories
524034|NCT01330992|Circadian rhythms|circadian rhythms
524035|NCT01330992|Melatonin|melatonin
524036|NCT01330992|Ocular light exposure|ocular light exposure
524037|NCT01330992|Darkness Exposure|darkness exposure
524038|NCT01330992|Performance|performance
524039|NCT01330992|Alertness|alertness
524040|NCT01330979|Intraocular pressure|intraocular pressure
524041|NCT01330966|surgically unresectable chondrosarcoma|surgically unresectable chondrosarcoma
524042|NCT01330953|Anemia|anemia
524043|NCT01330940|Kidney stones|kidney stones
524044|NCT01330940|Calcium|calcium
524045|NCT01330940|citrate|citrate
524046|NCT01330927|VA106483|va106483
524047|NCT01330927|Nocturia|nocturia
524048|NCT01330927|Benign Prostatic Hypertrophy|benign prostatic hypertrophy
524049|NCT01330927|BPH|bph
524050|NCT01330927|Elderly|elderly
524051|NCT01330927|Males|males
524052|NCT01330927|Nocturnal voids|nocturnal voids
524053|NCT01330927|Anti-diuretic|anti-diuretic
524054|NCT01330914|Obesity, Morbid|obesity, morbid
524055|NCT01330914|Bariatric Surgery|bariatric surgery
524056|NCT01330914|Gastric Bypass|gastric bypass
524057|NCT01330914|Calcium Metabolism Disorders|calcium metabolism disorders
524058|NCT01330914|Vitamin D|vitamin d
524059|NCT01330914|Bone Density|bone density
524060|NCT01330914|Body Composition|body composition
524061|NCT01330914|Weight Loss|weight loss
524062|NCT01330888|war|war
524063|NCT01330888|religion|religion
524064|NCT01330888|caregiver|caregiver
524065|NCT01330888|combat stress disorder|combat stress disorder
524066|NCT01330862|patient outcomes|patient outcomes
524067|NCT01330849|Attention-deficit/hyperactivity disorder|attention-deficit/hyperactivity disorder
524068|NCT01330849|School|school
524069|NCT01330849|Behavioral Intervention|behavioral intervention
524070|NCT01330849|RCT|rct
524071|NCT01330823|pancreatic carcinoma|pancreatic carcinoma
524072|NCT01330823|L-Carnitine|l-carnitine
524073|NCT01330823|quality of life|quality of life
524074|NCT01330823|survival|survival
524075|NCT01330823|malnutrition|malnutrition
524076|NCT01330823|cancer cachexia|cancer cachexia
524077|NCT01330823|fatigue|fatigue
524078|NCT01330810|Pharmacokinetics|pharmacokinetics
524079|NCT01330810|Dietary Supplements|dietary supplements
524080|NCT01330810|Curcumin|curcumin
524081|NCT01330797|Cataract|cataract
524082|NCT01330797|Intravitreal|intravitreal
524083|NCT01330797|Ranibizumab|ranibizumab
524084|NCT01330797|LOCS III|locs iii
524085|NCT01330758|Phase I|phase i
524086|NCT01330758|Healthy male and non-fertile female volunteers|healthy male and non-fertile female volunteers
524087|NCT01330758|Bioavailability|bioavailability
524088|NCT01330758|AZD8931|azd8931
524089|NCT01330745|cardiopulmonary bypass|cardiopulmonary bypass
524090|NCT01330745|mesenteric|mesenteric
524091|NCT01330745|microcirculatory function|microcirculatory function
524092|NCT01330732|SPINESCAN®|spinescan®
524093|NCT01330732|kyphosis|kyphosis
524094|NCT01330719|Periodontitis|periodontitis
524095|NCT01330706|Skin Diseases [C17.800]|skin diseases [c17.800]
524096|NCT01330706|Nail Diseases [C17.800.529]|nail diseases [c17.800.529]
524097|NCT01330706|Nails, Ingrown [C17.800.529.406]|nails, ingrown [c17.800.529.406]
524098|NCT01330693|ADHD|adhd
524099|NCT01330693|Atomoxetine|atomoxetine
524100|NCT01330693|Biomarker|biomarker
524101|NCT01330680|coffee|coffee
524102|NCT01330680|caffeine|caffeine
524103|NCT01330680|blood pressure|blood pressure
524104|NCT01330680|nutrigenetics|nutrigenetics
524105|NCT01330680|gene polymorphisms|gene polymorphisms
524106|NCT01330680|Acute Cardiovascular and Neuropsychologic Effects|acute cardiovascular and neuropsychologic effects
524107|NCT01330667|Hyperbilirubinemia|hyperbilirubinemia
524108|NCT01330667|Breastfeeding|breastfeeding
524109|NCT01330667|Limited Formula|limited formula
524110|NCT01330654|Intermediate risk of adverse cardiac event|intermediate risk of adverse cardiac event
524111|NCT01330654|Undergoing laparoscopic surgical procedure|undergoing laparoscopic surgical procedure
524112|NCT01330654|Age forty to seventy five|age forty to seventy five
524113|NCT01330641|Tendonitis|tendonitis
524114|NCT01330641|Rotator Cuff|rotator cuff
524115|NCT01330641|Shoulder|shoulder
524116|NCT01330641|Injection|injection
524117|NCT01330628|peripheral arterial disease|peripheral arterial disease
524118|NCT01330628|in stent restenosis|in stent restenosis
524119|NCT01330628|peripheral vascular disease|peripheral vascular disease
524120|NCT01330615|EMLA|emla
524121|NCT01330615|plantar warts|plantar warts
524122|NCT01330615|cryotherapy|cryotherapy
524123|NCT01330589|Percutaneous coronary intervention|percutaneous coronary intervention
524124|NCT01330589|Clopidogrel|clopidogrel
524125|NCT01330589|St. John's Wort|st. john's wort
524126|NCT01330589|CYP 2C19 loss-of-function allele|cyp 2c19 loss-of-function allele
524127|NCT01330576|Hypothermia|hypothermia
524128|NCT01330576|cooling|cooling
524129|NCT01330576|necrotizing enterocolitis|necrotizing enterocolitis
524130|NCT01330576|NEC|nec
524131|NCT01330576|neonates|neonates
524132|NCT01330576|preterm|preterm
524133|NCT01330563|Drug-Drug interaction between the CKD-501 and ketoconazole|drug-drug interaction between the ckd-501 and ketoconazole
524134|NCT01330550|High fiber sugar free biscuit|high fiber sugar free biscuit
524135|NCT01330550|pre-diabetics|pre-diabetics
524136|NCT01330537|perceptual development|perceptual development
524137|NCT01330537|topological perception theory|topological perception theory
524138|NCT01330537|familiarization/novelty preference method|familiarization/novelty preference method
524139|NCT01330537|Discriminate a disk and a ring (topologically different),|discriminate a disk and a ring (topologically different),
524140|NCT01330537|Discriminate a disk and a triangle (geometrically different)|discriminate a disk and a triangle (geometrically different)
524141|NCT01330537|Detect a change in the number of holes|detect a change in the number of holes
524142|NCT01330537|Detect the size of the hole|detect the size of the hole
524143|NCT01330511|Newborn infant|newborn infant
524144|NCT01330511|Congenital hydronephrosis|congenital hydronephrosis
524145|NCT01330511|Postnatal imaging evaluation|postnatal imaging evaluation
524146|NCT01330511|Diagnostic algorithm|diagnostic algorithm
524147|NCT01330498|Longitudinal assessment of biomarkers|longitudinal assessment of biomarkers
524148|NCT01330498|duration of natalizumab|duration of natalizumab
524149|NCT01330498|stratification of risk for PML|stratification of risk for pml
524150|NCT01330485|depression|depression
524151|NCT01330485|emotion regulation|emotion regulation
524152|NCT01330485|affect regulation|affect regulation
524153|NCT01330485|skills|skills
524154|NCT01330485|randomized controlled trial|randomized controlled trial
524155|NCT01330485|mediation|mediation
524156|NCT01330472|Alprazolam|alprazolam
524157|NCT01330472|Xanax|xanax
524158|NCT01330472|Bioequivalence|bioequivalence
524159|NCT01330472|Panic disorder with or without agoraphobia.|panic disorder with or without agoraphobia.
524160|NCT01330459|Pain during first trimester surgical abortion|pain during first trimester surgical abortion
524161|NCT01330446|Head and Neck Cancer|head and neck cancer
524162|NCT01330446|HNC|hnc
524163|NCT01330446|Fatigue|fatigue
524164|NCT01330446|Patient-Reported Fatigue|patient-reported fatigue
524165|NCT01330446|Fatigue-Symptom Intervention|fatigue-symptom intervention
524166|NCT01330446|Postoperative Radiation Therapy|postoperative radiation therapy
524167|NCT01330446|Postoperative Chemoradiation Therapy|postoperative chemoradiation therapy
524168|NCT01330446|Armodafinil|armodafinil
524169|NCT01330446|Nuvigil|nuvigil
524170|NCT01330446|Placebo|placebo
524171|NCT01330446|Sugar Pill|sugar pill
524172|NCT01330446|Questionnaires|questionnaires
524173|NCT01330446|Surveys|surveys
524174|NCT01330394|Alcoholism|alcoholism
524175|NCT01330394|Lesch's typology|lesch's typology
524176|NCT01330394|tDCS|tdcs
524178|NCT01330394|P300|p300
524179|NCT01330394|FAB|fab
524180|NCT01330394|MMSE|mmse
524181|NCT01330394|Cognitive tasks|cognitive tasks
666069|NCT00765284|HDL|hdl
524182|NCT01330368|Systemic Lupus Erythematosus|systemic lupus erythematosus
524183|NCT01330368|SLE|sle
524184|NCT01330368|Lupus|lupus
524185|NCT01330368|children with SLE|children with sle
524186|NCT01330355|Ocular infections, bacterial|ocular infections, bacterial
524187|NCT01330329|Obesity|obesity
524188|NCT01330329|Weight loss|weight loss
524189|NCT01330329|Exercise|exercise
524190|NCT01330329|Intervention studies|intervention studies
524191|NCT01330303|Bioequivalence|bioequivalence
524192|NCT01330303|Healthy volunteers|healthy volunteers
524193|NCT01330303|tamsulosin hydrochloride|tamsulosin hydrochloride
524194|NCT01330303|Fed administration|fed administration
524195|NCT01330290|Rotigotine|rotigotine
524196|NCT01330290|Neupro®|neupro®
524197|NCT01330290|Parkinson|parkinson
524198|NCT01330290|Treatment preference|treatment preference
524199|NCT01330290|Care-giving|care-giving
524200|NCT01330277|Hunter Disease|hunter disease
524201|NCT01330277|Biomarker|biomarker
524202|NCT01330264|Intracranial Pressure (ICP) Monitoring|intracranial pressure (icp) monitoring
524203|NCT01330264|Admission to Intensive Care Unit (ICU)|admission to intensive care unit (icu)
524204|NCT01330238|Low back pain|low back pain
524205|NCT01330238|Modic changes|modic changes
524206|NCT01330238|Vertebral endplate signal changes|vertebral endplate signal changes
524207|NCT01330238|Efficacy|efficacy
524208|NCT01330238|Zoledronic acid|zoledronic acid
524209|NCT01330238|Bisphosphonates|bisphosphonates
524210|NCT01330238|RCT|rct
524211|NCT01330199|Healthy|healthy
524212|NCT01330199|Female|female
524213|NCT01330199|Volunteer|volunteer
524214|NCT01330160|stroke|stroke
524215|NCT01330160|Brain ischemia|brain ischemia
524216|NCT01330160|Intracranial hemorrhage|intracranial hemorrhage
524217|NCT01330160|Dementia, Vascular|dementia, vascular
524218|NCT01330160|Alzheimer's disease|alzheimer's disease
524219|NCT01330147|HPV|hpv
524220|NCT01330147|oral cancer|oral cancer
524221|NCT01330147|oropharyngeal cancer|oropharyngeal cancer
524222|NCT01330147|tonsillectomy|tonsillectomy
524223|NCT01330134|procedural|procedural
524224|NCT01330121|Adherence with discharge diabetes medications|adherence with discharge diabetes medications
524225|NCT01330121|Diabeted mellitus type 2 greater than one year|diabeted mellitus type 2 greater than one year
524226|NCT01330121|Patient with provider and prescriptions filled within CCHS|patient with provider and prescriptions filled within cchs
524227|NCT01330108|Pulmonary Arterial Hypertension|pulmonary arterial hypertension
524228|NCT01330108|PAH|pah
524229|NCT01330108|WHO Group 1|who group 1
524230|NCT01330095|Bifidobacterium bifidum|bifidobacterium bifidum
524231|NCT01330095|Very low birth weight infant|very low birth weight infant
524232|NCT01330095|Enteral feeding|enteral feeding
524233|NCT01330095|Growth|growth
524234|NCT01330095|amount of enteral feeding|amount of enteral feeding
524235|NCT01330082|Photodynamic therapy|photodynamic therapy
524236|NCT01330082|Light-emitting diode|light-emitting diode
524237|NCT01330082|toluidine blue|toluidine blue
524238|NCT01330082|scaling and root planing|scaling and root planing
524239|NCT01330056|Laryngeal and pharyngeal preservation, survivals|laryngeal and pharyngeal preservation, survivals
524240|NCT01330043|smoking cessation intervention|smoking cessation intervention
524241|NCT01330017|Seasonal allergies|seasonal allergies
524242|NCT01329991|RA|ra
524243|NCT01329991|Methotrexate|methotrexate
524244|NCT01329978|Hepatitis C|hepatitis c
524245|NCT01329978|HCV|hcv
524246|NCT01329978|Chronic Hepatitis C|chronic hepatitis c
524247|NCT01329965|Cardiovascular disease|cardiovascular disease
524248|NCT01329965|Inflammation|inflammation
524249|NCT01329965|LPS|lps
524250|NCT01329965|Endotoxin|endotoxin
524251|NCT01329939|Asthma|asthma
524252|NCT01329939|Obesity|obesity
524253|NCT01329939|Pediatric|pediatric
524254|NCT01329939|Inflammation|inflammation
524255|NCT01329939|Leukotriene|leukotriene
524256|NCT01329939|Montelukast|montelukast
524257|NCT01329926|Parkinson's disease|parkinson's disease
524258|NCT01329926|Neural stem cells|neural stem cells
524259|NCT01329900|Chemotherapy|chemotherapy
524260|NCT01329900|Stem Cell Collection|stem cell collection
524261|NCT01329900|Ofatumumab|ofatumumab
524262|NCT01329900|Arzerra|arzerra
524263|NCT01329900|Ifosfamide|ifosfamide
524264|NCT01329900|Ifex|ifex
524265|NCT01329900|Etoposide|etoposide
524266|NCT01329900|VePesid|vepesid
524267|NCT01329900|Mesna|mesna
524268|NCT01329900|Mesnex|mesnex
524269|NCT01329900|G-CSF|g-csf
524270|NCT01329900|Filgrastim|filgrastim
524271|NCT01329900|Neupogen|neupogen
524272|NCT01329900|Apheresis|apheresis
524273|NCT01329887|microcirculation|microcirculation
524274|NCT01329887|SDF|sdf
524275|NCT01329887|ketanserin|ketanserin
524276|NCT01329887|severe sepsis|severe sepsis
524277|NCT01329861|chronic back pain|chronic back pain
524278|NCT01329861|internet based treatment|internet based treatment
524279|NCT01329861|pain management programme|pain management programme
524280|NCT01329861|cognitive behavioural therapy|cognitive behavioural therapy
524281|NCT01329861|minimal therapist contact|minimal therapist contact
524282|NCT01329848|Accommodation|accommodation
524283|NCT01329848|Reading|reading
524284|NCT01329848|Autorefraction|autorefraction
524285|NCT01329822|type 2 diabetes|type 2 diabetes
524286|NCT01329822|overweight|overweight
524287|NCT01329809|metastatic colorectal cancer|metastatic colorectal cancer
524288|NCT01329809|colon cancer|colon cancer
524289|NCT01329809|liver metastasis|liver metastasis
524290|NCT01329809|Pexa-vec|pexa-vec
524291|NCT01329809|JX-594|jx-594
524292|NCT01329796|dysmenorrhea,|dysmenorrhea,
524293|NCT01329796|pelvic pain|pelvic pain
524294|NCT01329796|dyspareunia|dyspareunia
524295|NCT01329796|endometriosis|endometriosis
524296|NCT01329770|Neurodevelopmental disability|neurodevelopmental disability
524297|NCT01329770|Hyperactivity|hyperactivity
524298|NCT01329770|Anxiety|anxiety
524299|NCT01329770|Cognitive problems|cognitive problems
524300|NCT01329770|Behavioural symptoms|behavioural symptoms
524301|NCT01329770|Fragile X syndrome|fragile x syndrome
524302|NCT01329770|Autism|autism
524303|NCT01329770|inherited Genetic condition|inherited genetic condition
524304|NCT01329757|Spinal Cord Injury|spinal cord injury
524305|NCT01329757|Growth Hormone|growth hormone
524306|NCT01329757|Trauma|trauma
524307|NCT01329757|Incomplete|incomplete
524308|NCT01329757|ASIA|asia
524309|NCT01329744|HIV lipodystrophy|hiv lipodystrophy
524310|NCT01329731|white spot lesion|white spot lesion
524311|NCT01329731|initial caries|initial caries
524312|NCT01329731|fluoride|fluoride
524313|NCT01329731|amine fluoride|amine fluoride
524314|NCT01329731|orthodontics|orthodontics
524315|NCT01329731|remineralization|remineralization
524316|NCT01329731|brackets|brackets
524317|NCT01329718|Stability of the Septin 9 biomarker|stability of the septin 9 biomarker
524318|NCT01329718|Epi Pro Colon Test|epi pro colon test
524319|NCT01329718|CRC|crc
524320|NCT01329692|RYGB|rygb
524321|NCT01329692|Intervention|intervention
524322|NCT01329692|follow-up|follow-up
524323|NCT01329692|standard-of-care|standard-of-care
524324|NCT01329692|Back on Track program|back on track program
524325|NCT01329692|poor weight loss|poor weight loss
524326|NCT01329692|morbidly obese|morbidly obese
524327|NCT01329666|Primary Hyperparathyroidism|primary hyperparathyroidism
524328|NCT01329666|Endocrinology|endocrinology
524329|NCT01329666|Hypercalcemia|hypercalcemia
524330|NCT01329666|Vitamin D deficiency|vitamin d deficiency
524331|NCT01329666|Parathyroid Hormone|parathyroid hormone
524332|NCT01329666|Osteoporosis|osteoporosis
524333|NCT01329666|Bone Density|bone density
524334|NCT01329666|Vitamin D repletion|vitamin d repletion
524335|NCT01329666|Vitamin D Supplements|vitamin d supplements
524336|NCT01329653|cerebral blood volume|cerebral blood volume
524337|NCT01329653|aging|aging
524338|NCT01329653|exercise|exercise
524339|NCT01329640|Metronimic chemotherapy|metronimic chemotherapy
524340|NCT01329640|Locally Advanced HER2-positive Breast Cancer|locally advanced her2-positive breast cancer
524341|NCT01329601|cognitive training|cognitive training
524342|NCT01329601|Alzheimer disease|alzheimer disease
524343|NCT01329601|tertiary prevention|tertiary prevention
524344|NCT01329588|Female sex workers|female sex workers
524345|NCT01329588|West Africa|west africa
524346|NCT01329588|Presumptive treatment|presumptive treatment
524347|NCT01329588|Sexually transmitted infections|sexually transmitted infections
524348|NCT01329575|endoluminal ultrasound|endoluminal ultrasound
524349|NCT01329575|Mediastinal LN invasion|mediastinal ln invasion
524350|NCT01329562|Menstrual migraine|menstrual migraine
524351|NCT01329562|Menstrually-related migraine|menstrually-related migraine
524352|NCT01329562|Treximet|treximet
524353|NCT01329562|CGRP|cgrp
524354|NCT01329562|calcitonin gene-related peptide|calcitonin gene-related peptide
524355|NCT01329536|Alzheimer's Disease|alzheimer's disease
524356|NCT01329536|Agitation|agitation
524357|NCT01329536|Genetics|genetics
524358|NCT01329536|Apolipoprotein|apolipoprotein
524359|NCT01329536|ApoE4|apoe4
524360|NCT01329523|Dementia|dementia
524361|NCT01329523|Insulin-like growth factor|insulin-like growth factor
524362|NCT01329523|IGF|igf
524363|NCT01329523|APO E4|apo e4
524364|NCT01329523|Genetics|genetics
524365|NCT01329510|ADHD|adhd
524366|NCT01329510|Adult|adult
524367|NCT01329484|Alzheimer|alzheimer
524368|NCT01329484|Dementia|dementia
524369|NCT01329484|Computer|computer
524370|NCT01329484|Cognitive training|cognitive training
524371|NCT01329484|Reminiscence therapy|reminiscence therapy
524373|NCT01329458|CEUS|ceus
524374|NCT01329458|SonoVue|sonovue
524375|NCT01329458|HCC|hcc
524376|NCT01329458|Liver metastases|liver metastases
524377|NCT01329458|Hemangiomas|hemangiomas
524378|NCT01329458|FNH|fnh
524379|NCT01329445|Cartilage repair|cartilage repair
524380|NCT01329445|Articular cartilage defects|articular cartilage defects
524381|NCT01329432|surfactant|surfactant
524382|NCT01329432|intubation|intubation
524383|NCT01329432|spontaneous breathing|spontaneous breathing
524384|NCT01329432|bronchopulmonary dysplasia|bronchopulmonary dysplasia
524385|NCT01329406|Osteoarthritis (OA)|osteoarthritis (oa)
524386|NCT01329406|Milnacipran|milnacipran
524387|NCT01329406|Serotonin-norepinephrine reuptake inhibitor (SNRI)|serotonin-norepinephrine reuptake inhibitor (snri)
524388|NCT01329406|Knee pain|knee pain
524389|NCT01329393|Disability|disability
524390|NCT01329393|Social Security|social security
524391|NCT01329393|Representative Payee|representative payee
524392|NCT01329380|Ankylosing Spondylitis|ankylosing spondylitis
524393|NCT01329367|EVASYON|evasyon
524394|NCT01329367|GENOI|genoi
524395|NCT01329367|antioxidants|antioxidants
524396|NCT01329367|legume|legume
524397|NCT01329367|fish|fish
524398|NCT01329354|Follicular lymphoma|follicular lymphoma
524399|NCT01329354|Follicular non-Hodgkin´s lymphoma|follicular non-hodgkin´s lymphoma
524400|NCT01329354|Autologous effector lymphocytes|autologous effector lymphocytes
524401|NCT01329354|Cell Therapy|cell therapy
524402|NCT01329354|Maintenance therapy|maintenance therapy
524403|NCT01329354|Rituximab|rituximab
524404|NCT01329341|PTSD|ptsd
524405|NCT01329341|Service Dogs|service dogs
524406|NCT01329328|whole-body vibration|whole-body vibration
524407|NCT01329328|radiofrequency|radiofrequency
524408|NCT01329328|hormonal status|hormonal status
524409|NCT01329328|muscular strength|muscular strength
524410|NCT01329328|balance|balance
524411|NCT01329276|COPD|copd
524412|NCT01329276|Symbicort|symbicort
524413|NCT01329276|Turbohaler|turbohaler
524414|NCT01329276|Computational Fluid Dynamics|computational fluid dynamics
524415|NCT01329276|Functional Imaging|functional imaging
524416|NCT01329276|Budesonide|budesonide
524417|NCT01329276|Formoterol|formoterol
524418|NCT01329263|menthol cigarettes|menthol cigarettes
524419|NCT01329250|Tuberculosis|tuberculosis
524420|NCT01329250|Moxifloxacin|moxifloxacin
524421|NCT01329250|Pharmacokinetics|pharmacokinetics
524422|NCT01329250|Safety|safety
524423|NCT01329237|drug-eluting stent|drug-eluting stent
524424|NCT01329237|coronary endothelial function|coronary endothelial function
524425|NCT01329237|coronary imaging|coronary imaging
524426|NCT01329224|acetylsalicylic acid resistance|acetylsalicylic acid resistance
524427|NCT01329211|Gastroparesis|gastroparesis
524428|NCT01329211|Quality of Life|quality of life
524429|NCT01329198|tourette|tourette
524430|NCT01329198|tourette's|tourette's
524431|NCT01329198|TS|ts
524432|NCT01329198|tourette syndrome|tourette syndrome
524433|NCT01329198|tourette's syndrome|tourette's syndrome
524434|NCT01329185|EBV Viremia in posttransplant kidney recipients|ebv viremia in posttransplant kidney recipients
524435|NCT01329185|CMV viremia in posttransplant kidney recipients|cmv viremia in posttransplant kidney recipients
524436|NCT01329172|PUFA|pufa
524437|NCT01329172|Cystic Fibrosis|cystic fibrosis
524438|NCT01329172|Nasal brushing|nasal brushing
524439|NCT01329172|Mucins|mucins
524440|NCT01329172|Mucin production|mucin production
524441|NCT01329159|High altitude|high altitude
524442|NCT01329159|respiratory function|respiratory function
524443|NCT01329159|cardiorespiratory health|cardiorespiratory health
524444|NCT01329159|indoor pollution|indoor pollution
524445|NCT01329146|pulse pressure variation|pulse pressure variation
524446|NCT01329146|preload dependency|preload dependency
524447|NCT01329146|one-lung ventilation|one-lung ventilation
524448|NCT01329146|thoracic surgery|thoracic surgery
524449|NCT01329133|Deep brain stimulation (DBS)|deep brain stimulation (dbs)
524450|NCT01329133|Obsessive compulsive disorder|obsessive compulsive disorder
524451|NCT01329133|ventral striatum|ventral striatum
524452|NCT01329133|subthalamic nucleus|subthalamic nucleus
524453|NCT01329107|Rehabilitation|rehabilitation
524454|NCT01329107|Enhanced Recovery|enhanced recovery
524455|NCT01329107|Health related Qouality of Life|health related qouality of life
524456|NCT01329107|Patient outcomes|patient outcomes
524457|NCT01329094|Severe mental illness|severe mental illness
524458|NCT01329094|physical activity|physical activity
524459|NCT01329094|evaluation|evaluation
524460|NCT01329081|Rehabilitation|rehabilitation
524461|NCT01329081|Strength training|strength training
524462|NCT01329081|Long-term effect|long-term effect
524463|NCT01329081|Activity and participation after fast-track knee arthroplasty|activity and participation after fast-track knee arthroplasty
524464|NCT01329068|breast cancer|breast cancer
524465|NCT01329042|Potassium sodium citrate|potassium sodium citrate
524466|NCT01329042|stone recurrence|stone recurrence
524467|NCT01329042|ESWL|eswl
524468|NCT01329042|PCNL|pcnl
524469|NCT01329042|Hypocitraturia|hypocitraturia
524470|NCT01329042|intervention|intervention
524471|NCT01329029|COPD|copd
524472|NCT01329029|Roflumilast|roflumilast
524473|NCT01329029|Daxas|daxas
524474|NCT01329016|Pregnancy|pregnancy
524475|NCT01329016|Glyburide|glyburide
524476|NCT01329016|Metformin|metformin
524477|NCT01329016|Pharmacokinetics|pharmacokinetics
524478|NCT01329016|Pharmacodynamics|pharmacodynamics
524479|NCT01329003|Silicosis|silicosis
524480|NCT01328990|IPTc|iptc
524481|NCT01328990|malaria|malaria
524482|NCT01328990|children|children
524483|NCT01328990|pharmacokinetics|pharmacokinetics
524484|NCT01328990|amodiaquiane|amodiaquiane
524485|NCT01328990|sulfadoxine-pyrimethamine|sulfadoxine-pyrimethamine
524486|NCT01328964|pediatric|pediatric
524487|NCT01328964|asthma|asthma
524488|NCT01328964|outcomes|outcomes
524489|NCT01328964|inhaled cortcosteroids|inhaled cortcosteroids
524490|NCT01328938|Pegfilgrastim|pegfilgrastim
524491|NCT01328938|neutropenia|neutropenia
524492|NCT01328925|Rotavirus|rotavirus
524493|NCT01328925|Viral gastroenteritis|viral gastroenteritis
524494|NCT01328925|Gastroenteritis|gastroenteritis
524495|NCT01328912|ischemic preconditioning|ischemic preconditioning
524496|NCT01328912|cardiac surgery|cardiac surgery
524497|NCT01328912|vascular surgery|vascular surgery
524498|NCT01328899|Emphysema|emphysema
524499|NCT01328899|COPD|copd
524500|NCT01328899|RePneu|repneu
524501|NCT01328886|omalizumab|omalizumab
524502|NCT01328886|allergic asthma|allergic asthma
524503|NCT01328886|pediatric patients|pediatric patients
524504|NCT01328873|Pulmonary infiltrates|pulmonary infiltrates
524505|NCT01328873|stem cell transplant|stem cell transplant
524506|NCT01328873|leukemia|leukemia
524507|NCT01328860|Autologous|autologous
524508|NCT01328860|Stem Cells|stem cells
524509|NCT01328860|Spinal Cord Injury|spinal cord injury
524510|NCT01328860|Children|children
524511|NCT01328834|Nephritis, Lupus|nephritis, lupus
524512|NCT01328834|Tacrolimus|tacrolimus
524513|NCT01328821|Safety|safety
524514|NCT01328821|Tolerability|tolerability
524515|NCT01328821|Pharmacokinetics|pharmacokinetics
524516|NCT01328821|Healthy volunteers|healthy volunteers
524517|NCT01328808|Acetaminophen|acetaminophen
524518|NCT01328808|Preterm Infants|preterm infants
524519|NCT01328795|Cardiogoniometry|cardiogoniometry
524520|NCT01328795|Chest Pain Unit|chest pain unit
524521|NCT01328795|ST-elevation|st-elevation
524522|NCT01328795|Troponin|troponin
524523|NCT01328795|Catheter intervention|catheter intervention
524524|NCT01328795|Fast Track|fast track
524525|NCT01328782|elbow fracture|elbow fracture
524526|NCT01328782|supracondylar elbow fracture|supracondylar elbow fracture
524527|NCT01328782|elbow|elbow
524528|NCT01328782|fracture|fracture
524529|NCT01328782|pain management|pain management
524530|NCT01328782|pediatric|pediatric
524531|NCT01328769|uric acid|uric acid
524532|NCT01328769|febuxostat|febuxostat
524533|NCT01328769|hypertension|hypertension
524534|NCT01328769|intra-renal renin-angiotensin system|intra-renal renin-angiotensin system
524535|NCT01328769|renal plasma flow|renal plasma flow
524536|NCT01328769|angiotensin II|angiotensin ii
524537|NCT01328756|ADHD|adhd
524538|NCT01328730|significant stenosis (>70% of lumen stenosis)|significant stenosis (>70% of lumen stenosis)
524539|NCT01328730|epicardial coronary arteries.|epicardial coronary arteries.
524540|NCT01328704|Iron deficiency|iron deficiency
524541|NCT01328704|Vitamin D deficiency|vitamin d deficiency
524542|NCT01328704|Anemia|anemia
524543|NCT01328704|Athletes|athletes
524544|NCT01328704|Triathletes|triathletes
524545|NCT01328704|Triathlon|triathlon
524546|NCT01328691|Carcinoma, Renal Cell|carcinoma, renal cell
524547|NCT01328691|thrombus|thrombus
524548|NCT01328691|body mass index|body mass index
524549|NCT01328691|grade|grade
524550|NCT01328678|Alopecia Areata|alopecia areata
524551|NCT01328678|Vitamin D|vitamin d
524552|NCT01328678|Parathyroid|parathyroid
524553|NCT01328678|Calcium|calcium
524554|NCT01328652|LPR|lpr
524555|NCT01328652|LTH|lth
524556|NCT01328639|Collaborative care|collaborative care
524557|NCT01328639|Diabetes management|diabetes management
524558|NCT01328639|Depression management|depression management
524559|NCT01328639|Primary care|primary care
524560|NCT01328626|Safety|safety
524561|NCT01328626|Maximum Tolerated Dose|maximum tolerated dose
524562|NCT01328626|Pharmacokinetics|pharmacokinetics
524563|NCT01328626|ABT-199|abt-199
524564|NCT01328626|Preliminary Efficacy|preliminary efficacy
524565|NCT01328626|Cancer|cancer
524566|NCT01328626|Non-Hodgkin Lymphoma|non-hodgkin lymphoma
524693|NCT01328054|safety|safety
524567|NCT01328626|Chronic Lymphocytic Leukemia|chronic lymphocytic leukemia
524568|NCT01328613|BDNF|bdnf
524569|NCT01328613|Homeosis|homeosis
524570|NCT01328613|Women|women
524571|NCT01328613|Childbirth|childbirth
524572|NCT01328613|Major Depressive Disorder|major depressive disorder
524573|NCT01328600|Placenta|placenta
524574|NCT01328600|Pregnancy|pregnancy
524575|NCT01328600|Hypertension|hypertension
524576|NCT01328600|Supplementation|supplementation
524577|NCT01328600|Antibody|antibody
524578|NCT01328587|Autoimmunity|autoimmunity
524579|NCT01328587|Neutropenia|neutropenia
524580|NCT01328587|Cytokine|cytokine
524581|NCT01328587|Hematopoiesis|hematopoiesis
524582|NCT01328587|Thrombocytopenia|thrombocytopenia
524583|NCT01328587|Aplastic Anemia|aplastic anemia
524584|NCT01328574|Progression-Free Survival|progression-free survival
524585|NCT01328574|Carcinoma of the Bladder|carcinoma of the bladder
524586|NCT01328574|Cancer of the Renal Pelvis|cancer of the renal pelvis
524587|NCT01328574|Ureter Cancer|ureter cancer
524588|NCT01328574|Survival|survival
666510|NCT00763139|RA|ra
524589|NCT01328574|Bladder Cancer|bladder cancer
524590|NCT01328574|Renal Pelvis Cancer|renal pelvis cancer
524591|NCT01328574|Urothelial Cancer|urothelial cancer
524592|NCT01328561|Arginine|arginine
524593|NCT01328561|Oxytocin|oxytocin
524594|NCT01328561|Vasopressin|vasopressin
524596|NCT01328561|Analgesia|analgesia
524597|NCT01328561|Healthy Volunteer|healthy volunteer
524598|NCT01328561|HV|hv
524599|NCT01328548|varicella-zoster virus|varicella-zoster virus
524600|NCT01328548|vaccine|vaccine
524601|NCT01328548|T-cell|t-cell
524602|NCT01328548|genes|genes
524603|NCT01328548|frail elderly|frail elderly
524604|NCT01328548|immunosenescence|immunosenescence
524605|NCT01328548|immune and genetic correlates of response to zoster vaccine in the elderly|immune and genetic correlates of response to zoster vaccine in the elderly
524606|NCT01328509|Zinc|zinc
524607|NCT01328496|Hematologic Malignancies|hematologic malignancies
524608|NCT01328496|Umbilical Cord Blood transplantation|umbilical cord blood transplantation
524609|NCT01328496|Hematopoietic Cell Transplantation|hematopoietic cell transplantation
524610|NCT01328483|Neonates|neonates
524611|NCT01328483|Intrapartum Oropharyngeal Suctioning|intrapartum oropharyngeal suctioning
524612|NCT01328483|Meconium Aspiration Syndrome|meconium aspiration syndrome
524613|NCT01328470|platelet|platelet
524614|NCT01328470|cilostazol|cilostazol
524615|NCT01328470|clopidogrel|clopidogrel
524616|NCT01328470|chronic kidney disease|chronic kidney disease
524617|NCT01328457|Leishmaniasis, Visceral|leishmaniasis, visceral
524618|NCT01328457|kala-azar|kala-azar
524619|NCT01328457|Paromomycin|paromomycin
524620|NCT01328457|Bangladesh|bangladesh
524621|NCT01328457|Injections, Intramuscular|injections, intramuscular
524622|NCT01328457|Treatment Outcome|treatment outcome
524623|NCT01328457|Patient compliance|patient compliance
524624|NCT01328457|Medication adherence|medication adherence
524625|NCT01328457|Drug toxicity|drug toxicity
524626|NCT01328431|Tobacco Use Cessation|tobacco use cessation
524627|NCT01328431|Smoking Cessation|smoking cessation
524628|NCT01328431|Nicotine Replacement Therapy|nicotine replacement therapy
524629|NCT01328431|Brief Intervention|brief intervention
524630|NCT01328418|Lengthening|lengthening
524631|NCT01328392|LPR|lpr
524632|NCT01328392|GERD|gerd
524633|NCT01328366|Quality of Life|quality of life
524634|NCT01328366|Psychosocial factors|psychosocial factors
524635|NCT01328353|triage|triage
524636|NCT01328353|aprn|aprn
524637|NCT01328353|telehealth|telehealth
524638|NCT01328353|CCHCN|cchcn
524639|NCT01328353|advanced practice nurse|advanced practice nurse
524640|NCT01328353|improve family quality of life|improve family quality of life
524641|NCT01328353|reduce unplanned use of health care services|reduce unplanned use of health care services
524642|NCT01328353|telehealth triage intervention|telehealth triage intervention
524643|NCT01328340|muscle power, exercise, aging|muscle power, exercise, aging
524644|NCT01328301|gait|gait
524645|NCT01328301|hemiplegia|hemiplegia
524646|NCT01328301|treadmill|treadmill
524647|NCT01328301|physiotherapy|physiotherapy
524648|NCT01328301|rehabilitation|rehabilitation
524649|NCT01328288|HIV related adverse events|hiv related adverse events
524650|NCT01328288|Immunological failure|immunological failure
524651|NCT01328288|virological failure|virological failure
524652|NCT01328288|quality of life|quality of life
524653|NCT01328288|depression|depression
524654|NCT01328288|genotypic resistance|genotypic resistance
524655|NCT01328275|HIV related adverse events|hiv related adverse events
524656|NCT01328275|immunological failure|immunological failure
524657|NCT01328275|virological failure|virological failure
524658|NCT01328275|quality of life|quality of life
524659|NCT01328275|depression|depression
524660|NCT01328275|genotypic resistance|genotypic resistance
524661|NCT01328262|Hemoglobins|hemoglobins
524662|NCT01328249|Breast Cancer|breast cancer
524663|NCT01328249|HER2-normal Stage I to III invasive breast cancer|her2-normal stage i to iii invasive breast cancer
524664|NCT01328236|Bortezomib|bortezomib
524665|NCT01328236|PCL|pcl
524666|NCT01328223|Hepatocellular carcinoma|hepatocellular carcinoma
524667|NCT01328223|radiotherapy|radiotherapy
524668|NCT01328223|sorafenib|sorafenib
524669|NCT01328210|metabolic syndrome|metabolic syndrome
524670|NCT01328210|Phlebotomy|phlebotomy
524671|NCT01328210|blood letting|blood letting
524672|NCT01328210|hypertension|hypertension
524673|NCT01328210|insulin sensitivity|insulin sensitivity
524674|NCT01328197|Treovance|treovance
524675|NCT01328197|aneurysm|aneurysm
524676|NCT01328197|AAA|aaa
524677|NCT01328158|Kaletra, Lopinavir (LPV)/Ritonavir (RTV), Human Immunodeficiency Virus (HIV) infection|kaletra, lopinavir (lpv)/ritonavir (rtv), human immunodeficiency virus (hiv) infection
524678|NCT01328132|Liver|liver
524679|NCT01328132|transplant|transplant
524680|NCT01328132|albumin|albumin
524681|NCT01328067|MRgFus|mrgfus
524682|NCT01328067|Uterine Fibroids|uterine fibroids
524683|NCT01328067|Pelvic Pain|pelvic pain
524684|NCT01328067|Quality of Life|quality of life
524685|NCT01328067|Symptomatic Uterine Fibroids|symptomatic uterine fibroids
524686|NCT01328054|cancer|cancer
524687|NCT01328054|cardiac repolarization|cardiac repolarization
524688|NCT01328054|Holter monitor|holter monitor
524689|NCT01328054|pharmacokinetics|pharmacokinetics
524690|NCT01328054|GW572016|gw572016
524691|NCT01328054|lapatinib|lapatinib
524692|NCT01328054|QTc interval|qtc interval
524694|NCT01328054|ECG|ecg
524695|NCT01328041|GSK1349572|gsk1349572
524696|NCT01328041|resistance to raltegravir or elvitegravir|resistance to raltegravir or elvitegravir
524697|NCT01328041|Integrase inhibitor|integrase inhibitor
524698|NCT01328041|ART-experienced|art-experienced
524699|NCT01328041|dolutegravir|dolutegravir
524700|NCT01328028|Invasive cervical cancer|invasive cervical cancer
524701|NCT01328028|Human papillomavirus|human papillomavirus
524702|NCT01328015|hyperhidrosis|hyperhidrosis
524703|NCT01328015|oxybutynin|oxybutynin
524704|NCT01328015|plantar sweating|plantar sweating
524705|NCT01328015|compensatory sweating|compensatory sweating
524706|NCT01328002|Fibromyalgia|fibromyalgia
524707|NCT01328002|Pediatric Fibromyalgia|pediatric fibromyalgia
524708|NCT01328002|Adolescent Fibromyalgia|adolescent fibromyalgia
524709|NCT01328002|milnacipran|milnacipran
524710|NCT01328002|Savella|savella
524711|NCT01328002|loss of therapeutic response|loss of therapeutic response
524712|NCT01328002|Forest Research Institute|forest research institute
524713|NCT01328002|Pain|pain
524714|NCT01328002|Fatigue|fatigue
524715|NCT01328002|Serotonin Norepinephrine Reuptake Inhibitors|serotonin norepinephrine reuptake inhibitors
524716|NCT01328002|Randomized Withdrawal|randomized withdrawal
524717|NCT01327989|Solitaire FR Device|solitaire fr device
524718|NCT01327989|Mechanical Thrombectomy|mechanical thrombectomy
524719|NCT01327989|Recanalization|recanalization
524720|NCT01327989|Brain artery recanalization|brain artery recanalization
524721|NCT01327989|Neurovascular intervention|neurovascular intervention
524722|NCT01327989|Interventional Neuroradiology|interventional neuroradiology
524723|NCT01327989|STAR|star
524724|NCT01327989|Acute Ischemic Stroke|acute ischemic stroke
524725|NCT01327976|Obesity|obesity
524726|NCT01327976|Bariatric surgery|bariatric surgery
524727|NCT01327976|Excess weight loss|excess weight loss
524728|NCT01327976|Vagus nerve|vagus nerve
524729|NCT01327976|Vagal blocking|vagal blocking
524730|NCT01327976|vBloc Therapy|vbloc therapy
524731|NCT01327963|Gastroesophageal reflux disease|gastroesophageal reflux disease
524732|NCT01327963|GERD|gerd
524733|NCT01327963|Heartburn|heartburn
524734|NCT01327963|Reflux|reflux
524735|NCT01327963|Regurgitation|regurgitation
524736|NCT01327963|Hoarseness|hoarseness
524737|NCT01327963|Cough|cough
524738|NCT01327950|Percutaneous treatment|percutaneous treatment
524739|NCT01327950|Superficial Femoral Artery lesions|superficial femoral artery lesions
524740|NCT01327950|EPIC Nitinol Vascular Stent System|epic nitinol vascular stent system
524741|NCT01327911|Mactel|mactel
524742|NCT01327911|Macular Telangiectasia Type 2|macular telangiectasia type 2
524743|NCT01327898|MSM|msm
524744|NCT01327898|HIV/AIDS|hiv/aids
524745|NCT01327898|sexual risk|sexual risk
524746|NCT01327898|substance use|substance use
524747|NCT01327872|Idiopathic Thrombocytopenia Purpura(ITP)|idiopathic thrombocytopenia purpura(itp)
524748|NCT01327872|Acute and Chronic Thrombocytopenia Associated with Chronic Liver Disease|acute and chronic thrombocytopenia associated with chronic liver disease
524749|NCT01327872|TLD|tld
524750|NCT01327846|Cardiovascular Death|cardiovascular death
524751|NCT01327846|Myocardial Infarction|myocardial infarction
524752|NCT01327846|Stroke|stroke
524753|NCT01327846|Canakinumab|canakinumab
524754|NCT01327846|IL-1B|il-1b
524755|NCT01327846|hsCRP|hscrp
524756|NCT01327820|Oxygen consumption|oxygen consumption
524757|NCT01327820|Aortic Aneurysm|aortic aneurysm
524758|NCT01327820|Peripheral Arterial Disease|peripheral arterial disease
524759|NCT01327807|Registries|registries
524760|NCT01327807|Cystinosis|cystinosis
524761|NCT01327807|Nephropathic Cystinosis|nephropathic cystinosis
524762|NCT01327807|Renal Fanconi Syndrome|renal fanconi syndrome
524763|NCT01327807|Cystine|cystine
524764|NCT01327807|Kidney|kidney
524765|NCT01327807|Rare Diseases|rare diseases
524766|NCT01327794|recurrent pancreatic cancer|recurrent pancreatic cancer
524767|NCT01327794|stage III pancreatic cancer|stage iii pancreatic cancer
524768|NCT01327794|stage IV pancreatic cancer|stage iv pancreatic cancer
524769|NCT01327768|Stroke,|stroke,
524770|NCT01327768|Stem Cell,|stem cell,
524771|NCT01327768|Olfactory Ensheathing Cells,|olfactory ensheathing cells,
524772|NCT01327768|Intracerebral Implantation of Olfactory Ensheathing Cells.|intracerebral implantation of olfactory ensheathing cells.
524773|NCT01327755|Selenium|selenium
524774|NCT01327755|HIV/ AIDS|hiv/ aids
524775|NCT01327755|CD4 counts|cd4 counts
524776|NCT01327755|Antiretroviral therapy|antiretroviral therapy
524777|NCT01327742|Relay|relay
524778|NCT01327742|Thoracic|thoracic
524779|NCT01327742|Aneurysm|aneurysm
524780|NCT01327729|pegylated interferon|pegylated interferon
524781|NCT01327729|interferon|interferon
524782|NCT01327729|HCV|hcv
524783|NCT01327729|genotype 4|genotype 4
666750|NCT00762125|FMS|fms
524784|NCT01327703|Exocrine Pancreatic Insufficiency|exocrine pancreatic insufficiency
524785|NCT01327703|Cystic Fibrosis|cystic fibrosis
524786|NCT01327703|Steatorrhea|steatorrhea
524787|NCT01327703|Malabsorption|malabsorption
524788|NCT01327703|Malnutrition|malnutrition
524789|NCT01327677|pain management|pain management
524790|NCT01327677|opioid analgesic therapy|opioid analgesic therapy
524791|NCT01327677|safety|safety
524792|NCT01327677|craniotomy|craniotomy
524793|NCT01327664|Quiescent uveitis|quiescent uveitis
524794|NCT01327664|intermediate uveitis|intermediate uveitis
524795|NCT01327664|panuveitis|panuveitis
524796|NCT01327664|posterior uveitis|posterior uveitis
524797|NCT01327664|uveitis|uveitis
524798|NCT01327651|Drug Administration Schedule|drug administration schedule
524799|NCT01327651|Nucleoside Reverse Transcriptase Inhibitors|nucleoside reverse transcriptase inhibitors
524800|NCT01327651|Pharmacokinetics|pharmacokinetics
524801|NCT01327625|Allogeneic hematopoietic cell transplantation|allogeneic hematopoietic cell transplantation
524802|NCT01327625|Graft versus host disease|graft versus host disease
524803|NCT01327625|Bronchiolitis obliterans|bronchiolitis obliterans
524804|NCT01327625|Azithromycin|azithromycin
524805|NCT01327625|N-acetylcystein|n-acetylcystein
524806|NCT01327625|Fluticasone|fluticasone
524807|NCT01327625|Inhaled steroid|inhaled steroid
524808|NCT01327612|AMG 655|amg 655
524809|NCT01327612|AMG 479|amg 479
524810|NCT01327612|Apoptosis|apoptosis
524811|NCT01327612|Monoclonal Antibody|monoclonal antibody
524812|NCT01327612|Tumor Necrosis Factor|tumor necrosis factor
524813|NCT01327612|Insulin-like Growth Factor|insulin-like growth factor
524814|NCT01327612|Bevacizumab|bevacizumab
524815|NCT01327612|Modified FOLFOX6|modified folfox6
524816|NCT01327612|mFOLFOX6|mfolfox6
524817|NCT01327612|FOLFOX|folfox
524818|NCT01327612|Lymphoma|lymphoma
524819|NCT01327612|Trail Receptor|trail receptor
524820|NCT01327612|ganitumab|ganitumab
524821|NCT01327612|conatumumab|conatumumab
524822|NCT01327599|Open-angle glaucoma|open-angle glaucoma
524823|NCT01327599|Ocular hypertension|ocular hypertension
524824|NCT01327599|Pigment dispersion glaucoma|pigment dispersion glaucoma
524825|NCT01327599|Intraocular pressure|intraocular pressure
524826|NCT01327586|disability|disability
524827|NCT01327586|substance abuse|substance abuse
524828|NCT01327586|cocaine abuse|cocaine abuse
524829|NCT01327586|dual diagnosis|dual diagnosis
524830|NCT01327586|representative payee|representative payee
524831|NCT01327586|HIV risk reduction|hiv risk reduction
524832|NCT01327573|chronic kidney allograft injury|chronic kidney allograft injury
524833|NCT01327573|complement protein|complement protein
524834|NCT01327573|eculizumab|eculizumab
524835|NCT01327573|Kidney transplantation|kidney transplantation
524836|NCT01327560|hemodialysis patients|hemodialysis patients
524837|NCT01327560|sleep quality|sleep quality
524838|NCT01327560|restless legs syndrome|restless legs syndrome
524839|NCT01327560|excessive daytime sleepiness|excessive daytime sleepiness
524840|NCT01327560|sleep apnea syndrome|sleep apnea syndrome
524841|NCT01327547|HIV coinfection|hiv coinfection
524842|NCT01327547|maraviroc|maraviroc
524843|NCT01327547|CCR5 blocker|ccr5 blocker
524844|NCT01327547|entry inhibitor|entry inhibitor
524845|NCT01327547|liver disease|liver disease
524846|NCT01327547|viral hepatitis|viral hepatitis
524847|NCT01327534|STEMI|stemi
524848|NCT01327534|clopidogrel|clopidogrel
524849|NCT01327534|prasugrel|prasugrel
524850|NCT01327534|platelet reactivity index|platelet reactivity index
524851|NCT01327534|ST resolution|st resolution
524852|NCT01327495|Androgen replacement in men|androgen replacement in men
524853|NCT01327482|Raltegravir|raltegravir
524854|NCT01327482|Pharmacokinetics|pharmacokinetics
524855|NCT01327456|health literacy|health literacy
524856|NCT01327456|self-management|self-management
524857|NCT01327456|inhaler technique|inhaler technique
524858|NCT01327443|NAFLD|nafld
524859|NCT01327443|NASH|nash
524860|NCT01327443|Weight loss|weight loss
524861|NCT01327443|Exercise|exercise
524862|NCT01327443|NAS scores|nas scores
524863|NCT01327443|Mitochondrial dysfunction|mitochondrial dysfunction
524864|NCT01327430|glycerophosphates|glycerophosphates
524865|NCT01327430|sphingomyelins|sphingomyelins
524866|NCT01327417|Depression|depression
524867|NCT01327404|Depression|depression
524868|NCT01327404|Diabetes Mellitus|diabetes mellitus
524869|NCT01327391|on line hemodiafiltration|on line hemodiafiltration
524870|NCT01327391|tolerance|tolerance
524871|NCT01327391|quality of life|quality of life
524872|NCT01327391|cardiovascular risk|cardiovascular risk
524873|NCT01327391|Hemodialysis patients|hemodialysis patients
524874|NCT01327365|significant coronary artery disease|significant coronary artery disease
524875|NCT01327365|PCI|pci
524876|NCT01327365|radial approach|radial approach
524877|NCT01327365|women|women
524878|NCT01327365|bifurcation lesion|bifurcation lesion
524879|NCT01327365|ostial lesion|ostial lesion
524880|NCT01327365|7 Fr guiding catheter|7 fr guiding catheter
524881|NCT01327365|percutaneous coronary intervention|percutaneous coronary intervention
524882|NCT01327352|lupus|lupus
524883|NCT01327326|Pain modulation|pain modulation
524884|NCT01327326|Experimental pain|experimental pain
524885|NCT01327313|alpha v integrin|alpha v integrin
524886|NCT01327313|antibody|antibody
524887|NCT01327313|solid tumor|solid tumor
524888|NCT01327313|Japanese|japanese
524889|NCT01327313|EMD525797|emd525797
524890|NCT01327300|Irritable Bowel Syndrome|irritable bowel syndrome
524891|NCT01327300|Irritable Bowel Syndrome Treatment|irritable bowel syndrome treatment
524892|NCT01327300|Mesalamine|mesalamine
524893|NCT01327300|Anti-inflammatory drugs|anti-inflammatory drugs
524894|NCT01327300|5-ASA drugs|5-asa drugs
524895|NCT01327300|Apriso ™|apriso ™
524896|NCT01327287|thoracic epidural|thoracic epidural
524897|NCT01327287|blunt|blunt
524898|NCT01327287|blunt thoracic injury|blunt thoracic injury
524899|NCT01327274|Pectus excavatum|pectus excavatum
524900|NCT01327274|Chest wall deformity|chest wall deformity
524901|NCT01327274|Magnetic Mini-Mover Procedure|magnetic mini-mover procedure
524902|NCT01327274|Pectus Severity Index|pectus severity index
524903|NCT01327274|pediatric medical device|pediatric medical device
524904|NCT01327274|magnetic alteration|magnetic alteration
524905|NCT01327274|sunken chest|sunken chest
524906|NCT01327261|levodopa|levodopa
524907|NCT01327261|benserazide|benserazide
524908|NCT01327261|bioequivalence|bioequivalence
524909|NCT01327261|pharmacokinetics|pharmacokinetics
524910|NCT01327261|A Single - Dose|a single - dose
524911|NCT01327261|Randomized- Sequence|randomized- sequence
524912|NCT01327261|Open -Label Crossover Study|open -label crossover study
524913|NCT01327248|Bronchiolitis obliterans|bronchiolitis obliterans
524914|NCT01327248|HRCT|hrct
524915|NCT01327248|Sputum|sputum
524916|NCT01327248|Blood|blood
524917|NCT01327248|Inflammation|inflammation
524918|NCT01327248|adaptive immune system|adaptive immune system
524919|NCT01327248|innate immune system|innate immune system
524920|NCT01327222|age-related macular degeneration|age-related macular degeneration
524921|NCT01327222|bevacizumab|bevacizumab
524922|NCT01327196|dementia|dementia
524923|NCT01327196|cardiovascular risk|cardiovascular risk
524924|NCT01327196|elderly|elderly
524925|NCT01327196|aging|aging
524926|NCT01327196|older 65-100 years|older 65-100 years
524927|NCT01327157|Facial Paralysis / rehabilitation.|facial paralysis / rehabilitation.
524928|NCT01327157|Dental Occlusion.|dental occlusion.
524929|NCT01327157|Occlusal Adjustment.|occlusal adjustment.
524930|NCT01327157|Malocclusion / therapy.|malocclusion / therapy.
524931|NCT01327092|Injury|injury
524932|NCT01327092|Injury Prevention|injury prevention
524933|NCT01327092|Cincinnati Home Injury Prevention|cincinnati home injury prevention
524934|NCT01327092|Injury Hazards|injury hazards
524935|NCT01327092|Modifiable Injury Hazards|modifiable injury hazards
524936|NCT01327092|CHIP|chip
524937|NCT01327092|Literacy Promotion|literacy promotion
524938|NCT01327092|Reduce exposure to injury hazards|reduce exposure to injury hazards
524939|NCT01327092|preventable and medically attended injury|preventable and medically attended injury
524940|NCT01327092|young children|young children
524941|NCT01327079|NICU|nicu
524942|NCT01327079|Methadone|methadone
524943|NCT01327079|neonates|neonates
524944|NCT01327066|QTc|qtc
524945|NCT01327066|ECG Effects|ecg effects
524946|NCT01327053|locally advanced basal cell carcinoma|locally advanced basal cell carcinoma
524947|NCT01327053|metastatic basal cell carcinoma|metastatic basal cell carcinoma
524948|NCT01327053|LDE225|lde225
524949|NCT01327053|sonidegib|sonidegib
524950|NCT01327053|Basel Cell Carcinoma (BCC)|basel cell carcinoma (bcc)
524951|NCT01327053|skin cancer|skin cancer
524952|NCT01327053|Basel Cell Carcinoma|basel cell carcinoma
524953|NCT01327053|BCC|bcc
524954|NCT01327040|light|light
524955|NCT01327040|melatonin|melatonin
524956|NCT01327040|circadian|circadian
524957|NCT01327040|delayed sleep phase disorder|delayed sleep phase disorder
524958|NCT01327040|circadian light sensitivity|circadian light sensitivity
524959|NCT01327040|circadian timing system|circadian timing system
524960|NCT01327027|vasopressin|vasopressin
524961|NCT01327027|antisocial|antisocial
524962|NCT01327027|affiliation|affiliation
524963|NCT01327014|Hyperlipidemia|hyperlipidemia
524964|NCT01327014|Cholesterol|cholesterol
524965|NCT01327014|Lipids|lipids
524966|NCT01327014|Lipoproteins|lipoproteins
524967|NCT01327014|XueZhiKang|xuezhikang
524968|NCT01327014|Botanical|botanical
524969|NCT01327001|Asthma bronchiale, fixed combination|asthma bronchiale, fixed combination
524970|NCT01326988|Spinal anesthesia|spinal anesthesia
524971|NCT01326988|ultrasound|ultrasound
524972|NCT01326988|real-time|real-time
524973|NCT01326975|infant, premature|infant, premature
524974|NCT01326975|infant, very low birth weight|infant, very low birth weight
524975|NCT01326975|diaphragm|diaphragm
524976|NCT01326975|apnea|apnea
524977|NCT01326975|continuous positive airway pressure|continuous positive airway pressure
524978|NCT01326936|Online education|online education
524979|NCT01326936|Medical education|medical education
524980|NCT01326936|Substance abuse training|substance abuse training
524981|NCT01326936|Drug abuse training|drug abuse training
524982|NCT01326923|Head|head
524983|NCT01326923|Neck|neck
524984|NCT01326923|Locally advanced|locally advanced
524985|NCT01326923|Squamous Cell|squamous cell
524986|NCT01326923|Hypopharynx|hypopharynx
524987|NCT01326923|Larynx|larynx
524988|NCT01326923|Oral Cavity|oral cavity
524989|NCT01326923|Base of Tongue|base of tongue
524990|NCT01326923|Tonsil|tonsil
524991|NCT01326923|Neck lymph node|neck lymph node
524992|NCT01326923|Resection|resection
524993|NCT01326910|Eczema|eczema
524994|NCT01326884|aortic aneurysm|aortic aneurysm
524995|NCT01326884|iliac aneurysm|iliac aneurysm
524996|NCT01326884|endovascular procedures|endovascular procedures
524997|NCT01326871|cancer|cancer
524998|NCT01326871|immunotherapy|immunotherapy
524999|NCT01326871|immunochemotherapy|immunochemotherapy
525000|NCT01326871|combinational therapy|combinational therapy
525001|NCT01326871|targeted|targeted
525002|NCT01326871|metastatic|metastatic
525003|NCT01326871|muscle invasive|muscle invasive
525004|NCT01326871|interleukin-2|interleukin-2
525005|NCT01326871|cisplatin|cisplatin
525006|NCT01326871|gemcitabine|gemcitabine
525007|NCT01326871|antitumor|antitumor
525008|NCT01326871|TCR|tcr
525009|NCT01326871|T-cell receptor|t-cell receptor
525010|NCT01326871|p53|p53
525011|NCT01326871|p53 gene|p53 gene
525012|NCT01326871|p53 tumor supressor protein|p53 tumor supressor protein
525013|NCT01326871|urothelial cancer|urothelial cancer
525014|NCT01326871|bladder cancer|bladder cancer
525015|NCT01326871|renal pelvis cancer|renal pelvis cancer
525016|NCT01326871|ureters cancer|ureters cancer
525017|NCT01326871|urethra cancer|urethra cancer
525018|NCT01326871|HLA-A2 positive|hla-a2 positive
525019|NCT01326871|HLA-A*0201/p53 aa264-272|hla-a*0201/p53 aa264-272
525020|NCT01326871|HLA complex|hla complex
525021|NCT01326871|Muscle Invasive or Metastatic|muscle invasive or metastatic
525022|NCT01326858|Ocular discomfort|ocular discomfort
525023|NCT01326858|AL-4943A Ophthalmic Solution|al-4943a ophthalmic solution
525024|NCT01326845|Gastrointestinal adverse events,|gastrointestinal adverse events,
525025|NCT01326845|myelodysplastic syndrome,|myelodysplastic syndrome,
525026|NCT01326845|transfusional iron overload diarrhea,|transfusional iron overload diarrhea,
525027|NCT01326845|constipation abdominal pain,|constipation abdominal pain,
525028|NCT01326845|vomiting|vomiting
525029|NCT01326832|THA|tha
525030|NCT01326819|Near infrared spectroscopy|near infrared spectroscopy
525031|NCT01326819|Skin pigmentation|skin pigmentation
525032|NCT01326819|Regional oxygen saturation|regional oxygen saturation
525033|NCT01326806|Parent-based intervention|parent-based intervention
525034|NCT01326806|Sexual risk behavior|sexual risk behavior
525035|NCT01326806|Adolescents|adolescents
525036|NCT01326793|telepsychiatry|telepsychiatry
525037|NCT01326793|MDD|mdd
525038|NCT01326793|Depression|depression
525039|NCT01326793|Major Depressive Disorder|major depressive disorder
525040|NCT01326793|Skype|skype
525041|NCT01326793|college|college
525042|NCT01326793|university|university
525043|NCT01326780|Acne|acne
525044|NCT01326780|Irritation|irritation
525045|NCT01326780|Safety|safety
525046|NCT01326780|Sebum|sebum
525047|NCT01326741|clonal mast cell disorder|clonal mast cell disorder
525048|NCT01326741|exercise-induced anaphylaxis|exercise-induced anaphylaxis
525049|NCT01326741|hypotension|hypotension
525050|NCT01326728|Relapse|relapse
525051|NCT01326728|Hematologic Malignancy|hematologic malignancy
525052|NCT01326728|Allogeneic|allogeneic
525053|NCT01326728|Hematopoietic Stem Cell Transplantation|hematopoietic stem cell transplantation
525054|NCT01326728|Leukemia|leukemia
525055|NCT01326728|Lymphoma|lymphoma
525056|NCT01326728|Hodgkin Lymphoma|hodgkin lymphoma
525057|NCT01326715|Mangafodipir|mangafodipir
525058|NCT01326715|Brain|brain
525059|NCT01326715|MEMRI|memri
525060|NCT01326715|Healthy Volunteer|healthy volunteer
525061|NCT01326715|Multiple Sclerosis|multiple sclerosis
525062|NCT01326676|Polypill|polypill
525063|NCT01326676|Red Heart Pill|red heart pill
525064|NCT01326676|Cardiovascular disease|cardiovascular disease
525065|NCT01326676|Secondary prevention|secondary prevention
525066|NCT01326676|carotid intima media thickness|carotid intima media thickness
525067|NCT01326663|Veterans|veterans
525068|NCT01326663|TBI|tbi
525069|NCT01326663|Alcoholism|alcoholism
525070|NCT01326663|Mood|mood
525071|NCT01326650|vitamin D, mortality, event-free survival, heart failure|vitamin d, mortality, event-free survival, heart failure
525072|NCT01326637|primary health care|primary health care
525073|NCT01326637|aged|aged
525074|NCT01326624|heart failure|heart failure
525075|NCT01326624|ventricular dysfunction|ventricular dysfunction
525076|NCT01326624|sudden death|sudden death
525077|NCT01326624|sudden cardiac arrest|sudden cardiac arrest
525078|NCT01326624|ventricular tachycardia|ventricular tachycardia
525377|NCT01325298|Ectasia|ectasia
525079|NCT01326624|ventricular fibrillation|ventricular fibrillation
525080|NCT01326624|wearable defibrillator|wearable defibrillator
525081|NCT01326611|Chronic lung disease|chronic lung disease
525082|NCT01326611|Clarithromycin|clarithromycin
525083|NCT01326611|Ureaplasma urealyticum|ureaplasma urealyticum
525084|NCT01326598|V Go™|v go™
525085|NCT01326598|Type 2 Diabetes|type 2 diabetes
525086|NCT01326598|Insulin|insulin
525087|NCT01326598|Oral Anti Hypoglycemic Drugs|oral anti hypoglycemic drugs
525088|NCT01326585|Scleral Buckling|scleral buckling
525089|NCT01326585|Dexamethasone|dexamethasone
525090|NCT01326585|Post-operative Nausea and Vomiting|post-operative nausea and vomiting
525092|NCT01326572|Pulmonary disease|pulmonary disease
525093|NCT01326572|emphysema|emphysema
525094|NCT01326572|COPD|copd
525095|NCT01326559|induction chemotherapy|induction chemotherapy
525096|NCT01326559|docetaxel|docetaxel
525097|NCT01326559|cisplatin|cisplatin
525098|NCT01326559|fluorouracil|fluorouracil
525099|NCT01326559|cetuximab|cetuximab
525100|NCT01326559|intensity-modulated radiotherapy|intensity-modulated radiotherapy
525101|NCT01326546|Therapeutic HBV Vaccine|therapeutic hbv vaccine
525102|NCT01326546|Chronic Hepatitis B|chronic hepatitis b
525103|NCT01326546|HBeAg positive|hbeag positive
525104|NCT01326546|HBV-specific Cytotoxic T Lymphocyte|hbv-specific cytotoxic t lymphocyte
525105|NCT01326533|pre-diabetes|pre-diabetes
525106|NCT01326533|hydroxychloroquine|hydroxychloroquine
525107|NCT01326533|frequently sampled intravenous glucose tolerance testing|frequently sampled intravenous glucose tolerance testing
525108|NCT01326533|insulin resistance|insulin resistance
525109|NCT01326533|insulin secretion|insulin secretion
525110|NCT01326533|glucose tolerance|glucose tolerance
525111|NCT01326507|pulmonary embolism|pulmonary embolism
525112|NCT01326507|Heart-type fatty acid-binding protein|heart-type fatty acid-binding protein
525113|NCT01326507|cardiac biomarkers|cardiac biomarkers
525114|NCT01326507|risk stratification|risk stratification
525115|NCT01326494|Upper Respiratory Tract Infection|upper respiratory tract infection
525116|NCT01326494|Asthma|asthma
525117|NCT01326494|URTI induced exacerbation of Asthma|urti induced exacerbation of asthma
525118|NCT01326481|TRC105|trc105
525119|NCT01326481|Breast Cancer|breast cancer
525120|NCT01326481|CD105|cd105
525121|NCT01326481|Endoglin|endoglin
525122|NCT01326481|TRACON Pharma|tracon pharma
525123|NCT01326481|Roswell Park Cancer Institute|roswell park cancer institute
525124|NCT01326481|Department of Defense|department of defense
525125|NCT01326468|head and neck cancer|head and neck cancer
525126|NCT01326468|temsirolimus|temsirolimus
525127|NCT01326468|cetuximab|cetuximab
525128|NCT01326468|cisplatin|cisplatin
525129|NCT01326468|radiation therapy|radiation therapy
525130|NCT01326455|transradial|transradial
525131|NCT01326455|angiogram|angiogram
525132|NCT01326455|device|device
525133|NCT01326455|Care of the radial artery post transradial angiogram|care of the radial artery post transradial angiogram
525134|NCT01326442|weight loss|weight loss
525135|NCT01326442|overweight|overweight
525136|NCT01326442|body composition|body composition
525137|NCT01326442|visceral obesity|visceral obesity
525138|NCT01326442|insulin|insulin
525139|NCT01326442|glucose tolerance|glucose tolerance
525140|NCT01326442|cholesterol|cholesterol
525141|NCT01326442|hypertriglyceridemia|hypertriglyceridemia
525142|NCT01326429|Sodium|sodium
525143|NCT01326429|Hyponatremia|hyponatremia
525144|NCT01326429|Hypernatremia|hypernatremia
525145|NCT01326429|Emergency department|emergency department
525146|NCT01326416|obesity|obesity
525147|NCT01326416|metabolic syndrome|metabolic syndrome
525148|NCT01326416|leucine|leucine
525149|NCT01326416|arginine|arginine
525150|NCT01326416|physical activity|physical activity
525151|NCT01326403|proximal|proximal
525152|NCT01326403|hip|hip
525153|NCT01326403|fractures|fractures
525154|NCT01326338|Diarrhea|diarrhea
525155|NCT01326325|Cancer|cancer
525156|NCT01326325|Refractory pain|refractory pain
525157|NCT01326325|Uncontrolled pain|uncontrolled pain
525158|NCT01326325|Ketamine|ketamine
525159|NCT01326286|Comparative Effectiveness Research|comparative effectiveness research
525160|NCT01326286|Prostatectomy|prostatectomy
525161|NCT01326286|radiotherapy|radiotherapy
525162|NCT01326286|quality of life|quality of life
525163|NCT01326273|CMV|cmv
525164|NCT01326273|cytomegalovirus|cytomegalovirus
525165|NCT01326273|autologous|autologous
525166|NCT01326273|leukemia|leukemia
525167|NCT01326273|hematological malignancies|hematological malignancies
525168|NCT01326273|stem cell transplantation|stem cell transplantation
525169|NCT01326273|CMV reactivation|cmv reactivation
525170|NCT01326273|adoptive therapy|adoptive therapy
525171|NCT01326260|resuscitation|resuscitation
525172|NCT01326260|trauma|trauma
525173|NCT01326260|THAM|tham
525174|NCT01326260|colloids|colloids
525175|NCT01326260|crystalloids|crystalloids
525176|NCT01326234|Smoking|smoking
525177|NCT01326234|Motivation|motivation
525178|NCT01326234|Cessation|cessation
525179|NCT01326221|Truvada|truvada
525180|NCT01326221|tenofovir|tenofovir
525181|NCT01326221|emtricitabine|emtricitabine
525182|NCT01326221|Pharmacokinetics|pharmacokinetics
525183|NCT01326221|Healthy Volunteers|healthy volunteers
525184|NCT01326208|electrical impedance tomography|electrical impedance tomography
525185|NCT01326208|positive end-expiratory pressure|positive end-expiratory pressure
525186|NCT01326208|regional ventilation delay index|regional ventilation delay index
525187|NCT01326195|HIV Prevention|hiv prevention
525188|NCT01326195|Dating Violence|dating violence
525189|NCT01326195|Females|females
525190|NCT01326195|Romantic relationships|romantic relationships
525191|NCT01326195|Adolescents|adolescents
525192|NCT01326195|Sexuality|sexuality
525193|NCT01326195|Underserved youth|underserved youth
525194|NCT01326182|asthma|asthma
525195|NCT01326182|depression|depression
525196|NCT01326182|Latino|latino
525197|NCT01326169|Alcohol|alcohol
525198|NCT01326169|brief intervention|brief intervention
525199|NCT01326169|injuries|injuries
525200|NCT01326156|Osteoarthritis|osteoarthritis
525201|NCT01326156|Knee|knee
525202|NCT01326156|Knee cap|knee cap
525203|NCT01326156|Patella|patella
525204|NCT01326156|Patellofemoral|patellofemoral
525205|NCT01326143|MRD|mrd
525206|NCT01326143|Narval|narval
525207|NCT01326143|Oral appliance|oral appliance
525208|NCT01326143|Obstructive Sleep apnea|obstructive sleep apnea
525209|NCT01326143|OSAH|osah
525210|NCT01326143|OSA treatment|osa treatment
525211|NCT01326130|Integrated care network|integrated care network
525212|NCT01326130|Chronic care model|chronic care model
525213|NCT01326130|Health services research|health services research
525214|NCT01326117|gastroparesis|gastroparesis
525215|NCT01326117|gastric emptying|gastric emptying
525216|NCT01326117|diabetes|diabetes
525217|NCT01326117|Stomach Diseases|stomach diseases
525218|NCT01326117|Gastrointestinal Diseases|gastrointestinal diseases
525219|NCT01326117|Digestive System Diseases|digestive system diseases
525220|NCT01326117|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors
525221|NCT01326117|Neurologic Manifestations|neurologic manifestations
525222|NCT01326117|Paralysis|paralysis
525223|NCT01326117|Signs and Symptoms|signs and symptoms
525224|NCT01326117|Pharmacologic Actions|pharmacologic actions
525225|NCT01326104|Medulloblastoma|medulloblastoma
525226|NCT01326104|Primitive Neuroectodermal Tumor|primitive neuroectodermal tumor
525227|NCT01326091|Lumbar fusion surgery|lumbar fusion surgery
525228|NCT01326078|sedation|sedation
525229|NCT01326078|children|children
525230|NCT01326078|leukemia|leukemia
525231|NCT01326078|bone marrow biopsy|bone marrow biopsy
525232|NCT01326013|Stool|stool
525233|NCT01326013|Feces|feces
525234|NCT01326013|Gastrointestinal|gastrointestinal
525235|NCT01326013|Pathogen|pathogen
525236|NCT01326013|Panel|panel
525237|NCT01326013|xTAG GPP|xtag gpp
525238|NCT01326013|Infectious colitis|infectious colitis
525239|NCT01326013|Gastroenteritis|gastroenteritis
525240|NCT01326013|Detection|detection
525241|NCT01325987|Type 2 diabetes|type 2 diabetes
525242|NCT01325987|Vitamin D deficiency|vitamin d deficiency
525243|NCT01325987|Glycemic control|glycemic control
525244|NCT01325974|Malaria|malaria
525245|NCT01325974|Plasmodium falciparum|plasmodium falciparum
525246|NCT01325974|Diagnosis|diagnosis
525247|NCT01325974|Rapid diagnostic test|rapid diagnostic test
525248|NCT01325974|malaria transmission|malaria transmission
525249|NCT01325961|prostate, cervical and anal canal cancers with pelvic lymph node irradiation|prostate, cervical and anal canal cancers with pelvic lymph node irradiation
525250|NCT01325948|COPD|copd
525251|NCT01325935|Coronary Artery Disease|coronary artery disease
525252|NCT01325935|Coronary Disease|coronary disease
525253|NCT01325935|Myocardial Ischemia|myocardial ischemia
525254|NCT01325935|Heart Disease|heart disease
525255|NCT01325935|Cardiovascular Disease|cardiovascular disease
525256|NCT01325935|Arteriosclerosis|arteriosclerosis
525257|NCT01325935|Arterial Occlusive Disease|arterial occlusive disease
525258|NCT01325935|Vascular Disease|vascular disease
525259|NCT01325935|Clopidogrel|clopidogrel
525260|NCT01325935|Platelet Aggregation Inhibitors|platelet aggregation inhibitors
525261|NCT01325896|Multiple Mieloma, PEG-Intron|multiple mieloma, peg-intron
525262|NCT01325870|cardiopulmonary resuscitation|cardiopulmonary resuscitation
525263|NCT01325818|Coronary Artery Disease|coronary artery disease
525264|NCT01325818|Coronary Disease|coronary disease
525265|NCT01325818|Dyslipidemia|dyslipidemia
525266|NCT01325818|Stable Angina Pectoris|stable angina pectoris
525267|NCT01325818|Heart Diseases|heart diseases
525268|NCT01325818|Cardiovascular Diseases|cardiovascular diseases
525269|NCT01325818|Arteriosclerosis|arteriosclerosis
525270|NCT01325818|Arterial Occlusive Diseases|arterial occlusive diseases
525271|NCT01325818|Vascular Diseases Pravastatin|vascular diseases pravastatin
525272|NCT01325818|Rosuvastatin|rosuvastatin
525273|NCT01325818|Anticholesteremic Agents|anticholesteremic agents
525274|NCT01325818|Antilipemic Agents|antilipemic agents
525275|NCT01325818|Antimetabolites|antimetabolites
525276|NCT01325818|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action
525277|NCT01325818|Pharmacologic Actions|pharmacologic actions
525278|NCT01325818|Therapeutic Uses|therapeutic uses
525979|NCT01322802|Stage III|stage iii
525279|NCT01325818|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors
525280|NCT01325805|Miscarriage|miscarriage
525281|NCT01325805|Recurrent Pregnancy Loss|recurrent pregnancy loss
525282|NCT01325805|Obesity|obesity
525283|NCT01325805|Overweight|overweight
525284|NCT01325805|Diet|diet
525285|NCT01325792|Complex ventral incisional hernia repair|complex ventral incisional hernia repair
525286|NCT01325792|reapproximation of the rectus abdominis muscle|reapproximation of the rectus abdominis muscle
525287|NCT01325792|retrorectus or intraperitoneal placement technique|retrorectus or intraperitoneal placement technique
525288|NCT01325792|mobility for midline fascial closure|mobility for midline fascial closure
525289|NCT01325779|deep venous thrombosis|deep venous thrombosis
525290|NCT01325779|DVT|dvt
525291|NCT01325779|enoxaparin|enoxaparin
525292|NCT01325779|heparin|heparin
525293|NCT01325779|surgical intensive care|surgical intensive care
525294|NCT01325766|Cystic Fibrosis|cystic fibrosis
525295|NCT01325766|Yoga|yoga
525296|NCT01325701|PCI-32765|pci-32765
525297|NCT01325701|Lymphoma, B-Cell|lymphoma, b-cell
525298|NCT01325701|Bruton's Tyrosine Kinase|bruton's tyrosine kinase
525299|NCT01325701|Non Hodgkin's Lymphoma|non hodgkin's lymphoma
525300|NCT01325701|Germinal Center B-Cell|germinal center b-cell
525301|NCT01325701|Activated B-Cell|activated b-cell
525302|NCT01325688|PEP005|pep005
525303|NCT01325688|Peplin|peplin
525304|NCT01325688|sBCC|sbcc
525305|NCT01325675|Atrial fibrillation|atrial fibrillation
525306|NCT01325675|Motor activity|motor activity
525307|NCT01325649|rectal cancer|rectal cancer
525308|NCT01325649|MRI|mri
525309|NCT01325649|selective preoperative radiochemotherapy|selective preoperative radiochemotherapy
525310|NCT01325649|involvement of circumferential resection margin|involvement of circumferential resection margin
525311|NCT01325649|locoregional recurrence rate|locoregional recurrence rate
525312|NCT01325636|Allogenic haematopoietic stem cell transplant|allogenic haematopoietic stem cell transplant
525313|NCT01325636|Cytomegalovirus or Adenovirus infection|cytomegalovirus or adenovirus infection
525314|NCT01325636|Graft versus Host|graft versus host
525315|NCT01325623|Automatic Magnet Mode (AMM)|automatic magnet mode (amm)
525316|NCT01325623|Vagal Nerve Stimulation|vagal nerve stimulation
525317|NCT01325610|vitamin D|vitamin d
525318|NCT01325610|kidney|kidney
525319|NCT01325610|renal|renal
525320|NCT01325597|Heart failure|heart failure
525321|NCT01325597|Electric stimulation|electric stimulation
525322|NCT01325597|Breathing exercises|breathing exercises
525323|NCT01325571|prograf|prograf
525324|NCT01325571|immunosuppressant|immunosuppressant
525325|NCT01325558|cancer|cancer
525326|NCT01325558|tissue factor|tissue factor
525327|NCT01325558|solid tumor|solid tumor
525328|NCT01325558|ovarian cancer|ovarian cancer
525329|NCT01325558|breast cancer|breast cancer
525330|NCT01325558|non-small cell lung cancer|non-small cell lung cancer
525331|NCT01325558|colon cancer|colon cancer
525332|NCT01325558|pancreatic cancer|pancreatic cancer
525333|NCT01325558|head and neck cancer|head and neck cancer
525334|NCT01325558|prostate cancer|prostate cancer
525335|NCT01325558|soft-tissue sarcoma|soft-tissue sarcoma
525336|NCT01325558|metastatic|metastatic
525337|NCT01325558|gemcitabine|gemcitabine
525338|NCT01325558|anti-tumor|anti-tumor
525339|NCT01325558|venous thromboembolism|venous thromboembolism
525340|NCT01325545|Stroke|stroke
525341|NCT01325545|Atrial Fibrillation|atrial fibrillation
525342|NCT01325532|depression|depression
525343|NCT01325532|Major Depressive Disorder|major depressive disorder
525344|NCT01325532|MDD|mdd
525345|NCT01325532|Cranial Electrical Stimulation|cranial electrical stimulation
525346|NCT01325532|CES|ces
525347|NCT01325506|Prostatectomy|prostatectomy
525348|NCT01325493|opioid tolerance|opioid tolerance
525349|NCT01325493|hyperalgesia|hyperalgesia
525350|NCT01325493|scoliosis|scoliosis
525351|NCT01325493|pupillometry|pupillometry
525352|NCT01325480|Cardiac Resynchronization Therapy|cardiac resynchronization therapy
525353|NCT01325480|Pacing|pacing
525354|NCT01325480|His Bundle|his bundle
525355|NCT01325467|coronary artery disease|coronary artery disease
525356|NCT01325467|high frequency QRS analysis|high frequency qrs analysis
525357|NCT01325467|ischemia|ischemia
525358|NCT01325467|exercise testing|exercise testing
525359|NCT01325467|diagnosis of coronary artery disease|diagnosis of coronary artery disease
525360|NCT01325454|Pleural effusion|pleural effusion
525361|NCT01325454|angiogenic cytokine|angiogenic cytokine
525362|NCT01325454|fibrinolytic activity|fibrinolytic activity
525363|NCT01325441|BBI608, thymic cancer|bbi608, thymic cancer
525364|NCT01325415|Phase 1|phase 1
525365|NCT01325415|healthy male volunteers|healthy male volunteers
525366|NCT01325415|cross-over study|cross-over study
525367|NCT01325415|NKTR-118|nktr-118
525368|NCT01325402|Radioligand|radioligand
525369|NCT01325402|Alzheimers disease|alzheimers disease
525370|NCT01325402|Maximum Diagnostic Mass|maximum diagnostic mass
525371|NCT01325402|Beta amyloid|beta amyloid
525372|NCT01325376|overweight|overweight
525373|NCT01325376|obesity|obesity
525374|NCT01325363|Schizophrenia|schizophrenia
667496|NCT00758849|JP-1730|jp-1730
525375|NCT01325363|Novel metaphor|novel metaphor
525376|NCT01325298|Keratoconus|keratoconus
525378|NCT01325298|cross linking|cross linking
525379|NCT01325298|collagen cross linking|collagen cross linking
525380|NCT01325298|corneal crosslinking|corneal crosslinking
525381|NCT01325298|corneal diseases|corneal diseases
525382|NCT01325298|eye diseases|eye diseases
525383|NCT01325285|Intraocular pressure|intraocular pressure
525384|NCT01325285|Hypercapnia|hypercapnia
525385|NCT01325285|Hyperoxia|hyperoxia
525386|NCT01325285|Rebreathing circuit|rebreathing circuit
525387|NCT01325272|otoacoustic emissions in newborns|otoacoustic emissions in newborns
525388|NCT01325246|ventral hernia|ventral hernia
525390|NCT01325246|clinical|clinical
525391|NCT01325246|reoperation|reoperation
525392|NCT01325233|Astragulus polysaccharides|astragulus polysaccharides
525393|NCT01325233|Hemorrhagic stroke|hemorrhagic stroke
525394|NCT01325207|Breast Cancer|breast cancer
525395|NCT01325194|DLBCL|dlbcl
525396|NCT01325194|FL grade 3B|fl grade 3b
525397|NCT01325194|high risk|high risk
525398|NCT01325194|CNS prophylaxis|cns prophylaxis
525399|NCT01325194|chemoimmunotherapy|chemoimmunotherapy
525400|NCT01325181|Chronic central serous chorioretinopathy|chronic central serous chorioretinopathy
525401|NCT01325181|Ranibizumab|ranibizumab
525402|NCT01325181|Photodynamic therapy|photodynamic therapy
525403|NCT01325168|PTSD|ptsd
525404|NCT01325168|empathy|empathy
525405|NCT01325168|oxytocin|oxytocin
525406|NCT01325155|Air Pollution|air pollution
525407|NCT01325155|particulate matter|particulate matter
525408|NCT01325155|cardiovascular Disease|cardiovascular disease
525409|NCT01325142|Osteonecrosis of the Jaw (ONJ)|osteonecrosis of the jaw (onj)
525410|NCT01325129|ESIN|esin
525411|NCT01325129|Clavicular Fracture|clavicular fracture
525412|NCT01325129|Dislocation|dislocation
525413|NCT01325129|Children|children
525414|NCT01325129|Adolescents|adolescents
525415|NCT01325116|STEMI|stemi
525416|NCT01325116|Medication Adherence|medication adherence
525417|NCT01325116|Quality Improvement|quality improvement
525418|NCT01325103|Spinal cord injury|spinal cord injury
525419|NCT01325103|Mesenchymal stem cells|mesenchymal stem cells
525420|NCT01325103|Bone marrow|bone marrow
525421|NCT01325090|neuropathic pain due to thoracotomy|neuropathic pain due to thoracotomy
525422|NCT01325090|Neuropathic Pain Due to Thoracoscopy|neuropathic pain due to thoracoscopy
525423|NCT01325077|Nurse-based, acute pain service, pediatric, postoperative,|nurse-based, acute pain service, pediatric, postoperative,
525424|NCT01325077|pain|pain
525425|NCT01325064|Carotid Artery Diseases|carotid artery diseases
525426|NCT01325064|Blood Pressure|blood pressure
525427|NCT01325064|Blood Pressure Monitoring, Ambulatory|blood pressure monitoring, ambulatory
525428|NCT01325064|Peripheral Vascular Diseases|peripheral vascular diseases
525429|NCT01325064|Retinal Vessels|retinal vessels
525430|NCT01325051|raltegravir|raltegravir
525431|NCT01325051|pharmacokinetics|pharmacokinetics
525432|NCT01325051|healthy|healthy
525433|NCT01325051|male|male
525434|NCT01325051|volunteers|volunteers
525435|NCT01325051|gastrointestinal|gastrointestinal
525436|NCT01325051|tract|tract
525437|NCT01325038|resting metabolic rate|resting metabolic rate
525438|NCT01325025|Metachromatic Leukodystrophy|metachromatic leukodystrophy
525439|NCT01325025|Demyelinating Diseases|demyelinating diseases
525440|NCT01325025|Magnetic Resonance Imaging|magnetic resonance imaging
525441|NCT01325025|Diffusion Tensor Imaging|diffusion tensor imaging
525442|NCT01325025|Relaxometry|relaxometry
525443|NCT01325025|Spectroscopy|spectroscopy
525444|NCT01325025|Longitudinal Studies|longitudinal studies
525445|NCT01325012|Pain|pain
525446|NCT01325012|Surgery|surgery
525447|NCT01325012|Catheter|catheter
525448|NCT01325012|Nerve Block|nerve block
525449|NCT01325012|Popliteal|popliteal
525450|NCT01325012|Subgluteal|subgluteal
525451|NCT01325012|Sciatic|sciatic
525452|NCT01325012|UCSD|ucsd
525453|NCT01325012|Moderate-to-severe pain|moderate-to-severe pain
525454|NCT01325012|Perineural Catheter|perineural catheter
525455|NCT01325012|Orthopedic Surgery|orthopedic surgery
525456|NCT01325012|foot surgery surgery|foot surgery surgery
525457|NCT01325012|sciatic perineural catheter|sciatic perineural catheter
525458|NCT01325012|age =>18|age =>18
525459|NCT01324999|Sarcoidosis Associated Pulmonary Hypertension|sarcoidosis associated pulmonary hypertension
525460|NCT01324986|extraesophageal symptoms of gastroesophageal reflux disease|extraesophageal symptoms of gastroesophageal reflux disease
525461|NCT01324973|Medical Informatics|medical informatics
525462|NCT01324973|Therapy, Computer-Assisted|therapy, computer-assisted
525463|NCT01324973|Health Education|health education
525464|NCT01324973|Diet|diet
525465|NCT01324973|Exercise|exercise
525466|NCT01324960|IPSS|ipss
525467|NCT01324960|High risk|high risk
525468|NCT01324960|Azacitidine|azacitidine
525469|NCT01324960|Ceplene|ceplene
525470|NCT01324947|Myeloma|myeloma
525471|NCT01324947|Multiple Myeloma|multiple myeloma
525472|NCT01324947|Relapsed Multiple Myeloma|relapsed multiple myeloma
525473|NCT01324947|Relapsed and Refractory Multiple Myeloma|relapsed and refractory multiple myeloma
525474|NCT01324947|Refractory Myeloma|refractory myeloma
525475|NCT01324947|Resistant Multiple Myeloma|resistant multiple myeloma
525476|NCT01324947|Treatment-resistant Multiple Myeloma|treatment-resistant multiple myeloma
525477|NCT01324947|Pomalidomide|pomalidomide
525478|NCT01324947|Lenalidomide-resistant|lenalidomide-resistant
525479|NCT01324947|Bortezomib-resistant|bortezomib-resistant
525480|NCT01324947|Companion|companion
525481|NCT01324934|acute rejection|acute rejection
525482|NCT01324934|chronic rejection|chronic rejection
525483|NCT01324934|subclinical rejection|subclinical rejection
525484|NCT01324934|renal transplantation|renal transplantation
525485|NCT01324934|steroid-free|steroid-free
525486|NCT01324934|kidney transplantation|kidney transplantation
525487|NCT01324895|Small intestinal bacterial overgrowth syndrome (SIBO)|small intestinal bacterial overgrowth syndrome (sibo)
525488|NCT01324895|bacterial overgrowth syndrome|bacterial overgrowth syndrome
525489|NCT01324895|Small Bowel Bacterial Overgrowth Syndrome (SBBOS)|small bowel bacterial overgrowth syndrome (sbbos)
525490|NCT01324895|14-Co2 D-Xylose Breath Testing|14-co2 d-xylose breath testing
525491|NCT01324895|Antibiotics|antibiotics
525492|NCT01324895|Prokinteics|prokinteics
525493|NCT01324895|Prokinetic Agents|prokinetic agents
525494|NCT01324882|colonoscopy|colonoscopy
525495|NCT01324869|KH902|kh902
525496|NCT01324869|Diabetic macular Edema|diabetic macular edema
525497|NCT01324869|Intravitreal injection|intravitreal injection
525498|NCT01324869|Multiple injections|multiple injections
525499|NCT01324869|20 patients|20 patients
525500|NCT01324869|0.5mg/eye/time|0.5mg/eye/time
525501|NCT01324856|pancreatic cancer|pancreatic cancer
525502|NCT01324856|periampulary cancer|periampulary cancer
525503|NCT01324856|pancreaticogastro vs pancreaticojejuno anastomosis|pancreaticogastro vs pancreaticojejuno anastomosis
525504|NCT01324843|Safety and Tolerability|safety and tolerability
525505|NCT01324843|Intradermal Electroporation|intradermal electroporation
525506|NCT01324817|Non-Contact|non-contact
525507|NCT01324817|Radar|radar
525508|NCT01324817|Doppler|doppler
525509|NCT01324817|Respiratory|respiratory
525510|NCT01324817|Respiration|respiration
525511|NCT01324817|Breathing|breathing
525512|NCT01324817|Rate|rate
525513|NCT01324817|Frequency|frequency
525514|NCT01324817|Respiratory Mechanics|respiratory mechanics
525515|NCT01324817|Respiratory Rate Measurement|respiratory rate measurement
525516|NCT01324817|Apnea|apnea
525517|NCT01324817|Sleep Apnea|sleep apnea
525518|NCT01324804|postoperative wound healing|postoperative wound healing
525519|NCT01324778|Edentulism in the Upper Jaw|edentulism in the upper jaw
525520|NCT01324765|Women|women
525521|NCT01324765|PTSD|ptsd
525522|NCT01324765|Group Therapy|group therapy
525523|NCT01324765|Incarceration|incarceration
525524|NCT01324752|Drug-drug interaction|drug-drug interaction
525525|NCT01324752|Pharmacokinetics|pharmacokinetics
525526|NCT01324752|PA21|pa21
525527|NCT01324726|Bacterial colonization|bacterial colonization
525528|NCT01324726|Extended spectrum beta lactamase producing organisms|extended spectrum beta lactamase producing organisms
525529|NCT01324687|Telemedicine|telemedicine
525530|NCT01324687|Geriatrics|geriatrics
525531|NCT01324674|Common Mental Disorder|common mental disorder
525532|NCT01324674|Efficacy of Bach´s flower remedy|efficacy of bach´s flower remedy
525533|NCT01324674|Spiritual well-being|spiritual well-being
525534|NCT01324648|Guided self-help|guided self-help
525535|NCT01324648|Telephone delivery|telephone delivery
525536|NCT01324648|Cognitive behavior therapy|cognitive behavior therapy
525537|NCT01324648|Bibliotherapy|bibliotherapy
525538|NCT01324635|glioma|glioma
525539|NCT01324635|meningioma|meningioma
525540|NCT01324635|brain metastasis|brain metastasis
525541|NCT01324635|stereotactic|stereotactic
525542|NCT01324635|radiotherapy|radiotherapy
525543|NCT01324635|radiosurgery|radiosurgery
525544|NCT01324622|Spinal Cord Diseases|spinal cord diseases
525545|NCT01324622|Myelopathy|myelopathy
525546|NCT01324622|Myeloradiculopathy|myeloradiculopathy
525547|NCT01324622|Laminectomy|laminectomy
525548|NCT01324622|Laminoplasty|laminoplasty
525549|NCT01324609|choroidal nevus|choroidal nevus
525550|NCT01324609|vitrectomy|vitrectomy
525551|NCT01324596|Lymphoma, Large B-Cell, Diffuse|lymphoma, large b-cell, diffuse
525552|NCT01324596|Bortezomib|bortezomib
525553|NCT01324596|R-CHOP|r-chop
525554|NCT01324596|Molecular profiling|molecular profiling
525555|NCT01324596|Chemotherapy|chemotherapy
525556|NCT01324570|Pain|pain
525557|NCT01324570|Opioid|opioid
525558|NCT01324570|Analgesia|analgesia
525559|NCT01324570|Moderate to severe pain|moderate to severe pain
525560|NCT01324557|Continuous glucose monitoring|continuous glucose monitoring
525561|NCT01324557|CAPD patients|capd patients
525562|NCT01324557|Insulin pump|insulin pump
525563|NCT01324544|Acute Pain|acute pain
525564|NCT01324544|Opioid|opioid
525565|NCT01324544|Analgesia|analgesia
525566|NCT01324531|Bankart repair|bankart repair
525567|NCT01324531|remplissage|remplissage
525568|NCT01324531|Hill-Sachs defect|hill-sachs defect
667750|NCT00757523|Akne|akne
525569|NCT01324531|shoulder instability|shoulder instability
525570|NCT01324531|anterior shoulder instability|anterior shoulder instability
525571|NCT01324492|phase Ib,|phase ib,
525572|NCT01324492|RAD001,|rad001,
525573|NCT01324492|advanced pulmonary neuroendocrine tumor|advanced pulmonary neuroendocrine tumor
525574|NCT01324479|Non-small cell lung cancer,|non-small cell lung cancer,
525575|NCT01324479|hepatocellular,|hepatocellular,
525576|NCT01324479|gastric,|gastric,
525577|NCT01324479|renal cell,|renal cell,
525578|NCT01324479|c-MET,|c-met,
525579|NCT01324479|refractory,|refractory,
525580|NCT01324479|glioblastoma,|glioblastoma,
525581|NCT01324479|breast,|breast,
525582|NCT01324479|nasopharyngeal,|nasopharyngeal,
525583|NCT01324479|confirmed evidence of c-MET dysregulation|confirmed evidence of c-met dysregulation
525584|NCT01324453|Acute Myocardial Infarction|acute myocardial infarction
525585|NCT01324453|STEMI|stemi
525586|NCT01324453|Post Conditioning|post conditioning
525587|NCT01324453|Primary Percutaneous Coronary Intervention|primary percutaneous coronary intervention
525588|NCT01324440|Bacterial Vaccines|bacterial vaccines
525589|NCT01324440|Staphylococcus Aureus|staphylococcus aureus
525590|NCT01324440|Adjuvanted Vaccine|adjuvanted vaccine
525591|NCT01324427|Telemedicine|telemedicine
525592|NCT01324427|Virtual Medical Visit|virtual medical visit
525593|NCT01324427|Quality of Life|quality of life
525594|NCT01324427|11-022|11-022
525595|NCT01324401|Peanut Allergy|peanut allergy
525596|NCT01324401|Peanut Hypersensitivity|peanut hypersensitivity
525597|NCT01324362|FP|fp
525598|NCT01324362|Asthma|asthma
525599|NCT01324362|Sont|sont
525600|NCT01324362|FSC|fsc
525601|NCT01324362|BHR|bhr
525602|NCT01324349|Hepatic|hepatic
525603|NCT01324349|Topical Hemostat|topical hemostat
525604|NCT01324336|ALL|all
525605|NCT01324336|acute lymphoblastic leukemia|acute lymphoblastic leukemia
525606|NCT01324336|6-Mercaptopurine|6-mercaptopurine
525607|NCT01324336|Pediatric|pediatric
525608|NCT01324323|ROMI-001|romi-001
525609|NCT01324323|romi|romi
525610|NCT01324323|Romidepsin|romidepsin
525611|NCT01324323|Istodax|istodax
525612|NCT01324323|advanced malignancy|advanced malignancy
525613|NCT01324323|PK|pk
525614|NCT01324323|pharmacokinetics|pharmacokinetics
525615|NCT01324310|ROMI-001|romi-001
525616|NCT01324310|romi|romi
525617|NCT01324310|Romidepsin|romidepsin
525618|NCT01324310|Istodax|istodax
525619|NCT01324310|advanced malignancy|advanced malignancy
525620|NCT01324310|PK|pk
525621|NCT01324310|pharmacokinetics|pharmacokinetics
525622|NCT01324297|Diagnostic Techniques and Procedures|diagnostic techniques and procedures
525623|NCT01324297|Sensitivity and Specificity|sensitivity and specificity
525624|NCT01324297|Skin Tests|skin tests
525625|NCT01324297|Biological Markers|biological markers
525626|NCT01324284|Lubiprostone|lubiprostone
525627|NCT01324284|Bowel preparation regime|bowel preparation regime
525628|NCT01324271|Tympanostomy tube placement|tympanostomy tube placement
525629|NCT01324258|pancreatic cancer (combination with gemcitabine)|pancreatic cancer (combination with gemcitabine)
525630|NCT01324258|Non-small cell lung cancer (combination with gemcitabine)|non-small cell lung cancer (combination with gemcitabine)
525631|NCT01324258|solid tumors (single agent)|solid tumors (single agent)
525632|NCT01324258|MEK inhibitor|mek inhibitor
525633|NCT01324258|GSK1120212|gsk1120212
525634|NCT01324258|biliary cancer (combination with gemcitabine)|biliary cancer (combination with gemcitabine)
525635|NCT01324258|urothelial cancer (combination with gemcitabine)|urothelial cancer (combination with gemcitabine)
525636|NCT01324245|Salt|salt
525637|NCT01324245|Balance|balance
525638|NCT01324245|Renin Angiotensin System|renin angiotensin system
525639|NCT01324245|Fenoldopam\blood Pressure|fenoldopam\blood pressure
525640|NCT01324245|Sodium|sodium
525641|NCT01324219|nursing staff|nursing staff
525642|NCT01324219|residents|residents
525643|NCT01324206|Magnetic Resonance Imaging|magnetic resonance imaging
525644|NCT01324206|Healthy Volunteers|healthy volunteers
525645|NCT01324180|ALL|all
525646|NCT01324180|Relapsed|relapsed
525647|NCT01324180|Refractory|refractory
525648|NCT01324167|schizophrenia|schizophrenia
525649|NCT01324167|schizoaffective disorder|schizoaffective disorder
525650|NCT01324141|Anal Cancer|anal cancer
525651|NCT01324141|Radioprotector|radioprotector
525652|NCT01324141|Topical|topical
525653|NCT01324141|Radiation|radiation
525654|NCT01324141|Dermatitis|dermatitis
525655|NCT01324128|PA21|pa21
525656|NCT01324128|Phosphate Binder|phosphate binder
525657|NCT01324115|unspecified adult solid tumor, protocol specific|unspecified adult solid tumor, protocol specific
525658|NCT01324102|Neoplasms|neoplasms
525659|NCT01324089|Resveratrol|resveratrol
525660|NCT01324089|Piperine|piperine
525661|NCT01324076|adult primary hepatocellular carcinoma|adult primary hepatocellular carcinoma
525662|NCT01324076|localized unresectable adult primary liver cancer|localized unresectable adult primary liver cancer
525663|NCT01324076|advanced adult primary liver cancer|advanced adult primary liver cancer
525664|NCT01324063|untreated adult acute myeloid leukemia|untreated adult acute myeloid leukemia
525665|NCT01324037|suspected upper extremity deep vein thrombosis|suspected upper extremity deep vein thrombosis
525666|NCT01324037|diagnostic algorithm|diagnostic algorithm
525667|NCT01324024|Menopause|menopause
525668|NCT01324024|Aging|aging
525669|NCT01324024|Memory|memory
525670|NCT01324024|Women|women
525671|NCT01323998|enlarged prostate|enlarged prostate
525672|NCT01323998|Benign prostatic hyperplasia|benign prostatic hyperplasia
525673|NCT01323998|alpha-blocker|alpha-blocker
525674|NCT01323998|5-alpha-reductase inhibitor|5-alpha-reductase inhibitor
525675|NCT01323972|Malaria|malaria
525676|NCT01323972|Plasmodium falciparum|plasmodium falciparum
525677|NCT01323959|BoostrixTM Polio|boostrixtm polio
525678|NCT01323959|dTpa-IPV|dtpa-ipv
525679|NCT01323959|booster|booster
525680|NCT01323946|H5N1|h5n1
525681|NCT01323946|influenza infection|influenza infection
525682|NCT01323946|Influenza vaccine GSK1562902A|influenza vaccine gsk1562902a
525683|NCT01323933|Solid tumors|solid tumors
525684|NCT01323933|Oncology|oncology
525685|NCT01323933|Cancer|cancer
525686|NCT01323920|Stem Cell Transplant|stem cell transplant
525687|NCT01323920|Allogeneic Transplant|allogeneic transplant
525688|NCT01323920|Donors|donors
525689|NCT01323907|Total Parenteral Nutrition-induced Cholestasis|total parenteral nutrition-induced cholestasis
525690|NCT01323907|Omegaven|omegaven
525691|NCT01323907|liver disease|liver disease
525692|NCT01323907|Cholestasis|cholestasis
525693|NCT01323907|Fat emulsions|fat emulsions
525694|NCT01323881|theta burst stimulation, stroke, motor, plasticity|theta burst stimulation, stroke, motor, plasticity
525695|NCT01323842|renal colic|renal colic
525696|NCT01323842|hydronephrosis|hydronephrosis
525697|NCT01323842|abdominal aortic aneurysm|abdominal aortic aneurysm
525698|NCT01323842|ultrasound|ultrasound
525699|NCT01323842|emergency medicine|emergency medicine
525700|NCT01323842|urolithiasis|urolithiasis
525701|NCT01323829|High Tone Pelvic Floor Dysfunction|high tone pelvic floor dysfunction
525702|NCT01323829|Botulinum toxin type A|botulinum toxin type a
525704|NCT01323803|Eosinophilic Esophagitis|eosinophilic esophagitis
525705|NCT01323790|Non-Cancer-Related Pain|non-cancer-related pain
525706|NCT01323790|Opioid-Induced Constipation|opioid-induced constipation
525707|NCT01323777|Cataracts|cataracts
525708|NCT01323777|Intraocular lens|intraocular lens
525709|NCT01323777|Multifocal|multifocal
525710|NCT01323777|Toric|toric
525711|NCT01323777|Astigmatism|astigmatism
525712|NCT01323777|Presbyopia|presbyopia
525713|NCT01323764|Hydrocephalus|hydrocephalus
525714|NCT01323764|CSF shunts|csf shunts
525715|NCT01323764|Normal Pressure Hydrocephalus|normal pressure hydrocephalus
525716|NCT01323764|NPH|nph
525717|NCT01323764|ShuntCheck|shuntcheck
525718|NCT01323764|Shunt Malfunction|shunt malfunction
525719|NCT01323764|Suspected shunt malfunction in adult hydrocephalus patients|suspected shunt malfunction in adult hydrocephalus patients
525720|NCT01323738|Psychoeducation|psychoeducation
525721|NCT01323738|Group Control|group control
525722|NCT01323725|Team-based financial incentives|team-based financial incentives
525723|NCT01323725|Smoking cessation|smoking cessation
525724|NCT01323712|CKD|ckd
525725|NCT01323712|LV mass|lv mass
525726|NCT01323712|Vitamin D|vitamin d
525727|NCT01323712|LV function|lv function
525728|NCT01323699|Parkinson Disease|parkinson disease
525729|NCT01323699|Anxiety|anxiety
525730|NCT01323699|Depression|depression
525731|NCT01323647|IPV|ipv
525732|NCT01323647|PoliorixTM|poliorixtm
525733|NCT01323647|China|china
525734|NCT01323608|Thalassemia|thalassemia
525735|NCT01323608|hypercalciuria|hypercalciuria
525736|NCT01323608|vitamin D|vitamin d
525737|NCT01323608|To conduct a pilot study to determine the effect of various doses of|to conduct a pilot study to determine the effect of various doses of
525738|NCT01323608|vitamin D supplementation on vitamin D stores and their association with calcium excretion|vitamin d supplementation on vitamin d stores and their association with calcium excretion
525739|NCT01323595|Pain control|pain control
525740|NCT01323595|testicular sperm extraction|testicular sperm extraction
525741|NCT01323595|sperm|sperm
525742|NCT01323582|Gastroparesis|gastroparesis
525743|NCT01323582|Gastroparesis Treatment|gastroparesis treatment
525744|NCT01323582|Gastric Emptying|gastric emptying
525745|NCT01323582|Prokinetic Agents|prokinetic agents
525746|NCT01323582|Macrolides|macrolides
525747|NCT01323582|Erythromycin|erythromycin
525748|NCT01323582|Azithromycin|azithromycin
525749|NCT01323582|Erythromycin Cardiac Side-effects|erythromycin cardiac side-effects
525750|NCT01323582|Erythromycin drug interactions|erythromycin drug interactions
525751|NCT01323582|AZI|azi
525752|NCT01323569|Sativex|sativex
525753|NCT01323569|Cannabinoids|cannabinoids
525754|NCT01323569|Abuse potential|abuse potential
525755|NCT01323569|Addiction|addiction
525756|NCT01323556|Panic disorder|panic disorder
525757|NCT01323556|agoraphobia|agoraphobia
525758|NCT01323556|panic attacks|panic attacks
525759|NCT01323556|exposure based learning|exposure based learning
525760|NCT01323556|interoceptive exposure exercises|interoceptive exposure exercises
525761|NCT01323556|fear augmentation|fear augmentation
525762|NCT01323556|in vivo exposure|in vivo exposure
525763|NCT01323543|Back Pain,|back pain,
525764|NCT01323543|Back Pains, Low|back pains, low
525765|NCT01323543|Low Back Pains|low back pains
525766|NCT01323543|Pain, Low Back|pain, low back
525767|NCT01323543|Pains, Low Back|pains, low back
525768|NCT01323543|Lumbago|lumbago
525769|NCT01323543|Lower Back Pain|lower back pain
525770|NCT01323543|Back Pain, Lower|back pain, lower
525771|NCT01323543|Back Pains, Lower|back pains, lower
525772|NCT01323543|Lower Back Pains|lower back pains
525773|NCT01323543|Pain, Lower Back|pain, lower back
525774|NCT01323543|Pains, Lower Back|pains, lower back
525775|NCT01323543|Low Back Ache|low back ache
525776|NCT01323543|Ache, Low Back|ache, low back
525777|NCT01323543|Aches, Low Back|aches, low back
525778|NCT01323543|Back Ache, Low|back ache, low
525779|NCT01323543|Back Aches, Low|back aches, low
525780|NCT01323543|Low Back Aches|low back aches
525781|NCT01323543|Low Backache|low backache
525782|NCT01323543|Backache, Low|backache, low
525783|NCT01323543|Backaches, Low|backaches, low
525784|NCT01323543|Low Backaches|low backaches
525785|NCT01323543|Low Back Pain, Recurrent|low back pain, recurrent
525786|NCT01323543|Recurrent Low Back Pain|recurrent low back pain
525787|NCT01323543|Low Back Pain, Postural|low back pain, postural
525788|NCT01323543|Postural Low Back Pain|postural low back pain
525789|NCT01323543|Low Back Pain, Mechanical|low back pain, mechanical
525790|NCT01323543|Mechanical Low Back Pain|mechanical low back pain
525791|NCT01323543|Low Back Pain, Posterior Compartment|low back pain, posterior compartment
525792|NCT01323530|metastatic breast cancer|metastatic breast cancer
525793|NCT01323517|skin|skin
525794|NCT01323517|DACTINOMYCIN|dactinomycin
525795|NCT01323517|MDX-010 (Ipilimumab)|mdx-010 (ipilimumab)
525796|NCT01323517|MELPHALAN|melphalan
525797|NCT01323517|Isolated Limb Infusion|isolated limb infusion
525798|NCT01323517|10-101|10-101
525799|NCT01323504|Stage 5 arteritis|stage 5 arteritis
525800|NCT01323504|Stage 6 arteritis|stage 6 arteritis
525801|NCT01323504|rutherford classification|rutherford classification
525802|NCT01323491|smoking cessation|smoking cessation
525803|NCT01323491|nicotine replacement therapy|nicotine replacement therapy
525804|NCT01323491|routine smokers|routine smokers
525805|NCT01323478|Depressive Disorder|depressive disorder
525806|NCT01323478|Depression|depression
525807|NCT01323478|Depressive Disorder, Major|depressive disorder, major
525808|NCT01323478|Mood Disorders|mood disorders
525809|NCT01323478|Mental Disorders|mental disorders
525810|NCT01323478|Behavioural Symptoms|behavioural symptoms
525811|NCT01323465|Sativex|sativex
525812|NCT01323465|Cytochrome P450|cytochrome p450
525813|NCT01323465|Pharmacokinetics|pharmacokinetics
525814|NCT01323465|Cannabinoids|cannabinoids
525815|NCT01323465|ketoconazole|ketoconazole
525816|NCT01323465|omeprazole|omeprazole
525817|NCT01323465|rifampicin|rifampicin
525818|NCT01323452|entecavir|entecavir
525819|NCT01323452|hepatitis B|hepatitis b
525820|NCT01323439|Patients presenting with an intracranial aneurysm|patients presenting with an intracranial aneurysm
525821|NCT01323426|urinary incontinence, stress|urinary incontinence, stress
525822|NCT01323426|autologous|autologous
525824|NCT01323413|penumbra|penumbra
525825|NCT01323413|determinants|determinants
525826|NCT01323413|CT perfusion|ct perfusion
525827|NCT01323400|GIST|gist
525828|NCT01323400|Resistant|resistant
525829|NCT01323400|Pazopanib|pazopanib
525830|NCT01323400|Tyrosine kinase inhibitor|tyrosine kinase inhibitor
525831|NCT01323400|Best supportive care|best supportive care
525832|NCT01323400|Progression-free survival|progression-free survival
525833|NCT01323400|Overall survival|overall survival
525834|NCT01323400|Objective response rate|objective response rate
525835|NCT01323400|Best response|best response
525836|NCT01323400|Tolerance profile|tolerance profile
525837|NCT01323374|Fibromyalgia|fibromyalgia
525838|NCT01323374|FMS|fms
525839|NCT01323374|droxidopa|droxidopa
525840|NCT01323374|pain|pain
525841|NCT01323361|inflammation|inflammation
525842|NCT01323361|laparoscopy|laparoscopy
525843|NCT01323361|hernia|hernia
525844|NCT01323361|incisional|incisional
525845|NCT01323361|trauma|trauma
525846|NCT01323348|Diabetes|diabetes
525847|NCT01323348|Diabetes Education|diabetes education
525848|NCT01323348|Diabetic Retinopathy|diabetic retinopathy
525849|NCT01323348|HbA1c|hba1c
525850|NCT01323335|Uric Acid|uric acid
525851|NCT01323335|Rasburicase|rasburicase
525852|NCT01323335|Inflammatory Markers|inflammatory markers
525853|NCT01323322|Socioeconomic Status|socioeconomic status
525854|NCT01323322|Longitudinal Study|longitudinal study
525855|NCT01323322|Health Disparities|health disparities
525856|NCT01323322|Epidemiology|epidemiology
525857|NCT01323322|Diversity|diversity
525858|NCT01323309|Supportive Psychotherapy|supportive psychotherapy
525859|NCT01323309|Therapy|therapy
525860|NCT01323309|11-021|11-021
525861|NCT01323296|Myocardial infarction|myocardial infarction
525862|NCT01323296|Magnetic resonance|magnetic resonance
525863|NCT01323296|Nanoparticle|nanoparticle
525864|NCT01323296|Iron|iron
525865|NCT01323296|Inflammation|inflammation
525866|NCT01323283|Omega-3|omega-3
525867|NCT01323283|physical activity|physical activity
525868|NCT01323283|children|children
525869|NCT01323283|obesity|obesity
525870|NCT01323283|sedentary|sedentary
525871|NCT01323283|accelerometry|accelerometry
525872|NCT01323283|BMI|bmi
525873|NCT01323283|fatty acids|fatty acids
525874|NCT01323283|inflammatory markers|inflammatory markers
525875|NCT01323283|intervention|intervention
525876|NCT01323283|randomized|randomized
525877|NCT01323283|double blind|double blind
525878|NCT01323270|Healthy adolescents|healthy adolescents
525879|NCT01323257|TMC435-TiDP16-C115|tmc435-tidp16-c115
525880|NCT01323257|TMC435-C115|tmc435-c115
525881|NCT01323257|TMC435|tmc435
525882|NCT01323257|HCV|hcv
525883|NCT01323257|Hepatitis C|hepatitis c
525884|NCT01323257|Hep C|hep c
525885|NCT01323257|healthy volunteers|healthy volunteers
525886|NCT01323244|TMC435-TiDP16-C213|tmc435-tidp16-c213
525887|NCT01323244|TMC435-C213|tmc435-c213
525888|NCT01323244|TMC435|tmc435
525889|NCT01323244|HCV|hcv
525890|NCT01323244|Hepatitis C|hepatitis c
525891|NCT01323231|XY-Zone|xy-zone
525892|NCT01323231|school drop-out risk|school drop-out risk
525893|NCT01323231|protective factors|protective factors
525894|NCT01323231|truancy|truancy
525895|NCT01323218|Obstructive sleep apnea-hypopnea syndrome|obstructive sleep apnea-hypopnea syndrome
525896|NCT01323218|OSAHS|osahs
525897|NCT01323218|Vitamin D|vitamin d
525898|NCT01323205|JNJ-40411813|jnj-40411813
525899|NCT01323192|Concerta|concerta
525900|NCT01323192|Adults|adults
525901|NCT01323192|Attention-Deficit/Hyperactivity Disorder|attention-deficit/hyperactivity disorder
525902|NCT01323192|ADHD|adhd
525903|NCT01323192|Methylphenidate hydrochloride|methylphenidate hydrochloride
525904|NCT01323179|Postoperative pain|postoperative pain
525905|NCT01323179|Postoperative opioid requirements|postoperative opioid requirements
525906|NCT01323166|rectal cancer|rectal cancer
525907|NCT01323140|hypogonadism, testosterone, transdermal system|hypogonadism, testosterone, transdermal system
525908|NCT01323114|type 2 diabetes mellitus|type 2 diabetes mellitus
525909|NCT01323114|non-morbidly obese|non-morbidly obese
525910|NCT01323114|laparoscopic duodenal exclusion|laparoscopic duodenal exclusion
525911|NCT01323088|Childhood obesity|childhood obesity
525912|NCT01323088|Visceral fat|visceral fat
525913|NCT01323088|Insulin resistance|insulin resistance
525914|NCT01323088|Liver fat|liver fat
525915|NCT01323088|Skeletal muscle lipid|skeletal muscle lipid
525916|NCT01323088|Regular exercise|regular exercise
525917|NCT01323062|chemotherapy naive|chemotherapy naive
525918|NCT01323062|stage IV non squamous non small cell lung cancer|stage iv non squamous non small cell lung cancer
525919|NCT01323062|Phase 1b|phase 1b
525920|NCT01323062|Bavituximab|bavituximab
525921|NCT01323062|Chimeric 3G4|chimeric 3g4
525922|NCT01323062|U of North Carolina at Chapel Hill|u of north carolina at chapel hill
525923|NCT01323049|extubation strategy|extubation strategy
525924|NCT01323010|asthma|asthma
525925|NCT01323010|albuterol|albuterol
525926|NCT01323010|metered dose inhalers|metered dose inhalers
525927|NCT01322984|ASD|asd
525928|NCT01322984|Startle|startle
525929|NCT01322971|Bacterial Vaginosis|bacterial vaginosis
525930|NCT01322971|Infertility|infertility
525931|NCT01322971|Miscarriage|miscarriage
525932|NCT01322971|Metronidazole|metronidazole
525933|NCT01322958|bedside ultrasound|bedside ultrasound
525934|NCT01322932|Medication Adherence|medication adherence
525935|NCT01322932|HIV Infection|hiv infection
525936|NCT01322932|efavirenz, emtricitabine, tenofovir disoproxil fumarate drug combination [Substance Name]|efavirenz, emtricitabine, tenofovir disoproxil fumarate drug combination [substance name]
525937|NCT01322932|efavirenz|efavirenz
525938|NCT01322932|emtricitabine|emtricitabine
525939|NCT01322932|Patient Satisfaction|patient satisfaction
525940|NCT01322932|tenofovir disoproxil fumarate|tenofovir disoproxil fumarate
525941|NCT01322919|PresbyLASIK|presbylasik
525942|NCT01322919|Presbyopia|presbyopia
525943|NCT01322919|LASIK|lasik
525944|NCT01322919|Supracor|supracor
525945|NCT01322919|refractive|refractive
525946|NCT01322919|Myopia|myopia
525947|NCT01322919|Hyperopia|hyperopia
525948|NCT01322906|ABMLF|abmlf
525949|NCT01322906|Allogenic Bone marrow Mesenchymal Stem Cells|allogenic bone marrow mesenchymal stem cells
525950|NCT01322906|Liver Failure|liver failure
525951|NCT01322906|Transplantation|transplantation
525952|NCT01322893|Metastatic breast cancer|metastatic breast cancer
525953|NCT01322893|Circulating tumour cells|circulating tumour cells
525954|NCT01322893|CTC|ctc
525955|NCT01322893|Prognostic factors|prognostic factors
525956|NCT01322893|Treatment response|treatment response
525957|NCT01322880|domestic violence|domestic violence
525958|NCT01322867|bioequivalence study|bioequivalence study
525959|NCT01322867|alprazolam|alprazolam
525960|NCT01322867|frontal|frontal
525961|NCT01322854|IMRT|imrt
525962|NCT01322854|Integrated boost|integrated boost
525963|NCT01322854|adjuvant radiotherapy|adjuvant radiotherapy
525964|NCT01322854|breast cancer|breast cancer
525965|NCT01322854|breast conserving surgery|breast conserving surgery
525966|NCT01322841|CHICA|chica
525967|NCT01322841|clinical decision support|clinical decision support
525968|NCT01322828|Bicep|bicep
525969|NCT01322828|Tendon|tendon
525970|NCT01322828|Distal|distal
525971|NCT01322828|Ruptures|ruptures
525972|NCT01322828|Randomized|randomized
525973|NCT01322828|Surgery|surgery
525974|NCT01322815|colon cancer|colon cancer
525975|NCT01322815|metastatic|metastatic
525976|NCT01322815|vaccine|vaccine
525977|NCT01322802|Ovarian Cancer|ovarian cancer
525978|NCT01322802|Vaccine|vaccine
525980|NCT01322802|Stage IV|stage iv
525981|NCT01322802|Remission|remission
525982|NCT01322789|Diabetes mellitus|diabetes mellitus
525983|NCT01322789|Stem cells|stem cells
525984|NCT01322789|Autologous stem cell transplantation|autologous stem cell transplantation
525985|NCT01322789|Autoimmune diseases|autoimmune diseases
525986|NCT01322776|Mantle Cell Lymphoma|mantle cell lymphoma
525987|NCT01322776|Recurrent|recurrent
525988|NCT01322776|Bortezomib|bortezomib
525989|NCT01322776|Combination Treatment|combination treatment
525990|NCT01322737|resection|resection
525991|NCT01322737|open|open
525992|NCT01322737|laparoscopic|laparoscopic
525993|NCT01322737|benign|benign
525994|NCT01322737|malignant|malignant
525995|NCT01322737|disease|disease
525996|NCT01322737|colon|colon
525997|NCT01322737|gastric|gastric
525998|NCT01322724|colonoscopy|colonoscopy
525999|NCT01322724|colon cancer screening|colon cancer screening
526000|NCT01322724|patient discomfort scores|patient discomfort scores
526001|NCT01322724|sedation medication requirements|sedation medication requirements
526002|NCT01322724|water insertion method|water insertion method
526003|NCT01322711|Thromboxane|thromboxane
526004|NCT01322711|Aspirin|aspirin
526005|NCT01322711|Atorvastatin|atorvastatin
526006|NCT01322711|Platelet activation|platelet activation
526007|NCT01322711|Thrombin Activation|thrombin activation
526008|NCT01322711|Oxidative stress|oxidative stress
526009|NCT01322698|ICU|icu
526010|NCT01322685|Tuberculosis|tuberculosis
526011|NCT01322685|Lung cancer|lung cancer
526012|NCT01322672|Anesthetic Agents|anesthetic agents
526013|NCT01322672|POCD|pocd
526014|NCT01322672|Delirium|delirium
526015|NCT01322672|Cognitive Testing|cognitive testing
526016|NCT01322672|Aging|aging
526017|NCT01322672|Surgery|surgery
526018|NCT01322672|fMRI|fmri
526019|NCT01322672|Diffusion Tensor Imaging|diffusion tensor imaging
526020|NCT01322672|White Matter|white matter
526021|NCT01322659|Mechanical ventilation|mechanical ventilation
526022|NCT01322659|Weaning|weaning
526023|NCT01322659|Noninvasive ventilation|noninvasive ventilation
526024|NCT01322659|Acute respiratory failure|acute respiratory failure
526025|NCT01322659|Helmet|helmet
526026|NCT01322646|ADHD|adhd
526027|NCT01322646|Driving|driving
526028|NCT01322646|Behavior modification|behavior modification
526029|NCT01322633|Pantoprazole|pantoprazole
526030|NCT01322633|proton pump inhibitor|proton pump inhibitor
526031|NCT01322633|gastric cancer|gastric cancer
526032|NCT01322633|digestive system cancer|digestive system cancer
526033|NCT01322633|cancer|cancer
526034|NCT01322607|Exercise|exercise
526035|NCT01322607|Rehabilitation|rehabilitation
526036|NCT01322607|Stroke|stroke
526037|NCT01322594|Chronic Obstructive Pulmonary Disease|chronic obstructive pulmonary disease
526038|NCT01322594|COPD|copd
526039|NCT01322581|Plasmodium|plasmodium
526040|NCT01322581|PBMC|pbmc
526041|NCT01322581|Malaria|malaria
526042|NCT01322568|Aging|aging
526043|NCT01322568|Gene|gene
526044|NCT01322568|Environment|environment
526045|NCT01322568|Inflammation|inflammation
526046|NCT01322568|Iceland|iceland
526047|NCT01322555|PBR28|pbr28
526048|NCT01322555|Positron Emission Tomography (PET)|positron emission tomography (pet)
526049|NCT01322555|Propofol|propofol
526050|NCT01322555|Autism|autism
526051|NCT01322555|Immune Response|immune response
526052|NCT01322555|Autism Spectrum Disorders|autism spectrum disorders
526053|NCT01322555|ASD|asd
526054|NCT01322555|Healthy Volunteer|healthy volunteer
526055|NCT01322555|HV|hv
526056|NCT01322529|nulliparity|nulliparity
526057|NCT01322529|pregnant women|pregnant women
526058|NCT01322529|pregnancy outcomes|pregnancy outcomes
526059|NCT01322529|pregnancy complications|pregnancy complications
526060|NCT01322490|PROSTVAC|prostvac
526061|NCT01322490|metastatic|metastatic
526062|NCT01322490|prostate cancer|prostate cancer
526063|NCT01322490|castrate-resistant|castrate-resistant
526064|NCT01322490|vaccine|vaccine
526065|NCT01322490|immunotherapy|immunotherapy
526066|NCT01322490|Phase 3|phase 3
526067|NCT01322477|Identification of treatment efficacy in patients with advanced HCC by PET/CT F18-FDG|identification of treatment efficacy in patients with advanced hcc by pet/ct f18-fdg
526068|NCT01322464|Sativex|sativex
526069|NCT01322464|bio-availability|bio-availability
526070|NCT01322464|cannabinoid|cannabinoid
526071|NCT01322464|pharmacokinetics|pharmacokinetics
526072|NCT01322451|Safety|safety
526073|NCT01322451|Tolerability|tolerability
526074|NCT01322451|Pharmacokinetics|pharmacokinetics
526075|NCT01322438|healthy volunteers|healthy volunteers
526076|NCT01322438|rifampin|rifampin
526077|NCT01322438|pharmacokinetics|pharmacokinetics
526078|NCT01322438|single dose|single dose
526079|NCT01322412|Adapted physical activity|adapted physical activity
526080|NCT01322412|breast cancer|breast cancer
526081|NCT01322399|low back pain|low back pain
526082|NCT01322399|chronic pain|chronic pain
526083|NCT01322399|manual therapy|manual therapy
526084|NCT01322399|Structural Integration|structural integration
526085|NCT01322386|PSC|psc
526086|NCT01322386|BA|ba
526087|NCT01322373|Alzheimer's disease|alzheimer's disease
526088|NCT01322373|magnetoencephalography|magnetoencephalography
526089|NCT01322373|MEG|meg
526090|NCT01322373|SNI|sni
526091|NCT01322347|End Stage Renal Disease|end stage renal disease
526092|NCT01322347|Hemodialysis|hemodialysis
526093|NCT01322347|SFP|sfp
526094|NCT01322347|Hemodialysis-dependent chronic renal failure|hemodialysis-dependent chronic renal failure
526095|NCT01322334|Snoring|snoring
526096|NCT01322334|Sleep apnea|sleep apnea
526097|NCT01322334|Pharyngeal muscle tone|pharyngeal muscle tone
526098|NCT01322321|ACZ885|acz885
526099|NCT01322321|diabetes|diabetes
526100|NCT01322321|type 1|type 1
526101|NCT01322321|C-peptide|c-peptide
526102|NCT01322308|lupus|lupus
526103|NCT01322308|HDL particles|hdl particles
526104|NCT01322308|endothelial function|endothelial function
526105|NCT01322308|pioglitazone|pioglitazone
526106|NCT01322243|Anxiety|anxiety
526107|NCT01322243|Metabolic state|metabolic state
526108|NCT01322243|Stress|stress
526109|NCT01322230|Instructional Design|instructional design
526110|NCT01322230|Online learning module|online learning module
526111|NCT01322230|Surgical education|surgical education
526112|NCT01322217|Medication adherence|medication adherence
526113|NCT01322217|Substance use|substance use
526114|NCT01322217|Sexual risk behaviors|sexual risk behaviors
526115|NCT01322204|codeine, neonates, pediatric pharmacology|codeine, neonates, pediatric pharmacology
526116|NCT01322191|pain, pain management, pediatrics, morphine pharmacokinetics|pain, pain management, pediatrics, morphine pharmacokinetics
526117|NCT01322178|cetuximab|cetuximab
526118|NCT01322178|colorectal carcinoma|colorectal carcinoma
526119|NCT01322165|Marfan syndrome|marfan syndrome
526120|NCT01322165|Turner syndrome|turner syndrome
526121|NCT01322165|Bicuspid aortic valve|bicuspid aortic valve
526122|NCT01322165|Ehlers-Danlos Syndrome|ehlers-danlos syndrome
526123|NCT01322165|Loeys-Dietz syndrome|loeys-dietz syndrome
526124|NCT01322165|Aneurysm|aneurysm
526125|NCT01322165|Genetic|genetic
526126|NCT01322165|aortic|aortic
526127|NCT01322165|thoracic|thoracic
526128|NCT01322165|mutation|mutation
526129|NCT01322165|dissection|dissection
526130|NCT01322152|metastases|metastases
526131|NCT01322152|neoplasm|neoplasm
526132|NCT01322139|Sativex|sativex
526133|NCT01322139|Cannabinoid|cannabinoid
526134|NCT01322139|Electrocardiogram|electrocardiogram
526135|NCT01322139|QT interval|qt interval
526136|NCT01322113|BIPOLAR|bipolar
526137|NCT01322113|MANIA|mania
526138|NCT01322113|DEPRESSION|depression
526139|NCT01322100|Brain Metastases, CNS Metastases|brain metastases, cns metastases
526140|NCT01322087|Nutrition|nutrition
526141|NCT01322087|new energy dense food concept|new energy dense food concept
526142|NCT01322074|Acute postoperative pain|acute postoperative pain
526143|NCT01322074|systemic inflammation|systemic inflammation
526144|NCT01322074|CRP|crp
526145|NCT01322074|IL6|il6
526146|NCT01322061|Gallbladder removal|gallbladder removal
526147|NCT01322061|acute cholecystitis|acute cholecystitis
526148|NCT01322061|Laparoscopic cholecestectomy|laparoscopic cholecestectomy
526149|NCT01322048|Sympathetic Hyperactivity|sympathetic hyperactivity
526150|NCT01322048|Traumatic Brain Injury|traumatic brain injury
526151|NCT01322048|Agitation|agitation
526152|NCT01322048|Severe TBI|severe tbi
526153|NCT01322048|TBI|tbi
526154|NCT01322048|Catecholamines|catecholamines
526155|NCT01322048|Heart rate variability|heart rate variability
526156|NCT01322048|Adrenergic alpha-Agonists|adrenergic alpha-agonists
526157|NCT01322048|Adrenergic beta-Antagonists|adrenergic beta-antagonists
526158|NCT01322048|Cognitive Impairment|cognitive impairment
526159|NCT01322022|Autism|autism
526160|NCT01322022|Autism Spectrum Disorders|autism spectrum disorders
526161|NCT01322022|Sleep Problems|sleep problems
526162|NCT01322022|Sleep Disturbances|sleep disturbances
526163|NCT01322022|Interventions|interventions
526164|NCT01322009|Children|children
526165|NCT01322009|Brain injury|brain injury
526166|NCT01322009|Trauma|trauma
526167|NCT01321996|PET/CT|pet/ct
526168|NCT01321996|68Ga-DOTANOC|68ga-dotanoc
526169|NCT01321996|IPF|ipf
526170|NCT01321996|NSIP|nsip
526171|NCT01321996|Idiopathic pulmonary fibrosis|idiopathic pulmonary fibrosis
526172|NCT01321931|Smoking Cessation|smoking cessation
526173|NCT01321931|Nicotine pharmacokinetics|nicotine pharmacokinetics
526174|NCT01321892|HRME|hrme
526175|NCT01321892|High-resolution microendoscope|high-resolution microendoscope
526176|NCT01321892|Optical imaging technology|optical imaging technology
526177|NCT01321892|Non-invasive fluorescence and reflectance imaging|non-invasive fluorescence and reflectance imaging
526178|NCT01321892|Upper aerodigestive tract|upper aerodigestive tract
526179|NCT01321892|Cancer surgery|cancer surgery
526180|NCT01321892|Squamous cell carcinoma|squamous cell carcinoma
526181|NCT01321892|Oral cavity|oral cavity
526182|NCT01321892|Oropharynx|oropharynx
526183|NCT01321892|Larynx|larynx
526184|NCT01321892|Hypopharynx|hypopharynx
526185|NCT01321892|Squamous cell carcinoma of the oral cavity, oropharynx, larynx, and/or hypopharynx|squamous cell carcinoma of the oral cavity, oropharynx, larynx, and/or hypopharynx
526186|NCT01321879|Gram Positive Bloodstream Infections|gram positive bloodstream infections
526187|NCT01321879|Sepsis|sepsis
526188|NCT01321879|Staphylococcus aureus|staphylococcus aureus
526189|NCT01321879|Enterococci|enterococci
526190|NCT01321879|Streptococci|streptococci
526191|NCT01321879|Pneumococci|pneumococci
526192|NCT01321879|Corynebacterium|corynebacterium
526193|NCT01321879|Propionibacterium or Bacillus species|propionibacterium or bacillus species
526194|NCT01321879|Telavancin|telavancin
526195|NCT01321879|Vibativ|vibativ
526196|NCT01321866|Angioplasty|angioplasty
526197|NCT01321866|cutting balloon|cutting balloon
526198|NCT01321853|Home health care|home health care
526199|NCT01321853|Medication Management|medication management
526200|NCT01321853|Cognitive impairment|cognitive impairment
526201|NCT01321853|Medication adherence|medication adherence
526202|NCT01321853|Older adults|older adults
526203|NCT01321853|Care Coordination management|care coordination management
526204|NCT01321840|Endometriosis|endometriosis
526205|NCT01321840|pain|pain
526206|NCT01321840|sart|sart
526207|NCT01321840|autonomic nervous system|autonomic nervous system
526208|NCT01321840|fMRI|fmri
526209|NCT01321840|perfusion|perfusion
526210|NCT01321840|connectivity|connectivity
526211|NCT01321840|hypnotherapy|hypnotherapy
526212|NCT01321840|traditional Chinese medicine|traditional chinese medicine
526213|NCT01321827|ABPA|abpa
526214|NCT01321814|Hyperacusis|hyperacusis
526215|NCT01321814|Personality|personality
526216|NCT01321814|Comorbidity|comorbidity
526217|NCT01321814|Treatment|treatment
526218|NCT01321814|Cognitive behavioral therapy|cognitive behavioral therapy
526219|NCT01321801|Pregabalin|pregabalin
526220|NCT01321801|Laparoscopic cholecystectomy|laparoscopic cholecystectomy
526221|NCT01321801|Postoperative pain|postoperative pain
526222|NCT01321801|Opioid consumption|opioid consumption
526223|NCT01321788|thromboprophylaxis|thromboprophylaxis
526224|NCT01321788|pregnancy|pregnancy
526225|NCT01321788|post-cesarian section|post-cesarian section
526226|NCT01321762|Prolapse|prolapse
526227|NCT01321762|Childbirth|childbirth
526228|NCT01321762|Pregnancy|pregnancy
526229|NCT01321749|ischemic cerebral vascular disease|ischemic cerebral vascular disease
526230|NCT01321749|stroke secondary prevention|stroke secondary prevention
526231|NCT01321749|remote ischemic preconditioning|remote ischemic preconditioning
526232|NCT01321736|dietary fiber|dietary fiber
526233|NCT01321736|enteral nutrition|enteral nutrition
526234|NCT01321736|laxation|laxation
526235|NCT01321723|Osteoporosis|osteoporosis
526236|NCT01321723|Bone Diseases, Metabolic|bone diseases, metabolic
526237|NCT01321723|Bone Diseases|bone diseases
526238|NCT01321723|Bone Density Conservation Agents|bone density conservation agents
526239|NCT01321710|sleep hygiene|sleep hygiene
526240|NCT01321710|actigraphy|actigraphy
526241|NCT01321710|maternal|maternal
526242|NCT01321710|infant|infant
526243|NCT01321710|postpartum period|postpartum period
526244|NCT01321710|immunization|immunization
526245|NCT01321710|acetaminophen|acetaminophen
526246|NCT01321697|Being seen in the Winthrop P. Rockefeller Cancer Institute for vulvar|being seen in the winthrop p. rockefeller cancer institute for vulvar
526247|NCT01321697|cancer requiring lymph node evaluation for the ipsilateral or contralateral|cancer requiring lymph node evaluation for the ipsilateral or contralateral
526248|NCT01321697|groin|groin
526249|NCT01321671|pregabalin|pregabalin
526250|NCT01321671|pharmacokinetics|pharmacokinetics
526251|NCT01321671|bioavailability|bioavailability
526252|NCT01321671|bioequivalence|bioequivalence
526253|NCT01321658|Geriatric Assessment|geriatric assessment
526254|NCT01321658|Perioperative Care|perioperative care
526255|NCT01321658|Colorectal Neoplasms|colorectal neoplasms
526256|NCT01321658|Frail Elderly|frail elderly
526257|NCT01321645|Acne Vulgaris|acne vulgaris
526258|NCT01321645|Homoeopathy|homoeopathy
526259|NCT01321645|Homeopathy|homeopathy
526260|NCT01321645|Azadirachta Indica|azadirachta indica
526261|NCT01321632|Acne Vulgaris|acne vulgaris
526262|NCT01321632|Homoeopathy|homoeopathy
526263|NCT01321632|Zingiber officinalis|zingiber officinalis
526264|NCT01321619|Chronic venous insufficiency|chronic venous insufficiency
526265|NCT01321619|Hemorrhoidal syndrome|hemorrhoidal syndrome
526266|NCT01321619|Varicell|varicell
526267|NCT01321606|infection|infection
526268|NCT01321606|probiotics|probiotics
526269|NCT01321567|rabeprazole sodium|rabeprazole sodium
526270|NCT01321567|refractory reflux esophagitis|refractory reflux esophagitis
668577|NCT00754247|HSE|hse
526271|NCT01321541|non-hodgkin lymphoma|non-hodgkin lymphoma
526272|NCT01321541|DLBCL|dlbcl
526273|NCT01321541|relapsed|relapsed
526274|NCT01321541|aggressive NHL|aggressive nhl
526275|NCT01321541|Diffuse large B-cell lymphoma|diffuse large b-cell lymphoma
526276|NCT01321541|Rituximab|rituximab
526277|NCT01321541|Rituxan|rituxan
526278|NCT01321541|Pixantrone|pixantrone
526279|NCT01321541|NHL|nhl
526280|NCT01321541|non hodgkin's lymphoma|non hodgkin's lymphoma
526281|NCT01321541|de novo DLBCL|de novo dlbcl
526282|NCT01321541|DLBCL transformed from Indolent Lymphoma|dlbcl transformed from indolent lymphoma
526283|NCT01321541|Follicular Grade 3 Lymphoma|follicular grade 3 lymphoma
526284|NCT01321502|treatment of herpes|treatment of herpes
526285|NCT01321489|Phase III|phase iii
526286|NCT01321489|Sildenafil Citrate Tablet Sublingual|sildenafil citrate tablet sublingual
526287|NCT01321489|Erectile dysfunction|erectile dysfunction
526288|NCT01321437|Melanoma|melanoma
526289|NCT01321437|Axitinib|axitinib
526290|NCT01321437|Anti-angiogenesis|anti-angiogenesis
526291|NCT01321437|Neoadjuvant Melanoma|neoadjuvant melanoma
526292|NCT01321424|Dry Eye|dry eye
526293|NCT01321424|Tear Osmolarity|tear osmolarity
526294|NCT01321424|Meibomain Gland Disease|meibomain gland disease
526295|NCT01321424|Aqueous Dificiency|aqueous dificiency
526296|NCT01321424|Tear film abnormality|tear film abnormality
526297|NCT01321411|Respiratory Muscle Blood Flow|respiratory muscle blood flow
526298|NCT01321411|Work of Breathing|work of breathing
526299|NCT01321411|Near Infrared Spectroscopy|near infrared spectroscopy
526300|NCT01321398|High Frequency Oscillation|high frequency oscillation
526301|NCT01321398|Oscillation|oscillation
526302|NCT01321398|HFO|hfo
526303|NCT01321398|Transpulmonary pressure|transpulmonary pressure
526304|NCT01321385|childhood acute myeloid leukemia in remission|childhood acute myeloid leukemia in remission
526305|NCT01321385|recurrent childhood acute myeloid leukemia|recurrent childhood acute myeloid leukemia
526306|NCT01321385|untreated childhood acute myeloid leukemia and other myeloid malignancies|untreated childhood acute myeloid leukemia and other myeloid malignancies
526307|NCT01321385|childhood acute erythroleukemia (M6)|childhood acute erythroleukemia (m6)
526308|NCT01321385|childhood acute megakaryocytic leukemia (M7)|childhood acute megakaryocytic leukemia (m7)
526309|NCT01321385|childhood acute monoblastic leukemia (M5a)|childhood acute monoblastic leukemia (m5a)
526310|NCT01321385|childhood acute monocytic leukemia (M5b)|childhood acute monocytic leukemia (m5b)
526311|NCT01321385|childhood acute myeloblastic leukemia with maturation (M2)|childhood acute myeloblastic leukemia with maturation (m2)
526312|NCT01321385|childhood acute myeloblastic leukemia without maturation (M1)|childhood acute myeloblastic leukemia without maturation (m1)
526313|NCT01321385|childhood acute myelomonocytic leukemia (M4)|childhood acute myelomonocytic leukemia (m4)
526314|NCT01321385|childhood acute minimally differentiated myeloid leukemia (M0)|childhood acute minimally differentiated myeloid leukemia (m0)
526315|NCT01321346|Relapse|relapse
526316|NCT01321346|Lymphoblastic|lymphoblastic
526317|NCT01321346|Leukemia|leukemia
526318|NCT01321346|Panobinostat|panobinostat
526319|NCT01321346|LBH589|lbh589
526320|NCT01321346|Refractory|refractory
526321|NCT01321346|Hodgkin's|hodgkin's
526322|NCT01321346|Non-Hodgkin's Lymphoma|non-hodgkin's lymphoma
526323|NCT01321346|Lymphoma|lymphoma
526324|NCT01321346|Myelogenous|myelogenous
526325|NCT01321346|Acute|acute
526326|NCT01321346|Childhood|childhood
526327|NCT01321346|Pediatric|pediatric
526328|NCT01321346|ALL|all
526329|NCT01321346|AML|aml
526330|NCT01321346|NHL|nhl
526331|NCT01321346|HD|hd
526332|NCT01321333|thoracic spinal cord injury|thoracic spinal cord injury
526333|NCT01321333|spinal cord injury thoracic|spinal cord injury thoracic
526334|NCT01321333|sub-acute spinal cord injury|sub-acute spinal cord injury
526335|NCT01321333|human neural stem cells|human neural stem cells
526336|NCT01321333|stem cells|stem cells
526337|NCT01321333|stem cells transplant|stem cells transplant
526338|NCT01321333|stem cells transplant spinal cord injury|stem cells transplant spinal cord injury
526339|NCT01321320|ICUAP|icuap
526340|NCT01321320|Critical illness|critical illness
526341|NCT01321320|Muscle wasting|muscle wasting
526342|NCT01321320|ICU|icu
526343|NCT01321307|Aphtostomatitis|aphtostomatitis
526344|NCT01321307|Mucositis|mucositis
526345|NCT01321307|Mouth sores|mouth sores
526346|NCT01321307|Natural|natural
526347|NCT01321307|Herbal|herbal
526348|NCT01321281|Osteoarthritis|osteoarthritis
526349|NCT01321268|orange peel skin|orange peel skin
526350|NCT01321268|cellulite|cellulite
526351|NCT01321255|Myocardial Infarction|myocardial infarction
526352|NCT01321255|Treatment Adherence|treatment adherence
526353|NCT01321242|Resting heart rate|resting heart rate
526354|NCT01321242|Stable Angina|stable angina
526355|NCT01321242|Hypertension|hypertension
526356|NCT01321242|beta-blockers|beta-blockers
526357|NCT01321229|Sleep apnea|sleep apnea
526358|NCT01321229|NIHSS scale|nihss scale
526359|NCT01321229|FIM scale|fim scale
526360|NCT01321229|FUGL-MEYER scale|fugl-meyer scale
526361|NCT01321216|rotavirus|rotavirus
526362|NCT01321216|gastroenteritis|gastroenteritis
526363|NCT01321216|children|children
526364|NCT01321216|Pediatric|pediatric
526365|NCT01321216|dehydration|dehydration
526366|NCT01321216|vaccine|vaccine
526367|NCT01321203|carbon dioxide insufflation|carbon dioxide insufflation
526368|NCT01321177|Schizophrenia|schizophrenia
526369|NCT01321177|Schizoaffective Disorder|schizoaffective disorder
526370|NCT01321177|Schizophreniform Disorder|schizophreniform disorder
526371|NCT01321177|Brief Psychotic Disorder|brief psychotic disorder
526372|NCT01321177|Psychotic Disorder NOS|psychotic disorder nos
526373|NCT01321177|First Episode|first episode
526374|NCT01321151|Mild Brain Injury|mild brain injury
526375|NCT01321151|Concussions|concussions
526376|NCT01321151|Resveratrol|resveratrol
526377|NCT01321151|Boxers|boxers
526378|NCT01321151|ImPACT|impact
526379|NCT01321151|MRI|mri
526380|NCT01321138|Electrophysiological study|electrophysiological study
526381|NCT01321138|Nerve block|nerve block
526382|NCT01321138|Analgesia, Patient-Controlled|analgesia, patient-controlled
526383|NCT01321138|Anterior cruciate ligament|anterior cruciate ligament
526384|NCT01321125|Antiseptics|antiseptics
526385|NCT01321125|Administration cutaneously|administration cutaneously
526386|NCT01321125|Chlorine compounds|chlorine compounds
526387|NCT01321125|Anti-infecting agents, local|anti-infecting agents, local
526388|NCT01321112|Conversion|conversion
526389|NCT01321112|Mycophenolate mofetil|mycophenolate mofetil
526390|NCT01321112|Calcineurin inhibitors|calcineurin inhibitors
526391|NCT01321112|Liver transplantation|liver transplantation
526392|NCT01321112|Gene expression|gene expression
526393|NCT01321099|Iron absorption|iron absorption
526394|NCT01321099|Complementary food fortificant|complementary food fortificant
526395|NCT01321099|Young children|young children
526396|NCT01321086|PAD|pad
526397|NCT01321060|severe acute pancreatitis|severe acute pancreatitis
526398|NCT01321060|acute fluid collection|acute fluid collection
526399|NCT01321060|catheter drainage|catheter drainage
526400|NCT01321060|repeated aspiration|repeated aspiration
526401|NCT01321047|sedation|sedation
526402|NCT01321047|benzodiazepine|benzodiazepine
526403|NCT01321047|opioid|opioid
526404|NCT01321047|propofol|propofol
526405|NCT01321034|Lipoprotein (a)|lipoprotein (a)
526406|NCT01321034|LPA|lpa
526407|NCT01321034|Niacin|niacin
526408|NCT01321034|Kringle IV-2 repeats|kringle iv-2 repeats
526409|NCT01321008|NK cell lymphoma-nasal type|nk cell lymphoma-nasal type
526410|NCT01321008|Stage I/II|stage i/ii
526411|NCT01321008|Radiation therapy|radiation therapy
526412|NCT01321008|XRT|xrt
526413|NCT01321008|chemotherapy|chemotherapy
526414|NCT01321008|CHOP|chop
526415|NCT01321008|Cyclophosphamide|cyclophosphamide
526416|NCT01321008|Cytoxan|cytoxan
526417|NCT01321008|Neosar|neosar
526418|NCT01321008|Adriamycin|adriamycin
526419|NCT01321008|Doxorubicin|doxorubicin
526420|NCT01321008|Rubex|rubex
526421|NCT01321008|Vincristine|vincristine
526422|NCT01321008|Oncovin|oncovin
526423|NCT01321008|Prednisone|prednisone
526424|NCT01320995|Second degree vaginal tear|second degree vaginal tear
526425|NCT01320995|Perineal ultrasound|perineal ultrasound
526426|NCT01320995|Anal incontinence|anal incontinence
526427|NCT01320982|Schizophrenia|schizophrenia
526428|NCT01320982|schizoaffective disorder|schizoaffective disorder
526429|NCT01320969|mindfulness, fear conditioning|mindfulness, fear conditioning
526430|NCT01320956|hypnosis|hypnosis
526431|NCT01320956|HYPNOANALGESIA|hypnoanalgesia
526432|NCT01320956|surgery|surgery
526433|NCT01320956|children|children
526434|NCT01320956|anxiety|anxiety
526435|NCT01320956|morphine|morphine
526436|NCT01320956|pain|pain
526437|NCT01320956|A-VAS|a-vas
526438|NCT01320956|orthopaedics|orthopaedics
526439|NCT01320956|osteotomy|osteotomy
526440|NCT01320956|tenotomy|tenotomy
526441|NCT01320956|arthrodesis|arthrodesis
526442|NCT01320956|spinal column surgery|spinal column surgery
526443|NCT01320943|stopping oral antiviral therapy|stopping oral antiviral therapy
526444|NCT01320943|HBsAg loss|hbsag loss
526445|NCT01320943|seroconversion|seroconversion
526446|NCT01320943|restarting oral antiviral therapy|restarting oral antiviral therapy
526447|NCT01320930|Effect of Pulmonary rehabilitation.|effect of pulmonary rehabilitation.
526448|NCT01320930|Exercise capacity|exercise capacity
526449|NCT01320930|Quality of life|quality of life
526450|NCT01320917|obesity|obesity
526451|NCT01320917|contraceptives hormonal|contraceptives hormonal
526452|NCT01320917|levonorgestrel-releasing intrauterine device|levonorgestrel-releasing intrauterine device
526453|NCT01320917|cardiovascular risk|cardiovascular risk
526454|NCT01320904|Closed Kinetic Chain|closed kinetic chain
526455|NCT01320904|NMES|nmes
526456|NCT01320904|Knee Osteoarthritis|knee osteoarthritis
526457|NCT01320891|general anaesthesia for major abdominal surgery|general anaesthesia for major abdominal surgery
526458|NCT01320878|pulmonary hypertension|pulmonary hypertension
526459|NCT01320852|Transplant|transplant
526460|NCT01320826|colonoscopy|colonoscopy
526461|NCT01320826|primary care physicians|primary care physicians
526462|NCT01320826|quality assurance|quality assurance
526463|NCT01320813|da vinci robot|da vinci robot
526464|NCT01320813|Thyroidectomy|thyroidectomy
526465|NCT01320787|Brain|brain
526466|NCT01320787|Adenocarcinoma of the prostate|adenocarcinoma of the prostate
526467|NCT01320787|Locally advanced breast cancer|locally advanced breast cancer
526468|NCT01320787|Estrogen receptor|estrogen receptor
526469|NCT01320787|ER|er
526470|NCT01320787|Progesterone receptor|progesterone receptor
526471|NCT01320787|PR|pr
526472|NCT01320787|Negative for ErbB2|negative for erbb2
526473|NCT01320787|Malignant tumor of the central nervous system|malignant tumor of the central nervous system
526474|NCT01320787|CNS|cns
526475|NCT01320761|Formulation Comparison|formulation comparison
526476|NCT01320748|Abstinence from alcohol|abstinence from alcohol
526477|NCT01320748|Substance Abuse and Mental Health Services|substance abuse and mental health services
526478|NCT01320748|Social Support|social support
526479|NCT01320748|Psychosocial Support Systems|psychosocial support systems
526480|NCT01320748|Psychological support|psychological support
526481|NCT01320748|Cognitive Support|cognitive support
526482|NCT01320748|Emotional Support|emotional support
526483|NCT01320748|Mental Support|mental support
526484|NCT01320748|Psychosocial Support|psychosocial support
526485|NCT01320748|Intervention Studies|intervention studies
526486|NCT01320748|Prevention & control|prevention & control
526487|NCT01320748|Preventive therapy|preventive therapy
526488|NCT01320748|Treatment|treatment
526489|NCT01320748|Therapy|therapy
526490|NCT01320748|Magnetic Resonance Imaging|magnetic resonance imaging
526491|NCT01320748|fMRI|fmri
526492|NCT01320748|Imaging|imaging
526493|NCT01320748|Magnetic Resonance Imaging, Functional|magnetic resonance imaging, functional
526494|NCT01320748|MRI Scans|mri scans
526495|NCT01320748|MRI, Functional|mri, functional
526496|NCT01320748|Clinical Protocols|clinical protocols
526497|NCT01320748|Protocols, Treatment|protocols, treatment
526498|NCT01320748|Drug Abuse Treatment Center|drug abuse treatment center
526499|NCT01320748|Substance Abuse Treatment Center|substance abuse treatment center
526500|NCT01320735|Lucrin Depot|lucrin depot
526501|NCT01320735|intermittent adjuvant regimen|intermittent adjuvant regimen
526502|NCT01320735|advanced prostate cancer|advanced prostate cancer
526503|NCT01320735|Leuprorelin|leuprorelin
526504|NCT01320722|renin angiotensin system|renin angiotensin system
526505|NCT01320722|vitamin D|vitamin d
526506|NCT01320722|uric acid|uric acid
526507|NCT01320722|allopurinol|allopurinol
526508|NCT01320722|probenecid|probenecid
526509|NCT01320722|endothelial function|endothelial function
526510|NCT01320709|Emergency contraception|emergency contraception
526511|NCT01320709|Contraception|contraception
526512|NCT01320670|pharmacoresistance|pharmacoresistance
526513|NCT01320657|Self-ligating|self-ligating
526514|NCT01320657|orthodontic|orthodontic
526515|NCT01320657|appliance|appliance
526516|NCT01320657|expansion|expansion
526517|NCT01320657|dental inclination|dental inclination
526518|NCT01320657|Expansion and inclination changes arising with orthodontic treatment|expansion and inclination changes arising with orthodontic treatment
526519|NCT01320644|Uterine prolapse|uterine prolapse
526520|NCT01320644|vaginal prolapse|vaginal prolapse
526521|NCT01320644|mesh erosion|mesh erosion
526522|NCT01320644|urinary incontinence|urinary incontinence
526523|NCT01320644|bowel symptoms|bowel symptoms
526524|NCT01320631|uterine prolapse|uterine prolapse
526525|NCT01320631|vaginal prolapse|vaginal prolapse
526526|NCT01320618|uterine prolapse|uterine prolapse
526527|NCT01320618|vaginal prolapse|vaginal prolapse
526528|NCT01320618|mesh erosion|mesh erosion
526529|NCT01320618|urinary incontinence|urinary incontinence
526530|NCT01320618|bowel symptoms|bowel symptoms
526531|NCT01320592|Patient must have histologically or cytologically-confirmed metastatic|patient must have histologically or cytologically-confirmed metastatic
526532|NCT01320592|breast cancer|breast cancer
526533|NCT01320592|Any ER, PR or Her2 status is allowed.|any er, pr or her2 status is allowed.
526534|NCT01320592|Tumor must express Retinoblastoma (Rb) protein, defined as|tumor must express retinoblastoma (rb) protein, defined as
526535|NCT01320592|any measurable staining by immunohistochemistry on the invasive tumor component|any measurable staining by immunohistochemistry on the invasive tumor component
526536|NCT01320592|<3 prior cyttoxic chemotherapy regimens for metastatic disease.|<3 prior cyttoxic chemotherapy regimens for metastatic disease.
526537|NCT01320592|Performance status of 0-1 on the ECOG Performance Scale and life expectancy > 3 months.|performance status of 0-1 on the ecog performance scale and life expectancy > 3 months.
526538|NCT01320592|Patient must have evaluable disease. Measureable disease is not required.|patient must have evaluable disease. measureable disease is not required.
526539|NCT01320592|The subject has adequate organ function|the subject has adequate organ function
526540|NCT01320579|atopic dermatitis|atopic dermatitis
526541|NCT01320579|cis-urocanic acid|cis-urocanic acid
526542|NCT01320566|Polymeric Lung Volume Reduction (PLVR)|polymeric lung volume reduction (plvr)
526543|NCT01320566|Bolilogic Lung Volume Reduction (BLVR)|bolilogic lung volume reduction (blvr)
526544|NCT01320566|AeriSeal|aeriseal
526545|NCT01320566|treatment|treatment
526546|NCT01320566|device|device
526547|NCT01320566|breathing|breathing
526548|NCT01320566|COPD|copd
526549|NCT01320566|emphysema|emphysema
526550|NCT01320566|heterogeneous|heterogeneous
526551|NCT01320566|homogeneous|homogeneous
526552|NCT01320566|Pathologic Processes|pathologic processes
526553|NCT01320566|Respiratory Tract Diseases|respiratory tract diseases
526554|NCT01320566|Lung Diseases|lung diseases
526555|NCT01320566|Pulmonary Disease, Chronic Obstructive|pulmonary disease, chronic obstructive
526556|NCT01320527|dietary supplement|dietary supplement
526557|NCT01320527|cognition|cognition
526558|NCT01320527|mood|mood
526559|NCT01320527|Alzheimer's disease|alzheimer's disease
526560|NCT01320527|memory loss|memory loss
526561|NCT01320501|Lung Cancer|lung cancer
526562|NCT01320488|Breast Cancer|breast cancer
526563|NCT01320475|thoracic epidural analgesia|thoracic epidural analgesia
526564|NCT01320475|epidural opioid|epidural opioid
526565|NCT01320475|ketamine|ketamine
526566|NCT01320475|adverse effect|adverse effect
526567|NCT01320462|Smoking|smoking
526568|NCT01320462|quit|quit
526569|NCT01320462|surgery|surgery
526570|NCT01320462|anesthesia|anesthesia
526571|NCT01320462|champix|champix
526572|NCT01320449|EPO|epo
526573|NCT01320449|Proteomics|proteomics
526574|NCT01320449|Carbohydrate metabolism|carbohydrate metabolism
526575|NCT01320449|Fat metabolism|fat metabolism
526576|NCT01320449|Protein metabolism|protein metabolism
526577|NCT01320436|Ulcerative colitis|ulcerative colitis
526578|NCT01320436|Curcumin|curcumin
526579|NCT01320423|Intracerebral Haemorrhage|intracerebral haemorrhage
526580|NCT01320384|ALI|ali
526581|NCT01320371|barbed sutures|barbed sutures
526582|NCT01320371|knotted sutures|knotted sutures
526583|NCT01320371|total knee arthroplasty|total knee arthroplasty
526584|NCT01320371|knee surgery|knee surgery
526585|NCT01320358|Patient compliance|patient compliance
526586|NCT01320358|ECMPS-IEM|ecmps-iem
526587|NCT01320358|transplantation|transplantation
526588|NCT01320358|renal maintenance|renal maintenance
526589|NCT01320358|Proteus|proteus
526590|NCT01320345|Diabetes Mellitus|diabetes mellitus
526591|NCT01320345|Type 1 Diabetes Mellitus|type 1 diabetes mellitus
526592|NCT01320345|Retinopathy|retinopathy
526593|NCT01320345|Diabetic Nephropathy|diabetic nephropathy
526594|NCT01320345|Fenofibrate|fenofibrate
526595|NCT01320332|Ulcerative colitis|ulcerative colitis
526596|NCT01320332|ASP3291|asp3291
526597|NCT01320293|Moderate to Severe Chronic plaque type psoriasis|moderate to severe chronic plaque type psoriasis
526598|NCT01320280|Prostate cancer, BIBW 2992 (Afatinib) , HER inhibitor|prostate cancer, bibw 2992 (afatinib) , her inhibitor
526599|NCT01320267|Resectable right colon cancer|resectable right colon cancer
526600|NCT01320254|Palliative treatment|palliative treatment
526601|NCT01320254|Panitumumab|panitumumab
526602|NCT01320254|Cisplatin|cisplatin
526603|NCT01320254|Cisplatinum|cisplatinum
526604|NCT01320254|Gemcitabine|gemcitabine
526605|NCT01320254|Vectibix|vectibix
526606|NCT01320228|Obesity|obesity
526607|NCT01320228|orlistat|orlistat
526608|NCT01320228|fat excretion|fat excretion
526609|NCT01320228|fiber|fiber
526610|NCT01320228|dairy calcium|dairy calcium
526611|NCT01320215|da Vinci Robot|da vinci robot
526612|NCT01320215|uterine prolapse|uterine prolapse
526613|NCT01320215|vaginal prolapse|vaginal prolapse
526614|NCT01320215|sacrohysteropexy|sacrohysteropexy
526615|NCT01320202|End Stage Renal Disease|end stage renal disease
526616|NCT01320202|Hemodialysis|hemodialysis
526617|NCT01320202|SFP|sfp
526618|NCT01320202|Hemodialysis-dependent chronic renal failure|hemodialysis-dependent chronic renal failure
526619|NCT01320189|Energy intake|energy intake
526620|NCT01320189|Protein requirement|protein requirement
526621|NCT01320189|Satiety|satiety
526622|NCT01320189|Protein leverage hypothesis|protein leverage hypothesis
526623|NCT01320150|persistent postsurgical pain (PPP)|persistent postsurgical pain (ppp)
526624|NCT01320137|Immunological assay|immunological assay
526625|NCT01320137|Birch allergy|birch allergy
526626|NCT01320124|Contractures|contractures
526627|NCT01320124|Total knee arthroplasty|total knee arthroplasty
526628|NCT01320124|Tissue bank|tissue bank
526629|NCT01320124|Osteoarthritis|osteoarthritis
526630|NCT01320124|Gene expressions|gene expressions
526631|NCT01320111|progression free survival|progression free survival
526632|NCT01320111|paclitaxel|paclitaxel
526633|NCT01320111|sorafenib|sorafenib
526634|NCT01320111|metastatic breast cancer|metastatic breast cancer
526635|NCT01320098|Attention|attention
526636|NCT01320098|Behavior Problems|behavior problems
526637|NCT01320098|Compliance|compliance
526638|NCT01320098|Evaluation|evaluation
526639|NCT01320098|Preschool|preschool
526640|NCT01320098|ADHD|adhd
526641|NCT01320098|Overactive|overactive
526642|NCT01320098|Inattentive|inattentive
526643|NCT01320098|Attention Deficit Hyperactivity Disorder in Preschoolers|attention deficit hyperactivity disorder in preschoolers
526644|NCT01320085|Metastatic melanoma,|metastatic melanoma,
526645|NCT01320085|BRAF-mutant,|braf-mutant,
526646|NCT01320085|NRAS-mutant|nras-mutant
526647|NCT01320072|aspirin|aspirin
526648|NCT01320072|asthma|asthma
526649|NCT01320072|diagnosis|diagnosis
526650|NCT01320072|prostaglandins|prostaglandins
526651|NCT01320072|leukotrienes|leukotrienes
526652|NCT01320059|18F-Fluoro-PEG6-IPQA|18f-fluoro-peg6-ipqa
526653|NCT01320059|Radioactive Imaging Solution|radioactive imaging solution
526654|NCT01320059|Non-Small Cell Lung Cancer|non-small cell lung cancer
526655|NCT01320059|Positron Emission Tomography|positron emission tomography
526656|NCT01320059|PET Scan|pet scan
526657|NCT01320059|CT|ct
526658|NCT01320059|Computed Tomography|computed tomography
526659|NCT01320046|Urinary Incontinence|urinary incontinence
526660|NCT01320046|Vulvar pruritus|vulvar pruritus
526661|NCT01320046|Vulvar contact dermatitis|vulvar contact dermatitis
526662|NCT01320033|acne vulgaris|acne vulgaris
526663|NCT01320033|inflammatory lesions|inflammatory lesions
526664|NCT01320020|Cancer|cancer
526665|NCT01320020|Neoplasm|neoplasm
526666|NCT01320020|Carcinoma|carcinoma
526667|NCT01320020|intravenous|intravenous
526668|NCT01320020|Monoclonal Antibody|monoclonal antibody
526669|NCT01320020|Removab|removab
526670|NCT01319994|glucocorticoid|glucocorticoid
526671|NCT01319981|Acute Lymphoblastic Leukemia|acute lymphoblastic leukemia
526672|NCT01319981|ALL|all
526673|NCT01319981|Lymphoblastic lymphoma|lymphoblastic lymphoma
526674|NCT01319981|Cytoxan|cytoxan
526675|NCT01319981|Neosar|neosar
526676|NCT01319981|Mesnex|mesnex
526677|NCT01319981|Liposomal Vincristine|liposomal vincristine
526678|NCT01319981|Vincristine Sulfate Liposomes Injection|vincristine sulfate liposomes injection
526679|NCT01319981|Marqibo|marqibo
526680|NCT01319981|Dexamethasone|dexamethasone
526681|NCT01319981|Adriamycin|adriamycin
526682|NCT01319981|Rubex|rubex
526683|NCT01319981|Cytarabine|cytarabine
526684|NCT01319981|Cytosar|cytosar
526685|NCT01319981|DepoCyt|depocyt
526686|NCT01319981|Cytosine Arabinosine Hydrochloride|cytosine arabinosine hydrochloride
526687|NCT01319981|Imatinib Mesylate|imatinib mesylate
526688|NCT01319981|Gleevec|gleevec
526689|NCT01319981|ST1571|st1571
526690|NCT01319981|NSC-716051|nsc-716051
526691|NCT01319981|Filgrastim|filgrastim
526692|NCT01319981|Neupogen|neupogen
526693|NCT01319968|Postpartum dyspareunia|postpartum dyspareunia
526694|NCT01319968|Vaginal atrophy|vaginal atrophy
526695|NCT01319955|Pneumonia|pneumonia
526696|NCT01319955|Influenza|influenza
526697|NCT01319955|Child|child
526698|NCT01319955|Respiratory|respiratory
526699|NCT01319955|Pathogen|pathogen
526700|NCT01319942|Radiotherapy|radiotherapy
526701|NCT01319942|Sorafenib|sorafenib
526702|NCT01319942|Treatment outcome|treatment outcome
526703|NCT01319929|Osteoarthritis, knee pain, osteoarthritic knee pain|osteoarthritis, knee pain, osteoarthritic knee pain
526704|NCT01319903|sepsis|sepsis
526705|NCT01319903|inflammation|inflammation
526706|NCT01319903|complement|complement
526707|NCT01319903|immune system|immune system
526708|NCT01319890|all histologic subtypes|all histologic subtypes
526709|NCT01319890|benign|benign
526710|NCT01319890|malignant|malignant
526711|NCT01319864|leukemia|leukemia
526712|NCT01319851|bone marrow transplant|bone marrow transplant
526713|NCT01319851|sickle cell disease|sickle cell disease
526714|NCT01319851|thalassemia|thalassemia
526715|NCT01319851|Glanzmann thrombasthenia|glanzmann thrombasthenia
526716|NCT01319851|Wiskott-Aldrich syndrome|wiskott-aldrich syndrome
526717|NCT01319851|chronic-granulomatous disease|chronic-granulomatous disease
526718|NCT01319851|severe congenital neutropenia|severe congenital neutropenia
526719|NCT01319851|leukocyte adhesion deficiency|leukocyte adhesion deficiency
526720|NCT01319851|Schwachman-Diamond syndrome|schwachman-diamond syndrome
526721|NCT01319851|Diamond-Blackfan anemia|diamond-blackfan anemia
526722|NCT01319851|Fanconi anemia|fanconi anemia
526723|NCT01319851|dyskeratosis-congenita|dyskeratosis-congenita
526724|NCT01319851|Chediak-Higashi syndrome|chediak-higashi syndrome
526725|NCT01319851|severe aplastic anemia|severe aplastic anemia
526726|NCT01319838|neuroblastoma|neuroblastoma
526727|NCT01319838|isotretinoin|isotretinoin
526728|NCT01319812|Vascular intervention|vascular intervention
526729|NCT01319812|Endovascular|endovascular
526730|NCT01319812|Peripheral stent|peripheral stent
526731|NCT01319799|Embolism|embolism
526732|NCT01319799|Nervous system|nervous system
526733|NCT01319799|Aorta|aorta
526734|NCT01319799|Valves|valves
526735|NCT01319799|Ultrasonics|ultrasonics
526736|NCT01319786|Hypertension|hypertension
526737|NCT01319786|Microvascular function|microvascular function
526738|NCT01319760|STEMI|stemi
526739|NCT01319747|atrial|atrial
526740|NCT01319747|fibrillation|fibrillation
526741|NCT01319747|pvi|pvi
526742|NCT01319747|vats|vats
526743|NCT01319747|ablation|ablation
526744|NCT01319734|Vitamin C|vitamin c
526745|NCT01319734|Oxidative stress|oxidative stress
526746|NCT01319734|Type 2DM|type 2dm
526747|NCT01319721|Amniotic membrane|amniotic membrane
526748|NCT01319721|Limbal conjunctival autograft|limbal conjunctival autograft
526749|NCT01319721|Limbal|limbal
526750|NCT01319721|Conjunctival|conjunctival
526751|NCT01319721|Mitomycin C|mitomycin c
526752|NCT01319721|Recurrent pterygium|recurrent pterygium
526753|NCT01319721|Pterygium|pterygium
526754|NCT01319708|ovarian stimulation|ovarian stimulation
526755|NCT01319708|climiphene citrate|climiphene citrate
526756|NCT01319708|Gonadotropin-Releasing Hormone agonists/antagonists|gonadotropin-releasing hormone agonists/antagonists
526757|NCT01319708|Follicle Stimulating Hormone|follicle stimulating hormone
526758|NCT01319695|corifollitropin alfa|corifollitropin alfa
526759|NCT01319695|FSH ovarian stimulation|fsh ovarian stimulation
526760|NCT01319695|IVF|ivf
526761|NCT01319682|Pain|pain
526762|NCT01319682|Preemptive|preemptive
526763|NCT01319682|Lidocaine|lidocaine
526764|NCT01319682|Intravenous|intravenous
526765|NCT01319682|Lumbar fusion|lumbar fusion
526766|NCT01319656|Chronic diseases|chronic diseases
526767|NCT01319656|Primary care|primary care
526768|NCT01319656|Rehabilitation|rehabilitation
526769|NCT01319656|Chronic Care Model|chronic care model
526770|NCT01319656|Patient centered medical home|patient centered medical home
526771|NCT01319643|Oxygen|oxygen
526772|NCT01319643|Hyperoxia|hyperoxia
526773|NCT01319643|Intensive care unit|intensive care unit
526774|NCT01319643|Mortality|mortality
526775|NCT01319643|Organ dysfunction|organ dysfunction
526776|NCT01319643|Postoperative care|postoperative care
526777|NCT01319630|sepsis|sepsis
526778|NCT01319630|microcirculation|microcirculation
526779|NCT01319630|saline|saline
526780|NCT01319630|crystalloid|crystalloid
526781|NCT01319630|colloid|colloid
526782|NCT01319630|albumin|albumin
526783|NCT01319630|hydroxyethyl starch|hydroxyethyl starch
526784|NCT01319578|chronic kidney disease|chronic kidney disease
526785|NCT01319578|phosphorus|phosphorus
526786|NCT01319578|phosphate|phosphate
526787|NCT01319578|saliva|saliva
526788|NCT01319578|K2CG|k2cg
526789|NCT01319578|medical food|medical food
526790|NCT01319578|chitosan|chitosan
526791|NCT01319565|Young TIL|young til
526792|NCT01319565|Metastatic Melanoma|metastatic melanoma
526793|NCT01319565|Immunotherapy|immunotherapy
526794|NCT01319565|Adoptive Cell Therapy|adoptive cell therapy
526795|NCT01319565|Skin Cancer|skin cancer
526796|NCT01319552|red blood cells|red blood cells
526797|NCT01319552|transfusion|transfusion
526798|NCT01319552|storage|storage
526799|NCT01319552|sickle cell disease|sickle cell disease
526800|NCT01319552|β-thalassemia|β-thalassemia
526801|NCT01319552|hemoglobin-associated iron|hemoglobin-associated iron
526802|NCT01319526|stage III adult Hodgkin lymphoma|stage iii adult hodgkin lymphoma
526803|NCT01319526|stage IV adult Hodgkin lymphoma|stage iv adult hodgkin lymphoma
526804|NCT01319526|HIV infection|hiv infection
526805|NCT01319500|Drug Utilization|drug utilization
526806|NCT01319500|Oral Contraceptives|oral contraceptives
526807|NCT01319474|Deep vein thrombosis|deep vein thrombosis
526808|NCT01319474|Pulmonary embolism|pulmonary embolism
526809|NCT01319474|Ultrasound|ultrasound
526810|NCT01319474|Pregnancy|pregnancy
526811|NCT01319461|Osteoarthritis|osteoarthritis
526812|NCT01319461|Hyalgan|hyalgan
526813|NCT01319448|Sickle cell disease|sickle cell disease
526814|NCT01319448|Malaria|malaria
526815|NCT01319448|Intermittent Preventive Treatment (IPT)|intermittent preventive treatment (ipt)
526816|NCT01319448|prophylaxis|prophylaxis
526817|NCT01319435|Ciprofloxacin|ciprofloxacin
526818|NCT01319435|Neonates|neonates
526819|NCT01319435|Gram negative infection|gram negative infection
526820|NCT01319422|myeloma|myeloma
526821|NCT01319422|multiple myeloma|multiple myeloma
526822|NCT01319422|pomalidomide|pomalidomide
526823|NCT01319422|immunomodulatory|immunomodulatory
526824|NCT01319409|Anterior cruciate ligament surgery|anterior cruciate ligament surgery
526825|NCT01319409|Anterior cruciate ligament reconstruction|anterior cruciate ligament reconstruction
526826|NCT01319409|Single bundle anterior cruciate ligament reconstruction|single bundle anterior cruciate ligament reconstruction
526827|NCT01319409|Double bundle anterior cruciate ligament reconstruction|double bundle anterior cruciate ligament reconstruction
526828|NCT01319409|Randomized clinical trial|randomized clinical trial
526829|NCT01319396|breathing rate|breathing rate
526830|NCT01319383|HIV-1 Infection|hiv-1 infection
526831|NCT01319383|HIV RNA <50 copies/mL|hiv rna <50 copies/ml
526832|NCT01319383|Stable ART|stable art
526833|NCT01319383|Resting CD4+ T cells|resting cd4+ t cells
526834|NCT01319383|Leukapheresis|leukapheresis
526835|NCT01319383|Vorinostat|vorinostat
526836|NCT01319383|HIV RNA expression|hiv rna expression
526837|NCT01319383|PK visits|pk visits
526838|NCT01319331|diabetes|diabetes
526839|NCT01319331|type 1 diabetes|type 1 diabetes
526840|NCT01319331|AAT|aat
526841|NCT01319331|Alpha-1 Antitrypsin|alpha-1 antitrypsin
526842|NCT01319279|Pharmacokinetics|pharmacokinetics
526843|NCT01319279|Hydrocodone|hydrocodone
526844|NCT01319279|Extended Release|extended release
526845|NCT01319279|Hepatic impairment|hepatic impairment
526846|NCT01319266|hydrocodone|hydrocodone
526847|NCT01319266|extended release|extended release
526848|NCT01319266|pharmacokinetics|pharmacokinetics
526849|NCT01319266|renal impairment|renal impairment
526850|NCT01319253|Cystic Fibrosis|cystic fibrosis
526851|NCT01319253|Pseudomonas aeruginosa|pseudomonas aeruginosa
526852|NCT01319227|Periprosthetic bone remodeling|periprosthetic bone remodeling
526853|NCT01319227|Stress shielding|stress shielding
526854|NCT01319227|Short femoral stem|short femoral stem
526855|NCT01319227|Porous Titanium Construct|porous titanium construct
526856|NCT01319227|Polyethylene wear|polyethylene wear
526857|NCT01319214|cocaine addiction treatment craving|cocaine addiction treatment craving
526858|NCT01319188|Age-related macular degeneration|age-related macular degeneration
526859|NCT01319188|ranibizumab|ranibizumab
526860|NCT01319188|acute thromboembolic events|acute thromboembolic events
526861|NCT01319188|coronary artery disease|coronary artery disease
526862|NCT01319188|cerebrovascular disease|cerebrovascular disease
526863|NCT01319175|hip flexion strength training|hip flexion strength training
526864|NCT01319175|elastic bands|elastic bands
526865|NCT01319175|external resistance|external resistance
526866|NCT01319162|PCOS|pcos
526867|NCT01319149|molecular methods|molecular methods
526868|NCT01319136|new infusion test method|new infusion test method
526869|NCT01319136|reference method|reference method
526870|NCT01319136|cerebrospinal fluid dynamics|cerebrospinal fluid dynamics
526871|NCT01319123|dressing for venous leg ulcers|dressing for venous leg ulcers
526872|NCT01319110|Cardiac Arrest|cardiac arrest
526873|NCT01319110|Post Cardiac Arrest|post cardiac arrest
526874|NCT01319110|CoQ10|coq10
526875|NCT01319110|Ubiquinone|ubiquinone
526876|NCT01319110|Post Arrest|post arrest
526877|NCT01319097|Reduction on local soft tissue edema|reduction on local soft tissue edema
526878|NCT01319058|obstructive sleep apnea|obstructive sleep apnea
526879|NCT01319058|Tonsillectomy|tonsillectomy
526880|NCT01319058|Tonsillotomy|tonsillotomy
526881|NCT01319058|Inflammation|inflammation
526882|NCT01319058|Pain|pain
526883|NCT01319058|Post tonsillectomy bleeding|post tonsillectomy bleeding
526884|NCT01319045|Pulmonary Arterial Hypertension|pulmonary arterial hypertension
526885|NCT01319045|Congenital Heart Disease|congenital heart disease
526886|NCT01319045|Eisenmenger's Syndrome|eisenmenger's syndrome
526887|NCT01319045|Prostacyclin|prostacyclin
526888|NCT01319045|Iloprost|iloprost
526889|NCT01319019|lung function|lung function
526890|NCT01319019|bronchodilator|bronchodilator
526891|NCT01319019|COPD, dose response, dosing interval, efficacy, safety, PD, PK|copd, dose response, dosing interval, efficacy, safety, pd, pk
526892|NCT01319006|relative bioavailability|relative bioavailability
526893|NCT01318993|GSK1605786A; Inflammatory Bowel Disease; Crohn's disease; long-term treatment; quality of life; CCR9 antagonist|gsk1605786a; inflammatory bowel disease; crohn's disease; long-term treatment; quality of life; ccr9 antagonist
526894|NCT01318980|ADME|adme
526895|NCT01318980|IV radiolabelled|iv radiolabelled
526896|NCT01318980|pharmacokinetics|pharmacokinetics
526897|NCT01318967|Renal blood flow|renal blood flow
526898|NCT01318967|Regional renal blood flow|regional renal blood flow
526900|NCT01318941|Ophthalmology, age-related macular degeneration, Diabetic Macular Edema, Retinal Vein Occlusion, ranibizumab|ophthalmology, age-related macular degeneration, diabetic macular edema, retinal vein occlusion, ranibizumab
526901|NCT01318941|Ophthalmology|ophthalmology
526902|NCT01318941|Age-related macular degeneration|age-related macular degeneration
526903|NCT01318941|Diabetic Macular Edema|diabetic macular edema
526904|NCT01318941|Retinal Vein Occlusion|retinal vein occlusion
526905|NCT01318941|LUMINOUS|luminous
526906|NCT01318941|Ranibizumab|ranibizumab
526907|NCT01318928|Periodontitis|periodontitis
526908|NCT01318928|antibiotics|antibiotics
526909|NCT01318928|treatment period|treatment period
526910|NCT01318928|microbiology|microbiology
526911|NCT01318915|Kidney transplantation|kidney transplantation
526912|NCT01318915|Living donor transplant|living donor transplant
526913|NCT01318915|Graft rejection|graft rejection
526914|NCT01318915|Graft loss|graft loss
526915|NCT01318915|Induction with rituximab and ATG|induction with rituximab and atg
526916|NCT01318915|Immunosuppression (IS)|immunosuppression (is)
526917|NCT01318889|Dexpanthenol|dexpanthenol
526918|NCT01318889|Radiotherapy|radiotherapy
526919|NCT01318889|chemotherapy|chemotherapy
526920|NCT01318889|Mucositis|mucositis
526921|NCT01318876|influenza|influenza
526922|NCT01318876|vaccine safety|vaccine safety
526923|NCT01318876|adverse events|adverse events
526924|NCT01318876|health care workers|health care workers
526925|NCT01318863|aged matched normal control samples|aged matched normal control samples
526926|NCT01318850|schizophrenia|schizophrenia
526927|NCT01318850|cognitive remediation|cognitive remediation
526928|NCT01318850|fMRI|fmri
526929|NCT01318837|OABSS|oabss
526930|NCT01318837|IPSS|ipss
526931|NCT01318837|PPBC|ppbc
526932|NCT01318837|Solifenacin|solifenacin
526933|NCT01318824|Neonatal Respiratory Failure|neonatal respiratory failure
526934|NCT01318824|Newborn Infant|newborn infant
526935|NCT01318824|BiPAP|bipap
526936|NCT01318824|NIPPV|nippv
526937|NCT01318811|Heparin|heparin
526938|NCT01318811|CRRT|crrt
526939|NCT01318811|Continuous renal replacement therapy|continuous renal replacement therapy
526940|NCT01318811|CVVHD|cvvhd
526941|NCT01318811|Anticoagulation|anticoagulation
526942|NCT01318798|Development|development
526943|NCT01318798|Pre- and intra-operative predictors|pre- and intra-operative predictors
526944|NCT01318798|Acute renal failure|acute renal failure
526945|NCT01318798|Liver Surgery|liver surgery
526946|NCT01318798|Prediction score|prediction score
526947|NCT01318798|Validation|validation
526948|NCT01318798|Clinical consequences|clinical consequences
526949|NCT01318798|Decision curve analysis|decision curve analysis
526950|NCT01318798|predictors of acute renal failure after liver resection|predictors of acute renal failure after liver resection
526951|NCT01318785|secondary arm-lymphedema|secondary arm-lymphedema
526952|NCT01318785|breast cancer related arm-lymphedema|breast cancer related arm-lymphedema
526953|NCT01318746|change of potassium amount, circadian and day-to-day variability|change of potassium amount, circadian and day-to-day variability
526954|NCT01318733|Rosacea|rosacea
526955|NCT01318720|Neck Pain|neck pain
526956|NCT01318720|Thrust Manipulation|thrust manipulation
526957|NCT01318720|Non-Thrust Manipulation|non-thrust manipulation
526958|NCT01318707|Severe Hemophilia A|severe hemophilia a
526959|NCT01318707|Hemophilia A Patients|hemophilia a patients
526960|NCT01318707|Serum collection vs a method of added FVIII to blood samples|serum collection vs a method of added fviii to blood samples
526961|NCT01318694|Chronic hepatitis C|chronic hepatitis c
526962|NCT01318694|Cyclophilin inhibitor|cyclophilin inhibitor
526963|NCT01318681|driving, memory, cognition|driving, memory, cognition
526964|NCT01318668|fmri smoking vaccination mood|fmri smoking vaccination mood
526965|NCT01318655|Phase I|phase i
526966|NCT01318655|Japan|japan
526967|NCT01318655|SAD|sad
526968|NCT01318655|MAD|mad
526969|NCT01318642|Adenocarcinoma|adenocarcinoma
526970|NCT01318642|pancreas|pancreas
526971|NCT01318642|pancreatic cancer|pancreatic cancer
526972|NCT01318642|local|local
526973|NCT01318642|unresectable|unresectable
526974|NCT01318642|stage II|stage ii
526975|NCT01318642|stage III|stage iii
526976|NCT01318616|hip adduction strength training|hip adduction strength training
526977|NCT01318616|Improvement in adductor strength|improvement in adductor strength
526978|NCT01318590|Pancreatitis, Chronic|pancreatitis, chronic
526979|NCT01318590|Abdominal Pain|abdominal pain
526980|NCT01318590|Celiac bloc|celiac bloc
526981|NCT01318590|Endosonography|endosonography
526982|NCT01318564|Type II Diabetes|type ii diabetes
526983|NCT01318564|Unit dose packaging devices|unit dose packaging devices
526984|NCT01318564|Metformin|metformin
526985|NCT01318564|Lisinopril|lisinopril
526986|NCT01318564|Enalapril|enalapril
526987|NCT01318564|Atorvastatin|atorvastatin
526988|NCT01318564|Lipitor|lipitor
526989|NCT01318564|Simvastatin|simvastatin
526990|NCT01318564|Aspirin|aspirin
526991|NCT01318564|Questionnaires|questionnaires
526992|NCT01318551|Anemia|anemia
526993|NCT01318538|Substance use disorders, Gender differences, women, treatment outcomes, group therapy|substance use disorders, gender differences, women, treatment outcomes, group therapy
526994|NCT01318499|cataract|cataract
526995|NCT01318499|inflammation|inflammation
526996|NCT01318499|pain|pain
526997|NCT01318499|inflammatory cells|inflammatory cells
526998|NCT01318499|aqueous flare|aqueous flare
526999|NCT01318473|cancer|cancer
527000|NCT01318460|coronary artery disease|coronary artery disease
527001|NCT01318460|levosimendan|levosimendan
527002|NCT01318460|coronary artery bypass grafting|coronary artery bypass grafting
527003|NCT01318460|cardiac surgery|cardiac surgery
527004|NCT01318447|Hepatic metastases|hepatic metastases
527005|NCT01318447|Liver metastases|liver metastases
527006|NCT01318447|Colorectal cancer|colorectal cancer
527007|NCT01318447|Colorectal adenocarcinoma|colorectal adenocarcinoma
527008|NCT01318447|Accuray|accuray
527009|NCT01318447|CyberKnife|cyberknife
527010|NCT01318434|Outpatient|outpatient
527011|NCT01318421|Relapsing forms of secondary progressive multiple sclerosis (SPMS)or relapsing-remitting multiple sclerosis (RRMS)|relapsing forms of secondary progressive multiple sclerosis (spms)or relapsing-remitting multiple sclerosis (rrms)
527012|NCT01318356|Q fever|q fever
527013|NCT01318356|Cognitive behavioral therapy|cognitive behavioral therapy
527014|NCT01318356|Doxycycline|doxycycline
527015|NCT01318356|Fatigue|fatigue
527016|NCT01318356|Coxiella|coxiella
527017|NCT01318343|Cryolipolysis|cryolipolysis
527018|NCT01318343|Abdominal Fat|abdominal fat
527019|NCT01318343|Adipose Tissue|adipose tissue
527020|NCT01318343|Fat Reduction|fat reduction
527021|NCT01318343|Non Invasive|non invasive
527022|NCT01318304|innate immunity|innate immunity
527023|NCT01318304|HIV|hiv
527024|NCT01318304|pregnancy|pregnancy
527025|NCT01318304|vaginal immunity|vaginal immunity
527026|NCT01318291|IVF|ivf
527027|NCT01318291|Drop out|drop out
527028|NCT01318278|Hypotension|hypotension
527029|NCT01318278|Low blood pressure|low blood pressure
527030|NCT01318278|Neonate|neonate
527031|NCT01318278|Dopamine|dopamine
527032|NCT01318278|Vasopressin|vasopressin
527033|NCT01318278|Extremely Low Birth Weight Infant|extremely low birth weight infant
527034|NCT01318265|drug interactions|drug interactions
527035|NCT01318265|ketoconazole|ketoconazole
527036|NCT01318265|pharmacokinetics|pharmacokinetics
527037|NCT01318265|human volunteers|human volunteers
527038|NCT01318252|Elevated IOP|elevated iop
527039|NCT01318226|postherpetic neuralgia|postherpetic neuralgia
527040|NCT01318226|shingles|shingles
527041|NCT01318226|analgesia|analgesia
527042|NCT01318226|neuropathic pain|neuropathic pain
527043|NCT01318213|VRE|vre
527044|NCT01318213|MRSA|mrsa
527045|NCT01318200|Primary liver cancer|primary liver cancer
527046|NCT01318200|Hepatocellular carcinoma|hepatocellular carcinoma
527047|NCT01318200|CyberKnife|cyberknife
527048|NCT01318200|Accuray|accuray
527049|NCT01318200|TACE|tace
527050|NCT01318200|Transarterial chemoembolization|transarterial chemoembolization
527051|NCT01318187|renal colic|renal colic
527052|NCT01318187|paracetamol|paracetamol
527053|NCT01318187|morphine|morphine
527054|NCT01318187|emergency department|emergency department
527055|NCT01318174|Pulmonary embolism|pulmonary embolism
527056|NCT01318174|Pulmonary Disease, Chronic Obstructive|pulmonary disease, chronic obstructive
527057|NCT01318161|Epidural analgesia|epidural analgesia
527058|NCT01318161|Patient controlled analgesia|patient controlled analgesia
527059|NCT01318161|Colorectal cancer|colorectal cancer
527060|NCT01318161|Morbidity|morbidity
527061|NCT01318161|Mortality|mortality
527062|NCT01318148|Echinocandins|echinocandins
527063|NCT01318148|Caspofungin|caspofungin
527064|NCT01318148|Pharmacokinetics|pharmacokinetics
527065|NCT01318148|Prophylaxis|prophylaxis
527066|NCT01318148|Antifungal|antifungal
527067|NCT01318148|Aspergillosis|aspergillosis
527068|NCT01318148|Acute Leucemia|acute leucemia
527069|NCT01318135|Diabetes Mellitus - Type 2|diabetes mellitus - type 2
527070|NCT01318135|Diabetes Mellitus|diabetes mellitus
527071|NCT01318135|Drug Therapy|drug therapy
527072|NCT01318122|Diabetes Mellitus - Type 2|diabetes mellitus - type 2
527073|NCT01318122|Diabetes Mellitus|diabetes mellitus
527074|NCT01318122|Drug Therapy|drug therapy
527075|NCT01318109|Diabetes Mellitus - Type 2|diabetes mellitus - type 2
527076|NCT01318109|Diabetes Mellitus|diabetes mellitus
527077|NCT01318109|Drug Therapy|drug therapy
527078|NCT01318096|safety|safety
527079|NCT01318096|efficacy|efficacy
527080|NCT01318096|raltegravir|raltegravir
527081|NCT01318096|HBV/HIV co-infection|hbv/hiv co-infection
527082|NCT01318083|Diabetes Mellitus - Type 2|diabetes mellitus - type 2
527083|NCT01318083|Diabetes Mellitus|diabetes mellitus
527084|NCT01318083|Drug Therapy|drug therapy
527085|NCT01318070|Diabetes Mellitus - Type2|diabetes mellitus - type2
527086|NCT01318070|Diabetes Mellitus|diabetes mellitus
527087|NCT01318070|Drug Therapy|drug therapy
527088|NCT01318057|Pharmacogenetics|pharmacogenetics
527089|NCT01318057|Warfarin|warfarin
527090|NCT01318057|Personalized Medicine|personalized medicine
527091|NCT01318057|Puerto Ricans|puerto ricans
527092|NCT01318057|Physiogenomics|physiogenomics
527093|NCT01318057|Hispanics|hispanics
527094|NCT01318057|Anticoagulants|anticoagulants
527095|NCT01318057|Cardiovascular|cardiovascular
527096|NCT01318057|Deep Vein Thrombosis with or without Pulmonary Embolism|deep vein thrombosis with or without pulmonary embolism
527097|NCT01318057|Cardiac Valvular Replacement|cardiac valvular replacement
527098|NCT01318044|thiopental|thiopental
527099|NCT01318044|propofol|propofol
527100|NCT01318044|sedation|sedation
527101|NCT01318044|MRI|mri
527102|NCT01318031|DDI|ddi
527103|NCT01318031|Healthy Volunteers|healthy volunteers
527104|NCT01318018|depression|depression
527105|NCT01318018|bispectral index|bispectral index
527106|NCT01318018|electroconvulsive therapy|electroconvulsive therapy
527107|NCT01318018|magnetic seizure therapy|magnetic seizure therapy
527108|NCT01317992|Medication overuse headache|medication overuse headache
527109|NCT01317992|ibudilast|ibudilast
527110|NCT01317992|glia|glia
527111|NCT01317940|Leukemia|leukemia
527112|NCT01317940|ALL|all
527113|NCT01317940|Vitamin D|vitamin d
527114|NCT01317940|Bone Density|bone density
527115|NCT01317940|Body Fat|body fat
527116|NCT01317940|Obesity|obesity
527117|NCT01317940|Adipose|adipose
527118|NCT01317927|belionstat|belionstat
527119|NCT01317927|warfarin|warfarin
527120|NCT01317927|hematological malignancy|hematological malignancy
527121|NCT01317927|solid tumors|solid tumors
527122|NCT01317927|PK/PD study|pk/pd study
527123|NCT01317901|follicular lymphoma|follicular lymphoma
527124|NCT01317901|small lymphocytic lymphoma|small lymphocytic lymphoma
527125|NCT01317901|marginal zone lymphoma|marginal zone lymphoma
527126|NCT01317901|non-Hodgkin's lymphoma|non-hodgkin's lymphoma
527127|NCT01317901|indolent lymphoma|indolent lymphoma
527128|NCT01317888|high grade gliomas of the brain|high grade gliomas of the brain
527129|NCT01317888|anti-body treatment|anti-body treatment
527130|NCT01317888|survival|survival
527131|NCT01317862|labor induction, transcervical foley catheter, prostaglandin|labor induction, transcervical foley catheter, prostaglandin
527132|NCT01317849|folic acid|folic acid
527133|NCT01317849|B vitamins|b vitamins
527134|NCT01317849|secondary prevention|secondary prevention
527135|NCT01317849|stroke|stroke
527136|NCT01317849|randomized controlled trial|randomized controlled trial
527137|NCT01317849|homocysteine|homocysteine
527138|NCT01317836|pancreatic cystic lesion|pancreatic cystic lesion
527139|NCT01317836|PET|pet
527140|NCT01317836|PET-CT|pet-ct
527141|NCT01317836|diagnosis|diagnosis
527142|NCT01317823|Multiparas, Bishop score, Cervical length, Cervical ripening|multiparas, bishop score, cervical length, cervical ripening
527143|NCT01317810|Overactive Bladder (OAB)|overactive bladder (oab)
527144|NCT01317810|Observational|observational
527145|NCT01317810|Registry|registry
527146|NCT01317797|Rheumatoid Arthritis|rheumatoid arthritis
527147|NCT01317797|MT203|mt203
527148|NCT01317797|Human IgG1 monoclonal antibody|human igg1 monoclonal antibody
527149|NCT01317797|GM-CSF monoclonal antibody|gm-csf monoclonal antibody
527150|NCT01317784|diagnosis screening|diagnosis screening
527151|NCT01317784|HIV serodiagnosis|hiv serodiagnosis
527152|NCT01317784|HCV antibodies|hcv antibodies
527153|NCT01317784|serologic tests|serologic tests
527154|NCT01317784|Bedside testing|bedside testing
527155|NCT01317784|diagnostic test kits|diagnostic test kits
527156|NCT01317784|syphilis serodiagnosis|syphilis serodiagnosis
527157|NCT01317771|Proximal Biceps Pathology|proximal biceps pathology
527158|NCT01317758|influenza, vaccine, H5N1|influenza, vaccine, h5n1
527159|NCT01317745|H5N1, vaccine, influenza|h5n1, vaccine, influenza
527160|NCT01317732|Energy expenditure, physical activity, accelerometer, magnetometer, monitoring|energy expenditure, physical activity, accelerometer, magnetometer, monitoring
527161|NCT01317719|Rupture of Distal Bicep Tendon|rupture of distal bicep tendon
527162|NCT01317706|Bishop score, Cervical length, Cervical ripening, Labor induction|bishop score, cervical length, cervical ripening, labor induction
527163|NCT01317693|LI-ESWT|li-eswt
527164|NCT01317693|Erectile Dysfunction|erectile dysfunction
527166|NCT01317693|Shock waves|shock waves
527167|NCT01317693|Therapy|therapy
527168|NCT01317680|Erectile Dysfunction|erectile dysfunction
527169|NCT01317680|ED|ed
527170|NCT01317680|PDE5 inhibitors|pde5 inhibitors
527171|NCT01317680|LI-ESWT|li-eswt
527172|NCT01317667|Ricin|ricin
527173|NCT01317667|RVEc|rvec
527174|NCT01317654|Tuberculosis meningitis|tuberculosis meningitis
527175|NCT01317628|tobacco smoke, intervention program|tobacco smoke, intervention program
527176|NCT01317615|Large cell carcinoma,|large cell carcinoma,
527177|NCT01317615|Lung cancer,|lung cancer,
527178|NCT01317615|Neuroendocrine Tumors,|neuroendocrine tumors,
527179|NCT01317615|RAD001|rad001
527180|NCT01317602|Atrial Fibrillation|atrial fibrillation
527181|NCT01317602|AF|af
527182|NCT01317589|Pain|pain
527183|NCT01317589|Cancer of Head and Neck|cancer of head and neck
527184|NCT01317589|methadone|methadone
527185|NCT01317589|Fentanyl|fentanyl
527186|NCT01317576|Magnetic Resonance Spectroscopy|magnetic resonance spectroscopy
527187|NCT01317576|Exercise|exercise
527188|NCT01317563|asthma|asthma
527189|NCT01317563|obesity|obesity
527190|NCT01317563|nutrition|nutrition
527191|NCT01317563|antioxidant|antioxidant
527192|NCT01317550|Non-Small Cell Lung Cancer|non-small cell lung cancer
527193|NCT01317550|NSCLC|nsclc
527194|NCT01317550|Symptoms|symptoms
527195|NCT01317550|Concurrent Chemoradiation|concurrent chemoradiation
527196|NCT01317550|CXRT|cxrt
527197|NCT01317550|Fatigue|fatigue
527198|NCT01317550|Pain|pain
527199|NCT01317550|Disturbed Sleep|disturbed sleep
527200|NCT01317550|Lack of Appetite|lack of appetite
527201|NCT01317550|Drowsiness|drowsiness
527202|NCT01317550|Armodafinil|armodafinil
527203|NCT01317550|Nuvigil|nuvigil
527204|NCT01317550|Minocycline|minocycline
527205|NCT01317550|Dynacin|dynacin
527206|NCT01317550|Minocin|minocin
527207|NCT01317550|Minocin PAC|minocin pac
527208|NCT01317550|Myrac|myrac
527209|NCT01317550|Solodyn|solodyn
527210|NCT01317550|Placebo|placebo
527211|NCT01317537|personal health records|personal health records
527212|NCT01317524|Milk|milk
527213|NCT01317524|Homogenization|homogenization
527214|NCT01317524|Postprandial hyperlipidemia|postprandial hyperlipidemia
527215|NCT01317524|Postprandial inflammation|postprandial inflammation
527216|NCT01317524|Overweight|overweight
527217|NCT01317498|ART|art
527218|NCT01317498|antiretroviral|antiretroviral
527219|NCT01317498|treatment|treatment
527220|NCT01317498|Vietnam|vietnam
527221|NCT01317498|Asia|asia
527222|NCT01317498|viral load|viral load
527223|NCT01317485|diverticulitis|diverticulitis
527224|NCT01317485|perforation|perforation
527225|NCT01317485|sigmoidectomy|sigmoidectomy
527226|NCT01317485|sigmoid resection|sigmoid resection
527227|NCT01317485|lavage|lavage
527228|NCT01317485|laparoscopic|laparoscopic
527229|NCT01317485|wash-out|wash-out
527230|NCT01317485|rinsing|rinsing
527231|NCT01317485|hartmann|hartmann
527232|NCT01317485|end-colostomy|end-colostomy
527233|NCT01317485|primary anastomosis|primary anastomosis
527234|NCT01317472|laryngopharyngeal reflux, acid reflux, throat reflux|laryngopharyngeal reflux, acid reflux, throat reflux
527235|NCT01317459|Self management|self management
527236|NCT01317459|Diabetes type one|diabetes type one
527237|NCT01317459|Empowerment|empowerment
527238|NCT01317459|Intrinsic motivation|intrinsic motivation
527239|NCT01317446|gingivitis index|gingivitis index
527240|NCT01317446|plaque index|plaque index
527241|NCT01317446|discoloration index|discoloration index
527242|NCT01317446|mouth rinse|mouth rinse
710756|NCT00588094|Second line therapy|second line therapy
527243|NCT01317446|amine fluoride/stannous fluoride|amine fluoride/stannous fluoride
527244|NCT01317446|clinical trial|clinical trial
527245|NCT01317433|Metastatic Colorectal Cancer|metastatic colorectal cancer
527246|NCT01317433|K-RAS wild-type|k-ras wild-type
527247|NCT01317433|FOLFIRI|folfiri
527248|NCT01317433|Cetuximab|cetuximab
527249|NCT01317407|postoperative delirium|postoperative delirium
527250|NCT01317394|non-albicans candidemia|non-albicans candidemia
527251|NCT01317368|Postoperative analgesic treatment|postoperative analgesic treatment
527252|NCT01317368|TAP block|tap block
527253|NCT01317368|Prostatectomy|prostatectomy
527254|NCT01317368|Double blinded randomized clinical trial|double blinded randomized clinical trial
527255|NCT01317355|Cancer|cancer
527256|NCT01317355|Symptom burden|symptom burden
527257|NCT01317355|Symptom cluster|symptom cluster
527258|NCT01317355|Distress|distress
527259|NCT01317355|Pain|pain
527260|NCT01317355|Fatigue|fatigue
527261|NCT01317355|Sleep disorder|sleep disorder
527262|NCT01317355|HRQoL|hrqol
527263|NCT01317342|liver transplantation|liver transplantation
527264|NCT01317342|machine liver perfusion|machine liver perfusion
527265|NCT01317342|extended criteria liver grafts|extended criteria liver grafts
527266|NCT01317342|donation after cardiac death|donation after cardiac death
527267|NCT01317342|hypothermic machine liver perfusion|hypothermic machine liver perfusion
527268|NCT01317342|liver reperfusion injury|liver reperfusion injury
527269|NCT01317303|paired associative stimulation|paired associative stimulation
527270|NCT01317303|theta burst stimulation|theta burst stimulation
527271|NCT01317303|transcranial magnetic stimulation|transcranial magnetic stimulation
527272|NCT01317303|neuroplasticity|neuroplasticity
527273|NCT01317303|healthy controls|healthy controls
527274|NCT01317290|Conversion of ALA|conversion of ala
527275|NCT01317277|interventions|interventions
527276|NCT01317277|technology|technology
527277|NCT01317277|drug abuse|drug abuse
527278|NCT01317277|methamphetamine|methamphetamine
527279|NCT01317264|β-glucan|β-glucan
527280|NCT01317264|cholesterol|cholesterol
527281|NCT01317264|bile acids|bile acids
527282|NCT01317264|blood glucose|blood glucose
527283|NCT01317264|appetite|appetite
527284|NCT01317251|Obesity prevention|obesity prevention
527285|NCT01317251|appetite regulation|appetite regulation
527286|NCT01317251|hyperlipidemia|hyperlipidemia
527287|NCT01317238|Smallpox vaccine efficacy|smallpox vaccine efficacy
527288|NCT01317225|Progesterone|progesterone
527289|NCT01317225|Obstetric labor, premature|obstetric labor, premature
527290|NCT01317225|Short cervix|short cervix
527291|NCT01317212|Glioblastoma multiforme|glioblastoma multiforme
527292|NCT01317212|Carboplatin|carboplatin
527293|NCT01317212|Convection-enhanced delivery|convection-enhanced delivery
527294|NCT01317199|Rising psa|rising psa
527295|NCT01317186|FGF 23|fgf 23
527296|NCT01317186|ADMA|adma
527297|NCT01317186|chronic kidney disease|chronic kidney disease
527298|NCT01317186|Ca-P metabolism disorder|ca-p metabolism disorder
527299|NCT01317173|Chronic kidney disease progression|chronic kidney disease progression
527300|NCT01317173|FGF 23|fgf 23
527301|NCT01317173|Klotho|klotho
527302|NCT01317160|Achilles Tendon|achilles tendon
527303|NCT01317160|Immobilization|immobilization
527304|NCT01317160|Wound Healing|wound healing
527305|NCT01317160|Intermittent Pneumatic Compression|intermittent pneumatic compression
527306|NCT01317160|Ultrasonography|ultrasonography
527307|NCT01317160|Microdialysis|microdialysis
527308|NCT01317147|pharmacokinetics|pharmacokinetics
527309|NCT01317147|serotonin reuptake inhibitors|serotonin reuptake inhibitors
527310|NCT01317147|gastric bypass|gastric bypass
527311|NCT01317147|depression|depression
527312|NCT01317147|bioavailability|bioavailability
527313|NCT01317147|drug absorption|drug absorption
527314|NCT01317147|area under curve|area under curve
527315|NCT01317134|Pulmonary Arterial Hypertension|pulmonary arterial hypertension
527316|NCT01317134|Prognostic factors|prognostic factors
527317|NCT01317134|Signal transduction|signal transduction
527318|NCT01317134|Genetics|genetics
527319|NCT01317121|Patients with a first episode of schizophrenia|patients with a first episode of schizophrenia
527320|NCT01317121|Subjects at risk for psychosis|subjects at risk for psychosis
527321|NCT01317108|node-negative|node-negative
527322|NCT01317095|Rigid fixation|rigid fixation
527323|NCT01317095|Sternal closure|sternal closure
527324|NCT01317095|Open heart surgery|open heart surgery
527325|NCT01317082|Postoperative Nausea & Vomiting.|postoperative nausea & vomiting.
527326|NCT01317017|Psoriasis|psoriasis
527327|NCT01317004|Multiple sclerosis|multiple sclerosis
527328|NCT01317004|Fingolimod|fingolimod
527329|NCT01317004|Disease Modifying Therapy|disease modifying therapy
527330|NCT01317004|TSQM-9|tsqm-9
527331|NCT01316991|chewing gum|chewing gum
527332|NCT01316991|appetite|appetite
527333|NCT01316991|hunger|hunger
527334|NCT01316991|satiety|satiety
527335|NCT01316991|metabolic|metabolic
527336|NCT01316991|nutrition|nutrition
527337|NCT01316991|gut peptide hormones|gut peptide hormones
527338|NCT01316991|psychological phenomena and processes|psychological phenomena and processes
527339|NCT01316965|Postoperative delirium|postoperative delirium
527340|NCT01316965|elderly|elderly
527341|NCT01316965|prevention|prevention
527342|NCT01316965|stepped wedge design|stepped wedge design
527343|NCT01316965|healthcare workers|healthcare workers
527344|NCT01316952|carvedilol|carvedilol
527345|NCT01316952|propranolol|propranolol
527346|NCT01316952|hypersensitivity reactions|hypersensitivity reactions
527347|NCT01316952|beta- blockers|beta- blockers
527348|NCT01316952|Coreg|coreg
527349|NCT01316939|Crohn's disease, oral CCR9 antagonist, placebo-controlled, maintenance of remission, 52-week treatment, quality of life|crohn's disease, oral ccr9 antagonist, placebo-controlled, maintenance of remission, 52-week treatment, quality of life
527350|NCT01316926|fast condition|fast condition
527351|NCT01316926|Paroxetine reference/test|paroxetine reference/test
527352|NCT01316926|healthy volunteers|healthy volunteers
527353|NCT01316926|Bioequivalence|bioequivalence
527354|NCT01316913|tiotropium|tiotropium
527355|NCT01316913|long-acting muscarinic antagonist|long-acting muscarinic antagonist
527356|NCT01316913|COPD|copd
527357|NCT01316913|long-acting beta agonist|long-acting beta agonist
527358|NCT01316900|long-acting muscarinic antagonist|long-acting muscarinic antagonist
527359|NCT01316900|tiotropium|tiotropium
527360|NCT01316900|COPD|copd
527361|NCT01316900|long-acting beta agonist|long-acting beta agonist
527362|NCT01316887|Chronic Obstructive Pulmonary Disease|chronic obstructive pulmonary disease
527363|NCT01316887|COPD|copd
527364|NCT01316887|nDPI|ndpi
527871|NCT01315561|MSAT|msat
527365|NCT01316887|long-acting beta agonist|long-acting beta agonist
527366|NCT01316887|long-acting muscarinic antagonist|long-acting muscarinic antagonist
527367|NCT01316887|tolerability|tolerability
527368|NCT01316887|safety|safety
527369|NCT01316874|Valrubicin|valrubicin
527370|NCT01316874|CIS|cis
527371|NCT01316874|AD 32, BCG-refractory CIS|ad 32, bcg-refractory cis
527372|NCT01316874|Carcinoma in situ (CIS) previously treated with BCG|carcinoma in situ (cis) previously treated with bcg
527373|NCT01316848|AV-951|av-951
527374|NCT01316848|tivozanib|tivozanib
527375|NCT01316848|healthy Subjects|healthy subjects
527376|NCT01316848|food Effect|food effect
527377|NCT01316848|pharmacokinetics|pharmacokinetics
527378|NCT01316835|retrospective,sitagliptin, glycemia control,real world|retrospective,sitagliptin, glycemia control,real world
527379|NCT01316822|CSF1R|csf1r
527380|NCT01316822|M-CSF|m-csf
527381|NCT01316822|CSF-1|csf-1
527382|NCT01316822|c-FMS|c-fms
527383|NCT01316822|Tumor-associated macrophage|tumor-associated macrophage
527384|NCT01316822|Macrophage-Colony Stimulating Factor-1|macrophage-colony stimulating factor-1
527385|NCT01316822|Receptor tyrosine kinase inhibitor|receptor tyrosine kinase inhibitor
527386|NCT01316822|Tumor cell-induced osteolysis|tumor cell-induced osteolysis
527387|NCT01316809|Brain|brain
527388|NCT01316809|Tumor|tumor
527389|NCT01316809|Recurrent|recurrent
527390|NCT01316809|Surgery|surgery
527391|NCT01316809|Radiation|radiation
527392|NCT01316809|Glioma|glioma
527393|NCT01316809|Brain Tumor|brain tumor
527394|NCT01316809|Glioblastoma Multiforme|glioblastoma multiforme
527395|NCT01316809|Astrocytoma|astrocytoma
527396|NCT01316809|Brainstem Glioma|brainstem glioma
527397|NCT01316796|Sickle Cell Disease|sickle cell disease
527398|NCT01316796|Hemolysis|hemolysis
527399|NCT01316796|Anemia|anemia
527400|NCT01316796|Nitric Oxide|nitric oxide
527401|NCT01316796|Blood Flow|blood flow
527402|NCT01316796|Leg Ulcer|leg ulcer
527403|NCT01316796|Sickle Cell Anemia|sickle cell anemia
527404|NCT01316796|Thalassemia|thalassemia
527405|NCT01316796|Hemolytic Blood Disorder|hemolytic blood disorder
527406|NCT01316783|Cardiometabolic Diseases|cardiometabolic diseases
527407|NCT01316783|African Descent|african descent
527408|NCT01316783|Cardiovascular Disease|cardiovascular disease
527409|NCT01316783|Diabetes|diabetes
527410|NCT01316770|Xerostomia|xerostomia
527411|NCT01316770|Sjögren's Syndrome|sjögren's syndrome
527412|NCT01316770|Interventional Study|interventional study
527413|NCT01316770|Sjogren's Syndrome|sjogren's syndrome
527414|NCT01316770|Dry Mouth|dry mouth
527415|NCT01316744|long-term effects secondary to cancer therapy in adults|long-term effects secondary to cancer therapy in adults
527416|NCT01316744|anxiety disorder|anxiety disorder
527417|NCT01316744|depression|depression
527418|NCT01316744|pain|pain
527419|NCT01316744|unspecified adult solid tumor, protocol specific|unspecified adult solid tumor, protocol specific
527420|NCT01316744|neuropathy|neuropathy
527421|NCT01316744|accelerated phase chronic myelogenous leukemia|accelerated phase chronic myelogenous leukemia
527422|NCT01316744|acute undifferentiated leukemia|acute undifferentiated leukemia
527423|NCT01316744|adult acute lymphoblastic leukemia in remission|adult acute lymphoblastic leukemia in remission
527424|NCT01316744|adult acute myeloid leukemia in remission|adult acute myeloid leukemia in remission
527425|NCT01316744|adult acute myeloid leukemia with 11q23 (MLL) abnormalities|adult acute myeloid leukemia with 11q23 (mll) abnormalities
527426|NCT01316744|adult acute myeloid leukemia with inv(16)(p13;q22)|adult acute myeloid leukemia with inv(16)(p13;q22)
527427|NCT01316744|adult acute myeloid leukemia with t(15;17)(q22;q12)|adult acute myeloid leukemia with t(15;17)(q22;q12)
527428|NCT01316744|adult acute myeloid leukemia with t(16;16)(p13;q22)|adult acute myeloid leukemia with t(16;16)(p13;q22)
710757|NCT00588094|ICE|ice
527429|NCT01316744|adult acute myeloid leukemia with t(8;21)(q22;q22)|adult acute myeloid leukemia with t(8;21)(q22;q22)
527430|NCT01316744|atypical chronic myeloid leukemia, BCR-ABL1 negative|atypical chronic myeloid leukemia, bcr-abl1 negative
527431|NCT01316744|blastic phase chronic myelogenous leukemia|blastic phase chronic myelogenous leukemia
527432|NCT01316744|chronic myelomonocytic leukemia|chronic myelomonocytic leukemia
527433|NCT01316744|chronic phase chronic myelogenous leukemia|chronic phase chronic myelogenous leukemia
527434|NCT01316744|mast cell leukemia|mast cell leukemia
527435|NCT01316744|meningeal chronic myelogenous leukemia|meningeal chronic myelogenous leukemia
527436|NCT01316744|progressive hairy cell leukemia, initial treatment|progressive hairy cell leukemia, initial treatment
527437|NCT01316744|prolymphocytic leukemia|prolymphocytic leukemia
527438|NCT01316744|recurrent adult acute lymphoblastic leukemia|recurrent adult acute lymphoblastic leukemia
527439|NCT01316744|recurrent adult acute myeloid leukemia|recurrent adult acute myeloid leukemia
527440|NCT01316744|recurrent adult T-cell leukemia/lymphoma|recurrent adult t-cell leukemia/lymphoma
527441|NCT01316744|refractory chronic lymphocytic leukemia|refractory chronic lymphocytic leukemia
527442|NCT01316744|refractory hairy cell leukemia|refractory hairy cell leukemia
527443|NCT01316744|relapsing chronic myelogenous leukemia|relapsing chronic myelogenous leukemia
527444|NCT01316744|secondary acute myeloid leukemia|secondary acute myeloid leukemia
527445|NCT01316744|stage I adult T-cell leukemia/lymphoma|stage i adult t-cell leukemia/lymphoma
527446|NCT01316744|stage I chronic lymphocytic leukemia|stage i chronic lymphocytic leukemia
527447|NCT01316744|stage II adult T-cell leukemia/lymphoma|stage ii adult t-cell leukemia/lymphoma
528158|NCT01314313|Transapical|transapical
527448|NCT01316744|stage II chronic lymphocytic leukemia|stage ii chronic lymphocytic leukemia
527449|NCT01316744|stage III adult T-cell leukemia/lymphoma|stage iii adult t-cell leukemia/lymphoma
527450|NCT01316744|stage III chronic lymphocytic leukemia|stage iii chronic lymphocytic leukemia
527451|NCT01316744|stage IV adult T-cell leukemia/lymphoma|stage iv adult t-cell leukemia/lymphoma
527452|NCT01316744|stage IV chronic lymphocytic leukemia|stage iv chronic lymphocytic leukemia
527453|NCT01316744|T-cell large granular lymphocyte leukemia|t-cell large granular lymphocyte leukemia
527454|NCT01316744|AIDS-related diffuse large cell lymphoma|aids-related diffuse large cell lymphoma
527455|NCT01316744|AIDS-related diffuse mixed cell lymphoma|aids-related diffuse mixed cell lymphoma
527456|NCT01316744|AIDS-related diffuse small cleaved cell lymphoma|aids-related diffuse small cleaved cell lymphoma
527457|NCT01316744|AIDS-related immunoblastic large cell lymphoma|aids-related immunoblastic large cell lymphoma
527458|NCT01316744|AIDS-related lymphoblastic lymphoma|aids-related lymphoblastic lymphoma
527459|NCT01316744|AIDS-related peripheral/systemic lymphoma|aids-related peripheral/systemic lymphoma
527460|NCT01316744|AIDS-related primary CNS lymphoma|aids-related primary cns lymphoma
527461|NCT01316744|AIDS-related small noncleaved cell lymphoma|aids-related small noncleaved cell lymphoma
527462|NCT01316744|HIV-associated Hodgkin lymphoma|hiv-associated hodgkin lymphoma
527463|NCT01316744|recurrent adult Hodgkin lymphoma|recurrent adult hodgkin lymphoma
527464|NCT01316744|stage I adult Hodgkin lymphoma|stage i adult hodgkin lymphoma
527465|NCT01316744|stage II adult Hodgkin lymphoma|stage ii adult hodgkin lymphoma
527466|NCT01316744|stage III adult Hodgkin lymphoma|stage iii adult hodgkin lymphoma
527467|NCT01316744|stage IV adult Hodgkin lymphoma|stage iv adult hodgkin lymphoma
527468|NCT01316744|anaplastic large cell lymphoma|anaplastic large cell lymphoma
527469|NCT01316744|angioimmunoblastic T-cell lymphoma|angioimmunoblastic t-cell lymphoma
527470|NCT01316744|cutaneous B-cell non-Hodgkin lymphoma|cutaneous b-cell non-hodgkin lymphoma
527471|NCT01316744|recurrent cutaneous T-cell non-Hodgkin lymphoma|recurrent cutaneous t-cell non-hodgkin lymphoma
527472|NCT01316744|stage I cutaneous T-cell non-Hodgkin lymphoma|stage i cutaneous t-cell non-hodgkin lymphoma
527473|NCT01316744|stage II cutaneous T-cell non-Hodgkin lymphoma|stage ii cutaneous t-cell non-hodgkin lymphoma
527474|NCT01316744|stage III cutaneous T-cell non-Hodgkin lymphoma|stage iii cutaneous t-cell non-hodgkin lymphoma
527475|NCT01316744|stage IV cutaneous T-cell non-Hodgkin lymphoma|stage iv cutaneous t-cell non-hodgkin lymphoma
527476|NCT01316744|recurrent mycosis fungoides/Sezary syndrome|recurrent mycosis fungoides/sezary syndrome
527477|NCT01316744|stage I mycosis fungoides/Sezary syndrome|stage i mycosis fungoides/sezary syndrome
527478|NCT01316744|stage II mycosis fungoides/Sezary syndrome|stage ii mycosis fungoides/sezary syndrome
527479|NCT01316744|stage III mycosis fungoides/Sezary syndrome|stage iii mycosis fungoides/sezary syndrome
527480|NCT01316744|stage IV mycosis fungoides/Sezary syndrome|stage iv mycosis fungoides/sezary syndrome
527481|NCT01316744|adult grade III lymphomatoid granulomatosis|adult grade iii lymphomatoid granulomatosis
527482|NCT01316744|adult nasal type extranodal NK/T-cell lymphoma|adult nasal type extranodal nk/t-cell lymphoma
527483|NCT01316744|Waldenstrom macroglobulinemia|waldenstrom macroglobulinemia
527484|NCT01316744|extranodal marginal zone B-cell lymphoma of mucosa-associated lymphoid tissue|extranodal marginal zone b-cell lymphoma of mucosa-associated lymphoid tissue
527485|NCT01316744|nodal marginal zone B-cell lymphoma|nodal marginal zone b-cell lymphoma
527486|NCT01316744|splenic marginal zone lymphoma|splenic marginal zone lymphoma
527487|NCT01316744|contiguous stage II adult Burkitt lymphoma|contiguous stage ii adult burkitt lymphoma
527488|NCT01316744|contiguous stage II adult diffuse large cell lymphoma|contiguous stage ii adult diffuse large cell lymphoma
527489|NCT01316744|contiguous stage II adult diffuse mixed cell lymphoma|contiguous stage ii adult diffuse mixed cell lymphoma
527490|NCT01316744|contiguous stage II adult diffuse small cleaved cell lymphoma|contiguous stage ii adult diffuse small cleaved cell lymphoma
527491|NCT01316744|contiguous stage II adult immunoblastic large cell lymphoma|contiguous stage ii adult immunoblastic large cell lymphoma
527492|NCT01316744|contiguous stage II adult lymphoblastic lymphoma|contiguous stage ii adult lymphoblastic lymphoma
527493|NCT01316744|contiguous stage II grade 1 follicular lymphoma|contiguous stage ii grade 1 follicular lymphoma
527494|NCT01316744|contiguous stage II grade 2 follicular lymphoma|contiguous stage ii grade 2 follicular lymphoma
527495|NCT01316744|contiguous stage II grade 3 follicular lymphoma|contiguous stage ii grade 3 follicular lymphoma
527496|NCT01316744|contiguous stage II mantle cell lymphoma|contiguous stage ii mantle cell lymphoma
527497|NCT01316744|contiguous stage II marginal zone lymphoma|contiguous stage ii marginal zone lymphoma
527498|NCT01316744|contiguous stage II small lymphocytic lymphoma|contiguous stage ii small lymphocytic lymphoma
527499|NCT01316744|stage I adult Burkitt lymphoma|stage i adult burkitt lymphoma
527500|NCT01316744|stage I adult diffuse large cell lymphoma|stage i adult diffuse large cell lymphoma
527501|NCT01316744|stage I adult diffuse mixed cell lymphoma|stage i adult diffuse mixed cell lymphoma
527502|NCT01316744|stage I adult diffuse small cleaved cell lymphoma|stage i adult diffuse small cleaved cell lymphoma
527503|NCT01316744|stage I adult immunoblastic large cell lymphoma|stage i adult immunoblastic large cell lymphoma
527504|NCT01316744|stage I adult lymphoblastic lymphoma|stage i adult lymphoblastic lymphoma
527505|NCT01316744|stage I grade 1 follicular lymphoma|stage i grade 1 follicular lymphoma
527506|NCT01316744|stage I grade 2 follicular lymphoma|stage i grade 2 follicular lymphoma
527507|NCT01316744|stage I grade 3 follicular lymphoma|stage i grade 3 follicular lymphoma
527508|NCT01316744|stage I mantle cell lymphoma|stage i mantle cell lymphoma
527509|NCT01316744|stage I marginal zone lymphoma|stage i marginal zone lymphoma
528159|NCT01314313|Transaortic|transaortic
527510|NCT01316744|stage I small lymphocytic lymphoma|stage i small lymphocytic lymphoma
527511|NCT01316744|noncontiguous stage II adult Burkitt lymphoma|noncontiguous stage ii adult burkitt lymphoma
527512|NCT01316744|noncontiguous stage II adult diffuse large cell lymphoma|noncontiguous stage ii adult diffuse large cell lymphoma
527513|NCT01316744|noncontiguous stage II adult diffuse mixed cell lymphoma|noncontiguous stage ii adult diffuse mixed cell lymphoma
527514|NCT01316744|noncontiguous stage II adult diffuse small cleaved cell lymphoma|noncontiguous stage ii adult diffuse small cleaved cell lymphoma
527515|NCT01316744|noncontiguous stage II adult immunoblastic large cell lymphoma|noncontiguous stage ii adult immunoblastic large cell lymphoma
527516|NCT01316744|noncontiguous stage II adult lymphoblastic lymphoma|noncontiguous stage ii adult lymphoblastic lymphoma
527517|NCT01316744|noncontiguous stage II grade 1 follicular lymphoma|noncontiguous stage ii grade 1 follicular lymphoma
527518|NCT01316744|noncontiguous stage II grade 2 follicular lymphoma|noncontiguous stage ii grade 2 follicular lymphoma
527519|NCT01316744|noncontiguous stage II grade 3 follicular lymphoma|noncontiguous stage ii grade 3 follicular lymphoma
527520|NCT01316744|noncontiguous stage II mantle cell lymphoma|noncontiguous stage ii mantle cell lymphoma
527521|NCT01316744|noncontiguous stage II marginal zone lymphoma|noncontiguous stage ii marginal zone lymphoma
527522|NCT01316744|noncontiguous stage II small lymphocytic lymphoma|noncontiguous stage ii small lymphocytic lymphoma
527523|NCT01316744|stage III adult Burkitt lymphoma|stage iii adult burkitt lymphoma
527524|NCT01316744|stage III adult diffuse large cell lymphoma|stage iii adult diffuse large cell lymphoma
527525|NCT01316744|stage III adult diffuse mixed cell lymphoma|stage iii adult diffuse mixed cell lymphoma
527526|NCT01316744|stage III adult diffuse small cleaved cell lymphoma|stage iii adult diffuse small cleaved cell lymphoma
527527|NCT01316744|stage III adult immunoblastic large cell lymphoma|stage iii adult immunoblastic large cell lymphoma
527528|NCT01316744|stage III adult lymphoblastic lymphoma|stage iii adult lymphoblastic lymphoma
527529|NCT01316744|stage III grade 1 follicular lymphoma|stage iii grade 1 follicular lymphoma
527530|NCT01316744|stage III grade 2 follicular lymphoma|stage iii grade 2 follicular lymphoma
527531|NCT01316744|stage III grade 3 follicular lymphoma|stage iii grade 3 follicular lymphoma
527532|NCT01316744|stage III mantle cell lymphoma|stage iii mantle cell lymphoma
527533|NCT01316744|stage III marginal zone lymphoma|stage iii marginal zone lymphoma
527534|NCT01316744|stage III small lymphocytic lymphoma|stage iii small lymphocytic lymphoma
527535|NCT01316744|stage IV adult Burkitt lymphoma|stage iv adult burkitt lymphoma
527536|NCT01316744|stage IV adult diffuse large cell lymphoma|stage iv adult diffuse large cell lymphoma
527537|NCT01316744|stage IV adult diffuse mixed cell lymphoma|stage iv adult diffuse mixed cell lymphoma
527538|NCT01316744|stage IV adult diffuse small cleaved cell lymphoma|stage iv adult diffuse small cleaved cell lymphoma
527539|NCT01316744|stage IV adult immunoblastic large cell lymphoma|stage iv adult immunoblastic large cell lymphoma
527540|NCT01316744|stage IV adult lymphoblastic lymphoma|stage iv adult lymphoblastic lymphoma
527541|NCT01316744|stage IV grade 1 follicular lymphoma|stage iv grade 1 follicular lymphoma
527542|NCT01316744|stage IV grade 2 follicular lymphoma|stage iv grade 2 follicular lymphoma
527543|NCT01316744|stage IV grade 3 follicular lymphoma|stage iv grade 3 follicular lymphoma
527544|NCT01316744|stage IV mantle cell lymphoma|stage iv mantle cell lymphoma
527545|NCT01316744|stage IV marginal zone lymphoma|stage iv marginal zone lymphoma
527546|NCT01316744|stage IV small lymphocytic lymphoma|stage iv small lymphocytic lymphoma
527547|NCT01316744|recurrent adult Burkitt lymphoma|recurrent adult burkitt lymphoma
527548|NCT01316744|recurrent adult diffuse large cell lymphoma|recurrent adult diffuse large cell lymphoma
527549|NCT01316744|recurrent adult diffuse mixed cell lymphoma|recurrent adult diffuse mixed cell lymphoma
527550|NCT01316744|recurrent adult diffuse small cleaved cell lymphoma|recurrent adult diffuse small cleaved cell lymphoma
527551|NCT01316744|recurrent adult grade III lymphomatoid granulomatosis|recurrent adult grade iii lymphomatoid granulomatosis
527552|NCT01316744|recurrent adult immunoblastic large cell lymphoma|recurrent adult immunoblastic large cell lymphoma
527553|NCT01316744|recurrent adult lymphoblastic lymphoma|recurrent adult lymphoblastic lymphoma
527554|NCT01316744|recurrent grade 1 follicular lymphoma|recurrent grade 1 follicular lymphoma
527555|NCT01316744|recurrent grade 2 follicular lymphoma|recurrent grade 2 follicular lymphoma
527556|NCT01316744|recurrent grade 3 follicular lymphoma|recurrent grade 3 follicular lymphoma
527557|NCT01316744|recurrent mantle cell lymphoma|recurrent mantle cell lymphoma
527558|NCT01316744|recurrent marginal zone lymphoma|recurrent marginal zone lymphoma
527559|NCT01316744|recurrent small lymphocytic lymphoma|recurrent small lymphocytic lymphoma
527560|NCT01316744|intraocular lymphoma|intraocular lymphoma
527561|NCT01316744|primary central nervous system non-Hodgkin lymphoma|primary central nervous system non-hodgkin lymphoma
527562|NCT01316744|primary central nervous system Hodgkin lymphoma|primary central nervous system hodgkin lymphoma
527563|NCT01316744|post-transplant lymphoproliferative disorder|post-transplant lymphoproliferative disorder
527564|NCT01316744|chronic eosinophilic leukemia|chronic eosinophilic leukemia
527565|NCT01316744|chronic neutrophilic leukemia|chronic neutrophilic leukemia
527566|NCT01316744|primary myelofibrosis|primary myelofibrosis
527567|NCT01316744|essential thrombocythemia|essential thrombocythemia
527568|NCT01316744|polycythemia vera|polycythemia vera
527569|NCT01316744|extramedullary plasmacytoma|extramedullary plasmacytoma
527570|NCT01316744|isolated plasmacytoma of bone|isolated plasmacytoma of bone
527571|NCT01316744|stage I multiple myeloma|stage i multiple myeloma
527572|NCT01316744|stage II multiple myeloma|stage ii multiple myeloma
527573|NCT01316744|stage III multiple myeloma|stage iii multiple myeloma
527574|NCT01316744|primary systemic amyloidosis|primary systemic amyloidosis
527575|NCT01316744|refractory multiple myeloma|refractory multiple myeloma
527576|NCT01316744|de novo myelodysplastic syndromes|de novo myelodysplastic syndromes
527577|NCT01316744|previously treated myelodysplastic syndromes|previously treated myelodysplastic syndromes
527578|NCT01316744|secondary myelodysplastic syndromes|secondary myelodysplastic syndromes
527579|NCT01316744|myelodysplastic/myeloproliferative neoplasm, unclassifiable|myelodysplastic/myeloproliferative neoplasm, unclassifiable
527580|NCT01316718|IBS|ibs
527581|NCT01316718|diarrhoea|diarrhoea
527582|NCT01316679|HCC|hcc
527583|NCT01316679|Liver Disease without HCC|liver disease without hcc
527584|NCT01316666|orthostatic hypotension|orthostatic hypotension
527585|NCT01316666|Multiple System Atrophy|multiple system atrophy
527586|NCT01316666|Pure Autonomic Failure|pure autonomic failure
527587|NCT01316666|Parkinson's Disease|parkinson's disease
527588|NCT01316627|Body Dysmorphic Disorder (BDD)|body dysmorphic disorder (bdd)
527589|NCT01316627|Cognitive Behavior Therapy (CBT)|cognitive behavior therapy (cbt)
527590|NCT01316627|Obsessive Compulsive Disorder (OCD)|obsessive compulsive disorder (ocd)
527591|NCT01316627|Mirror Retraining|mirror retraining
527592|NCT01316627|Crooked Mirror Externalization Therapy|crooked mirror externalization therapy
527593|NCT01316614|Fine-Needle Aspiration|fine-needle aspiration
527594|NCT01316614|Stylet|stylet
527595|NCT01316614|Solid Mass|solid mass
527596|NCT01316614|Endoscopic Ultrasound (EUS)|endoscopic ultrasound (eus)
527597|NCT01316588|recolonization|recolonization
527598|NCT01316588|Plastic adhesive drape|plastic adhesive drape
527599|NCT01316588|microbial sealant|microbial sealant
527600|NCT01316588|SSI|ssi
527601|NCT01316588|bacterial growth|bacterial growth
527602|NCT01316575|Continuous Positive Airway Pressure|continuous positive airway pressure
527603|NCT01316575|Postoperative Complications|postoperative complications
527604|NCT01316575|Respiratory Insufficiency|respiratory insufficiency
527605|NCT01316575|Colorectal Surgery|colorectal surgery
527606|NCT01316549|fludarabine|fludarabine
527607|NCT01316549|pharmacokinetics|pharmacokinetics
527608|NCT01316549|pediatric|pediatric
527609|NCT01316549|allogeneic|allogeneic
527610|NCT01316549|hematopoietic cell transplantation|hematopoietic cell transplantation
527611|NCT01316536|pain, agitation, music|pain, agitation, music
527612|NCT01316523|Lenalidomide|lenalidomide
527613|NCT01316523|Rituximab|rituximab
527614|NCT01316523|untreated indolent Non-Hodgkin's Lymphoma|untreated indolent non-hodgkin's lymphoma
527615|NCT01316510|Probiotic|probiotic
527616|NCT01316510|bifidobacteria|bifidobacteria
527617|NCT01316510|intestinal motility|intestinal motility
527618|NCT01316497|Acute kidney injury|acute kidney injury
527619|NCT01316497|Ischemic preconditioning|ischemic preconditioning
527620|NCT01316497|Congenital heart defects|congenital heart defects
527621|NCT01316497|Cardiac surgical procedures|cardiac surgical procedures
527622|NCT01316497|Infant|infant
527623|NCT01316497|Child|child
527624|NCT01316484|Cognitive Debriefing|cognitive debriefing
527625|NCT01316471|Chronic Pain|chronic pain
527626|NCT01316471|Abdominal Pain|abdominal pain
527627|NCT01316471|Headache|headache
527628|NCT01316471|Adolescents|adolescents
527629|NCT01316471|Internet Interventions|internet interventions
527630|NCT01316471|Behavioral Interventions|behavioral interventions
527631|NCT01316458|Prostate cancer,|prostate cancer,
527632|NCT01316458|radical prostatectomy,|radical prostatectomy,
527633|NCT01316458|PSA rise|psa rise
527634|NCT01316445|Electroencephalography|electroencephalography
527635|NCT01316445|Benzodiazepines|benzodiazepines
527636|NCT01316445|Midazolam|midazolam
527637|NCT01316432|Cenderitide|cenderitide
527638|NCT01316432|CD-NP|cd-np
527639|NCT01316432|Natriuretic peptide|natriuretic peptide
527640|NCT01316432|Heart failure|heart failure
527641|NCT01316432|Chronic heart failure|chronic heart failure
527642|NCT01316432|HF|hf
527643|NCT01316432|CHF|chf
527644|NCT01316406|safety|safety
527645|NCT01316406|efficacy|efficacy
527646|NCT01316406|treatment|treatment
527647|NCT01316406|PPES|ppes
527648|NCT01316406|Palmar-Plantar Erythrodysesthesia Syndrome|palmar-plantar erythrodysesthesia syndrome
527649|NCT01316406|Hand-foot syndrome|hand-foot syndrome
527650|NCT01316406|capecitabine|capecitabine
527651|NCT01316393|xerostomia, saliva, mucoprotection, oral health|xerostomia, saliva, mucoprotection, oral health
527652|NCT01316367|Health Promotion Education|health promotion education
527653|NCT01316367|Type 2 Diabetes Mellitus|type 2 diabetes mellitus
527654|NCT01316367|Cardiovascular Risk Factors|cardiovascular risk factors
527655|NCT01316367|Spain|spain
527656|NCT01316354|Arabinoxylan|arabinoxylan
527657|NCT01316354|Beta glucan|beta glucan
527658|NCT01316354|Whole grain|whole grain
527659|NCT01316354|Dietary fibre|dietary fibre
527660|NCT01316354|Metabolic syndrome|metabolic syndrome
527661|NCT01316354|Glycemic index|glycemic index
527662|NCT01316354|Satiety|satiety
527663|NCT01316328|toxicity after single shot partial breast irradiation (SSPBI)|toxicity after single shot partial breast irradiation (sspbi)
527664|NCT01316302|Social Anxiety Disorder|social anxiety disorder
527665|NCT01316302|Social Phobia|social phobia
527666|NCT01316302|SAD|sad
527667|NCT01316289|tibial fractures|tibial fractures
527668|NCT01316289|pilon|pilon
527669|NCT01316289|pilon fractures|pilon fractures
527670|NCT01316289|tibial plafond|tibial plafond
527671|NCT01316289|reduction quality|reduction quality
527672|NCT01316289|anatomical reduction|anatomical reduction
527673|NCT01316289|functional outcome|functional outcome
527674|NCT01316289|ankle joint|ankle joint
527675|NCT01316276|Cystic Fibrosis|cystic fibrosis
527676|NCT01316276|Respiratory Infections|respiratory infections
527677|NCT01316276|Pulmonary Cystic Fibrosis|pulmonary cystic fibrosis
527678|NCT01316276|cystic fibrosis transmembrane conductance regulator (CFTR)|cystic fibrosis transmembrane conductance regulator (cftr)
527679|NCT01316276|Anti-bacterial Agent|anti-bacterial agent
527680|NCT01316276|Arikayce|arikayce
527681|NCT01316276|ALIS|alis
527682|NCT01316276|LAI|lai
527683|NCT01316250|chronic myelogenous leukemia|chronic myelogenous leukemia
527684|NCT01316250|nilotinib|nilotinib
527685|NCT01316250|complete cytogenetic response|complete cytogenetic response
527686|NCT01316250|imatinib mesylate|imatinib mesylate
527687|NCT01316237|Hepatitis C|hepatitis c
527688|NCT01316237|HCV|hcv
527689|NCT01316237|HCV RNA|hcv rna
527690|NCT01316237|Polymerase inhibitor|polymerase inhibitor
527691|NCT01316237|Treatment naïve|treatment naïve
527692|NCT01316237|GS-6620|gs-6620
527693|NCT01316224|Psoriasis|psoriasis
527694|NCT01316224|Incidence|incidence
527695|NCT01316224|Quality of Life|quality of life
527696|NCT01316224|Psoriatic Arthritis|psoriatic arthritis
527697|NCT01316224|Prevalence|prevalence
527698|NCT01316211|Back Pains|back pains
527699|NCT01316211|Pain, Back|pain, back
527700|NCT01316211|Pains, Back|pains, back
527701|NCT01316211|Backache|backache
527702|NCT01316211|Backaches|backaches
527703|NCT01316211|Back Ache|back ache
527704|NCT01316211|Ache, Back|ache, back
527705|NCT01316211|Aches, Back|aches, back
527706|NCT01316211|Back Aches|back aches
527707|NCT01316211|Back Pain without Radiation|back pain without radiation
527708|NCT01316211|Vertebrogenic Pain Syndrome|vertebrogenic pain syndrome
527709|NCT01316211|Pain Syndrome, Vertebrogenic|pain syndrome, vertebrogenic
527710|NCT01316211|Pain Syndromes, Vertebrogenic|pain syndromes, vertebrogenic
527711|NCT01316211|Syndrome, Vertebrogenic Pain|syndrome, vertebrogenic pain
527712|NCT01316211|Syndromes, Vertebrogenic Pain|syndromes, vertebrogenic pain
527713|NCT01316211|Vertebrogenic Pain Syndromes|vertebrogenic pain syndromes
527714|NCT01316211|Back Pain with Radiation|back pain with radiation
527715|NCT01316211|Stenosis, spinal|stenosis, spinal
527716|NCT01316211|Caudal stenosis|caudal stenosis
527717|NCT01316211|Spondylopathy|spondylopathy
527718|NCT01316211|Spondylopathies|spondylopathies
527719|NCT01316211|Low back pain|low back pain
527720|NCT01316211|Lower back pain|lower back pain
527721|NCT01316198|human study|human study
527722|NCT01316198|AMD|amd
527723|NCT01316198|lutein|lutein
527724|NCT01316198|zeaxanthin|zeaxanthin
527725|NCT01316198|optical density|optical density
527726|NCT01316185|Hepatitis D|hepatitis d
527727|NCT01316185|HDV|hdv
527728|NCT01316185|Hepatitis|hepatitis
527729|NCT01316172|consultation|consultation
527730|NCT01316146|Hodgkin's Lymphoma|hodgkin's lymphoma
527731|NCT01316146|Non-Hodgkin's Lymphoma|non-hodgkin's lymphoma
527732|NCT01316146|Lymphoma|lymphoma
527733|NCT01316146|T lymphocytes|t lymphocytes
527734|NCT01316133|Tacrolimus|tacrolimus
527735|NCT01316133|Prograf|prograf
527736|NCT01316133|FK506|fk506
527737|NCT01316133|Proteinuria|proteinuria
527738|NCT01316133|Calcineurin inhibitor|calcineurin inhibitor
527739|NCT01316120|Self-collected vaginal samples|self-collected vaginal samples
527740|NCT01316120|HPV|hpv
527741|NCT01316120|HPV self-obtained sample|hpv self-obtained sample
527742|NCT01316120|HPV specimen transport medium|hpv specimen transport medium
527743|NCT01316107|ASP1941|asp1941
527744|NCT01316107|long-term safety|long-term safety
527745|NCT01316107|nateglinide|nateglinide
527746|NCT01316107|Diabetes mellitus|diabetes mellitus
527747|NCT01316094|Pharmacokinetics|pharmacokinetics
527748|NCT01316094|ASP1941|asp1941
527749|NCT01316094|Renal impairment|renal impairment
527750|NCT01316081|antioxidant supplementation|antioxidant supplementation
527751|NCT01316081|childhood obesity|childhood obesity
527752|NCT01316081|hepcidin|hepcidin
527753|NCT01316081|iron status|iron status
527754|NCT01316081|oxidative stress|oxidative stress
527755|NCT01316081|inflammation|inflammation
527756|NCT01316068|diabetic nephropathy|diabetic nephropathy
527757|NCT01316068|albuminuria|albuminuria
527758|NCT01316068|type 2 diabetes|type 2 diabetes
527759|NCT01316068|sulodexide|sulodexide
527760|NCT01316042|Puberty|puberty
527761|NCT01316042|Hormones|hormones
527762|NCT01316029|Laying-on-of-hands|laying-on-of-hands
527763|NCT01316029|Therapeutic touch|therapeutic touch
527764|NCT01316029|cross-sectional study|cross-sectional study
527765|NCT01316029|healing environment|healing environment
527766|NCT01316029|safety and effectiveness|safety and effectiveness
527767|NCT01316029|optimal condition for the intervention|optimal condition for the intervention
527768|NCT01316016|obesity|obesity
527769|NCT01316016|glucose intolerance|glucose intolerance
527770|NCT01316016|cholesterol|cholesterol
527771|NCT01316016|blood pressure|blood pressure
527772|NCT01316003|cone outer segment tips line|cone outer segment tips line
527773|NCT01316003|Optical coherence tomography|optical coherence tomography
527774|NCT01315990|Phase IV Study|phase iv study
527775|NCT01315990|Metastatic Colorectal Cancer (mCRC|metastatic colorectal cancer (mcrc
527776|NCT01315990|Cetuximab (Erbitux)|cetuximab (erbitux)
527777|NCT01315990|first-line treatment|first-line treatment
527778|NCT01315990|acneiform follicular exanthema|acneiform follicular exanthema
527779|NCT01315990|rash|rash
527780|NCT01315990|vitamin K1|vitamin k1
527781|NCT01315977|Type 2 Diabetes Mellitus|type 2 diabetes mellitus
527782|NCT01315977|Antioxidant oxidant balance|antioxidant oxidant balance
527783|NCT01315977|Activation of Antioxidant Response Element|activation of antioxidant response element
527784|NCT01315964|cholesterol|cholesterol
527785|NCT01315964|plant sterols|plant sterols
527786|NCT01315964|atherosclerosis|atherosclerosis
527787|NCT01315964|arterial stiffness|arterial stiffness
527788|NCT01315951|Non scalp Seborrheic Dermatitis|non scalp seborrheic dermatitis
527789|NCT01315925|Acute myeloid leukemia|acute myeloid leukemia
527790|NCT01315925|invasive fungal infection|invasive fungal infection
527791|NCT01315925|Aspergillosis|aspergillosis
527792|NCT01315925|candidiasis|candidiasis
527793|NCT01315912|clomiphene citrate|clomiphene citrate
527794|NCT01315912|infertility|infertility
527795|NCT01315912|letrozole|letrozole
527796|NCT01315899|Raynaud's phenomenon|raynaud's phenomenon
527797|NCT01315899|Systemic sclerosis|systemic sclerosis
527798|NCT01315886|sublingual|sublingual
527799|NCT01315886|fentanyl|fentanyl
527800|NCT01315886|titration|titration
527801|NCT01315886|conversion|conversion
527802|NCT01315886|breakthrough cancer pain|breakthrough cancer pain
527803|NCT01315886|pain intensity difference|pain intensity difference
527804|NCT01315886|PID|pid
527805|NCT01315886|Edmonton Symptom Assessment System|edmonton symptom assessment system
527806|NCT01315886|ESAS|esas
527807|NCT01315873|myeloma|myeloma
527808|NCT01315873|multiple myeloma|multiple myeloma
527809|NCT01315873|relapsed myeloma|relapsed myeloma
527810|NCT01315873|refractory myeloma|refractory myeloma
527811|NCT01315860|Low Back Pain|low back pain
527812|NCT01315860|Pregnancy|pregnancy
527813|NCT01315860|Biomechanics|biomechanics
527814|NCT01315821|Saccharomyces boulardii|saccharomyces boulardii
527815|NCT01315821|necrotizing enterocolitis|necrotizing enterocolitis
527816|NCT01315795|polycystic liver disease|polycystic liver disease
527817|NCT01315782|Sepsis|sepsis
527818|NCT01315782|Severe sepsis|severe sepsis
527819|NCT01315782|Septic shock|septic shock
527820|NCT01315782|Alveolar dead space|alveolar dead space
527821|NCT01315782|Multi-organ failure|multi-organ failure
527822|NCT01315730|stuttering|stuttering
527823|NCT01315730|haptic|haptic
527824|NCT01315730|feedback|feedback
527825|NCT01315730|fluency|fluency
527826|NCT01315691|Cystic Fibrosis|cystic fibrosis
527827|NCT01315691|Respiratory Infections|respiratory infections
527828|NCT01315691|Pulmonary Cystic Fibrosis|pulmonary cystic fibrosis
527829|NCT01315691|Amikacin|amikacin
527830|NCT01315691|Anti-bacterial agents|anti-bacterial agents
527831|NCT01315678|Cystic Fibrosis|cystic fibrosis
527832|NCT01315678|Respiratory Infections|respiratory infections
527833|NCT01315678|Pulmonary Cystic Fibrosis|pulmonary cystic fibrosis
527834|NCT01315678|CFTR|cftr
527835|NCT01315678|Amikacin|amikacin
527836|NCT01315678|Anti-bacterial Agents|anti-bacterial agents
527837|NCT01315678|Amikacin liposome inhalation suspension (ALIS)|amikacin liposome inhalation suspension (alis)
527838|NCT01315665|broccoli sprouts|broccoli sprouts
527839|NCT01315665|sulforaphane|sulforaphane
527840|NCT01315665|triterpenoid|triterpenoid
527841|NCT01315665|Nrf2 activation|nrf2 activation
527842|NCT01315665|cystic fibrosis|cystic fibrosis
527843|NCT01315665|healthy volunteers|healthy volunteers
527844|NCT01315665|anti-inflammatory|anti-inflammatory
527845|NCT01315652|1 Rheumatoid arthritis|1 rheumatoid arthritis
527846|NCT01315652|2 Education|2 education
527847|NCT01315652|3 Co-morbidities|3 co-morbidities
527848|NCT01315652|4 Nurse|4 nurse
527849|NCT01315639|Dementia|dementia
527850|NCT01315639|Cognitive impairment|cognitive impairment
527851|NCT01315639|Memory impairment|memory impairment
527852|NCT01315639|Mild Cognitive Impairment|mild cognitive impairment
527853|NCT01315639|Cerebrospinal fluid|cerebrospinal fluid
527854|NCT01315639|Plasma|plasma
527855|NCT01315639|Biomarker|biomarker
527856|NCT01315639|Longitudinal|longitudinal
527857|NCT01315639|Abeta peptide amyloid, saPP alpha|abeta peptide amyloid, sapp alpha
527858|NCT01315639|Oculomotor impairment|oculomotor impairment
527859|NCT01315626|Bronchiectasis|bronchiectasis
527860|NCT01315626|pulmonary exacerbations|pulmonary exacerbations
527861|NCT01315626|pulmonary infections|pulmonary infections
527862|NCT01315574|Glaucoma|glaucoma
527863|NCT01315574|Xalatan|xalatan
527864|NCT01315574|Travatan Z|travatan z
527865|NCT01315574|Latanoprost|latanoprost
527866|NCT01315574|Travoprost|travoprost
527867|NCT01315574|Dry Eye|dry eye
527868|NCT01315561|acute low back pain|acute low back pain
527869|NCT01315561|motion stlye acupuncture treatment|motion stlye acupuncture treatment
527870|NCT01315561|disability|disability
527872|NCT01315548|Contrast enhanced harmonic endoscopic ultrasound|contrast enhanced harmonic endoscopic ultrasound
527873|NCT01315548|Pancreatic adenocarcinoma|pancreatic adenocarcinoma
527874|NCT01315548|Chronic pancreatitis|chronic pancreatitis
527875|NCT01315535|Mandibular Advancement|mandibular advancement
527876|NCT01315535|Oral Appliance|oral appliance
527878|NCT01315522|Stents|stents
527879|NCT01315522|Endoscopy|endoscopy
527880|NCT01315522|Cholangiopancreatography|cholangiopancreatography
527881|NCT01315522|Endoscopic Retrograde|endoscopic retrograde
527882|NCT01315509|Severe mental illness|severe mental illness
527883|NCT01315509|Dental measures|dental measures
527884|NCT01315509|Resistant depression|resistant depression
527885|NCT01315496|Human Immunoglobulin G|human immunoglobulin g
527886|NCT01315496|Sepsis|sepsis
527887|NCT01315496|Septic shock|septic shock
527888|NCT01315483|Breast cancer|breast cancer
527889|NCT01315483|survivors|survivors
527890|NCT01315483|weight lose|weight lose
527891|NCT01315483|dietary pattern|dietary pattern
527892|NCT01315470|improving pregnancy rate and endometrial thickness|improving pregnancy rate and endometrial thickness
528136|NCT01314404|Human papillomavirus|human papillomavirus
527893|NCT01315457|alemtuzumab, infection, prophylaxis, treatment|alemtuzumab, infection, prophylaxis, treatment
527894|NCT01315431|Solid tumor malignancy, excluding lymphoma|solid tumor malignancy, excluding lymphoma
527895|NCT01315418|Probiotic - Lactobacillus casei DN-114 001 - dairy product -|probiotic - lactobacillus casei dn-114 001 - dairy product -
527896|NCT01315418|infections - firemen|infections - firemen
527897|NCT01315418|Common infectious diseases, occuring in healthy subjects,|common infectious diseases, occuring in healthy subjects,
527898|NCT01315418|including upper respiratory tract infections (defined as|including upper respiratory tract infections (defined as
527899|NCT01315418|rhinopharyngitis, sore throat, sinusitis and otitis)|rhinopharyngitis, sore throat, sinusitis and otitis)
527900|NCT01315418|lower respiratory tract infections (defined as bronchitis|lower respiratory tract infections (defined as bronchitis
527901|NCT01315418|pneumopathy and flu and flu-like syndromes)|pneumopathy and flu and flu-like syndromes)
527902|NCT01315418|gastrointestinal tract infection defined as gastroenteritis|gastrointestinal tract infection defined as gastroenteritis
527903|NCT01315405|Emotional facial expression|emotional facial expression
527904|NCT01315405|Apathy|apathy
527905|NCT01315405|Mirror neurons|mirror neurons
527906|NCT01315379|Prolonged Exposure|prolonged exposure
527908|NCT01315379|PTSD|ptsd
527909|NCT01315379|Mild Traumatic Brain Injury|mild traumatic brain injury
527910|NCT01315379|Post Concussive Syndrome|post concussive syndrome
527911|NCT01315366|Vitamin D|vitamin d
527912|NCT01315366|Elderly|elderly
527913|NCT01315366|Cardiovascular profile|cardiovascular profile
527914|NCT01315366|Insulin resistance|insulin resistance
527915|NCT01315366|Gene polymorphisms|gene polymorphisms
527916|NCT01315327|Tourette's Disorder, Obsessive-Compulsive Disorder, tics|tourette's disorder, obsessive-compulsive disorder, tics
527917|NCT01315314|Glucose degradation products|glucose degradation products
527918|NCT01315314|Inflammation|inflammation
527919|NCT01315314|Endothelial dysfunction|endothelial dysfunction
527920|NCT01315314|Soluble adhesion molecules|soluble adhesion molecules
527921|NCT01315314|Peritoneal dialysis|peritoneal dialysis
527922|NCT01315301|Efavirenz|efavirenz
527923|NCT01315301|Rifampicin|rifampicin
527924|NCT01315301|HAART|haart
527925|NCT01315301|Anti Tuberculosis|anti tuberculosis
527926|NCT01315288|Medical decision making|medical decision making
527927|NCT01315288|Asymptomatic Carotid Stenosis|asymptomatic carotid stenosis
527928|NCT01315275|visual impairment|visual impairment
527929|NCT01315275|macular edema|macular edema
527930|NCT01315275|ranibizumab|ranibizumab
527931|NCT01315275|visual impairment due to macular edema|visual impairment due to macular edema
527932|NCT01315262|Sildenafil 100|sildenafil 100
527933|NCT01315262|restoring erectile function after radical prostatectomy|restoring erectile function after radical prostatectomy
527934|NCT01315249|QVA149|qva149
527935|NCT01315249|indacaterol|indacaterol
527936|NCT01315249|NVA237|nva237
527937|NCT01315249|COPD|copd
527938|NCT01315249|fluticasone/salmeterol|fluticasone/salmeterol
527939|NCT01315236|Amikacin Liposome Inhalation Suspension (ALIS)|amikacin liposome inhalation suspension (alis)
527940|NCT01315236|Arikayce|arikayce
527941|NCT01315210|Fibromyalgia|fibromyalgia
527942|NCT01315210|Fatigue|fatigue
527943|NCT01315210|D-Ribose|d-ribose
527944|NCT01315197|Low back Pain|low back pain
527945|NCT01315184|Interactive Voice Response|interactive voice response
527946|NCT01315184|Computer-based Treatment|computer-based treatment
527947|NCT01315184|Opioid Agonist|opioid agonist
527948|NCT01315184|Buprenorphine|buprenorphine
527949|NCT01315184|Methadone|methadone
527950|NCT01315171|medium chain triglycerides|medium chain triglycerides
527951|NCT01315171|hypoglycemia|hypoglycemia
527952|NCT01315171|cognitive function|cognitive function
527953|NCT01315171|functional MRI|functional mri
527954|NCT01315158|Obstructive Sleep Apnea|obstructive sleep apnea
527955|NCT01315158|Body Mass Index|body mass index
527956|NCT01315132|Myeloablative Hematopoietic Stem Cell Transplant|myeloablative hematopoietic stem cell transplant
527957|NCT01315132|Cyclophosphamide tolerization|cyclophosphamide tolerization
527958|NCT01315132|2 Step Approach|2 step approach
527959|NCT01315132|Hematological malignancies|hematological malignancies
527960|NCT01315132|leukemia|leukemia
527961|NCT01315132|lymphoma|lymphoma
527962|NCT01315132|multiple myeloma|multiple myeloma
527963|NCT01315132|Hodgkin's Disease|hodgkin's disease
527964|NCT01315093|In Vitro Fertilisation|in vitro fertilisation
527965|NCT01315093|poor responders|poor responders
527966|NCT01315080|mammillary fistula|mammillary fistula
527967|NCT01315080|triamcinolone|triamcinolone
527968|NCT01315080|ultrasound management|ultrasound management
527969|NCT01315080|percutaneous treatment|percutaneous treatment
527970|NCT01315067|kidney transplantation|kidney transplantation
527971|NCT01315067|acute rejection|acute rejection
527972|NCT01315067|diagnosis|diagnosis
527973|NCT01315067|urine analysis|urine analysis
527974|NCT01315067|urinary peptides|urinary peptides
527975|NCT01315067|mass spectrometry|mass spectrometry
527976|NCT01315067|allograft biopsy|allograft biopsy
527977|NCT01315067|pathology|pathology
527978|NCT01315067|diagnostic study|diagnostic study
527979|NCT01315054|IDUs|idus
527980|NCT01315054|high risk behaviors|high risk behaviors
527981|NCT01315054|HIV|hiv
527982|NCT01315054|MMT dosage and retention|mmt dosage and retention
527983|NCT01315054|psychosocial services|psychosocial services
527984|NCT01315028|mania|mania
527985|NCT01315028|hypomania|hypomania
527986|NCT01315028|bipolar affective disorder|bipolar affective disorder
527987|NCT01315028|psychological intervention|psychological intervention
527988|NCT01315028|cognitive therapy|cognitive therapy
527989|NCT01315015|Breast cancer|breast cancer
527990|NCT01315015|Breast neoplasm|breast neoplasm
527991|NCT01315015|Magnetic Resonance Imaging|magnetic resonance imaging
527992|NCT01315015|Breast density|breast density
527993|NCT01315015|Early detection of cancer|early detection of cancer
527994|NCT01315015|Cancer screening test|cancer screening test
527995|NCT01315015|Secondary prevention|secondary prevention
527996|NCT01315002|nicotine|nicotine
527997|NCT01315002|schizophrenia|schizophrenia
527998|NCT01315002|endophenotype|endophenotype
527999|NCT01314976|Children|children
528000|NCT01314976|parasite|parasite
528001|NCT01314976|intestinal|intestinal
528002|NCT01314976|treatment|treatment
528003|NCT01314976|RCT|rct
528004|NCT01314937|preschool-age children|preschool-age children
528005|NCT01314937|soil-transmitted helminths|soil-transmitted helminths
528006|NCT01314937|growth|growth
528007|NCT01314937|development|development
528008|NCT01314937|deworming|deworming
528009|NCT01314924|Hypertension|hypertension
528010|NCT01314924|Endothelial dysfunction|endothelial dysfunction
528011|NCT01314924|Vascular stiffness|vascular stiffness
528012|NCT01314924|Use of one or two antihypertensive drugs|use of one or two antihypertensive drugs
528013|NCT01314911|H1N1|h1n1
528014|NCT01314911|Complications|complications
528015|NCT01314911|PCR|pcr
528016|NCT01314911|Seasonal Influenza|seasonal influenza
528017|NCT01314911|Viral Shedding|viral shedding
528018|NCT01314898|Single dose|single dose
528019|NCT01314898|cross-over|cross-over
528020|NCT01314898|active-control|active-control
528021|NCT01314898|placebo control|placebo control
528022|NCT01314898|antimineralocorticoid activity|antimineralocorticoid activity
528023|NCT01314885|Healthy|healthy
528024|NCT01314872|Overactive bladder|overactive bladder
528025|NCT01314872|MK-4618|mk-4618
528026|NCT01314872|tolterodine|tolterodine
528027|NCT01314859|Nifedipine|nifedipine
528028|NCT01314859|Obstetric Labor|obstetric labor
528029|NCT01314859|Premature|premature
528030|NCT01314859|Tocolysis|tocolysis
528031|NCT01314833|Luminal A|luminal a
528032|NCT01314833|Luminal B|luminal b
528033|NCT01314833|Her-2 overexpression|her-2 overexpression
528034|NCT01314833|DFS|dfs
528035|NCT01314833|DDFS|ddfs
528036|NCT01314833|OS|os
528037|NCT01314820|Knee|knee
528038|NCT01314820|Osteoarthritis|osteoarthritis
528039|NCT01314820|Effusion.|effusion.
528040|NCT01314807|COPD|copd
528041|NCT01314781|Overactive Bladder|overactive bladder
528042|NCT01314781|urinary frequency|urinary frequency
528043|NCT01314755|Head and Neck neoplasm|head and neck neoplasm
528044|NCT01314755|Nutrition|nutrition
528045|NCT01314755|Carcinoma|carcinoma
528046|NCT01314755|Infection|infection
528047|NCT01314755|Post-operative|post-operative
528048|NCT01314755|Surgery|surgery
528049|NCT01314755|Immune-enhancing|immune-enhancing
528050|NCT01314742|neonates|neonates
528051|NCT01314742|mechanical ventilation|mechanical ventilation
528052|NCT01314742|oral care|oral care
528053|NCT01314742|duration of mechanical ventilation|duration of mechanical ventilation
528054|NCT01314742|feasibility|feasibility
528055|NCT01314742|ventilator-associated pneumonia|ventilator-associated pneumonia
528056|NCT01314729|Orthodontic fixed retainer|orthodontic fixed retainer
528057|NCT01314729|fiber-reinforced-composite retainer|fiber-reinforced-composite retainer
528058|NCT01314729|composite-wire retainer|composite-wire retainer
528059|NCT01314690|obesity|obesity
528060|NCT01314690|low calorie diet|low calorie diet
528061|NCT01314690|intestinal microbiota|intestinal microbiota
528157|NCT01314313|Transfemoral|transfemoral
528062|NCT01314690|inflammation (systemic and in adipose tissue)|inflammation (systemic and in adipose tissue)
528063|NCT01314690|fat mass|fat mass
528064|NCT01314690|Impact of nutritional transition on intestinal microbiota|impact of nutritional transition on intestinal microbiota
528065|NCT01314690|relation between food intake, clinical parameters and intestinal microbiota|relation between food intake, clinical parameters and intestinal microbiota
528066|NCT01314664|Non-Muscle Invasive Bladder Cancer|non-muscle invasive bladder cancer
528068|NCT01314664|BCG Refractory|bcg refractory
528069|NCT01314651|Migraine Disorders|migraine disorders
528070|NCT01314651|Chronic migraine|chronic migraine
528071|NCT01314651|Insomnia|insomnia
528072|NCT01314651|Behavioral sleep management|behavioral sleep management
528073|NCT01314612|Insomnia|insomnia
528074|NCT01314612|group psychotherapy|group psychotherapy
528075|NCT01314612|nightmares|nightmares
528076|NCT01314612|PTSD|ptsd
528077|NCT01314612|posttraumatic stress disorder|posttraumatic stress disorder
528078|NCT01314612|Veterans|veterans
528079|NCT01314612|cognitive-behavioral intervention|cognitive-behavioral intervention
528080|NCT01314599|Leukemia|leukemia
528081|NCT01314599|lurbinectedin|lurbinectedin
528082|NCT01314599|PM01183|pm01183
528083|NCT01314599|Pharma Mar|pharma mar
528084|NCT01314599|Acute Leukemia in Relapse and Primary Refractory|acute leukemia in relapse and primary refractory
528085|NCT01314586|hypercholesterolemia|hypercholesterolemia
528086|NCT01314586|postmenopause|postmenopause
528087|NCT01314586|secoisolariciresinol diglucoside|secoisolariciresinol diglucoside
528088|NCT01314586|flaxseed|flaxseed
528089|NCT01314586|lignans|lignans
528090|NCT01314586|enterolactone|enterolactone
528091|NCT01314586|enterodiol|enterodiol
528092|NCT01314586|serum cholesterol|serum cholesterol
528093|NCT01314586|LDL cholesterol|ldl cholesterol
528094|NCT01314573|High intensity exercise training|high intensity exercise training
528095|NCT01314573|Vascular health|vascular health
528096|NCT01314573|Endothelial function|endothelial function
528097|NCT01314573|Circulating angiogenic cells|circulating angiogenic cells
528098|NCT01314573|endothelial progenitor cells|endothelial progenitor cells
528099|NCT01314573|Aerobic capacity|aerobic capacity
528100|NCT01314573|Arterial stiffness|arterial stiffness
528101|NCT01314573|Traditional and emerging cardiovascular disease risk factors|traditional and emerging cardiovascular disease risk factors
528102|NCT01314560|Lowe syndrome|lowe syndrome
528103|NCT01314560|OCRL|ocrl
528104|NCT01314560|Haemostasis|haemostasis
528105|NCT01314560|Bleeding Disorders|bleeding disorders
528106|NCT01314560|Platelet Function Tests|platelet function tests
528107|NCT01314547|Environment|environment
528108|NCT01314547|spondylarthritis|spondylarthritis
528109|NCT01314547|vasculitis|vasculitis
528110|NCT01314547|stress|stress
671027|NCT00745511|AMD|amd
528111|NCT01314547|life event|life event
528112|NCT01314547|vaccine|vaccine
528113|NCT01314534|Kabuki syndrome|kabuki syndrome
528114|NCT01314534|Genetic|genetic
528115|NCT01314534|CGH-array|cgh-array
528116|NCT01314521|Suicide|suicide
528117|NCT01314521|Depression|depression
528118|NCT01314521|Adolescents|adolescents
528119|NCT01314508|pre-pubertal children|pre-pubertal children
528120|NCT01314508|pre-transplant|pre-transplant
528121|NCT01314508|not treated with growth hormone for at least 3 months|not treated with growth hormone for at least 3 months
528122|NCT01314495|Alopecia Areata|alopecia areata
528123|NCT01314482|Neuropathic pain|neuropathic pain
528124|NCT01314482|Minocycline|minocycline
528125|NCT01314469|Quality of life in patients with macular edema compared to patients without macular edema.|quality of life in patients with macular edema compared to patients without macular edema.
528126|NCT01314456|Prostate biopsy|prostate biopsy
528127|NCT01314456|Trans-rectal ultrasound|trans-rectal ultrasound
528128|NCT01314456|Prostate cancer|prostate cancer
528129|NCT01314443|smoking cessation|smoking cessation
528130|NCT01314443|gamma-tocopherol|gamma-tocopherol
528131|NCT01314443|nicotine-replacement therapy|nicotine-replacement therapy
528132|NCT01314443|oxidative stress|oxidative stress
528133|NCT01314417|Uveitis|uveitis
528134|NCT01314417|Macular Edema|macular edema
528135|NCT01314417|Methotrexate|methotrexate
528137|NCT01314404|Prevalence|prevalence
528138|NCT01314404|Knowledge Attitude and Practice|knowledge attitude and practice
528139|NCT01314404|Willingness to Participate|willingness to participate
528140|NCT01314404|Vaccine|vaccine
528141|NCT01314404|HPV|hpv
528142|NCT01314391|stage I Wilms tumor|stage i wilms tumor
528143|NCT01314391|stage II Wilms tumor|stage ii wilms tumor
528144|NCT01314391|stage III Wilms tumor|stage iii wilms tumor
528145|NCT01314391|stage IV Wilms tumor|stage iv wilms tumor
528146|NCT01314391|stage V Wilms tumor|stage v wilms tumor
528147|NCT01314391|renal failure|renal failure
528148|NCT01314378|Mindfulness|mindfulness
528149|NCT01314378|Cognitive behavioral therapy|cognitive behavioral therapy
528150|NCT01314378|Smoking|smoking
528151|NCT01314378|Impulsivity|impulsivity
528152|NCT01314378|Inhibitory Control|inhibitory control
528153|NCT01314326|Optical Coherence Tomography|optical coherence tomography
528154|NCT01314326|Glaucoma|glaucoma
528155|NCT01314326|Advanced Imaging|advanced imaging
528156|NCT01314313|SAPIEN XT|sapien xt
528160|NCT01314313|NovaFlex|novaflex
528162|NCT01314313|Aortic Stenosis|aortic stenosis
528163|NCT01314313|THV|thv
528164|NCT01314313|Aortic Valve|aortic valve
528165|NCT01314313|Transcatheter Heart Valve|transcatheter heart valve
528166|NCT01314313|TAVR|tavr
528167|NCT01314300|Child, adolescent, young adult|child, adolescent, young adult
528168|NCT01314300|Plaster|plaster
528169|NCT01314300|Lidocaine|lidocaine
528170|NCT01314287|Anaesthesia|anaesthesia
528171|NCT01314287|pulmonary complications|pulmonary complications
528172|NCT01314287|Atelectasis|atelectasis
528173|NCT01314274|Epistaxis|epistaxis
528174|NCT01314274|Osler|osler
528175|NCT01314274|Weber|weber
528176|NCT01314274|Rendu|rendu
528177|NCT01314274|HHT|hht
528178|NCT01314274|Hereditary haemorrhagic telangiectasia|hereditary haemorrhagic telangiectasia
528179|NCT01314248|airway sealing pressure|airway sealing pressure
528180|NCT01314248|fiberoptic assessment|fiberoptic assessment
528181|NCT01314248|ease and time for successful insertion|ease and time for successful insertion
528182|NCT01314248|incidence of gastric insufflation|incidence of gastric insufflation
528183|NCT01314248|complications were also evaluated|complications were also evaluated
528184|NCT01314235|anticoagulation with ASS|anticoagulation with ass
528185|NCT01314235|anticoagulation with clopidogrel|anticoagulation with clopidogrel
528186|NCT01314209|dexmedetomidine|dexmedetomidine
528187|NCT01314209|pharmacokinetics|pharmacokinetics
528188|NCT01314209|critical illness|critical illness
528189|NCT01314209|continuous renal replacement therapy|continuous renal replacement therapy
528190|NCT01314196|biceps|biceps
528191|NCT01314196|resistance training|resistance training
528192|NCT01314196|rehabilitation|rehabilitation
528193|NCT01314196|impact syndrome|impact syndrome
528194|NCT01314183|Knee|knee
528195|NCT01314183|Physical Therapy|physical therapy
528196|NCT01314183|Exercise|exercise
528197|NCT01314170|Implant, glaucoma, refractory glaucoma.|implant, glaucoma, refractory glaucoma.
528198|NCT01314157|low back pain|low back pain
528199|NCT01314157|pain|pain
528200|NCT01314157|incapacity|incapacity
528201|NCT01314157|life quality|life quality
528202|NCT01314157|rehabilitation|rehabilitation
528203|NCT01314144|axillary clearance|axillary clearance
528204|NCT01314144|wound infiltration|wound infiltration
528205|NCT01314144|wound infusion|wound infusion
528206|NCT01314144|local anaesthetic wound infusion|local anaesthetic wound infusion
528207|NCT01314118|abiraterone acetate|abiraterone acetate
528208|NCT01314118|prednisone|prednisone
528209|NCT01314118|zytiga|zytiga
528210|NCT01314092|crohn's disease|crohn's disease
528211|NCT01314092|fistula|fistula
528212|NCT01314092|complex|complex
528213|NCT01314079|Crohn's fistula|crohn's fistula
528214|NCT01314079|Autologous adipose derived stem cell|autologous adipose derived stem cell
528215|NCT01314053|Daptomycin|daptomycin
528216|NCT01314053|Serious Gram-positive Infections|serious gram-positive infections
528217|NCT01314040|Dietary protein|dietary protein
528218|NCT01314040|Biomarkers|biomarkers
528219|NCT01314040|filtration rate|filtration rate
528220|NCT01314040|urinary acid excretion|urinary acid excretion
528221|NCT01314014|Non Hodgkin's Lymphoma|non hodgkin's lymphoma
528222|NCT01314014|Lymphoma, Low Grade|lymphoma, low grade
528223|NCT01314014|Lymphoma, Intermediate Grade|lymphoma, intermediate grade
528224|NCT01314014|Lymphoma, High Grade|lymphoma, high grade
528225|NCT01314014|Lymphoma, B Cell|lymphoma, b cell
528226|NCT01314001|Tobacco, Smoking, Varenicline, Nicotine Patch|tobacco, smoking, varenicline, nicotine patch
528227|NCT01313988|dose-response study|dose-response study
528228|NCT01313988|blood lipid profile|blood lipid profile
528229|NCT01313988|plant sterols|plant sterols
528230|NCT01313988|fish oil|fish oil
528231|NCT01313975|Electrolyte disturbances|electrolyte disturbances
528232|NCT01313975|Fluid balance|fluid balance
528233|NCT01313975|subarachnoid hemorrhage|subarachnoid hemorrhage
528234|NCT01313975|traumatic brain injury|traumatic brain injury
528235|NCT01313975|Cerebral salt wasting|cerebral salt wasting
528236|NCT01313975|SIADH|siadh
528237|NCT01313975|Diabetes insipidus|diabetes insipidus
528238|NCT01313962|antiviral|antiviral
528239|NCT01313962|intranasal|intranasal
528240|NCT01313962|influenza|influenza
528241|NCT01313949|Diabetes|diabetes
528242|NCT01313949|Peer Support|peer support
528243|NCT01313949|Structured Care|structured care
528244|NCT01313936|Neuroblastoma|neuroblastoma
528245|NCT01313936|MIBG|mibg
528246|NCT01313936|131I-MIBG|131i-mibg
528247|NCT01313936|Irinotecan|irinotecan
528248|NCT01313936|Vincristine|vincristine
528249|NCT01313936|Resistant|resistant
528250|NCT01313936|Relapsed|relapsed
528251|NCT01313936|Treatment|treatment
528252|NCT01313936|UCSF|ucsf
528253|NCT01313936|Pediatric|pediatric
528254|NCT01313936|Oncology|oncology
528255|NCT01313923|Pemphigus|pemphigus
528256|NCT01313910|HIV|hiv
528257|NCT01313910|diarrhea|diarrhea
528258|NCT01313897|Multiple Myeloma|multiple myeloma
528259|NCT01313832|ventricular septal defect|ventricular septal defect
528260|NCT01313832|remote ischemic preconditioning|remote ischemic preconditioning
528261|NCT01313832|pulmonary hypertension|pulmonary hypertension
528262|NCT01313832|infant with ventricular septal defect and pulmonary hypertension|infant with ventricular septal defect and pulmonary hypertension
528263|NCT01313819|Freezing|freezing
528264|NCT01313806|dementia|dementia
528265|NCT01313806|memory loss|memory loss
528266|NCT01313806|cognitive decline|cognitive decline
528267|NCT01313793|Bioequivalence (BE) Study|bioequivalence (be) study
528268|NCT01313793|Healthy Volunteers|healthy volunteers
528269|NCT01313780|cancer related pain|cancer related pain
528270|NCT01313767|spasticity|spasticity
528271|NCT01313767|upperlimb|upperlimb
528272|NCT01313767|Botulinum toxin|botulinum toxin
528273|NCT01313754|Skin closure|skin closure
528274|NCT01313754|dermabond|dermabond
528275|NCT01313754|vicryl|vicryl
528276|NCT01313754|monocryl|monocryl
528277|NCT01313754|Suburethral sling|suburethral sling
528278|NCT01313754|Transobturator Sling|transobturator sling
528279|NCT01313754|Pain|pain
528280|NCT01313754|Discomfort|discomfort
528281|NCT01313754|Skin irritation|skin irritation
528282|NCT01313728|Acne|acne
528283|NCT01313728|Irritation|irritation
528284|NCT01313715|Safety|safety
528285|NCT01313715|Immunogenicity|immunogenicity
528286|NCT01313715|inactivated EV71 vaccine|inactivated ev71 vaccine
528287|NCT01313702|polypill, compliance, cardiovascular disease|polypill, compliance, cardiovascular disease
528288|NCT01313689|OMB157|omb157
528289|NCT01313689|Lymphocytic|lymphocytic
528290|NCT01313689|Chronic|chronic
528291|NCT01313689|Safety|safety
528292|NCT01313689|Refractory|refractory
528293|NCT01313689|Chronic Lymphocytic Leukemia|chronic lymphocytic leukemia
528294|NCT01313689|Oncology|oncology
528295|NCT01313689|Ofatumumab|ofatumumab
528296|NCT01313689|Efficacy|efficacy
528297|NCT01313689|Physicians' Choice|physicians' choice
528298|NCT01313689|Bulky Fludarabine Refractory Chronic Lymphocytic Leukemia|bulky fludarabine refractory chronic lymphocytic leukemia
528299|NCT01313689|CLL|cll
528300|NCT01313676|COPD|copd
528301|NCT01313676|Cardiovascular disease|cardiovascular disease
528302|NCT01313676|Novel Dry Powder Inhaler|novel dry powder inhaler
528303|NCT01313676|Survival|survival
528304|NCT01313663|GW786034|gw786034
528305|NCT01313663|non-small cell lung cancer|non-small cell lung cancer
528306|NCT01313663|NSCLC|nsclc
528307|NCT01313663|pemetrexed|pemetrexed
528308|NCT01313663|pazopanib|pazopanib
528309|NCT01313650|long-acting beta agonist|long-acting beta agonist
528310|NCT01313650|anticholinergic|anticholinergic
528311|NCT01313637|anticholinergic|anticholinergic
671222|NCT00744692|MPS|mps
528312|NCT01313637|long-acting beta agonist|long-acting beta agonist
528313|NCT01313598|Patients with solid tumors|patients with solid tumors
528314|NCT01313598|Treatment-refractory|treatment-refractory
528315|NCT01313585|Primary care|primary care
528316|NCT01313585|asthma management|asthma management
528317|NCT01313585|inhaler device|inhaler device
528318|NCT01313585|maintenance therapy|maintenance therapy
528319|NCT01313585|reliever therapy|reliever therapy
528320|NCT01313585|Easibreathe salbutamol|easibreathe salbutamol
528321|NCT01313572|Coronary Artery Disease|coronary artery disease
528322|NCT01313572|Myocardial Perfusion Imaging|myocardial perfusion imaging
528323|NCT01313559|Castrate Resistant|castrate resistant
528324|NCT01313559|Chemotherapy Naive|chemotherapy naive
528325|NCT01313559|Prostate Cancer|prostate cancer
528326|NCT01313559|SOM230|som230
528327|NCT01313559|Everolimus|everolimus
528328|NCT01313546|Femoral nerve block|femoral nerve block
528329|NCT01313546|total knee arthroplasty|total knee arthroplasty
528330|NCT01313533|Atherosclerosis of Autologous Vein Bypass Graft|atherosclerosis of autologous vein bypass graft
528331|NCT01313507|Primary Immunodeficiency Disease|primary immunodeficiency disease
528332|NCT01313507|PID|pid
528333|NCT01313494|COPD|copd
528334|NCT01313494|Roflumilast|roflumilast
528335|NCT01313494|FEV1|fev1
528336|NCT01313494|China|china
528337|NCT01313481|Older persons|older persons
528338|NCT01313481|Exercise|exercise
528339|NCT01313481|Balance|balance
528340|NCT01313468|NEAT|neat
528341|NCT01313468|maximal oxygen uptake|maximal oxygen uptake
528342|NCT01313468|stroke volume|stroke volume
528343|NCT01313455|Oligomenorrhea|oligomenorrhea
528344|NCT01313455|Adrenal Hyperplasia|adrenal hyperplasia
528345|NCT01313455|Obesity|obesity
528346|NCT01313455|Hyperandrogenism|hyperandrogenism
528347|NCT01313455|Polycystic Ovarian Syndrome|polycystic ovarian syndrome
528348|NCT01313455|PCOS|pcos
528349|NCT01313455|Polycystic Ovary|polycystic ovary
528350|NCT01313455|Healthy Volunteer|healthy volunteer
528351|NCT01313455|HV|hv
528352|NCT01313442|Gut Microbiota|gut microbiota
528353|NCT01313442|Analysis of immune subsets with regard to their function|analysis of immune subsets with regard to their function
528354|NCT01313442|Samples|samples
528355|NCT01313442|Gastrointestinal Cancer|gastrointestinal cancer
528356|NCT01313442|Gastrointestinal Tract Cancer|gastrointestinal tract cancer
528357|NCT01313429|Metastatic Cancer|metastatic cancer
528358|NCT01313429|Cancer Vaccine|cancer vaccine
528359|NCT01313429|Immunotherapy|immunotherapy
528360|NCT01313429|Adjuvant Therapy|adjuvant therapy
528434|NCT01313208|DMARD|dmard
528361|NCT01313429|Chest Metastases|chest metastases
528362|NCT01313429|Cancer|cancer
528363|NCT01313429|Melanoma|melanoma
528364|NCT01313429|Lung Cancer|lung cancer
528365|NCT01313429|Sarcoma|sarcoma
528366|NCT01313416|Adjuvant Therapy|adjuvant therapy
528367|NCT01313416|Recombinant Monoclonal Antibody|recombinant monoclonal antibody
528368|NCT01313416|Adenocarcinoma of the Pancreas|adenocarcinoma of the pancreas
528369|NCT01313416|Vaccination|vaccination
528370|NCT01313416|PD-1 Receptor|pd-1 receptor
528371|NCT01313416|Pancreas Cancer|pancreas cancer
528372|NCT01313416|Pancreatic Cancer|pancreatic cancer
528373|NCT01313403|5-HT1A Receptors|5-ht1a receptors
528374|NCT01313403|Major Depression|major depression
528375|NCT01313403|PET Imaging|pet imaging
528376|NCT01313403|Depression|depression
528377|NCT01313403|Healthy Volunteer|healthy volunteer
528378|NCT01313403|HV|hv
528379|NCT01313390|recurrent squamous cell carcinoma of the hypopharynx|recurrent squamous cell carcinoma of the hypopharynx
528380|NCT01313390|stage III squamous cell carcinoma of the hypopharynx|stage iii squamous cell carcinoma of the hypopharynx
528381|NCT01313390|stage IV squamous cell carcinoma of the hypopharynx|stage iv squamous cell carcinoma of the hypopharynx
528382|NCT01313390|stage III squamous cell carcinoma of the larynx|stage iii squamous cell carcinoma of the larynx
528383|NCT01313390|stage III verrucous carcinoma of the larynx|stage iii verrucous carcinoma of the larynx
528384|NCT01313390|stage IV squamous cell carcinoma of the larynx|stage iv squamous cell carcinoma of the larynx
528385|NCT01313390|stage IV verrucous carcinoma of the larynx|stage iv verrucous carcinoma of the larynx
528386|NCT01313390|recurrent squamous cell carcinoma of the larynx|recurrent squamous cell carcinoma of the larynx
528387|NCT01313390|recurrent verrucous carcinoma of the larynx|recurrent verrucous carcinoma of the larynx
528388|NCT01313390|recurrent squamous cell carcinoma of the lip and oral cavity|recurrent squamous cell carcinoma of the lip and oral cavity
528389|NCT01313390|stage III squamous cell carcinoma of the lip and oral cavity|stage iii squamous cell carcinoma of the lip and oral cavity
528390|NCT01313390|stage IV squamous cell carcinoma of the lip and oral cavity|stage iv squamous cell carcinoma of the lip and oral cavity
528391|NCT01313390|recurrent verrucous carcinoma of the oral cavity|recurrent verrucous carcinoma of the oral cavity
528392|NCT01313390|stage III verrucous carcinoma of the oral cavity|stage iii verrucous carcinoma of the oral cavity
528393|NCT01313390|stage IV verrucous carcinoma of the oral cavity|stage iv verrucous carcinoma of the oral cavity
528394|NCT01313390|metastatic squamous neck cancer with occult primary squamous cell carcinoma|metastatic squamous neck cancer with occult primary squamous cell carcinoma
528395|NCT01313390|recurrent metastatic squamous neck cancer with occult primary|recurrent metastatic squamous neck cancer with occult primary
528396|NCT01313390|recurrent squamous cell carcinoma of the nasopharynx|recurrent squamous cell carcinoma of the nasopharynx
528397|NCT01313390|stage III squamous cell carcinoma of the nasopharynx|stage iii squamous cell carcinoma of the nasopharynx
528398|NCT01313390|stage IV squamous cell carcinoma of the nasopharynx|stage iv squamous cell carcinoma of the nasopharynx
528399|NCT01313390|recurrent squamous cell carcinoma of the oropharynx|recurrent squamous cell carcinoma of the oropharynx
528400|NCT01313390|stage III squamous cell carcinoma of the oropharynx|stage iii squamous cell carcinoma of the oropharynx
528401|NCT01313390|stage IV squamous cell carcinoma of the oropharynx|stage iv squamous cell carcinoma of the oropharynx
528402|NCT01313390|recurrent squamous cell carcinoma of the paranasal sinus and nasal cavity|recurrent squamous cell carcinoma of the paranasal sinus and nasal cavity
528403|NCT01313390|stage III squamous cell carcinoma of the paranasal sinus and nasal cavity|stage iii squamous cell carcinoma of the paranasal sinus and nasal cavity
528404|NCT01313390|stage IV squamous cell carcinoma of the paranasal sinus and nasal cavity|stage iv squamous cell carcinoma of the paranasal sinus and nasal cavity
528405|NCT01313390|recurrent salivary gland cancer|recurrent salivary gland cancer
528406|NCT01313390|salivary gland squamous cell carcinoma|salivary gland squamous cell carcinoma
528407|NCT01313390|stage III salivary gland cancer|stage iii salivary gland cancer
528408|NCT01313390|stage IV salivary gland cancer|stage iv salivary gland cancer
528409|NCT01313390|tongue cancer|tongue cancer
528410|NCT01313377|adenocarcinoma of the extrahepatic bile duct|adenocarcinoma of the extrahepatic bile duct
528411|NCT01313377|cholangiocarcinoma of the extrahepatic bile duct|cholangiocarcinoma of the extrahepatic bile duct
528412|NCT01313377|liver and intrahepatic biliary tract cancer|liver and intrahepatic biliary tract cancer
528413|NCT01313377|localized extrahepatic bile duct cancer|localized extrahepatic bile duct cancer
528414|NCT01313377|adenocarcinoma of the gallbladder|adenocarcinoma of the gallbladder
528415|NCT01313377|cholangiocarcinoma of the gallbladder|cholangiocarcinoma of the gallbladder
528416|NCT01313377|localized gallbladder cancer|localized gallbladder cancer
528417|NCT01313325|hippotherapy|hippotherapy
528418|NCT01313325|neuromuscular disorders|neuromuscular disorders
528419|NCT01313325|balance deficits|balance deficits
528420|NCT01313325|participation|participation
528421|NCT01313286|Diabetes Mellitus, Type 2|diabetes mellitus, type 2
528422|NCT01313260|Refractory partial epilepsies|refractory partial epilepsies
528423|NCT01313247|Paracetamol|paracetamol
528424|NCT01313247|opioids|opioids
528425|NCT01313247|cancer pain|cancer pain
528426|NCT01313221|plaque psoriasis|plaque psoriasis
528427|NCT01313221|moderate|moderate
528428|NCT01313221|severe|severe
528429|NCT01313221|etanercept|etanercept
528430|NCT01313221|Enbrel|enbrel
528431|NCT01313221|topical|topical
528432|NCT01313208|RA|ra
528433|NCT01313208|Enbrel|enbrel
528435|NCT01313208|Joint Count|joint count
528436|NCT01313208|Rheumatoid Arthritis|rheumatoid arthritis
528437|NCT01313208|Etanercept|etanercept
528438|NCT01313208|disease modifying anti-rheumatic drug|disease modifying anti-rheumatic drug
528439|NCT01313169|Electronic medical record reminders, Panel management|electronic medical record reminders, panel management
528440|NCT01313156|Metabolic Syndrome, Syndrome X, MetS,|metabolic syndrome, syndrome x, mets,
528441|NCT01313156|Type 2 Diabetes|type 2 diabetes
528442|NCT01313143|AOP200704, Esmolol, Pharmacokinetics, Pharmacodynamics|aop200704, esmolol, pharmacokinetics, pharmacodynamics
528443|NCT01313130|traumatic brain injury|traumatic brain injury
528444|NCT01313130|post traumatic stress disorder|post traumatic stress disorder
528445|NCT01313130|Diffusion tensor imaging|diffusion tensor imaging
528446|NCT01313130|resting state functional connectivity|resting state functional connectivity
528447|NCT01313130|genetic factors|genetic factors
528448|NCT01313117|chemotherapy|chemotherapy
528449|NCT01313117|peripheral neuropathy|peripheral neuropathy
528450|NCT01313117|paclitaxel|paclitaxel
528451|NCT01313117|breast cancer|breast cancer
528452|NCT01313078|Ovarian Cancer|ovarian cancer
528453|NCT01313078|Fallopian Tube Cancer|fallopian tube cancer
528454|NCT01313078|Primary Peritoneal Cancer|primary peritoneal cancer
528455|NCT01313078|Relapsed or Refractory|relapsed or refractory
528456|NCT01313078|Pegaspargase|pegaspargase
528457|NCT01313078|Pegylated L-Asparaginase|pegylated l-asparaginase
528458|NCT01313065|VX15/2503|vx15/2503
528459|NCT01313065|Semaphorin 4D|semaphorin 4d
528460|NCT01313065|SEMA4D|sema4d
528461|NCT01313065|CD100|cd100
528462|NCT01313065|safety|safety
528463|NCT01313065|tolerability|tolerability
528464|NCT01313065|pharmacokinetics|pharmacokinetics
528465|NCT01313065|pharmacodynamics|pharmacodynamics
528466|NCT01313065|advanced solid tumors|advanced solid tumors
528467|NCT01313052|Psychotic|psychotic
528468|NCT01313052|Criminal|criminal
528469|NCT01313039|Breast Cancer|breast cancer
528470|NCT01313039|ER-negative|er-negative
528471|NCT01313039|Allred Score|allred score
528472|NCT01313026|Percutaneous nerve evaluation|percutaneous nerve evaluation
528473|NCT01313026|Transanal irrigation|transanal irrigation
528474|NCT01313026|Low anterior resection syndrome|low anterior resection syndrome
710758|NCT00588094|Stem cell transplant|stem cell transplant
528475|NCT01313000|fat, transfer, autologous fat transfer, bicep|fat, transfer, autologous fat transfer, bicep
528476|NCT01312948|Obstructive sleep apnea|obstructive sleep apnea
528477|NCT01312948|OSA|osa
528478|NCT01312948|CPAP|cpap
528479|NCT01312948|CPAP mask|cpap mask
528480|NCT01312948|Non-invasive ventilation|non-invasive ventilation
528481|NCT01312948|NIV|niv
528482|NCT01312935|Percutaneous Coronary Intervention|percutaneous coronary intervention
528483|NCT01312935|Heparin|heparin
528484|NCT01312935|Angioplasty|angioplasty
528485|NCT01312935|LMWH|lmwh
528486|NCT01312909|smoking cessation in adolescents|smoking cessation in adolescents
528487|NCT01312857|colon|colon
528488|NCT01312857|rectal|rectal
528489|NCT01312857|liver|liver
528490|NCT01312857|AMG 954 (Panitumumab)|amg 954 (panitumumab)
528491|NCT01312857|DEXAMETHASONE|dexamethasone
528492|NCT01312857|FLOXURIDINE|floxuridine
528493|NCT01312857|FLUOROURACIL|fluorouracil
528494|NCT01312857|IRINOTECAN (CPT-11) CAMPTOSAR|irinotecan (cpt-11) camptosar
528495|NCT01312857|LEUCOVORIN|leucovorin
528496|NCT01312857|10-137|10-137
528497|NCT01312831|cobalamin|cobalamin
528498|NCT01312831|B12|b12
528499|NCT01312831|homocysteine|homocysteine
528500|NCT01312831|MMA|mma
528501|NCT01312831|holotranscobalamin|holotranscobalamin
528502|NCT01312831|Eligen|eligen
528503|NCT01312805|asthma|asthma
528504|NCT01312805|clinical decision support|clinical decision support
528505|NCT01312805|CHICA|chica
528506|NCT01312792|Severe Pneumonia|severe pneumonia
528507|NCT01312792|Pneumonia|pneumonia
528508|NCT01312792|ARI|ari
528509|NCT01312792|IMCI|imci
528510|NCT01312792|Modified IMCI|modified imci
528511|NCT01312792|1st level Health facilities|1st level health facilities
528512|NCT01312792|Children|children
528513|NCT01312792|Operational Research|operational research
528514|NCT01312792|Bangladesh|bangladesh
528515|NCT01312792|Treatment of Severe Pneumonia|treatment of severe pneumonia
528516|NCT01312779|Mitral Valve Replacement|mitral valve replacement
528517|NCT01312779|23mm CEP|23mm cep
528518|NCT01312779|Magna|magna
528519|NCT01312740|obesity|obesity
528520|NCT01312740|dietary treatment|dietary treatment
528521|NCT01312740|high protein diet|high protein diet
528522|NCT01312740|Low glycaemic index|low glycaemic index
528523|NCT01312740|adipocytes|adipocytes
528524|NCT01312740|fat mass|fat mass
528525|NCT01312740|systemic inflammatory markers|systemic inflammatory markers
528526|NCT01312740|improvement of complications|improvement of complications
528527|NCT01312740|effect on weight loss|effect on weight loss
528528|NCT01312727|Tubulointerstitial renal diseases|tubulointerstitial renal diseases
528529|NCT01312727|Hereditary renal diseases|hereditary renal diseases
528530|NCT01312727|Uromodulin|uromodulin
528531|NCT01312727|Renin gene|renin gene
528532|NCT01312714|Hemodialysis|hemodialysis
528533|NCT01312714|Peritoneal dialysis|peritoneal dialysis
528534|NCT01312714|Vitamin D Deficiency|vitamin d deficiency
528535|NCT01312714|blood pressure|blood pressure
528536|NCT01312714|arterial stiffness|arterial stiffness
528537|NCT01312714|Heart function|heart function
528538|NCT01312714|Renin-angiotensin system|renin-angiotensin system
528539|NCT01312714|Calcium|calcium
528540|NCT01312714|FGF-23|fgf-23
528541|NCT01312714|Brain natriuretic peptide|brain natriuretic peptide
528542|NCT01312701|cancer|cancer
528543|NCT01312701|immunomonitoring|immunomonitoring
528544|NCT01312701|CD247 -zeta chain|cd247 -zeta chain
528545|NCT01312701|chronic inflamation|chronic inflamation
528546|NCT01312701|anticancertherapy|anticancertherapy
528547|NCT01312688|Early Goal Directed Hemodunamic Therapy in Sepsis|early goal directed hemodunamic therapy in sepsis
528548|NCT01312675|severe sepsis|severe sepsis
528549|NCT01312675|mechanical ventilation|mechanical ventilation
528550|NCT01312610|orange juice|orange juice
528551|NCT01312610|cognitive function|cognitive function
528552|NCT01312610|flavonoids|flavonoids
528553|NCT01312610|flavanones|flavanones
528554|NCT01312597|Flavonoid|flavonoid
528555|NCT01312597|Cognitive performance|cognitive performance
528556|NCT01312597|Cognitive function|cognitive function
528557|NCT01312597|Executive function|executive function
528558|NCT01312597|fMRI|fmri
528559|NCT01312597|Cerebral blood flow|cerebral blood flow
528560|NCT01312597|Acute|acute
528561|NCT01312584|Flavanol|flavanol
528562|NCT01312584|Cocoa|cocoa
528563|NCT01312584|Vascular function|vascular function
528564|NCT01312584|Absorption|absorption
528565|NCT01312584|Metabolism|metabolism
528566|NCT01312584|Alkalisation|alkalisation
528567|NCT01312558|obstructive sleep apnoea/hypopnoea syndrome|obstructive sleep apnoea/hypopnoea syndrome
528568|NCT01312558|Mediterranean diet|mediterranean diet
528569|NCT01312558|exercise|exercise
528570|NCT01312558|weight loss|weight loss
528571|NCT01312558|continuous positive airway pressure|continuous positive airway pressure
528572|NCT01312558|lipid peroxidation|lipid peroxidation
528573|NCT01312545|orbital implant|orbital implant
528574|NCT01312545|evisceration|evisceration
528575|NCT01312545|economic|economic
528576|NCT01312545|polyethylene|polyethylene
528577|NCT01312545|porous|porous
528578|NCT01312532|Total knee arthroplasty|total knee arthroplasty
528579|NCT01312532|Fixed-bearing|fixed-bearing
528580|NCT01312532|Mobile-bearing|mobile-bearing
528581|NCT01312519|Bone marrow biopsy of iliac crest|bone marrow biopsy of iliac crest
528582|NCT01312506|metastatic|metastatic
528583|NCT01312506|melanoma|melanoma
528584|NCT01312506|CNS|cns
528585|NCT01312493|Head and neck cancer|head and neck cancer
528586|NCT01312493|Phase II|phase ii
528587|NCT01312493|Locally advanced|locally advanced
528588|NCT01312493|Panitumumab|panitumumab
528589|NCT01312493|Vectibix|vectibix
528590|NCT01312493|Lineberger|lineberger
528591|NCT01312493|Radiation Therapy|radiation therapy
528592|NCT01312493|Intensity modulated radiation therapy (IMRT)|intensity modulated radiation therapy (imrt)
528593|NCT01312493|Stage III to IVB|stage iii to ivb
528594|NCT01312480|Tobacco|tobacco
528595|NCT01312480|Tobacco Prevention|tobacco prevention
528596|NCT01312480|Tobacco Cessation|tobacco cessation
528597|NCT01312480|5A's Model|5a's model
528598|NCT01312480|Adolescence|adolescence
528599|NCT01312480|Media Use|media use
528600|NCT01312454|intravitreal injection|intravitreal injection
528601|NCT01312454|intraocular pressure|intraocular pressure
528602|NCT01312454|open-angle glaucoma|open-angle glaucoma
528603|NCT01312454|ocular hypertension|ocular hypertension
528604|NCT01312441|Vitamin D|vitamin d
528605|NCT01312441|Ergocalciferol|ergocalciferol
528606|NCT01312415|total knee arthroplasty|total knee arthroplasty
528607|NCT01312415|total knee replacement|total knee replacement
528608|NCT01312415|local infiltration analgesia|local infiltration analgesia
528609|NCT01312415|intra-articular local anaesthesia|intra-articular local anaesthesia
528610|NCT01312415|patients undergoing total knee arthroplasty (total knee replacement)|patients undergoing total knee arthroplasty (total knee replacement)
528611|NCT01312363|Alzheimer's disease|alzheimer's disease
528612|NCT01312363|Rivastigmine|rivastigmine
528613|NCT01312363|Patch|patch
528614|NCT01312363|Tolerability|tolerability
528615|NCT01312350|neoadjuvant chemotherapy|neoadjuvant chemotherapy
528616|NCT01312350|definitive chemoradiation therapy|definitive chemoradiation therapy
528617|NCT01312350|head and neck cancer|head and neck cancer
528618|NCT01312350|base of tongue|base of tongue
528619|NCT01312350|Locally advanced|locally advanced
528620|NCT01312337|gefitinib|gefitinib
528621|NCT01312337|EGFR mutation negative|egfr mutation negative
528622|NCT01312337|NSCLC|nsclc
528623|NCT01312324|neoadjuvant chemotherapy|neoadjuvant chemotherapy
528624|NCT01312324|thymic cancer|thymic cancer
528625|NCT01312311|nasopharyngeal cancer|nasopharyngeal cancer
528626|NCT01312311|weekly docetaxel|weekly docetaxel
528627|NCT01312311|cisplatin|cisplatin
528628|NCT01312298|Arthritis|arthritis
528629|NCT01312298|General anaesthesia|general anaesthesia
528630|NCT01312298|Spinal anaesthesia|spinal anaesthesia
528631|NCT01312285|osteoarthritis|osteoarthritis
528632|NCT01312285|painful hips|painful hips
528633|NCT01312272|Schizophrenia|schizophrenia
528634|NCT01312272|Social Intelligence|social intelligence
528635|NCT01312272|Perception, Social|perception, social
528636|NCT01312272|Oxytocin|oxytocin
528637|NCT01312259|Painful Bladder Syndrome|painful bladder syndrome
528638|NCT01312259|Interstitial Cystitis|interstitial cystitis
528639|NCT01312259|Pelvic Floor dysfunction|pelvic floor dysfunction
528640|NCT01312259|Fecal incontinence|fecal incontinence
528641|NCT01312259|Constipation|constipation
528642|NCT01312259|Sexual dysfunction|sexual dysfunction
528643|NCT01312259|Dyspareunia|dyspareunia
528644|NCT01312259|Vulvodynia|vulvodynia
528645|NCT01312246|vessel ligation|vessel ligation
528646|NCT01312246|colon resection|colon resection
528647|NCT01312207|tractional retinoschisis|tractional retinoschisis
528648|NCT01312207|traction retinal detachment|traction retinal detachment
528649|NCT01312194|Periapical Periodontitis|periapical periodontitis
528650|NCT01312194|Dental Pulp Necrosis|dental pulp necrosis
528651|NCT01312194|Root canal Therapy|root canal therapy
528652|NCT01312194|Adolescent|adolescent
528653|NCT01312181|Technology based intervention|technology based intervention
528654|NCT01312181|HIV primary care clinic|hiv primary care clinic
528655|NCT01312181|Brief behavioral intervention|brief behavioral intervention
528656|NCT01312181|Drug abuse|drug abuse
528657|NCT01312168|Cardiovascular disease|cardiovascular disease
528658|NCT01312168|Continuous positive airway pressure|continuous positive airway pressure
528659|NCT01312168|Endothelium|endothelium
528660|NCT01312168|Vascular function|vascular function
528661|NCT01312168|Inflammation|inflammation
528662|NCT01312168|Sleep Apnea|sleep apnea
528663|NCT01312168|Obstructive|obstructive
528664|NCT01312155|endotracheal|endotracheal
528665|NCT01312155|intubation|intubation
528667|NCT01312155|time|time
528668|NCT01312129|Alcohol|alcohol
528669|NCT01312129|Sulfasalazine|sulfasalazine
528670|NCT01312116|Internet treatment|internet treatment
528671|NCT01312116|GAD|gad
528672|NCT01312116|guided self-help|guided self-help
528673|NCT01312103|Safety Planning|safety planning
528674|NCT01312090|Weight loss|weight loss
528675|NCT01312090|brown adipose tissue|brown adipose tissue
528676|NCT01312090|white adipose tissue|white adipose tissue
528677|NCT01312090|muscle, metabolism|muscle, metabolism
528678|NCT01312090|cold exposure|cold exposure
528679|NCT01312077|total hip arthroplasty|total hip arthroplasty
528680|NCT01312077|total hip replacement|total hip replacement
528681|NCT01312077|local infiltration analgesia|local infiltration analgesia
528682|NCT01312077|wound infusion|wound infusion
528683|NCT01312077|patients undergoing total hip replacement (total hip arthroplasty)|patients undergoing total hip replacement (total hip arthroplasty)
528684|NCT01312064|rituximab|rituximab
528685|NCT01312064|everolimus|everolimus
528686|NCT01312038|Eustachian tube|eustachian tube
528687|NCT01312038|otitis|otitis
528688|NCT01312038|middle-ear pressure|middle-ear pressure
528689|NCT01312038|simethicone|simethicone
528690|NCT01312012|hepatitis B virus,mother-infant transmission, nucleoside analog,pregnant women|hepatitis b virus,mother-infant transmission, nucleoside analog,pregnant women
528691|NCT01311999|latent tuberculosis, renal failure, dialysis, interferon-gamma release assay|latent tuberculosis, renal failure, dialysis, interferon-gamma release assay
528692|NCT01311986|atopic dermatitis|atopic dermatitis
528693|NCT01311986|nummular eczema|nummular eczema
528694|NCT01311986|chemokines|chemokines
528695|NCT01311973|Chronic kidney disease, phosphorus, salivary phosphorus|chronic kidney disease, phosphorus, salivary phosphorus
528696|NCT01311960|pterygium|pterygium
528697|NCT01311960|recurrent pterygium|recurrent pterygium
528698|NCT01311960|bevacizumab|bevacizumab
528699|NCT01311960|VEGF|vegf
528700|NCT01311960|anti-VEGF|anti-vegf
528701|NCT01311947|Chronic hepatitis B|chronic hepatitis b
528702|NCT01311947|Peginterferon alfa-2a|peginterferon alfa-2a
528703|NCT01311921|enterovirus 71, host genetics, social, behavior, environmental factors|enterovirus 71, host genetics, social, behavior, environmental factors
528704|NCT01311908|Pancreaticoduodenectomy|pancreaticoduodenectomy
528705|NCT01311908|Roux-en-Y reconstruction|roux-en-y reconstruction
528706|NCT01311908|Reflux esophagitis|reflux esophagitis
528707|NCT01311895|acute|acute
528708|NCT01311895|pain|pain
528709|NCT01311895|emergency department|emergency department
528710|NCT01311895|hydromorphone|hydromorphone
528711|NCT01311856|Behavioral intervention|behavioral intervention
528712|NCT01311856|Exercise|exercise
528713|NCT01311856|Physical Assessment|physical assessment
528714|NCT01311856|Questionnaire|questionnaire
528715|NCT01311856|Survey|survey
528716|NCT01311856|Telephone counseling|telephone counseling
528717|NCT01311856|Internet interventions|internet interventions
528718|NCT01311856|Overweight cancer survivors|overweight cancer survivors
528719|NCT01311856|Exercise and weight management program|exercise and weight management program
528720|NCT01311791|Left ventricular augmentation|left ventricular augmentation
528721|NCT01311791|Left ventricular restoration|left ventricular restoration
528722|NCT01311765|Postoperative peritonitis|postoperative peritonitis
528723|NCT01311765|Intra-abdominal infection|intra-abdominal infection
528724|NCT01311765|Surgery|surgery
528725|NCT01311765|Laparotomy|laparotomy
528726|NCT01311765|Nosocomial infection|nosocomial infection
528727|NCT01311765|Antibiotic therapy|antibiotic therapy
528728|NCT01311765|Duration of treatment|duration of treatment
528729|NCT01311765|Multidrug resistant bacteria|multidrug resistant bacteria
528730|NCT01311752|human papillomavirus|human papillomavirus
528731|NCT01311752|follow up|follow up
528732|NCT01311739|Pharmacokinetics|pharmacokinetics
528733|NCT01311713|cancer|cancer
528734|NCT01311713|tumors|tumors
528735|NCT01311713|PARP|parp
528736|NCT01311700|Ischemia|ischemia
528737|NCT01311700|Reperfusion|reperfusion
528738|NCT01311700|Myocardial infarction|myocardial infarction
528739|NCT01311700|Beta blockers|beta blockers
528740|NCT01311700|Metoprolol|metoprolol
528741|NCT01311700|Acute myocardial infarction|acute myocardial infarction
528742|NCT01311700|Necrosis|necrosis
528743|NCT01311700|Salvaged Myocardium|salvaged myocardium
528744|NCT01311687|Myeloma|myeloma
528745|NCT01311687|Multiple Myeloma|multiple myeloma
528746|NCT01311687|Relapsed Multiple Myeloma|relapsed multiple myeloma
528747|NCT01311687|Relapsed and Refractory Multiple Myeloma|relapsed and refractory multiple myeloma
528748|NCT01311687|Refractory Myeloma|refractory myeloma
528749|NCT01311687|Resistant Multiple Myeloma|resistant multiple myeloma
528750|NCT01311687|Treatment-resistant Multiple Myeloma|treatment-resistant multiple myeloma
528751|NCT01311687|Pomalidomide|pomalidomide
528752|NCT01311687|Lenalidomide-resistant|lenalidomide-resistant
528753|NCT01311687|Bortezomib-resistant|bortezomib-resistant
528754|NCT01311648|recombinant factor VIII|recombinant factor viii
528755|NCT01311648|pediatric use|pediatric use
528756|NCT01311635|Phase 1|phase 1
528757|NCT01311635|bioavailability study|bioavailability study
528758|NCT01311635|AZD1981|azd1981
528759|NCT01311635|tablets|tablets
528760|NCT01311635|To study the relative bioavailability of single dose AZD1981 via three different tablets|to study the relative bioavailability of single dose azd1981 via three different tablets
528761|NCT01311635|To compare the bioavailability between three different AZD1981 tablets|to compare the bioavailability between three different azd1981 tablets
528762|NCT01311622|drug-drug interaction|drug-drug interaction
528763|NCT01311622|Phase 1|phase 1
528764|NCT01311622|healthy subjects|healthy subjects
528765|NCT01311622|warfarin|warfarin
528766|NCT01311622|Rheumatoid arthritis|rheumatoid arthritis
528767|NCT01311622|RA|ra
528768|NCT01311622|fostamatinib open-label|fostamatinib open-label
528769|NCT01311622|pharmacokinetics|pharmacokinetics
528770|NCT01311622|pharmacodynamics|pharmacodynamics
528771|NCT01311622|level of Warfarin in the blood|level of warfarin in the blood
528772|NCT01311609|Systane, Dry Eye|systane, dry eye
528773|NCT01311596|icons in clinic or office for patients with Autism|icons in clinic or office for patients with autism
528774|NCT01311583|Self-care|self-care
528775|NCT01311583|Teach Back|teach back
528776|NCT01311557|Tetanus|tetanus
528777|NCT01311557|Diphtheria|diphtheria
528778|NCT01311557|Pertussis|pertussis
528779|NCT01311557|Tdap vaccine|tdap vaccine
528780|NCT01311557|Adacel®|adacel®
528781|NCT01311531|Fracture|fracture
528782|NCT01311531|Radius|radius
528783|NCT01311531|Surgery|surgery
528784|NCT01311531|Osteosynthesis|osteosynthesis
528785|NCT01311518|Thymosin Beta 4|thymosin beta 4
528786|NCT01311518|Thymosin β4 (Tβ4) Injectable Solution|thymosin β4 (tβ4) injectable solution
528787|NCT01311518|RGN-352|rgn-352
528788|NCT01311505|bioequivalence; rifampicin|bioequivalence; rifampicin
528789|NCT01311492|Alzheimer's Disease|alzheimer's disease
528790|NCT01311492|exercise|exercise
528791|NCT01311492|physical activity|physical activity
528792|NCT01311492|intervention|intervention
528793|NCT01311479|Osteopathic Manipulation|osteopathic manipulation
528794|NCT01311479|Interstitial Cystitis|interstitial cystitis
528795|NCT01311479|Sacroiliac Joint Dysfunction|sacroiliac joint dysfunction
528796|NCT01311466|Liver transplantation|liver transplantation
528797|NCT01311466|Overall survival|overall survival
528798|NCT01311440|RCT|rct
528799|NCT01311440|modified Atkins diet|modified atkins diet
528800|NCT01311440|epilepsy|epilepsy
528801|NCT01311440|adults|adults
528802|NCT01311440|ketogenic diet|ketogenic diet
528803|NCT01311401|2 diabetes mellitus,Circassians, High fasting glucose|2 diabetes mellitus,circassians, high fasting glucose
528804|NCT01311388|cancer|cancer
528805|NCT01311375|spinal,, bone, cord injury, lipid,antioxidant|spinal,, bone, cord injury, lipid,antioxidant
528806|NCT01311362|Steady-state|steady-state
528807|NCT01311362|Ambrisentan|ambrisentan
528808|NCT01311362|St. Johns Wort|st. johns wort
528809|NCT01311349|Susceptibility of tigecycline|susceptibility of tigecycline
528810|NCT01311349|Drug Resistance, Bacterial|drug resistance, bacterial
528811|NCT01311336|Pegfilgrastim|pegfilgrastim
528812|NCT01311336|Loratadine|loratadine
528813|NCT01311336|Myalgia/arthralgia|myalgia/arthralgia
528814|NCT01311323|Multivessel Coronary Artery Disease|multivessel coronary artery disease
528815|NCT01311323|Left Main Narrowing|left main narrowing
528816|NCT01311323|Percutaneous Coronary Intervention|percutaneous coronary intervention
528817|NCT01311323|Coronary Artery Bypass Grafting|coronary artery bypass grafting
528818|NCT01311323|Drug-Eluting Stent|drug-eluting stent
528819|NCT01311310|troponin, open heart surgery, children|troponin, open heart surgery, children
528820|NCT01311284|Nasotracheal intubation|nasotracheal intubation
528821|NCT01311284|Macintosh laryngoscope|macintosh laryngoscope
528822|NCT01311284|Airtraq|airtraq
528823|NCT01311284|McGrath|mcgrath
528824|NCT01311284|Manikin|manikin
528825|NCT01311284|airway management|airway management
528826|NCT01311271|Stroke|stroke
528827|NCT01311271|Cerebrovascular disease|cerebrovascular disease
528828|NCT01311271|hemiplegia|hemiplegia
528829|NCT01311271|Transcranial magnetic stimulation|transcranial magnetic stimulation
528830|NCT01311271|repetitive transcranial magnetic stimulation|repetitive transcranial magnetic stimulation
528831|NCT01311271|rTMS|rtms
528832|NCT01311271|rehabilitation|rehabilitation
528833|NCT01311271|Upper Extremity|upper extremity
528834|NCT01311258|AML|aml
528835|NCT01311258|MDS|mds
528836|NCT01311245|Risky drinking|risky drinking
528837|NCT01311245|Brief intervention|brief intervention
528838|NCT01311245|Computer-generated feedback|computer-generated feedback
528839|NCT01311245|Stage-tailored|stage-tailored
528840|NCT01311245|Non-stage-tailored|non-stage-tailored
528841|NCT01311232|rituximab, lymphoma, hepatitis B virus|rituximab, lymphoma, hepatitis b virus
528842|NCT01311206|knee osteoarthritis|knee osteoarthritis
528843|NCT01311206|isokinetic knee extensor strength|isokinetic knee extensor strength
528844|NCT01311206|quadriceps volume|quadriceps volume
528845|NCT01311206|symptomatic knee osteoarthritis|symptomatic knee osteoarthritis
528846|NCT01311193|Circadian rhythms|circadian rhythms
528847|NCT01311193|Sleep-wake cycles|sleep-wake cycles
528848|NCT01311193|Melatonin|melatonin
528849|NCT01311193|Borderline Personality Disorder|borderline personality disorder
528850|NCT01311193|Light therapy|light therapy
528851|NCT01311167|Dexamethasone|dexamethasone
528852|NCT01311167|Sodium|sodium
528853|NCT01311154|carriers|carriers
528854|NCT01311154|resistant Enterobacteriaceae|resistant enterobacteriaceae
528855|NCT01311154|AMR|amr
528856|NCT01311154|antibiotic|antibiotic
528857|NCT01311128|Blood pressure|blood pressure
528858|NCT01311128|Heart rate|heart rate
528859|NCT01311128|Cardiac output|cardiac output
528860|NCT01311128|Critical care|critical care
528861|NCT01311128|Perioperative care|perioperative care
528862|NCT01311102|Pain score|pain score
528863|NCT01311102|IUD placement|iud placement
528864|NCT01311076|Type 1 Diabetes Mellitus|type 1 diabetes mellitus
528865|NCT01311076|Insulin|insulin
528866|NCT01311076|Glucose|glucose
528867|NCT01311076|Drug Therapy|drug therapy
528868|NCT01311050|Metastatic Colorectal Cancer|metastatic colorectal cancer
528869|NCT01311037|Premenopausal Women with Advanced Breast Cancer|premenopausal women with advanced breast cancer
528870|NCT01311024|Children|children
528871|NCT01311024|Pneumococcal Vaccines|pneumococcal vaccines
528872|NCT01311011|Critical Limb Ischemia|critical limb ischemia
528873|NCT01310998|Schizophrenia|schizophrenia
528874|NCT01310998|high intensity exercise|high intensity exercise
528875|NCT01310998|interval training exercise|interval training exercise
528876|NCT01310985|Rectal Cancer|rectal cancer
528877|NCT01310972|Adjuvant Colon Cancer|adjuvant colon cancer
528878|NCT01310959|Aplastic Anemia Marrow Failure Syndrome|aplastic anemia marrow failure syndrome
528879|NCT01310946|Acute Lymphocytic Leukemia|acute lymphocytic leukemia
528880|NCT01310894|Prostatic Disease|prostatic disease
528881|NCT01310894|Genital Neoplasm,male|genital neoplasm,male
528882|NCT01310894|Urogenital neoplasm|urogenital neoplasm
528883|NCT01310894|Genital disease,male|genital disease,male
528884|NCT01310894|Male urogenital disease|male urogenital disease
528885|NCT01310894|Neoplasms|neoplasms
528886|NCT01310894|Neoplasms by site|neoplasms by site
528887|NCT01310894|Prostatic neoplasm|prostatic neoplasm
528888|NCT01310894|Carcinoma|carcinoma
528889|NCT01310881|Neurogenesis|neurogenesis
528890|NCT01310881|hippocampal stem cells|hippocampal stem cells
528891|NCT01310881|depression|depression
528892|NCT01310881|stroke|stroke
528893|NCT01310868|adult giant cell glioblastoma|adult giant cell glioblastoma
528894|NCT01310868|adult gliosarcoma|adult gliosarcoma
528895|NCT01310868|adult glioblastoma|adult glioblastoma
528896|NCT01310855|adult giant cell glioblastoma|adult giant cell glioblastoma
528897|NCT01310855|adult glioblastoma|adult glioblastoma
528898|NCT01310855|adult gliosarcoma|adult gliosarcoma
528899|NCT01310855|recurrent adult brain tumor|recurrent adult brain tumor
528900|NCT01310842|Smoker|smoker
528901|NCT01310842|Smoking Cessation|smoking cessation
528902|NCT01310842|Social Determinants|social determinants
528903|NCT01310842|Environmental Effects|environmental effects
528904|NCT01310842|Individual-level effects|individual-level effects
528905|NCT01310842|Nicotine patch|nicotine patch
528906|NCT01310842|Smart Phone|smart phone
528907|NCT01310842|SP|sp
528908|NCT01310842|Global Positioning System|global positioning system
528909|NCT01310842|GPS|gps
528910|NCT01310842|Questionnaires|questionnaires
528911|NCT01310842|Saliva samples|saliva samples
528912|NCT01310829|Genetic counselor|genetic counselor
528913|NCT01310829|Genetic counseling degree program|genetic counseling degree program
528914|NCT01310829|Genetic counseling students|genetic counseling students
528915|NCT01310829|Virtual reality-based intervention|virtual reality-based intervention
528916|NCT01310829|VR|vr
529324|NCT01309321|Primiparous|primiparous
528917|NCT01310829|Genetic counseling|genetic counseling
528918|NCT01310829|hereditary cancers|hereditary cancers
528919|NCT01310829|Questionnaires|questionnaires
528920|NCT01310829|Physiological measurements|physiological measurements
528921|NCT01310829|Skin sensors|skin sensors
528922|NCT01310816|malignant neoplasms of the bone|malignant neoplasms of the bone
528923|NCT01310816|bone sarcoma|bone sarcoma
528924|NCT01310803|Urinary Bladder Neoplasms|urinary bladder neoplasms
528925|NCT01310803|Neoplasms|neoplasms
528926|NCT01310803|Urologic Neoplasms|urologic neoplasms
528927|NCT01310803|Urogenital Neoplasms|urogenital neoplasms
528928|NCT01310803|Neoplasms by Site|neoplasms by site
528929|NCT01310803|Urinary Bladder Diseases|urinary bladder diseases
528930|NCT01310803|Urologic Diseases|urologic diseases
528931|NCT01310803|TURBT|turbt
528932|NCT01310803|Valstar|valstar
528933|NCT01310790|septic shock|septic shock
528934|NCT01310790|lactic acid clearance|lactic acid clearance
528935|NCT01310790|ScVO2|scvo2
528936|NCT01310777|Open-Angle glaucoma|open-angle glaucoma
528937|NCT01310777|Ocular Hypertension|ocular hypertension
528938|NCT01310777|OAG|oag
528939|NCT01310777|OHT|oht
528940|NCT01310764|Intraocular pressure|intraocular pressure
528941|NCT01310764|Trabeculectomy|trabeculectomy
528942|NCT01310764|Mitomycin C|mitomycin c
528943|NCT01310764|Bevacizumab|bevacizumab
528944|NCT01310738|Visceral leishmaniasis|visceral leishmaniasis
528945|NCT01310738|Leishmania infantum|leishmania infantum
528946|NCT01310738|Leishmania chagasi|leishmania chagasi
528947|NCT01310725|CABG|cabg
528948|NCT01310725|LIMA|lima
528949|NCT01310725|saphenous vein|saphenous vein
528950|NCT01310725|radial artery|radial artery
528951|NCT01310712|hyperhidrosis|hyperhidrosis
528952|NCT01310712|oxybutynin|oxybutynin
528953|NCT01310699|Colonoscopy|colonoscopy
528954|NCT01310699|Diagnostic imaging|diagnostic imaging
528955|NCT01310699|Colorectal Neoplasm|colorectal neoplasm
528956|NCT01310699|Tandem Colonoscopy|tandem colonoscopy
528957|NCT01310699|Flat Polyp|flat polyp
528958|NCT01310699|Nonpolypoid|nonpolypoid
528959|NCT01310699|Flat and Depressed Lesions|flat and depressed lesions
528960|NCT01310699|Primary Prevention|primary prevention
528961|NCT01310699|Endoscopy|endoscopy
528962|NCT01310686|wet AMD anti-VEGF|wet amd anti-vegf
528963|NCT01310686|Genetic analysis of patients with Wet AMD who have not responded fully to anti-VEGF treatments|genetic analysis of patients with wet amd who have not responded fully to anti-vegf treatments
528964|NCT01310673|Gout|gout
528965|NCT01310673|Allopurinol|allopurinol
528966|NCT01310673|Acute gout|acute gout
528967|NCT01310647|estradiol|estradiol
528968|NCT01310647|testosterone|testosterone
528969|NCT01310647|combined oral contraceptive|combined oral contraceptive
528970|NCT01310647|low responders|low responders
528971|NCT01310647|ICSI|icsi
528972|NCT01310634|Neonates|neonates
528973|NCT01310634|Parenting|parenting
528974|NCT01310634|Anxiety|anxiety
528975|NCT01310634|Depression|depression
528976|NCT01310621|Neonate|neonate
528977|NCT01310621|Meconium aspiration syndrome|meconium aspiration syndrome
528978|NCT01310621|surfactant lung lavage|surfactant lung lavage
528979|NCT01310608|Atherosclerosis aorta|atherosclerosis aorta
528980|NCT01310608|A-View|a-view
528981|NCT01310608|Distal ascending aorta|distal ascending aorta
528982|NCT01310608|Transoesophageal echocardiography|transoesophageal echocardiography
528983|NCT01310608|CABG|cabg
528984|NCT01310608|Cerebral embolisation|cerebral embolisation
528985|NCT01310595|Musculoskeletal manipulations|musculoskeletal manipulations
528986|NCT01310595|Proprioception|proprioception
528987|NCT01310595|Postural balance|postural balance
528988|NCT01310582|Sevoflurane|sevoflurane
528989|NCT01310582|Desflurane|desflurane
528990|NCT01310569|PCOS, Skinfold thickness, HOMA-IR|pcos, skinfold thickness, homa-ir
528991|NCT01310556|OGTT|ogtt
528992|NCT01310556|coronary artery disease|coronary artery disease
528993|NCT01310543|Teenage pregnancy|teenage pregnancy
528994|NCT01310543|Adolescent|adolescent
528995|NCT01310543|Sexual health|sexual health
528996|NCT01310543|Youth development|youth development
528997|NCT01310530|Breast Cancer|breast cancer
528998|NCT01310530|Partial Breast|partial breast
528999|NCT01310530|Proton Beam|proton beam
529000|NCT01310517|Angiogram|angiogram
529001|NCT01310517|Injected Contrast|injected contrast
529002|NCT01310517|Heart Function|heart function
529003|NCT01310517|contrast dye|contrast dye
529004|NCT01310478|Recombinant human endostatin|recombinant human endostatin
529005|NCT01310478|Metastatic colorectal cancer|metastatic colorectal cancer
529006|NCT01310478|DLT|dlt
529007|NCT01310478|MTD|mtd
529008|NCT01310478|Pharmacokinetics|pharmacokinetics
529009|NCT01310452|diabetes, basal insulin, metformin, liver fat, visceral fat|diabetes, basal insulin, metformin, liver fat, visceral fat
529010|NCT01310426|Anal Sphincter injury|anal sphincter injury
529011|NCT01310426|Fecal Incontinence|fecal incontinence
529012|NCT01310413|Influenza|influenza
529013|NCT01310413|H5N1|h5n1
529014|NCT01310413|Pandemic|pandemic
529015|NCT01310400|Influenza|influenza
529016|NCT01310400|Virus|virus
529017|NCT01310400|Vaccination|vaccination
529719|NCT01307501|Tumors|tumors
529018|NCT01310400|Immunisation|immunisation
529019|NCT01310387|Lung cancer|lung cancer
529020|NCT01310387|Cancer pain|cancer pain
529021|NCT01310387|Opioid|opioid
529022|NCT01310374|influenza vaccine|influenza vaccine
529023|NCT01310374|immune response|immune response
529024|NCT01310374|dynamic changes|dynamic changes
529025|NCT01310361|Pharyngitis|pharyngitis
529026|NCT01310361|Group A β-hemolytic Streptococci|group a β-hemolytic streptococci
529027|NCT01310361|Exudate|exudate
529028|NCT01310361|Erythema Penicillin|erythema penicillin
529029|NCT01310361|Amoxicillin|amoxicillin
529030|NCT01310348|Bone|bone
529031|NCT01310348|Muscle strength|muscle strength
529032|NCT01310348|whole-body vibration|whole-body vibration
529033|NCT01310335|sclerostin|sclerostin
529034|NCT01310335|whole-body vibration|whole-body vibration
529035|NCT01310322|Phase I|phase i
529036|NCT01310322|Healthy male volunteers|healthy male volunteers
529037|NCT01310322|mild asthmatics|mild asthmatics
529038|NCT01310322|pharmacokinetics|pharmacokinetics
529039|NCT01310322|Bioavailability and AUC|bioavailability and auc
529040|NCT01310322|Level of AZD5423 in your blood|level of azd5423 in your blood
529041|NCT01310309|Stents|stents
529042|NCT01310309|Drug-eluting Stent|drug-eluting stent
529043|NCT01310309|Angioplasty|angioplasty
529044|NCT01310309|Coronary Artery stenosis|coronary artery stenosis
529045|NCT01310309|Coronary Artery Stent Restenosis|coronary artery stent restenosis
529046|NCT01310309|Stent Thrombosis|stent thrombosis
529047|NCT01310296|Phase 1|phase 1
529048|NCT01310296|Normal Healthy Volunteers|normal healthy volunteers
529049|NCT01310296|Mass Balance|mass balance
529050|NCT01310296|ADME|adme
529051|NCT01310296|Absolute Bioavailability|absolute bioavailability
529052|NCT01310283|dental caries|dental caries
529053|NCT01310283|children|children
672225|NCT00741208|asthma|asthma
529054|NCT01310283|mutans streptococci|mutans streptococci
529055|NCT01310283|lactobacilli|lactobacilli
529056|NCT01310283|cariogenic bacteria|cariogenic bacteria
529057|NCT01310244|Phase 1/2|phase 1/2
529058|NCT01310244|MTD|mtd
529059|NCT01310244|stage IV|stage iv
529060|NCT01310244|NSCLC|nsclc
529061|NCT01310244|chemo-naive|chemo-naive
529062|NCT01310244|Mixed-cell dose escalation|mixed-cell dose escalation
529063|NCT01310244|lung cancer|lung cancer
529064|NCT01310244|non-small-cell|non-small-cell
529065|NCT01310244|phase I|phase i
529066|NCT01310244|Belinostat|belinostat
529067|NCT01310244|Carboplatin|carboplatin
529068|NCT01310244|Paclitaxel|paclitaxel
529069|NCT01310244|adenocarcinoma|adenocarcinoma
529070|NCT01310244|PXD-101|pxd-101
529071|NCT01310231|Metastatic Breast Cancer|metastatic breast cancer
529072|NCT01310231|Metformin|metformin
529073|NCT01310218|orthopedics, carpal tunnel syndrome, postoperative care|orthopedics, carpal tunnel syndrome, postoperative care
529074|NCT01310205|HCV|hcv
529075|NCT01310205|Genotype 1|genotype 1
529076|NCT01310205|relapsers|relapsers
529077|NCT01310205|non cirrhotic|non cirrhotic
529078|NCT01310205|Chronic Hepatitis C|chronic hepatitis c
529079|NCT01310179|gene therapy|gene therapy
529080|NCT01310179|advanced solid tumors|advanced solid tumors
529081|NCT01310179|Head and Neck cancer|head and neck cancer
529082|NCT01310179|intratumoral therapy|intratumoral therapy
529083|NCT01310166|Multiple sclerosis|multiple sclerosis
529084|NCT01310166|RRMS|rrms
529085|NCT01310166|relapsing-remitting|relapsing-remitting
529086|NCT01310166|fingolimod|fingolimod
529087|NCT01310166|biomarkers|biomarkers
529088|NCT01310140|Metabolic Syndrome|metabolic syndrome
529089|NCT01310140|Insulin Resistance|insulin resistance
529090|NCT01310140|Massachusetts General Hospital|massachusetts general hospital
529091|NCT01310140|Major Depressive Disorder|major depressive disorder
529092|NCT01310140|Major Depressive Disorder with Psychotic Features|major depressive disorder with psychotic features
529093|NCT01310140|Cortisol|cortisol
529094|NCT01310140|Dexamethasone Suppression Test|dexamethasone suppression test
529095|NCT01310127|NSAID|nsaid
529096|NCT01310127|Ocular Inflammation|ocular inflammation
529097|NCT01310127|bromfenac|bromfenac
529098|NCT01310114|Human Placenta-Derived Cells|human placenta-derived cells
529099|NCT01310114|Stem cells|stem cells
529100|NCT01310114|Stroke|stroke
529101|NCT01310114|PDA001|pda001
529102|NCT01310114|Celgene|celgene
529103|NCT01310114|cenplacel-L|cenplacel-l
529104|NCT01310101|Chronic Lymphocytic Leukemia|chronic lymphocytic leukemia
529105|NCT01310101|Refractory|refractory
529106|NCT01310101|Relapse|relapse
529107|NCT01310101|Ofatumumab|ofatumumab
529108|NCT01310101|Dexamethasone|dexamethasone
529109|NCT01310088|Childhood|childhood
529110|NCT01310088|Child|child
529111|NCT01310088|adolescent|adolescent
529112|NCT01310088|central blood pressure|central blood pressure
529113|NCT01310088|ambulatory blood pressure monitoring|ambulatory blood pressure monitoring
529114|NCT01310088|ABPM|abpm
529115|NCT01310088|clinic blood pressure|clinic blood pressure
529116|NCT01310088|pulse wave velocity|pulse wave velocity
529117|NCT01310088|PWV|pwv
529118|NCT01310088|Pulse cave analysis|pulse cave analysis
529119|NCT01310088|PWA|pwa
529120|NCT01310088|heart rate variability|heart rate variability
529121|NCT01310088|HRV|hrv
529122|NCT01310088|Echocardiography|echocardiography
529123|NCT01310088|Urine microalbuminuria|urine microalbuminuria
529124|NCT01310088|blood samples|blood samples
529125|NCT01310075|Mastectomy|mastectomy
529126|NCT01310075|Bioprosthetic Mesh|bioprosthetic mesh
529127|NCT01310075|Breast Reconstruction|breast reconstruction
529128|NCT01310075|Tissue Expander|tissue expander
529129|NCT01310075|Alloderm|alloderm
529130|NCT01310075|Surgimend|surgimend
529131|NCT01310062|hepatocellular carcinoma|hepatocellular carcinoma
529132|NCT01310062|microarray|microarray
529133|NCT01310062|gene expression profiling|gene expression profiling
529134|NCT01310062|biomarkers|biomarkers
529135|NCT01310049|Exploratory study in healthy subjects|exploratory study in healthy subjects
529136|NCT01310023|Conditions and diagnoses potentially related to perinatal exposure to antiretroviral medications|conditions and diagnoses potentially related to perinatal exposure to antiretroviral medications
529137|NCT01309997|Imatinib|imatinib
529138|NCT01309997|Rituximab|rituximab
529139|NCT01309997|Chronic Graft-vs-Host Disease|chronic graft-vs-host disease
529140|NCT01309984|Monitored anesthesia care|monitored anesthesia care
529141|NCT01309971|Assessment|assessment
529142|NCT01309971|Questionable Caries|questionable caries
529143|NCT01309958|Dental Caries|dental caries
529144|NCT01309958|Intervention|intervention
529145|NCT01309958|Non-invasive treatment for early caries|non-invasive treatment for early caries
529146|NCT01309919|intrauterine device|intrauterine device
529147|NCT01309919|Mirena|mirena
529148|NCT01309919|levonorgestrel intrauterine system|levonorgestrel intrauterine system
529149|NCT01309919|postpartum contraception|postpartum contraception
529150|NCT01309893|Contact lens|contact lens
672351|NCT00740714|PD|pd
529151|NCT01309880|Contact lens|contact lens
529152|NCT01309854|Phase 1|phase 1
529153|NCT01309854|healthy volunteers|healthy volunteers
529154|NCT01309854|pharmacokinetics|pharmacokinetics
529155|NCT01309854|Rheumatoid arthritis|rheumatoid arthritis
529156|NCT01309854|RA|ra
529157|NCT01309854|fostamatinib|fostamatinib
529158|NCT01309854|pioglitazone|pioglitazone
529159|NCT01309854|drug-drug interaction|drug-drug interaction
529160|NCT01309841|Non-Cancer-Related Pain, Opioid-Induced Constipation|non-cancer-related pain, opioid-induced constipation
529161|NCT01309828|Renal Insufficiency|renal insufficiency
529162|NCT01309828|Kidney Diseases|kidney diseases
529163|NCT01309828|Hypertension|hypertension
529164|NCT01309828|Drug Therapy|drug therapy
529165|NCT01309815|neoplasms|neoplasms
529166|NCT01309815|existentialism|existentialism
529167|NCT01309815|existential concerns|existential concerns
529168|NCT01309815|Meaning making|meaning making
529169|NCT01309815|early palliative phase|early palliative phase
529170|NCT01309815|elderly|elderly
529171|NCT01309802|botox|botox
529172|NCT01309802|raynaud's|raynaud's
529173|NCT01309802|botulinum toxin|botulinum toxin
529174|NCT01309802|botulinum toxin A|botulinum toxin a
529175|NCT01309802|raynaud's disease|raynaud's disease
529176|NCT01309802|raynaud's syndrome|raynaud's syndrome
529177|NCT01309802|raynaud's phenomenon|raynaud's phenomenon
529178|NCT01309802|ischemic digits|ischemic digits
529179|NCT01309802|ischemia|ischemia
529180|NCT01309802|botox treatment|botox treatment
529181|NCT01309802|onabotulinum|onabotulinum
529182|NCT01309802|onabotulinum toxin|onabotulinum toxin
529183|NCT01309802|onabotulinum toxin type A|onabotulinum toxin type a
529184|NCT01309789|Antibodies, Monoclonal|antibodies, monoclonal
529185|NCT01309789|Antibody-Drug Conjugate|antibody-drug conjugate
529186|NCT01309789|Antigens, CD30|antigens, cd30
529187|NCT01309789|Drug Therapy|drug therapy
529188|NCT01309789|Hematologic Diseases|hematologic diseases
529189|NCT01309789|Lymphoma|lymphoma
529190|NCT01309789|monomethyl auristatin E|monomethyl auristatin e
529191|NCT01309789|Lymphoma, Large-Cell, Anaplastic|lymphoma, large-cell, anaplastic
529192|NCT01309789|Lymphoma, T-cell|lymphoma, t-cell
529193|NCT01309789|Lymphoma, NK-cell|lymphoma, nk-cell
529194|NCT01309737|Xeljanz|xeljanz
529195|NCT01309737|tofacitinib|tofacitinib
529196|NCT01309737|Jak-inhibitor|jak-inhibitor
529197|NCT01309737|oral treatment|oral treatment
529198|NCT01309737|chronic|chronic
529199|NCT01309737|severe|severe
529200|NCT01309737|moderate|moderate
529201|NCT01309737|Pruritus|pruritus
529202|NCT01309737|Itch|itch
529203|NCT01309737|DLQI|dlqi
529204|NCT01309737|treatment|treatment
529205|NCT01309737|safety|safety
529206|NCT01309737|efficacy|efficacy
529207|NCT01309737|CP-690,550|cp-690,550
529208|NCT01309737|Plaque Psoriasis|plaque psoriasis
529209|NCT01309737|Psoriasis Vulgaris|psoriasis vulgaris
529210|NCT01309724|Hypotension|hypotension
529211|NCT01309724|Fluid|fluid
529212|NCT01309711|MRI|mri
529213|NCT01309711|Biomarkers|biomarkers
529214|NCT01309711|Neonatal encephalopathy|neonatal encephalopathy
529215|NCT01309711|Therapeutic hypothermia|therapeutic hypothermia
529216|NCT01309698|Drug interaction|drug interaction
529217|NCT01309685|Cognition|cognition
529218|NCT01309685|Smoking|smoking
529219|NCT01309685|Nicotine|nicotine
529220|NCT01309685|Varenicline|varenicline
529221|NCT01309685|Withdrawal|withdrawal
529720|NCT01307488|HIV|hiv
529222|NCT01309672|adenocarcinoma of the prostate|adenocarcinoma of the prostate
529223|NCT01309672|hormone-resistant prostate cancer|hormone-resistant prostate cancer
529224|NCT01309672|stage IV prostate cancer|stage iv prostate cancer
529225|NCT01309672|recurrent prostate cancer|recurrent prostate cancer
529226|NCT01309659|Anemia|anemia
529227|NCT01309659|Unexplained anemia|unexplained anemia
529228|NCT01309659|elderly|elderly
529229|NCT01309659|geriatric|geriatric
529230|NCT01309659|older adults|older adults
529231|NCT01309659|UAE|uae
529232|NCT01309659|over 65|over 65
529233|NCT01309659|iron|iron
529234|NCT01309659|pactte|pactte
529235|NCT01309659|pactee|pactee
529236|NCT01309659|aging|aging
529237|NCT01309659|aged|aged
529238|NCT01309659|old|old
529239|NCT01309659|older|older
529240|NCT01309646|Primary vaccination|primary vaccination
529241|NCT01309646|combination vaccine|combination vaccine
529242|NCT01309646|South Korea|south korea
529243|NCT01309633|locally advanced|locally advanced
529244|NCT01309633|metastatic|metastatic
529245|NCT01309620|zinc, oxidative stress, vascular indices, type 2 diabetes|zinc, oxidative stress, vascular indices, type 2 diabetes
529246|NCT01309581|depression|depression
529247|NCT01309581|electroconvulsive therapy|electroconvulsive therapy
529248|NCT01309581|ketamine|ketamine
529249|NCT01309581|antidepressant|antidepressant
529250|NCT01309555|Growth disorders|growth disorders
529251|NCT01309555|Saizen|saizen
529252|NCT01309555|easypod™|easypod™
529253|NCT01309555|Growth hormone|growth hormone
529254|NCT01309555|Pediatric subject|pediatric subject
529255|NCT01309542|major depressive disorder|major depressive disorder
529256|NCT01309542|desvenlafaxine|desvenlafaxine
529257|NCT01309542|antidepressant|antidepressant
529258|NCT01309529|general thoracic surgery|general thoracic surgery
529259|NCT01309529|epidural analgesia|epidural analgesia
529260|NCT01309529|postoperative retention of urine|postoperative retention of urine
529261|NCT01309529|postoperative urinary tract infection|postoperative urinary tract infection
529262|NCT01309529|catheter associated urinary tract infection|catheter associated urinary tract infection
529263|NCT01309516|Postnatal depression|postnatal depression
529264|NCT01309516|Maternal depression|maternal depression
529265|NCT01309516|Psychosocial intervention|psychosocial intervention
529266|NCT01309490|high eIF4E expression|high eif4e expression
529267|NCT01309490|solid tumor cancer|solid tumor cancer
529268|NCT01309477|Refractory Nephrotic Syndrome|refractory nephrotic syndrome
529269|NCT01309477|Tacrolimus|tacrolimus
529270|NCT01309451|diabetic macular edema|diabetic macular edema
529271|NCT01309451|DME|dme
529272|NCT01309438|Healthy|healthy
529273|NCT01309438|Renal Insufficiency|renal insufficiency
529274|NCT01309438|Rivaroxaban (BAY 59-7939, JNJ-39039039)|rivaroxaban (bay 59-7939, jnj-39039039)
529275|NCT01309438|Erythromycin|erythromycin
529276|NCT01309438|Pharmacokinetic|pharmacokinetic
529277|NCT01309438|Pharmacodynamic|pharmacodynamic
529278|NCT01309425|tapentadol|tapentadol
529279|NCT01309425|NUCYNTA|nucynta
529280|NCT01309425|CG5503|cg5503
529281|NCT01309425|R331333|r331333
529282|NCT01309425|pharmacokinetics|pharmacokinetics
529283|NCT01309425|healthy volunteer|healthy volunteer
529284|NCT01309412|Relapsed or refractory multiple myeloma|relapsed or refractory multiple myeloma
529285|NCT01309412|CNTO 328|cnto 328
529286|NCT01309412|siltuximab|siltuximab
529287|NCT01309412|bortezomib|bortezomib
529288|NCT01309412|dexamethasone|dexamethasone
529289|NCT01309399|bone formation rate|bone formation rate
529290|NCT01309399|total hip arthroplasty|total hip arthroplasty
529291|NCT01309386|Tapentadol|tapentadol
529292|NCT01309386|Tumor related pain|tumor related pain
529293|NCT01309386|Opioid|opioid
529294|NCT01309386|Cancer related pain|cancer related pain
529295|NCT01309386|Morphine|morphine
529296|NCT01309373|Schizophrenia|schizophrenia
529297|NCT01309373|Schizoaffective Disorder|schizoaffective disorder
529298|NCT01309373|Remission|remission
529299|NCT01309373|Psychosocial|psychosocial
529300|NCT01309373|Symtomatic|symtomatic
529301|NCT01309373|Integration|integration
529302|NCT01309373|Schizoaffective|schizoaffective
529303|NCT01309373|Adherence|adherence
529304|NCT01309360|ultrasound|ultrasound
529305|NCT01309360|methaemoglobin|methaemoglobin
529306|NCT01309360|prilocaine|prilocaine
529307|NCT01309360|regional anesthesia|regional anesthesia
529308|NCT01309360|ASA risk groups I-II|asa risk groups i-ii
529309|NCT01309360|adult outpatients|adult outpatients
529310|NCT01309360|surgical spectrum covered procedures|surgical spectrum covered procedures
529311|NCT01309360|distal forearm|distal forearm
529312|NCT01309360|hand|hand
529313|NCT01309347|prosthetic socket, residual limb volume fluctuation|prosthetic socket, residual limb volume fluctuation
529314|NCT01309334|MRI|mri
529315|NCT01309334|PET-scan|pet-scan
529316|NCT01309334|multiple myeloma|multiple myeloma
529317|NCT01309334|prognosis|prognosis
529318|NCT01309334|pharmacoeconomic analysis|pharmacoeconomic analysis
529319|NCT01309321|Perinatal|perinatal
529320|NCT01309321|Handwashing|handwashing
529321|NCT01309321|Neonatal|neonatal
529322|NCT01309321|Morbidity|morbidity
529323|NCT01309321|Mortality|mortality
529325|NCT01309321|Health behavior|health behavior
529326|NCT01309321|Developing countries|developing countries
529327|NCT01309321|Sepsis|sepsis
529328|NCT01309321|Omphalitis|omphalitis
529329|NCT01309321|Infectious disease|infectious disease
529330|NCT01309321|Bangladesh|bangladesh
529331|NCT01309308|cervical length|cervical length
529332|NCT01309308|sweeping the membranes|sweeping the membranes
529333|NCT01309256|distal gastrectomy|distal gastrectomy
529334|NCT01309256|Robotic gastrectomy|robotic gastrectomy
529335|NCT01309256|registry|registry
529336|NCT01309256|learning curve|learning curve
529337|NCT01309256|cost-effectiveness|cost-effectiveness
529338|NCT01309256|quality of life|quality of life
529339|NCT01309256|acute inflammatory reaction|acute inflammatory reaction
529340|NCT01309256|Robotic and laparoscopic surgery|robotic and laparoscopic surgery
529341|NCT01309243|HIV|hiv
529342|NCT01309243|HIV-1|hiv-1
529343|NCT01309243|Antiretroviral Treatment-Naïve|antiretroviral treatment-naïve
529344|NCT01309230|Stage III|stage iii
529345|NCT01309230|Stage IV|stage iv
529346|NCT01309230|epithelial ovarian cancer|epithelial ovarian cancer
529347|NCT01309230|ovarian cancer|ovarian cancer
529348|NCT01309230|Adjuvant|adjuvant
529349|NCT01309230|immunotherapy|immunotherapy
529350|NCT01309204|open-angle glaucoma|open-angle glaucoma
529351|NCT01309204|ocular hypertension|ocular hypertension
529352|NCT01309204|OAG|oag
529353|NCT01309204|OHT|oht
529354|NCT01309191|Androgenetic Alopecia|androgenetic alopecia
529355|NCT01309191|Minoxidil|minoxidil
529356|NCT01309191|Microarray|microarray
529357|NCT01309165|stroke|stroke
529358|NCT01309165|cognition|cognition
529359|NCT01309165|cognitive strategies|cognitive strategies
529360|NCT01309165|motor skill acquisition|motor skill acquisition
529361|NCT01309165|participation|participation
529362|NCT01309152|cefazolin|cefazolin
529363|NCT01309152|microdialysis|microdialysis
529364|NCT01309152|morbid obesity|morbid obesity
529365|NCT01309152|pharmacokinetics|pharmacokinetics
529366|NCT01309126|Colorectal Cancer|colorectal cancer
529367|NCT01309126|KRAS Wild Type|kras wild type
529368|NCT01309126|Imprime PGG|imprime pgg
529369|NCT01309126|Cetuximab|cetuximab
529370|NCT01309126|Phase 3|phase 3
529371|NCT01309126|Efficacy|efficacy
529372|NCT01309126|Safety|safety
529373|NCT01309126|Recurrent or Progressive KRAS Wild Type Colorectal Cancer|recurrent or progressive kras wild type colorectal cancer
529374|NCT01309087|Gene Expression|gene expression
529375|NCT01309087|Lung Cancer|lung cancer
529376|NCT01309087|Smoking|smoking
529377|NCT01309074|Anxiety|anxiety
529378|NCT01309074|Epilepsy|epilepsy
529379|NCT01309048|bone metastasis|bone metastasis
529380|NCT01309048|Patients with bone metastasis|patients with bone metastasis
529381|NCT01309035|Prothesis fixation|prothesis fixation
529382|NCT01309035|Bloodlessness|bloodlessness
529383|NCT01309022|Diabetes Mellitus, Type 1|diabetes mellitus, type 1
529384|NCT01309022|T1D|t1d
529385|NCT01309022|T1DM|t1dm
529386|NCT01309022|Islets of Langerhans Transplantation|islets of langerhans transplantation
529387|NCT01309022|Pancreatic Islets Transplantation|pancreatic islets transplantation
529388|NCT01309022|Islet Transplant|islet transplant
529389|NCT01309022|Tacrolimus|tacrolimus
529390|NCT01309022|Sirolimus|sirolimus
529391|NCT01309022|Mycophenolate mofetil|mycophenolate mofetil
529392|NCT01309022|Mycophenolic acid|mycophenolic acid
529393|NCT01309009|Infantile Colic|infantile colic
529394|NCT01309009|Tachykinin antagonist|tachykinin antagonist
529395|NCT01309009|Nepadutant|nepadutant
529396|NCT01308996|alveolar ridge augmentation|alveolar ridge augmentation
529397|NCT01308996|edentulous ridge|edentulous ridge
529398|NCT01308996|alveolar ridge defect|alveolar ridge defect
529399|NCT01308996|posterior mandible defect|posterior mandible defect
529400|NCT01308996|bone morphogenic protein|bone morphogenic protein
529401|NCT01308996|osseointegration|osseointegration
529402|NCT01308983|Prehypertension|prehypertension
529403|NCT01308983|Flow mediated dilation|flow mediated dilation
529404|NCT01308983|Pulse wave velocity|pulse wave velocity
529405|NCT01308983|carotid compliance|carotid compliance
529406|NCT01308983|Prehypertension and amiloride|prehypertension and amiloride
529407|NCT01308944|invasive epithelial ovarian cancer,|invasive epithelial ovarian cancer,
529408|NCT01308944|primary peritoneal carcinoma,|primary peritoneal carcinoma,
529409|NCT01308944|fallopian tube cancer|fallopian tube cancer
529410|NCT01308931|Contraception|contraception
529411|NCT01308931|IUD|iud
529412|NCT01308931|Essure|essure
529413|NCT01308931|Tubal ligation|tubal ligation
529414|NCT01308931|Anti-Mullerian hormone|anti-mullerian hormone
529415|NCT01308918|Thoracic surgery|thoracic surgery
529416|NCT01308918|Double lumen tube intubation|double lumen tube intubation
529417|NCT01308918|GlideScope|glidescope
529418|NCT01308918|Stylet|stylet
529419|NCT01308905|Neuroblastoma|neuroblastoma
529420|NCT01308879|Contextualized Feedback System (CFS)|contextualized feedback system (cfs)
529421|NCT01308879|Mental health outcomes|mental health outcomes
529422|NCT01308879|Quality improvement|quality improvement
529423|NCT01308879|Feedback|feedback
529424|NCT01308879|Clinical trial|clinical trial
529721|NCT01307488|AIDS|aids
529425|NCT01308866|cardiovascular diseases|cardiovascular diseases
529426|NCT01308866|patient education|patient education
529427|NCT01308866|primary health care|primary health care
529428|NCT01308866|consumer participation|consumer participation
529429|NCT01308866|decision aids|decision aids
529430|NCT01308840|Unresectable|unresectable
529431|NCT01308840|metastatic|metastatic
529432|NCT01308840|biliary tract|biliary tract
529433|NCT01308840|gallbladder cancer|gallbladder cancer
529434|NCT01308827|Children 28 days to 36 months of age with suspected pneumococcal disease|children 28 days to 36 months of age with suspected pneumococcal disease
529435|NCT01308814|Perimenopause|perimenopause
529436|NCT01308814|Menopause|menopause
529437|NCT01308814|Depression|depression
529438|NCT01308814|Cardiovascular health|cardiovascular health
529439|NCT01308801|fibromyalgia|fibromyalgia
529440|NCT01308801|pain|pain
529441|NCT01308801|repetitive transcranial magnetic stimulation|repetitive transcranial magnetic stimulation
529442|NCT01308801|rehabilitation exercise|rehabilitation exercise
529443|NCT01308801|quality of life|quality of life
529444|NCT01308788|glaucoma blood flow|glaucoma blood flow
529445|NCT01308775|SIS.NET|sis.net
529446|NCT01308736|tobacco|tobacco
529447|NCT01308736|nicotine|nicotine
529448|NCT01308736|cigarette smoking|cigarette smoking
529449|NCT01308710|endothelial function|endothelial function
529450|NCT01308710|lipids|lipids
529451|NCT01308710|pediatrics|pediatrics
529452|NCT01308697|Flail|flail
529453|NCT01308697|Chest|chest
529454|NCT01308671|coronary artery disease|coronary artery disease
529455|NCT01308671|varenicline|varenicline
529456|NCT01308671|clopidogrel|clopidogrel
529457|NCT01308658|TMC114-C176|tmc114-c176
529458|NCT01308658|TMC114|tmc114
529459|NCT01308658|DRV|drv
529460|NCT01308658|HIV|hiv
529461|NCT01308658|Healthy volunteers|healthy volunteers
529462|NCT01308645|SBP Injection|sbp injection
529463|NCT01308645|HCC|hcc
529464|NCT01308632|glioblastoma|glioblastoma
529465|NCT01308632|temozolamide|temozolamide
529466|NCT01308632|radiotherapy|radiotherapy
529467|NCT01308632|TMZ|tmz
529468|NCT01308632|irinotecan|irinotecan
529469|NCT01308606|TMC435-TiDP16-C116|tmc435-tidp16-c116
529470|NCT01308606|TMC435-C116|tmc435-c116
529471|NCT01308606|TMC435|tmc435
529472|NCT01308606|HCV|hcv
529473|NCT01308606|Hepatitis C|hepatitis c
529474|NCT01308606|Hep C|hep c
529475|NCT01308606|healthy volunteers|healthy volunteers
529476|NCT01308554|TAP block|tap block
529477|NCT01308554|Pain|pain
529478|NCT01308554|Obesity|obesity
529479|NCT01308554|Surgery|surgery
529480|NCT01308554|Laparoscopic gastric bypass|laparoscopic gastric bypass
529481|NCT01308528|Venous Thromboembolism|venous thromboembolism
529482|NCT01308515|knee|knee
529483|NCT01308515|osteoarthritis|osteoarthritis
529484|NCT01308515|joint|joint
529485|NCT01308515|replacement|replacement
529486|NCT01308515|knee surgery|knee surgery
529487|NCT01308502|laryngopharyngeal reflux|laryngopharyngeal reflux
529488|NCT01308502|LPR|lpr
529489|NCT01308502|GERD|gerd
529490|NCT01308502|gastroesophageal reflux|gastroesophageal reflux
529491|NCT01308502|nasopharyngeal probe|nasopharyngeal probe
529492|NCT01308463|elbow long-term Survivorship|elbow long-term survivorship
529493|NCT01308463|Study participant Discovery Elbow Multi-center Study who|study participant discovery elbow multi-center study who
529494|NCT01308463|consent for the Discovery Elbow Long-term SurvivorshipStudy|consent for the discovery elbow long-term survivorshipstudy
529495|NCT01308450|ADHD Normative Control Group|adhd normative control group
529496|NCT01308424|Herpes Labialis|herpes labialis
529497|NCT01308424|Herpes Simplex|herpes simplex
529498|NCT01308424|Herpes|herpes
529499|NCT01308411|Asthma|asthma
529500|NCT01308411|Inhaled Corticosteroids|inhaled corticosteroids
529501|NCT01308411|Exhaled Nitric oxide|exhaled nitric oxide
529502|NCT01308411|Airways inflammation|airways inflammation
529503|NCT01308411|Step down|step down
529504|NCT01308411|Predicting response|predicting response
529505|NCT01308372|cardiovascular risk|cardiovascular risk
529506|NCT01308372|France|france
529507|NCT01308372|General practice|general practice
529508|NCT01308372|Primary prevention|primary prevention
529509|NCT01308372|Non treated patients|non treated patients
529510|NCT01308359|fetal movement|fetal movement
529511|NCT01308346|Bioabsorbable|bioabsorbable
529512|NCT01308346|Coronary Stent|coronary stent
529513|NCT01308346|Everolimus|everolimus
529514|NCT01308346|drug eluting stents|drug eluting stents
529515|NCT01308346|stents|stents
529516|NCT01308346|angioplasty|angioplasty
529517|NCT01308346|coronary artery disease|coronary artery disease
529518|NCT01308346|total coronary occlusion|total coronary occlusion
529519|NCT01308346|coronary artery restenosis|coronary artery restenosis
529520|NCT01308346|stent thrombosis|stent thrombosis
529521|NCT01308346|myocardial ischemia|myocardial ischemia
529522|NCT01308346|coronary artery stenosis|coronary artery stenosis
529523|NCT01308307|Non-cycloplegic photorefraction|non-cycloplegic photorefraction
529524|NCT01308307|cycloplegic refraction,|cycloplegic refraction,
529525|NCT01308307|Amblyopia|amblyopia
529526|NCT01308294|Melanoma|melanoma
529527|NCT01308294|Stage II-IV|stage ii-iv
529528|NCT01308294|Immunotherapy|immunotherapy
529529|NCT01308294|Vaccination|vaccination
529530|NCT01308294|HLA class I and II tumor-specific peptides|hla class i and ii tumor-specific peptides
529531|NCT01308294|IMP321|imp321
529532|NCT01308294|Montanide ISA-51 VG|montanide isa-51 vg
529534|NCT01308268|Soil-transmitted Helminthiasis|soil-transmitted helminthiasis
529535|NCT01308268|mass drug administration|mass drug administration
529536|NCT01308229|Bifurcation|bifurcation
529537|NCT01308229|Dedicated|dedicated
529538|NCT01308229|Drug-eluting stent|drug-eluting stent
529539|NCT01308229|Angioplasty|angioplasty
529540|NCT01308229|Coronary artery disease|coronary artery disease
529541|NCT01308229|Coronary artery stenosis|coronary artery stenosis
529542|NCT01308216|Transcranial Laser Therapy|transcranial laser therapy
529543|NCT01308216|Hemiplegia|hemiplegia
529544|NCT01308216|Rehabilitation|rehabilitation
529545|NCT01308216|Physiotherapy|physiotherapy
529546|NCT01308216|Ischemic stroke|ischemic stroke
529547|NCT01308190|Preoperative chemoradiotherapy|preoperative chemoradiotherapy
529548|NCT01308190|Transanal endoscopic microsurgery|transanal endoscopic microsurgery
529549|NCT01308190|Rectal Cancer|rectal cancer
529550|NCT01308190|T2-T3s-N0|t2-t3s-n0
529551|NCT01308164|Type 1 diabetes|type 1 diabetes
529552|NCT01308164|Insulin Pump Therapy|insulin pump therapy
529553|NCT01308151|CBT, self harm, depression, cultural adaptation, Pakistan|cbt, self harm, depression, cultural adaptation, pakistan
529554|NCT01308138|Physical Activity|physical activity
529555|NCT01308138|pathology|pathology
529556|NCT01308138|Physical Deconditioning|physical deconditioning
529557|NCT01308125|Stable Angina|stable angina
529558|NCT01308125|Coronary artery disease|coronary artery disease
529559|NCT01308125|PCI|pci
529560|NCT01308125|Reperfusion|reperfusion
529561|NCT01308125|Myocardial Infarction|myocardial infarction
529562|NCT01308125|collateral flow pressure index|collateral flow pressure index
529563|NCT01308125|CFpI|cfpi
529564|NCT01308125|pressure controlled intermittent coronary sinus occlusion|pressure controlled intermittent coronary sinus occlusion
529565|NCT01308125|PICSO|picso
529566|NCT01308112|Iron|iron
529567|NCT01308112|Plasmodium|plasmodium
529568|NCT01308112|Malaria|malaria
529569|NCT01308112|Pregnancy|pregnancy
529570|NCT01308112|Kenya|kenya
529571|NCT01308099|POTS|pots
529572|NCT01308099|Vascular Endothelial Function|vascular endothelial function
529573|NCT01308086|Cancer|cancer
529574|NCT01308086|colorectal cancer|colorectal cancer
529575|NCT01308086|adjuvant chemotherapy|adjuvant chemotherapy
529576|NCT01308086|capecitabine|capecitabine
529577|NCT01308086|oxaliplatin|oxaliplatin
529578|NCT01308086|5 fluorouracil|5 fluorouracil
529579|NCT01308060|Canthal lines|canthal lines
529580|NCT01308034|non GIST sarcomas|non gist sarcomas
529581|NCT01308034|sunitinib|sunitinib
529582|NCT01308034|radiotherapy|radiotherapy
529583|NCT01308034|dose escalation|dose escalation
529584|NCT01308021|Rhinoconjunctivitis|rhinoconjunctivitis
529585|NCT01308021|Allergy|allergy
529586|NCT01308021|Grass pollen|grass pollen
529587|NCT01308021|Hypersensitivity|hypersensitivity
529588|NCT01308021|Immune system disorder|immune system disorder
529589|NCT01308008|Type 2 Diabetes Mellitus|type 2 diabetes mellitus
529590|NCT01308008|Mobility Limitation|mobility limitation
529591|NCT01307995|GDM|gdm
529592|NCT01307995|incretin effect|incretin effect
529593|NCT01307995|gestation|gestation
529594|NCT01307995|reversibility|reversibility
529595|NCT01307982|Gastroesophageal Reflux|gastroesophageal reflux
529596|NCT01307982|Nervous System Diseases|nervous system diseases
529597|NCT01307982|Fundoplication|fundoplication
529598|NCT01307982|Enteral Nutrition|enteral nutrition
529599|NCT01307969|liposomes|liposomes
529600|NCT01307969|ropivacaine|ropivacaine
529601|NCT01307969|dental anesthesia|dental anesthesia
529602|NCT01307969|dentistry|dentistry
529603|NCT01307943|MBSR|mbsr
529604|NCT01307943|adolescent|adolescent
529605|NCT01307943|mental health|mental health
529606|NCT01307930|Echinocandin|echinocandin
529607|NCT01307930|Obesity|obesity
529608|NCT01307930|Pharmacokinetics|pharmacokinetics
529609|NCT01307930|Pharmacodynamics|pharmacodynamics
529610|NCT01307930|Fungal infection|fungal infection
529611|NCT01307917|diabetes mellitus|diabetes mellitus
529612|NCT01307917|diabetic nephropathy|diabetic nephropathy
529613|NCT01307917|vascular endothelial dysfunction|vascular endothelial dysfunction
529614|NCT01307917|flavonoids|flavonoids
529615|NCT01307917|flow-mediated dilation|flow-mediated dilation
529616|NCT01307904|Glycemic index|glycemic index
529617|NCT01307904|Dates|dates
529618|NCT01307904|Blood glucose|blood glucose
529619|NCT01307891|Triple negative breast cancer (TNBC)|triple negative breast cancer (tnbc)
529620|NCT01307891|Metastatic breast cancer|metastatic breast cancer
529621|NCT01307891|Tigatuzumab (CS-1008)|tigatuzumab (cs-1008)
529622|NCT01307891|Abraxane (ABI-007)|abraxane (abi-007)
529623|NCT01307891|HER-2-neu negative|her-2-neu negative
529624|NCT01307891|ER negative, PR negative|er negative, pr negative
529625|NCT01307865|midface volume loss|midface volume loss
529626|NCT01307865|aging of midface|aging of midface
529627|NCT01307865|sculptra|sculptra
529722|NCT01307488|Atazanavir|atazanavir
529628|NCT01307865|sculptra aesthetic|sculptra aesthetic
529629|NCT01307865|poly-L-lactic acid|poly-l-lactic acid
529630|NCT01307852|Fiber optic radiation detectors|fiber optic radiation detectors
529631|NCT01307852|Enhanced endorectal balloon|enhanced endorectal balloon
529632|NCT01307852|Radiation treatment|radiation treatment
529633|NCT01307852|Radiotherapy|radiotherapy
529634|NCT01307852|External beam radiation|external beam radiation
529635|NCT01307852|Dosimetry|dosimetry
529636|NCT01307839|labor|labor
529637|NCT01307839|epidural|epidural
529638|NCT01307826|massage|massage
529639|NCT01307826|shoulder|shoulder
529640|NCT01307826|pain|pain
529641|NCT01307826|range of motion|range of motion
529642|NCT01307826|restricted range of motion|restricted range of motion
529643|NCT01307813|colon distal|colon distal
529644|NCT01307813|surgical resection|surgical resection
529645|NCT01307787|exercise|exercise
529646|NCT01307787|education|education
529647|NCT01307787|self-management|self-management
529648|NCT01307787|rehabilitation|rehabilitation
529649|NCT01307774|parental acceptability of HPV vaccine|parental acceptability of hpv vaccine
529650|NCT01307761|fine needle aspiration; predictor; ultrasonography; thyroid cancer|fine needle aspiration; predictor; ultrasonography; thyroid cancer
529651|NCT01307748|aromatherapy|aromatherapy
529652|NCT01307748|stress|stress
529653|NCT01307748|older adults|older adults
529654|NCT01307748|stress-related change|stress-related change
529655|NCT01307735|myocarditis|myocarditis
529656|NCT01307735|edema|edema
529657|NCT01307735|hyperemia|hyperemia
529658|NCT01307735|fibrosis|fibrosis
529659|NCT01307735|necrosis|necrosis
529660|NCT01307735|cardiovascular magnetic resonance imaging|cardiovascular magnetic resonance imaging
529661|NCT01307722|left atrial distensibility|left atrial distensibility
529662|NCT01307722|advanced chronic heart failure|advanced chronic heart failure
529663|NCT01307722|decompensation|decompensation
529664|NCT01307722|rehospitalization|rehospitalization
529665|NCT01307722|prognosis|prognosis
529666|NCT01307722|all-cause mortality|all-cause mortality
529667|NCT01307722|heart failure with hospitalization|heart failure with hospitalization
529668|NCT01307722|the duration of hospitalization|the duration of hospitalization
529669|NCT01307696|Umbilical Hernia Repair|umbilical hernia repair
529670|NCT01307696|PVP Mesh|pvp mesh
529671|NCT01307683|Pregnancy|pregnancy
529672|NCT01307683|Overweight|overweight
529673|NCT01307683|Obese|obese
529674|NCT01307683|Stress|stress
529675|NCT01307683|Mindfulness|mindfulness
529676|NCT01307657|clopidogrel|clopidogrel
529677|NCT01307657|platelet|platelet
529678|NCT01307657|platelet function test|platelet function test
529679|NCT01307657|healthy|healthy
529680|NCT01307657|Platelet function tests|platelet function tests
529681|NCT01307644|Overweight|overweight
529682|NCT01307644|Obesity|obesity
529683|NCT01307644|Rural Health|rural health
529684|NCT01307644|Weight Loss|weight loss
529685|NCT01307644|Weight Maintenance|weight maintenance
529686|NCT01307644|Rural Middle Aged and Older Women|rural middle aged and older women
529687|NCT01307644|Web Intervention Weight Loss|web intervention weight loss
529688|NCT01307644|Class I, II, & III obese (BMI 28 to 45)|class i, ii, & iii obese (bmi 28 to 45)
529689|NCT01307605|contiguous stage II grade 1 follicular lymphoma|contiguous stage ii grade 1 follicular lymphoma
529690|NCT01307605|contiguous stage II grade 2 follicular lymphoma|contiguous stage ii grade 2 follicular lymphoma
529691|NCT01307605|contiguous stage II grade 3 follicular lymphoma|contiguous stage ii grade 3 follicular lymphoma
529692|NCT01307605|noncontiguous stage II grade 1 follicular lymphoma|noncontiguous stage ii grade 1 follicular lymphoma
529693|NCT01307605|noncontiguous stage II grade 2 follicular lymphoma|noncontiguous stage ii grade 2 follicular lymphoma
529694|NCT01307605|noncontiguous stage II grade 3 follicular lymphoma|noncontiguous stage ii grade 3 follicular lymphoma
529695|NCT01307605|stage III grade 1 follicular lymphoma|stage iii grade 1 follicular lymphoma
529696|NCT01307605|stage III grade 2 follicular lymphoma|stage iii grade 2 follicular lymphoma
529697|NCT01307605|stage III grade 3 follicular lymphoma|stage iii grade 3 follicular lymphoma
529698|NCT01307605|stage IV grade 1 follicular lymphoma|stage iv grade 1 follicular lymphoma
529699|NCT01307605|stage IV grade 2 follicular lymphoma|stage iv grade 2 follicular lymphoma
529700|NCT01307605|stage IV grade 3 follicular lymphoma|stage iv grade 3 follicular lymphoma
529701|NCT01307592|peripheral T-cell lymphoma|peripheral t-cell lymphoma
529702|NCT01307592|recurrent adult Burkitt lymphoma|recurrent adult burkitt lymphoma
529703|NCT01307592|recurrent adult diffuse large cell lymphoma|recurrent adult diffuse large cell lymphoma
529704|NCT01307592|recurrent adult lymphoblastic lymphoma|recurrent adult lymphoblastic lymphoma
529705|NCT01307592|recurrent grade 3 follicular lymphoma|recurrent grade 3 follicular lymphoma
529706|NCT01307579|Pediatrics|pediatrics
529707|NCT01307579|leukemia|leukemia
529708|NCT01307579|invasive fungal infection|invasive fungal infection
529709|NCT01307514|DIABETES|diabetes
529710|NCT01307514|PHARMACOKINETICS|pharmacokinetics
529711|NCT01307514|PHARMACODYNAMICS|pharmacodynamics
529712|NCT01307514|INSULIN|insulin
529713|NCT01307501|Cryoablation|cryoablation
529714|NCT01307501|Cryotherapy|cryotherapy
529715|NCT01307501|Cryosurgery|cryosurgery
529716|NCT01307501|Metastatic|metastatic
529717|NCT01307501|Lung|lung
529718|NCT01307501|Pleura|pleura
529723|NCT01307488|Simplification|simplification
529724|NCT01307475|Chronic Post-Traumatic Stress Disorder|chronic post-traumatic stress disorder
529725|NCT01307475|Delayed Onset Post-Traumatic Stress Disorder|delayed onset post-traumatic stress disorder
529726|NCT01307475|Post-Traumatic Neuroses|post-traumatic neuroses
529727|NCT01307475|Posttraumatic Neuroses|posttraumatic neuroses
529728|NCT01307475|Post-Traumatic Stress Disorders|post-traumatic stress disorders
529729|NCT01307475|Posttraumatic Stress Disorders|posttraumatic stress disorders
529730|NCT01307475|PTSD|ptsd
529731|NCT01307475|Post TraumaticStress Disorder|post traumaticstress disorder
529732|NCT01307475|Endogenous Depression|endogenous depression
529733|NCT01307475|Neurotic Depression|neurotic depression
529734|NCT01307475|Depressive Syndrome|depressive syndrome
529735|NCT01307475|Melancholia|melancholia
529736|NCT01307475|Depressive Neurosis|depressive neurosis
529737|NCT01307475|Unipolar Depression|unipolar depression
529738|NCT01307475|Depressive Symptoms|depressive symptoms
529739|NCT01307475|Emotional Depression|emotional depression
529740|NCT01307475|Quality of Life|quality of life
529741|NCT01307449|pneumococcal vaccine|pneumococcal vaccine
529742|NCT01307449|immune responses|immune responses
529743|NCT01307436|Hepatitis A Vaccine|hepatitis a vaccine
673099|NCT00738062|NOH|noh
529744|NCT01307436|Combined Vaccines|combined vaccines
529745|NCT01307436|DTP Vaccine|dtp vaccine
529746|NCT01307436|MMR Vaccine|mmr vaccine
529747|NCT01307423|psoriasis|psoriasis
529748|NCT01307423|Arthritis|arthritis
529749|NCT01307423|Psoriatic Arthritis|psoriatic arthritis
529750|NCT01307423|inflammation|inflammation
529751|NCT01307423|skin condition|skin condition
529752|NCT01307423|inflammatory cells|inflammatory cells
529753|NCT01307423|apremilast|apremilast
529754|NCT01307423|CC-10004|cc-10004
529755|NCT01307423|phosphodiesterase type 4|phosphodiesterase type 4
529756|NCT01307410|Patients with type 2 diabetes and participated in 3B Study|patients with type 2 diabetes and participated in 3b study
529757|NCT01307384|Total Hip Arthroplasty|total hip arthroplasty
529758|NCT01307384|Total Hip Replacement (THR)|total hip replacement (thr)
529759|NCT01307384|Primary Hip Arthroplasty|primary hip arthroplasty
529760|NCT01307384|THA|tha
529761|NCT01307384|THR|thr
529762|NCT01307371|Bone Marrow Mononuclear cells;|bone marrow mononuclear cells;
529763|NCT01307371|Diabetes;|diabetes;
529764|NCT01307371|ST-segment Elevation Myocardial Infarction;|st-segment elevation myocardial infarction;
529765|NCT01307371|Percutaneous Coronary Intervention;|percutaneous coronary intervention;
529766|NCT01307371|Left Ventricular Function|left ventricular function
529767|NCT01307332|Multiple Sclerosis|multiple sclerosis
529768|NCT01307332|MS|ms
529769|NCT01307332|Relapsing Remitting Multiple Sclerosis|relapsing remitting multiple sclerosis
529770|NCT01307332|RRMS|rrms
529771|NCT01307332|Alemtuzumab|alemtuzumab
529772|NCT01307332|Demyelination|demyelination
529773|NCT01307332|Remyelination|remyelination
529774|NCT01307332|Tolerogenic|tolerogenic
529775|NCT01307332|T cells|t cells
529776|NCT01307332|Demyelinating Autoimmune Diseases, CNS|demyelinating autoimmune diseases, cns
529777|NCT01307332|Autoimmune Diseases of the Nervous System|autoimmune diseases of the nervous system
529778|NCT01307332|Nervous System Diseases|nervous system diseases
529779|NCT01307332|Demyelinating Diseases|demyelinating diseases
529780|NCT01307332|Autoimmune Diseases|autoimmune diseases
529781|NCT01307332|Immune System Diseases|immune system diseases
529782|NCT01307319|Allergies|allergies
529783|NCT01307319|Hayfever|hayfever
529784|NCT01307306|Thermal injury|thermal injury
529785|NCT01307306|Chemical Burn|chemical burn
529786|NCT01307306|Flame Burn|flame burn
529787|NCT01307280|Behavioral Weight Management Intervention|behavioral weight management intervention
529788|NCT01307280|weight loss|weight loss
529789|NCT01307280|cost-effective analysis|cost-effective analysis
529790|NCT01307280|high blood pressure|high blood pressure
529791|NCT01307280|randomized clinical trial|randomized clinical trial
529792|NCT01307280|behavioral interventions|behavioral interventions
529793|NCT01307280|physical activity|physical activity
529794|NCT01307280|dietary change|dietary change
529795|NCT01307280|obesity|obesity
529796|NCT01307267|Phase 1|phase 1
529797|NCT01307267|Non-Hodgkin's Lymphoma|non-hodgkin's lymphoma
529798|NCT01307267|Advanced malignancies|advanced malignancies
529799|NCT01307241|Acute lymphoblastic leukemia|acute lymphoblastic leukemia
529800|NCT01307241|prognostic factor|prognostic factor
529801|NCT01307241|pharmacogenetics.|pharmacogenetics.
529802|NCT01307228|Knowledge translation|knowledge translation
529803|NCT01307228|Policymakers|policymakers
529804|NCT01307228|Health systems|health systems
529805|NCT01307215|TAP block|tap block
529806|NCT01307215|incision pain|incision pain
529807|NCT01307215|total hysterectomy|total hysterectomy
529808|NCT01307202|knee|knee
529809|NCT01307202|arthroplasty|arthroplasty
529810|NCT01307202|postoperative pain|postoperative pain
529811|NCT01307202|gabapentin|gabapentin
529812|NCT01307189|Chronic Obstructive Pulmonary Disease (COPD)|chronic obstructive pulmonary disease (copd)
529813|NCT01307189|Exercise|exercise
529814|NCT01307189|Endurance shuttle walking test|endurance shuttle walking test
529815|NCT01307189|Bronchodilation|bronchodilation
529816|NCT01307189|Tiotropium|tiotropium
529817|NCT01307176|ataxia|ataxia
529818|NCT01307176|exercise|exercise
529819|NCT01307176|training|training
529820|NCT01307176|cerebellar|cerebellar
529821|NCT01307176|rehabilitation|rehabilitation
529822|NCT01307163|saliva|saliva
529823|NCT01307163|liver transplantation|liver transplantation
529824|NCT01307163|children|children
529825|NCT01307163|In this prospective study 60 subjects will be examined|in this prospective study 60 subjects will be examined
529826|NCT01307163|children and adolescents|children and adolescents
529827|NCT01307163|after a successful liver transplantation|after a successful liver transplantation
529828|NCT01307163|informed consent forms signed be the examinees parents|informed consent forms signed be the examinees parents
529829|NCT01307150|Atopic Dermatitis|atopic dermatitis
529830|NCT01307150|Dead Sea|dead sea
529831|NCT01307150|Climatotherapy|climatotherapy
529832|NCT01307150|SCORAD|scorad
529833|NCT01307124|safety and efficacy|safety and efficacy
529834|NCT01307124|low dose LPV/r|low dose lpv/r
529835|NCT01307124|standard dose LPV/r|standard dose lpv/r
529836|NCT01307124|HIV infected children|hiv infected children
529837|NCT01307111|Misoprostol|misoprostol
529838|NCT01307111|IUD insertion|iud insertion
529839|NCT01307111|Nulliparous Women|nulliparous women
529840|NCT01307111|Contraception|contraception
529841|NCT01307111|Family Planning|family planning
529842|NCT01307111|IUD insertion in nulliparous women|iud insertion in nulliparous women
529843|NCT01307098|Enzyme Replacement Therapy (ERT)|enzyme replacement therapy (ert)
529844|NCT01307098|Lysosomal Storage Disease|lysosomal storage disease
529845|NCT01307098|Late Onset Lysosomal Acid Lipase (LAL) Deficiency|late onset lysosomal acid lipase (lal) deficiency
529846|NCT01307098|Acid cholesteryl ester hydrolase deficiency, type 2|acid cholesteryl ester hydrolase deficiency, type 2
529847|NCT01307098|Acid lipase disease|acid lipase disease
529848|NCT01307098|Cholesterol ester hydrolase deficiency|cholesterol ester hydrolase deficiency
529849|NCT01307098|LAL Deficiency|lal deficiency
529850|NCT01307098|LIPA Deficiency|lipa deficiency
529851|NCT01307098|Wolman disease|wolman disease
529852|NCT01307085|remote ischemic preconditioning|remote ischemic preconditioning
529853|NCT01307085|lung injury|lung injury
529854|NCT01307085|pulmonary resection|pulmonary resection
529855|NCT01307072|periodic examinations, compliance|periodic examinations, compliance
529856|NCT01307059|Growth disorders|growth disorders
529857|NCT01307059|Saizen|saizen
529858|NCT01307059|Easypod|easypod
529859|NCT01307059|Growth hormone|growth hormone
529860|NCT01307059|Pediatric subject|pediatric subject
529861|NCT01307046|Essential hypertension|essential hypertension
529862|NCT01307046|Uncontrolled hypertension|uncontrolled hypertension
529863|NCT01307046|Antihypertensive agents|antihypertensive agents
529864|NCT01307046|Blood pressure|blood pressure
529865|NCT01307033|Essential hypertension|essential hypertension
529866|NCT01307033|Uncontrolled hypertension|uncontrolled hypertension
529867|NCT01307033|Antihypertensive agents|antihypertensive agents
529868|NCT01307033|Blood pressure|blood pressure
529869|NCT01307020|Moderate to severe pain|moderate to severe pain
529870|NCT01307020|Postoperative pain|postoperative pain
529871|NCT01307020|Analgesics|analgesics
529872|NCT01307020|Dexketoprofen|dexketoprofen
529873|NCT01307020|Tramadol|tramadol
529874|NCT01306994|Exercise Test|exercise test
529875|NCT01306994|Bicycle Ergometry Test|bicycle ergometry test
529876|NCT01306994|Stress Test|stress test
529877|NCT01306981|Diabetes Mellitus|diabetes mellitus
529878|NCT01306981|Diabetes Complications|diabetes complications
529879|NCT01306981|Retinal Diseases|retinal diseases
529880|NCT01306981|Endothelial Growth Factors|endothelial growth factors
529881|NCT01306981|Monoclonal Antibodies|monoclonal antibodies
529882|NCT01306981|Ranibizumab|ranibizumab
529883|NCT01306981|Vitrectomy|vitrectomy
529884|NCT01306981|Vitreoretinal Surgery|vitreoretinal surgery
529885|NCT01306968|mild tramatic brain injury|mild tramatic brain injury
529886|NCT01306968|mTBI|mtbi
529887|NCT01306968|hyperbaric oxygen|hyperbaric oxygen
529888|NCT01306968|post concussive symptoms|post concussive symptoms
529889|NCT01306968|active duty military|active duty military
529890|NCT01306968|veterans|veterans
529891|NCT01306955|retinal vasculitis|retinal vasculitis
529892|NCT01306955|posterior uveitis|posterior uveitis
529893|NCT01306955|methylprednisolone|methylprednisolone
529894|NCT01306942|HER2 positive breast cancer|her2 positive breast cancer
529895|NCT01306942|first line treatment|first line treatment
529896|NCT01306942|Dasatinib|dasatinib
529897|NCT01306942|SRC kinase|src kinase
529898|NCT01306942|Trastuzumab resistance|trastuzumab resistance
529899|NCT01306929|Huntington Disease.|huntington disease.
529900|NCT01306916|thyroid disease, hyperthyroidism|thyroid disease, hyperthyroidism
529901|NCT01306903|Minimizing Cardiopulmonary Bypass MECC damage organ failure|minimizing cardiopulmonary bypass mecc damage organ failure
529902|NCT01306877|hemorrhoid|hemorrhoid
529903|NCT01306877|hemorrhoid stapler|hemorrhoid stapler
529904|NCT01306864|Endoscopic Hemostasis|endoscopic hemostasis
529905|NCT01306864|Peptic Ulcer|peptic ulcer
529906|NCT01306864|Recurrent Bleeding|recurrent bleeding
529907|NCT01306864|Injection Therapy|injection therapy
529908|NCT01306864|Thermal Probe|thermal probe
529909|NCT01306851|fibrin glue|fibrin glue
529910|NCT01306851|anastomotic leak|anastomotic leak
529911|NCT01306851|gastrointestinal high risk anastomosis|gastrointestinal high risk anastomosis
529912|NCT01306838|Short bowel syndrome|short bowel syndrome
529913|NCT01306838|Necrotizing enterocolitis|necrotizing enterocolitis
529914|NCT01306838|Small intestine perforation|small intestine perforation
529915|NCT01306838|Enterostomy|enterostomy
529916|NCT01306838|Intralipid|intralipid
529917|NCT01306838|Microlipid|microlipid
529918|NCT01306838|Fish oil|fish oil
529919|NCT01306825|Daptomycin|daptomycin
529920|NCT01306825|Bone disease,infectious|bone disease,infectious
529921|NCT01306825|Osteomyelitis|osteomyelitis
529922|NCT01306825|Diabetic foot|diabetic foot
529923|NCT01306825|Staphylococcus aureus|staphylococcus aureus
529924|NCT01306812|Adolescent|adolescent
529925|NCT01306812|Alcohol|alcohol
529926|NCT01306812|Criminology|criminology
529927|NCT01306812|Genes|genes
529928|NCT01306812|Environment|environment
529929|NCT01306812|Mono amine Oxidase|mono amine oxidase
529930|NCT01306812|Serotonin|serotonin
529931|NCT01306812|Social Support|social support
529932|NCT01306799|Barrett's Esophagus|barrett's esophagus
529933|NCT01306799|Erosive Esophagitis|erosive esophagitis
529934|NCT01306799|Proton Pump Inhibitor (PPI)|proton pump inhibitor (ppi)
529935|NCT01306799|Bone|bone
529936|NCT01306799|Bone Density|bone density
529937|NCT01306799|GERD|gerd
529938|NCT01306799|ulcer prophylaxis|ulcer prophylaxis
529939|NCT01306773|Influenza A|influenza a
529940|NCT01306773|convalescent plasma|convalescent plasma
529941|NCT01306773|death|death
529942|NCT01306760|depression|depression
529943|NCT01306760|electroconvulsive therapy|electroconvulsive therapy
529944|NCT01306760|ketamine|ketamine
529945|NCT01306747|Chronic pain|chronic pain
529946|NCT01306747|Stanford chronic pain self-management programme|stanford chronic pain self-management programme
529947|NCT01306747|Patient education|patient education
529948|NCT01306734|Extracorporeal circulation|extracorporeal circulation
529949|NCT01306734|Deep Hypothermic Circulatory Arrest|deep hypothermic circulatory arrest
529950|NCT01306734|aortic aneurism|aortic aneurism
529951|NCT01306734|neurological injury|neurological injury
529952|NCT01306734|inflammation|inflammation
529953|NCT01306734|coagulation|coagulation
529954|NCT01306708|Adhesive Capsulitis|adhesive capsulitis
529955|NCT01306708|Shoulder|shoulder
529956|NCT01306708|SPADI|spadi
529957|NCT01306695|Dementia|dementia
529958|NCT01306695|Depressive symptoms|depressive symptoms
529959|NCT01306695|Caregiver Burden|caregiver burden
529960|NCT01306695|Hispanic|hispanic
529961|NCT01306695|Latino|latino
529962|NCT01306695|Intervention|intervention
529963|NCT01306695|Geriatric Depression Scale|geriatric depression scale
529964|NCT01306695|Zarit Caregiver Burden Scale|zarit caregiver burden scale
529965|NCT01306656|Endocrinology|endocrinology
529966|NCT01306656|Metabolic Bone Disease|metabolic bone disease
529967|NCT01306656|Primary Hyperparathyroidism|primary hyperparathyroidism
529968|NCT01306656|PHPT|phpt
529969|NCT01306656|Vitamin D Deficiency|vitamin d deficiency
529970|NCT01306656|Bone Mineral Density|bone mineral density
529971|NCT01306656|Hyper-calcemia|hyper-calcemia
529972|NCT01306643|Indolent Non-Hodgkin's Lymphoma|indolent non-hodgkin's lymphoma
529973|NCT01306643|Non-Hodgkin Lymphoma|non-hodgkin lymphoma
529974|NCT01306643|iNHL|inhl
529975|NCT01306643|NHL|nhl
529976|NCT01306643|CAL-101|cal-101
529977|NCT01306643|PI3K|pi3k
529978|NCT01306643|Phosphatidylinositol 3-kinase|phosphatidylinositol 3-kinase
529979|NCT01306643|Follicular Lymphoma (FL)|follicular lymphoma (fl)
529980|NCT01306643|Small Lymphocytic Lymphoma (SLL)|small lymphocytic lymphoma (sll)
529981|NCT01306643|Marginal Zone Lymphoma (MZL)|marginal zone lymphoma (mzl)
529982|NCT01306630|AV-951|av-951
529983|NCT01306630|tivozanib|tivozanib
529984|NCT01306630|capecitabine (Xeloda®)|capecitabine (xeloda®)
529985|NCT01306604|Genetic Diseases|genetic diseases
529986|NCT01306604|Lipidoses|lipidoses
529987|NCT01306604|Lipid Metabolism|lipid metabolism
529988|NCT01306604|Lysosomal Storage Diseases|lysosomal storage diseases
529989|NCT01306604|Metabolic Diseases|metabolic diseases
529990|NCT01306604|Lipid Metabolism Disorders|lipid metabolism disorders
529991|NCT01306591|neovascular age-related macular degeneration|neovascular age-related macular degeneration
529992|NCT01306591|Bevacizumab|bevacizumab
529993|NCT01306591|Multicenter Randomized Study|multicenter randomized study
529994|NCT01306578|Guillain Barre syndrome|guillain barre syndrome
529995|NCT01306578|IVIG|ivig
529996|NCT01306578|Plasma exchange|plasma exchange
529997|NCT01306565|Unstable angina|unstable angina
529998|NCT01306565|NSTMI|nstmi
529999|NCT01306565|Statin|statin
530000|NCT01306565|Atorvastatin|atorvastatin
530001|NCT01306552|Tobacco use|tobacco use
530002|NCT01306552|Adolescents|adolescents
530003|NCT01306552|Primary prevention|primary prevention
530004|NCT01306552|Program effectiveness|program effectiveness
530005|NCT01306552|Parental component|parental component
530006|NCT01306539|deep brain stimulation|deep brain stimulation
530007|NCT01306539|subthalamic nucleus|subthalamic nucleus
530008|NCT01306526|Thin-cap fibroatheroma|thin-cap fibroatheroma
530009|NCT01306526|Vulnerable plaque|vulnerable plaque
530010|NCT01306526|Coronary artery disease|coronary artery disease
530011|NCT01306526|Obstructive sleep apnea|obstructive sleep apnea
530012|NCT01306526|Intravascular Ultrasound|intravascular ultrasound
530013|NCT01306513|emphysema|emphysema
530014|NCT01306513|lung volume reduction surgery|lung volume reduction surgery
530015|NCT01306513|mesenchymal stromal cells|mesenchymal stromal cells
530016|NCT01306500|Gastric lavage|gastric lavage
530017|NCT01306500|Neonate|neonate
530018|NCT01306500|Meconium stained amniotic fluid|meconium stained amniotic fluid
530019|NCT01306500|Feeding problems|feeding problems
530020|NCT01306487|macular hole|macular hole
530021|NCT01306474|CD4/CD25 Tr cell,TNF,IFN-γ,IL-2|cd4/cd25 tr cell,tnf,ifn-γ,il-2
530022|NCT01306448|constipation|constipation
530023|NCT01306448|gastro|gastro
530024|NCT01306448|vibrating capsule|vibrating capsule
530025|NCT01306448|safety|safety
530026|NCT01306435|Osteoarthritis|osteoarthritis
673518|NCT00736775|AD|ad
530027|NCT01306435|Low Power Laser Therapy|low power laser therapy
530028|NCT01306435|Exercise|exercise
530029|NCT01306435|Knee|knee
530030|NCT01306422|hoodia gordonii|hoodia gordonii
530031|NCT01306422|energy intake|energy intake
530032|NCT01306422|food intake|food intake
530033|NCT01306422|efficacy|efficacy
530034|NCT01306422|body weight|body weight
530035|NCT01306422|functional food|functional food
530036|NCT01306422|plant extract|plant extract
530037|NCT01306422|safety|safety
530038|NCT01306422|steroid glycosides|steroid glycosides
530039|NCT01306422|tolerability|tolerability
530040|NCT01306409|anemia|anemia
530041|NCT01306409|kidney disease|kidney disease
530042|NCT01306396|NAFLD|nafld
530043|NCT01306396|metabolic syndrome|metabolic syndrome
530044|NCT01306396|children|children
530045|NCT01306396|fructose|fructose
530046|NCT01306383|SODIS|sodis
530047|NCT01306383|waterborne|waterborne
530048|NCT01306383|Disease|disease
530049|NCT01306383|Diarrhoea|diarrhoea
530050|NCT01306383|dysentery|dysentery
530051|NCT01306370|primary knee arthroplasty|primary knee arthroplasty
530052|NCT01306370|fibrin glue|fibrin glue
530053|NCT01306370|tranexamic acid|tranexamic acid
530054|NCT01306370|topic|topic
530055|NCT01306357|Turner's syndrome|turner's syndrome
530056|NCT01306357|somatropin|somatropin
530057|NCT01306357|human growth hormone deficiency|human growth hormone deficiency
530058|NCT01306344|Qualitative Research|qualitative research
530059|NCT01306344|Interview, Psychological|interview, psychological
530060|NCT01306344|Patients|patients
530061|NCT01306344|Nurses|nurses
530062|NCT01306344|Physicians|physicians
530063|NCT01306305|Influenza|influenza
530064|NCT01306305|Virus|virus
530065|NCT01306305|Vaccination|vaccination
530066|NCT01306305|Immunisation|immunisation
530067|NCT01306292|Pulmonary hypertension|pulmonary hypertension
530068|NCT01306292|Right heart Catheterization|right heart catheterization
530069|NCT01306279|Cystic Fibrosis|cystic fibrosis
530070|NCT01306279|Infection|infection
530071|NCT01306279|Pulmonary exacerbation|pulmonary exacerbation
530072|NCT01306279|Hypermutators|hypermutators
530073|NCT01306279|Bacterial diversity|bacterial diversity
530074|NCT01306279|Quorum sensing|quorum sensing
530075|NCT01306266|active duty|active duty
530076|NCT01306266|blast induced|blast induced
530077|NCT01306266|headache|headache
530078|NCT01306253|Influenza|influenza
530079|NCT01306253|Virus|virus
530080|NCT01306253|Vaccination|vaccination
530081|NCT01306253|Immunisation|immunisation
530082|NCT01306240|Infant newborn|infant newborn
530083|NCT01306240|Infant preterm|infant preterm
530084|NCT01306240|Acute respiratory distress syndrome|acute respiratory distress syndrome
530085|NCT01306240|surfactant|surfactant
530086|NCT01306240|Hyaline Membrane disease|hyaline membrane disease
530087|NCT01306240|Newborn acute respiratory distress syndrome (ARDS)|newborn acute respiratory distress syndrome (ards)
530088|NCT01306227|Infant, newborn|infant, newborn
530089|NCT01306227|Infant, preterm|infant, preterm
530090|NCT01306227|Thyroid|thyroid
530091|NCT01306227|Outcome|outcome
530092|NCT01306227|Newborns less than 32 weeks of gestation|newborns less than 32 weeks of gestation
530093|NCT01306227|TSH < 20 mIU/L and a FT4 < 0.80 ng/dL|tsh < 20 miu/l and a ft4 < 0.80 ng/dl
530094|NCT01306201|Hospital Setting|hospital setting
530095|NCT01306188|metastatic cancer|metastatic cancer
530096|NCT01306188|lymphopenia|lymphopenia
530097|NCT01306188|T cell receptor diversity|t cell receptor diversity
530098|NCT01306149|biochemical parameters|biochemical parameters
530099|NCT01306149|mineral metabolism|mineral metabolism
530100|NCT01306149|protein-bound uremic retention solutes|protein-bound uremic retention solutes
530101|NCT01306149|incident PD patients|incident pd patients
530102|NCT01306136|Posttraumatic stress disorder|posttraumatic stress disorder
530103|NCT01306136|Prolonged exposure|prolonged exposure
530104|NCT01306136|Cognitive behavior therapy|cognitive behavior therapy
530105|NCT01306123|bioavailability|bioavailability
530106|NCT01306123|pharmacokinetics|pharmacokinetics
530107|NCT01306123|cyanocobalamin|cyanocobalamin
530108|NCT01306123|intranasal|intranasal
530109|NCT01306123|intramuscular|intramuscular
530110|NCT01306110|Liver fibrosis|liver fibrosis
530111|NCT01306110|diabetes|diabetes
530112|NCT01306110|Fibroscan|fibroscan
530113|NCT01306110|Fibrotest|fibrotest
530114|NCT01306110|noninvasive fibrosis biomarkers|noninvasive fibrosis biomarkers
530115|NCT01306097|Zinc Supplement|zinc supplement
530116|NCT01306097|Diarrhea|diarrhea
530117|NCT01306097|Sever Diarrhea|sever diarrhea
530118|NCT01306084|Respiratory Infections|respiratory infections
530119|NCT01306084|Norovirus|norovirus
530120|NCT01306084|Adenovirus|adenovirus
530121|NCT01306084|Viral Infection|viral infection
530122|NCT01306084|Respiratory Viruses|respiratory viruses
530123|NCT01306058|Hepatocellular Carcinoma|hepatocellular carcinoma
530124|NCT01306058|TRC105|trc105
530125|NCT01306058|Sorafenib|sorafenib
530126|NCT01306058|Liver Cancer|liver cancer
530127|NCT01306058|Monoclonal Antibody|monoclonal antibody
530128|NCT01306045|AZD6244|azd6244
530129|NCT01306045|MK-2206|mk-2206
530130|NCT01306045|Lapatinib|lapatinib
530131|NCT01306045|Erlotinib|erlotinib
530132|NCT01306045|Sunitinib|sunitinib
530133|NCT01306032|PARP Inhibitor|parp inhibitor
530134|NCT01306032|BRCA Mutations|brca mutations
530135|NCT01306032|DNA Damage Repair|dna damage repair
530136|NCT01306032|Pharmacodynamics|pharmacodynamics
530137|NCT01306032|Metronomic Cyclophosphamide|metronomic cyclophosphamide
530138|NCT01306032|Ovarian Cancer|ovarian cancer
530139|NCT01306032|Breast Cancer|breast cancer
530140|NCT01306032|Fallopian Tube Cancer|fallopian tube cancer
530141|NCT01306032|Peritoneal Cancer|peritoneal cancer
530142|NCT01306019|X-Linked Severe Combined Immunodeficiency (XSCID)|x-linked severe combined immunodeficiency (xscid)
530143|NCT01306019|Gene Transfer|gene transfer
530144|NCT01306019|Peripheral Blood Stem Cells|peripheral blood stem cells
530145|NCT01306019|Common Gamma Chain (GC), Immune Reconstitution|common gamma chain (gc), immune reconstitution
530146|NCT01306019|Immune Reconstitution|immune reconstitution
530147|NCT01306019|X-Linked Severe Combined Immunodeficiency|x-linked severe combined immunodeficiency
530148|NCT01306019|SCID|scid
530149|NCT01306006|Mortality|mortality
530150|NCT01306006|Vaccines|vaccines
530151|NCT01305954|Breast|breast
530152|NCT01305954|Cancer|cancer
530153|NCT01305954|Breast Cancer|breast cancer
530154|NCT01305954|New Diagnosis|new diagnosis
530155|NCT01305954|Treatment|treatment
530156|NCT01305954|Chemotherapy|chemotherapy
530157|NCT01305954|Blood|blood
530158|NCT01305954|Blood Draw|blood draw
530159|NCT01305954|Lab Draw|lab draw
530160|NCT01305954|Gene|gene
530161|NCT01305954|Gene Therapy|gene therapy
530162|NCT01305954|Geriatric|geriatric
530163|NCT01305954|Oncology|oncology
530164|NCT01305954|Muss|muss
530166|NCT01305954|North Carolina Cancer Hospital|north carolina cancer hospital
530167|NCT01305954|Initial Treatment|initial treatment
530168|NCT01305954|CBC|cbc
530169|NCT01305941|everolimus|everolimus
530170|NCT01305941|trastuzumab|trastuzumab
530171|NCT01305941|vinorelbine|vinorelbine
530172|NCT01305941|RAD001|rad001
530173|NCT01305941|Breast Cancer|breast cancer
530174|NCT01305941|Herceptin|herceptin
530175|NCT01305941|Navelbine|navelbine
530176|NCT01305941|Lineberger Comprehensive Cancer Center|lineberger comprehensive cancer center
530177|NCT01305941|Brain Metastases|brain metastases
530178|NCT01305915|single-session group|single-session group
530179|NCT01305915|psychoeducational intervention|psychoeducational intervention
530180|NCT01305889|Depression|depression
530181|NCT01305889|Cerebral perfusion|cerebral perfusion
530182|NCT01305889|Brain derived neurotropic factor|brain derived neurotropic factor
530183|NCT01305889|Problem Solving Therapy|problem solving therapy
530184|NCT01305889|Sertraline|sertraline
530185|NCT01305876|yoga|yoga
530186|NCT01305876|emotional behavioral disorder|emotional behavioral disorder
530187|NCT01305876|intervention|intervention
530188|NCT01305876|school|school
530189|NCT01305876|meditation|meditation
530190|NCT01305876|focus: yoga intervention in students with emotional behavioral disorders in an urban school|focus: yoga intervention in students with emotional behavioral disorders in an urban school
530191|NCT01305863|Peripheral Vascular Disease (PVD)|peripheral vascular disease (pvd)
530192|NCT01305850|Aliskiren|aliskiren
530193|NCT01305850|Losartan|losartan
530194|NCT01305850|Peritoneal membrane dysfunction|peritoneal membrane dysfunction
530195|NCT01305837|multiple sclerosis|multiple sclerosis
530196|NCT01305837|methylprednisolone|methylprednisolone
530197|NCT01305837|osteopontin|osteopontin
530198|NCT01305837|inflammation|inflammation
530199|NCT01305837|demyelinating|demyelinating
530200|NCT01305824|arteriovenous fistula|arteriovenous fistula
530201|NCT01305824|AVF|avf
530202|NCT01305824|hemodialysis|hemodialysis
530203|NCT01305824|vascular access|vascular access
530204|NCT01305824|dialysis|dialysis
530205|NCT01305824|fistula|fistula
530206|NCT01305824|PRT-201|prt-201
530207|NCT01305824|vonapanitase|vonapanitase
530208|NCT01305824|kidney|kidney
530209|NCT01305824|renal|renal
530210|NCT01305811|Complex Medical Illness|complex medical illness
530211|NCT01305811|Gulf War Illness|gulf war illness
530212|NCT01305811|Veteran|veteran
530213|NCT01305798|Biometric Screenings|biometric screenings
530214|NCT01305798|Active Choice|active choice
530215|NCT01305798|Behavioral Economics|behavioral economics
530216|NCT01305798|Default|default
530217|NCT01305772|SCCHN|scchn
530218|NCT01305772|untreated|untreated
530219|NCT01305772|Stage III or IVa-b (M0)|stage iii or iva-b (m0)
530220|NCT01305759|Total knee arthroplasty|total knee arthroplasty
530221|NCT01305759|Total hip arthroplasty|total hip arthroplasty
530222|NCT01305759|Peri acetabular osteotomy|peri acetabular osteotomy
530223|NCT01305759|Social class|social class
530224|NCT01305759|Health related quality of life|health related quality of life
530225|NCT01305746|SLE|sle
530226|NCT01305746|Lupus|lupus
530227|NCT01305746|Lupus Erythematosus, Systemic|lupus erythematosus, systemic
530228|NCT01305746|A-623|a-623
530229|NCT01305746|Autoimmune Diseases|autoimmune diseases
530230|NCT01305746|Blisibimod|blisibimod
530231|NCT01305733|Pain relief|pain relief
530232|NCT01305720|mydriatic|mydriatic
530233|NCT01305720|NIRS|nirs
530234|NCT01305720|preterm|preterm
530235|NCT01305720|eye drops|eye drops
530236|NCT01305720|cerebral|cerebral
530237|NCT01305720|mesenteric oxygenation|mesenteric oxygenation
530238|NCT01305707|Consolidation ECT|consolidation ect
530239|NCT01305707|Pharmacotherapy|pharmacotherapy
530240|NCT01305707|Efficacy|efficacy
530241|NCT01305707|Depression|depression
530242|NCT01305707|Prevention|prevention
530243|NCT01305707|Electroconvulsive therapy|electroconvulsive therapy
530244|NCT01305707|Drug therapy|drug therapy
530245|NCT01305668|COPD|copd
530246|NCT01305668|Emphysema phenotype|emphysema phenotype
530247|NCT01305655|Drug: Glucarpidase|drug: glucarpidase
530248|NCT01305642|Postnatal development|postnatal development
530249|NCT01305642|Breast milk fortification|breast milk fortification
530250|NCT01305642|Composition of breast milk|composition of breast milk
530251|NCT01305629|HIV|hiv
530252|NCT01305629|Medication Adherence|medication adherence
530253|NCT01305629|Substance Use|substance use
530254|NCT01305629|Older adults|older adults
530255|NCT01305629|Treatment|treatment
530256|NCT01305616|Open angle Glaucoma|open angle glaucoma
530257|NCT01305616|Yellow-tinted intraocular lens|yellow-tinted intraocular lens
530258|NCT01305616|Short-wavelength Automated Perimetry (SWAP)|short-wavelength automated perimetry (swap)
530259|NCT01305616|Standard Automated Perimetry (SAP)|standard automated perimetry (sap)
530260|NCT01305616|cataract|cataract
530261|NCT01305590|HIV|hiv
530262|NCT01305590|AIDS|aids
530263|NCT01305590|Medication Adherence|medication adherence
530264|NCT01305590|Commitment Devices|commitment devices
530265|NCT01305590|Behavioral Economics|behavioral economics
530266|NCT01305564|Pulmonary embolism (PE)|pulmonary embolism (pe)
530267|NCT01305564|Deep vein thrombosis (DVT)|deep vein thrombosis (dvt)
530268|NCT01305564|Vena cava|vena cava
530269|NCT01305564|Vena cava filter|vena cava filter
530270|NCT01305564|Inferior vena cava|inferior vena cava
530271|NCT01305564|Venous thromboembolic disease (VTED)|venous thromboembolic disease (vted)
530272|NCT01305525|SCS|scs
530273|NCT01305525|St. Jude Medical|st. jude medical
530274|NCT01305525|Neuromodulation|neuromodulation
530275|NCT01305512|Solid|solid
530276|NCT01305512|Tumor|tumor
530277|NCT01305512|Taxane|taxane
530278|NCT01305499|AML|aml
530279|NCT01305447|smoking cessation|smoking cessation
530280|NCT01305447|exercise maintenance|exercise maintenance
530281|NCT01305447|preventing relapse|preventing relapse
530282|NCT01305447|weight gain|weight gain
530283|NCT01305447|group-mediated cognitive behavioural therapy|group-mediated cognitive behavioural therapy
530284|NCT01305434|diabetes mellitus type 2|diabetes mellitus type 2
530285|NCT01305434|mulberry leaf extract|mulberry leaf extract
530286|NCT01305434|post prandial blood glucose|post prandial blood glucose
530287|NCT01305421|ICU|icu
530288|NCT01305421|muscle strength|muscle strength
530289|NCT01305421|mechanical ventilation|mechanical ventilation
530290|NCT01305421|weaning|weaning
530291|NCT01305408|Bipolar I Disorder|bipolar i disorder
530292|NCT01305395|Cardiac Allograft Vasculopathy in Heart Transplant|cardiac allograft vasculopathy in heart transplant
530293|NCT01305382|Cardiac Allograft Vasculopathy|cardiac allograft vasculopathy
530294|NCT01305369|ASTHMA|asthma
530295|NCT01305369|PLATELET RECEPTOR P2Y12|platelet receptor p2y12
530296|NCT01305369|PRASUGREL|prasugrel
530297|NCT01305369|INFLAMMATION|inflammation
530298|NCT01305356|degenerative joint disease|degenerative joint disease
530299|NCT01305356|DJD|djd
530300|NCT01305356|joint fusion|joint fusion
530301|NCT01305356|hindfoot|hindfoot
530302|NCT01305356|congenital deformity|congenital deformity
530303|NCT01305356|osteoarthritis|osteoarthritis
530304|NCT01305356|rheumatoid arthritis|rheumatoid arthritis
530305|NCT01305356|post-traumatic arthritis|post-traumatic arthritis
530306|NCT01305356|ankylosing spondylitis|ankylosing spondylitis
530307|NCT01305356|Augment(tm) Injectable Bone Graft|augment(tm) injectable bone graft
530308|NCT01305356|autologous bone graft|autologous bone graft
530309|NCT01305356|autogenous bone graft|autogenous bone graft
530310|NCT01305356|beta-TCP|beta-tcp
530311|NCT01305356|bovine collagen|bovine collagen
530312|NCT01305356|rhPDGF(bb)|rhpdgf(bb)
530313|NCT01305343|Spinal Deformity|spinal deformity
530314|NCT01305343|Scoliosis|scoliosis
530315|NCT01305343|Neurologic complications|neurologic complications
530316|NCT01305330|small renal mass|small renal mass
530317|NCT01305330|active surveillance|active surveillance
530318|NCT01305330|kidney mass|kidney mass
530319|NCT01305330|kidney tumour|kidney tumour
530320|NCT01305317|Statin|statin
530321|NCT01305291|dietary fiber|dietary fiber
530322|NCT01305291|satiety response|satiety response
530323|NCT01305291|hunger|hunger
530324|NCT01305291|CCK|cck
530325|NCT01305291|PYY|pyy
530326|NCT01305291|ghrelin|ghrelin
530327|NCT01305291|GIP|gip
530328|NCT01305291|GLP-1|glp-1
530329|NCT01305278|Balance|balance
530330|NCT01305278|Rehabilitation|rehabilitation
530331|NCT01305278|Vestibular|vestibular
530332|NCT01305265|sore throat|sore throat
530333|NCT01305265|dysphagia|dysphagia
530334|NCT01305265|hoarseness|hoarseness
530335|NCT01305265|post operative|post operative
530336|NCT01305265|endotracheal intubation|endotracheal intubation
530337|NCT01305239|Observational|observational
530338|NCT01305239|epidemiological|epidemiological
530339|NCT01305239|cohort|cohort
530340|NCT01305239|cross-sectional|cross-sectional
530341|NCT01305239|prospective|prospective
530342|NCT01305239|multicenter|multicenter
530343|NCT01305239|survey|survey
530344|NCT01305239|France.|france.
530345|NCT01305226|THR 100|thr 100
530346|NCT01305174|Common Iliac Artery and External Iliac Artery|common iliac artery and external iliac artery
530347|NCT01305161|1Allergy|1allergy
530348|NCT01305161|2 Neuromuscular blockers|2 neuromuscular blockers
530349|NCT01305148|warfarin|warfarin
530350|NCT01305148|genetic testing|genetic testing
530351|NCT01305148|personalized medicine|personalized medicine
530352|NCT01305148|anti-coagulants|anti-coagulants
530353|NCT01305148|coumadin|coumadin
530354|NCT01305135|myelodysplastic syndrome, azacitidine, idarubicin|myelodysplastic syndrome, azacitidine, idarubicin
530355|NCT01305122|Glioma|glioma
530356|NCT01305122|Neurocognitive functions|neurocognitive functions
530357|NCT01305096|heart rate variability|heart rate variability
530358|NCT01305096|oxygen uptake|oxygen uptake
530359|NCT01305096|heart rate recovery|heart rate recovery
530360|NCT01305096|perceived stress|perceived stress
530361|NCT01305096|sleep|sleep
530362|NCT01305096|blood pressure|blood pressure
530363|NCT01305096|body mass index|body mass index
530364|NCT01305096|body weight|body weight
530365|NCT01305096|hand grip strength|hand grip strength
530366|NCT01305096|sleep quality|sleep quality
530367|NCT01305096|subjective health complaints|subjective health complaints
530368|NCT01305096|blood lipids|blood lipids
530369|NCT01305096|salivary cortisol|salivary cortisol
530370|NCT01305096|blood sugar|blood sugar
530371|NCT01305096|HbA1C|hba1c
530372|NCT01305096|Adiponectin|adiponectin
530373|NCT01305096|Leptin|leptin
530374|NCT01305096|Adipolipoproteins|adipolipoproteins
530375|NCT01305096|blood proteins|blood proteins
530376|NCT01305096|cytokines|cytokines
530377|NCT01305096|insomnia|insomnia
530378|NCT01305096|sleeplessness|sleeplessness
530379|NCT01305096|yoga|yoga
530380|NCT01305070|Standard balloon angioplasty|standard balloon angioplasty
530381|NCT01305070|POBA|poba
530382|NCT01305070|Angioplasty with paclitaxel-eluting balloon|angioplasty with paclitaxel-eluting balloon
530383|NCT01305070|Superficial femoral artery|superficial femoral artery
530384|NCT01305057|dry skin condition|dry skin condition
530385|NCT01305044|tai chi|tai chi
530386|NCT01305044|elderly cancer survivor|elderly cancer survivor
530387|NCT01305044|mind body intervention|mind body intervention
530388|NCT01305031|Asphyxia|asphyxia
530389|NCT01305031|Resuscitation|resuscitation
530390|NCT01305031|Room Air|room air
530391|NCT01305018|Branched-chain amino acids|branched-chain amino acids
530392|NCT01305018|Leucine|leucine
530393|NCT01305018|Muscle damage|muscle damage
530394|NCT01305018|Inflammation|inflammation
530395|NCT01305018|supplementation|supplementation
530396|NCT01305018|resistance exercise-induced|resistance exercise-induced
530397|NCT01305005|blood flow|blood flow
530398|NCT01304992|Dietary protein|dietary protein
530399|NCT01304992|Lupin protein|lupin protein
530400|NCT01304992|Cholesterol metabolism|cholesterol metabolism
530401|NCT01304992|Protein metabolism|protein metabolism
530402|NCT01304992|Hypercholesterolemia|hypercholesterolemia
530403|NCT01304992|Protein-enriched drinks|protein-enriched drinks
530404|NCT01304979|acupuncture|acupuncture
530405|NCT01304979|auricular acu-therapy|auricular acu-therapy
530406|NCT01304979|gua sha therapy|gua sha therapy
530407|NCT01304979|low back 'spine fusion'|low back 'spine fusion'
530408|NCT01304979|post surgical pain|post surgical pain
530409|NCT01304979|post surgical recovery|post surgical recovery
530410|NCT01304979|Pain and recovery from 'spine fusion' surgery|pain and recovery from 'spine fusion' surgery
530411|NCT01304966|RRP|rrp
530412|NCT01304966|HPV|hpv
530413|NCT01304953|General anaesthetics|general anaesthetics
530414|NCT01304953|gynaecological laparoscopy|gynaecological laparoscopy
530415|NCT01304953|anaesthetic i.v.|anaesthetic i.v.
530416|NCT01304953|propofol|propofol
530417|NCT01304953|anaesthetic volatile|anaesthetic volatile
530418|NCT01304953|evoflurane|evoflurane
530419|NCT01304953|antiemetics|antiemetics
530420|NCT01304953|reopisetron|reopisetron
530421|NCT01304953|postoperative pain|postoperative pain
530422|NCT01304940|Stress|stress
530423|NCT01304940|Stress Disorders, Post-Traumatic|stress disorders, post-traumatic
530424|NCT01304940|Stress Disorders, Traumatic|stress disorders, traumatic
530425|NCT01304927|Reproduction|reproduction
530426|NCT01304927|Sex hormones|sex hormones
530427|NCT01304927|Glucose metabolism|glucose metabolism
530428|NCT01304927|Bone metabolism|bone metabolism
530429|NCT01304927|Calcium|calcium
530430|NCT01304927|Sperm|sperm
673959|NCT00735059|Diapes|diapes
530431|NCT01304927|testis|testis
530432|NCT01304927|bone|bone
530433|NCT01304927|endocrinology|endocrinology
530434|NCT01304914|Respiratory tract infections|respiratory tract infections
530435|NCT01304914|Gastrointestinal tract infections|gastrointestinal tract infections
530436|NCT01304914|Pediatrics|pediatrics
530437|NCT01304914|Specimen collection|specimen collection
530438|NCT01304901|Acute asthma|acute asthma
530439|NCT01304901|Children|children
530440|NCT01304901|Montelukast|montelukast
530441|NCT01304901|Emergency room|emergency room
530442|NCT01304888|Food consumption|food consumption
530443|NCT01304875|Fabry disease|fabry disease
530444|NCT01304875|alpha-galactosidase deficiency|alpha-galactosidase deficiency
530445|NCT01304875|exercise|exercise
530446|NCT01304875|pulmonary|pulmonary
530447|NCT01304849|Hodgkin's Lymphoma|hodgkin's lymphoma
530448|NCT01304849|PET CT scan|pet ct scan
530449|NCT01304849|Escalated BEACOPP|escalated beacopp
530450|NCT01304849|ABVD|abvd
530451|NCT01304849|Response adapted therapy|response adapted therapy
530452|NCT01304836|Kidney|kidney
530453|NCT01304836|Diabetes Mellitus|diabetes mellitus
530454|NCT01304836|Transplant|transplant
530455|NCT01304836|Immunosuppression|immunosuppression
530456|NCT01304823|T1R2/T1R3|t1r2/t1r3
530457|NCT01304823|gastric emptying|gastric emptying
530458|NCT01304823|gut|gut
530459|NCT01304823|lactisole|lactisole
530460|NCT01304823|nutrient sensing|nutrient sensing
530461|NCT01304810|NicVAX|nicvax
530462|NCT01304810|Smoking cessation|smoking cessation
530463|NCT01304797|MM302|mm302
530464|NCT01304797|Breast Cancer|breast cancer
530465|NCT01304797|Locally advanced/unresectable|locally advanced/unresectable
530466|NCT01304797|metastatic|metastatic
530467|NCT01304784|Solid tumors|solid tumors
530468|NCT01304784|Failed at least one line of standard therapy|failed at least one line of standard therapy
530469|NCT01304771|Safety|safety
530470|NCT01304771|AKSB|aksb
530471|NCT01304771|probiotic|probiotic
530472|NCT01304771|synbiotic|synbiotic
530473|NCT01304771|enterococcus|enterococcus
530474|NCT01304771|Saccharomyces|saccharomyces
530475|NCT01304771|elderly|elderly
530476|NCT01304771|influenza|influenza
530477|NCT01304771|vaccine|vaccine
530478|NCT01304771|immune|immune
530479|NCT01304771|response|response
530480|NCT01304693|AMD|amd
530481|NCT01304693|Wet AMD|wet amd
530482|NCT01304693|Exudative|exudative
530483|NCT01304693|CNV|cnv
530484|NCT01304667|Vulvar cancer|vulvar cancer
530485|NCT01304667|Radiotherapy|radiotherapy
530486|NCT01304667|Chemotherapy|chemotherapy
530487|NCT01304654|acute lung injury|acute lung injury
530488|NCT01304654|respiratory distress syndrome|respiratory distress syndrome
530489|NCT01304654|neoplasms|neoplasms
530490|NCT01304654|child|child
530491|NCT01304641|Dyslipidemia|dyslipidemia
530492|NCT01304641|Cardiovascular|cardiovascular
530493|NCT01304641|Statin|statin
530494|NCT01304628|asthma|asthma
530495|NCT01304615|Overweight|overweight
530496|NCT01304615|Obesity|obesity
530497|NCT01304615|Young Adults|young adults
530498|NCT01304615|Energy Density|energy density
530499|NCT01304615|Culinary Skills|culinary skills
530500|NCT01304615|Physical Activity|physical activity
530501|NCT01304615|Consumption of Self-made Meals|consumption of self-made meals
530502|NCT01304615|Family History of diabetes|family history of diabetes
530503|NCT01304602|colorectal cancer|colorectal cancer
530504|NCT01304602|BKM120|bkm120
530505|NCT01304602|irinotecan|irinotecan
530506|NCT01304589|provoked vestibulodynia|provoked vestibulodynia
530507|NCT01304589|vulvodynia|vulvodynia
530508|NCT01304589|PVD|pvd
530509|NCT01304576|stroke|stroke
530510|NCT01304576|parietal lesions|parietal lesions
530511|NCT01304550|non-invasive|non-invasive
530512|NCT01304550|hemoglobin|hemoglobin
530513|NCT01304524|CIN 2/3 or CIN 3|cin 2/3 or cin 3
530514|NCT01304524|Cervical cancer|cervical cancer
530515|NCT01304524|Papillomavirus|papillomavirus
530516|NCT01304485|Recurrent Prostate Carcinoma|recurrent prostate carcinoma
530517|NCT01304485|sodium acetate c11|sodium acetate c11
530518|NCT01304485|PET|pet
530519|NCT01304485|prostate cancer|prostate cancer
530520|NCT01304485|rising PSA|rising psa
530521|NCT01304485|PSA recurrence|psa recurrence
530522|NCT01304485|biochemical recurrence|biochemical recurrence
530523|NCT01304472|coronary angioplasty|coronary angioplasty
530524|NCT01304472|clopidogrel resistance|clopidogrel resistance
530525|NCT01304472|prasugrel|prasugrel
530828|NCT01303302|C19 246 300|c19 246 300
530526|NCT01304446|Nutritional support|nutritional support
530527|NCT01304446|Cancer|cancer
530528|NCT01304446|Malnutrition|malnutrition
530529|NCT01304446|Child|child
530530|NCT01304446|Adolescent|adolescent
530531|NCT01304446|pediatric|pediatric
530532|NCT01304420|Juvenile idiopathic arthritis|juvenile idiopathic arthritis
530533|NCT01304420|Ultrasonography|ultrasonography
530534|NCT01304420|Cartilage|cartilage
530535|NCT01304420|Cartilage biomarkers|cartilage biomarkers
530536|NCT01304420|Bone biomarkers|bone biomarkers
530537|NCT01304407|Rothmund-Thomson Syndrome|rothmund-thomson syndrome
530538|NCT01304407|Calcium absorption|calcium absorption
530539|NCT01304407|Bone density|bone density
530540|NCT01304394|Parenteral Nutrition|parenteral nutrition
530541|NCT01304394|Multi Chamber Bag|multi chamber bag
530542|NCT01304381|Heart failure|heart failure
530543|NCT01304381|Palliative care|palliative care
530544|NCT01304381|Integrated care|integrated care
530545|NCT01304368|Hyperthermia, Induced|hyperthermia, induced
530546|NCT01304368|Randomized Controlled Trial|randomized controlled trial
530547|NCT01304368|Neck Pain|neck pain
530548|NCT01304368|Sensory Thresholds|sensory thresholds
530549|NCT01304368|Pain Measurements|pain measurements
530550|NCT01304355|IBS|ibs
530551|NCT01304355|Cognition|cognition
530552|NCT01304355|Kynurenine Pathway|kynurenine pathway
530553|NCT01304355|Gastrointestinal|gastrointestinal
530554|NCT01304342|Propofol|propofol
530555|NCT01304342|remifentanil|remifentanil
530556|NCT01304342|fentanyl|fentanyl
530557|NCT01304342|ERCP|ercp
530558|NCT01304342|Quality of sedation|quality of sedation
530559|NCT01304342|recovery|recovery
530560|NCT01304342|satisfaction|satisfaction
530561|NCT01304342|respiratory depression|respiratory depression
530562|NCT01304303|solid|solid
530563|NCT01304303|tumor|tumor
530564|NCT01304303|taxane|taxane
530565|NCT01304303|platinum|platinum
530566|NCT01304290|inflammatory process|inflammatory process
530567|NCT01304290|hyperglycaemia|hyperglycaemia
530568|NCT01304290|inflammatory cytokine response|inflammatory cytokine response
530569|NCT01304290|organ survival|organ survival
530570|NCT01304290|hyperinsulinemic clamp|hyperinsulinemic clamp
530571|NCT01304277|Replagal|replagal
530572|NCT01304264|glaucoma, ocular, blood flow, fluctuations|glaucoma, ocular, blood flow, fluctuations
530573|NCT01304251|short-term fasting|short-term fasting
530574|NCT01304251|adjuvant chemotherapy|adjuvant chemotherapy
530575|NCT01304251|toxicity|toxicity
530576|NCT01304251|side-effects|side-effects
530577|NCT01304238|Retrospective evaluation of patients with acute Heparin-induced Thrombocytopenia type II treated with Fondaparinux|retrospective evaluation of patients with acute heparin-induced thrombocytopenia type ii treated with fondaparinux
530578|NCT01304225|diabetic retinopathy|diabetic retinopathy
530579|NCT01304225|photocoagulation|photocoagulation
530580|NCT01304225|PASCAL laser|pascal laser
530581|NCT01304212|total knee arthroplasty|total knee arthroplasty
530582|NCT01304212|intraarticular infiltration|intraarticular infiltration
530583|NCT01304212|femoral block|femoral block
530584|NCT01304199|Cancer survivor|cancer survivor
530585|NCT01304199|Neoplasms|neoplasms
530586|NCT01304199|Treatments|treatments
530587|NCT01304199|Physical status|physical status
530588|NCT01304199|Psychosocial status|psychosocial status
530589|NCT01304199|Survivorship survey|survivorship survey
530590|NCT01304199|Survivorship care|survivorship care
530591|NCT01304199|Research|research
530592|NCT01304199|Cancer patient|cancer patient
530593|NCT01304186|Health literacy|health literacy
530594|NCT01304186|HIV|hiv
530595|NCT01304186|Medication Adherence|medication adherence
530596|NCT01304186|IMB Model|imb model
530597|NCT01304173|BCG|bcg
530598|NCT01304173|refractory|refractory
530599|NCT01304173|NMIBC|nmibc
530600|NCT01304173|CIS|cis
530601|NCT01304173|non-muscle invasive|non-muscle invasive
530602|NCT01304160|pancreatic cancer|pancreatic cancer
530603|NCT01304160|stereotactic body radiotherapy|stereotactic body radiotherapy
530604|NCT01304160|radiation|radiation
530605|NCT01304160|gemcitabine|gemcitabine
530606|NCT01304160|locally advanced|locally advanced
530607|NCT01304147|ketamine|ketamine
530608|NCT01304147|depression|depression
530609|NCT01304147|treatment resistance|treatment resistance
530610|NCT01304147|intranasal, antidepressant|intranasal, antidepressant
530611|NCT01304147|glutamate|glutamate
530612|NCT01304147|NMDA receptor|nmda receptor
530613|NCT01304121|Bone tumors|bone tumors
530614|NCT01304121|Bioactive glass|bioactive glass
530615|NCT01304121|Autogenous bone grafting|autogenous bone grafting
530616|NCT01304121|Allogeneic bone grafting|allogeneic bone grafting
530617|NCT01304121|PET imaging|pet imaging
530618|NCT01304108|Venous Thromboembolism|venous thromboembolism
530619|NCT01304108|Delivery of Health Care|delivery of health care
530620|NCT01304108|Quality Improvement|quality improvement
530621|NCT01304108|Evidence-Based Practice|evidence-based practice
530622|NCT01304095|Coronary Artery Disease, Angina, Metabolic Syndrome|coronary artery disease, angina, metabolic syndrome
530623|NCT01304082|pain pH local anesthetics|pain ph local anesthetics
530624|NCT01304069|Pharmacokinetics|pharmacokinetics
531814|NCT01299142|Influenza|influenza
530625|NCT01304069|Pharmacodynamics|pharmacodynamics
530626|NCT01304056|Ventilatory physiology|ventilatory physiology
530627|NCT01304043|ovarian tumors|ovarian tumors
530628|NCT01304043|rare ovarian tumors|rare ovarian tumors
530629|NCT01304043|germinal tumors|germinal tumors
530630|NCT01304043|sexual cords tumors|sexual cords tumors
530631|NCT01304043|observatory|observatory
530633|NCT01304030|Empathy|empathy
530634|NCT01304017|rehabilitation|rehabilitation
530635|NCT01304017|stroke|stroke
530636|NCT01304017|intervention|intervention
530637|NCT01304017|physical activity|physical activity
530638|NCT01304017|participation|participation
530639|NCT01304004|Obesity|obesity
530640|NCT01304004|Yogurt|yogurt
530641|NCT01304004|Proteins|proteins
530642|NCT01304004|Fibres|fibres
530643|NCT01304004|Women|women
530644|NCT01304004|Satiety|satiety
530645|NCT01303952|cold agglutinin disease|cold agglutinin disease
530646|NCT01303952|hemolysis|hemolysis
530647|NCT01303952|eculizumab|eculizumab
530648|NCT01303952|terminal complement inhibition|terminal complement inhibition
530649|NCT01303939|Glaucoma|glaucoma
530650|NCT01303939|MRI Brain Scan|mri brain scan
530651|NCT01303939|Voxel-Based Morphometry|voxel-based morphometry
530652|NCT01303926|QoL|qol
530653|NCT01303926|EQ5D score|eq5d score
530654|NCT01303926|cisplatin pemetrexed|cisplatin pemetrexed
530655|NCT01303926|carboplatin paclitaxel bevacizumab|carboplatin paclitaxel bevacizumab
530656|NCT01303926|maintenance|maintenance
530657|NCT01303913|COPD|copd
530658|NCT01303913|Oxygen desaturation|oxygen desaturation
530659|NCT01303913|Walking test|walking test
530660|NCT01303900|Haemophilia|haemophilia
530661|NCT01303900|Cardiovascular disease|cardiovascular disease
530662|NCT01303900|Cardiovascular disease risk factors|cardiovascular disease risk factors
530663|NCT01303900|Prospective|prospective
530664|NCT01303900|QRISK2|qrisk2
530665|NCT01303900|Hypertension|hypertension
530666|NCT01303900|Hypercholesterolaemia|hypercholesterolaemia
530667|NCT01303900|Diabetes|diabetes
530668|NCT01303900|Obesity|obesity
530669|NCT01303887|PACIFICO|pacifico
530670|NCT01303887|Follicular Lymphoma|follicular lymphoma
530671|NCT01303887|Non-Hodgkin's Lymphoma|non-hodgkin's lymphoma
530672|NCT01303887|Rituximab|rituximab
530673|NCT01303887|R-CVP|r-cvp
530674|NCT01303887|R-FC|r-fc
530675|NCT01303887|Older|older
530676|NCT01303874|Rheumatoid arthritis|rheumatoid arthritis
530677|NCT01303874|Inflammatory arthritis|inflammatory arthritis
530678|NCT01303874|Undifferentiated arthritis|undifferentiated arthritis
530679|NCT01303874|Etanercept|etanercept
530680|NCT01303874|Combination Therapy|combination therapy
530681|NCT01303861|Nicotine addiction|nicotine addiction
530682|NCT01303861|Cigarette smoking|cigarette smoking
530683|NCT01303861|Smoking cessation|smoking cessation
530684|NCT01303861|Zyban|zyban
530685|NCT01303861|Chantix|chantix
530686|NCT01303861|Nicotine patches|nicotine patches
530687|NCT01303861|Nicotrol Inhaler|nicotrol inhaler
530688|NCT01303861|varenicline|varenicline
530689|NCT01303861|bupropion|bupropion
530690|NCT01303848|Blood lactate|blood lactate
530691|NCT01303848|Lipid transfer proteins|lipid transfer proteins
530692|NCT01303848|Lactate|lactate
530693|NCT01303848|PLTP|pltp
530694|NCT01303848|CETP|cetp
530695|NCT01303848|PPARs|ppars
530696|NCT01303848|CLOCk|clock
530697|NCT01303848|Bal1|bal1
530698|NCT01303835|malignant glioma|malignant glioma
530699|NCT01303835|glioblastoma multiforme|glioblastoma multiforme
530700|NCT01303835|quality of life|quality of life
530701|NCT01303835|naltrexone|naltrexone
530702|NCT01303809|Perioperative care|perioperative care
530703|NCT01303809|Fast-track|fast-track
530704|NCT01303809|Enhanced Recovery After Surgery|enhanced recovery after surgery
530705|NCT01303809|ERAS|eras
530706|NCT01303809|Obesity|obesity
530707|NCT01303809|Bariatric surgery|bariatric surgery
530708|NCT01303809|Laparoscopic Sleeve Gastrectomy|laparoscopic sleeve gastrectomy
530709|NCT01303796|AML|aml
530710|NCT01303783|Nifedipine GITS|nifedipine gits
530711|NCT01303783|Candesartan|candesartan
530712|NCT01303783|mild to moderate Hypertension|mild to moderate hypertension
530713|NCT01303783|Combination therapy|combination therapy
530714|NCT01303770|Multiple Sclerosis|multiple sclerosis
530715|NCT01303770|Cognitive impairment|cognitive impairment
530716|NCT01303770|Self-management programs|self-management programs
530717|NCT01303770|Occupational Therapy|occupational therapy
530718|NCT01303770|Rehabilitation|rehabilitation
530719|NCT01303757|obesity|obesity
530720|NCT01303731|Spinal anesthesia|spinal anesthesia
530721|NCT01303731|Cesarean section|cesarean section
530722|NCT01303731|Marcaine Spinal 0.5% Heavy minidose|marcaine spinal 0.5% heavy minidose
530723|NCT01303731|Fentanyl|fentanyl
530724|NCT01303731|Local Anesthetics|local anesthetics
530725|NCT01303718|LV Dysfunction|lv dysfunction
530726|NCT01303718|Heart Failure|heart failure
530727|NCT01303705|progressive metastatic prostate cancer|progressive metastatic prostate cancer
530728|NCT01303705|cancer of the prostate|cancer of the prostate
530729|NCT01303705|prostate cancer|prostate cancer
530730|NCT01303692|bone mineral loss|bone mineral loss
530731|NCT01303692|prostate cancer|prostate cancer
530732|NCT01303692|GnRH agonist alone vs. GnRH agonist plus anti-androgen combination|gnrh agonist alone vs. gnrh agonist plus anti-androgen combination
530733|NCT01303679|First line metastatic breast cancer|first line metastatic breast cancer
530734|NCT01303679|Positive estrogen receptors|positive estrogen receptors
530735|NCT01303679|Negative HER2 receptors|negative her2 receptors
530736|NCT01303679|At least stable disease after 4 months of paclitaxel-bevcizumab induction chemotheray|at least stable disease after 4 months of paclitaxel-bevcizumab induction chemotheray
530737|NCT01303653|endoscopic tissue closure,|endoscopic tissue closure,
530738|NCT01303653|gastro-gastric fistulas,|gastro-gastric fistulas,
530739|NCT01303653|gastrointestinal perforations|gastrointestinal perforations
530740|NCT01303640|Coronary stent|coronary stent
530741|NCT01303627|Remifentanil|remifentanil
530742|NCT01303627|Laryngeal mask airway removal|laryngeal mask airway removal
530743|NCT01303627|Hemodynamic changing|hemodynamic changing
530744|NCT01303627|Infusion|infusion
530745|NCT01303627|Ureterorenoscopy|ureterorenoscopy
530746|NCT01303614|hysterosalpingography|hysterosalpingography
530747|NCT01303614|prilocaine|prilocaine
530748|NCT01303614|local anaesthetic|local anaesthetic
530749|NCT01303614|pain relief|pain relief
530750|NCT01303614|gynecological pathology|gynecological pathology
530751|NCT01303601|Olanzapine|olanzapine
530752|NCT01303601|Monotherapy|monotherapy
530753|NCT01303601|bipolar Ⅰ depression|bipolar ⅰ depression
530754|NCT01303588|elderly patients|elderly patients
530755|NCT01303575|Adolescents|adolescents
530756|NCT01303575|Youth|youth
530757|NCT01303575|Sexual Health|sexual health
530758|NCT01303575|Sex Education|sex education
530759|NCT01303575|Pregnancy Prevention|pregnancy prevention
530760|NCT01303575|Abstinence Education|abstinence education
530761|NCT01303575|HIV|hiv
530762|NCT01303575|Human Immunodeficiency Virus|human immunodeficiency virus
530763|NCT01303575|STI|sti
530764|NCT01303575|Chlamydia|chlamydia
530765|NCT01303575|Gonorrhea|gonorrhea
530766|NCT01303575|Sexually Transmitted Infections|sexually transmitted infections
530767|NCT01303575|American Indian|american indian
530768|NCT01303575|Alaska Native|alaska native
530769|NCT01303575|Native American|native american
530770|NCT01303575|Internet-Based|internet-based
530771|NCT01303575|Computer-based Education|computer-based education
530772|NCT01303575|Computer-based learning|computer-based learning
530773|NCT01303562|oat|oat
530774|NCT01303562|barley|barley
530775|NCT01303562|whole grain|whole grain
530776|NCT01303562|bioavailability|bioavailability
530777|NCT01303562|phytochemical|phytochemical
530778|NCT01303549|Liver transplantation|liver transplantation
530779|NCT01303549|Hepatic transplant|hepatic transplant
530780|NCT01303549|Antifungal prophylaxis|antifungal prophylaxis
530781|NCT01303549|Anidulafungin|anidulafungin
530782|NCT01303549|Liposomal Amphotericin B|liposomal amphotericin b
530783|NCT01303523|LMWH|lmwh
530784|NCT01303523|heparin|heparin
530785|NCT01303523|immobilization|immobilization
530786|NCT01303523|anticoagulant prophylaxis|anticoagulant prophylaxis
530787|NCT01303523|leg injuries|leg injuries
530788|NCT01303523|thromboembolism|thromboembolism
530789|NCT01303510|Influenza|influenza
530790|NCT01303510|Virus|virus
530791|NCT01303510|Vaccination|vaccination
530792|NCT01303510|Immunisation|immunisation
530793|NCT01303497|Angiosarcoma|angiosarcoma
530794|NCT01303497|Paclitaxel|paclitaxel
530795|NCT01303497|bevacizumab|bevacizumab
530796|NCT01303471|pain assessment|pain assessment
530797|NCT01303471|anesthesia|anesthesia
530798|NCT01303471|analgesia|analgesia
530799|NCT01303471|opioid|opioid
530800|NCT01303471|HRV|hrv
530801|NCT01303471|APV|apv
530802|NCT01303471|autonomic nervous system (ANS)|autonomic nervous system (ans)
530803|NCT01303471|pupil size|pupil size
530804|NCT01303458|community resource|community resource
530805|NCT01303458|well-child care visit|well-child care visit
530806|NCT01303458|low-income|low-income
530807|NCT01303432|Joint discomfort|joint discomfort
530808|NCT01303432|Functional Food|functional food
530809|NCT01303432|Joint function|joint function
530810|NCT01303432|Mobilee|mobilee
530811|NCT01303419|mammography|mammography
530812|NCT01303406|randomized withdrawal|randomized withdrawal
530813|NCT01303406|idebenone|idebenone
530814|NCT01303406|friedreich's ataxia|friedreich's ataxia
530815|NCT01303406|Miconos|miconos
530816|NCT01303406|Patient reported outcome|patient reported outcome
530817|NCT01303406|ICARS|icars
530818|NCT01303393|Patient education. Patient discharge. Needs assessment.|patient education. patient discharge. needs assessment.
530819|NCT01303380|Hyper IgD syndrome|hyper igd syndrome
530820|NCT01303380|canakinumab|canakinumab
530821|NCT01303380|HIDS|hids
530822|NCT01303380|mevalonate kinase deficiency|mevalonate kinase deficiency
530823|NCT01303380|MKD|mkd
530824|NCT01303367|Dementia|dementia
530825|NCT01303367|behavioral and psychological symptoms of dementia|behavioral and psychological symptoms of dementia
530826|NCT01303354|Epidural, Transforaminal, Steroid Injection, Dexamethasone|epidural, transforaminal, steroid injection, dexamethasone
530827|NCT01303315|C19 246 300|c19 246 300
530829|NCT01303289|Total Enteral Nutrition|total enteral nutrition
530830|NCT01303289|Severe insufficient nutrition|severe insufficient nutrition
530831|NCT01303289|T-Diet plus Standard|t-diet plus standard
530832|NCT01303289|Lipidic profile|lipidic profile
530833|NCT01303289|Quality of life|quality of life
530834|NCT01303276|retinal vein occlusion|retinal vein occlusion
530835|NCT01303276|anti-VEGF|anti-vegf
530836|NCT01303276|blood flow|blood flow
530837|NCT01303263|efficiency|efficiency
530838|NCT01303263|cost-awareness|cost-awareness
530839|NCT01303263|hospitals|hospitals
530840|NCT01303263|graduate medical education|graduate medical education
530841|NCT01303250|goal-directed fluid optimization|goal-directed fluid optimization
530842|NCT01303250|hemodynamic optimization|hemodynamic optimization
530843|NCT01303250|crystalloid|crystalloid
530844|NCT01303250|colloid|colloid
530845|NCT01303237|LA SCCHN|la scchn
530846|NCT01303237|Cetuximab|cetuximab
530847|NCT01303237|RT|rt
530848|NCT01303237|PMS|pms
530849|NCT01303224|Irritable Bowel Syndrome|irritable bowel syndrome
530850|NCT01303224|Colon, irritable|colon, irritable
530851|NCT01303224|Bowel disease|bowel disease
530852|NCT01303211|Meningococcal serogroup A conjugate vaccine|meningococcal serogroup a conjugate vaccine
530853|NCT01303211|Vaccine efficacy|vaccine efficacy
530854|NCT01303211|Serogroup A meningococcal diseases|serogroup a meningococcal diseases
530855|NCT01303198|CPAP|cpap
530856|NCT01303198|APAP|apap
530857|NCT01303198|sleep apnea|sleep apnea
530858|NCT01303185|Psoriatic Nail|psoriatic nail
530859|NCT01303185|Pulsed dye laser|pulsed dye laser
530860|NCT01303159|Cholangiocarcinoma|cholangiocarcinoma
530861|NCT01303159|Pancreatic Cancer|pancreatic cancer
530862|NCT01303159|Radiofrequency|radiofrequency
530863|NCT01303159|Ablation|ablation
530864|NCT01303146|Metachromatic Leukodystrophy|metachromatic leukodystrophy
530865|NCT01303146|Enzyme replacement therapy|enzyme replacement therapy
530866|NCT01303146|Allogeneic hematopoietic stem cell transplantation|allogeneic hematopoietic stem cell transplantation
530867|NCT01303133|beta amyloid, Down Syndrome, Alzheimer's Disease|beta amyloid, down syndrome, alzheimer's disease
530868|NCT01303081|Smoking Cessation|smoking cessation
530869|NCT01303081|Work-site|work-site
530870|NCT01303081|Incentives|incentives
530871|NCT01303081|Health Behavior|health behavior
530872|NCT01303081|Smoking|smoking
530873|NCT01303068|CF|cf
530874|NCT01303055|Pancreatic beta Cell|pancreatic beta cell
530875|NCT01303055|Diabetes Mellitus, Type 2|diabetes mellitus, type 2
530876|NCT01303055|Glucose Metabolism Disorders|glucose metabolism disorders
530877|NCT01303055|Metabolic Diseases|metabolic diseases
530878|NCT01303055|Endocrine System Diseases|endocrine system diseases
530879|NCT01303055|Metformin|metformin
530880|NCT01303055|Hypoglycemic Agents|hypoglycemic agents
530881|NCT01303055|Physiological Effects of Drugs|physiological effects of drugs
530882|NCT01303055|Pharmacologic Actions|pharmacologic actions
530883|NCT01303055|hemoglobin A1c protein, human|hemoglobin a1c protein, human
530884|NCT01303055|Oral Glucose Tolerance Test|oral glucose tolerance test
530885|NCT01303042|insulin LISPRO|insulin lispro
530886|NCT01303042|Insulin therapy|insulin therapy
530887|NCT01303042|hemoglobin A1c protein, human|hemoglobin a1c protein, human
530888|NCT01303042|Blood Glucose Self-Monitoring|blood glucose self-monitoring
530889|NCT01303042|Quality of Life|quality of life
530890|NCT01303042|Hypoglycemia|hypoglycemia
530891|NCT01303042|Diabetes Mellitus|diabetes mellitus
530892|NCT01303042|1,5-Anhydroglucitol|1,5-anhydroglucitol
530893|NCT01303029|Pancreatic cancer|pancreatic cancer
530894|NCT01303029|gemcitabine|gemcitabine
530895|NCT01303029|erlotinib|erlotinib
530896|NCT01303029|capecitabine|capecitabine
530897|NCT01302990|Influenza|influenza
530898|NCT01302990|Respiratory disease|respiratory disease
530899|NCT01302990|Prevention|prevention
530900|NCT01302977|Congenital diaphragmatic hernia|congenital diaphragmatic hernia
530901|NCT01302977|Fetal anomalies|fetal anomalies
530902|NCT01302964|Autistic Disorder|autistic disorder
530903|NCT01302964|Asperger's Disorder|asperger's disorder
530904|NCT01302964|Pervasive Developmental Disorder|pervasive developmental disorder
530905|NCT01302951|pharmacokinetics|pharmacokinetics
530906|NCT01302951|liver resection|liver resection
530907|NCT01302938|Double-blind|double-blind
530908|NCT01302938|Placebo-controlled|placebo-controlled
530909|NCT01302938|frequency|frequency
530910|NCT01302938|urgency|urgency
530911|NCT01302938|web-based|web-based
530912|NCT01302938|incontinence|incontinence
530913|NCT01302938|methodology|methodology
530914|NCT01302938|ediary|ediary
530915|NCT01302938|safety|safety
530916|NCT01302938|efficacy|efficacy
530917|NCT01302938|tolerability ER|tolerability er
530918|NCT01302938|overactive bladder|overactive bladder
530919|NCT01302912|ocular adnexal lymphomas|ocular adnexal lymphomas
530920|NCT01302886|High risk Smoldering multiple myeloma,|high risk smoldering multiple myeloma,
530921|NCT01302886|BHQ880,|bhq880,
530922|NCT01302886|MM|mm
530923|NCT01302873|Tinnitus|tinnitus
530924|NCT01302873|AMPA Receptor antagonist|ampa receptor antagonist
530925|NCT01302860|Cryopyrin-associated periodic syndromes (CAPS)|cryopyrin-associated periodic syndromes (caps)
531815|NCT01299142|antibodies|antibodies
530926|NCT01302860|Familial Cold Autoinflammatory Syndrome (FCAS)|familial cold autoinflammatory syndrome (fcas)
710257|NCT00589563|recurrent cutaneous T-cell non-Hodgkin lymphoma|recurrent cutaneous t-cell non-hodgkin lymphoma
530927|NCT01302860|Muckle-Wells Syndrome (MWS) or Neonatal Onset Multisystem Inflammatory Disease (NOMID)|muckle-wells syndrome (mws) or neonatal onset multisystem inflammatory disease (nomid)
530928|NCT01302860|children|children
530929|NCT01302860|systemic autoinflammatory disease|systemic autoinflammatory disease
530930|NCT01302860|CIAS-1 gene|cias-1 gene
530931|NCT01302860|NALP-3|nalp-3
530932|NCT01302860|NLRP3|nlrp3
530933|NCT01302860|ACZ885|acz885
530934|NCT01302860|Ilaris|ilaris
530935|NCT01302860|human monoclonal anti-human interleukin-1 beta (IL-beta)|human monoclonal anti-human interleukin-1 beta (il-beta)
530936|NCT01302860|antibody|antibody
530937|NCT01302860|autosomal dominant|autosomal dominant
530938|NCT01302860|familial autoinflammatory syndrome|familial autoinflammatory syndrome
530939|NCT01302847|Integrase Inhibitors|integrase inhibitors
530940|NCT01302847|Infant|infant
530941|NCT01302847|Child|child
530942|NCT01302847|Adolescent|adolescent
530943|NCT01302834|stage III squamous cell carcinoma of the oropharynx|stage iii squamous cell carcinoma of the oropharynx
530944|NCT01302834|stage IV squamous cell carcinoma of the oropharynx|stage iv squamous cell carcinoma of the oropharynx
530945|NCT01302834|human papilloma virus infection|human papilloma virus infection
530946|NCT01302821|breast - male|breast - male
530947|NCT01302821|breast - female|breast - female
530948|NCT01302821|metastatic|metastatic
530949|NCT01302821|invasive|invasive
530950|NCT01302808|recurrent non-small cell lung cancer|recurrent non-small cell lung cancer
530951|NCT01302808|stage IIIB non-small cell lung cancer|stage iiib non-small cell lung cancer
530952|NCT01302808|stage IV non-small cell lung cancer|stage iv non-small cell lung cancer
530953|NCT01302808|malignant pleural effusion|malignant pleural effusion
530954|NCT01302808|adenocarcinoma of the lung|adenocarcinoma of the lung
530955|NCT01302808|adenosquamous cell lung cancer|adenosquamous cell lung cancer
530956|NCT01302808|bronchoalveolar cell lung cancer|bronchoalveolar cell lung cancer
530957|NCT01302808|large cell lung cancer|large cell lung cancer
530958|NCT01302808|squamous cell lung cancer|squamous cell lung cancer
530959|NCT01302795|Interleukin 1 beta|interleukin 1 beta
530960|NCT01302795|Canakinumab|canakinumab
530961|NCT01302795|autoinflammatory syndrome|autoinflammatory syndrome
530962|NCT01302782|Altitude|altitude
530963|NCT01302782|Glucose|glucose
530964|NCT01302769|Acute Sore Throat|acute sore throat
530965|NCT01302769|Ear Acupuncture|ear acupuncture
530966|NCT01302756|gestational diabetes|gestational diabetes
530967|NCT01302756|gestational hypertension|gestational hypertension
530968|NCT01302756|folic acid|folic acid
530969|NCT01302743|Diabetes|diabetes
530970|NCT01302743|Metformin|metformin
530971|NCT01302743|Cinnamon|cinnamon
530972|NCT01302730|ankylosing spondylitis|ankylosing spondylitis
530973|NCT01302730|spondylarthritis|spondylarthritis
530974|NCT01302730|inflammatory back pain|inflammatory back pain
530975|NCT01302730|seronegative|seronegative
530976|NCT01302717|Left ventricular pacing|left ventricular pacing
530977|NCT01302704|Vitamin D|vitamin d
530978|NCT01302704|Proton Pump Inhibitors|proton pump inhibitors
530979|NCT01302691|Essential hypertension|essential hypertension
530980|NCT01302691|Uncontrolled hypertension|uncontrolled hypertension
530981|NCT01302691|Antihypertensive agents|antihypertensive agents
530982|NCT01302691|Blood pressure|blood pressure
530983|NCT01302652|acromegaly|acromegaly
530984|NCT01302652|growth hormone|growth hormone
530985|NCT01302652|growth hormone deficiency|growth hormone deficiency
530986|NCT01302626|NSCLC|nsclc
530987|NCT01302626|SCLC|sclc
530988|NCT01302626|lung cancer|lung cancer
530990|NCT01302626|DNA|dna
530991|NCT01302626|imaging|imaging
530992|NCT01302626|genomics|genomics
530993|NCT01302626|proteomics|proteomics
530994|NCT01302626|predictive model|predictive model
530995|NCT01302626|prospective study|prospective study
530996|NCT01302613|rectal cancer|rectal cancer
530997|NCT01302574|T1R2/T1R3|t1r2/t1r3
530998|NCT01302574|gastric emptying|gastric emptying
530999|NCT01302574|gut|gut
531000|NCT01302574|lactisole|lactisole
531001|NCT01302574|nutrient sensing|nutrient sensing
531002|NCT01302561|adults|adults
531003|NCT01302561|fiber|fiber
531004|NCT01302561|cold|cold
531005|NCT01302561|flu|flu
531006|NCT01302561|immune function|immune function
531007|NCT01302561|microbiota|microbiota
531008|NCT01302548|Abscess|abscess
531009|NCT01302548|Wound Irrigation|wound irrigation
531010|NCT01302548|Wound Debridement|wound debridement
531011|NCT01302548|Wound Healing|wound healing
531012|NCT01302548|Incision and drainage|incision and drainage
531013|NCT01302548|Chlorhexidine|chlorhexidine
531014|NCT01302535|Yoga|yoga
531015|NCT01302535|Hypertension|hypertension
531016|NCT01302535|Quality of Life|quality of life
531017|NCT01302535|Primary Health Care|primary health care
531018|NCT01302509|Nutritional support.|nutritional support.
531019|NCT01302509|Cancer.|cancer.
531020|NCT01302509|Malnutrition.|malnutrition.
531021|NCT01302509|Child.|child.
531022|NCT01302509|Adolescent|adolescent
531023|NCT01302496|Previously Treated|previously treated
531024|NCT01302496|Unresectable|unresectable
531025|NCT01302496|Stage III or IV Melanoma|stage iii or iv melanoma
531026|NCT01302470|biventricular pacing|biventricular pacing
531027|NCT01302457|Thermal Burn Trauma|thermal burn trauma
531028|NCT01302444|treprostinil|treprostinil
531029|NCT01302444|pulmonary hypertension, tadalafil|pulmonary hypertension, tadalafil
531030|NCT01302431|experimental|experimental
531031|NCT01302431|intervention|intervention
531032|NCT01302431|nurse-led|nurse-led
531033|NCT01302431|nurse specialist|nurse specialist
531034|NCT01302431|multiple sclerosis|multiple sclerosis
531035|NCT01302431|support of caregivers|support of caregivers
531036|NCT01302418|Respiratory Virus|respiratory virus
531037|NCT01302418|Influenza|influenza
531038|NCT01302418|RSV|rsv
531039|NCT01302418|Parainfluenza|parainfluenza
531040|NCT01302418|Metapneumovirus|metapneumovirus
531041|NCT01302418|Rhinovirus|rhinovirus
531042|NCT01302418|Coxsackie virus|coxsackie virus
531043|NCT01302418|Echo virus|echo virus
531044|NCT01302418|Adenovirus|adenovirus
531045|NCT01302418|Coronavirus|coronavirus
531046|NCT01302418|Bocavirus|bocavirus
531047|NCT01302405|Advanced solid tumor|advanced solid tumor
531048|NCT01302405|cancer|cancer
531049|NCT01302405|phase 1|phase 1
531050|NCT01302405|pancreatic cancer|pancreatic cancer
531051|NCT01302405|colon cancer|colon cancer
531052|NCT01302405|unresectable neoplastic disease|unresectable neoplastic disease
531053|NCT01302405|Progressive cancer|progressive cancer
531054|NCT01302405|metastatic solid tumor|metastatic solid tumor
531055|NCT01302379|Obesity|obesity
531056|NCT01302379|Survival|survival
531057|NCT01302379|Weight loss|weight loss
531058|NCT01302379|Metformin|metformin
531059|NCT01302379|Biological markers|biological markers
531060|NCT01302366|multiple myeloma|multiple myeloma
531061|NCT01302366|myeloma|myeloma
531062|NCT01302366|asymptomatic myeloma|asymptomatic myeloma
531063|NCT01302366|smoldering myeloma|smoldering myeloma
531064|NCT01302366|Asymptomatic (smoldering) myeloma|asymptomatic (smoldering) myeloma
531065|NCT01302353|Phase I trial|phase i trial
531066|NCT01302353|Emulsified Isoflurane|emulsified isoflurane
531067|NCT01302353|Health volunteer|health volunteer
531068|NCT01302340|Dementia|dementia
531069|NCT01302340|Alzheimer|alzheimer
531070|NCT01302340|Cannabis|cannabis
531071|NCT01302340|THC|thc
531072|NCT01302340|Behavioral Disturbances|behavioral disturbances
531073|NCT01302340|Neuropsychiatric Inventory|neuropsychiatric inventory
531074|NCT01302327|Wolfram syndrome|wolfram syndrome
531075|NCT01302327|Diabetes mellitus|diabetes mellitus
531076|NCT01302327|Exenatide|exenatide
531077|NCT01302327|GLP-1 analog|glp-1 analog
531078|NCT01302327|beta cell function|beta cell function
531079|NCT01302301|endolumenal myotomy, per oral endoscopic myotomy|endolumenal myotomy, per oral endoscopic myotomy
531080|NCT01302288|endolumenal myotomy, per oral endoscopic myotomy|endolumenal myotomy, per oral endoscopic myotomy
531081|NCT01302275|neuropathic pain|neuropathic pain
531082|NCT01302275|oxcarbazepine|oxcarbazepine
531083|NCT01302275|pain mechanism|pain mechanism
531084|NCT01302262|Smoking-induced dopamine release|smoking-induced dopamine release
531085|NCT01302262|[11C]-(+)-PHNO PET Study|[11c]-(+)-phno pet study
531086|NCT01302249|Glaucoma|glaucoma
531087|NCT01302249|Intraocular pressure|intraocular pressure
531088|NCT01302249|Ocular hypertension|ocular hypertension
531089|NCT01302236|Elderly|elderly
531090|NCT01302236|Early stage chronic kidney disease|early stage chronic kidney disease
531091|NCT01302236|Hypertension|hypertension
531092|NCT01302236|Eplerenone|eplerenone
531093|NCT01302223|burns|burns
531094|NCT01302223|Growth Factors, Combined Defect of|growth factors, combined defect of
531095|NCT01302223|inflammation|inflammation
531096|NCT01302223|Cytokine Storm|cytokine storm
531097|NCT01302210|MRSA|mrsa
531098|NCT01302210|Cluster Randomized Trial|cluster randomized trial
531099|NCT01302210|Infection Control Intervention|infection control intervention
531100|NCT01302197|Stroke|stroke
531101|NCT01302197|Body Composition|body composition
531102|NCT01302197|Glucose Tolerance|glucose tolerance
531103|NCT01302171|dilated cardiomyopathy|dilated cardiomyopathy
531104|NCT01302171|adult stem cells|adult stem cells
531105|NCT01302171|bone marrow progenitor cells|bone marrow progenitor cells
531106|NCT01302171|bone marrow stem cells|bone marrow stem cells
531107|NCT01302171|autologous|autologous
531108|NCT01302171|granulocyte-colony stimulating factor|granulocyte-colony stimulating factor
531109|NCT01302171|intracoronary injection|intracoronary injection
531110|NCT01302171|left ventricular function|left ventricular function
531111|NCT01302171|To determine if patient's own bone marrow derived stem cells can be used to improve cardiac function|to determine if patient's own bone marrow derived stem cells can be used to improve cardiac function
531112|NCT01302158|Drug-Drug interaction|drug-drug interaction
531113|NCT01302158|ASP1941|asp1941
531114|NCT01302158|Glimepiride|glimepiride
531115|NCT01302158|Healthy subjects|healthy subjects
531116|NCT01302145|pharmacokinetics|pharmacokinetics
531117|NCT01302145|metformin|metformin
531118|NCT01302145|Drug to drug interaction|drug to drug interaction
531119|NCT01302145|ASP1941|asp1941
531816|NCT01299142|monoclonal|monoclonal
531120|NCT01302132|Mass Balance|mass balance
531121|NCT01302132|ASP1941|asp1941
531122|NCT01302132|Pharmacokinetics|pharmacokinetics
531123|NCT01302119|Onychomycosis|onychomycosis
531124|NCT01302119|nail fungus|nail fungus
531125|NCT01302119|toenail fungus|toenail fungus
531126|NCT01302119|fungal nail|fungal nail
531127|NCT01302119|hyperkeratosis|hyperkeratosis
531128|NCT01302119|nail infection|nail infection
531129|NCT01302119|nail treatment|nail treatment
531130|NCT01302119|toenail infection|toenail infection
531131|NCT01302119|toenail treatment|toenail treatment
531132|NCT01302119|foot dermatoses|foot dermatoses
531133|NCT01302119|fungal culture|fungal culture
531134|NCT01302119|onycholysis|onycholysis
531135|NCT01302119|podiatrist|podiatrist
531136|NCT01302119|podiatry|podiatry
531137|NCT01302119|subungual|subungual
531138|NCT01302119|tinea unguium|tinea unguium
531139|NCT01302119|antifungal|antifungal
531140|NCT01302119|anti-fungal|anti-fungal
531141|NCT01302119|dermatologist|dermatologist
531142|NCT01302119|dermatology|dermatology
531143|NCT01302119|dermatophyte|dermatophyte
531144|NCT01302119|distal subungual onychomycosis|distal subungual onychomycosis
531145|NCT01302119|yellow nail|yellow nail
531146|NCT01302119|thick nail|thick nail
531147|NCT01302119|brittle nail|brittle nail
531148|NCT01302119|crumbling nail|crumbling nail
531149|NCT01302119|discolored nail|discolored nail
531150|NCT01302119|weak nail|weak nail
531151|NCT01302106|Myelodysplastic Syndromes|myelodysplastic syndromes
531152|NCT01302106|Clofarabine|clofarabine
531153|NCT01302106|Low Dose Cytarabine|low dose cytarabine
531154|NCT01302106|Poor risk MDS|poor risk mds
531155|NCT01302080|prospective|prospective
531156|NCT01302080|cohort|cohort
531157|NCT01302080|sertraline|sertraline
531158|NCT01302080|long-term impact|long-term impact
531159|NCT01302080|cognition|cognition
531160|NCT01302080|emotional and physical development|emotional and physical development
531161|NCT01302080|pubertal maturation|pubertal maturation
531162|NCT01302054|Bladder Overactive|bladder overactive
531163|NCT01302054|Overactive urinary bladder|overactive urinary bladder
531164|NCT01302054|Overactive Bladder|overactive bladder
531165|NCT01302041|bone turnover|bone turnover
531166|NCT01302041|hormone-naïve|hormone-naïve
531167|NCT01302041|prostate specific antigen|prostate specific antigen
531168|NCT01302041|Prostate Cancer|prostate cancer
531169|NCT01302028|Renal Impairment|renal impairment
531170|NCT01302028|ASP1941|asp1941
531171|NCT01302028|Pharmacokinetics|pharmacokinetics
531172|NCT01302002|Breast Cancer|breast cancer
531173|NCT01302002|Metformin|metformin
531174|NCT01302002|Pre-Surgery|pre-surgery
531175|NCT01301989|Sleep|sleep
531176|NCT01301989|Children|children
531177|NCT01301989|Disparities|disparities
531178|NCT01301989|Minority|minority
531179|NCT01301989|Urban|urban
531180|NCT01301976|nutritional state|nutritional state
531181|NCT01301976|nutrients intake|nutrients intake
531182|NCT01301976|ulcerative colitis|ulcerative colitis
531183|NCT01301950|Arthroplasties, Knee Replacement|arthroplasties, knee replacement
531184|NCT01301950|Arthroplasties, Replacement, Knee|arthroplasties, replacement, knee
531185|NCT01301950|Arthroplasty, Knee Replacement|arthroplasty, knee replacement
531186|NCT01301950|Knee Replacement Arthroplasties|knee replacement arthroplasties
531187|NCT01301950|Knee Replacement Arthroplasty|knee replacement arthroplasty
531188|NCT01301950|Knee Replacement, Total|knee replacement, total
531189|NCT01301950|Replacement Arthroplasties, Knee|replacement arthroplasties, knee
531190|NCT01301950|Replacement Arthroplasty, Knee|replacement arthroplasty, knee
531191|NCT01301950|Replacement, Total Knee|replacement, total knee
531192|NCT01301950|Total Knee Replacement|total knee replacement
531193|NCT01301937|Mucosal Leishmaniasis|mucosal leishmaniasis
531194|NCT01301937|Leishmania braziliensis|leishmania braziliensis
531195|NCT01301937|Meglumine Antimoniate|meglumine antimoniate
531196|NCT01301937|Treatment Effectiveness|treatment effectiveness
531197|NCT01301937|Controlled Clinical Trials, Randomized|controlled clinical trials, randomized
531198|NCT01301924|Leishmaniasis Cutaneous|leishmaniasis cutaneous
531199|NCT01301924|Leishmania braziliensis|leishmania braziliensis
531200|NCT01301924|Meglumine Antimoniate|meglumine antimoniate
531201|NCT01301924|Treatment Effectiveness|treatment effectiveness
531202|NCT01301924|Controlled Clinical Trials, Randomized|controlled clinical trials, randomized
531203|NCT01301911|Breast cancer, Advanced|breast cancer, advanced
531204|NCT01301911|Cipatinib|cipatinib
531205|NCT01301911|phase I|phase i
531206|NCT01301911|HER2 positive or uncertain advanced breast cancer|her2 positive or uncertain advanced breast cancer
531207|NCT01301898|Hunter syndrome|hunter syndrome
531208|NCT01301898|MPS II|mps ii
531209|NCT01301898|Idursulfase|idursulfase
531210|NCT01301885|endometriosis|endometriosis
531211|NCT01301885|dysmenorrhea|dysmenorrhea
531212|NCT01301885|infertility|infertility
531213|NCT01301885|biomarker|biomarker
531214|NCT01301885|drug target|drug target
531215|NCT01301859|older adults|older adults
531216|NCT01301859|adherence|adherence
531217|NCT01301859|antidepressant|antidepressant
531218|NCT01301859|depression|depression
531219|NCT01301833|insulin resistance|insulin resistance
531220|NCT01301820|maintenance treatment|maintenance treatment
531221|NCT01301820|Disease free survival|disease free survival
531222|NCT01301794|Hypertriglyceridemia|hypertriglyceridemia
531223|NCT01301794|Fish oil|fish oil
531224|NCT01301794|Omega 3 fatty acids|omega 3 fatty acids
531225|NCT01301768|Dietary Intervention|dietary intervention
531226|NCT01301768|Pregnancy Jail|pregnancy jail
531227|NCT01301768|Iodine Deficiency|iodine deficiency
531228|NCT01301768|Iodine Nutrition|iodine nutrition
531229|NCT01301768|Dietary Habits|dietary habits
531230|NCT01301768|Urinary Iodine|urinary iodine
531231|NCT01301768|Pregnancy|pregnancy
531232|NCT01301768|Group Education|group education
531233|NCT01301768|Cluster Randomized Trial|cluster randomized trial
531234|NCT01301768|Primary Health Care|primary health care
531235|NCT01301703|rheumatoid pertussis tetanus|rheumatoid pertussis tetanus
531236|NCT01301690|neck mass|neck mass
531237|NCT01301690|ultrasound|ultrasound
531238|NCT01301690|FNA|fna
531239|NCT01301690|BMVC|bmvc
531240|NCT01301664|The bone marrow-derived mesenchymal stem cells (BMMSCs) were obtained from redundant bone marrow from drilling during the joint replacement surgery.|the bone marrow-derived mesenchymal stem cells (bmmscs) were obtained from redundant bone marrow from drilling during the joint replacement surgery.
531241|NCT01301664|The synovial-derived mesenchymal stem cells (SMSCs) were isolated from synovial membranes in the joint replacement surgery.|the synovial-derived mesenchymal stem cells (smscs) were isolated from synovial membranes in the joint replacement surgery.
531242|NCT01301664|Cartilage slices were obtained from discard cartilage in the joint replacement surgery.|cartilage slices were obtained from discard cartilage in the joint replacement surgery.
531243|NCT01301651|Virtual Reality|virtual reality
531244|NCT01301651|Balance|balance
531245|NCT01301651|Parkinson's disease|parkinson's disease
531246|NCT01301651|Dual Task|dual task
531247|NCT01301625|MitraClip|mitraclip
531248|NCT01301625|mitral regurgitation (MR)|mitral regurgitation (mr)
531249|NCT01301625|mitral valve insufficiency|mitral valve insufficiency
531371|NCT01300975|Leishmaniasis|leishmaniasis
531250|NCT01301625|percutaneous mitral valve repair|percutaneous mitral valve repair
531251|NCT01301625|congestive heart failure|congestive heart failure
531252|NCT01301612|carcinoma or adenocarcinoma or uterine cervix adenosquamous carcinoma|carcinoma or adenocarcinoma or uterine cervix adenosquamous carcinoma
531253|NCT01301599|Benign Prostatic Hyperplasia|benign prostatic hyperplasia
531254|NCT01301599|alpha blocker|alpha blocker
531255|NCT01301599|5-alpha reductase inhibitor|5-alpha reductase inhibitor
531256|NCT01301599|combination therapy|combination therapy
531257|NCT01301560|Asymptomatic brain metastasis|asymptomatic brain metastasis
531258|NCT01301560|NSCLC|nsclc
531259|NCT01301560|GKS|gks
531260|NCT01301534|abdominal aortic aneurysm|abdominal aortic aneurysm
531261|NCT01301521|Pre-Diabetes|pre-diabetes
531262|NCT01301521|cinnamon|cinnamon
531263|NCT01301508|atopic dermatitis|atopic dermatitis
531264|NCT01301495|Esophageal Cancer, Malignant, Dysphagia, Esophagus, Cancer|esophageal cancer, malignant, dysphagia, esophagus, cancer
531265|NCT01301482|Acute Sore Throat|acute sore throat
531266|NCT01301482|Ear Acupuncture|ear acupuncture
531267|NCT01301456|Phase 1|phase 1
531268|NCT01301456|Type 2 Diabetes|type 2 diabetes
531269|NCT01301456|CVX-096|cvx-096
531270|NCT01301443|Age Related Macular Degeneration|age related macular degeneration
531271|NCT01301430|Progressive glioblastoma multiforme|progressive glioblastoma multiforme
531272|NCT01301430|Recurrent glioblastoma multiforme|recurrent glioblastoma multiforme
531273|NCT01301430|Oncolytic virus|oncolytic virus
531274|NCT01301417|Compression Anastomosis|compression anastomosis
531275|NCT01301404|Postoperative nausea and vomiting (PONV)|postoperative nausea and vomiting (ponv)
531276|NCT01301404|Spinal morphine|spinal morphine
531277|NCT01301404|Total knee replacement (TKR)|total knee replacement (tkr)
531278|NCT01301404|blood sugar|blood sugar
531279|NCT01301404|carbohydrate drink|carbohydrate drink
531280|NCT01301391|B3 and C malignant thymoma|b3 and c malignant thymoma
531281|NCT01301365|autonomic response|autonomic response
531282|NCT01301352|Critical Care|critical care
531283|NCT01301352|Intubation, gastrointestinal|intubation, gastrointestinal
531284|NCT01301352|Child|child
531285|NCT01301352|Infant|infant
531286|NCT01301352|Adolescent|adolescent
531287|NCT01301352|Continuous positive airway pressure|continuous positive airway pressure
531288|NCT01301352|Enteral Nutrition|enteral nutrition
531289|NCT01301339|Pre-Diabetes|pre-diabetes
531290|NCT01301339|Diabetes|diabetes
531291|NCT01301339|cardiovascular risks|cardiovascular risks
531292|NCT01301326|retinal arterial macroaneurysm|retinal arterial macroaneurysm
531293|NCT01301326|laser treatment|laser treatment
531294|NCT01301313|Acute heart failure|acute heart failure
531295|NCT01301313|Children|children
531296|NCT01301313|Levosimendan|levosimendan
531297|NCT01301313|Inotropic treatment|inotropic treatment
531298|NCT01301274|hyponatremia|hyponatremia
531299|NCT01301274|maintenance solutions|maintenance solutions
531300|NCT01301274|pediatrics|pediatrics
531301|NCT01301261|Sugammadex|sugammadex
531302|NCT01301261|entropy|entropy
531303|NCT01301261|bispectral index|bispectral index
531304|NCT01301261|blood pressure|blood pressure
531305|NCT01301261|heart rate|heart rate
531306|NCT01301261|oxygenation|oxygenation
531307|NCT01301261|end-tidal CO2|end-tidal co2
531308|NCT01301261|hemodynamics|hemodynamics
531309|NCT01301261|general anesthesia|general anesthesia
531310|NCT01301248|locally advanced,|locally advanced,
531311|NCT01301248|unresectable,|unresectable,
531312|NCT01301248|head and neck squamous cell carcinoma,|head and neck squamous cell carcinoma,
531313|NCT01301248|stage III/IV|stage iii/iv
531314|NCT01301235|Mitochondria|mitochondria
531315|NCT01301222|octreotide|octreotide
531316|NCT01301222|pancreatic fistula|pancreatic fistula
531317|NCT01301222|soft pancreas|soft pancreas
531318|NCT01301222|pancreatoduodenectomy|pancreatoduodenectomy
531319|NCT01301196|sedentary behaviour|sedentary behaviour
531320|NCT01301196|diabetes|diabetes
531321|NCT01301196|structured education|structured education
531322|NCT01301196|18-30 years olds|18-30 years olds
531323|NCT01301196|family history of T2DM or CVD|family history of t2dm or cvd
531324|NCT01301196|BMI ≥ 25 (≥23 for south Asians)|bmi ≥ 25 (≥23 for south asians)
531325|NCT01301183|Anorexia Nervosa|anorexia nervosa
531326|NCT01301183|Estrogen|estrogen
531327|NCT01301183|Teenagers|teenagers
531328|NCT01301183|IGF-1|igf-1
531329|NCT01301170|Neck pain|neck pain
531330|NCT01301170|Dry Needling|dry needling
531331|NCT01301170|Manual Therapy|manual therapy
531332|NCT01301170|Manipulation|manipulation
531333|NCT01301144|Tuberculosis|tuberculosis
531334|NCT01301144|Urea Breath Test|urea breath test
531335|NCT01301118|Transplantation Infection|transplantation infection
531336|NCT01301118|Wound of skin|wound of skin
531337|NCT01301118|Burns|burns
531338|NCT01301118|Graft Loss|graft loss
531339|NCT01301118|Infection|infection
531340|NCT01301105|pain regulation|pain regulation
531341|NCT01301105|social stress|social stress
531342|NCT01301105|affect|affect
531343|NCT01301105|attention|attention
531344|NCT01301105|brain|brain
531345|NCT01301105|immune|immune
531346|NCT01301105|endocrine|endocrine
531347|NCT01301079|Remifentanil|remifentanil
531348|NCT01301079|Hyperalgesia|hyperalgesia
531349|NCT01301079|Ketamine|ketamine
531350|NCT01301079|Von Frey's filament|von frey's filament
531351|NCT01301079|Algometer|algometer
531352|NCT01301079|Interleukines|interleukines
531353|NCT01301079|Opioid-induced hyperalgesia|opioid-induced hyperalgesia
531354|NCT01301053|hyperglycemia and increased mortality in the ICU|hyperglycemia and increased mortality in the icu
531355|NCT01301053|hypoglycemia and increased mortality in the ICU|hypoglycemia and increased mortality in the icu
531356|NCT01301053|glucose variability and increased mortality in the ICU|glucose variability and increased mortality in the icu
531357|NCT01301053|Continuous Glucose Monitoring (CGM) and hypoglycemia|continuous glucose monitoring (cgm) and hypoglycemia
531358|NCT01301053|hypoglycemia|hypoglycemia
531359|NCT01301053|reducing ICU mortality|reducing icu mortality
531360|NCT01301040|breast cancer, elderly, early cardiac toxicity|breast cancer, elderly, early cardiac toxicity
531361|NCT01301027|End stage renal disease|end stage renal disease
531362|NCT01301027|Hemodialysis|hemodialysis
531363|NCT01301027|Pioglitazone|pioglitazone
531364|NCT01301027|Adipokines|adipokines
531365|NCT01301014|accuracy, anterior cruciate ligament, diagnostic value, examination, knee, Lachman test, sensitivity, specificity|accuracy, anterior cruciate ligament, diagnostic value, examination, knee, lachman test, sensitivity, specificity
531366|NCT01301001|Vulvodynia|vulvodynia
531367|NCT01300988|HIV infection|hiv infection
531368|NCT01300988|Neurokinin-1 receptor antagonist|neurokinin-1 receptor antagonist
531369|NCT01300988|CCR5 expression|ccr5 expression
531370|NCT01300988|Treatment Naive|treatment naive
531372|NCT01300975|intralesional antimony|intralesional antimony
531373|NCT01300975|cryotherapy|cryotherapy
531374|NCT01300962|Xeloda|xeloda
531375|NCT01300962|Capecitabine|capecitabine
531376|NCT01300962|BKM120|bkm120
531377|NCT01300962|Lineberger Comprehensive Cancer Center|lineberger comprehensive cancer center
531378|NCT01300962|Metastatic|metastatic
531379|NCT01300962|BYL719 Breast Cancer|byl719 breast cancer
531380|NCT01300949|Contrast Sensitivity|contrast sensitivity
531381|NCT01300949|Pelli-Robson Test|pelli-robson test
531382|NCT01300923|Fragile X Syndrome|fragile x syndrome
531383|NCT01300923|Acamprosate|acamprosate
531384|NCT01300910|Adult Males|adult males
531385|NCT01300910|Circumcision|circumcision
531386|NCT01300910|HIV prevention|hiv prevention
531387|NCT01300910|Device|device
531388|NCT01300910|Shang Ring|shang ring
531389|NCT01300897|cortical evoked potentials, motor evoked potential responses|cortical evoked potentials, motor evoked potential responses
531390|NCT01300845|Oxygen mask|oxygen mask
531391|NCT01300845|Oxygen cannula|oxygen cannula
531392|NCT01300845|Humidification|humidification
531393|NCT01300845|Oxygen therapy|oxygen therapy
531394|NCT01300845|Intensive Care Unit|intensive care unit
531395|NCT01300832|Surgery|surgery
531396|NCT01300832|Deep Vein Thrombosis|deep vein thrombosis
531397|NCT01300832|Preoperative|preoperative
531398|NCT01300819|Rotigotine|rotigotine
531399|NCT01300819|Neupro®|neupro®
531400|NCT01300819|Non-motor symptoms|non-motor symptoms
531401|NCT01300806|HIV|hiv
531402|NCT01300806|harmful substance use|harmful substance use
531403|NCT01300793|V-RICE|v-rice
531404|NCT01300793|Relapsed NHL|relapsed nhl
531817|NCT01299142|virus|virus
531405|NCT01300793|Primary Refractory NHL|primary refractory nhl
531406|NCT01300780|bleaching agent|bleaching agent
531407|NCT01300780|tooth bleaching|tooth bleaching
531408|NCT01300780|sensibility|sensibility
531409|NCT01300754|Osgood-Schlatter|osgood-schlatter
531410|NCT01300754|Tendinosis|tendinosis
531411|NCT01300754|Apophysitis|apophysitis
531412|NCT01300754|Enthesopathy|enthesopathy
531413|NCT01300754|Dextrose.|dextrose.
531414|NCT01300728|Intravenous immunotherapy|intravenous immunotherapy
531415|NCT01300728|Conversion to Alzheimer Disease|conversion to alzheimer disease
531416|NCT01300715|zygapophysial joint|zygapophysial joint
531417|NCT01300715|facet joint|facet joint
531418|NCT01300715|low back pain|low back pain
531419|NCT01300715|radiofrequency|radiofrequency
531420|NCT01300715|neurotomy|neurotomy
531421|NCT01300689|HPV|hpv
531422|NCT01300689|MSM|msm
531423|NCT01300689|Vaccine|vaccine
531424|NCT01300689|China|china
531425|NCT01300676|Tualang honey|tualang honey
531426|NCT01300676|HRT|hrt
531427|NCT01300676|safety profiles|safety profiles
531428|NCT01300676|cardiovascular parameters|cardiovascular parameters
531429|NCT01300676|hormonal levels|hormonal levels
531430|NCT01300676|bone changes|bone changes
531431|NCT01300676|postmenopausal women|postmenopausal women
531432|NCT01300650|Heart failure|heart failure
531433|NCT01300650|Inflammation|inflammation
531434|NCT01300650|Interleukin-1|interleukin-1
531435|NCT01300650|Cardiopulmonary exercise|cardiopulmonary exercise
531436|NCT01300637|schizophrenia|schizophrenia
531437|NCT01300637|clozapine|clozapine
531438|NCT01300637|metabolic dysregulation|metabolic dysregulation
531439|NCT01300637|metformin|metformin
531440|NCT01300624|Aphasia|aphasia
531441|NCT01300624|therapy|therapy
531442|NCT01300624|treatment|treatment
531443|NCT01300624|verbs|verbs
531444|NCT01300624|sentences|sentences
531445|NCT01300611|Double Cord Blood Transplantation|double cord blood transplantation
531446|NCT01300611|Neutrophil Engraftment|neutrophil engraftment
531447|NCT01300611|Platelet Engraftment|platelet engraftment
531448|NCT01300611|Immune Reconstitution|immune reconstitution
531449|NCT01300611|Mucositis|mucositis
531450|NCT01300585|Breast|breast
531451|NCT01300585|Cancer|cancer
531452|NCT01300559|efficacy|efficacy
531453|NCT01300559|hemoglobin|hemoglobin
531454|NCT01300559|spine|spine
531455|NCT01300546|Frequent migraine|frequent migraine
531456|NCT01300546|Migraine transformation|migraine transformation
531457|NCT01300546|Migraine|migraine
531458|NCT01300546|Treximet|treximet
531459|NCT01300546|Naproxen|naproxen
531460|NCT01300546|Sumatriptan|sumatriptan
531461|NCT01300533|Cancer|cancer
531462|NCT01300533|Neoplasms|neoplasms
531463|NCT01300533|Solid Tumor|solid tumor
531464|NCT01300533|Ovarian Cancer|ovarian cancer
531465|NCT01300533|Lung Cancer|lung cancer
531466|NCT01300533|Non-Small Cell Lung Cancer|non-small cell lung cancer
531467|NCT01300533|Pancreatic Cancer|pancreatic cancer
531468|NCT01300533|Breast Cancer|breast cancer
531469|NCT01300533|Endometrial Cancer|endometrial cancer
531470|NCT01300533|Melanoma|melanoma
531471|NCT01300533|Prostate Cancer|prostate cancer
531472|NCT01300533|Skin Cancer|skin cancer
531473|NCT01300533|Head and Neck Cancer|head and neck cancer
531474|NCT01300533|Solid Malignancies|solid malignancies
531475|NCT01300520|Fluoroscopy|fluoroscopy
531476|NCT01300520|Femoral fracture|femoral fracture
531477|NCT01300520|Tibial fracture|tibial fracture
531478|NCT01300520|Spinal Fusion|spinal fusion
531479|NCT01300507|stent thrombosis|stent thrombosis
531480|NCT01300507|intra coronary imaging|intra coronary imaging
531481|NCT01300507|blood platelet function testing|blood platelet function testing
531482|NCT01300494|bifurcation lesion|bifurcation lesion
531483|NCT01300494|optimal viewing angle|optimal viewing angle
531484|NCT01300494|automated software|automated software
531485|NCT01300468|advanced/metastatic solid tumors|advanced/metastatic solid tumors
531486|NCT01300455|Insomnia|insomnia
531487|NCT01300455|obstructive sleep apnea|obstructive sleep apnea
531488|NCT01300455|orexin receptor antagonist|orexin receptor antagonist
531489|NCT01300442|chronic obstructive pulmonary disease|chronic obstructive pulmonary disease
531490|NCT01300442|diaphragm|diaphragm
531491|NCT01300442|electrical stimulation|electrical stimulation
531492|NCT01300442|pulmonary rehabilitation|pulmonary rehabilitation
531493|NCT01300429|core biopsy|core biopsy
531494|NCT01300429|Resistance to Crizotinib|resistance to crizotinib
531495|NCT01300429|Non-small Cell Lung Cancer|non-small cell lung cancer
531496|NCT01300429|11-014|11-014
531497|NCT01300416|Kidney transplantation|kidney transplantation
531498|NCT01300416|mycophenolate sodium|mycophenolate sodium
531499|NCT01300416|EC-MPS|ec-mps
531500|NCT01300416|Health Related Quality of Life|health related quality of life
531501|NCT01300416|GI symptoms|gi symptoms
531502|NCT01300416|Immunosuppressants|immunosuppressants
531503|NCT01300416|HRQL|hrql
531504|NCT01300416|PGWB|pgwb
531505|NCT01300416|GIQLI|giqli
531506|NCT01300390|liver transplant|liver transplant
531507|NCT01300390|end-stage liver disease|end-stage liver disease
531508|NCT01300390|cirrhosis|cirrhosis
531509|NCT01300377|Post-operative pain|post-operative pain
531510|NCT01300377|pain|pain
531511|NCT01300377|pacemaker|pacemaker
531512|NCT01300377|defibrillator|defibrillator
531513|NCT01300377|post-operative narcotic use|post-operative narcotic use
531514|NCT01300377|local anesthesia|local anesthesia
531515|NCT01300351|Advanced breast cancer|advanced breast cancer
531516|NCT01300351|metastatic breast cancer|metastatic breast cancer
531517|NCT01300338|Diabetes|diabetes
531518|NCT01300325|Bronchiolitis, 3% Hypertonic Saline Solution|bronchiolitis, 3% hypertonic saline solution
531519|NCT01300312|eperisone|eperisone
531520|NCT01300312|diclofenac|diclofenac
531521|NCT01300312|low back pain|low back pain
531522|NCT01300299|lung cancer|lung cancer
531523|NCT01300299|radiation|radiation
531524|NCT01300299|stereotactic|stereotactic
531525|NCT01300273|Diabetic nephropathy|diabetic nephropathy
531526|NCT01300273|Podocyte|podocyte
531527|NCT01300273|Low Protein Diet|low protein diet
531528|NCT01300273|Ketoanalogs|ketoanalogs
531529|NCT01300234|tenofovir disoproxil fumarate|tenofovir disoproxil fumarate
531530|NCT01300234|chronic hepatitis B|chronic hepatitis b
531531|NCT01300234|adefovir dipivoxil|adefovir dipivoxil
531532|NCT01300221|Three dimension echocardiography|three dimension echocardiography
531533|NCT01300221|Congenital heart disease|congenital heart disease
531534|NCT01300221|Z-score|z-score
531535|NCT01300208|cutaneous lupus erythematosus|cutaneous lupus erythematosus
531536|NCT01300208|subacute lupus erythematosus|subacute lupus erythematosus
531537|NCT01300208|discoid lupus erythematosus|discoid lupus erythematosus
531538|NCT01300208|lupus|lupus
531539|NCT01300195|VATS|vats
531540|NCT01300195|standardized surgery|standardized surgery
531541|NCT01300195|persistent pain|persistent pain
531542|NCT01300182|ACLR|aclr
531543|NCT01300169|Suicide|suicide
531544|NCT01300169|Assessment|assessment
531545|NCT01300169|Intervention|intervention
531546|NCT01300169|CAMS|cams
531547|NCT01300156|Hodgkin's disease|hodgkin's disease
531548|NCT01300156|lymphoma|lymphoma
531549|NCT01300156|Relapsed|relapsed
531550|NCT01300156|refractory|refractory
531551|NCT01300130|neurological development|neurological development
531552|NCT01300130|preterm infants|preterm infants
531553|NCT01300130|fatty acid status|fatty acid status
531554|NCT01300117|cardiac surgery|cardiac surgery
531555|NCT01300117|adamts13|adamts13
531556|NCT01300117|TTP|ttp
531557|NCT01300117|extracorporeal circulation|extracorporeal circulation
531558|NCT01300117|Heart-Lung Machine|heart-lung machine
531559|NCT01300104|prostate cancer progression|prostate cancer progression
531560|NCT01300104|active surveillance|active surveillance
531561|NCT01300104|whole grain rye|whole grain rye
531562|NCT01300104|exercise|exercise
531563|NCT01300104|insulin sensitivity|insulin sensitivity
531564|NCT01300104|quality of life|quality of life
531565|NCT01300091|Shoulder|shoulder
531566|NCT01300091|Pain|pain
531567|NCT01300091|Range of Motion|range of motion
531568|NCT01300091|Disability Evaluation|disability evaluation
531569|NCT01300091|Function|function
531570|NCT01300091|Sick Leave|sick leave
531571|NCT01300091|Primary Health Care|primary health care
531572|NCT01300091|Visual Analog Scale|visual analog scale
531573|NCT01300091|Visual Analog Pain Scale|visual analog pain scale
531574|NCT01300091|The American Shoulder and Elbow Surgeons Standardized Shoulder Assessment Form|the american shoulder and elbow surgeons standardized shoulder assessment form
531575|NCT01300078|Hot Flashes|hot flashes
531576|NCT01300078|Hot Flushes|hot flushes
531577|NCT01300078|Vasomotor Symptoms|vasomotor symptoms
531578|NCT01300078|Menopausal Symptoms|menopausal symptoms
531579|NCT01300052|psoriasis|psoriasis
531580|NCT01300039|nephrolithiasis|nephrolithiasis
531581|NCT01300039|urolithiasis|urolithiasis
531582|NCT01300039|hyperoxaluria|hyperoxaluria
531583|NCT01300039|Helicobacter pylori|helicobacter pylori
531584|NCT01300026|Low intermediate grade B cell Lymphoma|low intermediate grade b cell lymphoma
531585|NCT01300026|Non-cutaneous T-cell NHL|non-cutaneous t-cell nhl
531586|NCT01300026|Mantle Cell Lymphoma|mantle cell lymphoma
531587|NCT01300026|PI3K delta|pi3k delta
531588|NCT01300026|Lymphoid|lymphoid
531589|NCT01300026|NHL|nhl
531590|NCT01300026|MCL|mcl
531591|NCT01300026|Hematologic|hematologic
531592|NCT01300026|CLL|cll
531593|NCT01300026|Chronic Lymphocytic Leukemia|chronic lymphocytic leukemia
531594|NCT01300013|Intravenous|intravenous
531595|NCT01300013|IV|iv
531596|NCT01300013|Left Ventricular Systolic Dysfunction|left ventricular systolic dysfunction
531597|NCT01300013|Hospitalized|hospitalized
531598|NCT01300013|Acute heart failure|acute heart failure
531599|NCT01300013|Heart failure|heart failure
531600|NCT01300013|Left ventricular ejection fraction|left ventricular ejection fraction
531601|NCT01300013|pharmacokinetics|pharmacokinetics
531602|NCT01300013|Pharmacodynamics|pharmacodynamics
675423|NCT00729456|Ulcer|ulcer
531603|NCT01300013|Dyspnea|dyspnea
531604|NCT01300013|hospitalization|hospitalization
531605|NCT01300013|In-patient|in-patient
531606|NCT01300013|Omecamtiv mecarbil|omecamtiv mecarbil
531607|NCT01300013|Double-blind|double-blind
531608|NCT01300013|Randomized|randomized
531609|NCT01300013|Placebo-controlled|placebo-controlled
531610|NCT01299987|Keywords provided by University Hospital Mannheim:|keywords provided by university hospital mannheim:
531611|NCT01299987|Intraoperative Radiotherapy|intraoperative radiotherapy
531612|NCT01299987|Early Breast Cancer|early breast cancer
531613|NCT01299987|Elderly Patients|elderly patients
531614|NCT01299974|Family-centered|family-centered
531615|NCT01299974|teaching|teaching
531616|NCT01299974|residents|residents
531617|NCT01299974|family faculty|family faculty
531618|NCT01299961|Rheumatoid Arthritis|rheumatoid arthritis
531619|NCT01299961|Subcutaneous Abatacept|subcutaneous abatacept
531620|NCT01299961|Ultrasound|ultrasound
531621|NCT01299948|HIV|hiv
531622|NCT01299948|AIDS|aids
531623|NCT01299948|CD4|cd4
531624|NCT01299948|progression|progression
531625|NCT01299948|immune activation|immune activation
531626|NCT01299935|stress reduction|stress reduction
531627|NCT01299935|Transcendental Meditation technique|transcendental meditation technique
531628|NCT01299935|secondary prevention of coronary heart disease|secondary prevention of coronary heart disease
531629|NCT01299922|Lupus nephritis|lupus nephritis
531630|NCT01299922|Therapy|therapy
531631|NCT01299922|Cyclosporin|cyclosporin
531632|NCT01299922|Mycophenolic acid|mycophenolic acid
531633|NCT01299909|Mindfulness Training for Smokers|mindfulness training for smokers
531634|NCT01299909|Smoking|smoking
531635|NCT01299909|Smoking cessation|smoking cessation
531636|NCT01299909|Addiction|addiction
531637|NCT01299909|behavioral intervention|behavioral intervention
531638|NCT01299909|Nicotine|nicotine
531639|NCT01299909|Tobacco|tobacco
531640|NCT01299909|Mindfulness|mindfulness
531641|NCT01299909|Meditation|meditation
531642|NCT01299909|MBSR|mbsr
531643|NCT01299909|Mindfulness Based Stress Reduction|mindfulness based stress reduction
531644|NCT01299909|Mindfulness Based Cognitive Therapy|mindfulness based cognitive therapy
531645|NCT01299909|MBCT|mbct
531646|NCT01299909|Mindfulness Based Relapse Prevention|mindfulness based relapse prevention
531647|NCT01299909|MBRP|mbrp
531648|NCT01299909|Mindfulness Training|mindfulness training
531649|NCT01299909|Nicotine Patch|nicotine patch
531650|NCT01299909|Quit Line|quit line
531651|NCT01299909|Phone counseling|phone counseling
531652|NCT01299909|Freedom from Smoking|freedom from smoking
531653|NCT01299896|Cigarette Smoking|cigarette smoking
531654|NCT01299896|Smoking, Tobacco|smoking, tobacco
531655|NCT01299896|Tobacco Smoking|tobacco smoking
531656|NCT01299896|Smoking Cessation|smoking cessation
531657|NCT01299896|Tobacco Dependence|tobacco dependence
531658|NCT01299883|Cancer|cancer
531659|NCT01299883|CVD|cvd
531660|NCT01299883|African American|african american
531661|NCT01299883|Health Education Intervention|health education intervention
531662|NCT01299883|Intervention RCT|intervention rct
531663|NCT01299883|Study focus is to examine the influence of health education regarding either CVD or CVD and cancer on health behaviors.|study focus is to examine the influence of health education regarding either cvd or cvd and cancer on health behaviors.
531664|NCT01299857|pemphigus|pemphigus
531665|NCT01299857|Mabthéra (R)|mabthéra (r)
531666|NCT01299857|B lymphocytes|b lymphocytes
531667|NCT01299857|desmogleines|desmogleines
531668|NCT01299844|Type 2 Diabetes|type 2 diabetes
531669|NCT01299818|central pain|central pain
531670|NCT01299818|spine surgey|spine surgey
531671|NCT01299818|outcome|outcome
531672|NCT01299818|patients undergo spinal surgery|patients undergo spinal surgery
531673|NCT01299805|Drug Therapy|drug therapy
531674|NCT01299805|pharmacodynamic|pharmacodynamic
531675|NCT01299792|spinal cord injury|spinal cord injury
531676|NCT01299792|urodynamics|urodynamics
531677|NCT01299792|ultrasound|ultrasound
531678|NCT01299792|neurogenic bladder dysfunction|neurogenic bladder dysfunction
531679|NCT01299779|hyponatremia|hyponatremia
531680|NCT01299779|PEG-SD|peg-sd
531681|NCT01299779|PEG-ELS|peg-els
531682|NCT01299766|Mild Cognitive Impairment|mild cognitive impairment
531683|NCT01299766|Memory|memory
531684|NCT01299727|Recombinant Human Heparan N-Sulfatase (rhHNS)|recombinant human heparan n-sulfatase (rhhns)
531685|NCT01299727|Sanfilippo Syndrome Type A (MPS IIIA)|sanfilippo syndrome type a (mps iiia)
531686|NCT01299727|Lysosomal storage disease (LSD)|lysosomal storage disease (lsd)
531687|NCT01299727|Mucopolysaccharidosis (MPS) III|mucopolysaccharidosis (mps) iii
531688|NCT01299714|Human Papilloma Virus|human papilloma virus
531689|NCT01299714|vaccine|vaccine
531690|NCT01299714|stress|stress
531691|NCT01299714|cervical cancer|cervical cancer
531692|NCT01299714|GARDASIL|gardasil
531693|NCT01299701|Advanced or metastatic cancer|advanced or metastatic cancer
531694|NCT01299701|refractory|refractory
531695|NCT01299701|core phase|core phase
531696|NCT01299701|extension phase|extension phase
531697|NCT01299701|dose escalation|dose escalation
531698|NCT01299701|standard chemotherapy|standard chemotherapy
531699|NCT01299701|docetaxel|docetaxel
531700|NCT01299701|paclitaxel|paclitaxel
531701|NCT01299701|carboplatin|carboplatin
531702|NCT01299701|safety|safety
531703|NCT01299701|tolerability|tolerability
531704|NCT01299675|MR conditional|mr conditional
531705|NCT01299649|CAD|cad
531706|NCT01299636|PM060184|pm060184
531707|NCT01299636|Phase I|phase i
531708|NCT01299636|Pharma Mar|pharma mar
531709|NCT01299623|breast cancer|breast cancer
531710|NCT01299623|breast cancer prevention|breast cancer prevention
531711|NCT01299623|African American women|african american women
531712|NCT01299610|Atopic Dermatitis|atopic dermatitis
531713|NCT01299610|GW870086X|gw870086x
531714|NCT01299610|TIS|tis
531715|NCT01299610|IGA|iga
531716|NCT01299597|repeat dose|repeat dose
531717|NCT01299597|statins|statins
531718|NCT01299597|safety and tolerability|safety and tolerability
531719|NCT01299597|drug interaction|drug interaction
531720|NCT01299597|sb649868|sb649868
531721|NCT01299597|healthy male subjects|healthy male subjects
531722|NCT01299597|pharmacokinetics|pharmacokinetics
531723|NCT01299558|pharmacokinetics|pharmacokinetics
531724|NCT01299558|GW642444|gw642444
531725|NCT01299558|absolute bioavailability|absolute bioavailability
531726|NCT01299558|healthy subjects|healthy subjects
531727|NCT01299558|fluticasone furoate|fluticasone furoate
531728|NCT01299558|GW685698|gw685698
531729|NCT01299545|Rheumatoid Arthritis|rheumatoid arthritis
531730|NCT01299545|Anti TNF|anti tnf
531731|NCT01299545|Infliximab|infliximab
531732|NCT01299545|Methotrexate|methotrexate
531733|NCT01299545|DMARDs|dmards
531734|NCT01299545|Gene expression biomarkers|gene expression biomarkers
531735|NCT01299519|obesity|obesity
531736|NCT01299519|weight loss|weight loss
531737|NCT01299519|insulin resistance|insulin resistance
531738|NCT01299506|soft tissue sarcoma|soft tissue sarcoma
531739|NCT01299506|trabectedin|trabectedin
531740|NCT01299506|Netherlands|netherlands
531741|NCT01299493|carcinoma|carcinoma
531742|NCT01299493|colorectal cancer|colorectal cancer
531743|NCT01299493|community health centers|community health centers
531744|NCT01299493|cluster-randomized|cluster-randomized
531745|NCT01299493|health behavior|health behavior
531746|NCT01299480|Healthy adolescents|healthy adolescents
531747|NCT01299467|Asthma|asthma
531748|NCT01299467|duration of action|duration of action
531749|NCT01299467|allergen challenge|allergen challenge
531750|NCT01299428|CEREBRAL OXYGENATION|cerebral oxygenation
531751|NCT01299428|HYPERNATREMİA|hypernatremia
531752|NCT01299428|NEWBORN|newborn
531753|NCT01299428|NA VALUES|na values
531754|NCT01299415|ASA404,|asa404,
531755|NCT01299415|Phase I,|phase i,
531756|NCT01299415|Oncology,|oncology,
531757|NCT01299415|CYP1A2,|cyp1a2,
531758|NCT01299415|fluvoxamine,|fluvoxamine,
531759|NCT01299415|drug drug interaction,|drug drug interaction,
531760|NCT01299415|Novartis,|novartis,
531761|NCT01299415|Antisoma|antisoma
531762|NCT01299389|Paliperidone palmitate|paliperidone palmitate
531763|NCT01299389|Schizophrenia|schizophrenia
531764|NCT01299376|Essential hypertension|essential hypertension
531765|NCT01299376|Antihypertensive agents|antihypertensive agents
531766|NCT01299376|Blood pressure|blood pressure
531767|NCT01299376|Uncontrolled hypertension|uncontrolled hypertension
531768|NCT01299363|Prolapse|prolapse
531769|NCT01299363|Pain with intercourse|pain with intercourse
531770|NCT01299363|Dyspareunia|dyspareunia
531771|NCT01299363|Post operative pain|post operative pain
531772|NCT01299350|Heart failure|heart failure
531773|NCT01299350|Nt-proBNP|nt-probnp
531774|NCT01299324|CHF|chf
531775|NCT01299311|insulin sensitivity|insulin sensitivity
531776|NCT01299285|Absorption|absorption
531777|NCT01299285|Distribution|distribution
531778|NCT01299285|Metabolism|metabolism
531779|NCT01299285|Excretion|excretion
531780|NCT01299285|Mass balance|mass balance
531781|NCT01299285|Metabolic profile|metabolic profile
531782|NCT01299285|Radiolabeled study|radiolabeled study
531783|NCT01299285|14C|14c
531784|NCT01299259|Text message reminders|text message reminders
531785|NCT01299259|Pelvic inflammatory disease|pelvic inflammatory disease
531786|NCT01299259|PID|pid
531787|NCT01299259|Primary care follow-up|primary care follow-up
531788|NCT01299259|Emergency department care|emergency department care
531789|NCT01299259|Discharge instructions|discharge instructions
531790|NCT01299246|Diabetic Foot|diabetic foot
531791|NCT01299246|non-invasive DFP assessment tools|non-invasive dfp assessment tools
531792|NCT01299246|early detection of DFP|early detection of dfp
531793|NCT01299220|Erlotinib|erlotinib
531794|NCT01299220|Acitretin|acitretin
531795|NCT01299220|Rash|rash
531796|NCT01299220|Dermatology|dermatology
531797|NCT01299220|Oncology|oncology
531798|NCT01299207|Stents|stents
531799|NCT01299207|Drug-Eluting Stents|drug-eluting stents
531800|NCT01299207|Stent Thrombosis|stent thrombosis
531801|NCT01299207|Bleeding|bleeding
531802|NCT01299207|Dual-Antiplatelet Therapy|dual-antiplatelet therapy
531803|NCT01299194|BRONCHIECTASIS|bronchiectasis
531804|NCT01299194|PSEUDOMONAS AERUGINOSA|pseudomonas aeruginosa
531805|NCT01299194|STATIN|statin
531806|NCT01299194|OUTCOME|outcome
531807|NCT01299181|Bronchiectasis|bronchiectasis
531808|NCT01299181|Outcome|outcome
531809|NCT01299181|Statin therapy|statin therapy
531810|NCT01299168|global gene expression|global gene expression
531811|NCT01299168|molecular diagnostic classifiers|molecular diagnostic classifiers
531812|NCT01299155|Intraocular Lens|intraocular lens
531813|NCT01299155|Presbyopia Correcting IOL|presbyopia correcting iol
531818|NCT01299129|Uveitis|uveitis
531819|NCT01299129|Cystoid macular edema|cystoid macular edema
531820|NCT01299129|microperimetry|microperimetry
531821|NCT01299129|functional visual acuity|functional visual acuity
531822|NCT01299129|intravitreal triamcinolone|intravitreal triamcinolone
531823|NCT01299116|AE-adverse event|ae-adverse event
531824|NCT01299116|FDA-(U.S.) Food and Drug Administration|fda-(u.s.) food and drug administration
531825|NCT01299116|GCP-Good Clinical Practice guidelines|gcp-good clinical practice guidelines
531826|NCT01299116|ICH-International Committee on Harmonisation|ich-international committee on harmonisation
531827|NCT01299116|IRB-Institutional Review Board|irb-institutional review board
531828|NCT01299116|IU-International units|iu-international units
531829|NCT01299116|mg-milligram(s)|mg-milligram(s)
531830|NCT01299116|mm3-cubic millimeter(s)|mm3-cubic millimeter(s)
531831|NCT01299116|LARC-Long-Acting reversible contraception|larc-long-acting reversible contraception
531832|NCT01299116|PPCNC-Planned Parenthood of North Carolina|ppcnc-planned parenthood of north carolina
531833|NCT01299116|SAE-serious adverse event|sae-serious adverse event
531834|NCT01299116|SARC-Short-Acting reversible contraception|sarc-short-acting reversible contraception
531835|NCT01299116|µg-microgram|µg-microgram
531836|NCT01299116|ULN-upper limit of the normal range|uln-upper limit of the normal range
531837|NCT01299116|SubQ-subcutaneous|subq-subcutaneous
531838|NCT01299103|wrinkle|wrinkle
531839|NCT01299103|rhytide|rhytide
531840|NCT01299090|wrinkles|wrinkles
531841|NCT01299090|rhytides|rhytides
531842|NCT01299077|Lumbar disc degenerative disease|lumbar disc degenerative disease
531843|NCT01299077|Methycobal|methycobal
531844|NCT01299064|mindfulness-based intervention|mindfulness-based intervention
531845|NCT01299064|symptoms reduction|symptoms reduction
531846|NCT01299064|mental health|mental health
531847|NCT01299051|Weight Management|weight management
531848|NCT01299051|Employee Health|employee health
531849|NCT01299038|Crestor|crestor
531850|NCT01299038|TFBP|tfbp
531851|NCT01299038|rosuvastatin|rosuvastatin
531852|NCT01299025|balance|balance
531853|NCT01299025|walking|walking
531854|NCT01298999|Barrett's Esophagus|barrett's esophagus
531855|NCT01298999|Esophageal Adenocarcinoma|esophageal adenocarcinoma
531856|NCT01298999|GERD|gerd
531857|NCT01298999|Acid Reflux|acid reflux
531858|NCT01298986|atrial fibrillation ablation procedures|atrial fibrillation ablation procedures
531859|NCT01298960|Poor Ovarian response in IVF|poor ovarian response in ivf
531860|NCT01298960|Metaphase II oocytes|metaphase ii oocytes
531861|NCT01298960|Pregnancy Rate|pregnancy rate
531862|NCT01298960|Growth Hormone|growth hormone
531863|NCT01298947|Photoablative Atherectomy|photoablative atherectomy
531864|NCT01298947|Paclitaxel-Coated Balloon|paclitaxel-coated balloon
531865|NCT01298947|Instent Femoro-popliteal Obstructions|instent femoro-popliteal obstructions
531866|NCT01298921|Headache|headache
531867|NCT01298921|Cluster Headache|cluster headache
531868|NCT01298921|Oxygen Therapy|oxygen therapy
531869|NCT01298908|varicose veins, oedema|varicose veins, oedema
531870|NCT01298895|optical components|optical components
531871|NCT01298895|pseudoexfoliation|pseudoexfoliation
531872|NCT01298895|cataract|cataract
531873|NCT01298895|LENSTAR® LS 900®|lenstar® ls 900®
531874|NCT01298882|Type 2 diabetes mellitus|type 2 diabetes mellitus
531875|NCT01298882|Overweight|overweight
531876|NCT01298882|Obesity|obesity
531877|NCT01298869|CKD|ckd
531878|NCT01298869|HPV infection|hpv infection
531879|NCT01298869|HPV vaccine|hpv vaccine
531880|NCT01298869|antibodies titer|antibodies titer
531881|NCT01298856|hydrotherapy|hydrotherapy
531882|NCT01298856|chronic ankle instability|chronic ankle instability
531883|NCT01298856|ankle taping|ankle taping
531884|NCT01298843|Confirmed or Suspected Infections|confirmed or suspected infections
531885|NCT01298817|Obesity|obesity
531886|NCT01298817|Aging|aging
531887|NCT01298817|Soy|soy
531888|NCT01298817|Weight Loss|weight loss
531889|NCT01298817|Ectopic Fat|ectopic fat
531890|NCT01298778|chronic pain post delivery|chronic pain post delivery
531891|NCT01298778|postpartum depression|postpartum depression
531892|NCT01298778|tailored pain management|tailored pain management
531893|NCT01298765|buccal soluble film|buccal soluble film
531894|NCT01298739|asthma control level , ACQ|asthma control level , acq
531895|NCT01298726|PHARMACEUTICAL SERVICES|pharmaceutical services
531896|NCT01298726|DIABETES MELLITUS|diabetes mellitus
531897|NCT01298713|Hormonoresistance|hormonoresistance
531898|NCT01298713|tamoxifen|tamoxifen
531899|NCT01298713|Previously received anti-aromatase treatment|previously received anti-aromatase treatment
531900|NCT01298713|mTor inhibitor|mtor inhibitor
531901|NCT01298687|open-angle glaucoma|open-angle glaucoma
531902|NCT01298687|ocular hypertension|ocular hypertension
531903|NCT01298687|divided dose|divided dose
531904|NCT01298661|Exercise Test|exercise test
531905|NCT01298661|Reproducibility of Results|reproducibility of results
531906|NCT01298661|Mortality|mortality
531907|NCT01298648|Crohn's Disease|crohn's disease
531908|NCT01298635|Primary angle-closure glaucoma|primary angle-closure glaucoma
531909|NCT01298635|cataract|cataract
531910|NCT01298635|trabeculectomy|trabeculectomy
531911|NCT01298635|phacotrabeculectomy|phacotrabeculectomy
531912|NCT01298609|Fibromyalgia|fibromyalgia
531913|NCT01298609|Occipital Nerve Stimulation|occipital nerve stimulation
531914|NCT01298570|Metastatic Colorectal Cancer|metastatic colorectal cancer
531915|NCT01298570|K-RAS mutation|k-ras mutation
531916|NCT01298570|BRAF mutation|braf mutation
531917|NCT01298570|Regorafenib|regorafenib
531918|NCT01298570|BAY 73-4506|bay 73-4506
531919|NCT01298570|FOLFIRI|folfiri
531920|NCT01298570|Irinotecan|irinotecan
531921|NCT01298570|5-FU|5-fu
531922|NCT01298570|Leucovorin|leucovorin
531923|NCT01298570|Placebo|placebo
531924|NCT01298570|Phase II|phase ii
531925|NCT01298570|Multi-Center|multi-center
531926|NCT01298570|Randomized|randomized
531927|NCT01298570|Lineberger|lineberger
531928|NCT01298570|North Carolina Cancer Hospital|north carolina cancer hospital
531929|NCT01298570|UNC|unc
531930|NCT01298557|Traumatic brain injury|traumatic brain injury
531931|NCT01298557|Post-concussive symptoms|post-concussive symptoms
531932|NCT01298557|Brain imaging|brain imaging
531933|NCT01298557|Neurocognitive testing|neurocognitive testing
531934|NCT01298544|Vaccine|vaccine
531935|NCT01298544|Prevenar|prevenar
531936|NCT01298544|Pneumococcal disease|pneumococcal disease
531937|NCT01298531|Etanercept|etanercept
531938|NCT01298531|Axial Spondyloarthritis|axial spondyloarthritis
531939|NCT01298531|NSAIDs sparing effect|nsaids sparing effect
531940|NCT01298518|multiple dose study in type 2 diabetes patients|multiple dose study in type 2 diabetes patients
531941|NCT01298505|Phase 1 multiple dose safety toleration fexofenadine|phase 1 multiple dose safety toleration fexofenadine
531942|NCT01298492|Active Crohn's disease|active crohn's disease
531943|NCT01298492|Anti-TNF Refractory|anti-tnf refractory
531944|NCT01298492|Immunosuppressant Refractory|immunosuppressant refractory
531945|NCT01298479|volume delivery|volume delivery
531946|NCT01298466|identification|identification
531947|NCT01298466|chronic|chronic
531948|NCT01298466|neuropathic|neuropathic
531949|NCT01298466|low back pain|low back pain
531950|NCT01298466|primary care|primary care
531951|NCT01298466|pregabalin|pregabalin
531952|NCT01298414|childhood acute myeloid leukemia/other myeloid malignancies|childhood acute myeloid leukemia/other myeloid malignancies
531953|NCT01298401|adenocarcinoma of the pancreas|adenocarcinoma of the pancreas
531954|NCT01298401|stage IIB pancreatic cancer|stage iib pancreatic cancer
531955|NCT01298401|stage III pancreatic cancer|stage iii pancreatic cancer
531956|NCT01298388|long-term effects secondary to cancer therapy in children|long-term effects secondary to cancer therapy in children
531957|NCT01298388|cancer survivor|cancer survivor
531958|NCT01298388|recurrent childhood acute lymphoblastic leukemia|recurrent childhood acute lymphoblastic leukemia
531959|NCT01298388|untreated childhood acute lymphoblastic leukemia|untreated childhood acute lymphoblastic leukemia
531960|NCT01298388|T-cell childhood acute lymphoblastic leukemia|t-cell childhood acute lymphoblastic leukemia
531961|NCT01298388|non-T, non-B childhood acute lymphoblastic leukemia|non-t, non-b childhood acute lymphoblastic leukemia
531962|NCT01298388|non-T, non-B, cALLa positive childhood acute lymphoblastic leukemia|non-t, non-b, calla positive childhood acute lymphoblastic leukemia
531963|NCT01298388|non-T, non-B, cALLa negative childhood acute lymphoblastic leukemia|non-t, non-b, calla negative childhood acute lymphoblastic leukemia
531964|NCT01298388|non-T, non-B, cALLa positive, pre-B childhood acute lymphoblastic leukemia|non-t, non-b, calla positive, pre-b childhood acute lymphoblastic leukemia
531965|NCT01298388|childhood acute lymphoblastic leukemia in remission|childhood acute lymphoblastic leukemia in remission
531966|NCT01298375|Metabolic flexibility|metabolic flexibility
531967|NCT01298375|Mitochondrial function|mitochondrial function
531968|NCT01298375|Human primary myoblasts|human primary myoblasts
531969|NCT01298375|Lipid metabolism|lipid metabolism
531970|NCT01298336|Mycobacterium Xenopi Pulmonary Infection|mycobacterium xenopi pulmonary infection
531971|NCT01298336|Clarithromycin|clarithromycin
531972|NCT01298336|Moxifloxacin|moxifloxacin
531973|NCT01298323|Medullary Thyroid Cancer|medullary thyroid cancer
531974|NCT01298323|Locally advanced|locally advanced
531975|NCT01298323|Metastatic|metastatic
531976|NCT01298323|Vandetanib|vandetanib
531977|NCT01298323|Patient Outreach|patient outreach
531978|NCT01298310|Morton's neuroma, QST measurements|morton's neuroma, qst measurements
531979|NCT01298297|Buprenorphine, acute pain, analgesia|buprenorphine, acute pain, analgesia
531980|NCT01298284|Variceal bleeding|variceal bleeding
531981|NCT01298284|portal hypertension|portal hypertension
531982|NCT01298284|hepatocelluar carcinoma|hepatocelluar carcinoma
531983|NCT01298284|endoscopic variceal ligation|endoscopic variceal ligation
531984|NCT01298284|non-selective beta-blocker|non-selective beta-blocker
675922|NCT00727701|veteran|veteran
531985|NCT01298284|rebleeding|rebleeding
531986|NCT01298271|gastric variceal bleeding|gastric variceal bleeding
531987|NCT01298271|primaryprevention|primaryprevention
531988|NCT01298271|cyanoacrylate injection|cyanoacrylate injection
531989|NCT01298271|non-selective beta-blocker|non-selective beta-blocker
531990|NCT01298245|diabetes|diabetes
531991|NCT01298245|diabetic retinopathy|diabetic retinopathy
531992|NCT01298245|Chinese|chinese
531993|NCT01298245|gene|gene
531994|NCT01298245|associations|associations
531995|NCT01298206|A/H1N1 Influenza|a/h1n1 influenza
531996|NCT01298206|swine flu|swine flu
531997|NCT01298206|virus disease|virus disease
531998|NCT01298206|Avian flu|avian flu
531999|NCT01298193|Early-stage breast cancer patients|early-stage breast cancer patients
532000|NCT01298180|Prader-Willi Syndrome|prader-willi syndrome
532001|NCT01298180|Growth Hormone Deficiency|growth hormone deficiency
532002|NCT01298167|Cyanoacrylate|cyanoacrylate
532003|NCT01298167|Fast Absorbing Gut|fast absorbing gut
532004|NCT01298167|Mohs Surgery|mohs surgery
532005|NCT01298167|Epidermal closure method|epidermal closure method
532006|NCT01298154|Food intake|food intake
532007|NCT01298154|Blood glucose|blood glucose
532008|NCT01298154|Pulses|pulses
532009|NCT01298154|Protein|protein
532010|NCT01298141|Replagal|replagal
532011|NCT01298141|Enzyme Replacement Therapy|enzyme replacement therapy
532012|NCT01298141|agalsidase alfa|agalsidase alfa
532013|NCT01298115|chronic kidney disease|chronic kidney disease
532014|NCT01298115|dialysis|dialysis
532015|NCT01298115|pre dialysis education|pre dialysis education
532016|NCT01298115|transplantation|transplantation
532017|NCT01298115|conservative care|conservative care
532018|NCT01298102|kidney|kidney
532019|NCT01298102|transplantation|transplantation
532020|NCT01298102|haemodialysis|haemodialysis
532021|NCT01298102|vaccination|vaccination
532022|NCT01298102|influenza H1N1 2009|influenza h1n1 2009
532023|NCT01298089|Flap|flap
532024|NCT01298089|LASIK|lasik
532025|NCT01298089|Corneal|corneal
532026|NCT01298076|Diabetes|diabetes
532027|NCT01298076|Retinopathy|retinopathy
532028|NCT01298076|Macular oedema|macular oedema
532029|NCT01298076|Laser|laser
532030|NCT01298076|Photocoagulation|photocoagulation
532031|NCT01298076|Fovea|fovea
532032|NCT01298076|Steroid|steroid
532033|NCT01298076|Bevacizumab|bevacizumab
532034|NCT01298076|Intravitreal|intravitreal
532035|NCT01298037|Immunology, Hepatitis B, HBV|immunology, hepatitis b, hbv
532036|NCT01298024|Achilles tendon rupture|achilles tendon rupture
532037|NCT01298024|Non-surgical treatment|non-surgical treatment
532038|NCT01298024|Exercise|exercise
532039|NCT01298024|Neuromuscular training|neuromuscular training
532040|NCT01298011|operable|operable
532041|NCT01298011|pancreas|pancreas
532042|NCT01298011|Abraxane|abraxane
532043|NCT01298011|Gemcitabine|gemcitabine
532044|NCT01298011|Preoperative|preoperative
532045|NCT01298011|potentially|potentially
532046|NCT01298011|Pancreatic Cancer|pancreatic cancer
532047|NCT01297985|Serious mental illness|serious mental illness
532048|NCT01297985|Psychiatric disability|psychiatric disability
532049|NCT01297985|Mental health peer-led|mental health peer-led
532050|NCT01297985|Mental illness education|mental illness education
532051|NCT01297985|Illness self-management|illness self-management
532052|NCT01297972|Aplastic Anemia|aplastic anemia
532053|NCT01297972|Mesenchymal Stem Cells|mesenchymal stem cells
532054|NCT01297959|Surgical Wound Infection|surgical wound infection
532055|NCT01297959|Therapeutic Enzyme System|therapeutic enzyme system
532056|NCT01297959|Singlet Oxygen|singlet oxygen
532057|NCT01297959|Peroxidase|peroxidase
532058|NCT01297959|Glucose Oxidase|glucose oxidase
532059|NCT01297959|Colorectal surgery|colorectal surgery
532060|NCT01297959|Incisional Surgical Site Infections (SSI)|incisional surgical site infections (ssi)
532061|NCT01297959|Anti-infective Agents, Local|anti-infective agents, local
532062|NCT01297959|Clinical Trial, Phase III|clinical trial, phase iii
532063|NCT01297933|parenteral nutrition associated liver disease|parenteral nutrition associated liver disease
532064|NCT01297933|cholestasis|cholestasis
532065|NCT01297933|short bowel syndrome|short bowel syndrome
532066|NCT01297933|Omegaven|omegaven
532067|NCT01297920|Open-Angle Glaucoma|open-angle glaucoma
532068|NCT01297920|Ocular Hypertension|ocular hypertension
532069|NCT01297920|Brinzolamide|brinzolamide
532070|NCT01297920|Brimonidine|brimonidine
532071|NCT01297920|Intraocular pressure|intraocular pressure
532072|NCT01297907|Crohn's Disease|crohn's disease
532073|NCT01297907|Bronchial hyper reactivity|bronchial hyper reactivity
532074|NCT01297907|Fractional exhaled NO|fractional exhaled no
532075|NCT01297907|Methacholine Challenge Test|methacholine challenge test
532076|NCT01297907|Pediatric Crohn's Disease Activity Index|pediatric crohn's disease activity index
532077|NCT01297907|To determine the frequency of bronchial hyperreactivity in pediatric patients followed and treated for Crohn disease|to determine the frequency of bronchial hyperreactivity in pediatric patients followed and treated for crohn disease
532078|NCT01297894|A. baumannii|a. baumannii
676060|NCT00727142|NPH|nph
532079|NCT01297894|colistin|colistin
532080|NCT01297894|fosfomycin|fosfomycin
532081|NCT01297881|Caucasian outpatients|caucasian outpatients
532082|NCT01297881|undiagnosed respiratory symptoms|undiagnosed respiratory symptoms
532083|NCT01297881|dyspnea|dyspnea
532084|NCT01297881|cough|cough
532085|NCT01297881|sputum|sputum
532086|NCT01297829|ibuprofen|ibuprofen
532087|NCT01297829|postoperative narcotics|postoperative narcotics
532088|NCT01297829|visual analog pain scale|visual analog pain scale
532089|NCT01297829|inguinal hernia repair|inguinal hernia repair
532090|NCT01297829|umbilical hernia repair|umbilical hernia repair
532091|NCT01297790|Cough|cough
532092|NCT01297790|Inhalational cough challenges|inhalational cough challenges
532093|NCT01297790|Cough reflex sensitivity|cough reflex sensitivity
532094|NCT01297790|Chronic cough.|chronic cough.
532095|NCT01297777|Mast cell|mast cell
532096|NCT01297777|Mastocytosis|mastocytosis
532097|NCT01297777|Mast cell disease|mast cell disease
532098|NCT01297738|diet manipulation|diet manipulation
532099|NCT01297738|serotonin|serotonin
532100|NCT01297738|dopamine|dopamine
532101|NCT01297738|insulin sensitivity|insulin sensitivity
532102|NCT01297725|Cesarean section|cesarean section
532103|NCT01297725|Cesarean section[*methods]|cesarean section[*methods]
532104|NCT01297725|Fascia [*surgery]|fascia [*surgery]
532105|NCT01297725|Randomized Controlled Trial|randomized controlled trial
532106|NCT01297725|Abdominal Wall [*surgery]|abdominal wall [*surgery]
532107|NCT01297725|Pain, postoperative|pain, postoperative
532108|NCT01297725|Surgical wound infection|surgical wound infection
532109|NCT01297712|screening colonoscopy|screening colonoscopy
532110|NCT01297712|adenoma|adenoma
532111|NCT01297712|hyperplastic polyp|hyperplastic polyp
532112|NCT01297712|differential diagnosis|differential diagnosis
532113|NCT01297699|Graves´ orbitopathy|graves´ orbitopathy
532114|NCT01297699|Graves´ ophthalmopathy|graves´ ophthalmopathy
532115|NCT01297699|Thyroid eye disease|thyroid eye disease
532116|NCT01297699|Thyroid-associated ophthalmopathy|thyroid-associated ophthalmopathy
532117|NCT01297699|Tocilizumab|tocilizumab
532118|NCT01297699|EUGOGO|eugogo
532119|NCT01297699|CAS|cas
532120|NCT01297686|Chronic plantar fasciitis|chronic plantar fasciitis
532121|NCT01297686|Workplace injury|workplace injury
532122|NCT01297686|Foot and Ankle Disability Index|foot and ankle disability index
532123|NCT01297686|Ultrasound measure of disease severity|ultrasound measure of disease severity
532124|NCT01297673|vesico-ureteral reflux|vesico-ureteral reflux
532125|NCT01297673|neurogenic bladder dysfunction|neurogenic bladder dysfunction
532126|NCT01297673|spinal cord injury|spinal cord injury
532127|NCT01297660|neurogenic detrusor overactivity|neurogenic detrusor overactivity
532128|NCT01297660|detrusor sphincter dyssynergia|detrusor sphincter dyssynergia
532129|NCT01297660|compliance|compliance
532130|NCT01297660|video urodynamic|video urodynamic
532131|NCT01297660|spinal cord injury|spinal cord injury
532132|NCT01297647|urinary tract infection|urinary tract infection
532133|NCT01297647|urodynamics|urodynamics
532134|NCT01297647|spinal cord injury|spinal cord injury
532135|NCT01297634|Botulinum toxin type A|botulinum toxin type a
532136|NCT01297634|Hyperfunctional forehead lines|hyperfunctional forehead lines
532137|NCT01297634|Randomized controlled trial|randomized controlled trial
532138|NCT01297634|Double-blinded trial|double-blinded trial
532139|NCT01297634|Electromyogram (EMG)|electromyogram (emg)
532140|NCT01297634|Electromyographic activity|electromyographic activity
532141|NCT01297634|Frontal Area|frontal area
532142|NCT01297621|breast hypertrophy|breast hypertrophy
532143|NCT01297621|physical activity|physical activity
532144|NCT01297621|sexuality|sexuality
532145|NCT01297621|patient satisfaction|patient satisfaction
532146|NCT01297595|relative bioavailability|relative bioavailability
532147|NCT01297595|pharmacokinetics|pharmacokinetics
532148|NCT01297595|crizotinib|crizotinib
532149|NCT01297595|oral liquid formulation|oral liquid formulation
532150|NCT01297595|formulated capsule|formulated capsule
532151|NCT01297582|ONO-6950|ono-6950
532152|NCT01297582|Healthy Adult Subjects|healthy adult subjects
532153|NCT01297569|Diabetic macular edema|diabetic macular edema
532154|NCT01297569|Macular edema|macular edema
532155|NCT01297569|DME|dme
532156|NCT01297569|Diabetic retinopathy|diabetic retinopathy
532157|NCT01297569|Diabetic eye disease|diabetic eye disease
532158|NCT01297569|anti-VEGF|anti-vegf
532159|NCT01297569|ranibizumab|ranibizumab
532160|NCT01297569|Lucentis|lucentis
532161|NCT01297556|Irritable Bowel Syndrome|irritable bowel syndrome
532162|NCT01297543|Induction chemotherapy|induction chemotherapy
532163|NCT01297543|Re-induction chemotherapy|re-induction chemotherapy
532164|NCT01297543|Consolidation chemotherapy|consolidation chemotherapy
532165|NCT01297543|Leukemia|leukemia
532166|NCT01297543|Myelodysplasia|myelodysplasia
532167|NCT01297530|Phase I|phase i
532168|NCT01297530|Dose Escalation|dose escalation
532169|NCT01297530|Hypoxia inducible factor 1 alpha|hypoxia inducible factor 1 alpha
532170|NCT01297530|Neoplasms|neoplasms
532171|NCT01297517|AOG|aog
532172|NCT01297517|OHT|oht
532173|NCT01297517|Open-Angle Glaucoma|open-angle glaucoma
532174|NCT01297517|Ocular Hypertension|ocular hypertension
532175|NCT01297504|palivizumab|palivizumab
532176|NCT01297504|lower respiratory tract infection|lower respiratory tract infection
532177|NCT01297504|Respiratory syncytial virus|respiratory syncytial virus
532178|NCT01297504|usage patterns|usage patterns
532179|NCT01297491|NSCLC|nsclc
532180|NCT01297491|PI3K|pi3k
532181|NCT01297465|Ovulation Induction|ovulation induction
532182|NCT01297465|Ovarian Stimulation|ovarian stimulation
532183|NCT01297465|Reproductive Technique, Assisted|reproductive technique, assisted
532184|NCT01297465|Assisted Reproductive Technics|assisted reproductive technics
532185|NCT01297465|Assisted Reproductive Technique|assisted reproductive technique
532186|NCT01297465|Reproductive Technology, Assisted|reproductive technology, assisted
532187|NCT01297452|BKM120|bkm120
532188|NCT01297452|CARBOPLATIN|carboplatin
532189|NCT01297452|TAXOL (PACLITAXEL)|taxol (paclitaxel)
532190|NCT01297452|Chemotherapy|chemotherapy
532191|NCT01297452|10-192|10-192
532600|NCT01295684|polyphenol|polyphenol
532192|NCT01297439|shoulder dystocia,|shoulder dystocia,
532193|NCT01297439|Mac Roberts' maneuver,|mac roberts' maneuver,
532194|NCT01297439|pushing maneuver|pushing maneuver
532195|NCT01297413|allogeneic|allogeneic
532196|NCT01297413|adult|adult
532197|NCT01297413|stem|stem
532198|NCT01297413|cells|cells
532199|NCT01297413|stroke|stroke
532200|NCT01297413|ischemic|ischemic
532201|NCT01297400|Burns, Partial Thickness Burns|burns, partial thickness burns
532202|NCT01297387|Diabetic Patients|diabetic patients
532203|NCT01297387|Critical Limb Ischemia|critical limb ischemia
532204|NCT01297387|Revascularization|revascularization
532205|NCT01297374|Obesity|obesity
532206|NCT01297348|Lybrel|lybrel
532207|NCT01297348|levonorgestrel|levonorgestrel
532208|NCT01297348|ethinyl estradiol|ethinyl estradiol
532209|NCT01297348|venus thromboembolism (VTE)|venus thromboembolism (vte)
532210|NCT01297348|oral contraceptives (OC)|oral contraceptives (oc)
532211|NCT01297348|safety|safety
532212|NCT01297348|database study|database study
532213|NCT01297348|case-control study|case-control study
532214|NCT01297335|intrathecal|intrathecal
532215|NCT01297335|clonidine|clonidine
532216|NCT01297335|poorly|poorly
532217|NCT01297335|controlled|controlled
532218|NCT01297335|hypertension|hypertension
532219|NCT01297322|vascular closure system|vascular closure system
532220|NCT01297322|manual compression|manual compression
532221|NCT01297322|femoral arteriotomy|femoral arteriotomy
532222|NCT01297322|percutaneous endovascular procedures|percutaneous endovascular procedures
532223|NCT01297309|PTH 1-84|pth 1-84
532224|NCT01297309|Hypoparathyroidism|hypoparathyroidism
532225|NCT01297309|Parathyroid Hormone 1-84|parathyroid hormone 1-84
532226|NCT01297309|NPSP558|npsp558
532227|NCT01297296|heart failure|heart failure
532228|NCT01297296|percutaneous|percutaneous
532229|NCT01297296|interventional cardiology|interventional cardiology
532230|NCT01297296|apical remodeling|apical remodeling
532231|NCT01297296|LV dilatation|lv dilatation
532232|NCT01297296|akinesis|akinesis
532233|NCT01297296|dyskinesis|dyskinesis
532234|NCT01297296|myocardial infarction|myocardial infarction
532235|NCT01297283|Heart failure|heart failure
532236|NCT01297283|Cardiac resynchronization|cardiac resynchronization
532237|NCT01297283|Leadless ECG|leadless ecg
532238|NCT01297283|Follow-up|follow-up
532239|NCT01297244|AV-951|av-951
532240|NCT01297244|Tivozanib|tivozanib
532241|NCT01297244|Advanced Renal Cell Carcinoma|advanced renal cell carcinoma
532242|NCT01297244|RCC|rcc
532243|NCT01297244|Biomarkers|biomarkers
532244|NCT01297231|fibroglandular tissue|fibroglandular tissue
532245|NCT01297231|tamoxifen|tamoxifen
532246|NCT01297231|MRI|mri
532247|NCT01297231|Background Parenchymal Enhancement|background parenchymal enhancement
532248|NCT01297231|10-217|10-217
532249|NCT01297218|Alzheimer, Mesenchymal Stem Cells, Umbilical Cord Blood|alzheimer, mesenchymal stem cells, umbilical cord blood
532250|NCT01297205|Human Umbilical Cord Blood Derived Mesenchymal Stem Cells|human umbilical cord blood derived mesenchymal stem cells
532251|NCT01297205|Bronchopulmonary dysplasia|bronchopulmonary dysplasia
532252|NCT01297205|Premature infants|premature infants
532253|NCT01297192|YM178|ym178
532254|NCT01297192|Mirabegron|mirabegron
532255|NCT01297192|DDI|ddi
532256|NCT01297192|Phase I|phase i
532257|NCT01297192|Solifenacin|solifenacin
532258|NCT01297192|Pharmacokinetics|pharmacokinetics
532259|NCT01297192|Pharmacokinetics of mirabegron|pharmacokinetics of mirabegron
532260|NCT01297179|Pharmacokinetics|pharmacokinetics
532261|NCT01297179|Oral contraceptives|oral contraceptives
532262|NCT01297179|Drug interactions|drug interactions
532263|NCT01297179|Pharmacokinetics of mirabegron|pharmacokinetics of mirabegron
532264|NCT01297153|Congenital Cataract|congenital cataract
532265|NCT01297153|Children younger than 2 years|children younger than 2 years
532266|NCT01297153|Aphakia|aphakia
532267|NCT01297153|Primary IOL Implantation|primary iol implantation
532268|NCT01297140|Psychiatry|psychiatry
532269|NCT01297140|Behaviour|behaviour
532270|NCT01297140|Alzheimer's|alzheimer's
532271|NCT01297140|Personality|personality
532272|NCT01297088|Proof of Mechanism|proof of mechanism
532273|NCT01297088|Phase I|phase i
532274|NCT01297088|Neoplasm|neoplasm
532275|NCT01297088|Inflammation|inflammation
532276|NCT01297075|Health Services Research|health services research
532277|NCT01297075|Chronic Care|chronic care
532278|NCT01297075|Outreach Visits|outreach visits
532279|NCT01297075|Primary care|primary care
532280|NCT01297075|chronic disease management|chronic disease management
532281|NCT01297062|Diabetes|diabetes
532282|NCT01297062|exenatide|exenatide
532283|NCT01297062|Amylin|amylin
532284|NCT01297062|Lilly|lilly
532285|NCT01297062|QT interval|qt interval
532286|NCT01297049|Diabetes|diabetes
532287|NCT01297049|obesity|obesity
532288|NCT01297049|behavior therapy|behavior therapy
532289|NCT01297049|self management|self management
532290|NCT01297036|Pharmacokinetics|pharmacokinetics
532291|NCT01297036|Bioequivalence|bioequivalence
532292|NCT01297036|Donepezil|donepezil
532293|NCT01297023|calcium phosphate|calcium phosphate
532294|NCT01297023|vitamin d3|vitamin d3
532295|NCT01297023|bone metabolism|bone metabolism
532296|NCT01297023|human study|human study
532297|NCT01297010|Nausea and Vomiting|nausea and vomiting
532298|NCT01297010|Vomiting|vomiting
532299|NCT01297010|Postoperative|postoperative
532300|NCT01297010|Anesthesia|anesthesia
532301|NCT01296997|calcium phosphate|calcium phosphate
532302|NCT01296997|incretins|incretins
532303|NCT01296997|human study|human study
532304|NCT01296984|Rectal cancer|rectal cancer
532306|NCT01296958|Taenia solium|taenia solium
532307|NCT01296958|cysticercosis|cysticercosis
532308|NCT01296958|neurocysticercosis|neurocysticercosis
532309|NCT01296919|Chronic rhinosinusitis|chronic rhinosinusitis
532310|NCT01296919|Histopathology|histopathology
532311|NCT01296919|Infundibulum|infundibulum
532312|NCT01296919|Lamina propria|lamina propria
532313|NCT01296919|Uncinate process|uncinate process
532314|NCT01296906|Reminder/recall messages|reminder/recall messages
532315|NCT01296906|reminders|reminders
532316|NCT01296906|recall|recall
532317|NCT01296906|immunizations|immunizations
532318|NCT01296906|immunization information systems|immunization information systems
532319|NCT01296906|effectiveness of reminder/recall|effectiveness of reminder/recall
532320|NCT01296906|population-based reminder/recall|population-based reminder/recall
532321|NCT01296867|Laser ablation algorithms|laser ablation algorithms
532322|NCT01296867|Excimer laser|excimer laser
532323|NCT01296867|Refractive correction|refractive correction
532324|NCT01296867|Corneal Asphericity Adjustment|corneal asphericity adjustment
532325|NCT01296854|spa therapy|spa therapy
532326|NCT01296841|telemedicine|telemedicine
532327|NCT01296841|remote consultation|remote consultation
532328|NCT01296841|telehealth|telehealth
532329|NCT01296841|ehealth|ehealth
532330|NCT01296841|image archiving|image archiving
532331|NCT01296841|inflammatory bowel disease|inflammatory bowel disease
532332|NCT01296815|Kaposi sarcoma|kaposi sarcoma
532333|NCT01296815|HIV|hiv
532334|NCT01296815|Bevacizumab|bevacizumab
532335|NCT01296802|Ecstasy|ecstasy
532336|NCT01296802|MDMA|mdma
532337|NCT01296802|Serotonin|serotonin
532338|NCT01296802|Neurotoxicity|neurotoxicity
532339|NCT01296802|dexfenfluramine|dexfenfluramine
532340|NCT01296802|Positron emission tomography|positron emission tomography
532341|NCT01296802|altanserin|altanserin
532342|NCT01296802|5-HT2A receptor|5-ht2a receptor
532343|NCT01296776|exercise|exercise
532344|NCT01296776|whole-body electromyostimulation|whole-body electromyostimulation
532345|NCT01296776|bone mineral density|bone mineral density
532346|NCT01296776|falls|falls
532347|NCT01296776|physical fitness|physical fitness
532348|NCT01296776|pain|pain
532349|NCT01296763|Irinotecan|irinotecan
532350|NCT01296763|Cisplatin|cisplatin
532351|NCT01296763|Carboplatin|carboplatin
532352|NCT01296763|Mitomycin-C|mitomycin-c
532353|NCT01296763|Olaparib|olaparib
532354|NCT01296763|AZD2281|azd2281
532355|NCT01296711|Rheumatoid arthritis|rheumatoid arthritis
532356|NCT01296711|CDP6038|cdp6038
532357|NCT01296711|Interleukin-6|interleukin-6
532358|NCT01296698|Smoking Cessation|smoking cessation
532359|NCT01296698|Tobacco Use Disorder|tobacco use disorder
532360|NCT01296685|cardiovascular surgical procedure|cardiovascular surgical procedure
532361|NCT01296672|Finasteride|finasteride
532362|NCT01296672|Placebo|placebo
532363|NCT01296672|Prostate cancer|prostate cancer
532364|NCT01296672|Prostate Specific Antigen (PSA)|prostate specific antigen (psa)
532365|NCT01296672|Men at intermediate risk of prostate cancer|men at intermediate risk of prostate cancer
532366|NCT01296672|Men scheduled for prostate biopsy|men scheduled for prostate biopsy
532367|NCT01296659|sarcoma|sarcoma
532368|NCT01296659|Ridaforolimus|ridaforolimus
532369|NCT01296659|soft tissue sarcoma|soft tissue sarcoma
532370|NCT01296659|unresectable sarcoma|unresectable sarcoma
532371|NCT01296646|Alcohol|alcohol
532372|NCT01296646|Alcoholics|alcoholics
532373|NCT01296646|Substance Abuse|substance abuse
532374|NCT01296646|Alcohol Abuse|alcohol abuse
532375|NCT01296646|Alcohol Addiction|alcohol addiction
532376|NCT01296633|health literacy|health literacy
532377|NCT01296633|patient education|patient education
532378|NCT01296633|medication adherence|medication adherence
532379|NCT01296633|patient/provider communication|patient/provider communication
532380|NCT01296633|Diabetes Mellitus|diabetes mellitus
532381|NCT01296607|Pharmacodynamics|pharmacodynamics
532382|NCT01296607|Pharmacokinetics|pharmacokinetics
532383|NCT01296607|Urocortin 2|urocortin 2
532384|NCT01296607|Urocortin 3|urocortin 3
532385|NCT01296607|Reproducibility|reproducibility
532386|NCT01296607|Onset/ Offset|onset/ offset
532387|NCT01296607|Forearm blood flow|forearm blood flow
532388|NCT01296607|Plethysmography|plethysmography
532389|NCT01296607|Heart Failure|heart failure
532390|NCT01296581|Cancer|cancer
532391|NCT01296581|Tumors|tumors
532392|NCT01296581|VEGFR|vegfr
532393|NCT01296581|PDGFR|pdgfr
532394|NCT01296568|metastatic solid tumors|metastatic solid tumors
532395|NCT01296568|Malignant/M-Neoplasm|malignant/m-neoplasm
532396|NCT01296568|Pancreas NOS|pancreas nos
532397|NCT01296568|Absorption|absorption
532398|NCT01296568|Distribution|distribution
532399|NCT01296568|Metabolism|metabolism
532400|NCT01296568|Excretion|excretion
532401|NCT01296568|Mass balance|mass balance
532402|NCT01296568|Metabolic profile|metabolic profile
532403|NCT01296568|Radiolabeled study|radiolabeled study
532404|NCT01296516|Women|women
532405|NCT01296516|Postpartum|postpartum
532407|NCT01296503|Multiple Myeloma|multiple myeloma
532408|NCT01296503|Treatment|treatment
532409|NCT01296503|Maintenance|maintenance
532410|NCT01296503|Thalidomide|thalidomide
532411|NCT01296490|oxidative stress, physical exercise, fitness level|oxidative stress, physical exercise, fitness level
532412|NCT01296477|Asthma|asthma
532413|NCT01296477|ASTHMA IQ tool|asthma iq tool
532414|NCT01296477|Asthma Control Test (ACT)|asthma control test (act)
532415|NCT01296477|EPR-3 Guidelines, Exacerbations|epr-3 guidelines, exacerbations
532416|NCT01296464|Parkinson's Disease|parkinson's disease
532417|NCT01296464|Motor response|motor response
532418|NCT01296464|Wearing-off|wearing-off
532419|NCT01296451|Hepatitis C|hepatitis c
532420|NCT01296451|vaccine|vaccine
532421|NCT01296451|Adenovirus|adenovirus
532423|NCT01296451|chronic infection|chronic infection
532424|NCT01296451|interferon|interferon
532425|NCT01296451|ribavirin|ribavirin
532426|NCT01296425|Growth disorders|growth disorders
532427|NCT01296425|Saizen|saizen
532428|NCT01296425|Easypod|easypod
532429|NCT01296425|Growth hormone|growth hormone
532430|NCT01296425|Pediatric subject|pediatric subject
532431|NCT01296399|in stent restenosis|in stent restenosis
532432|NCT01296399|bare metal stent|bare metal stent
532433|NCT01296399|drug eluting stent|drug eluting stent
532434|NCT01296399|de novo lesion|de novo lesion
532435|NCT01296373|HIV-1|hiv-1
532436|NCT01296373|immune|immune
532437|NCT01296373|restoration|restoration
532438|NCT01296373|observational|observational
532439|NCT01296360|immune response|immune response
532440|NCT01296360|IC51-325|ic51-325
532441|NCT01296360|Japanese Encephalitis|japanese encephalitis
532442|NCT01296360|Intercell AG|intercell ag
532443|NCT01296347|Ketamine|ketamine
532444|NCT01296347|Thoracotomy|thoracotomy
532445|NCT01296347|VATS|vats
532446|NCT01296347|Pain|pain
532447|NCT01296334|opioids|opioids
532448|NCT01296334|analgesia|analgesia
532449|NCT01296334|secondary hyperalgesia|secondary hyperalgesia
532450|NCT01296334|quantitative sensory testing|quantitative sensory testing
532451|NCT01296334|inflammatory injury|inflammatory injury
532452|NCT01296308|Diabetes Mellitus, Type 2|diabetes mellitus, type 2
532453|NCT01296308|Diabetic Neuropathy|diabetic neuropathy
532454|NCT01296308|Complementary Medicine|complementary medicine
532455|NCT01296308|Alternative Medicine|alternative medicine
532456|NCT01296308|Integrative Medicine|integrative medicine
532457|NCT01296308|Quality of Life|quality of life
532458|NCT01296308|Quantitative Sensory Testing|quantitative sensory testing
532459|NCT01296295|smoking cessation advice|smoking cessation advice
532460|NCT01296295|spirometry|spirometry
532461|NCT01296295|primary health care|primary health care
532462|NCT01296269|social cognition|social cognition
532463|NCT01296269|oxytocin|oxytocin
532464|NCT01296269|vasopressin|vasopressin
532465|NCT01296269|decision making|decision making
532466|NCT01296269|social decision making|social decision making
532467|NCT01296256|Bendamustine|bendamustine
532468|NCT01296256|Conditioning Therapy|conditioning therapy
532469|NCT01296256|Autologous Stem Cell Transplant|autologous stem cell transplant
532470|NCT01296256|Aggressive Non Hodgkin's Lymphoma|aggressive non hodgkin's lymphoma
532471|NCT01296243|Castration-resistant prostate cancer|castration-resistant prostate cancer
532472|NCT01296243|Tesetaxel|tesetaxel
532473|NCT01296243|Taxanes|taxanes
532474|NCT01296243|Chemotherapy-naive|chemotherapy-naive
532475|NCT01296243|Chemotherapy-exposed|chemotherapy-exposed
532476|NCT01296243|Progressive, metastatic castration-resistant prostate cancer|progressive, metastatic castration-resistant prostate cancer
710759|NCT00588081|Vaginal Reconstruction|vaginal reconstruction
532477|NCT01296217|Patients with infiltrant prostatic carcinoma|patients with infiltrant prostatic carcinoma
532478|NCT01296165|Travel|travel
532479|NCT01296165|Spread|spread
532480|NCT01296165|Antibiotic resistance|antibiotic resistance
532481|NCT01296139|Non-Cutaneous Malignancy|non-cutaneous malignancy
532482|NCT01296139|Prostatectomy|prostatectomy
532483|NCT01296139|Metastatic Prostate Cancer|metastatic prostate cancer
532484|NCT01296139|Imaging Study|imaging study
532485|NCT01296139|Magnetic Resonance Imaging|magnetic resonance imaging
532486|NCT01296139|Prostate Cancer|prostate cancer
532487|NCT01296126|Post Traumatic Stress Disorder (PTSD)|post traumatic stress disorder (ptsd)
532488|NCT01296126|MRI|mri
532489|NCT01296126|TBI|tbi
532490|NCT01296126|Traumatic Brain Injury|traumatic brain injury
532491|NCT01296126|Post Traumatic Stress Disorder|post traumatic stress disorder
532492|NCT01296126|PTSD|ptsd
532493|NCT01296100|impaired glucose tolerance|impaired glucose tolerance
532494|NCT01296100|nutrition|nutrition
532495|NCT01296100|physical activity|physical activity
532496|NCT01296087|Asthma|asthma
532497|NCT01296087|Mild to Moderate Asthma|mild to moderate asthma
532498|NCT01296074|monocyte|monocyte
532499|NCT01296074|cardiopulmonary bypass|cardiopulmonary bypass
532500|NCT01296074|cardiac surgery|cardiac surgery
532501|NCT01296061|Dialysis|dialysis
532502|NCT01296061|Renal Transplantation|renal transplantation
532503|NCT01296061|Failure of allograft|failure of allograft
532504|NCT01296048|weight|weight
532505|NCT01296048|body fat|body fat
532506|NCT01296048|total body water|total body water
532507|NCT01296048|bone mass|bone mass
532508|NCT01296048|muscle mass|muscle mass
532509|NCT01296035|recurrent ovarian cancer|recurrent ovarian cancer
532510|NCT01296035|platinum-refractory ovarian cancer|platinum-refractory ovarian cancer
532511|NCT01296022|Heart rhythm disturbances|heart rhythm disturbances
532512|NCT01296022|Implantable cardiac defibrillator|implantable cardiac defibrillator
532513|NCT01296009|embryonic implantation|embryonic implantation
532514|NCT01296009|endometrial receptivity|endometrial receptivity
532515|NCT01296009|traditional Chinese medicines|traditional chinese medicines
532516|NCT01296009|in vitro fertilization-embryo transfer|in vitro fertilization-embryo transfer
532517|NCT01296009|pregnant rate|pregnant rate
532518|NCT01295970|Surgery of the brain|surgery of the brain
532519|NCT01295970|Radiosurgery|radiosurgery
532520|NCT01295970|Brain Metastasis|brain metastasis
532521|NCT01295944|Chemotherapy|chemotherapy
532522|NCT01295944|Brain Tumor|brain tumor
532523|NCT01295944|Spinal Cord Tumor|spinal cord tumor
532524|NCT01295944|Malignancy|malignancy
532525|NCT01295944|Neurologic|neurologic
532526|NCT01295931|Near-infrared|near-infrared
532528|NCT01295931|Indocyanine green|indocyanine green
532529|NCT01295931|ICG|icg
532530|NCT01295931|Melanoma|melanoma
532531|NCT01295931|Fluorescent dyes|fluorescent dyes
532532|NCT01295931|Lymph nodes|lymph nodes
532533|NCT01295931|Experimental camera|experimental camera
532534|NCT01295918|probiotic|probiotic
532535|NCT01295918|AAD|aad
532536|NCT01295918|Lactobacillus reuteri|lactobacillus reuteri
532537|NCT01295918|diarrhea|diarrhea
532538|NCT01295892|menopause|menopause
532539|NCT01295892|obesity|obesity
532540|NCT01295892|capillary|capillary
532541|NCT01295892|microcirculation|microcirculation
532542|NCT01295892|estrogen|estrogen
532543|NCT01295892|Microvascular Function|microvascular function
532544|NCT01295879|Vitamin D insufficiency|vitamin d insufficiency
532545|NCT01295866|chronic nasal inflammation|chronic nasal inflammation
532546|NCT01295866|nasal nitric oxide|nasal nitric oxide
532547|NCT01295866|atopy|atopy
532548|NCT01295827|Melanoma|melanoma
532549|NCT01295827|Carcinoma|carcinoma
532550|NCT01295827|Cancer|cancer
532551|NCT01295827|Advanced cancer|advanced cancer
532552|NCT01295827|Metastatic cancer|metastatic cancer
532553|NCT01295827|Metastatic melanoma|metastatic melanoma
532554|NCT01295827|PD-1|pd-1
532555|NCT01295827|PD1|pd1
532556|NCT01295814|Interstitial cystitis|interstitial cystitis
532557|NCT01295814|Humira|humira
532558|NCT01295814|Adalimumab|adalimumab
532559|NCT01295801|Linezolid|linezolid
532560|NCT01295801|Vitamin B6|vitamin b6
532561|NCT01295801|Linezolid-associated cytopenias|linezolid-associated cytopenias
532562|NCT01295775|diabetic retinopathy|diabetic retinopathy
532563|NCT01295775|sulodexide|sulodexide
532564|NCT01295775|hard exudates|hard exudates
532565|NCT01295775|microaneurysms|microaneurysms
532566|NCT01295775|hemorrhages|hemorrhages
532567|NCT01295775|intraretinal microvascular abnormalities|intraretinal microvascular abnormalities
532568|NCT01295762|Children|children
532569|NCT01295762|Cancer|cancer
532570|NCT01295762|Immunomonitoring|immunomonitoring
532571|NCT01295762|Prognostic/Predictive Factors|prognostic/predictive factors
532572|NCT01295762|Immunotherapy|immunotherapy
532573|NCT01295749|cardiac arrest|cardiac arrest
532574|NCT01295749|No Flow|no flow
532575|NCT01295749|Emergency|emergency
532576|NCT01295749|Nurse|nurse
532577|NCT01295749|laryngeal Tube|laryngeal tube
532578|NCT01295736|scleroderma|scleroderma
676635|NCT00725127|Aspirin|aspirin
532579|NCT01295736|digital|digital
532580|NCT01295736|ulcer|ulcer
532581|NCT01295723|Breast cancer|breast cancer
532582|NCT01295723|Radiation therapy|radiation therapy
532583|NCT01295723|Mobetron|mobetron
532584|NCT01295723|IOERT|ioert
532585|NCT01295723|IORT|iort
532586|NCT01295723|Hypofractionated radiation therapy|hypofractionated radiation therapy
532587|NCT01295723|Partial breast radiation|partial breast radiation
532588|NCT01295710|adult acute myeloid leukemia|adult acute myeloid leukemia
532589|NCT01295710|adult acute lymphoid leukemia|adult acute lymphoid leukemia
532590|NCT01295710|adult myelodysplastic syndrome|adult myelodysplastic syndrome
532591|NCT01295710|allogenic stem cell transplantation|allogenic stem cell transplantation
532592|NCT01295710|unrelated donor|unrelated donor
532593|NCT01295710|GVHD|gvhd
532594|NCT01295710|US-ATG-F (Anti-human-T-lymphocyte Immune Globulin, Rabbit)|us-atg-f (anti-human-t-lymphocyte immune globulin, rabbit)
532595|NCT01295697|Patients with non-CNS or CNS tumors|patients with non-cns or cns tumors
532596|NCT01295697|Pediatric patients with Relapsed/Refractory Solid Tumors|pediatric patients with relapsed/refractory solid tumors
532597|NCT01295684|cranberry|cranberry
532598|NCT01295684|cardiovascular|cardiovascular
532599|NCT01295684|adhesion|adhesion
532601|NCT01295658|cancer|cancer
532602|NCT01295658|cancer survivorship|cancer survivorship
532603|NCT01295658|psychosocial needs|psychosocial needs
532604|NCT01295658|cancer experience|cancer experience
532605|NCT01295658|metastatic breast cancer|metastatic breast cancer
532606|NCT01295658|breast cancer|breast cancer
532607|NCT01295658|caregiver|caregiver
532608|NCT01295645|Stem Cell Transplant|stem cell transplant
532609|NCT01295645|Hemorrhagic Cystitis|hemorrhagic cystitis
532610|NCT01295645|Bladder inflammation|bladder inflammation
532611|NCT01295645|Frequent urination|frequent urination
532612|NCT01295645|Pain|pain
532613|NCT01295645|Polyomavirus hominis type I|polyomavirus hominis type i
532614|NCT01295645|BK virus|bk virus
532615|NCT01295645|BKV|bkv
532616|NCT01295645|Cidofovir|cidofovir
532617|NCT01295645|Vistide|vistide
532618|NCT01295632|Recurrent glioblastoma multiforme|recurrent glioblastoma multiforme
532619|NCT01295632|Hormone resistant prostate cancer|hormone resistant prostate cancer
532620|NCT01295632|Relapsed ovarian carcinoma|relapsed ovarian carcinoma
532621|NCT01295632|Refractory ovarian carcinoma|refractory ovarian carcinoma
532622|NCT01295632|Refractory breast cancer|refractory breast cancer
532623|NCT01295632|Relapsed breast cancer|relapsed breast cancer
532624|NCT01295619|Dura|dura
532625|NCT01295619|Sealant|sealant
532626|NCT01295619|Cranial|cranial
532627|NCT01295619|Craniotomy|craniotomy
532628|NCT01295619|CSF leakage|csf leakage
532629|NCT01295619|CSF leakage following cranial surgery|csf leakage following cranial surgery
532630|NCT01295606|cefazolin|cefazolin
532631|NCT01295606|prophylaxis|prophylaxis
532632|NCT01295606|pharmacokinetics|pharmacokinetics
532633|NCT01295606|newborn|newborn
532634|NCT01295593|CLL previously treated|cll previously treated
532635|NCT01295567|ischemia reperfusion injury|ischemia reperfusion injury
532636|NCT01295567|CABG|cabg
532637|NCT01295567|dipyridamole|dipyridamole
532638|NCT01295567|HS-troponin-I|hs-troponin-i
532639|NCT01295554|Peripheral arterial disease, MRA|peripheral arterial disease, mra
532640|NCT01295541|ICU LOS|icu los
532641|NCT01295541|Progressive Mobility|progressive mobility
532642|NCT01295541|Deconditioning|deconditioning
532643|NCT01295528|blood pressure|blood pressure
532644|NCT01295528|heart rate|heart rate
532645|NCT01295515|HIV|hiv
532646|NCT01295515|Replication|replication
532647|NCT01295515|Antiretroviral|antiretroviral
532648|NCT01295515|Interferon|interferon
532649|NCT01295515|Reservoirs|reservoirs
532650|NCT01295476|adult acute lymphoblastic leukemia in remission|adult acute lymphoblastic leukemia in remission
532651|NCT01295476|childhood acute lymphoblastic leukemia in remission|childhood acute lymphoblastic leukemia in remission
532652|NCT01295476|recurrent adult acute lymphoblastic leukemia|recurrent adult acute lymphoblastic leukemia
532653|NCT01295476|recurrent childhood acute lymphoblastic leukemia|recurrent childhood acute lymphoblastic leukemia
532654|NCT01295476|T-cell adult acute lymphoblastic leukemia|t-cell adult acute lymphoblastic leukemia
532655|NCT01295476|T-cell childhood acute lymphoblastic leukemia|t-cell childhood acute lymphoblastic leukemia
532656|NCT01295463|sexual dysfunction|sexual dysfunction
532657|NCT01295463|psychosocial effects of cancer and its treatment|psychosocial effects of cancer and its treatment
532658|NCT01295463|infertility|infertility
532659|NCT01295463|colon cancer|colon cancer
532660|NCT01295463|male breast cancer|male breast cancer
532661|NCT01295463|breast cancer|breast cancer
532662|NCT01295463|germ cell tumor|germ cell tumor
532663|NCT01295463|ovarian sarcoma|ovarian sarcoma
532664|NCT01295463|uterine sarcoma|uterine sarcoma
532665|NCT01295463|chronic lymphocytic leukemia|chronic lymphocytic leukemia
532666|NCT01295463|osteosarcoma|osteosarcoma
532667|NCT01295463|chronic myelogenous leukemia|chronic myelogenous leukemia
532668|NCT01295463|non-Hodgkin lymphoma|non-hodgkin lymphoma
532669|NCT01295463|adult acute myeloid leukemia with 11q23 (MLL) abnormalities|adult acute myeloid leukemia with 11q23 (mll) abnormalities
532670|NCT01295463|adult acute myeloid leukemia with inv(16)(p13;q22)|adult acute myeloid leukemia with inv(16)(p13;q22)
532671|NCT01295463|adult acute myeloid leukemia with t(15;17)(q22;q12)|adult acute myeloid leukemia with t(15;17)(q22;q12)
532672|NCT01295463|adult acute myeloid leukemia with t(16;16)(p13;q22)|adult acute myeloid leukemia with t(16;16)(p13;q22)
532673|NCT01295463|adult acute myeloid leukemia with t(8;21)(q22;q22)|adult acute myeloid leukemia with t(8;21)(q22;q22)
532674|NCT01295463|mast cell leukemia|mast cell leukemia
532675|NCT01295463|hairy cell leukemia|hairy cell leukemia
532676|NCT01295463|prolymphocytic leukemia|prolymphocytic leukemia
532677|NCT01295463|adult acute lymphoblastic leukemia|adult acute lymphoblastic leukemia
532678|NCT01295463|adult acute myeloid leukemia|adult acute myeloid leukemia
532679|NCT01295463|adult Hodgkin lymphoma|adult hodgkin lymphoma
532680|NCT01295463|adult T-cell leukemia/lymphoma|adult t-cell leukemia/lymphoma
532681|NCT01295463|small intestine lymphoma|small intestine lymphoma
532682|NCT01295463|anaplastic large cell lymphoma|anaplastic large cell lymphoma
532683|NCT01295463|angioimmunoblastic T-cell lymphoma|angioimmunoblastic t-cell lymphoma
532684|NCT01295463|mycosis fungoides/Sezary syndrome|mycosis fungoides/sezary syndrome
532685|NCT01295463|intraocular lymphoma|intraocular lymphoma
532686|NCT01295463|primary central nervous system non-Hodgkin lymphoma|primary central nervous system non-hodgkin lymphoma
532687|NCT01295463|primary central nervous system Hodgkin lymphoma|primary central nervous system hodgkin lymphoma
532688|NCT01295463|noncutaneous extranodal lymphoma|noncutaneous extranodal lymphoma
532689|NCT01295463|secondary acute myeloid leukemia|secondary acute myeloid leukemia
532690|NCT01295463|acute undifferentiated leukemia|acute undifferentiated leukemia
532691|NCT01295463|central nervous system leukemia|central nervous system leukemia
532692|NCT01295463|T-cell large granular lymphocyte leukemia|t-cell large granular lymphocyte leukemia
532693|NCT01295463|atypical chronic myeloid leukemia, BCR-ABL1 negative|atypical chronic myeloid leukemia, bcr-abl1 negative
532694|NCT01295463|clear cell sarcoma of the kidney|clear cell sarcoma of the kidney
532695|NCT01295463|Kaposi sarcoma|kaposi sarcoma
532696|NCT01295463|adult soft tissue sarcoma|adult soft tissue sarcoma
532697|NCT01295463|chronic myelomonocytic leukemia|chronic myelomonocytic leukemia
532698|NCT01295463|secondary central nervous system Hodgkin lymphoma|secondary central nervous system hodgkin lymphoma
532699|NCT01295463|cutaneous lymphoma|cutaneous lymphoma
532700|NCT01295463|adult non-Hodgkin lymphoma|adult non-hodgkin lymphoma
532701|NCT01295450|Phase III|phase iii
532702|NCT01295450|Apevinat BC|apevinat bc
532703|NCT01295450|Lack of appetite|lack of appetite
532704|NCT01295437|inguinal hernia, Lichtenstein hernioplasty, chronic pain|inguinal hernia, lichtenstein hernioplasty, chronic pain
532705|NCT01295424|Cardiac Arrest|cardiac arrest
532706|NCT01295424|Intensive Care Unit|intensive care unit
532707|NCT01295424|Emergency Medical Service|emergency medical service
532708|NCT01295385|type 2 diabetes|type 2 diabetes
532709|NCT01295385|Cardiovascular diseases|cardiovascular diseases
532710|NCT01295385|coronary syndrome have abnormalities of glucidic metabolism|coronary syndrome have abnormalities of glucidic metabolism
532711|NCT01295372|Schizophrenia|schizophrenia
532712|NCT01295372|Antipsychotic|antipsychotic
532713|NCT01295372|Risperidone|risperidone
532714|NCT01295372|Lu 31-130|lu 31-130
532715|NCT01295359|Chronic Obstructive Pulmonary Disease|chronic obstructive pulmonary disease
532716|NCT01295359|Walking|walking
532717|NCT01295359|Hospital|hospital
532718|NCT01295359|Exercise Tolerance|exercise tolerance
532719|NCT01295359|Physical Therapy|physical therapy
532720|NCT01295320|Herpes Zoster|herpes zoster
532721|NCT01295320|vaccine|vaccine
532722|NCT01295320|safety|safety
532723|NCT01295320|immunogenicity|immunogenicity
532724|NCT01295307|acute myeloid leukemia|acute myeloid leukemia
532725|NCT01295307|relapsed|relapsed
532726|NCT01295307|refractory|refractory
532727|NCT01295307|Relapsed or refractory AML|relapsed or refractory aml
532728|NCT01295294|Uterine Hemorrhage|uterine hemorrhage
532729|NCT01295294|Contraception|contraception
532730|NCT01295294|Contraceptive Methods|contraceptive methods
532731|NCT01295294|Intrauterine devices|intrauterine devices
532732|NCT01295294|Mirena|mirena
532733|NCT01295268|Vulvar pain|vulvar pain
532734|NCT01295268|Vulvodynia|vulvodynia
532735|NCT01295268|Vestibulodynia|vestibulodynia
532736|NCT01295268|Vulvar vestibulitis|vulvar vestibulitis
532737|NCT01295255|Allergic rhinitis|allergic rhinitis
532738|NCT01295255|Psychological status|psychological status
532739|NCT01295255|Asthma|asthma
532740|NCT01295255|Aeroallergen|aeroallergen
532742|NCT01295242|Cervical Cancer|cervical cancer
532743|NCT01295216|prehypertension|prehypertension
532744|NCT01295216|blood pressure|blood pressure
532745|NCT01295216|mobile technology|mobile technology
532746|NCT01295216|Latin America|latin america
532747|NCT01295216|behavioral change|behavioral change
532748|NCT01295216|healthy lifestyles|healthy lifestyles
532749|NCT01295216|mHealth|mhealth
532750|NCT01295177|wound healing|wound healing
532751|NCT01295177|diabetes mellitus|diabetes mellitus
532752|NCT01295164|keratoconus, wave-front sensing technology, aberrometer|keratoconus, wave-front sensing technology, aberrometer
532753|NCT01295138|Constipation|constipation
532754|NCT01295138|Caesarean section|caesarean section
532755|NCT01295138|Abdominal Pain|abdominal pain
532756|NCT01295138|Nausea|nausea
532757|NCT01295138|Vomiting|vomiting
532758|NCT01295125|Infected ventral hernia|infected ventral hernia
532759|NCT01295125|Contaminated incisional hernia|contaminated incisional hernia
532760|NCT01295099|scar formation|scar formation
532761|NCT01295099|5-FU|5-fu
532762|NCT01295099|genetic link|genetic link
532763|NCT01295099|psychological impact|psychological impact
532764|NCT01295099|social impact|social impact
532765|NCT01295086|Adenocarcinoma of the gastro-esophageal|adenocarcinoma of the gastro-esophageal
532766|NCT01295086|Her2|her2
532767|NCT01295086|Dose finding|dose finding
532768|NCT01295086|Taxotere (Docetaxel)|taxotere (docetaxel)
532769|NCT01295086|Eloxatin (Oxaliplatin)|eloxatin (oxaliplatin)
532770|NCT01295086|Xeloda (Capecitabine)|xeloda (capecitabine)
532771|NCT01295086|Herceptin (Trastuzumab)|herceptin (trastuzumab)
532772|NCT01295073|Trientine|trientine
532773|NCT01295073|Cataract surgery|cataract surgery
532774|NCT01295073|Macular Edema|macular edema
532775|NCT01295060|Acromegaly|acromegaly
532776|NCT01295060|Octreotide|octreotide
532777|NCT01295060|IGF-1|igf-1
532778|NCT01295060|Growth Hormone|growth hormone
532779|NCT01295060|Implant|implant
532780|NCT01295060|Hydrogel|hydrogel
532781|NCT01295047|Marfan Syndrome|marfan syndrome
532782|NCT01295047|Large arterial function|large arterial function
532783|NCT01295047|LV function|lv function
532784|NCT01295047|atenolol|atenolol
532785|NCT01295047|perindopril|perindopril
532786|NCT01295047|verapamil|verapamil
532787|NCT01295047|central arterial pressure|central arterial pressure
532788|NCT01295034|HIV|hiv
532789|NCT01295034|combination antiretroviral therapy|combination antiretroviral therapy
532790|NCT01295034|vitamin D|vitamin d
532791|NCT01295034|low bone density|low bone density
532792|NCT01295021|The prevalence of sympathetic overactivity in hypertensive patients.|the prevalence of sympathetic overactivity in hypertensive patients.
532793|NCT01295008|Fabry disease|fabry disease
532794|NCT01295008|Male pattern baldness|male pattern baldness
532795|NCT01295008|Alopecia|alopecia
532796|NCT01295008|GLA gene mutation|gla gene mutation
532797|NCT01295008|Alpha-galactosidase A|alpha-galactosidase a
532798|NCT01294995|short term consumption|short term consumption
532799|NCT01294995|Chinese liquor|chinese liquor
532800|NCT01294995|serum lipids|serum lipids
532801|NCT01294995|uric acid|uric acid
532802|NCT01294995|inflammation biomarkers|inflammation biomarkers
532803|NCT01294982|OAB|oab
532804|NCT01294982|Over Active Bladder|over active bladder
532805|NCT01294982|overactive bladder|overactive bladder
532806|NCT01294982|Urinary Urge Incontinence|urinary urge incontinence
532807|NCT01294982|Urinary Incontinence|urinary incontinence
532808|NCT01294969|Allergic conjunctivitis|allergic conjunctivitis
532809|NCT01294956|Dry eye|dry eye
532810|NCT01294956|artificial tears|artificial tears
532811|NCT01294956|corneal staining|corneal staining
532812|NCT01294943|Intensive Care Units|intensive care units
532813|NCT01294943|Biofilms|biofilms
532814|NCT01294943|Tongue|tongue
532815|NCT01294943|Infection|infection
532816|NCT01294943|Pneumonia/Aspiration|pneumonia/aspiration
532817|NCT01294930|hip fracture|hip fracture
532818|NCT01294930|mortality|mortality
532819|NCT01294930|complications|complications
532820|NCT01294904|Hormone|hormone
532821|NCT01294904|Sperm|sperm
532822|NCT01294904|Chronic kidney disease|chronic kidney disease
532823|NCT01294891|Rheology|rheology
532824|NCT01294891|Sickle cell|sickle cell
532825|NCT01294891|Paroxysmal nocturnal hemoglobinuria|paroxysmal nocturnal hemoglobinuria
532826|NCT01294891|contrast ultrasound|contrast ultrasound
532827|NCT01294878|anti-IgE treatment|anti-ige treatment
532828|NCT01294878|interstitial cystitis/bladder pain syndrome|interstitial cystitis/bladder pain syndrome
532829|NCT01294878|omalizumab|omalizumab
532830|NCT01294865|Sepsis|sepsis
532831|NCT01294865|late-onset|late-onset
532832|NCT01294865|suPAR|supar
532833|NCT01294852|prophylactic|prophylactic
532834|NCT01294852|surfactant|surfactant
532835|NCT01294852|premature|premature
532836|NCT01294852|mechanical ventilation|mechanical ventilation
532837|NCT01294852|mortality|mortality
532838|NCT01294852|morbidities|morbidities
532839|NCT01294839|sinus-node dysfunction|sinus-node dysfunction
532840|NCT01294839|RVOTs pacing|rvots pacing
532841|NCT01294839|RVA pacing|rva pacing
532842|NCT01294826|Colorectal Neoplasms|colorectal neoplasms
532843|NCT01294826|Intestinal Neoplasms|intestinal neoplasms
532844|NCT01294826|Gastrointestinal Neoplasms|gastrointestinal neoplasms
532845|NCT01294826|Digestive System Neoplasms|digestive system neoplasms
532846|NCT01294826|Neoplasms by Site|neoplasms by site
532847|NCT01294826|Neoplasms|neoplasms
532848|NCT01294826|Digestive System Diseases|digestive system diseases
532849|NCT01294826|Gastrointestinal Diseases|gastrointestinal diseases
532850|NCT01294826|Colonic Diseases|colonic diseases
532851|NCT01294826|Intestinal Diseases|intestinal diseases
532852|NCT01294826|Rectal Diseases|rectal diseases
532853|NCT01294826|Cetuximab|cetuximab
532854|NCT01294826|HSP90 Heat-Shock Proteins|hsp90 heat-shock proteins
532855|NCT01294826|EGFR protein, human|egfr protein, human
532856|NCT01294813|Electric Impedance Tomography (EIT)|electric impedance tomography (eit)
532857|NCT01294813|Ventilation|ventilation
532858|NCT01294813|Bronchoscopy|bronchoscopy
532859|NCT01294813|Lung Impedance|lung impedance
532860|NCT01294813|Recruitment|recruitment
532861|NCT01294800|Parkinson's disease|parkinson's disease
532862|NCT01294787|COPD|copd
532863|NCT01294787|QVA149|qva149
532864|NCT01294787|tiotropium|tiotropium
532865|NCT01294787|exercise|exercise
532866|NCT01294787|exercise tolerance|exercise tolerance
532867|NCT01294787|combination bronchodilator|combination bronchodilator
532868|NCT01294787|moderate to severe COPD|moderate to severe copd
532869|NCT01294774|Lupus erythematosus|lupus erythematosus
532870|NCT01294774|skin lupus|skin lupus
532871|NCT01294761|HIV-1|hiv-1
532872|NCT01294761|AIDS|aids
532873|NCT01294761|Clinical Trials, Randomized|clinical trials, randomized
532874|NCT01294748|Coronary Artery Disease|coronary artery disease
532875|NCT01294748|Drug-eluting Stent|drug-eluting stent
532876|NCT01294748|Sirolimus|sirolimus
532877|NCT01294735|Temozolomide|temozolomide
532878|NCT01294735|glioblastoma multiforme|glioblastoma multiforme
532879|NCT01294735|melanoma|melanoma
532880|NCT01294735|advanced neoplasm|advanced neoplasm
532881|NCT01294722|Rheumatoid Arthritis|rheumatoid arthritis
532882|NCT01294722|anti-TNF α|anti-tnf α
532883|NCT01294709|angina pectoris|angina pectoris
532884|NCT01294709|coronary artery disease|coronary artery disease
532885|NCT01294709|calcitonin gene-related peptide|calcitonin gene-related peptide
532886|NCT01294709|exercise tolerance,|exercise tolerance,
532887|NCT01294696|Osteoarthritis|osteoarthritis
532888|NCT01294696|Standard of care|standard of care
532889|NCT01294683|Low-density lipoprotein|low-density lipoprotein
532890|NCT01294683|LDL|ldl
532891|NCT01294683|High-density lipoprotein|high-density lipoprotein
532892|NCT01294683|HDL|hdl
532893|NCT01294683|Niacin|niacin
532894|NCT01294683|Lipid modifying therapy|lipid modifying therapy
532895|NCT01294683|Cholesterol|cholesterol
532896|NCT01294683|High cholesterol|high cholesterol
532897|NCT01294683|Triglycerides|triglycerides
532898|NCT01294683|Mixed Dyslipidemia|mixed dyslipidemia
532899|NCT01294670|ETOPOSIDE (VP-16)|etoposide (vp-16)
532900|NCT01294670|SAHA (SUBEROYLANILIDE HYDROXAMIC ACID) (Vorinostat)|saha (suberoylanilide hydroxamic acid) (vorinostat)
532901|NCT01294670|Pediatric|pediatric
532902|NCT01294670|10-096|10-096
532903|NCT01294670|POETIC|poetic
532904|NCT01294670|phase II component: the population will be restricted to relapsed/refractory sarcomas.|phase ii component: the population will be restricted to relapsed/refractory sarcomas.
532905|NCT01294657|Obesity|obesity
532906|NCT01294657|Cancer Risk|cancer risk
532907|NCT01294657|African Americans|african americans
532908|NCT01294657|Diet|diet
532909|NCT01294657|Physical Activity|physical activity
532910|NCT01294631|Canagliflozin|canagliflozin
532911|NCT01294631|JNJ-28431754|jnj-28431754
532912|NCT01294631|Hydrochlorothiazide|hydrochlorothiazide
532913|NCT01294631|Pharmacokinetic|pharmacokinetic
532914|NCT01294631|Pharmacodynamic|pharmacodynamic
532915|NCT01294618|Chronic Myelogenous Leukemia|chronic myelogenous leukemia
532916|NCT01294618|nilotinib|nilotinib
532917|NCT01294618|pegylated interferon|pegylated interferon
532918|NCT01294618|BCR-ABL Philadelphia chromosome|bcr-abl philadelphia chromosome
532919|NCT01294618|Hematologic, cytogenetic and molecular response rates and kinetics will be studied in addition to the safety of the combination|hematologic, cytogenetic and molecular response rates and kinetics will be studied in addition to the safety of the combination
532920|NCT01294605|DTPa|dtpa
532921|NCT01294605|Td|td
532922|NCT01294605|IPV|ipv
532923|NCT01294579|Non-Hodgkin's Lymphoma|non-hodgkin's lymphoma
532924|NCT01294579|Ofatumumab|ofatumumab
532925|NCT01294579|Relapsed|relapsed
532926|NCT01294579|Rituximab|rituximab
532927|NCT01294579|Bendamustine|bendamustine
532928|NCT01294566|safety|safety
532929|NCT01294566|motilin agonist|motilin agonist
532930|NCT01294566|single dose|single dose
532931|NCT01294566|ascending dose|ascending dose
532932|NCT01294566|GSK1322888|gsk1322888
532933|NCT01294566|migrating motor complex|migrating motor complex
532934|NCT01294566|tolerability|tolerability
532935|NCT01294566|FTIH|ftih
532936|NCT01294566|gastric emptying|gastric emptying
532937|NCT01294527|Cardiac Resynchronization Therapy|cardiac resynchronization therapy
532938|NCT01294527|cardiac pacing|cardiac pacing
532939|NCT01294527|electrical stimulation|electrical stimulation
532940|NCT01294527|bi-ventricular pacing|bi-ventricular pacing
532941|NCT01294514|Respiratory Rate|respiratory rate
532942|NCT01294501|Medication administration|medication administration
532943|NCT01294501|Medication errors|medication errors
532944|NCT01294501|Health Literacy|health literacy
532945|NCT01294501|Pediatric Emergency Department|pediatric emergency department
532946|NCT01294501|Web-based education|web-based education
532947|NCT01294488|PCIT|pcit
532948|NCT01294488|Child Maltreatment Prevention|child maltreatment prevention
532949|NCT01294488|Practitioner Fidelity|practitioner fidelity
677144|NCT00722982|hip|hip
532950|NCT01294462|acute coronary syndrome|acute coronary syndrome
532951|NCT01294462|coronary disease|coronary disease
532952|NCT01294462|coronary artery disease|coronary artery disease
532953|NCT01294436|Phase3|phase3
532954|NCT01294436|Clinical trial|clinical trial
532955|NCT01294436|Type 2 Diabetes Mellitus|type 2 diabetes mellitus
532956|NCT01294423|Phase3|phase3
532957|NCT01294423|Clinical trial|clinical trial
532958|NCT01294423|Type2 Diabetes Mellitus|type2 diabetes mellitus
532959|NCT01294397|Amgen|amgen
532960|NCT01294397|Phase 1|phase 1
532961|NCT01294397|Postmenopausal|postmenopausal
532962|NCT01294397|Osteopenia|osteopenia
532963|NCT01294397|Rheumatoid|rheumatoid
532964|NCT01294397|Bone Mineral Density|bone mineral density
532965|NCT01294397|Arthritis|arthritis
532966|NCT01294397|Pharmacokinetics|pharmacokinetics
532967|NCT01294397|Osteoporosis|osteoporosis
532968|NCT01294371|Lucrin Depot|lucrin depot
532969|NCT01294371|genital endometriosis|genital endometriosis
532970|NCT01294371|6 months therapy|6 months therapy
532971|NCT01294358|Pancreatic Cancer|pancreatic cancer
532972|NCT01294358|Regional Therapy|regional therapy
532973|NCT01294358|Selective Arterial Infusion|selective arterial infusion
532974|NCT01294358|Locally Advanced Disease|locally advanced disease
532975|NCT01294345|Genomics|genomics
532976|NCT01294345|Personalized|personalized
532977|NCT01294345|Congenital Malformations|congenital malformations
532978|NCT01294345|Birth Defects|birth defects
532979|NCT01294332|Cognition|cognition
532980|NCT01294332|TBI|tbi
532981|NCT01294332|Mood|mood
532982|NCT01294332|Aerobic Exercise Training|aerobic exercise training
532983|NCT01294332|Cardiorespiratory Fitness|cardiorespiratory fitness
532984|NCT01294332|Traumatic Brain Injury|traumatic brain injury
532985|NCT01294319|Cortical Resistance|cortical resistance
532986|NCT01294319|ACTH|acth
532987|NCT01294319|Glucocorticoid|glucocorticoid
532988|NCT01294319|Mifepristone|mifepristone
532989|NCT01294319|SPIRONOLACTONE|spironolactone
532990|NCT01294319|Exercise|exercise
532991|NCT01294319|Hypothalamic-Pituitary-Adrenal Axis|hypothalamic-pituitary-adrenal axis
532992|NCT01294319|Healthy Volunteer|healthy volunteer
532993|NCT01294319|HV|hv
532994|NCT01294280|Stage I Non-Small Cell Lung Cancer|stage i non-small cell lung cancer
532995|NCT01294280|Stage II Non-Small Cell Lung Cancer|stage ii non-small cell lung cancer
532996|NCT01294267|Ventricular Tachycardia|ventricular tachycardia
532997|NCT01294267|Radio Frequency Ablation|radio frequency ablation
532998|NCT01294267|Percutaneous Left Ventricular Assist Device|percutaneous left ventricular assist device
532999|NCT01294267|Hemodynamic Management|hemodynamic management
533000|NCT01294267|Interventional Cardiac Procedure|interventional cardiac procedure
533001|NCT01294267|Mechanical Cardiac Assistance|mechanical cardiac assistance
533002|NCT01294267|Intra-Aortic Balloon Pump|intra-aortic balloon pump
533003|NCT01294267|Coronary Intervention|coronary intervention
533004|NCT01294267|Impella 2.5|impella 2.5
533005|NCT01294267|Circulation Support system|circulation support system
533006|NCT01294254|wound reepithelialization|wound reepithelialization
533007|NCT01294241|Epidermolysis bullosa|epidermolysis bullosa
533008|NCT01294241|Wound healing|wound healing
533009|NCT01294241|Epithelialization|epithelialization
533010|NCT01294215|BAYA1040|baya1040
533011|NCT01294215|Nifedipine|nifedipine
533012|NCT01294215|Essential hypertension|essential hypertension
533013|NCT01294215|Japanese Patients|japanese patients
533014|NCT01294215|Phase III|phase iii
533015|NCT01294215|combination study|combination study
533016|NCT01294215|14024|14024
533017|NCT01294202|GIST|gist
533018|NCT01294202|Gastrointestinal Stromal Tumor|gastrointestinal stromal tumor
533019|NCT01294202|unresectable|unresectable
533020|NCT01294202|metastatic|metastatic
533021|NCT01294202|AT13387|at13387
533022|NCT01294202|Astex|astex
533023|NCT01294202|Gleevec|gleevec
533024|NCT01294202|Imatinib|imatinib
533025|NCT01294189|end-of-life decisions, critical care, advance directive|end-of-life decisions, critical care, advance directive
533026|NCT01294176|Optic Neuritis|optic neuritis
533027|NCT01294176|Lipoic Acid|lipoic acid
533028|NCT01294176|Multiple Sclerosis|multiple sclerosis
533029|NCT01294176|Antioxidant|antioxidant
533030|NCT01294176|OCT|oct
533031|NCT01294176|Acute|acute
533032|NCT01294163|Xenon|xenon
533033|NCT01294163|Sevoflurane|sevoflurane
533034|NCT01294163|Propofol|propofol
533035|NCT01294163|Total intravenous anaesthesia|total intravenous anaesthesia
533036|NCT01294163|Anaesthesia|anaesthesia
533037|NCT01294163|Coronary artery disease|coronary artery disease
533038|NCT01294163|Coronary artery bypass graft|coronary artery bypass graft
533039|NCT01294137|frail|frail
533040|NCT01294137|elderly|elderly
533041|NCT01294137|hospitalized|hospitalized
533042|NCT01294137|sleep apnea|sleep apnea
533043|NCT01294137|oximetry|oximetry
533044|NCT01294111|Fatigue|fatigue
533045|NCT01294111|Quality of life|quality of life
533046|NCT01294111|Elderly|elderly
533047|NCT01294098|Femoral Fractures|femoral fractures
533048|NCT01294098|Pediatrics|pediatrics
533049|NCT01294098|Pain, Postoperative|pain, postoperative
533050|NCT01294072|curcumin|curcumin
533051|NCT01294072|plant exosomes|plant exosomes
533052|NCT01294072|malignant colon tissue|malignant colon tissue
533053|NCT01294059|Fibromyalgia|fibromyalgia
533054|NCT01294059|Hyperalgesia|hyperalgesia
533055|NCT01294059|Pain|pain
533056|NCT01294059|Central Sensitization|central sensitization
533057|NCT01294046|Episodic migraine headache|episodic migraine headache
533058|NCT01294020|Transplant|transplant
533059|NCT01294020|Liver|liver
533060|NCT01294020|Tacrolimus|tacrolimus
533061|NCT01294020|Kidney|kidney
533062|NCT01294020|Heart|heart
533063|NCT01294020|Lung|lung
533064|NCT01294020|Immunosuppression|immunosuppression
533065|NCT01294020|Advagraf|advagraf
533066|NCT01294020|Pharmacokinetics|pharmacokinetics
533067|NCT01293994|Chronic Pain, Genetic Variation, Opioid Medications, Pain|chronic pain, genetic variation, opioid medications, pain
533068|NCT01293968|Aphthous Stomatitis|aphthous stomatitis
533069|NCT01293968|Ibuprofen|ibuprofen
533070|NCT01293968|treatment efficacy|treatment efficacy
533071|NCT01293955|cartilage|cartilage
533072|NCT01293955|knee osteoarthritis|knee osteoarthritis
533073|NCT01293955|protective effect|protective effect
533074|NCT01293942|unresectable liver-only metastases in colorectal cancer|unresectable liver-only metastases in colorectal cancer
533075|NCT01293916|pediatric|pediatric
533076|NCT01293916|femur|femur
533077|NCT01293916|femoral|femoral
533078|NCT01293916|fracture|fracture
533079|NCT01293916|spica|spica
533080|NCT01293916|cast|cast
533081|NCT01293916|diaphyseal|diaphyseal
533082|NCT01293916|single|single
533083|NCT01293916|double|double
533084|NCT01293916|patient age 2 to 6 years old|patient age 2 to 6 years old
533085|NCT01293903|Immunomodulation|immunomodulation
533086|NCT01293890|adherence|adherence
533087|NCT01293890|medication|medication
533088|NCT01293890|exacerbations|exacerbations
533089|NCT01293890|hospital admission|hospital admission
533090|NCT01293877|Laparoscopy|laparoscopy
533091|NCT01293877|obesity|obesity
533092|NCT01293877|gastric|gastric
533093|NCT01293877|restrictive|restrictive
533094|NCT01293864|structural analysis, diffusible proteins, glycosaminoglycans|structural analysis, diffusible proteins, glycosaminoglycans
533095|NCT01293851|Biomarkers|biomarkers
533096|NCT01293851|Gene Expression|gene expression
533097|NCT01293851|Neuropathic Pain|neuropathic pain
533098|NCT01293851|Neurotoxicity|neurotoxicity
533099|NCT01293851|Chemotherapy|chemotherapy
533100|NCT01293851|Peripheral Neuropathic Pain|peripheral neuropathic pain
533101|NCT01293851|Cancer|cancer
533102|NCT01293838|Adolescents|adolescents
533103|NCT01293838|Anxiety Disorder|anxiety disorder
533104|NCT01293838|Cipralex|cipralex
533105|NCT01293838|Social Phobia|social phobia
533106|NCT01293838|Separation Anxiety Disorder|separation anxiety disorder
533107|NCT01293838|Panic Disorder|panic disorder
533108|NCT01293838|Generalized Anxiety Disorder|generalized anxiety disorder
533109|NCT01293838|physiological arousal|physiological arousal
533110|NCT01293838|stress response|stress response
533111|NCT01293838|salivary cortisol|salivary cortisol
533112|NCT01293838|salivary alpha-amylase|salivary alpha-amylase
533113|NCT01293838|heart rate variability|heart rate variability
533114|NCT01293799|Randomized|randomized
533115|NCT01293799|Peritoneal dialysis|peritoneal dialysis
533116|NCT01293799|Peritonitis|peritonitis
533117|NCT01293799|Primary prevention|primary prevention
533118|NCT01293799|Quality control|quality control
533119|NCT01293799|Self care|self care
533120|NCT01293799|Kidney failure, chronic|kidney failure, chronic
533121|NCT01293786|magnesium|magnesium
533122|NCT01293786|kidney transplantation|kidney transplantation
533123|NCT01293786|hypomagnesemia|hypomagnesemia
533124|NCT01293773|Randomized controlled trial|randomized controlled trial
533125|NCT01293773|Drug-eluting Stent|drug-eluting stent
533126|NCT01293773|Multicenter study|multicenter study
533127|NCT01293760|intrauterine device|intrauterine device
533128|NCT01293760|contraception|contraception
533129|NCT01293747|Estrogen|estrogen
533130|NCT01293747|Progesterone|progesterone
533131|NCT01293747|Microspheres|microspheres
533132|NCT01293747|Menopause|menopause
533133|NCT01293747|Pharmacokinetics|pharmacokinetics
533134|NCT01293734|bronchial asthma|bronchial asthma
533135|NCT01293734|cold type|cold type
533136|NCT01293734|heat type|heat type
533137|NCT01293734|Asthenia type|asthenia type
533138|NCT01293734|TCM syndrome|tcm syndrome
533139|NCT01293734|symptoms|symptoms
533140|NCT01293734|physical signs|physical signs
533141|NCT01293721|Bone Mineral Density|bone mineral density
533142|NCT01293721|Vibration|vibration
533143|NCT01293721|Rehabilitation|rehabilitation
533144|NCT01293721|Fracture healing rate|fracture healing rate
533145|NCT01293708|Octogenarians|octogenarians
533146|NCT01293708|HRQOL|hrqol
533147|NCT01293708|mortality|mortality
533148|NCT01293708|prospective observational|prospective observational
533149|NCT01293708|Elderly|elderly
533150|NCT01293695|hot flashes|hot flashes
533151|NCT01293695|post menopausal women|post menopausal women
533152|NCT01293695|skin conductance monitors|skin conductance monitors
533153|NCT01293695|hypnosis|hypnosis
533154|NCT01293695|hypnotizability|hypnotizability
533155|NCT01293669|Type 2 Diabetes|type 2 diabetes
533156|NCT01293669|Type 2 Diabetes Mellitus|type 2 diabetes mellitus
533157|NCT01293604|Barley|barley
533158|NCT01293604|Oats|oats
533159|NCT01293604|Whole grains|whole grains
533160|NCT01293604|Cardiovascular disease|cardiovascular disease
533161|NCT01293604|adults not taking lipid-lowering or glucoregulatory medications.|adults not taking lipid-lowering or glucoregulatory medications.
533162|NCT01293591|Garlic|garlic
533163|NCT01293591|Cancer biomarkers|cancer biomarkers
533164|NCT01293591|Gene expression|gene expression
533165|NCT01293591|Oxidative stress|oxidative stress
533166|NCT01293591|DNA damage|dna damage
533167|NCT01293578|Decision Aids|decision aids
533168|NCT01293578|Shared Medical Decision Making|shared medical decision making
533169|NCT01293578|Patient Education|patient education
533170|NCT01293578|Endocrine System Diseases|endocrine system diseases
533171|NCT01293578|Glucose Metabolism Disorders|glucose metabolism disorders
533172|NCT01293578|Metabolic Diseases|metabolic diseases
533173|NCT01293565|X-Linked Hypohidrotic Ectodermal Dysplasia|x-linked hypohidrotic ectodermal dysplasia
533174|NCT01293565|Hypohidrotic Ectodermal Dysplasia|hypohidrotic ectodermal dysplasia
533175|NCT01293565|XLHED|xlhed
533176|NCT01293565|HED|hed
533177|NCT01293539|Retinoblastoma|retinoblastoma
533178|NCT01293539|intra-arterial chemotherapy|intra-arterial chemotherapy
533179|NCT01293539|angiography|angiography
533180|NCT01293526|Heart failure|heart failure
533181|NCT01293526|echocardiography|echocardiography
533282|NCT01293058|opioid|opioid
533283|NCT01293058|overdose|overdose
533182|NCT01293513|Only patients with Acute or Primary HIV infection will be studied|only patients with acute or primary hiv infection will be studied
533183|NCT01293500|SIRS|sirs
533184|NCT01293500|shock|shock
533185|NCT01293500|sepsis|sepsis
533186|NCT01293500|pediatric|pediatric
533187|NCT01293500|inter-facility transport|inter-facility transport
533188|NCT01293500|specialized transport|specialized transport
533189|NCT01293500|NIRS monitoring|nirs monitoring
533190|NCT01293487|Phase 1|phase 1
533191|NCT01293487|Osteopenia|osteopenia
533192|NCT01293487|RN564|rn564
533193|NCT01293448|Esophagectomy|esophagectomy
533194|NCT01293448|Barrett's Esophagus|barrett's esophagus
533195|NCT01293435|Community Acquired Pneumonia (CAP)|community acquired pneumonia (cap)
533196|NCT01293435|Complicated Skin and Skin Structures Infections (cSSSI)|complicated skin and skin structures infections (csssi)
533197|NCT01293435|Complicated Skin and Soft Tissues Infections (cSSTI)|complicated skin and soft tissues infections (cssti)
533198|NCT01293435|Antibiotics|antibiotics
533199|NCT01293435|Infection management|infection management
533200|NCT01293435|Use of Resources|use of resources
533201|NCT01293435|MRSA|mrsa
533202|NCT01293435|PRSP|prsp
533203|NCT01293422|PXR, glucose, cholesterol|pxr, glucose, cholesterol
533204|NCT01293396|insulin aspart 30|insulin aspart 30
533205|NCT01293396|insulin aspart 70|insulin aspart 70
533206|NCT01293396|insulin aspart|insulin aspart
533207|NCT01293396|postprandial glucose and lipid metabolism|postprandial glucose and lipid metabolism
533208|NCT01293396|consecutive mixed meals|consecutive mixed meals
533209|NCT01293344|Cardiovascular diseases|cardiovascular diseases
533210|NCT01293344|Controlled nutritional intervention|controlled nutritional intervention
533211|NCT01293344|Sex differences|sex differences
533212|NCT01293344|Women|women
533213|NCT01293344|Men|men
533214|NCT01293344|Cardiovascular risk|cardiovascular risk
533215|NCT01293344|Lipid profile|lipid profile
533216|NCT01293344|Blood pressure|blood pressure
533217|NCT01293344|Insulin sensitivity|insulin sensitivity
533218|NCT01293344|Inflammatory markers|inflammatory markers
533219|NCT01293344|Endothelial function|endothelial function
533220|NCT01293344|Oxidative stress|oxidative stress
533221|NCT01293331|Dengue Fever Fever Seroprevalence|dengue fever fever seroprevalence
533222|NCT01293318|Copeptin|copeptin
533223|NCT01293318|Vasopressin|vasopressin
533224|NCT01293318|antidiuretic hormone (ADH)|antidiuretic hormone (adh)
533225|NCT01293305|osteoarthritis|osteoarthritis
533226|NCT01293292|Osteoporosis|osteoporosis
533227|NCT01293292|Forsteo|forsteo
533228|NCT01293292|Teriparatide|teriparatide
533229|NCT01293279|HCV viral genotypes|hcv viral genotypes
533230|NCT01293279|host genotypes|host genotypes
533231|NCT01293279|IL28B|il28b
533232|NCT01293279|ITPA|itpa
533233|NCT01293279|RNA|rna
533234|NCT01293279|China|china
533235|NCT01293266|Propofol|propofol
533236|NCT01293266|Metabolic Acidosis|metabolic acidosis
533237|NCT01293266|Pediatric Cardiology|pediatric cardiology
533238|NCT01293266|Anesthesia|anesthesia
533239|NCT01293227|Wrist Fracture|wrist fracture
533240|NCT01293214|limb transplantation|limb transplantation
533241|NCT01293214|limb allotransplantation|limb allotransplantation
533242|NCT01293214|hand transplantation|hand transplantation
533243|NCT01293214|hand allotransplantation|hand allotransplantation
533244|NCT01293214|hand amputation|hand amputation
533245|NCT01293214|leg transplantation|leg transplantation
533247|NCT01293201|Seasonal Allergic Rhinitis|seasonal allergic rhinitis
533248|NCT01293188|Aortic Valve Replacement|aortic valve replacement
533249|NCT01293188|Bioprosthetic|bioprosthetic
533250|NCT01293175|whole grains|whole grains
533251|NCT01293175|polyphenols|polyphenols
533252|NCT01293175|overweight|overweight
533253|NCT01293175|bioavailability|bioavailability
533254|NCT01293175|antioxidant status|antioxidant status
533255|NCT01293175|inflammation|inflammation
533256|NCT01293162|Metabolic syndrome|metabolic syndrome
533257|NCT01293162|Cardiovascular risk|cardiovascular risk
533258|NCT01293149|knee, reconstructive surgery|knee, reconstructive surgery
533259|NCT01293149|femoral nerve block|femoral nerve block
533260|NCT01293136|knee|knee
533261|NCT01293136|reconstructive surgery|reconstructive surgery
533262|NCT01293136|femoral nerve block|femoral nerve block
533263|NCT01293123|HIV|hiv
533264|NCT01293123|raltegravir|raltegravir
533265|NCT01293123|cerebrospinal fluid|cerebrospinal fluid
533266|NCT01293110|urodynamics|urodynamics
533267|NCT01293110|neurogenic lower urinary tract dysfunction|neurogenic lower urinary tract dysfunction
533268|NCT01293110|neurological disease/injury|neurological disease/injury
533269|NCT01293084|mucociliary clearance|mucociliary clearance
533270|NCT01293084|children|children
533271|NCT01293084|cystic fibrosis|cystic fibrosis
533272|NCT01293084|hypertonic saline|hypertonic saline
533273|NCT01293071|Antibiotic rotation|antibiotic rotation
533274|NCT01293071|Cycling|cycling
533275|NCT01293071|Mixing|mixing
533276|NCT01293071|Gram-negative|gram-negative
533277|NCT01293071|EU|eu
533278|NCT01293071|Multi center|multi center
533279|NCT01293071|Multi Centre|multi centre
533280|NCT01293071|Cluster randomized trial|cluster randomized trial
533281|NCT01293071|Cross over|cross over
533284|NCT01293058|naloxone|naloxone
533285|NCT01293058|intranasal|intranasal
533286|NCT01293045|Osteoporosis|osteoporosis
533287|NCT01293045|Postmenopausal women|postmenopausal women
533288|NCT01293045|Functional food|functional food
533289|NCT01293045|Hydrolysed collagen|hydrolysed collagen
533290|NCT01293045|Bone metabolism|bone metabolism
533291|NCT01293045|Bone marker of resorption|bone marker of resorption
533292|NCT01293045|Bone marker of formation|bone marker of formation
533293|NCT01293032|Estrogen Receptor Positive|estrogen receptor positive
533294|NCT01293032|Progesterone Receptor Positive|progesterone receptor positive
533295|NCT01293032|HER2/Neu Negative|her2/neu negative
533296|NCT01293032|Breast Cancer|breast cancer
533297|NCT01293019|Complementary and alternative medicine|complementary and alternative medicine
533298|NCT01293019|Osteopathic treatment|osteopathic treatment
533299|NCT01293006|Pulmonary Disease, Chronic Obstructive|pulmonary disease, chronic obstructive
533300|NCT01292980|sDTI|sdti
533301|NCT01292980|Pressure ulcers|pressure ulcers
533302|NCT01292980|Therapy surfaces|therapy surfaces
533303|NCT01292980|Mattresses|mattresses
533304|NCT01292980|Deep Tissue Injury|deep tissue injury
533305|NCT01292980|pressure ulcer treatment|pressure ulcer treatment
533306|NCT01292967|Flavanol|flavanol
533307|NCT01292967|cocoa|cocoa
533308|NCT01292967|maltitol|maltitol
533309|NCT01292967|absorption|absorption
533310|NCT01292967|metabolism|metabolism
533311|NCT01292967|chocolate|chocolate
533312|NCT01292967|food matrix|food matrix
533313|NCT01292967|bioavailability|bioavailability
533314|NCT01292954|blueberries|blueberries
533315|NCT01292954|vascular function|vascular function
533316|NCT01292954|FMD|fmd
533317|NCT01292954|Blood pressure|blood pressure
533318|NCT01292954|Laser Doppler|laser doppler
533319|NCT01292954|pharmacokinetics|pharmacokinetics
533320|NCT01292954|absorption|absorption
533321|NCT01292954|metabolism|metabolism
533322|NCT01292954|polyphenols|polyphenols
533323|NCT01292954|flavonoids|flavonoids
533324|NCT01292928|Atherosclerosis, Superficial Femoral Artery (SFA), Proximal Popliteal Artery (PPA), lower extremities, Stenting|atherosclerosis, superficial femoral artery (sfa), proximal popliteal artery (ppa), lower extremities, stenting
533325|NCT01292915|Re-bleeding, NVUGIB|re-bleeding, nvugib
533326|NCT01292889|Seasonal Affective Disorder|seasonal affective disorder
533327|NCT01292889|Major Depressive Disorder|major depressive disorder
533328|NCT01292889|Depression|depression
533329|NCT01292889|Winter Blues|winter blues
533330|NCT01292876|MTURR|mturr
533331|NCT01292876|ECM|ecm
533332|NCT01292876|Muscle Loss|muscle loss
533333|NCT01292876|Tendon|tendon
533334|NCT01292876|Tendon Repair|tendon repair
533335|NCT01292876|Muscle Repair|muscle repair
533336|NCT01292876|Soft Tissue Repair|soft tissue repair
533337|NCT01292876|Scaffold|scaffold
533338|NCT01292876|Extracellular Matrix|extracellular matrix
533339|NCT01292863|Peritoneal dialysis|peritoneal dialysis
533340|NCT01292863|Biocompatible dialysis fluid|biocompatible dialysis fluid
533341|NCT01292850|Topical|topical
533342|NCT01292850|Skin|skin
533343|NCT01292850|sterility|sterility
533344|NCT01292850|ethylchloride|ethylchloride
533345|NCT01292850|ethyl|ethyl
533346|NCT01292850|chloride|chloride
533347|NCT01292850|spray|spray
533348|NCT01292837|Levetiracetam|levetiracetam
533349|NCT01292837|Epilepsy|epilepsy
533350|NCT01292837|Generalized tonic-clonic seizures|generalized tonic-clonic seizures
533351|NCT01292824|Hepatitis C virus|hepatitis c virus
533352|NCT01292824|Entry|entry
533353|NCT01292824|Scavenger receptor-BI|scavenger receptor-bi
533354|NCT01292824|High density lipoprotein|high density lipoprotein
533355|NCT01292824|Liver transplantation|liver transplantation
533356|NCT01292811|Spinal Cord Injury|spinal cord injury
533357|NCT01292811|Functional Electrical Stimulation|functional electrical stimulation
533358|NCT01292811|Hand function|hand function
533359|NCT01292811|Tetraplegia|tetraplegia
533360|NCT01292798|Diabetes|diabetes
533361|NCT01292798|Macula|macula
533362|NCT01292798|Edema|edema
533363|NCT01292798|Retina|retina
533364|NCT01292772|breast cancer|breast cancer
533365|NCT01292772|bilateral mastectomy|bilateral mastectomy
533366|NCT01292772|immediate breast reconstruction|immediate breast reconstruction
533367|NCT01292772|locally advanced unilateral breast cancer|locally advanced unilateral breast cancer
533368|NCT01292772|bilateral mastectomy for prophylaxis|bilateral mastectomy for prophylaxis
533369|NCT01292759|stroke volume|stroke volume
533370|NCT01292759|cardiac output|cardiac output
533371|NCT01292759|validation|validation
533372|NCT01292733|Women with increased risk for developing ovarian cancer|women with increased risk for developing ovarian cancer
533373|NCT01292733|Women diagnosed with reproductive cancer|women diagnosed with reproductive cancer
533374|NCT01292733|Women with relatives who have had ovarian or breast cancer|women with relatives who have had ovarian or breast cancer
533375|NCT01292720|vitamin D deficiency, vitamin D insufficiency, heart failure|vitamin d deficiency, vitamin d insufficiency, heart failure
533376|NCT01292707|malaria|malaria
533377|NCT01292707|rdt|rdt
533378|NCT01292707|fever|fever
533379|NCT01292707|treatment|treatment
533380|NCT01292694|supine hypertension|supine hypertension
533381|NCT01292694|autonomic failure|autonomic failure
533382|NCT01292694|angiotensin|angiotensin
533383|NCT01292694|losartan|losartan
533384|NCT01292694|captopril|captopril
533385|NCT01292681|colorectal cancer|colorectal cancer
533386|NCT01292681|FDG-PET-CT|fdg-pet-ct
533387|NCT01292681|MRS,|mrs,
533388|NCT01292681|DCE-MRI|dce-mri
533389|NCT01292681|DWI|dwi
533390|NCT01292681|colorectal cancer with histologically proven distant metastases|colorectal cancer with histologically proven distant metastases
533391|NCT01292642|cognitive behavioral therapy|cognitive behavioral therapy
533392|NCT01292642|nicotine dependence|nicotine dependence
533393|NCT01292642|cannabis dependence|cannabis dependence
533394|NCT01292642|smoking cessation|smoking cessation
533395|NCT01292642|nicotine replacement therapy|nicotine replacement therapy
533396|NCT01292629|intraocular lens|intraocular lens
533397|NCT01292629|IOL|iol
533398|NCT01292629|cataract|cataract
533399|NCT01292629|Hoya|hoya
533400|NCT01292629|surgical|surgical
533401|NCT01292629|optics|optics
533402|NCT01292629|ocular|ocular
533403|NCT01292629|visual acuity|visual acuity
533404|NCT01292577|Schizophrenia|schizophrenia
533405|NCT01292577|Schizoaffective Disorder|schizoaffective disorder
533406|NCT01292577|Cannabis|cannabis
533407|NCT01292577|Alcohol|alcohol
533408|NCT01292577|Substance Misuse|substance misuse
533409|NCT01292577|Cognition|cognition
533410|NCT01292577|Psychosocial Treatment|psychosocial treatment
533411|NCT01292577|Cognitive Enhancement Therapy|cognitive enhancement therapy
533412|NCT01292577|Personal Therapy|personal therapy
533413|NCT01292577|Treatment as Usual|treatment as usual
533414|NCT01292551|single ventricle physiology|single ventricle physiology
533415|NCT01292551|Fontan procedure|fontan procedure
533416|NCT01292525|Withdrawal of Tacrolimus and renal graft|withdrawal of tacrolimus and renal graft
533417|NCT01292525|renal allograft|renal allograft
533418|NCT01292525|stable renal function|stable renal function
533419|NCT01292512|Bereavement management|bereavement management
533420|NCT01292512|Complicated grief|complicated grief
533421|NCT01292499|psychotherapy|psychotherapy
533422|NCT01292499|psychoeducation|psychoeducation
533423|NCT01292499|depression|depression
533424|NCT01292447|Pain measurement|pain measurement
533425|NCT01292447|Intrauterine devices|intrauterine devices
533426|NCT01292447|Lidocaine|lidocaine
533427|NCT01292434|Diet|diet
533428|NCT01292434|Obesity|obesity
533429|NCT01292434|Child Preschool|child preschool
533430|NCT01292434|Treatment Outcome|treatment outcome
533431|NCT01292434|Body Mass Index|body mass index
533432|NCT01292434|Intervention Studies|intervention studies
533433|NCT01292434|Randomized Controlled Trial|randomized controlled trial
533434|NCT01292434|Child Day Care Centers|child day care centers
533435|NCT01292434|Schools Nursery|schools nursery
533436|NCT01292434|Child Care|child care
533437|NCT01292408|autophagy|autophagy
533438|NCT01292408|hydroxychloroquine|hydroxychloroquine
533439|NCT01292408|hypoxia|hypoxia
533440|NCT01292408|proven invasive adenocarcinoma of the breast: tumors are found to be ER negative (<10% ER pos cells)|proven invasive adenocarcinoma of the breast: tumors are found to be er negative (<10% er pos cells)
533441|NCT01292395|dietary supplement|dietary supplement
533442|NCT01292395|protein metabolism|protein metabolism
533443|NCT01292395|bone turnover|bone turnover
533444|NCT01292382|Elderly|elderly
533445|NCT01292382|Memory|memory
533446|NCT01292382|Cognition|cognition
533447|NCT01292382|Repetitive transcranial magnetic stimulation|repetitive transcranial magnetic stimulation
533448|NCT01292369|breath test|breath test
533449|NCT01292369|colon cancer|colon cancer
533450|NCT01292369|breast cancer|breast cancer
533451|NCT01292343|third molars|third molars
533452|NCT01292343|triclosan|triclosan
533453|NCT01292343|toothpaste|toothpaste
533454|NCT01292343|dry socket|dry socket
533455|NCT01292343|wound infection|wound infection
533456|NCT01292330|liver Tumor|liver tumor
533457|NCT01292317|NGAL|ngal
533458|NCT01292317|neutrophil gelatinase-associated Lipocalin|neutrophil gelatinase-associated lipocalin
533459|NCT01292317|contrast media nephropathy|contrast media nephropathy
533460|NCT01292317|CIN|cin
533461|NCT01292317|volume expansion|volume expansion
533462|NCT01292317|acute kidney injury|acute kidney injury
533463|NCT01292317|contrast media|contrast media
533464|NCT01292304|Cirrhotic|cirrhotic
533465|NCT01292304|Tolvaptan|tolvaptan
533466|NCT01292304|v2 receptor antagonist|v2 receptor antagonist
533467|NCT01292291|stage I prostate cancer|stage i prostate cancer
533468|NCT01292291|stage IIA prostate cancer|stage iia prostate cancer
533469|NCT01292291|stage IIB prostate cancer|stage iib prostate cancer
533470|NCT01292278|subarachnoid hemorrhage|subarachnoid hemorrhage
533471|NCT01292278|cerebral vasospasm|cerebral vasospasm
533472|NCT01292278|neuropeptide Y|neuropeptide y
533473|NCT01292278|spontaneous|spontaneous
533474|NCT01292278|aneurysmal|aneurysmal
533475|NCT01292265|Arthritis|arthritis
533476|NCT01292265|Joint pain|joint pain
533477|NCT01292265|Inflammation|inflammation
533478|NCT01292265|Rheumatoid Arthritis|rheumatoid arthritis
533479|NCT01292239|Hepatitis C, Chronic|hepatitis c, chronic
533480|NCT01292239|Hepatitis C|hepatitis c
533481|NCT01292239|Hepatitis C virus|hepatitis c virus
533482|NCT01292239|Interferon Alfa-2a|interferon alfa-2a
533483|NCT01292239|Ribavirin|ribavirin
533484|NCT01292239|Viral RNA|viral rna
533485|NCT01292213|Chronic cough|chronic cough
533486|NCT01292213|Haemophilus influenzae|haemophilus influenzae
533487|NCT01292200|Chinese women|chinese women
533488|NCT01292200|Mammography|mammography
533489|NCT01292200|Breast Cancer|breast cancer
533490|NCT01292187|Osteoporosis|osteoporosis
533491|NCT01292187|Osteopenia|osteopenia
533492|NCT01292187|Osteoporosis, Postmenopausal|osteoporosis, postmenopausal
533493|NCT01292187|Bone Diseases, Metabolic|bone diseases, metabolic
533494|NCT01292187|Bone Diseases|bone diseases
533495|NCT01292187|Musculoskeletal Diseases|musculoskeletal diseases
533496|NCT01292187|Salmon calcitonin|salmon calcitonin
533497|NCT01292187|Calcitonin|calcitonin
533498|NCT01292174|HIV prevention|hiv prevention
533499|NCT01292161|Hepatitis C|hepatitis c
533500|NCT01292161|Silymarin|silymarin
533501|NCT01292161|Quality of life|quality of life
533502|NCT01292148|resuscitation, hypothermia|resuscitation, hypothermia
533503|NCT01292135|Lymphoma, B-Cell|lymphoma, b-cell
533504|NCT01292135|Leukemia, Lymphoid|leukemia, lymphoid
533505|NCT01292135|Leukemia, B-Cell|leukemia, b-cell
533506|NCT01292135|Bruton's Tyrosine Kinase|bruton's tyrosine kinase
533507|NCT01292122|Wounds|wounds
533508|NCT01292122|Grafts|grafts
533509|NCT01292122|Wound Healing|wound healing
533510|NCT01292122|Cell Therapy|cell therapy
533511|NCT01292122|Split-thickness skin graft donor site wound|split-thickness skin graft donor site wound
533512|NCT01292109|endoscopy|endoscopy
533513|NCT01292109|colonoscopy|colonoscopy
533514|NCT01292109|preparation for surgery|preparation for surgery
533515|NCT01292096|homelessness|homelessness
533516|NCT01292096|substance use|substance use
533517|NCT01292096|frequent hospitalization|frequent hospitalization
533518|NCT01292096|frequent users of health services|frequent users of health services
533519|NCT01292096|enhanced care management|enhanced care management
533520|NCT01292096|coordination services p|coordination services p
533521|NCT01292096|high risk for frequent hospitalization|high risk for frequent hospitalization
533522|NCT01292070|Fel d 1 protein, Felis domesticus|fel d 1 protein, felis domesticus
533523|NCT01292070|Injections, Intradermal|injections, intradermal
533524|NCT01292057|Alcohol|alcohol
533525|NCT01292057|Aripiprazole|aripiprazole
533526|NCT01292057|Impulsivity|impulsivity
533527|NCT01292057|Alcoholism|alcoholism
533528|NCT01292057|drinking|drinking
533529|NCT01292057|treatment|treatment
533530|NCT01292057|craving|craving
533531|NCT01292057|brain imaging|brain imaging
533532|NCT01292057|genetics|genetics
533533|NCT01292044|elastography|elastography
533534|NCT01292044|cytology|cytology
533535|NCT01292031|VAP|vap
533536|NCT01292031|MDR-GNB|mdr-gnb
533537|NCT01292031|colistin|colistin
533538|NCT01292031|meropenem|meropenem
533539|NCT01292018|Management of dyslipidemia in Type 2 Diabetes Mellitus adult patients in India|management of dyslipidemia in type 2 diabetes mellitus adult patients in india
533540|NCT01292018|Dyslipidemia control rates in Type 2 diabetic Mellitus patients|dyslipidemia control rates in type 2 diabetic mellitus patients
533541|NCT01292005|pancreatitis|pancreatitis
533542|NCT01292005|pancreatic necrosis|pancreatic necrosis
533543|NCT01292005|severe acute pancreatitis (SAP)|severe acute pancreatitis (sap)
533544|NCT01292005|Alcoholic pancreatitis|alcoholic pancreatitis
533545|NCT01292005|gallstone pancreatitis|gallstone pancreatitis
533546|NCT01291992|Non-convulsive seizures|non-convulsive seizures
533547|NCT01291992|Cardiac Surgery|cardiac surgery
533548|NCT01291992|Postop|postop
533549|NCT01291992|24 hour EEG Monitoring|24 hour eeg monitoring
533550|NCT01291979|Pain|pain
533551|NCT01291979|Preemptive|preemptive
533552|NCT01291979|Lidocaine|lidocaine
533553|NCT01291979|Intravenous|intravenous
533554|NCT01291979|Tonsillectomy|tonsillectomy
533555|NCT01291966|medication errors|medication errors
533556|NCT01291966|Patient Compliance|patient compliance
533557|NCT01291966|patient safety|patient safety
533558|NCT01291966|polypharmacy|polypharmacy
533559|NCT01291953|atrial fibrillation|atrial fibrillation
533560|NCT01291953|screening|screening
533561|NCT01291953|prevention|prevention
533562|NCT01291953|case finding|case finding
533563|NCT01291953|primary care|primary care
533564|NCT01291927|Periampullary carcinoma|periampullary carcinoma
533565|NCT01291927|Pancreas-sparing Duodenectomy|pancreas-sparing duodenectomy
533566|NCT01291927|pancreaticoduodenectomy|pancreaticoduodenectomy
533567|NCT01291927|lymphadenectomy|lymphadenectomy
533568|NCT01291914|Osteoarthritis|osteoarthritis
533569|NCT01291914|knee|knee
533570|NCT01291914|intra-articular|intra-articular
533571|NCT01291914|safety|safety
533572|NCT01291914|efficacy|efficacy
533573|NCT01291914|pharmacokinetics|pharmacokinetics
533574|NCT01291914|pain|pain
533575|NCT01291901|pain|pain
533576|NCT01291901|cancer|cancer
533577|NCT01291901|malignancy|malignancy
533578|NCT01291901|intractable|intractable
533579|NCT01291901|gene therapy|gene therapy
533580|NCT01291901|enkephalin|enkephalin
533581|NCT01291901|opioid|opioid
533582|NCT01291875|Type 2 Diabetes mellitus|type 2 diabetes mellitus
533583|NCT01291875|Periodontal Disease|periodontal disease
533584|NCT01291875|metabolic control|metabolic control
533585|NCT01291875|periodontal treatment|periodontal treatment
533586|NCT01291875|inflammatory markers|inflammatory markers
533587|NCT01291849|nasal surgery|nasal surgery
533588|NCT01291849|endoscopic sinus surgery|endoscopic sinus surgery
533589|NCT01291849|septoplasty|septoplasty
533590|NCT01291849|Cough|cough
533591|NCT01291836|Acute Kidney Injury (AKI)|acute kidney injury (aki)
533592|NCT01291836|Acute Decompensated Heart Failure (ADHF)|acute decompensated heart failure (adhf)
533593|NCT01291836|Neutrophil Gelatinase Associated Lipocalin (NGAL)|neutrophil gelatinase associated lipocalin (ngal)
533594|NCT01291836|biomarker|biomarker
533595|NCT01291823|gefitinib|gefitinib
533596|NCT01291823|radiation|radiation
533597|NCT01291823|esophageal cancer|esophageal cancer
533598|NCT01291797|congenital heart disease|congenital heart disease
533599|NCT01291797|neurodevelopmental outcome|neurodevelopmental outcome
533600|NCT01291797|AEEG|aeeg
533601|NCT01291797|sleep wake cycles|sleep wake cycles
533602|NCT01291784|monoclonal antibody|monoclonal antibody
533603|NCT01291771|End stage renal disease|end stage renal disease
533604|NCT01291771|myocardial microvascular disease|myocardial microvascular disease
533605|NCT01291771|cardiorenal syndrome|cardiorenal syndrome
533606|NCT01291771|coronary flow reserve|coronary flow reserve
533607|NCT01291771|index of microvascular resistance|index of microvascular resistance
533608|NCT01291771|Patients with end stage renal disease scheduled or not for kidney or kidney + pancreatic transplantation|patients with end stage renal disease scheduled or not for kidney or kidney + pancreatic transplantation
533609|NCT01291758|Persian Gulf War|persian gulf war
533610|NCT01291758|Gulf War Syndrome|gulf war syndrome
533612|NCT01291758|Gulf War Illness|gulf war illness
533613|NCT01291758|Exercise|exercise
533614|NCT01291758|Chronic Fatigue|chronic fatigue
533615|NCT01291758|Fibromyalgia|fibromyalgia
533616|NCT01291758|Veterans|veterans
533617|NCT01291758|Irritable Bowel Syndrome|irritable bowel syndrome
533618|NCT01291758|Migraine headaches|migraine headaches
533619|NCT01291758|Neuropathy|neuropathy
533620|NCT01291719|closed loop glucose control|closed loop glucose control
533621|NCT01291719|intensive care glucose control|intensive care glucose control
533622|NCT01291706|Transcranial Doppler|transcranial doppler
533623|NCT01291706|Mild and moderate Traumatic Brain Injury|mild and moderate traumatic brain injury
533624|NCT01291706|Neurological deterioration|neurological deterioration
533625|NCT01291706|Brain CT scan|brain ct scan
533626|NCT01291693|Hazardous drinking|hazardous drinking
533627|NCT01291693|general hospital|general hospital
533628|NCT01291693|brief intervention|brief intervention
533629|NCT01291693|Motivational Interviewing|motivational interviewing
533630|NCT01291693|computer-generated feedback|computer-generated feedback
533631|NCT01291693|stage-tailored|stage-tailored
533632|NCT01291693|delivery channel|delivery channel
533633|NCT01291680|Pregnancy|pregnancy
533634|NCT01291680|Chronic pain|chronic pain
533635|NCT01291680|Fibromyalgia|fibromyalgia
533636|NCT01291654|PDA|pda
533637|NCT01291654|Paracetamol|paracetamol
533638|NCT01291654|Indomethacin|indomethacin
533639|NCT01291654|Ibuprofen|ibuprofen
533640|NCT01291641|Hyperlipidemias|hyperlipidemias
533641|NCT01291641|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors
533642|NCT01291641|Probucol|probucol
533643|NCT01291641|Cilostazol|cilostazol
533644|NCT01291628|Capecitabine|capecitabine
533645|NCT01291628|Hand and foot syndrome|hand and foot syndrome
533646|NCT01291628|Socks|socks
533647|NCT01291628|Copper|copper
533648|NCT01291628|Toxicity|toxicity
533649|NCT01291602|NXL104|nxl104
533650|NCT01291602|ceftazidime|ceftazidime
533651|NCT01291602|CAZ104|caz104
533652|NCT01291602|Healthy Japanese volunteers|healthy japanese volunteers
533653|NCT01291602|Phase 1|phase 1
533654|NCT01291602|Single and Multiple Dose Study|single and multiple dose study
533655|NCT01291589|HIV-infected|hiv-infected
533656|NCT01291589|MSM|msm
533657|NCT01291589|HIV prevention|hiv prevention
533658|NCT01291576|Deep infiltrating endometriosis|deep infiltrating endometriosis
533659|NCT01291576|Rectal endometriosis|rectal endometriosis
533660|NCT01291576|Colorectal resection|colorectal resection
533661|NCT01291576|Nodule excision|nodule excision
533662|NCT01291576|Rectal shaving|rectal shaving
533663|NCT01291576|Functional outcomes|functional outcomes
533664|NCT01291576|Constipation|constipation
533665|NCT01291563|TMC207TBC1003|tmc207tbc1003
533666|NCT01291563|TMC207|tmc207
533667|NCT01291563|M.Tuberculosis|m.tuberculosis
533668|NCT01291563|TBC|tbc
533669|NCT01291563|Moxifloxacin|moxifloxacin
533670|NCT01291563|ECG|ecg
533671|NCT01291563|QT/QTc|qt/qtc
533672|NCT01291563|Healthy volunteers|healthy volunteers
533673|NCT01291550|Detecting volatile biomarkers using breath sample|detecting volatile biomarkers using breath sample
533674|NCT01291537|Advanced|advanced
533675|NCT01291537|Severe form|severe form
533676|NCT01291524|pregabalin|pregabalin
533677|NCT01291524|pharmacokinetics|pharmacokinetics
533678|NCT01291524|bioavailability|bioavailability
533679|NCT01291524|bioequivalence|bioequivalence
533680|NCT01291511|Schizophrenia|schizophrenia
533681|NCT01291511|Mental Disorders|mental disorders
533682|NCT01291511|Antipsychotic Agents|antipsychotic agents
533683|NCT01291511|Iloperdione|iloperdione
533684|NCT01291511|Relapse Prevention|relapse prevention
533685|NCT01291498|Primary Parathyroid Adenomas|primary parathyroid adenomas
533686|NCT01291485|HIV|hiv
533687|NCT01291485|Medication adherence|medication adherence
533688|NCT01291485|computer-based intervention|computer-based intervention
533689|NCT01291472|ketorolac|ketorolac
533690|NCT01291472|pain|pain
533691|NCT01291472|pregnancy|pregnancy
533692|NCT01291472|non-pregnant state|non-pregnant state
533693|NCT01291459|HIV|hiv
533694|NCT01291459|naive patients|naive patients
533695|NCT01291459|maraviroc|maraviroc
533696|NCT01291459|raltegravir|raltegravir
533697|NCT01291446|Intestinal gas production|intestinal gas production
533698|NCT01291446|Intestinal microbiota|intestinal microbiota
533699|NCT01291407|Combined Modality|combined modality
533700|NCT01291407|Gastric Cancer|gastric cancer
533701|NCT01291407|Radiation Therapy|radiation therapy
533702|NCT01291407|S-1|s-1
533703|NCT01291394|Growth disorders|growth disorders
533704|NCT01291394|Saizen|saizen
533705|NCT01291394|Easypod|easypod
533706|NCT01291394|Growth hormone|growth hormone
533707|NCT01291394|Pediatric subject|pediatric subject
533708|NCT01291381|allergic rhinitis|allergic rhinitis
533709|NCT01291381|peripheral tolerance|peripheral tolerance
533710|NCT01291381|regulatory T cells|regulatory t cells
533711|NCT01291381|specific immunotherapy|specific immunotherapy
533712|NCT01291381|Tr1 cells|tr1 cells
533713|NCT01291368|Sedation|sedation
533714|NCT01291368|Delirium|delirium
533715|NCT01291368|PTSD|ptsd
533716|NCT01291368|Depression|depression
533717|NCT01291368|Anxiety|anxiety
533718|NCT01291368|HRQoL|hrqol
533719|NCT01291368|CAM-ICU|cam-icu
533720|NCT01291368|RASS|rass
533721|NCT01291368|SF-36|sf-36
533722|NCT01291368|ICU-memory tool|icu-memory tool
533723|NCT01291368|Antipsychotic Agents|antipsychotic agents
533724|NCT01291368|Mobilization|mobilization
533725|NCT01291368|ICU-nursing|icu-nursing
533726|NCT01291368|ICU|icu
533727|NCT01291368|intensive care|intensive care
533728|NCT01291368|critical care|critical care
533729|NCT01291368|critical care nursing|critical care nursing
533730|NCT01291355|Maternal position|maternal position
533731|NCT01291355|Occipitoposterior position|occipitoposterior position
533732|NCT01291355|Labor|labor
533733|NCT01291355|Dystocia|dystocia
533734|NCT01291355|Fetal presentation Abnormalities|fetal presentation abnormalities
533735|NCT01291342|Pregnancy|pregnancy
533736|NCT01291342|Preeclampsia|preeclampsia
533737|NCT01291342|Volatile biomarkers|volatile biomarkers
533738|NCT01291342|Chemical sensors|chemical sensors
533739|NCT01291342|Nanomaterials|nanomaterials
533740|NCT01291342|Nanosensors|nanosensors
533741|NCT01291342|NA-NOSE|na-nose
533742|NCT01291329|stem cell|stem cell
533743|NCT01291329|acute ST-Elevation Myocardial Infarction|acute st-elevation myocardial infarction
533744|NCT01291303|Non invasive ventilation|non invasive ventilation
533745|NCT01291303|acute exacerbation of COPD|acute exacerbation of copd
533746|NCT01291303|optimized ventilation|optimized ventilation
533747|NCT01291290|rAAA|raaa
533748|NCT01291290|Platelets|platelets
533749|NCT01291290|TEG|teg
533750|NCT01291290|Massive bleeding|massive bleeding
533751|NCT01291290|Coagulopathy|coagulopathy
533752|NCT01291277|gastrointestinal hemorrhage|gastrointestinal hemorrhage
533753|NCT01291277|esophageal varices|esophageal varices
533754|NCT01291277|gastrointestinal endoscopy|gastrointestinal endoscopy
533755|NCT01291277|ligation|ligation
533756|NCT01291264|Chlamydia trachomatis|chlamydia trachomatis
533757|NCT01291264|Neisseria gonorrhoeae|neisseria gonorrhoeae
533758|NCT01291264|Sexually Transmitted Diseases|sexually transmitted diseases
533759|NCT01291238|learning disability|learning disability
533760|NCT01291238|blood lipids|blood lipids
533761|NCT01291238|cardio metabolic risk factors|cardio metabolic risk factors
533762|NCT01291238|upper secondary school for learning disability students|upper secondary school for learning disability students
533763|NCT01291238|adolescents|adolescents
533764|NCT01291238|cardio respiratory fitness|cardio respiratory fitness
533765|NCT01291238|absorptiometry photos|absorptiometry photos
533766|NCT01291225|playgrounds|playgrounds
533767|NCT01291225|farms|farms
533768|NCT01291225|injury prevention|injury prevention
533769|NCT01291225|safety knowledge, attitudes and practices|safety knowledge, attitudes and practices
533770|NCT01291225|safe play|safe play
533771|NCT01291225|rural|rural
533772|NCT01291212|In Vitro Fertilization|in vitro fertilization
533773|NCT01291212|Testosterone|testosterone
533774|NCT01291212|Ovarian Stimulation|ovarian stimulation
533775|NCT01291212|Luteinizing Hormone|luteinizing hormone
533776|NCT01291199|double-blind placebo controlled cross-over study|double-blind placebo controlled cross-over study
533777|NCT01291186|spinal anesthesia|spinal anesthesia
533778|NCT01291186|intrathecal bupivacaine|intrathecal bupivacaine
533779|NCT01291186|median effective dose|median effective dose
533780|NCT01291186|height|height
533781|NCT01291147|pain|pain
533782|NCT01291147|anaesthetic|anaesthetic
533783|NCT01291121|Age related macular degeneration|age related macular degeneration
533784|NCT01291121|Intravitreal ranibizumab|intravitreal ranibizumab
533785|NCT01291121|Intravitreal expansile gas injection|intravitreal expansile gas injection
533786|NCT01291082|Breast cancer|breast cancer
533787|NCT01291082|metastasis|metastasis
533788|NCT01291082|bone|bone
533789|NCT01291082|diffusion MRI|diffusion mri
533790|NCT01291069|Fontan|fontan
533791|NCT01291069|Tadalafil|tadalafil
533792|NCT01291069|Exercise performance|exercise performance
533793|NCT01291056|Clomiphene citrate|clomiphene citrate
533794|NCT01291056|Mood symptoms|mood symptoms
533795|NCT01291056|Infertility|infertility
533796|NCT01291056|Superovulation|superovulation
533797|NCT01291056|Effects of clomiphene on mood|effects of clomiphene on mood
533798|NCT01291043|Shiatsu|shiatsu
533799|NCT01291043|Fibromyalgia|fibromyalgia
533800|NCT01291043|Pain|pain
533801|NCT01291043|Quality of sleep|quality of sleep
533802|NCT01291043|Balance|balance
533803|NCT01291043|Quality of life|quality of life
533804|NCT01291017|Advanced stage|advanced stage
533805|NCT01290952|off-pump|off-pump
533806|NCT01290952|bypass|bypass
533807|NCT01290952|coronary artery surgery|coronary artery surgery
533808|NCT01290939|adult glioblastoma|adult glioblastoma
533809|NCT01290939|recurrent adult brain tumor|recurrent adult brain tumor
533810|NCT01290939|Cognition Disorders|cognition disorders
533811|NCT01290939|functional defects|functional defects
533812|NCT01290926|advanced chemorefractory colorectal cancer|advanced chemorefractory colorectal cancer
533813|NCT01290926|sorafenib|sorafenib
533814|NCT01290926|capecitabine|capecitabine
533815|NCT01290926|FDG-PET|fdg-pet
533816|NCT01290926|early metabolic response|early metabolic response
533817|NCT01290913|peanut allergy|peanut allergy
533818|NCT01290913|Xolair|xolair
533819|NCT01290900|NXL104|nxl104
533820|NCT01290900|CAZ104|caz104
533821|NCT01290900|Ceftazidime|ceftazidime
533822|NCT01290900|CXL104|cxl104
533823|NCT01290900|Ceftaroline|ceftaroline
533824|NCT01290900|Healthy Male Volunteers|healthy male volunteers
533825|NCT01290900|Phase 1|phase 1
533826|NCT01290900|OT|ot
533827|NCT01290900|Single Dose Study|single dose study
533828|NCT01290874|Asthma|asthma
533829|NCT01290874|Blacks|blacks
533830|NCT01290874|LABA|laba
533831|NCT01290874|Tiotropium|tiotropium
533832|NCT01290874|Spiriva|spiriva
533833|NCT01290874|African American|african american
533834|NCT01290874|Serevent|serevent
533835|NCT01290874|salmeterol|salmeterol
533836|NCT01290874|Foradil|foradil
533837|NCT01290874|formoterol|formoterol
533838|NCT01290874|Advair|advair
533839|NCT01290874|Symbicort|symbicort
533840|NCT01290874|Dulera|dulera
533841|NCT01290861|Huntington's Disease|huntington's disease
533842|NCT01290861|Cognitive Battery|cognitive battery
533843|NCT01290861|Cognitive Testing|cognitive testing
533844|NCT01290861|Cognition|cognition
533845|NCT01290861|pre-manifest Huntington's Disease|pre-manifest huntington's disease
533846|NCT01290848|pediatrics|pediatrics
533847|NCT01290848|Health Promotion Campaign|health promotion campaign
533848|NCT01290848|Community events|community events
533849|NCT01290835|Stereotactic radiotherapy|stereotactic radiotherapy
533850|NCT01290835|CyberKnife following lumpectomy|cyberknife following lumpectomy
533851|NCT01290835|Breast cancer|breast cancer
533852|NCT01290822|Biventricular pacing|biventricular pacing
533853|NCT01290822|Dilated Cardiomyopathy|dilated cardiomyopathy
533854|NCT01290822|Ischemic Cardiomyopathy|ischemic cardiomyopathy
533855|NCT01290822|Congestive heart failure|congestive heart failure
533856|NCT01290822|Cardiac allograft|cardiac allograft
533857|NCT01290822|Cardiac surgery|cardiac surgery
533858|NCT01290822|AVD|avd
533859|NCT01290822|VVD|vvd
533860|NCT01290822|LV pacing site|lv pacing site
533861|NCT01290822|pacing optimization|pacing optimization
533862|NCT01290809|Prophylactic Cranial Irradiation|prophylactic cranial irradiation
533863|NCT01290809|lung cancer|lung cancer
533864|NCT01290783|mCRC|mcrc
533865|NCT01290783|CRC|crc
533866|NCT01290783|colorectal|colorectal
533867|NCT01290783|irinotecan|irinotecan
533868|NCT01290783|Hyaluronic acid|hyaluronic acid
533869|NCT01290783|Hyaluronan|hyaluronan
533870|NCT01290770|obesity|obesity
533871|NCT01290770|men|men
533872|NCT01290770|TFPI|tfpi
533873|NCT01290770|Lipoprotein(a)|lipoprotein(a)
533874|NCT01290770|Lp(a)|lp(a)
533875|NCT01290770|Tissue Factor pathway inhibitor|tissue factor pathway inhibitor
533876|NCT01290770|aspirin|aspirin
533877|NCT01290744|leprosy|leprosy
533878|NCT01290744|ENL|enl
533879|NCT01290744|clofazimine|clofazimine
533880|NCT01290731|Hepatitis C, Chronic|hepatitis c, chronic
533881|NCT01290731|Hepatitis C virus|hepatitis c virus
533882|NCT01290731|Interferon Alfa-2a|interferon alfa-2a
533883|NCT01290731|Ribavirin|ribavirin
533884|NCT01290731|Viral RNA|viral rna
533885|NCT01290705|Knee|knee
534191|NCT01289457|MDS|mds
533886|NCT01290705|Anterior Cruciate Ligament|anterior cruciate ligament
533887|NCT01290705|Pain|pain
533888|NCT01290705|Patella|patella
533889|NCT01290705|Exercise Therapy|exercise therapy
533890|NCT01290692|Brain Neoplasms|brain neoplasms
533891|NCT01290692|Central Nervous System Neoplasms|central nervous system neoplasms
533892|NCT01290692|Brain Diseases|brain diseases
533893|NCT01290692|Neoplasms|neoplasms
533894|NCT01290692|Nervous System Neoplasms|nervous system neoplasms
533895|NCT01290692|Glioblastoma|glioblastoma
533896|NCT01290692|Astrocytoma|astrocytoma
533897|NCT01290692|Nervous System Diseases|nervous system diseases
533898|NCT01290692|Central Nervous System Diseases|central nervous system diseases
533899|NCT01290692|Glioma|glioma
533900|NCT01290692|Recurrent astrocytoma|recurrent astrocytoma
533901|NCT01290692|Recurrent glioma|recurrent glioma
533902|NCT01290692|Cancer vaccine|cancer vaccine
533903|NCT01290692|Immunotherapy|immunotherapy
533904|NCT01290692|Killer T cells|killer t cells
533905|NCT01290692|Activated T cells|activated t cells
533906|NCT01290692|GM-CSF|gm-csf
533907|NCT01290692|Activated lymphocytes|activated lymphocytes
533908|NCT01290679|Hepatitis C|hepatitis c
533909|NCT01290679|TMC435|tmc435
533910|NCT01290679|HCV|hcv
533911|NCT01290679|Hep C|hep c
533912|NCT01290679|genotype 1|genotype 1
533913|NCT01290601|malaria|malaria
533914|NCT01290601|Plasmodium vivax|plasmodium vivax
533915|NCT01290601|adults|adults
533916|NCT01290601|treatment|treatment
533917|NCT01290601|tafenoquine|tafenoquine
533918|NCT01290562|SBRT|sbrt
533919|NCT01290562|spinal Metastases|spinal metastases
533920|NCT01290562|Paraspinal Metastases|paraspinal metastases
533921|NCT01290562|spinal Metastases and SBRT|spinal metastases and sbrt
533922|NCT01290562|Paraspinal Metastases and SBRT|paraspinal metastases and sbrt
533923|NCT01290536|Liver metastases|liver metastases
533924|NCT01290510|tendinopathy|tendinopathy
533925|NCT01290510|hyaluronan|hyaluronan
533926|NCT01290510|tendon|tendon
533927|NCT01290510|hyaluronic acid|hyaluronic acid
533928|NCT01290484|Lymphatic malformation, vascular malformation|lymphatic malformation, vascular malformation
533929|NCT01290458|Eccentric training|eccentric training
533930|NCT01290458|Free radicals|free radicals
533931|NCT01290458|Antioxidant supplements|antioxidant supplements
533932|NCT01290458|Training adaptations|training adaptations
533933|NCT01290458|Lipid profile|lipid profile
533934|NCT01290445|varenicline|varenicline
533935|NCT01290445|smoking|smoking
533936|NCT01290445|smoking cessation|smoking cessation
533937|NCT01290445|cohort study|cohort study
533938|NCT01290445|drug safety|drug safety
533939|NCT01290445|prospective study|prospective study
533940|NCT01290432|female fertility|female fertility
533941|NCT01290432|ovarian reserve|ovarian reserve
533942|NCT01290432|oocyte quality|oocyte quality
533943|NCT01290432|oocyte quantity|oocyte quantity
533944|NCT01290432|antimullerian hormone|antimullerian hormone
533945|NCT01290432|AMH|amh
533946|NCT01290432|dietary supplements|dietary supplements
533947|NCT01290432|inofolic plus|inofolic plus
533948|NCT01290432|myoinositol|myoinositol
533949|NCT01290432|folic acid|folic acid
533950|NCT01290419|RSV|rsv
533951|NCT01290406|Endometrial cancer,|endometrial cancer,
533952|NCT01290406|uterine cancer,|uterine cancer,
533953|NCT01290406|PI3K,|pi3k,
533954|NCT01290406|mTOR,|mtor,
533955|NCT01290406|targeted therapy|targeted therapy
533956|NCT01290393|vaccine|vaccine
533957|NCT01290393|Spontaneous abortions|spontaneous abortions
533958|NCT01290393|Human papillomavirus|human papillomavirus
533959|NCT01290393|HPV|hpv
533960|NCT01290393|Cervarix|cervarix
533961|NCT01290393|pregnancy|pregnancy
533962|NCT01290380|Solid tumor malignancies,|solid tumor malignancies,
533963|NCT01290380|simvastatin,|simvastatin,
533964|NCT01290380|caffeine,|caffeine,
533965|NCT01290380|omeprazole and diclofenac,|omeprazole and diclofenac,
533966|NCT01290380|ASA404,|asa404,
533967|NCT01290380|PK data|pk data
533968|NCT01290367|Chronic Lumbar Back Pain|chronic lumbar back pain
533969|NCT01290367|Low back pain|low back pain
533970|NCT01290367|Back pain|back pain
533971|NCT01290367|Degenerative Disc Disease|degenerative disc disease
533972|NCT01290367|Injection of Degenerated Lumbar Disc|injection of degenerated lumbar disc
533973|NCT01290367|Stem Cells|stem cells
533974|NCT01290367|Adult Stem Cells|adult stem cells
533975|NCT01290367|Allogeneic Mesenchymal Precursor cells (MPCs)|allogeneic mesenchymal precursor cells (mpcs)
533976|NCT01290367|Mesoblast|mesoblast
533977|NCT01290354|Brain penetration|brain penetration
533978|NCT01290354|positron emission tomography|positron emission tomography
533979|NCT01290354|Lapatinib|lapatinib
533980|NCT01290341|fungal infection|fungal infection
533981|NCT01290341|athlete foot|athlete foot
533982|NCT01290328|anemia|anemia
533983|NCT01290328|kidney transplant|kidney transplant
533984|NCT01290328|alloimmunity|alloimmunity
533985|NCT01290289|Labor|labor
533986|NCT01290289|Epidural|epidural
533987|NCT01290289|Combined spinal epidural|combined spinal epidural
533988|NCT01290289|pethidine|pethidine
533989|NCT01290276|Ondansetron|ondansetron
533990|NCT01290276|Methylphenidate|methylphenidate
533991|NCT01290263|Glioblastoma|glioblastoma
533993|NCT01290263|Brain Tumor|brain tumor
533994|NCT01290263|Glioma|glioma
533995|NCT01290237|vancomycin|vancomycin
533996|NCT01290237|loading dose|loading dose
533997|NCT01290237|pharmacokinetic|pharmacokinetic
533998|NCT01290237|pediatric|pediatric
533999|NCT01290237|Methicillin-Resistant Staphylococcus aureus (MRSA)|methicillin-resistant staphylococcus aureus (mrsa)
534000|NCT01290237|Serious infection with Gram positive bacteria|serious infection with gram positive bacteria
534001|NCT01290211|maraviroc|maraviroc
534002|NCT01290211|fosamprenavir|fosamprenavir
534003|NCT01290211|drug interaction|drug interaction
534004|NCT01290211|pharmacokinetics|pharmacokinetics
534005|NCT01290211|HIV|hiv
534006|NCT01290211|AIDS|aids
534007|NCT01290211|CCR5|ccr5
534008|NCT01290211|protease inhibitor|protease inhibitor
534009|NCT01290198|epoxy-eicosatrienoic acid|epoxy-eicosatrienoic acid
534010|NCT01290198|Laser Doppler|laser doppler
534011|NCT01290198|Endothelium derived hyperpolarizing factor|endothelium derived hyperpolarizing factor
534012|NCT01290198|cutaneous microcirculation|cutaneous microcirculation
534013|NCT01290198|post-occlusive hyperaemia|post-occlusive hyperaemia
534014|NCT01290198|thermal hyperemia|thermal hyperemia
534015|NCT01290198|intradermal microdialysis|intradermal microdialysis
534016|NCT01290198|fluconazole|fluconazole
534017|NCT01290185|Arthroplasty|arthroplasty
534018|NCT01290185|Pharmacol Nerve Block|pharmacol nerve block
534019|NCT01290172|Liver transplant|liver transplant
534020|NCT01290172|portal hypertension|portal hypertension
534021|NCT01290159|tolerance to heat|tolerance to heat
534022|NCT01290146|Heart Failure|heart failure
534023|NCT01290146|Levosimendan|levosimendan
534024|NCT01290146|Inotropic agents|inotropic agents
534025|NCT01290146|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors
534026|NCT01290146|Vasodilators|vasodilators
534027|NCT01290146|Diuretics|diuretics
534028|NCT01290120|Burkitt Lymphoma|burkitt lymphoma
534029|NCT01290120|B-ALL|b-all
534030|NCT01290120|Adult patients|adult patients
534031|NCT01290107|adult acute myeloid leukemia with 11q23 (MLL) abnormalities|adult acute myeloid leukemia with 11q23 (mll) abnormalities
534032|NCT01290107|childhood acute myeloid leukemia/other myeloid malignancies|childhood acute myeloid leukemia/other myeloid malignancies
534033|NCT01290081|Tuberculosis|tuberculosis
534034|NCT01290081|Injecting drug users|injecting drug users
534035|NCT01290081|Case management|case management
534036|NCT01290068|Intraocular Lens|intraocular lens
534037|NCT01290055|Yellow Fever|yellow fever
534038|NCT01290055|Vaccine|vaccine
534039|NCT01290055|Memory T Cells|memory t cells
534040|NCT01290029|pediatric|pediatric
534041|NCT01290029|CKD|ckd
534042|NCT01290029|dialysis|dialysis
534043|NCT01290029|paediatric|paediatric
534044|NCT01290016|randomized controlled trial|randomized controlled trial
534045|NCT01290016|children|children
534046|NCT01290016|obesity|obesity
534047|NCT01290016|nutrition|nutrition
534048|NCT01290016|exercise|exercise
534049|NCT01290003|Antibacterial agents|antibacterial agents
534050|NCT01290003|Neonate|neonate
534051|NCT01290003|Meconium stained amniotic fluid|meconium stained amniotic fluid
534052|NCT01290003|Neonatal sepsis|neonatal sepsis
534053|NCT01289977|Sandfly|sandfly
534054|NCT01289977|leishmaniasis|leishmaniasis
534055|NCT01289977|immune response|immune response
534056|NCT01289977|individuals age 18-50|individuals age 18-50
534057|NCT01289951|HIV|hiv
534058|NCT01289951|VHC|vhc
534059|NCT01289951|Advanced hepatic cirrhosis|advanced hepatic cirrhosis
534060|NCT01289951|Pharmacokinetic|pharmacokinetic
534061|NCT01289951|Raltegravir|raltegravir
534062|NCT01289938|pharmacokinetic|pharmacokinetic
534063|NCT01289938|pharmacogenetic|pharmacogenetic
534064|NCT01289938|Metoclopramide|metoclopramide
534065|NCT01289938|Diphenhydramine|diphenhydramine
534066|NCT01289938|CYP2D6 polymorphisms|cyp2d6 polymorphisms
534067|NCT01289925|dietary supplement|dietary supplement
534068|NCT01289925|selenium|selenium
534069|NCT01289925|healthy volunteer|healthy volunteer
534070|NCT01289925|Johns Hopkins|johns hopkins
534071|NCT01289925|older|older
534072|NCT01289925|aging|aging
534073|NCT01289925|geriatrics|geriatrics
534074|NCT01289925|baltimore|baltimore
534075|NCT01289925|mineral|mineral
534076|NCT01289925|over 70|over 70
534077|NCT01289912|Tuberous Sclerosis Complex|tuberous sclerosis complex
534078|NCT01289912|Autism|autism
534079|NCT01289912|Neurocognition|neurocognition
534080|NCT01289912|RAD001|rad001
534081|NCT01289912|Everolimus|everolimus
534082|NCT01289912|Afinitor|afinitor
534083|NCT01289912|TSC|tsc
534084|NCT01289899|BR-A-657|br-a-657
534085|NCT01289899|Fimasartan|fimasartan
534086|NCT01289899|multiple-dose|multiple-dose
534087|NCT01289899|pharmacokinetic|pharmacokinetic
534088|NCT01289899|pharmacodynamic|pharmacodynamic
534089|NCT01289899|safety|safety
534090|NCT01289886|single-dose|single-dose
534091|NCT01289886|pharmacokinetic|pharmacokinetic
534092|NCT01289886|pharmacodynamic|pharmacodynamic
534093|NCT01289886|safety|safety
534094|NCT01289847|Primary Immune Deficiency Disorders|primary immune deficiency disorders
534095|NCT01289847|Common Variable Immunodeficiency|common variable immunodeficiency
534096|NCT01289847|X-linked agammaglobulinemia|x-linked agammaglobulinemia
534097|NCT01289847|Hyper-IgM syndrome|hyper-igm syndrome
534098|NCT01289847|Wiskott-Aldrich Syndrome|wiskott-aldrich syndrome
534099|NCT01289847|Immunoglobulins|immunoglobulins
534100|NCT01289847|Bacterial Infections|bacterial infections
534101|NCT01289834|RSA|rsa
534102|NCT01289834|Bone Cement|bone cement
534103|NCT01289808|Glucose|glucose
534104|NCT01289808|analgesic|analgesic
534105|NCT01289808|newborns|newborns
534106|NCT01289795|Stroke|stroke
534107|NCT01289795|Cerebral Infarction|cerebral infarction
534108|NCT01289795|Cerebrovascular Disorders|cerebrovascular disorders
534109|NCT01289795|Brain Diseases|brain diseases
534110|NCT01289795|Central Nervous System Diseases|central nervous system diseases
534111|NCT01289782|Hepatitis C|hepatitis c
534112|NCT01289782|TMC435|tmc435
534113|NCT01289782|HCV|hcv
534114|NCT01289782|Hep C|hep c
534115|NCT01289782|Genotype 1|genotype 1
534116|NCT01289756|pharmacokinetic|pharmacokinetic
534117|NCT01289756|clomiphene|clomiphene
534118|NCT01289756|CYP2D6 polymorphisms|cyp2d6 polymorphisms
534119|NCT01289756|inhibition of CYP2D6 and CYP3A4|inhibition of cyp2d6 and cyp3a4
534120|NCT01289743|ankylosing spondylitis|ankylosing spondylitis
534121|NCT01289743|atanercept|atanercept
534122|NCT01289743|therapy|therapy
534123|NCT01289743|magnetic resonance imaging|magnetic resonance imaging
534124|NCT01289730|undifferentiated spondyloarthritis|undifferentiated spondyloarthritis
534125|NCT01289730|etanercept|etanercept
534126|NCT01289730|therapy|therapy
534127|NCT01289730|magnetic resonance imaging|magnetic resonance imaging
534128|NCT01289717|biomarkers|biomarkers
534129|NCT01289717|proteogenomic profiling|proteogenomic profiling
534130|NCT01289717|acute rejection|acute rejection
534131|NCT01289717|chronic allograft nephropathy/interstitial fibrosis and tubular atrophy|chronic allograft nephropathy/interstitial fibrosis and tubular atrophy
534132|NCT01289704|Charcot−Marie−Tooth disease,|charcot−marie−tooth disease,
534133|NCT01289704|CMT1A,|cmt1a,
534134|NCT01289704|rehabilitation,|rehabilitation,
534135|NCT01289704|treadmill,|treadmill,
534136|NCT01289704|stretching,|stretching,
534137|NCT01289704|proprioception,|proprioception,
534138|NCT01289704|Randomised Controlled Trial.|randomised controlled trial.
534139|NCT01289691|One Lung Ventilation|one lung ventilation
534140|NCT01289691|Atelectasis|atelectasis
534141|NCT01289691|Oxygenation|oxygenation
534142|NCT01289678|acute myelogenous leukemia|acute myelogenous leukemia
534143|NCT01289678|interleukin-2|interleukin-2
534144|NCT01289665|lubricating|lubricating
534146|NCT01289665|speculum|speculum
534147|NCT01289665|Pain, Pelvic|pain, pelvic
534148|NCT01289665|Examination, Gynecological|examination, gynecological
534149|NCT01289652|Acute hepatitis C (HCV)|acute hepatitis c (hcv)
534150|NCT01289652|Human immunodeficiency virus (HIV)|human immunodeficiency virus (hiv)
534151|NCT01289639|non-alcoholic fatty liver disease|non-alcoholic fatty liver disease
534152|NCT01289639|non-alcoholic steatohepatitis|non-alcoholic steatohepatitis
534153|NCT01289639|insulin resistance|insulin resistance
534154|NCT01289639|pioglitazone|pioglitazone
534155|NCT01289639|fenofibrate|fenofibrate
534156|NCT01289626|Calciphylaxis, dialysis|calciphylaxis, dialysis
534157|NCT01289613|Bispectral Index|bispectral index
534158|NCT01289613|Anesthesia|anesthesia
534159|NCT01289613|Asymmetry|asymmetry
534160|NCT01289587|Diabetes|diabetes
534161|NCT01289587|Physical activity|physical activity
534162|NCT01289587|Body composition|body composition
534163|NCT01289587|Aerobic fitness|aerobic fitness
534164|NCT01289587|Metabolic control|metabolic control
534165|NCT01289574|androgen receptor degradation enhancer|androgen receptor degradation enhancer
534166|NCT01289548|remote ischaemic preconditioning|remote ischaemic preconditioning
534167|NCT01289548|kidney transplantation|kidney transplantation
534168|NCT01289535|Influenza vaccine|influenza vaccine
534169|NCT01289535|immune response|immune response
534170|NCT01289535|elderly|elderly
534171|NCT01289522|Squamous cell carcinoma of the head and neck|squamous cell carcinoma of the head and neck
534172|NCT01289522|recurrent or metastatic|recurrent or metastatic
534173|NCT01289522|first line chemotherapy|first line chemotherapy
534174|NCT01289522|cetuximab|cetuximab
534175|NCT01289522|docetaxel|docetaxel
534176|NCT01289522|cisplatin|cisplatin
534177|NCT01289522|antineoplastic agents|antineoplastic agents
534178|NCT01289522|First Line Palliative Treatment|first line palliative treatment
534179|NCT01289496|Ribavirin|ribavirin
534180|NCT01289496|Pegasys|pegasys
534181|NCT01289496|Hepatitis|hepatitis
534182|NCT01289483|awake fiberoptic intubation (AFI)|awake fiberoptic intubation (afi)
534183|NCT01289483|difficult airway|difficult airway
534184|NCT01289483|fospropofol|fospropofol
534185|NCT01289470|NIRS Technology|nirs technology
534186|NCT01289470|Cardiovascular surgery|cardiovascular surgery
534187|NCT01289470|valvular surgery with cardiopulmonary bypass|valvular surgery with cardiopulmonary bypass
534188|NCT01289457|Acute Myelogenous Leukemia|acute myelogenous leukemia
534189|NCT01289457|AML|aml
534190|NCT01289457|High-Risk Myelodysplastic Syndrome|high-risk myelodysplastic syndrome
534192|NCT01289457|Relapsed|relapsed
534193|NCT01289457|Refractory|refractory
534194|NCT01289457|Clofarabine|clofarabine
534195|NCT01289457|Clofarex|clofarex
534196|NCT01289457|Clolar|clolar
534197|NCT01289457|Idarubicin|idarubicin
534198|NCT01289457|Idamycin|idamycin
534199|NCT01289457|Cytarabine|cytarabine
534200|NCT01289457|Ara-C|ara-c
534201|NCT01289457|Cytosar|cytosar
534202|NCT01289457|DepoCyt|depocyt
534203|NCT01289457|Cytosine Arabinosine Hydrochloride|cytosine arabinosine hydrochloride
534204|NCT01289444|palliative care|palliative care
534205|NCT01289444|AIDS|aids
534206|NCT01289444|adolescents|adolescents
534207|NCT01289444|quality of life|quality of life
534208|NCT01289444|adherence|adherence
534209|NCT01289444|spiritual|spiritual
534210|NCT01289444|threat appraisal|threat appraisal
534211|NCT01289444|treatment congruence|treatment congruence
534212|NCT01289444|treatment preferences|treatment preferences
534213|NCT01289444|dialysis|dialysis
534214|NCT01289444|hospitalization|hospitalization
534215|NCT01289444|communication|communication
534216|NCT01289444|family intervention|family intervention
534217|NCT01289444|Family Centered Advance Care Planning|family centered advance care planning
534218|NCT01289444|decision making|decision making
534219|NCT01289444|advance care planning|advance care planning
534220|NCT01289444|end of life|end of life
534221|NCT01289418|H1N1|h1n1
534222|NCT01289418|vaccine safety|vaccine safety
534223|NCT01289418|adverse events|adverse events
534224|NCT01289418|health care workers|health care workers
534225|NCT01289405|obstructive sleep apnea|obstructive sleep apnea
534226|NCT01289405|oropharyngeal exercises|oropharyngeal exercises
534227|NCT01289405|speech therapy|speech therapy
534228|NCT01289392|Obstructive Sleep Apnea|obstructive sleep apnea
534229|NCT01289392|CPAP|cpap
534230|NCT01289392|Oral appliance|oral appliance
534231|NCT01289392|Aerobic exercise|aerobic exercise
534232|NCT01289392|Resistance training|resistance training
534233|NCT01289379|pneumoperitoneum|pneumoperitoneum
534234|NCT01289379|laparoscopy|laparoscopy
534235|NCT01289379|HFJV|hfjv
534236|NCT01289379|cardiovascular|cardiovascular
534237|NCT01289379|Symptomatic|symptomatic
534238|NCT01289353|triple negative|triple negative
534239|NCT01289353|breast cancer|breast cancer
534240|NCT01289353|adjuvant therapy|adjuvant therapy
534241|NCT01289353|Carboplatin|carboplatin
534242|NCT01289353|chemotherapy|chemotherapy
534243|NCT01289353|radiation therapy|radiation therapy
534244|NCT01289353|chemo-radiotherapy|chemo-radiotherapy
534245|NCT01289353|accelerated radiotherapy|accelerated radiotherapy
534246|NCT01289340|wound healing|wound healing
534247|NCT01289340|pain|pain
534248|NCT01289340|burn|burn
534249|NCT01289314|total laparoscopic hysterectomy|total laparoscopic hysterectomy
534250|NCT01289314|laparoscopic supracervical hysterectomy|laparoscopic supracervical hysterectomy
678659|NCT00717925|NHL|nhl
534251|NCT01289301|renal transplantation|renal transplantation
534252|NCT01289301|polyoma BK virus infection|polyoma bk virus infection
534253|NCT01289301|everolimus|everolimus
534254|NCT01289301|calcineurin inhibitor|calcineurin inhibitor
534255|NCT01289301|mTOR inhibitor|mtor inhibitor
534256|NCT01289288|colorectal cancer screening|colorectal cancer screening
534257|NCT01289288|Chinese Americans|chinese americans
534258|NCT01289288|patients nonadherent with CRC Screening|patients nonadherent with crc screening
534259|NCT01289275|tobacco cessation|tobacco cessation
534260|NCT01289275|smoking cessation|smoking cessation
534261|NCT01289275|telephone|telephone
534262|NCT01289275|self-help|self-help
534263|NCT01289275|smoking abstinence|smoking abstinence
534264|NCT01289275|tobacco use disorder|tobacco use disorder
534265|NCT01289275|hospital|hospital
534266|NCT01289275|cardiopulmonary diseases|cardiopulmonary diseases
534267|NCT01289275|disparity|disparity
534268|NCT01289262|Cesarean section|cesarean section
534269|NCT01289262|Kerr incision|kerr incision
534270|NCT01289262|Purse string suturing in CS|purse string suturing in cs
534271|NCT01289262|Continuous locked suturing in CS|continuous locked suturing in cs
534272|NCT01289249|meropenem|meropenem
534273|NCT01289249|child|child
534274|NCT01289249|bacterial infection|bacterial infection
534275|NCT01289249|treatment evaluation|treatment evaluation
534276|NCT01289236|Shoulder Pain|shoulder pain
534277|NCT01289223|Indolent B-cell NHL, bendamustine, rituximab, progression-free survival|indolent b-cell nhl, bendamustine, rituximab, progression-free survival
534278|NCT01289210|B cell|b cell
534279|NCT01289210|lymphoma|lymphoma
534280|NCT01289184|Occupational Health Hazards|occupational health hazards
534281|NCT01289184|Air Pollution|air pollution
534282|NCT01289184|Photocopiers|photocopiers
534283|NCT01289184|Other Specified Personal Exposures|other specified personal exposures
534284|NCT01289184|History Presenting Hazards to Health|history presenting hazards to health
534285|NCT01289171|The efficacy, tolerability and safety of 15% glycolic acid lotion for treatment of diffuse flat warts among HIV+ children were investigated|the efficacy, tolerability and safety of 15% glycolic acid lotion for treatment of diffuse flat warts among hiv+ children were investigated
534286|NCT01289158|malonic and methylmalonic aciduria|malonic and methylmalonic aciduria
534287|NCT01289158|malonyl-coenzyme A decarboxylase|malonyl-coenzyme a decarboxylase
534288|NCT01289158|MLYCD|mlycd
534289|NCT01289145|Action Planning|action planning
534290|NCT01289145|Positive Outcome Expectancies|positive outcome expectancies
534291|NCT01289145|Randomized Controlled Trial|randomized controlled trial
534292|NCT01289145|Stages of change|stages of change
534293|NCT01289145|Health behavior|health behavior
534294|NCT01289145|Motivation|motivation
534295|NCT01289132|Drug Therapy|drug therapy
534296|NCT01289119|Type 2 Diabetes Mellitus|type 2 diabetes mellitus
534297|NCT01289119|Drug Therapy|drug therapy
534298|NCT01289106|Hepatitis B vaccine|hepatitis b vaccine
534299|NCT01289106|HIV infection|hiv infection
534300|NCT01289106|Modified HBV vaccine dose|modified hbv vaccine dose
534301|NCT01289106|Modified HBV vaccine schedule|modified hbv vaccine schedule
534302|NCT01289093|inguinal hernia|inguinal hernia
534303|NCT01289093|incisional hernia|incisional hernia
534304|NCT01289093|quality of life|quality of life
534305|NCT01289093|disease-specific|disease-specific
534306|NCT01289080|Schizophrenia|schizophrenia
534307|NCT01289080|psychiatric disorders|psychiatric disorders
534308|NCT01289080|renal failure|renal failure
534309|NCT01289067|Metastatic|metastatic
534310|NCT01289067|Castration Resistant|castration resistant
534311|NCT01289067|Prostate Cancer|prostate cancer
534312|NCT01289054|Female|female
534313|NCT01289054|Pregnancy|pregnancy
534314|NCT01289054|Hematologic Pregnancy|hematologic pregnancy
534315|NCT01289054|Complications|complications
534316|NCT01289054|Registry|registry
534317|NCT01289054|Pregnant Registry|pregnant registry
534318|NCT01289054|CML|cml
534319|NCT01289054|GIST|gist
534320|NCT01289054|Gleevec|gleevec
534321|NCT01289054|Tasigna|tasigna
534322|NCT01289054|Glivec|glivec
534323|NCT01289054|Pregnancy Exposure|pregnancy exposure
534324|NCT01289041|Advanced endometrial cancer|advanced endometrial cancer
534325|NCT01289041|PI3K pathway|pi3k pathway
534326|NCT01289041|second-line treatment|second-line treatment
534327|NCT01289028|GIST|gist
534328|NCT01289028|Imatinib|imatinib
534329|NCT01289028|Sunitinib|sunitinib
534330|NCT01289028|Gastrointestinal|gastrointestinal
534331|NCT01289028|Stromal|stromal
534332|NCT01289028|Tumors|tumors
534333|NCT01289015|fungal infection|fungal infection
534334|NCT01289015|athlete foot|athlete foot
534335|NCT01288989|Advanced Solid Tumors|advanced solid tumors
534336|NCT01288976|Mitral Valve|mitral valve
534337|NCT01288976|Mitral Regurgitation|mitral regurgitation
534338|NCT01288976|MitraClip|mitraclip
534339|NCT01288976|Mitral Valve Surgery|mitral valve surgery
534340|NCT01288976|Mitral Valve Insufficiency or Mitral Regurgitation|mitral valve insufficiency or mitral regurgitation
534341|NCT01288963|melanoma|melanoma
534342|NCT01288963|IL-2|il-2
534343|NCT01288963|Aldesleukin|aldesleukin
534344|NCT01288950|BCG vaccine|bcg vaccine
534345|NCT01288950|Vitamin D|vitamin d
534346|NCT01288950|Cholecalciferol|cholecalciferol
534347|NCT01288950|Tuberculosis|tuberculosis
534348|NCT01288937|Milnacipran|milnacipran
534349|NCT01288937|Idiopathic Peripheral Neuropathy|idiopathic peripheral neuropathy
534350|NCT01288937|Diabetic neuropathy|diabetic neuropathy
534351|NCT01288937|Neuropathic pain|neuropathic pain
534352|NCT01288911|Metastatic|metastatic
534353|NCT01288911|MDV3100|mdv3100
534354|NCT01288911|Prostate|prostate
534355|NCT01288911|progressive|progressive
534356|NCT01288911|Cancer|cancer
534357|NCT01288911|enzalutamide|enzalutamide
534358|NCT01288898|ASP1941|asp1941
534359|NCT01288898|Diabetes Mellitus|diabetes mellitus
534360|NCT01288898|Multiple ascending doses|multiple ascending doses
534361|NCT01288898|Healthy subjects|healthy subjects
534362|NCT01288885|ASP1941|asp1941
534363|NCT01288885|Diabetes Mellitus|diabetes mellitus
534364|NCT01288885|First in Men|first in men
534365|NCT01288872|Praziquantal, Schistosomiasis, pregnant women, Philippines|praziquantal, schistosomiasis, pregnant women, philippines
534366|NCT01288859|polyphenols|polyphenols
534367|NCT01288859|curcumin|curcumin
534368|NCT01288859|bioavailability|bioavailability
534369|NCT01288859|cocoa|cocoa
534370|NCT01288846|medication list|medication list
534371|NCT01288846|changes in medication|changes in medication
534372|NCT01288846|prescription medication|prescription medication
534373|NCT01288833|Colonoscopy|colonoscopy
534374|NCT01288833|Diagnostic Imaging|diagnostic imaging
534375|NCT01288833|Colorectal Neoplasm|colorectal neoplasm
534376|NCT01288833|Primary Prevention|primary prevention
534377|NCT01288833|Cost and Cost Analysis|cost and cost analysis
534378|NCT01288833|Endoscopy|endoscopy
534379|NCT01288807|Fibromyalgia|fibromyalgia
534380|NCT01288807|pain|pain
534381|NCT01288794|Cirrhosis|cirrhosis
534382|NCT01288794|Uncomplicated ascites|uncomplicated ascites
534383|NCT01288794|Refractory ascites|refractory ascites
534384|NCT01288794|Chronic albumin treatment|chronic albumin treatment
534385|NCT01288781|High Altitude Headache; intra-cranial pressure; hypoxia|high altitude headache; intra-cranial pressure; hypoxia
534386|NCT01288768|Meniscal injury|meniscal injury
534387|NCT01288768|Knee arthroscopy|knee arthroscopy
534388|NCT01288768|Middleaged|middleaged
534389|NCT01288768|Functional outcome|functional outcome
534390|NCT01288755|TMC278-TiDP6-C153|tmc278-tidp6-c153
534391|NCT01288755|TMC278-C153|tmc278-c153
534392|NCT01288755|TMC278|tmc278
534393|NCT01288755|HIV|hiv
534394|NCT01288742|TMC435-TiDP16-C108|tmc435-tidp16-c108
534395|NCT01288742|TMC435-C108|tmc435-c108
534396|NCT01288742|TMC435|tmc435
534397|NCT01288742|HPC|hpc
534398|NCT01288742|HCV|hcv
534399|NCT01288742|Hepatitis C|hepatitis c
534400|NCT01288716|ASD|asd
534401|NCT01288716|Autism|autism
534402|NCT01288716|Asperger Syndrome|asperger syndrome
534403|NCT01288703|urinary incontinence|urinary incontinence
534404|NCT01288690|Refugees|refugees
534405|NCT01288690|Trauma|trauma
534406|NCT01288690|Narrative|narrative
534407|NCT01288690|Exposure|exposure
534408|NCT01288690|Middle East|middle east
534409|NCT01288690|Therapy|therapy
534410|NCT01288677|Healthy volunteer|healthy volunteer
534411|NCT01288677|TMC649128HPC1001|tmc649128hpc1001
534412|NCT01288677|TMC649128|tmc649128
534413|NCT01288677|HCV|hcv
534414|NCT01288677|Hepatitis C|hepatitis c
534415|NCT01288677|healthy volunteers|healthy volunteers
534416|NCT01288677|Phase I trial|phase i trial
534417|NCT01288664|Lupus Nephritis|lupus nephritis
534418|NCT01288664|Tacrolimus|tacrolimus
534419|NCT01288664|Induction Phase|induction phase
534420|NCT01288651|Pulmonary arterial hypertension|pulmonary arterial hypertension
534421|NCT01288651|Iron deficiency|iron deficiency
534422|NCT01288651|Exercise|exercise
534423|NCT01288638|Polycystic Ovary Syndrome|polycystic ovary syndrome
534424|NCT01288638|Metabolic Syndrome|metabolic syndrome
534425|NCT01288638|Pulse|pulse
534426|NCT01288638|Lifestyle Intervention|lifestyle intervention
534427|NCT01288638|Aerobic Exercise|aerobic exercise
534428|NCT01288638|Diet|diet
534429|NCT01288625|Identify whether Cytofos can reduce the incidence and duration of HNC patients' oral mucositis caused by radiotherapy.|identify whether cytofos can reduce the incidence and duration of hnc patients' oral mucositis caused by radiotherapy.
534430|NCT01288612|Barrett's Esophagus|barrett's esophagus
534431|NCT01288599|Laparoscopy|laparoscopy
534432|NCT01288599|Randomized|randomized
534433|NCT01288599|Single port access|single port access
534434|NCT01288599|Adnexal disease|adnexal disease
534435|NCT01288599|LESS|less
534436|NCT01288586|Post Traumatic Arthritis|post traumatic arthritis
534437|NCT01288586|Rheumatoid Arthritis|rheumatoid arthritis
534438|NCT01288586|Osteoarthritis|osteoarthritis
534439|NCT01288560|medical imaging|medical imaging
534440|NCT01288560|heart failure|heart failure
534441|NCT01288560|morbidity and mortality|morbidity and mortality
534442|NCT01288560|PET/CT,CMR,SPECT, echo, coronary angiography|pet/ct,cmr,spect, echo, coronary angiography
534443|NCT01288560|knowledge translation|knowledge translation
534444|NCT01288560|cost effectiveness|cost effectiveness
534445|NCT01288560|quality of life|quality of life
534446|NCT01288560|prospective comparative effectiveness randomized clinical trial|prospective comparative effectiveness randomized clinical trial
534447|NCT01288547|cognition|cognition
534448|NCT01288547|attention|attention
534449|NCT01288547|methylxanthine|methylxanthine
534450|NCT01288521|kidney transplantation|kidney transplantation
534451|NCT01288521|tacrolimus|tacrolimus
534452|NCT01288521|P-glycoprotein|p-glycoprotein
534453|NCT01288521|ABCB1|abcb1
534454|NCT01288521|genotyping|genotyping
534455|NCT01288482|Methacholine challenge|methacholine challenge
534456|NCT01288482|nebulizer|nebulizer
534457|NCT01288482|English-Wright|english-wright
534458|NCT01288482|AeroEclipse II|aeroeclipse ii
534459|NCT01288469|10020603|10020603
534460|NCT01288456|medical device, space-occupying device|medical device, space-occupying device
534461|NCT01288430|Heat shock protein 90|heat shock protein 90
534462|NCT01288430|Advanced solid tumors|advanced solid tumors
534463|NCT01288430|Non-small cell lung carcinoma|non-small cell lung carcinoma
534464|NCT01288430|Epidermal growth factor receptor|epidermal growth factor receptor
534465|NCT01288430|Tyrosine kinase inhibitor acquired resistance|tyrosine kinase inhibitor acquired resistance
534466|NCT01288430|Non-small cell lung carcinoma with acquired resistance to erlotinib, gefitinib, afatinib or others.|non-small cell lung carcinoma with acquired resistance to erlotinib, gefitinib, afatinib or others.
534467|NCT01288417|HIV infections|hiv infections
534468|NCT01288417|HCV infections|hcv infections
534469|NCT01288417|interaction|interaction
534470|NCT01288417|pharmacokinetics|pharmacokinetics
534471|NCT01288417|raltegravir|raltegravir
534472|NCT01288417|boceprevir|boceprevir
534473|NCT01288404|Bevacizumab, impending recurrent pterygium|bevacizumab, impending recurrent pterygium
534474|NCT01288378|fungal infection|fungal infection
534475|NCT01288378|de novo myelodysplastic syndromes|de novo myelodysplastic syndromes
534476|NCT01288378|previously treated myelodysplastic syndromes|previously treated myelodysplastic syndromes
534477|NCT01288378|secondary myelodysplastic syndromes|secondary myelodysplastic syndromes
534478|NCT01288378|recurrent adult acute myeloid leukemia|recurrent adult acute myeloid leukemia
534479|NCT01288378|untreated adult acute myeloid leukemia|untreated adult acute myeloid leukemia
534480|NCT01288378|adult acute myeloid leukemia with 11q23 (MLL) abnormalities|adult acute myeloid leukemia with 11q23 (mll) abnormalities
534481|NCT01288378|adult acute myeloid leukemia with del(5q)|adult acute myeloid leukemia with del(5q)
534579|NCT01287962|Non-small Cell Lung Cancer|non-small cell lung cancer
534482|NCT01288378|adult acute myeloid leukemia with inv(16)(p13;q22)|adult acute myeloid leukemia with inv(16)(p13;q22)
534483|NCT01288378|adult acute myeloid leukemia with t(15;17)(q22;q12)|adult acute myeloid leukemia with t(15;17)(q22;q12)
534484|NCT01288378|adult acute myeloid leukemia with t(16;16)(p13;q22)|adult acute myeloid leukemia with t(16;16)(p13;q22)
534485|NCT01288378|adult acute myeloid leukemia with t(8;21)(q22;q22)|adult acute myeloid leukemia with t(8;21)(q22;q22)
534486|NCT01288378|secondary acute myeloid leukemia|secondary acute myeloid leukemia
534487|NCT01288365|heart failure|heart failure
534488|NCT01288365|preserved ejection fraction|preserved ejection fraction
534489|NCT01288352|early treatment|early treatment
534490|NCT01288352|rhythm control|rhythm control
534491|NCT01288352|atrial fibrillation|atrial fibrillation
534492|NCT01288352|cardiovascular complications|cardiovascular complications
534493|NCT01288313|human milk|human milk
534494|NCT01288313|polyunsaturated fatty acids|polyunsaturated fatty acids
534495|NCT01288313|linolenic acid|linolenic acid
534496|NCT01288313|rapeseed oil|rapeseed oil
534497|NCT01288287|Certolizumab pegol|certolizumab pegol
534498|NCT01288287|Cimzia®|cimzia®
534499|NCT01288274|Contraception|contraception
534500|NCT01288274|Family planning|family planning
534501|NCT01288274|Task Shifting|task shifting
534502|NCT01288274|Community based distribution|community based distribution
534503|NCT01288274|Ethiopia|ethiopia
534504|NCT01288274|DMPA|dmpa
534505|NCT01288248|Airway|airway
534506|NCT01288248|Airway laryngeal mask|airway laryngeal mask
534507|NCT01288248|Endotracheal tube|endotracheal tube
534508|NCT01288248|Respiration artificial|respiration artificial
534509|NCT01288248|Laryngospasm|laryngospasm
534510|NCT01288248|Safety of airway laryngeal mask|safety of airway laryngeal mask
534511|NCT01288235|proton radiotherapy|proton radiotherapy
534512|NCT01288222|acute myelogenous leukemia|acute myelogenous leukemia
534513|NCT01288222|hematopoietic cell transplantation|hematopoietic cell transplantation
534514|NCT01288222|unrelated donor|unrelated donor
534515|NCT01288209|Hepatitis C, Chronic|hepatitis c, chronic
534516|NCT01288209|Hepatitis C|hepatitis c
534517|NCT01288209|Hepatitis C virus|hepatitis c virus
534518|NCT01288209|Interferon Alfa-2a|interferon alfa-2a
534519|NCT01288209|Ribavirin|ribavirin
534520|NCT01288209|Viral RNA|viral rna
534521|NCT01288196|CNTO 6785|cnto 6785
534522|NCT01288196|Intravenous|intravenous
534523|NCT01288196|Subcutaneous|subcutaneous
534524|NCT01288196|Pharmacokinetics|pharmacokinetics
534525|NCT01288196|Immunogenicity|immunogenicity
534526|NCT01288196|Safety|safety
534527|NCT01288196|Tolerability|tolerability
534528|NCT01288183|tobacco|tobacco
534529|NCT01288183|smoking|smoking
534530|NCT01288183|tDCS|tdcs
534531|NCT01288183|DLPFC|dlpfc
534532|NCT01288170|cystic fibrosis, bioequivalence, pharmacokinetic, sputum, plasma|cystic fibrosis, bioequivalence, pharmacokinetic, sputum, plasma
534533|NCT01288157|healthy|healthy
534534|NCT01288157|adult|adult
534535|NCT01288157|Chinese|chinese
534536|NCT01288157|male|male
534537|NCT01288157|Simponi|simponi
534538|NCT01288157|CNTO 148|cnto 148
534539|NCT01288144|Screening|screening
534540|NCT01288144|Gestational diabetes mellitus|gestational diabetes mellitus
534541|NCT01288131|Anti-r-HuEpo antibody|anti-r-huepo antibody
534542|NCT01288131|Anti-r-HuEpo associated PRCA|anti-r-huepo associated prca
534543|NCT01288131|Treatment|treatment
534544|NCT01288131|Absolute reticulocyte count|absolute reticulocyte count
534545|NCT01288105|drug-eluting stents|drug-eluting stents
534546|NCT01288105|noncardiac surgery|noncardiac surgery
534547|NCT01288092|Metastatic breast cancer|metastatic breast cancer
534548|NCT01288092|HER2 negative|her2 negative
534549|NCT01288092|HR positive|hr positive
534550|NCT01288092|PI3K pathway|pi3k pathway
534551|NCT01288092|no more than 2 prior lines of chemotherapy|no more than 2 prior lines of chemotherapy
534552|NCT01288092|Metastatic Breast Cancer(MBC)|metastatic breast cancer(mbc)
534553|NCT01288079|Major Depressive Disorder|major depressive disorder
534554|NCT01288079|MDD|mdd
534555|NCT01288079|Monotherapy|monotherapy
534556|NCT01288079|Inadequate Response to Antidepressant Therapy|inadequate response to antidepressant therapy
534557|NCT01288066|Shoulder|shoulder
534558|NCT01288066|Total arthroplasty|total arthroplasty
534559|NCT01288066|Hemiarthroplasty|hemiarthroplasty
534560|NCT01288066|Resurfacing|resurfacing
534561|NCT01288066|Glenoid|glenoid
534562|NCT01288066|Constant score|constant score
534563|NCT01288040|stroke|stroke
534564|NCT01288040|treadmill|treadmill
534565|NCT01288040|walking|walking
534566|NCT01288040|hemiparesis|hemiparesis
534567|NCT01288040|training|training
534568|NCT01288014|immune response|immune response
534569|NCT01288014|varicella zoster virus (VZV)|varicella zoster virus (vzv)
534570|NCT01288014|cytokine levels|cytokine levels
534571|NCT01288014|immunization|immunization
534572|NCT01287975|Stroke Rehabilitation|stroke rehabilitation
534573|NCT01287975|Brain Computer Interface|brain computer interface
534574|NCT01287975|Upper Limb Rehabilitation|upper limb rehabilitation
534575|NCT01287975|EEG-based Motor Imagery|eeg-based motor imagery
534576|NCT01287975|Robotic Rehabilitation|robotic rehabilitation
534577|NCT01287975|Haptic Knob|haptic knob
534578|NCT01287962|Apatinib|apatinib
534580|NCT01287962|VEGFR TKIs|vegfr tkis
534581|NCT01287949|Diphtheria|diphtheria
534582|NCT01287949|Tetanus|tetanus
534583|NCT01287949|Poliomyelitis|poliomyelitis
534584|NCT01287949|Pertussis (acellular)|pertussis (acellular)
534585|NCT01287949|Biological/vaccine|biological/vaccine
534586|NCT01287936|Chronic Stroke|chronic stroke
534587|NCT01287936|Stable Stroke|stable stroke
534588|NCT01287923|Hematology|hematology
534589|NCT01287923|Secondary lymphoid organs|secondary lymphoid organs
534590|NCT01287910|Cardiac|cardiac
534591|NCT01287910|Angina|angina
534592|NCT01287910|Chest pain|chest pain
534593|NCT01287897|Crohn's Disease|crohn's disease
534594|NCT01287897|safety|safety
534595|NCT01287897|efficacy|efficacy
534596|NCT01287897|pharmacokinetics|pharmacokinetics
534597|NCT01287897|pharmacodynamics|pharmacodynamics
534598|NCT01287897|Crohn's Disease Activity Index (CDAI)|crohn's disease activity index (cdai)
534599|NCT01287884|ABG|abg
534600|NCT01287884|VBG|vbg
534601|NCT01287884|pH|ph
534602|NCT01287884|pCO2|pco2
534603|NCT01287871|Cervical Cancer Screening|cervical cancer screening
534604|NCT01287845|Prostate cancer|prostate cancer
534605|NCT01287845|Neoplasm|neoplasm
534606|NCT01287845|Diagnostic Imaging|diagnostic imaging
534607|NCT01287845|PET (Positron Emission Tomography) -tracer|pet (positron emission tomography) -tracer
534608|NCT01287845|PET-diagnosis|pet-diagnosis
534609|NCT01287832|Methicillin-resistant|methicillin-resistant
534610|NCT01287832|Staphylococcus aureus|staphylococcus aureus
534611|NCT01287806|ulinastatin|ulinastatin
534612|NCT01287806|inhalation injury|inhalation injury
534613|NCT01287780|Humans|humans
534614|NCT01287780|Prostheses and Implants|prostheses and implants
534615|NCT01287780|Gentamicin administration and dosage|gentamicin administration and dosage
534616|NCT01287780|Surgical sponges|surgical sponges
534617|NCT01287780|Treatment outcomes|treatment outcomes
534618|NCT01287767|Dementia|dementia
534619|NCT01287767|Depression|depression
534620|NCT01287767|Burden of care|burden of care
534621|NCT01287767|Psychosocial intervention|psychosocial intervention
534622|NCT01287767|Family home care|family home care
534623|NCT01287702|early feeding|early feeding
534624|NCT01287702|varices bleeding|varices bleeding
534625|NCT01287702|to evaluate impact of early feeding on early rebleeding after ligation of varices|to evaluate impact of early feeding on early rebleeding after ligation of varices
534626|NCT01287689|Non-interventional trial|non-interventional trial
534627|NCT01287689|immunodeficiency|immunodeficiency
534628|NCT01287689|outcome study, registry|outcome study, registry
534629|NCT01287689|long-term outcomes, drug utilization|long-term outcomes, drug utilization
534630|NCT01287689|effectiveness, treatment patterns|effectiveness, treatment patterns
534631|NCT01287689|patient characteristics under real life conditions|patient characteristics under real life conditions
534632|NCT01287689|factors for treatment success|factors for treatment success
534633|NCT01287689|long-term tolerability|long-term tolerability
534634|NCT01287689|quality of life|quality of life
534635|NCT01287637|Rectal cancer|rectal cancer
534636|NCT01287637|Temporary ileostomy|temporary ileostomy
534637|NCT01287637|Ealy reversal|ealy reversal
534638|NCT01287637|Morbidity|morbidity
534639|NCT01287637|Mortality|mortality
534640|NCT01287637|Quality of life|quality of life
534641|NCT01287637|Economic effect|economic effect
534642|NCT01287624|triple negative breast cancer|triple negative breast cancer
534643|NCT01287624|fine line chemotherapy|fine line chemotherapy
534644|NCT01287611|Cesarean section|cesarean section
534645|NCT01287611|Kerr incision|kerr incision
534646|NCT01287611|Purse string suturing in C/S|purse string suturing in c/s
534647|NCT01287611|Continuous locked suturing in C/S|continuous locked suturing in c/s
534648|NCT01287598|Phase I|phase i
534649|NCT01287598|Probe substrate|probe substrate
534650|NCT01287598|target therapy|target therapy
534651|NCT01287598|small molecule|small molecule
534652|NCT01287598|pharmacokinetics|pharmacokinetics
534653|NCT01287585|Hepatocellular carcinoma|hepatocellular carcinoma
534654|NCT01287585|Arginine|arginine
534655|NCT01287585|Arginine deiminase|arginine deiminase
534656|NCT01287585|ADI-PEG 20|adi-peg 20
534657|NCT01287572|TcCO2|tcco2
534658|NCT01287572|sedation|sedation
534659|NCT01287572|procedure|procedure
534660|NCT01287572|PICU|picu
534661|NCT01287559|NEC|nec
534662|NCT01287559|Premature Infant|premature infant
534663|NCT01287533|Rheumatoid arthritis|rheumatoid arthritis
534664|NCT01287533|Glucocorticoid induced osteoporosis|glucocorticoid induced osteoporosis
534665|NCT01287533|Vertebral fracture|vertebral fracture
534666|NCT01287507|VLBW, NEC, Late onset sepsis|vlbw, nec, late onset sepsis
534667|NCT01287494|elderly|elderly
534668|NCT01287494|care management|care management
534669|NCT01287494|primary care|primary care
534670|NCT01287481|Fibromyalgia|fibromyalgia
534671|NCT01287481|Behavioral interventions|behavioral interventions
534672|NCT01287481|Psychological interventions|psychological interventions
534673|NCT01287468|phytomedicines|phytomedicines
534674|NCT01287468|breast cancer|breast cancer
534675|NCT01287468|stromal fibroblasts|stromal fibroblasts
534676|NCT01287468|MDSCs|mdscs
534677|NCT01287468|functional mechanism|functional mechanism
534678|NCT01287455|Asthma|asthma
534679|NCT01287455|Vitamin D|vitamin d
534680|NCT01287455|airway reactivity|airway reactivity
534681|NCT01287455|metacholine challenge test|metacholine challenge test
534682|NCT01287429|Ultrasonography|ultrasonography
534683|NCT01287416|Suicide Intervention|suicide intervention
534684|NCT01287416|Applied Suicide Intervention Skills Training (ASIST)|applied suicide intervention skills training (asist)
534685|NCT01287416|Resilience Retreat|resilience retreat
534686|NCT01287416|First Nations|first nations
534687|NCT01287416|Suicide Intervention and Response Inventory (SIRI)|suicide intervention and response inventory (siri)
534688|NCT01287403|Cereals|cereals
534689|NCT01287403|Alkylresorcinols|alkylresorcinols
534690|NCT01287403|Betaine|betaine
534691|NCT01287403|Phenolics|phenolics
534692|NCT01287403|Plasma and urine cereal phytochemicals|plasma and urine cereal phytochemicals
534693|NCT01287390|squamous cell carcinoma|squamous cell carcinoma
534694|NCT01287390|oral cavity|oral cavity
534695|NCT01287390|oropharynx|oropharynx
534696|NCT01287390|hypopharynx|hypopharynx
534697|NCT01287390|larynx|larynx
534698|NCT01287377|tobacco cessation|tobacco cessation
534699|NCT01287377|smoking cessation|smoking cessation
534700|NCT01287377|nicotine|nicotine
534701|NCT01287377|counseling|counseling
534702|NCT01287377|telephone|telephone
534703|NCT01287377|self-help|self-help
534704|NCT01287377|smoking abstinence|smoking abstinence
534705|NCT01287377|tobacco use disorder|tobacco use disorder
534706|NCT01287377|nicotine replacement therapy|nicotine replacement therapy
534707|NCT01287364|perennial allergic rhinitis|perennial allergic rhinitis
534708|NCT01287364|PAR|par
534709|NCT01287351|Real-world|real-world
534710|NCT01287351|observational|observational
534711|NCT01287351|Fluticasone propionate|fluticasone propionate
534712|NCT01287351|Metred dose inhaler|metred dose inhaler
534713|NCT01287351|Extra-fine hydrofluoroalkane|extra-fine hydrofluoroalkane
534714|NCT01287351|Asthma management|asthma management
534715|NCT01287351|Inhaled corticosteroids|inhaled corticosteroids
534716|NCT01287351|Beclomethasone dipropionate|beclomethasone dipropionate
534717|NCT01287351|USA|usa
534718|NCT01287325|Chronic obstructive pulmonary disease|chronic obstructive pulmonary disease
534719|NCT01287325|Cough|cough
534720|NCT01287325|DNK333|dnk333
534721|NCT01287312|We will treat children age 1 month to 20 years with recurrent TEF after surgical failure|we will treat children age 1 month to 20 years with recurrent tef after surgical failure
534722|NCT01287299|pregnancy|pregnancy
534723|NCT01287299|obesity|obesity
534724|NCT01287299|diet glycemic load|diet glycemic load
534725|NCT01287299|body composition|body composition
534726|NCT01287299|body fat|body fat
534727|NCT01287299|gestational weight gain|gestational weight gain
534728|NCT01287299|insulin resistance|insulin resistance
534729|NCT01287286|Cancers|cancers
534730|NCT01287286|Antrodia cinnamomea|antrodia cinnamomea
534731|NCT01287286|Chemotherapy|chemotherapy
534732|NCT01287286|Gastrointestinal Disorder|gastrointestinal disorder
534733|NCT01287273|frozen-thawed|frozen-thawed
534734|NCT01287273|IVF|ivf
534735|NCT01287273|incubation|incubation
534736|NCT01287273|pregnancy rate|pregnancy rate
534737|NCT01287273|Pregnancy rate of frozen-thawed embryos of IVF treatments|pregnancy rate of frozen-thawed embryos of ivf treatments
534738|NCT01287260|BAYA1040_Nifedipine|baya1040_nifedipine
534739|NCT01287260|Nifedipine|nifedipine
534740|NCT01287260|Essential hypertension|essential hypertension
534741|NCT01287260|Japanese Patients|japanese patients
534742|NCT01287260|Phase III|phase iii
534743|NCT01287260|13176|13176
534744|NCT01287247|Cervical dystonia|cervical dystonia
534745|NCT01287247|Blepharospasm|blepharospasm
534746|NCT01287208|Physical activity|physical activity
534747|NCT01287208|Accelerometer|accelerometer
534748|NCT01287208|Steps|steps
534749|NCT01287208|Medical residents|medical residents
534750|NCT01287195|Ulcerative Colitis|ulcerative colitis
534751|NCT01287195|Inflammatory Bowel Disease|inflammatory bowel disease
534752|NCT01287182|Asymptomatic Myocardial Ischemic patients|asymptomatic myocardial ischemic patients
534753|NCT01287169|Bisphenol A|bisphenol a
534754|NCT01287156|Recruitment|recruitment
534755|NCT01287156|TBI|tbi
534756|NCT01287156|Screening|screening
534757|NCT01287156|Traumatic Brain Injury|traumatic brain injury
534758|NCT01287143|Fever|fever
534759|NCT01287143|Signs and Symptoms|signs and symptoms
534760|NCT01287143|Febrile Assessment Tool (FAST)|febrile assessment tool (fast)
534761|NCT01287130|Antibodies|antibodies
534762|NCT01287130|Pharmacokinetics|pharmacokinetics
534763|NCT01287130|Kinase Inhibitors|kinase inhibitors
534764|NCT01287130|Colon Cancer|colon cancer
534765|NCT01287130|K-Ras|k-ras
534766|NCT01287130|Colorectal Cancer|colorectal cancer
534767|NCT01287130|Solid Tumor|solid tumor
534768|NCT01287104|Leukemia/Lymphoma|leukemia/lymphoma
534769|NCT01287104|Hematologic Malignancies|hematologic malignancies
534770|NCT01287104|Leukemia|leukemia
534771|NCT01287104|Lymphoma|lymphoma
534772|NCT01287104|Ewing Sarcoma|ewing sarcoma
534773|NCT01287104|Rhabdomyosarcoma|rhabdomyosarcoma
534774|NCT01287104|Neuroblastoma|neuroblastoma
534775|NCT01287104|Healthy Donor|healthy donor
534978|NCT01286233|fatigue|fatigue
534776|NCT01287078|Peripheral Blood Stem Cell Transplant|peripheral blood stem cell transplant
534777|NCT01287078|Inhaled Cyclosporine|inhaled cyclosporine
534778|NCT01287078|Graft-Versus-Host Disease|graft-versus-host disease
534779|NCT01287078|GVHD|gvhd
534780|NCT01287078|Bronchiolitis Obliterans|bronchiolitis obliterans
534781|NCT01287078|Lung|lung
534782|NCT01287065|Fluticasone furoate|fluticasone furoate
534783|NCT01287065|Vilanterol|vilanterol
534784|NCT01287065|Efficacy|efficacy
534785|NCT01287065|FEV1|fev1
534786|NCT01287065|FF/VI Inhalation powder|ff/vi inhalation powder
534787|NCT01287052|Migraine|migraine
534788|NCT01287052|Pediatric|pediatric
534789|NCT01287052|Adolescent|adolescent
534790|NCT01287052|Nitrous Oxide|nitrous oxide
534791|NCT01287026|MRI Catheterization|mri catheterization
534792|NCT01287026|Right Heart Catheterization|right heart catheterization
534793|NCT01287026|Pulmonary Artery Catheterization|pulmonary artery catheterization
534794|NCT01287026|MRI Safety|mri safety
534795|NCT01287026|Jugular Vein Catheterization|jugular vein catheterization
534796|NCT01287026|Heart Catheterization|heart catheterization
534797|NCT01287026|Heart Disease|heart disease
534798|NCT01287026|Cardiovascular Disease|cardiovascular disease
534799|NCT01287013|Image Guided Procedures|image guided procedures
534800|NCT01287013|Xperguide CT|xperguide ct
534801|NCT01287013|Electromagnetic Tracking|electromagnetic tracking
534802|NCT01287013|Navigation|navigation
534803|NCT01287013|Image Guided Procedure|image guided procedure
534804|NCT01287013|Cancer|cancer
534805|NCT01287013|Granuloma|granuloma
534806|NCT01287000|Respiratory Health Outcomes|respiratory health outcomes
534807|NCT01287000|Mental Health|mental health
534808|NCT01287000|Dispersant(s)|dispersant(s)
534809|NCT01287000|Oil Spill|oil spill
534810|NCT01287000|Cancer|cancer
534811|NCT01286987|BRCA1 Protein|brca1 protein
534812|NCT01286987|BRCA2 Protein|brca2 protein
534813|NCT01286961|Bowel preparation|bowel preparation
534814|NCT01286961|Polyethylene glycols|polyethylene glycols
534815|NCT01286961|Colonoscopy|colonoscopy
534816|NCT01286961|Outpatient|outpatient
534817|NCT01286948|LNG gel|lng gel
534818|NCT01286948|oral LNG|oral lng
534819|NCT01286948|follicle rupture|follicle rupture
534820|NCT01286948|intra-vaginal administration|intra-vaginal administration
534821|NCT01286948|growth of the leading follicle|growth of the leading follicle
534822|NCT01286948|preovulatory peak of serum luteinizing hormone|preovulatory peak of serum luteinizing hormone
534823|NCT01286948|characteristics of the cervical mucus|characteristics of the cervical mucus
534824|NCT01286948|serum levels of estradiol (E2) and progesterone (P)|serum levels of estradiol (e2) and progesterone (p)
534825|NCT01286935|Parkinson's Disease|parkinson's disease
534826|NCT01286935|PD|pd
534827|NCT01286935|Levodopa|levodopa
534828|NCT01286935|Patients with idiopathic Parkinson's Disease with motor fluctuations,|patients with idiopathic parkinson's disease with motor fluctuations,
534829|NCT01286922|diabetes|diabetes
534830|NCT01286922|exercise|exercise
534831|NCT01286922|insulin resistance|insulin resistance
534832|NCT01286922|interval training|interval training
534833|NCT01286922|physical activity|physical activity
534834|NCT01286909|Metabolic|metabolic
534835|NCT01286896|advanced solid tumors|advanced solid tumors
534836|NCT01286883|stem cell markers|stem cell markers
534837|NCT01286883|prognostic markers|prognostic markers
534838|NCT01286883|metastatic colorectal cancer|metastatic colorectal cancer
534839|NCT01286883|circulating tumor cells|circulating tumor cells
534840|NCT01286883|tumor microenvironment|tumor microenvironment
534841|NCT01286883|colorectal cancer|colorectal cancer
534842|NCT01286883|advanced colorectal cancer|advanced colorectal cancer
534843|NCT01286870|Primary Breast Reconstruction|primary breast reconstruction
534844|NCT01286831|Accelerator Mass Spectrometry (AMS)|accelerator mass spectrometry (ams)
534845|NCT01286831|Beta-2 agonist|beta-2 agonist
534846|NCT01286831|Absorption, Distribution, Metabolism and Excretion (ADME)|absorption, distribution, metabolism and excretion (adme)
534847|NCT01286831|Radiolabel|radiolabel
534848|NCT01286818|Colon Cancer|colon cancer
534849|NCT01286818|Rectal Cancer|rectal cancer
534850|NCT01286766|unresectable|unresectable
534851|NCT01286766|locally advanced|locally advanced
534852|NCT01286740|HIV-1|hiv-1
534853|NCT01286740|HIV|hiv
534854|NCT01286740|Treatment Experienced|treatment experienced
534855|NCT01286701|Bioequivalence|bioequivalence
534856|NCT01286701|crossover|crossover
534857|NCT01286701|Terbinafine hydrochloride|terbinafine hydrochloride
534858|NCT01286701|fed|fed
534859|NCT01286688|Bioequivalence|bioequivalence
534860|NCT01286688|crossover|crossover
534861|NCT01286688|Terbinafine hydrochloride|terbinafine hydrochloride
534862|NCT01286688|Fasting|fasting
534863|NCT01286675|ASCT|asct
534864|NCT01286675|G-CSF|g-csf
534865|NCT01286662|gardner syndrome|gardner syndrome
534866|NCT01286662|colorectal carcinoma|colorectal carcinoma
534867|NCT01286662|desmoid tumor|desmoid tumor
534868|NCT01286662|resection|resection
534869|NCT01286662|colon|colon
534870|NCT01286649|Alopecia|alopecia
534871|NCT01286649|Alopecia, Androgenetic|alopecia, androgenetic
534872|NCT01286649|Androgenetic Alopecia|androgenetic alopecia
534873|NCT01286636|artificial neural network|artificial neural network
534874|NCT01286610|vibration|vibration
534876|NCT01286610|blood pressure|blood pressure
534877|NCT01286610|intracranial pressure|intracranial pressure
534878|NCT01286610|infection|infection
534879|NCT01286610|indirect calorimetry|indirect calorimetry
534880|NCT01286597|lactose intolerance|lactose intolerance
534881|NCT01286597|DNA sequencing|dna sequencing
534882|NCT01286597|psychosocial factors|psychosocial factors
534883|NCT01286597|irritable bowel syndrome|irritable bowel syndrome
534884|NCT01286597|visceral hypersensitivity|visceral hypersensitivity
534885|NCT01286584|varenicline|varenicline
534886|NCT01286584|alcohol|alcohol
534887|NCT01286584|placebo|placebo
534888|NCT01286584|smoking cessation|smoking cessation
534889|NCT01286545|Ankylosing spondylitis|ankylosing spondylitis
534890|NCT01286545|Infliximab|infliximab
534891|NCT01286545|Radiographic progression|radiographic progression
534892|NCT01286532|Asthma, Asthma in Children|asthma, asthma in children
534893|NCT01286519|pharmacokinetics|pharmacokinetics
534894|NCT01286506|Pulse pressure variation|pulse pressure variation
534895|NCT01286506|Continuous venovenous hemodialysis|continuous venovenous hemodialysis
534896|NCT01286506|Volume status|volume status
534897|NCT01286506|Critical care|critical care
534898|NCT01286493|HIV|hiv
534899|NCT01286493|booster|booster
534900|NCT01286493|rabies|rabies
534901|NCT01286493|immune response|immune response
534902|NCT01286480|Health Care Transition|health care transition
534903|NCT01286480|Adolescent|adolescent
534904|NCT01286467|PF-04449913|pf-04449913
534905|NCT01286467|Hedgehog Inhibitor|hedgehog inhibitor
534906|NCT01286467|Solid tumor|solid tumor
534907|NCT01286467|Pharmacokinetics|pharmacokinetics
534908|NCT01286467|Safety|safety
534909|NCT01286467|Pharmacodynamics|pharmacodynamics
534910|NCT01286454|BIOAVAILABILITY|bioavailability
534911|NCT01286454|FOOD EFFECT|food effect
534912|NCT01286441|Verruca vulgaris|verruca vulgaris
534913|NCT01286428|liver|liver
534914|NCT01286428|cancer|cancer
534915|NCT01286428|tumor|tumor
534916|NCT01286428|ablation|ablation
534917|NCT01286428|Pathfinder|pathfinder
534918|NCT01286415|Posttraumatic Stress Disorder|posttraumatic stress disorder
534919|NCT01286415|Cognitive Processing Therapy|cognitive processing therapy
534920|NCT01286415|combat|combat
534921|NCT01286415|military|military
534922|NCT01286415|CPT|cpt
534923|NCT01286415|group therapy|group therapy
534924|NCT01286402|Smoking cessation during pregnancy|smoking cessation during pregnancy
534925|NCT01286402|bupropion|bupropion
534926|NCT01286389|Mild cognitive impairment|mild cognitive impairment
534927|NCT01286389|Dementia|dementia
534928|NCT01286389|Obesity|obesity
534929|NCT01286389|Overweight|overweight
534930|NCT01286389|diet|diet
534931|NCT01286389|caloric restriction|caloric restriction
534932|NCT01286389|body composition|body composition
534933|NCT01286389|weight loss|weight loss
534934|NCT01286376|Symbiotics|symbiotics
534935|NCT01286376|Fiber|fiber
534936|NCT01286376|Constipation|constipation
534937|NCT01286363|Bite force|bite force
534938|NCT01286363|Dental occlusion|dental occlusion
534939|NCT01286363|Face|face
534940|NCT01286363|Mastication|mastication
534941|NCT01286363|Morphology|morphology
534942|NCT01286350|motivational interviewing|motivational interviewing
534943|NCT01286350|problem solving skills training|problem solving skills training
534944|NCT01286350|family communication|family communication
534945|NCT01286350|social support|social support
534946|NCT01286350|adolescents|adolescents
534947|NCT01286337|axilla|axilla
534948|NCT01286337|surgery|surgery
534949|NCT01286337|technique|technique
534950|NCT01286337|bipolar vessel sealing|bipolar vessel sealing
534951|NCT01286324|Matricaria|matricaria
534952|NCT01286324|Chamomile|chamomile
534953|NCT01286324|Herb|herb
534954|NCT01286324|Insomnia|insomnia
534955|NCT01286311|Health Education|health education
534956|NCT01286311|Health Knowledge, Attitudes, Practice|health knowledge, attitudes, practice
534957|NCT01286311|Hypolipidemic Agents/therapeutic use|hypolipidemic agents/therapeutic use
534958|NCT01286311|Patient Education as Topic|patient education as topic
534959|NCT01286298|diode laser|diode laser
534960|NCT01286298|gingival enlargement|gingival enlargement
534961|NCT01286298|gingival overgrowth|gingival overgrowth
534962|NCT01286298|gingival hyperplasia|gingival hyperplasia
534963|NCT01286298|orthodontics|orthodontics
534964|NCT01286285|influenza|influenza
534965|NCT01286285|acute respiratory infections|acute respiratory infections
534966|NCT01286285|paediatric|paediatric
534967|NCT01286285|intensive care units|intensive care units
534968|NCT01286285|epidemiology|epidemiology
534969|NCT01286259|HIV|hiv
534970|NCT01286259|HAART suppressed|haart suppressed
534971|NCT01286259|Disulfiram|disulfiram
534972|NCT01286259|Antabuse|antabuse
534973|NCT01286259|Latent reservoir|latent reservoir
534974|NCT01286259|Eradication|eradication
534975|NCT01286259|Cure|cure
534976|NCT01286246|Progesterone|progesterone
534977|NCT01286246|Randomized controlled trial|randomized controlled trial
534979|NCT01286233|sleep disorders|sleep disorders
534980|NCT01286233|depression|depression
534981|NCT01286233|stage IA breast cancer|stage ia breast cancer
534982|NCT01286233|stage IB breast cancer|stage ib breast cancer
534983|NCT01286233|stage II breast cancer|stage ii breast cancer
534984|NCT01286233|stage IIIA breast cancer|stage iiia breast cancer
534985|NCT01286207|Migraine headache|migraine headache
534986|NCT01286181|COPD|copd
534987|NCT01286181|Biofeedback|biofeedback
534988|NCT01286181|Dyspnea|dyspnea
534989|NCT01286181|Quality of life|quality of life
534990|NCT01286181|Stress|stress
534991|NCT01286168|Bilateral breast mastectomy|bilateral breast mastectomy
534992|NCT01286168|Immediate tissue expanders reconstruction|immediate tissue expanders reconstruction
534993|NCT01286155|Barrett's esophagus|barrett's esophagus
534994|NCT01286155|gastroesophageal reflux disease|gastroesophageal reflux disease
534995|NCT01286155|GERD|gerd
534996|NCT01286142|Prospective, Observational Safety Study|prospective, observational safety study
534997|NCT01286116|heart failure|heart failure
534998|NCT01286116|percutaneous|percutaneous
534999|NCT01286116|interventional cardiology|interventional cardiology
535000|NCT01286116|apical remodeling|apical remodeling
535001|NCT01286116|LV dilatation|lv dilatation
535002|NCT01286116|akinesis|akinesis
535003|NCT01286116|dyskinesis|dyskinesis
535004|NCT01286116|myocardial infarction|myocardial infarction
535005|NCT01286103|Canagliflozin|canagliflozin
535006|NCT01286103|Pharmacokinetics|pharmacokinetics
535007|NCT01286103|Pharmacodynamics|pharmacodynamics
535008|NCT01286090|Cisapride (PREPULSID)|cisapride (prepulsid)
535009|NCT01286090|Placebo|placebo
535010|NCT01286090|Diabetes mellitus|diabetes mellitus
535011|NCT01286090|Diabetic gastroparesis|diabetic gastroparesis
535012|NCT01286077|Multiple Myeloma|multiple myeloma
535013|NCT01286077|bortezomib|bortezomib
535014|NCT01286077|hematology|hematology
535015|NCT01286077|bone marrow cancer|bone marrow cancer
535016|NCT01286077|Myeloma-related bone disease|myeloma-related bone disease
535017|NCT01286077|bone mineral density|bone mineral density
535018|NCT01286077|bone markers|bone markers
535019|NCT01286064|adenocarcinoma,|adenocarcinoma,
535020|NCT01286064|colorectal tumors,|colorectal tumors,
535021|NCT01286064|endogenous porphyrins,|endogenous porphyrins,
535022|NCT01286064|fluorescence,|fluorescence,
535023|NCT01286064|tumor markers.|tumor markers.
535024|NCT01286051|ovulation induction, GnRH|ovulation induction, gnrh
535025|NCT01286038|platelets|platelets
535026|NCT01286025|medical education|medical education
535027|NCT01286025|problem-based learning|problem-based learning
535028|NCT01286025|interactive tutorial|interactive tutorial
535029|NCT01286012|End Stage Renal Disease, Hemodialysis, SFP|end stage renal disease, hemodialysis, sfp
535030|NCT01285986|Graft patency|graft patency
535031|NCT01285986|Limb salvage|limb salvage
535032|NCT01285960|Uterine fibroids|uterine fibroids
535033|NCT01285960|MRgFUS|mrgfus
535034|NCT01285960|ExAblate|exablate
535035|NCT01285960|Focused Ultrasound|focused ultrasound
535036|NCT01285960|Symptomatic uterine fibroids|symptomatic uterine fibroids
535037|NCT01285947|pain experience|pain experience
535038|NCT01285947|energy devices|energy devices
535039|NCT01285947|Ulthera|ulthera
535040|NCT01285947|Thermage|thermage
535041|NCT01285947|VBeam|vbeam
535042|NCT01285921|hippocampal|hippocampal
535043|NCT01285921|vestibular test|vestibular test
535044|NCT01285908|Baroreceptor|baroreceptor
535045|NCT01285908|Norepinephrine|norepinephrine
535046|NCT01285908|Orthostatic Hypotension|orthostatic hypotension
535047|NCT01285908|Sympathetic Nervous System|sympathetic nervous system
535048|NCT01285908|Blood Pressure|blood pressure
535049|NCT01285895|Lung and heart transplantations|lung and heart transplantations
535050|NCT01285895|Mucoviscidosis|mucoviscidosis
535051|NCT01285895|Educational needs|educational needs
535052|NCT01285882|Lung transplantations|lung transplantations
535053|NCT01285882|Representations|representations
535054|NCT01285882|Mucoviscidosis|mucoviscidosis
535055|NCT01285869|Pneumonia|pneumonia
535056|NCT01285869|Intervention Studies|intervention studies
535057|NCT01285869|Aged|aged
535058|NCT01285869|Aged, 80 and over|aged, 80 and over
535059|NCT01285869|Geriatric Assessment|geriatric assessment
535060|NCT01285856|patients|patients
535061|NCT01285856|illicit consumption of psychotropic agents and alcohol|illicit consumption of psychotropic agents and alcohol
535062|NCT01285856|buprenorphine|buprenorphine
535063|NCT01285856|methadone|methadone
535064|NCT01285830|Infants|infants
535065|NCT01285830|Probiotics|probiotics
535066|NCT01285830|Prevention|prevention
535067|NCT01285830|Lactobacillus reuteri|lactobacillus reuteri
535068|NCT01285830|Eczema|eczema
535069|NCT01285830|IgE|ige
535070|NCT01285830|Sensitization|sensitization
535071|NCT01285830|Microbiota|microbiota
535072|NCT01285830|Chemokines|chemokines
535073|NCT01285791|morbid obesity|morbid obesity
535074|NCT01285791|intra-abdominal visceral fat|intra-abdominal visceral fat
535075|NCT01285791|gastric bypass|gastric bypass
535076|NCT01285791|sleeve gastrectomy|sleeve gastrectomy
535077|NCT01285791|gastric banding|gastric banding
535078|NCT01285791|visceral fat|visceral fat
535079|NCT01285778|Anal squamous cell carcinoma|anal squamous cell carcinoma
535080|NCT01285778|panitumumab|panitumumab
535081|NCT01285778|chemoradiation|chemoradiation
535082|NCT01285778|anal cancer|anal cancer
535083|NCT01285778|GEMCAD-09-02|gemcad-09-02
535084|NCT01285739|Pulmonary Disease, Chronic Obstructive.|pulmonary disease, chronic obstructive.
535085|NCT01285739|Tracheostomy.|tracheostomy.
535086|NCT01285739|Invasive Mechanical Ventilation.|invasive mechanical ventilation.
535087|NCT01285739|Non-Invasive Mechanical Ventilation.|non-invasive mechanical ventilation.
535088|NCT01285726|Peritoneal dialysis|peritoneal dialysis
535089|NCT01285726|Hydration status|hydration status
535090|NCT01285726|Residual renal function|residual renal function
535091|NCT01285726|Bioimpedance spectroscopy|bioimpedance spectroscopy
535092|NCT01285726|Body composition monitor|body composition monitor
535093|NCT01285713|Dehydration|dehydration
535094|NCT01285713|Gastroenteritis|gastroenteritis
535095|NCT01285713|Dehydration in Gastroenteritis|dehydration in gastroenteritis
535096|NCT01285687|Tonsillectomy|tonsillectomy
535097|NCT01285687|Post-Operative Pain|post-operative pain
535098|NCT01285687|Acupuncture|acupuncture
535099|NCT01285674|cisplatin|cisplatin
535100|NCT01285674|ototoxicity|ototoxicity
535101|NCT01285674|intratympanic steroids|intratympanic steroids
535102|NCT01285661|Deep venous thrombosis|deep venous thrombosis
535103|NCT01285661|Pulmonary embolism|pulmonary embolism
535104|NCT01285661|Ultrasonography|ultrasonography
535105|NCT01285661|D-dimer|d-dimer
535106|NCT01285661|Venous thromboembolism|venous thromboembolism
535107|NCT01285661|Bleeding|bleeding
535108|NCT01285648|chest tubes,|chest tubes,
535109|NCT01285648|Continuous Positive Airway Pressure,|continuous positive airway pressure,
535110|NCT01285648|lung resection, thoracic surgery,|lung resection, thoracic surgery,
535111|NCT01285648|noninvasive ventilation,|noninvasive ventilation,
535112|NCT01285648|postoperative|postoperative
535113|NCT01285622|Surgery; gynecological|surgery; gynecological
535114|NCT01285622|Stroke volume|stroke volume
535115|NCT01285596|Pharmacokinetics|pharmacokinetics
535116|NCT01285596|Cardiography|cardiography
535117|NCT01285596|Impedance|impedance
535118|NCT01285596|Age groups|age groups
535119|NCT01285596|Gender Identity|gender identity
535120|NCT01285583|Amyotrophoc Lateral Sclerosis|amyotrophoc lateral sclerosis
535121|NCT01285583|TRO19622|tro19622
535122|NCT01285583|Olesoxime|olesoxime
535123|NCT01285583|Trophos|trophos
535124|NCT01285557|Gastric Cancer , S-1, Phase 3|gastric cancer , s-1, phase 3
535125|NCT01285544|statins|statins
535126|NCT01285544|cholesterol|cholesterol
535127|NCT01285544|hypercholesterolemia|hypercholesterolemia
535128|NCT01285544|atorvastatin|atorvastatin
535129|NCT01285544|Dyslipidemia in cardiovascular disease (KoLipinon)|dyslipidemia in cardiovascular disease (kolipinon)
535130|NCT01285531|lumbar puncture|lumbar puncture
535131|NCT01285531|Compass|compass
535132|NCT01285531|pressure transducer|pressure transducer
535133|NCT01285531|manometry|manometry
535134|NCT01285531|The focus of the study is to improve lumbar puncture(LP)success, reduce the number of LP attempts, reduce the number of traumatic attempts.|the focus of the study is to improve lumbar puncture(lp)success, reduce the number of lp attempts, reduce the number of traumatic attempts.
535135|NCT01285518|Type 2 diabetes|type 2 diabetes
535136|NCT01285518|intravenous|intravenous
535137|NCT01285518|single dose|single dose
535138|NCT01285505|alprazolam|alprazolam
535139|NCT01285505|sublingual|sublingual
535140|NCT01285505|bioequivalence|bioequivalence
535141|NCT01285492|COPD|copd
535142|NCT01285492|QVA149|qva149
535143|NCT01285492|NVA237|nva237
535144|NCT01285492|indacaterol|indacaterol
535145|NCT01285492|combination bronchodilator|combination bronchodilator
535146|NCT01285479|Fingolimod|fingolimod
535147|NCT01285479|FTY720|fty720
535148|NCT01285479|Gilenya|gilenya
535149|NCT01285479|Multiple sclerosis|multiple sclerosis
535151|NCT01285479|Safety|safety
535152|NCT01285479|Pregnancy|pregnancy
535153|NCT01285479|Pregnancy outcomes|pregnancy outcomes
535154|NCT01285466|Cancer|cancer
535155|NCT01285466|BEZ235|bez235
535156|NCT01285466|BKM120|bkm120
535157|NCT01285466|paclitaxel|paclitaxel
535158|NCT01285466|trastuzumab|trastuzumab
535159|NCT01285453|ASA404,|asa404,
535160|NCT01285453|vadimezan,|vadimezan,
535161|NCT01285453|docetaxel|docetaxel
535162|NCT01285440|breast|breast
535163|NCT01285440|biopsy|biopsy
535164|NCT01285440|suspicious lesion|suspicious lesion
535165|NCT01285440|molecular breast imaging|molecular breast imaging
535166|NCT01285427|DNA, sequencing|dna, sequencing
535167|NCT01285427|Identification and definition of Class I and II Human Leukocyte Antigens (HLA)|identification and definition of class i and ii human leukocyte antigens (hla)
535168|NCT01285414|Glioblastoma|glioblastoma
535169|NCT01285414|Brain Neoplasms|brain neoplasms
535170|NCT01285414|Brain Cancer|brain cancer
535171|NCT01285414|Verubulin|verubulin
535172|NCT01285401|Multiple Sclerosis|multiple sclerosis
535173|NCT01285401|Rebif|rebif
535174|NCT01285401|VigantOL® oil|vigantol® oil
535175|NCT01285401|Vitamin D|vitamin d
535176|NCT01285401|Add-on treatment|add-on treatment
535177|NCT01285388|Safety|safety
535178|NCT01285388|Tolerability|tolerability
535179|NCT01285388|Pharmacokinetic|pharmacokinetic
535180|NCT01285362|Fatty Liver Disease|fatty liver disease
535181|NCT01285362|Hepatic Steatosis|hepatic steatosis
535182|NCT01285362|Docosahexaenoic Acid|docosahexaenoic acid
535183|NCT01285362|Eicosapentanoic Acid|eicosapentanoic acid
535184|NCT01285362|Omega-3 Fatty Acids|omega-3 fatty acids
535185|NCT01285362|Elevated Transaminases|elevated transaminases
535186|NCT01285362|Fish oil supplements|fish oil supplements
535187|NCT01285349|HIV, STI, condom use, drug use,|hiv, sti, condom use, drug use,
535188|NCT01285336|Rheumatoid arthritis (RA)|rheumatoid arthritis (ra)
535189|NCT01285336|DNA repair system|dna repair system
535190|NCT01285336|polymorphism|polymorphism
535191|NCT01285336|susceptibility|susceptibility
535192|NCT01285336|copy number variation (CNV)|copy number variation (cnv)
535193|NCT01285310|Rheumatoid, Arthritis|rheumatoid, arthritis
535194|NCT01285297|Transmyocardial revascularization (TMR)|transmyocardial revascularization (tmr)
535195|NCT01285297|Bone marrow aspirate concentrate (BMAC)|bone marrow aspirate concentrate (bmac)
535196|NCT01285297|Angina|angina
535197|NCT01285284|Colonoscopy|colonoscopy
535198|NCT01285284|Music|music
535199|NCT01285284|Tolerance|tolerance
535200|NCT01285284|Pain|pain
535201|NCT01285284|Anxiety|anxiety
535202|NCT01285284|Dose of sedative drugs administered during the procedure|dose of sedative drugs administered during the procedure
535203|NCT01285271|xenon|xenon
535204|NCT01285271|sevoflurane|sevoflurane
535205|NCT01285271|cardiac anesthesia|cardiac anesthesia
535206|NCT01285271|CABG|cabg
535207|NCT01285271|Bypass surgery|bypass surgery
535208|NCT01285258|Peripartum|peripartum
535209|NCT01285258|hysterectomy|hysterectomy
535210|NCT01285258|placenta accreta|placenta accreta
535211|NCT01285258|mortality|mortality
535212|NCT01285245|insulin sensitivity|insulin sensitivity
535213|NCT01285245|interleukin-1 receptor antagonist|interleukin-1 receptor antagonist
535214|NCT01285245|inflammation|inflammation
535215|NCT01285245|hyperglycemia-induced insulin resistance|hyperglycemia-induced insulin resistance
535216|NCT01285219|Granulocyte colony-stimulating factor , recombinant|granulocyte colony-stimulating factor , recombinant
535217|NCT01285219|Polyethylene glycols|polyethylene glycols
535218|NCT01285219|Neutropenia|neutropenia
535219|NCT01285219|Drug therapy, combination|drug therapy, combination
535220|NCT01285193|hypertension|hypertension
535221|NCT01285193|high blood pressure|high blood pressure
535222|NCT01285193|treatment|treatment
535223|NCT01285193|breath control|breath control
535224|NCT01285193|breathing exercise|breathing exercise
535225|NCT01285193|audio CD|audio cd
535226|NCT01285180|COPD|copd
535227|NCT01285180|Quality of life|quality of life
535228|NCT01285180|sociodemographic data|sociodemographic data
535229|NCT01285180|cost-of-illness data|cost-of-illness data
535230|NCT01285180|roflumilast|roflumilast
535231|NCT01285180|Daxas|daxas
535232|NCT01285167|COPD|copd
535233|NCT01285167|Quality of life|quality of life
535234|NCT01285167|lung function|lung function
535235|NCT01285167|spirometry|spirometry
535236|NCT01285167|roflumilast|roflumilast
535237|NCT01285167|Daxas|daxas
535238|NCT01285167|severe COPD|severe copd
535239|NCT01285154|Hip dysplasia|hip dysplasia
535240|NCT01285154|Triple Osteotomy|triple osteotomy
535241|NCT01285154|Femoral Head Coverage|femoral head coverage
535242|NCT01285154|Femoral Head Medialization|femoral head medialization
535243|NCT01285141|HIV Infections|hiv infections
535244|NCT01285141|Acquired Immune Deficiency Syndrome|acquired immune deficiency syndrome
535245|NCT01285115|Generalized anxiety disorder|generalized anxiety disorder
535246|NCT01285115|Jingji-zhengchong|jingji-zhengchong
535247|NCT01285115|Gamisoyosan|gamisoyosan
535248|NCT01285115|anxiety|anxiety
535249|NCT01285063|overweight|overweight
535250|NCT01285063|obesity|obesity
535251|NCT01285063|physical fitness|physical fitness
535252|NCT01285063|kinder garden|kinder garden
535253|NCT01285063|preschool|preschool
535254|NCT01285050|HIV|hiv
535255|NCT01285050|Human immunodeficiency virus|human immunodeficiency virus
535256|NCT01285050|Acquired Immune Deficiency Syndrome Virus|acquired immune deficiency syndrome virus
535257|NCT01285050|AIDS Virus|aids virus
535258|NCT01285050|Immunodeficiency Virus, Human|immunodeficiency virus, human
535259|NCT01285050|Virus, Human Immunodeficiency|virus, human immunodeficiency
535260|NCT01285050|Hepatitis C|hepatitis c
535261|NCT01285050|Hepatitis C, chronic|hepatitis c, chronic
535262|NCT01285050|Hepatitis C virus|hepatitis c virus
535263|NCT01285050|Hepatitis C antibodies|hepatitis c antibodies
535264|NCT01285050|Hepatitis C antigens|hepatitis c antigens
535265|NCT01285024|total hip arthroplasty|total hip arthroplasty
535266|NCT01285024|transfusion|transfusion
535267|NCT01285024|hemostat|hemostat
535268|NCT01285011|arthrodesis|arthrodesis
535269|NCT01285011|PIP joint|pip joint
535270|NCT01284998|forefoot deformities|forefoot deformities
535271|NCT01284998|basal osteotomy|basal osteotomy
535272|NCT01284959|cognitive function|cognitive function
535273|NCT01284959|subjective experiences|subjective experiences
535274|NCT01284959|neuroleptic-induced deficit syndrome|neuroleptic-induced deficit syndrome
535275|NCT01284959|paliperidone extended-release|paliperidone extended-release
535276|NCT01284959|risperidone|risperidone
535277|NCT01284946|PCT sporadic or familial|pct sporadic or familial
535278|NCT01284946|Skin fragility and bullae lesions|skin fragility and bullae lesions
535279|NCT01284946|non-transfusion iron overload|non-transfusion iron overload
535280|NCT01284933|Stroke|stroke
535281|NCT01284933|Ischemic Attack, Transient|ischemic attack, transient
535282|NCT01284933|Magnetic Resonance Imaging|magnetic resonance imaging
535283|NCT01284933|Carotid Arteries|carotid arteries
535284|NCT01284933|Carotid Artery Plaque|carotid artery plaque
535285|NCT01284933|Atherosclerosis|atherosclerosis
535286|NCT01284920|docetaxel|docetaxel
535287|NCT01284920|Response Evaluation Criteria in Solid Tumor (RECIST)|response evaluation criteria in solid tumor (recist)
535288|NCT01284920|PSA level|psa level
535289|NCT01284920|MDV3100|mdv3100
535290|NCT01284907|Asthma|asthma
535291|NCT01284907|Asthma therapy|asthma therapy
535292|NCT01284907|Randomized controlled trial|randomized controlled trial
535293|NCT01284907|children|children
535294|NCT01284894|Dysphagia|dysphagia
535295|NCT01284894|Conventional manometry|conventional manometry
535296|NCT01284894|High resolution manometry|high resolution manometry
535297|NCT01284881|MRA|mra
535298|NCT01284881|compliance|compliance
535299|NCT01284881|OSAHS|osahs
535300|NCT01284868|Mechanisms of Pharmacological Action|mechanisms of pharmacological action
535301|NCT01284868|Pharmacodynamics|pharmacodynamics
535302|NCT01284868|Pharmacokinetics|pharmacokinetics
535303|NCT01284855|neurotoxic envenoming (WHO ICD-10 T63.0)|neurotoxic envenoming (who icd-10 t63.0)
535304|NCT01284842|sleep-deprivation|sleep-deprivation
535305|NCT01284842|virtual reality|virtual reality
535306|NCT01284842|residency|residency
535307|NCT01284842|performance|performance
535308|NCT01284816|severely obese patients|severely obese patients
535309|NCT01284803|patients|patients
535310|NCT01284803|moderate depression|moderate depression
535311|NCT01284777|cancerology|cancerology
535312|NCT01284777|genetic|genetic
535313|NCT01284764|Endoscopy|endoscopy
535314|NCT01284764|Gastrectomy|gastrectomy
535315|NCT01284764|Stomach neoplasms|stomach neoplasms
535316|NCT01284738|TM|tm
535317|NCT01284738|TI|ti
535318|NCT01284738|MP|mp
535319|NCT01284712|treatment by bleedings|treatment by bleedings
535320|NCT01284699|Parkinson|parkinson
535321|NCT01284699|contraindication to Intracerebral electrode implantation|contraindication to intracerebral electrode implantation
535322|NCT01284699|Gamma Knife radiosurgery|gamma knife radiosurgery
535323|NCT01284686|Pathophysiology|pathophysiology
535324|NCT01284686|Parkinson|parkinson
535325|NCT01284686|neuronal oscillations|neuronal oscillations
535326|NCT01284673|Cord blood stem|cord blood stem
535327|NCT01284673|neonatal asphyxia|neonatal asphyxia
535328|NCT01284647|Chronic Erosive Gastritis|chronic erosive gastritis
535329|NCT01284647|Teprenone|teprenone
535330|NCT01284647|Sucralfate|sucralfate
535331|NCT01284634|Cannabidiol|cannabidiol
535332|NCT01284634|Fatty liver|fatty liver
535333|NCT01284634|Diabetes|diabetes
535334|NCT01284634|Body fat|body fat
535335|NCT01284608|Observational|observational
535336|NCT01284608|prospective|prospective
535337|NCT01284608|metabolic changes|metabolic changes
535338|NCT01284608|metabolic syndrome|metabolic syndrome
535339|NCT01284608|diabetes|diabetes
535340|NCT01284608|prostatic cancer|prostatic cancer
535341|NCT01284608|risk fracture|risk fracture
535342|NCT01284595|Radioactive carbon|radioactive carbon
535343|NCT01284595|Absorption|absorption
535344|NCT01284595|Distribution|distribution
535345|NCT01284595|Metabolism|metabolism
535346|NCT01284595|Excretion|excretion
535347|NCT01284595|Healthy Volunteers|healthy volunteers
535348|NCT01284582|CETP|cetp
535349|NCT01284582|Vaccine|vaccine
535350|NCT01284582|Cholesterol|cholesterol
535351|NCT01284582|Inhibition|inhibition
535352|NCT01284556|partial onset seizures|partial onset seizures
535353|NCT01284530|Epilepsy|epilepsy
535354|NCT01284530|Pediatrics|pediatrics
535355|NCT01284530|Young Adults|young adults
535356|NCT01284517|Bipolar I Depression|bipolar i depression
535357|NCT01284517|Lurasidone|lurasidone
535358|NCT01284517|Latuda|latuda
535359|NCT01284491|Breast reduction|breast reduction
535360|NCT01284491|PlasmaBlade|plasmablade
535361|NCT01284491|Electrosurgery|electrosurgery
535362|NCT01284491|PEAK Surgical|peak surgical
535363|NCT01284491|Medtronic Advanced Energy|medtronic advanced energy
535364|NCT01284491|Medtronic|medtronic
535365|NCT01284478|pseudophakic cystoid macular edema, diabetic macular edema, Irvine Gass Syndrome, cataract surgery, ozurdex, dexamethasone|pseudophakic cystoid macular edema, diabetic macular edema, irvine gass syndrome, cataract surgery, ozurdex, dexamethasone
535366|NCT01284465|Type 2 diabetes self-management|type 2 diabetes self-management
535367|NCT01284465|Minority women|minority women
535368|NCT01284465|Barriers to diabetes self-management|barriers to diabetes self-management
535369|NCT01284452|Septic shock|septic shock
535370|NCT01284452|Severe sepsis|severe sepsis
535371|NCT01284452|Acute lung injury|acute lung injury
535372|NCT01284452|Acute respiratory distress syndrome|acute respiratory distress syndrome
535373|NCT01284452|ARDS|ards
535374|NCT01284426|Chronic urticaria|chronic urticaria
535375|NCT01284426|Natural course|natural course
535376|NCT01284426|Remission|remission
535377|NCT01284400|heart failure|heart failure
535378|NCT01284400|disease management|disease management
535379|NCT01284387|Mild to moderate Alzheimer's disease|mild to moderate alzheimer's disease
535380|NCT01284387|immunization|immunization
535381|NCT01284387|amyloid imaging|amyloid imaging
535382|NCT01284387|injection|injection
535383|NCT01284387|vaccine|vaccine
535384|NCT01284374|HPV Vaccines|hpv vaccines
535385|NCT01284374|Attitude to Health|attitude to health
535386|NCT01284374|Decision Making|decision making
535387|NCT01284374|Qualitative Research|qualitative research
535388|NCT01284361|intermittent catheter|intermittent catheter
535389|NCT01284361|preference|preference
535390|NCT01284348|Chemotherapy induced anemia|chemotherapy induced anemia
535391|NCT01284348|Non-small cell lung cancer|non-small cell lung cancer
535392|NCT01284335|Advanced solid tumors|advanced solid tumors
535393|NCT01284335|Unresectable|unresectable
535394|NCT01284335|Metastatic|metastatic
535395|NCT01284335|Limited treatment options|limited treatment options
535396|NCT01284335|Measurable or nonmeasurable disease|measurable or nonmeasurable disease
535397|NCT01284309|Intraocular Pressure (IOP)|intraocular pressure (iop)
535398|NCT01284309|YM178|ym178
535399|NCT01284283|Arthrosis|arthrosis
535400|NCT01284283|Rheumatoid Arthrosis|rheumatoid arthrosis
535401|NCT01284283|Arthritic Joint|arthritic joint
535402|NCT01284283|Rheumatoid Arthritis|rheumatoid arthritis
535403|NCT01284283|Osteoarthritis|osteoarthritis
535404|NCT01284283|Total Ankle Replacement|total ankle replacement
535405|NCT01284270|Cardiac MRI|cardiac mri
535406|NCT01284270|Plaque|plaque
535407|NCT01284257|EC-MPS|ec-mps
535408|NCT01284257|MMF|mmf
535409|NCT01284257|kidney transplant|kidney transplant
535410|NCT01284257|outcomes|outcomes
535411|NCT01284257|mycophenolate sodium|mycophenolate sodium
535412|NCT01284257|mycophenolic acid (MPA)|mycophenolic acid (mpa)
535413|NCT01284244|Urinary Incontinence, Stress|urinary incontinence, stress
680123|NCT00712530|HIV|hiv
535414|NCT01284244|pessary|pessary
535415|NCT01284244|conservative management|conservative management
535416|NCT01284231|MEDI-565, gastrointestinal adenocarcinomas, carcinoembryonic antigen, bispecific T-cell engager|medi-565, gastrointestinal adenocarcinomas, carcinoembryonic antigen, bispecific t-cell engager
535417|NCT01284205|non-muscle invasive bladder cancer|non-muscle invasive bladder cancer
535418|NCT01284205|superficial bladder cancer|superficial bladder cancer
535419|NCT01284192|B-cell Lymphoma|b-cell lymphoma
535420|NCT01284192|Advanced Malignancies|advanced malignancies
535421|NCT01284192|Anaplastic Lymphoma Kinase (ALK)|anaplastic lymphoma kinase (alk)
535422|NCT01284192|ASP3026|asp3026
535423|NCT01284192|Solid Tumor|solid tumor
535424|NCT01284179|Functional Chest Pain|functional chest pain
535425|NCT01284179|Functional GI Disorders|functional gi disorders
535426|NCT01284179|Home Hypnotherapy|home hypnotherapy
535427|NCT01284153|respiratory gating|respiratory gating
535428|NCT01284153|prone radiotherapy|prone radiotherapy
535429|NCT01284153|breast cancer|breast cancer
535430|NCT01284140|Critical illness|critical illness
535431|NCT01284140|Sleep|sleep
535432|NCT01284140|Polysomnography|polysomnography
535433|NCT01284140|Respiratory failure|respiratory failure
535434|NCT01284140|Circadian rhythm|circadian rhythm
535435|NCT01284140|Sedation|sedation
535436|NCT01284127|superficial siderosis|superficial siderosis
535437|NCT01284114|Elderly chronic kidney disease|elderly chronic kidney disease
535438|NCT01284114|Hypertension|hypertension
535439|NCT01284114|Aliskiren|aliskiren
535440|NCT01284088|Male Circumcision|male circumcision
535441|NCT01284088|HIV Prevention|hiv prevention
535442|NCT01284088|Medical Device|medical device
535443|NCT01284062|Active Ulcerative Colitis|active ulcerative colitis
535444|NCT01284062|Phase 2A|phase 2a
535445|NCT01284062|Double-blind|double-blind
535446|NCT01284062|Randomized|randomized
535447|NCT01284062|PK/PD Biomarker Study|pk/pd biomarker study
535448|NCT01284049|Home Parenteral Nutrition|home parenteral nutrition
535449|NCT01284049|Intralipid 20%®|intralipid 20%®
535450|NCT01284049|OMEGAVEN 10%®|omegaven 10%®
535451|NCT01284049|Liver diseases|liver diseases
535452|NCT01284036|Healthy subject|healthy subject
535453|NCT01284036|safety|safety
535454|NCT01284036|PK study|pk study
535455|NCT01284036|healthy volunteers|healthy volunteers
535456|NCT01284023|near infrared spectroscopy|near infrared spectroscopy
535457|NCT01284023|acute compartment syndrome|acute compartment syndrome
535458|NCT01284010|adult acute lymphoblastic leukemia|adult acute lymphoblastic leukemia
535459|NCT01283997|Multiple Myeloma|multiple myeloma
535460|NCT01283997|Neuropathy|neuropathy
535461|NCT01283997|Peripheral Nerve Function|peripheral nerve function
535462|NCT01283997|Touch Detection Threshold|touch detection threshold
535463|NCT01283997|Nerve Damage|nerve damage
535464|NCT01283997|Thalidomide|thalidomide
535465|NCT01283997|Bortezomib|bortezomib
535466|NCT01283997|Velcade|velcade
535467|NCT01283997|Minocycline|minocycline
535468|NCT01283997|Dynacin|dynacin
535469|NCT01283997|Minocin|minocin
535470|NCT01283997|Minocin PAC|minocin pac
535471|NCT01283997|Myrac|myrac
535472|NCT01283997|Solodyn|solodyn
535473|NCT01283984|Safety|safety
535474|NCT01283984|tolerability|tolerability
535475|NCT01283984|healthy|healthy
535476|NCT01283984|inhaled|inhaled
535477|NCT01283984|respiratory disease|respiratory disease
535478|NCT01283958|Iloprost, Eisenmenger's syndrome|iloprost, eisenmenger's syndrome
535479|NCT01283945|VEGFRs|vegfrs
535480|NCT01283945|FGFR1|fgfr1
535481|NCT01283945|angiogenesis|angiogenesis
535482|NCT01283906|Mucositis|mucositis
535483|NCT01283906|Head and Neck Cancer|head and neck cancer
535484|NCT01283906|Squamous Cell Cancer|squamous cell cancer
535485|NCT01283906|Chemotherapy|chemotherapy
535486|NCT01283906|Radiation Therapy|radiation therapy
535487|NCT01283906|Oral Rinse|oral rinse
535488|NCT01283880|kidney|kidney
535489|NCT01283880|transplantation|transplantation
535490|NCT01283880|metabolic acidosis|metabolic acidosis
535491|NCT01283880|renal tubular acidosis|renal tubular acidosis
535492|NCT01283880|nephrocalcinosis|nephrocalcinosis
535493|NCT01283815|Laparoscopy|laparoscopy
535494|NCT01283815|Drainage|drainage
535495|NCT01283815|Appendectomy|appendectomy
535496|NCT01283789|breast|breast
535497|NCT01283789|cancer|cancer
535498|NCT01283789|metastatic|metastatic
535499|NCT01283789|metastasis|metastasis
535500|NCT01283763|Cervical Intraepithelial Neoplasia, Imiquimod, conization|cervical intraepithelial neoplasia, imiquimod, conization
535501|NCT01283750|care coordination|care coordination
535502|NCT01283750|dementia care|dementia care
535503|NCT01283750|intervention|intervention
535504|NCT01283750|unmet needs|unmet needs
535505|NCT01283750|community|community
535506|NCT01283750|older adults|older adults
535507|NCT01283750|caregiver|caregiver
535508|NCT01283737|Osteochondritis Dissecans|osteochondritis dissecans
535509|NCT01283737|OCD|ocd
535510|NCT01283737|Mosaicplasty|mosaicplasty
535511|NCT01283737|Demineralised Bone Matrix|demineralised bone matrix
535512|NCT01283737|DBX|dbx
680259|NCT00712088|HIV|hiv
535513|NCT01283737|DBX Putty|dbx putty
535514|NCT01283724|Endometriosis|endometriosis
535515|NCT01283724|DEXA|dexa
535516|NCT01283724|Adolescent|adolescent
535517|NCT01283724|Safety|safety
535518|NCT01283724|Efficacy|efficacy
535519|NCT01283724|Post-menarche|post-menarche
535520|NCT01283711|wrinkles reduction|wrinkles reduction
535521|NCT01283711|rhytides reduction|rhytides reduction
535522|NCT01283711|RF treatment|rf treatment
535523|NCT01283698|psoriasis|psoriasis
535524|NCT01283698|topical|topical
535525|NCT01283698|PPT|ppt
535526|NCT01283685|Exercise, Physical|exercise, physical
535527|NCT01283672|Whole grains|whole grains
535528|NCT01283672|Barley|barley
535529|NCT01283672|Oats|oats
535530|NCT01283672|Cardiovascular disease|cardiovascular disease
535531|NCT01283672|Postprandial lipid metabolism|postprandial lipid metabolism
535532|NCT01283672|Endothelial function|endothelial function
535533|NCT01283672|Risk of cardiovascular disease in healthy men and women|risk of cardiovascular disease in healthy men and women
535534|NCT01283659|computed tomographic angiography|computed tomographic angiography
535535|NCT01283659|coronary angiogram|coronary angiogram
535536|NCT01283659|cost effectiveness|cost effectiveness
535537|NCT01283659|QoL|qol
535538|NCT01283659|Heart failure|heart failure
535539|NCT01283659|diagnostic accuracy|diagnostic accuracy
535540|NCT01283659|prospective comparative effectiveness randomized clinical trial|prospective comparative effectiveness randomized clinical trial
535541|NCT01283633|neuromodulation|neuromodulation
535542|NCT01283633|remote presence robotics|remote presence robotics
535543|NCT01283620|stroke|stroke
535544|NCT01283620|extremity, upper|extremity, upper
535545|NCT01283607|in vitro fertilization|in vitro fertilization
535546|NCT01283607|e-health|e-health
535547|NCT01283607|cognitive behavioral therapy|cognitive behavioral therapy
535548|NCT01283607|psychosocial risk profile|psychosocial risk profile
535549|NCT01283607|emotional maladjustment|emotional maladjustment
535550|NCT01283568|PMS, climacteric, depression|pms, climacteric, depression
535551|NCT01283555|Microbicide, Applicator, Safety|microbicide, applicator, safety
535552|NCT01283542|Non-functioning pituitary adenoma,|non-functioning pituitary adenoma,
535553|NCT01283542|pasireotide LAR,|pasireotide lar,
535554|NCT01283542|tumor volume|tumor volume
535555|NCT01283529|Intrathoracal blood volume|intrathoracal blood volume
535556|NCT01283529|Cardiac output|cardiac output
535557|NCT01283529|Children|children
535558|NCT01283516|ALK inhibitor,|alk inhibitor,
535559|NCT01283516|NSCLC,|nsclc,
535560|NCT01283516|LDK378,|ldk378,
535561|NCT01283516|ceritinib,|ceritinib,
535562|NCT01283516|genetic abnormalities|genetic abnormalities
535563|NCT01283503|PI3K,|pi3k,
535564|NCT01283503|Advanced solid tumor|advanced solid tumor
535565|NCT01283490|topical anesthetic, sonophoresis|topical anesthetic, sonophoresis
535566|NCT01283477|Caesarean Delivery|caesarean delivery
535567|NCT01283477|Pruritis|pruritis
535568|NCT01283477|Intrathecal Morphine|intrathecal morphine
535569|NCT01283477|Acupuncture At LI11|acupuncture at li11
535570|NCT01283464|Retinol|retinol
535571|NCT01283464|Tretinoin|tretinoin
535572|NCT01283451|near-infrared spectroscopy|near-infrared spectroscopy
535573|NCT01283425|MiniMed Paradigm insulin pump|minimed paradigm insulin pump
535670|NCT01282918|DF Test|df test
535574|NCT01283425|insulin Lispro|insulin lispro
535575|NCT01283425|Insulin Aspart|insulin aspart
535576|NCT01283425|Quick-set infusion set|quick-set infusion set
535577|NCT01283412|Delirium|delirium
535578|NCT01283412|Dexmedetomidine|dexmedetomidine
535579|NCT01283412|Adult Patients|adult patients
535580|NCT01283412|Elective Major Surgery|elective major surgery
535581|NCT01283412|General Anesthesia|general anesthesia
535582|NCT01283360|MSM|msm
535583|NCT01283360|HIV negative|hiv negative
535584|NCT01283360|microbicide|microbicide
535585|NCT01283360|prevention|prevention
535586|NCT01283347|Parkinson's disease|parkinson's disease
535587|NCT01283334|Head and Neck Cancer|head and neck cancer
535588|NCT01283334|Recurrent Metastatic Squamous Cell Carcinoma of the Head and Neck (SCCHN)|recurrent metastatic squamous cell carcinoma of the head and neck (scchn)
535589|NCT01283321|Hemostasis|hemostasis
535590|NCT01283321|Cardiopulmonary bypass (heart-lung machine)|cardiopulmonary bypass (heart-lung machine)
535591|NCT01283321|Fibrinogen|fibrinogen
535592|NCT01283321|platelet|platelet
535593|NCT01283308|Diabetes Mellitus, Type 2|diabetes mellitus, type 2
535594|NCT01283308|India|india
535595|NCT01283308|Prevention & Control|prevention & control
535596|NCT01283308|Lifestyle Intervention|lifestyle intervention
535597|NCT01283308|Translational Research|translational research
535598|NCT01283269|Rehabilitation|rehabilitation
535599|NCT01283269|Cognitive Intervention|cognitive intervention
535600|NCT01283269|Prevention|prevention
535601|NCT01283243|ARFI Imaging|arfi imaging
535602|NCT01283243|Normal values|normal values
535603|NCT01283243|HIV infection|hiv infection
535604|NCT01283230|ARFI imaging|arfi imaging
535605|NCT01283230|normal values|normal values
535606|NCT01283230|chronic liver disease|chronic liver disease
535607|NCT01283230|liver donors|liver donors
535608|NCT01283230|kidney donors|kidney donors
535609|NCT01283191|substance use|substance use
535610|NCT01283191|drug use|drug use
535611|NCT01283191|drug abuse|drug abuse
535612|NCT01283191|exercise|exercise
535613|NCT01283191|physical activity|physical activity
535614|NCT01283178|squamous cell carcinoma of the paranasal sinus and nasal cavity|squamous cell carcinoma of the paranasal sinus and nasal cavity
535615|NCT01283165|health education|health education
535616|NCT01283165|Polyparasitism|polyparasitism
535617|NCT01283165|school based deworming program|school based deworming program
535863|NCT01281982|Glioblastoma Multiforme|glioblastoma multiforme
535618|NCT01283165|integrated control of parasites|integrated control of parasites
535619|NCT01283152|Hepatic Encephalopathy|hepatic encephalopathy
535620|NCT01283152|HE|he
535621|NCT01283152|Cirrhosis|cirrhosis
535622|NCT01283152|PSE|pse
535623|NCT01283152|Portosystemic Encephalopathy|portosystemic encephalopathy
535624|NCT01283152|Hepatic coma|hepatic coma
535625|NCT01283152|AMS|ams
535626|NCT01283152|Altered mental status|altered mental status
535627|NCT01283152|Complications of cirrhosis|complications of cirrhosis
535628|NCT01283152|Chronic liver disease|chronic liver disease
535629|NCT01283139|SLE|sle
535630|NCT01283139|Systemic Lupus Erythematosus|systemic lupus erythematosus
535631|NCT01283139|Sifalimumab|sifalimumab
535632|NCT01283139|MEDI-545|medi-545
535633|NCT01283126|Hypoglycemia, cognitive function|hypoglycemia, cognitive function
535634|NCT01283113|Visceral Fat|visceral fat
535635|NCT01283113|Waist Circumference|waist circumference
535636|NCT01283113|Bioelectrical Impedance|bioelectrical impedance
535637|NCT01283113|Metabolic Syndrome|metabolic syndrome
535638|NCT01283113|Obesity|obesity
535639|NCT01283113|Type 2 Diabetes|type 2 diabetes
535640|NCT01283100|HIV, GSK2248761, GSK1349572, drug interaction, pharmacokinetics|hiv, gsk2248761, gsk1349572, drug interaction, pharmacokinetics
535641|NCT01283087|TNS|tns
535642|NCT01283087|Spinal anesthesia|spinal anesthesia
535643|NCT01283087|Lidocaine|lidocaine
535644|NCT01283048|Kidney Cancer|kidney cancer
535645|NCT01283048|Avastin|avastin
535646|NCT01283022|Pharmacokinetics|pharmacokinetics
535647|NCT01283022|Misoprostol Vaginal Insert|misoprostol vaginal insert
535648|NCT01283022|Induction of labor|induction of labor
535649|NCT01283022|Cervical Ripening|cervical ripening
535650|NCT01283022|Rate of Cesarean section|rate of cesarean section
535651|NCT01283009|pneumoniae|pneumoniae
535652|NCT01282996|Mechanical ventilation|mechanical ventilation
535653|NCT01282996|Postoperative pulmonary complications|postoperative pulmonary complications
535654|NCT01282996|Positive end-expiratory pressure|positive end-expiratory pressure
535655|NCT01282996|Protective lung ventilation|protective lung ventilation
535656|NCT01282996|Alveolar recruitment maneuver|alveolar recruitment maneuver
535657|NCT01282996|General anesthesia|general anesthesia
535658|NCT01282996|Abdominal surgery|abdominal surgery
535659|NCT01282983|fiber|fiber
535660|NCT01282983|orange juice|orange juice
535661|NCT01282983|digestive symptom|digestive symptom
535662|NCT01282944|physical activity in adults 65 or older|physical activity in adults 65 or older
535663|NCT01282931|Women|women
535664|NCT01282931|Stage IV|stage iv
535665|NCT01282931|Metastatic|metastatic
535666|NCT01282931|Breast Cancer|breast cancer
535667|NCT01282931|Progressed|progressed
535668|NCT01282931|Progression|progression
535669|NCT01282918|ICD|icd
535671|NCT01282918|intra-operative DF testing|intra-operative df testing
535672|NCT01282918|VT|vt
535673|NCT01282892|Visceral fat|visceral fat
535674|NCT01282892|fatty liver|fatty liver
535675|NCT01282892|atherosclerosis|atherosclerosis
535676|NCT01282892|coronary computed tomography angiography|coronary computed tomography angiography
535677|NCT01282879|Itraconazole oral solution|itraconazole oral solution
535678|NCT01282879|invasive fungal infections|invasive fungal infections
535679|NCT01282879|prophylaxis|prophylaxis
535680|NCT01282879|Graft vs Host Disease|graft vs host disease
535681|NCT01282879|transplantation|transplantation
535682|NCT01282853|peptic ulcer|peptic ulcer
535683|NCT01282853|hemorrhage|hemorrhage
535684|NCT01282853|rapid urease test|rapid urease test
535685|NCT01282853|urea breath test|urea breath test
535686|NCT01282840|LUTS|luts
535687|NCT01282814|Bioequivalence|bioequivalence
535688|NCT01282814|Healthy Subjects|healthy subjects
535689|NCT01282801|Bioequivalence|bioequivalence
535690|NCT01282801|Healthy Subjects|healthy subjects
535691|NCT01282788|infant nutrition|infant nutrition
535692|NCT01282788|complementary feeding|complementary feeding
535693|NCT01282788|malnutrition|malnutrition
535694|NCT01282788|stunting of growth|stunting of growth
535695|NCT01282775|overweight|overweight
535696|NCT01282775|obesity|obesity
535697|NCT01282775|worksite|worksite
535698|NCT01282762|Prevention of Hepatitis B infection.|prevention of hepatitis b infection.
535699|NCT01282762|End Stage Renal Disease|end stage renal disease
535700|NCT01282762|Hepatitis B vaccination|hepatitis b vaccination
535701|NCT01282762|Hepatitis B virus (HBV)|hepatitis b virus (hbv)
535702|NCT01282749|Overweight|overweight
535703|NCT01282749|Obesity|obesity
535704|NCT01282749|African American|african american
535705|NCT01282749|Women|women
535706|NCT01282749|Translational|translational
535707|NCT01282749|Faith based|faith based
535708|NCT01282749|Community based participatory research|community based participatory research
535709|NCT01282736|eating disorder|eating disorder
535710|NCT01282736|binge eating|binge eating
535711|NCT01282684|Safety|safety
535712|NCT01282684|Tolerability|tolerability
535713|NCT01282684|Pharmacokinetics|pharmacokinetics
535714|NCT01282684|PLX5622|plx5622
535715|NCT01282671|breathing exercises|breathing exercises
535716|NCT01282671|cardiac surgery|cardiac surgery
535717|NCT01282671|lung function|lung function
535718|NCT01282671|postoperative complication|postoperative complication
535719|NCT01282671|positive expiratory pressure|positive expiratory pressure
535720|NCT01282658|CPT-11,pharmacogenomics,colorectal cancer|cpt-11,pharmacogenomics,colorectal cancer
535721|NCT01282645|Cranial defect|cranial defect
535722|NCT01282645|PSI|psi
535723|NCT01282645|patient specific implant|patient specific implant
535724|NCT01282645|PEEK|peek
535725|NCT01282645|polyether ether ketone|polyether ether ketone
535726|NCT01282645|craniectomy|craniectomy
535727|NCT01282645|craniotomy|craniotomy
535728|NCT01282632|depression|depression
535729|NCT01282632|treatment resistant depression|treatment resistant depression
535730|NCT01282632|unipolar|unipolar
535731|NCT01282632|non- psychotic major depression|non- psychotic major depression
535732|NCT01282632|add-on to a serotonin type antidepressants|add-on to a serotonin type antidepressants
535733|NCT01282632|risperidone|risperidone
535734|NCT01282632|olanzapine|olanzapine
535735|NCT01282632|double blind comparison|double blind comparison
535736|NCT01282632|randomized|randomized
535737|NCT01282606|Chemonucleolysis|chemonucleolysis
535738|NCT01282606|Lumbar Vertebrae|lumbar vertebrae
535739|NCT01282606|Hernia|hernia
535740|NCT01282593|TEL/ALM1_positive ALL relapses|tel/alm1_positive all relapses
535741|NCT01282580|Women at high risk of developing breast cancer|women at high risk of developing breast cancer
535742|NCT01282541|Tearing, Epiphora, Botulinum Toxin A|tearing, epiphora, botulinum toxin a
535743|NCT01282502|rectal cancer|rectal cancer
535744|NCT01282502|chemotherapy|chemotherapy
535745|NCT01282502|chemoradiation|chemoradiation
535746|NCT01282476|DLBCL (Diffuse Large B Cell Lymphoma)|dlbcl (diffuse large b cell lymphoma)
535747|NCT01282476|Panobinostat|panobinostat
535748|NCT01282476|LBH589 (Panobinostat)|lbh589 (panobinostat)
535749|NCT01282476|LBH-589 (Panobinostat)|lbh-589 (panobinostat)
535750|NCT01282476|HDAC inhibitor (Histone deacetylase inhibitor)|hdac inhibitor (histone deacetylase inhibitor)
535751|NCT01282476|DAC inhibitor (deacetylase inhibitor)|dac inhibitor (deacetylase inhibitor)
535752|NCT01282476|deacetylase inhibitor|deacetylase inhibitor
535753|NCT01282476|lymphoma|lymphoma
535754|NCT01282463|Carcinoma, Renal Cell|carcinoma, renal cell
535755|NCT01282450|Radiotherapy|radiotherapy
535757|NCT01282424|indolent Non-Hodgkin Lymphoma|indolent non-hodgkin lymphoma
535758|NCT01282424|Non-Hodgkin Lymphoma|non-hodgkin lymphoma
535759|NCT01282424|iNHL|inhl
535760|NCT01282424|NHL|nhl
535761|NCT01282424|GS-1101|gs-1101
535762|NCT01282424|CAL-101|cal-101
535763|NCT01282424|PI3K|pi3k
535764|NCT01282424|Phosphatidylinositol 3-kinase|phosphatidylinositol 3-kinase
535765|NCT01282424|Follicular Lymphoma (FL)|follicular lymphoma (fl)
535766|NCT01282424|Small lymphocytic lymphoma (SLL)|small lymphocytic lymphoma (sll)
535767|NCT01282424|Lymphoplasmacytoid lymphoma (LPL)|lymphoplasmacytoid lymphoma (lpl)
535768|NCT01282424|Marginal zone lymphoma (MZL)|marginal zone lymphoma (mzl)
535769|NCT01282372|Ankylosing spondylitis|ankylosing spondylitis
535770|NCT01282372|Sleep|sleep
535771|NCT01282372|Psoriatic arthritis|psoriatic arthritis
535772|NCT01282372|Work Productivity|work productivity
535773|NCT01282372|Rheumatoid Arthritis|rheumatoid arthritis
535774|NCT01282359|Educational asthma program|educational asthma program
535775|NCT01282359|Clusters analysis study|clusters analysis study
535776|NCT01282359|Asthma Control Test|asthma control test
535777|NCT01282346|Glaucoma shunt|glaucoma shunt
535778|NCT01282346|Ocular implant|ocular implant
535779|NCT01282346|Gold|gold
535780|NCT01282346|Trabeculectomy|trabeculectomy
535781|NCT01282320|Randomized Controlled Trial|randomized controlled trial
535782|NCT01282320|Clinical Tria|clinical tria
535783|NCT01282320|Postmenopause|postmenopause
535784|NCT01282320|Hot-flashes|hot-flashes
535785|NCT01282320|Quality of life|quality of life
535786|NCT01282320|Physical Fitness|physical fitness
535787|NCT01282307|Guided Self-Determination|guided self-determination
535788|NCT01282307|Improving insight|improving insight
535789|NCT01282307|Autonomy-supportive problem solving intervention|autonomy-supportive problem solving intervention
535790|NCT01282307|Evaluate the effects of the method Guided Self-Determination|evaluate the effects of the method guided self-determination
535791|NCT01282307|Improving insight in patients diagnosed with schizophrenia|improving insight in patients diagnosed with schizophrenia
535792|NCT01282281|Bipolar Disorder|bipolar disorder
535793|NCT01282281|Youth|youth
535794|NCT01282281|Adults|adults
535795|NCT01282281|Endocrine-metabolic changes|endocrine-metabolic changes
680602|NCT00710788|death|death
535796|NCT01282268|fragile X syndrome|fragile x syndrome
535797|NCT01282268|autism spectrum disorder|autism spectrum disorder
535798|NCT01282242|acute stroke, IV rt-PA, Activase, Alteplase|acute stroke, iv rt-pa, activase, alteplase
535799|NCT01282229|LANAP, Laser dentistry|lanap, laser dentistry
535800|NCT01282203|General surgery|general surgery
535801|NCT01282203|General anesthesia|general anesthesia
535802|NCT01282203|Inhalation anesthesia|inhalation anesthesia
535803|NCT01282203|Sevorane|sevorane
535804|NCT01282203|Sevoflurane|sevoflurane
535805|NCT01282190|dyslipidemia, motivational interview, prevention|dyslipidemia, motivational interview, prevention
535806|NCT01282177|surveillance, safety , tolerability , vaccine|surveillance, safety , tolerability , vaccine
535807|NCT01282164|glucagon stimulation test|glucagon stimulation test
535808|NCT01282164|insulin tolerance test|insulin tolerance test
535809|NCT01282164|growth hormone deficiency|growth hormone deficiency
535810|NCT01282164|hypothalamic-pituitary disorders|hypothalamic-pituitary disorders
535811|NCT01282151|NSCLC|nsclc
535812|NCT01282151|Non Squamous cell|non squamous cell
535813|NCT01282151|Docetaxel|docetaxel
535814|NCT01282151|Pemetrexed|pemetrexed
535815|NCT01282138|Allergic conjunctivitis|allergic conjunctivitis
535816|NCT01282125|general population|general population
535817|NCT01282125|prevalence|prevalence
535818|NCT01282125|Norway|norway
535819|NCT01282099|all children entering the PICU eligible for enrollment|all children entering the picu eligible for enrollment
535820|NCT01282099|age range: neonate to 16 years|age range: neonate to 16 years
535821|NCT01282086|Sevorane|sevorane
535822|NCT01282086|Sevoflurane|sevoflurane
535823|NCT01282086|General anesthesia|general anesthesia
535824|NCT01282086|Inhalation anesthesia|inhalation anesthesia
535825|NCT01282086|General surgery|general surgery
535826|NCT01282073|Idiopathic membranous nephropathy|idiopathic membranous nephropathy
535827|NCT01282073|Mycophenolate mofetil|mycophenolate mofetil
535828|NCT01282073|Proteinuria|proteinuria
535829|NCT01282073|Renal function|renal function
535830|NCT01282060|HBA1C|hba1c
535831|NCT01282060|DIABETES-RELATED COMPLICATIONS|diabetes-related complications
535832|NCT01282060|GLYCAEMIC BALANCE|glycaemic balance
535833|NCT01282047|Lenalidomide|lenalidomide
535834|NCT01282047|Kaposi|kaposi
535835|NCT01282047|HIV|hiv
535836|NCT01282047|efficacy|efficacy
535837|NCT01282047|safety|safety
535838|NCT01282034|CHONDRAL|chondral
535839|NCT01282034|OSTEOCHONDRAL|osteochondral
535840|NCT01282021|Serologic RBC Antigens|serologic rbc antigens
535841|NCT01282021|RBC Antigen Molecular Studies|rbc antigen molecular studies
535842|NCT01282021|Blood Transfusion|blood transfusion
535843|NCT01282021|RBC Antigen Profiles|rbc antigen profiles
535844|NCT01282021|Alloimmunization|alloimmunization
535845|NCT01282008|Online Surveys|online surveys
535846|NCT01282008|Tobacco Corrective Statements|tobacco corrective statements
535847|NCT01282008|Message Testing|message testing
535848|NCT01282008|Focus Groups|focus groups
535849|NCT01281995|Biologic Samples|biologic samples
535850|NCT01281995|Hydrocortisone|hydrocortisone
535851|NCT01281995|Laboratory Research Specimens|laboratory research specimens
535852|NCT01281995|Glucocorticoids|glucocorticoids
535853|NCT01281995|Immune Modulation|immune modulation
535854|NCT01281995|Healthy Volunteer|healthy volunteer
535855|NCT01281995|HV|hv
535856|NCT01281982|Imaging|imaging
535857|NCT01281982|Gliomas|gliomas
535858|NCT01281982|Pet Scan|pet scan
535859|NCT01281982|Blood Brain Barrier|blood brain barrier
535860|NCT01281982|P-Glycoprotein|p-glycoprotein
535861|NCT01281982|Brain Tumor|brain tumor
535862|NCT01281982|Glioma|glioma
535864|NCT01281982|Astrocytoma|astrocytoma
535865|NCT01281969|Placebo Controlled|placebo controlled
535866|NCT01281969|Obsessive-Compulsive Disorder|obsessive-compulsive disorder
535867|NCT01281969|Children and Adolescents|children and adolescents
535868|NCT01281969|Intravenous Immunoglobulin|intravenous immunoglobulin
535869|NCT01281969|PANDAS|pandas
535870|NCT01281956|Epilepsy|epilepsy
535871|NCT01281956|Drug Trial|drug trial
535872|NCT01281956|Serotonin|serotonin
535873|NCT01281956|Serotonin 1A Receptor|serotonin 1a receptor
535874|NCT01281956|Temporal Lobe Epilepsy|temporal lobe epilepsy
535875|NCT01281956|Partial Epilepsy|partial epilepsy
535876|NCT01281930|Superficial abscess|superficial abscess
535877|NCT01281930|packing material|packing material
535878|NCT01281930|wick|wick
535879|NCT01281930|incision and drainage|incision and drainage
535880|NCT01281917|velcade|velcade
535881|NCT01281917|temsirolimus|temsirolimus
535882|NCT01281917|non-hodgkins lymphoma|non-hodgkins lymphoma
535883|NCT01281891|Drug: Morphine intrathecal|drug: morphine intrathecal
535884|NCT01281891|Pain: Postoperative|pain: postoperative
535885|NCT01281891|Surgery: Total hip arthroplasty|surgery: total hip arthroplasty
535886|NCT01281878|primary hyperoxaluria|primary hyperoxaluria
535887|NCT01281878|Pyridoxal-phosphate|pyridoxal-phosphate
535888|NCT01281839|Hepatitis C|hepatitis c
535889|NCT01281839|TMC435|tmc435
535890|NCT01281839|HCV|hcv
535891|NCT01281839|Hep C|hep c
535892|NCT01281839|Genotype 1|genotype 1
535893|NCT01281813|TMC114IFD3001|tmc114ifd3001
535894|NCT01281813|TMC114|tmc114
535895|NCT01281813|HIV|hiv
535896|NCT01281813|Darunavir|darunavir
535897|NCT01281813|PREZISTA|prezista
535898|NCT01281787|FAP= post-surgery atrial fibrillation|fap= post-surgery atrial fibrillation
535899|NCT01281787|ACEI= angiotensin converting enzyme-inhibitors|acei= angiotensin converting enzyme-inhibitors
535900|NCT01281787|ARBs= angiotensin II receptor blockers|arbs= angiotensin ii receptor blockers
535901|NCT01281787|NT-proBNP= brain natriuretic peptide|nt-probnp= brain natriuretic peptide
535902|NCT01281748|acute exacerbation of COPD|acute exacerbation of copd
535903|NCT01281735|treatment outcome|treatment outcome
535904|NCT01281735|side effects|side effects
535905|NCT01281735|Protein Kinase Inhibitors|protein kinase inhibitors
535906|NCT01281735|pediatrics|pediatrics
535907|NCT01281722|healthy adults|healthy adults
535908|NCT01281722|melanoma|melanoma
535909|NCT01281696|Breast cancer|breast cancer
535910|NCT01281696|CNS metastasis|cns metastasis
535911|NCT01281696|Brain metastasis|brain metastasis
535912|NCT01281696|Leptomeningeal metastasis|leptomeningeal metastasis
535913|NCT01281696|Bevacizumab|bevacizumab
535914|NCT01281696|Etoposide|etoposide
535915|NCT01281696|Cisplatin|cisplatin
535916|NCT01281670|H reflex; muscle activation; rate of force development; whole body vibration|h reflex; muscle activation; rate of force development; whole body vibration
535917|NCT01281657|Fingolimod|fingolimod
535918|NCT01281657|FTY720|fty720
535919|NCT01281657|Relapsing forms of multiple sclerosis|relapsing forms of multiple sclerosis
535920|NCT01281657|Multiple sclerosis|multiple sclerosis
535921|NCT01281657|MS|ms
535922|NCT01281657|Safety|safety
535923|NCT01281657|Efficacy|efficacy
535924|NCT01281644|Keratosis pilaris (KP)|keratosis pilaris (kp)
535925|NCT01281631|ALS|als
535926|NCT01281618|Barrett's esophagus|barrett's esophagus
535927|NCT01281605|Type 2 diabetes|type 2 diabetes
535928|NCT01281605|Basal insulin|basal insulin
535929|NCT01281605|Insulin detemir|insulin detemir
535930|NCT01281605|Insulin titration algorithm|insulin titration algorithm
535931|NCT01281579|Pharmacokinetics|pharmacokinetics
535932|NCT01281579|Pharmacodynamics|pharmacodynamics
535933|NCT01281579|Canagliflozin|canagliflozin
535934|NCT01281566|Cisapride (Prepulsid)|cisapride (prepulsid)
535935|NCT01281566|Feeding intolerance|feeding intolerance
535936|NCT01281566|Enteral feeding|enteral feeding
535937|NCT01281566|Nasogastric tube|nasogastric tube
535938|NCT01281566|Neonate|neonate
535939|NCT01281553|Cisapride (PREPULSID)|cisapride (prepulsid)
535940|NCT01281553|Placebo|placebo
535941|NCT01281553|Gastroesophageal Reflux Disease (GERD)|gastroesophageal reflux disease (gerd)
535942|NCT01281553|Gastro-oesophageal Reflux Disease (GORD)|gastro-oesophageal reflux disease (gord)
535943|NCT01281540|Cisapride ( PREPULSID )|cisapride ( prepulsid )
535944|NCT01281540|Placebo|placebo
535945|NCT01281540|Idiopathic|idiopathic
535946|NCT01281540|Stomach Diseases|stomach diseases
535947|NCT01281540|Stomach|stomach
535948|NCT01281527|Paliperidone palmitate|paliperidone palmitate
535949|NCT01281527|Schizophrenia|schizophrenia
535950|NCT01281527|Intramuscular injection|intramuscular injection
535951|NCT01281501|Dyspepsia|dyspepsia
535952|NCT01281501|Emergency treatment|emergency treatment
535953|NCT01281501|Pantoprazole|pantoprazole
535954|NCT01281501|Antacid|antacid
535955|NCT01281501|Pain measurement|pain measurement
535956|NCT01281475|Angelman syndrome|angelman syndrome
535957|NCT01281475|Levodopa|levodopa
535958|NCT01281475|Carbidopa|carbidopa
535959|NCT01281475|L-dopa|l-dopa
535960|NCT01281462|complicated Urinary Tract Infection|complicated urinary tract infection
535961|NCT01281462|Acute Pyelonephritis|acute pyelonephritis
535962|NCT01281436|childhood|childhood
535963|NCT01281436|overweight|overweight
535964|NCT01281436|obesity|obesity
535965|NCT01281436|Health information technology|health information technology
535966|NCT01281436|HeartSmartKids|heartsmartkids
535967|NCT01281436|Motivational Interviewing|motivational interviewing
535968|NCT01281410|respiratory muscles|respiratory muscles
535969|NCT01281410|hematopoetic stem cell transplantation|hematopoetic stem cell transplantation
535970|NCT01281410|inspiratory muscle training|inspiratory muscle training
535971|NCT01281397|cardiac surgery|cardiac surgery
535972|NCT01281397|aggregometry|aggregometry
535973|NCT01281397|thromboelastometry|thromboelastometry
535974|NCT01281397|platelet function|platelet function
535975|NCT01281397|bleeding|bleeding
535976|NCT01281397|antiplatelet therapy|antiplatelet therapy
535977|NCT01281384|cardiac magnetic resonance imaging|cardiac magnetic resonance imaging
535978|NCT01281384|echocardiography|echocardiography
535979|NCT01281384|heart failure|heart failure
535980|NCT01281384|imaging|imaging
535981|NCT01281384|cost effectiveness|cost effectiveness
535982|NCT01281384|quality of life|quality of life
535983|NCT01281384|definitive diagnosis|definitive diagnosis
535984|NCT01281384|prospective comparative effectiveness randomized clinical trial|prospective comparative effectiveness randomized clinical trial
535985|NCT01281358|Premature infants|premature infants
535986|NCT01281358|Motor Development|motor development
535987|NCT01281345|icu|icu
535988|NCT01281345|candida|candida
535989|NCT01281345|epidemiology|epidemiology
535990|NCT01281345|blood stream infection|blood stream infection
535991|NCT01281345|candidemia|candidemia
535992|NCT01281332|menopause|menopause
535993|NCT01281332|hot flash|hot flash
535994|NCT01281332|quality of life|quality of life
535995|NCT01281319|preterm labor|preterm labor
535996|NCT01281319|PROM|prom
535997|NCT01281319|mycoplasma|mycoplasma
535998|NCT01281319|ureaplasma|ureaplasma
535999|NCT01281319|high risk pregnancy|high risk pregnancy
536000|NCT01281306|hypertension|hypertension
536001|NCT01281306|blood pressure|blood pressure
536002|NCT01281306|LCZ696|lcz696
536003|NCT01281306|dual-acting|dual-acting
536004|NCT01281306|neprilysin|neprilysin
536005|NCT01281306|nep inhibitor|nep inhibitor
536006|NCT01281306|vasopeptidase|vasopeptidase
536007|NCT01281306|angiotensin receptor|angiotensin receptor
536008|NCT01281306|angiotensin receptor neprilysin inhibitor (ARNi)|angiotensin receptor neprilysin inhibitor (arni)
536009|NCT01281293|V-COMPAS; Vagus Nerve Stimulation Clinical Outcomes;|v-compas; vagus nerve stimulation clinical outcomes;
536010|NCT01281280|PuLsE 2, Drug-resistant Epilepsy Partial-onset Seizures|pulse 2, drug-resistant epilepsy partial-onset seizures
536011|NCT01281267|facial transplantation|facial transplantation
536012|NCT01281267|face transplantation|face transplantation
536013|NCT01281267|composite tissue allotransplantation|composite tissue allotransplantation
536014|NCT01281267|VCA|vca
536015|NCT01281267|composite tissue allograft|composite tissue allograft
536016|NCT01281267|facial allograft|facial allograft
536017|NCT01281254|Fallopian tube cancer|fallopian tube cancer
536018|NCT01281254|Primary peritoneal cancer|primary peritoneal cancer
536019|NCT01281254|AMG386|amg386
536020|NCT01281254|Pegylated Liposomal Doxorubicin|pegylated liposomal doxorubicin
536021|NCT01281254|Recurrent epithelial ovarian cancer|recurrent epithelial ovarian cancer
536022|NCT01281241|MTWA|mtwa
536023|NCT01281241|mechanical alternans|mechanical alternans
536024|NCT01281228|Exenatide|exenatide
536025|NCT01281228|Type 2 diabetes mellitus|type 2 diabetes mellitus
536026|NCT01281228|Incretin hormones|incretin hormones
536027|NCT01281228|GLP-1 agonist|glp-1 agonist
536028|NCT01281228|Satiety|satiety
536029|NCT01281228|Reward|reward
536030|NCT01281215|Pharmaceutical Education|pharmaceutical education
536031|NCT01281215|Rational Drug Use|rational drug use
536032|NCT01281215|Asthma|asthma
536033|NCT01281202|Cocaine|cocaine
536034|NCT01281202|Cocaine Addiction Treatment|cocaine addiction treatment
536035|NCT01281202|Cocaine Treatment|cocaine treatment
536036|NCT01281202|Vigabatrin|vigabatrin
536037|NCT01281202|CPP-109|cpp-109
536038|NCT01281202|Catalyst|catalyst
536039|NCT01281202|National Institute on Drug Abuse|national institute on drug abuse
536040|NCT01281189|Amyotrophic Lateral Sclerosis|amyotrophic lateral sclerosis
536041|NCT01281189|ALS|als
536042|NCT01281189|Motor Neurone Disease|motor neurone disease
536043|NCT01281137|stage IA breast cancer|stage ia breast cancer
536044|NCT01281137|stage IB breast cancer|stage ib breast cancer
536045|NCT01281137|stage II breast cancer|stage ii breast cancer
536046|NCT01281137|stage IIIA breast cancer|stage iiia breast cancer
536047|NCT01281098|High Risk Proliferative Diabetic Retinopathy|high risk proliferative diabetic retinopathy
536048|NCT01281098|Diabetes Mellitus Type I, Type II|diabetes mellitus type i, type ii
536049|NCT01281098|Pegaptanib|pegaptanib
536050|NCT01281098|Panretinal Photocoagulation|panretinal photocoagulation
536051|NCT01281085|Shoulder|shoulder
536052|NCT01281085|Outcome treatment|outcome treatment
536053|NCT01281085|Validation Studies|validation studies
536054|NCT01281085|Biomechanics|biomechanics
536055|NCT01281033|primary PCI|primary pci
536056|NCT01281033|ST-segment elevation myocardial infarction|st-segment elevation myocardial infarction
536057|NCT01281033|thrombus aspiration|thrombus aspiration
536058|NCT01281020|Glaucoma|glaucoma
536059|NCT01281020|Adherence|adherence
536060|NCT01281020|Fixed combination therapy|fixed combination therapy
536061|NCT01281007|Herpes Simplex Virus|herpes simplex virus
536062|NCT01280994|Lung Disease|lung disease
536063|NCT01280994|Pulmonary Disease|pulmonary disease
536064|NCT01280994|Diagnostic Imaging|diagnostic imaging
536065|NCT01280994|MRI|mri
536066|NCT01280981|Menorrhagia|menorrhagia
536067|NCT01280981|Heavy Menstrual Bleeding|heavy menstrual bleeding
536068|NCT01280981|Lysteda|lysteda
536069|NCT01280955|Plerixafor and Allogeneic Myeloablative Stem Cell Transplant|plerixafor and allogeneic myeloablative stem cell transplant
536070|NCT01280942|clinical deterioration|clinical deterioration
536071|NCT01280942|detection algorithms|detection algorithms
536072|NCT01280942|automated warning systems|automated warning systems
536073|NCT01280929|High Risk Proliferative Diabetic Retinopathy|high risk proliferative diabetic retinopathy
536074|NCT01280929|Ranibizumab|ranibizumab
536075|NCT01280929|Panretinal Photocoagulation|panretinal photocoagulation
536076|NCT01280903|Osteoarthritis, Knee|osteoarthritis, knee
536077|NCT01280903|Hypertension|hypertension
536078|NCT01280903|Exercise|exercise
536079|NCT01280903|Physical activity|physical activity
536080|NCT01280903|Self Efficacy|self efficacy
536081|NCT01280903|Patient Compliance|patient compliance
536082|NCT01280903|Aged|aged
536083|NCT01280890|Dementia|dementia
536084|NCT01280890|Nursing home|nursing home
536085|NCT01280890|Person-centred Care|person-centred care
536086|NCT01280890|Staff training|staff training
536087|NCT01280877|optic neuropathy|optic neuropathy
536088|NCT01280877|visual field|visual field
536089|NCT01280877|electric stimulation|electric stimulation
536090|NCT01280877|alternating current|alternating current
536091|NCT01280877|perimetry|perimetry
536092|NCT01280851|Living renal donor|living renal donor
536093|NCT01280851|Magnetic Resonance Imaging|magnetic resonance imaging
536094|NCT01280851|Renal vascular anatomy|renal vascular anatomy
536095|NCT01280851|Renal function|renal function
536096|NCT01280812|mobile phone|mobile phone
536097|NCT01280812|physical activity|physical activity
536098|NCT01280812|women|women
536099|NCT01280812|maintenance|maintenance
536100|NCT01280812|health promotion|health promotion
536101|NCT01280812|prevention|prevention
536102|NCT01280799|Anorexia Nervosa|anorexia nervosa
536103|NCT01280799|Adolescents|adolescents
536104|NCT01280799|Family Treatment|family treatment
536105|NCT01280799|Eating Disorder|eating disorder
536106|NCT01280799|Acceptance and Commitment Therapy|acceptance and commitment therapy
536107|NCT01280786|AML|aml
536108|NCT01280786|leukemia|leukemia
536109|NCT01280786|relapsed or refractory AML|relapsed or refractory aml
536235|NCT01280097|Sleep hygiene|sleep hygiene
536110|NCT01280773|weaning, mechanical ventilation|weaning, mechanical ventilation
536111|NCT01280747|Prior authorization|prior authorization
536112|NCT01280747|Fibromyalgia|fibromyalgia
536113|NCT01280747|Painful Diabetic Peripheral Neuropathy|painful diabetic peripheral neuropathy
536114|NCT01280747|Policy|policy
536115|NCT01280747|Real World Data|real world data
536116|NCT01280734|melatonin|melatonin
536117|NCT01280734|circadin|circadin
536118|NCT01280734|zolpidem|zolpidem
536119|NCT01280734|body sway|body sway
536120|NCT01280734|postural instability|postural instability
536121|NCT01280708|Urology|urology
536122|NCT01280708|Nephrology|nephrology
536123|NCT01280708|Renal and pancreas transplantation|renal and pancreas transplantation
536124|NCT01280708|Data base|data base
536125|NCT01280708|Epidemiology|epidemiology
536126|NCT01280695|Type 2|type 2
536127|NCT01280695|Diabetes Mellitus|diabetes mellitus
536128|NCT01280695|Diabetes|diabetes
536129|NCT01280695|High blood sugar|high blood sugar
536130|NCT01280695|Blood sugar|blood sugar
536131|NCT01280695|Blood glucose|blood glucose
536132|NCT01280695|Glucose|glucose
536133|NCT01280682|type 1 diabetes|type 1 diabetes
536134|NCT01280682|age|age
536135|NCT01280682|course of disease|course of disease
536136|NCT01280682|autoantibodies|autoantibodies
536137|NCT01280682|C-peptide levels|c-peptide levels
536138|NCT01280669|Non-infectious|non-infectious
536139|NCT01280669|Uveitis|uveitis
536140|NCT01280669|Panuveitis|panuveitis
536141|NCT01280643|stage IVA colon cancer|stage iva colon cancer
536142|NCT01280643|stage IVA rectal cancer|stage iva rectal cancer
536143|NCT01280643|stage IVB colon cancer|stage ivb colon cancer
536144|NCT01280643|stage IVB rectal cancer|stage ivb rectal cancer
536145|NCT01280630|ACS: Acute coronary syndrome Retrospective Registry|acs: acute coronary syndrome retrospective registry
536146|NCT01280617|Renal Transplant|renal transplant
536147|NCT01280617|Thymoglubulin|thymoglubulin
536148|NCT01280591|Naproxen sodium|naproxen sodium
536149|NCT01280591|Diphenhydramine|diphenhydramine
536150|NCT01280578|Migraine|migraine
536151|NCT01280565|Melanoma|melanoma
536152|NCT01280565|Tyrosine kinase inhibitor|tyrosine kinase inhibitor
536153|NCT01280565|c-Kit juxta membrane mutation|c-kit juxta membrane mutation
536154|NCT01280552|Glioblastoma Multiforme|glioblastoma multiforme
536155|NCT01280539|Multiple Sclerosis|multiple sclerosis
536536|NCT01278836|Flap|flap
536156|NCT01280539|Transcutaneous electrical nerve stimulation|transcutaneous electrical nerve stimulation
536157|NCT01280539|Cortical Excitability|cortical excitability
536158|NCT01280487|ZSTK474|zstk474
536159|NCT01280487|PI3K inhibitor|pi3k inhibitor
536160|NCT01280474|depression during pregnancy|depression during pregnancy
536161|NCT01280474|postpartum depression|postpartum depression
536162|NCT01280474|pregnancy outcomes|pregnancy outcomes
536163|NCT01280474|newborn development|newborn development
536164|NCT01280474|paternal psychopathology|paternal psychopathology
536165|NCT01280461|Pneumonia|pneumonia
536166|NCT01280448|Lung Cancer|lung cancer
536167|NCT01280448|Tobacco Smoking|tobacco smoking
536168|NCT01280448|gene polymorphism|gene polymorphism
536169|NCT01280435|Online Discourse|online discourse
536170|NCT01280435|e-Learning|e-learning
536171|NCT01280435|Biopsy|biopsy
536172|NCT01280435|Virtual Pathologic Section|virtual pathologic section
536173|NCT01280422|ROCDR|rocdr
536174|NCT01280396|metabolic|metabolic
536175|NCT01280396|SGAs|sgas
536176|NCT01280396|clozapine|clozapine
536177|NCT01280383|non-invasive ventilation|non-invasive ventilation
536178|NCT01280383|diaphragm|diaphragm
536179|NCT01280383|electrical activity|electrical activity
536180|NCT01280383|neurally adjusted ventilatory assist|neurally adjusted ventilatory assist
536181|NCT01280383|critically ill patients|critically ill patients
536182|NCT01280370|Incisional hernia repair|incisional hernia repair
536183|NCT01280357|Fetal Heart Rate (FHR)|fetal heart rate (fhr)
536184|NCT01280357|Uterine Activity (UA)|uterine activity (ua)
536185|NCT01280357|Labor & Delivery|labor & delivery
536186|NCT01280331|Bunionectomy|bunionectomy
536187|NCT01280305|schizophrenia|schizophrenia
536188|NCT01280305|schizoaffective disorder|schizoaffective disorder
536189|NCT01280292|central hypothyroidism, hypopituitarism, eltroxin|central hypothyroidism, hypopituitarism, eltroxin
536190|NCT01280279|Behavior modification, Behavior therapy, Nocturia, Polyuria, Quality of life|behavior modification, behavior therapy, nocturia, polyuria, quality of life
536191|NCT01280266|Pathological Conditions|pathological conditions
536192|NCT01280266|Signs and Symptoms|signs and symptoms
536193|NCT01280266|Blood circulation|blood circulation
536194|NCT01280253|Predictor|predictor
536195|NCT01280253|outcome|outcome
536196|NCT01280253|biochemical|biochemical
536197|NCT01280240|anemia|anemia
536198|NCT01280240|cancer|cancer
536199|NCT01280240|CIA|cia
536200|NCT01280227|Symptom management|symptom management
536201|NCT01280227|Symptom assessment|symptom assessment
536202|NCT01280227|Patient satisfaction|patient satisfaction
536203|NCT01280227|Patient-provider communication|patient-provider communication
536204|NCT01280201|Neuroendocrine Tumors|neuroendocrine tumors
536205|NCT01280201|Pazopanib|pazopanib
536206|NCT01280201|GETNE|getne
536207|NCT01280201|Biomarkers|biomarkers
536208|NCT01280188|Diabetes|diabetes
536209|NCT01280175|BDP|bdp
536210|NCT01280175|Formoterol|formoterol
536211|NCT01280175|pMDI|pmdi
536212|NCT01280175|Aerochamber Plus|aerochamber plus
536213|NCT01280175|Charcoal|charcoal
536214|NCT01280162|Plasmodium falciparum, Plasmodium vivax|plasmodium falciparum, plasmodium vivax
536215|NCT01280149|substance P|substance p
536216|NCT01280149|allergic rhinitis|allergic rhinitis
536217|NCT01280149|allergen immunotherapy|allergen immunotherapy
536218|NCT01280136|HIV|hiv
536219|NCT01280136|Sexually Transmitted Diseases|sexually transmitted diseases
536220|NCT01280136|Pregnancy Prevention|pregnancy prevention
536221|NCT01280136|Abstinence Education|abstinence education
536222|NCT01280136|Adolescents|adolescents
536223|NCT01280136|Sexual Health|sexual health
536224|NCT01280123|Parkinson's Disease|parkinson's disease
536225|NCT01280123|Biomarkers|biomarkers
536226|NCT01280110|dry eye|dry eye
536227|NCT01280110|pseudophakia|pseudophakia
536228|NCT01280110|cornea|cornea
536229|NCT01280110|lubricating drop|lubricating drop
536230|NCT01280110|BAK|bak
536231|NCT01280110|blood aqueous barrier|blood aqueous barrier
536232|NCT01280110|blood-retina barrier|blood-retina barrier
536233|NCT01280097|Intensive care unit delirium|intensive care unit delirium
536234|NCT01280097|Sleep disruption|sleep disruption
536236|NCT01280097|Early mobilization in the Intensive care unit|early mobilization in the intensive care unit
536237|NCT01280097|Sedative agents and sleep|sedative agents and sleep
536238|NCT01280097|Circadian rhythm|circadian rhythm
536239|NCT01280097|Cognitive disorder|cognitive disorder
536240|NCT01280097|Electroencephalography (EEG) to measure sleep|electroencephalography (eeg) to measure sleep
536241|NCT01280097|Confusion Assessment Method in the Intensive Care Unit|confusion assessment method in the intensive care unit
536242|NCT01280097|Immune function|immune function
536243|NCT01280097|REM sleep|rem sleep
536244|NCT01280084|neonate activity|neonate activity
536245|NCT01280084|labour analgesia|labour analgesia
536246|NCT01280032|intraoperative radiotherapy|intraoperative radiotherapy
536247|NCT01280032|kyphoplasty|kyphoplasty
536248|NCT01280032|spinal metastases|spinal metastases
536249|NCT01280019|functional residual capacity|functional residual capacity
536250|NCT01280019|electrical impedance tomography|electrical impedance tomography
536251|NCT01280019|inflammatory parameters|inflammatory parameters
536537|NCT01278836|leg defect|leg defect
536252|NCT01280006|Obstructive Sleep Apnea|obstructive sleep apnea
536253|NCT01280006|Hypoxia|hypoxia
536254|NCT01280006|Sleep|sleep
536255|NCT01280006|Blood Pressure|blood pressure
536256|NCT01280006|Hypertension|hypertension
536257|NCT01280006|Myocardial Infarction|myocardial infarction
536258|NCT01280006|Stroke|stroke
536259|NCT01280006|Ventilation|ventilation
536260|NCT01280006|Brain|brain
536261|NCT01280006|Cerebral Blood Flow|cerebral blood flow
536262|NCT01280006|Renal Blood Flow|renal blood flow
536263|NCT01279980|ERAS|eras
536264|NCT01279980|Local anaesthetic wound catheter|local anaesthetic wound catheter
536265|NCT01279980|Painbuster|painbuster
536266|NCT01279980|Epidural|epidural
536267|NCT01279980|colorectal surgery|colorectal surgery
536268|NCT01279980|enhanced recovery program|enhanced recovery program
536269|NCT01279967|Pleural Mesothelioma|pleural mesothelioma
536270|NCT01279967|ADI-PEG 20|adi-peg 20
536271|NCT01279928|paediatric and adolescent population|paediatric and adolescent population
536272|NCT01279928|nailfold capillaroscopy|nailfold capillaroscopy
536273|NCT01279928|laser Doppler flowmetry|laser doppler flowmetry
536274|NCT01279928|retinal vessel calibre|retinal vessel calibre
536275|NCT01279928|retinal vessel fractal analysis|retinal vessel fractal analysis
536276|NCT01279928|24 hour Ambulatory Blood Pressure Monitoring|24 hour ambulatory blood pressure monitoring
536277|NCT01279915|ASP0456|asp0456
536278|NCT01279915|Pharmacokinetics|pharmacokinetics
536279|NCT01279915|safety|safety
536280|NCT01279915|tolerability|tolerability
536281|NCT01279902|diffuse large B-cell lymphoma|diffuse large b-cell lymphoma
536282|NCT01279902|rituximab|rituximab
536283|NCT01279902|CHOP|chop
536284|NCT01279902|abbreviated therapy|abbreviated therapy
536285|NCT01279889|hypotension|hypotension
536286|NCT01279889|cesarean delivery|cesarean delivery
536287|NCT01279889|cardiac output|cardiac output
536288|NCT01279889|blood pressure|blood pressure
536289|NCT01279889|plethysmography variability index|plethysmography variability index
536290|NCT01279863|Pneumonia|pneumonia
536291|NCT01279863|Cough|cough
536292|NCT01279863|Shortness of breath|shortness of breath
536294|NCT01279850|Lyrica|lyrica
536295|NCT01279850|Regulatory Post Marketing Commitment Plan|regulatory post marketing commitment plan
536296|NCT01279850|Safety|safety
536297|NCT01279850|Neuropathic Pain|neuropathic pain
536298|NCT01279850|Post Marketing Surveillance|post marketing surveillance
536299|NCT01279837|swallowing disorders|swallowing disorders
536300|NCT01279837|swallowing therapy|swallowing therapy
536301|NCT01279837|head neck cancer|head neck cancer
536302|NCT01279837|oropharyngeal dysphagia|oropharyngeal dysphagia
536303|NCT01279824|swallowing, treatment, stroke,rehabilitation|swallowing, treatment, stroke,rehabilitation
536304|NCT01279811|spinal cord injury, CSF, biomarkers, CSF pressure|spinal cord injury, csf, biomarkers, csf pressure
536305|NCT01279798|Lung Cancer|lung cancer
536306|NCT01279798|NSCLC|nsclc
536307|NCT01279798|stage III or IV NSCLC|stage iii or iv nsclc
536308|NCT01279785|Molecular Imaging|molecular imaging
536309|NCT01279785|PSMA|psma
536310|NCT01279785|adenocarcinoma|adenocarcinoma
536311|NCT01279785|prostatectomy|prostatectomy
536312|NCT01279759|Anterior Cruciate Ligament Reconstruction Predictive Factors|anterior cruciate ligament reconstruction predictive factors
536313|NCT01279759|Function Downstairs walking Step time Symmetry|function downstairs walking step time symmetry
536314|NCT01279746|DVT Ultrasound compression Hypoxia Pulmonary Emboli|dvt ultrasound compression hypoxia pulmonary emboli
536315|NCT01279746|Occult DVT in hypoxic patients|occult dvt in hypoxic patients
536316|NCT01279733|microarray|microarray
536317|NCT01279720|Adenosine deaminase deficiency|adenosine deaminase deficiency
536318|NCT01279720|Gene therapy|gene therapy
536319|NCT01279694|newly-diagnosed multiple myeloma.|newly-diagnosed multiple myeloma.
536320|NCT01279681|neurotoxicity|neurotoxicity
536321|NCT01279681|cognitive/functional effects|cognitive/functional effects
536322|NCT01279681|stage IVA colon cancer|stage iva colon cancer
536323|NCT01279681|stage IVA rectal cancer|stage iva rectal cancer
536324|NCT01279681|stage IVB colon cancer|stage ivb colon cancer
536325|NCT01279681|stage IVB rectal cancer|stage ivb rectal cancer
536326|NCT01279681|recurrent colon cancer|recurrent colon cancer
536327|NCT01279681|recurrent rectal cancer|recurrent rectal cancer
536328|NCT01279668|Montelukast|montelukast
536329|NCT01279668|Persistent cough|persistent cough
536330|NCT01279668|Adults|adults
536331|NCT01279668|Double-blind randomised placebo controlled trial|double-blind randomised placebo controlled trial
536332|NCT01279642|Catheterization, Peripheral|catheterization, peripheral
536333|NCT01279642|Ultrasonography, Interventional|ultrasonography, interventional
536334|NCT01279642|Nursing|nursing
536335|NCT01279642|Pediatric|pediatric
536336|NCT01279629|chronic plaque psoriasis|chronic plaque psoriasis
536337|NCT01279629|To evaluate the efficacy of the drugs under study for treating chronic plaque psoriasis|to evaluate the efficacy of the drugs under study for treating chronic plaque psoriasis
536338|NCT01279616|sickle cell|sickle cell
536339|NCT01279616|stem cell transplant|stem cell transplant
536340|NCT01279603|Cancer|cancer
536341|NCT01279590|Hyperlipidemia|hyperlipidemia
536342|NCT01279590|Dyslipidemia|dyslipidemia
536343|NCT01279590|Metabolic diseases|metabolic diseases
536832|NCT01277679|MRI|mri
536344|NCT01279590|Lipid metabolism disorders|lipid metabolism disorders
536345|NCT01279590|Hyperlipoproteinemia Type IIa|hyperlipoproteinemia type iia
536346|NCT01279590|Hyperlipoproteinemia Type IIb|hyperlipoproteinemia type iib
536347|NCT01279590|Hypercholesterolemia, Autosomal Dominant|hypercholesterolemia, autosomal dominant
536348|NCT01279590|Hypercholesterolemia, Autosomal Dominant, Type B|hypercholesterolemia, autosomal dominant, type b
536349|NCT01279590|Frederickson Type IIa|frederickson type iia
536350|NCT01279590|Frederickson Type IIb Hyperlipidemia|frederickson type iib hyperlipidemia
536351|NCT01279577|Crohn´s disease|crohn´s disease
536352|NCT01279577|Trichuris suis|trichuris suis
536353|NCT01279577|randomized|randomized
536354|NCT01279577|placebo|placebo
536355|NCT01279577|induction of remission|induction of remission
536356|NCT01279577|porcine whipworm|porcine whipworm
536357|NCT01279564|Endotracheal intubation and its outcomes|endotracheal intubation and its outcomes
536358|NCT01279538|Kidney Transplantation|kidney transplantation
536359|NCT01279538|Pharmacokinetics|pharmacokinetics
536360|NCT01279538|Pharmacology|pharmacology
536361|NCT01279538|ASKP1240|askp1240
536362|NCT01279525|Falls|falls
536363|NCT01279525|Prevention|prevention
536364|NCT01279525|Elderly|elderly
536365|NCT01279512|Metformin Acarbose pco infertility overweight|metformin acarbose pco infertility overweight
536366|NCT01279499|Morbid obesity|morbid obesity
536367|NCT01279499|Sevoflurane|sevoflurane
536368|NCT01279499|Propofol|propofol
536369|NCT01279499|Remifentanyl|remifentanyl
536370|NCT01279499|BIS|bis
536371|NCT01279499|Cardiovascular stability|cardiovascular stability
536372|NCT01279499|Recovery scores|recovery scores
536373|NCT01279499|Drug consumption|drug consumption
536374|NCT01279486|Pregnancy,|pregnancy,
536375|NCT01279473|Chronic Myelogenous Leukemia|chronic myelogenous leukemia
536376|NCT01279473|CML|cml
536377|NCT01279473|Acute Lymphoblastic Leukemia|acute lymphoblastic leukemia
536378|NCT01279473|Philadelphia Chromosome Positive, ph+ ALL|philadelphia chromosome positive, ph+ all
536379|NCT01279473|Acute Lymphoblastic Leukemia (Philadelphia Chromosome Positive)|acute lymphoblastic leukemia (philadelphia chromosome positive)
536380|NCT01279460|chronic kidney disease|chronic kidney disease
536381|NCT01279460|CKD|ckd
536382|NCT01279460|pulse wave velocity|pulse wave velocity
536383|NCT01279460|PWV|pwv
536384|NCT01279447|infrapatellar nerve|infrapatellar nerve
536385|NCT01279447|saphenous nerve|saphenous nerve
536386|NCT01279447|knee arthroscopy|knee arthroscopy
536387|NCT01279447|nerve block|nerve block
536388|NCT01279408|Palliative treatment|palliative treatment
536389|NCT01279408|advanced non-small cell lung cancer|advanced non-small cell lung cancer
536390|NCT01279408|Patients with Asymptomatic Centrally Located Advance NSCLC who are palliative|patients with asymptomatic centrally located advance nsclc who are palliative
536391|NCT01279395|atherosclerosis|atherosclerosis
536392|NCT01279395|cholesterol|cholesterol
536393|NCT01279395|cyclooxygenase|cyclooxygenase
536394|NCT01279395|gene expression|gene expression
536395|NCT01279395|lipid metabolism|lipid metabolism
536396|NCT01279382|Symptoms|symptoms
536397|NCT01279382|Psychological status|psychological status
536398|NCT01279382|Hypnotherapy|hypnotherapy
536399|NCT01279382|Relaxation training|relaxation training
536400|NCT01279369|Pregnancy|pregnancy
536401|NCT01279369|Trauma|trauma
536402|NCT01279369|Placental Abruption|placental abruption
536403|NCT01279369|Fetal fibronectin|fetal fibronectin
536404|NCT01279356|Liver diseases|liver diseases
536405|NCT01279356|Volatile organic compounds|volatile organic compounds
536406|NCT01279356|Inflammation|inflammation
536407|NCT01279356|Oxidative stress|oxidative stress
536408|NCT01279356|non-invasive tests|non-invasive tests
536409|NCT01279343|labor induction|labor induction
536410|NCT01279343|foley bulb|foley bulb
536411|NCT01279343|misoprostol|misoprostol
536412|NCT01279330|Colorectal Cancer|colorectal cancer
536413|NCT01279330|Screening|screening
536414|NCT01279330|General Practitioner|general practitioner
536415|NCT01279330|Fecal Occult Blood Tests|fecal occult blood tests
536416|NCT01279304|breast cancer|breast cancer
536417|NCT01279304|locoregional recurrence rate|locoregional recurrence rate
536418|NCT01279304|neoadjuvant chemotherapy and surgery|neoadjuvant chemotherapy and surgery
536419|NCT01279304|radiotherapy|radiotherapy
536420|NCT01279304|risk model|risk model
536421|NCT01279304|overall survival|overall survival
536422|NCT01279304|relapse free survival|relapse free survival
536423|NCT01279304|cT1-2cN0-1 breast cancer|ct1-2cn0-1 breast cancer
536424|NCT01279291|advanced solid tumor|advanced solid tumor
536425|NCT01279291|Ovarian cancer|ovarian cancer
536426|NCT01279291|Primary peritoneal cancer|primary peritoneal cancer
536427|NCT01279291|Fallopian tube cancer|fallopian tube cancer
536428|NCT01279278|Colorectal Cancer|colorectal cancer
536429|NCT01279278|Screening|screening
536430|NCT01279278|General Practitioner|general practitioner
536431|NCT01279278|Fecal Occult Blood Tests|fecal occult blood tests
536432|NCT01279265|Lactobacillus|lactobacillus
536433|NCT01279265|Probiotic|probiotic
536434|NCT01279265|Crying time|crying time
536435|NCT01279265|Fecal microbiota|fecal microbiota
536436|NCT01279265|Calprotectin|calprotectin
536437|NCT01279265|Colic|colic
536438|NCT01279265|Infant Crying|infant crying
536439|NCT01279265|Barr Diary|barr diary
536440|NCT01279265|Breath Hydrogen|breath hydrogen
536441|NCT01279265|Clinical Design|clinical design
536442|NCT01279239|Poly Trauma|poly trauma
536443|NCT01279239|Metabonomics|metabonomics
536444|NCT01279239|NMR|nmr
536445|NCT01279239|MOF|mof
536446|NCT01279200|letrozole|letrozole
536447|NCT01279200|ovulation monitoring|ovulation monitoring
536448|NCT01279200|pregnancy rate|pregnancy rate
536449|NCT01279187|dental|dental
536450|NCT01279187|implant|implant
536451|NCT01279174|Hip, arthrosis|hip, arthrosis
536452|NCT01279161|overweight, obesity, children, insulin, pump therapy, FTO|overweight, obesity, children, insulin, pump therapy, fto
536453|NCT01279148|biopsy guidance|biopsy guidance
536454|NCT01279148|tracking device|tracking device
536455|NCT01279135|IGRT,Postoperative, Cervix, Late toxicity, Bowel|igrt,postoperative, cervix, late toxicity, bowel
536456|NCT01279109|gestational weight gain|gestational weight gain
536457|NCT01279096|Acute lymphoblastic leukemia|acute lymphoblastic leukemia
536458|NCT01279096|relapse|relapse
536459|NCT01279096|childhood|childhood
536460|NCT01279096|clofarabine|clofarabine
536461|NCT01279070|Schizophrenia|schizophrenia
536462|NCT01279070|Cognitive remediation|cognitive remediation
536463|NCT01279070|Group training|group training
536464|NCT01279070|Executive function|executive function
536465|NCT01279070|Social functioning|social functioning
536466|NCT01279057|Rhinitis, allergic, seasonal, fluticasone furoate, equivalence|rhinitis, allergic, seasonal, fluticasone furoate, equivalence
536467|NCT01279044|HIV|hiv
536468|NCT01279044|MSM|msm
536469|NCT01279044|SUMSM|sumsm
536470|NCT01279018|Persistent postsurgical pain|persistent postsurgical pain
536471|NCT01279018|breast cancer|breast cancer
536472|NCT01279018|postmastectomy pain syndrome|postmastectomy pain syndrome
536473|NCT01279018|neuropathic pain|neuropathic pain
536474|NCT01279005|MSM|msm
536475|NCT01279005|focus group|focus group
536476|NCT01279005|HIV|hiv
536477|NCT01279005|risk-taking|risk-taking
536478|NCT01279005|risk-denial|risk-denial
536479|NCT01279005|signature on inform consent, willing to participate, MSM either HIV positive or negative, age 20-50 years old|signature on inform consent, willing to participate, msm either hiv positive or negative, age 20-50 years old
536480|NCT01278992|fatigue|fatigue
536481|NCT01278992|adaptogen|adaptogen
536482|NCT01278992|Rhodiola rosea|rhodiola rosea
536483|NCT01278979|obstetric|obstetric
536484|NCT01278979|perineal tear|perineal tear
536485|NCT01278979|perineal injury|perineal injury
536486|NCT01278979|diagnosis|diagnosis
536487|NCT01278966|Epilepsy|epilepsy
536488|NCT01278966|Diet|diet
536489|NCT01278966|the Modified Atkins Diet|the modified atkins diet
536490|NCT01278966|Ketogenic diet|ketogenic diet
536491|NCT01278953|paroxysmal atrial fibrillation|paroxysmal atrial fibrillation
536492|NCT01278953|atrial fibrillation|atrial fibrillation
536493|NCT01278953|radiofrequency ablation|radiofrequency ablation
536494|NCT01278953|pulmonary vein isolation|pulmonary vein isolation
536495|NCT01278953|ablation catheter|ablation catheter
536496|NCT01278953|RF|rf
536497|NCT01278953|contact force sensing|contact force sensing
536498|NCT01278953|contact force|contact force
536499|NCT01278953|contact force assisted ablation|contact force assisted ablation
536500|NCT01278927|exercise|exercise
536501|NCT01278927|stress management|stress management
536502|NCT01278927|post transplant|post transplant
536503|NCT01278927|physical and emotional relaxation|physical and emotional relaxation
536504|NCT01278901|helicobacter pylori|helicobacter pylori
536505|NCT01278901|urease test|urease test
536506|NCT01278901|13C-UBT|13c-ubt
536507|NCT01278901|the focus of the study is to evaluate a possible effect of PPI therapy on Helicobacter pylori diagnostic tests|the focus of the study is to evaluate a possible effect of ppi therapy on helicobacter pylori diagnostic tests
536508|NCT01278888|Lung cancer|lung cancer
536509|NCT01278888|Pain|pain
536510|NCT01278888|Quality of life|quality of life
536511|NCT01278888|Economy|economy
536512|NCT01278875|High density lipoproteins|high density lipoproteins
536513|NCT01278875|Acute coronary syndromes|acute coronary syndromes
536514|NCT01278875|Cellular cholesterol efflux|cellular cholesterol efflux
536515|NCT01278875|HDL: proteomics|hdl: proteomics
536516|NCT01278875|Nitric Acid production|nitric acid production
536517|NCT01278862|Crowns|crowns
536518|NCT01278862|posterior teeth|posterior teeth
536519|NCT01278862|CAD CAM crowns|cad cam crowns
536520|NCT01278862|digital veneer system|digital veneer system
536521|NCT01278862|Lava|lava
536522|NCT01278862|clinical|clinical
536523|NCT01278849|Advanced or metastatic cancer,|advanced or metastatic cancer,
536524|NCT01278849|refractory,|refractory,
536525|NCT01278849|core phase,|core phase,
536526|NCT01278849|extension phase,|extension phase,
536527|NCT01278849|dose escalation,|dose escalation,
536528|NCT01278849|standard chemotherapy,|standard chemotherapy,
536529|NCT01278849|pharmacokinetics,|pharmacokinetics,
536530|NCT01278849|doctaxel,|doctaxel,
536531|NCT01278849|paclitaxel,|paclitaxel,
536532|NCT01278849|carboplatin,|carboplatin,
536533|NCT01278849|safety,|safety,
536534|NCT01278849|tolerability,|tolerability,
536535|NCT01278849|hepatic impairment|hepatic impairment
536538|NCT01278836|reconstruction|reconstruction
536539|NCT01278836|tissue|tissue
536540|NCT01278823|obesity|obesity
536541|NCT01278823|type 2 diabetes|type 2 diabetes
536542|NCT01278810|Icaritin,|icaritin,
536543|NCT01278810|ERa36|era36
536544|NCT01278784|Dry eye syndromes|dry eye syndromes
536545|NCT01278784|Chitosan-N-Acetylcysteine|chitosan-n-acetylcysteine
536546|NCT01278771|CHD|chd
536547|NCT01278758|Advanced or metastatic cancer,|advanced or metastatic cancer,
536548|NCT01278758|refractory,|refractory,
536549|NCT01278758|core phase,|core phase,
536550|NCT01278758|extension phase,|extension phase,
536551|NCT01278758|dose escalation,|dose escalation,
536552|NCT01278758|standard chemotherapy,|standard chemotherapy,
536553|NCT01278758|doctaxel,|doctaxel,
536554|NCT01278758|paclitaxel,|paclitaxel,
536555|NCT01278758|carboplatin,|carboplatin,
536556|NCT01278758|safety,|safety,
536557|NCT01278758|tolerability|tolerability
536558|NCT01278745|cardiac allograft vasculopathy (CAV)|cardiac allograft vasculopathy (cav)
536559|NCT01278745|prevention|prevention
536560|NCT01278745|cardiac transplantation|cardiac transplantation
536561|NCT01278745|rituximab|rituximab
536562|NCT01278732|arterial hypertension|arterial hypertension
536563|NCT01278719|Antrochoanal polyp|antrochoanal polyp
536564|NCT01278719|Ethmoidal polyp|ethmoidal polyp
536565|NCT01278719|Recurrence|recurrence
536566|NCT01278719|Risk factors|risk factors
536567|NCT01278719|Environmental factors|environmental factors
536568|NCT01278719|Gene expression|gene expression
536569|NCT01278719|Micro array|micro array
536570|NCT01278719|Mutation|mutation
536571|NCT01278693|Renal failure, hemodialysis, dyslipidemia, L-carnitine.|renal failure, hemodialysis, dyslipidemia, l-carnitine.
536572|NCT01278680|Behavioral economics|behavioral economics
536573|NCT01278680|Incentives|incentives
536574|NCT01278680|Health|health
536575|NCT01278667|ADHD|adhd
536576|NCT01278667|Memory|memory
536577|NCT01278667|Social|social
536578|NCT01278667|Emotion|emotion
536579|NCT01278667|Methylphenidate|methylphenidate
536580|NCT01278641|Fibromyalgia|fibromyalgia
536581|NCT01278641|Widespread pain|widespread pain
536582|NCT01278641|Fatigue|fatigue
536583|NCT01278641|Physical exercise|physical exercise
536584|NCT01278602|Diffuse large B-cell lymphoma|diffuse large b-cell lymphoma
536585|NCT01278602|Chemotherapy|chemotherapy
536586|NCT01278602|R-ESHAP|r-eshap
536587|NCT01278602|Autologous stem cell transplantation|autologous stem cell transplantation
536588|NCT01278576|Muscle spasticity|muscle spasticity
536589|NCT01278576|Stroke|stroke
536590|NCT01278576|Botulinum Toxins|botulinum toxins
536591|NCT01278576|Lower extremity|lower extremity
536592|NCT01278576|Ankle|ankle
536593|NCT01278563|Low Glycemic Index Diet|low glycemic index diet
536594|NCT01278537|elderly|elderly
536595|NCT01278537|cancer surgery|cancer surgery
536596|NCT01278537|quality of life|quality of life
536597|NCT01278537|empowerment|empowerment
536598|NCT01278537|shared-decision|shared-decision
536599|NCT01278524|Delirium|delirium
536600|NCT01278524|Analgosedation|analgosedation
536601|NCT01278524|ICU|icu
536602|NCT01278524|Pain|pain
536603|NCT01278524|Implementation|implementation
536604|NCT01278511|Canadian C-Spine Rule|canadian c-spine rule
536605|NCT01278511|Prehospital Emergency Care|prehospital emergency care
536606|NCT01278511|Cervical Spine Injuries|cervical spine injuries
536607|NCT01278511|Cervical Spine Fractures|cervical spine fractures
536608|NCT01278511|Emergency Medicine Undergraduates|emergency medicine undergraduates
536609|NCT01278498|Escitalopram|escitalopram
536610|NCT01278498|Depression|depression
536611|NCT01278498|Stroke|stroke
536612|NCT01278485|Diabetes complications|diabetes complications
536613|NCT01278472|cholecystectomy|cholecystectomy
536614|NCT01278472|laparoscopic|laparoscopic
536615|NCT01278472|single-port|single-port
536616|NCT01278472|gallstones|gallstones
536617|NCT01278459|endothelial function|endothelial function
536618|NCT01278459|cardiovascular|cardiovascular
536619|NCT01278446|Cow's Milk Allergy|cow's milk allergy
536620|NCT01278446|CMA|cma
536621|NCT01278433|Polio|polio
536622|NCT01278433|Poliovirus|poliovirus
536623|NCT01278433|IMOVAX Polio™|imovax polio™
536624|NCT01278420|Visual outcomes with bilateral implantation of Tecnis MF and ReSTOR IOLs Six months post cataract surgery|visual outcomes with bilateral implantation of tecnis mf and restor iols six months post cataract surgery
536625|NCT01278407|DLB|dlb
536626|NCT01278407|Dementia with Lewy bodies|dementia with lewy bodies
536627|NCT01278407|Lewy Body Disease|lewy body disease
536628|NCT01278407|Dementia|dementia
536629|NCT01278407|E2020|e2020
536630|NCT01278407|Donepezil|donepezil
536631|NCT01278407|Aricept|aricept
536632|NCT01278394|Onychomycosis|onychomycosis
536633|NCT01278394|Fungal Nail|fungal nail
536634|NCT01278381|pancreas, pancreaticoduodenectomy, major complications|pancreas, pancreaticoduodenectomy, major complications
536635|NCT01278368|pancreatic cancer, neoadjuvant chemotherapy|pancreatic cancer, neoadjuvant chemotherapy
536636|NCT01278355|pain|pain
536637|NCT01278355|acupuncture|acupuncture
536638|NCT01278342|Sandostatin LAR|sandostatin lar
536639|NCT01278342|High Dose|high dose
537517|NCT01274884|Injury|injury
536640|NCT01278342|GH-receptor antagonist|gh-receptor antagonist
536641|NCT01278342|combination with dopamine-agonist|combination with dopamine-agonist
536642|NCT01278342|acromegalic patients|acromegalic patients
536643|NCT01278342|octreotide acetate|octreotide acetate
536644|NCT01278342|Somavert|somavert
536645|NCT01278342|Dostinex|dostinex
536646|NCT01278342|pegvisomant|pegvisomant
536647|NCT01278342|cabergoline|cabergoline
536648|NCT01278342|not adequately controlled|not adequately controlled
536649|NCT01278342|active acromegaly|active acromegaly
536650|NCT01278329|Music|music
536651|NCT01278329|Foetal learning|foetal learning
536652|NCT01278329|Brazelton Neonatal Behavioral Assessment Scale|brazelton neonatal behavioral assessment scale
536653|NCT01278316|PTSD|ptsd
536654|NCT01278316|TBI|tbi
536655|NCT01278316|Cognition|cognition
536656|NCT01278316|Cognitive Training|cognitive training
536657|NCT01278303|Coarctation|coarctation
536658|NCT01278303|Aorta|aorta
536659|NCT01278290|Triptorelin acetate|triptorelin acetate
536660|NCT01278290|precocious puberty|precocious puberty
536661|NCT01278290|premature thelarche|premature thelarche
536662|NCT01278290|GnRH analog|gnrh analog
536663|NCT01278290|Diagnostic validation study|diagnostic validation study
536664|NCT01278277|Stargardt disease|stargardt disease
536665|NCT01278277|macula|macula
536666|NCT01278277|electroretinogram|electroretinogram
536667|NCT01278277|saffron|saffron
536668|NCT01278264|Transversus abdominis plane block|transversus abdominis plane block
536669|NCT01278264|Ultrasound guided|ultrasound guided
536670|NCT01278264|Abdominoplasty|abdominoplasty
536671|NCT01278238|Hypotension|hypotension
536672|NCT01278238|Caesarean section|caesarean section
536673|NCT01278238|Spinal anaesthesia|spinal anaesthesia
536674|NCT01278238|Lower limb compression / wrapping|lower limb compression / wrapping
536675|NCT01278238|Phenylephrine|phenylephrine
536676|NCT01278225|Neurofeedback|neurofeedback
536677|NCT01278225|Neural Function|neural function
536678|NCT01278225|Neuromodulation|neuromodulation
536679|NCT01278225|Chemotherapy-Induced Neuropathic Pain|chemotherapy-induced neuropathic pain
536680|NCT01278225|Electroencephalogram|electroencephalogram
536681|NCT01278225|EEG|eeg
536682|NCT01278225|Biofeedback|biofeedback
536683|NCT01278225|BF|bf
536684|NCT01278225|Quality of Life|quality of life
536685|NCT01278225|QOL|qol
536686|NCT01278225|Pain Quality Assessment Scale|pain quality assessment scale
536687|NCT01278225|PQAS|pqas
536688|NCT01278225|Brief Symptom Inventory|brief symptom inventory
536689|NCT01278225|BSI|bsi
536690|NCT01278225|Sleep Disturbances|sleep disturbances
536691|NCT01278225|Fatigue|fatigue
536692|NCT01278225|Questionnaires|questionnaires
536693|NCT01278212|breast cancer|breast cancer
536694|NCT01278212|breast neoplasm|breast neoplasm
536695|NCT01278212|breast tumor|breast tumor
536696|NCT01278212|radiotherapy|radiotherapy
536697|NCT01278212|radiation|radiation
536698|NCT01278212|accelerated|accelerated
536699|NCT01278212|lumpectomy|lumpectomy
536700|NCT01278199|Bronchial Artery Embolization|bronchial artery embolization
536701|NCT01278199|Non-severe Hemoptysis|non-severe hemoptysis
536702|NCT01278199|Bleeding mild-to-moderate abundance|bleeding mild-to-moderate abundance
536703|NCT01278199|Volume ranging from 100 ml to 200 ml|volume ranging from 100 ml to 200 ml
536704|NCT01278186|Coronary stenosis|coronary stenosis
536705|NCT01278186|Bifurcation|bifurcation
536706|NCT01278186|Drug-eluting balloon|drug-eluting balloon
536707|NCT01278186|Drug-eluting stent|drug-eluting stent
536708|NCT01278186|Angiographic follow-up|angiographic follow-up
536709|NCT01278186|Late Lumen Loss|late lumen loss
536710|NCT01278186|Restenosis|restenosis
536711|NCT01278173|Vigabatrin-associated vision change|vigabatrin-associated vision change
536712|NCT01278173|Adult refractory complex partial seizures|adult refractory complex partial seizures
536713|NCT01278173|CPS|cps
536714|NCT01278173|Epilepsy|epilepsy
536715|NCT01278173|Seizures|seizures
536716|NCT01278173|Brain diseases|brain diseases
536717|NCT01278173|Central Nervous System Diseases|central nervous system diseases
536718|NCT01278173|Nervous System Diseases|nervous system diseases
536719|NCT01278173|Neurologic Manifestations|neurologic manifestations
536720|NCT01278173|Enzyme Inhibitors|enzyme inhibitors
536721|NCT01278173|GABA Agents|gaba agents
536722|NCT01278147|cancer|cancer
536723|NCT01278147|fatigue program education|fatigue program education
536724|NCT01278121|Obesity|obesity
536725|NCT01278121|Diabetes Mellitus, Type 2|diabetes mellitus, type 2
536726|NCT01278121|Cardiovascular diseases|cardiovascular diseases
536727|NCT01278108|Safety|safety
536728|NCT01278108|Tolerability|tolerability
536729|NCT01278108|Pharmacokinetics|pharmacokinetics
536730|NCT01278095|Safety|safety
536731|NCT01278095|Tolerability|tolerability
536732|NCT01278095|Pharmacokinetics|pharmacokinetics
536733|NCT01278082|Randomized|randomized
536734|NCT01278082|double-blind|double-blind
536735|NCT01278082|Placebo-controlled|placebo-controlled
536736|NCT01278082|budesonide|budesonide
536737|NCT01278082|collagenous colitis|collagenous colitis
536738|NCT01278082|acute treatment|acute treatment
536739|NCT01278082|maintaining remission|maintaining remission
536740|NCT01278069|Acute myeloid Leukemia|acute myeloid leukemia
536741|NCT01278069|Myeloid Sarcoma|myeloid sarcoma
536742|NCT01278069|Extramedullary Acute myeloid Leukemia|extramedullary acute myeloid leukemia
536743|NCT01278069|18FDG-PET-CT|18fdg-pet-ct
536744|NCT01278056|Non-alcoholic steatohepatitis (NASH) and increased iron storage / disturbed distribution|non-alcoholic steatohepatitis (nash) and increased iron storage / disturbed distribution
536745|NCT01278043|Antiplatelet|antiplatelet
536746|NCT01278043|Percutaneous Coronary Intervention|percutaneous coronary intervention
536747|NCT01278043|Coronary artery disease|coronary artery disease
710258|NCT00589563|recurrent/refractory childhood Hodgkin lymphoma|recurrent/refractory childhood hodgkin lymphoma
536748|NCT01278043|Antiplatelet Response, Interval Variability & Events in Percutaneous Coronary Intervention|antiplatelet response, interval variability & events in percutaneous coronary intervention
536749|NCT01278017|nontyphoidal salmonellae|nontyphoidal salmonellae
536750|NCT01278017|enterocolitis|enterocolitis
536751|NCT01278017|ceftriaxone|ceftriaxone
536752|NCT01278004|Adult cancer patients with chemotherapy-induced painful peripheral neuropathy|adult cancer patients with chemotherapy-induced painful peripheral neuropathy
536753|NCT01277991|Bioequivalence|bioequivalence
536754|NCT01277991|healthy volunteer study|healthy volunteer study
536755|NCT01277991|Rheumatoid Arthritis|rheumatoid arthritis
536756|NCT01277978|Caesarean section|caesarean section
536757|NCT01277978|Cardiovascular effects|cardiovascular effects
536758|NCT01277978|Postpartum hemorrhage|postpartum hemorrhage
536759|NCT01277978|Carbetocin|carbetocin
536760|NCT01277978|Oxytocin|oxytocin
536761|NCT01277965|Algorithm basal insulin|algorithm basal insulin
536762|NCT01277965|physical activity|physical activity
536763|NCT01277965|Type 1 diabetes|type 1 diabetes
536764|NCT01277965|Insulin pump treatment|insulin pump treatment
536765|NCT01277952|Traumatic Brain Injury|traumatic brain injury
536766|NCT01277952|DBS|dbs
536767|NCT01277926|Breast Cancer|breast cancer
536768|NCT01277926|Hormone Receptor Positive, Advanced Breast Cancer|hormone receptor positive, advanced breast cancer
536769|NCT01277913|diabetes|diabetes
536770|NCT01277913|vitamin D|vitamin d
536771|NCT01277913|bone density|bone density
536772|NCT01277913|children|children
536773|NCT01277887|Smoking|smoking
536774|NCT01277887|Nicotine|nicotine
536775|NCT01277887|Nicotine polacrilex|nicotine polacrilex
536776|NCT01277887|Nicotine replacement|nicotine replacement
536777|NCT01277861|Desflurane, Fentanyl, Airway responses|desflurane, fentanyl, airway responses
536778|NCT01277848|PLAC1|plac1
536779|NCT01277848|pregnant|pregnant
536780|NCT01277848|first prenatal visit|first prenatal visit
536781|NCT01277848|pre-eclampsia|pre-eclampsia
536782|NCT01277835|video-assisted|video-assisted
536783|NCT01277835|thoracic surgery|thoracic surgery
536784|NCT01277835|VATS|vats
536785|NCT01277835|lidocaine infusion|lidocaine infusion
536786|NCT01277835|VATS procedures|vats procedures
536787|NCT01277822|Hypertension|hypertension
536788|NCT01277822|Uncontrolled hypertension|uncontrolled hypertension
536789|NCT01277822|High blood pressure|high blood pressure
536790|NCT01277822|Uncontrolled high blood pressure|uncontrolled high blood pressure
536791|NCT01277822|Untreated high blood pressure|untreated high blood pressure
536792|NCT01277822|Untreated hypertension|untreated hypertension
536793|NCT01277822|Essential hypertension|essential hypertension
536794|NCT01277809|Long term care|long term care
536795|NCT01277809|Aging|aging
536796|NCT01277809|Accidental Falls|accidental falls
536797|NCT01277809|Muscle Weakness|muscle weakness
536798|NCT01277809|Gait|gait
536799|NCT01277809|Physical Fitness|physical fitness
536800|NCT01277809|Muscle Strength|muscle strength
536801|NCT01277809|Postural Balance|postural balance
536802|NCT01277809|Activities of Daily Living|activities of daily living
536803|NCT01277809|Body Weight|body weight
536804|NCT01277809|Blood Pressure|blood pressure
536805|NCT01277809|Depression|depression
536806|NCT01277809|Behavior|behavior
536807|NCT01277809|Dementia|dementia
536808|NCT01277770|Thymoglobulin|thymoglobulin
536809|NCT01277770|Kidney Transplant Recipients|kidney transplant recipients
536810|NCT01277770|Steroid-Free|steroid-free
536811|NCT01277770|Immunosuppression|immunosuppression
536812|NCT01277744|Desmoplastic small round cell tumor|desmoplastic small round cell tumor
536813|NCT01277744|DSRCT|dsrct
536814|NCT01277744|Hyperthermic peritoneal perfusion|hyperthermic peritoneal perfusion
536815|NCT01277744|HIPEC|hipec
536816|NCT01277744|Complete abdominal tumor excision|complete abdominal tumor excision
536817|NCT01277744|Extensive abdominal disease|extensive abdominal disease
536818|NCT01277744|Non-carcinoma tumors|non-carcinoma tumors
536819|NCT01277744|Abdominal cavity|abdominal cavity
536820|NCT01277744|Cisplatin|cisplatin
536821|NCT01277744|Platinol-AQ|platinol-aq
536822|NCT01277744|Platinol|platinol
536823|NCT01277744|CDDP|cddp
536824|NCT01277744|Diffuse peritoneal tumor|diffuse peritoneal tumor
536825|NCT01277744|Retroperitoneal tumor|retroperitoneal tumor
536826|NCT01277744|Ovarian germ cell|ovarian germ cell
536827|NCT01277744|Wilms' tumor|wilms' tumor
536828|NCT01277705|Booster vaccination|booster vaccination
536829|NCT01277692|First administration to human, safety, pharmacokinetics, healthy subjects, antiviral activity, hepatitis C patients|first administration to human, safety, pharmacokinetics, healthy subjects, antiviral activity, hepatitis c patients
536830|NCT01277679|lung water measures|lung water measures
536831|NCT01277679|pulmonary edema|pulmonary edema
536833|NCT01277679|heart failure|heart failure
536834|NCT01277666|Crohn's disease|crohn's disease
536835|NCT01277666|capsule|capsule
536836|NCT01277666|GSK1605786A|gsk1605786a
536837|NCT01277666|quality of life|quality of life
536838|NCT01277666|inflammatory bowel disease|inflammatory bowel disease
536839|NCT01277666|oral therapy|oral therapy
536840|NCT01277653|Hepatocellular carcinoma|hepatocellular carcinoma
536841|NCT01277640|male tolerance|male tolerance
536842|NCT01277640|HIV-1|hiv-1
536843|NCT01277640|microbicide|microbicide
536844|NCT01277640|dapivirine|dapivirine
536845|NCT01277627|HCV|hcv
536846|NCT01277627|HIV|hiv
536847|NCT01277627|Nevirapine|nevirapine
536848|NCT01277627|HCV viral load|hcv viral load
536849|NCT01277627|Efavirenz|efavirenz
536850|NCT01277627|Protease inhibitors|protease inhibitors
536851|NCT01277614|lifestyle|lifestyle
536852|NCT01277614|diet|diet
536853|NCT01277614|exercise|exercise
536854|NCT01277601|Chronic Hepatitis B|chronic hepatitis b
536855|NCT01277601|Hep B|hep b
536856|NCT01277601|Non cirrhotic|non cirrhotic
536857|NCT01277601|Tenofovir disoproxil fumarate (TDF)|tenofovir disoproxil fumarate (tdf)
536858|NCT01277601|Peginterferon α-2a (Peg-IFN)|peginterferon α-2a (peg-ifn)
536859|NCT01277588|fetal scalp sampling|fetal scalp sampling
536860|NCT01277588|experience questionnaire|experience questionnaire
536861|NCT01277575|stroke|stroke
536862|NCT01277575|aphasia|aphasia
536863|NCT01277575|language|language
536864|NCT01277562|Breast Cancer|breast cancer
536865|NCT01277562|Prostate Cancer|prostate cancer
536866|NCT01277562|Osteopenia|osteopenia
536867|NCT01277562|Osteoporosis|osteoporosis
536868|NCT01277562|Secondary causes of bone loss|secondary causes of bone loss
536869|NCT01277549|Leukapheresis|leukapheresis
536870|NCT01277549|Hematopoetic Stem Cell Mobilization|hematopoetic stem cell mobilization
536871|NCT01277510|dialysis|dialysis
536872|NCT01277510|sensipar|sensipar
536873|NCT01277510|mimpara|mimpara
536874|NCT01277510|hemodialysis|hemodialysis
536875|NCT01277510|peritoneal dialysis|peritoneal dialysis
536876|NCT01277510|renal|renal
536877|NCT01277510|parathyroid hormone|parathyroid hormone
536878|NCT01277510|pediatric|pediatric
536879|NCT01277497|Chronic kidney disease|chronic kidney disease
536880|NCT01277497|Phosphate binder|phosphate binder
536881|NCT01277497|Sevelamer carbonate|sevelamer carbonate
536882|NCT01277497|Calcium acetate|calcium acetate
536883|NCT01277497|Vascular calcification|vascular calcification
536884|NCT01277497|Endothelial Dysfunction|endothelial dysfunction
536885|NCT01277484|decitabine|decitabine
536886|NCT01277484|dose|dose
536887|NCT01277484|schedule|schedule
536888|NCT01277484|safety|safety
536889|NCT01277484|allogeneic stem cell transplantation|allogeneic stem cell transplantation
536890|NCT01277471|meal frequency|meal frequency
536891|NCT01277471|type two diabetes|type two diabetes
536892|NCT01277458|HIV|hiv
536893|NCT01277458|MSM|msm
536894|NCT01277458|Ethnicity|ethnicity
536895|NCT01277445|gut microbiome|gut microbiome
536896|NCT01277445|prebiotics|prebiotics
536897|NCT01277445|immunological status|immunological status
536898|NCT01277445|fructans|fructans
536899|NCT01277432|Diabetes|diabetes
536900|NCT01277432|Depression|depression
536901|NCT01277406|Colorectal Carcinoma|colorectal carcinoma
536902|NCT01277406|Resminostat|resminostat
536903|NCT01277406|HDAC|hdac
536904|NCT01277406|4SC-201|4sc-201
536905|NCT01277406|Phase I|phase i
536906|NCT01277406|Phase II|phase ii
536907|NCT01277393|Enteral nutrition feeding|enteral nutrition feeding
536908|NCT01277380|H1N1 Influenza virus|h1n1 influenza virus
536909|NCT01277380|swine flu|swine flu
536910|NCT01277380|Real Time RT-PCR|real time rt-pcr
536911|NCT01277367|Obesity|obesity
536912|NCT01277367|Sedentary|sedentary
536913|NCT01277367|Physical activity|physical activity
536914|NCT01277367|exercise|exercise
536915|NCT01277367|incentives|incentives
536916|NCT01277354|Cognitive Processing Therapy (CPT)|cognitive processing therapy (cpt)
536917|NCT01277315|ALS|als
536918|NCT01277315|Anakinra|anakinra
536919|NCT01277315|Kineret|kineret
536920|NCT01277315|Progressive Muscular Atrophy|progressive muscular atrophy
536921|NCT01277315|PMA|pma
536922|NCT01277315|Safety Trial|safety trial
536923|NCT01277315|Tolerability Trial|tolerability trial
536924|NCT01277289|dexamethasone|dexamethasone
536925|NCT01277289|ery-dex|ery-dex
536926|NCT01277289|Chron's disease|chron's disease
536927|NCT01277289|CD|cd
536928|NCT01277276|Medical tool|medical tool
536929|NCT01277263|Breast Cancer|breast cancer
536930|NCT01277250|Hospitalized adults|hospitalized adults
536931|NCT01277250|Tobacco users|tobacco users
536932|NCT01277250|Smokers|smokers
536933|NCT01277250|Smoking cessation|smoking cessation
536934|NCT01277250|Web-based|web-based
536935|NCT01277250|Transition coach|transition coach
536936|NCT01277237|Non alcoholic fatty liver disease|non alcoholic fatty liver disease
536937|NCT01277224|physical activity|physical activity
536938|NCT01277224|obesity|obesity
536939|NCT01277224|adiposity|adiposity
536940|NCT01277224|children|children
536941|NCT01277224|blood lipids|blood lipids
536942|NCT01277224|blood pressure|blood pressure
536943|NCT01277224|randomized controlled trials|randomized controlled trials
536944|NCT01277211|Contraception|contraception
536945|NCT01277211|NuvaRing|nuvaring
536946|NCT01277198|kidney calculi|kidney calculi
536947|NCT01277198|ureteral calculi|ureteral calculi
536948|NCT01277198|cystoscopes|cystoscopes
536949|NCT01277198|laparoscopes|laparoscopes
536950|NCT01277185|calcium|calcium
536951|NCT01277185|healthy|healthy
536952|NCT01277185|Mexican-American adolescents|mexican-american adolescents
536953|NCT01277185|camp|camp
536954|NCT01277185|girls|girls
536955|NCT01277185|boys|boys
536956|NCT01277185|bone|bone
536957|NCT01277172|DLBCL|dlbcl
536958|NCT01277172|pharmacokinetics|pharmacokinetics
536959|NCT01277172|pharmacodynamics|pharmacodynamics
536960|NCT01277172|Rituximab|rituximab
536961|NCT01277172|LymphomaLymphoma|lymphomalymphoma
536962|NCT01277172|Non-HodgkinLymphoma|non-hodgkinlymphoma
536963|NCT01277172|B-CellLymphoma|b-celllymphoma
536964|NCT01277172|Large B-Cell|large b-cell
536965|NCT01277172|Disorders Lymphatic Diseases|disorders lymphatic diseases
536966|NCT01277172|Immunoproliferative Disorders|immunoproliferative disorders
536967|NCT01277172|Antineoplastic Agents|antineoplastic agents
536968|NCT01277172|Adverse Effects|adverse effects
536969|NCT01277159|Analgesia|analgesia
536970|NCT01277159|Duration|duration
536971|NCT01277159|Popliteal Fossa Nerve Block|popliteal fossa nerve block
536972|NCT01277159|Dexamethasone|dexamethasone
536973|NCT01277159|Buprenorphine|buprenorphine
536974|NCT01277159|Additives|additives
536975|NCT01277159|Ankle surgery|ankle surgery
536976|NCT01277146|Phase 1|phase 1
536977|NCT01277146|dose escalation|dose escalation
536978|NCT01277146|histologically confirmed|histologically confirmed
536979|NCT01277146|malignancy metastatic|malignancy metastatic
536980|NCT01277107|PSG|psg
536981|NCT01277107|LPS|lps
536982|NCT01277107|TST|tst
536983|NCT01277107|WASO|waso
536984|NCT01277107|Subjects With Insomnia characterized by both Difficulty in Falling Asleep and Staying Asleep|subjects with insomnia characterized by both difficulty in falling asleep and staying asleep
536985|NCT01277081|Paracetamol|paracetamol
536986|NCT01277081|Common cold|common cold
536987|NCT01277068|obese patients|obese patients
536988|NCT01277068|TRL|trl
536989|NCT01277068|the bariatric surgery|the bariatric surgery
536990|NCT01277042|Safety|safety
536991|NCT01277042|HPV vaccine|hpv vaccine
536992|NCT01277042|Immune response|immune response
536993|NCT01277042|Human papillomavirus|human papillomavirus
536994|NCT01277042|China|china
536995|NCT01277016|Amyloidosis|amyloidosis
536996|NCT01277016|Bortezomib|bortezomib
536997|NCT01276977|Migraine|migraine
536998|NCT01276977|Acute Migraine|acute migraine
536999|NCT01276977|Headache|headache
537000|NCT01276964|menses|menses
537001|NCT01276964|quantitative determination of menstrual losses|quantitative determination of menstrual losses
537002|NCT01276964|kinetic definition of menses|kinetic definition of menses
537003|NCT01276951|Cocoa|cocoa
537004|NCT01276951|Chocolate|chocolate
537005|NCT01276951|Endothelial disfunction|endothelial disfunction
537006|NCT01276951|Cardiovascular disease|cardiovascular disease
537007|NCT01276951|Blood Pressure|blood pressure
537008|NCT01276951|Hypertension|hypertension
537009|NCT01276938|Breast cancer|breast cancer
537010|NCT01276938|Intra Operative Radiation Therapy|intra operative radiation therapy
537011|NCT01276938|Toxicity|toxicity
537012|NCT01276925|Hip arthroplasty|hip arthroplasty
537013|NCT01276925|Peripheral nervous blockade|peripheral nervous blockade
537014|NCT01276925|Postoperative|postoperative
537015|NCT01276925|Pain|pain
537016|NCT01276925|Ropivacaine|ropivacaine
537017|NCT01276899|Breast Cancer|breast cancer
537018|NCT01276899|Triple negative breast cancer|triple negative breast cancer
537019|NCT01276899|ERnegative, PRnegative and Her2negative|ernegative, prnegative and her2negative
537020|NCT01276899|Taxanes|taxanes
537021|NCT01276899|Metastases|metastases
537022|NCT01276899|Biomarkers|biomarkers
537023|NCT01276899|Resistance|resistance
537024|NCT01276899|Biobanking|biobanking
537025|NCT01276899|Breast cancer with unresectable metastases to the liver|breast cancer with unresectable metastases to the liver
537026|NCT01276899|Breast cancer with unresectable metastases to the skin|breast cancer with unresectable metastases to the skin
537027|NCT01276899|Breast cancer with unresectable metastases to the lymph node|breast cancer with unresectable metastases to the lymph node
537028|NCT01276899|Neoadjuvant chemotherapy|neoadjuvant chemotherapy
537029|NCT01276886|Left sided acute diverticulitis diagnosed clinically by the presence of abdominal pain, leukocytosis (>11x109) and/or fever >38°C, confirmed by imaging.|left sided acute diverticulitis diagnosed clinically by the presence of abdominal pain, leukocytosis (>11x109) and/or fever >38°c, confirmed by imaging.
537030|NCT01276886|CT criteria: localized thickening (≥4 mm) of the colonic wall and signs of inflammation of the pericolic fat, abscess and/or extraluminal air and/or contrast.|ct criteria: localized thickening (≥4 mm) of the colonic wall and signs of inflammation of the pericolic fat, abscess and/or extraluminal air and/or contrast.
537127|NCT01276444|valve repair|valve repair
537128|NCT01276444|postoperative period|postoperative period
537518|NCT01274884|Dislocation|dislocation
537031|NCT01276886|US criteria: bowel wall thickening (>4 mm), diverticular inflammation, pericolic fat edema, intramural or pericolic inflammatory mass, intramural fistula.|us criteria: bowel wall thickening (>4 mm), diverticular inflammation, pericolic fat edema, intramural or pericolic inflammatory mass, intramural fistula.
537032|NCT01276886|WSCE criteria: segmental luminal narrowing and a tethered mucosa with or without a mass effect or extravasation of contrast and/or extraluminal air.|wsce criteria: segmental luminal narrowing and a tethered mucosa with or without a mass effect or extravasation of contrast and/or extraluminal air.
537033|NCT01276873|Artificial Respiration|artificial respiration
537034|NCT01276873|Suction|suction
537035|NCT01276873|Pain|pain
537036|NCT01276873|Nursing|nursing
537037|NCT01276873|Neonatology|neonatology
537038|NCT01276860|Obstructive Sleep Apnea|obstructive sleep apnea
537039|NCT01276860|Pediatric Obstructive Sleep Apnea|pediatric obstructive sleep apnea
537041|NCT01276860|PVT|pvt
537042|NCT01276860|Psychomotor Vigilance Testing|psychomotor vigilance testing
537043|NCT01276860|Psychomotor Vigilance Task|psychomotor vigilance task
537044|NCT01276847|psoriasis|psoriasis
537045|NCT01276847|Ustekinumab|ustekinumab
537046|NCT01276847|Stelara|stelara
537047|NCT01276847|Etanercept|etanercept
537048|NCT01276847|Enbrel|enbrel
537049|NCT01276821|Bronchiolitis|bronchiolitis
537050|NCT01276821|L-Epinephrine|l-epinephrine
537051|NCT01276821|3% Hypertonic Saline|3% hypertonic saline
537052|NCT01276821|Clinical Severity Score|clinical severity score
537053|NCT01276808|Magnetic navigation, percutaneous coronary intervention|magnetic navigation, percutaneous coronary intervention
537054|NCT01276769|Triple Negative Breast Cancer|triple negative breast cancer
537055|NCT01276769|Neoadjuvant chemotherapy|neoadjuvant chemotherapy
537056|NCT01276769|Platinum|platinum
537057|NCT01276730|Advanced cervical cancer|advanced cervical cancer
537058|NCT01276730|India|india
537059|NCT01276691|Vascular function|vascular function
537060|NCT01276691|Inflammation|inflammation
537061|NCT01276691|Oxidative stress|oxidative stress
537062|NCT01276691|Hemostatic balance|hemostatic balance
537063|NCT01276691|Aspirin|aspirin
537064|NCT01276691|Firefighting|firefighting
537065|NCT01276678|CAD|cad
537066|NCT01276665|Bladder cancer|bladder cancer
537067|NCT01276665|urinary diversion|urinary diversion
537068|NCT01276665|Postoperative Complications|postoperative complications
537069|NCT01276665|Fluid Therapy|fluid therapy
537070|NCT01276665|Norepinephrine|norepinephrine
537071|NCT01276652|Polysomnography|polysomnography
537072|NCT01276652|Circadian rhythmicity|circadian rhythmicity
537073|NCT01276639|Xeljanz|xeljanz
537074|NCT01276639|tofacitinib|tofacitinib
537075|NCT01276639|chronic|chronic
537076|NCT01276639|Pruritus|pruritus
537077|NCT01276639|Itch|itch
537078|NCT01276639|DLQI|dlqi
537079|NCT01276639|severe|severe
537080|NCT01276639|moderate|moderate
537081|NCT01276639|treatment|treatment
537082|NCT01276639|safety|safety
537083|NCT01276639|efficacy|efficacy
537084|NCT01276639|CP-690,550|cp-690,550
537085|NCT01276639|Plaque Psoriasis|plaque psoriasis
537086|NCT01276639|Psoriasis Vulgaris|psoriasis vulgaris
537087|NCT01276639|Jax-inhibitor|jax-inhibitor
537088|NCT01276639|Oral Treatment|oral treatment
537089|NCT01276613|Resectable Adenocarcinoma of the Pancreas|resectable adenocarcinoma of the pancreas
537090|NCT01276613|Gemcitabine|gemcitabine
537091|NCT01276613|Gemcitabine Hydrochloride|gemcitabine hydrochloride
537092|NCT01276613|Gemzar|gemzar
537093|NCT01276587|sickle cell disease|sickle cell disease
537094|NCT01276587|children|children
537095|NCT01276587|vitamin D|vitamin d
537096|NCT01276587|safety|safety
537097|NCT01276574|PET/CT|pet/ct
537098|NCT01276574|Ovarian cancer|ovarian cancer
537099|NCT01276574|HE4|he4
537100|NCT01276561|laparoscopy|laparoscopy
537101|NCT01276561|splenectomy|splenectomy
537102|NCT01276561|single site|single site
537103|NCT01276561|trial|trial
537104|NCT01276522|Schnitzler syndrome|schnitzler syndrome
537105|NCT01276522|IL-1 beta|il-1 beta
537106|NCT01276522|Canakinumab|canakinumab
537107|NCT01276522|Ilaris|ilaris
537108|NCT01276522|Treatment|treatment
537109|NCT01276522|Efficacy|efficacy
537110|NCT01276522|Safety|safety
537111|NCT01276509|Crohn's disease Safety Efficacy Pharmacokinetics Pharmacodynamics Crohn's Disease Activity Index (CDAI)|crohn's disease safety efficacy pharmacokinetics pharmacodynamics crohn's disease activity index (cdai)
537112|NCT01276483|GIST|gist
537113|NCT01276483|Response Monitoring|response monitoring
537114|NCT01276483|Functional Magnetic Imaging|functional magnetic imaging
537115|NCT01276483|Positron Emission Tomography|positron emission tomography
537116|NCT01276483|Computer Tomography|computer tomography
537117|NCT01276470|Adult and Pediatric Autoimmune Disease|adult and pediatric autoimmune disease
537118|NCT01276470|Antibody|antibody
537119|NCT01276470|Autoimmune Diseases|autoimmune diseases
537120|NCT01276470|Autoimmunity Pathogenesis|autoimmunity pathogenesis
537121|NCT01276470|Environmental Risk Factors|environmental risk factors
537122|NCT01276470|Myositis|myositis
537123|NCT01276457|immunosuppression|immunosuppression
537124|NCT01276457|kidney transplantation|kidney transplantation
537125|NCT01276457|everolimus|everolimus
537126|NCT01276457|safety|safety
537129|NCT01276444|goal-directed therapy|goal-directed therapy
537130|NCT01276444|pulmonary artery catheter|pulmonary artery catheter
537131|NCT01276444|transpulmonary thermodilution|transpulmonary thermodilution
537132|NCT01276444|central venous oxygen saturation|central venous oxygen saturation
537133|NCT01276392|regional and systemical anticoagulation|regional and systemical anticoagulation
537134|NCT01276392|continuous renal replacement therapy|continuous renal replacement therapy
537135|NCT01276392|multiplate|multiplate
537136|NCT01276392|rotational thrombelastometry|rotational thrombelastometry
537137|NCT01276379|colorectal cancer|colorectal cancer
537138|NCT01276379|advanced|advanced
537139|NCT01276379|metastatic|metastatic
537140|NCT01276379|KRAS|kras
537141|NCT01276379|biomarkers (BRAF, IGF1P/MMp7,PI3K-PTEN)|biomarkers (braf, igf1p/mmp7,pi3k-pten)
537142|NCT01276379|cetuximab|cetuximab
537143|NCT01276366|Heel lance|heel lance
537144|NCT01276366|Premature|premature
537145|NCT01276366|Breast milk|breast milk
537146|NCT01276353|Alzheimer Disease|alzheimer disease
537147|NCT01276353|Dementia|dementia
537148|NCT01276353|Delirium|delirium
537149|NCT01276353|Amnestic|amnestic
537150|NCT01276353|Cognitive Disorders|cognitive disorders
537151|NCT01276353|Donepezil|donepezil
537152|NCT01276353|Brain Diseases|brain diseases
537153|NCT01276353|Central Nervous System Diseases|central nervous system diseases
537154|NCT01276353|Nervous System Diseases|nervous system diseases
537155|NCT01276353|Tauopathies|tauopathies
537156|NCT01276353|Neurodegenerative Diseases|neurodegenerative diseases
537157|NCT01276353|Mental Disorders|mental disorders
537158|NCT01276353|Cholinesterase Inhibitors|cholinesterase inhibitors
537159|NCT01276353|Enzy|enzy
537160|NCT01276340|Urinary Incontinence|urinary incontinence
537161|NCT01276340|Urinary stress incontinence|urinary stress incontinence
537162|NCT01276340|Urinary urge incontinence|urinary urge incontinence
537163|NCT01276340|Women|women
537164|NCT01276340|electrical stimulation|electrical stimulation
537165|NCT01276340|KEAT stimulator|keat stimulator
537166|NCT01276340|quality of life|quality of life
537167|NCT01276314|SCAR|scar
537168|NCT01276314|anti-TNF-a|anti-tnf-a
537169|NCT01276275|Acute coronary syndrome, thienopyridine, epidemiology|acute coronary syndrome, thienopyridine, epidemiology
537170|NCT01276262|Phase 1, healthy female volunteers, oral contraceptive, pharmacokinetics, Rheumatoid arthritis, RA, fostamatinib|phase 1, healthy female volunteers, oral contraceptive, pharmacokinetics, rheumatoid arthritis, ra, fostamatinib
537171|NCT01276249|Aptus Endosystem|aptus endosystem
537172|NCT01276249|EndoStaple|endostaple
537173|NCT01276249|Endograft|endograft
537174|NCT01276249|Stent Graft|stent graft
537175|NCT01276249|Abdominal Aortic Aneurysm|abdominal aortic aneurysm
537176|NCT01276249|Heli-FX|heli-fx
537177|NCT01276249|EndoAnchor|endoanchor
537178|NCT01276236|Kaposi's Sarcoma|kaposi's sarcoma
537179|NCT01276236|Maraviroc|maraviroc
537180|NCT01276236|CCR5|ccr5
537181|NCT01276236|HIV|hiv
537182|NCT01276223|Dry eye|dry eye
537183|NCT01276223|ocular discomfort|ocular discomfort
537184|NCT01276197|hypertension|hypertension
537185|NCT01276197|healthcare disparities|healthcare disparities
537186|NCT01276197|minority health|minority health
537187|NCT01276197|health behavior|health behavior
537188|NCT01276184|HPV Vaccine|hpv vaccine
537189|NCT01276184|HPV vaccination|hpv vaccination
537190|NCT01276184|SMS|sms
537191|NCT01276184|Text Message|text message
537192|NCT01276184|Gardasil|gardasil
537193|NCT01276145|pudendal artery disease|pudendal artery disease
537194|NCT01276145|erectile dysfunction|erectile dysfunction
537195|NCT01276145|coronary angiography|coronary angiography
537196|NCT01276145|coronary disease|coronary disease
537197|NCT01276145|cardiac|cardiac
537198|NCT01276132|percutaneous coronary artery intervention|percutaneous coronary artery intervention
537199|NCT01276132|coronary disease|coronary disease
537200|NCT01276119|CDP6038|cdp6038
537201|NCT01276119|single-dose|single-dose
537202|NCT01276119|pharmacokinetics|pharmacokinetics
537203|NCT01276119|healthy subjects|healthy subjects
537204|NCT01276106|AC-201|ac-201
537205|NCT01276106|Interleukin 1 inhibitor|interleukin 1 inhibitor
537206|NCT01276093|Atrial fibrillation|atrial fibrillation
537207|NCT01276093|PVI ablation|pvi ablation
537208|NCT01276093|Elderly patients|elderly patients
537209|NCT01276093|Efficacy|efficacy
537210|NCT01276041|MAB 2C4 (PERTUZUMAB)|mab 2c4 (pertuzumab)
537211|NCT01276041|MAB HER 2 (HERCEPTIN) (TRASTUZUMAB)|mab her 2 (herceptin) (trastuzumab)
537212|NCT01276041|TAXOL (PACLITAXEL)|taxol (paclitaxel)
537213|NCT01276041|10-142|10-142
537214|NCT01276041|Stage IV HER2 (+) breast cancer|stage iv her2 (+) breast cancer
537215|NCT01276028|Acupuncture|acupuncture
537216|NCT01276028|Hot Flashes|hot flashes
537217|NCT01276028|Menopause|menopause
537218|NCT01276028|Vasomotor Symptoms|vasomotor symptoms
537219|NCT01276015|BoNT-A-botulinum neurotoxin type A|bont-a-botulinum neurotoxin type a
537220|NCT01276015|CMAP-compound muscle action potential|cmap-compound muscle action potential
537221|NCT01276015|CP-cerebral palsy|cp-cerebral palsy
537222|NCT01276015|LG-lateral gastrocnemius|lg-lateral gastrocnemius
537223|NCT01276015|MG-medial gastrocnemius|mg-medial gastrocnemius
537224|NCT01276015|TA-tibialis anterior|ta-tibialis anterior
537225|NCT01276015|PROMS-passive range of movement|proms-passive range of movement
537226|NCT01276015|MAS-modified Ashworth scale|mas-modified ashworth scale
537227|NCT01276015|EVGS-Edinburgh visual gait scale|evgs-edinburgh visual gait scale
537228|NCT01276015|GMF-CS-gross motor function classification system|gmf-cs-gross motor function classification system
537229|NCT01276002|disrupted duct|disrupted duct
537230|NCT01276002|pancreatic pseudocysts|pancreatic pseudocysts
537231|NCT01275976|C1-esterase inhibitor|c1-esterase inhibitor
537232|NCT01275976|Systemic inflammation|systemic inflammation
537233|NCT01275976|Sepsis|sepsis
537234|NCT01275976|Trauma|trauma
537235|NCT01275976|Multiple Organ Dysfunction Syndrome|multiple organ dysfunction syndrome
537236|NCT01275976|Cytokines|cytokines
537237|NCT01275963|Echocardiography|echocardiography
537238|NCT01275963|Strain imaging|strain imaging
537239|NCT01275963|Ventricular Dysfunction|ventricular dysfunction
537240|NCT01275963|Cardiomyopathy|cardiomyopathy
537241|NCT01275963|Longitudinal left ventricular function|longitudinal left ventricular function
537242|NCT01275950|Tobacco vendor|tobacco vendor
537243|NCT01275950|students|students
537244|NCT01275950|knowledge|knowledge
537245|NCT01275950|attitude|attitude
537246|NCT01275950|practice|practice
537247|NCT01275950|direct advertisements|direct advertisements
537248|NCT01275950|surrogate advertisements|surrogate advertisements
537249|NCT01275924|Syndesmosis|syndesmosis
537250|NCT01275924|Injury|injury
537251|NCT01275924|Ankle|ankle
537252|NCT01275924|Fracture|fracture
537253|NCT01275898|NIRS|nirs
537254|NCT01275898|cerebral oxygenation|cerebral oxygenation
537255|NCT01275885|cholecalciferol|cholecalciferol
537256|NCT01275885|infant|infant
537257|NCT01275885|bone mineral density|bone mineral density
537258|NCT01275872|guided imagery|guided imagery
537259|NCT01275872|progressive muscle relaxation|progressive muscle relaxation
537260|NCT01275872|complimentary and alternative medicine|complimentary and alternative medicine
537261|NCT01275872|quality of life|quality of life
537262|NCT01275872|stress|stress
537263|NCT01275872|pain|pain
537264|NCT01275872|anxiety|anxiety
537265|NCT01275859|Neoadjuvant|neoadjuvant
537266|NCT01275859|Letrozole|letrozole
537267|NCT01275859|Lapatinib|lapatinib
537268|NCT01275859|Postmenopausal|postmenopausal
537269|NCT01275846|heart failure|heart failure
537270|NCT01275846|congestive heart failure|congestive heart failure
537271|NCT01275846|telemedicine|telemedicine
537272|NCT01275833|Implantable ICD|implantable icd
537273|NCT01275833|First Degree AV block|first degree av block
537274|NCT01275820|diabetes, insulin, blood sugar|diabetes, insulin, blood sugar
537275|NCT01275807|climacteric, climacteric syndrome|climacteric, climacteric syndrome
537276|NCT01275794|Type 2 Diabetes|type 2 diabetes
537277|NCT01275781|Phase 1|phase 1
537278|NCT01275781|healthy male volunteers|healthy male volunteers
537279|NCT01275781|radioactivity|radioactivity
537280|NCT01275781|excretion|excretion
537281|NCT01275781|metabolism|metabolism
537282|NCT01275781|AZD9742|azd9742
537283|NCT01275781|amount of radioactive AZD9742 in urine, feces, and vomitus (if appropriate)|amount of radioactive azd9742 in urine, feces, and vomitus (if appropriate)
537284|NCT01275768|radio-frequency ablation|radio-frequency ablation
537285|NCT01275768|Malignant jaundice|malignant jaundice
537286|NCT01275755|opioid therapy|opioid therapy
537287|NCT01275755|constipation|constipation
537288|NCT01275755|chronic noncancer pain|chronic noncancer pain
537289|NCT01275755|mu opioid receptor antagonist|mu opioid receptor antagonist
537290|NCT01275755|ADL5945|adl5945
537291|NCT01275755|Opioid Induced Constipation|opioid induced constipation
537292|NCT01275742|Heart failure|heart failure
537293|NCT01275742|Depression|depression
537294|NCT01275742|Depressive symptoms|depressive symptoms
537295|NCT01275742|Cognitive therapy|cognitive therapy
537296|NCT01275742|Hospitalization|hospitalization
537297|NCT01275742|Quality of life|quality of life
537298|NCT01275729|Renal Replacement Therapy|renal replacement therapy
537299|NCT01275729|Diuretics|diuretics
537300|NCT01275729|Biomarkers|biomarkers
537301|NCT01275729|Renal Insufficiency|renal insufficiency
537302|NCT01275729|Furosemide|furosemide
537303|NCT01275729|Therapeutic Uses|therapeutic uses
537304|NCT01275729|Physiological Effects of Drugs|physiological effects of drugs
537305|NCT01275729|Biological Markers|biological markers
537306|NCT01275716|Patient Education|patient education
537307|NCT01275716|coronary artery disease|coronary artery disease
537308|NCT01275716|Impact of Coronary Images Used During Patient Education on Coronary Artery Disease and Subsequent Lifestyle Modifications.|impact of coronary images used during patient education on coronary artery disease and subsequent lifestyle modifications.
537309|NCT01275703|To determine the utility of a noninvasive method of measuring cardiac output during exercise testing in patients with PH|to determine the utility of a noninvasive method of measuring cardiac output during exercise testing in patients with ph
537310|NCT01275690|cardiac|cardiac
537311|NCT01275690|pulmonary hypertension|pulmonary hypertension
537312|NCT01275690|To determine the accuracy of a noninvasive method of measuring cardiac output as compared to the standard invasive approach in patients with PH|to determine the accuracy of a noninvasive method of measuring cardiac output as compared to the standard invasive approach in patients with ph
537313|NCT01275651|adenocarcinoma of the prostate|adenocarcinoma of the prostate
537314|NCT01275651|recurrent prostate cancer|recurrent prostate cancer
537315|NCT01275638|cortisol, prednisolone, adrenal insufficiency, sepsis|cortisol, prednisolone, adrenal insufficiency, sepsis
537316|NCT01275625|maraviroc|maraviroc
537318|NCT01275625|hiv|hiv
537319|NCT01275625|zidovudine|zidovudine
537320|NCT01275625|lamivudine|lamivudine
537321|NCT01275625|combivir|combivir
537322|NCT01275625|Clade A|clade a
537323|NCT01275612|Mesenchymal Stromal Cells|mesenchymal stromal cells
537324|NCT01275612|Solid tumors|solid tumors
537325|NCT01275612|Cisplatin therapy|cisplatin therapy
537326|NCT01275612|Acute kidney injury|acute kidney injury
537327|NCT01275586|NF1|nf1
537328|NCT01275586|plexiform neurofibromas|plexiform neurofibromas
537329|NCT01275586|nilotinib|nilotinib
537330|NCT01275586|Tasigna|tasigna
537331|NCT01275573|Repetitive Transcranial Magnetic Stimulation|repetitive transcranial magnetic stimulation
537332|NCT01275573|pain threshold|pain threshold
537333|NCT01275573|Parkinson's disease|parkinson's disease
537334|NCT01275573|Pain threshold in Parkinson's disease|pain threshold in parkinson's disease
537335|NCT01275547|Patient controlled analgesia|patient controlled analgesia
537336|NCT01275547|Morphine|morphine
537337|NCT01275547|S-Ketamine intranasal|s-ketamine intranasal
537338|NCT01275547|Midazolam intranasal|midazolam intranasal
537339|NCT01275534|Stem cell transplantation|stem cell transplantation
537340|NCT01275534|Symptom experience|symptom experience
537341|NCT01275534|Late effects|late effects
537342|NCT01275534|Self-management|self-management
537343|NCT01275508|Subjects with active Crohn's disease|subjects with active crohn's disease
537344|NCT01275508|Safety and tolerability of FITC-Adalimumab|safety and tolerability of fitc-adalimumab
537345|NCT01275508|Intestinal topical application|intestinal topical application
537346|NCT01275495|Stroke|stroke
537347|NCT01275495|Family Caregivers|family caregivers
537348|NCT01275495|Cerebrovascular Accident|cerebrovascular accident
537349|NCT01275495|Carers|carers
537350|NCT01275495|Care Givers|care givers
537351|NCT01275495|Depression|depression
537352|NCT01275495|Life change events|life change events
537353|NCT01275495|Family health|family health
537354|NCT01275495|Quality of life|quality of life
537355|NCT01275495|Cost|cost
537356|NCT01275495|Intervention studies|intervention studies
537357|NCT01275495|Clinical trial|clinical trial
537358|NCT01275482|Latent Myofascial trigger point.|latent myofascial trigger point.
537359|NCT01275482|Transverse friction massage|transverse friction massage
537360|NCT01275482|Local twitch response|local twitch response
537361|NCT01275482|Effectiveness|effectiveness
537362|NCT01275469|Impaired Glucose tolerance|impaired glucose tolerance
537363|NCT01275469|OGTT|ogtt
537364|NCT01275469|PPARs|ppars
537365|NCT01275456|allergen provocation|allergen provocation
537366|NCT01275456|environmental challenge|environmental challenge
537367|NCT01275456|allergen chamber|allergen chamber
537368|NCT01275456|house dust mite|house dust mite
537369|NCT01275456|immunotherapy|immunotherapy
537370|NCT01275443|HIV|hiv
537371|NCT01275430|central venous catheters|central venous catheters
537372|NCT01275430|peripherally inserted central catheters (PICC_|peripherally inserted central catheters (picc_
537373|NCT01275430|Electrocardiography (ECG)|electrocardiography (ecg)
537374|NCT01275430|intravascular ECG|intravascular ecg
537375|NCT01275430|Tip Positioning System|tip positioning system
537376|NCT01275417|Acupuncture|acupuncture
537377|NCT01275404|Erectile Dysfunction|erectile dysfunction
537378|NCT01275404|focus group|focus group
537379|NCT01275404|Quality of Life|quality of life
537380|NCT01275404|10-204|10-204
537381|NCT01275391|Tobacco use|tobacco use
537382|NCT01275391|Alcohol abuse|alcohol abuse
537383|NCT01275391|Drug abuse|drug abuse
537384|NCT01275391|Substance use|substance use
537385|NCT01275391|Prevention|prevention
537386|NCT01275391|Brief intervention|brief intervention
537387|NCT01275391|Screening|screening
537388|NCT01275391|Adolescents|adolescents
537389|NCT01275365|Mobility Limitation|mobility limitation
537390|NCT01275365|Low Protein Intake|low protein intake
537391|NCT01275365|Older Men|older men
537392|NCT01275365|Testosterone|testosterone
537393|NCT01275352|left ventricular hypertrophy|left ventricular hypertrophy
537394|NCT01275352|heart failure|heart failure
537395|NCT01275339|Aortic valve stenosis|aortic valve stenosis
537396|NCT01275339|Tadalafil|tadalafil
537397|NCT01275339|Phosphodiesterase inhibitors|phosphodiesterase inhibitors
537398|NCT01275339|Hypertension, pulmonary|hypertension, pulmonary
537399|NCT01275339|Hypertrophy, left ventricular|hypertrophy, left ventricular
537400|NCT01275326|Indoor Air Quality|indoor air quality
537401|NCT01275326|Infectious Aerosols|infectious aerosols
537402|NCT01275313|Pressure ulcers|pressure ulcers
537403|NCT01275313|wheelchairs|wheelchairs
537404|NCT01275313|wheelchair functional capacity|wheelchair functional capacity
537405|NCT01275313|custom-fitted wheelchair|custom-fitted wheelchair
537406|NCT01275287|Anti-Neutrophil Cytoplasmic Antibody-Associated Vasculitis|anti-neutrophil cytoplasmic antibody-associated vasculitis
537407|NCT01275287|Complement Activation|complement activation
537408|NCT01275274|ANCA|anca
537409|NCT01275274|Vasculitis|vasculitis
537410|NCT01275274|Pauci-immune vasculitis|pauci-immune vasculitis
537411|NCT01275261|Stroke|stroke
537412|NCT01275261|Urinary Tract Infection|urinary tract infection
537413|NCT01275248|OCD|ocd
537414|NCT01275248|Obsessive Compulsive Disorder|obsessive compulsive disorder
537415|NCT01275222|GIST|gist
537416|NCT01275222|everolimus|everolimus
537417|NCT01275222|mTOR|mtor
537418|NCT01275222|Imatinib resistant|imatinib resistant
537419|NCT01275222|Imatinib-refractory/resistant gastrointestinal stromal tumors|imatinib-refractory/resistant gastrointestinal stromal tumors
537420|NCT01275209|HCD122|hcd122
537421|NCT01275209|Lucatumumab|lucatumumab
537422|NCT01275209|CD40|cd40
537423|NCT01275209|Follicular Lymphoma|follicular lymphoma
537424|NCT01275209|Non-Hodgkin's Lymphoma|non-hodgkin's lymphoma
537425|NCT01275209|Antibody|antibody
537426|NCT01275196|Newly diagnosed,|newly diagnosed,
537427|NCT01275196|Ph+ chronic myeloid leukemia,|ph+ chronic myeloid leukemia,
537428|NCT01275196|CML-CP|cml-cp
537429|NCT01275183|HNSCC|hnscc
537430|NCT01275183|SCC|scc
537431|NCT01275183|head and neck|head and neck
537432|NCT01275183|squamous cell|squamous cell
537433|NCT01275183|nasopharyngeal|nasopharyngeal
537434|NCT01275157|Absorption|absorption
537435|NCT01275157|Distribution|distribution
537436|NCT01275157|Metabolism|metabolism
537437|NCT01275157|Excretion|excretion
537438|NCT01275157|Mass balance|mass balance
537439|NCT01275157|Metabolic profile|metabolic profile
537440|NCT01275157|Radiolabeled study|radiolabeled study
537441|NCT01275157|14C|14c
537442|NCT01275131|Insulin analog|insulin analog
537443|NCT01275131|Type 1 diabetes mellitus|type 1 diabetes mellitus
537444|NCT01275131|Pharmacokinetic|pharmacokinetic
537445|NCT01275131|Glucodynamic|glucodynamic
537446|NCT01275131|Phase 1|phase 1
537447|NCT01275092|robotic-assisted PCI|robotic-assisted pci
537448|NCT01275092|coronary intervention|coronary intervention
537449|NCT01275092|CorPath PRECISE|corpath precise
537450|NCT01275092|PCI|pci
537451|NCT01275079|tonsillectomy|tonsillectomy
537452|NCT01275079|nasalance|nasalance
537453|NCT01275079|tonsil volume|tonsil volume
537454|NCT01275079|Thai|thai
537455|NCT01275079|adult|adult
537456|NCT01275066|Mucopolysaccharidosis IV type A|mucopolysaccharidosis iv type a
537457|NCT01275066|MPS IV Type A|mps iv type a
537458|NCT01275066|Mucopolysaccharidosis IVA|mucopolysaccharidosis iva
537459|NCT01275066|MPS IVA|mps iva
537460|NCT01275066|Morquio A Syndrome|morquio a syndrome
537461|NCT01275066|Lysosomal Storage Disorder|lysosomal storage disorder
537462|NCT01275066|LSD|lsd
537463|NCT01275066|N-acetylgalactosamine-6-sulfatase|n-acetylgalactosamine-6-sulfatase
537464|NCT01275066|N-acetylgalactosamine-6-sulfate sulfatase|n-acetylgalactosamine-6-sulfate sulfatase
537465|NCT01275066|galactose-6-sulfatase|galactose-6-sulfatase
537466|NCT01275066|GALNS|galns
537467|NCT01275066|enzyme replacement therapy|enzyme replacement therapy
537468|NCT01275066|ERT|ert
537470|NCT01275053|In Vivo|in vivo
537471|NCT01275053|Diabetic|diabetic
537472|NCT01275053|Obese|obese
537473|NCT01275053|Lean|lean
537474|NCT01275040|diabetes|diabetes
537475|NCT01275040|mobile screening|mobile screening
537476|NCT01275040|complications|complications
537477|NCT01275040|primary care|primary care
537478|NCT01275040|specialised care|specialised care
537479|NCT01275040|quality of care|quality of care
537480|NCT01275027|diabetes|diabetes
537481|NCT01275027|blood sugar|blood sugar
537482|NCT01275027|insulin|insulin
537483|NCT01275027|nutritional supplement|nutritional supplement
537484|NCT01275027|nutraceutical|nutraceutical
537485|NCT01275014|TMJ|tmj
537486|NCT01275014|corticosteroids|corticosteroids
537487|NCT01275014|osteoarthritis|osteoarthritis
537488|NCT01275014|arthrocentesis|arthrocentesis
537489|NCT01275014|pain|pain
537490|NCT01275001|brain|brain
537491|NCT01275001|brain development|brain development
537492|NCT01275001|MRI|mri
537493|NCT01275001|preschool children|preschool children
537494|NCT01275001|cortical mantle thickness|cortical mantle thickness
537495|NCT01275001|hippocampal volume|hippocampal volume
537496|NCT01274988|Opiate dependence|opiate dependence
537497|NCT01274988|Deep brain stimulation|deep brain stimulation
537498|NCT01274988|Nucleus accumbens|nucleus accumbens
537499|NCT01274949|LI-ESWT|li-eswt
537500|NCT01274949|Erectile Dysfunction|erectile dysfunction
537501|NCT01274949|Radical Prostatectomy|radical prostatectomy
537502|NCT01274949|Non PDE5 inhibitor responders|non pde5 inhibitor responders
537503|NCT01274949|Shock wave|shock wave
537504|NCT01274923|Erectile dysfunction|erectile dysfunction
537505|NCT01274923|Low Intensity Shock Wave|low intensity shock wave
537506|NCT01274910|Fish Oil|fish oil
537507|NCT01274910|Knee|knee
537508|NCT01274910|Analgetics|analgetics
537509|NCT01274897|Meningococcal|meningococcal
537510|NCT01274897|ACWY-CRM|acwy-crm
537511|NCT01274897|Conjugate Vaccine|conjugate vaccine
537512|NCT01274897|Meningitis|meningitis
537513|NCT01274897|Adolescents|adolescents
537514|NCT01274897|Persistence|persistence
537515|NCT01274897|Adults|adults
537516|NCT01274884|Acromioclavicular|acromioclavicular
537519|NCT01274884|Surgery|surgery
537520|NCT01274871|Thoracotomy|thoracotomy
537521|NCT01274871|Chronic Pain|chronic pain
537522|NCT01274871|persistent post-surgical pain|persistent post-surgical pain
537523|NCT01274858|persistent pain|persistent pain
537524|NCT01274858|neuropathic pain|neuropathic pain
537525|NCT01274858|Thoracotomy|thoracotomy
537526|NCT01274858|Chronic Pain|chronic pain
537527|NCT01274845|Meconium aspiration syndrome|meconium aspiration syndrome
537528|NCT01274845|Heliox|heliox
537529|NCT01274845|Mechanical ventilation|mechanical ventilation
537530|NCT01274845|Newborn|newborn
537531|NCT01274832|Parkinson|parkinson
537532|NCT01274832|DBS of STN|dbs of stn
537533|NCT01274832|PD|pd
537534|NCT01274832|Deep Brain stimulation of STN|deep brain stimulation of stn
537535|NCT01274832|Early treatment|early treatment
537536|NCT01274819|delirium|delirium
537537|NCT01274819|confusion|confusion
537538|NCT01274806|breast cancer|breast cancer
537539|NCT01274806|physical therapy|physical therapy
537540|NCT01274806|massage|massage
537541|NCT01274806|core stability|core stability
537542|NCT01274793|functional constipation|functional constipation
537543|NCT01274793|functional diarrhea|functional diarrhea
537544|NCT01274793|acupuncture|acupuncture
537545|NCT01274754|neuroprotection|neuroprotection
537546|NCT01274754|erythromycin|erythromycin
537547|NCT01274754|neurocognitive assessment|neurocognitive assessment
537548|NCT01274741|Posttraumatic stress disorder|posttraumatic stress disorder
537549|NCT01274741|Substance use disorder|substance use disorder
537550|NCT01274741|Treatment efficacy|treatment efficacy
537551|NCT01274741|Randomized trial|randomized trial
537552|NCT01274741|Trauma|trauma
537553|NCT01274741|Substance abuse|substance abuse
537554|NCT01274741|Addiction|addiction
537555|NCT01274728|Acute myocardial infarction|acute myocardial infarction
537556|NCT01274728|Primary percutaneous coronary intervention|primary percutaneous coronary intervention
537557|NCT01274728|Drug-eluting balloon|drug-eluting balloon
537558|NCT01274728|Bivalirudin|bivalirudin
537559|NCT01274715|Behavioral health coaching|behavioral health coaching
537560|NCT01274715|Diabetes|diabetes
537561|NCT01274715|Emotional health|emotional health
537562|NCT01274702|History of|history of
537563|NCT01274702|Patients|patients
537564|NCT01274702|acute|acute
537565|NCT01274689|lagophthalmos|lagophthalmos
537566|NCT01274689|parotis tumor|parotis tumor
537567|NCT01274689|m. orbicularis oculi paresis|m. orbicularis oculi paresis
537568|NCT01274676|stenting|stenting
537569|NCT01274676|carotid plaque|carotid plaque
537570|NCT01274676|stenosis|stenosis
537571|NCT01274676|angioplasty|angioplasty
537572|NCT01274663|Single Ascending Dose|single ascending dose
537573|NCT01274663|Phase 1|phase 1
537574|NCT01274663|Safety and Tolerability|safety and tolerability
537575|NCT01274663|PK|pk
537576|NCT01274663|Healthy Subjects|healthy subjects
537577|NCT01274637|postpartum|postpartum
537578|NCT01274637|low molecular weight heparin|low molecular weight heparin
537579|NCT01274637|venous thromboembolism|venous thromboembolism
537580|NCT01274637|prophylaxis|prophylaxis
537581|NCT01274637|Dalteparin Sodium|dalteparin sodium
537582|NCT01274624|Colorectal|colorectal
537583|NCT01274624|Cancer|cancer
537584|NCT01274624|REOLYSIN®|reolysin®
537585|NCT01274624|Chemotherapy|chemotherapy
537586|NCT01274624|FOLFIRI|folfiri
537587|NCT01274624|Reovirus|reovirus
537588|NCT01274624|Oncolytic virus|oncolytic virus
537589|NCT01274624|Fluorouracil|fluorouracil
537590|NCT01274624|Irinotecan|irinotecan
537591|NCT01274624|Leucovorin|leucovorin
537592|NCT01274624|Bevacizumab|bevacizumab
537593|NCT01274611|sweating|sweating
537594|NCT01274611|sweat|sweat
537595|NCT01274611|underarm|underarm
537596|NCT01274611|axillary|axillary
537597|NCT01274611|hyperhidrosis|hyperhidrosis
537598|NCT01274611|botox|botox
537599|NCT01274611|liposuction|liposuction
537600|NCT01274611|suction-curettage|suction-curettage
537602|NCT01274611|curettage|curettage
537603|NCT01274598|Probiotics|probiotics
537604|NCT01274598|Safety|safety
537605|NCT01274598|Elderly|elderly
537606|NCT01274598|Lactobacillus|lactobacillus
537607|NCT01274598|LGG|lgg
537608|NCT01274559|MK-0524A/ER|mk-0524a/er
537609|NCT01274559|Hypercholesterolemia|hypercholesterolemia
537610|NCT01274559|Dyslipidemia|dyslipidemia
537611|NCT01274559|Niacin|niacin
537612|NCT01274559|Laropiprant|laropiprant
537613|NCT01274533|ATLL|atll
537614|NCT01274520|ECD liver transplant allografts|ecd liver transplant allografts
537615|NCT01274520|Hypothermic machine perfusion|hypothermic machine perfusion
537616|NCT01274520|Cold storage preservation|cold storage preservation
537617|NCT01274520|liver transplant|liver transplant
537618|NCT01274520|portable bypass system|portable bypass system
537619|NCT01274520|machine perfusion preservation|machine perfusion preservation
537620|NCT01274520|extended criteria liver|extended criteria liver
537621|NCT01274507|Asthma|asthma
537622|NCT01274507|Pulmonary Disease, Chronic Obstructive|pulmonary disease, chronic obstructive
537623|NCT01274507|Healthy|healthy
537624|NCT01274507|Longitudinal Study|longitudinal study
537625|NCT01274507|Bronchoscopy|bronchoscopy
537626|NCT01274494|Hypertension|hypertension
537627|NCT01274481|Acute Respiratory Distress Syndrome|acute respiratory distress syndrome
537628|NCT01274481|Acute Lung Injury|acute lung injury
537629|NCT01274481|pulmonary hypertension|pulmonary hypertension
537630|NCT01274481|oxygenation|oxygenation
537631|NCT01274481|lung mechanics|lung mechanics
537632|NCT01274481|gas exchange|gas exchange
537633|NCT01274455|Gene therapy|gene therapy
537634|NCT01274455|pancreatic carcinoma|pancreatic carcinoma
537635|NCT01274455|gemcitabine|gemcitabine
537636|NCT01274455|endoscopic ultrasound|endoscopic ultrasound
537637|NCT01274442|dental implant|dental implant
537638|NCT01274429|Peanut allergy|peanut allergy
537639|NCT01274429|Immunotherapy|immunotherapy
537640|NCT01274429|OIT|oit
537641|NCT01274416|Anorexia Nervosa|anorexia nervosa
537642|NCT01274416|Eating Disorder|eating disorder
537643|NCT01274416|Treatment|treatment
537644|NCT01274416|Acceptance and Commitment Therapy|acceptance and commitment therapy
537645|NCT01274416|Separated Family Treatment|separated family treatment
537646|NCT01274403|Multiple Myeloma|multiple myeloma
537647|NCT01274403|Elderly patients|elderly patients
537648|NCT01274390|Cardiac Surgery|cardiac surgery
537649|NCT01274390|Red Blood Cell|red blood cell
537650|NCT01274390|Transfusion|transfusion
537651|NCT01274390|Oxygen Saturation|oxygen saturation
537652|NCT01274390|Microvascular Flow|microvascular flow
537653|NCT01274377|nonmyeloablative allogeneic stem cell transplantation|nonmyeloablative allogeneic stem cell transplantation
537654|NCT01274377|cytomegalovirus|cytomegalovirus
537655|NCT01274377|donor lymphocyte infusions|donor lymphocyte infusions
537656|NCT01274377|cytotoxic T lymphocyte|cytotoxic t lymphocyte
537657|NCT01274364|Diabetes|diabetes
537658|NCT01274364|Structured Care|structured care
537659|NCT01274351|First line treatment|first line treatment
537660|NCT01274351|newly diagnosed|newly diagnosed
537661|NCT01274351|Philadelphia chromosome positive|philadelphia chromosome positive
537662|NCT01274351|Chronic Myelogenous Leukemia|chronic myelogenous leukemia
537663|NCT01274351|Ph+|ph+
537664|NCT01274351|CML-CP|cml-cp
537665|NCT01274351|major molecular response|major molecular response
537666|NCT01274351|Social risk|social risk
537667|NCT01274325|asthma|asthma
537668|NCT01274312|Somato-sensory reflex arch|somato-sensory reflex arch
537669|NCT01274312|Spinal cord injury|spinal cord injury
537670|NCT01274312|Xiao Procedure|xiao procedure
537671|NCT01274299|Infants|infants
537672|NCT01274299|morphometry|morphometry
537673|NCT01274299|face|face
537674|NCT01274299|3D|3d
537675|NCT01274286|hospital accreditation|hospital accreditation
537676|NCT01274286|patient-centered|patient-centered
537677|NCT01274286|healthcare quality index|healthcare quality index
537678|NCT01274286|documentary analysis|documentary analysis
537679|NCT01274286|meta analysis|meta analysis
537680|NCT01274273|Bevacizumab|bevacizumab
537681|NCT01274273|interleukin-2|interleukin-2
537682|NCT01274273|interferon-alpha|interferon-alpha
537683|NCT01274260|child|child
537684|NCT01274260|infant|infant
537685|NCT01274260|lung injury|lung injury
537686|NCT01274260|inflammation|inflammation
537687|NCT01274260|pneumonia|pneumonia
537688|NCT01274260|ventilator|ventilator
537689|NCT01274247|Tongue-tie|tongue-tie
537690|NCT01274247|Ankyloglossia|ankyloglossia
537691|NCT01274234|EPC capturing sirolimus eluting COMBO stent|epc capturing sirolimus eluting combo stent
537692|NCT01274234|Optical coherence tomography (OCT)|optical coherence tomography (oct)
537693|NCT01274234|Early neointimal healing and stent coverage|early neointimal healing and stent coverage
537694|NCT01274234|Late neointimal thickness, neointimal area, and lumen loss|late neointimal thickness, neointimal area, and lumen loss
537695|NCT01274208|Gaucher disease, Hepatitis C , Glucocerebroside immunity|gaucher disease, hepatitis c , glucocerebroside immunity
537696|NCT01274195|Hematopoietic stem cell transplantation|hematopoietic stem cell transplantation
537697|NCT01274156|Erectile dysfunction|erectile dysfunction
537698|NCT01274156|Low Intensity Shock Wave|low intensity shock wave
537699|NCT01274143|Colorectal|colorectal
537700|NCT01274143|Cancer|cancer
537701|NCT01274143|Colon|colon
537702|NCT01274143|Rectal|rectal
537703|NCT01274143|Behavioral Intervention|behavioral intervention
537704|NCT01274143|Screening|screening
537705|NCT01274143|Motivational Interviewing|motivational interviewing
537706|NCT01274143|Extended Parallel Process Model|extended parallel process model
537707|NCT01274143|Implementation Intentions|implementation intentions
537708|NCT01274143|Family CARE|family care
537709|NCT01274117|Chronic renal failure|chronic renal failure
537710|NCT01274117|Basilic vein transposition fistula|basilic vein transposition fistula
537711|NCT01274104|statin-related myalgia|statin-related myalgia
537712|NCT01274104|high cholesterol|high cholesterol
537713|NCT01274091|Gene-diet interaction|gene-diet interaction
537714|NCT01274091|PPARgamma gene|ppargamma gene
537715|NCT01274091|Pro12Ala|pro12ala
537716|NCT01274091|Fatty acids|fatty acids
537717|NCT01274091|Dietary modification|dietary modification
537718|NCT01274091|Insulin sensitivity|insulin sensitivity
537719|NCT01274091|Glucose metabolism|glucose metabolism
537720|NCT01274078|inflammation|inflammation
537722|NCT01274078|CRP|crp
537723|NCT01274065|psychiatry|psychiatry
537724|NCT01274065|psychiatric illness|psychiatric illness
537725|NCT01274065|developmental disability|developmental disability
537726|NCT01274065|mental health|mental health
537727|NCT01274065|medication burden|medication burden
537728|NCT01274052|Gestational diabetes mellitus|gestational diabetes mellitus
537729|NCT01274052|Meal test|meal test
537730|NCT01274052|Incretin hormones|incretin hormones
537731|NCT01274052|Glucagon-like peptide-1 (GLP-1)|glucagon-like peptide-1 (glp-1)
537732|NCT01274052|Glucose-dependent insulinotropic polypeptide|glucose-dependent insulinotropic polypeptide
537733|NCT01274052|Insulin|insulin
537734|NCT01274052|C-peptide|c-peptide
537735|NCT01274052|Glucagon|glucagon
537736|NCT01274026|phenylketonuria|phenylketonuria
537737|NCT01274026|PKU|pku
537738|NCT01274026|phenylalanine|phenylalanine
537739|NCT01274026|neurotransmitters|neurotransmitters
537740|NCT01274026|gene|gene
537741|NCT01274026|Kuvan|kuvan
537742|NCT01274026|sapropterin|sapropterin
537743|NCT01274013|Hepatitis C|hepatitis c
537744|NCT01274013|Chronic Hepatitis C|chronic hepatitis c
537745|NCT01274013|Vitamin D|vitamin d
537746|NCT01274013|Vitamin D deficiency|vitamin d deficiency
537747|NCT01274000|diarrhea|diarrhea
537748|NCT01274000|IBS|ibs
537749|NCT01274000|Colonic disease|colonic disease
537750|NCT01274000|YM060|ym060
537751|NCT01274000|Ramosetron|ramosetron
537752|NCT01273974|intradermal influenza vaccine|intradermal influenza vaccine
537753|NCT01273974|hemodialysis patients|hemodialysis patients
537754|NCT01273935|Aspirin, Acute Cerebrovascular Ischemia, Platelet Function|aspirin, acute cerebrovascular ischemia, platelet function
537755|NCT01273922|NDV-3|ndv-3
537756|NCT01273922|vaccine|vaccine
537757|NCT01273922|Staphylococcus aureus|staphylococcus aureus
537758|NCT01273922|MRSA|mrsa
537759|NCT01273922|Candida|candida
537760|NCT01273909|Breast Cancer|breast cancer
537761|NCT01273909|BRACA1/2 Genotype|braca1/2 genotype
537762|NCT01273909|Acquired Lymphedema|acquired lymphedema
537763|NCT01273909|Congenital Lymphedema|congenital lymphedema
537764|NCT01273896|STA-9090|sta-9090
537765|NCT01273896|advanced breast cancer|advanced breast cancer
537766|NCT01273896|10-145|10-145
537767|NCT01273883|hearing|hearing
537768|NCT01273883|magnesium|magnesium
537769|NCT01273870|hemodialysis|hemodialysis
537770|NCT01273870|high-flux-dialyzer|high-flux-dialyzer
537771|NCT01273870|performance|performance
537772|NCT01273870|blood compatibility|blood compatibility
537773|NCT01273857|Cardiac progenitor cells|cardiac progenitor cells
537774|NCT01273857|Cell therapy|cell therapy
537775|NCT01273857|Hypoplastic Left Heart Syndrome|hypoplastic left heart syndrome
537776|NCT01273857|Single Ventricle|single ventricle
537777|NCT01273857|Norwood|norwood
537778|NCT01273857|Sano modification|sano modification
537779|NCT01273857|Glenn|glenn
537780|NCT01273857|Fontan|fontan
537781|NCT01273844|hematopoietic stem cell transplantation|hematopoietic stem cell transplantation
537782|NCT01273844|amyloidosis|amyloidosis
537783|NCT01273844|Bortezomib|bortezomib
537784|NCT01273831|intraocular pressure, anesthesia,cisatracurium,atracurium.|intraocular pressure, anesthesia,cisatracurium,atracurium.
537785|NCT01273818|inguinal hernia|inguinal hernia
537786|NCT01273818|infection prophylaxis|infection prophylaxis
537787|NCT01273818|topical gentamicin|topical gentamicin
537788|NCT01273805|metastatic pancreatic cancer|metastatic pancreatic cancer
537789|NCT01273805|hydroxychloroquine|hydroxychloroquine
537790|NCT01273779|sepsis|sepsis
537791|NCT01273779|talactoferrin|talactoferrin
537792|NCT01273779|lactoferrin|lactoferrin
537793|NCT01273779|recombinant human lactoferrin|recombinant human lactoferrin
537794|NCT01273753|End-stage renal disease|end-stage renal disease
537795|NCT01273753|Hemodialysis|hemodialysis
537796|NCT01273753|Bioimpedance analysis|bioimpedance analysis
537797|NCT01273753|Blood volume monitoring|blood volume monitoring
537798|NCT01273740|PTFE bypass|ptfe bypass
537799|NCT01273740|femoro-popliteal|femoro-popliteal
537800|NCT01273740|femoro-crural|femoro-crural
537801|NCT01273740|popliteal arteries|popliteal arteries
537802|NCT01273740|crural arteries|crural arteries
537803|NCT01273740|external support|external support
537804|NCT01273740|crtical limb ischemia|crtical limb ischemia
537805|NCT01273727|epiretinal membrane|epiretinal membrane
537806|NCT01273727|macular pucker|macular pucker
537807|NCT01273727|cellophane maculopathy|cellophane maculopathy
537808|NCT01273727|macular edema|macular edema
537809|NCT01273727|retinal edema|retinal edema
537810|NCT01273727|ozurdex|ozurdex
537811|NCT01273727|dexamethasone|dexamethasone
537812|NCT01273727|intravitreal implant|intravitreal implant
537813|NCT01273714|benign thyroid disease|benign thyroid disease
537814|NCT01273714|incidental thyroid cancer|incidental thyroid cancer
537815|NCT01273714|recurrent goiter|recurrent goiter
537816|NCT01273714|revision thyroid surgery|revision thyroid surgery
537817|NCT01273701|amphetamine|amphetamine
537818|NCT01273701|methamphetamine|methamphetamine
537819|NCT01273701|psychosocial intervention|psychosocial intervention
537820|NCT01273701|contingency management|contingency management
537821|NCT01273701|slow prosecution|slow prosecution
537822|NCT01273701|substance use disorder|substance use disorder
537823|NCT01273688|pain|pain
537824|NCT01273688|elbow|elbow
537825|NCT01273688|tendinopathy|tendinopathy
537826|NCT01273675|Hypertension|hypertension
537827|NCT01273675|Primary disease|primary disease
537828|NCT01273662|HCC|hcc
537829|NCT01273649|muscle activation|muscle activation
537830|NCT01273649|ACL reconstruction|acl reconstruction
537831|NCT01273649|cryotherapy|cryotherapy
537832|NCT01273649|TENS|tens
537833|NCT01273636|Endometrial hyperplasia|endometrial hyperplasia
537834|NCT01273636|Hysterectomy|hysterectomy
537835|NCT01273636|Endometrial carcinoma|endometrial carcinoma
537836|NCT01273623|PAD, Peripheral Arterial Disease, Calcium, Atherectomy, Jetstream|pad, peripheral arterial disease, calcium, atherectomy, jetstream
537837|NCT01273610|Breast Neoplasms|breast neoplasms
537838|NCT01273610|HER2 protein, human|her2 protein, human
537839|NCT01273610|Geriatric Health Services|geriatric health services
537840|NCT01273610|Antineoplastic Agents, Combined|antineoplastic agents, combined
537841|NCT01273610|Geriatric Assessment|geriatric assessment
537842|NCT01273610|Pharmacokinetics|pharmacokinetics
537843|NCT01273610|Toxicity|toxicity
537844|NCT01273610|Patient Adherence|patient adherence
537845|NCT01273597|Parathyroid hormone,Kidney failure, chronic,Hyperparathyroidism, secondary|parathyroid hormone,kidney failure, chronic,hyperparathyroidism, secondary
537846|NCT01273584|Metformin, obese, pregnancy, gestational diabetes|metformin, obese, pregnancy, gestational diabetes
537847|NCT01273571|Canagliflozin|canagliflozin
537848|NCT01273571|Metformin (GLUCOPHAGE IR)|metformin (glucophage ir)
537849|NCT01273571|Pharmacokinetics|pharmacokinetics
537850|NCT01273571|Pharmacodynamics|pharmacodynamics
537851|NCT01273558|Canagliflozin|canagliflozin
537852|NCT01273558|Renal threshold for glucose|renal threshold for glucose
537853|NCT01273558|Pharmacodynamics|pharmacodynamics
537854|NCT01273545|Dapoxetine hydrochloride (PRILIGY)|dapoxetine hydrochloride (priligy)
537855|NCT01273545|Premature ejaculation|premature ejaculation
537856|NCT01273532|tapentadol|tapentadol
537857|NCT01273532|NUCYNTA|nucynta
537858|NCT01273532|CG5503|cg5503
537859|NCT01273532|R331333|r331333
537860|NCT01273532|pharmacokinetics|pharmacokinetics
537861|NCT01273532|healthy volunteer|healthy volunteer
537862|NCT01273519|Ankylosing|ankylosing
537863|NCT01273519|Rheumatoid|rheumatoid
537864|NCT01273519|Antibodies|antibodies
537865|NCT01273519|Arthritis|arthritis
537866|NCT01273519|Pain|pain
537867|NCT01273519|Antirheumatic Agents|antirheumatic agents
537868|NCT01273519|Psoriatic|psoriatic
537869|NCT01273519|Spondylitis|spondylitis
537870|NCT01273519|Monoclonals|monoclonals
537871|NCT01273506|tapentadol|tapentadol
537872|NCT01273506|NUCYNTA|nucynta
537873|NCT01273506|CG5503|cg5503
537874|NCT01273506|R331333|r331333
537875|NCT01273506|pharmacokinetics|pharmacokinetics
537876|NCT01273506|healthy volunteer|healthy volunteer
537877|NCT01273493|Trabectedin, YONDELIS|trabectedin, yondelis
537878|NCT01273493|Antineoplastic Agents|antineoplastic agents
537879|NCT01273493|Solid tumors|solid tumors
537880|NCT01273493|Locally advanced or metastatic disease|locally advanced or metastatic disease
537881|NCT01273493|Chemotherapy|chemotherapy
537882|NCT01273493|Pharmacokinetics|pharmacokinetics
537883|NCT01273493|Hepatic Dysfunction|hepatic dysfunction
537884|NCT01273480|Trabectedin, YONDELIS|trabectedin, yondelis
537885|NCT01273480|Rifampin (RIFADIN)|rifampin (rifadin)
537886|NCT01273480|Antineoplastic Agents|antineoplastic agents
537887|NCT01273480|Solid tumors|solid tumors
537888|NCT01273480|Locally advanced or metastatic disease|locally advanced or metastatic disease
537889|NCT01273480|Chemotherapy|chemotherapy
537890|NCT01273480|Pharmacokinetics|pharmacokinetics
537891|NCT01273467|Ischemic Cerebral Infarction|ischemic cerebral infarction
537892|NCT01273467|Stroke|stroke
537893|NCT01273467|CNTO0007|cnto0007
537894|NCT01273467|42037788|42037788
537895|NCT01273454|Open-label|open-label
537896|NCT01273454|Non-interventional|non-interventional
537897|NCT01273454|OROS hydromorphone|oros hydromorphone
537898|NCT01273454|Korean cancer patients|korean cancer patients
537899|NCT01273415|hormone receptor-positive breast cancer|hormone receptor-positive breast cancer
537900|NCT01273415|nomogram|nomogram
537901|NCT01273415|Ki67|ki67
537902|NCT01273415|Effects of Chemotherapy|effects of chemotherapy
537903|NCT01273402|colorectal cancer|colorectal cancer
537904|NCT01273402|TF2 (Recombinant, humanized Tri-Fab bsMAb composed of 2 humanized MN-14 anti-CEA Fab x and one 679 anti-HSG Fab)|tf2 (recombinant, humanized tri-fab bsmab composed of 2 humanized mn-14 anti-cea fab x and one 679 anti-hsg fab)
537905|NCT01273402|IMP288 (DOTA-di-HSG hapten-peptide for 111In/90Y labeling)|imp288 (dota-di-hsg hapten-peptide for 111in/90y labeling)
537906|NCT01273389|Lupus nephritis|lupus nephritis
537907|NCT01273389|CNTO 136|cnto 136
537908|NCT01273389|Sirukumab|sirukumab
537909|NCT01273389|Kidney diseases|kidney diseases
537910|NCT01273389|Proteinuria|proteinuria
683379|NCT00698672|RSA|rsa
537911|NCT01273389|Glomerulonephritis|glomerulonephritis
537912|NCT01273376|MDD|mdd
537913|NCT01273376|Depression|depression
537914|NCT01273376|Major Depression|major depression
537915|NCT01273363|Asthma|asthma
538275|NCT01272063|Dry AMD|dry amd
537916|NCT01273363|Asthma in Children|asthma in children
537917|NCT01273350|internal carotid artery|internal carotid artery
537918|NCT01273350|common carotid artery|common carotid artery
537919|NCT01273350|bruit|bruit
537920|NCT01273350|tia|tia
537921|NCT01273337|Stroke|stroke
537922|NCT01273337|Ischemia|ischemia
537923|NCT01273337|Ischemic Stroke|ischemic stroke
537924|NCT01273337|Middle Cerebral Artery|middle cerebral artery
537925|NCT01273337|MCA|mca
537926|NCT01273337|Stem Cells|stem cells
537927|NCT01273337|Stem Cell|stem cell
537928|NCT01273337|Autologous Bone Marrow|autologous bone marrow
537929|NCT01273337|Ipsilateral MCA|ipsilateral mca
537930|NCT01273324|Osteoarthritis|osteoarthritis
537931|NCT01273311|Brain Aging|brain aging
537932|NCT01273311|Diabetes|diabetes
537933|NCT01273311|Aging|aging
537934|NCT01273311|Obesity|obesity
537935|NCT01273311|CARDIA|cardia
537936|NCT01273298|chronic obstructive pulmonary disease|chronic obstructive pulmonary disease
537937|NCT01273298|exercise|exercise
537938|NCT01273298|dynamic hyperinflation|dynamic hyperinflation
537939|NCT01273298|cardioselective beta blockers|cardioselective beta blockers
537940|NCT01273272|Cognitive Behavior Therapy|cognitive behavior therapy
537941|NCT01273272|Early dementia, Alzheimer type|early dementia, alzheimer type
537942|NCT01273259|Hypertension, pulmonary|hypertension, pulmonary
537943|NCT01273259|DHEA|dhea
537944|NCT01273259|six-minute walk test|six-minute walk test
537945|NCT01273259|pulmonary arterial pressure|pulmonary arterial pressure
537946|NCT01273220|Epidemiology|epidemiology
537947|NCT01273220|Epidemiologic Survey|epidemiologic survey
537948|NCT01273220|Alcohol|alcohol
537949|NCT01273207|Peripheral Blood Stem Cell Transplant|peripheral blood stem cell transplant
537950|NCT01273207|Inhaled Cyclosporine|inhaled cyclosporine
537951|NCT01273207|Graft-Versus-Host Disease|graft-versus-host disease
537952|NCT01273194|Palliative Care|palliative care
537953|NCT01273194|Survey|survey
537954|NCT01273194|Quality of Life|quality of life
537955|NCT01273194|Attitudes|attitudes
537956|NCT01273194|Pediatric Cancer|pediatric cancer
537957|NCT01273181|Immunotherapy|immunotherapy
537958|NCT01273181|Gene Therapy|gene therapy
537959|NCT01273181|Metastatic Cancer|metastatic cancer
537960|NCT01273181|Clinical Response|clinical response
537961|NCT01273181|Metastatic Melanoma|metastatic melanoma
537962|NCT01273181|Metastatic Renal Cell Cancer|metastatic renal cell cancer
537963|NCT01273168|Pharmacokinetics|pharmacokinetics
537964|NCT01273168|Advanced Cancer|advanced cancer
537965|NCT01273168|Cytochrome P 450|cytochrome p 450
537966|NCT01273168|Selective Estrogen Receptor Modulator|selective estrogen receptor modulator
537967|NCT01273168|Tamoxifen Metabolite|tamoxifen metabolite
537968|NCT01273168|Gynecologic Cancer|gynecologic cancer
537969|NCT01273168|Breast Cancer|breast cancer
537970|NCT01273168|Desmoid Tumor|desmoid tumor
537971|NCT01273168|Endometrial Cancer|endometrial cancer
537972|NCT01273168|Ovarian Cancer|ovarian cancer
537973|NCT01273168|Uterine Cancer|uterine cancer
537974|NCT01273168|Fallopian Tube Cancer|fallopian tube cancer
537975|NCT01273168|Peritoneal Cancer|peritoneal cancer
537976|NCT01273155|Histone Deacetylase Inhibitor|histone deacetylase inhibitor
537977|NCT01273155|Liver Dysfunction|liver dysfunction
537978|NCT01273155|Pharmacokinetics|pharmacokinetics
537979|NCT01273155|UGT1A1 Polymorphisms|ugt1a1 polymorphisms
537980|NCT01273155|Solid Tumor|solid tumor
537981|NCT01273155|Cancer|cancer
537982|NCT01273155|Lymphoma|lymphoma
537983|NCT01273142|Human Immunodeficiency Virus, liver toxicity, hapatitis co-infection|human immunodeficiency virus, liver toxicity, hapatitis co-infection
537984|NCT01273129|Neurosurgery|neurosurgery
537985|NCT01273129|Childhood Epilepsy|childhood epilepsy
537986|NCT01273129|Epilepsy|epilepsy
537987|NCT01273129|Frontal Lobe Epilepsy|frontal lobe epilepsy
537988|NCT01273129|Temporal Lobe Epilepsy|temporal lobe epilepsy
537989|NCT01273116|frailty|frailty
537990|NCT01273116|integrated care|integrated care
537991|NCT01273116|hospital|hospital
537992|NCT01273116|geriatrics|geriatrics
537993|NCT01273116|hospital-wide intervention|hospital-wide intervention
537994|NCT01273090|unspecified childhood solid tumor, protocol specific|unspecified childhood solid tumor, protocol specific
537995|NCT01273090|recurrent childhood anaplastic large cell lymphoma|recurrent childhood anaplastic large cell lymphoma
537996|NCT01273090|recurrent childhood grade III lymphomatoid granulomatosis|recurrent childhood grade iii lymphomatoid granulomatosis
537997|NCT01273090|recurrent childhood large cell lymphoma|recurrent childhood large cell lymphoma
537998|NCT01273090|recurrent childhood lymphoblastic lymphoma|recurrent childhood lymphoblastic lymphoma
537999|NCT01273090|recurrent childhood small noncleaved cell lymphoma|recurrent childhood small noncleaved cell lymphoma
538000|NCT01273090|recurrent/refractory childhood Hodgkin lymphoma|recurrent/refractory childhood hodgkin lymphoma
538001|NCT01273090|recurrent childhood brain stem glioma|recurrent childhood brain stem glioma
538002|NCT01273090|recurrent childhood anaplastic astrocytoma|recurrent childhood anaplastic astrocytoma
538003|NCT01273090|recurrent childhood anaplastic oligoastrocytoma|recurrent childhood anaplastic oligoastrocytoma
538004|NCT01273090|recurrent childhood anaplastic oligodendroglioma|recurrent childhood anaplastic oligodendroglioma
538005|NCT01273090|recurrent childhood cerebellar astrocytoma|recurrent childhood cerebellar astrocytoma
538006|NCT01273090|recurrent childhood cerebral astrocytoma|recurrent childhood cerebral astrocytoma
538007|NCT01273090|recurrent childhood diffuse astrocytoma|recurrent childhood diffuse astrocytoma
538008|NCT01273090|recurrent childhood fibrillary astrocytoma|recurrent childhood fibrillary astrocytoma
538009|NCT01273090|recurrent childhood gemistocytic astrocytoma|recurrent childhood gemistocytic astrocytoma
538010|NCT01273090|recurrent childhood giant cell glioblastoma|recurrent childhood giant cell glioblastoma
538011|NCT01273090|recurrent childhood glioblastoma|recurrent childhood glioblastoma
538012|NCT01273090|recurrent childhood gliomatosis cerebri|recurrent childhood gliomatosis cerebri
538013|NCT01273090|recurrent childhood gliosarcoma|recurrent childhood gliosarcoma
538014|NCT01273090|recurrent childhood oligoastrocytoma|recurrent childhood oligoastrocytoma
538015|NCT01273090|recurrent childhood oligodendroglioma|recurrent childhood oligodendroglioma
538016|NCT01273090|recurrent childhood pilocytic astrocytoma|recurrent childhood pilocytic astrocytoma
538017|NCT01273090|recurrent childhood pilomyxoid astrocytoma|recurrent childhood pilomyxoid astrocytoma
538018|NCT01273090|recurrent childhood pleomorphic xanthoastrocytoma|recurrent childhood pleomorphic xanthoastrocytoma
538019|NCT01273090|recurrent childhood protoplasmic astrocytoma|recurrent childhood protoplasmic astrocytoma
538020|NCT01273090|recurrent childhood subependymal giant cell astrocytoma|recurrent childhood subependymal giant cell astrocytoma
538021|NCT01273090|recurrent childhood visual pathway and hypothalamic glioma|recurrent childhood visual pathway and hypothalamic glioma
538022|NCT01273090|recurrent childhood visual pathway glioma|recurrent childhood visual pathway glioma
538023|NCT01273090|childhood pineal parenchymal tumor|childhood pineal parenchymal tumor
538024|NCT01273090|recurrent childhood central nervous system embryonal tumor|recurrent childhood central nervous system embryonal tumor
538025|NCT01273090|childhood central nervous system choriocarcinoma|childhood central nervous system choriocarcinoma
538026|NCT01273090|childhood central nervous system germ cell tumor|childhood central nervous system germ cell tumor
538027|NCT01273090|childhood central nervous system germinoma|childhood central nervous system germinoma
538028|NCT01273090|childhood central nervous system mixed germ cell tumor|childhood central nervous system mixed germ cell tumor
538029|NCT01273090|childhood central nervous system teratoma|childhood central nervous system teratoma
538030|NCT01273090|childhood central nervous system yolk sac tumor|childhood central nervous system yolk sac tumor
538031|NCT01273090|recurrent childhood pineoblastoma|recurrent childhood pineoblastoma
538032|NCT01273090|childhood diffuse large cell lymphoma|childhood diffuse large cell lymphoma
538033|NCT01273090|childhood nasal type extranodal NK/T-cell lymphoma|childhood nasal type extranodal nk/t-cell lymphoma
538034|NCT01273090|childhood nodular lymphocyte predominant Hodgkin lymphoma|childhood nodular lymphocyte predominant hodgkin lymphoma
538035|NCT01273090|angioimmunoblastic T-cell lymphoma|angioimmunoblastic t-cell lymphoma
538036|NCT01273090|childhood Burkitt lymphoma|childhood burkitt lymphoma
538037|NCT01273090|childhood grade III lymphomatoid granulomatosis|childhood grade iii lymphomatoid granulomatosis
538038|NCT01273090|childhood immunoblastic large cell lymphoma|childhood immunoblastic large cell lymphoma
538039|NCT01273090|cutaneous B-cell non-Hodgkin lymphoma|cutaneous b-cell non-hodgkin lymphoma
538040|NCT01273090|hepatosplenic T-cell lymphoma|hepatosplenic t-cell lymphoma
538041|NCT01273090|intraocular lymphoma|intraocular lymphoma
538042|NCT01273090|noncutaneous extranodal lymphoma|noncutaneous extranodal lymphoma
538043|NCT01273090|peripheral T-cell lymphoma|peripheral t-cell lymphoma
538044|NCT01273090|post-transplant lymphoproliferative disorder|post-transplant lymphoproliferative disorder
538045|NCT01273090|recurrent cutaneous T-cell non-Hodgkin lymphoma|recurrent cutaneous t-cell non-hodgkin lymphoma
538046|NCT01273090|recurrent mycosis fungoides/Sezary syndrome|recurrent mycosis fungoides/sezary syndrome
538047|NCT01273090|small intestine lymphoma|small intestine lymphoma
538048|NCT01273077|Rotavirus|rotavirus
538049|NCT01273077|Rotarix|rotarix
538050|NCT01273064|HCV|hcv
538051|NCT01273064|Null Responders|null responders
538052|NCT01273051|Rectal Cancer|rectal cancer
538053|NCT01273051|Radiochemotherapy|radiochemotherapy
538054|NCT01273051|TEM|tem
538055|NCT01273051|Organ preservation|organ preservation
538056|NCT01273025|pharmacokinetic|pharmacokinetic
538057|NCT01273025|lime powder regimen|lime powder regimen
538058|NCT01273025|kidney stone|kidney stone
538059|NCT01273025|Oxidative stress|oxidative stress
538060|NCT01273012|probiotic|probiotic
538061|NCT01273012|cost-effectiveness|cost-effectiveness
538062|NCT01273012|diarrhea|diarrhea
538063|NCT01273012|children|children
538064|NCT01273012|Sum of the monetary cost of the hospitalization|sum of the monetary cost of the hospitalization
538065|NCT01272999|Acute otitis media|acute otitis media
538066|NCT01272999|Prevnar 13|prevnar 13
538067|NCT01272999|Streptococcus pneumoniae|streptococcus pneumoniae
710259|NCT00589563|stage I adult Hodgkin lymphoma|stage i adult hodgkin lymphoma
710760|NCT00588068|Adrenal Gland|adrenal gland
538068|NCT01272986|Determination of the level of oxidised LDL by measuring the level of IgG in Blood|determination of the level of oxidised ldl by measuring the level of igg in blood
538069|NCT01272960|Contraception|contraception
538070|NCT01272960|Postnatal care|postnatal care
538071|NCT01272947|Blunt soft tissue injury/contusion|blunt soft tissue injury/contusion
538072|NCT01272934|Ankle Sprain, soft tissue injury|ankle sprain, soft tissue injury
538073|NCT01272895|OCT images|oct images
538074|NCT01272895|Stent strut coverage|stent strut coverage
538075|NCT01272895|Endothelialization|endothelialization
538076|NCT01272895|Neointimal thickness, area and hyperplasia|neointimal thickness, area and hyperplasia
538077|NCT01272895|Stent malapposition|stent malapposition
538276|NCT01272063|OCT|oct
538078|NCT01272830|total joint arthroplasty|total joint arthroplasty
538079|NCT01272830|synovitis|synovitis
538080|NCT01272830|ALVAL (Aseptic Lymphocyte-Dominant Vasculitis-Associated Lesion)|alval (aseptic lymphocyte-dominant vasculitis-associated lesion)
538081|NCT01272830|osteolysis|osteolysis
538082|NCT01272830|periprosthetic metallosis|periprosthetic metallosis
538083|NCT01272817|Nonmyeloablative transplant|nonmyeloablative transplant
538084|NCT01272817|Allogeneic transplant|allogeneic transplant
538085|NCT01272817|Transplant|transplant
538086|NCT01272804|Pharmacokinetics PK Pharmacodynamics PD T2DM Phase 1 Type 2 diabetes mellitus safety and tolerability|pharmacokinetics pk pharmacodynamics pd t2dm phase 1 type 2 diabetes mellitus safety and tolerability
538087|NCT01272791|metastatic stage IV pancreatic cancer|metastatic stage iv pancreatic cancer
538088|NCT01272765|obesity|obesity
538089|NCT01272765|weight loss|weight loss
538090|NCT01272765|weight management|weight management
538091|NCT01272765|anti-psychotic medication|anti-psychotic medication
538092|NCT01272765|Zyprexa|zyprexa
538093|NCT01272765|Seroquel|seroquel
538094|NCT01272765|Risperdal|risperdal
538095|NCT01272752|obesity|obesity
538096|NCT01272752|weight loss|weight loss
538097|NCT01272752|weight management|weight management
538098|NCT01272752|anti-psychotic medication|anti-psychotic medication
538099|NCT01272752|nutriceutical|nutriceutical
538100|NCT01272739|obesity|obesity
538101|NCT01272739|weight loss|weight loss
538102|NCT01272739|weight management|weight management
538103|NCT01272739|overweight|overweight
538104|NCT01272739|nutriceutical|nutriceutical
538105|NCT01272687|Parkinson Disease|parkinson disease
538106|NCT01272687|Parkinsonian Disorders|parkinsonian disorders
538107|NCT01272687|Brain Diseases|brain diseases
538108|NCT01272687|Central Nervous System Diseases|central nervous system diseases
538109|NCT01272687|Nervous System Diseases|nervous system diseases
538110|NCT01272687|Neurodegenerative Diseases|neurodegenerative diseases
538111|NCT01272661|breastfeeding|breastfeeding
538112|NCT01272661|low-income|low-income
538113|NCT01272661|high-risk|high-risk
538114|NCT01272661|African-American|african-american
538115|NCT01272661|health disparity|health disparity
538116|NCT01272648|Rehabilitation|rehabilitation
538117|NCT01272648|Coping|coping
538118|NCT01272648|Prostate cancer|prostate cancer
538119|NCT01272648|Nursing|nursing
538120|NCT01272648|Physiotherapy|physiotherapy
538121|NCT01272648|Pelvic floor exercises|pelvic floor exercises
538122|NCT01272648|Motivational Interviewing|motivational interviewing
538123|NCT01272635|Asthma|asthma
538124|NCT01272635|Wheezing|wheezing
538125|NCT01272635|Respiratory Tract Illness|respiratory tract illness
538126|NCT01272635|Azythromycin|azythromycin
538127|NCT01272635|Prednisolone|prednisolone
538128|NCT01272635|Preschool-age|preschool-age
538129|NCT01272622|Quality of life|quality of life
538130|NCT01272622|Endocrinology|endocrinology
538131|NCT01272622|Oncology|oncology
538132|NCT01272622|Hypothalamus|hypothalamus
538133|NCT01272622|Irradiation|irradiation
538134|NCT01272622|Neurosurgery|neurosurgery
538135|NCT01272622|Pediatric Brain tumors|pediatric brain tumors
538136|NCT01272622|Randomized trial|randomized trial
538137|NCT01272596|Multiple Sclerosis|multiple sclerosis
538138|NCT01272596|Visual Contrast Acuity|visual contrast acuity
538139|NCT01272596|Visual Contrast Sensitivity|visual contrast sensitivity
538140|NCT01272596|Sloan Charts|sloan charts
538141|NCT01272583|Type 1 diabetes|type 1 diabetes
538142|NCT01272583|DPP-4 inhibitor|dpp-4 inhibitor
538143|NCT01272583|Glucagon|glucagon
538144|NCT01272570|breast|breast
538145|NCT01272570|oral|oral
538146|NCT01272570|cancer|cancer
538147|NCT01272557|HCC|hcc
538148|NCT01272544|Dental caries|dental caries
538149|NCT01272544|Epidemiology|epidemiology
538150|NCT01272544|Gingivitis|gingivitis
538151|NCT01272544|Oral health|oral health
538152|NCT01272531|pharmacogenetics|pharmacogenetics
538153|NCT01272531|bipolar disorders|bipolar disorders
538154|NCT01272531|affective disorders|affective disorders
538155|NCT01272531|mood disorders|mood disorders
538156|NCT01272531|pharmacologic actions|pharmacologic actions
538157|NCT01272531|psychotropic drugs|psychotropic drugs
538158|NCT01272531|antimanic agents|antimanic agents
538159|NCT01272531|antidepressant agents|antidepressant agents
538160|NCT01272531|lithium|lithium
538161|NCT01272531|lithium carbonate|lithium carbonate
538162|NCT01272531|Lithobid|lithobid
538163|NCT01272531|Eskalith|eskalith
538164|NCT01272531|divalproex|divalproex
538165|NCT01272531|divalproex sodium|divalproex sodium
538166|NCT01272531|Depakote|depakote
538167|NCT01272531|valproate|valproate
538168|NCT01272518|chaos theory heart rate variability mania bipolar disorder|chaos theory heart rate variability mania bipolar disorder
538169|NCT01272479|hemodialysis|hemodialysis
538170|NCT01272479|hepatitis C|hepatitis c
538171|NCT01272479|inflammation|inflammation
538172|NCT01272479|iron stores|iron stores
538173|NCT01272479|prohepcidin|prohepcidin
538174|NCT01272466|multiple myeloma|multiple myeloma
538175|NCT01272466|vaccination|vaccination
538176|NCT01272466|antiapoptotic proteins|antiapoptotic proteins
538177|NCT01272466|proteasome inhibition|proteasome inhibition
538178|NCT01272453|coronary artery disease|coronary artery disease
538179|NCT01272453|CT scan|ct scan
538180|NCT01272453|coronary angiography|coronary angiography
538181|NCT01272453|chest pain|chest pain
538182|NCT01272453|aortic aneurysm|aortic aneurysm
538183|NCT01272453|pulmonary embolism|pulmonary embolism
538184|NCT01272440|PEG-asparaginase|peg-asparaginase
538185|NCT01272440|children|children
538186|NCT01272440|pharmacokinetics|pharmacokinetics
538187|NCT01272440|antibodies|antibodies
538188|NCT01272440|acute lymphoblastic leukaemia|acute lymphoblastic leukaemia
538189|NCT01272440|adverse effects|adverse effects
538190|NCT01272414|Eyelid retraction|eyelid retraction
538191|NCT01272414|Botulinum Toxins|botulinum toxins
538192|NCT01272388|Aortic valve stenosis|aortic valve stenosis
538193|NCT01272388|Tadalafil|tadalafil
538194|NCT01272388|Phosphodiesterase inhibitors|phosphodiesterase inhibitors
538195|NCT01272388|Hypertension, pulmonary|hypertension, pulmonary
538196|NCT01272388|Hypertrophy, left ventricular|hypertrophy, left ventricular
538197|NCT01272362|Indacaterol|indacaterol
538198|NCT01272362|COPD|copd
538199|NCT01272362|LABA|laba
538200|NCT01272362|Reversibility|reversibility
538201|NCT01272349|spinal cord injury|spinal cord injury
538202|NCT01272349|walking|walking
538203|NCT01272349|low oxygen|low oxygen
538204|NCT01272349|air|air
538205|NCT01272349|strength|strength
538206|NCT01272336|spinal cord injury, low oxygen, strength, motor control|spinal cord injury, low oxygen, strength, motor control
538207|NCT01272323|Cat allergy|cat allergy
538208|NCT01272323|Rhinoconjunctivitis|rhinoconjunctivitis
538209|NCT01272310|Chronic Hepatitis C|chronic hepatitis c
538210|NCT01272310|Combination Therapy|combination therapy
538211|NCT01272310|Hydroxychloroquine|hydroxychloroquine
538212|NCT01272310|Pegylated Interferon Alpha-2a|pegylated interferon alpha-2a
538213|NCT01272310|Ribavirin|ribavirin
538214|NCT01272310|Chronic Hepatitis C Genotype 1 infected adult subjects|chronic hepatitis c genotype 1 infected adult subjects
538215|NCT01272297|LI-ESWT|li-eswt
538216|NCT01272297|Erectile Dysfunction|erectile dysfunction
538217|NCT01272297|Non PDE5 inhibitor responders|non pde5 inhibitor responders
538218|NCT01272297|Shock wave|shock wave
538219|NCT01272284|Female|female
538220|NCT01272284|Stress urinary incontinence|stress urinary incontinence
538221|NCT01272284|Mini sling|mini sling
538222|NCT01272284|Single incision sling|single incision sling
538223|NCT01272284|Urinary incontinence|urinary incontinence
538224|NCT01272284|Mixed urinary incontinence|mixed urinary incontinence
538225|NCT01272284|Additional relevant MeSH terms:|additional relevant mesh terms:
538226|NCT01272284|Stress|stress
538227|NCT01272284|Urinary Incontinence, Stress|urinary incontinence, stress
538228|NCT01272284|Pathological Processes|pathological processes
538229|NCT01272284|Urination Disorders|urination disorders
538230|NCT01272284|Urological Disorders|urological disorders
538231|NCT01272284|Urological Manifestations|urological manifestations
538232|NCT01272284|Signs and Symptoms|signs and symptoms
538233|NCT01272271|Contact lens|contact lens
538234|NCT01272271|Infection|infection
538235|NCT01272271|Cornea|cornea
538236|NCT01272245|Acute Myelogenous Leukemia|acute myelogenous leukemia
538237|NCT01272245|AML|aml
538238|NCT01272245|High-Risk Myelodysplastic Syndrome|high-risk myelodysplastic syndrome
538239|NCT01272245|MDS|mds
538240|NCT01272245|Omacetaxine|omacetaxine
538241|NCT01272245|Cytarabine|cytarabine
538242|NCT01272245|ARA-C|ara-c
538243|NCT01272245|Cytosar|cytosar
538244|NCT01272245|DepoCyt|depocyt
538245|NCT01272245|Cytosine Arabinosine Hydrochloride|cytosine arabinosine hydrochloride
538246|NCT01272180|Safety|safety
538247|NCT01272180|Immunogenicity|immunogenicity
538248|NCT01272180|Vaccine|vaccine
538249|NCT01272180|Meningococcal|meningococcal
538250|NCT01272180|Seroresponse|seroresponse
538251|NCT01272167|Post-menopausal women|post-menopausal women
538252|NCT01272167|Grapefruit juice|grapefruit juice
538253|NCT01272167|Naringin|naringin
538254|NCT01272167|Vascular protection|vascular protection
538255|NCT01272167|Bone metabolism|bone metabolism
538256|NCT01272154|Cerebellum|cerebellum
538257|NCT01272154|Cortical plasticity|cortical plasticity
538258|NCT01272154|Sensorimotor adaptation|sensorimotor adaptation
538259|NCT01272154|Dystonia|dystonia
538260|NCT01272154|Cerebral Palsy|cerebral palsy
710761|NCT00588068|No stage requirement|no stage requirement
538261|NCT01272154|Transcranial Magnetic Stimulation|transcranial magnetic stimulation
538262|NCT01272154|and|and
538263|NCT01272141|Metastatic breast cancer|metastatic breast cancer
538264|NCT01272141|Triple negative breast cancer|triple negative breast cancer
538265|NCT01272141|Estrogen receptor (ER)/progesterone receptor (PR)/human epidermal growth factor receptor 2 (HER2)-negative breast cancer|estrogen receptor (er)/progesterone receptor (pr)/human epidermal growth factor receptor 2 (her2)-negative breast cancer
538266|NCT01272115|Climacteric stage|climacteric stage
538267|NCT01272115|Integrative health care model|integrative health care model
538268|NCT01272115|Empowerment approach|empowerment approach
538269|NCT01272115|Primary care services|primary care services
538270|NCT01272076|Age Related Macular Degeneration|age related macular degeneration
538271|NCT01272076|Geographic Atrophy|geographic atrophy
538272|NCT01272076|Imaging|imaging
538273|NCT01272076|OCT|oct
538274|NCT01272063|Drusen|drusen
538277|NCT01272063|Imaging|imaging
538278|NCT01272050|adenocarcinoma of the prostate|adenocarcinoma of the prostate
538279|NCT01272050|recurrent prostate cancer|recurrent prostate cancer
538280|NCT01272050|stage IIA prostate cancer|stage iia prostate cancer
538281|NCT01272050|stage IIB prostate cancer|stage iib prostate cancer
538282|NCT01272050|stage III prostate cancer|stage iii prostate cancer
538283|NCT01272024|clinical trial|clinical trial
538284|NCT01272024|symptom education|symptom education
538285|NCT01272024|advanced cancer|advanced cancer
538286|NCT01272011|Respiration|respiration
538287|NCT01272011|Spinal cord injuries|spinal cord injuries
538288|NCT01272011|Walking recovery|walking recovery
538289|NCT01271998|antibiotic|antibiotic
538290|NCT01271998|healthy subjects|healthy subjects
538291|NCT01271998|pharmacokinetics|pharmacokinetics
538292|NCT01271985|Cardiovascular Diseases|cardiovascular diseases
538293|NCT01271985|Drug Combinations|drug combinations
538294|NCT01271985|prevention and control|prevention and control
538295|NCT01271985|Aspirin|aspirin
538296|NCT01271985|Antihypertensive Agents|antihypertensive agents
538297|NCT01271985|Antilipemic Agents|antilipemic agents
538298|NCT01271959|Ovarian|ovarian
538299|NCT01271959|Fallopian Tube|fallopian tube
538300|NCT01271959|Peritoneal|peritoneal
538301|NCT01271959|Uterine Neoplasms|uterine neoplasms
538302|NCT01271959|Vulva|vulva
538303|NCT01271959|Endometrial|endometrial
538304|NCT01271959|Cervical|cervical
538305|NCT01271959|Lung|lung
538306|NCT01271959|Carcinoid|carcinoid
538307|NCT01271959|Sarcoma|sarcoma
538308|NCT01271959|Mesothelioma|mesothelioma
538309|NCT01271959|Adenocarcinoma|adenocarcinoma
538310|NCT01271959|Colorectal|colorectal
538311|NCT01271959|Breast|breast
538312|NCT01271959|Assay|assay
538313|NCT01271959|Chemotherapy|chemotherapy
538314|NCT01271959|Recurrent|recurrent
538315|NCT01271959|Refractory|refractory
538316|NCT01271959|Persistent|persistent
538317|NCT01271959|Chemoresponse|chemoresponse
538318|NCT01271933|fibromyalgia|fibromyalgia
538319|NCT01271933|pain|pain
538320|NCT01271933|pregabalin|pregabalin
538321|NCT01271933|Lyrica|lyrica
538322|NCT01271920|Trastuzumab-refractory|trastuzumab-refractory
538323|NCT01271920|advanced HER2-positive breast cancer,|advanced her2-positive breast cancer,
538324|NCT01271920|Hsp90,|hsp90,
538325|NCT01271920|2nd or 3rd line treatment|2nd or 3rd line treatment
538326|NCT01271907|Skin Cancer|skin cancer
538327|NCT01271907|Malignancy|malignancy
538328|NCT01271907|Immunotherapy|immunotherapy
538329|NCT01271907|Melanoma Peptides|melanoma peptides
538330|NCT01271907|Melanoma|melanoma
538331|NCT01271907|Metastatic Melanoma|metastatic melanoma
538332|NCT01271894|HIV|hiv
538333|NCT01271894|efavirenz|efavirenz
538334|NCT01271894|pharmacokinetic|pharmacokinetic
538335|NCT01271881|Hemodialysis|hemodialysis
538336|NCT01271881|Fistula|fistula
538337|NCT01271881|Angiograph|angiograph
538338|NCT01271881|Angiogram|angiogram
538339|NCT01271881|Adult patients who are currently receiving hemodialysis treatment via an AV vascular graft or fistula located in the upper extremity|adult patients who are currently receiving hemodialysis treatment via an av vascular graft or fistula located in the upper extremity
538340|NCT01271868|Recombinant Factor IX|recombinant factor ix
538341|NCT01271855|Belladonna|belladonna
538342|NCT01271855|Opium|opium
538343|NCT01271855|Suppository|suppository
538344|NCT01271829|Avocados|avocados
538345|NCT01271829|Satiety|satiety
538346|NCT01271829|Feeding study|feeding study
538347|NCT01271816|genetics|genetics
538348|NCT01271816|sudden death|sudden death
538349|NCT01271816|monitoring|monitoring
538350|NCT01271816|loop recorder|loop recorder
538351|NCT01271816|cardiomyopathy|cardiomyopathy
538352|NCT01271790|Hepatitis C|hepatitis c
538353|NCT01271790|HCV|hcv
538354|NCT01271790|Rapid Virologic Response|rapid virologic response
538355|NCT01271790|Sustained Virologic Response|sustained virologic response
538356|NCT01271790|Direct Acting Antiviral|direct acting antiviral
538357|NCT01271790|Combination Therapy|combination therapy
538358|NCT01271790|HCV RNA|hcv rna
538359|NCT01271790|Polymerase inhibitor|polymerase inhibitor
538360|NCT01271790|Protease inhibitor|protease inhibitor
538361|NCT01271790|Treatment naïve|treatment naïve
538362|NCT01271790|GS-9190|gs-9190
538363|NCT01271790|GS-9451|gs-9451
538364|NCT01271777|Pre-diabetes|pre-diabetes
538365|NCT01271777|Clamp technique|clamp technique
538366|NCT01271777|PPARs|ppars
538367|NCT01271777|Insulin resistance|insulin resistance
538368|NCT01271751|Atherogenic-dyslipidaemia|atherogenic-dyslipidaemia
538369|NCT01271751|PPARs|ppars
538370|NCT01271738|Breast Cancer|breast cancer
538371|NCT01271738|Tumors or cancer of the human breast|tumors or cancer of the human breast
538372|NCT01271738|Breast Tumors|breast tumors
538373|NCT01271738|Cancer of Breast|cancer of breast
538374|NCT01271738|Cancer of the Breast|cancer of the breast
538375|NCT01271738|Human Mammary Carcinoma|human mammary carcinoma
538376|NCT01271738|Neoplasms, Breast|neoplasms, breast
538377|NCT01271712|Gastrointestinal stromal cancer|gastrointestinal stromal cancer
538378|NCT01271712|GIST|gist
538877|NCT01269554|diarrhea|diarrhea
538379|NCT01271712|multikinase inhibitor|multikinase inhibitor
538380|NCT01271699|Fabry Disease|fabry disease
538381|NCT01271699|Fabry´s Disease|fabry´s disease
538382|NCT01271699|Anderson-Fabry Disease|anderson-fabry disease
538383|NCT01271699|Multiple Sclerosis|multiple sclerosis
538384|NCT01271660|muscle cramp|muscle cramp
538385|NCT01271660|liver cirrhosis|liver cirrhosis
538386|NCT01271660|pregabalin|pregabalin
538387|NCT01271647|osteopenia,chinese herb|osteopenia,chinese herb
538388|NCT01271634|cross-transmission|cross-transmission
538389|NCT01271634|offending vessel|offending vessel
538390|NCT01271621|Airtraq, Intraocular pressure|airtraq, intraocular pressure
538391|NCT01271608|Accident prevention|accident prevention
538392|NCT01271608|Blood-borne pathogens|blood-borne pathogens
538393|NCT01271608|Protective devices.|protective devices.
538394|NCT01271608|Needlestick injuries|needlestick injuries
538395|NCT01271608|Injections subcutaneous|injections subcutaneous
538396|NCT01271608|Injections intradermal|injections intradermal
538397|NCT01271595|acupuncture|acupuncture
538398|NCT01271595|autonomic nervous system|autonomic nervous system
538399|NCT01271595|seasonal allergic rhinitis|seasonal allergic rhinitis
538400|NCT01271582|Colorecatal cancer|colorecatal cancer
538401|NCT01271582|Gastric cancer|gastric cancer
538402|NCT01271582|Irinotecan|irinotecan
538403|NCT01271582|UGT1A1|ugt1a1
538404|NCT01271582|Neutropenia|neutropenia
538405|NCT01271556|COPD|copd
538406|NCT01271556|LABA|laba
538407|NCT01271556|salmeterol|salmeterol
538408|NCT01271543|Comparison of hemodynamic|comparison of hemodynamic
538409|NCT01271543|endotracheal intubation|endotracheal intubation
538410|NCT01271543|changes induced by|changes induced by
538411|NCT01271543|performed|performed
538412|NCT01271543|the aid of the SOS|the aid of the sos
538413|NCT01271543|as compared to the Macintosh Laryngoscope|as compared to the macintosh laryngoscope
538414|NCT01271530|Late Effects of Polio|late effects of polio
538415|NCT01271530|Cardiovascular Fitness|cardiovascular fitness
538416|NCT01271530|Fatigue|fatigue
538417|NCT01271530|Energy cost of Walking|energy cost of walking
538418|NCT01271530|Pain|pain
538419|NCT01271517|Basal insulin|basal insulin
538420|NCT01271517|long acting insulin analogs|long acting insulin analogs
538421|NCT01271517|metabolic control|metabolic control
538422|NCT01271517|HbA1c|hba1c
538423|NCT01271517|C-peptide|c-peptide
538424|NCT01271517|IGF-I|igf-i
538425|NCT01271517|GH|gh
538426|NCT01271517|IGFBP|igfbp
538427|NCT01271504|Cancer|cancer
538428|NCT01271504|liver|liver
538429|NCT01271504|hepatocellular carcinoma|hepatocellular carcinoma
538430|NCT01271504|phase I|phase i
538431|NCT01271504|phase II|phase ii
538432|NCT01271491|Pediatric|pediatric
538433|NCT01271478|inflammation|inflammation
538434|NCT01271478|telmisartan|telmisartan
538435|NCT01271478|captopril|captopril
538436|NCT01271478|hemodialysis|hemodialysis
538437|NCT01271426|Polypoidal Choroidal Vasculopathy|polypoidal choroidal vasculopathy
538438|NCT01271426|Ranibizumab|ranibizumab
538439|NCT01271400|Infertility treatments|infertility treatments
538440|NCT01271400|Frozen embryo transfers (FET).|frozen embryo transfers (fet).
538441|NCT01271400|IVF.|ivf.
538442|NCT01271400|ART.|art.
538443|NCT01271400|Cryopreservation|cryopreservation
538444|NCT01271400|Slow-Freeze|slow-freeze
538445|NCT01271400|Freeze / thaw survival rates|freeze / thaw survival rates
538446|NCT01271400|Blastocyst formation|blastocyst formation
538447|NCT01271400|Pregnancy|pregnancy
538448|NCT01271387|Liver disease|liver disease
538449|NCT01271387|pharmacokinetics|pharmacokinetics
538450|NCT01271374|African American|african american
538451|NCT01271374|Hypertension|hypertension
538452|NCT01271374|Cardiometabolic Syndrome|cardiometabolic syndrome
538453|NCT01271361|thrombus aspiration|thrombus aspiration
538454|NCT01271361|Drug-Eluting Stent|drug-eluting stent
538455|NCT01271361|optical frequency domain imaging (OFDI)|optical frequency domain imaging (ofdi)
538456|NCT01271335|CTO|cto
538457|NCT01271335|Angioplasty|angioplasty
538458|NCT01271335|PCI|pci
538459|NCT01271322|PET|pet
538460|NCT01271322|response evaluation|response evaluation
684080|NCT00695682|CNV|cnv
538461|NCT01271322|neoadjuvant|neoadjuvant
538462|NCT01271322|radiochemotherapy|radiochemotherapy
538463|NCT01271322|adenocarcinoma of the esophagogastric junction|adenocarcinoma of the esophagogastric junction
538464|NCT01271322|esophageal carcinoma|esophageal carcinoma
538465|NCT01271322|evaluation of preoperative (radio)-chemotherapy in patients with adenocarcinomas of the oesophagogastric junction|evaluation of preoperative (radio)-chemotherapy in patients with adenocarcinomas of the oesophagogastric junction
538466|NCT01271296|Addison Disease|addison disease
538467|NCT01271296|Pharmacokinetics|pharmacokinetics
538468|NCT01271296|Hormone Replacement Therapy|hormone replacement therapy
538469|NCT01271296|cortisone acetate|cortisone acetate
538470|NCT01271296|Quality of Life|quality of life
538471|NCT01271270|Age-Related Macular Degeneration (AMD)|age-related macular degeneration (amd)
538472|NCT01271270|Palomid 529|palomid 529
538473|NCT01271270|Age Related Macular Degeneration|age related macular degeneration
538474|NCT01271270|AMD|amd
538475|NCT01271257|misoprostol, pharmacokinetics|misoprostol, pharmacokinetics
539178|NCT01268163|Docetaxel|docetaxel
538476|NCT01271231|periodontal treatment, diabetes, glycemia, glycated hemoglobin|periodontal treatment, diabetes, glycemia, glycated hemoglobin
538477|NCT01271205|pneumonia|pneumonia
538478|NCT01271205|RDW|rdw
538479|NCT01271205|mortality|mortality
538480|NCT01271205|prognostic factor|prognostic factor
538481|NCT01271192|local recurrent rectal cancer|local recurrent rectal cancer
538482|NCT01271192|surgical resection|surgical resection
538483|NCT01271192|adjuvant therapy|adjuvant therapy
538484|NCT01271179|orthotopic liver transplantation|orthotopic liver transplantation
538485|NCT01271179|preservation solution|preservation solution
538486|NCT01271179|peribiliary plexus|peribiliary plexus
538487|NCT01271179|nonanastomotic biliary strictures|nonanastomotic biliary strictures
538488|NCT01271179|primary non-function|primary non-function
538489|NCT01271166|Colorectal,|colorectal,
538490|NCT01271166|Cancer|cancer
538491|NCT01271153|Septic shock|septic shock
538492|NCT01271127|radiation therapy|radiation therapy
538493|NCT01271127|coronary artery disease|coronary artery disease
538494|NCT01271127|Hodgkin Lymphoma|hodgkin lymphoma
538495|NCT01271101|Non-ST-elevated acute coronary syndromes (NSTE-ACS)|non-st-elevated acute coronary syndromes (nste-acs)
538496|NCT01271101|anticoagulation|anticoagulation
538497|NCT01271088|ototoxicity|ototoxicity
538498|NCT01271088|aminoglycoside|aminoglycoside
538499|NCT01271088|vancomycine|vancomycine
538500|NCT01271088|peritoneal dialysis|peritoneal dialysis
538501|NCT01271088|peritonitis|peritonitis
538502|NCT01271075|urticaria|urticaria
538503|NCT01271075|bilastine|bilastine
538504|NCT01271062|Resolvment of Diabetes Mellitus, Type 2|resolvment of diabetes mellitus, type 2
538505|NCT01271062|gastric bypass|gastric bypass
538506|NCT01271036|Lubricating Agents|lubricating agents
538507|NCT01271036|Personal Lubricant|personal lubricant
538508|NCT01270984|Imatinib mesylate|imatinib mesylate
538509|NCT01270984|Pharmacokinetics|pharmacokinetics
538510|NCT01270984|Healthy volunteers|healthy volunteers
538511|NCT01270971|Onychomycosis|onychomycosis
538512|NCT01270971|nail fungus|nail fungus
538513|NCT01270971|toenail fungus|toenail fungus
538514|NCT01270971|fungal nail|fungal nail
538515|NCT01270971|hyperkeratosis|hyperkeratosis
538516|NCT01270971|nail infection|nail infection
538517|NCT01270971|nail treatment|nail treatment
538518|NCT01270971|toenail infection|toenail infection
538519|NCT01270971|toenail treatment|toenail treatment
538520|NCT01270971|foot dermatoses|foot dermatoses
538521|NCT01270971|fungal culture|fungal culture
538522|NCT01270971|onycholysis|onycholysis
538523|NCT01270971|podiatrist|podiatrist
538524|NCT01270971|podiatry|podiatry
538525|NCT01270971|subungual|subungual
538526|NCT01270971|tinea unguium|tinea unguium
538527|NCT01270971|antifungal|antifungal
538528|NCT01270971|anti-fungal|anti-fungal
538529|NCT01270971|dermatologist|dermatologist
538530|NCT01270971|dermatology|dermatology
538531|NCT01270971|dermatophyte|dermatophyte
538532|NCT01270971|distal subungual onychomycosis|distal subungual onychomycosis
538533|NCT01270971|yellow nail|yellow nail
538534|NCT01270971|thick nail|thick nail
538535|NCT01270971|brittle nail|brittle nail
538536|NCT01270971|crumbling nail|crumbling nail
538537|NCT01270971|discolored nail|discolored nail
538538|NCT01270971|weak nail|weak nail
538539|NCT01270958|AVY-REG00108VN|avy-reg00108vn
538540|NCT01270906|Neoplasms|neoplasms
538541|NCT01270906|Cancer|cancer
538542|NCT01270906|Tumors|tumors
538543|NCT01270906|Administration|administration
538544|NCT01270906|oral|oral
538545|NCT01270906|CHIR258|chir258
538546|NCT01270906|CHIR-258|chir-258
538547|NCT01270906|CHIR 258|chir 258
538548|NCT01270906|TKI258|tki258
538549|NCT01270906|TKI-258|tki-258
538550|NCT01270906|TKI 258|tki 258
538551|NCT01270906|dose finding|dose finding
538552|NCT01270893|Gastrointestinal stromal tumor|gastrointestinal stromal tumor
538553|NCT01270893|GIST|gist
538554|NCT01270893|Nilotinib|nilotinib
538555|NCT01270893|AMN107|amn107
538556|NCT01270893|Tasigna|tasigna
538557|NCT01270867|Ischemia|ischemia
538558|NCT01270867|Stroke|stroke
538559|NCT01270867|Ischemic Stroke|ischemic stroke
538560|NCT01270867|Mechanical Thrombectomy|mechanical thrombectomy
538561|NCT01270867|Brain|brain
538562|NCT01270867|Brain clot|brain clot
538563|NCT01270867|Cerebrovascular disease|cerebrovascular disease
538564|NCT01270867|Recanalization|recanalization
538565|NCT01270867|Revascularization|revascularization
538566|NCT01270854|Normal saline|normal saline
538567|NCT01270854|Plasmalyte|plasmalyte
538568|NCT01270854|Intravenous fluid|intravenous fluid
538569|NCT01270854|Traumatic injury|traumatic injury
538570|NCT01270854|Fluid resuscitation|fluid resuscitation
538571|NCT01270828|Control Release Pregabalin in Post Herpetic Neuralgia|control release pregabalin in post herpetic neuralgia
538572|NCT01270815|pregabalin|pregabalin
538573|NCT01270815|pharmacokinetics|pharmacokinetics
538574|NCT01270815|bioavailability|bioavailability
538575|NCT01270815|bioequivalence|bioequivalence
538576|NCT01270802|Endothelial function|endothelial function
538577|NCT01270802|Vitamin D|vitamin d
538578|NCT01270802|Efavirenz|efavirenz
538579|NCT01270802|Raltegravir|raltegravir
538580|NCT01270789|beta-cell function|beta-cell function
538581|NCT01270789|GLP-1 analogue|glp-1 analogue
538582|NCT01270789|diabetes|diabetes
538583|NCT01270776|Randomized Controlled Trial|randomized controlled trial
538584|NCT01270776|Chlorhexidine|chlorhexidine
538585|NCT01270776|Infant, Premature|infant, premature
538586|NCT01270763|Obesity|obesity
538587|NCT01270763|physical fitness|physical fitness
538588|NCT01270763|cholesterol levels|cholesterol levels
538589|NCT01270763|genetics|genetics
538590|NCT01270763|weight loss|weight loss
538591|NCT01270750|ENDOTHELIN RECEPTOR ANTAGONIST|endothelin receptor antagonist
538592|NCT01270750|BOSENTAN|bosentan
538593|NCT01270750|SECONDARY PULMONARY HYPERTENSION|secondary pulmonary hypertension
538594|NCT01270750|RHEUMATOID FEVER|rheumatoid fever
538595|NCT01270750|CONGESTIVE HEART FAILURE|congestive heart failure
538596|NCT01270750|SECONDARY PULMONARY HYPERTENSION DUE TO MITRAL STENOSIS|secondary pulmonary hypertension due to mitral stenosis
538597|NCT01270711|compliance study|compliance study
538598|NCT01270711|effectiveness study|effectiveness study
538599|NCT01270711|hyperprolactinemia|hyperprolactinemia
538600|NCT01270711|Parkinson's disease|parkinson's disease
538601|NCT01270711|retrospective cohort study|retrospective cohort study
538602|NCT01270698|colorectal cancer|colorectal cancer
538603|NCT01270672|MDMA|mdma
538604|NCT01270672|carvedilol|carvedilol
538605|NCT01270672|norepinephrine|norepinephrine
538606|NCT01270672|alpha - beta receptor|alpha - beta receptor
538607|NCT01270672|Ecstasy|ecstasy
538608|NCT01270672|stimulant|stimulant
538609|NCT01270659|Fentanyl buccal tablet|fentanyl buccal tablet
538610|NCT01270646|Cardiac insufficiency|cardiac insufficiency
538611|NCT01270646|Invasive procedure|invasive procedure
538612|NCT01270646|Heart Failure|heart failure
538613|NCT01270646|Noninvasive procedure|noninvasive procedure
538614|NCT01270646|Congestive Heart Failure|congestive heart failure
538615|NCT01270646|Mapping|mapping
538616|NCT01270646|Cardiac resynchronisation therapy|cardiac resynchronisation therapy
538617|NCT01270646|Open study|open study
538618|NCT01270646|Cardiac Pacings, Artificial|cardiac pacings, artificial
538619|NCT01270646|Hemodynamics|hemodynamics
538620|NCT01270620|elderly obese|elderly obese
538621|NCT01270581|transient tachypnea of the newborn|transient tachypnea of the newborn
538622|NCT01270581|high flow nasal cannula|high flow nasal cannula
538623|NCT01270581|bubble nasal|bubble nasal
538624|NCT01270581|continuous positive airway pressure|continuous positive airway pressure
538625|NCT01270568|positive psychology|positive psychology
538626|NCT01270568|cardiovascular disease|cardiovascular disease
538627|NCT01270542|Traction Retinal Detachment (PDR)|traction retinal detachment (pdr)
538628|NCT01270542|Proliferative Diabetic Retinopathy (PDR)|proliferative diabetic retinopathy (pdr)
538629|NCT01270529|Physical Activity|physical activity
538630|NCT01270529|Physical Performance|physical performance
538631|NCT01270529|Physical Functioning|physical functioning
538632|NCT01270529|CKD|ckd
538633|NCT01270529|ESRD|esrd
538634|NCT01270529|Transplant Recipients|transplant recipients
538635|NCT01270516|diaphragm|diaphragm
538636|NCT01270516|limb muscle|limb muscle
538637|NCT01270516|EPA|epa
538638|NCT01270516|HMB|hmb
538639|NCT01270516|ICU patients|icu patients
538640|NCT01270503|Meningitis|meningitis
538641|NCT01270503|Meningococcal disease|meningococcal disease
538642|NCT01270503|Menactra®|menactra®
538643|NCT01270490|candidemia|candidemia
538644|NCT01270490|candida sepsis|candida sepsis
538645|NCT01270490|invasive fungal disease|invasive fungal disease
538646|NCT01270477|Frost injury|frost injury
538647|NCT01270451|Weight maintenance|weight maintenance
538648|NCT01270451|Group counseling|group counseling
538649|NCT01270451|Prevention of diseases|prevention of diseases
538650|NCT01270425|systemic sclerosis|systemic sclerosis
538651|NCT01270425|hashimoto thyroiditis|hashimoto thyroiditis
538652|NCT01270425|thyroid nodules|thyroid nodules
538653|NCT01270412|Osteoarthritis|osteoarthritis
538654|NCT01270412|PRP|prp
538655|NCT01270412|PRGF|prgf
538656|NCT01270412|Hyaluronic acid|hyaluronic acid
538657|NCT01270386|NSCLC|nsclc
538658|NCT01270386|apatinib|apatinib
538659|NCT01270386|phase II|phase ii
538660|NCT01270386|lung|lung
538661|NCT01270386|cancer|cancer
538662|NCT01270373|neoadjuvant therapy|neoadjuvant therapy
538663|NCT01270373|drug therapy|drug therapy
538664|NCT01270321|Thyroid Cancer|thyroid cancer
538665|NCT01270308|Bioequivalence|bioequivalence
538666|NCT01270308|two way crossover|two way crossover
538667|NCT01270295|Receptor for advanced glycation end products (RAGE)|receptor for advanced glycation end products (rage)
538668|NCT01270295|Soluble RAGE (sRAGE)|soluble rage (srage)
538669|NCT01270295|Endogenous secretory RAGE (esRAGE)|endogenous secretory rage (esrage)
538670|NCT01270295|High-mobility group box-1 protein (HMGB-1)|high-mobility group box-1 protein (hmgb-1)
538671|NCT01270295|Extracellular newly-identified RAGE-binding protein (EN-RAGE or S100A12)|extracellular newly-identified rage-binding protein (en-rage or s100a12)
538672|NCT01270295|Advanced glycation endproducts (AGEs)|advanced glycation endproducts (ages)
538673|NCT01270295|Pentosidine|pentosidine
538674|NCT01270295|N--carboxymethyllysine|n--carboxymethyllysine
538675|NCT01270295|Acute lung injury (ALI)|acute lung injury (ali)
538676|NCT01270295|Acute respiratory distress syndrome (ARDS)|acute respiratory distress syndrome (ards)
538677|NCT01270295|Alveolar epithelium|alveolar epithelium
538678|NCT01270295|Mechanical ventilation|mechanical ventilation
538679|NCT01270295|Intensive Care Unit (ICU)|intensive care unit (icu)
538680|NCT01270269|Asthenia|asthenia
538681|NCT01270269|Muscle Weakness|muscle weakness
538682|NCT01270269|Brain Injuries|brain injuries
538683|NCT01270269|Critical Illness|critical illness
538684|NCT01270269|Critical Illness Myoneuropathy|critical illness myoneuropathy
538685|NCT01270269|Rehabilitation|rehabilitation
538686|NCT01270269|Sepsis|sepsis
538687|NCT01270269|Respiratory Failure|respiratory failure
538688|NCT01270269|Delirium|delirium
538689|NCT01270269|Over-sedation|over-sedation
538690|NCT01270269|Immobility|immobility
538691|NCT01270269|Aging|aging
538692|NCT01270269|Signs and Symptoms|signs and symptoms
538693|NCT01270269|Muscular Diseases|muscular diseases
538694|NCT01270269|Musculoskeletal Diseases|musculoskeletal diseases
538695|NCT01270269|Neuromuscular Manifestations|neuromuscular manifestations
538696|NCT01270269|Neurologic Manifestations|neurologic manifestations
538697|NCT01270269|Pathologic Processes|pathologic processes
538698|NCT01270269|Brain Diseases|brain diseases
538699|NCT01270269|Central Nervous System Diseases|central nervous system diseases
538700|NCT01270269|Craniocerebral Trauma|craniocerebral trauma
538701|NCT01270269|Trauma, Nervous System|trauma, nervous system
538702|NCT01270269|Wounds and Injuries|wounds and injuries
538703|NCT01270269|Disorders of Environmental Origin|disorders of environmental origin
538704|NCT01270256|allergy|allergy
538705|NCT01270230|HIV Prevention Intervention|hiv prevention intervention
538706|NCT01270230|African American Men who have Sex with Men|african american men who have sex with men
538707|NCT01270217|Automobile driving|automobile driving
538708|NCT01270217|Driving under the influence|driving under the influence
538709|NCT01270217|Interview, psychological|interview, psychological
538710|NCT01270217|Brief intervention|brief intervention
538711|NCT01270217|Brief motivational interview|brief motivational interview
538712|NCT01270204|Dysphagia|dysphagia
538713|NCT01270204|Swallowing Problems|swallowing problems
538714|NCT01270204|Dynamic Fluoroscopic Swallow Study|dynamic fluoroscopic swallow study
538715|NCT01270204|Aspiration|aspiration
538716|NCT01270204|Regurgitation|regurgitation
538717|NCT01270204|Acid Reflux|acid reflux
538718|NCT01270191|Exenatide, Beta-Cell Function, Glycemic Control|exenatide, beta-cell function, glycemic control
538719|NCT01270191|in Newly Diagnosed Type 2 Diabetic Patients|in newly diagnosed type 2 diabetic patients
538720|NCT01270165|lamivudine|lamivudine
538721|NCT01270165|telbivudine|telbivudine
538722|NCT01270165|adefovir|adefovir
538723|NCT01270165|lamivudine resistance|lamivudine resistance
538724|NCT01270152|ascorbic acid|ascorbic acid
538725|NCT01270152|catheterization central venous|catheterization central venous
538726|NCT01270152|nursing care|nursing care
538727|NCT01270139|nanoparticles|nanoparticles
538728|NCT01270139|mesenchymal stem cell|mesenchymal stem cell
538729|NCT01270139|plasmonics|plasmonics
538730|NCT01270139|atherosclerosis|atherosclerosis
538731|NCT01270139|IVUS|ivus
538732|NCT01270139|stenting|stenting
538733|NCT01270126|optic neuropathy|optic neuropathy
538734|NCT01270126|alternating current stimulation|alternating current stimulation
538735|NCT01270126|vision recovery|vision recovery
538736|NCT01270126|restoration|restoration
538737|NCT01270126|plasticity|plasticity
538738|NCT01270087|Rheumatoid arthritis, cardiovascular disease, adalimumab|rheumatoid arthritis, cardiovascular disease, adalimumab
538739|NCT01270074|double blind placebo controlled randomised clinical trial|double blind placebo controlled randomised clinical trial
538740|NCT01270074|azithromycin|azithromycin
538741|NCT01270074|infant|infant
538742|NCT01270074|pediatric|pediatric
538743|NCT01270074|cystic fibrosis|cystic fibrosis
538744|NCT01270074|bronchiectasis|bronchiectasis
538745|NCT01270061|HIV testing|hiv testing
538746|NCT01270061|black Africans|black africans
538747|NCT01270061|immigrants|immigrants
538748|NCT01270061|health screening|health screening
538749|NCT01270048|Hwa-byung, Bunsimgi-eum(Fenxinqiyin)|hwa-byung, bunsimgi-eum(fenxinqiyin)
538750|NCT01269996|type 2 diabetes mellitus|type 2 diabetes mellitus
538751|NCT01269996|JUBILEE Study|jubilee study
538752|NCT01269996|Janumet|janumet
538753|NCT01269996|Lantus|lantus
538754|NCT01269983|low back pain|low back pain
538755|NCT01269983|fascial manipulation|fascial manipulation
538756|NCT01269983|physioterapy|physioterapy
538757|NCT01269983|physical activity|physical activity
538758|NCT01269957|halitosis|halitosis
538759|NCT01269957|pediatric dentistry|pediatric dentistry
538760|NCT01269957|mouth breathing|mouth breathing
538761|NCT01269944|osteoarthritis|osteoarthritis
538762|NCT01269944|knee|knee
538763|NCT01269944|high wedge tibial osteotomy|high wedge tibial osteotomy
538764|NCT01269944|dGEMRIC|dgemric
538765|NCT01269931|endobronchial ultrasound|endobronchial ultrasound
538766|NCT01269931|bronchoscopy|bronchoscopy
538767|NCT01269931|education|education
538768|NCT01269931|interventional bronchoscopy|interventional bronchoscopy
538769|NCT01269931|simulation|simulation
538770|NCT01269918|Craniotomy, pain relief|craniotomy, pain relief
538771|NCT01269918|Adult solid neoplasm|adult solid neoplasm
538772|NCT01269892|diarrhea, lactose, milk, weight, acute.|diarrhea, lactose, milk, weight, acute.
538773|NCT01269879|epicondylitis|epicondylitis
538774|NCT01269879|pain|pain
538775|NCT01269879|tendon|tendon
538776|NCT01269866|Lupus Pain|lupus pain
538777|NCT01269866|Lupus|lupus
538778|NCT01269866|Pain|pain
538779|NCT01269866|Systemic Lupus Erythematosus|systemic lupus erythematosus
538780|NCT01269866|Duloxetine|duloxetine
538781|NCT01269866|Cymbalta|cymbalta
538782|NCT01269853|GBM|gbm
538783|NCT01269853|AA|aa
538784|NCT01269853|AO|ao
538785|NCT01269853|Brain|brain
538786|NCT01269853|Tumors|tumors
538787|NCT01269853|Malignant|malignant
538788|NCT01269853|Glioblastoma|glioblastoma
538789|NCT01269853|Multiforme|multiforme
538790|NCT01269853|Anaplastic|anaplastic
538791|NCT01269853|Astrocytoma|astrocytoma
538792|NCT01269827|inflammation|inflammation
538793|NCT01269827|pentoxifylline|pentoxifylline
538794|NCT01269827|hemodialysis|hemodialysis
538795|NCT01269814|Gastrointestinal bleeding|gastrointestinal bleeding
538796|NCT01269814|Emergency endoscopy|emergency endoscopy
538797|NCT01269814|Rockall Risk Scoring System|rockall risk scoring system
538798|NCT01269801|BOTOX|botox
538799|NCT01269801|JUVEDERM|juvederm
538800|NCT01269801|Prospective|prospective
538801|NCT01269801|Open Label|open label
538802|NCT01269801|Randomized|randomized
538803|NCT01269801|Crossover Study|crossover study
538804|NCT01269788|non-erosive reflux disease|non-erosive reflux disease
538805|NCT01269788|heartburn|heartburn
538806|NCT01269788|functional|functional
538807|NCT01269788|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation
538808|NCT01269788|Proton Pump Inhibitors|proton pump inhibitors
538809|NCT01269762|Red yeast rice|red yeast rice
538810|NCT01269762|Lovastatin|lovastatin
538811|NCT01269762|Drug-drug interaction|drug-drug interaction
538812|NCT01269762|Pharmacokinetics|pharmacokinetics
538813|NCT01269749|Hyperthyroidism|hyperthyroidism
538814|NCT01269749|Antithyroid drugs|antithyroid drugs
538815|NCT01269749|Cancer|cancer
538816|NCT01269749|Dosimetry|dosimetry
538817|NCT01269749|Children|children
538818|NCT01269736|electrocardiographic monitoring|electrocardiographic monitoring
538819|NCT01269736|arrhythmia|arrhythmia
538820|NCT01269736|myocardial ischemia|myocardial ischemia
538821|NCT01269723|Smoking|smoking
538822|NCT01269723|influenza|influenza
538823|NCT01269723|influenza vaccine|influenza vaccine
538824|NCT01269710|Second Generation Antipsychotics|second generation antipsychotics
538825|NCT01269710|Schizophrenia|schizophrenia
538826|NCT01269710|Schizoaffective|schizoaffective
538827|NCT01269710|Schizophreniform|schizophreniform
538828|NCT01269710|Psychosis NOS|psychosis nos
538829|NCT01269710|Mood Disorders|mood disorders
538830|NCT01269710|Weight|weight
538831|NCT01269710|Autism|autism
538832|NCT01269697|AMD|amd
538833|NCT01269697|food supplementation|food supplementation
538834|NCT01269697|macular pigments|macular pigments
538835|NCT01269697|luthéine|luthéine
538836|NCT01269697|zéaxanthine|zéaxanthine
538837|NCT01269697|visual acuity|visual acuity
538838|NCT01269697|prevention|prevention
538839|NCT01269697|genetique risk|genetique risk
538840|NCT01269684|Kidney|kidney
538841|NCT01269684|renal|renal
538842|NCT01269684|transplantation|transplantation
538843|NCT01269684|tacrolimus|tacrolimus
538844|NCT01269684|everolimus|everolimus
538845|NCT01269684|stable allograft recipients|stable allograft recipients
538846|NCT01269671|Functional Abdominal Pain|functional abdominal pain
538847|NCT01269671|Irritable Bowel Syndrome|irritable bowel syndrome
538848|NCT01269671|IBS|ibs
538849|NCT01269671|Functional Dyspepsia|functional dyspepsia
538850|NCT01269671|Melatonin|melatonin
538851|NCT01269671|Simethicone|simethicone
538852|NCT01269671|Peppermint Oil|peppermint oil
538853|NCT01269671|mentharil|mentharil
538854|NCT01269671|functional bowel disorders|functional bowel disorders
538855|NCT01269671|quality of life|quality of life
538856|NCT01269645|Cancer|cancer
538857|NCT01269645|Clinical trials|clinical trials
538858|NCT01269632|teenagers to adult transition|teenagers to adult transition
538859|NCT01269632|comparison|comparison
538860|NCT01269619|back pain|back pain
538861|NCT01269619|posture|posture
538862|NCT01269619|lumbar support|lumbar support
538863|NCT01269619|dynamic support|dynamic support
538864|NCT01269593|PET Scan|pet scan
538865|NCT01269593|124I-PUH71|124i-puh71
538866|NCT01269593|10-139|10-139
538867|NCT01269567|RectalNeoplasms|rectalneoplasms
538868|NCT01269567|Colorectal Neoplasms|colorectal neoplasms
538869|NCT01269567|Intestinal Neoplasms|intestinal neoplasms
538870|NCT01269567|Gastrointestinal Neoplasms|gastrointestinal neoplasms
538871|NCT01269567|Digestive System Neoplasms|digestive system neoplasms
538872|NCT01269567|Neoplasms by Site|neoplasms by site
538873|NCT01269567|Digestive System Diseases|digestive system diseases
538874|NCT01269567|Gastrointestinal Diseases|gastrointestinal diseases
538875|NCT01269567|Intestinal Diseases|intestinal diseases
538876|NCT01269567|Rectal Diseases|rectal diseases
538878|NCT01269554|Guinea-Bissau|guinea-bissau
538879|NCT01269554|Finland|finland
538880|NCT01269554|Children|children
538881|NCT01269554|Adults|adults
538882|NCT01269554|Intestinal pathogens|intestinal pathogens
538883|NCT01269554|Bacteria|bacteria
538884|NCT01269554|Virus|virus
538885|NCT01269554|Parasites|parasites
538886|NCT01269528|Palivizumab|palivizumab
538887|NCT01269528|Airway Hyperreactivity|airway hyperreactivity
538888|NCT01269528|EBC|ebc
538889|NCT01269528|MCT|mct
538890|NCT01269515|Cox-2 inhibitor|cox-2 inhibitor
538891|NCT01269515|HIV|hiv
538892|NCT01269515|immune activation|immune activation
538893|NCT01269515|immune modulating|immune modulating
538894|NCT01269515|progression markers|progression markers
538895|NCT01269515|vaccine|vaccine
538896|NCT01269489|quality of life|quality of life
538897|NCT01269489|general Slovenian population|general slovenian population
538898|NCT01269489|EORTC QLQ C30|eortc qlq c30
538899|NCT01269463|Attention deficit|attention deficit
538900|NCT01269463|Hyperactivity|hyperactivity
538901|NCT01269463|Impulsivity|impulsivity
538902|NCT01269463|Inattention|inattention
538903|NCT01269450|second trimester vaginal bleeding|second trimester vaginal bleeding
538904|NCT01269450|late abortion|late abortion
538905|NCT01269450|preterm birth|preterm birth
538906|NCT01269450|progesterone|progesterone
538907|NCT01269437|mild to moderate asthma|mild to moderate asthma
538908|NCT01269424|adult giant cell glioblastoma|adult giant cell glioblastoma
538909|NCT01269424|adult glioblastoma|adult glioblastoma
538910|NCT01269424|adult gliosarcoma|adult gliosarcoma
538911|NCT01269385|Imprime PGG|imprime pgg
538912|NCT01269372|polyps|polyps
538913|NCT01269372|capsule endoscopy|capsule endoscopy
538914|NCT01269372|colonoscopy|colonoscopy
538915|NCT01269346|Locally recurrent|locally recurrent
538916|NCT01269346|metastatic HER2Positive breast cancer|metastatic her2positive breast cancer
538917|NCT01269307|Anesthesia|anesthesia
538918|NCT01269307|Pain|pain
538919|NCT01269307|Procedural sedation|procedural sedation
538920|NCT01269307|Airway/Anesthesia/Analgesia|airway/anesthesia/analgesia
538921|NCT01269294|Hepatitis C|hepatitis c
538922|NCT01269294|TMC435-TiDP16-C117|tmc435-tidp16-c117
538923|NCT01269294|TMC435-C117|tmc435-c117
538924|NCT01269294|TMC435|tmc435
538925|NCT01269294|HCV|hcv
538926|NCT01269294|Moxifloxacin|moxifloxacin
538927|NCT01269294|ECG|ecg
538928|NCT01269294|QT|qt
538929|NCT01269294|QTc|qtc
538930|NCT01269281|Bioequivalence|bioequivalence
538931|NCT01269281|two way crossover|two way crossover
538932|NCT01269242|coronary restenosis|coronary restenosis
538933|NCT01269242|angioplasty|angioplasty
538934|NCT01269242|stent|stent
538935|NCT01269242|MCP-1/CCL2|mcp-1/ccl2
538936|NCT01269242|MCP-3/CCL7|mcp-3/ccl7
538937|NCT01269203|multiple myeloma|multiple myeloma
538938|NCT01269203|MM|mm
538939|NCT01269203|maintenance therapy|maintenance therapy
538940|NCT01269203|lenalidomide|lenalidomide
538941|NCT01269203|bone marrow transplantation|bone marrow transplantation
538942|NCT01269203|auto-HSCT|auto-hsct
538943|NCT01269203|Autologous Hematopoietic Stem Cell Transplantation|autologous hematopoietic stem cell transplantation
538944|NCT01269203|NF-kB inhibition|nf-kb inhibition
538945|NCT01269203|reducing symptoms|reducing symptoms
538946|NCT01269203|maintenance chemotherapy|maintenance chemotherapy
538947|NCT01269203|inflammatory cytokines|inflammatory cytokines
538948|NCT01269203|nuclear factor kappa B|nuclear factor kappa b
538949|NCT01269203|NF-kB|nf-kb
538950|NCT01269203|interleukin|interleukin
538951|NCT01269203|IL-6|il-6
538952|NCT01269203|tumor necrosis factor|tumor necrosis factor
538953|NCT01269203|TNF-a|tnf-a
538954|NCT01269203|NF-kB activation levels|nf-kb activation levels
538955|NCT01269177|ACPE|acpe
538956|NCT01269177|Acute respiratory failure|acute respiratory failure
538957|NCT01269177|Non invasive ventilation|non invasive ventilation
538958|NCT01269177|acute cardiogenic pulmonary edema|acute cardiogenic pulmonary edema
538959|NCT01269164|Face Transplant|face transplant
538960|NCT01269164|Facial Transplantation|facial transplantation
538961|NCT01269164|Composite Facial Allograft Transplantation|composite facial allograft transplantation
538962|NCT01269151|Age-Related Macular Degeneration|age-related macular degeneration
538963|NCT01269151|Retinal Function|retinal function
538964|NCT01269151|multifocal-ERG|multifocal-erg
538965|NCT01269151|Electroretinography|electroretinography
538966|NCT01269151|microperimetry|microperimetry
538967|NCT01269151|Lucentis|lucentis
538968|NCT01269151|Ranibizumab|ranibizumab
538969|NCT01269151|longterm effects|longterm effects
538970|NCT01269151|best corrected visual acuity|best corrected visual acuity
538971|NCT01269151|BCVA|bcva
538972|NCT01269138|Inherited Factor VII deficiency|inherited factor vii deficiency
538973|NCT01269138|Inhibitor development in Factor VII deficiency|inhibitor development in factor vii deficiency
538974|NCT01269138|Bleeding in Factor VII Deficiency|bleeding in factor vii deficiency
538975|NCT01269138|Surgery in Factor VII deficiency|surgery in factor vii deficiency
538976|NCT01269138|Prophylaxis in Factor VII Deficiency|prophylaxis in factor vii deficiency
538977|NCT01269125|cytokines|cytokines
538978|NCT01269125|endometriosis|endometriosis
538979|NCT01269125|fertilization rate|fertilization rate
538980|NCT01269125|follicular fluid|follicular fluid
538981|NCT01269125|pregnancy rate|pregnancy rate
538982|NCT01269099|hypokalemia|hypokalemia
538983|NCT01269099|intravenous patient controlled analgesia|intravenous patient controlled analgesia
538984|NCT01269086|Primary Heath Care|primary heath care
538985|NCT01269086|Preventive Medicine|preventive medicine
538986|NCT01269086|Adolescent Health Services|adolescent health services
538987|NCT01269086|Spouses|spouses
538988|NCT01269086|Family|family
538989|NCT01269086|Family Practice|family practice
538990|NCT01269073|Obstructive Sleep Apnea|obstructive sleep apnea
538991|NCT01269060|Colorectal Cancer, laparoscopic surgery|colorectal cancer, laparoscopic surgery
538992|NCT01269047|type 1 diabetes|type 1 diabetes
538993|NCT01269047|Symlin|symlin
538994|NCT01269047|Byetta|byetta
538995|NCT01269047|CGMS iPro|cgms ipro
538996|NCT01269034|Type 1 diabetes Milletus|type 1 diabetes milletus
538997|NCT01269034|diabetes|diabetes
538998|NCT01269034|healthy controls|healthy controls
538999|NCT01269034|exenatide|exenatide
539000|NCT01269034|byetta|byetta
539001|NCT01269021|MMF treatment IgA Nephropathy (IgAN)|mmf treatment iga nephropathy (igan)
539002|NCT01269008|Closed loop|closed loop
539003|NCT01269008|type 1 diabetes|type 1 diabetes
539004|NCT01269008|Symlin|symlin
539005|NCT01269008|Byetta|byetta
539006|NCT01269008|diabetes|diabetes
539007|NCT01269008|insulin|insulin
539008|NCT01269008|insulin pump|insulin pump
539009|NCT01268995|NODAT|nodat
539010|NCT01268995|kidney transplantation|kidney transplantation
539011|NCT01268995|beta cell function|beta cell function
539012|NCT01268995|insulin|insulin
539013|NCT01268995|Tacrolimus|tacrolimus
539014|NCT01268995|Cyclosporine A|cyclosporine a
539015|NCT01268982|socket preservation|socket preservation
539016|NCT01268982|alveolar ridge augmentation|alveolar ridge augmentation
539017|NCT01268969|pilonidal disease PND|pilonidal disease pnd
539018|NCT01268943|rectal neoplasms|rectal neoplasms
539019|NCT01268943|aged|aged
539020|NCT01268943|radiotherapy|radiotherapy
539021|NCT01268943|drug therapy|drug therapy
539022|NCT01268943|dose-escalation|dose-escalation
539023|NCT01268943|capecitabine|capecitabine
539024|NCT01268930|ovarian reserve|ovarian reserve
539025|NCT01268930|endometrioma excision|endometrioma excision
539026|NCT01268930|hemostatic matrix|hemostatic matrix
539027|NCT01268930|bipolar electrocoagulation|bipolar electrocoagulation
539028|NCT01268930|thermal injury|thermal injury
539029|NCT01268917|coronary artery disease|coronary artery disease
539030|NCT01268917|off-pump coronary artery bypass|off-pump coronary artery bypass
539031|NCT01268917|aspirin|aspirin
539032|NCT01268891|Azilect|azilect
539033|NCT01268891|Motor fluctuations|motor fluctuations
539034|NCT01268891|Parkinson´s Disease|parkinson´s disease
539035|NCT01268891|Rasagiline|rasagiline
539036|NCT01268878|effect of febrile neutropenia resulting chemotherapy by TPF|effect of febrile neutropenia resulting chemotherapy by tpf
539037|NCT01268865|Acoustic Radiation Force Impulse (ARFI)|acoustic radiation force impulse (arfi)
539038|NCT01268865|Virtual Touch Quantification (VTQ)|virtual touch quantification (vtq)
539039|NCT01268865|liver stiffness measurement (LSM)|liver stiffness measurement (lsm)
539040|NCT01268865|liver fibrosis|liver fibrosis
539041|NCT01268865|cirrhosis|cirrhosis
539042|NCT01268865|hepatitis B|hepatitis b
539043|NCT01268865|hepatitis C|hepatitis c
539044|NCT01268839|TMC278, rilpivirine, efavirenz, healthy volunteer|tmc278, rilpivirine, efavirenz, healthy volunteer
539045|NCT01268800|AML|aml
539046|NCT01268800|Induction|induction
539047|NCT01268761|Ovarian hyperstimulation syndrome (OHSS)|ovarian hyperstimulation syndrome (ohss)
539048|NCT01268761|GnRH antagonist|gnrh antagonist
684818|NCT00692770|HCC|hcc
539049|NCT01268761|Ascitis.|ascitis.
539050|NCT01268748|single site surgery|single site surgery
539051|NCT01268748|laparoscopic surgery|laparoscopic surgery
539052|NCT01268748|pain|pain
539053|NCT01268748|nausea|nausea
539054|NCT01268735|Dysfunctional Tear Syndrome|dysfunctional tear syndrome
539055|NCT01268735|Dry Eye|dry eye
539056|NCT01268735|LIPCOF|lipcof
539057|NCT01268735|Hydroxypropyl-guar|hydroxypropyl-guar
539058|NCT01268722|Nitinol Stent|nitinol stent
539059|NCT01268722|Balloon angioplasty|balloon angioplasty
539060|NCT01268722|Chronic total occlusions|chronic total occlusions
539061|NCT01268722|Femoropopliteal|femoropopliteal
539062|NCT01268696|diabetes|diabetes
539063|NCT01268696|obesity|obesity
539064|NCT01268696|hypertension|hypertension
539065|NCT01268696|dyslipidemia|dyslipidemia
539066|NCT01268683|Ischemic stroke|ischemic stroke
539067|NCT01268657|PTSD|ptsd
539068|NCT01268657|Fear of Falling|fear of falling
539069|NCT01268657|Older Adults|older adults
539070|NCT01268657|Injurious Falls|injurious falls
539071|NCT01268657|Exposure Therapy|exposure therapy
539072|NCT01268644|Type 1 Diabetes Mellitus|type 1 diabetes mellitus
539073|NCT01268631|Fibromyalgia|fibromyalgia
539074|NCT01268631|Pain modulation|pain modulation
539075|NCT01268618|IBS|ibs
539076|NCT01268618|Diarrhea|diarrhea
539077|NCT01268618|Dyspepsia|dyspepsia
539078|NCT01268605|Dental caries|dental caries
539079|NCT01268605|Resin based composite|resin based composite
539080|NCT01268605|Hypersensitivity|hypersensitivity
539081|NCT01268605|Teeth|teeth
539082|NCT01268605|Dentistry|dentistry
539083|NCT01268605|Practice-based research network|practice-based research network
539084|NCT01268592|fertility preservation|fertility preservation
539085|NCT01268592|oocyte cryopreservation|oocyte cryopreservation
539086|NCT01268592|vitrification|vitrification
539087|NCT01268592|egg freezing|egg freezing
539088|NCT01268592|fertility preservation in female cancer patients|fertility preservation in female cancer patients
539089|NCT01268579|ribavirin|ribavirin
539090|NCT01268579|VIRAZOLE|virazole
539091|NCT01268579|tonsil|tonsil
539092|NCT01268579|base of tongue|base of tongue
539093|NCT01268579|squamous cell carcinoma|squamous cell carcinoma
539094|NCT01268579|10-218|10-218
539095|NCT01268566|Glioblastoma|glioblastoma
539096|NCT01268553|pulmonary arterial hypertension|pulmonary arterial hypertension
539097|NCT01268553|inhaled prostacyclin|inhaled prostacyclin
539098|NCT01268540|intraocular lens|intraocular lens
539099|NCT01268540|IOL|iol
539100|NCT01268540|cataract|cataract
539101|NCT01268540|refractive astigmatism|refractive astigmatism
539102|NCT01268540|Aspheric|aspheric
539103|NCT01268540|Toric|toric
539104|NCT01268540|Hoya|hoya
539105|NCT01268540|Surgical|surgical
539106|NCT01268540|Optics|optics
539107|NCT01268540|visual acuity|visual acuity
539108|NCT01268527|Psoriasis vulgaris|psoriasis vulgaris
539109|NCT01268514|Complex|complex
539110|NCT01268514|Abdominal Wall Reconstruction|abdominal wall reconstruction
539111|NCT01268514|AWR|awr
539112|NCT01268514|Hernia|hernia
539113|NCT01268475|Bronchiectasis|bronchiectasis
539114|NCT01268475|Quality of Life|quality of life
539115|NCT01268475|Respiratory Function Tests|respiratory function tests
539116|NCT01268475|Exercise Test|exercise test
539117|NCT01268449|Tinnitus|tinnitus
539118|NCT01268449|Low power laser|low power laser
539119|NCT01268423|Percutaneous tracheostomy|percutaneous tracheostomy
539120|NCT01268423|Swallowing dysfunction|swallowing dysfunction
539121|NCT01268423|Mechanical ventilation|mechanical ventilation
539122|NCT01268423|Intensive Care|intensive care
539123|NCT01268410|Acute respiratory failure|acute respiratory failure
539124|NCT01268410|Acute lung injury|acute lung injury
539125|NCT01268410|Acute respiratory distress syndrome|acute respiratory distress syndrome
539126|NCT01268410|Mechanical Ventilation|mechanical ventilation
539127|NCT01268410|Non-Invasive Ventilation|non-invasive ventilation
539128|NCT01268397|elderly|elderly
539129|NCT01268397|wrist fracture|wrist fracture
539130|NCT01268397|fracture of the distal radius|fracture of the distal radius
539131|NCT01268397|volar plate|volar plate
539132|NCT01268397|plaster cast|plaster cast
539133|NCT01268384|pancreatic cancer|pancreatic cancer
539134|NCT01268384|neoadjuvant chemotherapy|neoadjuvant chemotherapy
539135|NCT01268384|gemcitabine|gemcitabine
539136|NCT01268384|capecitabine|capecitabine
539137|NCT01268371|Coronary artery disease|coronary artery disease
539138|NCT01268371|Stent|stent
539139|NCT01268345|blood glucose|blood glucose
539140|NCT01268332|Placebo IVR as a delivery method|placebo ivr as a delivery method
539141|NCT01268319|Myocardial Infarction|myocardial infarction
539142|NCT01268319|percutaneous coronary intervention|percutaneous coronary intervention
539143|NCT01268319|embolization|embolization
539144|NCT01268319|necrotic core|necrotic core
539145|NCT01268319|vulnerable plaque|vulnerable plaque
539146|NCT01268319|coronary plaque rupture|coronary plaque rupture
539147|NCT01268306|contact lens|contact lens
539148|NCT01268306|corneal staining|corneal staining
539149|NCT01268306|fluorescein staining|fluorescein staining
539150|NCT01268306|preservatives|preservatives
539151|NCT01268306|keratitis|keratitis
539152|NCT01268306|punctate keratopathy|punctate keratopathy
539153|NCT01268306|superficial punctate keratopathy|superficial punctate keratopathy
539154|NCT01268306|SPK|spk
539155|NCT01268293|Cancer|cancer
539156|NCT01268254|wine|wine
539157|NCT01268254|aging|aging
539158|NCT01268254|atherosclerosis|atherosclerosis
539159|NCT01268254|telomere|telomere
539160|NCT01268254|tomography|tomography
539161|NCT01268254|coronary vessels|coronary vessels
539162|NCT01268241|Fabry Disease|fabry disease
539163|NCT01268241|Fabry´s Disease|fabry´s disease
539164|NCT01268241|Anderson-Fabry Disease|anderson-fabry disease
539165|NCT01268228|intracoronary ECG|intracoronary ecg
539166|NCT01268228|coronary bifurcation stenosis|coronary bifurcation stenosis
539167|NCT01268228|side branch compromise|side branch compromise
539168|NCT01268228|Periprocedural myonecrosis during coronary bifurcation lesion stenting assessed with ic ECG|periprocedural myonecrosis during coronary bifurcation lesion stenting assessed with ic ecg
539169|NCT01268215|Bronchopulmonary Dysplasia|bronchopulmonary dysplasia
539170|NCT01268215|Budesonide|budesonide
539171|NCT01268215|Infasurf|infasurf
539172|NCT01268202|cutaneous radioinduced fibrosis|cutaneous radioinduced fibrosis
539173|NCT01268189|burn wound|burn wound
539174|NCT01268189|management with oxygen|management with oxygen
539175|NCT01268176|Vitamin D|vitamin d
539176|NCT01268176|vitamin D deficiency|vitamin d deficiency
539177|NCT01268176|vitamin D absorption|vitamin d absorption
539179|NCT01268163|Phase I|phase i
539180|NCT01268163|Pharmacokinetic|pharmacokinetic
539181|NCT01268163|Bioequivalence|bioequivalence
539182|NCT01268137|MDD|mdd
539183|NCT01268137|DBS|dbs
539184|NCT01268124|Japanese|japanese
539185|NCT01268111|vitamin D deficiency, insulin sensitivity|vitamin d deficiency, insulin sensitivity
539186|NCT01268098|Hypoparathyroidism, rhPTH[1-84], NPSP558|hypoparathyroidism, rhpth[1-84], npsp558
539187|NCT01268085|Radiation Safety|radiation safety
539188|NCT01268085|Computerized Physician Order Entry|computerized physician order entry
539189|NCT01268085|Decision Support|decision support
539190|NCT01268085|Cat Scans|cat scans
539191|NCT01268072|COPD|copd
539192|NCT01268059|Non-small cell lung cancer|non-small cell lung cancer
539193|NCT01268059|NSCLC|nsclc
539194|NCT01268046|aging|aging
539195|NCT01268046|postmenopausal women|postmenopausal women
539196|NCT01268046|estrogen|estrogen
539197|NCT01268046|memory|memory
539198|NCT01268033|rituximab|rituximab
539199|NCT01268033|idiopathic nephrotic syndrome|idiopathic nephrotic syndrome
539200|NCT01268033|minimal change disease|minimal change disease
539201|NCT01268033|focal and segmental glomerulosclerosis|focal and segmental glomerulosclerosis
539202|NCT01268020|Alzheimer|alzheimer
539203|NCT01268020|AD|ad
539204|NCT01267994|Steroid|steroid
539205|NCT01267994|Steroid-Resistant|steroid-resistant
539206|NCT01267994|Autoimmune Inner Ear Disease|autoimmune inner ear disease
539207|NCT01267994|Immune Mediated Hearing Loss|immune mediated hearing loss
539208|NCT01267994|Sudden Sensorineural Hearing Loss|sudden sensorineural hearing loss
539209|NCT01267994|Meniere's Disease|meniere's disease
539210|NCT01267994|Autoimmune|autoimmune
539211|NCT01267994|Hearing|hearing
539212|NCT01267981|Small bowel|small bowel
539213|NCT01267981|video-capsule endoscopy|video-capsule endoscopy
539214|NCT01267981|gastrointestinal bleeding|gastrointestinal bleeding
539215|NCT01267981|polyethylene glycol|polyethylene glycol
539216|NCT01267968|pharmacokinetics|pharmacokinetics
539217|NCT01267968|bronchoalveolar lavage|bronchoalveolar lavage
539218|NCT01267968|GSK2251052|gsk2251052
539219|NCT01267968|pulmonary|pulmonary
539220|NCT01267968|healthy volunteer|healthy volunteer
539221|NCT01267968|antimicrobial|antimicrobial
539222|NCT01267942|Adenotonsillectomy.|adenotonsillectomy.
539223|NCT01267929|Children with cerebral palsy|children with cerebral palsy
539224|NCT01267929|Gross Motor Function Measure|gross motor function measure
539225|NCT01267929|Imitative learning|imitative learning
539226|NCT01267929|Mirror neuron|mirror neuron
539227|NCT01267929|Action observation|action observation
539228|NCT01267929|Conventional physical therapy|conventional physical therapy
539229|NCT01267916|intrinsic positive end-expiratory pressure|intrinsic positive end-expiratory pressure
539230|NCT01267916|obesity|obesity
539231|NCT01267916|ventilator setting|ventilator setting
539232|NCT01267916|respiratory rate|respiratory rate
539233|NCT01267903|Vaccines Adverse Reaction|vaccines adverse reaction
539234|NCT01267890|ethics|ethics
539235|NCT01267890|law|law
539236|NCT01267890|surrogate|surrogate
539237|NCT01267890|conflict|conflict
539238|NCT01267877|U.S. Preventive Services Task Force|u.s. preventive services task force
539239|NCT01267877|Patient attitude|patient attitude
539240|NCT01267877|Mammogram|mammogram
539241|NCT01267877|Guideline|guideline
539242|NCT01267864|migraine|migraine
539243|NCT01267864|emergency|emergency
539244|NCT01267864|metoclopramide|metoclopramide
539245|NCT01267864|ketorolac|ketorolac
539246|NCT01267864|valproate|valproate
539247|NCT01267851|gynecologic disease|gynecologic disease
539248|NCT01267838|Coronary artery disease|coronary artery disease
539249|NCT01267838|Restenosis|restenosis
539250|NCT01267838|Stent thrombosis|stent thrombosis
539251|NCT01267825|Disc herniation|disc herniation
539252|NCT01267825|Lumbosacral radiculopathy|lumbosacral radiculopathy
539253|NCT01267825|Corticosteroids|corticosteroids
539254|NCT01267786|Oxidotic stress|oxidotic stress
539255|NCT01267773|depression|depression
539256|NCT01267773|conduct problems|conduct problems
539257|NCT01267760|dialysis|dialysis
539258|NCT01267760|hemodialysis|hemodialysis
539259|NCT01267760|Effect of recycled low-volume dialysate on dialysis efficacy|effect of recycled low-volume dialysate on dialysis efficacy
539260|NCT01267747|Atrial fibrillation|atrial fibrillation
539261|NCT01267747|Atrial Flutter|atrial flutter
539262|NCT01267747|Primary Aldosteronism|primary aldosteronism
539263|NCT01267747|Aldosterone Producing Adenoma|aldosterone producing adenoma
539264|NCT01267734|Everolimus|everolimus
539265|NCT01267734|Zotarolimus|zotarolimus
539266|NCT01267734|Cilostazol|cilostazol
539267|NCT01267734|Clopidogrel|clopidogrel
539268|NCT01267721|heart surgery|heart surgery
539269|NCT01267695|Gastrointestinal Stromal Tumor|gastrointestinal stromal tumor
539270|NCT01267695|Imatinib mesylate|imatinib mesylate
539271|NCT01267695|Perioperative therapy|perioperative therapy
539272|NCT01267682|Delirium|delirium
539273|NCT01267682|Dementia|dementia
539274|NCT01267682|Non-pharmacological Intervention|non-pharmacological intervention
539275|NCT01267682|Post-acute care|post-acute care
539276|NCT01267669|Variceal bleeding|variceal bleeding
539673|NCT01266083|vaccine|vaccine
539277|NCT01267669|Endoscopic therapy|endoscopic therapy
539278|NCT01267669|Band ligation|band ligation
539279|NCT01267669|Somatostatin|somatostatin
539280|NCT01267669|Vasoactive drugs|vasoactive drugs
539281|NCT01267669|Octreotide|octreotide
539282|NCT01267643|Alefacept|alefacept
539283|NCT01267643|Amevive|amevive
539284|NCT01267643|Aplastic Anemia|aplastic anemia
539285|NCT01267643|Moderate to Severe Aplastic Anemia|moderate to severe aplastic anemia
539286|NCT01267630|Delirium of Mixed Origin|delirium of mixed origin
539287|NCT01267630|Subacute Delirium|subacute delirium
539288|NCT01267630|Mental Disorders, Organic|mental disorders, organic
539289|NCT01267630|Organic Brain Syndrome, Nonpsychotic|organic brain syndrome, nonpsychotic
539290|NCT01267630|Organic Mental Disorders|organic mental disorders
539291|NCT01267630|Organic Mental Disorders, Psychotic|organic mental disorders, psychotic
539292|NCT01267630|Psychoses, Traumatic|psychoses, traumatic
539293|NCT01267630|Cognition Disorder|cognition disorder
539294|NCT01267630|Confusion state|confusion state
539295|NCT01267630|Disorientation|disorientation
539296|NCT01267617|hemodialysis|hemodialysis
539297|NCT01267617|hypotension|hypotension
539298|NCT01267617|circulatory stress|circulatory stress
539299|NCT01267617|photo-plethysmography|photo-plethysmography
539300|NCT01267578|Epitope peptide, CTL, Esophageal cancer, Vaccination|epitope peptide, ctl, esophageal cancer, vaccination
539301|NCT01267565|ventilator-acquired pneumonia|ventilator-acquired pneumonia
539302|NCT01267565|prevention|prevention
539303|NCT01267565|amylase|amylase
539304|NCT01267565|tracheal aspiration|tracheal aspiration
539305|NCT01267565|microaspiration|microaspiration
539306|NCT01267552|Breast cancer|breast cancer
539307|NCT01267552|Surgery|surgery
539308|NCT01267552|Complications|complications
539309|NCT01267552|Drainage|drainage
539310|NCT01267552|Seroma|seroma
539311|NCT01267539|Suan Zao Ren Tang, climacteric, PSQI, WHOQOL-BREF|suan zao ren tang, climacteric, psqi, whoqol-bref
539312|NCT01267526|Growth disorders|growth disorders
539313|NCT01267526|Saizen|saizen
539314|NCT01267526|Easypod|easypod
539315|NCT01267526|Growth hormone|growth hormone
539316|NCT01267526|Pediatric subject|pediatric subject
539317|NCT01267513|oxygen saturation|oxygen saturation
539318|NCT01267513|pulse rate|pulse rate
539319|NCT01267513|tachycardia|tachycardia
539320|NCT01267513|bradycardia|bradycardia
539321|NCT01267513|hypoxia|hypoxia
539322|NCT01267487|Heparin|heparin
539323|NCT01267487|Protamine|protamine
539324|NCT01267487|Cardiopulmonary Bypass|cardiopulmonary bypass
539325|NCT01267487|Titration|titration
539326|NCT01267474|School children|school children
539327|NCT01267474|Sugar intake|sugar intake
539328|NCT01267474|Nutritional education program|nutritional education program
539329|NCT01267461|To asses the biological actions of insulin analogs in primary tumor cells|to asses the biological actions of insulin analogs in primary tumor cells
539330|NCT01267448|Diabetes Mellitus Type2.|diabetes mellitus type2.
539331|NCT01267448|Severe Hyperglycemia - blood glucose levels >300mg/dl.|severe hyperglycemia - blood glucose levels >300mg/dl.
539332|NCT01267435|Arthroscopy, Anterior Cruciate Ligament, Tibial Tunnel.|arthroscopy, anterior cruciate ligament, tibial tunnel.
539333|NCT01267422|Leber's Hereditary Optic Neuropathy,11778 LHON mutation,|leber's hereditary optic neuropathy,11778 lhon mutation,
539334|NCT01267422|rAAV2-ND4,triamcinolone acetonide|raav2-nd4,triamcinolone acetonide
539335|NCT01267409|Mapping the emotional territories of the STN|mapping the emotional territories of the stn
539336|NCT01267409|Identifying the emotional spectral signature of the STN single unit activity|identifying the emotional spectral signature of the stn single unit activity
539337|NCT01267409|Manipulating emotional processing of PD patients by high and low frequency stimulation|manipulating emotional processing of pd patients by high and low frequency stimulation
539338|NCT01267409|Affecting long-term emotional states of the PD patients|affecting long-term emotional states of the pd patients
539339|NCT01267396|Bioequivalence|bioequivalence
539340|NCT01267396|Sertraline|sertraline
539341|NCT01267396|crossover|crossover
539342|NCT01267383|Bioequivalence|bioequivalence
539343|NCT01267383|Sertraline|sertraline
539344|NCT01267383|crossover|crossover
539345|NCT01267370|clinical trial|clinical trial
539346|NCT01267370|dietary fiber|dietary fiber
539347|NCT01267370|constipation|constipation
539348|NCT01267370|children|children
539349|NCT01267357|Serous Papillary Endometrial Cancer|serous papillary endometrial cancer
539350|NCT01267357|Endometrioid endometrial cancer|endometrioid endometrial cancer
539351|NCT01267357|biomarkers|biomarkers
539352|NCT01267357|P16|p16
539353|NCT01267357|P53|p53
539354|NCT01267357|Prognosis|prognosis
539355|NCT01267344|biliary tract cancer|biliary tract cancer
539356|NCT01267344|BTC|btc
539357|NCT01267344|cetuximaba|cetuximaba
539358|NCT01267331|Old Myocardial Infarction|old myocardial infarction
539359|NCT01267331|Stem Cell Therapy|stem cell therapy
539360|NCT01267331|Coronary Artery Bypass Grafting|coronary artery bypass grafting
539361|NCT01267331|Coronary Artery Disease|coronary artery disease
539362|NCT01267318|Gastric juice|gastric juice
539363|NCT01267318|Stomach|stomach
539364|NCT01267318|GI|gi
539365|NCT01267318|Gastric juice samples with presence of blood.|gastric juice samples with presence of blood.
539366|NCT01267305|esophagectomy|esophagectomy
539367|NCT01267305|lung resection|lung resection
539368|NCT01267305|venous thromboembolism|venous thromboembolism
539369|NCT01267305|low molecular weight heparin|low molecular weight heparin
539370|NCT01267305|chest drainage|chest drainage
539371|NCT01267305|TEG|teg
539372|NCT01267292|cocaine dependence|cocaine dependence
539373|NCT01267292|psychopharmacology|psychopharmacology
539374|NCT01267292|attentional bias|attentional bias
539375|NCT01267292|risky decision making|risky decision making
539376|NCT01267292|buspirone|buspirone
539377|NCT01267292|methylphenidate|methylphenidate
539378|NCT01267227|Hyperlipidemia|hyperlipidemia
539379|NCT01267227|Cholesterol|cholesterol
539380|NCT01267227|Blood Pressure|blood pressure
539381|NCT01267227|Oxidative Stress|oxidative stress
539382|NCT01267227|Pterostilbene|pterostilbene
539383|NCT01267227|Blueberry|blueberry
539384|NCT01267227|Grape Extract|grape extract
539385|NCT01267201|Single dose bioavailability study of methylprednisolone powder for oral suspension (4mg/mL) versus methylprednisolone tablet (32 mg)|single dose bioavailability study of methylprednisolone powder for oral suspension (4mg/ml) versus methylprednisolone tablet (32 mg)
539386|NCT01267162|CHB|chb
539387|NCT01267149|superficial vertical perioral lines|superficial vertical perioral lines
539388|NCT01267149|superficial horizontal and lateral canthal lines|superficial horizontal and lateral canthal lines
539389|NCT01267149|correct moderate to severe facial wrinkles and folds|correct moderate to severe facial wrinkles and folds
539390|NCT01267136|Tonsillectomy|tonsillectomy
539391|NCT01267136|Pain|pain
539392|NCT01267136|Pediatric|pediatric
539393|NCT01267136|Opioids|opioids
539394|NCT01267136|Tramadol|tramadol
539395|NCT01267136|Codeine|codeine
539396|NCT01267097|Pediatric Obesity|pediatric obesity
539397|NCT01267097|Treatment|treatment
539398|NCT01267097|Cognitive Behavioural Therapy|cognitive behavioural therapy
539399|NCT01267097|Psychoeducation|psychoeducation
539400|NCT01267097|Canada|canada
539401|NCT01267084|Trabectedin (YONDELIS)|trabectedin (yondelis)
539402|NCT01267084|Ketoconazole|ketoconazole
539403|NCT01267084|Antineoplastic Agents|antineoplastic agents
539404|NCT01267084|Solid tumors|solid tumors
539405|NCT01267084|Locally advanced or metastatic disease|locally advanced or metastatic disease
539406|NCT01267084|Chemotherapy|chemotherapy
539407|NCT01267084|Pharmacokinetics|pharmacokinetics
539408|NCT01267071|Entero-test|entero-test
539409|NCT01267071|Phase I|phase i
539410|NCT01267071|GSK962040|gsk962040
539411|NCT01267071|i.v. microtracer|i.v. microtracer
539412|NCT01267071|radioactivity|radioactivity
539413|NCT01267071|pharmacokinetics|pharmacokinetics
539414|NCT01267071|healthy volunteer|healthy volunteer
539415|NCT01267058|Booster vaccination|booster vaccination
539416|NCT01267045|Persian Gulf Syndrome|persian gulf syndrome
539417|NCT01267045|Pain|pain
539418|NCT01267045|Fatigue|fatigue
539419|NCT01267045|Attention|attention
539420|NCT01267045|Meditation|meditation
539421|NCT01267019|social cognition|social cognition
539422|NCT01267019|training intervention|training intervention
539423|NCT01266993|Immunogenicity|immunogenicity
539424|NCT01266993|Persistence|persistence
539425|NCT01266993|Safety|safety
539426|NCT01266993|Conjugate vaccine|conjugate vaccine
539427|NCT01266993|Meningococcal vaccine|meningococcal vaccine
539428|NCT01266980|cortisol|cortisol
539429|NCT01266980|renal impairment|renal impairment
539430|NCT01266980|serum potassium|serum potassium
539431|NCT01266980|pharmacokinetics|pharmacokinetics
539432|NCT01266980|Fluticasone furoate|fluticasone furoate
539433|NCT01266980|heart rate|heart rate
539434|NCT01266967|GSK2118436|gsk2118436
539435|NCT01266967|Metastatic melanoma to the brain|metastatic melanoma to the brain
539436|NCT01266967|Brain metastases|brain metastases
539437|NCT01266967|Braf mutation|braf mutation
539438|NCT01266967|Brain neoplasm|brain neoplasm
539439|NCT01266967|BRAF inhibitor|braf inhibitor
539440|NCT01266954|Cancer|cancer
539441|NCT01266954|18F FDG|18f fdg
539442|NCT01266954|PK|pk
539443|NCT01266954|PET|pet
539444|NCT01266954|Positron Emission Tomography|positron emission tomography
539445|NCT01266954|PD|pd
539446|NCT01266954|AKT Inhibitor|akt inhibitor
539447|NCT01266954|GSK2141795|gsk2141795
539448|NCT01266941|pharmacokinetics|pharmacokinetics
539449|NCT01266941|hepatic impairment|hepatic impairment
539450|NCT01266941|heart rate|heart rate
539451|NCT01266941|serum potassium|serum potassium
539452|NCT01266941|serum cortisol|serum cortisol
539453|NCT01266941|GW642444M|gw642444m
539454|NCT01266941|Fluticasone furoate (GW685698)|fluticasone furoate (gw685698)
539455|NCT01266915|SCLE|scle
539456|NCT01266915|CLE|cle
539457|NCT01266915|DLE|dle
539458|NCT01266902|HIV-1 Infection|hiv-1 infection
539459|NCT01266902|HIV-1|hiv-1
539460|NCT01266902|HIV|hiv
539461|NCT01266902|TMC278-TiDP6-C222|tmc278-tidp6-c222
539462|NCT01266902|TMC278-C222|tmc278-c222
539463|NCT01266902|TMC278|tmc278
539464|NCT01266902|Rilpivirine|rilpivirine
539465|NCT01266889|preterm infant,cerebral oxygenation, intracranial haemorrhagia|preterm infant,cerebral oxygenation, intracranial haemorrhagia
539466|NCT01266863|Hospital-acquired pneumonia|hospital-acquired pneumonia
539467|NCT01266863|E test|e test
539468|NCT01266863|Antibiogram|antibiogram
539469|NCT01266863|Bronchoalveolar lavage|bronchoalveolar lavage
539470|NCT01266850|vaccine, rotavirus, gastroenteritis, infants|vaccine, rotavirus, gastroenteritis, infants
539471|NCT01266837|metastatic renal cell carcinoma|metastatic renal cell carcinoma
539472|NCT01266837|biomarker|biomarker
539473|NCT01266837|Everolimus|everolimus
539474|NCT01266824|Pain|pain
539475|NCT01266824|Retinopathy of Prematurity|retinopathy of prematurity
539476|NCT01266824|Neonates|neonates
539477|NCT01266811|dexamethasone|dexamethasone
539478|NCT01266811|Siltuximab|siltuximab
539479|NCT01266811|CNTO 328|cnto 328
539480|NCT01266811|IL-6|il-6
539481|NCT01266811|Monoclonal Antibody|monoclonal antibody
539482|NCT01266811|Multiple Myeloma|multiple myeloma
539483|NCT01266811|Relapsed or Refractory|relapsed or refractory
539484|NCT01266811|Velcade|velcade
539485|NCT01266811|bortezomib|bortezomib
539486|NCT01266798|Health literacy, participation|health literacy, participation
539487|NCT01266785|crohn's|crohn's
539488|NCT01266785|Infliximab|infliximab
539489|NCT01266785|Inflammatory bowel disease|inflammatory bowel disease
539490|NCT01266785|digestive tract|digestive tract
539491|NCT01266785|Interleukin|interleukin
539492|NCT01266772|asthma; children; montelukast; treatment; exacerbation|asthma; children; montelukast; treatment; exacerbation
539493|NCT01266759|Menorrhagia|menorrhagia
539494|NCT01266759|Vaginal ring|vaginal ring
539495|NCT01266759|Norethisterone Acetate|norethisterone acetate
539496|NCT01266746|gas tamponade,|gas tamponade,
539497|NCT01266746|macular hole,|macular hole,
539498|NCT01266746|macular hole retinal detachment,|macular hole retinal detachment,
539499|NCT01266746|optical coherence tomography|optical coherence tomography
539500|NCT01266733|fibromyalgia, non pharmacological intervention|fibromyalgia, non pharmacological intervention
539501|NCT01266720|pancreatic cancer|pancreatic cancer
539502|NCT01266720|peptide vaccine|peptide vaccine
539503|NCT01266720|VEGFR|vegfr
539504|NCT01266720|gemcitabine|gemcitabine
539505|NCT01266707|Hepatocellular carcinoma|hepatocellular carcinoma
539506|NCT01266707|peptide vaccine|peptide vaccine
539507|NCT01266707|VEGFR|vegfr
539508|NCT01266694|Pericardial effusion|pericardial effusion
539509|NCT01266694|Cardiac surgery|cardiac surgery
539510|NCT01266694|Tamponade|tamponade
539511|NCT01266694|colchicine|colchicine
539512|NCT01266668|Diffuse large B cell lymphoma|diffuse large b cell lymphoma
539513|NCT01266668|Breast|breast
539514|NCT01266668|Rituximab|rituximab
539515|NCT01266642|Breast cancer|breast cancer
539516|NCT01266642|Early invasive breast cancer|early invasive breast cancer
539517|NCT01266642|Ductal carcinoma in situ of the breast|ductal carcinoma in situ of the breast
539518|NCT01266642|Tis|tis
539519|NCT01266642|T1|t1
539520|NCT01266642|T2|t2
539521|NCT01266642|N0|n0
539522|NCT01266642|N1mic|n1mic
539523|NCT01266642|N1a|n1a
539524|NCT01266642|Lumpectomy|lumpectomy
539525|NCT01266642|Hypofractionated whole breast irradiation|hypofractionated whole breast irradiation
539526|NCT01266642|HF-WBI|hf-wbi
539527|NCT01266642|Conventionally fractionated whole breast irradiation|conventionally fractionated whole breast irradiation
539528|NCT01266642|CF-WBI|cf-wbi
539529|NCT01266642|Radiation therapy|radiation therapy
539530|NCT01266642|Radiotherapy|radiotherapy
539531|NCT01266629|small bowel|small bowel
539532|NCT01266616|Interleukin-12|interleukin-12
539533|NCT01266616|Electroporation|electroporation
539534|NCT01266616|HIV Therapeutic Vaccine|hiv therapeutic vaccine
539535|NCT01266603|Metastatic Melanoma|metastatic melanoma
539536|NCT01266603|Unresectable Melanoma|unresectable melanoma
539537|NCT01266603|HDIL-2|hdil-2
539538|NCT01266603|Interleukin-2|interleukin-2
539539|NCT01266603|IL-2|il-2
539540|NCT01266603|Aldesleukin|aldesleukin
539541|NCT01266603|Proleukin|proleukin
539542|NCT01266603|recMAGE-A3 + AS15|recmage-a3 + as15
539543|NCT01266603|ASCI|asci
539544|NCT01266603|recMAGE-A3|recmage-a3
539545|NCT01266603|Recombinant MAGE-A3 protein|recombinant mage-a3 protein
539546|NCT01266603|recMAGE-A3 + AS15 ASCI|recmage-a3 + as15 asci
539547|NCT01266603|MAGE-A3|mage-a3
539548|NCT01266603|MAGE-A3 ASCI|mage-a3 asci
539549|NCT01266577|Brain Metabolism|brain metabolism
539550|NCT01266577|Neurochemistry|neurochemistry
539551|NCT01266577|Magnetic Resonance Imaging|magnetic resonance imaging
539552|NCT01266577|Mental Illness|mental illness
539553|NCT01266577|Magnetic Resonance Spectroscopy|magnetic resonance spectroscopy
539554|NCT01266577|Healthy Volunteer|healthy volunteer
539555|NCT01266577|HV|hv
539556|NCT01266551|Antireflux procedure|antireflux procedure
539557|NCT01266551|Gastroesophageal reflux|gastroesophageal reflux
539558|NCT01266551|Infant sleep position|infant sleep position
539559|NCT01266551|pH monitoring|ph monitoring
539560|NCT01266499|Klebsiella , pneumonia, carbapenem-hydrolyzing lactamase, carbapenem-resistant Klebsiella (KPC), eradication,|klebsiella , pneumonia, carbapenem-hydrolyzing lactamase, carbapenem-resistant klebsiella (kpc), eradication,
539561|NCT01266486|Breast cancer|breast cancer
539562|NCT01266486|Pharmacodynamics|pharmacodynamics
539563|NCT01266486|AMPK|ampk
539564|NCT01266486|PET Scan|pet scan
539565|NCT01266473|Adults|adults
539566|NCT01266434|moderate persistent asthma|moderate persistent asthma
539674|NCT01266083|10-143|10-143
539567|NCT01266434|Inhaled corticosteroids|inhaled corticosteroids
539568|NCT01266421|DNG|dng
539569|NCT01266421|Anemia|anemia
539570|NCT01266421|Depression|depression
539571|NCT01266408|Drospirenone|drospirenone
539572|NCT01266408|Dienogest|dienogest
539573|NCT01266408|Metafolin|metafolin
539574|NCT01266408|Folic acid|folic acid
539575|NCT01266408|Safety|safety
539576|NCT01266395|morning symptoms COPD|morning symptoms copd
539577|NCT01266369|mastocytosis|mastocytosis
539578|NCT01266369|D816V|d816v
539579|NCT01266369|handicaps|handicaps
539580|NCT01266356|Minor Traumatic Brain Injury|minor traumatic brain injury
539581|NCT01266356|Translation|translation
539582|NCT01266343|Glaucoma|glaucoma
539583|NCT01266343|anterior chamber paracentesis|anterior chamber paracentesis
539584|NCT01266343|conventional Mannitol infusion|conventional mannitol infusion
539585|NCT01266330|dairy|dairy
539586|NCT01266330|inflammation|inflammation
539587|NCT01266330|reactive oxygen species|reactive oxygen species
539588|NCT01266330|oxidative stress|oxidative stress
539589|NCT01266330|body composition|body composition
539590|NCT01266291|Tuberous sclerosis|tuberous sclerosis
539591|NCT01266291|TS|ts
539592|NCT01266291|Seizures|seizures
539593|NCT01266278|shoulder injuries|shoulder injuries
539594|NCT01266265|pulmonary arterial hypertension|pulmonary arterial hypertension
539595|NCT01266265|PAH|pah
539596|NCT01266265|treprostinil sodium|treprostinil sodium
539597|NCT01266265|Tyvaso|tyvaso
539598|NCT01266265|inhalation|inhalation
539599|NCT01266265|Ventavis|ventavis
539600|NCT01266265|iloprost|iloprost
539601|NCT01266265|prostacyclin|prostacyclin
539602|NCT01266265|epoprostenol sodium|epoprostenol sodium
539603|NCT01266265|Flolan|flolan
539604|NCT01266265|Veletri|veletri
539605|NCT01266265|subcutaneous and intravenous prostacyclin analogue|subcutaneous and intravenous prostacyclin analogue
539606|NCT01266265|Remodulin|remodulin
539607|NCT01266265|oral ERA|oral era
539608|NCT01266265|bosentan|bosentan
539609|NCT01266265|Tracleer|tracleer
539610|NCT01266265|ambrisentan|ambrisentan
539611|NCT01266265|Letairis|letairis
539612|NCT01266265|oral PDE5 inhibitors|oral pde5 inhibitors
539613|NCT01266265|sildenafil|sildenafil
539614|NCT01266265|Revatio|revatio
539615|NCT01266265|tadalafil|tadalafil
539616|NCT01266265|Adcirca|adcirca
539617|NCT01266265|Opsumit|opsumit
539618|NCT01266265|macitentan|macitentan
539619|NCT01266265|Adempas|adempas
539620|NCT01266265|riociguat|riociguat
539621|NCT01266265|Orenitram|orenitram
539622|NCT01266265|oral treprostinil|oral treprostinil
539623|NCT01266252|neonates|neonates
539624|NCT01266252|single organ respiratory failure|single organ respiratory failure
539625|NCT01266239|Bifurcation lesion, drug-eluting stent, symmetric expansion|bifurcation lesion, drug-eluting stent, symmetric expansion
539626|NCT01266226|Rotator cuff tears|rotator cuff tears
539627|NCT01266226|ACP|acp
539628|NCT01266213|fulvestrant|fulvestrant
539629|NCT01266213|anastrozole|anastrozole
539630|NCT01266213|goserelin|goserelin
539631|NCT01266213|tamoxifen|tamoxifen
539632|NCT01266213|premenopausal|premenopausal
539633|NCT01266213|hormone receptor positive|hormone receptor positive
539634|NCT01266200|microcirculation|microcirculation
539635|NCT01266200|vertebral fracture|vertebral fracture
539636|NCT01266200|inflammation|inflammation
539637|NCT01266200|minimal-invasive surgery|minimal-invasive surgery
539638|NCT01266187|FOLFOX|folfox
539639|NCT01266187|liver metastasis|liver metastasis
539640|NCT01266187|cetuximab|cetuximab
539641|NCT01266174|CIAS|cias
539642|NCT01266174|Cognition|cognition
539643|NCT01266174|Schizophrenia|schizophrenia
539644|NCT01266174|Eltoprazine|eltoprazine
539645|NCT01266161|dental pain|dental pain
539646|NCT01266161|multiple dose|multiple dose
539647|NCT01266161|ibuprofen|ibuprofen
539648|NCT01266161|third molar extraction|third molar extraction
539649|NCT01266135|Interstitial Lung Disease|interstitial lung disease
539650|NCT01266135|Usual Interstitial Pneumonia|usual interstitial pneumonia
539651|NCT01266135|Fibrosis,|fibrosis,
539652|NCT01266135|Pulmonary Fibrosis,|pulmonary fibrosis,
539653|NCT01266135|Respiratory Disease,|respiratory disease,
539654|NCT01266135|Interstitial Lung Disease,|interstitial lung disease,
539655|NCT01266135|Biological Therapy,|biological therapy,
539656|NCT01266135|Therapeutic Uses,|therapeutic uses,
539657|NCT01266122|HIV|hiv
539658|NCT01266122|Psychosocial problems|psychosocial problems
539659|NCT01266122|MSM|msm
539660|NCT01266122|India|india
539661|NCT01266109|Substance Use|substance use
539662|NCT01266109|Delinquency|delinquency
539663|NCT01266109|Juvenile Drug Court|juvenile drug court
539664|NCT01266109|Contingency Management|contingency management
539665|NCT01266109|Family Engagement|family engagement
539666|NCT01266096|124I-cRGDY-PEG-dots|124i-crgdy-peg-dots
539667|NCT01266096|Pet scan|pet scan
539668|NCT01266096|10-155|10-155
539669|NCT01266096|melanoma|melanoma
539670|NCT01266096|brain|brain
539671|NCT01266083|MONTANIDE ISA 51|montanide isa 51
539672|NCT01266083|WT1 PEPTIDE SPECIFIC T CELLS|wt1 peptide specific t cells
539675|NCT01266070|VHL|vhl
539676|NCT01266070|Hemangioblastoma|hemangioblastoma
539677|NCT01266070|Tumor of the central nervous system|tumor of the central nervous system
539678|NCT01266070|TKI258|tki258
539679|NCT01266057|Advanced Malignancies|advanced malignancies
539680|NCT01266057|Metastatic cancers|metastatic cancers
539681|NCT01266057|Sirolimus|sirolimus
539682|NCT01266057|Hydroxychloroquine|hydroxychloroquine
539683|NCT01266057|Vorinostat|vorinostat
539684|NCT01266057|Plaquenil|plaquenil
539685|NCT01266057|Rapamune|rapamune
539686|NCT01266057|Saha|saha
539687|NCT01266057|Suberoylanilide Hydroxamic Acid|suberoylanilide hydroxamic acid
539688|NCT01266057|MSK-390|msk-390
539689|NCT01266057|Zolinza|zolinza
539690|NCT01266044|Radiation-induced xerostomia|radiation-induced xerostomia
539691|NCT01266044|Acupuncture|acupuncture
539692|NCT01266044|Oropharyngeal cancer|oropharyngeal cancer
539693|NCT01266044|Radiation Therapy|radiation therapy
539694|NCT01266044|IMRT|imrt
539695|NCT01266044|Dry mouth|dry mouth
539696|NCT01266031|Glioblastoma Multiforme|glioblastoma multiforme
539697|NCT01266018|small cell lung cancer|small cell lung cancer
539698|NCT01266018|SCLC|sclc
539699|NCT01266018|ADI-PEG 20|adi-peg 20
539700|NCT01266018|arginine deiminase pegylated|arginine deiminase pegylated
539701|NCT01266005|HBe Ag(-) Chronic Hepatitis B|hbe ag(-) chronic hepatitis b
539702|NCT01265992|Secondary hyperparathyroidism|secondary hyperparathyroidism
539703|NCT01265992|Mineral and Bone Disorder (CKD-MBD)|mineral and bone disorder (ckd-mbd)
539704|NCT01265992|Chronic Kidney Disease|chronic kidney disease
539705|NCT01265979|advanced|advanced
539706|NCT01265979|metastatic|metastatic
539707|NCT01265979|gastro-intestinal|gastro-intestinal
539709|NCT01265979|GIST|gist
539710|NCT01265979|regorafenib|regorafenib
539711|NCT01265966|Moderate Sedation|moderate sedation
539712|NCT01265966|Sedation, Deep|sedation, deep
539713|NCT01265953|cancer prevention|cancer prevention
539714|NCT01265953|isothiocyanate|isothiocyanate
539715|NCT01265953|sulforaphane|sulforaphane
539716|NCT01265940|bladder cancer|bladder cancer
539717|NCT01265940|urothelial cancer|urothelial cancer
539718|NCT01265940|metastatic urothelial cancer|metastatic urothelial cancer
539719|NCT01265940|advanced urothelial cancer|advanced urothelial cancer
539720|NCT01265927|Breast Cancer|breast cancer
539721|NCT01265927|Breast Tumors|breast tumors
539722|NCT01265927|Cancer of Breast|cancer of breast
539723|NCT01265927|Cancer of the Breast|cancer of the breast
539724|NCT01265927|Genes, HER-2|genes, her-2
539725|NCT01265927|Genes, HER2|genes, her2
539726|NCT01265901|Metastatic Renal Cell Carcinoma|metastatic renal cell carcinoma
539727|NCT01265901|First line|first line
539728|NCT01265901|Eligible for sunitinib|eligible for sunitinib
539729|NCT01265888|PAH|pah
539730|NCT01265888|PH IPF|ph ipf
539731|NCT01265875|Chronic Pancreatitis|chronic pancreatitis
539732|NCT01265862|Tracheal intubation|tracheal intubation
539733|NCT01265862|Supraglottic airway devices|supraglottic airway devices
539734|NCT01265862|Patients undergoing general anesthesia|patients undergoing general anesthesia
711346|NCT00585182|venous thrombosis|venous thrombosis
685669|NCT00689793|Don|don
539735|NCT01265836|Dyslipidemia Treatment and Cardiovascular Outcomes|dyslipidemia treatment and cardiovascular outcomes
539736|NCT01265823|Humira|humira
539737|NCT01265823|Adalimumab|adalimumab
539738|NCT01265823|Plaque Psoriasis|plaque psoriasis
539739|NCT01265810|stomatitis|stomatitis
539740|NCT01265810|targeted therapy|targeted therapy
539741|NCT01265810|Caphosol|caphosol
539742|NCT01265810|mouthrinses|mouthrinses
539743|NCT01265771|Arrhythmia|arrhythmia
539744|NCT01265771|Children|children
539745|NCT01265758|Atrial fibrillation|atrial fibrillation
539746|NCT01265758|Cardiac arrhythmia|cardiac arrhythmia
539747|NCT01265758|ECG|ecg
539748|NCT01265758|Telemonitoring|telemonitoring
539749|NCT01265758|Telemetry|telemetry
539750|NCT01265758|Holter|holter
539751|NCT01265745|Phase I|phase i
539752|NCT01265732|Phase 1|phase 1
539753|NCT01265732|relative bioavailability|relative bioavailability
539754|NCT01265732|healthy volunteers|healthy volunteers
539755|NCT01265732|pharmacokinetics|pharmacokinetics
539756|NCT01265732|suspension|suspension
539757|NCT01265732|dispersion|dispersion
539758|NCT01265719|Prospective|prospective
539759|NCT01265719|non-interventional|non-interventional
539760|NCT01265719|longitudinal|longitudinal
539761|NCT01265719|cohort study|cohort study
539762|NCT01265706|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors
539763|NCT01265680|Blood Transfusion|blood transfusion
539764|NCT01265680|Heart surgery|heart surgery
539765|NCT01265680|Erythropoietin|erythropoietin
539766|NCT01265680|HRE|hre
539767|NCT01265667|Psoriasis|psoriasis
539768|NCT01265667|Plaque psoriasis|plaque psoriasis
539769|NCT01265654|Advanced Breast Cancer|advanced breast cancer
539770|NCT01265654|Hormonal Treatment|hormonal treatment
539771|NCT01265615|chronic allograft nephropathy|chronic allograft nephropathy
539772|NCT01265615|stem-progenitor cells|stem-progenitor cells
539773|NCT01265615|cardiorenal syndrome|cardiorenal syndrome
539774|NCT01265615|calcitriol|calcitriol
539775|NCT01265615|paricalcitol|paricalcitol
539776|NCT01265615|cholecalciferol|cholecalciferol
539777|NCT01265615|cardiac repair|cardiac repair
539778|NCT01265615|renal repair|renal repair
539779|NCT01265602|Actinic Keratosis|actinic keratosis
539780|NCT01265602|AK|ak
539781|NCT01265602|NMSC|nmsc
539782|NCT01265589|RDS|rds
539783|NCT01265589|Infant, newborn|infant, newborn
539784|NCT01265589|Vitamin A|vitamin a
539785|NCT01265589|Surfactant|surfactant
539786|NCT01265563|silymarin|silymarin
539787|NCT01265563|glutathione|glutathione
539788|NCT01265563|diabetic nephropathies|diabetic nephropathies
539789|NCT01265563|oxidative stress|oxidative stress
539790|NCT01265563|N-acetylcysteine|n-acetylcysteine
539791|NCT01265563|protein tholation|protein tholation
539792|NCT01265537|Transplant|transplant
539793|NCT01265537|Tacrolimus|tacrolimus
539794|NCT01265537|Diabetes after transplant|diabetes after transplant
539795|NCT01265537|Acute rejection prevention|acute rejection prevention
539796|NCT01265537|New onset diabetes after transplant|new onset diabetes after transplant
539797|NCT01265511|Hepatitis C|hepatitis c
539798|NCT01265511|SCY-635|scy-635
539799|NCT01265511|Ribavirin|ribavirin
539800|NCT01265511|Interferon|interferon
539801|NCT01265498|Farnesoid X Receptor|farnesoid x receptor
539802|NCT01265498|FXR|fxr
539803|NCT01265498|Nonalcoholic fatty liver disease|nonalcoholic fatty liver disease
539804|NCT01265498|Nonalcoholic steatohepatitis|nonalcoholic steatohepatitis
539805|NCT01265498|NAFLD|nafld
539806|NCT01265498|NASH|nash
539807|NCT01265498|obeticholic acid|obeticholic acid
539808|NCT01265472|Translocator Protein|translocator protein
539809|NCT01265472|Basal Cell Carcinoma|basal cell carcinoma
539810|NCT01265472|Squamous Cell Carcinoma|squamous cell carcinoma
539811|NCT01265472|Malignancy|malignancy
539812|NCT01265446|Sore throat, upper respiratory tract infection, lozenge with lidocaine and cetylpyridinium chloride.|sore throat, upper respiratory tract infection, lozenge with lidocaine and cetylpyridinium chloride.
539813|NCT01265433|GM-CSF|gm-csf
539814|NCT01265433|MONTANIDE ISA 51|montanide isa 51
539815|NCT01265433|WT1 PEPTIDE SPECIFIC T CELLS|wt1 peptide specific t cells
539816|NCT01265433|Vaccine|vaccine
539817|NCT01265433|10-134|10-134
539818|NCT01265420|Dupuytren|dupuytren
539819|NCT01265420|Dupuytren's Disease|dupuytren's disease
539820|NCT01265407|Children|children
539821|NCT01265407|Hemoglobinopathies|hemoglobinopathies
539822|NCT01265407|Epidemiology|epidemiology
539823|NCT01265407|Malaria|malaria
539824|NCT01265394|Amyloid|amyloid
539825|NCT01265394|Magnetic resonance imaging|magnetic resonance imaging
539826|NCT01265394|Positron Emission Tomography|positron emission tomography
539827|NCT01265394|Standard uptake value ratios|standard uptake value ratios
539828|NCT01265394|Healthy Subjects|healthy subjects
539829|NCT01265381|Cohort|cohort
539830|NCT01265381|Radiation|radiation
539831|NCT01265381|Thyroid Cancer|thyroid cancer
539832|NCT01265368|Advanced Renal Cell Carcinoma|advanced renal cell carcinoma
539833|NCT01265368|Tumor Vaccine|tumor vaccine
539834|NCT01265368|Cell-based Therapy|cell-based therapy
539835|NCT01265342|Bronchial Spasm|bronchial spasm
539836|NCT01265342|Respiratory Tract Infections|respiratory tract infections
539837|NCT01265342|Viral wheezing|viral wheezing
539838|NCT01265342|Child, Preschool|child, preschool
539839|NCT01265342|Beclomethasone|beclomethasone
539840|NCT01265342|Italy|italy
539841|NCT01265342|Physicians, Primary Care|physicians, primary care
539842|NCT01265342|Pediatrics|pediatrics
539843|NCT01265316|Cardiac arrest, CPR, pediatric|cardiac arrest, cpr, pediatric
539844|NCT01265303|ablation, cardiac arrhythmia, atrial fibrillation, telemonitoring, telemetry|ablation, cardiac arrhythmia, atrial fibrillation, telemonitoring, telemetry
539845|NCT01265290|Cardiac arrhythmia|cardiac arrhythmia
539846|NCT01265290|Cardiogenic syncope|cardiogenic syncope
539847|NCT01265290|Pediatrics|pediatrics
539848|NCT01265290|Children|children
539849|NCT01265277|sudden infant death syndrome|sudden infant death syndrome
539850|NCT01265277|SIDS|sids
539851|NCT01265277|infant|infant
539852|NCT01265277|licensed day care|licensed day care
539853|NCT01265277|sleep patterns|sleep patterns
539854|NCT01265277|stress levels|stress levels
539855|NCT01265264|Gout|gout
539856|NCT01265264|hyperuricemia|hyperuricemia
539857|NCT01265264|arthritis|arthritis
539858|NCT01265264|joint diseases|joint diseases
539859|NCT01265264|allopurinol|allopurinol
539860|NCT01265251|Normal Pressure Hydrocephalus|normal pressure hydrocephalus
539861|NCT01265251|Neuropsychological Test|neuropsychological test
539862|NCT01265251|Assessment of cognitive disorders/dementia|assessment of cognitive disorders/dementia
539863|NCT01265251|Neuropsychological assessment|neuropsychological assessment
539864|NCT01265238|Spastic equinovarus foot|spastic equinovarus foot
539865|NCT01265238|Stroke|stroke
539866|NCT01265238|Neurotomy|neurotomy
539867|NCT01265238|Tendon surgery|tendon surgery
539868|NCT01265225|breast cancer stages 0-II|breast cancer stages 0-ii
539869|NCT01265199|AML|aml
539870|NCT01265186|Sedation|sedation
539871|NCT01265186|BIS|bis
539872|NCT01265186|aEEG|aeeg
539873|NCT01265186|Neonatal Pain and Sedation Scale|neonatal pain and sedation scale
539874|NCT01265186|neonate|neonate
539875|NCT01265186|newborn|newborn
539876|NCT01265173|SBP|sbp
539877|NCT01265173|liver cirrhosis|liver cirrhosis
539878|NCT01265173|antibiotics|antibiotics
539879|NCT01265134|the elders|the elders
539880|NCT01265134|falling|falling
539881|NCT01265134|loss balance|loss balance
539882|NCT01265121|Acromegaly|acromegaly
539883|NCT01265121|Insulin resistance|insulin resistance
539884|NCT01265121|Euglycemic Clamp|euglycemic clamp
539885|NCT01265121|Somatostatin analogues|somatostatin analogues
539886|NCT01265095|VRE|vre
539887|NCT01265069|Helicobacter pylori|helicobacter pylori
539888|NCT01265069|concomitant therapy|concomitant therapy
539889|NCT01265069|high dose dual therapy|high dose dual therapy
539890|NCT01265069|antibiotic resistance|antibiotic resistance
539891|NCT01265043|oral health|oral health
539892|NCT01265043|oral hygiene|oral hygiene
539893|NCT01265043|bacteria|bacteria
539894|NCT01265043|quality of life|quality of life
539895|NCT01265043|Clinical oral health in patients following acute stroke|clinical oral health in patients following acute stroke
539896|NCT01265043|Oral opportunistic pathogens in patients following acute stroke|oral opportunistic pathogens in patients following acute stroke
539897|NCT01265043|Oral health-related quality of life in patients following acute stroke|oral health-related quality of life in patients following acute stroke
539898|NCT01265030|Desmoid Tumor|desmoid tumor
539899|NCT01265030|Sirolimus|sirolimus
539900|NCT01265030|Surgically-Resectable Desmoid Tumor|surgically-resectable desmoid tumor
539901|NCT01265017|type 1 diabetes|type 1 diabetes
539902|NCT01265017|pregnancy|pregnancy
539903|NCT01265017|insulin requirement|insulin requirement
539904|NCT01265004|Functional outcome|functional outcome
539905|NCT01264991|Sham|sham
539906|NCT01264991|Meniscus tear|meniscus tear
539907|NCT01264991|Meniscectomy|meniscectomy
539908|NCT01264978|COPD|copd
539909|NCT01264978|Rehabilitation|rehabilitation
539910|NCT01264978|Neuromuscular stimulation|neuromuscular stimulation
539911|NCT01264978|Quadriceps muscle|quadriceps muscle
539912|NCT01264978|Magnetic stimulation|magnetic stimulation
539913|NCT01264965|Pain|pain
539914|NCT01264965|Analgesia|analgesia
539915|NCT01264965|Cognitive impairment|cognitive impairment
539916|NCT01264965|Randomized controlled trial|randomized controlled trial
539917|NCT01264965|Physical function|physical function
539918|NCT01264952|Liver metastases of colorectal cancer|liver metastases of colorectal cancer
539919|NCT01264952|Bleomycin|bleomycin
539920|NCT01264952|Electrochemotherapy|electrochemotherapy
539921|NCT01264900|Psychotherapy|psychotherapy
539922|NCT01264900|Cognitive Behavioral Therapy|cognitive behavioral therapy
539923|NCT01264900|Aggression|aggression
539924|NCT01264900|fMRI|fmri
539925|NCT01264900|Behavioral Intervention|behavioral intervention
539926|NCT01264887|analgesia|analgesia
539927|NCT01264887|analgesics|analgesics
539928|NCT01264887|chronic pain|chronic pain
539929|NCT01264887|tumour related pain|tumour related pain
685923|NCT00688844|PKU|pku
539930|NCT01264887|chronic malignant tumor-related pain|chronic malignant tumor-related pain
539931|NCT01264861|Evaluate dopamine and serotonin activity in the brain at 3 doses of Safinamide|evaluate dopamine and serotonin activity in the brain at 3 doses of safinamide
539932|NCT01264848|multiple sclerosis|multiple sclerosis
539933|NCT01264848|venous insufficiency|venous insufficiency
539934|NCT01264822|Rabeprazole Sodium|rabeprazole sodium
539935|NCT01264822|Helicobacter pylori|helicobacter pylori
539936|NCT01264822|stomach neoplasms|stomach neoplasms
539937|NCT01264809|diabetes|diabetes
539938|NCT01264796|Korean American, type 2 diabetes, culturally tailored|korean american, type 2 diabetes, culturally tailored
539939|NCT01264770|Rheumatoid Arthritis|rheumatoid arthritis
539940|NCT01264770|OSKIRA|oskira
539941|NCT01264770|fostamatinib|fostamatinib
539942|NCT01264757|pedometer|pedometer
539943|NCT01264757|accelerometer|accelerometer
539944|NCT01264757|moderate-to-vigorous physical activity|moderate-to-vigorous physical activity
539945|NCT01264757|adult|adult
539946|NCT01264757|randomized trial|randomized trial
539947|NCT01264744|Bladder cancer|bladder cancer
539948|NCT01264744|Chromosomal aberrations|chromosomal aberrations
539949|NCT01264744|FISH|fish
539950|NCT01264744|Urine sample|urine sample
539951|NCT01264731|melanoma|melanoma
539952|NCT01264731|peptide vaccine|peptide vaccine
539953|NCT01264731|aldara|aldara
539954|NCT01264731|imiquimod|imiquimod
539955|NCT01264731|immunotherapy|immunotherapy
539956|NCT01264718|minority health|minority health
539957|NCT01264718|child|child
539958|NCT01264718|Medicaid|medicaid
539959|NCT01264705|Cirrhosis|cirrhosis
539960|NCT01264705|GI Cancer|gi cancer
539961|NCT01264705|Hepatitis|hepatitis
539962|NCT01264705|Oncology|oncology
539963|NCT01264679|Iron deficiency anemia|iron deficiency anemia
539964|NCT01264679|Feraheme|feraheme
539965|NCT01264679|ferumoxytol|ferumoxytol
539966|NCT01264679|chronic kidney disease|chronic kidney disease
539967|NCT01264679|CKD|ckd
539968|NCT01264679|pediatric|pediatric
539969|NCT01264679|dialysis-dependent|dialysis-dependent
539970|NCT01264679|nondialysis-dependent|nondialysis-dependent
539971|NCT01264666|Chinese tea flavor liquor|chinese tea flavor liquor
539972|NCT01264666|postprandial|postprandial
539973|NCT01264666|uric acid|uric acid
540073|NCT01264172|Functional outcome|functional outcome
539974|NCT01264666|high-sensitive C-reactive protein|high-sensitive c-reactive protein
539975|NCT01264653|cataract|cataract
539976|NCT01264640|Brain-derived neurotrophic factor (BDNF)|brain-derived neurotrophic factor (bdnf)
539977|NCT01264640|Platelets|platelets
539978|NCT01264640|Aspirin|aspirin
539979|NCT01264640|Clopidogrel|clopidogrel
539980|NCT01264627|Hypertension|hypertension
539981|NCT01264627|Blood pressure|blood pressure
539982|NCT01264627|Breathing|breathing
539983|NCT01264627|PetCO2|petco2
539984|NCT01264627|Stress|stress
539985|NCT01264614|exercise|exercise
539986|NCT01264614|neuropsychological|neuropsychological
539987|NCT01264614|dementia|dementia
539988|NCT01264614|Alzheimer's Disease|alzheimer's disease
539989|NCT01264614|mild cognitive impairment|mild cognitive impairment
539990|NCT01264614|strength|strength
539991|NCT01264614|MCI|mci
539992|NCT01264614|AD|ad
539993|NCT01264614|EEG|eeg
539994|NCT01264614|neurophysiological|neurophysiological
539995|NCT01264614|growth factor|growth factor
539996|NCT01264614|cognitive decline|cognitive decline
539997|NCT01264614|executive function|executive function
539998|NCT01264601|Anaphylaxis to Egg|anaphylaxis to egg
539999|NCT01264601|Severe Egg Allergy|severe egg allergy
540000|NCT01264575|spinal anesthesia|spinal anesthesia
540001|NCT01264575|intrathecal bupivacaine|intrathecal bupivacaine
540002|NCT01264575|epinephrine|epinephrine
540003|NCT01264575|ED50|ed50
540004|NCT01264575|ED95|ed95
540005|NCT01264562|chemotherapy, adjuvant|chemotherapy, adjuvant
540006|NCT01264562|adverse effects|adverse effects
540007|NCT01264562|breast neoplasms|breast neoplasms
540008|NCT01264562|cognition disorders|cognition disorders
540009|NCT01264562|Stress Disorders, post-traumatic|stress disorders, post-traumatic
540010|NCT01264562|cortisol|cortisol
540011|NCT01264549|ischemic stroke|ischemic stroke
540012|NCT01264549|stroke-associated infections|stroke-associated infections
540013|NCT01264549|biomarkers|biomarkers
540014|NCT01264549|PCT|pct
540015|NCT01264549|immune and infection parameters|immune and infection parameters
540016|NCT01264536|lactoferrin|lactoferrin
540017|NCT01264536|sepsis|sepsis
540018|NCT01264536|neonates|neonates
540019|NCT01264536|prevention|prevention
540020|NCT01264536|infections|infections
540021|NCT01264523|chrononutrition|chrononutrition
540022|NCT01264523|moderately high protein|moderately high protein
540023|NCT01264523|glycemic index|glycemic index
540024|NCT01264523|type-2 diabetes|type-2 diabetes
540025|NCT01264523|overweight|overweight
540026|NCT01264523|obesity|obesity
540027|NCT01264523|weight management|weight management
540028|NCT01264510|conductive hearing loss|conductive hearing loss
540029|NCT01264510|mixed hearing loss|mixed hearing loss
540030|NCT01264510|unilateral deafness|unilateral deafness
540031|NCT01264510|implanted with Baha|implanted with baha
540032|NCT01264510|conductive or mixed hearing loss implanted with a Baha or|conductive or mixed hearing loss implanted with a baha or
540033|NCT01264510|unilateral deafness implanted with a Baha|unilateral deafness implanted with a baha
540034|NCT01264484|Advantage|advantage
540035|NCT01264484|Non-interventional|non-interventional
540036|NCT01264484|Post market release study|post market release study
540037|NCT01264484|Germany|germany
540038|NCT01264484|Treated with Advantage prosthetic heart valve|treated with advantage prosthetic heart valve
540039|NCT01264471|Gulf War Syndrome|gulf war syndrome
540040|NCT01264471|Gulf War Illness|gulf war illness
540041|NCT01264471|Mitochondrial defects|mitochondrial defects
540042|NCT01264471|Mitochondrial disorders|mitochondrial disorders
540043|NCT01264471|Persian Gulf Syndrome|persian gulf syndrome
540044|NCT01264445|HIV|hiv
540045|NCT01264328|Head and neck cancer, panitumumab, TTCC-2009-03|head and neck cancer, panitumumab, ttcc-2009-03
540046|NCT01264315|Lenalidomide|lenalidomide
540047|NCT01264315|Tandem Autologous-Allogeneic Transplant|tandem autologous-allogeneic transplant
540048|NCT01264302|Bioequivalence|bioequivalence
540049|NCT01264302|Finasteride|finasteride
540050|NCT01264302|crossover|crossover
540051|NCT01264289|Bioequivalence|bioequivalence
540052|NCT01264289|Finasteride|finasteride
540053|NCT01264289|crossover|crossover
540054|NCT01264276|ROP|rop
540055|NCT01264276|Retinopathy of Prematurity|retinopathy of prematurity
540056|NCT01264276|Telemedicine|telemedicine
540057|NCT01264263|cIMT|cimt
540058|NCT01264263|hs CRP (C-reactive protein)|hs crp (c-reactive protein)
540059|NCT01264263|DM (Diabetic Mellitus)|dm (diabetic mellitus)
540060|NCT01264263|Korea|korea
540061|NCT01264263|Corelation between cIMT (carotid intima media thickness)|corelation between cimt (carotid intima media thickness)
540062|NCT01264263|Cardio Vascular risk in Diabetic Mellitus|cardio vascular risk in diabetic mellitus
540063|NCT01264250|Safety|safety
540064|NCT01264250|Tolerability|tolerability
540065|NCT01264250|pharmacokinetics|pharmacokinetics
540066|NCT01264250|drug metabolism|drug metabolism
540067|NCT01264237|Postherpetic neuralgia|postherpetic neuralgia
540068|NCT01264237|Neuropathic pain|neuropathic pain
540069|NCT01264237|Etoricoxib|etoricoxib
540070|NCT01264211|Efficacy of Diacerein|efficacy of diacerein
540071|NCT01264211|Safety of Diacerein|safety of diacerein
540072|NCT01264211|Carry-over effect of Diacerein|carry-over effect of diacerein
540074|NCT01264172|Microcirculation|microcirculation
540075|NCT01264172|Inflammatory response|inflammatory response
540076|NCT01264159|Developing acute heart failure|developing acute heart failure
540077|NCT01264146|hyperbaric oxygen therapy|hyperbaric oxygen therapy
540078|NCT01264146|calcaneal fracture|calcaneal fracture
540079|NCT01264146|calcaneal plating|calcaneal plating
540080|NCT01264146|wound infection|wound infection
540081|NCT01264146|microcirculation|microcirculation
540082|NCT01264120|Obesity|obesity
540083|NCT01264120|Bariatric surgery|bariatric surgery
540084|NCT01264120|Health Psychology|health psychology
540085|NCT01264081|Lapatinib|lapatinib
540086|NCT01264081|Melanoma|melanoma
540087|NCT01264081|ERBB4 Mutation|erbb4 mutation
540088|NCT01264081|Malignant Melanoma|malignant melanoma
540089|NCT01264081|Skin Cancer|skin cancer
540090|NCT01264068|Suan-Tsao-Jen-Tang ,Jia-Wey-Shiau-Yau-San,metabolomics,menopause|suan-tsao-jen-tang ,jia-wey-shiau-yau-san,metabolomics,menopause
540091|NCT01264055|Rare Diseases of Airways|rare diseases of airways
540092|NCT01264055|Chronic Cough|chronic cough
540093|NCT01264055|Nontuberculous Mycobacteriam Infection|nontuberculous mycobacteriam infection
540094|NCT01264055|Bronchiectasis|bronchiectasis
540095|NCT01264055|Idiopathic Bronchiectasis|idiopathic bronchiectasis
540096|NCT01264042|Iron Supplementation,|iron supplementation,
540097|NCT01264042|week 24 to 28 at study day|week 24 to 28 at study day
540098|NCT01264029|Well-Being|well-being
540099|NCT01264029|Tai Chi|tai chi
540100|NCT01264029|Obesity|obesity
540101|NCT01264029|Mindfulness|mindfulness
540102|NCT01264029|Meditation|meditation
540103|NCT01264029|Overweight|overweight
540104|NCT01264003|inguinal hernia, antibiotic, prophylaxis|inguinal hernia, antibiotic, prophylaxis
540105|NCT01263990|hemodynamic monitoring systems|hemodynamic monitoring systems
540106|NCT01263990|stroke volume|stroke volume
540107|NCT01263977|septic shock|septic shock
540108|NCT01263977|goal directed volume therapy|goal directed volume therapy
540109|NCT01263977|outcome|outcome
540110|NCT01263964|ischemic stroke|ischemic stroke
540111|NCT01263964|troponin elevation|troponin elevation
540112|NCT01263964|transient apical ballooning|transient apical ballooning
540113|NCT01263964|acute coronary syndrome|acute coronary syndrome
540114|NCT01263964|troponin elevation,|troponin elevation,
540115|NCT01263964|culprit lesion on coronary angiogram,|culprit lesion on coronary angiogram,
540116|NCT01263964|troponin elevation and stroke localisation (temporal lobe?)|troponin elevation and stroke localisation (temporal lobe?)
540117|NCT01263951|Differentiated metastatic thyroid cancer|differentiated metastatic thyroid cancer
540118|NCT01263938|HIV|hiv
540119|NCT01263938|monocytes|monocytes
686158|NCT00688064|Acne|acne
540120|NCT01263938|CD16+|cd16+
540121|NCT01263938|statins|statins
540122|NCT01263938|mcp1|mcp1
540123|NCT01263938|inflammation|inflammation
540124|NCT01263925|Alprostadil|alprostadil
540125|NCT01263925|Prostaglandin E1|prostaglandin e1
540126|NCT01263925|Prostavasin®|prostavasin®
540127|NCT01263925|PAOD|paod
540128|NCT01263912|Polyunsaturated fatty acids|polyunsaturated fatty acids
540129|NCT01263912|Cognitive development|cognitive development
540130|NCT01263912|Growth|growth
540131|NCT01263912|Infection|infection
540132|NCT01263899|Lymphoid malignancies|lymphoid malignancies
540133|NCT01263899|Hodgkin lymphoma|hodgkin lymphoma
540134|NCT01263899|Mantle Cell Lymphoma|mantle cell lymphoma
540135|NCT01263899|Indolent Lymphoma|indolent lymphoma
540136|NCT01263899|SB1518|sb1518
540137|NCT01263847|Dietary Supplement: Galactooligosaccharide|dietary supplement: galactooligosaccharide
540138|NCT01263834|Trabeculectomy|trabeculectomy
540139|NCT01263834|bevacizumab|bevacizumab
540140|NCT01263834|intraocular pressure|intraocular pressure
540141|NCT01263821|glioma|glioma
540142|NCT01263821|biologic imaging|biologic imaging
540143|NCT01263821|magnetic resonance spectroscopy|magnetic resonance spectroscopy
540144|NCT01263821|magnetic resonance imaging|magnetic resonance imaging
540145|NCT01263821|perfusion imaging|perfusion imaging
540146|NCT01263821|diffusion imaging|diffusion imaging
540147|NCT01263821|functional magnetic resonance imaging|functional magnetic resonance imaging
540148|NCT01263821|radiation therapy|radiation therapy
540149|NCT01263821|intensity modulated radiation therapy|intensity modulated radiation therapy
540150|NCT01263808|Indacaterol|indacaterol
540151|NCT01263808|Moxifloxacin|moxifloxacin
540152|NCT01263782|Non-Small Cell Lung Cancer|non-small cell lung cancer
540153|NCT01263782|NSCLL|nscll
540154|NCT01263782|Nonsquamous cell|nonsquamous cell
540155|NCT01263782|Metastatic disease|metastatic disease
540156|NCT01263782|Cixutumumab|cixutumumab
540157|NCT01263782|IMC-A12|imc-a12
540158|NCT01263782|Carboplatin|carboplatin
540159|NCT01263782|Paraplatin|paraplatin
540160|NCT01263782|Pemetrexed|pemetrexed
540161|NCT01263782|LY231514|ly231514
540162|NCT01263782|Alimta|alimta
540163|NCT01263782|MTA|mta
540164|NCT01263782|Multitargeted Antifolate|multitargeted antifolate
540165|NCT01263782|NSC-698037|nsc-698037
540166|NCT01263782|Bevacizumab|bevacizumab
540167|NCT01263782|Avastin|avastin
540168|NCT01263782|Anti-VEGF monoclonal antibody|anti-vegf monoclonal antibody
540169|NCT01263782|rhuMAb-VEGF|rhumab-vegf
540366|NCT01262898|phase II|phase ii
540562|NCT01262144|SUV Max|suv max
540170|NCT01263769|Locally advanced clear cell renal cell carcinoma|locally advanced clear cell renal cell carcinoma
540171|NCT01263769|AG-013736|ag-013736
540172|NCT01263769|Axitinib|axitinib
540173|NCT01263769|Radical nephrectomy|radical nephrectomy
540174|NCT01263756|Driving|driving
540175|NCT01263756|Autism Spectrum Disorders|autism spectrum disorders
540176|NCT01263756|ASD|asd
540177|NCT01263756|Attention Deficits|attention deficits
540178|NCT01263756|Adults|adults
540179|NCT01263756|Adolescents|adolescents
540180|NCT01263756|Pervasive Developmental Disorders|pervasive developmental disorders
540181|NCT01263743|Stage 1 hypertension|stage 1 hypertension
540182|NCT01263717|HIV|hiv
540183|NCT01263717|lipodystrophy|lipodystrophy
540184|NCT01263717|tesamorelin|tesamorelin
540185|NCT01263717|Egrifta|egrifta
540186|NCT01263717|growth hormone releasing hormone|growth hormone releasing hormone
540187|NCT01263691|AVA|ava
540188|NCT01263691|AV7909|av7909
540189|NCT01263691|Anthrax vaccine|anthrax vaccine
540190|NCT01263678|Decisional Conflict|decisional conflict
540191|NCT01263678|Coaching|coaching
540192|NCT01263678|Decisional Regret|decisional regret
540193|NCT01263665|stent-graft|stent-graft
540194|NCT01263665|superficial femoral artery|superficial femoral artery
540195|NCT01263665|SFA|sfa
540196|NCT01263665|peripheral artery disease|peripheral artery disease
540197|NCT01263665|PAD|pad
540198|NCT01263652|Pain|pain
540199|NCT01263652|intramuscular|intramuscular
540200|NCT01263652|oral|oral
540201|NCT01263652|spine|spine
540202|NCT01263652|preference|preference
540203|NCT01263639|patient satisfaction|patient satisfaction
540204|NCT01263639|patient-physician relationship|patient-physician relationship
540205|NCT01263639|orthopaedic trauma|orthopaedic trauma
540206|NCT01263626|Cough|cough
540207|NCT01263626|Chronic Cough|chronic cough
540208|NCT01263626|Reflux|reflux
540209|NCT01263600|Hepatitis B|hepatitis b
540211|NCT01263600|Pediatric|pediatric
540212|NCT01263587|Hepatitis B|hepatitis b
540213|NCT01263587|HBV|hbv
540214|NCT01263587|Cohort Study|cohort study
540215|NCT01263574|Catheter related infections prevention/control|catheter related infections prevention/control
540216|NCT01263574|Anti infective agents|anti infective agents
540217|NCT01263574|Catheter related infections prevention|catheter related infections prevention
540218|NCT01263561|glaucoma|glaucoma
540219|NCT01263561|filtration surgery|filtration surgery
540220|NCT01263561|trabeculectomy|trabeculectomy
540221|NCT01263561|ExPRESS shunt|express shunt
540222|NCT01263522|primary prevention|primary prevention
540223|NCT01263522|endurance|endurance
540224|NCT01263522|cardiovascular risk factors|cardiovascular risk factors
540225|NCT01263522|training|training
540226|NCT01263522|exercise|exercise
540227|NCT01263522|non-responder|non-responder
540228|NCT01263509|Diabetes Mellitus - Type 2|diabetes mellitus - type 2
540229|NCT01263509|Diabetes Mellitus|diabetes mellitus
540230|NCT01263509|Drug Therapy|drug therapy
540231|NCT01263496|Diabetes Mellitus - Type 2|diabetes mellitus - type 2
540232|NCT01263496|Diabetes Mellitus|diabetes mellitus
540233|NCT01263496|Drug Therapy|drug therapy
540234|NCT01263483|Diabetes Mellitus - Type 2|diabetes mellitus - type 2
540235|NCT01263483|Diabetes Mellitus|diabetes mellitus
540236|NCT01263483|Drug Therapy|drug therapy
540237|NCT01263470|Diabetes Mellitus - Type 2|diabetes mellitus - type 2
540238|NCT01263470|Diabetes Mellitus|diabetes mellitus
540239|NCT01263470|Drug Therapy|drug therapy
540240|NCT01263457|Growth disorders|growth disorders
540241|NCT01263457|Saizen|saizen
540242|NCT01263457|EasypodTM|easypodtm
540243|NCT01263457|Growth hormone|growth hormone
540244|NCT01263457|Pediatric subject|pediatric subject
540245|NCT01263444|AZARGA®|azarga®
540246|NCT01263444|Open angle glaucoma|open angle glaucoma
540247|NCT01263444|Prostaglandin Therapy|prostaglandin therapy
540248|NCT01263431|Hemorrhoidectomy, haemorrhoidal dearterialisation, anopexy|hemorrhoidectomy, haemorrhoidal dearterialisation, anopexy
540249|NCT01263418|Follicular Lymphoma|follicular lymphoma
540250|NCT01263418|Marginal Zone Lymphoma|marginal zone lymphoma
540251|NCT01263418|Non-Hodgkins Lymphoma|non-hodgkins lymphoma
540252|NCT01263418|Elderly|elderly
540253|NCT01263418|Newly Diagnosed|newly diagnosed
540254|NCT01263418|Lineberger Comprehensive Cancer Center|lineberger comprehensive cancer center
540255|NCT01263418|University of North Carolina|university of north carolina
540256|NCT01263418|Ofatumumab|ofatumumab
540257|NCT01263418|Arzerra|arzerra
540258|NCT01263418|Phase 2|phase 2
540259|NCT01263418|Geriatric|geriatric
540260|NCT01263418|Lymphoma|lymphoma
540261|NCT01263405|Sarcoma|sarcoma
540262|NCT01263392|Neurogenic bladder|neurogenic bladder
540263|NCT01263392|Spina bifida|spina bifida
540264|NCT01263392|Intermittent catheterization|intermittent catheterization
540265|NCT01263392|Urinary tract infections|urinary tract infections
540266|NCT01263379|gene transfer|gene transfer
540267|NCT01263366|Radiodermatitis|radiodermatitis
540268|NCT01263366|Prevention|prevention
540269|NCT01263366|Radiotherapy|radiotherapy
540270|NCT01263366|Breast|breast
540271|NCT01263366|Radiation Dermatitis|radiation dermatitis
540272|NCT01263353|Carcinoid tumor,|carcinoid tumor,
540273|NCT01263353|Gastroenteropancreatic Neuroendocrine Tumors,|gastroenteropancreatic neuroendocrine tumors,
540274|NCT01263353|Pulmonary Neuroendocrine Tumors,|pulmonary neuroendocrine tumors,
540275|NCT01263353|pasireotide LAR,|pasireotide lar,
540276|NCT01263353|SOM230 LAR,|som230 lar,
540277|NCT01263353|everolimus,|everolimus,
540278|NCT01263353|RAD001,|rad001,
540279|NCT01263353|Advanced Neuroendocrine Tumor,|advanced neuroendocrine tumor,
540280|NCT01263353|Gastroenteropancreatic System|gastroenteropancreatic system
540281|NCT01263340|COPD|copd
540282|NCT01263340|observational study|observational study
540283|NCT01263340|prevalence|prevalence
540284|NCT01263340|characterisation|characterisation
540285|NCT01263327|human papillomavirus vaccine|human papillomavirus vaccine
540286|NCT01263314|Hypertension|hypertension
540287|NCT01263301|subclavian steal|subclavian steal
540288|NCT01263301|carotid duplex|carotid duplex
540289|NCT01263301|subclavian stenosis|subclavian stenosis
540290|NCT01263301|hemodialysis with vascular access in the upper limbs|hemodialysis with vascular access in the upper limbs
540291|NCT01263301|the focus of this study is to see if duplex can be used as an tool to differentiate the different causes of subclavian steal syndromes|the focus of this study is to see if duplex can be used as an tool to differentiate the different causes of subclavian steal syndromes
540292|NCT01263275|depression|depression
540293|NCT01263275|direct current stimulation|direct current stimulation
540294|NCT01263275|alternative electrode montage|alternative electrode montage
540295|NCT01263262|Surgical site infection|surgical site infection
540296|NCT01263262|Corneal toxicity|corneal toxicity
540297|NCT01263262|Ototoxicity|ototoxicity
540298|NCT01263262|Povidone-iodine|povidone-iodine
540299|NCT01263262|Chlorhexidine-alcohol|chlorhexidine-alcohol
540300|NCT01263249|Femoral|femoral
540301|NCT01263249|Nerve Block|nerve block
540302|NCT01263249|Anterior|anterior
540303|NCT01263249|Posterior|posterior
540304|NCT01263249|Continuous Infusion|continuous infusion
540305|NCT01263249|Perineural Catheter|perineural catheter
540306|NCT01263249|Volunteer|volunteer
540307|NCT01263249|Lower Extremity Nerve Blocks|lower extremity nerve blocks
540308|NCT01263236|Depression|depression
540309|NCT01263210|Recurrent acute otitis media|recurrent acute otitis media
540310|NCT01263210|Conjugate pneumococcal vaccine|conjugate pneumococcal vaccine
540311|NCT01263210|Ventilation tube treatment|ventilation tube treatment
540312|NCT01263210|Nasopharyngeal flora|nasopharyngeal flora
540313|NCT01263184|shoulder|shoulder
540314|NCT01263184|strength|strength
540315|NCT01263184|quality of life|quality of life
540316|NCT01263171|adenocarcinoma of the rectum|adenocarcinoma of the rectum
540317|NCT01263171|stage IIIB rectal cancer|stage iiib rectal cancer
540318|NCT01263171|stage IIIC rectal cancer|stage iiic rectal cancer
540319|NCT01263158|randomised controlled trial|randomised controlled trial
540320|NCT01263158|nulliparous women|nulliparous women
540321|NCT01263158|slow labour progress|slow labour progress
540322|NCT01263158|prolonged labour|prolonged labour
540323|NCT01263158|oxytocin augmentation|oxytocin augmentation
540324|NCT01263158|operative delivery|operative delivery
540325|NCT01263158|childbirth experience|childbirth experience
540326|NCT01263132|Polyneuropathy|polyneuropathy
540327|NCT01263132|Diabetes Mellitus|diabetes mellitus
540328|NCT01263132|Diabetic peripheral neuropathy|diabetic peripheral neuropathy
540329|NCT01263080|mirtazapine|mirtazapine
540330|NCT01263080|folic acid|folic acid
540331|NCT01263080|schizophrenia|schizophrenia
540332|NCT01263067|Posttraumatic Stress Disorder|posttraumatic stress disorder
540333|NCT01263067|PTSD|ptsd
540334|NCT01263067|Car Accident|car accident
540335|NCT01263067|Auto Accident|auto accident
540336|NCT01263067|Lifespan Integration|lifespan integration
540337|NCT01263054|Back Pain|back pain
540338|NCT01263054|Low Back Pain|low back pain
540339|NCT01263054|Discogenic Back Pain|discogenic back pain
540340|NCT01263041|Glutamine, NEC, L-arginine,Preterm,Sepsis|glutamine, nec, l-arginine,preterm,sepsis
540341|NCT01263015|GSK1349572|gsk1349572
540342|NCT01263015|Abacavir/Lamivudine|abacavir/lamivudine
540343|NCT01263015|Treatment-naive|treatment-naive
540344|NCT01263015|HIV Infection|hiv infection
540345|NCT01263015|Dolutegravir|dolutegravir
540346|NCT01263015|integrase inhibitor|integrase inhibitor
540347|NCT01263015|Atripla|atripla
540348|NCT01262989|Bioequivalence|bioequivalence
540349|NCT01262989|Tamsulosin|tamsulosin
540350|NCT01262989|Healthy volunteers|healthy volunteers
540351|NCT01262989|Fast conditions|fast conditions
540352|NCT01262976|Tuberculosis vaccine|tuberculosis vaccine
540353|NCT01262963|GSK2118436|gsk2118436
540354|NCT01262963|BRAF inhibitor|braf inhibitor
540355|NCT01262963|BRAF positive tumor|braf positive tumor
540356|NCT01262963|ADME|adme
540357|NCT01262963|Oncology|oncology
540358|NCT01262937|confocal, biliary, esophagus|confocal, biliary, esophagus
540359|NCT01262924|Booster vaccination|booster vaccination
540360|NCT01262898|tolerability|tolerability
540361|NCT01262898|pharmacokinetics|pharmacokinetics
540362|NCT01262898|13 C oral breath test|13 c oral breath test
540363|NCT01262898|Type I and II Diabetes mellitus|type i and ii diabetes mellitus
540364|NCT01262898|gastroparesis|gastroparesis
540365|NCT01262898|gut motility|gut motility
540367|NCT01262898|pharmacodynamics|pharmacodynamics
540368|NCT01262898|repeat dose|repeat dose
540369|NCT01262898|gastric emptying|gastric emptying
540370|NCT01262898|symptoms|symptoms
540371|NCT01262898|GSK962040|gsk962040
540372|NCT01262885|pharmacokinetics|pharmacokinetics
540373|NCT01262885|tolerability|tolerability
540374|NCT01262885|single dose|single dose
540375|NCT01262885|antibiotics|antibiotics
540376|NCT01262885|repeat dose|repeat dose
540377|NCT01262885|GSK2251052|gsk2251052
540378|NCT01262885|safety|safety
540379|NCT01262872|Haemophilus influenzae|haemophilus influenzae
540380|NCT01262872|Streptococcus pneumoniae|streptococcus pneumoniae
540381|NCT01262872|The Gambia|the gambia
540382|NCT01262872|immunogenicity|immunogenicity
540383|NCT01262872|nasopharyngeal carriage|nasopharyngeal carriage
540384|NCT01262872|infants|infants
540385|NCT01262872|safety|safety
540386|NCT01262872|Pneumococcal vaccine|pneumococcal vaccine
540387|NCT01262872|children|children
540388|NCT01262846|HIV|hiv
540389|NCT01262846|Flu vaccination|flu vaccination
540390|NCT01262846|HIV infected individuals|hiv infected individuals
540391|NCT01262846|Fluzone SD|fluzone sd
540392|NCT01262846|Fluzone HD|fluzone hd
540393|NCT01262820|Pazopanib|pazopanib
540394|NCT01262820|Non Squamous Non Small Cell Lung Cancer|non squamous non small cell lung cancer
540395|NCT01262820|After Progress on first line therapy|after progress on first line therapy
540396|NCT01262820|Using Bevacizumab|using bevacizumab
540397|NCT01262807|fracture|fracture
540398|NCT01262807|radius|radius
540399|NCT01262807|adult|adult
540400|NCT01262807|range of motion|range of motion
540401|NCT01262794|Healthy volunteers|healthy volunteers
540402|NCT01262794|Japanese|japanese
540403|NCT01262781|neonatal adiposity|neonatal adiposity
540404|NCT01262781|metabolic syndrome|metabolic syndrome
540405|NCT01262781|fructose|fructose
540406|NCT01262781|maternal diet|maternal diet
540407|NCT01262768|Nutrition|nutrition
540408|NCT01262768|Obesity|obesity
540409|NCT01262768|Parent|parent
540410|NCT01262768|Portion Size Estimation|portion size estimation
540411|NCT01262768|Accuracy|accuracy
540412|NCT01262755|GERD|gerd
540413|NCT01262755|IBS|ibs
540414|NCT01262755|Minority|minority
540415|NCT01262742|pregnancy|pregnancy
540416|NCT01262742|postpartum hemorrhage|postpartum hemorrhage
540417|NCT01262742|Cesarean delivery|cesarean delivery
540418|NCT01262742|carbetocin|carbetocin
540419|NCT01262729|xenon inhalation|xenon inhalation
540420|NCT01262729|therapeutical hypothermia|therapeutical hypothermia
540421|NCT01262729|patients after cardiopulmonary resuscitation|patients after cardiopulmonary resuscitation
540422|NCT01262729|efficacy|efficacy
540423|NCT01262729|safety|safety
540424|NCT01262716|Chest wall progression breast cancer|chest wall progression breast cancer
540425|NCT01262716|PDT|pdt
540426|NCT01262716|Photofrin|photofrin
540427|NCT01262716|Photosensitizer|photosensitizer
540428|NCT01262690|First-in-human (FIH)|first-in-human (fih)
540429|NCT01262690|Single Ascending Dose (SAD) Study|single ascending dose (sad) study
540430|NCT01262690|TAM-163|tam-163
540431|NCT01262690|PF-05230901|pf-05230901
540432|NCT01262690|Cachexia|cachexia
540433|NCT01262677|Partial epilepsy|partial epilepsy
540434|NCT01262677|partial seizures|partial seizures
540435|NCT01262677|epilepsy|epilepsy
540436|NCT01262677|seizures|seizures
540437|NCT01262677|adjunctive therapy|adjunctive therapy
540438|NCT01262677|intervention|intervention
540439|NCT01262677|controlled-release|controlled-release
540440|NCT01262677|placebo-controlled|placebo-controlled
540441|NCT01262677|seizure|seizure
540442|NCT01262664|Advanced prostate cancer|advanced prostate cancer
540443|NCT01262664|Castrate-Resistant Prostate Cancer|castrate-resistant prostate cancer
540444|NCT01262664|Prohibitin-TP01|prohibitin-tp01
540445|NCT01262651|Cancer pain|cancer pain
540446|NCT01262651|Opioid therapy|opioid therapy
540447|NCT01262651|Inadequate analgesia|inadequate analgesia
540448|NCT01262651|Optimized chronic opioid therapy|optimized chronic opioid therapy
540449|NCT01262625|stable angina|stable angina
540450|NCT01262625|recurrent chest pain|recurrent chest pain
540451|NCT01262625|chest pain|chest pain
540452|NCT01262625|angina equivalent|angina equivalent
540453|NCT01262625|diagnosis|diagnosis
540454|NCT01262625|coronary artery disease|coronary artery disease
540455|NCT01262612|cediranib|cediranib
540456|NCT01262612|malignant ascites|malignant ascites
540457|NCT01262612|malignant pleural effusion|malignant pleural effusion
540458|NCT01262599|Breast and abdomen morbidities after TRAM flap surgery|breast and abdomen morbidities after tram flap surgery
540459|NCT01262599|TRAM flap surgery|tram flap surgery
540460|NCT01262599|Post-mastectomy breast reconstructive surgery|post-mastectomy breast reconstructive surgery
540461|NCT01262586|Type II Diabetes Mellitus|type ii diabetes mellitus
540462|NCT01262586|Vildagliptin|vildagliptin
540463|NCT01262586|Glimepiride|glimepiride
540464|NCT01262586|Continuous glucose monitoring|continuous glucose monitoring
540465|NCT01262560|pain|pain
540466|NCT01262560|dysphagia|dysphagia
540467|NCT01262560|recurrent non-small cell lung cancer|recurrent non-small cell lung cancer
540468|NCT01262560|stage IA non-small cell lung cancer|stage ia non-small cell lung cancer
540469|NCT01262560|stage IB non-small cell lung cancer|stage ib non-small cell lung cancer
540470|NCT01262560|stage IIA non-small cell lung cancer|stage iia non-small cell lung cancer
540471|NCT01262560|stage IIB non-small cell lung cancer|stage iib non-small cell lung cancer
540472|NCT01262560|stage IIIA non-small cell lung cancer|stage iiia non-small cell lung cancer
540473|NCT01262560|stage IIIB non-small cell lung cancer|stage iiib non-small cell lung cancer
540474|NCT01262560|extensive stage small cell lung cancer|extensive stage small cell lung cancer
540475|NCT01262560|limited stage small cell lung cancer|limited stage small cell lung cancer
540476|NCT01262560|recurrent small cell lung cancer|recurrent small cell lung cancer
540477|NCT01262560|esophagitis|esophagitis
540478|NCT01262534|Psoriasis|psoriasis
540479|NCT01262534|comorbidities, associated treatment, quality of life|comorbidities, associated treatment, quality of life
540480|NCT01262521|Dietary nitrate|dietary nitrate
540481|NCT01262508|autonomic nervous system|autonomic nervous system
540482|NCT01262482|adenocarcinoma|adenocarcinoma
540483|NCT01262482|gastric|gastric
540484|NCT01262482|gastroesophageal junction|gastroesophageal junction
540485|NCT01262482|Relapsed|relapsed
540486|NCT01262482|sorafenib|sorafenib
540487|NCT01262482|oxaliplatin|oxaliplatin
540488|NCT01262443|Atrial flutter|atrial flutter
540489|NCT01262430|Osteoarthritis|osteoarthritis
540490|NCT01262417|colorectal cancer|colorectal cancer
540491|NCT01262417|two stage surgery for the resection of hepatic metastases|two stage surgery for the resection of hepatic metastases
540492|NCT01262417|resorbable barrier membrane|resorbable barrier membrane
540493|NCT01262417|abdominal and peri-hepatic adhesion|abdominal and peri-hepatic adhesion
540494|NCT01262391|Overactive bladder|overactive bladder
540495|NCT01262391|Solifenacin suspension|solifenacin suspension
540496|NCT01262391|Pharmacokinetics|pharmacokinetics
540497|NCT01262391|Single-dose|single-dose
540498|NCT01262391|Pediatric|pediatric
540499|NCT01262365|Lupus|lupus
540500|NCT01262365|Monoclonal antibody|monoclonal antibody
540501|NCT01262365|B-Cell immunotherapy|b-cell immunotherapy
540502|NCT01262365|Epratuzumab|epratuzumab
540503|NCT01262339|Primary focal hyperhidrosis|primary focal hyperhidrosis
540504|NCT01262339|interdermal injections|interdermal injections
540505|NCT01262339|iontophoresis|iontophoresis
540506|NCT01262339|BTX-A|btx-a
540507|NCT01262300|Immunosenescence|immunosenescence
540508|NCT01262300|Shingles|shingles
540509|NCT01262300|Vitamin D|vitamin d
540510|NCT01262300|Varicella Zoster Virus|varicella zoster virus
540511|NCT01262300|Vaccine|vaccine
540512|NCT01262300|Immune Response|immune response
540513|NCT01262300|Geriatrics|geriatrics
540514|NCT01262287|Randomized Trial|randomized trial
540515|NCT01262287|Medication for Heavy Drinking|medication for heavy drinking
540516|NCT01262287|Dutasteride Treatment|dutasteride treatment
540517|NCT01262261|opioid dependence|opioid dependence
540518|NCT01262261|opioid addiction|opioid addiction
540519|NCT01262261|buprenorphine|buprenorphine
540520|NCT01262261|implant|implant
540521|NCT01262261|methadone|methadone
540522|NCT01262261|heroin|heroin
540523|NCT01262261|suboxone|suboxone
540524|NCT01262261|opioid pain medication|opioid pain medication
540525|NCT01262261|opioid withdrawal|opioid withdrawal
540526|NCT01262248|small colorectal polyps|small colorectal polyps
540527|NCT01262248|narrow band imaging|narrow band imaging
540528|NCT01262248|vascularization|vascularization
540529|NCT01262248|computer-based classification|computer-based classification
540530|NCT01262235|Solid tumor|solid tumor
540531|NCT01262235|Non-Hodgkin's Lymphoma|non-hodgkin's lymphoma
540532|NCT01262235|Hodgkin's Disease|hodgkin's disease
540533|NCT01262235|Neuroendocrine tumors (NET)|neuroendocrine tumors (net)
540534|NCT01262235|Adrenocortical carcinoma (ACC)|adrenocortical carcinoma (acc)
540535|NCT01262235|Carcinoid|carcinoid
540536|NCT01262222|Predictive Value For Postoperative Cardiac Events|predictive value for postoperative cardiac events
540537|NCT01262222|Endothelial Dysfunction|endothelial dysfunction
540538|NCT01262222|10-206|10-206
540539|NCT01262209|Vision loss|vision loss
540540|NCT01262209|Chronic glaucoma|chronic glaucoma
540541|NCT01262209|Low vision rehabilitation|low vision rehabilitation
540542|NCT01262196|Trauma|trauma
540543|NCT01262196|Hemorrhage|hemorrhage
540544|NCT01262196|Hemorrhagic shock|hemorrhagic shock
540545|NCT01262196|Lactic acidosis|lactic acidosis
540546|NCT01262196|Oxygen carriers|oxygen carriers
540547|NCT01262196|Oxygen therapeutics|oxygen therapeutics
540548|NCT01262196|Hemoglobin solutions|hemoglobin solutions
540549|NCT01262196|Red cell substitutes|red cell substitutes
540550|NCT01262196|PEG-hemoglobin|peg-hemoglobin
540551|NCT01262183|oesophagus cancer|oesophagus cancer
540552|NCT01262183|chemoradiotherapy|chemoradiotherapy
540553|NCT01262183|panitumumab|panitumumab
540554|NCT01262183|irresectable|irresectable
540555|NCT01262170|dietary supplement|dietary supplement
540556|NCT01262170|nutraceutical|nutraceutical
540557|NCT01262157|Erectile dysfunction|erectile dysfunction
540558|NCT01262157|PDE5 Inhibitor|pde5 inhibitor
540559|NCT01262157|Low intensity shock wave therapy.|low intensity shock wave therapy.
540560|NCT01262144|Cervical Cancer|cervical cancer
540561|NCT01262144|PET CT|pet ct
540563|NCT01262131|Fibromyalgia|fibromyalgia
540564|NCT01262131|Pain associated with Fibromyalgia|pain associated with fibromyalgia
540565|NCT01262118|Cholesterol metabolism|cholesterol metabolism
540566|NCT01262118|Cholesterol flux|cholesterol flux
540567|NCT01262118|Rheumatoid Arthritis|rheumatoid arthritis
540568|NCT01262118|Tasocitinib|tasocitinib
540569|NCT01262118|CP-690|cp-690
540570|NCT01262118|550|550
540571|NCT01262105|CFU|cfu
540572|NCT01262105|surgery site|surgery site
540573|NCT01262092|opioid dependent|opioid dependent
540574|NCT01262092|detoxification|detoxification
540575|NCT01262092|buprenorphine|buprenorphine
540576|NCT01262092|suboxone|suboxone
540577|NCT01262092|opiate|opiate
540578|NCT01262079|influenza|influenza
540579|NCT01262079|healthy volunteer|healthy volunteer
540580|NCT01262079|immunity|immunity
540581|NCT01262079|antibody|antibody
540582|NCT01262079|blood sample|blood sample
540583|NCT01262066|hypertension|hypertension
540584|NCT01262066|stress reduction|stress reduction
540585|NCT01262053|Computerized Physician Order Entry|computerized physician order entry
540586|NCT01262053|CPOE|cpoe
540587|NCT01262053|Wrong Patient|wrong patient
540588|NCT01262053|Juxtaposition|juxtaposition
540589|NCT01262053|Patient Safety|patient safety
540590|NCT01262053|Medical Errors|medical errors
540591|NCT01262040|NBI|nbi
540592|NCT01262040|ENDOMETRIUM|endometrium
540593|NCT01262040|FALLOPIAN TUBE|fallopian tube
540594|NCT01262040|OVARY|ovary
540595|NCT01262040|PERITONEUM|peritoneum
540596|NCT01262040|Surgery|surgery
540597|NCT01262040|Lung|lung
540598|NCT01262040|Pancreatic|pancreatic
540599|NCT01262040|Esophageal|esophageal
540600|NCT01262040|thorascopic|thorascopic
540601|NCT01262040|laparoscopic|laparoscopic
540602|NCT01262040|robotic|robotic
540603|NCT01262040|10-180|10-180
540604|NCT01262027|Metastatic inflammatory breast cancer|metastatic inflammatory breast cancer
540605|NCT01262027|Stage IV disease|stage iv disease
540606|NCT01262027|HER2-negative|her2-negative
540607|NCT01262027|Dovitinib|dovitinib
540608|NCT01262027|TKI258|tki258
540609|NCT01262014|platinum|platinum
540610|NCT01262014|resistant|resistant
540611|NCT01262014|advanced|advanced
540612|NCT01262014|ovarian|ovarian
540613|NCT01262014|cancer|cancer
540614|NCT01261975|Ocular Surgery|ocular surgery
540615|NCT01261975|Intraocular Lens|intraocular lens
540616|NCT01261962|Humoral immunity|humoral immunity
540617|NCT01261962|Neutrophil function|neutrophil function
540618|NCT01261962|Gene expression|gene expression
540619|NCT01261949|Tinnitus|tinnitus
540620|NCT01261949|chronic subjective tinnitus|chronic subjective tinnitus
540621|NCT01261949|transcranial magnetic stimulation|transcranial magnetic stimulation
540622|NCT01261949|sensation disorders|sensation disorders
540623|NCT01261949|hearing disorders|hearing disorders
540624|NCT01261936|Menorrhagia|menorrhagia
540625|NCT01261936|Congenital Bleeding Disorders(CBDs)|congenital bleeding disorders(cbds)
540626|NCT01261936|Diagnosis and treatment of menorrhagia in CBDs|diagnosis and treatment of menorrhagia in cbds
540627|NCT01261897|Adductor-Canal-Blockade|adductor-canal-blockade
540628|NCT01261897|postoperative pain|postoperative pain
540629|NCT01261897|US-guided nerve block|us-guided nerve block
540630|NCT01261897|total knee arthroplasty|total knee arthroplasty
540631|NCT01261884|Pregnancy|pregnancy
540632|NCT01261884|Exercise|exercise
540633|NCT01261884|Hypertension|hypertension
540634|NCT01261884|Preeclampsia|preeclampsia
540635|NCT01261884|Resistance exercise|resistance exercise
540636|NCT01261858|Sternal closure|sternal closure
540637|NCT01261858|Coronary artery bypass grafting|coronary artery bypass grafting
540638|NCT01261858|Biologic bone cement|biologic bone cement
540639|NCT01261845|Delivery of Health Care|delivery of health care
540640|NCT01261845|Equity in Health Services|equity in health services
540641|NCT01261845|Ethnic Groups|ethnic groups
540642|NCT01261845|Health Services Research|health services research
540643|NCT01261845|Health Surveys|health surveys
540644|NCT01261845|Immigration|immigration
540645|NCT01261845|Referral and Consultation|referral and consultation
540646|NCT01261845|Resource Allocation|resource allocation
540647|NCT01261845|Social Justice|social justice
540648|NCT01261845|Vulnerable Populations|vulnerable populations
540649|NCT01261832|Acute Myocardial Infarction|acute myocardial infarction
540650|NCT01261832|Percutaneous coronary intervention|percutaneous coronary intervention
540651|NCT01261819|cystoscopy, minimally invasive hysterectomy|cystoscopy, minimally invasive hysterectomy
540652|NCT01261793|Lupus|lupus
540653|NCT01261793|Monoclonal antibody|monoclonal antibody
540654|NCT01261793|B-Cell immunotherapy|b-cell immunotherapy
540655|NCT01261793|Epratuzumab|epratuzumab
540656|NCT01261780|neuropathy,paraneoplastic|neuropathy,paraneoplastic
540657|NCT01261780|paraneoplastic peripheral neuropathy|paraneoplastic peripheral neuropathy
540658|NCT01261780|pain|pain
540659|NCT01261780|hyperalgesia|hyperalgesia
540660|NCT01261754|Metastatic Prostate Adenocarcinoma|metastatic prostate adenocarcinoma
540661|NCT01261728|Gemcitabine|gemcitabine
540662|NCT01261728|Cisplatin|cisplatin
540663|NCT01261728|Bladder|bladder
540950|NCT01260350|HCV|hcv
540664|NCT01261728|radical nephroureterectomy|radical nephroureterectomy
540665|NCT01261728|ureterectomy|ureterectomy
540666|NCT01261728|10-208|10-208
540667|NCT01261702|Magnesium sulphate|magnesium sulphate
540668|NCT01261702|Post Pulmonary Resection|post pulmonary resection
540669|NCT01261702|Pain|pain
540670|NCT01261689|Epidural analgesia|epidural analgesia
540671|NCT01261689|Instrumental delivery|instrumental delivery
540672|NCT01261689|Maternal outcome|maternal outcome
540673|NCT01261689|Neonatal outcome|neonatal outcome
540674|NCT01261676|caesarean section|caesarean section
540675|NCT01261676|labour, obstetric|labour, obstetric
540676|NCT01261676|implementation guidelines|implementation guidelines
540677|NCT01261676|quality indicators|quality indicators
540678|NCT01261650|widespread chronic pain, transcranial direct current stimulation, fibromyalgia|widespread chronic pain, transcranial direct current stimulation, fibromyalgia
540679|NCT01261637|cesarean, pain, transversus abdominus plane block|cesarean, pain, transversus abdominus plane block
540680|NCT01261624|poly JIA|poly jia
540681|NCT01261598|Positron-Emission Tomography|positron-emission tomography
540682|NCT01261598|PET Scan|pet scan
540683|NCT01261598|Non-Small-Cell Lung Carcinoma|non-small-cell lung carcinoma
540684|NCT01261598|Radiation Oncology|radiation oncology
540686|NCT01261585|Positron-Emission Tomography|positron-emission tomography
540687|NCT01261585|PET Scan|pet scan
540688|NCT01261585|FDG|fdg
540689|NCT01261585|FLT|flt
540690|NCT01261585|FMISO|fmiso
540691|NCT01261585|Non-Small-Cell Lung Carcinoma|non-small-cell lung carcinoma
540692|NCT01261585|chemo-Radiation Oncology|chemo-radiation oncology
540693|NCT01261585|SUV|suv
540694|NCT01261572|Prostatic neoplasms|prostatic neoplasms
540695|NCT01261572|Degarelix|degarelix
540696|NCT01261572|ASP3550|asp3550
540697|NCT01261572|Prostate cancer|prostate cancer
540698|NCT01261559|Computed tomography|computed tomography
540699|NCT01261559|Radiation dose|radiation dose
540700|NCT01261559|Dose reduction|dose reduction
540701|NCT01261559|Breast displacement|breast displacement
540702|NCT01261559|Chrysalis device|chrysalis device
686896|NCT00685009|Memory|memory
540703|NCT01261559|Image quality|image quality
540704|NCT01261546|pleural effusion, empyema, corticoids, dexamethasone|pleural effusion, empyema, corticoids, dexamethasone
540705|NCT01261533|vitreous body substitute|vitreous body substitute
540706|NCT01261533|foldable capsular vitreous body|foldable capsular vitreous body
540707|NCT01261507|lung neoplasm nodule image processing computer-assisted|lung neoplasm nodule image processing computer-assisted
540708|NCT01261494|Diabetes Mellitus, Type 2|diabetes mellitus, type 2
540709|NCT01261494|Glucose Metabolism Disorders|glucose metabolism disorders
540710|NCT01261494|Metabolic Diseases|metabolic diseases
540711|NCT01261494|Cardiovascular Diseases|cardiovascular diseases
540712|NCT01261494|PPARs|ppars
540713|NCT01261494|OGTT|ogtt
540714|NCT01261481|Bioavailability|bioavailability
540715|NCT01261468|Chronic pain|chronic pain
540716|NCT01261468|Electric Stimulation Therapy|electric stimulation therapy
540717|NCT01261468|Neurologic Examination|neurologic examination
540718|NCT01261442|distal symmetric polyneuropathy|distal symmetric polyneuropathy
540719|NCT01261442|diabetic peripheral neuropathy|diabetic peripheral neuropathy
540720|NCT01261442|posterior tibial nerve|posterior tibial nerve
540721|NCT01261442|regional anesthesia|regional anesthesia
540722|NCT01261442|nerve conduction study|nerve conduction study
540723|NCT01261429|Pigmented villonodular synovitis|pigmented villonodular synovitis
540724|NCT01261429|tenosynovial giant cell tumour|tenosynovial giant cell tumour
540725|NCT01261429|nilotinib|nilotinib
540726|NCT01261416|seizures|seizures
540727|NCT01261416|epilepsy|epilepsy
540728|NCT01261416|neonatal|neonatal
540729|NCT01261416|levetiracetam|levetiracetam
540730|NCT01261403|Human Placenta-Derived Cells|human placenta-derived cells
540731|NCT01261390|Sleep Apnea|sleep apnea
540732|NCT01261390|Heart Disease|heart disease
540733|NCT01261390|Risk factors for heart disease|risk factors for heart disease
540734|NCT01261377|COPD, obstructive sleep apnea, OSA, BPAP, CPAP|copd, obstructive sleep apnea, osa, bpap, cpap
540735|NCT01261364|GeneSight|genesight
540736|NCT01261364|Assurex|assurex
540737|NCT01261364|AssureRx|assurerx
540738|NCT01261351|Pre eclampsia|pre eclampsia
540739|NCT01261351|Endogenous thrombin potential|endogenous thrombin potential
540740|NCT01261338|PCBs|pcbs
540741|NCT01261338|Olestra|olestra
540742|NCT01261325|Epilepsy|epilepsy
540743|NCT01261325|Brivaracetam|brivaracetam
540744|NCT01261325|Partial Onset Seizures|partial onset seizures
540745|NCT01261325|Adjunctive treatment|adjunctive treatment
540746|NCT01261312|SGI-110|sgi-110
540747|NCT01261312|DNA Hypomethylating Agent|dna hypomethylating agent
540748|NCT01261312|Intermediate 1, Intermediate 2, CMML or High Risk MDS|intermediate 1, intermediate 2, cmml or high risk mds
540750|NCT01261299|Phase 0 Clinical trial|phase 0 clinical trial
540751|NCT01261299|Human microdosing trial|human microdosing trial
540752|NCT01261299|Drug resistance, neoplasm|drug resistance, neoplasm
540753|NCT01261299|Carcinoma, Non-small cell lung|carcinoma, non-small cell lung
540754|NCT01261299|Urinary Bladder Neoplasm|urinary bladder neoplasm
540755|NCT01261299|Individualized Medicine|individualized medicine
540756|NCT01261299|Carboplatin|carboplatin
540757|NCT01261299|Carboplatin-DNA adducts|carboplatin-dna adducts
540758|NCT01261286|inflammation|inflammation
540759|NCT01261286|receptor downregulation|receptor downregulation
540760|NCT01261286|reduced response|reduced response
540761|NCT01261286|calcium channels|calcium channels
540762|NCT01261286|PK-PD relationship|pk-pd relationship
540763|NCT01261273|PCI|pci
540764|NCT01261273|observational registry|observational registry
540765|NCT01261260|uridine|uridine
540766|NCT01261260|gamma-amino butyric acid|gamma-amino butyric acid
540767|NCT01261260|Magnetic Resonance Imaging|magnetic resonance imaging
540768|NCT01261260|Magnetic Resonance Spectroscopy|magnetic resonance spectroscopy
540769|NCT01261260|Proton Echo-Planar Spectroscopic Imaging|proton echo-planar spectroscopic imaging
540770|NCT01261234|Carotid Artery Disease|carotid artery disease
540771|NCT01261234|Carotid Artery Stenting|carotid artery stenting
540772|NCT01261234|In stent restenosis|in stent restenosis
540773|NCT01261234|Cardiovascular event|cardiovascular event
540774|NCT01261234|Intima Media Thickness|intima media thickness
540775|NCT01261208|HIV, AIDS, Helicobacter pylori|hiv, aids, helicobacter pylori
540776|NCT01261182|Malnutrition|malnutrition
540777|NCT01261182|School feeding|school feeding
540778|NCT01261182|Infant nutrition|infant nutrition
540779|NCT01261182|Mother's nutrition|mother's nutrition
540780|NCT01261182|Fortified food|fortified food
540781|NCT01261182|Anemia|anemia
540782|NCT01261182|Cluster randomized controlled trials|cluster randomized controlled trials
540783|NCT01261182|Effectiveness|effectiveness
540784|NCT01261182|Impact evaluation studies|impact evaluation studies
540785|NCT01261182|Uganda|uganda
540786|NCT01261169|Mycophenolate sodium (Myfortic®)|mycophenolate sodium (myfortic®)
540787|NCT01261169|Corticosteroid-refractory autoimmune Uveitis|corticosteroid-refractory autoimmune uveitis
540788|NCT01261130|Human Hookworm Vaccine Initiative|human hookworm vaccine initiative
540789|NCT01261130|HHVI|hhvi
540790|NCT01261130|Human Hookworm|human hookworm
540791|NCT01261130|Hookworm|hookworm
540792|NCT01261130|Hookworm Disease|hookworm disease
540793|NCT01261130|N. americanus|n. americanus
540794|NCT01261130|Soil-transmitted helminth infection|soil-transmitted helminth infection
540795|NCT01261130|Intestinal blood loss|intestinal blood loss
540796|NCT01261130|Iron deficiency anemia|iron deficiency anemia
540797|NCT01261117|Patent ductus arteriosis|patent ductus arteriosis
540798|NCT01261117|İbuprofen|ibuprofen
540799|NCT01261117|Extremely Low Birth Weigh infant|extremely low birth weigh infant
540800|NCT01261104|hearing loss|hearing loss
540801|NCT01261104|handicap|handicap
540802|NCT01261104|counseling|counseling
540803|NCT01261091|Neurocritical Care|neurocritical care
540804|NCT01261091|Ischemic Stroke|ischemic stroke
540805|NCT01261091|Intracerebral Hemorrhage|intracerebral hemorrhage
540806|NCT01261091|Subarachnoid Hemorrhage|subarachnoid hemorrhage
540807|NCT01261091|Tracheostomy|tracheostomy
540808|NCT01261091|Tracheotomy|tracheotomy
540809|NCT01261091|Percutaneous Dilatative Tracheostomy|percutaneous dilatative tracheostomy
540810|NCT01261091|Weaning|weaning
540811|NCT01261091|Ventilation|ventilation
540812|NCT01261078|intrathecal epinephrine|intrathecal epinephrine
540813|NCT01261078|duration of anesthesia|duration of anesthesia
540814|NCT01261078|quality of anesthesia|quality of anesthesia
540815|NCT01261078|intrathecal fentanyl|intrathecal fentanyl
540816|NCT01261065|beta blockers|beta blockers
540817|NCT01261065|heart failure|heart failure
540818|NCT01261065|contractility|contractility
540819|NCT01261065|remodeling|remodeling
540820|NCT01261052|glucose sensors|glucose sensors
540821|NCT01261052|artificial pancreas|artificial pancreas
540822|NCT01261052|Diabetes Mellitus|diabetes mellitus
540823|NCT01261013|Keratoconus|keratoconus
540824|NCT01261013|intrastromal corneal ring segment|intrastromal corneal ring segment
540825|NCT01261013|To evaluate the visual and refractive outcomes of intrastromal corneal ring segment in keratoconic eyes at different stages|to evaluate the visual and refractive outcomes of intrastromal corneal ring segment in keratoconic eyes at different stages
540826|NCT01261000|Acromegaly|acromegaly
540827|NCT01260987|Moderate to severe actinic keratoses|moderate to severe actinic keratoses
540828|NCT01260987|Difficult to treat nodular basal cell carcinomas|difficult to treat nodular basal cell carcinomas
540829|NCT01260974|Invasive fungal infections|invasive fungal infections
540830|NCT01260974|Liver Transplantation|liver transplantation
540831|NCT01260974|Organ Transplantation|organ transplantation
540832|NCT01260974|Mycoses|mycoses
540833|NCT01260974|Fungus Diseases|fungus diseases
540834|NCT01260974|Antifungal Agents|antifungal agents
540835|NCT01260974|Invasive Mycosis|invasive mycosis
540836|NCT01260948|Bioequivalence|bioequivalence
540837|NCT01260948|Healthy Subjects|healthy subjects
540838|NCT01260935|GERD|gerd
540839|NCT01260935|laparoscopic surgery|laparoscopic surgery
540840|NCT01260935|gastroesophageal|gastroesophageal
540841|NCT01260935|reflux|reflux
540842|NCT01260922|Bioequivalence|bioequivalence
540843|NCT01260922|Healthy Subjects|healthy subjects
540844|NCT01260896|Bioequivalence|bioequivalence
540845|NCT01260896|Healthy Subjects|healthy subjects
540846|NCT01260883|ketorolac pharmacokinetics|ketorolac pharmacokinetics
540847|NCT01260883|ketorolac stereo-isomers|ketorolac stereo-isomers
540848|NCT01260883|infants|infants
540849|NCT01260883|postoperative analgesia|postoperative analgesia
540850|NCT01260883|safety|safety
540851|NCT01260857|Spirinolactone|spirinolactone
540852|NCT01260857|Hydroflumethiazide|hydroflumethiazide
540853|NCT01260857|Hypertension|hypertension
540854|NCT01260857|Filipinos|filipinos
540855|NCT01260857|Diabetes mellitus|diabetes mellitus
540856|NCT01260857|Proteinuria|proteinuria
540857|NCT01260831|BedsidePEWS|bedsidepews
540858|NCT01260831|Intensive Care|intensive care
540859|NCT01260818|Tranexamic Acid|tranexamic acid
540860|NCT01260805|bioequivalence|bioequivalence
540861|NCT01260805|study|study
540862|NCT01260805|ethinylestradiol|ethinylestradiol
540863|NCT01260805|gestodene|gestodene
540864|NCT01260740|Traumatic Brain Injury|traumatic brain injury
540865|NCT01260740|Explicit Learning|explicit learning
540866|NCT01260740|Primary Motor Cortex|primary motor cortex
540867|NCT01260740|Dorsolateral Prefrontal Cortex|dorsolateral prefrontal cortex
540868|NCT01260740|Implicit Learning|implicit learning
540869|NCT01260740|Healthy Volunteer|healthy volunteer
540870|NCT01260740|HV|hv
540871|NCT01260727|HIV Preventive Vaccine|hiv preventive vaccine
540872|NCT01260675|phase 1 study|phase 1 study
540873|NCT01260675|volunteers|volunteers
540874|NCT01260662|Deep Procedural Sedation|deep procedural sedation
540875|NCT01260662|Propofol|propofol
540876|NCT01260662|Ketamine|ketamine
540877|NCT01260662|Emergency Department|emergency department
540878|NCT01260662|Monitoring|monitoring
540879|NCT01260662|Capnography|capnography
540880|NCT01260662|Procedural Sedation in the Emergency Department|procedural sedation in the emergency department
540881|NCT01260649|Electroconvulsive treatment|electroconvulsive treatment
540882|NCT01260649|ketamine|ketamine
540883|NCT01260649|Major Depression|major depression
540884|NCT01260649|Treatment-resistant Major Depressive Disorder|treatment-resistant major depressive disorder
687164|NCT00683839|NRT|nrt
540885|NCT01260623|asthma|asthma
540886|NCT01260623|pharmacokinetics|pharmacokinetics
540887|NCT01260623|prednisone|prednisone
540888|NCT01260623|prednisolone|prednisolone
540889|NCT01260623|asthma exacerbation|asthma exacerbation
540890|NCT01260623|pharmacokinetic profile|pharmacokinetic profile
540891|NCT01260610|Hepatitis B, Tenofovir, Telbivudine|hepatitis b, tenofovir, telbivudine
540892|NCT01260597|smoking|smoking
540893|NCT01260597|quit line re-enrollment and IVR systems|quit line re-enrollment and ivr systems
540894|NCT01260584|thienopyridine|thienopyridine
540895|NCT01260584|antiplatelet|antiplatelet
540896|NCT01260584|prasugrel|prasugrel
540897|NCT01260584|clopidogrel|clopidogrel
540898|NCT01260571|blackheads and pimples|blackheads and pimples
540899|NCT01260571|Acne vulgaris grade II|acne vulgaris grade ii
540900|NCT01260532|Autoimmune thyroid disease|autoimmune thyroid disease
540901|NCT01260506|Relapsed Glioblastoma Multiforme, GBM|relapsed glioblastoma multiforme, gbm
540902|NCT01260493|very frail|very frail
540903|NCT01260493|case manager|case manager
540904|NCT01260493|integrated care|integrated care
540905|NCT01260493|multiprofessional|multiprofessional
540906|NCT01260493|intervention|intervention
540907|NCT01260480|Carcinoma, non-small-cell lung|carcinoma, non-small-cell lung
540908|NCT01260480|Head and neck neoplasms|head and neck neoplasms
540909|NCT01260480|Diagnostic imaging|diagnostic imaging
540910|NCT01260467|recurrent|recurrent
540911|NCT01260454|Qutenza|qutenza
540912|NCT01260454|Capsaicin|capsaicin
540913|NCT01260454|Remodulin|remodulin
540914|NCT01260454|Treprostinil|treprostinil
540915|NCT01260428|hypoxia|hypoxia
540916|NCT01260428|O2 diffusion and convection|o2 diffusion and convection
540917|NCT01260428|cardiac output|cardiac output
540918|NCT01260428|PEEP|peep
540919|NCT01260428|Effects of hypoxia|effects of hypoxia
540920|NCT01260415|colorectal cancer|colorectal cancer
540921|NCT01260415|liver metastases|liver metastases
540922|NCT01260415|panitumumab|panitumumab
540923|NCT01260415|FOLFOX|folfox
540924|NCT01260415|Colorectal cancer with liver metastases|colorectal cancer with liver metastases
540925|NCT01260402|heart failure|heart failure
540926|NCT01260402|Cardiomyopathy, dilated|cardiomyopathy, dilated
540927|NCT01260402|Coronary disease|coronary disease
540928|NCT01260402|Cardiac Pacing, Artificial|cardiac pacing, artificial
540929|NCT01260402|cardiac resynchronization therapy|cardiac resynchronization therapy
540930|NCT01260402|Hemodynamics|hemodynamics
540931|NCT01260402|Randomized Controlled Trials|randomized controlled trials
540932|NCT01260402|Open Study|open study
540933|NCT01260389|Chronic Obstructive Pulmonary Disease|chronic obstructive pulmonary disease
540934|NCT01260389|COPD|copd
540935|NCT01260376|VLDL-TG|vldl-tg
540936|NCT01260376|Metabolism|metabolism
540937|NCT01260376|Exercise|exercise
540938|NCT01260376|Free Fatty Acids|free fatty acids
540939|NCT01260350|PSI-7977|psi-7977
540940|NCT01260350|Sofosbuvir|sofosbuvir
540941|NCT01260350|GS-7977|gs-7977
540942|NCT01260350|GS-5885|gs-5885
540943|NCT01260350|GS-9669|gs-9669
540944|NCT01260350|FDC|fdc
540945|NCT01260350|ribavirin|ribavirin
540946|NCT01260350|RBV|rbv
540947|NCT01260350|Pegylated Interferon|pegylated interferon
540948|NCT01260350|PEG-IFN|peg-ifn
540949|NCT01260350|Chronic Hepatitis C Infection|chronic hepatitis c infection
540951|NCT01260350|Hepatitis|hepatitis
540952|NCT01260350|Genotype 1|genotype 1
540953|NCT01260350|Genotype 2|genotype 2
540954|NCT01260350|Genotype 3|genotype 3
540955|NCT01260350|GT 1|gt 1
540956|NCT01260350|GT 2|gt 2
540957|NCT01260350|GT 3|gt 3
540958|NCT01260350|Hemophilia|hemophilia
540959|NCT01260337|Weight loss|weight loss
540960|NCT01260337|Type 2 Diabetes|type 2 diabetes
540961|NCT01260337|Behavior Modification|behavior modification
540962|NCT01260337|portion control|portion control
540963|NCT01260324|Phosphodiesterase type 5 inhibitors|phosphodiesterase type 5 inhibitors
540964|NCT01260324|non-arteritic anterior ischemic optic neuropathy|non-arteritic anterior ischemic optic neuropathy
540965|NCT01260324|descriptive epidemiology study|descriptive epidemiology study
540966|NCT01260311|Observational|observational
540967|NCT01260298|MC1 VASER VASERShape|mc1 vaser vasershape
540968|NCT01260272|Cardiovascular|cardiovascular
540969|NCT01260272|Risk Factors|risk factors
540970|NCT01260272|Cardiovascular Disease|cardiovascular disease
540971|NCT01260272|Glucose|glucose
540972|NCT01260272|Blood Pressure|blood pressure
540973|NCT01260272|BMI|bmi
540974|NCT01260272|Weight|weight
540975|NCT01260272|Waist Circumference|waist circumference
540976|NCT01260259|Pediatric|pediatric
540977|NCT01260259|Cardiac|cardiac
540978|NCT01260259|Surgery|surgery
540979|NCT01260259|Cardiopulmonary|cardiopulmonary
540980|NCT01260259|Bypass|bypass
540981|NCT01260259|Myocardial|myocardial
540982|NCT01260259|Kidney|kidney
540983|NCT01260259|Lung|lung
540984|NCT01260259|Injury|injury
540985|NCT01260233|smoking cessation|smoking cessation
540986|NCT01260233|complications|complications
540987|NCT01260233|cigarettes|cigarettes
540988|NCT01260233|preoperative|preoperative
540989|NCT01260233|perioperative|perioperative
540990|NCT01260233|surgery|surgery
540991|NCT01260233|education|education
540992|NCT01260233|nicotine replacement therapy|nicotine replacement therapy
540993|NCT01260207|Acute Coronary Syndrome|acute coronary syndrome
540994|NCT01260207|Interactive Voice Response Technology|interactive voice response technology
540995|NCT01260207|Best Practice Guidelines|best practice guidelines
540996|NCT01260207|Compliance|compliance
540997|NCT01260207|Health Care Utilization|health care utilization
540998|NCT01260168|Cancer|cancer
540999|NCT01260168|Colorectal Cancer|colorectal cancer
541000|NCT01260168|Neoplasm|neoplasm
541001|NCT01260168|Colorectal Neoplasm|colorectal neoplasm
541002|NCT01260168|Intestinal Neoplasms|intestinal neoplasms
541003|NCT01260168|Gastrointestinal Neoplasms|gastrointestinal neoplasms
541004|NCT01260168|Digestive System Neoplasms|digestive system neoplasms
541005|NCT01260168|Neoplasms by Site|neoplasms by site
541006|NCT01260168|Neoplasms|neoplasms
541007|NCT01260168|Digestive System Diseases|digestive system diseases
541008|NCT01260168|Gastrointestinal Diseases|gastrointestinal diseases
541009|NCT01260168|Colonic Diseases|colonic diseases
541010|NCT01260168|Intestinal Diseases|intestinal diseases
541011|NCT01260168|Rectal Diseases|rectal diseases
541012|NCT01260129|BPH|bph
541013|NCT01260129|silodosin|silodosin
541014|NCT01260116|Efficacy,safety,ziprasidone,depressive symptoms ,schizophrenia|efficacy,safety,ziprasidone,depressive symptoms ,schizophrenia
541015|NCT01260103|Optic pathway glioma, recurrent|optic pathway glioma, recurrent
541016|NCT01260103|Optic pathway glioma, progressive|optic pathway glioma, progressive
541017|NCT01260103|Temozolomide|temozolomide
541018|NCT01260103|Temodar|temodar
541019|NCT01260103|TMZ|tmz
541020|NCT01260103|Antineoplastons|antineoplastons
541021|NCT01260103|ANP therapy|anp therapy
541022|NCT01260103|Atengenal (A10)|atengenal (a10)
541023|NCT01260103|Astugenal (AS2-1)|astugenal (as2-1)
541024|NCT01260090|Minimally conscious states|minimally conscious states
541025|NCT01260090|Persistently vegetative states|persistently vegetative states
541026|NCT01260090|Traumatic brain injury|traumatic brain injury
541027|NCT01260064|Appendicitis|appendicitis
541028|NCT01260064|Open appendectomy|open appendectomy
541029|NCT01260064|Laparoscopic appendectomy|laparoscopic appendectomy
541030|NCT01260064|Endoclip|endoclip
541031|NCT01260064|Intracorporeal suture|intracorporeal suture
541032|NCT01260064|Quality-of-life|quality-of-life
541033|NCT01260038|Non Small Cell Lung Cancer|non small cell lung cancer
541034|NCT01260038|observational study|observational study
541035|NCT01260038|EGFR mutation analysis|egfr mutation analysis
541036|NCT01260038|EGFR mutation status|egfr mutation status
541037|NCT01260038|testing turn around time|testing turn around time
541038|NCT01260025|Tolerability|tolerability
541039|NCT01260025|Pharmacokinetics|pharmacokinetics
541040|NCT01260025|Endostatin|endostatin
541041|NCT01260025|antiangiogenesis|antiangiogenesis
541042|NCT01260025|cancer|cancer
541043|NCT01260012|Schistosoma mansoni|schistosoma mansoni
541044|NCT01260012|Schistosomiasis|schistosomiasis
541045|NCT01260012|periportal fibrosis|periportal fibrosis
541046|NCT01260012|antioxidant|antioxidant
541047|NCT01260012|fibrosis reversal|fibrosis reversal
541048|NCT01259999|malnutrition|malnutrition
541049|NCT01259999|oleic-acid|oleic-acid
541050|NCT01259999|micronutrient supplement|micronutrient supplement
541051|NCT01259999|old peoples home|old peoples home
541052|NCT01259986|Vitiligo|vitiligo
541053|NCT01259986|Laser|laser
541054|NCT01259986|Segmental vitiligo|segmental vitiligo
541055|NCT01259986|Acral vitiligo|acral vitiligo
541056|NCT01259973|Pharmacogenetics|pharmacogenetics
541057|NCT01259973|Antipsychotics|antipsychotics
541058|NCT01259973|Extrapyramidal Symptoms|extrapyramidal symptoms
541059|NCT01259947|headache|headache
541060|NCT01259947|migraine|migraine
541061|NCT01259947|medicinal plant|medicinal plant
541062|NCT01259947|essential oil|essential oil
541063|NCT01259947|phytotherapy|phytotherapy
541064|NCT01259934|Randomized Phase III trial|randomized phase iii trial
541065|NCT01259934|Adjuvant therapy|adjuvant therapy
541066|NCT01259934|Interferon|interferon
541067|NCT01259934|Melanoma|melanoma
541068|NCT01259921|EEG biofeedback|eeg biofeedback
541069|NCT01259921|neurofeedback|neurofeedback
541070|NCT01259921|PTSD|ptsd
541071|NCT01259921|Affect Regulation|affect regulation
541072|NCT01259921|Chronic Trauma|chronic trauma
541073|NCT01259908|laparoscopic aortic surgery|laparoscopic aortic surgery
541074|NCT01259908|aorto-iliac occlusive disease|aorto-iliac occlusive disease
541075|NCT01259882|Pharmacokinetics Safety Tolerability Pharmacodynamics|pharmacokinetics safety tolerability pharmacodynamics
541076|NCT01259856|Polycythemia vera|polycythemia vera
541077|NCT01259856|Essential thrombocythemia|essential thrombocythemia
541078|NCT01259856|Hydroxyurea|hydroxyurea
541079|NCT01259856|PEGASYS|pegasys
541080|NCT01259856|Pegylated Interferon Alfa-2a|pegylated interferon alfa-2a
541081|NCT01259843|Acute aortic syndrome|acute aortic syndrome
541082|NCT01259830|fast-track|fast-track
541083|NCT01259830|colon or rectal surgery|colon or rectal surgery
541084|NCT01259830|pain relief|pain relief
541085|NCT01259817|Polycythemia Vera|polycythemia vera
541086|NCT01259817|Essential Thrombocythemia|essential thrombocythemia
541087|NCT01259817|Hydroxyurea Resistant|hydroxyurea resistant
541088|NCT01259817|Abdominal Vein Thrombosis|abdominal vein thrombosis
541089|NCT01259817|PEGASYS|pegasys
541090|NCT01259804|peanut|peanut
541091|NCT01259804|food allergy|food allergy
541092|NCT01259804|anaphylaxis|anaphylaxis
541093|NCT01259804|immunotherapy|immunotherapy
541094|NCT01259778|Growth disorders|growth disorders
541095|NCT01259778|Saizen|saizen
541096|NCT01259778|easypod™|easypod™
541097|NCT01259778|Growth hormone|growth hormone
541098|NCT01259778|Pediatric subject|pediatric subject
541099|NCT01259765|llama antibody|llama antibody
541100|NCT01259765|rotavirus diarrhoea|rotavirus diarrhoea
541101|NCT01259765|children|children
541102|NCT01259752|Trauma|trauma
541103|NCT01259752|ankle sprain|ankle sprain
541104|NCT01259752|emergency|emergency
541105|NCT01259752|compression stocking|compression stocking
541106|NCT01259739|trained cyclists|trained cyclists
541107|NCT01259739|no medications|no medications
541108|NCT01259739|no diseases|no diseases
541109|NCT01259739|non-smokers|non-smokers
541110|NCT01259726|Diarrhea|diarrhea
541111|NCT01259726|Clostridium difficile|clostridium difficile
541112|NCT01259726|Clostridium infections|clostridium infections
541113|NCT01259726|Signs and Symptoms Digestive|signs and symptoms digestive
541114|NCT01259726|Bacterial Infections|bacterial infections
541115|NCT01259726|Pharmacologic Actions|pharmacologic actions
541116|NCT01259713|Ambisome|ambisome
541117|NCT01259713|ALL|all
541118|NCT01259713|invasive fungal infection|invasive fungal infection
541119|NCT01259713|prophylaxis|prophylaxis
541120|NCT01259713|liposomal amphotericin B|liposomal amphotericin b
541121|NCT01259713|Invasive fungal infection prophylaxis|invasive fungal infection prophylaxis
541122|NCT01259700|High blood pressure|high blood pressure
541123|NCT01259700|Primary care|primary care
541124|NCT01259700|Cardiovascular disease prevention|cardiovascular disease prevention
541125|NCT01259700|Salt reduction|salt reduction
541126|NCT01259687|Electrocardiogram|electrocardiogram
541127|NCT01259687|Arterial line waveform|arterial line waveform
541128|NCT01259687|Cardiac output|cardiac output
541129|NCT01259674|Pediatric|pediatric
541130|NCT01259674|children|children
541131|NCT01259674|acute cough|acute cough
541132|NCT01259674|treatment|treatment
541133|NCT01259674|syrup|syrup
541134|NCT01259674|protective natural extracts|protective natural extracts
541135|NCT01259661|physical activity|physical activity
541136|NCT01259661|metabolic syndrome|metabolic syndrome
541137|NCT01259661|postmenopausal women|postmenopausal women
541138|NCT01259661|exercise training|exercise training
541139|NCT01259648|remifentanil|remifentanil
541140|NCT01259648|anesthesia induction|anesthesia induction
541141|NCT01259648|reactional tachycardia|reactional tachycardia
541142|NCT01259635|Parkinson's disease|parkinson's disease
541143|NCT01259635|freezing of gait|freezing of gait
541144|NCT01259609|Diabetic Macular Edema|diabetic macular edema
541145|NCT01259609|Ciliary Body|ciliary body
541146|NCT01259609|Ultrasound Biomicroscopy|ultrasound biomicroscopy
541147|NCT01259609|Vitrectomy|vitrectomy
541148|NCT01259596|anxiety|anxiety
541149|NCT01259596|rural|rural
541150|NCT01259596|elderly|elderly
541151|NCT01259544|CP-Chronic Pancreatitis|cp-chronic pancreatitis
542143|NCT01255007|MDCT|mdct
541152|NCT01259544|DPT-Di peptide breath test|dpt-di peptide breath test
541153|NCT01259544|ePFT- Endoscopic pancreatic function test|epft- endoscopic pancreatic function test
541154|NCT01259531|strong|strong
541155|NCT01259531|silodosin|silodosin
541156|NCT01259531|benign prostatic hyperplasia|benign prostatic hyperplasia
541157|NCT01259531|BPH|bph
541158|NCT01259531|lower urinary tract symptoms associated with severe BPH|lower urinary tract symptoms associated with severe bph
541159|NCT01259505|no number|no number
541160|NCT01259492|Attention Deficit /Hyperactivity Disorder, hyperactivity|attention deficit /hyperactivity disorder, hyperactivity
541161|NCT01259479|Solid Tumors|solid tumors
541162|NCT01259479|Maximum Tolerated Dose|maximum tolerated dose
541163|NCT01259479|Parmacokinetics|parmacokinetics
541164|NCT01259479|Pharmacogenomics|pharmacogenomics
541165|NCT01259479|Satraplatin|satraplatin
541166|NCT01259479|Cancer|cancer
541167|NCT01259479|Solid Tumor|solid tumor
541168|NCT01259479|Brain Tumor|brain tumor
541169|NCT01259466|Smoking cessation|smoking cessation
541170|NCT01259466|Overweight|overweight
541171|NCT01259466|Obesity|obesity
541172|NCT01259466|Internet treatment|internet treatment
541173|NCT01259453|Hepatitis B vaccination|hepatitis b vaccination
541174|NCT01259453|Syringe exchange programs|syringe exchange programs
541175|NCT01259453|Injection drug users|injection drug users
541176|NCT01259453|Hepatitis B prevention through vaccination|hepatitis b prevention through vaccination
541177|NCT01259440|Telemedicine|telemedicine
541178|NCT01259440|continuous positive airway pressure|continuous positive airway pressure
541179|NCT01259440|treatment adherence|treatment adherence
541180|NCT01259427|Mental Disorders|mental disorders
541181|NCT01259427|Psychotic Disorders|psychotic disorders
541182|NCT01259427|Schizophrenia|schizophrenia
541183|NCT01259427|Stigmatization|stigmatization
541184|NCT01259427|Mood Disorders|mood disorders
541185|NCT01259427|Schizophrenia and Disorders with Psychotic Feature|schizophrenia and disorders with psychotic feature
541186|NCT01259414|Carcinoma,Hepatocellular|carcinoma,hepatocellular
541187|NCT01259414|Liver Neoplasms|liver neoplasms
541188|NCT01259414|Survival analysis|survival analysis
541189|NCT01259414|treatment outcome|treatment outcome
541190|NCT01259414|administration drugs|administration drugs
541191|NCT01259414|Chemoembolization,|chemoembolization,
541192|NCT01259414|TACE|tace
541193|NCT01259414|polyvinyl alcohol|polyvinyl alcohol
541194|NCT01259414|water-soluble contrast mesium|water-soluble contrast mesium
541195|NCT01259414|iopamidol|iopamidol
541196|NCT01259414|lipiodol|lipiodol
541197|NCT01259414|distilled water|distilled water
541198|NCT01259401|Sleep|sleep
541199|NCT01259401|Rehabilitation|rehabilitation
541200|NCT01259401|Behavior therapy|behavior therapy
541201|NCT01259401|Insomnia|insomnia
541202|NCT01259388|Multiple sclerosis|multiple sclerosis
541203|NCT01259388|Lithium|lithium
541204|NCT01259349|cataract,|cataract,
541205|NCT01259349|phacoemulsification,|phacoemulsification,
541206|NCT01259349|one percent ultrasound|one percent ultrasound
541207|NCT01259349|endothelial cell density|endothelial cell density
541208|NCT01259336|Itraconazole|itraconazole
541209|NCT01259336|chronic cavitary pulmonary aspergillosis|chronic cavitary pulmonary aspergillosis
541210|NCT01259336|Aspergillosis|aspergillosis
541211|NCT01259336|fungal ball|fungal ball
541212|NCT01259336|mycetoma|mycetoma
541213|NCT01259336|efficacy|efficacy
541214|NCT01259336|safety|safety
541215|NCT01259310|fertility|fertility
541216|NCT01259310|women|women
541217|NCT01259310|epilepsy|epilepsy
541218|NCT01259310|pregnancy|pregnancy
541219|NCT01259310|seizures|seizures
541220|NCT01259310|seizure frequency|seizure frequency
541221|NCT01259310|ovulation|ovulation
541222|NCT01259310|menstruation|menstruation
541223|NCT01259310|hormones|hormones
541224|NCT01259310|progesterone|progesterone
541225|NCT01259297|Aliskiren|aliskiren
541226|NCT01259297|Elderly|elderly
541227|NCT01259297|Major Cardiovascular Events|major cardiovascular events
541228|NCT01259297|Effect of aliskiren-based regimen on major CV events (composite of CV death, non-fatal MI, non-fatal stroke and significant heart failure) in the elderly|effect of aliskiren-based regimen on major cv events (composite of cv death, non-fatal mi, non-fatal stroke and significant heart failure) in the elderly
541229|NCT01259284|Breast cancer|breast cancer
541230|NCT01259284|Colorectal cancer|colorectal cancer
541231|NCT01259284|Genitourinary cancer|genitourinary cancer
541232|NCT01259284|Head and neck cancers|head and neck cancers
541233|NCT01259284|Lung cancer|lung cancer
541234|NCT01259284|Melanoma|melanoma
541235|NCT01259284|Sarcoma|sarcoma
541236|NCT01259284|Atorvastatin|atorvastatin
541237|NCT01259284|Lipitor|lipitor
541238|NCT01259284|Fish Oil supplement|fish oil supplement
541239|NCT01259284|Placebo|placebo
541240|NCT01259271|human|human
541241|NCT01259271|nerve|nerve
541242|NCT01259271|modulation|modulation
541243|NCT01259271|Healthy human|healthy human
541244|NCT01259271|sNCT|snct
541245|NCT01259271|stimulation|stimulation
541246|NCT01259258|varicocele, methylene blue, varicocelectomy, hydrocele,|varicocele, methylene blue, varicocelectomy, hydrocele,
541247|NCT01259245|Chronic obstructive pulmonary disease COPD|chronic obstructive pulmonary disease copd
541248|NCT01259245|pulmonary rehabilitation program PRP|pulmonary rehabilitation program prp
541250|NCT01259219|HIV|hiv
541251|NCT01259219|Completion of TB treamtment|completion of tb treamtment
541252|NCT01259206|Calcaneal Spur, Diabetic Obese Patients|calcaneal spur, diabetic obese patients
541253|NCT01259193|Hepatocellular Carcinoma|hepatocellular carcinoma
541254|NCT01259193|Sorafenib|sorafenib
541255|NCT01259193|Zoledronic Acid|zoledronic acid
541256|NCT01259193|toxic reaction|toxic reaction
541257|NCT01259180|acupuncture|acupuncture
541258|NCT01259167|JOBA, Low Back Pain, Physical Exercise|joba, low back pain, physical exercise
541259|NCT01259141|macrolide- resistant Mycoplasma pneumoniae,|macrolide- resistant mycoplasma pneumoniae,
541260|NCT01259141|Mycoplasm pneumonia antibiotic therapy|mycoplasm pneumonia antibiotic therapy
541261|NCT01259115|Healthy subjects|healthy subjects
541262|NCT01259115|Opioid|opioid
541263|NCT01259115|Transdermal|transdermal
541264|NCT01259102|Healthy subjects|healthy subjects
541265|NCT01259102|Opioid|opioid
541266|NCT01259102|Transdermal|transdermal
541267|NCT01259089|Adenocarcinoma of the Lung|adenocarcinoma of the lung
541268|NCT01259089|Non-small Cell Lung Cancer|non-small cell lung cancer
541269|NCT01259063|GEMCITABINE|gemcitabine
541270|NCT01259063|RAD001(EVEROLIMUS)|rad001(everolimus)
541271|NCT01259063|urinary|urinary
541272|NCT01259063|BCG-Refractory|bcg-refractory
541273|NCT01259063|Intravesical|intravesical
541274|NCT01259063|10-165|10-165
541275|NCT01259050|ALS treatment|als treatment
541276|NCT01259050|Zinc|zinc
687632|NCT00682058|fat|fat
541277|NCT01259050|Copper|copper
541278|NCT01259050|BMAA|bmaa
541279|NCT01259050|ALS|als
541280|NCT01259037|Elastography|elastography
541281|NCT01259037|Cutaneous|cutaneous
541282|NCT01259037|Imaging|imaging
541283|NCT01259024|hepatocellular carcinoma|hepatocellular carcinoma
541284|NCT01259024|chemoembolization|chemoembolization
541285|NCT01259024|transarterial chemoembolization|transarterial chemoembolization
541286|NCT01259024|liver cancer|liver cancer
541287|NCT01259024|doxorubicin|doxorubicin
541288|NCT01259024|drug-eluting beads|drug-eluting beads
541289|NCT01259024|LC Bead|lc bead
541290|NCT01259011|end stage renal disease|end stage renal disease
541291|NCT01259011|dialysis|dialysis
541292|NCT01259011|end of life decision making|end of life decision making
541293|NCT01259011|surrogate psychological morbidities|surrogate psychological morbidities
541294|NCT01258985|Knee|knee
541295|NCT01258985|Knee osteoarthritis|knee osteoarthritis
541296|NCT01258985|osteoarthritis|osteoarthritis
541297|NCT01258985|Knee pain|knee pain
541298|NCT01258985|Tai Chi|tai chi
541299|NCT01258985|Physical Therapy|physical therapy
541300|NCT01258985|mind-body exercise|mind-body exercise
541301|NCT01258972|Bifurcation lesions|bifurcation lesions
541302|NCT01258959|Ultrasound, retrobulbar, parabulbar, ophthalmic surgery.|ultrasound, retrobulbar, parabulbar, ophthalmic surgery.
541303|NCT01258946|epicardial adipose pcos|epicardial adipose pcos
541304|NCT01258933|Leukemia|leukemia
541305|NCT01258933|Chronic Lymphocytic Leukemia|chronic lymphocytic leukemia
541306|NCT01258933|CLL|cll
541307|NCT01258933|Lymphoma|lymphoma
541308|NCT01258933|Small Lymphocytic Lymphoma|small lymphocytic lymphoma
541309|NCT01258933|SLL|sll
541310|NCT01258933|Ofatumumab|ofatumumab
541311|NCT01258920|Schizophrenia|schizophrenia
541312|NCT01258920|Paliperidone palmitate|paliperidone palmitate
541313|NCT01258920|Intramascular Injection|intramascular injection
541314|NCT01258907|BI-204|bi-204
541315|NCT01258868|Mesothelioma|mesothelioma
541316|NCT01258868|Esophageal Cancer|esophageal cancer
541317|NCT01258868|Lung Cancer|lung cancer
541318|NCT01258868|Thoracic Malignancies|thoracic malignancies
541319|NCT01258868|Tumor Cell Vaccine|tumor cell vaccine
541320|NCT01258842|Influenza|influenza
541321|NCT01258842|Prevention|prevention
541322|NCT01258842|Probiotic|probiotic
541323|NCT01258829|Heart Failure Cardiac Resynchronisation Therapy|heart failure cardiac resynchronisation therapy
541324|NCT01258816|Acute Myeloid Leukaemia (AML)|acute myeloid leukaemia (aml)
541325|NCT01258816|Pharmacokinetics|pharmacokinetics
541326|NCT01258816|Elacytarabine|elacytarabine
541327|NCT01258816|CP-4055|cp-4055
541328|NCT01258803|asthma|asthma
541329|NCT01258803|children|children
541330|NCT01258803|persistent|persistent
541331|NCT01258790|TS|ts
541332|NCT01258790|tics|tics
541333|NCT01258790|tourette|tourette
541334|NCT01258777|Healthy volunteers|healthy volunteers
541335|NCT01258777|Japanese male|japanese male
541336|NCT01258777|Caucasian male|caucasian male
541337|NCT01258777|Simponi|simponi
541338|NCT01258764|hypertension|hypertension
541339|NCT01258764|Blood Pressure control|blood pressure control
541340|NCT01258764|hypertension treatment|hypertension treatment
541341|NCT01258764|antihypertensive|antihypertensive
541342|NCT01258764|N of 1 study|n of 1 study
541343|NCT01258751|Healthy Volunteers|healthy volunteers
541344|NCT01258738|Early ankylosing spondylitis (SpA) study; efficacy and safety and health out comes|early ankylosing spondylitis (spa) study; efficacy and safety and health out comes
541345|NCT01258725|amnioinfusion, severe idiopahic oligohydramnios|amnioinfusion, severe idiopahic oligohydramnios
541346|NCT01258673|Fimasartan|fimasartan
541347|NCT01258673|Fimasartan/Hydrochlorothiazide combination|fimasartan/hydrochlorothiazide combination
541348|NCT01258647|infant nutrition|infant nutrition
541349|NCT01258647|complementary feeding|complementary feeding
541350|NCT01258647|malnutrition|malnutrition
541351|NCT01258647|stunting of growth|stunting of growth
541352|NCT01258634|Osteosarcoma|osteosarcoma
541353|NCT01258634|Surgically Resectable High Grade Osteosarcoma|surgically resectable high grade osteosarcoma
541354|NCT01258634|Lung Metastases Only|lung metastases only
541355|NCT01258621|distal pancreatectomy, laparoscopy, learning curve|distal pancreatectomy, laparoscopy, learning curve
541356|NCT01258608|advanced hepatocellular carcinoma|advanced hepatocellular carcinoma
541357|NCT01258608|Mapatumumab|mapatumumab
541358|NCT01258608|HGS1012|hgs1012
541359|NCT01258608|sorafenib|sorafenib
541360|NCT01258595|Influenza|influenza
541361|NCT01258595|Trivalent Inactivated Influenza Vaccine|trivalent inactivated influenza vaccine
541362|NCT01258595|High-Dose Trivalent Inactivated Influenza Vaccine|high-dose trivalent inactivated influenza vaccine
541363|NCT01258595|Influenza vaccines|influenza vaccines
541364|NCT01258582|HIV|hiv
541365|NCT01258582|Testing|testing
541366|NCT01258582|HIV Seronegativity|hiv seronegativity
541367|NCT01258569|laparoscopic|laparoscopic
541368|NCT01258569|colon|colon
541369|NCT01258569|resection|resection
541370|NCT01258569|Entereg|entereg
541371|NCT01258543|Global osteopathic evaluation|global osteopathic evaluation
541372|NCT01258543|Non-specific back pain|non-specific back pain
541373|NCT01258543|Inter-examiner reliability|inter-examiner reliability
541374|NCT01258530|influenza, bioequivalence, oseltamivir, Tamiflu, over-encapsulation|influenza, bioequivalence, oseltamivir, tamiflu, over-encapsulation
541375|NCT01258517|RDS|rds
541376|NCT01258517|surfactant|surfactant
541377|NCT01258517|cerebral oxygenation|cerebral oxygenation
541378|NCT01258517|near infrared spectroscopy|near infrared spectroscopy
541379|NCT01258504|Steady-state|steady-state
541380|NCT01258504|Bosentan|bosentan
541381|NCT01258504|St. Johns Wort|st. johns wort
541382|NCT01258478|NSCLC, rehabilitation, CPET, lung resection|nsclc, rehabilitation, cpet, lung resection
541383|NCT01258465|Communication|communication
541384|NCT01258465|Pivotal Response Training|pivotal response training
541385|NCT01258465|Picture Exchange Communication System|picture exchange communication system
541386|NCT01258439|HIV|hiv
541387|NCT01258439|cardiovascular disease|cardiovascular disease
541388|NCT01258439|post prandial lipids|post prandial lipids
541389|NCT01258439|ritonavir|ritonavir
541390|NCT01258439|darunavir|darunavir
541391|NCT01258439|raltegravir|raltegravir
541392|NCT01258439|arterial stiffness|arterial stiffness
541393|NCT01258439|tonometry|tonometry
541394|NCT01258413|Cervical Cancer|cervical cancer
541395|NCT01258413|Radical hysterectomy, Laparoscopic|radical hysterectomy, laparoscopic
541396|NCT01258413|Overall survival|overall survival
541397|NCT01258413|Disease-free five-years survival|disease-free five-years survival
541398|NCT01258374|Pharmacokinetics, raltegravir, darunavir, NRTI sparing regimen|pharmacokinetics, raltegravir, darunavir, nrti sparing regimen
541399|NCT01258361|preoperative fasting|preoperative fasting
541400|NCT01258296|Postoperative pain|postoperative pain
541401|NCT01258296|Breast reconstruction|breast reconstruction
541402|NCT01258296|Abdominal flap breast reconstruction|abdominal flap breast reconstruction
541403|NCT01258257|Aneurysm|aneurysm
541404|NCT01258257|Subarachnoid hemorrhage|subarachnoid hemorrhage
541405|NCT01258257|Lumbar drain|lumbar drain
541406|NCT01258257|Cerebral vasospasm|cerebral vasospasm
541407|NCT01258257|Cerebral Ventricles|cerebral ventricles
541408|NCT01258257|Cerebrospinal Fluid|cerebrospinal fluid
541409|NCT01258257|Prospective Studies|prospective studies
541410|NCT01258257|Drainage/methods*|drainage/methods*
541411|NCT01258257|Humans|humans
541412|NCT01258257|Subarachnoid Hemorrhage/cerebrospinal fluid*|subarachnoid hemorrhage/cerebrospinal fluid*
541413|NCT01258257|Subarachnoid Hemorrhage/complications*|subarachnoid hemorrhage/complications*
541414|NCT01258257|Subarachnoid Space/surgery*|subarachnoid space/surgery*
541415|NCT01258257|Vasospasm, Intracranial/etiology|vasospasm, intracranial/etiology
541416|NCT01258257|Vasospasm, Intracranial/surgery*|vasospasm, intracranial/surgery*
541417|NCT01258244|Out-of-Hospital Cardiac Arrest, OHCA|out-of-hospital cardiac arrest, ohca
541418|NCT01258205|Amgen|amgen
541419|NCT01258205|AMG 139|amg 139
541420|NCT01258205|Crohn's Disease|crohn's disease
541421|NCT01258192|esophageal squamous cell carcinoma|esophageal squamous cell carcinoma
541422|NCT01258192|neoadjuvant chemotherapy|neoadjuvant chemotherapy
541423|NCT01258192|albumin-bound paclitaxel|albumin-bound paclitaxel
541424|NCT01258192|cisplatin|cisplatin
541425|NCT01258153|Infantile Colic|infantile colic
541426|NCT01258153|tachykinin antagonist|tachykinin antagonist
541427|NCT01258153|Nepadutant|nepadutant
541428|NCT01258140|CT angiography|ct angiography
541429|NCT01258140|radiation dose|radiation dose
541430|NCT01258140|contrast medium|contrast medium
541431|NCT01258127|Pemetrexed|pemetrexed
541432|NCT01258127|Vinorelbine|vinorelbine
541433|NCT01258127|Carboplatin|carboplatin
541434|NCT01258114|Overweight|overweight
541435|NCT01258114|Obesity|obesity
541436|NCT01258114|Balneotherapy|balneotherapy
541437|NCT01258114|Spa Therapy|spa therapy
541438|NCT01258114|balneology|balneology
541439|NCT01258114|hydrotherapy|hydrotherapy
541440|NCT01258114|SF 12|sf 12
541441|NCT01258114|Nutritional counselling|nutritional counselling
541442|NCT01258114|Zelen double consent|zelen double consent
541443|NCT01258114|Lifestyle modification program|lifestyle modification program
541444|NCT01258114|IMC|imc
541445|NCT01258088|psoriasis|psoriasis
541446|NCT01258075|Type 2 diabetes mellitus|type 2 diabetes mellitus
541447|NCT01258075|Blood glucose|blood glucose
541448|NCT01258075|Anti-diabetic|anti-diabetic
541449|NCT01258075|Bile acid sequestrant|bile acid sequestrant
541450|NCT01258075|Colesevelam HCl|colesevelam hcl
541451|NCT01258075|Oral suspension|oral suspension
541452|NCT01258075|Pediatric|pediatric
541453|NCT01258075|Add-on therapy|add-on therapy
541454|NCT01258075|Add-on to metformin|add-on to metformin
541455|NCT01258075|Metformin|metformin
541456|NCT01258075|Adolescent|adolescent
541457|NCT01258075|Lipid|lipid
541458|NCT01258049|Plasmodium infections|plasmodium infections
541459|NCT01258049|Remittent fever|remittent fever
541460|NCT01258049|Artemether|artemether
541461|NCT01258049|Artemesinins|artemesinins
541462|NCT01258049|Quinine|quinine
541463|NCT01258049|Malaria|malaria
541464|NCT01258049|Protozoan infections|protozoan infections
541465|NCT01258049|sublingual drug delivery|sublingual drug delivery
541466|NCT01258049|Parasitic disease|parasitic disease
541467|NCT01258049|Antiprotozoan agents|antiprotozoan agents
541468|NCT01258036|Bone microarchitecture|bone microarchitecture
541469|NCT01258036|Bone mineral density|bone mineral density
541470|NCT01258036|Bone markers|bone markers
541471|NCT01258036|hereditary determinism|hereditary determinism
541472|NCT01258010|Red blood cell transfusion|red blood cell transfusion
541473|NCT01258010|Neurosurgery|neurosurgery
541474|NCT01258010|Orthopedic surgery|orthopedic surgery
541475|NCT01258010|Tranexamic acid|tranexamic acid
541476|NCT01258010|Surgical blood loss|surgical blood loss
541477|NCT01257997|No specific experimental conditions|no specific experimental conditions
541478|NCT01257971|Cholesterol|cholesterol
541479|NCT01257971|HMG-CoA reductase inhibitor|hmg-coa reductase inhibitor
541480|NCT01257971|cardiovascular risk|cardiovascular risk
541481|NCT01257971|LDLl|ldll
541482|NCT01257958|Vitamin D, 19 nor Vitamin D, Multiple Sclerosis|vitamin d, 19 nor vitamin d, multiple sclerosis
541483|NCT01257932|Breast Cancer|breast cancer
541484|NCT01257906|acne|acne
541485|NCT01257906|Ziana|ziana
541486|NCT01257906|clindamycin|clindamycin
541487|NCT01257906|tretinoin|tretinoin
541488|NCT01257893|migraine|migraine
541489|NCT01257893|chronic migraine|chronic migraine
541490|NCT01257893|migraine with aura|migraine with aura
541491|NCT01257893|migraine without aura|migraine without aura
541492|NCT01257893|aspirin|aspirin
541493|NCT01257893|platelets|platelets
541494|NCT01257880|Migraine|migraine
541495|NCT01257880|Migraine with Aura|migraine with aura
541496|NCT01257880|Aura|aura
541497|NCT01257880|Patent Foramen Ovale|patent foramen ovale
541498|NCT01257880|Platelets|platelets
541499|NCT01257880|Sleep Apnea|sleep apnea
541500|NCT01257880|Cognitive Function|cognitive function
541501|NCT01257867|Brain-derived neurotrophic factor|brain-derived neurotrophic factor
541502|NCT01257867|Oxidative stress|oxidative stress
541503|NCT01257867|Neurogenesis|neurogenesis
541504|NCT01257867|Lithium|lithium
541505|NCT01257867|Lithia water|lithia water
541506|NCT01257854|busulfan|busulfan
541507|NCT01257854|pharmacogenetic|pharmacogenetic
541508|NCT01257854|pharmacokinetic|pharmacokinetic
541509|NCT01257854|toxicity|toxicity
541510|NCT01257854|survival|survival
541511|NCT01257841|Fasting|fasting
541512|NCT01257841|Gut hormones|gut hormones
541513|NCT01257841|Inflammatory Cytokines|inflammatory cytokines
541514|NCT01257815|Diabetes mellitus|diabetes mellitus
541515|NCT01257815|Diabetic retinopathy|diabetic retinopathy
541516|NCT01257815|Macular oedema|macular oedema
541517|NCT01257815|Visual acuity|visual acuity
541518|NCT01257789|laparoscopic gastric bypass|laparoscopic gastric bypass
541519|NCT01257789|learning curve|learning curve
541520|NCT01257789|complications|complications
541521|NCT01257789|operative time|operative time
541522|NCT01257776|Critical Limb Ischemia (CLI)|critical limb ischemia (cli)
541523|NCT01257776|Diabetes|diabetes
541524|NCT01257776|Mesenchymal Stem Cells|mesenchymal stem cells
541525|NCT01257776|Regenerative Therapy|regenerative therapy
541526|NCT01257763|needles/adverse effects|needles/adverse effects
541527|NCT01257763|administration, cutaneous|administration, cutaneous
541528|NCT01257763|erythema|erythema
541529|NCT01257763|pain measurement|pain measurement
541530|NCT01257763|Safety|safety
541531|NCT01257763|Microstructure Transdermal System|microstructure transdermal system
541532|NCT01257750|corneal neovascularization|corneal neovascularization
541533|NCT01257750|pazopanib|pazopanib
541534|NCT01257750|votrient|votrient
541535|NCT01257750|rosacea|rosacea
541536|NCT01257737|Urea Cycle Disorders|urea cycle disorders
541537|NCT01257737|GT4P|gt4p
541538|NCT01257737|HPN-100|hpn-100
541539|NCT01257737|Sodium Phenylbutyrate (NaPBA)|sodium phenylbutyrate (napba)
541644|NCT01257191|Diesel Exhaust|diesel exhaust
541540|NCT01257737|Glyceryl tri-(4-phenylbutyrate)|glyceryl tri-(4-phenylbutyrate)
541541|NCT01257737|Phenylbutyrate|phenylbutyrate
541542|NCT01257737|Hyperion|hyperion
541543|NCT01257737|BUPHENYL|buphenyl
541544|NCT01257737|hyperammonemia|hyperammonemia
541545|NCT01257724|Knowledge translation|knowledge translation
541546|NCT01257724|Community based organizations|community based organizations
541547|NCT01257724|HIV/AIDS|hiv/aids
541548|NCT01257711|Gastric Cancer|gastric cancer
541549|NCT01257711|Gastrectomy|gastrectomy
541550|NCT01257711|Billroth 2|billroth 2
541551|NCT01257711|Roux-en-Y|roux-en-y
541552|NCT01257698|Vitrectomy|vitrectomy
541553|NCT01257698|Gas bubble|gas bubble
541554|NCT01257698|Retinal detachment|retinal detachment
541555|NCT01257698|Macular hole|macular hole
541556|NCT01257698|Aqueous suppressant|aqueous suppressant
541557|NCT01257672|acute gastroenteritis|acute gastroenteritis
541558|NCT01257672|vomiting|vomiting
541559|NCT01257672|ondansetron|ondansetron
541560|NCT01257672|domperidon|domperidon
541561|NCT01257672|symptomatic treatment|symptomatic treatment
541562|NCT01257659|Rectocele|rectocele
541563|NCT01257659|Trans anal STARR resection|trans anal starr resection
541564|NCT01257659|Transvaginal repair|transvaginal repair
541565|NCT01257633|da Vinci surgical robot|da vinci surgical robot
541566|NCT01257633|laryngeal cancer|laryngeal cancer
541567|NCT01257620|Inflammatory Bowel Disease|inflammatory bowel disease
541568|NCT01257620|Coeliac Disease|coeliac disease
541569|NCT01257594|Gliomas|gliomas
541570|NCT01257594|Erlotinib|erlotinib
541571|NCT01257594|Glioblastoma|glioblastoma
541572|NCT01257594|GBM|gbm
541573|NCT01257594|Gliosarcoma|gliosarcoma
541574|NCT01257594|Glioma|glioma
541575|NCT01257581|ALS|als
541576|NCT01257581|Lou Gehrig's Disease|lou gehrig's disease
541577|NCT01257581|Amyotrophic Lateral Sclerosis|amyotrophic lateral sclerosis
541578|NCT01257581|Creatine|creatine
541579|NCT01257581|Tamoxifen|tamoxifen
541580|NCT01257581|Selection Design|selection design
541581|NCT01257542|randomized|randomized
541582|NCT01257542|parallel|parallel
541583|NCT01257542|double-blind|double-blind
541584|NCT01257542|placebo-controlled|placebo-controlled
541585|NCT01257542|cough|cough
541586|NCT01257542|efficacy|efficacy
541587|NCT01257542|safety|safety
541588|NCT01257542|dextromethorphan|dextromethorphan
541589|NCT01257529|pregabalin|pregabalin
541590|NCT01257529|pharmacokinetics|pharmacokinetics
541591|NCT01257529|bioavailability|bioavailability
541592|NCT01257529|bioequivalence|bioequivalence
541593|NCT01257516|pregabalin|pregabalin
541594|NCT01257516|pharmacokinetics|pharmacokinetics
541595|NCT01257516|bioavailability|bioavailability
541596|NCT01257516|bioequivalence|bioequivalence
541597|NCT01257503|children|children
541598|NCT01257503|upper respiratory tract infections|upper respiratory tract infections
541599|NCT01257503|homeopathy|homeopathy
541600|NCT01257477|Diarrhea|diarrhea
541601|NCT01257477|IBS|ibs
541602|NCT01257477|Irritable Bowel Syndrome|irritable bowel syndrome
541603|NCT01257464|CFRD|cfrd
541604|NCT01257464|sitagliptin|sitagliptin
541605|NCT01257464|cystic fibrosis-related diabetes|cystic fibrosis-related diabetes
541606|NCT01257464|incretins|incretins
541607|NCT01257464|hyperglycemia|hyperglycemia
541608|NCT01257464|GIP|gip
541609|NCT01257464|GLP-1|glp-1
541610|NCT01257451|Type 2 Diabetes Mellitus, Vildagliptin, Elderly Patients|type 2 diabetes mellitus, vildagliptin, elderly patients
541611|NCT01257412|Phase III|phase iii
541612|NCT01257412|Type 2 Diabetes Mellitus|type 2 diabetes mellitus
541613|NCT01257412|inadequate glycaemic control|inadequate glycaemic control
541614|NCT01257360|RAS-Wildtype|ras-wildtype
541615|NCT01257360|Radiotherapy|radiotherapy
541616|NCT01257360|Neoadjuvant treatment|neoadjuvant treatment
541617|NCT01257347|Medication adherence|medication adherence
541618|NCT01257347|clinical inertia|clinical inertia
541619|NCT01257347|treatment intensification|treatment intensification
541620|NCT01257347|quality of care|quality of care
541621|NCT01257334|type 2 diabetes|type 2 diabetes
541622|NCT01257308|lung cancer|lung cancer
541623|NCT01257295|dietary fiber|dietary fiber
541624|NCT01257295|energy intake|energy intake
541625|NCT01257295|appetite|appetite
541626|NCT01257295|satiety hormones|satiety hormones
541627|NCT01257295|glucose|glucose
541628|NCT01257295|gastric emptying|gastric emptying
541629|NCT01257269|Thrombotic thrombocytopenic purpura|thrombotic thrombocytopenic purpura
541630|NCT01257269|ADAMTS13|adamts13
541631|NCT01257269|Von Willebrand factor|von willebrand factor
541632|NCT01257269|Von Willebrand factor cleaving protease|von willebrand factor cleaving protease
541633|NCT01257269|Thrombocytopenia|thrombocytopenia
541634|NCT01257269|Hemolytic anemia|hemolytic anemia
541635|NCT01257256|infertile patients|infertile patients
541636|NCT01257243|cough|cough
541637|NCT01257243|symptoms|symptoms
541638|NCT01257243|cold|cold
541639|NCT01257243|flu|flu
541640|NCT01257217|Intraocular Lens|intraocular lens
541641|NCT01257217|Presbyopia|presbyopia
541642|NCT01257217|multifocal|multifocal
541643|NCT01257191|Vehicle Emissions|vehicle emissions
541645|NCT01257165|Automobile driving|automobile driving
541646|NCT01257165|Zopiclone|zopiclone
541647|NCT01257165|Drug safety|drug safety
541648|NCT01257165|Traffic accidents|traffic accidents
541649|NCT01257139|To evaluate a geriatric scale designed to help with treatment|to evaluate a geriatric scale designed to help with treatment
541650|NCT01257139|allocation to dual-agent therapy based on platinum or to|allocation to dual-agent therapy based on platinum or to
541651|NCT01257139|single-agent chemotherapy in elderly subjects with advancedstage|single-agent chemotherapy in elderly subjects with advancedstage
541652|NCT01257139|NSCLC, based on the time to failure in the two arms|nsclc, based on the time to failure in the two arms
541653|NCT01257126|Upper respiratory tract infections|upper respiratory tract infections
541654|NCT01257126|diclofenac potassium|diclofenac potassium
541655|NCT01257126|nimesulide|nimesulide
541656|NCT01257126|fever|fever
541657|NCT01257126|pain|pain
541658|NCT01257113|shoulder pain|shoulder pain
541659|NCT01257113|shoulder impingement|shoulder impingement
541660|NCT01257113|rotatorcuff pathology|rotatorcuff pathology
541661|NCT01257113|supervised exercise|supervised exercise
541662|NCT01257113|homebased exercise|homebased exercise
541663|NCT01257100|Nasopharyngeal Carcinoma|nasopharyngeal carcinoma
541664|NCT01257100|Epstein-Barr Virus|epstein-barr virus
541665|NCT01257100|NPC|npc
541666|NCT01257087|Type 2 Diabetes Mellitus|type 2 diabetes mellitus
541667|NCT01257087|Obesity|obesity
541668|NCT01257087|Bariatric Surgery|bariatric surgery
541669|NCT01257087|Glycaemic control|glycaemic control
541670|NCT01257087|Microvascular complications|microvascular complications
541671|NCT01257087|Intensive|intensive
541672|NCT01257087|Conservative|conservative
541673|NCT01257074|Herpes Simplex|herpes simplex
541674|NCT01257061|Dermatitis|dermatitis
541675|NCT01257061|Dermatitis, Atopic|dermatitis, atopic
541676|NCT01257048|Oxygen enhanced magnetic resonance imaging|oxygen enhanced magnetic resonance imaging
541677|NCT01257048|chronic obstructive pulmonary disease|chronic obstructive pulmonary disease
541678|NCT01257048|method evaluation|method evaluation
541679|NCT01257035|Rectum cancer|rectum cancer
541680|NCT01257035|FAZA|faza
541681|NCT01257035|18F-FAZA-PET/CT|18f-faza-pet/ct
541682|NCT01257035|Radiotherapy|radiotherapy
541683|NCT01257035|Chemoradiotherapy|chemoradiotherapy
541684|NCT01257022|Prevention|prevention
541685|NCT01257022|HIV|hiv
541686|NCT01257022|Substance use|substance use
541687|NCT01257022|Hispanic|hispanic
541688|NCT01257022|Adolescents|adolescents
541689|NCT01257022|Unsafe sexual behavior|unsafe sexual behavior
541690|NCT01257022|Behavioral intervention|behavioral intervention
541691|NCT01257009|sympathetic activity|sympathetic activity
541692|NCT01257009|chronic kidney disease|chronic kidney disease
541693|NCT01257009|atorvastatin|atorvastatin
541694|NCT01257009|lipitor|lipitor
541695|NCT01256983|Sleep quality|sleep quality
541696|NCT01256983|Daytime Sleepiness|daytime sleepiness
541697|NCT01256944|PCOS|pcos
541698|NCT01256944|DM|dm
541699|NCT01256944|Hypertension|hypertension
541700|NCT01256944|CVD|cvd
541701|NCT01256931|2009 H1N1 influenza vaccine, organ transplant patients,|2009 h1n1 influenza vaccine, organ transplant patients,
541702|NCT01256931|booster with Fluarix|booster with fluarix
541703|NCT01256918|cataract|cataract
541704|NCT01256918|phacoemulsification|phacoemulsification
541705|NCT01256918|phacochop|phacochop
541706|NCT01256918|phacotip|phacotip
541707|NCT01256879|cimetidine|cimetidine
541708|NCT01256879|pharmacokinetics|pharmacokinetics
541709|NCT01256879|formulation|formulation
541710|NCT01256866|Dexmedetomidine|dexmedetomidine
541711|NCT01256866|Midazolam|midazolam
541712|NCT01256866|Sedation|sedation
541713|NCT01256866|Mechanical ventilation|mechanical ventilation
541714|NCT01256866|Critically ill patients|critically ill patients
541715|NCT01256853|histologically confirmed EBV+ NPC patients|histologically confirmed ebv+ npc patients
541716|NCT01256827|age-related macular degeneration|age-related macular degeneration
541717|NCT01256827|ranibizumab|ranibizumab
541718|NCT01256827|geographic atrophy|geographic atrophy
541719|NCT01256827|ANCHOR Study|anchor study
541720|NCT01256827|MARINA Study|marina study
541721|NCT01256814|HIV/AIDS|hiv/aids
541722|NCT01256814|Adult|adult
541723|NCT01256814|Behavioral Intervention|behavioral intervention
541724|NCT01256814|Sleep|sleep
541725|NCT01256814|Physical Activity|physical activity
541726|NCT01256801|Metastatic Breast Neoplasms|metastatic breast neoplasms
541727|NCT01256801|Gene Expression Profiling|gene expression profiling
541728|NCT01256801|immunotherapy|immunotherapy
541729|NCT01256788|viscosupplementation|viscosupplementation
541730|NCT01256788|meniscus tear|meniscus tear
541731|NCT01256788|degenerative joint disease|degenerative joint disease
541732|NCT01256775|atherosclerosis|atherosclerosis
541733|NCT01256775|carotid intima-media thickness|carotid intima-media thickness
541734|NCT01256775|intermittent claudication|intermittent claudication
541735|NCT01256775|Nitric Oxide / NO|nitric oxide / no
541736|NCT01256762|imetelstat|imetelstat
541737|NCT01256762|imetelstat sodium|imetelstat sodium
541738|NCT01256762|GRN163L|grn163l
541739|NCT01256762|telomerase inhibitor|telomerase inhibitor
541740|NCT01256762|telomerase inhibition|telomerase inhibition
541741|NCT01256762|metastatic breast cancer|metastatic breast cancer
541742|NCT01256762|locally recurrent breast cancer|locally recurrent breast cancer
541743|NCT01256762|Bevacizumab|bevacizumab
541744|NCT01256762|Paclitaxel|paclitaxel
541746|NCT01256762|Taxol|taxol
541747|NCT01256762|HER-2-negative|her-2-negative
541748|NCT01256762|First-Line Chemotherapy|first-line chemotherapy
541749|NCT01256762|Second-Line Chemotherapy|second-line chemotherapy
541750|NCT01256723|drug eluting stent (DES)|drug eluting stent (des)
541751|NCT01256723|unprotected left main coronary artery (ULMCA)|unprotected left main coronary artery (ulmca)
541752|NCT01256684|Vulvar/vaginal atrophy|vulvar/vaginal atrophy
541753|NCT01256684|Atrophic Vaginitis|atrophic vaginitis
541754|NCT01256684|Dehydroepiandrosterone|dehydroepiandrosterone
541755|NCT01256684|DHEA|dhea
541756|NCT01256684|Prasterone|prasterone
541757|NCT01256684|Vaginorm|vaginorm
541758|NCT01256684|Menopause|menopause
541759|NCT01256684|Intrarosa|intrarosa
541760|NCT01256671|Vulvar/Vaginal Atrophy|vulvar/vaginal atrophy
541761|NCT01256671|Atrophic Vaginitis|atrophic vaginitis
541762|NCT01256671|Dehydroepiandrosterone|dehydroepiandrosterone
541763|NCT01256671|DHEA|dhea
541764|NCT01256671|Prasterone|prasterone
541765|NCT01256671|Vaginorm|vaginorm
541766|NCT01256671|Menopause|menopause
541767|NCT01256671|Intrarosa|intrarosa
541768|NCT01256658|P. falciparum|p. falciparum
541769|NCT01256658|malaria|malaria
541770|NCT01256658|asymptomatic carriers|asymptomatic carriers
541771|NCT01256658|bed-nets|bed-nets
541772|NCT01256658|ITN-insecticide-treated net|itn-insecticide-treated net
541773|NCT01256658|idiopathic trigeminal neuralgia|idiopathic trigeminal neuralgia
541774|NCT01256658|RDT-Rapid diagnostic test|rdt-rapid diagnostic test
541775|NCT01256645|weaning|weaning
541776|NCT01256645|mechanical ventilation|mechanical ventilation
541777|NCT01256645|blood transfusion|blood transfusion
541778|NCT01256645|spontaneous breathing trials|spontaneous breathing trials
541779|NCT01256619|Marvelon|marvelon
541780|NCT01256619|PMS|pms
541781|NCT01256619|serum Lipids|serum lipids
541782|NCT01256593|Lyrica|lyrica
541783|NCT01256593|Regulatory Post Marketing Commitment Plan|regulatory post marketing commitment plan
541784|NCT01256593|Safety|safety
541785|NCT01256593|Neuropathic Pain|neuropathic pain
541786|NCT01256593|Post Marketing Surveillance|post marketing surveillance
541787|NCT01256554|Stereotactic Radiosurgery|stereotactic radiosurgery
541788|NCT01256554|SSRS|ssrs
541789|NCT01256554|Radiation|radiation
541790|NCT01256554|Radiotherapy|radiotherapy
541791|NCT01256554|Metastatic Epidural Spinal Cord Compression|metastatic epidural spinal cord compression
541792|NCT01256554|MESCC|mescc
541793|NCT01256528|Invasive breast carcinoma|invasive breast carcinoma
541794|NCT01256528|Breast reconstruction|breast reconstruction
541795|NCT01256528|Mastectomy|mastectomy
541796|NCT01256528|Breast cancer|breast cancer
541797|NCT01256528|Delayed-delayed breast reconstruction|delayed-delayed breast reconstruction
541798|NCT01256528|Post-mastectomy radiation therapy|post-mastectomy radiation therapy
541799|NCT01256515|Healthy adults aged 50 or older|healthy adults aged 50 or older
541800|NCT01256489|KPro|kpro
541801|NCT01256489|Keratoprosthesis|keratoprosthesis
541802|NCT01256489|Stevens-Johnson Syndrome|stevens-johnson syndrome
541803|NCT01256489|Infliximab|infliximab
541804|NCT01256489|Corneal Blindness|corneal blindness
541805|NCT01256450|buccal soluble film|buccal soluble film
541806|NCT01256450|enriched enrollment|enriched enrollment
541807|NCT01256450|randomized withdrawal|randomized withdrawal
541808|NCT01256437|Acneiform eruption|acneiform eruption
541809|NCT01256437|papulopustular|papulopustular
541810|NCT01256437|EGFR|egfr
541811|NCT01256437|cetuximab|cetuximab
541812|NCT01256437|erlotinib|erlotinib
541813|NCT01256437|gefitinib|gefitinib
541814|NCT01256437|panitumumab|panitumumab
541815|NCT01256437|eruption secondary to treatment with either cetuximab|eruption secondary to treatment with either cetuximab
541816|NCT01256424|CIN|cin
541817|NCT01256411|hypertension|hypertension
541818|NCT01256411|blood pressure|blood pressure
541819|NCT01256411|LCZ696|lcz696
541820|NCT01256411|dual-acting|dual-acting
541821|NCT01256411|neprilysin|neprilysin
541822|NCT01256411|nep inhibitor|nep inhibitor
541823|NCT01256411|vasopeptidase|vasopeptidase
541824|NCT01256411|angiotensin receptor|angiotensin receptor
541825|NCT01256411|angiotensin receptor neprilysin inhibitor (ARNi)|angiotensin receptor neprilysin inhibitor (arni)
541826|NCT01256372|Cardiac surgery|cardiac surgery
541827|NCT01256372|Acute kidney injury|acute kidney injury
541828|NCT01256346|Premature|premature
541829|NCT01256346|baby|baby
541830|NCT01256346|heart rate|heart rate
541831|NCT01256346|resuscitation|resuscitation
541832|NCT01256307|Obstructive Sleep Apnea/Hypopnea Syndrome|obstructive sleep apnea/hypopnea syndrome
541833|NCT01256307|Exercise training program|exercise training program
541834|NCT01256307|Inflammation|inflammation
541835|NCT01256307|Oxidative Stress|oxidative stress
541836|NCT01256307|Insulin resistance|insulin resistance
541837|NCT01256294|Renal transplant|renal transplant
541838|NCT01256294|kidney transplant|kidney transplant
541839|NCT01256294|immunosuppressive therapy|immunosuppressive therapy
541840|NCT01256294|anti-rejection medication|anti-rejection medication
541841|NCT01256294|pharmacokinetics|pharmacokinetics
541842|NCT01256294|tacrolimus|tacrolimus
541843|NCT01256281|Sickle Cell Disease|sickle cell disease
541844|NCT01256281|Pain|pain
541845|NCT01256281|Vasoocclusion|vasoocclusion
541846|NCT01256281|Nerve Block|nerve block
541847|NCT01256281|Regional Anesthesia|regional anesthesia
541848|NCT01256268|metastatic|metastatic
541849|NCT01256268|recurrent|recurrent
541850|NCT01256268|Solid Cancer|solid cancer
541851|NCT01256255|transplant|transplant
541852|NCT01256255|influenza infection|influenza infection
541853|NCT01256242|tendon|tendon
541854|NCT01256242|shoulder|shoulder
541855|NCT01256242|rotator cuff|rotator cuff
541856|NCT01256242|Glenohumeral|glenohumeral
541857|NCT01256229|deafness|deafness
541858|NCT01256229|hearing loss|hearing loss
541859|NCT01256229|developmental delay|developmental delay
541860|NCT01256229|mental retardation|mental retardation
541861|NCT01256216|Arthritis|arthritis
541862|NCT01256216|Osteoarthritis|osteoarthritis
541863|NCT01256216|Arthroplasty|arthroplasty
541865|NCT01256203|Porfimer sodium|porfimer sodium
541866|NCT01256203|Phototoxicity|phototoxicity
541867|NCT01256203|Sunscreen|sunscreen
541868|NCT01256177|Bipolar Depression|bipolar depression
541869|NCT01256177|Mental disease,|mental disease,
541870|NCT01256164|fibrin sealants|fibrin sealants
541871|NCT01256164|hemostatics|hemostatics
541872|NCT01256164|time to hemostasis|time to hemostasis
541873|NCT01256151|Bioequivalence|bioequivalence
541874|NCT01256151|sublingual|sublingual
541875|NCT01256151|alprazolam|alprazolam
541876|NCT01256151|pharmacokinetics|pharmacokinetics
541877|NCT01256138|Allogene MSCs|allogene mscs
541878|NCT01256138|transplantation|transplantation
541879|NCT01256138|chronic liver diseases|chronic liver diseases
541880|NCT01256138|portal vein|portal vein
541881|NCT01256125|allogene MSCs|allogene mscs
541882|NCT01256125|transplantation|transplantation
541883|NCT01256125|chronic liver diseases|chronic liver diseases
541884|NCT01256125|peripheral vein|peripheral vein
541885|NCT01256112|obesity|obesity
541886|NCT01256112|behavioral intervention|behavioral intervention
541887|NCT01256112|family based|family based
541888|NCT01256112|weight loss|weight loss
541889|NCT01256099|Self-help treatment|self-help treatment
541890|NCT01256099|Internet treatment|internet treatment
541891|NCT01256099|CBT|cbt
541892|NCT01256099|Prevention|prevention
541893|NCT01256099|Comorbidity|comorbidity
541894|NCT01256060|Autism Spectrum disorder|autism spectrum disorder
541895|NCT01256060|Oxytocin|oxytocin
541896|NCT01256060|Clinical Trial|clinical trial
541897|NCT01256060|Children|children
541898|NCT01256060|Pharmacology|pharmacology
541899|NCT01256047|immunonutrition|immunonutrition
541900|NCT01256047|hepatectomy|hepatectomy
541901|NCT01256047|Th1|th1
541902|NCT01256047|Th2|th2
541903|NCT01256034|immunonutrition|immunonutrition
541904|NCT01256034|pancreaticoduodenectomy|pancreaticoduodenectomy
541905|NCT01256034|Th1|th1
541906|NCT01256034|Th2|th2
541907|NCT01256008|Breast Cancer|breast cancer
541908|NCT01256008|Depression|depression
541909|NCT01256008|Anxiety|anxiety
541910|NCT01256008|Cognitive-Behavioral Therapy|cognitive-behavioral therapy
541911|NCT01255995|PXF|pxf
541912|NCT01255982|Bipolar depression|bipolar depression
541913|NCT01255982|subsyndromal symptoms|subsyndromal symptoms
541914|NCT01255982|functioning|functioning
541915|NCT01255982|cognitive function|cognitive function
541916|NCT01255969|Dialysis|dialysis
541917|NCT01255969|Physical exercise|physical exercise
541918|NCT01255969|Clinical Trial|clinical trial
541919|NCT01255969|Quality of Life|quality of life
541920|NCT01255969|Performance|performance
541921|NCT01255969|Fitness|fitness
541922|NCT01255969|Cardiovascular Mortality|cardiovascular mortality
541923|NCT01255969|Vascular access|vascular access
541924|NCT01255956|restenosis|restenosis
541925|NCT01255956|ISR|isr
541926|NCT01255956|in-stent restenosis|in-stent restenosis
541927|NCT01255956|drug eluting stent|drug eluting stent
541928|NCT01255956|rapamycin eluting stent|rapamycin eluting stent
541929|NCT01255956|paclitaxel eluting balloon catheter|paclitaxel eluting balloon catheter
541930|NCT01255943|MRSA|mrsa
541931|NCT01255943|bloodstream infections|bloodstream infections
541932|NCT01255943|hemodialysis|hemodialysis
541933|NCT01255930|Pregnant Women|pregnant women
541934|NCT01255930|Sonographic Textures|sonographic textures
541935|NCT01255917|Tio identify role of NGF in pain in CP|tio identify role of ngf in pain in cp
541936|NCT01255917|Identify biomarkers related to progression of CP|identify biomarkers related to progression of cp
541937|NCT01255891|high risk localized adenocarcinoma of the prostate|high risk localized adenocarcinoma of the prostate
541938|NCT01255878|Sleep bruxism|sleep bruxism
541939|NCT01255878|Gabapentine|gabapentine
541940|NCT01255878|Occlusal splint|occlusal splint
541941|NCT01255878|Polysomnography|polysomnography
541942|NCT01255865|Thermometry|thermometry
541943|NCT01255865|Deep Tissue Temperature|deep tissue temperature
541944|NCT01255865|Core Temperature|core temperature
541945|NCT01255865|Body Temperature|body temperature
541946|NCT01255865|Rectal Temperature|rectal temperature
541947|NCT01255865|Oral Temperature|oral temperature
541948|NCT01255852|atorvastatin|atorvastatin
541949|NCT01255852|intracranial artery stenting|intracranial artery stenting
541950|NCT01255852|restenosis|restenosis
541951|NCT01255839|double-balloon|double-balloon
541952|NCT01255839|balloon catheter|balloon catheter
541953|NCT01255839|prostaglandin|prostaglandin
541954|NCT01255839|minprostin|minprostin
541955|NCT01255839|induction of labour|induction of labour
541956|NCT01255839|fetal outcome|fetal outcome
541957|NCT01255826|Preterm|preterm
541958|NCT01255826|Neonates|neonates
541959|NCT01255826|Delivery room|delivery room
541960|NCT01255826|Resuscitation|resuscitation
541961|NCT01255826|Ventilation|ventilation
541962|NCT01255826|Neopuff|neopuff
541963|NCT01255826|CPAP|cpap
688531|NCT00678509|TTK|ttk
541964|NCT01255813|Chronic Cluster Headache|chronic cluster headache
541965|NCT01255787|Major Depressive Disorder|major depressive disorder
541966|NCT01255787|Depression|depression
541967|NCT01255787|Melancholia|melancholia
541968|NCT01255787|Drug Therapy|drug therapy
541969|NCT01255774|subfoveal CNV|subfoveal cnv
541970|NCT01255774|Wet (Exudative) AMD|wet (exudative) amd
541971|NCT01255774|macular degeneration|macular degeneration
541972|NCT01255761|Certolizumab Pegol|certolizumab pegol
541973|NCT01255761|Cimzia|cimzia
541974|NCT01255761|Rheumatoid Arthritis|rheumatoid arthritis
541975|NCT01255761|CDAI|cdai
541976|NCT01255761|RAPID3|rapid3
541977|NCT01255748|cancer, proton, radiation|cancer, proton, radiation
541978|NCT01255735|pediatrics|pediatrics
541979|NCT01255735|voice|voice
541980|NCT01255735|voice therapy|voice therapy
541981|NCT01255735|vocal therapy|vocal therapy
541982|NCT01255735|hoarseness|hoarseness
541983|NCT01255722|iodinated contrast media, coronary artery disease|iodinated contrast media, coronary artery disease
541984|NCT01255709|Asthma|asthma
541985|NCT01255709|shortness of breath|shortness of breath
541986|NCT01255709|wheezing|wheezing
541987|NCT01255696|Celiac Disease|celiac disease
541988|NCT01255696|Coeliac Disease|coeliac disease
541989|NCT01255696|Celiac Sprue|celiac sprue
541990|NCT01255696|Keliakia Disease|keliakia disease
541991|NCT01255683|Chronic|chronic
541992|NCT01255683|Sinusitis|sinusitis
541993|NCT01255683|Steroid|steroid
541994|NCT01255683|treatment|treatment
541995|NCT01255670|Peritonsillar Abscess|peritonsillar abscess
541996|NCT01255670|Quinsy|quinsy
541997|NCT01255670|Penicillin|penicillin
541998|NCT01255670|Metronidazole|metronidazole
541999|NCT01255670|Recurrence|recurrence
542000|NCT01255605|Intermittent preventive treatment with sulfadoxin-pyrimethamine|intermittent preventive treatment with sulfadoxin-pyrimethamine
542001|NCT01255605|in Bobo-Dioulasso peri-urban areas, 5 years after its implementation|in bobo-dioulasso peri-urban areas, 5 years after its implementation
542002|NCT01255605|Burkina Faso.|burkina faso.
542003|NCT01255592|Bronchiectasis|bronchiectasis
542004|NCT01255592|Neutrophil|neutrophil
542005|NCT01255592|Respiratory disease|respiratory disease
542006|NCT01255592|Sputum|sputum
542007|NCT01255579|asthma|asthma
542008|NCT01255579|small airways|small airways
542009|NCT01255579|inhaled corticosteroids|inhaled corticosteroids
542010|NCT01255540|Coronary heart disease in patients over|coronary heart disease in patients over
542011|NCT01255540|80 years of age.|80 years of age.
542012|NCT01255488|Search engine|search engine
542013|NCT01255488|Clinical decision-making|clinical decision-making
542014|NCT01255488|Research abstracts|research abstracts
542015|NCT01255488|Full-text manuscripts|full-text manuscripts
542016|NCT01255488|Family Nurse Practitioners|family nurse practitioners
542017|NCT01255462|AMD,|amd,
542018|NCT01255462|ARMD,|armd,
542019|NCT01255462|Age-related Macular Degeneration,|age-related macular degeneration,
542020|NCT01255462|Eye Disease,|eye disease,
542021|NCT01255462|Wet AMD,|wet amd,
542022|NCT01255462|Neovascular AMD,|neovascular amd,
542023|NCT01255462|Choroidal Neovascular Membrane,|choroidal neovascular membrane,
542024|NCT01255462|Choroidal Neovascularization,|choroidal neovascularization,
542025|NCT01255462|Drusen,|drusen,
542026|NCT01255462|Geographic Atrophy,|geographic atrophy,
542027|NCT01255462|Complement,|complement,
542028|NCT01255462|C5,|c5,
542029|NCT01255462|Antibody|antibody
542030|NCT01255449|Forced oscillation technique|forced oscillation technique
542031|NCT01255449|Respiratory input impedance|respiratory input impedance
542032|NCT01255449|Allogeneic hematopoietic stem cell transplantation|allogeneic hematopoietic stem cell transplantation
542033|NCT01255449|Obliterative bronchiolitis|obliterative bronchiolitis
542034|NCT01255423|Ankle sprain, soft tissue injury|ankle sprain, soft tissue injury
542035|NCT01255397|male infertility|male infertility
542036|NCT01255397|natural cycle IVF|natural cycle ivf
542037|NCT01255397|in-vitro fertilization|in-vitro fertilization
542038|NCT01255397|intrauterine inseminatio|intrauterine inseminatio
542039|NCT01255371|HIV|hiv
542040|NCT01255371|Second line antiretroviral treatment|second line antiretroviral treatment
542041|NCT01255371|Sub saharian Africa|sub saharian africa
542042|NCT01255371|Generic|generic
542043|NCT01255358|Ataxia Teleangiectasia|ataxia teleangiectasia
542044|NCT01255358|AT|at
542045|NCT01255358|Ery-Dex|ery-dex
542046|NCT01255358|Dexamethasone|dexamethasone
542047|NCT01255358|Dexamethasone sodium phosphate|dexamethasone sodium phosphate
542048|NCT01255345|Physiotherapy|physiotherapy
542049|NCT01255345|Multidisciplinary Pain Centers|multidisciplinary pain centers
542050|NCT01255345|Pain measurements|pain measurements
542051|NCT01255345|Physical activity|physical activity
542052|NCT01255345|Quality of life|quality of life
542053|NCT01255332|ITP|itp
542054|NCT01255319|MDS|mds
542055|NCT01255306|Rhegmatogenous retinal detachment|rhegmatogenous retinal detachment
542056|NCT01255306|Pars plana vitrectomy|pars plana vitrectomy
542057|NCT01255306|Silicone oil|silicone oil
542058|NCT01255306|Retinal nerve fibre layer|retinal nerve fibre layer
542059|NCT01255293|Retinal detachment|retinal detachment
542060|NCT01255293|Proliferative vitreoretinopathy|proliferative vitreoretinopathy
542061|NCT01255293|Diabetic retinopathy|diabetic retinopathy
542062|NCT01255293|Vitrectomy|vitrectomy
542063|NCT01255293|Silicone oil|silicone oil
542064|NCT01255280|Crystal methamphetamine abuse|crystal methamphetamine abuse
542065|NCT01255280|Crystal methamphetamine dependence|crystal methamphetamine dependence
542066|NCT01255280|Sexual risk behavior|sexual risk behavior
542067|NCT01255280|Men who have sex with men (MSM)|men who have sex with men (msm)
542068|NCT01255280|Behavioral activation|behavioral activation
542069|NCT01255267|Acute coronary syndrome and chronic coronary artery disease patients|acute coronary syndrome and chronic coronary artery disease patients
542070|NCT01255254|he effect of gingival scaling on Metabolic control|he effect of gingival scaling on metabolic control
542071|NCT01255241|Lower Limbs Deformities|lower limbs deformities
542072|NCT01255241|kinetics|kinetics
542073|NCT01255241|kinematics|kinematics
542074|NCT01255241|gait|gait
542075|NCT01255241|energy expenditure|energy expenditure
542076|NCT01255228|obesity|obesity
542077|NCT01255228|body composition|body composition
542078|NCT01255228|adipocyte-derived cytokine|adipocyte-derived cytokine
542079|NCT01255228|low glycemic index|low glycemic index
542080|NCT01255215|malaria|malaria
542081|NCT01255215|children|children
542082|NCT01255202|preeclampsia|preeclampsia
542083|NCT01255202|toxemia|toxemia
542084|NCT01255202|twin|twin
542085|NCT01255202|pregnancy|pregnancy
542086|NCT01255202|pp13|pp13
542087|NCT01255202|prediction|prediction
542088|NCT01255202|kongo red|kongo red
542089|NCT01255189|NIRS|nirs
542090|NCT01255176|Infant|infant
542091|NCT01255176|Physical Therapy|physical therapy
542092|NCT01255163|Alzheimer's|alzheimer's
542093|NCT01255163|Brain insulin resistance|brain insulin resistance
542094|NCT01255163|Diabetes|diabetes
542095|NCT01255150|Genetic Ancestry Analysis|genetic ancestry analysis
542096|NCT01255150|Molecular Profiling|molecular profiling
542097|NCT01255150|Smoking Status|smoking status
542098|NCT01255150|Wood Smoke Exposure|wood smoke exposure
542099|NCT01255150|EGFR Mutation Analysis|egfr mutation analysis
542100|NCT01255150|Non Small Cell Lung Cancer|non small cell lung cancer
542101|NCT01255137|Selective VEGF Inhibitor|selective vegf inhibitor
542102|NCT01255137|Clinical Activity|clinical activity
542103|NCT01255137|Response Rate|response rate
542104|NCT01255137|Measurable Disease|measurable disease
542105|NCT01255137|Biological Markers|biological markers
542106|NCT01255137|Adrenocortical Cancer|adrenocortical cancer
542107|NCT01255111|Chronic respiratory failure|chronic respiratory failure
542108|NCT01255111|Noninvasive ventilation|noninvasive ventilation
542109|NCT01255111|Patient-ventilator interactions|patient-ventilator interactions
542110|NCT01255111|Sleep|sleep
542111|NCT01255111|Sleep fragmentation|sleep fragmentation
542112|NCT01255085|Obesity|obesity
542113|NCT01255085|Food intake regulation|food intake regulation
542114|NCT01255085|blood glucose regulation|blood glucose regulation
542115|NCT01255085|protein|protein
542116|NCT01255085|fiber|fiber
542117|NCT01255085|pulses|pulses
542118|NCT01255085|yellow peas|yellow peas
542119|NCT01255072|TMS|tms
542120|NCT01255072|elderly|elderly
542121|NCT01255072|depression|depression
542122|NCT01255072|neuronavegation|neuronavegation
542123|NCT01255072|neurocognition|neurocognition
542124|NCT01255059|Genome-wide association studies(GWAS)|genome-wide association studies(gwas)
542125|NCT01255059|Single nucleotide polymorphism(SNP)|single nucleotide polymorphism(snp)
542126|NCT01255059|Lung cancer|lung cancer
542127|NCT01255033|perioperative surgery|perioperative surgery
542128|NCT01255033|regional oxygenation|regional oxygenation
542129|NCT01255033|hypoxemia|hypoxemia
542130|NCT01255033|brain hypoxemia|brain hypoxemia
542131|NCT01255033|spectroscopy, near-infrared|spectroscopy, near-infrared
542132|NCT01255020|α-Keto Acid|α-keto acid
542133|NCT01255020|Restricted Protein Diet|restricted protein diet
542134|NCT01255020|Residual Renal Function|residual renal function
542135|NCT01255007|Colorectal|colorectal
542136|NCT01255007|liver|liver
542137|NCT01255007|metastases|metastases
542138|NCT01255007|Primovist|primovist
542139|NCT01255007|MRI|mri
542140|NCT01255007|CT|ct
542141|NCT01255007|cancer|cancer
542142|NCT01255007|resection|resection
542144|NCT01255007|Diffusion|diffusion
542145|NCT01255007|Weighted|weighted
542147|NCT01254994|hepatitis B|hepatitis b
542148|NCT01254994|acute on chronic liver failure (ACHBLF)|acute on chronic liver failure (achblf)
542149|NCT01254994|entecavir|entecavir
542150|NCT01254994|treatment|treatment
542151|NCT01254994|predicting|predicting
542152|NCT01254981|Percutaneous coronary intervention|percutaneous coronary intervention
542153|NCT01254981|DES|des
542154|NCT01254981|Angina pectoris|angina pectoris
542155|NCT01254981|Stent|stent
542156|NCT01254968|blood flow in the middle cerebral artery of brain|blood flow in the middle cerebral artery of brain
542157|NCT01254955|2009 H1N1 influenza vaccine, organ transplant patients|2009 h1n1 influenza vaccine, organ transplant patients
542158|NCT01254942|exercise|exercise
542159|NCT01254942|hip fractures|hip fractures
542160|NCT01254942|rehabilitation|rehabilitation
542161|NCT01254942|aged|aged
542162|NCT01254942|aged 80 and over|aged 80 and over
542163|NCT01254929|Cancer|cancer
542164|NCT01254929|Bone metastases|bone metastases
542165|NCT01254916|Chronic Rhinosinusitis|chronic rhinosinusitis
542166|NCT01254916|Sinonasal Outcome test 22|sinonasal outcome test 22
542167|NCT01254903|Stereotactic Radiosurgery|stereotactic radiosurgery
542168|NCT01254903|Radiation|radiation
542169|NCT01254903|Radiotherapy|radiotherapy
542170|NCT01254903|Metastatic Epidural Spinal Cord Compression|metastatic epidural spinal cord compression
542171|NCT01254903|MESCC|mescc
542172|NCT01254890|Relapsed Acute Leukemia|relapsed acute leukemia
542173|NCT01254890|Chronic Myelomonocytic Leukemia|chronic myelomonocytic leukemia
542174|NCT01254890|CMML|cmml
542175|NCT01254890|Myelodysplastic Syndrome|myelodysplastic syndrome
542176|NCT01254890|MDS|mds
542177|NCT01254890|Acute myeloid leukemia|acute myeloid leukemia
542178|NCT01254890|AML|aml
542179|NCT01254890|5-azacitidine|5-azacitidine
542180|NCT01254890|Azacitidine|azacitidine
542181|NCT01254890|5-aza|5-aza
542182|NCT01254890|Vidaza|vidaza
542183|NCT01254890|5-AZC|5-azc
542184|NCT01254890|AZA-CR|aza-cr
542185|NCT01254890|Ladakamycin|ladakamycin
542186|NCT01254890|NSC-102816|nsc-102816
542187|NCT01254890|Sorafenib|sorafenib
542188|NCT01254890|Nexavar|nexavar
542189|NCT01254890|BAY43-9006|bay43-9006
542190|NCT01254877|HIV|hiv
542191|NCT01254864|Castrate resistant prostate cancer|castrate resistant prostate cancer
542192|NCT01254864|Adenocarcinoma of the prostate|adenocarcinoma of the prostate
542193|NCT01254864|Sunitinib Malate|sunitinib malate
542194|NCT01254864|SUO11248|suo11248
542195|NCT01254864|Sutent|sutent
542196|NCT01254864|BMS-354825|bms-354825
542197|NCT01254864|Sprycel|sprycel
542198|NCT01254851|discharge criteria, gynecologic surgery, post-op ambulation|discharge criteria, gynecologic surgery, post-op ambulation
542199|NCT01254825|Adductor Canal Block (ACB)|adductor canal block (acb)
542200|NCT01254825|Diagnostic Knee Arthroscopy|diagnostic knee arthroscopy
542201|NCT01254825|Saphenous nerve|saphenous nerve
542202|NCT01254825|Pain|pain
542203|NCT01254825|Ultrasound block|ultrasound block
542204|NCT01254812|pulmonary function|pulmonary function
542205|NCT01254812|BD-TAP-block|bd-tap-block
542206|NCT01254786|VATS|vats
542207|NCT01254786|one lung ventilation|one lung ventilation
542208|NCT01254786|continuous positive pressure ventilation|continuous positive pressure ventilation
542209|NCT01254786|high frequency positive pressure ventilation|high frequency positive pressure ventilation
542210|NCT01254721|Acute bipolar mania|acute bipolar mania
542211|NCT01254721|Seroquel XR|seroquel xr
542212|NCT01254721|Seroquel XR plus lithium|seroquel xr plus lithium
542213|NCT01254721|Quetiapine fumarate|quetiapine fumarate
542214|NCT01254695|Idiopathic Fecal Incontinence|idiopathic fecal incontinence
542215|NCT01254695|Fecal Incontinence|fecal incontinence
542216|NCT01254695|Sacral Nerve Stimulation|sacral nerve stimulation
542217|NCT01254695|Sacral Nerve Neuromodulation|sacral nerve neuromodulation
542218|NCT01254682|wrist|wrist
542219|NCT01254682|joint|joint
542220|NCT01254682|arthroscopy|arthroscopy
542221|NCT01254682|hyaluronan|hyaluronan
542222|NCT01254682|hyaluronic acid|hyaluronic acid
542223|NCT01254682|Necessity of Arthroscopic surgery|necessity of arthroscopic surgery
542224|NCT01254669|Haitian girls, African American girls|haitian girls, african american girls
542225|NCT01254669|Brief Negotiated Interview|brief negotiated interview
542226|NCT01254669|cognitive behavioral intervention|cognitive behavioral intervention
542227|NCT01254669|HPV vaccine|hpv vaccine
542228|NCT01254669|cervical cancer|cervical cancer
542229|NCT01254643|Papillomavirus vaccines|papillomavirus vaccines
542230|NCT01254643|Uterine cervical cancer|uterine cervical cancer
542231|NCT01254643|Human Papilloma Virus infections|human papilloma virus infections
542232|NCT01254630|Herpes zoster|herpes zoster
542233|NCT01254630|vaccine|vaccine
542234|NCT01254630|herpes-zoster-related complications|herpes-zoster-related complications
542235|NCT01254630|immunocompromised|immunocompromised
542236|NCT01254630|herpes zoster-associated pain|herpes zoster-associated pain
542237|NCT01254630|solid tumor malignancy|solid tumor malignancy
542238|NCT01254630|hematologic malignancy|hematologic malignancy
542239|NCT01254604|Tafluprost|tafluprost
542240|NCT01254604|Glaucoma|glaucoma
542241|NCT01254604|Ocular Hypertension|ocular hypertension
542242|NCT01254604|Timolol|timolol
542243|NCT01254604|Eye Disorder|eye disorder
542244|NCT01254604|Preservative-Free|preservative-free
542245|NCT01254604|Prostaglandin Analogue|prostaglandin analogue
542246|NCT01254591|stage IA non-small cell lung cancer|stage ia non-small cell lung cancer
542247|NCT01254591|stage IB non-small cell lung cancer|stage ib non-small cell lung cancer
542248|NCT01254591|stage IIA non-small cell lung cancer|stage iia non-small cell lung cancer
542249|NCT01254591|stage IIB non-small cell lung cancer|stage iib non-small cell lung cancer
542250|NCT01254591|stage IIIA non-small cell lung cancer|stage iiia non-small cell lung cancer
542251|NCT01254591|stage I colon cancer|stage i colon cancer
542252|NCT01254591|stage IIA colon cancer|stage iia colon cancer
542253|NCT01254591|stage IIB colon cancer|stage iib colon cancer
542254|NCT01254591|stage IIC colon cancer|stage iic colon cancer
542255|NCT01254591|stage IIIA colon cancer|stage iiia colon cancer
542256|NCT01254591|stage I rectal cancer|stage i rectal cancer
542257|NCT01254591|stage IIA rectal cancer|stage iia rectal cancer
542258|NCT01254591|stage IIB rectal cancer|stage iib rectal cancer
542259|NCT01254591|stage IIC rectal cancer|stage iic rectal cancer
542260|NCT01254591|stage IIIA rectal cancer|stage iiia rectal cancer
542261|NCT01254591|stage IA breast cancer|stage ia breast cancer
542262|NCT01254591|stage IB breast cancer|stage ib breast cancer
542263|NCT01254591|stage II breast cancer|stage ii breast cancer
542264|NCT01254591|stage IIIA breast cancer|stage iiia breast cancer
542265|NCT01254591|stage IIIB breast cancer|stage iiib breast cancer
542266|NCT01254591|stage I esophageal cancer|stage i esophageal cancer
542267|NCT01254591|stage II esophageal cancer|stage ii esophageal cancer
542268|NCT01254591|stage III esophageal cancer|stage iii esophageal cancer
542269|NCT01254591|stage I hypopharyngeal cancer|stage i hypopharyngeal cancer
542270|NCT01254591|stage II hypopharyngeal cancer|stage ii hypopharyngeal cancer
542271|NCT01254591|stage III hypopharyngeal cancer|stage iii hypopharyngeal cancer
542272|NCT01254591|stage I laryngeal cancer|stage i laryngeal cancer
542273|NCT01254591|stage II laryngeal cancer|stage ii laryngeal cancer
542274|NCT01254591|stage III laryngeal cancer|stage iii laryngeal cancer
542275|NCT01254591|stage I lip and oral cavity cancer|stage i lip and oral cavity cancer
542276|NCT01254591|stage II lip and oral cavity cancer|stage ii lip and oral cavity cancer
542277|NCT01254591|stage III lip and oral cavity cancer|stage iii lip and oral cavity cancer
542278|NCT01254591|stage I nasopharyngeal cancer|stage i nasopharyngeal cancer
542279|NCT01254591|stage II nasopharyngeal cancer|stage ii nasopharyngeal cancer
542280|NCT01254591|stage III nasopharyngeal cancer|stage iii nasopharyngeal cancer
542281|NCT01254591|stage I oropharyngeal cancer|stage i oropharyngeal cancer
542282|NCT01254591|stage II oropharyngeal cancer|stage ii oropharyngeal cancer
542283|NCT01254591|stage III oropharyngeal cancer|stage iii oropharyngeal cancer
542284|NCT01254591|stage I paranasal sinus and nasal cavity cancer|stage i paranasal sinus and nasal cavity cancer
542285|NCT01254591|stage II paranasal sinus and nasal cavity cancer|stage ii paranasal sinus and nasal cavity cancer
542286|NCT01254591|stage III paranasal sinus and nasal cavity cancer|stage iii paranasal sinus and nasal cavity cancer
542287|NCT01254591|stage I salivary gland cancer|stage i salivary gland cancer
542288|NCT01254591|stage II salivary gland cancer|stage ii salivary gland cancer
542289|NCT01254591|stage III salivary gland cancer|stage iii salivary gland cancer
542290|NCT01254591|tongue cancer|tongue cancer
542291|NCT01254565|Clinical Trial, Phase 2|clinical trial, phase 2
542292|NCT01254565|Renal Dialysis|renal dialysis
542293|NCT01254565|Secondary Hyperparathyroidism|secondary hyperparathyroidism
542294|NCT01254565|Parathyroid hormone|parathyroid hormone
542295|NCT01254539|Amyotrophic Lateral Sclerosis|amyotrophic lateral sclerosis
542296|NCT01254539|Bone marrow|bone marrow
542297|NCT01254539|Stem cells|stem cells
542298|NCT01254539|Autologous|autologous
542299|NCT01254539|Safety|safety
542300|NCT01254513|Metastatic Prostate cancer|metastatic prostate cancer
542301|NCT01254513|Elderly patients|elderly patients
542302|NCT01254513|Vulnerable and Frail (SIOG classification)|vulnerable and frail (siog classification)
542303|NCT01254513|castration-resistant|castration-resistant
542304|NCT01254500|patients with brain lesions|patients with brain lesions
542305|NCT01254474|Depolarization, tissue|depolarization, tissue
542306|NCT01254474|Repolarization, tissue|repolarization, tissue
542307|NCT01254474|Cardiac Arrhythmias|cardiac arrhythmias
542308|NCT01254474|Action potentials, monophasic|action potentials, monophasic
542309|NCT01254474|Mapping, Catheter|mapping, catheter
542310|NCT01254474|Cardiac activation|cardiac activation
542311|NCT01254461|Phase 1|phase 1
542312|NCT01254461|Drug-Drug interaction|drug-drug interaction
542313|NCT01254461|pravastatin|pravastatin
542314|NCT01254461|AZD1981|azd1981
542315|NCT01254461|The pharmacokinetics resulting from AZD1981 and pravastatin interaction|the pharmacokinetics resulting from azd1981 and pravastatin interaction
542316|NCT01254461|The effects of taking a combination of AZD1981 and pravastatin|the effects of taking a combination of azd1981 and pravastatin
542317|NCT01254448|Alzheimer's Disease|alzheimer's disease
542318|NCT01254435|Colonoscopy|colonoscopy
542319|NCT01254435|Positioning in colonoscopy|positioning in colonoscopy
542320|NCT01254435|Quality control|quality control
542321|NCT01254422|Dengue fever|dengue fever
542322|NCT01254422|Dengue hemorrhagic fever|dengue hemorrhagic fever
542935|NCT01251341|meditation|meditation
542323|NCT01254422|CYD dengue vaccine|cyd dengue vaccine
542324|NCT01254409|pulmonary, fibrosis|pulmonary, fibrosis
542325|NCT01254396|Bioavailability Food Effect Oral Dissolving Tablet (ODT)|bioavailability food effect oral dissolving tablet (odt)
542326|NCT01254383|Bioequivalence Oral Dissolving Tablet|bioequivalence oral dissolving tablet
542327|NCT01254357|Burns|burns
542328|NCT01254357|Trauma|trauma
542329|NCT01254357|Outcomes|outcomes
542330|NCT01254357|Quality of Life|quality of life
542331|NCT01254344|Colorectal surgery|colorectal surgery
542332|NCT01254318|hematological malignancy|hematological malignancy
542333|NCT01254318|fungal infection|fungal infection
542334|NCT01254318|leukemia|leukemia
542335|NCT01254305|Depression|depression
542336|NCT01254305|Fatigue|fatigue
542337|NCT01254305|Major Depressive Disorder|major depressive disorder
542338|NCT01254266|morbid obesity|morbid obesity
542339|NCT01254266|adolescents|adolescents
542340|NCT01254266|inpatient treatment|inpatient treatment
542341|NCT01254253|percutaneous coronary intervention|percutaneous coronary intervention
542342|NCT01254253|chronic total occlusion|chronic total occlusion
542343|NCT01254253|coronary angiography|coronary angiography
542344|NCT01254253|single photon emission CT|single photon emission ct
542345|NCT01254253|Multislice coronary CT angiography|multislice coronary ct angiography
542346|NCT01254227|Cardiac iron overload,|cardiac iron overload,
542347|NCT01254227|deferasirox,|deferasirox,
542348|NCT01254227|deferoxamine|deferoxamine
542349|NCT01254214|Mindfulness|mindfulness
542350|NCT01254214|Quality of life|quality of life
542351|NCT01254214|Transplantation|transplantation
542352|NCT01254214|Renal disease|renal disease
542353|NCT01254188|Chronic myeloid leukemia,|chronic myeloid leukemia,
542354|NCT01254188|CML,|cml,
542355|NCT01254188|nilotinib,|nilotinib,
542356|NCT01254188|myelogenous,|myelogenous,
542357|NCT01254188|Philadelphia chromosome|philadelphia chromosome
542358|NCT01254162|Oily Skin|oily skin
542359|NCT01254162|Sebum|sebum
542360|NCT01254123|Glucagon Like Peptide-1|glucagon like peptide-1
542361|NCT01254123|Exenatide|exenatide
542362|NCT01254123|myocardial infarction|myocardial infarction
542363|NCT01254123|MRI|mri
542364|NCT01254123|PCI|pci
542365|NCT01254084|Herbal medicine; Type 2 diabetes; Gynostemma pentaphyllum Tea; Insulin sensitivity;|herbal medicine; type 2 diabetes; gynostemma pentaphyllum tea; insulin sensitivity;
542366|NCT01254071|GI198745|gi198745
542367|NCT01254071|Tamsulosin hydrochloride|tamsulosin hydrochloride
542368|NCT01254071|Dutasteride|dutasteride
542369|NCT01254071|food effect|food effect
542370|NCT01254071|healthy male subjects|healthy male subjects
542371|NCT01254071|north-east Asian ancestry|north-east asian ancestry
542372|NCT01254071|Bioequivalence|bioequivalence
542373|NCT01254071|cross-over design|cross-over design
542374|NCT01254071|Pilot bioequivalence|pilot bioequivalence
542375|NCT01254032|CAT|cat
542376|NCT01254032|COPD|copd
542377|NCT01254019|Duchenne Muscular Dystrophy|duchenne muscular dystrophy
542378|NCT01254019|DMD|dmd
542379|NCT01254019|968|968
542380|NCT01254019|GSK|gsk
542381|NCT01254019|Duchenne|duchenne
542382|NCT01253993|Disruptive Behavior Disorders, Substance abuse,|disruptive behavior disorders, substance abuse,
542383|NCT01253993|Iowa Gambling Task, Decision Making.|iowa gambling task, decision making.
542384|NCT01253980|pneumonitis|pneumonitis
542385|NCT01253980|paraffin|paraffin
542386|NCT01253980|kerosene|kerosene
542387|NCT01253967|Gastroenteritis|gastroenteritis
542388|NCT01253967|Hospital surveillance|hospital surveillance
542389|NCT01253967|Rotavirus gastroenteritis|rotavirus gastroenteritis
542390|NCT01253954|invasive candida infection|invasive candida infection
542391|NCT01253941|COPD, Intensive Resistive Breathing, Cytokine IL6,|copd, intensive resistive breathing, cytokine il6,
542392|NCT01253928|body composition|body composition
542393|NCT01253928|insulin sensitivity|insulin sensitivity
542394|NCT01253928|protein metabolism|protein metabolism
542395|NCT01253928|pioglitazone|pioglitazone
542396|NCT01253889|Functional echocardiography|functional echocardiography
542397|NCT01253889|oral glucose|oral glucose
542398|NCT01253889|neonatal stress|neonatal stress
542399|NCT01253863|Clinical Examination, Accuracy, Hand, Tendon, Injury.|clinical examination, accuracy, hand, tendon, injury.
542400|NCT01253850|hiv|hiv
542401|NCT01253850|antiretroviral|antiretroviral
542402|NCT01253850|adherence|adherence
542403|NCT01253850|adolescent|adolescent
542404|NCT01253837|L19|l19
542405|NCT01253837|antibody|antibody
542406|NCT01253837|monoclonal|monoclonal
542407|NCT01253837|tumor targeting|tumor targeting
542408|NCT01253837|TNFa|tnfa
542409|NCT01253837|colorectal cancer|colorectal cancer
542410|NCT01253837|Phase I: Patients with relapsed or refractory locally advanced or metastatic solid tumors not amenable to standard systemic therapy.|phase i: patients with relapsed or refractory locally advanced or metastatic solid tumors not amenable to standard systemic therapy.
542411|NCT01253837|Phase II: Patients with relapsed or refractory locally advanced or metastatic colorectal cancer not amenable to standard systemic therapy.|phase ii: patients with relapsed or refractory locally advanced or metastatic colorectal cancer not amenable to standard systemic therapy.
542412|NCT01253824|NPC-01|npc-01
542413|NCT01253824|IKH-01|ikh-01
542414|NCT01253824|Pharmacodynamics|pharmacodynamics
542415|NCT01253824|Norethisterone|norethisterone
542416|NCT01253824|Ethinyl Estradiol|ethinyl estradiol
542417|NCT01253824|Estradiol|estradiol
542418|NCT01253824|Progesterone|progesterone
542420|NCT01253824|LH|lh
542421|NCT01253798|exercise|exercise
542422|NCT01253798|hydrotherapy|hydrotherapy
542423|NCT01253759|Transpupillary thermotherapy|transpupillary thermotherapy
542424|NCT01253759|Choroidal melanoma|choroidal melanoma
542425|NCT01253759|ICG-Photodynamic therapy|icg-photodynamic therapy
542426|NCT01253746|NTD|ntd
542427|NCT01253746|open NTD|open ntd
542428|NCT01253746|spina bifida|spina bifida
542429|NCT01253746|anencephaly|anencephaly
542430|NCT01253746|closed NTD|closed ntd
542431|NCT01253746|lipomeningocele|lipomeningocele
542432|NCT01253746|tethered cord.|tethered cord.
542433|NCT01253733|Cystic Fibrosis|cystic fibrosis
542434|NCT01253733|Inflammatory Bowel Disease|inflammatory bowel disease
542435|NCT01253733|Type 1 Diabetes|type 1 diabetes
542436|NCT01253733|Chronic Disease Management|chronic disease management
542437|NCT01253733|SMS|sms
542438|NCT01253733|Text messages|text messages
542439|NCT01253733|Internet|internet
542440|NCT01253733|Healthcare Interactions|healthcare interactions
542441|NCT01253720|obesity|obesity
542442|NCT01253720|text messages|text messages
542443|NCT01253720|internet|internet
542444|NCT01253720|cancer|cancer
542445|NCT01253720|overweight|overweight
542446|NCT01253707|Solid Tumors|solid tumors
542447|NCT01253707|C-met inhibitor|c-met inhibitor
542448|NCT01253694|Diabetes|diabetes
542449|NCT01253694|edema|edema
542450|NCT01253694|ranibizumab|ranibizumab
542451|NCT01253694|bevacizumab|bevacizumab
542452|NCT01253694|refractory|refractory
542453|NCT01253681|AMG 386|amg 386
542454|NCT01253681|Ovarian Cancer|ovarian cancer
542455|NCT01253655|Healthy Volunteers|healthy volunteers
542456|NCT01253629|Fragile X Syndrome|fragile x syndrome
542457|NCT01253629|Martin-Bell Syndrome|martin-bell syndrome
542458|NCT01253629|Genetic Diseases|genetic diseases
542459|NCT01253629|X-Linked|x-linked
542460|NCT01253603|Asthma|asthma
542461|NCT01253590|atrial fibrillation|atrial fibrillation
542462|NCT01253590|ECG monitor|ecg monitor
542463|NCT01253590|Blood pressure device|blood pressure device
542464|NCT01253590|Remote Cardiac Monitoring|remote cardiac monitoring
542465|NCT01253551|VX-950HEP1001|vx-950hep1001
542466|NCT01253551|hepatitis|hepatitis
542467|NCT01253551|telaprevir|telaprevir
542468|NCT01253551|raltegravir|raltegravir
542469|NCT01253551|crossover|crossover
542470|NCT01253551|healthy volunteers|healthy volunteers
542471|NCT01253551|VX-950.|vx-950.
542472|NCT01253525|Adenocarcinoma|adenocarcinoma
542473|NCT01253525|Gastroesophageal Junction|gastroesophageal junction
542474|NCT01253512|Ischemic Stroke|ischemic stroke
542475|NCT01253512|Thrombolysis|thrombolysis
542476|NCT01253486|expressive writing|expressive writing
542477|NCT01253486|cardiac rehabilitation|cardiac rehabilitation
542478|NCT01253473|COPD|copd
542479|NCT01253460|Chronic Lymphocytic Leukemia|chronic lymphocytic leukemia
542480|NCT01253460|CLL|cll
542481|NCT01253460|Small Lymphocytic Lymphoma|small lymphocytic lymphoma
542482|NCT01253460|SLL|sll
542483|NCT01253460|Cyclophosphamide|cyclophosphamide
542484|NCT01253460|Rituximab|rituximab
542485|NCT01253460|Sapacitabine|sapacitabine
542486|NCT01253460|Cytoxan|cytoxan
542487|NCT01253460|Neosar|neosar
542488|NCT01253460|Rituxan|rituxan
542489|NCT01253434|Transdermal Administration|transdermal administration
542490|NCT01253421|MDD|mdd
542491|NCT01253421|Major Depressive Disorder|major depressive disorder
542492|NCT01253421|Amisulpride|amisulpride
542493|NCT01253408|anandamide|anandamide
542494|NCT01253408|cannabinoid|cannabinoid
542495|NCT01253408|fatty acid amide hydrolase|fatty acid amide hydrolase
542496|NCT01253408|gastric|gastric
542497|NCT01253408|motility|motility
542498|NCT01253408|small bowel|small bowel
542499|NCT01253395|Exercise|exercise
542500|NCT01253395|Pain|pain
542501|NCT01253369|pazopanib|pazopanib
542502|NCT01253317|Rett Syndrome|rett syndrome
542503|NCT01253317|IGF-1|igf-1
542504|NCT01253317|Increlex|increlex
542505|NCT01253317|Mecasermin|mecasermin
542506|NCT01253317|IGF1|igf1
542507|NCT01253317|MECP2|mecp2
542508|NCT01253317|RTT|rtt
542509|NCT01253252|Abdominal Aortic Aneurysm|abdominal aortic aneurysm
542510|NCT01253252|Prosthesis|prosthesis
542511|NCT01253252|Fluorodeoxyglucose F18|fluorodeoxyglucose f18
542512|NCT01253252|Positron-emission Tomography|positron-emission tomography
542513|NCT01253252|Spiral computed tomography|spiral computed tomography
542514|NCT01253252|Biological markers|biological markers
542515|NCT01253239|Visual outcomes|visual outcomes
542516|NCT01253239|Patient satisfaction|patient satisfaction
542517|NCT01253213|Prostate cancer|prostate cancer
542518|NCT01253213|Ultrasound molecular imaging|ultrasound molecular imaging
542519|NCT01253213|Contrast agent|contrast agent
542520|NCT01253213|BR55|br55
542521|NCT01253213|VEGFR2|vegfr2
542522|NCT01253200|Type 1 Atrial Flutter|type 1 atrial flutter
542523|NCT01253200|Typical Atrial Flutter|typical atrial flutter
542524|NCT01253200|Arrhythmias, Cardiac|arrhythmias, cardiac
542525|NCT01253200|Heart Diseases|heart diseases
542526|NCT01253200|Cardiovascular Diseases|cardiovascular diseases
542527|NCT01253161|advanced|advanced
542528|NCT01253161|metastatic|metastatic
542529|NCT01253161|unresectable|unresectable
542530|NCT01253161|carcinoma|carcinoma
542531|NCT01253161|gastrointestinal tract|gastrointestinal tract
542533|NCT01253161|colon|colon
542534|NCT01253161|liver|liver
689341|NCT00675415|EUS|eus
542535|NCT01253161|rectum|rectum
542536|NCT01253161|small intestine|small intestine
542537|NCT01253161|stomach|stomach
542538|NCT01253161|pancreatic|pancreatic
542539|NCT01253148|Liver|liver
542540|NCT01253148|Bile Duct|bile duct
542541|NCT01253135|Fibrin, white petrolatum, wound healing|fibrin, white petrolatum, wound healing
542542|NCT01253096|Interleukin|interleukin
542543|NCT01253096|IL2|il2
542544|NCT01253096|monoclonal|monoclonal
542545|NCT01253096|antibody|antibody
542546|NCT01253096|cytokine|cytokine
542547|NCT01253096|metastatic|metastatic
542548|NCT01253096|melanoma|melanoma
542549|NCT01253096|tumor targeting|tumor targeting
542550|NCT01253096|intratumoral|intratumoral
542551|NCT01253096|Malignant melanoma with presence of injectable soft-tissue metastases either in clinical stage III or stage IV without visceral metastases.|malignant melanoma with presence of injectable soft-tissue metastases either in clinical stage iii or stage iv without visceral metastases.
542552|NCT01253083|Mobility|mobility
542553|NCT01253083|Developmental Delay|developmental delay
542554|NCT01253083|Cerebral Palsy|cerebral palsy
542555|NCT01253083|Early Walking|early walking
542556|NCT01253083|Postural Control|postural control
542557|NCT01253057|cleaning staff|cleaning staff
542558|NCT01253057|antineoplastic agents|antineoplastic agents
542559|NCT01253044|OEF/OIF|oef/oif
542560|NCT01253044|Veterans|veterans
542561|NCT01253044|Psychotherapy|psychotherapy
542562|NCT01253031|hearing loss|hearing loss
542563|NCT01253031|aging|aging
542564|NCT01253031|short term memory|short term memory
542565|NCT01253031|attentional blink|attentional blink
542566|NCT01253018|stroke|stroke
542567|NCT01253018|robotics|robotics
542568|NCT01253018|upper extremity rehabilitation|upper extremity rehabilitation
542569|NCT01252992|Extrapulmonary|extrapulmonary
542570|NCT01252992|Tuberculosis|tuberculosis
542571|NCT01252992|Paradoxical reaction|paradoxical reaction
542572|NCT01252992|Risk factors|risk factors
542573|NCT01252992|Incidence|incidence
542574|NCT01252992|CT scan|ct scan
542575|NCT01252992|Natural history|natural history
542576|NCT01252992|Immune system phenomena|immune system phenomena
542577|NCT01252992|Immune markers|immune markers
542578|NCT01252992|Gene Expression Profiling|gene expression profiling
542579|NCT01252979|MELAS|melas
542580|NCT01252979|Ketones|ketones
542581|NCT01252979|Medium Chain Triglycerides|medium chain triglycerides
542582|NCT01252979|MCT oil|mct oil
542583|NCT01252979|Mitochondrial Disorder|mitochondrial disorder
542584|NCT01252979|Heteroplasmy|heteroplasmy
542585|NCT01252979|3243AG|3243ag
542586|NCT01252979|Subject is informed and given ample opportunity to consider his/her participation and has given his/her written consent.|subject is informed and given ample opportunity to consider his/her participation and has given his/her written consent.
542587|NCT01252979|Subject is willing and able to comply with all trial requirements.|subject is willing and able to comply with all trial requirements.
542588|NCT01252979|Subject harbors the 3243 A>G mtDNA mutation at a level detectable in blood.|subject harbors the 3243 a>g mtdna mutation at a level detectable in blood.
542589|NCT01252979|Female subjects of child-bearing potential must not be pregnant.|female subjects of child-bearing potential must not be pregnant.
542590|NCT01252979|Subjects must not have Diabetes Mellitus.|subjects must not have diabetes mellitus.
542591|NCT01252966|Tobacco|tobacco
542592|NCT01252966|Smoking|smoking
542593|NCT01252966|Cognition|cognition
542594|NCT01252966|Behavioral Training|behavioral training
542595|NCT01252966|Relapse|relapse
542596|NCT01252953|vascular disease|vascular disease
542597|NCT01252953|lipids|lipids
542598|NCT01252953|cholesteryl ester transfer protein (CETP) inhibition|cholesteryl ester transfer protein (cetp) inhibition
542599|NCT01252953|anacetrapib|anacetrapib
542600|NCT01252940|HIV-1|hiv-1
542601|NCT01252940|HIV|hiv
542602|NCT01252940|Treatment Experienced|treatment experienced
542603|NCT01252914|Open angle|open angle
542604|NCT01252914|Glaucoma|glaucoma
542605|NCT01252914|Surgery|surgery
542606|NCT01252914|Ocular Hypertension|ocular hypertension
542607|NCT01252914|Eye Diseases|eye diseases
542608|NCT01252901|WT1|wt1
542609|NCT01252901|Wilms Tumor|wilms tumor
542610|NCT01252901|Denys-Drash Syndrome|denys-drash syndrome
542611|NCT01252901|Nephrotic Syndrome|nephrotic syndrome
542612|NCT01252901|Proteinuria|proteinuria
542613|NCT01252888|Open angle|open angle
542614|NCT01252888|Glaucoma|glaucoma
542615|NCT01252888|Surgery|surgery
542616|NCT01252888|Glaucoma Open-Angle|glaucoma open-angle
542617|NCT01252888|Ocular Hypertension|ocular hypertension
542618|NCT01252888|Eye Diseases|eye diseases
542619|NCT01252875|LDL-C|ldl-c
542620|NCT01252875|Cholesterol|cholesterol
542621|NCT01252875|Stroke|stroke
542622|NCT01252875|Transient ischemic attack|transient ischemic attack
542623|NCT01252875|Statin|statin
542624|NCT01252875|Lipid lowering therapy|lipid lowering therapy
542625|NCT01252862|Open angle|open angle
542626|NCT01252862|Glaucoma|glaucoma
542627|NCT01252862|Surgery|surgery
542628|NCT01252862|Ocular Hypertension|ocular hypertension
542629|NCT01252862|eye diseases|eye diseases
542630|NCT01252849|Open angle|open angle
542631|NCT01252849|Glaucoma|glaucoma
542632|NCT01252849|surgery|surgery
542633|NCT01252849|Glaucoma, Open-Angle|glaucoma, open-angle
542634|NCT01252849|Ocular Hypertension|ocular hypertension
542635|NCT01252849|Eye Diseases|eye diseases
542636|NCT01252823|Hemodialysis|hemodialysis
542637|NCT01252823|Cardiac Arrhythmia|cardiac arrhythmia
542638|NCT01252823|Cardiac Death|cardiac death
542639|NCT01252823|Implantable Loop Recorder|implantable loop recorder
542640|NCT01252810|CATH Catheterization|cath catheterization
542641|NCT01252810|CI-AKI Contrast-induced acute kidney injury|ci-aki contrast-induced acute kidney injury
542642|NCT01252810|DM Diabetes mellitus|dm diabetes mellitus
542643|NCT01252810|eGFR Estimated glomerular filtration rate|egfr estimated glomerular filtration rate
542644|NCT01252810|MDRD Modification of Diet in Renal Disease|mdrd modification of diet in renal disease
542645|NCT01252810|NYHA New York Heart Association|nyha new york heart association
542646|NCT01252810|PCI Percutaneous coronary intervention|pci percutaneous coronary intervention
542647|NCT01252810|SCr Serum creatinine|scr serum creatinine
542648|NCT01252797|brain metastases|brain metastases
542649|NCT01252784|higher risk MDS|higher risk mds
542650|NCT01252771|phosphorus|phosphorus
542651|NCT01252771|dialysis|dialysis
542652|NCT01252771|PhosLo|phoslo
542653|NCT01252732|ABSSSI|absssi
542654|NCT01252732|Skin Infection|skin infection
542655|NCT01252732|Abscess|abscess
542656|NCT01252719|ABSSSI|absssi
542657|NCT01252719|Skin Infection|skin infection
542658|NCT01252719|Abscess|abscess
542659|NCT01252706|brief intervention|brief intervention
542660|NCT01252706|alcohol|alcohol
542661|NCT01252706|nicotine|nicotine
542662|NCT01252706|drug abuse|drug abuse
542663|NCT01252654|Lasik|lasik
542664|NCT01252654|Femtosecond Laser|femtosecond laser
542665|NCT01252654|Visumax|visumax
542666|NCT01252654|IntraLase|intralase
542667|NCT01252654|Myopia|myopia
542668|NCT01252654|Myopic Patients undergoing LASIK|myopic patients undergoing lasik
542669|NCT01252641|HIV|hiv
542670|NCT01252628|CRC|crc
542671|NCT01252628|SCCHN|scchn
542672|NCT01252628|PX-866|px-866
542673|NCT01252628|Cetuximab|cetuximab
542674|NCT01252628|ERBITUX|erbitux
542675|NCT01252628|Colon|colon
542676|NCT01252628|Head and Neck|head and neck
542677|NCT01252628|Colorectal cancer|colorectal cancer
542678|NCT01252628|Squamous cell carcinoma|squamous cell carcinoma
542679|NCT01252628|PI-3K|pi-3k
542680|NCT01252628|PI3 kinase|pi3 kinase
542681|NCT01252628|PI3K|pi3k
542682|NCT01252615|ICD|icd
542683|NCT01252615|HF|hf
542684|NCT01252615|cardiac arrest|cardiac arrest
542685|NCT01252615|VF|vf
542686|NCT01252615|cardiac arrhythmias|cardiac arrhythmias
542687|NCT01252602|breastfeeding, EPDS, prenatal depression|breastfeeding, epds, prenatal depression
542688|NCT01252589|Chronic Myeloid Leukemia|chronic myeloid leukemia
542689|NCT01252589|Quality of Life|quality of life
542690|NCT01252589|Symptoms|symptoms
542691|NCT01252589|Patient-Reported outcomes|patient-reported outcomes
542692|NCT01252589|Questionnaire|questionnaire
542693|NCT01252576|FSFI|fsfi
542694|NCT01252576|female sexual function|female sexual function
542695|NCT01252576|italian validation|italian validation
542696|NCT01252563|ENTER10|enter10
542697|NCT01252563|Hypertension|hypertension
542698|NCT01252563|Japanese|japanese
542699|NCT01252563|Norvasc 10mg|norvasc 10mg
542700|NCT01252563|Post Marketing surveillance|post marketing surveillance
542701|NCT01252550|IBS|ibs
542702|NCT01252550|GI|gi
542703|NCT01252550|QOL|qol
542704|NCT01252550|Pathophysiology|pathophysiology
542705|NCT01252550|Gut microbiota|gut microbiota
542706|NCT01252550|Danone|danone
542707|NCT01252550|Activia|activia
542708|NCT01252550|Probiotics|probiotics
542709|NCT01252537|HIV|hiv
542710|NCT01252537|Tuberculosis|tuberculosis
542711|NCT01252537|Immunosuppression|immunosuppression
542712|NCT01252537|ART|art
542713|NCT01252537|Ethiopia|ethiopia
542714|NCT01252537|Primary health care|primary health care
542715|NCT01252524|diabetes mellitus|diabetes mellitus
542716|NCT01252524|fiber|fiber
542717|NCT01252524|glycemic control|glycemic control
542718|NCT01252524|calcium polycarbophil|calcium polycarbophil
542719|NCT01252511|Malabsorption after RYGB|malabsorption after rygb
542720|NCT01252511|Fat Malabsorption and maldigestion|fat malabsorption and maldigestion
542721|NCT01252511|Obesity surgery|obesity surgery
542722|NCT01252511|Bariatric surgery|bariatric surgery
542723|NCT01252498|Cancer of the head and neck|cancer of the head and neck
542724|NCT01252498|Radiotherapy|radiotherapy
542725|NCT01252498|Prostaglandins|prostaglandins
542726|NCT01252485|AML|aml
542727|NCT01252485|Registry study|registry study
542936|NCT01251341|compassion|compassion
542728|NCT01252485|Biology and Outcome|biology and outcome
542729|NCT01252485|Higher Risk MDS|higher risk mds
542730|NCT01252472|Flomax|flomax
542731|NCT01252472|Floppy iris Syndrome|floppy iris syndrome
542732|NCT01252472|Tamsulosin|tamsulosin
542733|NCT01252459|AA-PET|aa-pet
542734|NCT01252459|T1-Gd-MRI|t1-gd-mri
542735|NCT01252459|re-irradiation|re-irradiation
542736|NCT01252459|recurrent glioma|recurrent glioma
542737|NCT01252446|ICD 10|icd 10
542738|NCT01252446|Attention-Deficit-Hyperactivity-Disorder (ADHD)|attention-deficit-hyperactivity-disorder (adhd)
542739|NCT01252446|Comorbidity|comorbidity
542740|NCT01252446|Social-demographic profile|social-demographic profile
542741|NCT01252420|Distal Vein Thrombosis|distal vein thrombosis
542742|NCT01252420|Proximal Vein Thrombosis|proximal vein thrombosis
542743|NCT01252420|Pulmonary Embolism|pulmonary embolism
542744|NCT01252420|Post-thrombotic syndrome|post-thrombotic syndrome
542745|NCT01252420|Limited duration treatment|limited duration treatment
542746|NCT01252407|Transcutaneous electrical nerve stimulation|transcutaneous electrical nerve stimulation
542747|NCT01252407|Sympathetic nervous system|sympathetic nervous system
542748|NCT01252407|Parasympathetic nervous system|parasympathetic nervous system
542749|NCT01252407|heart rate|heart rate
542750|NCT01252342|Oxytocin|oxytocin
542751|NCT01252342|Intramyometrial|intramyometrial
542752|NCT01252329|high risk cutaneous squamous cell carcinoma|high risk cutaneous squamous cell carcinoma
542753|NCT01252329|selective neck dissection|selective neck dissection
542754|NCT01252329|elective lymph node management|elective lymph node management
542755|NCT01252329|clinical nodal observation|clinical nodal observation
542756|NCT01252303|Obesity, weight loss, meal replacements|obesity, weight loss, meal replacements
542757|NCT01252264|biorepository|biorepository
542758|NCT01252264|genetics|genetics
542759|NCT01252264|craniofacial|craniofacial
542760|NCT01252264|cleft lip|cleft lip
542761|NCT01252264|cleft palate|cleft palate
542762|NCT01252251|PASIREOTIDE (SOM230)|pasireotide (som230)
542763|NCT01252251|RAD001 (EVEROLIMUS)|rad001 (everolimus)
542764|NCT01252251|eye|eye
542765|NCT01252251|10-123|10-123
542766|NCT01252225|Chronic Cough|chronic cough
542767|NCT01252225|Lidocaine|lidocaine
542768|NCT01252212|HIV, antiretroviral, adherence, SMS, cell phone|hiv, antiretroviral, adherence, sms, cell phone
542769|NCT01252199|Shigamabs|shigamabs
542770|NCT01252199|Monoclonal|monoclonal
542771|NCT01252199|Antibodies|antibodies
542772|NCT01252199|Shiga|shiga
542773|NCT01252199|Toxin|toxin
542774|NCT01252199|E.coli|e.coli
542775|NCT01252199|HUS|hus
542776|NCT01252199|Bloody|bloody
542777|NCT01252199|Diarrhea|diarrhea
542778|NCT01252186|Contraception|contraception
542779|NCT01252186|Hemostasis|hemostasis
542780|NCT01252186|Blood Coagulation|blood coagulation
542781|NCT01252173|endotracheal|endotracheal
542782|NCT01252173|intubation|intubation
542783|NCT01252173|tracheal|tracheal
542784|NCT01252173|pressure|pressure
542785|NCT01252173|cufflator|cufflator
542786|NCT01252160|Neuralgia, Postherpetic|neuralgia, postherpetic
542787|NCT01252160|QUTENZA|qutenza
542788|NCT01252134|Soft Contact lens|soft contact lens
542789|NCT01252134|Multi-purpose solution|multi-purpose solution
542790|NCT01252134|Wettability|wettability
542791|NCT01252121|Dry Eye|dry eye
542792|NCT01252121|Ocular Retention Time|ocular retention time
542793|NCT01252108|Helicobacter pylori|helicobacter pylori
542794|NCT01252108|peptic ulcer disease|peptic ulcer disease
542795|NCT01252108|stomach ulcers|stomach ulcers
542796|NCT01252108|gastric cancer|gastric cancer
542797|NCT01252095|PG545|pg545
542798|NCT01252095|Phase I|phase i
542799|NCT01252095|Progen|progen
542800|NCT01252095|antimetastatic|antimetastatic
542801|NCT01252095|antiangiogenic|antiangiogenic
542802|NCT01252095|advanced cancer patients|advanced cancer patients
542803|NCT01252095|solid tumors|solid tumors
542804|NCT01252095|solid tumours|solid tumours
542805|NCT01252082|metabolic control|metabolic control
542806|NCT01252082|fasting plasma glucose|fasting plasma glucose
542807|NCT01252082|glycated hemoglobin|glycated hemoglobin
542808|NCT01252043|cholestasis|cholestasis
542809|NCT01252043|children|children
542810|NCT01252030|CAD, physical activity, rehabilitation, prevention|cad, physical activity, rehabilitation, prevention
542811|NCT01252004|Left ventricular ballooning|left ventricular ballooning
542812|NCT01251978|Choroidal melanoma|choroidal melanoma
542813|NCT01251978|Ranibizumab|ranibizumab
542814|NCT01251978|Transpupillary Thermotherapy|transpupillary thermotherapy
542815|NCT01251978|CSTIP|cstip
542816|NCT01251978|Indocyanine Green|indocyanine green
542817|NCT01251965|Relapsed Acute Leukemia|relapsed acute leukemia
542818|NCT01251965|Acute myeloid leukemia|acute myeloid leukemia
542819|NCT01251965|AML|aml
542820|NCT01251965|Acute lymphocytic leukemia|acute lymphocytic leukemia
542821|NCT01251965|ALL|all
542822|NCT01251965|Ruxolitinib|ruxolitinib
542823|NCT01251965|Jakafi|jakafi
542824|NCT01251965|INC424|inc424
542825|NCT01251965|INCB018424|incb018424
542826|NCT01251926|Bevacizumab|bevacizumab
542827|NCT01251926|Camptothecin|camptothecin
542828|NCT01251926|EZN-2208|ezn-2208
542829|NCT01251926|Anti-Angiogenesis|anti-angiogenesis
542830|NCT01251926|Advanced Cancer|advanced cancer
542831|NCT01251926|Cancer|cancer
542832|NCT01251926|Solid Tumor|solid tumor
542833|NCT01251913|Tissue Harvest|tissue harvest
542834|NCT01251913|Hospice|hospice
542835|NCT01251913|Autopsy|autopsy
542836|NCT01251913|Crainiotomy|crainiotomy
542837|NCT01251913|Brain Tumor|brain tumor
542838|NCT01251913|Glioma|glioma
542839|NCT01251913|Astrocytoma|astrocytoma
542840|NCT01251900|Triple Negative Disease|triple negative disease
542841|NCT01251900|BRCA1|brca1
542842|NCT01251900|BRCA2|brca2
542843|NCT01251900|Hispanic/Latino|hispanic/latino
542844|NCT01251900|Breast Cancer|breast cancer
542845|NCT01251887|Lipids|lipids
542846|NCT01251887|Obesity|obesity
542847|NCT01251887|Omega-3 Fatty Acids|omega-3 fatty acids
542848|NCT01251887|Overweight|overweight
542849|NCT01251848|Sitaxentan|sitaxentan
542850|NCT01251848|ritonavir|ritonavir
542851|NCT01251848|drug interaction|drug interaction
542852|NCT01251848|pharmacokinetics|pharmacokinetics
542853|NCT01251835|Sitaxsentan|sitaxsentan
542854|NCT01251835|Rifampin|rifampin
542855|NCT01251835|Drug Interaction|drug interaction
542856|NCT01251835|Pharmacokinetics|pharmacokinetics
542857|NCT01251809|Asparaginase|asparaginase
542858|NCT01251809|ALL|all
542859|NCT01251783|term babies|term babies
542860|NCT01251770|Hyponatremia|hyponatremia
542861|NCT01251770|Water-Electrolyte Imbalance|water-electrolyte imbalance
542862|NCT01251757|diabetes|diabetes
542863|NCT01251757|cardiovascular disease|cardiovascular disease
542864|NCT01251757|randomized clinical trial|randomized clinical trial
542865|NCT01251757|medication adherence|medication adherence
542866|NCT01251757|health information technology|health information technology
542867|NCT01251757|adult|adult
542868|NCT01251757|telephone calls|telephone calls
542869|NCT01251757|IVR|ivr
542870|NCT01251744|Pregnancy|pregnancy
542871|NCT01251744|Congenital|congenital
542872|NCT01251744|Cytomegalovirus infection|cytomegalovirus infection
542873|NCT01251718|Donepezil hydrochloride|donepezil hydrochloride
542874|NCT01251718|Alzheimer's Disease|alzheimer's disease
542875|NCT01251705|Cornea|cornea
542876|NCT01251705|SL OCT|sl oct
542877|NCT01251705|Spectral OCT Cornea modul|spectral oct cornea modul
542878|NCT01251705|ultrasound pachymetry|ultrasound pachymetry
542879|NCT01251705|Pentacam|pentacam
542880|NCT01251692|Corneal erosions|corneal erosions
542881|NCT01251692|PTK|ptk
542882|NCT01251679|handwashing|handwashing
542883|NCT01251679|masks|masks
542884|NCT01251679|infectious disease transmission|infectious disease transmission
542885|NCT01251666|Colorectal cancer|colorectal cancer
542886|NCT01251666|Screening|screening
542887|NCT01251666|Average-risk population|average-risk population
542888|NCT01251666|faecal occult blood tests|faecal occult blood tests
542889|NCT01251640|pancreatic cancer,|pancreatic cancer,
542890|NCT01251640|MEK-inhibitor|mek-inhibitor
542891|NCT01251627|Myelodysplastic Syndromes, Chronic Myelomonocytic Leukemia, Decitabine|myelodysplastic syndromes, chronic myelomonocytic leukemia, decitabine
542892|NCT01251614|Randomized|randomized
542893|NCT01251614|Double-blind|double-blind
542894|NCT01251614|Chronic plaque psoriasis|chronic plaque psoriasis
542895|NCT01251614|Pediatric|pediatric
542896|NCT01251588|Cartilage legions|cartilage legions
542897|NCT01251588|Symptomatic focal cartilage defects|symptomatic focal cartilage defects
542898|NCT01251588|Microfracture|microfracture
542899|NCT01251588|MACI|maci
542900|NCT01251588|Autologous chondrocyte|autologous chondrocyte
542901|NCT01251549|ReWalk|rewalk
542902|NCT01251549|Paraplegia|paraplegia
542903|NCT01251549|Spinal Cord Injuries (SCI)|spinal cord injuries (sci)
542904|NCT01251536|colorectal cancer|colorectal cancer
542905|NCT01251536|K-Ras wildtype|k-ras wildtype
542906|NCT01251536|first line metastatic|first line metastatic
542907|NCT01251536|standard cetuximab + FOLFIRI|standard cetuximab + folfiri
542908|NCT01251536|dose escalation cetuximab|dose escalation cetuximab
542909|NCT01251523|Asthma|asthma
542910|NCT01251471|major depressive disorder|major depressive disorder
542911|NCT01251471|MDD|mdd
542912|NCT01251471|imaging genetics|imaging genetics
542913|NCT01251471|pharmacoMRI|pharmacomri
542914|NCT01251432|otitis media|otitis media
542915|NCT01251432|Eustachian tube|eustachian tube
542916|NCT01251432|allergy|allergy
542917|NCT01251432|gastroesophageal reflux|gastroesophageal reflux
542918|NCT01251432|tympanostomy tube|tympanostomy tube
542919|NCT01251419|Generic Medication|generic medication
542920|NCT01251419|Brand Name Medication|brand name medication
542921|NCT01251419|Conversion Rates|conversion rates
542922|NCT01251419|Social Proximity|social proximity
542923|NCT01251419|Behavioral Economics|behavioral economics
542924|NCT01251406|Stable|stable
542925|NCT01251406|Chronic Heart Failure|chronic heart failure
542926|NCT01251406|Systolic|systolic
542927|NCT01251393|Cocaine|cocaine
542928|NCT01251393|crack|crack
542929|NCT01251393|treatment|treatment
542930|NCT01251393|dependence|dependence
542931|NCT01251393|biperiden|biperiden
542932|NCT01251341|inflammation|inflammation
542933|NCT01251341|immune system|immune system
542934|NCT01251341|cytokines|cytokines
542937|NCT01251341|attention|attention
542938|NCT01251315|Glutathione|glutathione
542939|NCT01251315|Antioxidant|antioxidant
542940|NCT01251315|Free radical|free radical
542941|NCT01251315|Oxidative stress|oxidative stress
542942|NCT01251315|N-Acetyl Cysteine|n-acetyl cysteine
542943|NCT01251315|Glutathione precursor|glutathione precursor
542944|NCT01251302|Corus CAD|corus cad
542945|NCT01251302|Age/Sex/Gene Expression Score|age/sex/gene expression score
542946|NCT01251302|Molecular Genetics|molecular genetics
542947|NCT01251302|Atherosclerosis|atherosclerosis
542948|NCT01251302|ASGES|asges
542949|NCT01251302|Gene Expression|gene expression
542950|NCT01251302|GES|ges
542951|NCT01251302|CAD|cad
542952|NCT01251302|CVD|cvd
542953|NCT01251302|CHD|chd
542954|NCT01251302|Clinical Utility|clinical utility
542955|NCT01251302|Precision Medicine|precision medicine
542956|NCT01251302|Coronary Artery Disease|coronary artery disease
542957|NCT01251302|Angina Pectoris|angina pectoris
542958|NCT01251302|Chest Pain|chest pain
542959|NCT01251302|Cardiovascular Disease|cardiovascular disease
542960|NCT01251302|Coronary Heart Disease|coronary heart disease
542961|NCT01251302|IMPACT|impact
542962|NCT01251302|IMPACT-CARD|impact-card
542963|NCT01251263|headaches|headaches
542964|NCT01251263|migraines|migraines
542965|NCT01251263|breakthrough bleeding|breakthrough bleeding
542966|NCT01251263|breakthrough spotting|breakthrough spotting
542967|NCT01251263|menstrually associated migraines|menstrually associated migraines
542968|NCT01251263|breakthrough bleeding or breakthrough spotting|breakthrough bleeding or breakthrough spotting
542969|NCT01251224|asthma|asthma
542970|NCT01251224|mouse allergen|mouse allergen
542971|NCT01251224|environmental intervention|environmental intervention
542972|NCT01251211|BOTULINUM TOXIN|botulinum toxin
542973|NCT01251211|NEUROPATHIC PAIN|neuropathic pain
542974|NCT01251211|RANDOMIZED CONTROLLED TRIAL|randomized controlled trial
542975|NCT01251185|Extracorporeal Shockwave Therapy|extracorporeal shockwave therapy
542976|NCT01251185|Heart Failure|heart failure
542977|NCT01251185|Congestive Heart Failure|congestive heart failure
542978|NCT01251185|Non-invasive|non-invasive
542979|NCT01251185|Device Trial|device trial
542980|NCT01251185|NYHA (New York Heart Association)|nyha (new york heart association)
542981|NCT01251185|Ischemic cardiomyopathy|ischemic cardiomyopathy
542982|NCT01251185|Ischemia|ischemia
542983|NCT01251185|Myocardial contractility|myocardial contractility
542984|NCT01251159|adult acute myeloid leukemia with 11q23 (MLL) abnormalities|adult acute myeloid leukemia with 11q23 (mll) abnormalities
542985|NCT01251159|adult acute myeloid leukemia with del(5q)|adult acute myeloid leukemia with del(5q)
542986|NCT01251159|adult acute myeloid leukemia with inv(16)(p13;q22)|adult acute myeloid leukemia with inv(16)(p13;q22)
542987|NCT01251159|adult acute myeloid leukemia with t(16;16)(p13;q22)|adult acute myeloid leukemia with t(16;16)(p13;q22)
542988|NCT01251159|adult acute myeloid leukemia with t(8;21)(q22;q22)|adult acute myeloid leukemia with t(8;21)(q22;q22)
542989|NCT01251159|untreated adult acute myeloid leukemia|untreated adult acute myeloid leukemia
542990|NCT01251159|adult acute minimally differentiated myeloid leukemia (M0)|adult acute minimally differentiated myeloid leukemia (m0)
542991|NCT01251159|adult acute myeloblastic leukemia with maturation (M2)|adult acute myeloblastic leukemia with maturation (m2)
542992|NCT01251159|adult acute myeloblastic leukemia without maturation (M1)|adult acute myeloblastic leukemia without maturation (m1)
542993|NCT01251159|adult acute myelomonocytic leukemia (M4)|adult acute myelomonocytic leukemia (m4)
542994|NCT01251159|adult acute monoblastic leukemia (M5a)|adult acute monoblastic leukemia (m5a)
542995|NCT01251159|adult acute monocytic leukemia (M5b)|adult acute monocytic leukemia (m5b)
542996|NCT01251159|adult erythroleukemia (M6a)|adult erythroleukemia (m6a)
542997|NCT01251159|adult pure erythroid leukemia (M6b)|adult pure erythroid leukemia (m6b)
542998|NCT01251159|adult acute megakaryoblastic leukemia (M7)|adult acute megakaryoblastic leukemia (m7)
542999|NCT01251146|Hypertension|hypertension
543000|NCT01251146|Bisoprolol|bisoprolol
543001|NCT01251146|Atenolol|atenolol
543002|NCT01251133|Communicable Diseases|communicable diseases
543003|NCT01251133|Infection|infection
543004|NCT01251133|Influenza|influenza
543005|NCT01251133|Orthomyxoviridae Infections|orthomyxoviridae infections
543006|NCT01251133|RNA Virus Infections|rna virus infections
543007|NCT01251133|Virus Diseases|virus diseases
543008|NCT01251133|Respiratory Tract Infections|respiratory tract infections
543009|NCT01251133|Respiratory Tract Diseases|respiratory tract diseases
543010|NCT01251107|Hodgkin lymphoma|hodgkin lymphoma
543011|NCT01251107|ABVD|abvd
543012|NCT01251107|BEACOPP|beacopp
543013|NCT01251107|Salvage high dose chemotherapy|salvage high dose chemotherapy
543014|NCT01251094|Dementia|dementia
543015|NCT01251094|Parkinson's|parkinson's
543016|NCT01251094|impairment|impairment
543017|NCT01251094|Dementia Registry for Parkinson's Disease|dementia registry for parkinson's disease
543018|NCT01251081|high volume hemofiltration|high volume hemofiltration
543019|NCT01251081|sepsis|sepsis
543020|NCT01251081|acute kidney injury|acute kidney injury
543021|NCT01251081|survival|survival
543022|NCT01251068|anemic preterms, cerebral oxygenation,somatic oxygenation, blood transfusion|anemic preterms, cerebral oxygenation,somatic oxygenation, blood transfusion
543023|NCT01251055|N-methyl-D-aspartate receptor|n-methyl-d-aspartate receptor
543903|NCT01247051|precoating|precoating
543024|NCT01251055|glycine transporter|glycine transporter
543025|NCT01251055|schizophrenia|schizophrenia
689901|NCT00673400|ODS|ods
543026|NCT01251016|Type 2 diabetes mellitus|type 2 diabetes mellitus
543027|NCT01251016|Y-Roux gastric bypass|y-roux gastric bypass
543028|NCT01251016|Gut hormones|gut hormones
543029|NCT01251016|Gene expression|gene expression
543030|NCT01251016|Surgery|surgery
543031|NCT01251003|Traumatic Brain Injury|traumatic brain injury
543032|NCT01251003|TBI|tbi
543033|NCT01251003|Pediatric|pediatric
543034|NCT01251003|Chronic|chronic
543035|NCT01250990|Niacin|niacin
543036|NCT01250990|HDL|hdl
543037|NCT01250990|Reverse cholesterol transport|reverse cholesterol transport
543038|NCT01250977|Non-treatment seeking smokers, reporting consumption of at least|non-treatment seeking smokers, reporting consumption of at least
543039|NCT01250977|10 cigarettes per day for at least the past 6 months|10 cigarettes per day for at least the past 6 months
543040|NCT01250951|Iron Overload|iron overload
543041|NCT01250951|hemotranfusion|hemotranfusion
543042|NCT01250951|deferasirox|deferasirox
543043|NCT01250951|ferritin|ferritin
543044|NCT01250951|Rare anemia|rare anemia
543045|NCT01250951|Transfusional Iron Overload|transfusional iron overload
543046|NCT01250938|autism|autism
543047|NCT01250938|autism spectrum disorders|autism spectrum disorders
543048|NCT01250938|pervasive developmental disorders|pervasive developmental disorders
543049|NCT01250938|intervention|intervention
543050|NCT01250938|low-income|low-income
543051|NCT01250938|underserved populations|underserved populations
543052|NCT01250938|underrepresented populations|underrepresented populations
543053|NCT01250925|Contact lens|contact lens
543054|NCT01250925|Lens care|lens care
543055|NCT01250912|Ablation|ablation
543056|NCT01250912|Arrythmia|arrythmia
543057|NCT01250912|Imaging|imaging
543058|NCT01250899|HIV|hiv
543059|NCT01250899|Vitamin D|vitamin d
543060|NCT01250899|HAART|haart
543061|NCT01250860|Manual therapy|manual therapy
543062|NCT01250860|DoboMed exercise|dobomed exercise
543063|NCT01250860|Spirometric test|spirometric test
543064|NCT01250847|ARMS|arms
543065|NCT01250847|Ultra High Risk|ultra high risk
543066|NCT01250847|Quetiapine|quetiapine
543067|NCT01250847|Verbal memory|verbal memory
543068|NCT01250821|Infertility|infertility
543069|NCT01250821|Anovulation|anovulation
543070|NCT01250821|Ovulation induction|ovulation induction
543071|NCT01250795|Prevention|prevention
543072|NCT01250782|Glutamine, trauma patients, infections, mortality|glutamine, trauma patients, infections, mortality
543073|NCT01250769|dental|dental
543074|NCT01250769|dentist|dentist
543075|NCT01250769|plaque|plaque
543076|NCT01250769|IP Cleaning|ip cleaning
543077|NCT01250756|vaccine|vaccine
543078|NCT01250756|pneumococcal conjugate|pneumococcal conjugate
543079|NCT01250743|genotype 1|genotype 1
543080|NCT01250730|PK profile in Japanese healthy male volunteers|pk profile in japanese healthy male volunteers
543081|NCT01250717|prostatectomy|prostatectomy
543082|NCT01250717|docetaxel|docetaxel
543083|NCT01250704|Neuromyotonia, Isaac's syndrome; Peripheral nerve hyperexcitability; Myokymia; Potassium channelopathy|neuromyotonia, isaac's syndrome; peripheral nerve hyperexcitability; myokymia; potassium channelopathy
543084|NCT01250691|pneumonia|pneumonia
543085|NCT01250691|ICU|icu
543086|NCT01250691|isolation room|isolation room
543087|NCT01250691|clinical epidemiology|clinical epidemiology
543088|NCT01250691|infection control|infection control
543089|NCT01250678|multiple sclerosis|multiple sclerosis
543090|NCT01250678|cognitive impairment|cognitive impairment
543091|NCT01250678|natalizumab|natalizumab
543092|NCT01250678|SDMT|sdmt
543093|NCT01250665|multiple sclerosis|multiple sclerosis
543094|NCT01250665|cognitive impairment|cognitive impairment
543095|NCT01250665|interferon-beta 1b|interferon-beta 1b
543096|NCT01250665|corpus callosum index|corpus callosum index
543097|NCT01250652|Chronic urticaria|chronic urticaria
543098|NCT01250652|Urticaria|urticaria
543099|NCT01250652|Antihistamine|antihistamine
543100|NCT01250639|Type 2 Diabetes Mellitus|type 2 diabetes mellitus
543101|NCT01250639|non-aboriginal Taiwanese|non-aboriginal taiwanese
543102|NCT01250639|Genome-wide association study|genome-wide association study
543103|NCT01250626|Inulin|inulin
543104|NCT01250626|childhood GFR formula|childhood gfr formula
543105|NCT01250587|Open label|open label
543106|NCT01250587|dose-finding Phase 1 study|dose-finding phase 1 study
543107|NCT01250574|CD64|cd64
543108|NCT01250574|Procalcitonin|procalcitonin
543109|NCT01250561|gabapentin|gabapentin
543110|NCT01250561|valacyclovir|valacyclovir
543111|NCT01250561|phn|phn
543112|NCT01250561|shingles|shingles
543113|NCT01250548|Rheumatoid arthritis|rheumatoid arthritis
543114|NCT01250548|RA|ra
543115|NCT01250548|Active rheumatoid arthritis|active rheumatoid arthritis
543116|NCT01250535|Drug drug interactions|drug drug interactions
543117|NCT01250535|Warfarin|warfarin
543118|NCT01250535|Anticoagulants|anticoagulants
543119|NCT01250535|Lovastatin|lovastatin
543120|NCT01250535|Statins|statins
543121|NCT01250535|CYP4F2|cyp4f2
543122|NCT01250535|Vitamin K|vitamin k
543123|NCT01250509|Obesity|obesity
543124|NCT01250509|Mindfulness based stress reduction|mindfulness based stress reduction
543125|NCT01250509|Mindful eating|mindful eating
543127|NCT01250509|Overnutrition|overnutrition
543128|NCT01250509|Nutrition Disorders|nutrition disorders
543129|NCT01250509|Overweight|overweight
543130|NCT01250509|Body Weight|body weight
543131|NCT01250509|Signs and Symptoms|signs and symptoms
543132|NCT01250496|regadenoson|regadenoson
543133|NCT01250496|lexiscan|lexiscan
543134|NCT01250496|aminophylline|aminophylline
543135|NCT01250496|SPECT|spect
543136|NCT01250496|Myocardial Perfusion Imaging|myocardial perfusion imaging
543137|NCT01250496|pharmacologic stress test|pharmacologic stress test
543138|NCT01250483|prostate|prostate
543139|NCT01250483|prostate-specific antigen|prostate-specific antigen
543140|NCT01250483|benign prostatic hyperplasia|benign prostatic hyperplasia
543141|NCT01250483|adrenergic alpha-Antagonists|adrenergic alpha-antagonists
543142|NCT01250444|Inspiratory Muscle Training|inspiratory muscle training
543143|NCT01250444|Hypertension|hypertension
543144|NCT01250444|Breathing Exercises|breathing exercises
543145|NCT01250444|Cardiac Rehabilitation|cardiac rehabilitation
543146|NCT01250418|Bispectral Index|bispectral index
543147|NCT01250418|Ketamine|ketamine
543148|NCT01250392|Active choice|active choice
543149|NCT01250392|Nurse visits|nurse visits
543150|NCT01250392|Behavioral economics|behavioral economics
543151|NCT01250366|Safety and Pharmacokinetics|safety and pharmacokinetics
543152|NCT01250353|ocular surface reconstruction|ocular surface reconstruction
543153|NCT01250353|conjunctival healing|conjunctival healing
543154|NCT01250353|pterygium|pterygium
543155|NCT01250353|latex biomembrane|latex biomembrane
543156|NCT01250353|pterygium surgery|pterygium surgery
543157|NCT01250340|Diabetes|diabetes
543158|NCT01250340|Isoprostanes|isoprostanes
543159|NCT01250340|Thromboxane|thromboxane
543160|NCT01250340|Aspirin|aspirin
543161|NCT01250327|right ventricular outflow tract|right ventricular outflow tract
543162|NCT01250327|endovascular valve insertion|endovascular valve insertion
543163|NCT01250327|economic evaluation|economic evaluation
543164|NCT01250327|valved stent|valved stent
543165|NCT01250314|osteoporosis|osteoporosis
543166|NCT01250314|men|men
543167|NCT01250314|bone micro-architecture|bone micro-architecture
543168|NCT01250314|bone markers|bone markers
543169|NCT01250301|Smoking Cessation|smoking cessation
543170|NCT01250301|Tobacco Dependence|tobacco dependence
543171|NCT01250301|De-nicotinised cigarettes|de-nicotinised cigarettes
543172|NCT01250288|Health Information Technology|health information technology
543173|NCT01250288|Health Records, Personal|health records, personal
543174|NCT01250288|Hospital Information Systems|hospital information systems
543175|NCT01250288|Patient Access to Records|patient access to records
543176|NCT01250288|Medical Records|medical records
543177|NCT01250288|Medical Record Systems, Computerized|medical record systems, computerized
543178|NCT01250275|Canola Oil|canola oil
543179|NCT01250275|Peripheral Arterial Disease|peripheral arterial disease
543180|NCT01250275|Peripheral Vascular Disease|peripheral vascular disease
543181|NCT01250275|PAD|pad
543182|NCT01250262|low back pain|low back pain
543183|NCT01250262|obese|obese
543184|NCT01250262|fear avoidance|fear avoidance
543185|NCT01250262|disability and low back pain|disability and low back pain
543186|NCT01250262|chronic low back pain in obese older adults|chronic low back pain in obese older adults
543187|NCT01250249|To compare Safety and Reactogenecity of BCG vaccine of Green Signal Biopharma Private Limited with BCG vaccine of serum institute of India limited|to compare safety and reactogenecity of bcg vaccine of green signal biopharma private limited with bcg vaccine of serum institute of india limited
543188|NCT01250236|brimonidine|brimonidine
543189|NCT01250236|alpha-2 adrenoceptor|alpha-2 adrenoceptor
543190|NCT01250236|cornea|cornea
543191|NCT01250236|corneal thickness|corneal thickness
543192|NCT01250223|Lymphoma, Follicular|lymphoma, follicular
543193|NCT01250223|Prognosis|prognosis
543194|NCT01250223|Progression-Free Survival|progression-free survival
543195|NCT01250223|Outcome|outcome
543196|NCT01250223|International Cooperation|international cooperation
543197|NCT01250223|Data Collection|data collection
543198|NCT01250223|Prospective studies|prospective studies
543199|NCT01250223|Rare Diseases|rare diseases
543200|NCT01250210|contraception|contraception
543201|NCT01250210|pregnancy prevention|pregnancy prevention
543202|NCT01250197|Normal Volunteers|normal volunteers
543203|NCT01250184|Myofascial pain|myofascial pain
543204|NCT01250184|Trigger points.|trigger points.
543205|NCT01250184|Lidocaine injection.|lidocaine injection.
543206|NCT01250184|Physical therapy|physical therapy
543207|NCT01250171|Dry eye|dry eye
543208|NCT01250171|IL17/ IL-1β|il17/ il-1β
543209|NCT01250171|Biologic|biologic
543210|NCT01250158|Liver Percutaneous Isolated Localized Perfusion|liver percutaneous isolated localized perfusion
543211|NCT01250158|PILP|pilp
543212|NCT01250158|Isolated Hepatic Perfusion|isolated hepatic perfusion
543213|NCT01250158|IHP|ihp
543214|NCT01250158|Liver metastases|liver metastases
543215|NCT01250158|Unresectable liver metastases of different etiologies|unresectable liver metastases of different etiologies
543216|NCT01250132|Traumatic brain injury|traumatic brain injury
543217|NCT01250132|Paediatrics|paediatrics
543218|NCT01250132|Hypopituitarism|hypopituitarism
543219|NCT01250106|probiotics|probiotics
543220|NCT01250106|prevention|prevention
543221|NCT01250106|dietary intervention|dietary intervention
543222|NCT01250106|insulin resistance|insulin resistance
543223|NCT01250106|obesity|obesity
543224|NCT01250106|type 2 diabetes|type 2 diabetes
543225|NCT01250015|colorectal cancer|colorectal cancer
543226|NCT01250015|consent|consent
543227|NCT01250015|screening|screening
543228|NCT01250002|Pain|pain
543229|NCT01250002|MQOR 40|mqor 40
543230|NCT01250002|Lidocaine|lidocaine
543231|NCT01250002|Gynecologic|gynecologic
543232|NCT01250002|Surgery|surgery
543233|NCT01250002|Laparoscopic|laparoscopic
543234|NCT01249989|Physical Activity|physical activity
543235|NCT01249989|Sedentary Lifestyle|sedentary lifestyle
543236|NCT01249989|Diet|diet
543237|NCT01249989|Health Behavior|health behavior
543238|NCT01249976|blood culture|blood culture
543239|NCT01249976|central venous catheter|central venous catheter
543240|NCT01249976|acridine orange leucocyte cytospin test|acridine orange leucocyte cytospin test
543241|NCT01249976|semi-quantitative skin culture|semi-quantitative skin culture
543242|NCT01249963|acute pancreatitis|acute pancreatitis
543243|NCT01249963|enteral nutrition|enteral nutrition
543244|NCT01249963|nutritional status|nutritional status
543245|NCT01249963|pancreas|pancreas
543246|NCT01249963|T-Diet plus Atémpero|t-diet plus atémpero
543247|NCT01249950|Morbid obesity|morbid obesity
543248|NCT01249950|teenagers|teenagers
543249|NCT01249950|co-morbidities|co-morbidities
543250|NCT01249950|bariatric surgery|bariatric surgery
543251|NCT01249950|epidemiology|epidemiology
543252|NCT01249937|Macular Degeneration|macular degeneration
543253|NCT01249937|Age-related macular degeneration|age-related macular degeneration
543254|NCT01249937|Anti-inflammatory|anti-inflammatory
543255|NCT01249937|Anti-vascular endothelial growth factor (Anti-VEGF)|anti-vascular endothelial growth factor (anti-vegf)
543256|NCT01249937|Lucentis|lucentis
543257|NCT01249937|Ranibizumab|ranibizumab
543258|NCT01249937|Kenalog|kenalog
543259|NCT01249937|Triamcinolone Acetonide|triamcinolone acetonide
543260|NCT01249937|Vision loss|vision loss
543261|NCT01249924|Obstructive sleep apnea (OSA), continuous positive airway pressure(CPAP), surgery, anesthesia|obstructive sleep apnea (osa), continuous positive airway pressure(cpap), surgery, anesthesia
543262|NCT01249911|Infants|infants
543263|NCT01249898|Fracture in the Scaphoid fractures|fracture in the scaphoid fractures
543264|NCT01249885|pacifier sucking|pacifier sucking
543265|NCT01249885|children|children
543266|NCT01249885|occlusion|occlusion
543267|NCT01249885|drooling|drooling
543268|NCT01249872|open gastric by-pass|open gastric by-pass
543269|NCT01249872|super morbidly obese patients|super morbidly obese patients
543270|NCT01249872|postoperative thoracic epidural analgesia|postoperative thoracic epidural analgesia
543271|NCT01249872|different drug regimens (morphine and levobupivacaine)|different drug regimens (morphine and levobupivacaine)
543272|NCT01249872|Lung function tests|lung function tests
543273|NCT01249872|Postoperative Bowel recovery|postoperative bowel recovery
543274|NCT01249872|Postoperative Ambulation|postoperative ambulation
543275|NCT01249859|stomach disease|stomach disease
543276|NCT01249859|signet ring cell carcinoma|signet ring cell carcinoma
543277|NCT01249859|chemotherapy|chemotherapy
543278|NCT01249859|Prognostic|prognostic
543279|NCT01249833|Influenza|influenza
543280|NCT01249833|Cognition|cognition
543281|NCT01249833|Attention|attention
543282|NCT01249833|Simple Reaction Time|simple reaction time
543283|NCT01249833|Alertness|alertness
543284|NCT01249833|Calmness|calmness
543285|NCT01249833|Contentment|contentment
543286|NCT01249833|Mood|mood
543287|NCT01249820|anidulafungin|anidulafungin
543288|NCT01249820|antifungal prophylaxis|antifungal prophylaxis
543289|NCT01249820|allogeneic haematopoietic stem cell transplant|allogeneic haematopoietic stem cell transplant
543290|NCT01249820|myeloablative chemotherapy|myeloablative chemotherapy
543291|NCT01249820|AML-MDS|aml-mds
543292|NCT01249820|pharmacokinetics|pharmacokinetics
543293|NCT01249807|Cancer Screening|cancer screening
543294|NCT01249807|health service utilization model|health service utilization model
543295|NCT01249807|quality of health life|quality of health life
543296|NCT01249794|NIV|niv
543297|NCT01249794|non invasive ventilation|non invasive ventilation
543298|NCT01249794|cardiac surgery|cardiac surgery
543299|NCT01249794|continuous positive airway pressure|continuous positive airway pressure
543300|NCT01249768|Prospective study|prospective study
543301|NCT01249768|diagnostic accuracy|diagnostic accuracy
543302|NCT01249768|CSF|csf
543303|NCT01249768|MRI|mri
543304|NCT01249742|diabetes mellitus|diabetes mellitus
543305|NCT01249742|adolescent|adolescent
543306|NCT01249742|online intervention|online intervention
543307|NCT01249742|psychosocial|psychosocial
543308|NCT01249742|quality of life|quality of life
543309|NCT01249729|Magnetic Resonance Imaging, 3D reconstructed image|magnetic resonance imaging, 3d reconstructed image
543310|NCT01249716|follow-up home visit|follow-up home visit
543311|NCT01249716|Geriatric Disorder|geriatric disorder
543312|NCT01249716|rehabilitation|rehabilitation
543440|NCT01249027|DES|des
543904|NCT01246999|Influenza|influenza
543313|NCT01249690|Bortezomib,Thalidomide,bone metabolites|bortezomib,thalidomide,bone metabolites
543314|NCT01249677|type 2 diabetes|type 2 diabetes
543315|NCT01249677|first phase insulin secretion|first phase insulin secretion
543316|NCT01249677|beta-cell rest|beta-cell rest
543317|NCT01249677|basal insulin|basal insulin
543318|NCT01249664|sham-controlled|sham-controlled
543319|NCT01249664|pathologic myopia|pathologic myopia
543320|NCT01249664|mCNV|mcnv
543321|NCT01249664|choroidal neovascularization|choroidal neovascularization
543322|NCT01249664|intravitreal injection|intravitreal injection
543323|NCT01249664|vision loss|vision loss
543324|NCT01249664|macular damage|macular damage
543325|NCT01249651|Patients, Single|patients, single
543326|NCT01249638|Bevacizumab|bevacizumab
543327|NCT01249638|Capecitabine|capecitabine
543328|NCT01249638|Irinotecan|irinotecan
543329|NCT01249638|mCRC|mcrc
543330|NCT01249625|Influenza|influenza
543331|NCT01249625|H1N1|h1n1
543332|NCT01249625|Respiratory protection|respiratory protection
543333|NCT01249625|N95 respirator|n95 respirator
543334|NCT01249625|Medical mask|medical mask
543335|NCT01249625|Personal protective equipment|personal protective equipment
543336|NCT01249625|Facial protective equipment|facial protective equipment
543337|NCT01249625|Pandemic planning|pandemic planning
543338|NCT01249612|Knee joint icing|knee joint icing
543339|NCT01249612|knee-extension strength|knee-extension strength
543340|NCT01249599|Takotsubo Syndrome|takotsubo syndrome
543341|NCT01249599|apical balooning syndrome|apical balooning syndrome
543342|NCT01249599|stress-cardiomyopathy|stress-cardiomyopathy
543343|NCT01249599|endothelial function|endothelial function
543344|NCT01249599|sympathetic nervous activity|sympathetic nervous activity
543345|NCT01249599|platelet adhesion|platelet adhesion
543346|NCT01249599|arterial compliance|arterial compliance
543347|NCT01249573|fascia therapy|fascia therapy
543348|NCT01249573|transcutaneous fibrolysis|transcutaneous fibrolysis
543349|NCT01249573|acute ankle distortion|acute ankle distortion
543350|NCT01249495|leg ulcer|leg ulcer
543351|NCT01249495|wound therapy|wound therapy
543352|NCT01249495|Pro-inflammatory interleukins|pro-inflammatory interleukins
543353|NCT01249482|Helicobacter pylori|helicobacter pylori
543354|NCT01249482|reflux|reflux
543355|NCT01249482|acid rebound|acid rebound
543356|NCT01249391|Hand|hand
543357|NCT01249391|osteoarthritis|osteoarthritis
543358|NCT01249391|splint|splint
543359|NCT01249391|pain|pain
543360|NCT01249391|deformity|deformity
543361|NCT01249391|function|function
543362|NCT01249378|Nutrition|nutrition
543363|NCT01249378|Lipid|lipid
543364|NCT01249378|Digestion|digestion
543365|NCT01249378|Endotoxemia|endotoxemia
543366|NCT01249378|Inflammation|inflammation
543367|NCT01249378|Metabolism|metabolism
543368|NCT01249378|Stable Isotope|stable isotope
543369|NCT01249378|Obesity|obesity
543370|NCT01249365|medically significant conditions|medically significant conditions
543371|NCT01249365|cervical neoplasia|cervical neoplasia
543372|NCT01249365|serious adverse events (SAEs)|serious adverse events (saes)
543373|NCT01249365|HPV vaccine|hpv vaccine
543374|NCT01249352|Esophageal Cancer|esophageal cancer
543375|NCT01249352|Nimotuzumab|nimotuzumab
543376|NCT01249352|EF024|ef024
543377|NCT01249352|EF024-201|ef024-201
543378|NCT01249339|smokeless tobacco|smokeless tobacco
543379|NCT01249339|Nicotine|nicotine
543380|NCT01249339|Cadmium|cadmium
543381|NCT01249339|lead|lead
543382|NCT01249339|Tobacco Specific Nitrosamines|tobacco specific nitrosamines
543383|NCT01249326|Morbid obesity,|morbid obesity,
543384|NCT01249326|Bariatric surgery, by-pass, sleeve gastrectomy,|bariatric surgery, by-pass, sleeve gastrectomy,
543385|NCT01249326|Nitrogen balance,|nitrogen balance,
543386|NCT01249326|Protein requirement,|protein requirement,
543387|NCT01249326|Weight loss|weight loss
543388|NCT01249326|Muscle wasting, muscle disability|muscle wasting, muscle disability
543389|NCT01249313|Risk|risk
543390|NCT01249313|outcome|outcome
543391|NCT01249300|Dysphagia caused by cerebral vascular accidents|dysphagia caused by cerebral vascular accidents
543392|NCT01249287|stroke|stroke
543393|NCT01249287|stem cell|stem cell
543394|NCT01249274|cocaine abuse|cocaine abuse
543395|NCT01249274|cocaine dependence|cocaine dependence
543396|NCT01249274|postpartum period|postpartum period
543397|NCT01249261|Postmenopausal Women|postmenopausal women
543398|NCT01249261|Osteoporosis|osteoporosis
543399|NCT01249248|Heart rate variability|heart rate variability
543400|NCT01249248|Autonomic dysfunction|autonomic dysfunction
543401|NCT01249248|Exercise|exercise
543402|NCT01249248|Sports|sports
543403|NCT01249248|Competition|competition
543404|NCT01249248|Athletes|athletes
543405|NCT01249209|obesity|obesity
543406|NCT01249209|adults|adults
543407|NCT01249209|lifestyle intervention|lifestyle intervention
710260|NCT00589563|stage I childhood Hodgkin lymphoma|stage i childhood hodgkin lymphoma
690431|NCT00671411|07-165|07-165
543408|NCT01249209|effect after two years treatment for lifestyle change - morbid obesity adults|effect after two years treatment for lifestyle change - morbid obesity adults
543409|NCT01249183|Diphtheria|diphtheria
543410|NCT01249183|Tetanus|tetanus
543411|NCT01249183|Pertussis (acellular, component)|pertussis (acellular, component)
543412|NCT01249183|Diphteria|diphteria
543413|NCT01249183|Biological / vaccine|biological / vaccine
543414|NCT01249170|Communication skills|communication skills
543415|NCT01249157|MRI|mri
543416|NCT01249157|PEM|pem
543417|NCT01249157|10-189|10-189
543418|NCT01249144|Intraocular Lens (IOL)|intraocular lens (iol)
543419|NCT01249144|Quarter Diopter|quarter diopter
543420|NCT01249144|Biaspheric|biaspheric
543421|NCT01249105|MK-2206|mk-2206
543422|NCT01249105|GBM|gbm
543423|NCT01249092|biliary cirrhosis|biliary cirrhosis
543424|NCT01249066|AMP-activated protein kinase|amp-activated protein kinase
543425|NCT01249066|lung adenocarcinomas|lung adenocarcinomas
543426|NCT01249066|Prognosis|prognosis
543427|NCT01249066|Observation study|observation study
543428|NCT01249053|OPA1|opa1
543429|NCT01249053|lung adenocarcinomas|lung adenocarcinomas
543430|NCT01249053|Prognosis|prognosis
543431|NCT01249053|Expression of optic atrophy type 1 (OPA1) protein in lung adenocarcinoma|expression of optic atrophy type 1 (opa1) protein in lung adenocarcinoma
543432|NCT01249040|Frozen shoulder|frozen shoulder
543433|NCT01249040|pain scale|pain scale
543434|NCT01249040|range of motion(ROM)|range of motion(rom)
543435|NCT01249040|muscle strength|muscle strength
543436|NCT01249040|shoulder arthrography|shoulder arthrography
543437|NCT01249027|Drug eluting stents|drug eluting stents
543438|NCT01249027|Stents|stents
543439|NCT01249027|China|china
543441|NCT01249027|XIENCE V EECSS|xience v eecss
543442|NCT01249001|pediatrics|pediatrics
543443|NCT01249001|nausea|nausea
543444|NCT01249001|vomiting|vomiting
543445|NCT01249001|chemotherapy|chemotherapy
543446|NCT01249001|antiemetic|antiemetic
543447|NCT01248988|Pneumococcal vaccine|pneumococcal vaccine
543448|NCT01248988|Safety|safety
543449|NCT01248988|Synflorix|synflorix
543450|NCT01248988|Pneumococcal diseases|pneumococcal diseases
543451|NCT01248975|asthma|asthma
543452|NCT01248975|GSK2190915|gsk2190915
543453|NCT01248962|BEVACIZUMAB (AVASTIN)|bevacizumab (avastin)
543454|NCT01248962|CARBOPLATIN|carboplatin
543455|NCT01248962|DEXAMETHASONE|dexamethasone
543456|NCT01248962|GEMCITABINE|gemcitabine
543457|NCT01248962|LIPODOX(LIPOSOMAL DOXORUBICIN)|lipodox(liposomal doxorubicin)
543458|NCT01248962|MONTELUKAST (SINGULAR)|montelukast (singular)
543459|NCT01248962|TAXOL (PACLITAXEL|taxol (paclitaxel
543460|NCT01248962|Fallopian Tubes|fallopian tubes
543461|NCT01248962|10-184|10-184
543462|NCT01248949|Advanced solid tumors|advanced solid tumors
543463|NCT01248949|Advanced recurrent ovarian tumors|advanced recurrent ovarian tumors
543464|NCT01248949|MEDI3617|medi3617
543465|NCT01248949|Ang2|ang2
543466|NCT01248949|Ovarian cancer|ovarian cancer
543467|NCT01248949|Malignant glioma|malignant glioma
543468|NCT01248923|relapsed multiple myeloma|relapsed multiple myeloma
543469|NCT01248923|plasma cell dyscrasia|plasma cell dyscrasia
543470|NCT01248923|plasmacytoma|plasmacytoma
543471|NCT01248923|kinesin spindle protein|kinesin spindle protein
543472|NCT01248923|anti-mitotic|anti-mitotic
543473|NCT01248884|combination vaccine|combination vaccine
543474|NCT01248884|Primary vaccination|primary vaccination
543475|NCT01248871|renal|renal
543476|NCT01248871|transplantation|transplantation
543477|NCT01248871|Volatile|volatile
543478|NCT01248871|anesthetic|anesthetic
543479|NCT01248845|Mechanical ventilation|mechanical ventilation
543480|NCT01248845|Electrical diaphragmatic activity|electrical diaphragmatic activity
543481|NCT01248832|tobacco cessation|tobacco cessation
543482|NCT01248832|smoking cessation|smoking cessation
543483|NCT01248832|telephone|telephone
543484|NCT01248832|self-help|self-help
543485|NCT01248832|smoking abstinence|smoking abstinence
543486|NCT01248832|tobacco use disorder|tobacco use disorder
543487|NCT01248832|disparity|disparity
543488|NCT01248819|Laparoscopic Cholecystectomy|laparoscopic cholecystectomy
543489|NCT01248819|Nebulization|nebulization
543490|NCT01248819|Ropivacaine|ropivacaine
543491|NCT01248806|Lung nodule|lung nodule
543492|NCT01248806|Screening|screening
543493|NCT01248806|Spiral low - dose computed tomography|spiral low - dose computed tomography
543494|NCT01248806|Lung cancer|lung cancer
543495|NCT01248793|Ankylosing Sponylitis, injection, golimumab, simponi|ankylosing sponylitis, injection, golimumab, simponi
543496|NCT01248780|Rheumatoid Arthritis|rheumatoid arthritis
543497|NCT01248780|injection|injection
543498|NCT01248780|golimumab|golimumab
543499|NCT01248780|simponi|simponi
543500|NCT01248767|Pathological gambling|pathological gambling
543501|NCT01248767|"at risk gambling"|"at risk gambling"
543502|NCT01248767|cohort|cohort
543503|NCT01248767|cognitive distortions|cognitive distortions
543504|NCT01248767|impulsivity|impulsivity
543505|NCT01248767|psychiatric comorbidities|psychiatric comorbidities
543506|NCT01248767|gambling trajectory|gambling trajectory
543507|NCT01248767|gambling practice evolution|gambling practice evolution
543508|NCT01248767|addiction|addiction
543509|NCT01248754|Neurosurgery|neurosurgery
543510|NCT01248754|Neuronavigation|neuronavigation
543511|NCT01248754|Positron emission tomography|positron emission tomography
543512|NCT01248754|FDOPA|fdopa
543513|NCT01248741|prostate cancer|prostate cancer
543514|NCT01248741|interstitial radiation,|interstitial radiation,
543515|NCT01248741|brachytherapy|brachytherapy
543516|NCT01248728|Autism Spectrum Disorder|autism spectrum disorder
543517|NCT01248728|Clinical Trial|clinical trial
543518|NCT01248728|Omega-3 Fatty Acids|omega-3 fatty acids
543519|NCT01248728|Toddlers|toddlers
543520|NCT01248715|pneumonia, bacterial|pneumonia, bacterial
543521|NCT01248715|pneumonia, viral|pneumonia, viral
543522|NCT01248715|respiratory tract infections|respiratory tract infections
543523|NCT01248715|oseltamivir, therapeutic use|oseltamivir, therapeutic use
543524|NCT01248702|Myocardial Infarction|myocardial infarction
543525|NCT01248702|Heart Failure|heart failure
543526|NCT01248702|Sudden Cardiac Death|sudden cardiac death
543527|NCT01248702|Critical Pathways|critical pathways
543528|NCT01248676|cancer radiation patient education|cancer radiation patient education
543529|NCT01248663|pancreatic cancer|pancreatic cancer
543530|NCT01248663|pylorus-preserving pancreaticoduodenectomy|pylorus-preserving pancreaticoduodenectomy
543531|NCT01248663|delayed gastric emptying|delayed gastric emptying
543532|NCT01248663|reconstruction|reconstruction
543533|NCT01248650|Safety evaluation|safety evaluation
543534|NCT01248650|Pharmacokinetic analysis|pharmacokinetic analysis
543535|NCT01248637|pancreas|pancreas
543536|NCT01248637|pancreatic cancer|pancreatic cancer
543537|NCT01248637|pancreatic tumor|pancreatic tumor
543538|NCT01248637|pimonidazole|pimonidazole
543539|NCT01248637|hypoxia|hypoxia
543540|NCT01248637|whipple's resection|whipple's resection
543541|NCT01248624|Palliative Care|palliative care
543542|NCT01248624|Quality of Life|quality of life
543543|NCT01248624|Satisfaction with Care|satisfaction with care
543544|NCT01248611|pain|pain
543545|NCT01248611|adverse effects|adverse effects
543546|NCT01248611|safety|safety
543547|NCT01248611|feasibility|feasibility
543548|NCT01248585|Symptom Control|symptom control
543549|NCT01248572|Cataract|cataract
543550|NCT01248572|Biaspheric intraocular lens|biaspheric intraocular lens
543551|NCT01248572|Uniplanar intraocular lens|uniplanar intraocular lens
543552|NCT01248572|Effective lens position|effective lens position
543553|NCT01248546|Breast cancer|breast cancer
543554|NCT01248546|Computer-aided detection|computer-aided detection
543555|NCT01248546|Mammography screening|mammography screening
543556|NCT01248546|Digital breast tomosynthesis|digital breast tomosynthesis
543557|NCT01248533|Abdominal aortic aneurysm, atherosclerosis|abdominal aortic aneurysm, atherosclerosis
543558|NCT01248520|Pregnancy|pregnancy
543559|NCT01248520|Influenza Vaccination|influenza vaccination
543560|NCT01248507|COPD|copd
543561|NCT01248481|Acarbose/Glucobay®|acarbose/glucobay®
543562|NCT01248481|Basal insulin|basal insulin
543563|NCT01248481|PPG (Postprandial Glycaemia)|ppg (postprandial glycaemia)
543564|NCT01248468|Pain, Migraine|pain, migraine
543565|NCT01248455|Monoclonal Antibody|monoclonal antibody
543566|NCT01248455|NK Cell Mediated Killing|nk cell mediated killing
543567|NCT01248455|Response Rate|response rate
543568|NCT01248455|Pharmacokinetics|pharmacokinetics
543569|NCT01248455|Biological Activity|biological activity
543570|NCT01248455|Smoldering Multiple Myeloma|smoldering multiple myeloma
543571|NCT01248455|SMM|smm
543572|NCT01248442|Vitamin D Deficiency|vitamin d deficiency
543573|NCT01248442|Autoimmune disease|autoimmune disease
543574|NCT01248442|Diabetes|diabetes
543575|NCT01248429|thyrosine kinase inhibitor|thyrosine kinase inhibitor
543576|NCT01248429|phosphokinase creatinin|phosphokinase creatinin
543577|NCT01248429|myalgia|myalgia
543578|NCT01248416|Aromatase|aromatase
543579|NCT01248416|Growth|growth
543580|NCT01248416|Letrozole|letrozole
543581|NCT01248416|Anastrozole|anastrozole
543582|NCT01248416|GH|gh
543583|NCT01248416|Children|children
543584|NCT01248416|Puberty|puberty
543585|NCT01248403|RAD001|rad001
543586|NCT01248403|Paclitaxel|paclitaxel
543587|NCT01248403|gastric cancer|gastric cancer
543588|NCT01248403|advanced gastric or esophagogastric junction cancer|advanced gastric or esophagogastric junction cancer
543589|NCT01248390|traumatic brain injury|traumatic brain injury
543590|NCT01248390|post-concussion|post-concussion
543591|NCT01248377|Cephalosporins|cephalosporins
543592|NCT01248377|Drug hypersensitivity|drug hypersensitivity
543593|NCT01248351|aspirin, clopidogrel, pharmacodynamics, platelet transfusion|aspirin, clopidogrel, pharmacodynamics, platelet transfusion
543594|NCT01248299|Chemotherapy|chemotherapy
543595|NCT01248299|Best Supportive Care|best supportive care
543596|NCT01248286|Diabetes|diabetes
543597|NCT01248286|Prediabetes|prediabetes
543598|NCT01248286|Prevention|prevention
543599|NCT01248286|Whole grain|whole grain
543600|NCT01248286|Advanced glycation end products|advanced glycation end products
543601|NCT01248286|Insulin sensitivity|insulin sensitivity
543602|NCT01248273|GLOBO H-KLH CONJUGATE|globo h-klh conjugate
543603|NCT01248273|MUC-1 KLH|muc-1 klh
543604|NCT01248273|QS-21|qs-21
543605|NCT01248273|TF(C)-KLH|tf(c)-klh
543606|NCT01248273|TN(C)-KLH|tn(c)-klh
543607|NCT01248273|Immunization|immunization
543608|NCT01248273|Vaccine|vaccine
543609|NCT01248273|09-184|09-184
543610|NCT01248260|Fetal body size|fetal body size
543611|NCT01248260|Fetal brain size|fetal brain size
543612|NCT01248260|Folic acid|folic acid
544961|NCT01242059|Obesity|obesity
543613|NCT01248247|Non small cell lung cancer|non small cell lung cancer
543614|NCT01248247|Biopsy accessible tumor|biopsy accessible tumor
543615|NCT01248247|Stage IIIB non small cell lung cancer|stage iiib non small cell lung cancer
543616|NCT01248247|Stage IV non small cell lung cancer|stage iv non small cell lung cancer
543618|NCT01248234|hypertensive|hypertensive
543619|NCT01248234|anesthesia|anesthesia
543620|NCT01248221|Breath test|breath test
543621|NCT01248221|Dyspepsia|dyspepsia
543622|NCT01248221|Gastric Emptying|gastric emptying
543623|NCT01248221|Gastroparesis|gastroparesis
543624|NCT01248208|egg allergy|egg allergy
543625|NCT01248208|influenza vaccine|influenza vaccine
543626|NCT01248195|Schizophrenia|schizophrenia
543627|NCT01248195|Schizophreniform disorder|schizophreniform disorder
543628|NCT01248195|Schizoaffective disorder|schizoaffective disorder
543629|NCT01248195|Imaging|imaging
543630|NCT01248195|Prognosis|prognosis
543631|NCT01248195|Treatment guidelines|treatment guidelines
543632|NCT01248195|Pharmacogenetics|pharmacogenetics
543633|NCT01248182|acetabular fracture|acetabular fracture
543634|NCT01248182|pelvic ring injury|pelvic ring injury
543635|NCT01248143|Green Tea|green tea
543636|NCT01248143|Fermented papaya preparation|fermented papaya preparation
543637|NCT01248143|Diabetes|diabetes
543638|NCT01248143|Cardiovascular diseases|cardiovascular diseases
543639|NCT01248143|Atherosclerotic plaques|atherosclerotic plaques
543640|NCT01248143|Glucose|glucose
543641|NCT01248143|Dietary supplements and functional foods|dietary supplements and functional foods
543642|NCT01248130|Omega-3 Fatty Acid|omega-3 fatty acid
543643|NCT01248130|Autism Spectrum Disorders|autism spectrum disorders
543644|NCT01248130|Pervasive Developmental Disorders|pervasive developmental disorders
543645|NCT01248130|Children|children
543646|NCT01248130|Cognitive Functioning|cognitive functioning
543647|NCT01248117|PCV|pcv
543648|NCT01248117|polypoidal|polypoidal
543649|NCT01248117|choroidal|choroidal
543650|NCT01248117|vasculopathy|vasculopathy
543651|NCT01248104|Cardiac Surgery|cardiac surgery
543652|NCT01248104|Antifibrinolytic agents|antifibrinolytic agents
543653|NCT01248104|Blood transfusion|blood transfusion
543654|NCT01248104|epsilon aminocaproic acid|epsilon aminocaproic acid
543655|NCT01248104|tranexamic acid|tranexamic acid
543656|NCT01248091|IUD, Insertion, Decrease, Pain|iud, insertion, decrease, pain
543657|NCT01248078|elective cesarean section|elective cesarean section
543658|NCT01248078|antibiotic prophylaxis|antibiotic prophylaxis
543659|NCT01248078|cefazoline|cefazoline
543660|NCT01248078|wound infection|wound infection
543661|NCT01248065|Asthma|asthma
543662|NCT01248065|Vitamin D|vitamin d
543663|NCT01248065|Corticosteroids|corticosteroids
543664|NCT01248065|Treatment failure|treatment failure
543665|NCT01248039|Muscle strength, functional performance, joint replacement|muscle strength, functional performance, joint replacement
543666|NCT01248026|Cardiovascular disease|cardiovascular disease
543667|NCT01248026|Buttermilk|buttermilk
543668|NCT01248026|Blood lipids|blood lipids
543669|NCT01248026|Cholesterol absorption|cholesterol absorption
543670|NCT01248026|Cholesterol synthesis|cholesterol synthesis
543671|NCT01248000|Hodgkin lymphoma|hodgkin lymphoma
543672|NCT01248000|FDG-PET|fdg-pet
543673|NCT01248000|prognostic factor|prognostic factor
543674|NCT01248000|clinical trial|clinical trial
543675|NCT01247987|IVF, assisted reproduction, embryo transfer|ivf, assisted reproduction, embryo transfer
543676|NCT01247974|Coronary Artery Bypass Grafting|coronary artery bypass grafting
543677|NCT01247974|New Onset Postoperative Atrial Fibrillation|new onset postoperative atrial fibrillation
543678|NCT01247948|pedicle screw of fixation operation|pedicle screw of fixation operation
543679|NCT01247948|spine surgery|spine surgery
543680|NCT01247948|navigation assisted|navigation assisted
543681|NCT01247935|Pain|pain
543682|NCT01247935|Acupuncture|acupuncture
543683|NCT01247935|Transcutaneous electrical nerve stimulation|transcutaneous electrical nerve stimulation
543684|NCT01247935|Colonoscopy|colonoscopy
543685|NCT01247922|Pediatric Ependymoma|pediatric ependymoma
543686|NCT01247922|Ependymoma|ependymoma
543687|NCT01247922|Tarceva|tarceva
543688|NCT01247922|Erlotinib|erlotinib
543689|NCT01247883|Phase 1|phase 1
543690|NCT01247883|relative bioavailability|relative bioavailability
543691|NCT01247883|healthy volunteers|healthy volunteers
543692|NCT01247883|pharmacokinetics|pharmacokinetics
543693|NCT01247883|solution|solution
543694|NCT01247883|tablet|tablet
543695|NCT01247870|Chronic obstructive pulmonary disease, COPD, metformin|chronic obstructive pulmonary disease, copd, metformin
543696|NCT01247857|Laparoscopic Cholecystectomy|laparoscopic cholecystectomy
543697|NCT01247857|Nebulization|nebulization
543698|NCT01247857|Ropivacaine|ropivacaine
543699|NCT01247844|adult Males|adult males
543700|NCT01247844|circumcision|circumcision
543701|NCT01247844|HIV prevention|hiv prevention
543702|NCT01247844|device|device
543703|NCT01247831|glaucoma, selective laser trabeculoplasty, ocular rigidity|glaucoma, selective laser trabeculoplasty, ocular rigidity
543704|NCT01247805|Bioequivalence|bioequivalence
543705|NCT01247805|Powder for oral suspention|powder for oral suspention
543706|NCT01247792|sepsis|sepsis
543707|NCT01247792|organ failure|organ failure
543708|NCT01247792|end-of-life decisions|end-of-life decisions
543709|NCT01247792|patient-centered communication|patient-centered communication
543710|NCT01247779|gynecology|gynecology
543711|NCT01247779|oncology|oncology
543712|NCT01247779|coelioscopy|coelioscopy
543713|NCT01247779|robot|robot
543714|NCT01247779|morbidity|morbidity
543715|NCT01247727|Heart rate variability|heart rate variability
543716|NCT01247727|extracorporeal membrane oxygenation|extracorporeal membrane oxygenation
543717|NCT01247714|T-Diet plus Diabet NP|t-diet plus diabet np
543718|NCT01247714|Diabetic|diabetic
543719|NCT01247714|Enteral Nutrition|enteral nutrition
543720|NCT01247714|Glycaemic response|glycaemic response
543721|NCT01247714|Metabolic Syndrome|metabolic syndrome
543722|NCT01247714|Insulin resistance|insulin resistance
543723|NCT01247714|Lipidic profile|lipidic profile
543724|NCT01247701|UCB|ucb
543725|NCT01247701|Umbilical Cord Blood|umbilical cord blood
543726|NCT01247701|Transplant|transplant
543727|NCT01247701|Umbilical Cord Blood Transplant|umbilical cord blood transplant
543728|NCT01247701|Cord Blood Stem Cell Transplantation|cord blood stem cell transplantation
543729|NCT01247701|Pediatric|pediatric
543730|NCT01247701|Myeloid Hematological Malignancies|myeloid hematological malignancies
543731|NCT01247701|Busulfan|busulfan
543732|NCT01247701|Cytoxan|cytoxan
543733|NCT01247701|Cyclophosphamide|cyclophosphamide
543734|NCT01247701|Fludarabine|fludarabine
543735|NCT01247688|Lymphoid|lymphoid
543736|NCT01247688|hematologic malignancy|hematologic malignancy
543737|NCT01247688|UCB|ucb
543738|NCT01247688|Umbilical Cord Blood Transplant|umbilical cord blood transplant
543739|NCT01247688|Total Body Irradiation|total body irradiation
543740|NCT01247688|Cytoxan|cytoxan
543741|NCT01247688|Cyclophosphamide|cyclophosphamide
543742|NCT01247688|Fludarabine|fludarabine
543743|NCT01247662|Autism spectrum disorder|autism spectrum disorder
543744|NCT01247662|Social Responsiveness Scale|social responsiveness scale
543745|NCT01247662|Childhood Asperger's Syndrome Test|childhood asperger's syndrome test
543746|NCT01247662|Adult Autism Spectrum Quotient|adult autism spectrum quotient
543747|NCT01247662|psychometric|psychometric
543748|NCT01247649|Continuous glucose monitoring system|continuous glucose monitoring system
543749|NCT01247649|Non invasive|non invasive
543750|NCT01247649|Type 1 diabetes|type 1 diabetes
543751|NCT01247649|Dielectric spectroscopy|dielectric spectroscopy
543752|NCT01247636|HLRQ|hlrq
543753|NCT01247636|Elderly|elderly
543754|NCT01247636|Balance|balance
543755|NCT01247636|Mobility|mobility
543756|NCT01247636|Fear of falling|fear of falling
543757|NCT01247623|Non-resectable, advanced malignant melanoma.|non-resectable, advanced malignant melanoma.
543758|NCT01247597|Thyroid Cancer|thyroid cancer
543759|NCT01247597|Germline DICER1 Mutation|germline dicer1 mutation
543760|NCT01247597|MicroRNA Biogenesis|microrna biogenesis
543761|NCT01247597|Pleuropulmonary Blastoma|pleuropulmonary blastoma
543762|NCT01247597|PPB|ppb
543763|NCT01247584|childhood acute myeloid leukemia/other myeloid malignancies|childhood acute myeloid leukemia/other myeloid malignancies
543764|NCT01247584|childhood acute erythroleukemia (M6)|childhood acute erythroleukemia (m6)
543765|NCT01247584|childhood acute megakaryocytic leukemia (M7)|childhood acute megakaryocytic leukemia (m7)
543766|NCT01247584|childhood acute monoblastic leukemia (M5a)|childhood acute monoblastic leukemia (m5a)
543767|NCT01247584|childhood acute monocytic leukemia (M5b)|childhood acute monocytic leukemia (m5b)
543768|NCT01247584|childhood acute myeloblastic leukemia without maturation (M1)|childhood acute myeloblastic leukemia without maturation (m1)
543769|NCT01247584|childhood acute myelomonocytic leukemia (M4)|childhood acute myelomonocytic leukemia (m4)
543770|NCT01247584|childhood acute myeloblastic leukemia with maturation (M2)|childhood acute myeloblastic leukemia with maturation (m2)
543771|NCT01247558|Metanx®|metanx®
543772|NCT01247558|diabetes|diabetes
543773|NCT01247558|neuropathy|neuropathy
543774|NCT01247558|peripheral neurological disorder|peripheral neurological disorder
543775|NCT01247558|peripheral circulation disorder|peripheral circulation disorder
543776|NCT01247558|folic acid|folic acid
543777|NCT01247558|folate|folate
543778|NCT01247558|L-methylfolate|l-methylfolate
543779|NCT01247558|vitamin B6|vitamin b6
543780|NCT01247558|Pyridoxal 5'-phosphate|pyridoxal 5'-phosphate
543781|NCT01247558|vitamin B12|vitamin b12
543782|NCT01247558|methylcobalamin|methylcobalamin
543783|NCT01247545|Remote ischemic preconditioning|remote ischemic preconditioning
543784|NCT01247545|Coronary artery bypass graft surgery|coronary artery bypass graft surgery
543785|NCT01247545|Cardioprotection|cardioprotection
543786|NCT01247545|Clinical Outcomes|clinical outcomes
543787|NCT01247532|Cancer|cancer
543788|NCT01247532|Fatigue|fatigue
543789|NCT01247532|Mindfulness|mindfulness
543790|NCT01247532|Meditation|meditation
543791|NCT01247532|Neoplasms|neoplasms
543792|NCT01247506|microRNA|microrna
543793|NCT01247493|fludarabine|fludarabine
543794|NCT01247493|AML|aml
543795|NCT01247493|Efficacy|efficacy
543796|NCT01247493|tolerability|tolerability
543797|NCT01247454|CVD|cvd
543798|NCT01247454|primary prevention|primary prevention
543799|NCT01247454|ASA|asa
543800|NCT01247454|physician behavioral change|physician behavioral change
543801|NCT01247454|Patient behavioral change|patient behavioral change
543802|NCT01247441|All breast cancer patients who were diagnosed or managed in NUH will be included into this registry|all breast cancer patients who were diagnosed or managed in nuh will be included into this registry
543803|NCT01247428|Coronary Artery Disease|coronary artery disease
543804|NCT01247428|Drug-eluting Stent|drug-eluting stent
543805|NCT01247428|Sirolimus|sirolimus
543806|NCT01247415|anaphylaxis|anaphylaxis
543807|NCT01247415|allergy|allergy
543808|NCT01247415|IgE mediated|ige mediated
543809|NCT01247415|ORS|ors
543810|NCT01247415|oculorespiratory syndrome|oculorespiratory syndrome
543811|NCT01247415|Allergic-like reactions|allergic-like reactions
543812|NCT01247415|H1N1|h1n1
543813|NCT01247415|Arepanrix|arepanrix
543814|NCT01247402|peripheral arterial disease|peripheral arterial disease
543815|NCT01247402|in-stent restenosis|in-stent restenosis
543816|NCT01247402|drug eluting balloon|drug eluting balloon
543817|NCT01247389|laparoscopy|laparoscopy
543818|NCT01247389|colon resection|colon resection
543819|NCT01247389|incisional hernia|incisional hernia
543820|NCT01247376|inflammation|inflammation
543821|NCT01247376|arthroscopy|arthroscopy
543822|NCT01247376|knee|knee
543823|NCT01247376|microdialysis|microdialysis
543824|NCT01247363|Diabetes glucokinase safety|diabetes glucokinase safety
543825|NCT01247311|Vitamin D|vitamin d
543826|NCT01247311|pulse wave velocity|pulse wave velocity
543827|NCT01247298|Hepatocellular Carcinoma (HCC)|hepatocellular carcinoma (hcc)
543828|NCT01247298|Trans-Arterial Chemobolizaion (TACE)|trans-arterial chemobolizaion (tace)
543829|NCT01247298|Radiation Induced Liver Disease (RILD)|radiation induced liver disease (rild)
543830|NCT01247298|Stereotactic Body Radiation Therapy (SBRT)|stereotactic body radiation therapy (sbrt)
543831|NCT01247285|Bioequivalence|bioequivalence
543832|NCT01247285|Healthy Subjects|healthy subjects
543833|NCT01247272|Bioequivalence|bioequivalence
543834|NCT01247272|Healthy Subjects|healthy subjects
543835|NCT01247259|allergic rhinitis|allergic rhinitis
543836|NCT01247259|immunotherapy|immunotherapy
543837|NCT01247259|sublingual|sublingual
543838|NCT01247246|Oral Mucositis|oral mucositis
543839|NCT01247246|Head and Neck|head and neck
543840|NCT01247246|Head and Neck Neoplasms|head and neck neoplasms
543841|NCT01247246|Mucositis|mucositis
543842|NCT01247246|Stomatitis|stomatitis
543843|NCT01247246|Neoplasms by Site|neoplasms by site
543844|NCT01247246|Neoplasms|neoplasms
543845|NCT01247246|Gastroenteritis|gastroenteritis
543846|NCT01247246|Gastrointestinal Diseases|gastrointestinal diseases
543847|NCT01247246|Digestive System Diseases|digestive system diseases
543848|NCT01247246|Mouth Diseases|mouth diseases
543849|NCT01247246|Stomatognathic Diseases|stomatognathic diseases
543850|NCT01247246|SCV-07|scv-07
543851|NCT01247233|breast cancer|breast cancer
543852|NCT01247233|Accelerated Partial Breast Irradiation|accelerated partial breast irradiation
543853|NCT01247233|invasive cancer|invasive cancer
543854|NCT01247233|Hypofractionated Irradiation|hypofractionated irradiation
543855|NCT01247233|Lumpectomy|lumpectomy
543856|NCT01247220|Macular Edema|macular edema
543857|NCT01247220|Branch retinal vein occlusion|branch retinal vein occlusion
543858|NCT01247220|Ranibizumab|ranibizumab
543859|NCT01247207|Duchenne muscular dystrophy|duchenne muscular dystrophy
543860|NCT01247207|Becker muscular dystrophy|becker muscular dystrophy
543861|NCT01247207|Nonsense mutation|nonsense mutation
543862|NCT01247207|Premature stop codon|premature stop codon
543864|NCT01247207|BMD|bmd
543865|NCT01247207|nmDBMD|nmdbmd
543866|NCT01247207|DBMD|dbmd
543867|NCT01247207|Ataluren|ataluren
543868|NCT01247207|PTC124|ptc124
543869|NCT01247194|hepatitis C|hepatitis c
543870|NCT01247194|NS5A|ns5a
543871|NCT01247194|HCV RNA|hcv rna
543872|NCT01247181|compliance|compliance
543873|NCT01247181|observance|observance
543874|NCT01247181|mobile phone|mobile phone
543875|NCT01247181|SMS|sms
543876|NCT01247181|text message|text message
543877|NCT01247181|ARV|arv
543878|NCT01247181|HAART|haart
543879|NCT01247181|AIDS|aids
543880|NCT01247168|Refractory|refractory
543881|NCT01247168|Solid tumors|solid tumors
543882|NCT01247168|Cancer|cancer
543883|NCT01247142|invasive pulmonary aspergillosis|invasive pulmonary aspergillosis
543884|NCT01247142|exhaled breath condensate|exhaled breath condensate
543885|NCT01247129|Superficial inferior epigastric artery flap, delay phenomenon|superficial inferior epigastric artery flap, delay phenomenon
543886|NCT01247103|healthy volunteers|healthy volunteers
543887|NCT01247103|safety|safety
543888|NCT01247103|tolerability|tolerability
543889|NCT01247090|hypertension|hypertension
543890|NCT01247090|end stage renal disease|end stage renal disease
543891|NCT01247090|vasopressin|vasopressin
543892|NCT01247090|Arginine Vasopressin|arginine vasopressin
543893|NCT01247090|AVP|avp
543894|NCT01247090|Pitressin®|pitressin®
543895|NCT01247077|selenium|selenium
543896|NCT01247077|neuropsychological testing|neuropsychological testing
543897|NCT01247077|autoantibodies|autoantibodies
543898|NCT01247064|Bronchiolitis|bronchiolitis
543899|NCT01247064|Hypertonic Saline|hypertonic saline
543900|NCT01247051|priming|priming
543901|NCT01247051|cardiac surgery|cardiac surgery
543902|NCT01247051|cardio pulmonary bypass|cardio pulmonary bypass
543905|NCT01246999|A/California/7/2009-like (2009 H1N1)|a/california/7/2009-like (2009 h1n1)
543906|NCT01246999|A/Perth/16/2009-like (H3N2)|a/perth/16/2009-like (h3n2)
543907|NCT01246999|B/Brisbane/60/2008-like (B/Victoria lineage)|b/brisbane/60/2008-like (b/victoria lineage)
543908|NCT01246973|Oral Curcumin|oral curcumin
543909|NCT01246973|Radiation Dermatitis|radiation dermatitis
543910|NCT01246973|Breast Cancer Patients|breast cancer patients
543911|NCT01246960|cancer|cancer
543912|NCT01246960|stomach|stomach
543913|NCT01246960|esophagus|esophagus
543914|NCT01246960|gastroesophageal|gastroesophageal
543915|NCT01246947|Moderate Tricuspid Valve Regurgitation|moderate tricuspid valve regurgitation
543916|NCT01246947|Tricuspid Valve Repair|tricuspid valve repair
543917|NCT01246947|Mitral Value Surgery|mitral value surgery
543918|NCT01246921|Vitiligo, repigmentation, satisfaction|vitiligo, repigmentation, satisfaction
543919|NCT01246908|TRD|trd
543920|NCT01246895|Cartilage repair|cartilage repair
543921|NCT01246895|Cartilage|cartilage
543922|NCT01246895|Knee|knee
543923|NCT01246895|Knee Pain|knee pain
543924|NCT01246895|Microfracture|microfracture
543925|NCT01246895|Arthroscopy|arthroscopy
543926|NCT01246895|Bone Marrow Stimulation|bone marrow stimulation
543927|NCT01246895|Chondrogenesis|chondrogenesis
543928|NCT01246895|Scaffold|scaffold
543929|NCT01246895|Chitosan|chitosan
543930|NCT01246895|Articular Cartilage Repair|articular cartilage repair
543931|NCT01246882|Stroke, gait, walking, disability|stroke, gait, walking, disability
543932|NCT01246882|wireless inertial sensing|wireless inertial sensing
543933|NCT01246882|mobile health|mobile health
543934|NCT01246869|brain, cancer,glioblastoma multiforme, meningioma, glioma|brain, cancer,glioblastoma multiforme, meningioma, glioma
543935|NCT01246856|Cardiotoxicity|cardiotoxicity
543936|NCT01246856|Breast cancer treatment|breast cancer treatment
543937|NCT01246856|MIBG scintigraphy|mibg scintigraphy
543938|NCT01246856|Strain Echocardiography|strain echocardiography
543939|NCT01246856|patients who have been treated with TAC one year previously|patients who have been treated with tac one year previously
543940|NCT01246843|sunitinib|sunitinib
543941|NCT01246843|sorafenib|sorafenib
543942|NCT01246843|cognitive functioning|cognitive functioning
543943|NCT01246817|Carcinoma, Renal Cell|carcinoma, renal cell
543944|NCT01246817|temsirolimus|temsirolimus
543945|NCT01246817|FLT-PET|flt-pet
543946|NCT01246817|FDG-PET|fdg-pet
543947|NCT01246817|Adult patients with metastatic RCC (any histology and any MSKCC prognostic score), with documented|adult patients with metastatic rcc (any histology and any mskcc prognostic score), with documented
543948|NCT01246817|progressive disease after more than two prior systemic treatments with any of the following: cytokines (±|progressive disease after more than two prior systemic treatments with any of the following: cytokines (±
543949|NCT01246817|chemotherapy), sunitinib, sorafenib, or bevacizumab (± IFN).|chemotherapy), sunitinib, sorafenib, or bevacizumab (± ifn).
543950|NCT01246804|HIV infections|hiv infections
543951|NCT01246804|interaction|interaction
543952|NCT01246804|pharmacokinetics|pharmacokinetics
543953|NCT01246791|NPC-01|npc-01
543954|NCT01246791|Pharmacokinetics|pharmacokinetics
543955|NCT01246791|Healthy female volunteer|healthy female volunteer
543956|NCT01246791|Norethisterone|norethisterone
543957|NCT01246791|Ethinyl Estradiol|ethinyl estradiol
543958|NCT01246765|Atypical Antipsychotics and pregnancy|atypical antipsychotics and pregnancy
543959|NCT01246765|Pregnancy|pregnancy
543960|NCT01246765|Medication use during pregnancy|medication use during pregnancy
543961|NCT01246752|AML, Leukemia|aml, leukemia
543962|NCT01246752|Acute Myeloid Leukemia|acute myeloid leukemia
543963|NCT01246752|HSCT|hsct
543964|NCT01246752|Stem Cell Transplantation|stem cell transplantation
543965|NCT01246752|Tx|tx
543966|NCT01246752|Chemotherapy|chemotherapy
543967|NCT01246739|mild hypercortisolism|mild hypercortisolism
543968|NCT01246739|adrenal tumour|adrenal tumour
543969|NCT01246739|surgical procedures, elective|surgical procedures, elective
543970|NCT01246739|indication|indication
543971|NCT01246726|cancer, breast, radiotherapy, boost|cancer, breast, radiotherapy, boost
543972|NCT01246713|acetaminophen|acetaminophen
543973|NCT01246713|excipients|excipients
543974|NCT01246700|Parkinson's disease|parkinson's disease
543975|NCT01246700|Randomized single-blind crossover trial|randomized single-blind crossover trial
543976|NCT01246700|Sensory Attention Focused Exercise|sensory attention focused exercise
543977|NCT01246674|function, hip muscle strength, hip replacement, hip pain,|function, hip muscle strength, hip replacement, hip pain,
543978|NCT01246609|acid base balance|acid base balance
543979|NCT01246609|Percutaneous Lithotripsy|percutaneous lithotripsy
543980|NCT01246583|Multi Site|multi site
543981|NCT01246583|Randomized|randomized
543982|NCT01246583|Placebo Controlled|placebo controlled
543983|NCT01246583|Double Blind|double blind
543984|NCT01246583|Parallel Group|parallel group
543985|NCT01246583|chronic plaque psoriasis|chronic plaque psoriasis
543986|NCT01246583|topical treatment|topical treatment
543987|NCT01246583|skin diseases|skin diseases
543988|NCT01246583|papulosquamous|papulosquamous
543989|NCT01246570|exercise|exercise
543990|NCT01246570|heart|heart
543991|NCT01246570|coronary disease|coronary disease
543992|NCT01246570|rehabilitation|rehabilitation
544084|NCT01246050|Congestive Heart Failure|congestive heart failure
543993|NCT01246557|Patients with Chronic Lymphatic Leukemia relapsing or resistant to treatment|patients with chronic lymphatic leukemia relapsing or resistant to treatment
543994|NCT01246544|Patient Safety|patient safety
543995|NCT01246544|The Helsinki Declaration on Patient Safety in Anaesthesiology|the helsinki declaration on patient safety in anaesthesiology
543996|NCT01246544|Helsinki Declaration on Patient Safety|helsinki declaration on patient safety
543997|NCT01246544|European Board of Anaesthesiology (EBA)|european board of anaesthesiology (eba)
543998|NCT01246544|European Society of Anaesthesiology (ESA)|european society of anaesthesiology (esa)
543999|NCT01246531|Urolithiasis|urolithiasis
544000|NCT01246531|Renal calculi|renal calculi
544001|NCT01246531|Aging|aging
544002|NCT01246531|Osteoporosis|osteoporosis
544003|NCT01246518|distal subungual onychomycosis|distal subungual onychomycosis
544004|NCT01246466|Persistent Atrial Fibrillation, Longstanding Persistent Atrial Fibrillation, Ablation, catheter ablation|persistent atrial fibrillation, longstanding persistent atrial fibrillation, ablation, catheter ablation
544005|NCT01246427|Adjuvant hormonal therapy|adjuvant hormonal therapy
544006|NCT01246427|Homeopathic treatment|homeopathic treatment
544007|NCT01246427|Hot flashes|hot flashes
544008|NCT01246427|Quality of life|quality of life
544009|NCT01246427|Hot flash score|hot flash score
544010|NCT01246414|Asthma|asthma
544011|NCT01246414|Exhaled breath condensates|exhaled breath condensates
544012|NCT01246414|Cytokines|cytokines
544013|NCT01246388|Fibrosis|fibrosis
544014|NCT01246388|Steatosis|steatosis
544015|NCT01246388|Liver biopsy|liver biopsy
544016|NCT01246388|Elastography|elastography
544017|NCT01246388|MRI|mri
544018|NCT01246349|Motivational Interviewing|motivational interviewing
544019|NCT01246349|Child and Adolescent Self-Efficacy|child and adolescent self-efficacy
544020|NCT01246349|Health Behaviours|health behaviours
544021|NCT01246336|Parkinson's disease, Parkinsonism|parkinson's disease, parkinsonism
544022|NCT01246336|Biomarkers|biomarkers
544023|NCT01246336|Exhaled breath|exhaled breath
544024|NCT01246336|Nanothechnology|nanothechnology
544025|NCT01246323|Visual analogue scale|visual analogue scale
544026|NCT01246323|pain level|pain level
544027|NCT01246323|analgesia|analgesia
544028|NCT01246323|combined anesthesia|combined anesthesia
544029|NCT01246284|Alopecia areata|alopecia areata
544030|NCT01246284|Intralesional|intralesional
544031|NCT01246284|Triamcinolone acetonide|triamcinolone acetonide
544032|NCT01246284|Concentration|concentration
544033|NCT01246258|primary ciliary dyskinesia|primary ciliary dyskinesia
544034|NCT01246258|otolith|otolith
544035|NCT01246258|vestibular tests|vestibular tests
544036|NCT01246245|PIN SITE INFECTION AFTER EXTERNAL FIXATION|pin site infection after external fixation
544037|NCT01246219|Idiopathic Short stature|idiopathic short stature
544038|NCT01246219|Self Image|self image
544039|NCT01246219|GH therapy|gh therapy
544040|NCT01246219|Psychological distress|psychological distress
544041|NCT01246206|● Non-Hodgkin lymphoma,|● non-hodgkin lymphoma,
544042|NCT01246206|● Hodgkin disease,|● hodgkin disease,
544043|NCT01246206|● Acute Myelogenous or Acute Lymphocytic Leukemia|● acute myelogenous or acute lymphocytic leukemia
544044|NCT01246206|● Myelodysplastic Syndromes,|● myelodysplastic syndromes,
544045|NCT01246206|● Chronic Myelogenous Leukemia|● chronic myelogenous leukemia
544046|NCT01246206|● Multiple Myeloma|● multiple myeloma
544047|NCT01246206|● Chronic Lymphocytic Leukemia|● chronic lymphocytic leukemia
544048|NCT01246206|● Myelofibrosis and other myeloproliferative disorders;|● myelofibrosis and other myeloproliferative disorders;
544049|NCT01246193|CKD-828|ckd-828
544050|NCT01246193|Hypertension|hypertension
544051|NCT01246193|Primary Hypertension|primary hypertension
544052|NCT01246193|Healthy Volunteer|healthy volunteer
544053|NCT01246193|S-Amlodipine|s-amlodipine
544054|NCT01246193|Telmisartan|telmisartan
544055|NCT01246193|Amlodipine|amlodipine
544056|NCT01246193|Pharmacokinetic|pharmacokinetic
544057|NCT01246193|Phase 1|phase 1
544058|NCT01246180|Skin, microcirculation; ASIC, pressure ulcer|skin, microcirculation; asic, pressure ulcer
544059|NCT01246167|Proximal humerus fracture|proximal humerus fracture
544060|NCT01246167|conservative|conservative
544061|NCT01246167|locking plate|locking plate
544062|NCT01246167|Philos|philos
544063|NCT01246167|Hemiprosthesis|hemiprosthesis
544064|NCT01246154|ASTHMA|asthma
544065|NCT01246141|tricuspid valve regurgitation|tricuspid valve regurgitation
544066|NCT01246141|replacement|replacement
544067|NCT01246141|repair|repair
544068|NCT01246141|outcomes|outcomes
544069|NCT01246128|Nicotinic Acetylcholine Receptors|nicotinic acetylcholine receptors
544070|NCT01246128|Schizophrenia Smokers|schizophrenia smokers
544071|NCT01246128|PET Imaging|pet imaging
544072|NCT01246102|Targeted Therapy|targeted therapy
544073|NCT01246102|HER2 Positive Cancer|her2 positive cancer
544074|NCT01246102|Cancer|cancer
544075|NCT01246102|Solid Tumor|solid tumor
544076|NCT01246102|Breast Cancer|breast cancer
544077|NCT01246089|Ranibizumab|ranibizumab
544078|NCT01246089|Myopia|myopia
544079|NCT01246089|Complications|complications
544080|NCT01246089|Neovascularization|neovascularization
544081|NCT01246089|OCT|oct
544082|NCT01246050|Heart Failure|heart failure
544083|NCT01246050|Outcome Assessment|outcome assessment
545161|NCT01241305|GPA|gpa
544085|NCT01246037|Pulmonary Arterial Hypertension|pulmonary arterial hypertension
544086|NCT01246037|Beta-blocker|beta-blocker
544087|NCT01246037|Adrenergic Receptor Antagonist|adrenergic receptor antagonist
544088|NCT01245998|Thrombophlebitis|thrombophlebitis
544089|NCT01245998|Venous thrombosis|venous thrombosis
544090|NCT01245998|Pulmonary embolism|pulmonary embolism
544091|NCT01245998|Anticoagulants|anticoagulants
544092|NCT01245998|Low-Molecular-Weight Heparin|low-molecular-weight heparin
544093|NCT01245985|SCCHN|scchn
544094|NCT01245985|squamous cell carcinoma of the head and neck|squamous cell carcinoma of the head and neck
544095|NCT01245985|oropharyngeal carcinoma|oropharyngeal carcinoma
544096|NCT01245985|hypopharyngeal carcinoma|hypopharyngeal carcinoma
544097|NCT01245985|laryngeal carcinoma|laryngeal carcinoma
544098|NCT01245972|pulsed dye laser|pulsed dye laser
544099|NCT01245972|PDL|pdl
544100|NCT01245972|basal cell carcinoma|basal cell carcinoma
544101|NCT01245972|squamous cell carcinoma|squamous cell carcinoma
544102|NCT01245972|BCC|bcc
544103|NCT01245972|SCC|scc
544104|NCT01245972|594nM laser|594nm laser
544105|NCT01245959|Nasopharyngeal carcinoma|nasopharyngeal carcinoma
544106|NCT01245959|Concurrent chemoradiotherapy|concurrent chemoradiotherapy
544107|NCT01245959|Induction chemotherapy|induction chemotherapy
544108|NCT01245959|Clinical trial|clinical trial
544109|NCT01245946|Acne moderate|acne moderate
544110|NCT01245946|Photodynamic Therapy|photodynamic therapy
544111|NCT01245946|Topical retinoids|topical retinoids
544112|NCT01245946|Antimicrobial agents|antimicrobial agents
544113|NCT01245933|COPD|copd
544114|NCT01245933|register|register
544115|NCT01245933|comorbidities|comorbidities
544116|NCT01245933|systemic inflammation|systemic inflammation
544117|NCT01245920|Dental implant|dental implant
544118|NCT01245920|Alveolar bone|alveolar bone
544119|NCT01245920|Clinical attachment Level|clinical attachment level
544120|NCT01245907|Hot flashes|hot flashes
544121|NCT01245907|Menopause|menopause
544122|NCT01245907|HRQoL|hrqol
544123|NCT01245907|Applied relaxation|applied relaxation
544124|NCT01245907|Insomnia|insomnia
544125|NCT01245907|Women's knowledge|women's knowledge
544126|NCT01245894|Index of microcirculatory resistance|index of microcirculatory resistance
544127|NCT01245894|Fractional Flow Reserve|fractional flow reserve
544128|NCT01245881|controlled trial|controlled trial
544129|NCT01245881|fractional photothermolysis|fractional photothermolysis
544130|NCT01245881|laser surgery|laser surgery
544131|NCT01245881|melasma|melasma
544132|NCT01245881|pigment disorder|pigment disorder
544133|NCT01245868|Spinal anaesthesia|spinal anaesthesia
544134|NCT01245868|Bupivacaine|bupivacaine
544135|NCT01245868|Lidocaine|lidocaine
544136|NCT01245868|Duration of blockade|duration of blockade
544137|NCT01245855|Prostaglandin E1|prostaglandin e1
544138|NCT01245855|percutaneous coronary intervention|percutaneous coronary intervention
544139|NCT01245855|Cardiac troponin T|cardiac troponin t
544140|NCT01245855|Creatine kinase-MB|creatine kinase-mb
544141|NCT01245829|Cross Infection|cross infection
544142|NCT01245829|Nosocomial Infection|nosocomial infection
544143|NCT01245829|Healthcare Acquired Infection|healthcare acquired infection
544144|NCT01245829|Hospital Paperwork|hospital paperwork
544145|NCT01245829|Observation Charts|observation charts
544146|NCT01245829|Critical Care|critical care
544147|NCT01245829|Contamination|contamination
544148|NCT01245816|colon polyps|colon polyps
544149|NCT01245803|rosuvastatin|rosuvastatin
544150|NCT01245803|angioplasty|angioplasty
544151|NCT01245803|acute coronary syndrome|acute coronary syndrome
544152|NCT01245790|Phase 1|phase 1
544153|NCT01245790|healthy volunteers|healthy volunteers
544154|NCT01245790|volunteers with renal impairment|volunteers with renal impairment
544155|NCT01245790|pharmacokinetics|pharmacokinetics
544156|NCT01245790|Rheumatoid arthritis|rheumatoid arthritis
544157|NCT01245790|RA|ra
544158|NCT01245790|fostamatinib|fostamatinib
544159|NCT01245790|Patients|patients
544160|NCT01245777|RLS|rls
544161|NCT01245777|Pregnancy|pregnancy
544162|NCT01245777|Iron Deficiency|iron deficiency
544163|NCT01245777|Anaemia|anaemia
544164|NCT01245764|Cervical cancer|cervical cancer
544165|NCT01245764|vulvar cancer|vulvar cancer
544166|NCT01245764|vaginal cancer|vaginal cancer
544167|NCT01245764|genital warts|genital warts
544168|NCT01245764|human papillomavirus|human papillomavirus
544169|NCT01245751|Shingles|shingles
544170|NCT01245751|Vaccine|vaccine
544171|NCT01245699|Cardiac arrest, CPR, quality improvement|cardiac arrest, cpr, quality improvement
544172|NCT01245686|Diet interventions|diet interventions
544173|NCT01245686|Physical activity interventions|physical activity interventions
544174|NCT01245686|Medication adherence|medication adherence
544175|NCT01245686|Tailored interventions|tailored interventions
544176|NCT01245673|Advanced Disease|advanced disease
544177|NCT01245673|MAGE-A3 Immunizations with Hiltonol|mage-a3 immunizations with hiltonol
544178|NCT01245673|Vaccine-Primed Autologous T-Cells|vaccine-primed autologous t-cells
544179|NCT01245673|Lenalidomide Maintenance|lenalidomide maintenance
544180|NCT01245660|Phase 0|phase 0
544181|NCT01245660|Bladder carcinoma|bladder carcinoma
544182|NCT01245660|egf pathway|egf pathway
544183|NCT01245660|infiltrative bladder carcinoma|infiltrative bladder carcinoma
544184|NCT01245660|cystectomy|cystectomy
544185|NCT01245660|LAPATINIB|lapatinib
544186|NCT01245647|women|women
544187|NCT01245647|HIV|hiv
544188|NCT01245647|alcohol|alcohol
544189|NCT01245647|medication|medication
544190|NCT01245647|adherence|adherence
544191|NCT01245647|acceptability|acceptability
544192|NCT01245621|palliative care|palliative care
544193|NCT01245621|end of life care|end of life care
544194|NCT01245621|quality of life|quality of life
544195|NCT01245621|caregivers|caregivers
544196|NCT01245608|Atorvastatin|atorvastatin
544197|NCT01245608|Aspirin|aspirin
544198|NCT01245608|nonalcoholic steatohepatitis|nonalcoholic steatohepatitis
544199|NCT01245608|nonalcoholic fatty liver disease|nonalcoholic fatty liver disease
544200|NCT01245608|antihypertensive agents|antihypertensive agents
544201|NCT01245595|Acute Kidney Injury (AKI)|acute kidney injury (aki)
544202|NCT01245595|Cardiopulmonary bypass (CPB)|cardiopulmonary bypass (cpb)
544203|NCT01245530|Alzheimer disease|alzheimer disease
544204|NCT01245517|hyperphosphatemia or malnutrition|hyperphosphatemia or malnutrition
544205|NCT01245478|Surgical Procedures, Elective|surgical procedures, elective
544206|NCT01245452|Rheumatoid arthritis|rheumatoid arthritis
544207|NCT01245452|Tocilizumab|tocilizumab
544208|NCT01245452|Cardiorespiratory endurance|cardiorespiratory endurance
544209|NCT01245426|Asthma|asthma
544210|NCT01245426|GW870086|gw870086
544211|NCT01245426|Efficacy|efficacy
544212|NCT01245426|FEV1|fev1
544213|NCT01245413|Stoma|stoma
544214|NCT01245413|adhesive|adhesive
544215|NCT01245413|warm|warm
544216|NCT01245413|moist|moist
544217|NCT01245413|cycling|cycling
544218|NCT01245413|men|men
544219|NCT01245413|peel-value|peel-value
544220|NCT01245413|healthy men 50-70 years old|healthy men 50-70 years old
544221|NCT01245413|men with colostoma, above 18 years|men with colostoma, above 18 years
544222|NCT01245400|Z-Lig|z-lig
544223|NCT01245400|allograft|allograft
544224|NCT01245400|ACL|acl
544225|NCT01245400|Anterior Cruciate Ligament|anterior cruciate ligament
544226|NCT01245400|ACLR|aclr
544227|NCT01245400|Anterior Cruciate Ligament Reconstruction|anterior cruciate ligament reconstruction
544228|NCT01245400|EU|eu
544229|NCT01245400|European Union|european union
544230|NCT01245400|S. Africa|s. africa
544231|NCT01245400|Reconstruction of ruptured anterior cruciate ligaments|reconstruction of ruptured anterior cruciate ligaments
544232|NCT01245387|prospective|prospective
544233|NCT01245387|observational|observational
544234|NCT01245387|Phase 4|phase 4
544235|NCT01245387|non-interventional|non-interventional
544236|NCT01245387|open-label|open-label
544237|NCT01245361|Undifferentiated Arthritis|undifferentiated arthritis
544238|NCT01245361|Rheumatoid Arthritis|rheumatoid arthritis
544239|NCT01245361|Infliximab|infliximab
544240|NCT01245348|Schizophrenia|schizophrenia
544241|NCT01245348|Bipolar Disorder|bipolar disorder
544242|NCT01245348|atypical antipsychotic|atypical antipsychotic
544243|NCT01245348|adherence|adherence
544244|NCT01245348|cost effectiveness|cost effectiveness
544245|NCT01245348|pharmacogenetics|pharmacogenetics
544246|NCT01245348|mental illness|mental illness
544247|NCT01245348|SULT4A1|sult4a1
544248|NCT01245335|CLI|cli
544249|NCT01245335|Critical Limb Ischemia|critical limb ischemia
544250|NCT01245335|PAOD|paod
544251|NCT01245335|Peripheral Arterial Disease|peripheral arterial disease
544252|NCT01245335|Stem Cells|stem cells
544253|NCT01245335|Limb amputation|limb amputation
544254|NCT01245335|Leg ulcers|leg ulcers
544255|NCT01245322|treatment, lactobacilli|treatment, lactobacilli
544256|NCT01245296|Umbilical cord|umbilical cord
544257|NCT01245296|cord clamping|cord clamping
544258|NCT01245296|iron|iron
544259|NCT01245296|Ferritin|ferritin
544260|NCT01245296|newborn|newborn
544261|NCT01245296|jaundice|jaundice
544262|NCT01245296|infant|infant
544263|NCT01245296|development|development
544264|NCT01245296|infections|infections
544265|NCT01245283|knee|knee
544266|NCT01245283|osteoarthritis|osteoarthritis
544267|NCT01245283|pain|pain
691513|NCT00667030|Aging|aging
544268|NCT01245283|function|function
544269|NCT01245283|impairment|impairment
544270|NCT01245270|anthocyanin|anthocyanin
544271|NCT01245270|blaeberries|blaeberries
544272|NCT01245270|bilberries|bilberries
544273|NCT01245270|blueberries|blueberries
544274|NCT01245270|mirtoselect|mirtoselect
544275|NCT01245270|glucose AUC|glucose auc
544276|NCT01245257|Inflammation|inflammation
544277|NCT01245257|Urea Synthesis|urea synthesis
544278|NCT01245257|Catabolism|catabolism
544279|NCT01245257|Nitrogen balance|nitrogen balance
544280|NCT01245231|childhood acute myeloid leukemia/other myeloid malignancies|childhood acute myeloid leukemia/other myeloid malignancies
544281|NCT01245179|sickle cell anemia|sickle cell anemia
544282|NCT01245179|sickle cell thalassemia|sickle cell thalassemia
544283|NCT01245179|HDAC inhibitor|hdac inhibitor
544284|NCT01245179|hemoglobin F|hemoglobin f
544285|NCT01245179|sickle beta thalassemia|sickle beta thalassemia
544286|NCT01245179|Fetal Hemoglobin|fetal hemoglobin
544481|NCT01244269|Methylphenidate|methylphenidate
544287|NCT01245153|Urinary incontinence, Pelvic floor muscle training|urinary incontinence, pelvic floor muscle training
544288|NCT01245140|Palmo-Plantar Pustolosis|palmo-plantar pustolosis
544289|NCT01245127|Schnitzler syndrome|schnitzler syndrome
544290|NCT01245101|HIV raltegravir intensification replication activation|hiv raltegravir intensification replication activation
544291|NCT01245088|Crohn's disease|crohn's disease
544292|NCT01245088|chondroitin sulfate|chondroitin sulfate
544293|NCT01245062|MEK inhibitor|mek inhibitor
544294|NCT01245062|Cancer|cancer
544295|NCT01245062|Metastatic Melanoma|metastatic melanoma
544296|NCT01245062|BRAF mutant metastatic melanoma|braf mutant metastatic melanoma
544297|NCT01245062|GSK1120212|gsk1120212
544298|NCT01245049|MMR|mmr
544299|NCT01245049|dTpa-IPV|dtpa-ipv
544300|NCT01245049|Boostrix Polio|boostrix polio
544301|NCT01245049|Repevax|repevax
544302|NCT01245049|Priorix|priorix
544303|NCT01245036|Sarcoidosis|sarcoidosis
544304|NCT01245036|Tuberculosis|tuberculosis
544305|NCT01245010|Metabolic Syndrome|metabolic syndrome
544307|NCT01245010|Obesity|obesity
544308|NCT01245010|Clinical trial|clinical trial
544309|NCT01245010|Prevention|prevention
544310|NCT01244997|Partial edentulism|partial edentulism
544311|NCT01244997|Bone atrophy|bone atrophy
544312|NCT01244997|Bone healing|bone healing
544313|NCT01244984|asthma|asthma
544314|NCT01244984|Fluticasone furoate|fluticasone furoate
544315|NCT01244984|GW642444|gw642444
544316|NCT01244958|Active rheumatoid arthritis|active rheumatoid arthritis
544317|NCT01244958|leflunomide|leflunomide
544318|NCT01244958|rituximab|rituximab
544319|NCT01244958|inadequate clinical response to leflunomide|inadequate clinical response to leflunomide
544320|NCT01244945|Functional Constipation|functional constipation
544321|NCT01244945|Functional Foods|functional foods
544322|NCT01244945|Probiotics|probiotics
544323|NCT01244945|Lactobacillus reuteri|lactobacillus reuteri
544324|NCT01244906|Chronic Myelogenous Leukemia|chronic myelogenous leukemia
544325|NCT01244906|Acute Myelogenous Leukemia|acute myelogenous leukemia
544326|NCT01244906|Myelodysplastic Syndrome|myelodysplastic syndrome
544327|NCT01244906|Myelofibrosis|myelofibrosis
544328|NCT01244906|Acute Lymphocytic Leukemia|acute lymphocytic leukemia
544329|NCT01244906|Acute Lymphoblastic Lymphoma|acute lymphoblastic lymphoma
544330|NCT01244906|Chronic Lymphocytic Leukemia|chronic lymphocytic leukemia
544331|NCT01244906|Prolymphocytic Leukemia|prolymphocytic leukemia
544332|NCT01244906|Low-grade non-Hodgkin's Lymphoma|low-grade non-hodgkin's lymphoma
544333|NCT01244906|Mantle Cell Lymphoma|mantle cell lymphoma
544334|NCT01244906|Hodgkin Lymphoma|hodgkin lymphoma
544335|NCT01244906|Myeloma|myeloma
544336|NCT01244880|PF-02545920|pf-02545920
544337|NCT01244880|ketamine|ketamine
544338|NCT01244880|fMRI|fmri
544339|NCT01244880|associative Learning|associative learning
544340|NCT01244854|chronic mental disorders|chronic mental disorders
544341|NCT01244854|cardiovascular disease|cardiovascular disease
544342|NCT01244854|behavior change|behavior change
544343|NCT01244841|ST elevation acute myocardial infarction|st elevation acute myocardial infarction
544344|NCT01244841|Primary percutaneous coronary intervention|primary percutaneous coronary intervention
544345|NCT01244841|Discharge|discharge
544346|NCT01244841|Health status|health status
544347|NCT01244841|Quality of care|quality of care
544348|NCT01244815|Bi-polar I disorder|bi-polar i disorder
544349|NCT01244815|antipsychotic|antipsychotic
544350|NCT01244815|serotonin|serotonin
544351|NCT01244815|dopamine|dopamine
544352|NCT01244815|noradrenalin|noradrenalin
544353|NCT01244815|histamine|histamine
544354|NCT01244815|pediatric|pediatric
544355|NCT01244802|yellow fever vaccine|yellow fever vaccine
544356|NCT01244789|endometrial cancer|endometrial cancer
544357|NCT01244789|chemotherapy|chemotherapy
544358|NCT01244789|carboplatin|carboplatin
544359|NCT01244789|paclitaxel|paclitaxel
544360|NCT01244789|Stage 1 & 2|stage 1 & 2
544361|NCT01244789|node-negative|node-negative
544362|NCT01244789|intermediate risk|intermediate risk
544363|NCT01244789|high risk|high risk
544364|NCT01244763|Kidney|kidney
544365|NCT01244763|Chronic Kidney Disease|chronic kidney disease
544366|NCT01244763|CKD|ckd
544367|NCT01244763|Renal|renal
544368|NCT01244763|Anemia|anemia
544369|NCT01244763|Oral anemia treatment|oral anemia treatment
544370|NCT01244763|Hemoglobin levels|hemoglobin levels
544371|NCT01244763|Erythropoietin|erythropoietin
544372|NCT01244763|Blood count|blood count
544373|NCT01244763|Predialysis|predialysis
544374|NCT01244763|Pre-dialysis|pre-dialysis
544375|NCT01244763|Hb|hb
544376|NCT01244763|Non-dialysis|non-dialysis
544377|NCT01244750|Chronic Phase - Chronic Myeloid Leukemia|chronic phase - chronic myeloid leukemia
544378|NCT01244737|Brain neoplasms|brain neoplasms
544379|NCT01244737|Children|children
544380|NCT01244737|Positron-Emission Tomography|positron-emission tomography
544381|NCT01244737|18F-FLT|18f-flt
544382|NCT01244711|Major Depression|major depression
544383|NCT01244711|Generalized Anxiety Disorder|generalized anxiety disorder
544384|NCT01244711|Benzodiazepine|benzodiazepine
544385|NCT01244711|Quetiapine|quetiapine
544482|NCT01244269|Non motor symptoms|non motor symptoms
545162|NCT01241305|WG|wg
544386|NCT01244698|Surgical Site Infection, Breast Reconstruction, Antibiotics|surgical site infection, breast reconstruction, antibiotics
544387|NCT01244685|bowel resection|bowel resection
544388|NCT01244685|Deltex CardioQ Probe|deltex cardioq probe
544389|NCT01244685|fluid management|fluid management
544390|NCT01244672|Hemorrhoids|hemorrhoids
544392|NCT01244672|Ferguson|ferguson
544393|NCT01244659|Tacrolimus|tacrolimus
544394|NCT01244659|Immunosuppressive Agents|immunosuppressive agents
544395|NCT01244659|Kidney transplantation|kidney transplantation
544396|NCT01244646|Diabetes Mellitus|diabetes mellitus
544397|NCT01244646|Type 2|type 2
544398|NCT01244646|DMT2|dmt2
544399|NCT01244646|T2DM|t2dm
544400|NCT01244646|metformin|metformin
544401|NCT01244646|sulfonylurea|sulfonylurea
544402|NCT01244646|hypoglycemia|hypoglycemia
544403|NCT01244646|weight|weight
544404|NCT01244646|quality of life|quality of life
544405|NCT01244646|compliance|compliance
544406|NCT01244633|Tourette's|tourette's
544407|NCT01244633|Ecopipam|ecopipam
544408|NCT01244633|Dopamine receptors|dopamine receptors
544409|NCT01244633|Efficacy|efficacy
544410|NCT01244633|Safety|safety
544411|NCT01244633|Adults|adults
544412|NCT01244620|A pharmacokinetic drug-drug interaction study between sitaxsentan and tadalafil and between sitaxsentan and sildenafil at the steady-state|a pharmacokinetic drug-drug interaction study between sitaxsentan and tadalafil and between sitaxsentan and sildenafil at the steady-state
544413|NCT01244594|Spinal Cord Injury|spinal cord injury
544414|NCT01244594|Cycling|cycling
544415|NCT01244594|Functional Electrical Stimulation|functional electrical stimulation
544416|NCT01244581|middle ear effusion|middle ear effusion
544417|NCT01244581|amoxicillin-clavulanate|amoxicillin-clavulanate
544418|NCT01244581|tympanometry|tympanometry
544419|NCT01244568|Prostate Cancer|prostate cancer
544420|NCT01244568|Decision support interventions (DESI)|decision support interventions (desi)
544421|NCT01244568|Comparative Effectiveness Research (CER)|comparative effectiveness research (cer)
544422|NCT01244542|Schizophrenia|schizophrenia
544423|NCT01244542|DSM IV criteria|dsm iv criteria
544424|NCT01244542|Pain insensitivity|pain insensitivity
544425|NCT01244542|Painful perception|painful perception
544426|NCT01244542|Opioid receptors|opioid receptors
544427|NCT01244490|ADHD|adhd
544428|NCT01244477|Stress Disorders, Post Traumatic|stress disorders, post traumatic
544429|NCT01244477|Trust|trust
544430|NCT01244477|functional Magnetic Resonance Imaging (fMRI)|functional magnetic resonance imaging (fmri)
544431|NCT01244464|Poliomyelitis|poliomyelitis
544432|NCT01244464|IMOVAX POLIO™|imovax polio™
544433|NCT01244464|Polio|polio
544434|NCT01244451|CLL|cll
544435|NCT01244451|relapsed|relapsed
544436|NCT01244451|refractory|refractory
544437|NCT01244451|Bendamustine|bendamustine
544438|NCT01244451|Ofatumumab|ofatumumab
544439|NCT01244438|endometrial cancer|endometrial cancer
544440|NCT01244438|FGFR2 mutations|fgfr2 mutations
544441|NCT01244412|Fundus photography|fundus photography
544442|NCT01244399|inositol|inositol
544443|NCT01244399|caffeine|caffeine
544444|NCT01244399|NTDs|ntds
544445|NCT01244386|Computed tomography|computed tomography
544446|NCT01244386|Iterative reconstruction|iterative reconstruction
544447|NCT01244386|Automatic tube current modulation|automatic tube current modulation
544448|NCT01244386|Crohn's disease|crohn's disease
544449|NCT01244386|Inflammatory bowel disease|inflammatory bowel disease
544450|NCT01244386|Radiation dose optimization|radiation dose optimization
544451|NCT01244386|C reactive protein|c reactive protein
544452|NCT01244373|Best-corrected visual acuity|best-corrected visual acuity
544453|NCT01244373|posterior capsule opacification|posterior capsule opacification
544454|NCT01244373|QUATRIX® Aspheric Evolutive pre-loaded|quatrix® aspheric evolutive pre-loaded
544455|NCT01244360|resveratrol|resveratrol
544456|NCT01244360|insulin|insulin
544457|NCT01244360|inflammation|inflammation
544458|NCT01244360|cognition|cognition
544459|NCT01244360|metabolism|metabolism
544460|NCT01244347|folic acid|folic acid
544461|NCT01244347|malformations|malformations
544462|NCT01244347|prevention|prevention
544463|NCT01244334|cataract surgery, vision, corneal edema, retinal thickness|cataract surgery, vision, corneal edema, retinal thickness
544464|NCT01244321|End stage heart failure|end stage heart failure
544465|NCT01244321|heart transplantation|heart transplantation
544466|NCT01244321|Ventricular assist device|ventricular assist device
544467|NCT01244321|Patients with end stage heart failure|patients with end stage heart failure
544468|NCT01244321|awaiting heart transplantation|awaiting heart transplantation
544469|NCT01244308|Phrenic nerve stimulation|phrenic nerve stimulation
544470|NCT01244308|LV pacing configuration|lv pacing configuration
544471|NCT01244308|CRT|crt
544472|NCT01244308|Cardiac resynchronisation therapy|cardiac resynchronisation therapy
544473|NCT01244308|Heart failure|heart failure
544474|NCT01244295|Grief|grief
544475|NCT01244295|Bereavement|bereavement
544476|NCT01244295|Psychotherapy|psychotherapy
544477|NCT01244295|Randomized controlled trial|randomized controlled trial
544478|NCT01244295|Treatment study|treatment study
544479|NCT01244282|brain imaging|brain imaging
544480|NCT01244269|Parkinson's disease|parkinson's disease
544483|NCT01244269|Postural control|postural control
544484|NCT01244243|stroke|stroke
544485|NCT01244243|rehabilitation|rehabilitation
544486|NCT01244204|vitamin D deficiency|vitamin d deficiency
544487|NCT01244204|tuberculin sin test|tuberculin sin test
544488|NCT01244204|immunity|immunity
544489|NCT01244204|tuberculosis|tuberculosis
544490|NCT01244191|Non squamous, non-small-cell lung cancer|non squamous, non-small-cell lung cancer
544491|NCT01244191|Epidermal growth factor receptor, wild type|epidermal growth factor receptor, wild type
544492|NCT01244191|c-Met inhibitor|c-met inhibitor
544493|NCT01244178|Sepsis|sepsis
544494|NCT01244178|Insulin|insulin
544495|NCT01244139|BIIB033|biib033
544496|NCT01244139|Multiple Sclerosis|multiple sclerosis
544497|NCT01244139|anti-LINGO-1 antibody|anti-lingo-1 antibody
544498|NCT01244139|Relapsing Remitting MS|relapsing remitting ms
544499|NCT01244139|remyelination|remyelination
544500|NCT01244139|myelin repair|myelin repair
544501|NCT01244139|Multiple ascending dose|multiple ascending dose
544502|NCT01244139|Secondary progessive MS|secondary progessive ms
544503|NCT01244126|otitis media|otitis media
544504|NCT01244126|recurrent ear infections (otitis media)|recurrent ear infections (otitis media)
544505|NCT01244100|Food-effects PK study in healthy subjects.|food-effects pk study in healthy subjects.
544506|NCT01244087|Inquiry-based stress reduction|inquiry-based stress reduction
544507|NCT01244087|Quality of life|quality of life
544508|NCT01244087|breast cancer|breast cancer
544509|NCT01244048|n3 LC-PUFA, yoghurt, inflammatory markers|n3 lc-pufa, yoghurt, inflammatory markers
544510|NCT01244035|High blood pressure|high blood pressure
544511|NCT01244022|Colorectal cancer|colorectal cancer
544512|NCT01244022|Surgical stress response|surgical stress response
544513|NCT01244022|interleukins|interleukins
544514|NCT01244009|Poly (ADP-ribose) polymerase (PARP) inhibitor|poly (adp-ribose) polymerase (parp) inhibitor
544515|NCT01243996|Patent ductus arteriosus, ibuprofen, preterm infants|patent ductus arteriosus, ibuprofen, preterm infants
544516|NCT01243970|Spinal anaesthesia|spinal anaesthesia
544517|NCT01243970|phenylephrine|phenylephrine
544518|NCT01243970|ephedrine|ephedrine
544519|NCT01243970|ECG changes|ecg changes
544520|NCT01243970|Caesarean delivery|caesarean delivery
544521|NCT01243970|Myocardial ischaemia|myocardial ischaemia
544522|NCT01243970|Cardiac output|cardiac output
544523|NCT01243970|hypotension|hypotension
544524|NCT01243944|INCB018424|incb018424
544525|NCT01243931|Phototherapeutic keratectomy|phototherapeutic keratectomy
544526|NCT01243931|Optical coherence tomography|optical coherence tomography
544527|NCT01243931|Corneal opacity|corneal opacity
544528|NCT01243931|Corneal dystrophy|corneal dystrophy
544529|NCT01243918|Acute respiratory failure|acute respiratory failure
544530|NCT01243918|Oxygen therapy delivery systems|oxygen therapy delivery systems
544531|NCT01243918|Non invasive ventilation|non invasive ventilation
544532|NCT01243918|High concentration mask|high concentration mask
544533|NCT01243918|Hypoxemic pneumonia|hypoxemic pneumonia
544534|NCT01243879|fasting|fasting
544535|NCT01243879|starvation|starvation
544536|NCT01243879|calorie restriction|calorie restriction
544537|NCT01243879|fMRI|fmri
544538|NCT01243840|Central aortic pressure|central aortic pressure
544539|NCT01243840|Aortic pulse wave velocity|aortic pulse wave velocity
544540|NCT01243840|Aortic PWV using a single pressure recording|aortic pwv using a single pressure recording
544541|NCT01243840|Vascular aging|vascular aging
544542|NCT01243840|Left ventricular hypertrophy|left ventricular hypertrophy
544543|NCT01243840|Left ventricular diastolic function|left ventricular diastolic function
544544|NCT01243827|Hypertension, carvedilol, bisoprolol, central pulse pressure, pulse pressure amplification, reflection magnitude, LV mass index, LV diastolic function|hypertension, carvedilol, bisoprolol, central pulse pressure, pulse pressure amplification, reflection magnitude, lv mass index, lv diastolic function
544545|NCT01243814|hyaluronate|hyaluronate
544546|NCT01243814|hyaluronic acid|hyaluronic acid
544547|NCT01243814|viscosupplementation|viscosupplementation
544548|NCT01243801|chronic pain|chronic pain
544549|NCT01243801|persistent postsurgical pain|persistent postsurgical pain
544550|NCT01243801|hyperalgesia|hyperalgesia
544551|NCT01243801|ketamine|ketamine
544552|NCT01243801|quantitative sensory testing|quantitative sensory testing
544553|NCT01243788|COPD|copd
544554|NCT01243788|Seretide|seretide
544555|NCT01243788|Combivent|combivent
544556|NCT01243788|effect and safety|effect and safety
544557|NCT01243788|Twelve weeks|twelve weeks
544558|NCT01243775|NSCLC|nsclc
544559|NCT01243762|Colorectal cancer|colorectal cancer
544560|NCT01243762|Solid tumors|solid tumors
544561|NCT01243762|Ovarian cancer|ovarian cancer
544562|NCT01243762|Fallopian tube cancer|fallopian tube cancer
544563|NCT01243762|Primary peritoneal cancer|primary peritoneal cancer
544564|NCT01243749|Target Vessel Revascularization (TVR)|target vessel revascularization (tvr)
544565|NCT01243749|Target Lesion Revascularization (TLR)|target lesion revascularization (tlr)
544566|NCT01243749|Myocardial Infarction (MI)|myocardial infarction (mi)
544567|NCT01243749|Target Vessel Failure (TVF)|target vessel failure (tvf)
544568|NCT01243749|Target Lesion Failure (TLF)|target lesion failure (tlf)
544569|NCT01243749|Stent Thrombosis|stent thrombosis
544570|NCT01243749|Restenotic Lesion|restenotic lesion
544665|NCT01243372|stage IVB colon cancer|stage ivb colon cancer
544571|NCT01243749|Percutaneous Coronary Intervention (PCI)|percutaneous coronary intervention (pci)
544572|NCT01243749|Real-world|real-world
544573|NCT01243736|anemic|anemic
544574|NCT01243736|bleeding|bleeding
544575|NCT01243736|blood in stool|blood in stool
544576|NCT01243736|abdomen pain|abdomen pain
544577|NCT01243736|Gastrointestinal bleeding|gastrointestinal bleeding
544578|NCT01243736|capsule endoscopy (CE)|capsule endoscopy (ce)
544579|NCT01243723|Dyschesia treatment|dyschesia treatment
544580|NCT01243723|Inconfort related to dyschesia|inconfort related to dyschesia
544581|NCT01243723|Quality of life|quality of life
544582|NCT01243723|Bowel function index|bowel function index
544583|NCT01243697|Desogestrel|desogestrel
544584|NCT01243697|Chemosensitivity|chemosensitivity
544585|NCT01243684|Spinal cord|spinal cord
544586|NCT01243684|cervical spondylosis|cervical spondylosis
544587|NCT01243684|myelopathy|myelopathy
544588|NCT01243671|Behçet's, intestinal|behçet's, intestinal
544589|NCT01243658|Oxytocin|oxytocin
544590|NCT01243658|BPD|bpd
544591|NCT01243658|Borderline|borderline
544592|NCT01243632|malignant pleural mesothelioma|malignant pleural mesothelioma
544593|NCT01243632|chemotherapy|chemotherapy
544594|NCT01243632|gemcitabine|gemcitabine
544595|NCT01243632|cisplatin|cisplatin
544596|NCT01243632|long infusion|long infusion
544597|NCT01243619|PET|pet
544598|NCT01243619|CT|ct
544599|NCT01243619|radiotherapy|radiotherapy
544600|NCT01243606|Anxiety|anxiety
544601|NCT01243606|Depression|depression
544602|NCT01243606|Obsessive Compulsive Disorder|obsessive compulsive disorder
544603|NCT01243606|Panic Disorder|panic disorder
544604|NCT01243606|Generalized Anxiety Disorder|generalized anxiety disorder
544605|NCT01243606|Social Anxiety Disorder|social anxiety disorder
544606|NCT01243606|Transdiagnostic Treatment|transdiagnostic treatment
544607|NCT01243606|CBT|cbt
544608|NCT01243593|pediatrics|pediatrics
544609|NCT01243593|anesthesia|anesthesia
544610|NCT01243593|pyeloplasty|pyeloplasty
544611|NCT01243593|Transversus Abdominis Plane Block|transversus abdominis plane block
544612|NCT01243593|Regional Anesthesia|regional anesthesia
544613|NCT01243580|PK and safety|pk and safety
544614|NCT01243580|Pharmacokinetic profile (PK) and safety|pharmacokinetic profile (pk) and safety
544615|NCT01243554|Exercise training|exercise training
544616|NCT01243554|Pregnancy|pregnancy
544617|NCT01243554|Obesity|obesity
544618|NCT01243528|Malnutrition|malnutrition
544619|NCT01243528|Infection|infection
544620|NCT01243528|Neurological|neurological
544621|NCT01243515|Central Venous Pressure|central venous pressure
544622|NCT01243515|Kidney Diseases|kidney diseases
544623|NCT01243515|Chronic Kidney Disease|chronic kidney disease
544624|NCT01243515|Healthy Subjects|healthy subjects
544625|NCT01243515|Non-Invasive Monitor|non-invasive monitor
544626|NCT01243489|CML|cml
544627|NCT01243489|compliance|compliance
544628|NCT01243489|compliance supporting measures|compliance supporting measures
544629|NCT01243489|complete cytogenetic response|complete cytogenetic response
544630|NCT01243489|mayor molecular remission|mayor molecular remission
544631|NCT01243489|Philadelphia chromosome|philadelphia chromosome
544632|NCT01243489|BCR-ABL|bcr-abl
544633|NCT01243489|Imatinib|imatinib
544634|NCT01243489|tyrosine kinase inhibitor|tyrosine kinase inhibitor
544635|NCT01243489|smart blister|smart blister
544636|NCT01243476|myelodysplastic syndrome|myelodysplastic syndrome
544637|NCT01243476|5q deletion|5q deletion
544638|NCT01243476|anemia|anemia
544639|NCT01243476|lenalidomide|lenalidomide
544640|NCT01243476|red blood cells transfusion|red blood cells transfusion
544641|NCT01243437|plague, ciprofloxacin|plague, ciprofloxacin
544642|NCT01243411|Peyronie's Disease, penile plaque, penile curvature|peyronie's disease, penile plaque, penile curvature
544643|NCT01243398|adenocarcinoma of the gastroesophageal junction|adenocarcinoma of the gastroesophageal junction
544644|NCT01243398|adenocarcinoma of the esophagus|adenocarcinoma of the esophagus
544645|NCT01243398|squamous cell carcinoma of the esophagus|squamous cell carcinoma of the esophagus
692038|NCT00665353|HIV|hiv
544646|NCT01243398|recurrent esophageal cancer|recurrent esophageal cancer
544647|NCT01243398|stage IA esophageal cancer|stage ia esophageal cancer
544648|NCT01243398|stage IB esophageal cancer|stage ib esophageal cancer
544649|NCT01243398|stage IIA esophageal cancer|stage iia esophageal cancer
544650|NCT01243398|stage IIB esophageal cancer|stage iib esophageal cancer
544651|NCT01243398|stage IIIA esophageal cancer|stage iiia esophageal cancer
544652|NCT01243398|stage IIIB esophageal cancer|stage iiib esophageal cancer
544653|NCT01243398|stage IIIC esophageal cancer|stage iiic esophageal cancer
544654|NCT01243398|stage IV esophageal cancer|stage iv esophageal cancer
544655|NCT01243385|adenocarcinoma of the prostate|adenocarcinoma of the prostate
544656|NCT01243385|hormone-resistant prostate cancer|hormone-resistant prostate cancer
544657|NCT01243385|stage III prostate cancer|stage iii prostate cancer
544658|NCT01243385|stage IV prostate cancer|stage iv prostate cancer
544659|NCT01243385|recurrent prostate cancer|recurrent prostate cancer
544660|NCT01243372|recurrent colon cancer|recurrent colon cancer
544661|NCT01243372|stage IIIA colon cancer|stage iiia colon cancer
544662|NCT01243372|stage IIIB colon cancer|stage iiib colon cancer
544663|NCT01243372|stage IIIC colon cancer|stage iiic colon cancer
544664|NCT01243372|stage IVA colon cancer|stage iva colon cancer
544666|NCT01243372|recurrent rectal cancer|recurrent rectal cancer
544667|NCT01243372|stage III rectal cancer|stage iii rectal cancer
544668|NCT01243372|stage IV rectal cancer|stage iv rectal cancer
544669|NCT01243346|Gastrointestinal Stromal Tumor|gastrointestinal stromal tumor
544670|NCT01243346|PDGFR Inhibitor|pdgfr inhibitor
544671|NCT01243346|Crenolanib (CP-868,596)|crenolanib (cp-868,596)
544672|NCT01243281|hepatitis B|hepatitis b
544673|NCT01243281|HBeAg|hbeag
544674|NCT01243281|pegylated interferon|pegylated interferon
544675|NCT01243281|entecavir|entecavir
544676|NCT01243255|hypercholesterolemia|hypercholesterolemia
544677|NCT01243255|low density lipoprotein|low density lipoprotein
544678|NCT01243255|undertreatment of hypercholesterolemia|undertreatment of hypercholesterolemia
544679|NCT01243242|ADHD,Adults,MG01CI,METADOXINE|adhd,adults,mg01ci,metadoxine
544680|NCT01243216|Pregnancy|pregnancy
544681|NCT01243216|Labor|labor
544682|NCT01243216|Epidural Analgesia|epidural analgesia
544683|NCT01243216|Epidural Anesthesia|epidural anesthesia
544684|NCT01243216|Spinal Anesthesia|spinal anesthesia
544685|NCT01243216|Ultrasound|ultrasound
544686|NCT01243216|Neuraxial Analgesia|neuraxial analgesia
544687|NCT01243216|Neuraxial Anesthesia|neuraxial anesthesia
544688|NCT01243216|Cesarean delivery|cesarean delivery
544689|NCT01243203|Smoking, surgery, Anesthesia, quit|smoking, surgery, anesthesia, quit
544690|NCT01243190|leukemia|leukemia
544691|NCT01243190|small lymphocytic leukemia|small lymphocytic leukemia
544693|NCT01243190|CLL|cll
544694|NCT01243190|ofatumumab|ofatumumab
544695|NCT01243190|untreated|untreated
544696|NCT01243190|early stage|early stage
544697|NCT01243190|high-risk|high-risk
544698|NCT01243177|Lacosamide|lacosamide
544699|NCT01243177|Vimpat®|vimpat®
544700|NCT01243177|Epilepsy|epilepsy
544701|NCT01243177|Monotherapy|monotherapy
544702|NCT01243177|Velocity|velocity
544703|NCT01243164|confidence|confidence
544704|NCT01243164|wheelchair performance|wheelchair performance
544705|NCT01243151|Hypercholesterolemia|hypercholesterolemia
544706|NCT01243151|Dyslipidemia|dyslipidemia
544707|NCT01243151|LDL|ldl
544708|NCT01243151|High Cholesterol|high cholesterol
544709|NCT01243151|Japanese Volunteers|japanese volunteers
544710|NCT01243151|PF-04950615|pf-04950615
544711|NCT01243151|RN316|rn316
544712|NCT01243138|Cross-sectional|cross-sectional
544713|NCT01243138|epidemiological study|epidemiological study
544714|NCT01243138|to evaluate the prevalence of CV risk factors in patients attending general practice in AfME region|to evaluate the prevalence of cv risk factors in patients attending general practice in afme region
544715|NCT01243125|Blockage|blockage
544716|NCT01243125|Encrustation|encrustation
544717|NCT01243125|Catheter|catheter
544718|NCT01243125|Spinal Cord Injury|spinal cord injury
544719|NCT01243125|SCI|sci
544720|NCT01243086|Macular Degeneration|macular degeneration
544721|NCT01243086|Age-related macular degeneration|age-related macular degeneration
544722|NCT01243086|Anti-inflammatory|anti-inflammatory
544723|NCT01243086|Anti-vascular endothelial growth factor (Anti-VEGF)|anti-vascular endothelial growth factor (anti-vegf)
544724|NCT01243086|Lucentis|lucentis
544725|NCT01243086|Ranibizumab|ranibizumab
544726|NCT01243086|OZURDEX|ozurdex
544727|NCT01243086|Dexamethasone|dexamethasone
544728|NCT01243086|Vision loss|vision loss
544729|NCT01243073|imetelstat|imetelstat
544730|NCT01243073|imetelstat sodium|imetelstat sodium
544731|NCT01243073|GRN163L|grn163l
544732|NCT01243073|telomerase inhibitor|telomerase inhibitor
544733|NCT01243073|telomerase|telomerase
544734|NCT01243073|essential thrombocytosis|essential thrombocytosis
544735|NCT01243073|essential thrombocythemia|essential thrombocythemia
544736|NCT01243073|ET|et
544737|NCT01243073|polycythemia vera|polycythemia vera
544738|NCT01243073|PV|pv
544739|NCT01243060|Sleep Aid|sleep aid
544740|NCT01243047|Second line treatment for metastatic colorectal cancer|second line treatment for metastatic colorectal cancer
544741|NCT01243008|Lyme disease|lyme disease
544742|NCT01243008|Borreliosis|borreliosis
544743|NCT01243008|Azithromycin|azithromycin
544744|NCT01242982|5. metacarpal fracture/fractures|5. metacarpal fracture/fractures
544745|NCT01242982|subcapital|subcapital
544746|NCT01242982|shaft|shaft
544747|NCT01242982|closed|closed
544748|NCT01242956|stroke|stroke
544749|NCT01242956|video-based training|video-based training
544750|NCT01242956|rehabilitation|rehabilitation
544751|NCT01242943|I131|i131
544752|NCT01242943|L19|l19
544753|NCT01242943|antibody|antibody
544754|NCT01242943|monoclonal|monoclonal
544755|NCT01242943|tumour targeting|tumour targeting
544756|NCT01242943|radioimmunotherapy|radioimmunotherapy
544757|NCT01242943|cancer|cancer
544758|NCT01242930|imetelstat|imetelstat
544759|NCT01242930|imetelstat sodium|imetelstat sodium
544760|NCT01242930|GRN163L|grn163l
544761|NCT01242930|telomerase inhibitor|telomerase inhibitor
544762|NCT01242930|telomerase inhibition|telomerase inhibition
544763|NCT01242930|multiple myeloma|multiple myeloma
544764|NCT01242930|myeloma|myeloma
544765|NCT01242930|myeloma progenitor cells|myeloma progenitor cells
544766|NCT01242904|dialysis solutions|dialysis solutions
544767|NCT01242904|renal replacement therapy|renal replacement therapy
544768|NCT01242904|peritoneal dialysis|peritoneal dialysis
544769|NCT01242904|bimodal solution|bimodal solution
544770|NCT01242904|glucose sparing therapy|glucose sparing therapy
544771|NCT01242891|Ventricular Assist Device|ventricular assist device
544772|NCT01242891|Pediatric Ventricular Assist Device|pediatric ventricular assist device
544773|NCT01242878|HbSS|hbss
544774|NCT01242878|Sickle cell anemia|sickle cell anemia
544775|NCT01242878|HbSC|hbsc
544776|NCT01242878|HbSbetathalassemia|hbsbetathalassemia
544777|NCT01242878|Hemoglobinopathy|hemoglobinopathy
544778|NCT01242878|Hemoglobinopathies|hemoglobinopathies
544779|NCT01242865|Stress|stress
544780|NCT01242865|Anxiety|anxiety
544781|NCT01242865|Resilience|resilience
544782|NCT01242865|Mindfulness|mindfulness
544783|NCT01242865|Quality of Life|quality of life
544784|NCT01242865|Stress Management|stress management
544785|NCT01242852|Hysteroscopy|hysteroscopy
544786|NCT01242852|infertility|infertility
544787|NCT01242852|subfertility|subfertility
544788|NCT01242852|intrauterine abnormalities|intrauterine abnormalities
544789|NCT01242852|intracavitary pathology|intracavitary pathology
544790|NCT01242852|IVF|ivf
544791|NCT01242852|ICSI|icsi
544792|NCT01242852|in vitro fertilization|in vitro fertilization
544793|NCT01242852|intracytoplasmic sperm injection|intracytoplasmic sperm injection
544794|NCT01242839|CACICOL20|cacicol20
544795|NCT01242813|TNF-receptor associated periodic syndrome|tnf-receptor associated periodic syndrome
544796|NCT01242813|fevers|fevers
544797|NCT01242813|rashes|rashes
544798|NCT01242813|musculoskeletal and abdominal pain|musculoskeletal and abdominal pain
544799|NCT01242813|periorbital edema|periorbital edema
544800|NCT01242813|TNFR1|tnfr1
544801|NCT01242800|male breast cancer|male breast cancer
544802|NCT01242800|stage IV breast cancer|stage iv breast cancer
544803|NCT01242787|Chronic hepatitis B|chronic hepatitis b
544804|NCT01242787|LB80380|lb80380
544805|NCT01242787|treatment-naive|treatment-naive
544806|NCT01242787|entecavir|entecavir
544807|NCT01242787|Extension|extension
544808|NCT01242774|AML|aml
544809|NCT01242774|bone marrow|bone marrow
544810|NCT01242774|abnormal blast cells of myeloid|abnormal blast cells of myeloid
544811|NCT01242774|acute leukemia|acute leukemia
544812|NCT01242774|cytogenetic abnormalities|cytogenetic abnormalities
544813|NCT01242774|HDACi|hdaci
544814|NCT01242761|Accuracy of diagnostic ultrasound based in community or as part of a specialist hospital-based service|accuracy of diagnostic ultrasound based in community or as part of a specialist hospital-based service
544815|NCT01242735|Obsessive Compulsive Disorder|obsessive compulsive disorder
544816|NCT01242735|OCD|ocd
544817|NCT01242735|Exercise|exercise
544818|NCT01242735|Aerobic Exercise|aerobic exercise
544819|NCT01242722|Heart failure|heart failure
544820|NCT01242722|auto threshold|auto threshold
544821|NCT01242722|pacing|pacing
544822|NCT01242722|CRT-D recipients|crt-d recipients
544823|NCT01242722|Left Ventricular (LV) evoked response signals|left ventricular (lv) evoked response signals
544824|NCT01242696|Drug Eluting Stents|drug eluting stents
544825|NCT01242696|Observational|observational
544826|NCT01242696|All-Comers|all-comers
544827|NCT01242657|Tobacco Use Cessation|tobacco use cessation
544828|NCT01242657|Youth Tobacco Use|youth tobacco use
544829|NCT01242657|Physical Activity|physical activity
544830|NCT01242657|Smoking Cessation Intervention|smoking cessation intervention
544831|NCT01242618|nasal cartilage diseases|nasal cartilage diseases
544832|NCT01242605|unresectable|unresectable
544833|NCT01242605|advanced|advanced
544834|NCT01242566|Temozolomide|temozolomide
544835|NCT01242566|Elderly|elderly
544836|NCT01242566|Glioblastoma|glioblastoma
544837|NCT01242566|Karnofsky performance score (KPS)|karnofsky performance score (kps)
544838|NCT01242540|Pain|pain
544839|NCT01242540|Functional Magnetic Resonance Imaging|functional magnetic resonance imaging
544840|NCT01242527|dyslipidemia|dyslipidemia
544841|NCT01242527|hyperlipidemia|hyperlipidemia
544842|NCT01242527|omega-3 carboxylic acid|omega-3 carboxylic acid
544843|NCT01242514|Rheumatoid Arthritis|rheumatoid arthritis
544844|NCT01242514|OSKIRA|oskira
544845|NCT01242514|Fostamatinib|fostamatinib
544846|NCT01242501|Prevention|prevention
544847|NCT01242501|Counseling|counseling
544848|NCT01242501|Behavioral interventions|behavioral interventions
544849|NCT01242501|HIV risk reduction|hiv risk reduction
544850|NCT01242488|Rheumatoid Arthritis|rheumatoid arthritis
544851|NCT01242488|CDP6038|cdp6038
544852|NCT01242488|Interleukin-6|interleukin-6
544853|NCT01242488|Tocilizumab|tocilizumab
544854|NCT01242475|tuberculosis|tuberculosis
544855|NCT01242475|rdESAT-6|rdesat-6
544856|NCT01242475|CFP-10|cfp-10
544857|NCT01242475|skin test|skin test
544858|NCT01242475|diagnostic test|diagnostic test
544859|NCT01242462|Conventional mechanical ventilation|conventional mechanical ventilation
544860|NCT01242462|Mid-frequency ventilation|mid-frequency ventilation
544861|NCT01242462|Respiratory Distress Syndrome|respiratory distress syndrome
544862|NCT01242462|Preterm Newborn Infant|preterm newborn infant
544863|NCT01242462|Mean Airway Pressure|mean airway pressure
544864|NCT01242462|Mean Arterial Pressure|mean arterial pressure
544865|NCT01242462|Mean Peak Inspiratory Pressure|mean peak inspiratory pressure
544866|NCT01242449|Breast cancer|breast cancer
544867|NCT01242449|Metastatic|metastatic
544868|NCT01242449|HER2 positive|her2 positive
544869|NCT01242449|vinorelbine|vinorelbine
544870|NCT01242436|Ovarian Cancer|ovarian cancer
544871|NCT01242436|Peritoneal Metastasis|peritoneal metastasis
544872|NCT01242436|Whole body diffusion MRI|whole body diffusion mri
544873|NCT01242436|therapy|therapy
544874|NCT01242423|musculoskeletal shockwave therapy|musculoskeletal shockwave therapy
544875|NCT01242410|Short cervix|short cervix
544876|NCT01242410|Preterm birth|preterm birth
544877|NCT01242410|Cervical pessary|cervical pessary
544878|NCT01242410|Twins|twins
544879|NCT01242371|Schizophrenia|schizophrenia
544880|NCT01242371|Schizoaffective|schizoaffective
544881|NCT01242371|Probiotic supplements|probiotic supplements
544882|NCT01242371|Gliadin|gliadin
544883|NCT01242371|Casein|casein
544884|NCT01242358|hypoxaemia - capnography - integrated pulmonary index - PEG|hypoxaemia - capnography - integrated pulmonary index - peg
544885|NCT01242345|Hypoxemia|hypoxemia
544886|NCT01242345|Capnography|capnography
544887|NCT01242345|Integrated pulmonary index|integrated pulmonary index
544888|NCT01242345|Sedation|sedation
544889|NCT01242345|Propofol|propofol
544890|NCT01242345|Safety|safety
544891|NCT01242332|perioperative|perioperative
544892|NCT01242332|pregabalin|pregabalin
544893|NCT01242332|arthroscopic anterior cruciate ligament reconstruction|arthroscopic anterior cruciate ligament reconstruction
544894|NCT01242332|postoperative pain management|postoperative pain management
544895|NCT01242319|quality improvement|quality improvement
544896|NCT01242319|implementation trials|implementation trials
544897|NCT01242319|cholesterol guidelines|cholesterol guidelines
544898|NCT01242319|patient activation|patient activation
544899|NCT01242306|endothelial dysfunction acetylcholine bms ses|endothelial dysfunction acetylcholine bms ses
544900|NCT01242280|Acute variceal bleeding|acute variceal bleeding
544901|NCT01242280|Massive bleeding|massive bleeding
544902|NCT01242280|Liver Cirrhosis|liver cirrhosis
544903|NCT01242280|Esophageal tamponade|esophageal tamponade
544904|NCT01242280|Esophageal stent|esophageal stent
544905|NCT01242267|multiple myeloma|multiple myeloma
544906|NCT01242267|transplant|transplant
544907|NCT01242267|Multiple myeloma patients undergoing transplant|multiple myeloma patients undergoing transplant
544908|NCT01242254|KH902|kh902
544909|NCT01242254|age-related macular degeneration|age-related macular degeneration
544910|NCT01242254|choroidal neovascularization|choroidal neovascularization
544911|NCT01242254|intravitreal injection|intravitreal injection
544912|NCT01242254|multiple injections|multiple injections
544913|NCT01242241|Propofol|propofol
544914|NCT01242241|Childhood obesity|childhood obesity
544915|NCT01242241|Pharmacodynamics|pharmacodynamics
545168|NCT01241266|Peptic Ulcer Bleeding|peptic ulcer bleeding
544916|NCT01242228|Dipeptidyl peptidase-4 inhibitor|dipeptidyl peptidase-4 inhibitor
544917|NCT01242228|ASP1941|asp1941
544918|NCT01242228|DPP-4 inhibitor|dpp-4 inhibitor
544919|NCT01242228|long-term safety|long-term safety
544920|NCT01242228|Diabetes mellitus|diabetes mellitus
544921|NCT01242215|Diabetes mellitus|diabetes mellitus
544922|NCT01242215|sulfonylurea|sulfonylurea
544923|NCT01242215|ASP1941|asp1941
544924|NCT01242202|Diabetes mellitus|diabetes mellitus
544925|NCT01242202|alpha glucosidase inhibitor|alpha glucosidase inhibitor
544926|NCT01242202|ASP1941|asp1941
544927|NCT01242202|long-term safety|long-term safety
544928|NCT01242150|Acute Respiratory Failure|acute respiratory failure
544929|NCT01242150|Continuous Positive Airway Pressure|continuous positive airway pressure
544930|NCT01242150|Infants|infants
544931|NCT01242150|Helmet|helmet
544932|NCT01242111|Mucopolysaccharidosis IV type A|mucopolysaccharidosis iv type a
544933|NCT01242111|MPS IV Type A|mps iv type a
544934|NCT01242111|Mucopolysaccharidosis IVA|mucopolysaccharidosis iva
544935|NCT01242111|MPS IVA|mps iva
544936|NCT01242111|Morquio A Syndrome|morquio a syndrome
544937|NCT01242111|Lysosomal Storage Disorder|lysosomal storage disorder
544938|NCT01242111|LSD|lsd
544939|NCT01242111|N-acetylgalactosamine-6-sulfatase|n-acetylgalactosamine-6-sulfatase
544940|NCT01242111|N-acetylgalactosamine-6-sulfate sulfatase|n-acetylgalactosamine-6-sulfate sulfatase
544941|NCT01242111|galactose-6-sulfatase|galactose-6-sulfatase
544942|NCT01242111|GALNS|galns
544943|NCT01242111|enzyme replacement therapy|enzyme replacement therapy
544944|NCT01242111|ERT|ert
544945|NCT01242098|Asthma|asthma
544946|NCT01242098|Combination therapy|combination therapy
544947|NCT01242098|Primary care management|primary care management
544948|NCT01242098|Switch|switch
544949|NCT01242098|ICS/LABA|ics/laba
544950|NCT01242098|Fostair|fostair
544951|NCT01242098|Seretide|seretide
544952|NCT01242085|alignment|alignment
544953|NCT01242072|malignancy|malignancy
544954|NCT01242072|etoposide and carboplatin|etoposide and carboplatin
544955|NCT01242072|non small cell lung cancer|non small cell lung cancer
544956|NCT01242072|small cell lung cancer|small cell lung cancer
544957|NCT01242072|testicular cancer|testicular cancer
544958|NCT01242072|thymoma|thymoma
544959|NCT01242072|ovarian cancer|ovarian cancer
544960|NCT01242072|osteosarcoma|osteosarcoma
544962|NCT01242059|Food intake regulation|food intake regulation
544963|NCT01242059|blood glucose regulation|blood glucose regulation
544964|NCT01242059|protein|protein
544965|NCT01242059|fiber|fiber
544966|NCT01242059|pulses|pulses
544967|NCT01242059|yellow peas|yellow peas
544968|NCT01242046|female sexual arousal|female sexual arousal
544969|NCT01242033|red raspberries|red raspberries
544970|NCT01242033|post-prandial|post-prandial
544971|NCT01242033|oxidative stress|oxidative stress
544972|NCT01242033|antioxidants|antioxidants
544973|NCT01242033|polyphenols|polyphenols
544974|NCT01242033|vitamin C|vitamin c
544975|NCT01242033|acute dietary intervention|acute dietary intervention
544976|NCT01242007|Myotonic dystrophy|myotonic dystrophy
544977|NCT01242007|Steinert's disease|steinert's disease
544978|NCT01241981|Breast|breast
544979|NCT01241981|Cancer|cancer
544980|NCT01241981|Digital|digital
544981|NCT01241981|Mammography|mammography
544982|NCT01241981|Tomosynthesis|tomosynthesis
544983|NCT01241968|Extracorporeal Shockwave Therapy|extracorporeal shockwave therapy
544984|NCT01241968|Myocardial Ischemia|myocardial ischemia
544985|NCT01241968|Refractory Angina|refractory angina
544986|NCT01241955|CPR|cpr
544987|NCT01241942|Lung Transplant|lung transplant
544988|NCT01241942|Emphysema|emphysema
544989|NCT01241942|Chronic Obstructive Pulmonary Disease (COPD)|chronic obstructive pulmonary disease (copd)
544990|NCT01241942|Cystic Fibrosis|cystic fibrosis
544991|NCT01241942|Pulmonary Fibrosis|pulmonary fibrosis
544992|NCT01241942|Bronchiectasis|bronchiectasis
544993|NCT01241942|Sarcoidosis|sarcoidosis
544994|NCT01241942|Pulmonary Hypertension|pulmonary hypertension
544995|NCT01241942|Alpha-1 Antitrypsin Deficiency|alpha-1 antitrypsin deficiency
544996|NCT01241929|advanced cancer|advanced cancer
544997|NCT01241916|elbow, splint|elbow, splint
544998|NCT01241903|Platelet activation|platelet activation
544999|NCT01241903|platelet leukocyte aggregates|platelet leukocyte aggregates
545000|NCT01241890|Cystic Fibrosis|cystic fibrosis
545001|NCT01241890|Children|children
545002|NCT01241890|Exhaled Breath Condensate|exhaled breath condensate
545003|NCT01241890|Non-invasive Inflammatory Markers|non-invasive inflammatory markers
545004|NCT01241890|Volatile Organic Compounds|volatile organic compounds
545005|NCT01241890|Home monitoring|home monitoring
545006|NCT01241890|Quality of life|quality of life
545007|NCT01241838|Heart failure|heart failure
545008|NCT01241838|Left ventricular hypertrophy|left ventricular hypertrophy
545009|NCT01241838|Diastolic dysfunction|diastolic dysfunction
545010|NCT01241825|capsule endoscopy|capsule endoscopy
545011|NCT01241825|chewing gum|chewing gum
545012|NCT01241825|small bowel transit time|small bowel transit time
545013|NCT01241812|knee|knee
545014|NCT01241812|osteoarthritis|osteoarthritis
545015|NCT01241799|endoscopic ultrasound guided fine needle aspiration (EUS-FNA)|endoscopic ultrasound guided fine needle aspiration (eus-fna)
545016|NCT01241799|pancreatic biopsy|pancreatic biopsy
545017|NCT01241799|randomized|randomized
545018|NCT01241799|single blind|single blind
545019|NCT01241799|fine needle aspiration (FNA) adequacy|fine needle aspiration (fna) adequacy
545020|NCT01241799|fine needle aspiration (FNA) accuracy|fine needle aspiration (fna) accuracy
545021|NCT01241786|chronic lymphocytic leukemia (CLL)|chronic lymphocytic leukemia (cll)
545022|NCT01241786|small lymphocytic lymphoma (SLL)|small lymphocytic lymphoma (sll)
545023|NCT01241773|TMC435-TiDP16-C123|tmc435-tidp16-c123
545024|NCT01241773|TMC435-C123|tmc435-c123
545025|NCT01241773|TMC435|tmc435
545026|NCT01241773|HCV|hcv
545027|NCT01241773|Hepatitis C|hepatitis c
545028|NCT01241760|Genotype 1 chronic hepatitis C|genotype 1 chronic hepatitis c
545029|NCT01241760|VX-950-C211|vx-950-c211
545030|NCT01241760|VX-950|vx-950
545031|NCT01241760|IL28B|il28b
545032|NCT01241760|Telaprevir|telaprevir
545033|NCT01241760|Hepatitis C|hepatitis c
545034|NCT01241760|BID|bid
545035|NCT01241760|Q8h|q8h
545036|NCT01241760|SOC|soc
545037|NCT01241734|Diffuse Large B cell Lymphoma|diffuse large b cell lymphoma
545038|NCT01241721|Breast Diseases|breast diseases
545039|NCT01241721|Breast Neoplasms|breast neoplasms
545040|NCT01241721|Neoplasms|neoplasms
545169|NCT01241266|high risk|high risk
545041|NCT01241695|Oral nutritional supplement, diabetes mellitus type 2, glycaemic control|oral nutritional supplement, diabetes mellitus type 2, glycaemic control
545042|NCT01241695|Oral nutritional supplement (Food for special medical purposes)|oral nutritional supplement (food for special medical purposes)
545043|NCT01241682|Mesothelioma|mesothelioma
545044|NCT01241682|Dendritic cells|dendritic cells
545045|NCT01241682|Cyclophosphamide|cyclophosphamide
545046|NCT01241682|Tumor lysate-loaded|tumor lysate-loaded
545047|NCT01241682|Immunotherapy|immunotherapy
545048|NCT01241656|Prostate cancer|prostate cancer
545049|NCT01241656|Decision support intervention (DESI)|decision support intervention (desi)
545050|NCT01241656|Shared medical appointments (SMA)|shared medical appointments (sma)
545051|NCT01241656|Comparative effectiveness research (CER)|comparative effectiveness research (cer)
545052|NCT01241643|interleukin-7|interleukin-7
545053|NCT01241643|immune-based therapies|immune-based therapies
545054|NCT01241643|HIV|hiv
545055|NCT01241643|infectious disease|infectious disease
545056|NCT01241643|immune non-responders|immune non-responders
545057|NCT01241630|Somato-sensory reflex arch|somato-sensory reflex arch
545058|NCT01241630|Spinal cord injury|spinal cord injury
545059|NCT01241630|Xiao Procedure|xiao procedure
545060|NCT01241617|Lung disease|lung disease
545061|NCT01241617|Lobectomy|lobectomy
545062|NCT01241617|Pulmonary resection|pulmonary resection
545063|NCT01241591|CP-690,550|cp-690,550
545064|NCT01241591|Etanercept|etanercept
545065|NCT01241591|Moderate|moderate
545066|NCT01241591|Severe|severe
545067|NCT01241591|Chronic|chronic
545068|NCT01241591|Plaque|plaque
545069|NCT01241591|Psoriasis|psoriasis
545070|NCT01241591|Efficacy|efficacy
545071|NCT01241591|Safety|safety
545072|NCT01241591|Tofacitinib|tofacitinib
545073|NCT01241591|Xeljanz|xeljanz
545074|NCT01241591|OPT Compare|opt compare
545075|NCT01241591|OPT|opt
545076|NCT01241591|head-to-head|head-to-head
545077|NCT01241591|non-inferiority|non-inferiority
545078|NCT01241591|Psoriasis vulgaris|psoriasis vulgaris
545079|NCT01241591|short-term|short-term
545080|NCT01241591|Itch|itch
545081|NCT01241591|Pruritus|pruritus
545082|NCT01241591|Plaque psoriasis|plaque psoriasis
545083|NCT01241591|DLQI|dlqi
545084|NCT01241578|Obesity|obesity
545085|NCT01241578|Behavior Therapy|behavior therapy
545086|NCT01241578|Lifestyle|lifestyle
545087|NCT01241578|Technology|technology
545088|NCT01241578|Cellular Phone|cellular phone
545089|NCT01241565|lung cancer|lung cancer
545090|NCT01241565|lobectomy|lobectomy
545091|NCT01241565|wedge resection|wedge resection
545092|NCT01241552|Clostridium difficile|clostridium difficile
545093|NCT01241552|recurrent Clostridium difficile|recurrent clostridium difficile
545094|NCT01241552|vancomycin|vancomycin
545095|NCT01241552|metronidazole|metronidazole
545096|NCT01241552|monoclonal antibody|monoclonal antibody
545097|NCT01241552|Clostridium difficile infection (CDI)|clostridium difficile infection (cdi)
545098|NCT01241526|COPD|copd
545099|NCT01241526|COMET|comet
545100|NCT01241526|Disease management|disease management
545101|NCT01241513|glutathione|glutathione
545102|NCT01241513|redox status|redox status
545103|NCT01241513|carotid body chemosensitivity|carotid body chemosensitivity
545104|NCT01241513|ventilation|ventilation
545105|NCT01241500|Myelodysplastic syndromes|myelodysplastic syndromes
545106|NCT01241500|MDS|mds
545107|NCT01241487|Hypertension, Valsartan/Amlodipine,|hypertension, valsartan/amlodipine,
545108|NCT01241461|Advanced Cancer|advanced cancer
545109|NCT01241461|Metastatic Cancer|metastatic cancer
545110|NCT01241461|p70s6 inhibitor|p70s6 inhibitor
545111|NCT01241448|Type 2 Diabetes Mellitus|type 2 diabetes mellitus
545112|NCT01241422|Asthma|asthma
545113|NCT01241422|Mild asthma|mild asthma
545114|NCT01241422|Singulair|singulair
545115|NCT01241422|JNJ 40929837|jnj 40929837
545116|NCT01241422|Montelukast|montelukast
545117|NCT01241409|Healthy|healthy
545118|NCT01241409|Sprinkle Capsule Formulation|sprinkle capsule formulation
545119|NCT01241409|Rabeprazole sodium|rabeprazole sodium
545120|NCT01241409|Pharmacokinetics|pharmacokinetics
545121|NCT01241409|Bioequivalence|bioequivalence
545122|NCT01241409|Safety|safety
545123|NCT01241396|Multiple Myeloma|multiple myeloma
545124|NCT01241396|observational|observational
545125|NCT01241396|survey|survey
545126|NCT01241396|non-interventional|non-interventional
545127|NCT01241396|international|international
545128|NCT01241396|epidemiology|epidemiology
545129|NCT01241396|treatment|treatment
545130|NCT01241396|routine clinical practice|routine clinical practice
545131|NCT01241396|retrospective|retrospective
545132|NCT01241396|prospective|prospective
545133|NCT01241383|Scleroderma renal crisis|scleroderma renal crisis
545134|NCT01241383|angiotensin converting enzyme inhibitors|angiotensin converting enzyme inhibitors
545135|NCT01241383|bosentan|bosentan
545136|NCT01241383|endothelin receptor antagonist|endothelin receptor antagonist
545137|NCT01241370|Retinal endothelia dysfunction|retinal endothelia dysfunction
545138|NCT01241370|Type 2 diabetes mellitus|type 2 diabetes mellitus
545139|NCT01241370|Insulin-resistance|insulin-resistance
545140|NCT01241370|micro-lightguide spectrophotometry|micro-lightguide spectrophotometry
545141|NCT01241370|laserdopplerfluxmetry|laserdopplerfluxmetry
545142|NCT01241357|Iron|iron
545143|NCT01241357|Iron overload|iron overload
545144|NCT01241357|Hepatic iron concentration|hepatic iron concentration
545145|NCT01241357|High-temperature superconductivity|high-temperature superconductivity
545146|NCT01241357|Magnetic susceptibility|magnetic susceptibility
545147|NCT01241357|Susceptometer|susceptometer
545148|NCT01241344|Adv|adv
545149|NCT01241344|Hematopoeitic Stem cell Transplant|hematopoeitic stem cell transplant
545150|NCT01241344|HSCT|hsct
545151|NCT01241331|moderate to severe facial acne vulgaris|moderate to severe facial acne vulgaris
545152|NCT01241318|neonate|neonate
545153|NCT01241318|omphalitis|omphalitis
545154|NCT01241318|neonatal mortality|neonatal mortality
545155|NCT01241318|maternal health|maternal health
545156|NCT01241318|umbilical cord infection|umbilical cord infection
545157|NCT01241305|Vasculitis|vasculitis
545158|NCT01241305|CSS|css
545159|NCT01241305|EGPA|egpa
545160|NCT01241305|GCA|gca
545163|NCT01241305|MPA|mpa
545164|NCT01241305|PAN|pan
545165|NCT01241305|TAK|tak
545166|NCT01241279|cataract surgery|cataract surgery
545167|NCT01241279|intraocular lens|intraocular lens
545170|NCT01241266|None-Interventional Study|none-interventional study
545171|NCT01241266|he proportion of peptic ulcer bleeding patients who are at high risk (Forrest Ia-IIb)|he proportion of peptic ulcer bleeding patients who are at high risk (forrest ia-iib)
545172|NCT01241253|legumes|legumes
545173|NCT01241253|glycemic response|glycemic response
545174|NCT01241253|glucose|glucose
545175|NCT01241253|type 2 diabetes mellitus|type 2 diabetes mellitus
545176|NCT01241227|liver fibrosis|liver fibrosis
545177|NCT01241227|survival|survival
545178|NCT01241227|transient elastography|transient elastography
545179|NCT01241214|Seasonal allergic rhinitis|seasonal allergic rhinitis
545181|NCT01241214|Allergic rhinitis|allergic rhinitis
545182|NCT01241214|Allergies|allergies
545183|NCT01241201|intestinal health|intestinal health
545184|NCT01241201|probiotics|probiotics
545185|NCT01241201|inflammation|inflammation
545186|NCT01241201|biomarkers|biomarkers
545187|NCT01241188|tuberculosis|tuberculosis
545188|NCT01241188|rdESAT-6|rdesat-6
545189|NCT01241188|CFP-10|cfp-10
545190|NCT01241188|skin test|skin test
545191|NCT01241188|diagnostic test|diagnostic test
545192|NCT01241175|IOP|iop
545193|NCT01241175|ophthalmic anesthesia|ophthalmic anesthesia
545194|NCT01241175|magnesium sulfate|magnesium sulfate
545195|NCT01241162|Neuroblastoma|neuroblastoma
545196|NCT01241162|Ewings sarcoma|ewings sarcoma
545197|NCT01241162|osteogenic sarcoma|osteogenic sarcoma
545198|NCT01241162|rhabdomyosarcoma|rhabdomyosarcoma
545199|NCT01241162|synovial sarcoma|synovial sarcoma
545200|NCT01241162|high-risk|high-risk
545201|NCT01241162|relapsed|relapsed
545202|NCT01241162|children|children
545203|NCT01241149|Nissen fundoplication|nissen fundoplication
545204|NCT01241149|non-acid reflux disease|non-acid reflux disease
545205|NCT01241149|anti-reflux surgery|anti-reflux surgery
545206|NCT01241136|pilonidal disease, cystectomy, recurrence|pilonidal disease, cystectomy, recurrence
545207|NCT01241123|return of bowel function, post-operative, colon surgery|return of bowel function, post-operative, colon surgery
545208|NCT01241110|PID, Ofloxacin, Azitromicine, Metronidazole|pid, ofloxacin, azitromicine, metronidazole
545209|NCT01241097|endothelial function|endothelial function
545210|NCT01241097|statins|statins
545211|NCT01241097|ezetimibe|ezetimibe
545212|NCT01241097|pleiotropism|pleiotropism
545213|NCT01241084|asthmatic children|asthmatic children
545214|NCT01241071|Lumbar region|lumbar region
545215|NCT01241071|Pain|pain
545216|NCT01241071|Fascia|fascia
545217|NCT01241071|Electromyography|electromyography
545218|NCT01241071|Goniometry|goniometry
545219|NCT01241058|pediatrics, crohn's disease, disease course, therapy|pediatrics, crohn's disease, disease course, therapy
545220|NCT01241032|DA-8159|da-8159
545221|NCT01241032|Udenafil|udenafil
545222|NCT01241032|Alcohol|alcohol
545223|NCT01241019|asphyxia neonatorum, hypothermia, neuroprotection|asphyxia neonatorum, hypothermia, neuroprotection
545224|NCT01241006|Relapse|relapse
545225|NCT01241006|Corticosteroids|corticosteroids
545226|NCT01240993|parenting intervention|parenting intervention
545227|NCT01240993|mother-child relations|mother-child relations
545228|NCT01240993|substance abuse|substance abuse
545229|NCT01240993|attachment|attachment
545230|NCT01240993|child development|child development
545231|NCT01240967|Phase 1|phase 1
545232|NCT01240967|healthy volunteers|healthy volunteers
545233|NCT01240967|volunteers with renal impairment|volunteers with renal impairment
545234|NCT01240967|pharmacokinetics|pharmacokinetics
545235|NCT01240967|TC-5214|tc-5214
545236|NCT01240954|Rhinitis|rhinitis
545237|NCT01240954|Allergic|allergic
545238|NCT01240954|Immunotherapy|immunotherapy
545239|NCT01240915|safety efficacy MultiStem(r) moderate to severe Ulcerative Colitis|safety efficacy multistem(r) moderate to severe ulcerative colitis
545240|NCT01240902|Valvular Heart Disease|valvular heart disease
545241|NCT01240902|Critical Aortic Stenosis|critical aortic stenosis
545242|NCT01240902|Severe Aortic Stenosis|severe aortic stenosis
545243|NCT01240902|High Risk|high risk
545244|NCT01240902|Aortic Valve Replacement|aortic valve replacement
545245|NCT01240889|Ragweed allergies|ragweed allergies
545246|NCT01240889|acoustic rhinometry|acoustic rhinometry
545247|NCT01240889|nasal allergen challenge|nasal allergen challenge
545248|NCT01240876|Sciatica|sciatica
545249|NCT01240876|Pain|pain
545250|NCT01240863|osteoarthritis|osteoarthritis
545251|NCT01240863|low back pain|low back pain
545252|NCT01240863|Moderate to Severe Pain|moderate to severe pain
545253|NCT01240850|Retroperitoneal fibrosis|retroperitoneal fibrosis
545254|NCT01240850|Inflammatory aneurysms|inflammatory aneurysms
545255|NCT01240850|Methotrexate|methotrexate
545256|NCT01240850|Prednisone|prednisone
545257|NCT01240850|Aorta|aorta
545258|NCT01240837|glycaemic index|glycaemic index
545259|NCT01240837|arenga pinnata sugar|arenga pinnata sugar
545260|NCT01240837|palm sugar|palm sugar
545261|NCT01240837|diabetes|diabetes
545262|NCT01240824|bladder cancer|bladder cancer
545263|NCT01240824|urothelial carcinoma|urothelial carcinoma
545264|NCT01240824|transitional cell carcinoma bladder|transitional cell carcinoma bladder
545265|NCT01240824|ureter|ureter
545266|NCT01240811|intrauterine device|intrauterine device
545267|NCT01240811|IUD|iud
545268|NCT01240811|levonorgestrel|levonorgestrel
545269|NCT01240811|copper|copper
545270|NCT01240811|CD4|cd4
545271|NCT01240811|CCR5|ccr5
545272|NCT01240811|microflora|microflora
545273|NCT01240798|Depression|depression
545274|NCT01240798|Anxiety|anxiety
545275|NCT01240798|Coronary disease|coronary disease
545276|NCT01240785|gestational diabetes|gestational diabetes
545277|NCT01240785|metformin|metformin
545278|NCT01240785|insulin|insulin
545279|NCT01240772|Haemorrhoids, Surgery, Cost-effectiveness, Morbidity, Risk assessment,RCT, Stapled haemorrhoidopexy, Doppler-guided, Haemorrhoidal artery ligation, Outcome|haemorrhoids, surgery, cost-effectiveness, morbidity, risk assessment,rct, stapled haemorrhoidopexy, doppler-guided, haemorrhoidal artery ligation, outcome
545280|NCT01240759|Type 2 Diabetes Mellitus|type 2 diabetes mellitus
545281|NCT01240759|Metformin|metformin
545282|NCT01240746|Influenza|influenza
545283|NCT01240746|Quadrivalent Influenza Vaccine|quadrivalent influenza vaccine
545284|NCT01240746|Trivalent Influenza Vaccine|trivalent influenza vaccine
545285|NCT01240746|Influenza viruses|influenza viruses
545286|NCT01240746|Fluzone®|fluzone®
545287|NCT01240720|I131|i131
545288|NCT01240720|F16|f16
545289|NCT01240720|antibody|antibody
545290|NCT01240720|monoclonal|monoclonal
545291|NCT01240720|tumor targeting|tumor targeting
545292|NCT01240720|radioimmunotherapy|radioimmunotherapy
545293|NCT01240720|lymphoma, breast and lung cancer|lymphoma, breast and lung cancer
545294|NCT01240720|Patients with different cancer types|patients with different cancer types
545295|NCT01240694|Lupus|lupus
545297|NCT01240681|Locally Advanced Breast Cancer (LABC)|locally advanced breast cancer (labc)
545298|NCT01240681|neoadjuvant chemotherapy|neoadjuvant chemotherapy
545299|NCT01240681|Fluorothymidine Positron Emission Tomography (FLT PET)|fluorothymidine positron emission tomography (flt pet)
545300|NCT01240681|Blood Oxygen Level Dependent Magnetic Resonance Imaging (BOLD MRI)|blood oxygen level dependent magnetic resonance imaging (bold mri)
545301|NCT01240681|tumor response|tumor response
545302|NCT01240681|mastectomy|mastectomy
545303|NCT01240668|Hyponatremia|hyponatremia
545304|NCT01240668|Euvolemia|euvolemia
545305|NCT01240668|Hypervolemia|hypervolemia
545306|NCT01240668|Euvolemic|euvolemic
545307|NCT01240668|Hypervolemic|hypervolemic
545308|NCT01240655|LCL161|lcl161
545309|NCT01240655|solid tumors|solid tumors
545310|NCT01240655|paclitaxel|paclitaxel
545311|NCT01240642|Advanced or metastatic cancer|advanced or metastatic cancer
545312|NCT01240642|refractory|refractory
545313|NCT01240642|core phase|core phase
545314|NCT01240642|extension phase|extension phase
545315|NCT01240642|dose escalation|dose escalation
545316|NCT01240642|standard chemotherapy|standard chemotherapy
545317|NCT01240642|doctaxel|doctaxel
545318|NCT01240642|paclitaxel|paclitaxel
545319|NCT01240642|carboplatin|carboplatin
545320|NCT01240642|safety|safety
545321|NCT01240642|tolerability|tolerability
545322|NCT01240616|Nicotine|nicotine
545323|NCT01240616|Mecamylamine|mecamylamine
545324|NCT01240616|Attention|attention
545325|NCT01240616|fMRI|fmri
545326|NCT01240616|Default Network|default network
545327|NCT01240616|Healthy Volunteer|healthy volunteer
545328|NCT01240616|HV|hv
545329|NCT01240603|Artemisinin|artemisinin
545330|NCT01240603|Malaria|malaria
545331|NCT01240603|Drug Resistance|drug resistance
545332|NCT01240603|Hemoglobin E|hemoglobin e
545333|NCT01240590|Anaplastic Thyroid Cancer|anaplastic thyroid cancer
545334|NCT01240590|Crolibulin|crolibulin
545335|NCT01240590|Solid Tumors|solid tumors
545336|NCT01240590|ATC|atc
545337|NCT01240577|IPdR|ipdr
545338|NCT01240577|Pharmacokinetics|pharmacokinetics
545339|NCT01240577|Early Phase I|early phase i
545340|NCT01240577|Cancer|cancer
545341|NCT01240577|Solid Tumor|solid tumor
545342|NCT01240577|Lymphoma|lymphoma
545343|NCT01240551|Imaging|imaging
545344|NCT01240551|Bone Metastasis|bone metastasis
545345|NCT01240551|Bone Scan|bone scan
545346|NCT01240551|Radiopharmaceutical|radiopharmaceutical
545347|NCT01240551|Pet Scan|pet scan
545348|NCT01240551|Prostate Cancer|prostate cancer
545349|NCT01240525|graft versus host disease|graft versus host disease
545350|NCT01240525|recurrent grade 1 follicular lymphoma|recurrent grade 1 follicular lymphoma
545351|NCT01240525|recurrent grade 2 follicular lymphoma|recurrent grade 2 follicular lymphoma
545352|NCT01240525|recurrent small lymphocytic lymphoma|recurrent small lymphocytic lymphoma
545353|NCT01240525|stage III small lymphocytic lymphoma|stage iii small lymphocytic lymphoma
545354|NCT01240525|stage IV small lymphocytic lymphoma|stage iv small lymphocytic lymphoma
545355|NCT01240525|Waldenstrom macroglobulinemia|waldenstrom macroglobulinemia
545356|NCT01240525|stage III grade 1 follicular lymphoma|stage iii grade 1 follicular lymphoma
545357|NCT01240525|stage III grade 2 follicular lymphoma|stage iii grade 2 follicular lymphoma
545358|NCT01240525|stage IV grade 1 follicular lymphoma|stage iv grade 1 follicular lymphoma
545359|NCT01240525|stage IV grade 2 follicular lymphoma|stage iv grade 2 follicular lymphoma
545459|NCT01240070|risk factor|risk factor
545360|NCT01240525|stage III chronic lymphocytic leukemia|stage iii chronic lymphocytic leukemia
545361|NCT01240525|stage IV chronic lymphocytic leukemia|stage iv chronic lymphocytic leukemia
545362|NCT01240525|refractory chronic lymphocytic leukemia|refractory chronic lymphocytic leukemia
545363|NCT01240525|Non-Hodgkin's lymphoma|non-hodgkin's lymphoma
545364|NCT01240525|Hodgkin's lymphoma|hodgkin's lymphoma
545365|NCT01240525|Chronic (Pro-)lymphocytic leukaemia|chronic (pro-)lymphocytic leukaemia
545366|NCT01240525|Plasma cell myeloma|plasma cell myeloma
545367|NCT01240525|Acute myeloid leukaemia|acute myeloid leukaemia
545368|NCT01240525|Acute lymphoblastic leukaemia|acute lymphoblastic leukaemia
545369|NCT01240525|Myelodysplastic syndrome|myelodysplastic syndrome
545370|NCT01240525|Chronic myelomonocytic leukaemia|chronic myelomonocytic leukaemia
545371|NCT01240499|Weight management|weight management
545372|NCT01240499|New weight paradigm|new weight paradigm
545373|NCT01240499|Overweight women|overweight women
545374|NCT01240499|Eating behaviors|eating behaviors
545375|NCT01240499|Appetite ratings|appetite ratings
545376|NCT01240499|Blood lipids|blood lipids
545377|NCT01240486|IRIS|iris
545378|NCT01240486|HIV|hiv
545379|NCT01240486|Immune|immune
545380|NCT01240486|Reconstitution|reconstitution
545381|NCT01240486|Inflammatory|inflammatory
545382|NCT01240486|Syndrome|syndrome
545383|NCT01240473|kala azar|kala azar
545384|NCT01240473|visceral leishmaniasis|visceral leishmaniasis
545385|NCT01240473|diagnosis|diagnosis
545386|NCT01240473|drug resistance|drug resistance
545387|NCT01240473|Therapeutics|therapeutics
545388|NCT01240473|Capacity Building|capacity building
545389|NCT01240447|NSCLC|nsclc
545390|NCT01240447|lung cancer, small-cell|lung cancer, small-cell
545391|NCT01240447|advanced lung cancer|advanced lung cancer
545392|NCT01240434|trocar hernia closure laparoscopy|trocar hernia closure laparoscopy
545393|NCT01240421|Metastatic breast cancer with no other treatment options|metastatic breast cancer with no other treatment options
545394|NCT01240395|Multiple chemical sensitivities|multiple chemical sensitivities
545395|NCT01240395|MCS|mcs
545396|NCT01240395|Mindfulness-based cognitive therapy|mindfulness-based cognitive therapy
545397|NCT01240395|MBCT|mbct
545398|NCT01240369|VEGFC|vegfc
545399|NCT01240369|CTTN|cttn
545400|NCT01240369|miR326|mir326
545401|NCT01240369|ESCC|escc
545402|NCT01240369|NSCLC|nsclc
545403|NCT01240356|transcranial doppler|transcranial doppler
545404|NCT01240356|sonothrombolysis|sonothrombolysis
545405|NCT01240356|ultrasound|ultrasound
545406|NCT01240356|stroke|stroke
545407|NCT01240343|Biobank|biobank
545408|NCT01240343|Genetics|genetics
545409|NCT01240330|Deep Vein Thrombosis|deep vein thrombosis
545410|NCT01240330|Effects of compression therapy|effects of compression therapy
545411|NCT01240330|Peak Flow Velocity|peak flow velocity
545412|NCT01240317|expert system|expert system
545413|NCT01240317|decision support system|decision support system
545414|NCT01240317|human patient simulator|human patient simulator
545415|NCT01240317|anesthesia|anesthesia
545416|NCT01240291|glutamine|glutamine
545417|NCT01240291|trauma|trauma
545418|NCT01240291|alanyl-glutamine|alanyl-glutamine
545419|NCT01240265|Vitamin D deficiency|vitamin d deficiency
545420|NCT01240265|Rickets|rickets
545421|NCT01240265|Infant|infant
545422|NCT01240265|Nutrition|nutrition
545423|NCT01240252|diabetes|diabetes
545424|NCT01240252|insulin resistance|insulin resistance
545425|NCT01240239|Pre anesthesia consultation|pre anesthesia consultation
545426|NCT01240239|telemedicine|telemedicine
545427|NCT01240213|Vitamin D|vitamin d
545428|NCT01240213|lifestyle intervention|lifestyle intervention
545429|NCT01240213|postmenopausal women|postmenopausal women
545430|NCT01240200|diabetes|diabetes
545431|NCT01240200|elderly|elderly
545432|NCT01240200|insulin injections|insulin injections
545433|NCT01240187|epilepsy|epilepsy
545434|NCT01240174|Antibiotic|antibiotic
545435|NCT01240174|Antimicrobial|antimicrobial
545436|NCT01240174|Prescribing|prescribing
545437|NCT01240174|Cough|cough
545438|NCT01240174|Acute Bronchitis|acute bronchitis
545439|NCT01240161|Glioblastoma multiforme|glioblastoma multiforme
545440|NCT01240161|FLT|flt
545441|NCT01240161|PET|pet
545442|NCT01240148|Allodynia|allodynia
545443|NCT01240148|hyperalgesia|hyperalgesia
545444|NCT01240148|paresthesia|paresthesia
545445|NCT01240135|Contact Lens Wear|contact lens wear
545446|NCT01240135|Contact Lens Solution|contact lens solution
545447|NCT01240135|Multi-purpose disinfecting solution|multi-purpose disinfecting solution
545448|NCT01240135|Myopia|myopia
545449|NCT01240122|Corneal staining and comfort evaluation in normal, habitual contact lens wearers.|corneal staining and comfort evaluation in normal, habitual contact lens wearers.
545450|NCT01240096|Functional dyspepsia|functional dyspepsia
545451|NCT01240096|Weight loss|weight loss
545452|NCT01240096|Mirtazapine|mirtazapine
545453|NCT01240083|Depression|depression
545454|NCT01240083|Transcranial magnetic stimulation|transcranial magnetic stimulation
545455|NCT01240083|Thetaburst Stimulation|thetaburst stimulation
545456|NCT01240083|Alternative treatment methods|alternative treatment methods
545457|NCT01240070|diabetes,|diabetes,
545458|NCT01240070|cardiovascular|cardiovascular
545460|NCT01240070|cardiovascular event|cardiovascular event
545461|NCT01240070|intervention|intervention
545462|NCT01240057|Isolated Congenital Diaphragmatic Hernia|isolated congenital diaphragmatic hernia
545463|NCT01240057|Fetal Surgery|fetal surgery
545464|NCT01240057|Pulmonary Hypoplasia|pulmonary hypoplasia
545465|NCT01240044|Newborn Pain|newborn pain
545466|NCT01240044|Respiratory Physiotherapy|respiratory physiotherapy
545467|NCT01240044|Neonatal intensive care unit|neonatal intensive care unit
545468|NCT01240031|Malnutrition|malnutrition
545469|NCT01240031|Nutritional Risk|nutritional risk
545470|NCT01240031|Intake|intake
545471|NCT01240031|Food sensory|food sensory
545472|NCT01240031|Nutritional therapy|nutritional therapy
545473|NCT01240031|Energy|energy
545474|NCT01240031|Protein|protein
545475|NCT01240031|Handgrip strength|handgrip strength
545476|NCT01240031|Reaction time|reaction time
545477|NCT01240031|Quality of Life|quality of life
545478|NCT01239979|coronary artery disease|coronary artery disease
545479|NCT01239966|Acute Respiratory Distress syndrome|acute respiratory distress syndrome
545480|NCT01239966|Acute renal Failure|acute renal failure
545481|NCT01239953|In-stent restenosis|in-stent restenosis
545482|NCT01239953|Drug-eluting balloon|drug-eluting balloon
545483|NCT01239953|Drug-eluting stent|drug-eluting stent
545484|NCT01239953|Angiography|angiography
545485|NCT01239953|Minimal lumen diameter|minimal lumen diameter
545486|NCT01239940|In-stent restenosis|in-stent restenosis
545487|NCT01239940|Drug-eluting balloon|drug-eluting balloon
545488|NCT01239940|Drug-eluting stent|drug-eluting stent
545489|NCT01239940|Angiography|angiography
545490|NCT01239940|Minimal lumen diameter|minimal lumen diameter
545491|NCT01239927|diverticulitis|diverticulitis
545492|NCT01239927|hartmann|hartmann
545493|NCT01239927|anastomosis|anastomosis
545494|NCT01239914|drug eluting stent|drug eluting stent
545495|NCT01239914|coronary artery disease|coronary artery disease
545496|NCT01239914|Korean registry|korean registry
545497|NCT01239901|sickle cell disease|sickle cell disease
545498|NCT01239901|sickle cell anemia|sickle cell anemia
545499|NCT01239901|sickled cells|sickled cells
545500|NCT01239901|blood vessel|blood vessel
545501|NCT01239901|iron overload|iron overload
545502|NCT01239888|Depression|depression
545503|NCT01239888|Treatment resistant depression|treatment resistant depression
545504|NCT01239888|Oxytocin|oxytocin
545505|NCT01239888|Estrogen Modulators|estrogen modulators
545506|NCT01239888|HPA axis|hpa axis
545507|NCT01239888|Mental Disorders|mental disorders
545508|NCT01239888|Estrogens|estrogens
545509|NCT01239888|Tibolone|tibolone
545510|NCT01239888|Estrogen Receptor Modulators|estrogen receptor modulators
545511|NCT01239888|Androgens|androgens
545512|NCT01239888|Hormones|hormones
545513|NCT01239888|Hormone Substitutes|hormone substitutes
545514|NCT01239888|Physiological Effects of Drugs|physiological effects of drugs
545515|NCT01239888|Pharmacologic Actions|pharmacologic actions
545516|NCT01239888|Hormone Antagonists|hormone antagonists
545517|NCT01239888|Bone Density Conservation Agents|bone density conservation agents
545518|NCT01239888|Estrogen Antagonists|estrogen antagonists
545519|NCT01239862|pulmonary, silicosis, chronic and accelerated silicosis, autologous transplantation|pulmonary, silicosis, chronic and accelerated silicosis, autologous transplantation
545520|NCT01239862|bone marrow cells, stem cells, cell therapy|bone marrow cells, stem cells, cell therapy
693011|NCT00661830|biliary|biliary
545521|NCT01239849|Diabetes Mellitus, Hypercholesterolemia|diabetes mellitus, hypercholesterolemia
545522|NCT01239836|urinary incontinence, self-management, cost, self-efficacy, continence promotion|urinary incontinence, self-management, cost, self-efficacy, continence promotion
545523|NCT01239823|osteoarthritis|osteoarthritis
545524|NCT01239823|whole body vibration|whole body vibration
545525|NCT01239823|mobility|mobility
545526|NCT01239823|rehabilitation|rehabilitation
545527|NCT01239810|hyaluronic acid|hyaluronic acid
545528|NCT01239810|cartilage|cartilage
545529|NCT01239810|T2 mapping|t2 mapping
545530|NCT01239810|quantitative|quantitative
545531|NCT01239810|MRI|mri
545532|NCT01239810|volume|volume
545533|NCT01239784|pediatrics|pediatrics
545534|NCT01239784|Heart Defects|heart defects
545535|NCT01239784|Neurodevelopmental deficit|neurodevelopmental deficit
545536|NCT01239784|Neurodevelopmental Rehabilitation|neurodevelopmental rehabilitation
545537|NCT01239771|Safety|safety
545538|NCT01239771|tolerability|tolerability
545539|NCT01239771|healthy|healthy
545540|NCT01239771|stable disease|stable disease
545541|NCT01239771|oral|oral
545542|NCT01239771|tablet|tablet
545543|NCT01239745|Hormone adjuvant treatment of early breast cancer with aromatase inhibitors following 2-3 years of tamoxifen|hormone adjuvant treatment of early breast cancer with aromatase inhibitors following 2-3 years of tamoxifen
545544|NCT01239719|Allergic dermatitis|allergic dermatitis
545545|NCT01239693|Stunting|stunting
545546|NCT01239693|Growth failure|growth failure
545547|NCT01239693|Malnutrition|malnutrition
545548|NCT01239693|Lipid based nutrient supplement|lipid based nutrient supplement
545549|NCT01239693|LNS|lns
545550|NCT01239693|Prevention|prevention
545551|NCT01239693|Malawi|malawi
545552|NCT01239693|Sub-Saharan Africa|sub-saharan africa
545553|NCT01239693|Dietary supplementation|dietary supplementation
545554|NCT01239693|Efficacy|efficacy
545555|NCT01239693|Pregnancy|pregnancy
545556|NCT01239693|Infancy|infancy
545557|NCT01239693|Newborn|newborn
545558|NCT01239680|hemorrhagic shock|hemorrhagic shock
545559|NCT01239680|glutamine|glutamine
545560|NCT01239680|trauma resuscitation|trauma resuscitation
545561|NCT01239680|department of defense|department of defense
545562|NCT01239680|trauma|trauma
545563|NCT01239667|Health related quality of Life, Self Care behavior, activities of daily living|health related quality of life, self care behavior, activities of daily living
545564|NCT01239654|acute|acute
545565|NCT01239654|coronary|coronary
545566|NCT01239654|syndrome|syndrome
545567|NCT01239654|everolimus|everolimus
545568|NCT01239654|zotarolimus|zotarolimus
545569|NCT01239654|optical|optical
545570|NCT01239654|coherence|coherence
545571|NCT01239654|tomography|tomography
545572|NCT01239641|Uterine Fibroids|uterine fibroids
545573|NCT01239641|Myoectomy|myoectomy
545574|NCT01239641|High Intensity Focused Ultrasound|high intensity focused ultrasound
545575|NCT01239641|ablation|ablation
545576|NCT01239602|changes in cortical excitability in subjects with chronic stroke after stem cell therapy|changes in cortical excitability in subjects with chronic stroke after stem cell therapy
545577|NCT01239589|Patients admitted as for an acute bipolar manic episode|patients admitted as for an acute bipolar manic episode
545578|NCT01239589|Description of management patterns and hospital stay in patients admitted for acute bipolar manic episode and treated with either quetiapine IR or quetiapine XR|description of management patterns and hospital stay in patients admitted for acute bipolar manic episode and treated with either quetiapine ir or quetiapine xr
545579|NCT01239563|kidney transplantation|kidney transplantation
545580|NCT01239563|donation after cardiac death|donation after cardiac death
545581|NCT01239563|ischemia-reperfusion injury|ischemia-reperfusion injury
545582|NCT01239563|thymoglobulin|thymoglobulin
545583|NCT01239563|steroid avoidance|steroid avoidance
545584|NCT01239563|lymphocyte|lymphocyte
545585|NCT01239550|Insulin|insulin
545586|NCT01239550|Detemir|detemir
545587|NCT01239550|Dopamine, brain,neurotransmitter|dopamine, brain,neurotransmitter
545588|NCT01239550|Diabetes|diabetes
545589|NCT01239550|Obesity|obesity
545590|NCT01239550|Neurotransmitters|neurotransmitters
545591|NCT01239524|breast reconstruction, latissimus dorsi flap, thoracodorsal nerve, skeletal muscle disuse, breast MRI|breast reconstruction, latissimus dorsi flap, thoracodorsal nerve, skeletal muscle disuse, breast mri
545592|NCT01239485|Pediatric refractory or relapsed acute leukemia|pediatric refractory or relapsed acute leukemia
545593|NCT01239472|chronic allograft nephropathy|chronic allograft nephropathy
545594|NCT01239472|cytokines|cytokines
545595|NCT01239472|kidney transplant|kidney transplant
545596|NCT01239472|calcineurin inhibitors withdrawn|calcineurin inhibitors withdrawn
545597|NCT01239446|Hodgkin lymphoma|hodgkin lymphoma
545598|NCT01239446|mediastinal irradiation|mediastinal irradiation
545599|NCT01239446|Coronary Artery Disease|coronary artery disease
545601|NCT01239394|ofatumumab|ofatumumab
545602|NCT01239381|proton radiation|proton radiation
545603|NCT01239381|stereotactic body radiotherapy|stereotactic body radiotherapy
545604|NCT01239381|SBRT|sbrt
545605|NCT01239368|Multiple Myeloma|multiple myeloma
545606|NCT01239368|High Risk|high risk
545607|NCT01239368|Newly Diagnosed|newly diagnosed
545608|NCT01239368|Adoptive Immunotherapy|adoptive immunotherapy
545609|NCT01239368|Autologous|autologous
545610|NCT01239329|Complex multiple disabilities|complex multiple disabilities
545611|NCT01239329|Malnutrition|malnutrition
545612|NCT01239277|muscle|muscle
545613|NCT01239277|FSR|fsr
545614|NCT01239277|protein|protein
545615|NCT01239277|carbohydrate|carbohydrate
545616|NCT01239277|leucine|leucine
545617|NCT01239251|GlowCap|glowcap
545618|NCT01239251|adjuvant endocrine therapy|adjuvant endocrine therapy
545619|NCT01239238|asthma|asthma
545620|NCT01239238|children|children
545621|NCT01239238|home monitoring|home monitoring
545622|NCT01239238|exhaled breath condensate|exhaled breath condensate
545623|NCT01239238|non-invasive inflammatory markers|non-invasive inflammatory markers
545624|NCT01239238|volatile organic compounds|volatile organic compounds
545625|NCT01239225|Patients undergoing coronary angiography|patients undergoing coronary angiography
545626|NCT01239212|seizures|seizures
545627|NCT01239212|neonate|neonate
545628|NCT01239212|levetiracetam|levetiracetam
545629|NCT01239212|Epilepsy|epilepsy
545630|NCT01239212|central nervous system diseases|central nervous system diseases
545631|NCT01239212|anticonvulsants|anticonvulsants
545632|NCT01239199|Infants|infants
545633|NCT01239199|Exhaled Nitric Oxide|exhaled nitric oxide
545634|NCT01239199|Asthma|asthma
545635|NCT01239199|Tobacco smoke exposure|tobacco smoke exposure
545636|NCT01239199|environment|environment
545637|NCT01239186|methylation|methylation
545638|NCT01239186|micro array|micro array
545639|NCT01239186|locus H19|locus h19
545640|NCT01239186|male infertility|male infertility
545641|NCT01239173|Posttraumatic stress disorder|posttraumatic stress disorder
545642|NCT01239173|functional Magnetic Resonance Imaging|functional magnetic resonance imaging
545643|NCT01239173|Amygdala|amygdala
545644|NCT01239173|emotion regulation|emotion regulation
545645|NCT01239173|memory|memory
545646|NCT01239160|lymphedema|lymphedema
545647|NCT01239160|pneumatic compression device|pneumatic compression device
545648|NCT01239160|randomised clinical trial|randomised clinical trial
545649|NCT01239160|volume reduction|volume reduction
545650|NCT01239147|weight maintenance|weight maintenance
545651|NCT01239134|Malignant melanoma|malignant melanoma
545652|NCT01239134|Metastatic|metastatic
545653|NCT01239134|Unresectable|unresectable
545654|NCT01239134|Stage III or Stage IV|stage iii or stage iv
545655|NCT01239134|Solid tumor|solid tumor
545656|NCT01239121|drug toxicity|drug toxicity
545657|NCT01239121|drug interactions|drug interactions
545658|NCT01239121|electronic health records|electronic health records
545659|NCT01239121|medical errors|medical errors
545660|NCT01239043|Meningitis|meningitis
545661|NCT01239043|Meningococcal Meningitis|meningococcal meningitis
545662|NCT01239043|Meningococcal Infections|meningococcal infections
545663|NCT01239043|Menactra®|menactra®
545664|NCT01239043|Menomune®|menomune®
545665|NCT01239043|Meningococcal vaccine|meningococcal vaccine
545666|NCT01239030|inattention|inattention
545667|NCT01239030|impulsivity|impulsivity
545668|NCT01239030|hyperactivity|hyperactivity
545669|NCT01239030|ADHD|adhd
545670|NCT01239004|dyslipidemia|dyslipidemia
545671|NCT01239004|hyperlipidemia|hyperlipidemia
545672|NCT01239004|hyperglycemia|hyperglycemia
545673|NCT01239004|impaired fasting glucose|impaired fasting glucose
545674|NCT01238978|Diabetes mellitus, vildagliptin, hypoglycemia, elderly|diabetes mellitus, vildagliptin, hypoglycemia, elderly
545675|NCT01238952|solid tumors|solid tumors
545676|NCT01238952|breast cancer|breast cancer
545677|NCT01238952|triple negative breast cancer|triple negative breast cancer
545678|NCT01238952|HER2 negative|her2 negative
545679|NCT01238952|ER negative|er negative
545680|NCT01238952|PR negative|pr negative
545681|NCT01238939|solid tumors|solid tumors
545682|NCT01238939|colorectal cancer|colorectal cancer
545683|NCT01238926|Oxidative stress|oxidative stress
545684|NCT01238926|Parkinson's disease|parkinson's disease
545685|NCT01238926|Homocysteine|homocysteine
545686|NCT01238926|Glutathione|glutathione
545687|NCT01238926|B vitamins|b vitamins
545688|NCT01238887|Satiety|satiety
545689|NCT01238887|Food Intake|food intake
545690|NCT01238887|Weight Loss|weight loss
545691|NCT01238887|Oxidative Stress|oxidative stress
545692|NCT01238887|botanicals|botanicals
545693|NCT01238887|Garcinia Cambogia-derived hydroxycitric acid|garcinia cambogia-derived hydroxycitric acid
545694|NCT01238861|Asthma|asthma
545695|NCT01238861|Benralizumab|benralizumab
545696|NCT01238861|MEDI-563|medi-563
545697|NCT01238848|Hypertonic|hypertonic
545698|NCT01238848|Saline|saline
545699|NCT01238848|Bronchiolitis|bronchiolitis
545700|NCT01238848|Efficacy|efficacy
545701|NCT01238835|Sapien XT Valve|sapien xt valve
545702|NCT01238835|Valvular Heart Disease|valvular heart disease
545703|NCT01238835|Aortic Stenosis|aortic stenosis
545704|NCT01238835|Heart Valve Therapy|heart valve therapy
545705|NCT01238835|Transapical|transapical
545706|NCT01238835|Transcatheter|transcatheter
545707|NCT01238809|Compliance|compliance
545708|NCT01238809|France|france
545709|NCT01238796|telavancin|telavancin
545710|NCT01238796|Pharmacokinetics|pharmacokinetics
545711|NCT01238796|Severe renal disease|severe renal disease
545712|NCT01238796|VIBATIV®|vibativ®
545713|NCT01238796|ASP9809|asp9809
545714|NCT01238770|Ovarian cancer|ovarian cancer
545715|NCT01238757|Prospective Studies|prospective studies
545716|NCT01238757|Humans, pediatric|humans, pediatric
545717|NCT01238757|Positive-Pressure Respiration/methods*|positive-pressure respiration/methods*
545718|NCT01238757|Respiration, Artificial/methods*|respiration, artificial/methods*
545719|NCT01238757|Intensive Care|intensive care
545720|NCT01238757|Intensive Care Units/statistics & numerical data*|intensive care units/statistics & numerical data*
545721|NCT01238757|Respiration, Artificial/statistics & numerical data*|respiration, artificial/statistics & numerical data*
545722|NCT01238757|Patients/statistics & numerical data*|patients/statistics & numerical data*
545723|NCT01238757|Prevalence|prevalence
545724|NCT01238757|Respiratory Muscles/innervation|respiratory muscles/innervation
545725|NCT01238757|Child|child
545726|NCT01238757|Child, Preschool|child, preschool
545727|NCT01238757|Infant|infant
545728|NCT01238757|Infant, Newborn|infant, newborn
545729|NCT01238757|Intensive Care Units, Pediatric|intensive care units, pediatric
545730|NCT01238757|Respiratory Rate*|respiratory rate*
545731|NCT01238731|Valve replacement|valve replacement
545732|NCT01238731|pulmonary hypertension|pulmonary hypertension
545733|NCT01238731|long term follow up|long term follow up
545734|NCT01238718|lidocaine|lidocaine
545735|NCT01238718|anesthetic depth|anesthetic depth
545736|NCT01238718|hemodynamics|hemodynamics
545737|NCT01238718|rapid sequence induction|rapid sequence induction
545738|NCT01238718|BIS|bis
545739|NCT01238705|Hypertension|hypertension
545740|NCT01238705|Antihypertensive Agents|antihypertensive agents
545741|NCT01238705|Combination|combination
545742|NCT01238705|Sexual Dysfunction|sexual dysfunction
545743|NCT01238705|Oxidative Stress|oxidative stress
545744|NCT01238692|Diffuse large B cell lymphoma|diffuse large b cell lymphoma
545745|NCT01238692|DLBCL|dlbcl
545746|NCT01238692|Relapsed B-cell lymphoma|relapsed b-cell lymphoma
545747|NCT01238692|Refractory B-cell lymphoma|refractory b-cell lymphoma
545748|NCT01238692|B-cell Lymphoma|b-cell lymphoma
545749|NCT01238692|Panobinostat|panobinostat
545750|NCT01238692|LBH589|lbh589
545751|NCT01238692|Rituximab|rituximab
545752|NCT01238692|Histone Deacetylase Inhibitors|histone deacetylase inhibitors
545753|NCT01238679|safety|safety
545754|NCT01238679|tolerability|tolerability
545755|NCT01238679|pharmacokinetics|pharmacokinetics
545756|NCT01238679|healthy volunteers|healthy volunteers
545757|NCT01238666|liver|liver
545758|NCT01238666|cancer|cancer
545759|NCT01238666|tumor|tumor
545760|NCT01238666|ablation|ablation
545761|NCT01238666|Pathfinder|pathfinder
545762|NCT01238653|liver|liver
545763|NCT01238653|cancer|cancer
545764|NCT01238653|tumor|tumor
545765|NCT01238653|Pathfinder|pathfinder
545766|NCT01238640|Smoking Cessation|smoking cessation
545767|NCT01238640|Nicotine|nicotine
545768|NCT01238627|Smoking Cessation|smoking cessation
545769|NCT01238627|Nicotine pharmacokinetics|nicotine pharmacokinetics
545770|NCT01238614|maternal depression|maternal depression
545771|NCT01238614|clinical decision support|clinical decision support
545772|NCT01238601|Breast augmentation|breast augmentation
545773|NCT01238575|Pervasive Developmental Disorders|pervasive developmental disorders
545774|NCT01238575|PDD|pdd
545775|NCT01238575|PDD-NOS|pdd-nos
545776|NCT01238575|Autistic Disorder|autistic disorder
545777|NCT01238575|Autism|autism
545778|NCT01238575|Asperger's Disorder|asperger's disorder
545779|NCT01238575|Hyperactivity|hyperactivity
545780|NCT01238575|Attention Deficit Hyperactivity Disorder|attention deficit hyperactivity disorder
545781|NCT01238575|ADHD|adhd
545782|NCT01238575|Medication|medication
545783|NCT01238575|Drug|drug
545784|NCT01238575|Guanfacine|guanfacine
545785|NCT01238575|Intuniv|intuniv
545786|NCT01238575|Placebo|placebo
545787|NCT01238575|Methylphenidate|methylphenidate
545788|NCT01238562|cancer patient|cancer patient
545789|NCT01238562|chemotherapy|chemotherapy
545790|NCT01238562|carboplatin|carboplatin
545791|NCT01238562|taxol|taxol
545792|NCT01238562|cyclophosphamide|cyclophosphamide
545793|NCT01238562|pharmorubicin|pharmorubicin
545794|NCT01238549|Spinal Cord Injuries|spinal cord injuries
545795|NCT01238549|Quality of Life|quality of life
545796|NCT01238536|Epidural Steroid Injection|epidural steroid injection
545797|NCT01238536|Low Back Pain|low back pain
545798|NCT01238536|Spinal Stenosis|spinal stenosis
545799|NCT01238536|Elderly|elderly
545800|NCT01238523|tibia|tibia
545801|NCT01238523|shaft|shaft
545802|NCT01238523|fracture|fracture
545803|NCT01238523|children|children
545804|NCT01238497|SAPIEN XT™|sapien xt™
545805|NCT01238497|Transfemoral|transfemoral
545806|NCT01238497|NovaFlex|novaflex
545807|NCT01238497|NovaFlex+|novaflex+
545808|NCT01238497|NF|nf
545809|NCT01238497|NF+|nf+
545810|NCT01238497|Transapical|transapical
545811|NCT01238497|Transaortic|transaortic
545812|NCT01238497|Ascendra2|ascendra2
545813|NCT01238497|Ascendra+|ascendra+
545814|NCT01238497|Asc+|asc+
545815|NCT01238497|aortic stenosis|aortic stenosis
545816|NCT01238497|aortic valve|aortic valve
545817|NCT01238497|Transcatheter Heart Valve|transcatheter heart valve
545818|NCT01238497|THV|thv
545819|NCT01238484|Ankle Equinus|ankle equinus
545820|NCT01238484|Ankle contracture|ankle contracture
545821|NCT01238484|Diabetes Mellitus|diabetes mellitus
545822|NCT01238484|Dynasplint|dynasplint
545823|NCT01238484|AFD|afd
545824|NCT01238471|retinopathy of prematurity|retinopathy of prematurity
545825|NCT01238471|Propranolol|propranolol
545826|NCT01238471|Vascular endothelial growth factor|vascular endothelial growth factor
545827|NCT01238471|premature infant|premature infant
545828|NCT01238458|[18F]AV-45 PET amyloid binding imaging|[18f]av-45 pet amyloid binding imaging
545829|NCT01238458|Alzheimer's disease|alzheimer's disease
545830|NCT01238458|mild cognitive impartment,|mild cognitive impartment,
545831|NCT01238445|Pediatric|pediatric
545832|NCT01238432|Pediatric|pediatric
545833|NCT01238432|Polymorphism, Genetic|polymorphism, genetic
545834|NCT01238432|Adrenergic beta-Agonists|adrenergic beta-agonists
545835|NCT01238406|Type 1 diabetes|type 1 diabetes
545836|NCT01238406|Closed loop|closed loop
545837|NCT01238406|Artificial Pancreas|artificial pancreas
545838|NCT01238380|Monogenic diabetes|monogenic diabetes
545839|NCT01238380|HNF1A|hnf1a
545840|NCT01238380|HNF4A|hnf4a
545841|NCT01238380|GCK|gck
545842|NCT01238380|genetic testing|genetic testing
545843|NCT01238380|health economic model|health economic model
545844|NCT01238354|Weight Loss|weight loss
545845|NCT01238354|Social support|social support
545846|NCT01238341|Pancreatobiliary disease in patients with altered gastric anatomy.|pancreatobiliary disease in patients with altered gastric anatomy.
545847|NCT01238328|Mucopolysaccharidosis|mucopolysaccharidosis
545848|NCT01238328|HSCT|hsct
545849|NCT01238315|Batten's disease|batten's disease
545850|NCT01238315|INCL|incl
545851|NCT01238315|LINCL|lincl
546580|NCT01235767|pregnancy|pregnancy
545852|NCT01238315|Neuronal Ceroid Lipofuscinosis|neuronal ceroid lipofuscinosis
545853|NCT01238315|NCL|ncl
545854|NCT01238289|peer education|peer education
545855|NCT01238289|diabetes|diabetes
545856|NCT01238289|randomized|randomized
545857|NCT01238289|trial|trial
545858|NCT01238276|soft tissue infection|soft tissue infection
545859|NCT01238276|wound infection|wound infection
545860|NCT01238276|cellulitis|cellulitis
545861|NCT01238276|foot ulcer|foot ulcer
545862|NCT01238276|Diabetes|diabetes
545863|NCT01238276|antibiotics|antibiotics
545864|NCT01238276|cefazolin|cefazolin
545865|NCT01238276|cephazolin|cephazolin
545866|NCT01238276|Ancef|ancef
545867|NCT01238276|Kefzol|kefzol
545868|NCT01238276|subcutaneous fluid administration|subcutaneous fluid administration
545869|NCT01238276|ultrasound|ultrasound
545870|NCT01238276|MRSA|mrsa
545871|NCT01238276|Methicillin-resistant Staphylococcus aureus|methicillin-resistant staphylococcus aureus
545872|NCT01238263|Atopic dermatitis, autologous serum skin testing, IgE autoantibodies|atopic dermatitis, autologous serum skin testing, ige autoantibodies
545873|NCT01238250|16p11.2|16p11.2
545874|NCT01238250|16p11.2 del|16p11.2 del
545875|NCT01238250|16p11.2 deletion|16p11.2 deletion
545876|NCT01238250|16p11.2 dup|16p11.2 dup
545877|NCT01238250|16p11.2 duplication|16p11.2 duplication
545878|NCT01238250|chromosome 16|chromosome 16
545879|NCT01238250|chromosome 16p|chromosome 16p
545880|NCT01238250|chromosome 16p11|chromosome 16p11
545881|NCT01238250|chromosome 16p11.2|chromosome 16p11.2
545882|NCT01238250|1q21.1|1q21.1
545883|NCT01238250|1q21.1 del|1q21.1 del
545884|NCT01238250|1q21.1 deletion|1q21.1 deletion
545885|NCT01238250|1q21.1 dup|1q21.1 dup
545886|NCT01238250|1q21.1 duplication|1q21.1 duplication
545887|NCT01238250|chromosome 1|chromosome 1
545888|NCT01238250|chromosome 1q|chromosome 1q
545889|NCT01238250|chromosome 1q21|chromosome 1q21
545890|NCT01238250|chromosome 1q21.1|chromosome 1q21.1
545891|NCT01238250|genetic mutation|genetic mutation
545892|NCT01238250|genetic variant|genetic variant
545893|NCT01238250|gene variant|gene variant
545894|NCT01238250|autism|autism
545895|NCT01238250|ADNP|adnp
545896|NCT01238250|ANKRD11|ankrd11
545897|NCT01238250|ARID1B|arid1b
545898|NCT01238250|ASXL3|asxl3
545899|NCT01238250|ACTL6B|actl6b
545900|NCT01238250|AHDC1|ahdc1
545901|NCT01238250|BAF190|baf190
545902|NCT01238250|ANK2|ank2
545903|NCT01238250|ASH1L|ash1l
545904|NCT01238250|BCL11A|bcl11a
545905|NCT01238250|CHD2|chd2
545906|NCT01238250|CHD8|chd8
545907|NCT01238250|CTNNB1|ctnnb1
545908|NCT01238250|CUL3|cul3
545909|NCT01238250|DST|dst
545910|NCT01238250|DYRK1A|dyrk1a
545911|NCT01238250|FOXP1|foxp1
545912|NCT01238250|GRIN2B|grin2b
545913|NCT01238250|KDM6B|kdm6b
545914|NCT01238250|KMT2E|kmt2e
545915|NCT01238250|MBD5|mbd5
545916|NCT01238250|MED13L|med13l
545917|NCT01238250|PTEN|pten
545918|NCT01238250|REST|rest
545919|NCT01238250|SCN2A|scn2a
545920|NCT01238250|SMARCC1|smarcc1
545921|NCT01238250|SMARCC2|smarcc2
545922|NCT01238250|SYNGAP1|syngap1
545923|NCT01238250|HIVEP2|hivep2
545924|NCT01238250|HNRNPH2|hnrnph2
545925|NCT01238250|PPP2R5D|ppp2r5d
545926|NCT01238250|CHAMP1|champ1
545927|NCT01238250|CSNK2A1|csnk2a1
545928|NCT01238250|CTBP1|ctbp1
545929|NCT01238250|DDX3X|ddx3x
545930|NCT01238250|DNMT3A|dnmt3a
545931|NCT01238250|DSCAM|dscam
545932|NCT01238250|GRIN2A|grin2a
545933|NCT01238250|KAT6A|kat6a
545934|NCT01238250|KATNAL2|katnal2
545935|NCT01238250|KDM5B|kdm5b
545936|NCT01238250|KMT2C|kmt2c
545937|NCT01238250|KMT5B|kmt5b
545938|NCT01238250|SUV420H1|suv420h1
545939|NCT01238250|PACS1|pacs1
545940|NCT01238250|PBRM1|pbrm1
545941|NCT01238250|PTCHD1|ptchd1
545942|NCT01238250|PURA|pura
545943|NCT01238250|SETBP1|setbp1
545944|NCT01238250|SETD5|setd5
545945|NCT01238250|SMARCA4|smarca4
545946|NCT01238250|STXBP1|stxbp1
545947|NCT01238250|TBR1|tbr1
545948|NCT01238250|ARHGEF9|arhgef9
545949|NCT01238250|HNRNPU|hnrnpu
545950|NCT01238250|KCNQ2|kcnq2
545951|NCT01238250|PPP2B|ppp2b
545952|NCT01238250|PPP2R1A|ppp2r1a
545953|NCT01238250|SLC6A1|slc6a1
545954|NCT01238237|Glioblastoma Multiforme|glioblastoma multiforme
545955|NCT01238237|Anaplastic Astrocytoma|anaplastic astrocytoma
545956|NCT01238237|High Grade Glial Neoplasms|high grade glial neoplasms
545957|NCT01238237|Brain Tumor|brain tumor
545958|NCT01238237|EGFR|egfr
545959|NCT01238237|Epidermal Growth Factor Receptor|epidermal growth factor receptor
545960|NCT01238237|EGFRvIII|egfrviii
545961|NCT01238224|Insulin resistance|insulin resistance
545962|NCT01238224|Phosphodiesterase-5 inhibition|phosphodiesterase-5 inhibition
545963|NCT01238224|Microdialysis|microdialysis
545964|NCT01238224|Type 2 diabetes|type 2 diabetes
545965|NCT01238224|Endothelial dysfunction|endothelial dysfunction
545966|NCT01238224|Oral hypoglycaemic agents|oral hypoglycaemic agents
545967|NCT01238185|oral leukoplakia|oral leukoplakia
546581|NCT01235767|nutrition|nutrition
545968|NCT01238172|stage I prostate cancer|stage i prostate cancer
545969|NCT01238172|stage IIB prostate cancer|stage iib prostate cancer
545970|NCT01238172|stage IIA prostate cancer|stage iia prostate cancer
545971|NCT01238172|adenocarcinoma of the prostate|adenocarcinoma of the prostate
545972|NCT01238159|Natural killer cell|natural killer cell
545973|NCT01238159|T cell|t cell
545974|NCT01238159|Lymphoma|lymphoma
545975|NCT01238159|Radiation|radiation
545976|NCT01238159|Chemotherapy|chemotherapy
545977|NCT01238120|Cancer|cancer
545978|NCT01238120|Cognitive difficulties|cognitive difficulties
545979|NCT01238107|Cachexia|cachexia
545980|NCT01238107|Cancer|cancer
545981|NCT01238094|colorectal cancer|colorectal cancer
545982|NCT01238094|simvastatin|simvastatin
545983|NCT01238094|second-line chemotherapy|second-line chemotherapy
545984|NCT01238081|Cystic fibrosis|cystic fibrosis
545985|NCT01238055|advanced gastric cancer|advanced gastric cancer
545986|NCT01238055|sunitinib|sunitinib
545987|NCT01238055|docetaxel|docetaxel
545988|NCT01238055|fluoropyrimidine platinum based chemotherapy|fluoropyrimidine platinum based chemotherapy
545989|NCT01238029|Dose finding study|dose finding study
545990|NCT01238029|Combination|combination
545991|NCT01237990|liver|liver
545992|NCT01237990|cancer|cancer
545993|NCT01237990|tumor|tumor
545994|NCT01237951|Autologous Hematopoietic-Cell Support|autologous hematopoietic-cell support
545995|NCT01237951|Stem Cell Transplant|stem cell transplant
545996|NCT01237951|Busulfan|busulfan
545997|NCT01237951|Myleran|myleran
545998|NCT01237951|Busulfex|busulfex
545999|NCT01237951|Gemcitabine|gemcitabine
546000|NCT01237951|Gemzar|gemzar
546001|NCT01237951|Melphalan|melphalan
546002|NCT01237951|Alkeran|alkeran
546003|NCT01237951|Decadron|decadron
546004|NCT01237951|Dexamethasone|dexamethasone
546005|NCT01237951|G-CSF|g-csf
546006|NCT01237951|Filgrastim|filgrastim
546007|NCT01237951|Neupogen|neupogen
546008|NCT01237925|Sunburn|sunburn
546009|NCT01237925|Dexchlorpheniramine|dexchlorpheniramine
546010|NCT01237925|Gel|gel
546011|NCT01237925|Cream|cream
546012|NCT01237899|Kidney|kidney
546013|NCT01237899|Renal|renal
546014|NCT01237886|spontaneous breathing trial|spontaneous breathing trial
546015|NCT01237886|heart rate variability|heart rate variability
546016|NCT01237886|respiratory rate variability|respiratory rate variability
546017|NCT01237873|Aliskiren|aliskiren
546018|NCT01237873|Amlodipine|amlodipine
546019|NCT01237873|Essential hypertension|essential hypertension
546020|NCT01237873|Long term|long term
546021|NCT01237860|Foot drop|foot drop
546022|NCT01237860|Thigh muscle weakness|thigh muscle weakness
546023|NCT01237860|Upper Motor Neuron injury or disease|upper motor neuron injury or disease
546024|NCT01237847|inflammatory bowel disease|inflammatory bowel disease
546025|NCT01237847|IBD|ibd
546026|NCT01237847|Crohn's disease|crohn's disease
546027|NCT01237847|ulcerative colitis|ulcerative colitis
546028|NCT01237847|adolescent|adolescent
546029|NCT01237808|AML|aml
546030|NCT01237808|NPM1 Mutation|npm1 mutation
546031|NCT01237808|elderly patients (>60 years)|elderly patients (>60 years)
546032|NCT01237808|unfit for intensive chemotherapy|unfit for intensive chemotherapy
546033|NCT01237795|Chloramine T|chloramine t
546034|NCT01237795|Complete Denture|complete denture
546035|NCT01237795|Dental Plaque Index|dental plaque index
546036|NCT01237795|Dentifrice|dentifrice
546037|NCT01237795|Denture Bases|denture bases
546038|NCT01237795|Denture Cleansers|denture cleansers
546039|NCT01237795|Edentulous Mouth|edentulous mouth
546040|NCT01237795|Fluorosurfactant|fluorosurfactant
546041|NCT01237795|Oral Health|oral health
546042|NCT01237795|Toothpaste|toothpaste
546043|NCT01237782|Candida|candida
546044|NCT01237782|Complete Denture|complete denture
546045|NCT01237782|Dental Plaque Index|dental plaque index
546046|NCT01237782|Denture Bases|denture bases
546047|NCT01237782|Denture Cleansers|denture cleansers
546048|NCT01237782|Edentulous Mouth|edentulous mouth
546049|NCT01237782|Mutans Streptococci|mutans streptococci
546050|NCT01237782|Oral Health|oral health
546051|NCT01237782|Propolis|propolis
546052|NCT01237782|Streptococcus mutans|streptococcus mutans
546053|NCT01237769|vitamin D|vitamin d
546054|NCT01237769|Metabolic syndrome|metabolic syndrome
546055|NCT01237769|Hypertension|hypertension
546056|NCT01237769|Dyslipidemia|dyslipidemia
546057|NCT01237769|Dysglycemia|dysglycemia
546058|NCT01237769|Inflammation|inflammation
546059|NCT01237756|pediatric anesthesia|pediatric anesthesia
546060|NCT01237756|endotracheal tube|endotracheal tube
546061|NCT01237756|electrical impedance tomography|electrical impedance tomography
546062|NCT01237756|misplacement|misplacement
546063|NCT01237756|endobronchial|endobronchial
546064|NCT01237743|Embolism|embolism
546065|NCT01237743|Nervous system|nervous system
546066|NCT01237743|Aorta|aorta
546067|NCT01237743|Valves|valves
546068|NCT01237743|Ultrasonics|ultrasonics
546069|NCT01237730|percutaneous endoscopic gastrostomy|percutaneous endoscopic gastrostomy
546070|NCT01237730|peristomal wound infection|peristomal wound infection
546071|NCT01237730|prophylactic antibiotics|prophylactic antibiotics
546072|NCT01237717|hypertension|hypertension
546073|NCT01237691|drug use|drug use
546074|NCT01237691|drug arrests|drug arrests
546075|NCT01237691|incarceration|incarceration
546076|NCT01237678|Immunogen|immunogen
546077|NCT01237678|Lung|lung
546078|NCT01237678|Small Cell Lung Cancer|small cell lung cancer
546079|NCT01237678|Carboplatin|carboplatin
546081|NCT01237665|locally resectable advanced adenocarcinoma of the rectum|locally resectable advanced adenocarcinoma of the rectum
546082|NCT01237652|Isolated Systolic Hypertension|isolated systolic hypertension
546083|NCT01237652|Perioperative Myocardial Ischemia|perioperative myocardial ischemia
546084|NCT01237652|Perioperative Cardiovascular adverse events|perioperative cardiovascular adverse events
546085|NCT01237639|Red Cells|red cells
546086|NCT01237639|Transfusion|transfusion
546087|NCT01237639|Trigger|trigger
546088|NCT01237639|Threshold|threshold
546089|NCT01237639|Hematopoietic Stem cell Transplantation|hematopoietic stem cell transplantation
546090|NCT01237626|Driving|driving
546091|NCT01237626|Aging|aging
546092|NCT01237626|Older drivers|older drivers
546093|NCT01237626|Medical Fitness to drive|medical fitness to drive
546094|NCT01237626|Health Status|health status
546095|NCT01237626|At-fault collisions|at-fault collisions
546096|NCT01237613|Achilles|achilles
546097|NCT01237613|Rupture|rupture
546098|NCT01237613|Tendon|tendon
546099|NCT01237613|Artelon|artelon
546100|NCT01237600|Ocular surface damage|ocular surface damage
546101|NCT01237600|Limbal deficiency|limbal deficiency
546102|NCT01237600|Cultivated corneal epithelial stem cell transplantation|cultivated corneal epithelial stem cell transplantation
546103|NCT01237587|Adolescents|adolescents
546104|NCT01237587|Juvenile Primary Fibromyalgia Syndrome|juvenile primary fibromyalgia syndrome
546105|NCT01237574|Liver Diseases|liver diseases
546106|NCT01237574|Alcoholic|alcoholic
546107|NCT01237574|Metabolic Diseases|metabolic diseases
546108|NCT01237574|cohort|cohort
546109|NCT01237574|liver disease|liver disease
546110|NCT01237561|Chronic Obstructive Pulmonary Disease|chronic obstructive pulmonary disease
546111|NCT01237561|COPD Guidelines|copd guidelines
546112|NCT01237561|Patient Activation|patient activation
546113|NCT01237561|Lung Age|lung age
546114|NCT01237548|water pipe smoking|water pipe smoking
546115|NCT01237548|acute effect|acute effect
546116|NCT01237548|Endothelial|endothelial
546117|NCT01237548|healthy adults who smoke narghile|healthy adults who smoke narghile
546118|NCT01237535|Unexplained infertility|unexplained infertility
546119|NCT01237535|Insemination|insemination
546120|NCT01237535|Luteal phase support|luteal phase support
546121|NCT01237535|Ovarian stimulation|ovarian stimulation
546122|NCT01237522|Diabetes Mellitus, Type 2|diabetes mellitus, type 2
546123|NCT01237522|Metabolic Clearance Rate|metabolic clearance rate
546124|NCT01237522|Pharmacokinetics|pharmacokinetics
546125|NCT01237522|Pharmacogenetics|pharmacogenetics
546126|NCT01237509|EEG|eeg
546127|NCT01237509|Sleep|sleep
546128|NCT01237509|device|device
546129|NCT01237509|diabetes|diabetes
546130|NCT01237509|hypoglycemia|hypoglycemia
546131|NCT01237483|reirradiation with Erbitux|reirradiation with erbitux
546132|NCT01237483|HNSCC|hnscc
546133|NCT01237483|local recurrent inoperable Squamous Cell Cancer of the Head and Neck|local recurrent inoperable squamous cell cancer of the head and neck
546134|NCT01237470|inguinal hernia|inguinal hernia
546135|NCT01237470|hernia recurrence|hernia recurrence
546136|NCT01237470|no mesh techniques|no mesh techniques
546137|NCT01237470|Desarda technique|desarda technique
546138|NCT01237444|Lopinavir/ritonavir plus 3TC as a dual therapy regimen.|lopinavir/ritonavir plus 3tc as a dual therapy regimen.
546139|NCT01237431|Water drinking|water drinking
546140|NCT01237431|osmoreceptors|osmoreceptors
546141|NCT01237431|autonomic failure|autonomic failure
546142|NCT01237431|syncope|syncope
546143|NCT01237431|blood pressure|blood pressure
546144|NCT01237431|liver transplant|liver transplant
546145|NCT01237405|osteoarthritis|osteoarthritis
546146|NCT01237405|nuclear medicine|nuclear medicine
546147|NCT01237405|macrophages|macrophages
546148|NCT01237392|wound debridement|wound debridement
546149|NCT01237392|requiring debridement|requiring debridement
546150|NCT01237366|HIV/AIDS|hiv/aids
546151|NCT01237366|Methamphetamine|methamphetamine
546152|NCT01237366|Trauma|trauma
546153|NCT01237340|Adult Growth Hormone Deficiency (AGHD)|adult growth hormone deficiency (aghd)
546154|NCT01237340|immunogenicity|immunogenicity
546155|NCT01237340|growth hormone|growth hormone
546156|NCT01237340|antibodies|antibodies
546157|NCT01237340|GH biomarkers|gh biomarkers
546158|NCT01237340|IGF-I|igf-i
546159|NCT01237327|Metastatic Breast Cancer|metastatic breast cancer
546160|NCT01237327|Advanced|advanced
546161|NCT01237327|Postmenopausal|postmenopausal
546162|NCT01237327|Exemestane vs Megestrol|exemestane vs megestrol
546163|NCT01237314|type 2 diabetes|type 2 diabetes
546164|NCT01237314|metformin|metformin
546165|NCT01237314|glargine|glargine
546166|NCT01237314|exenatide|exenatide
546167|NCT01237314|glycemic impact of food|glycemic impact of food
546168|NCT01237314|continuous glucose monitoring|continuous glucose monitoring
546169|NCT01237301|Type 2 Diabetes|type 2 diabetes
546582|NCT01235767|Vietnam|vietnam
546170|NCT01237301|Continuous Glucose Monitoring|continuous glucose monitoring
546171|NCT01237275|Pharmacogenomics|pharmacogenomics
546172|NCT01237275|Prediction of Antidepressant Response|prediction of antidepressant response
546173|NCT01237275|Depressed Patients|depressed patients
546174|NCT01237262|psoriasis|psoriasis
546175|NCT01237262|immune infiltrate|immune infiltrate
546176|NCT01237262|dendritic cells|dendritic cells
546177|NCT01237262|cytokine expression|cytokine expression
546178|NCT01237249|Multiple Myeloma|multiple myeloma
546179|NCT01237249|Velcade|velcade
546180|NCT01237249|Revlimid|revlimid
546181|NCT01237236|Advanced solid tumor|advanced solid tumor
546182|NCT01237236|lymphoma|lymphoma
546183|NCT01237223|Aliskiren|aliskiren
546184|NCT01237223|Amlodipine|amlodipine
546185|NCT01237223|Essential hypertension|essential hypertension
546186|NCT01237210|Parkinson's Disease|parkinson's disease
546187|NCT01237210|PD|pd
546188|NCT01237210|magnetic resonance spectroscopy|magnetic resonance spectroscopy
546189|NCT01237184|initial dental implant stability|initial dental implant stability
546190|NCT01237184|maxillary sinus proximity|maxillary sinus proximity
546191|NCT01237184|bicortical fixation|bicortical fixation
546192|NCT01237171|Brachytherapy|brachytherapy
546193|NCT01237171|Lung Brachytherapy|lung brachytherapy
546194|NCT01237171|NSCLC|nsclc
546195|NCT01237171|Sub-lobar resection|sub-lobar resection
546196|NCT01237158|GAD1,|gad1,
546197|NCT01237158|GAD67,|gad67,
546198|NCT01237158|bipolar,|bipolar,
546199|NCT01237158|GABA,|gaba,
546200|NCT01237158|Glutamate,|glutamate,
546201|NCT01237158|Reelin,|reelin,
546202|NCT01237158|Rln,|rln,
546203|NCT01237158|Spectroscopy|spectroscopy
546204|NCT01237158|euthymic bipolar I patients|euthymic bipolar i patients
546205|NCT01237145|pigeon|pigeon
546206|NCT01237145|bird fancier|bird fancier
546207|NCT01237145|extrinsic allergic alveolitis|extrinsic allergic alveolitis
546208|NCT01237145|BAL|bal
546209|NCT01237145|broncho-alveolar lavage|broncho-alveolar lavage
546210|NCT01237145|elispot|elispot
546211|NCT01237145|antigen|antigen
546212|NCT01237106|PCOS|pcos
546213|NCT01237106|IVM|ivm
546214|NCT01237106|Polycystic ovarian syndrome|polycystic ovarian syndrome
546215|NCT01237106|In Vitro Maturation|in vitro maturation
546216|NCT01237106|IVF|ivf
546217|NCT01237093|Fish Diet|fish diet
546218|NCT01237093|Meat Diet|meat diet
546219|NCT01237093|Biomarkers|biomarkers
546220|NCT01237093|Stable Isotopes|stable isotopes
546221|NCT01237093|Dietary Intake|dietary intake
546222|NCT01237067|PARP inhibitor, womens's cancers, relapsed, recurrent|parp inhibitor, womens's cancers, relapsed, recurrent
546223|NCT01237067|Ovarian, breast, endometrial, cervical|ovarian, breast, endometrial, cervical
546224|NCT01237067|Carboplatin|carboplatin
546225|NCT01237067|BRCA 1 and BRCA 2|brca 1 and brca 2
546226|NCT01237054|18-FDG PET/CT|18-fdg pet/ct
546227|NCT01237054|Abnormal Plasma Cells|abnormal plasma cells
546228|NCT01237054|Serum Free Light-Chain Abnormality|serum free light-chain abnormality
546229|NCT01237054|Serum M-Protein|serum m-protein
546230|NCT01237054|DCE-MRI|dce-mri
546231|NCT01237054|Multiple Myeloma|multiple myeloma
546232|NCT01237054|Smoldering Multiple Myeloma|smoldering multiple myeloma
546233|NCT01237054|SMM|smm
546234|NCT01237054|MM|mm
546235|NCT01237041|Child|child
546236|NCT01237041|Body Fat|body fat
546237|NCT01237041|Niacin|niacin
546238|NCT01237041|Growth Hormone|growth hormone
546239|NCT01237041|Obesity|obesity
546240|NCT01237041|Overweight|overweight
546241|NCT01237041|Growth Hormones|growth hormones
546242|NCT01237041|Short Stature|short stature
546243|NCT01237041|Children|children
546244|NCT01237015|Neonate|neonate
546245|NCT01237015|Oral feeding|oral feeding
546246|NCT01237015|Nasal CPAP|nasal cpap
546247|NCT01237015|Sucking|sucking
546248|NCT01237015|Swallowing|swallowing
546249|NCT01237015|Breathing|breathing
546250|NCT01237002|Liver ischemia; Pringle time|liver ischemia; pringle time
546251|NCT01236989|anatomical resection|anatomical resection
546252|NCT01236989|non-anatomical resection|non-anatomical resection
546253|NCT01236989|IOUS-guided finger compression|ious-guided finger compression
546254|NCT01236963|Clinical trial|clinical trial
546255|NCT01236963|Prevention mouthrinse|prevention mouthrinse
546256|NCT01236963|Dental Floss|dental floss
546257|NCT01236950|Clinical Trial|clinical trial
546258|NCT01236950|Prevention Mouthrinse|prevention mouthrinse
546259|NCT01236937|CT, lung nodule biopsy, Respiration Gated, Lung Cancer|ct, lung nodule biopsy, respiration gated, lung cancer
546260|NCT01236911|Calcium , TBI,complications, days in hospital|calcium , tbi,complications, days in hospital
546261|NCT01236898|N-acetylneuraminic acid,|n-acetylneuraminic acid,
546262|NCT01236898|pharmacokinetics|pharmacokinetics
546263|NCT01236898|hIBM|hibm
546264|NCT01236872|Nitrate|nitrate
546265|NCT01236872|Nitrite|nitrite
546266|NCT01236872|Vegetable|vegetable
546267|NCT01236872|Aortic stiffness|aortic stiffness
546268|NCT01236859|Gabapentin|gabapentin
546269|NCT01236859|prophylaxis|prophylaxis
546270|NCT01236859|incidence of pruritus|incidence of pruritus
546271|NCT01236859|intrathecal morphine|intrathecal morphine
546775|NCT01234714|Fatty Liver|fatty liver
546272|NCT01236846|Vitamin D fortification|vitamin d fortification
546273|NCT01236846|Yogurt Drink|yogurt drink
546274|NCT01236846|Efficacy|efficacy
546275|NCT01236833|Lactated Ringer's Solution|lactated ringer's solution
546276|NCT01236833|Isotonic Solution|isotonic solution
546277|NCT01236833|Intestinal Disease|intestinal disease
546278|NCT01236833|Feeding Intolerance|feeding intolerance
546279|NCT01236833|Necrotizing Enterocolitis|necrotizing enterocolitis
546280|NCT01236833|Newborn|newborn
546281|NCT01236833|Premature Infant|premature infant
546282|NCT01236820|L5|l5
546283|NCT01236820|LDL|ldl
546284|NCT01236820|Cardiovascular disease|cardiovascular disease
546285|NCT01236820|Chronic kidney disease|chronic kidney disease
546286|NCT01236820|Hemodialysis|hemodialysis
546287|NCT01236807|Adenosine|adenosine
546288|NCT01236807|Magnetic Resonance Imaging|magnetic resonance imaging
546289|NCT01236807|MR perfusion|mr perfusion
546290|NCT01236807|Fractional Flow Reserve, Myocardial|fractional flow reserve, myocardial
546291|NCT01236807|FFR|ffr
546292|NCT01236807|Pressure wire|pressure wire
546293|NCT01236807|Coronary Disease|coronary disease
546294|NCT01236807|Heart Diseases|heart diseases
546295|NCT01236807|Cardiovascular Diseases|cardiovascular diseases
546296|NCT01236807|Arteriosclerosis|arteriosclerosis
546297|NCT01236781|breast cancer|breast cancer
546298|NCT01236781|screening|screening
546299|NCT01236781|diagnostics|diagnostics
546300|NCT01236781|diagnosis|diagnosis
546301|NCT01236781|high-risk|high-risk
546302|NCT01236781|breast neoplasms|breast neoplasms
546303|NCT01236781|digital mammography|digital mammography
546304|NCT01236781|mammography|mammography
546305|NCT01236781|tomosynthesis|tomosynthesis
546306|NCT01236781|dense breasts|dense breasts
546307|NCT01236781|radiation dose|radiation dose
546308|NCT01236781|comparison|comparison
546309|NCT01236781|Hologic|hologic
546310|NCT01236781|Pennsylvania|pennsylvania
546311|NCT01236781|Philadelphia|philadelphia
546312|NCT01236781|breast study|breast study
546313|NCT01236781|mammo|mammo
546314|NCT01236781|tomo|tomo
546315|NCT01236781|mammary|mammary
546316|NCT01236768|Contraceptive|contraceptive
546317|NCT01236755|children|children
546318|NCT01236755|corneal reshaping|corneal reshaping
546319|NCT01236755|myopia|myopia
546320|NCT01236755|myopia progression|myopia progression
546321|NCT01236755|orthokeratology|orthokeratology
546322|NCT01236742|children|children
546323|NCT01236742|corneal reshaping|corneal reshaping
546324|NCT01236742|myopia|myopia
546325|NCT01236742|myopia progression|myopia progression
546326|NCT01236742|orthokeratology|orthokeratology
546327|NCT01236729|knee replacement|knee replacement
546328|NCT01236729|disability|disability
546329|NCT01236729|older people|older people
546330|NCT01236716|squamous cell carcinoma of lung|squamous cell carcinoma of lung
546331|NCT01236716|Albumin bound paclitaxel|albumin bound paclitaxel
546332|NCT01236716|chemotherapy|chemotherapy
546333|NCT01236703|SIRS|sirs
546334|NCT01236703|Sepsis|sepsis
546335|NCT01236703|hematological infection score|hematological infection score
546336|NCT01236690|Transcatheter arterial embolization|transcatheter arterial embolization
546337|NCT01236690|Cinobufacin injection|cinobufacin injection
546338|NCT01236690|hepatoma|hepatoma
546339|NCT01236677|Pathogen|pathogen
546340|NCT01236664|memory training|memory training
546341|NCT01236664|mnemonics|mnemonics
546342|NCT01236664|cognition|cognition
546343|NCT01236664|work|work
546344|NCT01236638|Primary Myelofibrosis|primary myelofibrosis
546345|NCT01236638|Post-Polycythemia Vera|post-polycythemia vera
546346|NCT01236638|Post-Essential Thrombocythemia|post-essential thrombocythemia
546347|NCT01236638|CYT387 (momelotinib)|cyt387 (momelotinib)
546348|NCT01236625|Tissue Adhesions|tissue adhesions
546349|NCT01236625|Adhesiolysis|adhesiolysis
546350|NCT01236625|Inadvertent enterotomy|inadvertent enterotomy
546351|NCT01236625|Prospective cohort study|prospective cohort study
546352|NCT01236625|Quality of life|quality of life
546353|NCT01236612|Plasmodium|plasmodium
546354|NCT01236612|falciparum|falciparum
546355|NCT01236612|malaria|malaria
546356|NCT01236612|chloroquine|chloroquine
546357|NCT01236612|immunity|immunity
546358|NCT01236599|preterm infant, thermoregulation, polyethylene bag|preterm infant, thermoregulation, polyethylene bag
546359|NCT01236586|Maximum Tolerated Dose|maximum tolerated dose
546360|NCT01236586|Toxicity|toxicity
546361|NCT01236586|Pharmacokinetics|pharmacokinetics
546362|NCT01236586|NOTCH Signaling Pathway|notch signaling pathway
546363|NCT01236586|Expression of JAGGED 1 and 2|expression of jagged 1 and 2
546364|NCT01236586|Cancer|cancer
546365|NCT01236586|Solid Tumor|solid tumor
546366|NCT01236586|Brain Tumor|brain tumor
546367|NCT01236586|Wilms Tumor|wilms tumor
546368|NCT01236586|Osteosarcoma|osteosarcoma
546369|NCT01236586|Lymphoma|lymphoma
546370|NCT01236573|Gene Therapy|gene therapy
546371|NCT01236573|Immunotherapy|immunotherapy
546372|NCT01236573|Adoptive Cell Therapy|adoptive cell therapy
546373|NCT01236573|Metastatic Melanoma|metastatic melanoma
546374|NCT01236534|Multiple Sclerosis|multiple sclerosis
546776|NCT01234714|Liver|liver
546375|NCT01236534|Constipation|constipation
546376|NCT01236534|Multiple Sclerosis Associated Constipation|multiple sclerosis associated constipation
546377|NCT01236521|Back pain|back pain
546378|NCT01236521|Care Management|care management
546379|NCT01236521|Pain|pain
546380|NCT01236521|Patient outcomes|patient outcomes
546381|NCT01236521|Patient-center Care|patient-center care
546382|NCT01236521|Primary care|primary care
546383|NCT01236508|White Matter Hyperintensity|white matter hyperintensity
546384|NCT01236508|Stroke|stroke
546385|NCT01236508|Carotid Artery Plaque Inflammation|carotid artery plaque inflammation
546386|NCT01236508|FDG PET|fdg pet
546387|NCT01236508|MRI|mri
546388|NCT01236508|TIA|tia
546389|NCT01236495|thoracotomy|thoracotomy
546390|NCT01236495|postoperative pain|postoperative pain
546391|NCT01236495|spinal morphine|spinal morphine
546392|NCT01236482|Pregnancy|pregnancy
546393|NCT01236482|Postpartum hemorrhage|postpartum hemorrhage
546394|NCT01236482|Uterine tone|uterine tone
546395|NCT01236482|Oxytocin|oxytocin
546396|NCT01236482|Ergometrine|ergometrine
546397|NCT01236482|Pharmacokinetic-pharmacodynamic analysis|pharmacokinetic-pharmacodynamic analysis
546398|NCT01236469|Aortic Valve|aortic valve
546399|NCT01236456|chronic inflammatory demyelinating polyneuropathy|chronic inflammatory demyelinating polyneuropathy
546400|NCT01236456|cyclophosphamide|cyclophosphamide
546401|NCT01236456|autoimmune|autoimmune
546402|NCT01236430|Hyperlipidemia|hyperlipidemia
546403|NCT01236430|statin|statin
546404|NCT01236430|Ezetimibe|ezetimibe
546405|NCT01236430|Zetia|zetia
546406|NCT01236430|Atorvastatin|atorvastatin
546407|NCT01236430|Lipitor|lipitor
546408|NCT01236391|Pharmacyclics|pharmacyclics
546409|NCT01236391|Mantle|mantle
546410|NCT01236391|Mantle Cell|mantle cell
546411|NCT01236391|Lymphoma|lymphoma
546412|NCT01236391|Non-Hodgkins|non-hodgkins
546413|NCT01236391|Bortezomib|bortezomib
546414|NCT01236391|Velcade|velcade
546415|NCT01236391|Naive|naive
546416|NCT01236391|PCYC|pcyc
546417|NCT01236378|Organ Transplants|organ transplants
546418|NCT01236378|Anti-Rejection Therapy|anti-rejection therapy
546419|NCT01236378|Pharmacokinetics|pharmacokinetics
546420|NCT01236365|Type 1 diabetes|type 1 diabetes
546421|NCT01236365|Children|children
546422|NCT01236365|Statins|statins
546423|NCT01236365|Hypercholesterolemia|hypercholesterolemia
546424|NCT01236365|Lipoproteins|lipoproteins
546425|NCT01236365|C reactive protein|c reactive protein
546426|NCT01236365|Continuous glucose monitors|continuous glucose monitors
546427|NCT01236365|Adolescence|adolescence
546428|NCT01236365|Abdominal magnetic resonance imaging|abdominal magnetic resonance imaging
546429|NCT01236365|Toll like receptors|toll like receptors
546430|NCT01236365|Receptors of advanced glycation end products|receptors of advanced glycation end products
546431|NCT01236365|Nutrition|nutrition
546432|NCT01236352|Advanced Cancer, Various, NOS|advanced cancer, various, nos
546433|NCT01236313|TEE|tee
546434|NCT01236313|Cardiac Surgery|cardiac surgery
546435|NCT01236313|Pulse Pressure|pulse pressure
546436|NCT01236300|Pancreatic cysts|pancreatic cysts
546437|NCT01236274|Myocardial Infarction|myocardial infarction
546438|NCT01236274|Antipsychotic agents|antipsychotic agents
546439|NCT01236274|Self-controlled case series method|self-controlled case series method
546440|NCT01236274|General Practice Research Database|general practice research database
546441|NCT01236274|Myocardial Ischaemia National Audit Project|myocardial ischaemia national audit project
546442|NCT01236274|CALIBER|caliber
546443|NCT01236261|Fungemia, fungal infection, susceptibility, antifungal|fungemia, fungal infection, susceptibility, antifungal
546444|NCT01236248|drugs|drugs
546445|NCT01236248|youth|youth
546446|NCT01236248|parent|parent
546447|NCT01236248|computer|computer
546448|NCT01236248|prevention|prevention
546449|NCT01236222|commuter cycling|commuter cycling
546450|NCT01236222|fitness|fitness
546451|NCT01236222|metabolic syndrome|metabolic syndrome
546452|NCT01236222|children|children
546453|NCT01236196|pain|pain
546454|NCT01236196|chronic pain|chronic pain
546455|NCT01236196|cognitive therapy|cognitive therapy
546456|NCT01236196|telehealth|telehealth
546457|NCT01236183|manual skill|manual skill
546458|NCT01236183|anesthesia residents|anesthesia residents
546459|NCT01236170|Amputees|amputees
546460|NCT01236170|spinal cord injuries|spinal cord injuries
546461|NCT01236170|quality of life|quality of life
546462|NCT01236170|satisfaction|satisfaction
546463|NCT01236170|healthcare disparities|healthcare disparities
546464|NCT01236170|wheelchairs|wheelchairs
546465|NCT01236157|Cardiology|cardiology
546466|NCT01236144|Myeloid|myeloid
546467|NCT01236144|Leukaemia|leukaemia
546468|NCT01236144|Acute|acute
546469|NCT01236144|Myelodysplastic|myelodysplastic
546470|NCT01236144|Pilot|pilot
546471|NCT01236144|Cardiff|cardiff
546472|NCT01236144|Haematology|haematology
546473|NCT01236144|Burnett|burnett
546474|NCT01236144|AC220|ac220
546475|NCT01236144|Plerixafor|plerixafor
546476|NCT01236144|Ganetespib|ganetespib
546477|NCT01236092|resolution of low back pain|resolution of low back pain
546778|NCT01234714|Surgery|surgery
546478|NCT01236092|show measurable improvement in disc measurement|show measurable improvement in disc measurement
546479|NCT01236092|conservative therapy vs. surgery in resolving low back pain|conservative therapy vs. surgery in resolving low back pain
546480|NCT01236066|Rotavirus Gastroenteritis|rotavirus gastroenteritis
546481|NCT01236066|Rotarix|rotarix
546482|NCT01236066|RotaTeq|rotateq
546483|NCT01236066|Gastroenteritis|gastroenteritis
546484|NCT01236053|renal cancer|renal cancer
546485|NCT01236053|pancreatic cancer|pancreatic cancer
546486|NCT01236053|epidemiology|epidemiology
546487|NCT01236053|renal cell carcinoma|renal cell carcinoma
546488|NCT01236053|nervous system cancer|nervous system cancer
546489|NCT01236053|lung cancer|lung cancer
546490|NCT01236053|breast cancer|breast cancer
546491|NCT01236053|case-control|case-control
546492|NCT01236053|GPRD|gprd
546493|NCT01236053|Gapabentin|gapabentin
546494|NCT01236053|cancer|cancer
546495|NCT01236053|anal cancer|anal cancer
546496|NCT01236053|bone and joint cancer|bone and joint cancer
546497|NCT01236053|renal pelvis cancer|renal pelvis cancer
546498|NCT01236053|penis cancer|penis cancer
546499|NCT01236053|stomach cancer|stomach cancer
546500|NCT01236053|bladder cancer|bladder cancer
546501|NCT01236040|H5N1|h5n1
546502|NCT01236040|Influenza|influenza
546503|NCT01236040|Pandemic|pandemic
546504|NCT01236001|Lacosamide|lacosamide
546505|NCT01236001|Vimpat®|vimpat®
546506|NCT01235975|Neisseria meningitidis|neisseria meningitidis
546507|NCT01235975|Meningococcal Vaccines|meningococcal vaccines
546508|NCT01235975|serogroups A,C, W-135 or Y|serogroups a,c, w-135 or y
546509|NCT01235975|meningococcal diseases|meningococcal diseases
546510|NCT01235975|meningococcal conjugate vaccine|meningococcal conjugate vaccine
546511|NCT01235975|Immunogenicity|immunogenicity
546512|NCT01235962|anti-angiogenic agent|anti-angiogenic agent
546513|NCT01235962|renal cell carcinoma|renal cell carcinoma
546514|NCT01235962|pazopanib|pazopanib
546515|NCT01235962|adjuvant therapy|adjuvant therapy
546516|NCT01235962|VEGFR inhibitor|vegfr inhibitor
546517|NCT01235949|Pneumococcal vaccine|pneumococcal vaccine
546518|NCT01235949|Immunogenicity|immunogenicity
546519|NCT01235949|Safety|safety
546520|NCT01235949|Fever|fever
546521|NCT01235949|Primary vaccination|primary vaccination
546522|NCT01235949|Booster vaccination|booster vaccination
546523|NCT01235949|Pneumococcal disease|pneumococcal disease
546524|NCT01235949|Prophylactic antipyretic|prophylactic antipyretic
546525|NCT01235936|anemia|anemia
546526|NCT01235936|chronic kidney disease|chronic kidney disease
546527|NCT01235936|CKD|ckd
546528|NCT01235936|chronic renal insufficiency|chronic renal insufficiency
546529|NCT01235936|renal impairment|renal impairment
546530|NCT01235936|erythropoietin|erythropoietin
546531|NCT01235936|safety|safety
546532|NCT01235936|efficacy|efficacy
546533|NCT01235936|tolerability|tolerability
546534|NCT01235936|pharmacokinetics|pharmacokinetics
546535|NCT01235923|anemia|anemia
546536|NCT01235923|transfusions|transfusions
546537|NCT01235923|erythropoiesis|erythropoiesis
546538|NCT01235923|neonate|neonate
546539|NCT01235923|preterm|preterm
546540|NCT01235910|Hypertension|hypertension
546541|NCT01235910|Cardiac transplantation|cardiac transplantation
546542|NCT01235910|Aliskiren|aliskiren
546543|NCT01235910|Cyclosporine|cyclosporine
546544|NCT01235897|Neoplasms|neoplasms
546545|NCT01235897|Paclitaxel|paclitaxel
546546|NCT01235897|Trastuzumab|trastuzumab
546547|NCT01235884|gaseous colic, regurgitation and of constipation|gaseous colic, regurgitation and of constipation
546548|NCT01235871|Safety|safety
546549|NCT01235871|Tolerability|tolerability
546550|NCT01235871|SB1578|sb1578
546551|NCT01235858|Epidural analgesia|epidural analgesia
546552|NCT01235858|Epidural anesthesia labor|epidural anesthesia labor
546553|NCT01235858|Aseptic technique|aseptic technique
546554|NCT01235858|gown|gown
546555|NCT01235858|no gown|no gown
546556|NCT01235832|cholesterol|cholesterol
546557|NCT01235832|triglycerides|triglycerides
546558|NCT01235832|low-density lipoprotein|low-density lipoprotein
546559|NCT01235832|high-density lipoprotein|high-density lipoprotein
546560|NCT01235832|reverse cholesterol transport|reverse cholesterol transport
546561|NCT01235819|type 1 diabetes|type 1 diabetes
546562|NCT01235819|exenatide|exenatide
546563|NCT01235819|sitagliptin|sitagliptin
546564|NCT01235806|scaphoid|scaphoid
546565|NCT01235806|MRI|mri
546566|NCT01235806|ESAOTE|esaote
546567|NCT01235793|Relapsed|relapsed
546568|NCT01235793|Refractory|refractory
546569|NCT01235793|Primary Central Nervous System B-cell Lymphoma|primary central nervous system b-cell lymphoma
546570|NCT01235793|Autologous Stem Cell Transplant|autologous stem cell transplant
546571|NCT01235793|Temozolomide|temozolomide
546572|NCT01235793|B-Cell Lymphoma|b-cell lymphoma
546573|NCT01235793|RBEAM|rbeam
546574|NCT01235793|Conditioning Regimen|conditioning regimen
546575|NCT01235780|corneal hysteresis, ocular response analyzer|corneal hysteresis, ocular response analyzer
546576|NCT01235767|birth weight|birth weight
546577|NCT01235767|prematurity|prematurity
546578|NCT01235767|gestational age|gestational age
546579|NCT01235767|low birth weight|low birth weight
546583|NCT01235754|testosterone|testosterone
546584|NCT01235754|hypoactive sexual desire disorder|hypoactive sexual desire disorder
546585|NCT01235754|menopause|menopause
546586|NCT01235741|Pramlintide|pramlintide
546587|NCT01235741|Metreleptin|metreleptin
546588|NCT01235741|Obesity|obesity
546589|NCT01235741|Amylin|amylin
546590|NCT01235741|Takeda|takeda
546591|NCT01235715|osteoarthritis|osteoarthritis
546592|NCT01235715|total knee replacement|total knee replacement
546593|NCT01235702|high blood pressure, hypertension, African Americans, perceived stress|high blood pressure, hypertension, african americans, perceived stress
546594|NCT01235676|obesity|obesity
546595|NCT01235676|lifestyle|lifestyle
546596|NCT01235676|pregnancy|pregnancy
546597|NCT01235676|newborn infant|newborn infant
546598|NCT01235663|obesity, insulin resistance|obesity, insulin resistance
546599|NCT01235637|COMFORT B score|comfort b score
546600|NCT01235637|Bis score|bis score
546601|NCT01235624|Autosomal dominant retinitis pigmentosa|autosomal dominant retinitis pigmentosa
546602|NCT01235624|Rare disease|rare disease
546603|NCT01235624|Genetics|genetics
546604|NCT01235598|Cimzia®|cimzia®
546605|NCT01235598|CDP870|cdp870
546606|NCT01235598|CZP|czp
546607|NCT01235598|Certolizumab Pegol|certolizumab pegol
546608|NCT01235598|Rheumatoid Arthritis|rheumatoid arthritis
546609|NCT01235598|MRI|mri
546610|NCT01235572|Acute myeloid leukemia with multilineage dysplasia following myelodysplastic syndrome|acute myeloid leukemia with multilineage dysplasia following myelodysplastic syndrome
546611|NCT01235572|Adult acute eosinophilic leukemia|adult acute eosinophilic leukemia
546612|NCT01235572|Adult acute basophilic leukemia|adult acute basophilic leukemia
546613|NCT01235572|De|de
546614|NCT01235572|novo myelodysplastic syndromes|novo myelodysplastic syndromes
546615|NCT01235572|Secondary myelodysplastic syndromes|secondary myelodysplastic syndromes
546616|NCT01235572|Untreated adult acute myeloid leukemia|untreated adult acute myeloid leukemia
546617|NCT01235546|Pregnancy|pregnancy
546618|NCT01235546|Cesarean section|cesarean section
546619|NCT01235546|Antibiotic|antibiotic
546620|NCT01235546|Infections|infections
546621|NCT01235533|late-life depression|late-life depression
546622|NCT01235533|recurrence of depression|recurrence of depression
546623|NCT01235533|cognition|cognition
546624|NCT01235533|N-3 polyunsaturated fatty acids|n-3 polyunsaturated fatty acids
546625|NCT01235481|pulmonary rehabilitation|pulmonary rehabilitation
546626|NCT01235481|exercise therapy|exercise therapy
546627|NCT01235481|chronic lung disease|chronic lung disease
546628|NCT01235481|self-efficacy|self-efficacy
546629|NCT01235468|umbilical cord blood|umbilical cord blood
546630|NCT01235468|ex vivo expansion|ex vivo expansion
546631|NCT01235468|engraftment|engraftment
546632|NCT01235468|GVHD|gvhd
546633|NCT01235455|Multiple Sclerosis|multiple sclerosis
546634|NCT01235455|Adherence|adherence
546635|NCT01235455|Interferon beta-1b|interferon beta-1b
546636|NCT01235455|Coping styles|coping styles
546637|NCT01235442|Psoriasis|psoriasis
546638|NCT01235442|Topical|topical
546639|NCT01235442|etanercept|etanercept
546640|NCT01235442|clobetasol propionate|clobetasol propionate
546641|NCT01235429|Diabetes|diabetes
546642|NCT01235429|Behavioral intervention|behavioral intervention
546643|NCT01235429|diabetes self-management|diabetes self-management
546644|NCT01235429|Native Hawaiians|native hawaiians
546645|NCT01235429|health disparities|health disparities
546646|NCT01235403|Epilepsy treatment.|epilepsy treatment.
546647|NCT01235403|Anti-epileptic drugs|anti-epileptic drugs
546648|NCT01235403|Seizures|seizures
546649|NCT01235390|Postmenopausal women|postmenopausal women
546650|NCT01235390|walnuts|walnuts
546651|NCT01235377|prescribing patterns|prescribing patterns
546652|NCT01235377|thiazide|thiazide
546653|NCT01235377|chlorthalidone|chlorthalidone
546654|NCT01235377|hydrochlorothiazide|hydrochlorothiazide
546655|NCT01235377|target dose|target dose
546656|NCT01235377|cluster randomized trial|cluster randomized trial
546657|NCT01235364|Foley catheter|foley catheter
546658|NCT01235364|induction|induction
546659|NCT01235364|labour|labour
546660|NCT01235364|skin conductance|skin conductance
546661|NCT01235364|visual analogue scale|visual analogue scale
546662|NCT01235364|mechanical method|mechanical method
546663|NCT01235351|Myocardial infarction|myocardial infarction
546664|NCT01235351|Percutaneous coronary intervention|percutaneous coronary intervention
546665|NCT01235351|Clopidogrel|clopidogrel
546666|NCT01235351|Genetics|genetics
546667|NCT01235351|Platelet Function|platelet function
546668|NCT01235325|vitamin K|vitamin k
546669|NCT01235325|supplementation|supplementation
546670|NCT01235325|bone health indices|bone health indices
546671|NCT01235325|adult|adult
546672|NCT01235325|Crohn's disease|crohn's disease
546673|NCT01235286|remote ischemic preconditioning, free flap, microcirculation|remote ischemic preconditioning, free flap, microcirculation
546674|NCT01235260|REGRANEX (becaplermin)|regranex (becaplermin)
546675|NCT01235260|Platelet-derived growth factor BB|platelet-derived growth factor bb
546676|NCT01235260|Cancer|cancer
546677|NCT01235260|Cancer incidence|cancer incidence
546678|NCT01235260|Cancer mortality|cancer mortality
546777|NCT01234714|Magnetic Resonance Imaging|magnetic resonance imaging
546679|NCT01235260|Lower Extremity Diabetic Neuropathic Ulcer|lower extremity diabetic neuropathic ulcer
546680|NCT01235234|Dry eye disease|dry eye disease
546682|NCT01235234|Aqueous Deficient Dry Eye|aqueous deficient dry eye
546683|NCT01235208|Overweight|overweight
546684|NCT01235208|Obesity|obesity
546685|NCT01235208|Metabolic syndrome|metabolic syndrome
546686|NCT01235208|Diet|diet
546687|NCT01235208|Carbohydrate|carbohydrate
546688|NCT01235208|Low glycemic index|low glycemic index
546689|NCT01235208|Eurodiet|eurodiet
546690|NCT01235195|bioequivalence study|bioequivalence study
546691|NCT01235195|sertraline 50 mg|sertraline 50 mg
546692|NCT01235195|capsules vs tablets|capsules vs tablets
546693|NCT01235182|acute dyspnea|acute dyspnea
546694|NCT01235182|prehospital emergency setting|prehospital emergency setting
546695|NCT01235182|differential diagnosis|differential diagnosis
546696|NCT01235182|ultrasound|ultrasound
546697|NCT01235182|NT-proBNP|nt-probnp
546698|NCT01235156|Premature ventricular contraction|premature ventricular contraction
546699|NCT01235156|Frequent premature ventricular contraction, with or without a short array of non-sustained ventricular tachycardia|frequent premature ventricular contraction, with or without a short array of non-sustained ventricular tachycardia
546700|NCT01235143|incidence|incidence
546701|NCT01235143|emergence agitation|emergence agitation
546702|NCT01235143|sevoflurane|sevoflurane
546703|NCT01235143|desflurane|desflurane
546704|NCT01235143|ambulatory pediatric surgery|ambulatory pediatric surgery
546705|NCT01235117|chronic myelomonocytic leukemia|chronic myelomonocytic leukemia
546706|NCT01235091|HIV prevention|hiv prevention
546707|NCT01235091|substance abuse|substance abuse
546708|NCT01235091|high risk behaviors|high risk behaviors
546709|NCT01235091|peer intervention|peer intervention
546710|NCT01235065|airway management|airway management
546711|NCT01235065|trauma|trauma
546712|NCT01235065|intubation|intubation
546713|NCT01235052|Head and neck neoplasms|head and neck neoplasms
546714|NCT01235052|Positron Emission Tomography|positron emission tomography
546715|NCT01235052|F18 fluoromisonidazole|f18 fluoromisonidazole
546716|NCT01235026|Obesity|obesity
546717|NCT01235026|Type-2 Diabetes|type-2 diabetes
546718|NCT01235026|Metabolic syndrome|metabolic syndrome
546719|NCT01235026|Low grade inflammation|low grade inflammation
546720|NCT01235026|Metabolic endotoxinemia|metabolic endotoxinemia
546721|NCT01235026|Insulin resistance|insulin resistance
546722|NCT01235026|Lipopolysaccharide|lipopolysaccharide
546723|NCT01235026|LPS-binding protein|lps-binding protein
546724|NCT01235026|sCD14|scd14
694535|NCT00655395|MDS|mds
546725|NCT01235026|Synbiotic|synbiotic
546726|NCT01235026|Oligofructose|oligofructose
546727|NCT01235026|Bifidobacterium animalis subsp. lactis Bb12|bifidobacterium animalis subsp. lactis bb12
546728|NCT01235026|probiotic|probiotic
546729|NCT01235026|Prebiotic|prebiotic
546730|NCT01235013|HIV-1 infection|hiv-1 infection
546731|NCT01235013|Maraviroc|maraviroc
546732|NCT01235013|CD4 lymphocyte count|cd4 lymphocyte count
546733|NCT01235000|Influenza vaccines|influenza vaccines
546734|NCT01235000|Infant|infant
546735|NCT01235000|Dose-Response relationship, immunologic|dose-response relationship, immunologic
546736|NCT01235000|Prime-boost response|prime-boost response
546737|NCT01234987|Cancer|cancer
546738|NCT01234987|Breast Cancer|breast cancer
546739|NCT01234987|Colon cancer|colon cancer
546740|NCT01234987|Lung Cancer|lung cancer
546741|NCT01234974|multiple myeloma|multiple myeloma
546742|NCT01234948|Halitosis|halitosis
546743|NCT01234948|VSC|vsc
546744|NCT01234948|Periodontitis|periodontitis
546745|NCT01234948|Gingivitis|gingivitis
546746|NCT01234948|Putative periodontal pathogens|putative periodontal pathogens
546747|NCT01234948|Real-time PCR|real-time pcr
546748|NCT01234909|Missed immunizations|missed immunizations
546749|NCT01234896|Smoking Cessation, Nicotine pharmacokinetics|smoking cessation, nicotine pharmacokinetics
546750|NCT01234883|dehydration|dehydration
546751|NCT01234883|gastroenteritis|gastroenteritis
546752|NCT01234870|Myocardial Perfusion Imaging|myocardial perfusion imaging
546753|NCT01234870|Magnetic Resonance Imaging|magnetic resonance imaging
546754|NCT01234857|mTOR|mtor
546755|NCT01234857|breast cancer|breast cancer
546756|NCT01234857|estrogen receptor positive|estrogen receptor positive
546757|NCT01234844|pet-therapy|pet-therapy
546758|NCT01234844|guinea-pigs|guinea-pigs
546759|NCT01234844|rehabilitation|rehabilitation
546760|NCT01234844|elderly|elderly
546761|NCT01234831|MRSA|mrsa
546762|NCT01234831|colonization|colonization
546763|NCT01234831|nucleic acid amplification|nucleic acid amplification
546764|NCT01234831|chromogenic agar|chromogenic agar
546765|NCT01234818|Endometrial hyperplasia|endometrial hyperplasia
546766|NCT01234818|LNG-IUS|lng-ius
546767|NCT01234792|Smoking Cessation, Nicotine pharmacokinetics|smoking cessation, nicotine pharmacokinetics
546768|NCT01234753|Adults with CHD|adults with chd
546769|NCT01234753|GUCH|guch
546770|NCT01234753|Congenital heart disease|congenital heart disease
546771|NCT01234753|Computer-based education|computer-based education
546772|NCT01234753|Nursing|nursing
546773|NCT01234740|Los Angeles|los angeles
546774|NCT01234727|diabetes, SMBG, glucose testing systems, accuracy|diabetes, smbg, glucose testing systems, accuracy
546779|NCT01234701|Liver|liver
546780|NCT01234701|Neoplasms|neoplasms
546781|NCT01234701|Magnetic Resonance Imaging|magnetic resonance imaging
546782|NCT01234701|Surgery|surgery
546783|NCT01234701|Pathology|pathology
546784|NCT01234688|Exercise Tolerance|exercise tolerance
546785|NCT01234688|Physical Endurance|physical endurance
546786|NCT01234675|Fibromyalgia|fibromyalgia
546787|NCT01234675|Sleep disorders|sleep disorders
546788|NCT01234675|Forest Laboratories|forest laboratories
546789|NCT01234675|Milnacipran|milnacipran
546790|NCT01234662|Elective cesarean sections|elective cesarean sections
546791|NCT01234662|Postoperative pain level|postoperative pain level
546792|NCT01234662|Spinal anesthesia|spinal anesthesia
546793|NCT01234662|Combined spinal epidural anesthesia|combined spinal epidural anesthesia
546794|NCT01234662|Epidural catheter|epidural catheter
546795|NCT01234649|gestational diabetes mellitus|gestational diabetes mellitus
546796|NCT01234649|type 2 diabetes mellitus|type 2 diabetes mellitus
546797|NCT01234649|metabolic dysfunction|metabolic dysfunction
546798|NCT01234649|impaired fasting glucose|impaired fasting glucose
546799|NCT01234649|impaired glucose tolerance|impaired glucose tolerance
546800|NCT01234649|incretin mimetic|incretin mimetic
546801|NCT01234636|Platelets|platelets
546802|NCT01234636|Platelet aggregation|platelet aggregation
546803|NCT01234636|Platelet activation|platelet activation
546804|NCT01234636|Platelet function|platelet function
546805|NCT01234636|Light transmission aggregometry|light transmission aggregometry
546806|NCT01234636|Flow cytometry|flow cytometry
546807|NCT01234636|Platelet function analyzer-100 (PFA-100)|platelet function analyzer-100 (pfa-100)
546808|NCT01234636|Linoleic acid, conjugated|linoleic acid, conjugated
546809|NCT01234636|cis9, trans11 conjugated linoleic acid|cis9, trans11 conjugated linoleic acid
546810|NCT01234636|dietary supplement|dietary supplement
546811|NCT01234636|short-term intervention|short-term intervention
546812|NCT01234623|Umbilical cord serum, eyedrops, GVHD, SS-I, corneal healing|umbilical cord serum, eyedrops, gvhd, ss-i, corneal healing
546813|NCT01234610|Exercise|exercise
546814|NCT01234610|Aortic aneurysm|aortic aneurysm
546815|NCT01234610|Feasibility|feasibility
546816|NCT01234610|Vascular disease|vascular disease
546817|NCT01234571|Pulmonary hypertension|pulmonary hypertension
546818|NCT01234571|Remodulin (Treprostenil sodium)|remodulin (treprostenil sodium)
546819|NCT01234571|End-stage renal disease|end-stage renal disease
546820|NCT01234571|Hemo-dialysis|hemo-dialysis
546821|NCT01234558|depression|depression
546822|NCT01234558|NMDA antagonist|nmda antagonist
546823|NCT01234558|treatment resistant|treatment resistant
546824|NCT01234519|ureter cancer|ureter cancer
546825|NCT01234519|renal pelvis cancer|renal pelvis cancer
546826|NCT01234519|bladder cancer|bladder cancer
546827|NCT01234519|urethra|urethra
546828|NCT01234506|long term care|long term care
546829|NCT01234506|lignans|lignans
546830|NCT01234506|oxidative stress|oxidative stress
546831|NCT01234506|inflammation|inflammation
546832|NCT01234506|aging|aging
546833|NCT01234506|dementia|dementia
546834|NCT01234506|postural balance|postural balance
546835|NCT01234506|depression|depression
546836|NCT01234506|muscle weakness|muscle weakness
546837|NCT01234506|quality of life|quality of life
546838|NCT01234506|pain|pain
546839|NCT01234493|ankle; fracture; syndesmosis;|ankle; fracture; syndesmosis;
546840|NCT01234467|Diffuse Large B-Cell Lymphoma|diffuse large b-cell lymphoma
546841|NCT01234467|Elderly|elderly
546842|NCT01234467|Newly Diagnosed|newly diagnosed
546843|NCT01234467|Lineberger Comprehensive Cancer Center|lineberger comprehensive cancer center
546844|NCT01234467|University of North Carolina|university of north carolina
546845|NCT01234467|Bendamustine|bendamustine
546846|NCT01234467|Rituximab|rituximab
546847|NCT01234467|Rituxan|rituxan
546848|NCT01234467|Treanda|treanda
546849|NCT01234467|Phase 2|phase 2
546850|NCT01234467|Geriatric|geriatric
546851|NCT01234467|Lymphoma|lymphoma
546852|NCT01234428|laparoscopy|laparoscopy
546853|NCT01234428|adjustable gastric banding|adjustable gastric banding
546854|NCT01234428|morbid obesity|morbid obesity
546855|NCT01234428|esophageal motility|esophageal motility
546856|NCT01234428|esophageal dilatation|esophageal dilatation
546857|NCT01234415|nasal|nasal
546858|NCT01234415|septum|septum
546859|NCT01234415|reconstruction|reconstruction
546860|NCT01234402|Breast Cancer|breast cancer
546861|NCT01234363|Renal allograft|renal allograft
546862|NCT01234363|kidney|kidney
546863|NCT01234363|fibrosis|fibrosis
546864|NCT01234363|elastography|elastography
546865|NCT01234363|elasticity|elasticity
546866|NCT01234337|Breast Cancer|breast cancer
546867|NCT01234337|HER2-neu|her2-neu
546868|NCT01234324|Stomach Neoplasms|stomach neoplasms
546869|NCT01234324|Gastroesophageal Junction Neoplasms|gastroesophageal junction neoplasms
546870|NCT01234324|gastric cancer|gastric cancer
546871|NCT01234324|cancer of the gastroesophageal junction|cancer of the gastroesophageal junction
546872|NCT01234285|sepsis|sepsis
546873|NCT01234285|septic shock|septic shock
546874|NCT01234285|anticoagulation|anticoagulation
546875|NCT01234285|intensive care unit|intensive care unit
546876|NCT01234272|patients with|patients with
546877|NCT01234272|undergoing|undergoing
546878|NCT01234272|gastrectomy|gastrectomy
546879|NCT01234259|Wrinkles|wrinkles
546880|NCT01234259|rhytides|rhytides
546881|NCT01234259|Cellulite|cellulite
546882|NCT01234259|circumference reduction|circumference reduction
546883|NCT01234246|Colorectal cancer|colorectal cancer
546884|NCT01234246|Sexual function|sexual function
546885|NCT01234246|Sexual dysfunction|sexual dysfunction
546886|NCT01234246|Quality of (sexual) life|quality of (sexual) life
546887|NCT01234246|Partners|partners
546888|NCT01234246|Body image|body image
546889|NCT01234246|Anxiety (state and trait)|anxiety (state and trait)
546890|NCT01234246|Depressive symptoms|depressive symptoms
546891|NCT01234246|Personality|personality
546892|NCT01234233|hypothermia, accidental|hypothermia, accidental
546893|NCT01234233|prewarming|prewarming
546894|NCT01234233|body temperature monitoring|body temperature monitoring
546895|NCT01234233|preoperative warming|preoperative warming
546896|NCT01234233|sublingual temperature assessment|sublingual temperature assessment
546897|NCT01234233|tympanic temperature assessment|tympanic temperature assessment
546898|NCT01234220|Aldosterone|aldosterone
546899|NCT01234220|Primary Aldosteronism|primary aldosteronism
546900|NCT01234220|Aldosterone Producing Adenoma (APA)|aldosterone producing adenoma (apa)
546901|NCT01234220|Idiopathic Adrenal Hyperplasia (IHA)|idiopathic adrenal hyperplasia (iha)
546902|NCT01234220|Adrenal Venous Sampling|adrenal venous sampling
546903|NCT01234207|Progressive addition lenses|progressive addition lenses
546904|NCT01234207|Customized free-form|customized free-form
546905|NCT01234207|Presbyopia|presbyopia
546906|NCT01234207|Bifocals|bifocals
546907|NCT01234207|Subjective assessment|subjective assessment
546908|NCT01234207|Visual performance|visual performance
546909|NCT01234207|Visual acuity|visual acuity
546910|NCT01234207|Amsler grid|amsler grid
546911|NCT01234194|Composite Variability Index|composite variability index
546912|NCT01234194|Bispectral Index|bispectral index
546913|NCT01234194|Electromyography|electromyography
546914|NCT01234194|Nociception|nociception
546916|NCT01234155|Exercise|exercise
546917|NCT01234155|Diabetes|diabetes
546918|NCT01234155|Obesity|obesity
546919|NCT01234155|Insulin Sensitivity|insulin sensitivity
546920|NCT01234155|Insulin Secretion|insulin secretion
546921|NCT01234155|Beta-cell Function|beta-cell function
546922|NCT01234155|Glycemic Control|glycemic control
694732|NCT00654589|HCT|hct
546923|NCT01234155|GIP|gip
546924|NCT01234155|GLP-1|glp-1
546925|NCT01234142|varenicline transdermal percutaneous transcutaneous transdermal delivery system patch|varenicline transdermal percutaneous transcutaneous transdermal delivery system patch
546926|NCT01234129|multiple myeloma|multiple myeloma
546927|NCT01234129|stem cell transplant|stem cell transplant
546928|NCT01234129|zoledronic acid|zoledronic acid
546929|NCT01234116|Post exposure prophylaxis|post exposure prophylaxis
546930|NCT01234116|Health Care Workers|health care workers
546931|NCT01234103|sexually transmitted infection|sexually transmitted infection
546932|NCT01234103|sexual risk|sexual risk
546933|NCT01234103|HIV|hiv
546934|NCT01234103|young adults|young adults
546935|NCT01234103|cognitive-behavioral intervention|cognitive-behavioral intervention
546936|NCT01234090|Aphasia|aphasia
546937|NCT01234090|Quality of Life|quality of life
546938|NCT01234077|scheduled for a polysomnogram (overnight sleep study)|scheduled for a polysomnogram (overnight sleep study)
546939|NCT01234064|Symptomatic Venous Thromboembolism|symptomatic venous thromboembolism
546940|NCT01234064|Graduated Compression Stockings|graduated compression stockings
546941|NCT01234064|Randomized Controlled Trial|randomized controlled trial
546942|NCT01234064|Noncardiac Surgery|noncardiac surgery
546943|NCT01234038|Non-small cell lung cancer|non-small cell lung cancer
546944|NCT01234025|Castrate-Resistant Prostate Cancer|castrate-resistant prostate cancer
546945|NCT01234012|melanoma|melanoma
546946|NCT01234012|breast cancer|breast cancer
546947|NCT01234012|ovarian cancer|ovarian cancer
546948|NCT01234012|prostate cancer|prostate cancer
546949|NCT01234012|esophageal cancer|esophageal cancer
546950|NCT01234012|uterine cancer|uterine cancer
546951|NCT01234012|sarcoma|sarcoma
546952|NCT01234012|NY-ESO-1|ny-eso-1
546953|NCT01233999|Scleroderma|scleroderma
546954|NCT01233999|Raynaud's Syndrome|raynaud's syndrome
546955|NCT01233986|Acute Ischemic Stroke|acute ischemic stroke
546956|NCT01233986|Atherosclerosis|atherosclerosis
546957|NCT01233986|Apolipoprotein B48|apolipoprotein b48
546958|NCT01233973|nursing home|nursing home
546959|NCT01233973|advance care planning|advance care planning
546960|NCT01233960|Crohn's Disease|crohn's disease
546961|NCT01233960|Adult Stem Cell Therapy|adult stem cell therapy
546962|NCT01233960|inflammation of the gastrointestinal tract|inflammation of the gastrointestinal tract
546963|NCT01233934|Insect bites|insect bites
546964|NCT01233934|Dexchlorpheniramine|dexchlorpheniramine
546965|NCT01233934|Gel|gel
546966|NCT01233934|Cream|cream
546967|NCT01233882|Renal impairment|renal impairment
546968|NCT01233882|healthy volunteers|healthy volunteers
546969|NCT01233869|Bosutinib|bosutinib
546970|NCT01233869|Autosomal Dominant Polycystic Kidney Disease|autosomal dominant polycystic kidney disease
546971|NCT01233843|induction chemotherapy|induction chemotherapy
547060|NCT01233414|Tantrums|tantrums
546972|NCT01233843|followed by irradiation and concurrent Erbitux, or radiochemotherapy|followed by irradiation and concurrent erbitux, or radiochemotherapy
546973|NCT01233830|safety, tolerability, pharmacokinetics, AZD2423, Japanese|safety, tolerability, pharmacokinetics, azd2423, japanese
546974|NCT01233817|Spinal muscular atrophy|spinal muscular atrophy
546975|NCT01233817|Neuromuscular disorder|neuromuscular disorder
546976|NCT01233817|Progressive strength training|progressive strength training
546977|NCT01233817|Children|children
546978|NCT01233804|influenza vaccination rates|influenza vaccination rates
546979|NCT01233791|high tone pelvic floor dysfunction|high tone pelvic floor dysfunction
546980|NCT01233791|levator pain|levator pain
546981|NCT01233791|dyspareunia|dyspareunia
546982|NCT01233778|Cardiovascular disease|cardiovascular disease
546983|NCT01233778|Omega-3 fatty acids|omega-3 fatty acids
546984|NCT01233778|Inflammation|inflammation
546985|NCT01233778|Endothelial function|endothelial function
546986|NCT01233778|Canola oil|canola oil
546987|NCT01233765|Periodontitis|periodontitis
546988|NCT01233765|Neutrophil|neutrophil
546989|NCT01233765|Inflammation|inflammation
546990|NCT01233752|systemic morphine analgesia|systemic morphine analgesia
546991|NCT01233752|pharmacogenetics|pharmacogenetics
546992|NCT01233752|pharmacokinetics|pharmacokinetics
546993|NCT01233739|rhizarthrosis|rhizarthrosis
546994|NCT01233739|Chondroitin sulfate|chondroitin sulfate
546996|NCT01233726|Critical illness|critical illness
546997|NCT01233726|Hyperglycemia|hyperglycemia
546998|NCT01233726|Mechanical Ventilation|mechanical ventilation
546999|NCT01233726|Enteral nutrition|enteral nutrition
547000|NCT01233726|T-Diet plus Diabet IR|t-diet plus diabet ir
547001|NCT01233726|Malnutrition|malnutrition
547002|NCT01233726|Insulin resistance|insulin resistance
547003|NCT01233726|Metabolic stress|metabolic stress
547004|NCT01233713|Emergency Surgery|emergency surgery
547005|NCT01233713|Bowel perforation|bowel perforation
547006|NCT01233713|Diverticulitis|diverticulitis
547007|NCT01233713|Neoplasms|neoplasms
547008|NCT01233713|Postoperative Complications|postoperative complications
547009|NCT01233713|Randomized Controlled Trial|randomized controlled trial
547010|NCT01233700|living donation|living donation
547011|NCT01233700|organ donation|organ donation
694923|NCT00654147|HIV|hiv
547012|NCT01233700|psychological adaptation|psychological adaptation
547013|NCT01233700|mental health|mental health
547014|NCT01233700|physical well-being|physical well-being
547015|NCT01233700|interpersonal relations|interpersonal relations
547016|NCT01233700|quality of life|quality of life
547017|NCT01233700|psychosocial factors|psychosocial factors
547018|NCT01233687|Recurrent|recurrent
547019|NCT01233687|progressive|progressive
547020|NCT01233687|advanced|advanced
547021|NCT01233648|heart failure|heart failure
547022|NCT01233648|CRT-D|crt-d
547023|NCT01233609|retinitis pigmentosa|retinitis pigmentosa
547024|NCT01233609|valproic acid|valproic acid
547025|NCT01233609|visual field|visual field
547026|NCT01233596|congenital nasolacrimal duct obstruction|congenital nasolacrimal duct obstruction
547027|NCT01233596|monocanalicular intubation|monocanalicular intubation
547028|NCT01233596|bicanalicular intubation|bicanalicular intubation
547029|NCT01233596|complications|complications
547030|NCT01233583|Regulatory T-cells, psoriasis, IL-10.|regulatory t-cells, psoriasis, il-10.
547031|NCT01233570|Cutaneous Crohns Disease|cutaneous crohns disease
547032|NCT01233570|Topical Tacrolimus|topical tacrolimus
547033|NCT01233570|Protopic|protopic
547034|NCT01233570|Metastatic Crohns Disease|metastatic crohns disease
547035|NCT01233570|Pyoderma Gangrenosum|pyoderma gangrenosum
547036|NCT01233570|Granulomatous chelitis|granulomatous chelitis
547037|NCT01233570|Oral crohns disease|oral crohns disease
547038|NCT01233570|Perianal crohns disease|perianal crohns disease
547039|NCT01233544|Colorectal carcinoma|colorectal carcinoma
547040|NCT01233544|Liver metastases|liver metastases
547041|NCT01233544|Stereotactic body radiation therapy|stereotactic body radiation therapy
547042|NCT01233544|Radiofrequency ablation|radiofrequency ablation
547043|NCT01233518|CCTA Coronary Artery Disease CAD|ccta coronary artery disease cad
547044|NCT01233492|adult glioblastoma|adult glioblastoma
547045|NCT01233492|adult giant cell glioblastoma|adult giant cell glioblastoma
547046|NCT01233492|adult gliosarcoma|adult gliosarcoma
547047|NCT01233479|untreated childhood medulloblastoma|untreated childhood medulloblastoma
547048|NCT01233479|untreated childhood cerebellar astrocytoma|untreated childhood cerebellar astrocytoma
547049|NCT01233479|untreated childhood cerebral astrocytoma|untreated childhood cerebral astrocytoma
547050|NCT01233479|untreated childhood brain stem glioma|untreated childhood brain stem glioma
547051|NCT01233479|childhood medulloepithelioma|childhood medulloepithelioma
547052|NCT01233479|childhood infratentorial ependymoma|childhood infratentorial ependymoma
547053|NCT01233479|newly diagnosed childhood ependymoma|newly diagnosed childhood ependymoma
547180|NCT01232920|antimetabolite|antimetabolite
547054|NCT01233479|childhood atypical teratoid/rhabdoid tumor|childhood atypical teratoid/rhabdoid tumor
547055|NCT01233414|Pervasive Developmental Disorder|pervasive developmental disorder
547056|NCT01233414|Autism|autism
547057|NCT01233414|Children|children
547058|NCT01233414|Behavior Therapy|behavior therapy
547059|NCT01233414|Aggression|aggression
547061|NCT01233414|Noncompliance|noncompliance
547062|NCT01233401|Pertussis, Vaccination, Adult|pertussis, vaccination, adult
547063|NCT01233375|cancer|cancer
547064|NCT01233375|metastatic|metastatic
547065|NCT01233375|pancreatic|pancreatic
547066|NCT01233375|pancreas|pancreas
547067|NCT01233375|adenocarcinoma|adenocarcinoma
547068|NCT01233375|gemcitabine|gemcitabine
547069|NCT01233375|human equilibrative nucleoside transporter-1 (hENT1)|human equilibrative nucleoside transporter-1 (hent1)
547070|NCT01233375|CO-1.01|co-1.01
547071|NCT01233375|CO-101|co-101
547072|NCT01233375|CO101|co101
547073|NCT01233375|Stage 4|stage 4
547074|NCT01233375|Stage IV|stage iv
547075|NCT01233375|Gemcitabine-Refractory|gemcitabine-refractory
547076|NCT01233375|Second-Line Therapy|second-line therapy
547077|NCT01233362|Cholera|cholera
547078|NCT01233362|Vaccine|vaccine
547079|NCT01233362|Kolkata|kolkata
547080|NCT01233362|West Bengal|west bengal
547081|NCT01233362|India|india
547082|NCT01233362|Immunogenicity|immunogenicity
547083|NCT01233362|Vaccination Schedules|vaccination schedules
547084|NCT01233349|overweight|overweight
547085|NCT01233349|obesity|obesity
547086|NCT01233349|weight loss|weight loss
547087|NCT01233349|body fat|body fat
547088|NCT01233349|waist circumference|waist circumference
547089|NCT01233349|satiety|satiety
547090|NCT01233336|ACS,|acs,
547091|NCT01233336|HGF,|hgf,
547092|NCT01233336|myocardial infarction|myocardial infarction
547093|NCT01233336|markers of myocardial injury|markers of myocardial injury
547094|NCT01233336|acute coronary syndrome (ACS)|acute coronary syndrome (acs)
547095|NCT01233336|prognostic factors in patients with ACS|prognostic factors in patients with acs
547096|NCT01233323|Phrenic nerve stimulation|phrenic nerve stimulation
547097|NCT01233323|Cardiac Resynchronization Therapy|cardiac resynchronization therapy
547098|NCT01233323|Heart Failure|heart failure
547099|NCT01233323|Heart Diseases|heart diseases
547100|NCT01233310|Crohn's Disease|crohn's disease
547101|NCT01233297|wheeze|wheeze
547102|NCT01233297|infections|infections
547103|NCT01233271|algorithm|algorithm
547104|NCT01233271|tight glycemic control|tight glycemic control
547105|NCT01233271|glucose control|glucose control
547106|NCT01233271|intensive care|intensive care
547107|NCT01233271|insulin|insulin
547108|NCT01233271|ICU|icu
547109|NCT01233258|Haemophilia treatment|haemophilia treatment
547110|NCT01233258|rFVIII|rfviii
547111|NCT01233245|Multiple Sclerosis|multiple sclerosis
547112|NCT01233245|Adherence|adherence
547113|NCT01233245|Interferon beta-1b|interferon beta-1b
547114|NCT01233245|Coping Styles|coping styles
547115|NCT01233232|Chronic Obstructive Pulmonary Disease, Neutrophil, Respiratory Disease|chronic obstructive pulmonary disease, neutrophil, respiratory disease
547116|NCT01233219|systemic morphine analgesia|systemic morphine analgesia
547117|NCT01233219|pharmacogenetics|pharmacogenetics
547118|NCT01233219|pharmacokinetics|pharmacokinetics
547119|NCT01233206|PCOS|pcos
547120|NCT01233206|Polycystic ovary syndrome|polycystic ovary syndrome
547121|NCT01233206|Cancelled cycles|cancelled cycles
547122|NCT01233206|OHSS|ohss
547123|NCT01233206|Infertility|infertility
547124|NCT01233193|Home blood pressure measurement|home blood pressure measurement
547125|NCT01233193|Pharmaceutical Services|pharmaceutical services
547126|NCT01233193|Medication adherence|medication adherence
547127|NCT01233193|hypertension management|hypertension management
547128|NCT01233193|Blood Pressure|blood pressure
547129|NCT01233180|neck pain|neck pain
547130|NCT01233180|massage|massage
547131|NCT01233180|hyperthermia, induced|hyperthermia, induced
547132|NCT01233180|touch perception|touch perception
547133|NCT01233180|randomized controlled trial|randomized controlled trial
547134|NCT01233167|dual antiplatelet therapy|dual antiplatelet therapy
547135|NCT01233167|sirolimus drug-eluting stent|sirolimus drug-eluting stent
547136|NCT01233167|major adverse cardiac events|major adverse cardiac events
547137|NCT01233167|bleeding|bleeding
547138|NCT01233141|peripheral artery disease stage IV (Fontaine's classification) or stage 5 and 6 (Rutherford's classification|peripheral artery disease stage iv (fontaine's classification) or stage 5 and 6 (rutherford's classification
547139|NCT01233102|liver Cirrhosis|liver cirrhosis
547140|NCT01233102|Mesenchymal stem cells|mesenchymal stem cells
547141|NCT01233102|Hepatic artery infusion|hepatic artery infusion
547142|NCT01233102|Intravenous infusion|intravenous infusion
547143|NCT01233089|Myopia|myopia
547144|NCT01233089|contact lenses|contact lenses
547145|NCT01233089|children|children
547146|NCT01233063|behavior change|behavior change
547147|NCT01233063|physical activity|physical activity
547148|NCT01233063|nutrition|nutrition
547149|NCT01233063|fruits and vegetables|fruits and vegetables
547150|NCT01233063|saturated fat|saturated fat
547151|NCT01233063|trans fat|trans fat
547152|NCT01233063|added sugars|added sugars
547153|NCT01233063|email|email
547154|NCT01233063|web|web
547155|NCT01233063|obesity|obesity
547156|NCT01233063|aging|aging
547157|NCT01233050|undergoing elective colon and /or rectal surgical procedures involving an abdominal incision|undergoing elective colon and /or rectal surgical procedures involving an abdominal incision
547158|NCT01233024|Adult|adult
547159|NCT01233024|Women|women
547160|NCT01233024|Dietary Fiber|dietary fiber
547161|NCT01233024|Satiety Response|satiety response
547162|NCT01233024|Food Intake|food intake
547163|NCT01233011|Intubating laryngeal airway|intubating laryngeal airway
547164|NCT01233011|Pediatric|pediatric
547165|NCT01233011|Observational study|observational study
547166|NCT01232998|Patient Satisfaction|patient satisfaction
547167|NCT01232985|Atopic Dermatitis|atopic dermatitis
547168|NCT01232985|Pruritus|pruritus
547169|NCT01232972|vitrification|vitrification
547170|NCT01232972|egg freezing|egg freezing
547171|NCT01232972|oocyte cryopreservation|oocyte cryopreservation
547172|NCT01232972|female fertility potential|female fertility potential
547173|NCT01232972|fertility preservation|fertility preservation
547174|NCT01232972|Fertility preservation, female|fertility preservation, female
547175|NCT01232959|Gallbladder removal|gallbladder removal
547176|NCT01232946|Diabetes|diabetes
547177|NCT01232946|Myocardial metabolism|myocardial metabolism
547178|NCT01232933|PICC|picc
547179|NCT01232920|uveitis|uveitis
547181|NCT01232920|immunosuppressive|immunosuppressive
547182|NCT01232920|clinical trial|clinical trial
547183|NCT01232907|Spinal Cord Injury (SCI)|spinal cord injury (sci)
547184|NCT01232894|indacaterol|indacaterol
547185|NCT01232894|COPD|copd
547186|NCT01232894|Long-acting beta2-agonist (LABA)|long-acting beta2-agonist (laba)
547187|NCT01232868|Innate immunity|innate immunity
547188|NCT01232868|Adaptive immunity|adaptive immunity
547189|NCT01232868|Slu shot|slu shot
547190|NCT01232868|Elderly|elderly
547191|NCT01232855|adult acute myeloid leukemia with t(15;17)(q22;q12)|adult acute myeloid leukemia with t(15;17)(q22;q12)
547192|NCT01232855|adult acute promyelocytic leukemia (M3)|adult acute promyelocytic leukemia (m3)
547193|NCT01232855|childhood acute promyelocytic leukemia (M3)|childhood acute promyelocytic leukemia (m3)
547194|NCT01232855|adult acute myeloid leukemia in remission|adult acute myeloid leukemia in remission
547195|NCT01232855|untreated adult acute myeloid leukemia|untreated adult acute myeloid leukemia
547196|NCT01232855|childhood acute myeloid leukemia in remission|childhood acute myeloid leukemia in remission
547197|NCT01232855|untreated childhood acute myeloid leukemia and other myeloid malignancies|untreated childhood acute myeloid leukemia and other myeloid malignancies
547198|NCT01232842|adult acute myeloid leukemia|adult acute myeloid leukemia
547199|NCT01232842|childhood acute myeloid leukemia/other myeloid malignancies|childhood acute myeloid leukemia/other myeloid malignancies
547200|NCT01232803|Rectal Microbicides|rectal microbicides
547201|NCT01232803|Tenofovir|tenofovir
547202|NCT01232803|Rectal use|rectal use
547203|NCT01232803|Rectal mucosal damage|rectal mucosal damage
547204|NCT01232790|Schizophrenia|schizophrenia
547205|NCT01232790|working memory|working memory
547206|NCT01232790|N-Acetylcysteine|n-acetylcysteine
547207|NCT01232777|Retinopathy of Prematurity|retinopathy of prematurity
547208|NCT01232777|Bevacizumab|bevacizumab
547209|NCT01232777|Avastin|avastin
547210|NCT01232777|Vascular Endothelial Growth Factor|vascular endothelial growth factor
547211|NCT01232751|health|health
547212|NCT01232751|women|women
547213|NCT01232725|BSID III|bsid iii
547214|NCT01232725|Human Milk|human milk
547215|NCT01232725|Donor Human Milk|donor human milk
547216|NCT01232725|Preterm infant|preterm infant
547217|NCT01232725|Breastfeeding|breastfeeding
547218|NCT01232712|MUC1|muc1
547219|NCT01232712|ImMucin|immucin
547220|NCT01232712|Vaccine|vaccine
547221|NCT01232712|Multiple Myeloma|multiple myeloma
547222|NCT01232699|obesity|obesity
547223|NCT01232699|weight loss|weight loss
547224|NCT01232699|internet treatment|internet treatment
547225|NCT01232699|motivational interviewing|motivational interviewing
547226|NCT01232686|Communicable Diseases|communicable diseases
547227|NCT01232686|Epidemiology|epidemiology
547228|NCT01232686|Population surveillance|population surveillance
547229|NCT01232686|Computerized Medical Record|computerized medical record
547230|NCT01232686|Data collection|data collection
547231|NCT01232673|Critical Limb Ischemia|critical limb ischemia
547232|NCT01232673|Bone-Marrow Aspiration Concentrate|bone-marrow aspiration concentrate
547233|NCT01232673|Diabetes Mellitus|diabetes mellitus
547234|NCT01232673|Major Amputation|major amputation
547235|NCT01232647|osteoporosis|osteoporosis
547236|NCT01232647|vitamin K|vitamin k
547237|NCT01232647|BONE MINERAL DENSITY|bone mineral density
547238|NCT01232647|BIOCHEMICAL MARKERS OF BONE TURNOVER|biochemical markers of bone turnover
547239|NCT01232634|pediatrics|pediatrics
547240|NCT01232634|haemophilia|haemophilia
547241|NCT01232634|ultrasound|ultrasound
547242|NCT01232634|MRI|mri
547243|NCT01232634|arthropathy|arthropathy
547244|NCT01232608|Coronary Artery Disease|coronary artery disease
547245|NCT01232608|Atherosclerosis.|atherosclerosis.
547246|NCT01232608|Diabetes Mellitus, type 2|diabetes mellitus, type 2
547247|NCT01232608|Exercise|exercise
547248|NCT01232608|HbA1c|hba1c
547249|NCT01232608|Carotid Atherosclerotic Disease|carotid atherosclerotic disease
547250|NCT01232608|Inflammation|inflammation
547251|NCT01232595|Clostridium difficile,|clostridium difficile,
547252|NCT01232595|C. difficile,|c. difficile,
547253|NCT01232595|CDI,|cdi,
547254|NCT01232595|Clostridium difficile-associated disease,|clostridium difficile-associated disease,
547255|NCT01232595|CDAD,|cdad,
547256|NCT01232595|pseudomembranous colitis,|pseudomembranous colitis,
547257|NCT01232595|PMC,|pmc,
547258|NCT01232595|antibiotic-associated diarrhea|antibiotic-associated diarrhea
547259|NCT01232582|Lower back pain, Facets joints Osteoarthritis|lower back pain, facets joints osteoarthritis
547260|NCT01232556|inotuzumab ozogamicin|inotuzumab ozogamicin
547261|NCT01232556|aggressive Non-Hodgkin lymphoma|aggressive non-hodgkin lymphoma
547262|NCT01232556|diffuse large b-cell lymphoma|diffuse large b-cell lymphoma
547263|NCT01232556|relapsed/refractory lymphoma|relapsed/refractory lymphoma
547264|NCT01232543|Atopic Dermatitis|atopic dermatitis
547265|NCT01232530|Malria, ACT, Safety, Efficacy, pregarnancy|malria, act, safety, efficacy, pregarnancy
547266|NCT01232504|Allo-HSCT|allo-hsct
547267|NCT01232504|rhGM-CSF|rhgm-csf
547268|NCT01232504|Systemic fungal infection (SFI)|systemic fungal infection (sfi)
547269|NCT01232478|Cystic Fibrosis|cystic fibrosis
547270|NCT01232478|Adherence|adherence
547271|NCT01232478|Problem-Solving|problem-solving
547272|NCT01232478|Adolescents|adolescents
547273|NCT01232478|Education|education
547274|NCT01232478|Skills Remediation|skills remediation
547275|NCT01232465|sperm DNA integrity|sperm dna integrity
547276|NCT01232465|Toluidine blue assay (TBA)|toluidine blue assay (tba)
547277|NCT01232465|IVF outcome|ivf outcome
547278|NCT01232452|lung cancer|lung cancer
547279|NCT01232452|advanced|advanced
547280|NCT01232452|non-small cell|non-small cell
547281|NCT01232413|Thorough QT (TQT)|thorough qt (tqt)
547282|NCT01232413|ASP1941|asp1941
547283|NCT01232400|subarachnoid hemorrhage|subarachnoid hemorrhage
547284|NCT01232400|esmolol|esmolol
547285|NCT01232400|cardiac function|cardiac function
547286|NCT01232400|cardiac electrophysiology|cardiac electrophysiology
547287|NCT01232387|Fetomaternal hemorrhage|fetomaternal hemorrhage
547288|NCT01232387|neonatal anemia|neonatal anemia
547289|NCT01232387|perinatal epidemiology|perinatal epidemiology
547290|NCT01232387|Kleihauer-Betke|kleihauer-betke
547291|NCT01232387|flow cytometry|flow cytometry
547292|NCT01232374|Nimotuzumab|nimotuzumab
547293|NCT01232374|local advanced esophageal squamous cell carcinoma|local advanced esophageal squamous cell carcinoma
547294|NCT01232374|chemo-irradiation|chemo-irradiation
547295|NCT01232361|ADHD|adhd
547296|NCT01232361|HIV|hiv
547297|NCT01232361|Pharmacokinetics|pharmacokinetics
547298|NCT01232348|bronchial asthma|bronchial asthma
547299|NCT01232348|Symbicort|symbicort
547300|NCT01232335|bronchial asthma|bronchial asthma
547301|NCT01232335|Symbicort|symbicort
547302|NCT01232335|long term use,|long term use,
547303|NCT01232322|bronchial asthma|bronchial asthma
547304|NCT01232322|Pulmicort Respules|pulmicort respules
547305|NCT01232322|long term use|long term use
547306|NCT01232322|pediatrics|pediatrics
547307|NCT01232309|Arterial Health|arterial health
547308|NCT01232309|Fiber|fiber
547309|NCT01232309|Chitin-glucan|chitin-glucan
547310|NCT01232309|oxidized LDL|oxidized ldl
547311|NCT01232296|Hepatocellular Carcinoma|hepatocellular carcinoma
547312|NCT01232296|HCC|hcc
547313|NCT01232296|Liver cancer|liver cancer
547314|NCT01232296|Child Pugh A|child pugh a
547315|NCT01232296|HCC Stage C|hcc stage c
547316|NCT01232257|Chronic kidney disease|chronic kidney disease
547317|NCT01232257|Chronic kidney failure|chronic kidney failure
547318|NCT01232257|End stage kidney disease|end stage kidney disease
547319|NCT01232257|End stage renal disease|end stage renal disease
547320|NCT01232257|Hydrogen sulfide|hydrogen sulfide
547321|NCT01232257|N-acetylcysteine|n-acetylcysteine
547322|NCT01232257|Acetylcysteine|acetylcysteine
547323|NCT01232244|Incretin hormones|incretin hormones
547324|NCT01232244|Glucagon|glucagon
547325|NCT01232244|Satiety|satiety
547326|NCT01232244|Hunger|hunger
547327|NCT01232244|Energy expenditure|energy expenditure
547328|NCT01232231|methicillin-resistant Staphylococcus aureus|methicillin-resistant staphylococcus aureus
547329|NCT01232231|decolonization|decolonization
547330|NCT01232231|random allocation|random allocation
547331|NCT01232231|outpatient|outpatient
547332|NCT01232218|Cerebral Vascular Accident|cerebral vascular accident
547333|NCT01232218|Stroke|stroke
547334|NCT01232218|Hemiplegic|hemiplegic
547335|NCT01232218|Shoulder pain|shoulder pain
547336|NCT01232218|range of motion|range of motion
547337|NCT01232218|scapula|scapula
547338|NCT01232218|mobilization|mobilization
547339|NCT01232205|antioxidant supplementation|antioxidant supplementation
547340|NCT01232205|preeclampsia|preeclampsia
547341|NCT01232153|chest tube|chest tube
547342|NCT01232153|preoxygenation|preoxygenation
547343|NCT01232153|NIV|niv
547344|NCT01232153|out-of-hospital|out-of-hospital
547345|NCT01232153|patients needing tracheal chest tube managed by Medical Mobile Emergency rescue services|patients needing tracheal chest tube managed by medical mobile emergency rescue services
547346|NCT01232140|COPD|copd
547347|NCT01232140|exacerbation|exacerbation
547348|NCT01232140|antibiotic treatment|antibiotic treatment
547349|NCT01232140|CRP|crp
547350|NCT01232140|sputum|sputum
547351|NCT01232140|inflammation|inflammation
547352|NCT01232101|covered, uncovered, palliative treatment, stent|covered, uncovered, palliative treatment, stent
547353|NCT01232088|drug labelling|drug labelling
548039|NCT01228929|MGD|mgd
547354|NCT01232088|standardized drug syringe labelling|standardized drug syringe labelling
547355|NCT01232088|European ICU|european icu
547356|NCT01232075|Letrozole ,Clomiphene citrate , IUI,unexplained infertility|letrozole ,clomiphene citrate , iui,unexplained infertility
547357|NCT01232062|breast neoplasm|breast neoplasm
547358|NCT01232062|Neoplasm Metastasis|neoplasm metastasis
547359|NCT01232062|Drug Therapy|drug therapy
547360|NCT01232049|healthy volunteers|healthy volunteers
547361|NCT01232036|healthy volunteers|healthy volunteers
547362|NCT01232023|Indobufen|indobufen
547363|NCT01232023|healthy volunteers|healthy volunteers
547364|NCT01232010|SK-3530|sk-3530
547365|NCT01232010|renal impairment|renal impairment
547366|NCT01232010|healthy volunteers|healthy volunteers
547367|NCT01231997|Udenafil|udenafil
547368|NCT01231997|DA-8159|da-8159
547369|NCT01231997|renal impairment|renal impairment
547370|NCT01231997|healthy volunteers|healthy volunteers
547371|NCT01231984|diabetes|diabetes
547372|NCT01231984|obesity|obesity
547373|NCT01231984|hypoglycemia|hypoglycemia
547374|NCT01231984|hyperglycemia|hyperglycemia
547375|NCT01231984|pen needle|pen needle
547376|NCT01231971|amyloid|amyloid
547377|NCT01231971|plaques|plaques
547378|NCT01231971|neuroimaging|neuroimaging
547379|NCT01231971|biomarkers|biomarkers
547380|NCT01231971|cognition disorder|cognition disorder
547381|NCT01231971|early detection|early detection
547382|NCT01231971|Amnestic MCI|amnestic mci
547383|NCT01231971|pre-dementia|pre-dementia
547384|NCT01231971|dementia|dementia
547385|NCT01231971|Alzheimer's disease|alzheimer's disease
547386|NCT01231971|tau|tau
547387|NCT01231958|Puerto Rican; CVD; Hispanic; health disparities; allostatic load; diet|puerto rican; cvd; hispanic; health disparities; allostatic load; diet
547388|NCT01231945|Cervical Cancer|cervical cancer
547389|NCT01231945|Human Papilloma Virus (HPV)|human papilloma virus (hpv)
547390|NCT01231945|Cervical Intraepithelial Neoplasia (CIN)|cervical intraepithelial neoplasia (cin)
547391|NCT01231932|Fatigue|fatigue
547392|NCT01231932|Cytokines|cytokines
547393|NCT01231932|Cancer Therapy|cancer therapy
547394|NCT01231932|Cancer Treatment|cancer treatment
547395|NCT01231932|Gene Expression Patterns|gene expression patterns
547396|NCT01231932|Cancer|cancer
547397|NCT01231893|human, spinal cord injury, olfactory ensheathing cells, transplantation|human, spinal cord injury, olfactory ensheathing cells, transplantation
547398|NCT01231880|Malaria|malaria
547399|NCT01231867|Coronary Heart Disease|coronary heart disease
547400|NCT01231867|Acute Coronary Syndrome|acute coronary syndrome
547401|NCT01231867|Drug interactions|drug interactions
547402|NCT01231867|Clopidogrel|clopidogrel
547403|NCT01231867|Proton Pump Inhibitors|proton pump inhibitors
547404|NCT01231867|Gastrointestinal Hemorrhage|gastrointestinal hemorrhage
547405|NCT01231854|atopic hand dermatitis|atopic hand dermatitis
547406|NCT01231854|Chronic hand dermatitis|chronic hand dermatitis
547407|NCT01231828|sleep|sleep
547408|NCT01231828|cirrhosis|cirrhosis
547409|NCT01231828|encephalopathy|encephalopathy
547410|NCT01231828|simulated driving|simulated driving
547411|NCT01231828|sleep disorders|sleep disorders
547412|NCT01231815|Heart transplantation|heart transplantation
547413|NCT01231789|cardiac surgery|cardiac surgery
547414|NCT01231789|RIPC|ripc
547415|NCT01231789|brain injury|brain injury
547416|NCT01231776|cardiopulmonary bypass|cardiopulmonary bypass
547417|NCT01231776|sleep|sleep
547418|NCT01231776|acupuncture|acupuncture
547419|NCT01231763|HIV prevention|hiv prevention
547420|NCT01231763|Vaginal film|vaginal film
547421|NCT01231763|Microbicide|microbicide
547422|NCT01231763|Administration, intravaginal|administration, intravaginal
547423|NCT01231737|Prophylasy|prophylasy
547424|NCT01231737|recurrent urinary tract infection|recurrent urinary tract infection
547425|NCT01231737|prulifloxacin|prulifloxacin
547426|NCT01231737|phosphomycin|phosphomycin
547427|NCT01231711|depression|depression
547428|NCT01231711|post traumatic stress syndrome|post traumatic stress syndrome
547429|NCT01231711|functional status|functional status
547430|NCT01231711|veteran|veteran
547431|NCT01231711|military|military
547432|NCT01231711|stigma|stigma
547433|NCT01231711|mental health self-efficacy|mental health self-efficacy
547434|NCT01231698|septic shock|septic shock
547435|NCT01231698|esmolol|esmolol
547436|NCT01231698|tachycardia|tachycardia
547437|NCT01231698|betablockers|betablockers
547438|NCT01231685|Liver fibrosis|liver fibrosis
547439|NCT01231685|HIV|hiv
547440|NCT01231685|Hepatitis C Virus|hepatitis c virus
547441|NCT01231685|Coinfection|coinfection
547442|NCT01231659|RAD001 (Everolimus)|rad001 (everolimus)
547443|NCT01231659|Letrozole|letrozole
547444|NCT01231659|Breast cancer|breast cancer
547445|NCT01231659|Metastatic Breast cancer|metastatic breast cancer
547446|NCT01231659|Estrogen receptor positive|estrogen receptor positive
547447|NCT01231659|Failure of Tamoxifen|failure of tamoxifen
547448|NCT01231659|Anastrozole or Examestane|anastrozole or examestane
547449|NCT01231646|Folate Receptor Autoantibodies|folate receptor autoantibodies
547450|NCT01231646|Epilepsy|epilepsy
547451|NCT01231646|Psychiatric conditions|psychiatric conditions
547452|NCT01231633|Macular Edema|macular edema
548040|NCT01228929|Environment|environment
547453|NCT01231633|Central Retinal Vein Occlusion|central retinal vein occlusion
547454|NCT01231620|Seasonal Influenza|seasonal influenza
547455|NCT01231620|Pandemic|pandemic
547456|NCT01231620|Orthomyxoviridae Infections|orthomyxoviridae infections
547457|NCT01231620|Influenza|influenza
547458|NCT01231620|Influenza A Virus, H1N1 Subtype|influenza a virus, h1n1 subtype
547459|NCT01231620|Enzyme Inhibitors|enzyme inhibitors
547460|NCT01231620|Influenza, seasonal|influenza, seasonal
547461|NCT01231620|Respiratory Tract Diseases|respiratory tract diseases
547462|NCT01231620|Zanamivir|zanamivir
547463|NCT01231620|Pharmacologic Actions|pharmacologic actions
547464|NCT01231620|Antiviral Agents|antiviral agents
547465|NCT01231620|Anti-Infective Agents|anti-infective agents
547466|NCT01231620|H1N1|h1n1
547467|NCT01231620|Neuraminidase inhibitor|neuraminidase inhibitor
547468|NCT01231620|Influenza B virus|influenza b virus
547469|NCT01231594|BRAF Inhibitor|braf inhibitor
547470|NCT01231594|Cancer|cancer
547471|NCT01231594|Safety|safety
547472|NCT01231594|GSK2118436|gsk2118436
547473|NCT01231594|BRAF mutation positive tumors|braf mutation positive tumors
547474|NCT01231568|food effect; high fat meal|food effect; high fat meal
547475|NCT01231568|GSK2118436|gsk2118436
547476|NCT01231568|pharmacokinetic|pharmacokinetic
547477|NCT01231568|particle size|particle size
547478|NCT01231568|BRAF inhibitor|braf inhibitor
547479|NCT01231568|BRAF positive tumor|braf positive tumor
547480|NCT01231555|antiretroviral|antiretroviral
547481|NCT01231555|HAART|haart
547482|NCT01231555|NNRTI|nnrti
547483|NCT01231555|emtricitabine|emtricitabine
547484|NCT01231555|Sexually Transmitted Disease|sexually transmitted disease
711347|NCT00585182|Anticoagulants|anticoagulants
547485|NCT01231555|antiretroviral therapy (ART)-naive adults|antiretroviral therapy (art)-naive adults
547486|NCT01231555|Immunologic Deficiency Syndrome|immunologic deficiency syndrome
547487|NCT01231555|tenofovir|tenofovir
547488|NCT01231555|abacavir|abacavir
547489|NCT01231555|Retroviridae Infections|retroviridae infections
547490|NCT01231555|GSK2248761|gsk2248761
547491|NCT01231555|lamivudine|lamivudine
547492|NCT01231555|Acquired ImmunoDeficiency Syndrome (AIDS)|acquired immunodeficiency syndrome (aids)
547493|NCT01231555|HIV infection|hiv infection
547494|NCT01231555|efavirenz|efavirenz
547495|NCT01231542|GSK1349572|gsk1349572
547496|NCT01231542|pharmacokinetics|pharmacokinetics
547497|NCT01231542|dolutegravir|dolutegravir
547498|NCT01231542|integrase|integrase
547499|NCT01231542|rifabutin|rifabutin
547500|NCT01231542|rifampin|rifampin
547501|NCT01231516|ART-experienced|art-experienced
547502|NCT01231516|Integrase inhibitor|integrase inhibitor
547503|NCT01231516|Raltegravir|raltegravir
547504|NCT01231516|GSK1349572|gsk1349572
547505|NCT01231516|Integrase inhibitor naive|integrase inhibitor naive
547506|NCT01231503|Africa|africa
547507|NCT01231503|malaria vaccine|malaria vaccine
547508|NCT01231503|schedule|schedule
547509|NCT01231503|EPI|epi
547510|NCT01231503|Plasmodium falciparum|plasmodium falciparum
547511|NCT01231477|anaesthetic techniques, inhalation|anaesthetic techniques, inhalation
547512|NCT01231477|sevoflurane|sevoflurane
547513|NCT01231477|Cytokines|cytokines
547514|NCT01231477|Immune response|immune response
547515|NCT01231464|safety|safety
547516|NCT01231464|efficacy|efficacy
547517|NCT01231464|placebo|placebo
547518|NCT01231464|allergic rhinitis|allergic rhinitis
547519|NCT01231464|fluticasone furoate|fluticasone furoate
547520|NCT01231451|HIV Infection|hiv infection
547521|NCT01231438|Renal failure stage 3B|renal failure stage 3b
547522|NCT01231425|Back pain|back pain
547523|NCT01231425|cervicalgia|cervicalgia
547524|NCT01231425|dorsalgia|dorsalgia
547525|NCT01231425|lumbalgia|lumbalgia
547526|NCT01231425|acupuncture|acupuncture
547527|NCT01231386|Female Breast Cancer|female breast cancer
547528|NCT01231386|miRNA expression|mirna expression
547529|NCT01231386|Neoadjuvant/Adjuvant Treatment|neoadjuvant/adjuvant treatment
547530|NCT01231386|Locally and Inflammatory Breast Cancer|locally and inflammatory breast cancer
547531|NCT01231373|varicose veins|varicose veins
547532|NCT01231360|claudication|claudication
547533|NCT01231360|peripheral artery disease|peripheral artery disease
547534|NCT01231360|PAD|pad
547535|NCT01231347|pancreas|pancreas
547536|NCT01231347|gemcitabine|gemcitabine
547537|NCT01231347|metastatic|metastatic
547538|NCT01231347|jaundice|jaundice
547539|NCT01231321|Adalimumab added to inadequate standard anti-rheumatic therapy in patients with active Rheumatoid Arthritis|adalimumab added to inadequate standard anti-rheumatic therapy in patients with active rheumatoid arthritis
547540|NCT01231256|Quality of life|quality of life
547541|NCT01231256|preventive health consultation|preventive health consultation
547542|NCT01231256|General practice|general practice
547543|NCT01231256|resources|resources
547544|NCT01231256|life style|life style
547545|NCT01231243|tooth bleaching, bleaching agent, hydrogen peroxide|tooth bleaching, bleaching agent, hydrogen peroxide
547546|NCT01231230|asthma, corticosteroids, bronchodilator, airway blood flow|asthma, corticosteroids, bronchodilator, airway blood flow
547547|NCT01231204|Breast Cancer|breast cancer
547548|NCT01231204|Mastectomy|mastectomy
547549|NCT01231204|UCSD|ucsd
547550|NCT01231204|Surgery|surgery
547551|NCT01231204|PVB Catheter|pvb catheter
547552|NCT01231204|Paravertebral Catheter|paravertebral catheter
547553|NCT01231204|Breast Pain|breast pain
547554|NCT01231204|Mastectomy Pain|mastectomy pain
547555|NCT01231204|Postoperative Pain|postoperative pain
547556|NCT01231139|Brain Injury|brain injury
547557|NCT01231139|Temperature|temperature
547558|NCT01231139|Paracetamol|paracetamol
547559|NCT01231139|Phase 2|phase 2
547560|NCT01231139|TBI|tbi
547561|NCT01231126|Induced labor|induced labor
547562|NCT01231126|Misoprostol|misoprostol
547563|NCT01231126|Postpartum blood|postpartum blood
547564|NCT01231126|Erythrocyte indices|erythrocyte indices
547565|NCT01231126|Vaginal delivery|vaginal delivery
547566|NCT01231113|malaria,|malaria,
547567|NCT01231113|pregnancy,|pregnancy,
547568|NCT01231113|dihydroartemisinin-piperaquine,|dihydroartemisinin-piperaquine,
547569|NCT01231113|efficacy,|efficacy,
547570|NCT01231113|safety,|safety,
547571|NCT01231113|Ghana|ghana
547572|NCT01231087|energy expenditure|energy expenditure
547573|NCT01231087|morbid obesity|morbid obesity
547574|NCT01231087|bariatric surgery|bariatric surgery
547575|NCT01231087|nutritional follow-up|nutritional follow-up
547576|NCT01231074|obesity|obesity
547577|NCT01231074|weight gain|weight gain
547578|NCT01231074|metformin|metformin
547579|NCT01231074|psychotropic drugs|psychotropic drugs
547580|NCT01231061|spine metastasis|spine metastasis
547581|NCT01231061|SBRT|sbrt
547582|NCT01231061|Radiosurgery|radiosurgery
547583|NCT01231035|acute cardiac syndrome|acute cardiac syndrome
547584|NCT01231035|stent thrombosis|stent thrombosis
547585|NCT01231035|platelet function|platelet function
547586|NCT01231035|antiplatelet therapy|antiplatelet therapy
547587|NCT01231022|breast neoplasm|breast neoplasm
547588|NCT01231022|Neoplasm Metastasis|neoplasm metastasis
547589|NCT01231022|Stem Cells|stem cells
547590|NCT01231022|Drug-Induced Liver Injury|drug-induced liver injury
547591|NCT01230996|cervical adenocarcinoma|cervical adenocarcinoma
547592|NCT01230996|cervical adenosquamous cell carcinoma|cervical adenosquamous cell carcinoma
547593|NCT01230996|cervical squamous cell carcinoma|cervical squamous cell carcinoma
547594|NCT01230996|stage IB cervical cancer|stage ib cervical cancer
547595|NCT01230996|stage IIA cervical cancer|stage iia cervical cancer
547596|NCT01230996|stage IIB cervical cancer|stage iib cervical cancer
547597|NCT01230996|stage III cervical cancer|stage iii cervical cancer
547598|NCT01230996|stage IVA cervical cancer|stage iva cervical cancer
547599|NCT01230983|stage III childhood lymphoblastic lymphoma|stage iii childhood lymphoblastic lymphoma
547600|NCT01230983|stage IV childhood lymphoblastic lymphoma|stage iv childhood lymphoblastic lymphoma
547601|NCT01230983|untreated childhood acute lymphoblastic leukemia|untreated childhood acute lymphoblastic leukemia
547602|NCT01230983|T-cell childhood acute lymphoblastic leukemia|t-cell childhood acute lymphoblastic leukemia
547603|NCT01230983|cardiac toxicity|cardiac toxicity
547604|NCT01230957|Clostridium difficile infection|clostridium difficile infection
547605|NCT01230957|Diarrhea|diarrhea
547606|NCT01230957|Pseudomembranous colitis|pseudomembranous colitis
547607|NCT01230957|Clostridium Difficile Toxoid Vaccine|clostridium difficile toxoid vaccine
547608|NCT01230957|ACAM-CDIFF™ vaccine|acam-cdiff™ vaccine
547609|NCT01230944|GERD|gerd
547610|NCT01230944|LNF|lnf
547611|NCT01230944|CNF|cnf
547612|NCT01230944|Laparoscopic Nissen fundoplication|laparoscopic nissen fundoplication
547613|NCT01230944|Open Nissen fundoplication|open nissen fundoplication
547614|NCT01230944|Antireflux surgery|antireflux surgery
547615|NCT01230931|Acetabulum|acetabulum
547616|NCT01230931|Fracture|fracture
547617|NCT01230931|Hemostatis|hemostatis
547618|NCT01230931|Vitagel|vitagel
547619|NCT01230931|Fibrin sealant|fibrin sealant
547620|NCT01230918|Hypertrophic Cardiomyopathy|hypertrophic cardiomyopathy
547621|NCT01230918|Acute Coronary Syndrome|acute coronary syndrome
547622|NCT01230918|Myocardial Fibrosis|myocardial fibrosis
547623|NCT01230918|Fibrogenesis|fibrogenesis
547624|NCT01230918|Intimal Hyperplasia|intimal hyperplasia
547625|NCT01230918|Sudden Death|sudden death
547626|NCT01230918|avB3 Integrin Expression|avb3 integrin expression
547627|NCT01230905|Androgen Suppression Therapy|androgen suppression therapy
547628|NCT01230905|Hormonal Toxicity|hormonal toxicity
547629|NCT01230905|Quantitative PET|quantitative pet
547630|NCT01230905|Myocardial blood flow|myocardial blood flow
547631|NCT01230905|Coronary blood flow reserve|coronary blood flow reserve
547632|NCT01230905|Endothelial dysfunction|endothelial dysfunction
547633|NCT01230905|Coronary Artery Disease|coronary artery disease
547634|NCT01230879|Aging lung|aging lung
547635|NCT01230879|Airway remodeling|airway remodeling
547636|NCT01230879|Airway segmentation|airway segmentation
547637|NCT01230879|Chest CT|chest ct
547638|NCT01230866|Proton Radiation Prostate Cancer|proton radiation prostate cancer
547639|NCT01230840|fiber|fiber
547640|NCT01230840|calcium|calcium
547641|NCT01230840|magnesium|magnesium
547642|NCT01230827|Juvenile Idiopathic Arthritis|juvenile idiopathic arthritis
547643|NCT01230827|golimumab|golimumab
547644|NCT01230827|juvenile arthritis|juvenile arthritis
547645|NCT01230827|GO KIDS|go kids
547646|NCT01230827|anti TNF alpha medications|anti tnf alpha medications
547647|NCT01230827|juvenile psoriatic arthritis|juvenile psoriatic arthritis
547648|NCT01230814|Bacterial vaginosis, metronidazole, miconazole, vulvovaginal candidiasis, trichomonas vaginalis, women, Kenya|bacterial vaginosis, metronidazole, miconazole, vulvovaginal candidiasis, trichomonas vaginalis, women, kenya
547649|NCT01230788|ALL|all
547650|NCT01230788|Leukemia|leukemia
547651|NCT01230788|Rituximab|rituximab
547652|NCT01230788|Pediatrics|pediatrics
547653|NCT01230762|Dapoxetine, Orgasmic disorder|dapoxetine, orgasmic disorder
547654|NCT01230762|Premature ejaculation|premature ejaculation
547655|NCT01230762|Sexual dysfunction|sexual dysfunction
547656|NCT01230762|Sexual intercourse|sexual intercourse
547657|NCT01230762|Ejaculation|ejaculation
547658|NCT01230762|Erectile Dysfunction|erectile dysfunction
547659|NCT01230749|Diabetes Mellitus, Type 2|diabetes mellitus, type 2
547660|NCT01230749|Diabetes Mellitus|diabetes mellitus
547661|NCT01230749|Hyperglycemia|hyperglycemia
547662|NCT01230749|JNJ-41443532|jnj-41443532
547663|NCT01230749|Pioglitazone|pioglitazone
547664|NCT01230749|Placebo|placebo
547665|NCT01230697|Advanced|advanced
547666|NCT01230697|hepatocarcinoma|hepatocarcinoma
547667|NCT01230684|CEUS|ceus
547668|NCT01230684|Endoleaks|endoleaks
547669|NCT01230684|Abdominal Aortic Aneurysm|abdominal aortic aneurysm
547670|NCT01230658|prophylactic enoxaparin|prophylactic enoxaparin
547671|NCT01230658|Roux en Y gastric bypass surgery|roux en y gastric bypass surgery
547672|NCT01230632|assisted reproduction technology|assisted reproduction technology
547673|NCT01230632|Metabolic risk factors|metabolic risk factors
547674|NCT01230632|In Vitro Fertilisation|in vitro fertilisation
547675|NCT01230606|Percutaneous Intervention|percutaneous intervention
547676|NCT01230606|Percutaneous Coronary Intervention|percutaneous coronary intervention
547677|NCT01230606|Catheterization|catheterization
547678|NCT01230606|Coronary Catheterization|coronary catheterization
547679|NCT01230606|Same day Discharge|same day discharge
547680|NCT01230606|Next Day Discharge|next day discharge
547681|NCT01230606|Patient Satisfaction|patient satisfaction
547682|NCT01230606|Multi-Center|multi-center
547683|NCT01230606|Randomized|randomized
547684|NCT01230606|Low-risk PCI|low-risk pci
547685|NCT01230606|BlindedClosure device|blindedclosure device
547686|NCT01230606|Vascular closure device|vascular closure device
547687|NCT01230580|Protease Inhibitors|protease inhibitors
547688|NCT01230580|RNA virus infections|rna virus infections
547689|NCT01230580|Virus diseases|virus diseases
547690|NCT01230580|Sexually Transmitted Diseases viral|sexually transmitted diseases viral
547691|NCT01230580|Immune system diseases|immune system diseases
547692|NCT01230580|Anti-infective Agents|anti-infective agents
547693|NCT01230580|Drug resistance|drug resistance
547694|NCT01230567|Problem wounds|problem wounds
547695|NCT01230567|Non healing wounds|non healing wounds
547697|NCT01230567|SCC|scc
547698|NCT01230567|Vasculitis|vasculitis
547699|NCT01230554|contact lens|contact lens
547700|NCT01230541|Semen characteristics|semen characteristics
547701|NCT01230541|Erectile Dysfunction|erectile dysfunction
547702|NCT01230515|Oncology Pain Management in outpatient hospice setting|oncology pain management in outpatient hospice setting
547703|NCT01230502|immunosuppression|immunosuppression
547704|NCT01230502|anti-rejection|anti-rejection
547705|NCT01230502|immune tolerance|immune tolerance
547706|NCT01230476|Locally advanced nasopharyngeal carcinoma|locally advanced nasopharyngeal carcinoma
547707|NCT01230476|Neoadjuvant chemotherapy|neoadjuvant chemotherapy
547708|NCT01230476|Chemoradiation|chemoradiation
547709|NCT01230476|Cetuximab|cetuximab
547710|NCT01230463|Pain, Postoperative|pain, postoperative
547711|NCT01230463|Ketorolac|ketorolac
547712|NCT01230463|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal
547713|NCT01230463|Intraoperative Care|intraoperative care
547714|NCT01230450|urodynamic urinary incontinence, sub-urethral tape|urodynamic urinary incontinence, sub-urethral tape
547715|NCT01230437|montelukast|montelukast
547716|NCT01230437|asthma|asthma
547717|NCT01230437|allergic rhinitis|allergic rhinitis
547718|NCT01230437|nasal epithelial cells|nasal epithelial cells
547719|NCT01230437|inflammatory mediators|inflammatory mediators
547720|NCT01230424|OA|oa
547721|NCT01230424|Knee arthritis|knee arthritis
547722|NCT01230424|MRI|mri
547723|NCT01230424|Steroid|steroid
547724|NCT01230411|Episodic migraine|episodic migraine
547725|NCT01230385|lersivirine|lersivirine
547726|NCT01230385|UK-453|uk-453
547727|NCT01230385|061|061
547728|NCT01230385|safety|safety
547729|NCT01230385|tolerability|tolerability
547730|NCT01230385|pharmacokinetics|pharmacokinetics
547731|NCT01230385|HIV|hiv
547732|NCT01230385|non-nucleoside reverse transcriptase inhibitor|non-nucleoside reverse transcriptase inhibitor
547733|NCT01230385|NNRTI|nnrti
547734|NCT01230359|Autism|autism
547735|NCT01230359|Children|children
547736|NCT01230359|ASD|asd
547737|NCT01230359|Vitamin B6|vitamin b6
547738|NCT01230359|Magnesium|magnesium
547739|NCT01230320|Cost estimates|cost estimates
547740|NCT01230320|Complete Denture|complete denture
547741|NCT01230320|Dental Economics|dental economics
547742|NCT01230320|Dental Impression Technique|dental impression technique
547743|NCT01230320|Denture Retention|denture retention
547744|NCT01230320|Edentulous|edentulous
547745|NCT01230320|Edentulism|edentulism
547746|NCT01230320|Oral Health-Related Quality of Life|oral health-related quality of life
547747|NCT01230320|Patient Acceptance of Health Care|patient acceptance of health care
547748|NCT01230320|Patient Satisfaction|patient satisfaction
547749|NCT01230320|Quality of Health Care|quality of health care
547750|NCT01230320|Quality of Life|quality of life
547751|NCT01230307|Vitamin D|vitamin d
547752|NCT01230307|Systolic failure|systolic failure
547753|NCT01230307|Genomics|genomics
547754|NCT01230307|Biomarkers|biomarkers
547755|NCT01230307|Exercise|exercise
547756|NCT01230307|Quality of Life|quality of life
547757|NCT01230294|echocardiography of the right heart|echocardiography of the right heart
547758|NCT01230294|3D 4D echocardiography|3d 4d echocardiography
547759|NCT01230294|strain measurement|strain measurement
547760|NCT01230294|chronic heart failure|chronic heart failure
547761|NCT01230294|pulmonary hypertension|pulmonary hypertension
547763|NCT01230281|Oxidative stress|oxidative stress
547764|NCT01230281|Antioxidant|antioxidant
547765|NCT01230281|Black bean|black bean
547766|NCT01230268|C3G|c3g
547767|NCT01230268|Oxidative stress|oxidative stress
547768|NCT01230268|Antioxidant|antioxidant
547769|NCT01230268|Mulberry|mulberry
547770|NCT01230255|intra-abdominal pressure|intra-abdominal pressure
547771|NCT01230255|intra-abdominal hypertension|intra-abdominal hypertension
547772|NCT01230255|abdominal compartment syndrome|abdominal compartment syndrome
547773|NCT01230255|open abdomen|open abdomen
547774|NCT01230255|percutaneous|percutaneous
547775|NCT01230242|Mirena|mirena
547776|NCT01230242|postplacental intrauterine device|postplacental intrauterine device
547777|NCT01230242|postpartum insertion|postpartum insertion
547778|NCT01230229|Intermittent claudication|intermittent claudication
547779|NCT01230229|Superficial femoral artery|superficial femoral artery
547780|NCT01230229|Stenting|stenting
547781|NCT01230229|Medical treatment|medical treatment
547782|NCT01230229|Quality of life|quality of life
547783|NCT01230216|coronary artery disease|coronary artery disease
547784|NCT01230216|hypertension|hypertension
547785|NCT01230190|infants|infants
547786|NCT01230190|adaptive immunology|adaptive immunology
547787|NCT01230190|atopic dermatitis|atopic dermatitis
547788|NCT01230190|probiotics|probiotics
547789|NCT01230151|Deep Brain Stimulation|deep brain stimulation
547790|NCT01230151|DBS|dbs
547791|NCT01230151|Parkinson's disease|parkinson's disease
547792|NCT01230151|PD|pd
547793|NCT01230151|Patients who have a preexisting Deep Brain Stimulation (DBS) system for the treatment of Parkinson's disease (PD)|patients who have a preexisting deep brain stimulation (dbs) system for the treatment of parkinson's disease (pd)
547794|NCT01230125|Inflammation|inflammation
547795|NCT01230125|Pain|pain
547796|NCT01230125|Ocular surgery|ocular surgery
547797|NCT01230099|Critical Illness|critical illness
547798|NCT01230099|Mechanical Ventilation|mechanical ventilation
547799|NCT01230099|Palliative Care|palliative care
547800|NCT01230099|Caregivers|caregivers
547801|NCT01230086|ICD|icd
547802|NCT01230086|DFT-testing|dft-testing
547803|NCT01230073|ICD|icd
547804|NCT01230073|Home-Monitoring|home-monitoring
547805|NCT01230073|Quality of life|quality of life
547806|NCT01230060|ocular surgery|ocular surgery
547807|NCT01230060|phacoemulsification|phacoemulsification
547808|NCT01230047|depression|depression
547809|NCT01230047|anxiety|anxiety
547810|NCT01230047|psychoeducation|psychoeducation
547811|NCT01230047|self-help|self-help
547812|NCT01230047|psychosocial|psychosocial
547813|NCT01230034|Imidapril, Ramipril, Hypertension, Type 2 diabetes mellitus, Microalbuminuria|imidapril, ramipril, hypertension, type 2 diabetes mellitus, microalbuminuria
547814|NCT01230008|primary mediastinal lymphoma|primary mediastinal lymphoma
547815|NCT01230008|radiotherapy|radiotherapy
547816|NCT01230008|chemotherapy|chemotherapy
547817|NCT01230008|rituximab|rituximab
547818|NCT01229969|falls, balance problems, gaming systems, balance assessments|falls, balance problems, gaming systems, balance assessments
547819|NCT01229956|childhood acute myeloid leukemia in remission|childhood acute myeloid leukemia in remission
547820|NCT01229956|recurrent childhood acute myeloid leukemia|recurrent childhood acute myeloid leukemia
547821|NCT01229956|untreated childhood acute myeloid leukemia and other myeloid malignancies|untreated childhood acute myeloid leukemia and other myeloid malignancies
547822|NCT01229930|cervical adenocarcinoma|cervical adenocarcinoma
547823|NCT01229930|cervical adenosquamous cell carcinoma|cervical adenosquamous cell carcinoma
547824|NCT01229930|cervical squamous cell carcinoma|cervical squamous cell carcinoma
547825|NCT01229930|recurrent cervical cancer|recurrent cervical cancer
547826|NCT01229930|stage IVB cervical cancer|stage ivb cervical cancer
547827|NCT01229930|stage IVA cervical cancer|stage iva cervical cancer
547828|NCT01229891|vitamin D fortification|vitamin d fortification
547829|NCT01229891|yogurt drink|yogurt drink
547830|NCT01229891|type 2 diabetes|type 2 diabetes
547831|NCT01229891|efficacy|efficacy
547832|NCT01229852|Fibromyalgia|fibromyalgia
547833|NCT01229852|Transcranial Magnetic Stimulation|transcranial magnetic stimulation
547834|NCT01229852|Pain|pain
547835|NCT01229839|Carcinoma,Hepatocellular|carcinoma,hepatocellular
547836|NCT01229839|Liver Neoplasms|liver neoplasms
547837|NCT01229839|Therapeutic|therapeutic
547838|NCT01229839|Chemoembolization,|chemoembolization,
547839|NCT01229839|TACE|tace
547840|NCT01229839|pharmacokinetics|pharmacokinetics
547841|NCT01229839|Iodized Oil/administration & dosage|iodized oil/administration & dosage
547842|NCT01229839|polyvinyl alcohol|polyvinyl alcohol
547843|NCT01229839|Humans|humans
547844|NCT01229826|Uterine fibroids|uterine fibroids
547845|NCT01229826|Uterine leiomyomas|uterine leiomyomas
547846|NCT01229826|MR Elastography|mr elastography
547847|NCT01229826|MRI (Magnetic Resonance Imaging)|mri (magnetic resonance imaging)
547848|NCT01229826|Symptomatic Uterine Fibroids|symptomatic uterine fibroids
547849|NCT01229813|Untreated|untreated
547850|NCT01229813|First line|first line
547851|NCT01229813|Chemotherapy|chemotherapy
547852|NCT01229813|Maintenance treatment|maintenance treatment
547853|NCT01229813|KRAS wt|kras wt
547854|NCT01229813|KRAS mutated|kras mutated
547855|NCT01229813|Anti-angiogenetic treatment|anti-angiogenetic treatment
547856|NCT01229813|Metronomic capecitabine|metronomic capecitabine
547857|NCT01229813|bevacizumab|bevacizumab
547858|NCT01229813|erlotinib|erlotinib
547859|NCT01229813|Translational research|translational research
547860|NCT01229800|Polyethylene Glycol, Sodium Phosphate, Bowel preparation, Efficacy|polyethylene glycol, sodium phosphate, bowel preparation, efficacy
547861|NCT01229787|asthma|asthma
547862|NCT01229787|allergies|allergies
547863|NCT01229787|obesity|obesity
547864|NCT01229761|HIV|hiv
695975|NCT00648908|MS|ms
547865|NCT01229761|Trimethoprim-Sulfamethoxazole Combination|trimethoprim-sulfamethoxazole combination
547866|NCT01229761|Breast Feeding|breast feeding
547867|NCT01229761|Infant Mortality|infant mortality
547868|NCT01229761|Morbidity|morbidity
547869|NCT01229761|Botswana|botswana
547870|NCT01229761|Africa|africa
547871|NCT01229761|Infectious disease transmission, vertical|infectious disease transmission, vertical
547872|NCT01229761|adverse drug event|adverse drug event
547873|NCT01229735|levetiracetam|levetiracetam
547874|NCT01229735|topiramate|topiramate
547875|NCT01229735|epilepsy|epilepsy
547876|NCT01229735|partial seizures|partial seizures
547877|NCT01229722|adherence|adherence
547878|NCT01229722|reminders|reminders
547879|NCT01229722|text messages|text messages
547880|NCT01229722|SMS|sms
547881|NCT01229722|mHealth|mhealth
547882|NCT01229709|Tinnitus|tinnitus
547883|NCT01229709|Mindfulness|mindfulness
547884|NCT01229709|MBSR|mbsr
547885|NCT01229709|Mindfulness Based Stress Reduction|mindfulness based stress reduction
547886|NCT01229709|MBTR|mbtr
547887|NCT01229696|Popliteal|popliteal
547888|NCT01229696|UCSD|ucsd
547889|NCT01229696|Postoperative pain|postoperative pain
547890|NCT01229696|Foot surgery|foot surgery
547891|NCT01229696|Ankle surgery|ankle surgery
547892|NCT01229696|Popliteal Catheter|popliteal catheter
547893|NCT01229696|Popliteal Nerve Block|popliteal nerve block
547894|NCT01229696|Lower extremity surgery|lower extremity surgery
547895|NCT01229696|Bifurcation|bifurcation
547896|NCT01229696|Catheter Insertion Site|catheter insertion site
547897|NCT01229683|UCSD|ucsd
547898|NCT01229683|Perineural Nerve Block|perineural nerve block
547899|NCT01229683|Shoulder Surgery|shoulder surgery
547900|NCT01229683|Pain|pain
547901|NCT01229683|Grip Strength|grip strength
547902|NCT01229683|Sensation|sensation
547903|NCT01229683|Interscalene Nerve Block|interscalene nerve block
547904|NCT01229670|Heart failure|heart failure
547905|NCT01229670|Hemorheology|hemorheology
547906|NCT01229670|Atherothrombosis|atherothrombosis
547907|NCT01229670|Angiogenesis|angiogenesis
547908|NCT01229657|Reopening of macular hole;|reopening of macular hole;
547909|NCT01229657|Visual acuity;|visual acuity;
547910|NCT01229657|Phacoemulsification cataract surgery;|phacoemulsification cataract surgery;
547911|NCT01229657|Vitrectomy|vitrectomy
547912|NCT01229644|Glioma|glioma
547913|NCT01229644|Brain Cancer|brain cancer
547914|NCT01229644|Recurrent glioma|recurrent glioma
547915|NCT01229644|Low grade glioma|low grade glioma
547916|NCT01229644|PDGFR Inhibitor|pdgfr inhibitor
547917|NCT01229644|Crenolanib (CP-868,596)|crenolanib (cp-868,596)
547918|NCT01229644|Neo-adjuvant Therapy|neo-adjuvant therapy
547919|NCT01229631|Periodontitis|periodontitis
547920|NCT01229631|Dietary supplementation|dietary supplementation
547921|NCT01229618|Prostate Cancer|prostate cancer
547922|NCT01229592|infection|infection
547923|NCT01229592|catheter|catheter
547924|NCT01229592|bacteriaemia|bacteriaemia
547925|NCT01229592|ethanol|ethanol
547926|NCT01229579|poliomyelitis|poliomyelitis
547927|NCT01229579|OPV|opv
547928|NCT01229579|zinc supplement|zinc supplement
547929|NCT01229579|diarrhea|diarrhea
547930|NCT01229579|placebo|placebo
547931|NCT01229579|double blind randomized control trial|double blind randomized control trial
547932|NCT01229579|elemental zinc|elemental zinc
547933|NCT01229579|seroconversion|seroconversion
547934|NCT01229579|bOPV|bopv
547935|NCT01229579|infants|infants
547936|NCT01229579|immunity|immunity
547937|NCT01229527|Colonoscopy|colonoscopy
547938|NCT01229527|Remifentanil|remifentanil
547939|NCT01229527|Sedation|sedation
547940|NCT01229514|Children|children
547941|NCT01229514|before|before
547942|NCT01229514|the age of 2 years|the age of 2 years
547943|NCT01229475|Atrial fibrillation|atrial fibrillation
547944|NCT01229475|recurrence|recurrence
547945|NCT01229475|repeat procedure|repeat procedure
547946|NCT01229475|linear ablation|linear ablation
547947|NCT01229475|stepwise approach|stepwise approach
547948|NCT01229449|Dental pain|dental pain
547949|NCT01229449|Ibuprofen|ibuprofen
547950|NCT01229449|Acetaminophen|acetaminophen
547951|NCT01229449|Nurofen Plus®|nurofen plus®
547952|NCT01229449|Panadeine® Extra|panadeine® extra
547953|NCT01229449|Paracetamol|paracetamol
547954|NCT01229436|Dupuytren's|dupuytren's
547955|NCT01229436|treatment|treatment
547956|NCT01229436|injection|injection
547957|NCT01229436|recovery|recovery
547958|NCT01229436|health care resources|health care resources
547959|NCT01229397|Influenza|influenza
547960|NCT01229397|Virus|virus
547961|NCT01229397|Vaccination|vaccination
547962|NCT01229397|Immunisation|immunisation
547963|NCT01229371|Influenza|influenza
547964|NCT01229371|Virus|virus
547965|NCT01229371|Vaccination|vaccination
547966|NCT01229371|Immunisation|immunisation
547967|NCT01229358|vascular surgery|vascular surgery
547968|NCT01229358|wound infection|wound infection
696117|NCT00647439|AMD|amd
547969|NCT01229358|wound complication|wound complication
547970|NCT01229332|Motor fluctuations levodopa pharmacokinetics carbidopa solution continuous|motor fluctuations levodopa pharmacokinetics carbidopa solution continuous
547971|NCT01229319|actinic keratosis, keratocytic lesion, keratoses, cryotherapy, imiquimod|actinic keratosis, keratocytic lesion, keratoses, cryotherapy, imiquimod
547972|NCT01229293|Mechanical muscle function|mechanical muscle function
547973|NCT01229293|Muscle strength|muscle strength
547974|NCT01229293|Hip replacement|hip replacement
547975|NCT01229293|Osteoarthritis|osteoarthritis
547976|NCT01229293|Hip arthroplasty|hip arthroplasty
547977|NCT01229280|Bioequivalence|bioequivalence
547978|NCT01229280|Darifenacin|darifenacin
547979|NCT01229280|Healthy volunteers|healthy volunteers
547980|NCT01229280|Postprandial|postprandial
547981|NCT01229267|Herpes zoster|herpes zoster
547982|NCT01229267|vaccine|vaccine
547983|NCT01229267|herpes zoster-related complications|herpes zoster-related complications
547984|NCT01229267|immunocompromised|immunocompromised
547985|NCT01229267|autologous hematopoietic cell transplants|autologous hematopoietic cell transplants
547986|NCT01229254|Betrixaban|betrixaban
547987|NCT01229254|MK-4448|mk-4448
547988|NCT01229254|nonvalvular atrial fibrillation|nonvalvular atrial fibrillation
547989|NCT01229241|local anesthetic|local anesthetic
547990|NCT01229241|epidural|epidural
547991|NCT01229241|pharmacokinetics|pharmacokinetics
547992|NCT01229241|plasmatic concentration|plasmatic concentration
547993|NCT01229241|epidural continuous infusion|epidural continuous infusion
547994|NCT01229202|trabeculectomy|trabeculectomy
547995|NCT01229202|glaucoma surgery|glaucoma surgery
547996|NCT01229202|bevacizumab|bevacizumab
547997|NCT01229202|Vascular Endothelial Growth Inhibitor|vascular endothelial growth inhibitor
547998|NCT01229202|glaucoma|glaucoma
547999|NCT01229189|Vitamin D|vitamin d
548000|NCT01229189|Effectiveness|effectiveness
548001|NCT01229189|Pregnant women and their neonates|pregnant women and their neonates
548002|NCT01229163|Motivational Incentive|motivational incentive
548003|NCT01229163|Automation|automation
548004|NCT01229163|Contingency Management|contingency management
548005|NCT01229163|Counseling Adherance|counseling adherance
548006|NCT01229150|Kinase Signal Transduction Pathway|kinase signal transduction pathway
548007|NCT01229150|Tumor Mutational Analysis|tumor mutational analysis
548008|NCT01229150|Tissue Immunohistochemistry|tissue immunohistochemistry
548009|NCT01229150|MIB-1 (Ki-67) Rate|mib-1 (ki-67) rate
548010|NCT01229150|PERK Level|perk level
548011|NCT01229150|Lung Cancer|lung cancer
548012|NCT01229150|Non-Small Cell Lung Cancer|non-small cell lung cancer
548013|NCT01229124|childhood acute myeloid leukemia/other myeloid malignancies|childhood acute myeloid leukemia/other myeloid malignancies
548014|NCT01229085|Psoriasis, mometasone, salicylic acid.|psoriasis, mometasone, salicylic acid.
548015|NCT01229072|Safety|safety
548016|NCT01229072|Non-inferiority|non-inferiority
548017|NCT01229059|FFA|ffa
548018|NCT01229059|insulin resistance|insulin resistance
548019|NCT01229059|mitochondria|mitochondria
548020|NCT01229046|presumed sepsis|presumed sepsis
548021|NCT01229033|Atrial fibrillation|atrial fibrillation
548022|NCT01229033|ablation|ablation
548023|NCT01229033|atrial flutter|atrial flutter
548024|NCT01229020|Emphysema|emphysema
548025|NCT01229020|COPD|copd
548026|NCT01229020|lung sounds|lung sounds
548027|NCT01229020|vibration response imaging|vibration response imaging
548028|NCT01229007|Hemophilia A|hemophilia a
548029|NCT01229007|Children|children
548030|NCT01228994|smoking cessation treatment|smoking cessation treatment
548031|NCT01228994|baclofen|baclofen
548032|NCT01228994|Smoking cessation counselling|smoking cessation counselling
548033|NCT01228968|obesity|obesity
548034|NCT01228942|ovarian cancer|ovarian cancer
548035|NCT01228942|fallopian tube cancer|fallopian tube cancer
548036|NCT01228942|primary peritoneal cancer|primary peritoneal cancer
548037|NCT01228929|Dry Eye|dry eye
548038|NCT01228929|Non-invasive instruments|non-invasive instruments
548041|NCT01228929|Thermal Imaging|thermal imaging
548042|NCT01228916|tobacco|tobacco
548043|NCT01228916|smoking|smoking
548044|NCT01228916|secondhand smoke|secondhand smoke
548163|NCT01228305|oxidative stress|oxidative stress
548045|NCT01228903|uric acid kidney disease endothelial dysfunction|uric acid kidney disease endothelial dysfunction
548046|NCT01228851|Parkinson's Disease|parkinson's disease
548047|NCT01228851|Rehabilitation|rehabilitation
548048|NCT01228851|Balance|balance
548049|NCT01228851|Exercise|exercise
548050|NCT01228851|Parkinson's disease with balance deficits|parkinson's disease with balance deficits
548051|NCT01228851|H&Y 2.5-3|h&y 2.5-3
548052|NCT01228838|postherpetic neuralgia|postherpetic neuralgia
548053|NCT01228838|PHN|phn
548054|NCT01228838|capsaicin|capsaicin
548055|NCT01228838|herpes zoster|herpes zoster
548056|NCT01228838|shingles|shingles
548057|NCT01228838|analgesics|analgesics
548058|NCT01228838|neuropathy|neuropathy
548059|NCT01228825|Cardiac surgery|cardiac surgery
548060|NCT01228825|Cardiopulmonary bypass|cardiopulmonary bypass
548061|NCT01228825|Antibiotic prophylaxis|antibiotic prophylaxis
548062|NCT01228825|Cefuroxime|cefuroxime
548063|NCT01228812|Rheumatoid arthritis, physical activity|rheumatoid arthritis, physical activity
548064|NCT01228799|trabeculectomy,|trabeculectomy,
548065|NCT01228799|canaloplasty,|canaloplasty,
548066|NCT01228799|glaucoma surgery|glaucoma surgery
548067|NCT01228799|non-penetrating surgery|non-penetrating surgery
548068|NCT01228786|VDR, CaSR, PTH, Cyclin D1, Ki67, PCNA|vdr, casr, pth, cyclin d1, ki67, pcna
548069|NCT01228773|Cancer Survivors, Fatigue, web-based, tailored program|cancer survivors, fatigue, web-based, tailored program
548070|NCT01228760|Castration-Resistant Prostate Cancer|castration-resistant prostate cancer
548071|NCT01228760|ASG-5ME|asg-5me
548072|NCT01228760|Pharmacokinetics of ASG-5ME|pharmacokinetics of asg-5me
548073|NCT01228747|Levetiracetam|levetiracetam
548074|NCT01228747|epilepsy|epilepsy
548075|NCT01228747|generalized tonic-clonic|generalized tonic-clonic
548076|NCT01228734|Metastatic colorectal cancer|metastatic colorectal cancer
548077|NCT01228734|RAS wild type|ras wild type
548078|NCT01228734|Cetuximab|cetuximab
548079|NCT01228734|First line treatment|first line treatment
548080|NCT01228734|First occurrence of metastatic colorectal cancer in Chinese subjects with RAS wildtype|first occurrence of metastatic colorectal cancer in chinese subjects with ras wildtype
548081|NCT01228734|status|status
548082|NCT01228708|Implementation strategy|implementation strategy
548083|NCT01228708|Chronic disease management programme|chronic disease management programme
548084|NCT01228708|COPD|copd
548085|NCT01228695|steroids|steroids
548086|NCT01228695|patients treated with systemic steroids|patients treated with systemic steroids
548087|NCT01228682|Sodium|sodium
548088|NCT01228682|SIADH|siadh
548089|NCT01228682|Hyponatremia|hyponatremia
548090|NCT01228682|Vasopressin|vasopressin
548091|NCT01228682|Salt|salt
548092|NCT01228682|Water|water
548093|NCT01228656|Psoriasis|psoriasis
548094|NCT01228643|Pancreatic enzymes.|pancreatic enzymes.
548095|NCT01228643|To evaluate the efficacy of drugs in chronic renal failure|to evaluate the efficacy of drugs in chronic renal failure
548096|NCT01228630|rhinitis, loratadine, coated pill|rhinitis, loratadine, coated pill
548097|NCT01228617|Smoking Cessation|smoking cessation
548098|NCT01228617|Nicotine pharmacokinetics|nicotine pharmacokinetics
548099|NCT01228604|open label|open label
548100|NCT01228604|Ritalin®|ritalin®
548101|NCT01228604|ADHD|adhd
548102|NCT01228578|Multivitamins|multivitamins
548103|NCT01228578|HIV/AIDS|hiv/aids
548104|NCT01228578|Immune reconstitution|immune reconstitution
548105|NCT01228578|Weight Gain|weight gain
548106|NCT01228578|Quality of Life|quality of life
548107|NCT01228565|Head and neck carcinoma treated by radiotherapy plus erbitux|head and neck carcinoma treated by radiotherapy plus erbitux
548108|NCT01228552|Acute Migraine Treatment|acute migraine treatment
548109|NCT01228552|Migraine Treatment|migraine treatment
548110|NCT01228552|Migraine|migraine
548111|NCT01228552|Headache|headache
548112|NCT01228552|Treatment|treatment
548113|NCT01228539|PTSD|ptsd
548114|NCT01228539|Anger|anger
548115|NCT01228539|Aggression|aggression
548116|NCT01228539|Military|military
548117|NCT01228487|Oxidative Dysbalance|oxidative dysbalance
548118|NCT01228487|Oxidative Stress|oxidative stress
548119|NCT01228487|Biomarker|biomarker
548120|NCT01228461|Hodgkin Lymphoma Survivors|hodgkin lymphoma survivors
548121|NCT01228461|Adolescent and Young Adults|adolescent and young adults
548122|NCT01228448|external beam proton radiotherapy|external beam proton radiotherapy
548123|NCT01228448|PET|pet
548124|NCT01228435|NSCLC|nsclc
548125|NCT01228435|IPI-504|ipi-504
548126|NCT01228435|ALK translocation|alk translocation
548127|NCT01228435|Hsp90 inhibitor|hsp90 inhibitor
548128|NCT01228422|Will be studied 24 subjects divided Research and 2 parallel groups|will be studied 24 subjects divided research and 2 parallel groups
548129|NCT01228422|The treatment is a dose of 3MUI of alpha interferon 2nd|the treatment is a dose of 3mui of alpha interferon 2nd
548130|NCT01228422|There will be collection of blood at times: 0, 2, 4, 6, 8, 10, 12, 16, 24, 36, 48, 72 and 96 hours.|there will be collection of blood at times: 0, 2, 4, 6, 8, 10, 12, 16, 24, 36, 48, 72 and 96 hours.
548225|NCT01227954|cognitive/functional effects|cognitive/functional effects
548131|NCT01228422|The volunteers will be hospitalized 24 hours.|the volunteers will be hospitalized 24 hours.
548132|NCT01228422|Will be measured labels the AUC, Tmax, Cmax, neopterin and beta2-microglobulin|will be measured labels the auc, tmax, cmax, neopterin and beta2-microglobulin
548133|NCT01228409|Psoriasis|psoriasis
548134|NCT01228409|phototherapy|phototherapy
548135|NCT01228409|soriatane|soriatane
548136|NCT01228409|acitretin|acitretin
548137|NCT01228409|retinoid-related adverse events|retinoid-related adverse events
548138|NCT01228396|bladder|bladder
548139|NCT01228396|optic neuritis|optic neuritis
548140|NCT01228396|secondary progressive multiple sclerosis|secondary progressive multiple sclerosis
548141|NCT01228396|AIMSPRO|aimspro
548142|NCT01228396|hyperimmune caprine serum|hyperimmune caprine serum
548143|NCT01228396|hyperimmune goat serum|hyperimmune goat serum
548144|NCT01228383|Monoclonal antibody|monoclonal antibody
548145|NCT01228383|Rabies|rabies
548146|NCT01228383|Post-exposure prophylaxis|post-exposure prophylaxis
548147|NCT01228370|sildosin|sildosin
548148|NCT01228370|neurogenic bladder|neurogenic bladder
696326|NCT00646568|IVF|ivf
548149|NCT01228370|voiding dysfunction|voiding dysfunction
548150|NCT01228357|Pharmacogenomics|pharmacogenomics
548151|NCT01228357|Depressed Patients|depressed patients
548152|NCT01228344|Artemether-lumefantrine|artemether-lumefantrine
548153|NCT01228344|demographics|demographics
548154|NCT01228344|malaria|malaria
548155|NCT01228331|childhood acute lymphoblastic leukemia|childhood acute lymphoblastic leukemia
548156|NCT01228331|untreated childhood acute lymphoblastic leukemia|untreated childhood acute lymphoblastic leukemia
548157|NCT01228318|HAART|haart
548158|NCT01228318|Antiresorptive drugs|antiresorptive drugs
548159|NCT01228318|HIV/AIDS|hiv/aids
548160|NCT01228318|Bone loss|bone loss
548161|NCT01228305|ventricular septal defect|ventricular septal defect
548162|NCT01228305|atrioventricular septal defect|atrioventricular septal defect
548164|NCT01228305|cardiopulmonary bypass|cardiopulmonary bypass
548165|NCT01228305|acetaminophen|acetaminophen
548166|NCT01228305|hemolysis|hemolysis
548167|NCT01228305|acute kidney injury|acute kidney injury
548168|NCT01228305|Congenital heart disease undergoing cardiopulmonary bypass|congenital heart disease undergoing cardiopulmonary bypass
548169|NCT01228292|Anticoagulation|anticoagulation
548170|NCT01228292|Intensive Care Medicine|intensive care medicine
548171|NCT01228292|Hemodialysis|hemodialysis
548172|NCT01228292|Critical Ill Patients|critical ill patients
548173|NCT01228279|Peritoneal Dialysis|peritoneal dialysis
548174|NCT01228279|Dialysis Solutions|dialysis solutions
548175|NCT01228279|Artificial Kidney|artificial kidney
548176|NCT01228279|Renal Replacement Therapy|renal replacement therapy
548177|NCT01228279|Renal Dialysis|renal dialysis
548178|NCT01228279|Sympathetic Nervous System|sympathetic nervous system
548179|NCT01228279|Leptin|leptin
548180|NCT01228279|Icodextrin|icodextrin
548181|NCT01228266|Multiple Sclerosis|multiple sclerosis
548182|NCT01228240|Diabetes mellitus, type 2, Metformin, Generic, Efficacy|diabetes mellitus, type 2, metformin, generic, efficacy
548183|NCT01228227|Myonecrosis|myonecrosis
548184|NCT01228227|Percutaneous Angioplasty|percutaneous angioplasty
548185|NCT01228227|Myocardial Infarction|myocardial infarction
548186|NCT01228188|FTMH|ftmh
548187|NCT01228188|PPV|ppv
548188|NCT01228188|inverted ILM repositioning|inverted ilm repositioning
548189|NCT01228149|glaucoma|glaucoma
548190|NCT01228149|trabeculectomy|trabeculectomy
548191|NCT01228149|intraocular pressure|intraocular pressure
548192|NCT01228136|Adenotonsillectomy|adenotonsillectomy
548193|NCT01228136|Tranexamic acid|tranexamic acid
548194|NCT01228136|Blood loss|blood loss
548195|NCT01228136|Postoperative hemorrhage|postoperative hemorrhage
548196|NCT01228084|sulforaphane|sulforaphane
548197|NCT01228084|broccoli sprout extract (BSE)|broccoli sprout extract (bse)
548198|NCT01228084|prostate cancer|prostate cancer
548199|NCT01228084|recurrent prostate cancer|recurrent prostate cancer
548200|NCT01228084|phase II|phase ii
548201|NCT01228071|testosterone deficiency|testosterone deficiency
548202|NCT01228071|hypogonadism|hypogonadism
548203|NCT01228058|Trauma|trauma
548204|NCT01228058|Coagulopathy|coagulopathy
548205|NCT01228058|Coagulopathy in adult trauma patients|coagulopathy in adult trauma patients
548206|NCT01228045|Patients with histologically proved adenocarcinoma of advanced gastric cancer|patients with histologically proved adenocarcinoma of advanced gastric cancer
548207|NCT01228019|Usual practice re-examination|usual practice re-examination
548208|NCT01228006|Reduction of stress and fatigue|reduction of stress and fatigue
548209|NCT01227993|Central Serous Chorioretinopathy|central serous chorioretinopathy
548210|NCT01227993|Finasteride|finasteride
548211|NCT01227993|Proscar|proscar
548212|NCT01227993|Retinal Eye Disease|retinal eye disease
548213|NCT01227980|Addiction|addiction
548214|NCT01227980|Alcohol|alcohol
548215|NCT01227980|Alcohol Treatment|alcohol treatment
548216|NCT01227980|Alcoholics|alcoholics
548217|NCT01227980|Alcohol Dependence|alcohol dependence
548218|NCT01227980|Anxiety Disorder|anxiety disorder
548219|NCT01227980|Alcoholism|alcoholism
548220|NCT01227967|Adaptive Design|adaptive design
548221|NCT01227967|At Risk|at risk
548222|NCT01227967|H1N1|h1n1
548223|NCT01227967|Synergy|synergy
548224|NCT01227967|TCAD|tcad
548318|NCT01227551|Melanoma|melanoma
548226|NCT01227954|tumors metastatic to brain|tumors metastatic to brain
548227|NCT01227954|unspecified adult solid tumor, protocol specific|unspecified adult solid tumor, protocol specific
548228|NCT01227941|advanced solid tumors|advanced solid tumors
548229|NCT01227941|ovarian cancer|ovarian cancer
548230|NCT01227941|pegylated liposomal doxorubicin|pegylated liposomal doxorubicin
548231|NCT01227941|Doxil|doxil
548232|NCT01227941|Caelyx|caelyx
548233|NCT01227928|tyrosine kinase inhibitors|tyrosine kinase inhibitors
548234|NCT01227928|Primary Peritoneal Carcinoma|primary peritoneal carcinoma
548235|NCT01227928|primary peritoneal cancer|primary peritoneal cancer
548236|NCT01227928|ovarian cancer|ovarian cancer
548237|NCT01227928|Fallopian Tube Cancer|fallopian tube cancer
548238|NCT01227928|gynecologic cancer|gynecologic cancer
548239|NCT01227928|anti-angiogenesis|anti-angiogenesis
548240|NCT01227928|pazopanib|pazopanib
548241|NCT01227915|SIGNS AND SYMPTOMS OF ACUTE BACTERIAL CONJUNCTIVITIS|signs and symptoms of acute bacterial conjunctivitis
548242|NCT01227902|Seizures|seizures
548243|NCT01227902|retigabine IR|retigabine ir
548244|NCT01227902|GW582892|gw582892
548245|NCT01227902|Epilepsy|epilepsy
548246|NCT01227902|Open label, flexible dose|open label, flexible dose
548247|NCT01227902|Partial-onset seizures|partial-onset seizures
548248|NCT01227889|Metastatic melanoma|metastatic melanoma
548249|NCT01227889|melanoma|melanoma
548250|NCT01227889|BRAF mutant|braf mutant
548251|NCT01227889|Advanced melanoma|advanced melanoma
548252|NCT01227876|Control of postoperative inflammation in cataract surgery by phacoemulsification|control of postoperative inflammation in cataract surgery by phacoemulsification
548253|NCT01227863|SIGNS AND SYMPTOMS OF ACUTE BACTERIAL CONJUNCTIVITIS|signs and symptoms of acute bacterial conjunctivitis
548254|NCT01227850|Leptin|leptin
548255|NCT01227850|IGF1|igf1
548256|NCT01227850|Refeeding Index|refeeding index
548257|NCT01227850|Hypophosphataemia|hypophosphataemia
548258|NCT01227850|Primary focus of the study was to detemine whether the 'Refeeding Index', could reliably predict,that the refeeding syndrome would occur|primary focus of the study was to detemine whether the 'refeeding index', could reliably predict,that the refeeding syndrome would occur
548259|NCT01227837|omega 3|omega 3
548260|NCT01227837|CRT_AICD|crt_aicd
548261|NCT01227837|congestive heart failure|congestive heart failure
548262|NCT01227837|CHF|chf
548263|NCT01227824|integrase inhibitor|integrase inhibitor
548264|NCT01227824|HIV Infection|hiv infection
548265|NCT01227824|raltegravir|raltegravir
548266|NCT01227824|GSK1349572|gsk1349572
548267|NCT01227811|Darifenacin|darifenacin
548268|NCT01227811|Bioequivalence|bioequivalence
548269|NCT01227811|Healthy volunteers|healthy volunteers
548270|NCT01227811|Postprandial|postprandial
548271|NCT01227798|influenza A, H1N1|influenza a, h1n1
548272|NCT01227772|gastric cancer vaccine|gastric cancer vaccine
548273|NCT01227772|OTSGC-A24|otsgc-a24
548274|NCT01227772|A Phase I/IIa study|a phase i/iia study
548275|NCT01227772|HLA-A24-positive|hla-a24-positive
548276|NCT01227746|Advanced gastro-intestinal stromal tumors|advanced gastro-intestinal stromal tumors
548277|NCT01227720|Smoking Cessation, Nicotine pharmacokinetics|smoking cessation, nicotine pharmacokinetics
548278|NCT01227694|Cell therapy|cell therapy
548279|NCT01227694|Regenerative therapy|regenerative therapy
548280|NCT01227694|Advance therapy|advance therapy
548281|NCT01227694|Bone marrow|bone marrow
548282|NCT01227694|Mesenchymal stem cell|mesenchymal stem cell
548283|NCT01227694|Autologous|autologous
548284|NCT01227694|Interventional clinical trial|interventional clinical trial
548285|NCT01227694|Osteoarthrosis|osteoarthrosis
548286|NCT01227694|Osteoarthritis|osteoarthritis
548287|NCT01227694|Knee|knee
548288|NCT01227655|Parkinson|parkinson
548289|NCT01227655|PD|pd
548290|NCT01227655|Wearing-off|wearing-off
548291|NCT01227655|Levodopa/DDCI|levodopa/ddci
548292|NCT01227642|Prostate Cancer|prostate cancer
548293|NCT01227642|Prostate brachytherapy|prostate brachytherapy
548294|NCT01227642|Ultrasound treatment planning|ultrasound treatment planning
548295|NCT01227616|Iron deficiency anemia (IDA), Feraheme, ferumoxytol, chronic kidney disease (CKD), hemodialysis, magnetic resonance imaging (MRI)|iron deficiency anemia (ida), feraheme, ferumoxytol, chronic kidney disease (ckd), hemodialysis, magnetic resonance imaging (mri)
548296|NCT01227603|Bioequivalence|bioequivalence
548297|NCT01227603|Nifedipine|nifedipine
548298|NCT01227603|Candesartan|candesartan
548299|NCT01227603|FDC|fdc
548300|NCT01227590|Herbal medicine|herbal medicine
548301|NCT01227590|African Potato|african potato
548302|NCT01227590|Hypoxis obtusa|hypoxis obtusa
548303|NCT01227590|Drug interaction|drug interaction
548304|NCT01227590|HIV Infections|hiv infections
548305|NCT01227590|Acquired Immunodeficiency Syndrome|acquired immunodeficiency syndrome
548306|NCT01227590|Healthy Subjects|healthy subjects
548307|NCT01227590|Anti-retroviral Agents|anti-retroviral agents
548308|NCT01227590|Lopinavir|lopinavir
548309|NCT01227590|Ritonavir|ritonavir
548310|NCT01227577|CML|cml
548311|NCT01227577|Chronic Myelogenous Leukemia|chronic myelogenous leukemia
548312|NCT01227577|Leukemia|leukemia
548313|NCT01227577|CML-CP|cml-cp
548314|NCT01227577|Nilotinib|nilotinib
548315|NCT01227564|Early Alzheimer's disease|early alzheimer's disease
548316|NCT01227564|active immunization|active immunization
548317|NCT01227564|amyloid imaging|amyloid imaging
548319|NCT01227551|CALM|calm
548320|NCT01227538|Beta cell reserve, urinary C peptide|beta cell reserve, urinary c peptide
548321|NCT01227512|Hyponatremia|hyponatremia
548322|NCT01227512|Dilutional Hyponatremia|dilutional hyponatremia
548323|NCT01227512|Euvolemic Hyponatremia|euvolemic hyponatremia
548324|NCT01227512|Hypervolemic Hyponatremia|hypervolemic hyponatremia
548325|NCT01227512|Fluid Restriction|fluid restriction
548326|NCT01227512|Tolvaptan|tolvaptan
548327|NCT01227486|Intubation, intratracheal|intubation, intratracheal
548328|NCT01227486|Ultrasonography|ultrasonography
548329|NCT01227486|Auscultation|auscultation
548330|NCT01227486|Capnography|capnography
548331|NCT01227486|Obesity|obesity
548332|NCT01227473|prediabetes|prediabetes
548333|NCT01227473|African Americans|african americans
548334|NCT01227473|mindfulness|mindfulness
696625|NCT00645411|Flu|flu
548335|NCT01227473|behavioral|behavioral
548336|NCT01227473|diabetes|diabetes
548337|NCT01227460|Type 1 diabetes, Sitagliptin|type 1 diabetes, sitagliptin
548338|NCT01227434|Glioblastoma|glioblastoma
548339|NCT01227434|Gliosarcoma|gliosarcoma
548340|NCT01227434|Anaplastic astrocytoma|anaplastic astrocytoma
548341|NCT01227434|Malignant astrocytoma NOS|malignant astrocytoma nos
548342|NCT01227434|Malignant glioma|malignant glioma
548343|NCT01227434|GBM|gbm
548344|NCT01227421|influenza|influenza
548345|NCT01227408|Patients with confirmed breast cancer for neoadjuvant chemotherapy|patients with confirmed breast cancer for neoadjuvant chemotherapy
548346|NCT01227395|HIV|hiv
548347|NCT01227395|Post Marketing Surveillance|post marketing surveillance
548348|NCT01227369|Bisphosphonates|bisphosphonates
548349|NCT01227369|OPSAT-Q|opsat-q
548350|NCT01227356|Chronic myeloid leukemia, imatinib, interferon|chronic myeloid leukemia, imatinib, interferon
548351|NCT01227343|Gender differences|gender differences
548352|NCT01227343|nicotine|nicotine
548353|NCT01227343|cigarette smoking habits|cigarette smoking habits
548354|NCT01227343|behavior changes|behavior changes
548355|NCT01227317|Dyspnea|dyspnea
548356|NCT01227317|Mortality|mortality
548357|NCT01227291|Glaucoma|glaucoma
548358|NCT01227291|IOP|iop
548359|NCT01227291|siRNAs|sirnas
548360|NCT01227291|RNAi|rnai
548361|NCT01227291|beta inhibitor|beta inhibitor
548362|NCT01227278|Benralizumab|benralizumab
548363|NCT01227278|MEDI-563|medi-563
548364|NCT01227278|Pulmonary Disease, Chronic Obstructive|pulmonary disease, chronic obstructive
548365|NCT01227226|Dry eye|dry eye
548366|NCT01227187|Hemodialysis|hemodialysis
548367|NCT01227187|Anticoagulation|anticoagulation
548368|NCT01227187|Xigris|xigris
548369|NCT01227187|PTT|ptt
548370|NCT01227174|propofol only|propofol only
548371|NCT01227174|safety and efficacy|safety and efficacy
548372|NCT01227161|ASA I-II children between the age 0-7|asa i-ii children between the age 0-7
548373|NCT01227161|general anesthesia|general anesthesia
548374|NCT01227148|critical care, glycemic control, insulin, nitrogen balance|critical care, glycemic control, insulin, nitrogen balance
548375|NCT01227135|chronic phase chronic myelogenous leukemia|chronic phase chronic myelogenous leukemia
548376|NCT01227135|chronic myelogenous leukemia, BCR-ABL1 positive|chronic myelogenous leukemia, bcr-abl1 positive
548377|NCT01227122|NGAL plasmatic level|ngal plasmatic level
548378|NCT01227122|Preoperative KIDNEY FAILURE, CHRONIC|preoperative kidney failure, chronic
548379|NCT01227122|Postoperative KIDNEY FAILURE, ACUTE|postoperative kidney failure, acute
548380|NCT01227122|Cardiac Surgery Procedures|cardiac surgery procedures
548381|NCT01227109|Infections|infections
548382|NCT01227109|Cancer|cancer
548383|NCT01227109|Procalcitonin|procalcitonin
548384|NCT01227109|C reactive protein|c reactive protein
548385|NCT01227096|electroacupuncture pediatric cardioprotection|electroacupuncture pediatric cardioprotection
548386|NCT01227083|AQLQ and cAQOL|aqlq and caqol
548387|NCT01227070|Asthma, hospitalization, children, exhaled nitric oxide, lung function, breath condensate, cysteinyl leukotrienes|asthma, hospitalization, children, exhaled nitric oxide, lung function, breath condensate, cysteinyl leukotrienes
548388|NCT01227057|exposure therapy|exposure therapy
548389|NCT01227057|case management|case management
548390|NCT01227057|older adults|older adults
548391|NCT01227057|cognitive rehabilitation|cognitive rehabilitation
548392|NCT01227044|Substance Abuse Counseling|substance abuse counseling
548393|NCT01227044|Adherence (medication)|adherence (medication)
548394|NCT01227044|Alcohol Abuse|alcohol abuse
548395|NCT01227044|Highly Active Antiretroviral Therapy (HAART)|highly active antiretroviral therapy (haart)
548396|NCT01227044|Naltrexone|naltrexone
548397|NCT01227044|Vivitrol|vivitrol
548398|NCT01227044|HIV|hiv
548399|NCT01227031|Genetic susceptibility of androgenetic alopecia|genetic susceptibility of androgenetic alopecia
548400|NCT01227031|Genetic difference in Finasteride response|genetic difference in finasteride response
548401|NCT01227005|Transfusion|transfusion
548402|NCT01227005|Whole Blood|whole blood
548403|NCT01227005|Trauma|trauma
548404|NCT01227005|Coagulopathy|coagulopathy
548405|NCT01227005|Component Therapy|component therapy
548406|NCT01227005|Civilian|civilian
548407|NCT01227005|Military|military
548408|NCT01226992|Clostridium difficile|clostridium difficile
548409|NCT01226992|Fecal Transplant|fecal transplant
548410|NCT01226992|Recurrent Diarrhea|recurrent diarrhea
548411|NCT01226992|Abdominal distension/bloating|abdominal distension/bloating
548412|NCT01226992|Fever|fever
548413|NCT01226979|rectal cancer|rectal cancer
548414|NCT01226979|high dose endorectal brachytherapy|high dose endorectal brachytherapy
548415|NCT01226953|Haemophilus influenzae type b (Hib)|haemophilus influenzae type b (hib)
548416|NCT01226953|Vaccine|vaccine
548417|NCT01226953|Anti-PRP antibody|anti-prp antibody
548418|NCT01226914|EVICEL, Fibrin Sealant, Thyroidectomy|evicel, fibrin sealant, thyroidectomy
548419|NCT01226901|Poly (ADP-ribose) polymerase (PARP) inhibitor|poly (adp-ribose) polymerase (parp) inhibitor
548420|NCT01226901|tumor|tumor
548421|NCT01226901|cancer|cancer
548422|NCT01226888|brown adipose tissue|brown adipose tissue
548423|NCT01226888|androgen deprivation therapy|androgen deprivation therapy
548424|NCT01226875|SWL|swl
548425|NCT01226875|kidney stones|kidney stones
548426|NCT01226875|renal calculi|renal calculi
548427|NCT01226862|Stroke|stroke
548428|NCT01226862|Telemedicine|telemedicine
548429|NCT01226862|Telestroke|telestroke
548430|NCT01226849|diffuse large B-cell lymphoma relapse refractory|diffuse large b-cell lymphoma relapse refractory
548431|NCT01226836|Pulmonary Rehabilitation|pulmonary rehabilitation
548432|NCT01226823|cholestasis|cholestasis
548433|NCT01226823|pregnancy|pregnancy
548434|NCT01226823|ursodeoxycholic acid|ursodeoxycholic acid
548435|NCT01226823|ICP|icp
548436|NCT01226797|Chronic HCV infection|chronic hcv infection
548437|NCT01226797|raised ALT|raised alt
548438|NCT01226797|transaminitis|transaminitis
548439|NCT01226797|HCV infection|hcv infection
548440|NCT01226771|hepatitis V virus|hepatitis v virus
548441|NCT01226771|genotype 1|genotype 1
548442|NCT01226771|ribavirin|ribavirin
548443|NCT01226771|interferon|interferon
548444|NCT01226771|Alternative ribavirin dosing|alternative ribavirin dosing
548445|NCT01226758|Safety|safety
548446|NCT01226758|Tolerability|tolerability
548447|NCT01226758|Efficacy|efficacy
548448|NCT01226758|Influenza|influenza
548449|NCT01226758|Flu|flu
548450|NCT01226758|Virus|virus
548451|NCT01226758|Vaccine|vaccine
548452|NCT01226745|Multiple sclerosis|multiple sclerosis
548453|NCT01226745|ONO-4641|ono-4641
548454|NCT01226745|MSC2430913A|msc2430913a
548455|NCT01226745|Efficacy|efficacy
548456|NCT01226732|Solid tumor|solid tumor
548457|NCT01226732|Capecitabine|capecitabine
548458|NCT01226732|Hsp90 inhibitor AUY922|hsp90 inhibitor auy922
548459|NCT01226719|liver-only metastatic KRAS wild-type colorectal cancer|liver-only metastatic kras wild-type colorectal cancer
548460|NCT01226719|Panitumumab|panitumumab
548461|NCT01226719|Oxaliplatin|oxaliplatin
548462|NCT01226719|Irinotecan|irinotecan
548463|NCT01226719|Leucovorin|leucovorin
548464|NCT01226719|5-Fluorouracil|5-fluorouracil
548465|NCT01226706|Urinary incontinence, urge|urinary incontinence, urge
548466|NCT01226706|detrusor hyperreflexia|detrusor hyperreflexia
548467|NCT01226706|detrusor instability|detrusor instability
548468|NCT01226706|non-neurogenic|non-neurogenic
548469|NCT01226706|Female Urogenital Diseases and Pregnancy Complications|female urogenital diseases and pregnancy complications
548470|NCT01226706|Female Urogenital Diseases|female urogenital diseases
548471|NCT01226706|Urologic Diseases|urologic diseases
548472|NCT01226706|Urination Disorders|urination disorders
548473|NCT01226706|Urinary Incontinence|urinary incontinence
548474|NCT01226693|pharmacokinetic|pharmacokinetic
548475|NCT01226693|single dose bioequivalence study|single dose bioequivalence study
548476|NCT01226693|balanced incomplete block design|balanced incomplete block design
548477|NCT01226693|PH-797804|ph-797804
548478|NCT01226693|P38 kinase inhibitor|p38 kinase inhibitor
548479|NCT01226680|Dry Eye|dry eye
548480|NCT01226680|Schirmer test|schirmer test
548481|NCT01226680|corneal staining|corneal staining
548482|NCT01226680|OSDI|osdi
548483|NCT01226680|OCI|oci
548484|NCT01226667|fibromyalgia|fibromyalgia
548485|NCT01226667|lyrica|lyrica
548486|NCT01226667|pregabalin|pregabalin
548487|NCT01226654|Quantitative Imaging of Multiple Sclerosis|quantitative imaging of multiple sclerosis
548488|NCT01226641|Obstructive Sleep Apnea Syndrome|obstructive sleep apnea syndrome
548489|NCT01226641|SCORE|score
548490|NCT01226641|Telemedicine|telemedicine
548491|NCT01226641|Arterial blood pressure|arterial blood pressure
548492|NCT01226641|Daily physical activity|daily physical activity
548493|NCT01226628|Macular degeneration|macular degeneration
548494|NCT01226628|Age-related macular degeneration|age-related macular degeneration
548495|NCT01226628|Cell therapy|cell therapy
548496|NCT01226628|CNTO 2476|cnto 2476
548497|NCT01226628|Human umbilical tissue-derived cells|human umbilical tissue-derived cells
548498|NCT01226628|hUTC|hutc
548499|NCT01226628|Geographic Atrophy|geographic atrophy
548500|NCT01226628|Subretinal|subretinal
548501|NCT01226628|Visual Acuity|visual acuity
548502|NCT01226615|Chondroitin sulphate|chondroitin sulphate
548503|NCT01226615|Knee osteoarthritis|knee osteoarthritis
548504|NCT01226615|Functional Magnetic Resonance Imaging|functional magnetic resonance imaging
548505|NCT01226602|Ticagrelor|ticagrelor
548506|NCT01226602|Healthy|healthy
548507|NCT01226602|Coronary flow velocity|coronary flow velocity
548508|NCT01226602|Adenosine|adenosine
548509|NCT01226589|Cancer cancer|cancer cancer
548510|NCT01226589|MRS|mrs
548511|NCT01226589|Treatment response|treatment response
548512|NCT01226589|Histologically confirmed diagnosed Breast cancer.|histologically confirmed diagnosed breast cancer.
548513|NCT01226589|Patient is 18 years or older.|patient is 18 years or older.
548514|NCT01226589|Karnofsky performance score is equal to or greater than 70.|karnofsky performance score is equal to or greater than 70.
548515|NCT01226589|No previously irradiated or recurrent breast.|no previously irradiated or recurrent breast.
548516|NCT01226589|No contraindication to MRS/MRI.|no contraindication to mrs/mri.
548517|NCT01226576|MRgFUS|mrgfus
548518|NCT01226576|Prostate Cancer|prostate cancer
548519|NCT01226576|Low-Intermediate Risk Prostate Cancer|low-intermediate risk prostate cancer
548520|NCT01226576|Localized Prostate Cancer|localized prostate cancer
548521|NCT01226576|InSightec|insightec
548522|NCT01226576|ExAblate|exablate
548523|NCT01226563|STEMI|stemi
548524|NCT01226563|Acute Myocardial Infarction|acute myocardial infarction
548525|NCT01226563|Congestive Heart Failure|congestive heart failure
548526|NCT01226563|Left Ventricular Remodeling|left ventricular remodeling
548527|NCT01226563|Devices, Medical|devices, medical
548528|NCT01226550|hyperthermic intraoperative peritoneal chemotherapy (HIPEC)|hyperthermic intraoperative peritoneal chemotherapy (hipec)
548529|NCT01226550|Irinotecan|irinotecan
548530|NCT01226550|Pharmacokinetics|pharmacokinetics
548531|NCT01226550|peritoneal carcinomatosis (PC)|peritoneal carcinomatosis (pc)
548532|NCT01226537|Taurine,Diabetes mellitus,oxidative stress,glycemic control|taurine,diabetes mellitus,oxidative stress,glycemic control
548533|NCT01226498|Blood Transfusion, Autologous|blood transfusion, autologous
548534|NCT01226498|Blood Preservation/adverse effects|blood preservation/adverse effects
548535|NCT01226498|Blood Transfusion/adverse effects|blood transfusion/adverse effects
548536|NCT01226498|Endothelium, Vascular/physiopathology|endothelium, vascular/physiopathology
548537|NCT01226498|Inflammation Mediators|inflammation mediators
548538|NCT01226485|Cancer|cancer
548539|NCT01226485|Terminal|terminal
548540|NCT01226485|Solid Tumor|solid tumor
548541|NCT01226485|End Stage|end stage
548542|NCT01226485|Metastatic|metastatic
548543|NCT01226472|PTCL|ptcl
548544|NCT01226472|CTCL|ctcl
548545|NCT01226472|MF|mf
548546|NCT01226472|SS|ss
548547|NCT01226459|Female Pattern Baldness|female pattern baldness
548548|NCT01226433|AE adverse event|ae adverse event
548549|NCT01226433|AIDS acquired immunodeficiency syndrome|aids acquired immunodeficiency syndrome
548550|NCT01226433|ALT (SGPT) alanine aminotransferase|alt (sgpt) alanine aminotransferase
548551|NCT01226433|ART antiretroviral therapy|art antiretroviral therapy
548552|NCT01226433|AST (SGOT) aspartate aminotransferase|ast (sgot) aspartate aminotransferase
548553|NCT01226433|DCF data collection forms|dcf data collection forms
548554|NCT01226433|DMC Data Monitoring Committee|dmc data monitoring committee
548555|NCT01226433|FDA (U.S.) Food and Drug Administration|fda (u.s.) food and drug administration
548556|NCT01226433|GCP Good Clinical Practice guidelines|gcp good clinical practice guidelines
548557|NCT01226433|HB sAg Hepatitis B surface antigen|hb sag hepatitis b surface antigen
548558|NCT01226433|ICH International Conference of Harmonisation|ich international conference of harmonisation
548559|NCT01226433|IND Investigational New Drug Application|ind investigational new drug application
548560|NCT01226433|IRB Institutional Review Board|irb institutional review board
548561|NCT01226433|IU International units|iu international units
548562|NCT01226433|mg milligram(s)|mg milligram(s)
548563|NCT01226433|mm3 cubic millimeter(s)|mm3 cubic millimeter(s)
548564|NCT01226433|PCR polymerase chain reaction|pcr polymerase chain reaction
548565|NCT01226433|SAE serious adverse event|sae serious adverse event
548566|NCT01226433|µg microgram|µg microgram
548567|NCT01226433|ULN upper limit of the normal range|uln upper limit of the normal range
548568|NCT01226433|WB Western Blot|wb western blot
548569|NCT01226420|GVHD|gvhd
548570|NCT01226420|Alefacept|alefacept
548571|NCT01226420|Amevive|amevive
548572|NCT01226407|Solid Tumour|solid tumour
548573|NCT01226394|peritoneal carcinomatosis|peritoneal carcinomatosis
548574|NCT01226394|HIPEC|hipec
548575|NCT01226394|controlled clinical trial|controlled clinical trial
548576|NCT01226381|Paracetamol and setrons|paracetamol and setrons
548577|NCT01226381|No disease, healthy volunteers|no disease, healthy volunteers
548578|NCT01226368|HIV, HPV, cervical-vaginal smear|hiv, hpv, cervical-vaginal smear
548579|NCT01226342|Chronic obstructive pulmonary disease|chronic obstructive pulmonary disease
548580|NCT01226329|Minority Groups|minority groups
548581|NCT01226329|Decision Making|decision making
548582|NCT01226329|Patient Participation|patient participation
548583|NCT01226329|Mental Health Services|mental health services
548584|NCT01226329|retention|retention
548585|NCT01226329|attendance|attendance
548586|NCT01226329|patient activation|patient activation
548587|NCT01226329|Hispanic Americans|hispanic americans
548588|NCT01226329|patient-provider communication|patient-provider communication
548589|NCT01226316|Advanced solid malignancy,PIK3CA mutated,AKT1 mutated, PTEN mutation, PTEN alteration, metastatic,ER+,breast,ovarian,endometrial,AZD5363,AKT inhibitor,|advanced solid malignancy,pik3ca mutated,akt1 mutated, pten mutation, pten alteration, metastatic,er+,breast,ovarian,endometrial,azd5363,akt inhibitor,
548590|NCT01226290|uterine fibroid RF ablation|uterine fibroid rf ablation
548591|NCT01226290|intrauterine ultrasound|intrauterine ultrasound
548592|NCT01226290|VizAblate|vizablate
548593|NCT01226264|Uterine cervical cancer|uterine cervical cancer
548594|NCT01226264|diffusion-weighted MRI|diffusion-weighted mri
548595|NCT01226264|recurrence|recurrence
548596|NCT01226251|oral malodour|oral malodour
548597|NCT01226251|halitosis|halitosis
548598|NCT01226251|Subjects consulting a bad breath clinic|subjects consulting a bad breath clinic
548599|NCT01226225|Patients with recent coronary event|patients with recent coronary event
548600|NCT01226212|Older people|older people
548601|NCT01226212|Synbiotic|synbiotic
548602|NCT01226212|Prebiotic|prebiotic
548603|NCT01226212|Probiotic|probiotic
548604|NCT01226212|Bacteria|bacteria
548605|NCT01226212|Immune|immune
548606|NCT01226186|Knee replacement|knee replacement
548607|NCT01226186|Pain control|pain control
548608|NCT01226186|Self medication|self medication
548609|NCT01226173|Prospective screening of blood donors.|prospective screening of blood donors.
548610|NCT01226147|Lupus Nephritis|lupus nephritis
548611|NCT01226147|SLE|sle
548612|NCT01226147|retinoid|retinoid
548613|NCT01226147|tamibarotene|tamibarotene
548614|NCT01226134|Functional Dyspepsia|functional dyspepsia
548615|NCT01226134|Itopride|itopride
548616|NCT01226134|Gastric Emptying|gastric emptying
548617|NCT01226134|Gastric Accommodation|gastric accommodation
548618|NCT01226134|Dyspeptic Symptoms|dyspeptic symptoms
548619|NCT01226121|dupuytren|dupuytren
548620|NCT01226121|dupuytren's|dupuytren's
548621|NCT01226095|Osteoarthritis|osteoarthritis
548622|NCT01226095|Pain|pain
548623|NCT01226095|Morning stiffness|morning stiffness
548624|NCT01226069|superficial phlebitis|superficial phlebitis
548625|NCT01226069|cannula-related vein inflammation|cannula-related vein inflammation
548626|NCT01226069|Glycerine magnesium sulphate|glycerine magnesium sulphate
548627|NCT01226069|Hirudoid cream|hirudoid cream
548628|NCT01226069|Nursing|nursing
548629|NCT01226056|advanced solid tumors|advanced solid tumors
548630|NCT01226056|Sorafenib (Nexavar®)|sorafenib (nexavar®)
548631|NCT01226056|RAD001 (everolimus)|rad001 (everolimus)
548632|NCT01226056|tumor molecular targets|tumor molecular targets
548633|NCT01226030|Advanced Solid Tumors|advanced solid tumors
548634|NCT01226017|Oxytocin|oxytocin
548635|NCT01226017|Animal Assisted therapy|animal assisted therapy
548636|NCT01226017|Farm animals|farm animals
548637|NCT01226017|Healthy nursing students|healthy nursing students
548638|NCT01226004|radiosurgery|radiosurgery
548639|NCT01226004|prostate|prostate
548640|NCT01226004|cancer|cancer
548641|NCT01226004|early|early
548642|NCT01226004|intermediate|intermediate
548643|NCT01226004|CyberKnife|cyberknife
548644|NCT01225991|Pain, Fatigue, Geriatric, Rheumatoid Arthritis, Milnacipran|pain, fatigue, geriatric, rheumatoid arthritis, milnacipran
548645|NCT01225978|Genetic Information|genetic information
548646|NCT01225978|Variant Updates|variant updates
548647|NCT01225978|Information Technology|information technology
548648|NCT01225978|Hypertrophic Cardiomyopathy|hypertrophic cardiomyopathy
548649|NCT01225978|Hearing Loss|hearing loss
548650|NCT01225978|Oncology|oncology
548651|NCT01225965|Particulate Matter induced inflammation of the lung|particulate matter induced inflammation of the lung
548652|NCT01225952|phacoemulsification|phacoemulsification
548653|NCT01225952|intraocular lens|intraocular lens
548654|NCT01225939|Type 2 diabetes mellitus|type 2 diabetes mellitus
548655|NCT01225939|Healthy|healthy
548656|NCT01225926|Intraocular Lens|intraocular lens
548657|NCT01225926|Toric|toric
548658|NCT01225913|asthma|asthma
548659|NCT01225913|lung function|lung function
548660|NCT01225913|inflammation|inflammation
548661|NCT01225874|untreated childhood acute lymphoblastic leukemia|untreated childhood acute lymphoblastic leukemia
548662|NCT01225874|B-cell childhood acute lymphoblastic leukemia|b-cell childhood acute lymphoblastic leukemia
548663|NCT01225874|non-T, non-B, cALLa positive, pre-B childhood acute lymphoblastic leukemia|non-t, non-b, calla positive, pre-b childhood acute lymphoblastic leukemia
548664|NCT01225809|AD01 follow-up extension|ad01 follow-up extension
548665|NCT01225796|Bicarbonate|bicarbonate
548666|NCT01225796|Chronic allograft nephropathy|chronic allograft nephropathy
548667|NCT01225796|Urinary TGF-beta|urinary tgf-beta
548668|NCT01225796|Urinary acid excretion|urinary acid excretion
548669|NCT01225770|green tea|green tea
548670|NCT01225770|gargling|gargling
548671|NCT01225770|prophylaxis|prophylaxis
548672|NCT01225770|influenza|influenza
548673|NCT01225770|Respiratory Tract Infections|respiratory tract infections
548674|NCT01225770|high school students|high school students
548675|NCT01225757|Echocardiography|echocardiography
548676|NCT01225757|HIPEC|hipec
548677|NCT01225692|Brain Injury|brain injury
548678|NCT01225692|Head Trauma|head trauma
548679|NCT01225692|Trauma Systems|trauma systems
548680|NCT01225692|Head Injury Guideline|head injury guideline
548681|NCT01225692|Time to Tertiary Care|time to tertiary care
548682|NCT01225679|Congenital Central Hypoventilation Syndrome|congenital central hypoventilation syndrome
548683|NCT01225679|Phox2B gene|phox2b gene
548684|NCT01225679|invasive ventilation|invasive ventilation
548685|NCT01225679|genetics|genetics
548686|NCT01225679|late-onset|late-onset
548687|NCT01225679|sleep|sleep
548688|NCT01225679|central sleep apnea|central sleep apnea
548689|NCT01225666|MOD-4023|mod-4023
548792|NCT01225146|Occlusion|occlusion
548690|NCT01225666|Growth Hormone Deficient Adults|growth hormone deficient adults
548691|NCT01225666|Phase II|phase ii
548692|NCT01225653|Latanoprost|latanoprost
548693|NCT01225653|vasodilation|vasodilation
548694|NCT01225653|diabetic retinopathy|diabetic retinopathy
548695|NCT01225640|Tuberculosis|tuberculosis
548696|NCT01225640|EBA|eba
548697|NCT01225640|WBA|wba
548698|NCT01225627|Chronic disease management|chronic disease management
548699|NCT01225627|Chronic obstructive pulmonary disease|chronic obstructive pulmonary disease
548700|NCT01225627|Discharge planning|discharge planning
548701|NCT01225627|Discharge coordinator|discharge coordinator
548702|NCT01225614|Home ventilation|home ventilation
548703|NCT01225614|Myotonic dystrophy type 1 (DM1)|myotonic dystrophy type 1 (dm1)
548704|NCT01225575|large cartilage defects|large cartilage defects
548705|NCT01225575|knee joint|knee joint
548706|NCT01225575|femoral condyle, tibia, trochlear, retropatellar|femoral condyle, tibia, trochlear, retropatellar
548707|NCT01225562|Heart attack|heart attack
548708|NCT01225562|Heart Disease|heart disease
548709|NCT01225562|Acute coronary syndrome|acute coronary syndrome
548710|NCT01225562|ACS|acs
548711|NCT01225562|Cardiovascular Disease|cardiovascular disease
548712|NCT01225549|Allergen Challenge|allergen challenge
548713|NCT01225549|Asthma|asthma
548714|NCT01225549|Inhaled selective glucocorticoid receptor agonist (iSEGRA)|inhaled selective glucocorticoid receptor agonist (isegra)
548715|NCT01225536|BRAF mutations|braf mutations
548716|NCT01225510|recurrent glioblastoma multiforme (GBM)|recurrent glioblastoma multiforme (gbm)
548717|NCT01225510|CVX-060|cvx-060
548718|NCT01225510|PF-04856884|pf-04856884
548719|NCT01225510|phase 2|phase 2
548720|NCT01225510|open-label|open-label
548721|NCT01225510|bevacizumab|bevacizumab
548722|NCT01225510|anti-angiogenic|anti-angiogenic
548723|NCT01225497|Randomized|randomized
548724|NCT01225497|Pilot study|pilot study
548725|NCT01225497|VISA-A|visa-a
548726|NCT01225497|VAS|vas
548727|NCT01225484|Knee arthroplasty, perioperative analgesia|knee arthroplasty, perioperative analgesia
548728|NCT01225471|novel epitope peptide|novel epitope peptide
548729|NCT01225471|CTL|ctl
548730|NCT01225471|advanced prostate cancer|advanced prostate cancer
548731|NCT01225458|Elderly patients|elderly patients
548732|NCT01225458|renal insufficiency|renal insufficiency
548733|NCT01225458|systematized gerontologic evaluation|systematized gerontologic evaluation
548734|NCT01225419|Plerixafor|plerixafor
548735|NCT01225419|Hematopoietic Stem Cell Transplant mobilization|hematopoietic stem cell transplant mobilization
548736|NCT01225419|children|children
548737|NCT01225406|Third line ARV therapy|third line arv therapy
548738|NCT01225406|HIV RNA|hiv rna
548739|NCT01225406|Absolute CD4+ T cell count|absolute cd4+ t cell count
548740|NCT01225406|serious adverse events (SAEs)|serious adverse events (saes)
548741|NCT01225406|Drug resistance|drug resistance
548742|NCT01225380|Hepatitis C|hepatitis c
548743|NCT01225380|HCV|hcv
548744|NCT01225380|Rapid Virologic Response|rapid virologic response
548745|NCT01225380|Sustained Virologic Response|sustained virologic response
548746|NCT01225380|Direct Acting Antiviral|direct acting antiviral
548747|NCT01225380|Combination Therapy|combination therapy
548748|NCT01225380|HCV RNA|hcv rna
548749|NCT01225380|Polymerase inhibitor|polymerase inhibitor
548750|NCT01225380|Protease inhibitor|protease inhibitor
548751|NCT01225380|Treatment naïve|treatment naïve
548752|NCT01225380|GS-9190|gs-9190
548753|NCT01225380|GS-9256|gs-9256
548754|NCT01225354|Cheek|cheek
548755|NCT01225354|Cheek flattening|cheek flattening
548756|NCT01225354|Malar deficiency|malar deficiency
548757|NCT01225354|Filler|filler
548758|NCT01225341|HSV-1|hsv-1
548759|NCT01225341|Herpes labialis|herpes labialis
548760|NCT01225341|Cold sores|cold sores
548761|NCT01225341|Fever blisters|fever blisters
548762|NCT01225289|Multiple Sclerosis|multiple sclerosis
548763|NCT01225289|Vitamin A|vitamin a
548764|NCT01225289|CD4-Positive T-Lymphocytes|cd4-positive t-lymphocytes
548765|NCT01225289|Th1 Cells|th1 cells
548766|NCT01225289|Th2 Cells|th2 cells
548767|NCT01225276|CIDP|cidp
548768|NCT01225276|IVIG|ivig
548769|NCT01225263|Migraine disorders|migraine disorders
548770|NCT01225263|Headache|headache
548771|NCT01225263|Simvastatin|simvastatin
548772|NCT01225263|Vitamin D|vitamin d
548773|NCT01225250|Caudal septal extension graft|caudal septal extension graft
548774|NCT01225250|Primary rhinoplasty|primary rhinoplasty
548775|NCT01225250|Secondary rhinoplasty|secondary rhinoplasty
548776|NCT01225237|diarrhea|diarrhea
548777|NCT01225237|IBS|ibs
548778|NCT01225237|Colonic disease|colonic disease
548779|NCT01225237|YM060|ym060
548780|NCT01225224|ASP015K|asp015k
548781|NCT01225224|Ethnic difference|ethnic difference
548782|NCT01225198|Vitamins|vitamins
548783|NCT01225198|Minerals|minerals
548784|NCT01225185|neurological complications|neurological complications
548785|NCT01225185|brain blood flow autoregulation|brain blood flow autoregulation
548786|NCT01225159|tight glycemic control|tight glycemic control
548787|NCT01225159|cardiac surgery|cardiac surgery
548788|NCT01225146|Ischemic|ischemic
548789|NCT01225146|Central|central
548790|NCT01225146|Retinal|retinal
548791|NCT01225146|Vein|vein
548793|NCT01225146|Ranibizumab|ranibizumab
548794|NCT01225146|Lucentis|lucentis
548795|NCT01225146|CRVO|crvo
548796|NCT01225146|ISCRVO|iscrvo
548797|NCT01225133|Osteoarthritis, Osteoarthrosis, Arthritis, Arthrosis|osteoarthritis, osteoarthrosis, arthritis, arthrosis
548798|NCT01225107|Burns|burns
548799|NCT01225107|Infections|infections
548800|NCT01225107|Cranberry|cranberry
548801|NCT01225094|AAA|aaa
548802|NCT01225094|abdominal aortic aneurysm|abdominal aortic aneurysm
548803|NCT01225094|acute kidney injury|acute kidney injury
548804|NCT01225094|ischemia-reperfusion|ischemia-reperfusion
548805|NCT01225081|ASP1941|asp1941
548806|NCT01225081|Diabetes mellitus|diabetes mellitus
548807|NCT01225081|pioglitazone|pioglitazone
548808|NCT01225042|infectious diarrhea|infectious diarrhea
548809|NCT01225042|probiotics|probiotics
548810|NCT01225042|prevention|prevention
548811|NCT01225042|dietary intervention|dietary intervention
548812|NCT01225042|E. coli infection|e. coli infection
548813|NCT01225042|intestinal infection|intestinal infection
548814|NCT01225042|intestinal resistance|intestinal resistance
548815|NCT01225029|premature birth|premature birth
548816|NCT01225029|late preterm birth|late preterm birth
548817|NCT01225029|respiratory distress of the newborn|respiratory distress of the newborn
548818|NCT01225029|Transient tachypnea of the newborn|transient tachypnea of the newborn
548819|NCT01225003|gliomas|gliomas
548820|NCT01225003|magnetic resonance|magnetic resonance
548821|NCT01225003|diffusion kurtosis imaging|diffusion kurtosis imaging
548822|NCT01225003|MR spectroscopy|mr spectroscopy
548823|NCT01225003|grading|grading
548824|NCT01224990|gastro-intestinal tumor|gastro-intestinal tumor
548825|NCT01224990|accurate staging|accurate staging
548826|NCT01224990|whole-body diffusion weighted MRI|whole-body diffusion weighted mri
548827|NCT01224990|non-invasive|non-invasive
548828|NCT01224925|carious exposure|carious exposure
548829|NCT01224925|pulp capping|pulp capping
548830|NCT01224925|MTA|mta
548831|NCT01224925|Dycal|dycal
548832|NCT01224912|Insomnia|insomnia
548833|NCT01224912|Intervention|intervention
548834|NCT01224912|Self-help|self-help
548835|NCT01224912|Internet|internet
548836|NCT01224899|Heart Failure|heart failure
548837|NCT01224899|Sympathetic Nervous System|sympathetic nervous system
548838|NCT01224899|Sympathectomy|sympathectomy
548839|NCT01224899|Adrenergic beta-Antagonists|adrenergic beta-antagonists
548840|NCT01224899|Ventricular Dysfunction, Left|ventricular dysfunction, left
548841|NCT01224886|Aging|aging
548842|NCT01224886|Insulin resistance|insulin resistance
548843|NCT01224886|Ectopic lipids|ectopic lipids
548844|NCT01224886|Obesity|obesity
548845|NCT01224886|Exercise|exercise
548846|NCT01224886|Physical activity|physical activity
548847|NCT01224886|Oxidative capacity|oxidative capacity
548848|NCT01224886|Diabetes|diabetes
548849|NCT01224886|Metabolic syndrome|metabolic syndrome
548850|NCT01224873|breast cancer|breast cancer
548851|NCT01224873|bone metastasis|bone metastasis
548852|NCT01224873|comparison of diagnostic methods|comparison of diagnostic methods
548853|NCT01224873|bone scintigraphy|bone scintigraphy
548854|NCT01224873|fluoride PET/CT|fluoride pet/ct
548855|NCT01224873|FDG-PET/CT|fdg-pet/ct
548856|NCT01224860|Telmisartan|telmisartan
548857|NCT01224860|Losartan|losartan
548858|NCT01224860|Renal transplant|renal transplant
548859|NCT01224847|AMD|amd
548860|NCT01224847|Intravitreal Injection|intravitreal injection
548861|NCT01224847|Anesthesia|anesthesia
548862|NCT01224834|Ragweed, allergy, sublingual immunotherapy|ragweed, allergy, sublingual immunotherapy
548863|NCT01224821|iodine I 131 tositumomab|iodine i 131 tositumomab
548864|NCT01224821|anti-B1 Antibody|anti-b1 antibody
548865|NCT01224821|Bexxar|bexxar
548866|NCT01224821|radioimmunotherapy|radioimmunotherapy
548867|NCT01224821|tositumomab|tositumomab
548868|NCT01224808|von Willebrand Disease|von willebrand disease
548869|NCT01224795|uncomplicated influenza|uncomplicated influenza
548870|NCT01224782|Zemplar capsules|zemplar capsules
548871|NCT01224782|Chronic kidney disease (CKD) stage 3 or 4|chronic kidney disease (ckd) stage 3 or 4
548872|NCT01224782|Secondary hyperparathyroidism (SHPT)|secondary hyperparathyroidism (shpt)
548873|NCT01224782|Postmarketing observational study (PMOS)|postmarketing observational study (pmos)
548874|NCT01224756|Tonsillitis|tonsillitis
548875|NCT01224756|Pharyngitis|pharyngitis
548876|NCT01224756|Sore Throat|sore throat
548877|NCT01224756|Drug Therapy|drug therapy
548878|NCT01224717|Osteoporosis|osteoporosis
548879|NCT01224704|Hypertonic Saline Infusion|hypertonic saline infusion
548880|NCT01224704|Water Deprivation|water deprivation
548881|NCT01224704|Thirst|thirst
548882|NCT01224704|Water/Electrolytes Homeostasis|water/electrolytes homeostasis
548883|NCT01224704|Obesity|obesity
548884|NCT01224691|TGF Beta|tgf beta
548885|NCT01224691|Asthma|asthma
548886|NCT01224691|Healthy Volunteer|healthy volunteer
548887|NCT01224691|Respiratory Syncytial Virus|respiratory syncytial virus
548888|NCT01224691|RSV|rsv
548889|NCT01224678|breast cancer|breast cancer
548890|NCT01224665|stage II bladder cancer|stage ii bladder cancer
548891|NCT01224665|stage III bladder cancer|stage iii bladder cancer
548990|NCT01224249|Fish|fish
548892|NCT01224665|transitional cell carcinoma of the bladder|transitional cell carcinoma of the bladder
548893|NCT01224652|gastric cancer|gastric cancer
548894|NCT01224652|paclitaxel|paclitaxel
548895|NCT01224652|irinotecan|irinotecan
548896|NCT01224639|dengue fever|dengue fever
548897|NCT01224639|live attenuated tetravalent dengue vaccine|live attenuated tetravalent dengue vaccine
548898|NCT01224639|TDV|tdv
548899|NCT01224639|Drug therapy|drug therapy
548900|NCT01224626|VRE|vre
548901|NCT01224626|Japanese|japanese
548902|NCT01224626|Post Marketing Surveillance|post marketing surveillance
548903|NCT01224600|lower limbs|lower limbs
548904|NCT01224600|Arterial Diseases|arterial diseases
548905|NCT01224587|Imaging technique|imaging technique
548906|NCT01224587|gastric transport through the gut|gastric transport through the gut
548907|NCT01224574|atrial fribrillation, cardiovascular events, aging, D-dimer|atrial fribrillation, cardiovascular events, aging, d-dimer
548908|NCT01224561|Thinness|thinness
548909|NCT01224561|Leanness|leanness
548910|NCT01224561|healthy volunteers|healthy volunteers
548911|NCT01224561|Lipid metabolism disorder|lipid metabolism disorder
548912|NCT01224548|vegan|vegan
548913|NCT01224548|diet|diet
548914|NCT01224548|diabetes|diabetes
548915|NCT01224548|overweight|overweight
548916|NCT01224548|workplace|workplace
548917|NCT01224548|nutrition|nutrition
548918|NCT01224548|diabetes and/or overweight|diabetes and/or overweight
548919|NCT01224535|Complementary foods|complementary foods
548920|NCT01224535|Amaranth|amaranth
548921|NCT01224535|Food Based approaches|food based approaches
548922|NCT01224535|Iron Deficiency anemia|iron deficiency anemia
548923|NCT01224535|Arid Areas|arid areas
548924|NCT01224535|Africa|africa
548925|NCT01224522|Randomized Controlled Trial|randomized controlled trial
548926|NCT01224522|Total Knee Arthroplasty|total knee arthroplasty
548927|NCT01224522|Patient Matched Cutting Blocks|patient matched cutting blocks
548928|NCT01224509|Cervix|cervix
548929|NCT01224509|EP3 receptors|ep3 receptors
548930|NCT01224509|Mifepristone|mifepristone
548931|NCT01224509|Prostaglandin|prostaglandin
548932|NCT01224509|Receptors|receptors
548933|NCT01224509|Steroids|steroids
548934|NCT01224496|Chronic cytopenic haematological diseases|chronic cytopenic haematological diseases
548935|NCT01224496|Chinese herbal concoction|chinese herbal concoction
548936|NCT01224496|Supportive management|supportive management
548937|NCT01224444|colon polyps|colon polyps
548938|NCT01224444|adenoma resection|adenoma resection
548939|NCT01224444|colon cancer screening|colon cancer screening
548940|NCT01224444|colonoscopy|colonoscopy
548941|NCT01224431|pain|pain
548942|NCT01224431|lidocaine|lidocaine
548943|NCT01224431|lumbar puncture|lumbar puncture
548944|NCT01224431|j-tip|j-tip
548945|NCT01224418|Tacrolimus|tacrolimus
548946|NCT01224418|Prograf|prograf
548947|NCT01224418|Calcinurin inhibitor|calcinurin inhibitor
548948|NCT01224418|Rheumatoid arthritis(RA)|rheumatoid arthritis(ra)
548949|NCT01224392|colorectal cancer|colorectal cancer
548950|NCT01224392|colorectal neoplasms|colorectal neoplasms
548951|NCT01224392|radiotherapy|radiotherapy
548952|NCT01224392|chemoradiotherapy|chemoradiotherapy
548953|NCT01224392|T3-4 rectal cancer|t3-4 rectal cancer
548954|NCT01224379|Lumbar spine|lumbar spine
548955|NCT01224379|fusion|fusion
548956|NCT01224379|adjacent instability|adjacent instability
548957|NCT01224379|topping-off.|topping-off.
548958|NCT01224366|Add-on to insulin|add-on to insulin
548959|NCT01224327|Liver cirrhosis|liver cirrhosis
548960|NCT01224327|Radiology|radiology
548961|NCT01224327|Mesenchymal Stem Cells|mesenchymal stem cells
548962|NCT01224327|Umbilical Cord|umbilical cord
548963|NCT01224314|Haemodynamics|haemodynamics
548964|NCT01224314|Hypotension|hypotension
548965|NCT01224314|Potassium|potassium
548966|NCT01224314|Haemodialysis|haemodialysis
548967|NCT01224314|Dialysis fluids|dialysis fluids
548968|NCT01224301|seasonal influenza vaccine|seasonal influenza vaccine
548969|NCT01224301|school-based clinics|school-based clinics
548970|NCT01224301|economic analysis of school based influenza vaccine delivery|economic analysis of school based influenza vaccine delivery
548971|NCT01224301|pediatric influenza vaccine rates|pediatric influenza vaccine rates
548972|NCT01224301|Influenza vaccine information for parents|influenza vaccine information for parents
548973|NCT01224288|RCC|rcc
548974|NCT01224288|Kidney cancer|kidney cancer
548975|NCT01224288|Metastatic renal cell carcinoma|metastatic renal cell carcinoma
548976|NCT01224288|mRCC|mrcc
548977|NCT01224288|Dynamic contrast enhanced CT|dynamic contrast enhanced ct
548978|NCT01224288|DCE-CT|dce-ct
548979|NCT01224288|Tumor perfusion|tumor perfusion
548980|NCT01224275|group based care|group based care
548981|NCT01224275|antenatal care|antenatal care
548982|NCT01224275|parents satisfaction|parents satisfaction
548983|NCT01224275|Antenatal care´s organization and patient satisfaction|antenatal care´s organization and patient satisfaction
548984|NCT01224262|influenza vaccine|influenza vaccine
548985|NCT01224262|seasonal influenza|seasonal influenza
548986|NCT01224262|novel vaccine|novel vaccine
548987|NCT01224262|flu|flu
548988|NCT01224249|Selenium|selenium
548989|NCT01224249|Selenoprotein P|selenoprotein p
548991|NCT01224249|Shellfish|shellfish
548992|NCT01224249|Bioavailability|bioavailability
548993|NCT01224223|asthma|asthma
548994|NCT01224210|portopulmonary hypertension|portopulmonary hypertension
548995|NCT01224210|portal hypertension|portal hypertension
548996|NCT01224210|esophageal or gastric varices|esophageal or gastric varices
548997|NCT01224210|right heart catheterization|right heart catheterization
548998|NCT01224210|transpulmonary gradient|transpulmonary gradient
548999|NCT01224210|Endothelin Receptor Antagonist|endothelin receptor antagonist
549000|NCT01224210|Ambrisentan|ambrisentan
549001|NCT01224210|Letairis|letairis
549002|NCT01224210|pulmonary hemodynamics|pulmonary hemodynamics
549003|NCT01224197|TMC435HPC1004|tmc435hpc1004
549004|NCT01224197|TMC435|tmc435
549005|NCT01224197|HCV|hcv
549006|NCT01224197|Hepatitis C|hepatitis c
549007|NCT01224197|Healthy Chinese volunteer|healthy chinese volunteer
549008|NCT01224184|HIV|hiv
549009|NCT01224184|Sexually Transmitted Diseases|sexually transmitted diseases
549010|NCT01224184|Substance Abuse Detection|substance abuse detection
549011|NCT01224184|Randomized Controlled Trial|randomized controlled trial
549012|NCT01224132|Atopic dermatitis, probiotic, SCORAD index, prick tests, cytokines|atopic dermatitis, probiotic, scorad index, prick tests, cytokines
549013|NCT01224119|foot ankle arthritis bone graft|foot ankle arthritis bone graft
549014|NCT01224054|Tolerance alimentary|tolerance alimentary
549015|NCT01224054|Morbid obesity|morbid obesity
549016|NCT01224054|Type 2 Diabetes Mellitus|type 2 diabetes mellitus
549017|NCT01224041|Tacrolimus|tacrolimus
549018|NCT01224041|Prograf|prograf
549019|NCT01224041|Calcinurin inhibitor|calcinurin inhibitor
549020|NCT01224041|Rheumatoid arthritis (RA)|rheumatoid arthritis (ra)
549021|NCT01224028|Tacrolimus|tacrolimus
549022|NCT01224028|Prograf|prograf
549023|NCT01224028|Calcinurin inhibitor|calcinurin inhibitor
549024|NCT01224028|Albuminurea|albuminurea
549025|NCT01224028|Proteinurea|proteinurea
549026|NCT01224028|FK506|fk506
549027|NCT01224002|Cross-Sectional|cross-sectional
549028|NCT01224002|Observational|observational
549029|NCT01224002|Comparative|comparative
549030|NCT01224002|Retrospective|retrospective
549031|NCT01224002|Feasibility|feasibility
549032|NCT01224002|Dental Decay|dental decay
549033|NCT01224002|Drug Abuse|drug abuse
549034|NCT01224002|Survey|survey
549035|NCT01223989|overweight|overweight
549036|NCT01223989|obesity|obesity
549037|NCT01223989|bread|bread
549038|NCT01223989|hypocaloric diet|hypocaloric diet
549039|NCT01223976|latent tuberculosis psoriasis arthritis TST QTF|latent tuberculosis psoriasis arthritis tst qtf
549040|NCT01223976|Screening of latent tuberculosis in psoriasis|screening of latent tuberculosis in psoriasis
549041|NCT01223963|Macrolane|macrolane
549042|NCT01223963|Retrospective|retrospective
549043|NCT01223924|cancer|cancer
549044|NCT01223898|CML,|cml,
549045|NCT01223898|nilotinib,|nilotinib,
549046|NCT01223898|midazolam|midazolam
549047|NCT01223859|Radiofrequency, ablation, RFA, RFTA, RFITT, soft palate.|radiofrequency, ablation, rfa, rfta, rfitt, soft palate.
549048|NCT01223833|breast cancer|breast cancer
549049|NCT01223833|postmenopausal|postmenopausal
549050|NCT01223833|aromatase inhibitors|aromatase inhibitors
549051|NCT01223833|tamoxifen|tamoxifen
549052|NCT01223833|arthralgia|arthralgia
549053|NCT01223833|IGF-I|igf-i
549054|NCT01223833|BMI|bmi
549055|NCT01223833|grip strength|grip strength
549056|NCT01223807|COPD, diaphragm, rehabilitation|copd, diaphragm, rehabilitation
549057|NCT01223794|Fall|fall
549058|NCT01223794|all in surgical & Medical in-patient|all in surgical & medical in-patient
549059|NCT01223781|Freezing|freezing
549060|NCT01223781|biofeedback|biofeedback
549061|NCT01223781|motor learning|motor learning
549062|NCT01223781|freezing of gait in PD|freezing of gait in pd
549063|NCT01223755|Autosomal dominant polycystic kidney disease|autosomal dominant polycystic kidney disease
549064|NCT01223755|Sirolimus|sirolimus
549065|NCT01223755|Renal insufficiency|renal insufficiency
549066|NCT01223729|Acetyl-L-carnitine;|acetyl-l-carnitine;
549067|NCT01223729|Minimal hepatic encephalopathy;|minimal hepatic encephalopathy;
549068|NCT01223729|Quality of life;|quality of life;
549069|NCT01223729|Depression.|depression.
549070|NCT01223716|amblyopia treatment|amblyopia treatment
549071|NCT01223716|neural plasticity|neural plasticity
549072|NCT01223716|perceptual learning|perceptual learning
549073|NCT01223716|vision therapy|vision therapy
549074|NCT01223716|spatial vision|spatial vision
549075|NCT01223716|video games|video games
549076|NCT01223716|occlusion therapy|occlusion therapy
549077|NCT01223703|n-3 PUFAs|n-3 pufas
549078|NCT01223703|Heart Failure|heart failure
549079|NCT01223703|Dilated cardiomyopathy|dilated cardiomyopathy
549080|NCT01223703|Ejection Fraction|ejection fraction
549081|NCT01223703|Exercise Capacity|exercise capacity
549082|NCT01223690|sepsis|sepsis
549083|NCT01223690|infection|infection
549084|NCT01223690|bacteremia|bacteremia
549085|NCT01223690|clarithromycin|clarithromycin
549086|NCT01223664|ABMSC|abmsc
549087|NCT01223664|Allogenic bone marrow mesenchymal stem cells|allogenic bone marrow mesenchymal stem cells
549088|NCT01223664|Liver cirrhosis|liver cirrhosis
549089|NCT01223664|Transplantation|transplantation
549965|NCT01220128|neoadjuvant|neoadjuvant
549090|NCT01223651|Diabetes Mellitus, Type 1|diabetes mellitus, type 1
549091|NCT01223651|Continuous Glucose Monitoring System|continuous glucose monitoring system
549092|NCT01223651|Accuracy|accuracy
549093|NCT01223651|Altitude|altitude
549094|NCT01223638|Congenital hypothyroidism(CH)|congenital hypothyroidism(ch)
549095|NCT01223638|Hearing loss among children with CH|hearing loss among children with ch
549096|NCT01223612|Diabetes Mellitus|diabetes mellitus
549097|NCT01223612|Diabetes Complications|diabetes complications
549098|NCT01223612|Retinal Diseases|retinal diseases
549099|NCT01223612|Edema|edema
549100|NCT01223612|Endothelial Growth Factors|endothelial growth factors
549101|NCT01223612|Monoclonal Antibodies|monoclonal antibodies
549102|NCT01223612|Ranibizumab|ranibizumab
549103|NCT01223612|Laser therapy|laser therapy
549104|NCT01223599|pilonidal disease|pilonidal disease
549105|NCT01223599|natal cleft|natal cleft
549106|NCT01223599|limberg flap|limberg flap
549107|NCT01223560|Artificial pancreas|artificial pancreas
549108|NCT01223560|Model predictive control|model predictive control
549109|NCT01223560|Virtual patient|virtual patient
549110|NCT01223547|Carbohydrate counting|carbohydrate counting
549111|NCT01223547|Insulin bolus calculation|insulin bolus calculation
549112|NCT01223534|Tuberculosis|tuberculosis
549113|NCT01223534|Latent tuberculosis infection|latent tuberculosis infection
549114|NCT01223534|Tuberculin skin test|tuberculin skin test
549115|NCT01223534|Interferon-gamma release assays|interferon-gamma release assays
549116|NCT01223534|Contact-tracing study|contact-tracing study
549117|NCT01223521|Contraception|contraception
549118|NCT01223521|Abortion|abortion
549119|NCT01223521|First trimester|first trimester
549120|NCT01223521|Intrauterine device|intrauterine device
549121|NCT01223482|Miscarriage|miscarriage
549122|NCT01223482|Karyotyping|karyotyping
549123|NCT01223482|Genetic testing|genetic testing
549124|NCT01223469|Atrial Fibrillation|atrial fibrillation
549125|NCT01223469|Supraventricular Tachycardia|supraventricular tachycardia
549126|NCT01223469|Contact Force|contact force
549127|NCT01223469|RF Ablation|rf ablation
549128|NCT01223469|Radiofrequency|radiofrequency
549129|NCT01223469|Pulmonary Vein Isolation|pulmonary vein isolation
549130|NCT01223469|Paroxysmal Atrial Fibrillation|paroxysmal atrial fibrillation
549131|NCT01223456|Saxagliptin|saxagliptin
549132|NCT01223456|type 2 diabetes|type 2 diabetes
549133|NCT01223456|clinical practice|clinical practice
549134|NCT01223443|Coronary Artery Bypass Grafting|coronary artery bypass grafting
549135|NCT01223443|Drug Eluting Stent|drug eluting stent
549136|NCT01223443|Saphenous Vein Graft|saphenous vein graft
549137|NCT01223430|septic shock|septic shock
549138|NCT01223430|shock reversal|shock reversal
549139|NCT01223430|ICU|icu
549140|NCT01223430|traditional Chinese medicine|traditional chinese medicine
549141|NCT01223404|nicotine|nicotine
549142|NCT01223404|mecamylamine|mecamylamine
549143|NCT01223404|attention|attention
549144|NCT01223404|default network|default network
549145|NCT01223404|fMRI|fmri
549146|NCT01223391|orthostatic|orthostatic
549147|NCT01223391|abdominal compression|abdominal compression
549148|NCT01223365|moderate to severe pain|moderate to severe pain
549149|NCT01223365|diabetic peripheral neuropathy|diabetic peripheral neuropathy
549150|NCT01223365|postherpetic neuralgia|postherpetic neuralgia
549151|NCT01223365|traumatic injury|traumatic injury
549152|NCT01223365|complex regional pain syndrome|complex regional pain syndrome
549153|NCT01223365|back pain|back pain
549154|NCT01223365|neck pain|neck pain
549155|NCT01223365|osteoarthritis|osteoarthritis
549156|NCT01223365|rheumatoid arthritis|rheumatoid arthritis
549157|NCT01223352|pulmonary arterial hypertension|pulmonary arterial hypertension
549158|NCT01223352|children|children
549159|NCT01223352|pediatric|pediatric
549160|NCT01223352|bosentan|bosentan
549161|NCT01223339|Ertugliflozin|ertugliflozin
549162|NCT01223339|Japanese and Western population|japanese and western population
549163|NCT01223339|pharmacokinetics|pharmacokinetics
549164|NCT01223339|pharmacodynamics|pharmacodynamics
549165|NCT01223326|Acetylcysteine|acetylcysteine
549166|NCT01223313|Contraception|contraception
549167|NCT01223313|Woman's Condom|woman's condom
549168|NCT01223313|Female Condom|female condom
549169|NCT01223313|Condom|condom
549170|NCT01223287|NICHD Neonatal Research Network|nichd neonatal research network
549171|NCT01223287|Extremely Low Birth Weight (ELBW)|extremely low birth weight (elbw)
549172|NCT01223287|Very Low Birth Weight (VLBW)|very low birth weight (vlbw)
549173|NCT01223287|Prematurity|prematurity
549174|NCT01223287|Mechanical ventilation|mechanical ventilation
549175|NCT01223287|Chronic Lung Disease (CLD)|chronic lung disease (cld)
549176|NCT01223274|NICHD Neonatal Research Network|nichd neonatal research network
549177|NCT01223274|Extremely Low Birth Weight (ELBW)|extremely low birth weight (elbw)
549178|NCT01223274|Very Low Birth Weight (VLBW)|very low birth weight (vlbw)
549179|NCT01223274|Prematurity|prematurity
549180|NCT01223274|Mechanical ventilation|mechanical ventilation
549181|NCT01223274|Positive-Pressure Ventilation|positive-pressure ventilation
549182|NCT01223274|Surfactant|surfactant
549183|NCT01223274|Intubation|intubation
549184|NCT01223274|Pulse oximetry|pulse oximetry
549185|NCT01223274|Oxygen saturation|oxygen saturation
549186|NCT01223261|NICHD Neonatal Research Network|nichd neonatal research network
549187|NCT01223261|Very Low Birth Weight (VLBW)|very low birth weight (vlbw)
549188|NCT01223261|Extremely Low Birth Weight (ELBW)|extremely low birth weight (elbw)
549189|NCT01223261|Prematurity|prematurity
549190|NCT01223261|Laparotomy|laparotomy
549191|NCT01223261|Drainage|drainage
549192|NCT01223261|Isolated intestinal perforation|isolated intestinal perforation
549193|NCT01223261|Focal intestinal performation|focal intestinal performation
549194|NCT01223248|radiation|radiation
549195|NCT01223248|Hypofractionated Image- Guided|hypofractionated image- guided
549196|NCT01223248|IGIMRT|igimrt
549198|NCT01223248|10-154|10-154
549199|NCT01223235|FALLOPIAN TUBE|fallopian tube
549200|NCT01223235|OVARY|ovary
549201|NCT01223235|PERITONEUM|peritoneum
549202|NCT01223235|BEVACIZUMAB (AVASTIN)|bevacizumab (avastin)
549203|NCT01223235|GLOBO H-KLH CONJUGATE|globo h-klh conjugate
549204|NCT01223235|MUC-1 KLH|muc-1 klh
549205|NCT01223235|OPT-821|opt-821
549206|NCT01223235|TF (C) - KLH|tf (c) - klh
549207|NCT01223235|TN(C)-KLH|tn(c)-klh
549208|NCT01223235|10-099|10-099
549209|NCT01223222|Uncomplicated skin infections|uncomplicated skin infections
549210|NCT01223222|Impetigo|impetigo
549211|NCT01223222|Gram-negative|gram-negative
549212|NCT01223222|Diagnosis of uncomplicated, Gram-positive, skin infection. This may include patients with mild eczema/dermatoses such as atopic dermatitis.|diagnosis of uncomplicated, gram-positive, skin infection. this may include patients with mild eczema/dermatoses such as atopic dermatitis.
549213|NCT01223222|Gram-positive organisms which in the opinion of the investigator are causative for infection of the lesion(s),|gram-positive organisms which in the opinion of the investigator are causative for infection of the lesion(s),
549214|NCT01223209|Cancer|cancer
549215|NCT01223209|Carcinoma|carcinoma
549216|NCT01223209|Curative surgery|curative surgery
549217|NCT01223209|Curative surgery for carcinoma at least three months and not more than 5 years prior to treatment start|curative surgery for carcinoma at least three months and not more than 5 years prior to treatment start
549218|NCT01223196|Type 2 Diabetes, Thiazolidinediones, TIMP-3, TACE, TNF-a,|type 2 diabetes, thiazolidinediones, timp-3, tace, tnf-a,
549219|NCT01223196|insulin resistance|insulin resistance
549220|NCT01223183|cystic fibrosis|cystic fibrosis
549221|NCT01223183|nuclear medicine|nuclear medicine
549222|NCT01223183|aerosol|aerosol
549223|NCT01223183|nebulizer|nebulizer
549224|NCT01223170|Tailoring|tailoring
549225|NCT01223170|Cardiac rehabilitation|cardiac rehabilitation
549226|NCT01223170|Internet based intervention|internet based intervention
549227|NCT01223170|Exercise|exercise
549228|NCT01223170|Cardiovascular Disease rehabilitation|cardiovascular disease rehabilitation
549229|NCT01223157|obesity|obesity
549230|NCT01223157|endocannabinoids|endocannabinoids
549231|NCT01223144|Cognition|cognition
549232|NCT01223144|orbitofrontal cortex|orbitofrontal cortex
549233|NCT01223144|Iowa Gambling Task|iowa gambling task
549234|NCT01223144|facial emotion recognition|facial emotion recognition
549235|NCT01223118|Oocyte|oocyte
549236|NCT01223118|vitrification|vitrification
549237|NCT01223118|IVF|ivf
549238|NCT01223118|PGD|pgd
549239|NCT01223118|embryo biopsy|embryo biopsy
549240|NCT01223105|slow freeze|slow freeze
549241|NCT01223105|cryopreservation|cryopreservation
549242|NCT01223105|vitrification|vitrification
549243|NCT01223105|oocyte preservation|oocyte preservation
549244|NCT01223092|IVF|ivf
549245|NCT01223092|infertility|infertility
549246|NCT01223092|DNA|dna
549247|NCT01223079|r-hFSH|r-hfsh
549248|NCT01223079|r-hLH|r-hlh
549249|NCT01223066|Macrolane|macrolane
549250|NCT01223053|Sprain|sprain
549251|NCT01223053|Strain|strain
549252|NCT01223053|Pain|pain
549253|NCT01223053|Ankle Pain|ankle pain
549254|NCT01223053|Knee Pain|knee pain
549255|NCT01223053|Wrist Pain|wrist pain
549256|NCT01223053|Hand Pain|hand pain
549257|NCT01223027|Dovitinib|dovitinib
549258|NCT01223027|TKI|tki
549259|NCT01223027|Renal cell cancer|renal cell cancer
549260|NCT01223027|RCC|rcc
549261|NCT01223027|mRCC|mrcc
549262|NCT01223014|Radioactive|radioactive
549263|NCT01223014|ADME|adme
549264|NCT01223014|Neuropathic pain|neuropathic pain
549265|NCT01223001|Depression|depression
549266|NCT01223001|Traumatic brain injury|traumatic brain injury
549267|NCT01223001|Duloxetine|duloxetine
549268|NCT01223001|Cymbalta|cymbalta
549269|NCT01223001|impaired cognitive function|impaired cognitive function
549270|NCT01222975|risperidone fasting study|risperidone fasting study
549271|NCT01222936|LBH581|lbh581
549272|NCT01222936|Panobinostat|panobinostat
549273|NCT01222936|Small Cell Lung Carcinoma|small cell lung carcinoma
549274|NCT01222923|Risperidone fed study|risperidone fed study
549275|NCT01222910|Valacyclovir hydrochloride fasting study|valacyclovir hydrochloride fasting study
549276|NCT01222897|Valacyclovir hydrochloride fed study|valacyclovir hydrochloride fed study
549277|NCT01222871|Treatment|treatment
549278|NCT01222858|Obesity|obesity
549279|NCT01222858|Primary Care|primary care
549280|NCT01222858|Internet|internet
549281|NCT01222858|Technology|technology
549282|NCT01222858|Behavior Modification|behavior modification
549283|NCT01222819|Febrile neutropenia|febrile neutropenia
549284|NCT01222819|growth factors|growth factors
549285|NCT01222819|leukemia|leukemia
549286|NCT01222806|Functional Magnetic Resonance Imaging (fMRI)|functional magnetic resonance imaging (fmri)
549287|NCT01222806|Cocaine|cocaine
549288|NCT01222806|Cue-Induced Craving|cue-induced craving
549289|NCT01222806|Repetitive TMS (rTMS)|repetitive tms (rtms)
549290|NCT01222806|Cocaine Craving|cocaine craving
549291|NCT01222793|High Weight Gain Liability (HWLA)|high weight gain liability (hwla)
549292|NCT01222793|Antipsychotic|antipsychotic
549293|NCT01222793|Obesity|obesity
549294|NCT01222793|Low Weight Gain|low weight gain
549295|NCT01222793|Schizophrenia|schizophrenia
549296|NCT01222793|Food Craving|food craving
549297|NCT01222780|Hematologic Malignancies|hematologic malignancies
549298|NCT01222780|Vincristine Sulfate|vincristine sulfate
549299|NCT01222780|Maximum Tolerated Dose|maximum tolerated dose
549300|NCT01222780|Pharmacokinetics|pharmacokinetics
549301|NCT01222780|Solid Tumors|solid tumors
549302|NCT01222780|Cancer|cancer
549303|NCT01222780|Pediatrics|pediatrics
549304|NCT01222780|Sarcoma|sarcoma
549305|NCT01222780|Wilms Tumor|wilms tumor
549306|NCT01222780|Leukemia|leukemia
549307|NCT01222780|Lymphoma|lymphoma
549308|NCT01222780|Brain Tumor|brain tumor
549309|NCT01222767|EFT|eft
549310|NCT01222767|PNET|pnet
549311|NCT01222767|EOE|eoe
549312|NCT01222754|Newly Diagnosed|newly diagnosed
549313|NCT01222754|DIPG|dipg
549314|NCT01222754|Radiation Therapy|radiation therapy
549315|NCT01222754|CC-5013|cc-5013
549316|NCT01222754|XRT|xrt
549317|NCT01222754|Brain Tumor|brain tumor
549318|NCT01222754|Glioma|glioma
549319|NCT01222754|Pediatrics|pediatrics
549320|NCT01222741|AIRE- Autoimmune Regulator Gene|aire- autoimmune regulator gene
549321|NCT01222741|APECED- Autoimmune Polyendocrinopathy-Candidiasis Ectodermal Dystrophy|apeced- autoimmune polyendocrinopathy-candidiasis ectodermal dystrophy
549322|NCT01222741|CGD (Chronic Granulomatous Disease)|cgd (chronic granulomatous disease)
549323|NCT01222741|CMC- Chronic Mucocutaneous Candidiasis|cmc- chronic mucocutaneous candidiasis
549324|NCT01222728|PET Imaging|pet imaging
549325|NCT01222728|Vestibular Schwannoma|vestibular schwannoma
549326|NCT01222728|Neurofibromatosis|neurofibromatosis
549327|NCT01222728|Neurofibromatosis Type 2|neurofibromatosis type 2
549328|NCT01222728|NF2|nf2
549329|NCT01222702|CDIFF|cdiff
549330|NCT01222702|CDAD|cdad
549331|NCT01222702|CDI|cdi
549332|NCT01222702|Clostridium difficile infection|clostridium difficile infection
549333|NCT01222676|transitional cell carcinoma of the bladder|transitional cell carcinoma of the bladder
549334|NCT01222676|stage II bladder cancer|stage ii bladder cancer
549335|NCT01222676|stage III bladder cancer|stage iii bladder cancer
549336|NCT01222676|stage IV bladder cancer|stage iv bladder cancer
549337|NCT01222663|peritonitis|peritonitis
549338|NCT01222663|septic shock|septic shock
549339|NCT01222663|hemoperfusion|hemoperfusion
549340|NCT01222663|Polymyxin B|polymyxin b
549341|NCT01222663|endotoxin|endotoxin
549342|NCT01222650|Benign Prostatic Hyperplasia|benign prostatic hyperplasia
549343|NCT01222650|I-PSS|i-pss
549344|NCT01222650|α1A-AR antagonist|α1a-ar antagonist
549345|NCT01222637|advanced solid cancers|advanced solid cancers
549346|NCT01222637|metastatic solid cancers|metastatic solid cancers
549347|NCT01222624|advanced solid malignancies|advanced solid malignancies
549348|NCT01222611|HIV|hiv
549349|NCT01222611|HCV|hcv
549350|NCT01222611|HIV/HCV|hiv/hcv
549351|NCT01222611|Coinfection|coinfection
549352|NCT01222611|Fosamprenavir|fosamprenavir
549353|NCT01222585|Metronidazole|metronidazole
549354|NCT01222585|Neonate|neonate
549355|NCT01222585|Premature|premature
549356|NCT01222585|Sepsis|sepsis
549357|NCT01222585|Necrotizing enterocolitis|necrotizing enterocolitis
549358|NCT01222572|radiation therapy|radiation therapy
549359|NCT01222572|stereotactic radiotherapy|stereotactic radiotherapy
549360|NCT01222572|stereotactic boost|stereotactic boost
549361|NCT01222559|Cartilage defects|cartilage defects
549362|NCT01222559|Knee joint|knee joint
549363|NCT01222559|Femoral Condyle|femoral condyle
549364|NCT01222507|tinnitus|tinnitus
549365|NCT01222507|cognition|cognition
549366|NCT01222507|brain processing speed|brain processing speed
549367|NCT01222507|Brain Fitness Program|brain fitness program
549368|NCT01222507|Posit Science|posit science
549369|NCT01222494|Child Psychiatry|child psychiatry
549370|NCT01222494|Obesity|obesity
549371|NCT01222494|Antipsychotic|antipsychotic
549372|NCT01222481|Head and Neck Cancer|head and neck cancer
549373|NCT01222481|Functional Status|functional status
549374|NCT01222481|Cognitive Status|cognitive status
549375|NCT01222481|Neurocognitive Assessments|neurocognitive assessments
549376|NCT01222481|Performance-based Assessments|performance-based assessments
549377|NCT01222481|Cancer|cancer
549378|NCT01222481|Function|function
549379|NCT01222481|Cognition|cognition
549380|NCT01222481|Quality of Life|quality of life
549381|NCT01222468|Spasticity, Spinal Cord Injury|spasticity, spinal cord injury
549382|NCT01222455|Phase 1|phase 1
549383|NCT01222455|Healthy volunteers|healthy volunteers
549384|NCT01222455|Volunteers with hepatic impairment|volunteers with hepatic impairment
549385|NCT01222455|Pharmacokinetics|pharmacokinetics
549386|NCT01222455|Fostamatinib|fostamatinib
549387|NCT01222442|Respiratory disease|respiratory disease
549388|NCT01222442|Bronchiolitis|bronchiolitis
549389|NCT01222442|Emphysema|emphysema
549390|NCT01222442|Lung disease causing persistent narrowing of the airways|lung disease causing persistent narrowing of the airways
549391|NCT01222390|Breast Cancer Reconstruction|breast cancer reconstruction
549392|NCT01222390|Tissue Expander|tissue expander
549393|NCT01222390|3-D Camera|3-d camera
549394|NCT01222390|Breast Reconstruction|breast reconstruction
549395|NCT01222390|Crescentric|crescentric
549396|NCT01222390|Expander Profile|expander profile
549397|NCT01222390|Fill-Volume|fill-volume
549398|NCT01222390|Lower Pole|lower pole
549399|NCT01222390|Upper Pole|upper pole
549400|NCT01222390|Acellular Dermis|acellular dermis
549401|NCT01222390|3-D Imaging|3-d imaging
549402|NCT01222364|NICHD Neonatal Research Network|nichd neonatal research network
549403|NCT01222364|Extremely Low Birth Weight (ELBW)|extremely low birth weight (elbw)
549404|NCT01222364|Very Low Birth Weight (VLBW)|very low birth weight (vlbw)
549405|NCT01222364|Prematurity|prematurity
549406|NCT01222351|Alzheimer's disease|alzheimer's disease
549407|NCT01222351|Positron emission tomography|positron emission tomography
549408|NCT01222351|Biomarker|biomarker
549409|NCT01222351|Plasma Aβ|plasma aβ
549410|NCT01222351|Brain amyloid plaque load|brain amyloid plaque load
549411|NCT01222338|Mycobacterium|mycobacterium
549412|NCT01222338|MDR-TB|mdr-tb
549413|NCT01222338|XDR-TB|xdr-tb
549414|NCT01222338|HIV|hiv
549415|NCT01222338|HCV|hcv
549416|NCT01222325|kidney calculi|kidney calculi
549417|NCT01222325|urolithiasis|urolithiasis
549418|NCT01222325|urologic surgical procedures|urologic surgical procedures
549419|NCT01222325|extracorporeal shockwave lithotripsy|extracorporeal shockwave lithotripsy
549420|NCT01222312|advanced NSCLC|advanced nsclc
549421|NCT01222312|oxaliplatin|oxaliplatin
549422|NCT01222312|cisplatin|cisplatin
549423|NCT01222312|docetaxel|docetaxel
549424|NCT01222312|locally advanced or metastatic non small cell lung cancer (stage IIIB-IV)|locally advanced or metastatic non small cell lung cancer (stage iiib-iv)
549425|NCT01222286|Smoldering Multiple Myeloma|smoldering multiple myeloma
549426|NCT01222273|cystic fibrosis|cystic fibrosis
549427|NCT01222273|Allergic bronchopulmonary aspergillosis|allergic bronchopulmonary aspergillosis
549428|NCT01222273|A. fumigatus|a. fumigatus
549429|NCT01222273|Immune response|immune response
549430|NCT01222260|Amyloidosis|amyloidosis
549431|NCT01222260|Dexamethasone|dexamethasone
549432|NCT01222260|Bendamustine|bendamustine
549433|NCT01222260|Relapsed AL Amyloidosis|relapsed al amyloidosis
549434|NCT01222247|Betamethasone|betamethasone
549435|NCT01222247|Steroids|steroids
549436|NCT01222247|Perinatology|perinatology
549437|NCT01222247|Late Preterm|late preterm
549438|NCT01222221|adult gliosarcoma|adult gliosarcoma
549439|NCT01222221|adult giant cell glioblastoma|adult giant cell glioblastoma
549440|NCT01222221|adult glioblastoma|adult glioblastoma
549441|NCT01222208|Bowel resection|bowel resection
549442|NCT01222195|Myelodysplastic Syndrome|myelodysplastic syndrome
549443|NCT01222195|Red cell transfusion independence|red cell transfusion independence
549444|NCT01222195|Darbepoetin alfa|darbepoetin alfa
549445|NCT01222195|Lenalidomide|lenalidomide
549446|NCT01222195|CC-5013|cc-5013
549447|NCT01222195|Revlimid|revlimid
549448|NCT01222195|Aranesp|aranesp
549449|NCT01222195|Erythropoietin|erythropoietin
549450|NCT01222195|Erythropoiesis Stimulating Protein|erythropoiesis stimulating protein
549451|NCT01222182|low density lipoprotein (LDL) cholesterol|low density lipoprotein (ldl) cholesterol
549452|NCT01222182|statin|statin
549453|NCT01222182|dose equivalent|dose equivalent
549454|NCT01222182|Hypercholesterolemia (defined by LDL guidelines)|hypercholesterolemia (defined by ldl guidelines)
549455|NCT01222169|Anesthesia|anesthesia
549456|NCT01222169|Children|children
549457|NCT01222169|Larynx|larynx
549458|NCT01222156|Cardiac arrhythmias|cardiac arrhythmias
549459|NCT01222156|Catheter ablation|catheter ablation
549460|NCT01222156|Electrophysiology|electrophysiology
549461|NCT01222156|Magnetic|magnetic
549462|NCT01222156|Mapping|mapping
549463|NCT01222156|Remote navigation|remote navigation
549464|NCT01222143|AML|aml
549465|NCT01222143|NOVE-HiDAC|nove-hidac
549466|NCT01222143|Nilotinib|nilotinib
549467|NCT01222130|HIV|hiv
549468|NCT01222130|Infant infection|infant infection
549469|NCT01222130|Diagnosis|diagnosis
549470|NCT01222130|Non-virological algorithm|non-virological algorithm
549471|NCT01222117|Acute Limb Ischemia|acute limb ischemia
549472|NCT01222104|vascular closure|vascular closure
549473|NCT01222104|Angio-Seal|angio-seal
549474|NCT01222104|Interventional radiology|interventional radiology
549475|NCT01222104|femoral artery|femoral artery
549476|NCT01222078|newly diagnosed type 1 diabetes mellitus|newly diagnosed type 1 diabetes mellitus
549477|NCT01222078|re-treatment|re-treatment
549478|NCT01222078|intravenous otelixizumab|intravenous otelixizumab
549479|NCT01222078|beta-cell preservation|beta-cell preservation
549480|NCT01222065|Glaucoma|glaucoma
549481|NCT01222065|Neurotubules|neurotubules
549482|NCT01222065|Birefringence|birefringence
550058|NCT01219712|NT-proBNP|nt-probnp
549483|NCT01222065|Retinal Nerve Fiber Layer (RNFL)|retinal nerve fiber layer (rnfl)
549484|NCT01222052|high risk breast cancer|high risk breast cancer
549485|NCT01222052|low risk breast cancer|low risk breast cancer
549487|NCT01222052|urokinase-type plasminogen activator|urokinase-type plasminogen activator
549488|NCT01222052|PAI|pai
549489|NCT01222052|plasminogen activator inhibitor-type|plasminogen activator inhibitor-type
549490|NCT01222039|Graft versus host disease|graft versus host disease
549491|NCT01222039|Mesenchymal stem cell|mesenchymal stem cell
549492|NCT01222039|Allogeneic mesenchymal stem cell|allogeneic mesenchymal stem cell
549493|NCT01222039|Adipose tissue|adipose tissue
549494|NCT01222039|Allotransplant|allotransplant
549495|NCT01222039|Allogenic|allogenic
549496|NCT01222039|Mesenchymal Stem Cells|mesenchymal stem cells
549497|NCT01222039|Immune System Diseases|immune system diseases
549498|NCT01222039|Chronic|chronic
549499|NCT01222039|Expanded|expanded
549500|NCT01222026|Primary Hyperparathyroidism|primary hyperparathyroidism
549501|NCT01222026|Osteopenia|osteopenia
549502|NCT01222026|Osteoporosis|osteoporosis
549503|NCT01221987|Human papillomavirus|human papillomavirus
549504|NCT01221987|neoplasia|neoplasia
549505|NCT01221974|Hydrosalpinx or infertility|hydrosalpinx or infertility
549506|NCT01221961|Major spine surgery|major spine surgery
549507|NCT01221961|Hemoglobin|hemoglobin
549508|NCT01221961|Blood transfusion|blood transfusion
549509|NCT01221948|Deep Brain Stimulation|deep brain stimulation
549510|NCT01221948|Parkinson's Disease|parkinson's disease
549511|NCT01221935|retrospective chart review study|retrospective chart review study
549512|NCT01221935|desvenlafaxine utilization|desvenlafaxine utilization
549513|NCT01221935|psychiatrists and primary care physicians|psychiatrists and primary care physicians
549514|NCT01221935|treatment of major depressive disorder|treatment of major depressive disorder
549515|NCT01221909|bleeding|bleeding
549516|NCT01221909|dacryocystorhinostomy|dacryocystorhinostomy
549517|NCT01221909|operative duration|operative duration
549518|NCT01221896|Localization of a parathyroid adenoma in patients with primary hyperparathyroidism.|localization of a parathyroid adenoma in patients with primary hyperparathyroidism.
549519|NCT01221883|Posttraumatic Stress|posttraumatic stress
549520|NCT01221883|Prevention|prevention
549521|NCT01221883|Diazepam|diazepam
549522|NCT01221870|Metastatic breast cancer|metastatic breast cancer
549523|NCT01221870|First-line therapy|first-line therapy
549524|NCT01221870|Tesetaxel|tesetaxel
549525|NCT01221870|Oral taxane|oral taxane
549526|NCT01221857|Double Umbilical Cord Blood Stem Cell Transplantation|double umbilical cord blood stem cell transplantation
549527|NCT01221857|Hematological Malignancies|hematological malignancies
549528|NCT01221857|HLA Mismatched Donors|hla mismatched donors
549529|NCT01221857|Cord Blood Transplantation|cord blood transplantation
549530|NCT01221844|Lactoferrin|lactoferrin
549531|NCT01221844|Pregnancy|pregnancy
549532|NCT01221844|Hereditary Thrombophilia|hereditary thrombophilia
549533|NCT01221844|Iron deficiency|iron deficiency
549534|NCT01221844|Iron deficiency anemia|iron deficiency anemia
549535|NCT01221818|Inflammatory Bowel Disease|inflammatory bowel disease
549536|NCT01221805|deep venous thrombosis|deep venous thrombosis
549537|NCT01221805|pulmonary embolism|pulmonary embolism
549538|NCT01221805|venous thromboembolism|venous thromboembolism
549539|NCT01221805|D-dimer|d-dimer
549540|NCT01221805|Wells score|wells score
549541|NCT01221805|Wells clinical pretest probability|wells clinical pretest probability
549542|NCT01221792|PTSD|ptsd
549543|NCT01221792|Anxiety|anxiety
549544|NCT01221792|Trauma|trauma
549545|NCT01221792|Assault|assault
549546|NCT01221792|Victim|victim
549547|NCT01221792|Witness|witness
549548|NCT01221792|Post Traumatic Stress Disorder|post traumatic stress disorder
549549|NCT01221792|Combat veteran|combat veteran
549550|NCT01221792|Flashbacks|flashbacks
549551|NCT01221792|Nightmares|nightmares
549552|NCT01221792|Sleep Disturbance|sleep disturbance
549553|NCT01221792|Hyperarousal|hyperarousal
549554|NCT01221792|Numbness|numbness
549555|NCT01221792|Avoidance|avoidance
549556|NCT01221779|Intensive language therapy|intensive language therapy
549557|NCT01221779|Anomia|anomia
549558|NCT01221779|Magnetic Resonance Imaging|magnetic resonance imaging
549559|NCT01221766|adnexal|adnexal
549560|NCT01221766|hair and nail|hair and nail
549561|NCT01221766|chronic graft vs host disease|chronic graft vs host disease
549562|NCT01221766|children|children
549563|NCT01221753|SSCHN|sschn
549564|NCT01221753|HPV|hpv
549565|NCT01221753|IMRT|imrt
549566|NCT01221740|To show that patients with greater pain sensitivity|to show that patients with greater pain sensitivity
549567|NCT01221740|will show greater improvement in their symptoms|will show greater improvement in their symptoms
549568|NCT01221740|(self-reported pain intensity, mood, sleep, and|(self-reported pain intensity, mood, sleep, and
711348|NCT00585169|Pathological Gambling|pathological gambling
549569|NCT01221740|quality of life) than those with lower pain|quality of life) than those with lower pain
549570|NCT01221740|sensitivity, based on QST, after taking milnacipran.|sensitivity, based on qst, after taking milnacipran.
549571|NCT01221740|To compare outcome differences|to compare outcome differences
549572|NCT01221740|(pain intensity, mood, activity interference,|(pain intensity, mood, activity interference,
549662|NCT01221454|Liver Failure|liver failure
549573|NCT01221740|sleep, and side effects) with those patients|sleep, and side effects) with those patients
549574|NCT01221740|who are either taking or not taking opioids for|who are either taking or not taking opioids for
549575|NCT01221740|their pain 10 weeks after being prescribed milnacipran.|their pain 10 weeks after being prescribed milnacipran.
549576|NCT01221740|To show that patients who are older, male,|to show that patients who are older, male,
549577|NCT01221740|with more medical comorbidities, greater disability,|with more medical comorbidities, greater disability,
549578|NCT01221740|and longer pain duration will report less improvement|and longer pain duration will report less improvement
549579|NCT01221740|(pain, mood, sleep, health-related quality of life)|(pain, mood, sleep, health-related quality of life)
549580|NCT01221740|and treatment satisfaction while taking milnacipran|and treatment satisfaction while taking milnacipran
549581|NCT01221740|compared with others without such characteristics.|compared with others without such characteristics.
549582|NCT01221740|identify patients back or neck pain|identify patients back or neck pain
549583|NCT01221740|greater 6 months|greater 6 months
549584|NCT01221740|QST|qst
549585|NCT01221740|10 weeks|10 weeks
549586|NCT01221740|milnacipran|milnacipran
549587|NCT01221740|pain intensity|pain intensity
549588|NCT01221740|mood|mood
549589|NCT01221740|activity|activity
549590|NCT01221740|interference|interference
549591|NCT01221740|sleep|sleep
549592|NCT01221740|side effects|side effects
549593|NCT01221740|age|age
549594|NCT01221740|gender|gender
549595|NCT01221740|medical comorbidities|medical comorbidities
549596|NCT01221740|pain diagnosis|pain diagnosis
549597|NCT01221740|pain duration|pain duration
549598|NCT01221740|disability status|disability status
549599|NCT01221727|Amgen|amgen
549600|NCT01221727|Phase 1|phase 1
549601|NCT01221727|Postmenopausal|postmenopausal
549602|NCT01221727|Osteoporosis|osteoporosis
549603|NCT01221714|nutritional supplements|nutritional supplements
549604|NCT01221714|supplements|supplements
549605|NCT01221714|vitamins|vitamins
549606|NCT01221714|omega-3|omega-3
549607|NCT01221714|Amerisciences|amerisciences
549608|NCT01221714|Carlos Montesinos|carlos montesinos
549609|NCT01221701|depression|depression
549610|NCT01221701|psychological treatments|psychological treatments
549611|NCT01221701|Cognitive Behavioral Therapy|cognitive behavioral therapy
549612|NCT01221701|child social/emotional functioning|child social/emotional functioning
549613|NCT01221701|parenting|parenting
549614|NCT01221701|home visitation|home visitation
549615|NCT01221688|Sentinel lymph node biopsy (SLNB)|sentinel lymph node biopsy (slnb)
549616|NCT01221688|large operable breast cancer|large operable breast cancer
549617|NCT01221688|neoadjuvant chemotherapy|neoadjuvant chemotherapy
549618|NCT01221688|patients with large operable breast cancer after neoadjuvant chemotherapy (NAC)|patients with large operable breast cancer after neoadjuvant chemotherapy (nac)
549619|NCT01221675|Small Cell Lung Cancer or CEA-expressing Non Small Cell Lung Carcinoma (NSCLC)|small cell lung cancer or cea-expressing non small cell lung carcinoma (nsclc)
549620|NCT01221675|Radio Immunotherapy|radio immunotherapy
549621|NCT01221675|Lutetium|lutetium
549622|NCT01221675|patient ≥ 18 years of age with CEA-positive SCLC in partial response|patient ≥ 18 years of age with cea-positive sclc in partial response
549623|NCT01221675|or who failed at least two lines of standard radiation and/or chemotherapy|or who failed at least two lines of standard radiation and/or chemotherapy
549624|NCT01221675|or Patients with histologic diagnosis of NSCLC|or patients with histologic diagnosis of nsclc
549625|NCT01221662|Siwu tang|siwu tang
549626|NCT01221662|brain hypoperfusion|brain hypoperfusion
549627|NCT01221662|cognition function|cognition function
549628|NCT01221623|Peyronie's Disease|peyronie's disease
549629|NCT01221623|penile plaque|penile plaque
549630|NCT01221623|penile curvature|penile curvature
549631|NCT01221610|Stenosis|stenosis
549632|NCT01221610|Occlusions|occlusions
549633|NCT01221610|SFA|sfa
549634|NCT01221610|PTA|pta
549635|NCT01221610|POBA|poba
549636|NCT01221610|DRB|drb
549637|NCT01221597|Peyronie's Disease|peyronie's disease
549638|NCT01221597|penile plaque|penile plaque
549639|NCT01221597|penile curvature|penile curvature
549640|NCT01221584|Dyslipidaemia|dyslipidaemia
549641|NCT01221584|LDL-C goals|ldl-c goals
549642|NCT01221584|guidelines|guidelines
549643|NCT01221571|Phase I|phase i
549644|NCT01221571|Dose escalation|dose escalation
549645|NCT01221571|AFM 13|afm 13
549646|NCT01221571|Natural killer cell|natural killer cell
549647|NCT01221545|Diabetes Mellitus|diabetes mellitus
549648|NCT01221519|Phase I|phase i
549649|NCT01221519|Bioavailability|bioavailability
549650|NCT01221519|Type 2 Diabetes Mellitus|type 2 diabetes mellitus
549651|NCT01221519|Diabetic treatment|diabetic treatment
549652|NCT01221519|Metformin|metformin
549653|NCT01221519|High blood sugar|high blood sugar
549654|NCT01221506|unresectable|unresectable
549655|NCT01221506|metastatic|metastatic
549656|NCT01221506|clear cell renal carcinoma|clear cell renal carcinoma
549657|NCT01221493|solitary pulmonary nodules|solitary pulmonary nodules
549658|NCT01221493|transbronchial lung biopsy|transbronchial lung biopsy
549659|NCT01221493|endobronchial ultrasound|endobronchial ultrasound
549660|NCT01221454|ABMSC|abmsc
549661|NCT01221454|Allogenic bone marrow mesenchymal stem cells|allogenic bone marrow mesenchymal stem cells
549964|NCT01220128|WT1|wt1
549663|NCT01221454|Transplantation|transplantation
549664|NCT01221441|Cartilage|cartilage
549665|NCT01221441|Knee|knee
549666|NCT01221441|Osteoarthritis|osteoarthritis
549667|NCT01221428|Ulcerative colitis|ulcerative colitis
549668|NCT01221428|Mesenchymal Stem Cells|mesenchymal stem cells
549669|NCT01221428|Umbilical Cord|umbilical cord
549670|NCT01221389|hemorrhage|hemorrhage
549671|NCT01221389|plasma|plasma
549672|NCT01221389|coagulopathy|coagulopathy
549673|NCT01221389|trauma|trauma
549674|NCT01221363|Life style disease|life style disease
549675|NCT01221363|Obesity|obesity
549676|NCT01221363|Sedentary behaviour|sedentary behaviour
549677|NCT01221363|Cardiovascular biomarkers|cardiovascular biomarkers
549678|NCT01221350|Asthma|asthma
549679|NCT01221350|Allergic rhinitis|allergic rhinitis
549680|NCT01221350|Respiratory disease|respiratory disease
549681|NCT01221350|Allergy|allergy
549682|NCT01221350|Lipoic acid|lipoic acid
549683|NCT01221350|Thioctic acid|thioctic acid
549684|NCT01221350|Antioxidant|antioxidant
549685|NCT01221350|Oxidative stress|oxidative stress
549686|NCT01221311|stenosis|stenosis
549687|NCT01221311|bile duct|bile duct
549688|NCT01221311|chronic pancreatitis|chronic pancreatitis
549689|NCT01221311|postoperative|postoperative
549690|NCT01221311|post-liver transplant|post-liver transplant
549691|NCT01221285|Cockroach|cockroach
549692|NCT01221285|Immunotherapy|immunotherapy
549693|NCT01221285|Subcutaneous immunotherapy|subcutaneous immunotherapy
549694|NCT01221285|Inner city asthma|inner city asthma
549695|NCT01221272|SPECT MPI|spect mpi
549696|NCT01221246|Acute Middle Cerebral Artery Ischemic Stroke within 18 hours|acute middle cerebral artery ischemic stroke within 18 hours
549697|NCT01221207|diabetic foot ulcers|diabetic foot ulcers
549698|NCT01221207|casting|casting
549699|NCT01221207|wound care|wound care
549700|NCT01221194|diabetes|diabetes
549701|NCT01221194|foot ulcer prevention|foot ulcer prevention
549702|NCT01221194|therapeutic stockings|therapeutic stockings
549703|NCT01221181|Dense deposit disease|dense deposit disease
549704|NCT01221181|C3 nephropathy|c3 nephropathy
549705|NCT01221181|Eculizumab|eculizumab
549706|NCT01221168|prostate|prostate
549707|NCT01221168|cancer|cancer
549708|NCT01221168|genetic|genetic
549709|NCT01221168|epidemiology|epidemiology
549710|NCT01221168|susceptibility|susceptibility
549711|NCT01221155|Musculoskeletal|musculoskeletal
549712|NCT01221142|Hypothermia, ICH|hypothermia, ich
549713|NCT01221129|zinc|zinc
549714|NCT01221129|reticulocyte|reticulocyte
549715|NCT01221129|PBMC|pbmc
549716|NCT01221129|whole blood|whole blood
549717|NCT01221129|transcriptome|transcriptome
549718|NCT01221129|microarray|microarray
549719|NCT01221116|coronary artery disease,|coronary artery disease,
549720|NCT01221116|aortic stenosis,|aortic stenosis,
549721|NCT01221116|heart failure|heart failure
549722|NCT01221103|Dexamethasone|dexamethasone
549723|NCT01221103|Ofatumumab|ofatumumab
549724|NCT01221103|Bendamustine|bendamustine
549725|NCT01221103|Lymphoma, Mantle-Cell|lymphoma, mantle-cell
549726|NCT01221103|Non-Hodgkin lymphoma|non-hodgkin lymphoma
549727|NCT01221090|Type 2 diabetes|type 2 diabetes
549728|NCT01221090|Health disparities|health disparities
549729|NCT01221090|Central Texas|central texas
549730|NCT01221090|PDA|pda
549731|NCT01221090|CDSMP|cdsmp
549732|NCT01221077|NSCLC|nsclc
549733|NCT01221077|Epidermal Growth Factor Receptor|epidermal growth factor receptor
549734|NCT01221077|EGFR|egfr
549735|NCT01221077|Non-small cell lung cancer|non-small cell lung cancer
549736|NCT01221077|Tarceva|tarceva
549737|NCT01221077|Activating mutations|activating mutations
549738|NCT01221077|OSI-906|osi-906
549739|NCT01221077|Chemonaive|chemonaive
549740|NCT01221077|IGF-IR|igf-ir
549741|NCT01221077|Erlotinib|erlotinib
549742|NCT01221064|Breast cancer|breast cancer
549743|NCT01221064|Axillary clearance|axillary clearance
549744|NCT01221064|lymphorrhoea|lymphorrhoea
549745|NCT01221051|third stage of labor,oxytocics, postpartum hemorrhage,|third stage of labor,oxytocics, postpartum hemorrhage,
549746|NCT01221025|Parecoxib;|parecoxib;
549747|NCT01221025|emergence delirium;|emergence delirium;
549748|NCT01221025|postoperative pain;|postoperative pain;
549749|NCT01221025|elderly patients;|elderly patients;
549750|NCT01221025|abdominal surgery|abdominal surgery
549751|NCT01221025|Parecoxib on emergence agitation and postoperative pain|parecoxib on emergence agitation and postoperative pain
549752|NCT01220999|Clinical trial|clinical trial
549753|NCT01220999|CS-1008 mAb|cs-1008 mab
549754|NCT01220999|monoclonal antibody CS-1008|monoclonal antibody cs-1008
549755|NCT01220999|Positron-Emission Tomography|positron-emission tomography
549756|NCT01220999|Pharmacokinetics|pharmacokinetics
549757|NCT01220999|Pharmacodynamics|pharmacodynamics
549758|NCT01220999|apoptosis|apoptosis
549759|NCT01220999|caspases|caspases
549760|NCT01220986|Liver regeneration|liver regeneration
549761|NCT01220986|Innate immune response|innate immune response
549762|NCT01220973|stage IV prostate cancer|stage iv prostate cancer
549763|NCT01220973|stage III prostate cancer|stage iii prostate cancer
549764|NCT01220973|recurrent prostate cancer|recurrent prostate cancer
549765|NCT01220973|stage IIB prostate cancer|stage iib prostate cancer
549766|NCT01220973|stage IIA prostate cancer|stage iia prostate cancer
549767|NCT01220960|art therapy|art therapy
549768|NCT01220960|breast cancer|breast cancer
549770|NCT01220960|young women|young women
549771|NCT01220960|older women|older women
549772|NCT01220960|quality of life|quality of life
549773|NCT01220960|meaning making|meaning making
549774|NCT01220960|support group|support group
549775|NCT01220960|art making|art making
549776|NCT01220960|art symbols|art symbols
549777|NCT01220908|LVRS (Lung Volume Reduction Surgery)|lvrs (lung volume reduction surgery)
549778|NCT01220908|LVRC (Lung Volume Reduction Coil)|lvrc (lung volume reduction coil)
549779|NCT01220908|Emphysema|emphysema
549780|NCT01220908|coil|coil
549781|NCT01220908|RePneu|repneu
549782|NCT01220895|Adoptive cellular therapy|adoptive cellular therapy
549783|NCT01220895|Hematopoietic Stem Cell Transplantation|hematopoietic stem cell transplantation
549784|NCT01220882|Slipped capital femoral epiphysis|slipped capital femoral epiphysis
549785|NCT01220856|Islet transplantation|islet transplantation
549786|NCT01220856|Type 1 diabetes mellitus|type 1 diabetes mellitus
549787|NCT01220843|chronic renal failure|chronic renal failure
549788|NCT01220843|FGF23|fgf23
549789|NCT01220843|Sevelamer carbonate|sevelamer carbonate
549790|NCT01220830|Multiple sclerosis|multiple sclerosis
549791|NCT01220830|RFQMR|rfqmr
549792|NCT01220830|Cytotron|cytotron
549793|NCT01220830|EDSS|edss
549794|NCT01220830|QOL assessment with FAMS|qol assessment with fams
549795|NCT01220817|prostate|prostate
549796|NCT01220817|cancer|cancer
549797|NCT01220817|psa|psa
549798|NCT01220817|psadt|psadt
549799|NCT01220817|pomegranate|pomegranate
549800|NCT01220817|POMx|pomx
549801|NCT01220791|methylprednisolone|methylprednisolone
549802|NCT01220791|IVF|ivf
549803|NCT01220791|progesterone|progesterone
549804|NCT01220791|corticosteroid|corticosteroid
549805|NCT01220791|late follicular phase|late follicular phase
549806|NCT01220791|pregnancy rates|pregnancy rates
549807|NCT01220765|hypoxemia|hypoxemia
549808|NCT01220765|capnography|capnography
549809|NCT01220765|sedation|sedation
549810|NCT01220752|IMRT|imrt
549811|NCT01220752|carbon ion therapy|carbon ion therapy
549812|NCT01220752|paranasal sinus|paranasal sinus
549813|NCT01220752|nasal cavity|nasal cavity
549814|NCT01220752|adenocarcinoma|adenocarcinoma
549815|NCT01220752|squamous cell carcinoma|squamous cell carcinoma
549816|NCT01220739|ischemic stroke|ischemic stroke
549817|NCT01220739|transcranial laser|transcranial laser
549818|NCT01220739|tissue plasminogen activator|tissue plasminogen activator
549819|NCT01220739|therapy|therapy
549820|NCT01220726|OAB|oab
549821|NCT01220713|Traumatic Brain Injury|traumatic brain injury
549822|NCT01220713|Veterans|veterans
549823|NCT01220713|Hyperbaric Oxygen Treatment|hyperbaric oxygen treatment
549824|NCT01220713|OEF/OIF|oef/oif
549825|NCT01220713|Post-Concussive Symptoms|post-concussive symptoms
549826|NCT01220713|Blast Exposure|blast exposure
549827|NCT01220687|Prematurity|prematurity
549828|NCT01220687|Oxygen exposure|oxygen exposure
549829|NCT01220687|Nitric Oxide|nitric oxide
549830|NCT01220674|neuropsychological assessment|neuropsychological assessment
549831|NCT01220674|cognitive impairment|cognitive impairment
549832|NCT01220674|computer-aided diagnostic tool|computer-aided diagnostic tool
549833|NCT01220661|Colorectal Surgery|colorectal surgery
549834|NCT01220661|Surgical Wound Infection|surgical wound infection
549835|NCT01220661|Laparoscopy|laparoscopy
549836|NCT01220661|Anti-Bacterial Agents|anti-bacterial agents
549837|NCT01220648|Chronic myeloid leukemia|chronic myeloid leukemia
549838|NCT01220648|interferon alfa|interferon alfa
549839|NCT01220648|nilotinib|nilotinib
549840|NCT01220648|combination|combination
549841|NCT01220648|CML|cml
549842|NCT01220648|Philadelphia chromosome positive (Ph+) chronic myeloid leukemia patients in chronic phase (CML-CP) after switch from previous CML treatment|philadelphia chromosome positive (ph+) chronic myeloid leukemia patients in chronic phase (cml-cp) after switch from previous cml treatment
549843|NCT01220635|Depressive Symptoms|depressive symptoms
549844|NCT01220635|Depression prevention|depression prevention
549845|NCT01220635|Adolescents|adolescents
549846|NCT01220635|School-Based Services|school-based services
549847|NCT01220635|Health Behavior|health behavior
549848|NCT01220622|Stroke|stroke
549849|NCT01220622|Mild cognitive impairment|mild cognitive impairment
549850|NCT01220622|Nimodipine|nimodipine
549851|NCT01220583|stage I salivary gland cancer|stage i salivary gland cancer
549852|NCT01220583|stage II salivary gland cancer|stage ii salivary gland cancer
549853|NCT01220583|stage III salivary gland cancer|stage iii salivary gland cancer
549854|NCT01220583|high-grade salivary gland mucoepidermoid carcinoma|high-grade salivary gland mucoepidermoid carcinoma
549855|NCT01220583|salivary gland adenocarcinoma|salivary gland adenocarcinoma
549856|NCT01220583|stage IVA salivary gland cancer|stage iva salivary gland cancer
549857|NCT01220583|stage IVB salivary gland cancer|stage ivb salivary gland cancer
549858|NCT01220583|stage IVC salivary gland cancer|stage ivc salivary gland cancer
549859|NCT01220570|breast cancer|breast cancer
549860|NCT01220570|ridaforolimus|ridaforolimus
549861|NCT01220570|ridaforolimus/dalotuzumab combination therapy|ridaforolimus/dalotuzumab combination therapy
549862|NCT01220557|Diabetes mellitus, education, self management|diabetes mellitus, education, self management
549863|NCT01220531|DiGeorge Anomaly|digeorge anomaly
549864|NCT01220531|Thymus Transplantation|thymus transplantation
549865|NCT01220531|DiGeorge Syndrome|digeorge syndrome
549866|NCT01220531|Athymia|athymia
549867|NCT01220531|Low T cell numbers|low t cell numbers
549868|NCT01220531|Immunoreconstitution|immunoreconstitution
549869|NCT01220531|Immunodeficiency|immunodeficiency
549870|NCT01220531|Complete DiGeorge|complete digeorge
549871|NCT01220531|Typical DiGeorge|typical digeorge
549872|NCT01220531|Atypical DiGeorge|atypical digeorge
549873|NCT01220531|Complete DiGeorge Anomaly|complete digeorge anomaly
549874|NCT01220505|scoliosis|scoliosis
549875|NCT01220505|kyphosis|kyphosis
549876|NCT01220505|spinal deformity|spinal deformity
549877|NCT01220505|curvature|curvature
549878|NCT01220505|lordosis|lordosis
549879|NCT01220492|liver cirrhosis|liver cirrhosis
549880|NCT01220492|mesenchymal stem cells|mesenchymal stem cells
549881|NCT01220492|longer term survival|longer term survival
549882|NCT01220492|safety|safety
549883|NCT01220479|Type 1 Diabetes, Bone mineral density, Growth|type 1 diabetes, bone mineral density, growth
549884|NCT01220479|Cardiovascular diseases, Exercise, Training,|cardiovascular diseases, exercise, training,
549885|NCT01220479|Child, Adolescent|child, adolescent
549886|NCT01220440|ADHD|adhd
549887|NCT01220440|Children|children
549888|NCT01220440|Methylphenidate|methylphenidate
549889|NCT01220440|Dextroamphetamine|dextroamphetamine
549890|NCT01220440|Placebo|placebo
549891|NCT01220440|Crossover|crossover
549892|NCT01220440|Double Blind|double blind
549893|NCT01220440|Neuropsychological tests|neuropsychological tests
549894|NCT01220440|Behavioural Questionnaires|behavioural questionnaires
549895|NCT01220427|high-risk prostate cancer|high-risk prostate cancer
549896|NCT01220427|radical prostatectomy|radical prostatectomy
549897|NCT01220427|micro-RNA|micro-rna
549898|NCT01220401|Nightmare|nightmare
549899|NCT01220401|PTSD|ptsd
549900|NCT01220401|Posttraumatic stress disorder|posttraumatic stress disorder
549901|NCT01220401|Suicide|suicide
549902|NCT01220401|Exposure Relaxation Rescription Therapy|exposure relaxation rescription therapy
549903|NCT01220401|Sleep|sleep
549904|NCT01220388|Aldosterone|aldosterone
549905|NCT01220388|L-lysine|l-lysine
549906|NCT01220388|Cortisol|cortisol
549907|NCT01220388|Adrenal glands|adrenal glands
549908|NCT01220375|Mobilization of autologous peripheral blood progenitor cells PBPC|mobilization of autologous peripheral blood progenitor cells pbpc
549909|NCT01220375|Autologous stem cell mobilization|autologous stem cell mobilization
549910|NCT01220375|Multiple Myeloma|multiple myeloma
549911|NCT01220375|Plerixafor|plerixafor
549912|NCT01220362|Analgesia, Epidural|analgesia, epidural
549913|NCT01220362|Urodynamics|urodynamics
549914|NCT01220362|Urinary Retention|urinary retention
549915|NCT01220284|solid tumors|solid tumors
549916|NCT01220284|oral treatment|oral treatment
549917|NCT01220284|platinum compound|platinum compound
549918|NCT01220284|vinca alkaloid|vinca alkaloid
549919|NCT01220284|drug combination|drug combination
549920|NCT01220271|Glioma|glioma
549921|NCT01220271|Glioblastoma|glioblastoma
549922|NCT01220245|endoluminal|endoluminal
549923|NCT01220245|surgical|surgical
549924|NCT01220245|bypass|bypass
549925|NCT01220245|patency|patency
549926|NCT01220245|quality of life|quality of life
549927|NCT01220245|multicentre|multicentre
549928|NCT01220245|RCT|rct
549929|NCT01220245|superficial femoral artery|superficial femoral artery
549930|NCT01220245|vascular patency|vascular patency
549931|NCT01220232|Lersivirine|lersivirine
549932|NCT01220232|UK-453|uk-453
549933|NCT01220232|061|061
549934|NCT01220232|NNRTI|nnrti
549935|NCT01220232|Abacavir|abacavir
549936|NCT01220232|Lamivudine|lamivudine
549937|NCT01220232|Combivir|combivir
549938|NCT01220232|Pharmacokinetics|pharmacokinetics
549939|NCT01220232|Drug Interaction|drug interaction
549940|NCT01220232|HIV|hiv
549941|NCT01220232|AIDS|aids
549942|NCT01220219|pregabalin|pregabalin
549943|NCT01220219|pharmacokinetics|pharmacokinetics
549944|NCT01220219|bioavailability|bioavailability
549945|NCT01220219|bioequivalence|bioequivalence
549946|NCT01220206|ED|ed
549947|NCT01220206|POMx|pomx
549948|NCT01220206|Pomegranate|pomegranate
549949|NCT01220206|Erectile dysfunction|erectile dysfunction
549950|NCT01220180|epilepsy|epilepsy
698602|NCT00637013|RCT|rct
549951|NCT01220180|neuropathic pain|neuropathic pain
549952|NCT01220180|fibromyalgia|fibromyalgia
549953|NCT01220180|post-market surveillance|post-market surveillance
549954|NCT01220180|prospective observational|prospective observational
549955|NCT01220154|ovarian|ovarian
549956|NCT01220154|cancer|cancer
549957|NCT01220154|fallopian tube|fallopian tube
549958|NCT01220154|peritoneal|peritoneal
549959|NCT01220154|intraperitoneal|intraperitoneal
549960|NCT01220154|bevacizumab|bevacizumab
549961|NCT01220154|carboplatin|carboplatin
549962|NCT01220154|paclitaxel|paclitaxel
549963|NCT01220154|chemo-naive|chemo-naive
549966|NCT01220128|tumor antigen|tumor antigen
549967|NCT01220128|immunotherapy|immunotherapy
549968|NCT01220128|breast cancer|breast cancer
549969|NCT01220128|adult|adult
549970|NCT01220115|sickle cell disease|sickle cell disease
549971|NCT01220115|iron over load|iron over load
549972|NCT01220102|acne|acne
549973|NCT01220102|Epiduo|epiduo
549974|NCT01220102|adapalene/ benzoyl peroxide|adapalene/ benzoyl peroxide
549975|NCT01220089|obesity|obesity
549976|NCT01220089|weight loss|weight loss
549977|NCT01220076|Tamoxifen,|tamoxifen,
549978|NCT01220076|Breat Cancer|breat cancer
549979|NCT01220076|Pharmacogenetic|pharmacogenetic
549980|NCT01220076|non metastatic breast cancer, HR +|non metastatic breast cancer, hr +
549981|NCT01220063|RSHF|rshf
549982|NCT01220063|Irinotecan|irinotecan
549983|NCT01220063|Colorectal Cancer|colorectal cancer
549984|NCT01220063|metastases|metastases
549985|NCT01220050|Paricalcitol|paricalcitol
549986|NCT01220050|Renal transplant|renal transplant
549987|NCT01220050|Secondary Hyperparathyroidism|secondary hyperparathyroidism
549988|NCT01220011|Fetoscopic Laser surgery|fetoscopic laser surgery
549989|NCT01220011|Stage 1 Twin - twin transfusion syndrome|stage 1 twin - twin transfusion syndrome
549990|NCT01219998|Postoperative Complications|postoperative complications
549991|NCT01219998|Acute Kidney Failure|acute kidney failure
549992|NCT01219998|Peritoneal Dialysis|peritoneal dialysis
549993|NCT01219998|NGAL|ngal
549994|NCT01219985|positron emission tomography / computed tomography|positron emission tomography / computed tomography
549995|NCT01219985|18F-fluoro-2-deoxyglucose|18f-fluoro-2-deoxyglucose
549996|NCT01219985|liver neoplasm|liver neoplasm
549997|NCT01219985|respiratory motion|respiratory motion
549998|NCT01219972|Bone marrow transplant|bone marrow transplant
549999|NCT01219972|Pulmonary complications|pulmonary complications
550000|NCT01219959|ESRD|esrd
550001|NCT01219959|Diabetes|diabetes
550002|NCT01219959|CAPD|capd
550003|NCT01219946|Chronic Obstructive Pulmonary Disease, symptoms|chronic obstructive pulmonary disease, symptoms
550004|NCT01219920|Metastatic colorectal cancer|metastatic colorectal cancer
550005|NCT01219920|Phase III|phase iii
550006|NCT01219920|FOLFOXIRI|folfoxiri
550007|NCT01219920|FOLFIRI|folfiri
550008|NCT01219894|Coronary Disease|coronary disease
550009|NCT01219894|Stent|stent
550010|NCT01219894|Healing|healing
550011|NCT01219894|Anti-platelet therapy|anti-platelet therapy
550012|NCT01219881|desflurane|desflurane
550013|NCT01219881|sevoflurane|sevoflurane
550014|NCT01219855|Parathyroid Diseases|parathyroid diseases
550015|NCT01219855|Renal Insufficiency|renal insufficiency
550016|NCT01219855|Kidney Failure, Chronic|kidney failure, chronic
550017|NCT01219855|Hyperparathyroidism, Secondary|hyperparathyroidism, secondary
550018|NCT01219855|Vitamin D|vitamin d
550019|NCT01219855|Hyperparathyroidism|hyperparathyroidism
550020|NCT01219855|Kidney Diseases|kidney diseases
550021|NCT01219855|Kidney Failure|kidney failure
550022|NCT01219855|Renal Insufficiency, Chronic|renal insufficiency, chronic
550023|NCT01219842|Intermittent claudication|intermittent claudication
550024|NCT01219842|Health Related Quality of Life|health related quality of life
550025|NCT01219842|Walking performance|walking performance
550026|NCT01219842|Daily walking capacity|daily walking capacity
550027|NCT01219829|Pancreatic intraepithelial neoplasia (PanIN)|pancreatic intraepithelial neoplasia (panin)
550028|NCT01219829|Pancreatic Cancer|pancreatic cancer
550029|NCT01219829|Recurrence of pancreatic cancer|recurrence of pancreatic cancer
550030|NCT01219829|Field Effect|field effect
550031|NCT01219829|Genetic mutations in pancreatic cancer|genetic mutations in pancreatic cancer
550032|NCT01219816|efficacy of Chemo-immunotherapy|efficacy of chemo-immunotherapy
550033|NCT01219803|Dose-Response Relationship, type 2 diabetes,TCM|dose-response relationship, type 2 diabetes,tcm
550034|NCT01219790|Patients with painful vertebral metastases with a prostate cancer with an indication of analgesic treatment.|patients with painful vertebral metastases with a prostate cancer with an indication of analgesic treatment.
550035|NCT01219777|bevacizumab|bevacizumab
550036|NCT01219777|paclitaxel|paclitaxel
550037|NCT01219777|carboplatin|carboplatin
550038|NCT01219777|ovarian|ovarian
550039|NCT01219777|cancer|cancer
550040|NCT01219777|fallopian tube|fallopian tube
550041|NCT01219777|primary peritoneal|primary peritoneal
550042|NCT01219764|Helicobacter pylori infection|helicobacter pylori infection
550043|NCT01219764|quadruple therapy|quadruple therapy
550044|NCT01219764|Amoxicillin|amoxicillin
550045|NCT01219764|Metronidazole|metronidazole
550046|NCT01219764|Clarithromycin|clarithromycin
550047|NCT01219764|Rabeprazole|rabeprazole
550048|NCT01219738|Asthma, airway blood flow, budesonide, glucocorticosteroid.|asthma, airway blood flow, budesonide, glucocorticosteroid.
550049|NCT01219725|Body composition|body composition
550050|NCT01219725|Endothelial function|endothelial function
550051|NCT01219725|Lipoprotein profile|lipoprotein profile
550052|NCT01219725|Inflammatory markers|inflammatory markers
550053|NCT01219725|Aerobic capacity|aerobic capacity
550054|NCT01219725|Thrombotic markers|thrombotic markers
550055|NCT01219725|Arterial stiffness|arterial stiffness
550056|NCT01219725|Cardiac function|cardiac function
550057|NCT01219725|Traditional and emerging cardiovascular disease risk factors|traditional and emerging cardiovascular disease risk factors
550059|NCT01219712|non-cardiac surgery|non-cardiac surgery
550060|NCT01219712|left ventricular dysfunction|left ventricular dysfunction
550061|NCT01219712|cardiac complications|cardiac complications
550062|NCT01219699|advanced solid tumors|advanced solid tumors
550063|NCT01219699|mutation|mutation
550064|NCT01219699|amplification|amplification
550065|NCT01219699|wild type|wild type
550066|NCT01219699|PIK3CA gene|pik3ca gene
550067|NCT01219699|dose-escalation|dose-escalation
550068|NCT01219699|estrogen receptor positive breast cancer|estrogen receptor positive breast cancer
550069|NCT01219686|unipolar depression, escitalopram, pindolol|unipolar depression, escitalopram, pindolol
550070|NCT01219673|Epithelial carcinoma|epithelial carcinoma
550071|NCT01219673|Oropharynx|oropharynx
550072|NCT01219673|Larynx|larynx
550073|NCT01219673|Symptom-management|symptom-management
550074|NCT01219673|Chemoradiation|chemoradiation
550075|NCT01219673|Placebo|placebo
550076|NCT01219673|Armodafinil|armodafinil
550077|NCT01219673|Nuvigil|nuvigil
550078|NCT01219673|Bupropion|bupropion
550079|NCT01219673|Wellbutrin|wellbutrin
550080|NCT01219673|Wellbutrin SR|wellbutrin sr
550081|NCT01219673|Zyban|zyban
550082|NCT01219673|Minocycline|minocycline
550083|NCT01219673|Dynacin|dynacin
550084|NCT01219673|Minocin|minocin
550085|NCT01219673|Minocin PAC|minocin pac
550086|NCT01219673|Myrac|myrac
550087|NCT01219673|Solodyn|solodyn
550088|NCT01219660|sleep|sleep
550089|NCT01219660|apnea|apnea
550090|NCT01219647|Multiple Sclerosis|multiple sclerosis
550091|NCT01219647|Exercise|exercise
550092|NCT01219647|Cognition|cognition
550093|NCT01219621|Symphony DR 2550,|symphony dr 2550,
550094|NCT01219621|Dual Chamber Pacemaker,|dual chamber pacemaker,
550095|NCT01219621|Sorin,|sorin,
550096|NCT01219621|Ela Medical,|ela medical,
550097|NCT01219621|DDD Mode,|ddd mode,
550098|NCT01219621|AAIsafeR2 mode,|aaisafer2 mode,
550099|NCT01219621|AV-Conduction,|av-conduction,
550100|NCT01219621|Reducing Ventricular Pacing,|reducing ventricular pacing,
550101|NCT01219621|Congestive Heart Failure,|congestive heart failure,
550102|NCT01219621|Cardiac Function,|cardiac function,
550103|NCT01219621|Atrial Arrhythmia,|atrial arrhythmia,
550104|NCT01219621|Atrial Fibrillation,|atrial fibrillation,
550105|NCT01219621|Atrial and Ventricular Hemodynamics,|atrial and ventricular hemodynamics,
550106|NCT01219621|Long AV-delays.|long av-delays.
550107|NCT01219621|Ventricular Function,|ventricular function,
550108|NCT01219621|Implantation,|implantation,
550109|NCT01219595|Urinary Tract Infection|urinary tract infection
550111|NCT01219582|Diabetes Mellitus Type-2|diabetes mellitus type-2
550112|NCT01219582|Acarbose|acarbose
550113|NCT01219582|Metformin|metformin
550114|NCT01219582|Drug Therapy, Combination|drug therapy, combination
550115|NCT01219569|blindness|blindness
550116|NCT01219569|ischemic optic neuropathy|ischemic optic neuropathy
550117|NCT01219556|Hypertension|hypertension
550118|NCT01219556|Antihypertensive Agents|antihypertensive agents
550119|NCT01219556|Drug Therapy, Combination|drug therapy, combination
550120|NCT01219556|Olmesartan Medoxomil|olmesartan medoxomil
550121|NCT01219556|Hydrochlorothiazide|hydrochlorothiazide
550122|NCT01219543|Advanced solid malignancies|advanced solid malignancies
550123|NCT01219543|Child-Pugh A to B7 advanced hepatocellular carcinoma|child-pugh a to b7 advanced hepatocellular carcinoma
550124|NCT01219543|EGFR and/or ROS mutant NSCLC|egfr and/or ros mutant nsclc
550125|NCT01219543|Non-smokers with lung metastasis|non-smokers with lung metastasis
550126|NCT01219543|Gastric cancer|gastric cancer
550127|NCT01219543|Solid tumour|solid tumour
550128|NCT01219543|AZD1480|azd1480
550129|NCT01219543|JAK1/JAK2 kinase inhibitor|jak1/jak2 kinase inhibitor
550130|NCT01219530|gestational carrier|gestational carrier
550131|NCT01219530|intended parent|intended parent
550132|NCT01219517|IVF|ivf
550133|NCT01219517|embryo biopsy|embryo biopsy
550134|NCT01219517|DNA fingerprinting|dna fingerprinting
550135|NCT01219517|SNP|snp
550136|NCT01219504|PGD|pgd
550137|NCT01219504|IVF|ivf
550138|NCT01219491|egg donor|egg donor
550139|NCT01219491|recipients|recipients
550140|NCT01219491|donor characteristics|donor characteristics
550141|NCT01219478|To investigate the relationship between retinal thickness (RT) and metabolic risks (MRs) in patients without retinal lesion|to investigate the relationship between retinal thickness (rt) and metabolic risks (mrs) in patients without retinal lesion
698860|NCT00635856|PSA|psa
550142|NCT01219465|Diabetes Mellitus|diabetes mellitus
550143|NCT01219465|Diabetes Mellitus, Type 1|diabetes mellitus, type 1
550144|NCT01219465|mesenchymal stem cells|mesenchymal stem cells
550145|NCT01219465|Umbilical cord|umbilical cord
550146|NCT01219452|Dilated Cardiomyopathy|dilated cardiomyopathy
550147|NCT01219452|Umbilical cord|umbilical cord
550148|NCT01219452|Mesenchymal stem cells|mesenchymal stem cells
550149|NCT01219452|Children|children
550150|NCT01219439|discarded pathological specimens|discarded pathological specimens
550151|NCT01219439|discarded media|discarded media
550152|NCT01219439|IVF|ivf
550153|NCT01219426|Gambling|gambling
550154|NCT01219426|cognitive distortions|cognitive distortions
550155|NCT01219426|assessment tool|assessment tool
550156|NCT01219426|validation|validation
550157|NCT01219426|French|french
550158|NCT01219413|aliskiren|aliskiren
550159|NCT01219413|renin inhibitor|renin inhibitor
550160|NCT01219413|proteinuria|proteinuria
550161|NCT01219413|chronic kidney diseases|chronic kidney diseases
550162|NCT01219413|ACE inhibitor|ace inhibitor
550163|NCT01219400|DPP-4|dpp-4
550164|NCT01219400|GLP-1|glp-1
550165|NCT01219400|Glucagon|glucagon
550166|NCT01219400|Catecholamines|catecholamines
550167|NCT01219400|Counterregulation|counterregulation
550168|NCT01219400|Insulin-treatment|insulin-treatment
550169|NCT01219400|Type 2 diabetes|type 2 diabetes
550171|NCT01219387|inhibin B|inhibin b
550172|NCT01219387|infertility|infertility
550173|NCT01219374|egg donor|egg donor
550174|NCT01219361|Donated embryos|donated embryos
550175|NCT01219348|IDO enzyme|ido enzyme
550176|NCT01219348|Vaccination trial|vaccination trial
550177|NCT01219348|Immunotherapy|immunotherapy
550178|NCT01219348|NSCLC, stage III_IV|nsclc, stage iii_iv
550179|NCT01219348|Indeolamine 2,3 dioxygenase = IDO|indeolamine 2,3 dioxygenase = ido
550180|NCT01219335|IVF|ivf
550181|NCT01219322|general endotracheal anesthesia|general endotracheal anesthesia
550182|NCT01219322|ASA I or II|asa i or ii
550183|NCT01219309|Attention-deficit/hyperactivity disorder|attention-deficit/hyperactivity disorder
550184|NCT01219309|Omega 3/6 fatty acids|omega 3/6 fatty acids
550185|NCT01219309|Developmental coordination disorder|developmental coordination disorder
550186|NCT01219309|Reading/writing difficulties.|reading/writing difficulties.
550187|NCT01219296|infertility|infertility
550188|NCT01219296|IVF|ivf
550189|NCT01219283|PGD|pgd
550190|NCT01219283|IVF|ivf
550191|NCT01219270|Radiocontrast media,|radiocontrast media,
550192|NCT01219270|hyponatremia|hyponatremia
550193|NCT01219257|SpA|spa
550194|NCT01219257|Anti-TNF alpha treatment|anti-tnf alpha treatment
550195|NCT01219257|Ultrasonography|ultrasonography
550196|NCT01219257|Synovitis|synovitis
550197|NCT01219257|Enthesitis|enthesitis
550198|NCT01219244|memory|memory
550199|NCT01219244|diet|diet
550200|NCT01219244|elderly|elderly
550201|NCT01219244|cognition|cognition
550202|NCT01219244|prevention|prevention
550203|NCT01219244|lifestyle|lifestyle
550204|NCT01219231|Exercise|exercise
550205|NCT01219231|elderly|elderly
550206|NCT01219231|cognition|cognition
550207|NCT01219231|prevention|prevention
550208|NCT01219231|cognitive decline|cognitive decline
550209|NCT01219231|Lifestyle|lifestyle
550210|NCT01219218|Extracorporeal Shockwave Therapy|extracorporeal shockwave therapy
550211|NCT01219218|Myocardial Ischemia|myocardial ischemia
550212|NCT01219218|Refractory Angina|refractory angina
550213|NCT01219205|macular edema secondary to retinal benous occlusion|macular edema secondary to retinal benous occlusion
550214|NCT01219179|Extremely Low Birth Weight Infants|extremely low birth weight infants
550215|NCT01219179|Hypernatremia|hypernatremia
550216|NCT01219179|Enteral Sterile Water Feeds|enteral sterile water feeds
550217|NCT01219153|Letrozole ,IVF, poor responders , GnRH antagonist|letrozole ,ivf, poor responders , gnrh antagonist
550218|NCT01219140|POMx|pomx
550219|NCT01219140|Osteopenia|osteopenia
550220|NCT01219140|postmenopausal women|postmenopausal women
550221|NCT01219140|Pomegranate|pomegranate
550222|NCT01219127|Hyperbaric oxygen therapy|hyperbaric oxygen therapy
550223|NCT01219114|Daptomycin|daptomycin
550224|NCT01219114|endocarditis|endocarditis
550225|NCT01219114|complicated skin and skin structure infection|complicated skin and skin structure infection
550226|NCT01219101|Ethinyl estradiol|ethinyl estradiol
550227|NCT01219101|Polycystic ovary syndrome|polycystic ovary syndrome
550228|NCT01219101|Intrauterine insemination|intrauterine insemination
550229|NCT01219049|Diet|diet
550230|NCT01219049|Fibromyalgia|fibromyalgia
550231|NCT01219049|Pain|pain
550232|NCT01219049|Drug|drug
550233|NCT01219049|Amino-acid|amino-acid
550234|NCT01219049|Fatigue|fatigue
550235|NCT01219036|Asthma|asthma
550236|NCT01219036|Non-adherence|non-adherence
550237|NCT01219036|Fractional exhaled nitric oxide|fractional exhaled nitric oxide
550238|NCT01219023|Hand foot syndrome|hand foot syndrome
550239|NCT01219023|Palmar Plantar Erythrodysesthesia|palmar plantar erythrodysesthesia
550240|NCT01219023|chemotherapy|chemotherapy
550241|NCT01219023|Sunitinib|sunitinib
550242|NCT01219023|Capecitebine|capecitebine
550243|NCT01219023|Sildenafil|sildenafil
550244|NCT01219010|Monoclonal Gammopathy of Undetermined Significance|monoclonal gammopathy of undetermined significance
550245|NCT01219010|Smoldering Multiple Myeloma|smoldering multiple myeloma
550246|NCT01219010|Indolent Multiple Myeloma|indolent multiple myeloma
550247|NCT01219010|QT|qt
550248|NCT01219010|Siltuximab|siltuximab
550249|NCT01219010|CNTO 328|cnto 328
550250|NCT01219010|IL-6|il-6
550251|NCT01219010|Monoclonal Antibody|monoclonal antibody
550252|NCT01218997|Alcoholism|alcoholism
550253|NCT01218997|Alcohol dependence|alcohol dependence
550254|NCT01218984|Opiate Dependence|opiate dependence
550255|NCT01218971|Alcohol Dependence|alcohol dependence
550256|NCT01218958|Alcoholism|alcoholism
550257|NCT01218932|primaquine|primaquine
550258|NCT01218932|chloroquine|chloroquine
550259|NCT01218932|pharmacokinetic|pharmacokinetic
550260|NCT01218932|interactions|interactions
550261|NCT01218906|Dengue Fever Fever Dengue Infection|dengue fever fever dengue infection
550262|NCT01218867|Clinical Response|clinical response
550263|NCT01218867|Metastatic Cancer|metastatic cancer
550264|NCT01218867|Immunotherapy|immunotherapy
550265|NCT01218867|Adoptive Cell Therapy|adoptive cell therapy
550266|NCT01218867|Metastatic Melanoma|metastatic melanoma
550267|NCT01218854|Biopsy|biopsy
550268|NCT01218854|Surgical Navigation|surgical navigation
550269|NCT01218854|Image-guided Therapy|image-guided therapy
550270|NCT01218854|CT- Guided Biopsy|ct- guided biopsy
550271|NCT01218854|Cancer|cancer
550272|NCT01218841|Fish oil|fish oil
550273|NCT01218841|Omega-3 fatty acids|omega-3 fatty acids
550274|NCT01218841|Parenteral lipid emulsions|parenteral lipid emulsions
550275|NCT01218841|Immune response|immune response
550276|NCT01218841|Surgery|surgery
550277|NCT01218828|Contrast|contrast
550278|NCT01218828|nephropathy|nephropathy
550279|NCT01218828|cardiac catheterization|cardiac catheterization
550280|NCT01218828|angiography|angiography
550281|NCT01218828|percutaneous coronary intervention is|percutaneous coronary intervention is
550282|NCT01218802|HIV|hiv
550283|NCT01218802|Heart Disease|heart disease
550284|NCT01218802|Bone Density|bone density
550285|NCT01218789|Blindness|blindness
550286|NCT01218789|Eye Diseases|eye diseases
550287|NCT01218789|Nap Disorders|nap disorders
550288|NCT01218789|Circadian Rhythm Disorders|circadian rhythm disorders
550289|NCT01218789|Sleep disorders|sleep disorders
550290|NCT01218789|Circadian Rhythm Sleep Disorders|circadian rhythm sleep disorders
550291|NCT01218789|Dyssomnias|dyssomnias
550292|NCT01218789|Nervous System Diseases|nervous system diseases
550293|NCT01218776|Acute Coronary Syndrome, Eastern Europe, Therapies|acute coronary syndrome, eastern europe, therapies
550294|NCT01218763|Cardiac Event recorder|cardiac event recorder
550295|NCT01218763|Sensitivity|sensitivity
550296|NCT01218763|Efficacy|efficacy
550297|NCT01218750|DDME, ppV, ILM peeling, bevacizumab injection|ddme, ppv, ilm peeling, bevacizumab injection
550298|NCT01218685|Immunocompromised patients|immunocompromised patients
550299|NCT01218685|Safety of pandemic influenza A (H1N1)vaccine|safety of pandemic influenza a (h1n1)vaccine
550300|NCT01218685|Immunogenicity of pandemic influenza A (H1N1)vaccine|immunogenicity of pandemic influenza a (h1n1)vaccine
550301|NCT01218672|BPH|bph
550302|NCT01218672|Benign Prostatic Hyperplasia|benign prostatic hyperplasia
550303|NCT01218659|Amicus Therapeutics|amicus therapeutics
550304|NCT01218659|Galafold|galafold
550305|NCT01218659|AT1001|at1001
550306|NCT01218659|Migalastat|migalastat
550307|NCT01218646|Influenza|influenza
550308|NCT01218646|Quadrivalent Inactivated Influenza Vaccine|quadrivalent inactivated influenza vaccine
550309|NCT01218646|Trivalent Inactivated Influenza Vaccine|trivalent inactivated influenza vaccine
550310|NCT01218646|Influenza viruses|influenza viruses
550311|NCT01218607|Heart Septal Defects, Atrial|heart septal defects, atrial
550312|NCT01218607|Pulmonary Circulation|pulmonary circulation
550313|NCT01218607|Ventricular Function, Right|ventricular function, right
550314|NCT01218607|Echocardiography, Stress|echocardiography, stress
550315|NCT01218607|Ergometry|ergometry
550316|NCT01218607|Tissue Doppler Imaging|tissue doppler imaging
550317|NCT01218594|Stage III|stage iii
550318|NCT01218594|Unresectable|unresectable
550319|NCT01218594|Non-small cell lung cancer|non-small cell lung cancer
550320|NCT01218581|Adenomyosis, letrozole, GnRH-a|adenomyosis, letrozole, gnrh-a
550321|NCT01218555|kidney cancer|kidney cancer
550322|NCT01218555|adenoidcystic cancer|adenoidcystic cancer
550323|NCT01218542|Secondary brain malignancies|secondary brain malignancies
550324|NCT01218542|RapidArc|rapidarc
550325|NCT01218542|Volumetric modulated arc therapy|volumetric modulated arc therapy
550326|NCT01218529|Brain metastases from lung and breast tumors|brain metastases from lung and breast tumors
550327|NCT01218490|surgery|surgery
550328|NCT01218490|ovarian cancer|ovarian cancer
550329|NCT01218490|lymphadectomy|lymphadectomy
550330|NCT01218477|Leukemia|leukemia
550331|NCT01218477|(Chronic Myeloid Leukemia-Chronic Phase and Advanced)|(chronic myeloid leukemia-chronic phase and advanced)
550332|NCT01218464|Liver Failure|liver failure
550333|NCT01218464|Mesenchymal Stem Cells|mesenchymal stem cells
550334|NCT01218464|Model for End-Stage Liver Disease|model for end-stage liver disease
550335|NCT01218464|Ascite|ascite
550336|NCT01218464|Serum Albumin|serum albumin
550337|NCT01218425|dopamine|dopamine
550338|NCT01218425|EEG|eeg
550339|NCT01218425|episodic memory|episodic memory
550340|NCT01218425|contingent negative variation|contingent negative variation
550341|NCT01218425|response preparation|response preparation
550342|NCT01218425|levodopa|levodopa
550343|NCT01218425|methylphenidate|methylphenidate
550344|NCT01218412|Physical Activity|physical activity
550345|NCT01218412|Motivational Interviewing|motivational interviewing
550346|NCT01218412|Web-based|web-based
550347|NCT01218412|Physician Referral|physician referral
550348|NCT01218399|Asthma|asthma
550349|NCT01218386|ICSI|icsi
550350|NCT01218386|GnRH antagonists|gnrh antagonists
550351|NCT01218386|planning|planning
550352|NCT01218373|older people|older people
550353|NCT01218373|living independently at home|living independently at home
550354|NCT01218360|Crohn's disease|crohn's disease
550355|NCT01218360|standard-of-care|standard-of-care
550356|NCT01218360|Crohn Disease|crohn disease
550357|NCT01218360|Active Crohn's Disease|active crohn's disease
550358|NCT01218347|OATP1B1|oatp1b1
550359|NCT01218347|rosuvastatin|rosuvastatin
550360|NCT01218321|antiepileptic drugs|antiepileptic drugs
550361|NCT01218321|mitochondria|mitochondria
550362|NCT01218308|Influenza|influenza
550363|NCT01218295|COPD|copd
550364|NCT01218295|inspiratory muscles training|inspiratory muscles training
550365|NCT01218282|COPD|copd
550366|NCT01218282|home exercise training|home exercise training
550367|NCT01218269|anastomoses|anastomoses
550368|NCT01218256|diabetes mellitus|diabetes mellitus
550369|NCT01218256|type 2 diabetes|type 2 diabetes
550370|NCT01218256|T2DM|t2dm
550371|NCT01218256|resistance training|resistance training
550372|NCT01218256|hypertrophy training|hypertrophy training
550373|NCT01218256|endurance training|endurance training
550374|NCT01218243|Acupuncture|acupuncture
550375|NCT01218243|Mild and moderate BPH|mild and moderate bph
550376|NCT01218230|Pegaptanib, myopic CNVM, intravitreal anti-VEGF|pegaptanib, myopic cnvm, intravitreal anti-vegf
550377|NCT01218217|TB|tb
550378|NCT01218217|Tuberculosis|tuberculosis
550379|NCT01218217|EBA|eba
550380|NCT01218217|Pulmonary|pulmonary
550381|NCT01218217|Early Bactericidal Activity|early bactericidal activity
550382|NCT01218204|Pharmacodynamics|pharmacodynamics
550383|NCT01218204|Lipids|lipids
550384|NCT01218204|Dyslipidemia|dyslipidemia
550385|NCT01218204|Safety|safety
550386|NCT01218204|GSK1292263|gsk1292263
550387|NCT01218204|Ezetimibe|ezetimibe
550388|NCT01218204|Statin|statin
550389|NCT01218204|Pharmacokinetics|pharmacokinetics
550390|NCT01218204|Tolerability|tolerability
550391|NCT01218204|Atorvastatin|atorvastatin
550392|NCT01218191|subarachnoid hemorrhage|subarachnoid hemorrhage
550393|NCT01218191|scintigraphy|scintigraphy
550394|NCT01218191|neurocardiogenic injury|neurocardiogenic injury
550395|NCT01218178|acute myocardial infarction|acute myocardial infarction
550396|NCT01218178|acute kidney injury|acute kidney injury
550397|NCT01218178|contrast induced nephropathy|contrast induced nephropathy
550398|NCT01218178|primary PCI|primary pci
550399|NCT01218178|sodium-bicarbonate|sodium-bicarbonate
550400|NCT01218178|N-acetylcysteine|n-acetylcysteine
550401|NCT01218165|Healthy Eldery People|healthy eldery people
550402|NCT01218152|NF1|nf1
550403|NCT01218152|MPNST|mpnst
550404|NCT01218152|plasma|plasma
550405|NCT01218152|microarray CGH|microarray cgh
550406|NCT01218139|neurofibroma|neurofibroma
550407|NCT01218139|MPNST|mpnst
550408|NCT01218139|array CGH|array cgh
550409|NCT01218139|sequencing|sequencing
550410|NCT01218113|Human Immunodeficiency Virus (HIV)-1|human immunodeficiency virus (hiv)-1
550411|NCT01218113|safety|safety
550412|NCT01218113|vaccine|vaccine
550413|NCT01218113|immunogenicity|immunogenicity
550414|NCT01218113|reactogenicity|reactogenicity
550415|NCT01218113|HIV infection|hiv infection
550416|NCT01218087|Positional Head Shape Deformity|positional head shape deformity
550417|NCT01218074|bleeding|bleeding
550418|NCT01218074|blood sparing procedure|blood sparing procedure
550419|NCT01218074|desmopressin|desmopressin
550420|NCT01218074|aggregometry|aggregometry
550421|NCT01218074|thromboelastography|thromboelastography
550422|NCT01218061|Pre-diabetes|pre-diabetes
550423|NCT01218061|Type 2 diabetes|type 2 diabetes
550424|NCT01218061|Biomarkers|biomarkers
550425|NCT01218061|Cohort|cohort
550426|NCT01218061|Diabetes Risk Score|diabetes risk score
550427|NCT01218048|Carcinoma|carcinoma
550428|NCT01218048|Head and Neck|head and neck
550429|NCT01218048|Cetuximab|cetuximab
550430|NCT01218048|Locally Advanced Head and Neck Squamous Cell Carcinoma|locally advanced head and neck squamous cell carcinoma
550431|NCT01218035|Hip osteoarthritis|hip osteoarthritis
550432|NCT01218035|Bisphophonate therapy|bisphophonate therapy
550433|NCT01218035|Zoledronic acid|zoledronic acid
550434|NCT01218035|Radiostereometric analysis|radiostereometric analysis
550435|NCT01218035|Osteoporosis|osteoporosis
550436|NCT01218009|asthma|asthma
550437|NCT01218009|dry powder inhaler|dry powder inhaler
550438|NCT01218009|short-acting beta2-agonist|short-acting beta2-agonist
550439|NCT01218009|SABA|saba
550440|NCT01218009|bronchoconstriction|bronchoconstriction
550441|NCT01218009|bronchodilation|bronchodilation
550442|NCT01218009|bronchodilator|bronchodilator
550443|NCT01218009|metered dose inhaler|metered dose inhaler
550444|NCT01217996|working memory intervention|working memory intervention
550445|NCT01217996|memory impairment|memory impairment
550446|NCT01217996|cognitive late effects|cognitive late effects
550447|NCT01217996|Childhood Cancer Survivors|childhood cancer survivors
550448|NCT01217970|methamphetamine|methamphetamine
550449|NCT01217970|dependence|dependence
550450|NCT01217970|stimulant|stimulant
550451|NCT01217970|amphetamine|amphetamine
550452|NCT01217970|los angeles|los angeles
550453|NCT01217970|meth|meth
550454|NCT01217970|speed|speed
550455|NCT01217970|crank|crank
550456|NCT01217970|abuse|abuse
550457|NCT01217957|Drug therapy|drug therapy
550458|NCT01217944|Pathologic myopia|pathologic myopia
550460|NCT01217944|choroidal neovascularization|choroidal neovascularization
550461|NCT01217944|CNV|cnv
550462|NCT01217944|ranibizumab|ranibizumab
550463|NCT01217944|verteporfin PDT|verteporfin pdt
550464|NCT01217931|Renal Cell Carcinoma|renal cell carcinoma
550465|NCT01217931|Metastatic Renal Cell Carcinoma|metastatic renal cell carcinoma
550466|NCT01217931|Clear cell component|clear cell component
550467|NCT01217931|RCC|rcc
550468|NCT01217931|Bevacizumab|bevacizumab
550469|NCT01217931|Everolimus|everolimus
550470|NCT01217931|Pazopanib|pazopanib
550471|NCT01217931|GW786034|gw786034
550472|NCT01217931|Avastin|avastin
550473|NCT01217931|Anti-VEGF monoclonal antibody|anti-vegf monoclonal antibody
550474|NCT01217931|rhuMAb-VEGF|rhumab-vegf
550475|NCT01217931|Afinitor|afinitor
550476|NCT01217931|RAD001|rad001
550477|NCT01217918|PH-797804|ph-797804
550478|NCT01217918|Japanese|japanese
550479|NCT01217918|Phase 1|phase 1
550480|NCT01217918|multiple dose study|multiple dose study
550481|NCT01217905|Phase 1|phase 1
550482|NCT01217905|Type 2 diabetes|type 2 diabetes
550483|NCT01217905|obesity|obesity
550484|NCT01217905|Japanese healthy volunteer|japanese healthy volunteer
550485|NCT01217905|AZD7687|azd7687
550486|NCT01217892|Type 2 diabetes|type 2 diabetes
550487|NCT01217892|metformin treated|metformin treated
550488|NCT01217892|inadequate control|inadequate control
550489|NCT01217892|metformin treatment alone|metformin treatment alone
550490|NCT01217879|Cough|cough
550491|NCT01217879|Telmisartan|telmisartan
550492|NCT01217879|Bradykinin|bradykinin
550493|NCT01217879|Tolerability|tolerability
550494|NCT01217866|laparoscopic|laparoscopic
550495|NCT01217866|vaginal|vaginal
550496|NCT01217866|hysterectomy|hysterectomy
550497|NCT01217840|Adolescents, Vitamin D|adolescents, vitamin d
550498|NCT01217788|Generalized Social Phobia|generalized social phobia
550499|NCT01217788|Social Anxiety Disorder|social anxiety disorder
550500|NCT01217788|Social Phobia|social phobia
550501|NCT01217788|Phobic Disorders|phobic disorders
550502|NCT01217788|Phobias|phobias
550503|NCT01217775|PMDD, Premenstrual, Dysphoria, Mood Swings, Bloating.|pmdd, premenstrual, dysphoria, mood swings, bloating.
550504|NCT01217762|Oraya|oraya
550505|NCT01217762|Oraya Therapeutics, Inc.|oraya therapeutics, inc.
550506|NCT01217762|low voltage stereotactic radiosurgery|low voltage stereotactic radiosurgery
550507|NCT01217762|radiosurgery|radiosurgery
550508|NCT01217762|radiotherapy|radiotherapy
550509|NCT01217762|IRay|iray
550510|NCT01217762|AMD|amd
550511|NCT01217762|Macular Degeneration|macular degeneration
550512|NCT01217762|Wet AMD|wet amd
550513|NCT01217762|xray|xray
550514|NCT01217762|radiation|radiation
550515|NCT01217762|x ray|x ray
550516|NCT01217762|external beam radiation|external beam radiation
550517|NCT01217762|Ranibizumab|ranibizumab
550518|NCT01217762|Lucentis|lucentis
550519|NCT01217723|Acute leukemia (myeloid,lymphoid,or biphenotypic)|acute leukemia (myeloid,lymphoid,or biphenotypic)
550520|NCT01217723|Chronic myeloid leukemia|chronic myeloid leukemia
550521|NCT01217723|Chronic lymphocytic leukemia|chronic lymphocytic leukemia
550522|NCT01217723|Lymphoma|lymphoma
550523|NCT01217723|Myelodysplastic syndrome|myelodysplastic syndrome
550524|NCT01217723|Myeloproliferative disorder|myeloproliferative disorder
550525|NCT01217710|Chronic Obstructive Pulmonary Disease|chronic obstructive pulmonary disease
550526|NCT01217710|Physical Activity|physical activity
550527|NCT01217710|Self Management|self management
550528|NCT01217710|Exercise|exercise
550529|NCT01217710|Technology|technology
550530|NCT01217710|Motivational Interviewing|motivational interviewing
550531|NCT01217697|Metastatic Castration-Resistant Prostate Cancer (CRPC)|metastatic castration-resistant prostate cancer (crpc)
550532|NCT01217697|Abiraterone Acetate|abiraterone acetate
550533|NCT01217671|Pulmonary, Emphysema|pulmonary, emphysema
550534|NCT01217671|Alpha-1 Antitrypsin Deficiency|alpha-1 antitrypsin deficiency
550535|NCT01217658|Randomized Trial|randomized trial
550536|NCT01217658|Infant Colic|infant colic
550537|NCT01217658|Abusive Head Trauma|abusive head trauma
550538|NCT01217658|Shaken Baby Syndrome|shaken baby syndrome
550539|NCT01217645|Major depression disorder|major depression disorder
550540|NCT01217632|Connective tissue growth factor (CTGF)|connective tissue growth factor (ctgf)
550541|NCT01217632|human IgG1 monoclonal antibody|human igg1 monoclonal antibody
550542|NCT01217619|neoadjuvant treatment|neoadjuvant treatment
550543|NCT01217593|mastectomy|mastectomy
550544|NCT01217593|breast cancer|breast cancer
550545|NCT01217593|breast surgery|breast surgery
550546|NCT01217580|c-section|c-section
550547|NCT01217580|cesarean section|cesarean section
550548|NCT01217580|TAP block|tap block
550549|NCT01217580|pain|pain
550550|NCT01217580|pain after delivery|pain after delivery
550551|NCT01217580|pain after C-section|pain after c-section
550552|NCT01217580|pain after C-section delivery|pain after c-section delivery
550553|NCT01217580|pain after cesarean delivery|pain after cesarean delivery
550554|NCT01217580|pain after cesarean|pain after cesarean
550555|NCT01217567|cicatrix|cicatrix
550556|NCT01217567|cesarean section|cesarean section
550557|NCT01217567|sutures|sutures
550558|NCT01217567|surgical staples|surgical staples
550559|NCT01217567|postoperative pain|postoperative pain
550560|NCT01217567|Infection|infection
550561|NCT01217554|Low Back Pain|low back pain
550562|NCT01217554|Disability|disability
550563|NCT01217554|Kinematic measures|kinematic measures
550564|NCT01217541|Dementia|dementia
550565|NCT01217541|BPSD|bpsd
550566|NCT01217541|Quality of Life|quality of life
550567|NCT01217541|Person-centred care|person-centred care
550568|NCT01217541|Job satisfaction|job satisfaction
550569|NCT01217541|Nursing home|nursing home
550570|NCT01217541|Primary care|primary care
550571|NCT01217528|ICD|icd
550572|NCT01217528|CRTD|crtd
550573|NCT01217528|Sudden cardiac death|sudden cardiac death
550574|NCT01217528|Device settings|device settings
550575|NCT01217528|Patients who received ICD/CRTD for primary prevention of sudden cardiac death|patients who received icd/crtd for primary prevention of sudden cardiac death
550576|NCT01217502|Aged|aged
550577|NCT01217502|Homes for the aged|homes for the aged
550578|NCT01217502|Self management|self management
550579|NCT01217502|Personal autonomy|personal autonomy
550580|NCT01217502|Disease management|disease management
550581|NCT01217502|Self efficacy|self efficacy
550582|NCT01217502|Participation|participation
550583|NCT01217489|breast|breast
550584|NCT01217489|cancer|cancer
550585|NCT01217489|diagnosis|diagnosis
550586|NCT01217489|electrical|electrical
550587|NCT01217489|non-invasive|non-invasive
550588|NCT01217489|mammography|mammography
550589|NCT01217476|Diabetic foot|diabetic foot
550590|NCT01217476|Neuropathic|neuropathic
550591|NCT01217476|Wound|wound
550592|NCT01217476|Growth factor|growth factor
550593|NCT01217463|Diabetic foot|diabetic foot
550594|NCT01217463|Neuropathic|neuropathic
550595|NCT01217463|Wound|wound
550596|NCT01217463|Growth factor|growth factor
550597|NCT01217424|psychosocial effects of cancer and its treatment|psychosocial effects of cancer and its treatment
550598|NCT01217424|pain|pain
550599|NCT01217424|unspecified adult solid tumor, protocol specific|unspecified adult solid tumor, protocol specific
550600|NCT01217398|ciliary body and choroid melanoma, medium/large size|ciliary body and choroid melanoma, medium/large size
550601|NCT01217398|ciliary body and choroid melanoma, small size|ciliary body and choroid melanoma, small size
550602|NCT01217398|iris melanoma|iris melanoma
550603|NCT01217398|metastatic intraocular melanoma|metastatic intraocular melanoma
550604|NCT01217398|stage IV intraocular melanoma|stage iv intraocular melanoma
550605|NCT01217385|stage IIIA breast cancer|stage iiia breast cancer
550606|NCT01217385|stage IIIB breast cancer|stage iiib breast cancer
550607|NCT01217385|stage IIIC breast cancer|stage iiic breast cancer
550608|NCT01217372|Recurrent idiopathic calcium oxalate nephrolithiasis.|recurrent idiopathic calcium oxalate nephrolithiasis.
550609|NCT01217333|Telephones|telephones
550610|NCT01217333|Community-Based Participatory Research|community-based participatory research
550611|NCT01217333|Participation, Patient|participation, patient
550612|NCT01217333|Rural health services|rural health services
550613|NCT01217320|rheumatology|rheumatology
550614|NCT01217320|creatine supplementation|creatine supplementation
550615|NCT01217320|quality of life|quality of life
550616|NCT01217320|strength|strength
550617|NCT01217320|juvenile systemic lupus erythematosus|juvenile systemic lupus erythematosus
550618|NCT01217320|juvenile dermatomyositis|juvenile dermatomyositis
550619|NCT01217307|Metformin|metformin
550620|NCT01217307|ST elevation myocardial infarction (STEMI)|st elevation myocardial infarction (stemi)
550621|NCT01217307|Coronary artery disease|coronary artery disease
550622|NCT01217307|Heart failure|heart failure
550623|NCT01217307|Diabetes|diabetes
550624|NCT01217294|anaesthetic techniques, regional|anaesthetic techniques, regional
550625|NCT01217294|analgesia, post-operative|analgesia, post-operative
550626|NCT01217294|fascia iliaca compartment block|fascia iliaca compartment block
550627|NCT01217294|ultrasound guided|ultrasound guided
550628|NCT01217294|surgery, orthopaedic|surgery, orthopaedic
550629|NCT01217281|CKD, Renal, Chronic Kidney Disease, Periodontitis, Perio|ckd, renal, chronic kidney disease, periodontitis, perio
550630|NCT01217255|Hemophilia|hemophilia
550631|NCT01217255|Burden of Illness|burden of illness
550632|NCT01217255|Pediatric|pediatric
550633|NCT01217255|Quality of Life|quality of life
550634|NCT01217255|Disability|disability
550635|NCT01217255|Participation|participation
550636|NCT01217242|cerebral palsy|cerebral palsy
550637|NCT01217242|walking activity|walking activity
550638|NCT01217242|physical activity|physical activity
550639|NCT01217242|participation|participation
550640|NCT01217242|activity performance|activity performance
550641|NCT01217242|activity capacity|activity capacity
550642|NCT01217229|Hodgkin Lymphoma|hodgkin lymphoma
550643|NCT01217216|Breast Cancer|breast cancer
550644|NCT01217216|Weight loss|weight loss
550645|NCT01217216|Group Intervention|group intervention
550646|NCT01217216|Telephone Intervention|telephone intervention
550647|NCT01217177|Cervical cancer,|cervical cancer,
550648|NCT01217177|radiotherapy,|radiotherapy,
550649|NCT01217177|chemotherapy,|chemotherapy,
550650|NCT01217177|rad001,|rad001,
550651|NCT01217177|everolimus|everolimus
550652|NCT01217164|nutrition|nutrition
550653|NCT01217164|very low birth weight|very low birth weight
550654|NCT01217164|premature|premature
550655|NCT01217151|Hemodynamic Monitoring|hemodynamic monitoring
550656|NCT01217151|Goal-Directed Therapy|goal-directed therapy
550657|NCT01217138|Anaphylaxis, autoinjector, design, epinephrine|anaphylaxis, autoinjector, design, epinephrine
550658|NCT01217125|tuberousclerosis, angiomyolipoma, rapamycin|tuberousclerosis, angiomyolipoma, rapamycin
550659|NCT01217112|Dyslipidemias|dyslipidemias
550660|NCT01217112|Diabetes|diabetes
550661|NCT01217112|Liver Fat|liver fat
550662|NCT01217112|Body Fat|body fat
550663|NCT01217099|refractory mycoplasma pneumoniae pneumonia|refractory mycoplasma pneumoniae pneumonia
550664|NCT01217060|Adenocarcinoma|adenocarcinoma
550665|NCT01217060|Squamous cell carcinoma|squamous cell carcinoma
550666|NCT01217060|Thoracic esophagus|thoracic esophagus
550667|NCT01217060|Gastroesophageal junction|gastroesophageal junction
550668|NCT01217060|Chemoradiotherapy|chemoradiotherapy
550669|NCT01217060|Esophagectomy|esophagectomy
550670|NCT01217060|5-Fluorouracil|5-fluorouracil
550671|NCT01217060|Docetaxel|docetaxel
550672|NCT01217060|Radiation|radiation
550673|NCT01217060|Radiotherapy|radiotherapy
550674|NCT01217060|XRT|xrt
550675|NCT01217060|IMRT|imrt
550676|NCT01217060|Taxotere|taxotere
550677|NCT01217060|Adrucil|adrucil
550678|NCT01217060|Efudex|efudex
550679|NCT01217060|Dexamethasone|dexamethasone
550680|NCT01217060|Decadron|decadron
550681|NCT01217047|Spinal cord injury|spinal cord injury
550682|NCT01217047|Functional electrical stimulation|functional electrical stimulation
550683|NCT01217047|Rehabilitation|rehabilitation
550684|NCT01217047|Growth factors|growth factors
550685|NCT01217047|Cytokines|cytokines
550686|NCT01217034|Transcatheter arterial chemoembolization|transcatheter arterial chemoembolization
550687|NCT01217034|TACE|tace
550688|NCT01217034|sorafenib|sorafenib
550689|NCT01217034|Time to untreatable progression|time to untreatable progression
550690|NCT01217034|TTUP|ttup
550691|NCT01217008|Spinal Cord Injury|spinal cord injury
550692|NCT01217008|GRNOPC1|grnopc1
550693|NCT01216995|Heart Attack|heart attack
550694|NCT01216995|Regenerative Cells|regenerative cells
550695|NCT01216995|Stem Cells|stem cells
550696|NCT01216982|Mood Disorders|mood disorders
550697|NCT01216982|Depression|depression
550698|NCT01216982|Combat Disorders|combat disorders
550699|NCT01216982|Stress Disorders|stress disorders
550700|NCT01216982|Fatty Acids, Omega-3|fatty acids, omega-3
550701|NCT01216982|Military Personnel|military personnel
550702|NCT01216982|Docosahexaenoic Acids/*therapeutic use|docosahexaenoic acids/*therapeutic use
550703|NCT01216982|Eicosapentaenoic Acid/*therapeutic use|eicosapentaenoic acid/*therapeutic use
550704|NCT01216956|extended release nicotinic acid|extended release nicotinic acid
550705|NCT01216956|non esterified fatty acid (NEFA)|non esterified fatty acid (nefa)
550706|NCT01216956|insulin resistance|insulin resistance
550707|NCT01216956|Cholesteryl ester transfer protein (CETP)|cholesteryl ester transfer protein (cetp)
550708|NCT01216956|High density lipoprotein cholesterol|high density lipoprotein cholesterol
550709|NCT01216891|Schizophrenia|schizophrenia
550710|NCT01216891|Schizoaffective Disorder|schizoaffective disorder
550711|NCT01216891|Schizophreniform Disorder|schizophreniform disorder
550712|NCT01216891|Delusional Disorder|delusional disorder
550713|NCT01216891|Psychosis|psychosis
550714|NCT01216891|First episode|first episode
550715|NCT01216865|Diabetic foot|diabetic foot
550716|NCT01216865|critical limb ischemia|critical limb ischemia
550717|NCT01216865|mesenchymal stem cells|mesenchymal stem cells
550718|NCT01216865|umbilical cord|umbilical cord
550719|NCT01216813|esophageal cancer|esophageal cancer
550720|NCT01216813|gastric cancer|gastric cancer
550721|NCT01216813|cervical cancer|cervical cancer
550722|NCT01216813|fallopian tube cancer|fallopian tube cancer
550723|NCT01216813|ovarian epithelial cancer|ovarian epithelial cancer
550724|NCT01216813|ovarian germ cell tumor|ovarian germ cell tumor
550725|NCT01216813|ovarian sarcoma|ovarian sarcoma
550726|NCT01216813|ovarian stromal cancer|ovarian stromal cancer
550727|NCT01216813|endometrial cancer|endometrial cancer
550728|NCT01216813|uterine sarcoma|uterine sarcoma
550729|NCT01216813|vaginal cancer|vaginal cancer
550730|NCT01216813|vulvar cancer|vulvar cancer
550731|NCT01216813|adenocarcinoma of the gastroesophageal junction|adenocarcinoma of the gastroesophageal junction
550732|NCT01216800|ototoxicity|ototoxicity
550733|NCT01216800|radiation toxicity|radiation toxicity
550734|NCT01216800|stage I salivary gland cancer|stage i salivary gland cancer
550735|NCT01216800|stage II salivary gland cancer|stage ii salivary gland cancer
550736|NCT01216800|stage III salivary gland cancer|stage iii salivary gland cancer
550737|NCT01216761|Bacteremia|bacteremia
550738|NCT01216761|Blood culture|blood culture
550739|NCT01216761|Contamination|contamination
550740|NCT01216761|Antiseptic agents|antiseptic agents
550741|NCT01216748|airway blood flow|airway blood flow
550742|NCT01216748|albuterol|albuterol
550743|NCT01216748|acidosis|acidosis
550744|NCT01216748|alkalosis|alkalosis
550745|NCT01216735|smokers|smokers
550746|NCT01216735|inhaled corticosteroids|inhaled corticosteroids
550747|NCT01216735|brachial flow|brachial flow
550748|NCT01216735|airway blood flow|airway blood flow
550749|NCT01216735|albuterol|albuterol
550750|NCT01216735|spirometry|spirometry
550751|NCT01216735|endothelial dysfunction|endothelial dysfunction
550752|NCT01216722|Muscle Wasting|muscle wasting
550753|NCT01216722|Strengthening|strengthening
550754|NCT01216722|Liver Disease|liver disease
550755|NCT01216722|Transplant|transplant
550756|NCT01216709|Infant|infant
550757|NCT01216709|Dietary Supplements|dietary supplements
550758|NCT01216709|Food, Fortified|food, fortified
550759|NCT01216709|Iron Absorption|iron absorption
550760|NCT01216696|ipilimumab|ipilimumab
550761|NCT01216696|melanoma|melanoma
550762|NCT01216696|NY-ESO-1|ny-eso-1
550763|NCT01216683|contiguous stage II grade 1 follicular lymphoma|contiguous stage ii grade 1 follicular lymphoma
550764|NCT01216683|contiguous stage II grade 2 follicular lymphoma|contiguous stage ii grade 2 follicular lymphoma
550765|NCT01216683|contiguous stage II grade 3 follicular lymphoma|contiguous stage ii grade 3 follicular lymphoma
550766|NCT01216683|noncontiguous stage II grade 1 follicular lymphoma|noncontiguous stage ii grade 1 follicular lymphoma
550767|NCT01216683|noncontiguous stage II grade 2 follicular lymphoma|noncontiguous stage ii grade 2 follicular lymphoma
550768|NCT01216683|noncontiguous stage II grade 3 follicular lymphoma|noncontiguous stage ii grade 3 follicular lymphoma
550769|NCT01216683|stage III grade 1 follicular lymphoma|stage iii grade 1 follicular lymphoma
550770|NCT01216683|stage III grade 2 follicular lymphoma|stage iii grade 2 follicular lymphoma
550771|NCT01216683|stage III grade 3 follicular lymphoma|stage iii grade 3 follicular lymphoma
550772|NCT01216683|stage IV grade 1 follicular lymphoma|stage iv grade 1 follicular lymphoma
550773|NCT01216683|stage IV grade 2 follicular lymphoma|stage iv grade 2 follicular lymphoma
550774|NCT01216683|stage IV grade 3 follicular lymphoma|stage iv grade 3 follicular lymphoma
550775|NCT01216670|Reveal® XT|reveal® xt
550776|NCT01216670|Acute Heart Failure|acute heart failure
550777|NCT01216670|Low Ejection Fraction|low ejection fraction
550778|NCT01216670|Reveal® XT implanted|reveal® xt implanted
550779|NCT01216657|melanoma|melanoma
550780|NCT01216657|sunitinib|sunitinib
550781|NCT01216644|gastric cancer|gastric cancer
550782|NCT01216644|perioperative|perioperative
550783|NCT01216644|FLOT|flot
550785|NCT01216644|pathological complete remission|pathological complete remission
550786|NCT01216644|locally advanced resectable adenocarcinoma of the esophagogastric juction or the stomach|locally advanced resectable adenocarcinoma of the esophagogastric juction or the stomach
550787|NCT01216631|seronegative|seronegative
550788|NCT01216631|oligoarthritis|oligoarthritis
550789|NCT01216631|infliximab|infliximab
550790|NCT01216631|intraarticular|intraarticular
550791|NCT01216618|MiniMed paradigm insulin pumps|minimed paradigm insulin pumps
550792|NCT01216618|insulin Lispro|insulin lispro
550793|NCT01216618|Insulin Asprt.|insulin asprt.
550794|NCT01216592|COPD|copd
550795|NCT01216592|Airway inflammation|airway inflammation
550796|NCT01216592|Symptoms|symptoms
550797|NCT01216592|Lung function|lung function
550798|NCT01216592|Correlation|correlation
550799|NCT01216553|Bronchiolitis|bronchiolitis
550800|NCT01216553|Infants|infants
550801|NCT01216553|Nebulized Inhalation|nebulized inhalation
550802|NCT01216553|RSV|rsv
550803|NCT01216553|Oxygen|oxygen
550804|NCT01216540|vancomycin|vancomycin
550805|NCT01216540|nephrotoxicity|nephrotoxicity
550806|NCT01216540|length of stay|length of stay
550807|NCT01216540|costs|costs
550808|NCT01216527|Stage IIB or III squamous cell esophageal carcinoma.|stage iib or iii squamous cell esophageal carcinoma.
550809|NCT01216514|chronic inflammatory bowel diseases|chronic inflammatory bowel diseases
550810|NCT01216514|crohn disease|crohn disease
550811|NCT01216514|hemorrhagic rectocolitis|hemorrhagic rectocolitis
550812|NCT01216514|immunological markers|immunological markers
550813|NCT01216514|serological markers|serological markers
550814|NCT01216514|ANCA|anca
550815|NCT01216514|ASCA|asca
550816|NCT01216488|Forearm surgery|forearm surgery
550817|NCT01216488|Hand surgery|hand surgery
550818|NCT01216488|Anesthesia|anesthesia
550819|NCT01216462|Acute Coronary Syndrome|acute coronary syndrome
550820|NCT01216449|Citalopram|citalopram
550821|NCT01216449|Functional Magnetic Resonance Imaging|functional magnetic resonance imaging
550822|NCT01216449|fMRI|fmri
550823|NCT01216449|Pharmacokinetics|pharmacokinetics
550824|NCT01216449|Pharmacodynamics|pharmacodynamics
550825|NCT01216449|Amygdala|amygdala
550826|NCT01216449|Elderly|elderly
550827|NCT01216436|melanoma|melanoma
550828|NCT01216436|immunotherapy|immunotherapy
550829|NCT01216436|dendritic cell|dendritic cell
550830|NCT01216436|GITR-ligand|gitr-ligand
550831|NCT01216436|CTLA-4|ctla-4
550832|NCT01216423|Patent Foramen Ovale|patent foramen ovale
550833|NCT01216423|Pulmonary embolism|pulmonary embolism
550834|NCT01216423|Stroke|stroke
550835|NCT01216410|Nausea|nausea
550836|NCT01216410|Vomiting|vomiting
550837|NCT01216371|carcinoma|carcinoma
550838|NCT01216371|metastases|metastases
550839|NCT01216371|renal|renal
550840|NCT01216371|lung|lung
550841|NCT01216358|Headache|headache
550842|NCT01216358|Contraception|contraception
550843|NCT01216319|Biodesign|biodesign
550844|NCT01216319|Nipple Reconstruction|nipple reconstruction
550845|NCT01216319|Breast Cancer|breast cancer
550846|NCT01216319|Mastectomy|mastectomy
550847|NCT01216306|Obesity|obesity
550848|NCT01216306|Physical Activity|physical activity
550849|NCT01216306|Sedentary Activity|sedentary activity
550850|NCT01216306|Television viewing|television viewing
550851|NCT01216306|Latino|latino
550852|NCT01216306|Hispanic|hispanic
550853|NCT01216306|Preschool|preschool
550854|NCT01216306|School|school
550855|NCT01216306|Head Start|head start
550856|NCT01216293|Drug Therapy|drug therapy
550857|NCT01216280|Natura-alpha|natura-alpha
550858|NCT01216280|ulcerative colitis|ulcerative colitis
550859|NCT01216280|cytokines|cytokines
550860|NCT01216280|Th1|th1
550861|NCT01216280|Th17|th17
550862|NCT01216267|chromogranin A|chromogranin a
550863|NCT01216267|neuroendocrine|neuroendocrine
550864|NCT01216267|carcinoid|carcinoid
550865|NCT01216267|Proton Pump Inhibitor|proton pump inhibitor
550866|NCT01216254|breast cancer|breast cancer
550867|NCT01216254|stage 2|stage 2
550868|NCT01216254|breast conserving therapy|breast conserving therapy
550869|NCT01216254|sentinel lymph node dissection|sentinel lymph node dissection
550870|NCT01216254|high frequency electrocoagulation|high frequency electrocoagulation
550871|NCT01216202|Rectal cancer|rectal cancer
550872|NCT01216202|Preoperative radiotherapy|preoperative radiotherapy
550873|NCT01216202|Pelvic surgery|pelvic surgery
550874|NCT01216202|Sexual function|sexual function
550875|NCT01216202|Wellbeing|wellbeing
550876|NCT01216202|Hormone levels|hormone levels
550877|NCT01216202|Spermatogenesis|spermatogenesis
550878|NCT01216189|Rectal cancer|rectal cancer
550879|NCT01216189|Preoperative radiotherapy|preoperative radiotherapy
550880|NCT01216189|Pelvic surgery|pelvic surgery
550881|NCT01216189|Sexual function|sexual function
550882|NCT01216189|Wellbeing|wellbeing
550883|NCT01216189|Hormone levels|hormone levels
550884|NCT01216176|Breast Cancer|breast cancer
550885|NCT01216176|Postmenopausal|postmenopausal
550886|NCT01216176|Metastatic Phase I ONLY|metastatic phase i only
550887|NCT01216176|AZD0530 (saracatinib)|azd0530 (saracatinib)
550888|NCT01216176|Anastrozole|anastrozole
550889|NCT01216176|Phase I for metastatic disease|phase i for metastatic disease
550890|NCT01216176|Phase II for newly diagnosed breast cancer|phase ii for newly diagnosed breast cancer
550891|NCT01216176|Pharmacokinetic|pharmacokinetic
550892|NCT01216176|PK|pk
550893|NCT01216176|Hormone Receptor|hormone receptor
550894|NCT01216176|Estrogen Receptor|estrogen receptor
550895|NCT01216176|Progesterone Receptor|progesterone receptor
550896|NCT01216176|ER+|er+
550897|NCT01216176|PR+|pr+
550898|NCT01216176|HER negative|her negative
550899|NCT01216176|Aromatase Inhibitors|aromatase inhibitors
550900|NCT01216163|Pain following third molar extraction (wisdom tooth)|pain following third molar extraction (wisdom tooth)
550901|NCT01216150|antifibrinolytic drug|antifibrinolytic drug
550902|NCT01216150|coronary surgery|coronary surgery
550903|NCT01216150|hemorrhage|hemorrhage
550904|NCT01216150|aspirin|aspirin
550905|NCT01216150|clopidogrel|clopidogrel
550906|NCT01216137|Multiple Sclerosis|multiple sclerosis
550907|NCT01216137|Fatigue|fatigue
550908|NCT01216137|Balance|balance
550909|NCT01216137|Upright Postural Control|upright postural control
550910|NCT01216137|Dizziness|dizziness
550911|NCT01216124|triple negative local advanced breast cancer(TNLABC),neoadjuvant chemotherapy|triple negative local advanced breast cancer(tnlabc),neoadjuvant chemotherapy
550912|NCT01216111|triple negative breast cancer，local recurrence,distant metastasis|triple negative breast cancer，local recurrence,distant metastasis
550913|NCT01216098|Intrapartum|intrapartum
550914|NCT01216098|Clinical trial|clinical trial
550915|NCT01216098|Perinatal|perinatal
550916|NCT01216098|Doula|doula
550917|NCT01216098|VBAC|vbac
550918|NCT01216098|Perinatal Outcomes|perinatal outcomes
550919|NCT01216072|Relapsing Forms of Multiple Sclerosis|relapsing forms of multiple sclerosis
550920|NCT01216072|Disease Modifying Therapy|disease modifying therapy
550921|NCT01216072|fingolimod|fingolimod
550922|NCT01216072|Patient Reported Outcomes|patient reported outcomes
550923|NCT01216059|adherence|adherence
550924|NCT01216059|text message|text message
550925|NCT01216059|reminder|reminder
550926|NCT01216059|adolescents|adolescents
550927|NCT01216033|Breast cancer|breast cancer
550928|NCT01216033|Diagnostics|diagnostics
550929|NCT01216033|HER2|her2
550930|NCT01216033|Imaging|imaging
550931|NCT01216033|Metastases|metastases
550932|NCT01216033|SPECT|spect
550933|NCT01216033|Imaging of metastases|imaging of metastases
550934|NCT01216020|Head and Neck Cancer|head and neck cancer
550935|NCT01216020|Radiotherapy|radiotherapy
550936|NCT01216020|Cetuximab|cetuximab
550937|NCT01216020|Cisplatin|cisplatin
550938|NCT01216007|Plasma|plasma
550939|NCT01216007|bupivacaine|bupivacaine
550940|NCT01216007|concentration|concentration
550941|NCT01216007|caudal|caudal
550942|NCT01216007|epidural|epidural
550943|NCT01216007|TIVA|tiva
550944|NCT01216007|Inhalational|inhalational
550945|NCT01216007|anesthesia|anesthesia
550946|NCT01216007|Caudal epidural|caudal epidural
550947|NCT01215981|influenza vaccine|influenza vaccine
550948|NCT01215955|Type 2 Diabetes|type 2 diabetes
550949|NCT01215955|Insulin|insulin
550950|NCT01215955|Algorithms|algorithms
550951|NCT01215955|Blood glucose levels|blood glucose levels
550952|NCT01215942|Rheumatoid Arthritis|rheumatoid arthritis
550953|NCT01215929|methamphetamine withdrawal|methamphetamine withdrawal
550954|NCT01215929|mood|mood
550955|NCT01215929|retention|retention
550956|NCT01215929|sleep|sleep
550957|NCT01215916|Solid tumors|solid tumors
550958|NCT01215890|Crohn's disease|crohn's disease
550959|NCT01215890|Low bone mineral density|low bone mineral density
550960|NCT01215890|inflammatory bowel disease|inflammatory bowel disease
550961|NCT01215890|bisphosphonate|bisphosphonate
550962|NCT01215877|Bladder cancer|bladder cancer
550963|NCT01215877|Previously treated patients|previously treated patients
550964|NCT01215877|Tesetaxel|tesetaxel
550965|NCT01215877|Oral taxane|oral taxane
550966|NCT01215864|metastatic tumors|metastatic tumors
550967|NCT01215864|refractory tumors|refractory tumors
550968|NCT01215864|recurrent tumors|recurrent tumors
550969|NCT01215851|Tuberculosis|tuberculosis
550970|NCT01215851|EBA|eba
550971|NCT01215851|TMC207|tmc207
550972|NCT01215851|pretomanid|pretomanid
550973|NCT01215851|Early Bactericidal Activity|early bactericidal activity
550974|NCT01215851|Pulmonary Tuberculosis|pulmonary tuberculosis
550975|NCT01215851|PA-824|pa-824
550976|NCT01215851|bedaquiline|bedaquiline
550977|NCT01215851|pyrazinamide|pyrazinamide
550978|NCT01215851|moxifloxacin|moxifloxacin
550979|NCT01215851|ethambutol|ethambutol
550980|NCT01215851|rifafour|rifafour
550981|NCT01215838|HCC|hcc
550982|NCT01215838|hepatocellular carcinoma|hepatocellular carcinoma
550983|NCT01215838|Eovist|eovist
550984|NCT01215838|MR|mr
550985|NCT01215838|MRI|mri
550986|NCT01215838|magnetic resonance|magnetic resonance
550987|NCT01215825|Chronic obstructive pulmonary disease|chronic obstructive pulmonary disease
550988|NCT01215825|systemic steroid|systemic steroid
550989|NCT01215799|Hormone Refractory Prostate Cancer|hormone refractory prostate cancer
550990|NCT01215799|HRPC|hrpc
550991|NCT01215760|peripheral nerve injury|peripheral nerve injury
550992|NCT01215760|sensory reeducation|sensory reeducation
550993|NCT01215760|brain plasticity|brain plasticity
550994|NCT01215760|training with a mirror|training with a mirror
550995|NCT01215760|rehabilitation|rehabilitation
550996|NCT01215747|Kiacta for AA amyloidosis|kiacta for aa amyloidosis
550997|NCT01215721|Incontinence|incontinence
550998|NCT01215721|Robotic Prostatectomy|robotic prostatectomy
550999|NCT01215721|Prostate Cancer|prostate cancer
551000|NCT01215708|Kidney calculi|kidney calculi
551001|NCT01215708|Lithotripsy|lithotripsy
551002|NCT01215708|Calcium channel blockers|calcium channel blockers
551003|NCT01215708|Adrenergic alpha-antagonists.|adrenergic alpha-antagonists.
551004|NCT01215695|Intubation, Endotracheal|intubation, endotracheal
551005|NCT01215695|Endotracheal Intubation, adverse events|endotracheal intubation, adverse events
551006|NCT01215682|infections|infections
551007|NCT01215682|immune system|immune system
551008|NCT01215682|vitamin D|vitamin d
551009|NCT01215682|sport|sport
551010|NCT01215682|children|children
551011|NCT01215669|Influenza|influenza
551012|NCT01215669|Influenza Virus Vaccines|influenza virus vaccines
551013|NCT01215669|Intradermal Injections|intradermal injections
551014|NCT01215643|Chronic hepatitis C genotype 2|chronic hepatitis c genotype 2
551015|NCT01215643|Chronic hepatitis C genotype 3|chronic hepatitis c genotype 3
551016|NCT01215643|Cyclophilin inhibitor|cyclophilin inhibitor
551017|NCT01215630|Veins|veins
551018|NCT01215630|Exercise tests|exercise tests
551019|NCT01215630|maximal oxygen uptake|maximal oxygen uptake
551020|NCT01215630|VO2max|vo2max
551021|NCT01215617|Randomized controlled study|randomized controlled study
551022|NCT01215617|Exercise training|exercise training
551023|NCT01215617|Lung function|lung function
551024|NCT01215617|Heart function|heart function
551025|NCT01215604|elderly patients|elderly patients
551026|NCT01215604|acute infection|acute infection
551027|NCT01215604|translation initiation factors|translation initiation factors
551028|NCT01215604|eIF4E|eif4e
551029|NCT01215604|eIF4G|eif4g
551030|NCT01215591|Neonatal|neonatal
551031|NCT01215591|Nasal CPAP|nasal cpap
551032|NCT01215591|Randomized controlled trial|randomized controlled trial
551033|NCT01215591|Weaning|weaning
551034|NCT01215578|Neuroendocrine Tumors|neuroendocrine tumors
551035|NCT01215578|Neuroectodermal Tumors|neuroectodermal tumors
551036|NCT01215578|Neoplasms, Germ Cell and Embryonal|neoplasms, germ cell and embryonal
551037|NCT01215578|Neoplasms by Histologic Type|neoplasms by histologic type
551038|NCT01215578|Neoplasms|neoplasms
551039|NCT01215578|Neoplasms, Glandular and Epithelial|neoplasms, glandular and epithelial
551040|NCT01215578|Neoplasms, Nerve Tissue|neoplasms, nerve tissue
551041|NCT01215578|Pancreatic Neoplasms|pancreatic neoplasms
551042|NCT01215578|Digestive System Neoplasms|digestive system neoplasms
551043|NCT01215578|Neoplasms by Site|neoplasms by site
551044|NCT01215578|Endocrine Gland Neoplasms|endocrine gland neoplasms
551045|NCT01215578|Adenoma, Islet Cell|adenoma, islet cell
551046|NCT01215578|Adenocarcinoma|adenocarcinoma
551047|NCT01215578|Carcinoma|carcinoma
551048|NCT01215578|Adenoma|adenoma
551049|NCT01215578|Digestive System Diseases|digestive system diseases
551050|NCT01215578|Pancreatic Diseases|pancreatic diseases
551051|NCT01215578|Endocrine System Diseases|endocrine system diseases
551052|NCT01215578|Sunitinib|sunitinib
551053|NCT01215578|Antineoplastic Agents|antineoplastic agents
551054|NCT01215578|Therapeutic Uses|therapeutic uses
551055|NCT01215578|Pharmacologic Actions|pharmacologic actions
551056|NCT01215578|Angiogenesis Inhibitors|angiogenesis inhibitors
551057|NCT01215578|Angiogenesis Modulating Agents|angiogenesis modulating agents
551058|NCT01215578|Growth Substances|growth substances
551059|NCT01215578|Physiological Effects of Drugs|physiological effects of drugs
551060|NCT01215578|Growth Inhibitors|growth inhibitors
551061|NCT01215565|Carcinoma, Hepatocellular|carcinoma, hepatocellular
551062|NCT01215565|Carcinoma|carcinoma
551063|NCT01215565|Fibrosis|fibrosis
551064|NCT01215565|Liver Neoplasms|liver neoplasms
551065|NCT01215565|Pathologic Processes|pathologic processes
551066|NCT01215565|Digestive System Neoplasms|digestive system neoplasms
551067|NCT01215565|Neoplasms by Site|neoplasms by site
551068|NCT01215565|Neoplasms|neoplasms
551069|NCT01215565|Liver Diseases|liver diseases
551070|NCT01215565|Adenocarcinoma|adenocarcinoma
551071|NCT01215565|Neoplasms, Glandular and Epithelial|neoplasms, glandular and epithelial
551072|NCT01215565|Neoplasms by Histologic Type|neoplasms by histologic type
551073|NCT01215565|Sunitinib|sunitinib
551074|NCT01215565|Antineoplastic Agents|antineoplastic agents
551075|NCT01215565|Therapeutic Uses|therapeutic uses
551076|NCT01215565|Pharmacologic Actions|pharmacologic actions
551077|NCT01215565|Angiogenesis Inhibitors|angiogenesis inhibitors
551078|NCT01215565|Angiogenesis Modulating Agents|angiogenesis modulating agents
551079|NCT01215565|Growth Substances|growth substances
551080|NCT01215565|Physiological Effects of Drugs|physiological effects of drugs
551081|NCT01215565|Growth Inhibitors|growth inhibitors
551082|NCT01215500|solid tumor cancer|solid tumor cancer
551083|NCT01215500|epithelial carcinoma|epithelial carcinoma
551084|NCT01215487|CML Predictive Study|cml predictive study
551085|NCT01215461|Neonatal mortality|neonatal mortality
551086|NCT01215461|Preterm birth|preterm birth
551087|NCT01215461|Low gestational age|low gestational age
551088|NCT01215461|VLBW|vlbw
551089|NCT01215448|Fatigue|fatigue
551090|NCT01215448|Quality of life|quality of life
551091|NCT01215448|Lifestyle|lifestyle
551092|NCT01215448|Complementary medicine|complementary medicine
551093|NCT01215422|Surgical procedures|surgical procedures
551094|NCT01215422|Intubation|intubation
551095|NCT01215422|Anesthesiologist|anesthesiologist
551096|NCT01215422|Laryngoscope|laryngoscope
551097|NCT01215422|Videolaryngoscope|videolaryngoscope
551098|NCT01215409|Levitra|levitra
551099|NCT01215409|Erectile dysfunction|erectile dysfunction
551100|NCT01215409|Taiwan|taiwan
551101|NCT01215396|Branched Chain Amino Acids|branched chain amino acids
551102|NCT01215396|Mental Performance|mental performance
551103|NCT01215396|Muscular Performance|muscular performance
551104|NCT01215396|Central Fatigue Theory|central fatigue theory
551105|NCT01215383|HDL|hdl
551106|NCT01215383|psychiatric patients|psychiatric patients
551107|NCT01215383|psychiatric patients before and during antipsychotic therapy|psychiatric patients before and during antipsychotic therapy
551108|NCT01215357|Pathological Gambling|pathological gambling
551109|NCT01215357|ecopipam|ecopipam
551110|NCT01215357|Dopamine|dopamine
551111|NCT01215331|Gestational Diabetes Mellitus|gestational diabetes mellitus
551112|NCT01215331|Treatment|treatment
551113|NCT01215331|Insulin|insulin
551114|NCT01215331|Metformin|metformin
551115|NCT01215331|Glyburide|glyburide
551116|NCT01215318|FDG PET/CT, vaginal tampon, urinary contamination, pitfall|fdg pet/ct, vaginal tampon, urinary contamination, pitfall
551117|NCT01215305|Gastroesophageal Reflux Disease, extraesophageal symptoms|gastroesophageal reflux disease, extraesophageal symptoms
551118|NCT01215292|testosterone|testosterone
551119|NCT01215292|acyline|acyline
551120|NCT01215292|ketoconazole|ketoconazole
551121|NCT01215292|dutasteride|dutasteride
551122|NCT01215292|anastrazole|anastrazole
551123|NCT01215292|Intratesticular hormone concentration|intratesticular hormone concentration
551124|NCT01215279|Respiratory disease|respiratory disease
551125|NCT01215279|Chronic Obstructive Pulmonary Disease|chronic obstructive pulmonary disease
551126|NCT01215266|Bladder cancer|bladder cancer
551127|NCT01215266|Chemotherapy|chemotherapy
551128|NCT01215266|Urothelium cancer|urothelium cancer
551129|NCT01215253|Sudden Death|sudden death
551130|NCT01215253|Ranolazine|ranolazine
551131|NCT01215253|Heart failure|heart failure
551132|NCT01215253|Ventricular tachycardia|ventricular tachycardia
551133|NCT01215253|Ventricular fibrillation|ventricular fibrillation
551134|NCT01215253|Implantable cardioverter-defibrillator|implantable cardioverter-defibrillator
551135|NCT01215214|metabolite profiles|metabolite profiles
551136|NCT01215214|pharmacokinetics|pharmacokinetics
551137|NCT01215214|CYP3A|cyp3a
551138|NCT01215214|metabolomics|metabolomics
551139|NCT01215201|Periodontal maintenance|periodontal maintenance
551140|NCT01215201|≥5mm probing depth|≥5mm probing depth
551141|NCT01215201|bleeding on probing and/or suppuration|bleeding on probing and/or suppuration
551535|NCT01213238|Eloxatin|eloxatin
551142|NCT01215188|Invasive pneumococcal disease|invasive pneumococcal disease
551143|NCT01215188|Pneumonia|pneumonia
551144|NCT01215188|Pneumococcal conjugate vaccine|pneumococcal conjugate vaccine
551145|NCT01215175|Pneumococcal vaccines|pneumococcal vaccines
551146|NCT01215149|HIV|hiv
551147|NCT01215110|Bedaquiline|bedaquiline
551148|NCT01215110|Sirturo|sirturo
551149|NCT01215110|Early Bactericidal Activity|early bactericidal activity
551150|NCT01215110|EBA|eba
551151|NCT01215110|Pulmonary Tuberculosis|pulmonary tuberculosis
551152|NCT01215110|TMC207|tmc207
551153|NCT01215084|Human Volunteers|human volunteers
551154|NCT01215071|Lymphadenectomy|lymphadenectomy
551155|NCT01215071|Extension|extension
551156|NCT01215071|Bladder cancer|bladder cancer
551157|NCT01215058|Compliance, France|compliance, france
551158|NCT01215058|Gastrointestinal bleeding ulcer or symptomatic ulcer with NSAID|gastrointestinal bleeding ulcer or symptomatic ulcer with nsaid
551159|NCT01215045|AcrySof ReSTOR Aspheric +4|acrysof restor aspheric +4
551160|NCT01215032|castration-resistant prostate cancer|castration-resistant prostate cancer
551161|NCT01215032|insulin levels|insulin levels
551162|NCT01215032|metformin|metformin
551163|NCT01215019|traumatic brain injury|traumatic brain injury
551164|NCT01214993|GSK1349572|gsk1349572
551165|NCT01214993|para-aminohippurate|para-aminohippurate
551166|NCT01214993|iohexol|iohexol
551167|NCT01214980|Low-frequency ultrasound|low-frequency ultrasound
551168|NCT01214980|Wound healing|wound healing
551169|NCT01214980|Split thickness wound healing|split thickness wound healing
551170|NCT01214980|Skin graft donor site healing|skin graft donor site healing
551171|NCT01214967|risk factors for maternal depression|risk factors for maternal depression
551172|NCT01214954|Total Hip Replacement|total hip replacement
551173|NCT01214954|Rehabilitation|rehabilitation
551174|NCT01214954|Resistance training|resistance training
551175|NCT01214928|vitamin D|vitamin d
551176|NCT01214928|cholecalciferol|cholecalciferol
551177|NCT01214928|hemodialysis|hemodialysis
551178|NCT01214928|randomized controlled trial|randomized controlled trial
551179|NCT01214928|pilot|pilot
551180|NCT01214889|Diphtheria|diphtheria
551181|NCT01214889|Tetanus|tetanus
551182|NCT01214889|Pertussis|pertussis
551183|NCT01214889|Haemophilus influenzae type B|haemophilus influenzae type b
551184|NCT01214889|Poliomyelitis|poliomyelitis
551185|NCT01214889|PENTAXIM™|pentaxim™
551186|NCT01214889|TETRAXIM™|tetraxim™
551187|NCT01214863|Toric Intraocular Lens (IOL)|toric intraocular lens (iol)
551188|NCT01214850|Meningococcal vaccines|meningococcal vaccines
551189|NCT01214850|Meningococcal B|meningococcal b
551190|NCT01214850|Meningococcal ACWY serogroups|meningococcal acwy serogroups
551191|NCT01214837|Meningococcal|meningococcal
551192|NCT01214837|ACWY|acwy
551193|NCT01214837|Conjugate Vaccine|conjugate vaccine
551194|NCT01214837|Meningitis|meningitis
551195|NCT01214837|Infants|infants
551196|NCT01214837|Persistence|persistence
551197|NCT01214824|Diabetes|diabetes
551198|NCT01214824|Continuous Glucose Monitoring|continuous glucose monitoring
551199|NCT01214811|The change in signs of inflammation/local infection|the change in signs of inflammation/local infection
551200|NCT01214811|To evaluate the comfort, conformability,|to evaluate the comfort, conformability,
551201|NCT01214811|Pain during wear|pain during wear
551202|NCT01214798|sesamoid displacement,|sesamoid displacement,
551203|NCT01214798|metacarpophalangeal joint,|metacarpophalangeal joint,
551204|NCT01214798|radial condylar ridge of the metacarpal head.|radial condylar ridge of the metacarpal head.
551205|NCT01214772|pregnancy|pregnancy
551206|NCT01214772|heparin|heparin
551207|NCT01214772|fertilization|fertilization
551208|NCT01214759|HIV|hiv
551209|NCT01214759|prevention|prevention
551210|NCT01214759|prophylaxis|prophylaxis
551211|NCT01214759|Raltegravir|raltegravir
551212|NCT01214759|Truvada|truvada
551213|NCT01214746|Statin|statin
551214|NCT01214746|L-NMMA|l-nmma
551215|NCT01214746|Healthy subjects|healthy subjects
551216|NCT01214746|Nephrology|nephrology
551217|NCT01214707|Exercise/No active Treatment|exercise/no active treatment
551218|NCT01214694|TBI|tbi
551219|NCT01214694|intracranial edema|intracranial edema
551220|NCT01214694|brain edema|brain edema
551221|NCT01214694|craniocerebral trauma|craniocerebral trauma
551222|NCT01214694|head injury|head injury
551223|NCT01214694|brain hemorrhage, traumatic|brain hemorrhage, traumatic
551224|NCT01214694|subdural hematoma|subdural hematoma
551225|NCT01214694|brain concussion|brain concussion
551226|NCT01214694|head injuries, closed|head injuries, closed
551227|NCT01214694|epidural hematoma|epidural hematoma
551228|NCT01214694|extra-axial hemorrhage|extra-axial hemorrhage
551229|NCT01214694|cortical contusion|cortical contusion
551230|NCT01214694|Additional relevant MeSH terms:|additional relevant mesh terms:
551231|NCT01214694|Nervous System Diseases|nervous system diseases
551232|NCT01214694|Wounds and Injuries|wounds and injuries
551233|NCT01214694|Disorders of Environmental Origin|disorders of environmental origin
551234|NCT01214694|Central Nervous System Diseases|central nervous system diseases
551235|NCT01214694|Trauma, Nervous System|trauma, nervous system
551236|NCT01214694|Brain Diseases|brain diseases
551237|NCT01214694|Brain Injuries|brain injuries
551238|NCT01214681|Biomarkers|biomarkers
551239|NCT01214681|Colorectal cancer|colorectal cancer
551240|NCT01214681|Resistant starch|resistant starch
551241|NCT01214681|Polydextrose|polydextrose
551242|NCT01214681|Non-digestible carbohydrate|non-digestible carbohydrate
551243|NCT01214655|Acute Myelogenous Leukemia|acute myelogenous leukemia
551244|NCT01214655|Acute Lymphoblastic Leukemia|acute lymphoblastic leukemia
551245|NCT01214655|Chronic Myelogenous Leukemia,Blast Crisis|chronic myelogenous leukemia,blast crisis
551246|NCT01214642|Advanced Cancer|advanced cancer
551248|NCT01214629|Advanced Cancer|advanced cancer
551249|NCT01214629|Metastatic Cancer|metastatic cancer
551250|NCT01214629|Cancer|cancer
551251|NCT01214603|Acute Myelogenous Leukemia, Acute Myeloid Leukemia, Acute|acute myelogenous leukemia, acute myeloid leukemia, acute
551252|NCT01214603|Leukemia, Leukemia|leukemia, leukemia
551253|NCT01214577|PEP005|pep005
551254|NCT01214577|Peplin|peplin
551255|NCT01214577|Photo-damage|photo-damage
551256|NCT01214564|PEP005|pep005
551257|NCT01214564|Peplin|peplin
551258|NCT01214564|Seborrhoeic Keratosis|seborrhoeic keratosis
551259|NCT01214538|Vaccine pneumococcal natural history Acute otitis media|vaccine pneumococcal natural history acute otitis media
551260|NCT01214525|Meatal stenosis|meatal stenosis
551261|NCT01214525|Meatotomy|meatotomy
551262|NCT01214525|Uroflow|uroflow
551263|NCT01214525|Postvoid residual|postvoid residual
551264|NCT01214499|Refractory angina|refractory angina
551265|NCT01214499|Transmyocardial revascularization|transmyocardial revascularization
551266|NCT01214499|Stem cells|stem cells
551267|NCT01214499|Diffuse coronary disease not amenable to percutaneous coronary intervention, and angina, despite proper medical treatment|diffuse coronary disease not amenable to percutaneous coronary intervention, and angina, despite proper medical treatment
551268|NCT01214486|HIV|hiv
551269|NCT01214486|RAL|ral
551270|NCT01214486|Raltegravir|raltegravir
551271|NCT01214486|Isentress|isentress
551272|NCT01214486|Pharmacokinetics|pharmacokinetics
551273|NCT01214473|Clinical sepsis|clinical sepsis
551274|NCT01214473|Pneumonia|pneumonia
551275|NCT01214473|Diarrhea|diarrhea
551276|NCT01214473|Probiotics|probiotics
551277|NCT01214473|Synbiotics|synbiotics
551278|NCT01214460|MET|met
551279|NCT01214447|Hemodialysis|hemodialysis
551280|NCT01214447|Inflammation|inflammation
551281|NCT01214447|Malnutrition|malnutrition
551282|NCT01214447|Phase Angle|phase angle
551283|NCT01214434|Cradle Cap|cradle cap
551284|NCT01214434|Infantile seborrheic Dermatitis|infantile seborrheic dermatitis
551285|NCT01214421|Kidney Disease|kidney disease
551286|NCT01214421|ADPKD|adpkd
551287|NCT01214421|Autosomal Dominant Polycystic Kidney Disease|autosomal dominant polycystic kidney disease
551288|NCT01214421|Adult Polycystic Kidney Disease|adult polycystic kidney disease
551289|NCT01214395|haemodialysis|haemodialysis
551290|NCT01214395|peritoneal dialysis|peritoneal dialysis
551291|NCT01214382|Gastric Bypass|gastric bypass
551292|NCT01214382|Bariatric Surgery|bariatric surgery
551293|NCT01214382|Sertraline|sertraline
551294|NCT01214382|Zoloft|zoloft
551295|NCT01214382|Pharmacokinetic|pharmacokinetic
551296|NCT01214369|intraosseous injection|intraosseous injection
551297|NCT01214369|X-tip|x-tip
551298|NCT01214369|PDL injection|pdl injection
551299|NCT01214369|Supplementary Injection|supplementary injection
551300|NCT01214356|diabetes|diabetes
551301|NCT01214356|kidney disease|kidney disease
551302|NCT01214356|vitamin D|vitamin d
551303|NCT01214343|sorafenib|sorafenib
551304|NCT01214343|Hepatic intraarterial infusion chemotherapy|hepatic intraarterial infusion chemotherapy
551305|NCT01214343|HAIC|haic
551306|NCT01214343|Low dose FP|low dose fp
551307|NCT01214343|cisplatin|cisplatin
551308|NCT01214343|fluorouracil|fluorouracil
551309|NCT01214330|cervical cancer|cervical cancer
551310|NCT01214317|multiple sclerosis|multiple sclerosis
551311|NCT01214317|mitoxantrone|mitoxantrone
551312|NCT01214317|plasmapheresis|plasmapheresis
551313|NCT01214317|induction therapy|induction therapy
551314|NCT01214304|Colposcopy|colposcopy
551315|NCT01214291|fractures|fractures
551316|NCT01214291|prostate cancer|prostate cancer
551317|NCT01214291|androgen deprivation therapy|androgen deprivation therapy
551318|NCT01214278|bioavailability|bioavailability
551319|NCT01214278|marine n-3 fatty acids|marine n-3 fatty acids
551320|NCT01214278|EPA|epa
551321|NCT01214278|DHA|dha
551322|NCT01214252|Repair of patients' abdominal wall defects|repair of patients' abdominal wall defects
551323|NCT01214187|idiopathic pulmonary fibrosis|idiopathic pulmonary fibrosis
551324|NCT01214187|IPF|ipf
551325|NCT01214187|pulmonary fibrosis|pulmonary fibrosis
551326|NCT01214187|carbon monoxide|carbon monoxide
551327|NCT01214174|cataract|cataract
551328|NCT01214174|inflammation|inflammation
551329|NCT01214161|IUD|iud
551330|NCT01214161|Lidocaine gel|lidocaine gel
551331|NCT01214135|Mental disorder|mental disorder
551332|NCT01214135|antipsychotic treatment|antipsychotic treatment
551333|NCT01214122|Phase 1|phase 1
551334|NCT01214122|Drug-Drug interaction|drug-drug interaction
551335|NCT01214122|warfarin|warfarin
551336|NCT01214122|AZD9668|azd9668
551337|NCT01214122|resulting from AZD9668 and Warfarin interaction|resulting from azd9668 and warfarin interaction
551338|NCT01214122|pharmacokinetics|pharmacokinetics
551339|NCT01214122|pharmacodynamics|pharmacodynamics
551340|NCT01214096|Chronic Heart failure|chronic heart failure
551341|NCT01214096|rhNRG-1|rhnrg-1
551342|NCT01214096|MRI|mri
551343|NCT01214083|N-acetylcysteine|n-acetylcysteine
551344|NCT01214083|naltrexone|naltrexone
551345|NCT01214070|Visual Perception|visual perception
551346|NCT01214070|Vision, Ocular|vision, ocular
551347|NCT01214070|Neuronal Plasticity|neuronal plasticity
551348|NCT01214057|chronic rhinosinusitis|chronic rhinosinusitis
551349|NCT01214057|endoscopic sinus surgery|endoscopic sinus surgery
551350|NCT01214057|TIVA|tiva
551351|NCT01214057|surgical field visualization|surgical field visualization
551352|NCT01214031|Confocal laser endomicroscope|confocal laser endomicroscope
551353|NCT01214031|Adenomatous polyps|adenomatous polyps
551354|NCT01214031|Colonoscopy|colonoscopy
551355|NCT01214005|nicotine|nicotine
551356|NCT01214005|reinforcement|reinforcement
551357|NCT01214005|craving|craving
551358|NCT01214005|relapse|relapse
551359|NCT01213966|Acute uncomplicated Plasmodium Falciparum malaria|acute uncomplicated plasmodium falciparum malaria
551360|NCT01213966|Blood stage Plasmodium Vivax malaria|blood stage plasmodium vivax malaria
551361|NCT01213953|Vertebral disc, mesenchymal stem cell.|vertebral disc, mesenchymal stem cell.
551362|NCT01213914|Burns|burns
551363|NCT01213914|Hemofiltration|hemofiltration
551364|NCT01213914|Vasopressins|vasopressins
551365|NCT01213914|Kidney Failure Acute|kidney failure acute
551366|NCT01213914|Shock, Septic|shock, septic
551367|NCT01213901|Insulin absorption|insulin absorption
551368|NCT01213901|Insulin injection technique|insulin injection technique
551369|NCT01213888|Diabetic retinopathy|diabetic retinopathy
551370|NCT01213888|pan-retinal photocoagulation|pan-retinal photocoagulation
551371|NCT01213888|macular edema|macular edema
551372|NCT01213875|heart failure|heart failure
551373|NCT01213875|nursing|nursing
551374|NCT01213875|home based intervention|home based intervention
551375|NCT01213875|cost|cost
551376|NCT01213875|efficacy|efficacy
551377|NCT01213862|Home Based education|home based education
551378|NCT01213862|Knowledge of Disease|knowledge of disease
551379|NCT01213862|Self-Care Skills|self-care skills
551380|NCT01213862|Quality of Life|quality of life
551381|NCT01213862|Heart Failure|heart failure
551382|NCT01213862|Randomized Clinical Trial|randomized clinical trial
551383|NCT01213836|Stable schizophrenia|stable schizophrenia
551384|NCT01213836|cognitive functioning|cognitive functioning
551385|NCT01213823|invasive candidiasis|invasive candidiasis
551386|NCT01213823|candidemia|candidemia
551387|NCT01213823|severe hepatic injury|severe hepatic injury
551388|NCT01213823|echinocandins|echinocandins
551389|NCT01213823|anidulafungin|anidulafungin
551390|NCT01213823|caspofungin|caspofungin
551391|NCT01213823|micafungin|micafungin
551392|NCT01213810|HIV|hiv
551393|NCT01213810|VZV (Varicella zoster Virus)|vzv (varicella zoster virus)
551394|NCT01213810|vaccine|vaccine
551395|NCT01213810|T cell|t cell
551396|NCT01213810|immunogenicity|immunogenicity
551397|NCT01213810|safety|safety
551398|NCT01213797|Suicide|suicide
551399|NCT01213771|Preoperative|preoperative
551400|NCT01213771|Intervention|intervention
551401|NCT01213771|Support|support
551402|NCT01213771|Care|care
551403|NCT01213758|liver function|liver function
551404|NCT01213758|galactose|galactose
551405|NCT01213758|18-F-deoxy-galactose|18-f-deoxy-galactose
551406|NCT01213758|PET/CT|pet/ct
551407|NCT01213758|stereotactic body radiation therapy|stereotactic body radiation therapy
551408|NCT01213758|SBRT|sbrt
551409|NCT01213745|lung|lung
551410|NCT01213745|cancer|cancer
551411|NCT01213745|quality of life|quality of life
551412|NCT01213732|L19, antibody, monoclonal, tumor targeting, TNFa, ILP, melanoma|l19, antibody, monoclonal, tumor targeting, tnfa, ilp, melanoma
551413|NCT01213719|betaine, creatine, strength|betaine, creatine, strength
551414|NCT01213706|airway blood flow|airway blood flow
551415|NCT01213706|albuterol|albuterol
551416|NCT01213706|Whole Body Periodic Acceleration (WBPA)|whole body periodic acceleration (wbpa)
551417|NCT01213706|Nitric Oxide|nitric oxide
551418|NCT01213706|Endothelial Dysfunction|endothelial dysfunction
551419|NCT01213693|COPD|copd
551420|NCT01213693|Bacteria|bacteria
551421|NCT01213693|Virus|virus
551422|NCT01213693|Inhaled Corticosteroids|inhaled corticosteroids
551423|NCT01213680|Inflammatory Bowel Disease, IBD|inflammatory bowel disease, ibd
551424|NCT01213654|Lung cancer|lung cancer
551425|NCT01213654|VATS Lobectomy|vats lobectomy
551426|NCT01213641|Cryopyrin-associated periodic syndromes(CAPS)|cryopyrin-associated periodic syndromes(caps)
551427|NCT01213641|CIAS1 protein|cias1 protein
551428|NCT01213641|NLRP3 protein|nlrp3 protein
551429|NCT01213641|human cryopyrin protein|human cryopyrin protein
551430|NCT01213641|Familial Cold Autoinflammatory Syndrome(FCAS)|familial cold autoinflammatory syndrome(fcas)
551431|NCT01213641|Muckle-Wells Syndrome(MWS)|muckle-wells syndrome(mws)
551432|NCT01213641|Neonatal Onset Multisystem Inflammatory disease(NOMID)|neonatal onset multisystem inflammatory disease(nomid)
551433|NCT01213641|NALP3|nalp3
551434|NCT01213641|canakinumab|canakinumab
551435|NCT01213641|Interleukin-1(IL-1)|interleukin-1(il-1)
551436|NCT01213628|abdominal surgery|abdominal surgery
551437|NCT01213628|hypothermia|hypothermia
551438|NCT01213628|wound desiccation|wound desiccation
551439|NCT01213628|warming|warming
551440|NCT01213602|Trauma patients|trauma patients
551441|NCT01213589|descending|descending
551442|NCT01213589|thoracic|thoracic
551443|NCT01213589|aortic|aortic
551444|NCT01213589|dissection|dissection
551445|NCT01213589|Valiant|valiant
551446|NCT01213589|Medtronic|medtronic
551447|NCT01213589|Type B|type b
551448|NCT01213589|VIRTUE|virtue
551449|NCT01213589|stent|stent
551450|NCT01213576|Lymphatic filariasis|lymphatic filariasis
551451|NCT01213576|microfilaria|microfilaria
551452|NCT01213576|Albendazole|albendazole
551453|NCT01213576|ivermectin|ivermectin
551454|NCT01213576|human immunodeficiency|human immunodeficiency
551455|NCT01213563|Diabetes Mellitus, Type 2|diabetes mellitus, type 2
551456|NCT01213537|Heart failure|heart failure
551457|NCT01213524|nicotine|nicotine
551458|NCT01213524|craving|craving
551459|NCT01213524|dual-diagnosis|dual-diagnosis
551460|NCT01213524|comorbidity|comorbidity
551461|NCT01213511|coronary artery disease; coronary artery bypass grafting; cardiopulmonary bypass; minimal extracorporeal circulation|coronary artery disease; coronary artery bypass grafting; cardiopulmonary bypass; minimal extracorporeal circulation
551462|NCT01213498|Nephrology|nephrology
551463|NCT01213498|Atorvastatin|atorvastatin
551464|NCT01213498|L-NMMA|l-nmma
551466|NCT01213472|ASCI|asci
551467|NCT01213472|melanoma|melanoma
551468|NCT01213472|tumor antigen|tumor antigen
551469|NCT01213472|unresectable|unresectable
551470|NCT01213472|progressive|progressive
551471|NCT01213472|NY-ESO-1|ny-eso-1
551472|NCT01213472|adult|adult
551473|NCT01213472|cancer-testis antigen|cancer-testis antigen
551474|NCT01213472|Immunotherapy|immunotherapy
551475|NCT01213459|Human papillomavirus|human papillomavirus
551476|NCT01213446|Von Willebrand Disease|von willebrand disease
551477|NCT01213420|Donor sites after wound closure|donor sites after wound closure
551478|NCT01213407|Dendritic cell|dendritic cell
551479|NCT01213407|Cancer vaccine|cancer vaccine
551480|NCT01213407|Anti-tumor immune therapy|anti-tumor immune therapy
551481|NCT01213407|Interleukine-12|interleukine-12
551482|NCT01213407|Individualised autologous therapy|individualised autologous therapy
551483|NCT01213407|Brain cancer|brain cancer
551484|NCT01213407|Temozolomide|temozolomide
551485|NCT01213407|Radiotherapy|radiotherapy
551486|NCT01213407|Irradiation|irradiation
551487|NCT01213407|High-grade glioma|high-grade glioma
551488|NCT01213407|Advanced therapy medicinal product ATMP|advanced therapy medicinal product atmp
551489|NCT01213407|Somatic cell therapy|somatic cell therapy
551490|NCT01213407|Leukocyte apheresis|leukocyte apheresis
551491|NCT01213407|Neurosurgery|neurosurgery
551492|NCT01213407|Neurooncology|neurooncology
551493|NCT01213407|Neurology|neurology
551494|NCT01213407|Immunology|immunology
551495|NCT01213407|Tumor immunology|tumor immunology
551496|NCT01213407|Transfusion medicine|transfusion medicine
551497|NCT01213407|Monocyte|monocyte
551498|NCT01213407|Killer cell|killer cell
551499|NCT01213407|Cytotoxic T-cell|cytotoxic t-cell
551500|NCT01213407|Cytotoxic T-lymphocyte|cytotoxic t-lymphocyte
551501|NCT01213394|Framingham score|framingham score
551502|NCT01213394|kidney transplant|kidney transplant
551503|NCT01213394|immunosuppression|immunosuppression
551504|NCT01213394|cardiovascular disease|cardiovascular disease
551505|NCT01213394|CellCept|cellcept
551506|NCT01213394|mycophenolate mofetil|mycophenolate mofetil
551507|NCT01213355|Randomized|randomized
551508|NCT01213355|double-blind|double-blind
551509|NCT01213355|placebo-controlled|placebo-controlled
551510|NCT01213355|5-way crossover|5-way crossover
551511|NCT01213355|single oral administrations of PF 05212377|single oral administrations of pf 05212377
551512|NCT01213355|scopolamine induced deficits in healthy subjects|scopolamine induced deficits in healthy subjects
551513|NCT01213342|dry eye disease|dry eye disease
551514|NCT01213316|HIV|hiv
551515|NCT01213316|antiretroviral|antiretroviral
551516|NCT01213316|human immunodeficiency virus|human immunodeficiency virus
551517|NCT01213316|Raltegravir|raltegravir
551518|NCT01213316|Adults with HIV-1 infection|adults with hiv-1 infection
551519|NCT01213303|cardiovascular risk|cardiovascular risk
551520|NCT01213303|metabolic syndrome|metabolic syndrome
551521|NCT01213303|fatty acids|fatty acids
551522|NCT01213303|oxysterols|oxysterols
551523|NCT01213303|antioxidants|antioxidants
551524|NCT01213303|oxidative stress|oxidative stress
551525|NCT01213290|Endoscopic ultrasound-guided fine-needle aspiration (EUS-FNA)|endoscopic ultrasound-guided fine-needle aspiration (eus-fna)
551526|NCT01213290|Stylet|stylet
551527|NCT01213277|Diabetes Mellitus|diabetes mellitus
551528|NCT01213277|HbA1c|hba1c
551529|NCT01213277|Glycation Rate|glycation rate
551530|NCT01213277|Fructosamine|fructosamine
551531|NCT01213264|neuromuscular blockade, NMBA, sugammadex, Bridion, TOF,|neuromuscular blockade, nmba, sugammadex, bridion, tof,
551532|NCT01213238|Liver metastasis|liver metastasis
551533|NCT01213238|hepatic arterial infusion|hepatic arterial infusion
551534|NCT01213238|HAI|hai
551536|NCT01213238|Xeloda|xeloda
551537|NCT01213238|Avastin|avastin
551538|NCT01213238|Anti-VEGF monoclonal antibody|anti-vegf monoclonal antibody
551539|NCT01213238|rhuMAb-VEGF|rhumab-vegf
551540|NCT01213238|Oxaliplatin|oxaliplatin
551541|NCT01213238|Capecitabine|capecitabine
551542|NCT01213238|Bevacizumab|bevacizumab
551543|NCT01213225|Elderly|elderly
551544|NCT01213225|Hospitalization|hospitalization
551545|NCT01213225|Geriatrics|geriatrics
551546|NCT01213225|Mortality|mortality
551547|NCT01213225|Readmission|readmission
551548|NCT01213225|Length of Stay|length of stay
551549|NCT01213212|Caloric restriction|caloric restriction
551550|NCT01213212|type 2 diabetes|type 2 diabetes
551551|NCT01213212|abdominal obesity|abdominal obesity
551552|NCT01213212|renal disease|renal disease
551553|NCT01213186|stem cell|stem cell
551554|NCT01213186|hiv|hiv
551555|NCT01213186|CD4|cd4
551556|NCT01213186|immune activation|immune activation
551557|NCT01213173|angina pectoris|angina pectoris
551558|NCT01213173|chest pain|chest pain
551559|NCT01213173|heart rate|heart rate
551560|NCT01213160|Phase I|phase i
551561|NCT01213160|cancer|cancer
551562|NCT01213160|solid tumours|solid tumours
551563|NCT01213160|advanced solid malignancies|advanced solid malignancies
551564|NCT01213160|dose escalation|dose escalation
551565|NCT01213160|FGFR TKI|fgfr tki
551566|NCT01213160|Japanese|japanese
551567|NCT01213147|Pregnancy|pregnancy
551568|NCT01213147|Clomiphene Citrate|clomiphene citrate
551569|NCT01213147|Fertilization|fertilization
551570|NCT01213147|Buserelin|buserelin
551571|NCT01213134|Medical Education|medical education
551572|NCT01213134|Resident Training|resident training
551573|NCT01213134|Portfolio|portfolio
551574|NCT01213121|bipolar depression|bipolar depression
551575|NCT01213121|heart rate variability|heart rate variability
551576|NCT01213121|cardio-respiratory coupling|cardio-respiratory coupling
551577|NCT01213121|electroencephalography|electroencephalography
551578|NCT01213108|Örebro prevention program|örebro prevention program
551579|NCT01213108|Youth drinking|youth drinking
551580|NCT01213095|Lymphoma|lymphoma
551581|NCT01213095|B-Cell|b-cell
551582|NCT01213095|Marginal Zone|marginal zone
551583|NCT01213095|Rituximab|rituximab
551584|NCT01213082|Exudative Age-related Macular Degeneration|exudative age-related macular degeneration
551585|NCT01213082|Proton beam irradiation|proton beam irradiation
551586|NCT01213082|ranibizumab|ranibizumab
551587|NCT01213082|bevacizumab|bevacizumab
551588|NCT01213082|anti-VEGF therapy|anti-vegf therapy
551589|NCT01213056|Mindfulness Based Cognitive Therapy|mindfulness based cognitive therapy
551590|NCT01213056|Chronic Headache Pain|chronic headache pain
551591|NCT01213056|Randomized Controlled Trial.|randomized controlled trial.
551592|NCT01213043|emphysema|emphysema
551593|NCT01213043|alpha 1-antitrypsin|alpha 1-antitrypsin
551594|NCT01213043|alpha 1-antitrypsin deficiency (AATD)|alpha 1-antitrypsin deficiency (aatd)
551595|NCT01213043|alpha 1-proteinase inhibitor (Alpha-1 PI)|alpha 1-proteinase inhibitor (alpha-1 pi)
551596|NCT01213030|HX4|hx4
551597|NCT01213030|[F-18]HX4|[f-18]hx4
551598|NCT01213030|FMISO|fmiso
551599|NCT01213030|[F-18]FMISO|[f-18]fmiso
551600|NCT01213030|Solitary Tumor|solitary tumor
551601|NCT01213030|Hypoxia|hypoxia
551602|NCT01213017|Certolizumab pegol|certolizumab pegol
551603|NCT01213017|Magnetic Resonance Imaging|magnetic resonance imaging
551604|NCT01213017|Rheumatoid Arthritis|rheumatoid arthritis
551605|NCT01213017|RAPID 3|rapid 3
551606|NCT01213004|gastro-esophageal junction|gastro-esophageal junction
551607|NCT01213004|lung|lung
551608|NCT01213004|abdominal|abdominal
551609|NCT01213004|cone-beam CT (CBCT)|cone-beam ct (cbct)
551610|NCT01213004|10-146|10-146
551611|NCT01212991|Progressive Metastatic Prostate Cancer|progressive metastatic prostate cancer
551612|NCT01212978|Aging|aging
551613|NCT01212978|Endothelium,Vascular|endothelium,vascular
551614|NCT01212978|Arterial Remodeling|arterial remodeling
551615|NCT01212978|Ventricular Vascular Coupling|ventricular vascular coupling
551616|NCT01212978|Nitric Oxide|nitric oxide
551617|NCT01212978|Walking|walking
551618|NCT01212978|Software|software
551619|NCT01212965|Selenium|selenium
551620|NCT01212965|Lymphatic Malformations|lymphatic malformations
551621|NCT01212965|Adolescents|adolescents
551622|NCT01212939|Dead pulps and open root ends|dead pulps and open root ends
551623|NCT01212939|Patients who have teeth with dead pulp and open root ends|patients who have teeth with dead pulp and open root ends
551624|NCT01212900|Atherosclerosis|atherosclerosis
551625|NCT01212900|Cardiovascular Disease|cardiovascular disease
551626|NCT01212900|Cardiac MRI|cardiac mri
551627|NCT01212900|Cardiac CT|cardiac ct
551628|NCT01212900|Cholesterol|cholesterol
551746|NCT01212523|propofol|propofol
551629|NCT01212887|unspecified adult solid tumor, protocol specific|unspecified adult solid tumor, protocol specific
551630|NCT01212887|recurrent colon cancer|recurrent colon cancer
551631|NCT01212887|stage IIIA colon cancer|stage iiia colon cancer
551632|NCT01212887|stage IIIB colon cancer|stage iiib colon cancer
551633|NCT01212887|stage IIIC colon cancer|stage iiic colon cancer
551634|NCT01212887|stage IV colon cancer|stage iv colon cancer
551635|NCT01212887|stage IVB colon cancer|stage ivb colon cancer
551636|NCT01212887|recurrent rectal cancer|recurrent rectal cancer
551637|NCT01212887|stage IIIA rectal cancer|stage iiia rectal cancer
551638|NCT01212887|stage IIIB rectal cancer|stage iiib rectal cancer
551639|NCT01212887|stage IIIC rectal cancer|stage iiic rectal cancer
551640|NCT01212887|stage IVA rectal cancer|stage iva rectal cancer
551641|NCT01212887|stage IVB rectal cancer|stage ivb rectal cancer
551642|NCT01212887|recurrent gastric cancer|recurrent gastric cancer
551643|NCT01212887|stage IV gastric cancer|stage iv gastric cancer
551644|NCT01212887|recurrent pancreatic cancer|recurrent pancreatic cancer
551645|NCT01212887|stage III pancreatic cancer|stage iii pancreatic cancer
551646|NCT01212887|stage IV pancreatic cancer|stage iv pancreatic cancer
551647|NCT01212887|recurrent breast cancer|recurrent breast cancer
551648|NCT01212887|stage IIIC breast cancer|stage iiic breast cancer
551649|NCT01212887|stage IV breast cancer|stage iv breast cancer
551650|NCT01212887|extensive stage small cell lung cancer|extensive stage small cell lung cancer
551651|NCT01212887|recurrent non-small cell lung cancer|recurrent non-small cell lung cancer
551652|NCT01212887|recurrent small cell lung cancer|recurrent small cell lung cancer
551653|NCT01212887|stage IIIA non-small cell lung cancer|stage iiia non-small cell lung cancer
551654|NCT01212887|stage IIIB non-small cell lung cancer|stage iiib non-small cell lung cancer
551655|NCT01212887|stage IV non-small cell lung cancer|stage iv non-small cell lung cancer
551656|NCT01212887|recurrent ovarian epithelial cancer|recurrent ovarian epithelial cancer
551657|NCT01212887|recurrent ovarian germ cell tumor|recurrent ovarian germ cell tumor
551658|NCT01212887|stage IIIA ovarian epithelial cancer|stage iiia ovarian epithelial cancer
551659|NCT01212887|stage IIIA ovarian germ cell tumor|stage iiia ovarian germ cell tumor
551660|NCT01212887|stage IIIB ovarian epithelial cancer|stage iiib ovarian epithelial cancer
551661|NCT01212887|stage IIIB ovarian germ cell tumor|stage iiib ovarian germ cell tumor
551662|NCT01212887|stage IIIC ovarian epithelial cancer|stage iiic ovarian epithelial cancer
551663|NCT01212887|stage IIIC ovarian germ cell tumor|stage iiic ovarian germ cell tumor
551664|NCT01212887|stage IV ovarian epithelial cancer|stage iv ovarian epithelial cancer
551665|NCT01212887|stage IV ovarian germ cell tumor|stage iv ovarian germ cell tumor
551666|NCT01212848|Transcranial Magnetic Stimulation|transcranial magnetic stimulation
551667|NCT01212848|Suicidal ideation|suicidal ideation
551669|NCT01212835|gastroesophageal reflux disease|gastroesophageal reflux disease
551670|NCT01212835|Morbid obesity|morbid obesity
551671|NCT01212835|esophagitis|esophagitis
551672|NCT01212835|GERD|gerd
551673|NCT01212835|silastic ring|silastic ring
551674|NCT01212835|Gastric bypass|gastric bypass
551675|NCT01212796|allogeneic stem cell transplantation|allogeneic stem cell transplantation
551676|NCT01212783|depression|depression
551677|NCT01212783|psychological treatments|psychological treatments
551678|NCT01212783|Cognitive Behavioral Therapy|cognitive behavioral therapy
551679|NCT01212783|child development|child development
551680|NCT01212783|parenting|parenting
551681|NCT01212783|home visitation|home visitation
551682|NCT01212770|Psoriatic Arthritis|psoriatic arthritis
551683|NCT01212770|Psoriasis|psoriasis
551684|NCT01212770|Arthritis|arthritis
551685|NCT01212770|inflammation|inflammation
551686|NCT01212770|skin condition|skin condition
551687|NCT01212770|inflammatory cells|inflammatory cells
551688|NCT01212770|apremilast|apremilast
551689|NCT01212770|CC-10004|cc-10004
551690|NCT01212770|phosphodiesterase type 4|phosphodiesterase type 4
551691|NCT01212757|Psoriasis|psoriasis
551692|NCT01212757|Arthritis|arthritis
551693|NCT01212757|Psoriatic Arthritis|psoriatic arthritis
551694|NCT01212757|inflammation|inflammation
551695|NCT01212757|skin condition|skin condition
551696|NCT01212757|inflammatory cells|inflammatory cells
551697|NCT01212757|apremilast|apremilast
551698|NCT01212757|CC-10004|cc-10004
551699|NCT01212757|phosphodiesterase type 4|phosphodiesterase type 4
551700|NCT01212744|PEG PAL; PKU; injection;|peg pal; pku; injection;
551701|NCT01212731|Patients with malignancies of the skull base or patients with low grade glioma who require radiotherapy.|patients with malignancies of the skull base or patients with low grade glioma who require radiotherapy.
551702|NCT01212718|Colorectal Cancer|colorectal cancer
551703|NCT01212718|non resectable metastasis|non resectable metastasis
551704|NCT01212718|reference lesion|reference lesion
551705|NCT01212718|biopsy|biopsy
551706|NCT01212718|thymidylate synthase quantitation|thymidylate synthase quantitation
551707|NCT01212679|nerve growth factor|nerve growth factor
551708|NCT01212679|traumatic brain injury|traumatic brain injury
551709|NCT01212679|intranasal|intranasal
551710|NCT01212679|prognosis|prognosis
551711|NCT01212679|neurological function|neurological function
551712|NCT01212666|Adductor Canal Block (ACB)|adductor canal block (acb)
551713|NCT01212666|Anterior Cruciate Ligament (ACL) Reconstruction|anterior cruciate ligament (acl) reconstruction
551714|NCT01212666|Saphenous nerve|saphenous nerve
551715|NCT01212666|Pain|pain
551716|NCT01212666|Ultrasound block|ultrasound block
551717|NCT01212653|Ankylosing Spondylitis|ankylosing spondylitis
551718|NCT01212653|Golimumab|golimumab
551719|NCT01212653|Simponi|simponi
551720|NCT01212653|Anti-TNF alpha|anti-tnf alpha
551721|NCT01212653|EPCs|epcs
551722|NCT01212653|Vascular stiffness|vascular stiffness
551723|NCT01212640|Transfusion, distress|transfusion, distress
551724|NCT01212627|Non-Small Cell Lung Cancer|non-small cell lung cancer
551725|NCT01212601|safety|safety
551726|NCT01212601|efficacy|efficacy
551727|NCT01212601|Chinese patients|chinese patients
551728|NCT01212601|practice|practice
551729|NCT01212588|BPD|bpd
551730|NCT01212588|Borderline|borderline
551731|NCT01212588|personality disorder|personality disorder
551732|NCT01212588|mifepristone|mifepristone
551733|NCT01212575|Mental disorder|mental disorder
551734|NCT01212575|Antipsychotic treatment|antipsychotic treatment
551735|NCT01212562|basal cell carcinoma|basal cell carcinoma
551736|NCT01212562|cryosurgery|cryosurgery
551737|NCT01212562|imiquimod|imiquimod
551738|NCT01212562|immunocryosurgery|immunocryosurgery
551739|NCT01212549|basal cell carcinoma|basal cell carcinoma
551740|NCT01212549|cryosurgery|cryosurgery
551741|NCT01212549|imiquimod|imiquimod
551742|NCT01212549|immunocryosurgery|immunocryosurgery
551743|NCT01212536|children|children
551744|NCT01212536|intubation|intubation
551745|NCT01212536|laryngoscope|laryngoscope
551747|NCT01212523|isoflurane|isoflurane
551748|NCT01212523|pulmonary hypertension|pulmonary hypertension
551749|NCT01212523|congenital heart disease|congenital heart disease
551750|NCT01212510|metastatic colorectal cancer|metastatic colorectal cancer
551751|NCT01212510|circulating tumor markers|circulating tumor markers
551752|NCT01212510|circulating tumor cell|circulating tumor cell
551753|NCT01212510|circulating tumor DNA|circulating tumor dna
551754|NCT01212510|marker's kinetic|marker's kinetic
551755|NCT01212497|mindfulness|mindfulness
551756|NCT01212497|meditation|meditation
551757|NCT01212497|training|training
551758|NCT01212497|coaching|coaching
551759|NCT01212497|virtual coach|virtual coach
551760|NCT01212471|Sign and symptoms of dry eye disease|sign and symptoms of dry eye disease
551761|NCT01212458|gesunde Probanden|gesunde probanden
551762|NCT01212432|Gram positive infection and CRRT|gram positive infection and crrt
551763|NCT01212406|Organ rejection|organ rejection
551764|NCT01212406|Lung transplantation|lung transplantation
551765|NCT01212406|Bronchiolitis Obliterans|bronchiolitis obliterans
551766|NCT01212406|Vitamin D|vitamin d
551767|NCT01212406|Prevention|prevention
551768|NCT01212393|venous thromboembolism disease|venous thromboembolism disease
551769|NCT01212393|emergency|emergency
551770|NCT01212393|prevention|prevention
551771|NCT01212393|thromboprophylaxis|thromboprophylaxis
551772|NCT01212393|medical|medical
551773|NCT01212393|hosptitalization|hosptitalization
551774|NCT01212393|health care risks|health care risks
551775|NCT01212380|Chronic Lymphocytic Leukemia|chronic lymphocytic leukemia
551776|NCT01212380|Small Lymphocytic Lymphoma|small lymphocytic lymphoma
551777|NCT01212380|Prolymphocytic Leukemia|prolymphocytic leukemia
551778|NCT01212367|Gene transfer|gene transfer
551779|NCT01212367|Immunology|immunology
551780|NCT01212367|Cancer|cancer
551781|NCT01212354|intensity modulated radiotherapy|intensity modulated radiotherapy
551782|NCT01212354|selective dose escalation|selective dose escalation
551783|NCT01212354|hypoxia|hypoxia
551784|NCT01212354|head cancer|head cancer
551785|NCT01212354|neck cancer|neck cancer
551786|NCT01212341|Allogenetic NK cells|allogenetic nk cells
551787|NCT01212341|Lymphomas|lymphomas
551788|NCT01212341|Solid tumors|solid tumors
551789|NCT01212328|T2DM|t2dm
551790|NCT01212328|Decision support software|decision support software
551791|NCT01212328|care coordinator|care coordinator
551792|NCT01212315|Wound infection|wound infection
551793|NCT01212315|SSI|ssi
551794|NCT01212315|Suture|suture
551795|NCT01212302|Clopidogrel|clopidogrel
551796|NCT01212302|ASA|asa
551797|NCT01212302|Low Response|low response
551798|NCT01212302|Resistance|resistance
551799|NCT01212263|PCOS|pcos
551800|NCT01212263|Clomiphene resistance|clomiphene resistance
551801|NCT01212263|ovulation induction|ovulation induction
551802|NCT01212263|low dose uFSH|low dose ufsh
551803|NCT01212263|uFSH step-up protocol|ufsh step-up protocol
551804|NCT01212237|glioma|glioma
551805|NCT01212237|meningioma|meningioma
551806|NCT01212237|anaplastic astrocytoma|anaplastic astrocytoma
551807|NCT01212211|Hyponatremia; Sodium level|hyponatremia; sodium level
551808|NCT01212211|Falls|falls
551809|NCT01212211|Gait|gait
551810|NCT01212211|elderly|elderly
551811|NCT01212185|oxytocin|oxytocin
551812|NCT01212185|alcohol withdrawal|alcohol withdrawal
551813|NCT01212185|lorazepam|lorazepam
551814|NCT01212185|alcoholism|alcoholism
551815|NCT01212185|intranasal administration|intranasal administration
551816|NCT01212185|CIWA-Ar|ciwa-ar
551817|NCT01212172|Hair removal|hair removal
551818|NCT01212172|Laser|laser
551819|NCT01212172|Diode laser|diode laser
551820|NCT01212159|Internet based monitoring system|internet based monitoring system
551821|NCT01212146|Artichokes|artichokes
551822|NCT01212146|Constipation|constipation
551823|NCT01212146|Functional Foods|functional foods
551824|NCT01212146|Prebiotics|prebiotics
551825|NCT01212146|Probiotics|probiotics
551826|NCT01212120|Diabetic foot|diabetic foot
551827|NCT01212107|Advanced cancer|advanced cancer
551828|NCT01212107|Metastatic cancer|metastatic cancer
551829|NCT01212107|Oncology|oncology
551830|NCT01212094|Rituximab|rituximab
551831|NCT01212094|Multiple Sclerosis|multiple sclerosis
551832|NCT01212094|Intrathecal|intrathecal
551833|NCT01212094|MS|ms
551834|NCT01212094|Secondary-Progressive Multiple Sclerosis|secondary-progressive multiple sclerosis
551835|NCT01212094|SP-MS|sp-ms
551836|NCT01212081|Virtual Reality|virtual reality
551837|NCT01212081|Schizophrenia|schizophrenia
551838|NCT01212081|Cannabis|cannabis
551839|NCT01212081|Assessment|assessment
551840|NCT01212081|Craving|craving
551841|NCT01212068|MEG|meg
551842|NCT01212068|Epilepsy|epilepsy
551843|NCT01212068|Brain Imaging|brain imaging
551844|NCT01212068|Brain Scan|brain scan
551845|NCT01212068|Auditory Processing|auditory processing
551846|NCT01212068|Auditory Perceptual Disorder|auditory perceptual disorder
551847|NCT01212055|PBSC Collection|pbsc collection
551848|NCT01212055|Immunodeficiency|immunodeficiency
551849|NCT01212055|Spectra Apheresis System|spectra apheresis system
551850|NCT01212055|Stem Cell Mobilization|stem cell mobilization
551851|NCT01212055|Leukapheresis|leukapheresis
551852|NCT01212042|Pneumonia|pneumonia
551853|NCT01212042|Pulmonary Pathogens|pulmonary pathogens
551854|NCT01212042|HIV|hiv
551855|NCT01212042|Immunocompromised Host|immunocompromised host
551856|NCT01212042|Respiratory Infection|respiratory infection
551857|NCT01212042|Mycobacteria|mycobacteria
551858|NCT01212029|fNIRS|fnirs
551859|NCT01212029|Healthy Volunteer|healthy volunteer
551860|NCT01212029|HV|hv
551861|NCT01212016|Eosinophilic Esophagitis|eosinophilic esophagitis
551862|NCT01212016|Eosinophilic Gastroenteritis|eosinophilic gastroenteritis
551863|NCT01212016|Peanut Allergy|peanut allergy
551864|NCT01212016|T Cell|t cell
551865|NCT01212016|IgE|ige
551866|NCT01212016|Food Allergy|food allergy
551867|NCT01212003|TB|tb
551868|NCT01212003|Mycobacterium Tuberculosis|mycobacterium tuberculosis
551869|NCT01212003|Active Tuberculosis|active tuberculosis
551870|NCT01212003|Latent Tuberculosis|latent tuberculosis
551871|NCT01212003|MDR TB|mdr tb
551872|NCT01212003|Tuberculosis|tuberculosis
551873|NCT01211990|Pediatric|pediatric
551874|NCT01211990|Children|children
551875|NCT01211990|Cancer|cancer
551876|NCT01211990|Bone Marrow Transplant|bone marrow transplant
551877|NCT01211977|Muckle Wells Syndrome|muckle wells syndrome
551878|NCT01211977|Autoinflammatory|autoinflammatory
551879|NCT01211977|Interleukin-1|interleukin-1
551880|NCT01211951|Dry eye syndromes|dry eye syndromes
551881|NCT01211951|Corneal diseases|corneal diseases
551882|NCT01211951|Conjunctival diseases|conjunctival diseases
551883|NCT01211938|phase II/III|phase ii/iii
551884|NCT01211938|upper aerodigestive tract carcinoma|upper aerodigestive tract carcinoma
551885|NCT01211938|re irradiation|re irradiation
551886|NCT01211938|Recurrent or second upper aerodigestive tract carcinoma|recurrent or second upper aerodigestive tract carcinoma
551887|NCT01211925|unreconstructable peripheral arterial disease|unreconstructable peripheral arterial disease
551888|NCT01211912|Fetal movement|fetal movement
551889|NCT01211912|Fetal breathing|fetal breathing
551890|NCT01211912|Acetaminophen|acetaminophen
551891|NCT01211899|polymorphism,|polymorphism,
551892|NCT01211899|plasminogen activator inhibitor,|plasminogen activator inhibitor,
551893|NCT01211899|disseminated intravascular coagulation,|disseminated intravascular coagulation,
551894|NCT01211886|Brain natriuretic peptide|brain natriuretic peptide
551895|NCT01211886|Cardio-renal syndrome|cardio-renal syndrome
551896|NCT01211873|CNS|cns
551897|NCT01211873|Contrast Agent|contrast agent
551898|NCT01211873|MRI|mri
551899|NCT01211873|Dotarem|dotarem
551900|NCT01211873|Magnevist|magnevist
551901|NCT01211860|DCCR|dccr
551902|NCT01211860|Diazoxide Chonline Controlled-Release Tablet = DCCR|diazoxide chonline controlled-release tablet = dccr
551903|NCT01211860|Hypertriglyceridemia|hypertriglyceridemia
551904|NCT01211860|Triglycerides|triglycerides
551905|NCT01211860|Pharmacokinetics|pharmacokinetics
551906|NCT01211847|triglycerides|triglycerides
551907|NCT01211847|Apo B|apo b
551908|NCT01211847|non-HDL|non-hdl
551909|NCT01211847|statin|statin
551910|NCT01211847|fenofibrate|fenofibrate
551911|NCT01211795|Migraine|migraine
551912|NCT01211795|Prevention|prevention
551913|NCT01211795|Treatment|treatment
551914|NCT01211795|Ketoprofen|ketoprofen
551915|NCT01211795|Trigeminal nerve|trigeminal nerve
551916|NCT01211782|Alzheimer's disease|alzheimer's disease
551917|NCT01211782|AD|ad
551918|NCT01211782|AC-1204|ac-1204
551919|NCT01211782|ketogenic|ketogenic
551920|NCT01211782|ketosis|ketosis
551921|NCT01211769|PUFAs|pufas
551922|NCT01211769|Alcoholism|alcoholism
551923|NCT01211769|Treatment|treatment
551924|NCT01211769|Effectiveness|effectiveness
551925|NCT01211743|SILS|sils
551926|NCT01211743|Oxidative Stress|oxidative stress
551927|NCT01211743|8-epiPGF2a|8-epipgf2a
551928|NCT01211743|SILS vs standard laparoscopic cholecystectomy|sils vs standard laparoscopic cholecystectomy
551929|NCT01211730|Liver|liver
551930|NCT01211730|transplantation|transplantation
551931|NCT01211730|Glucose|glucose
551932|NCT01211730|Hyperglycemia|hyperglycemia
551933|NCT01211730|Insulin|insulin
551934|NCT01211730|Rejection|rejection
551935|NCT01211730|Hypoglycemia|hypoglycemia
551936|NCT01211717|Branched Chained Amino Acids|branched chained amino acids
551937|NCT01211717|Delayed Onset Muscle Soreness|delayed onset muscle soreness
551938|NCT01211717|Diabetes|diabetes
551939|NCT01211717|Muscle Damage|muscle damage
551940|NCT01211704|Bipolar, Alcoholism|bipolar, alcoholism
551941|NCT01211691|Hematologic|hematologic
551942|NCT01211691|Leukemia|leukemia
551943|NCT01211691|Malignancies|malignancies
551944|NCT01211691|Myeloproliferative Neoplasms|myeloproliferative neoplasms
551945|NCT01211665|IVMP|ivmp
551946|NCT01211665|corticosteroids|corticosteroids
551947|NCT01211665|IRIS|iris
551948|NCT01211665|Progressive Multifocal Leukoencephalopathy|progressive multifocal leukoencephalopathy
551949|NCT01211665|Immune reconstitution inflammatory syndrome|immune reconstitution inflammatory syndrome
551950|NCT01211665|PML|pml
551951|NCT01211652|Compliance|compliance
551952|NCT01211652|France|france
551953|NCT01211652|Self-administered questionnaire to patients|self-administered questionnaire to patients
551954|NCT01211613|Manipulation|manipulation
551955|NCT01211613|Chiropractic|chiropractic
551956|NCT01211613|Low Back Pain|low back pain
551957|NCT01211600|Staples|staples
551958|NCT01211600|Sutures|sutures
551959|NCT01211600|Wound infections|wound infections
551960|NCT01211600|Cosmesis|cosmesis
551961|NCT01211600|Aesthetic appearance of skin incision|aesthetic appearance of skin incision
551962|NCT01211587|Parkinson's Disease|parkinson's disease
551963|NCT01211587|Cognition|cognition
551964|NCT01211587|Safinamide|safinamide
551965|NCT01211587|Phase 2|phase 2
551966|NCT01211587|Non-demented patients|non-demented patients
551967|NCT01211587|Levodopa|levodopa
551968|NCT01211587|Dopamine agonist|dopamine agonist
551969|NCT01211535|Soft contact lenses|soft contact lenses
551970|NCT01211535|Multi-purpose Solution|multi-purpose solution
551971|NCT01211522|Delirium|delirium
551972|NCT01211522|Intensive care|intensive care
551973|NCT01211522|Mechanical ventilation|mechanical ventilation
551974|NCT01211522|Antipsychotic|antipsychotic
551975|NCT01211522|Haloperidol|haloperidol
551976|NCT01211522|Ziprasidone|ziprasidone
551977|NCT01211522|Randomized|randomized
551978|NCT01211522|Placebo|placebo
551979|NCT01211522|Sepsis|sepsis
551980|NCT01211522|Sedation|sedation
551981|NCT01211522|Long-term cognitive impairment|long-term cognitive impairment
551982|NCT01211509|montelukast|montelukast
551983|NCT01211509|cysteinyl leukotriene|cysteinyl leukotriene
551984|NCT01211509|lung transplantation|lung transplantation
551985|NCT01211509|bronchiolitis obliterans syndrome|bronchiolitis obliterans syndrome
551986|NCT01211496|functional testing|functional testing
551987|NCT01211496|resistance training|resistance training
551988|NCT01211496|velocity training|velocity training
551989|NCT01211496|elderly|elderly
551990|NCT01211496|geriatric|geriatric
551991|NCT01211496|knee|knee
551992|NCT01211496|leg|leg
551993|NCT01211496|leg strength|leg strength
551994|NCT01211483|Lung cancer|lung cancer
551995|NCT01211470|MRSA|mrsa
551996|NCT01211470|ABSSSI|absssi
551997|NCT01211470|Staphylococcus aureus|staphylococcus aureus
551998|NCT01211457|Sapacitabine|sapacitabine
551999|NCT01211457|decitabine|decitabine
552000|NCT01211457|venetoclax|venetoclax
552001|NCT01211457|elderly|elderly
552002|NCT01211457|AML|aml
552003|NCT01211457|MDS|mds
552004|NCT01211457|Refractory|refractory
552005|NCT01211457|relapsed|relapsed
552006|NCT01211457|untreated|untreated
552007|NCT01211444|Obstructive Sleep Apnea|obstructive sleep apnea
552008|NCT01211444|OSA|osa
552009|NCT01211444|Hypoglossal nerve stimulation|hypoglossal nerve stimulation
552010|NCT01211444|Sleep apnea|sleep apnea
552011|NCT01211431|cesarean section|cesarean section
552012|NCT01211431|pain|pain
552013|NCT01211431|ropivacain|ropivacain
552014|NCT01211431|diclofena|diclofena
552015|NCT01211431|morphine|morphine
552016|NCT01211405|MDMA|mdma
552017|NCT01211405|Psychotherapy|psychotherapy
552018|NCT01211405|Veterans|veterans
552019|NCT01211405|Posttraumatic Stress Disorder|posttraumatic stress disorder
552020|NCT01211379|colorectal cancer screening|colorectal cancer screening
552021|NCT01211379|primary care|primary care
552022|NCT01211379|health disparities|health disparities
552023|NCT01211366|cell saver|cell saver
552024|NCT01211366|allogeneic RBCs|allogeneic rbcs
552025|NCT01211366|washed cells|washed cells
552026|NCT01211366|PRBC transfusion|prbc transfusion
552027|NCT01211353|Alcohol|alcohol
552028|NCT01211353|Brief Intervention|brief intervention
552029|NCT01211353|Personalized Feedback|personalized feedback
552030|NCT01211353|Veterans|veterans
552031|NCT01211340|Hospice|hospice
552032|NCT01211340|Caregivers|caregivers
552033|NCT01211340|Interdisciplinary Team|interdisciplinary team
552034|NCT01211340|Pain management|pain management
552035|NCT01211314|hypertension|hypertension
552036|NCT01211314|Fixed combination|fixed combination
552037|NCT01211314|lercanidipine|lercanidipine
552038|NCT01211314|enalapril|enalapril
552039|NCT01211314|Blood Pressure Monitoring, Ambulatory|blood pressure monitoring, ambulatory
552040|NCT01211301|obesity|obesity
552041|NCT01211301|overweight|overweight
552042|NCT01211301|weight loss|weight loss
552043|NCT01211301|randomized controlled trial|randomized controlled trial
552044|NCT01211301|Medifast|medifast
552045|NCT01211288|HIV|hiv
552046|NCT01211288|Implant|implant
552047|NCT01211288|Crown|crown
552048|NCT01211275|mesothelioma|mesothelioma
552049|NCT01211275|chemotherapy|chemotherapy
552050|NCT01211275|translational research|translational research
552051|NCT01211275|axitinib|axitinib
552052|NCT01211262|Melanoma|melanoma
552053|NCT01211262|Phase I|phase i
552054|NCT01211262|Biologic|biologic
552055|NCT01211249|Methotrexate-refractory|methotrexate-refractory
552056|NCT01211223|Chronic periodontitis|chronic periodontitis
552057|NCT01211223|Metronidazole plus Amoxicillin|metronidazole plus amoxicillin
552058|NCT01211223|Mechanical periodontal therapy|mechanical periodontal therapy
552059|NCT01211223|Scaling and Root Planning|scaling and root planning
552060|NCT01211223|Periodontal treatment|periodontal treatment
552061|NCT01211210|rectal cancer|rectal cancer
552062|NCT01211210|neoadjuvant therapy|neoadjuvant therapy
552063|NCT01211210|oxaliplatin|oxaliplatin
552064|NCT01211210|radiation|radiation
552065|NCT01211184|Hip surgery|hip surgery
552066|NCT01211184|Metabolism|metabolism
552067|NCT01211184|Glucose|glucose
552068|NCT01211184|Body fluids|body fluids
552069|NCT01211184|Complications|complications
552070|NCT01211171|Cough|cough
552071|NCT01211171|Telmisartan|telmisartan
552072|NCT01211171|Bradykinin|bradykinin
552073|NCT01211171|Tolerability|tolerability
552074|NCT01211158|emergency department|emergency department
552075|NCT01211158|procedural sedation|procedural sedation
552076|NCT01211158|ketofol|ketofol
552077|NCT01211158|ketamine|ketamine
552078|NCT01211158|propofol|propofol
552079|NCT01211158|conscious sedation|conscious sedation
552080|NCT01211145|Migraine|migraine
552081|NCT01211145|Headache|headache
552082|NCT01211145|Pain|pain
552083|NCT01211145|Efficacy|efficacy
552084|NCT01211145|Adolescents|adolescents
552085|NCT01211132|Colon polyps|colon polyps
552086|NCT01211132|Adenoma detection|adenoma detection
552087|NCT01211132|Cap|cap
552088|NCT01211132|Standard|standard
552089|NCT01211132|Colon Cancer|colon cancer
552090|NCT01211106|Treatment|treatment
552091|NCT01211106|PTSD|ptsd
552092|NCT01211106|Addiction|addiction
552093|NCT01211093|vibration|vibration
552094|NCT01211093|muscle|muscle
552095|NCT01211093|cerebrovascular accident|cerebrovascular accident
552096|NCT01211093|exercise|exercise
552097|NCT01211093|rehabilitation|rehabilitation
552098|NCT01211080|infancy hemangioma|infancy hemangioma
552099|NCT01211080|propranolol|propranolol
552100|NCT01211080|study design|study design
552101|NCT01211080|side effects|side effects
552102|NCT01211080|safety|safety
552103|NCT01211067|Inguinal hernia|inguinal hernia
552104|NCT01211067|Inguinal ring|inguinal ring
552105|NCT01211067|Histology|histology
552106|NCT01211067|Hernioplasty|hernioplasty
552107|NCT01211067|Lichtenstein|lichtenstein
552108|NCT01211041|Candida albicans, fungemia , prognostic factor|candida albicans, fungemia , prognostic factor
552109|NCT01211028|Critical leg ischemia|critical leg ischemia
552110|NCT01211028|Adipose derived Stroma/Stem Cells|adipose derived stroma/stem cells
552111|NCT01211028|Autologous|autologous
552112|NCT01211028|Angiogenesis|angiogenesis
552113|NCT01211002|Radiotherapy|radiotherapy
552114|NCT01211002|rh-endostatin|rh-endostatin
552115|NCT01211002|chemotherapy|chemotherapy
552116|NCT01211002|NSCLC|nsclc
552117|NCT01210976|levosimendan|levosimendan
552118|NCT01210976|CABG|cabg
552119|NCT01210976|AVR|avr
552120|NCT01210950|distraction|distraction
552121|NCT01210950|osteogenesis|osteogenesis
552122|NCT01210950|limb length discrepancy|limb length discrepancy
552123|NCT01210950|callus|callus
552124|NCT01210937|Internal Carotid Artery Stenosis|internal carotid artery stenosis
552125|NCT01210937|Carotid Endarterectomy|carotid endarterectomy
552126|NCT01210937|Stroke|stroke
552127|NCT01210937|Cerebrovascular|cerebrovascular
552128|NCT01210937|Atherosclerosis|atherosclerosis
552129|NCT01210924|children|children
552130|NCT01210924|Acquired Immunodeficiency Syndrome|acquired immunodeficiency syndrome
552131|NCT01210924|antiretroviral therapy|antiretroviral therapy
552132|NCT01210924|China|china
552133|NCT01210924|Mortality|mortality
552134|NCT01210911|pancreatic cancer|pancreatic cancer
552135|NCT01210911|metformin|metformin
552136|NCT01210911|MAPK pathway|mapk pathway
552137|NCT01210911|PI3K/Akt pathway|pi3k/akt pathway
552138|NCT01210911|gemcitabine|gemcitabine
552139|NCT01210898|Influenza|influenza
552140|NCT01210898|Trivalent|trivalent
552141|NCT01210898|Adjuvanted|adjuvanted
552142|NCT01210898|Vaccine|vaccine
552143|NCT01210898|Children|children
552144|NCT01210885|Meningococcal Disease|meningococcal disease
552145|NCT01210885|Vaccines|vaccines
552146|NCT01210885|Adolescents|adolescents
552147|NCT01210872|stage I squamous cell carcinoma of the lip and oral cavity|stage i squamous cell carcinoma of the lip and oral cavity
552148|NCT01210872|stage II squamous cell carcinoma of the lip and oral cavity|stage ii squamous cell carcinoma of the lip and oral cavity
552149|NCT01210872|stage III squamous cell carcinoma of the lip and oral cavity|stage iii squamous cell carcinoma of the lip and oral cavity
552150|NCT01210872|stage I lymphoepithelioma of the oropharynx|stage i lymphoepithelioma of the oropharynx
552151|NCT01210872|stage II lymphoepithelioma of the oropharynx|stage ii lymphoepithelioma of the oropharynx
552152|NCT01210872|stage III lymphoepithelioma of the oropharynx|stage iii lymphoepithelioma of the oropharynx
552153|NCT01210872|stage I squamous cell carcinoma of the oropharynx|stage i squamous cell carcinoma of the oropharynx
552154|NCT01210872|stage II squamous cell carcinoma of the oropharynx|stage ii squamous cell carcinoma of the oropharynx
552155|NCT01210872|stage III squamous cell carcinoma of the oropharynx|stage iii squamous cell carcinoma of the oropharynx
552156|NCT01210872|stage I lymphoepithelioma of the nasopharynx|stage i lymphoepithelioma of the nasopharynx
552157|NCT01210872|stage II lymphoepithelioma of the nasopharynx|stage ii lymphoepithelioma of the nasopharynx
552158|NCT01210872|stage III lymphoepithelioma of the nasopharynx|stage iii lymphoepithelioma of the nasopharynx
552159|NCT01210872|stage I squamous cell carcinoma of the nasopharynx|stage i squamous cell carcinoma of the nasopharynx
552160|NCT01210872|stage II squamous cell carcinoma of the nasopharynx|stage ii squamous cell carcinoma of the nasopharynx
552161|NCT01210872|stage III squamous cell carcinoma of the nasopharynx|stage iii squamous cell carcinoma of the nasopharynx
552162|NCT01210872|stage I squamous cell carcinoma of the hypopharynx|stage i squamous cell carcinoma of the hypopharynx
552163|NCT01210872|stage II squamous cell carcinoma of the hypopharynx|stage ii squamous cell carcinoma of the hypopharynx
552164|NCT01210872|stage III squamous cell carcinoma of the hypopharynx|stage iii squamous cell carcinoma of the hypopharynx
552165|NCT01210872|stage I squamous cell carcinoma of the larynx|stage i squamous cell carcinoma of the larynx
552166|NCT01210872|stage II squamous cell carcinoma of the larynx|stage ii squamous cell carcinoma of the larynx
552167|NCT01210872|stage III squamous cell carcinoma of the larynx|stage iii squamous cell carcinoma of the larynx
552168|NCT01210872|stage I verrucous carcinoma of the larynx|stage i verrucous carcinoma of the larynx
552169|NCT01210872|stage II verrucous carcinoma of the larynx|stage ii verrucous carcinoma of the larynx
552170|NCT01210872|stage III verrucous carcinoma of the larynx|stage iii verrucous carcinoma of the larynx
552171|NCT01210872|tongue cancer|tongue cancer
552172|NCT01210859|detrusitol|detrusitol
552173|NCT01210859|overactive|overactive
552174|NCT01210859|bladder|bladder
552175|NCT01210859|ureteral|ureteral
552176|NCT01210859|stents|stents
552177|NCT01210846|AV-951|av-951
552178|NCT01210846|tivozanib|tivozanib
552179|NCT01210846|QTc|qtc
552180|NCT01210846|advanced solid tumors|advanced solid tumors
552181|NCT01210846|pharmacokinetics|pharmacokinetics
552182|NCT01210833|Finger Fractures|finger fractures
552183|NCT01210833|Tendon Injuries|tendon injuries
552184|NCT01210833|Soft Tissue Injuries|soft tissue injuries
711349|NCT00585169|Compulsive Gambling|compulsive gambling
552185|NCT01210781|All indication for deep brain stimulation (DBS)|all indication for deep brain stimulation (dbs)
552186|NCT01210768|Phase II|phase ii
552187|NCT01210768|Pegylated Liposomal Doxorubicin|pegylated liposomal doxorubicin
552188|NCT01210768|Adjuvant Chemotherapy|adjuvant chemotherapy
552189|NCT01210768|Breast Cancer|breast cancer
552190|NCT01210755|Antithrombotics|antithrombotics
552191|NCT01210755|Haemostatics|haemostatics
552192|NCT01210755|Antidote|antidote
552193|NCT01210729|stroke|stroke
552194|NCT01210729|mechanical recanalization|mechanical recanalization
552195|NCT01210729|self-expanding stent|self-expanding stent
552196|NCT01210729|Solitaire|solitaire
552197|NCT01210716|Therapeutic plasma exchange|therapeutic plasma exchange
552198|NCT01210716|Autoimmune diseases|autoimmune diseases
552199|NCT01210716|Kidney transplant|kidney transplant
552200|NCT01210716|Hematologic disorders|hematologic disorders
552201|NCT01210716|Monoclonal gammopathy|monoclonal gammopathy
552202|NCT01210716|Neurologic disorders|neurologic disorders
552203|NCT01210703|Acoustic Pharyngometry|acoustic pharyngometry
552204|NCT01210703|CPAP|cpap
552205|NCT01210703|Obstructive Sleep Apnea Syndrome|obstructive sleep apnea syndrome
552206|NCT01210690|Levetiracetam|levetiracetam
552207|NCT01210690|Keppra® Oral Solution|keppra® oral solution
552208|NCT01210690|Keppra® in Children|keppra® in children
552209|NCT01210677|Cardiac Sarcoidosis|cardiac sarcoidosis
552210|NCT01210677|Sarcoidosis|sarcoidosis
552211|NCT01210664|Diabetes|diabetes
552212|NCT01210664|Treg|treg
552213|NCT01210651|Yoga|yoga
552214|NCT01210651|Major Depression|major depression
552215|NCT01210651|Self-Efficacy|self-efficacy
552216|NCT01210651|Self-Esteem|self-esteem
552217|NCT01210651|Hatha yoga|hatha yoga
552218|NCT01210651|mind-body therapies|mind-body therapies
552219|NCT01210651|depression|depression
552220|NCT01210625|Constipation|constipation
552221|NCT01210599|Back Pain|back pain
552222|NCT01210599|Bisphosphonate|bisphosphonate
552223|NCT01210599|Pamidronate|pamidronate
552224|NCT01210599|Bone Pain|bone pain
552225|NCT01210573|Heart Failure|heart failure
552226|NCT01210573|Heart-Assist Devices|heart-assist devices
552227|NCT01210573|Left Ventricular Assist Device|left ventricular assist device
552228|NCT01210560|Kidney Disease|kidney disease
552229|NCT01210560|Polycystic Kidney Disease|polycystic kidney disease
552230|NCT01210521|Asthmatic Patients|asthmatic patients
552231|NCT01210521|Vitamin D|vitamin d
552232|NCT01210521|Steroid Resistant Asthmatic Patients|steroid resistant asthmatic patients
552233|NCT01210521|cholecalciferol|cholecalciferol
552234|NCT01210508|Cancer patients with metastases to the spinal column|cancer patients with metastases to the spinal column
552235|NCT01210495|Hepatocellular Carcinoma|hepatocellular carcinoma
552236|NCT01210482|Torisel|torisel
552237|NCT01210482|Regulatory Post Marketing Commitment Plan|regulatory post marketing commitment plan
552238|NCT01210469|elderly|elderly
552239|NCT01210469|postural balance|postural balance
552240|NCT01210469|musculoskeletal equilibrium|musculoskeletal equilibrium
552241|NCT01210469|posture|posture
552242|NCT01210469|muscle strength|muscle strength
552243|NCT01210469|muscle stretching exercises|muscle stretching exercises
552244|NCT01210456|Chronic Kidney Disease|chronic kidney disease
552245|NCT01210456|Contrast Media|contrast media
552246|NCT01210456|Acute Kidney Injury|acute kidney injury
552247|NCT01210456|N-Acetylcysteine|n-acetylcysteine
552248|NCT01210456|Bicarbonate|bicarbonate
552249|NCT01210443|sitaxentan sodium pulmonary hypertension|sitaxentan sodium pulmonary hypertension
552250|NCT01210430|Postural Tachycardia Syndrome|postural tachycardia syndrome
552251|NCT01210430|Orthostatic Intolerance|orthostatic intolerance
552252|NCT01210430|Reactive Oxygen Species|reactive oxygen species
552253|NCT01210430|Oxidative Stress|oxidative stress
552254|NCT01210430|Angiotensin II|angiotensin ii
552255|NCT01210430|Nitric Oxide|nitric oxide
552256|NCT01210430|Blood Flow|blood flow
552257|NCT01210430|POTS|pots
552258|NCT01210430|Ascorbic Acid|ascorbic acid
552259|NCT01210430|Vitamin C|vitamin c
552260|NCT01210430|Losartan|losartan
552261|NCT01210417|Trauma|trauma
552262|NCT01210417|Hypovolemia|hypovolemia
552263|NCT01210417|Hemorrhage|hemorrhage
552264|NCT01210417|Out of hospital trauma|out of hospital trauma
552265|NCT01210404|Drug interaction with methadone.|drug interaction with methadone.
552266|NCT01210378|NSCLC|nsclc
552267|NCT01210378|Nitroglycerin|nitroglycerin
552268|NCT01210378|Tumour perfusion|tumour perfusion
552269|NCT01210378|Hypoxia|hypoxia
552270|NCT01210378|Toxicity|toxicity
552271|NCT01210378|Phase II|phase ii
552272|NCT01210378|HX4|hx4
552273|NCT01210365|CHF functional class II|chf functional class ii
552274|NCT01210365|Patients with CHF|patients with chf
552275|NCT01210365|Patients with CHF functional class II (NYHA) of any etiology|patients with chf functional class ii (nyha) of any etiology
552276|NCT01210352|surgical pain|surgical pain
552277|NCT01210352|acute pain|acute pain
552278|NCT01210352|Acute Post Surgical Pain|acute post surgical pain
552279|NCT01210339|phase 1|phase 1
552280|NCT01210339|cross-over|cross-over
552281|NCT01210339|drug-drug Interaction|drug-drug interaction
552282|NCT01210339|esomeprazole|esomeprazole
552283|NCT01210339|acetylsalicylic acid|acetylsalicylic acid
552284|NCT01210339|clopidogrel|clopidogrel
552285|NCT01210339|healthy volunteers|healthy volunteers
552286|NCT01210339|cardiovascular disease|cardiovascular disease
552287|NCT01210339|patients with acid associated gastrointestinal symptoms|patients with acid associated gastrointestinal symptoms
552288|NCT01210326|TESE|tese
552289|NCT01210326|TESA|tesa
552290|NCT01210326|non obstructive|non obstructive
552291|NCT01210326|azoospermi|azoospermi
552292|NCT01210313|physical activity|physical activity
552293|NCT01210300|caesarean section|caesarean section
552294|NCT01210300|vaginal birth after caesarean section|vaginal birth after caesarean section
552295|NCT01210300|repeat caesarean section|repeat caesarean section
552296|NCT01210300|childbirth expectation|childbirth expectation
552297|NCT01210300|childbirth experience|childbirth experience
552298|NCT01210287|hepatitis B virus reactivation|hepatitis b virus reactivation
552299|NCT01210287|HBsAg negative|hbsag negative
552300|NCT01210287|HBcAb positive|hbcab positive
552301|NCT01210287|lymphoma|lymphoma
552302|NCT01210287|rituximab|rituximab
552303|NCT01210261|OSA|osa
552304|NCT01210261|CPAP|cpap
552305|NCT01210261|APAP|apap
552306|NCT01210261|SPAP|spap
552307|NCT01210261|Obstructive Sleep Apnea|obstructive sleep apnea
552308|NCT01210261|Sleep Apnea|sleep apnea
552309|NCT01210235|colorectal cancer screening|colorectal cancer screening
552310|NCT01210235|preventive health|preventive health
552311|NCT01210235|primary care|primary care
552312|NCT01210209|Ewing sarcoma|ewing sarcoma
552313|NCT01210209|Ewing sarcoma/peripheral primitive neuroectodermal tumor (PNET)|ewing sarcoma/peripheral primitive neuroectodermal tumor (pnet)
552314|NCT01210196|Fabry|fabry
552315|NCT01210183|Dextrose|dextrose
552316|NCT01210183|Cartilage|cartilage
552317|NCT01210183|Regeneration|regeneration
552318|NCT01210170|asthma,|asthma,
552319|NCT01210170|inhaled corticosteroids,|inhaled corticosteroids,
552320|NCT01210170|airway blood flow,|airway blood flow,
552321|NCT01210170|mometasone,|mometasone,
552322|NCT01210170|albuterol|albuterol
552323|NCT01210170|spirometry|spirometry
552324|NCT01210144|Infertility|infertility
552325|NCT01210144|Gonal-f|gonal-f
552326|NCT01210144|gene expression|gene expression
552626|NCT01208740|metformin|metformin
552327|NCT01210144|Assisted Reproductive Technologies|assisted reproductive technologies
552328|NCT01210144|Follitropin alfa|follitropin alfa
552329|NCT01210144|endometrium|endometrium
552330|NCT01210131|Toxicity|toxicity
552331|NCT01210131|Progression|progression
552332|NCT01210131|Survival|survival
552333|NCT01210131|SCLC|sclc
552334|NCT01210118|Pregnancy|pregnancy
552335|NCT01210118|Smoking cessation|smoking cessation
552336|NCT01210118|Cognitive-Behavioural interventions|cognitive-behavioural interventions
552337|NCT01210105|intubation|intubation
552338|NCT01210105|video laryngoscopes|video laryngoscopes
552339|NCT01210079|opioid-induced hyperalgesia|opioid-induced hyperalgesia
552340|NCT01210079|methadone|methadone
552341|NCT01210079|gabapentin|gabapentin
552342|NCT01210079|opioid addiction|opioid addiction
552343|NCT01210066|inflammation|inflammation
552344|NCT01210066|opioid-induced hyperalgesia|opioid-induced hyperalgesia
552345|NCT01210066|bupenorphine|bupenorphine
552346|NCT01210066|prescription opioid abuse|prescription opioid abuse
552347|NCT01210053|Non-Small Cell Lung Cancer|non-small cell lung cancer
552348|NCT01210040|Pregnancy|pregnancy
552349|NCT01210040|Iron deficiency|iron deficiency
552350|NCT01210040|Iron supplementation|iron supplementation
552351|NCT01210040|Burkina Faso|burkina faso
552352|NCT01210014|Recurrent aphthous stomatitis|recurrent aphthous stomatitis
552353|NCT01210014|treatment|treatment
552354|NCT01210014|zinc sulphate|zinc sulphate
552355|NCT01209975|blood flow|blood flow
552356|NCT01209975|glaucoma|glaucoma
552357|NCT01209975|SLT|slt
552358|NCT01209936|Body Fat|body fat
552359|NCT01209936|Total body water|total body water
552360|NCT01209923|Percent body fat|percent body fat
552361|NCT01209923|Body Composition|body composition
552362|NCT01209923|Stayhealthy|stayhealthy
552363|NCT01209897|Smoking|smoking
552364|NCT01209858|epilepsy|epilepsy
552365|NCT01209845|depression|depression
552366|NCT01209845|suicide ideation|suicide ideation
552367|NCT01209845|emergency department|emergency department
552368|NCT01209845|ketamine|ketamine
552369|NCT01209832|Metastatic Tumors|metastatic tumors
552370|NCT01209832|Lymphoma|lymphoma
552371|NCT01209819|Bone Mineral Density|bone mineral density
552372|NCT01209819|Adults|adults
552373|NCT01209780|seasonal influenza, vaccine|seasonal influenza, vaccine
552374|NCT01209767|Cellulite|cellulite
552375|NCT01209767|Cryolipolysis|cryolipolysis
552376|NCT01209767|Zeltiq|zeltiq
552377|NCT01209767|Subcision|subcision
552378|NCT01209754|Pregnancy|pregnancy
552379|NCT01209754|Chemoprophylactic Exposure|chemoprophylactic exposure
552380|NCT01209754|Mother|mother
552381|NCT01209754|Infant|infant
552382|NCT01209754|malformations|malformations
552383|NCT01209754|HIV|hiv
552384|NCT01209728|insomnia|insomnia
552385|NCT01209728|insomniacs|insomniacs
552386|NCT01209728|simulated driving|simulated driving
552387|NCT01209728|alcohol|alcohol
552388|NCT01209728|ethanol|ethanol
552389|NCT01209715|airway blood flow,|airway blood flow,
552390|NCT01209715|COPD,|copd,
552391|NCT01209715|endothelial dysfunction|endothelial dysfunction
552392|NCT01209715|inhaled corticosteroids|inhaled corticosteroids
552393|NCT01209676|melanoma, with advanced unresectable|melanoma, with advanced unresectable
552394|NCT01209663|General Surgery|general surgery
552395|NCT01209663|Emergency treatment|emergency treatment
552396|NCT01209663|Postoperative care|postoperative care
552397|NCT01209663|Intermediate care unit|intermediate care unit
552398|NCT01209663|High dependency unit|high dependency unit
552399|NCT01209663|Mortality|mortality
552400|NCT01209637|stable coronary artery disease|stable coronary artery disease
552401|NCT01209637|significant coronary stenosis|significant coronary stenosis
552402|NCT01209624|prospective|prospective
552403|NCT01209624|non-interventional|non-interventional
552404|NCT01209624|observational|observational
552405|NCT01209624|multi-center|multi-center
552406|NCT01209624|long-term|long-term
552407|NCT01209598|soft tissue|soft tissue
552408|NCT01209598|Palbociclib (PD0332991)|palbociclib (pd0332991)
552409|NCT01209598|10-094|10-094
552410|NCT01209572|energy expenditure|energy expenditure
552411|NCT01209572|heart rate|heart rate
552412|NCT01209572|accelerometry|accelerometry
552413|NCT01209572|body temperature|body temperature
552414|NCT01209572|heat flow galvanic response of skin|heat flow galvanic response of skin
552415|NCT01209546|Bronchiectasis|bronchiectasis
552416|NCT01209546|Pulmonary function|pulmonary function
552417|NCT01209546|Respiratory muscle strength|respiratory muscle strength
552418|NCT01209546|Respiratory secretions|respiratory secretions
552419|NCT01209533|Asthma|asthma
552420|NCT01209520|Lung Cancer|lung cancer
552421|NCT01209520|Non-Small Cell Lung Carcinoma|non-small cell lung carcinoma
552422|NCT01209520|NSCLC|nsclc
552423|NCT01209520|Methylation Analysis|methylation analysis
552424|NCT01209520|Hypermethylation|hypermethylation
552425|NCT01209520|Targeted Genes|targeted genes
552426|NCT01209520|Tumorigenesis|tumorigenesis
552427|NCT01209520|Tumor Supressor Genes|tumor supressor genes
552428|NCT01209507|Adrenal suppression|adrenal suppression
552429|NCT01209507|Chemotherapy fatigue|chemotherapy fatigue
552430|NCT01209507|Quality of life|quality of life
552431|NCT01209494|sudden cardiac death|sudden cardiac death
552432|NCT01209494|implantable cardioverter defibrillator|implantable cardioverter defibrillator
552433|NCT01209494|ventricular arrhythmias|ventricular arrhythmias
552434|NCT01209494|genetic syndromes|genetic syndromes
552435|NCT01209494|calcium metabolism|calcium metabolism
552436|NCT01209494|ventricular repolarization|ventricular repolarization
552437|NCT01209494|ECG|ecg
552438|NCT01209494|T wave|t wave
552439|NCT01209494|programmed electrical stimulation|programmed electrical stimulation
552440|NCT01209494|alternans|alternans
552441|NCT01209494|late potentials|late potentials
552442|NCT01209494|risk stratification|risk stratification
552443|NCT01209481|fruits|fruits
552444|NCT01209481|vegetables|vegetables
552445|NCT01209481|primary health care|primary health care
552446|NCT01209481|nutritional education|nutritional education
552447|NCT01209455|Acetylcysteine|acetylcysteine
552448|NCT01209455|Adverse effects|adverse effects
552449|NCT01209455|Acetaminophen|acetaminophen
552450|NCT01209455|Anaphylactoid reactions|anaphylactoid reactions
552451|NCT01209442|Glioblastoma|glioblastoma
552452|NCT01209442|Multiforme|multiforme
552453|NCT01209429|Calorie restriction|calorie restriction
552454|NCT01209429|GH/IGF-I axis|gh/igf-i axis
552455|NCT01209429|STATb5|statb5
552456|NCT01209429|SIRT1|sirt1
552457|NCT01209429|Intracellular signaling peptides and proteins|intracellular signaling peptides and proteins
552458|NCT01209429|Fasting|fasting
552459|NCT01209429|Growth hormone|growth hormone
552460|NCT01209429|IGF-1|igf-1
552461|NCT01209416|ghrelin|ghrelin
552462|NCT01209416|metabolism|metabolism
552463|NCT01209416|type 2 diabetes|type 2 diabetes
552464|NCT01209416|insulin resistance|insulin resistance
552465|NCT01209403|Dialysis|dialysis
552466|NCT01209403|Malnutrition|malnutrition
552467|NCT01209403|Insulin-Like Growth Factor I|insulin-like growth factor i
552468|NCT01209403|Insulin-Like Growth Factor Binding Protein 1|insulin-like growth factor binding protein 1
552469|NCT01209403|Inflammation|inflammation
552470|NCT01209390|osteochondral|osteochondral
552471|NCT01209390|regenerative|regenerative
552472|NCT01209390|repair|repair
552473|NCT01209390|cartilage lesion|cartilage lesion
552474|NCT01209377|standard|standard
552475|NCT01209377|fixed|fixed
552476|NCT01209377|no focus|no focus
552477|NCT01209377|EMDR treatment with bilateral stimulation via eye movement|emdr treatment with bilateral stimulation via eye movement
552478|NCT01209377|EMDR treatment with fixed eyes|emdr treatment with fixed eyes
552479|NCT01209377|Trauma exposition without external stimulus|trauma exposition without external stimulus
552480|NCT01209364|comparative|comparative
552481|NCT01209364|randomized|randomized
552482|NCT01209364|double-blind|double-blind
552483|NCT01209364|non-inferior|non-inferior
552484|NCT01209364|knee OA|knee oa
552485|NCT01209351|Pharmacokinetics|pharmacokinetics
552486|NCT01209351|Pharmacodynamics|pharmacodynamics
552487|NCT01209351|teduglutide|teduglutide
552488|NCT01209325|human papilloma virus infection|human papilloma virus infection
552489|NCT01209325|anal cancer|anal cancer
552490|NCT01209325|penile cancer|penile cancer
552491|NCT01209325|HIV infection|hiv infection
552492|NCT01209299|recurrent melanoma|recurrent melanoma
552493|NCT01209299|stage IIIC melanoma|stage iiic melanoma
552494|NCT01209299|stage IV melanoma|stage iv melanoma
552495|NCT01209286|Blinatumomab|blinatumomab
552496|NCT01209286|B-ALL|b-all
552497|NCT01209286|adult ALL|adult all
552498|NCT01209286|relapsed ALL|relapsed all
552499|NCT01209286|refractory ALL|refractory all
552500|NCT01209286|Leukemia|leukemia
552501|NCT01209286|ALL|all
552502|NCT01209286|Lymphatic diseases|lymphatic diseases
552503|NCT01209286|Lymphoproliferative disorders|lymphoproliferative disorders
552504|NCT01209286|bispecific antibody|bispecific antibody
552505|NCT01209286|anti-CD19|anti-cd19
552506|NCT01209286|Immunotherapeutic treatment|immunotherapeutic treatment
552507|NCT01209273|Quality of Life|quality of life
552508|NCT01209273|Automated Peritoneal Dialysis|automated peritoneal dialysis
552509|NCT01209273|Continuous Ambulatory Peritoneal Dialysis|continuous ambulatory peritoneal dialysis
552510|NCT01209273|End Stage Renal Disease|end stage renal disease
552511|NCT01209260|Transseptal Puncture|transseptal puncture
552512|NCT01209260|Radiofrequency Energy|radiofrequency energy
552513|NCT01209260|Left Atrium Access|left atrium access
552514|NCT01209260|Left Atrial Catheterization|left atrial catheterization
552515|NCT01209260|Ablation|ablation
552516|NCT01209260|Transseptal Catheterization|transseptal catheterization
552517|NCT01209260|Electrocautery|electrocautery
552518|NCT01209260|Catheter Ablation|catheter ablation
552519|NCT01209260|Atrial Fibrillation|atrial fibrillation
552520|NCT01209247|Fluoroquinolone -resistance|fluoroquinolone -resistance
552521|NCT01209247|Commensal flora|commensal flora
552522|NCT01209247|Emergence of resistance|emergence of resistance
552523|NCT01209234|Methicillin-resistant Staphylococcus aureus|methicillin-resistant staphylococcus aureus
552524|NCT01209234|MRSA|mrsa
552525|NCT01209195|Ovarian cancer|ovarian cancer
552526|NCT01209195|HER-2 negative breast cancer|her-2 negative breast cancer
552527|NCT01209195|Breast cancer|breast cancer
552528|NCT01209195|Fallopian tube cancer|fallopian tube cancer
552529|NCT01209169|Kidney Renal|kidney renal
552530|NCT01209117|formulation|formulation
552531|NCT01209117|bioavailability|bioavailability
552532|NCT01209117|pharmacokinetics|pharmacokinetics
552533|NCT01209117|GSK2248761|gsk2248761
552534|NCT01209104|omeprazole|omeprazole
552535|NCT01209104|proton pump inhibitor|proton pump inhibitor
552536|NCT01209104|COPD|copd
552537|NCT01209104|CXCR2 inhibitor|cxcr2 inhibitor
552538|NCT01209104|bioavailability|bioavailability
552539|NCT01209104|food-effect|food-effect
552540|NCT01209078|methicillin-resistant Staphylococcus aureus|methicillin-resistant staphylococcus aureus
552541|NCT01209078|linezolid|linezolid
552542|NCT01209078|repeat dose|repeat dose
552543|NCT01209078|GSK1322322|gsk1322322
552544|NCT01209065|integrase|integrase
552545|NCT01209065|fosamprenavir|fosamprenavir
552546|NCT01209065|ritonavir|ritonavir
552547|NCT01209065|GSK1349572|gsk1349572
552548|NCT01209052|COPD|copd
552549|NCT01209052|CXCR2 inhibitor|cxcr2 inhibitor
552550|NCT01209039|Schizophrenia|schizophrenia
552551|NCT01209039|PET|pet
552552|NCT01209026|Fluticasone furoate (GW685698)|fluticasone furoate (gw685698)
552553|NCT01209026|moxifloxacin|moxifloxacin
552554|NCT01209026|QTc|qtc
552555|NCT01209026|GW642444|gw642444
552556|NCT01209026|pharmacokinetics|pharmacokinetics
552557|NCT01209013|PDT|pdt
552558|NCT01209013|porfimer sodium|porfimer sodium
552559|NCT01209013|BE|be
552560|NCT01209000|Focal and Segmental Glomerulosclerosis|focal and segmental glomerulosclerosis
552561|NCT01209000|Focal & Segmental Glomerulosclerosis|focal & segmental glomerulosclerosis
552562|NCT01209000|Focal Segmental Glomerulosclerosis|focal segmental glomerulosclerosis
552563|NCT01209000|FSGS|fsgs
552564|NCT01209000|Minimal change disease|minimal change disease
552565|NCT01209000|MCD|mcd
552566|NCT01209000|Membranous Nephropathy|membranous nephropathy
552567|NCT01209000|MN|mn
552568|NCT01209000|Nephrotic Syndrome|nephrotic syndrome
552569|NCT01209000|Neph Syndrome|neph syndrome
552570|NCT01209000|NEPTUNE|neptune
552571|NCT01209000|NephCure|nephcure
552572|NCT01209000|Halpin|halpin
552573|NCT01208974|Breast Cancer|breast cancer
552574|NCT01208974|Nipple Area Complex|nipple area complex
552575|NCT01208974|Mastectomy|mastectomy
552576|NCT01208974|Radiation Therapy|radiation therapy
552577|NCT01208974|Nipple-Sparing|nipple-sparing
552578|NCT01208974|Breast Reconstruction|breast reconstruction
552579|NCT01208961|Eicosapentaenoic Acid|eicosapentaenoic acid
552580|NCT01208961|Docosahexaenoic Acid|docosahexaenoic acid
552581|NCT01208961|Hypertriglyceridemia|hypertriglyceridemia
552582|NCT01208961|Omega-3 acid ethyl esters|omega-3 acid ethyl esters
552583|NCT01208961|Omega-3 carboxylic acids|omega-3 carboxylic acids
552584|NCT01208961|Epanova|epanova
552585|NCT01208961|Lovaza|lovaza
552586|NCT01208961|bioavailability|bioavailability
552587|NCT01208961|pharmacokinetics|pharmacokinetics
552588|NCT01208961|low-fat meal|low-fat meal
552589|NCT01208961|high-fat meal|high-fat meal
552590|NCT01208948|macular edema|macular edema
552591|NCT01208948|diabetes mellitus|diabetes mellitus
552592|NCT01208948|prevention alpha lipoic acid|prevention alpha lipoic acid
552593|NCT01208935|Randomized|randomized
552594|NCT01208935|Double blind|double blind
552595|NCT01208935|double-dummy|double-dummy
552596|NCT01208935|placebo-controlled|placebo-controlled
552597|NCT01208896|Allogeneic hematopoietic stem cell transplantation|allogeneic hematopoietic stem cell transplantation
552598|NCT01208896|Reduced-intensity conditioning|reduced-intensity conditioning
552599|NCT01208896|Chemosensitive relapsed follicular lymphoma|chemosensitive relapsed follicular lymphoma
552600|NCT01208883|Primary non-operated squamous cell carcinoma of the oral cavity, oropharynx, hypopharynx and larynx.|primary non-operated squamous cell carcinoma of the oral cavity, oropharynx, hypopharynx and larynx.
552601|NCT01208831|Advanced tumors|advanced tumors
552602|NCT01208831|hedgehog|hedgehog
552603|NCT01208831|smoothened inhibitor|smoothened inhibitor
552604|NCT01208792|Auto antibodies|auto antibodies
552605|NCT01208792|Target antigens|target antigens
552606|NCT01208792|2D-immunoblot|2d-immunoblot
552607|NCT01208792|Reactive oxygen species|reactive oxygen species
552608|NCT01208792|Pulmonary arterial hypertension|pulmonary arterial hypertension
552609|NCT01208792|Systemic sclerosis|systemic sclerosis
552610|NCT01208792|Human immunodeficiency virus infection|human immunodeficiency virus infection
552611|NCT01208792|Porto pulmonary hypertension|porto pulmonary hypertension
552612|NCT01208792|Congenital heart defect|congenital heart defect
552613|NCT01208792|Systemic lupus erythematosus|systemic lupus erythematosus
552614|NCT01208792|Mixed connective tissue disease|mixed connective tissue disease
552615|NCT01208792|Sjögren's syndrome|sjögren's syndrome
552616|NCT01208779|Compliance|compliance
552617|NCT01208779|HR+ breast cancer|hr+ breast cancer
552618|NCT01208779|epidemiology|epidemiology
552619|NCT01208766|Multiple Myeloma (Kahler's disease)|multiple myeloma (kahler's disease)
552620|NCT01208753|Safety|safety
552621|NCT01208753|Tolerability|tolerability
552622|NCT01208753|Pharmacokinetics|pharmacokinetics
552623|NCT01208740|Gonadotropins|gonadotropins
552624|NCT01208740|infertility|infertility
552625|NCT01208740|IVF|ivf
552627|NCT01208740|PCOS|pcos
552628|NCT01208740|poor prognosis|poor prognosis
552629|NCT01208740|poor responder|poor responder
552630|NCT01208727|Myocardial infarction|myocardial infarction
552631|NCT01208727|Postconditioning|postconditioning
552632|NCT01208727|Microvascular obstruction|microvascular obstruction
552633|NCT01208727|No reflow|no reflow
552634|NCT01208727|MRI|mri
552635|NCT01208714|Renal artery stenosis|renal artery stenosis
552636|NCT01208714|Atherosclerosis|atherosclerosis
552637|NCT01208714|Arterial hypertension|arterial hypertension
552638|NCT01208714|Percutaneous renal angioplasty|percutaneous renal angioplasty
552639|NCT01208714|Stenting|stenting
552640|NCT01208701|Atorvastatin|atorvastatin
552641|NCT01208701|L-NMMA|l-nmma
552642|NCT01208701|NO|no
552643|NCT01208701|Nephrology|nephrology
552644|NCT01208701|Diabetes Mellitus|diabetes mellitus
552645|NCT01208688|Spinal Cord Injuries|spinal cord injuries
552646|NCT01208662|Lenalidomide|lenalidomide
552647|NCT01208662|Bortezomib|bortezomib
552648|NCT01208662|Dexamethasone|dexamethasone
552649|NCT01208662|Stem Cell Transplant|stem cell transplant
552650|NCT01208662|Myeloma|myeloma
552651|NCT01208662|Multiple Myeloma|multiple myeloma
552652|NCT01208649|exenatide|exenatide
552653|NCT01208649|hepatic steatosis|hepatic steatosis
552654|NCT01208649|insulin resistance|insulin resistance
552655|NCT01208649|insulin sensitizers|insulin sensitizers
552656|NCT01208649|nonalcoholic fatty liver disease|nonalcoholic fatty liver disease
552657|NCT01208649|- GLP1-Analog|- glp1-analog
552658|NCT01208636|Vitamin D deficiency|vitamin d deficiency
552659|NCT01208636|Sun|sun
552660|NCT01208636|Genetics|genetics
552661|NCT01208584|functional MRI,primary motor cortex,spinal cord injury|functional mri,primary motor cortex,spinal cord injury
552662|NCT01208571|Harmful use|harmful use
552663|NCT01208571|Hazardous use|hazardous use
552664|NCT01208571|Dependence|dependence
552665|NCT01208558|Blood pressure|blood pressure
552666|NCT01208558|Cereals|cereals
552667|NCT01208558|Diet Therapy|diet therapy
552668|NCT01208558|Dietary carbohydrates|dietary carbohydrates
552669|NCT01208558|Dietary fiber|dietary fiber
552670|NCT01208558|Exercise Therapy|exercise therapy
552671|NCT01208558|Food|food
552672|NCT01208558|Glucose intolerance|glucose intolerance
552673|NCT01208558|Lifestyle|lifestyle
552674|NCT01208558|Physiotherapy|physiotherapy
552675|NCT01208558|Stroke|stroke
552676|NCT01208558|TIA|tia
552677|NCT01208558|Waist circumference|waist circumference
552678|NCT01208558|Weight loss|weight loss
552679|NCT01208545|taxol|taxol
552680|NCT01208545|vincristine|vincristine
552681|NCT01208545|oxaliplatin|oxaliplatin
552682|NCT01208545|chemotherapy|chemotherapy
552683|NCT01208545|nerve degeneration|nerve degeneration
552684|NCT01208545|nerve conduction|nerve conduction
552685|NCT01208545|cancer|cancer
552686|NCT01208545|nerve conduction studies|nerve conduction studies
552687|NCT01208519|Drug resistance, Microbial|drug resistance, microbial
552688|NCT01208519|Methicillin-Resistant Staphylococcus aureus|methicillin-resistant staphylococcus aureus
552689|NCT01208519|ESBL|esbl
552690|NCT01208519|Colonisation|colonisation
552691|NCT01208519|Screening|screening
552692|NCT01208519|Gram-negative|gram-negative
552693|NCT01208493|prematurity|prematurity
552694|NCT01208493|enteral feeding|enteral feeding
552695|NCT01208493|proteins|proteins
552696|NCT01208493|formula|formula
552697|NCT01208480|stage II breast cancer|stage ii breast cancer
552698|NCT01208480|stage IIIA breast cancer|stage iiia breast cancer
552699|NCT01208480|stage IIIB breast cancer|stage iiib breast cancer
552700|NCT01208480|stage IIIC breast cancer|stage iiic breast cancer
552701|NCT01208480|triple-negative breast cancer|triple-negative breast cancer
552702|NCT01208428|Depression|depression
552703|NCT01208415|Zenith aortoiliac aneurysm|zenith aortoiliac aneurysm
552704|NCT01208415|iliac aneurysm|iliac aneurysm
552705|NCT01208415|branch|branch
552706|NCT01208415|connections|connections
552707|NCT01208415|endovascular graft|endovascular graft
552708|NCT01208415|graft-iliac bifurcation|graft-iliac bifurcation
552709|NCT01208415|Aneurysm|aneurysm
552710|NCT01208415|Vascular Diseases|vascular diseases
552711|NCT01208415|Cardiovascular Diseases|cardiovascular diseases
552712|NCT01208363|Iron fortification|iron fortification
552713|NCT01208363|polyphenols|polyphenols
552714|NCT01208363|NaFeEDTA|nafeedta
552715|NCT01208363|cowpea|cowpea
552716|NCT01208363|school feeding program|school feeding program
552717|NCT01208350|Weight Loss|weight loss
552718|NCT01208350|Motivation|motivation
552719|NCT01208350|Workplace|workplace
552720|NCT01208350|Web platform|web platform
552721|NCT01208337|Rejection|rejection
552722|NCT01208324|Cognitive difficulties|cognitive difficulties
552723|NCT01208324|memory impairment|memory impairment
552724|NCT01208324|mood changes|mood changes
552725|NCT01208324|brain activation|brain activation
552726|NCT01208311|Alcoholic cirrhosis|alcoholic cirrhosis
552727|NCT01208311|hepatitis c cirrhosis|hepatitis c cirrhosis
552728|NCT01208311|cirrhosis|cirrhosis
552729|NCT01208298|Cold Sore Patch|cold sore patch
552730|NCT01208272|Body Mass Index|body mass index
552731|NCT01208272|Bulimia/therapy|bulimia/therapy
552732|NCT01208272|Comorbidity|comorbidity
552733|NCT01208272|Interpersonal Relations|interpersonal relations
552734|NCT01208272|Psychotherapy/methods|psychotherapy/methods
552735|NCT01208259|Body Mass Index|body mass index
552736|NCT01208259|Bulimia/therapy|bulimia/therapy
552737|NCT01208259|Comorbidity|comorbidity
552738|NCT01208259|Interpersonal Relations|interpersonal relations
552739|NCT01208259|Psychotherapy/methods|psychotherapy/methods
552740|NCT01208233|Phase 2 Ischemic stroke Safety and efficacy|phase 2 ischemic stroke safety and efficacy
552741|NCT01208220|Collagenase Santyl|collagenase santyl
552742|NCT01208220|Enzymatic debridement|enzymatic debridement
552743|NCT01208220|maintenance debridement|maintenance debridement
552744|NCT01208220|VAC|vac
552745|NCT01208220|NPWT|npwt
552746|NCT01208194|Advanced colorectal carcinoma|advanced colorectal carcinoma
552747|NCT01208194|Maintenance therapy|maintenance therapy
552748|NCT01208194|Immunomodulator|immunomodulator
552749|NCT01208168|toenail fungus|toenail fungus
552750|NCT01208168|onychomycosis|onychomycosis
552751|NCT01208168|nail infection|nail infection
552752|NCT01208155|Phase 1|phase 1
552753|NCT01208155|Healthy|healthy
552754|NCT01208155|pharmacokinetics|pharmacokinetics
552755|NCT01208155|Fostamatinib|fostamatinib
552756|NCT01208142|toe walker|toe walker
552757|NCT01208142|Pediatric toe walking|pediatric toe walking
552758|NCT01208142|ankle flexion|ankle flexion
552759|NCT01208129|toenail fungus|toenail fungus
552760|NCT01208129|onychomycosis|onychomycosis
552761|NCT01208129|nail infection|nail infection
552762|NCT01208116|Atherosclerosis|atherosclerosis
552763|NCT01208116|Prognosis|prognosis
552764|NCT01208116|Flow-mediated dilatation|flow-mediated dilatation
552765|NCT01208116|Brachial-ankle pulse wave velocity|brachial-ankle pulse wave velocity
552766|NCT01208116|Carotid Intimal-Medial Thickness|carotid intimal-medial thickness
552767|NCT01208116|coronary artery calcification score|coronary artery calcification score
552768|NCT01208116|Ankle-brachial index|ankle-brachial index
552769|NCT01208090|psoriasis|psoriasis
552770|NCT01208090|chronic plaque psoriasis|chronic plaque psoriasis
552771|NCT01208090|Moderate to severe chronic plaque psoriasis|moderate to severe chronic plaque psoriasis
552772|NCT01208077|ED hemodynamic profiles|ed hemodynamic profiles
552773|NCT01208077|patients treated under current clinical standards|patients treated under current clinical standards
552774|NCT01208077|Acute CHF|acute chf
552775|NCT01208077|Stroke syndromes|stroke syndromes
552776|NCT01208077|Systemic infection|systemic infection
552777|NCT01208064|adenocarcinoma of the lung|adenocarcinoma of the lung
552778|NCT01208064|adenosquamous cell lung cancer|adenosquamous cell lung cancer
552779|NCT01208064|bronchoalveolar cell lung cancer|bronchoalveolar cell lung cancer
552780|NCT01208064|large cell lung cancer|large cell lung cancer
552781|NCT01208064|recurrent non-small cell lung cancer|recurrent non-small cell lung cancer
552782|NCT01208064|stage IIIB non-small cell lung cancer|stage iiib non-small cell lung cancer
552783|NCT01208064|stage IV non-small cell lung cancer|stage iv non-small cell lung cancer
552784|NCT01208025|Plaque|plaque
552785|NCT01208025|Imaging|imaging
552786|NCT01208012|Diabetes Mellitus treatment Metformin|diabetes mellitus treatment metformin
552787|NCT01207999|Human papillomavirus|human papillomavirus
552788|NCT01207960|dental phobia|dental phobia
552789|NCT01207960|psychotherapy|psychotherapy
552790|NCT01207960|eye movement desensitization and reprocessing - EMDR|eye movement desensitization and reprocessing - emdr
552791|NCT01207960|efficacy|efficacy
552792|NCT01207960|wait-list control|wait-list control
552793|NCT01207947|Vardenafil|vardenafil
552794|NCT01207947|Erectile dysfunction|erectile dysfunction
552795|NCT01207947|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors
552796|NCT01207947|Combination use with alpha-blockers|combination use with alpha-blockers
552797|NCT01207934|diabetes|diabetes
552798|NCT01207934|obesity|obesity
552799|NCT01207908|DMD|dmd
552800|NCT01207908|Duchenne Muscular Dystrophy|duchenne muscular dystrophy
552801|NCT01207908|Insulin like growth factor|insulin like growth factor
552802|NCT01207908|6 minute walk test|6 minute walk test
552803|NCT01207869|Bronchopulmonary dysplasia (BPD)|bronchopulmonary dysplasia (bpd)
552804|NCT01207869|Extremely premature infant|extremely premature infant
552805|NCT01207869|Mesenchymal stem cells (MSCs)|mesenchymal stem cells (mscs)
552806|NCT01207869|umbilical cord|umbilical cord
552807|NCT01207856|Multiple sclerosis|multiple sclerosis
552808|NCT01207856|functional MRI|functional mri
552809|NCT01207856|cognitive rehabilitation|cognitive rehabilitation
552810|NCT01207856|ecological evaluation|ecological evaluation
552811|NCT01207856|neuroplasticity|neuroplasticity
552812|NCT01207843|Computed tomography|computed tomography
552813|NCT01207830|Obesity|obesity
552814|NCT01207817|a light flash in each eye for a total of 48 measurements|a light flash in each eye for a total of 48 measurements
552815|NCT01207804|Obesity|obesity
552816|NCT01207791|drug abuse|drug abuse
552817|NCT01207791|emergency department|emergency department
552818|NCT01207791|brief intervention|brief intervention
552819|NCT01207791|motivational interviewing|motivational interviewing
552820|NCT01207791|SBIRT|sbirt
552821|NCT01207778|brain|brain
552822|NCT01207778|development|development
552925|NCT01207388|adult ALL|adult all
552823|NCT01207778|erythropoietin|erythropoietin
552824|NCT01207778|neuroprotection|neuroprotection
552826|NCT01207765|Multiple Myeloma|multiple myeloma
552827|NCT01207765|Zevalin|zevalin
552828|NCT01207752|dry eye, meibomian gland dysfunction, tear film break up time|dry eye, meibomian gland dysfunction, tear film break up time
552829|NCT01207739|Prolonged antibiotic treatment in Lyme disease|prolonged antibiotic treatment in lyme disease
552830|NCT01207739|Doxycycline|doxycycline
552831|NCT01207739|Clarithromycin|clarithromycin
552832|NCT01207739|Hydroxychloroquine|hydroxychloroquine
552833|NCT01207700|post discharge intervention|post discharge intervention
552834|NCT01207700|adherence|adherence
552835|NCT01207700|compliance|compliance
552836|NCT01207700|community health worker|community health worker
552837|NCT01207674|Pathological gambling|pathological gambling
552838|NCT01207674|"at risk gambling"|"at risk gambling"
552839|NCT01207674|gambling practice evolution|gambling practice evolution
552840|NCT01207674|psychiatric comorbidities|psychiatric comorbidities
552841|NCT01207674|gambling trajectory|gambling trajectory
552842|NCT01207674|cognitive distortions|cognitive distortions
552843|NCT01207674|ADHD|adhd
552844|NCT01207674|addiction|addiction
552845|NCT01207674|recourse to care|recourse to care
552846|NCT01207661|Mesenchymal cells|mesenchymal cells
552847|NCT01207661|osteoarthritis|osteoarthritis
552848|NCT01207661|intra articular injection|intra articular injection
552849|NCT01207648|Interferon beta 1a|interferon beta 1a
552850|NCT01207648|Autoimmune Diseases|autoimmune diseases
552851|NCT01207648|Demyelinating Diseases|demyelinating diseases
552852|NCT01207648|Immune System Diseases|immune system diseases
552853|NCT01207648|Immunologic Factors|immunologic factors
552854|NCT01207648|Nervous System Diseases|nervous system diseases
552855|NCT01207648|Physiological Effects of Drugs|physiological effects of drugs
552856|NCT01207648|Demyelinating Autoimmune Diseases, CNS|demyelinating autoimmune diseases, cns
552857|NCT01207648|Autoimmune Diseases of the Nervous System|autoimmune diseases of the nervous system
552858|NCT01207648|Retrospective Cohort Study|retrospective cohort study
552859|NCT01207635|Cancer|cancer
552860|NCT01207635|Arimidex|arimidex
552861|NCT01207609|Obesity|obesity
552862|NCT01207609|Morbid Obesity|morbid obesity
552863|NCT01207609|Bariatric Surgery|bariatric surgery
552864|NCT01207609|Laparoscopic Gastric Plication|laparoscopic gastric plication
552865|NCT01207596|Pain|pain
552866|NCT01207596|Neuropathy|neuropathy
552867|NCT01207596|Neuropathic Pain|neuropathic pain
552868|NCT01207596|Hydromorphone|hydromorphone
552869|NCT01207583|vaccine|vaccine
552870|NCT01207583|infant|infant
552871|NCT01207583|healthy subjects|healthy subjects
552872|NCT01207570|flexibility|flexibility
552873|NCT01207570|muscle|muscle
552874|NCT01207570|stretching|stretching
552875|NCT01207570|cerebral palsy|cerebral palsy
552876|NCT01207570|developmental|developmental
552877|NCT01207557|Healthcare personnel|healthcare personnel
552878|NCT01207557|influenza|influenza
552879|NCT01207557|immunization|immunization
552880|NCT01207557|flu|flu
552881|NCT01207557|vaccine|vaccine
552882|NCT01207544|motor|motor
552883|NCT01207544|balance|balance
552884|NCT01207544|developmental|developmental
552885|NCT01207544|physiotherapy|physiotherapy
552886|NCT01207531|sepsis|sepsis
552887|NCT01207531|miRNA|mirna
552888|NCT01207518|influenza|influenza
552889|NCT01207518|immunization|immunization
552890|NCT01207518|healthcare personnel|healthcare personnel
552891|NCT01207505|bipolar disorder|bipolar disorder
552892|NCT01207505|depression|depression
552893|NCT01207505|mania|mania
552894|NCT01207505|emotion regulation|emotion regulation
552895|NCT01207505|dialectical behavior therapy|dialectical behavior therapy
552896|NCT01207505|group therapy|group therapy
552897|NCT01207505|mindfulness|mindfulness
552898|NCT01207492|nilotinib|nilotinib
552899|NCT01207453|Arthritis, Rheumatoid|arthritis, rheumatoid
552900|NCT01207453|Milnacipran|milnacipran
552901|NCT01207453|Pain|pain
552902|NCT01207440|CML|cml
552903|NCT01207440|ALL|all
552904|NCT01207440|PH|ph
552905|NCT01207440|ponatinib|ponatinib
552906|NCT01207440|Ph+ALL|ph+all
552907|NCT01207440|T315I mutation|t315i mutation
552908|NCT01207440|Philadelphia Chromosome Positive Acute Lymphoblastic Leukemia|philadelphia chromosome positive acute lymphoblastic leukemia
552909|NCT01207427|opioid therapy|opioid therapy
552910|NCT01207427|constipation|constipation
552911|NCT01207427|chronic noncancer pain|chronic noncancer pain
552912|NCT01207427|mu opioid receptor antagonist|mu opioid receptor antagonist
552913|NCT01207427|ADL5945|adl5945
552914|NCT01207414|Schizophrenia|schizophrenia
552915|NCT01207414|iloperidone|iloperidone
552916|NCT01207414|switch|switch
552917|NCT01207414|gradual switch|gradual switch
552918|NCT01207414|immediate switch|immediate switch
552919|NCT01207401|intrauterine device|intrauterine device
552920|NCT01207401|local anesthetic|local anesthetic
552921|NCT01207388|Blinatumomab|blinatumomab
552922|NCT01207388|MRD|mrd
552923|NCT01207388|B-ALL|b-all
552924|NCT01207388|Minimal residual disease|minimal residual disease
552926|NCT01207388|Leukemia|leukemia
552927|NCT01207388|ALL|all
552928|NCT01207388|Lymphatic diseases|lymphatic diseases
552929|NCT01207388|Lymphoproliferative disorders|lymphoproliferative disorders
552930|NCT01207388|bispecific antibody|bispecific antibody
552931|NCT01207388|anti-CD19|anti-cd19
552932|NCT01207388|Immunotherapeutic treatment|immunotherapeutic treatment
552933|NCT01207375|memory|memory
552934|NCT01207375|learning|learning
552935|NCT01207375|Traumatic Brain Injury|traumatic brain injury
552936|NCT01207375|cognition|cognition
552937|NCT01207375|treatment|treatment
552938|NCT01207375|therapy|therapy
552939|NCT01207349|Type 2 diabetes|type 2 diabetes
552940|NCT01207349|Secondary prevention|secondary prevention
552941|NCT01207349|Physical activity|physical activity
552942|NCT01207349|Nutritional education|nutritional education
552943|NCT01207349|HbA1c|hba1c
552944|NCT01207349|Reunion island|reunion island
552945|NCT01207349|diabetic patients, both female and male, age >=18 years, able to practise a physical activity, in Saint Pierre (GHSR) and Saint Denis (CHD)|diabetic patients, both female and male, age >=18 years, able to practise a physical activity, in saint pierre (ghsr) and saint denis (chd)
552946|NCT01207336|stroke|stroke
552947|NCT01207336|rehabilitation|rehabilitation
552948|NCT01207336|transcranial direct current stimulation|transcranial direct current stimulation
552949|NCT01207336|nerve stimulation|nerve stimulation
552950|NCT01207310|smoking|smoking
552951|NCT01207310|smoking of 10 cigarettes per day|smoking of 10 cigarettes per day
552952|NCT01207297|Lupus nephritis|lupus nephritis
552953|NCT01207297|tacrolimus|tacrolimus
552954|NCT01207297|cyclophosphamide|cyclophosphamide
552955|NCT01207271|depression|depression
552956|NCT01207271|community mental health|community mental health
552957|NCT01207271|treatment|treatment
552958|NCT01207271|psychotherapy|psychotherapy
552959|NCT01207271|mediators|mediators
552960|NCT01207258|Motivational Interviewing|motivational interviewing
552961|NCT01207258|Brief Intervention|brief intervention
552962|NCT01207258|Intimate Partner Violence|intimate partner violence
552963|NCT01207258|Domestic Violence|domestic violence
552964|NCT01207258|Alcohol Abuse|alcohol abuse
552965|NCT01207245|Cystic fibrosis|cystic fibrosis
552966|NCT01207245|Tobramycin|tobramycin
552967|NCT01207245|Pharmacokinetics|pharmacokinetics
552968|NCT01207245|Toxicity|toxicity
552969|NCT01207232|seasonal influenza|seasonal influenza
552970|NCT01207232|behavioral economics|behavioral economics
552971|NCT01207232|implementation intentions|implementation intentions
552972|NCT01207232|planning prompt|planning prompt
552973|NCT01207232|nudge|nudge
552974|NCT01207219|psychosis|psychosis
552975|NCT01207219|yoga|yoga
552976|NCT01207219|aerobic exercise|aerobic exercise
552977|NCT01207219|memory|memory
552978|NCT01207219|attention|attention
552979|NCT01207219|neuro cognition|neuro cognition
552980|NCT01207206|Patient suffering from severe cancer pain despite the opioid treatment|patient suffering from severe cancer pain despite the opioid treatment
552981|NCT01207206|Opiate tolerance suspected on the basis of rapid escalation in opiate dose|opiate tolerance suspected on the basis of rapid escalation in opiate dose
552982|NCT01207206|Severe opiate side effects|severe opiate side effects
552983|NCT01207193|bone cyst bone defect mesenchymal cell|bone cyst bone defect mesenchymal cell
552984|NCT01207180|emergency medicine|emergency medicine
552985|NCT01207180|primary care physicians|primary care physicians
552986|NCT01207141|Liver Transplantation|liver transplantation
552987|NCT01207141|Thymoglobulin|thymoglobulin
552988|NCT01207141|Rejection|rejection
552989|NCT01207102|Breast cancer|breast cancer
552990|NCT01207102|Triple negative|triple negative
552991|NCT01207089|Safety|safety
552992|NCT01207089|tolerability|tolerability
552993|NCT01207089|PK|pk
552994|NCT01207089|healthy|healthy
552995|NCT01207089|overweight|overweight
552996|NCT01207089|obese|obese
552997|NCT01207076|CD45+ disease|cd45+ disease
552998|NCT01207063|Radiotherapy|radiotherapy
552999|NCT01207063|NSCLC|nsclc
553000|NCT01207063|Stage II-III non-small cell lung cancer|stage ii-iii non-small cell lung cancer
553001|NCT01207050|sleep disorders|sleep disorders
553002|NCT01207050|traumatic brain injury|traumatic brain injury
553003|NCT01207024|knee arthrosis|knee arthrosis
553004|NCT01207024|obesity|obesity
553005|NCT01207024|MRI|mri
553006|NCT01207024|bariatric surgery|bariatric surgery
553007|NCT01206998|preterm labor|preterm labor
553008|NCT01206998|progesterone|progesterone
553009|NCT01206998|tocolysis|tocolysis
553010|NCT01206998|cervical length|cervical length
553011|NCT01206985|Paracetamol|paracetamol
553012|NCT01206985|per-oral mucosa PMB|per-oral mucosa pmb
553013|NCT01206985|No disease, healthy volunteers|no disease, healthy volunteers
553014|NCT01206972|venous thromboembolism|venous thromboembolism
553015|NCT01206972|prevention|prevention
553016|NCT01206972|orthopaedic surgery|orthopaedic surgery
553017|NCT01206959|BP|bp
553018|NCT01206946|Respiratory distress|respiratory distress
553019|NCT01206946|Antenatal steroids|antenatal steroids
553020|NCT01206946|late preterm|late preterm
553021|NCT01206933|HIV/HCV Coinfection|hiv/hcv coinfection
553022|NCT01206933|Tat Protein|tat protein
553023|NCT01206933|HCV|hcv
553024|NCT01206920|HIV|hiv
553025|NCT01206920|AIDS|aids
553026|NCT01206920|Co-morbidities|co-morbidities
553027|NCT01206907|sickle cell anemia|sickle cell anemia
553028|NCT01206907|juvenile rheumatoid arthritis|juvenile rheumatoid arthritis
553029|NCT01206907|burn victim|burn victim
553030|NCT01206907|cancer|cancer
553031|NCT01206907|Chronic pain of malignant or non-malignant etiology|chronic pain of malignant or non-malignant etiology
553032|NCT01206894|lung cancer|lung cancer
553033|NCT01206894|chest wall invasion|chest wall invasion
553034|NCT01206894|transthoracic ultrasound|transthoracic ultrasound
553035|NCT01206881|breast cancer|breast cancer
553036|NCT01206881|neoadjuvant|neoadjuvant
553037|NCT01206881|liposomal doxorubicin|liposomal doxorubicin
553038|NCT01206881|PET scan|pet scan
553039|NCT01206868|kidney, transplantation, surgery, complications, lymphocele, fluid collections.|kidney, transplantation, surgery, complications, lymphocele, fluid collections.
553040|NCT01206855|MIST Therapy|mist therapy
553041|NCT01206842|functional capacity|functional capacity
553042|NCT01206842|training|training
553043|NCT01206842|neurocognition|neurocognition
553044|NCT01206829|Hearing Impaired Persons|hearing impaired persons
553045|NCT01206829|Tinnitus|tinnitus
553046|NCT01206829|Life Change Events|life change events
553047|NCT01206829|Adaptation, Psychological|adaptation, psychological
553048|NCT01206829|Rehabilitation, Vocational|rehabilitation, vocational
553049|NCT01206829|Cognitive Therapy|cognitive therapy
553050|NCT01206829|Avoidance Learning|avoidance learning
553051|NCT01206829|Escape Reaction|escape reaction
553052|NCT01206803|ovarian stimulation|ovarian stimulation
553053|NCT01206803|recombinant FSH|recombinant fsh
553054|NCT01206803|GnRH-antagonist|gnrh-antagonist
553055|NCT01206803|corifollitropin alfa|corifollitropin alfa
553056|NCT01206790|PTSD|ptsd
553057|NCT01206790|Narrative Exposure Therapy|narrative exposure therapy
553058|NCT01206790|torture victims|torture victims
553059|NCT01206790|immune system|immune system
553060|NCT01206777|Hypersensitivity Reactions|hypersensitivity reactions
553061|NCT01206777|B-cell malignancies|b-cell malignancies
553062|NCT01206764|RCC,|rcc,
553063|NCT01206764|mTOR pathway,|mtor pathway,
553064|NCT01206764|angiogenesis,|angiogenesis,
553065|NCT01206764|PFS,|pfs,
553066|NCT01206764|partial response [PR] + complete response [CR])|partial response [pr] + complete response [cr])
553067|NCT01206764|metastatic recurrent renal cell carcinoma|metastatic recurrent renal cell carcinoma
553068|NCT01206764|metastatic unresectable renal cell carcinoma|metastatic unresectable renal cell carcinoma
553069|NCT01206725|Diabetes type 2|diabetes type 2
553070|NCT01206725|exercise|exercise
553071|NCT01206725|tissue Doppler velocity|tissue doppler velocity
553072|NCT01206712|Diabetes Mellitus Type 2|diabetes mellitus type 2
553073|NCT01206712|insulin glargine|insulin glargine
553074|NCT01206712|Metformin|metformin
553075|NCT01206686|seasonal influenza|seasonal influenza
553076|NCT01206686|behavioral economics|behavioral economics
553077|NCT01206686|nudge|nudge
553078|NCT01206686|implementations intentions|implementations intentions
553079|NCT01206686|vaccination|vaccination
553080|NCT01206621|dyspnea|dyspnea
553081|NCT01206621|COPD|copd
553082|NCT01206621|CHF|chf
553083|NCT01206621|asthma|asthma
553084|NCT01206608|Breast augmentation|breast augmentation
553085|NCT01206608|Pain|pain
553086|NCT01206608|Analgesia|analgesia
553087|NCT01206595|Postoperative Pain|postoperative pain
553088|NCT01206595|Bunionectomy|bunionectomy
553089|NCT01206595|Analgesia|analgesia
553090|NCT01206569|glomerulonephritis|glomerulonephritis
553091|NCT01206569|systemic lupus erythematosus|systemic lupus erythematosus
553092|NCT01206556|HUMAN PAPILLOMA VIRUS|human papilloma virus
553093|NCT01206556|HPV|hpv
553094|NCT01206543|Craniopharyngioma|craniopharyngioma
553095|NCT01206543|Surgery|surgery
553096|NCT01206543|Intraoperative imaging|intraoperative imaging
553097|NCT01206543|Rate of total removal|rate of total removal
553098|NCT01206530|histologically documented|histologically documented
553099|NCT01206530|advanced|advanced
553100|NCT01206530|metastatic|metastatic
553101|NCT01206530|adenocarcinoma|adenocarcinoma
553102|NCT01206530|colon|colon
553103|NCT01206530|rectum|rectum
553104|NCT01206517|asenapine|asenapine
553105|NCT01206517|pediatric schizophrenia|pediatric schizophrenia
553106|NCT01206517|bipolar I disorder|bipolar i disorder
553107|NCT01206504|West Nile virus|west nile virus
553108|NCT01206504|WNV|wnv
553109|NCT01206504|Encephalitis|encephalitis
553110|NCT01206504|Meningitis|meningitis
553111|NCT01206504|Acute Flaccid Paralysis|acute flaccid paralysis
553112|NCT01206504|Monoclonal Antibody|monoclonal antibody
553113|NCT01206504|WNND|wnnd
553114|NCT01206504|West Nile Neuroinvasive Disease|west nile neuroinvasive disease
553115|NCT01206504|Accidental Exposure to West Nile Virus|accidental exposure to west nile virus
553116|NCT01206452|Atrial Fibrillation; Ablation|atrial fibrillation; ablation
553117|NCT01206426|Urothelial, cancer, cisplatin, neoadjuvant, chemotherapy, germline|urothelial, cancer, cisplatin, neoadjuvant, chemotherapy, germline
553118|NCT01206413|overweight; treatment; women|overweight; treatment; women
553119|NCT01206400|eugonadal, testosterone|eugonadal, testosterone
553120|NCT01206374|Vitiligo Vulgaris|vitiligo vulgaris
553121|NCT01206361|Real world|real world
553122|NCT01206361|observational|observational
553123|NCT01206361|retrospective|retrospective
553124|NCT01206361|database analysis|database analysis
553125|NCT01206348|Acne|acne
553126|NCT01206335|Cancer Cachexia|cancer cachexia
553127|NCT01206335|Anorexia|anorexia
553128|NCT01206335|Advanced Malignancies|advanced malignancies
553129|NCT01206335|Weight Loss|weight loss
553130|NCT01206335|Fatigue|fatigue
553131|NCT01206335|Karnofsky|karnofsky
553132|NCT01206335|C-Reactive Protein|c-reactive protein
553133|NCT01206335|Simmonds Functional Assessment|simmonds functional assessment
553134|NCT01206322|diabetes, blood flow, brain perfusion, cognitive function|diabetes, blood flow, brain perfusion, cognitive function
553135|NCT01206309|Graft vs Host Disease|graft vs host disease
553136|NCT01206309|Allogeneic Hematopoietic Cell Transplantation|allogeneic hematopoietic cell transplantation
553137|NCT01206309|Bone Marrow Transplantation|bone marrow transplantation
553138|NCT01206309|Peripheral Blood Stem Cell Transplantation|peripheral blood stem cell transplantation
553139|NCT01206309|Umbilical Cord Blood Stem Cell Transplantation|umbilical cord blood stem cell transplantation
553140|NCT01206296|Adjuvant|adjuvant
553141|NCT01206296|Intraperitoneal|intraperitoneal
553142|NCT01206296|Gemcitabine|gemcitabine
553143|NCT01206296|Pancreas|pancreas
553144|NCT01206296|Adenocarcinoma|adenocarcinoma
553145|NCT01206283|traumatic brain injury|traumatic brain injury
553146|NCT01206283|subarachnoid hemorrhage|subarachnoid hemorrhage
553147|NCT01206283|secondary brain ischemia|secondary brain ischemia
553148|NCT01206283|microdialysis|microdialysis
553149|NCT01206283|modified Lund concept|modified lund concept
553150|NCT01206283|cerebral perfusion pressure|cerebral perfusion pressure
553151|NCT01206283|intracranial pressure|intracranial pressure
553152|NCT01206270|Klinefelter|klinefelter
553153|NCT01206270|Leydig|leydig
553154|NCT01206270|Testicular Tumor|testicular tumor
553155|NCT01206270|LH|lh
553156|NCT01206270|Infertility|infertility
553157|NCT01206257|Survey|survey
553158|NCT01206257|Angiography|angiography
553159|NCT01206257|ADR|adr
553160|NCT01206257|Image quality|image quality
553161|NCT01206244|dry eye|dry eye
553162|NCT01206244|tear meniscus|tear meniscus
553163|NCT01206244|tear osmolarity|tear osmolarity
553164|NCT01206231|Standard daily practice in managing patients with hypercholesterolemia|standard daily practice in managing patients with hypercholesterolemia
553165|NCT01206218|Gastric Cancer, BRCA1|gastric cancer, brca1
553166|NCT01206205|De novo Multiple Myeloma|de novo multiple myeloma
553167|NCT01206205|Bortezomib|bortezomib
553168|NCT01206205|Lenalidomide|lenalidomide
553169|NCT01206205|induction therapy|induction therapy
553170|NCT01206205|consolidation therapy|consolidation therapy
553171|NCT01206205|maintenance therapy|maintenance therapy
553172|NCT01206205|High dose therapy|high dose therapy
553173|NCT01206205|frontline therapy including new drugs and high dose therapy|frontline therapy including new drugs and high dose therapy
553174|NCT01206192|Intimate Terrorism|intimate terrorism
553175|NCT01206192|Situational couple violence|situational couple violence
553176|NCT01206192|Mental health|mental health
553177|NCT01206192|Chinese|chinese
553178|NCT01206192|Women|women
553179|NCT01206179|nonunion fracture bone formation pain relief|nonunion fracture bone formation pain relief
553180|NCT01206166|Randomized trial|randomized trial
553181|NCT01206166|Parental nutrition|parental nutrition
553182|NCT01206166|Enteral nutrition|enteral nutrition
553183|NCT01206166|Intensive care unit|intensive care unit
553184|NCT01206166|BMI < 25 or ≥ 35|bmi < 25 or ≥ 35
553185|NCT01206114|2009 H1N1 influenza|2009 h1n1 influenza
553186|NCT01206114|vaccination|vaccination
553187|NCT01206114|pandemic|pandemic
553188|NCT01206114|effectiveness|effectiveness
553189|NCT01206075|Beta Thalassemia Major|beta thalassemia major
553190|NCT01206075|Hematopoietic Stem Cell Mobilization|hematopoietic stem cell mobilization
553191|NCT01206075|Gene Transfer Techniques|gene transfer techniques
553192|NCT01206062|blood pressure|blood pressure
553193|NCT01206062|antihypertensive|antihypertensive
553194|NCT01206062|systolic|systolic
553195|NCT01206062|diastolic|diastolic
553196|NCT01206062|heart failure|heart failure
553197|NCT01206062|myocardial infarction|myocardial infarction
553198|NCT01206062|stroke|stroke
553199|NCT01206062|chronic kidney disease|chronic kidney disease
553200|NCT01206062|dementia|dementia
553201|NCT01206062|cognitive decline|cognitive decline
553202|NCT01206049|Cholangiocarcinoma|cholangiocarcinoma
553203|NCT01206049|Inoperable|inoperable
553204|NCT01206049|KRAS mutation|kras mutation
553205|NCT01206049|Biological treatment|biological treatment
553206|NCT01206049|Combination chemotherapy|combination chemotherapy
553207|NCT01206049|Monoclonal antibody|monoclonal antibody
553208|NCT01206036|castration|castration
553209|NCT01206036|prostate cancer|prostate cancer
553210|NCT01206036|castration resistant prostate cancer|castration resistant prostate cancer
553211|NCT01206036|PSA|psa
553212|NCT01206036|Docetaxel|docetaxel
553213|NCT01206036|Temsirolimus|temsirolimus
553214|NCT01206036|disease progression free survival|disease progression free survival
553215|NCT01206036|DPFS|dpfs
553216|NCT01206036|dose escalation|dose escalation
553217|NCT01206023|Multiple Sclerosis|multiple sclerosis
553218|NCT01206023|Breath|breath
553219|NCT01206023|Diagnosis|diagnosis
553220|NCT01206023|Discrimination MS/healthy subj. via exhaled breath samples|discrimination ms/healthy subj. via exhaled breath samples
553221|NCT01206010|Tobacco Dependence|tobacco dependence
553222|NCT01206010|Smoking cessation|smoking cessation
553223|NCT01206010|Varenicline|varenicline
553224|NCT01206010|Tailored dosing|tailored dosing
553225|NCT01205997|magnesium|magnesium
553226|NCT01205997|fentanyl|fentanyl
553227|NCT01205997|intrathecal|intrathecal
553228|NCT01205997|pain|pain
553229|NCT01205984|Chronic rhinosinusitis|chronic rhinosinusitis
553230|NCT01205984|Computed tomography scan|computed tomography scan
553231|NCT01205984|Methylprednisolone|methylprednisolone
553232|NCT01205971|Motivational interviewing|motivational interviewing
553233|NCT01205971|Community-based multimodal intervention|community-based multimodal intervention
553234|NCT01205971|Dental Health Advocates|dental health advocates
553235|NCT01205971|Prevention of ECC|prevention of ecc
553236|NCT01205971|Randomized clinical trial|randomized clinical trial
553237|NCT01205958|Cervical pain|cervical pain
553238|NCT01205958|Neck pain|neck pain
553239|NCT01205958|western medicine|western medicine
553240|NCT01205958|oriental medicine|oriental medicine
553241|NCT01205958|acupuncture|acupuncture
553242|NCT01205958|needle|needle
553243|NCT01205945|Aortic aneurysm, abdominal|aortic aneurysm, abdominal
553244|NCT01205945|Screening|screening
553245|NCT01205945|Mortality|mortality
553246|NCT01205932|venous thromboembolism|venous thromboembolism
553247|NCT01205932|prevention|prevention
553248|NCT01205932|othopaedic surgery|othopaedic surgery
553249|NCT01205919|Tinnitus|tinnitus
553250|NCT01205919|Internet Training|internet training
553251|NCT01205919|Cognitive-Behavior Therapy|cognitive-behavior therapy
553252|NCT01205919|CBT|cbt
553253|NCT01205906|Tinnitus|tinnitus
553254|NCT01205906|Internet Training|internet training
553255|NCT01205906|Cognitive-Behavior Therapy|cognitive-behavior therapy
553256|NCT01205906|CBT|cbt
553257|NCT01205880|combination treatment|combination treatment
553258|NCT01205880|topical corticosteroid|topical corticosteroid
553259|NCT01205880|vitamin D analogue|vitamin d analogue
553260|NCT01205880|clobex|clobex
553261|NCT01205880|vectical|vectical
553262|NCT01205880|clobetasol|clobetasol
553263|NCT01205880|calcitriol|calcitriol
553264|NCT01205867|Butyrylcholinesterase deficiency|butyrylcholinesterase deficiency
553265|NCT01205867|tolerability|tolerability
553266|NCT01205867|safety|safety
553267|NCT01205867|AZD8848|azd8848
553268|NCT01205867|pharmacokinetics|pharmacokinetics
553269|NCT01205867|pharmacodynamics|pharmacodynamics
553270|NCT01205867|BChE deficient subjects and matched control subject|bche deficient subjects and matched control subject
553271|NCT01205854|rheumatoid arthritis|rheumatoid arthritis
553272|NCT01205854|ultrasonography|ultrasonography
553273|NCT01205854|remission|remission
553274|NCT01205854|imaging remission|imaging remission
553275|NCT01205854|tight control|tight control
553276|NCT01205854|treat to target|treat to target
553277|NCT01205841|Ottawa Ankle and Foot Rules|ottawa ankle and foot rules
553278|NCT01205841|Buffalo Rule|buffalo rule
553279|NCT01205841|Bernese Ankle Rules|bernese ankle rules
553280|NCT01205841|Low Risk Exam|low risk exam
553281|NCT01205841|Malleolar Zone Algorithm|malleolar zone algorithm
553282|NCT01205841|Clinical decision rule|clinical decision rule
553283|NCT01205841|Ankle injury|ankle injury
553284|NCT01205841|Ankle sprain|ankle sprain
553285|NCT01205841|Inversion trauma|inversion trauma
553286|NCT01205828|liver cancer|liver cancer
553287|NCT01205828|hepatocellular|hepatocellular
553288|NCT01205828|temozolomide|temozolomide
553289|NCT01205828|veliparib|veliparib
553290|NCT01205802|patency, hepatic venous congestion, liver transplantation|patency, hepatic venous congestion, liver transplantation
553291|NCT01205789|Drug eluting stents|drug eluting stents
553292|NCT01205789|Stents|stents
553293|NCT01205789|Angioplasty|angioplasty
553294|NCT01205789|Left Main Coronary Artery Disease|left main coronary artery disease
553295|NCT01205776|Drug eluting stents|drug eluting stents
553296|NCT01205776|Stents|stents
553297|NCT01205776|Unprotected Left Main Coronary Artery Disease|unprotected left main coronary artery disease
553298|NCT01205776|Coronary artery bypass graft surgery|coronary artery bypass graft surgery
553299|NCT01205737|DLBCL|dlbcl
553300|NCT01205737|pharmacokinetics|pharmacokinetics
553301|NCT01205737|pharmacodynamics|pharmacodynamics
553302|NCT01205711|recurrent colon cancer|recurrent colon cancer
553303|NCT01205711|stage IV colon cancer|stage iv colon cancer
553304|NCT01205711|recurrent rectal cancer|recurrent rectal cancer
553305|NCT01205711|stage IV rectal cancer|stage iv rectal cancer
553306|NCT01205672|Endometrium|endometrium
553307|NCT01205672|Gynecologic malignancy|gynecologic malignancy
553308|NCT01205672|Endometrial adenocarcinoma|endometrial adenocarcinoma
553309|NCT01205672|Insulin/glucose metabolism|insulin/glucose metabolism
553310|NCT01205672|Metformin|metformin
553311|NCT01205646|prostate cancer|prostate cancer
553312|NCT01205646|metastatic|metastatic
553313|NCT01205646|zoledronate|zoledronate
553314|NCT01205646|zometa|zometa
553315|NCT01205633|neurodegenerative disease|neurodegenerative disease
553316|NCT01205633|neurovascular disease|neurovascular disease
553317|NCT01205633|fatigue|fatigue
553318|NCT01205633|Hubbard Foundation|hubbard foundation
553319|NCT01205633|angioplasty|angioplasty
553320|NCT01205620|CABG|cabg
553321|NCT01205607|traumatic brain injury|traumatic brain injury
553322|NCT01205594|CABG surgery|cabg surgery
553323|NCT01205581|Fluzone|fluzone
553324|NCT01205581|Trivalent Influenza Vaccine|trivalent influenza vaccine
553325|NCT01205555|intra uterine insemination|intra uterine insemination
553326|NCT01205529|Atrial Fibrillation|atrial fibrillation
553327|NCT01205529|ST elevation|st elevation
553328|NCT01205529|Genotype|genotype
553329|NCT01205503|chemobrain|chemobrain
553330|NCT01205503|Oxidative Stress|oxidative stress
553331|NCT01205503|Mesna|mesna
553332|NCT01205477|Anserine bursitis|anserine bursitis
553333|NCT01205464|Persistent symptoms|persistent symptoms
553334|NCT01205464|Doxycycline|doxycycline
553335|NCT01205464|Placebo|placebo
553336|NCT01205464|Neuroborreliosis|neuroborreliosis
553337|NCT01205451|GSK1358820|gsk1358820
553338|NCT01205451|upper limb|upper limb
553339|NCT01205451|spasticity|spasticity
553340|NCT01205451|post-stroke|post-stroke
553341|NCT01205438|SLE|sle
553342|NCT01205438|Systemic Lupus Erythematosis|systemic lupus erythematosis
553343|NCT01205438|Lupus|lupus
553344|NCT01205438|autoimmune disease|autoimmune disease
553345|NCT01205438|LY2127399|ly2127399
553346|NCT01205438|Immune System Disease|immune system disease
553347|NCT01205425|Computed coronary angiography|computed coronary angiography
553348|NCT01205425|Stent implantation|stent implantation
553349|NCT01205425|IVUS|ivus
553350|NCT01205386|CTO|cto
553351|NCT01205386|peripheral artery occlusive disease|peripheral artery occlusive disease
553352|NCT01205386|PAOD|paod
553353|NCT01205386|SFA|sfa
553354|NCT01205386|superficial femoral artery|superficial femoral artery
553355|NCT01205360|Analgesia, labour;|analgesia, labour;
553356|NCT01205360|Analgesic techniques, epidural;|analgesic techniques, epidural;
553357|NCT01205360|Drug delivery, intermittent bolus;|drug delivery, intermittent bolus;
553358|NCT01205360|Anesthetics local, Bupivacaine;|anesthetics local, bupivacaine;
553359|NCT01205360|Analgesics opioid, Fentanyl;|analgesics opioid, fentanyl;
553360|NCT01205347|Statin|statin
553361|NCT01205347|Myocardial infarction|myocardial infarction
553362|NCT01205347|Insulin sensitivity|insulin sensitivity
553363|NCT01205334|Glioblastoma multiforme|glioblastoma multiforme
553364|NCT01205334|GBM|gbm
553365|NCT01205334|Brain Cancer|brain cancer
553366|NCT01205334|CTL|ctl
553367|NCT01205321|Neoplasm|neoplasm
553368|NCT01205321|PET/CT diagnosis|pet/ct diagnosis
553369|NCT01205321|PET tracer|pet tracer
553370|NCT01205308|Plant stanols|plant stanols
553371|NCT01205308|type 1 diabetes|type 1 diabetes
553372|NCT01205308|sterol metabolism|sterol metabolism
553373|NCT01205308|cholesterol|cholesterol
553374|NCT01205295|hip|hip
553375|NCT01205295|shoulder|shoulder
553376|NCT01205295|mental disorders|mental disorders
553377|NCT01205295|anxiety|anxiety
553378|NCT01205295|concern|concern
553379|NCT01205295|efficacy of treatment|efficacy of treatment
553380|NCT01205282|ASD|asd
553381|NCT01205269|Chronic Obstructive Pulmonary Disease (COPD)|chronic obstructive pulmonary disease (copd)
553382|NCT01205269|safety|safety
553383|NCT01205269|inhalation|inhalation
553384|NCT01205269|long-acting muscarinic receptor antagonist (LAMA)|long-acting muscarinic receptor antagonist (lama)
553385|NCT01205256|Methadone pharmacokinetics in adolescents|methadone pharmacokinetics in adolescents
553386|NCT01205243|Abacavir|abacavir
553387|NCT01205243|post-marketing surveillance|post-marketing surveillance
553388|NCT01205230|Esomeprazole|esomeprazole
553389|NCT01205230|Pharmacogenetics|pharmacogenetics
553390|NCT01205230|Pharmacokinetics|pharmacokinetics
553391|NCT01205230|Ketoconazole|ketoconazole
553392|NCT01205230|Pazopanib|pazopanib
553393|NCT01205230|Drug Interaction|drug interaction
553394|NCT01205230|Safety|safety
553395|NCT01205230|Solid Tumors|solid tumors
553396|NCT01205217|lapatinib|lapatinib
553397|NCT01205217|epirubicin|epirubicin
553398|NCT01205217|cyclophosphamide|cyclophosphamide
553399|NCT01205217|trastuzumab|trastuzumab
553400|NCT01205217|paclitaxel|paclitaxel
553401|NCT01205217|neoadjuvant therapy|neoadjuvant therapy
553402|NCT01205217|Breast Cancer|breast cancer
553403|NCT01205204|Clonidine|clonidine
553404|NCT01205204|Fentanyl|fentanyl
553405|NCT01205204|Bupivacaine|bupivacaine
553406|NCT01205204|Spinal Anesthesia|spinal anesthesia
553407|NCT01205204|Lower Segment Caesarian Section|lower segment caesarian section
553408|NCT01205191|Cognitive behavioural therapy|cognitive behavioural therapy
553409|NCT01205191|Anxiety|anxiety
553410|NCT01205191|Primary care|primary care
553411|NCT01205191|Effectiveness trial|effectiveness trial
553412|NCT01205191|Cell-phone supported therapy|cell-phone supported therapy
553413|NCT01205152|Hypophosphatasia|hypophosphatasia
553414|NCT01205152|HPP|hpp
553415|NCT01205152|Bone disease|bone disease
553416|NCT01205152|Soft bones|soft bones
553417|NCT01205152|Low alkaline phosphatase|low alkaline phosphatase
553418|NCT01205152|Genetic metabolic disorder|genetic metabolic disorder
553419|NCT01205152|Alkaline phosphatase|alkaline phosphatase
553420|NCT01205152|Tissue non-specific alkaline phosphatase|tissue non-specific alkaline phosphatase
553421|NCT01205152|Rickets|rickets
553422|NCT01205152|Osteomalacia|osteomalacia
553423|NCT01205139|TMC435-TiDP16-C114|tmc435-tidp16-c114
553424|NCT01205139|TMC435-C114|tmc435-c114
553425|NCT01205139|TMC435|tmc435
553426|NCT01205139|HCV|hcv
553427|NCT01205139|Hepatitis C|hepatitis c
553428|NCT01205126|Pain|pain
553429|NCT01205126|Hydromorphone hydrochloride|hydromorphone hydrochloride
553430|NCT01205126|Oxycodone hydrochloride|oxycodone hydrochloride
553431|NCT01205100|Gastrointestinal Diseases|gastrointestinal diseases
553432|NCT01205100|Irritable Bowel Syndrome|irritable bowel syndrome
553433|NCT01205100|Behavioral Research|behavioral research
553434|NCT01205100|Biofeedback|biofeedback
553435|NCT01205074|Patients with chronic liver disease and cirrhosis|patients with chronic liver disease and cirrhosis
553436|NCT01205035|Idiopathic Parafoveal Telangiectasia|idiopathic parafoveal telangiectasia
553437|NCT01205035|Macular Telangiectasia|macular telangiectasia
553438|NCT01205035|Macula Lutea/pathology|macula lutea/pathology
553439|NCT01205035|Retinal Diseases/pathology|retinal diseases/pathology
553440|NCT01205035|Retinal Pigments/metabolism|retinal pigments/metabolism
553441|NCT01205035|Telangiectasis/metabolism|telangiectasis/metabolism
553442|NCT01205035|Telangiectasis/pathology|telangiectasis/pathology
553443|NCT01205009|in-vitro fertilization|in-vitro fertilization
553444|NCT01205009|poor responders|poor responders
553445|NCT01205009|human chorionic gonadotropin|human chorionic gonadotropin
553446|NCT01205009|Fertility Agents, Female|fertility agents, female
553447|NCT01204996|monoclonal antibody|monoclonal antibody
553448|NCT01204996|solid tumor|solid tumor
553449|NCT01204996|chemotherapy|chemotherapy
553450|NCT01204996|standard of care|standard of care
553451|NCT01204983|very low birth weight infant|very low birth weight infant
553452|NCT01204983|donor human milk|donor human milk
553453|NCT01204970|Confocal Laser Scanning Microendoscopy|confocal laser scanning microendoscopy
553454|NCT01204970|Small airways|small airways
553455|NCT01204970|COPD|copd
553456|NCT01204970|Lung transplantation|lung transplantation
553457|NCT01204957|Homocysteine|homocysteine
553458|NCT01204957|Insulin-like growth factor|insulin-like growth factor
553459|NCT01204957|Insulin-like growth factor binding protein|insulin-like growth factor binding protein
553460|NCT01204957|Serum estrogen|serum estrogen
553461|NCT01204957|Urinary phytoestrogens|urinary phytoestrogens
553462|NCT01204957|Thyroid hormones|thyroid hormones
553463|NCT01204931|reflux|reflux
553464|NCT01204931|gastroesophageal reflux disease|gastroesophageal reflux disease
553465|NCT01204931|GERD|gerd
553466|NCT01204918|MDD|mdd
553467|NCT01204918|Depression|depression
553468|NCT01204918|Treatment refractory|treatment refractory
553469|NCT01204918|Glutamate|glutamate
553470|NCT01204918|Riluzole|riluzole
553471|NCT01204918|Major depressive disorder|major depressive disorder
553472|NCT01204918|psychopharmacology|psychopharmacology
553473|NCT01204918|rilutek|rilutek
553474|NCT01204905|HIV-1|hiv-1
553475|NCT01204905|CD4|cd4
553476|NCT01204905|Viral Load|viral load
553477|NCT01204905|Human Immunodeficiency Virus (HIV)|human immunodeficiency virus (hiv)
553478|NCT01204866|Allergic-Like Reaction|allergic-like reaction
553479|NCT01204866|Selected Formulation Components|selected formulation components
553480|NCT01204853|sitaxentan sodium hypertension|sitaxentan sodium hypertension
553481|NCT01204840|in vitro fertilization|in vitro fertilization
553482|NCT01204840|IVF|ivf
553483|NCT01204840|poor responder|poor responder
553484|NCT01204840|growth hormone|growth hormone
553485|NCT01204840|Poor responders to in vitro fertilization treatments|poor responders to in vitro fertilization treatments
553486|NCT01204827|Patients with chronic HBeAg negative hepatitis B virus infection treated with Sebivo (Telbivudine)|patients with chronic hbeag negative hepatitis b virus infection treated with sebivo (telbivudine)
553487|NCT01204814|HIV|hiv
553488|NCT01204814|Drug resistance|drug resistance
553489|NCT01204814|mutations|mutations
553490|NCT01204814|ARV's|arv's
553491|NCT01204801|Cancer|cancer
553492|NCT01204801|Breast Cancer|breast cancer
553493|NCT01204801|Breast Tumor|breast tumor
553494|NCT01204801|Breast Neoplasm|breast neoplasm
553495|NCT01204801|Neoplasms by Site|neoplasms by site
553496|NCT01204801|Neoplasms|neoplasms
553497|NCT01204801|Breast Diseases|breast diseases
553498|NCT01204801|Breast Conserving Surgery|breast conserving surgery
553499|NCT01204801|Breast Conservation|breast conservation
553500|NCT01204801|Partial Mastectomy|partial mastectomy
553501|NCT01204801|Lumpectomy|lumpectomy
553502|NCT01204801|Mastectomy|mastectomy
553503|NCT01204801|Surgery|surgery
553504|NCT01204801|Neoadjuvant Therapy|neoadjuvant therapy
553505|NCT01204801|Primary Therapy|primary therapy
553506|NCT01204801|Neoadjuvant Systemic Therapy|neoadjuvant systemic therapy
553507|NCT01204801|Thermotherapy|thermotherapy
553508|NCT01204801|Fever Therapy|fever therapy
553509|NCT01204801|Hot Temperature|hot temperature
553510|NCT01204801|Hyperthermia|hyperthermia
553511|NCT01204801|Hyperthermia, Therapeutic|hyperthermia, therapeutic
553512|NCT01204801|Hyperthermia, Local|hyperthermia, local
553513|NCT01204801|Hyperthermia, Induced|hyperthermia, induced
553514|NCT01204801|Therapeutic Hyperthermia|therapeutic hyperthermia
553515|NCT01204801|Microwave|microwave
553516|NCT01204801|Focused Microwave|focused microwave
553517|NCT01204801|Focused Microwave Thermotherapy|focused microwave thermotherapy
553518|NCT01204801|Minimally Invasive|minimally invasive
553519|NCT01204801|Doxorubicin|doxorubicin
553520|NCT01204801|Epirubicin|epirubicin
553521|NCT01204801|Epidoxirubicin|epidoxirubicin
553522|NCT01204801|Immunosuppresive Agent|immunosuppresive agent
553523|NCT01204801|Immunologic Factors|immunologic factors
553524|NCT01204801|Physiological Effects of Drugs|physiological effects of drugs
553525|NCT01204801|Chemotherapy|chemotherapy
553526|NCT01204801|Drug Therapy|drug therapy
553527|NCT01204801|Pharmalogic Actions|pharmalogic actions
553528|NCT01204801|Antirheumatic Agents|antirheumatic agents
553529|NCT01204801|Therapeutic Uses|therapeutic uses
553530|NCT01204801|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating
553531|NCT01204801|Alkylating Agents|alkylating agents
553532|NCT01204801|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action
553533|NCT01204801|Antineoplastic Agents|antineoplastic agents
553534|NCT01204801|Myeloblative Agonists|myeloblative agonists
553535|NCT01204801|Antibiotics, Antineoplastic|antibiotics, antineoplastic
553536|NCT01204801|Anthracycline Agents|anthracycline agents
553537|NCT01204788|Acute myelogenous leukemia|acute myelogenous leukemia
553539|NCT01204788|Undifferentiated and bi-phenotypic leukemia|undifferentiated and bi-phenotypic leukemia
553540|NCT01204788|High-risk myelodysplastic syndrome|high-risk myelodysplastic syndrome
553541|NCT01204788|Chronic myelogenous leukemia|chronic myelogenous leukemia
553542|NCT01204788|Infection|infection
553543|NCT01204788|Radiated Prophylactic White Cell Transfusions|radiated prophylactic white cell transfusions
553544|NCT01204788|Therapeutic Radiated White Cell Transfusion|therapeutic radiated white cell transfusion
553545|NCT01204788|prophylactic antibiotics|prophylactic antibiotics
553546|NCT01204749|AMGEN|amgen
553547|NCT01204749|AMG 386|amg 386
553548|NCT01204749|Angiogenesis Inhibitors|angiogenesis inhibitors
553549|NCT01204749|Fallopian Tube Cancer|fallopian tube cancer
553550|NCT01204749|Primary Peritoneal Cancer|primary peritoneal cancer
553551|NCT01204749|Paclitaxel|paclitaxel
553552|NCT01204749|Ovarian Cancer|ovarian cancer
553553|NCT01204749|TRINOVA-1|trinova-1
553554|NCT01204736|tendon transfer|tendon transfer
553555|NCT01204736|elbow|elbow
553556|NCT01204723|Marijuana Abuse|marijuana abuse
553557|NCT01204723|Nicotine Dependence|nicotine dependence
553558|NCT01204723|Nicotine Withdrawal|nicotine withdrawal
553559|NCT01204723|neurokinin Receptor|neurokinin receptor
553560|NCT01204723|NK1 Receptor antagonist|nk1 receptor antagonist
553561|NCT01204723|Substance P|substance p
553562|NCT01204723|Recurrence|recurrence
553563|NCT01204723|Substance Withdrawal Syndrome|substance withdrawal syndrome
553564|NCT01204723|Substance-Related Disorders|substance-related disorders
553565|NCT01204723|Disorders of Environmental Origin|disorders of environmental origin
553566|NCT01204723|Mental Disorders|mental disorders
553567|NCT01204723|Disease Attributes|disease attributes
553568|NCT01204723|Pathologic Processes|pathologic processes
553569|NCT01204723|Tetrahydrocannabinol|tetrahydrocannabinol
553570|NCT01204723|Therapeutic Uses|therapeutic uses
553571|NCT01204723|Psychotropic Drugs|psychotropic drugs
553572|NCT01204723|Analgesics, Non-Narcotic|analgesics, non-narcotic
553573|NCT01204723|Analgesics|analgesics
553574|NCT01204723|Sensory System Agents|sensory system agents
553575|NCT01204723|Peripheral Nervous System Agents|peripheral nervous system agents
553576|NCT01204723|Neurotransmitter Agents|neurotransmitter agents
553577|NCT01204723|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action
553578|NCT01204723|Narcotic Antagonists|narcotic antagonists
553579|NCT01204723|cannabis|cannabis
553580|NCT01204710|Prostate Cancer|prostate cancer
553581|NCT01204684|dendritic cells|dendritic cells
553582|NCT01204684|glioma|glioma
553583|NCT01204684|vaccine|vaccine
553584|NCT01204684|glioma of WHO Grade III or IV|glioma of who grade iii or iv
553585|NCT01204671|influenza infection|influenza infection
553586|NCT01204671|GSK Biologicals influenza vaccine GSK2321138A|gsk biologicals influenza vaccine gsk2321138a
553587|NCT01204658|Haemophilus influenzae|haemophilus influenzae
553588|NCT01204658|Streptococcus pneumoniae|streptococcus pneumoniae
553589|NCT01204658|immunogenicity|immunogenicity
553590|NCT01204658|Pneumococcal vaccine|pneumococcal vaccine
553591|NCT01204658|infants|infants
553592|NCT01204658|safety|safety
553593|NCT01204619|peritoneal dialysis|peritoneal dialysis
553594|NCT01204567|HLRQ|hlrq
553595|NCT01204567|elderly|elderly
553596|NCT01204567|aerobic fitness|aerobic fitness
553597|NCT01204567|cognitive capacity|cognitive capacity
553598|NCT01204554|perforator flaps|perforator flaps
553599|NCT01204541|Non-exudative age-related macular degeneration|non-exudative age-related macular degeneration
553600|NCT01204528|Dysfunction in CKD|dysfunction in ckd
553601|NCT01204515|IBS|ibs
553602|NCT01204515|irritable bowel syndrome|irritable bowel syndrome
553603|NCT01204515|abdominal pain|abdominal pain
553604|NCT01204515|urgency|urgency
553605|NCT01204515|bloating|bloating
553606|NCT01204515|diarrhea|diarrhea
553607|NCT01204515|constipation|constipation
553608|NCT01204502|Gene therapy|gene therapy
553609|NCT01204502|Haploidentical|haploidentical
553610|NCT01204502|Bone marrow transplant|bone marrow transplant
553611|NCT01204502|Graft versus host disease|graft versus host disease
553612|NCT01204502|haploidentical stem cell transplantation|haploidentical stem cell transplantation
553613|NCT01204502|T-cell suicide gene therapy|t-cell suicide gene therapy
553614|NCT01204450|recurrent childhood brain tumor|recurrent childhood brain tumor
553615|NCT01204450|recurrent childhood rhabdomyosarcoma|recurrent childhood rhabdomyosarcoma
553616|NCT01204450|recurrent childhood soft tissue sarcoma|recurrent childhood soft tissue sarcoma
553617|NCT01204450|recurrent childhood supratentorial primitive neuroectodermal tumor|recurrent childhood supratentorial primitive neuroectodermal tumor
553618|NCT01204450|recurrent Ewing sarcoma/peripheral primitive neuroectodermal tumor|recurrent ewing sarcoma/peripheral primitive neuroectodermal tumor
553619|NCT01204450|recurrent neuroblastoma|recurrent neuroblastoma
553620|NCT01204450|recurrent osteosarcoma|recurrent osteosarcoma
553621|NCT01204450|unspecified childhood solid tumor, protocol specific|unspecified childhood solid tumor, protocol specific
553622|NCT01204437|adjuvant chemotherapy|adjuvant chemotherapy
553623|NCT01204437|primary carcinoma|primary carcinoma
553624|NCT01204437|elderly non frail patients|elderly non frail patients
553626|NCT01204437|CMF|cmf
553627|NCT01204437|Capecitabine|capecitabine
553628|NCT01204437|Nab-Paclitaxel|nab-paclitaxel
553629|NCT01204424|minimal invasive|minimal invasive
553630|NCT01204424|sinus floor augmentation|sinus floor augmentation
553631|NCT01204424|sinuslift|sinuslift
553632|NCT01204424|dental implants|dental implants
553633|NCT01204411|Efficacy|efficacy
553634|NCT01204411|Safety|safety
553635|NCT01204411|Artesunate-amodiaquine|artesunate-amodiaquine
553636|NCT01204411|Malaria|malaria
553637|NCT01204411|Plasmodium falciparum|plasmodium falciparum
553638|NCT01204411|Malnutrition|malnutrition
553639|NCT01204385|Non-typeable Haemophilus Influenzae|non-typeable haemophilus influenzae
553640|NCT01204385|Acute Otitis Media|acute otitis media
553641|NCT01204385|Streptococcus Pneumoniae|streptococcus pneumoniae
553642|NCT01204385|etiology|etiology
553643|NCT01204372|Metastatic pancreatic adenocarcinoma|metastatic pancreatic adenocarcinoma
553644|NCT01204372|First-line chemotherapy|first-line chemotherapy
553645|NCT01204372|Combination chemotherapy|combination chemotherapy
553646|NCT01204372|Targeted agents|targeted agents
553647|NCT01204346|adolescents|adolescents
553648|NCT01204346|MBT|mbt
553649|NCT01204346|depression|depression
553650|NCT01204346|emerging personality disorder|emerging personality disorder
553651|NCT01204333|Cerebral venous and sinus thrombosis|cerebral venous and sinus thrombosis
553652|NCT01204333|Cerebral venous thrombosis|cerebral venous thrombosis
553653|NCT01204333|Sinus Thrombosis, Intracranial|sinus thrombosis, intracranial
553654|NCT01204333|Endovascular thrombolysis|endovascular thrombolysis
553655|NCT01204333|Thrombolysis|thrombolysis
553656|NCT01204333|Thrombectomy|thrombectomy
553657|NCT01204320|Restenosis|restenosis
553658|NCT01204320|POBA|poba
553659|NCT01204320|Stenting|stenting
553660|NCT01204320|Paclitaxel|paclitaxel
553661|NCT01204281|Proportional Assist Ventilation plus|proportional assist ventilation plus
553662|NCT01204281|Acute respiratory failure|acute respiratory failure
553663|NCT01204281|Mechanical ventilation|mechanical ventilation
553664|NCT01204268|cerebral ischemia|cerebral ischemia
553665|NCT01204268|sevoflurane preconditioning|sevoflurane preconditioning
553666|NCT01204268|intracranial aneurysm surgery|intracranial aneurysm surgery
553667|NCT01204255|healthy, no evidence of disease|healthy, no evidence of disease
553668|NCT01204242|Breast Cancer|breast cancer
553669|NCT01204229|Alcohol Consumption|alcohol consumption
553670|NCT01204229|Social Anxiety|social anxiety
553671|NCT01204229|Depression|depression
553672|NCT01204229|Brief Intervention|brief intervention
553673|NCT01204229|Motivational Interviewing|motivational interviewing
553674|NCT01204229|Cognitive Behavioral Therapy|cognitive behavioral therapy
553675|NCT01204229|Sub-Clinical Social Anxiety|sub-clinical social anxiety
553676|NCT01204229|Sub-Clinical Depression|sub-clinical depression
553677|NCT01204216|Hemoglobin A1c|hemoglobin a1c
553678|NCT01204216|HbA1c|hba1c
553679|NCT01204216|glycated serum proteins|glycated serum proteins
553680|NCT01204216|fructosamine|fructosamine
553681|NCT01204216|glycated albumin|glycated albumin
553682|NCT01204216|glycation gap|glycation gap
553683|NCT01204203|mesothelioma|mesothelioma
553684|NCT01204203|zoledronic acid|zoledronic acid
553685|NCT01204203|zometa|zometa
553686|NCT01204203|bisphosphonate therapy|bisphosphonate therapy
553687|NCT01204203|CT scan|ct scan
553688|NCT01204203|PET scan|pet scan
553689|NCT01204190|Administration|administration
553690|NCT01204190|Cutaneous|cutaneous
553691|NCT01204177|Hepatocellular carcinoma (HCC)|hepatocellular carcinoma (hcc)
553692|NCT01204177|MEK inhibitor|mek inhibitor
553693|NCT01204177|Sorafenib|sorafenib
553694|NCT01204177|Disease control rate (DCR)|disease control rate (dcr)
553695|NCT01204177|Safety|safety
553696|NCT01204164|AML|aml
553697|NCT01204164|ALL|all
553698|NCT01204164|MDS|mds
553699|NCT01204164|CML in blast crisis|cml in blast crisis
553700|NCT01204164|Multiple Myeloma|multiple myeloma
553701|NCT01204164|Carfilzomib refractory|carfilzomib refractory
553702|NCT01204138|RA, treatment, TNF, cytokines|ra, treatment, tnf, cytokines
553703|NCT01204112|Drug-Drug Interaction|drug-drug interaction
553704|NCT01204112|Tasocitinib (CP-690|tasocitinib (cp-690
553705|NCT01204112|550)|550)
553706|NCT01204112|Rifampin|rifampin
553707|NCT01204112|Healthy Volunteers|healthy volunteers
553708|NCT01204099|PX-866|px-866
553709|NCT01204099|Non small cell lung cancer|non small cell lung cancer
553710|NCT01204099|solid tumors|solid tumors
553711|NCT01204099|Squamous cell cancer of the head and neck|squamous cell cancer of the head and neck
553712|NCT01204099|docetaxel|docetaxel
553713|NCT01204099|NSCLC|nsclc
553714|NCT01204099|taxotere|taxotere
553715|NCT01204099|SCCHN|scchn
553716|NCT01204099|PI-3K|pi-3k
553717|NCT01204099|PI3 kinase|pi3 kinase
553718|NCT01204099|PI3K|pi3k
553719|NCT01204086|Major Depressive Disorder|major depressive disorder
553720|NCT01204086|Antidepressants|antidepressants
553721|NCT01204086|Pharmacogenetics|pharmacogenetics
553722|NCT01204086|venlafaxine|venlafaxine
553723|NCT01204086|fluoxetine|fluoxetine
553724|NCT01204060|Nasal Allergen Lipopolysaccharide Inflammation Asthma|nasal allergen lipopolysaccharide inflammation asthma
553725|NCT01204034|COPD|copd
553726|NCT01204034|Formoterol|formoterol
553727|NCT01204034|Beclomethasone Dipropionate|beclomethasone dipropionate
553728|NCT01204034|Computational Fluid Dynamics|computational fluid dynamics
553729|NCT01204034|Functional Imaging|functional imaging
553730|NCT01204034|Central and Peripheral Airways|central and peripheral airways
553731|NCT01204034|BODE index|bode index
553732|NCT01204034|COPD Assessment Test (CAT)|copd assessment test (cat)
553733|NCT01204034|Borg CR10 scale|borg cr10 scale
553734|NCT01204021|Stress|stress
553735|NCT01204021|loneliness|loneliness
553736|NCT01204021|social isolation|social isolation
553737|NCT01204021|autonomic activity|autonomic activity
553738|NCT01204021|inflammation|inflammation
553739|NCT01204021|Perceived social isolation|perceived social isolation
553740|NCT01204021|Chronic stress|chronic stress
553741|NCT01203982|CIMT|cimt
553742|NCT01203982|IVUS-VH|ivus-vh
553743|NCT01203982|Coronary artery disease|coronary artery disease
553744|NCT01203956|AutoAdjust|autoadjust
553745|NCT01203956|SmartFlex|smartflex
553746|NCT01203956|Apnea Hypopnea Index|apnea hypopnea index
553747|NCT01203956|Patient reported outcomes|patient reported outcomes
553748|NCT01203943|Idiopathic Pulmonary Fibrosis|idiopathic pulmonary fibrosis
553749|NCT01203943|Pulmonary Fibrosis|pulmonary fibrosis
553750|NCT01203943|Fibrosis|fibrosis
553751|NCT01203943|Interstitial Lung Disease|interstitial lung disease
553752|NCT01203943|Lung Diseases, Interstitial|lung diseases, interstitial
553753|NCT01203943|CC-930|cc-930
553754|NCT01203930|CLL|cll
553755|NCT01203930|SLL|sll
553756|NCT01203930|GS-1101|gs-1101
553757|NCT01203930|CAL-101|cal-101
553758|NCT01203930|Phosphatidylinositol 3-kinase (PI3K)|phosphatidylinositol 3-kinase (pi3k)
553759|NCT01203930|Rituximab|rituximab
553760|NCT01203930|Rituxan|rituxan
553761|NCT01203917|Gefitinib|gefitinib
553762|NCT01203917|EGFR TKI|egfr tki
553763|NCT01203917|efficacy|efficacy
553764|NCT01203917|Caucasian patients|caucasian patients
553765|NCT01203917|EGFR mutation positive advanced NSCLC|egfr mutation positive advanced nsclc
553766|NCT01203917|safety|safety
553767|NCT01203904|bronchial asthma, Pulmicort, long term use, pediatrics|bronchial asthma, pulmicort, long term use, pediatrics
553768|NCT01203891|SPECT|spect
553769|NCT01203891|Imaging|imaging
553770|NCT01203891|Healthy brain|healthy brain
553771|NCT01203891|regional cerebral blood flow|regional cerebral blood flow
553772|NCT01203878|Imiquimod|imiquimod
553773|NCT01203878|Photodynamic therapy|photodynamic therapy
553774|NCT01203878|Actinic keratoses|actinic keratoses
553775|NCT01203878|Sequential therapy|sequential therapy
553776|NCT01203878|Therapeutic uses|therapeutic uses
553777|NCT01203865|Fibromyalgia|fibromyalgia
553778|NCT01203865|Fatigue|fatigue
553779|NCT01203852|hypertension|hypertension
553780|NCT01203852|antihypertensive drug|antihypertensive drug
553781|NCT01203852|pharmacogenetics|pharmacogenetics
553782|NCT01203852|genetics|genetics
553783|NCT01203852|blood pressure|blood pressure
553784|NCT01203852|glucose|glucose
553785|NCT01203839|stage 1 breast cancer|stage 1 breast cancer
553786|NCT01203839|invasive ductal breast|invasive ductal breast
553787|NCT01203839|Partial Breast Irradiation (PBI)|partial breast irradiation (pbi)
553788|NCT01203839|radiation|radiation
553789|NCT01203839|10-114|10-114
553790|NCT01203826|Hypophosphatasia|hypophosphatasia
553791|NCT01203826|HPP|hpp
553792|NCT01203826|Bone Disease|bone disease
553793|NCT01203826|Soft Bones|soft bones
553794|NCT01203826|Low Alkaline Phosphatase|low alkaline phosphatase
553795|NCT01203826|genetic metabolic disorder|genetic metabolic disorder
553796|NCT01203826|alkaline phosphatase|alkaline phosphatase
553797|NCT01203826|tissue non-specific alkaline phosphatase|tissue non-specific alkaline phosphatase
553798|NCT01203826|rickets|rickets
553799|NCT01203826|osteomalacia|osteomalacia
553988|NCT01203072|factor Xa|factor xa
553800|NCT01203813|Chronic kidney disease|chronic kidney disease
553801|NCT01203813|Quality improvement|quality improvement
553802|NCT01203813|Self management support|self management support
553803|NCT01203813|Electronic health records|electronic health records
553804|NCT01203813|Clinical decision support|clinical decision support
553805|NCT01203813|Electronic reminders|electronic reminders
553806|NCT01203813|Patient outreach|patient outreach
553807|NCT01203787|Hepatocellular Carcinoma|hepatocellular carcinoma
553808|NCT01203787|HCC|hcc
553809|NCT01203787|Liver Cancer|liver cancer
553810|NCT01203774|Diabetes|diabetes
553811|NCT01203761|loneliness|loneliness
553812|NCT01203735|Non-small-cell lung cancer|non-small-cell lung cancer
553813|NCT01203735|Valproic acid|valproic acid
553814|NCT01203735|Chemotherapy|chemotherapy
553815|NCT01203735|Radiotherapy|radiotherapy
553816|NCT01203722|Reduced intensity|reduced intensity
553817|NCT01203722|partially HLA mismatched allogeneic BMT|partially hla mismatched allogeneic bmt
553818|NCT01203722|Acute leukemias|acute leukemias
553819|NCT01203722|Chronic leukemias|chronic leukemias
553820|NCT01203722|Myelodysplasia|myelodysplasia
553821|NCT01203722|Lymphomas|lymphomas
553822|NCT01203722|Unrelated or non-first-degree related donors|unrelated or non-first-degree related donors
553823|NCT01203722|Peripheral blood stem cell transplant|peripheral blood stem cell transplant
553824|NCT01203709|lupus|lupus
553825|NCT01203709|nephritis|nephritis
553826|NCT01203709|glomerulonephritis|glomerulonephritis
553827|NCT01203709|nephropathy|nephropathy
553828|NCT01203709|refractory|refractory
553829|NCT01203696|Clopidogrel|clopidogrel
553830|NCT01203696|Platelet reactivity|platelet reactivity
553831|NCT01203696|Amlodipine|amlodipine
553832|NCT01203683|depression|depression
553833|NCT01203670|Glomerular filtration rate (GFR)|glomerular filtration rate (gfr)
553834|NCT01203670|Aspartate Amino Transferase (ASAT)|aspartate amino transferase (asat)
553835|NCT01203670|Alanine Amino transferase (ALAT)|alanine amino transferase (alat)
553836|NCT01203670|gamma Glutamyl transpeptidase (gamma GT)|gamma glutamyl transpeptidase (gamma gt)
553837|NCT01203670|Lipase|lipase
553838|NCT01203670|Amylase|amylase
553839|NCT01203657|exercise|exercise
553840|NCT01203657|physical activity|physical activity
553841|NCT01203657|tai chi|tai chi
553842|NCT01203644|Postoperative pain|postoperative pain
553843|NCT01203644|Analgesia|analgesia
553844|NCT01203618|Resectable, non-functioning pituitary adenoma|resectable, non-functioning pituitary adenoma
553845|NCT01203618|Pituitary tumor|pituitary tumor
553846|NCT01203618|Pituitary adenoma|pituitary adenoma
553847|NCT01203618|Pituitary macroadenoma|pituitary macroadenoma
553848|NCT01203605|Operative surgical procedures|operative surgical procedures
553849|NCT01203605|mortality|mortality
553850|NCT01203605|adverse effects|adverse effects
553851|NCT01203605|Postoperative complications|postoperative complications
553852|NCT01203605|Epidemiological Study|epidemiological study
553853|NCT01203592|Congenital myasthenic syndrome|congenital myasthenic syndrome
553854|NCT01203592|Albuterol|albuterol
553855|NCT01203592|Neuromuscular transmission|neuromuscular transmission
553856|NCT01203579|CDT-Lung,CT scan,lung cancer detection|cdt-lung,ct scan,lung cancer detection
553857|NCT01203566|Single incision laparoscopic surgery|single incision laparoscopic surgery
553858|NCT01203566|Single site access laparoscopic surgery|single site access laparoscopic surgery
553859|NCT01203566|SILS|sils
553860|NCT01203566|Single-port access|single-port access
553861|NCT01203566|Laparoendoscopic single site surgery|laparoendoscopic single site surgery
553862|NCT01203566|Appendectomy|appendectomy
553863|NCT01203553|Incisional hernias|incisional hernias
553864|NCT01203553|Prophylaxis|prophylaxis
553865|NCT01203553|Preperitoneal mesh|preperitoneal mesh
553866|NCT01203527|H1N1 influenza|h1n1 influenza
553867|NCT01203527|Swine flu|swine flu
553868|NCT01203527|Oseltamivir|oseltamivir
553869|NCT01203527|Tamiflu|tamiflu
553870|NCT01203527|Pregnancy|pregnancy
553871|NCT01203514|NICHD Neonatal Research Network|nichd neonatal research network
553872|NCT01203514|Extremely Low Birth Weight (ELBW)|extremely low birth weight (elbw)
553873|NCT01203514|Prematurity|prematurity
553874|NCT01203514|Erythrocyte transfusions|erythrocyte transfusions
553875|NCT01203514|Erythropoietin (Epo)|erythropoietin (epo)
553876|NCT01203514|Blood loss|blood loss
553877|NCT01203514|Phlebotomy|phlebotomy
553878|NCT01203501|NICHD Neonatal Research Network|nichd neonatal research network
553879|NCT01203501|Extremely Low Birth Weight (ELBW)|extremely low birth weight (elbw)
553880|NCT01203501|Prematurity|prematurity
553881|NCT01203501|Antenatal Magnesium sulfate|antenatal magnesium sulfate
553882|NCT01203488|NICHD Neonatal Research Network|nichd neonatal research network
553883|NCT01203488|Extremely Low Birth Weight (ELBW)|extremely low birth weight (elbw)
553884|NCT01203488|Prematurity|prematurity
553885|NCT01203488|Vitamin A|vitamin a
553886|NCT01203488|Chronic Lung Disease|chronic lung disease
553887|NCT01203475|NICHD Neonatal Research Network|nichd neonatal research network
553888|NCT01203475|Extremely Low Birth Weight (ELBW)|extremely low birth weight (elbw)
553889|NCT01203475|Prematurity|prematurity
553890|NCT01203475|Growth Curve|growth curve
553891|NCT01203475|Head Circumference|head circumference
553892|NCT01203475|Length|length
554193|NCT01202370|Cancer|cancer
553893|NCT01203449|NICHD Neonatal Research Network|nichd neonatal research network
553894|NCT01203449|Extremely Low Birth Weight (ELBW)|extremely low birth weight (elbw)
553895|NCT01203449|Prematurity|prematurity
553896|NCT01203449|Gestational Age|gestational age
553897|NCT01203436|NICHD Neonatal Research Network|nichd neonatal research network
553898|NCT01203436|Very Low Birth Weight (VLBW)|very low birth weight (vlbw)
553899|NCT01203436|Extremely Low Birth Weight (ELBW)|extremely low birth weight (elbw)
553900|NCT01203436|Prematurity|prematurity
553901|NCT01203423|NICHD Neonatal Research Network|nichd neonatal research network
553902|NCT01203423|Extremely Low Birth Weight (ELBW)|extremely low birth weight (elbw)
553903|NCT01203423|Prematurity|prematurity
553904|NCT01203423|Persistent Pulmonary Hypertension of Newborn (PPHN)|persistent pulmonary hypertension of newborn (pphn)
553905|NCT01203410|NICHD Neonatal Research Network|nichd neonatal research network
553906|NCT01203410|Term infant|term infant
553907|NCT01203410|Hyperbilirubinemia|hyperbilirubinemia
553908|NCT01203397|SUPERFICIAL VARICOSE VEINS|superficial varicose veins
553909|NCT01203371|naftopidil|naftopidil
553910|NCT01203371|symptoms of lower urinary tract|symptoms of lower urinary tract
553911|NCT01203371|benign prostate hyperplasia|benign prostate hyperplasia
553913|NCT01203358|NICHD Neonatal Research Network|nichd neonatal research network
553914|NCT01203358|Extremely Low Birth Weight (ELBW)|extremely low birth weight (elbw)
553915|NCT01203358|Prematurity|prematurity
553916|NCT01203358|Respiratory distress syndrome|respiratory distress syndrome
553917|NCT01203358|Surfactant|surfactant
553918|NCT01203345|NICHD Neonatal Research Network|nichd neonatal research network
553919|NCT01203345|Extremely Low Birth Weight (ELBW)|extremely low birth weight (elbw)
553920|NCT01203345|Prematurity|prematurity
553921|NCT01203345|Septicemia|septicemia
553922|NCT01203345|Meningitis|meningitis
553923|NCT01203345|Urinary tract infection|urinary tract infection
553924|NCT01203345|Immune globulin|immune globulin
553925|NCT01203332|HIV testing|hiv testing
553926|NCT01203332|Latino|latino
553927|NCT01203332|Latina|latina
553928|NCT01203332|Men who have sex with men|men who have sex with men
553929|NCT01203319|immunogenicity|immunogenicity
553930|NCT01203319|safety|safety
553931|NCT01203319|recombinant hepatitis B vaccine|recombinant hepatitis b vaccine
553932|NCT01203319|nonresponders|nonresponders
553933|NCT01203306|bevacizumab|bevacizumab
553934|NCT01203306|somatostatin analogue|somatostatin analogue
553935|NCT01203306|metronomic capecitabine|metronomic capecitabine
553936|NCT01203306|neuroendocrine tumors|neuroendocrine tumors
553937|NCT01203280|icing|icing
553938|NCT01203280|boxer|boxer
553939|NCT01203280|balance|balance
553940|NCT01203280|neck range of motion|neck range of motion
553941|NCT01203280|neck isometric strength|neck isometric strength
553942|NCT01203280|balance performance|balance performance
553943|NCT01203267|Breast Neoplasms|breast neoplasms
553944|NCT01203267|Neoadjuvant|neoadjuvant
553945|NCT01203267|Chemotherapy|chemotherapy
553946|NCT01203267|Paclitaxel|paclitaxel
553947|NCT01203267|Carboplatin|carboplatin
553948|NCT01203267|Pathological Complete Remission|pathological complete remission
553949|NCT01203254|Colesevelam|colesevelam
553950|NCT01203254|IBD|ibd
553951|NCT01203254|Bile Acid Malabsorption|bile acid malabsorption
553952|NCT01203254|Crohns disease|crohns disease
553953|NCT01203228|Reduced Intensity conditioning|reduced intensity conditioning
553954|NCT01203228|Myeloablative conditionig|myeloablative conditionig
553955|NCT01203228|Allogeneic stem cell transplantation|allogeneic stem cell transplantation
553956|NCT01203228|MUD|mud
553957|NCT01203215|exercise|exercise
553958|NCT01203215|physical activity|physical activity
553959|NCT01203215|women|women
553960|NCT01203215|community|community
553961|NCT01203202|PE|pe
553962|NCT01203202|IELT|ielt
553963|NCT01203202|DCIT|dcit
553964|NCT01203189|dandruff, flaky scalp|dandruff, flaky scalp
553965|NCT01203176|Endometrial polyp|endometrial polyp
553966|NCT01203176|Endometrial carcinoma|endometrial carcinoma
553967|NCT01203176|Endometrial hyperplasia|endometrial hyperplasia
553968|NCT01203176|Postmenopausal symptomatic women|postmenopausal symptomatic women
553969|NCT01203176|Postmenopausal asymptomatic women|postmenopausal asymptomatic women
553970|NCT01203163|PDT|pdt
553971|NCT01203163|porfimer sodium|porfimer sodium
553972|NCT01203163|esophageal cancer|esophageal cancer
553973|NCT01203163|NSCLC|nsclc
553974|NCT01203163|HGD in BE|hgd in be
553975|NCT01203137|tricuspid regurgitation, severe|tricuspid regurgitation, severe
553976|NCT01203124|Intranasal|intranasal
553977|NCT01203124|Biomarker|biomarker
553978|NCT01203124|Healthy|healthy
553979|NCT01203124|Effect of different doses and dosing regimens of AZD8848 on biomarkers|effect of different doses and dosing regimens of azd8848 on biomarkers
553980|NCT01203124|Effect different doses and dosing frequency of AZD8848 on biomarkers|effect different doses and dosing frequency of azd8848 on biomarkers
553981|NCT01203098|prevention|prevention
553982|NCT01203098|venous thromboembolism|venous thromboembolism
553983|NCT01203098|edoxaban|edoxaban
553984|NCT01203098|anticoagulants|anticoagulants
553985|NCT01203072|prevention|prevention
553986|NCT01203072|venous thromboembolism|venous thromboembolism
553987|NCT01203072|edoxaban|edoxaban
553989|NCT01203046|DURATION OF THERAPY|duration of therapy
553990|NCT01203046|PENETRATING ABDOMINAL TRAUMA|penetrating abdominal trauma
553991|NCT01203033|acute myeloid leukemia|acute myeloid leukemia
553992|NCT01203033|single cell network profiling|single cell network profiling
553993|NCT01203033|AML|aml
553994|NCT01203033|SCNP|scnp
553995|NCT01203020|Hodgkin's|hodgkin's
553996|NCT01203020|non-Hodgkin's|non-hodgkin's
553997|NCT01203020|lymphomas|lymphomas
553998|NCT01203020|allogeneic hematopoietic progenitor cell transplant|allogeneic hematopoietic progenitor cell transplant
553999|NCT01203020|HPCT|hpct
554000|NCT01203020|busulfex|busulfex
554001|NCT01203020|fludarabine|fludarabine
554002|NCT01203020|reduced-toxicity conditioning|reduced-toxicity conditioning
554003|NCT01203020|reduced-intensity conditioning|reduced-intensity conditioning
554004|NCT01202994|Alzheimer's disease|alzheimer's disease
554005|NCT01202994|Mild cognitive impairment|mild cognitive impairment
554006|NCT01202994|PET|pet
554007|NCT01202994|Practice effects|practice effects
554008|NCT01202981|glistenings|glistenings
554009|NCT01202981|contrast sensitivity|contrast sensitivity
554010|NCT01202981|visual quality|visual quality
554011|NCT01202981|straylight|straylight
554012|NCT01202981|AcrySof IOL|acrysof iol
554013|NCT01202968|intubation electric stimulation deglutition disorder|intubation electric stimulation deglutition disorder
554014|NCT01202955|Smoking, Abstinence|smoking, abstinence
554015|NCT01202929|High Resolution Manometry|high resolution manometry
554016|NCT01202929|achalasia|achalasia
554017|NCT01202929|dysphagia|dysphagia
554018|NCT01202929|GERD|gerd
554019|NCT01202929|chest pain|chest pain
554020|NCT01202929|Post fundoplication|post fundoplication
554021|NCT01202916|children with congenital heart disease|children with congenital heart disease
554022|NCT01202903|omalizumab|omalizumab
554023|NCT01202903|asthma|asthma
554024|NCT01202903|immunoglobulin E|immunoglobulin e
554025|NCT01202903|IgE|ige
554026|NCT01202890|lenalidomide|lenalidomide
554027|NCT01202890|revlimid|revlimid
554028|NCT01202890|liposomal doxorubicin|liposomal doxorubicin
554029|NCT01202890|doxil|doxil
554030|NCT01202890|bevacizumab|bevacizumab
554031|NCT01202890|avastin|avastin
554032|NCT01202890|platinum resistant ovarian cancer|platinum resistant ovarian cancer
554033|NCT01202890|ovarian cancer|ovarian cancer
554034|NCT01202877|Myelodysplastic Syndrome|myelodysplastic syndrome
554035|NCT01202877|MDS|mds
554036|NCT01202877|Refractory acute leukemias|refractory acute leukemias
554037|NCT01202877|Relapsed acute leukemia|relapsed acute leukemia
554038|NCT01202877|Acute myeloid leukemia|acute myeloid leukemia
554039|NCT01202877|AML|aml
554040|NCT01202877|5-Azacytidine|5-azacytidine
554041|NCT01202877|Azacitidine|azacitidine
554042|NCT01202877|5-aza|5-aza
554043|NCT01202877|Vidaza|vidaza
554044|NCT01202877|5-AZC|5-azc
554045|NCT01202877|AZA-CR|aza-cr
554046|NCT01202877|Ladakamycin|ladakamycin
554047|NCT01202877|NSC-102816|nsc-102816
554048|NCT01202877|PKC412|pkc412
554049|NCT01202864|Intracerebral Hemorrhage|intracerebral hemorrhage
554050|NCT01202864|ICH|ich
554051|NCT01202864|Stroke|stroke
554052|NCT01202864|Cerebrovascular accident|cerebrovascular accident
554053|NCT01202851|radiotherapy|radiotherapy
554054|NCT01202851|radiation therapy|radiation therapy
554055|NCT01202851|stretching|stretching
554056|NCT01202851|relaxation|relaxation
554057|NCT01202851|quality of life|quality of life
554058|NCT01202851|QOL|qol
554059|NCT01202851|fatigue|fatigue
554060|NCT01202851|sleep disturbances|sleep disturbances
554061|NCT01202851|mental health|mental health
554062|NCT01202851|cost-effectiveness analysis|cost-effectiveness analysis
554063|NCT01202851|work productivity|work productivity
554064|NCT01202851|home productivity|home productivity
554065|NCT01202851|cortisol rhythmicity|cortisol rhythmicity
554066|NCT01202838|Cranial bone reconstruction, composite|cranial bone reconstruction, composite
554067|NCT01202825|HCV genotype 1 infected patients|hcv genotype 1 infected patients
554068|NCT01202825|TMC647055HPC1001|tmc647055hpc1001
554069|NCT01202825|TMC647055|tmc647055
554070|NCT01202825|HPC|hpc
554071|NCT01202825|Hepatitis C|hepatitis c
554072|NCT01202825|Healthy volunteers|healthy volunteers
554073|NCT01202825|TMC435|tmc435
554074|NCT01202812|Sickle Cell Anemia|sickle cell anemia
554075|NCT01202812|Sickle Cell Disease|sickle cell disease
554076|NCT01202812|Hemoglobin SS Disease|hemoglobin ss disease
554077|NCT01202812|Hemoglobin S beta-0 Thalassemia|hemoglobin s beta-0 thalassemia
554078|NCT01202812|Inflammation|inflammation
554079|NCT01202812|Quality of Life|quality of life
554080|NCT01202812|Sickle Thalassemia|sickle thalassemia
554081|NCT01202812|C-Reative Protein|c-reative protein
554082|NCT01202812|Hemolytic Anemia|hemolytic anemia
554083|NCT01202812|Hemostasis|hemostasis
554084|NCT01202812|Biomarkers|biomarkers
554085|NCT01202812|Coagulation|coagulation
554086|NCT01202812|Omega-3 Fatty Acids|omega-3 fatty acids
554087|NCT01202812|Eicosapentaenoic Acid|eicosapentaenoic acid
554088|NCT01202812|Docosahexaenoic Acid|docosahexaenoic acid
554089|NCT01202812|Fish Oils|fish oils
554090|NCT01202812|Drug: Placebo|drug: placebo
554091|NCT01202812|Drug: LOVAZA|drug: lovaza
554092|NCT01202799|Pharmacokinetics|pharmacokinetics
554093|NCT01202799|Healthy volunteers|healthy volunteers
554094|NCT01202799|PENNSAID|pennsaid
554095|NCT01202799|Topical NSAID|topical nsaid
554096|NCT01202799|Diclofenac|diclofenac
554097|NCT01202786|Cancer of Unknown Primary Site (CUP)|cancer of unknown primary site (cup)
554098|NCT01202773|Rheumatoid Arthritis|rheumatoid arthritis
554099|NCT01202760|Rheumatoid Arthritis|rheumatoid arthritis
554100|NCT01202734|CONCERTA|concerta
554101|NCT01202734|Methylphenidate HCl|methylphenidate hcl
554102|NCT01202734|Pharmacokinetic|pharmacokinetic
554103|NCT01202734|Safety|safety
554104|NCT01202734|Adult|adult
554105|NCT01202734|Men|men
554106|NCT01202734|Male|male
554107|NCT01202721|Congenital|congenital
554108|NCT01202721|Aortic Valve|aortic valve
554109|NCT01202721|Bicuspid|bicuspid
554110|NCT01202721|Aortopathy|aortopathy
554111|NCT01202721|bicuspid aortic valve aortopathy|bicuspid aortic valve aortopathy
554112|NCT01202708|chronic renal failure|chronic renal failure
554113|NCT01202708|hemodiafiltration|hemodiafiltration
554114|NCT01202682|Healthy subject exercise study|healthy subject exercise study
554115|NCT01202656|Fertility Agents, Female|fertility agents, female
554116|NCT01202656|In vitro fertilization|in vitro fertilization
554117|NCT01202643|Thin Endometrium|thin endometrium
554118|NCT01202643|Asherman's Syndrome|asherman's syndrome
554119|NCT01202643|Endometrial Scarring|endometrial scarring
554120|NCT01202630|Clostridium difficile|clostridium difficile
554121|NCT01202630|diarrhea|diarrhea
554122|NCT01202617|Seroquel XR|seroquel xr
554123|NCT01202617|schizophrenia|schizophrenia
554124|NCT01202617|relapse prevention|relapse prevention
554125|NCT01202604|Bipolar disorder I and II|bipolar disorder i and ii
554126|NCT01202604|mood event|mood event
554127|NCT01202604|manic or depressive|manic or depressive
554128|NCT01202604|Greece|greece
554129|NCT01202591|Breast Cancer|breast cancer
554131|NCT01202591|FGFR1|fgfr1
554132|NCT01202591|Exemestane|exemestane
554133|NCT01202591|AZD4547|azd4547
554134|NCT01202591|Fulvestrant|fulvestrant
554135|NCT01202565|Post-marketing observational study (PMOS) Protocol|post-marketing observational study (pmos) protocol
554136|NCT01202565|Moderate to Severe Plaque Psoriasis|moderate to severe plaque psoriasis
554137|NCT01202565|Treatment of Scalp and Nail Affection|treatment of scalp and nail affection
554138|NCT01202565|Effectiveness of Adalimumab (HUMIRA®)|effectiveness of adalimumab (humira®)
554139|NCT01202552|influenza|influenza
554140|NCT01202552|aged|aged
554141|NCT01202552|intradermal injection|intradermal injection
554142|NCT01202526|Insulin resistance|insulin resistance
554143|NCT01202526|Gastric bypass|gastric bypass
554144|NCT01202513|Vitiligo|vitiligo
554145|NCT01202513|Repigmentation|repigmentation
554146|NCT01202487|Laceration|laceration
554147|NCT01202487|Lacerations|lacerations
554148|NCT01202487|LET|let
554149|NCT01202487|Lidocaine Epinephrine Tetracaine|lidocaine epinephrine tetracaine
554150|NCT01202487|LAT|lat
554151|NCT01202487|Lidocaine Adrenaline Tetracaine|lidocaine adrenaline tetracaine
554152|NCT01202487|Tissue Adhesive|tissue adhesive
554153|NCT01202487|Skin Glue|skin glue
554154|NCT01202487|Pre-Treatment with LET|pre-treatment with let
554155|NCT01202487|Pre-Treatment with LAT|pre-treatment with lat
554156|NCT01202487|Pre-Treatment with Lidocaine Epinephrine Tetracaine|pre-treatment with lidocaine epinephrine tetracaine
554157|NCT01202487|Pre-Treatment with Lidocaine Adrenaline Tetracaine|pre-treatment with lidocaine adrenaline tetracaine
554158|NCT01202487|Use of LET with Skin Glue|use of let with skin glue
554159|NCT01202487|Use of LET with Tissue Adhesive|use of let with tissue adhesive
554160|NCT01202487|Histoacryl|histoacryl
554161|NCT01202461|Diabetic macular edema|diabetic macular edema
554162|NCT01202461|Combination therapy for DME|combination therapy for dme
554163|NCT01202461|DME|dme
554164|NCT01202448|Diffuse large B cell lymphoma|diffuse large b cell lymphoma
554165|NCT01202448|central nervous system|central nervous system
554166|NCT01202448|prognosis|prognosis
554167|NCT01202435|pregabalin|pregabalin
554168|NCT01202435|pharmacokinetics|pharmacokinetics
554169|NCT01202435|bioavailability|bioavailability
554170|NCT01202435|bioequivalence|bioequivalence
554171|NCT01202422|pregabalin|pregabalin
554172|NCT01202422|pharmacokinetics|pharmacokinetics
554173|NCT01202422|bioavailability|bioavailability
554174|NCT01202422|bioequivalence|bioequivalence
554175|NCT01202409|Ampulla of Vater|ampulla of vater
554176|NCT01202409|Adenocarcinoma of the small bowel|adenocarcinoma of the small bowel
554177|NCT01202409|Metastatic|metastatic
554178|NCT01202409|Kirsten rat sarcoma|kirsten rat sarcoma
554179|NCT01202409|KRAS|kras
554180|NCT01202409|Capecitabine|capecitabine
554181|NCT01202409|Xeloda|xeloda
554182|NCT01202409|Oxaliplatin|oxaliplatin
554183|NCT01202409|Eloxatin|eloxatin
554184|NCT01202409|CAPOX|capox
554185|NCT01202409|Panitumumab|panitumumab
554186|NCT01202409|Vectibix|vectibix
554187|NCT01202396|pouch|pouch
554188|NCT01202396|pouchitis|pouchitis
554189|NCT01202396|ulcerative colitis|ulcerative colitis
554190|NCT01202396|microbiota|microbiota
554191|NCT01202396|defensins|defensins
554192|NCT01202396|epithelial integrity|epithelial integrity
554194|NCT01202370|Tumors|tumors
554195|NCT01202357|Psychotic Disorders|psychotic disorders
554196|NCT01202357|Psychosis|psychosis
554197|NCT01202344|Angioplasty|angioplasty
554198|NCT01202344|Stenosis|stenosis
554199|NCT01202344|Restenosis|restenosis
554200|NCT01202344|Elastic Recoil|elastic recoil
554201|NCT01202344|cheduled for percutaneous dilation of a peripheral artery|cheduled for percutaneous dilation of a peripheral artery
554202|NCT01202344|Target lesion in native artery|target lesion in native artery
554203|NCT01202344|Baseline lumen diameter greater than 4 mm|baseline lumen diameter greater than 4 mm
554204|NCT01202331|Bacterial Infections|bacterial infections
554205|NCT01202331|Chlamydia Infections|chlamydia infections
554206|NCT01202331|Eye Diseases|eye diseases
554207|NCT01202318|Cerebrovascular Accident|cerebrovascular accident
554208|NCT01202318|Stroke,Acute|stroke,acute
554209|NCT01202305|HIV|hiv
554210|NCT01202305|HIV persistence|hiv persistence
554211|NCT01202305|Lymph node fibrosis|lymph node fibrosis
554212|NCT01202292|overweight|overweight
554213|NCT01202292|obesity|obesity
554214|NCT01202292|motivational intervention|motivational intervention
554215|NCT01202279|Acute Upper Respiratory Track Infection Who Seek Treatment|acute upper respiratory track infection who seek treatment
554216|NCT01202266|Multiple Ascending Dose|multiple ascending dose
554217|NCT01202266|Phase 1|phase 1
554218|NCT01202266|Safety and Tolerability|safety and tolerability
554219|NCT01202266|PK|pk
554220|NCT01202266|Healthy Subjects|healthy subjects
554221|NCT01202253|Ecalta|ecalta
554222|NCT01202253|Eraxis|eraxis
554223|NCT01202253|Candida|candida
554224|NCT01202253|Candidemia|candidemia
554225|NCT01202253|Systemic Candidiasis|systemic candidiasis
554226|NCT01202253|ICU|icu
554227|NCT01202253|Intensive Care Unit|intensive care unit
554228|NCT01202253|Critical Care Unit|critical care unit
554229|NCT01202240|Drug-Drug Interaction|drug-drug interaction
554230|NCT01202240|Healthy Volunteers|healthy volunteers
554231|NCT01202240|Tasocitinib (CP-690|tasocitinib (cp-690
554232|NCT01202240|550)|550)
554233|NCT01202240|Ketoconazole|ketoconazole
554234|NCT01202227|Central Nervous System Diseases|central nervous system diseases
554235|NCT01202227|Therapeutic Uses|therapeutic uses
554236|NCT01202227|Wounds and Injuries|wounds and injuries
554237|NCT01202227|Trauma|trauma
554238|NCT01202227|Nervous System|nervous system
554239|NCT01202227|pregabalin|pregabalin
554362|NCT01201629|t DC stimulation|t dc stimulation
554240|NCT01202188|QVA149, COPD, combination bronchodilator, indacaterol, glycopyrronium bromide|qva149, copd, combination bronchodilator, indacaterol, glycopyrronium bromide
554241|NCT01202175|Genetic risk of hypertension|genetic risk of hypertension
554242|NCT01202162|Induction|induction
554243|NCT01202162|Coughing|coughing
554244|NCT01202162|Anesthesia|anesthesia
554245|NCT01202149|eczema|eczema
554246|NCT01202149|elidel|elidel
554247|NCT01202149|non-medicated device|non-medicated device
554248|NCT01202149|hylatopic plus|hylatopic plus
554249|NCT01202149|pimecrolimus|pimecrolimus
554250|NCT01202149|bilateral comparison study|bilateral comparison study
554251|NCT01202149|topical therapy|topical therapy
554252|NCT01202136|pancreatic cyst|pancreatic cyst
554253|NCT01202136|IPMN|ipmn
554254|NCT01202136|PAN INs|pan ins
554255|NCT01202136|Pancreatic cancer|pancreatic cancer
554256|NCT01202136|pancreatic neoplasia|pancreatic neoplasia
554257|NCT01202071|Rabeprazole|rabeprazole
554258|NCT01202071|proton pump inhibitor|proton pump inhibitor
554259|NCT01202071|pharmacokinetics|pharmacokinetics
554260|NCT01202071|pharmacodynamics|pharmacodynamics
554261|NCT01202071|healthy adult male Japanese subjects|healthy adult male japanese subjects
554262|NCT01202058|Coronary artery disease|coronary artery disease
554263|NCT01202058|Drug-eluting stents|drug-eluting stents
554264|NCT01202058|Reservoir technology|reservoir technology
554265|NCT01202045|Echocardiography, Stress|echocardiography, stress
554266|NCT01202045|right heart catheterization|right heart catheterization
554267|NCT01202032|Metastatic renal cell carcinoma|metastatic renal cell carcinoma
554268|NCT01202032|Advanced solid tumors|advanced solid tumors
554269|NCT01202032|Dose escalation|dose escalation
554270|NCT01202032|Association Pazopanib-Bevacizumab|association pazopanib-bevacizumab
554271|NCT01202019|cardiovascular risk|cardiovascular risk
554272|NCT01202019|exercise|exercise
554273|NCT01202019|post-exercise diet supplementation|post-exercise diet supplementation
554274|NCT01202006|Heart failure|heart failure
554275|NCT01202006|Diagnosis|diagnosis
554276|NCT01202006|Treatment|treatment
554277|NCT01202006|Primary care|primary care
554278|NCT01201993|syncope|syncope
554279|NCT01201993|evaluation|evaluation
554280|NCT01201993|recurrence|recurrence
554281|NCT01201993|morbidity|morbidity
554282|NCT01201980|essential arterial hypertension|essential arterial hypertension
554283|NCT01201980|calcium antagonist|calcium antagonist
554284|NCT01201967|Collaborative care|collaborative care
554285|NCT01201967|Cardiovascular disease|cardiovascular disease
554286|NCT01201967|Depression|depression
554287|NCT01201967|Anxiety|anxiety
554288|NCT01201954|pain|pain
554289|NCT01201954|sucrose|sucrose
554290|NCT01201954|newborn|newborn
554291|NCT01201954|mechanical ventilation|mechanical ventilation
554292|NCT01201876|Dental Caries|dental caries
554293|NCT01201876|Assessments|assessments
554294|NCT01201876|dental materials|dental materials
554295|NCT01201863|Testosterone|testosterone
554296|NCT01201863|Traumatic Brain Injury|traumatic brain injury
554297|NCT01201863|Hypogonadism|hypogonadism
554298|NCT01201863|Endocrine Dysfunction|endocrine dysfunction
554299|NCT01201863|Low Testosterone in men with new Traumatic Brain Injury|low testosterone in men with new traumatic brain injury
554300|NCT01201850|radiation necrosis|radiation necrosis
554301|NCT01201850|Bevacizumab (Avastin®)|bevacizumab (avastin®)
554302|NCT01201850|Central Nervous System Tumors|central nervous system tumors
554303|NCT01201837|Acute coronary syndrome|acute coronary syndrome
554304|NCT01201837|HDL mimetic|hdl mimetic
554305|NCT01201837|ApoA-I|apoa-i
554306|NCT01201824|lung cancer|lung cancer
554307|NCT01201824|intracavitary ultrasound|intracavitary ultrasound
554308|NCT01201824|pulmonary nodules|pulmonary nodules
554309|NCT01201824|VATS procedures|vats procedures
554310|NCT01201811|Myelodysplastic Syndromes|myelodysplastic syndromes
554311|NCT01201811|Taiwan|taiwan
554312|NCT01201811|Azacitidine|azacitidine
554313|NCT01201811|Vidaza|vidaza
554314|NCT01201811|Celgene|celgene
554315|NCT01201811|Pathologic Processes|pathologic processes
554316|NCT01201811|Neoplasms|neoplasms
554317|NCT01201811|Bone Marrow Diseases|bone marrow diseases
554318|NCT01201811|Hematologic Diseases|hematologic diseases
554319|NCT01201811|Antineoplastic Agents|antineoplastic agents
554320|NCT01201811|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic
554321|NCT01201811|Antimetabolites|antimetabolites
554322|NCT01201811|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action
554323|NCT01201811|Pharmacologic Actions|pharmacologic actions
554324|NCT01201811|Therapeutic Uses|therapeutic uses
554325|NCT01201811|Enzyme inhibitors|enzyme inhibitors
554326|NCT01201785|diabetes mellitus, coronary artery disease, aspirin therapy|diabetes mellitus, coronary artery disease, aspirin therapy
554327|NCT01201772|coronary artery disease|coronary artery disease
554328|NCT01201772|percutaneous coronary revascularization|percutaneous coronary revascularization
554329|NCT01201772|prasugrel therapy|prasugrel therapy
554330|NCT01201759|cardiovascular risk|cardiovascular risk
554331|NCT01201746|Non-surgical periodontal therapy|non-surgical periodontal therapy
554332|NCT01201746|Coronary heart disease (CHD)|coronary heart disease (chd)
554333|NCT01201746|periodontal Disease|periodontal disease
554334|NCT01201746|hsCRP|hscrp
554335|NCT01201746|Fibrinogen|fibrinogen
554336|NCT01201746|WBCs|wbcs
554337|NCT01201720|cirrhosis|cirrhosis
554338|NCT01201720|cirrhotic patients with acute on chronic liver failure|cirrhotic patients with acute on chronic liver failure
554339|NCT01201707|Multiple Sclerosis|multiple sclerosis
554340|NCT01201707|Angioplasty|angioplasty
554341|NCT01201707|Vein|vein
554342|NCT01201694|Advanced malignancies|advanced malignancies
554343|NCT01201694|Surface-controlled water soluble curcumin|surface-controlled water soluble curcumin
554344|NCT01201694|Turmeric|turmeric
554345|NCT01201694|Dietary supplements|dietary supplements
554346|NCT01201681|Post-operative pain|post-operative pain
554347|NCT01201681|intra-operative pain|intra-operative pain
554348|NCT01201681|root canal therapy|root canal therapy
554349|NCT01201681|feasibility|feasibility
554350|NCT01201681|post-surgical persistent pain|post-surgical persistent pain
554351|NCT01201668|post-operative pain|post-operative pain
554352|NCT01201668|root canal therapy|root canal therapy
554353|NCT01201668|feasibility|feasibility
554354|NCT01201668|post-surgical persistent pain|post-surgical persistent pain
554355|NCT01201655|Posthepatitic cirrhosis;|posthepatitic cirrhosis;
554356|NCT01201655|Hepatocarcinogenesis;|hepatocarcinogenesis;
554357|NCT01201655|Splenectomy;|splenectomy;
554358|NCT01201642|Bell's palsy|bell's palsy
554359|NCT01201642|Prednisolone|prednisolone
554360|NCT01201642|acupuncture|acupuncture
554361|NCT01201629|Ischemic Strokes|ischemic strokes
554363|NCT01201629|Functional recovery|functional recovery
554364|NCT01201616|Cognitive function|cognitive function
554365|NCT01201616|mood|mood
554366|NCT01201616|women|women
554367|NCT01201616|high fat diet|high fat diet
554368|NCT01201616|high carbohydrate diet|high carbohydrate diet
554369|NCT01201603|Women|women
554370|NCT01201603|Orange Juice|orange juice
554371|NCT01201603|Insulin Resistance|insulin resistance
554372|NCT01201603|Obesity|obesity
554373|NCT01201590|Insulin resistance|insulin resistance
554374|NCT01201590|obesity|obesity
554375|NCT01201590|cocoa|cocoa
554376|NCT01201590|women|women
554377|NCT01201577|Quorum sensing|quorum sensing
554378|NCT01201577|Prebiotics|prebiotics
554379|NCT01201577|Probiotics|probiotics
554380|NCT01201577|Sepsis|sepsis
554381|NCT01201564|umbilical hernia,|umbilical hernia,
554382|NCT01201564|wound complications,|wound complications,
554383|NCT01201564|mesh repair, IPOM,|mesh repair, ipom,
554384|NCT01201564|quality of life,|quality of life,
554385|NCT01201564|sublay mesh repair,|sublay mesh repair,
554386|NCT01201564|recurrence rate|recurrence rate
554387|NCT01201551|Alphagan|alphagan
554388|NCT01201551|Xalatan|xalatan
554389|NCT01201551|corneal temperature|corneal temperature
554390|NCT01201551|primary vascular dysregulation|primary vascular dysregulation
554391|NCT01201512|TMJD pain|tmjd pain
554392|NCT01201512|feasibility|feasibility
554393|NCT01201486|Ultrasound|ultrasound
554394|NCT01201486|Pregnancy|pregnancy
554395|NCT01201486|Fetal heart defects|fetal heart defects
554396|NCT01201486|Color doppler|color doppler
554397|NCT01201473|effect of participation|effect of participation
554398|NCT01201473|effect of association|effect of association
554399|NCT01201460|glucose testing|glucose testing
554400|NCT01201447|Assessment|assessment
554401|NCT01201447|Questionable Caries|questionable caries
554402|NCT01201434|cystic fibrosis|cystic fibrosis
554403|NCT01201434|probiotics|probiotics
554404|NCT01201434|pulmonary|pulmonary
554405|NCT01201434|infections|infections
554406|NCT01201421|patient satisfaction|patient satisfaction
554407|NCT01201421|assessments|assessments
554408|NCT01201421|dental caries|dental caries
554409|NCT01201421|dental materials|dental materials
554410|NCT01201408|Dental Caries|dental caries
554411|NCT01201408|Assessments|assessments
554412|NCT01201408|dental materials|dental materials
554413|NCT01201395|Dental Caries|dental caries
554414|NCT01201395|Assessment|assessment
554415|NCT01201395|dental materials|dental materials
554416|NCT01201382|Depression|depression
554417|NCT01201382|Prevention|prevention
554418|NCT01201382|Adolescents|adolescents
704165|NCT00615433|Latuda|latuda
554419|NCT01201369|Percutaneous Coronary Intervention|percutaneous coronary intervention
554420|NCT01201369|Coronary Artery Stenosis|coronary artery stenosis
554421|NCT01201369|Acute Myocardial Infarction|acute myocardial infarction
554422|NCT01201369|Coronary Artery Stent|coronary artery stent
554423|NCT01201369|Optical Coherence Tomography|optical coherence tomography
554424|NCT01201356|Fingolimod|fingolimod
554425|NCT01201356|FTY720|fty720
554426|NCT01201356|Relapsing forms of MS|relapsing forms of ms
554427|NCT01201356|Multiple Sclerosis|multiple sclerosis
554428|NCT01201356|Efficacy|efficacy
554429|NCT01201343|Multiple sclerosis, relapsing, remitting|multiple sclerosis, relapsing, remitting
554430|NCT01201343|Interferon-beta|interferon-beta
554431|NCT01201330|ONJ|onj
554432|NCT01201317|Analgesic effect|analgesic effect
554433|NCT01201304|Anxiety sensitivity|anxiety sensitivity
554434|NCT01201304|Panic|panic
554435|NCT01201291|TBI|tbi
554436|NCT01201291|Normobaric hyperoxia|normobaric hyperoxia
554437|NCT01201291|Outcome|outcome
554438|NCT01201291|GOS|gos
554439|NCT01201291|GOSE|gose
554440|NCT01201278|intranasal insulin|intranasal insulin
554441|NCT01201252|children|children
554442|NCT01201252|gastroenteritis|gastroenteritis
554443|NCT01201252|Rotavirus|rotavirus
554444|NCT01201239|raltegravir|raltegravir
554445|NCT01201239|HIV-1|hiv-1
554446|NCT01201239|drug resistance|drug resistance
554447|NCT01201226|Primordial ovarian follicles|primordial ovarian follicles
554448|NCT01201226|PTEN|pten
554449|NCT01201226|PI3K activating peptide|pi3k activating peptide
554450|NCT01201226|Low ovarian reserve|low ovarian reserve
554451|NCT01201226|Gonadotrophins|gonadotrophins
554452|NCT01201213|Bupivacaine|bupivacaine
554453|NCT01201213|levobupivacaine|levobupivacaine
554454|NCT01201213|ropivacaine|ropivacaine
554455|NCT01201200|Obstructive Sleep Apnea|obstructive sleep apnea
554456|NCT01201200|Right Ventricular Function|right ventricular function
554457|NCT01201200|Pulmonary Hypertension|pulmonary hypertension
554458|NCT01201187|ADHD(Attention Deficit Hyperactivity Disorder)|adhd(attention deficit hyperactivity disorder)
554459|NCT01201174|Hemolysis in Patients with Hereditary Spherocytosis|hemolysis in patients with hereditary spherocytosis
554460|NCT01201174|with documented family history of HS.|with documented family history of hs.
554461|NCT01201174|spherocyte morphology,|spherocyte morphology,
554462|NCT01201174|splenomegaly and non-immune mediated hemolysis.|splenomegaly and non-immune mediated hemolysis.
554463|NCT01201161|Diabetic Retinopathy|diabetic retinopathy
554464|NCT01201161|Retinal detachment|retinal detachment
554465|NCT01201161|Vitreous Hemorrhage|vitreous hemorrhage
554466|NCT01201161|Preoperative Ranibizumab|preoperative ranibizumab
554467|NCT01201161|pars plana vitrectomy|pars plana vitrectomy
554468|NCT01201148|depression|depression
554469|NCT01201148|transcranial direct current stimulation (tDCS)|transcranial direct current stimulation (tdcs)
554470|NCT01201148|random noise stimulation|random noise stimulation
554471|NCT01201148|oscillatory tDCS|oscillatory tdcs
554472|NCT01201148|intermittent tDCS|intermittent tdcs
554473|NCT01201122|Pediatric|pediatric
554474|NCT01201122|Ulcerative colitis|ulcerative colitis
554475|NCT01201122|5-ASA|5-asa
554476|NCT01201122|Mesalamine|mesalamine
554477|NCT01201122|Dosing|dosing
554478|NCT01201109|Carpal tunnel syndrome|carpal tunnel syndrome
554479|NCT01201109|Entrapment neuropathies|entrapment neuropathies
554480|NCT01201109|Diabetes|diabetes
554481|NCT01201096|neuroendocrine tumor|neuroendocrine tumor
554482|NCT01201096|liver metastasis|liver metastasis
554483|NCT01201096|peptide receptor therapy|peptide receptor therapy
554484|NCT01201096|gastro-entero-pancreatic system|gastro-entero-pancreatic system
554485|NCT01201057|SPL7013|spl7013
554486|NCT01201057|VivaGel|vivagel
554487|NCT01201057|bacterial vaginosis|bacterial vaginosis
554488|NCT01201057|BV|bv
554490|NCT01201044|3DCRT|3dcrt
554491|NCT01201031|for the active surveillance of VRE colinization and infection|for the active surveillance of vre colinization and infection
554492|NCT01201018|Tumor|tumor
554493|NCT01201018|cancer|cancer
554494|NCT01201018|metastasis|metastasis
554495|NCT01200992|Urinary Bladder Neoplasms|urinary bladder neoplasms
554496|NCT01200992|Neoplasms|neoplasms
554497|NCT01200992|Urologic Neoplasms|urologic neoplasms
554498|NCT01200992|Urogenital Neoplasms|urogenital neoplasms
554499|NCT01200992|Neoplasms by Site|neoplasms by site
554500|NCT01200992|Urinary Bladder Diseases|urinary bladder diseases
554501|NCT01200992|Urologic Diseases|urologic diseases
554502|NCT01200992|Mycobacterial cell wall DNA complex|mycobacterial cell wall dna complex
554503|NCT01200992|Intravesical drug administration|intravesical drug administration
554504|NCT01200979|Gene Expression|gene expression
554505|NCT01200979|IN VITRO|in vitro
554506|NCT01200979|Immunosuppression|immunosuppression
554507|NCT01200979|Infection|infection
554508|NCT01200979|Neutrophils|neutrophils
554509|NCT01200979|Pregnancy|pregnancy
554510|NCT01200979|Immune Function|immune function
554511|NCT01200966|Essential Tremor|essential tremor
554512|NCT01200966|Transcranial Magnetic Stimulation (TMS)|transcranial magnetic stimulation (tms)
554513|NCT01200966|Ethanol|ethanol
554514|NCT01200966|Alcohol|alcohol
554515|NCT01200966|Alcohol Clamp|alcohol clamp
554516|NCT01200966|ET|et
554517|NCT01200953|Select Agents|select agents
554518|NCT01200953|Biosafety|biosafety
554519|NCT01200953|Bioterrorism|bioterrorism
554520|NCT01200953|SCSU (Special Clinical Studies Unit)|scsu (special clinical studies unit)
554521|NCT01200953|Infectious Disease|infectious disease
554522|NCT01200953|Bioterrorism-Related Illness|bioterrorism-related illness
554523|NCT01200940|GLP-1|glp-1
554524|NCT01200940|Glucose Tolerance|glucose tolerance
554525|NCT01200940|Gut Hormones|gut hormones
554526|NCT01200927|infant|infant
554527|NCT01200927|sitting|sitting
554528|NCT01200927|postural control|postural control
554529|NCT01200914|Hemodialysis|hemodialysis
554530|NCT01200914|Fistula|fistula
554531|NCT01200914|Angiograph|angiograph
554532|NCT01200914|Angiogram|angiogram
554533|NCT01200901|depression|depression
554534|NCT01200901|healthy|healthy
554535|NCT01200875|PRP|prp
554536|NCT01200875|platelet rich plasma|platelet rich plasma
554537|NCT01200875|platelet|platelet
554538|NCT01200875|growth hormone|growth hormone
554539|NCT01200875|tendonitis|tendonitis
554540|NCT01200875|tendinosis|tendinosis
554541|NCT01200875|tendinopathy|tendinopathy
554542|NCT01200875|enthesopathy|enthesopathy
554543|NCT01200875|muscle|muscle
554544|NCT01200875|sport|sport
554545|NCT01200875|tendon|tendon
554546|NCT01200862|Obese|obese
554547|NCT01200862|obesity|obesity
554548|NCT01200862|hypogonadism|hypogonadism
554549|NCT01200862|hypogonadotropic|hypogonadotropic
554550|NCT01200862|hyperestrogenemic|hyperestrogenemic
554551|NCT01200862|testosterone|testosterone
554552|NCT01200862|hypogonadal|hypogonadal
554553|NCT01200836|Statins|statins
554554|NCT01200836|Immune Modulation|immune modulation
554555|NCT01200836|Healthy Volunteer|healthy volunteer
554556|NCT01200823|Laboratory Research|laboratory research
554557|NCT01200823|Biologic Samples|biologic samples
554558|NCT01200823|Tissue Collection|tissue collection
554559|NCT01200823|Tissue Procurement|tissue procurement
554560|NCT01200771|FDG-PET/CT|fdg-pet/ct
554561|NCT01200771|FUO|fuo
554562|NCT01200771|Chronic Inflammatory syndrome|chronic inflammatory syndrome
554563|NCT01200771|Fever of unknown origin|fever of unknown origin
554564|NCT01200745|neck pain|neck pain
554565|NCT01200745|capsaicin|capsaicin
554566|NCT01200745|dermal patch|dermal patch
554567|NCT01200732|Tadalafil|tadalafil
554568|NCT01200732|phosphodiesterase-5 inhibitor|phosphodiesterase-5 inhibitor
554569|NCT01200732|Eisenmenger syndrome|eisenmenger syndrome
554570|NCT01200719|brain electrical stimulation|brain electrical stimulation
554571|NCT01200719|sub-acute post-stroke|sub-acute post-stroke
554572|NCT01200719|rehabilitation|rehabilitation
554573|NCT01200706|children aged under 5 years|children aged under 5 years
554574|NCT01200706|Non-severe|non-severe
554575|NCT01200693|Angioplasty, Transluminal, Percutaneous Coronary|angioplasty, transluminal, percutaneous coronary
554576|NCT01200693|Drug-Eluting Stents|drug-eluting stents
554577|NCT01200680|Pediatric and Adult|pediatric and adult
554578|NCT01200680|Gene Identification|gene identification
554579|NCT01200680|Rare Bone Cancer|rare bone cancer
554580|NCT01200680|All Chordoma Sites|all chordoma sites
554581|NCT01200680|Sporadic Chordoma|sporadic chordoma
554582|NCT01200680|Bone Cancer|bone cancer
554583|NCT01200654|Population pharmacokinetics|population pharmacokinetics
554584|NCT01200654|Linezolid|linezolid
554585|NCT01200654|Monolix|monolix
554586|NCT01200654|nonlinear mixed effects models|nonlinear mixed effects models
554587|NCT01200641|melatonin|melatonin
554588|NCT01200641|gabapentin|gabapentin
554589|NCT01200641|anxiety|anxiety
554590|NCT01200641|pain|pain
554591|NCT01200641|retrobulbar block|retrobulbar block
554592|NCT01200628|posttraumatic stress disorder|posttraumatic stress disorder
554593|NCT01200628|acute PTSD|acute ptsd
554594|NCT01200628|PTSD|ptsd
554595|NCT01200628|motor vehicle accident|motor vehicle accident
554596|NCT01200615|nocebo side-effects SSRI informed consent|nocebo side-effects ssri informed consent
554597|NCT01200589|Randomized trial|randomized trial
554598|NCT01200589|Ofatumumab|ofatumumab
554599|NCT01200589|Rituximab|rituximab
554600|NCT01200589|Indolent B-Cell Non Hodgkin Lymphoma|indolent b-cell non hodgkin lymphoma
554601|NCT01200576|CRF: Case Report Form|crf: case report form
554602|NCT01200576|DM: Data Management|dm: data management
554603|NCT01200576|FHI: FHI (formerly known as Family Health International)|fhi: fhi (formerly known as family health international)
554604|NCT01200576|IRB: Institutional Review Board|irb: institutional review board
554605|NCT01200576|IUD: Intra-uterine Device|iud: intra-uterine device
554606|NCT01200576|LTPM: Long-term and Permanent Contraceptive Methods|ltpm: long-term and permanent contraceptive methods
554607|NCT01200576|MSI: Marie Stopes International|msi: marie stopes international
554608|NCT01200576|MSM: Marie Stopes Madagascar|msm: marie stopes madagascar
554609|NCT01200576|PHSC: Protection of Human Subjects Committee|phsc: protection of human subjects committee
554610|NCT01200576|PI: Principal Investigator|pi: principal investigator
554611|NCT01200576|SAE: Serious Adverse Event|sae: serious adverse event
554612|NCT01200576|Sino-Implant (II)|sino-implant (ii)
554613|NCT01200576|SOP: Standard Operating Procedure|sop: standard operating procedure
554614|NCT01200576|Zarin|zarin
554615|NCT01200563|MIST Therapy|mist therapy
554616|NCT01200563|Negative Pressure Wound Therapy|negative pressure wound therapy
554617|NCT01200563|Wound care in long-term acute care hospital|wound care in long-term acute care hospital
554618|NCT01200563|Wound care in skilled nursing facility setting|wound care in skilled nursing facility setting
554619|NCT01200550|Gastroesophageal reflux disease|gastroesophageal reflux disease
554620|NCT01200550|GERD Impact Scale|gerd impact scale
554622|NCT01200537|poor responders|poor responders
554623|NCT01200537|follicle synchrony|follicle synchrony
554624|NCT01200537|IVF response|ivf response
554625|NCT01200537|estrogen|estrogen
554626|NCT01200537|estradiol (E2)|estradiol (e2)
554627|NCT01200537|oral contraceptive pill (OCP)|oral contraceptive pill (ocp)
554628|NCT01200537|birth control pill (BCP)|birth control pill (bcp)
554629|NCT01200524|Analgesic effect|analgesic effect
554630|NCT01200511|intraocular lens|intraocular lens
554631|NCT01200511|multifocal|multifocal
554632|NCT01200511|toric|toric
554633|NCT01200498|Primary Polycythemia Vera|primary polycythemia vera
554634|NCT01200498|Post Polycythemia Vera|post polycythemia vera
554635|NCT01200498|Post Essential Thrombocythemia Myelofibrosis|post essential thrombocythemia myelofibrosis
554636|NCT01200498|SB939|sb939
554638|NCT01200498|post-PV MF|post-pv mf
554639|NCT01200498|post-ET MF|post-et mf
554640|NCT01200485|Supportive Care|supportive care
554641|NCT01200485|Recombinant urate oxidase|recombinant urate oxidase
554642|NCT01200485|Chemotherapy|chemotherapy
554643|NCT01200485|Tumor Lysis Syndrome (TLS)|tumor lysis syndrome (tls)
554644|NCT01200485|Hematologic malignancies|hematologic malignancies
554645|NCT01200485|Acute myeloid leukemia|acute myeloid leukemia
554646|NCT01200472|EHOA|ehoa
554647|NCT01200459|Obesity|obesity
554648|NCT01200459|Weight Loss|weight loss
554649|NCT01200459|Healthy Lifestyle|healthy lifestyle
554650|NCT01200459|Social|social
554651|NCT01200459|Mobile|mobile
554652|NCT01200459|Facebook|facebook
554653|NCT01200459|Text Messages|text messages
554654|NCT01200446|Asthma|asthma
554655|NCT01200446|Exercise-Induced Bronchoconstriction|exercise-induced bronchoconstriction
554656|NCT01200446|Inflammation|inflammation
554657|NCT01200446|Airway|airway
554658|NCT01200446|Fish Oil|fish oil
554659|NCT01200446|Docosahexaenoic Acid|docosahexaenoic acid
554660|NCT01200446|DHA|dha
554661|NCT01200433|dexmedetomidine|dexmedetomidine
554662|NCT01200433|propofol|propofol
554663|NCT01200433|cerebral blood flow|cerebral blood flow
554664|NCT01200433|brain oxygenation|brain oxygenation
554665|NCT01200420|Antisense|antisense
554666|NCT01200420|miR-122 antagonist|mir-122 antagonist
554667|NCT01200420|host factor|host factor
554668|NCT01200420|CHC|chc
554669|NCT01200407|Hypertension|hypertension
554670|NCT01200407|fixed drug combination|fixed drug combination
554671|NCT01200407|Filipinos|filipinos
554672|NCT01200407|Amlodipine|amlodipine
554673|NCT01200407|Olmesartan medoxomil|olmesartan medoxomil
554674|NCT01200407|uncontrolled hypertension|uncontrolled hypertension
554675|NCT01200407|difficult to treat hypertension|difficult to treat hypertension
554676|NCT01200394|Diabetic nephropathy|diabetic nephropathy
554677|NCT01200394|chronic kidney disease|chronic kidney disease
554678|NCT01200394|PF-00489791|pf-00489791
554679|NCT01200394|phosphodiesterase|phosphodiesterase
554680|NCT01200394|PDE5|pde5
554681|NCT01200381|ICD|icd
554682|NCT01200381|CRTD|crtd
554683|NCT01200381|Remote care|remote care
554684|NCT01200381|Remote monitoring|remote monitoring
554685|NCT01200381|Heart failure|heart failure
554686|NCT01200368|vaccine|vaccine
554687|NCT01200368|pneumococcal conjugate|pneumococcal conjugate
554688|NCT01200355|MICAFUNGIN|micafungin
554689|NCT01200355|POSACONAZOLE|posaconazole
554690|NCT01200355|antifungal|antifungal
554691|NCT01200355|prolonged neutropenia|prolonged neutropenia
554692|NCT01200355|10-038|10-038
554693|NCT01200342|Uveal melanoma|uveal melanoma
554694|NCT01200342|Carboplatin|carboplatin
554695|NCT01200342|Genasense|genasense
554696|NCT01200342|Paclitaxel|paclitaxel
554697|NCT01200342|oblimersen|oblimersen
554699|NCT01200329|Hodgkin's disease|hodgkin's disease
554700|NCT01200329|Relapsed|relapsed
554701|NCT01200329|Refractory|refractory
554702|NCT01200329|High-dose chemotherapy|high-dose chemotherapy
554703|NCT01200329|Busulfan|busulfan
554704|NCT01200329|Gemcitabine|gemcitabine
554705|NCT01200329|Melphalan|melphalan
554706|NCT01200316|Colon Cancer|colon cancer
554707|NCT01200316|Abdominal Surgery|abdominal surgery
554708|NCT01200316|Stress|stress
554709|NCT01200316|Rocking Motion|rocking motion
554710|NCT01200316|Salivary Cortisol|salivary cortisol
554711|NCT01200316|Postoperative Ileus|postoperative ileus
554712|NCT01200303|colon cancer|colon cancer
554713|NCT01200303|adenomatous colonic polyps|adenomatous colonic polyps
554714|NCT01200303|colon screening|colon screening
554715|NCT01200303|CT Colonography (Virtual Colonoscopy)|ct colonography (virtual colonoscopy)
554716|NCT01200303|Computer Aided Detection|computer aided detection
554717|NCT01200303|Electronic Cleansing|electronic cleansing
554718|NCT01200290|end stage renal disease|end stage renal disease
554719|NCT01200290|end stage kidney disease|end stage kidney disease
554720|NCT01200290|ESRD|esrd
554721|NCT01200290|Uremia|uremia
554722|NCT01200290|Renal Dialysis|renal dialysis
554723|NCT01200277|osteoporosis|osteoporosis
554724|NCT01200277|vertebral fracture|vertebral fracture
554725|NCT01200277|vertebroplasty|vertebroplasty
554726|NCT01200277|percutaneous|percutaneous
554727|NCT01200238|STA9090|sta9090
554728|NCT01200238|STA-9090|sta-9090
554729|NCT01200238|HSP90|hsp90
554730|NCT01200212|Palliative Therapy|palliative therapy
554731|NCT01200212|bevacizimab|bevacizimab
554732|NCT01200212|Avastin|avastin
554733|NCT01200212|Xeloda|xeloda
554734|NCT01200212|metastatic breast cancer|metastatic breast cancer
554735|NCT01200212|Progression Free Survival|progression free survival
554736|NCT01200212|Time to Progression|time to progression
554737|NCT01200212|Overall survival|overall survival
554738|NCT01200173|Probiotic - Lactobacillus casei DN-114 001 - dairy|probiotic - lactobacillus casei dn-114 001 - dairy
554739|NCT01200173|product - infections - children|product - infections - children
554740|NCT01200160|Low-Density Lipoprotein Cholesterol|low-density lipoprotein cholesterol
554741|NCT01200160|Hypertriglyceridemia|hypertriglyceridemia
554742|NCT01200160|Latin America|latin america
554743|NCT01200160|Cardiovascular Diseases|cardiovascular diseases
554744|NCT01200160|Cholesterol|cholesterol
554745|NCT01200160|Sedentary Lifestyle|sedentary lifestyle
554746|NCT01200160|High-Density Lipoprotein Cholesterol|high-density lipoprotein cholesterol
554747|NCT01200134|glioma patients : anaplasic glioma (grade III) and GBM (grade IV)|glioma patients : anaplasic glioma (grade iii) and gbm (grade iv)
554748|NCT01200121|Symptomatic malignant ascites due to advanced-stage gastrointestinal cancers|symptomatic malignant ascites due to advanced-stage gastrointestinal cancers
554749|NCT01200108|Severe Asthma, requiring chronic oral steroid use|severe asthma, requiring chronic oral steroid use
554750|NCT01200082|chronic hepatitis C/B|chronic hepatitis c/b
554751|NCT01200082|alcoholic liver disease|alcoholic liver disease
554752|NCT01200082|primary biliary cirrhosis|primary biliary cirrhosis
554753|NCT01200082|primary sclerosing cholangitis|primary sclerosing cholangitis
554754|NCT01200082|progressive familial intrahepatic cholestasis|progressive familial intrahepatic cholestasis
554755|NCT01200069|depression,myalgia|depression,myalgia
554756|NCT01200056|Volumetric virtual histology intravascular ultrasound.|volumetric virtual histology intravascular ultrasound.
554757|NCT01200056|Statin-naive patient.|statin-naive patient.
554758|NCT01200056|Varying doses atorvastatin.|varying doses atorvastatin.
554759|NCT01200056|Clinical outcomes.|clinical outcomes.
554760|NCT01200043|Childhood obesity|childhood obesity
554761|NCT01200043|metabolic syndrome|metabolic syndrome
554762|NCT01200043|insulin resistance|insulin resistance
554763|NCT01200043|intrahepatic fat|intrahepatic fat
554764|NCT01200043|hypertension|hypertension
554765|NCT01200030|Sitting balance|sitting balance
554766|NCT01200030|Stroke|stroke
554767|NCT01200017|T cell depleted|t cell depleted
554768|NCT01200017|Matched unrelated donors|matched unrelated donors
554769|NCT01200017|Haplocompatible donors|haplocompatible donors
554770|NCT01200017|Graft vs Host Disease|graft vs host disease
554771|NCT01200017|Hemoglobinopathies|hemoglobinopathies
554772|NCT01200017|Leukemia|leukemia
554773|NCT01200017|Leukemia, Lymphoid|leukemia, lymphoid
554774|NCT01200017|Precursor Cell Lymphoblastic Leukemia-Lymphoma|precursor cell lymphoblastic leukemia-lymphoma
554775|NCT01200017|Leukemia, Myeloid, Acute|leukemia, myeloid, acute
554776|NCT01200017|Leukemia, Myeloid|leukemia, myeloid
554777|NCT01200017|Leukemia, Myelogenous, Chronic, BCR-ABL Positive|leukemia, myelogenous, chronic, bcr-abl positive
554778|NCT01200017|Lymphoma|lymphoma
554779|NCT01200017|Myelodysplastic Syndromes|myelodysplastic syndromes
554780|NCT01200017|Preleukemia|preleukemia
554781|NCT01200017|Osteopetrosis|osteopetrosis
554782|NCT01200017|Pancytopenia|pancytopenia
554783|NCT01200017|Immune System Diseases|immune system diseases
554784|NCT01200017|Hematologic Diseases|hematologic diseases
554785|NCT01200017|Genetic Diseases, Inborn|genetic diseases, inborn
554786|NCT01200017|Neoplasms by Histologic Type|neoplasms by histologic type
554787|NCT01200017|Neoplasms|neoplasms
554788|NCT01200017|Lymphoproliferative Disorders|lymphoproliferative disorders
554789|NCT01200017|Lymphatic Diseases|lymphatic diseases
554790|NCT01200017|Immunoproliferative Disorders|immunoproliferative disorders
554791|NCT01200017|Myeloproliferative Disorders|myeloproliferative disorders
554792|NCT01200017|Bone Marrow Diseases|bone marrow diseases
554793|NCT01200017|Precancerous Conditions|precancerous conditions
554794|NCT01200017|Osteosclerosis|osteosclerosis
554795|NCT01200017|Osteochondrodysplasias|osteochondrodysplasias
554796|NCT01200017|Bone Diseases, Developmental|bone diseases, developmental
554797|NCT01200017|Bone Diseases|bone diseases
554798|NCT01200017|Musculoskeletal Diseases|musculoskeletal diseases
554799|NCT01200017|Severe acquired and congenital cytopenias|severe acquired and congenital cytopenias
704666|NCT00613054|ZD6474|zd6474
554800|NCT01200017|White and red blood cell abnormalities|white and red blood cell abnormalities
554801|NCT01200004|Advanced solid tumor|advanced solid tumor
554802|NCT01200004|Azacitidine|azacitidine
554803|NCT01200004|Grifola frondosa|grifola frondosa
554804|NCT01200004|Basidiomycete fungus|basidiomycete fungus
554805|NCT01200004|Lenalidomide|lenalidomide
554806|NCT01199978|radiation|radiation
554807|NCT01199978|fractionated proton radiation|fractionated proton radiation
554808|NCT01199952|contraception|contraception
554809|NCT01199939|Human Immunodeficiency Virus|human immunodeficiency virus
554811|NCT01199939|Etravirine|etravirine
554812|NCT01199939|Darunavir|darunavir
554813|NCT01199939|Prezista|prezista
554814|NCT01199939|Intelence|intelence
554815|NCT01199939|Ritonavir|ritonavir
554816|NCT01199939|INROADS|inroads
554817|NCT01199926|25-hydroxyvitamin D|25-hydroxyvitamin d
554818|NCT01199926|Parathyroid hormone|parathyroid hormone
554819|NCT01199926|Lean mass|lean mass
554820|NCT01199926|Muscular strength|muscular strength
554821|NCT01199926|Glucose tolerance|glucose tolerance
554822|NCT01199913|problems with thinking after surgery;|problems with thinking after surgery;
554823|NCT01199900|Healthy People|healthy people
554824|NCT01199900|Glucocorticoids|glucocorticoids
554825|NCT01199900|Prednisone|prednisone
554826|NCT01199887|safety, biologic effects, IPF, autoimmune|safety, biologic effects, ipf, autoimmune
554827|NCT01199874|Rotavirus|rotavirus
554828|NCT01199874|Rotavirus vaccine|rotavirus vaccine
554829|NCT01199874|Dosing schedule|dosing schedule
554830|NCT01199874|Immunogenicity|immunogenicity
554831|NCT01199874|Breast feeding|breast feeding
554832|NCT01199874|Pakistan|pakistan
554833|NCT01199861|Relapsing multiple sclerosis|relapsing multiple sclerosis
554834|NCT01199861|MS|ms
554835|NCT01199861|Immune response|immune response
554836|NCT01199848|nutrition|nutrition
554837|NCT01199848|polyphenolic|polyphenolic
554838|NCT01199848|strawberry|strawberry
554839|NCT01199848|insulin resistance|insulin resistance
554840|NCT01199848|metabolic syndrome|metabolic syndrome
554841|NCT01199835|obesity|obesity
554842|NCT01199835|metabolic syndrome|metabolic syndrome
554843|NCT01199835|fecal fat excretion|fecal fat excretion
554844|NCT01199835|fecal calcium|fecal calcium
554845|NCT01199835|weight loss|weight loss
554846|NCT01199835|appetite regulation|appetite regulation
554847|NCT01199835|intestinal micro flora|intestinal micro flora
554848|NCT01199835|lipid profile|lipid profile
554849|NCT01199835|energy balance|energy balance
554850|NCT01199783|Diabetic Foot,MRSA,|diabetic foot,mrsa,
554851|NCT01199783|Complicated skin and skin structure infections|complicated skin and skin structure infections
554852|NCT01199783|Antimicrobial therapy|antimicrobial therapy
554853|NCT01199783|Daptomycin|daptomycin
554854|NCT01199770|pasta|pasta
554855|NCT01199770|appetite|appetite
554856|NCT01199770|hunger|hunger
554857|NCT01199770|satiety|satiety
554858|NCT01199770|nutrition|nutrition
554859|NCT01199770|metabolic|metabolic
554860|NCT01199770|gut peptide hormones|gut peptide hormones
554861|NCT01199770|psychological phenomena and processes|psychological phenomena and processes
554862|NCT01199757|ocular symptoms|ocular symptoms
554863|NCT01199757|nasal symptoms|nasal symptoms
554864|NCT01199757|Allergic Rhinitis|allergic rhinitis
554865|NCT01199757|Symptom Free Days|symptom free days
554866|NCT01199757|Quality of Life|quality of life
554867|NCT01199744|Influenza|influenza
554868|NCT01199744|Relenza®|relenza®
554869|NCT01199744|SSMP|ssmp
554870|NCT01199731|raltegravir|raltegravir
554871|NCT01199731|NNRTI|nnrti
554872|NCT01199731|ritonavir|ritonavir
554873|NCT01199731|darunavir|darunavir
554874|NCT01199731|HIV|hiv
554875|NCT01199731|GSK2248761|gsk2248761
554876|NCT01199731|antiretroviral|antiretroviral
554877|NCT01199731|HIV Infection|hiv infection
554878|NCT01199731|HAART|haart
554879|NCT01199718|Multiple myeloma|multiple myeloma
554880|NCT01199718|Plasmacytoma|plasmacytoma
554881|NCT01199705|Immune globulin subcutaneous|immune globulin subcutaneous
554882|NCT01199705|SCIG|scig
554883|NCT01199705|Primary immunodeficiency|primary immunodeficiency
554884|NCT01199705|PID|pid
554885|NCT01199679|Gastroesophageal Reflux Disease|gastroesophageal reflux disease
554886|NCT01199679|Heartburn|heartburn
554887|NCT01199679|Regurgitation|regurgitation
554888|NCT01199679|Dyspepsia|dyspepsia
554889|NCT01199666|Underimmunization, text message, vaccination|underimmunization, text message, vaccination
554890|NCT01199666|Underimmunization|underimmunization
554891|NCT01199653|clavicle fractures|clavicle fractures
554892|NCT01199653|midshaft|midshaft
554893|NCT01199653|dislocated|dislocated
554894|NCT01199653|operative treatment|operative treatment
554895|NCT01199653|conservative treatment|conservative treatment
554896|NCT01199653|non-operative treatment|non-operative treatment
554897|NCT01199653|randomized controlled trial|randomized controlled trial
554898|NCT01199653|bone plates|bone plates
554899|NCT01199627|total hip replacement|total hip replacement
554900|NCT01199627|tranexamic acid|tranexamic acid
554901|NCT01199614|Hypoparathyroidism|hypoparathyroidism
554902|NCT01199614|Hypopara|hypopara
554903|NCT01199614|HPTH|hpth
554904|NCT01199614|Hypocalcemia|hypocalcemia
554905|NCT01199614|Hypercalciuria|hypercalciuria
554906|NCT01199614|PTH|pth
554907|NCT01199614|PTH(1-84)|pth(1-84)
554908|NCT01199588|VLU|vlu
554909|NCT01199588|Venous Leg Ulcers|venous leg ulcers
554910|NCT01199588|Ulcers|ulcers
554911|NCT01199588|chronic wounds|chronic wounds
554912|NCT01199588|wounds|wounds
554913|NCT01199588|Nexagon|nexagon
554914|NCT01199588|CoDa|coda
554915|NCT01199575|Chronic Lymphocytic Leukemia|chronic lymphocytic leukemia
554916|NCT01199575|CLL|cll
554917|NCT01199575|Relapsed or Refractory|relapsed or refractory
554918|NCT01199575|previously treated|previously treated
554919|NCT01199536|Helicobacter-positive duodenal ulcer|helicobacter-positive duodenal ulcer
554920|NCT01199523|YM178|ym178
554921|NCT01199523|Mirabegron|mirabegron
554922|NCT01199523|QT|qt
554923|NCT01199497|cough, acute rhinitis, nasal congestion, common cold, nasal symptoms, children.|cough, acute rhinitis, nasal congestion, common cold, nasal symptoms, children.
554924|NCT01199497|Nasal congestion and non-productive cough, with or without associate other nasal and extranasal symptoms.|nasal congestion and non-productive cough, with or without associate other nasal and extranasal symptoms.
554925|NCT01199484|Cow's milk allergy|cow's milk allergy
554926|NCT01199484|food allergy|food allergy
554927|NCT01199484|oral desensitization|oral desensitization
554928|NCT01199484|randomized trial|randomized trial
554929|NCT01199484|specific oral tolerance induction.|specific oral tolerance induction.
554930|NCT01199471|Sevoflurane|sevoflurane
554931|NCT01199471|Physician's Practice Patterns|physician's practice patterns
554932|NCT01199471|Economics, Pharmaceutical|economics, pharmaceutical
554933|NCT01199471|Chinese|chinese
554934|NCT01199458|Lower Esophageal Sphincter|lower esophageal sphincter
554935|NCT01199458|Barrier pressure|barrier pressure
554936|NCT01199445|vitamin A deficiency|vitamin a deficiency
554937|NCT01199432|Primary Breast Cancer|primary breast cancer
554938|NCT01199419|multivessel coronary artery disease|multivessel coronary artery disease
554939|NCT01199419|drug-eluting stent|drug-eluting stent
554940|NCT01199419|CABG|cabg
554941|NCT01199419|cost-effectiveness|cost-effectiveness
554942|NCT01199406|gallstone|gallstone
554943|NCT01199406|gallbladder|gallbladder
554944|NCT01199406|cholecystectomy|cholecystectomy
554945|NCT01199406|laparoscopic|laparoscopic
554946|NCT01199406|pain|pain
554947|NCT01199393|breast neoplasm|breast neoplasm
554948|NCT01199393|drug therapy|drug therapy
554949|NCT01199393|polymorphism|polymorphism
554950|NCT01199393|gene|gene
554951|NCT01199380|Smoking, Smoking Cessation|smoking, smoking cessation
554952|NCT01199367|advanced or metastatic breast cancer|advanced or metastatic breast cancer
554953|NCT01199354|Invasive breast carcinoma|invasive breast carcinoma
554954|NCT01199341|Phase 1|phase 1
554955|NCT01199341|Drug-Drug interaction|drug-drug interaction
554956|NCT01199341|warfarin|warfarin
554957|NCT01199341|AZD1981|azd1981
554958|NCT01199328|Nexium|nexium
554959|NCT01199328|aspirin|aspirin
554960|NCT01199328|peptic ulcers|peptic ulcers
554961|NCT01199328|pharmacodynamic (PD)|pharmacodynamic (pd)
554962|NCT01199328|Esomoeprazole|esomoeprazole
554963|NCT01199315|safety|safety
554964|NCT01199315|tolerability|tolerability
554965|NCT01199315|AZD1446|azd1446
554966|NCT01199315|AD|ad
554967|NCT01199315|ADHD|adhd
554968|NCT01199315|Japanese|japanese
554969|NCT01199302|Amgen|amgen
554970|NCT01199302|Crohn's|crohn's
554971|NCT01199302|Inflammatory Bowel Disease|inflammatory bowel disease
554972|NCT01199302|IBD|ibd
554973|NCT01199302|Irritable Bowel Syndrome|irritable bowel syndrome
554974|NCT01199302|IBS|ibs
554975|NCT01199302|Inflammation|inflammation
554976|NCT01199302|bowel|bowel
554977|NCT01199302|colon|colon
554978|NCT01199302|gastrointestinal|gastrointestinal
554979|NCT01199289|Amgen|amgen
554980|NCT01199289|chronic inflammatory disease|chronic inflammatory disease
554981|NCT01199289|wheezing|wheezing
554982|NCT01199276|Delirium|delirium
554983|NCT01199276|Hip Fracture|hip fracture
554984|NCT01199276|Elderly|elderly
554985|NCT01199237|Reflex, Pharyngeal|reflex, pharyngeal
554986|NCT01199237|Anesthetics, Inhalation|anesthetics, inhalation
554987|NCT01199224|Solid Tumors|solid tumors
554988|NCT01199224|veliparib|veliparib
554989|NCT01199224|refractory|refractory
554990|NCT01199224|relapsed|relapsed
554991|NCT01199211|hypertrophy, exercise, HDL, lipids, cholesterol|hypertrophy, exercise, hdl, lipids, cholesterol
554992|NCT01199198|Hyponatremia|hyponatremia
554993|NCT01199198|Serum sodium|serum sodium
554994|NCT01199198|Tolvaptan|tolvaptan
554995|NCT01199198|Placebo|placebo
554996|NCT01199172|Student teachers with normal or mildly disordered voices|student teachers with normal or mildly disordered voices
554997|NCT01199159|misoprostol|misoprostol
554998|NCT01199159|hysterectomy|hysterectomy
554999|NCT01199159|operative blood loss|operative blood loss
555000|NCT01199159|total abdominal hysterectomy|total abdominal hysterectomy
555001|NCT01199146|Abiraterone acetate|abiraterone acetate
555002|NCT01199120|Omega-3|omega-3
555003|NCT01199120|Cognition|cognition
555004|NCT01199120|Malnourishment|malnourishment
555005|NCT01199107|PTSD|ptsd
555006|NCT01199107|Anxiety|anxiety
555007|NCT01199107|Behavior Therapy|behavior therapy
555008|NCT01199107|Prolonged Exposure|prolonged exposure
555009|NCT01199107|Exercise|exercise
555010|NCT01199107|Wellness|wellness
555011|NCT01199107|Posttraumatic|posttraumatic
555012|NCT01199107|Stress|stress
555013|NCT01199094|low density lipoprotein receptor 5|low density lipoprotein receptor 5
555014|NCT01199094|high bone mass|high bone mass
555015|NCT01199094|autosomal dominant osteopetrosis type I|autosomal dominant osteopetrosis type i
555016|NCT01199094|bone turnover markers|bone turnover markers
555017|NCT01199068|PPAR gamma agonist|ppar gamma agonist
555018|NCT01199068|Tumor|tumor
555019|NCT01199068|Cancer|cancer
555020|NCT01199068|Antineoplastic Agent|antineoplastic agent
555021|NCT01199068|Respiratory Tract Neoplasms|respiratory tract neoplasms
555022|NCT01199068|Erlotinib|erlotinib
555023|NCT01199068|Protein Kinase Inhibitors|protein kinase inhibitors
555024|NCT01199068|Neoplasms|neoplasms
555025|NCT01199055|PPAR gamma agonist|ppar gamma agonist
555026|NCT01199055|Tumor|tumor
555027|NCT01199055|Cancer|cancer
555028|NCT01199055|Antineoplastic Agent|antineoplastic agent
555029|NCT01199055|Respiratory Tract Neoplasms|respiratory tract neoplasms
555030|NCT01199055|Carboplatin|carboplatin
555031|NCT01199055|Paclitaxel|paclitaxel
555032|NCT01199055|Neoplasms|neoplasms
555033|NCT01199029|Healthy People|healthy people
555034|NCT01199029|Glucocorticoids|glucocorticoids
555035|NCT01199029|Prednisone|prednisone
555036|NCT01199016|Acute otitis media|acute otitis media
555037|NCT01199016|Prevnar 13|prevnar 13
555038|NCT01199016|Streptococcus pneumoniae|streptococcus pneumoniae
555039|NCT01199016|nasopharyngeal colonization.|nasopharyngeal colonization.
555040|NCT01198977|multiple sclerosis|multiple sclerosis
555041|NCT01198977|Fatigue|fatigue
555042|NCT01198977|exercise|exercise
555043|NCT01198977|telemedicine|telemedicine
555044|NCT01198977|motivational interviewing|motivational interviewing
555045|NCT01198977|counseling|counseling
555046|NCT01198977|depression|depression
555047|NCT01198977|physical activity|physical activity
555048|NCT01198964|ECoG|ecog
555049|NCT01198964|Epilepsy|epilepsy
555050|NCT01198964|cortical|cortical
555051|NCT01198964|stimulation|stimulation
555052|NCT01198964|Electrocorticography|electrocorticography
555053|NCT01198964|electrodes|electrodes
555054|NCT01198964|mapping|mapping
555055|NCT01198938|Cardiac surgery, delirium, melatonin|cardiac surgery, delirium, melatonin
555056|NCT01198925|Infectious disease|infectious disease
555057|NCT01198925|piperacillin|piperacillin
555058|NCT01198925|continuous infusion|continuous infusion
555059|NCT01198925|extended infusion|extended infusion
555060|NCT01198912|rhinosinusitis|rhinosinusitis
555061|NCT01198912|doxycycline|doxycycline
555062|NCT01198912|Chronic rhinosinusitis with or without nasal polyps|chronic rhinosinusitis with or without nasal polyps
555063|NCT01198899|Fabry-Anderson disease|fabry-anderson disease
555064|NCT01198899|gen mutation|gen mutation
555065|NCT01198899|left ventricular hypertrophy|left ventricular hypertrophy
555066|NCT01198886|Mobility disability|mobility disability
555067|NCT01198886|Older adults|older adults
555068|NCT01198886|Physical activity|physical activity
555069|NCT01198886|Nutritional status|nutritional status
555070|NCT01198860|HBsAg|hbsag
555071|NCT01198847|child overweight|child overweight
555072|NCT01198847|child obesity|child obesity
555073|NCT01198847|prevention|prevention
555074|NCT01198847|targeted intervention|targeted intervention
555075|NCT01198847|development of overweight|development of overweight
555076|NCT01198834|ankle sprains|ankle sprains
555077|NCT01198821|pancreas|pancreas
555078|NCT01198821|adenocarcinoma|adenocarcinoma
555079|NCT01198821|metastatic|metastatic
555080|NCT01198821|unresectable|unresectable
555081|NCT01198808|Bladder cancer|bladder cancer
555082|NCT01198808|chemotherapy|chemotherapy
555083|NCT01198808|T cells|t cells
555084|NCT01198808|Immunotherapy|immunotherapy
555085|NCT01198808|Tumor-specific immunity in bladder cancer|tumor-specific immunity in bladder cancer
555086|NCT01198795|depression|depression
555087|NCT01198795|major depressive disorder|major depressive disorder
555088|NCT01198795|escitalopram|escitalopram
555089|NCT01198795|Lexapro|lexapro
555090|NCT01198795|pediatric|pediatric
555091|NCT01198769|Human rotavirus vaccine|human rotavirus vaccine
555092|NCT01198756|Influenza|influenza
555093|NCT01198743|Genetics modifications|genetics modifications
555094|NCT01198743|colorectal cancer|colorectal cancer
555095|NCT01198743|prognosis aim|prognosis aim
555096|NCT01198743|DNA|dna
555097|NCT01198743|Plasma|plasma
555098|NCT01198730|DM|dm
555099|NCT01198730|CAD|cad
555100|NCT01198730|Meal tolerance test|meal tolerance test
555101|NCT01198730|Acarbose|acarbose
555102|NCT01198704|Hepatocellular carcinoma|hepatocellular carcinoma
555103|NCT01198704|Cirrhosis|cirrhosis
555104|NCT01198704|Transplantation|transplantation
555105|NCT01198691|metallic staples|metallic staples
555106|NCT01198691|absorbable staples|absorbable staples
555107|NCT01198691|Cesarean Delivery|cesarean delivery
555108|NCT01198665|RAD001|rad001
555109|NCT01198665|chemotherpy|chemotherpy
555110|NCT01198665|T cell lymphoma|t cell lymphoma
555111|NCT01198626|community-acquired bacterial pneumonia|community-acquired bacterial pneumonia
555112|NCT01198626|CABP|cabp
555113|NCT01198626|CAP|cap
555114|NCT01198626|pneumonia|pneumonia
555115|NCT01198626|pneumonia, bacterial|pneumonia, bacterial
555116|NCT01198626|bacterial infections|bacterial infections
555117|NCT01198626|anti-bacterial agents|anti-bacterial agents
555118|NCT01198626|anti-infective agents|anti-infective agents
555119|NCT01198626|lung disease, interstitial|lung disease, interstitial
555120|NCT01198626|respiratory tract diseases|respiratory tract diseases
555121|NCT01198626|respiratory tract infections|respiratory tract infections
555122|NCT01198626|community-acquired infections|community-acquired infections
555123|NCT01198613|Ragweed allergy|ragweed allergy
555124|NCT01198613|Rhinoconjunctivitis|rhinoconjunctivitis
555125|NCT01198613|Exposure chamber|exposure chamber
555126|NCT01198613|Immunotherapy|immunotherapy
555127|NCT01198613|ToleroMune Ragweed|toleromune ragweed
555128|NCT01198587|Diarrhea|diarrhea
555129|NCT01198587|Gastroenteritis|gastroenteritis
555130|NCT01198587|Zinc Supplementation|zinc supplementation
555131|NCT01198574|anemia|anemia
555132|NCT01198574|iron supplementation|iron supplementation
555133|NCT01198574|sub-clinical inflammation|sub-clinical inflammation
555134|NCT01198574|adolescents|adolescents
555135|NCT01198561|repetitive Transcranial Magnetic Stimulation|repetitive transcranial magnetic stimulation
555136|NCT01198561|Major Depressive Disorder|major depressive disorder
555137|NCT01198522|Interleukin, IL2, Gemcitabine, monoclonal, antibody, cytokine, tumour targeting, dose finding, fusion protein, Pancreatic cancer,|interleukin, il2, gemcitabine, monoclonal, antibody, cytokine, tumour targeting, dose finding, fusion protein, pancreatic cancer,
555138|NCT01198522|L19|l19
555139|NCT01198509|rheumatoid arthritis|rheumatoid arthritis
555140|NCT01198509|psoriatic arthritis|psoriatic arthritis
555141|NCT01198509|periodontitis|periodontitis
555142|NCT01198509|microbiota|microbiota
555143|NCT01198509|microbiome|microbiome
555144|NCT01198509|vancomycin|vancomycin
555145|NCT01198509|doxycycline|doxycycline
555146|NCT01198509|T cell|t cell
555147|NCT01198509|Th17|th17
555148|NCT01198496|hypertension|hypertension
555149|NCT01198496|stroke|stroke
555150|NCT01198496|blood pressure|blood pressure
555151|NCT01198483|refraction|refraction
555152|NCT01198483|refractive error|refractive error
555153|NCT01198483|combined surgery|combined surgery
555154|NCT01198483|microincision|microincision
555155|NCT01198483|smallincision|smallincision
555156|NCT01198483|cataract surgery|cataract surgery
555157|NCT01198483|vitrectomy|vitrectomy
555158|NCT01198470|Low back pain|low back pain
555159|NCT01198470|Leg pain|leg pain
555160|NCT01198470|Discogenic pain|discogenic pain
555161|NCT01198470|Degenerative Disc Disease (DDD)|degenerative disc disease (ddd)
555162|NCT01198470|Herniated disc|herniated disc
555163|NCT01198470|Radiculopathy|radiculopathy
555164|NCT01198457|Clodronate|clodronate
555165|NCT01198457|Compliance|compliance
555166|NCT01198444|Contraception|contraception
555167|NCT01198444|Compliance|compliance
555168|NCT01198431|Appetite regulation|appetite regulation
555169|NCT01198431|Physical activity|physical activity
555170|NCT01198431|Energy balance|energy balance
555171|NCT01198418|STI|sti
555172|NCT01198418|MSM|msm
555173|NCT01198418|HIV|hiv
555174|NCT01198418|Prevention|prevention
555175|NCT01198418|Men having sex with men|men having sex with men
555176|NCT01198405|coronary artery disease|coronary artery disease
555177|NCT01198405|enhanced external counterpulsation|enhanced external counterpulsation
555178|NCT01198392|gastric cancer|gastric cancer
555179|NCT01198379|aspirin|aspirin
555180|NCT01198379|aspirin resistance|aspirin resistance
555181|NCT01198379|hemodialysis|hemodialysis
555182|NCT01198379|cardiovascular|cardiovascular
555287|NCT01197781|verapamil|verapamil
555288|NCT01197781|healthy volunteers|healthy volunteers
555183|NCT01198379|Prevalence of aspirin resistance, cardiovascular events, and safety profile|prevalence of aspirin resistance, cardiovascular events, and safety profile
555184|NCT01198366|Tuberculosis|tuberculosis
555185|NCT01198366|Vaccine|vaccine
555186|NCT01198366|Immunogenicity|immunogenicity
555187|NCT01198366|Prevention of Tuberculosis|prevention of tuberculosis
555188|NCT01198353|Schizophrenia|schizophrenia
555189|NCT01198353|Schizoaffective Disorder|schizoaffective disorder
555190|NCT01198353|Ziprasidone|ziprasidone
555191|NCT01198353|Switch|switch
555192|NCT01198353|Metabolic syndrome|metabolic syndrome
555193|NCT01198327|RVO|rvo
555194|NCT01198327|CRVO|crvo
555195|NCT01198327|BRVO|brvo
555196|NCT01198327|Horizon|horizon
555197|NCT01198327|Bravo|bravo
555198|NCT01198327|Cruise|cruise
555199|NCT01198314|long term|long term
555200|NCT01198314|stable|stable
555201|NCT01198314|recipients|recipients
555202|NCT01198301|Metastatic Breast Neoplasms|metastatic breast neoplasms
555203|NCT01198301|Gene Expression Profiling|gene expression profiling
555204|NCT01198301|Drug Therapy|drug therapy
555205|NCT01198288|COPD|copd
555206|NCT01198288|Respiratory Physiotherapy|respiratory physiotherapy
555207|NCT01198275|PUFA atrial fibrillation|pufa atrial fibrillation
555208|NCT01198262|polymerase chain reaction|polymerase chain reaction
555209|NCT01198236|hematological malignancy|hematological malignancy
555210|NCT01198236|previous proven or probable invasive fungal infection|previous proven or probable invasive fungal infection
555211|NCT01198223|denture stomatitis|denture stomatitis
555212|NCT01198223|nystatin|nystatin
555213|NCT01198223|garlic|garlic
555214|NCT01198210|pain|pain
555215|NCT01198210|tonsillectomy|tonsillectomy
555216|NCT01198210|peritonsillar infiltration|peritonsillar infiltration
555217|NCT01198210|postoperative pain|postoperative pain
555218|NCT01198197|Nociceptin/Orphanin FQ Peptide (NOP)|nociceptin/orphanin fq peptide (nop)
555219|NCT01198197|PET Imaging|pet imaging
555220|NCT01198197|Brain Imaging|brain imaging
555221|NCT01198197|Healthy Volunteer|healthy volunteer
555222|NCT01198197|HV|hv
555223|NCT01198145|diarrhea|diarrhea
555224|NCT01198145|gastrointestinal complications|gastrointestinal complications
555225|NCT01198145|unspecified adult solid tumor, protocol specific|unspecified adult solid tumor, protocol specific
555226|NCT01198132|Multiple Sclerosis Relapsing-Remitting|multiple sclerosis relapsing-remitting
555227|NCT01198132|Relapsing Multiple Sclerosis (RMS)|relapsing multiple sclerosis (rms)
555228|NCT01198132|Rebif|rebif
555229|NCT01198132|Vitamin D3|vitamin d3
555230|NCT01198132|Cholecalciferol|cholecalciferol
555231|NCT01198119|oral cavity tumor|oral cavity tumor
555232|NCT01198119|narrow band imaging|narrow band imaging
555233|NCT01198119|subclinical cancer lesion|subclinical cancer lesion
555234|NCT01198106|simulator sickness|simulator sickness
555235|NCT01198106|scopolamine|scopolamine
555236|NCT01198106|cinnarizine|cinnarizine
555237|NCT01198093|Alzheimer's disease|alzheimer's disease
555238|NCT01198093|Mild Cognitive Impairment|mild cognitive impairment
555239|NCT01198093|cohort study|cohort study
555240|NCT01198080|Avascular osteonecrosis,CD133+,core decompression|avascular osteonecrosis,cd133+,core decompression
555241|NCT01198054|AML|aml
555242|NCT01198054|Lenalidomide|lenalidomide
555243|NCT01198015|Rett syndrome|rett syndrome
555244|NCT01198015|Nutritional status|nutritional status
555245|NCT01198015|Creatine metabolism|creatine metabolism
555246|NCT01198002|Rheumatoid Arthritis|rheumatoid arthritis
555247|NCT01197989|pustulosis|pustulosis
555248|NCT01197989|soles|soles
555249|NCT01197989|teflon|teflon
555250|NCT01197976|psoriasis|psoriasis
555251|NCT01197976|soles|soles
555252|NCT01197976|teflon|teflon
555253|NCT01197963|Type 2 diabetes mellitus|type 2 diabetes mellitus
555254|NCT01197950|acupuncture|acupuncture
555255|NCT01197950|labour|labour
555256|NCT01197950|pain|pain
555257|NCT01197950|pain relief|pain relief
555258|NCT01197950|complementary|complementary
555259|NCT01197924|child cancer brain|child cancer brain
555260|NCT01197898|Diabetic|diabetic
555261|NCT01197898|Foot|foot
555262|NCT01197898|Ulcers|ulcers
555263|NCT01197898|Wounds|wounds
555264|NCT01197833|varicose veins|varicose veins
555265|NCT01197833|Great saphenous vein|great saphenous vein
555266|NCT01197833|varicosities|varicosities
555267|NCT01197820|HIFU|hifu
555268|NCT01197820|mobile organs|mobile organs
555269|NCT01197820|thermometry|thermometry
555270|NCT01197820|MR|mr
555271|NCT01197820|liver|liver
555272|NCT01197820|kidney|kidney
555273|NCT01197820|cancer|cancer
555274|NCT01197820|Liver tumors, kidney carcinoma|liver tumors, kidney carcinoma
555275|NCT01197807|Suctioning|suctioning
555276|NCT01197807|Wiping|wiping
555277|NCT01197807|Neonate|neonate
555278|NCT01197807|Resuscitation|resuscitation
555279|NCT01197794|Efficacy|efficacy
555280|NCT01197794|safety|safety
555281|NCT01197794|tolerability|tolerability
555282|NCT01197794|dose finding|dose finding
555283|NCT01197794|asthma patients|asthma patients
555284|NCT01197781|Phase I|phase i
555285|NCT01197781|FosD|fosd
555286|NCT01197781|fostamatinib disodium|fostamatinib disodium
555289|NCT01197755|Rheumatoid Arthritis|rheumatoid arthritis
555290|NCT01197742|Diabetes|diabetes
555291|NCT01197742|STEMI|stemi
555292|NCT01197742|NSTEMI|nstemi
555293|NCT01197742|Myocardial infarction|myocardial infarction
555294|NCT01197729|Myocardial infarction|myocardial infarction
555295|NCT01197729|ST-Elevation myocardial infarction|st-elevation myocardial infarction
555296|NCT01197729|Non-ST-Elevation myocardial infarction|non-st-elevation myocardial infarction
555297|NCT01197729|Register|register
555298|NCT01197729|CARDS|cards
555299|NCT01197716|Chest Pain Unit|chest pain unit
555300|NCT01197716|Myocardial infarction|myocardial infarction
555301|NCT01197716|Register|register
555302|NCT01197716|Admission to a Chest Pain Unit for any reason|admission to a chest pain unit for any reason
555303|NCT01197703|Clinical Practice Cardiac CT|clinical practice cardiac ct
705236|NCT00611325|GBM|gbm
555304|NCT01197703|Clinical Implications Coronary CT Angiography|clinical implications coronary ct angiography
555305|NCT01197703|Radiation Exposure of Coronary CT Angiography|radiation exposure of coronary ct angiography
555306|NCT01197703|Registry|registry
555307|NCT01197690|Bronchial asthma|bronchial asthma
555308|NCT01197690|level of control of asthma|level of control of asthma
555309|NCT01197690|fractional exhaled nitric oxide (FeNO)|fractional exhaled nitric oxide (feno)
555310|NCT01197690|asthma control test (ACT)|asthma control test (act)
555311|NCT01197677|CMR|cmr
555312|NCT01197677|Register|register
555313|NCT01197677|CAD|cad
555314|NCT01197677|myocard scarring|myocard scarring
555315|NCT01197651|Aorta|aorta
555316|NCT01197651|Aorta-Stent-Graft|aorta-stent-graft
555317|NCT01197651|Surgical operation|surgical operation
555318|NCT01197651|Aortic dissection|aortic dissection
555319|NCT01197638|Cardiac arrhythmia|cardiac arrhythmia
555320|NCT01197638|Catheter ablation|catheter ablation
555321|NCT01197638|Register|register
555322|NCT01197625|Vaccination treatment, dendritic cells|vaccination treatment, dendritic cells
555323|NCT01197599|Healthy Control|healthy control
555324|NCT01197586|surfactant protein B|surfactant protein b
555325|NCT01197586|differential diagnostics|differential diagnostics
555326|NCT01197560|Diffuse Large B-Cell Lymphoma|diffuse large b-cell lymphoma
555327|NCT01197560|Non Hodgkin's Lymphoma|non hodgkin's lymphoma
555328|NCT01197560|relapsed|relapsed
555329|NCT01197560|refractory|refractory
555330|NCT01197560|relapsed/refractory|relapsed/refractory
555331|NCT01197560|DLBCL|dlbcl
555332|NCT01197560|Diffuse Large B Cell Lymphoma|diffuse large b cell lymphoma
555333|NCT01197547|Menorrhagia|menorrhagia
555334|NCT01197534|Rheumatoid Arthritis|rheumatoid arthritis
555335|NCT01197521|Rheumatoid Arthritis|rheumatoid arthritis
555336|NCT01197508|Major Depressive Disorder, MDD, Depression|major depressive disorder, mdd, depression
555337|NCT01197482|asthma|asthma
555338|NCT01197482|inhalation|inhalation
555339|NCT01197469|Secondary Pulmonary Hypertension|secondary pulmonary hypertension
555340|NCT01197456|Breast cancer|breast cancer
555341|NCT01197456|Ovarian insufficiency|ovarian insufficiency
555342|NCT01197456|Ovarian failure|ovarian failure
555343|NCT01197456|Reproduction|reproduction
555344|NCT01197443|obesity|obesity
555345|NCT01197443|overweight|overweight
555346|NCT01197443|overweight children|overweight children
555347|NCT01197443|overweight parents|overweight parents
555348|NCT01197443|families with overweight child|families with overweight child
555349|NCT01197443|body mass index|body mass index
555350|NCT01197443|BMI|bmi
555351|NCT01197443|weight|weight
555352|NCT01197443|childhood obesity|childhood obesity
555353|NCT01197443|diet|diet
555354|NCT01197443|treatment|treatment
555355|NCT01197443|parent modeling|parent modeling
555356|NCT01197443|traffic light diet|traffic light diet
555357|NCT01197443|stop light diet|stop light diet
555358|NCT01197430|volleyball|volleyball
555359|NCT01197430|neck vertical stability training|neck vertical stability training
555360|NCT01197430|eye-hand coordination|eye-hand coordination
555361|NCT01197417|Sickle Cell Disease|sickle cell disease
555362|NCT01197417|Magnesium Sulfate|magnesium sulfate
555363|NCT01197417|Pediatric|pediatric
555364|NCT01197404|HIV Prevention|hiv prevention
555365|NCT01197378|cystinosis|cystinosis
555366|NCT01197378|cysteamine|cysteamine
555367|NCT01197378|inheritable disease|inheritable disease
555368|NCT01197378|orphan disease|orphan disease
555369|NCT01197378|CTNS protein, human|ctns protein, human
555370|NCT01197378|metabolic disease|metabolic disease
555371|NCT01197378|nephropathic cystinosis|nephropathic cystinosis
555372|NCT01197365|Acidified milk|acidified milk
555373|NCT01197365|Beta-palmitate|beta-palmitate
555374|NCT01197365|Bifidobacteria|bifidobacteria
555375|NCT01197365|Infant formula|infant formula
555376|NCT01197365|Galacto-oligosaccharides|galacto-oligosaccharides
555377|NCT01197365|Growth|growth
555378|NCT01197365|Infants|infants
555379|NCT01197365|Prebiotics|prebiotics
555380|NCT01197352|Alcohol|alcohol
555381|NCT01197352|Abuse|abuse
555382|NCT01197352|Drinking|drinking
555383|NCT01197352|Behavior|behavior
555384|NCT01197352|Text|text
555385|NCT01197352|Computer|computer
555386|NCT01197339|acute phonotrauma|acute phonotrauma
555387|NCT01197339|computer modeling|computer modeling
555388|NCT01197339|resonant voice|resonant voice
555389|NCT01197339|breathy voice|breathy voice
555390|NCT01197339|voice rest|voice rest
555391|NCT01197339|relaxation|relaxation
555392|NCT01197326|patient deterioration|patient deterioration
555393|NCT01197326|unplanned ICU admissions|unplanned icu admissions
555394|NCT01197326|rapid response teams|rapid response teams
555395|NCT01197313|chronic heart failure (CHF); anxiety and depression; quality of life (QOL); exercise|chronic heart failure (chf); anxiety and depression; quality of life (qol); exercise
710261|NCT00589563|stage I cutaneous T-cell non-Hodgkin lymphoma|stage i cutaneous t-cell non-hodgkin lymphoma
710262|NCT00589563|stage II adult Hodgkin lymphoma|stage ii adult hodgkin lymphoma
555396|NCT01197300|Osteoporosis, children and adolescents, zoledronic acid, chronic inflammation, Duchenne muscular dystrophy, glucocorticoids, chronic inflammatory conditions|osteoporosis, children and adolescents, zoledronic acid, chronic inflammation, duchenne muscular dystrophy, glucocorticoids, chronic inflammatory conditions
555397|NCT01197287|Chronic obstructive pulmonary disease|chronic obstructive pulmonary disease
555398|NCT01197274|allergy|allergy
555399|NCT01197274|skin prick test|skin prick test
555400|NCT01197274|mite sensitivity|mite sensitivity
555401|NCT01197261|Severe pain|severe pain
555402|NCT01197261|Bladder Pain Syndrome|bladder pain syndrome
555403|NCT01197261|Interstitial Cystitis|interstitial cystitis
555404|NCT01197261|Painful Bladder Syndrome|painful bladder syndrome
555405|NCT01197261|Severe pain due to Bladder Pain Syndrome/Interstitial Cystitis/Painful Bladder Syndrome|severe pain due to bladder pain syndrome/interstitial cystitis/painful bladder syndrome
555406|NCT01197248|cystocele|cystocele
555407|NCT01197248|voiding|voiding
555408|NCT01197248|dysfunction|dysfunction
555409|NCT01197235|darbepoetin, chronic kidney disease, coronary angiography|darbepoetin, chronic kidney disease, coronary angiography
555410|NCT01197222|Laparoscopic|laparoscopic
555411|NCT01197222|EndoClear|endoclear
555412|NCT01197222|Lens Cleaning Device|lens cleaning device
555413|NCT01197209|Prostate Cancer|prostate cancer
555414|NCT01197209|Prostatectomy|prostatectomy
555415|NCT01197209|Postectomy|postectomy
555416|NCT01197209|Oncology|oncology
555417|NCT01197209|REIC|reic
555418|NCT01197209|Dikkoff|dikkoff
555419|NCT01197209|Apoptosis|apoptosis
555420|NCT01197196|Migraine|migraine
555421|NCT01197196|Obesity|obesity
555422|NCT01197196|Weight loss|weight loss
555423|NCT01197196|Lifestyle|lifestyle
555424|NCT01197196|Behavior|behavior
555425|NCT01197183|Hypothyroidism|hypothyroidism
555426|NCT01197183|Thyroid hormones|thyroid hormones
555427|NCT01197170|Hormonal therapies|hormonal therapies
555428|NCT01197170|Estrogen receptor|estrogen receptor
555429|NCT01197170|Progesterone receptor|progesterone receptor
555430|NCT01197170|Hormone blockade|hormone blockade
555431|NCT01197170|Hormone-positive tumors|hormone-positive tumors
555432|NCT01197170|Advanced cancer|advanced cancer
555433|NCT01197170|Metastatic cancer|metastatic cancer
555434|NCT01197170|Avastin|avastin
555435|NCT01197170|Anti-VEGF monoclonal antibody|anti-vegf monoclonal antibody
555436|NCT01197170|rhuMAB-VEGF|rhumab-vegf
555437|NCT01197170|Afinitor|afinitor
555438|NCT01197170|RAD001|rad001
555439|NCT01197170|Nexavar|nexavar
555440|NCT01197170|BAY43-9006|bay43-9006
555441|NCT01197170|OSI-774|osi-774
555442|NCT01197170|Tarceva|tarceva
555443|NCT01197157|chronic hepatitis C|chronic hepatitis c
555444|NCT01197157|genotype 4|genotype 4
555445|NCT01197157|treatment naive patients|treatment naive patients
555446|NCT01197157|Egypt|egypt
555447|NCT01197144|TNF|tnf
555448|NCT01197144|functional Magnetic Resonance Imaging|functional magnetic resonance imaging
555449|NCT01197144|Autonomic|autonomic
555450|NCT01197144|Vagus|vagus
555451|NCT01197144|adalimumab|adalimumab
555452|NCT01197131|autism|autism
555453|NCT01197131|autism spectrum disorder|autism spectrum disorder
555454|NCT01197131|steroids|steroids
555455|NCT01197131|steroid metabolites|steroid metabolites
555456|NCT01197131|urinary steroid metabolites|urinary steroid metabolites
555457|NCT01197131|hormone formation|hormone formation
555458|NCT01197131|androgen precursor|androgen precursor
555459|NCT01197118|gastric cancer|gastric cancer
555460|NCT01197118|sequence chemoradiotherapy|sequence chemoradiotherapy
555461|NCT01197118|OLF regimen|olf regimen
555462|NCT01197118|survival rate|survival rate
555463|NCT01197105|gingivitis|gingivitis
555464|NCT01197105|schinus terebinthifolius|schinus terebinthifolius
555465|NCT01197105|natural products|natural products
555466|NCT01197092|Diabetes|diabetes
555467|NCT01197079|HPV|hpv
555468|NCT01197079|Vaccine|vaccine
555469|NCT01197079|Vaccine utilization|vaccine utilization
555470|NCT01197079|Disease awareness|disease awareness
555471|NCT01197053|Peanut Allergy|peanut allergy
555472|NCT01197053|Food Allergy|food allergy
555473|NCT01197053|Epicutaneous Immunotherapy (EPIT)|epicutaneous immunotherapy (epit)
555474|NCT01197053|Food Challenge|food challenge
555475|NCT01197040|Minimal Change Nephrotic Syndrome|minimal change nephrotic syndrome
555476|NCT01197040|Complete remission|complete remission
555477|NCT01197040|Myfortic|myfortic
555478|NCT01197040|Minimal Change Disease|minimal change disease
555479|NCT01197014|Amlodipine, Losartan|amlodipine, losartan
555480|NCT01197001|Amlodipine, Losartan|amlodipine, losartan
555481|NCT01196988|GSK Biologicals influenza vaccine GSK2321138A|gsk biologicals influenza vaccine gsk2321138a
555482|NCT01196988|influenza infection|influenza infection
555483|NCT01196975|Influenza|influenza
555484|NCT01196962|central venous catheter|central venous catheter
555485|NCT01196962|complications|complications
555486|NCT01196962|internal jugular vein|internal jugular vein
555487|NCT01196962|randomized trial|randomized trial
555488|NCT01196962|subclavian vein|subclavian vein
555490|NCT01196949|Chronic|chronic
555491|NCT01196949|Instability|instability
555492|NCT01196949|Manipulative|manipulative
555493|NCT01196949|Rehabilitative|rehabilitative
555494|NCT01196949|Manipulation|manipulation
555495|NCT01196949|Rehabilitation|rehabilitation
555496|NCT01196936|Cancer survivors|cancer survivors
555497|NCT01196936|Low Dose Tamoxifen|low dose tamoxifen
555498|NCT01196936|Breast Cancer Risk Reduction|breast cancer risk reduction
555499|NCT01196897|Atrial fibrillation|atrial fibrillation
555500|NCT01196897|Stroke|stroke
555501|NCT01196897|Warfarin|warfarin
555502|NCT01196897|Coumadin|coumadin
555503|NCT01196897|TIA|tia
555504|NCT01196897|Trans Ischemic Attack|trans ischemic attack
555505|NCT01196884|Patients with primary Immune Thrombocytopenia (ITP)|patients with primary immune thrombocytopenia (itp)
555506|NCT01196871|Amicus Therapeutics|amicus therapeutics
555507|NCT01196871|AT1001|at1001
555508|NCT01196871|Galafold|galafold
555509|NCT01196871|Migalastat|migalastat
555510|NCT01196871|Pharmacokinetics|pharmacokinetics
555511|NCT01196845|adipose tissue|adipose tissue
555512|NCT01196845|obese patients|obese patients
555513|NCT01196845|inflammation|inflammation
555514|NCT01196845|oxidative stress|oxidative stress
555515|NCT01196845|sleep apnea syndrome|sleep apnea syndrome
555516|NCT01196806|Non-Invasive Blood Pressure(NIBP)|non-invasive blood pressure(nibp)
555517|NCT01196793|Feverish illness in children|feverish illness in children
555518|NCT01196767|Sternotomy|sternotomy
555519|NCT01196767|Pain|pain
555520|NCT01196767|Respiratory function|respiratory function
555521|NCT01196767|Opiates|opiates
555522|NCT01196767|Patient-controlled|patient-controlled
555523|NCT01196767|Scheduled cardiac surgery under general anaesthesia without any locoregional anaesthesia protocol other than this presently studied|scheduled cardiac surgery under general anaesthesia without any locoregional anaesthesia protocol other than this presently studied
555524|NCT01196754|Pharmacokinetics|pharmacokinetics
555525|NCT01196754|Sevoflurane|sevoflurane
555526|NCT01196754|Fluorides|fluorides
555527|NCT01196754|Sedation|sedation
555528|NCT01196754|Adult patients with a predicted sedation more than 48 h|adult patients with a predicted sedation more than 48 h
555529|NCT01196754|Stable respiratory and hemodynamic conditions for SBT|stable respiratory and hemodynamic conditions for sbt
555530|NCT01196754|Consent of patients|consent of patients
555531|NCT01196754|Arterial line|arterial line
555532|NCT01196715|Quality of Life|quality of life
555533|NCT01196715|Erythroid response|erythroid response
555534|NCT01196715|disease progression|disease progression
555535|NCT01196715|survival|survival
555536|NCT01196715|Overall erythroid response at 24 weeks|overall erythroid response at 24 weeks
555537|NCT01196715|Quality of life at 24 weeks|quality of life at 24 weeks
555538|NCT01196715|Quality of life at 12, 36 and 52 weeks|quality of life at 12, 36 and 52 weeks
555539|NCT01196715|Overall erythroid response at 12 and 52 weeks|overall erythroid response at 12 and 52 weeks
555540|NCT01196715|Incidence of disease progression|incidence of disease progression
555541|NCT01196715|Overall Survival|overall survival
555542|NCT01196702|common variable immunodeficiency|common variable immunodeficiency
555543|NCT01196702|granulomatous disease|granulomatous disease
555544|NCT01196702|crohns disease|crohns disease
555545|NCT01196702|bronchiectasis|bronchiectasis
555546|NCT01196702|immunoglobulin replacement or treatment|immunoglobulin replacement or treatment
555547|NCT01196702|B-cell immunophenotyping|b-cell immunophenotyping
555548|NCT01196689|Pharmacokinetics AZD1981|pharmacokinetics azd1981
555549|NCT01196689|Asthma|asthma
555550|NCT01196676|AZD4451|azd4451
555551|NCT01196676|Bipolar|bipolar
555552|NCT01196676|depression|depression
555553|NCT01196663|TMS|tms
555554|NCT01196637|thoracic outlet syndrome|thoracic outlet syndrome
555555|NCT01196637|brachial plexopathy|brachial plexopathy
555556|NCT01196637|ultrasonography|ultrasonography
555557|NCT01196624|PTSD|ptsd
555558|NCT01196624|FLASHBACKS|flashbacks
555559|NCT01196624|TMS|tms
555560|NCT01196624|EXPOSURE|exposure
555561|NCT01196611|Voice disorders|voice disorders
555562|NCT01196611|Voice|voice
555563|NCT01196598|pelvic floor|pelvic floor
555564|NCT01196598|pelvic organ prolapse|pelvic organ prolapse
555565|NCT01196585|Pleura|pleura
555566|NCT01196585|biopsy|biopsy
555567|NCT01196585|diagnosis|diagnosis
555568|NCT01196585|CT|ct
555569|NCT01196585|ultrasonography|ultrasonography
555570|NCT01196572|stricture|stricture
555571|NCT01196572|urethra|urethra
555572|NCT01196572|laser|laser
555573|NCT01196572|urethrotomy|urethrotomy
555574|NCT01196572|holmium|holmium
555575|NCT01196572|bladder outlet obstruction|bladder outlet obstruction
555576|NCT01196559|ovarian cancer|ovarian cancer
555577|NCT01196546|Type 2 Diabetes Mellitus|type 2 diabetes mellitus
555578|NCT01196546|vildagliptin|vildagliptin
555579|NCT01196546|metformin|metformin
555580|NCT01196520|Burkitt Lymphoma|burkitt lymphoma
555581|NCT01196520|Epstein-Barr Virus|epstein-barr virus
555582|NCT01196520|Malaria|malaria
555583|NCT01196494|Obstructive left-sided colonic cancer|obstructive left-sided colonic cancer
555584|NCT01196494|Colorectal stent|colorectal stent
555585|NCT01196494|Intraoperative colon lavage|intraoperative colon lavage
555586|NCT01196494|Lavage|lavage
555587|NCT01196494|Stent|stent
555588|NCT01196468|HIV|hiv
555589|NCT01196468|Testing|testing
555590|NCT01196468|Targeted|targeted
555591|NCT01196468|Indicator|indicator
555592|NCT01196468|Diseases|diseases
555593|NCT01196468|Anal dysplasia|anal dysplasia
555594|NCT01196468|Cervical dysplasia|cervical dysplasia
555595|NCT01196468|STI|sti
555596|NCT01196468|Lymphoma|lymphoma
555597|NCT01196468|Seborrhoeic dermatitis|seborrhoeic dermatitis
555598|NCT01196468|Exanthema|exanthema
555599|NCT01196468|Thrombocytpaenia|thrombocytpaenia
555600|NCT01196468|Lymphopaenia|lymphopaenia
555601|NCT01196468|Hypergammaglobulinaemia|hypergammaglobulinaemia
555602|NCT01196455|Metastatic breast cancer patients|metastatic breast cancer patients
555603|NCT01196403|transitional cell carcinoma of the bladder|transitional cell carcinoma of the bladder
555604|NCT01196403|squamous cell carcinoma of the bladder|squamous cell carcinoma of the bladder
555605|NCT01196403|adenocarcinoma of the bladder|adenocarcinoma of the bladder
555606|NCT01196403|stage I bladder cancer|stage i bladder cancer
555607|NCT01196403|stage II bladder cancer|stage ii bladder cancer
555608|NCT01196403|stage III bladder cancer|stage iii bladder cancer
555609|NCT01196377|Asthma|asthma
555610|NCT01196377|Acute asthma|acute asthma
555611|NCT01196377|Pediatrics|pediatrics
555612|NCT01196364|Girls|girls
555613|NCT01196351|boys|boys
555614|NCT01196351|obesity|obesity
555615|NCT01196351|physical activity|physical activity
555616|NCT01196351|exercise|exercise
555617|NCT01196338|Ankle fracture|ankle fracture
555618|NCT01196338|Return to work|return to work
555619|NCT01196338|Return to function|return to function
555620|NCT01196338|Rehabilitation|rehabilitation
555621|NCT01196338|Weight-bearing|weight-bearing
555622|NCT01196325|Diabetes|diabetes
555623|NCT01196325|Diabetic Macular Edema|diabetic macular edema
555624|NCT01196325|Laser|laser
555625|NCT01196325|Anti-VEGF|anti-vegf
555626|NCT01196325|Morphology|morphology
555627|NCT01196325|Blood Flow|blood flow
555628|NCT01196325|Vision|vision
555629|NCT01196312|anxiety sensitivity|anxiety sensitivity
555630|NCT01196312|heroin|heroin
555631|NCT01196299|diffusion tensor imaging|diffusion tensor imaging
555632|NCT01196299|magnetic resonance spectroscopy|magnetic resonance spectroscopy
555633|NCT01196299|traumatic brain injury|traumatic brain injury
555634|NCT01196299|Metabolite changes|metabolite changes
555635|NCT01196299|Cerebral perfusion|cerebral perfusion
555636|NCT01196299|Hemorrhagic burden|hemorrhagic burden
555637|NCT01196286|First-episode psychosis|first-episode psychosis
555638|NCT01196286|cognitive remediation|cognitive remediation
555639|NCT01196286|family psychoeducation|family psychoeducation
555640|NCT01196273|Cardiac Diseases,|cardiac diseases,
555641|NCT01196273|HIV-Infection,|hiv-infection,
555642|NCT01196273|AIDS,|aids,
555643|NCT01196273|Antiretroviral Therapy,|antiretroviral therapy,
555644|NCT01196273|Cardiovascular Medication,|cardiovascular medication,
555645|NCT01196273|Risk Factors,|risk factors,
555646|NCT01196273|coronary heart disease,|coronary heart disease,
555647|NCT01196273|heart failure,|heart failure,
555648|NCT01196273|metabolic syndrome|metabolic syndrome
555649|NCT01196260|efficiency|efficiency
555650|NCT01196260|capecitabine|capecitabine
555651|NCT01196260|oxaliplatin|oxaliplatin
555652|NCT01196260|colorectal cancer|colorectal cancer
555653|NCT01196247|pancreatic cancer|pancreatic cancer
555654|NCT01196247|molecular profiling|molecular profiling
555655|NCT01196247|SU2C|su2c
555656|NCT01196247|Second line therapy|second line therapy
555657|NCT01196247|Stage 4|stage 4
555658|NCT01196208|Disease, Hodgkin|disease, hodgkin
555659|NCT01196208|Lymphoma|lymphoma
555660|NCT01196208|Monomethylauristatin E|monomethylauristatin e
555661|NCT01196208|Lymphoma, Large-Cell, Anaplastic|lymphoma, large-cell, anaplastic
555662|NCT01196208|Lymphoma, T-Cell, Cutaneous|lymphoma, t-cell, cutaneous
555663|NCT01196208|Lymphoma, Non-Hodgkin|lymphoma, non-hodgkin
555664|NCT01196208|Antibodies, Monoclonal|antibodies, monoclonal
555665|NCT01196208|Antibody-Drug Conjugate|antibody-drug conjugate
555666|NCT01196208|Antigens, CD30|antigens, cd30
555667|NCT01196208|Hematologic Diseases|hematologic diseases
555668|NCT01196208|Immunotherapy|immunotherapy
555669|NCT01196195|antiretroviral therapy|antiretroviral therapy
555670|NCT01196195|child|child
555671|NCT01196195|HIV-1|hiv-1
555672|NCT01196169|daptomycin|daptomycin
555673|NCT01196169|vancomycin|vancomycin
555674|NCT01196169|perioperative|perioperative
555675|NCT01196169|prophylaxis|prophylaxis
555676|NCT01196169|arthroplasty|arthroplasty
555677|NCT01196169|prosthesis|prosthesis
555678|NCT01196169|preoperative|preoperative
555679|NCT01196156|Infant, Small for Gestational Age|infant, small for gestational age
555680|NCT01196156|Dwarfism Pituitary|dwarfism pituitary
555681|NCT01196156|Saizen|saizen
555682|NCT01196156|Somatropin; Growth Hormone|somatropin; growth hormone
555683|NCT01196156|Insulin resistance|insulin resistance
555684|NCT01196143|Ovulation induction|ovulation induction
555685|NCT01196143|Intrauterine insemination|intrauterine insemination
555686|NCT01196143|Gonal-f|gonal-f
555687|NCT01196143|Controlled ovarian stimulation|controlled ovarian stimulation
555688|NCT01196143|Female infertility|female infertility
555689|NCT01196130|Metastatic colorectal cancer|metastatic colorectal cancer
555690|NCT01196130|CRC|crc
555691|NCT01196130|Colorectal adenocarcinoma|colorectal adenocarcinoma
555692|NCT01196130|Biomarker determination|biomarker determination
555693|NCT01196130|Tumor tissue|tumor tissue
555694|NCT01196130|Treatment protocols|treatment protocols
555695|NCT01196117|automatic positive airway pressure (APAP)|automatic positive airway pressure (apap)
555696|NCT01196117|continuous positive airway pressure (CPAP)|continuous positive airway pressure (cpap)
555697|NCT01196117|Salivary Cortisol|salivary cortisol
555698|NCT01196117|Apnea|apnea
555699|NCT01196117|Sleep Apnea and/or any Sleep Disordered Breathing|sleep apnea and/or any sleep disordered breathing
555700|NCT01196091|Lupus|lupus
555701|NCT01196091|SLE|sle
555702|NCT01196091|Systemic Lupus Erythematosis|systemic lupus erythematosis
555703|NCT01196091|autoimmune disease|autoimmune disease
555704|NCT01196091|LY2127399|ly2127399
555705|NCT01196091|Immune system disease|immune system disease
555706|NCT01196026|Influenza|influenza
555707|NCT01196026|H1N1|h1n1
555708|NCT01196026|Fluarix|fluarix
555709|NCT01196026|Pandemrix|pandemrix
555710|NCT01195987|Hepatitis C|hepatitis c
555711|NCT01195987|Arthritis|arthritis
555712|NCT01195974|oral contraceptive, drug interaction, pharmacokinetics|oral contraceptive, drug interaction, pharmacokinetics
555713|NCT01195961|Direct Current Stimulation|direct current stimulation
555714|NCT01195961|Learning|learning
555715|NCT01195961|Cognitive Enhancement|cognitive enhancement
555716|NCT01195961|Cognitive Tasks|cognitive tasks
555717|NCT01195961|Cognitive Training|cognitive training
555718|NCT01195961|Developmental Dyscalculia|developmental dyscalculia
555719|NCT01195961|Learning Disability|learning disability
555720|NCT01195961|Cognition Disorder|cognition disorder
555721|NCT01195948|Uveitis|uveitis
555722|NCT01195948|Oral Tolerance|oral tolerance
555723|NCT01195922|Head and Neck Squamous Cell Carcinoma|head and neck squamous cell carcinoma
555724|NCT01195922|Oral Cancer|oral cancer
555725|NCT01195922|mTOR Inhibitors|mtor inhibitors
555726|NCT01195922|Targeted Therapies|targeted therapies
555727|NCT01195922|Signal Transduction Inhibitors|signal transduction inhibitors
555728|NCT01195922|Head and Neck Cancer|head and neck cancer
555729|NCT01195922|Squamous Cell Carcinoma|squamous cell carcinoma
555730|NCT01195922|Tongue Cancer|tongue cancer
555731|NCT01195883|IV fluid|iv fluid
555732|NCT01195883|recovery|recovery
555733|NCT01195883|goal directed fluid replacement|goal directed fluid replacement
555734|NCT01195883|improved patient recovery|improved patient recovery
555735|NCT01195870|Multiple sclerosis|multiple sclerosis
555736|NCT01195870|Rebif|rebif
555737|NCT01195870|Interferon beta-1a|interferon beta-1a
555738|NCT01195857|Multiple sclerosis|multiple sclerosis
555739|NCT01195857|Rebif|rebif
555740|NCT01195857|Interferon beta-1a|interferon beta-1a
555741|NCT01195844|Pediatric gastroenteritis, rotavirus infection|pediatric gastroenteritis, rotavirus infection
555742|NCT01195818|Albuminuria, hyperfiltration, RAS inhibitors, ADMA|albuminuria, hyperfiltration, ras inhibitors, adma
555743|NCT01195805|Blood pressure, PWV, HRV, PWV, potassium|blood pressure, pwv, hrv, pwv, potassium
555744|NCT01195792|Opioid receptors|opioid receptors
555745|NCT01195792|Body weight|body weight
555746|NCT01195792|Over-eating behaviour|over-eating behaviour
555747|NCT01195792|Obesity|obesity
555748|NCT01195792|Fat mass|fat mass
555749|NCT01195779|immunogenicity|immunogenicity
555750|NCT01195779|safety|safety
555751|NCT01195779|Influenza|influenza
555752|NCT01195779|children|children
555753|NCT01195779|vaccine|vaccine
555754|NCT01195766|Hodgkin|hodgkin
555755|NCT01195766|Ofatumumab|ofatumumab
555756|NCT01195766|Lymphoma|lymphoma
555757|NCT01195753|Urea cycle Disorders|urea cycle disorders
555758|NCT01195740|Suicide Ideation|suicide ideation
555759|NCT01195740|Depression|depression
555760|NCT01195740|Family Conflict|family conflict
555761|NCT01195701|female sexual dysfunction|female sexual dysfunction
555762|NCT01195701|anorgasmia|anorgasmia
555763|NCT01195701|clitoral complex|clitoral complex
555764|NCT01195701|pelvic MRI|pelvic mri
555765|NCT01195701|testosterone|testosterone
555766|NCT01195662|Diabetes Mellitus, Type 2|diabetes mellitus, type 2
555767|NCT01195662|Diabetes Mellitus|diabetes mellitus
555768|NCT01195662|Endocrine System Diseases|endocrine system diseases
555769|NCT01195662|Glucose Metabolism Disorders|glucose metabolism disorders
555770|NCT01195662|Metabolic Diseases|metabolic diseases
555771|NCT01195662|Angiotensin Receptor Inhibitors|angiotensin receptor inhibitors
555772|NCT01195662|Angiotensin-Converting Enzyme Inhibitors|angiotensin-converting enzyme inhibitors
555773|NCT01195662|Antihypertensive Agents|antihypertensive agents
555774|NCT01195662|Cardiovascular Agents|cardiovascular agents
555775|NCT01195662|Pharmacological Actions|pharmacological actions
555875|NCT01195207|CNTO 3157|cnto 3157
555776|NCT01195636|Pain from Shingles, PHN, Postherpetic Neuralgia|pain from shingles, phn, postherpetic neuralgia
555777|NCT01195623|varicose veins|varicose veins
555778|NCT01195623|venous insufficiency|venous insufficiency
555779|NCT01195623|surgery|surgery
555780|NCT01195623|duplex|duplex
555781|NCT01195623|recurrence|recurrence
555782|NCT01195597|electronic cigarette|electronic cigarette
555783|NCT01195597|ENDD|endd
555784|NCT01195597|nicotine|nicotine
555785|NCT01195597|smoking cessation|smoking cessation
555786|NCT01195597|smoking reduction|smoking reduction
555787|NCT01195584|complication rate in 3 cohorts (BMI < 25, > 25 and > 30)|complication rate in 3 cohorts (bmi < 25, > 25 and > 30)
555788|NCT01195558|Non-24|non-24
555789|NCT01195558|N24HSWD|n24hswd
555790|NCT01195558|Blindness|blindness
555791|NCT01195558|Sleep|sleep
555792|NCT01195558|Wake|wake
555793|NCT01195558|Circadian Rhythm|circadian rhythm
555794|NCT01195558|Nap|nap
555795|NCT01195545|Veritas® Collagen Matrix, Hiatal hernia|veritas® collagen matrix, hiatal hernia
555796|NCT01195532|hypoglycemic drug|hypoglycemic drug
555797|NCT01195519|peritoneal dialysis|peritoneal dialysis
555798|NCT01195519|hemodialysis patients|hemodialysis patients
555799|NCT01195506|We Will Collect the Bone Marrow Specimens From AML Patients|we will collect the bone marrow specimens from aml patients
555800|NCT01195493|Chronic periodontitis|chronic periodontitis
555801|NCT01195480|Immunotherapy|immunotherapy
555802|NCT01195480|Gene Therapy|gene therapy
555803|NCT01195480|Paediatric|paediatric
555804|NCT01195480|B cell Acute Lymphoblastic Leukaemia|b cell acute lymphoblastic leukaemia
555805|NCT01195441|Preeclampsia|preeclampsia
555806|NCT01195441|Doppler ultrasound|doppler ultrasound
555807|NCT01195441|First trimester|first trimester
555808|NCT01195441|Acetylsalicylic acid|acetylsalicylic acid
555809|NCT01195402|COPD|copd
555810|NCT01195402|pulmonary rehabilitation|pulmonary rehabilitation
555811|NCT01195389|dementia|dementia
555812|NCT01195389|memory loss|memory loss
555813|NCT01195389|cognitive decline|cognitive decline
555814|NCT01195376|PI3K|pi3k
555815|NCT01195376|mTOR|mtor
555816|NCT01195376|Advanced solid tumor|advanced solid tumor
555817|NCT01195363|bipolar disorder, mania, depression|bipolar disorder, mania, depression
555818|NCT01195350|Ischemic Stroke|ischemic stroke
555819|NCT01195350|Hemorrhagic Stroke|hemorrhagic stroke
555820|NCT01195350|Blood pressure|blood pressure
555821|NCT01195350|Intensive care|intensive care
555822|NCT01195337|Sedentary minority adult|sedentary minority adult
555823|NCT01195337|Psychosocial factors|psychosocial factors
555824|NCT01195337|Environmental factors|environmental factors
555825|NCT01195337|Obesity|obesity
555826|NCT01195337|Physical Activity|physical activity
555827|NCT01195337|PA|pa
555828|NCT01195337|Cancer Risk|cancer risk
555829|NCT01195337|African Americans|african americans
555830|NCT01195337|Latino|latino
555831|NCT01195324|Canagliflozin (JNJ-28431754)|canagliflozin (jnj-28431754)
555832|NCT01195324|Warfarin|warfarin
555833|NCT01195324|Pharmacokinetic|pharmacokinetic
555834|NCT01195324|Pharmacodynamic|pharmacodynamic
555835|NCT01195324|Prothrombin time (PT)|prothrombin time (pt)
555836|NCT01195324|International normalized ratio (INR)|international normalized ratio (inr)
555837|NCT01195311|Refractory, Advanced malignancies|refractory, advanced malignancies
555838|NCT01195298|metastatic breast cancer|metastatic breast cancer
555839|NCT01195298|elderly patients|elderly patients
555840|NCT01195298|chemoimmunotherapy|chemoimmunotherapy
555841|NCT01195298|Triple negative metastatic breast cancer|triple negative metastatic breast cancer
555842|NCT01195285|Laparoscopic cholecystectomy|laparoscopic cholecystectomy
555843|NCT01195285|Quality of life|quality of life
555844|NCT01195285|Biliary Cholic|biliary cholic
555845|NCT01195285|Chronic Cholecystitis|chronic cholecystitis
555846|NCT01195285|Symptomatic Cholelithiasis|symptomatic cholelithiasis
555847|NCT01195259|rosiglitazone|rosiglitazone
555848|NCT01195259|ADOPT|adopt
555849|NCT01195259|metformin|metformin
555850|NCT01195259|malignancy|malignancy
555851|NCT01195259|RECORD|record
555852|NCT01195246|end stage renal failure|end stage renal failure
555853|NCT01195246|renal failure|renal failure
555854|NCT01195246|kidney failure|kidney failure
555855|NCT01195246|kidney failure, chronic|kidney failure, chronic
555856|NCT01195246|chronic kidney failure|chronic kidney failure
555857|NCT01195246|hepatitis B virus (HBV) vaccine|hepatitis b virus (hbv) vaccine
555858|NCT01195246|hepatitis B vaccine|hepatitis b vaccine
555859|NCT01195246|hepatitis B|hepatitis b
555860|NCT01195246|hepatitis|hepatitis
555861|NCT01195246|HBV|hbv
555862|NCT01195246|prevention and control|prevention and control
555863|NCT01195246|dialysis|dialysis
555864|NCT01195233|Xerostomia|xerostomia
555865|NCT01195233|Radiotherapy of head and neck|radiotherapy of head and neck
555866|NCT01195233|BioXtra|bioxtra
555867|NCT01195220|STI screening|sti screening
555868|NCT01195220|Emergency Department|emergency department
555869|NCT01195220|Chlamydia|chlamydia
555870|NCT01195220|Gonorrhea|gonorrhea
555871|NCT01195220|HIV|hiv
555872|NCT01195220|behavior|behavior
555873|NCT01195220|teenagers|teenagers
555874|NCT01195220|intervention|intervention
555876|NCT01195207|healthy volunteers|healthy volunteers
555877|NCT01195207|asthma|asthma
555878|NCT01195194|T-cell lymphocyte allo-recognition|t-cell lymphocyte allo-recognition
555879|NCT01195194|CNI-free immunosuppressive regimen|cni-free immunosuppressive regimen
555880|NCT01195194|Enzyme-linked immunospot (ELISPOT)|enzyme-linked immunospot (elispot)
555881|NCT01195181|peginterferon alfa 2a and 2b type|peginterferon alfa 2a and 2b type
555882|NCT01195181|ribavirin|ribavirin
555883|NCT01195181|chronic hepatitis C|chronic hepatitis c
555884|NCT01195181|antiviral therapy cost/efficacy|antiviral therapy cost/efficacy
555885|NCT01195181|viral kinetics|viral kinetics
555886|NCT01195168|PCOS|pcos
555887|NCT01195155|PCOS|pcos
555888|NCT01195142|PCOS|pcos
555889|NCT01195129|Stent|stent
555890|NCT01195129|cerebral aneursym|cerebral aneursym
555891|NCT01195129|neurology|neurology
555892|NCT01195129|radiology|radiology
555893|NCT01195116|Post-operative pain management|post-operative pain management
555894|NCT01195116|Pain Management|pain management
555895|NCT01195116|Painful bladder syndrome|painful bladder syndrome
555896|NCT01195116|frequency and urgency|frequency and urgency
555897|NCT01195116|Dexmedetomidine|dexmedetomidine
555898|NCT01195116|hydrodistension|hydrodistension
555899|NCT01195103|Procedural sedation|procedural sedation
555900|NCT01195103|Regional Anesthesia block|regional anesthesia block
555901|NCT01195103|Orthopedic surgery|orthopedic surgery
555902|NCT01195103|Lusedra|lusedra
555903|NCT01195103|Fospropofol disodium|fospropofol disodium
555904|NCT01195103|Midazolam|midazolam
555905|NCT01195090|sitagliptin|sitagliptin
555906|NCT01195090|pioglitazone|pioglitazone
555907|NCT01195090|type 2 diabetes|type 2 diabetes
555908|NCT01195077|HIV|hiv
555909|NCT01195077|Dietary intervention|dietary intervention
555910|NCT01195077|Algae|algae
555911|NCT01195077|HIV progression|hiv progression
555912|NCT01195077|Algae specific kind|algae specific kind
555913|NCT01195064|COPD patients|copd patients
555914|NCT01195064|OSAS patients|osas patients
555915|NCT01195064|cardiovascular surgery|cardiovascular surgery
555916|NCT01195064|Endothelial function|endothelial function
555917|NCT01195051|Medication Reconciliation|medication reconciliation
555918|NCT01195051|Inpatient|inpatient
555919|NCT01195051|Electronic Medical Records|electronic medical records
555920|NCT01195038|Avian influenza, H5N1, pandemic, recombinant HA vaccine|avian influenza, h5n1, pandemic, recombinant ha vaccine
555921|NCT01195025|Blood volume|blood volume
555922|NCT01195025|blood coagulation|blood coagulation
555923|NCT01195025|volume kinetics|volume kinetics
555924|NCT01195012|child|child
555925|NCT01195012|primary care|primary care
555926|NCT01195012|treatment|treatment
555927|NCT01195012|parenting|parenting
555928|NCT01195012|lifestyle behaviors|lifestyle behaviors
555929|NCT01194999|OAB|oab
555930|NCT01194999|Urinary Bladder, Overactive|urinary bladder, overactive
555931|NCT01194999|Overactive Bladder Syndrome|overactive bladder syndrome
555932|NCT01194999|VESIcare|vesicare
555933|NCT01194999|Urgency|urgency
555934|NCT01194999|Nocturia|nocturia
555935|NCT01194999|Frequency|frequency
555936|NCT01194999|Urge Urinary Incontinence|urge urinary incontinence
555937|NCT01194999|UUI|uui
555938|NCT01194999|Pubovaginal Sling|pubovaginal sling
555939|NCT01194999|PVS|pvs
555940|NCT01194999|Incontinence|incontinence
555941|NCT01194986|Receptor binding|receptor binding
555942|NCT01194986|Histamine H3 receptor|histamine h3 receptor
555943|NCT01194986|binding|binding
555944|NCT01194986|radioligand|radioligand
555945|NCT01194973|Atypical Hemolytic-Uremic Syndrome|atypical hemolytic-uremic syndrome
555946|NCT01194960|cancer of prostate|cancer of prostate
555947|NCT01194960|cancer of the prostate|cancer of the prostate
555948|NCT01194960|neoplasms prostate|neoplasms prostate
555949|NCT01194960|neoplasms prostatic|neoplasms prostatic
555950|NCT01194960|prostate cancer|prostate cancer
555951|NCT01194960|prostate neoplasms|prostate neoplasms
555952|NCT01194960|prostatic cancer|prostatic cancer
555953|NCT01194960|prostate specific antigen|prostate specific antigen
555954|NCT01194960|prostatic hyperplasia|prostatic hyperplasia
555955|NCT01194947|banal-appearing nevi|banal-appearing nevi
555956|NCT01194947|NEVUS|nevus
555957|NCT01194934|Stem Cell Transplantation|stem cell transplantation
555958|NCT01194934|SDF-1|sdf-1
555959|NCT01194934|L-oligonucleotide Aptamer|l-oligonucleotide aptamer
555960|NCT01194934|Spiegelmer|spiegelmer
555961|NCT01194934|Hematopoietic Stem Cells|hematopoietic stem cells
555962|NCT01194908|Breast Cancer|breast cancer
555963|NCT01194908|Breast Tumors|breast tumors
555964|NCT01194908|Breast Neoplasms|breast neoplasms
555965|NCT01194895|esophagectomy|esophagectomy
555966|NCT01194895|acute lung injury|acute lung injury
555967|NCT01194895|protective ventilation|protective ventilation
555968|NCT01194869|Breast Cancer|breast cancer
555969|NCT01194856|HIV|hiv
555970|NCT01194856|Lipoatrophy|lipoatrophy
555971|NCT01194856|mitochondrial dysfunction|mitochondrial dysfunction
555972|NCT01194817|total knee arthroplasty|total knee arthroplasty
555973|NCT01194817|total knee replacement|total knee replacement
555974|NCT01194817|cementless TKA|cementless tka
555975|NCT01194817|high flexion|high flexion
555976|NCT01194817|trabecular metal|trabecular metal
555977|NCT01194804|Hemolytic Paroxysmal Nocturnal Hemoglobinuria|hemolytic paroxysmal nocturnal hemoglobinuria
555978|NCT01194804|Eculizumab|eculizumab
706075|NCT00608023|HIV|hiv
555979|NCT01194804|PNH|pnh
555980|NCT01194791|Amyloidosis|amyloidosis
555981|NCT01194791|Lenalidomide|lenalidomide
555982|NCT01194713|Alzheimer Disease|alzheimer disease
555983|NCT01194713|Cerebrospinal fluid|cerebrospinal fluid
555984|NCT01194713|Sleep|sleep
555985|NCT01194713|Abeta|abeta
555986|NCT01194700|lung bioavailability|lung bioavailability
555987|NCT01194700|asthma|asthma
555988|NCT01194700|seretide|seretide
555989|NCT01194700|Spacer|spacer
555990|NCT01194687|Estrogens|estrogens
555991|NCT01194687|Fecal Microbiome|fecal microbiome
555992|NCT01194687|Fecal Occult Blood|fecal occult blood
555993|NCT01194674|Microplasmin|microplasmin
555994|NCT01194674|Macular Edema|macular edema
555995|NCT01194674|Uveitis|uveitis
555996|NCT01194661|Inhibitory Control|inhibitory control
555997|NCT01194661|Executive Function|executive function
555998|NCT01194661|fMRI|fmri
555999|NCT01194661|TMS|tms
556000|NCT01194661|TBI|tbi
556001|NCT01194661|Traumatic Brain Injury|traumatic brain injury
556002|NCT01194661|Healthy Volunteer|healthy volunteer
556003|NCT01194661|HV|hv
556004|NCT01194648|urinary incontinence|urinary incontinence
556005|NCT01194648|male erectile disorder|male erectile disorder
556006|NCT01194648|therapy-related toxicity|therapy-related toxicity
556007|NCT01194648|stage I prostate cancer|stage i prostate cancer
556008|NCT01194648|stage IIB prostate cancer|stage iib prostate cancer
556009|NCT01194648|stage IIA prostate cancer|stage iia prostate cancer
556010|NCT01194635|stage IV squamous cell carcinoma of the lip and oral cavity|stage iv squamous cell carcinoma of the lip and oral cavity
556011|NCT01194635|stage IV verrucous carcinoma of the oral cavity|stage iv verrucous carcinoma of the oral cavity
556012|NCT01194635|stage IV squamous cell carcinoma of the nasopharynx|stage iv squamous cell carcinoma of the nasopharynx
556013|NCT01194635|stage IV squamous cell carcinoma of the oropharynx|stage iv squamous cell carcinoma of the oropharynx
556014|NCT01194635|stage IV squamous cell carcinoma of the hypopharynx|stage iv squamous cell carcinoma of the hypopharynx
556015|NCT01194635|stage IV squamous cell carcinoma of the larynx|stage iv squamous cell carcinoma of the larynx
556016|NCT01194635|stage IV verrucous carcinoma of the larynx|stage iv verrucous carcinoma of the larynx
556017|NCT01194609|Low dose radiation|low dose radiation
556018|NCT01194609|Adoptive immune cell therapy|adoptive immune cell therapy
556019|NCT01194609|Cervical cancer|cervical cancer
556020|NCT01194609|Pilot study|pilot study
556021|NCT01194596|smoking cessation advice|smoking cessation advice
556022|NCT01194596|spirometry|spirometry
556023|NCT01194596|primary health care|primary health care
556024|NCT01194583|electronic cigarette|electronic cigarette
556025|NCT01194583|nicotine|nicotine
556026|NCT01194583|smoking cessation|smoking cessation
556027|NCT01194583|smoking reduction|smoking reduction
556028|NCT01194557|history of fever|history of fever
556029|NCT01194557|measured fever|measured fever
556030|NCT01194557|appropriate treatment|appropriate treatment
556031|NCT01194557|appropriate referral|appropriate referral
556032|NCT01194531|Preimplantation Gentic Screening|preimplantation gentic screening
556033|NCT01194531|PGS|pgs
556034|NCT01194531|In Vitro Fertilization|in vitro fertilization
556035|NCT01194531|IVF|ivf
556036|NCT01194531|Preimplantation Genetic Diagnosis|preimplantation genetic diagnosis
556037|NCT01194531|PGD|pgd
556038|NCT01194518|Life experience|life experience
556039|NCT01194518|Life style|life style
556040|NCT01194518|Health behavior|health behavior
556041|NCT01194518|Mixed method|mixed method
556042|NCT01194505|anterior cruciate ligament reconstruction|anterior cruciate ligament reconstruction
556043|NCT01194505|obturator nerve block|obturator nerve block
556044|NCT01194505|sciatic nerve block|sciatic nerve block
556045|NCT01194505|femoral nerve block|femoral nerve block
556046|NCT01194505|posterior lumbar plexus block|posterior lumbar plexus block
556047|NCT01194505|ultrasound guided nerve block|ultrasound guided nerve block
556048|NCT01194492|plasma albumin|plasma albumin
556049|NCT01194492|inflammatory reaction|inflammatory reaction
556050|NCT01194492|systemic inflammatory response syndrome|systemic inflammatory response syndrome
556051|NCT01194479|type 1 diabetes|type 1 diabetes
556052|NCT01194479|hypoglycemia|hypoglycemia
556053|NCT01194479|formoterol|formoterol
556054|NCT01194466|Head and Neck Cancer|head and neck cancer
556055|NCT01194466|Oral Cancer|oral cancer
556056|NCT01194466|Laryngeal Cancer|laryngeal cancer
556057|NCT01194466|Oropharyngeal Cancer|oropharyngeal cancer
556058|NCT01194466|Transcutaneous Electrical Nerve Stimulation (TENS)|transcutaneous electrical nerve stimulation (tens)
556059|NCT01194466|Oral Mucositis|oral mucositis
556060|NCT01194466|Pain|pain
556061|NCT01194466|Function|function
556062|NCT01194466|TENS|tens
556063|NCT01194466|Functional Pain|functional pain
556064|NCT01194466|Non-pharamcologic|non-pharamcologic
556065|NCT01194466|Quality of Life|quality of life
556066|NCT01194427|Preoperative|preoperative
556067|NCT01194427|Neoadjuvant|neoadjuvant
556068|NCT01194388|Patients presenting with an intracranial aneurysm|patients presenting with an intracranial aneurysm
556372|NCT01193101|ARNi|arni
556069|NCT01194362|aortic valve disease|aortic valve disease
556070|NCT01194362|gene expression|gene expression
556071|NCT01194349|S. pneumoniae|s. pneumoniae
556072|NCT01194349|thrombocytosis|thrombocytosis
556073|NCT01194349|pediatric patients|pediatric patients
556074|NCT01194349|The study aimed to understand the diagnostic value of thrombocytosis in children with S. pneumoniae infection|the study aimed to understand the diagnostic value of thrombocytosis in children with s. pneumoniae infection
556075|NCT01194336|Central nervous system|central nervous system
556076|NCT01194336|Cholinesterase|cholinesterase
556077|NCT01194336|Neurocognitive performance testing|neurocognitive performance testing
556078|NCT01194323|esophageal erosion|esophageal erosion
556079|NCT01194323|abnormal pH monitoring|abnormal ph monitoring
556080|NCT01194310|glaucoma|glaucoma
556081|NCT01194310|cataract|cataract
556082|NCT01194297|influenza|influenza
556083|NCT01194297|premature infant|premature infant
556084|NCT01194297|very low birth weight infant|very low birth weight infant
556085|NCT01194297|immunization|immunization
556086|NCT01194297|vaccine|vaccine
556087|NCT01194271|Hormone Ablation|hormone ablation
556088|NCT01194271|Prostate adenocarcinoma|prostate adenocarcinoma
556089|NCT01194271|Radical prostatectomy|radical prostatectomy
556090|NCT01194271|Leuprolide Acetate|leuprolide acetate
556091|NCT01194271|Lupron Depot|lupron depot
556092|NCT01194271|Ipilimumab|ipilimumab
556093|NCT01194271|BMS-734016|bms-734016
556094|NCT01194271|MDX010|mdx010
556095|NCT01194258|Type 2 diabetes|type 2 diabetes
556096|NCT01194245|Type 1 diabetes|type 1 diabetes
556097|NCT01194232|Cystic Fibrosis|cystic fibrosis
556098|NCT01194232|CF|cf
556099|NCT01194232|CMRI|cmri
556100|NCT01194232|vascularization|vascularization
556101|NCT01194232|perfusion|perfusion
556102|NCT01194219|Plaque Psoriasis|plaque psoriasis
556103|NCT01194193|Cancer|cancer
556104|NCT01194193|Advanced solid tumours|advanced solid tumours
556105|NCT01194193|lymphomas|lymphomas
556106|NCT01194193|dose escalation|dose escalation
556107|NCT01194193|preliminary anti-tumour activity|preliminary anti-tumour activity
556108|NCT01194193|Tor kinase inhibitor|tor kinase inhibitor
556109|NCT01194193|oral administration|oral administration
556110|NCT01194193|intermittent dosing|intermittent dosing
556111|NCT01194180|Mycobacterium tuberculosis|mycobacterium tuberculosis
556112|NCT01194180|BCG|bcg
556113|NCT01194180|MVA85A|mva85a
556114|NCT01194167|Platelet refractory thrombocytopenia|platelet refractory thrombocytopenia
556115|NCT01194141|Barth syndrome|barth syndrome
556116|NCT01194141|cardiomyopathy|cardiomyopathy
556117|NCT01194141|mitochondria|mitochondria
556118|NCT01194141|cardiolipin|cardiolipin
556119|NCT01194128|caregivers,|caregivers,
556120|NCT01194128|institutionalization,|institutionalization,
556121|NCT01194128|dementia patients,|dementia patients,
556122|NCT01194128|bereavement,|bereavement,
556123|NCT01194128|grief|grief
556124|NCT01194128|complicated grief|complicated grief
556125|NCT01194115|surgical site infection|surgical site infection
556126|NCT01194115|obesity|obesity
556127|NCT01194115|pregnancy|pregnancy
556128|NCT01194115|cesarean section|cesarean section
556129|NCT01194115|cesarean delivery|cesarean delivery
556130|NCT01194102|Stroke|stroke
556131|NCT01194102|Exercise|exercise
556132|NCT01194102|Physical function|physical function
556133|NCT01194102|Community program|community program
556134|NCT01194102|Patient education|patient education
556135|NCT01194102|Self-management|self-management
556136|NCT01194089|Nicotine|nicotine
556137|NCT01194089|Postoperative pain|postoperative pain
556138|NCT01194089|Bariatric surgery|bariatric surgery
556139|NCT01194076|cognitive behavior therapy|cognitive behavior therapy
556140|NCT01194076|exposure and response prevention|exposure and response prevention
556141|NCT01194076|pediatric|pediatric
556142|NCT01194076|obsessive compulsive disorder|obsessive compulsive disorder
556143|NCT01194076|child|child
556144|NCT01194076|anxiety|anxiety
556145|NCT01194076|intensive|intensive
556146|NCT01194076|OCD|ocd
556147|NCT01194076|CBT|cbt
556148|NCT01194063|short bowel syndrome|short bowel syndrome
556149|NCT01194063|parenteral nutrition associated liver disease|parenteral nutrition associated liver disease
556150|NCT01194063|pediatric|pediatric
556151|NCT01194037|Hepatitis C|hepatitis c
556152|NCT01194037|HCV|hcv
556153|NCT01194037|Interferon|interferon
556154|NCT01194037|Hanferon|hanferon
556155|NCT01194024|Inhalation Injury, Smoke|inhalation injury, smoke
556156|NCT01194024|Inhalation Injury, Acute|inhalation injury, acute
556157|NCT01194011|Health care quality, information openness, health care information website|health care quality, information openness, health care information website
556158|NCT01193972|Smoking cessation|smoking cessation
556159|NCT01193972|Smoking|smoking
556160|NCT01193972|Tobacco|tobacco
556161|NCT01193946|Protein requirement|protein requirement
556162|NCT01193946|Elderly women|elderly women
556163|NCT01193946|Indicator amino acid oxidation|indicator amino acid oxidation
556164|NCT01193933|adult ALL|adult all
556165|NCT01193933|Ph-negative|ph-negative
556166|NCT01193933|dexamethasone|dexamethasone
556167|NCT01193933|L-asparaginase|l-asparaginase
556754|NCT01191801|Vosaroxin|vosaroxin
556168|NCT01193920|Group B streptococcus|group b streptococcus
556169|NCT01193920|GBS|gbs
556170|NCT01193920|Vaccine|vaccine
556171|NCT01193920|Prevention of group B streptococcus infection|prevention of group b streptococcus infection
556172|NCT01193907|Typhoid fever|typhoid fever
556173|NCT01193907|Glycoconjugate vaccine|glycoconjugate vaccine
556174|NCT01193907|Vi polysaccharide|vi polysaccharide
556175|NCT01193907|Immunogenicity|immunogenicity
556176|NCT01193894|IBD|ibd
556177|NCT01193894|UC|uc
556178|NCT01193894|Profermin|profermin
556179|NCT01193894|Fresubin|fresubin
556180|NCT01193894|Probiotics|probiotics
556181|NCT01193894|Dietetic|dietetic
556182|NCT01193855|stage IIB prostate cancer|stage iib prostate cancer
556183|NCT01193855|stage IIA prostate cancer|stage iia prostate cancer
556184|NCT01193816|restlessness during mechanical ventilation weaning|restlessness during mechanical ventilation weaning
556185|NCT01193803|Prosthetic Joint Infections|prosthetic joint infections
556186|NCT01193803|Vertebral Osteomyelitis|vertebral osteomyelitis
556187|NCT01193803|Septic arthritis|septic arthritis
556188|NCT01193803|Molecular methods|molecular methods
556189|NCT01193790|chronic tonsillitis|chronic tonsillitis
556190|NCT01193790|radio-frequency coblation|radio-frequency coblation
556191|NCT01193790|radio-frequency coblation in chronic tonsillitis treatment|radio-frequency coblation in chronic tonsillitis treatment
556192|NCT01193777|Carnitine|carnitine
556193|NCT01193777|Shock|shock
556194|NCT01193777|Sepsis|sepsis
556195|NCT01193764|acne|acne
556196|NCT01193764|cocoa|cocoa
556197|NCT01193764|chocolate|chocolate
556198|NCT01193764|gelatin|gelatin
556199|NCT01193764|pustule|pustule
556200|NCT01193764|comedones|comedones
556201|NCT01193764|papules|papules
556202|NCT01193764|pustules|pustules
556203|NCT01193751|Birth Asphyxia|birth asphyxia
556204|NCT01193751|Newborn's Resuscitation|newborn's resuscitation
556205|NCT01193751|Death|death
556206|NCT01193751|Neurodevelopmental Impairment|neurodevelopmental impairment
556207|NCT01193738|osteopathy|osteopathy
556208|NCT01193725|Combat Disorders|combat disorders
556209|NCT01193725|Exposure Therapy|exposure therapy
556210|NCT01193725|Army Personnel|army personnel
556211|NCT01193712|Electrophysiologic Techniques, Cardiac|electrophysiologic techniques, cardiac
556212|NCT01193660|umbilical cord blood|umbilical cord blood
556213|NCT01193660|stem cell|stem cell
556214|NCT01193660|cerebral palsy|cerebral palsy
556215|NCT01193634|ICD VR 9250, DR 9550 and CRT 9750 - PARADYM RF ICD|icd vr 9250, dr 9550 and crt 9750 - paradym rf icd
556216|NCT01193621|early evaluation|early evaluation
556217|NCT01193621|pharmacokinetics|pharmacokinetics
556218|NCT01193621|pharmacodynamics|pharmacodynamics
556219|NCT01193621|Biodistribution|biodistribution
556220|NCT01193621|D2-receptor occupancy|d2-receptor occupancy
556221|NCT01193608|Randomized|randomized
556222|NCT01193608|Safety Study|safety study
556223|NCT01193608|Adaptive|adaptive
556224|NCT01193608|Double Blind|double blind
556225|NCT01193582|Prevenar|prevenar
556226|NCT01193582|catch-up|catch-up
556227|NCT01193582|pneumococcal|pneumococcal
556228|NCT01193582|pneumonia|pneumonia
556229|NCT01193556|Tonsillectomy|tonsillectomy
556230|NCT01193556|PlasmaBlade|plasmablade
556231|NCT01193556|Electrosurgery|electrosurgery
556232|NCT01193556|PEAK Surgical|peak surgical
556233|NCT01193556|Medtronic Advanced Energy|medtronic advanced energy
556234|NCT01193556|Medtronic|medtronic
556235|NCT01193530|Sleep Disturbances|sleep disturbances
556236|NCT01193530|Depression|depression
556237|NCT01193530|Anxiety|anxiety
556238|NCT01193530|Fatigue|fatigue
556239|NCT01193530|Quality of life|quality of life
556240|NCT01193517|Refractory metastatic colorectal cancer|refractory metastatic colorectal cancer
556241|NCT01193517|CRC|crc
556242|NCT01193517|colorectal adenocarcinoma with metastatic disease|colorectal adenocarcinoma with metastatic disease
556243|NCT01193517|Azacitidine|azacitidine
556244|NCT01193517|5-Azacytidine|5-azacytidine
556245|NCT01193517|5-aza|5-aza
556246|NCT01193517|Vidaza|vidaza
556247|NCT01193517|5-AZC|5-azc
556248|NCT01193517|AZA-CR|aza-cr
556249|NCT01193517|Ladakamycin|ladakamycin
556250|NCT01193517|NSC-102816|nsc-102816
556251|NCT01193517|Capecitabine|capecitabine
556252|NCT01193517|Oxaliplatin|oxaliplatin
556253|NCT01193517|CAPOX|capox
556254|NCT01193517|Xeloda|xeloda
556255|NCT01193517|Eloxatin|eloxatin
556256|NCT01193517|Hypermethylation|hypermethylation
556257|NCT01193517|CpG island methylator phenotype|cpg island methylator phenotype
556258|NCT01193504|Prevention of Retinal Thickening and CME Following Phacoemulsification|prevention of retinal thickening and cme following phacoemulsification
556259|NCT01193504|Pseudophakia following cataract surgery|pseudophakia following cataract surgery
556260|NCT01193491|Phase 1|phase 1
556261|NCT01193491|AML|aml
556262|NCT01193491|CML|cml
556263|NCT01193491|MPD|mpd
556264|NCT01193491|Client Proteins|client proteins
556265|NCT01193491|Hsp90|hsp90
556266|NCT01193478|Hepatitis C|hepatitis c
556267|NCT01193478|HCV RNA|hcv rna
706444|NCT00606502|Tarceva|tarceva
556268|NCT01193478|multiple ascending dose|multiple ascending dose
556269|NCT01193478|NS5A|ns5a
556270|NCT01193478|GS-5885|gs-5885
556271|NCT01193478|chronic genotype 1 HCV infection|chronic genotype 1 hcv infection
556272|NCT01193465|Humidity|humidity
556273|NCT01193465|Temperature|temperature
556274|NCT01193465|Low Flow Anesthesia|low flow anesthesia
556275|NCT01193452|elderly patients|elderly patients
556276|NCT01193452|advanced colorectal cancer|advanced colorectal cancer
556277|NCT01193452|chemotherapy|chemotherapy
556278|NCT01193452|S-1|s-1
556279|NCT01193452|5-fluorouracil|5-fluorouracil
556280|NCT01193452|leucovorin|leucovorin
556281|NCT01193439|thoracoscopy|thoracoscopy
556282|NCT01193439|pleural diseases|pleural diseases
556283|NCT01193439|complications|complications
556284|NCT01193439|safety|safety
556285|NCT01193426|Hepatic|hepatic
556286|NCT01193426|cirrhosis|cirrhosis
556287|NCT01193426|IL-6|il-6
556288|NCT01193426|IL-8|il-8
556289|NCT01193426|Leptine|leptine
556290|NCT01193413|acute pancreatitis|acute pancreatitis
556291|NCT01193413|Drainage|drainage
556292|NCT01193413|Pancreatic surgery|pancreatic surgery
556293|NCT01193413|Biological Markers/analysis|biological markers/analysis
556294|NCT01193413|Infection diagnosis|infection diagnosis
556295|NCT01193413|ROC Curve|roc curve
556296|NCT01193413|Sensitivity and Specificity|sensitivity and specificity
556297|NCT01193413|Endoscopic ultrasonography|endoscopic ultrasonography
556298|NCT01193400|Acute myelogenous leukemia|acute myelogenous leukemia
556299|NCT01193400|Clofarabine|clofarabine
556300|NCT01193400|Cytarabine|cytarabine
556301|NCT01193374|Childhood Obesity|childhood obesity
556302|NCT01193374|Primary Care|primary care
556303|NCT01193374|Counseling|counseling
556304|NCT01193374|Screening|screening
556305|NCT01193348|Atypical Hemolytic-Uremic Syndrome|atypical hemolytic-uremic syndrome
556306|NCT01193335|13-valent pneumococcal conjugate vaccine|13-valent pneumococcal conjugate vaccine
556307|NCT01193335|premature|premature
556308|NCT01193335|immunization|immunization
556309|NCT01193335|safety.|safety.
556310|NCT01193296|Diabetes mellitus, vildagliptin, continuous glucose monitoring|diabetes mellitus, vildagliptin, continuous glucose monitoring
556311|NCT01193283|Aplastic Anemia|aplastic anemia
556312|NCT01193283|Immunosuppression|immunosuppression
556313|NCT01193283|T-Cells|t-cells
556314|NCT01193283|Hematopoiesis|hematopoiesis
556315|NCT01193283|Autoimmunity|autoimmunity
556316|NCT01193283|Severe Aplastic Anemia|severe aplastic anemia
556317|NCT01193270|NICHD Neonatal Research Network|nichd neonatal research network
556318|NCT01193270|Intraventricular Hemorrhage (IVH)|intraventricular hemorrhage (ivh)
556319|NCT01193270|Very Low Birth Weight (VLBW)|very low birth weight (vlbw)
556320|NCT01193270|Extremely Low Birth Weight (ELBW)|extremely low birth weight (elbw)
556321|NCT01193270|Prematurity|prematurity
556322|NCT01193257|Drug therapy|drug therapy
556323|NCT01193231|Laser Vision Correction|laser vision correction
556324|NCT01193231|Photorefractive Keratectomy|photorefractive keratectomy
556325|NCT01193231|PRK|prk
556326|NCT01193231|Nearsighted|nearsighted
556327|NCT01193231|Myopia|myopia
556328|NCT01193205|Borderline Personality Disorder|borderline personality disorder
556329|NCT01193205|Skills Training|skills training
556330|NCT01193205|Dialectical Behavior Therapy|dialectical behavior therapy
556331|NCT01193205|Suicidal and parasuicidal behavior|suicidal and parasuicidal behavior
556332|NCT01193192|Neevo|neevo
556333|NCT01193192|Neevo DHA|neevo dha
556334|NCT01193192|L-methylfolate|l-methylfolate
556335|NCT01193192|anemia during pregnancy|anemia during pregnancy
556336|NCT01193192|folic acid|folic acid
556337|NCT01193192|vitamin B12|vitamin b12
556338|NCT01193192|prenatal vitamins|prenatal vitamins
556339|NCT01193192|hemoglobin|hemoglobin
556340|NCT01193192|iron deficiency|iron deficiency
556341|NCT01193192|Pregnancy|pregnancy
556342|NCT01193166|Schizophrenia|schizophrenia
556343|NCT01193166|Risperidone|risperidone
556344|NCT01193166|Risperdal|risperdal
556345|NCT01193166|Paliperidone palmitate|paliperidone palmitate
556346|NCT01193166|Aripiprazole|aripiprazole
556347|NCT01193166|Haloperidol|haloperidol
556348|NCT01193166|Olanzapine|olanzapine
556349|NCT01193166|Paliperidone|paliperidone
556350|NCT01193166|Perphenazine|perphenazine
556351|NCT01193166|Quetiapine|quetiapine
556352|NCT01193153|schizoaffective disorder|schizoaffective disorder
556353|NCT01193153|paliperidone palmitate|paliperidone palmitate
556354|NCT01193153|INVEGA SUSTENNA|invega sustenna
556355|NCT01193153|schizoaffective disorder relapse prevention|schizoaffective disorder relapse prevention
556356|NCT01193140|veliparib|veliparib
556357|NCT01193140|relapsed and refractory tumors|relapsed and refractory tumors
556358|NCT01193140|Temodar|temodar
556359|NCT01193140|temozolomide|temozolomide
556360|NCT01193140|ABT-888|abt-888
556361|NCT01193140|Solid Tumors|solid tumors
556362|NCT01193114|substance abuse|substance abuse
556363|NCT01193114|homeless mothers|homeless mothers
556364|NCT01193101|hypertension|hypertension
556365|NCT01193101|blood pressure|blood pressure
556366|NCT01193101|LCZ696|lcz696
556367|NCT01193101|dual-acting|dual-acting
556368|NCT01193101|neprilysin|neprilysin
556369|NCT01193101|nep inhibitor|nep inhibitor
556370|NCT01193101|vasopeptidase|vasopeptidase
556371|NCT01193101|angiotensin receptor|angiotensin receptor
556373|NCT01193101|Essential hypertension|essential hypertension
556374|NCT01193088|CMT|cmt
556375|NCT01193088|CMT1A|cmt1a
556376|NCT01193075|Charcot Marie Tooth disease|charcot marie tooth disease
556377|NCT01193075|CMT|cmt
556378|NCT01193075|HMSN|hmsn
556379|NCT01193075|HMN|hmn
556380|NCT01193075|HSN|hsn
556381|NCT01193075|CMT1|cmt1
556382|NCT01193075|CMT2|cmt2
556383|NCT01193062|healthy volunteers|healthy volunteers
556384|NCT01193062|pharmacokinetics-pharmacodynamics|pharmacokinetics-pharmacodynamics
556385|NCT01193062|cerebrospinal fluid|cerebrospinal fluid
556386|NCT01193062|serial sampling|serial sampling
556387|NCT01193049|Nasal Allergen Challenge, Inhaled Allergen Challenge, Asthma|nasal allergen challenge, inhaled allergen challenge, asthma
556388|NCT01193036|Psychosocial|psychosocial
556389|NCT01193036|Skin Problems|skin problems
556390|NCT01193036|Supportive Care|supportive care
556391|NCT01193036|Melanoma|melanoma
556392|NCT01193036|Questionnaire|questionnaire
556393|NCT01193023|Prospective Studies|prospective studies
556394|NCT01193023|Humans, pediatric|humans, pediatric
556395|NCT01193023|Positive-Pressure Respiration/methods*|positive-pressure respiration/methods*
556396|NCT01193023|Respiration, Artificial/methods*|respiration, artificial/methods*
556397|NCT01193023|Intensive Care|intensive care
556398|NCT01193023|Intensive Care Units/statistics & numerical data*|intensive care units/statistics & numerical data*
556399|NCT01193023|Respiration, Artificial/statistics & numerical data*|respiration, artificial/statistics & numerical data*
556400|NCT01193023|Patients/statistics & numerical data*|patients/statistics & numerical data*
556401|NCT01193023|Prevalence|prevalence
556402|NCT01193023|Respiratory Muscles/innervation|respiratory muscles/innervation
556403|NCT01192997|Meningitis|meningitis
556404|NCT01192997|Meningococci|meningococci
556405|NCT01192997|Meningitis C|meningitis c
556406|NCT01192997|Meningitis A|meningitis a
556407|NCT01192997|Meningitis W135|meningitis w135
556408|NCT01192997|Meningitis Y|meningitis y
556409|NCT01192997|Antibody|antibody
556410|NCT01192971|hcc, apatinib, phase II, cancer|hcc, apatinib, phase ii, cancer
556411|NCT01192958|swine flu|swine flu
556412|NCT01192958|novel h1n1v|novel h1n1v
556413|NCT01192958|novel h1n1|novel h1n1
556414|NCT01192958|h1n1|h1n1
556415|NCT01192945|Azacitidin|azacitidin
556416|NCT01192945|Vidaza|vidaza
556417|NCT01192945|Piaza|piaza
556418|NCT01192945|myelodysplastic syndrome|myelodysplastic syndrome
556419|NCT01192945|MDS|mds
556420|NCT01192945|chronic myelomonocytic leukemia|chronic myelomonocytic leukemia
556421|NCT01192945|CMML|cmml
556422|NCT01192945|acute myeloid leukemia|acute myeloid leukemia
556423|NCT01192945|AML|aml
556424|NCT01192945|daily routine|daily routine
556425|NCT01192945|concomitant antiemetic therapy|concomitant antiemetic therapy
556426|NCT01192945|germany|germany
556427|NCT01192945|non-interventional study|non-interventional study
556428|NCT01192919|bronchial carcinoma|bronchial carcinoma
556429|NCT01192919|registry|registry
556430|NCT01192919|real life treatment|real life treatment
556431|NCT01192919|cohort study|cohort study
556432|NCT01192919|NSCLC|nsclc
556433|NCT01192919|SCLC|sclc
556434|NCT01192919|Germany|germany
556435|NCT01192854|Clevudine|clevudine
556436|NCT01192854|efficacy|efficacy
556437|NCT01192854|safety|safety
556438|NCT01192854|chronic hepatitis B|chronic hepatitis b
556439|NCT01192841|physician uniform|physician uniform
556440|NCT01192841|MRSA|mrsa
556441|NCT01192841|bacterial contamination|bacterial contamination
556442|NCT01192828|cystathionine beta-synthase (CBS)|cystathionine beta-synthase (cbs)
556443|NCT01192802|albendazole|albendazole
556444|NCT01192802|ascaris|ascaris
556445|NCT01192802|trichiurus|trichiurus
556446|NCT01192802|hookworms|hookworms
556447|NCT01192789|Severe pneumonia|severe pneumonia
556448|NCT01192789|Pneumonia|pneumonia
556449|NCT01192789|Lady health workers|lady health workers
556450|NCT01192789|Amoxicillin|amoxicillin
556451|NCT01192789|Treatment failure|treatment failure
556452|NCT01192789|Injectable Antibiotics|injectable antibiotics
556453|NCT01192789|Referral treatment|referral treatment
556454|NCT01192789|Health Facility|health facility
556455|NCT01192789|Under five children|under five children
556456|NCT01192789|home based management|home based management
556457|NCT01192789|community case management|community case management
556458|NCT01192776|NICHD Neonatal Research Network|nichd neonatal research network
556459|NCT01192776|Hypoxic-ischemic encephalopathy (HIE)|hypoxic-ischemic encephalopathy (hie)
556460|NCT01192776|Hypothermia|hypothermia
556461|NCT01192776|Neonatal depression|neonatal depression
556462|NCT01192776|Perinatal asphyxia|perinatal asphyxia
556463|NCT01192776|Fetal acidosis|fetal acidosis
556464|NCT01192750|recurrent metastatic squamous neck cancer with occult primary|recurrent metastatic squamous neck cancer with occult primary
556465|NCT01192750|recurrent squamous cell carcinoma of the hypopharynx|recurrent squamous cell carcinoma of the hypopharynx
556466|NCT01192750|recurrent squamous cell carcinoma of the larynx|recurrent squamous cell carcinoma of the larynx
556467|NCT01192750|recurrent squamous cell carcinoma of the lip and oral cavity|recurrent squamous cell carcinoma of the lip and oral cavity
556468|NCT01192750|recurrent squamous cell carcinoma of the nasopharynx|recurrent squamous cell carcinoma of the nasopharynx
556469|NCT01192750|recurrent squamous cell carcinoma of the oropharynx|recurrent squamous cell carcinoma of the oropharynx
556470|NCT01192750|recurrent squamous cell carcinoma of the paranasal sinus and nasal cavity|recurrent squamous cell carcinoma of the paranasal sinus and nasal cavity
556471|NCT01192750|stage IV squamous cell carcinoma of the hypopharynx|stage iv squamous cell carcinoma of the hypopharynx
556472|NCT01192750|stage IV squamous cell carcinoma of the larynx|stage iv squamous cell carcinoma of the larynx
556473|NCT01192750|stage IV squamous cell carcinoma of the lip and oral cavity|stage iv squamous cell carcinoma of the lip and oral cavity
556474|NCT01192750|stage IV squamous cell carcinoma of the nasopharynx|stage iv squamous cell carcinoma of the nasopharynx
556475|NCT01192750|stage IV squamous cell carcinoma of the oropharynx|stage iv squamous cell carcinoma of the oropharynx
556476|NCT01192750|stage IV squamous cell carcinoma of the paranasal sinus and nasal cavity|stage iv squamous cell carcinoma of the paranasal sinus and nasal cavity
556477|NCT01192750|recurrent verrucous carcinoma of the larynx|recurrent verrucous carcinoma of the larynx
556478|NCT01192750|recurrent verrucous carcinoma of the oral cavity|recurrent verrucous carcinoma of the oral cavity
556479|NCT01192750|stage IV verrucous carcinoma of the larynx|stage iv verrucous carcinoma of the larynx
556480|NCT01192750|stage IV verrucous carcinoma of the oral cavity|stage iv verrucous carcinoma of the oral cavity
556481|NCT01192750|recurrent salivary gland cancer|recurrent salivary gland cancer
556482|NCT01192750|salivary gland squamous cell carcinoma|salivary gland squamous cell carcinoma
556483|NCT01192737|pandemic|pandemic
556484|NCT01192737|A/H1N1|a/h1n1
556485|NCT01192737|pregnancy|pregnancy
556486|NCT01192737|cohort|cohort
556487|NCT01192737|vaccine|vaccine
556488|NCT01192737|Influenza and Pregnancy|influenza and pregnancy
556489|NCT01192724|Antiplatelet|antiplatelet
556490|NCT01192724|Coronary artery diseae|coronary artery diseae
556491|NCT01192724|Percutaneous coronary intervention|percutaneous coronary intervention
556492|NCT01192711|diabetes|diabetes
556493|NCT01192711|telemedicine|telemedicine
556494|NCT01192711|self monitoring blood glucose|self monitoring blood glucose
556495|NCT01192698|cirrhosis|cirrhosis
556496|NCT01192698|hepatitis C|hepatitis c
556497|NCT01192685|Depression|depression
556498|NCT01192685|Depressed|depressed
556499|NCT01192685|TMS|tms
556500|NCT01192685|Transcranial Magnetic Stimulation|transcranial magnetic stimulation
556501|NCT01192646|maternal health|maternal health
556502|NCT01192646|birth preparedness|birth preparedness
556503|NCT01192646|cost effectiveness|cost effectiveness
556504|NCT01192646|male involvement|male involvement
556505|NCT01192646|delivery at hospital|delivery at hospital
556506|NCT01192646|complication readiness|complication readiness
556507|NCT01192646|Health seeking behavior in pregnancy, labour and pregnancy complication|health seeking behavior in pregnancy, labour and pregnancy complication
556508|NCT01192633|Sarcoma|sarcoma
556509|NCT01192633|gemcitabine|gemcitabine
556510|NCT01192633|vincristine|vincristine
556511|NCT01192633|cisplatin|cisplatin
556512|NCT01192633|chemotherapy|chemotherapy
556513|NCT01192620|Pediatric Appendicitis|pediatric appendicitis
556514|NCT01192620|Pathway|pathway
556515|NCT01192594|symptom management|symptom management
556516|NCT01192594|empowerment|empowerment
556517|NCT01192594|medication adherence|medication adherence
556518|NCT01192594|recovery|recovery
556519|NCT01192594|schizophrenia|schizophrenia
556520|NCT01192594|post-psychotic adjustment process|post-psychotic adjustment process
556521|NCT01192594|psychological adjustment|psychological adjustment
556522|NCT01192594|psychiatric case managers|psychiatric case managers
556523|NCT01192594|psychosis|psychosis
556524|NCT01192594|insight|insight
556525|NCT01192594|cognitive function|cognitive function
556526|NCT01192581|brain hypoperfusion|brain hypoperfusion
556527|NCT01192581|Vuloven|vuloven
556528|NCT01192581|computed tomography perfusion|computed tomography perfusion
556529|NCT01192555|Neuroblastoma|neuroblastoma
556530|NCT01192555|Chemotherapy|chemotherapy
556531|NCT01192555|Pediatrics|pediatrics
556532|NCT01192555|Cytoxan|cytoxan
556533|NCT01192555|immunotherapy|immunotherapy
556534|NCT01192555|vaccine|vaccine
556535|NCT01192529|Senile|senile
556536|NCT01192529|Dementia|dementia
556537|NCT01192529|Neurodegenerative|neurodegenerative
556538|NCT01192529|Supressi|supressi
556539|NCT01192529|Specific diet|specific diet
556540|NCT01192529|Cognitive Status|cognitive status
556541|NCT01192529|Memory|memory
556542|NCT01192529|Malnutrition|malnutrition
556543|NCT01192529|Parkinson|parkinson
556544|NCT01192529|Alzheimer|alzheimer
556545|NCT01192516|Osteoarthritis|osteoarthritis
556546|NCT01192516|Activity Pacing|activity pacing
556547|NCT01192503|Restless Legs Syndrome|restless legs syndrome
556548|NCT01192503|rasagiline|rasagiline
556549|NCT01192503|futility|futility
706856|NCT00604201|SAA|saa
556550|NCT01192477|Air pollution|air pollution
556551|NCT01192477|Ozone|ozone
556552|NCT01192477|Health effects of ozone exposure|health effects of ozone exposure
556553|NCT01192464|Hodgkin's Lymphoma|hodgkin's lymphoma
556554|NCT01192464|Non-Hodgkin's Lymphoma|non-hodgkin's lymphoma
556555|NCT01192438|prostate|prostate
556556|NCT01192438|cancer|cancer
556557|NCT01192438|ablation|ablation
556558|NCT01192438|laser-induced|laser-induced
556559|NCT01192438|focal therapy|focal therapy
556755|NCT01191801|Cytarabine|cytarabine
556560|NCT01192425|PNH clone cells|pnh clone cells
556561|NCT01192425|Aplastic Anemia|aplastic anemia
556562|NCT01192425|AA|aa
556563|NCT01192425|Myelodysplastic Syndromes|myelodysplastic syndromes
556564|NCT01192425|MDS|mds
556565|NCT01192425|bone marrow failure syndromes|bone marrow failure syndromes
556566|NCT01192425|FLAER|flaer
556567|NCT01192425|Paroxysmal Nocturnal Hemoglobinuria|paroxysmal nocturnal hemoglobinuria
556568|NCT01192412|hypertension|hypertension
556569|NCT01192412|pregnancy|pregnancy
556570|NCT01192412|antihypertensive therapy|antihypertensive therapy
556571|NCT01192412|perinatal outcome|perinatal outcome
556572|NCT01192412|maternal outcome|maternal outcome
556573|NCT01192412|Non-severe, non-proteinuric pre-existing or gestational hypertension in pregnancy|non-severe, non-proteinuric pre-existing or gestational hypertension in pregnancy
556574|NCT01192399|Hemolytic Paroxysmal Nocturnal Hemoglobinuria|hemolytic paroxysmal nocturnal hemoglobinuria
556575|NCT01192399|Eculizumab|eculizumab
556576|NCT01192399|PNH|pnh
556577|NCT01192399|Japan|japan
556578|NCT01192360|pediatrics|pediatrics
556579|NCT01192360|Heart Disease|heart disease
556580|NCT01192360|Cystic Fibrosis|cystic fibrosis
556581|NCT01192360|Severe Asthma|severe asthma
556582|NCT01192360|Magnetic Resonance Imaging|magnetic resonance imaging
556583|NCT01192334|knee osteoarthritis arthroplasty postural balance|knee osteoarthritis arthroplasty postural balance
556584|NCT01192321|intraocular lens|intraocular lens
556585|NCT01192321|Toric|toric
556586|NCT01192308|Breast cancer|breast cancer
556587|NCT01192308|Tamoxifen|tamoxifen
556588|NCT01192308|Pharmacokinetics|pharmacokinetics
556589|NCT01192308|Pharmacogenetics|pharmacogenetics
556590|NCT01192308|CYP2D6|cyp2d6
556591|NCT01192295|Malignant pain|malignant pain
556592|NCT01192295|Nonmalignant pain|nonmalignant pain
556593|NCT01192295|Pediatric|pediatric
556594|NCT01192295|Opioid|opioid
556595|NCT01192295|Moderate to severe malignant or nonmalignant pain|moderate to severe malignant or nonmalignant pain
556596|NCT01192282|Female Genital Warts|female genital warts
556597|NCT01192282|HPV Typing|hpv typing
556598|NCT01192282|HIV Status|hiv status
556599|NCT01192282|Treatment Modalities and Recurrence|treatment modalities and recurrence
556600|NCT01192282|Socio-economic Burdens|socio-economic burdens
556601|NCT01192269|cheek cells|cheek cells
556602|NCT01192269|phospholipids|phospholipids
556603|NCT01192269|fatty acids|fatty acids
556604|NCT01192269|docosahexaenoic acid|docosahexaenoic acid
556605|NCT01192269|Buccal Cheek cells|buccal cheek cells
556606|NCT01192269|non invasive fatty acid status marker|non invasive fatty acid status marker
556607|NCT01192256|smoking|smoking
556608|NCT01192256|cessation|cessation
556609|NCT01192256|mortality|mortality
556610|NCT01192256|quality of life|quality of life
556611|NCT01192243|Objective response rate|objective response rate
556612|NCT01192243|Time to Progression|time to progression
556613|NCT01192243|Quality of Live|quality of live
556614|NCT01192230|Objective response rate|objective response rate
556615|NCT01192230|Disease control rate|disease control rate
556616|NCT01192230|Disease free survival|disease free survival
556617|NCT01192230|Overall survival|overall survival
556618|NCT01192230|Quality of Live|quality of live
556619|NCT01192230|Nonsmall cell lung cancer|nonsmall cell lung cancer
556620|NCT01192230|toxicity|toxicity
556621|NCT01192217|video-assisted thoracic surgery|video-assisted thoracic surgery
556622|NCT01192217|axillary mini-thoracotomy|axillary mini-thoracotomy
556623|NCT01192217|bullectomy|bullectomy
556624|NCT01192204|FBR, OSCC, chemoprevention|fbr, oscc, chemoprevention
556625|NCT01192191|GW642444|gw642444
556626|NCT01192191|COPD|copd
556627|NCT01192191|Fluticasone Furoate|fluticasone furoate
556628|NCT01192178|pediatric|pediatric
556629|NCT01192178|exacerbation|exacerbation
556630|NCT01192178|viral induced exacerbation|viral induced exacerbation
556631|NCT01192178|asthma|asthma
556632|NCT01192165|Taxotere|taxotere
556633|NCT01192165|Cisplatin|cisplatin
556634|NCT01192165|Carboplatin|carboplatin
556635|NCT01192165|Trametinib|trametinib
556636|NCT01192165|GSK1120212|gsk1120212
556637|NCT01192165|Tarceva|tarceva
556638|NCT01192165|KRAS|kras
556639|NCT01192165|Pemetrexed|pemetrexed
556640|NCT01192165|MEK inhibitor|mek inhibitor
556641|NCT01192165|nab-Paclitaxel|nab-paclitaxel
556642|NCT01192165|Docetaxel|docetaxel
556643|NCT01192165|Alimta|alimta
556644|NCT01192165|Abraxane|abraxane
556645|NCT01192165|Erlotinib|erlotinib
556646|NCT01192113|Mecobalamin|mecobalamin
556647|NCT01192113|peripheral neuropathy|peripheral neuropathy
556648|NCT01192113|diabetic neuropathy|diabetic neuropathy
556649|NCT01192100|Protein-rich breakfast|protein-rich breakfast
556650|NCT01192100|Breakfast Skipping|breakfast skipping
556651|NCT01192100|Adolescents|adolescents
556652|NCT01192100|Obesity|obesity
556653|NCT01192100|Increased dietary protein|increased dietary protein
556654|NCT01192100|Breakfast|breakfast
556655|NCT01192100|fMRI|fmri
556656|NCT01192100|Ghrelin|ghrelin
556657|NCT01192100|PYY|pyy
556658|NCT01192087|adenoid cystic carcinoma|adenoid cystic carcinoma
556659|NCT01192087|carbon ion therapy|carbon ion therapy
556756|NCT01191801|First Relapsed AML|first relapsed aml
556660|NCT01192087|IMRT (intensity-modulated therapy)|imrt (intensity-modulated therapy)
556661|NCT01192087|radioimmunotherapy|radioimmunotherapy
556662|NCT01192087|Cetuximab|cetuximab
556663|NCT01192074|Obstetric|obstetric
556664|NCT01192074|Analgesia|analgesia
556665|NCT01192074|Anesthesia|anesthesia
556666|NCT01192074|Obstetric Anesthesia|obstetric anesthesia
556667|NCT01192074|Obstetric Analgesia|obstetric analgesia
556668|NCT01192074|ultrasound|ultrasound
556669|NCT01192074|ultrasonography|ultrasonography
556670|NCT01192074|epidural analgesia|epidural analgesia
556671|NCT01192074|epidural anesthesia|epidural anesthesia
556672|NCT01192074|spinal anesthesia|spinal anesthesia
556673|NCT01192074|neuraxial anesthesia|neuraxial anesthesia
556674|NCT01192074|neuraxial analgesia|neuraxial analgesia
556675|NCT01192074|pregnancy|pregnancy
556676|NCT01192074|labor|labor
556677|NCT01192074|cesarean delivery|cesarean delivery
556678|NCT01192074|cesarean section|cesarean section
556679|NCT01192061|autonomic nervous system|autonomic nervous system
556680|NCT01192061|heart rate variability|heart rate variability
556681|NCT01192061|blood pressure variability|blood pressure variability
556682|NCT01192061|retrobulbar hemodynamics|retrobulbar hemodynamics
556683|NCT01192061|vascular dysregulation|vascular dysregulation
556684|NCT01192048|Congenital Heart Disease|congenital heart disease
556685|NCT01192048|birth defect|birth defect
556686|NCT01192048|genetics|genetics
556687|NCT01192048|gene|gene
556688|NCT01192048|DNA|dna
556689|NCT01192048|direct sequencing|direct sequencing
556690|NCT01192048|microarray|microarray
556691|NCT01192048|single nucleotide polymorphism|single nucleotide polymorphism
556692|NCT01192048|whole genome array comparative genomic hybridization|whole genome array comparative genomic hybridization
556693|NCT01192048|chromosomal copy number change|chromosomal copy number change
556694|NCT01192048|nucleotide sequence variation|nucleotide sequence variation
556695|NCT01192048|exome sequencing|exome sequencing
556696|NCT01192048|whole exome sequencing|whole exome sequencing
556697|NCT01192035|Africa, Western|africa, western
556698|NCT01192035|Antiretroviral Therapy, Highly Active|antiretroviral therapy, highly active
556699|NCT01192022|Liver resection|liver resection
556700|NCT01192022|Liver transplantation|liver transplantation
556701|NCT01192022|Liver surgery|liver surgery
556702|NCT01192022|Secondary hemostasis|secondary hemostasis
556703|NCT01192009|Leucine|leucine
556704|NCT01192009|Skeletal Muscle Disuse|skeletal muscle disuse
556705|NCT01192009|Atrophy|atrophy
556706|NCT01192009|Proteolysis|proteolysis
556707|NCT01191996|SPMS|spms
556708|NCT01191996|PPMS|ppms
556709|NCT01191996|MS|ms
556710|NCT01191996|Multiple Sclerosis|multiple sclerosis
556711|NCT01191970|epidural|epidural
556712|NCT01191970|beta-endorphins|beta-endorphins
556713|NCT01191970|breast-feeding|breast-feeding
556714|NCT01191970|colostrum|colostrum
556715|NCT01191970|feeding|feeding
556716|NCT01191957|Acute Myeloid Leukemia|acute myeloid leukemia
556717|NCT01191957|Allogeneic hematopoietic stem cell transplantation|allogeneic hematopoietic stem cell transplantation
556718|NCT01191918|acetylcholinesterase inhibitor|acetylcholinesterase inhibitor
556719|NCT01191918|donepezil|donepezil
556720|NCT01191918|bipolar disorder|bipolar disorder
556721|NCT01191918|mania|mania
556722|NCT01191918|lithium|lithium
556723|NCT01191892|metastatic transitional cell cancer of the renal pelvis and ureter|metastatic transitional cell cancer of the renal pelvis and ureter
556724|NCT01191892|regional transitional cell cancer of the renal pelvis and ureter|regional transitional cell cancer of the renal pelvis and ureter
556725|NCT01191892|transitional cell carcinoma of the bladder|transitional cell carcinoma of the bladder
556726|NCT01191892|stage III bladder cancer|stage iii bladder cancer
556727|NCT01191892|stage IV bladder cancer|stage iv bladder cancer
556728|NCT01191892|anterior urethral cancer|anterior urethral cancer
556729|NCT01191892|posterior urethral cancer|posterior urethral cancer
556730|NCT01191892|urethral cancer associated with invasive bladder cancer|urethral cancer associated with invasive bladder cancer
556731|NCT01191892|ureter cancer|ureter cancer
556732|NCT01191866|diabetes mellitus|diabetes mellitus
556733|NCT01191866|psychosocial|psychosocial
556734|NCT01191866|metabolic control|metabolic control
556735|NCT01191866|quality of life questionnaires|quality of life questionnaires
556736|NCT01191866|children|children
556737|NCT01191866|adolescents|adolescents
556738|NCT01191853|Post Swine Flu Blood Samples|post swine flu blood samples
707098|NCT00603304|BPH|bph
556739|NCT01191853|Biologic Sample Collection|biologic sample collection
556740|NCT01191853|Laboratory Research Samples|laboratory research samples
556741|NCT01191853|Healthy Volunteer|healthy volunteer
556742|NCT01191853|HV|hv
556743|NCT01191840|staphylococci|staphylococci
556744|NCT01191814|pancreatic cancer|pancreatic cancer
556745|NCT01191814|obstructive jaundice|obstructive jaundice
556746|NCT01191814|Obstructive jaundice secondary to pancreatic cancer|obstructive jaundice secondary to pancreatic cancer
556747|NCT01191801|Leukemia|leukemia
556748|NCT01191801|Acute Myeloid Leukemia|acute myeloid leukemia
556749|NCT01191801|Hematologic|hematologic
556750|NCT01191801|Hematologic diseases|hematologic diseases
556751|NCT01191801|Blood|blood
556752|NCT01191801|Cancer|cancer
556753|NCT01191801|Malignancy|malignancy
556757|NCT01191801|Refractory AML|refractory aml
556758|NCT01191801|VALOR|valor
556759|NCT01191801|Sunesis|sunesis
556760|NCT01191801|Voreloxin|voreloxin
556761|NCT01191801|SNS-595|sns-595
556762|NCT01191788|Depression|depression
556763|NCT01191788|Substance Use|substance use
556764|NCT01191788|Group Cognitive Behavioral Therapy|group cognitive behavioral therapy
556765|NCT01191775|Oligonucleotide|oligonucleotide
556766|NCT01191775|DNAi|dnai
556767|NCT01191775|Oncology|oncology
556768|NCT01191775|Antineoplastic agent|antineoplastic agent
556769|NCT01191775|Lymphoma|lymphoma
556770|NCT01191775|PNT2258|pnt2258
556771|NCT01191762|secondary hyperparathyroidism|secondary hyperparathyroidism
556772|NCT01191762|phosphate|phosphate
556773|NCT01191762|calcium|calcium
556774|NCT01191762|chronic kidney disease|chronic kidney disease
556775|NCT01191749|Hematologic Disorder|hematologic disorder
556776|NCT01191749|Aplastic Anemia|aplastic anemia
556777|NCT01191749|T - Cell Large Granular Lymphocytic Leukemia|t - cell large granular lymphocytic leukemia
556778|NCT01191749|T-LGL|t-lgl
556779|NCT01191749|Myelodysplastic Syndrome|myelodysplastic syndrome
556780|NCT01191749|Chronic Lymphocytic Leukemia|chronic lymphocytic leukemia
556781|NCT01191749|CLL|cll
556782|NCT01191749|Chemotherapy|chemotherapy
556783|NCT01191749|Alemtuzumab|alemtuzumab
556784|NCT01191736|hands only|hands only
556785|NCT01191736|CPR|cpr
556786|NCT01191736|resuscitation|resuscitation
556787|NCT01191736|cardiac arrest|cardiac arrest
556788|NCT01191736|Education of general public regarding resuscitation methods|education of general public regarding resuscitation methods
556789|NCT01191723|Healthy Volunteers|healthy volunteers
556790|NCT01191710|progesterone|progesterone
556791|NCT01191697|HER2 positive|her2 positive
556792|NCT01191671|Child Development|child development
556793|NCT01191671|Child|child
556794|NCT01191671|Daycare centers|daycare centers
556795|NCT01191671|Language|language
556796|NCT01191645|Lower esophageal sphincter pressure|lower esophageal sphincter pressure
556797|NCT01191645|Esophageal motility|esophageal motility
556798|NCT01191645|Remifentanil|remifentanil
556799|NCT01191645|Metoclopramide|metoclopramide
556800|NCT01191645|Naloxone|naloxone
556801|NCT01191645|High resolution solid state manometry|high resolution solid state manometry
556802|NCT01191632|T cell|t cell
556803|NCT01191632|surgery|surgery
556804|NCT01191632|radiation|radiation
556805|NCT01191619|McIvor retractor|mcivor retractor
556806|NCT01191619|Proseal laryngeal mask airway|proseal laryngeal mask airway
556807|NCT01191606|pressure controlled|pressure controlled
556808|NCT01191606|volume controlled|volume controlled
556809|NCT01191606|arterial oxygenation|arterial oxygenation
556810|NCT01191606|one lung ventilation|one lung ventilation
556811|NCT01191593|Adductor-Canal-Blockade|adductor-canal-blockade
556812|NCT01191593|postoperative pain|postoperative pain
556813|NCT01191593|US-guided nerve block|us-guided nerve block
556814|NCT01191593|revision knee arthroplasty|revision knee arthroplasty
556815|NCT01191567|acute wounds|acute wounds
556816|NCT01191567|postoperative wounds|postoperative wounds
556817|NCT01191541|ara-c|ara-c
556818|NCT01191541|As2O3|as2o3
556819|NCT01191541|pediatric|pediatric
556820|NCT01191541|acute|acute
556821|NCT01191528|Adult|adult
556822|NCT01191528|Post|post
556823|NCT01191528|operative|operative
556824|NCT01191528|oximetry|oximetry
556825|NCT01191528|capnometry|capnometry
556826|NCT01191528|Integrated|integrated
556827|NCT01191528|Pulmonary|pulmonary
556828|NCT01191528|Index|index
556829|NCT01191528|End-tidal|end-tidal
556830|NCT01191528|Monitoring Respiratory status|monitoring respiratory status
556831|NCT01191528|post-operative|post-operative
556832|NCT01191515|Previous Cataract patients|previous cataract patients
556833|NCT01191515|Monofocal IOL implant|monofocal iol implant
556834|NCT01191515|Evaluation|evaluation
556835|NCT01191502|Patients who have had binocular implantation of the Tecnis Multifocal IOL or the Crystalens™ HD Accommodating IOL.|patients who have had binocular implantation of the tecnis multifocal iol or the crystalens™ hd accommodating iol.
556836|NCT01191476|Sevoflurane|sevoflurane
556837|NCT01191476|Propofol|propofol
556838|NCT01191476|Economics|economics
556839|NCT01191476|Pharmaceutical|pharmaceutical
556840|NCT01191476|Chinese|chinese
556841|NCT01191450|chlortalidone|chlortalidone
556842|NCT01191450|amiloride|amiloride
556843|NCT01191450|arterial hypertension|arterial hypertension
556844|NCT01191424|Asthma|asthma
556845|NCT01191424|PK|pk
556846|NCT01191424|Adolescents|adolescents
556847|NCT01191424|Adults|adults
556848|NCT01191411|colorectal neoplasms|colorectal neoplasms
556849|NCT01191411|screening|screening
556850|NCT01191398|Hypersalivation|hypersalivation
556851|NCT01191398|Conscious Sedation|conscious sedation
556852|NCT01191398|Procedural Sedation|procedural sedation
556853|NCT01191398|Ketamine|ketamine
556854|NCT01191398|Atropine|atropine
556855|NCT01191398|Glycopyrrolate|glycopyrrolate
556856|NCT01191385|HCC|hcc
556857|NCT01191385|Liver cancer|liver cancer
556858|NCT01191385|Cancer of liver|cancer of liver
556859|NCT01191385|Cancer, liver|cancer, liver
556860|NCT01191385|Hepatic cancer|hepatic cancer
556861|NCT01191385|Cancer, hepatic|cancer, hepatic
556862|NCT01191385|Carcinoma, hepatocellular|carcinoma, hepatocellular
556863|NCT01191372|Hemophilia A|hemophilia a
556864|NCT01191372|Hemophilia B|hemophilia b
556865|NCT01191372|pharmacokinetics|pharmacokinetics
556866|NCT01191372|pharmacodynamics|pharmacodynamics
556867|NCT01191372|Tissue Factor Pathway Inhibitor|tissue factor pathway inhibitor
556868|NCT01191333|Mood Disorder|mood disorder
556869|NCT01191333|Depression|depression
556870|NCT01191333|stress disorder, post-traumatic|stress disorder, post-traumatic
556871|NCT01191333|Depressive Disorder|depressive disorder
556872|NCT01191333|Stress Disorders, Traumatic|stress disorders, traumatic
556873|NCT01191333|substance related disorders|substance related disorders
556874|NCT01191333|Transcranial Magnetic Stimulation, repetitive|transcranial magnetic stimulation, repetitive
556875|NCT01191333|transcranial magnetic stimulation|transcranial magnetic stimulation
556876|NCT01191333|Veterans|veterans
556877|NCT01191333|mental health|mental health
556878|NCT01191320|Adult onset hypogonadotropic hypogonadism|adult onset hypogonadotropic hypogonadism
556879|NCT01191307|Primary dystonia|primary dystonia
556880|NCT01191307|Epilepsy|epilepsy
556881|NCT01191307|Hydrocephalus|hydrocephalus
556882|NCT01191307|Bladder Control|bladder control
556883|NCT01191307|Deaf or Hearing Impaired|deaf or hearing impaired
556884|NCT01191294|Melanoma|melanoma
556885|NCT01191294|Simulation Training|simulation training
556886|NCT01191294|Medical Students|medical students
556887|NCT01191281|food habits|food habits
556888|NCT01191281|nutrition requirements|nutrition requirements
556889|NCT01191281|antiretroviral therapy|antiretroviral therapy
556890|NCT01191255|ESRD|esrd
556891|NCT01191255|end-stage renal disease|end-stage renal disease
556892|NCT01191255|dialysis|dialysis
556893|NCT01191255|hemodialysis|hemodialysis
556894|NCT01191255|peritoneal dialysis|peritoneal dialysis
556895|NCT01191255|hemodialysis (HD)|hemodialysis (hd)
556896|NCT01191255|peritoneal dialysis (PD)|peritoneal dialysis (pd)
556897|NCT01191255|chronic renal insufficiency|chronic renal insufficiency
556898|NCT01191255|phosphate binder|phosphate binder
556899|NCT01191255|kidney failure|kidney failure
556900|NCT01191255|renal failure|renal failure
556901|NCT01191242|methadone|methadone
556902|NCT01191242|genetic|genetic
556903|NCT01191203|Acceptability and Adherence to methods|acceptability and adherence to methods
556904|NCT01191190|Leukemia|leukemia
556905|NCT01191190|Chronic leukemia|chronic leukemia
556906|NCT01191190|Chronic Lymphocytic Leukemia|chronic lymphocytic leukemia
556907|NCT01191190|Relapsed|relapsed
556908|NCT01191190|Refractory|refractory
556909|NCT01191177|oral fish oil|oral fish oil
556910|NCT01191177|Lovaza|lovaza
556911|NCT01191177|Omega-3-acid supplementation|omega-3-acid supplementation
556912|NCT01191164|Brachytherapy, Partial Breast Irradiation, Breast Seed Implant, Palladium Seeds|brachytherapy, partial breast irradiation, breast seed implant, palladium seeds
556913|NCT01191151|Orthopedic surgery|orthopedic surgery
556914|NCT01191151|sports medicine|sports medicine
556915|NCT01191138|Delayed Gastric emptying|delayed gastric emptying
556916|NCT01191138|Gastric emptying scintigraphy|gastric emptying scintigraphy
556917|NCT01191138|Pancreatic fistula|pancreatic fistula
556918|NCT01191138|Pancreatic Neoplasms|pancreatic neoplasms
556919|NCT01191138|Whipple Operation|whipple operation
556920|NCT01191086|Epilepsy|epilepsy
556921|NCT01191086|partial onset seizure|partial onset seizure
556922|NCT01191086|adjunctive therapy|adjunctive therapy
556923|NCT01191073|edentulous|edentulous
556924|NCT01191060|Progression free survival prolongation|progression free survival prolongation
556925|NCT01191060|Disease Progression|disease progression
556926|NCT01191060|Overall survival|overall survival
556927|NCT01191021|breath|breath
556928|NCT01191021|propofol|propofol
556929|NCT01191021|general anesthesia|general anesthesia
556930|NCT01191008|Xalacom Regulatory post marketing commitment plan safety|xalacom regulatory post marketing commitment plan safety
556931|NCT01190995|Pain|pain
556932|NCT01190995|Neonate|neonate
556933|NCT01190995|Procedure|procedure
556934|NCT01190995|Neurobehavioural outcome|neurobehavioural outcome
556935|NCT01190969|Elderly|elderly
556936|NCT01190969|malnutrition|malnutrition
556937|NCT01190969|nutritional supplement|nutritional supplement
556938|NCT01190917|Autism|autism
556939|NCT01190917|Autism Spectrum Disorder|autism spectrum disorder
556940|NCT01190917|Disorder|disorder
556941|NCT01190917|Autistic|autistic
556942|NCT01190917|Asperger Syndrome|asperger syndrome
556943|NCT01190917|social skills group|social skills group
556944|NCT01190917|behavioral intervention|behavioral intervention
556945|NCT01190917|Imaging, Magnetic Resonance|imaging, magnetic resonance
556946|NCT01190917|fMRI|fmri
556947|NCT01190917|Functional MRI|functional mri
556948|NCT01190917|MRI, Functional|mri, functional
556949|NCT01190917|Magnetic Resonance Imaging|magnetic resonance imaging
556950|NCT01190917|Functional|functional
556951|NCT01190904|Androgen deficiency|androgen deficiency
556952|NCT01190904|Erectile dysfunction|erectile dysfunction
556953|NCT01190904|Coronary Artery Disease|coronary artery disease
556954|NCT01190904|Coronary Revascularization|coronary revascularization
556955|NCT01190904|Diabetes mellitus|diabetes mellitus
556956|NCT01190904|MI|mi
556957|NCT01190904|Stroke|stroke
556958|NCT01190904|MACCE|macce
556959|NCT01190904|DM|dm
556960|NCT01190904|ED|ed
556961|NCT01190904|CAD|cad
556962|NCT01190904|Development of predictive cardiovascular/cerebrovascular AE|development of predictive cardiovascular/cerebrovascular ae
556963|NCT01190891|Rotator cuff tendonitis|rotator cuff tendonitis
556964|NCT01190891|Shoulder pain|shoulder pain
556965|NCT01190891|Shoulder impingement|shoulder impingement
556966|NCT01190839|Crohn's Disease|crohn's disease
556967|NCT01190839|Inflammatory Bowel Disease|inflammatory bowel disease
556968|NCT01190839|infliximab|infliximab
556969|NCT01190839|TNF-alpha|tnf-alpha
556970|NCT01190826|Stable moderate asthma|stable moderate asthma
556971|NCT01190813|amblyopia, levodopa|amblyopia, levodopa
556972|NCT01190800|Alzheimer's Disease|alzheimer's disease
556973|NCT01190800|Capacity assessment|capacity assessment
556974|NCT01190800|Decision-making assessment|decision-making assessment
556975|NCT01190800|Capacity to consent to treatment|capacity to consent to treatment
556976|NCT01190800|Capacity to vote|capacity to vote
556977|NCT01190800|Capacity to appoint a proxy|capacity to appoint a proxy
556978|NCT01190787|Multiple Myeloma|multiple myeloma
556979|NCT01190787|Elderly Patients|elderly patients
556980|NCT01190787|Diagnosis|diagnosis
556981|NCT01190787|Velcade subcutaneous|velcade subcutaneous
556982|NCT01190787|Prednisone|prednisone
556983|NCT01190787|Melphalan|melphalan
556984|NCT01190787|Cyclophosphamide|cyclophosphamide
556985|NCT01190774|dental anxiety|dental anxiety
556986|NCT01190774|state anxiety|state anxiety
556987|NCT01190774|randomised control trial|randomised control trial
556988|NCT01190774|psychological intervention|psychological intervention
556989|NCT01190761|Bioequivalence|bioequivalence
556990|NCT01190761|Galantamine|galantamine
556991|NCT01190761|Reminyl|reminyl
556992|NCT01190761|Galantamine hydrobromide|galantamine hydrobromide
556993|NCT01190761|Healthy subjects|healthy subjects
556994|NCT01190748|Bioequivalence|bioequivalence
556995|NCT01190748|Galantamine|galantamine
556996|NCT01190748|Reminyl|reminyl
556997|NCT01190748|Galantamine hydrobromide|galantamine hydrobromide
556998|NCT01190748|Healthy subjects|healthy subjects
556999|NCT01190735|Caffeine|caffeine
557000|NCT01190735|Parkinson's Disease|parkinson's disease
557001|NCT01190735|Parkinson Disease|parkinson disease
557002|NCT01190735|Parkinsonian Disorders|parkinsonian disorders
557003|NCT01190735|Basal Ganglia Diseases|basal ganglia diseases
557004|NCT01190735|Brain Diseases|brain diseases
557005|NCT01190735|Central Nervous System Diseases|central nervous system diseases
557006|NCT01190735|Nervous System Diseases|nervous system diseases
557007|NCT01190735|Movement Disorders|movement disorders
557008|NCT01190735|Neurodegenerative Diseases|neurodegenerative diseases
557009|NCT01190735|Caffeine citrate|caffeine citrate
557010|NCT01190735|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action
557011|NCT01190735|Pharmacologic Actions|pharmacologic actions
557012|NCT01190735|Central Nervous System Stimulants|central nervous system stimulants
557013|NCT01190735|Physiological Effects of Drugs|physiological effects of drugs
557014|NCT01190735|Central Nervous System Agents|central nervous system agents
557015|NCT01190735|Therapeutic Uses|therapeutic uses
557016|NCT01190722|Day case surgery|day case surgery
557017|NCT01190722|postoperative pain|postoperative pain
557018|NCT01190722|NSAIDs|nsaids
557019|NCT01190722|Coxibs|coxibs
557020|NCT01190709|Close Fracture|close fracture
557021|NCT01190709|Tibia|tibia
557022|NCT01190709|Unreamed Intramedullary Nailing|unreamed intramedullary nailing
557023|NCT01190709|Dynamic Compression Plate|dynamic compression plate
557024|NCT01190696|Spica Cast|spica cast
557025|NCT01190696|TEN|ten
557026|NCT01190696|Femoral Shaft Fracture|femoral shaft fracture
557027|NCT01190696|Children|children
557028|NCT01190670|ASP015K|asp015k
557029|NCT01190670|tacrolimus|tacrolimus
557030|NCT01190670|healthy volunteers|healthy volunteers
557031|NCT01190657|Teprenone|teprenone
557032|NCT01190657|safety|safety
557033|NCT01190657|efficacy|efficacy
557034|NCT01190657|acute gastric lesion|acute gastric lesion
557035|NCT01190657|chronic gastritis|chronic gastritis
557036|NCT01190644|Red Blood Cell Mass|red blood cell mass
557037|NCT01190644|Plasma Volume|plasma volume
557038|NCT01190644|Solid Tumors|solid tumors
557039|NCT01190631|intraocular lens|intraocular lens
557040|NCT01190631|cataracts|cataracts
557041|NCT01190631|total residual spherical aberration|total residual spherical aberration
557042|NCT01190631|high order aberrations|high order aberrations
557043|NCT01190605|HIV|hiv
557044|NCT01190605|postpartum|postpartum
557045|NCT01190605|postpartum entry into HIV care|postpartum entry into hiv care
557046|NCT01190592|Resistance training|resistance training
557047|NCT01190592|Body Composition|body composition
557048|NCT01190592|Cardiovascular Risk factors|cardiovascular risk factors
557049|NCT01190592|Dairy|dairy
557050|NCT01190579|Coronary Artery Disease|coronary artery disease
557051|NCT01190579|Chest Pain|chest pain
557052|NCT01190579|Computed Tomography|computed tomography
557825|NCT01187095|Infertility|infertility
557053|NCT01190566|Magnetic Resonance Imaging, Functional|magnetic resonance imaging, functional
557054|NCT01190566|Tomography, Positron-Emission|tomography, positron-emission
557055|NCT01190566|chemotherapy|chemotherapy
557056|NCT01190553|amantadine|amantadine
557057|NCT01190553|parkinson disease|parkinson disease
557058|NCT01190553|dyskinesia|dyskinesia
557059|NCT01190540|On site support services.|on site support services.
557060|NCT01190540|mid level health professionals.|mid level health professionals.
557061|NCT01190540|cost effectiveness.|cost effectiveness.
557062|NCT01190540|infectious disease.|infectious disease.
557063|NCT01190540|capacity building.|capacity building.
557064|NCT01190514|DVS SR|dvs sr
557065|NCT01190514|healthy|healthy
557066|NCT01190514|Bioequivalence study|bioequivalence study
557067|NCT01190501|blood pressure|blood pressure
557068|NCT01190501|antihypertensive treatments|antihypertensive treatments
557069|NCT01190488|End of life decision making|end of life decision making
557070|NCT01190488|End of life decision aid|end of life decision aid
557071|NCT01190488|Palliative care decision making|palliative care decision making
557072|NCT01190488|Palliative care decision aid|palliative care decision aid
557073|NCT01190488|Advanced care planning|advanced care planning
557074|NCT01190488|Decision Aid|decision aid
557075|NCT01190475|Endometriosis|endometriosis
557076|NCT01190475|Infertility|infertility
557077|NCT01190475|Pain|pain
557078|NCT01190475|Vaginal Diseases|vaginal diseases
557079|NCT01190475|Uterine Diseases|uterine diseases
557080|NCT01190462|recurrent colon cancer|recurrent colon cancer
557081|NCT01190462|stage III colon cancer|stage iii colon cancer
557082|NCT01190462|stage IV colon cancer|stage iv colon cancer
557083|NCT01190462|recurrent rectal cancer|recurrent rectal cancer
557084|NCT01190462|stage III rectal cancer|stage iii rectal cancer
557085|NCT01190462|stage IV rectal cancer|stage iv rectal cancer
557086|NCT01190449|stage III grade 1 follicular lymphoma|stage iii grade 1 follicular lymphoma
557087|NCT01190449|stage III grade 2 follicular lymphoma|stage iii grade 2 follicular lymphoma
557088|NCT01190449|stage III grade 3 follicular lymphoma|stage iii grade 3 follicular lymphoma
557089|NCT01190449|stage IV grade 1 follicular lymphoma|stage iv grade 1 follicular lymphoma
557090|NCT01190449|stage IV grade 2 follicular lymphoma|stage iv grade 2 follicular lymphoma
557091|NCT01190449|stage IV grade 3 follicular lymphoma|stage iv grade 3 follicular lymphoma
557092|NCT01190449|contiguous stage II grade 1 follicular lymphoma|contiguous stage ii grade 1 follicular lymphoma
557093|NCT01190449|contiguous stage II grade 2 follicular lymphoma|contiguous stage ii grade 2 follicular lymphoma
557094|NCT01190449|contiguous stage II grade 3 follicular lymphoma|contiguous stage ii grade 3 follicular lymphoma
557095|NCT01190449|noncontiguous stage II grade 1 follicular lymphoma|noncontiguous stage ii grade 1 follicular lymphoma
557096|NCT01190449|noncontiguous stage II grade 2 follicular lymphoma|noncontiguous stage ii grade 2 follicular lymphoma
557097|NCT01190449|noncontiguous stage II grade 3 follicular lymphoma|noncontiguous stage ii grade 3 follicular lymphoma
557098|NCT01190436|Hypertension|hypertension
557099|NCT01190436|Diabetes Mellitus|diabetes mellitus
557100|NCT01190436|Bisoprolol|bisoprolol
557101|NCT01190423|AN|an
557102|NCT01190410|Certolizumab Pegol|certolizumab pegol
557103|NCT01190410|Cimzia®|cimzia®
557104|NCT01190410|Crohn's Disease|crohn's disease
557105|NCT01190410|Children and Adolescents with Crohn's Disease|children and adolescents with crohn's disease
557106|NCT01190397|Warming goggles|warming goggles
557107|NCT01190384|Metabolic Syndrome|metabolic syndrome
557108|NCT01190384|Inflammation|inflammation
557109|NCT01190384|Antioxidants|antioxidants
557110|NCT01190384|Satiety|satiety
557111|NCT01190384|Fiber|fiber
557112|NCT01190371|Artemisinin tolerance|artemisinin tolerance
557113|NCT01190345|breast cancer|breast cancer
557114|NCT01190332|common bile duct stones|common bile duct stones
557115|NCT01190319|blood pressure|blood pressure
557116|NCT01190319|strawberry|strawberry
557117|NCT01190319|fruit phenolics|fruit phenolics
557118|NCT01190319|LDL oxidation|ldl oxidation
557119|NCT01190319|Flow mediated dilation (FMD)|flow mediated dilation (fmd)
557120|NCT01190254|Asenapine|asenapine
557121|NCT01190254|adolescents|adolescents
557122|NCT01190254|schizophrenia|schizophrenia
557123|NCT01190254|phase IIIb|phase iiib
557124|NCT01190254|placebo-controlled|placebo-controlled
557125|NCT01190241|targeted therapy|targeted therapy
557126|NCT01190241|individualized medicine|individualized medicine
557127|NCT01190241|tyrosine kinase inhibitor|tyrosine kinase inhibitor
557128|NCT01190241|kinome profiling|kinome profiling
557129|NCT01190241|Metastasized|metastasized
557130|NCT01190228|Japanese Encephalitis|japanese encephalitis
557131|NCT01190228|Japanese encephalitis chimeric virus vaccine|japanese encephalitis chimeric virus vaccine
557132|NCT01190228|Varicella|varicella
557133|NCT01190228|Varicella vaccine|varicella vaccine
557134|NCT01190215|Influenza|influenza
557135|NCT01190215|Pandemrix|pandemrix
557136|NCT01190215|H1N1|h1n1
557137|NCT01190215|Fluarix|fluarix
557138|NCT01190202|Malaria|malaria
557139|NCT01190202|Plasmodium falciparum|plasmodium falciparum
557140|NCT01190189|Serious adverse events (SAEs)|serious adverse events (saes)
557141|NCT01190189|HPV vaccine|hpv vaccine
557142|NCT01190189|Medically significant conditions|medically significant conditions
557143|NCT01190189|Cervical neoplasia|cervical neoplasia
557144|NCT01190176|HPV|hpv
557145|NCT01190176|HPV vaccine|hpv vaccine
557146|NCT01190176|Cervical neoplasia|cervical neoplasia
557147|NCT01190176|Human papillomavirus|human papillomavirus
557148|NCT01190176|Papillomavirus|papillomavirus
557149|NCT01190176|Cervical cancer|cervical cancer
557150|NCT01190176|Human papillomavirus (HPV) type 16/18 infections|human papillomavirus (hpv) type 16/18 infections
557151|NCT01190163|Vaginal Birth delivery within 24 hours and C-section rate|vaginal birth delivery within 24 hours and c-section rate
557152|NCT01190150|Cyclic Heavy Menstrual Bleed|cyclic heavy menstrual bleed
557153|NCT01190150|Menorraghia|menorraghia
557154|NCT01190137|Optimal vitamin D status|optimal vitamin d status
557155|NCT01190137|25-hydroxy vitamin D|25-hydroxy vitamin d
557156|NCT01190137|Rickets and bone mineralization|rickets and bone mineralization
557157|NCT01190137|Breast fed infants|breast fed infants
557158|NCT01190137|Cholecalciferol and ergocalciferol|cholecalciferol and ergocalciferol
557159|NCT01190124|HIV infections|hiv infections
557160|NCT01190124|HIV-1|hiv-1
557161|NCT01190124|HIV-2|hiv-2
557162|NCT01190124|Acquired Immunodeficiency Syndrome|acquired immunodeficiency syndrome
557163|NCT01190124|AIDS|aids
557164|NCT01190124|Anti-Retroviral Agents|anti-retroviral agents
557165|NCT01190124|Raltegravir|raltegravir
557166|NCT01190124|Integrase Inhibitors|integrase inhibitors
557167|NCT01190124|multiple-experienced HIV infected patients|multiple-experienced hiv infected patients
557168|NCT01190111|interleukin-7|interleukin-7
557169|NCT01190111|immune-based therapy|immune-based therapy
557170|NCT01190111|HIV|hiv
557171|NCT01190111|viral disease|viral disease
557172|NCT01190098|Partial epilepsy|partial epilepsy
557173|NCT01190098|Excessive daytime sleepiness|excessive daytime sleepiness
557174|NCT01190098|Epworth Sleepiness Scale|epworth sleepiness scale
557175|NCT01190098|Maintenance of Wakefulness Test|maintenance of wakefulness test
557176|NCT01190085|alcoholism|alcoholism
557177|NCT01190085|ghrelin|ghrelin
557178|NCT01190085|craving|craving
557179|NCT01190072|Blood lipids|blood lipids
557180|NCT01190072|percutaneous coronary intervention|percutaneous coronary intervention
557181|NCT01190072|lipid lowering treatment|lipid lowering treatment
557182|NCT01190059|Lung|lung
557183|NCT01190059|Transplantation|transplantation
557184|NCT01190059|Lung Transplantation|lung transplantation
557185|NCT01190059|Transplantation Lung|transplantation lung
557186|NCT01190046|elderly|elderly
557187|NCT01190046|muscle|muscle
557188|NCT01190046|disuse|disuse
557189|NCT01190046|osteoarthritis|osteoarthritis
557190|NCT01190046|exercise|exercise
557191|NCT01189994|Fibromyalgia|fibromyalgia
557192|NCT01189994|Acupuncture|acupuncture
557193|NCT01189994|Randomized Controlled Trial|randomized controlled trial
557194|NCT01189994|Pain|pain
557195|NCT01189994|Quality of Life|quality of life
557196|NCT01189968|Phase 1,|phase 1,
557197|NCT01189968|dose escalation,|dose escalation,
557198|NCT01189968|histologically|histologically
557199|NCT01189968|confirmed|confirmed
557200|NCT01189968|malignancy|malignancy
557201|NCT01189968|metastatic|metastatic
557202|NCT01189955|thyroidectomy|thyroidectomy
557203|NCT01189955|harmonic|harmonic
557204|NCT01189955|RLN|rln
557205|NCT01189942|Phase 1|phase 1
557206|NCT01189942|dose escalation|dose escalation
557207|NCT01189942|histologically|histologically
557208|NCT01189942|confirmed|confirmed
557209|NCT01189942|malignancy|malignancy
557210|NCT01189942|metastatic|metastatic
557211|NCT01189929|Phase 1,|phase 1,
557212|NCT01189929|dose escalation,|dose escalation,
557213|NCT01189929|histologically|histologically
557214|NCT01189929|cytologically|cytologically
557215|NCT01189929|confirmed|confirmed
557216|NCT01189929|malignancy|malignancy
557217|NCT01189929|metastatic|metastatic
710263|NCT00589563|stage II childhood Hodgkin lymphoma|stage ii childhood hodgkin lymphoma
710264|NCT00589563|stage II cutaneous T-cell non-Hodgkin lymphoma|stage ii cutaneous t-cell non-hodgkin lymphoma
557218|NCT01189890|Type 2 Diabetes Mellitus, Hemoglobin A1C, glucagon-like peptide 1 (GLP-1), gastric inhibitory polypeptide (GIP), dipeptidyl peptidase 4 inhibitor (DPP-4)|type 2 diabetes mellitus, hemoglobin a1c, glucagon-like peptide 1 (glp-1), gastric inhibitory polypeptide (gip), dipeptidyl peptidase 4 inhibitor (dpp-4)
557219|NCT01189877|Direct pO2 Measurements|direct po2 measurements
557220|NCT01189877|10-121|10-121
557221|NCT01189851|breast|breast
557222|NCT01189851|IORT|iort
557223|NCT01189851|electronic brachytherapy|electronic brachytherapy
557224|NCT01189838|Cancer|cancer
557225|NCT01189838|cysteine-rich 61|cysteine-rich 61
557226|NCT01189838|prognosis|prognosis
557227|NCT01189838|transitional cell carcinoma|transitional cell carcinoma
557228|NCT01189825|Physiological|physiological
557229|NCT01189825|Antidepressive Agents|antidepressive agents
557230|NCT01189812|hopelessness|hopelessness
557231|NCT01189812|alone|alone
557232|NCT01189812|sad|sad
557233|NCT01189812|troubled|troubled
557234|NCT01189812|depression|depression
557235|NCT01189799|Co-occurring Disorders|co-occurring disorders
557236|NCT01189799|Depression|depression
557237|NCT01189799|Substance Dependence|substance dependence
557238|NCT01189799|Motivational Therapy|motivational therapy
557239|NCT01189799|Aftercare|aftercare
557240|NCT01189799|Cognitive Behavioral Therapy|cognitive behavioral therapy
557826|NCT01187095|IVF|ivf
557241|NCT01189786|Haploidentical Stem Cell Transplant|haploidentical stem cell transplant
557242|NCT01189786|CD34+ Selection|cd34+ selection
557243|NCT01189786|CliniMACS CD34 Reagent system|clinimacs cd34 reagent system
557244|NCT01189773|pain control|pain control
557245|NCT01189773|limb trauma|limb trauma
557246|NCT01189734|common bile duct stones|common bile duct stones
557247|NCT01189734|laparoscopic common bile duct exploration|laparoscopic common bile duct exploration
557248|NCT01189734|intraoperative ercp|intraoperative ercp
557249|NCT01189734|Preoperatively diagnosed common bile duct stones|preoperatively diagnosed common bile duct stones
557250|NCT01189721|remifentanil|remifentanil
557251|NCT01189721|hyperalgesia|hyperalgesia
557252|NCT01189708|Abdominal aortic aneurysm|abdominal aortic aneurysm
557253|NCT01189708|Abdominal hernia|abdominal hernia
557254|NCT01189695|HIV or AIDS|hiv or aids
557255|NCT01189695|Lopinavir|lopinavir
557256|NCT01189695|Ritonavir|ritonavir
557257|NCT01189695|Anti-Retroviral Agents|anti-retroviral agents
557258|NCT01189695|treatment failure|treatment failure
557259|NCT01189695|treatment experienced|treatment experienced
557260|NCT01189695|NNRTI failure|nnrti failure
557261|NCT01189695|monotherapy|monotherapy
557262|NCT01189682|catheter|catheter
557263|NCT01189682|dressing|dressing
557264|NCT01189682|chlorhexidine|chlorhexidine
557265|NCT01189682|Patient admitted in ICU with a CVC or art. catheter|patient admitted in icu with a cvc or art. catheter
557266|NCT01189669|PCOS|pcos
557267|NCT01189656|Chronic hepatitis B patients|chronic hepatitis b patients
557268|NCT01189643|BEVACIZUMAB (AVASTIN)|bevacizumab (avastin)
557269|NCT01189643|IRINOTECAN (CPT-11) CAMPTOSAR|irinotecan (cpt-11) camptosar
557270|NCT01189643|TEMOZOLOMIDE|temozolomide
557271|NCT01189643|DSRCT|dsrct
557272|NCT01189643|10-091|10-091
557273|NCT01189630|"Real World Electronic Database with clinical information"|"real world electronic database with clinical information"
557274|NCT01189630|related to Implantable Cardiac devices.|related to implantable cardiac devices.
557275|NCT01189617|Personal Lubricant|personal lubricant
557276|NCT01189604|propofol endoscopy sedation|propofol endoscopy sedation
557277|NCT01189578|Recreational|recreational
557278|NCT01189578|cocaine|cocaine
557279|NCT01189578|fMRI|fmri
557280|NCT01189578|neuroimaging|neuroimaging
557281|NCT01189578|craving|craving
557282|NCT01189578|impulsivity|impulsivity
557283|NCT01189565|Total Hip Replacement/Revision|total hip replacement/revision
557284|NCT01189526|Branch retinal vein occlusion|branch retinal vein occlusion
557285|NCT01189526|macular edema|macular edema
557286|NCT01189526|intravitreal injection|intravitreal injection
557287|NCT01189526|ranibizumab|ranibizumab
557288|NCT01189513|Recurrent Glioblastoma|recurrent glioblastoma
557289|NCT01189513|Gliosarcoma|gliosarcoma
557290|NCT01189513|SCH 900105|sch 900105
557291|NCT01189500|Pharmacokinetic|pharmacokinetic
557292|NCT01189500|safety and tolerability|safety and tolerability
557293|NCT01189500|genetic testing|genetic testing
557294|NCT01189500|CYP 2D6|cyp 2d6
557295|NCT01189487|ampicillin sodium/sulbactam sodium|ampicillin sodium/sulbactam sodium
557296|NCT01189487|Unasyn-S|unasyn-s
557297|NCT01189487|community acquired pneumonia|community acquired pneumonia
557298|NCT01189487|bacterial pneumonia|bacterial pneumonia
557299|NCT01189474|Meibomian Gland Dysfunction|meibomian gland dysfunction
557300|NCT01189461|pegaptanib sodium|pegaptanib sodium
557301|NCT01189461|diabetic macular edema|diabetic macular edema
557302|NCT01189448|Congenital Toxoplasmosis,|congenital toxoplasmosis,
557303|NCT01189448|Pregnancy,|pregnancy,
557304|NCT01189448|prenatal diagnosis,|prenatal diagnosis,
557305|NCT01189448|mother-to-child transmission,|mother-to-child transmission,
557306|NCT01189448|prevention,|prevention,
557307|NCT01189448|spiramycine,|spiramycine,
557308|NCT01189448|pyrimethamine-sulfadiazine|pyrimethamine-sulfadiazine
557309|NCT01189435|OSI-774, TARCEVA (ERLOTINIB)|osi-774, tarceva (erlotinib)
557310|NCT01189435|Lung|lung
557311|NCT01189435|recurrent|recurrent
557312|NCT01189435|10-097|10-097
557313|NCT01189435|Gefitinib|gefitinib
557314|NCT01189422|Type 1 Diabetes Mellitus|type 1 diabetes mellitus
557315|NCT01189422|T1DM|t1dm
557316|NCT01189409|Constipation|constipation
557317|NCT01189409|Opioids|opioids
557318|NCT01189409|Cancer|cancer
557319|NCT01189409|Polyethylene glycol|polyethylene glycol
557320|NCT01189409|Sennosides|sennosides
557321|NCT01189409|Opioid Therapy|opioid therapy
557322|NCT01189396|asthma|asthma
557323|NCT01189396|bronchospasm|bronchospasm
557324|NCT01189396|COPD|copd
557325|NCT01189396|reversibility|reversibility
557326|NCT01189396|efficacy|efficacy
557327|NCT01189383|Melanoma|melanoma
557328|NCT01189383|Vaccine|vaccine
557329|NCT01189383|Dendritic Cell|dendritic cell
557330|NCT01189383|Immune response|immune response
557331|NCT01189383|Safety|safety
557332|NCT01189383|Efficacy|efficacy
557333|NCT01189370|carcinoma, renal cell|carcinoma, renal cell
557334|NCT01189370|kidney|kidney
557335|NCT01189370|cancer|cancer
557336|NCT01189357|meniscal transplant|meniscal transplant
557337|NCT01189344|Obesity|obesity
557338|NCT01189344|LT4|lt4
557339|NCT01189344|Absorption|absorption
557340|NCT01189344|Thyroid function|thyroid function
557341|NCT01189331|Coronary artery disease|coronary artery disease
557342|NCT01189331|CT|ct
557343|NCT01189331|Computational flow dynamics|computational flow dynamics
557344|NCT01189305|Drug Abuse|drug abuse
557345|NCT01189305|Female Patients|female patients
557346|NCT01189292|postoperative nausea and vomitus|postoperative nausea and vomitus
557347|NCT01189292|PONV|ponv
557348|NCT01189292|thyroid surgery|thyroid surgery
557349|NCT01189253|stage III adult soft tissue sarcoma|stage iii adult soft tissue sarcoma
557350|NCT01189253|stage IV adult soft tissue sarcoma|stage iv adult soft tissue sarcoma
557351|NCT01189253|adult alveolar soft-part sarcoma|adult alveolar soft-part sarcoma
557352|NCT01189253|adult angiosarcoma|adult angiosarcoma
557353|NCT01189253|adult desmoplastic small round cell tumor|adult desmoplastic small round cell tumor
557354|NCT01189253|adult epithelioid sarcoma|adult epithelioid sarcoma
557355|NCT01189253|adult extraskeletal chondrosarcoma|adult extraskeletal chondrosarcoma
557356|NCT01189253|adult extraskeletal osteosarcoma|adult extraskeletal osteosarcoma
557357|NCT01189253|adult fibrosarcoma|adult fibrosarcoma
557358|NCT01189253|adult leiomyosarcoma|adult leiomyosarcoma
557359|NCT01189253|adult malignant fibrous histiocytoma|adult malignant fibrous histiocytoma
557360|NCT01189253|adult malignant hemangiopericytoma|adult malignant hemangiopericytoma
557361|NCT01189253|adult malignant mesenchymoma|adult malignant mesenchymoma
557362|NCT01189253|adult neurofibrosarcoma|adult neurofibrosarcoma
557363|NCT01189253|adult synovial sarcoma|adult synovial sarcoma
557364|NCT01189227|stage IV colon cancer|stage iv colon cancer
557365|NCT01189227|adenocarcinoma of the colon|adenocarcinoma of the colon
557366|NCT01189227|stage IV rectal cancer|stage iv rectal cancer
557367|NCT01189227|adenocarcinoma of the rectum|adenocarcinoma of the rectum
557368|NCT01189227|liver metastases|liver metastases
557369|NCT01189162|Primary treatment of RDS and treatment of RDS post extubation|primary treatment of rds and treatment of rds post extubation
557370|NCT01189136|Voiding dysfunction|voiding dysfunction
557371|NCT01189123|influenza|influenza
557372|NCT01189123|vaccine|vaccine
557373|NCT01189123|cell mediated immunity|cell mediated immunity
557374|NCT01189123|elderly|elderly
557375|NCT01189123|high dose influenza vaccine|high dose influenza vaccine
557376|NCT01189110|smoking cessation|smoking cessation
557377|NCT01189110|veterans|veterans
557378|NCT01189110|auriculotherapy|auriculotherapy
557379|NCT01189084|Alzheimer's disease|alzheimer's disease
557380|NCT01189084|amyloid beta|amyloid beta
557381|NCT01189084|vaccine|vaccine
557382|NCT01189071|Stents [E07.695.750]|stents [e07.695.750]
557383|NCT01189071|Darifenacin (C101207)|darifenacin (c101207)
557384|NCT01189071|Kidney calculi|kidney calculi
557385|NCT01189058|Perinatal stroke|perinatal stroke
557386|NCT01189058|Periventricular venous infarction|periventricular venous infarction
557387|NCT01189058|Presumed perinatal stroke|presumed perinatal stroke
557388|NCT01189058|Neonatal stroke|neonatal stroke
557389|NCT01189058|Arterial ischemic stroke|arterial ischemic stroke
557390|NCT01189058|Fetal stroke|fetal stroke
557391|NCT01189058|Transcranial magnetic stimulation|transcranial magnetic stimulation
557392|NCT01189058|Constraint-induced movement therapy|constraint-induced movement therapy
557393|NCT01189058|CIMT|cimt
557394|NCT01189058|Cerebral palsy|cerebral palsy
557395|NCT01189058|Congenital hemiplegia|congenital hemiplegia
557396|NCT01189058|Hemiplegic cerebral palsy|hemiplegic cerebral palsy
557397|NCT01189058|Neuroplasticity|neuroplasticity
557398|NCT01189058|Developmental plasticity|developmental plasticity
557399|NCT01189045|Stroke|stroke
557400|NCT01189045|Exercise|exercise
557401|NCT01189045|Rehabilitation|rehabilitation
557402|NCT01189045|Risk factors|risk factors
557403|NCT01189019|ranibizumab|ranibizumab
557404|NCT01189019|Wet macular degeneration|wet macular degeneration
557405|NCT01189019|macular degeneration|macular degeneration
557406|NCT01189019|PED|ped
557407|NCT01189019|Retinal Pigment Epithelial Detachment|retinal pigment epithelial detachment
557408|NCT01188967|Drugs, Investigational|drugs, investigational
557409|NCT01188967|Nicotine Dependence|nicotine dependence
557410|NCT01188967|Therapies for Relapse to Nicotine|therapies for relapse to nicotine
557411|NCT01188967|Relapse Prevention|relapse prevention
557412|NCT01188967|Smoking Cessation|smoking cessation
557413|NCT01188967|Nicotine Cessation Therapies|nicotine cessation therapies
557414|NCT01188954|Seroma|seroma
557415|NCT01188954|Doxycycline|doxycycline
557416|NCT01188954|Cardiopulmonary By-Pass|cardiopulmonary by-pass
557417|NCT01188954|Femoral Artery/Vein Cannulation|femoral artery/vein cannulation
557418|NCT01188954|Prevent Seroma Formation|prevent seroma formation
557419|NCT01188915|Hodgkin disease|hodgkin disease
557420|NCT01188915|Breast cancer|breast cancer
557421|NCT01188889|Chronic Myeloid Leukemia|chronic myeloid leukemia
557422|NCT01188876|carboplatin|carboplatin
557423|NCT01188876|recurrent|recurrent
557424|NCT01188876|platinum sensitive|platinum sensitive
557425|NCT01188876|pralatrexate|pralatrexate
557426|NCT01188850|CIN 2 or 3|cin 2 or 3
557427|NCT01188850|cervical cancer|cervical cancer
557428|NCT01188850|Human Papillomavirus (HPV)|human papillomavirus (hpv)
557429|NCT01188837|Osteoarthritis, Knee|osteoarthritis, knee
557430|NCT01188837|Manipulation Therapy|manipulation therapy
557431|NCT01188811|Multiple Sclerosis|multiple sclerosis
557432|NCT01188811|Multiple sclerosis, chronic progressive|multiple sclerosis, chronic progressive
557433|NCT01188811|Neuroprotective agents|neuroprotective agents
557434|NCT01188811|Magnetic resonance imaging|magnetic resonance imaging
557435|NCT01188811|Optical coherence tomography|optical coherence tomography
557436|NCT01188811|Gait|gait
557437|NCT01188811|Thioctic acid|thioctic acid
557438|NCT01188811|Alpha-lipoic acid|alpha-lipoic acid
557439|NCT01188798|Allogeneic Bone Marrow Transplantation|allogeneic bone marrow transplantation
557440|NCT01188798|Graft versus host disease|graft versus host disease
557441|NCT01188798|Tacrolimus|tacrolimus
557442|NCT01188798|Sirolimus|sirolimus
557443|NCT01188798|Methotrexate|methotrexate
557444|NCT01188798|Pentostatin|pentostatin
557445|NCT01188785|siRNA|sirna
557446|NCT01188785|RNA interference (RNAi)|rna interference (rnai)
557447|NCT01188785|Cancer|cancer
557448|NCT01188785|Pancreatic ductal adenocarcinoma|pancreatic ductal adenocarcinoma
557449|NCT01188785|Pancreatic cancer|pancreatic cancer
557450|NCT01188785|Solid tumor|solid tumor
557451|NCT01188785|Operable pancreatic ductal adenocarcinoma|operable pancreatic ductal adenocarcinoma
557452|NCT01188785|Non operable pancreatic ductal adenocarcinoma|non operable pancreatic ductal adenocarcinoma
557453|NCT01188772|Hepatitis C Virus|hepatitis c virus
557454|NCT01188772|HCV|hcv
557455|NCT01188772|hepatitis|hepatitis
557456|NCT01188772|Genotype 1|genotype 1
557457|NCT01188772|Genotype 2|genotype 2
557458|NCT01188772|Genotype 3|genotype 3
557459|NCT01188759|Aspergillosis|aspergillosis
557460|NCT01188759|Combination Therapy|combination therapy
557461|NCT01188759|Voriconazole|voriconazole
557462|NCT01188759|Anidulafungin|anidulafungin
557463|NCT01188746|catheter|catheter
557464|NCT01188746|palliative|palliative
557465|NCT01188746|quality of life|quality of life
557466|NCT01188746|10-059|10-059
557467|NCT01188733|portal hypertension|portal hypertension
557468|NCT01188733|varices|varices
557469|NCT01188733|cirrhosis|cirrhosis
557470|NCT01188733|octreotide|octreotide
557471|NCT01188733|somatostatin analog|somatostatin analog
557472|NCT01188733|Child Pugh Class A,B|child pugh class a,b
557473|NCT01188707|Non small cell lung cancer|non small cell lung cancer
557474|NCT01188707|Belinostat|belinostat
557475|NCT01188707|Erlotinib|erlotinib
557476|NCT01188707|HDAC inhibitor|hdac inhibitor
557477|NCT01188707|Phase I/II|phase i/ii
557478|NCT01188681|CLL|cll
557479|NCT01188681|TRU-016|tru-016
557480|NCT01188681|chronic lymphocytic leukemia|chronic lymphocytic leukemia
557481|NCT01188681|relapsed CLL|relapsed cll
557482|NCT01188681|bendamustine|bendamustine
557483|NCT01188668|Pharmacokinetic|pharmacokinetic
557484|NCT01188668|safety and tolerability|safety and tolerability
557485|NCT01188668|genetic testing|genetic testing
557486|NCT01188668|CYP 2D6 and CYP 3A4|cyp 2d6 and cyp 3a4
557487|NCT01188655|Ankylosing Spondylitis|ankylosing spondylitis
557488|NCT01188642|childhood obesity|childhood obesity
557489|NCT01188642|adipocytokines|adipocytokines
557490|NCT01188642|physical exercise|physical exercise
557491|NCT01188642|nutrition education|nutrition education
557492|NCT01188629|Preventive Care|preventive care
557493|NCT01188629|Medication Management|medication management
557494|NCT01188629|Electronic Medical Records|electronic medical records
557495|NCT01188629|Automated Telephone System|automated telephone system
557496|NCT01188616|Childhood Obesity|childhood obesity
557497|NCT01188616|Obesity Intervention|obesity intervention
557498|NCT01188590|Post operative Respiratory insufficiency|post operative respiratory insufficiency
557499|NCT01188577|asthma|asthma
557500|NCT01188577|bronchospasm|bronchospasm
557501|NCT01188577|wheezing|wheezing
557502|NCT01188577|shortness of breath|shortness of breath
557503|NCT01188564|Hereditary Angioedema|hereditary angioedema
557504|NCT01188564|HAE|hae
557505|NCT01188564|Angioedema|angioedema
557506|NCT01188564|Recombinant C1 Inhibitor|recombinant c1 inhibitor
557507|NCT01188564|rhC1INH|rhc1inh
557508|NCT01188551|myringotomy|myringotomy
557509|NCT01188551|pressure equalization tubes|pressure equalization tubes
557510|NCT01188538|P. acnes, Acne vulgaris|p. acnes, acne vulgaris
557511|NCT01188525|pharmacokinetics|pharmacokinetics
557512|NCT01188525|enzymes|enzymes
557513|NCT01188525|metabolism prediction|metabolism prediction
557514|NCT01188512|Live nasal vaccine for prevention of pertussis|live nasal vaccine for prevention of pertussis
557515|NCT01188473|Status Asthmaticus|status asthmaticus
557516|NCT01188473|Noninvasive Positive Pressure Ventilation|noninvasive positive pressure ventilation
557517|NCT01188473|Asthma in Children|asthma in children
557518|NCT01188460|Insomnia|insomnia
557519|NCT01188460|Chronic pain|chronic pain
557520|NCT01188447|cervical-spine injuries|cervical-spine injuries
557521|NCT01188447|cervical-spine fractures|cervical-spine fractures
557522|NCT01188447|spinal cord injury|spinal cord injury
557523|NCT01188447|neck injury|neck injury
557524|NCT01188447|Canadian C-Spine Rule|canadian c-spine rule
557525|NCT01188447|paramedics|paramedics
557526|NCT01188447|emergency medical services|emergency medical services
557527|NCT01188434|Methamphetamine|methamphetamine
557528|NCT01188434|Substance Abuse|substance abuse
557529|NCT01188434|Child Neglect|child neglect
557827|NCT01187095|EWI|ewi
557530|NCT01188434|Child Welfare|child welfare
557531|NCT01188434|Evidence Based Practice|evidence based practice
557532|NCT01188382|Intracranial pressure|intracranial pressure
557533|NCT01188382|resistance|resistance
557534|NCT01188382|CSF outflow|csf outflow
557535|NCT01188382|elderly|elderly
557536|NCT01188382|reference value|reference value
557537|NCT01188369|levosimendan|levosimendan
557538|NCT01188369|heart failure|heart failure
557539|NCT01188369|inotropics|inotropics
557540|NCT01188369|diastolic dysfunction|diastolic dysfunction
557541|NCT01188369|left ventricular hypertrophy|left ventricular hypertrophy
557542|NCT01188369|aortic valve stenosis|aortic valve stenosis
557543|NCT01188356|Reply|reply
557544|NCT01188356|Symphony|symphony
557545|NCT01188356|Atrial arrhythmias|atrial arrhythmias
557546|NCT01188356|V pacing|v pacing
557547|NCT01188356|Evaluate the incidence and evolution over-time of co-morbidities|evaluate the incidence and evolution over-time of co-morbidities
557548|NCT01188343|Japanese Encephalitis|japanese encephalitis
557549|NCT01188343|Japanese encephalitis chimeric virus vaccine|japanese encephalitis chimeric virus vaccine
557550|NCT01188343|Measles|measles
557551|NCT01188343|Mumps|mumps
557552|NCT01188343|Rubella|rubella
557553|NCT01188330|acute myeloid leukemia|acute myeloid leukemia
557554|NCT01188291|Optical Coherence Tomography|optical coherence tomography
557555|NCT01188291|Retinal Nerve Fiber Layer Thickness|retinal nerve fiber layer thickness
557556|NCT01188291|Obstructive Sleep Apnea|obstructive sleep apnea
557557|NCT01188291|Hypopnea syndrome|hypopnea syndrome
557558|NCT01188291|Glaucoma|glaucoma
557559|NCT01188252|Phase I|phase i
557560|NCT01188252|Dose escalation|dose escalation
557561|NCT01188252|Kinase inhibitor|kinase inhibitor
557562|NCT01188252|Cyclin-dependent kinases|cyclin-dependent kinases
557563|NCT01188239|electronic cigarette|electronic cigarette
557564|NCT01188239|nicotine|nicotine
557565|NCT01188239|smoking cessation|smoking cessation
557566|NCT01188239|smoking reduction|smoking reduction
557567|NCT01188187|custirsen sodium|custirsen sodium
557568|NCT01188187|prostate cancer|prostate cancer
557569|NCT01188187|overall survival|overall survival
557570|NCT01188187|Metastatic Castrate Resistant Prostate Cancer|metastatic castrate resistant prostate cancer
557571|NCT01188174|AML|aml
557572|NCT01188174|primary induction failure|primary induction failure
557573|NCT01188161|Posturography|posturography
557574|NCT01188161|Balance|balance
557575|NCT01188161|Falls|falls
557576|NCT01188161|Gyroscope|gyroscope
557577|NCT01188161|Rotational Chair|rotational chair
557578|NCT01188161|Vestibular|vestibular
557579|NCT01188161|Movement Disorders|movement disorders
557580|NCT01188135|depression|depression
557581|NCT01188135|interactive voice messaging|interactive voice messaging
557582|NCT01188135|patient persistence with antidepressant medication treatment|patient persistence with antidepressant medication treatment
557583|NCT01188122|VAP|vap
557584|NCT01188109|Pancreatic Neoplasms|pancreatic neoplasms
557585|NCT01188109|Pancreatic cancer|pancreatic cancer
557586|NCT01188096|glioma|glioma
557587|NCT01188096|pediatrics|pediatrics
557588|NCT01188096|cancer|cancer
557589|NCT01188096|brain tumor|brain tumor
557590|NCT01188096|low grade glioma|low grade glioma
557591|NCT01188083|NASH|nash
557592|NCT01188083|non-alcoholic fatty-liver disease|non-alcoholic fatty-liver disease
557593|NCT01188083|Hispanic|hispanic
557594|NCT01188083|overweight|overweight
557595|NCT01188070|Behavioral/Social|behavioral/social
557596|NCT01188070|Cardiology|cardiology
557597|NCT01188070|Clinical Laboratory Methods|clinical laboratory methods
557598|NCT01188070|Congestive Heart Failure|congestive heart failure
557599|NCT01188070|Heart Disease|heart disease
557600|NCT01188070|Knowledge Dissemination|knowledge dissemination
557601|NCT01188070|Lipids|lipids
557602|NCT01188070|Nursing|nursing
557603|NCT01188070|Health Promotion|health promotion
557604|NCT01188070|Alzheimer's Disease/Dementia|alzheimer's disease/dementia
557605|NCT01188057|Bioequivalence|bioequivalence
557606|NCT01188057|ALPRAZOLAM|alprazolam
557607|NCT01188057|Healthy subjects|healthy subjects
557608|NCT01188044|Motor activity|motor activity
557609|NCT01188044|Infant|infant
557610|NCT01188044|Validation studies|validation studies
557611|NCT01188044|Malawi|malawi
557612|NCT01188044|Sub-Saharan Africa|sub-saharan africa
557613|NCT01188031|Bioequivalence|bioequivalence
557614|NCT01188031|ALPRAZOLAM|alprazolam
557615|NCT01188031|Healthy subjects|healthy subjects
557616|NCT01188018|Smoking|smoking
557617|NCT01188018|Smoking Cessation|smoking cessation
557618|NCT01188018|Nicotine Dependence|nicotine dependence
557619|NCT01188018|Tobacco Use Cessation|tobacco use cessation
557620|NCT01188018|Health Education|health education
557621|NCT01188018|Patient Education|patient education
557622|NCT01188005|OSAS|osas
557623|NCT01188005|Sleep Apnoea|sleep apnoea
557624|NCT01188005|IL6|il6
557625|NCT01188005|TNFα|tnfα
557626|NCT01188005|Oxidative Stress|oxidative stress
557627|NCT01188005|Antioxidants|antioxidants
557628|NCT01187992|Atorvastatin|atorvastatin
557629|NCT01187992|Acute coronary syndrome|acute coronary syndrome
557927|NCT01186705|colon|colon
557630|NCT01187992|Advanced coronary artery disease|advanced coronary artery disease
557631|NCT01187979|Cash incentive|cash incentive
557632|NCT01187979|HIV prevention|hiv prevention
557633|NCT01187979|Adolescents|adolescents
557634|NCT01187979|South Africa|south africa
557635|NCT01187979|HIV|hiv
557636|NCT01187966|Parkinson's Disease|parkinson's disease
557637|NCT01187966|PD|pd
557638|NCT01187966|Levodopa|levodopa
557639|NCT01187966|Patients with idiopathic Parkinson's disease with motor fluctuations|patients with idiopathic parkinson's disease with motor fluctuations
557640|NCT01187953|Tacrolimus|tacrolimus
557641|NCT01187953|Acute Rejection|acute rejection
557642|NCT01187953|Kidney|kidney
557643|NCT01187940|Autism Spectrum Disorder;|autism spectrum disorder;
557644|NCT01187940|Psychoeducation|psychoeducation
557645|NCT01187914|Paroxysmal Atrial Fibrillation|paroxysmal atrial fibrillation
557646|NCT01187914|Radio-frequency Ablation|radio-frequency ablation
557647|NCT01187914|Ablation|ablation
557648|NCT01187914|Open irrigation cooled-tip|open irrigation cooled-tip
557649|NCT01187901|Familial Adenomatous Polyposis|familial adenomatous polyposis
557650|NCT01187901|Attenuated Familial Polyposis|attenuated familial polyposis
557651|NCT01187888|PSP|psp
557652|NCT01187888|Progressive Supranuclear Palsy|progressive supranuclear palsy
557653|NCT01187888|Rasagiline|rasagiline
557654|NCT01187888|Azilect|azilect
557655|NCT01187888|PROSPERA|prospera
557656|NCT01187875|satiety, dietary fiber|satiety, dietary fiber
557657|NCT01187823|Chronic heart failure|chronic heart failure
557658|NCT01187823|Central sleep apnea|central sleep apnea
557659|NCT01187823|Obstructive sleep apnea|obstructive sleep apnea
557660|NCT01187823|Adaptive servo ventilation|adaptive servo ventilation
557661|NCT01187810|leukemia,lymphoma|leukemia,lymphoma
557662|NCT01187758|antibiotic use|antibiotic use
557663|NCT01187758|antibiotic prescription|antibiotic prescription
557664|NCT01187758|antibiotic resistant S. pneumoniae|antibiotic resistant s. pneumoniae
557665|NCT01187758|MRSA|mrsa
557666|NCT01187745|renal calculi|renal calculi
557667|NCT01187732|skin damage|skin damage
557668|NCT01187732|intertrigo|intertrigo
557669|NCT01187732|dermatitis|dermatitis
557670|NCT01187732|erythema|erythema
557671|NCT01187732|aggression|aggression
557672|NCT01187732|body Wipes|body wipes
557673|NCT01187732|soaps|soaps
557674|NCT01187732|no rinse|no rinse
557675|NCT01187732|cost effectiveness|cost effectiveness
557676|NCT01187732|nursing home residents|nursing home residents
557677|NCT01187732|nurse|nurse
557678|NCT01187719|HIV|hiv
557679|NCT01187719|pregnancy|pregnancy
557680|NCT01187719|phenytoin|phenytoin
557681|NCT01187719|ARV prophylaxis|arv prophylaxis
557682|NCT01187719|nevirapine|nevirapine
557683|NCT01187706|gynecological cancer survivors|gynecological cancer survivors
557684|NCT01187706|quality of life|quality of life
557685|NCT01187680|Tissue adhesions|tissue adhesions
557686|NCT01187680|Laparoscopy|laparoscopy
557687|NCT01187667|delirium|delirium
557688|NCT01187667|prevention|prevention
557689|NCT01187667|critical care|critical care
557690|NCT01187667|haloperidol|haloperidol
557691|NCT01187654|myocardial infarction|myocardial infarction
557692|NCT01187654|bone marrow stem cell|bone marrow stem cell
557693|NCT01187654|AC133|ac133
557694|NCT01187654|mono nuclear cell|mono nuclear cell
557695|NCT01187641|cancer, colon, MRI scan|cancer, colon, mri scan
557696|NCT01187628|Long-term study in Chronic Kidney Disease|long-term study in chronic kidney disease
557697|NCT01187628|Lanthanum Carbonate|lanthanum carbonate
557698|NCT01187615|Nonsquamous Non-small cell lung cancer|nonsquamous non-small cell lung cancer
557699|NCT01187615|Phase I|phase i
557700|NCT01187576|Physical activity|physical activity
557701|NCT01187576|Hypertension|hypertension
557702|NCT01187576|Diabetes mellitus|diabetes mellitus
557703|NCT01187576|Motivational interviewing|motivational interviewing
557704|NCT01187563|Rheumatoid arthritis, tocilizumab|rheumatoid arthritis, tocilizumab
557705|NCT01187550|Dwarfism, pituitary|dwarfism, pituitary
557706|NCT01187550|Growth hormone|growth hormone
557707|NCT01187537|Knee Replacement|knee replacement
557708|NCT01187537|Analgesia|analgesia
557709|NCT01187537|Analgesics|analgesics
557710|NCT01187537|Nerve blocks|nerve blocks
557711|NCT01187537|Recovery of functions|recovery of functions
557712|NCT01187537|Post operative analgesia|post operative analgesia
557713|NCT01187524|Patient Registry|patient registry
557714|NCT01187524|FMR1 Gene|fmr1 gene
557715|NCT01187524|Fragile X Syndrome|fragile x syndrome
557716|NCT01187524|Primary Ovarian Insufficiency|primary ovarian insufficiency
557717|NCT01187524|Premature Ovarian Failure|premature ovarian failure
557718|NCT01187524|Premature Ovarian Insufficiency|premature ovarian insufficiency
557719|NCT01187511|Addiction|addiction
557720|NCT01187511|Alcohol Dependence|alcohol dependence
557721|NCT01187511|Anxiety|anxiety
557722|NCT01187511|CRH Antagonist|crh antagonist
557723|NCT01187511|Stress Induced Craving|stress induced craving
557724|NCT01187498|Overactive bladder|overactive bladder
557725|NCT01187498|Behavioral treatment|behavioral treatment
557726|NCT01187498|Drug therapy|drug therapy
557727|NCT01187498|Lower urinary tract symptoms|lower urinary tract symptoms
557928|NCT01186705|rectal|rectal
557728|NCT01187498|Urinary incontinence|urinary incontinence
557729|NCT01187498|Clinical trial|clinical trial
557730|NCT01187485|Androderm®|androderm®
557731|NCT01187485|Testosterone|testosterone
557732|NCT01187485|refractory|refractory
557733|NCT01187485|prostate|prostate
557734|NCT01187485|cancer|cancer
557735|NCT01187485|"Patients with hormone refractory prostate cancer will be treated with a daily testosterone patch Androderm® applied every 24 hours to the skin"|"patients with hormone refractory prostate cancer will be treated with a daily testosterone patch androderm® applied every 24 hours to the skin"
557736|NCT01187472|Head|head
557737|NCT01187472|neck|neck
557738|NCT01187472|cancer|cancer
557739|NCT01187472|advanced|advanced
557740|NCT01187472|oral cavity|oral cavity
557741|NCT01187472|lip|lip
557742|NCT01187472|larynx|larynx
557743|NCT01187459|Vitamin D|vitamin d
557744|NCT01187459|Crohn's Disease|crohn's disease
557745|NCT01187459|Dose Response|dose response
557746|NCT01187446|Cutaneous T-cell Lymphoma|cutaneous t-cell lymphoma
557747|NCT01187433|Dengue|dengue
557748|NCT01187433|Dengue hemorrhagic fever|dengue hemorrhagic fever
557749|NCT01187433|CYD Dengue Vaccines|cyd dengue vaccines
557750|NCT01187420|Cerebral vasospasm|cerebral vasospasm
557751|NCT01187420|delayed cerebral ischemia (DCI)|delayed cerebral ischemia (dci)
557752|NCT01187420|subarachnoid hemorrhage (SAH) patients|subarachnoid hemorrhage (sah) patients
557753|NCT01187394|Frozen Plasma|frozen plasma
557754|NCT01187394|Fresh Frozen Plasma|fresh frozen plasma
557755|NCT01187394|Cardiac Surgery|cardiac surgery
557756|NCT01187394|Bleeding|bleeding
557757|NCT01187394|Knowledge Translation|knowledge translation
557758|NCT01187368|heart failure|heart failure
557759|NCT01187368|LVAS|lvas
557760|NCT01187368|LVAD|lvad
557761|NCT01187368|bridge-to-transplant|bridge-to-transplant
557762|NCT01187368|rotary pump|rotary pump
557763|NCT01187355|Symptomatic, Contact lens care|symptomatic, contact lens care
557764|NCT01187355|Multi-purpose solution|multi-purpose solution
557765|NCT01187342|Stroke|stroke
557766|NCT01187329|Hyperglycemia|hyperglycemia
557767|NCT01187329|open heart surgery|open heart surgery
557768|NCT01187329|bypass|bypass
557769|NCT01187316|Facial Pain|facial pain
557770|NCT01187316|Temporomandibular Joint Disorders|temporomandibular joint disorders
557771|NCT01187316|Transcutaneous Electric Nerve Stimulation|transcutaneous electric nerve stimulation
557772|NCT01187316|Adolescent|adolescent
557773|NCT01187290|Preoperative chemoradiotherapy|preoperative chemoradiotherapy
557774|NCT01187290|stage IIIA, N2|stage iiia, n2
557775|NCT01187277|stroke|stroke
557776|NCT01187277|rehabilitation|rehabilitation
557777|NCT01187277|gait training|gait training
557778|NCT01187277|robot-assisted therapy|robot-assisted therapy
557779|NCT01187251|tinnitus|tinnitus
557780|NCT01187251|mp3 players|mp3 players
557781|NCT01187251|noise induced hearing loss|noise induced hearing loss
557782|NCT01187251|high frequencies audiometry|high frequencies audiometry
557783|NCT01187251|acoustic otoemissions|acoustic otoemissions
557784|NCT01187238|Nasopharyngeal carcinoma|nasopharyngeal carcinoma
557785|NCT01187238|Stage II|stage ii
557786|NCT01187238|Intensity-modulated radiotherapy|intensity-modulated radiotherapy
557787|NCT01187238|Concurrent chemoradiotherapy|concurrent chemoradiotherapy
557788|NCT01187238|Cisplatin|cisplatin
557789|NCT01187225|Cardiac surgical procedures|cardiac surgical procedures
557790|NCT01187225|Fibrinogen|fibrinogen
557791|NCT01187225|Bleeding|bleeding
708394|NCT00597584|ESA|esa
557792|NCT01187225|Cryoprecipitate|cryoprecipitate
557793|NCT01187212|First line chemotherapy in advanced gastric cancer|first line chemotherapy in advanced gastric cancer
557794|NCT01187199|Metastatic cancer|metastatic cancer
557795|NCT01187199|Chemotherapy|chemotherapy
557796|NCT01187199|Avastin|avastin
557797|NCT01187199|Carboplatin|carboplatin
557798|NCT01187199|Paclitaxel|paclitaxel
557799|NCT01187199|Sorafenib|sorafenib
557800|NCT01187199|Temsirolimus|temsirolimus
557801|NCT01187186|Liver disease|liver disease
557802|NCT01187186|ASP1941|asp1941
557803|NCT01187160|Obstructive sleep apnea|obstructive sleep apnea
557804|NCT01187147|Asthma, green tea, antioxidants|asthma, green tea, antioxidants
557805|NCT01187134|sepsis|sepsis
557806|NCT01187134|shock, septic|shock, septic
557807|NCT01187134|quality assurance, health care|quality assurance, health care
557808|NCT01187134|quality control|quality control
557809|NCT01187134|Survival Rate|survival rate
557810|NCT01187134|Follow-Up Studies|follow-up studies
557811|NCT01187134|Anti-Infective Agents/*therapeutic use|anti-infective agents/*therapeutic use
557812|NCT01187121|Graduated Sanctions|graduated sanctions
557813|NCT01187121|Probationary failure|probationary failure
557814|NCT01187121|recidivism|recidivism
557815|NCT01187121|drug relapse|drug relapse
557816|NCT01187121|criminal justice|criminal justice
557817|NCT01187108|Cobalt|cobalt
557818|NCT01187108|Excessive Erythrocytosis|excessive erythrocytosis
557819|NCT01187108|Monge's Disease|monge's disease
557820|NCT01187108|Acetazolamide|acetazolamide
557821|NCT01187108|N-acetylcysteine|n-acetylcysteine
557822|NCT01187108|Altitude Sickness|altitude sickness
557823|NCT01187108|Chronic Mountain Sickness|chronic mountain sickness
557824|NCT01187095|Involuntary childlessness|involuntary childlessness
557828|NCT01187095|Couples in IVF treatment|couples in ivf treatment
557829|NCT01187095|Psychosocial intervention|psychosocial intervention
557830|NCT01187082|overactive bladder|overactive bladder
557831|NCT01187082|women|women
557832|NCT01187082|bladder training|bladder training
557833|NCT01187082|groups|groups
557834|NCT01187069|Motivation|motivation
557835|NCT01187069|patients with type 2 diabetes|patients with type 2 diabetes
557836|NCT01187069|practice nurses|practice nurses
557837|NCT01187069|general practice|general practice
557838|NCT01187069|Self-determination Theory|self-determination theory
557839|NCT01187056|Shared decision-making|shared decision-making
557840|NCT01187056|Risk information|risk information
557841|NCT01187056|Decision aids|decision aids
557842|NCT01187043|Liver Function|liver function
557843|NCT01187043|Steady State Exposure|steady state exposure
557844|NCT01187030|Frozen Plasma|frozen plasma
557845|NCT01187030|Fresh Frozen Plasma|fresh frozen plasma
557846|NCT01187030|Prothrombin Complex Concentrates|prothrombin complex concentrates
557847|NCT01187030|RAND UCLA|rand ucla
557848|NCT01187030|Modified Delphi Methodology|modified delphi methodology
557849|NCT01187030|Expert Panel|expert panel
557850|NCT01187030|Appropriateness Rating|appropriateness rating
557851|NCT01187017|Severe Aplastic Anemia|severe aplastic anemia
557852|NCT01187017|Aplastic Anemia|aplastic anemia
557853|NCT01187017|Immunosuppression|immunosuppression
557854|NCT01187017|Immunosuppressive Therapy|immunosuppressive therapy
557855|NCT01187017|T-Cells|t-cells
557856|NCT01186965|Diabetes|diabetes
557857|NCT01186965|Second Life|second life
557858|NCT01186965|virtual community|virtual community
557859|NCT01186965|diabetes education|diabetes education
557860|NCT01186965|diabetes support group|diabetes support group
557861|NCT01186952|overweight|overweight
557862|NCT01186952|obesity|obesity
557863|NCT01186952|type 2 diabetes|type 2 diabetes
557864|NCT01186952|caloric restriction|caloric restriction
557865|NCT01186952|exercise program|exercise program
557866|NCT01186952|epicardial fat|epicardial fat
557867|NCT01186939|Myelodysplastic Syndromes|myelodysplastic syndromes
557868|NCT01186939|MDS|mds
557869|NCT01186926|Obstructive sleep apnea|obstructive sleep apnea
557870|NCT01186926|OSA|osa
557871|NCT01186926|hypoglossal nerve stimulation|hypoglossal nerve stimulation
557872|NCT01186926|sleep apnea|sleep apnea
557873|NCT01186913|Severe Combined Immunodeficiency (SCID)|severe combined immunodeficiency (scid)
557874|NCT01186913|natural history study|natural history study
557875|NCT01186913|SCID treatment|scid treatment
557876|NCT01186900|skin abscess|skin abscess
557877|NCT01186900|needle aspiration|needle aspiration
557878|NCT01186900|incision and drainage|incision and drainage
557879|NCT01186887|primary ACL reconstruction with a hamstring graft|primary acl reconstruction with a hamstring graft
557880|NCT01186861|OSI-906|osi-906
557881|NCT01186861|Erlotinib|erlotinib
557882|NCT01186861|Platinum-based chemotherapy|platinum-based chemotherapy
557883|NCT01186861|Placebo|placebo
557884|NCT01186861|NSCLC|nsclc
557885|NCT01186848|Stretch marks|stretch marks
557886|NCT01186848|Striae distensae|striae distensae
557887|NCT01186809|hematologic malignancies (excluding Chronic Myeloid Leukemia)|hematologic malignancies (excluding chronic myeloid leukemia)
557888|NCT01186796|Women|women
557889|NCT01186796|Fulvestrant Study|fulvestrant study
557890|NCT01186796|Post Menopausal Women|post menopausal women
557891|NCT01186796|Hormones|hormones
557892|NCT01186796|Healthy Adult Women|healthy adult women
557893|NCT01186783|heart rate|heart rate
557894|NCT01186783|multiple organ dysfunction syndrome|multiple organ dysfunction syndrome
557895|NCT01186783|ivabradine|ivabradine
557896|NCT01186783|sepsis|sepsis
557897|NCT01186783|cardiogenic shock|cardiogenic shock
557898|NCT01186770|Treatment of Opioid-Induced Constipation in Participants with Chronic, Non-Malignant Pain|treatment of opioid-induced constipation in participants with chronic, non-malignant pain
557899|NCT01186744|OPT Retreatment|opt retreatment
557900|NCT01186744|OPT|opt
557901|NCT01186744|chronic|chronic
557902|NCT01186744|moderate|moderate
557903|NCT01186744|severe|severe
557904|NCT01186744|treatment|treatment
557905|NCT01186744|safety|safety
557906|NCT01186744|treatment withdrawal|treatment withdrawal
557907|NCT01186744|retreatment|retreatment
557908|NCT01186744|retreatment withdrawal|retreatment withdrawal
557909|NCT01186744|CP-690,550|cp-690,550
557910|NCT01186744|Psoriasis Vulgaris|psoriasis vulgaris
557911|NCT01186744|Plaque Psoriasis|plaque psoriasis
557912|NCT01186744|tofacitinib|tofacitinib
557913|NCT01186744|Xeljanz|xeljanz
557914|NCT01186744|nail psoriasis|nail psoriasis
557915|NCT01186744|Jak-inhibitor|jak-inhibitor
557916|NCT01186744|oral treatment|oral treatment
557917|NCT01186744|Pruritus|pruritus
557918|NCT01186744|Itch|itch
557919|NCT01186744|DLQI|dlqi
557920|NCT01186744|rebound|rebound
557921|NCT01186744|intermittent|intermittent
557922|NCT01186744|retreat|retreat
557923|NCT01186731|SPARC (secreted protein acid rich in cysteine)|sparc (secreted protein acid rich in cysteine)
557924|NCT01186731|serum Carbohydrate Antigen CA 19-9|serum carbohydrate antigen ca 19-9
557925|NCT01186718|Cervical, motions, kinematics|cervical, motions, kinematics
557926|NCT01186705|MK-2206|mk-2206
557929|NCT01186705|10-068|10-068
557930|NCT01186666|Atherosclerosis|atherosclerosis
557931|NCT01186666|Vulnerable plaque|vulnerable plaque
557932|NCT01186666|Intravascular ultrasound|intravascular ultrasound
557933|NCT01186666|Virtual histology|virtual histology
557934|NCT01186666|Fluorodeoxyglucose|fluorodeoxyglucose
557935|NCT01186666|Positron emission tomography|positron emission tomography
557936|NCT01186666|Multidetector computed tomography|multidetector computed tomography
557937|NCT01186640|T-PLL|t-pll
557938|NCT01186640|Polychemotherapy|polychemotherapy
557939|NCT01186640|Alemtuzumab|alemtuzumab
557940|NCT01186640|Efficacy|efficacy
557941|NCT01186627|Neurodevelopmental Impairment|neurodevelopmental impairment
557942|NCT01186627|Intraventricular hemorrhage|intraventricular hemorrhage
557943|NCT01186627|Retinopathy of prematurity|retinopathy of prematurity
557944|NCT01186627|Mortality|mortality
557945|NCT01186627|Apgar Score|apgar score
557946|NCT01186614|cardiac arrest|cardiac arrest
557947|NCT01186614|ECMO|ecmo
557948|NCT01186614|hypothermia|hypothermia
557949|NCT01186614|automated CPR|automated cpr
557950|NCT01186614|coronary intervention|coronary intervention
557951|NCT01186601|Prostatic Neoplasms|prostatic neoplasms
557952|NCT01186601|Colorectal Neoplasms|colorectal neoplasms
557953|NCT01186601|Head and Neck Neoplasms|head and neck neoplasms
557954|NCT01186601|Melanoma|melanoma
557955|NCT01186601|Neoplasm Metastasis|neoplasm metastasis
557956|NCT01186588|Canagliflozin|canagliflozin
557957|NCT01186588|JNJ-28431754|jnj-28431754
557958|NCT01186588|Liver diseases|liver diseases
557959|NCT01186588|Hepatic impairment|hepatic impairment
557960|NCT01186588|Pharmacokinetic|pharmacokinetic
557961|NCT01186588|Normal hepatic function|normal hepatic function
557962|NCT01186575|HIV Infections|hiv infections
557963|NCT01186575|Acquired Immunodeficiency Syndrome|acquired immunodeficiency syndrome
557964|NCT01186575|Circumcision, Male|circumcision, male
557965|NCT01186575|Coitus|coitus
557966|NCT01186575|Patient Compliance|patient compliance
557967|NCT01186575|Cellular Phone|cellular phone
557968|NCT01186562|Pancreatitis|pancreatitis
557969|NCT01186562|Pancreatectomy|pancreatectomy
557970|NCT01186562|Islet autotransplant|islet autotransplant
557971|NCT01186562|Sitagliptin|sitagliptin
557972|NCT01186562|Diabetes|diabetes
557973|NCT01186549|propofol|propofol
557974|NCT01186549|ephedrine|ephedrine
557976|NCT01186536|Whey Protein|whey protein
557977|NCT01186536|Soy Protein|soy protein
557978|NCT01186536|Resistance training|resistance training
557979|NCT01186536|Weight Management|weight management
557980|NCT01186523|Obesity|obesity
557981|NCT01186523|Weight Management|weight management
557982|NCT01186523|Physical Activity|physical activity
557983|NCT01186497|Healthy|healthy
557984|NCT01186497|Rabeprazole sodium|rabeprazole sodium
557985|NCT01186497|Rabeprazole sprinkle capsule granule formulation|rabeprazole sprinkle capsule granule formulation
557986|NCT01186497|Pharmacokinetics|pharmacokinetics
557987|NCT01186497|Bioavailability|bioavailability
557988|NCT01186497|Safety|safety
557989|NCT01186497|Adult|adult
557990|NCT01186484|Castration-resistant prostate cancer|castration-resistant prostate cancer
557991|NCT01186484|Abiraterone acetate|abiraterone acetate
557992|NCT01186484|JNJ-212082|jnj-212082
557993|NCT01186471|Symptomatic treatment|symptomatic treatment
557994|NCT01186471|Cognition|cognition
557995|NCT01186471|Cognitive deficits|cognitive deficits
557996|NCT01186471|Schizophrenia|schizophrenia
557997|NCT01186445|Acute Myocardial Infarction|acute myocardial infarction
557998|NCT01186445|Cardioprotective effect|cardioprotective effect
557999|NCT01186445|Pharmacological postconditioning|pharmacological postconditioning
558000|NCT01186445|Morphine Chlorhydrate|morphine chlorhydrate
558001|NCT01186445|Cardiac MRI|cardiac mri
558002|NCT01186419|Beta-thalassemia|beta-thalassemia
558003|NCT01186419|Sickle cell anemia|sickle cell anemia
558004|NCT01186419|Transfusional iron overload|transfusional iron overload
558005|NCT01186419|Iron overload|iron overload
558006|NCT01186419|Iron chelation|iron chelation
558007|NCT01186406|glioblastoma multiforme|glioblastoma multiforme
558008|NCT01186406|gliosarcoma|gliosarcoma
558009|NCT01186406|malignant glioma|malignant glioma
558010|NCT01186406|glioma|glioma
558011|NCT01186406|Gliadel|gliadel
558012|NCT01186406|carmustine wafers|carmustine wafers
558013|NCT01186406|Avastin|avastin
558014|NCT01186406|bevacizumab|bevacizumab
558015|NCT01186406|Temodar|temodar
558016|NCT01186406|temozolomide|temozolomide
558017|NCT01186406|Pro00025180|pro00025180
558018|NCT01186406|Desjardins|desjardins
558019|NCT01186406|Duke|duke
558020|NCT01186406|Preston Robert Tisch Brain Tumor Center|preston robert tisch brain tumor center
558021|NCT01186393|Weight Loss|weight loss
558022|NCT01186393|Potatoes|potatoes
558023|NCT01186393|Dietary Meetings|dietary meetings
558024|NCT01186393|Glycemic Control|glycemic control
558025|NCT01186380|TEE|tee
558026|NCT01186380|Transesophageal|transesophageal
558027|NCT01186380|Transducer|transducer
558028|NCT01186380|Esophagus|esophagus
558029|NCT01186380|Ease of passage and during transitioning into and down the esophagus to complete a normal TEE study|ease of passage and during transitioning into and down the esophagus to complete a normal tee study
558030|NCT01186367|breast cancer|breast cancer
558031|NCT01186367|Linear Versus Nonlinear Aerobic Training|linear versus nonlinear aerobic training
558032|NCT01186367|15-147|15-147
558033|NCT01186354|Type 2 diabetes|type 2 diabetes
558034|NCT01186354|health literacy|health literacy
558035|NCT01186354|genetic literacy|genetic literacy
558036|NCT01186354|genetic risk|genetic risk
558037|NCT01186341|Chronic Pain|chronic pain
558038|NCT01186328|Relapse|relapse
558039|NCT01186328|T cell|t cell
558040|NCT01186328|Lymphoblastic|lymphoblastic
558041|NCT01186328|Leukemia|leukemia
558042|NCT01186328|EZN3042|ezn3042
558043|NCT01186328|Refractory|refractory
558044|NCT01186328|Precursor B|precursor b
558045|NCT01186328|Pre B cell|pre b cell
558046|NCT01186328|Survivin|survivin
558047|NCT01186328|Acute|acute
558048|NCT01186328|Childhood|childhood
558049|NCT01186328|Pediatric|pediatric
558050|NCT01186315|Addiction|addiction
558051|NCT01186315|Posttraumatic Stress|posttraumatic stress
558052|NCT01186315|substance abuse and posttraumatic stress|substance abuse and posttraumatic stress
558053|NCT01186302|medical abortion|medical abortion
558054|NCT01186302|Nepal|nepal
558055|NCT01186302|midlevel providers|midlevel providers
558056|NCT01186289|Neurocognitive Dysfunction|neurocognitive dysfunction
558057|NCT01186263|liver metastases|liver metastases
558058|NCT01186263|MAA|maa
558059|NCT01186263|B20|b20
558060|NCT01186263|SIR spheres|sir spheres
558061|NCT01186263|SPECT|spect
558062|NCT01186263|intra-hepatic distribution|intra-hepatic distribution
558063|NCT01186250|cardiac allograft vasculopathy|cardiac allograft vasculopathy
558064|NCT01186250|pioglitazone|pioglitazone
558065|NCT01186250|insulin resistance|insulin resistance
558066|NCT01186250|heart transplant|heart transplant
558067|NCT01186237|Colon/Rectal Cancer Rectal Cancer|colon/rectal cancer rectal cancer
558068|NCT01186237|Quality of Life|quality of life
558069|NCT01186211|knee, joint|knee, joint
558070|NCT01186198|Coronary Dilatation Catheter|coronary dilatation catheter
558071|NCT01186198|Balloon Dilatation Catheter|balloon dilatation catheter
558072|NCT01186198|Predilatation Balloon|predilatation balloon
558073|NCT01186198|Angioplasty|angioplasty
558074|NCT01186198|Myocardial Ischemia|myocardial ischemia
558075|NCT01186198|Coronary Stenosis|coronary stenosis
558076|NCT01186198|PCI|pci
558077|NCT01186198|PTCA|ptca
558078|NCT01186198|CTO|cto
558079|NCT01186185|sudden|sudden
558080|NCT01186185|sensorineural|sensorineural
558081|NCT01186185|hearing loss|hearing loss
558082|NCT01186185|fludrocortisone|fludrocortisone
558083|NCT01186185|mineralocorticoid|mineralocorticoid
558084|NCT01186185|steroid|steroid
558085|NCT01186172|ethanol|ethanol
558086|NCT01186172|lock therapy|lock therapy
558087|NCT01186172|vascular access|vascular access
558088|NCT01186172|central venous catheter|central venous catheter
558089|NCT01186172|sepsis|sepsis
558090|NCT01186159|COX-2|cox-2
558091|NCT01186159|PMNL|pmnl
558092|NCT01186159|pain|pain
558093|NCT01186159|macrophages|macrophages
558094|NCT01186159|NSAIDs|nsaids
558095|NCT01186146|coronary disease|coronary disease
558096|NCT01186146|stents|stents
558097|NCT01186146|antiplatelet drugs|antiplatelet drugs
558098|NCT01186146|drug-eluting stents|drug-eluting stents
558099|NCT01186133|coronary disease|coronary disease
558100|NCT01186133|drug eluting stent|drug eluting stent
558101|NCT01186120|coronary disease|coronary disease
558102|NCT01186120|stent|stent
558103|NCT01186107|coronary disease|coronary disease
558104|NCT01186107|stent|stent
558105|NCT01186094|Coronary Artery Disease|coronary artery disease
558106|NCT01186094|Stent|stent
558107|NCT01186081|Rectal cancer|rectal cancer
558108|NCT01186081|Preoperative CCRT|preoperative ccrt
558109|NCT01186081|Postoperative CCRT|postoperative ccrt
558110|NCT01186081|Capecitabine|capecitabine
558111|NCT01186068|Rosacea, erythema|rosacea, erythema
558112|NCT01186055|Smoking Relapse|smoking relapse
558113|NCT01186055|Nicotine Abstinence|nicotine abstinence
558114|NCT01186042|HIV|hiv
558115|NCT01186042|Aging|aging
558116|NCT01186042|Neuropsychological function|neuropsychological function
558117|NCT01186042|Activity|activity
558118|NCT01186042|Sleep patterns|sleep patterns
558119|NCT01186042|Frailty|frailty
558120|NCT01186042|Emotional well-being|emotional well-being
558121|NCT01186042|Sexual health|sexual health
558122|NCT01186029|Looking at adding drug to already established treatment regimen for|looking at adding drug to already established treatment regimen for
558123|NCT01186029|Nausea and Vomiting|nausea and vomiting
558124|NCT01186016|Genetic Education|genetic education
558125|NCT01186016|Smoking Cessation|smoking cessation
558126|NCT01186016|Quitting Smoking|quitting smoking
558127|NCT01186016|Standard Smoking Cessation Program|standard smoking cessation program
558128|NCT01186016|Genetic Education for Smoking Cessation|genetic education for smoking cessation
558129|NCT01186003|Diabetes|diabetes
558130|NCT01185977|Major Depressive Disorder|major depressive disorder
558131|NCT01185977|Fluoxetine|fluoxetine
558132|NCT01185977|QEEG|qeeg
558133|NCT01185977|cordance|cordance
558134|NCT01185977|ATR|atr
558135|NCT01185964|Sarcoma, Soft Tissue|sarcoma, soft tissue
558136|NCT01185964|Advanced Soft Tissue Sarcoma|advanced soft tissue sarcoma
558137|NCT01185951|Achilles Tendon|achilles tendon
558138|NCT01185951|Patella|patella
558139|NCT01185951|Allergy|allergy
558140|NCT01185951|Necrosis|necrosis
558141|NCT01185951|Infection|infection
558142|NCT01185938|statin|statin
558143|NCT01185938|CIN|cin
558144|NCT01185938|periprocedural damage|periprocedural damage
558145|NCT01185925|PDE5-inhibition|pde5-inhibition
558146|NCT01185925|exercise ventilation|exercise ventilation
558147|NCT01185925|heart failure|heart failure
558148|NCT01185925|sildenafil|sildenafil
558149|NCT01185925|pulmonary hemodynamics|pulmonary hemodynamics
558150|NCT01185912|Cardiac MRI|cardiac mri
558151|NCT01185912|Cardiac ultrasound|cardiac ultrasound
558152|NCT01185912|Cardiac surgery|cardiac surgery
558153|NCT01185899|heart attack|heart attack
558154|NCT01185899|acute myocardial infarction|acute myocardial infarction
558155|NCT01185899|STEMI|stemi
558156|NCT01185899|NSTEMI|nstemi
558157|NCT01185899|Unstable Angina|unstable angina
558158|NCT01185899|suspected acute coronary syndrome|suspected acute coronary syndrome
558159|NCT01185899|Non-ischemic chest pain|non-ischemic chest pain
558160|NCT01185886|untreated childhood acute lymphoblastic leukemia|untreated childhood acute lymphoblastic leukemia
558161|NCT01185886|L1 childhood acute lymphoblastic leukemia|l1 childhood acute lymphoblastic leukemia
558162|NCT01185886|L2 childhood acute lymphoblastic leukemia|l2 childhood acute lymphoblastic leukemia
558163|NCT01185886|B-cell childhood acute lymphoblastic leukemia|b-cell childhood acute lymphoblastic leukemia
558164|NCT01185886|T-cell childhood acute lymphoblastic leukemia|t-cell childhood acute lymphoblastic leukemia
558165|NCT01185886|stage I childhood lymphoblastic lymphoma|stage i childhood lymphoblastic lymphoma
558166|NCT01185886|stage II childhood lymphoblastic lymphoma|stage ii childhood lymphoblastic lymphoma
558167|NCT01185886|stage III childhood lymphoblastic lymphoma|stage iii childhood lymphoblastic lymphoma
558168|NCT01185886|stage IV childhood lymphoblastic lymphoma|stage iv childhood lymphoblastic lymphoma
558169|NCT01185886|Philadelphia chromosome positive childhood precursor acute lymphoblastic leukemia|philadelphia chromosome positive childhood precursor acute lymphoblastic leukemia
558170|NCT01185821|BAF312|baf312
558171|NCT01185821|siponimod|siponimod
558172|NCT01185821|Multiple Sclerosis|multiple sclerosis
558173|NCT01185821|Relapsing remitting Multiple Sclerosis|relapsing remitting multiple sclerosis
558174|NCT01185821|Demyelinating Autoimmune Diseases|demyelinating autoimmune diseases
558175|NCT01185821|MS|ms
558176|NCT01185821|RRMS|rrms
558177|NCT01185821|inflammatory disease|inflammatory disease
558178|NCT01185808|sinusitis|sinusitis
558179|NCT01185808|chronic sinusitis with polyps|chronic sinusitis with polyps
558180|NCT01185795|yogurt|yogurt
558181|NCT01185795|probiotic|probiotic
558182|NCT01185795|cholesterol|cholesterol
558183|NCT01185782|Infertility|infertility
558184|NCT01185782|Ovulation induction|ovulation induction
558185|NCT01185782|Gonalef® (Follitropin alfa)|gonalef® (follitropin alfa)
708914|NCT00595426|VTE|vte
558186|NCT01185782|Purified pituitary gonadotropin (Fertinorm-P®)|purified pituitary gonadotropin (fertinorm-p®)
558187|NCT01185782|gonadotropin|gonadotropin
558188|NCT01185782|Reproductive technologies, assisted|reproductive technologies, assisted
558189|NCT01185782|Polycystic ovary syndrome|polycystic ovary syndrome
558190|NCT01185769|Vitamin E|vitamin e
558191|NCT01185769|Absorption|absorption
558192|NCT01185756|Heart failure|heart failure
558193|NCT01185756|Sudden death|sudden death
558194|NCT01185756|Implantable Cardioverter Defibrillator|implantable cardioverter defibrillator
558195|NCT01185756|MIBG scintigraphy|mibg scintigraphy
558196|NCT01185743|healthy volunteers|healthy volunteers
558197|NCT01185743|antipsychotics|antipsychotics
558198|NCT01185743|gene expression|gene expression
558199|NCT01185730|Pulmonary hypertension|pulmonary hypertension
558200|NCT01185730|Prognostic factors|prognostic factors
558201|NCT01185730|Idiopathic pulmonary hypertension|idiopathic pulmonary hypertension
558202|NCT01185730|Family pulmonary hypertension|family pulmonary hypertension
558203|NCT01185730|use anorectics|use anorectics
558204|NCT01185704|Cetrorelix acetate; follitropin alfa; human chorionic-gonadotropin alfa; follicular maturation; pregnancy; ovarian stimulation|cetrorelix acetate; follitropin alfa; human chorionic-gonadotropin alfa; follicular maturation; pregnancy; ovarian stimulation
558205|NCT01185678|Contraception|contraception
558206|NCT01185678|Compliance|compliance
558207|NCT01185665|FBSS|fbss
558208|NCT01185652|Smoking|smoking
558209|NCT01185652|airflow obstruction|airflow obstruction
558210|NCT01185652|pulmonary function tests|pulmonary function tests
558211|NCT01185639|lung cancer|lung cancer
558212|NCT01185639|metastatic|metastatic
558213|NCT01185639|SBRT|sbrt
558214|NCT01185639|Stereotactic body radiation therapy|stereotactic body radiation therapy
558215|NCT01185639|liver|liver
558216|NCT01185639|spine|spine
558217|NCT01185639|adrenal|adrenal
558218|NCT01185639|bone cancer|bone cancer
558219|NCT01185639|Spinal Column|spinal column
558220|NCT01185626|patients|patients
558221|NCT01185600|transfusion complications|transfusion complications
558222|NCT01185600|washed RBC|washed rbc
558223|NCT01185600|microparticles|microparticles
558224|NCT01185600|storage lesion|storage lesion
558225|NCT01185587|SCN5A protein|scn5a protein
558226|NCT01185587|voltage-gated Na+ channel|voltage-gated na+ channel
558227|NCT01185561|Diabetes|diabetes
558228|NCT01185561|SWEEP|sweep
558229|NCT01185561|Dysphoria|dysphoria
558230|NCT01185548|Advanced or Metastatic Solid Tumors or Lymphoma|advanced or metastatic solid tumors or lymphoma
558231|NCT01185535|topical anesthesia|topical anesthesia
558232|NCT01185535|tracheal intubation|tracheal intubation
558233|NCT01185535|difficult airway|difficult airway
558234|NCT01185509|HER2 negative|her2 negative
558235|NCT01185509|HER2 positive|her2 positive
558236|NCT01185496|diabetes mellitus|diabetes mellitus
558237|NCT01185483|Endoscopic submucosal dissection|endoscopic submucosal dissection
558238|NCT01185483|Submucosal tumor|submucosal tumor
558239|NCT01185483|Minimal invasive|minimal invasive
558240|NCT01185483|Gastroscopy|gastroscopy
558241|NCT01185470|Chronic pain|chronic pain
558242|NCT01185470|Morphine Sufate|morphine sufate
558243|NCT01185470|Intrathecal|intrathecal
558244|NCT01185470|Implantable drug delivery pumps|implantable drug delivery pumps
558245|NCT01185457|Shoulder surgery|shoulder surgery
558246|NCT01185457|Beach chair position|beach chair position
558247|NCT01185457|Interscalene block|interscalene block
558248|NCT01185457|HRV|hrv
558249|NCT01185457|Autonomic nervous system|autonomic nervous system
558250|NCT01185444|Knee Balance|knee balance
558251|NCT01185444|Hyaluronate|hyaluronate
558252|NCT01185444|Osteoarthritis|osteoarthritis
558253|NCT01185444|Viscosupplementation|viscosupplementation
558254|NCT01185431|Ficus Carica|ficus carica
558255|NCT01185431|Functional Constipation|functional constipation
558256|NCT01185431|Dietary Supplement|dietary supplement
558257|NCT01185431|Fig Paste|fig paste
558258|NCT01185405|Voriconazole|voriconazole
558259|NCT01185405|Therapeutic drug monitoring|therapeutic drug monitoring
558260|NCT01185405|Intensive care unit|intensive care unit
558261|NCT01185392|Cardiac Resynchronisation Therapy in Heart Failure|cardiac resynchronisation therapy in heart failure
558262|NCT01185379|Docosahexaenoic acid|docosahexaenoic acid
558263|NCT01185379|omega 3|omega 3
558264|NCT01185379|cerebral blood flow|cerebral blood flow
558265|NCT01185379|Near Infrared spectroscopy|near infrared spectroscopy
558266|NCT01185379|cognitive function|cognitive function
558267|NCT01185379|mood|mood
558268|NCT01185366|Advanced non-clear cell renal cell cancer (RCC)|advanced non-clear cell renal cell cancer (rcc)
558269|NCT01185366|Clear-cell renal cell carcinoma|clear-cell renal cell carcinoma
558270|NCT01185366|Collecting duct carcinoma|collecting duct carcinoma
558271|NCT01185366|Translocation carcinoma|translocation carcinoma
558272|NCT01185366|Chromophobe|chromophobe
558273|NCT01185366|Everolimus|everolimus
558274|NCT01185366|Sunitinib|sunitinib
558275|NCT01185366|Afinitor|afinitor
558276|NCT01185366|RAD001|rad001
558277|NCT01185366|Sunitinib Malate|sunitinib malate
709025|NCT00594893|Hip|hip
558278|NCT01185366|SUO11248|suo11248
558279|NCT01185366|Sutent|sutent
558280|NCT01185366|ESPN|espn
558281|NCT01185353|Rheumatoid Arthritis|rheumatoid arthritis
558282|NCT01185353|RA|ra
558283|NCT01185340|Depression|depression
558284|NCT01185340|MDD|mdd
558285|NCT01185327|Regurgitation|regurgitation
558286|NCT01185327|Infants to Israeli Ethiopian-origin mothers|infants to israeli ethiopian-origin mothers
558287|NCT01185314|NSCLC, EGFR mutation|nsclc, egfr mutation
558288|NCT01185301|Arthritis|arthritis
558289|NCT01185301|Erosion|erosion
558290|NCT01185301|Humira|humira
558291|NCT01185301|Adalimumab|adalimumab
558292|NCT01185301|Injection|injection
558293|NCT01185301|Rheumatoid|rheumatoid
558294|NCT01185301|Methotrexate|methotrexate
558295|NCT01185288|Rheumatoid Arthritis|rheumatoid arthritis
558296|NCT01185262|Recurrent and refractory chronic lymphocytic leukemia|recurrent and refractory chronic lymphocytic leukemia
558297|NCT01185249|CHF|chf
558298|NCT01185249|congestive heart failure|congestive heart failure
558299|NCT01185236|Diabetes mellitus|diabetes mellitus
558300|NCT01185223|Valganciclovir|valganciclovir
558301|NCT01185223|Ganciclovir|ganciclovir
558302|NCT01185223|Antiviral Drug|antiviral drug
558303|NCT01185223|CMV disease|cmv disease
558304|NCT01185197|Minimal Change Nephrotic Syndrome|minimal change nephrotic syndrome
558305|NCT01185197|Corticosteroid|corticosteroid
558306|NCT01185197|Mycophenolate|mycophenolate
558307|NCT01185197|Remission|remission
558308|NCT01185197|Safety|safety
558309|NCT01185184|Relative bioavailability|relative bioavailability
558310|NCT01185184|controlled release|controlled release
558311|NCT01185184|Phase 1|phase 1
558312|NCT01185184|CP-690|cp-690
558313|NCT01185184|550|550
558314|NCT01185171|Larynx|larynx
558315|NCT01185171|Lip|lip
558316|NCT01185171|Oral Cavity and Pharynx|oral cavity and pharynx
558317|NCT01185158|Larynx|larynx
558318|NCT01185158|Lip|lip
558319|NCT01185158|Oral Cavity and Pharynx|oral cavity and pharynx
558320|NCT01185145|breast-conservation|breast-conservation
558321|NCT01185145|accelerated partial breast irradiation|accelerated partial breast irradiation
558322|NCT01185145|APBI|apbi
558323|NCT01185145|IMRT|imrt
558324|NCT01185145|Intensity modulated radiotherapy|intensity modulated radiotherapy
558325|NCT01185145|breast brachytherapy|breast brachytherapy
558326|NCT01185145|lumpectomy|lumpectomy
558327|NCT01185145|early stage breast cancer|early stage breast cancer
558328|NCT01185145|DCIS|dcis
558329|NCT01185145|Mammosite|mammosite
558330|NCT01185132|breast-conservation|breast-conservation
558331|NCT01185132|adjuvant radiotherapy|adjuvant radiotherapy
558332|NCT01185132|breast cancer|breast cancer
558333|NCT01185132|early-stage breast cancer|early-stage breast cancer
558334|NCT01185132|DCIS|dcis
558335|NCT01185132|lumpectomy|lumpectomy
558336|NCT01185132|accelerated partial breast irradiation|accelerated partial breast irradiation
558337|NCT01185132|APBI|apbi
558338|NCT01185132|three dimensional conformal external radiotherapy|three dimensional conformal external radiotherapy
558339|NCT01185132|intensity modulated radiotherapy|intensity modulated radiotherapy
558340|NCT01185132|3D CRT|3d crt
558341|NCT01185132|IMRT|imrt
558342|NCT01185119|glucose uptake and metabolism in brain|glucose uptake and metabolism in brain
558343|NCT01185093|Cells|cells
558344|NCT01185093|Prevention|prevention
558345|NCT01185093|Cancer education|cancer education
558346|NCT01185093|Nutrition|nutrition
558347|NCT01185093|Healthy living|healthy living
558348|NCT01185093|Physical activity|physical activity
558349|NCT01185093|Dangers of tobacco|dangers of tobacco
558350|NCT01185093|Sun protection|sun protection
558351|NCT01185080|AZD8848|azd8848
558352|NCT01185080|allergic rhinitis|allergic rhinitis
558353|NCT01185080|efficacy|efficacy
558354|NCT01185080|tolerability|tolerability
558355|NCT01185080|safety|safety
558356|NCT01185080|nasal symptoms|nasal symptoms
558357|NCT01185067|Hypertension|hypertension
558358|NCT01185067|Endothelial function|endothelial function
558359|NCT01185067|Antioxidants|antioxidants
558360|NCT01185067|Oxidative stress|oxidative stress
558361|NCT01185067|Grapes|grapes
558362|NCT01185067|Polyphenols|polyphenols
558363|NCT01185067|Resveratrol|resveratrol
558364|NCT01185067|Quercetin|quercetin
558365|NCT01185067|Anthocyanins|anthocyanins
558366|NCT01185067|Flavanols|flavanols
558367|NCT01185067|Flavonols|flavonols
558368|NCT01185067|Congestive heart failure|congestive heart failure
558369|NCT01185067|Heart failure with normal ejection fraction|heart failure with normal ejection fraction
558370|NCT01185067|Heart failure with preserved systolic function|heart failure with preserved systolic function
558371|NCT01185067|HFNEF|hfnef
558372|NCT01185067|HFPSF|hfpsf
558373|NCT01185067|HFPEF|hfpef
558375|NCT01185054|Pediatrics|pediatrics
558376|NCT01185054|Gastroenteritis|gastroenteritis
558377|NCT01185054|Oral Rehydration|oral rehydration
558378|NCT01185054|Electrolyte Maintenance Solution|electrolyte maintenance solution
558379|NCT01185041|Arterial Stiffness|arterial stiffness
558380|NCT01185041|Wave Reflection|wave reflection
558381|NCT01185041|Watermelon Supplementation|watermelon supplementation
558382|NCT01185041|Aortic Blood Pressure|aortic blood pressure
558383|NCT01185041|Obesity|obesity
558384|NCT01185028|Chronic HCV|chronic hcv
558385|NCT01185028|HCV Treatment Nonresponders|hcv treatment nonresponders
558386|NCT01185028|HCV Treatment Relapsers|hcv treatment relapsers
558387|NCT01185028|HIV-HCV Co-Infection|hiv-hcv co-infection
558388|NCT01185028|Nitazoxanide|nitazoxanide
558389|NCT01185028|Hepatitis C|hepatitis c
558390|NCT01185015|Angina Pectoris, Coronary disease|angina pectoris, coronary disease
558392|NCT01185002|colonoscopy|colonoscopy
558393|NCT01185002|colon|colon
558394|NCT01185002|Eligable for colon evaluation|eligable for colon evaluation
558395|NCT01184976|H5N1|h5n1
558396|NCT01184976|Avian Influenza|avian influenza
558397|NCT01184976|DNA Vaccine|dna vaccine
558398|NCT01184976|Electroporation|electroporation
558399|NCT01184976|Intramuscular (IM) Injection|intramuscular (im) injection
558400|NCT01184963|PCOS|pcos
558401|NCT01184963|High protein diet|high protein diet
558402|NCT01184924|Arthritis|arthritis
558403|NCT01184924|Tai Chi|tai chi
558404|NCT01184911|Malaria|malaria
558405|NCT01184911|Pregnancy|pregnancy
558406|NCT01184898|AML|aml
558407|NCT01184898|mTOR|mtor
558408|NCT01184898|rapamycin|rapamycin
558409|NCT01184885|hyperCVAD|hypercvad
558410|NCT01184885|rapamycin|rapamycin
558411|NCT01184885|lymphoid malignancies|lymphoid malignancies
558412|NCT01184885|lymphoblastic leukemia|lymphoblastic leukemia
558413|NCT01184885|B and T cell|b and t cell
558414|NCT01184885|philadelphia chromosome negative|philadelphia chromosome negative
558415|NCT01184885|burkitt lymphoma|burkitt lymphoma
558416|NCT01184885|burkitt-type lymphoma|burkitt-type lymphoma
558417|NCT01184885|lymphoblastic lymphoma|lymphoblastic lymphoma
558418|NCT01184885|mantle cell lymphoma|mantle cell lymphoma
558419|NCT01184885|adult t cell leukemia|adult t cell leukemia
558420|NCT01184885|adult t cell lymphoma|adult t cell lymphoma
558421|NCT01184872|Skin infection|skin infection
558422|NCT01184872|Daptomycin|daptomycin
558423|NCT01184872|Elderly|elderly
558424|NCT01184872|Gram positive|gram positive
558425|NCT01184872|Complicated skin and soft tissue infections|complicated skin and soft tissue infections
558426|NCT01184859|nocturia|nocturia
558427|NCT01184859|bladder function|bladder function
558527|NCT01184430|goal-directed therapy|goal-directed therapy
558428|NCT01184846|Chronic inflammatory demyelinating polyneuropathy|chronic inflammatory demyelinating polyneuropathy
558429|NCT01184846|CIDP|cidp
558430|NCT01184833|Multiple sclerosis|multiple sclerosis
558431|NCT01184833|Interferon beta-1b|interferon beta-1b
558432|NCT01184833|Compliance to treatment|compliance to treatment
558433|NCT01184833|Premature treatment discontinuation|premature treatment discontinuation
558434|NCT01184820|Pharmacokinetics|pharmacokinetics
558435|NCT01184820|Safety|safety
558436|NCT01184807|Advanced solid tumor|advanced solid tumor
558437|NCT01184794|Analgesia laparoscopy|analgesia laparoscopy
558438|NCT01184768|type 2 diabetes|type 2 diabetes
558439|NCT01184768|HbA1c|hba1c
558440|NCT01184768|vitamin D|vitamin d
558441|NCT01184768|diagnosis|diagnosis
558442|NCT01184755|Device-guided breathing|device-guided breathing
558443|NCT01184755|hypertension|hypertension
558444|NCT01184755|behavioral intervention|behavioral intervention
558445|NCT01184755|stress reduction|stress reduction
558446|NCT01184755|Heart Rate Variability (HRV) biofeedback|heart rate variability (hrv) biofeedback
558447|NCT01184729|aerobic capacity|aerobic capacity
558448|NCT01184716|Vitamin D status (serum 25-hydroxyvitamin D)|vitamin d status (serum 25-hydroxyvitamin d)
558449|NCT01184703|Diabetes Mellitus, Type 1|diabetes mellitus, type 1
558450|NCT01184703|Glycemic Index Diet|glycemic index diet
558451|NCT01184703|HbA1c|hba1c
558452|NCT01184703|Lipids|lipids
558453|NCT01184690|double-balloon endoscopy|double-balloon endoscopy
558454|NCT01184690|diagnostic yield|diagnostic yield
558455|NCT01184664|Smoking cessation|smoking cessation
558456|NCT01184664|Tobacco dependence|tobacco dependence
558457|NCT01184664|Varenicline|varenicline
558458|NCT01184664|Nicotine Replacement Therapy|nicotine replacement therapy
558459|NCT01184664|Combination therapy|combination therapy
558460|NCT01184651|Congenital Adrenal Hyperplasia|congenital adrenal hyperplasia
558461|NCT01184651|CAH|cah
558462|NCT01184651|sex differences|sex differences
558463|NCT01184651|adolescence|adolescence
558464|NCT01184651|androgen|androgen
558465|NCT01184651|behavior|behavior
558466|NCT01184651|gender development|gender development
558467|NCT01184638|Cognitive Disorders|cognitive disorders
558468|NCT01184638|General anesthesia|general anesthesia
558469|NCT01184638|Sevoflurane|sevoflurane
558470|NCT01184638|Propofol|propofol
558471|NCT01184638|Memory|memory
558472|NCT01184625|Myositis|myositis
558473|NCT01184625|Physical exercise|physical exercise
558474|NCT01184625|Disability|disability
558475|NCT01184612|Inmates with heavy use of alcohol or drugs|inmates with heavy use of alcohol or drugs
558476|NCT01184599|Aliskiren|aliskiren
558477|NCT01184599|Albuminuria|albuminuria
709277|NCT00593749|schools|schools
558478|NCT01184599|Angiotensinogen|angiotensinogen
558479|NCT01184599|collagen type IV|collagen type iv
558480|NCT01184599|Transforming Growth Factor beta|transforming growth factor beta
558481|NCT01184599|aldosterone|aldosterone
558482|NCT01184599|renin|renin
558483|NCT01184599|prorenin receptor|prorenin receptor
558484|NCT01184599|des-angiotensin I renin substrate|des-angiotensin i renin substrate
558485|NCT01184599|oxidative stress|oxidative stress
558486|NCT01184599|advanced glycosylation end-product receptor|advanced glycosylation end-product receptor
558487|NCT01184599|N,N-dimethylarginine|n,n-dimethylarginine
558488|NCT01184586|function|function
558489|NCT01184586|DASH|dash
558491|NCT01184586|pain|pain
558492|NCT01184586|strength|strength
558493|NCT01184573|chronic pancreatitis|chronic pancreatitis
558494|NCT01184573|breath test|breath test
558495|NCT01184573|bicarbonate|bicarbonate
558496|NCT01184560|obesity|obesity
558497|NCT01184534|Lung Biopsy|lung biopsy
558498|NCT01184534|Multimedia patient education tool|multimedia patient education tool
558499|NCT01184534|Multimedia Education Tool|multimedia education tool
558500|NCT01184534|Computed tomography guided lung biopsy|computed tomography guided lung biopsy
558501|NCT01184534|Computerized Tomography|computerized tomography
558502|NCT01184534|CT|ct
558503|NCT01184534|Questionnaire|questionnaire
558504|NCT01184534|Lung nodules|lung nodules
558505|NCT01184508|classic with aura|classic with aura
558506|NCT01184508|common without aura|common without aura
558507|NCT01184508|migraine|migraine
558508|NCT01184508|headache|headache
558509|NCT01184495|Erythropoietin|erythropoietin
558510|NCT01184495|Chronic renal failure|chronic renal failure
558511|NCT01184495|Hemodialysis|hemodialysis
558512|NCT01184495|Anemia|anemia
558513|NCT01184482|recurrent colorectal cancer|recurrent colorectal cancer
558514|NCT01184482|recurrent head and neck cancer|recurrent head and neck cancer
558515|NCT01184482|recurrent lung cancer|recurrent lung cancer
558516|NCT01184482|cetuximab|cetuximab
558517|NCT01184482|lapatinib|lapatinib
558518|NCT01184456|AIDS|aids
558519|NCT01184456|Acquired Immunodeficiency Syndrome|acquired immunodeficiency syndrome
558520|NCT01184456|HIV|hiv
558521|NCT01184456|Human Immunodeficiency Virus|human immunodeficiency virus
558522|NCT01184443|Anorexia Nervosa|anorexia nervosa
558523|NCT01184443|Eating Disorder Not Otherwise Specified|eating disorder not otherwise specified
558524|NCT01184443|Olanzapine|olanzapine
558525|NCT01184443|Pediatric|pediatric
558526|NCT01184430|advanced hemodynamic monitoring|advanced hemodynamic monitoring
558528|NCT01184430|cardiac surgery|cardiac surgery
558529|NCT01184430|hemodynamic monitoring|hemodynamic monitoring
558530|NCT01184404|Congenital heart disease|congenital heart disease
558531|NCT01184404|Cardiac surgery|cardiac surgery
558532|NCT01184404|Bosentan|bosentan
558533|NCT01184378|infant formula|infant formula
558534|NCT01184378|dairy fat|dairy fat
558535|NCT01184378|soluble milk protein|soluble milk protein
558536|NCT01184365|fatigue|fatigue
558537|NCT01184365|energy management|energy management
558538|NCT01184365|spinal cord injury|spinal cord injury
558539|NCT01184365|self-efficacy|self-efficacy
558540|NCT01184365|environment|environment
558541|NCT01184339|Staphylococcus|staphylococcus
558542|NCT01184339|aureus|aureus
558543|NCT01184339|methicillin|methicillin
558544|NCT01184339|resistant|resistant
558545|NCT01184339|MRSA|mrsa
558546|NCT01184339|MSSA|mssa
558547|NCT01184339|Blood Culture|blood culture
558548|NCT01184339|diagnostic|diagnostic
558549|NCT01184326|RAD001|rad001
558550|NCT01184326|pazopanib|pazopanib
558551|NCT01184326|everolimus|everolimus
558552|NCT01184326|advanced cancer|advanced cancer
558553|NCT01184313|aortic valve surgery|aortic valve surgery
558554|NCT01184313|CPB|cpb
558555|NCT01184313|lung injury|lung injury
558556|NCT01184300|CYP2C19*2|cyp2c19*2
558557|NCT01184300|Pharmacogenomics|pharmacogenomics
558558|NCT01184300|Clopidogrel|clopidogrel
558559|NCT01184300|Prasugrel|prasugrel
558560|NCT01184300|Percutaneous Coronary Intervention|percutaneous coronary intervention
558561|NCT01184287|Non Small Cell Lung Cancer, NSCLC, Lung Cancer|non small cell lung cancer, nsclc, lung cancer
558562|NCT01184287|Previously untreated Non-Squamous, Non-Small Cell Lung Cancer|previously untreated non-squamous, non-small cell lung cancer
558563|NCT01184235|Circadian Disorders|circadian disorders
558564|NCT01184235|Autism Spectrum Disorders|autism spectrum disorders
558565|NCT01184235|Mood Disorders|mood disorders
558566|NCT01184235|Executive Functioning|executive functioning
558567|NCT01184235|Pediatric Mood Disorders|pediatric mood disorders
558568|NCT01184196|knee replacement|knee replacement
558569|NCT01184196|knee arthroplasty|knee arthroplasty
558570|NCT01184196|total knee replacement|total knee replacement
558571|NCT01184196|arthroplasty, knee replacement|arthroplasty, knee replacement
558572|NCT01184183|Patch for Carotid Endarterectomy|patch for carotid endarterectomy
558573|NCT01184170|obesity|obesity
558574|NCT01184170|metabolism|metabolism
558575|NCT01184170|cardiovascular metabolic syndrome|cardiovascular metabolic syndrome
558576|NCT01184144|Endometriosis|endometriosis
558577|NCT01184144|Peritoneal fluid|peritoneal fluid
558578|NCT01184144|Cytokines|cytokines
558579|NCT01184144|Peroxisome Proliferator-Activated Receptors|peroxisome proliferator-activated receptors
558580|NCT01184131|Mentor Training|mentor training
558581|NCT01184131|Randomized trial of mentoring effectiveness|randomized trial of mentoring effectiveness
558582|NCT01184131|Mentoring clinical researchers|mentoring clinical researchers
558583|NCT01184118|asthma|asthma
558584|NCT01184118|sleep apnea|sleep apnea
558585|NCT01184092|Bioequivalence|bioequivalence
558586|NCT01184092|healthy volunteer study|healthy volunteer study
558587|NCT01184092|Rheumatoid Arthritis|rheumatoid arthritis
558588|NCT01184079|human papillomavirus vaccine L1, type 6,11,16,18|human papillomavirus vaccine l1, type 6,11,16,18
558589|NCT01184079|HPV Vaccines|hpv vaccines
558590|NCT01184079|HPV L1 vaccine, quadrivalent 6,11,16,18|hpv l1 vaccine, quadrivalent 6,11,16,18
558591|NCT01184066|Chemotherapy|chemotherapy
558592|NCT01184066|Patient Adherence|patient adherence
558593|NCT01184066|African Americans|african americans
558594|NCT01184066|Cancer Survivor|cancer survivor
558595|NCT01184066|Decision Making|decision making
558596|NCT01184066|Communication|communication
558597|NCT01184066|Quality of Life|quality of life
558598|NCT01184066|Social Support|social support
558599|NCT01184066|Patient Education|patient education
558600|NCT01184053|endometrial|endometrial
558601|NCT01184053|carcinoma|carcinoma
558602|NCT01184053|recurrent|recurrent
558603|NCT01184053|metastatic|metastatic
558604|NCT01184053|Trisenox|trisenox
558605|NCT01184053|arsenic trioxide|arsenic trioxide
558606|NCT01184053|Phase II|phase ii
558607|NCT01184053|VEGF|vegf
558608|NCT01184053|gynecology|gynecology
558609|NCT01184053|Lineberger|lineberger
558611|NCT01184053|vascular endothelial growth factor|vascular endothelial growth factor
558612|NCT01184053|University of North Carolina at Chapel Hill|university of north carolina at chapel hill
558613|NCT01184027|head and neck cancer|head and neck cancer
558614|NCT01184027|surgery|surgery
558615|NCT01184027|nutrition|nutrition
558616|NCT01184014|corticosteroid|corticosteroid
558617|NCT01184014|hyperglycemia|hyperglycemia
558618|NCT01184014|hospital|hospital
558619|NCT01184014|corticosteroid induced hyperglycemia in the hospital|corticosteroid induced hyperglycemia in the hospital
558620|NCT01184001|Healthy subjects|healthy subjects
558621|NCT01184001|Food Effect Study|food effect study
558622|NCT01183962|CAD|cad
558623|NCT01183962|Vitamin D|vitamin d
558624|NCT01183962|CVD|cvd
558625|NCT01183949|Neoplasms|neoplasms
558626|NCT01183949|Neoplasms, Plasma Cell|neoplasms, plasma cell
558824|NCT01183299|bed rest|bed rest
558627|NCT01183949|Neoplasms by Histologic Type|neoplasms by histologic type
558628|NCT01183949|Hemostatic Disorders|hemostatic disorders
558629|NCT01183949|Paraproteinemias|paraproteinemias
558630|NCT01183949|Blood Protein Disorders|blood protein disorders
558631|NCT01183949|Hematologic Diseases|hematologic diseases
558632|NCT01183949|Hemorrhagic Disorders|hemorrhagic disorders
558633|NCT01183949|Lymphoproliferative Disorders|lymphoproliferative disorders
558634|NCT01183949|Immunoproliferative Disorders|immunoproliferative disorders
558635|NCT01183949|Immune System Diseases|immune system diseases
558636|NCT01183949|Bortezomib|bortezomib
558637|NCT01183949|Antineoplastic Agents|antineoplastic agents
558638|NCT01183936|Melanoma/mortality/pathology/*surgery|melanoma/mortality/pathology/*surgery
558639|NCT01183936|Randomized Controlled Trials as Topic|randomized controlled trials as topic
558640|NCT01183936|Survival|survival
558641|NCT01183936|Disease-Free Survival|disease-free survival
558642|NCT01183923|asthma|asthma
558643|NCT01183923|dietary interventions|dietary interventions
558644|NCT01183923|mouse allergy|mouse allergy
558645|NCT01183910|PURPURA|purpura
558646|NCT01183910|SENILE PURPURA|senile purpura
558647|NCT01183910|BATEMAN'S PURPURA|bateman's purpura
558648|NCT01183897|GM-CSF|gm-csf
558649|NCT01183897|MAB 3F8|mab 3f8
558650|NCT01183897|RETINOIC ACID (CIS-9 & 13)|retinoic acid (cis-9 & 13)
558651|NCT01183897|09-161|09-161
558652|NCT01183884|GM-CSF|gm-csf
558653|NCT01183884|MAB 3F8|mab 3f8
558654|NCT01183884|RETINOIC ACID (CIS-9 & 13)|retinoic acid (cis-9 & 13)
558655|NCT01183884|09-160|09-160
558656|NCT01183871|Cerebral oxygenation|cerebral oxygenation
558657|NCT01183871|thoracotomy|thoracotomy
558658|NCT01183871|lung resection|lung resection
558659|NCT01183871|pulmonary dysfunction|pulmonary dysfunction
558660|NCT01183845|Crohn Disease|crohn disease
558661|NCT01183845|Crohn's Disease Endoscopy Index of Severity|crohn's disease endoscopy index of severity
558662|NCT01183845|Colon Capsule Endoscopy|colon capsule endoscopy
558663|NCT01183845|Crohn's Disease located in colon and/or ileum|crohn's disease located in colon and/or ileum
558664|NCT01183832|Breast cancer|breast cancer
558665|NCT01183832|radiotherapy|radiotherapy
558666|NCT01183832|hormonotherapy|hormonotherapy
558667|NCT01183819|cognitive function|cognitive function
558668|NCT01183819|fMRI|fmri
558669|NCT01183819|apoE|apoe
558670|NCT01183819|inflammatory markers|inflammatory markers
558671|NCT01183819|exercise|exercise
558672|NCT01183819|cognitive intervention|cognitive intervention
558673|NCT01183819|Space Fortress|space fortress
558674|NCT01183806|Alzheimer's disease|alzheimer's disease
558675|NCT01183806|Exercise|exercise
558676|NCT01183806|Rivastigmine|rivastigmine
558677|NCT01183806|Quality of life|quality of life
558678|NCT01183793|Gastrointestinal Tract [A03.556]|gastrointestinal tract [a03.556]
558679|NCT01183780|second line|second line
558680|NCT01183780|metastatic colorectal cancer|metastatic colorectal cancer
558681|NCT01183780|FOLFIRI|folfiri
558682|NCT01183780|ramucirumab|ramucirumab
558683|NCT01183780|CRC|crc
558684|NCT01183780|mCRC|mcrc
558685|NCT01183767|Duchenne Muscular Dystrophy|duchenne muscular dystrophy
558686|NCT01183767|Epigallocatechin-Gallate|epigallocatechin-gallate
558687|NCT01183767|Green tea extract|green tea extract
558688|NCT01183754|coronary disease|coronary disease
558689|NCT01183754|platelet reactivity|platelet reactivity
558690|NCT01183754|drug-eluting stent|drug-eluting stent
558691|NCT01183741|Hypertension|hypertension
558692|NCT01183741|Hypotension|hypotension
558693|NCT01183741|Blood pressure|blood pressure
558694|NCT01183728|Knee degenerative disease|knee degenerative disease
558695|NCT01183728|osteoarthritis|osteoarthritis
558696|NCT01183728|gonarthrosis|gonarthrosis
558697|NCT01183728|stem cell|stem cell
558698|NCT01183728|cellular therapy|cellular therapy
558699|NCT01183728|regenerative therapy|regenerative therapy
558700|NCT01183728|Mesenchymal stem cells|mesenchymal stem cells
558701|NCT01183728|Bone marrow|bone marrow
558702|NCT01183728|musculoskeletal Diseases|musculoskeletal diseases
558703|NCT01183715|Single Ascending Dose|single ascending dose
558704|NCT01183715|Phase 1|phase 1
558705|NCT01183715|Safety and Tolerability|safety and tolerability
558706|NCT01183715|PK|pk
558707|NCT01183715|Healthy Subjects|healthy subjects
558708|NCT01183702|LASIK vs. non-LASIK|lasik vs. non-lasik
558709|NCT01183663|Lenalidomide|lenalidomide
558710|NCT01183663|Bevacizumab|bevacizumab
558711|NCT01183663|Sorafenib|sorafenib
558712|NCT01183663|Temsirolimus|temsirolimus
558713|NCT01183663|5-Fluorouracil|5-fluorouracil
558714|NCT01183663|Leucovorin|leucovorin
558715|NCT01183663|Oxaliplatin|oxaliplatin
558716|NCT01183663|Avastin|avastin
558717|NCT01183663|Anti-VEGF monoclonal antibody|anti-vegf monoclonal antibody
558718|NCT01183663|rhuMAB-VEGF|rhumab-vegf
558719|NCT01183663|CC-5013|cc-5013
558720|NCT01183663|Revlimid|revlimid
558721|NCT01183663|Nexavar|nexavar
558722|NCT01183663|BAY 43-90006|bay 43-90006
558723|NCT01183663|Metastatic cancer|metastatic cancer
558724|NCT01183663|Metastatic colorectal cancer|metastatic colorectal cancer
558725|NCT01183663|Advanced solid tumors|advanced solid tumors
558726|NCT01183663|Hematologic malignancies|hematologic malignancies
558727|NCT01183663|Colon cancer|colon cancer
558728|NCT01183663|Advanced colorectal cancer|advanced colorectal cancer
558729|NCT01183663|Breast cancer|breast cancer
558730|NCT01183663|Pancreatic cancer|pancreatic cancer
558731|NCT01183663|Gastric cancer|gastric cancer
558732|NCT01183663|Advanced renal cell carcinoma|advanced renal cell carcinoma
558733|NCT01183663|Prostate cancer|prostate cancer
558734|NCT01183663|Melanoma|melanoma
558735|NCT01183663|Unresectable hepatocellular carcinoma|unresectable hepatocellular carcinoma
558736|NCT01183663|Renal cell carcinoma|renal cell carcinoma
558737|NCT01183663|Metastatic breast cancer|metastatic breast cancer
558738|NCT01183663|Glioblastoma|glioblastoma
558739|NCT01183663|Multiple myeloma|multiple myeloma
558740|NCT01183637|Cartilage|cartilage
558741|NCT01183637|Knee|knee
558742|NCT01183637|Osteochondral|osteochondral
558743|NCT01183624|Osteoarthritis|osteoarthritis
558744|NCT01183624|Pain|pain
558745|NCT01183624|Herbal medicine|herbal medicine
558746|NCT01183624|Topical administration|topical administration
558747|NCT01183611|safety|safety
558748|NCT01183611|immunogenicity|immunogenicity
558749|NCT01183611|HBV vaccine|hbv vaccine
558750|NCT01183611|perinatal transmission|perinatal transmission
558751|NCT01183572|multivitamins|multivitamins
558752|NCT01183572|folate|folate
558753|NCT01183572|iron|iron
558754|NCT01183572|periconception|periconception
558755|NCT01183546|rehabilitation|rehabilitation
558756|NCT01183546|spinal cord injury|spinal cord injury
558757|NCT01183546|wheelchairs|wheelchairs
558758|NCT01183533|Wake-Up Stroke|wake-up stroke
558759|NCT01183533|Ischemic stroke|ischemic stroke
558760|NCT01183533|ischemic stroke patients who wake-up with their symptoms|ischemic stroke patients who wake-up with their symptoms
558761|NCT01183481|nausea|nausea
558762|NCT01183481|vomiting|vomiting
558763|NCT01183481|antiemetics|antiemetics
558764|NCT01183481|radiotherapy|radiotherapy
558765|NCT01183481|Radiation-induced nausea and vomiting|radiation-induced nausea and vomiting
558766|NCT01183468|Diabetes Mellitus, Type 1 (new-onset)|diabetes mellitus, type 1 (new-onset)
558767|NCT01183468|Diabetes Mellitus, Insulin-Dependent (new-onset)|diabetes mellitus, insulin-dependent (new-onset)
558768|NCT01183468|new-onset T1DM|new-onset t1dm
558769|NCT01183468|new-onset T1D|new-onset t1d
558770|NCT01183468|Diabetes Mellitus, Juvenile-Onset|diabetes mellitus, juvenile-onset
558771|NCT01183468|Diabetes, Autoimmune|diabetes, autoimmune
558772|NCT01183468|Aralast NP|aralast np
558773|NCT01183468|Alpha-1 Antitrypsin|alpha-1 antitrypsin
558774|NCT01183468|AAT|aat
558775|NCT01183455|Diabetes Mellitus, Type 1 (new-onset)|diabetes mellitus, type 1 (new-onset)
558776|NCT01183455|T1DM (new-onset)|t1dm (new-onset)
558777|NCT01183455|T1D (new-onset)|t1d (new-onset)
558778|NCT01183455|Diabetes, Autoimmune|diabetes, autoimmune
558779|NCT01183455|Alpha1-Proteinase Inhibitor|alpha1-proteinase inhibitor
558780|NCT01183455|Alpha-1 Antitrypsin|alpha-1 antitrypsin
558781|NCT01183455|AAT|aat
558782|NCT01183442|endothelial function|endothelial function
558783|NCT01183442|insulin sensitivity|insulin sensitivity
558784|NCT01183429|MAB 3F8|mab 3f8
558785|NCT01183429|RETINOIC ACID (CIS-9 & 13)|retinoic acid (cis-9 & 13)
558786|NCT01183429|Bone Marrow|bone marrow
558787|NCT01183429|09-159|09-159
558788|NCT01183416|GM-CSF|gm-csf
558789|NCT01183416|MAB 3F8|mab 3f8
558790|NCT01183416|RETINOIC ACID (CIS-9 & 13)|retinoic acid (cis-9 & 13)
558791|NCT01183416|09-158|09-158
558792|NCT01183403|stricture|stricture
558793|NCT01183403|anti-TNF|anti-tnf
558794|NCT01183403|ileal Crohn'Disease|ileal crohn'disease
558795|NCT01183403|patients with ileal Crohn's disease complicated by|patients with ileal crohn's disease complicated by
558796|NCT01183403|symptomatic stricture after failure of corticosteroids|symptomatic stricture after failure of corticosteroids
558797|NCT01183403|and/or immunosuppressives|and/or immunosuppressives
558798|NCT01183390|Bioequivalence|bioequivalence
558799|NCT01183390|Healthy Subjects|healthy subjects
558800|NCT01183377|Female Athlete Triad syndrom|female athlete triad syndrom
558801|NCT01183377|Eating disorder|eating disorder
558802|NCT01183377|osteoprosis|osteoprosis
558803|NCT01183364|solid tumor malignancies|solid tumor malignancies
558804|NCT01183364|tumor|tumor
558805|NCT01183364|cancer|cancer
558806|NCT01183364|STA-9090|sta-9090
558807|NCT01183364|ganetespib|ganetespib
558808|NCT01183364|HSP90 inhibitor|hsp90 inhibitor
558809|NCT01183351|Dementia|dementia
558810|NCT01183351|Agitation|agitation
558811|NCT01183351|Challenging behaviour|challenging behaviour
558812|NCT01183351|Behavioural and psychological symptoms in dementia (BPSD)|behavioural and psychological symptoms in dementia (bpsd)
558813|NCT01183338|SpO2|spo2
558814|NCT01183338|Oxygen saturation|oxygen saturation
558815|NCT01183325|Umbilical and small ventral hernias less than 3cm diameter|umbilical and small ventral hernias less than 3cm diameter
558816|NCT01183312|Hypersomnia|hypersomnia
558817|NCT01183312|Primary Hypersomnia|primary hypersomnia
558818|NCT01183312|Idiopathic Hypersomnia|idiopathic hypersomnia
558819|NCT01183312|Narcolepsy without Cataplexy|narcolepsy without cataplexy
558820|NCT01183312|Flumazenil|flumazenil
558821|NCT01183299|bone metabolism|bone metabolism
558822|NCT01183299|salt intake|salt intake
558823|NCT01183299|acid base balance|acid base balance
558825|NCT01183260|revision total hip arthroplasty|revision total hip arthroplasty
558826|NCT01183260|bone mineral density|bone mineral density
558827|NCT01183260|trabecular metal|trabecular metal
558828|NCT01183260|DEXA|dexa
558829|NCT01183247|Everolimus,|everolimus,
558830|NCT01183247|rapamycin,|rapamycin,
558831|NCT01183247|prednisone,|prednisone,
558832|NCT01183247|tacrolimus,|tacrolimus,
558833|NCT01183247|MMF,|mmf,
558834|NCT01183247|steroid-free,|steroid-free,
558835|NCT01183247|protocol biopsy|protocol biopsy
558836|NCT01183182|Lung nodule|lung nodule
558837|NCT01183182|Lung lesion|lung lesion
558838|NCT01183169|Chronic hepatitis C|chronic hepatitis c
558839|NCT01183169|Cyclophilin inhibitor|cyclophilin inhibitor
558840|NCT01183156|Colorectal Cancer|colorectal cancer
558841|NCT01183156|Screening|screening
558842|NCT01183156|Colonoscopy|colonoscopy
558843|NCT01183156|Attendance|attendance
558844|NCT01183156|Participation|participation
558845|NCT01183143|Infertility|infertility
558846|NCT01183143|Ovulation induction|ovulation induction
558847|NCT01183143|Gonal-F|gonal-f
558848|NCT01183143|Follitropin alpha|follitropin alpha
558849|NCT01183143|Controlled ovarian stimulation|controlled ovarian stimulation
558850|NCT01183130|opiate dependence|opiate dependence
558851|NCT01183130|compliance monitoring|compliance monitoring
558852|NCT01183130|substitution treatment|substitution treatment
558853|NCT01183104|Type 2 Diabetes|type 2 diabetes
558854|NCT01183104|Sitagliptin|sitagliptin
558855|NCT01183104|Glimepiride|glimepiride
558856|NCT01183104|Elderly patients|elderly patients
558857|NCT01183104|Japanese|japanese
558858|NCT01183091|Atrial fibrillation|atrial fibrillation
558859|NCT01183091|Ablation|ablation
558860|NCT01183078|efficacy|efficacy
558861|NCT01183078|drill placement|drill placement
558862|NCT01183078|nail placement|nail placement
558863|NCT01183078|radiation|radiation
558864|NCT01183078|Operative time|operative time
558865|NCT01183078|Reduction in exposure to radiation|reduction in exposure to radiation
558866|NCT01183078|Accuracy for nail placement|accuracy for nail placement
558867|NCT01183065|Pralatrexate|pralatrexate
558868|NCT01183065|Vitamin B12|vitamin b12
558869|NCT01183065|Folic Acid|folic acid
558870|NCT01183065|10-112|10-112
709770|NCT00591526|APL|apl
558871|NCT01183052|COPD|copd
558872|NCT01183052|exercise tolerance|exercise tolerance
558873|NCT01183052|oxidative stress|oxidative stress
558874|NCT01183039|Sedentary|sedentary
558875|NCT01183000|Formation of adhesions assessed at subsequent cs|formation of adhesions assessed at subsequent cs
558876|NCT01182987|Quality improvement|quality improvement
558877|NCT01182987|Quality of care|quality of care
558878|NCT01182987|Health care utilization|health care utilization
558879|NCT01182987|Behavioral change|behavioral change
558880|NCT01182974|fever in severe sepsis|fever in severe sepsis
558881|NCT01182961|Gait|gait
558882|NCT01182961|Falls|falls
558883|NCT01182961|Virtual reality|virtual reality
558884|NCT01182948|aerobic training|aerobic training
558885|NCT01182948|resistance training|resistance training
558886|NCT01182948|type 2 diabetes|type 2 diabetes
558887|NCT01182948|therapy|therapy
558888|NCT01182935|vitamin D|vitamin d
558889|NCT01182935|triglycerides|triglycerides
558890|NCT01182935|type 2 diabetes|type 2 diabetes
558891|NCT01182922|Attendance|attendance
558892|NCT01182922|Colorectal cancer|colorectal cancer
558893|NCT01182922|Screening|screening
558894|NCT01182922|Invitation letter|invitation letter
558895|NCT01182909|NPC|npc
558896|NCT01182909|Environmental and Genetic|environmental and genetic
558897|NCT01182909|evaluate putative environmental exposures and NPC|evaluate putative environmental exposures and npc
558898|NCT01182909|assess the effect of genetic factors|assess the effect of genetic factors
558899|NCT01182909|investigate gene-environment interactions|investigate gene-environment interactions
558900|NCT01182909|examine the natural history of EBV infection|examine the natural history of ebv infection
558901|NCT01182883|Maximum Tolerated Dose|maximum tolerated dose
558902|NCT01182883|Dose Escalation|dose escalation
558903|NCT01182883|Pharmacokinetics|pharmacokinetics
558904|NCT01182883|Antitumor Activity|antitumor activity
558905|NCT01182883|Biologic Activity|biologic activity
558906|NCT01182870|vitamin D|vitamin d
558907|NCT01182870|influenza|influenza
558908|NCT01182870|prevention|prevention
558909|NCT01182857|Quality of Life|quality of life
558910|NCT01182857|Gene Therapy|gene therapy
558911|NCT01182857|ADA-SCID|ada-scid
558912|NCT01182857|SCID-ADA|scid-ada
558913|NCT01182857|Severe Combined Immunodeficiency|severe combined immunodeficiency
558914|NCT01182844|metabolic syndrome, probiotic|metabolic syndrome, probiotic
558915|NCT01182831|carcinoma pancreas|carcinoma pancreas
558916|NCT01182831|percutaneous celiac plexus neurolysis|percutaneous celiac plexus neurolysis
558917|NCT01182831|endosonography guided celiac plexus neurolysis|endosonography guided celiac plexus neurolysis
558918|NCT01182818|Cerebrovascular Accident|cerebrovascular accident
558919|NCT01182818|Cerebrovascular Accident, Acute|cerebrovascular accident, acute
558920|NCT01182818|Fabry Disease|fabry disease
558921|NCT01182818|Fabry´s Disease|fabry´s disease
558922|NCT01182818|Anderson-Fabry Disease|anderson-fabry disease
559118|NCT01181947|aneurysm|aneurysm
558923|NCT01182818|CVA (Cerebrovascular Accident)|cva (cerebrovascular accident)
558924|NCT01182818|Stroke, Acute|stroke, acute
558925|NCT01182818|Cerebral Stroke|cerebral stroke
558926|NCT01182792|Endothelial Function|endothelial function
558927|NCT01182792|Chronic Hypoxia|chronic hypoxia
558928|NCT01182792|Oxidative Stress|oxidative stress
558929|NCT01182779|base of skull chordoma|base of skull chordoma
558930|NCT01182779|radiation|radiation
558931|NCT01182779|carbon ions|carbon ions
558932|NCT01182779|protons|protons
558933|NCT01182766|alcohol|alcohol
558934|NCT01182766|alcoholism|alcoholism
558935|NCT01182766|nicotine|nicotine
558936|NCT01182766|cigarette|cigarette
558937|NCT01182753|Chondrosarcoma|chondrosarcoma
558938|NCT01182753|Radiation|radiation
558939|NCT01182753|carbon ion|carbon ion
558940|NCT01182727|schizophrenia|schizophrenia
558941|NCT01182727|salsalate|salsalate
558942|NCT01182727|obesity|obesity
558943|NCT01182714|Hysterectomy|hysterectomy
558944|NCT01182714|Catheterisation|catheterisation
558945|NCT01182701|Type 2 Diabetes|type 2 diabetes
558946|NCT01182701|Asian Pacific Islanders|asian pacific islanders
558947|NCT01182701|Cognitive behavioral intervention|cognitive behavioral intervention
558948|NCT01182688|utilization of Procalcitonin in the cardiac setting|utilization of procalcitonin in the cardiac setting
558949|NCT01182675|SCID|scid
558950|NCT01182675|Transplant|transplant
558951|NCT01182675|Alemtuzumab|alemtuzumab
558952|NCT01182675|Plerixafor|plerixafor
558953|NCT01182662|Bone Marrow Disease|bone marrow disease
558954|NCT01182662|Aplastic Anemia|aplastic anemia
558955|NCT01182662|Umbilical Cord/placenta-Derived MSC|umbilical cord/placenta-derived msc
558956|NCT01182662|Transplantation|transplantation
558957|NCT01182649|Drug Eluting Stents|drug eluting stents
558958|NCT01182649|Everolimus Eluting Stent|everolimus eluting stent
558959|NCT01182649|Coronary Angioplasty|coronary angioplasty
558960|NCT01182636|Bioequivalence|bioequivalence
558961|NCT01182636|Acne Vulgaris|acne vulgaris
558962|NCT01182623|FICE|fice
558963|NCT01182623|Chromoendoscopy|chromoendoscopy
558964|NCT01182623|Colonic polyps|colonic polyps
558965|NCT01182623|Adenomas|adenomas
558966|NCT01182623|Hyperplastic polyps|hyperplastic polyps
558967|NCT01182597|Oral PPI treatment has similar benefit as proton pump inhibitor infusion in patient with bleeding ulcers after combined endoscopic hemostasis|oral ppi treatment has similar benefit as proton pump inhibitor infusion in patient with bleeding ulcers after combined endoscopic hemostasis
558968|NCT01182571|Heart Transplantation|heart transplantation
558969|NCT01182571|Symptom Distress|symptom distress
558970|NCT01182571|Fatigue|fatigue
558971|NCT01182571|Depression|depression
558972|NCT01182571|Quality Of Life.|quality of life.
558973|NCT01182558|Muscle|muscle
558974|NCT01182558|Activation|activation
558975|NCT01182558|Effect|effect
558976|NCT01182558|Compound muscle action potential|compound muscle action potential
558977|NCT01182545|Anaesthesia|anaesthesia
558978|NCT01182545|laparoscopic cholecystectomy|laparoscopic cholecystectomy
558979|NCT01182545|CO2 insufflation|co2 insufflation
558980|NCT01182545|hemodynamic|hemodynamic
558981|NCT01182545|hyperventilation|hyperventilation
558982|NCT01182532|Mild type of hand, foot and mouth disease|mild type of hand, foot and mouth disease
558983|NCT01182532|Traditional Chinese Medicine|traditional chinese medicine
558984|NCT01182532|Effectiveness|effectiveness
558985|NCT01182532|Safety|safety
558986|NCT01182519|lung inflammation|lung inflammation
558987|NCT01182519|lung metastases|lung metastases
558988|NCT01182519|10-115|10-115
558989|NCT01182506|Cogmed Working Memory Training (CWMT)|cogmed working memory training (cwmt)
558990|NCT01182506|cognitive|cognitive
558991|NCT01182506|10-105|10-105
558992|NCT01182506|Breast cancer survivor|breast cancer survivor
558993|NCT01182493|Diabetes Mellitus|diabetes mellitus
558994|NCT01182493|MDI|mdi
558995|NCT01182493|pump therapy|pump therapy
558996|NCT01182467|Inflammatory bowel disease, PET scan, Crohn's disease|inflammatory bowel disease, pet scan, crohn's disease
558997|NCT01182454|blood pressure|blood pressure
558998|NCT01182441|atrial fibrillation|atrial fibrillation
558999|NCT01182441|stroke|stroke
559000|NCT01182441|TIA|tia
559001|NCT01182441|trans ischemic attack|trans ischemic attack
559002|NCT01182441|warfarin|warfarin
559003|NCT01182441|Coumadin|coumadin
559004|NCT01182428|Stents|stents
559005|NCT01182428|Angioplasty|angioplasty
559006|NCT01182428|Total coronary occlusions|total coronary occlusions
559007|NCT01182428|Coronary restenosis|coronary restenosis
559008|NCT01182428|Stent thrombosis|stent thrombosis
559009|NCT01182428|Everolimus|everolimus
559010|NCT01182415|CNS involvement|cns involvement
559011|NCT01182402|opiate dependence|opiate dependence
559012|NCT01182402|substitution treatment|substitution treatment
559013|NCT01182402|unsupervised dosing|unsupervised dosing
559014|NCT01182402|monitoring|monitoring
559015|NCT01182389|Ventricular Tachycardia|ventricular tachycardia
559016|NCT01182389|Implantable Cardioverter Defibrillator|implantable cardioverter defibrillator
559017|NCT01182389|Catheter Ablation|catheter ablation
559018|NCT01182389|Robotic|robotic
559019|NCT01182376|Multaq|multaq
559020|NCT01182376|dronedarone|dronedarone
559021|NCT01182376|Atrial Fibrillation|atrial fibrillation
559022|NCT01182363|maternal depression|maternal depression
559023|NCT01182363|prematurity|prematurity
559024|NCT01182363|early intervention|early intervention
559025|NCT01182363|developmental delay|developmental delay
559026|NCT01182350|Molecularly Determined Treatment|molecularly determined treatment
559027|NCT01182324|Expectations|expectations
559028|NCT01182324|Duchenne Muscular Dystrophy|duchenne muscular dystrophy
559029|NCT01182324|Clinical Trial|clinical trial
559030|NCT01182324|Motivations|motivations
559031|NCT01182311|Hepatitis B Virus|hepatitis b virus
559032|NCT01182311|Hepatitis B Vaccine|hepatitis b vaccine
559033|NCT01182311|Immunity|immunity
559034|NCT01182311|B-Cell Response|b-cell response
559035|NCT01182311|T-Cell Response|t-cell response
559036|NCT01182311|Hepatitis B Immunity|hepatitis b immunity
559037|NCT01182311|Hepatitis B Virus Vaccine|hepatitis b virus vaccine
559038|NCT01182298|Latino|latino
559039|NCT01182298|HCV|hcv
559040|NCT01182298|pegIFN|pegifn
559041|NCT01182298|Viral Kinetics|viral kinetics
559042|NCT01182298|IL-28 Haplotype|il-28 haplotype
559043|NCT01182285|Depakote|depakote
559044|NCT01182285|Poorly Differentiated Thyroid Cancer|poorly differentiated thyroid cancer
559045|NCT01182285|RAI Uptake|rai uptake
559046|NCT01182285|Thyrogen|thyrogen
559047|NCT01182272|adult primary hepatocellular carcinoma|adult primary hepatocellular carcinoma
559048|NCT01182272|localized resectable adult primary liver cancer|localized resectable adult primary liver cancer
559049|NCT01182246|adenocarcinoma|adenocarcinoma
559050|NCT01182246|Pancreatic cancer|pancreatic cancer
559051|NCT01182233|Multiple Myeloma|multiple myeloma
559052|NCT01182233|Autologous Hematopoietic Stem Cell Transplant|autologous hematopoietic stem cell transplant
559053|NCT01182233|Total Skeletal Irradiation|total skeletal irradiation
559054|NCT01182233|High dose chemotherapy|high dose chemotherapy
559055|NCT01182220|epidural|epidural
559056|NCT01182220|labor pain|labor pain
559057|NCT01182220|ultrasound|ultrasound
559058|NCT01182207|Bioequivalence|bioequivalence
559059|NCT01182207|Healthy Subjects|healthy subjects
559060|NCT01182194|Bioequivalence|bioequivalence
559061|NCT01182194|Healthy Subjects|healthy subjects
559062|NCT01182181|Healthy Subjects|healthy subjects
559063|NCT01182181|Bioequivalence|bioequivalence
559064|NCT01182168|CISPLATIN|cisplatin
559065|NCT01182168|GEMCITABINE|gemcitabine
559066|NCT01182168|RAD001 (EVEROLIMUS)|rad001 (everolimus)
559067|NCT01182168|10-106|10-106
559068|NCT01182155|Lung Cancer Non-Small Cell Cancer (NSCLC)|lung cancer non-small cell cancer (nsclc)
559069|NCT01182155|Lung Cancer Small Cell Lung Cancer (SCLC)|lung cancer small cell lung cancer (sclc)
559070|NCT01182129|Nicotine Polacrilex chewing gum versus Swedish Snus|nicotine polacrilex chewing gum versus swedish snus
559071|NCT01182116|J pouch|j pouch
559072|NCT01182116|colorectal|colorectal
559073|NCT01182116|rectal cancer|rectal cancer
559074|NCT01182116|coloplasty|coloplasty
559075|NCT01182103|Major depression|major depression
559076|NCT01182103|BDNF|bdnf
559077|NCT01182103|DNA methylation|dna methylation
559078|NCT01182103|Histone modification|histone modification
559079|NCT01182090|pelvic organ prolapse|pelvic organ prolapse
559080|NCT01182090|colposacropexy|colposacropexy
559081|NCT01182090|surgery|surgery
559082|NCT01182077|ASP015K|asp015k
559083|NCT01182077|midazolam|midazolam
559084|NCT01182077|healthy volunteers|healthy volunteers
559085|NCT01182064|Heart injuries|heart injuries
559086|NCT01182064|Posttraumatic myocardial infarction|posttraumatic myocardial infarction
559087|NCT01182064|Echocardiography|echocardiography
559088|NCT01182064|Coronary angiography|coronary angiography
559089|NCT01182051|headache|headache
559090|NCT01182051|anxiety|anxiety
559091|NCT01182051|pediatric headache and anxiety|pediatric headache and anxiety
559092|NCT01182038|birth seat|birth seat
559093|NCT01182038|childbirth|childbirth
559094|NCT01182038|instrumental delivery|instrumental delivery
559095|NCT01182038|upright position|upright position
559096|NCT01182025|Mild type of hand, foot and mouth disease|mild type of hand, foot and mouth disease
559097|NCT01182025|Xiyanping Injection|xiyanping injection
559098|NCT01182025|Effectiveness|effectiveness
559099|NCT01182025|Safety|safety
559100|NCT01182012|Cardiovascular risk factor|cardiovascular risk factor
559101|NCT01182012|Severe mental illness|severe mental illness
559102|NCT01182012|Drug appropriateness|drug appropriateness
559103|NCT01182012|Drug compliance|drug compliance
559104|NCT01182012|Lifestyle counseling|lifestyle counseling
559105|NCT01181999|diffuse large B-cell lymphoma|diffuse large b-cell lymphoma
559106|NCT01181999|elderly patients|elderly patients
559107|NCT01181999|rituximab augmentation|rituximab augmentation
559108|NCT01181986|Type 2 diabetes mellitus, Impaired glucose tolerance|type 2 diabetes mellitus, impaired glucose tolerance
559109|NCT01181973|Relative bioavailability|relative bioavailability
559110|NCT01181973|pegvisomant|pegvisomant
559111|NCT01181960|Risperidone long acting injectable|risperidone long acting injectable
559112|NCT01181960|Risperdal Consta|risperdal consta
559113|NCT01181960|Paliperidone Palmitate|paliperidone palmitate
559114|NCT01181960|Invega Sustenna|invega sustenna
559115|NCT01181947|Stent graft|stent graft
559116|NCT01181947|thoracic aorta|thoracic aorta
559117|NCT01181947|dissection|dissection
559119|NCT01181947|TEVAR|tevar
559120|NCT01181947|VALIANT|valiant
559121|NCT01181947|CAPTIVIA|captivia
559122|NCT01181947|endovascular|endovascular
559123|NCT01181934|symptomatic treatment|symptomatic treatment
559124|NCT01181934|cognition|cognition
559125|NCT01181934|cognitive deficits|cognitive deficits
559126|NCT01181934|Schizophrenia|schizophrenia
559127|NCT01181921|Alzheimer Disease|alzheimer disease
559128|NCT01181921|Dementia|dementia
559129|NCT01181921|Sleep Disorders|sleep disorders
559130|NCT01181921|Galantamine|galantamine
559131|NCT01181921|Reminyl|reminyl
559132|NCT01181908|alcohol|alcohol
559133|NCT01181908|drug interaction|drug interaction
559134|NCT01181908|pharmacodynamic|pharmacodynamic
559135|NCT01181895|asthma|asthma
559136|NCT01181882|Cardiovascular Disease|cardiovascular disease
559137|NCT01181882|Aspirin Resistance|aspirin resistance
559138|NCT01181882|Diabetes Mellitus, Type 2|diabetes mellitus, type 2
559139|NCT01181882|Platelet Function|platelet function
559140|NCT01181882|Omega-3 Fatty Acids|omega-3 fatty acids
559141|NCT01181882|Aspirin|aspirin
559142|NCT01181882|Lysophospholipids|lysophospholipids
559143|NCT01181882|Lysophosphatidic Acid|lysophosphatidic acid
559144|NCT01181882|Lysophosphatidylcholine|lysophosphatidylcholine
559145|NCT01181869|respiratory failure|respiratory failure
559146|NCT01181869|oxygen|oxygen
559147|NCT01181869|sleep apnoea|sleep apnoea
559148|NCT01181869|ventilation|ventilation
559149|NCT01181856|Vaccine|vaccine
559150|NCT01181856|MVA 85A|mva 85a
559151|NCT01181843|postoperative pain management|postoperative pain management
559152|NCT01181843|respiratory depression|respiratory depression
559153|NCT01181843|capnography|capnography
559154|NCT01181843|duramorph|duramorph
559155|NCT01181830|magnesium|magnesium
559156|NCT01181830|metabolic syndrome|metabolic syndrome
559157|NCT01181830|diabetes|diabetes
559158|NCT01181830|family history|family history
559159|NCT01181817|FBSS|fbss
559160|NCT01181817|at least one prior spinal surgery|at least one prior spinal surgery
559161|NCT01181804|boceprevir|boceprevir
559162|NCT01181804|hepatitis C|hepatitis c
559163|NCT01181804|bioequivalence|bioequivalence
559164|NCT01181804|SCH 503034|sch 503034
559165|NCT01181791|probiotics|probiotics
559166|NCT01181791|premature infants|premature infants
559167|NCT01181791|feeding tolerance|feeding tolerance
559168|NCT01181778|hormonal contraceptive methods|hormonal contraceptive methods
559169|NCT01181778|combined hormonal contraceptive methods|combined hormonal contraceptive methods
559170|NCT01181778|physician counseling|physician counseling
559171|NCT01181765|Crohn's Disease|crohn's disease
559172|NCT01181765|infliximab|infliximab
559173|NCT01181765|capsule endoscopy|capsule endoscopy
559174|NCT01181752|proficiency|proficiency
559175|NCT01181752|eye drop instillation|eye drop instillation
559176|NCT01181752|postoperative cataract surgery|postoperative cataract surgery
559177|NCT01181752|Ghana|ghana
559178|NCT01181739|Colonoscopy|colonoscopy
559179|NCT01181739|Virtual Colonoscopy|virtual colonoscopy
559180|NCT01181739|Colonography|colonography
559181|NCT01181739|Colorectal Cancer|colorectal cancer
559182|NCT01181739|Colonic Polyps|colonic polyps
559183|NCT01181739|Screening|screening
559184|NCT01181726|Bioequivalence|bioequivalence
559185|NCT01181726|Healthy Subjects|healthy subjects
559186|NCT01181687|COMFORT behavioral scale|comfort behavioral scale
559187|NCT01181687|pain assessment scale|pain assessment scale
559188|NCT01181687|child|child
559189|NCT01181687|validity|validity
559190|NCT01181687|reliability|reliability
559191|NCT01181674|Diabetes|diabetes
559192|NCT01181674|Insulin|insulin
559193|NCT01181674|Glargine|glargine
559194|NCT01181674|Metformin|metformin
559195|NCT01181674|Acarbose|acarbose
559196|NCT01181674|Diet|diet
559197|NCT01181674|Exercise|exercise
559198|NCT01181674|Lifestyle|lifestyle
559199|NCT01181661|Cigarette|cigarette
559200|NCT01181661|Smoking|smoking
559201|NCT01181661|Nicotine|nicotine
559202|NCT01181661|Contingency Management|contingency management
559203|NCT01181661|Voucher Reinforcement|voucher reinforcement
559204|NCT01181661|Smoking Abstinence|smoking abstinence
559205|NCT01181661|Internet|internet
559206|NCT01181661|Internet-based Treatment|internet-based treatment
559207|NCT01181661|Group Contingencies|group contingencies
559208|NCT01181648|Survivor|survivor
559209|NCT01181648|Human Papillomavirus (HPV)|human papillomavirus (hpv)
559210|NCT01181648|Quality of Life|quality of life
559211|NCT01181648|Surviving Oropharynx Cancer|surviving oropharynx cancer
559212|NCT01181648|10-111|10-111
559213|NCT01181596|neonates and infants, from the 23-week gestational (0.5 kg)|neonates and infants, from the 23-week gestational (0.5 kg)
559214|NCT01181596|up to a 6 month old born at term (7 kg), for whom the PIV,|up to a 6 month old born at term (7 kg), for whom the piv,
559215|NCT01181596|PAC, UAC, UVC or PICC catheter insertion is medically|pac, uac, uvc or picc catheter insertion is medically
559216|NCT01181596|indicated.|indicated.
559217|NCT01181570|psoriasis|psoriasis
559218|NCT01181570|adalimumab|adalimumab
559219|NCT01181570|obstructive sleep apnea|obstructive sleep apnea
559220|NCT01181570|obesity|obesity
559424|NCT01180816|GBM|gbm
559221|NCT01181557|quality of life|quality of life
559222|NCT01181544|Anticoagulation|anticoagulation
559224|NCT01181544|Hemodialysis|hemodialysis
559225|NCT01181544|Dialysis|dialysis
559226|NCT01181544|Renal Dialysis|renal dialysis
559227|NCT01181531|Secondary Hyperthyroidism|secondary hyperthyroidism
559228|NCT01181531|Hemodialysis|hemodialysis
559229|NCT01181531|Parathyroid|parathyroid
559230|NCT01181531|PARADIGM|paradigm
559231|NCT01181518|Tamoxifen|tamoxifen
559232|NCT01181518|Pharmacogenomics|pharmacogenomics
559233|NCT01181518|Breast cancer|breast cancer
559234|NCT01181505|HNF4a|hnf4a
559235|NCT01181505|CYP2D6|cyp2d6
559236|NCT01181505|Toterodine|toterodine
559237|NCT01181505|Genetic polymorphism|genetic polymorphism
559238|NCT01181492|gene polymorphism|gene polymorphism
559239|NCT01181492|CYP3A4|cyp3a4
559240|NCT01181492|fentanyl|fentanyl
559241|NCT01181492|HPLC|hplc
559242|NCT01181492|Analgesics|analgesics
559243|NCT01181479|Contraceptive|contraceptive
559244|NCT01181466|PLVR|plvr
559245|NCT01181466|BLVR|blvr
559246|NCT01181466|AeriSeal|aeriseal
559247|NCT01181466|treatment|treatment
559248|NCT01181466|device|device
559249|NCT01181466|breathing|breathing
559250|NCT01181466|COPD|copd
559251|NCT01181466|emphysema|emphysema
559252|NCT01181466|polymeric lung volume reduction|polymeric lung volume reduction
559253|NCT01181466|biologic lung volume reduction|biologic lung volume reduction
559254|NCT01181466|heterogeneous|heterogeneous
559255|NCT01181466|homogeneous|homogeneous
559256|NCT01181466|Pathologic Processes|pathologic processes
559257|NCT01181466|Respiratory Tract Diseases|respiratory tract diseases
559258|NCT01181466|Lung Diseases|lung diseases
559259|NCT01181466|Pulmonary Disease, Chronic Obstructive|pulmonary disease, chronic obstructive
559260|NCT01181453|Diabetic foot ulcer|diabetic foot ulcer
559261|NCT01181453|Randomized trial|randomized trial
559262|NCT01181453|Clinical trial|clinical trial
559263|NCT01181453|Dermagraft|dermagraft
559264|NCT01181453|Standard care|standard care
559265|NCT01181440|Diabetic foot ulcer|diabetic foot ulcer
559266|NCT01181440|Randomized trial|randomized trial
559267|NCT01181440|Clinical trial|clinical trial
559268|NCT01181440|Dermagraft|dermagraft
559269|NCT01181440|Conventional care|conventional care
559270|NCT01181414|Permanent Atrial Fibrillation|permanent atrial fibrillation
559271|NCT01181414|Resynchronization therapy|resynchronization therapy
559272|NCT01181414|Ablation|ablation
559273|NCT01181401|induction chemotherapy|induction chemotherapy
559274|NCT01181401|radiotherapy|radiotherapy
559275|NCT01181401|locally advanced head neck tumor|locally advanced head neck tumor
559276|NCT01181401|toxicity|toxicity
559277|NCT01181401|LA SCCHN|la scchn
559278|NCT01181401|Unresectable squamous cell cancer of the head and neck,|unresectable squamous cell cancer of the head and neck,
559279|NCT01181401|Stage IV (UICC)|stage iv (uicc)
559280|NCT01181375|cervical cancer|cervical cancer
559281|NCT01181375|assay|assay
559282|NCT01181375|hypoxia|hypoxia
559283|NCT01181362|Endoscopy|endoscopy
559284|NCT01181362|Head and Neck region|head and neck region
559285|NCT01181362|Scope|scope
559286|NCT01181349|neuromuscular blockade; general anesthesia|neuromuscular blockade; general anesthesia
559287|NCT01181336|Safety|safety
559288|NCT01181336|Tolerability|tolerability
559289|NCT01181336|Immunogenicity|immunogenicity
559290|NCT01181336|Influenza|influenza
559291|NCT01181336|Virus|virus
559292|NCT01181336|Vaccine|vaccine
559293|NCT01181323|influenza, vaccine, breastfeeding, post-partum women, infant, LAIV, TIV, parent protocol|influenza, vaccine, breastfeeding, post-partum women, infant, laiv, tiv, parent protocol
559294|NCT01181310|dementia, cognitive impairment, neurodegeneration, Alzheimer's, acetylcholine, AchE|dementia, cognitive impairment, neurodegeneration, alzheimer's, acetylcholine, ache
559295|NCT01181297|Confirmed milk allergy|confirmed milk allergy
559296|NCT01181284|Pulmonary Arterial Hypertension (PAH)|pulmonary arterial hypertension (pah)
559297|NCT01181271|Lymphoma|lymphoma
559298|NCT01181271|non-hodgkins lymphoma|non-hodgkins lymphoma
559299|NCT01181271|Hodgkin's lymphoma|hodgkin's lymphoma
559300|NCT01181271|Hodgkin's disease|hodgkin's disease
559301|NCT01181271|stem cell transplant|stem cell transplant
559302|NCT01181271|High-risk diffuse large B cell|high-risk diffuse large b cell
559303|NCT01181271|Transformed low grade lymphoma|transformed low grade lymphoma
559304|NCT01181271|T-cell non-Hodgkin's lymphoma|t-cell non-hodgkin's lymphoma
559305|NCT01181271|Mantle cell lymphoma at any time in therapy|mantle cell lymphoma at any time in therapy
559306|NCT01181271|"Double-hit lymphoma"|"double-hit lymphoma"
559307|NCT01181258|related HLA-haploidentical donor|related hla-haploidentical donor
559308|NCT01181245|Pancreatic Cancer|pancreatic cancer
559309|NCT01181232|insomnia|insomnia
559310|NCT01181232|zolpidem|zolpidem
559311|NCT01181206|Surgical site infections|surgical site infections
559312|NCT01181206|Covering the abdominal wound edge in laparotomies|covering the abdominal wound edge in laparotomies
559313|NCT01181193|glioblastoma multiforme|glioblastoma multiforme
559314|NCT01181193|chemoradiotherapy|chemoradiotherapy
559315|NCT01181193|vitamin D|vitamin d
559316|NCT01181180|Ageing|ageing
559317|NCT01181180|Balance control|balance control
559318|NCT01181180|Falls|falls
559319|NCT01181180|dehydration|dehydration
559320|NCT01181167|Anticoagulants|anticoagulants
559321|NCT01181167|Venous thromboembolism|venous thromboembolism
559322|NCT01181167|Thromboembolism|thromboembolism
559323|NCT01181167|Thrombosis|thrombosis
559324|NCT01181167|enoxaparin sodium|enoxaparin sodium
559325|NCT01181167|Embolism|embolism
559326|NCT01181167|Deep vein thrombosis|deep vein thrombosis
559327|NCT01181167|DU-176b|du-176b
559328|NCT01181167|edoxaban|edoxaban
559329|NCT01181167|factor Xa|factor xa
559330|NCT01181167|total hip arthroplasty|total hip arthroplasty
559331|NCT01181154|Auto-Immune|auto-immune
559332|NCT01181154|Hemolytic|hemolytic
559333|NCT01181154|Anemia|anemia
559334|NCT01181154|AHA|aha
559335|NCT01181154|AIHA|aiha
559336|NCT01181154|Rituximab|rituximab
559337|NCT01181141|Anticoagulants|anticoagulants
559338|NCT01181141|Enoxaparin sodium|enoxaparin sodium
559339|NCT01181141|venous thromboembolism.|venous thromboembolism.
559340|NCT01181141|thromboembolism|thromboembolism
559341|NCT01181141|Thrombosis|thrombosis
559342|NCT01181141|deep vein thrombosis|deep vein thrombosis
559343|NCT01181141|DU-176b|du-176b
559344|NCT01181141|Edoxaban|edoxaban
559345|NCT01181141|factor Xa|factor xa
559346|NCT01181141|hip fracture surgery|hip fracture surgery
559347|NCT01181141|embolism|embolism
559348|NCT01181115|Chinese Patients|chinese patients
559349|NCT01181115|Relapsing MS|relapsing ms
559350|NCT01181115|Safety|safety
559351|NCT01181115|Avonex|avonex
559352|NCT01181115|Tolerability|tolerability
559353|NCT01181115|Gadolinium|gadolinium
559354|NCT01181115|Interferon Beta 1a|interferon beta 1a
559355|NCT01181102|anticoagulant|anticoagulant
559356|NCT01181102|venus thromboembolism|venus thromboembolism
559357|NCT01181102|thrombosis|thrombosis
559358|NCT01181102|thromboembolism|thromboembolism
559359|NCT01181102|embolism and thrombosis|embolism and thrombosis
559360|NCT01181102|deep vein thrombosis|deep vein thrombosis
559361|NCT01181102|DU-176b|du-176b
559362|NCT01181102|Edoxaban|edoxaban
559363|NCT01181102|factor Xa|factor xa
559364|NCT01181102|total knee arthroplasty|total knee arthroplasty
559365|NCT01181102|Enoxaparin sodium|enoxaparin sodium
559366|NCT01181076|Stem cell transplantation|stem cell transplantation
559367|NCT01181076|Individualized Nutrition|individualized nutrition
559368|NCT01181076|Quality of life|quality of life
559369|NCT01181076|Oral Mucositis|oral mucositis
559370|NCT01181076|Adult|adult
559371|NCT01181063|Asthma|asthma
559372|NCT01181063|Easyhaler|easyhaler
559373|NCT01181037|Displaced subcapital femoral fracture|displaced subcapital femoral fracture
559374|NCT01181037|Bbipolar H.A.|bbipolar h.a.
559375|NCT01181037|CRIF with Ttrochanteric Antegrade Nail|crif with ttrochanteric antegrade nail
559376|NCT01180972|Obesity, diabetes, hispanic, physical activity, nutrition|obesity, diabetes, hispanic, physical activity, nutrition
559377|NCT01180959|Advanced Liver Cancer|advanced liver cancer
559378|NCT01180959|primary neoplasm of the liver|primary neoplasm of the liver
559379|NCT01180959|Erlotinib|erlotinib
559380|NCT01180959|Bevacizumab|bevacizumab
559381|NCT01180959|Hepatocellular Carcinoma|hepatocellular carcinoma
559382|NCT01180959|HCC|hcc
559383|NCT01180959|Avastin|avastin
559384|NCT01180959|Anti-VEGF monoclonal antibody|anti-vegf monoclonal antibody
559385|NCT01180959|rhuMAb-VEGF|rhumab-vegf
559386|NCT01180959|OSI-774|osi-774
559387|NCT01180959|Tarceva|tarceva
559388|NCT01180946|FGF23|fgf23
559389|NCT01180946|FGF-23|fgf-23
559390|NCT01180946|vitamin D|vitamin d
559391|NCT01180946|vitamin D deficiency|vitamin d deficiency
559392|NCT01180946|insulin resistance|insulin resistance
559393|NCT01180946|Healthy volunteers|healthy volunteers
559394|NCT01180933|docosahexaenoic acid|docosahexaenoic acid
559395|NCT01180933|folate|folate
559396|NCT01180933|neurological development|neurological development
559397|NCT01180933|allergies|allergies
559398|NCT01180933|long term consequences for the offspring|long term consequences for the offspring
559399|NCT01180933|allergy risk|allergy risk
559400|NCT01180920|Dental|dental
559401|NCT01180920|Periodontal|periodontal
559402|NCT01180920|Surgery|surgery
559403|NCT01180920|Gums|gums
559404|NCT01180907|18F-FAC|18f-fac
559405|NCT01180907|imaging|imaging
559406|NCT01180907|cancer|cancer
559407|NCT01180907|inflammation|inflammation
559408|NCT01180907|PET|pet
559409|NCT01180894|Trauma|trauma
559410|NCT01180894|Anemia|anemia
559411|NCT01180894|Iron|iron
559412|NCT01180894|Erythropoeisis|erythropoeisis
559413|NCT01180881|Proton Radiation|proton radiation
559414|NCT01180881|CNS tumors|cns tumors
559415|NCT01180881|Brain Tumors|brain tumors
559416|NCT01180881|Neurobehavioral functioning|neurobehavioral functioning
559417|NCT01180868|imaging probe|imaging probe
559418|NCT01180868|cancer|cancer
559419|NCT01180868|inflammatory tissue|inflammatory tissue
559420|NCT01180868|inflammatory diseases|inflammatory diseases
559421|NCT01180855|Melatonin|melatonin
559422|NCT01180855|Cognitive Behavior Therapy|cognitive behavior therapy
559423|NCT01180842|CF|cf
559426|NCT01180816|AO|ao
559427|NCT01180816|Brain|brain
559428|NCT01180816|Tumors|tumors
559429|NCT01180816|Malignant|malignant
559430|NCT01180816|Glioblastoma|glioblastoma
559431|NCT01180816|Multiforme|multiforme
559432|NCT01180816|Anaplastic|anaplastic
559433|NCT01180816|Astrocytoma|astrocytoma
559434|NCT01180803|COPD - long term oxygenotherapy|copd - long term oxygenotherapy
559435|NCT01180803|COPD patients with respiratory failure|copd patients with respiratory failure
559436|NCT01180790|HCV|hcv
559437|NCT01180790|Hepatitis C Genotype 1|hepatitis c genotype 1
559438|NCT01180764|hypertriglyceridemia|hypertriglyceridemia
559439|NCT01180764|omega-3 acid ethyl esters|omega-3 acid ethyl esters
559440|NCT01180764|high-density lipoproteins|high-density lipoproteins
559441|NCT01180764|fish oil|fish oil
559442|NCT01180751|Positron Emission Tomography|positron emission tomography
559443|NCT01180751|Fluorodeoxyglucose|fluorodeoxyglucose
559444|NCT01180751|FDG (18F-Fluorodeoxyglucose)|fdg (18f-fluorodeoxyglucose)
559445|NCT01180751|Oncology|oncology
559446|NCT01180751|Neurology|neurology
559447|NCT01180738|chronic stroke|chronic stroke
559448|NCT01180738|walking training|walking training
559449|NCT01180738|rehabilitation|rehabilitation
559450|NCT01180738|body weight supported treadmill training|body weight supported treadmill training
559451|NCT01180738|physical therapy|physical therapy
559452|NCT01180738|balance|balance
559453|NCT01180725|To investigate and compare the effects of dried plums and psyllium on the overall relief of constipation symptoms|to investigate and compare the effects of dried plums and psyllium on the overall relief of constipation symptoms
559454|NCT01180725|To investigate and compare the taste of dried plums and psyllium|to investigate and compare the taste of dried plums and psyllium
559455|NCT01180725|To investigate and compare the quality of life of dried plums and psyllium|to investigate and compare the quality of life of dried plums and psyllium
559456|NCT01180712|anthocyanin|anthocyanin
559457|NCT01180712|blaeberries|blaeberries
559458|NCT01180712|bilberries|bilberries
559459|NCT01180712|blueberries|blueberries
559460|NCT01180712|mirtoselect|mirtoselect
559461|NCT01180712|type 2 diabetes|type 2 diabetes
559462|NCT01180712|insulin resistance|insulin resistance
559463|NCT01180712|Adipose tissue|adipose tissue
559464|NCT01180712|inflammation|inflammation
559465|NCT01180699|adult solid organ transplant patients|adult solid organ transplant patients
559466|NCT01180686|low back pain|low back pain
559467|NCT01180686|chiropractic|chiropractic
559468|NCT01180686|manipulation|manipulation
559469|NCT01180673|Hypertension|hypertension
559470|NCT01180673|Older Adults|older adults
559471|NCT01180673|Motivational Interviewing|motivational interviewing
559472|NCT01180673|Lifestyle Counseling|lifestyle counseling
559473|NCT01180673|Senior Centers|senior centers
559474|NCT01180660|Gastric Surgery|gastric surgery
559475|NCT01180660|Pain|pain
559476|NCT01180660|Recovery|recovery
559477|NCT01180660|Laparoscopic Surgery|laparoscopic surgery
559478|NCT01180647|Extended-release naltrexone|extended-release naltrexone
559479|NCT01180647|Prisoners|prisoners
559480|NCT01180647|Opioid addiction prevention|opioid addiction prevention
559481|NCT01180647|Medication Treatment Alternatives|medication treatment alternatives
559482|NCT01180647|Prevention of Relapse to Opioid Addiction|prevention of relapse to opioid addiction
559483|NCT01180621|vaccine|vaccine
559484|NCT01180621|Seasonal Influenza Vaccine|seasonal influenza vaccine
559485|NCT01180621|Influenza Vaccine|influenza vaccine
559486|NCT01180621|Vaccine Safety|vaccine safety
559487|NCT01180621|Vaccine Immunogenicity|vaccine immunogenicity
559488|NCT01180621|Fluviral 2010-2011|fluviral 2010-2011
559489|NCT01180608|neuropathic pain|neuropathic pain
559490|NCT01180608|Diabetic Polyneuropathy|diabetic polyneuropathy
559491|NCT01180595|osteoarthritis|osteoarthritis
559492|NCT01180595|arthroplasty|arthroplasty
559493|NCT01180595|knee joint|knee joint
559494|NCT01180595|radiography|radiography
559495|NCT01180595|surgery|surgery
559496|NCT01180595|Bone Density|bone density
559497|NCT01180595|Outcome Assessment (Health Care)|outcome assessment (health care)
559498|NCT01180582|knee|knee
559499|NCT01180582|arthroplasty|arthroplasty
559500|NCT01180582|RSA|rsa
559501|NCT01180582|migration|migration
559502|NCT01180582|micromotion|micromotion
559503|NCT01180582|osteoarthritis|osteoarthritis
559504|NCT01180569|Lenalidomide|lenalidomide
559505|NCT01180569|10-022|10-022
559506|NCT01180556|childhood|childhood
559507|NCT01180556|abdominal pain|abdominal pain
559508|NCT01180556|probiotics|probiotics
559509|NCT01180517|Angioplasty Balloon|angioplasty balloon
559510|NCT01180504|ovarian cancer|ovarian cancer
559511|NCT01180504|whole-abdominal radiotherapy|whole-abdominal radiotherapy
559512|NCT01180504|consolidation treatment|consolidation treatment
559513|NCT01180504|helical tomotherapy|helical tomotherapy
559514|NCT01180491|Discoloured and deformed nails resulting from onychomycosis|discoloured and deformed nails resulting from onychomycosis
559515|NCT01180478|Bladder Cancer|bladder cancer
559516|NCT01180478|Urothelial carcinoma|urothelial carcinoma
559517|NCT01180478|Stage pTa or pT1|stage pta or pt1
559518|NCT01180478|NMIBC Ta/T1|nmibc ta/t1
559519|NCT01180478|Narrow Band Imaging|narrow band imaging
559520|NCT01180478|White Light Cystoscopy|white light cystoscopy
559521|NCT01180478|Transurethral resection|transurethral resection
559522|NCT01180478|Superficial bladder tumor|superficial bladder tumor
559523|NCT01180478|Positive urine cytology|positive urine cytology
559524|NCT01180465|Treatment of abdominal adiposity|treatment of abdominal adiposity
559525|NCT01180452|Crohn disease|crohn disease
559526|NCT01180452|dysplasia|dysplasia
559527|NCT01180452|adenocarcinoma|adenocarcinoma
559528|NCT01180452|endoscopy|endoscopy
559529|NCT01180452|jejunum|jejunum
559530|NCT01180452|ileum|ileum
559531|NCT01180439|Non-invasive ventilation|non-invasive ventilation
559532|NCT01180439|Chronic Obstructive Pulmonary Disease|chronic obstructive pulmonary disease
559533|NCT01180439|Patient-ventilator synchronisation|patient-ventilator synchronisation
559534|NCT01180439|Sleep study|sleep study
559535|NCT01180439|Polysomnography|polysomnography
559536|NCT01180426|Relapse Refractory Acute Myeloid Leukemia|relapse refractory acute myeloid leukemia
559537|NCT01180413|Inward eutrophic remodelling|inward eutrophic remodelling
559538|NCT01180400|Major Depressive Disorder|major depressive disorder
559539|NCT01180400|MDD|mdd
559540|NCT01180400|Depression|depression
559541|NCT01180400|Safety|safety
559542|NCT01180400|add-on therapy|add-on therapy
559543|NCT01180374|Cannabis|cannabis
559544|NCT01180374|Marijuana|marijuana
559545|NCT01180374|Cannabidiol|cannabidiol
559546|NCT01180374|CBD|cbd
559547|NCT01180374|THC|thc
559548|NCT01180374|Psychotic Disorders|psychotic disorders
559549|NCT01180361|rheumatoid arthritis|rheumatoid arthritis
559550|NCT01180361|systemic lupus erythematosus|systemic lupus erythematosus
559551|NCT01180361|atherosclerosis|atherosclerosis
559552|NCT01180361|adenosine|adenosine
559553|NCT01180348|Wrinkles, glabellar, facial.|wrinkles, glabellar, facial.
559554|NCT01180335|Genomic driven chemotherapy|genomic driven chemotherapy
559555|NCT01180322|azacitidine|azacitidine
559556|NCT01180322|Acute myeloid Leukemia (AML)|acute myeloid leukemia (aml)
559557|NCT01180309|Tongue frenum|tongue frenum
559558|NCT01180309|Lingual frenum|lingual frenum
559559|NCT01180309|Audio Phonology|audio phonology
559560|NCT01180309|Speech disorders|speech disorders
559561|NCT01180296|Preterm birth, prevention, progesterone, oral|preterm birth, prevention, progesterone, oral
559562|NCT01180283|Erectile dysfunction|erectile dysfunction
559563|NCT01180283|Lodenafil carbonate|lodenafil carbonate
559564|NCT01180283|Diabetes|diabetes
559565|NCT01180270|Cervical dystonia|cervical dystonia
559566|NCT01180270|torticollis spasmodicus|torticollis spasmodicus
559567|NCT01180270|botulinum toxin|botulinum toxin
559568|NCT01180270|Subjective visual vertical (SVV)|subjective visual vertical (svv)
559569|NCT01180270|SVV|svv
559570|NCT01180270|static graviceptive function|static graviceptive function
559571|NCT01180244|fibromyalgia|fibromyalgia
559572|NCT01180244|noninvasive|noninvasive
559573|NCT01180244|electrical|electrical
559574|NCT01180244|cortical|cortical
559575|NCT01180244|stimulation|stimulation
559576|NCT01180244|pain|pain
559577|NCT01180244|brain|brain
559578|NCT01180244|tender point|tender point
559579|NCT01180231|Overweight or obese young adults (18 to 30 years old) with no previous history of cardiovascular disease/psychiatric illness, and not on medications|overweight or obese young adults (18 to 30 years old) with no previous history of cardiovascular disease/psychiatric illness, and not on medications
559580|NCT01180218|myocardial revascularization|myocardial revascularization
559581|NCT01180218|myocardial infarction|myocardial infarction
559582|NCT01180205|FMD|fmd
559583|NCT01180205|hypertension|hypertension
559584|NCT01180205|Telmisartan|telmisartan
559585|NCT01180205|Amlodipine|amlodipine
559586|NCT01180192|blood loss|blood loss
559587|NCT01180192|oxygen inhalation|oxygen inhalation
559588|NCT01180179|H. pylori-negative idiopathic peptic ulcers|h. pylori-negative idiopathic peptic ulcers
559589|NCT01180179|Recurrent ulcer bleeding|recurrent ulcer bleeding
559590|NCT01180166|Gastric cancer|gastric cancer
559591|NCT01180166|concurrent chemoradiotherapy|concurrent chemoradiotherapy
559592|NCT01180166|target therapy|target therapy
559593|NCT01180153|40 S-1/L-OHP|40 s-1/l-ohp
559594|NCT01180153|biliary tract|biliary tract
559595|NCT01180153|ampullary carcinoma|ampullary carcinoma
559596|NCT01180140|Seamguard|seamguard
559597|NCT01180140|staple-line reinforcement|staple-line reinforcement
559598|NCT01180140|leak|leak
559599|NCT01180140|bleeding|bleeding
559600|NCT01180127|flavonol|flavonol
559601|NCT01180127|exercise|exercise
559602|NCT01180127|dentate gyrus|dentate gyrus
559603|NCT01180127|cerebral blood volume|cerebral blood volume
559604|NCT01180127|dentate gyrus CBV|dentate gyrus cbv
559605|NCT01180114|economic empowerment model,|economic empowerment model,
559606|NCT01180114|orphaned children and youth,|orphaned children and youth,
559607|NCT01180114|Uganda,|uganda,
559608|NCT01180114|sub-Saharan Africa|sub-saharan africa
559609|NCT01180101|Obesity|obesity
559610|NCT01180101|Chronic Kidney Disease|chronic kidney disease
559611|NCT01180088|LIVER TUMOURS|liver tumours
559612|NCT01180062|Latanoprost subconjunctival insert|latanoprost subconjunctival insert
559613|NCT01180049|Mantle Cell Lymphoma|mantle cell lymphoma
559614|NCT01180049|Non-Hodgkin's Lymphoma|non-hodgkin's lymphoma
559615|NCT01180049|temsirolimus|temsirolimus
559616|NCT01180036|Membranous Nephropathy|membranous nephropathy
559617|NCT01180023|GBS|gbs
559618|NCT01180023|Membrane sweeping|membrane sweeping
559619|NCT01180010|Hodgkin's Lymphoma|hodgkin's lymphoma
559620|NCT01180010|Lung Cancer|lung cancer
559621|NCT01180010|Lung Nodule|lung nodule
559622|NCT01180010|CT scan|ct scan
559623|NCT01179971|n-3 fatty acids|n-3 fatty acids
559624|NCT01179971|n-6 fatty acids|n-6 fatty acids
559625|NCT01179971|anti-inflammatory action|anti-inflammatory action
559626|NCT01179971|clinical trial|clinical trial
559627|NCT01179971|randomized double-blinded|randomized double-blinded
559628|NCT01179971|incorporation of fatty acids|incorporation of fatty acids
559629|NCT01179958|cognitive function|cognitive function
559630|NCT01179958|fMRI|fmri
559631|NCT01179958|apoE|apoe
559632|NCT01179958|inflammatory markers|inflammatory markers
559633|NCT01179958|exercise|exercise
559634|NCT01179945|diabetes|diabetes
559635|NCT01179945|benzoic acid|benzoic acid
559636|NCT01179945|benzoate|benzoate
559637|NCT01179945|soda|soda
559638|NCT01179945|soft drink|soft drink
559639|NCT01179945|preservative|preservative
559640|NCT01179945|blood sugar|blood sugar
559641|NCT01179932|Pilot|pilot
559642|NCT01179932|Charting|charting
559643|NCT01179932|Anesthesia Record|anesthesia record
559644|NCT01179932|Cardiac surgical operating room|cardiac surgical operating room
559645|NCT01179932|Cardiac surgical intensive care unit|cardiac surgical intensive care unit
559646|NCT01179932|Electrophysiology lab|electrophysiology lab
559647|NCT01179919|Oseltamivir|oseltamivir
559648|NCT01179919|Obesity|obesity
559649|NCT01179919|Influenza|influenza
559650|NCT01179919|Pharmacokinetics in Obesity|pharmacokinetics in obesity
559651|NCT01179906|CKD|ckd
559652|NCT01179893|Myasthenia Gravis|myasthenia gravis
559653|NCT01179893|IVIG|ivig
559654|NCT01179893|PLEX|plex
559655|NCT01179880|Dermatitis|dermatitis
559656|NCT01179880|Atopic|atopic
559657|NCT01179867|Medication reconciliation|medication reconciliation
559658|NCT01179867|Adverse drug events|adverse drug events
559659|NCT01179867|Hospital readmission|hospital readmission
559660|NCT01179867|Medication management|medication management
559661|NCT01179841|Autism Spectrum Disorder|autism spectrum disorder
559662|NCT01179841|language|language
559663|NCT01179841|social|social
559664|NCT01179841|toddlers|toddlers
559665|NCT01179828|Quantitative sensory testing|quantitative sensory testing
559666|NCT01179828|Drug efficacy|drug efficacy
559667|NCT01179828|Low back pain syndrome|low back pain syndrome
559668|NCT01179828|Imipramine|imipramine
559669|NCT01179828|Oxycodone|oxycodone
559670|NCT01179828|Clobazam|clobazam
559671|NCT01179828|Tolterodine|tolterodine
559672|NCT01179815|Patients with type 1 or type 2 diabetes mellitus|patients with type 1 or type 2 diabetes mellitus
559673|NCT01179815|Monogenetic diabetes|monogenetic diabetes
559674|NCT01179815|Pancreatogenic diabetes,|pancreatogenic diabetes,
559675|NCT01179815|Drug-induced diabetes, other forms|drug-induced diabetes, other forms
559676|NCT01179815|Cohort Studies|cohort studies
559677|NCT01179789|Healthy Elderly People|healthy elderly people
559678|NCT01179776|ST-eleveation|st-eleveation
559679|NCT01179776|Myocardial infarct|myocardial infarct
559680|NCT01179776|Percutaneous coronary intervention|percutaneous coronary intervention
559681|NCT01179776|Myocardial infarct STEMI patients|myocardial infarct stemi patients
559682|NCT01179763|Amblyopia|amblyopia
559683|NCT01179763|Retinal layer thickness|retinal layer thickness
559684|NCT01179750|Ultrasonic coagulating shears in gastrectomy|ultrasonic coagulating shears in gastrectomy
559685|NCT01179737|Pulmonary Arterial Hypertension|pulmonary arterial hypertension
559686|NCT01179737|Nilotinib|nilotinib
559687|NCT01179737|6MWD|6mwd
559688|NCT01179737|Pulmonary Hypertension|pulmonary hypertension
559689|NCT01179711|accommodative esotropia|accommodative esotropia
559690|NCT01179698|computer-assisted surgery|computer-assisted surgery
559691|NCT01179698|bone tumor|bone tumor
559692|NCT01179698|We will evaluate whether computer-assisted surgery|we will evaluate whether computer-assisted surgery
559693|NCT01179698|will be feasible and safe for bone tumor resection|will be feasible and safe for bone tumor resection
559694|NCT01179672|Diabetic Peripheral Neuropathic Pain|diabetic peripheral neuropathic pain
559695|NCT01179659|Single dose crossover BE study|single dose crossover be study
559696|NCT01179646|Bioequivalency|bioequivalency
559697|NCT01179620|Hemodialysis, Certoparin|hemodialysis, certoparin
559698|NCT01179581|Safety|safety
559699|NCT01179581|Tolerability|tolerability
559700|NCT01179581|Pharmacokinetics|pharmacokinetics
559701|NCT01179568|Grief|grief
559702|NCT01179568|Bereavement|bereavement
559703|NCT01179568|Psychotherapy|psychotherapy
559704|NCT01179568|Medication|medication
559705|NCT01179568|Treatment study|treatment study
559706|NCT01179555|Diabetic Complications|diabetic complications
559707|NCT01179555|Intervention Studies|intervention studies
559708|NCT01179555|African Americans|african americans
559709|NCT01179555|Vision Screening|vision screening
559710|NCT01179555|Vision, Low|vision, low
559711|NCT01179555|Geriatric Assessment|geriatric assessment
559712|NCT01179555|Outcomes Assessment|outcomes assessment
559713|NCT01179555|Cultural Characteristics|cultural characteristics
559714|NCT01179555|Cultural Competency|cultural competency
559715|NCT01179555|Appointment Adherence|appointment adherence
559716|NCT01179555|Cost-effectiveness|cost-effectiveness
559717|NCT01179555|Personalization of care|personalization of care
559718|NCT01179555|Follow-up Care|follow-up care
559842|NCT01178892|Fish oil|fish oil
559719|NCT01179542|iugr pet eIF4E Translation Initiation Factor|iugr pet eif4e translation initiation factor
559720|NCT01179542|4E (eIF4E) in Human Placental Implantation and in the Pathological Pregnancies: Preeclampsia and IUGR|4e (eif4e) in human placental implantation and in the pathological pregnancies: preeclampsia and iugr
559721|NCT01179529|Atopic dermatitis (atopic eczema)|atopic dermatitis (atopic eczema)
559722|NCT01179516|Major Depressive Disorder|major depressive disorder
559723|NCT01179516|Depression|depression
559724|NCT01179516|Drug Therapy|drug therapy
559725|NCT01179503|vitamin D|vitamin d
559726|NCT01179503|physical performance|physical performance
559727|NCT01179490|Multiple Myeloma|multiple myeloma
559728|NCT01179477|Left heart pacing lead|left heart pacing lead
559729|NCT01179477|Cardiac resynchronization therapy (CRT)|cardiac resynchronization therapy (crt)
559730|NCT01179477|Heart failure|heart failure
559731|NCT01179425|marijuana|marijuana
559732|NCT01179425|dependence|dependence
559733|NCT01179425|cognition|cognition
559735|NCT01179386|methylphenidate|methylphenidate
559736|NCT01179386|ADHD|adhd
559737|NCT01179386|driving|driving
559738|NCT01179386|simulator|simulator
559739|NCT01179386|pressure|pressure
559740|NCT01179386|adolescent|adolescent
559741|NCT01179360|Locally advanced|locally advanced
559742|NCT01179360|HNSCC|hnscc
559743|NCT01179334|Pulmonary Hypertension|pulmonary hypertension
559744|NCT01179334|Riociguat|riociguat
559745|NCT01179334|Blood Pressure|blood pressure
559746|NCT01179308|regional analgesia|regional analgesia
559747|NCT01179308|routine general anesthesia|routine general anesthesia
559748|NCT01179308|immune system response|immune system response
559749|NCT01179308|lung cancer (stage 1-3)|lung cancer (stage 1-3)
559750|NCT01179295|MEK inhibitor|mek inhibitor
559751|NCT01179295|BAY86-9766|bay86-9766
559752|NCT01179295|RDEA 119|rdea 119
559753|NCT01179295|Solid tumor|solid tumor
559754|NCT01179282|DUST MITE ALLERGIES|dust mite allergies
559755|NCT01179269|Non-small cell lung cancer|non-small cell lung cancer
559756|NCT01179269|Pazopanib|pazopanib
559757|NCT01179269|Stage IIIB/IV non small cell lung cancer|stage iiib/iv non small cell lung cancer
559758|NCT01179256|ASTHMA|asthma
559759|NCT01179243|microcirculatory alterations|microcirculatory alterations
559760|NCT01179243|SDF imaging|sdf imaging
559761|NCT01179230|CAD|cad
559762|NCT01179230|chest pain|chest pain
559763|NCT01179230|acute coronary syndrome|acute coronary syndrome
559764|NCT01179230|Myocardial perfusion imaging|myocardial perfusion imaging
559765|NCT01179217|Sickle Cell Anemia|sickle cell anemia
559766|NCT01179217|Sickle Cell Pain Crises|sickle cell pain crises
559767|NCT01179217|Painful Crises|painful crises
559768|NCT01179217|Sickle Cell Pain|sickle cell pain
559769|NCT01179217|Vaso-occlusive Crises|vaso-occlusive crises
559770|NCT01179191|chronic pain|chronic pain
559771|NCT01179191|Embeda|embeda
559772|NCT01179191|opioid|opioid
559773|NCT01179191|moderate pain|moderate pain
559774|NCT01179191|severe pain|severe pain
559775|NCT01179191|conversion|conversion
559776|NCT01179191|converting|converting
559777|NCT01179191|switching|switching
559778|NCT01179191|morphine|morphine
559779|NCT01179191|aberrant behavior|aberrant behavior
559780|NCT01179191|Pain (DT) + Chronic Disease (DT)|pain (dt) + chronic disease (dt)
559781|NCT01179152|asthma, september epidemic, children, preventive|asthma, september epidemic, children, preventive
559782|NCT01179139|CRS|crs
559783|NCT01179126|myocardial infarction|myocardial infarction
559784|NCT01179126|primary angioplasty|primary angioplasty
559785|NCT01179126|multivessel disease|multivessel disease
559786|NCT01179126|stress echocardiography|stress echocardiography
559787|NCT01179113|Laminectomy|laminectomy
559788|NCT01179113|Esmolol Infusion|esmolol infusion
559789|NCT01179113|Quality of recovery|quality of recovery
559790|NCT01179113|beta-blockers|beta-blockers
559791|NCT01179113|Pain management|pain management
559792|NCT01179113|Postoperative pain|postoperative pain
559793|NCT01179113|Opioid requirements|opioid requirements
559794|NCT01179113|Intraoperative esmolol infusion|intraoperative esmolol infusion
559795|NCT01179113|Return to normal activities of daily living|return to normal activities of daily living
559796|NCT01179100|elderly|elderly
559797|NCT01179100|general anesthesia|general anesthesia
559798|NCT01179100|lidocaine infusion|lidocaine infusion
559799|NCT01179100|lidocaine|lidocaine
559800|NCT01179100|local anesthetic|local anesthetic
559801|NCT01179100|pain management|pain management
559802|NCT01179100|cognitive function|cognitive function
559803|NCT01179087|sleep disordered breathing|sleep disordered breathing
559804|NCT01179087|lung transplantation|lung transplantation
559805|NCT01179074|palliation inoperable oesophageal cancer|palliation inoperable oesophageal cancer
559806|NCT01179061|Apelin|apelin
559807|NCT01179061|Heart failure|heart failure
559808|NCT01179061|Pulmonary artery pressure|pulmonary artery pressure
559809|NCT01179061|Inotropic|inotropic
559810|NCT01179061|Diuretic|diuretic
559811|NCT01179035|Post-release, community health|post-release, community health
559812|NCT01179022|Bacteremia|bacteremia
559813|NCT01179022|Argon Plasma Coagulation|argon plasma coagulation
559814|NCT01179022|Endobronchial Lesions|endobronchial lesions
559815|NCT01179009|depression|depression
559816|NCT01178983|work related musculoskeletal disorders (WRMSD) among computer operators|work related musculoskeletal disorders (wrmsd) among computer operators
559817|NCT01178957|Type 1 diabetes|type 1 diabetes
559818|NCT01178957|Very-Low-Density-Lipoprotein(VLDL)|very-low-density-lipoprotein(vldl)
559819|NCT01178957|Hyperglycemia|hyperglycemia
559820|NCT01178931|IVF|ivf
559821|NCT01178931|luteal phase support|luteal phase support
559822|NCT01178931|oral progesterone|oral progesterone
559823|NCT01178931|vaginal progesterone|vaginal progesterone
559824|NCT01178931|pregnancy rate|pregnancy rate
559825|NCT01178931|safety|safety
559826|NCT01178931|tolerability|tolerability
559827|NCT01178918|Influenza H1N1|influenza h1n1
559828|NCT01178918|Vaccine|vaccine
559829|NCT01178918|Adjuvant|adjuvant
559830|NCT01178918|T Lymphocytes|t lymphocytes
559831|NCT01178918|Non-specific response|non-specific response
559832|NCT01178918|Interleukin-2|interleukin-2
559833|NCT01178918|Non-specific T cell responce|non-specific t cell responce
559834|NCT01178905|Postnatal CMV infection of preterm infants|postnatal cmv infection of preterm infants
559835|NCT01178905|breast milk|breast milk
559836|NCT01178892|Hot Flashes|hot flashes
559837|NCT01178892|Menopause|menopause
559838|NCT01178892|Vasomotor symptoms|vasomotor symptoms
559839|NCT01178892|Yoga|yoga
559840|NCT01178892|Exercise|exercise
559841|NCT01178892|Omega-3|omega-3
559843|NCT01178879|Telehealth|telehealth
559844|NCT01178879|nurse consultation|nurse consultation
559845|NCT01178879|outpatient clinic|outpatient clinic
559846|NCT01178866|thoracic surgery|thoracic surgery
559847|NCT01178866|myocardial revascularization|myocardial revascularization
559848|NCT01178866|left ventricular dysfunction|left ventricular dysfunction
559849|NCT01178866|tissue perfusion|tissue perfusion
559850|NCT01178866|prognosis|prognosis
559851|NCT01178853|Healthy Volunteers|healthy volunteers
559852|NCT01178840|female condom|female condom
559853|NCT01178840|condom|condom
559854|NCT01178840|clinical failure|clinical failure
559855|NCT01178840|prostate-specific antigen|prostate-specific antigen
559856|NCT01178840|semen exposure|semen exposure
559857|NCT01178840|acceptability|acceptability
559858|NCT01178840|Prevention of semen exposure|prevention of semen exposure
559859|NCT01178801|liver cancer|liver cancer
559860|NCT01178801|data mining|data mining
559861|NCT01178801|knowledge discovering|knowledge discovering
559862|NCT01178801|The clinical data of the patients with liver cancer.|the clinical data of the patients with liver cancer.
559863|NCT01178788|Progestagens|progestagens
559864|NCT01178788|Tertiary Prophylaxis|tertiary prophylaxis
559865|NCT01178788|Micronized Progesterone|micronized progesterone
559866|NCT01178788|17 alpha hydroxy P|17 alpha hydroxy p
559867|NCT01178788|Preterm Delivery|preterm delivery
559868|NCT01178788|Cervical shortening|cervical shortening
559869|NCT01178775|fatigue|fatigue
559870|NCT01178775|meaning|meaning
559871|NCT01178775|education|education
559872|NCT01178775|walking program|walking program
559873|NCT01178762|Oral Azithromycin|oral azithromycin
559874|NCT01178762|Chlamydial Conjunctivitis|chlamydial conjunctivitis
559875|NCT01178749|Hepatitis C|hepatitis c
559876|NCT01178749|Interferon|interferon
559877|NCT01178749|Symptom Distress|symptom distress
559878|NCT01178749|Quality of Life|quality of life
559879|NCT01178736|neoplasms|neoplasms
559880|NCT01178723|breakfast size|breakfast size
559881|NCT01178723|blood glucose balance|blood glucose balance
559882|NCT01178723|hormonal profile|hormonal profile
559883|NCT01178723|appetite hormones|appetite hormones
559884|NCT01178723|adipokines|adipokines
559885|NCT01178723|pro-inflammatory cytokines|pro-inflammatory cytokines
559886|NCT01178684|ENFD|enfd
559887|NCT01178684|epidermal nerve fiber density|epidermal nerve fiber density
559888|NCT01178684|HIV|hiv
559889|NCT01178684|HIV-infection|hiv-infection
559890|NCT01178671|PTSD|ptsd
559891|NCT01178671|trauma|trauma
559892|NCT01178671|anxiety disorder|anxiety disorder
559893|NCT01178671|medication|medication
559894|NCT01178671|sertraline|sertraline
559895|NCT01178671|mirtazapine|mirtazapine
559896|NCT01178671|pharmacotherapy|pharmacotherapy
559897|NCT01178632|Herbal|herbal
559898|NCT01178632|Phytotherapy|phytotherapy
559899|NCT01178632|Passiflora|passiflora
559900|NCT01178632|Valeriana|valeriana
559901|NCT01178632|Anxiety|anxiety
559902|NCT01178619|IUGR fetuses|iugr fetuses
559903|NCT01178619|symmetrical IUGR|symmetrical iugr
559904|NCT01178619|asymmetrical IUGR|asymmetrical iugr
559905|NCT01178606|echogenic halo around lateral fetal ventricles|echogenic halo around lateral fetal ventricles
559906|NCT01178593|IBS|ibs
559907|NCT01178593|RCT|rct
559908|NCT01178593|psychology|psychology
559909|NCT01178593|hypnosis|hypnosis
559910|NCT01178593|psychotherapy|psychotherapy
559911|NCT01178593|group therapy|group therapy
559912|NCT01178580|fibrinolytic activity|fibrinolytic activity
559913|NCT01178580|Community acquired pneumonia (CAP)|community acquired pneumonia (cap)
559914|NCT01178580|Pleural effusion|pleural effusion
559915|NCT01178567|laparoscopic sleeve gastrectomy|laparoscopic sleeve gastrectomy
559916|NCT01178567|Gastrectomy|gastrectomy
559917|NCT01178567|Pulmonary Complications|pulmonary complications
559918|NCT01178554|anxiety disorders|anxiety disorders
559919|NCT01178554|depression|depression
559920|NCT01178554|depressive disorders|depressive disorders
559921|NCT01178554|disruptive behavioral problems|disruptive behavioral problems
559922|NCT01178554|conduct problems|conduct problems
559923|NCT01178541|ventricles|ventricles
559924|NCT01178541|fetal|fetal
559925|NCT01178541|brain|brain
559926|NCT01178541|asymmetry|asymmetry
559927|NCT01178528|heart failure|heart failure
559928|NCT01178528|heart rate|heart rate
559929|NCT01178528|ivabradine|ivabradine
559930|NCT01178528|carvedilol|carvedilol
559931|NCT01178515|epidemiological risk|epidemiological risk
559932|NCT01178515|diet|diet
559933|NCT01178515|fat intake|fat intake
559934|NCT01178450|Renal transplant|renal transplant
559935|NCT01178450|Hypercalcemia|hypercalcemia
559936|NCT01178437|seizure disorder,|seizure disorder,
559937|NCT01178437|seizures,|seizures,
559938|NCT01178437|convulsions,|convulsions,
559939|NCT01178437|grand mal,|grand mal,
559940|NCT01178437|petit mal,|petit mal,
559941|NCT01178437|absence seizures,|absence seizures,
559942|NCT01178437|repeated seizures,|repeated seizures,
559943|NCT01178437|children's seizures,|children's seizures,
559944|NCT01178437|secondary epilepsy,|secondary epilepsy,
559945|NCT01178437|symptomatic epilepsy,|symptomatic epilepsy,
559946|NCT01178437|generalized seizures,|generalized seizures,
559947|NCT01178437|partial seizure,|partial seizure,
559948|NCT01178437|focal seizure,|focal seizure,
559949|NCT01178437|partial complex seizure,|partial complex seizure,
559950|NCT01178437|anticonvulsant medication|anticonvulsant medication
559951|NCT01178424|Unipolar depression|unipolar depression
559952|NCT01178424|Mindfulness based cognitive therapy|mindfulness based cognitive therapy
559953|NCT01178424|Cognitive behavioural Therapy|cognitive behavioural therapy
559954|NCT01178424|Functional magnetic resonance imaging|functional magnetic resonance imaging
559955|NCT01178424|Relapse|relapse
559956|NCT01178424|Depressive relapse|depressive relapse
559957|NCT01178424|Dysphoric|dysphoric
559958|NCT01178424|Cognitive reactivity|cognitive reactivity
559959|NCT01178424|Serotonin transporter gene|serotonin transporter gene
559960|NCT01178411|hepatocellular carcinoma|hepatocellular carcinoma
559961|NCT01178411|renal cell carcinoma|renal cell carcinoma
559962|NCT01178411|melanoma|melanoma
559963|NCT01178411|non-small cell lung cancer|non-small cell lung cancer
559964|NCT01178411|breast cancer|breast cancer
559965|NCT01178411|ovarian cancer|ovarian cancer
559966|NCT01178411|MiT tumors|mit tumors
559967|NCT01178398|fish|fish
559968|NCT01178398|pregnancy|pregnancy
559969|NCT01178398|nutrition|nutrition
559970|NCT01178398|mercury|mercury
559971|NCT01178398|focus group|focus group
559972|NCT01178398|omega-3 fatty acid|omega-3 fatty acid
559973|NCT01178398|docosahexaenoic acid (DHA)|docosahexaenoic acid (dha)
559974|NCT01178385|Autism|autism
559975|NCT01178385|Asperger's Syndrome|asperger's syndrome
559976|NCT01178385|Treatment|treatment
559977|NCT01178385|Cognitive-behavioral therapy|cognitive-behavioral therapy
559978|NCT01178385|Anxiety|anxiety
559979|NCT01178385|Children|children
559980|NCT01178385|Therapy|therapy
559981|NCT01178372|hepatic encephalopathy|hepatic encephalopathy
559982|NCT01178372|lactulose|lactulose
559983|NCT01178372|probiotics|probiotics
559984|NCT01178359|cardiac arrest|cardiac arrest
559985|NCT01178359|ventricular fibrillation|ventricular fibrillation
559986|NCT01178359|nitrite|nitrite
559987|NCT01178346|Pharmacoeconomic|pharmacoeconomic
559988|NCT01178346|Quality of Life|quality of life
559989|NCT01178346|Health Outcomes|health outcomes
559990|NCT01178346|Smoking|smoking
559991|NCT01178346|NicVAX|nicvax
559992|NCT01178346|Smoking vaccine|smoking vaccine
559993|NCT01178346|Smoking cessation|smoking cessation
559994|NCT01178333|Thrombocytopenia|thrombocytopenia
559995|NCT01178333|Heparin|heparin
559996|NCT01178320|Magnetic Resonance Imaging|magnetic resonance imaging
559997|NCT01178320|Atherosclerotic Plaque|atherosclerotic plaque
559998|NCT01178320|Lipid Lowering Therapy|lipid lowering therapy
559999|NCT01178307|GI cancers|gi cancers
560000|NCT01178307|GIST|gist
560001|NCT01178307|Symptom Severity|symptom severity
560002|NCT01178307|Quality of Life|quality of life
560003|NCT01178307|Questionnaire|questionnaire
560004|NCT01178307|M.D. Anderson Symptom Inventory|m.d. anderson symptom inventory
560005|NCT01178307|MDASI-GIST|mdasi-gist
560006|NCT01178307|patient-reported outcomes|patient-reported outcomes
560007|NCT01178294|haemophilia A|haemophilia a
560008|NCT01178294|blood coagulation disorders|blood coagulation disorders
560009|NCT01178294|coagulation protein disorder|coagulation protein disorder
560010|NCT01178294|hemophilia A|hemophilia a
560011|NCT01178294|Acquired Hemophilia A|acquired hemophilia a
560012|NCT01178294|hematologic diseases|hematologic diseases
560013|NCT01178294|hemorrhagic disorders|hemorrhagic disorders
560014|NCT01178281|Myelofibrosis|myelofibrosis
560015|NCT01178281|Post-polycythemia vera myelofibrosis|post-polycythemia vera myelofibrosis
560016|NCT01178281|Post-essential thrombocythemia myelofibrosis|post-essential thrombocythemia myelofibrosis
560017|NCT01178281|RBC-transfusion-dependence|rbc-transfusion-dependence
560018|NCT01178281|Primary Myelofibrosis|primary myelofibrosis
560019|NCT01178268|Drug eluting stents|drug eluting stents
560020|NCT01178268|Stents|stents
560021|NCT01178268|Angioplasty|angioplasty
560022|NCT01178255|depression|depression
560023|NCT01178255|homoeopathy|homoeopathy
560024|NCT01178242|Labial mucous membrane|labial mucous membrane
560025|NCT01178242|symblepharon|symblepharon
560026|NCT01178242|dry eye|dry eye
560027|NCT01178242|Stevens -Johnson syndrome|stevens -johnson syndrome
560028|NCT01178242|salivary gland|salivary gland
560029|NCT01178242|ocular surface disease|ocular surface disease
560030|NCT01178242|transplantation|transplantation
560031|NCT01178229|Sleep bruxism|sleep bruxism
560032|NCT01178229|Airway remodeling|airway remodeling
560033|NCT01178229|Physical therapy modalities|physical therapy modalities
560034|NCT01178229|Child preschool.|child preschool.
560035|NCT01178216|Kidney transplant|kidney transplant
560036|NCT01178216|highly sensitized|highly sensitized
560037|NCT01178203|Endodontics|endodontics
560038|NCT01178203|pain|pain
560039|NCT01178203|visual analogue scale|visual analogue scale
560040|NCT01178203|NSAIDs|nsaids
560041|NCT01178190|narrow band imaging|narrow band imaging
560042|NCT01178190|malignant lesion|malignant lesion
560043|NCT01178190|lung cancer|lung cancer
560044|NCT01178190|NBI|nbi
560045|NCT01178177|Invasive pulmonary aspergillosis|invasive pulmonary aspergillosis
560046|NCT01178177|Solid organ transplantation|solid organ transplantation
560047|NCT01178177|Hematologic disease|hematologic disease
560048|NCT01178164|chronic pains|chronic pains
560049|NCT01178164|unknown aetiology|unknown aetiology
560050|NCT01178151|Peutz-Jeghers syndrome|peutz-jeghers syndrome
560051|NCT01178151|mTOR inhibition|mtor inhibition
560052|NCT01178151|cancer|cancer
560053|NCT01178138|substance abuse|substance abuse
560054|NCT01178125|Pregnancy Prevention|pregnancy prevention
560055|NCT01178125|Oral Contraceptives|oral contraceptives
560056|NCT01178112|Metastasis|metastasis
560057|NCT01178112|Carboplatin|carboplatin
560058|NCT01178112|Trientine|trientine
560059|NCT01178112|Chemotherapy|chemotherapy
560060|NCT01178073|Pulmonary Arterial Hypertension|pulmonary arterial hypertension
560061|NCT01178073|Ambrisentan|ambrisentan
560062|NCT01178073|Sponsor Rest of World: GSK|sponsor rest of world: gsk
560063|NCT01178073|Tadalafil|tadalafil
560064|NCT01178073|PAH|pah
560065|NCT01178073|Sponsor US: Gilead|sponsor us: gilead
560066|NCT01178060|Stroke|stroke
560067|NCT01178060|Risk|risk
560068|NCT01178060|Communication|communication
560069|NCT01178060|Cardiovascular Disease Knowledge|cardiovascular disease knowledge
560070|NCT01178060|Improve Risk Communication|improve risk communication
560071|NCT01178034|Warfarin|warfarin
560072|NCT01178034|Dose|dose
560073|NCT01178034|Pharmacogenetic|pharmacogenetic
560074|NCT01178034|INR|inr
560075|NCT01178021|malaria|malaria
560076|NCT01178021|vivax|vivax
560077|NCT01178021|relapse|relapse
560078|NCT01178008|Insomnia|insomnia
560079|NCT01178008|Post-partum Depression|post-partum depression
560080|NCT01178008|Electroacupuncture|electroacupuncture
560081|NCT01178008|Acupuncture|acupuncture
560082|NCT01178008|Randomized Clinical Trial|randomized clinical trial
560083|NCT01178008|Traditional Chinese Medicine|traditional chinese medicine
560084|NCT01177982|pregnancy, opioid, cocaine, alcohol, benzodiazepines, neonate|pregnancy, opioid, cocaine, alcohol, benzodiazepines, neonate
560085|NCT01177969|Autism|autism
560086|NCT01177969|Anxiety|anxiety
560087|NCT01177969|Asperger's Syndrome|asperger's syndrome
560088|NCT01177969|Cognitive-behavioral therapy|cognitive-behavioral therapy
560089|NCT01177969|Treatment|treatment
560090|NCT01177969|Obsessive-compulsive disorder|obsessive-compulsive disorder
560091|NCT01177969|Fears|fears
560092|NCT01177956|Recurrent and/or metastatic squamous cell carcinoma of the head and neck|recurrent and/or metastatic squamous cell carcinoma of the head and neck
560093|NCT01177956|1st-line|1st-line
560094|NCT01177956|Cetuximab|cetuximab
560095|NCT01177956|Chemotherapy|chemotherapy
560096|NCT01177956|EMR 62241 -055|emr 62241 -055
560097|NCT01177956|Merck KGaA|merck kgaa
560098|NCT01177956|Recurrent and/or metastatic squamous cell carcinoma of the head and neck (SCCHN)|recurrent and/or metastatic squamous cell carcinoma of the head and neck (scchn)
560099|NCT01177865|adenocarcinoma of the prostate|adenocarcinoma of the prostate
560100|NCT01177865|stage I prostate cancer|stage i prostate cancer
560101|NCT01177865|stage IIB prostate cancer|stage iib prostate cancer
560102|NCT01177865|stage IIA prostate cancer|stage iia prostate cancer
560103|NCT01177865|stage III prostate cancer|stage iii prostate cancer
560104|NCT01177852|cough, acute rhinitis, common cold, nasal symptoms, children.|cough, acute rhinitis, common cold, nasal symptoms, children.
560105|NCT01177852|Acute inflammation upper airway|acute inflammation upper airway
560106|NCT01177826|Hospitalized|hospitalized
560107|NCT01177826|Rotavirus|rotavirus
560108|NCT01177826|Children|children
560109|NCT01177826|effectiveness|effectiveness
560110|NCT01177826|Gastroenteritis|gastroenteritis
560111|NCT01177800|Psoriasis|psoriasis
560112|NCT01177800|Infliximab|infliximab
560113|NCT01177800|Remicade|remicade
560114|NCT01177787|cryolipolysis fat zeltiq thigh Korean women|cryolipolysis fat zeltiq thigh korean women
560115|NCT01177774|functional connectivity MRI|functional connectivity mri
560116|NCT01177774|brain volumetry|brain volumetry
560117|NCT01177774|negative reinforcement|negative reinforcement
560119|NCT01177774|ADHD|adhd
560120|NCT01177761|Osteoporosis|osteoporosis
560121|NCT01177761|exercise|exercise
560122|NCT01177761|fractures|fractures
560123|NCT01177761|Bone Mineral Density|bone mineral density
560124|NCT01177761|CHD-risk|chd-risk
560125|NCT01177748|Stroke|stroke
560126|NCT01177748|Cardiac Monitoring|cardiac monitoring
560127|NCT01177735|Pomalidomide|pomalidomide
560128|NCT01177735|multiple myeloma|multiple myeloma
560129|NCT01177735|relapsed|relapsed
560130|NCT01177722|Diphtheria|diphtheria
560131|NCT01177722|Tetanus|tetanus
560132|NCT01177722|Whooping cough|whooping cough
560133|NCT01177722|Hepatitis B|hepatitis b
560134|NCT01177722|Poliomyelitis|poliomyelitis
560135|NCT01177722|Diphtheria-Tetanus-acellular Pertussis Vaccines|diphtheria-tetanus-acellular pertussis vaccines
560136|NCT01177709|schizophrenia|schizophrenia
560137|NCT01177709|antipsychotics|antipsychotics
560138|NCT01177709|obesity|obesity
560139|NCT01177709|diabetes|diabetes
560140|NCT01177696|caregivers|caregivers
560141|NCT01177696|Family Health|family health
560142|NCT01177696|Psychotherapeutic|psychotherapeutic
560143|NCT01177696|Primary Health Care|primary health care
560144|NCT01177670|Adiana Permanent Contraception System|adiana permanent contraception system
560145|NCT01177670|women seeking permanent sterilization.|women seeking permanent sterilization.
560146|NCT01177631|Carcinoma, hepatocellular|carcinoma, hepatocellular
560147|NCT01177631|Portal vein|portal vein
560148|NCT01177631|Proteomics|proteomics
560149|NCT01177618|Chronic Obstructive Pulmonary Disease|chronic obstructive pulmonary disease
560150|NCT01177618|COPD|copd
560151|NCT01177618|Emphysema|emphysema
560152|NCT01177618|Chronic Bronchitis|chronic bronchitis
560153|NCT01177618|Genetics|genetics
560154|NCT01177618|Association Studies|association studies
560155|NCT01177579|Bariatric surgery, copper deficiency, biomarkers|bariatric surgery, copper deficiency, biomarkers
560156|NCT01177566|Atopic dermatitis|atopic dermatitis
560157|NCT01177566|Elidel|elidel
560158|NCT01177566|pimecrolimus cream 1%|pimecrolimus cream 1%
560159|NCT01177566|Eletone|eletone
560160|NCT01177566|medical device cream|medical device cream
560161|NCT01177566|topical calcineurin inhibitor|topical calcineurin inhibitor
560162|NCT01177553|Intrauterine Growth Retardation in Monochorionic Twins|intrauterine growth retardation in monochorionic twins
560163|NCT01177527|Waldenstrom|waldenstrom
560164|NCT01177527|myeloma|myeloma
560165|NCT01177527|smoldering|smoldering
560166|NCT01177527|lymphoma|lymphoma
560167|NCT01177527|MGUS|mgus
560168|NCT01177527|distinct B-cell lymphoproliferative disorder|distinct b-cell lymphoproliferative disorder
560169|NCT01177514|Refractive surgery|refractive surgery
560170|NCT01177514|PRK|prk
560171|NCT01177514|PAIN|pain
560172|NCT01177514|Gabapentin|gabapentin
560173|NCT01177501|Ovarian cancer|ovarian cancer
560174|NCT01177501|Topotecan|topotecan
560175|NCT01177501|Carboplatine|carboplatine
560176|NCT01177501|Higt dose chemotherapy|higt dose chemotherapy
560177|NCT01177488|Military|military
560178|NCT01177488|Health Service Delivery|health service delivery
560179|NCT01177488|Behavioral Symptoms|behavioral symptoms
560180|NCT01177488|Telepsychology|telepsychology
560181|NCT01177488|Behavioral Activation|behavioral activation
560182|NCT01177488|Exposure Therapy|exposure therapy
560183|NCT01177488|Veterans|veterans
560184|NCT01177488|Telemedicine|telemedicine
560185|NCT01177475|kidney-transplant recipients|kidney-transplant recipients
560186|NCT01177462|coordinate system|coordinate system
560187|NCT01177462|normal|normal
560188|NCT01177449|prolotherapy|prolotherapy
560189|NCT01177436|prostate cancer|prostate cancer
560190|NCT01177436|benign prostatic hypertrophy|benign prostatic hypertrophy
560191|NCT01177423|restorative odontology|restorative odontology
560192|NCT01177423|Patients cared in restorative odontology department|patients cared in restorative odontology department
560193|NCT01177410|IBS|ibs
560194|NCT01177410|Diarrhea|diarrhea
560195|NCT01177410|IBS-D|ibs-d
560196|NCT01177410|Irritable Bowel Syndrome|irritable bowel syndrome
560197|NCT01177410|Abdominal pain|abdominal pain
560198|NCT01177410|Bloating|bloating
560199|NCT01177397|Advanced solid malignant neoplasms,Non-Hodgkin Lymphoma,|advanced solid malignant neoplasms,non-hodgkin lymphoma,
560200|NCT01177397|Multiple Myeloma|multiple myeloma
560201|NCT01177384|Type 2 diabetes mellitus|type 2 diabetes mellitus
560202|NCT01177384|T2DM|t2dm
560203|NCT01177358|Scar|scar
560204|NCT01177358|Botox|botox
560205|NCT01177332|FFA|ffa
560206|NCT01177332|Liver|liver
560207|NCT01177332|steatosis|steatosis
560208|NCT01177332|exercise|exercise
560209|NCT01177319|Parkinson's Disease|parkinson's disease
560210|NCT01177319|Glutathione|glutathione
560211|NCT01177306|ADHD, working memory|adhd, working memory
560212|NCT01177293|biological availability|biological availability
560213|NCT01177293|bioavailability|bioavailability
560214|NCT01177293|amlodipine|amlodipine
560215|NCT01177293|orally disintegrating tablet|orally disintegrating tablet
560216|NCT01177293|ODT|odt
560217|NCT01177293|tablets|tablets
560218|NCT01177280|retrospective chronic low back pain|retrospective chronic low back pain
560219|NCT01177267|retrospective database analysis in osteoarthritis patients|retrospective database analysis in osteoarthritis patients
560220|NCT01177254|retrospective chronic low back pain|retrospective chronic low back pain
560221|NCT01177241|retrospective chronic low back pain|retrospective chronic low back pain
560222|NCT01177215|Algorithm|algorithm
560223|NCT01177215|Treatment Protocol|treatment protocol
560224|NCT01177215|Thoracic Drainage Device|thoracic drainage device
560225|NCT01177202|HAC1, H1N1|hac1, h1n1
560226|NCT01177189|Oxidative Stress|oxidative stress
560227|NCT01177189|Free radicals|free radicals
560228|NCT01177189|Aging|aging
560229|NCT01177176|Cigarette smoking|cigarette smoking
560230|NCT01177176|Tobacco smoking|tobacco smoking
560231|NCT01177163|Type 2 diabetes mellitus|type 2 diabetes mellitus
560232|NCT01177163|Canagliflozin|canagliflozin
560233|NCT01177163|JNJ-28431754|jnj-28431754
560234|NCT01177163|Insulin|insulin
560235|NCT01177163|Pharmacokinetic|pharmacokinetic
560236|NCT01177163|Pharmacodynamic|pharmacodynamic
560237|NCT01177163|SGLT-1|sglt-1
560238|NCT01177150|Sodium-Glucose Transporter 2|sodium-glucose transporter 2
560239|NCT01177150|Canagliflozin|canagliflozin
560240|NCT01177150|Pharmacodynamic|pharmacodynamic
560241|NCT01177150|Pharmacokinetic|pharmacokinetic
560242|NCT01177150|Safety|safety
560243|NCT01177150|Tolerability|tolerability
560244|NCT01177137|tinnitus|tinnitus
560245|NCT01177137|tinnitus retraining therapy|tinnitus retraining therapy
560246|NCT01177137|standard of care|standard of care
560247|NCT01177137|directive counseling|directive counseling
560248|NCT01177137|sound therapy|sound therapy
560249|NCT01177137|tinnitus questionnaire|tinnitus questionnaire
560250|NCT01177137|tinnitus handicap inventory|tinnitus handicap inventory
560251|NCT01177124|Breast cancer|breast cancer
560252|NCT01177124|Survivors|survivors
560253|NCT01177124|Mindfulness-Based Stress Reduction (MBSR)|mindfulness-based stress reduction (mbsr)
560254|NCT01177124|Symptoms|symptoms
560255|NCT01177124|Immune markers|immune markers
560256|NCT01177085|obesity|obesity
560257|NCT01177085|weight|weight
560258|NCT01177085|weight-loss|weight-loss
560259|NCT01177085|mushroom|mushroom
560260|NCT01177085|oxidative|oxidative
560261|NCT01177085|stress|stress
560262|NCT01177085|immune|immune
560263|NCT01177085|function|function
560264|NCT01177085|inflammation|inflammation
560265|NCT01177072|PTSD|ptsd
560266|NCT01177059|Gene Therapy|gene therapy
560267|NCT01177059|Anti-HIV-1 Ribozyme|anti-hiv-1 ribozyme
560268|NCT01177059|OZ1|oz1
560269|NCT01177059|HIV-1 Infections|hiv-1 infections
560270|NCT01177046|Women receiving labour epidural for most recent delivery|women receiving labour epidural for most recent delivery
560271|NCT01177007|Gastrointestinal Diseases|gastrointestinal diseases
560272|NCT01177007|Colonic Diseases|colonic diseases
560273|NCT01177007|Intestinal Diseases|intestinal diseases
560274|NCT01177007|Rectal Diseases|rectal diseases
560275|NCT01177007|Neoplastic Processes|neoplastic processes
560276|NCT01177007|Pathologic Processes|pathologic processes
560277|NCT01177007|Neuroendocrine Tumors|neuroendocrine tumors
560278|NCT01177007|Neuroectodermal Tumors|neuroectodermal tumors
560279|NCT01177007|Neoplasms, Germ Cell and Embryonal|neoplasms, germ cell and embryonal
560280|NCT01177007|Adenocarcinoma|adenocarcinoma
560281|NCT01177007|Neoplasms, Nerve Tissue|neoplasms, nerve tissue
560282|NCT01177007|Liver Diseases|liver diseases
560283|NCT01177007|Neoplasms|neoplasms
560284|NCT01177007|Carcinoma|carcinoma
560285|NCT01177007|Colorectal Neoplasms|colorectal neoplasms
560286|NCT01177007|Neoplasm Metastasis|neoplasm metastasis
560287|NCT01177007|Carcinoma, Neuroendocrine|carcinoma, neuroendocrine
560288|NCT01177007|Liver Neoplasms|liver neoplasms
560289|NCT01177007|Neoplasms, Glandular and Epithelial|neoplasms, glandular and epithelial
560290|NCT01177007|Neoplasms by Histologic Type|neoplasms by histologic type
560291|NCT01177007|Intestinal Neoplasms|intestinal neoplasms
560292|NCT01177007|Gastrointestinal Neoplasms|gastrointestinal neoplasms
560293|NCT01177007|Digestive System Neoplasms|digestive system neoplasms
560294|NCT01177007|Neoplasms by Site|neoplasms by site
560295|NCT01177007|Digestive System Diseases|digestive system diseases
560296|NCT01176994|Patients with skin lesions that are treated by dermatologists with destructive modalities without histological evaluation.|patients with skin lesions that are treated by dermatologists with destructive modalities without histological evaluation.
560297|NCT01176981|pediatrics|pediatrics
560298|NCT01176981|Osteosarcoma|osteosarcoma
560299|NCT01176981|Methotrexate|methotrexate
560300|NCT01176981|Outpatient|outpatient
560301|NCT01176968|Eplerenone|eplerenone
560302|NCT01176968|myocardial infarction|myocardial infarction
560303|NCT01176968|mortality|mortality
560304|NCT01176968|morbidity|morbidity
560305|NCT01176955|Acne|acne
560306|NCT01176955|Acne vulgaris|acne vulgaris
560307|NCT01176955|Adherence|adherence
560308|NCT01176955|Compliance|compliance
560309|NCT01176955|MEMS|mems
560310|NCT01176955|Benzoyl peroxide|benzoyl peroxide
560311|NCT01176929|Suicide, Attempted|suicide, attempted
560312|NCT01176929|prevention suicidal act|prevention suicidal act
560313|NCT01176929|telephone contact|telephone contact
560314|NCT01176929|professional coordination|professional coordination
560315|NCT01176916|breast cancer|breast cancer
560316|NCT01176916|Aromasin|aromasin
560317|NCT01176916|adjuvant chemotherapy|adjuvant chemotherapy
560318|NCT01176916|endocrine therapy|endocrine therapy
560319|NCT01176890|truncal vagotomy|truncal vagotomy
560320|NCT01176890|GLP-1|glp-1
560321|NCT01176890|gastric emptying|gastric emptying
560322|NCT01176890|appetite|appetite
560323|NCT01176890|food intake|food intake
560324|NCT01176864|Small-Bowel Disorders|small-bowel disorders
560325|NCT01176864|Double-balloon enteroscopy|double-balloon enteroscopy
560326|NCT01176864|Single-balloon enteroscopy|single-balloon enteroscopy
560327|NCT01176851|None (study in healthy volunteers)|none (study in healthy volunteers)
560328|NCT01176838|Breast Cancer Quality of Life Survey|breast cancer quality of life survey
560329|NCT01176825|bipolar disorder|bipolar disorder
560330|NCT01176825|cognitive behavior therapy|cognitive behavior therapy
560331|NCT01176825|alcohol abuse|alcohol abuse
560332|NCT01176825|drug abuse|drug abuse
560333|NCT01176825|high risk behaviors|high risk behaviors
560334|NCT01176825|medication adherence|medication adherence
560335|NCT01176825|psychosocial functioning|psychosocial functioning
560336|NCT01176812|Facialwasting|facialwasting
560337|NCT01176812|Juvederm|juvederm
560338|NCT01176812|Restylane|restylane
560339|NCT01176799|Breast cancer patients with measurable primary breast cancer tumor.|breast cancer patients with measurable primary breast cancer tumor.
560340|NCT01176786|infection|infection
560341|NCT01176786|tissue expander|tissue expander
560342|NCT01176786|breast implant|breast implant
560343|NCT01176786|breast reconstruction|breast reconstruction
560344|NCT01176786|Infections rates|infections rates
560345|NCT01176760|vagotomy|vagotomy
560346|NCT01176760|vagus|vagus
560347|NCT01176760|GLP-1|glp-1
560348|NCT01176760|Insulin secretion|insulin secretion
560349|NCT01176734|Pulsatile Tinnitus|pulsatile tinnitus
560350|NCT01176734|Ringing-Buzzing-Tinnitus|ringing-buzzing-tinnitus
560351|NCT01176734|Spontaneous Oto-Acoustic Emission Tinnitus|spontaneous oto-acoustic emission tinnitus
560352|NCT01176734|Tensor Palatini Induced Tinnitus|tensor palatini induced tinnitus
560353|NCT01176734|Tensor Tympani Induced Tinnitus|tensor tympani induced tinnitus
560354|NCT01176734|Tinnitus of Vascular Origin|tinnitus of vascular origin
560355|NCT01176734|Tinnitus, Clicking|tinnitus, clicking
560356|NCT01176734|Tinnitus, Leudet|tinnitus, leudet
560357|NCT01176734|Tinnitus, Leudet's|tinnitus, leudet's
560358|NCT01176734|Tinnitus, Noise Induced|tinnitus, noise induced
560359|NCT01176734|Tinnitus, Objective|tinnitus, objective
560360|NCT01176734|Tinnitus, Spontaneous Oto-Acoustic Emission|tinnitus, spontaneous oto-acoustic emission
560361|NCT01176734|Tinnitus, Subjective|tinnitus, subjective
560362|NCT01176734|Tinnitus, Tensor Palatini Induced|tinnitus, tensor palatini induced
560363|NCT01176734|Tinnitus, Tensor Tympani Induced|tinnitus, tensor tympani induced
560364|NCT01176734|Vascular Origin Tinnitus|vascular origin tinnitus
560365|NCT01176721|schizophrenic disorders|schizophrenic disorders
560366|NCT01176721|psychosis|psychosis
560367|NCT01176721|psychotic|psychotic
560368|NCT01176721|dementia|dementia
560369|NCT01176721|delusional|delusional
560370|NCT01176721|delusions|delusions
560371|NCT01176721|hallucinations|hallucinations
560372|NCT01176721|residual-type schizophrenia|residual-type schizophrenia
560373|NCT01176721|illusions|illusions
560374|NCT01176721|split mind|split mind
560375|NCT01176721|mental health disorder|mental health disorder
560376|NCT01176721|schizoid|schizoid
560377|NCT01176721|paranoid-type schizophrenia|paranoid-type schizophrenia
560378|NCT01176721|disorganized-type schizophrenia|disorganized-type schizophrenia
560379|NCT01176721|undifferentiated-type schizophrenia|undifferentiated-type schizophrenia
560380|NCT01176721|catatonic-type schizophrenia|catatonic-type schizophrenia
560381|NCT01176721|mental illness|mental illness
560382|NCT01176721|tardive dyskinesia|tardive dyskinesia
560383|NCT01176721|neuroleptic malignant syndrome|neuroleptic malignant syndrome
560385|NCT01176721|antipsychotics|antipsychotics
560386|NCT01176721|atypical antipsychotics|atypical antipsychotics
560387|NCT01176721|psychosocial treatments|psychosocial treatments
560388|NCT01176721|rehabilitation|rehabilitation
560389|NCT01176708|liver transplantation|liver transplantation
560390|NCT01176708|kidney transplanted|kidney transplanted
560391|NCT01176708|glucagon-like peptide-1|glucagon-like peptide-1
560392|NCT01176708|insulin secretion|insulin secretion
560393|NCT01176708|vagotomy|vagotomy
560394|NCT01176682|NSAID-treated patients|nsaid-treated patients
560395|NCT01176682|gastrointestinal events|gastrointestinal events
560495|NCT01176279|Intensive care unit|intensive care unit
560396|NCT01176682|Non-steroid anti-inflammatory drug (NSAID)|non-steroid anti-inflammatory drug (nsaid)
560397|NCT01176682|Gastrointestinal events (GI events)|gastrointestinal events (gi events)
560398|NCT01176682|Proton Pump Inhibitors (PPI)|proton pump inhibitors (ppi)
560399|NCT01176669|Apatinib|apatinib
560400|NCT01176669|Triple-Negative Breast Cancer|triple-negative breast cancer
560401|NCT01176669|Metastatic Breast Cancer|metastatic breast cancer
560402|NCT01176669|ER/PR Negative|er/pr negative
560403|NCT01176669|Her2/Neu Negative|her2/neu negative
560404|NCT01176656|Type 2 Diabetes Mellitus|type 2 diabetes mellitus
560405|NCT01176656|Hypoglycemia|hypoglycemia
560406|NCT01176643|SLE|sle
560407|NCT01176643|Yoga|yoga
560408|NCT01176630|metabolic syndrome, ESRD patient|metabolic syndrome, esrd patient
560409|NCT01176617|Atrial Fibrillation|atrial fibrillation
560410|NCT01176617|A-Fib|a-fib
560411|NCT01176617|AF|af
560412|NCT01176617|Persistent|persistent
560413|NCT01176617|Permanent|permanent
560414|NCT01176617|Pulmonary Vein isolation|pulmonary vein isolation
560415|NCT01176617|Ablation|ablation
560416|NCT01176591|Cocaine and alcohol dependence (CAD)|cocaine and alcohol dependence (cad)
560417|NCT01176565|Acute hypertensive response|acute hypertensive response
560418|NCT01176565|intracerebral hemorrhage|intracerebral hemorrhage
560419|NCT01176565|blood pressure|blood pressure
560420|NCT01176565|outcome|outcome
560421|NCT01176565|nicardipine|nicardipine
560422|NCT01176552|Kidney Cancer|kidney cancer
560423|NCT01176552|Renal cell carcinoma|renal cell carcinoma
560424|NCT01176552|High risk|high risk
560425|NCT01176552|Adjuvant therapy|adjuvant therapy
560426|NCT01176526|Coping|coping
560427|NCT01176526|Quality of Life|quality of life
560428|NCT01176526|Prostate Cancer|prostate cancer
560429|NCT01176513|Prostate Cancer|prostate cancer
560430|NCT01176513|MRI|mri
560431|NCT01176513|PET|pet
560432|NCT01176513|GE-148 (18F)|ge-148 (18f)
560433|NCT01176500|PET Imaging|pet imaging
560434|NCT01176500|(18F)Fluciclatide|(18f)fluciclatide
560435|NCT01176500|Anti-Angiogenic Therapies|anti-angiogenic therapies
560436|NCT01176500|Solid Tumors|solid tumors
560437|NCT01176487|recurrent non-small cell lung cancer|recurrent non-small cell lung cancer
560438|NCT01176487|recurrent small cell lung cancer|recurrent small cell lung cancer
560439|NCT01176487|extensive stage small cell lung cancer|extensive stage small cell lung cancer
560440|NCT01176487|stage IIIA non-small cell lung cancer|stage iiia non-small cell lung cancer
560441|NCT01176487|stage IIIB non-small cell lung cancer|stage iiib non-small cell lung cancer
560442|NCT01176487|stage IV non-small cell lung cancer|stage iv non-small cell lung cancer
560443|NCT01176474|stage IV melanoma|stage iv melanoma
560444|NCT01176474|stage IIIC melanoma|stage iiic melanoma
560445|NCT01176461|recurrent melanoma|recurrent melanoma
560446|NCT01176461|stage IIIA melanoma|stage iiia melanoma
560447|NCT01176461|stage IIIB melanoma|stage iiib melanoma
560448|NCT01176461|stage IIIC melanoma|stage iiic melanoma
560449|NCT01176461|stage IV melanoma|stage iv melanoma
560450|NCT01176448|Cicatrix|cicatrix
560451|NCT01176448|Dermabrasion|dermabrasion
560452|NCT01176448|Coagulation, Laser|coagulation, laser
560453|NCT01176435|Levodopa|levodopa
560454|NCT01176435|Albinism|albinism
560455|NCT01176435|Vision|vision
560456|NCT01176422|AML|aml
560457|NCT01176422|MDS|mds
560458|NCT01176396|Dental Caries|dental caries
560459|NCT01176396|Preventive Dentistry|preventive dentistry
560460|NCT01176396|Dental Prophylaxis|dental prophylaxis
560461|NCT01176396|Dental Care|dental care
560462|NCT01176383|Nicotine addiction|nicotine addiction
560463|NCT01176383|Behaviour|behaviour
560464|NCT01176383|Gene test|gene test
560465|NCT01176383|Lung cancer|lung cancer
560466|NCT01176383|Lifetime risk of lung cancer in smokers|lifetime risk of lung cancer in smokers
560467|NCT01176370|Heart Failure|heart failure
560468|NCT01176370|Device|device
560469|NCT01176370|Implantable|implantable
560470|NCT01176370|Active|active
560471|NCT01176370|Class III and Class IV|class iii and class iv
560472|NCT01176370|Counterpulsation|counterpulsation
560473|NCT01176357|Coronary artery disease (CAD)|coronary artery disease (cad)
560474|NCT01176357|atherosclerosis|atherosclerosis
560475|NCT01176357|mediastinal adipose tissue|mediastinal adipose tissue
560476|NCT01176357|adiponectin, inflammatory mediators|adiponectin, inflammatory mediators
560477|NCT01176344|Vitamin D supplementation|vitamin d supplementation
560478|NCT01176344|Osteoarthritis|osteoarthritis
560479|NCT01176344|Knee|knee
560480|NCT01176344|Randomised clinical trial (RCT)|randomised clinical trial (rct)
560481|NCT01176344|Cartilage|cartilage
560482|NCT01176344|MRI|mri
560483|NCT01176318|cough|cough
560484|NCT01176318|exacerbation|exacerbation
560485|NCT01176318|quality of life|quality of life
560486|NCT01176305|Thromboembolic event|thromboembolic event
560487|NCT01176292|total knee replacement|total knee replacement
560488|NCT01176292|high flexion|high flexion
560489|NCT01176292|range of motion|range of motion
560490|NCT01176292|rotating platform|rotating platform
560491|NCT01176292|TKA|tka
560492|NCT01176279|Critical illness|critical illness
560493|NCT01176279|Hyperglycemia|hyperglycemia
560494|NCT01176279|Catheters, Indwelling|catheters, indwelling
560496|NCT01176266|Hypophosphatasia|hypophosphatasia
560497|NCT01176266|HPP|hpp
560498|NCT01176266|Bone Disease|bone disease
560499|NCT01176266|Soft Bones|soft bones
560500|NCT01176266|Low Alkaline Phosphatase|low alkaline phosphatase
560501|NCT01176266|Genetic metabolic disorder|genetic metabolic disorder
560502|NCT01176266|Alkaline phosphatase|alkaline phosphatase
560503|NCT01176266|Tissue-specific alkaline phosphatase (TNSALP)|tissue-specific alkaline phosphatase (tnsalp)
560504|NCT01176266|Rickets|rickets
560505|NCT01176266|Osteomalacia|osteomalacia
560506|NCT01176253|Type I DM|type i dm
560507|NCT01176240|lightheadedness|lightheadedness
560508|NCT01176240|unsteadiness|unsteadiness
560509|NCT01176240|dizziness|dizziness
560510|NCT01176240|weak|weak
560511|NCT01176240|fatigue|fatigue
560512|NCT01176240|concentration|concentration
560513|NCT01176240|head & neck pain|head & neck pain
560514|NCT01176240|standing/walking for a short time|standing/walking for a short time
560515|NCT01176240|standing/walking for a long time|standing/walking for a long time
560516|NCT01176240|Neurogenic Orthostatic Hypotension|neurogenic orthostatic hypotension
560517|NCT01176240|falls|falls
560518|NCT01176240|NOH|noh
560519|NCT01176240|Parkinson's disease|parkinson's disease
560520|NCT01176240|weakness|weakness
560521|NCT01176227|bloating|bloating
560522|NCT01176227|constipation|constipation
560523|NCT01176227|diarrhea|diarrhea
560524|NCT01176227|gas|gas
560525|NCT01176227|mucous|mucous
560526|NCT01176227|cramping|cramping
560527|NCT01176214|supratentorial intracerebral hemorrhage|supratentorial intracerebral hemorrhage
560528|NCT01176214|tracheostomy|tracheostomy
560529|NCT01176214|sedation|sedation
560530|NCT01176214|weaning|weaning
560531|NCT01176201|SLV337|slv337
560532|NCT01176201|Diabetes|diabetes
560533|NCT01176201|Relative bioavailability|relative bioavailability
560534|NCT01176201|ADME|adme
560535|NCT01176188|Pediatric Intensive Care Unit|pediatric intensive care unit
560536|NCT01176188|Environmental Stressors|environmental stressors
560537|NCT01176188|Sleep|sleep
560538|NCT01176188|Psychological Outcomes|psychological outcomes
560539|NCT01176188|Pediatrics|pediatrics
560540|NCT01176175|Progesterone|progesterone
560541|NCT01176175|Microspheres|microspheres
560542|NCT01176175|postmenopausal|postmenopausal
560543|NCT01176175|Luteal phase support|luteal phase support
560544|NCT01176162|Non Invasive measurement|non invasive measurement
560545|NCT01176162|Preterm infants|preterm infants
560546|NCT01176162|Aldosterone resistance|aldosterone resistance
560547|NCT01176149|Diabetes|diabetes
560548|NCT01176149|Self monitoring blood glucose|self monitoring blood glucose
560549|NCT01176136|ADHD|adhd
560550|NCT01176136|School-Based|school-based
560551|NCT01176136|Organizational Skills|organizational skills
560552|NCT01176136|Homework|homework
560553|NCT01176136|Time Management|time management
560554|NCT01176123|Cognitive behavioral therapy|cognitive behavioral therapy
560555|NCT01176123|Insomnia|insomnia
560556|NCT01176123|Traumatic Stress|traumatic stress
560557|NCT01176110|hypothermia|hypothermia
560558|NCT01176110|minimal invasive valve replacement|minimal invasive valve replacement
560559|NCT01176097|First in man study evaluating AZD5658 in Type 2 Diabetics.|first in man study evaluating azd5658 in type 2 diabetics.
560560|NCT01176097|Effect of fasting|effect of fasting
560561|NCT01176097|Safety|safety
560562|NCT01176097|Tolerability|tolerability
560563|NCT01176084|low carbohydrate diet|low carbohydrate diet
560564|NCT01176084|obesity|obesity
560565|NCT01176084|moderate exercise|moderate exercise
560566|NCT01176084|men|men
560567|NCT01176071|galactomannan|galactomannan
560568|NCT01176071|beta-D-glucan|beta-d-glucan
560569|NCT01176071|aspergillosis|aspergillosis
560570|NCT01176071|outcome|outcome
560571|NCT01176058|Phase 3b|phase 3b
560572|NCT01176058|Efficacy and Safety evaluation of Anidulafungin|efficacy and safety evaluation of anidulafungin
560573|NCT01176058|ICC|icc
560574|NCT01176045|Dry Eye Disease|dry eye disease
560575|NCT01176045|Osmolarity|osmolarity
560576|NCT01176045|Refractive Surgery|refractive surgery
560577|NCT01176045|Lasik|lasik
560578|NCT01176045|TearLab|tearlab
560579|NCT01176032|Aliskiren|aliskiren
560580|NCT01176032|hypertension|hypertension
560581|NCT01176032|concentric LVH|concentric lvh
560582|NCT01176032|LV remodeling|lv remodeling
560583|NCT01176032|LVMI|lvmi
560584|NCT01176032|biomarkers|biomarkers
560585|NCT01176032|PICP|picp
560586|NCT01176032|CT-1|ct-1
560587|NCT01176032|MMP-1|mmp-1
560588|NCT01176032|TIMP-1|timp-1
560589|NCT01176032|AnxA5|anxa5
560590|NCT01176032|Aldosterone|aldosterone
560591|NCT01176032|Essential hypertension with concentric left ventricle hypertrophy|essential hypertension with concentric left ventricle hypertrophy
560592|NCT01176019|Amniocentesis|amniocentesis
560593|NCT01176019|Chorionic Villus Sampling|chorionic villus sampling
560594|NCT01176019|First trimester screening|first trimester screening
560595|NCT01176019|Down syndrome|down syndrome
560596|NCT01176006|DOCK8|dock8
560597|NCT01176006|Molluscum|molluscum
560598|NCT01176006|Transplant|transplant
560599|NCT01176006|Immunodeficiency|immunodeficiency
560600|NCT01175993|Motor Training|motor training
560601|NCT01175993|Post-Traumatic Stress Disorder (PTSD)|post-traumatic stress disorder (ptsd)
560602|NCT01175993|Balance|balance
560603|NCT01175967|psychosocial effects of cancer and its treatment|psychosocial effects of cancer and its treatment
560604|NCT01175967|perioperative/postoperative complications|perioperative/postoperative complications
560605|NCT01175967|stage III ovarian epithelial cancer|stage iii ovarian epithelial cancer
560606|NCT01175967|stage IV ovarian epithelial cancer|stage iv ovarian epithelial cancer
560607|NCT01175954|Partial Epilepsy|partial epilepsy
560608|NCT01175928|Diabetic polyneuropathy|diabetic polyneuropathy
560609|NCT01175928|Pneumatic Compression Device|pneumatic compression device
560610|NCT01175915|Mild type of hand, foot and mouth disease|mild type of hand, foot and mouth disease
560611|NCT01175915|Reduning Injection|reduning injection
560612|NCT01175915|Effectiveness|effectiveness
560613|NCT01175915|Safety|safety
560614|NCT01175902|Normal tension glaucoma|normal tension glaucoma
560615|NCT01175876|MMSE|mmse
560616|NCT01175876|NSE|nse
560617|NCT01175876|S100B|s100b
560618|NCT01175876|hsCRP|hscrp
560619|NCT01175876|DWI-MRI|dwi-mri
560620|NCT01175863|intravascular ultrasound|intravascular ultrasound
560621|NCT01175863|fractional flow reserve|fractional flow reserve
560622|NCT01175824|Metabolic Diseases|metabolic diseases
560623|NCT01175824|Diabetes Mellitus, Type 2|diabetes mellitus, type 2
560624|NCT01175824|Glargine|glargine
560625|NCT01175824|Diabetes Mellitus|diabetes mellitus
560626|NCT01175824|Insulin LISPRO|insulin lispro
560627|NCT01175824|Insulin|insulin
560628|NCT01175811|Metabolic Diseases|metabolic diseases
560629|NCT01175811|Diabetes Mellitus, Type 2|diabetes mellitus, type 2
560630|NCT01175811|Glargine|glargine
560631|NCT01175811|Diabetes Mellitus|diabetes mellitus
560632|NCT01175811|Insulin LISPRO|insulin lispro
560633|NCT01175811|Insulin|insulin
560634|NCT01175798|Vitamin D deficiency|vitamin d deficiency
560635|NCT01175798|End-stage renal disease|end-stage renal disease
560636|NCT01175798|Immunity|immunity
560637|NCT01175772|Ovary|ovary
560638|NCT01175772|Carcinoma|carcinoma
560639|NCT01175772|Maintenance|maintenance
560640|NCT01175772|Metronomic|metronomic
560641|NCT01175772|Chemotherapy|chemotherapy
560642|NCT01175772|Time to Progression|time to progression
560643|NCT01175772|overall survival|overall survival
560644|NCT01175759|Unexplained Recurrent Pregnancy Loss|unexplained recurrent pregnancy loss
560645|NCT01175759|Recurrent Abortions|recurrent abortions
560646|NCT01175759|Recurrent Miscarriages|recurrent miscarriages
560647|NCT01175759|Hormones|hormones
560648|NCT01175759|Skin tests|skin tests
560649|NCT01175759|Allergen|allergen
560650|NCT01175759|Immunotherapy|immunotherapy
560651|NCT01175759|Hypersensitivity|hypersensitivity
560652|NCT01175759|Skin reaction|skin reaction
560653|NCT01175746|healthy adult patients|healthy adult patients
560654|NCT01175746|ASA class I|asa class i
560655|NCT01175746|hypotensive anesthesia|hypotensive anesthesia
560656|NCT01175733|Panitumumab|panitumumab
560657|NCT01175733|Chemoradiation|chemoradiation
560658|NCT01175733|Pancreatic cancer|pancreatic cancer
560659|NCT01175733|Locally advanced|locally advanced
560660|NCT01175733|Inoperable|inoperable
560661|NCT01175720|gingival recession|gingival recession
560662|NCT01175720|acellular dermal matrix graft|acellular dermal matrix graft
560663|NCT01175720|root coverage|root coverage
560664|NCT01175694|Brachytherapy|brachytherapy
560665|NCT01175694|APBI|apbi
560666|NCT01175694|dose modification|dose modification
560667|NCT01175694|local recurrences|local recurrences
560668|NCT01175694|side effects|side effects
560669|NCT01175694|cosmetic result|cosmetic result
560670|NCT01175681|rheumatic heart disease|rheumatic heart disease
560671|NCT01175681|degenerated heart valve disease|degenerated heart valve disease
560672|NCT01175681|heart valve prolapse|heart valve prolapse
560673|NCT01175655|Mesenchymal stromal cells|mesenchymal stromal cells
560674|NCT01175655|Bronchiolitis obliterans|bronchiolitis obliterans
560675|NCT01175655|Lung transplant|lung transplant
560676|NCT01175642|Schizophrenia|schizophrenia
560677|NCT01175642|Psychosis|psychosis
560678|NCT01175642|Schizoaffective Disorder|schizoaffective disorder
560679|NCT01175629|Stress Disorders, Post-Traumatic|stress disorders, post-traumatic
560680|NCT01175629|Depression|depression
560681|NCT01175629|Diabetes|diabetes
560682|NCT01175629|Cardiovascular Disease|cardiovascular disease
560683|NCT01175629|Depressive Disorder|depressive disorder
560684|NCT01175629|Behavioral Symptoms|behavioral symptoms
560685|NCT01175629|Metabolic Diseases|metabolic diseases
560686|NCT01175629|Mental Disorders|mental disorders
560687|NCT01175629|Anxiety Disorders|anxiety disorders
560688|NCT01175616|Depression|depression
560689|NCT01175616|Adults|adults
560690|NCT01175603|depression, African American, home visiting, prevention|depression, african american, home visiting, prevention
560691|NCT01175577|mixed carotenes|mixed carotenes
560692|NCT01175564|TC-5214|tc-5214
560693|NCT01175564|safety|safety
560694|NCT01175564|pharmacokinetics|pharmacokinetics
560695|NCT01175564|single dose|single dose
560696|NCT01175564|repeated dose|repeated dose
560697|NCT01175564|Japanese|japanese
560698|NCT01175564|healthy subjects|healthy subjects
560699|NCT01175551|Preterm Birth|preterm birth
560700|NCT01175551|Cervix|cervix
560701|NCT01175551|Cervical Shortening|cervical shortening
560702|NCT01175551|Cervical remodeling|cervical remodeling
560704|NCT01175538|Hepatic encephalopathy|hepatic encephalopathy
560705|NCT01175538|Lactulose|lactulose
560706|NCT01175499|laryngoscopy|laryngoscopy
560707|NCT01175499|Laryngoscopic Surgery|laryngoscopic surgery
560708|NCT01175499|laryngoscopes|laryngoscopes
560709|NCT01175499|upper aerodigestive tract lesions|upper aerodigestive tract lesions
560710|NCT01175499|endoscopy|endoscopy
560711|NCT01175499|biopsy|biopsy
560712|NCT01175486|thiazolidinediones|thiazolidinediones
560713|NCT01175486|diabetes|diabetes
560714|NCT01175486|retinopathy|retinopathy
560715|NCT01175486|nephropathy|nephropathy
560716|NCT01175460|esophageal Cancer|esophageal cancer
560717|NCT01175460|radiation|radiation
560719|NCT01175460|nedaplatin|nedaplatin
560720|NCT01175447|S-1|s-1
560721|NCT01175447|radiation|radiation
560722|NCT01175447|esophageal Cancer|esophageal cancer
560723|NCT01175434|Asthma|asthma
560724|NCT01175421|snoring|snoring
560725|NCT01175421|sleep apnea|sleep apnea
560726|NCT01175421|sleep study|sleep study
560727|NCT01175421|cardiovascular outcomes|cardiovascular outcomes
560728|NCT01175408|Remote Blood Glucose Monitoring System,|remote blood glucose monitoring system,
560729|NCT01175408|Continuous Glucose Monitoring System,|continuous glucose monitoring system,
560730|NCT01175408|Self Monitoring Blood Glucose,|self monitoring blood glucose,
560731|NCT01175408|Strip Counting,|strip counting,
560732|NCT01175408|Type 2 Diabetes|type 2 diabetes
560733|NCT01175395|Choroidal neovascular membranes|choroidal neovascular membranes
560734|NCT01175395|CNV|cnv
560735|NCT01175395|AMD|amd
560736|NCT01175395|Age-relate Macular Degeneration|age-relate macular degeneration
560737|NCT01175395|CNVM|cnvm
560738|NCT01175395|subfoveal|subfoveal
560739|NCT01175382|Male Urogenital Diseases|male urogenital diseases
560740|NCT01175382|Urinary Bladder, overactive|urinary bladder, overactive
560741|NCT01175382|Behavioral Medicine|behavioral medicine
560742|NCT01175382|Drug Therapy|drug therapy
560743|NCT01175369|Asthma|asthma
560744|NCT01175330|Omega-3 fatty acid|omega-3 fatty acid
560745|NCT01175330|Ischemic Heart Disease|ischemic heart disease
560746|NCT01175330|Atrial Fibrillation|atrial fibrillation
560747|NCT01175330|Subcutaneous cardiac monitoring|subcutaneous cardiac monitoring
560748|NCT01175317|Hemodynamic optimization|hemodynamic optimization
560749|NCT01175317|Enhanced recovery after surgery|enhanced recovery after surgery
560750|NCT01175317|Goal-directed fluid|goal-directed fluid
560751|NCT01175304|sleep|sleep
560752|NCT01175304|sleep apnea|sleep apnea
560753|NCT01175304|work|work
560754|NCT01175304|sleep habits|sleep habits
560755|NCT01175304|sleepiness|sleepiness
560756|NCT01175291|colon|colon
560757|NCT01175291|rectum|rectum
560758|NCT01175291|colorectal|colorectal
560759|NCT01175291|metastatic|metastatic
560760|NCT01175291|adenocarcinoma|adenocarcinoma
560761|NCT01175278|vertebral|vertebral
560762|NCT01175278|compression|compression
560763|NCT01175278|fracture|fracture
560764|NCT01175278|VCF|vcf
560765|NCT01175278|kyphoplasty|kyphoplasty
560766|NCT01175278|spine|spine
560767|NCT01175265|clinically stable|clinically stable
560768|NCT01175265|COPD (GOLD-classification I-IV)|copd (gold-classification i-iv)
560769|NCT01175265|COPD|copd
560770|NCT01175265|breathing retraining|breathing retraining
560771|NCT01175265|pulmonary rehabilitation|pulmonary rehabilitation
560772|NCT01175265|cardiac autonomic function|cardiac autonomic function
560773|NCT01175265|quality of life|quality of life
560774|NCT01175265|exercise capacity|exercise capacity
560775|NCT01175265|pulmonary function|pulmonary function
560776|NCT01175252|Gastroenteritis|gastroenteritis
560777|NCT01175239|X-linked severe combined immunodeficiency, gene therapy|x-linked severe combined immunodeficiency, gene therapy
560778|NCT01175239|Patients will be enrolled following diagnosis and referral to Great Ormond Street Immunology Service.|patients will be enrolled following diagnosis and referral to great ormond street immunology service.
560779|NCT01175226|Human rhinovirus|human rhinovirus
560780|NCT01175226|Aviragen Therapeutics, Inc.|aviragen therapeutics, inc.
560781|NCT01175226|Aviragen Therapeutics|aviragen therapeutics
560782|NCT01175226|Aviragen|aviragen
560783|NCT01175187|evron|evron
560784|NCT01175174|asthma|asthma
560785|NCT01175174|preschool children|preschool children
560786|NCT01175174|adenosine provocation test|adenosine provocation test
560787|NCT01175174|metacholine provocation test|metacholine provocation test
560788|NCT01175174|pediatric emergency department|pediatric emergency department
560789|NCT01175161|Postpartum Contraception|postpartum contraception
560790|NCT01175161|Intrauterine device|intrauterine device
560791|NCT01175161|feasibility|feasibility
560792|NCT01175161|IUD|iud
560793|NCT01175161|Immediate postpartum IUD|immediate postpartum iud
560794|NCT01175148|HSCT|hsct
560795|NCT01175148|HPC|hpc
560796|NCT01175148|HCT|hct
560797|NCT01175148|BMT|bmt
560798|NCT01175148|lipitor|lipitor
560799|NCT01175148|atorvastatin|atorvastatin
560800|NCT01175148|HMG-CoA Reductase Inhibitor|hmg-coa reductase inhibitor
560801|NCT01175148|Hematopoietic stem cell transplant|hematopoietic stem cell transplant
560802|NCT01175148|allogeneic transplant|allogeneic transplant
560803|NCT01175148|GVHD|gvhd
560804|NCT01175148|graft-versus-host-disease|graft-versus-host-disease
560805|NCT01175148|Graft vs Host Disease|graft vs host disease
560806|NCT01175135|schizophrenia|schizophrenia
560807|NCT01175135|acute exacerbation|acute exacerbation
560808|NCT01175135|inpatient|inpatient
560809|NCT01175109|Chordoma|chordoma
560810|NCT01175096|neuroendocrine tumors|neuroendocrine tumors
560811|NCT01175096|carcinoid tumor|carcinoid tumor
560812|NCT01175096|RAD001 (everolimus, Afinitor®)|rad001 (everolimus, afinitor®)
560813|NCT01175083|Immunogenicity|immunogenicity
560814|NCT01175083|Booster vaccination|booster vaccination
560815|NCT01175083|Catch-up vaccination|catch-up vaccination
560816|NCT01175083|Pneumococcal vaccine|pneumococcal vaccine
560817|NCT01175083|Pneumococcal disease|pneumococcal disease
560818|NCT01175083|Sickle cell disease|sickle cell disease
560819|NCT01175083|Safety|safety
560820|NCT01175070|diabetic macular oedema|diabetic macular oedema
560821|NCT01175070|ischaemia|ischaemia
560822|NCT01175070|anti VEGF|anti vegf
560823|NCT01175070|pegaptanib|pegaptanib
560824|NCT01175070|Ischaemic diabetic macular oedema|ischaemic diabetic macular oedema
560825|NCT01175057|feasibility|feasibility
560826|NCT01175057|compliance|compliance
560827|NCT01175057|telemedical home monitoring|telemedical home monitoring
560828|NCT01175057|post stationary rehabilitation|post stationary rehabilitation
560829|NCT01175057|patients with myocardial infarction|patients with myocardial infarction
560830|NCT01175044|Revision|revision
560831|NCT01175044|Knee|knee
560832|NCT01175044|Arthroplasty|arthroplasty
560833|NCT01175044|Betadine|betadine
560834|NCT01175044|Lavage|lavage
560835|NCT01175044|Infection|infection
560836|NCT01175018|Acute myocardial infarction|acute myocardial infarction
560837|NCT01175018|Heart Failure|heart failure
560838|NCT01175018|Cardiac Remodeling|cardiac remodeling
560839|NCT01175005|Fever|fever
560840|NCT01175005|Central venous catheter|central venous catheter
560841|NCT01175005|Procalcitonin|procalcitonin
560842|NCT01175005|Fever with a central venous catheter|fever with a central venous catheter
560843|NCT01174992|Fibrin sealant|fibrin sealant
560844|NCT01174992|CSF leak|csf leak
560845|NCT01174979|Morbus Meniere|morbus meniere
560846|NCT01174979|Sudden hearing loss|sudden hearing loss
560847|NCT01174979|Blast injury|blast injury
560848|NCT01174979|Presbyacusis|presbyacusis
560849|NCT01174979|Chron. Otitis Media|chron. otitis media
560850|NCT01174966|oxygen challenge test|oxygen challenge test
560851|NCT01174966|shock|shock
560852|NCT01174966|mortality|mortality
560853|NCT01174966|Oxygen Delivery Index|oxygen delivery index
560854|NCT01174966|cardiac output index|cardiac output index
560855|NCT01174953|prostate cancer|prostate cancer
560856|NCT01174940|myelogenous leukemia|myelogenous leukemia
560857|NCT01174940|lymphocytic leukemia|lymphocytic leukemia
560858|NCT01174940|lymphoblastic leukemia|lymphoblastic leukemia
560859|NCT01174940|myelodysplastic syndrome|myelodysplastic syndrome
560860|NCT01174940|non-Hodgkin's lymphoma|non-hodgkin's lymphoma
560861|NCT01174940|Hodgkin's disease|hodgkin's disease
560862|NCT01174927|Substance use disorder|substance use disorder
560863|NCT01174927|Stress|stress
560864|NCT01174901|cephalalgia|cephalalgia
560865|NCT01174901|copeptins|copeptins
560866|NCT01174901|biomarkers|biomarkers
560867|NCT01174901|headache|headache
560868|NCT01174901|C-terminal provasopression|c-terminal provasopression
560869|NCT01174901|physiological stress response|physiological stress response
560870|NCT01174888|Acute Myeloid Leukemia|acute myeloid leukemia
560871|NCT01174888|AML|aml
560872|NCT01174875|Epigenetics|epigenetics
560873|NCT01174875|Development|development
560874|NCT01174875|Metabolic|metabolic
560875|NCT01174875|Neurodevelopment|neurodevelopment
560876|NCT01174862|aspirin|aspirin
560877|NCT01174862|aspirin responsiveness|aspirin responsiveness
560878|NCT01174862|long-term outcome|long-term outcome
560879|NCT01174862|CABG|cabg
560880|NCT01174849|otitis media|otitis media
560881|NCT01174849|pneumococcal vaccines|pneumococcal vaccines
560882|NCT01174849|randomised controlled trial|randomised controlled trial
560883|NCT01174849|high-risk children|high-risk children
560884|NCT01174849|indigenous|indigenous
560885|NCT01174849|Australia|australia
560886|NCT01174836|CT utilization|ct utilization
560887|NCT01174836|physician attitudes|physician attitudes
560888|NCT01174810|Parkinson's Disease|parkinson's disease
560889|NCT01174810|PD|pd
560890|NCT01174810|Moderate Parkinson's Disease|moderate parkinson's disease
560891|NCT01174784|Chronic Total Occlusions|chronic total occlusions
560892|NCT01174784|Superficial Femoral Artery|superficial femoral artery
560893|NCT01174784|Popliteal Artery|popliteal artery
560894|NCT01174771|Transcranial magnetic stimulation|transcranial magnetic stimulation
560895|NCT01174771|Cortical excitability|cortical excitability
560896|NCT01174771|parkinsonism|parkinsonism
561000|NCT01174316|Hypoventilation|hypoventilation
560897|NCT01174771|Progressive Supranuclear Palsy|progressive supranuclear palsy
560898|NCT01174771|Corticobasal Degeneration|corticobasal degeneration
560899|NCT01174771|PSP|psp
560900|NCT01174771|CBD|cbd
560901|NCT01174771|CBGD|cbgd
560902|NCT01174758|balance|balance
560903|NCT01174758|mobility|mobility
560904|NCT01174758|ON/OFF Levodopa|on/off levodopa
560905|NCT01174732|asthma|asthma
560906|NCT01174732|bronchospasm|bronchospasm
560907|NCT01174732|COPD|copd
560908|NCT01174732|chronic respiratory disease|chronic respiratory disease
560909|NCT01174719|Hydroxyethylstarch|hydroxyethylstarch
560910|NCT01174719|Humanalbumin|humanalbumin
560911|NCT01174719|Ringer Lactate|ringer lactate
560912|NCT01174719|patients undergoing cardiac surgery|patients undergoing cardiac surgery
560913|NCT01174706|infections|infections
560914|NCT01174706|flu|flu
560915|NCT01174706|abdominal pain|abdominal pain
712375|NCT00580359|S-1|s-1
560916|NCT01174706|chest pain|chest pain
560917|NCT01174706|cold|cold
560918|NCT01174706|fever|fever
560919|NCT01174706|different acute care conditions|different acute care conditions
560920|NCT01174693|prospective|prospective
560921|NCT01174693|randomized|randomized
560922|NCT01174693|open label|open label
560923|NCT01174693|multi-center|multi-center
560924|NCT01174693|double-blind for CYP2C19 genotypes|double-blind for cyp2c19 genotypes
560925|NCT01174680|cardiogoniometry|cardiogoniometry
560926|NCT01174680|stable angina pectoris patients|stable angina pectoris patients
560927|NCT01174667|Myofascial pain|myofascial pain
560928|NCT01174667|Trigger points|trigger points
560929|NCT01174641|unilateral neglect|unilateral neglect
560930|NCT01174641|TMS intervention|tms intervention
560931|NCT01174628|Exercise Tolerance|exercise tolerance
560932|NCT01174628|Venous Thrombosis|venous thrombosis
560933|NCT01174628|Pulmonary Embolism|pulmonary embolism
560934|NCT01174628|Quality of Life (QOL)|quality of life (qol)
560935|NCT01174615|Blood/bone marrow collection, hematologic diseases, leukemia|blood/bone marrow collection, hematologic diseases, leukemia
560936|NCT01174589|Lower limb strength training|lower limb strength training
560937|NCT01174589|Randomized clinical trial|randomized clinical trial
560938|NCT01174589|Patients with Hip fracture|patients with hip fracture
560939|NCT01174589|6 vs. 12 weeks physical strength training|6 vs. 12 weeks physical strength training
560940|NCT01174576|coffee|coffee
560941|NCT01174576|appetite|appetite
560942|NCT01174576|energy intake|energy intake
560943|NCT01174576|inflammation|inflammation
560944|NCT01174576|cortisol|cortisol
560945|NCT01174576|glucose|glucose
560946|NCT01174576|randomized controlled trial|randomized controlled trial
560947|NCT01174550|chest pain|chest pain
560948|NCT01174550|coronary artery disease|coronary artery disease
560949|NCT01174550|CAD|cad
560950|NCT01174537|NDV|ndv
560951|NCT01174537|Metastatic|metastatic
560952|NCT01174537|Refractory|refractory
560953|NCT01174537|Cancer|cancer
560954|NCT01174537|Progression-free|progression-free
560955|NCT01174537|survival|survival
560956|NCT01174537|recurrent|recurrent
560957|NCT01174524|Quality of life|quality of life
560958|NCT01174524|Menopause|menopause
560959|NCT01174524|Contraception|contraception
560960|NCT01174511|ATOPIC DERMATITIS|atopic dermatitis
560961|NCT01174511|A-1 COOL CREAM|a-1 cool cream
560962|NCT01174498|discomfort|discomfort
560963|NCT01174498|distress|distress
560964|NCT01174498|hurt|hurt
560965|NCT01174498|sting|sting
560966|NCT01174485|Liposuction|liposuction
560967|NCT01174485|exercise|exercise
560968|NCT01174485|metabolism|metabolism
560969|NCT01174485|adiposity|adiposity
560970|NCT01174472|Dialysis access|dialysis access
560971|NCT01174472|angioplasty|angioplasty
560972|NCT01174472|drug eluting balloon|drug eluting balloon
560973|NCT01174433|Bifurcation coronary artery disease|bifurcation coronary artery disease
560974|NCT01174433|Percutaneous coronary intervention|percutaneous coronary intervention
560975|NCT01174433|Tryton Stent|tryton stent
560976|NCT01174420|ologen|ologen
560977|NCT01174420|Mitomycin-C|mitomycin-c
560978|NCT01174420|Collagen Matrix|collagen matrix
560979|NCT01174420|trabeculectomy|trabeculectomy
560980|NCT01174420|glaucoma|glaucoma
560981|NCT01174420|filtering surgery|filtering surgery
560982|NCT01174394|Acupuncture|acupuncture
560983|NCT01174394|Post Stroke Depression|post stroke depression
560984|NCT01174394|Depressive Disorder|depressive disorder
560985|NCT01174394|Cardiovascular Accident|cardiovascular accident
560986|NCT01174394|Stroke|stroke
560987|NCT01174394|Apoplexy|apoplexy
560988|NCT01174394|CVA|cva
560989|NCT01174381|Non communicable disease|non communicable disease
560990|NCT01174381|Lifestyle Modification|lifestyle modification
560991|NCT01174381|Community Based organization|community based organization
560992|NCT01174381|community based study|community based study
560993|NCT01174342|Intraocular pressure|intraocular pressure
560994|NCT01174342|Ocular tonometry|ocular tonometry
560995|NCT01174342|Obstetric delivery|obstetric delivery
560996|NCT01174316|Acute exacerbation|acute exacerbation
560997|NCT01174316|Respiratory insufficiency|respiratory insufficiency
560998|NCT01174316|Respiratory failure|respiratory failure
560999|NCT01174316|Hypercapnia|hypercapnia
561001|NCT01174316|Sleep|sleep
561002|NCT01174316|Hypoxia|hypoxia
561003|NCT01174316|Titration|titration
561004|NCT01174316|Non Invasive Ventilation|non invasive ventilation
561005|NCT01174290|subsyndromal delirium|subsyndromal delirium
561006|NCT01174290|delirium|delirium
561007|NCT01174290|haloperidol|haloperidol
561008|NCT01174290|antipsychotic|antipsychotic
561009|NCT01174290|randomized controlled trial|randomized controlled trial
561010|NCT01174290|placebo-controlled|placebo-controlled
561011|NCT01174290|intensive care unit|intensive care unit
561012|NCT01174290|critical care|critical care
561013|NCT01174290|subsyndromal delirium in the intensive care unit|subsyndromal delirium in the intensive care unit
711350|NCT00585169|Gambling Addiction|gambling addiction
561014|NCT01174277|chronic graft versus host disease|chronic graft versus host disease
561015|NCT01174277|transplant|transplant
561016|NCT01174277|stem cell|stem cell
561017|NCT01174251|general anesthesia|general anesthesia
561018|NCT01174251|electrocardiography|electrocardiography
561019|NCT01174251|long QT syndrome, acquired|long qt syndrome, acquired
561020|NCT01174238|Melanoma|melanoma
561021|NCT01174238|Axitinib|axitinib
561022|NCT01174238|Carboplatin|carboplatin
561023|NCT01174238|Paclitaxel|paclitaxel
561024|NCT01174225|Copper IUD|copper iud
561025|NCT01174225|Nova T 200|nova t 200
561026|NCT01174225|Flexi T 380|flexi t 380
561027|NCT01174225|expulsion|expulsion
561028|NCT01174225|contraception satisfaction|contraception satisfaction
561029|NCT01174225|post-abortion contraception|post-abortion contraception
561030|NCT01174212|revision|revision
561031|NCT01174212|infection|infection
561032|NCT01174212|knee|knee
561034|NCT01174212|replacement|replacement
561035|NCT01174212|antibiotics|antibiotics
561036|NCT01174173|Angina|angina
561037|NCT01174173|Right Ventricular Ischemia|right ventricular ischemia
561038|NCT01174173|Pulmonary Arterial Hypertension|pulmonary arterial hypertension
561039|NCT01174173|Pulmonary Hypertension|pulmonary hypertension
561040|NCT01174160|Atrial Fibrillation|atrial fibrillation
561041|NCT01174121|Digestive Tract Cancers|digestive tract cancers
561042|NCT01174121|Breast Cancer|breast cancer
561043|NCT01174121|Glioblastoma|glioblastoma
561044|NCT01174121|Ovarian/Endometrial Cancer|ovarian/endometrial cancer
561045|NCT01174121|Genitourinary Cancer|genitourinary cancer
561046|NCT01174108|National Marrow Donor Program (NMDP)|national marrow donor program (nmdp)
561047|NCT01174108|Myelodysplastic Syndrome (MDS)|myelodysplastic syndrome (mds)
561048|NCT01174108|Severe Aplastic Anemia|severe aplastic anemia
561049|NCT01174108|Pure Red Cell Aplasia|pure red cell aplasia
561050|NCT01174108|Paroxysmal Nocturnal Hemoglobinuria (PNH)|paroxysmal nocturnal hemoglobinuria (pnh)
561051|NCT01174108|Miltenyi CD34 Reagent System|miltenyi cd34 reagent system
561052|NCT01174095|Diffuse Coronary Artery Disease|diffuse coronary artery disease
561053|NCT01174095|Ischemic Myocardium|ischemic myocardium
561054|NCT01174095|Ischemia|ischemia
561055|NCT01174082|Multiple Myeloma|multiple myeloma
561056|NCT01174082|Vaccine|vaccine
561057|NCT01174082|Lymphocyte Infusion|lymphocyte infusion
561058|NCT01174069|NOTES|notes
561059|NCT01174069|cholecystectomy|cholecystectomy
561060|NCT01174069|endoscopic|endoscopic
561061|NCT01174056|Lung inflammation|lung inflammation
561062|NCT01174056|positron emission tomography|positron emission tomography
561063|NCT01174056|fluorodeoxyglucose|fluorodeoxyglucose
561064|NCT01174056|rosiglitazone|rosiglitazone
561065|NCT01174056|zileuton|zileuton
561066|NCT01174056|lung anti-inflammatory therapy|lung anti-inflammatory therapy
561067|NCT01174043|Leukemia, Myelomonocytic, Acute|leukemia, myelomonocytic, acute
561068|NCT01174043|Erlotinib|erlotinib
561069|NCT01174017|prostate cancer|prostate cancer
561070|NCT01174017|Iodine 125 brachytherapy|iodine 125 brachytherapy
561071|NCT01174017|seed migration|seed migration
561072|NCT01174017|seed migration in the first month after brachytherapy|seed migration in the first month after brachytherapy
561073|NCT01173991|carbohydrate counting|carbohydrate counting
561074|NCT01173991|continuous subcutaneous insulin infusion|continuous subcutaneous insulin infusion
561075|NCT01173991|type 1 diabetes mellitus|type 1 diabetes mellitus
561076|NCT01173978|Incretin hormones|incretin hormones
561077|NCT01173978|Glucagon|glucagon
561078|NCT01173978|Insulin/c-peptide|insulin/c-peptide
561079|NCT01173978|Plasma glucose|plasma glucose
561080|NCT01173978|Insulin resistance|insulin resistance
561081|NCT01173978|Deteriorated glucose homeostasis|deteriorated glucose homeostasis
561082|NCT01173978|Inactivity|inactivity
561083|NCT01173939|Hypercholesterolemia with concomitant type 2 diabetes and hypertension|hypercholesterolemia with concomitant type 2 diabetes and hypertension
561084|NCT01173913|oral docetaxel|oral docetaxel
561085|NCT01173913|ModraDoc|modradoc
561086|NCT01173913|pharmacokinetics|pharmacokinetics
561087|NCT01173913|safety|safety
561088|NCT01173913|MTD|mtd
561089|NCT01173913|DLT|dlt
561090|NCT01173900|human papillomavirus|human papillomavirus
561091|NCT01173900|vaccine|vaccine
561092|NCT01173900|school girls|school girls
561093|NCT01173900|Tanzania|tanzania
561094|NCT01173900|acceptability|acceptability
561095|NCT01173900|vaccine coverage|vaccine coverage
561096|NCT01173900|Cervical cancer prevention|cervical cancer prevention
561097|NCT01173874|Cognition|cognition
561098|NCT01173874|Function|function
561099|NCT01173874|Attention|attention
561100|NCT01173874|Vigilance|vigilance
561101|NCT01173874|Verbal Memory|verbal memory
561102|NCT01173874|Visual Memory|visual memory
561103|NCT01173874|Processing Speed|processing speed
561104|NCT01173874|Problem Solving|problem solving
561105|NCT01173874|Social Cognition|social cognition
561106|NCT01173848|CKD|ckd
561107|NCT01173848|Vitamin D|vitamin d
561108|NCT01173835|Adolescent tobacco use|adolescent tobacco use
561109|NCT01173835|Tobacco Free and Win|tobacco free and win
711351|NCT00585169|Gambling|gambling
561110|NCT01173835|Incentive-based intervention|incentive-based intervention
561111|NCT01173835|Contingency Management|contingency management
561112|NCT01173835|Smoking Prevention|smoking prevention
561113|NCT01173835|Smoking cessation|smoking cessation
561114|NCT01173822|cardiopulmonary bypass|cardiopulmonary bypass
561115|NCT01173822|hemorrhage|hemorrhage
561116|NCT01173822|trials|trials
561117|NCT01173822|surgery|surgery
561118|NCT01173809|AF|af
561119|NCT01173809|Catheter Ablation|catheter ablation
561120|NCT01173809|Recurrence of AF|recurrence of af
561121|NCT01173809|Amiodarone|amiodarone
561122|NCT01173783|Heart failure|heart failure
561123|NCT01173783|Cardiac insufficiency|cardiac insufficiency
561124|NCT01173783|Implantable Cardioverter/Defibrillator|implantable cardioverter/defibrillator
561125|NCT01173783|Cardiac Resynchronization therapy|cardiac resynchronization therapy
561126|NCT01173783|ICD|icd
561127|NCT01173783|CRT|crt
561128|NCT01173783|Register|register
561129|NCT01173757|Healthy Volunteers|healthy volunteers
561130|NCT01173744|Intertrochanteric femoral fractures - unstable|intertrochanteric femoral fractures - unstable
561131|NCT01173731|Parkinson Disease|parkinson disease
561132|NCT01173731|L-dopa|l-dopa
561133|NCT01173731|Levodopa|levodopa
561134|NCT01173731|Dyskinesia|dyskinesia
561135|NCT01173731|involuntary movement|involuntary movement
561136|NCT01173731|motor complication|motor complication
561137|NCT01173718|Hemodialysis|hemodialysis
561138|NCT01173718|Vascular Graft|vascular graft
561139|NCT01173705|Obesity|obesity
561140|NCT01173705|Insulin Resistance|insulin resistance
561141|NCT01173705|Inflammation|inflammation
561142|NCT01173692|Oropharynx Cancer|oropharynx cancer
561143|NCT01173692|Radiation Therapy|radiation therapy
561144|NCT01173692|XRT|xrt
561145|NCT01173692|Radiotherapy|radiotherapy
561146|NCT01173692|Minocycline|minocycline
561147|NCT01173692|Symptoms|symptoms
561148|NCT01173692|Head and Neck|head and neck
561149|NCT01173679|CLL|cll
561150|NCT01173679|fludarabine|fludarabine
561151|NCT01173679|rituximab|rituximab
561152|NCT01173679|dasatinib|dasatinib
561153|NCT01173679|refractory|refractory
561154|NCT01173679|relapsed|relapsed
561155|NCT01173666|RAS|ras
561156|NCT01173666|LVMI|lvmi
561157|NCT01173666|Renal revascularization|renal revascularization
561158|NCT01173653|smoking|smoking
561159|NCT01173653|smoking cessation|smoking cessation
561160|NCT01173653|health behavior|health behavior
561161|NCT01173640|drug interactions|drug interactions
561162|NCT01173640|midazolam|midazolam
561163|NCT01173640|cytochrome P450|cytochrome p450
561164|NCT01173640|resveratrol|resveratrol
561165|NCT01173640|pharmacokinetics|pharmacokinetics
561166|NCT01173627|Bioequivalence|bioequivalence
561167|NCT01173627|Fentanyl|fentanyl
561168|NCT01173588|bowel function|bowel function
561169|NCT01173588|functional foods|functional foods
561170|NCT01173562|Healthy volunteers|healthy volunteers
561171|NCT01173562|Parasitic Diseases|parasitic diseases
561172|NCT01173562|Mebendazole (VERMOX)|mebendazole (vermox)
561173|NCT01173562|Anthelmintics|anthelmintics
561174|NCT01173562|Antiparasitic Agents|antiparasitic agents
561175|NCT01173562|Soil-transmitted helminth (STH) infections|soil-transmitted helminth (sth) infections
561176|NCT01173562|Pediatric|pediatric
561177|NCT01173549|Canagliflozin|canagliflozin
561178|NCT01173549|Pharmacodynamic|pharmacodynamic
561179|NCT01173549|Glucose absorption|glucose absorption
561180|NCT01173549|Glucose metabolism|glucose metabolism
561181|NCT01173523|Hsp90 Inhibitor|hsp90 inhibitor
561182|NCT01173523|relapsed|relapsed
561183|NCT01173523|refractory|refractory
561184|NCT01173510|HIV|hiv
561185|NCT01173510|AIDS|aids
561186|NCT01173510|Atripla|atripla
561187|NCT01173510|Truvada|truvada
561188|NCT01173510|Raltegravir|raltegravir
561189|NCT01173510|Human Immunodeficiency Virus|human immunodeficiency virus
561190|NCT01173510|Acquired Immune Deficiency Syndrome Virus|acquired immune deficiency syndrome virus
561191|NCT01173497|Triple negative breast cancer|triple negative breast cancer
561192|NCT01173497|Brain metastasis|brain metastasis
561193|NCT01173497|BSI-201|bsi-201
561194|NCT01173497|iniparib|iniparib
561195|NCT01173484|Idiopathic gastroparesis|idiopathic gastroparesis
561196|NCT01173484|Vomiting|vomiting
561197|NCT01173484|Dyspepsia|dyspepsia
561198|NCT01173484|GERD|gerd
561199|NCT01173471|Raised intraocular pressure|raised intraocular pressure
561200|NCT01173458|cancer|cancer
561201|NCT01173458|lung|lung
561202|NCT01173458|small cell|small cell
561203|NCT01173445|cancer|cancer
561204|NCT01173445|kidney|kidney
561205|NCT01173445|renal cell|renal cell
561206|NCT01173445|tumor cells|tumor cells
561207|NCT01173445|circulating tumor cells|circulating tumor cells
561208|NCT01173445|circulating endothelial cells|circulating endothelial cells
561209|NCT01173432|obstructive sleep apnea|obstructive sleep apnea
561210|NCT01173432|metabolic dysfunction|metabolic dysfunction
561211|NCT01173432|metabolic syndrome|metabolic syndrome
561212|NCT01173432|adipocyte fatty acid binding protein|adipocyte fatty acid binding protein
561213|NCT01173419|Great Saphenous Vein|great saphenous vein
561214|NCT01173406|Continuous Positive Airway Pressure treatment|continuous positive airway pressure treatment
561215|NCT01173406|Adherence|adherence
561216|NCT01173406|Education|education
561217|NCT01173393|out of hospital cardiac arrest|out of hospital cardiac arrest
561218|NCT01173393|OHCA|ohca
561219|NCT01173393|EMS|ems
561220|NCT01173393|Emergency medical System|emergency medical system
561221|NCT01173393|non-VF|non-vf
561222|NCT01173393|non-ventricular fibrillation|non-ventricular fibrillation
561223|NCT01173380|Soy|soy
561224|NCT01173380|Equol|equol
561225|NCT01173380|Metabolic syndrome|metabolic syndrome
561226|NCT01173380|Endothelial function|endothelial function
561227|NCT01173367|Fever|fever
561228|NCT01173367|ICU|icu
561229|NCT01173367|Acetaminophen|acetaminophen
561230|NCT01173367|Inflammatory mediators|inflammatory mediators
561231|NCT01173367|Safety|safety
561232|NCT01173354|COPD|copd
561233|NCT01173354|Protein metabolism|protein metabolism
561234|NCT01173354|Essential amino acid intake|essential amino acid intake
561235|NCT01173341|Chemotherapy-induced cardiotoxicity|chemotherapy-induced cardiotoxicity
561236|NCT01173341|Anthracycline|anthracycline
561237|NCT01173341|Trastuzumab|trastuzumab
561238|NCT01173328|exercise tolerance|exercise tolerance
561239|NCT01173328|dynamic hyperinflation|dynamic hyperinflation
561240|NCT01173328|respiratory mechanics|respiratory mechanics
561241|NCT01173315|Type 2 diabetes|type 2 diabetes
561242|NCT01173315|micronutrients|micronutrients
561243|NCT01173315|nephropathy|nephropathy
561244|NCT01173315|neuropathy|neuropathy
561245|NCT01173302|Rabies|rabies
561246|NCT01173302|Anti-rabies antibody|anti-rabies antibody
561247|NCT01173302|Persistence|persistence
561248|NCT01173289|Thyroid Carcinoma|thyroid carcinoma
561249|NCT01173289|External Beam Radiotherapy|external beam radiotherapy
561250|NCT01173276|Acquired Immune Deficiency Syndrome|acquired immune deficiency syndrome
561251|NCT01173276|Assisted Reproductive Technology|assisted reproductive technology
561252|NCT01173276|Fertility|fertility
561253|NCT01173276|HIV|hiv
561254|NCT01173276|HIV Discordant|hiv discordant
561255|NCT01173276|Infertility|infertility
561256|NCT01173276|Intrauterine Insemination|intrauterine insemination
561257|NCT01173276|Sexually Transmitted Diseases|sexually transmitted diseases
561258|NCT01173276|Sperm Washing|sperm washing
561259|NCT01173263|breathing machine|breathing machine
561260|NCT01173263|mechanical ventilator|mechanical ventilator
561261|NCT01173250|total proctocolectomy with ileal pouch anal anastomosis with and without ileostomy|total proctocolectomy with ileal pouch anal anastomosis with and without ileostomy
561262|NCT01173237|tracheal intubation|tracheal intubation
561263|NCT01173237|proseal laryngeal mask airway|proseal laryngeal mask airway
561264|NCT01173237|neonate|neonate
561265|NCT01173237|surfactant|surfactant
561266|NCT01173237|respiratory distress syndrome|respiratory distress syndrome
561267|NCT01173224|influenza, DAS181, antiviral|influenza, das181, antiviral
561268|NCT01173211|pregnant, women, influenza, vaccine|pregnant, women, influenza, vaccine
561269|NCT01173198|LOW TO MODERATE MYOPIC PATIENTS|low to moderate myopic patients
561270|NCT01173172|Boron neutron capture therapy (BNCT)|boron neutron capture therapy (bnct)
561271|NCT01173172|Head and neck cancer|head and neck cancer
561272|NCT01173172|toxicities|toxicities
561273|NCT01173172|response rate|response rate
561274|NCT01173159|Parenteral Nutrition|parenteral nutrition
561275|NCT01173159|Cholestasis|cholestasis
561276|NCT01173146|Primary prostate cancer undergoing prostatectomy|primary prostate cancer undergoing prostatectomy
561277|NCT01173133|Free Flap|free flap
561278|NCT01173133|Surgery|surgery
561279|NCT01173133|Ischemia|ischemia
561280|NCT01173133|Outcome|outcome
561281|NCT01173133|Reconstructive Plastic Surgery|reconstructive plastic surgery
561282|NCT01173133|Monitoring|monitoring
561283|NCT01173094|Critical limb ischemia|critical limb ischemia
561284|NCT01173094|Diabetes Mellitus|diabetes mellitus
561285|NCT01173094|Diabetes foot|diabetes foot
561286|NCT01173081|Jones fracture|jones fracture
561287|NCT01173081|fifth metatarsal fracture|fifth metatarsal fracture
561288|NCT01173081|teriparatide|teriparatide
561289|NCT01173081|fracture healing|fracture healing
561290|NCT01173068|Ertapenem|ertapenem
561291|NCT01173068|Clinical outcome|clinical outcome
561292|NCT01173068|Complicated Urinary Tract Infections|complicated urinary tract infections
561293|NCT01173042|Overweight|overweight
561294|NCT01173042|Obese|obese
561295|NCT01173029|Systemic arterial hypertension|systemic arterial hypertension
561296|NCT01173029|Hypertension Resistant to Conventional Therapy|hypertension resistant to conventional therapy
561297|NCT01173029|Genetic polymorphisms|genetic polymorphisms
561298|NCT01173029|Renin-angiotensin-aldosterone system genetic polymorphism|renin-angiotensin-aldosterone system genetic polymorphism
561299|NCT01173029|Risk markers|risk markers
561300|NCT01173029|Adverse events|adverse events
561301|NCT01173029|Acute myocardial infarction|acute myocardial infarction
561302|NCT01173029|Stroke|stroke
561303|NCT01173016|mucopolysaccharide IH (MPS IH)|mucopolysaccharide ih (mps ih)
561304|NCT01173003|Medical abortion|medical abortion
561305|NCT01173003|mifepristone|mifepristone
561306|NCT01173003|misoprostol|misoprostol
561307|NCT01173003|Tunisia|tunisia
561308|NCT01172990|ST Depression|st depression
561309|NCT01172977|Diabetes mellitus|diabetes mellitus
561310|NCT01172977|Stroke|stroke
561311|NCT01172964|Los Angeles|los angeles
561312|NCT01172951|Post-prandial|post-prandial
561313|NCT01172951|Nutrigenomic|nutrigenomic
561314|NCT01172951|Test meal|test meal
561315|NCT01172951|Oral glucose tolerance test|oral glucose tolerance test
561316|NCT01172951|Oral lipid tolerance test|oral lipid tolerance test
561317|NCT01172938|Psoriatic Arthritis|psoriatic arthritis
561318|NCT01172938|Psoriasis|psoriasis
561319|NCT01172938|Arthritis|arthritis
561320|NCT01172938|inflammation|inflammation
561321|NCT01172938|skin condition|skin condition
561322|NCT01172938|inflammatory cells|inflammatory cells
561323|NCT01172938|apremilast|apremilast
561324|NCT01172938|CC-10004|cc-10004
561325|NCT01172938|phosphodiesterase type 4|phosphodiesterase type 4
561326|NCT01172925|NSCLC|nsclc
561327|NCT01172925|dyspnea|dyspnea
561328|NCT01172925|phase II|phase ii
561329|NCT01172925|crossover|crossover
561330|NCT01172925|tiotropium|tiotropium
561331|NCT01172912|recurrent extragonadal germ cell tumor|recurrent extragonadal germ cell tumor
561332|NCT01172912|recurrent extragonadal non-seminomatous germ cell tumor|recurrent extragonadal non-seminomatous germ cell tumor
561333|NCT01172912|recurrent malignant testicular germ cell tumor|recurrent malignant testicular germ cell tumor
561334|NCT01172912|stage IV extragonadal non-seminomatous germ cell tumor|stage iv extragonadal non-seminomatous germ cell tumor
561335|NCT01172912|stage III malignant testicular germ cell tumor|stage iii malignant testicular germ cell tumor
561336|NCT01172912|recurrent extragonadal seminoma|recurrent extragonadal seminoma
561337|NCT01172912|stage IV extragonadal seminoma|stage iv extragonadal seminoma
561338|NCT01172912|testicular mature teratoma|testicular mature teratoma
561339|NCT01172912|adult central nervous system germ cell tumor|adult central nervous system germ cell tumor
561340|NCT01172912|testicular immature teratoma|testicular immature teratoma
561341|NCT01172899|Bariatric Surgery|bariatric surgery
561342|NCT01172899|Adolescent|adolescent
561343|NCT01172886|Metabolic Syndrome obesity visceral adiposity breast cancer|metabolic syndrome obesity visceral adiposity breast cancer
561344|NCT01172873|OCD|ocd
561345|NCT01172873|DCS|dcs
561346|NCT01172873|D-cycloserine|d-cycloserine
561347|NCT01172873|CBT|cbt
561348|NCT01172873|E/RP|e/rp
561349|NCT01172873|exposure response prevention|exposure response prevention
561350|NCT01172860|Inoperable|inoperable
561351|NCT01172860|Colorectal|colorectal
561352|NCT01172860|Endoscopic|endoscopic
561353|NCT01172860|Electroporation|electroporation
561354|NCT01172860|Outpatient|outpatient
561355|NCT01172834|Nurses|nurses
561356|NCT01172795|Whiplash associated disorder|whiplash associated disorder
561357|NCT01172795|chronic pain|chronic pain
561358|NCT01172795|neural inhibition|neural inhibition
561359|NCT01172795|neuropsychological tests|neuropsychological tests
561360|NCT01172769|HNSCC|hnscc
561361|NCT01172756|Pulmonary Hypertension|pulmonary hypertension
561362|NCT01172756|Left ventricular dysfunction|left ventricular dysfunction
561363|NCT01172743|Diabetes Mellitus|diabetes mellitus
561364|NCT01172743|Diabetes|diabetes
561365|NCT01172743|Type-2|type-2
561366|NCT01172743|Adult Onset|adult onset
561367|NCT01172730|Post operative pain|post operative pain
561368|NCT01172730|thoracic epidural|thoracic epidural
561369|NCT01172730|acute pain|acute pain
561370|NCT01172730|Ultrasound scanning of the thoracic spine|ultrasound scanning of the thoracic spine
561371|NCT01172717|Carcinoid|carcinoid
561372|NCT01172717|Carcinoid syndrome|carcinoid syndrome
561373|NCT01172704|Motivational Interviewing|motivational interviewing
561374|NCT01172704|Serious Mental Illness|serious mental illness
561375|NCT01172704|HIV/AIDS|hiv/aids
561376|NCT01172704|HIV Testing|hiv testing
561377|NCT01172691|Liver transplant|liver transplant
561378|NCT01172665|Celiac Disease|celiac disease
561379|NCT01172652|Bipolar disorder|bipolar disorder
561380|NCT01172652|Anxiety|anxiety
561381|NCT01172652|Panic|panic
561382|NCT01172652|GAD|gad
561383|NCT01172652|Generalized Anxiety Disorder|generalized anxiety disorder
561384|NCT01172639|CoBRA|cobra
561385|NCT01172626|epilepsy|epilepsy
561386|NCT01172626|valproate sodium|valproate sodium
561387|NCT01172626|metabolic enzymes|metabolic enzymes
561388|NCT01172626|adverse effects|adverse effects
561389|NCT01172626|systemic adverse effects|systemic adverse effects
561390|NCT01172613|allergic rhinitis|allergic rhinitis
561391|NCT01172613|concentration of diagnostic reagent|concentration of diagnostic reagent
561392|NCT01172613|allergen extract, house dust mites (Dp)|allergen extract, house dust mites (dp)
561393|NCT01172613|skin prick test|skin prick test
561394|NCT01172613|nasal allergen provocation test|nasal allergen provocation test
561395|NCT01172600|radiating back pain|radiating back pain
561396|NCT01172600|epidural block|epidural block
561397|NCT01172600|steroid|steroid
561398|NCT01172600|recurrent low back pain|recurrent low back pain
710265|NCT00589563|stage III adult Hodgkin lymphoma|stage iii adult hodgkin lymphoma
561399|NCT01172600|Lumbar Epidural Steroid Block with 3 injections|lumbar epidural steroid block with 3 injections
561400|NCT01172587|Cognitive Behavioral Therapy|cognitive behavioral therapy
561401|NCT01172587|Couples Treatment|couples treatment
561402|NCT01172587|Alcohol Use|alcohol use
561403|NCT01172587|Effects on Youth|effects on youth
561404|NCT01172574|Osteoporosis|osteoporosis
561405|NCT01172574|Pain|pain
561406|NCT01172574|Kyphosis|kyphosis
561407|NCT01172574|Posture|posture
561408|NCT01172574|Exercise therapy|exercise therapy
561409|NCT01172548|Resected GIST|resected gist
561410|NCT01172548|primary GIST|primary gist
561411|NCT01172548|tumor recurrence|tumor recurrence
561412|NCT01172548|KIT receptor|kit receptor
561413|NCT01172548|KIT positive|kit positive
561414|NCT01172548|advanced GIST|advanced gist
561415|NCT01172548|minimal toxicity|minimal toxicity
561416|NCT01172548|GIST|gist
561417|NCT01172535|Lopinavir/ritonavir|lopinavir/ritonavir
561418|NCT01172535|Pediatric dosing|pediatric dosing
561419|NCT01172535|World Health Organization|world health organization
561420|NCT01172522|Under eye dark circles|under eye dark circles
561421|NCT01172522|Under eye puffiness|under eye puffiness
561422|NCT01172509|plasticity|plasticity
561423|NCT01172509|excitatory|excitatory
561424|NCT01172509|inhibitory|inhibitory
561425|NCT01172509|synaptic plasticity|synaptic plasticity
561426|NCT01172509|R-Baclofen|r-baclofen
561427|NCT01172509|TMS|tms
561428|NCT01172509|transcranial magnetic stimulation|transcranial magnetic stimulation
561429|NCT01172509|biomarker|biomarker
561430|NCT01172509|autism|autism
561431|NCT01172483|primary care|primary care
561432|NCT01172483|physical and aquatic exercises|physical and aquatic exercises
561433|NCT01172483|promotion physical activity|promotion physical activity
561434|NCT01172483|chronic disorders|chronic disorders
561435|NCT01172470|Recurrent head and neck cancer|recurrent head and neck cancer
561436|NCT01172470|larynx, lip, oral cavity and pharynx|larynx, lip, oral cavity and pharynx
561437|NCT01172457|low back pain|low back pain
561438|NCT01172457|failed back surgery syndrome (FBSS)|failed back surgery syndrome (fbss)
561439|NCT01172457|epidural fibrosis|epidural fibrosis
561440|NCT01172457|ozone therapy|ozone therapy
561441|NCT01172457|oxygen therapy|oxygen therapy
561442|NCT01172457|epiduroscopy|epiduroscopy
561443|NCT01172457|spinal endoscopy|spinal endoscopy
561444|NCT01172444|Mild to Moderate Ulcerative Proctitis|mild to moderate ulcerative proctitis
561445|NCT01172431|hypertension|hypertension
561446|NCT01172431|renal insufficiency|renal insufficiency
561447|NCT01172431|indapamide|indapamide
561448|NCT01172431|hydrochlorothiazide|hydrochlorothiazide
561449|NCT01172418|adult|adult
561450|NCT01172418|primary kidney transplant recipient|primary kidney transplant recipient
561451|NCT01172405|Headache|headache
561452|NCT01172405|Migraine|migraine
561453|NCT01172405|Ibuprofen|ibuprofen
561454|NCT01172405|Caffeine|caffeine
561455|NCT01172366|Open label, single dose, pharmacokinetic study|open label, single dose, pharmacokinetic study
561456|NCT01172353|contras-induced nephropathy|contras-induced nephropathy
561457|NCT01172340|behavioral|behavioral
561458|NCT01172340|diet|diet
561459|NCT01172340|exercise|exercise
561460|NCT01172314|NSCLC|nsclc
561461|NCT01172314|Weight loss|weight loss
561462|NCT01172314|protein metabolism|protein metabolism
561463|NCT01172314|essential amino acid intake|essential amino acid intake
561464|NCT01172301|CF|cf
561465|NCT01172301|protein metabolism|protein metabolism
561466|NCT01172301|essential amino acid intake|essential amino acid intake
561467|NCT01172288|Tic disorders,|tic disorders,
561468|NCT01172288|Tourette syndrome|tourette syndrome
561469|NCT01172288|Chronic Tic Disorders|chronic tic disorders
561470|NCT01172275|Obsessive-Compulsive Disorder|obsessive-compulsive disorder
561472|NCT01172262|Tinnitus|tinnitus
561473|NCT01172262|MRI|mri
561474|NCT01172262|fMRI|fmri
561475|NCT01172262|task based MRI|task based mri
561476|NCT01172262|Otolaryngology|otolaryngology
561477|NCT01172249|Osteoarthritis|osteoarthritis
561478|NCT01172249|Knee|knee
561479|NCT01172249|Glucosamine|glucosamine
561480|NCT01172249|Chondroitin|chondroitin
561481|NCT01172223|HER2-positive|her2-positive
561482|NCT01172223|early breast cancer|early breast cancer
561483|NCT01172197|local anesthetic|local anesthetic
561484|NCT01172197|levobupivacaine|levobupivacaine
561485|NCT01172197|ropivacaine|ropivacaine
561486|NCT01172197|femoral perineural block|femoral perineural block
561487|NCT01172184|Left atrial distensibility|left atrial distensibility
561488|NCT01172184|Left ventricular filling pressure|left ventricular filling pressure
561489|NCT01172184|Severe mitral regurgitation|severe mitral regurgitation
561490|NCT01172184|Prognosis|prognosis
561491|NCT01172184|Post-operation (mitral valve replacement or valvuloplasty) atrial fibrillation|post-operation (mitral valve replacement or valvuloplasty) atrial fibrillation
561492|NCT01172171|Ischemia-reperfusion injury|ischemia-reperfusion injury
561493|NCT01172171|Acute Myocardial Infarction|acute myocardial infarction
561494|NCT01172171|Intracoronary melatonin|intracoronary melatonin
561495|NCT01172158|forgotten ureteral stents, SMS Reminder|forgotten ureteral stents, sms reminder
561496|NCT01172145|apathy|apathy
561497|NCT01172145|Alzheimer's disease|alzheimer's disease
561498|NCT01172145|activities of daily living performance|activities of daily living performance
561499|NCT01172145|caregiver burden|caregiver burden
561500|NCT01172132|Leukemia|leukemia
561501|NCT01172132|Lymphoma|lymphoma
561502|NCT01172132|Bone-Marrow Transplant|bone-marrow transplant
561503|NCT01172132|Neutropenia|neutropenia
561504|NCT01172132|Acute respiratory failure|acute respiratory failure
561505|NCT01172132|Mechanical ventilation|mechanical ventilation
561506|NCT01172132|Post ICU burden|post icu burden
561507|NCT01172132|ICU triage|icu triage
561508|NCT01172132|Dialysis|dialysis
561509|NCT01172132|Septic shock|septic shock
561510|NCT01172119|Coronary Disease, Coronary Stenosis, Angioplasty, Coronary restenosis, Drug Eluting Stent|coronary disease, coronary stenosis, angioplasty, coronary restenosis, drug eluting stent
561511|NCT01172106|Postpartum psychosis|postpartum psychosis
561512|NCT01172106|Perceived social support|perceived social support
561513|NCT01172106|Family psychoeducation|family psychoeducation
561514|NCT01172093|obstructive sleep apnea|obstructive sleep apnea
561515|NCT01172093|prevalence|prevalence
561516|NCT01172093|diabetes mellitus|diabetes mellitus
561517|NCT01172093|Chinese|chinese
561518|NCT01172080|colonoscopy|colonoscopy
561519|NCT01172080|adherence|adherence
561520|NCT01172080|reminders|reminders
561521|NCT01172080|quality|quality
561523|NCT01172067|heart failure|heart failure
561524|NCT01172067|optimization|optimization
561525|NCT01172067|Timing cycle optimization methods|timing cycle optimization methods
561526|NCT01172054|influenza vaccine recombinant|influenza vaccine recombinant
561527|NCT01172028|stage IIIA non-small cell lung cancer|stage iiia non-small cell lung cancer
561528|NCT01172028|stage IIIB non-small cell lung cancer|stage iiib non-small cell lung cancer
561529|NCT01172028|stage IV non-small cell lung cancer|stage iv non-small cell lung cancer
561530|NCT01172028|recurrent non-small cell lung cancer|recurrent non-small cell lung cancer
561531|NCT01172028|male breast cancer|male breast cancer
561532|NCT01172028|stage IIIA breast cancer|stage iiia breast cancer
561533|NCT01172028|stage IIIB breast cancer|stage iiib breast cancer
561534|NCT01172028|stage IIIC breast cancer|stage iiic breast cancer
561535|NCT01172028|stage IV breast cancer|stage iv breast cancer
561536|NCT01172028|recurrent breast cancer|recurrent breast cancer
561537|NCT01172028|stage III prostate cancer|stage iii prostate cancer
561538|NCT01172028|stage IV prostate cancer|stage iv prostate cancer
561539|NCT01172028|recurrent prostate cancer|recurrent prostate cancer
561540|NCT01172028|stage III esophageal cancer|stage iii esophageal cancer
561541|NCT01172028|stage IV esophageal cancer|stage iv esophageal cancer
561542|NCT01172028|recurrent esophageal cancer|recurrent esophageal cancer
561543|NCT01172028|recurrent adenoid cystic carcinoma of the oral cavity|recurrent adenoid cystic carcinoma of the oral cavity
561544|NCT01172028|recurrent mucoepidermoid carcinoma of the oral cavity|recurrent mucoepidermoid carcinoma of the oral cavity
561545|NCT01172028|stage III adenoid cystic carcinoma of the oral cavity|stage iii adenoid cystic carcinoma of the oral cavity
561546|NCT01172028|stage III mucoepidermoid carcinoma of the oral cavity|stage iii mucoepidermoid carcinoma of the oral cavity
561547|NCT01172028|stage IV adenoid cystic carcinoma of the oral cavity|stage iv adenoid cystic carcinoma of the oral cavity
561548|NCT01172028|stage IV mucoepidermoid carcinoma of the oral cavity|stage iv mucoepidermoid carcinoma of the oral cavity
561549|NCT01172028|recurrent basal cell carcinoma of the lip|recurrent basal cell carcinoma of the lip
561550|NCT01172028|stage III basal cell carcinoma of the lip|stage iii basal cell carcinoma of the lip
561551|NCT01172028|stage IV basal cell carcinoma of the lip|stage iv basal cell carcinoma of the lip
561552|NCT01172028|recurrent lymphoepithelioma of the nasopharynx|recurrent lymphoepithelioma of the nasopharynx
561553|NCT01172028|stage III lymphoepithelioma of the nasopharynx|stage iii lymphoepithelioma of the nasopharynx
561554|NCT01172028|stage IV lymphoepithelioma of the nasopharynx|stage iv lymphoepithelioma of the nasopharynx
561555|NCT01172028|recurrent lymphoepithelioma of the oropharynx|recurrent lymphoepithelioma of the oropharynx
561556|NCT01172028|stage III lymphoepithelioma of the oropharynx|stage iii lymphoepithelioma of the oropharynx
561557|NCT01172028|stage IV lymphoepithelioma of the oropharynx|stage iv lymphoepithelioma of the oropharynx
561558|NCT01172028|recurrent esthesioneuroblastoma of the paranasal sinus and nasal cavity|recurrent esthesioneuroblastoma of the paranasal sinus and nasal cavity
561559|NCT01172028|recurrent inverted papilloma of the paranasal sinus and nasal cavity|recurrent inverted papilloma of the paranasal sinus and nasal cavity
561560|NCT01172028|recurrent midline lethal granuloma of the paranasal sinus and nasal cavity|recurrent midline lethal granuloma of the paranasal sinus and nasal cavity
561561|NCT01172028|stage III esthesioneuroblastoma of the paranasal sinus and nasal cavity|stage iii esthesioneuroblastoma of the paranasal sinus and nasal cavity
561562|NCT01172028|stage III inverted papilloma of the paranasal sinus and nasal cavity|stage iii inverted papilloma of the paranasal sinus and nasal cavity
561563|NCT01172028|stage III midline lethal granuloma of the paranasal sinus and nasal cavity|stage iii midline lethal granuloma of the paranasal sinus and nasal cavity
561564|NCT01172028|stage IV esthesioneuroblastoma of the paranasal sinus and nasal cavity|stage iv esthesioneuroblastoma of the paranasal sinus and nasal cavity
561565|NCT01172028|stage IV inverted papilloma of the paranasal sinus and nasal cavity|stage iv inverted papilloma of the paranasal sinus and nasal cavity
710266|NCT00589563|stage III childhood Hodgkin lymphoma|stage iii childhood hodgkin lymphoma
561566|NCT01172028|stage IV midline lethal granuloma of the paranasal sinus and nasal cavity|stage iv midline lethal granuloma of the paranasal sinus and nasal cavity
561567|NCT01172028|recurrent salivary gland cancer|recurrent salivary gland cancer
561568|NCT01172028|stage III salivary gland cancer|stage iii salivary gland cancer
561569|NCT01172028|stage IV salivary gland cancer|stage iv salivary gland cancer
561570|NCT01172028|stage III ovarian epithelial cancer|stage iii ovarian epithelial cancer
561571|NCT01172028|stage IV ovarian epithelial cancer|stage iv ovarian epithelial cancer
561572|NCT01172028|recurrent ovarian epithelial cancer|recurrent ovarian epithelial cancer
561573|NCT01172028|stage III ovarian germ cell tumor|stage iii ovarian germ cell tumor
561574|NCT01172028|stage IV ovarian germ cell tumor|stage iv ovarian germ cell tumor
561575|NCT01172028|recurrent ovarian germ cell tumor|recurrent ovarian germ cell tumor
561576|NCT01172028|stage III gastric cancer|stage iii gastric cancer
561577|NCT01172028|stage IV gastric cancer|stage iv gastric cancer
561578|NCT01172028|recurrent gastric cancer|recurrent gastric cancer
561579|NCT01172028|recurrent hypopharyngeal cancer|recurrent hypopharyngeal cancer
561580|NCT01172028|stage III hypopharyngeal cancer|stage iii hypopharyngeal cancer
561581|NCT01172028|stage IV hypopharyngeal cancer|stage iv hypopharyngeal cancer
561582|NCT01172028|recurrent laryngeal cancer|recurrent laryngeal cancer
561583|NCT01172028|stage III laryngeal cancer|stage iii laryngeal cancer
561584|NCT01172028|stage IV laryngeal cancer|stage iv laryngeal cancer
561585|NCT01172002|Lupus Nephritis|lupus nephritis
561586|NCT01172002|Leflunomide|leflunomide
561587|NCT01172002|Azathioprine|azathioprine
561588|NCT01171989|booster vaccination|booster vaccination
561589|NCT01171989|combined vaccine|combined vaccine
561590|NCT01171976|DME|dme
561591|NCT01171976|Diabetic macula edema|diabetic macula edema
561592|NCT01171976|RETAIN|retain
561593|NCT01171976|ranibizumab|ranibizumab
561594|NCT01171963|Liquid human retrovirus vaccine|liquid human retrovirus vaccine
561595|NCT01171950|Thoratec Corporation|thoratec corporation
561596|NCT01171937|ages 8-16|ages 8-16
561597|NCT01171937|Repetitive Behaviors|repetitive behaviors
561598|NCT01171924|Head and Neck Cancer|head and neck cancer
561599|NCT01171924|Liver Cancer|liver cancer
561600|NCT01171924|Breast Cancer|breast cancer
561601|NCT01171924|Gastric Cancer|gastric cancer
561602|NCT01171924|Non-Small Cell Lung Cancer|non-small cell lung cancer
561603|NCT01171924|EGFR|egfr
561604|NCT01171924|HDAC|hdac
561605|NCT01171924|Her2|her2
561606|NCT01171924|CUDC-101|cudc-101
561607|NCT01171911|Endothelial shear stress|endothelial shear stress
561608|NCT01171911|Calcium channel blocker|calcium channel blocker
561609|NCT01171898|Non-Metastatic|non-metastatic
561610|NCT01171898|Rising PSA|rising psa
561611|NCT01171898|Castration-Resistant|castration-resistant
561612|NCT01171898|Treatment-Naive|treatment-naive
561613|NCT01171898|Post-abiraterone|post-abiraterone
561614|NCT01171885|Superficial cervical block|superficial cervical block
561615|NCT01171885|Thyroidectomy|thyroidectomy
561616|NCT01171885|Pain|pain
561617|NCT01171872|Inflammatory Bowel Disease|inflammatory bowel disease
561618|NCT01171872|Inflammatory Bowel Disease (IBD)|inflammatory bowel disease (ibd)
561619|NCT01171872|Crohn's Disease|crohn's disease
561620|NCT01171872|Ulcerative Colitis|ulcerative colitis
561621|NCT01171872|Indeterminate Colitis|indeterminate colitis
561622|NCT01171872|IBD|ibd
561623|NCT01171872|CD|cd
561624|NCT01171872|UC|uc
561625|NCT01171872|IC|ic
561626|NCT01171859|amyloidosis|amyloidosis
561627|NCT01171859|transthyretin|transthyretin
561628|NCT01171859|doxycycline|doxycycline
561629|NCT01171859|Tauroursodeoxycholic acid|tauroursodeoxycholic acid
561630|NCT01171846|prevention|prevention
561631|NCT01171846|pelvic floor muscle training|pelvic floor muscle training
561632|NCT01171846|prolapse symptoms|prolapse symptoms
561633|NCT01171846|urinary symptoms|urinary symptoms
561634|NCT01171846|sexual function|sexual function
561635|NCT01171846|randomised controlled trial|randomised controlled trial
561636|NCT01171833|Anesthetic induction|anesthetic induction
561637|NCT01171833|Desflurane|desflurane
561638|NCT01171833|Isoflurane|isoflurane
561639|NCT01171833|Sevoflurane|sevoflurane
561640|NCT01171833|Ventilation|ventilation
561641|NCT01171820|drug eluting stents|drug eluting stents
561642|NCT01171820|stents|stents
561643|NCT01171820|Angioplasty|angioplasty
561644|NCT01171820|coronary artery disease|coronary artery disease
561645|NCT01171820|total coronary occlusion|total coronary occlusion
561646|NCT01171820|coronary artery restenosis|coronary artery restenosis
561647|NCT01171820|stent thrombosis|stent thrombosis
561648|NCT01171820|vascular disease|vascular disease
561649|NCT01171820|myocardial ischemia|myocardial ischemia
561650|NCT01171820|coronary artery stenosis|coronary artery stenosis
561651|NCT01171807|Ulcerative colitis|ulcerative colitis
561652|NCT01171807|Steroid-dependency|steroid-dependency
561653|NCT01171807|Steroid adverse events|steroid adverse events
561654|NCT01171807|Erythrocytes|erythrocytes
561655|NCT01171768|Vascular endothelial growth factor|vascular endothelial growth factor
561656|NCT01171768|angiopoietin-2|angiopoietin-2
561657|NCT01171729|Prostate cancer|prostate cancer
561658|NCT01171729|PSA|psa
713306|NCT00576797|vaginal|vaginal
561659|NCT01171729|Hormone refractory prostatic cancer|hormone refractory prostatic cancer
561660|NCT01171716|overweight, protein intake, satiety, eating, meal patterns|overweight, protein intake, satiety, eating, meal patterns
561661|NCT01171703|Critical limb ischemia|critical limb ischemia
561662|NCT01171703|Diabetes|diabetes
561663|NCT01171703|Femoropopliteal artery bypass|femoropopliteal artery bypass
561664|NCT01171703|Stent|stent
561665|NCT01171690|Hypoparathyroidism|hypoparathyroidism
561666|NCT01171677|addiction|addiction
561667|NCT01171677|exercise|exercise
561668|NCT01171677|cognitive function|cognitive function
561669|NCT01171677|mood|mood
561670|NCT01171677|self efficacy|self efficacy
561671|NCT01171664|Phase 2|phase 2
561672|NCT01171664|SAR|sar
561673|NCT01171664|STAHIST|stahist
561674|NCT01171651|Vaccinia|vaccinia
561675|NCT01171651|Vaccinia Virus|vaccinia virus
561676|NCT01171651|JX-594|jx-594
561677|NCT01171651|Jennerex|jennerex
561678|NCT01171651|Primary Hepatocellular Carcinoma|primary hepatocellular carcinoma
561679|NCT01171651|Primary Liver Cancer|primary liver cancer
561680|NCT01171651|Liver Cancer|liver cancer
561681|NCT01171651|Sorafenib|sorafenib
561682|NCT01171651|Nexavar|nexavar
561683|NCT01171651|Pexa-Vec|pexa-vec
561684|NCT01171638|near infrared spectroscopy|near infrared spectroscopy
561685|NCT01171638|compartment syndrome|compartment syndrome
561686|NCT01171638|fasciotomy|fasciotomy
561687|NCT01171638|INVOS|invos
561688|NCT01171625|PERIMOUNT, Aortic valve replacement/regurgitation|perimount, aortic valve replacement/regurgitation
561689|NCT01171612|Coronary Stent|coronary stent
561690|NCT01171612|BMS stent|bms stent
561691|NCT01171612|DES stent|des stent
561692|NCT01171612|Date of stent implantation|date of stent implantation
561693|NCT01171612|cardiac event|cardiac event
561694|NCT01171612|neurovascular event|neurovascular event
561695|NCT01171612|Bleeding|bleeding
561696|NCT01171612|transfusion|transfusion
561697|NCT01171599|Weight Loss|weight loss
561698|NCT01171599|Obesity|obesity
561699|NCT01171599|Overweight|overweight
561700|NCT01171599|Physical Activity|physical activity
561701|NCT01171599|Nutrition|nutrition
561702|NCT01171599|Youth|youth
561703|NCT01171599|Adolescent|adolescent
561704|NCT01171599|Technology|technology
561705|NCT01171586|Obesity|obesity
561706|NCT01171586|overweight|overweight
561707|NCT01171586|weight loss|weight loss
561708|NCT01171586|weight maintenance|weight maintenance
561709|NCT01171586|SMS|sms
561710|NCT01171586|technology|technology
561711|NCT01171586|cell phone|cell phone
561712|NCT01171586|physical activity|physical activity
561713|NCT01171586|nutrition|nutrition
561714|NCT01171573|Polymyositis|polymyositis
561715|NCT01171573|Dermatomyositis|dermatomyositis
561716|NCT01171573|Inclusion Body Myositis|inclusion body myositis
561717|NCT01171560|EZ Blocker|ez blocker
561718|NCT01171560|Double-lumen Tube|double-lumen tube
561719|NCT01171560|Airway|airway
561720|NCT01171560|thoracic surgery|thoracic surgery
561721|NCT01171560|time for intubation|time for intubation
561722|NCT01171560|blind insertion|blind insertion
561723|NCT01171560|conditions of surgery|conditions of surgery
561724|NCT01171560|postoperative sore throat|postoperative sore throat
561725|NCT01171560|postoperative hoarseness|postoperative hoarseness
561726|NCT01171547|pharmacokinetics|pharmacokinetics
561727|NCT01171508|Circadian Rhythm Disorders|circadian rhythm disorders
561728|NCT01171508|Breast Neoplasms Surgery|breast neoplasms surgery
561729|NCT01171508|Sleep|sleep
561730|NCT01171508|Heart Rate|heart rate
561731|NCT01171495|HIV/AIDS|hiv/aids
561732|NCT01171495|Nutrition Therapy|nutrition therapy
561733|NCT01171495|Dietary Supplement|dietary supplement
561734|NCT01171495|Antioxidant|antioxidant
561735|NCT01171495|Immunity|immunity
561736|NCT01171495|CD4 count|cd4 count
561737|NCT01171495|Anthropometry|anthropometry
561738|NCT01171495|Body Mass Index|body mass index
561739|NCT01171469|Brain tumor|brain tumor
561740|NCT01171469|Immunotherapy|immunotherapy
561741|NCT01171469|Glioma|glioma
561742|NCT01171456|GDM|gdm
561743|NCT01171456|Gestational Diabetes|gestational diabetes
561744|NCT01171456|Diabetes|diabetes
561745|NCT01171456|Pregnancy|pregnancy
561746|NCT01171430|multiple myeloma|multiple myeloma
561747|NCT01171430|Autologous Stem Cell Transplantation|autologous stem cell transplantation
561748|NCT01171417|Fulvestrant|fulvestrant
561749|NCT01171417|Exemestane|exemestane
561750|NCT01171417|postmenopausal patients|postmenopausal patients
561751|NCT01171417|advanced HR+ breast cancer|advanced hr+ breast cancer
561752|NCT01171417|Hormone Receptor positive|hormone receptor positive
561753|NCT01171417|advanced breast cancer|advanced breast cancer
561754|NCT01171404|Acute coronary syndrome|acute coronary syndrome
561755|NCT01171404|heart attack|heart attack
561756|NCT01171404|myocardial infarction|myocardial infarction
561757|NCT01171404|ACS long-tem follow up|acs long-tem follow up
561758|NCT01171404|antithrombotic management|antithrombotic management
561759|NCT01171404|quality of life|quality of life
561760|NCT01171404|Antithrombotic|antithrombotic
561761|NCT01171391|Nocturia|nocturia
561762|NCT01171391|Pharmacokinetics|pharmacokinetics
561763|NCT01171391|Pharmacodynamics|pharmacodynamics
561764|NCT01171391|Water-loading|water-loading
561765|NCT01171391|Females|females
561766|NCT01171378|Richter's Syndrome|richter's syndrome
561767|NCT01171378|High-grade transformation in patients with B cell chronic lymphocytic leukemia|high-grade transformation in patients with b cell chronic lymphocytic leukemia
561768|NCT01171378|Feasibility|feasibility
561769|NCT01171378|Ofatumumab Induction and maintenance|ofatumumab induction and maintenance
561770|NCT01171378|CHOP|chop
561771|NCT01171378|CHOP-0|chop-0
561772|NCT01171378|CHOP-OR|chop-or
561773|NCT01171378|Non Hodgkin's lymphoma|non hodgkin's lymphoma
561774|NCT01171365|Ciclesonide|ciclesonide
561775|NCT01171365|Asthma|asthma
561776|NCT01171365|Therapeutic Uses|therapeutic uses
561777|NCT01171365|Pulmonary Eosinophilia|pulmonary eosinophilia
561778|NCT01171365|Nitric Oxide|nitric oxide
561779|NCT01171365|Lung Diseases|lung diseases
561780|NCT01171365|Respiratory Tract Diseases|respiratory tract diseases
561781|NCT01171352|hemodialysis|hemodialysis
561782|NCT01171352|dialysis|dialysis
561783|NCT01171352|hypotension|hypotension
561784|NCT01171352|CritLine|critline
561785|NCT01171352|PiCCO|picco
561786|NCT01171352|Thermodilution|thermodilution
561787|NCT01171352|CVVHDF|cvvhdf
561788|NCT01171352|IHD|ihd
561789|NCT01171339|elderly|elderly
561790|NCT01171339|multimorbidity|multimorbidity
561791|NCT01171339|polypharmacy|polypharmacy
561792|NCT01171339|multimedication|multimedication
561793|NCT01171339|medication appropriateness|medication appropriateness
561794|NCT01171339|medication appropriateness index|medication appropriateness index
561795|NCT01171339|cluster-randomised controlled trial|cluster-randomised controlled trial
561796|NCT01171339|pragmatic trial|pragmatic trial
561797|NCT01171326|topical|topical
561798|NCT01171326|minocycline|minocycline
561799|NCT01171326|foam|foam
561800|NCT01171326|phase II|phase ii
561801|NCT01171326|impetigo|impetigo
561802|NCT01171300|staged T3-4 N0 and T1-4N1-2|staged t3-4 n0 and t1-4n1-2
561803|NCT01171300|adenocarcinoma of the rectum|adenocarcinoma of the rectum
561804|NCT01171300|rectum|rectum
561805|NCT01171287|Automobile Driving|automobile driving
561806|NCT01171287|Fracture Fixation/instrumentation|fracture fixation/instrumentation
561807|NCT01171287|Lower Extremity|lower extremity
561808|NCT01171287|Orthopedic Fixation Devices|orthopedic fixation devices
561809|NCT01171287|Orthopedic Procedures|orthopedic procedures
561810|NCT01171287|Reaction Time|reaction time
561811|NCT01171287|Task Performance and Analysis|task performance and analysis
561812|NCT01171287|Time Factors|time factors
561813|NCT01171274|neck pain|neck pain
561814|NCT01171274|yoga|yoga
561815|NCT01171274|proprioception|proprioception
561816|NCT01171274|sensory thresholds|sensory thresholds
561817|NCT01171274|randomized controlled trial|randomized controlled trial
561818|NCT01171261|Physical Activity|physical activity
561819|NCT01171261|Sedentary Behavior|sedentary behavior
561820|NCT01171261|Video Games|video games
561821|NCT01171261|Exergames|exergames
561822|NCT01171248|nocturnal blood pressure dip|nocturnal blood pressure dip
561823|NCT01171248|complications|complications
561824|NCT01171248|ambulatory blood pressure|ambulatory blood pressure
561825|NCT01171235|Laryngeal Neoplasms|laryngeal neoplasms
561826|NCT01171235|Pharyngeal Neoplasms|pharyngeal neoplasms
561827|NCT01171222|soccer|soccer
561828|NCT01171222|prevention|prevention
561829|NCT01171222|veteran athletes|veteran athletes
561830|NCT01171222|exercise|exercise
561831|NCT01171222|Cardiovascular|cardiovascular
561832|NCT01171209|MS|ms
561833|NCT01171196|Sleep Apnea|sleep apnea
561834|NCT01171196|Questionnaire|questionnaire
561835|NCT01171183|cocaine dependence|cocaine dependence
561836|NCT01171183|cocaine withdrawal|cocaine withdrawal
561837|NCT01171170|non small cell lung cancer|non small cell lung cancer
561838|NCT01171170|stage IV|stage iv
561839|NCT01171170|nitroglycerin|nitroglycerin
561840|NCT01171170|carboplatin|carboplatin
561841|NCT01171170|paclitaxel|paclitaxel
561842|NCT01171170|bevacizumab|bevacizumab
561843|NCT01171157|Influenza-like illness|influenza-like illness
561844|NCT01171157|vaccine effectiveness|vaccine effectiveness
561845|NCT01171157|elderly|elderly
561846|NCT01171157|Influenza|influenza
561847|NCT01171131|TBI|tbi
561848|NCT01171131|Brain Injury|brain injury
561849|NCT01171118|Breathing|breathing
561850|NCT01171118|Sedation|sedation
561851|NCT01171105|AZD5213 Phase 1|azd5213 phase 1
561852|NCT01171105|Safety|safety
561853|NCT01171105|tolerability|tolerability
561854|NCT01171092|stem cell|stem cell
561855|NCT01171092|transplant|transplant
561856|NCT01171092|myeloma|myeloma
561857|NCT01171092|lymphoma|lymphoma
561858|NCT01171092|BMT|bmt
561859|NCT01171092|autologous|autologous
561860|NCT01171079|postoperative adhesion after thyroidectomy|postoperative adhesion after thyroidectomy
561861|NCT01171053|Cognitive behavior therapy|cognitive behavior therapy
561862|NCT01171053|Internet|internet
561863|NCT01171053|Cost-effectiveness|cost-effectiveness
561864|NCT01171053|Irritable bowel syndrome|irritable bowel syndrome
561865|NCT01171040|left atrial distensibility|left atrial distensibility
561866|NCT01171040|mortality|mortality
561867|NCT01171040|heart failure|heart failure
561868|NCT01171040|atrial fibrillation|atrial fibrillation
561869|NCT01171040|stroke|stroke
561870|NCT01171040|prognosis|prognosis
561871|NCT01171027|Cholecystectomy|cholecystectomy
561872|NCT01171027|NOTES|notes
561873|NCT01171027|Transvaginal|transvaginal
561874|NCT01171027|Transgastric|transgastric
561875|NCT01171027|Natural orifice|natural orifice
561876|NCT01171027|Gallbladder removal|gallbladder removal
561877|NCT01170988|patients scheduled for bypass grafting|patients scheduled for bypass grafting
561878|NCT01170975|Advanced solid tumors|advanced solid tumors
561879|NCT01170949|urticaria|urticaria
561880|NCT01170936|Urticarial vasculitis|urticarial vasculitis
561881|NCT01170936|anti-IL1ß therapy|anti-il1ß therapy
561882|NCT01170923|non small cell lung cancer|non small cell lung cancer
561883|NCT01170923|FDG PET|fdg pet
561884|NCT01170910|Chronic renal failure|chronic renal failure
561885|NCT01170910|Transplantation|transplantation
561886|NCT01170910|Marginal kidney graft|marginal kidney graft
561887|NCT01170910|Pulsatile perfusion machine|pulsatile perfusion machine
561888|NCT01170897|PEGPH20|pegph20
561889|NCT01170897|PEGylated Recombinant Human Hyaluronidase|pegylated recombinant human hyaluronidase
561890|NCT01170897|Metastatic or Locally Advanced Solid Tumors|metastatic or locally advanced solid tumors
561891|NCT01170845|Esophagectomy|esophagectomy
561892|NCT01170845|Postoperative respiratory complications|postoperative respiratory complications
561893|NCT01170845|neutrophil elastase inhibitor|neutrophil elastase inhibitor
561894|NCT01170819|Cervical ripening|cervical ripening
561895|NCT01170819|Induction of labor|induction of labor
561896|NCT01170819|Prostaglandins|prostaglandins
561897|NCT01170819|Mechanical methods|mechanical methods
561898|NCT01170819|Balloon catheter|balloon catheter
561899|NCT01170806|Intestinal lipase|intestinal lipase
561900|NCT01170806|Orlistat|orlistat
561901|NCT01170806|fecal fat|fecal fat
561902|NCT01170806|obesity|obesity
561903|NCT01170793|education, quality of life|education, quality of life
561904|NCT01170780|Inguinal hernia|inguinal hernia
561905|NCT01170780|Transabdominal preperitoneal hernia repair|transabdominal preperitoneal hernia repair
561906|NCT01170780|TAPP|tapp
561907|NCT01170780|Dexamethasone|dexamethasone
561908|NCT01170780|Pain|pain
561909|NCT01170767|Age-related Macular Degeneration|age-related macular degeneration
561910|NCT01170767|Bevacizumab|bevacizumab
561911|NCT01170767|Ranibizumab|ranibizumab
561912|NCT01170754|PEG-3350, polyethylene glycol, colonoscopy|peg-3350, polyethylene glycol, colonoscopy
561913|NCT01170728|Male Sling|male sling
561914|NCT01170728|Fixation|fixation
561915|NCT01170728|Stress Urinary Incontinence|stress urinary incontinence
561916|NCT01170728|Urinary incontinence|urinary incontinence
561917|NCT01170715|Psoriasis|psoriasis
561918|NCT01170715|Co morbidities|co morbidities
561919|NCT01170715|Inflammation|inflammation
561920|NCT01170702|Cesarean Delivery|cesarean delivery
561921|NCT01170702|Ropivicaine|ropivicaine
561922|NCT01170702|TAP block|tap block
561923|NCT01170689|Schizophrenia|schizophrenia
561924|NCT01170689|inpatient|inpatient
561925|NCT01170689|obesity|obesity
561926|NCT01170689|prevalence|prevalence
561927|NCT01170676|asthma|asthma
561928|NCT01170676|smoking|smoking
561929|NCT01170676|teens|teens
561930|NCT01170663|Metastatic Adenocarcinoma|metastatic adenocarcinoma
561931|NCT01170663|Gastric Adenocarcinoma|gastric adenocarcinoma
561932|NCT01170663|Gastroesophageal Junction Adenocarcinoma|gastroesophageal junction adenocarcinoma
561933|NCT01170650|cancer|cancer
561934|NCT01170650|ovarian|ovarian
561935|NCT01170650|platinum-resistant|platinum-resistant
561936|NCT01170650|Phase III|phase iii
561937|NCT01170650|EC145|ec145
561938|NCT01170650|EC20|ec20
561939|NCT01170624|PhD|phd
561940|NCT01170624|EGM|egm
561941|NCT01170624|CRT-D|crt-d
561942|NCT01170624|The study will particularly focus on a new-based diagnostic feature, called PhD-Clinical Status (PhD)|the study will particularly focus on a new-based diagnostic feature, called phd-clinical status (phd)
561943|NCT01170598|acute myeloid leukemia|acute myeloid leukemia
561944|NCT01170598|AML|aml
561945|NCT01170598|chemotherapy|chemotherapy
561946|NCT01170598|exercise|exercise
561947|NCT01170598|quality of life|quality of life
561948|NCT01170598|cancer-related fatigue|cancer-related fatigue
561950|NCT01170598|physical fitness|physical fitness
561951|NCT01170598|muscular strength|muscular strength
561952|NCT01170598|Feasibility|feasibility
561953|NCT01170598|Efficacy|efficacy
561954|NCT01170598|Safety|safety
561955|NCT01170546|anterior cruciate ligament|anterior cruciate ligament
561956|NCT01170546|agility|agility
561957|NCT01170546|knee stability|knee stability
561958|NCT01170546|hamstring|hamstring
561959|NCT01170546|knee internal rotator|knee internal rotator
561960|NCT01170533|proton pump inhibitor|proton pump inhibitor
561961|NCT01170533|clopidogrel|clopidogrel
561962|NCT01170533|platelet function|platelet function
561963|NCT01170520|adolescent resistant depression|adolescent resistant depression
561964|NCT01170520|repetitive transcranial magnetic stimulation|repetitive transcranial magnetic stimulation
561965|NCT01170520|treatment of resistant adolescent depression|treatment of resistant adolescent depression
561966|NCT01170507|vitamin D3, 25 OH vitamin D3 level|vitamin d3, 25 oh vitamin d3 level
561967|NCT01170494|vitamin D2, vitamin D3, 25 Oh vitamin D2, 25 Oh vitamin D3|vitamin d2, vitamin d3, 25 oh vitamin d2, 25 oh vitamin d3
561968|NCT01170481|anterior and intermediate uveitis|anterior and intermediate uveitis
561969|NCT01170481|papilloedema|papilloedema
561970|NCT01170468|Prediabetics|prediabetics
561972|NCT01170468|vitamin D|vitamin d
561973|NCT01170455|nasal|nasal
561974|NCT01170455|intubation|intubation
561975|NCT01170455|direct laryngoscope|direct laryngoscope
561976|NCT01170455|blind|blind
561977|NCT01170455|normal airway|normal airway
561978|NCT01170429|Cough Variant Asthma|cough variant asthma
561979|NCT01170429|Procaterol Hydrochloride|procaterol hydrochloride
561980|NCT01170416|Ventricular Tachycardia|ventricular tachycardia
561981|NCT01170416|Body Surface Mapping|body surface mapping
561982|NCT01170403|coronary heart disease|coronary heart disease
561983|NCT01170403|Multidetector row cardiac computed tomography|multidetector row cardiac computed tomography
561984|NCT01170403|type 2 diabetes|type 2 diabetes
561985|NCT01170403|metabolic syndrome|metabolic syndrome
561986|NCT01170390|Obesity|obesity
561987|NCT01170390|Body weight|body weight
561988|NCT01170390|Oral contraception|oral contraception
561989|NCT01170390|Efficacy|efficacy
561990|NCT01170377|Intravenous sedation|intravenous sedation
561991|NCT01170377|Dental treatment|dental treatment
561992|NCT01170377|Mental retardation|mental retardation
561993|NCT01170377|Antiepileptic drug|antiepileptic drug
561994|NCT01170377|Valproate|valproate
561995|NCT01170377|Propofol|propofol
561996|NCT01170364|Obesity|obesity
561997|NCT01170364|sibutramine|sibutramine
561998|NCT01170364|eating behavior|eating behavior
561999|NCT01170351|autoimmune hepatitis|autoimmune hepatitis
562000|NCT01170351|corticosteroids|corticosteroids
562001|NCT01170351|cysclosporine-A|cysclosporine-a
562002|NCT01170351|treatment|treatment
562003|NCT01170351|treatment-naive|treatment-naive
562004|NCT01170351|induction of remossion|induction of remossion
562005|NCT01170351|efficacy|efficacy
562006|NCT01170351|tolerability|tolerability
562007|NCT01170338|smoking|smoking
562008|NCT01170338|tobacco abuse|tobacco abuse
562009|NCT01170325|Valproic Acid|valproic acid
562010|NCT01170325|Divalproex|divalproex
562011|NCT01170325|Autism|autism
562012|NCT01170325|EEG|eeg
562013|NCT01170325|Electroencephalogram (EEG)|electroencephalogram (eeg)
562014|NCT01170325|Depakote|depakote
562015|NCT01170312|Arthroscopic repair|arthroscopic repair
562016|NCT01170312|Rotator cuff|rotator cuff
562017|NCT01170312|Platelet rich plasma|platelet rich plasma
562018|NCT01170312|Randomized|randomized
562019|NCT01170312|Pilot|pilot
562020|NCT01170299|radiation toxicity|radiation toxicity
562021|NCT01170299|gastrointestinal complications|gastrointestinal complications
562022|NCT01170299|cervical cancer|cervical cancer
562023|NCT01170299|fallopian tube cancer|fallopian tube cancer
562024|NCT01170299|ovarian epithelial cancer|ovarian epithelial cancer
562025|NCT01170299|ovarian germ cell tumor|ovarian germ cell tumor
562026|NCT01170299|ovarian sarcoma|ovarian sarcoma
562027|NCT01170299|ovarian stromal cancer|ovarian stromal cancer
562028|NCT01170299|uterine sarcoma|uterine sarcoma
562029|NCT01170299|bladder cancer|bladder cancer
562030|NCT01170299|colon cancer|colon cancer
562031|NCT01170299|rectal cancer|rectal cancer
562032|NCT01170299|anal cancer|anal cancer
562033|NCT01170286|Food allergy|food allergy
562034|NCT01170286|Immediate hypersensitivity|immediate hypersensitivity
562035|NCT01170286|Whole peanut extract|whole peanut extract
562036|NCT01170286|Allergenic product|allergenic product
562037|NCT01170286|Specific Immunotherapy|specific immunotherapy
562038|NCT01170286|Epicutaneous Immunotherapy (EPIT)|epicutaneous immunotherapy (epit)
562039|NCT01170286|Safety|safety
562040|NCT01170273|aged|aged
562041|NCT01170273|vitamin d deficiency|vitamin d deficiency
562042|NCT01170247|Procedural Sedation|procedural sedation
562043|NCT01170234|Exhaled nitric oxide|exhaled nitric oxide
562044|NCT01170234|Eosinophilic esophagitis|eosinophilic esophagitis
562045|NCT01170221|ABSSSI|absssi
562046|NCT01170221|Tedizolid Phosphate|tedizolid phosphate
562047|NCT01170221|TR-701|tr-701
562048|NCT01170221|Acute Bacterial Skin and Skin Structure Infections|acute bacterial skin and skin structure infections
562049|NCT01170208|insulin|insulin
562050|NCT01170208|dosage software|dosage software
562051|NCT01170195|Postmenopausal|postmenopausal
562052|NCT01170195|licorice|licorice
562053|NCT01170195|vaginal complaints|vaginal complaints
562054|NCT01170156|deep sedation|deep sedation
562055|NCT01170156|respiratory resuscitation|respiratory resuscitation
562056|NCT01170156|Hi-Lo Evac tube|hi-lo evac tube
562057|NCT01170156|suctioning manoeuvre|suctioning manoeuvre
562058|NCT01170143|IIB-IIIB Breast Cancer|iib-iiib breast cancer
562059|NCT01170143|Her2 positive|her2 positive
562060|NCT01170130|Cataract|cataract
562061|NCT01170130|Mydriasis|mydriasis
562062|NCT01170130|Lidocaine|lidocaine
562063|NCT01170117|Eating Disorders|eating disorders
562064|NCT01170117|Anorexia Nervosa|anorexia nervosa
562065|NCT01170104|Hepatocellular Carcinoma|hepatocellular carcinoma
562066|NCT01170104|Sorafenib|sorafenib
562067|NCT01170104|TACE|tace
562068|NCT01170104|locally, advanced Hepatocellular Carcinoma|locally, advanced hepatocellular carcinoma
562069|NCT01170078|chronic renal failure requiring hemodialysis|chronic renal failure requiring hemodialysis
562070|NCT01170052|Relapsed Mantle Cell Lymphoma|relapsed mantle cell lymphoma
562071|NCT01170052|Refractory Mantle Cell Lymphoma|refractory mantle cell lymphoma
562072|NCT01170052|Non-Hodgkins Lymphoma|non-hodgkins lymphoma
562073|NCT01170052|Temsirolimus|temsirolimus
562074|NCT01170052|Bendamustine|bendamustine
562075|NCT01170052|Phase 1/2|phase 1/2
562076|NCT01170039|Constipation|constipation
562077|NCT01170039|Diabetes|diabetes
562078|NCT01170039|Lubiprostone|lubiprostone
562080|NCT01170039|African Americans|african americans
562081|NCT01170026|substance use|substance use
562082|NCT01170026|adolescents|adolescents
562083|NCT01170026|intervention|intervention
562084|NCT01170026|truancy|truancy
562085|NCT01170026|sexual risk behavior|sexual risk behavior
562086|NCT01170013|substance use|substance use
562087|NCT01170013|adolescents|adolescents
562088|NCT01170013|initiation|initiation
562089|NCT01169987|Multicenter study|multicenter study
562090|NCT01169974|Microcirculation|microcirculation
562091|NCT01169974|laser flowmetry|laser flowmetry
562092|NCT01169974|Skin|skin
562093|NCT01169974|Physiology|physiology
562094|NCT01169961|IRON OVERLOAD IN HEMODIALYSIS PATIENTS|iron overload in hemodialysis patients
562095|NCT01169948|Coronary disease|coronary disease
562096|NCT01169948|Coronary artery bypass|coronary artery bypass
562097|NCT01169948|Cardiac surgery|cardiac surgery
562098|NCT01169948|Computed tomography|computed tomography
562099|NCT01169948|Coronary angiography|coronary angiography
562100|NCT01169935|MRI|mri
562101|NCT01169935|SPIO|spio
562102|NCT01169935|Healthy Volunteer|healthy volunteer
562103|NCT01169909|Pterygium|pterygium
562104|NCT01169896|Impact of ventricular pacing on the incidence of VT/VF episodes for each models|impact of ventricular pacing on the incidence of vt/vf episodes for each models
562105|NCT01169883|adherence|adherence
562106|NCT01169883|asthma|asthma
562107|NCT01169883|pediatrics|pediatrics
562108|NCT01169883|behavioral intervention|behavioral intervention
562109|NCT01169883|inner city|inner city
562110|NCT01169870|metastatic|metastatic
562111|NCT01169857|Proliferative lupus nephritis|proliferative lupus nephritis
562112|NCT01169857|WHO class III/IV/V lupus nephritis|who class iii/iv/v lupus nephritis
562113|NCT01169857|Proteinuria|proteinuria
562114|NCT01169857|Hematuria|hematuria
562115|NCT01169857|Velcade|velcade
562116|NCT01169857|SLE|sle
562117|NCT01169857|Bortezomib|bortezomib
562118|NCT01169857|Proteasome inhibitor|proteasome inhibitor
562119|NCT01169844|Psoriatic arthritis|psoriatic arthritis
562120|NCT01169844|IgG1K monoclonal antibody|igg1k monoclonal antibody
562121|NCT01169844|Interleukin -17A neutralizing|interleukin -17a neutralizing
562122|NCT01169792|Tamoxifen|tamoxifen
562123|NCT01169792|Cytochrome P-450 CYP2D6|cytochrome p-450 cyp2d6
562124|NCT01169792|Polymorphism|polymorphism
562125|NCT01169792|Single nucleotide|single nucleotide
562126|NCT01169792|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal
562127|NCT01169753|Chronic Myeloid Leukemia|chronic myeloid leukemia
562128|NCT01169753|CML|cml
562129|NCT01169753|Nuvigil|nuvigil
562130|NCT01169753|Armodafinil|armodafinil
562131|NCT01169753|Fatigue|fatigue
562132|NCT01169740|Hyperbilirubinemia|hyperbilirubinemia
562133|NCT01169740|Neonatal|neonatal
562134|NCT01169740|Serum bilirubin|serum bilirubin
562135|NCT01169740|Transcutaneous bilirubin|transcutaneous bilirubin
562136|NCT01169740|Skin color|skin color
562137|NCT01169727|COPD and CCQ score|copd and ccq score
562138|NCT01169727|Changes in PEF,overall CCQ score|changes in pef,overall ccq score
562139|NCT01169714|multiple dose|multiple dose
562140|NCT01169714|healthy volunteer|healthy volunteer
562141|NCT01169714|healthy elderly volunteer|healthy elderly volunteer
562142|NCT01169714|safety|safety
562143|NCT01169714|pharmacokinetic|pharmacokinetic
562144|NCT01169701|Renal transplant, everolimus, cardiovascular profile, CNI-free immunosuppression, left ventricular hypertrophy, biopsy proved acute rejection (BPAR)|renal transplant, everolimus, cardiovascular profile, cni-free immunosuppression, left ventricular hypertrophy, biopsy proved acute rejection (bpar)
562145|NCT01169688|Cataract Surgery|cataract surgery
562146|NCT01169688|Pupillary Dilation|pupillary dilation
562147|NCT01169649|MK-2206|mk-2206
562148|NCT01169649|Neuroendocrine Tumors|neuroendocrine tumors
562149|NCT01169649|10-067|10-067
562150|NCT01169636|Chemotherapy|chemotherapy
562151|NCT01169636|Panobinostat|panobinostat
562152|NCT01169636|Ifosfamide|ifosfamide
562153|NCT01169636|Mesna|mesna
562154|NCT01169636|Etoposide|etoposide
562155|NCT01169636|Carboplatin|carboplatin
562156|NCT01169636|Pegfilgrastim|pegfilgrastim
562157|NCT01169636|ICE|ice
562158|NCT01169623|Supportive leadership behaviour|supportive leadership behaviour
562159|NCT01169623|Nurse Performance|nurse performance
562160|NCT01169623|Educational Intervention|educational intervention
562161|NCT01169610|Alcohol|alcohol
562162|NCT01169610|Smoking|smoking
562163|NCT01169597|polymyalgia rheumatica|polymyalgia rheumatica
562164|NCT01169597|prednisone|prednisone
562165|NCT01169597|clinical examination|clinical examination
562166|NCT01169597|remission|remission
562167|NCT01169597|ultrasonography|ultrasonography
562168|NCT01169584|Phase I|phase i
562169|NCT01169584|advanced metastatic pediatric solid tumors|advanced metastatic pediatric solid tumors
562170|NCT01169584|pediatric|pediatric
562171|NCT01169584|vaccinia virus|vaccinia virus
562172|NCT01169584|oncolytic virus|oncolytic virus
562173|NCT01169584|neuroblastoma|neuroblastoma
562174|NCT01169584|rhabdomyosarcoma|rhabdomyosarcoma
562175|NCT01169584|lymphoma|lymphoma
562176|NCT01169584|Wilm's tumor|wilm's tumor
562177|NCT01169584|Ewing's sarcoma|ewing's sarcoma
562178|NCT01169584|osteosarcoma|osteosarcoma
562179|NCT01169584|non-rhabdomyosarcoma soft tissue sarcomas|non-rhabdomyosarcoma soft tissue sarcomas
562180|NCT01169584|malignant peripheral nerve sheath tumors|malignant peripheral nerve sheath tumors
562181|NCT01169584|Pexa-Vec|pexa-vec
562182|NCT01169571|Initially intubated|initially intubated
562183|NCT01169571|Mechanically ventilated|mechanically ventilated
562184|NCT01169571|Post-surgical|post-surgical
562185|NCT01169545|any type of cancer|any type of cancer
562186|NCT01169519|Hypoplastic left heart syndrome|hypoplastic left heart syndrome
562187|NCT01169519|Hypoplastic right heart syndrome|hypoplastic right heart syndrome
562188|NCT01169519|Superior cavopulmonary anastomosis|superior cavopulmonary anastomosis
562189|NCT01169519|Total cavopulmonary anastomosis|total cavopulmonary anastomosis
562190|NCT01169519|Children with single ventricle anatomy|children with single ventricle anatomy
562191|NCT01169506|blood gas analysis|blood gas analysis
562192|NCT01169506|ventilatory insufficiency|ventilatory insufficiency
562193|NCT01169493|Heart Failure|heart failure
562194|NCT01169493|Right Bundle-Branch Block|right bundle-branch block
562195|NCT01169493|Cardiac Resynchronization Therapy|cardiac resynchronization therapy
562196|NCT01169480|Massage|massage
562197|NCT01169480|Therapist, Massage|therapist, massage
562198|NCT01169480|DASS|dass
562199|NCT01169480|Depression|depression
562200|NCT01169480|Anxiety, State|anxiety, state
562201|NCT01169480|Anxiety, Trait|anxiety, trait
562202|NCT01169480|Stress|stress
562203|NCT01169480|Touch|touch
562204|NCT01169480|Therapeutic Relationship|therapeutic relationship
562205|NCT01169454|Cerebral Spinal Fluid|cerebral spinal fluid
562206|NCT01169454|Ventriculostomy|ventriculostomy
562207|NCT01169454|Subarachnoid hemorrhage|subarachnoid hemorrhage
562208|NCT01169454|Vasospasm|vasospasm
562209|NCT01169454|Human Subjects|human subjects
562210|NCT01169441|ICD leads|icd leads
562211|NCT01169441|Removal|removal
562212|NCT01169441|Extraction|extraction
562213|NCT01169441|Ventricular leads|ventricular leads
562214|NCT01169441|Extract|extract
562215|NCT01169441|laser|laser
562216|NCT01169441|Observe the lead with x-ray during movement and collect information on current ways of removing an ICD lead.|observe the lead with x-ray during movement and collect information on current ways of removing an icd lead.
562217|NCT01169428|Mindfulness-Based Weight Loss Maintenance|mindfulness-based weight loss maintenance
562218|NCT01169428|prevention of weight regain|prevention of weight regain
562219|NCT01169428|Obesity|obesity
562220|NCT01169415|Randomized|randomized
562221|NCT01169415|Dexamethasone|dexamethasone
562222|NCT01169415|Abbreviated|abbreviated
562223|NCT01169415|Protracted|protracted
562224|NCT01169415|Post-operatively|post-operatively
562225|NCT01169402|extracorporeal membrane oxygenation|extracorporeal membrane oxygenation
562226|NCT01169402|ECMO|ecmo
562227|NCT01169402|extracorporeal life support|extracorporeal life support
562228|NCT01169402|fluconazole|fluconazole
562229|NCT01169402|diflucan|diflucan
562230|NCT01169402|pharmacokinetics|pharmacokinetics
562231|NCT01169402|pharmacodynamics|pharmacodynamics
562232|NCT01169376|disseminated neuroblastoma|disseminated neuroblastoma
562233|NCT01169376|localized resectable neuroblastoma|localized resectable neuroblastoma
562234|NCT01169376|localized unresectable neuroblastoma|localized unresectable neuroblastoma
562235|NCT01169376|regional neuroblastoma|regional neuroblastoma
562236|NCT01169376|stage 4S neuroblastoma|stage 4s neuroblastoma
562237|NCT01169363|adult acute myeloid leukemia in remission|adult acute myeloid leukemia in remission
562238|NCT01169363|recurrent adult acute myeloid leukemia|recurrent adult acute myeloid leukemia
562239|NCT01169363|adult erythroleukemia (M6a)|adult erythroleukemia (m6a)
562240|NCT01169363|adult pure erythroid leukemia (M6b)|adult pure erythroid leukemia (m6b)
562241|NCT01169363|adult acute megakaryoblastic leukemia (M7)|adult acute megakaryoblastic leukemia (m7)
562242|NCT01169363|adult acute minimally differentiated myeloid leukemia (M0)|adult acute minimally differentiated myeloid leukemia (m0)
562243|NCT01169363|adult acute monoblastic leukemia (M5a)|adult acute monoblastic leukemia (m5a)
562244|NCT01169363|adult acute monocytic leukemia (M5b)|adult acute monocytic leukemia (m5b)
562245|NCT01169363|adult acute myeloblastic leukemia with maturation (M2)|adult acute myeloblastic leukemia with maturation (m2)
562246|NCT01169363|adult acute myeloblastic leukemia without maturation (M1)|adult acute myeloblastic leukemia without maturation (m1)
562247|NCT01169363|adult acute myelomonocytic leukemia (M4)|adult acute myelomonocytic leukemia (m4)
562248|NCT01169363|adult acute myeloid leukemia with 11q23 (MLL) abnormalities|adult acute myeloid leukemia with 11q23 (mll) abnormalities
562249|NCT01169363|adult acute myeloid leukemia with del(5q)|adult acute myeloid leukemia with del(5q)
562250|NCT01169363|adult acute myeloid leukemia with inv(16)(p13;q22)|adult acute myeloid leukemia with inv(16)(p13;q22)
562251|NCT01169363|adult acute myeloid leukemia with t(16;16)(p13;q22)|adult acute myeloid leukemia with t(16;16)(p13;q22)
562252|NCT01169363|adult acute myeloid leukemia with t(8;21)(q22;q22)|adult acute myeloid leukemia with t(8;21)(q22;q22)
562253|NCT01169324|Parkinson's disease|parkinson's disease
562254|NCT01169324|Tremor|tremor
562255|NCT01169324|Dystonia|dystonia
562256|NCT01169324|DBS|dbs
562257|NCT01169324|Sleep|sleep
562258|NCT01169311|Hemorrhoids|hemorrhoids
562259|NCT01169311|Hemorrhoid|hemorrhoid
562260|NCT01169311|grade II, III, IV|grade ii, iii, iv
562261|NCT01169298|Adult T-cell Leukemia-Lymphoma|adult t-cell leukemia-lymphoma
562262|NCT01169298|Peripheral T-cell Lymphoma|peripheral t-cell lymphoma
562263|NCT01169298|PTCL|ptcl
562264|NCT01169298|HTLV-1|htlv-1
562265|NCT01169285|Burn Department Nursing Staff|burn department nursing staff
562266|NCT01169272|ICD CRT 9770 - PARADYM RF ICD - SonR atrial lead|icd crt 9770 - paradym rf icd - sonr atrial lead
562267|NCT01169259|vitamin D3|vitamin d3
562268|NCT01169259|omega-3 fatty acids|omega-3 fatty acids
562269|NCT01169259|fish oil|fish oil
562270|NCT01169259|cardiovascular disease|cardiovascular disease
562271|NCT01169259|cancer|cancer
562272|NCT01169259|primary prevention|primary prevention
562273|NCT01169246|ATP,CRT, ICD PARADYM|atp,crt, icd paradym
562274|NCT01169233|Sleep|sleep
562275|NCT01169233|Alertness|alertness
562276|NCT01169233|fatigue|fatigue
562277|NCT01169233|performance|performance
562278|NCT01169233|spaceflight|spaceflight
562279|NCT01169233|isolation|isolation
562280|NCT01169233|light|light
562281|NCT01169233|Sleep , alertness and performance during a simulated spaceflight mission|sleep , alertness and performance during a simulated spaceflight mission
562282|NCT01169220|Colonoscopy|colonoscopy
562283|NCT01169220|Bowel preparation|bowel preparation
562284|NCT01169207|Inflammatory Bowel Disease|inflammatory bowel disease
562285|NCT01169207|Crohn's Disease|crohn's disease
562286|NCT01169207|Ulcerative Colitis|ulcerative colitis
562287|NCT01169207|Indeterminate Colitis|indeterminate colitis
562288|NCT01169207|IBD|ibd
562289|NCT01169207|CD|cd
562290|NCT01169207|UC|uc
562291|NCT01169207|IC|ic
562292|NCT01169194|Inflammatory Bowel Disease|inflammatory bowel disease
562293|NCT01169194|Crohn's Disease|crohn's disease
562294|NCT01169194|Ulcerative Colitis|ulcerative colitis
562295|NCT01169194|Indeterminate Colitis|indeterminate colitis
562296|NCT01169194|IBD|ibd
562297|NCT01169194|CD|cd
562298|NCT01169194|UC|uc
562299|NCT01169194|IC|ic
562300|NCT01169194|African American IBD|african american ibd
562301|NCT01169194|African American CD|african american cd
562302|NCT01169194|African American UC|african american uc
562303|NCT01169194|African American IC|african american ic
562304|NCT01169194|Black IBD|black ibd
562305|NCT01169194|Black CD|black cd
562306|NCT01169194|Black UC|black uc
562307|NCT01169194|Black IC|black ic
562308|NCT01169194|African American Inflammatory Bowel Disease|african american inflammatory bowel disease
562309|NCT01169194|African American Crohn's Disease|african american crohn's disease
562310|NCT01169194|African American Ulcerative Colitis|african american ulcerative colitis
562311|NCT01169194|African American Indeterminate Colitis|african american indeterminate colitis
562312|NCT01169194|Black Inflammatory Bowel Disease|black inflammatory bowel disease
562313|NCT01169194|Black Crohn's Disease|black crohn's disease
562314|NCT01169194|Black Ulcerative Colitis|black ulcerative colitis
562315|NCT01169194|Black Indeterminate Colitis|black indeterminate colitis
562316|NCT01169181|Stroke|stroke
562317|NCT01169181|Cerebrovascular Accident|cerebrovascular accident
562318|NCT01169181|Plegia|plegia
562319|NCT01169181|Upper Extremity|upper extremity
562320|NCT01169181|rTMS|rtms
562321|NCT01169181|tDCS|tdcs
562322|NCT01169168|fibrinogen|fibrinogen
562323|NCT01169168|SIRS|sirs
562324|NCT01169168|sepsis|sepsis
562325|NCT01169168|liver disease|liver disease
562326|NCT01169168|chronic liver disease|chronic liver disease
562327|NCT01169168|septic shock|septic shock
562328|NCT01169155|Smoke inhalation injury|smoke inhalation injury
562329|NCT01169155|Burns|burns
562330|NCT01169155|Injuries|injuries
562331|NCT01169142|Vitamin D|vitamin d
562332|NCT01169142|Schizophrenia|schizophrenia
562333|NCT01169142|Severely Mentally Ill|severely mentally ill
562334|NCT01169129|brain metastases|brain metastases
562335|NCT01169129|radiosurgery|radiosurgery
562336|NCT01169129|neurosurgery|neurosurgery
562337|NCT01169129|surgery|surgery
562338|NCT01169129|radiotherapy|radiotherapy
711352|NCT00585169|Treatment|treatment
714189|NCT00572598|PET|pet
562339|NCT01169129|resectable brain metastases|resectable brain metastases
562340|NCT01169116|radiotherapy|radiotherapy
562341|NCT01169116|radiation oncology|radiation oncology
562342|NCT01169116|brain metastasis|brain metastasis
562343|NCT01169116|metastases|metastases
562344|NCT01169116|radiosurgery|radiosurgery
562345|NCT01169116|neurosurgery|neurosurgery
562346|NCT01169116|hypofractionation|hypofractionation
562347|NCT01169116|stereotaxy|stereotaxy
562348|NCT01169103|Obesity|obesity
562349|NCT01169103|Adolescent|adolescent
562350|NCT01169103|Insulin resistance|insulin resistance
562351|NCT01169103|Growth hormone|growth hormone
562352|NCT01169103|Visceral fat|visceral fat
562353|NCT01169103|Adolescent obesity|adolescent obesity
562354|NCT01169077|malaria, plasmodium falciparum, electroporation|malaria, plasmodium falciparum, electroporation
562355|NCT01169064|Wound infection prevention|wound infection prevention
562356|NCT01169064|Silver-containing surgical dressing|silver-containing surgical dressing
562357|NCT01169064|Cesarean delivery infection prevention|cesarean delivery infection prevention
562358|NCT01169051|Esophagectomy|esophagectomy
562359|NCT01169051|Pulmonary wedge resection|pulmonary wedge resection
562360|NCT01169051|Pulmonary lobectomy|pulmonary lobectomy
562361|NCT01169051|Pulmonary pneumonectomy|pulmonary pneumonectomy
562362|NCT01169051|Thoracic Surgery|thoracic surgery
562363|NCT01169051|Lung Cancer|lung cancer
562364|NCT01169051|Esophageal Cancer|esophageal cancer
562365|NCT01169038|sarcoidosis|sarcoidosis
562366|NCT01169038|mycobacteria|mycobacteria
562367|NCT01169038|lung|lung
562368|NCT01169038|pulmonary|pulmonary
562369|NCT01169038|radiographic improvement|radiographic improvement
562370|NCT01169025|Analgesia|analgesia
562371|NCT01169025|Pain|pain
562372|NCT01169012|Myelodysplastic syndrome|myelodysplastic syndrome
562373|NCT01169012|Acute Myeloid Leukemia|acute myeloid leukemia
562374|NCT01169012|Acute Lymphoblastic Leukemia|acute lymphoblastic leukemia
562375|NCT01169012|Chronic myelomonocytic leukemia|chronic myelomonocytic leukemia
562376|NCT01169012|Clofarabine|clofarabine
562377|NCT01169012|Clolar|clolar
562378|NCT01169012|University of North Carolina at Chapel Hill|university of north carolina at chapel hill
562379|NCT01169012|Lineberger Comprehensive Cancer Center|lineberger comprehensive cancer center
562380|NCT01168999|low back pain|low back pain
562381|NCT01168999|spinal manipulation|spinal manipulation
562382|NCT01168999|manual therapy|manual therapy
562383|NCT01168999|placebo|placebo
562384|NCT01168986|neck pain|neck pain
562385|NCT01168986|manual therapy|manual therapy
562386|NCT01168986|exercise|exercise
562387|NCT01168973|second line|second line
562388|NCT01168973|non small cell lung cancer|non small cell lung cancer
562389|NCT01168973|NSCLC|nsclc
562390|NCT01168973|phase 3|phase 3
562391|NCT01168973|ramucirumab|ramucirumab
562392|NCT01168973|lung cancer|lung cancer
562393|NCT01168973|docetaxel|docetaxel
562394|NCT01168973|taxotere|taxotere
562395|NCT01168947|sodium|sodium
562396|NCT01168947|hypertension|hypertension
562397|NCT01168947|fluid overload|fluid overload
562398|NCT01168947|hemodialysis|hemodialysis
562399|NCT01168947|dialysate|dialysate
562400|NCT01168947|interdialytic weight gain|interdialytic weight gain
562401|NCT01168947|intradialytic hypotension|intradialytic hypotension
562402|NCT01168934|healthy volunteers|healthy volunteers
562403|NCT01168934|crizotinib|crizotinib
562404|NCT01168934|absolute bioavailability|absolute bioavailability
562405|NCT01168934|pharmacokinetics|pharmacokinetics
562406|NCT01168921|Chronic Lymphocytic Leukemia|chronic lymphocytic leukemia
562408|NCT01168921|Thrombocytopenia|thrombocytopenia
562409|NCT01168921|Small lymphocytic lymphoma|small lymphocytic lymphoma
562410|NCT01168921|SLL|sll
562411|NCT01168921|Eltrombopag|eltrombopag
562412|NCT01168921|Promacta|promacta
562413|NCT01168921|thrombopoietin (TPO)-receptor agonist|thrombopoietin (tpo)-receptor agonist
562414|NCT01168921|platelets|platelets
562415|NCT01168908|Clinical trial|clinical trial
562416|NCT01168908|Revatio|revatio
562417|NCT01168908|Sildenafil|sildenafil
562418|NCT01168908|Muscular Dystrophy|muscular dystrophy
562419|NCT01168908|Duchenne|duchenne
562420|NCT01168908|Becker|becker
562421|NCT01168908|Adult|adult
562422|NCT01168908|Adolescent|adolescent
562423|NCT01168895|75 mg dose strength|75 mg dose strength
562424|NCT01168895|Safety|safety
562425|NCT01168895|Pharmacokinetics|pharmacokinetics
562426|NCT01168882|RGB-286638|rgb-286638
562427|NCT01168882|Hematological Malignancies|hematological malignancies
562428|NCT01168869|Manifestation|manifestation
562429|NCT01168869|Coronary Heart Disease|coronary heart disease
562430|NCT01168869|Myocardial infarction|myocardial infarction
562431|NCT01168869|Angina pectoris|angina pectoris
562432|NCT01168869|Unheralded|unheralded
562433|NCT01168869|General Practice Research Database|general practice research database
562434|NCT01168869|Myocardial Ischaemia National Audit Project|myocardial ischaemia national audit project
562435|NCT01168869|CALIBER|caliber
562436|NCT01168817|Combination Drug Therapy|combination drug therapy
562437|NCT01168817|Phosphodiesterase inhibitors|phosphodiesterase inhibitors
562438|NCT01168804|multiple myeloma|multiple myeloma
562439|NCT01168804|bendamustine|bendamustine
562440|NCT01168804|bortezomib|bortezomib
562441|NCT01168804|dexamethasone|dexamethasone
562442|NCT01168791|Metastatic|metastatic
562443|NCT01168791|Front line|front line
562444|NCT01168765|Physical Activity, Mexican-American, Obesity, Diabetes, Nutrition, Border Health|physical activity, mexican-american, obesity, diabetes, nutrition, border health
562445|NCT01168752|Cancer|cancer
562446|NCT01168752|solid tumour|solid tumour
562447|NCT01168752|lymphoma|lymphoma
562734|NCT01167491|DAP12|dap12
562448|NCT01168752|dose-escalation|dose-escalation
562449|NCT01168752|Hsp90 inhibitor|hsp90 inhibitor
562450|NCT01168739|thermotolerance|thermotolerance
562451|NCT01168739|heat acclimation|heat acclimation
562452|NCT01168739|quercetin|quercetin
562453|NCT01168739|exertional heat illness|exertional heat illness
562454|NCT01168739|gastrointestinal barrier permeability|gastrointestinal barrier permeability
562455|NCT01168713|Adults with Community-Acquired Bacterial Pneumonia|adults with community-acquired bacterial pneumonia
562456|NCT01168700|Metabolic syndrome, Aged Garlic Extract, Insulin, inflammation, endothelium.|metabolic syndrome, aged garlic extract, insulin, inflammation, endothelium.
562458|NCT01168687|levetiracetam|levetiracetam
562459|NCT01168687|alcoholism|alcoholism
562460|NCT01168687|genetics|genetics
562461|NCT01168687|subjective report|subjective report
562462|NCT01168674|Major Depressive Disorder|major depressive disorder
562463|NCT01168674|MDD|mdd
562464|NCT01168674|Bipolar Disorder|bipolar disorder
562465|NCT01168674|BD|bd
562466|NCT01168674|Depression|depression
562467|NCT01168674|Major Depressive Disorder with Bipolar features|major depressive disorder with bipolar features
562468|NCT01168661|Stress|stress
562469|NCT01168661|Burnout|burnout
562470|NCT01168661|Anxiety|anxiety
562471|NCT01168661|Depression|depression
562472|NCT01168648|Yoga|yoga
562473|NCT01168648|Stress|stress
562474|NCT01168648|Stress management|stress management
562475|NCT01168648|Hypothalamus-pituitary-adrenal axis|hypothalamus-pituitary-adrenal axis
562476|NCT01168635|Asthma|asthma
562477|NCT01168635|Spirometry|spirometry
562478|NCT01168635|Pediatric|pediatric
562479|NCT01168635|Primary Health Care|primary health care
562480|NCT01168635|Education, Distance|education, distance
562481|NCT01168609|Left atrial distensibility|left atrial distensibility
562482|NCT01168609|left ventricular filling pressure|left ventricular filling pressure
562483|NCT01168609|tissue Doppler|tissue doppler
562484|NCT01168609|prognosis|prognosis
562485|NCT01168609|acute myocardial infarction|acute myocardial infarction
562486|NCT01168596|Parkinson's Disease|parkinson's disease
562487|NCT01168596|Fatigue|fatigue
562488|NCT01168570|familial Mediterranean fever|familial mediterranean fever
562489|NCT01168570|amyloidosis AA|amyloidosis aa
562490|NCT01168570|serum amyloid A|serum amyloid a
562491|NCT01168570|renal failure|renal failure
562492|NCT01168570|nephrotic syndrome|nephrotic syndrome
562493|NCT01168557|electric impedance tomography|electric impedance tomography
562494|NCT01168557|stress-echocardiography|stress-echocardiography
562495|NCT01168557|ventilation|ventilation
562496|NCT01168557|perfusion|perfusion
562497|NCT01168544|Vitamin D|vitamin d
562498|NCT01168544|Colecalciferol|colecalciferol
562499|NCT01168544|Nursing home|nursing home
562500|NCT01168544|Loading dose|loading dose
562501|NCT01168531|patients undergoing lumbar spinal surgery|patients undergoing lumbar spinal surgery
562502|NCT01168518|Evaluate the Sorin Group new passive- and active- fixation pacing leads|evaluate the sorin group new passive- and active- fixation pacing leads
562503|NCT01168492|pediatric|pediatric
562504|NCT01168492|gastroscopy|gastroscopy
562505|NCT01168492|colonoscopy|colonoscopy
562506|NCT01168492|sedation|sedation
562507|NCT01168492|ketamine|ketamine
562508|NCT01168479|prostate cancer|prostate cancer
562509|NCT01168479|external beam radiotherapy|external beam radiotherapy
562510|NCT01168479|dose escalation|dose escalation
562511|NCT01168479|dose painting|dose painting
562512|NCT01168479|95Gy in 35 fractions|95gy in 35 fractions
562513|NCT01168479|MRI|mri
562514|NCT01168479|FLAME|flame
562515|NCT01168466|Frontotemporal Lobar Degeneration|frontotemporal lobar degeneration
562516|NCT01168466|EEG Biofeedback|eeg biofeedback
562517|NCT01168466|Cerebral oxygenation biofeedback|cerebral oxygenation biofeedback
562518|NCT01168466|Frontotemporal Dementia|frontotemporal dementia
562519|NCT01168466|Peak Alpha Amplitude|peak alpha amplitude
562520|NCT01168466|Quantitative EEG Assessment|quantitative eeg assessment
562521|NCT01168453|jugular vein|jugular vein
562522|NCT01168453|anatomy|anatomy
562523|NCT01168453|ultrasonography|ultrasonography
562524|NCT01168440|von Hippel-Lindau|von hippel-lindau
562525|NCT01168440|VHL|vhl
562526|NCT01168440|sunitinib|sunitinib
562527|NCT01168401|Vaccine, norovirus, acute gastroenteritis|vaccine, norovirus, acute gastroenteritis
562528|NCT01168388|Dystonia|dystonia
562529|NCT01168388|Hemifacial spasm|hemifacial spasm
562530|NCT01168388|Cervical dystonia|cervical dystonia
562531|NCT01168388|Blepharospasm|blepharospasm
562532|NCT01168362|coronary artery disease|coronary artery disease
562533|NCT01168362|cardiovascular risk|cardiovascular risk
562534|NCT01168362|pericardial fat|pericardial fat
562535|NCT01168336|betahistine olanzapine weight sleepiness|betahistine olanzapine weight sleepiness
562536|NCT01168336|olanzapine induced weight gain and sleepiness|olanzapine induced weight gain and sleepiness
562537|NCT01168323|Medical Education|medical education
562538|NCT01168323|Educational Technology|educational technology
562539|NCT01168323|Clinical Practice Guideline|clinical practice guideline
562540|NCT01168323|Prostate specific antigen|prostate specific antigen
562541|NCT01168310|Pulmonary, Obstructive, lungs, COPD|pulmonary, obstructive, lungs, copd
562542|NCT01168297|Obesity|obesity
562543|NCT01168297|Type 2 Diabetes Mellitus|type 2 diabetes mellitus
562544|NCT01168297|Genetics|genetics
562545|NCT01168297|Energy Expenditure|energy expenditure
562546|NCT01168297|Physical Activity|physical activity
562547|NCT01168284|Autism Spectrum Disorders|autism spectrum disorders
562548|NCT01168271|Observational|observational
562549|NCT01168271|Newborns|newborns
562550|NCT01168271|Hospitalized|hospitalized
562551|NCT01168271|Febrile|febrile
562552|NCT01168271|Resistance|resistance
562553|NCT01168258|Diabetic Retinopathy|diabetic retinopathy
562554|NCT01168258|Diabetes|diabetes
562555|NCT01168258|Single Nucleotide Polymorphism (SNP)|single nucleotide polymorphism (snp)
562556|NCT01168258|Diabetic Macular Edema|diabetic macular edema
562557|NCT01168245|Alzheimer Disease|alzheimer disease
562558|NCT01168245|Dementia|dementia
562559|NCT01168245|Brain Diseases|brain diseases
562560|NCT01168245|Central Nervous System Diseases|central nervous system diseases
562561|NCT01168245|Nervous System Disease|nervous system disease
562562|NCT01168245|Cognitive Training|cognitive training
562563|NCT01168245|Cortical Reorganization|cortical reorganization
562564|NCT01168245|Brain Plasticity|brain plasticity
562565|NCT01168193|surgery|surgery
562566|NCT01168193|post operative|post operative
562567|NCT01168193|complications|complications
562568|NCT01168193|length of stay|length of stay
562569|NCT01168180|Traditional Thai Massage|traditional thai massage
562570|NCT01168180|Scapulocostal Syndrome|scapulocostal syndrome
562571|NCT01168167|Antiretroviral Therapy, Highly Active|antiretroviral therapy, highly active
562572|NCT01168167|MK 0518|mk 0518
562573|NCT01168167|HIV-1 DNA species|hiv-1 dna species
562574|NCT01168167|viral slope|viral slope
562575|NCT01168167|Ribonucleic Acid|ribonucleic acid
562576|NCT01168167|DNA, Complementary|dna, complementary
562577|NCT01168154|Diverticula|diverticula
562578|NCT01168154|Diverticular disease|diverticular disease
562579|NCT01168154|Diverticulitis|diverticulitis
562580|NCT01168154|Probiotics|probiotics
562581|NCT01168141|Castrate-resistant prostate cancer with bone metastasis|castrate-resistant prostate cancer with bone metastasis
562582|NCT01168128|Enteral Nutrition|enteral nutrition
562583|NCT01168128|Parenteral Nutrition|parenteral nutrition
562584|NCT01168128|Critically ill|critically ill
562585|NCT01168128|Nutrition Therapy|nutrition therapy
562586|NCT01168128|Nutrition Support|nutrition support
562587|NCT01168128|Practice Guidelines as Topic|practice guidelines as topic
562588|NCT01168128|Guideline Adherence|guideline adherence
562589|NCT01168128|Quality Assurance, Health Care|quality assurance, health care
562590|NCT01168128|Nutrition Surveys|nutrition surveys
562591|NCT01168128|Questionnaires|questionnaires
562592|NCT01168063|Helicobacter pylori|helicobacter pylori
562593|NCT01168063|Diagnostic molecular testing|diagnostic molecular testing
562594|NCT01168063|Antibiotic resistance|antibiotic resistance
562595|NCT01168063|Treatment protocols|treatment protocols
562596|NCT01168050|Malignant Skin Melanoma T0|malignant skin melanoma t0
562597|NCT01168050|stage III unresectable melanomas,|stage iii unresectable melanomas,
562598|NCT01168050|or stage IV melanomas with c-KIT mutation|or stage iv melanomas with c-kit mutation
562599|NCT01168050|or amplification.|or amplification.
562600|NCT01168037|Aorta|aorta
562601|NCT01168037|Aneurysm|aneurysm
562602|NCT01168037|endovascular|endovascular
562603|NCT01168037|stent-graft|stent-graft
562604|NCT01168024|Acute Kidney Injury|acute kidney injury
562605|NCT01168024|Iodinated Contrast Agent Retrieval|iodinated contrast agent retrieval
562606|NCT01168024|Coronary Sinus Cannulation|coronary sinus cannulation
562607|NCT01167985|antibacterial polyethyleneimine nanoparticles|antibacterial polyethyleneimine nanoparticles
562608|NCT01167985|quaternary ammonium|quaternary ammonium
562609|NCT01167985|dental|dental
562610|NCT01167985|Endodotnic|endodotnic
562611|NCT01167985|pulp|pulp
562612|NCT01167985|bacteria|bacteria
562613|NCT01167985|Root canal sealer|root canal sealer
562614|NCT01167985|temporary filling|temporary filling
562615|NCT01167985|provisional restoration|provisional restoration
562616|NCT01167972|M + mutation|m + mutation
562617|NCT01167972|Non Small Cell Lung Cancer adenocarcinoma|non small cell lung cancer adenocarcinoma
562618|NCT01167972|To determine the proportion of patients with M + mutation status among patients with NSCLC adenocarcinoma|to determine the proportion of patients with m + mutation status among patients with nsclc adenocarcinoma
562619|NCT01167959|Obesity|obesity
562620|NCT01167959|Diabetes|diabetes
562621|NCT01167959|Bariatric surgery|bariatric surgery
562622|NCT01167946|Alopecia Areata|alopecia areata
562623|NCT01167946|Alopecia totalis|alopecia totalis
562624|NCT01167946|Alopecia Universalis|alopecia universalis
562625|NCT01167946|Ophiasic alopecia|ophiasic alopecia
562626|NCT01167946|Oral Pulse steroid|oral pulse steroid
562627|NCT01167946|Methylprednisolone|methylprednisolone
562628|NCT01167933|Bioequivalence|bioequivalence
562629|NCT01167933|Crossover|crossover
562630|NCT01167933|Simvastatin|simvastatin
562631|NCT01167920|High Blood Pressure|high blood pressure
562632|NCT01167920|Hypertension|hypertension
562633|NCT01167920|Home Blood Pressure Measurements|home blood pressure measurements
562634|NCT01167920|Wireless communication of measurements|wireless communication of measurements
562735|NCT01167491|NKG2D|nkg2d
562635|NCT01167920|Wireless communication of blood pressure measurements|wireless communication of blood pressure measurements
562636|NCT01167907|ankle|ankle
562637|NCT01167907|arthrodesis|arthrodesis
562638|NCT01167907|internal fixation|internal fixation
562639|NCT01167907|bi/tri malleolar fracture|bi/tri malleolar fracture
562640|NCT01167894|Bioequivalence|bioequivalence
562641|NCT01167894|Crossover|crossover
562642|NCT01167894|Simvastatin|simvastatin
562643|NCT01167868|fostamatinib disodium|fostamatinib disodium
562644|NCT01167868|FosD|fosd
562645|NCT01167868|Japanese|japanese
562646|NCT01167868|Healthy volunteers|healthy volunteers
562647|NCT01167868|Phase 1|phase 1
562648|NCT01167868|Single and Multiple Ascending Dose Study|single and multiple ascending dose study
562649|NCT01167868|Healthy Japanese volunteers|healthy japanese volunteers
562650|NCT01167868|Healthy White volunteers|healthy white volunteers
562651|NCT01167855|Pediatric Asthma|pediatric asthma
562652|NCT01167855|Low-income|low-income
562653|NCT01167855|Arkansas Delta Region|arkansas delta region
562654|NCT01167829|Experimental|experimental
562655|NCT01167829|Acyline plus 27 oral testosterone pills|acyline plus 27 oral testosterone pills
562656|NCT01167829|taken 3x/day|taken 3x/day
562657|NCT01167803|Bariatric surgery|bariatric surgery
562658|NCT01167803|Anesthesia|anesthesia
562659|NCT01167790|Precancerous lesions of the oral mucosa|precancerous lesions of the oral mucosa
562660|NCT01167790|Fluorescence visualization|fluorescence visualization
562661|NCT01167777|CT|ct
562662|NCT01167777|GC|gc
562663|NCT01167777|NG|ng
562664|NCT01167777|chlamydia|chlamydia
562665|NCT01167777|gonorrhoeae|gonorrhoeae
562666|NCT01167764|hemoptysis|hemoptysis
562667|NCT01167764|recurrence|recurrence
562668|NCT01167751|Myocardial infarction|myocardial infarction
562669|NCT01167751|Bone marrow stem cells|bone marrow stem cells
562670|NCT01167751|AC133|ac133
562671|NCT01167738|adenocarcinoma of the pancreas|adenocarcinoma of the pancreas
562672|NCT01167738|stage IV pancreatic cancer|stage iv pancreatic cancer
562673|NCT01167725|mucinous adenocarcinoma of the colon|mucinous adenocarcinoma of the colon
562674|NCT01167725|stage III colon cancer|stage iii colon cancer
562675|NCT01167725|stage IV colon cancer|stage iv colon cancer
562676|NCT01167699|Oxycodone/naloxone|oxycodone/naloxone
562677|NCT01167699|patient preference|patient preference
562678|NCT01167699|WHO step I/II|who step i/ii
562679|NCT01167699|Moderate to severe non-malignant pain|moderate to severe non-malignant pain
562680|NCT01167686|Respiratory infection|respiratory infection
562681|NCT01167686|Viral infection|viral infection
562682|NCT01167686|Food supplement|food supplement
562683|NCT01167686|Goldtrain Plus (GT+)|goldtrain plus (gt+)
562684|NCT01167673|irritable bowel syndrome|irritable bowel syndrome
562685|NCT01167673|selenium|selenium
562686|NCT01167673|curcumin|curcumin
562687|NCT01167673|green tea|green tea
562688|NCT01167660|Coagulation tests|coagulation tests
562689|NCT01167660|Neonates|neonates
562690|NCT01167660|Non invasive|non invasive
562691|NCT01167647|Tuberculosis, culture, bronchoscopy|tuberculosis, culture, bronchoscopy
562692|NCT01167634|Weight Loss|weight loss
562693|NCT01167634|Motivation|motivation
562694|NCT01167634|Contracts|contracts
562695|NCT01167621|Refractory Acute Respiratory Distress Syndrome|refractory acute respiratory distress syndrome
562696|NCT01167621|Indexed Extra-vascular Lung Water|indexed extra-vascular lung water
562697|NCT01167621|HFO-ventilation|hfo-ventilation
562698|NCT01167608|Parkinson's disease|parkinson's disease
562699|NCT01167608|Depression|depression
562700|NCT01167608|Anxiety|anxiety
562701|NCT01167608|Treatment|treatment
562702|NCT01167595|Critically ill|critically ill
562703|NCT01167595|Nutrition therapy|nutrition therapy
562704|NCT01167595|Enteral nutrition|enteral nutrition
562705|NCT01167582|blood transfusion|blood transfusion
562706|NCT01167582|red blood cell transfusion|red blood cell transfusion
562707|NCT01167582|myocardial infarction|myocardial infarction
562708|NCT01167582|acute coronary syndrome|acute coronary syndrome
562709|NCT01167582|anemia|anemia
562710|NCT01167569|Free Radicals|free radicals
562711|NCT01167569|Ascorbic Acid|ascorbic acid
562712|NCT01167569|Cardiac Surgery|cardiac surgery
562713|NCT01167569|Prevention of Reperfusion Injury|prevention of reperfusion injury
562714|NCT01167556|Family intervention|family intervention
562715|NCT01167556|Recent-onset schizophrenia|recent-onset schizophrenia
562716|NCT01167556|Motivational Interviewing|motivational interviewing
562717|NCT01167556|Cannabis use|cannabis use
562718|NCT01167530|Everolimus|everolimus
562719|NCT01167530|Radiotherapy|radiotherapy
562720|NCT01167530|Chemotherapy|chemotherapy
562721|NCT01167517|Breast milk|breast milk
562722|NCT01167517|Feeding|feeding
562723|NCT01167517|Prematurity|prematurity
562724|NCT01167517|Low birth weight infant|low birth weight infant
562725|NCT01167517|Low maternal breast milk feeding|low maternal breast milk feeding
562726|NCT01167504|saliva|saliva
562727|NCT01167504|food|food
562728|NCT01167504|sensory|sensory
562729|NCT01167504|oral health|oral health
562730|NCT01167504|film|film
562731|NCT01167504|pellicle|pellicle
562732|NCT01167491|Wegener|wegener
562733|NCT01167491|CD4+ T cells|cd4+ t cells
562736|NCT01167478|Exercise|exercise
562737|NCT01167478|Caffeine|caffeine
562738|NCT01167478|Reserve|reserve
562739|NCT01167465|Diaper Dermatitis|diaper dermatitis
562740|NCT01167465|Diaper Rash|diaper rash
562741|NCT01167465|Erythema|erythema
562742|NCT01167452|Obesity|obesity
562743|NCT01167452|Pharmacokinetics|pharmacokinetics
562744|NCT01167452|MRSA|mrsa
562745|NCT01167452|Tuberculosis|tuberculosis
562746|NCT01167452|PCP|pcp
562747|NCT01167439|OPMD, dysphagia|opmd, dysphagia
562748|NCT01167439|Dysphagia severity|dysphagia severity
562749|NCT01167439|Nutritional state|nutritional state
562750|NCT01167439|Speech quality|speech quality
562751|NCT01167439|Upper esophageal sphincter myotomy|upper esophageal sphincter myotomy
562752|NCT01167426|Relapsing Remitting Multiple Sclerosis|relapsing remitting multiple sclerosis
562753|NCT01167426|RRMS|rrms
562754|NCT01167426|Clinically Isolated Syndrome|clinically isolated syndrome
562755|NCT01167426|CIS|cis
562756|NCT01167426|Copaxone|copaxone
562757|NCT01167426|glatiramer acetate|glatiramer acetate
562758|NCT01167426|Autoject 2|autoject 2
562759|NCT01167400|exercise|exercise
562760|NCT01167400|executive function|executive function
562761|NCT01167400|older adults|older adults
562762|NCT01167387|carbohydrate|carbohydrate
562763|NCT01167387|glucose metabolism|glucose metabolism
562764|NCT01167387|surgery, outcome|surgery, outcome
562765|NCT01167387|major elective surgery|major elective surgery
562766|NCT01167387|urology|urology
562767|NCT01167387|hyperglicemia|hyperglicemia
562768|NCT01167374|HCC|hcc
562769|NCT01167361|upper respiratory tract infection|upper respiratory tract infection
562770|NCT01167361|lower respiratory tract infection|lower respiratory tract infection
562771|NCT01167348|auricular acupressure|auricular acupressure
562772|NCT01167348|obesity|obesity
562773|NCT01167348|schizophrenia|schizophrenia
562774|NCT01167348|body weight|body weight
562775|NCT01167335|partial onset seizure|partial onset seizure
562776|NCT01167335|seizure frequency|seizure frequency
562777|NCT01167335|nervous system diseases|nervous system diseases
562778|NCT01167335|central nervous system diseases|central nervous system diseases
562779|NCT01167335|CNS|cns
562780|NCT01167335|brain diseases|brain diseases
562781|NCT01167335|neurologic manifestations|neurologic manifestations
562782|NCT01167335|adjunctive treatment|adjunctive treatment
562783|NCT01167335|AEDs|aeds
562784|NCT01167335|antiepileptic drug|antiepileptic drug
562785|NCT01167322|NPC-07, 5-ALA, photodynamic diagnosis, pharmacokinetics|npc-07, 5-ala, photodynamic diagnosis, pharmacokinetics
562786|NCT01167309|Safety and tolerability of LEO 27847|safety and tolerability of leo 27847
562787|NCT01167296|Intrauterine adhesion|intrauterine adhesion
562788|NCT01167296|Cook balloon uterine stent|cook balloon uterine stent
562789|NCT01167283|COPD|copd
562790|NCT01167270|Infant Diet|infant diet
562791|NCT01167270|Toddler Diet|toddler diet
562792|NCT01167270|Responsive Feeding|responsive feeding
562793|NCT01167270|Infant Temperament|infant temperament
562794|NCT01167270|Parent competency|parent competency
562795|NCT01167270|Childhood Obesity prevention|childhood obesity prevention
562796|NCT01167270|Rapid infant weight gain|rapid infant weight gain
562797|NCT01167257|Overactive bladder|overactive bladder
562798|NCT01167257|Detrusor overactivity|detrusor overactivity
562799|NCT01167257|Liposome|liposome
562800|NCT01167257|Botulinum toxin A|botulinum toxin a
562801|NCT01167231|Diabetes|diabetes
562802|NCT01167231|Acarbose|acarbose
562803|NCT01167218|verify now assay for hematological disorders|verify now assay for hematological disorders
562804|NCT01167205|Healthy adults with BMI over 25.0 kg/m2|healthy adults with bmi over 25.0 kg/m2
562805|NCT01167179|head and neck cancer|head and neck cancer
562806|NCT01167179|nurse-led care|nurse-led care
562807|NCT01167179|follow-up care|follow-up care
562808|NCT01167179|professional-patient relations|professional-patient relations
562809|NCT01167179|psychosocial adjustment|psychosocial adjustment
562810|NCT01167179|quasi-experimental|quasi-experimental
562811|NCT01167179|prospective|prospective
562812|NCT01167179|quality of life|quality of life
562813|NCT01167166|Acute Myelocytic Leukemia|acute myelocytic leukemia
562814|NCT01167166|Acute Lymphocytic Leukemia|acute lymphocytic leukemia
562815|NCT01167166|Myeloproliferative Disease|myeloproliferative disease
562816|NCT01167166|Myelofibrosis|myelofibrosis
711353|NCT00585169|Memantine|memantine
562817|NCT01167166|Essential thrombocythemia|essential thrombocythemia
562818|NCT01167166|Polycythemia vera|polycythemia vera
562819|NCT01167166|Chronic Myeloid Leukemia|chronic myeloid leukemia
562820|NCT01167153|Hypertension|hypertension
562821|NCT01167153|Valsartan Amlodipine single pill combination|valsartan amlodipine single pill combination
562822|NCT01167153|BP control|bp control
562823|NCT01167153|ABPM|abpm
562824|NCT01167153|Hypertensive patients not adequately controlled by mono antihypertensive drugs|hypertensive patients not adequately controlled by mono antihypertensive drugs
562825|NCT01167127|Oxycodone/naloxone|oxycodone/naloxone
562826|NCT01167127|pain relief|pain relief
562827|NCT01167127|bowel function|bowel function
562828|NCT01167127|moderate to severe non-malignant pain|moderate to severe non-malignant pain
562829|NCT01167114|STA-9090|sta-9090
562830|NCT01167101|Rebamipide|rebamipide
563225|NCT01165203|safety|safety
562831|NCT01167101|gastric ulcer|gastric ulcer
562832|NCT01167101|healing rate|healing rate
562833|NCT01167101|iatrogenic gastric ulcer after endoscopic submucosal dissection|iatrogenic gastric ulcer after endoscopic submucosal dissection
562834|NCT01167088|Double-blind|double-blind
562835|NCT01167088|Placebo-controlled|placebo-controlled
562836|NCT01167088|Non-alcoholic fatty liver disease|non-alcoholic fatty liver disease
562837|NCT01167088|NAFLD|nafld
562838|NCT01167075|critically ill|critically ill
562839|NCT01167075|sepsis|sepsis
562840|NCT01167075|antioxidants|antioxidants
562841|NCT01167075|enteral nutrition|enteral nutrition
562842|NCT01167075|SIRS (APACHE score 10-30)|sirs (apache score 10-30)
562843|NCT01167075|enteral feeding within 48 h of admission|enteral feeding within 48 h of admission
562844|NCT01167049|gastric cancer with liver metastasis|gastric cancer with liver metastasis
562845|NCT01167036|Myofascial pain syndrome|myofascial pain syndrome
562846|NCT01167036|Trigger points, Myofascial|trigger points, myofascial
562847|NCT01167036|Chiropractic|chiropractic
562848|NCT01167036|Massage|massage
562849|NCT01167036|Musculoskeletal manipulation|musculoskeletal manipulation
562850|NCT01167023|Sickle Cell Disease|sickle cell disease
562851|NCT01167023|Sickle Cell Anemia|sickle cell anemia
562852|NCT01167023|Adult|adult
562853|NCT01166997|Pulmonary embolism|pulmonary embolism
562854|NCT01166997|Pulmonary thromboembolism|pulmonary thromboembolism
562855|NCT01166997|anticoagulation|anticoagulation
562856|NCT01166997|thrombolysis|thrombolysis
562857|NCT01166997|ultrasound accelerated thrombolysis|ultrasound accelerated thrombolysis
562858|NCT01166984|sepsis|sepsis
562859|NCT01166984|septic shock|septic shock
562860|NCT01166971|presbyopia|presbyopia
562861|NCT01166971|intraocular lens|intraocular lens
562862|NCT01166945|Child|child
562863|NCT01166945|Child, preschool|child, preschool
562864|NCT01166945|Sinusitis|sinusitis
562865|NCT01166945|Antimicrobial agents|antimicrobial agents
562866|NCT01166932|pneumonia|pneumonia
562867|NCT01166932|children|children
562868|NCT01166932|antibiotics|antibiotics
562869|NCT01166906|pain blocking|pain blocking
562870|NCT01166893|burn wound|burn wound
562871|NCT01166880|assessment|assessment
562872|NCT01166867|assessment|assessment
562873|NCT01166854|muscle and bone disease|muscle and bone disease
562874|NCT01166841|minimally invasive cardiac surgery|minimally invasive cardiac surgery
562875|NCT01166841|cardiac surgery|cardiac surgery
562876|NCT01166841|near infrared spectroscopy|near infrared spectroscopy
562877|NCT01166841|mitral valve repair|mitral valve repair
562878|NCT01166841|mitral valve replacement|mitral valve replacement
562879|NCT01166828|Spinal cord injury|spinal cord injury
562880|NCT01166828|telehealth|telehealth
562881|NCT01166828|pressure ulcers|pressure ulcers
562882|NCT01166828|quality of life|quality of life
562883|NCT01166815|diarrhea morbidity|diarrhea morbidity
562884|NCT01166815|malaria incidence|malaria incidence
562885|NCT01166815|zinc supplementation|zinc supplementation
562886|NCT01166802|questionnaire development|questionnaire development
562887|NCT01166802|hypervigilance|hypervigilance
562888|NCT01166802|pain sensitivity|pain sensitivity
562889|NCT01166789|IBS|ibs
562890|NCT01166789|pain threshold|pain threshold
562891|NCT01166789|constipation|constipation
562892|NCT01166776|Wharton's jelly|wharton's jelly
562893|NCT01166776|umbilical cord|umbilical cord
562894|NCT01166776|decellularization|decellularization
562895|NCT01166763|breast atypia|breast atypia
562896|NCT01166763|high risk for breast cancer|high risk for breast cancer
562897|NCT01166763|random periareolar fine needle aspiration|random periareolar fine needle aspiration
562898|NCT01166763|RPFNA|rpfna
562899|NCT01166763|breast epithelial hyperplasia|breast epithelial hyperplasia
562900|NCT01166763|ki-67|ki-67
562901|NCT01166763|chemoprevention|chemoprevention
562902|NCT01166763|vitamin D3|vitamin d3
562903|NCT01166763|Additional relevant MeSH terms:|additional relevant mesh terms:
562904|NCT01166763|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action
562905|NCT01166763|Physiological Effects of Drugs|physiological effects of drugs
562906|NCT01166763|Breast Neoplasms|breast neoplasms
562907|NCT01166763|Pharmacologic Actions|pharmacologic actions
562908|NCT01166763|Hyperplasia|hyperplasia
562909|NCT01166763|high risk for development of breast cancer|high risk for development of breast cancer
562910|NCT01166763|Neoplasms|neoplasms
562911|NCT01166763|Neoplasms by Site|neoplasms by site
562912|NCT01166763|Pathologic Processes|pathologic processes
562913|NCT01166763|Antirheumatic Agents|antirheumatic agents
562914|NCT01166763|Breast Diseases|breast diseases
562915|NCT01166737|Ovarian Cancer|ovarian cancer
562916|NCT01166737|Cancer of the fallopian tube|cancer of the fallopian tube
562917|NCT01166737|Primary peritoneal cancer|primary peritoneal cancer
562918|NCT01166737|Recurrent disease|recurrent disease
562919|NCT01166737|Platinum-sensitive|platinum-sensitive
562920|NCT01166737|Surgery|surgery
562921|NCT01166737|Chemotherapy|chemotherapy
562922|NCT01166737|Quality of Life|quality of life
562923|NCT01166737|First recurrence of platinum sensitive:|first recurrence of platinum sensitive:
562924|NCT01166737|Fallopian Tube Cancer|fallopian tube cancer
562925|NCT01166737|or Ovarian Cancer|or ovarian cancer
562926|NCT01166737|or Peritoneal Cavity Cancer|or peritoneal cavity cancer
562927|NCT01166724|Kidney transplant|kidney transplant
562928|NCT01166698|Safety|safety
562929|NCT01166698|tolerability|tolerability
562930|NCT01166698|healthy|healthy
562931|NCT01166698|inhalation|inhalation
562932|NCT01166685|coronary artery disease|coronary artery disease
562933|NCT01166685|drug-eluting stent|drug-eluting stent
562934|NCT01166685|anti-thrombotic therapy|anti-thrombotic therapy
562935|NCT01166685|bare-metal stent|bare-metal stent
562936|NCT01166685|long-term outcome|long-term outcome
562937|NCT01166672|obese women (BMI greater than or equal to 30), do not already have a diagnosis of lymphedema, who are done|obese women (bmi greater than or equal to 30), do not already have a diagnosis of lymphedema, who are done
562938|NCT01166672|with surgery, chemotherapy, and radiation therapy, and who were diagnosed with breast cancer within the|with surgery, chemotherapy, and radiation therapy, and who were diagnosed with breast cancer within the
562939|NCT01166672|past 2 years will be invited to participate.|past 2 years will be invited to participate.
562940|NCT01166659|Glaucoma|glaucoma
562941|NCT01166659|Glaucoma device|glaucoma device
562942|NCT01166659|Glaucoma surgery|glaucoma surgery
562943|NCT01166659|Intraocular pressure|intraocular pressure
562944|NCT01166633|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors
562945|NCT01166633|hyperlipidemia|hyperlipidemia
562946|NCT01166594|Glaucoma|glaucoma
562947|NCT01166594|Elevated Intraocular Pressure (IOP)|elevated intraocular pressure (iop)
562948|NCT01166594|Optic Neuropathy|optic neuropathy
562949|NCT01166594|Bleb Failure|bleb failure
562950|NCT01166594|Avastin (Bevacizumab)|avastin (bevacizumab)
562951|NCT01166581|early stage breast cancer|early stage breast cancer
562952|NCT01166581|preoperative breast MRI|preoperative breast mri
562953|NCT01166581|mastectomy|mastectomy
562954|NCT01166568|Presbyopia|presbyopia
562955|NCT01166568|Reading Vision|reading vision
562956|NCT01166568|Near Vision|near vision
562957|NCT01166555|Safety and tolerability|safety and tolerability
562958|NCT01166555|Pharmacokinetics|pharmacokinetics
562959|NCT01166555|PF-04236921|pf-04236921
562960|NCT01166555|Rheumatoid Arthritis|rheumatoid arthritis
562961|NCT01166542|carcinoma|carcinoma
562962|NCT01166542|squamous cell|squamous cell
562963|NCT01166542|head|head
562964|NCT01166542|neck|neck
562965|NCT01166542|REOLYSIN (Reovirus Type 3 Dearing)|reolysin (reovirus type 3 dearing)
562966|NCT01166542|chemotherapy|chemotherapy
562967|NCT01166542|Carboplatin|carboplatin
562968|NCT01166542|Paclitaxel|paclitaxel
562969|NCT01166542|metastatic|metastatic
562970|NCT01166542|recurrent|recurrent
562971|NCT01166516|Prolonged air leak|prolonged air leak
562972|NCT01166516|lobectomy|lobectomy
562973|NCT01166516|segmentectomy|segmentectomy
562974|NCT01166516|lung volume reduction surgery (LVRS)|lung volume reduction surgery (lvrs)
562975|NCT01166503|pediatrics|pediatrics
562976|NCT01166503|Esotropia|esotropia
562977|NCT01166503|Surgery|surgery
562978|NCT01166490|Monomethyl auristatin E (MMAE)|monomethyl auristatin e (mmae)
562979|NCT01166490|Immunotherapy|immunotherapy
562980|NCT01166490|AGS-5 Antigen|ags-5 antigen
562981|NCT01166490|SLC44A4 Antigen|slc44a4 antigen
562982|NCT01166490|Gastric Neoplasms|gastric neoplasms
562983|NCT01166490|Pancreatic Neoplasms|pancreatic neoplasms
562984|NCT01166490|Antibody-Drug Conjugate|antibody-drug conjugate
562985|NCT01166490|Antibodies, Monoclonal|antibodies, monoclonal
562986|NCT01166490|Drug Therapy|drug therapy
562987|NCT01166464|tobacco|tobacco
562988|NCT01166464|smoking|smoking
562989|NCT01166464|text message|text message
562990|NCT01166464|therapy|therapy
562991|NCT01166451|iron deficiency anemia|iron deficiency anemia
562992|NCT01166451|cognitive development|cognitive development
562993|NCT01166451|motor development|motor development
562994|NCT01166438|incontinence|incontinence
562995|NCT01166438|overactive bladder|overactive bladder
562996|NCT01166438|botox|botox
562997|NCT01166438|anticholinergic|anticholinergic
562998|NCT01166399|Fecal Incontinence,|fecal incontinence,
562999|NCT01166399|bowel incontinence,|bowel incontinence,
563000|NCT01166399|pelvic floor disorder|pelvic floor disorder
563001|NCT01166386|rehabilitation|rehabilitation
563002|NCT01166386|brain injury|brain injury
563003|NCT01166373|prolapse|prolapse
563004|NCT01166373|urinary incontinence|urinary incontinence
563005|NCT01166373|uterosacral vaginal vault ligament suspension|uterosacral vaginal vault ligament suspension
563006|NCT01166373|sacrospinous ligament fixation|sacrospinous ligament fixation
563007|NCT01166373|behavioral therapy|behavioral therapy
563008|NCT01166373|pelvic muscle training|pelvic muscle training
563009|NCT01166360|Risk prediction|risk prediction
563010|NCT01166360|Euroscore|euroscore
563011|NCT01166360|GDF-15|gdf-15
563012|NCT01166360|hsTnT|hstnt
563013|NCT01166360|cardiac surgery|cardiac surgery
563014|NCT01166334|Smoking|smoking
563015|NCT01166334|Smoke|smoke
563016|NCT01166334|Cigarette|cigarette
563017|NCT01166334|Cessation|cessation
563018|NCT01166334|Quit|quit
563019|NCT01166334|Online|online
563020|NCT01166334|Web|web
563021|NCT01166334|Stop|stop
563022|NCT01166321|Atypical Meningioma|atypical meningioma
563776|NCT01162863|IBSC|ibsc
563023|NCT01166308|Recurrent Glioma|recurrent glioma
563024|NCT01166282|inflammatory back pain|inflammatory back pain
563025|NCT01166282|ankylosing spondylitis|ankylosing spondylitis
563026|NCT01166282|sacroiliitis|sacroiliitis
563027|NCT01166282|Juvenile Idiopathic Arthritis|juvenile idiopathic arthritis
563028|NCT01166282|enthesitis|enthesitis
563029|NCT01166282|arthritis|arthritis
563030|NCT01166269|grass-pollen allergy|grass-pollen allergy
563031|NCT01166256|respiratory failure|respiratory failure
563032|NCT01166243|Hemostasis|hemostasis
563033|NCT01166217|Single Dose Study in Healthy Subjects|single dose study in healthy subjects
563034|NCT01166204|Radiotherapy|radiotherapy
563035|NCT01166204|NSCLC|nsclc
563036|NCT01166191|Radiotherapy|radiotherapy
563037|NCT01166191|SCLC|sclc
563038|NCT01166178|Multiple Sclerosis|multiple sclerosis
563039|NCT01166178|Osteoporosis|osteoporosis
563040|NCT01166178|Zoledronic Acid|zoledronic acid
563041|NCT01166165|Hypertension|hypertension
563042|NCT01166165|blood pressure|blood pressure
563043|NCT01166165|vitamin d|vitamin d
563044|NCT01166165|winter|winter
563045|NCT01166165|cholecalciferol|cholecalciferol
563046|NCT01166165|arterial stiffness|arterial stiffness
563047|NCT01166165|renin|renin
563048|NCT01166165|angiotensin|angiotensin
563049|NCT01166165|aldosterone|aldosterone
563050|NCT01166165|calcium|calcium
563051|NCT01166152|autistic spectrum disorders|autistic spectrum disorders
563052|NCT01166152|developmental disorders|developmental disorders
563053|NCT01166139|Systemic Sclerosis|systemic sclerosis
563054|NCT01166113|Pomalidomide|pomalidomide
563055|NCT01166113|Relapsed/Refractory to Lenalidomide|relapsed/refractory to lenalidomide
563056|NCT01166100|Bioequivalence|bioequivalence
563057|NCT01166100|Crossover|crossover
563058|NCT01166100|Fluoxetine Hydrochloride|fluoxetine hydrochloride
563059|NCT01166087|Bioequivalence|bioequivalence
563060|NCT01166087|Crossover|crossover
563061|NCT01166087|Fluoxetine Hydrochloride|fluoxetine hydrochloride
563062|NCT01166061|Grass Allergy|grass allergy
563063|NCT01166061|Immunotherapy|immunotherapy
563064|NCT01166061|Rhinoconjunctivitis|rhinoconjunctivitis
563065|NCT01166061|ToleroMune Grass|toleromune grass
563066|NCT01166048|Chronic Low Back Pain|chronic low back pain
563067|NCT01166048|Radicular component|radicular component
563068|NCT01166048|neuropathic pain|neuropathic pain
563069|NCT01166048|duloxetine|duloxetine
563070|NCT01166048|CLBP|clbp
563071|NCT01166035|Solid tumors|solid tumors
563072|NCT01166035|Lenalidomide|lenalidomide
563073|NCT01166035|Cetuximab|cetuximab
563074|NCT01166035|Colorectal Cancer|colorectal cancer
563075|NCT01166035|Non-Small Cell Lung Cancer|non-small cell lung cancer
563076|NCT01166035|Head and Neck Cancer|head and neck cancer
563077|NCT01166022|Spinal Muscular Atrophy|spinal muscular atrophy
563078|NCT01166022|Exercise|exercise
563079|NCT01166022|Conditioning|conditioning
563080|NCT01166022|Strengthening|strengthening
563081|NCT01166009|Data Collection|data collection
563082|NCT01166009|CIBMTR|cibmtr
563083|NCT01166009|NMDP|nmdp
563084|NCT01166009|Stem Cell Transplantation|stem cell transplantation
563085|NCT01165996|previously treated myelodysplastic syndromes|previously treated myelodysplastic syndromes
563086|NCT01165996|secondary myelodysplastic syndromes|secondary myelodysplastic syndromes
563087|NCT01165970|enamel|enamel
563088|NCT01165970|dentin|dentin
563089|NCT01165970|saliva substitute|saliva substitute
563090|NCT01165970|demineralization|demineralization
563091|NCT01165970|remineralization|remineralization
563092|NCT01165957|Knee replacement|knee replacement
563093|NCT01165957|Mobile and fixed bearings|mobile and fixed bearings
563094|NCT01165957|Volumetric wear|volumetric wear
563095|NCT01165957|Micro-CT analysis|micro-ct analysis
563096|NCT01165957|Articular and backside wear|articular and backside wear
563097|NCT01165944|Post transplant diabetes mellitus|post transplant diabetes mellitus
563098|NCT01165931|Coronary artery disease|coronary artery disease
563099|NCT01165905|cancer|cancer
563100|NCT01165905|solid malignancy|solid malignancy
563101|NCT01165905|tumor|tumor
563102|NCT01165905|malignant neoplasm|malignant neoplasm
711354|NCT00585169|Pharmacology|pharmacology
563103|NCT01165905|histologically confirmed solid malignancy|histologically confirmed solid malignancy
563104|NCT01165892|Pulmonary embolism|pulmonary embolism
563105|NCT01165892|contrast agent|contrast agent
563106|NCT01165879|Pregnancy|pregnancy
563107|NCT01165879|Term|term
563108|NCT01165879|Preterm|preterm
563109|NCT01165879|Uterine Contractions|uterine contractions
563110|NCT01165866|Ondansetron|ondansetron
563111|NCT01165866|Metoclopramide|metoclopramide
563112|NCT01165866|Gastroenteritis|gastroenteritis
563113|NCT01165840|Obesity|obesity
563114|NCT01165840|Pharmacokinetics|pharmacokinetics
563115|NCT01165840|Dapsone|dapsone
563116|NCT01165840|Leprosy|leprosy
563117|NCT01165840|Tuberculosis|tuberculosis
563118|NCT01165827|Aortic Valve Insufficiency|aortic valve insufficiency
563119|NCT01165827|Aortic Valve Stenosis|aortic valve stenosis
563120|NCT01165827|Aortic Valve Valvuloplasty|aortic valve valvuloplasty
563121|NCT01165827|Aortic valve Replacement|aortic valve replacement
563122|NCT01165827|Aortic valve Intervention|aortic valve intervention
563123|NCT01165814|Pain control after cesarean section|pain control after cesarean section
563125|NCT01165801|Cataract surgery|cataract surgery
563126|NCT01165801|Size of AMD|size of amd
563127|NCT01165801|Influence of cataract surgery on AMD Size|influence of cataract surgery on amd size
563128|NCT01165788|Blood and Marrow Transplant (BMT)|blood and marrow transplant (bmt)
563129|NCT01165736|pharmacokinetics|pharmacokinetics
563130|NCT01165736|safety|safety
563131|NCT01165736|tolerability|tolerability
563132|NCT01165736|Chronic Pain|chronic pain
563133|NCT01165723|safety|safety
563134|NCT01165723|tolerability|tolerability
563135|NCT01165723|pharmacokinetics|pharmacokinetics
563136|NCT01165723|pharmacodynamics|pharmacodynamics
563137|NCT01165723|chronic pain|chronic pain
563138|NCT01165710|Irregular heart beat|irregular heart beat
563139|NCT01165697|Fabry Disease|fabry disease
563140|NCT01165697|vascular disease|vascular disease
563141|NCT01165697|storage endotheliopathy|storage endotheliopathy
563142|NCT01165671|Primary Glioblastoma|primary glioblastoma
563143|NCT01165658|non-small cell lung cancer|non-small cell lung cancer
563144|NCT01165658|NSCLC|nsclc
563145|NCT01165658|small cell lung cancer|small cell lung cancer
563146|NCT01165658|SCLC|sclc
563147|NCT01165658|carcinoid|carcinoid
563148|NCT01165658|thymic cancer|thymic cancer
563149|NCT01165658|lung cancer|lung cancer
563150|NCT01165658|radiation therapy|radiation therapy
563151|NCT01165658|radiotherapy|radiotherapy
563152|NCT01165658|proton therapy|proton therapy
563153|NCT01165645|recurrent adult Hodgkin lymphoma|recurrent adult hodgkin lymphoma
563154|NCT01165554|Amyloid|amyloid
563155|NCT01165554|PET-Positron Emission Tomography|pet-positron emission tomography
563156|NCT01165554|SUVR-Standard uptake value ratios|suvr-standard uptake value ratios
563157|NCT01165502|MAD study CM3.1-AC100|mad study cm3.1-ac100
563158|NCT01165502|Healthy men, age 18 - 50|healthy men, age 18 - 50
563159|NCT01165489|Laryngomalacia|laryngomalacia
563160|NCT01165489|Congenital Anomalies|congenital anomalies
563161|NCT01165489|Associated Health Problems|associated health problems
563162|NCT01165476|treprostinil|treprostinil
563163|NCT01165476|bioavailability|bioavailability
563164|NCT01165476|bioequivalence|bioequivalence
563165|NCT01165463|Aging|aging
563166|NCT01165463|Healthy|healthy
563167|NCT01165450|persistent epithelial defect|persistent epithelial defect
563168|NCT01165450|cornea|cornea
563169|NCT01165437|Peripheral|peripheral
563170|NCT01165437|Arterial|arterial
563171|NCT01165437|Vascular|vascular
563172|NCT01165411|Central Catheterization|central catheterization
563173|NCT01165411|Central Line|central line
563174|NCT01165411|Database|database
563175|NCT01165411|Registry|registry
563176|NCT01165411|Registries|registries
563177|NCT01165398|Education|education
563178|NCT01165398|central lines|central lines
563179|NCT01165398|infections|infections
563180|NCT01165398|complications|complications
563181|NCT01165398|Bundles|bundles
563182|NCT01165385|Relapsed or refractory solid tumors|relapsed or refractory solid tumors
563183|NCT01165385|Pazopanib|pazopanib
563184|NCT01165385|Cisplatin|cisplatin
563185|NCT01165372|Malaria|malaria
563186|NCT01165372|Drug resistance|drug resistance
563187|NCT01165346|liver cancer|liver cancer
563188|NCT01165346|hepatocellular carcinoma|hepatocellular carcinoma
563189|NCT01165333|Paediatric oncology|paediatric oncology
563190|NCT01165333|Cilengitide|cilengitide
563191|NCT01165333|Glioma|glioma
563192|NCT01165307|Menorrhagia|menorrhagia
563193|NCT01165307|Endometrial ablation|endometrial ablation
563194|NCT01165307|Heavy menstrual bleeding|heavy menstrual bleeding
563195|NCT01165294|Ketamine|ketamine
563196|NCT01165281|Pain|pain
563197|NCT01165281|R331333 (JNS024ER, CG5503), tapentadol (NUCYNTA)|r331333 (jns024er, cg5503), tapentadol (nucynta)
563198|NCT01165281|Opioid analgesic|opioid analgesic
563199|NCT01165281|Oxycodone CR (OXYCONTIN CR)|oxycodone cr (oxycontin cr)
563200|NCT01165281|Chronic malignant tumor related cancer pain|chronic malignant tumor related cancer pain
563201|NCT01165255|congenital malformation|congenital malformation
563202|NCT01165255|cardiovascular malformation|cardiovascular malformation
563203|NCT01165255|cardiovascular defect|cardiovascular defect
563204|NCT01165255|antidepressants|antidepressants
563205|NCT01165255|pregnancy|pregnancy
563206|NCT01165255|first trimester|first trimester
563207|NCT01165255|Bupropion|bupropion
563208|NCT01165255|prevalence|prevalence
563209|NCT01165242|Neisseria meningitidis|neisseria meningitidis
563210|NCT01165242|Adult|adult
563211|NCT01165242|Adolescent|adolescent
563212|NCT01165242|Safety|safety
563213|NCT01165242|Vaccines, conjugate|vaccines, conjugate
563214|NCT01165242|Meningococcal vaccines|meningococcal vaccines
563215|NCT01165242|Immunogenicity|immunogenicity
563216|NCT01165229|Immunogenicity|immunogenicity
563217|NCT01165229|Subjects 70 years and older|subjects 70 years and older
563218|NCT01165229|Efficacy|efficacy
563219|NCT01165229|Herpes Zoster|herpes zoster
563220|NCT01165229|Safety|safety
563221|NCT01165229|Adults|adults
563222|NCT01165229|Vaccine|vaccine
563223|NCT01165203|immunogenicity|immunogenicity
563224|NCT01165203|vaccine|vaccine
563227|NCT01165203|Herpes Zoster|herpes zoster
563228|NCT01165177|subjects 50 years and older|subjects 50 years and older
563229|NCT01165177|vaccine|vaccine
563230|NCT01165177|immunogenicity|immunogenicity
563231|NCT01165177|efficacy|efficacy
563232|NCT01165177|Herpes Zoster|herpes zoster
563233|NCT01165177|safety|safety
563234|NCT01165164|Dry eye|dry eye
563235|NCT01165164|artificial tears|artificial tears
563236|NCT01165151|obesity|obesity
563237|NCT01165151|weight loss|weight loss
563238|NCT01165151|group size|group size
563239|NCT01165138|GW642444|gw642444
563240|NCT01165138|Vilanterol|vilanterol
563241|NCT01165138|Asthma|asthma
563242|NCT01165138|Fluticasone Furoate|fluticasone furoate
563243|NCT01165125|pharmacodynamics|pharmacodynamics
563244|NCT01165125|drug interaction|drug interaction
563245|NCT01165125|ketoconazole|ketoconazole
563246|NCT01165125|pharmacokinetics|pharmacokinetics
563247|NCT01165125|Fluticasone furoate|fluticasone furoate
563248|NCT01165125|GW642444|gw642444
563249|NCT01165099|acupuncture|acupuncture
563250|NCT01165099|induced labour|induced labour
563251|NCT01165099|labour outcome|labour outcome
563252|NCT01165099|nulliparae|nulliparae
563253|NCT01165099|pain-relief|pain-relief
563254|NCT01165099|epidural during labour|epidural during labour
563255|NCT01165073|Cirrhosis|cirrhosis
563256|NCT01165073|Malnutrition|malnutrition
563257|NCT01165073|Enteral nutrition|enteral nutrition
563258|NCT01165060|X-ALD|x-ald
563259|NCT01165060|AMN|amn
563260|NCT01165060|adrenomyeloneuropathy phenotype|adrenomyeloneuropathy phenotype
563261|NCT01164995|MK-1775|mk-1775
563262|NCT01164995|Carboplatin|carboplatin
563263|NCT01164995|epithelial ovarian cancer|epithelial ovarian cancer
563264|NCT01164995|p53|p53
563265|NCT01164956|methylphenidate|methylphenidate
563266|NCT01164956|fatigue|fatigue
563267|NCT01164917|Lupus|lupus
563268|NCT01164917|Discoid Lupus|discoid lupus
563269|NCT01164917|Cutaneous Lupus|cutaneous lupus
563270|NCT01164904|Inflammatory Bowel Disease|inflammatory bowel disease
563271|NCT01164904|Amgen|amgen
563272|NCT01164878|Cholestasis|cholestasis
563273|NCT01164878|Liver damage|liver damage
563274|NCT01164878|Parenteral Nutrition|parenteral nutrition
563275|NCT01164878|Aggressive Nutrition|aggressive nutrition
563276|NCT01164878|Preterm|preterm
563277|NCT01164878|Extreme low birth weight infant|extreme low birth weight infant
563278|NCT01164878|Parenteral Nutrition Associated Cholestasis|parenteral nutrition associated cholestasis
563279|NCT01164865|Soft Contact lens|soft contact lens
563280|NCT01164865|Multi-Purpose Solution|multi-purpose solution
563281|NCT01164865|Hydrogen Peroxide|hydrogen peroxide
563282|NCT01164839|coronary artery|coronary artery
563283|NCT01164839|CT angiography|ct angiography
563284|NCT01164839|image quality|image quality
563285|NCT01164839|multicenter trial|multicenter trial
563286|NCT01164826|Bioequivalence|bioequivalence
563287|NCT01164826|Crossover|crossover
563288|NCT01164826|Nabumetone|nabumetone
563289|NCT01164813|Bioequivalence|bioequivalence
563290|NCT01164813|Crossover|crossover
563291|NCT01164813|Nabumetone|nabumetone
563292|NCT01164800|Bioequivalence|bioequivalence
563293|NCT01164800|Crossover|crossover
563294|NCT01164800|Trandolapril|trandolapril
563295|NCT01164787|Bioequivalence|bioequivalence
563296|NCT01164787|Crossover|crossover
563297|NCT01164787|Trandolapril|trandolapril
563298|NCT01164774|Bioavailability|bioavailability
563299|NCT01164774|Crossover|crossover
563300|NCT01164774|Ramipril|ramipril
563301|NCT01164761|Bioavailability|bioavailability
563302|NCT01164761|Crossover|crossover
563303|NCT01164761|Ramipril|ramipril
563304|NCT01164722|anal cancer|anal cancer
563305|NCT01164722|HIV infection|hiv infection
563306|NCT01164722|human papilloma virus infection|human papilloma virus infection
563307|NCT01164722|neoplasm of uncertain malignant potential|neoplasm of uncertain malignant potential
563308|NCT01164722|high-grade squamous intraepithelial lesion|high-grade squamous intraepithelial lesion
711457|NCT00584597|TRAUMEEL|traumeel
563309|NCT01164709|refractory multiple myeloma|refractory multiple myeloma
563310|NCT01164709|recurrent adult acute myeloid leukemia|recurrent adult acute myeloid leukemia
563311|NCT01164709|recurrent adult acute lymphoblastic leukemia|recurrent adult acute lymphoblastic leukemia
563312|NCT01164709|recurrent adult diffuse large cell lymphoma|recurrent adult diffuse large cell lymphoma
563313|NCT01164709|recurrent adult Hodgkin lymphoma|recurrent adult hodgkin lymphoma
563314|NCT01164709|recurrent mantle cell lymphoma|recurrent mantle cell lymphoma
563315|NCT01164709|recurrent adult T-cell leukemia/lymphoma|recurrent adult t-cell leukemia/lymphoma
563316|NCT01164709|adult nasal type extranodal NK/T-cell lymphoma|adult nasal type extranodal nk/t-cell lymphoma
563317|NCT01164709|angioimmunoblastic T-cell lymphoma|angioimmunoblastic t-cell lymphoma
563318|NCT01164709|peripheral T-cell lymphoma|peripheral t-cell lymphoma
563319|NCT01164709|T-cell large granular lymphocyte leukemia|t-cell large granular lymphocyte leukemia
563320|NCT01164709|anaplastic large cell lymphoma|anaplastic large cell lymphoma
563321|NCT01164709|recurrent grade 3 follicular lymphoma|recurrent grade 3 follicular lymphoma
563322|NCT01164709|recurrent cutaneous T-cell non-Hodgkin lymphoma|recurrent cutaneous t-cell non-hodgkin lymphoma
563323|NCT01164709|recurrent mycosis fungoides/Sezary syndrome|recurrent mycosis fungoides/sezary syndrome
563324|NCT01164709|aggressive NK-cell leukemia|aggressive nk-cell leukemia
563325|NCT01164709|adult acute myeloid leukemia with 11q23 (MLL) abnormalities|adult acute myeloid leukemia with 11q23 (mll) abnormalities
563326|NCT01164709|adult acute myeloid leukemia with inv(16)(p13;q22)|adult acute myeloid leukemia with inv(16)(p13;q22)
563327|NCT01164709|adult acute myeloid leukemia with t(15;17)(q22;q12)|adult acute myeloid leukemia with t(15;17)(q22;q12)
563328|NCT01164709|adult acute myeloid leukemia with t(16;16)(p13;q22)|adult acute myeloid leukemia with t(16;16)(p13;q22)
563329|NCT01164709|adult acute myeloid leukemia with t(8;21)(q22;q22)|adult acute myeloid leukemia with t(8;21)(q22;q22)
563330|NCT01164709|secondary acute myeloid leukemia|secondary acute myeloid leukemia
563331|NCT01164709|stage III adult diffuse large cell lymphoma|stage iii adult diffuse large cell lymphoma
563332|NCT01164709|stage IV adult diffuse large cell lymphoma|stage iv adult diffuse large cell lymphoma
563333|NCT01164709|stage III adult Hodgkin lymphoma|stage iii adult hodgkin lymphoma
563334|NCT01164709|stage IV adult Hodgkin lymphoma|stage iv adult hodgkin lymphoma
563335|NCT01164709|stage III mantle cell lymphoma|stage iii mantle cell lymphoma
563336|NCT01164709|stage IV mantle cell lymphoma|stage iv mantle cell lymphoma
563337|NCT01164709|stage III adult T-cell leukemia/lymphoma|stage iii adult t-cell leukemia/lymphoma
563338|NCT01164709|stage IV adult T-cell leukemia/lymphoma|stage iv adult t-cell leukemia/lymphoma
563339|NCT01164709|stage III grade 3 follicular lymphoma|stage iii grade 3 follicular lymphoma
563340|NCT01164709|stage IV grade 3 follicular lymphoma|stage iv grade 3 follicular lymphoma
563341|NCT01164709|stage III mycosis fungoides/Sezary syndrome|stage iii mycosis fungoides/sezary syndrome
563342|NCT01164709|stage IV mycosis fungoides/Sezary syndrome|stage iv mycosis fungoides/sezary syndrome
563343|NCT01164709|stage III cutaneous T-cell non-Hodgkin lymphoma|stage iii cutaneous t-cell non-hodgkin lymphoma
563344|NCT01164709|stage IV cutaneous T-cell non-Hodgkin lymphoma|stage iv cutaneous t-cell non-hodgkin lymphoma
563345|NCT01164709|prolymphocytic leukemia|prolymphocytic leukemia
563346|NCT01164696|Quality of Life, Health Care Costs|quality of life, health care costs
563347|NCT01164683|sleep apnea|sleep apnea
563348|NCT01164683|adherence|adherence
563349|NCT01164657|upright position|upright position
563350|NCT01164657|birth position|birth position
563351|NCT01164657|childbirth|childbirth
563352|NCT01164657|instrumental deliveries|instrumental deliveries
563353|NCT01164657|primiparous|primiparous
563354|NCT01164644|ecchymosis|ecchymosis
563355|NCT01164644|bruising|bruising
563356|NCT01164644|rhinoplasty|rhinoplasty
563357|NCT01164644|nose job|nose job
563358|NCT01164644|arnica|arnica
563359|NCT01164644|arnica montana|arnica montana
563360|NCT01164631|Sleep Apnea Syndrome|sleep apnea syndrome
563361|NCT01164631|Orthodontics|orthodontics
563362|NCT01164631|Tonsillectomy|tonsillectomy
563363|NCT01164631|Child|child
563364|NCT01164618|pediatrics|pediatrics
563365|NCT01164618|Remote ischemic preconditioning|remote ischemic preconditioning
563366|NCT01164605|NRTI-regimen|nrti-regimen
563367|NCT01164605|Raltegravir|raltegravir
563368|NCT01164605|Elvitegravir|elvitegravir
563369|NCT01164605|HIV-1 integrase inhibitor|hiv-1 integrase inhibitor
563370|NCT01164605|Fat Waste|fat waste
563371|NCT01164592|Heart failure (HF)|heart failure (hf)
563372|NCT01164592|Sleep disordered breathing (SDB)|sleep disordered breathing (sdb)
563373|NCT01164592|Cheyne Stokes Respiration (CSR)|cheyne stokes respiration (csr)
563374|NCT01164592|Adaptive Servoventilation (ASV)|adaptive servoventilation (asv)
563375|NCT01164579|Early Rheumatoid Arthritis|early rheumatoid arthritis
563376|NCT01164579|Joint Structure|joint structure
563377|NCT01164579|Magnetic Resonance Imaging|magnetic resonance imaging
563378|NCT01164579|Janus Kinase (JAK) Inhibitor|janus kinase (jak) inhibitor
563379|NCT01164579|Tasocitinib|tasocitinib
563380|NCT01164579|Tofacitinib|tofacitinib
563381|NCT01164553|influenza, pediatric, vaccine|influenza, pediatric, vaccine
563382|NCT01164540|Deep venous thrombosis|deep venous thrombosis
563383|NCT01164540|Pulmonary embolism|pulmonary embolism
563384|NCT01164540|rosuvastatin treatment|rosuvastatin treatment
711458|NCT00584597|Mucositis|mucositis
563385|NCT01164514|bacterial sepsis, septicemia, vaccine|bacterial sepsis, septicemia, vaccine
563386|NCT01164449|algorithm|algorithm
563387|NCT01164449|tight glycemic control|tight glycemic control
563388|NCT01164449|glucose control|glucose control
563389|NCT01164449|intensive care|intensive care
563390|NCT01164449|insulin|insulin
563392|NCT01164423|algorithm|algorithm
563393|NCT01164423|tight glycemic control|tight glycemic control
563394|NCT01164423|glucose control|glucose control
563395|NCT01164423|intensive care|intensive care
563396|NCT01164423|insulin|insulin
563397|NCT01164423|ICU|icu
563398|NCT01164397|Hypercholesterolemia|hypercholesterolemia
563399|NCT01164397|Statins|statins
563400|NCT01164371|coronary disease|coronary disease
563401|NCT01164371|cardiovascular disease|cardiovascular disease
563402|NCT01164371|cardiovascular risk|cardiovascular risk
563403|NCT01164371|cardiovascular risk management|cardiovascular risk management
563404|NCT01164371|primary care|primary care
563405|NCT01164371|angina|angina
563406|NCT01164371|stable angina|stable angina
563407|NCT01164371|angina pectoris|angina pectoris
563408|NCT01164371|acute coronary syndrome|acute coronary syndrome
563409|NCT01164371|coronary death|coronary death
563410|NCT01164371|unheralded acute coronary syndrome|unheralded acute coronary syndrome
563411|NCT01164371|unheralded coronary death|unheralded coronary death
563412|NCT01164371|gender differences|gender differences
563413|NCT01164371|sex differences|sex differences
563414|NCT01164371|myocardial infarction|myocardial infarction
563415|NCT01164371|ST elevation myocardial infarction|st elevation myocardial infarction
563416|NCT01164371|non ST elevation myocardial infarction|non st elevation myocardial infarction
563417|NCT01164371|STEMI|stemi
563418|NCT01164371|nSTEMI|nstemi
563419|NCT01164371|unstable angina|unstable angina
563420|NCT01164358|Presbyopia|presbyopia
563421|NCT01164358|INTRACOR|intracor
563422|NCT01164358|patient satisfaction|patient satisfaction
563423|NCT01164358|long term|long term
563424|NCT01164345|non-Hodgkin's lymphoma|non-hodgkin's lymphoma
563425|NCT01164345|Hodgkin's lymphoma|hodgkin's lymphoma
563426|NCT01164345|stem cell mobilization|stem cell mobilization
563427|NCT01164345|autologous stem cell transplantation|autologous stem cell transplantation
563428|NCT01164319|Atrial fibrillation|atrial fibrillation
563429|NCT01164319|Percutaneous continous monitoring|percutaneous continous monitoring
563430|NCT01164319|ablation|ablation
563431|NCT01164306|LifeSkills Training|lifeskills training
563432|NCT01164306|Tobacco prevention|tobacco prevention
563433|NCT01164306|Tobacco cessation|tobacco cessation
563434|NCT01164306|Healthy lifestyles|healthy lifestyles
563435|NCT01164306|Tobacco control|tobacco control
563436|NCT01164293|Atopy patch test|atopy patch test
563437|NCT01164254|Exposure Assessment|exposure assessment
563438|NCT01164254|Web-Based Dietary Assessment|web-based dietary assessment
563439|NCT01164254|Web-Based Physical Activity Assessment|web-based physical activity assessment
563440|NCT01164241|CARD14|card14
563441|NCT01164241|Tryptase|tryptase
563442|NCT01164241|CARD11|card11
563443|NCT01164241|Genetics|genetics
563444|NCT01164241|Atopy|atopy
563445|NCT01164228|recurrent renal cell cancer|recurrent renal cell cancer
563446|NCT01164228|stage IV renal cell cancer|stage iv renal cell cancer
563447|NCT01164228|clear cell renal cell carcinoma|clear cell renal cell carcinoma
563448|NCT01164228|papillary renal cell carcinoma|papillary renal cell carcinoma
563449|NCT01164228|clear cell sarcoma of the kidney|clear cell sarcoma of the kidney
563450|NCT01164215|neutropenia|neutropenia
563451|NCT01164215|diarrhea|diarrhea
563452|NCT01164215|stage I colon cancer|stage i colon cancer
563453|NCT01164215|stage II colon cancer|stage ii colon cancer
563454|NCT01164215|stage III colon cancer|stage iii colon cancer
563455|NCT01164215|stage IV colon cancer|stage iv colon cancer
563456|NCT01164215|recurrent colon cancer|recurrent colon cancer
563457|NCT01164215|stage I rectal cancer|stage i rectal cancer
563458|NCT01164215|stage II rectal cancer|stage ii rectal cancer
563459|NCT01164215|stage III rectal cancer|stage iii rectal cancer
563460|NCT01164215|stage IV rectal cancer|stage iv rectal cancer
563461|NCT01164215|recurrent rectal cancer|recurrent rectal cancer
563462|NCT01164202|adult primary hepatocellular carcinoma|adult primary hepatocellular carcinoma
563463|NCT01164202|localized unresectable adult primary liver cancer|localized unresectable adult primary liver cancer
563464|NCT01164202|advanced adult primary liver cancer|advanced adult primary liver cancer
563465|NCT01164189|adult anaplastic astrocytoma|adult anaplastic astrocytoma
563466|NCT01164189|adult diffuse astrocytoma|adult diffuse astrocytoma
563467|NCT01164189|adult pilocytic astrocytoma|adult pilocytic astrocytoma
563468|NCT01164189|adult pineal gland astrocytoma|adult pineal gland astrocytoma
563469|NCT01164189|adult subependymal giant cell astrocytoma|adult subependymal giant cell astrocytoma
563470|NCT01164189|adult oligodendroglioma|adult oligodendroglioma
563471|NCT01164189|adult anaplastic oligodendroglioma|adult anaplastic oligodendroglioma
563472|NCT01164189|recurrent adult brain tumor|recurrent adult brain tumor
563473|NCT01164189|adult giant cell glioblastoma|adult giant cell glioblastoma
563474|NCT01164189|adult glioblastoma|adult glioblastoma
563475|NCT01164189|adult gliosarcoma|adult gliosarcoma
563476|NCT01164189|adult mixed glioma|adult mixed glioma
563477|NCT01164176|anaplastic thyroid cancer|anaplastic thyroid cancer
563478|NCT01164176|insular thyroid cancer|insular thyroid cancer
563479|NCT01164176|recurrent thyroid cancer|recurrent thyroid cancer
563480|NCT01164176|stage III follicular thyroid cancer|stage iii follicular thyroid cancer
563481|NCT01164176|stage III papillary thyroid cancer|stage iii papillary thyroid cancer
563482|NCT01164176|stage IV follicular thyroid cancer|stage iv follicular thyroid cancer
563483|NCT01164176|stage IV papillary thyroid cancer|stage iv papillary thyroid cancer
563484|NCT01164176|thyroid gland medullary carcinoma|thyroid gland medullary carcinoma
563485|NCT01164163|unspecified childhood solid tumor, protocol specific|unspecified childhood solid tumor, protocol specific
563486|NCT01164163|recurrent childhood acute lymphoblastic leukemia|recurrent childhood acute lymphoblastic leukemia
563487|NCT01164163|recurrent childhood acute myeloid leukemia|recurrent childhood acute myeloid leukemia
563488|NCT01164163|refractory chronic lymphocytic leukemia|refractory chronic lymphocytic leukemia
563489|NCT01164163|relapsing chronic myelogenous leukemia|relapsing chronic myelogenous leukemia
563490|NCT01164163|childhood myelodysplastic syndromes|childhood myelodysplastic syndromes
563491|NCT01164163|previously treated myelodysplastic syndromes|previously treated myelodysplastic syndromes
563492|NCT01164163|atypical chronic myeloid leukemia, BCR-ABL1 negative|atypical chronic myeloid leukemia, bcr-abl1 negative
563493|NCT01164163|chronic myelomonocytic leukemia|chronic myelomonocytic leukemia
563494|NCT01164163|juvenile myelomonocytic leukemia|juvenile myelomonocytic leukemia
563495|NCT01164163|myelodysplastic/myeloproliferative neoplasm, unclassifiable|myelodysplastic/myeloproliferative neoplasm, unclassifiable
563496|NCT01164163|polycythemia vera|polycythemia vera
563497|NCT01164163|essential thrombocythemia|essential thrombocythemia
563498|NCT01164163|childhood acute promyelocytic leukemia (M3)|childhood acute promyelocytic leukemia (m3)
563499|NCT01164163|acute myeloid leukemia/transient myeloproliferative disorder|acute myeloid leukemia/transient myeloproliferative disorder
563500|NCT01164163|primary myelofibrosis|primary myelofibrosis
563501|NCT01164150|gastrointestinal complications|gastrointestinal complications
563502|NCT01164150|urinary complications|urinary complications
563503|NCT01164150|radiation toxicity|radiation toxicity
563504|NCT01164150|recurrent endometrial carcinoma|recurrent endometrial carcinoma
563505|NCT01164150|endometrial adenocarcinoma|endometrial adenocarcinoma
563506|NCT01164150|stage IA endometrial carcinoma|stage ia endometrial carcinoma
563507|NCT01164150|stage IB endometrial carcinoma|stage ib endometrial carcinoma
563508|NCT01164150|stage II endometrial carcinoma|stage ii endometrial carcinoma
563509|NCT01164150|stage IIIA endometrial carcinoma|stage iiia endometrial carcinoma
563510|NCT01164150|stage IIIB endometrial carcinoma|stage iiib endometrial carcinoma
563511|NCT01164150|stage IIIC endometrial carcinoma|stage iiic endometrial carcinoma
563512|NCT01164137|Adverse Drug Events|adverse drug events
563513|NCT01164137|Medication Reconciliation|medication reconciliation
563514|NCT01164137|Pharmacist-led Intervention|pharmacist-led intervention
563515|NCT01164124|extremely low birth weight|extremely low birth weight
563516|NCT01164124|probiotics|probiotics
563517|NCT01164124|growth|growth
563518|NCT01164124|nutrition|nutrition
563519|NCT01164124|premature infants|premature infants
563520|NCT01164124|growth in extremely low birth weight infants|growth in extremely low birth weight infants
563521|NCT01164111|osteoarthritis|osteoarthritis
563522|NCT01164111|hip arthroplasty|hip arthroplasty
563523|NCT01164111|resistance training|resistance training
563524|NCT01164111|preoperative training|preoperative training
563525|NCT01164085|Inflammation|inflammation
563526|NCT01164085|Macular Edema|macular edema
563527|NCT01164072|electronic cigarette|electronic cigarette
563528|NCT01164072|nicotine|nicotine
563529|NCT01164072|smoking cessation|smoking cessation
563530|NCT01164072|smoking reduction|smoking reduction
563531|NCT01164059|Schizophrenia|schizophrenia
563532|NCT01164059|atypical antipsychotic drugs|atypical antipsychotic drugs
563533|NCT01164059|conventional antipsychotic drugs|conventional antipsychotic drugs
563534|NCT01164059|olanzapine|olanzapine
563535|NCT01164059|quetiapine|quetiapine
563536|NCT01164059|aripiprazole|aripiprazole
563537|NCT01164059|haloperidol|haloperidol
563538|NCT01164059|flupentixol|flupentixol
563539|NCT01164046|anticoagulants|anticoagulants
563540|NCT01164046|Heparin, Low-Molecular-Weight|heparin, low-molecular-weight
563541|NCT01164046|4-Hydroxycoumarins|4-hydroxycoumarins
563542|NCT01164046|recurrent venous thrombosis|recurrent venous thrombosis
563543|NCT01164020|cognition|cognition
563544|NCT01164020|supplementation creatine|supplementation creatine
563545|NCT01164020|resistance training|resistance training
563546|NCT01164020|aging|aging
563547|NCT01163994|erythema migrans|erythema migrans
563548|NCT01163994|Lyme borreliosis|lyme borreliosis
563549|NCT01163994|ceftriaxone treatment|ceftriaxone treatment
563550|NCT01163994|doxycycline treatment|doxycycline treatment
563551|NCT01163994|outcome|outcome
563552|NCT01163994|subjective symptoms|subjective symptoms
563553|NCT01163981|duplex Ultrasound|duplex ultrasound
563554|NCT01163981|Haemodialysis|haemodialysis
563555|NCT01163981|Vascular Access|vascular access
563556|NCT01163968|Weight reduction|weight reduction
711459|NCT00584597|Radiation|radiation
563557|NCT01163968|Cardiac revascularization|cardiac revascularization
563558|NCT01163968|Percutaneous Coronary Intervention|percutaneous coronary intervention
563559|NCT01163968|Cardiac Rehabilitation|cardiac rehabilitation
563560|NCT01163968|Rural|rural
563561|NCT01163955|Posture analysis|posture analysis
563562|NCT01163955|Video gaming|video gaming
563563|NCT01163955|Forward Head Position|forward head position
563564|NCT01163955|Rounded Shoulder Position|rounded shoulder position
563565|NCT01163955|Spine Posture|spine posture
563566|NCT01163929|breast cancer|breast cancer
563567|NCT01163929|HER2 positive|her2 positive
563568|NCT01163929|Phase II|phase ii
563569|NCT01163929|RAD001|rad001
563570|NCT01163929|paclitaxel|paclitaxel
563571|NCT01163929|trastuzumab|trastuzumab
563572|NCT01163929|everolimus|everolimus
563573|NCT01163916|Rheumatoid Arthritis|rheumatoid arthritis
563574|NCT01163916|Psoriatic Arthritis|psoriatic arthritis
563575|NCT01163916|Ankylosing Spondylitis|ankylosing spondylitis
563576|NCT01163903|Advanced solid tumours|advanced solid tumours
563577|NCT01163903|Pantoprazole|pantoprazole
563578|NCT01163903|Doxorubicin|doxorubicin
563579|NCT01163903|PANTO IV|panto iv
563580|NCT01163903|Adriamycin|adriamycin
563581|NCT01163903|no standard treatment options|no standard treatment options
563582|NCT01163903|dose-escalation schedule|dose-escalation schedule
563583|NCT01163903|Phase I|phase i
563584|NCT01163903|single-centre|single-centre
563585|NCT01163903|open label|open label
563586|NCT01163903|dose finding|dose finding
563974|NCT01162122|Adjuvants|adjuvants
563587|NCT01163903|recommended phase II dose|recommended phase ii dose
563588|NCT01163903|proton pump inhibitor|proton pump inhibitor
563589|NCT01163903|advanced cancer|advanced cancer
563590|NCT01163903|anthracycline|anthracycline
563591|NCT01163903|gastric acid secretion|gastric acid secretion
563592|NCT01163890|Depression|depression
563593|NCT01163890|Work Performance and Productivity|work performance and productivity
563594|NCT01163890|Worksite Intervention|worksite intervention
563595|NCT01163877|iron absorption|iron absorption
563596|NCT01163877|iron utilization|iron utilization
563597|NCT01163877|malaria|malaria
563598|NCT01163877|helminth|helminth
563599|NCT01163877|Ivory Coast|ivory coast
563600|NCT01163877|Acute symptomatic uncomplicated falciparum malaria|acute symptomatic uncomplicated falciparum malaria
563601|NCT01163877|Asymptomatic falciparum malaria|asymptomatic falciparum malaria
563602|NCT01163877|Moderate to heavy hookworm infection|moderate to heavy hookworm infection
563603|NCT01163877|Heavy Schistosoma haematobium infection|heavy schistosoma haematobium infection
563604|NCT01163864|smoking|smoking
563605|NCT01163864|smoking relapse|smoking relapse
563606|NCT01163864|smoking cessation|smoking cessation
563607|NCT01163864|pregnancy|pregnancy
563608|NCT01163864|smoking cessation in pregnant women|smoking cessation in pregnant women
563609|NCT01163851|Hypercholesterolemia|hypercholesterolemia
563610|NCT01163851|Dyslipidemia|dyslipidemia
563611|NCT01163851|LDL|ldl
563612|NCT01163851|Cholesterol|cholesterol
563613|NCT01163851|High Cholesterol|high cholesterol
563614|NCT01163851|PF-04950615|pf-04950615
563615|NCT01163851|RN316|rn316
563616|NCT01163838|Hypercholesterolemia|hypercholesterolemia
563617|NCT01163838|Dyslipidemia|dyslipidemia
563618|NCT01163838|LDL|ldl
563619|NCT01163838|Cholesterol|cholesterol
563620|NCT01163838|High Cholesterol|high cholesterol
563621|NCT01163812|D2 lymph node dissection|d2 lymph node dissection
563622|NCT01163799|Kidney|kidney
563623|NCT01163799|Transplant|transplant
563624|NCT01163799|Northwestern|northwestern
563625|NCT01163799|Calcineurin Inhibitor|calcineurin inhibitor
563626|NCT01163799|Corticosteroids|corticosteroids
563627|NCT01163799|Steroid avoidance|steroid avoidance
563628|NCT01163786|Bortezomib GVHD Bronchiolitis Obliterans|bortezomib gvhd bronchiolitis obliterans
563629|NCT01163773|Cardiovascular disease|cardiovascular disease
563630|NCT01163773|Milk|milk
563631|NCT01163773|Metabolic syndrome|metabolic syndrome
563632|NCT01163773|Blood lipids|blood lipids
563633|NCT01163773|Menopausal women|menopausal women
563634|NCT01163734|Heart Failure with Preserved Ejection Fraction (HFpEF)|heart failure with preserved ejection fraction (hfpef)
563635|NCT01163734|Coronary Artery Disease (CAD)|coronary artery disease (cad)
563636|NCT01163721|Type 2 diabetes mellitus|type 2 diabetes mellitus
563637|NCT01163721|T2DM|t2dm
563638|NCT01163721|Ranolazine|ranolazine
563639|NCT01163721|Ranexa|ranexa
563640|NCT01163721|HbA1c|hba1c
563641|NCT01163695|economic empowerment model, orphans, sub-Saharan Africa|economic empowerment model, orphans, sub-saharan africa
563642|NCT01163682|Taxane induced neuropathy|taxane induced neuropathy
563643|NCT01163669|hyperparathyroidism|hyperparathyroidism
563644|NCT01163656|Neonate|neonate
563645|NCT01163656|Laryngoscopes|laryngoscopes
563646|NCT01163630|open label, randomized|open label, randomized
563647|NCT01163630|single-center|single-center
563648|NCT01163630|2-way crossover|2-way crossover
563649|NCT01163630|food interaction study|food interaction study
563650|NCT01163617|Rheumatoid|rheumatoid
563651|NCT01163617|Arthritis|arthritis
563652|NCT01163604|Argatroban|argatroban
563653|NCT01163604|intracranial artery stenting|intracranial artery stenting
563654|NCT01163604|extracranial artery stenting|extracranial artery stenting
563655|NCT01163604|occlusion|occlusion
563656|NCT01163604|restenosis|restenosis
563657|NCT01163591|Diabetes|diabetes
563658|NCT01163591|Nephropathy|nephropathy
563659|NCT01163591|Screening|screening
563660|NCT01163578|Transplantation|transplantation
563661|NCT01163578|Rejection|rejection
563662|NCT01163565|Thyroidectomy|thyroidectomy
563663|NCT01163552|pleural metastases|pleural metastases
563664|NCT01163513|ethnicity|ethnicity
563665|NCT01163513|prognosis|prognosis
563666|NCT01163474|Telemedicine|telemedicine
563667|NCT01163474|Surgery, Cardiac|surgery, cardiac
563668|NCT01163448|Prostate|prostate
563669|NCT01163448|Radiation|radiation
563670|NCT01163448|Radical prostatectomy|radical prostatectomy
563671|NCT01163448|09-013|09-013
563672|NCT01163435|Helicobacter pylori|helicobacter pylori
563673|NCT01163435|antibiotic resistance|antibiotic resistance
563674|NCT01163435|high dose dual therapy|high dose dual therapy
563675|NCT01163435|sequential therapy|sequential therapy
563676|NCT01163435|clarithromycin-based triple therapy|clarithromycin-based triple therapy
563677|NCT01163435|levofloxacin-based triple therapy|levofloxacin-based triple therapy
563678|NCT01163422|Right ventricular failure|right ventricular failure
563679|NCT01163422|Pacemaker|pacemaker
563680|NCT01163422|Cardiac resynchronization therapy|cardiac resynchronization therapy
563681|NCT01163422|Pulmonary hypertension|pulmonary hypertension
563682|NCT01163409|juvenile fibromyalgia|juvenile fibromyalgia
563683|NCT01163409|acupuncture|acupuncture
563684|NCT01163409|exercise training|exercise training
563685|NCT01163383|Refractory Neuroblastoma|refractory neuroblastoma
563686|NCT01163383|Recurrent Neuroblastoma|recurrent neuroblastoma
563687|NCT01163383|Neuroblastoma|neuroblastoma
563688|NCT01163383|stage IV neuroblastoma|stage iv neuroblastoma
563689|NCT01163383|metastatic pheochromocytoma|metastatic pheochromocytoma
563690|NCT01163383|paraganglioma|paraganglioma
563691|NCT01163370|creatine supplementation|creatine supplementation
563692|NCT01163370|resistance training|resistance training
563693|NCT01163370|osteopenia|osteopenia
563694|NCT01163370|osteoporosis|osteoporosis
563695|NCT01163370|bone mineral density|bone mineral density
563696|NCT01163344|Gait, balance, Parkinson's Disease|gait, balance, parkinson's disease
563697|NCT01163331|Parkinson's Disease, voice quality, vocal strength, voice loudness|parkinson's disease, voice quality, vocal strength, voice loudness
563698|NCT01163318|Rheumatoid Arthritis|rheumatoid arthritis
563699|NCT01163305|Identifying an early indicator of drug efficacy|identifying an early indicator of drug efficacy
563700|NCT01163292|Rheumatoid Arthritis|rheumatoid arthritis
563701|NCT01163279|Age-related changes|age-related changes
563702|NCT01163266|Major Depressive Disorder|major depressive disorder
563703|NCT01163266|Depression|depression
563704|NCT01163266|Melancholia|melancholia
563705|NCT01163266|Drug Therapy|drug therapy
563706|NCT01163253|chronic|chronic
563707|NCT01163253|severe|severe
563708|NCT01163253|treatment|treatment
563709|NCT01163253|safety|safety
563710|NCT01163253|CP-690,55|cp-690,55
563711|NCT01163253|Plaque Psoriasis|plaque psoriasis
563712|NCT01163253|Psoriasis Vulgaris|psoriasis vulgaris
563713|NCT01163253|Xeljanz|xeljanz
563714|NCT01163253|Tofacitinib|tofacitinib
563715|NCT01163240|hepatitis B|hepatitis b
563716|NCT01163240|HBV|hbv
563717|NCT01163240|chronic hepatitis B|chronic hepatitis b
563718|NCT01163240|pediatric|pediatric
563719|NCT01163227|Hallucinations,|hallucinations,
563720|NCT01163227|psychotic,|psychotic,
563721|NCT01163227|delusions,|delusions,
563722|NCT01163227|cognitive deficits|cognitive deficits
563723|NCT01163188|very low birthweight/ very preterm children|very low birthweight/ very preterm children
563724|NCT01163188|Bavarian Longitudinal Study (BLS)|bavarian longitudinal study (bls)
563725|NCT01163188|Quality of life and social adjustment in adulthood|quality of life and social adjustment in adulthood
563726|NCT01163175|Cardiovascular disease|cardiovascular disease
563727|NCT01163175|Trans fatty acids|trans fatty acids
563728|NCT01163175|Ruminant|ruminant
563729|NCT01163175|Blood lipids|blood lipids
563730|NCT01163162|Chronic Kidney Disease|chronic kidney disease
563731|NCT01163162|Vitamin D|vitamin d
563732|NCT01163149|Hypophosphatasia|hypophosphatasia
563733|NCT01163149|HPP|hpp
563734|NCT01163149|Bone Disease|bone disease
563735|NCT01163149|Soft Bones|soft bones
563736|NCT01163149|Low Alkaline Phosphatase|low alkaline phosphatase
563737|NCT01163149|genetic metabolic disorder|genetic metabolic disorder
563738|NCT01163149|alkaline phosphatase|alkaline phosphatase
563739|NCT01163149|tissue-specific alkaline phosphatase (TNSALP)|tissue-specific alkaline phosphatase (tnsalp)
563740|NCT01163149|rickets|rickets
563741|NCT01163149|osteomalacia|osteomalacia
563742|NCT01163136|Parental decision making|parental decision making
563743|NCT01163136|Decision Making in Serious Pediatric Illness (DSPI)|decision making in serious pediatric illness (dspi)
563744|NCT01163136|palliative care decision making|palliative care decision making
563745|NCT01163123|Subclinical infection of Japanese encephalitis virus|subclinical infection of japanese encephalitis virus
563746|NCT01163045|neurostimulation|neurostimulation
563747|NCT01163045|intraoperative neuromonitoring|intraoperative neuromonitoring
563748|NCT01163045|recurrent laryngeal nerve|recurrent laryngeal nerve
563749|NCT01163045|palsy of recurrent laryngeal nerve|palsy of recurrent laryngeal nerve
563750|NCT01163045|RCT|rct
563751|NCT01163032|Blindness|blindness
563752|NCT01163032|Eye Diseases|eye diseases
563753|NCT01163032|Nap Disorders|nap disorders
563754|NCT01163032|Circadian Rhythm Disorders|circadian rhythm disorders
563755|NCT01163032|Sleep disorders|sleep disorders
563756|NCT01163032|Circadian Rhythm Sleep Disorders|circadian rhythm sleep disorders
563757|NCT01163032|Dyssomnias|dyssomnias
563758|NCT01163032|Nervous System Diseases|nervous system diseases
563759|NCT01163019|Chest pain|chest pain
563760|NCT01163019|acute coronary syndrome|acute coronary syndrome
563761|NCT01163019|Emergency department|emergency department
563762|NCT01163019|speckle tracking imaging|speckle tracking imaging
563763|NCT01163019|2D strain|2d strain
563764|NCT01163019|Echocardiography|echocardiography
563765|NCT01162993|Electric stimulation therapy|electric stimulation therapy
563766|NCT01162993|Diabetic Neuropathies|diabetic neuropathies
563767|NCT01162980|ACE inhibitors|ace inhibitors
563768|NCT01162980|ARBs|arbs
563769|NCT01162954|Eye drop, Dry eye|eye drop, dry eye
563770|NCT01162941|ITP|itp
563771|NCT01162928|critically ill, mechanically ventilated patients requiring enteral and parenteral nutritional support|critically ill, mechanically ventilated patients requiring enteral and parenteral nutritional support
563772|NCT01162915|Spinal Cord Injury|spinal cord injury
563773|NCT01162889|pharmacokinetics|pharmacokinetics
563774|NCT01162889|Crohn's disease|crohn's disease
563775|NCT01162876|Diabetes, Type 2|diabetes, type 2
563777|NCT01162863|irritable bowel syndrome|irritable bowel syndrome
563778|NCT01162863|constipation|constipation
563780|NCT01162837|Acne|acne
563781|NCT01162824|Endothelial Dysfunction|endothelial dysfunction
563782|NCT01162824|Microvascular dysfunction|microvascular dysfunction
563783|NCT01162824|Coronary artery spasm|coronary artery spasm
563784|NCT01162824|Inflammation|inflammation
563785|NCT01162824|CD4+CD28null T cells|cd4+cd28null t cells
563786|NCT01162824|Myocardial ischemia|myocardial ischemia
563787|NCT01162824|Early atherosclerosis|early atherosclerosis
563788|NCT01162811|Visualization|visualization
563789|NCT01162811|relaxation|relaxation
563790|NCT01162811|self hypnotic relaxation|self hypnotic relaxation
563791|NCT01162811|hypnosis|hypnosis
563792|NCT01162811|invasive medical procedures|invasive medical procedures
563793|NCT01162811|atrial fibrillation|atrial fibrillation
563794|NCT01162811|ablation|ablation
563795|NCT01162811|catheter ablation|catheter ablation
563796|NCT01162811|pain|pain
563797|NCT01162811|anxiety|anxiety
563798|NCT01162798|infant formula|infant formula
563799|NCT01162798|premature infants|premature infants
563800|NCT01162798|Growth and Development|growth and development
563801|NCT01162785|BCG Refractory Superficial Bladder Cancer|bcg refractory superficial bladder cancer
563802|NCT01162785|SCH 721015|sch 721015
563803|NCT01162785|Syn3|syn3
563804|NCT01162785|novel excipient|novel excipient
563805|NCT01162785|interferon -alpha-2b|interferon -alpha-2b
563806|NCT01162785|Intravesical|intravesical
563807|NCT01162785|urine IFNa|urine ifna
563808|NCT01162785|transitional cell carcinoma of the bladder|transitional cell carcinoma of the bladder
563809|NCT01162785|superficial non-muscle invasive tumor|superficial non-muscle invasive tumor
563810|NCT01162759|hypertension, intervention|hypertension, intervention
563811|NCT01162733|Vancomycin|vancomycin
563812|NCT01162733|Therapeutic Levels|therapeutic levels
563813|NCT01162733|Infectious Disease|infectious disease
563814|NCT01162733|Recommendations|recommendations
563815|NCT01162720|Primary knee replacement|primary knee replacement
563816|NCT01162720|Unilateral knee replacement|unilateral knee replacement
563817|NCT01162694|Remote Blood Glucose Monitoring System,|remote blood glucose monitoring system,
563818|NCT01162694|Continuous Glucose Monitoring System,|continuous glucose monitoring system,
563819|NCT01162694|Type 2 Diabetes|type 2 diabetes
563821|NCT01162681|Lupus|lupus
563822|NCT01162681|Lupus Erythematosus, Systemic|lupus erythematosus, systemic
563823|NCT01162681|Autoimmune Diseases|autoimmune diseases
563824|NCT01162681|A-623|a-623
563825|NCT01162681|Blisibimod|blisibimod
563826|NCT01162668|bariatric surgery|bariatric surgery
563827|NCT01162668|obesity|obesity
563828|NCT01162668|outcomes|outcomes
563829|NCT01162655|Insomnia|insomnia
563830|NCT01162655|Cognitive-Behavioral Therapy|cognitive-behavioral therapy
563831|NCT01162655|Internet|internet
563832|NCT01162655|Telehealth|telehealth
563833|NCT01162642|Healthy moderately heavy smokers|healthy moderately heavy smokers
563834|NCT01162629|bounded saddles|bounded saddles
563835|NCT01162629|missing teeth|missing teeth
563836|NCT01162629|dental implants|dental implants
563837|NCT01162629|Tooth, Nonvital|tooth, nonvital
563838|NCT01162616|iron absorption|iron absorption
563839|NCT01162616|polyphenols|polyphenols
563840|NCT01162616|sodium iron EDTA|sodium iron edta
563841|NCT01162616|sorghum|sorghum
563842|NCT01162590|Human Rotavirus vaccine|human rotavirus vaccine
563843|NCT01162577|Weight|weight
563844|NCT01162577|Smoking|smoking
563845|NCT01162577|Quitline|quitline
563846|NCT01162551|Leukemia|leukemia
563847|NCT01162551|Non-Hodgkin's Lymphoma|non-hodgkin's lymphoma
563848|NCT01162538|Raltegravir, non B subtype, naive patients|raltegravir, non b subtype, naive patients
563849|NCT01162525|Fecal Incontinence|fecal incontinence
563850|NCT01162525|Fecal Urge Incontinence|fecal urge incontinence
563851|NCT01162525|Percutaneous tibial nerve stimulation|percutaneous tibial nerve stimulation
563852|NCT01162512|physical activity|physical activity
563853|NCT01162512|obesity|obesity
563854|NCT01162512|adolescents|adolescents
563855|NCT01162512|telephone|telephone
563856|NCT01162512|BMI|bmi
563857|NCT01162512|body mass index|body mass index
563858|NCT01162499|Post prandial hypoglycemia|post prandial hypoglycemia
563859|NCT01162499|hypoglycemia|hypoglycemia
563860|NCT01162499|Nissen fundoplication|nissen fundoplication
563861|NCT01162499|Dumping|dumping
563862|NCT01162486|Anti-infective agents|anti-infective agents
563863|NCT01162486|Anti-bacterial agents|anti-bacterial agents
563864|NCT01162486|Rifampin|rifampin
563865|NCT01162486|Rifapentine|rifapentine
563866|NCT01162486|Midazolam|midazolam
563867|NCT01162486|Molecular mechanisms of pharmacological action|molecular mechanisms of pharmacological action
563868|NCT01162486|Antitubercular agents|antitubercular agents
563869|NCT01162486|Pharmacologic actions|pharmacologic actions
563870|NCT01162473|Food hypersensitivity|food hypersensitivity
563871|NCT01162473|Milk hypersensitivity|milk hypersensitivity
563872|NCT01162473|Milk allergy|milk allergy
563873|NCT01162473|Food allergy|food allergy
563874|NCT01162447|BMP- 4 and 7, polycystic ovarian syndrome|bmp- 4 and 7, polycystic ovarian syndrome
563875|NCT01162434|Treatment resistant depression|treatment resistant depression
563876|NCT01162434|Deep brain stimulation|deep brain stimulation
563877|NCT01162434|Brain volumetric analysis|brain volumetric analysis
563878|NCT01162421|Rheumatoid Arthritis|rheumatoid arthritis
563879|NCT01162421|Anti-Inflammatory|anti-inflammatory
563880|NCT01162421|Biological Therapy|biological therapy
563881|NCT01162421|adalimumab|adalimumab
563882|NCT01162421|Disease-Modifying Antirheumatic Drugs|disease-modifying antirheumatic drugs
563883|NCT01162421|Antirheumatic Agents|antirheumatic agents
563884|NCT01162421|Agents|agents
563885|NCT01162408|ICU|icu
563886|NCT01162395|Prostate Cancer|prostate cancer
563887|NCT01162395|Tumour|tumour
563888|NCT01162395|Castration Resistant|castration resistant
563889|NCT01162395|Prostate Androgen Receptor Down Regulator|prostate androgen receptor down regulator
563890|NCT01162395|Metastatic|metastatic
563891|NCT01162382|transcranial magnetic stimulation|transcranial magnetic stimulation
563892|NCT01162382|TMS|tms
563893|NCT01162382|rTMS|rtms
563894|NCT01162382|depression|depression
563895|NCT01162382|fcMRI|fcmri
563896|NCT01162382|EEG|eeg
563897|NCT01162369|Delirium, diagnosis, elderly, hospitalization|delirium, diagnosis, elderly, hospitalization
563898|NCT01162356|Vitrectomy|vitrectomy
563899|NCT01162356|Glaucoma|glaucoma
563900|NCT01162356|Macula|macula
563901|NCT01162356|Optic nerve|optic nerve
563902|NCT01162356|Ocular Coherence Tomography|ocular coherence tomography
563903|NCT01162343|Delirium, diagnosis, elderly, hospitalization|delirium, diagnosis, elderly, hospitalization
563904|NCT01162330|Screening|screening
563905|NCT01162330|Congenital Cytomegalovirus|congenital cytomegalovirus
563906|NCT01162330|CMV|cmv
563907|NCT01162330|Hearing loss|hearing loss
563908|NCT01162317|Acupuncture|acupuncture
563909|NCT01162317|Sleep|sleep
563910|NCT01162317|Traumatic brain injury|traumatic brain injury
563911|NCT01162304|Chronic Pain|chronic pain
563912|NCT01162304|This clinical trial will compare immediate-release (IR)|this clinical trial will compare immediate-release (ir)
563913|NCT01162304|oxycodone and extended-release (ER) oxycodone in the|oxycodone and extended-release (er) oxycodone in the
563914|NCT01162304|management of chronic pain|management of chronic pain
563915|NCT01162291|intramuscular|intramuscular
563916|NCT01162291|distribution|distribution
563917|NCT01162291|NaCl|nacl
563918|NCT01162291|botulinum toxin|botulinum toxin
563919|NCT01162291|muscle|muscle
563920|NCT01162291|volume|volume
563921|NCT01162291|movement|movement
563922|NCT01162291|biceps brachii|biceps brachii
563923|NCT01162291|primary distribution of intramuscular NaCl representative for primary distribution of intramuscular botulinum toxin|primary distribution of intramuscular nacl representative for primary distribution of intramuscular botulinum toxin
563924|NCT01162291|shift from extracellular to intracellular viewed by DTI technology|shift from extracellular to intracellular viewed by dti technology
563925|NCT01162291|effect of volume|effect of volume
563926|NCT01162291|effect of muscle movement|effect of muscle movement
563927|NCT01162278|liver metastases|liver metastases
563928|NCT01162278|Stereotactic Body Radiation Therapy|stereotactic body radiation therapy
563929|NCT01162265|Tuberculosis|tuberculosis
563930|NCT01162265|IGRA|igra
563931|NCT01162265|latent|latent
563932|NCT01162252|psoriasis|psoriasis
563933|NCT01162252|mindfulness|mindfulness
563934|NCT01162252|MBSR|mbsr
563935|NCT01162252|stress|stress
563936|NCT01162252|living well|living well
716241|NCT00563745|ALS|als
563937|NCT01162239|smoking|smoking
563938|NCT01162239|tobacco|tobacco
563939|NCT01162239|nicotine|nicotine
563940|NCT01162239|smoking cessation|smoking cessation
563941|NCT01162226|gait|gait
563942|NCT01162226|movement disorders|movement disorders
563943|NCT01162226|balance|balance
563944|NCT01162226|function|function
563945|NCT01162213|Postmenopausal Women|postmenopausal women
563946|NCT01162213|Healthy Males|healthy males
563947|NCT01162213|Cardiovascular|cardiovascular
563948|NCT01162213|Flavanols|flavanols
563949|NCT01162187|secondary prevention|secondary prevention
563950|NCT01162187|aspirin|aspirin
563951|NCT01162187|beta blocker|beta blocker
563952|NCT01162187|ACE inhibitor|ace inhibitor
563953|NCT01162187|statin|statin
563954|NCT01162187|acute coronary syndrome|acute coronary syndrome
563955|NCT01162187|myocardial infarction|myocardial infarction
563956|NCT01162187|unstable angina|unstable angina
563957|NCT01162187|trends|trends
563958|NCT01162174|Flavanols|flavanols
563959|NCT01162174|cardiovascular|cardiovascular
563960|NCT01162161|sphingolipid|sphingolipid
563961|NCT01162161|ceramide|ceramide
563962|NCT01162161|sphingomyelinase|sphingomyelinase
563963|NCT01162148|inspiratory muscle training|inspiratory muscle training
563964|NCT01162148|pulmonary rehabilitation|pulmonary rehabilitation
563965|NCT01162135|Digoxin|digoxin
563966|NCT01162135|Recurrent Prostate Cancer|recurrent prostate cancer
563967|NCT01162135|Prostate Specific Antigen|prostate specific antigen
563968|NCT01162122|Elderly|elderly
563969|NCT01162122|Influenza|influenza
563970|NCT01162122|Immunogenicity|immunogenicity
563971|NCT01162122|Safety|safety
563972|NCT01162122|Adjuvant|adjuvant
563973|NCT01162122|Adjuvanted|adjuvanted
563975|NCT01162122|Vaccines|vaccines
563976|NCT01162109|Zinc|zinc
563977|NCT01162109|sepsis|sepsis
563978|NCT01162109|critical illness|critical illness
563979|NCT01162109|mechanical ventilation|mechanical ventilation
563980|NCT01162109|ICU|icu
563981|NCT01162096|Reduced Intensity Haploidentical Transplant|reduced intensity haploidentical transplant
563982|NCT01162083|Exercise Physiology|exercise physiology
563983|NCT01162083|Cardiopulmonary Interaction|cardiopulmonary interaction
563984|NCT01162083|Heart Failure|heart failure
563985|NCT01162070|Uveitis|uveitis
563986|NCT01162070|etiological diagnosis|etiological diagnosis
563987|NCT01162070|standardized strategy|standardized strategy
563988|NCT01162057|Hemodialysis|hemodialysis
563989|NCT01162057|Hearing|hearing
563990|NCT01162057|Hemodialysis patients|hemodialysis patients
563991|NCT01162044|PTSD|ptsd
563992|NCT01162044|prevention|prevention
563993|NCT01162005|Primary Nephrotic syndrome|primary nephrotic syndrome
563994|NCT01161992|Primary Sclerosing Cholangitis|primary sclerosing cholangitis
563995|NCT01161992|PSC|psc
563996|NCT01161992|Cholestatic Liver Disease|cholestatic liver disease
563997|NCT01161953|Primary Biliary Cirrhosis|primary biliary cirrhosis
563998|NCT01161953|PBC|pbc
563999|NCT01161953|Cholestatic Liver Disease|cholestatic liver disease
564000|NCT01161940|Bioavailability|bioavailability
564001|NCT01161940|Nizatidine|nizatidine
564002|NCT01161940|Crossover|crossover
564003|NCT01161927|Bioavailability|bioavailability
564004|NCT01161927|Nizatidine|nizatidine
564005|NCT01161927|Crossover|crossover
564006|NCT01161914|Type I Gaucher|type i gaucher
564007|NCT01161901|ARDS|ards
564008|NCT01161901|Plasmatic biomarkers|plasmatic biomarkers
564009|NCT01161901|Lung Morphology|lung morphology
564010|NCT01161901|Mechanical ventilation|mechanical ventilation
564011|NCT01161901|CT scan|ct scan
564012|NCT01161862|Closed-loop|closed-loop
564013|NCT01161862|Artificial pancreas|artificial pancreas
564014|NCT01161862|Bi-hormonal|bi-hormonal
564015|NCT01161862|Insulin|insulin
564016|NCT01161862|Glucagon|glucagon
564017|NCT01161862|Diabetes mellitus type 1|diabetes mellitus type 1
564018|NCT01161849|lactate|lactate
564019|NCT01161849|urgent surgery|urgent surgery
564020|NCT01161849|major surgery|major surgery
564021|NCT01161849|surgical complications|surgical complications
564022|NCT01161849|possum|possum
564023|NCT01161849|sapsII|sapsii
564024|NCT01161849|relaparotomy|relaparotomy
564025|NCT01161810|Burn|burn
564026|NCT01161810|Rehabilitation|rehabilitation
564027|NCT01161797|1,5-Anhydroglucitol|1,5-anhydroglucitol
564028|NCT01161784|Functional constipation|functional constipation
564029|NCT01161784|Probiotic|probiotic
564030|NCT01161784|Probiotic microorganism|probiotic microorganism
564031|NCT01161784|Lactobacillus casei Shirota (LcS)|lactobacillus casei shirota (lcs)
564032|NCT01161758|physical therapy|physical therapy
564033|NCT01161758|pain threshold|pain threshold
564034|NCT01161758|electromyography|electromyography
564035|NCT01161758|musculoskeletal manipulation|musculoskeletal manipulation
564036|NCT01161758|neck muscles|neck muscles
564037|NCT01161745|sepsis|sepsis
564038|NCT01161732|aortic stenosis|aortic stenosis
564039|NCT01161732|surgery, survival|surgery, survival
564040|NCT01161719|ADHD|adhd
711460|NCT00584597|Oral cancer|oral cancer
564041|NCT01161719|Parent training|parent training
564042|NCT01161719|Videoconference|videoconference
564043|NCT01161706|vegetable juice|vegetable juice
564044|NCT01161706|cardiovascular|cardiovascular
564045|NCT01161706|blood pressure|blood pressure
564046|NCT01161693|Cesarean section|cesarean section
564047|NCT01161693|spinal anesthesia|spinal anesthesia
564048|NCT01161693|CSE|cse
564049|NCT01161693|ramped up position|ramped up position
564050|NCT01161693|TROOP pillow|troop pillow
564051|NCT01161693|elevation pillow|elevation pillow
564052|NCT01161693|maternal comfort|maternal comfort
564053|NCT01161693|Maternal Comfort after CSE during elective Cesarean Section in relation to adequate height of Anesthetic Block|maternal comfort after cse during elective cesarean section in relation to adequate height of anesthetic block
564054|NCT01161680|Cross sectional and Longitudinal Observational study|cross sectional and longitudinal observational study
564055|NCT01161641|Protein Losing Enteropathy|protein losing enteropathy
564056|NCT01161628|Chronic Graft versus Host Disease|chronic graft versus host disease
564057|NCT01161628|allogeneic stem cell transplant|allogeneic stem cell transplant
564058|NCT01161615|tendonitis and/or bursitis of the shoulder|tendonitis and/or bursitis of the shoulder
564059|NCT01161615|acute tendonitis and/or bursitis of the shoulder|acute tendonitis and/or bursitis of the shoulder
564060|NCT01161602|Symptoms of Gastroesophageal Reflux Disease (GERD)|symptoms of gastroesophageal reflux disease (gerd)
564061|NCT01161589|sensing|sensing
564062|NCT01161589|S-ICD|s-icd
564063|NCT01161589|ICD|icd
564064|NCT01161589|CRT D|crt d
564065|NCT01161576|Batten Disease|batten disease
564066|NCT01161576|Late Infantile Neuronal Lipofuscinosis|late infantile neuronal lipofuscinosis
564067|NCT01161576|gene transfer|gene transfer
564068|NCT01161563|palliative treatment|palliative treatment
564069|NCT01161563|prostate cancer|prostate cancer
564070|NCT01161511|CLL|cll
564071|NCT01161511|SLL|sll
564072|NCT01161511|CD19|cd19
564073|NCT01161498|squamous cell|squamous cell
564074|NCT01161498|OncoVEX^GM-CSF|oncovex^gm-csf
564075|NCT01161498|Oncovex|oncovex
564076|NCT01161498|chemoradiation|chemoradiation
564077|NCT01161498|Cisplatin|cisplatin
564078|NCT01161485|HIV Infections|hiv infections
564079|NCT01161485|Treatment|treatment
564080|NCT01161485|Methamphetamine|methamphetamine
564081|NCT01161459|Idiopathic Membranous Nephropathy|idiopathic membranous nephropathy
564082|NCT01161459|Treatment|treatment
564083|NCT01161459|FK506|fk506
564084|NCT01161459|Tripterygium wilfordii|tripterygium wilfordii
564085|NCT01161446|HIV|hiv
564086|NCT01161446|Home testing|home testing
564087|NCT01161446|Self-testing|self-testing
564088|NCT01161446|HIV Infections/diagnosis|hiv infections/diagnosis
564089|NCT01161446|HIV Infections/prevention and control|hiv infections/prevention and control
564090|NCT01161446|AIDS Serodiagnosis|aids serodiagnosis
564091|NCT01161446|Oral fluids|oral fluids
564092|NCT01161446|Homosexuality, Male|homosexuality, male
564093|NCT01161446|Sexually transmitted diseases|sexually transmitted diseases
564094|NCT01161446|Sexual behavior|sexual behavior
564095|NCT01161433|Asthma|asthma
564096|NCT01161433|Spirometry|spirometry
564097|NCT01161433|Pediatric|pediatric
564098|NCT01161433|Primary Health Care|primary health care
564099|NCT01161433|Education, Distance|education, distance
564100|NCT01161420|tongue|tongue
564101|NCT01161420|surgery|surgery
564102|NCT01161420|neurostimulation|neurostimulation
564103|NCT01161420|hypoglossal nerve|hypoglossal nerve
564104|NCT01161420|upper airway stimulation|upper airway stimulation
564105|NCT01161381|OSAHS|osahs
564106|NCT01161381|nonlinear analysis|nonlinear analysis
564107|NCT01161381|polysomnography|polysomnography
564108|NCT01161381|biosignal analysis|biosignal analysis
564109|NCT01161381|DFA|dfa
564110|NCT01161381|APEN|apen
564111|NCT01161381|LLE|lle
564112|NCT01161368|Metastatic Breast Cancer|metastatic breast cancer
564113|NCT01161355|Safety|safety
564114|NCT01161355|tolerability|tolerability
564115|NCT01161355|healthy|healthy
564116|NCT01161355|microdose|microdose
564117|NCT01161342|Malnutrition|malnutrition
564118|NCT01161342|Aged|aged
564119|NCT01161342|Aged 80 and over|aged 80 and over
564120|NCT01161342|Prevalence|prevalence
564121|NCT01161342|Mortality|mortality
564122|NCT01161329|stroke|stroke
564123|NCT01161329|physical activity|physical activity
564124|NCT01161329|balance|balance
564125|NCT01161329|muscle-strength|muscle-strength
564126|NCT01161316|metastatic colorectal cancer|metastatic colorectal cancer
564127|NCT01161316|wild-type KRAS tumours|wild-type kras tumours
564128|NCT01161316|cetuximab|cetuximab
564129|NCT01161316|mFOLFOX-6|mfolfox-6
564130|NCT01161303|Asthma|asthma
564131|NCT01161303|TNF alpha|tnf alpha
564132|NCT01161303|epithelial cell culture|epithelial cell culture
564133|NCT01161290|Telemedicine|telemedicine
564134|NCT01161290|Internet|internet
564135|NCT01161290|Dyspnea|dyspnea
564136|NCT01161290|Self care|self care
564137|NCT01161290|Breathing Exercises|breathing exercises
564138|NCT01161290|Real-Time Systems|real-time systems
564139|NCT01161277|Aripiprazole|aripiprazole
564140|NCT01161277|Haloperidol|haloperidol
564141|NCT01161277|Ventral striatum|ventral striatum
564142|NCT01161277|Reward|reward
564143|NCT01161277|fMRI|fmri
564144|NCT01161264|Elderly|elderly
564145|NCT01161264|Influenza|influenza
564146|NCT01161264|Immunogenicity|immunogenicity
564147|NCT01161264|Safety|safety
564148|NCT01161264|Influenza vaccine|influenza vaccine
564149|NCT01161251|Atrial Fibrillation|atrial fibrillation
564150|NCT01161251|ABI|abi
564151|NCT01161251|PAD|pad
564152|NCT01161251|Registry|registry
564153|NCT01161251|Italian|italian
564154|NCT01161225|Adolescents|adolescents
564155|NCT01161225|Peer leader program|peer leader program
564156|NCT01161225|asthma camp|asthma camp
564157|NCT01161225|asthma control|asthma control
564158|NCT01161225|quality of life|quality of life
564159|NCT01161225|self-efficacy|self-efficacy
564160|NCT01161225|knowledge|knowledge
564161|NCT01161225|attitudes|attitudes
564162|NCT01161225|barrier perceptions|barrier perceptions
564163|NCT01161212|body mass index|body mass index
564164|NCT01161212|health-related quality of life|health-related quality of life
564165|NCT01161212|physical education|physical education
564166|NCT01161212|children|children
564167|NCT01161212|cluster randomized controlled trial|cluster randomized controlled trial
564168|NCT01161212|prevention|prevention
564169|NCT01161212|Child|child
564170|NCT01161212|French|french
564171|NCT01161212|Schoolchildren|schoolchildren
564172|NCT01161199|HIV|hiv
564173|NCT01161199|latent reservoir|latent reservoir
564174|NCT01161199|functional cure|functional cure
564175|NCT01161199|leukapheresis|leukapheresis
564176|NCT01161186|pancreas|pancreas
564177|NCT01161186|cancer|cancer
564178|NCT01161186|abraxane|abraxane
564179|NCT01161186|metastatic|metastatic
564180|NCT01161186|gemcitabine|gemcitabine
564181|NCT01161186|capecitabine|capecitabine
564182|NCT01161186|adenocarcinoma|adenocarcinoma
564183|NCT01161160|H1N1|h1n1
564184|NCT01161160|Influenza|influenza
564185|NCT01161160|Pandemic|pandemic
564186|NCT01161160|GSK Bio's influenza vaccines GSK2340274A and GSK234072A|gsk bio's influenza vaccines gsk2340274a and gsk234072a
564187|NCT01161121|Fractional flow reserve|fractional flow reserve
564188|NCT01161121|adenosine|adenosine
564189|NCT01161121|regadenoson|regadenoson
564190|NCT01161108|Pediatrics|pediatrics
564191|NCT01161108|Epilepsy|epilepsy
564192|NCT01161108|Insomnia|insomnia
564193|NCT01161108|Melatonin|melatonin
564194|NCT01161095|Intrauterine Device|intrauterine device
564195|NCT01161095|Postpartum contraception|postpartum contraception
564196|NCT01161095|Long-acting reversible contraception|long-acting reversible contraception
564197|NCT01161069|phase 1|phase 1
564198|NCT01161069|healthy young adult volunteers|healthy young adult volunteers
564199|NCT01161069|healthy elderly adult volunteers|healthy elderly adult volunteers
564200|NCT01161043|diabetes|diabetes
564201|NCT01161043|glucose|glucose
564202|NCT01161043|sensor|sensor
564203|NCT01161017|migraine patients|migraine patients
564204|NCT01160991|schizophrenia|schizophrenia
564205|NCT01160991|olanzapine|olanzapine
564206|NCT01160991|atypical antipsychotic drugs|atypical antipsychotic drugs
564207|NCT01160991|amisulpride|amisulpride
564208|NCT01160991|diabetes|diabetes
564209|NCT01160991|insulin resistance|insulin resistance
564210|NCT01160991|insulin secretion|insulin secretion
564211|NCT01160991|glucose|glucose
564212|NCT01160991|euglycemic hyperinsulinemic clamp|euglycemic hyperinsulinemic clamp
564213|NCT01160991|hyperglycemic clamp|hyperglycemic clamp
564214|NCT01160978|Transplantation|transplantation
564215|NCT01160978|Simvastatin treatment|simvastatin treatment
564216|NCT01160978|Ischemia-reperfusion injury|ischemia-reperfusion injury
564217|NCT01160978|Rejection|rejection
564218|NCT01160965|epidural top-up|epidural top-up
564219|NCT01160965|emergency Caesarean section|emergency caesarean section
564220|NCT01160952|primary prophylaxis|primary prophylaxis
564221|NCT01160952|itraconazole|itraconazole
564222|NCT01160952|stem cell transplantation|stem cell transplantation
564223|NCT01160939|Exercise|exercise
564224|NCT01160939|heart failure|heart failure
564225|NCT01160939|rehabilitation|rehabilitation
564226|NCT01160926|rectal cancer|rectal cancer
564227|NCT01160926|capecitabine|capecitabine
564228|NCT01160926|radiotherapy|radiotherapy
564229|NCT01160926|AZD6244|azd6244
564230|NCT01160926|MEK inhibitor|mek inhibitor
564231|NCT01160926|AZD2171|azd2171
564232|NCT01160926|Cediranib|cediranib
564233|NCT01160926|VEGFR inhibitor|vegfr inhibitor
564234|NCT01160926|FLT-PET (fluoro-l-pyrimidine positron emission tomography)|flt-pet (fluoro-l-pyrimidine positron emission tomography)
564235|NCT01160926|DCE-MRI (dynamic contrast enhanced magnetic resonance imaging)|dce-mri (dynamic contrast enhanced magnetic resonance imaging)
564236|NCT01160900|cardiovascular diseases|cardiovascular diseases
564237|NCT01160900|heart disease|heart disease
564238|NCT01160900|hemorrhage|hemorrhage
564239|NCT01160900|coronary angioplasty|coronary angioplasty
564240|NCT01160900|drug eluting stents|drug eluting stents
564241|NCT01160874|Attention Deficit Disorder / Hyperactivity (ADHD)|attention deficit disorder / hyperactivity (adhd)
564242|NCT01160874|Cognition|cognition
716560|NCT00562432|CABG|cabg
564243|NCT01160874|Sleepiness|sleepiness
564244|NCT01160874|Driving|driving
564245|NCT01160848|Moderate to severe Acne Vulgaris|moderate to severe acne vulgaris
564246|NCT01160835|total knee arthroplasty|total knee arthroplasty
564247|NCT01160835|minimally invasive|minimally invasive
564248|NCT01160835|quadriceps-sparing|quadriceps-sparing
564249|NCT01160835|Quadriceps-sparing total knee arthroplasty|quadriceps-sparing total knee arthroplasty
564250|NCT01160822|Osteo arthritis|osteo arthritis
564251|NCT01160822|pain control|pain control
564252|NCT01160822|intra- articular injections|intra- articular injections
564253|NCT01160822|Knee OA|knee oa
564254|NCT01160809|Malaria|malaria
564255|NCT01160809|Mosquito repellent|mosquito repellent
564256|NCT01160809|LLINs|llins
564257|NCT01160783|Autism|autism
564258|NCT01160783|Asperger's Syndrome|asperger's syndrome
564259|NCT01160783|Asperger Syndrome|asperger syndrome
564260|NCT01160783|Autistic Disorder|autistic disorder
564261|NCT01160783|Autism Spectrum Disorder|autism spectrum disorder
564262|NCT01160783|Pervasive Developmental Disorders|pervasive developmental disorders
564263|NCT01160783|Pervasive Developmental Disorder-Not Otherwise Specified|pervasive developmental disorder-not otherwise specified
564264|NCT01160783|Child Development Disorders, Pervasive|child development disorders, pervasive
564265|NCT01160783|PDD-NOS|pdd-nos
564266|NCT01160770|Lennox-Gastaut Syndrome (LGS)|lennox-gastaut syndrome (lgs)
564267|NCT01160770|Epilepsy|epilepsy
564268|NCT01160770|Drop Seizures|drop seizures
564269|NCT01160770|Clobazam|clobazam
564270|NCT01160744|Lung neoplasms|lung neoplasms
564271|NCT01160744|Lung cancer|lung cancer
564272|NCT01160744|Non-small Cell Lung Cancer|non-small cell lung cancer
564273|NCT01160744|pemetrexed|pemetrexed
564274|NCT01160744|squamous|squamous
564275|NCT01160744|nonsquamous|nonsquamous
564276|NCT01160731|extensive stage small cell lung cancer|extensive stage small cell lung cancer
564277|NCT01160718|estrogen receptor-positive breast cancer|estrogen receptor-positive breast cancer
564278|NCT01160718|HER2-positive breast cancer|her2-positive breast cancer
564279|NCT01160718|HER2-negative breast cancer|her2-negative breast cancer
564280|NCT01160718|progesterone receptor-positive breast cancer|progesterone receptor-positive breast cancer
564281|NCT01160718|recurrent breast cancer|recurrent breast cancer
564282|NCT01160718|stage IIIA breast cancer|stage iiia breast cancer
564283|NCT01160718|stage IIIB breast cancer|stage iiib breast cancer
564284|NCT01160718|stage IIIC breast cancer|stage iiic breast cancer
564285|NCT01160718|stage IV breast cancer|stage iv breast cancer
564286|NCT01160705|adenocarcinoma of the prostate|adenocarcinoma of the prostate
564287|NCT01160705|recurrent prostate cancer|recurrent prostate cancer
564288|NCT01160705|stage III prostate cancer|stage iii prostate cancer
564289|NCT01160705|stage IV prostate cancer|stage iv prostate cancer
564290|NCT01160705|bone metastases|bone metastases
564291|NCT01160705|liver metastases|liver metastases
564292|NCT01160705|lung metastases|lung metastases
564293|NCT01160705|hormone-resistant prostate cancer|hormone-resistant prostate cancer
564294|NCT01160692|Memory|memory
564295|NCT01160692|Cognitive Function|cognitive function
564296|NCT01160692|Elderly|elderly
564297|NCT01160692|Gingko|gingko
564298|NCT01160692|Age Associated Memory Impairment (AAMI)|age associated memory impairment (aami)
564299|NCT01160679|anhedonic features in patients with schizophrenia|anhedonic features in patients with schizophrenia
564300|NCT01160666|Belimumab|belimumab
564301|NCT01160666|Sjögren's syndrome|sjögren's syndrome
564302|NCT01160666|Sjögren disease|sjögren disease
564303|NCT01160653|stroke|stroke
564304|NCT01160653|Gait training|gait training
564305|NCT01160653|Cognitive Training|cognitive training
564306|NCT01160640|PID|pid
564307|NCT01160640|Pelvic Inflammatory Disease|pelvic inflammatory disease
564308|NCT01160627|CIN STEMI|cin stemi
564309|NCT01160614|Pediatric|pediatric
564310|NCT01160614|Post-operative|post-operative
564311|NCT01160614|Nonsurgical|nonsurgical
564312|NCT01160614|patients|patients
564313|NCT01160614|Opioid|opioid
564314|NCT01160601|NSCLC|nsclc
564315|NCT01160601|lung cancer|lung cancer
564316|NCT01160601|non small cell lung cancer|non small cell lung cancer
564317|NCT01160601|bavituximab|bavituximab
564318|NCT01160601|monoclonal antibody|monoclonal antibody
564319|NCT01160588|Anxiety|anxiety
564320|NCT01160588|Social Phobia|social phobia
564321|NCT01160588|Social Anxiety|social anxiety
564322|NCT01160588|Generalized Anxiety|generalized anxiety
564323|NCT01160588|Separation Anxiety|separation anxiety
564324|NCT01160575|Counseling|counseling
564325|NCT01160575|Epidemiology|epidemiology
564326|NCT01160575|HIV|hiv
564327|NCT01160575|AIDS|aids
564328|NCT01160575|Prevention|prevention
564329|NCT01160562|Prevalence|prevalence
564330|NCT01160562|Incidence|incidence
564331|NCT01160562|Children|children
564332|NCT01160562|Adults|adults
564333|NCT01160562|Global Positioning system|global positioning system
564334|NCT01160549|Pregnancy|pregnancy
564335|NCT01160549|Hormones|hormones
564336|NCT01160549|Mongolia|mongolia
564337|NCT01160549|Asian|asian
564338|NCT01160549|Breast Cancer|breast cancer
564339|NCT01160536|Hypertrophic Cardiomyopathy (HCM)|hypertrophic cardiomyopathy (hcm)
564340|NCT01160536|Genetic Testing|genetic testing
564341|NCT01160523|Podoconiosis|podoconiosis
564342|NCT01160523|Genetic Education|genetic education
564343|NCT01160523|Primary Prevention|primary prevention
564344|NCT01160523|Ethiopa|ethiopa
564345|NCT01160523|Youth|youth
564346|NCT01160510|Breast|breast
564347|NCT01160510|Mammographic Density|mammographic density
564348|NCT01160484|multiple myeloma|multiple myeloma
564349|NCT01160484|refractory|refractory
564350|NCT01160484|relapsed|relapsed
564351|NCT01160484|bortezomib|bortezomib
564352|NCT01160484|doxil|doxil
564353|NCT01160471|Heart Failure|heart failure
564354|NCT01160471|MRI|mri
564355|NCT01160471|Ultrasound|ultrasound
564356|NCT01160471|Fibrosis|fibrosis
564357|NCT01160471|Biomarker|biomarker
564358|NCT01160458|Monoclonal Antibody|monoclonal antibody
564359|NCT01160458|Pleural Mesothelioma|pleural mesothelioma
564360|NCT01160458|Peritoneal Mesothelioma|peritoneal mesothelioma
564361|NCT01160445|Metastatic Melanoma|metastatic melanoma
564362|NCT01160445|Metastatic Kidney Cancer|metastatic kidney cancer
564363|NCT01160445|Clinical Performance|clinical performance
564364|NCT01160445|Tumor Regression|tumor regression
564365|NCT01160445|Toxicity|toxicity
564366|NCT01160432|opiate dependence|opiate dependence
564367|NCT01160432|methadone|methadone
564368|NCT01160432|naloxone|naloxone
564369|NCT01160432|withdrawal symptom|withdrawal symptom
564370|NCT01160432|substitution treatment|substitution treatment
564371|NCT01160406|silent paroxysmal atrial fibrillation|silent paroxysmal atrial fibrillation
564372|NCT01160406|stroke|stroke
564373|NCT01160406|tele ECG|tele ecg
564374|NCT01160393|Atrial fibrillation|atrial fibrillation
564375|NCT01160393|Cardiac surgery|cardiac surgery
564376|NCT01160393|Prevention|prevention
564377|NCT01160393|Conventional bypass system|conventional bypass system
564378|NCT01160393|Miniaturized bypass system|miniaturized bypass system
564379|NCT01160393|Arrhythmia|arrhythmia
564480|NCT01159899|osteochondral defects|osteochondral defects
564380|NCT01160393|The Incidence of atrial fibrillation after cardiac surgery|the incidence of atrial fibrillation after cardiac surgery
564381|NCT01160380|cancer related fatigue|cancer related fatigue
564382|NCT01160380|fatigue|fatigue
564383|NCT01160380|multiple myeloma|multiple myeloma
564384|NCT01160380|cancer|cancer
564385|NCT01160380|quality of life|quality of life
564386|NCT01160354|Leukemia|leukemia
564387|NCT01160354|AML|aml
564388|NCT01160354|Clofarabine|clofarabine
564389|NCT01160354|Plerixafor|plerixafor
564390|NCT01160354|elderly patients|elderly patients
564391|NCT01160354|previously untreated|previously untreated
564392|NCT01160354|unfavorable prognostic factors|unfavorable prognostic factors
564393|NCT01160341|Metabolic syndrome|metabolic syndrome
564394|NCT01160341|Hypogonadism|hypogonadism
564395|NCT01160341|Testosterone|testosterone
564396|NCT01160328|Regional Fat Storage|regional fat storage
564397|NCT01160328|Fat Oxidation|fat oxidation
564398|NCT01160328|Testosterone|testosterone
564399|NCT01160328|Male|male
564400|NCT01160315|ovarian failure, chemotherapy, lymphoma, GnRH agonist|ovarian failure, chemotherapy, lymphoma, gnrh agonist
564401|NCT01160302|cancer|cancer
564402|NCT01160276|renal graft|renal graft
564403|NCT01160276|colchicine|colchicine
564404|NCT01160276|drug interaction|drug interaction
564405|NCT01160276|cyclosporine|cyclosporine
564406|NCT01160276|tacrolimus|tacrolimus
564407|NCT01160276|renal transplantation|renal transplantation
564408|NCT01160276|renal transplant|renal transplant
564409|NCT01160276|ABCB1|abcb1
564410|NCT01160276|CYP3A5|cyp3a5
564411|NCT01160276|SLCO1B1|slco1b1
564412|NCT01160263|ALS|als
564413|NCT01160263|serotonin|serotonin
564414|NCT01160263|dopamine|dopamine
564415|NCT01160237|H1N1|h1n1
564416|NCT01160237|Pandemrix|pandemrix
564417|NCT01160237|Fluarix|fluarix
564418|NCT01160237|Influenza|influenza
564419|NCT01160224|Asthma|asthma
564420|NCT01160224|CCR3 receptor antagonists|ccr3 receptor antagonists
564421|NCT01160224|GW766944|gw766944
564422|NCT01160211|1st line MBC|1st line mbc
564423|NCT01160211|MBC|mbc
564424|NCT01160211|hormone receptor positive|hormone receptor positive
564425|NCT01160211|lapatinib|lapatinib
564426|NCT01160211|trastuzumab|trastuzumab
564427|NCT01160211|HER2 positive|her2 positive
564428|NCT01160211|aromatase inhibitor|aromatase inhibitor
564429|NCT01160172|vaccine|vaccine
564430|NCT01160172|young adults|young adults
564431|NCT01160172|Staphylococcus aureus|staphylococcus aureus
564432|NCT01160159|Venous thrombosis|venous thrombosis
564433|NCT01160159|Women|women
564434|NCT01160159|Vasodilatation endothelium-dependent|vasodilatation endothelium-dependent
564435|NCT01160159|IMT|imt
564436|NCT01160159|Arterial stiffness|arterial stiffness
564437|NCT01160159|Arterial compliance|arterial compliance
564438|NCT01160159|Capillary density|capillary density
564439|NCT01160146|Obestiy|obestiy
564440|NCT01160146|Over weight|over weight
564441|NCT01160146|referral patterns|referral patterns
564442|NCT01160146|Continuing Medical Education|continuing medical education
564443|NCT01160133|Systane|systane
564444|NCT01160133|Refresh Tears|refresh tears
564445|NCT01160133|Dry Eye|dry eye
564446|NCT01160133|Moderate to Severe Dry Eye|moderate to severe dry eye
564447|NCT01160120|fixed dose combinations|fixed dose combinations
564448|NCT01160120|tenofovir|tenofovir
564449|NCT01160120|lamivudine|lamivudine
564450|NCT01160120|efavirenz|efavirenz
564451|NCT01160120|therapeutic drug levels|therapeutic drug levels
564452|NCT01160120|safety and efficacy|safety and efficacy
564453|NCT01160120|HIV|hiv
564454|NCT01160120|To evaluation new formulations of FDC of TDF/3TC/EFV|to evaluation new formulations of fdc of tdf/3tc/efv
564455|NCT01160107|Diagnosis|diagnosis
564456|NCT01160107|Elderly Patients|elderly patients
564457|NCT01160107|Imids|imids
564458|NCT01160107|Chemotherapy|chemotherapy
564459|NCT01160094|Trastuzumab|trastuzumab
564460|NCT01160094|Metastatic Breast Cancer|metastatic breast cancer
564461|NCT01160094|Breast Cancer|breast cancer
564462|NCT01160094|Observational Study|observational study
564463|NCT01160094|Lapatinib|lapatinib
564464|NCT01160003|ACTH stimulation test|acth stimulation test
564465|NCT01160003|Pharmacokinetics|pharmacokinetics
564466|NCT01160003|Nebules|nebules
564467|NCT01160003|Cortisol|cortisol
564468|NCT01159990|HIV Preventive Vaccine|hiv preventive vaccine
564469|NCT01159990|HIV Seronegativity|hiv seronegativity
564470|NCT01159964|Antigen-Specific Cancer Immunotherapeutic (ASCI)|antigen-specific cancer immunotherapeutic (asci)
564471|NCT01159964|PRAME|prame
564472|NCT01159964|PRAME-positive stage IB, II or IIIA Non-Small Cell Lung Cancer patients after complete surgical resection|prame-positive stage ib, ii or iiia non-small cell lung cancer patients after complete surgical resection
564473|NCT01159964|Non-Small Cell Lung Cancer|non-small cell lung cancer
564474|NCT01159912|fluticasone propionate|fluticasone propionate
564475|NCT01159912|Fluticasone furoate|fluticasone furoate
564476|NCT01159899|Osteoarthritis|osteoarthritis
564477|NCT01159899|knee arthritis|knee arthritis
564478|NCT01159899|Knee arthrosis|knee arthrosis
564479|NCT01159899|articular cartilage defects|articular cartilage defects
564761|NCT01158599|Ixiaro|ixiaro
564481|NCT01159899|mesenchymal stem cells|mesenchymal stem cells
564482|NCT01159899|stem cells|stem cells
564483|NCT01159899|cellules souches,|cellules souches,
564484|NCT01159899|genou|genou
564485|NCT01159899|arthrose genou|arthrose genou
564486|NCT01159899|PRP platelet rich plasma|prp platelet rich plasma
564487|NCT01159899|thérapie cellulaire|thérapie cellulaire
564488|NCT01159899|implantation cellules souches mésenchymateuses|implantation cellules souches mésenchymateuses
564489|NCT01159899|régénération cartilage|régénération cartilage
564490|NCT01159899|cicatrisation ménisque|cicatrisation ménisque
564491|NCT01159899|ligament|ligament
564492|NCT01159899|plasma riche plaquettaire|plasma riche plaquettaire
564493|NCT01159899|platelet rich plasma|platelet rich plasma
564494|NCT01159899|stem cell|stem cell
564495|NCT01159899|regrowt cartilage|regrowt cartilage
564496|NCT01159899|cellules souches|cellules souches
564497|NCT01159899|PRP|prp
564498|NCT01159886|Tuberculosis|tuberculosis
564499|NCT01159886|IBD|ibd
564500|NCT01159886|endoscopy|endoscopy
564501|NCT01159860|seborrheic keratoses|seborrheic keratoses
564502|NCT01159860|cryosurgery|cryosurgery
564503|NCT01159860|curettage|curettage
564504|NCT01159847|sitagliptin|sitagliptin
564505|NCT01159847|LADA|lada
564506|NCT01159847|C-Peptide|c-peptide
564507|NCT01159847|Flow Cytometry|flow cytometry
564508|NCT01159847|ELISPOT|elispot
564509|NCT01159834|HPV infection|hpv infection
564510|NCT01159834|Cervical cancer|cervical cancer
564511|NCT01159834|HPV vaccine|hpv vaccine
564512|NCT01159821|31001074|31001074
564513|NCT01159821|Paroxetine|paroxetine
564514|NCT01159821|CYP2D6 inhibitor|cyp2d6 inhibitor
564515|NCT01159808|Safety and Pharmacokinetics|safety and pharmacokinetics
564516|NCT01159795|Respiratory Syncytial Virus|respiratory syncytial virus
564517|NCT01159795|Infant|infant
564518|NCT01159795|Interferon|interferon
564519|NCT01159769|Allergic conjunctivitis|allergic conjunctivitis
564520|NCT01159756|Travacom|travacom
564521|NCT01159756|Glaucoma|glaucoma
564522|NCT01159756|Travoprost|travoprost
564523|NCT01159756|Timolol|timolol
564524|NCT01159743|lipodystrophy|lipodystrophy
564525|NCT01159743|Lipoatrophy|lipoatrophy
564526|NCT01159743|antiretroviral treatment|antiretroviral treatment
564527|NCT01159704|HIV infection|hiv infection
564528|NCT01159704|Intervention|intervention
564529|NCT01159704|Risk-reduction|risk-reduction
564530|NCT01159704|Injection drug users|injection drug users
564531|NCT01159691|Rotigotine|rotigotine
564532|NCT01159691|Neupro®|neupro®
564533|NCT01159691|Parkinson's disease|parkinson's disease
564534|NCT01159691|Gastrointestinal|gastrointestinal
564535|NCT01159691|Switch from oral therapy to patch|switch from oral therapy to patch
564536|NCT01159652|sleep|sleep
564537|NCT01159652|memory|memory
564538|NCT01159652|hypnotics|hypnotics
564539|NCT01159652|zaleplon|zaleplon
564540|NCT01159652|zolpidem|zolpidem
564541|NCT01159652|Sonata|sonata
564542|NCT01159652|Ambien|ambien
564543|NCT01159652|Hypnotics and Sedatives|hypnotics and sedatives
564544|NCT01159652|Polysomnography|polysomnography
564545|NCT01159652|Monitoring, sleep|monitoring, sleep
564546|NCT01159639|aspirin resistance|aspirin resistance
564547|NCT01159639|coronary artery bypass grafting|coronary artery bypass grafting
564548|NCT01159639|multiple electrode aggregometry|multiple electrode aggregometry
564549|NCT01159639|multiplate|multiplate
564550|NCT01159626|Phase1|phase1
564551|NCT01159626|Pharmacokinetics|pharmacokinetics
564552|NCT01159626|Healthy Male|healthy male
564553|NCT01159626|Japanese|japanese
564554|NCT01159626|Schizophrenia|schizophrenia
564555|NCT01159613|SVR|svr
564556|NCT01159613|Cholesterol level|cholesterol level
564557|NCT01159613|fibrosis score|fibrosis score
564558|NCT01159613|HDL|hdl
564559|NCT01159535|substance use|substance use
564560|NCT01159535|addiction|addiction
564561|NCT01159535|meditation|meditation
564562|NCT01159535|mindfulness|mindfulness
564563|NCT01159535|relapse prevention|relapse prevention
564564|NCT01159522|Advanced Solid Tumors Who Have Failed Standard Therapy|advanced solid tumors who have failed standard therapy
564565|NCT01159509|hypertrophic pyloric stenosis|hypertrophic pyloric stenosis
564566|NCT01159509|sodium intake|sodium intake
564567|NCT01159509|Healthy children with no chronic diseases|healthy children with no chronic diseases
564568|NCT01159509|Status post HPS|status post hps
564569|NCT01159483|safety|safety
564570|NCT01159483|tolerability|tolerability
564571|NCT01159483|pharmacokinetics|pharmacokinetics
564572|NCT01159470|CRP velocity|crp velocity
564573|NCT01159457|Celiac Disease|celiac disease
564574|NCT01159457|Hepatitis B vaccination|hepatitis b vaccination
564575|NCT01159444|noninvasive ventilation|noninvasive ventilation
564576|NCT01159444|ventilator software|ventilator software
564577|NCT01159444|ventilator settings|ventilator settings
564578|NCT01159444|domiciliary ventilation|domiciliary ventilation
564579|NCT01159431|partial seizures|partial seizures
564580|NCT01159431|poorly controlled epilepsy|poorly controlled epilepsy
564581|NCT01159431|intractable epilepsy|intractable epilepsy
564582|NCT01159431|treatment resistant epilepsy|treatment resistant epilepsy
564583|NCT01159431|Trigeminal Nerve|trigeminal nerve
564584|NCT01159431|Trigeminal Nerve Stimulation|trigeminal nerve stimulation
564585|NCT01159418|solid tumors|solid tumors
564586|NCT01159418|Panobinostat|panobinostat
564587|NCT01159418|histone deacetylase inhibitors|histone deacetylase inhibitors
564588|NCT01159392|brain injury|brain injury
564589|NCT01159392|mechanical ventilation|mechanical ventilation
564590|NCT01159392|acute lung injury|acute lung injury
564591|NCT01159392|lung recruitment|lung recruitment
564592|NCT01159379|IgE-mediated allergy|ige-mediated allergy
564593|NCT01159379|Beta-lactams|beta-lactams
564594|NCT01159379|Ertapenem|ertapenem
564595|NCT01159379|Cross-reactivity|cross-reactivity
564596|NCT01159379|Immediate-type skin tests|immediate-type skin tests
564597|NCT01159379|Intravenous tolerance tests|intravenous tolerance tests
564598|NCT01159366|myocardial infarction|myocardial infarction
564599|NCT01159366|coronary occlusion|coronary occlusion
564600|NCT01159366|myocardial revascularization|myocardial revascularization
564601|NCT01159366|collaterals|collaterals
564602|NCT01159366|prognosis|prognosis
564603|NCT01159327|Sorafenib (nexavar)|sorafenib (nexavar)
564604|NCT01159327|ED-SCLC|ed-sclc
564605|NCT01159327|Maintenance|maintenance
564606|NCT01159327|Extensive Disease Small cell lung cancer|extensive disease small cell lung cancer
564607|NCT01159314|glaucoma|glaucoma
564608|NCT01159314|Baerveldt Implants|baerveldt implants
564609|NCT01159288|Advanced unresectable non small cell lung cancer|advanced unresectable non small cell lung cancer
564610|NCT01159288|Responding or stabilized after induction chemotherapy|responding or stabilized after induction chemotherapy
564611|NCT01159275|lopinavir/ritonavir|lopinavir/ritonavir
564612|NCT01159275|pharmacokinetics|pharmacokinetics
564613|NCT01159275|HIV-1 infected adults|hiv-1 infected adults
564614|NCT01159275|aim to investigate the lower dose of boosted lopinavir in Thais and to compare the levels of lopinavir/ritonavir from Abbot and GPO|aim to investigate the lower dose of boosted lopinavir in thais and to compare the levels of lopinavir/ritonavir from abbot and gpo
564615|NCT01159262|Initially intubated and mechanically ventilated neonates|initially intubated and mechanically ventilated neonates
564616|NCT01159249|Vildagliptin, Type 2 Diabetes, HbA1c, Fasting Plasma Glucose, Long-Term Safety|vildagliptin, type 2 diabetes, hba1c, fasting plasma glucose, long-term safety
564617|NCT01159236|Gene signatures|gene signatures
564618|NCT01159236|HER-2 normal stage I-III breast cancer|her-2 normal stage i-iii breast cancer
564619|NCT01159236|Estrogen Receptor|estrogen receptor
564620|NCT01159236|ER-positive|er-positive
564621|NCT01159236|ER-negative|er-negative
564622|NCT01159236|RCB categories II-III|rcb categories ii-iii
564623|NCT01159236|Neoadjuvant Chemotherapy|neoadjuvant chemotherapy
564624|NCT01159236|adjuvant systemic therapy|adjuvant systemic therapy
564625|NCT01159236|molecular testing|molecular testing
564626|NCT01159236|Fluorouracil|fluorouracil
564627|NCT01159236|5-fluorouracil|5-fluorouracil
564628|NCT01159236|5-FU|5-fu
564629|NCT01159236|Doxorubicin|doxorubicin
564630|NCT01159236|Adriamycin|adriamycin
564631|NCT01159236|Rubex|rubex
564632|NCT01159236|Epirubicin|epirubicin
564633|NCT01159236|Ellence|ellence
564634|NCT01159236|Cyclophosphamide|cyclophosphamide
564635|NCT01159236|Cytoxan|cytoxan
564636|NCT01159236|Neosar|neosar
564637|NCT01159236|Bevacizumab|bevacizumab
564638|NCT01159236|Avastin|avastin
564639|NCT01159236|Anti-VEGF monoclonal|anti-vegf monoclonal
564640|NCT01159236|rhu-MAb-VEGF|rhu-mab-vegf
564641|NCT01159223|atazanavir / ritonavir|atazanavir / ritonavir
564642|NCT01159223|low dose|low dose
564643|NCT01159223|noninferiority|noninferiority
564644|NCT01159223|safety and efficacy|safety and efficacy
564645|NCT01159223|efficacy and safety of lower dose atazanavir/ritonavir in suppressed HIV-infected adults|efficacy and safety of lower dose atazanavir/ritonavir in suppressed hiv-infected adults
564646|NCT01159197|sleep disturbance|sleep disturbance
564647|NCT01159197|cognitive behavioral therapy|cognitive behavioral therapy
564648|NCT01159197|inflammation|inflammation
564649|NCT01159197|oxidative stress|oxidative stress
564650|NCT01159197|hemodialysis|hemodialysis
564651|NCT01159184|stress|stress
564652|NCT01159184|coping methods|coping methods
564653|NCT01159184|social support|social support
564654|NCT01159184|diabetes mellitus|diabetes mellitus
564655|NCT01159145|Healthy volunteer|healthy volunteer
564656|NCT01159145|Japanese males|japanese males
564657|NCT01159145|homo-EM/hetero-EM/PM|homo-em/hetero-em/pm
564658|NCT01159132|pharmacokinetics|pharmacokinetics
564659|NCT01159132|low dose raltegravir|low dose raltegravir
564661|NCT01159132|To study the pharmacokinetics profile of low dose raltegravir (RAL) (400mg OD and 800mg OD) and standard dose of 400mg BID in Thai HIV-infected patients.|to study the pharmacokinetics profile of low dose raltegravir (ral) (400mg od and 800mg od) and standard dose of 400mg bid in thai hiv-infected patients.
564662|NCT01159119|Chronic Abdominal Pain|chronic abdominal pain
564663|NCT01159119|Exocrine Pancreatic Insufficiency|exocrine pancreatic insufficiency
564664|NCT01159106|Positive Pressure Ventilation|positive pressure ventilation
564665|NCT01159106|Neurally Adjusted Ventilatory Assist|neurally adjusted ventilatory assist
564666|NCT01159106|Patient/ventilator Asynchrony|patient/ventilator asynchrony
564667|NCT01159106|Pediatric patient|pediatric patient
564668|NCT01159106|Infant|infant
564669|NCT01159093|Clinical Decision Support Systems|clinical decision support systems
564670|NCT01159080|immunosuppression control in kidney transplantation|immunosuppression control in kidney transplantation
564671|NCT01159067|HSCT, iron overload, deferasirox, labile plasma iron|hsct, iron overload, deferasirox, labile plasma iron
564672|NCT01159041|Depression, children, adolescent, family|depression, children, adolescent, family
564673|NCT01159028|Liposomal Grb-2 treatment of CML, AML, CLL, MDS|liposomal grb-2 treatment of cml, aml, cll, mds
564674|NCT01159028|Liposomal Grb-2 with LDAC for AML|liposomal grb-2 with ldac for aml
564675|NCT01159002|Endoscopy, Video Capsule|endoscopy, video capsule
564676|NCT01159002|Motility, Gastrointestinal|motility, gastrointestinal
564677|NCT01158989|Critical care|critical care
564678|NCT01158989|Endoscopy, Video Capsule|endoscopy, video capsule
564679|NCT01158989|Nutrition, Enteral|nutrition, enteral
564680|NCT01158937|meropenem|meropenem
564681|NCT01158937|cystic fibrosis|cystic fibrosis
564682|NCT01158937|extended infusion|extended infusion
564683|NCT01158937|pharmacokinetic|pharmacokinetic
564684|NCT01158911|kidney disease|kidney disease
564685|NCT01158911|uric acid|uric acid
564686|NCT01158911|outcomes|outcomes
564687|NCT01158911|cardiovascular|cardiovascular
564688|NCT01158911|mortality|mortality
564689|NCT01158911|kidney failure|kidney failure
564690|NCT01158911|Uric Acid levels in patients with Chronic Kidney Disease|uric acid levels in patients with chronic kidney disease
564691|NCT01158898|Mild to moderate asthma|mild to moderate asthma
564692|NCT01158898|Allergen inhalation challenge|allergen inhalation challenge
564693|NCT01158885|relapsed|relapsed
564694|NCT01158885|relapse|relapse
564695|NCT01158885|refractory|refractory
564696|NCT01158885|Minimal Residual disease|minimal residual disease
564698|NCT01158885|MRD positive|mrd positive
564699|NCT01158885|MRD+|mrd+
564700|NCT01158885|ALL|all
564701|NCT01158885|Acute lymphoblastic leukemia|acute lymphoblastic leukemia
564702|NCT01158885|AML|aml
564703|NCT01158885|Acute myelogenous leukemia|acute myelogenous leukemia
564704|NCT01158885|Relapsed AML|relapsed aml
564705|NCT01158859|Anesthesia, General|anesthesia, general
564706|NCT01158859|Propofol|propofol
564707|NCT01158859|Pregabalin|pregabalin
564708|NCT01158859|Preoperative care|preoperative care
564709|NCT01158859|Laparoscopic surgery|laparoscopic surgery
564710|NCT01158846|STEMI|stemi
564711|NCT01158846|Primary PCI|primary pci
564712|NCT01158846|anticoagulants|anticoagulants
564713|NCT01158846|antiplatelets|antiplatelets
564714|NCT01158833|Cerebral palsy|cerebral palsy
564715|NCT01158833|diplegia|diplegia
564716|NCT01158833|gait|gait
564717|NCT01158833|classification|classification
564718|NCT01158820|bronchoscopy|bronchoscopy
564719|NCT01158807|Hereditary Hemorrhagic Telangiectasia|hereditary hemorrhagic telangiectasia
564720|NCT01158807|Cerebral arteriovenous malformations|cerebral arteriovenous malformations
564721|NCT01158794|Iron overload|iron overload
564722|NCT01158794|Blood Transfusion|blood transfusion
564723|NCT01158781|TBI|tbi
564724|NCT01158781|motor learning|motor learning
564725|NCT01158781|robotics|robotics
564726|NCT01158781|Functional electrical stimulation|functional electrical stimulation
564727|NCT01158768|domestic violence in childhood/adolescence|domestic violence in childhood/adolescence
564728|NCT01158768|comorbidities|comorbidities
564729|NCT01158768|climactery|climactery
564730|NCT01158768|domestic violence against women|domestic violence against women
564731|NCT01158768|trauma questionnaire|trauma questionnaire
564732|NCT01158768|Violence|violence
564733|NCT01158755|Meningitis, tuberculous|meningitis, tuberculous
564734|NCT01158755|Intensified Regimen|intensified regimen
564735|NCT01158755|PK/PD and tolerability|pk/pd and tolerability
564736|NCT01158755|Outcome|outcome
564737|NCT01158742|Glomerular Filtration Rate|glomerular filtration rate
564738|NCT01158729|Antithrombin III|antithrombin iii
564739|NCT01158729|Postoperative Hemorrhage|postoperative hemorrhage
564740|NCT01158729|Cardiopulmonary Bypass|cardiopulmonary bypass
564741|NCT01158729|Pediatrics|pediatrics
564742|NCT01158729|Blood Transfusion|blood transfusion
564743|NCT01158716|percutaneous coronary intervention|percutaneous coronary intervention
564744|NCT01158716|remote ischemic preconditioning|remote ischemic preconditioning
564745|NCT01158703|aspirin|aspirin
564746|NCT01158703|clopidogrel|clopidogrel
564747|NCT01158703|coronary artery bypass graft|coronary artery bypass graft
564748|NCT01158703|Plavix|plavix
564749|NCT01158690|Intimate partner violence|intimate partner violence
564750|NCT01158677|meniscectomy|meniscectomy
564751|NCT01158664|dental implants|dental implants
564752|NCT01158664|different tread pitch design|different tread pitch design
564753|NCT01158651|NF1|nf1
564754|NCT01158651|low-grade glioma|low-grade glioma
564755|NCT01158651|progressive|progressive
564756|NCT01158651|children|children
564757|NCT01158651|Participants studied have NF Type 1 and a low grade glioma that has either not responded to one or more standard treatments.|participants studied have nf type 1 and a low grade glioma that has either not responded to one or more standard treatments.
564758|NCT01158638|Physical Activity Enhancement|physical activity enhancement
564759|NCT01158599|Japanese Encephalitis|japanese encephalitis
564760|NCT01158599|Vaccination|vaccination
564762|NCT01158599|elderly population|elderly population
564763|NCT01158586|post total knee replacement|post total knee replacement
564764|NCT01158586|patient control|patient control
564765|NCT01158586|epidural analgesia|epidural analgesia
564766|NCT01158573|Asthma|asthma
564767|NCT01158573|Obesity|obesity
564768|NCT01158560|upper respiratory tract infections|upper respiratory tract infections
564769|NCT01158560|rhinovirus infections|rhinovirus infections
564770|NCT01158560|vitamin D|vitamin d
564771|NCT01158534|recurrent renal cell cancer|recurrent renal cell cancer
564772|NCT01158508|cerebral aneurysm|cerebral aneurysm
564773|NCT01158508|cerebral vasospasm|cerebral vasospasm
564774|NCT01158508|subarachnoid hemorrhage|subarachnoid hemorrhage
564775|NCT01158508|remote ischemic preconditioning|remote ischemic preconditioning
564776|NCT01158456|smoking|smoking
564777|NCT01158456|lung cancer|lung cancer
564778|NCT01158456|ethnic racial differences|ethnic racial differences
564779|NCT01158456|tobacco specific nitrosamines|tobacco specific nitrosamines
564780|NCT01158456|metabolism of carcinogens|metabolism of carcinogens
564781|NCT01158443|HIV+|hiv+
564782|NCT01158443|fatigue|fatigue
564783|NCT01158443|return to work|return to work
564784|NCT01158430|Hypochondriasis|hypochondriasis
564785|NCT01158430|Acceptance and Commitment Therapy|acceptance and commitment therapy
564786|NCT01158430|ACT|act
564787|NCT01158417|Type 2 Diabetes|type 2 diabetes
564788|NCT01158417|Obesity|obesity
564789|NCT01158417|Insulin Resistance|insulin resistance
564790|NCT01158417|Resveratrol|resveratrol
564791|NCT01158417|Inflammation|inflammation
564792|NCT01158404|Metastatic Cancer|metastatic cancer
564793|NCT01158404|Solid Tumors|solid tumors
564794|NCT01158391|Premature Birth|premature birth
564795|NCT01158378|Adherus Dural Sealant|adherus dural sealant
564796|NCT01158378|Adherus AutoSpray Dural Sealant|adherus autospray dural sealant
564797|NCT01158352|Growth|growth
564798|NCT01158352|Low weight|low weight
564799|NCT01158352|Low height|low height
564800|NCT01158352|Nutritional Formula|nutritional formula
564801|NCT01158339|Low back pain|low back pain
564802|NCT01158339|Cognitive behavioural therapy|cognitive behavioural therapy
564803|NCT01158339|Group therapy|group therapy
564804|NCT01158339|Exposure in session|exposure in session
564805|NCT01158326|reducing symptoms|reducing symptoms
564806|NCT01158326|events|events
564807|NCT01158326|Common Cold|common cold
564808|NCT01158326|flu syndrome|flu syndrome
564809|NCT01158326|Symptomatic treatment of the Common Cold and Flu syndrome|symptomatic treatment of the common cold and flu syndrome
564810|NCT01158300|recurrent childhood malignant germ cell tumor|recurrent childhood malignant germ cell tumor
564811|NCT01158300|recurrent childhood brain stem glioma|recurrent childhood brain stem glioma
564812|NCT01158300|recurrent childhood brain tumor|recurrent childhood brain tumor
564813|NCT01158300|recurrent childhood central nervous system embryonal tumor|recurrent childhood central nervous system embryonal tumor
564814|NCT01158300|recurrent childhood cerebellar astrocytoma|recurrent childhood cerebellar astrocytoma
564815|NCT01158300|recurrent childhood cerebral astrocytoma|recurrent childhood cerebral astrocytoma
564816|NCT01158300|recurrent childhood ependymoma|recurrent childhood ependymoma
564817|NCT01158300|recurrent childhood medulloblastoma|recurrent childhood medulloblastoma
564818|NCT01158300|recurrent childhood pineoblastoma|recurrent childhood pineoblastoma
564819|NCT01158300|recurrent childhood rhabdomyosarcoma|recurrent childhood rhabdomyosarcoma
564820|NCT01158300|recurrent childhood spinal cord neoplasm|recurrent childhood spinal cord neoplasm
564821|NCT01158300|recurrent childhood subependymal giant cell astrocytoma|recurrent childhood subependymal giant cell astrocytoma
564822|NCT01158300|recurrent childhood visual pathway and hypothalamic glioma|recurrent childhood visual pathway and hypothalamic glioma
564823|NCT01158300|recurrent childhood visual pathway glioma|recurrent childhood visual pathway glioma
564824|NCT01158300|childhood central nervous system choriocarcinoma|childhood central nervous system choriocarcinoma
564825|NCT01158300|childhood central nervous system germ cell tumor|childhood central nervous system germ cell tumor
564826|NCT01158300|childhood central nervous system germinoma|childhood central nervous system germinoma
564827|NCT01158300|childhood central nervous system mixed germ cell tumor|childhood central nervous system mixed germ cell tumor
564828|NCT01158300|childhood central nervous system teratoma|childhood central nervous system teratoma
564829|NCT01158300|childhood central nervous system yolk sac tumor|childhood central nervous system yolk sac tumor
564830|NCT01158300|childhood astrocytoma|childhood astrocytoma
564831|NCT01158300|childhood medulloepithelioma|childhood medulloepithelioma
564832|NCT01158300|childhood meningioma|childhood meningioma
564833|NCT01158300|childhood mixed glioma|childhood mixed glioma
564834|NCT01158300|childhood oligodendroglioma|childhood oligodendroglioma
564835|NCT01158300|childhood pineal parenchymal tumor|childhood pineal parenchymal tumor
564836|NCT01158287|adenocarcinoma of the esophagus|adenocarcinoma of the esophagus
564837|NCT01158287|recurrent esophageal cancer|recurrent esophageal cancer
564838|NCT01158287|recurrent gastric cancer|recurrent gastric cancer
564839|NCT01158287|adenocarcinoma of the stomach|adenocarcinoma of the stomach
564840|NCT01158261|hemostasis|hemostasis
564841|NCT01158248|cervical adenocarcinoma|cervical adenocarcinoma
564842|NCT01158248|cervical adenosquamous cell carcinoma|cervical adenosquamous cell carcinoma
564843|NCT01158248|cervical small cell carcinoma|cervical small cell carcinoma
565236|NCT01156532|Psoriasis|psoriasis
564844|NCT01158248|stage IB cervical cancer|stage ib cervical cancer
564845|NCT01158248|stage IIA cervical cancer|stage iia cervical cancer
564846|NCT01158248|stage IIB cervical cancer|stage iib cervical cancer
564847|NCT01158248|stage III cervical cancer|stage iii cervical cancer
564848|NCT01158248|cervical squamous cell carcinoma|cervical squamous cell carcinoma
564849|NCT01158235|MRSA|mrsa
564850|NCT01158235|nose|nose
564851|NCT01158196|laser|laser
564852|NCT01158196|keloid|keloid
564853|NCT01158196|scar|scar
564854|NCT01158183|Outcomes|outcomes
564855|NCT01158183|real world and web tool|real world and web tool
564856|NCT01158183|electronic data capture|electronic data capture
564857|NCT01158170|nonsmall cell lung cancer|nonsmall cell lung cancer
564858|NCT01158170|brain metastasis|brain metastasis
564859|NCT01158170|prophylactic cranial irradiation|prophylactic cranial irradiation
564860|NCT01158144|Non-small cell lung cancer|non-small cell lung cancer
564861|NCT01158144|Locally advanced|locally advanced
564862|NCT01158144|Radiotherapy|radiotherapy
564863|NCT01158144|Concomitant Chemotherapy|concomitant chemotherapy
564864|NCT01158144|Endostar|endostar
564865|NCT01158131|Gestational diabetes mellitus (GDM) in the most recent pregnancy|gestational diabetes mellitus (gdm) in the most recent pregnancy
564866|NCT01158118|Precursor Cell Lymphoblastic Leukemia-Lymphoma|precursor cell lymphoblastic leukemia-lymphoma
564867|NCT01158118|Leukemia, Myelogenous, Chronic, BCR-ABL Positive|leukemia, myelogenous, chronic, bcr-abl positive
564868|NCT01158105|Steroid refractory chronic graft vs host disease (cGVHD)|steroid refractory chronic graft vs host disease (cgvhd)
564869|NCT01158105|Bortezomib|bortezomib
564870|NCT01158105|Velcade|velcade
564871|NCT01158079|Liver|liver
564872|NCT01158079|Solid Tumors|solid tumors
564873|NCT01158079|Advanced Solid Tumors with Liver Involvement|advanced solid tumors with liver involvement
564874|NCT01158066|NAFLD|nafld
564875|NCT01158066|Calcium score|calcium score
564876|NCT01158066|Liver Fat|liver fat
564877|NCT01158066|Visceral fat|visceral fat
564878|NCT01158066|excessive visceral fat|excessive visceral fat
564879|NCT01158066|excessive liver fat accumulation|excessive liver fat accumulation
565001|NCT01157351|Risperidone|risperidone
564880|NCT01158066|Biomarkers of insulin resistance (HOMA), inflammation (CRP) and (MDA-Paraoxonase)|biomarkers of insulin resistance (homa), inflammation (crp) and (mda-paraoxonase)
564881|NCT01158040|Maternal intrapartum glycemic control|maternal intrapartum glycemic control
564882|NCT01158040|Pregestational diabetes|pregestational diabetes
564883|NCT01158014|pterygium|pterygium
564884|NCT01158014|conjunctival graft|conjunctival graft
564885|NCT01158014|recurrence|recurrence
564886|NCT01158014|primary pterygium|primary pterygium
711461|NCT00584597|Inflammation of the mouth|inflammation of the mouth
564887|NCT01158001|Posttraumatic stress disorders|posttraumatic stress disorders
564888|NCT01158001|Telemedicine|telemedicine
564889|NCT01158001|Psychotherapy|psychotherapy
564890|NCT01158001|Neuropsychological test|neuropsychological test
564891|NCT01158001|Depression|depression
564892|NCT01157988|bulky diffuse large B cell lymphoma|bulky diffuse large b cell lymphoma
564893|NCT01157988|90Y-ibritumomab tiuxetan|90y-ibritumomab tiuxetan
564894|NCT01157988|clinical response|clinical response
564895|NCT01157988|Safety and toxicity|safety and toxicity
564896|NCT01157962|Sentinel Concept|sentinel concept
564897|NCT01157962|Lymphadenectomy|lymphadenectomy
564898|NCT01157962|Early Stage Cervical Cancer|early stage cervical cancer
564899|NCT01157962|Overall Survive|overall survive
564900|NCT01157962|Improvement Therapy|improvement therapy
564901|NCT01157936|hypertension|hypertension
564902|NCT01157936|hyperuricemia|hyperuricemia
564903|NCT01157936|metabolic syndrome|metabolic syndrome
564904|NCT01157923|Type 1 diabetes|type 1 diabetes
564905|NCT01157923|Insulin Pump Therapy|insulin pump therapy
564906|NCT01157910|Ear infection|ear infection
564907|NCT01157910|Chronic|chronic
564908|NCT01157897|Malaria|malaria
564909|NCT01157897|Plasmodium Vivax|plasmodium vivax
564910|NCT01157897|Vaccine|vaccine
564911|NCT01157884|body composition|body composition
564912|NCT01157884|obesity|obesity
564913|NCT01157884|kidney transplantation|kidney transplantation
564914|NCT01157858|liver cyst|liver cyst
564915|NCT01157832|water pipe smoking acute effect|water pipe smoking acute effect
564916|NCT01157819|swimmer's ear|swimmer's ear
564917|NCT01157819|ear drops|ear drops
564918|NCT01157819|ear foam|ear foam
564919|NCT01157819|otic foam|otic foam
564920|NCT01157819|ear infection|ear infection
564921|NCT01157819|ear pain|ear pain
564922|NCT01157819|ear inflammation|ear inflammation
564923|NCT01157806|rectal cancer|rectal cancer
564924|NCT01157806|unresectable synchronous metastases|unresectable synchronous metastases
564925|NCT01157806|pelvic radiochemotherapy|pelvic radiochemotherapy
564926|NCT01157793|Dwarfism|dwarfism
564927|NCT01157793|Growth hormone deficiency|growth hormone deficiency
564928|NCT01157793|Growth hormone|growth hormone
564929|NCT01157780|Fish oil|fish oil
564930|NCT01157767|exercise|exercise
564931|NCT01157767|lymphedema|lymphedema
564932|NCT01157767|post-operative chemotherapy|post-operative chemotherapy
564933|NCT01157767|post-operative radiation|post-operative radiation
564934|NCT01157767|10-062|10-062
564935|NCT01157754|Infertility patients requiring IVF|infertility patients requiring ivf
564936|NCT01157754|good prognosis|good prognosis
564937|NCT01157741|Community based follow up, severely underweight children|community based follow up, severely underweight children
564938|NCT01157728|Multiple sclerosis|multiple sclerosis
564939|NCT01157728|Cognitive impairment|cognitive impairment
564940|NCT01157715|KH902|kh902
564941|NCT01157715|age-related macular degeneration (AMD)|age-related macular degeneration (amd)
564942|NCT01157715|choroidal neovascularization (CNV)|choroidal neovascularization (cnv)
564943|NCT01157715|intravitreal injection|intravitreal injection
564944|NCT01157715|best corrected visual acuity (BCVA)|best corrected visual acuity (bcva)
564945|NCT01157715|central retinal thickness|central retinal thickness
564946|NCT01157689|malaria|malaria
564947|NCT01157689|children|children
564948|NCT01157689|Guinea-Bissau|guinea-bissau
564949|NCT01157689|artemether|artemether
564950|NCT01157689|lumefantrine|lumefantrine
564951|NCT01157689|effectiveness|effectiveness
564952|NCT01157676|open cystectomy|open cystectomy
564953|NCT01157676|robotic assisted radical cystectomy|robotic assisted radical cystectomy
564954|NCT01157676|bladder cancer|bladder cancer
564955|NCT01157663|Functional ankle instability|functional ankle instability
564956|NCT01157650|Fistulizing Crohn's disease|fistulizing crohn's disease
564957|NCT01157650|stem cells implant|stem cells implant
564958|NCT01157624|hypoxia or hypercarbia during surgery under the drape|hypoxia or hypercarbia during surgery under the drape
564959|NCT01157611|online based mentoring program,|online based mentoring program,
564960|NCT01157611|type 1 diabetes,|type 1 diabetes,
564961|NCT01157611|blood glucose,|blood glucose,
564962|NCT01157611|satisfaction score|satisfaction score
564963|NCT01157598|gastric adenoma|gastric adenoma
564964|NCT01157598|early gastric cancer|early gastric cancer
564965|NCT01157572|Aortic valve insufficiency|aortic valve insufficiency
564966|NCT01157572|Beta-blocker|beta-blocker
564967|NCT01157533|Vancomycin|vancomycin
564968|NCT01157533|Pharmacokinetic testing|pharmacokinetic testing
564969|NCT01157533|PK|pk
564970|NCT01157507|Botulinum A toxin|botulinum a toxin
564971|NCT01157507|Painful Bladder Syndrome (PBS)|painful bladder syndrome (pbs)
564972|NCT01157507|Bladder overdistention|bladder overdistention
564973|NCT01157494|cerebral palsy|cerebral palsy
564974|NCT01157494|hemiplegia|hemiplegia
564975|NCT01157494|upper limb|upper limb
564976|NCT01157494|assessment|assessment
564977|NCT01157494|classification system|classification system
564978|NCT01157481|Diastolic Heart Failure|diastolic heart failure
564979|NCT01157481|Heart failure with preserved ejection fraction|heart failure with preserved ejection fraction
564980|NCT01157481|nifedipine|nifedipine
564981|NCT01157468|Systemic Lupus Erythematosus in Martinique|systemic lupus erythematosus in martinique
564982|NCT01157468|Hydrolase and DNase activities|hydrolase and dnase activities
564983|NCT01157455|Stent|stent
564984|NCT01157455|Coronary artery diseases|coronary artery diseases
564985|NCT01157442|prevention of maternal to child transmission of HIV|prevention of maternal to child transmission of hiv
564986|NCT01157442|mhealth|mhealth
564987|NCT01157442|access to antenatal care|access to antenatal care
564988|NCT01157442|pregnancy|pregnancy
564989|NCT01157429|Cognitive Behavior Therapy|cognitive behavior therapy
564990|NCT01157429|Children|children
564991|NCT01157429|Adolescents|adolescents
564992|NCT01157429|Pharmacotherapy|pharmacotherapy
564993|NCT01157416|Cognitive Behavior Therapy|cognitive behavior therapy
564994|NCT01157416|Children|children
564995|NCT01157416|Pharmacotherapy|pharmacotherapy
564996|NCT01157403|mesenchymal stem cells|mesenchymal stem cells
564997|NCT01157390|Term-infant|term-infant
564998|NCT01157390|sn-2 palmitic acid|sn-2 palmitic acid
564999|NCT01157390|infant formula|infant formula
565000|NCT01157351|Schizophrenia|schizophrenia
565002|NCT01157351|Risperdal|risperdal
565003|NCT01157351|Paliperidone palmitate|paliperidone palmitate
565004|NCT01157351|Aripiprazole|aripiprazole
565005|NCT01157351|Haloperidol|haloperidol
565006|NCT01157351|Olanzapine|olanzapine
565007|NCT01157351|Paliperidone|paliperidone
565008|NCT01157351|Perphenazine|perphenazine
565009|NCT01157351|Quetiapine|quetiapine
565010|NCT01157338|Catheter|catheter
565011|NCT01157338|coronary artery disease|coronary artery disease
565012|NCT01157338|embolus|embolus
565013|NCT01157338|stroke|stroke
565014|NCT01157338|retinal emboli|retinal emboli
565015|NCT01157325|Epidural analgesia|epidural analgesia
565016|NCT01157325|Latent analgesia|latent analgesia
565017|NCT01157325|Active analgesia|active analgesia
565018|NCT01157325|Cesarean section|cesarean section
565019|NCT01157312|Polycystic ovary syndrome|polycystic ovary syndrome
565020|NCT01157312|clomiphene citrate|clomiphene citrate
565021|NCT01157312|minimal stimulation|minimal stimulation
565022|NCT01157312|infertility treatment|infertility treatment
565023|NCT01157299|Hemodynamics|hemodynamics
565024|NCT01157299|Pediatric Intensive Care Unit|pediatric intensive care unit
565025|NCT01157299|Low cardiac output|low cardiac output
565026|NCT01157299|Thermodilution|thermodilution
565027|NCT01157299|Stroke volume|stroke volume
565028|NCT01157299|Global end-diastolic volume|global end-diastolic volume
565029|NCT01157299|Fluid responsiveness|fluid responsiveness
565030|NCT01157299|Passive leg raising|passive leg raising
565031|NCT01157299|Infant|infant
565032|NCT01157286|OBSTRUCTIVE SLEEP APNEA LARINGECTOMY CPAP|obstructive sleep apnea laringectomy cpap
565033|NCT01157273|Behavior|behavior
565034|NCT01157273|Anxiety|anxiety
565035|NCT01157273|Communication|communication
565036|NCT01157273|Voice|voice
565037|NCT01157260|Indoxyl sulfate|indoxyl sulfate
565038|NCT01157260|AST-120|ast-120
565039|NCT01157247|Anesthetic techniques|anesthetic techniques
565040|NCT01157247|regional, spinal|regional, spinal
565041|NCT01157247|Pain|pain
565042|NCT01157247|lumbar puncture|lumbar puncture
565043|NCT01157247|Analgesia, local|analgesia, local
565044|NCT01157247|Analgesia, intravenous|analgesia, intravenous
565045|NCT01157234|Hypertension|hypertension
565046|NCT01157234|Kidney transplantation|kidney transplantation
565047|NCT01157234|Renal function|renal function
565048|NCT01157234|Nitric Oxide|nitric oxide
565049|NCT01157234|Nebivolol|nebivolol
565050|NCT01157208|chronic pain|chronic pain
565051|NCT01157208|headache|headache
565052|NCT01157208|nutrition|nutrition
565053|NCT01157208|inflammation|inflammation
565054|NCT01157208|complementary medicine|complementary medicine
565055|NCT01157195|stroke|stroke
565056|NCT01157195|chronic|chronic
565057|NCT01157195|arm|arm
565058|NCT01157195|rehabilitation|rehabilitation
565059|NCT01157195|tele-health|tele-health
565060|NCT01157182|Healthy|healthy
565061|NCT01157182|Bioequivalence|bioequivalence
565062|NCT01157182|Post-Menopausal|post-menopausal
565063|NCT01157169|Bioequivalence|bioequivalence
565064|NCT01157169|Healthy|healthy
565065|NCT01157130|Breast Cancer|breast cancer
565066|NCT01157130|Exercise|exercise
565067|NCT01157130|CRP|crp
565068|NCT01157130|C-reactive protein|c-reactive protein
565069|NCT01157130|BMI|bmi
565070|NCT01157130|Nevada Cancer Institute|nevada cancer institute
565071|NCT01157130|Rehabilitation|rehabilitation
565072|NCT01157130|Prescriptive exercise|prescriptive exercise
565073|NCT01157130|Physical Activity|physical activity
565074|NCT01157130|DEXA|dexa
565075|NCT01157130|Obesity|obesity
565076|NCT01157130|lifestyle intervention|lifestyle intervention
565077|NCT01157130|Early Stage Breast Cancer Patients (stage 0-III)|early stage breast cancer patients (stage 0-iii)
565078|NCT01157117|food allergy|food allergy
565079|NCT01157104|HCV|hcv
565080|NCT01157104|Hepatitis C|hepatitis c
565081|NCT01157078|Major Depressive Disorder|major depressive disorder
565082|NCT01157078|MDD|mdd
565083|NCT01157078|Depression|depression
717648|NCT00557908|VWD|vwd
565084|NCT01157078|Safety|safety
565085|NCT01157078|add-on therapy|add-on therapy
565086|NCT01157065|Wet AMD|wet amd
565087|NCT01157065|Intravitreal Injection|intravitreal injection
565088|NCT01157065|Macular Degeneration|macular degeneration
565089|NCT01157065|VEGF treatment|vegf treatment
565090|NCT01157052|magnesium|magnesium
565091|NCT01157052|calcium|calcium
565092|NCT01157052|adverse effects|adverse effects
565093|NCT01157052|kinetics, drug|kinetics, drug
565094|NCT01157039|glutamine|glutamine
565095|NCT01157039|oxaliplatin|oxaliplatin
565096|NCT01157039|adverse effects|adverse effects
565097|NCT01157026|Breast cancer|breast cancer
565098|NCT01157026|Tocotrienol-rich fraction with tamoxifen|tocotrienol-rich fraction with tamoxifen
565099|NCT01157013|Positron Emission Tomography|positron emission tomography
565100|NCT01157013|Hepatocellular carcinoma|hepatocellular carcinoma
565101|NCT01157013|Liver Cancer|liver cancer
565102|NCT01157013|Sorafenib|sorafenib
565103|NCT01157013|Response Evaluation|response evaluation
565104|NCT01157000|Canagliflozin|canagliflozin
565105|NCT01157000|Pharmacokinetic|pharmacokinetic
565106|NCT01157000|Bioavailability|bioavailability
565107|NCT01156974|care management|care management
565108|NCT01156974|chronic disease|chronic disease
565109|NCT01156974|outpatient|outpatient
565110|NCT01156948|misoprostol|misoprostol
565111|NCT01156948|nulliparous|nulliparous
565112|NCT01156948|hysteroscopy|hysteroscopy
565113|NCT01156935|Neoplasm|neoplasm
565114|NCT01156935|Laugh-Yoga|laugh-yoga
565115|NCT01156935|Mood|mood
565116|NCT01156935|Quality of life|quality of life
565117|NCT01156922|Chronic fatigue syndrome|chronic fatigue syndrome
565118|NCT01156922|CFS|cfs
565119|NCT01156922|Myalgic encephalomyelitis|myalgic encephalomyelitis
565120|NCT01156922|Rituximab|rituximab
565121|NCT01156922|B-cell depletion|b-cell depletion
565122|NCT01156909|Chronic fatigue syndrome|chronic fatigue syndrome
565123|NCT01156909|CFS|cfs
565124|NCT01156909|Myalgic encephalomyelitis|myalgic encephalomyelitis
565125|NCT01156909|Rituximab|rituximab
565126|NCT01156909|B-cell depletion|b-cell depletion
565127|NCT01156896|Non-transferrin-bound iron|non-transferrin-bound iron
565128|NCT01156896|Iron stable isotopes|iron stable isotopes
565129|NCT01156896|Iron deficiency|iron deficiency
565130|NCT01156896|Malaria|malaria
565131|NCT01156896|Iron supplementation|iron supplementation
565132|NCT01156896|Iron fortification|iron fortification
565133|NCT01156883|B-cell adult acute lymphoblastic leukemia|b-cell adult acute lymphoblastic leukemia
565134|NCT01156883|recurrent adult acute lymphoblastic leukemia|recurrent adult acute lymphoblastic leukemia
565135|NCT01156883|T-cell adult acute lymphoblastic leukemia|t-cell adult acute lymphoblastic leukemia
565136|NCT01156883|untreated adult acute lymphoblastic leukemia|untreated adult acute lymphoblastic leukemia
565137|NCT01156844|Indacaterol|indacaterol
565139|NCT01156844|Bronchodilation|bronchodilation
565140|NCT01156844|Beta-agonist|beta-agonist
565141|NCT01156831|Esophageal cancer|esophageal cancer
565142|NCT01156831|PET-CT planning|pet-ct planning
565143|NCT01156818|Wheeze measurements|wheeze measurements
565144|NCT01156805|Children|children
565145|NCT01156805|School-based program|school-based program
565146|NCT01156805|Obesity|obesity
565147|NCT01156792|asthma|asthma
565148|NCT01156792|GSK2190915|gsk2190915
565149|NCT01156779|SR-Exenatide|sr-exenatide
565150|NCT01156766|Fracture|fracture
565151|NCT01156766|Radius|radius
565152|NCT01156766|Osteosynthesis|osteosynthesis
565153|NCT01156766|Metaphyseal|metaphyseal
565154|NCT01156766|Pinning|pinning
565155|NCT01156766|Locking anterior plate|locking anterior plate
565156|NCT01156753|CR011-vcMMAE|cr011-vcmmae
565157|NCT01156753|locally advanced breast cancer|locally advanced breast cancer
565158|NCT01156753|metastatic breast cancer|metastatic breast cancer
565159|NCT01156753|breast cancer|breast cancer
565160|NCT01156753|CDX-011|cdx-011
565161|NCT01156753|GPNMB|gpnmb
565162|NCT01156753|Targeted treatment for breast cancer|targeted treatment for breast cancer
565163|NCT01156753|Locally advanced or metastatic breast cancer|locally advanced or metastatic breast cancer
565164|NCT01156740|streptococcal pharyngitis|streptococcal pharyngitis
565165|NCT01156740|randomized clinical trial|randomized clinical trial
565166|NCT01156740|amoxicillin|amoxicillin
565167|NCT01156740|intramuscular benzathine penicillin G.|intramuscular benzathine penicillin g.
565168|NCT01156727|OEF/OIF|oef/oif
565169|NCT01156727|Mental Health|mental health
565170|NCT01156727|Veterans|veterans
565171|NCT01156714|Parkinson's Disease|parkinson's disease
565172|NCT01156714|Treadmill Training|treadmill training
565173|NCT01156714|Exercise|exercise
565174|NCT01156714|Cognitive Training|cognitive training
565175|NCT01156714|Executive Function|executive function
565176|NCT01156714|Dual Task|dual task
565177|NCT01156701|Influenza|influenza
565178|NCT01156701|Zanamivir|zanamivir
565179|NCT01156701|Influenza prophylaxis|influenza prophylaxis
565180|NCT01156701|Relenza|relenza
710865|NCT00587522|Gastroesophageal Reflux Disease (GERD)|gastroesophageal reflux disease (gerd)
565181|NCT01156688|medical abortion for pregnancy of less than 9 weeks gestation|medical abortion for pregnancy of less than 9 weeks gestation
565182|NCT01156675|Back pain|back pain
565183|NCT01156675|Pain|pain
565184|NCT01156675|Spinal Diseases|spinal diseases
565185|NCT01156675|Spinal Stenosis|spinal stenosis
565186|NCT01156675|Lumbar Vertebrae|lumbar vertebrae
565187|NCT01156675|Spinal Canal|spinal canal
565188|NCT01156662|Thrombus aspiration|thrombus aspiration
565189|NCT01156662|Percutaneous coronary intervention|percutaneous coronary intervention
565190|NCT01156649|Obstructive sleep apnea|obstructive sleep apnea
565191|NCT01156649|neurocognitive function|neurocognitive function
565192|NCT01156649|cognition|cognition
565193|NCT01156649|pediatrics|pediatrics
565194|NCT01156649|children|children
565195|NCT01156649|continuous positive airway pressure therapy|continuous positive airway pressure therapy
565196|NCT01156649|sham treatment|sham treatment
565197|NCT01156649|randomized clinical trial|randomized clinical trial
565198|NCT01156649|behavior|behavior
565199|NCT01156649|treatment|treatment
565200|NCT01156636|Diastolic Heart Failure|diastolic heart failure
565201|NCT01156636|Pulmonary Hypertension|pulmonary hypertension
565202|NCT01156623|EBUS-TBNA|ebus-tbna
565203|NCT01156623|NSCLC|nsclc
565204|NCT01156623|Mediastinal lymph node|mediastinal lymph node
565205|NCT01156623|tuberculosis|tuberculosis
565206|NCT01156610|Smoking|smoking
565207|NCT01156610|Smoking Cessation|smoking cessation
565208|NCT01156610|Electronic Health Record|electronic health record
565209|NCT01156610|Telephone|telephone
565210|NCT01156597|diabetes|diabetes
565211|NCT01156597|dyslipidemia|dyslipidemia
565212|NCT01156597|pioglitazone|pioglitazone
565213|NCT01156597|HDL-Cholesterol|hdl-cholesterol
565214|NCT01156597|Reverse cholesterol transport|reverse cholesterol transport
565215|NCT01156584|glioma|glioma
565216|NCT01156584|glioblastoma|glioblastoma
565217|NCT01156584|glioblastoma multiforme|glioblastoma multiforme
565218|NCT01156584|Grade IV astrocytoma|grade iv astrocytoma
565219|NCT01156584|brain cancer|brain cancer
565220|NCT01156584|recurrent glioblastoma|recurrent glioblastoma
565221|NCT01156584|GBM|gbm
565222|NCT01156584|AA|aa
565223|NCT01156584|AOD|aod
565224|NCT01156584|anaplastic astrocytoma|anaplastic astrocytoma
565225|NCT01156584|anaplastic oligodendroglioma|anaplastic oligodendroglioma
565226|NCT01156584|anaplastic oligoastrocytoma|anaplastic oligoastrocytoma
565227|NCT01156584|malignant glioma|malignant glioma
565228|NCT01156584|high grade glioma|high grade glioma
565229|NCT01156545|BIBW 2992|bibw 2992
565230|NCT01156545|Simvastatin|simvastatin
565231|NCT01156545|NSCLC|nsclc
565232|NCT01156545|advanced stage|advanced stage
565233|NCT01156545|previously treated patients|previously treated patients
565234|NCT01156545|non-adenocarcinoma|non-adenocarcinoma
565235|NCT01156532|adalimumab therapy|adalimumab therapy
565237|NCT01156532|observational study|observational study
565238|NCT01156519|Infra-clinic cortisol adenoma|infra-clinic cortisol adenoma
565239|NCT01156519|Salivary cortisol|salivary cortisol
565240|NCT01156519|Obesity|obesity
565241|NCT01156506|quality of life|quality of life
565242|NCT01156506|patient education|patient education
565243|NCT01156506|rehabilitation|rehabilitation
565244|NCT01156506|focus group interview|focus group interview
565245|NCT01156493|feeding intolerance|feeding intolerance
565246|NCT01156493|prematurity|prematurity
565247|NCT01156480|necrotizing enterocolitis|necrotizing enterocolitis
565248|NCT01156480|NEC|nec
565249|NCT01156480|premature|premature
565250|NCT01156480|hydrocortisone|hydrocortisone
565251|NCT01156480|steroids|steroids
565252|NCT01156480|anti-inflammatory|anti-inflammatory
565253|NCT01156467|Neurally adjusted ventilatory assist NAVA|neurally adjusted ventilatory assist nava
565254|NCT01156467|Premature infant|premature infant
565255|NCT01156467|Edi-signal|edi-signal
565256|NCT01156454|sentinel lymph node dissection|sentinel lymph node dissection
565257|NCT01156454|radiology|radiology
565258|NCT01156454|X-ray identification of nodes in a surgical specimen|x-ray identification of nodes in a surgical specimen
565259|NCT01156441|Myocardial Infarction|myocardial infarction
565260|NCT01156441|Mitral Regurgitation|mitral regurgitation
565261|NCT01156441|Percutaneous Coronary Intervention|percutaneous coronary intervention
565262|NCT01156428|Nephritic syndrome|nephritic syndrome
565263|NCT01156428|Nephrotic syndrome|nephrotic syndrome
565264|NCT01156428|Proteinuria|proteinuria
565265|NCT01156428|Acute kidney injury|acute kidney injury
565266|NCT01156428|Chronic kidney disease|chronic kidney disease
565267|NCT01156428|Lupus nephritis|lupus nephritis
565268|NCT01156415|agomelatine|agomelatine
565269|NCT01156415|Major Depressive Disorder|major depressive disorder
565270|NCT01156415|MDD|mdd
565271|NCT01156415|depression|depression
565272|NCT01156402|Obesity|obesity
565273|NCT01156402|Pediatric Obesity|pediatric obesity
565274|NCT01156389|malaria|malaria
565275|NCT01156389|artemisinin-based combination therapy|artemisinin-based combination therapy
565276|NCT01156350|Neuroblastoma - Haplo HSCT - Reduced Intensity Conditioning - immunotherapy NK|neuroblastoma - haplo hsct - reduced intensity conditioning - immunotherapy nk
717888|NCT00556634|HIV|hiv
565277|NCT01156337|Heart failure III NYHA class|heart failure iii nyha class
565278|NCT01156337|Furosemide|furosemide
565279|NCT01156337|Sodium|sodium
565280|NCT01156337|water restriction|water restriction
565281|NCT01156337|decompensated heart failure|decompensated heart failure
565282|NCT01156337|Hypertonic saline solution|hypertonic saline solution
565283|NCT01156337|Moderate sodium restriction|moderate sodium restriction
565284|NCT01156324|IVF|ivf
565285|NCT01156324|Stress management|stress management
565286|NCT01156311|BG00012|bg00012
565287|NCT01156311|MS|ms
565288|NCT01156311|RRMS|rrms
565289|NCT01156272|Isolated aortic valve replacement|isolated aortic valve replacement
565290|NCT01156272|heart valve|heart valve
565291|NCT01156259|B cell cll/lymphoma, human|b cell cll/lymphoma, human
565292|NCT01156246|Healthy volunteers|healthy volunteers
565293|NCT01156246|Dapagliflozin|dapagliflozin
565294|NCT01156246|Diabetes Type 2|diabetes type 2
565295|NCT01156246|Food interaction|food interaction
565296|NCT01156233|evaluating precision of tube tip position with two methods|evaluating precision of tube tip position with two methods
565297|NCT01156220|gender, diuretics, furosemide, aminohippuric acid|gender, diuretics, furosemide, aminohippuric acid
565298|NCT01156207|To establish the coupling between components of arterial load ( and components of LV myocardial deformations at baseline and 6 months after randomization.|to establish the coupling between components of arterial load ( and components of lv myocardial deformations at baseline and 6 months after randomization.
565299|NCT01156207|To establish the role of EPCs on modulation of the components of arterial load and LV myocardial deformations and their coupling.|to establish the role of epcs on modulation of the components of arterial load and lv myocardial deformations and their coupling.
565300|NCT01156194|third stage, labor, postpartum hemorrhage, homeopathy, arnica, bellis perennis|third stage, labor, postpartum hemorrhage, homeopathy, arnica, bellis perennis
565301|NCT01156181|Cervical mucus, Embryo transfer, ICSI cycle, Pregnancy rate|cervical mucus, embryo transfer, icsi cycle, pregnancy rate
565302|NCT01156168|male breast cancer|male breast cancer
565303|NCT01156168|stage IV breast cancer|stage iv breast cancer
565304|NCT01156168|recurrent breast cancer|recurrent breast cancer
565305|NCT01156155|rheumatoid arthritis|rheumatoid arthritis
565306|NCT01156155|osteoarthritis|osteoarthritis
565307|NCT01156155|periodontal disease|periodontal disease
565308|NCT01156142|oral complications of radiation therapy|oral complications of radiation therapy
565309|NCT01156142|mucositis|mucositis
565310|NCT01156142|pain|pain
565311|NCT01156142|stage I squamous cell carcinoma of the paranasal sinus and nasal cavity|stage i squamous cell carcinoma of the paranasal sinus and nasal cavity
565312|NCT01156142|recurrent squamous cell carcinoma of the hypopharynx|recurrent squamous cell carcinoma of the hypopharynx
565313|NCT01156142|squamous cell carcinoma of the hypopharynx|squamous cell carcinoma of the hypopharynx
565314|NCT01156142|recurrent squamous cell carcinoma of the larynx|recurrent squamous cell carcinoma of the larynx
565315|NCT01156142|recurrent verrucous carcinoma of the larynx|recurrent verrucous carcinoma of the larynx
565316|NCT01156142|squamous cell carcinoma of the larynx|squamous cell carcinoma of the larynx
565317|NCT01156142|verrucous carcinoma of the larynx|verrucous carcinoma of the larynx
565318|NCT01156142|recurrent adenoid cystic carcinoma of the oral cavity|recurrent adenoid cystic carcinoma of the oral cavity
565319|NCT01156142|recurrent mucoepidermoid carcinoma of the oral cavity|recurrent mucoepidermoid carcinoma of the oral cavity
565320|NCT01156142|recurrent verrucous carcinoma of the oral cavity|recurrent verrucous carcinoma of the oral cavity
565321|NCT01156142|adenoid cystic carcinoma of the oral cavity|adenoid cystic carcinoma of the oral cavity
565322|NCT01156142|mucoepidermoid carcinoma of the oral cavity|mucoepidermoid carcinoma of the oral cavity
565323|NCT01156142|verrucous carcinoma of the oral cavity|verrucous carcinoma of the oral cavity
565324|NCT01156142|squamous cell carcinoma of the lip and oral cavity|squamous cell carcinoma of the lip and oral cavity
565325|NCT01156142|recurrent basal cell carcinoma of the lip|recurrent basal cell carcinoma of the lip
565326|NCT01156142|recurrent squamous cell carcinoma of the lip and oral cavity|recurrent squamous cell carcinoma of the lip and oral cavity
565327|NCT01156142|basal cell carcinoma of the lip|basal cell carcinoma of the lip
565328|NCT01156142|metastatic squamous neck cancer with occult primary squamous cell carcinoma|metastatic squamous neck cancer with occult primary squamous cell carcinoma
565329|NCT01156142|recurrent metastatic squamous neck cancer with occult primary|recurrent metastatic squamous neck cancer with occult primary
565330|NCT01156142|untreated metastatic squamous neck cancer with occult primary|untreated metastatic squamous neck cancer with occult primary
565331|NCT01156142|recurrent lymphoepithelioma of the nasopharynx|recurrent lymphoepithelioma of the nasopharynx
565332|NCT01156142|recurrent squamous cell carcinoma of the nasopharynx|recurrent squamous cell carcinoma of the nasopharynx
565333|NCT01156142|lymphoepithelioma of the nasopharynx|lymphoepithelioma of the nasopharynx
565334|NCT01156142|squamous cell carcinoma of the nasopharynx|squamous cell carcinoma of the nasopharynx
565335|NCT01156142|recurrent lymphoepithelioma of the oropharynx|recurrent lymphoepithelioma of the oropharynx
565336|NCT01156142|recurrent squamous cell carcinoma of the oropharynx|recurrent squamous cell carcinoma of the oropharynx
565337|NCT01156142|lymphoepithelioma of the oropharynx|lymphoepithelioma of the oropharynx
565338|NCT01156142|squamous cell carcinoma of the oropharynx|squamous cell carcinoma of the oropharynx
710866|NCT00587522|NDO Full-thickness Plicator|ndo full-thickness plicator
565339|NCT01156142|recurrent esthesioneuroblastoma of the paranasal sinus and nasal cavity|recurrent esthesioneuroblastoma of the paranasal sinus and nasal cavity
565340|NCT01156142|recurrent inverted papilloma of the paranasal sinus and nasal cavity|recurrent inverted papilloma of the paranasal sinus and nasal cavity
565341|NCT01156142|recurrent midline lethal granuloma of the paranasal sinus and nasal cavity|recurrent midline lethal granuloma of the paranasal sinus and nasal cavity
565342|NCT01156142|recurrent squamous cell carcinoma of the paranasal sinus and nasal cavity|recurrent squamous cell carcinoma of the paranasal sinus and nasal cavity
565343|NCT01156142|esthesioneuroblastoma of the paranasal sinus and nasal cavity|esthesioneuroblastoma of the paranasal sinus and nasal cavity
565344|NCT01156142|inverted papilloma of the paranasal sinus and nasal cavity|inverted papilloma of the paranasal sinus and nasal cavity
565345|NCT01156142|midline lethal granuloma of the paranasal sinus and nasal cavity|midline lethal granuloma of the paranasal sinus and nasal cavity
565346|NCT01156142|squamous cell carcinoma of the paranasal sinus and nasal cavity|squamous cell carcinoma of the paranasal sinus and nasal cavity
565347|NCT01156142|high-grade salivary gland mucoepidermoid carcinoma|high-grade salivary gland mucoepidermoid carcinoma
565348|NCT01156142|low-grade salivary gland mucoepidermoid carcinoma|low-grade salivary gland mucoepidermoid carcinoma
565349|NCT01156142|recurrent salivary gland cancer|recurrent salivary gland cancer
565350|NCT01156142|salivary gland acinic cell tumor|salivary gland acinic cell tumor
565351|NCT01156142|salivary gland adenocarcinoma|salivary gland adenocarcinoma
565476|NCT01155557|Tension-Type Headache|tension-type headache
565352|NCT01156142|salivary gland adenoid cystic carcinoma|salivary gland adenoid cystic carcinoma
565353|NCT01156142|salivary gland anaplastic carcinoma|salivary gland anaplastic carcinoma
565354|NCT01156142|salivary gland malignant mixed cell type tumor|salivary gland malignant mixed cell type tumor
565355|NCT01156142|salivary gland poorly differentiated carcinoma|salivary gland poorly differentiated carcinoma
565356|NCT01156142|salivary gland squamous cell carcinoma|salivary gland squamous cell carcinoma
565357|NCT01156142|salivary gland cancer|salivary gland cancer
565358|NCT01156142|tongue cancer|tongue cancer
565359|NCT01156129|liver transplant|liver transplant
565360|NCT01156129|liver resection|liver resection
565361|NCT01156116|CPAP|cpap
565362|NCT01156116|diabetes|diabetes
565363|NCT01156116|sleep apnea|sleep apnea
565364|NCT01156103|obesity|obesity
565365|NCT01156103|minority|minority
565366|NCT01156103|child|child
565367|NCT01156103|physical fitness|physical fitness
565368|NCT01156103|school|school
565369|NCT01156103|physical activity|physical activity
565370|NCT01156090|vectibix|vectibix
565371|NCT01156077|antibiotic|antibiotic
565372|NCT01156077|Adolescents receiving antibiotics|adolescents receiving antibiotics
565373|NCT01156064|Endoscopy|endoscopy
565374|NCT01156064|Confocal laser endomicroscopy|confocal laser endomicroscopy
565375|NCT01156064|Digestive Diseases|digestive diseases
565376|NCT01156051|ADHD|adhd
565377|NCT01156051|ADD|add
565378|NCT01156051|sleep disturbance|sleep disturbance
565379|NCT01156038|Atopy patch test|atopy patch test
565380|NCT01156025|GV550|gv550
565381|NCT01156025|Acute adenoviral keratoconjunctivitis|acute adenoviral keratoconjunctivitis
565382|NCT01155986|analgesic|analgesic
565383|NCT01155986|analgesics|analgesics
565384|NCT01155986|pain|pain
565385|NCT01155986|chronic pain|chronic pain
565386|NCT01155986|localized pain|localized pain
565387|NCT01155986|focal pain|focal pain
565388|NCT01155986|neuropathic pain|neuropathic pain
565389|NCT01155986|postoperative pain|postoperative pain
565390|NCT01155986|topical analgesia|topical analgesia
565391|NCT01155973|Hypertension.|hypertension.
565392|NCT01155973|Cardiovascular risk.|cardiovascular risk.
565393|NCT01155973|Monitoring.|monitoring.
565394|NCT01155973|Primary health care.|primary health care.
565395|NCT01155973|Randomised controlled trial.|randomised controlled trial.
565396|NCT01155973|Cluster analysis|cluster analysis
565397|NCT01155960|Bioavailability|bioavailability
565398|NCT01155960|Anastrozole|anastrozole
565399|NCT01155960|Crossover|crossover
565400|NCT01155947|Bioavailability|bioavailability
565401|NCT01155947|Anastrozole|anastrozole
565402|NCT01155947|Crossover|crossover
565403|NCT01155934|Bioavailability|bioavailability
565404|NCT01155934|Crossover|crossover
565405|NCT01155934|Risperidone|risperidone
565406|NCT01155921|Bioavailability|bioavailability
565407|NCT01155921|Crossover|crossover
565408|NCT01155921|Risperidone|risperidone
565409|NCT01155908|Bioavailability|bioavailability
565410|NCT01155908|10 mg Amlodipine besylate/20 mg benazepril hydrochloride capsules|10 mg amlodipine besylate/20 mg benazepril hydrochloride capsules
565411|NCT01155908|Crossover|crossover
565412|NCT01155895|Bioavailability|bioavailability
565413|NCT01155895|10 mg Amlopdipine besylate /20 mg Benazepril Hydrochloride|10 mg amlopdipine besylate /20 mg benazepril hydrochloride
565414|NCT01155895|Crossover|crossover
565415|NCT01155869|alcohol dependence|alcohol dependence
565416|NCT01155869|homelessness|homelessness
565417|NCT01155869|naltrexone|naltrexone
565418|NCT01155856|telemedicine|telemedicine
565419|NCT01155856|COPD|copd
565420|NCT01155830|inflammatory cytokines|inflammatory cytokines
565421|NCT01155830|extracorporeal membrane oxygenation|extracorporeal membrane oxygenation
565422|NCT01155830|ECMO|ecmo
565423|NCT01155804|preparation of the delivery|preparation of the delivery
565424|NCT01155804|lumbago|lumbago
565425|NCT01155804|anxiety|anxiety
565426|NCT01155804|urinary incontinence|urinary incontinence
565427|NCT01155778|Mucopolysaccharidosis (MPS) IIIA|mucopolysaccharidosis (mps) iiia
565428|NCT01155778|Recombinant Human Heparan N-Sulfatase (rhHNS)|recombinant human heparan n-sulfatase (rhhns)
565429|NCT01155778|Sanfilippo Syndrome Type A (MPS IIIA)|sanfilippo syndrome type a (mps iiia)
565430|NCT01155778|Lysosomal Storage Disease (LSD)|lysosomal storage disease (lsd)
565431|NCT01155778|Intrathecal Drug Delivery Device (IDDD)|intrathecal drug delivery device (iddd)
565432|NCT01155765|Clopidogrel Resistance|clopidogrel resistance
565433|NCT01155765|prasugrel|prasugrel
565434|NCT01155765|Hemodialysis|hemodialysis
565435|NCT01155752|sinusitis|sinusitis
565436|NCT01155752|cystic fibrosis|cystic fibrosis
565437|NCT01155752|therapy|therapy
565438|NCT01155713|Neoplasms|neoplasms
565439|NCT01155713|Cancer|cancer
565440|NCT01155713|Tumors|tumors
565441|NCT01155713|Administration, oral|administration, oral
565442|NCT01155713|Capsules|capsules
565443|NCT01155713|CHIR258, CHIR-258, CHIR 258, TKI258, TKI-258, TKI 258,|chir258, chir-258, chir 258, tki258, tki-258, tki 258,
565444|NCT01155713|Bioavailability,|bioavailability,
565445|NCT01155713|Food|food
565446|NCT01155700|omalizumab|omalizumab
565447|NCT01155700|allergic asthma|allergic asthma
565448|NCT01155700|pediatric patients|pediatric patients
565449|NCT01155687|afghanistan|afghanistan
565450|NCT01155687|depression|depression
565451|NCT01155687|anxiety|anxiety
565452|NCT01155687|social stress|social stress
565453|NCT01155687|counseling|counseling
565454|NCT01155687|medication|medication
565455|NCT01155687|psychotherapy|psychotherapy
565456|NCT01155687|mental health|mental health
565457|NCT01155674|Innate immunity|innate immunity
565458|NCT01155674|Neutrophils|neutrophils
565459|NCT01155674|Band forms|band forms
565460|NCT01155648|Mechanical ventilation|mechanical ventilation
565461|NCT01155648|Chest physiotherapy|chest physiotherapy
565462|NCT01155648|Chest wall compression|chest wall compression
565463|NCT01155635|Myocardial infarction|myocardial infarction
565464|NCT01155635|Adrenergic beta-Antagonists|adrenergic beta-antagonists
565465|NCT01155635|Percutaneous coronary intervention|percutaneous coronary intervention
565466|NCT01155622|Hypothermia, induced|hypothermia, induced
565467|NCT01155622|Cardiac arrest|cardiac arrest
565468|NCT01155622|Disability evaluation|disability evaluation
565469|NCT01155622|Cardiac arrhythmia|cardiac arrhythmia
565470|NCT01155622|Ventricular function|ventricular function
565471|NCT01155622|Internal cooling|internal cooling
565472|NCT01155622|Out-of-hospital cardiac arrest|out-of-hospital cardiac arrest
565473|NCT01155622|Post-cardiac arrest syndrome|post-cardiac arrest syndrome
565474|NCT01155596|Acute respiratory failure patients in medical ICUs.|acute respiratory failure patients in medical icus.
565475|NCT01155570|Psoriasis|psoriasis
565477|NCT01155557|Strength Capacity|strength capacity
565478|NCT01155557|Neck and Shoulder|neck and shoulder
565479|NCT01155544|Aripiprazole|aripiprazole
565480|NCT01155544|Psychotic experiences|psychotic experiences
565481|NCT01155544|Substance abuse|substance abuse
565482|NCT01155544|Substance dependence|substance dependence
565483|NCT01155544|Craving|craving
565484|NCT01155544|Mood|mood
565485|NCT01155544|Substance use|substance use
565486|NCT01155531|Obesity|obesity
565487|NCT01155531|Overweight|overweight
565488|NCT01155531|Sertraline|sertraline
565489|NCT01155531|Telenzepine|telenzepine
565490|NCT01155531|Decrease appetite|decrease appetite
565491|NCT01155531|Reduce appetite|reduce appetite
565492|NCT01155531|Lose weight|lose weight
565493|NCT01155518|hypogonadism|hypogonadism
565494|NCT01155518|diabetes|diabetes
565495|NCT01155518|spermatogenesis|spermatogenesis
565496|NCT01155518|insulin resistance|insulin resistance
565497|NCT01155492|lipopolysaccharides|lipopolysaccharides
565498|NCT01155492|etiology|etiology
565499|NCT01155492|inflammation|inflammation
565500|NCT01155492|colonic bacteria|colonic bacteria
565501|NCT01155492|intestinal permeability|intestinal permeability
565502|NCT01155466|Idiopathic Parkinson Disease|idiopathic parkinson disease
565503|NCT01155466|Idiopathic Parkinson's Disease|idiopathic parkinson's disease
565504|NCT01155453|BKM120|bkm120
565505|NCT01155453|RAS RAF mutations,|ras raf mutations,
565506|NCT01155453|triple negative breast cancer,|triple negative breast cancer,
565507|NCT01155453|pancreatic cancer,|pancreatic cancer,
565508|NCT01155453|PI3K inhibitor,|pi3k inhibitor,
565509|NCT01155453|MEK inhibitor|mek inhibitor
565510|NCT01155440|60 patients scheduled to have a colorectal surgery|60 patients scheduled to have a colorectal surgery
565511|NCT01155440|recruit at Montreal General Hospital|recruit at montreal general hospital
565512|NCT01155401|acute upper gastrointestinal bleeding|acute upper gastrointestinal bleeding
565513|NCT01155401|patients with drug-induced upper gastrointestinal bleeding|patients with drug-induced upper gastrointestinal bleeding
565514|NCT01155401|routine management|routine management
565515|NCT01155388|Iron deficiency anemia|iron deficiency anemia
565516|NCT01155388|Feraheme|feraheme
565517|NCT01155388|ferumoxytol|ferumoxytol
565518|NCT01155388|CKD|ckd
565519|NCT01155388|pediatric|pediatric
565520|NCT01155388|nondialysis-dependent|nondialysis-dependent
565521|NCT01155375|Iron deficiency anemia|iron deficiency anemia
565522|NCT01155375|Feraheme|feraheme
565523|NCT01155375|ferumoxytol|ferumoxytol
565524|NCT01155375|CKD|ckd
565525|NCT01155375|pediatric|pediatric
565526|NCT01155375|dialysis-dependent|dialysis-dependent
565527|NCT01155375|nondialysis-dependent|nondialysis-dependent
565528|NCT01155362|Human Placenta-Derived Cells for the Treatment of Moderate-to-Severe Crohn's Disease|human placenta-derived cells for the treatment of moderate-to-severe crohn's disease
565529|NCT01155349|brain fitness|brain fitness
565530|NCT01155349|cognitive training|cognitive training
565531|NCT01155349|cognitive intervention|cognitive intervention
565532|NCT01155349|speed of processing training|speed of processing training
565533|NCT01155349|Parkinson's disease|parkinson's disease
565534|NCT01155336|Acute Coronary Syndrome|acute coronary syndrome
565535|NCT01155336|Fish Oils|fish oils
565536|NCT01155336|Platelet Function Tests|platelet function tests
565537|NCT01155336|Cardiac Electrophysiology|cardiac electrophysiology
565538|NCT01155310|Exacerbation of COPD|exacerbation of copd
565539|NCT01155310|Helium/Oxygen|helium/oxygen
565540|NCT01155310|ICU|icu
565541|NCT01155310|Non-Invasive Ventilation|non-invasive ventilation
565542|NCT01155310|Patient with known or suspected COPD|patient with known or suspected copd
565543|NCT01155310|patient Admitted in an ICU|patient admitted in an icu
565544|NCT01155310|Patient presenting current exacerbation of COPD|patient presenting current exacerbation of copd
565545|NCT01155297|Quality of Life|quality of life
565546|NCT01155297|Biological Markers|biological markers
565547|NCT01155297|Renal Insufficiency|renal insufficiency
565548|NCT01155297|Resistance Training|resistance training
565549|NCT01155297|Exercise|exercise
565550|NCT01155297|Chronic Kidney Failure|chronic kidney failure
565551|NCT01155284|diabetes|diabetes
565552|NCT01155284|HGB A1C|hgb a1c
565553|NCT01155284|Beta Cell Regeneration|beta cell regeneration
565554|NCT01155245|osteoporosis|osteoporosis
565555|NCT01155245|HR-pQCT|hr-pqct
565556|NCT01155245|PTH|pth
565557|NCT01155232|osteoporosis|osteoporosis
565558|NCT01155232|Forteo|forteo
565559|NCT01155232|Parathyroid hormone|parathyroid hormone
565560|NCT01155232|HR-pQCT|hr-pqct
565561|NCT01155219|Bilateral Glaucoma|bilateral glaucoma
565562|NCT01155219|Bilateral ocular hypertension|bilateral ocular hypertension
565563|NCT01155219|Bilateral primary open angle glaucoma|bilateral primary open angle glaucoma
565564|NCT01155219|Bilateral ocular hypertension already treated and controlled by mono-therapy of Xalatan® (1drop per day)|bilateral ocular hypertension already treated and controlled by mono-therapy of xalatan® (1drop per day)
565565|NCT01155219|With local intolerance signs in at least one eye|with local intolerance signs in at least one eye
565566|NCT01155206|glucagon,|glucagon,
565567|NCT01155206|high physiological dose and basal dose of glucagon|high physiological dose and basal dose of glucagon
565568|NCT01155206|hepatic lipoprotein production,|hepatic lipoprotein production,
565569|NCT01155206|free fatty acid|free fatty acid
565570|NCT01155206|intestinal lipoprotein production|intestinal lipoprotein production
565571|NCT01155206|particle|particle
565572|NCT01155206|glucagon affects production of fat in intestine and liver.|glucagon affects production of fat in intestine and liver.
565573|NCT01155193|Children|children
565574|NCT01155193|Pre-term infants|pre-term infants
566923|NCT01149629|Droxidopa|droxidopa
565575|NCT01155193|Congenital heart disease|congenital heart disease
565576|NCT01155193|Infection|infection
565577|NCT01155193|Respiratory syncytial virus|respiratory syncytial virus
565578|NCT01155193|Bronchopulmonary dysplasia (BPD)|bronchopulmonary dysplasia (bpd)
565579|NCT01155193|Chronic lung disease (CLD)|chronic lung disease (cld)
565580|NCT01155167|radial artery spasm|radial artery spasm
565581|NCT01155154|wounds and lacerations|wounds and lacerations
565582|NCT01155154|hand|hand
565583|NCT01155154|infection|infection
565584|NCT01155154|Antibiotics|antibiotics
565585|NCT01155154|antibacterial agents|antibacterial agents
565586|NCT01155128|physical activity|physical activity
565587|NCT01155128|exercise|exercise
565588|NCT01155128|sedentarism|sedentarism
565589|NCT01155128|chronic renal disease|chronic renal disease
565590|NCT01155128|failure renal chronic|failure renal chronic
565591|NCT01155128|proteinuria|proteinuria
565592|NCT01155128|progression|progression
565593|NCT01155128|Renal Protective Effects of Exercise|renal protective effects of exercise
565594|NCT01155128|quality of life changes with exercise in CKD|quality of life changes with exercise in ckd
565595|NCT01155128|Endothelial progenitor cells in CKD|endothelial progenitor cells in ckd
565596|NCT01155128|Chronic Kidney Disease and Ankle Brachial Index|chronic kidney disease and ankle brachial index
565597|NCT01155115|pediatrics|pediatrics
565598|NCT01155115|CF|cf
565599|NCT01155115|PCD|pcd
565600|NCT01155115|exacerbation|exacerbation
565601|NCT01155115|inflammatory markers|inflammatory markers
565602|NCT01155115|induced sputum|induced sputum
565603|NCT01155063|Exemestane|exemestane
565604|NCT01155063|Adjuvant Treatment In Postmenopausal Women|adjuvant treatment in postmenopausal women
710867|NCT00587522|Plicator|plicator
565605|NCT01155063|Estrogen Receptor Positive Early Breast Cancer|estrogen receptor positive early breast cancer
565606|NCT01155063|Tamoxifen|tamoxifen
565607|NCT01155050|overweight|overweight
565608|NCT01155050|obese|obese
565609|NCT01155050|type II diabetes|type ii diabetes
565610|NCT01155050|hypertension|hypertension
565611|NCT01155037|HIV, influenza A H1N1, vaccine|hiv, influenza a h1n1, vaccine
565612|NCT01155024|Lower extremity amputation|lower extremity amputation
565613|NCT01155024|Prosthetic Sockets|prosthetic sockets
565614|NCT01155024|Direct Manufactured (DM)|direct manufactured (dm)
565615|NCT01155011|Older adults|older adults
565616|NCT01155011|physical activity|physical activity
565617|NCT01155011|sedentary|sedentary
565618|NCT01155011|retirement communities|retirement communities
565619|NCT01155011|advocacy|advocacy
565620|NCT01155011|built environment|built environment
565621|NCT01155011|peer mentoring|peer mentoring
565622|NCT01155011|walkability|walkability
565623|NCT01154998|non-specific interstitial pneumonia|non-specific interstitial pneumonia
565624|NCT01154985|omega-3 fatty acids|omega-3 fatty acids
565625|NCT01154985|alanine transaminase|alanine transaminase
565626|NCT01154985|triglycerides|triglycerides
565627|NCT01154985|lipids|lipids
565628|NCT01154985|EPA|epa
565629|NCT01154985|ethyl-EPA|ethyl-epa
565630|NCT01154985|ethyl icosapentate|ethyl icosapentate
565631|NCT01154985|Non Alcoholic steatohepatitis|non alcoholic steatohepatitis
565632|NCT01154985|Non Alcoholic fatty liver disease|non alcoholic fatty liver disease
565633|NCT01154985|fatty acids|fatty acids
565634|NCT01154972|breast|breast
565635|NCT01154972|cancer|cancer
565636|NCT01154972|sentinel lymph node|sentinel lymph node
565637|NCT01154959|Pulmonary TB|pulmonary tb
565638|NCT01154959|Immune response|immune response
565639|NCT01154959|ATT|att
565640|NCT01154959|Immune responses in pulmonary tuberculosis|immune responses in pulmonary tuberculosis
565641|NCT01154959|Predictors for relapse|predictors for relapse
565642|NCT01154946|detrusor after-contraction|detrusor after-contraction
565643|NCT01154946|urodynamic|urodynamic
565644|NCT01154946|LUTS|luts
565645|NCT01154946|urinary bladder, overactive|urinary bladder, overactive
565646|NCT01154946|bladder dysfunction|bladder dysfunction
565647|NCT01154933|type 2 diabetes|type 2 diabetes
565648|NCT01154933|obesity|obesity
565649|NCT01154920|Head and Neck Cancer|head and neck cancer
565650|NCT01154920|HNSCC|hnscc
565651|NCT01154920|Paclitaxel|paclitaxel
565652|NCT01154920|Carboplatin|carboplatin
565653|NCT01154920|Cetuximab|cetuximab
565654|NCT01154920|Docetaxel|docetaxel
565655|NCT01154920|Taxotere|taxotere
565656|NCT01154920|Cisplatin|cisplatin
565657|NCT01154920|Platinol-AQ|platinol-aq
565658|NCT01154920|Platinol|platinol
565659|NCT01154920|CDDP|cddp
565660|NCT01154920|Fluorouracil|fluorouracil
565661|NCT01154920|5-FU|5-fu
565662|NCT01154920|Adrucil|adrucil
565663|NCT01154920|Efudex|efudex
565664|NCT01154920|chemotherapy|chemotherapy
565665|NCT01154920|radiation|radiation
565666|NCT01154920|Chemoradiotherapy|chemoradiotherapy
565667|NCT01154907|Uro-genital schistosomiasis|uro-genital schistosomiasis
565668|NCT01154907|Female|female
565669|NCT01154907|South Africa|south africa
565670|NCT01154907|Rural|rural
565671|NCT01154907|Sexually transmitted diseases|sexually transmitted diseases
565672|NCT01154894|arachidonic acid|arachidonic acid
565673|NCT01154894|autism spectrum disorders|autism spectrum disorders
565674|NCT01154894|social interaction|social interaction
565675|NCT01154894|randomized controlled trial|randomized controlled trial
565677|NCT01154855|Periodontal disease|periodontal disease
565678|NCT01154855|Gum disease|gum disease
565679|NCT01154855|Dental|dental
565680|NCT01154855|Inflammation|inflammation
565681|NCT01154855|Microorganisms|microorganisms
565682|NCT01154855|Bacteria|bacteria
565683|NCT01154842|FGF-23|fgf-23
565684|NCT01154842|Dialysis|dialysis
565685|NCT01154842|plasma FGF-23 levels|plasma fgf-23 levels
565686|NCT01154842|echocardiography|echocardiography
565687|NCT01154829|dopamine|dopamine
565688|NCT01154829|first episode|first episode
565689|NCT01154829|reward|reward
565690|NCT01154829|cognition|cognition
565691|NCT01154829|MRI|mri
565692|NCT01154829|fMRI|fmri
565693|NCT01154829|PPI|ppi
565694|NCT01154829|P300|p300
565695|NCT01154829|P50 gating|p50 gating
565696|NCT01154829|endophenotypes|endophenotypes
565697|NCT01154803|Supplementation|supplementation
565698|NCT01154803|RUTF|rutf
565699|NCT01154803|Micronutrients|micronutrients
565700|NCT01154803|Plumpynut|plumpynut
565701|NCT01154803|Mixme|mixme
565702|NCT01154803|sprinkles|sprinkles
565703|NCT01154803|convalescence|convalescence
565704|NCT01154803|weight|weight
565705|NCT01154803|morbidity|morbidity
565706|NCT01154790|healthy volunteers|healthy volunteers
565707|NCT01154777|Neurofeedback|neurofeedback
565708|NCT01154777|Braintraining|braintraining
565709|NCT01154777|Autism|autism
565710|NCT01154777|Mild|mild
565711|NCT01154777|Moderate|moderate
565712|NCT01154777|Mild to Moderate Autism|mild to moderate autism
565713|NCT01154764|healthy male volunteers|healthy male volunteers
565714|NCT01154751|Femoral artery stenosis|femoral artery stenosis
565715|NCT01154751|Peripheral vascular Disease|peripheral vascular disease
565716|NCT01154725|Patient education|patient education
565717|NCT01154725|Health-Related Quality of Life|health-related quality of life
565718|NCT01154725|patients with stomas|patients with stomas
565719|NCT01154725|stomatherapy|stomatherapy
565720|NCT01154725|health economics|health economics
565721|NCT01154712|Gambling|gambling
565722|NCT01154712|Deep TMS|deep tms
565723|NCT01154712|addiction|addiction
565724|NCT01154712|Brain stimulation|brain stimulation
565725|NCT01154699|Asthma|asthma
565726|NCT01154699|Nocturnal Asthma|nocturnal asthma
565727|NCT01154699|Lung volumes|lung volumes
565728|NCT01154699|Deep inspiration|deep inspiration
565729|NCT01154699|Obstructive sleep apnea|obstructive sleep apnea
565730|NCT01154660|any operation that required for general anesthesia|any operation that required for general anesthesia
565731|NCT01154634|Pharmacodynamic effect|pharmacodynamic effect
565732|NCT01154634|Reflux inhibition|reflux inhibition
565733|NCT01154621|Phase I|phase i
565734|NCT01154621|Double-blind|double-blind
565735|NCT01154621|Randomized|randomized
565736|NCT01154621|Placebo-controlled study|placebo-controlled study
565737|NCT01154621|Safety and tolerability of single intravenous dose of AZD9742 in healthy elderly volunteers|safety and tolerability of single intravenous dose of azd9742 in healthy elderly volunteers
565738|NCT01154608|Protein absorption in pancreatitis|protein absorption in pancreatitis
565739|NCT01154608|Protein metabolism in pancreatitis|protein metabolism in pancreatitis
565740|NCT01154595|moderate acute malnutrition, prevention, Lipid-based supplement|moderate acute malnutrition, prevention, lipid-based supplement
565741|NCT01154582|ingestive behavior|ingestive behavior
565742|NCT01154569|drug absorption|drug absorption
565743|NCT01154569|azithromycin|azithromycin
565744|NCT01154569|obesity|obesity
565745|NCT01154569|bariatric surgery|bariatric surgery
565746|NCT01154556|Antiretroviral therapy experienced|antiretroviral therapy experienced
565747|NCT01154556|failed NNRTI regime|failed nnrti regime
565748|NCT01154543|Recurrent genital Herpes Simplex Virus|recurrent genital herpes simplex virus
565749|NCT01154530|Gastroscopy|gastroscopy
565750|NCT01154530|Bacteria|bacteria
565751|NCT01154530|Chlorhexidine|chlorhexidine
565752|NCT01154530|General surgery|general surgery
565753|NCT01154504|adrenomedullin|adrenomedullin
565754|NCT01154504|heart failure|heart failure
565755|NCT01154504|ultrafiltration|ultrafiltration
565756|NCT01154504|hemofiltration|hemofiltration
565757|NCT01154491|hip fractures|hip fractures
565758|NCT01154491|blood substitutes|blood substitutes
565759|NCT01154491|blood transfusion|blood transfusion
565760|NCT01154491|intravenous infusion|intravenous infusion
565761|NCT01154491|erythropoietin, recombinant|erythropoietin, recombinant
565762|NCT01154491|frail elderly|frail elderly
565763|NCT01154478|polyphenols omega-3 postprandial lipemia adipose tissue|polyphenols omega-3 postprandial lipemia adipose tissue
565764|NCT01154465|Central venous catheterization|central venous catheterization
565765|NCT01154465|Obese|obese
565766|NCT01154465|Ultrasound guidance|ultrasound guidance
565767|NCT01154465|Jugular|jugular
565768|NCT01154465|Randomized|randomized
565769|NCT01154465|Intensive Care Unit|intensive care unit
565770|NCT01154439|secondary acute myeloid leukemia|secondary acute myeloid leukemia
565771|NCT01154439|untreated adult acute myeloid leukemia|untreated adult acute myeloid leukemia
565772|NCT01154439|adult acute basophilic leukemia|adult acute basophilic leukemia
565773|NCT01154439|adult acute eosinophilic leukemia|adult acute eosinophilic leukemia
565774|NCT01154439|adult erythroleukemia (M6a)|adult erythroleukemia (m6a)
565775|NCT01154439|adult pure erythroid leukemia (M6b)|adult pure erythroid leukemia (m6b)
565776|NCT01154439|adult acute megakaryoblastic leukemia (M7)|adult acute megakaryoblastic leukemia (m7)
565777|NCT01154439|adult acute minimally differentiated myeloid leukemia (M0)|adult acute minimally differentiated myeloid leukemia (m0)
565778|NCT01154439|adult acute monoblastic leukemia (M5a)|adult acute monoblastic leukemia (m5a)
565779|NCT01154439|adult acute monocytic leukemia (M5b)|adult acute monocytic leukemia (m5b)
565780|NCT01154439|adult acute myeloblastic leukemia with maturation (M2)|adult acute myeloblastic leukemia with maturation (m2)
565781|NCT01154439|adult acute myeloblastic leukemia without maturation (M1)|adult acute myeloblastic leukemia without maturation (m1)
565782|NCT01154439|adult acute myelomonocytic leukemia (M4)|adult acute myelomonocytic leukemia (m4)
565783|NCT01154439|adult acute myeloid leukemia with 11q23 (MLL) abnormalities|adult acute myeloid leukemia with 11q23 (mll) abnormalities
565784|NCT01154439|adult acute myeloid leukemia with inv(16)(p13;q22)|adult acute myeloid leukemia with inv(16)(p13;q22)
565785|NCT01154439|adult acute myeloid leukemia with t(16;16)(p13;q22)|adult acute myeloid leukemia with t(16;16)(p13;q22)
565786|NCT01154439|adult acute myeloid leukemia with t(8;21)(q22;q22)|adult acute myeloid leukemia with t(8;21)(q22;q22)
565787|NCT01154400|casein protein|casein protein
565788|NCT01154400|whey protein|whey protein
565789|NCT01154400|hydrolysates|hydrolysates
565790|NCT01154400|leucine|leucine
565791|NCT01154400|protein metabolism|protein metabolism
565792|NCT01154400|COPD|copd
565793|NCT01154387|Kidney|kidney
565794|NCT01154387|Renal|renal
565795|NCT01154387|Transplant|transplant
565796|NCT01154387|Kidney Transplant|kidney transplant
565797|NCT01154387|Kidney Failure|kidney failure
565798|NCT01154387|Induction|induction
565799|NCT01154387|Monoclonal|monoclonal
565800|NCT01154387|Antibody|antibody
565801|NCT01154387|T cell|t cell
565802|NCT01154387|Anti-rejection|anti-rejection
565803|NCT01154387|Immunosuppression|immunosuppression
565804|NCT01154374|Diabetic Foot Ulcers (DFUs)|diabetic foot ulcers (dfus)
565805|NCT01154361|ACE inhibitor induced angioedema|ace inhibitor induced angioedema
565806|NCT01154361|Bradykinin|bradykinin
565807|NCT01154361|Non-itching edema|non-itching edema
565808|NCT01154361|Non-allergic angioedema|non-allergic angioedema
565809|NCT01154361|Quincke edema|quincke edema
565810|NCT01154361|Drug induced angioedema|drug induced angioedema
565811|NCT01154361|Bradykinin B2 receptor antagonist|bradykinin b2 receptor antagonist
565812|NCT01154361|Icatibant|icatibant
565813|NCT01154361|HOE 140|hoe 140
565814|NCT01154348|Metformin|metformin
565815|NCT01154335|refractory metastatic colorectal cancer|refractory metastatic colorectal cancer
565816|NCT01154309|Depression|depression
565817|NCT01154309|Substance Use|substance use
565818|NCT01154309|Group Cognitive Behavioral Therapy|group cognitive behavioral therapy
565820|NCT01154296|Rapid Testing|rapid testing
565821|NCT01154296|Counseling|counseling
565822|NCT01154296|STD|std
565823|NCT01154296|U.S.|u.s.
565824|NCT01154270|cancer of the salivary glands|cancer of the salivary glands
565825|NCT01154270|radiation|radiation
565826|NCT01154270|carbon ion therapy|carbon ion therapy
565827|NCT01154257|Dental plaque|dental plaque
565828|NCT01154257|Gingivitis|gingivitis
565829|NCT01154244|Insulin resistance|insulin resistance
565830|NCT01154244|Insulin deficiency|insulin deficiency
565831|NCT01154244|HOMA-IR|homa-ir
565832|NCT01154244|Drug naive|drug naive
565833|NCT01154244|Diabetes mellitus, type II|diabetes mellitus, type ii
565834|NCT01154231|BeneFIX Regulatory Post Marketing Commitment Plan|benefix regulatory post marketing commitment plan
565835|NCT01154218|bioequivalence|bioequivalence
565836|NCT01154218|food effect|food effect
565837|NCT01154218|pharmacokinetics|pharmacokinetics
565838|NCT01154218|crizotinib|crizotinib
565839|NCT01154192|PCOS|pcos
565840|NCT01154192|oligomenorrhea|oligomenorrhea
565841|NCT01154192|irregular menses|irregular menses
565842|NCT01154192|hyperandrogenemia|hyperandrogenemia
565843|NCT01154192|elevated testosterone|elevated testosterone
565844|NCT01154192|adolescents|adolescents
565845|NCT01154192|androgens|androgens
565846|NCT01154192|ovary|ovary
565847|NCT01154192|LH|lh
565848|NCT01154179|permissive underfeeding|permissive underfeeding
565849|NCT01154179|hypocaloric feeding|hypocaloric feeding
565850|NCT01154179|artificial nutrition|artificial nutrition
565851|NCT01154140|open label|open label
565852|NCT01154140|randomized Phase 3|randomized phase 3
565853|NCT01154140|first line treatment|first line treatment
565854|NCT01154140|non squamous lung cancer|non squamous lung cancer
565855|NCT01154140|ALK translocation event positive|alk translocation event positive
565856|NCT01154127|NVA237|nva237
565857|NCT01154127|COPD|copd
565858|NCT01154127|bronchodilator|bronchodilator
565859|NCT01154127|exercise endurance|exercise endurance
565860|NCT01154114|healthy volunteer|healthy volunteer
565861|NCT01154114|hepatic impairment|hepatic impairment
565862|NCT01154114|darapladib|darapladib
565863|NCT01154114|atherosclerosis|atherosclerosis
565864|NCT01154088|Adolescent|adolescent
565865|NCT01154088|Vaccine, conjugate|vaccine, conjugate
565866|NCT01154088|Adult|adult
565867|NCT01154088|Neisseria meningitidis|neisseria meningitidis
565868|NCT01154088|Immunogenicity|immunogenicity
565869|NCT01154088|Meningococcal vaccine|meningococcal vaccine
565870|NCT01154088|Safety|safety
565871|NCT01154075|Liver transplant|liver transplant
565872|NCT01154075|Adherence|adherence
565873|NCT01154075|Compliance|compliance
565874|NCT01154075|Tacrolimus|tacrolimus
565875|NCT01154062|age-related macular degeneration|age-related macular degeneration
565876|NCT01154062|pazopanib|pazopanib
565877|NCT01154062|choroidal neovascularization|choroidal neovascularization
565878|NCT01154062|GW786034|gw786034
565879|NCT01154049|Schistosomiasis|schistosomiasis
565880|NCT01154049|Vaccine|vaccine
565881|NCT01154049|sm14|sm14
565882|NCT01154023|Sleep Initiation and Maintenance Disorders|sleep initiation and maintenance disorders
565883|NCT01154023|Behavior Therapy|behavior therapy
565884|NCT01154010|PEMF|pemf
565885|NCT01154010|iritis|iritis
565886|NCT01154010|anterior uveitis|anterior uveitis
565887|NCT01153958|Vaginosis, Bacterial|vaginosis, bacterial
565888|NCT01153958|Colposeptine|colposeptine
565889|NCT01153958|Metronidazole|metronidazole
565890|NCT01153945|Hypothyroid and non hypothyroid|hypothyroid and non hypothyroid
565891|NCT01153932|968|968
565892|NCT01153932|muscular dystrophy|muscular dystrophy
565893|NCT01153932|duchenne|duchenne
565894|NCT01153932|DMD|dmd
565895|NCT01153906|autoimmune diseases|autoimmune diseases
565896|NCT01153906|HPV vaccine|hpv vaccine
565897|NCT01153906|papillomavirus|papillomavirus
565898|NCT01153906|human papillomavirus|human papillomavirus
565899|NCT01153906|HPV|hpv
565900|NCT01153893|Pneumococcal disease|pneumococcal disease
565901|NCT01153893|Pneumococcal vaccine|pneumococcal vaccine
565902|NCT01153893|Catch-up vaccination|catch-up vaccination
565903|NCT01153893|Immunogenicity|immunogenicity
565904|NCT01153893|Booster vaccination|booster vaccination
565905|NCT01153893|Safety|safety
565906|NCT01153880|Altabax|altabax
565907|NCT01153880|United States|united states
565908|NCT01153880|topical|topical
565909|NCT01153880|Mupirocin|mupirocin
565910|NCT01153880|Retapamulin|retapamulin
565911|NCT01153880|Bactroban|bactroban
565912|NCT01153867|Schema Focused Therapy|schema focused therapy
565913|NCT01153867|Chronic Depression|chronic depression
565914|NCT01153867|Mechanisms of Change|mechanisms of change
565915|NCT01153854|acute diarrhea|acute diarrhea
565916|NCT01153854|Acute diarrhea (three or more watery or semi-watery bowel movements for at least one day lasting no more than 5 days before being admitted)|acute diarrhea (three or more watery or semi-watery bowel movements for at least one day lasting no more than 5 days before being admitted)
565917|NCT01153841|Pneumococcal vaccine|pneumococcal vaccine
565918|NCT01153828|Altargo|altargo
565919|NCT01153828|Bactroban|bactroban
565920|NCT01153828|Fucidin|fucidin
565921|NCT01153828|Fusidic acid|fusidic acid
565922|NCT01153828|Mupirocin|mupirocin
565923|NCT01153828|topical|topical
565924|NCT01153828|Retapamulin|retapamulin
565925|NCT01153828|United Kingdom|united kingdom
565926|NCT01153815|efficacy|efficacy
565927|NCT01153815|Spasticity, Post-Stroke|spasticity, post-stroke
565928|NCT01153815|safety|safety
565929|NCT01153815|Botulinum toxin type A|botulinum toxin type a
565930|NCT01153815|placebo|placebo
565931|NCT01153815|spasticity|spasticity
565932|NCT01153802|Positron Emission Tomography|positron emission tomography
565933|NCT01153802|serotonin|serotonin
565934|NCT01153802|inhibitor of the neurotransmitters|inhibitor of the neurotransmitters
565935|NCT01153802|safety of single oral doses|safety of single oral doses
565936|NCT01153802|norepinephrine|norepinephrine
565937|NCT01153802|dopamine|dopamine
565938|NCT01153789|Vergence-accommodation evaluation|vergence-accommodation evaluation
565939|NCT01153789|Vergence and postural control|vergence and postural control
565940|NCT01153789|Dynamic visual acuity|dynamic visual acuity
565941|NCT01153776|Arterial switch operation|arterial switch operation
565942|NCT01153776|Transposition of the great arteries|transposition of the great arteries
565943|NCT01153776|Congenital heart diseases|congenital heart diseases
565944|NCT01153776|CT coronary angiography|ct coronary angiography
565945|NCT01153763|Metastatic melanoma|metastatic melanoma
565946|NCT01153763|BRAF mutant|braf mutant
565947|NCT01153763|Melanoma|melanoma
565948|NCT01153763|BRAF mutant metastatic melanoma|braf mutant metastatic melanoma
565949|NCT01153750|cholangiocellular carcinoma|cholangiocellular carcinoma
565950|NCT01153750|bile duct cancer|bile duct cancer
565951|NCT01153737|Neck pain|neck pain
565952|NCT01153737|Primary Health Care|primary health care
565953|NCT01153737|Manual Therapy|manual therapy
565954|NCT01153737|TENS|tens
565955|NCT01153685|Fluviral®Influenza|fluviral®influenza
565956|NCT01153659|rabeprazole|rabeprazole
565957|NCT01153659|esomeprazole|esomeprazole
565958|NCT01153659|h. pylori-negative|h. pylori-negative
565959|NCT01153659|nocturnal acid breakthrough|nocturnal acid breakthrough
565960|NCT01153659|intragastric pH, PK/PD|intragastric ph, pk/pd
565961|NCT01153659|effect on gastric pH in healthy, H. pylori-Negative subjects|effect on gastric ph in healthy, h. pylori-negative subjects
565962|NCT01153646|HIV|hiv
565963|NCT01153646|Gene Transfer|gene transfer
565964|NCT01153646|T-Cell Immunotherapy|t-cell immunotherapy
565965|NCT01153646|HIV-1 infected patients who have failed anti-retroviral therapy|hiv-1 infected patients who have failed anti-retroviral therapy
565966|NCT01153620|Acute traumatic wounds|acute traumatic wounds
565967|NCT01153607|Alzheimer's disease|alzheimer's disease
565968|NCT01153607|Diagnostic imaging|diagnostic imaging
565969|NCT01153607|PET diagnosis|pet diagnosis
565970|NCT01153607|PET tracer|pet tracer
565971|NCT01153594|Substance Use Disorders|substance use disorders
565972|NCT01153594|Relapse|relapse
565973|NCT01153594|Recovery|recovery
565974|NCT01153594|Disease Management|disease management
565975|NCT01153594|Long term outcomes|long term outcomes
565976|NCT01153594|Addiction Treatment|addiction treatment
565977|NCT01153568|Vitamin D|vitamin d
565978|NCT01153568|osteoporosis|osteoporosis
565979|NCT01153568|african american women|african american women
565980|NCT01153529|PTSD|ptsd
565981|NCT01153516|Type 2 diabetes|type 2 diabetes
565982|NCT01153516|Bariatric surgery|bariatric surgery
565983|NCT01153516|Obesity|obesity
565984|NCT01153516|Weight loss|weight loss
565985|NCT01153503|Postoperative pain, TAP block, Hysterectomy|postoperative pain, tap block, hysterectomy
565986|NCT01153490|Quetiapine|quetiapine
565987|NCT01153490|Psychotic experiences|psychotic experiences
565988|NCT01153490|Cannabis dependence|cannabis dependence
565989|NCT01153490|Craving|craving
565990|NCT01153490|Mood|mood
565991|NCT01153490|Substance use|substance use
565992|NCT01153451|Pending tests|pending tests
565993|NCT01153451|Discharge|discharge
565994|NCT01153451|Awareness|awareness
565995|NCT01153451|Care transitions|care transitions
565996|NCT01153438|Diabetes|diabetes
565997|NCT01153438|Obesity|obesity
565998|NCT01153438|Bariatric surgery|bariatric surgery
565999|NCT01153438|Gut hormones|gut hormones
566000|NCT01153438|Glucagon like peptide 1|glucagon like peptide 1
566001|NCT01153438|Insulin|insulin
566002|NCT01153425|Osteoporosis|osteoporosis
566003|NCT01153425|Osteopenia|osteopenia
566004|NCT01153425|Fracture Risk|fracture risk
566005|NCT01153425|teriparatide or Forteo|teriparatide or forteo
566006|NCT01153425|zoledronic acid or Reclast|zoledronic acid or reclast
566007|NCT01153399|Non Small Cell Lung Cancer|non small cell lung cancer
566008|NCT01153399|EGFR mutations|egfr mutations
566009|NCT01153386|Pulmonary arterial hypertension|pulmonary arterial hypertension
566010|NCT01153386|Treprostinil|treprostinil
566011|NCT01153386|Pharmacokinetics|pharmacokinetics
566012|NCT01153373|Detection of tobacco, alcohol, and drug use.|detection of tobacco, alcohol, and drug use.
566013|NCT01153347|Major Depressive Disorder|major depressive disorder
566015|NCT01153347|Depression|depression
566016|NCT01153347|Safety|safety
566017|NCT01153347|add-on therapy|add-on therapy
566018|NCT01153321|Respiratory disease|respiratory disease
566019|NCT01153321|chronic obstructive pulmonary disease|chronic obstructive pulmonary disease
566020|NCT01153308|Morbid Obesity|morbid obesity
566021|NCT01153308|Obesity|obesity
566022|NCT01153308|Weight Loss|weight loss
566023|NCT01153308|Bariatric Surgery|bariatric surgery
566024|NCT01153295|IBS|ibs
566025|NCT01153295|Irritable bowel syndrome|irritable bowel syndrome
566026|NCT01153295|diagnosis|diagnosis
566027|NCT01153295|safety|safety
566028|NCT01153295|Health related quality of life|health related quality of life
566029|NCT01153282|Breast Cancer patients|breast cancer patients
566030|NCT01153269|Human Immunodeficiency Virus|human immunodeficiency virus
566031|NCT01153269|Co-infection with Hepatitis B or Hepatitis C|co-infection with hepatitis b or hepatitis c
566032|NCT01153269|Tolerability|tolerability
566033|NCT01153269|Effectiveness|effectiveness
566034|NCT01153243|inflammatory markers|inflammatory markers
566035|NCT01153230|PQ|pq
566036|NCT01153217|Tenofovir|tenofovir
566037|NCT01153217|HIV-infection|hiv-infection
566038|NCT01153217|BMD|bmd
566039|NCT01153217|Osteoporosis|osteoporosis
566040|NCT01153217|Osteopenia|osteopenia
566041|NCT01153204|Erectile Dysfunction|erectile dysfunction
566042|NCT01153204|Group Psychotherapy|group psychotherapy
566043|NCT01153204|Sildenafil [Substance Name]|sildenafil [substance name]
566044|NCT01153204|Patient Satisfaction|patient satisfaction
566045|NCT01153204|Efficacy|efficacy
566046|NCT01153204|Randomized Controlled Trial [Publication Type]|randomized controlled trial [publication type]
566047|NCT01153191|colorectal surgery|colorectal surgery
566048|NCT01153165|Refractory|refractory
566049|NCT01153165|Asthma|asthma
566050|NCT01153165|Depression|depression
566051|NCT01153152|wisdom teeth|wisdom teeth
566052|NCT01153152|acute pulpitis|acute pulpitis
566053|NCT01153152|extraction|extraction
566054|NCT01153152|pain|pain
566055|NCT01153152|Pain Following Removal of Wisdom Teeth with Acute Pulpitis|pain following removal of wisdom teeth with acute pulpitis
566056|NCT01153139|Transcranial Magnetic Stimulation|transcranial magnetic stimulation
566057|NCT01153139|Depression|depression
566058|NCT01153139|Theta Burst Stimulation|theta burst stimulation
566059|NCT01153126|Diagnostic Imaging|diagnostic imaging
566060|NCT01153126|Breast Screening|breast screening
566061|NCT01153126|Breast Cancer|breast cancer
566062|NCT01153126|To be eligible for the study, subjects must:|to be eligible for the study, subjects must:
566063|NCT01153126|Be females at least 18 years of age,|be females at least 18 years of age,
566064|NCT01153126|Have had their screening mammogram performed at the UW Breast Center,|have had their screening mammogram performed at the uw breast center,
566065|NCT01153126|Be able to read and write English at the 6th grade level (as shown by their, ability to understand the informed consent),|be able to read and write english at the 6th grade level (as shown by their, ability to understand the informed consent),
566066|NCT01153126|Have access to a computer with internet capability.|have access to a computer with internet capability.
566067|NCT01153113|adenocarcinoma of the prostate|adenocarcinoma of the prostate
566068|NCT01153113|metastatic prostate adenocarcinoma, Stage (T1-4, N+, M0) or (T1-4, N0-3, M+)|metastatic prostate adenocarcinoma, stage (t1-4, n+, m0) or (t1-4, n0-3, m+)
566069|NCT01153113|rising PSA levels while maintained on LHRH analogues|rising psa levels while maintained on lhrh analogues
566070|NCT01153100|Diabetes|diabetes
566071|NCT01153074|Bronchopleural fistula|bronchopleural fistula
566072|NCT01153074|Bronchoscopy|bronchoscopy
566073|NCT01153048|Intensification of Education|intensification of education
566074|NCT01153048|learning nest methodology|learning nest methodology
566075|NCT01153048|peer educators|peer educators
566076|NCT01153048|type 2 diabetes|type 2 diabetes
566077|NCT01153048|Mali|mali
566078|NCT01153048|the focus of this study is on the intensification of education on the treatment of type 2 diabetes|the focus of this study is on the intensification of education on the treatment of type 2 diabetes
566079|NCT01153035|Breast Conservation Therapy|breast conservation therapy
566080|NCT01153035|Lumpectomy|lumpectomy
566081|NCT01153035|Radiofrequency Ablation|radiofrequency ablation
566082|NCT01153035|Radiation|radiation
566083|NCT01153022|Musculoskeletal manipulations|musculoskeletal manipulations
566084|NCT01153022|Muscle spasticity|muscle spasticity
566085|NCT01153009|Major Depressive Disorder|major depressive disorder
566086|NCT01153009|Depression|depression
566087|NCT01153009|Melancholia|melancholia
566088|NCT01153009|Drug Therapy|drug therapy
566089|NCT01152996|Depression|depression
566090|NCT01152996|Melancholia|melancholia
566091|NCT01152996|Paraphrenia|paraphrenia
566092|NCT01152996|Drug Therapy|drug therapy
566093|NCT01152983|Finger sticks|finger sticks
566094|NCT01152983|Rapid Ring|rapid ring
566095|NCT01152983|Finger sticks method of obtaining blood for diagnostic testing|finger sticks method of obtaining blood for diagnostic testing
566096|NCT01152957|diabetes|diabetes
566097|NCT01152957|cardiovascular|cardiovascular
566098|NCT01152957|chronic|chronic
566099|NCT01152957|Community Health Workers|community health workers
566100|NCT01152957|behavioral|behavioral
566101|NCT01152957|social|social
566102|NCT01152957|diet|diet
566103|NCT01152957|exercise|exercise
566104|NCT01152957|patient|patient
566105|NCT01152957|cholesterol|cholesterol
566106|NCT01152957|A1C|a1c
566107|NCT01152957|blood pressure|blood pressure
566108|NCT01152944|Symptomatic intracranial atherosclerotic disease enrolled in the medical arm of SAMMPRIS|symptomatic intracranial atherosclerotic disease enrolled in the medical arm of sammpris
566109|NCT01152931|Antioxidants|antioxidants
566110|NCT01152931|Micronutrients|micronutrients
566111|NCT01152931|Malaria|malaria
566112|NCT01152931|focus is to determine the effect of antioxidant micronutrients in malaria|focus is to determine the effect of antioxidant micronutrients in malaria
566113|NCT01152918|HIV Prevention|hiv prevention
566114|NCT01152918|HIV Treatment|hiv treatment
566115|NCT01152918|HIV Test and Treat Model of Prevention|hiv test and treat model of prevention
566116|NCT01152918|ART for Prevention|art for prevention
566117|NCT01152918|Prevention for HIV Positives|prevention for hiv positives
566118|NCT01152918|Financial Incentives|financial incentives
566119|NCT01152918|Computer-delivered risk-reduction counseling|computer-delivered risk-reduction counseling
566120|NCT01152905|Neuromuscular blockade|neuromuscular blockade
566121|NCT01152905|Neuromuscular blocking agents|neuromuscular blocking agents
566122|NCT01152905|Atracurium|atracurium
566123|NCT01152905|Nitrous oxide|nitrous oxide
566124|NCT01152892|end stage renal disease|end stage renal disease
566125|NCT01152892|chronic kidney disease|chronic kidney disease
566126|NCT01152892|cardiovascular event|cardiovascular event
566127|NCT01152892|sudden cardiac death|sudden cardiac death
566128|NCT01152892|autonomic function|autonomic function
566129|NCT01152879|Parenteral Nutrition|parenteral nutrition
566130|NCT01152879|Quality of Life|quality of life
566131|NCT01152866|Multifollicular stimulation|multifollicular stimulation
566132|NCT01152866|Pregnancy|pregnancy
566133|NCT01152866|Reproductive Techniques, Assisted|reproductive techniques, assisted
566134|NCT01152866|Fertilization in Vitro|fertilization in vitro
566135|NCT01152866|Infertility|infertility
566136|NCT01152853|advanced gastric cancer|advanced gastric cancer
566137|NCT01152853|HER2|her2
566138|NCT01152853|PF00299804|pf00299804
566139|NCT01152840|Adenoid cystic carcinoma|adenoid cystic carcinoma
566140|NCT01152840|RAD001|rad001
566141|NCT01152827|Pheochromocytoma|pheochromocytoma
566142|NCT01152827|extra-adrenal paraganglioma|extra-adrenal paraganglioma
566143|NCT01152827|non-functioning carcinoid|non-functioning carcinoid
566144|NCT01152827|RAD001|rad001
566145|NCT01152814|Seasonal influenza|seasonal influenza
566146|NCT01152814|Vaccine|vaccine
566147|NCT01152801|mRCC,|mrcc,
566148|NCT01152801|everolimus,|everolimus,
566149|NCT01152801|mTOR,|mtor,
566150|NCT01152801|intolerant of VEGF-therapies|intolerant of vegf-therapies
566151|NCT01152775|partnered surgical decision-making|partnered surgical decision-making
566152|NCT01152775|impact of multimedia-based teaching|impact of multimedia-based teaching
566153|NCT01152775|patient education|patient education
566154|NCT01152775|understanding and retention by patients|understanding and retention by patients
566155|NCT01152762|Physiotherapy, COPD, effectiveness, primary care|physiotherapy, copd, effectiveness, primary care
566156|NCT01152749|Smoking Cessation|smoking cessation
566157|NCT01152749|Nicotine pharmacokinetics|nicotine pharmacokinetics
566158|NCT01152736|Smoking Cessation, Nicotine pharmacokinetics|smoking cessation, nicotine pharmacokinetics
566159|NCT01152723|Smoking Cessation, Nicotine pharmacokinetics|smoking cessation, nicotine pharmacokinetics
566160|NCT01152710|capecitabine|capecitabine
566161|NCT01152710|chemoradiation|chemoradiation
566162|NCT01152710|rectal cancer|rectal cancer
566163|NCT01152710|phase II study|phase ii study
566164|NCT01152697|nonadherence|nonadherence
566165|NCT01152697|noncompliance|noncompliance
566166|NCT01152697|homeless|homeless
566167|NCT01152697|schizophrenia|schizophrenia
566168|NCT01152697|schizoaffective|schizoaffective
566169|NCT01152684|CAM|cam
566170|NCT01152684|HIV-Positive|hiv-positive
566171|NCT01152684|Latinos|latinos
566172|NCT01152684|US-Mexico Border region|us-mexico border region
566173|NCT01152684|San Diego-Tijuana|san diego-tijuana
566174|NCT01152684|Identify the nature and extent of complementary and alternative medicine use among HIV-positive Latinos in the US-Mexico border region|identify the nature and extent of complementary and alternative medicine use among hiv-positive latinos in the us-mexico border region
566175|NCT01152658|Partial supraspinatus tear|partial supraspinatus tear
566176|NCT01152658|partial tear ssp per echo|partial tear ssp per echo
566177|NCT01152645|Advanced/recurrent gastric cancer|advanced/recurrent gastric cancer
566178|NCT01152632|acupuncture|acupuncture
566179|NCT01152632|migraine|migraine
566180|NCT01152632|specific acupoints|specific acupoints
566181|NCT01152632|brain network|brain network
566182|NCT01152580|melatonin|melatonin
566183|NCT01152580|menopause|menopause
566184|NCT01152580|perimenopause|perimenopause
566185|NCT01152580|sleep|sleep
566186|NCT01152580|osteoporosis|osteoporosis
566187|NCT01152580|osteopenia|osteopenia
566188|NCT01152580|anxiety|anxiety
566189|NCT01152580|depression|depression
566190|NCT01152580|hypertension|hypertension
566191|NCT01152567|Hypertension|hypertension
566192|NCT01152567|ACE|ace
566193|NCT01152567|ARB|arb
566194|NCT01152567|real life data|real life data
566195|NCT01152567|CVD|cvd
566196|NCT01152567|cost effectiveness|cost effectiveness
566197|NCT01152554|Major Depressive Disorder|major depressive disorder
566198|NCT01152554|MDD|mdd
566199|NCT01152554|Depression|depression
566200|NCT01152554|Safety|safety
566201|NCT01152554|add-on therapy|add-on therapy
566202|NCT01152541|Keratoconus|keratoconus
566203|NCT01152541|Corneal Ectasia|corneal ectasia
566204|NCT01152541|Collagen Crosslinking|collagen crosslinking
566205|NCT01152541|Riboflavin|riboflavin
566206|NCT01152528|bacterial vaginosis|bacterial vaginosis
566207|NCT01152528|screening|screening
566208|NCT01152528|abortion|abortion
566209|NCT01152528|preterm delivery|preterm delivery
566210|NCT01152515|safety and efficacy of maintaining a remifentanil infusion during extubation in propofol-remifentanil sedated patients after surgery|safety and efficacy of maintaining a remifentanil infusion during extubation in propofol-remifentanil sedated patients after surgery
566211|NCT01152502|Post operative conditions, paracetamol metabolites|post operative conditions, paracetamol metabolites
566212|NCT01152489|Pain|pain
566213|NCT01152476|healthy pediatric patients undergoing tonsillectomy and adenoidectomy|healthy pediatric patients undergoing tonsillectomy and adenoidectomy
566214|NCT01152463|thoracic ultrasound (US)|thoracic ultrasound (us)
566215|NCT01152463|post-op care|post-op care
566216|NCT01152463|pneumothorax|pneumothorax
566217|NCT01152463|pleural effusion|pleural effusion
566218|NCT01152424|Acute eosinophilic pneumonia|acute eosinophilic pneumonia
566219|NCT01152424|Exhaled nitric oxide|exhaled nitric oxide
566220|NCT01152411|Renal Failure|renal failure
566221|NCT01152411|Chronic Kidney Disease|chronic kidney disease
566222|NCT01152411|Chronic Renal Failure|chronic renal failure
566223|NCT01152398|Breast cancer|breast cancer
566224|NCT01152398|Vaccine|vaccine
566225|NCT01152398|Metastatic|metastatic
566226|NCT01152398|HER-2-positive|her-2-positive
566227|NCT01152398|Phase I|phase i
566228|NCT01152398|HER-2 Positive Breast Cancer|her-2 positive breast cancer
566229|NCT01152385|Type 2 diabetes mellitus|type 2 diabetes mellitus
566230|NCT01152385|Japanese|japanese
566231|NCT01152385|phase 2|phase 2
566232|NCT01152385|AZD1656|azd1656
566233|NCT01152385|efficacy|efficacy
566234|NCT01152385|dose regimen|dose regimen
566235|NCT01152385|pharmacokinetics|pharmacokinetics
566236|NCT01152359|obesity|obesity
566237|NCT01152359|diet, low carbohydrate|diet, low carbohydrate
566238|NCT01152359|diet, fat-restricted|diet, fat-restricted
566239|NCT01152359|food preferences|food preferences
566240|NCT01152359|quality of life|quality of life
566241|NCT01152359|patient compliance|patient compliance
566242|NCT01152346|Bioequivalence|bioequivalence
566243|NCT01152346|Myelodysplastic Syndrome|myelodysplastic syndrome
566245|NCT01152346|Azacitidine|azacitidine
566246|NCT01152320|Asthma|asthma
566247|NCT01152320|Spirometry|spirometry
566248|NCT01152320|Pediatric|pediatric
566249|NCT01152320|Primary Health Care|primary health care
566250|NCT01152320|Education, Distance|education, distance
566251|NCT01152307|Depression|depression
566252|NCT01152307|Depressive disorder|depressive disorder
566253|NCT01152307|Decision Making|decision making
566254|NCT01152307|Decision Aids|decision aids
566255|NCT01152307|Decision Quality Instrument|decision quality instrument
566256|NCT01152294|Menopause|menopause
566257|NCT01152294|Decision making|decision making
566258|NCT01152294|Decision aids|decision aids
566259|NCT01152294|Decision quality instrument|decision quality instrument
566260|NCT01152281|retention|retention
566261|NCT01152281|attrition|attrition
566262|NCT01152281|empowering|empowering
566263|NCT01152281|reactance|reactance
566264|NCT01152281|motivational|motivational
566265|NCT01152281|goals|goals
566266|NCT01152281|Basic control|basic control
566267|NCT01152281|Control with stories of people with AIDS|control with stories of people with aids
566268|NCT01152281|Instrumental|instrumental
566269|NCT01152281|Instrumental and Empowering|instrumental and empowering
566270|NCT01152268|sperm banking|sperm banking
566271|NCT01152268|Adolescent males|adolescent males
566272|NCT01152268|Infertility|infertility
566273|NCT01152268|Adolescents diagnosed with cancer|adolescents diagnosed with cancer
566274|NCT01152255|Treatment of HIV-1 Infection|treatment of hiv-1 infection
566275|NCT01152242|Insulin|insulin
566276|NCT01152203|Bendamustine|bendamustine
566277|NCT01152203|Bevacizumab|bevacizumab
566278|NCT01152177|Heading Health Plan Implementation|heading health plan implementation
566279|NCT01152177|General Practice|general practice
566280|NCT01152177|Point of care testing|point of care testing
566281|NCT01152177|education|education
566282|NCT01152164|quality of life|quality of life
566283|NCT01152164|rectal cancer|rectal cancer
566284|NCT01152151|Heading Health Plan Implementation|heading health plan implementation
566285|NCT01152151|General Practice|general practice
566286|NCT01152151|Point of care testing|point of care testing
566287|NCT01152151|education|education
566288|NCT01152138|Acute myocardial infarction|acute myocardial infarction
566289|NCT01152138|Closed cell stent|closed cell stent
566290|NCT01152138|Open cell stent|open cell stent
566291|NCT01152138|primary percutaneous coronary intervention|primary percutaneous coronary intervention
566292|NCT01152125|Osteoarthritis|osteoarthritis
566293|NCT01152125|stem cell implantation|stem cell implantation
566294|NCT01152125|bone marrow|bone marrow
566295|NCT01152125|autologous|autologous
566296|NCT01152112|morcellator|morcellator
566297|NCT01152112|hysteroscope|hysteroscope
566298|NCT01152112|myomectomy|myomectomy
566299|NCT01152112|polypectomy|polypectomy
566300|NCT01152112|uterine fibroids|uterine fibroids
566301|NCT01152112|uterine polyps|uterine polyps
566302|NCT01152112|office|office
566303|NCT01152112|cost|cost
566304|NCT01152112|local anesthetic|local anesthetic
566305|NCT01152112|cervical block|cervical block
566306|NCT01152112|pain management|pain management
566307|NCT01152099|Postmastectomy|postmastectomy
566308|NCT01152086|Physical activity|physical activity
566309|NCT01152086|mountain hiking|mountain hiking
566310|NCT01152086|exercise|exercise
566311|NCT01152086|training program|training program
566312|NCT01152086|hopelessness|hopelessness
566313|NCT01152086|chronic suicidality|chronic suicidality
566314|NCT01152086|depression|depression
566315|NCT01152086|suicide attempt|suicide attempt
566316|NCT01152086|suicide|suicide
566317|NCT01152073|Cholesterol|cholesterol
566318|NCT01152073|Statin|statin
566319|NCT01152073|Nutraceuticals|nutraceuticals
566320|NCT01152073|Niacin|niacin
566321|NCT01152073|Hyperlipidemia|hyperlipidemia
566322|NCT01152073|Liquid|liquid
566323|NCT01152060|remission of proteinuria|remission of proteinuria
566324|NCT01152060|HBVe-antigen|hbve-antigen
566325|NCT01152047|oxytocin|oxytocin
566326|NCT01152047|satiety|satiety
566327|NCT01152047|dyspepsia|dyspepsia
566328|NCT01152034|Bipolar disorder|bipolar disorder
566329|NCT01152034|psychosocial intervention|psychosocial intervention
566330|NCT01152034|group therapy|group therapy
566331|NCT01152034|relapse prevention|relapse prevention
566332|NCT01152034|parasuicide|parasuicide
566333|NCT01152034|Recurrence|recurrence
566334|NCT01152034|hospitalization|hospitalization
566335|NCT01152034|Medication adherence|medication adherence
566336|NCT01152034|Self-Injurious Behavior|self-injurious behavior
566337|NCT01152034|Quality of Life|quality of life
566338|NCT01152021|dexmedetomidine|dexmedetomidine
566339|NCT01152021|propofol|propofol
566340|NCT01152021|sedation|sedation
566341|NCT01152021|MRI|mri
566342|NCT01152021|scanning|scanning
566343|NCT01152021|pediatric|pediatric
566344|NCT01152021|children|children
566345|NCT01152021|Magnetic Resonance Imaging|magnetic resonance imaging
566346|NCT01152008|Microcirculation|microcirculation
566347|NCT01152008|laser flowmetry|laser flowmetry
566348|NCT01152008|Skin|skin
566349|NCT01152008|Physiology|physiology
566350|NCT01151995|Clinical Trial Monitoring|clinical trial monitoring
566351|NCT01151995|Effectiveness of remote monitoring|effectiveness of remote monitoring
566352|NCT01151995|Efficiency of remote monitoring|efficiency of remote monitoring
566353|NCT01151995|Costs of remote monitoring|costs of remote monitoring
566354|NCT01151982|Depression|depression
566355|NCT01151982|Primary prevention.|primary prevention.
566356|NCT01151982|Primary health care.|primary health care.
566357|NCT01151982|Randomised controlled trial.|randomised controlled trial.
566358|NCT01151969|Health Service Misuse|health service misuse
566359|NCT01151969|Overutilization of Health Services|overutilization of health services
566360|NCT01151969|Primary Health Care|primary health care
566361|NCT01151969|Cost Effectiveness|cost effectiveness
566362|NCT01151969|Quality of life|quality of life
566363|NCT01151969|Randomised Controlled Trial|randomised controlled trial
566364|NCT01151969|Multilevel analysis|multilevel analysis
566365|NCT01151956|observational study|observational study
566366|NCT01151956|actinic keratosis|actinic keratosis
566367|NCT01151956|imiquimod|imiquimod
566368|NCT01151943|cesarean section|cesarean section
566369|NCT01151943|continuous wound infiltration|continuous wound infiltration
566370|NCT01151943|transversus abdominis plane block|transversus abdominis plane block
566371|NCT01151930|Advanced solid tumor failed with standard therapy|advanced solid tumor failed with standard therapy
566372|NCT01151917|Bilio-pancreatic diversion|bilio-pancreatic diversion
566373|NCT01151917|morbid obesity|morbid obesity
566374|NCT01151917|insulin resistance|insulin resistance
566375|NCT01151917|proteomics|proteomics
566376|NCT01151891|Pedal puncture wounds|pedal puncture wounds
566377|NCT01151891|Infection in pedal puncture wounds|infection in pedal puncture wounds
566378|NCT01151891|Diabetes education and pedal puncture wounds|diabetes education and pedal puncture wounds
566379|NCT01151878|constipation|constipation
566380|NCT01151878|children|children
566381|NCT01151865|Delirium|delirium
566382|NCT01151865|Intensive Care Unit|intensive care unit
566383|NCT01151865|Dexmedetomidine|dexmedetomidine
566384|NCT01151852|Imatinib|imatinib
566385|NCT01151852|Re-challenge|re-challenge
566386|NCT01151839|Esophagus|esophagus
566387|NCT01151839|squamous cell carcinoma|squamous cell carcinoma
566388|NCT01151839|neoadjuvant chemoradiation|neoadjuvant chemoradiation
566389|NCT01151826|Lung transplantation|lung transplantation
566390|NCT01151826|Primary Graft Dysfunction|primary graft dysfunction
566391|NCT01151826|Extravascular Lung Water|extravascular lung water
566392|NCT01151826|Receptor for Advanced Glycation Endproducts (RAGE)|receptor for advanced glycation endproducts (rage)
566393|NCT01151826|Intercellular Adhesion Molecule-1 (ICAM-1)|intercellular adhesion molecule-1 (icam-1)
566394|NCT01151800|ACS|acs
566395|NCT01151800|Interactive Voice Response Technology|interactive voice response technology
566396|NCT01151800|Best Practice Guidelines|best practice guidelines
566397|NCT01151800|Health Care Utilization|health care utilization
566398|NCT01151800|Outcome Assessment|outcome assessment
566399|NCT01151787|migraine|migraine
566400|NCT01151735|Angioedema|angioedema
566401|NCT01151735|Hereditary Diseases|hereditary diseases
566402|NCT01151735|Orphan Disease|orphan disease
566403|NCT01151735|HAE|hae
566404|NCT01151709|Gout|gout
566405|NCT01151709|Chronic condition management|chronic condition management
566406|NCT01151709|Gout management|gout management
566407|NCT01151696|Pain|pain
566408|NCT01151696|morphine|morphine
566409|NCT01151696|hydroxyzine|hydroxyzine
566410|NCT01151696|acute pain|acute pain
566411|NCT01151696|traumatic pain|traumatic pain
566412|NCT01151696|anxiety|anxiety
566413|NCT01151696|post trauma stress|post trauma stress
566414|NCT01151696|post trauma anxiety|post trauma anxiety
566415|NCT01151696|post trauma disorders|post trauma disorders
566416|NCT01151683|hypertension|hypertension
566417|NCT01151683|endothelial dysfunction|endothelial dysfunction
566418|NCT01151670|radiation therapy|radiation therapy
566419|NCT01151670|cognitive dysfunction|cognitive dysfunction
566420|NCT01151670|brain tumor|brain tumor
566421|NCT01151670|memory problems|memory problems
566422|NCT01151670|short term memory loss|short term memory loss
566423|NCT01151657|IBS|ibs
566424|NCT01151657|Irritable bowel syndrome|irritable bowel syndrome
566425|NCT01151657|Probiotics|probiotics
566426|NCT01151657|Treatment|treatment
566427|NCT01151657|Adequate relief|adequate relief
566428|NCT01151644|H1N1 VACCINE|h1n1 vaccine
566429|NCT01151644|INFLUENZA|influenza
566430|NCT01151644|RHEUMATIC DISEASES|rheumatic diseases
566431|NCT01151644|ANTI-H1N1 IMMUNIZATION|anti-h1n1 immunization
566432|NCT01151618|COPD|copd
566433|NCT01151592|Iron deficiency anemia in Chronic Kidney Disease Patients|iron deficiency anemia in chronic kidney disease patients
566434|NCT01151579|Tachycardia|tachycardia
566435|NCT01151579|tachyarrhythmias|tachyarrhythmias
566436|NCT01151579|bronchodilator therapy|bronchodilator therapy
566437|NCT01151579|Critically ill patients|critically ill patients
566438|NCT01151566|Ultrasound|ultrasound
566439|NCT01151566|Contrast enhanced Ultrasound (CEUS)|contrast enhanced ultrasound (ceus)
566440|NCT01151566|Nephrotoxicity|nephrotoxicity
566441|NCT01151566|CT contrast agents|ct contrast agents
566442|NCT01151553|Cardiology|cardiology
566443|NCT01151553|Cardiomyopathy|cardiomyopathy
566444|NCT01151553|Cardiovascular Disease|cardiovascular disease
566445|NCT01151553|Cardiac Resynchronization Therapy (CRT)|cardiac resynchronization therapy (crt)
566446|NCT01151540|Epilepsy|epilepsy
566447|NCT01151540|Seizures|seizures
566448|NCT01151514|No referral|no referral
566449|NCT01151514|Late referral|late referral
566450|NCT01151514|Acute kidney injury|acute kidney injury
566451|NCT01151514|Intensive care unit|intensive care unit
566452|NCT01151514|In-hospital mortality|in-hospital mortality
566453|NCT01151514|Renal outcome|renal outcome
566454|NCT01151514|Requirement for renal replacement therapy|requirement for renal replacement therapy
566455|NCT01151514|Length of hospital stay|length of hospital stay
566456|NCT01151514|Impact|impact
566457|NCT01151514|Incidence|incidence
566458|NCT01151501|acute hypoxemic respiratory failure|acute hypoxemic respiratory failure
566459|NCT01151501|intermittent positive-pressure ventilation|intermittent positive-pressure ventilation
566460|NCT01151501|noninvasive positive pressure ventilation|noninvasive positive pressure ventilation
719591|NCT00549523|HIV|hiv
566461|NCT01151501|ventilator weaning|ventilator weaning
566462|NCT01151475|liver cirrhosis|liver cirrhosis
566463|NCT01151475|hepatic encephalopathy|hepatic encephalopathy
566464|NCT01151475|ammonia|ammonia
566465|NCT01151475|cerebral blood flow|cerebral blood flow
566466|NCT01151462|Postnatal HCMV infection in very preterm infants|postnatal hcmv infection in very preterm infants
566467|NCT01151462|Neurodevelopmental disabilities|neurodevelopmental disabilities
566468|NCT01151462|Hearing loss|hearing loss
566469|NCT01151462|Mental retardation|mental retardation
566470|NCT01151462|Microcephaly|microcephaly
566471|NCT01151462|Chorioretinitis|chorioretinitis
566472|NCT01151462|Growth|growth
566473|NCT01151436|Facial wrinkle correction|facial wrinkle correction
566474|NCT01151410|Pediatric hypertension|pediatric hypertension
566475|NCT01151410|primary hypertension|primary hypertension
566476|NCT01151410|secondary|secondary
566477|NCT01151410|hypertension|hypertension
566478|NCT01151397|SVR|svr
566479|NCT01151397|VITAMIN D|vitamin d
566480|NCT01151397|Hepatitis C|hepatitis c
566481|NCT01151397|Genotype 2,3|genotype 2,3
566482|NCT01151397|Naive|naive
566483|NCT01151397|RVR|rvr
566484|NCT01151384|Cancer Patients|cancer patients
566485|NCT01151358|radioimmunotherapy|radioimmunotherapy
566486|NCT01151358|follicular non-Hodgkin´s lymphoma|follicular non-hodgkin´s lymphoma
566487|NCT01151358|FDG-PET|fdg-pet
566488|NCT01151358|prognostic factors|prognostic factors
566489|NCT01151358|multicenter study|multicenter study
566490|NCT01151345|diltiazem|diltiazem
566491|NCT01151345|angiotrofin|angiotrofin
566492|NCT01151345|bioequivalence|bioequivalence
566493|NCT01151293|Type D personality|type d personality
566494|NCT01151293|diabetes|diabetes
566495|NCT01151293|medical compliance|medical compliance
566496|NCT01151293|HbA1c|hba1c
566497|NCT01151293|complication|complication
566498|NCT01151293|mortality|mortality
566499|NCT01151293|T2DM|t2dm
566500|NCT01151267|Isocapnic hyperpnoea (IH)|isocapnic hyperpnoea (ih)
566501|NCT01151267|Anesthesia|anesthesia
566502|NCT01151267|Accelerate elimination of inhalation agents|accelerate elimination of inhalation agents
566503|NCT01151267|Recovery from anesthesia|recovery from anesthesia
566504|NCT01151254|Cardiac Surgery|cardiac surgery
566505|NCT01151254|Sedation|sedation
566506|NCT01151254|Intensive care|intensive care
566507|NCT01151254|Volatile anesthesia|volatile anesthesia
566508|NCT01151254|Intravenous anesthesia|intravenous anesthesia
566509|NCT01151254|Pre and post conditioning after cardiac surgery|pre and post conditioning after cardiac surgery
566510|NCT01151241|elbow surgery|elbow surgery
566511|NCT01151241|infraclavicular nerve block|infraclavicular nerve block
566512|NCT01151241|continuous passive motion|continuous passive motion
566513|NCT01151241|ultrasound guided regional anesthesia|ultrasound guided regional anesthesia
566514|NCT01151241|early discharge|early discharge
566515|NCT01151228|gastroscopy|gastroscopy
566516|NCT01151228|ultrasound|ultrasound
566517|NCT01151228|stomach volume|stomach volume
566518|NCT01151228|patients having gastroscopy|patients having gastroscopy
566519|NCT01151215|Cancer|cancer
566520|NCT01151215|tumour|tumour
566521|NCT01151215|breast cancer|breast cancer
566522|NCT01151215|metastatic|metastatic
566523|NCT01151215|secondary|secondary
566524|NCT01151215|locally advanced|locally advanced
566525|NCT01151202|acute upper respiratory tract infection, chronic inflamatory bronchitis|acute upper respiratory tract infection, chronic inflamatory bronchitis
566526|NCT01151189|HIV|hiv
566527|NCT01151189|Tuberculosis|tuberculosis
566528|NCT01151189|Vaccine|vaccine
566529|NCT01151176|Intensive Insulin Therapy|intensive insulin therapy
566530|NCT01151176|Glucose control|glucose control
566531|NCT01151176|Acute Coronary Syndrome|acute coronary syndrome
566532|NCT01151176|Intensive Care|intensive care
566533|NCT01150916|natriuretic peptide|natriuretic peptide
566534|NCT01150916|heart failure|heart failure
566535|NCT01150916|ascites|ascites
566536|NCT01150916|liver cirrhosis|liver cirrhosis
566537|NCT01150838|intubation of children without neuromuscular blockade|intubation of children without neuromuscular blockade
566538|NCT01149226|pediatric patients|pediatric patients
566539|NCT01149226|ASA physical status I or II|asa physical status i or ii
566540|NCT01149226|aged between 1-5 yrs|aged between 1-5 yrs
566541|NCT01151163|Fibromyalgia, Peripheral arterial tonometry, sleep|fibromyalgia, peripheral arterial tonometry, sleep
566542|NCT01151111|Parkinson's disease|parkinson's disease
566543|NCT01151111|Relaxation|relaxation
566544|NCT01151111|Visual imagery|visual imagery
566545|NCT01151111|Motor fluctuations|motor fluctuations
566546|NCT01151111|Treatment|treatment
566547|NCT01151098|Chronic nonmalignant pain|chronic nonmalignant pain
566548|NCT01151098|Opioid|opioid
566549|NCT01151098|Transdermal|transdermal
566550|NCT01151098|Butrans (BTDS)|butrans (btds)
566551|NCT01151085|Systemic Mycosis|systemic mycosis
566552|NCT01151085|Aspergillus infection|aspergillus infection
566553|NCT01151085|Candidiasis|candidiasis
566554|NCT01151085|Cryptococcal infections|cryptococcal infections
566555|NCT01151085|Japanese|japanese
566556|NCT01151085|voriconazole|voriconazole
719621|NCT00549367|HIV|hiv
566557|NCT01151085|VFEND|vfend
566558|NCT01151085|Regulatory Post Marketing Commitment Plan.|regulatory post marketing commitment plan.
566559|NCT01151059|seasonal influenza|seasonal influenza
566560|NCT01151059|vaccine|vaccine
566561|NCT01151046|Breast Cancer|breast cancer
566562|NCT01151046|Her2 negative|her2 negative
566563|NCT01151046|Estrogen Receptor Positive|estrogen receptor positive
566564|NCT01151046|Progesterone Receptor Positive|progesterone receptor positive
566565|NCT01151046|MM-121|mm-121
566566|NCT01151046|Exemestane|exemestane
566567|NCT01151046|Postmenopausal Women|postmenopausal women
566568|NCT01151033|ProNOVA XR Polymer Free Drug Eluting Coronary Stent System|pronova xr polymer free drug eluting coronary stent system
566569|NCT01151033|DES|des
566570|NCT01151033|stent|stent
566571|NCT01151033|coronary artery lesions|coronary artery lesions
566572|NCT01151033|ProNOVA|pronova
566573|NCT01151033|stent implantation|stent implantation
566574|NCT01151020|Aortic Aneurysm|aortic aneurysm
566575|NCT01151020|Aneurysm|aneurysm
566576|NCT01151020|Vascular Prosthesis|vascular prosthesis
566577|NCT01151020|Vascular Disease|vascular disease
566578|NCT01151020|Blood Vessel Prosthesis Implantation|blood vessel prosthesis implantation
566579|NCT01151007|Kras mutation|kras mutation
566580|NCT01151007|colorectal carcinoma|colorectal carcinoma
566581|NCT01151007|Martinique|martinique
566582|NCT01150994|Suicide screening among ED patients|suicide screening among ed patients
566583|NCT01150955|Resveratrol|resveratrol
566584|NCT01150955|Diabetes|diabetes
566585|NCT01150955|SIRT1|sirt1
566586|NCT01150955|STAT5|stat5
566587|NCT01150955|IGF-I|igf-i
566588|NCT01150955|Growth hormone|growth hormone
566589|NCT01150955|NAFLD|nafld
566590|NCT01150955|Longevity|longevity
566591|NCT01150955|Substrate metabolism|substrate metabolism
566592|NCT01150955|Calorie restriction|calorie restriction
566593|NCT01150942|JEV|jev
566594|NCT01150942|vero cell|vero cell
566595|NCT01150929|Knee arthroplasty|knee arthroplasty
566596|NCT01150929|RSA|rsa
566597|NCT01150929|DXA|dxa
566598|NCT01150929|Gait analysis|gait analysis
566599|NCT01150929|Motion analysis|motion analysis
566600|NCT01150903|erectile dysfunction|erectile dysfunction
566601|NCT01150903|phosphodiesterase inhibitor|phosphodiesterase inhibitor
566602|NCT01150903|cardiovascular diseases|cardiovascular diseases
566603|NCT01150890|Ileal Crohn's Disease|ileal crohn's disease
566604|NCT01150890|Ileo-colonic Crohn's Disease|ileo-colonic crohn's disease
566605|NCT01150890|Colonic Chron's Disease|colonic chron's disease
566606|NCT01150877|Vitamin D|vitamin d
566607|NCT01150877|Vitamin D3|vitamin d3
566608|NCT01150877|colon cancer|colon cancer
566609|NCT01150877|rectal cancer|rectal cancer
566610|NCT01150877|Cholecalciferol|cholecalciferol
566611|NCT01150864|Hot water humidifier, Passive heat and moisture exchangers|hot water humidifier, passive heat and moisture exchangers
566612|NCT01150825|STEMI|stemi
566613|NCT01150825|NSTEMI|nstemi
566614|NCT01150825|acute ischemia|acute ischemia
566615|NCT01150825|non-invasive diagnosis|non-invasive diagnosis
566616|NCT01150825|elevated troponin|elevated troponin
566617|NCT01150812|First time in man|first time in man
566618|NCT01150812|healthy|healthy
566619|NCT01150812|thrombin inhibitor|thrombin inhibitor
566620|NCT01150786|inflammation|inflammation
566621|NCT01150786|oxidative stress|oxidative stress
566622|NCT01150786|selenium|selenium
566623|NCT01150786|hemodialysis|hemodialysis
566624|NCT01150760|GI recovery after bowel resection|gi recovery after bowel resection
566625|NCT01150760|morbidity after bowel resection|morbidity after bowel resection
566626|NCT01150760|mortality|mortality
566627|NCT01150760|readmission|readmission
566628|NCT01150760|length of stay|length of stay
566629|NCT01150734|differences of Muscle evoked potentials (MEP) in psychiatric illnesses|differences of muscle evoked potentials (mep) in psychiatric illnesses
566630|NCT01150734|differences in neuromodulation|differences in neuromodulation
566631|NCT01150734|normalization of neuromodulation after pharmacological treatment|normalization of neuromodulation after pharmacological treatment
566632|NCT01150721|COMPUTERIZED TOMOGRAPHY|computerized tomography
566633|NCT01150721|COLONY FORMING UNITS|colony forming units
566634|NCT01150721|Cystic Fibrosis|cystic fibrosis
566635|NCT01150721|Analysis of Variance|analysis of variance
566636|NCT01150721|Forced Expiratory Volume|forced expiratory volume
566637|NCT01150708|Syringomyelia|syringomyelia
566638|NCT01150708|Magnetic Resonance Imaging|magnetic resonance imaging
566639|NCT01150708|Natural History Study|natural history study
566640|NCT01150708|Neurological Examination|neurological examination
566641|NCT01150695|vaccine, Francisella tularensis, Tularemia, rabbit fever, parent protocol|vaccine, francisella tularensis, tularemia, rabbit fever, parent protocol
566642|NCT01150682|endometrial adenocarcinoma|endometrial adenocarcinoma
566643|NCT01150682|stage II endometrial carcinoma|stage ii endometrial carcinoma
566644|NCT01150682|stage III endometrial carcinoma|stage iii endometrial carcinoma
566645|NCT01150682|stage IV endometrial carcinoma|stage iv endometrial carcinoma
566646|NCT01150682|endometrial adenosquamous cell carcinoma|endometrial adenosquamous cell carcinoma
566647|NCT01150682|endometrial clear cell carcinoma|endometrial clear cell carcinoma
566648|NCT01150682|endometrial papillary serous carcinoma|endometrial papillary serous carcinoma
566649|NCT01150656|childhood acute myeloid leukemia/other myeloid malignancies|childhood acute myeloid leukemia/other myeloid malignancies
566650|NCT01150643|stage III grade 1 follicular lymphoma|stage iii grade 1 follicular lymphoma
566651|NCT01150643|stage III grade 2 follicular lymphoma|stage iii grade 2 follicular lymphoma
566652|NCT01150643|stage IV grade 1 follicular lymphoma|stage iv grade 1 follicular lymphoma
566653|NCT01150643|stage IV grade 2 follicular lymphoma|stage iv grade 2 follicular lymphoma
566654|NCT01150630|adenocarcinoma of the pancreas|adenocarcinoma of the pancreas
566655|NCT01150630|stage I pancreatic cancer|stage i pancreatic cancer
566656|NCT01150630|stage II pancreatic cancer|stage ii pancreatic cancer
566657|NCT01150617|Type 2 diabetes mellitus|type 2 diabetes mellitus
566658|NCT01150617|Normoglycemia|normoglycemia
566659|NCT01150617|Peripheral angioplasty|peripheral angioplasty
566660|NCT01150604|Cognitive Behavioral Therapy|cognitive behavioral therapy
566661|NCT01150604|Mood Management|mood management
566662|NCT01150604|Self-help|self-help
566663|NCT01150604|Internet|internet
566664|NCT01150578|Echocardiography, 2D|echocardiography, 2d
566665|NCT01150578|speckle tracking|speckle tracking
566666|NCT01150578|Lexiscan|lexiscan
566667|NCT01150578|regadenoson|regadenoson
566668|NCT01150578|Myocardial ischemia|myocardial ischemia
566669|NCT01150578|Myocardial perfusion imaging|myocardial perfusion imaging
566670|NCT01150578|cost and cost analysis|cost and cost analysis
566671|NCT01150578|Cardiac-Gated SPECT Imaging|cardiac-gated spect imaging
566672|NCT01150578|Echocardiography|echocardiography
566673|NCT01150552|Serology|serology
566674|NCT01150552|Poultry|poultry
566675|NCT01150552|H5N1 virus|h5n1 virus
566676|NCT01150552|HPAI virus|hpai virus
566677|NCT01150526|Acute Exercise|acute exercise
566678|NCT01150526|Muscle Inflammation|muscle inflammation
566679|NCT01150526|CaHMB|cahmb
566680|NCT01150526|HMB Free Acid Gel|hmb free acid gel
566681|NCT01150526|Healthy Subjects|healthy subjects
566682|NCT01150513|TRIPLE-NEGATIVE|triple-negative
566683|NCT01150513|BREAST CANCER|breast cancer
566684|NCT01150500|Medtronic|medtronic
566685|NCT01150500|Japan|japan
566686|NCT01150500|Arterial Occlusive Diseases|arterial occlusive diseases
566687|NCT01150500|Myocardial Ischemia|myocardial ischemia
566688|NCT01150500|Cardiovascular Diseases|cardiovascular diseases
566689|NCT01150500|Coronary Artery Disease|coronary artery disease
566690|NCT01150500|Small Vessel Stent|small vessel stent
566691|NCT01150487|kidney transplant|kidney transplant
566692|NCT01150474|Belladonna|belladonna
566693|NCT01150474|Morphine|morphine
566694|NCT01150474|Suppositories|suppositories
566695|NCT01150474|Vaginal|vaginal
566696|NCT01150474|Surgery|surgery
566697|NCT01150474|Postoperative|postoperative
566698|NCT01150474|Pain|pain
566699|NCT01150461|Hypertrophic nonobstructive cardiomyopathy|hypertrophic nonobstructive cardiomyopathy
566700|NCT01150448|Paliperidone palmitate|paliperidone palmitate
566701|NCT01150448|paliperidone ER (INVEGA)|paliperidone er (invega)
566702|NCT01150448|R092670PSY1008|r092670psy1008
566703|NCT01150448|Risperidone|risperidone
566704|NCT01150448|Risperdal (RISPERDAL CONSTA)|risperdal (risperdal consta)
566705|NCT01150448|Pharmacokinetics|pharmacokinetics
566706|NCT01150422|medical abortion|medical abortion
566707|NCT01150409|Sepsis|sepsis
566708|NCT01150409|hydrocortisone|hydrocortisone
566709|NCT01150396|extremely premature infant|extremely premature infant
566710|NCT01150396|outcome|outcome
566711|NCT01150396|follow-up|follow-up
566712|NCT01150383|Lung Diseases, Obstructive|lung diseases, obstructive
566713|NCT01150383|Respiratory Tract Diseases|respiratory tract diseases
566714|NCT01150383|Lung Diseases|lung diseases
566715|NCT01150383|Respiration Disorders|respiration disorders
566716|NCT01150383|Pulmonary Disease, Chronic Obstructive|pulmonary disease, chronic obstructive
566717|NCT01150383|COPD|copd
566718|NCT01150383|Chronic Obstructive Lung Disease|chronic obstructive lung disease
566719|NCT01150383|Chronic Obstructive Airway Disease|chronic obstructive airway disease
566720|NCT01150383|Chronic Airflow Obstruction|chronic airflow obstruction
566721|NCT01150383|oxygen|oxygen
566722|NCT01150383|oxygen supplementation|oxygen supplementation
566723|NCT01150370|male circumcision|male circumcision
566724|NCT01150370|HIV|hiv
566725|NCT01150370|Rwanda|rwanda
566726|NCT01150370|HIV Seronegativity|hiv seronegativity
566727|NCT01150357|Pediatric hypertension|pediatric hypertension
566728|NCT01150357|primary hypertension|primary hypertension
566729|NCT01150357|secondary hypertension|secondary hypertension
566730|NCT01150344|Multicentric study|multicentric study
566731|NCT01150344|Antimalarial|antimalarial
566732|NCT01150344|P. falciparum|p. falciparum
566733|NCT01150344|Efficacy|efficacy
566734|NCT01150344|Failures|failures
566735|NCT01150344|Malarone|malarone
566736|NCT01150344|RIAMET|riamet
566737|NCT01150331|status epilepticus|status epilepticus
566738|NCT01150331|generalised convulsive status epilepticus|generalised convulsive status epilepticus
566739|NCT01150331|first line treatments|first line treatments
566740|NCT01150331|double-blind randomized controlled trial|double-blind randomized controlled trial
566741|NCT01150331|prehospital treatment|prehospital treatment
566742|NCT01150318|Male|male
566743|NCT01150318|Infertility|infertility
566744|NCT01150318|Radioisotopes Therapy|radioisotopes therapy
566745|NCT01150318|Follicular thyroid cancer|follicular thyroid cancer
566746|NCT01150305|Autosomal dominant inheritance|autosomal dominant inheritance
566747|NCT01150305|Mutation|mutation
566748|NCT01150305|Prevalence|prevalence
566749|NCT01150292|DHA supplementation|dha supplementation
566750|NCT01150292|Type 2 diabetic patient|type 2 diabetic patient
566751|NCT01150292|Platelet function|platelet function
566752|NCT01150279|medical abortion|medical abortion
566753|NCT01150279|Medical Abortion Follow Up Care|medical abortion follow up care
566754|NCT01150266|stroke|stroke
566755|NCT01150266|ischemia|ischemia
566756|NCT01150266|thrombolysis|thrombolysis
566757|NCT01150266|thrombolytics|thrombolytics
566758|NCT01150266|tPA|tpa
566759|NCT01150266|rt-PA|rt-pa
566760|NCT01150266|t-PA|t-pa
566761|NCT01150266|Activase®|activase®
566762|NCT01150266|Alteplase|alteplase
566763|NCT01150266|wake-up stroke|wake-up stroke
566764|NCT01150266|waking onset stroke|waking onset stroke
566765|NCT01150266|sleep|sleep
566766|NCT01150240|Primary Immunodeficiency Disease|primary immunodeficiency disease
566767|NCT01150214|atrial fibrillation|atrial fibrillation
566768|NCT01150214|af|af
566769|NCT01150214|magnetic resonance imaging|magnetic resonance imaging
566770|NCT01150214|mri|mri
566771|NCT01150214|left atrium|left atrium
566772|NCT01150214|fibrosis|fibrosis
566773|NCT01150214|structural remodeling|structural remodeling
566774|NCT01150201|CKD|ckd
566775|NCT01150201|proteinuria|proteinuria
566776|NCT01150201|eGFR|egfr
566777|NCT01150201|Progression of chronic kidney disease|progression of chronic kidney disease
566778|NCT01150188|aging|aging
566779|NCT01150188|lipid metabolism|lipid metabolism
566780|NCT01150188|very low density lipoproteins|very low density lipoproteins
566781|NCT01150188|amino acids|amino acids
566782|NCT01150188|dietary supplements|dietary supplements
566783|NCT01150175|END-HF|end-hf
566784|NCT01150149|Influenza|influenza
566785|NCT01150149|Humans|humans
566786|NCT01150149|Experimental|experimental
566787|NCT01150149|Challenge|challenge
566788|NCT01150136|choline|choline
566789|NCT01150136|cystic fibrosis|cystic fibrosis
566790|NCT01150136|methyl metabolism|methyl metabolism
566791|NCT01150136|oxidative stress|oxidative stress
566792|NCT01150123|Group B streptococcus|group b streptococcus
566793|NCT01150123|GBS|gbs
566794|NCT01150123|Vaccine|vaccine
566795|NCT01150123|Group B streptococcus (GBS) disease|group b streptococcus (gbs) disease
566796|NCT01150110|Temporomandibular disorders|temporomandibular disorders
566797|NCT01150110|occlusal splints|occlusal splints
566798|NCT01150110|electromyography|electromyography
566799|NCT01150110|TMD (muscle and joint dysfunction)|tmd (muscle and joint dysfunction)
566800|NCT01150110|masseteres e anterior temporalis muscles.|masseteres e anterior temporalis muscles.
566801|NCT01150097|Liver transplantation|liver transplantation
566802|NCT01150097|Everolimus|everolimus
566803|NCT01150097|Calcineurin inhibitors|calcineurin inhibitors
566804|NCT01150097|Tacrolimus|tacrolimus
566805|NCT01150097|Renal function|renal function
566806|NCT01150097|Progression of HCV related allograft fibrosis|progression of hcv related allograft fibrosis
566807|NCT01150084|increasing physical activity in sedentary employees|increasing physical activity in sedentary employees
566808|NCT01150071|extremely premature infant|extremely premature infant
566809|NCT01150071|follow-up|follow-up
566810|NCT01150071|behavior|behavior
566811|NCT01150071|growth|growth
566812|NCT01150071|mental health|mental health
566813|NCT01150071|lung function|lung function
566814|NCT01150071|spirometry|spirometry
566815|NCT01150071|muscle mass|muscle mass
566816|NCT01150071|bone density|bone density
566817|NCT01150071|magnetic Resonance imaging|magnetic resonance imaging
566818|NCT01150058|adult acute myeloid leukemia with 11q23 (MLL) abnormalities|adult acute myeloid leukemia with 11q23 (mll) abnormalities
566819|NCT01150058|adult acute myeloid leukemia with del(5q)|adult acute myeloid leukemia with del(5q)
566946|NCT01149577|Schizophrenia|schizophrenia
566820|NCT01150058|adult acute myeloid leukemia with inv(16)(p13;q22)|adult acute myeloid leukemia with inv(16)(p13;q22)
566821|NCT01150058|adult acute myeloid leukemia with t(15;17)(q22;q12)|adult acute myeloid leukemia with t(15;17)(q22;q12)
566822|NCT01150058|adult acute myeloid leukemia with t(16;16)(p13;q22)|adult acute myeloid leukemia with t(16;16)(p13;q22)
566823|NCT01150058|adult acute myeloid leukemia with t(8;21)(q22;q22)|adult acute myeloid leukemia with t(8;21)(q22;q22)
566824|NCT01150058|childhood acute myeloid leukemia/other myeloid malignancies|childhood acute myeloid leukemia/other myeloid malignancies
566825|NCT01150058|adult acute myeloid leukemia|adult acute myeloid leukemia
566826|NCT01150045|adenocarcinoma of the colon|adenocarcinoma of the colon
566827|NCT01150045|stage III colon cancer|stage iii colon cancer
566828|NCT01150032|Osteoporosis|osteoporosis
566829|NCT01150032|Fracture|fracture
566830|NCT01150032|Bone microarchitecture|bone microarchitecture
566831|NCT01150019|atherosclerosis|atherosclerosis
566832|NCT01150019|vascular inflammation|vascular inflammation
566833|NCT01150019|resistin|resistin
566834|NCT01150019|adiponectin|adiponectin
566835|NCT01150019|18FDG-PET|18fdg-pet
566836|NCT01150006|atherosclerosis|atherosclerosis
566837|NCT01150006|vascular inflammation|vascular inflammation
566838|NCT01150006|adipocyte fatty acid binding protein|adipocyte fatty acid binding protein
566839|NCT01150006|adiponectin|adiponectin
566840|NCT01150006|leptin|leptin
566841|NCT01150006|18FDG-PET|18fdg-pet
566842|NCT01149993|living donation|living donation
566843|NCT01149993|kidney transplantation|kidney transplantation
566844|NCT01149993|delayed graft function|delayed graft function
566845|NCT01149993|ischemia reperfusion injury|ischemia reperfusion injury
566846|NCT01149980|Bioequivalence|bioequivalence
566847|NCT01149980|Crossover|crossover
566848|NCT01149980|Citalopram|citalopram
566849|NCT01149967|Bioequivalence|bioequivalence
566850|NCT01149967|Citalopram|citalopram
566851|NCT01149967|Crossover|crossover
566852|NCT01149954|Bioequivalence|bioequivalence
566853|NCT01149954|Crossover|crossover
566854|NCT01149954|Ibuprofen|ibuprofen
566855|NCT01149941|Bioequivalence|bioequivalence
566856|NCT01149941|Crossover|crossover
566857|NCT01149941|Ibuprofen|ibuprofen
566858|NCT01149928|Fetal lung fluid|fetal lung fluid
566859|NCT01149928|Pulmonary adaptation|pulmonary adaptation
566860|NCT01149928|Transient tachypnea of the newborn|transient tachypnea of the newborn
566861|NCT01149928|Epinephrine|epinephrine
566862|NCT01149928|Stress hormones|stress hormones
566863|NCT01149915|Advanced Leukemias|advanced leukemias
566864|NCT01149915|Relapsed/Refractory Leukemias|relapsed/refractory leukemias
566865|NCT01149915|AML|aml
566866|NCT01149915|ALL|all
566867|NCT01149915|CML|cml
566868|NCT01149915|MDS|mds
566869|NCT01149915|CLL|cll
566870|NCT01149915|MF|mf
566871|NCT01149915|Evofosfamide|evofosfamide
566872|NCT01149863|Autologous Transplantation|autologous transplantation
566873|NCT01149850|adult giant cell glioblastoma|adult giant cell glioblastoma
566874|NCT01149850|adult glioblastoma|adult glioblastoma
566875|NCT01149850|adult gliosarcoma|adult gliosarcoma
566876|NCT01149837|HTLV|htlv
566877|NCT01149837|HTLV I|htlv i
566878|NCT01149837|HTLV II|htlv ii
566879|NCT01149837|HTLV Type I and/or HTLV Type II antibody|htlv type i and/or htlv type ii antibody
566880|NCT01149824|Salvia divinorum|salvia divinorum
566881|NCT01149824|Salvinorin A|salvinorin a
566882|NCT01149811|Dyskinesia|dyskinesia
566883|NCT01149798|metastatic breast cancer|metastatic breast cancer
566884|NCT01149798|combined chemotherapy|combined chemotherapy
566885|NCT01149785|crizotinib|crizotinib
566886|NCT01149785|healthy volunteers|healthy volunteers
566887|NCT01149785|ketoconazole|ketoconazole
566888|NCT01149785|pharmacokinetics|pharmacokinetics
566889|NCT01149785|single dose|single dose
566890|NCT01149772|Chronic Obstructive Pulmonary Disease|chronic obstructive pulmonary disease
566891|NCT01149772|Heart Failure|heart failure
566892|NCT01149772|Anxiety|anxiety
566893|NCT01149772|Depression|depression
566894|NCT01149759|Atopic Dermatitis|atopic dermatitis
566895|NCT01149759|Eczema|eczema
566896|NCT01149720|Relative bioavailability|relative bioavailability
566897|NCT01149720|ARQ 197|arq 197
566898|NCT01149707|PUR 0110|pur 0110
566899|NCT01149707|PUR 0110 Rectal Enema|pur 0110 rectal enema
566900|NCT01149707|Distal Ulcerative Colitis|distal ulcerative colitis
566901|NCT01149707|Left-Sided Ulcerative Colitis|left-sided ulcerative colitis
566902|NCT01149707|Mild|mild
566903|NCT01149707|Moderate|moderate
566904|NCT01149694|PurGenesis Technologies Inc.|purgenesis technologies inc.
566905|NCT01149694|PUR 0110 rectal enema|pur 0110 rectal enema
566906|NCT01149694|Ulcerative colitis|ulcerative colitis
566907|NCT01149694|Distal|distal
566908|NCT01149694|Normal healthy volunteers|normal healthy volunteers
566909|NCT01149681|Aplidin|aplidin
566910|NCT01149681|Plitidepsin|plitidepsin
566911|NCT01149681|Myelofibrosis|myelofibrosis
566912|NCT01149681|Pharma Mar|pharma mar
566913|NCT01149668|PCI-24781|pci-24781
566914|NCT01149668|Lymphoma|lymphoma
566915|NCT01149668|Non-Hodgkin's|non-hodgkin's
566916|NCT01149668|Hodgkin Disease|hodgkin disease
566917|NCT01149668|Multiple Myeloma|multiple myeloma
566918|NCT01149668|Leukemia|leukemia
566919|NCT01149668|Lymphocytic|lymphocytic
566920|NCT01149668|Chronic|chronic
566921|NCT01149655|Adolescent|adolescent
566922|NCT01149655|Schizophrenia|schizophrenia
566924|NCT01149629|Randomized|randomized
566925|NCT01149629|Crossover|crossover
566926|NCT01149629|Open Label|open label
566927|NCT01149629|Bioequivalence|bioequivalence
566928|NCT01149629|Fed Fast|fed fast
566929|NCT01149629|TID|tid
566930|NCT01149603|failing Fontan|failing fontan
566931|NCT01149603|single-ventricle|single-ventricle
566932|NCT01149603|destination therapy|destination therapy
566933|NCT01149603|HeartMate II|heartmate ii
566934|NCT01149603|HMII|hmii
566935|NCT01149603|cardiac congenital anomaly|cardiac congenital anomaly
566936|NCT01149603|ventricular assist device|ventricular assist device
566937|NCT01149603|VAD|vad
566938|NCT01149590|Angina|angina
566939|NCT01149590|Coronary Heart Disease|coronary heart disease
566940|NCT01149590|Computed Tomography|computed tomography
566941|NCT01149590|Angiogram|angiogram
566942|NCT01149590|Coronary Artery Calcium Score|coronary artery calcium score
566943|NCT01149590|Chest Pain|chest pain
566944|NCT01149590|Angina Pectoris due to Coronary Heart Disease|angina pectoris due to coronary heart disease
566945|NCT01149577|Olanzapine|olanzapine
566947|NCT01149577|Polysomnography|polysomnography
566948|NCT01149577|Slow wave sleep|slow wave sleep
566949|NCT01149551|Schizophrenia|schizophrenia
566950|NCT01149551|Bipolar disorder|bipolar disorder
566951|NCT01149551|Genetic research|genetic research
566952|NCT01149538|FASD|fasd
566953|NCT01149538|FAS|fas
566954|NCT01149538|Alcohol|alcohol
566955|NCT01149538|Prenatal Alcohol|prenatal alcohol
566956|NCT01149525|Multiple Sclerosis/complications|multiple sclerosis/complications
566957|NCT01149525|Fatigue Syndrome|fatigue syndrome
566958|NCT01149525|Chronic/drug therapy|chronic/drug therapy
566959|NCT01149486|Bioequivalence|bioequivalence
566960|NCT01149486|Healthy Subjects|healthy subjects
566961|NCT01149473|Bioequivalence|bioequivalence
566962|NCT01149473|Healthy Subjects|healthy subjects
566963|NCT01149447|cryptogenic stroke|cryptogenic stroke
566964|NCT01149447|percutaneous closure of PFO|percutaneous closure of pfo
566965|NCT01149447|follow-up exams|follow-up exams
566966|NCT01149434|Low grade endocrine tumors|low grade endocrine tumors
566967|NCT01149434|ovarian cancers|ovarian cancers
566968|NCT01149434|K-RAS mutant colon cancers|k-ras mutant colon cancers
566969|NCT01149421|Type 2 Diabetes|type 2 diabetes
566970|NCT01149421|Diabetes|diabetes
566971|NCT01149421|Ambulatory Blood Pressure Monitoring|ambulatory blood pressure monitoring
566972|NCT01149421|ABPM|abpm
566973|NCT01149421|Blood Pressure|blood pressure
566974|NCT01149421|Heart Rate|heart rate
566975|NCT01149408|AML|aml
566976|NCT01149408|Decitabine|decitabine
566977|NCT01149408|Acute Myeloid Leukemia|acute myeloid leukemia
566978|NCT01149408|Elderly Patients|elderly patients
566979|NCT01149408|Cancer|cancer
566980|NCT01149395|Heartburn|heartburn
566981|NCT01149395|Gastroesophageal Reflux Disease|gastroesophageal reflux disease
566982|NCT01149382|flu shot|flu shot
566983|NCT01149382|islet cell transplant recipients|islet cell transplant recipients
566984|NCT01149369|gastroparesis|gastroparesis
566985|NCT01149369|nausea|nausea
566986|NCT01149369|vomiting|vomiting
566987|NCT01149343|PRAME|prame
566988|NCT01149343|Cancer immunotherapeutic|cancer immunotherapeutic
566989|NCT01149343|Malignant melanoma|malignant melanoma
566990|NCT01149343|ASCI (Antigen-Specific Cancer Immunotherapeutic)|asci (antigen-specific cancer immunotherapeutic)
566991|NCT01149330|Adapalene|adapalene
566992|NCT01149330|Benzoyl Peroxide|benzoyl peroxide
566993|NCT01149330|Acne Vulgaris|acne vulgaris
566994|NCT01149317|acupuncture|acupuncture
566995|NCT01149317|health services research|health services research
566996|NCT01149317|chronic pain|chronic pain
566997|NCT01149317|health disparities|health disparities
566998|NCT01149304|brachytherapy|brachytherapy
566999|NCT01149304|liver metastases|liver metastases
567000|NCT01149304|irradiation|irradiation
567001|NCT01149304|radiation induced liver disease|radiation induced liver disease
567002|NCT01149304|dosimetry|dosimetry
567003|NCT01149291|high sensitivity C-reactive protein (hsCRP)|high sensitivity c-reactive protein (hscrp)
567004|NCT01149291|cardiorenal|cardiorenal
567005|NCT01149291|end stage renal disease (ESRD)|end stage renal disease (esrd)
567006|NCT01149291|Secondary hyperparathyroidism (SHPT)|secondary hyperparathyroidism (shpt)
567007|NCT01149291|dialysis|dialysis
567008|NCT01149291|paricalcitol|paricalcitol
567009|NCT01149291|osteodystrophy|osteodystrophy
567010|NCT01149291|selective Vitamin D receptor activators (sVDRA)|selective vitamin d receptor activators (svdra)
567011|NCT01149291|chronic kidney disease|chronic kidney disease
567012|NCT01149252|Psoriasis|psoriasis
567013|NCT01149213|Major depressive disorder|major depressive disorder
567014|NCT01149213|follow-up|follow-up
567015|NCT01149213|relapse|relapse
567016|NCT01149213|remission|remission
567017|NCT01149213|transcranial direct current stimulation|transcranial direct current stimulation
567018|NCT01149200|Irritable Bowel Syndrome|irritable bowel syndrome
567019|NCT01149200|IBS-C|ibs-c
567020|NCT01149174|intravesical chemotherapy|intravesical chemotherapy
567021|NCT01149174|early single instillation|early single instillation
567022|NCT01149174|mitomycin-C|mitomycin-c
567204|NCT01148355|Craving|craving
567023|NCT01149174|electromotive drug administration|electromotive drug administration
567024|NCT01149161|neck dissection|neck dissection
567025|NCT01149161|sentinel lymph node|sentinel lymph node
567026|NCT01149161|Carcinoma|carcinoma
567027|NCT01149161|Papillary|papillary
567028|NCT01149161|thyroid|thyroid
567029|NCT01149161|dissection|dissection
567030|NCT01149148|Aortic Surgeries|aortic surgeries
567031|NCT01149148|Deep Hypothermic Circulatory Arrest|deep hypothermic circulatory arrest
567032|NCT01149135|Seasonal Affective Disorder|seasonal affective disorder
567033|NCT01149135|phototherapy|phototherapy
567034|NCT01149135|circadian rhythms|circadian rhythms
567035|NCT01149135|blue enriched light|blue enriched light
567036|NCT01149135|melanopsin|melanopsin
567037|NCT01149135|low intensity|low intensity
567038|NCT01149122|unresectable, metastatic biliary tract carcinoma|unresectable, metastatic biliary tract carcinoma
567039|NCT01149122|Gemcitabine/Oxaliplatin (GEMOX)|gemcitabine/oxaliplatin (gemox)
567040|NCT01149122|Erlotinib|erlotinib
567041|NCT01149109|MGMT promotor status|mgmt promotor status
567042|NCT01149109|overall survival|overall survival
567043|NCT01149070|Infertility|infertility
567044|NCT01149070|Controlled ovarian stimulation|controlled ovarian stimulation
567045|NCT01149070|Reproductive techniques, assisted|reproductive techniques, assisted
567046|NCT01149070|Sperm injections, intracytoplasmic|sperm injections, intracytoplasmic
567047|NCT01149070|Gonal-f|gonal-f
567048|NCT01149070|Ovitrelle|ovitrelle
567049|NCT01149044|Acute Coronary Syndrome|acute coronary syndrome
567050|NCT01149044|PCI|pci
567051|NCT01149044|Percutaneous Coronary Intervention|percutaneous coronary intervention
567052|NCT01149044|STEMI|stemi
567053|NCT01149044|Thrombectomy|thrombectomy
567054|NCT01149031|Provoked Vestibulodynia|provoked vestibulodynia
567055|NCT01149031|Low Level Laser Therapy|low level laser therapy
567056|NCT01149018|Fibromyalgia|fibromyalgia
567057|NCT01149018|Tetrahydrocannabinol|tetrahydrocannabinol
567058|NCT01149018|Chronic Widespread Pain|chronic widespread pain
567059|NCT01149005|Normal Glucose Tolerance Test|normal glucose tolerance test
567060|NCT01149005|Mixed Meal Tolerance Test|mixed meal tolerance test
567061|NCT01149005|Cystic Fibrosis|cystic fibrosis
567062|NCT01149005|Pulmonary Exacerbation|pulmonary exacerbation
567063|NCT01149005|Impaired Glucose Tolerance Test|impaired glucose tolerance test
567064|NCT01149005|Insulin Therapy|insulin therapy
567065|NCT01148979|Major Depressive Disorder|major depressive disorder
567066|NCT01148979|Cognitive Impairment|cognitive impairment
567067|NCT01148979|Partial Response|partial response
567068|NCT01148979|Residual Symptoms|residual symptoms
567069|NCT01148940|sickle cell trait|sickle cell trait
567070|NCT01148940|thrombosis|thrombosis
567071|NCT01148940|D-Dimer|d-dimer
567072|NCT01148914|Inflammatory biomarkers|inflammatory biomarkers
567073|NCT01148914|Atrial fibrillation|atrial fibrillation
567074|NCT01148914|Catheter ablation|catheter ablation
567075|NCT01148914|To assess if pre-ablation levels of inflammatory biomarkers serve as independent predictors of procedure outcome|to assess if pre-ablation levels of inflammatory biomarkers serve as independent predictors of procedure outcome
567076|NCT01148914|To evaluate the inflammatory activation following catheter ablation and examine its predictive role in procedure success|to evaluate the inflammatory activation following catheter ablation and examine its predictive role in procedure success
567077|NCT01148914|To determine if a change in the baseline level of biomarkers at 3-months follow-up has any correlation with long-term outcome|to determine if a change in the baseline level of biomarkers at 3-months follow-up has any correlation with long-term outcome
567078|NCT01148914|To study the association of certain biomarkers with specific types of AF (paroxysmal or persistent or long standing persistent)|to study the association of certain biomarkers with specific types of af (paroxysmal or persistent or long standing persistent)
567079|NCT01148901|Ankylosing spondylitis|ankylosing spondylitis
567080|NCT01148901|Hip arthritis|hip arthritis
567081|NCT01148901|Infliximab|infliximab
567082|NCT01148888|pediatrics|pediatrics
567083|NCT01148888|Anaesthesia|anaesthesia
567084|NCT01148888|Scoliosis|scoliosis
567085|NCT01148888|Magnesium|magnesium
567086|NCT01148875|breast cancer screening|breast cancer screening
567087|NCT01148875|mammography adherence|mammography adherence
567088|NCT01148875|non-adherent|non-adherent
567089|NCT01148862|ASPIRE (Automation to Simulate Pancreatic Insulin Response)|aspire (automation to simulate pancreatic insulin response)
567090|NCT01148862|X54|x54
567091|NCT01148862|Medtronic Diabetes|medtronic diabetes
567092|NCT01148862|Diabetes Mellitus|diabetes mellitus
567093|NCT01148862|Type 1|type 1
567094|NCT01148849|HER2 positive|her2 positive
567095|NCT01148849|breast cancer|breast cancer
567096|NCT01148849|gastric cancer|gastric cancer
567097|NCT01148836|Coenzyme Q-10|coenzyme q-10
567098|NCT01148836|Pulmonary Arterial Hypertension|pulmonary arterial hypertension
567099|NCT01148836|Pulmonary Arterial Hypertension Class I (Venice 2003)|pulmonary arterial hypertension class i (venice 2003)
567100|NCT01148823|breast|breast
567101|NCT01148823|plastic surgery|plastic surgery
567102|NCT01148823|bandages|bandages
567103|NCT01148823|surgical site infection|surgical site infection
567104|NCT01148823|skin colonization|skin colonization
567205|NCT01148355|Moods|moods
567206|NCT01148355|Adolescents|adolescents
567207|NCT01148355|Nicotine|nicotine
567208|NCT01148355|Reinforcement|reinforcement
567209|NCT01148342|Ecstacy|ecstacy
567105|NCT01148810|Inflammatory muscle disease, Muscle weakness, Myositis, inflammatory myopathy, inclusion body myositis, skin rash, autoimmune, difficulty swallowing, dysphagia|inflammatory muscle disease, muscle weakness, myositis, inflammatory myopathy, inclusion body myositis, skin rash, autoimmune, difficulty swallowing, dysphagia
567106|NCT01148797|FMF, Colchicine resistant|fmf, colchicine resistant
567107|NCT01148797|Colchicine intolerant|colchicine intolerant
567108|NCT01148797|Flare rate|flare rate
567109|NCT01148797|Canakinumab|canakinumab
567110|NCT01148784|anterior cruciate ligament tear|anterior cruciate ligament tear
567111|NCT01148784|ACL|acl
567112|NCT01148784|ligament|ligament
567113|NCT01148784|knee|knee
567114|NCT01148784|allograft|allograft
567115|NCT01148771|Pharmacokinetics|pharmacokinetics
567116|NCT01148771|Safety|safety
567117|NCT01148732|Endotracheal tube|endotracheal tube
567118|NCT01148732|ultrasonography|ultrasonography
567119|NCT01148719|Heart Failure|heart failure
567120|NCT01148719|Chronic Obstructive Pulmonary Disease|chronic obstructive pulmonary disease
567121|NCT01148719|Dyspnea|dyspnea
567122|NCT01148719|Elderly|elderly
567123|NCT01148719|Diagnosis|diagnosis
567124|NCT01148719|Primary health care|primary health care
567125|NCT01148706|thorax|thorax
567126|NCT01148706|abdomen|abdomen
567127|NCT01148693|Cholangitis; Cholangiopancreatography, Endoscopic Retrograde; stents; cholestasis|cholangitis; cholangiopancreatography, endoscopic retrograde; stents; cholestasis
567128|NCT01148680|Islet Cell Transplantation|islet cell transplantation
567129|NCT01148680|Metabolic Diseases|metabolic diseases
567130|NCT01148680|Endocrine System Diseases|endocrine system diseases
567131|NCT01148667|atopic dermatitis|atopic dermatitis
567132|NCT01148667|barrier function|barrier function
567133|NCT01148667|gut|gut
567134|NCT01148667|probiotics|probiotics
567135|NCT01148667|skin|skin
567136|NCT01148654|preterm birth|preterm birth
567137|NCT01148654|preterm labor|preterm labor
567138|NCT01148654|PTB|ptb
567139|NCT01148654|PTL|ptl
567140|NCT01148641|Lipid-based supplements|lipid-based supplements
567141|NCT01148641|LNS|lns
567142|NCT01148641|Acceptability|acceptability
567143|NCT01148641|Infant nutrition|infant nutrition
567144|NCT01148641|Guatemala|guatemala
567145|NCT01148641|Malnutrition|malnutrition
567146|NCT01148602|Acute stroke|acute stroke
567147|NCT01148602|Emergency departments|emergency departments
567148|NCT01148602|Quality Improvement|quality improvement
567149|NCT01148602|Improved Processes|improved processes
567150|NCT01148602|tPA|tpa
567151|NCT01148602|door-to-needle|door-to-needle
567152|NCT01148602|door-to-treatment|door-to-treatment
567153|NCT01148576|hepatic steatosis, chronic hepatitis B, entecavir|hepatic steatosis, chronic hepatitis b, entecavir
567154|NCT01148563|congestive heart failure|congestive heart failure
567155|NCT01148563|systolic|systolic
567156|NCT01148563|chronic disease|chronic disease
567157|NCT01148563|heart failure|heart failure
567158|NCT01148550|neonatal acute liver failure|neonatal acute liver failure
567159|NCT01148550|late-onset liver failure|late-onset liver failure
567160|NCT01148550|cholestasis,|cholestasis,
567161|NCT01148550|fatty liver,|fatty liver,
567162|NCT01148550|liver dysfunction,|liver dysfunction,
567163|NCT01148550|cirrhosis|cirrhosis
567164|NCT01148537|Healthy subjects|healthy subjects
567165|NCT01148537|Opioid|opioid
567166|NCT01148537|Transdermal|transdermal
567167|NCT01148524|Meningococcal disease|meningococcal disease
567168|NCT01148524|Vaccines|vaccines
567169|NCT01148524|Adolescents|adolescents
567170|NCT01148511|Macula degeneration|macula degeneration
567171|NCT01148511|Ranibizumab|ranibizumab
567172|NCT01148511|Choroidal neovascularisation|choroidal neovascularisation
567173|NCT01148511|Treat and extend|treat and extend
567174|NCT01148511|Treat and observe|treat and observe
567175|NCT01148485|- Staphylococcus aureus Carriage among Athletes|- staphylococcus aureus carriage among athletes
567176|NCT01148472|Depressive disorder, major|depressive disorder, major
567177|NCT01148472|Randomized controlled trials|randomized controlled trials
567178|NCT01148472|Antidepressive agents|antidepressive agents
567179|NCT01148459|Plasmodium falciparum|plasmodium falciparum
567180|NCT01148459|schedule|schedule
567181|NCT01148459|HIV|hiv
567182|NCT01148459|malaria vaccine|malaria vaccine
567183|NCT01148459|EPI|epi
567184|NCT01148459|Africa|africa
567185|NCT01148446|DLBCL|dlbcl
567186|NCT01148446|R-CHOP|r-chop
567187|NCT01148446|R-CEOP|r-ceop
567188|NCT01148446|Elderly patients|elderly patients
567189|NCT01148407|breast cancer|breast cancer
567190|NCT01148407|platelets|platelets
567191|NCT01148407|metastatic cancer|metastatic cancer
567192|NCT01148407|malignancy|malignancy
567193|NCT01148394|Colorectal surgery|colorectal surgery
567194|NCT01148394|multimodal rehabilitation|multimodal rehabilitation
567195|NCT01148394|fast track|fast track
567196|NCT01148394|early feeding|early feeding
567197|NCT01148381|Genotype|genotype
567198|NCT01148381|Phenotype|phenotype
567199|NCT01148381|Characterization|characterization
567200|NCT01148381|fMRI|fmri
567201|NCT01148368|fimasartan|fimasartan
567202|NCT01148368|renal impairment|renal impairment
567203|NCT01148368|hypertension|hypertension
567210|NCT01148342|fMRI|fmri
567211|NCT01148342|Alternative Matrices|alternative matrices
567212|NCT01148342|Cognitive Training|cognitive training
567213|NCT01148342|Brain Imaging|brain imaging
567214|NCT01148329|Coronary stenting|coronary stenting
567215|NCT01148329|Drug-eluting stent|drug-eluting stent
567216|NCT01148329|Post-market surveillance study|post-market surveillance study
567217|NCT01148329|Promus Element stent|promus element stent
720439|NCT00545012|Keppra|keppra
567218|NCT01148316|Developmental Psychiatry|developmental psychiatry
567219|NCT01148316|Sequential Randomized Clinical Trial|sequential randomized clinical trial
567220|NCT01148316|Obsessive-Compulsive Disorder D009771|obsessive-compulsive disorder d009771
567221|NCT01148303|Headache|headache
567222|NCT01148303|Fasting|fasting
567223|NCT01148303|Fasting Headache|fasting headache
567224|NCT01148303|Ramadan|ramadan
567225|NCT01148303|Ramadan Headache|ramadan headache
567226|NCT01148303|Yom Kippur|yom kippur
567227|NCT01148303|Yom Kippur Headache|yom kippur headache
567228|NCT01148290|bulking agent|bulking agent
567229|NCT01148290|emivulvectomy|emivulvectomy
567230|NCT01148290|radical vulvectomy|radical vulvectomy
567231|NCT01148290|TVT|tvt
567232|NCT01148290|urinary incontinence|urinary incontinence
567233|NCT01148290|vulvar cancer|vulvar cancer
567234|NCT01148277|Endoscopies|endoscopies
567235|NCT01148277|Liver diseases|liver diseases
567236|NCT01148277|Propofol|propofol
567237|NCT01148277|Midazolam and remifentanyl|midazolam and remifentanyl
567238|NCT01148264|break-through|break-through
567239|NCT01148264|emesis|emesis
567240|NCT01148264|break through emesis after prophylaxis with dexamethasone, 5-HT 3RA and aprepitant|break through emesis after prophylaxis with dexamethasone, 5-ht 3ra and aprepitant
567241|NCT01148238|Autoimmune diabetes|autoimmune diabetes
567242|NCT01148238|LADA|lada
567243|NCT01148238|T-reg|t-reg
567244|NCT01148238|cytokine|cytokine
567245|NCT01148225|Intermediate-Uveitis|intermediate-uveitis
567246|NCT01148225|Non-infectious Uveitis|non-infectious uveitis
567247|NCT01148225|Posterior-Uveitis|posterior-uveitis
567248|NCT01148225|Active Uveitis|active uveitis
567249|NCT01148225|Pan-uveitis|pan-uveitis
567250|NCT01148225|Uveitis|uveitis
567251|NCT01148199|biliary anastomotic stricture|biliary anastomotic stricture
567252|NCT01148199|orthotopic liver transplantation|orthotopic liver transplantation
567253|NCT01148199|ERCP|ercp
567254|NCT01148186|Polypharmacy|polypharmacy
567255|NCT01148186|Benzodiazepine use|benzodiazepine use
567256|NCT01148186|Oxybutynin use|oxybutynin use
567257|NCT01148186|cognition disorders/drug therapy|cognition disorders/drug therapy
567258|NCT01148186|incontinence|incontinence
567259|NCT01148173|CNS relapse|cns relapse
567260|NCT01148173|aggressive lymphoma|aggressive lymphoma
567261|NCT01148173|HD-ASCT|hd-asct
567262|NCT01148160|voriconazole|voriconazole
567263|NCT01148160|invasive pulmonary aspergillosis|invasive pulmonary aspergillosis
567264|NCT01148160|hematologic malignancy|hematologic malignancy
567265|NCT01148160|therapeutic drug monitoring|therapeutic drug monitoring
567266|NCT01148160|genetic polymorphism|genetic polymorphism
567267|NCT01148160|efficacy|efficacy
567268|NCT01148160|safety|safety
567269|NCT01148147|Adenosine|adenosine
567270|NCT01148147|randomized trial|randomized trial
567271|NCT01148147|periprocedural myocardial necrosis|periprocedural myocardial necrosis
567272|NCT01148147|elective coronary angioplasty|elective coronary angioplasty
567273|NCT01148108|NHL|nhl
567274|NCT01148108|Non-Hodgkins Lymphoma|non-hodgkins lymphoma
567275|NCT01148108|Lymphoma|lymphoma
567276|NCT01148108|Mantle Cell|mantle cell
567277|NCT01148108|Diffuse Large B Cell|diffuse large b cell
567278|NCT01148108|Multiple Myeloma|multiple myeloma
567279|NCT01148108|Telcyta|telcyta
567280|NCT01148108|canfosfamide|canfosfamide
567281|NCT01148108|TLK286|tlk286
567282|NCT01148108|Prodrug|prodrug
567283|NCT01148108|Enzyme activated drug|enzyme activated drug
567284|NCT01148108|Glutathione Transferase P1-1 activated drug|glutathione transferase p1-1 activated drug
567285|NCT01148108|GSTp1-1 activated drug|gstp1-1 activated drug
567286|NCT01148108|Glutathione Transferase activated drug|glutathione transferase activated drug
567287|NCT01148108|Glutathione|glutathione
567288|NCT01148108|Glutathione analong|glutathione analong
567289|NCT01148095|AZD2516|azd2516
567290|NCT01148095|Phase 1|phase 1
567291|NCT01148095|Healthy volunteer|healthy volunteer
567292|NCT01148095|pharmacokinetics|pharmacokinetics
567293|NCT01148095|safety|safety
567294|NCT01148095|tolerability|tolerability
567295|NCT01148095|Multiple ascending doses|multiple ascending doses
567296|NCT01148082|Carcinomas (including Squamous Cell and Adenocarcinoma)|carcinomas (including squamous cell and adenocarcinoma)
567297|NCT01148069|IMRT-IGRT|imrt-igrt
567298|NCT01148069|radiotherapy toxicity|radiotherapy toxicity
567299|NCT01148069|seminal vesicles|seminal vesicles
567300|NCT01148056|IMRT|imrt
567301|NCT01148056|radiation therapy|radiation therapy
567302|NCT01148017|Meningococcal|meningococcal
567303|NCT01148017|ACWY|acwy
567304|NCT01148017|Conjugate Vaccine|conjugate vaccine
567305|NCT01148017|Meningitis|meningitis
567306|NCT01148017|Children|children
567307|NCT01148017|Persistence|persistence
567805|NCT01146119|universal|universal
567308|NCT01148017|Booster dose|booster dose
567309|NCT01148004|HIV|hiv
567310|NCT01148004|Hypertriglyceridemia|hypertriglyceridemia
567311|NCT01148004|Protease Inhibitors|protease inhibitors
567312|NCT01148004|Healthy Volunteer|healthy volunteer
567313|NCT01148004|HV|hv
567314|NCT01147991|Epstein-Barr virus infection|epstein-barr virus infection
567315|NCT01147991|stage I nasopharyngeal cancer|stage i nasopharyngeal cancer
567316|NCT01147991|stage II nasopharyngeal cancer|stage ii nasopharyngeal cancer
567317|NCT01147991|stage I adult Hodgkin lymphoma|stage i adult hodgkin lymphoma
567318|NCT01147991|stage II adult Hodgkin lymphoma|stage ii adult hodgkin lymphoma
567319|NCT01147991|post-transplant lymphoproliferative disorder|post-transplant lymphoproliferative disorder
567320|NCT01147991|stage I gastric cancer|stage i gastric cancer
567321|NCT01147991|stage II gastric cancer|stage ii gastric cancer
567322|NCT01147991|adult nasal type extranodal NK/T-cell lymphoma|adult nasal type extranodal nk/t-cell lymphoma
567323|NCT01147991|angioimmunoblastic T-cell lymphoma|angioimmunoblastic t-cell lymphoma
567324|NCT01147991|stage I adult Burkitt lymphoma|stage i adult burkitt lymphoma
567325|NCT01147991|contiguous stage II adult Burkitt lymphoma|contiguous stage ii adult burkitt lymphoma
567326|NCT01147991|contiguous stage II adult immunoblastic large cell lymphoma|contiguous stage ii adult immunoblastic large cell lymphoma
567327|NCT01147991|stage I adult immunoblastic large cell lymphoma|stage i adult immunoblastic large cell lymphoma
567328|NCT01147978|ICU|icu
567329|NCT01147978|Anxiety|anxiety
567330|NCT01147978|Depression|depression
567331|NCT01147978|PTSD|ptsd
567332|NCT01147965|Colon Cancer|colon cancer
567333|NCT01147965|Lung Cancer|lung cancer
567334|NCT01147965|Breast Cancer|breast cancer
567335|NCT01147965|CEA|cea
567336|NCT01147952|angina|angina
567337|NCT01147952|gene expression|gene expression
567338|NCT01147952|depression|depression
567339|NCT01147952|anxiety|anxiety
567340|NCT01147939|Acute Myeloid Leukaemia|acute myeloid leukaemia
567341|NCT01147939|AML|aml
567342|NCT01147939|Haematology|haematology
567343|NCT01147939|Investigator's Choice|investigator's choice
567344|NCT01147939|Elacytarabine|elacytarabine
567345|NCT01147939|Refractory or relapsed AML|refractory or relapsed aml
567346|NCT01147939|Phase III|phase iii
567347|NCT01147939|Randomized|randomized
567348|NCT01147939|CLAVELA|clavela
567349|NCT01147939|CP4055-306|cp4055-306
567350|NCT01147939|Elacyt|elacyt
567351|NCT01147926|Constipation|constipation
567352|NCT01147926|Male|male
567353|NCT01147913|Major Depression|major depression
567354|NCT01147913|Depression|depression
567355|NCT01147913|Anxiety|anxiety
567356|NCT01147913|Dysthymia|dysthymia
567357|NCT01147900|Immune persistence|immune persistence
567358|NCT01147900|Boostrix|boostrix
567359|NCT01147900|dTpa booster study|dtpa booster study
567360|NCT01147887|26489112|26489112
567361|NCT01147887|Omeprazole|omeprazole
567362|NCT01147887|Tolbutamide|tolbutamide
567363|NCT01147874|non-therapeutic|non-therapeutic
567364|NCT01147874|interventional|interventional
567365|NCT01147861|T2DM|t2dm
567366|NCT01147861|Pharmacodynamics|pharmacodynamics
567367|NCT01147861|GSK256073|gsk256073
567368|NCT01147848|Salmeterol|salmeterol
567369|NCT01147848|fluticasone furoate|fluticasone furoate
567370|NCT01147848|Vilanterol|vilanterol
567371|NCT01147848|fluticasone propionate|fluticasone propionate
567372|NCT01147848|GW642444|gw642444
567373|NCT01147835|Herbal lollipops|herbal lollipops
567374|NCT01147835|Asthma|asthma
567375|NCT01147835|Dental Caries|dental caries
567376|NCT01147835|Streptococcus mutans levels|streptococcus mutans levels
567377|NCT01147835|DMFT/dmft scores|dmft/dmft scores
567378|NCT01147822|SUTENT|sutent
567379|NCT01147822|GW76034|gw76034
567380|NCT01147822|Sunitinib|sunitinib
567381|NCT01147822|Renal cell carcinoma|renal cell carcinoma
567382|NCT01147822|Pazopanib|pazopanib
567383|NCT01147809|Solid Tumor|solid tumor
567384|NCT01147809|Eltrombopag|eltrombopag
567385|NCT01147809|chemotherapy-induced thrombocytopenia|chemotherapy-induced thrombocytopenia
567386|NCT01147809|Thrombocytopenia|thrombocytopenia
567387|NCT01147796|Thrombus|thrombus
567388|NCT01147796|computed tomography|computed tomography
567389|NCT01147796|Transoesophageal echocardiography|transoesophageal echocardiography
567390|NCT01147770|progesterone|progesterone
567391|NCT01147770|antagonist|antagonist
567392|NCT01147770|rec FSH|rec fsh
567393|NCT01147770|IVF|ivf
567394|NCT01147770|pregnancy|pregnancy
567395|NCT01147757|pediatric patients (ASA physical status I or II) aged between|pediatric patients (asa physical status i or ii) aged between
567396|NCT01147744|Efficacy|efficacy
567397|NCT01147744|Asthma|asthma
567398|NCT01147744|Safety|safety
567399|NCT01147744|Fluticasone Propionate|fluticasone propionate
567400|NCT01147744|FLAP|flap
567401|NCT01147744|Beta-agonists|beta-agonists
567402|NCT01147744|GSK2190915|gsk2190915
567403|NCT01147744|Montelukast|montelukast
567404|NCT01147744|Placebo|placebo
567405|NCT01147744|FLAIR|flair
567406|NCT01147731|pharmacokinetics|pharmacokinetics
567407|NCT01147731|albiglutide|albiglutide
567408|NCT01147731|warfarin|warfarin
567409|NCT01147731|Healthy volunteers|healthy volunteers
567410|NCT01147718|pharmacokinetics|pharmacokinetics
567411|NCT01147718|albiglutide|albiglutide
567412|NCT01147718|Healthy volunteer|healthy volunteer
567413|NCT01147718|digoxin|digoxin
567414|NCT01147705|Peripheral arterial disease|peripheral arterial disease
567415|NCT01147705|Allopurinol|allopurinol
567416|NCT01147692|albiglutide|albiglutide
567417|NCT01147692|simvastatin|simvastatin
567418|NCT01147692|healthy volunteers|healthy volunteers
567419|NCT01147692|pharmacokinetics|pharmacokinetics
567420|NCT01147679|Frontotemporal dementia|frontotemporal dementia
567421|NCT01147679|Alzheimer's disease|alzheimer's disease
567422|NCT01147679|Young-Onset|young-onset
567423|NCT01147679|Frontotemporal degeneration|frontotemporal degeneration
567424|NCT01147679|control|control
567425|NCT01147679|social|social
567426|NCT01147679|behavior|behavior
567427|NCT01147679|observation|observation
567428|NCT01147679|emotion|emotion
567429|NCT01147679|morality|morality
567430|NCT01147679|dementia|dementia
567431|NCT01147679|brain|brain
567432|NCT01147679|relationships|relationships
567433|NCT01147679|caregiver|caregiver
567434|NCT01147679|MRI|mri
567435|NCT01147679|neurology|neurology
567436|NCT01147666|Kidney|kidney
567437|NCT01147666|End Stage Renal Disease|end stage renal disease
567438|NCT01147666|ESRD|esrd
567439|NCT01147666|Chronic Kidney Disease|chronic kidney disease
567440|NCT01147666|CKD|ckd
567441|NCT01147666|Renal|renal
567442|NCT01147666|Anemia|anemia
567443|NCT01147666|Oral anemia treatment|oral anemia treatment
567444|NCT01147666|Hemoglobin levels|hemoglobin levels
567445|NCT01147666|Blood count|blood count
567446|NCT01147666|Erythropoietin|erythropoietin
567447|NCT01147666|Hemodialysis|hemodialysis
567448|NCT01147666|Normoresponder|normoresponder
567449|NCT01147666|Hyporesponder|hyporesponder
567450|NCT01147653|Cerebral Palsy|cerebral palsy
567451|NCT01147653|CP|cp
567452|NCT01147653|Spastic Cerebral Palsy|spastic cerebral palsy
567453|NCT01147653|Cord Blood|cord blood
567454|NCT01147653|Umbilical Cord Blood|umbilical cord blood
567455|NCT01147653|Autologous Cord Blood|autologous cord blood
567456|NCT01147627|diabetes mellitus, type 2|diabetes mellitus, type 2
567457|NCT01147627|newly diagnosed|newly diagnosed
567458|NCT01147627|exenatide|exenatide
567459|NCT01147627|premixed insulin analog|premixed insulin analog
567460|NCT01147627|thiazolidinedione|thiazolidinedione
567461|NCT01147627|β-cell function|β-cell function
567462|NCT01147627|glycemic control|glycemic control
567463|NCT01147614|Child|child
567464|NCT01147614|adolescent|adolescent
567465|NCT01147614|anxiety|anxiety
567466|NCT01147614|depression|depression
567467|NCT01147614|internalizing|internalizing
567468|NCT01147614|cognitive behavioral therapy|cognitive behavioral therapy
567469|NCT01147614|pediatric primary care|pediatric primary care
567470|NCT01147601|topical 0.5% Timolol|topical 0.5% timolol
567471|NCT01147601|infantile hemangioma (IH)|infantile hemangioma (ih)
567472|NCT01147588|open label|open label
567473|NCT01147588|randomized|randomized
567474|NCT01147588|4-treatment|4-treatment
567475|NCT01147588|3-period|3-period
567476|NCT01147588|crossover|crossover
567477|NCT01147588|interaction study|interaction study
567478|NCT01147588|Safety|safety
567479|NCT01147588|tolerability|tolerability
567480|NCT01147588|pharmacokinetics|pharmacokinetics
567481|NCT01147588|pharmacodynamics|pharmacodynamics
567482|NCT01147575|Rett Syndrome, Randomized, Methylation|rett syndrome, randomized, methylation
567483|NCT01147562|Lung cancer|lung cancer
567484|NCT01147562|Biopsy|biopsy
567485|NCT01147562|Biomarker|biomarker
567486|NCT01147562|Tissue Collection|tissue collection
567487|NCT01147549|ADME|adme
567488|NCT01147523|nonalcoholic fatty liver disease|nonalcoholic fatty liver disease
567489|NCT01147523|nonalcoholic steatohepatitis|nonalcoholic steatohepatitis
567490|NCT01147523|adipokines|adipokines
567491|NCT01147523|spironolactone|spironolactone
567492|NCT01147523|vitamin E|vitamin e
567493|NCT01147523|adiponectin|adiponectin
567494|NCT01147523|visfatin|visfatin
567495|NCT01147523|leptin|leptin
567496|NCT01147523|resistin|resistin
567497|NCT01147523|TNF-alpha|tnf-alpha
567498|NCT01147523|IL-6|il-6
567499|NCT01147523|IL-1|il-1
567500|NCT01147510|asthma control in elderly patients|asthma control in elderly patients
567501|NCT01147510|age 60-75|age 60-75
567502|NCT01147497|IUD insertion|iud insertion
567503|NCT01147497|nulliparous women|nulliparous women
567504|NCT01147497|contraception|contraception
567505|NCT01147497|family planning|family planning
567506|NCT01147497|IUD insertion in nulliparous women|iud insertion in nulliparous women
567507|NCT01147484|Breast Cancer|breast cancer
567508|NCT01147471|flail chest|flail chest
567509|NCT01147471|rib fixation|rib fixation
567510|NCT01147458|Cross-over|cross-over
567511|NCT01147458|safety|safety
567512|NCT01147458|efficacy|efficacy
567513|NCT01147458|tolerability|tolerability
567514|NCT01147458|osteoarthritis|osteoarthritis
567515|NCT01147458|knee|knee
567516|NCT01147458|pain|pain
567806|NCT01146119|vaccine|vaccine
567517|NCT01147445|Enterotoxigenic Escherichia coli, vaccine|enterotoxigenic escherichia coli, vaccine
567518|NCT01147432|Healthy male volunteers|healthy male volunteers
567519|NCT01147432|capsaicin challenge|capsaicin challenge
567520|NCT01147432|safety|safety
567521|NCT01147432|toleration|toleration
567522|NCT01147419|critical limb ischemia|critical limb ischemia
567523|NCT01147419|peripheral artery occlusive disease|peripheral artery occlusive disease
567524|NCT01147419|femoropopliteal artery bypass|femoropopliteal artery bypass
567525|NCT01147419|Stent|stent
567526|NCT01147367|exercise|exercise
567527|NCT01147367|breast cancer|breast cancer
567528|NCT01147367|physical activity|physical activity
567529|NCT01147367|fatigue|fatigue
567530|NCT01147367|sleep dysfunction|sleep dysfunction
567531|NCT01147367|cytokines|cytokines
567532|NCT01147367|muscle strength|muscle strength
567533|NCT01147367|inflammation|inflammation
567534|NCT01147354|Hemodialysis|hemodialysis
567535|NCT01147354|oxidative stress|oxidative stress
567536|NCT01147354|selenium|selenium
567537|NCT01147354|inflammation|inflammation
567538|NCT01147341|rheumatoid arthritis|rheumatoid arthritis
567539|NCT01147341|anti-TNF therapy|anti-tnf therapy
567540|NCT01147328|Health information technology|health information technology
567541|NCT01147328|Health information exchange|health information exchange
567542|NCT01147328|Virtual health record|virtual health record
567543|NCT01147328|Health care utilization|health care utilization
567544|NCT01147315|mandibular osteoradionecrosis|mandibular osteoradionecrosis
567545|NCT01147315|hybrid bone substitution|hybrid bone substitution
567546|NCT01147315|calcium-phosphate ceramic biomaterial|calcium-phosphate ceramic biomaterial
567547|NCT01147315|autologous bone marrow|autologous bone marrow
567548|NCT01147289|lumbar sciatic pain|lumbar sciatic pain
567549|NCT01147289|moderate to severe lumbar sciatic pain within the last three days|moderate to severe lumbar sciatic pain within the last three days
567550|NCT01147276|DPP-4|dpp-4
567551|NCT01147276|GLP-1|glp-1
567552|NCT01147276|Glucagon|glucagon
567553|NCT01147276|Catecholamines|catecholamines
567554|NCT01147276|Counterregulation|counterregulation
567555|NCT01147276|Type 1 diabetes|type 1 diabetes
567556|NCT01147263|Fibromyalgia|fibromyalgia
567557|NCT01147263|Autonomic dysfunction|autonomic dysfunction
567558|NCT01147263|Tachycardia|tachycardia
567559|NCT01147263|Palpitations|palpitations
567560|NCT01147224|Asthma|asthma
567561|NCT01147224|Allergy|allergy
567562|NCT01147224|Ciclesonide|ciclesonide
567563|NCT01147224|Alvesco|alvesco
567564|NCT01147224|Inhaled steroids|inhaled steroids
567565|NCT01147211|dose defining|dose defining
567566|NCT01147211|MK-2206|mk-2206
567567|NCT01147211|NSCLC With EGFR Mutation|nsclc with egfr mutation
567568|NCT01147211|NSCLC|nsclc
567569|NCT01147198|Moderate|moderate
567570|NCT01147198|Wasting|wasting
567571|NCT01147198|Malnutrition|malnutrition
567572|NCT01147198|Ready to Use Food|ready to use food
567573|NCT01147198|Fortified Blended Flour|fortified blended flour
567574|NCT01147185|Spinal Cord Injuries, Locomotor training, Dose-Response|spinal cord injuries, locomotor training, dose-response
567575|NCT01147172|Nasolabial Folds|nasolabial folds
567576|NCT01147172|Cosmetic|cosmetic
567577|NCT01147172|Injectable Dermal Filler|injectable dermal filler
567578|NCT01147172|Hyaluronic Acid with Lidocaine|hyaluronic acid with lidocaine
567579|NCT01147146|transurethral surgery|transurethral surgery
567580|NCT01147133|Platelet aggregation|platelet aggregation
567581|NCT01147133|Generic|generic
567582|NCT01147133|Clopidogrel|clopidogrel
567583|NCT01147133|Comparison|comparison
567584|NCT01147133|VASP-PRI|vasp-pri
567585|NCT01147107|HIV/HCV co-infection|hiv/hcv co-infection
567586|NCT01147107|Antiretroviral therapy|antiretroviral therapy
567587|NCT01147081|Influenza vaccine|influenza vaccine
567588|NCT01147081|Vaccine|vaccine
567589|NCT01147068|Influenza|influenza
567590|NCT01147055|crizotinib|crizotinib
567591|NCT01147055|healthy volunteers|healthy volunteers
567592|NCT01147055|rifampin|rifampin
567593|NCT01147055|pharmacokinetics|pharmacokinetics
567594|NCT01147055|single dose|single dose
567595|NCT01147042|NADPH Oxidase-Nicotinamide Adenine Dinucleotide Phosphate|nadph oxidase-nicotinamide adenine dinucleotide phosphate
567596|NCT01147042|Chronic Granulomatous Disease|chronic granulomatous disease
567597|NCT01147042|Gene Mutation|gene mutation
567598|NCT01147042|Superoxide by Phagocytes|superoxide by phagocytes
567599|NCT01147042|Interferon-Gamma|interferon-gamma
567600|NCT01147029|unspecified adult solid tumor, protocol specific|unspecified adult solid tumor, protocol specific
567601|NCT01147016|estrogen receptor-negative breast cancer|estrogen receptor-negative breast cancer
567602|NCT01147016|HER2-negative breast cancer|her2-negative breast cancer
567603|NCT01147016|male breast cancer|male breast cancer
567604|NCT01147016|progesterone receptor-negative breast cancer|progesterone receptor-negative breast cancer
567605|NCT01147016|recurrent breast cancer|recurrent breast cancer
567606|NCT01147016|stage IIA breast cancer|stage iia breast cancer
567607|NCT01147016|stage IIB breast cancer|stage iib breast cancer
567608|NCT01147016|stage IIIA breast cancer|stage iiia breast cancer
567609|NCT01147016|stage IIIB breast cancer|stage iiib breast cancer
567610|NCT01147016|triple-negative breast cancer|triple-negative breast cancer
567611|NCT01147003|Seizure frequency|seizure frequency
567612|NCT01147003|nervous system diseases|nervous system diseases
567613|NCT01147003|brain diseases|brain diseases
567614|NCT01147003|neurologic manifestations|neurologic manifestations
567615|NCT01147003|adjunctive treatment|adjunctive treatment
567616|NCT01147003|AEDs|aeds
567617|NCT01147003|antiepileptic drug|antiepileptic drug
567618|NCT01146990|17P Efficacy Trial Follow up|17p efficacy trial follow up
567619|NCT01146977|CBF(+)|cbf(+)
567620|NCT01146964|Age related cataract|age related cataract
567621|NCT01146964|Phacoemulsification|phacoemulsification
567622|NCT01146964|Manual super small incision cataract surgery|manual super small incision cataract surgery
567623|NCT01146951|Epilepsy|epilepsy
567624|NCT01146951|Seizures|seizures
567625|NCT01146938|fimasartan|fimasartan
567626|NCT01146938|hepatic impairment|hepatic impairment
567627|NCT01146925|Acute Kidney Injury|acute kidney injury
567628|NCT01146925|Contrast-Induced Nephropathy|contrast-induced nephropathy
567629|NCT01146925|Labile Iron|labile iron
567630|NCT01146925|Iron Chelation|iron chelation
567631|NCT01146925|Deferiprone|deferiprone
567632|NCT01146912|Influenza, text message, vaccination|influenza, text message, vaccination
567633|NCT01146899|influenza, vaccine, clinical decision support|influenza, vaccine, clinical decision support
567634|NCT01146860|BNO 1016, acute rhinosinusitis|bno 1016, acute rhinosinusitis
567635|NCT01146847|algorithm|algorithm
567636|NCT01146847|tight glycemic control|tight glycemic control
567637|NCT01146847|glucose control|glucose control
567638|NCT01146847|intensive care|intensive care
567639|NCT01146847|insulin|insulin
567640|NCT01146847|ICU|icu
567641|NCT01146808|Vaccination|vaccination
567642|NCT01146808|Immunocompromised Host|immunocompromised host
567643|NCT01146808|Antiviral Agents|antiviral agents
567644|NCT01146808|Drug Resistance, Viral|drug resistance, viral
567645|NCT01146808|Resource Allocation|resource allocation
567646|NCT01146769|Cancer of rectum|cancer of rectum
567647|NCT01146769|Physiotherapy|physiotherapy
567648|NCT01146756|MEK inhibitor|mek inhibitor
567649|NCT01146756|thoracic radiotherapy|thoracic radiotherapy
567650|NCT01146756|lung cancer|lung cancer
567651|NCT01146743|EUS-guided transmural cholecystostomy|eus-guided transmural cholecystostomy
567652|NCT01146730|Anxiety|anxiety
567653|NCT01146730|Depression|depression
567654|NCT01146730|Vocational Rehabilitation|vocational rehabilitation
567655|NCT01146730|Common Mental Disorders|common mental disorders
567656|NCT01146730|Mental Health Problems|mental health problems
567657|NCT01146730|Work Related Therapy|work related therapy
567658|NCT01146717|Mild Cognitive Impairment|mild cognitive impairment
567659|NCT01146717|Exercise|exercise
567660|NCT01146704|Obesity|obesity
567661|NCT01146691|Organizational models|organizational models
567662|NCT01146691|Intensive care units|intensive care units
567663|NCT01146691|Physicians|physicians
567664|NCT01146691|Staffing and scheduling|staffing and scheduling
567665|NCT01146691|Burnout, professional|burnout, professional
567666|NCT01146691|Job satisfaction|job satisfaction
567667|NCT01146691|Education, medical|education, medical
567668|NCT01146691|Patient satisfaction|patient satisfaction
567669|NCT01146665|alcohol consumption|alcohol consumption
567670|NCT01146665|personalized assessment feedback|personalized assessment feedback
567671|NCT01146665|youth|youth
567672|NCT01146665|emergency department|emergency department
567673|NCT01146639|EVAR DynaCT|evar dynact
567674|NCT01146626|Vitamin D|vitamin d
567675|NCT01146626|Hepatitis C|hepatitis c
567676|NCT01146626|Genotype2,3|genotype2,3
567677|NCT01146626|SVR|svr
567678|NCT01146626|Naive|naive
567679|NCT01146626|RVR rate|rvr rate
567680|NCT01146626|EVR rate|evr rate
567681|NCT01146626|SVR rate|svr rate
567682|NCT01146613|Alcohol|alcohol
567683|NCT01146613|Alcohol abuse|alcohol abuse
567684|NCT01146613|Alcoholism|alcoholism
567685|NCT01146613|Alcohol Dependence|alcohol dependence
567686|NCT01146613|Varenicline|varenicline
567687|NCT01146613|Drinking|drinking
567688|NCT01146600|Primary hypersomnia|primary hypersomnia
567689|NCT01146600|CNS hypersomnia|cns hypersomnia
567690|NCT01146600|hypersomnia|hypersomnia
567691|NCT01146600|idiopathic hypersomnia|idiopathic hypersomnia
567692|NCT01146600|clarithromycin|clarithromycin
567693|NCT01146600|Narcolepsy without Cataplexy|narcolepsy without cataplexy
567694|NCT01146587|Stroke|stroke
567695|NCT01146587|Robotics|robotics
567696|NCT01146587|Gait|gait
567697|NCT01146587|Rehabilitation|rehabilitation
567698|NCT01146574|End-Stage Renal Disease|end-stage renal disease
567699|NCT01146574|Anemia|anemia
567700|NCT01146574|Hemodialysis|hemodialysis
567701|NCT01146574|Renal Anemia|renal anemia
567702|NCT01146574|ESRD|esrd
567703|NCT01146548|Fluoxetine effect|fluoxetine effect
567704|NCT01146548|Multiple System Atrophy|multiple system atrophy
567705|NCT01146548|MSA|msa
567706|NCT01146535|interferon-alpha|interferon-alpha
567707|NCT01146535|oseltamivir|oseltamivir
567708|NCT01146535|drug therapy, combination|drug therapy, combination
567709|NCT01146535|influenza|influenza
567710|NCT01146535|therapies, investigational|therapies, investigational
567905|NCT01145612|Losartan|losartan
567711|NCT01146522|Familial hyperchylomicronemia|familial hyperchylomicronemia
567712|NCT01146522|Lipoprotein lipase deficiency|lipoprotein lipase deficiency
567713|NCT01146522|Hyperlipoproteinemia|hyperlipoproteinemia
720950|NCT00543777|MRE|mre
567714|NCT01146522|Triglycerides|triglycerides
567715|NCT01146522|Hypertriglyceridemia|hypertriglyceridemia
567716|NCT01146522|LCQ908|lcq908
567717|NCT01146522|Hyperlipoproteinemia associated with lipoprotein lipase deficiency|hyperlipoproteinemia associated with lipoprotein lipase deficiency
567718|NCT01146509|migraine|migraine
567719|NCT01146509|headache|headache
567720|NCT01146496|Pesticide poisoning|pesticide poisoning
567721|NCT01146496|Suicide|suicide
567722|NCT01146496|Unintentional poisoning|unintentional poisoning
567723|NCT01146496|Prevention|prevention
567724|NCT01146496|Cluster randomised controlled trial|cluster randomised controlled trial
567725|NCT01146457|Obstetric anesthesia|obstetric anesthesia
567726|NCT01146457|labor analgesia|labor analgesia
567727|NCT01146457|morphine|morphine
567728|NCT01146457|epidural analgesia|epidural analgesia
567729|NCT01146444|Sunscreening Agents|sunscreening agents
567730|NCT01146418|Reproductive Techniques, Assisted|reproductive techniques, assisted
567731|NCT01146418|Follicle Stimulating Hormone, Human|follicle stimulating hormone, human
567732|NCT01146418|Fertilization In Vitro|fertilization in vitro
567733|NCT01146405|Laparoscopic|laparoscopic
567734|NCT01146392|Epidemiological|epidemiological
567735|NCT01146392|COPD health care|copd health care
567736|NCT01146392|treatment in primary care|treatment in primary care
567737|NCT01146379|stroke|stroke
567738|NCT01146379|upper extremity|upper extremity
567739|NCT01146379|paresis|paresis
567740|NCT01146379|function|function
567741|NCT01146379|translational research|translational research
567742|NCT01146366|Early stage lung cancer|early stage lung cancer
567743|NCT01146366|Cervical mediastinoscopy|cervical mediastinoscopy
567744|NCT01146366|Observational study|observational study
567745|NCT01146366|clinical stage T2N0M0 and select T1N0M0 (suvMAX on FDG-PET of >/=10)|clinical stage t2n0m0 and select t1n0m0 (suvmax on fdg-pet of >/=10)
567746|NCT01146353|peramivir|peramivir
567747|NCT01146353|CVVH|cvvh
567748|NCT01146353|CRRT|crrt
567749|NCT01146353|CVVHD|cvvhd
567750|NCT01146353|influenza|influenza
567751|NCT01146353|sieving coefficient|sieving coefficient
567752|NCT01146353|clearance|clearance
567753|NCT01146340|Prostatic Neoplasms|prostatic neoplasms
567754|NCT01146340|Radiotherapy|radiotherapy
567755|NCT01146340|Hypofractionation|hypofractionation
567756|NCT01146340|Low and Intermediate Risk Prostate Cancer|low and intermediate risk prostate cancer
567757|NCT01146327|Multiple Dose Study in Overweight Healthy Subjects|multiple dose study in overweight healthy subjects
567758|NCT01146327|body weight|body weight
567759|NCT01146314|family-focused intervention|family-focused intervention
567760|NCT01146314|pediatric obesity|pediatric obesity
567761|NCT01146314|diabetes prevention|diabetes prevention
567762|NCT01146301|Platelet Aggregation Inhibitors|platelet aggregation inhibitors
567763|NCT01146301|Coronary Artery Bypass Grafting|coronary artery bypass grafting
567764|NCT01146288|obesity|obesity
567765|NCT01146288|acetazolamide|acetazolamide
567766|NCT01146288|furosemide|furosemide
567767|NCT01146275|Patients who participated in pilot study (31GB0601) and performed breast augmentation with previous formulation of Macrolane|patients who participated in pilot study (31gb0601) and performed breast augmentation with previous formulation of macrolane
567768|NCT01146262|Antitumoral immune response after autologous dendritic cells vaccination|antitumoral immune response after autologous dendritic cells vaccination
567769|NCT01146249|Multisensorial integration|multisensorial integration
567770|NCT01146249|Postural control|postural control
567771|NCT01146249|Visual reliance|visual reliance
567772|NCT01146236|Surgical|surgical
567773|NCT01146236|Infection|infection
567774|NCT01146236|Post-operative|post-operative
567775|NCT01146236|Sutures|sutures
567776|NCT01146236|Staples|staples
567777|NCT01146197|Hypokalemia|hypokalemia
567778|NCT01146197|Hypomagnesemia|hypomagnesemia
567779|NCT01146197|Salt loosing nephropathy|salt loosing nephropathy
567780|NCT01146184|Cholelithiasis|cholelithiasis
567781|NCT01146184|Single Incision|single incision
567782|NCT01146184|Flexible Endoscope|flexible endoscope
567783|NCT01146184|Ethicon Manually Articulating Device|ethicon manually articulating device
567784|NCT01146184|Pain|pain
567785|NCT01146158|Axillary dissection|axillary dissection
567786|NCT01146145|postoperative|postoperative
567787|NCT01146145|pain|pain
567788|NCT01146145|analgesia|analgesia
567789|NCT01146145|morphine|morphine
567790|NCT01146145|titration|titration
567791|NCT01146145|ketamine|ketamine
567792|NCT01146132|Nutrition|nutrition
567793|NCT01146132|Physical activity|physical activity
567794|NCT01146132|Cerebrovascular disease|cerebrovascular disease
567795|NCT01146132|wine consumption|wine consumption
567797|NCT01146132|Pulse transit time|pulse transit time
567798|NCT01146132|transcranial Doppler sonography|transcranial doppler sonography
567799|NCT01146119|HAI|hai
567800|NCT01146119|Influenza|influenza
567801|NCT01146119|prime|prime
567802|NCT01146119|boost|boost
567803|NCT01146119|immune response|immune response
567804|NCT01146119|seroconversion|seroconversion
567807|NCT01146080|drug eluting stent|drug eluting stent
567808|NCT01146080|everolimus eluting stent|everolimus eluting stent
567809|NCT01146080|optical coherence tomography|optical coherence tomography
567810|NCT01146080|intravascular ultrasound|intravascular ultrasound
567811|NCT01146067|Bioequivalence|bioequivalence
567812|NCT01146041|Bioequivalence|bioequivalence
567813|NCT01146015|Influenza|influenza
567814|NCT01146015|Vaccine|vaccine
567815|NCT01146015|CHMP criteria|chmp criteria
567816|NCT01146002|Attention-deficit/hyperactivity disorder, primarily inattentive or combined type.|attention-deficit/hyperactivity disorder, primarily inattentive or combined type.
567817|NCT01145989|Relapsed or Refractory Multiple Myeloma|relapsed or refractory multiple myeloma
567818|NCT01145976|aplastic anemia, fludarabine, cyclophosphamide, thymoglobulin|aplastic anemia, fludarabine, cyclophosphamide, thymoglobulin
567819|NCT01145963|pasta|pasta
567820|NCT01145963|appetite|appetite
567821|NCT01145963|hunger|hunger
567822|NCT01145963|satiation|satiation
567823|NCT01145963|nutrition|nutrition
567824|NCT01145963|Psychological Phenomena and Processes|psychological phenomena and processes
567825|NCT01145950|Etanercept|etanercept
567826|NCT01145950|Enbrel|enbrel
567827|NCT01145950|healthy volunteers|healthy volunteers
567828|NCT01145937|Keratoconus|keratoconus
567829|NCT01145937|Corneal grafting|corneal grafting
567830|NCT01145937|Corneal transplantation|corneal transplantation
567831|NCT01145937|Anterior Lamellar Keratoplasty|anterior lamellar keratoplasty
567832|NCT01145924|bronchoscopy|bronchoscopy
567833|NCT01145924|endobronchial ultrasound|endobronchial ultrasound
567834|NCT01145924|transbronchial needle aspiration|transbronchial needle aspiration
567835|NCT01145924|lung cancer|lung cancer
567836|NCT01145924|staging|staging
567837|NCT01145911|Glaucoma|glaucoma
567838|NCT01145911|Blood Flow|blood flow
567839|NCT01145911|Progression|progression
567840|NCT01145898|Glaucoma|glaucoma
567841|NCT01145898|Cosopt|cosopt
567842|NCT01145898|blood flow|blood flow
567843|NCT01145898|progression|progression
567844|NCT01145872|Mindfulness|mindfulness
567845|NCT01145872|clinical trial|clinical trial
567846|NCT01145872|intervention|intervention
567847|NCT01145872|prevention|prevention
567848|NCT01145859|Venous Thrombosis|venous thrombosis
567849|NCT01145859|Pediatrics|pediatrics
567850|NCT01145833|obesity|obesity
567851|NCT01145833|guided self help treatment|guided self help treatment
567852|NCT01145833|treatment method|treatment method
567853|NCT01145833|overweight|overweight
567854|NCT01145833|overweight children and parents|overweight children and parents
567855|NCT01145833|families with overweight child|families with overweight child
567856|NCT01145833|efficacy|efficacy
567857|NCT01145833|body mass index|body mass index
567858|NCT01145833|weight|weight
567859|NCT01145820|third molar|third molar
567860|NCT01145820|trauma|trauma
567861|NCT01145820|pain|pain
567862|NCT01145820|wound healing|wound healing
567863|NCT01145820|post operative morbidity|post operative morbidity
567864|NCT01145820|acute trauma|acute trauma
567865|NCT01145820|short-term wound healing|short-term wound healing
567866|NCT01145807|Distal Subungual Toenail Onychomycosis|distal subungual toenail onychomycosis
567867|NCT01145794|SHS|shs
567868|NCT01145781|ectocervical CIN lesions|ectocervical cin lesions
567869|NCT01145768|Double-blind|double-blind
567870|NCT01145768|randomized|randomized
567871|NCT01145768|placebo-controlled|placebo-controlled
567872|NCT01145768|parallel-group study|parallel-group study
567873|NCT01145768|Safety|safety
567874|NCT01145768|pharmacokinetics|pharmacokinetics
567875|NCT01145755|Depression|depression
567876|NCT01145742|Type 2 diabetes|type 2 diabetes
567877|NCT01145742|Hypertension|hypertension
567878|NCT01145742|Health services research|health services research
567879|NCT01145742|Health disparities|health disparities
567880|NCT01145742|Behavior change|behavior change
567881|NCT01145729|Biomarker feedback|biomarker feedback
567882|NCT01145729|Smoking cessation|smoking cessation
567883|NCT01145729|Childhood secondhand smoke exposure|childhood secondhand smoke exposure
567884|NCT01145716|TFCC injuries|tfcc injuries
567885|NCT01145716|Distal radius fractures|distal radius fractures
567886|NCT01145703|Body Composition|body composition
567887|NCT01145703|Cardiovascular Risk|cardiovascular risk
567888|NCT01145703|Cognitive Function|cognitive function
567889|NCT01145690|cognitive behaviour therapy|cognitive behaviour therapy
567890|NCT01145677|Alcohol dependence|alcohol dependence
567891|NCT01145677|Alcoholism|alcoholism
567892|NCT01145677|Topiramate|topiramate
567893|NCT01145664|Chinese medicines|chinese medicines
567894|NCT01145664|Severe hand-foot-mouth diseases|severe hand-foot-mouth diseases
567895|NCT01145664|effectiveness|effectiveness
567896|NCT01145664|safety|safety
567897|NCT01145638|cancer|cancer
567898|NCT01145638|chemotherapy induced anaemia|chemotherapy induced anaemia
567899|NCT01145638|iron|iron
567900|NCT01145638|Patients with non-myeloid malignancies and Chemotherapy Induced Anaemia (CIA)|patients with non-myeloid malignancies and chemotherapy induced anaemia (cia)
567901|NCT01145638|CIA|cia
567902|NCT01145625|Female Pattern Baldness|female pattern baldness
567903|NCT01145612|Aortic dilation|aortic dilation
721203|NCT00542503|MRI|mri
567904|NCT01145612|Marfan syndrome|marfan syndrome
567906|NCT01145612|Atenolol|atenolol
567907|NCT01145573|calcium|calcium
567908|NCT01145573|vitamin D|vitamin d
567909|NCT01145573|bone|bone
567910|NCT01145573|pregnancy|pregnancy
567911|NCT01145560|severe sepsis|severe sepsis
567912|NCT01145560|TNF neutralisation|tnf neutralisation
567913|NCT01145560|septic shock patients|septic shock patients
567914|NCT01145547|glycemic index|glycemic index
567915|NCT01145547|Diabetes Mellitus|diabetes mellitus
567916|NCT01145547|continuous glucose monitoring|continuous glucose monitoring
567917|NCT01145534|diabetes,|diabetes,
567918|NCT01145534|medicinal plants,|medicinal plants,
567919|NCT01145534|glucose|glucose
567920|NCT01145482|Memory Disorders|memory disorders
567921|NCT01145482|Alzheimer's Disease|alzheimer's disease
567922|NCT01145469|stage I chronic lymphocytic leukemia|stage i chronic lymphocytic leukemia
567923|NCT01145469|stage II chronic lymphocytic leukemia|stage ii chronic lymphocytic leukemia
567924|NCT01145469|stage III chronic lymphocytic leukemia|stage iii chronic lymphocytic leukemia
567925|NCT01145469|stage IV chronic lymphocytic leukemia|stage iv chronic lymphocytic leukemia
567926|NCT01145469|B-cell chronic lymphocytic leukemia|b-cell chronic lymphocytic leukemia
567927|NCT01145443|Organizational models|organizational models
567928|NCT01145443|Intensive care units|intensive care units
567929|NCT01145443|Physicians|physicians
567930|NCT01145443|Staffing and scheduling|staffing and scheduling
567931|NCT01145443|Burnout, professional|burnout, professional
567932|NCT01145443|Job satisfaction|job satisfaction
567933|NCT01145417|peripheral neuropathic pain|peripheral neuropathic pain
567934|NCT01145417|pregabalin|pregabalin
567935|NCT01145417|safety|safety
567936|NCT01145404|Her2 Gastro Gastric Esophageal Cancer|her2 gastro gastric esophageal cancer
567937|NCT01145391|hypertension|hypertension
567938|NCT01145391|blood pressure|blood pressure
567939|NCT01145391|primary care|primary care
567940|NCT01145391|patient centered medical home|patient centered medical home
567941|NCT01145391|health information technology|health information technology
567942|NCT01145391|clinical inertia|clinical inertia
567943|NCT01145365|Crohns|crohns
567944|NCT01145365|Fistula|fistula
567945|NCT01145365|Perianal Abscess|perianal abscess
567946|NCT01145365|Perianal|perianal
567947|NCT01145352|Enbrel-JIA|enbrel-jia
567948|NCT01145326|venipuncture|venipuncture
567949|NCT01145326|phlebotomy|phlebotomy
567950|NCT01145326|pain perception|pain perception
567951|NCT01145300|COPD|copd
567952|NCT01145300|Inflammation|inflammation
567953|NCT01145300|Small airways|small airways
567954|NCT01145287|Celiac disease|celiac disease
567955|NCT01145287|Gluten-free diet|gluten-free diet
567956|NCT01145287|Screen-detected|screen-detected
567957|NCT01145287|Asymptomatic|asymptomatic
567958|NCT01145287|Quality of life|quality of life
567959|NCT01145287|Self-perceived health|self-perceived health
567960|NCT01145287|Healthcare resource utilization|healthcare resource utilization
567961|NCT01145274|allopurinol|allopurinol
567962|NCT01145274|chronic kidney diseae|chronic kidney diseae
567963|NCT01145261|Anxiety,|anxiety,
567964|NCT01145261|Emotional Regulation|emotional regulation
567965|NCT01145248|Cholangiocellular Carcinoma|cholangiocellular carcinoma
567966|NCT01145235|Breast augmentation with Macrolane|breast augmentation with macrolane
567967|NCT01145222|CNS 7056|cns 7056
567968|NCT01145222|Procedural Sedation|procedural sedation
567969|NCT01145222|Colonoscopy|colonoscopy
567970|NCT01145209|Arzerra|arzerra
567971|NCT01145209|Chemoimmunotherapy|chemoimmunotherapy
567972|NCT01145209|SLL|sll
567973|NCT01145209|Monoclonal Antibody Therapy|monoclonal antibody therapy
567974|NCT01145209|CLL|cll
567975|NCT01145209|Ofatumumab|ofatumumab
567976|NCT01145196|Retinal Disease|retinal disease
567977|NCT01145196|Plaquenil-Induced|plaquenil-induced
567978|NCT01145183|Cocaine Dependence|cocaine dependence
567979|NCT01145183|Substance Related Disorders|substance related disorders
567980|NCT01145183|genotype|genotype
567981|NCT01145170|brainstem gliomas|brainstem gliomas
567982|NCT01145170|pediatric patients|pediatric patients
567983|NCT01145157|knee|knee
567984|NCT01145157|arthroplasty|arthroplasty
567985|NCT01145144|Dehydroepiandrosterone|dehydroepiandrosterone
567986|NCT01145144|DHEA|dhea
567987|NCT01145144|IVF outcome|ivf outcome
567988|NCT01145144|long protocol IVF|long protocol ivf
567989|NCT01145144|poor-responder|poor-responder
567990|NCT01145144|recombinant LH|recombinant lh
567991|NCT01145144|embryo quality|embryo quality
567992|NCT01145144|pregnancy rate|pregnancy rate
567993|NCT01145144|live birth rate|live birth rate
567994|NCT01145144|poor response to ovarian stimulation|poor response to ovarian stimulation
567995|NCT01145131|muscle|muscle
567996|NCT01145131|FSR|fsr
567997|NCT01145131|protein|protein
567998|NCT01145131|meat|meat
567999|NCT01145118|Plantar Fasciitis|plantar fasciitis
568000|NCT01145118|Physiotherapy|physiotherapy
568001|NCT01145105|Low back pain|low back pain
568002|NCT01145105|Sciatica|sciatica
568003|NCT01145105|Pain|pain
568004|NCT01145105|Physiotherapy|physiotherapy
568005|NCT01145092|type 2 diabetes|type 2 diabetes
568006|NCT01145092|exercise training|exercise training
568007|NCT01145092|ATP-synthesis|atp-synthesis
568008|NCT01145092|intramyocellular lipids|intramyocellular lipids
568009|NCT01145092|hepatocellular lipids|hepatocellular lipids
568010|NCT01145092|first degree relatives of T2DM patients|first degree relatives of t2dm patients
568011|NCT01145066|diabetes|diabetes
568012|NCT01145066|metabolic syndrome|metabolic syndrome
568013|NCT01145066|inflammation|inflammation
568014|NCT01145066|botanical oils|botanical oils
568015|NCT01145040|Overt primary hypothyroidism|overt primary hypothyroidism
568016|NCT01145040|Overt primary hyperthyroidism|overt primary hyperthyroidism
568017|NCT01145040|Thyrotropic feedback control|thyrotropic feedback control
568018|NCT01145040|Mathematical modelling|mathematical modelling
568019|NCT01145040|Nonlinear modelling|nonlinear modelling
568020|NCT01145040|Thyroid|thyroid
568021|NCT01145040|Pituitary|pituitary
568022|NCT01145040|Physiological cybernetics|physiological cybernetics
568023|NCT01145040|Full-dose levothyroxine substitution therapy|full-dose levothyroxine substitution therapy
568024|NCT01145040|Syndrome T|syndrome t
568025|NCT01145027|Capillary recruitment|capillary recruitment
568026|NCT01145027|Cephalic Phase of Insulin Secretion|cephalic phase of insulin secretion
568027|NCT01145027|Dietary Intake|dietary intake
568028|NCT01145001|smoking|smoking
568029|NCT01145001|adolescents|adolescents
568030|NCT01145001|contingency management|contingency management
568031|NCT01145001|nicotine replacement therapy|nicotine replacement therapy
568032|NCT01144988|Recurrent Malignant Glioma|recurrent malignant glioma
568033|NCT01144988|Bevacizumab / Irinotecan|bevacizumab / irinotecan
568034|NCT01144988|Functional MR Imaging|functional mr imaging
568035|NCT01144988|Metabolic Imaging (FET/FLT-PET)|metabolic imaging (fet/flt-pet)
568036|NCT01144975|Diabetes|diabetes
568037|NCT01144975|Type 2|type 2
568038|NCT01144975|Mellitus|mellitus
568039|NCT01144962|Crohn's Disease|crohn's disease
568040|NCT01144962|Fistula|fistula
568041|NCT01144962|Mesenchymal Stem Cell|mesenchymal stem cell
568042|NCT01144962|Mesenchymal Stromal Cell|mesenchymal stromal cell
568043|NCT01144962|MSC|msc
568044|NCT01144962|IBD|ibd
568045|NCT01144949|ureteral calculi|ureteral calculi
568046|NCT01144949|renal colic|renal colic
568047|NCT01144949|ureteral stones|ureteral stones
568048|NCT01144949|kidney stones|kidney stones
568049|NCT01144949|medical expulsive therapy|medical expulsive therapy
568050|NCT01144923|epidural steroid injection|epidural steroid injection
568051|NCT01144923|neck pain|neck pain
568052|NCT01144923|pharmacotherapy|pharmacotherapy
568053|NCT01144923|radiculopathy|radiculopathy
568054|NCT01144910|asthma|asthma
568055|NCT01144910|preschool child|preschool child
568056|NCT01144910|bronchial hyperresponsiveness|bronchial hyperresponsiveness
568057|NCT01144910|methacholine challenge test|methacholine challenge test
568058|NCT01144910|atopy|atopy
568059|NCT01144897|Castrate resistant|castrate resistant
568060|NCT01144897|Prostate cancer|prostate cancer
568061|NCT01144897|Docetaxel|docetaxel
568062|NCT01144897|Taxotere|taxotere
568063|NCT01144897|PET Acetate|pet acetate
568064|NCT01144884|Neck pain|neck pain
568065|NCT01144884|education|education
568066|NCT01144884|exercise|exercise
568067|NCT01144884|clinical prediction rule|clinical prediction rule
568068|NCT01144871|adolescent|adolescent
568069|NCT01144871|reproductive health|reproductive health
568070|NCT01144871|parents|parents
568071|NCT01144871|STIs|stis
568072|NCT01144871|confidentiality|confidentiality
568073|NCT01144871|Examine parental knowledge/attitudes of confidential health services/STI care for adolescents.|examine parental knowledge/attitudes of confidential health services/sti care for adolescents.
568074|NCT01144871|Examine how parental knowledge/attitudes affects parent's behavioral intentions to support adolescent's access to confidential care.|examine how parental knowledge/attitudes affects parent's behavioral intentions to support adolescent's access to confidential care.
568075|NCT01144871|Identify key mechanisms to form an intervention to parents knowledge/skills to facilitate teen's access to confidential STI services.|identify key mechanisms to form an intervention to parents knowledge/skills to facilitate teen's access to confidential sti services.
568076|NCT01144858|atrial fibrillation|atrial fibrillation
568077|NCT01144858|ablation catheter|ablation catheter
568078|NCT01144858|left atrial appendage peak emptying velocity|left atrial appendage peak emptying velocity
568079|NCT01144858|tool for predicting successful catheter ablation|tool for predicting successful catheter ablation
568080|NCT01144845|Thoracotomy|thoracotomy
568081|NCT01144845|Thoracic Surgery|thoracic surgery
568082|NCT01144845|Thoracic Surgical Procedures|thoracic surgical procedures
568083|NCT01144845|Thoracic Surgery, Video-Assisted|thoracic surgery, video-assisted
568084|NCT01144845|Lung Neoplasms|lung neoplasms
568085|NCT01144845|Thoracic Nerves|thoracic nerves
568086|NCT01144832|visceral hypersensitivity|visceral hypersensitivity
568087|NCT01144832|mast cells|mast cells
568088|NCT01144819|STEMI|stemi
568089|NCT01144819|Acute myocardial infarction|acute myocardial infarction
568090|NCT01144819|Antiplatelet therapy|antiplatelet therapy
568091|NCT01144819|aspirin|aspirin
568092|NCT01144819|clopidogrel|clopidogrel
568093|NCT01144819|VerifyNow aggregometry|verifynow aggregometry
568094|NCT01144819|Multiplate aggregometry|multiplate aggregometry
568095|NCT01144806|SAM|sam
568096|NCT01144806|RUTF|rutf
568097|NCT01144806|BIA|bia
568098|NCT01144806|D2O|d2o
568099|NCT01144806|Children with severe malnutrition|children with severe malnutrition
568100|NCT01144741|rehabilitation|rehabilitation
568101|NCT01144741|surgery|surgery
568102|NCT01144741|therapy|therapy
568103|NCT01144741|Quality Of Life|quality of life
568104|NCT01144741|Health-Related Quality Of Life|health-related quality of life
568105|NCT01144741|Health Status|health status
568106|NCT01144741|Depressive Symptoms|depressive symptoms
568107|NCT01144741|Situational Depression|situational depression
568108|NCT01144715|Stroke Rehabilitation|stroke rehabilitation
568109|NCT01144715|Home rehabilitation|home rehabilitation
568110|NCT01144715|robotic therapy|robotic therapy
568111|NCT01144702|malaria|malaria
568112|NCT01144702|Plasmodium falciparum|plasmodium falciparum
568113|NCT01144702|artesunate and mefloquine combination (ASMQ)|artesunate and mefloquine combination (asmq)
568114|NCT01144702|treatment|treatment
568115|NCT01144702|Juruá Valley|juruá valley
568116|NCT01144702|Brazil|brazil
568117|NCT01144702|multidrug resistance 1 gene of Plasmodium falciparum -Pfmdr1|multidrug resistance 1 gene of plasmodium falciparum -pfmdr1
568118|NCT01144689|mindfulness|mindfulness
568119|NCT01144689|smoking|smoking
568120|NCT01144689|stress|stress
568121|NCT01144663|Infants|infants
568122|NCT01144663|conjugate vaccine|conjugate vaccine
568123|NCT01144663|immunogenicity|immunogenicity
568124|NCT01144663|meningococcal vaccine|meningococcal vaccine
568125|NCT01144663|non-inferiority|non-inferiority
568126|NCT01144663|co-administration|co-administration
568127|NCT01144650|Dapsone|dapsone
568128|NCT01144650|Cerebrovascular Accident, Acute|cerebrovascular accident, acute
568129|NCT01144650|Neuroprotection|neuroprotection
568130|NCT01144624|TNF neutralisation|tnf neutralisation
568131|NCT01144611|valve replacement|valve replacement
568132|NCT01144611|CABG|cabg
568133|NCT01144611|SIRTS|sirts
568134|NCT01144611|Combined aortic valve replacement and CABG surgery|combined aortic valve replacement and cabg surgery
568135|NCT01144598|Rheumatoid Arthritis|rheumatoid arthritis
568136|NCT01144598|Disease-Modifying Anti-Rheumatic Drug|disease-modifying anti-rheumatic drug
568137|NCT01144598|Work Limitation|work limitation
568138|NCT01144585|RIPC|ripc
568139|NCT01144585|lung protection|lung protection
568140|NCT01144585|ischemic reperfusion injury|ischemic reperfusion injury
568141|NCT01144585|cardiopulmonary bypass|cardiopulmonary bypass
568142|NCT01144572|Quality of Life|quality of life
568143|NCT01144572|postmenopausal HR(+)|postmenopausal hr(+)
568144|NCT01144572|Early Breast Cancer|early breast cancer
568145|NCT01144572|adjuvant AI treatment|adjuvant ai treatment
568146|NCT01144572|Quality of Life in Chinese postmenopausal HR(+) EBC patients during adjuvant Aromatase Inhibitors(AIs) treatment|quality of life in chinese postmenopausal hr(+) ebc patients during adjuvant aromatase inhibitors(ais) treatment
568147|NCT01144559|Femoral|femoral
568148|NCT01144559|Nerve Block|nerve block
568149|NCT01144559|Bolus|bolus
568150|NCT01144559|Continuous Infusion|continuous infusion
568151|NCT01144559|UCSD|ucsd
568152|NCT01144559|Perineural Catheter|perineural catheter
568153|NCT01144559|Volunteer|volunteer
568154|NCT01144559|lower extremity nerve blocks|lower extremity nerve blocks
568155|NCT01144546|Passive leg raising|passive leg raising
568156|NCT01144546|FloTrac/Vigileo|flotrac/vigileo
568157|NCT01144546|Anesthesia hypotension|anesthesia hypotension
568158|NCT01144507|Cystic Fibrosis|cystic fibrosis
568159|NCT01144507|Pancreatic insufficiency|pancreatic insufficiency
568160|NCT01144494|Aqueous Humor Dynamics|aqueous humor dynamics
568161|NCT01144494|Aqueous Humor Dynamics and Circadian Rhythms|aqueous humor dynamics and circadian rhythms
568162|NCT01144481|bone metastasis|bone metastasis
568163|NCT01144481|breast cancer|breast cancer
568164|NCT01144481|skeletal related event|skeletal related event
568165|NCT01144481|HR-pQCT|hr-pqct
568166|NCT01144481|VFA|vfa
568167|NCT01144468|breast cancer prevention|breast cancer prevention
568168|NCT01144468|osteoporosis|osteoporosis
568169|NCT01144455|Locally Advanced Unresectable Pancreatic Adenocarcinoma|locally advanced unresectable pancreatic adenocarcinoma
568170|NCT01144455|Metastatic Pancreatic Adenocarcinoma|metastatic pancreatic adenocarcinoma
568171|NCT01144455|Locally Advanced Unresectable or Metastatic Pancreatic Adenocarcinoma|locally advanced unresectable or metastatic pancreatic adenocarcinoma
568172|NCT01144442|recurrent ovarian cancer|recurrent ovarian cancer
568173|NCT01144442|recurrent fallopian tube cancer|recurrent fallopian tube cancer
568174|NCT01144442|recurrent peritoneal carcinoma|recurrent peritoneal carcinoma
568175|NCT01144429|Allergic Rhinitis +- intermittent asthma|allergic rhinitis +- intermittent asthma
568176|NCT01144429|Allergic Rhinoconjunctivitis +- intermittent asthma|allergic rhinoconjunctivitis +- intermittent asthma
568177|NCT01144429|Specific Immunotherapy|specific immunotherapy
568178|NCT01144416|Reproductive Techniques, Assisted|reproductive techniques, assisted
568179|NCT01144416|Follicle Stimulating Hormone, Human|follicle stimulating hormone, human
568180|NCT01144416|Fertilization In Vitro|fertilization in vitro
568181|NCT01144390|heroin dependence|heroin dependence
721651|NCT00540332|KGF|kgf
568182|NCT01144390|community-based|community-based
568183|NCT01144390|MMT|mmt
568184|NCT01144377|osteoporosis|osteoporosis
568185|NCT01144351|MS|ms
568186|NCT01144351|SPMS|spms
568187|NCT01144351|RRMS|rrms
568285|NCT01143896|Depression|depression
568387|NCT01143519|Apoptosis|apoptosis
568188|NCT01144351|Relapsing Forms of Secondary Progressive Multiple Sclerosis (SPMS)|relapsing forms of secondary progressive multiple sclerosis (spms)
568189|NCT01144351|or Relapsing-Remitting Multiple Sclerosis (RRMS)|or relapsing-remitting multiple sclerosis (rrms)
568190|NCT01144338|exenatide once weekly|exenatide once weekly
568191|NCT01144338|cardiovascular|cardiovascular
568192|NCT01144338|Bydureon|bydureon
568193|NCT01144338|Amylin|amylin
568194|NCT01144325|Minimally Invasive Esophagectomy|minimally invasive esophagectomy
568195|NCT01144312|LDLT|ldlt
568196|NCT01144299|Influenza|influenza
568197|NCT01144286|VVC|vvc
568198|NCT01144286|candidiasis|candidiasis
568199|NCT01144286|vaginal candidiasis|vaginal candidiasis
568200|NCT01144260|CLL|cll
568201|NCT01144260|leukemia|leukemia
568202|NCT01144260|chronic lymphocytic leukemia|chronic lymphocytic leukemia
568203|NCT01144247|Recurrent Grade III or Grade IV Gliomas|recurrent grade iii or grade iv gliomas
568204|NCT01144247|anaplastic astrocytoma|anaplastic astrocytoma
568205|NCT01144247|anaplastic oligodendroglioma|anaplastic oligodendroglioma
568206|NCT01144247|anaplastic mixed glioma|anaplastic mixed glioma
568207|NCT01144247|glioblastoma multiforme|glioblastoma multiforme
568208|NCT01144247|biotherapy|biotherapy
568209|NCT01144247|malignant meningioma|malignant meningioma
568210|NCT01144234|Prevention of mother-to-child transmission of HIV-1|prevention of mother-to-child transmission of hiv-1
568211|NCT01144221|Chronic Ischemic Heart Disease|chronic ischemic heart disease
568212|NCT01144208|Radius fracture|radius fracture
568213|NCT01144208|Adverse effects|adverse effects
568214|NCT01144208|Wrist|wrist
568215|NCT01144208|Postoperative complications|postoperative complications
568216|NCT01144208|Colles' fracture|colles' fracture
568217|NCT01144208|Intraoperative complications|intraoperative complications
568218|NCT01144208|Osteoporosis|osteoporosis
568219|NCT01144208|Dual-energy x-ray absorptiometry (DXA)|dual-energy x-ray absorptiometry (dxa)
568220|NCT01144208|Bone Density|bone density
568221|NCT01144182|heart failure|heart failure
568222|NCT01144182|quality of life|quality of life
568223|NCT01144182|readmissions|readmissions
568224|NCT01144169|Renal cell carcinoma|renal cell carcinoma
568225|NCT01144169|Hydroxychloroquine|hydroxychloroquine
568226|NCT01144169|Nephrectomy|nephrectomy
568227|NCT01144169|Autophagy|autophagy
568228|NCT01144156|Crohn's disease|crohn's disease
568229|NCT01144156|Small bowel|small bowel
568230|NCT01144156|Mucosal healing|mucosal healing
568231|NCT01144156|Capsule endoscopy|capsule endoscopy
568232|NCT01144156|Adalimumab|adalimumab
568233|NCT01144156|Small bowel Crohn's disease|small bowel crohn's disease
568234|NCT01144143|Mild to moderate osteoarthritis of the knee|mild to moderate osteoarthritis of the knee
568235|NCT01144117|Progressive Multiple Sclerosis|progressive multiple sclerosis
568236|NCT01144091|diabetes mellitus|diabetes mellitus
568237|NCT01144091|creatinin level|creatinin level
568238|NCT01144091|contrast induced nephropathy|contrast induced nephropathy
568239|NCT01144091|prevention contrast induced nephropathy in high risk patients|prevention contrast induced nephropathy in high risk patients
568240|NCT01144078|Adiposity|adiposity
568241|NCT01144078|Exercise training|exercise training
568242|NCT01144078|Older adults|older adults
568243|NCT01144065|Myocardial infarction|myocardial infarction
568244|NCT01144065|Cortisol|cortisol
568245|NCT01144065|Testosterone|testosterone
568246|NCT01144052|Natalizumab|natalizumab
568247|NCT01144052|Interferon-beta 1b|interferon-beta 1b
568248|NCT01144052|De-escalation|de-escalation
568249|NCT01144052|Ticino|ticino
568250|NCT01144026|HIV|hiv
568251|NCT01144026|vaccine|vaccine
568252|NCT01144026|lipopeptide|lipopeptide
568253|NCT01144026|Tat|tat
568254|NCT01144026|TUTI-16|tuti-16
568255|NCT01144026|THYMON|thymon
568256|NCT01144000|Prosthetic joint infection|prosthetic joint infection
568257|NCT01144000|daptomycin|daptomycin
568258|NCT01144000|staphylococcus|staphylococcus
568259|NCT01143987|hyperparathyroidism|hyperparathyroidism
568260|NCT01143987|pulse wave velocity|pulse wave velocity
568261|NCT01143987|end-stage renal disease|end-stage renal disease
568262|NCT01143987|arterial stiffness|arterial stiffness
568263|NCT01143974|progress free survival|progress free survival
568264|NCT01143974|response rate|response rate
568265|NCT01143974|safety|safety
568266|NCT01143961|Positive pressure ventilation|positive pressure ventilation
568267|NCT01143961|Electrical impedance tomography|electrical impedance tomography
568268|NCT01143948|Diabetes|diabetes
568269|NCT01143948|Cirrhosis|cirrhosis
568270|NCT01143948|Insulin|insulin
568271|NCT01143948|Inpatient|inpatient
568272|NCT01143935|Liver volume estimation|liver volume estimation
568273|NCT01143935|Indian population|indian population
568274|NCT01143922|Intraoperative ultrasound|intraoperative ultrasound
721675|NCT00540202|Coartem|coartem
568275|NCT01143922|GI tract malignancies|gi tract malignancies
568276|NCT01143922|modality|modality
568277|NCT01143922|ultrasound|ultrasound
568278|NCT01143922|staging modality|staging modality
568279|NCT01143909|Fresh frozen plasma|fresh frozen plasma
568280|NCT01143909|Coagulopathy|coagulopathy
568281|NCT01143909|Intensive care|intensive care
568282|NCT01143909|Adverse effects|adverse effects
568283|NCT01143909|Lung injury|lung injury
568284|NCT01143896|Hepatitis C|hepatitis c
568286|NCT01143896|Collaborative care|collaborative care
568287|NCT01143896|Antiviral treatment|antiviral treatment
568288|NCT01143883|All patients undergoing a colorectal resection|all patients undergoing a colorectal resection
568289|NCT01143883|surgical site infections|surgical site infections
568290|NCT01143844|Oncofertility|oncofertility
568291|NCT01143844|Fertility|fertility
568292|NCT01143844|Late effects|late effects
568293|NCT01143844|cancer|cancer
568294|NCT01143844|chemotherapy|chemotherapy
568295|NCT01143844|radiation therapy|radiation therapy
568296|NCT01143844|survivor|survivor
568297|NCT01143844|ovarian reserve|ovarian reserve
568298|NCT01143844|premature ovarian failure|premature ovarian failure
568299|NCT01143844|early menopause|early menopause
568300|NCT01143844|healthy volunteers|healthy volunteers
568301|NCT01143844|perimenopause|perimenopause
568302|NCT01143844|middle age|middle age
568303|NCT01143844|pediatric survivors|pediatric survivors
568304|NCT01143844|healthy women|healthy women
568305|NCT01143831|Vitamin K|vitamin k
568306|NCT01143831|Thrombosis|thrombosis
568307|NCT01143818|Male hypogonadism|male hypogonadism
568308|NCT01143805|Absolute Bioavailability|absolute bioavailability
568309|NCT01143805|Rheumatoid Arthritis|rheumatoid arthritis
568310|NCT01143792|Substance abuse|substance abuse
568311|NCT01143792|Homelessness|homelessness
568312|NCT01143792|HIV risk behavior|hiv risk behavior
568313|NCT01143779|Advanced Malignancy|advanced malignancy
568314|NCT01143779|FLT-PET Scan|flt-pet scan
568315|NCT01143779|[F-18]-fluoro-L-thymidine|[f-18]-fluoro-l-thymidine
568316|NCT01143779|FLT|flt
568317|NCT01143779|Positron emission tomography|positron emission tomography
568318|NCT01143779|PET|pet
568319|NCT01143779|Imaging Biomarker|imaging biomarker
568320|NCT01143779|Temsirolimus|temsirolimus
568321|NCT01143779|Topotecan|topotecan
568322|NCT01143779|Bortezomib|bortezomib
568323|NCT01143766|Sedation|sedation
568324|NCT01143766|Gabapentin|gabapentin
568325|NCT01143766|ERCP|ercp
568326|NCT01143766|Endoscopy|endoscopy
568327|NCT01143675|Humerus fractures|humerus fractures
568328|NCT01143675|Tomography, x-ray computed|tomography, x-ray computed
568329|NCT01143675|Bone and bones|bone and bones
568330|NCT01143675|Orthopedic fixation devices|orthopedic fixation devices
568331|NCT01143675|Surgery|surgery
568332|NCT01143675|Postoperative complications|postoperative complications
568333|NCT01143675|Osteoporosis|osteoporosis
568334|NCT01143675|Intraoperative complications|intraoperative complications
568335|NCT01143675|Bone density|bone density
568336|NCT01143675|Radiography, dual-energy scanned projection|radiography, dual-energy scanned projection
568337|NCT01143662|peginterferon|peginterferon
568338|NCT01143662|interferon|interferon
568339|NCT01143662|Pegasys|pegasys
568340|NCT01143662|HBV|hbv
568341|NCT01143662|Hepatitis B|hepatitis b
568342|NCT01143662|HBeAg positive|hbeag positive
568343|NCT01143649|Stroke|stroke
568344|NCT01143649|Transcranial direct current stimulation|transcranial direct current stimulation
568345|NCT01143649|Motor function|motor function
568346|NCT01143636|Transcranial direct current stimulation|transcranial direct current stimulation
568347|NCT01143636|Chronic Pelvic Pain|chronic pelvic pain
568348|NCT01143623|antibiotic|antibiotic
568349|NCT01143623|diarrhea|diarrhea
568350|NCT01143623|probiotic|probiotic
568351|NCT01143610|Root coverage|root coverage
568352|NCT01143610|Graft|graft
568353|NCT01143610|Soft tissue|soft tissue
568354|NCT01143610|Periodontal regeneration|periodontal regeneration
568355|NCT01143597|task-specific training|task-specific training
568356|NCT01143597|arm and hand function|arm and hand function
568357|NCT01143597|corticomotor plasticity|corticomotor plasticity
568358|NCT01143597|individuals with motor-incomplete spinal cord injury|individuals with motor-incomplete spinal cord injury
568359|NCT01143584|Prolactin|prolactin
568360|NCT01143584|Cabergoline|cabergoline
568361|NCT01143584|Macroadenomas|macroadenomas
568362|NCT01143584|escalation|escalation
568363|NCT01143571|Microbiome|microbiome
568364|NCT01143571|Samples|samples
568365|NCT01143558|Borrelia Burgdorferi|borrelia burgdorferi
568366|NCT01143558|Xenodiagnosis|xenodiagnosis
568367|NCT01143558|Ticks|ticks
568368|NCT01143558|Skin Biopsy|skin biopsy
568369|NCT01143558|Lyme Disease|lyme disease
568370|NCT01143545|Cancer Vaccine|cancer vaccine
568371|NCT01143545|Immunotherapy|immunotherapy
568372|NCT01143545|Adjuvant Therapy|adjuvant therapy
568373|NCT01143545|Surgical Intervention|surgical intervention
568374|NCT01143545|Lung Cancer|lung cancer
568375|NCT01143545|Esophageal Cancer|esophageal cancer
568376|NCT01143545|Thymic Carcinoma|thymic carcinoma
568377|NCT01143545|Malignant Pleural Mesothelioma|malignant pleural mesothelioma
568378|NCT01143532|African-Americans|african-americans
568379|NCT01143532|MYH9|myh9
568380|NCT01143532|Chronic Allograft Nephropathy|chronic allograft nephropathy
568381|NCT01143532|Chronic Kidney Disease|chronic kidney disease
568382|NCT01143532|Proteinuria|proteinuria
568383|NCT01143532|Kidney Disease|kidney disease
568384|NCT01143532|Kidney Transplant|kidney transplant
568385|NCT01143532|African-American|african-american
568386|NCT01143519|Gene Expression|gene expression
568388|NCT01143519|Lymphocytes|lymphocytes
568389|NCT01143519|Environmental Factors|environmental factors
568390|NCT01143519|Single Nucleotide Polymorphism|single nucleotide polymorphism
568391|NCT01143519|Healthy Volunteer|healthy volunteer
568393|NCT01143506|Sense of Agency|sense of agency
568394|NCT01143506|Ulnar Nerve Block|ulnar nerve block
568395|NCT01143506|Healthy Volunteer|healthy volunteer
568396|NCT01143506|fMRI|fmri
568397|NCT01143506|EEG|eeg
568398|NCT01143493|Genetic Polymorphism|genetic polymorphism
568399|NCT01143493|Glucocorticoid|glucocorticoid
568400|NCT01143493|Health Volunteer|health volunteer
568401|NCT01143493|HV|hv
568402|NCT01143480|Endotoxin|endotoxin
568403|NCT01143480|Innate Immunity|innate immunity
568404|NCT01143480|Healthy Volunteer|healthy volunteer
568405|NCT01143480|HV|hv
568406|NCT01143467|Fatigue|fatigue
568407|NCT01143467|Mitochondria|mitochondria
568408|NCT01143467|Mitochondrial Abnormality|mitochondrial abnormality
568409|NCT01143467|Oxidative Stress|oxidative stress
568410|NCT01143467|Gene Expression|gene expression
568411|NCT01143467|Prostate Cancer|prostate cancer
568412|NCT01143454|Cardiac Disease|cardiac disease
568413|NCT01143454|iPS Cells|ips cells
568414|NCT01143454|Cardiac Risk Factors|cardiac risk factors
568415|NCT01143454|Cardiac Disease Discovery|cardiac disease discovery
568416|NCT01143454|Heart Disease|heart disease
568417|NCT01143454|Heart Disease Risk|heart disease risk
568418|NCT01143441|Multiple Sclerosis|multiple sclerosis
568419|NCT01143441|Daclizumab|daclizumab
568420|NCT01143428|Motor Neuron Disease|motor neuron disease
568421|NCT01143428|Primary Lateral Sclerosis|primary lateral sclerosis
568422|NCT01143428|Oxidative Stress|oxidative stress
568423|NCT01143428|Physiology|physiology
568424|NCT01143428|PLS|pls
568425|NCT01143389|Keratoconus|keratoconus
568426|NCT01143389|Ectasia|ectasia
568427|NCT01143389|cross linking|cross linking
568428|NCT01143389|collagen cross linking|collagen cross linking
568429|NCT01143376|Obesity|obesity
568430|NCT01143376|exercise|exercise
568431|NCT01143376|body composition|body composition
568432|NCT01143376|insulin sensitivity|insulin sensitivity
568433|NCT01143376|appetite|appetite
568434|NCT01143376|food intake|food intake
568435|NCT01143363|Obesity|obesity
568436|NCT01143363|exercise|exercise
568437|NCT01143363|appetite|appetite
568438|NCT01143363|hunger|hunger
568439|NCT01143363|satiety|satiety
568440|NCT01143363|food intake|food intake
568441|NCT01143337|Rheumatoid Arthritis|rheumatoid arthritis
568442|NCT01143324|Single or double level instrumented fusion|single or double level instrumented fusion
568443|NCT01143324|Degenerative lumbar spine|degenerative lumbar spine
568444|NCT01143324|PLIF|plif
568445|NCT01143324|TLIF|tlif
568446|NCT01143324|MAST procedure|mast procedure
568447|NCT01143285|Active nutritional and dietary management|active nutritional and dietary management
568448|NCT01143285|Metastatic colorectal cancer|metastatic colorectal cancer
568449|NCT01143285|Non surgical metastatic colorectal cancer|non surgical metastatic colorectal cancer
568450|NCT01143272|antibiotic|antibiotic
568451|NCT01143272|associated|associated
568452|NCT01143272|diarrhoea|diarrhoea
568453|NCT01143272|saccharomyces boulardii|saccharomyces boulardii
568454|NCT01143272|Antibiotic-associated diarrhoea (AAD)|antibiotic-associated diarrhoea (aad)
568455|NCT01143272|Clostridium difficile-associated-diarrhoea (CDAD)|clostridium difficile-associated-diarrhoea (cdad)
568456|NCT01143259|Ileus|ileus
568457|NCT01143259|Post operative ileus|post operative ileus
568458|NCT01143246|Hepatorenal syndrome|hepatorenal syndrome
568459|NCT01143246|Renal failure|renal failure
568460|NCT01143246|Cirrhosis|cirrhosis
568461|NCT01143246|Alcoholic hepatitis|alcoholic hepatitis
568462|NCT01143246|Ascites|ascites
568463|NCT01143220|Cardiac Resynchronization Therapy|cardiac resynchronization therapy
568464|NCT01143220|Heart Failure|heart failure
568465|NCT01143220|Pathologic Processes|pathologic processes
568466|NCT01143220|Heart Diseases|heart diseases
568467|NCT01143220|Tachycardia|tachycardia
568468|NCT01143220|Cardiovascular Diseases|cardiovascular diseases
568469|NCT01143220|Ventricular Flutter|ventricular flutter
568470|NCT01143220|Tachycardia, Ventricular|tachycardia, ventricular
568471|NCT01143220|Ventricular Fibrillation|ventricular fibrillation
568472|NCT01143220|Arrhythmias, Cardiac|arrhythmias, cardiac
568473|NCT01143220|Ease of Use|ease of use
568474|NCT01143207|AE adverse event|ae adverse event
568475|NCT01143207|DCF data collection forms|dcf data collection forms
568476|NCT01143207|DMC Data Monitoring Committee|dmc data monitoring committee
568477|NCT01143207|FDA U.S.) Food and Drug Administration|fda u.s.) food and drug administration
568478|NCT01143207|GCP Good Clinical Practice guidelines|gcp good clinical practice guidelines
568479|NCT01143207|ICH International Conference of Harmonisation|ich international conference of harmonisation
568480|NCT01143207|IND Investigational New Drug Application|ind investigational new drug application
568481|NCT01143207|IRB Institutional Review Board|irb institutional review board
568482|NCT01143207|IU International units|iu international units
568483|NCT01143207|mg milligram(s)|mg milligram(s)
568484|NCT01143207|SAE serious adverse event|sae serious adverse event
568485|NCT01143207|µg microgram|µg microgram
568486|NCT01143207|ULN upper limit of the normal range|uln upper limit of the normal range
568487|NCT01143194|Attention|attention
568488|NCT01143194|Vigilance|vigilance
568489|NCT01143194|Concentration|concentration
568490|NCT01143194|Memory|memory
568491|NCT01143194|Healthy Volunteer|healthy volunteer
568492|NCT01143181|CMV, ADV, HSV, VAVC, VARV|cmv, adv, hsv, vavc, varv
568493|NCT01143181|life threatening|life threatening
568494|NCT01143168|stem cells;|stem cells;
568495|NCT01143168|diabetes mellitus;|diabetes mellitus;
568496|NCT01143168|treatment.|treatment.
568497|NCT01143155|Pneumonia|pneumonia
568498|NCT01143155|Community-acquired pneumonia|community-acquired pneumonia
568499|NCT01143155|Healthcare-associated pneumonia|healthcare-associated pneumonia
568500|NCT01143155|Failure|failure
568501|NCT01143155|Cardiovascular events|cardiovascular events
568502|NCT01143155|Outcome|outcome
568503|NCT01143142|Human papillomavirus|human papillomavirus
568504|NCT01143142|HPV|hpv
568505|NCT01143142|Prevention|prevention
568506|NCT01143142|Tailoring|tailoring
568507|NCT01143142|Persuasive communication|persuasive communication
568508|NCT01143142|Adolescent|adolescent
568509|NCT01143129|Atrial fibrillation|atrial fibrillation
568510|NCT01143129|Cardiac surgery|cardiac surgery
568511|NCT01143129|Cardiopulmonary bypass|cardiopulmonary bypass
568512|NCT01143129|New-onset|new-onset
568513|NCT01143103|Respiratory therapy in neurologic disorder|respiratory therapy in neurologic disorder
568514|NCT01143090|Schizophrenia|schizophrenia
568515|NCT01143090|Lurasidone|lurasidone
568516|NCT01143090|Latuda|latuda
568517|NCT01143077|Lurasidone|lurasidone
568518|NCT01143077|Schizophrenia|schizophrenia
568519|NCT01143077|Latuda|latuda
568520|NCT01143064|Brain Injury|brain injury
568521|NCT01143064|Trauma|trauma
568522|NCT01143051|Asthma|asthma
568523|NCT01143051|Pharmacokinetics|pharmacokinetics
568524|NCT01143051|Epinephrine|epinephrine
568525|NCT01143051|Bronchodilator|bronchodilator
568526|NCT01143051|metered dose inhaler|metered dose inhaler
568527|NCT01143038|ITP|itp
568528|NCT01143025|Laparoscopic Cholecystectomy|laparoscopic cholecystectomy
568529|NCT01143025|Nebulization|nebulization
568530|NCT01143025|Ropivacaine|ropivacaine
568531|NCT01143012|Group eczema education|group eczema education
568532|NCT01142986|Methadone|methadone
568533|NCT01142986|Syringe exchange|syringe exchange
568534|NCT01142986|Treatment retention|treatment retention
568535|NCT01142986|Voucher incentives|voucher incentives
568536|NCT01142947|Inhaled corticosteroids|inhaled corticosteroids
568537|NCT01142947|Asthma|asthma
568538|NCT01142947|Pharmacogenomics|pharmacogenomics
568539|NCT01142947|Genome wide association study|genome wide association study
568540|NCT01142947|Admixture mapping|admixture mapping
568541|NCT01142947|Continental population groups|continental population groups
568542|NCT01142934|Catheter-related bloodstream infections|catheter-related bloodstream infections
568543|NCT01142934|Chlorhexidine|chlorhexidine
568544|NCT01142934|Transparent dressings|transparent dressings
568545|NCT01142921|Stent Occlusion|stent occlusion
568546|NCT01142921|Biliary Bleeding|biliary bleeding
568547|NCT01142921|Biliary Perforation|biliary perforation
568548|NCT01142908|Cardiovascular Disease|cardiovascular disease
568549|NCT01142908|Hypertension|hypertension
568550|NCT01142908|Diabetes|diabetes
568551|NCT01142908|Hyperlipidemia|hyperlipidemia
568552|NCT01142908|Adherence|adherence
568553|NCT01142882|adolescent HIV prevention|adolescent hiv prevention
568554|NCT01142882|web-based interventions|web-based interventions
568555|NCT01142882|adolescent substance abuse treatment|adolescent substance abuse treatment
568675|NCT01142336|Prevention|prevention
568556|NCT01142882|comparative effectiveness research|comparative effectiveness research
568557|NCT01142882|HIV prevention|hiv prevention
568558|NCT01142882|hepatitis prevention|hepatitis prevention
568559|NCT01142882|STI prevention|sti prevention
568560|NCT01142869|Carcinoma, Squamous Cell|carcinoma, squamous cell
568561|NCT01142869|Erbitux|erbitux
568562|NCT01142869|Neoplasms, Squamous Cell|neoplasms, squamous cell
568563|NCT01142843|clinical trial|clinical trial
568564|NCT01142843|mouthwash|mouthwash
568565|NCT01142843|green propolis|green propolis
568566|NCT01142843|dental plaque|dental plaque
568567|NCT01142843|gingivitis|gingivitis
568568|NCT01142830|Craniotomy|craniotomy
568569|NCT01142830|Pain|pain
568570|NCT01142830|Children|children
568571|NCT01142817|HIV|hiv
568572|NCT01142817|Women|women
568573|NCT01142817|Menopause|menopause
568574|NCT01142817|Dyslipidemia|dyslipidemia
568575|NCT01142817|Bone Mineral Density|bone mineral density
568576|NCT01142804|Walking programs|walking programs
568577|NCT01142804|Physical Activity|physical activity
568578|NCT01142804|Behavior Modification|behavior modification
568579|NCT01142804|Social Support|social support
568580|NCT01142791|Uterine fibroids|uterine fibroids
568581|NCT01142791|MRgFUS|mrgfus
568582|NCT01142791|ExAblate|exablate
568583|NCT01142791|Focused Ultrasound|focused ultrasound
568584|NCT01142791|Symptomatic uterine fibroids|symptomatic uterine fibroids
568585|NCT01142765|Vaccine|vaccine
568586|NCT01142765|Safety|safety
568587|NCT01142765|Immunogenicity|immunogenicity
568588|NCT01142765|Protection|protection
568589|NCT01142765|Sporozoite challenge|sporozoite challenge
568590|NCT01142713|Small Bowel Radiotherapy Dose|small bowel radiotherapy dose
568591|NCT01142713|This is a prospective non-randomized open study to evaluate the impact of patient's positioning and use of belly board in rectal radiotherapy|this is a prospective non-randomized open study to evaluate the impact of patient's positioning and use of belly board in rectal radiotherapy
568592|NCT01142687|Resting energy expenditure (REE)|resting energy expenditure (ree)
568593|NCT01142687|metabolic rate|metabolic rate
568594|NCT01142674|Lymphoma, T-Cell, Peripheral|lymphoma, t-cell, peripheral
568595|NCT01142674|Prognosis|prognosis
568596|NCT01142674|Outcome|outcome
568597|NCT01142674|International Cooperation|international cooperation
568598|NCT01142674|Biological Characteristics|biological characteristics
568599|NCT01142674|Heterogeneity|heterogeneity
568600|NCT01142674|Rare Diseases|rare diseases
568601|NCT01142661|Advanced breast cancer refractory to all commercially available therapies|advanced breast cancer refractory to all commercially available therapies
568602|NCT01142648|Electroencephalogram|electroencephalogram
568603|NCT01142648|Electromyogram|electromyogram
568604|NCT01142648|Entropy Index|entropy index
568605|NCT01142648|Bispectral Index|bispectral index
568606|NCT01142648|Reversal of neuromuscular blockade|reversal of neuromuscular blockade
568607|NCT01142635|Electroencephalogram|electroencephalogram
568608|NCT01142635|Electromyogram|electromyogram
568609|NCT01142635|Entropy Index|entropy index
568610|NCT01142635|Bispectral Index|bispectral index
568611|NCT01142635|Neuromuscular blockade; rocuronium|neuromuscular blockade; rocuronium
568612|NCT01142635|Propofol|propofol
568613|NCT01142635|Intubation|intubation
568614|NCT01142622|Ovarian Cysts|ovarian cysts
568615|NCT01142622|Nebulization|nebulization
568616|NCT01142622|Ropivacaine|ropivacaine
568617|NCT01142609|Web based videoconferencing|web based videoconferencing
568618|NCT01142609|methadone|methadone
568619|NCT01142609|substance abuse counseling|substance abuse counseling
568620|NCT01142583|Multiple sclerosis|multiple sclerosis
568621|NCT01142583|Expanded Disability Status Scale|expanded disability status scale
568622|NCT01142583|Multiple Sclerosis, Relapsing-Remitting|multiple sclerosis, relapsing-remitting
568623|NCT01142570|Mechanical Ventilation|mechanical ventilation
568624|NCT01142557|Multiple sclerosis|multiple sclerosis
568625|NCT01142557|Rebif|rebif
568626|NCT01142557|Interferon-beta|interferon-beta
568627|NCT01142544|acute lung injury|acute lung injury
568628|NCT01142544|incidence|incidence
568629|NCT01142544|lung damage|lung damage
568630|NCT01142544|PaO2/FiO2 ratio|pao2/fio2 ratio
568631|NCT01142518|Interferon beta-1a|interferon beta-1a
568632|NCT01142518|Multiple Sclerosis|multiple sclerosis
568633|NCT01142505|wheeze|wheeze
568634|NCT01142505|preschool|preschool
568635|NCT01142505|leukotriene|leukotriene
568636|NCT01142505|montelukast|montelukast
568637|NCT01142505|5-lipoxygenase|5-lipoxygenase
568638|NCT01142492|Interferon beta|interferon beta
568639|NCT01142492|Multiple Sclerosis|multiple sclerosis
568640|NCT01142479|Breast Cancer|breast cancer
568641|NCT01142479|Radiotherapy|radiotherapy
568642|NCT01142479|Chinese herbal medicine|chinese herbal medicine
568643|NCT01142479|TPE-1|tpe-1
568644|NCT01142479|Leukopenia|leukopenia
568645|NCT01142466|Multiple sclerosis|multiple sclerosis
568646|NCT01142466|Expanded Disability Status Scale|expanded disability status scale
568647|NCT01142466|Multiple Sclerosis, Relapsing-Remitting|multiple sclerosis, relapsing-remitting
568648|NCT01142466|Rebif|rebif
568649|NCT01142466|Beta-1, interferon|beta-1, interferon
568650|NCT01142453|Multiple sclerosis|multiple sclerosis
568651|NCT01142453|Rebif|rebif
568652|NCT01142453|Interferon|interferon
568653|NCT01142414|stage III squamous cell carcinoma of the hypopharynx|stage iii squamous cell carcinoma of the hypopharynx
568654|NCT01142414|stage IV squamous cell carcinoma of the hypopharynx|stage iv squamous cell carcinoma of the hypopharynx
568655|NCT01142414|stage III squamous cell carcinoma of the larynx|stage iii squamous cell carcinoma of the larynx
568656|NCT01142414|stage IV squamous cell carcinoma of the larynx|stage iv squamous cell carcinoma of the larynx
568657|NCT01142414|stage III squamous cell carcinoma of the lip and oral cavity|stage iii squamous cell carcinoma of the lip and oral cavity
568658|NCT01142414|stage IV squamous cell carcinoma of the lip and oral cavity|stage iv squamous cell carcinoma of the lip and oral cavity
568659|NCT01142414|stage III squamous cell carcinoma of the oropharynx|stage iii squamous cell carcinoma of the oropharynx
568660|NCT01142414|stage IV squamous cell carcinoma of the oropharynx|stage iv squamous cell carcinoma of the oropharynx
568661|NCT01142414|tongue cancer|tongue cancer
568662|NCT01142375|AML|aml
568663|NCT01142362|H5N1|h5n1
568664|NCT01142362|Avian Influenza|avian influenza
568665|NCT01142362|DNA Vaccine|dna vaccine
568666|NCT01142362|Intramuscular (IM) Injection|intramuscular (im) injection
568667|NCT01142362|Electroporation|electroporation
568668|NCT01142362|Healthy Adults|healthy adults
568669|NCT01142349|Arthritis|arthritis
568670|NCT01142349|Group Program|group program
568671|NCT01142349|Pain|pain
568672|NCT01142349|Insomnia|insomnia
568673|NCT01142349|Pain dysfunction and sleep disturbance among older adults with osteoarthritis.|pain dysfunction and sleep disturbance among older adults with osteoarthritis.
568674|NCT01142336|Alzheimer's Disease|alzheimer's disease
568676|NCT01142336|Spinal Fluid|spinal fluid
568677|NCT01142336|Biomarkers|biomarkers
568678|NCT01142336|Simvastatin|simvastatin
568679|NCT01142297|dental implant|dental implant
568680|NCT01142297|implant stabilization|implant stabilization
568681|NCT01142297|type 2 diabetes|type 2 diabetes
568682|NCT01142297|glycated hemoglobin 8.0-12.0%|glycated hemoglobin 8.0-12.0%
568683|NCT01142284|Biomarker|biomarker
568684|NCT01142284|Endothelial Function|endothelial function
568685|NCT01142284|Peripheral Artery Disease|peripheral artery disease
568686|NCT01142284|Coronary Artery Disease|coronary artery disease
568687|NCT01142284|Flow Mediated Dilation|flow mediated dilation
568688|NCT01142284|Cilostazol|cilostazol
568689|NCT01142284|Probucol|probucol
568690|NCT01142271|Distal gastrectomy|distal gastrectomy
568691|NCT01142271|Reconstruction|reconstruction
568692|NCT01142271|Reflux|reflux
568693|NCT01142271|subtotal gastrectomy|subtotal gastrectomy
568694|NCT01142258|Sleep Disturbances|sleep disturbances
568695|NCT01142258|Alzheimer disease|alzheimer disease
568696|NCT01142258|Insomnia|insomnia
568697|NCT01142258|Trazodone|trazodone
568698|NCT01142258|Treatment|treatment
568699|NCT01142245|ulcer bleeding|ulcer bleeding
568700|NCT01142245|endoscopic therapy|endoscopic therapy
568701|NCT01142232|autologous stem cell transplantation|autologous stem cell transplantation
568702|NCT01142219|sickle cell disease|sickle cell disease
568703|NCT01142219|L-arginine|l-arginine
568704|NCT01142219|hemolysis|hemolysis
568705|NCT01142219|nitric oxide|nitric oxide
568706|NCT01142219|pulmonary arterial hypertension|pulmonary arterial hypertension
568707|NCT01142206|Obesity|obesity
568708|NCT01142206|Weight Loss|weight loss
568709|NCT01142206|Leisure-time activities|leisure-time activities
568710|NCT01142206|Physical Activity|physical activity
568711|NCT01142206|Television watching|television watching
568712|NCT01142206|Dietary Intake|dietary intake
568713|NCT01142206|Energy|energy
568714|NCT01142206|Behavioral|behavioral
568715|NCT01142206|Healthy Eating|healthy eating
568716|NCT01142193|Epilepsy|epilepsy
568717|NCT01142193|partial onset seizure|partial onset seizure
568718|NCT01142193|adjunctive therapy|adjunctive therapy
568719|NCT01142180|Bleeding peptic ulcer|bleeding peptic ulcer
568720|NCT01142180|Active bleeding|active bleeding
568721|NCT01142180|Trans-arterial angiographic embolization|trans-arterial angiographic embolization
568722|NCT01142167|Ultra-thin colonoscope|ultra-thin colonoscope
568723|NCT01142154|Cockayne Syndrome|cockayne syndrome
568724|NCT01142154|Ageing|ageing
568725|NCT01142154|pediatrics|pediatrics
568726|NCT01142154|Pharmacokinetics|pharmacokinetics
568727|NCT01142154|Prodarsan|prodarsan
568728|NCT01142154|Dwarfism|dwarfism
568729|NCT01142154|Genetic disease, inborn|genetic disease, inborn
568730|NCT01142154|DNA Repair-Deficiency Disorders|dna repair-deficiency disorders
568731|NCT01142154|Tolerability|tolerability
568732|NCT01142154|Safety|safety
568733|NCT01142102|Bladder|bladder
568734|NCT01142102|Radiotherapy|radiotherapy
568735|NCT01142102|Online|online
568736|NCT01142102|Adaptive|adaptive
568737|NCT01142089|traveler's|traveler's
568738|NCT01142089|diarrhea|diarrhea
568739|NCT01142089|Rifamycin SV MMX|rifamycin sv mmx
568740|NCT01142089|Rifamycin|rifamycin
568741|NCT01142089|MMX|mmx
568742|NCT01142089|Traveler's Diarrhea|traveler's diarrhea
568743|NCT01142076|adiposity|adiposity
568744|NCT01142063|Neratinib|neratinib
568745|NCT01142050|stem cells;|stem cells;
568746|NCT01142050|diabetes mellitus;|diabetes mellitus;
568747|NCT01142050|treatment.|treatment.
568748|NCT01142037|Healthy volunteer|healthy volunteer
568749|NCT01142024|contrast medium induced nephropathy|contrast medium induced nephropathy
568750|NCT01142024|polymorphism of oxidative stress genes|polymorphism of oxidative stress genes
568751|NCT01142024|antioxidant prevention|antioxidant prevention
568752|NCT01142011|Waldenstroms|waldenstroms
568753|NCT01142011|Belimumab|belimumab
568754|NCT01142011|anti Blys|anti blys
568755|NCT01142011|monoclonal antibody|monoclonal antibody
568756|NCT01141985|cataract|cataract
568757|NCT01141985|cornea|cornea
568758|NCT01141985|keratoplasty|keratoplasty
568759|NCT01141972|Vitamin D|vitamin d
568760|NCT01141972|Obesity|obesity
568761|NCT01141972|Menopause|menopause
568762|NCT01141972|Hot Flashes|hot flashes
568763|NCT01141959|hematopoietic stem cell transplantation|hematopoietic stem cell transplantation
568764|NCT01141959|cyclophosphamide|cyclophosphamide
568765|NCT01141959|fludarabine|fludarabine
568766|NCT01141959|mycophenolate mofetil|mycophenolate mofetil
568767|NCT01141959|mycophenolic acid|mycophenolic acid
568768|NCT01141959|biomarkers|biomarkers
568769|NCT01141946|lung cancer|lung cancer
568770|NCT01141946|pleural effusion|pleural effusion
568771|NCT01141946|post-op care|post-op care
568772|NCT01141946|diaphragmatic ultrasound|diaphragmatic ultrasound
568773|NCT01141933|Creating meaning|creating meaning
568774|NCT01141933|Therapy|therapy
568775|NCT01141933|Cancer|cancer
568776|NCT01141933|Oncology|oncology
568777|NCT01141933|Existential|existential
568778|NCT01141933|Spirituality|spirituality
568779|NCT01141933|Quality of life|quality of life
568781|NCT01141933|Psycho-oncology|psycho-oncology
568782|NCT01141933|French-canadian|french-canadian
568783|NCT01141933|Cognitive therapy|cognitive therapy
568784|NCT01141933|Existentialism|existentialism
568785|NCT01141920|treatment retention|treatment retention
568786|NCT01141920|methadone maintenance|methadone maintenance
568787|NCT01141920|treatment induction|treatment induction
568788|NCT01141920|Retention in methadone maintenance treatment|retention in methadone maintenance treatment
568789|NCT01141907|heart failure|heart failure
568790|NCT01141907|self care|self care
568791|NCT01141907|decision support|decision support
568792|NCT01141907|telemonitoring|telemonitoring
568793|NCT01141907|navigator|navigator
568794|NCT01141894|Proximal Femoral Fracture|proximal femoral fracture
568795|NCT01141881|Tissue Plasminogen activator,|tissue plasminogen activator,
568796|NCT01141881|Clinically significant macular edema,|clinically significant macular edema,
568797|NCT01141881|Refractory Diabetic macular edema ,|refractory diabetic macular edema ,
568798|NCT01141881|posterior vitreous detachment|posterior vitreous detachment
568799|NCT01141868|insomnia|insomnia
568800|NCT01141868|breast cancer survivor|breast cancer survivor
568801|NCT01141868|Internet intervention|internet intervention
568802|NCT01141855|Cardiovascular Diseases|cardiovascular diseases
568803|NCT01141855|Peripheral Vascular Diseases|peripheral vascular diseases
568804|NCT01141855|Cerebrovascular Stroke|cerebrovascular stroke
568805|NCT01141855|Lung Diseases, Obstructive|lung diseases, obstructive
568806|NCT01141855|Asthma|asthma
568807|NCT01141855|Tobacco Use Disorder|tobacco use disorder
568808|NCT01141855|Smoking|smoking
568809|NCT01141855|Smoking Cessation|smoking cessation
568810|NCT01141842|lung cancer|lung cancer
568811|NCT01141842|exhalation analysis|exhalation analysis
568812|NCT01141842|chronic obstructive pulmonary disease|chronic obstructive pulmonary disease
568813|NCT01141842|cancer screening test|cancer screening test
568814|NCT01141829|NADPH oxidase|nadph oxidase
568815|NCT01141816|renal cell carcinoma|renal cell carcinoma
568816|NCT01141816|radiofrequency ablation|radiofrequency ablation
568817|NCT01141816|contrast enhanced ultrasound|contrast enhanced ultrasound
568818|NCT01141816|monitoring|monitoring
568819|NCT01141816|follow up|follow up
568820|NCT01141803|Apple|apple
568821|NCT01141803|Apple pomace|apple pomace
568822|NCT01141803|Metabolomics|metabolomics
568823|NCT01141803|Gene expression|gene expression
568824|NCT01141803|Lipid metabolism|lipid metabolism
568825|NCT01141803|Prevention|prevention
568826|NCT01141803|Antiinflammatory effect|antiinflammatory effect
568827|NCT01141790|Glasgow Coma Scale|glasgow coma scale
568828|NCT01141790|Glasgow Outcome Scale|glasgow outcome scale
568829|NCT01141790|Ethics|ethics
568830|NCT01141777|Spirulina platensis|spirulina platensis
568831|NCT01141777|Insulin resistance|insulin resistance
568832|NCT01141777|HIV/AIDS|hiv/aids
568833|NCT01141777|HAART|haart
568834|NCT01141777|Soya beans|soya beans
568835|NCT01141764|pediatrics|pediatrics
568836|NCT01141764|Epilepsy|epilepsy
568837|NCT01141764|Deep Brain Stimulation|deep brain stimulation
568838|NCT01141764|Positron Emission Tomography|positron emission tomography
568839|NCT01141751|Multiple sclerosis|multiple sclerosis
568840|NCT01141751|Expanded Disability Status Scale|expanded disability status scale
568841|NCT01141751|Multiple Sclerosis, Relapsing-Remitting; Rebif|multiple sclerosis, relapsing-remitting; rebif
568842|NCT01141751|Beta-1, interferon|beta-1, interferon
568843|NCT01141738|stroke|stroke
568844|NCT01141738|caregiver|caregiver
568845|NCT01141738|depression|depression
568846|NCT01141738|mediators|mediators
568847|NCT01141738|problem-solving|problem-solving
568848|NCT01141712|HIV|hiv
568849|NCT01141712|B-cell Lymphoma|b-cell lymphoma
568850|NCT01141712|Burkitt's Lymphoma|burkitt's lymphoma
568851|NCT01141712|Follicular Lymphoma|follicular lymphoma
568852|NCT01141712|Hodgkin's Lymphoma|hodgkin's lymphoma
568853|NCT01141699|women health behaviors|women health behaviors
568854|NCT01141686|lung cancer|lung cancer
568855|NCT01141673|FLT3-ITD|flt3-itd
568856|NCT01141673|acute myeloid leukemia|acute myeloid leukemia
568857|NCT01141673|FLT3|flt3
568858|NCT01141673|D835|d835
568859|NCT01141647|Adult|adult
568860|NCT01141647|Depression|depression
568861|NCT01141647|Supported Employment|supported employment
568862|NCT01141647|Health Service|health service
568863|NCT01141647|Humans|humans
568864|NCT01141647|Outcomes|outcomes
568865|NCT01141647|Quality of Life|quality of life
568866|NCT01141647|Veterans/rh (rehabilitation)|veterans/rh (rehabilitation)
568867|NCT01141647|Workplace|workplace
568868|NCT01141647|Spinal Cord Injuries|spinal cord injuries
568869|NCT01141634|Attention Deficit Hyperactivity Disorder|attention deficit hyperactivity disorder
568870|NCT01141634|Attention Deficit Disorder|attention deficit disorder
568871|NCT01141634|ADHD|adhd
568872|NCT01141634|ADD|add
568873|NCT01141634|Homeopathy|homeopathy
568874|NCT01141621|HS|hs
568875|NCT01141621|congenital hemolytic anemia|congenital hemolytic anemia
568876|NCT01141621|splenectomy|splenectomy
568877|NCT01141621|quality of life|quality of life
568878|NCT01141556|selenium|selenium
568879|NCT01141556|clinical outcome|clinical outcome
568880|NCT01141556|heart surgery|heart surgery
568881|NCT01141543|Plerixafor injection|plerixafor injection
568882|NCT01141530|Identify novel genes and predict putative proteins in breast cancer.|identify novel genes and predict putative proteins in breast cancer.
568883|NCT01141530|Find biomarkers that can be used for early detection, diagnosis, and prognosis.|find biomarkers that can be used for early detection, diagnosis, and prognosis.
568884|NCT01141517|adolescent quit-smoking program.|adolescent quit-smoking program.
568885|NCT01141504|Supplemental ATP|supplemental atp
568886|NCT01141504|Muscle Work Performed|muscle work performed
568887|NCT01141504|Muscle Fatigue|muscle fatigue
568888|NCT01141491|Sarcoma|sarcoma
568889|NCT01141491|Metastatic|metastatic
568890|NCT01141491|Vaccine|vaccine
568891|NCT01141491|Adjuvant|adjuvant
568892|NCT01141478|Carcinoma, Hepatocellular|carcinoma, hepatocellular
568893|NCT01141478|Proton Beam Radiotherapy|proton beam radiotherapy
568894|NCT01141478|Sorafenib|sorafenib
568895|NCT01141465|Primary care|primary care
568896|NCT01141465|Asthma management|asthma management
568897|NCT01141465|Combined therapy|combined therapy
568898|NCT01141465|Real-world|real-world
568899|NCT01141465|Effectiveness|effectiveness
568900|NCT01141465|Control|control
568901|NCT01141465|Exacerbations|exacerbations
568902|NCT01141452|chronic obstructive pulmonary disease|chronic obstructive pulmonary disease
568903|NCT01141452|inhaled corticosteroid|inhaled corticosteroid
568904|NCT01141452|increase|increase
568905|NCT01141452|initiate|initiate
568906|NCT01141452|exacerbations|exacerbations
568907|NCT01141452|treatment success|treatment success
568908|NCT01141439|Primary care|primary care
568909|NCT01141439|Asthma management|asthma management
568910|NCT01141439|Inhaled corticosteroids|inhaled corticosteroids
568911|NCT01141439|Beclomethasone dipropionate|beclomethasone dipropionate
568912|NCT01141439|Fluticasone propionate|fluticasone propionate
568913|NCT01141439|Metred dose inhaler|metred dose inhaler
568914|NCT01141439|Extra-fine hydrofluoroalkane|extra-fine hydrofluoroalkane
568915|NCT01141439|Chlorofluorocarbon|chlorofluorocarbon
568916|NCT01141426|depression|depression
568917|NCT01141426|treatment-resistance|treatment-resistance
568918|NCT01141426|psychodynamic psychotherapy|psychodynamic psychotherapy
568919|NCT01141426|Treatment refractory depression|treatment refractory depression
568920|NCT01141374|Stress|stress
568921|NCT01141361|Claudication|claudication
568922|NCT01141361|Artery|artery
568923|NCT01141361|Ambulatory technique|ambulatory technique
568924|NCT01141361|GPS|gps
568925|NCT01141335|shrinkage|shrinkage
568926|NCT01141335|postoperative pain and discomfort|postoperative pain and discomfort
569049|NCT01140880|Cocaine|cocaine
568927|NCT01141322|drug-induced liver injury|drug-induced liver injury
568928|NCT01141322|hepatitis, toxic|hepatitis, toxic
568929|NCT01141322|ursodeoxycholic acid|ursodeoxycholic acid
568930|NCT01141309|Everolimus|everolimus
568931|NCT01141309|Sorafenib|sorafenib
568932|NCT01141309|Thyroid|thyroid
568933|NCT01141309|10-060|10-060
568934|NCT01141283|Osteoarthritis|osteoarthritis
568935|NCT01141283|Opioid|opioid
568936|NCT01141283|Transdermal|transdermal
568937|NCT01141270|recombinant human follicle stimulating hormone|recombinant human follicle stimulating hormone
568938|NCT01141270|pharmacokinetics|pharmacokinetics
568939|NCT01141270|bioequivalence|bioequivalence
568940|NCT01141257|Angiocal®; PRS-050-PEG40; Solid tumor; Phase I|angiocal®; prs-050-peg40; solid tumor; phase i
568941|NCT01141218|non-small cell lung cancer|non-small cell lung cancer
568942|NCT01141205|AIDS vaccines|aids vaccines
568943|NCT01141205|HIV-1 vaccine|hiv-1 vaccine
568944|NCT01141205|Therapeutic vaccine|therapeutic vaccine
568945|NCT01141205|Cellular immunity|cellular immunity
568946|NCT01141192|vitamin D status|vitamin d status
568947|NCT01141192|25-OH D|25-oh d
568948|NCT01141192|ionized calcium|ionized calcium
568949|NCT01141192|fasting glucose|fasting glucose
568950|NCT01141192|hemoglobin A1c|hemoglobin a1c
568951|NCT01141192|fasting insulin|fasting insulin
568952|NCT01141192|glucose metabolism|glucose metabolism
568953|NCT01141192|HOMA index|homa index
568954|NCT01141192|blood lipids|blood lipids
568955|NCT01141192|type 2 diabetes|type 2 diabetes
568956|NCT01141192|PTH|pth
568957|NCT01141192|adiposity|adiposity
568958|NCT01141192|body fat percentage|body fat percentage
710868|NCT00587522|Endoluminal GERD Therapy|endoluminal gerd therapy
568959|NCT01141192|dual energy x-ray absorptiometry|dual energy x-ray absorptiometry
568960|NCT01141192|pulse wave velocity|pulse wave velocity
568961|NCT01141192|arterial stiffness|arterial stiffness
568962|NCT01141192|flow-mediated dilation|flow-mediated dilation
568963|NCT01141192|African American|african american
568964|NCT01141192|inflammatory markers|inflammatory markers
568965|NCT01141166|ELDERLY|elderly
568966|NCT01141166|NUTRITION|nutrition
568967|NCT01141153|atrial fibrillation|atrial fibrillation
568968|NCT01141153|Coronary Stent implantation|coronary stent implantation
568969|NCT01141153|Low-moderate risk of stroke|low-moderate risk of stroke
568970|NCT01141153|dual antiplatelet therapy|dual antiplatelet therapy
568971|NCT01141153|anticoagulation|anticoagulation
568972|NCT01141127|tranexamic acid in pediatric surgery|tranexamic acid in pediatric surgery
568973|NCT01141127|fibrinolysis and paediatric cardiac surgery|fibrinolysis and paediatric cardiac surgery
568974|NCT01141114|community health centers|community health centers
568975|NCT01141114|colorectal cancer screening|colorectal cancer screening
568976|NCT01141114|urban health|urban health
568977|NCT01141101|Methicillin-resistant Staphylococcus aureus|methicillin-resistant staphylococcus aureus
568978|NCT01141101|Neonatal|neonatal
568979|NCT01141101|Vertical transmission|vertical transmission
568980|NCT01141101|Horizontal transmission|horizontal transmission
568981|NCT01141101|MRSA colonization in enrolled infants|mrsa colonization in enrolled infants
568982|NCT01141101|MRSA colonization obtained from maternal source|mrsa colonization obtained from maternal source
568983|NCT01141101|MRSA colonization obtained from source other that mother|mrsa colonization obtained from source other that mother
568984|NCT01141062|Uterine Fibroids|uterine fibroids
568985|NCT01141049|Alcohol Withdrawal|alcohol withdrawal
568986|NCT01141049|Reducing Alcohol Consumption|reducing alcohol consumption
568987|NCT01141049|Promoting abstinence in alcohol-dependent patients|promoting abstinence in alcohol-dependent patients
568988|NCT01141049|Gabapentin|gabapentin
568989|NCT01141036|Propofol|propofol
568990|NCT01141036|Midazolam|midazolam
568991|NCT01141036|sedation|sedation
568992|NCT01141036|cirrhosis|cirrhosis
568993|NCT01141036|endoscopy|endoscopy
568994|NCT01141036|recovery time|recovery time
568995|NCT01141036|efficacy and safety of sedation|efficacy and safety of sedation
568996|NCT01141036|patient satisfaction|patient satisfaction
568997|NCT01141036|return to baseline function|return to baseline function
568998|NCT01141036|saturation of oxygen|saturation of oxygen
568999|NCT01141023|Parkinson|parkinson
569000|NCT01141023|Bio-markers|bio-markers
569001|NCT01141023|Neurodegenerative disorder|neurodegenerative disorder
569002|NCT01141023|Imaging|imaging
569003|NCT01141023|Prodromal|prodromal
569004|NCT01141010|Linguistic|linguistic
569005|NCT01141010|Stress response|stress response
569006|NCT01141010|Corticosteroid|corticosteroid
569007|NCT01141010|Cesarean section|cesarean section
569008|NCT01141010|Anxiety|anxiety
569009|NCT01141010|Depression|depression
569010|NCT01141010|Maternal psychosis|maternal psychosis
569011|NCT01140997|HCV|hcv
569012|NCT01140997|CHC|chc
569013|NCT01140997|Hepatitis C, Chronic|hepatitis c, chronic
569014|NCT01140997|Liver Diseases|liver diseases
569015|NCT01140997|Hepatitis, Chronic|hepatitis, chronic
569016|NCT01140997|Hepatitis, Viral, Human|hepatitis, viral, human
569017|NCT01140997|Hepadnaviridae Infections|hepadnaviridae infections
569018|NCT01140997|Antiviral Agents|antiviral agents
569019|NCT01140997|Virus Diseases|virus diseases
569020|NCT01140997|Peginterferon alfa|peginterferon alfa
569021|NCT01140984|acute graft versus host disease|acute graft versus host disease
569022|NCT01140984|intra arterial steroid infusion|intra arterial steroid infusion
569023|NCT01140984|steroid resistant acute hepatic graft versus host disease|steroid resistant acute hepatic graft versus host disease
569024|NCT01140971|Balloon dilatation,|balloon dilatation,
569025|NCT01140971|misoprostol,|misoprostol,
569026|NCT01140971|cervical ripening,|cervical ripening,
569027|NCT01140971|obstetric labor,|obstetric labor,
569028|NCT01140971|labor induced.|labor induced.
569029|NCT01140958|lung cancer|lung cancer
569030|NCT01140958|pharmacoeconomics|pharmacoeconomics
569031|NCT01140958|new agents|new agents
569032|NCT01140932|Retina|retina
569033|NCT01140932|Electroretinography|electroretinography
569034|NCT01140932|Diabetes Mellitus|diabetes mellitus
569035|NCT01140932|Glucose Intolerance|glucose intolerance
569036|NCT01140932|Physiology|physiology
569037|NCT01140906|Major depressive disorder|major depressive disorder
569038|NCT01140906|Placebo-controlled|placebo-controlled
569039|NCT01140906|Active reference|active reference
569040|NCT01140906|Multicenter study|multicenter study
569041|NCT01140906|Randomised study|randomised study
569042|NCT01140906|Acute treatment|acute treatment
569043|NCT01140893|Type 2 diabetes|type 2 diabetes
569044|NCT01140893|CSII|csii
569045|NCT01140893|Exenatide|exenatide
569046|NCT01140893|Double Blind Placebo Controlled Study|double blind placebo controlled study
569047|NCT01140880|Methamphetamine|methamphetamine
569048|NCT01140880|Amphetamine|amphetamine
569050|NCT01140880|HIV|hiv
569051|NCT01140880|Post-exposure prophylaxis|post-exposure prophylaxis
569052|NCT01140880|HIV seronegativity|hiv seronegativity
722519|NCT00538590|ologen|ologen
569053|NCT01140854|hypertension|hypertension
569054|NCT01140854|hypotension|hypotension
569055|NCT01140854|cognitive|cognitive
569056|NCT01140854|neurocognitive|neurocognitive
569057|NCT01140854|cognitive dysfunction|cognitive dysfunction
569058|NCT01140854|postoperative cognitive dysfunction (POCD)|postoperative cognitive dysfunction (pocd)
569059|NCT01140854|neuropsychometric|neuropsychometric
569060|NCT01140841|Dyskinesia|dyskinesia
569061|NCT01140828|Arthritis|arthritis
569062|NCT01140828|Bone pain|bone pain
569063|NCT01140828|dyspepsia|dyspepsia
569064|NCT01140815|Total Knee Arthroplasty|total knee arthroplasty
569065|NCT01140815|Bicompartmental Knee Arthroplasty|bicompartmental knee arthroplasty
569066|NCT01140802|First degree relatives|first degree relatives
569067|NCT01140802|Crohn's disease|crohn's disease
569068|NCT01140802|Ulcerative colitis|ulcerative colitis
569069|NCT01140802|Healthy control|healthy control
569070|NCT01140776|metastasis|metastasis
569071|NCT01140776|molecular pathology|molecular pathology
569072|NCT01140763|metastasis|metastasis
569073|NCT01140750|Heart Rate Variability|heart rate variability
569074|NCT01140750|Temperature Curve Complexity|temperature curve complexity
569075|NCT01140750|Autonomic Dysfunction|autonomic dysfunction
569076|NCT01140750|Prolonged Mechanical Ventilation|prolonged mechanical ventilation
569077|NCT01140750|Failure to Wean|failure to wean
569078|NCT01140737|advanced soft tissue sarcoma|advanced soft tissue sarcoma
569079|NCT01140724|pain|pain
569080|NCT01140724|genes|genes
569081|NCT01140724|morphine|morphine
569082|NCT01140724|respiratory depression|respiratory depression
569083|NCT01140724|tonsillectomy|tonsillectomy
569084|NCT01140724|children|children
569085|NCT01140724|Opioid adverse effects|opioid adverse effects
569086|NCT01140724|Pharmacogenetics of morphine|pharmacogenetics of morphine
569087|NCT01140724|Pharmacokinetics of morphine|pharmacokinetics of morphine
569088|NCT01140724|Personalizing analgesia|personalizing analgesia
569089|NCT01140685|mucus-stimulated (induced sputum)|mucus-stimulated (induced sputum)
569090|NCT01140685|lung disease (asthma, COPD, ILD and OLD)|lung disease (asthma, copd, ild and old)
569091|NCT01140685|HO-1 (heme oxigenase-1)|ho-1 (heme oxigenase-1)
569092|NCT01140685|oxidative stress|oxidative stress
569093|NCT01140685|CO (carbon monoxide)|co (carbon monoxide)
569094|NCT01140685|The oxidative stress in lung diseases|the oxidative stress in lung diseases
569095|NCT01140672|Healthy volunteers|healthy volunteers
569096|NCT01140672|pharmacokinetics|pharmacokinetics
569097|NCT01140672|safety|safety
569098|NCT01140672|tolerability|tolerability
569099|NCT01140672|multiple dosing|multiple dosing
569100|NCT01140672|Diabetic Nephropathies|diabetic nephropathies
569101|NCT01140659|Hyperhidrosis|hyperhidrosis
569102|NCT01140659|Thoracic sympathectomy|thoracic sympathectomy
569103|NCT01140659|Objective measurement of sweat|objective measurement of sweat
569104|NCT01140646|Hot flashes, dietary supplements, symptom management|hot flashes, dietary supplements, symptom management
569105|NCT01140633|HIV/AIDS|hiv/aids
569106|NCT01140633|pediatric|pediatric
569107|NCT01140633|wireless adherence monitoring|wireless adherence monitoring
569108|NCT01140633|HIV Infections|hiv infections
569109|NCT01140620|NMDA receptor antagonism|nmda receptor antagonism
569110|NCT01140620|cognitive processes|cognitive processes
569111|NCT01140620|healthy volunteers|healthy volunteers
569112|NCT01140620|dopamine antagonist|dopamine antagonist
569113|NCT01140620|schizophrenia|schizophrenia
569114|NCT01140568|glioma|glioma
569115|NCT01140568|PDGFR|pdgfr
569116|NCT01140568|kinase|kinase
569117|NCT01140568|inhibitor|inhibitor
569118|NCT01140568|malignant|malignant
569119|NCT01140568|nilotinib|nilotinib
569120|NCT01140542|Diabetes Mellitus Type 2|diabetes mellitus type 2
569121|NCT01140542|Roflumilast|roflumilast
569122|NCT01140529|Dexmedetomidine|dexmedetomidine
569123|NCT01140516|Antenatal|antenatal
569124|NCT01140490|Hemodialysis|hemodialysis
569125|NCT01140490|Sub-total Parathyroidectomy|sub-total parathyroidectomy
569126|NCT01140464|Adolescents|adolescents
569127|NCT01140438|Latent autoimmune diabetes|latent autoimmune diabetes
569128|NCT01140438|adults|adults
569129|NCT01140438|Beta cell rest|beta cell rest
569130|NCT01140438|Insulin secretion|insulin secretion
569131|NCT01140425|PF-00232798|pf-00232798
569132|NCT01140425|CCR5|ccr5
569133|NCT01140425|QT|qt
569134|NCT01140425|QTc|qtc
569135|NCT01140425|pharmacokinetics|pharmacokinetics
569136|NCT01140412|maraviroc|maraviroc
569137|NCT01140412|fosamprenavir|fosamprenavir
569138|NCT01140412|drug interaction|drug interaction
569139|NCT01140412|pharmacokinetics|pharmacokinetics
569140|NCT01140412|HIV|hiv
569141|NCT01140412|AIDS|aids
569142|NCT01140412|CCR5|ccr5
569143|NCT01140412|protease inhibitor|protease inhibitor
569144|NCT01140399|1 Acute Decompensated Heart Failure|1 acute decompensated heart failure
569145|NCT01140399|2 Cardiorenal Syndrome|2 cardiorenal syndrome
569146|NCT01140399|3 Ultrafiltration|3 ultrafiltration
569147|NCT01140399|4 Dopamine|4 dopamine
569148|NCT01140386|venous thromboembolism|venous thromboembolism
569149|NCT01140386|duplex ultrasound|duplex ultrasound
569150|NCT01140386|pediatric population|pediatric population
569151|NCT01140386|Vascular lab duplex ultrasound database|vascular lab duplex ultrasound database
569152|NCT01140386|Inpatient hospital admission/discharge ICD-9 database|inpatient hospital admission/discharge icd-9 database
569153|NCT01140386|PTSF pediatric trauma database|ptsf pediatric trauma database
569154|NCT01140373|Prostate|prostate
569155|NCT01140373|Autologous T Cells|autologous t cells
569156|NCT01140373|Castrate Metastatic Prostate Cancer|castrate metastatic prostate cancer
569157|NCT01140373|cyclophosphamide|cyclophosphamide
569158|NCT01140373|09-036|09-036
569159|NCT01140360|Neurofibromas|neurofibromas
569160|NCT01140347|Hepatocellular carcinoma (HCC)|hepatocellular carcinoma (hcc)
569161|NCT01140347|recombinant human immunoglobulin G|recombinant human immunoglobulin g
569162|NCT01140347|subclass 1 (IgG1) monoclonal antibody (MAb)|subclass 1 (igg1) monoclonal antibody (mab)
569260|NCT01139853|pyloric stenosis|pyloric stenosis
570442|NCT01136330|Prognosis|prognosis
569163|NCT01140347|Hepatocellular Carcinoma (HCC) following First-Line Therapy With Sorafenib|hepatocellular carcinoma (hcc) following first-line therapy with sorafenib
569164|NCT01140334|Psychiatric adherence|psychiatric adherence
569165|NCT01140334|Voucher incentives|voucher incentives
569166|NCT01140334|Methadone treatment|methadone treatment
569167|NCT01140321|Thalassemia|thalassemia
569168|NCT01140321|Neridronate|neridronate
569169|NCT01140321|Osteopenia|osteopenia
569170|NCT01140321|Osteoporosis|osteoporosis
569171|NCT01140308|Statin Myopathy|statin myopathy
569172|NCT01140308|CoEnzyme Q10|coenzyme q10
569173|NCT01140308|CoQ10|coq10
569174|NCT01140308|Statin Myalgia|statin myalgia
569175|NCT01140295|Preparation|preparation
569176|NCT01140295|Pediatric|pediatric
569177|NCT01140295|Colonoscopy|colonoscopy
569178|NCT01140282|cancer survivor|cancer survivor
569179|NCT01140269|Burn|burn
569180|NCT01140269|Sepsis|sepsis
569181|NCT01140269|Infection|infection
569182|NCT01140256|Zinc|zinc
569183|NCT01140256|SGA|sga
569184|NCT01140256|AGA|aga
569185|NCT01140256|stable isotope|stable isotope
569186|NCT01140243|fat formulation|fat formulation
569187|NCT01140230|rotator cuff tear|rotator cuff tear
569188|NCT01140230|rotator cuff repair|rotator cuff repair
569189|NCT01140230|age|age
569190|NCT01140230|timing to surgery|timing to surgery
569191|NCT01140217|contraception|contraception
569192|NCT01140217|pregnancy|pregnancy
569193|NCT01140204|stent|stent
569194|NCT01140204|contrast media|contrast media
569195|NCT01140204|paclitaxel|paclitaxel
569196|NCT01140204|stent implantation|stent implantation
569197|NCT01140191|leishmaniasis|leishmaniasis
569198|NCT01140191|cutaneous|cutaneous
569199|NCT01140191|WR 279,396|wr 279,396
569200|NCT01140191|paromomycin|paromomycin
569201|NCT01140191|gentamicin|gentamicin
569202|NCT01140191|pharmacokinetics|pharmacokinetics
569203|NCT01140191|safety|safety
569204|NCT01140191|efficacy|efficacy
569205|NCT01140191|military|military
569206|NCT01140178|Photodynamic Therapy|photodynamic therapy
569207|NCT01140178|Oral dysplasia|oral dysplasia
569208|NCT01140178|oral cavity carcinoma|oral cavity carcinoma
569209|NCT01140178|oropharynx carcinoma.|oropharynx carcinoma.
569210|NCT01140152|intestinal transplantation|intestinal transplantation
569211|NCT01140152|rejection|rejection
569212|NCT01140152|proteomics|proteomics
569213|NCT01140152|innate immunity|innate immunity
569214|NCT01140126|HIV-1, CD4, antibody, immunotherapy|hiv-1, cd4, antibody, immunotherapy
569215|NCT01140113|hemoconcentration|hemoconcentration
569216|NCT01140113|ultrafiltration|ultrafiltration
569217|NCT01140113|coronary artery disease|coronary artery disease
569218|NCT01140087|Face Transplant|face transplant
569219|NCT01140087|Composite Tissue Allograft|composite tissue allograft
569220|NCT01140087|Facial Allotransplantation|facial allotransplantation
569221|NCT01140074|acute diarrhoea, children|acute diarrhoea, children
569222|NCT01140048|Asthma|asthma
569223|NCT01140035|Insulin|insulin
569224|NCT01140035|Deceased donors|deceased donors
569225|NCT01140035|Renal Allograft Function|renal allograft function
569226|NCT01140035|Transplanted Allograft Outcomes|transplanted allograft outcomes
569227|NCT01140022|Chlamydia, Screening, young women, kiosk, computer module|chlamydia, screening, young women, kiosk, computer module
569228|NCT01140009|Vaccine|vaccine
569229|NCT01140009|Seasonal Influenza vaccine|seasonal influenza vaccine
569230|NCT01140009|Influenza vaccine|influenza vaccine
569231|NCT01140009|Vaccine safety|vaccine safety
569232|NCT01140009|Vaccine immunogenicity|vaccine immunogenicity
569233|NCT01140009|Fluviral 2010/11|fluviral 2010/11
569234|NCT01139983|osteosarcoma|osteosarcoma
569235|NCT01139944|recurrent non-small cell lung cancer|recurrent non-small cell lung cancer
569236|NCT01139944|stage I non-small cell lung cancer|stage i non-small cell lung cancer
569237|NCT01139944|stage II non-small cell lung cancer|stage ii non-small cell lung cancer
569238|NCT01139944|squamous cell lung cancer|squamous cell lung cancer
569239|NCT01139931|childhood acute myeloid leukemia/other myeloid malignancies|childhood acute myeloid leukemia/other myeloid malignancies
569240|NCT01139918|psoriatic arthritis|psoriatic arthritis
569241|NCT01139918|psoriasis|psoriasis
569242|NCT01139918|Quality of life|quality of life
569243|NCT01139905|Lopinavir/ritonavir|lopinavir/ritonavir
569244|NCT01139905|pharmacokinetic|pharmacokinetic
569245|NCT01139905|low dose|low dose
569246|NCT01139905|HIV-infected children|hiv-infected children
569247|NCT01139905|pharmacokinetics of low-dose lopinavir/ritonavir in HIV-1 infected Thai children.|pharmacokinetics of low-dose lopinavir/ritonavir in hiv-1 infected thai children.
569248|NCT01139892|Unruptured aneurysm|unruptured aneurysm
569249|NCT01139892|endovascular treatment|endovascular treatment
569250|NCT01139892|surgical treatment|surgical treatment
569251|NCT01139892|randomized|randomized
569252|NCT01139892|intracranial aneurysm|intracranial aneurysm
569253|NCT01139879|Pressure Ulcer treatment Mattresses|pressure ulcer treatment mattresses
569254|NCT01139879|Home Care|home care
569255|NCT01139879|Extended Care|extended care
569256|NCT01139879|Wound measurements|wound measurements
569257|NCT01139866|Long-term Safety|long-term safety
569258|NCT01139866|Shoulder Surgery|shoulder surgery
569259|NCT01139866|bupivacaine|bupivacaine
570734|NCT01134926|misoprostol|misoprostol
569261|NCT01139853|nasogastric tube|nasogastric tube
569262|NCT01139853|pyloromyotomy|pyloromyotomy
569263|NCT01139840|vitamin D2|vitamin d2
569264|NCT01139840|vitamin D3|vitamin d3
569265|NCT01139840|ergocalciferol|ergocalciferol
569266|NCT01139840|cholecalciferol|cholecalciferol
569267|NCT01139840|vitamin D status|vitamin d status
569268|NCT01139840|To determine relative potency of vitamins D2 and D3 under conditions of continuous administration|to determine relative potency of vitamins d2 and d3 under conditions of continuous administration
569269|NCT01139840|To determine change in vitamin D content of subcutaneous fat after 12 weeks' administration|to determine change in vitamin d content of subcutaneous fat after 12 weeks' administration
569270|NCT01139827|atherosclerosis|atherosclerosis
569271|NCT01139827|inflammation|inflammation
569272|NCT01139827|hsCRP|hscrp
569273|NCT01139827|Framingham risk score|framingham risk score
569274|NCT01139827|positron emission tomography|positron emission tomography
569275|NCT01139827|inflammation in FDG-PET|inflammation in fdg-pet
569276|NCT01139814|atrial flutter|atrial flutter
569277|NCT01139814|AVNRT|avnrt
569278|NCT01139814|right sided accessory pathway|right sided accessory pathway
569279|NCT01139814|ventricular tachycardia|ventricular tachycardia
569280|NCT01139814|Patients who have one or more standard indications for a right-sided diagnostic electrophysiology procedure.|patients who have one or more standard indications for a right-sided diagnostic electrophysiology procedure.
569281|NCT01139801|Cervical Ripening|cervical ripening
569282|NCT01139801|Rate of Cesearean Section|rate of cesearean section
569283|NCT01139788|Cancer|cancer
569284|NCT01139775|solid tumors|solid tumors
569285|NCT01139775|Mesothelioma|mesothelioma
569286|NCT01139775|Carcinoma|carcinoma
569287|NCT01139762|Benign Prostatic Hyperplasia (BPH)|benign prostatic hyperplasia (bph)
569288|NCT01139762|Enlarged Prostate|enlarged prostate
569289|NCT01139749|oral isotretinoin|oral isotretinoin
569290|NCT01139749|sebaceous secretion|sebaceous secretion
569291|NCT01139749|seborrhea|seborrhea
569292|NCT01139749|seborrheic dermatitis|seborrheic dermatitis
569293|NCT01139749|quality of life|quality of life
569294|NCT01139749|Malassezia|malassezia
569295|NCT01139736|Irritable bowel syndrome|irritable bowel syndrome
569296|NCT01139736|IBS|ibs
569297|NCT01139736|probiotics|probiotics
569298|NCT01139736|rectal sensitivity|rectal sensitivity
569299|NCT01139736|gut flora|gut flora
569300|NCT01139736|gut bacteria|gut bacteria
569301|NCT01139710|SARCOIDOSIS|sarcoidosis
569302|NCT01139710|PULMONARY HYPERTENSION|pulmonary hypertension
569303|NCT01139710|outpatients clinic at Meir medical center|outpatients clinic at meir medical center
569304|NCT01139697|Heart failure|heart failure
569305|NCT01139697|Cortisol|cortisol
569306|NCT01139697|Testosterone|testosterone
569307|NCT01139684|Exercise test|exercise test
569308|NCT01139671|Remifentanil|remifentanil
569309|NCT01139671|Sufentanil|sufentanil
569310|NCT01139671|Surgical removal of three to four wisdom teeth|surgical removal of three to four wisdom teeth
569311|NCT01139671|General anaesthesia|general anaesthesia
569312|NCT01139671|Ambulatory oral surgery|ambulatory oral surgery
569313|NCT01139671|Target Controlled Infusion (TCI)|target controlled infusion (tci)
569314|NCT01139671|Opioid induced hyperalgesia|opioid induced hyperalgesia
569315|NCT01139671|Postoperative nausea and vomiting|postoperative nausea and vomiting
569316|NCT01139671|Postoperative Morphine consumption|postoperative morphine consumption
569317|NCT01139671|Under General anaesthesia|under general anaesthesia
569318|NCT01139671|In Ambulatory surgery|in ambulatory surgery
569319|NCT01139645|Calcium|calcium
569320|NCT01139645|bone|bone
569321|NCT01139645|metabolism|metabolism
569322|NCT01139645|Proton Pump Inhibitors|proton pump inhibitors
569323|NCT01139645|Rabeprazole|rabeprazole
569324|NCT01139645|Esomeprazole|esomeprazole
569325|NCT01139645|Lanzoprazole|lanzoprazole
569326|NCT01139645|Vitamin D|vitamin d
569327|NCT01139645|bone and bones|bone and bones
569328|NCT01139632|NAFLD|nafld
569329|NCT01139632|lP-pla2|lp-pla2
569330|NCT01139632|Coronary Arthery Disease|coronary arthery disease
569331|NCT01139619|Biopsy Mapping|biopsy mapping
569332|NCT01139619|Non small cell lung cancer|non small cell lung cancer
569333|NCT01139619|NSCLC|nsclc
569334|NCT01139619|Lung cancer diagnosis|lung cancer diagnosis
569335|NCT01139619|Retrospective|retrospective
569336|NCT01139619|Inoperable Non Small Cell Lung Cancer|inoperable non small cell lung cancer
569337|NCT01139593|IVF|ivf
569338|NCT01139593|ICSI|icsi
569339|NCT01139593|gonadotropin|gonadotropin
569340|NCT01139593|am dose|am dose
569341|NCT01139593|pm dose|pm dose
569342|NCT01139593|pregnancy|pregnancy
569343|NCT01139593|implantation|implantation
569344|NCT01139593|live birth|live birth
569345|NCT01139580|Plaque Psoriasis|plaque psoriasis
569346|NCT01139580|Psoriasis|psoriasis
569347|NCT01139567|Diabetic Wounds|diabetic wounds
569348|NCT01139567|Hyperbaric Oxygen|hyperbaric oxygen
569349|NCT01139567|Laser Speckle Imaging|laser speckle imaging
569350|NCT01139567|Hyperbaric Oxygenation|hyperbaric oxygenation
569351|NCT01139528|Fracture|fracture
569352|NCT01139528|5th metacarpal bone|5th metacarpal bone
569353|NCT01139528|Bouquet pinning|bouquet pinning
569354|NCT01139528|Fractures of the neck of the 5th metacarpal bone|fractures of the neck of the 5th metacarpal bone
569355|NCT01139515|pharmacokinetic|pharmacokinetic
569356|NCT01139515|eletriptan|eletriptan
569358|NCT01139515|crossover|crossover
569359|NCT01139502|schizophrenia spectrum disorders|schizophrenia spectrum disorders
569360|NCT01139502|work rehabilitation|work rehabilitation
569361|NCT01139502|cognitive therapy|cognitive therapy
569362|NCT01139502|cognitive training|cognitive training
569363|NCT01139502|Adaptation to work|adaptation to work
569364|NCT01139502|Work as a treatment factor|work as a treatment factor
569365|NCT01139489|Procalcitonin|procalcitonin
569366|NCT01139489|antibiotic therapy|antibiotic therapy
569367|NCT01139489|antibiotics|antibiotics
569368|NCT01139489|sepsis|sepsis
569369|NCT01139489|infections|infections
569370|NCT01139489|biomarker|biomarker
569371|NCT01139476|Multiple Myeloma|multiple myeloma
569372|NCT01139476|MGUS|mgus
569373|NCT01139476|Leukemia|leukemia
569374|NCT01139476|Biorepository|biorepository
569375|NCT01139463|antipsychotics|antipsychotics
569376|NCT01139463|lactates|lactates
569377|NCT01139463|side effects|side effects
569378|NCT01139450|Atopic Dermatitis|atopic dermatitis
569379|NCT01139437|Vaccine|vaccine
569380|NCT01139437|HPIV2|hpiv2
569381|NCT01139437|Infants|infants
569382|NCT01139424|surgical leak|surgical leak
569383|NCT01139424|endoscopic suturing|endoscopic suturing
569384|NCT01139424|Anastomotic leakage|anastomotic leakage
569385|NCT01139424|esophageal or gastric resection|esophageal or gastric resection
569386|NCT01139398|Cholesterol|cholesterol
569387|NCT01139398|LDL-cholesterol|ldl-cholesterol
569388|NCT01139398|Coronary artery disease|coronary artery disease
569389|NCT01139398|Red yeast rice|red yeast rice
569390|NCT01139398|Plants extract|plants extract
569391|NCT01139398|Cholesterol excess.|cholesterol excess.
569392|NCT01139372|Dry eye, artificial tears|dry eye, artificial tears
569393|NCT01139359|Lymphoma|lymphoma
569394|NCT01139359|Darinaparsin|darinaparsin
569395|NCT01139359|CHOP|chop
569396|NCT01139359|Frontline|frontline
569397|NCT01139359|PTCL|ptcl
569398|NCT01139359|B-cell|b-cell
569399|NCT01139346|carcinoma|carcinoma
569400|NCT01139346|sarcoma|sarcoma
569401|NCT01139346|metastatic|metastatic
569402|NCT01139346|solid tumor|solid tumor
569403|NCT01139333|childhood acute myeloid leukemia/other myeloid malignancies|childhood acute myeloid leukemia/other myeloid malignancies
569404|NCT01139320|untreated childhood acute myeloid leukemia and other myeloid malignancies|untreated childhood acute myeloid leukemia and other myeloid malignancies
569405|NCT01139307|adult acute megakaryoblastic leukemia (M7)|adult acute megakaryoblastic leukemia (m7)
569406|NCT01139307|childhood acute megakaryocytic leukemia (M7)|childhood acute megakaryocytic leukemia (m7)
569407|NCT01139307|recurrent adult acute myeloid leukemia|recurrent adult acute myeloid leukemia
569408|NCT01139307|recurrent childhood acute myeloid leukemia|recurrent childhood acute myeloid leukemia
569409|NCT01139307|untreated adult acute myeloid leukemia|untreated adult acute myeloid leukemia
569410|NCT01139307|untreated childhood acute myeloid leukemia and other myeloid malignancies|untreated childhood acute myeloid leukemia and other myeloid malignancies
569411|NCT01139294|cardiac output|cardiac output
569412|NCT01139294|dehydration|dehydration
569413|NCT01139294|pediatrics|pediatrics
569414|NCT01139281|Ear protection|ear protection
569415|NCT01139281|Ginkgo Biloba Extract|ginkgo biloba extract
569416|NCT01139281|Distortion-product otoacoustic emission|distortion-product otoacoustic emission
569417|NCT01139281|Ototoxicity|ototoxicity
569418|NCT01139281|Cisplatin|cisplatin
569419|NCT01139268|embryo viability|embryo viability
569420|NCT01139242|CRC screening status|crc screening status
569421|NCT01139242|physical activity level|physical activity level
569422|NCT01139242|fruit and vegetable consumption|fruit and vegetable consumption
569423|NCT01139242|Early Detection of Cancer|early detection of cancer
569424|NCT01139242|Colorectal Cancer (CRC) screening status|colorectal cancer (crc) screening status
569425|NCT01139229|Esophagogastrostomy|esophagogastrostomy
569426|NCT01139229|Circular everted anastomosis|circular everted anastomosis
569427|NCT01139229|Side-side anastomosis|side-side anastomosis
569428|NCT01139229|Randomized clinical trial|randomized clinical trial
569429|NCT01139216|Digestive system diseases|digestive system diseases
569430|NCT01139216|Gastrointestinal diseases|gastrointestinal diseases
569431|NCT01139216|Intestinal diseases|intestinal diseases
569432|NCT01139216|Colonic inertia|colonic inertia
569433|NCT01139203|HBV recurrence|hbv recurrence
569434|NCT01139203|entecavir|entecavir
569435|NCT01139190|NSAID-induced gastroduodenal ulcerations or erosion|nsaid-induced gastroduodenal ulcerations or erosion
569436|NCT01139177|Peripheral vascular disease - SFA and popliteal arteries.|peripheral vascular disease - sfa and popliteal arteries.
569437|NCT01139164|high-risk hematological malignancies|high-risk hematological malignancies
569438|NCT01139151|Advanced Hematologic Malignancies|advanced hematologic malignancies
569439|NCT01139151|4'-Thio-araC|4'-thio-arac
569440|NCT01139151|Thiarabine|thiarabine
569441|NCT01139151|4'-thio-â-D-arabinofuranosylcytosine|4'-thio-â-d-arabinofuranosylcytosine
569442|NCT01139151|deoxycytidine nucleoside analog|deoxycytidine nucleoside analog
569443|NCT01139151|poor-risk myelodysplasia|poor-risk myelodysplasia
569444|NCT01139151|MDS|mds
569445|NCT01139151|refractory anemia|refractory anemia
569446|NCT01139151|Excess blasts|excess blasts
569447|NCT01139151|RAEB-1|raeb-1
569448|NCT01139151|RAEB-2|raeb-2
569449|NCT01139151|Chronic myelomonocytic leukemia|chronic myelomonocytic leukemia
569450|NCT01139151|CMML|cmml
569451|NCT01139151|Relapsed/refractory leukemia|relapsed/refractory leukemia
569452|NCT01139151|Acute non-lymphocytic leukemia|acute non-lymphocytic leukemia
569453|NCT01139151|AML|aml
569454|NCT01139151|Acute lymphocytic leukemia|acute lymphocytic leukemia
569455|NCT01139151|ALL|all
569456|NCT01139151|Chronic lymphocytic leukemia|chronic lymphocytic leukemia
569457|NCT01139151|CLL|cll
569458|NCT01139151|Chronic myelogenous leukemia|chronic myelogenous leukemia
569459|NCT01139151|CML|cml
569460|NCT01139151|blast crisis|blast crisis
569461|NCT01139138|Colorectal Cancer|colorectal cancer
569462|NCT01139138|Colorectal Carcinoma|colorectal carcinoma
569463|NCT01139138|Colorectal Tumors|colorectal tumors
569464|NCT01139138|Neoplasms, Colorectal|neoplasms, colorectal
569465|NCT01139112|Necrotizing Fasciitis, Klebsiella Pneumoniae|necrotizing fasciitis, klebsiella pneumoniae
569466|NCT01139086|chronic heart failure|chronic heart failure
569467|NCT01139086|isokinetic test|isokinetic test
569468|NCT01139086|near-infrared spectroscopy|near-infrared spectroscopy
569469|NCT01139086|laser Doppler flowmetry|laser doppler flowmetry
569470|NCT01139086|endothelial function|endothelial function
569471|NCT01139073|Halitosis|halitosis
569472|NCT01139060|chronic or recurrent depression|chronic or recurrent depression
569473|NCT01139021|Children|children
569474|NCT01139021|Meningococcal disease|meningococcal disease
569475|NCT01139021|Prevention|prevention
569476|NCT01139021|Vaccination|vaccination
569477|NCT01138995|Poststroke/CVA hemiparesis|poststroke/cva hemiparesis
569478|NCT01138995|Drop Foot|drop foot
569479|NCT01138995|Gait Disorders, Neurological|gait disorders, neurological
569480|NCT01138995|Gait, Drop foot|gait, drop foot
569481|NCT01138982|Youth mentoring|youth mentoring
569482|NCT01138982|Effectiveness|effectiveness
569483|NCT01138982|Sweden|sweden
569484|NCT01138982|low-risk youth|low-risk youth
569485|NCT01138969|proton pump inhibitor|proton pump inhibitor
569486|NCT01138969|peptic ulcer|peptic ulcer
569487|NCT01138969|clopidogrel|clopidogrel
569488|NCT01138969|prevention|prevention
569489|NCT01138956|Visceral leishmaniasis|visceral leishmaniasis
569490|NCT01138956|N-acetylcysteine|n-acetylcysteine
569491|NCT01138956|Antimony|antimony
569492|NCT01138956|Immune response|immune response
569493|NCT01138943|Chlorhexidine mouthrinse|chlorhexidine mouthrinse
569494|NCT01138943|Plaque control|plaque control
569495|NCT01138930|Polycystic Ovary Syndrome|polycystic ovary syndrome
569496|NCT01138930|Obesity|obesity
569497|NCT01138917|Second Degree Burn Injuries|second degree burn injuries
569498|NCT01138904|gastric cancer|gastric cancer
569499|NCT01138904|oxaliplatin|oxaliplatin
569500|NCT01138904|irinotecan|irinotecan
569501|NCT01138904|sequential treatment|sequential treatment
569502|NCT01138891|Breast implants|breast implants
569503|NCT01138891|capsular contraction|capsular contraction
569504|NCT01138891|sonication|sonication
569505|NCT01138891|biofilm|biofilm
569506|NCT01138891|Complications|complications
569507|NCT01138891|surgery|surgery
569508|NCT01138878|HIV|hiv
569509|NCT01138878|testing|testing
569510|NCT01138878|non traditional settings|non traditional settings
569511|NCT01138878|acceptability|acceptability
569512|NCT01138878|feasibility|feasibility
569513|NCT01138865|Obstructive sleep apnea|obstructive sleep apnea
569514|NCT01138865|Cytokine levels|cytokine levels
569515|NCT01138865|Insulin resistance|insulin resistance
569516|NCT01138865|Hypertension|hypertension
569517|NCT01138865|Dyslipidemia|dyslipidemia
569518|NCT01138865|Albumin-creatinine ratio|albumin-creatinine ratio
569519|NCT01138865|Continuous positive airway pressure (CPAP)|continuous positive airway pressure (cpap)
569520|NCT01138852|post-cesarean infections|post-cesarean infections
569521|NCT01138852|ampicillin-sulbactam|ampicillin-sulbactam
569522|NCT01138852|cefuroxime|cefuroxime
569523|NCT01138852|cesarean|cesarean
569524|NCT01138839|HELLP 1|hellp 1
569525|NCT01138839|Dexamethasone|dexamethasone
569526|NCT01138839|Clinical trial|clinical trial
569527|NCT01138826|biological availability|biological availability
569528|NCT01138826|bioavailability|bioavailability
569529|NCT01138826|amlodipine|amlodipine
569530|NCT01138826|orally disintegrating tablet|orally disintegrating tablet
569531|NCT01138826|ODT|odt
569532|NCT01138826|tablets|tablets
569533|NCT01138813|magnetic resonance spectroscopy (MRS)|magnetic resonance spectroscopy (mrs)
569534|NCT01138813|lactate editing|lactate editing
569535|NCT01138813|metabolite content|metabolite content
569536|NCT01138813|glioma|glioma
569537|NCT01138774|Obesity|obesity
569538|NCT01138774|Calorie restriction|calorie restriction
569539|NCT01138774|Eicosapentaenoic acid (EPA)|eicosapentaenoic acid (epa)
569540|NCT01138774|Lipoic acid|lipoic acid
569541|NCT01138774|Weight loss|weight loss
569542|NCT01138774|Insulin sensitivity|insulin sensitivity
569543|NCT01138774|Lipid metabolism|lipid metabolism
569544|NCT01138774|Adipokines|adipokines
569545|NCT01138774|Inflammation|inflammation
569546|NCT01138774|Oxidative stress|oxidative stress
569547|NCT01138774|Adipose tissue gene profile|adipose tissue gene profile
569548|NCT01138774|Metabolomic profile|metabolomic profile
569549|NCT01138761|pediatric atopic dermatitis|pediatric atopic dermatitis
569551|NCT01138761|REALM-SF|realm-sf
569552|NCT01138761|nurse instruction|nurse instruction
569553|NCT01138761|health literacy|health literacy
569554|NCT01138748|inoperable early stage non-small cell lung cancer|inoperable early stage non-small cell lung cancer
569555|NCT01138748|radiation therapy|radiation therapy
569556|NCT01138722|early stage non-small cell lung cancer|early stage non-small cell lung cancer
569557|NCT01138722|hypofractionated radiation therapy|hypofractionated radiation therapy
569559|NCT01138683|Acute decompensated heart failure|acute decompensated heart failure
569560|NCT01138683|ultrafiltration|ultrafiltration
569561|NCT01138683|diuretics|diuretics
569562|NCT01138683|AKI|aki
569563|NCT01138657|inflammation of uvea|inflammation of uvea
569564|NCT01138644|Atrial Fibrillation|atrial fibrillation
569565|NCT01138644|Atrial Flutter|atrial flutter
569566|NCT01138631|IVF, Infertility, embryo selection, embryoscope, time-lapse|ivf, infertility, embryo selection, embryoscope, time-lapse
569567|NCT01138618|Clozapine|clozapine
569568|NCT01138618|hematological monitoring|hematological monitoring
569569|NCT01138618|CHEMPAQ|chempaq
569570|NCT01138618|Granulocytes|granulocytes
569571|NCT01138618|WBC|wbc
569572|NCT01138605|TMC114|tmc114
569573|NCT01138605|TMC114-TiDP29-C232|tmc114-tidp29-c232
569574|NCT01138605|TMC114-C232|tmc114-c232
569575|NCT01138605|Darunavir|darunavir
569576|NCT01138605|PREZISTA|prezista
569577|NCT01138579|FBTA05|fbta05
569578|NCT01138579|CD20|cd20
569579|NCT01138579|CLL|cll
569580|NCT01138579|NHL|nhl
569581|NCT01138579|DLI|dli
569582|NCT01138579|allogeneic transplantation|allogeneic transplantation
569583|NCT01138579|CD20 positive chronic lymphocytic leukemia (CLL)|cd20 positive chronic lymphocytic leukemia (cll)
569584|NCT01138579|low and high grade non-Hodgkin´s lymphoma (NHL) after allogeneic stem cell transplantation with active disease|low and high grade non-hodgkin´s lymphoma (nhl) after allogeneic stem cell transplantation with active disease
569585|NCT01138566|community-onset urinary tract infections caused by Enterobacteriaceae|community-onset urinary tract infections caused by enterobacteriaceae
569586|NCT01138553|biomarker|biomarker
569587|NCT01138553|breast cancer|breast cancer
569588|NCT01138553|antiprogesterone|antiprogesterone
569589|NCT01138540|VAP|vap
569590|NCT01138527|multi-parametric MRI approach|multi-parametric mri approach
569591|NCT01138475|PTH|pth
569592|NCT01138475|Gastric bypass surgery|gastric bypass surgery
569593|NCT01138475|vitamin D|vitamin d
569594|NCT01138475|paricalcitol|paricalcitol
569595|NCT01138462|Methicillin-Resistant Staphylococcus aureus|methicillin-resistant staphylococcus aureus
569596|NCT01138462|Decolonisation|decolonisation
569597|NCT01138462|Nursing homes|nursing homes
569598|NCT01138462|Infection Control|infection control
569599|NCT01138449|Vitamin A|vitamin a
569600|NCT01138449|Neonatal mortality|neonatal mortality
569601|NCT01138449|Infant mortality|infant mortality
569602|NCT01138436|Venous Leg Ulcers, VLU|venous leg ulcers, vlu
569603|NCT01138423|Hypertension|hypertension
569604|NCT01138423|Metabolic Syndrome X|metabolic syndrome x
569605|NCT01138423|Obesity|obesity
569606|NCT01138423|Adiposity|adiposity
569607|NCT01138423|Clinical trial|clinical trial
569608|NCT01138410|Immunotherapy|immunotherapy
569609|NCT01138410|Melanoma|melanoma
569610|NCT01138410|Gene therapy|gene therapy
569611|NCT01138410|DNA plasmid|dna plasmid
569612|NCT01138410|Cancer vaccine|cancer vaccine
569613|NCT01138410|Electroporation|electroporation
569614|NCT01138410|CTL response|ctl response
569615|NCT01138397|Influenza|influenza
569616|NCT01138397|Influenza vaccine|influenza vaccine
569617|NCT01138397|Influenza virus|influenza virus
569618|NCT01138397|Intradermal|intradermal
569619|NCT01138384|Breast Cancer|breast cancer
723307|NCT00535223|War|war
569620|NCT01138371|LDL apheresis|ldl apheresis
569621|NCT01138371|Familial hypercholesterolemia|familial hypercholesterolemia
569622|NCT01138371|Inflammatory markers|inflammatory markers
569623|NCT01138371|Hyperlipidemia|hyperlipidemia
569624|NCT01138371|Cardiovascular disease|cardiovascular disease
569625|NCT01138358|dyspnea|dyspnea
569626|NCT01138358|lung metastases|lung metastases
569627|NCT01138358|recurrent non-small cell lung cancer|recurrent non-small cell lung cancer
569628|NCT01138358|recurrent small cell lung cancer|recurrent small cell lung cancer
569629|NCT01138358|extensive stage small cell lung cancer|extensive stage small cell lung cancer
569630|NCT01138358|stage IIIA non-small cell lung cancer|stage iiia non-small cell lung cancer
569631|NCT01138358|stage IIIB non-small cell lung cancer|stage iiib non-small cell lung cancer
569632|NCT01138358|stage IV non-small cell lung cancer|stage iv non-small cell lung cancer
569633|NCT01138345|cancer survivor|cancer survivor
569634|NCT01138345|stage I breast cancer|stage i breast cancer
569635|NCT01138345|stage II breast cancer|stage ii breast cancer
569636|NCT01138345|stage IIIA breast cancer|stage iiia breast cancer
569637|NCT01138345|stage IIIB breast cancer|stage iiib breast cancer
569638|NCT01138345|stage IIIC breast cancer|stage iiic breast cancer
569639|NCT01138332|childhood acute myeloid leukemia/other myeloid malignancies|childhood acute myeloid leukemia/other myeloid malignancies
569640|NCT01138319|adult acute myeloid leukemia|adult acute myeloid leukemia
569641|NCT01138319|childhood acute myeloid leukemia/other myeloid malignancies|childhood acute myeloid leukemia/other myeloid malignancies
569642|NCT01138306|childhood acute myeloid leukemia/other myeloid malignancies|childhood acute myeloid leukemia/other myeloid malignancies
569643|NCT01138293|differences between patients´ self-assessment and objective perception of physical activity and eating habits|differences between patients´ self-assessment and objective perception of physical activity and eating habits
569644|NCT01138280|biofilm formation|biofilm formation
569645|NCT01138280|proinflammatory cytokines|proinflammatory cytokines
569646|NCT01138280|high sensitive c reactive protein|high sensitive c reactive protein
569647|NCT01138280|cardiovascular events|cardiovascular events
569648|NCT01138280|overall mortality|overall mortality
569649|NCT01138280|hemodialysis|hemodialysis
569650|NCT01138267|pharmacogenomics|pharmacogenomics
569651|NCT01138267|ATV|atv
569652|NCT01138267|EFV|efv
569653|NCT01138267|pharmacogenomics of ATV and EFV|pharmacogenomics of atv and efv
569654|NCT01138254|flow,echocardiography,far infrared therapy,nitric oxide|flow,echocardiography,far infrared therapy,nitric oxide
569655|NCT01138241|HIV|hiv
569656|NCT01138241|Chronic kidney disease|chronic kidney disease
569657|NCT01138241|Glomerular Filtration Rate (GFR)|glomerular filtration rate (gfr)
569658|NCT01138241|Tenofovir|tenofovir
569659|NCT01138241|Serum creatinine (sCr)|serum creatinine (scr)
569660|NCT01138241|24 hr urine creatinine clearance|24 hr urine creatinine clearance
569661|NCT01138241|Serum Cystatin C[40]|serum cystatin c[40]
569662|NCT01138241|Modification of Diet in Renal Disease (MDRD)|modification of diet in renal disease (mdrd)
569663|NCT01138241|Cockcroft Gault Equation|cockcroft gault equation
569664|NCT01138241|Chronic Kidney Disease Epidemiology Collaboration (CKD-EPI)|chronic kidney disease epidemiology collaboration (ckd-epi)
569665|NCT01138241|99mTc-diethylenetriaminepentaacetic acid (Tc-99m DTPA) scan|99mtc-diethylenetriaminepentaacetic acid (tc-99m dtpa) scan
569666|NCT01138241|Validate which renal function assessments can accurately detect GFR and assess the effect of TDF concentration on renal function|validate which renal function assessments can accurately detect gfr and assess the effect of tdf concentration on renal function
569667|NCT01138228|intravenous cannulation|intravenous cannulation
569668|NCT01138228|vein identification|vein identification
569669|NCT01138228|vascular identification|vascular identification
569670|NCT01138228|vein cannulation|vein cannulation
569671|NCT01138215|varicella-zoster virus vaccine|varicella-zoster virus vaccine
569672|NCT01138215|varicella-zoster virus antibody|varicella-zoster virus antibody
569673|NCT01138215|immunogenicity|immunogenicity
569674|NCT01138215|safety and efficacy|safety and efficacy
569675|NCT01138215|HIV-infected children|hiv-infected children
569676|NCT01138215|Assess protective VZV Antibody|assess protective vzv antibody
569677|NCT01138215|Adverse events from VZV vaccine|adverse events from vzv vaccine
569678|NCT01138202|pharmacokinetics|pharmacokinetics
569679|NCT01138202|safety|safety
569680|NCT01138202|efficacy|efficacy
569681|NCT01138202|Lopinavir/ritonavir|lopinavir/ritonavir
569682|NCT01138202|HIV/TB|hiv/tb
569683|NCT01138202|rifampicin containing anti-tuberculosis therapy|rifampicin containing anti-tuberculosis therapy
569684|NCT01138202|Pharmacokinetics and safety of Lopinavir/ritonavir with rifampicin containing anti-tuberculosis therapy|pharmacokinetics and safety of lopinavir/ritonavir with rifampicin containing anti-tuberculosis therapy
569685|NCT01138189|Wavefront-guided LASIK.|wavefront-guided lasik.
569686|NCT01138189|Wavefront-optimized LASIK.|wavefront-optimized lasik.
569687|NCT01138189|Custom LASIK|custom lasik
569688|NCT01138176|Neonatal encephalopathy|neonatal encephalopathy
569689|NCT01138176|Therapeutic hypothermia|therapeutic hypothermia
569690|NCT01138176|Phase changing material|phase changing material
569691|NCT01138176|MR imaging|mr imaging
569692|NCT01138163|NSCLC|nsclc
569693|NCT01138163|second-line|second-line
569694|NCT01138163|lung cancer|lung cancer
569695|NCT01138163|non small cell lung cancer|non small cell lung cancer
569696|NCT01138163|bavituximab|bavituximab
569697|NCT01138163|monoclonal antibody|monoclonal antibody
569698|NCT01138150|migraine, headache, sumatriptan, naproxen sodium|migraine, headache, sumatriptan, naproxen sodium
569699|NCT01138137|ovarian cancer|ovarian cancer
569700|NCT01138137|epithelial ovarian cancer|epithelial ovarian cancer
569701|NCT01138137|peritoneal cancer|peritoneal cancer
569702|NCT01138124|renal cell carcinoma|renal cell carcinoma
569703|NCT01138124|epidemiology|epidemiology
569704|NCT01138124|pancreatic cancer|pancreatic cancer
569705|NCT01138124|renal cancer|renal cancer
569706|NCT01138124|renal pelvis cancer|renal pelvis cancer
569707|NCT01138124|GPRD|gprd
569708|NCT01138124|case-control|case-control
569709|NCT01138124|Gapabentin|gapabentin
569710|NCT01138111|Florbetaben|florbetaben
569711|NCT01138111|Amyloid beta-protein|amyloid beta-protein
569712|NCT01138111|MCI|mci
569713|NCT01138111|Alzheimer's disease|alzheimer's disease
569714|NCT01138098|Persistence|persistence
569715|NCT01138098|challenge dose|challenge dose
569716|NCT01138098|Engerix-B|engerix-b
569717|NCT01138098|immune response|immune response
569718|NCT01138085|Triple negative breast cancer|triple negative breast cancer
569719|NCT01138085|BRAF wild-type melanoma|braf wild-type melanoma
569720|NCT01138085|Solid tumors|solid tumors
569721|NCT01138085|Endometrial Cancer|endometrial cancer
569722|NCT01138085|Oncology|oncology
569723|NCT01138085|GSK2141795|gsk2141795
569724|NCT01138085|AKT Inhibitor|akt inhibitor
569725|NCT01138085|GSK1120212|gsk1120212
569726|NCT01138072|GSK2248761, atorvastatin, rosuvastatin, simvastatin, drug interaction, pharmacokinetics|gsk2248761, atorvastatin, rosuvastatin, simvastatin, drug interaction, pharmacokinetics
569727|NCT01138059|Acute ischemic stroke with unclear onset time|acute ischemic stroke with unclear onset time
569728|NCT01138046|advanced/metastatic breast cancer|advanced/metastatic breast cancer
569729|NCT01138046|lapatinib|lapatinib
569731|NCT01138046|ErbB2-overexpressing|erbb2-overexpressing
569732|NCT01138046|pharmacokinetics|pharmacokinetics
569733|NCT01138046|dual kinase inhibitor|dual kinase inhibitor
569734|NCT01138046|HER-2/neu|her-2/neu
569735|NCT01138046|EGFR|egfr
569736|NCT01138046|ErbB1|erbb1
569737|NCT01138033|pharmacodynamics|pharmacodynamics
569738|NCT01138033|cancer|cancer
569739|NCT01138033|focal adhesion kinase inhibitor|focal adhesion kinase inhibitor
569740|NCT01138033|pharmacokinetics|pharmacokinetics
569741|NCT01138033|solid tumors|solid tumors
569742|NCT01138033|Phase 1|phase 1
569743|NCT01138020|Rehabilitation Outcome|rehabilitation outcome
569744|NCT01138020|Cognitive treatment|cognitive treatment
569745|NCT01138020|TBI|tbi
569746|NCT01138007|Bupropion|bupropion
569747|NCT01138007|323U66 Sustained Release (SR)|323u66 sustained release (sr)
569748|NCT01138007|MDD (Major Depressive Disorder)|mdd (major depressive disorder)
569749|NCT01138007|IVRS HAM-D|ivrs ham-d
569750|NCT01138007|IDS-SR|ids-sr
569751|NCT01138007|MADRS|madrs
569752|NCT01137994|ErbB2|erbb2
569753|NCT01137994|Trastuzumab|trastuzumab
569754|NCT01137994|p95HER2|p95her2
569755|NCT01137994|Metastatic Breast Cancer|metastatic breast cancer
569756|NCT01137994|HER2|her2
569757|NCT01137994|Lapatinib|lapatinib
569758|NCT01137981|Combivir (Zidovudine+Lamivudine)|combivir (zidovudine+lamivudine)
569759|NCT01137981|Antiretrovirals|antiretrovirals
569760|NCT01137981|ARV|arv
569761|NCT01137981|HAART|haart
569762|NCT01137981|Maraviroc|maraviroc
569763|NCT01137981|Delavirdine|delavirdine
569764|NCT01137981|Lamivudine|lamivudine
569765|NCT01137981|Antiretroviral Pregnancy Registry|antiretroviral pregnancy registry
569766|NCT01137981|Fosamprenavir|fosamprenavir
569767|NCT01137981|APR|apr
569768|NCT01137981|Zidovudine|zidovudine
569769|NCT01137981|pregnancy registry|pregnancy registry
569770|NCT01137981|Amprenavir|amprenavir
569771|NCT01137981|HIV|hiv
569772|NCT01137981|Trizivir (Abacavir+Lamivudine+Zidovudine)|trizivir (abacavir+lamivudine+zidovudine)
569773|NCT01137981|Epzicom (Abacavir+Lamivudine)|epzicom (abacavir+lamivudine)
569774|NCT01137968|imetelstat|imetelstat
569775|NCT01137968|imetelstat sodium|imetelstat sodium
569776|NCT01137968|GRN163L|grn163l
569777|NCT01137968|telomerase inhibitor|telomerase inhibitor
569778|NCT01137968|telomerase inhibition|telomerase inhibition
569779|NCT01137968|maintenance therapy|maintenance therapy
569780|NCT01137968|non-small cell lung cancer|non-small cell lung cancer
569781|NCT01137968|relapsed non-small cell lung cancer|relapsed non-small cell lung cancer
569782|NCT01137968|advanced non-small cell lung cancer|advanced non-small cell lung cancer
569783|NCT01137968|NSCLC, cancer stem cells|nsclc, cancer stem cells
569784|NCT01137968|Bevacizumab|bevacizumab
569785|NCT01137968|post induction chemotherapy|post induction chemotherapy
569786|NCT01137955|Gastrointestinal Symptom Rating Scale (GSRS)|gastrointestinal symptom rating scale (gsrs)
569787|NCT01137955|Poorly responsive|poorly responsive
569788|NCT01137955|Refractory|refractory
569789|NCT01137955|Small intestine bacterial overgrowth|small intestine bacterial overgrowth
569790|NCT01137955|Breath test|breath test
569791|NCT01137942|helicobacter pylori|helicobacter pylori
710869|NCT00587496|HSV DNA|hsv dna
569792|NCT01137942|eradication failure|eradication failure
569793|NCT01137929|Vesicoureteral reflux|vesicoureteral reflux
569794|NCT01137929|Kidney|kidney
569795|NCT01137929|Renal Scar|renal scar
569796|NCT01137929|Urinary tract infection|urinary tract infection
569797|NCT01137903|Diabetic foot|diabetic foot
569798|NCT01137903|Osteomyelitis|osteomyelitis
569799|NCT01137903|Diabetic foot ulcers|diabetic foot ulcers
569800|NCT01137903|Foot infections|foot infections
569801|NCT01137890|cocaine|cocaine
569802|NCT01137890|addiction|addiction
569803|NCT01137890|drug dependence|drug dependence
569804|NCT01137890|anticonvulsant|anticonvulsant
569805|NCT01137890|zonisamide|zonisamide
569806|NCT01137890|drug self-administration|drug self-administration
569807|NCT01137890|nicotine withdrawal|nicotine withdrawal
569808|NCT01137890|neurocognition|neurocognition
569809|NCT01137864|Emergency wards|emergency wards
569810|NCT01137864|Hospitalization|hospitalization
569811|NCT01137864|Adults|adults
569812|NCT01137864|Antimicrobial therapy|antimicrobial therapy
569813|NCT01137825|cognitive/functional effects|cognitive/functional effects
569814|NCT01137825|unspecified adult solid tumor, protocol specific|unspecified adult solid tumor, protocol specific
569815|NCT01137825|accelerated phase chronic myelogenous leukemia|accelerated phase chronic myelogenous leukemia
569816|NCT01137825|acute undifferentiated leukemia|acute undifferentiated leukemia
569817|NCT01137825|adult acute lymphoblastic leukemia in remission|adult acute lymphoblastic leukemia in remission
569818|NCT01137825|adult acute myeloid leukemia in remission|adult acute myeloid leukemia in remission
569819|NCT01137825|adult acute myeloid leukemia with 11q23 (MLL) abnormalities|adult acute myeloid leukemia with 11q23 (mll) abnormalities
569820|NCT01137825|adult acute myeloid leukemia with inv(16)(p13;q22)|adult acute myeloid leukemia with inv(16)(p13;q22)
569821|NCT01137825|adult acute myeloid leukemia with t(15;17)(q22;q12)|adult acute myeloid leukemia with t(15;17)(q22;q12)
569822|NCT01137825|adult acute myeloid leukemia with t(16;16)(p13;q22)|adult acute myeloid leukemia with t(16;16)(p13;q22)
569823|NCT01137825|adult acute myeloid leukemia with t(8;21)(q22;q22)|adult acute myeloid leukemia with t(8;21)(q22;q22)
569824|NCT01137825|atypical chronic myeloid leukemia, BCR-ABL negative|atypical chronic myeloid leukemia, bcr-abl negative
569825|NCT01137825|blastic phase chronic myelogenous leukemia|blastic phase chronic myelogenous leukemia
569826|NCT01137825|chronic myelomonocytic leukemia|chronic myelomonocytic leukemia
569827|NCT01137825|chronic phase chronic myelogenous leukemia|chronic phase chronic myelogenous leukemia
569828|NCT01137825|mast cell leukemia|mast cell leukemia
569829|NCT01137825|meningeal chronic myelogenous leukemia|meningeal chronic myelogenous leukemia
569830|NCT01137825|progressive hairy cell leukemia, initial treatment|progressive hairy cell leukemia, initial treatment
569831|NCT01137825|prolymphocytic leukemia|prolymphocytic leukemia
569832|NCT01137825|recurrent adult acute lymphoblastic leukemia|recurrent adult acute lymphoblastic leukemia
569833|NCT01137825|recurrent adult acute myeloid leukemia|recurrent adult acute myeloid leukemia
569834|NCT01137825|recurrent adult T-cell leukemia/lymphoma|recurrent adult t-cell leukemia/lymphoma
569835|NCT01137825|refractory chronic lymphocytic leukemia|refractory chronic lymphocytic leukemia
569836|NCT01137825|refractory hairy cell leukemia|refractory hairy cell leukemia
569837|NCT01137825|relapsing chronic myelogenous leukemia|relapsing chronic myelogenous leukemia
569838|NCT01137825|secondary acute myeloid leukemia|secondary acute myeloid leukemia
569839|NCT01137825|stage 0 chronic lymphocytic leukemia|stage 0 chronic lymphocytic leukemia
569840|NCT01137825|stage I adult T-cell leukemia/lymphoma|stage i adult t-cell leukemia/lymphoma
569841|NCT01137825|stage I chronic lymphocytic leukemia|stage i chronic lymphocytic leukemia
569842|NCT01137825|stage II adult T-cell leukemia/lymphoma|stage ii adult t-cell leukemia/lymphoma
569843|NCT01137825|stage II chronic lymphocytic leukemia|stage ii chronic lymphocytic leukemia
569844|NCT01137825|stage III adult T-cell leukemia/lymphoma|stage iii adult t-cell leukemia/lymphoma
569845|NCT01137825|stage III chronic lymphocytic leukemia|stage iii chronic lymphocytic leukemia
569846|NCT01137825|stage IV adult T-cell leukemia/lymphoma|stage iv adult t-cell leukemia/lymphoma
569847|NCT01137825|stage IV chronic lymphocytic leukemia|stage iv chronic lymphocytic leukemia
569848|NCT01137825|T-cell large granular lymphocyte leukemia|t-cell large granular lymphocyte leukemia
569849|NCT01137825|untreated adult acute lymphoblastic leukemia|untreated adult acute lymphoblastic leukemia
569850|NCT01137825|untreated adult acute myeloid leukemia|untreated adult acute myeloid leukemia
569851|NCT01137825|untreated hairy cell leukemia|untreated hairy cell leukemia
569852|NCT01137825|recurrent adult Hodgkin lymphoma|recurrent adult hodgkin lymphoma
569853|NCT01137825|stage I adult Hodgkin lymphoma|stage i adult hodgkin lymphoma
569854|NCT01137825|stage II adult Hodgkin lymphoma|stage ii adult hodgkin lymphoma
569855|NCT01137825|stage III adult Hodgkin lymphoma|stage iii adult hodgkin lymphoma
569856|NCT01137825|stage IV adult Hodgkin lymphoma|stage iv adult hodgkin lymphoma
569857|NCT01137825|anaplastic large cell lymphoma|anaplastic large cell lymphoma
569858|NCT01137825|angioimmunoblastic T-cell lymphoma|angioimmunoblastic t-cell lymphoma
569859|NCT01137825|cutaneous B-cell non-Hodgkin lymphoma|cutaneous b-cell non-hodgkin lymphoma
569860|NCT01137825|recurrent cutaneous T-cell non-Hodgkin lymphoma|recurrent cutaneous t-cell non-hodgkin lymphoma
569861|NCT01137825|stage I cutaneous T-cell non-Hodgkin lymphoma|stage i cutaneous t-cell non-hodgkin lymphoma
569862|NCT01137825|stage II cutaneous T-cell non-Hodgkin lymphoma|stage ii cutaneous t-cell non-hodgkin lymphoma
710870|NCT00587496|volunteers|volunteers
569863|NCT01137825|stage III cutaneous T-cell non-Hodgkin lymphoma|stage iii cutaneous t-cell non-hodgkin lymphoma
569864|NCT01137825|stage IV cutaneous T-cell non-Hodgkin lymphoma|stage iv cutaneous t-cell non-hodgkin lymphoma
569865|NCT01137825|recurrent mycosis fungoides/Sezary syndrome|recurrent mycosis fungoides/sezary syndrome
569866|NCT01137825|stage I mycosis fungoides/Sezary syndrome|stage i mycosis fungoides/sezary syndrome
569867|NCT01137825|stage II mycosis fungoides/Sezary syndrome|stage ii mycosis fungoides/sezary syndrome
569868|NCT01137825|stage III mycosis fungoides/Sezary syndrome|stage iii mycosis fungoides/sezary syndrome
569869|NCT01137825|stage IV mycosis fungoides/Sezary syndrome|stage iv mycosis fungoides/sezary syndrome
569870|NCT01137825|adult grade III lymphomatoid granulomatosis|adult grade iii lymphomatoid granulomatosis
569871|NCT01137825|adult nasal type extranodal NK/T-cell lymphoma|adult nasal type extranodal nk/t-cell lymphoma
569872|NCT01137825|Waldenstrom macroglobulinemia|waldenstrom macroglobulinemia
569873|NCT01137825|extranodal marginal zone B-cell lymphoma of mucosa-associated lymphoid tissue|extranodal marginal zone b-cell lymphoma of mucosa-associated lymphoid tissue
569874|NCT01137825|nodal marginal zone B-cell lymphoma|nodal marginal zone b-cell lymphoma
569875|NCT01137825|splenic marginal zone lymphoma|splenic marginal zone lymphoma
569876|NCT01137825|contiguous stage II adult Burkitt lymphoma|contiguous stage ii adult burkitt lymphoma
569877|NCT01137825|contiguous stage II adult diffuse large cell lymphoma|contiguous stage ii adult diffuse large cell lymphoma
569878|NCT01137825|contiguous stage II adult diffuse mixed cell lymphoma|contiguous stage ii adult diffuse mixed cell lymphoma
569879|NCT01137825|contiguous stage II adult diffuse small cleaved cell lymphoma|contiguous stage ii adult diffuse small cleaved cell lymphoma
569880|NCT01137825|contiguous stage II adult immunoblastic large cell lymphoma|contiguous stage ii adult immunoblastic large cell lymphoma
571434|NCT01132209|surgery|surgery
569881|NCT01137825|contiguous stage II adult lymphoblastic lymphoma|contiguous stage ii adult lymphoblastic lymphoma
569882|NCT01137825|contiguous stage II grade 1 follicular lymphoma|contiguous stage ii grade 1 follicular lymphoma
569883|NCT01137825|contiguous stage II grade 2 follicular lymphoma|contiguous stage ii grade 2 follicular lymphoma
569884|NCT01137825|contiguous stage II grade 3 follicular lymphoma|contiguous stage ii grade 3 follicular lymphoma
569885|NCT01137825|contiguous stage II mantle cell lymphoma|contiguous stage ii mantle cell lymphoma
569886|NCT01137825|contiguous stage II marginal zone lymphoma|contiguous stage ii marginal zone lymphoma
569887|NCT01137825|contiguous stage II small lymphocytic lymphoma|contiguous stage ii small lymphocytic lymphoma
569888|NCT01137825|stage I adult Burkitt lymphoma|stage i adult burkitt lymphoma
569889|NCT01137825|stage I adult diffuse large cell lymphoma|stage i adult diffuse large cell lymphoma
569890|NCT01137825|stage I adult diffuse mixed cell lymphoma|stage i adult diffuse mixed cell lymphoma
569891|NCT01137825|stage I adult diffuse small cleaved cell lymphoma|stage i adult diffuse small cleaved cell lymphoma
569892|NCT01137825|stage I adult immunoblastic large cell lymphoma|stage i adult immunoblastic large cell lymphoma
569893|NCT01137825|stage I adult lymphoblastic lymphoma|stage i adult lymphoblastic lymphoma
569894|NCT01137825|stage I grade 1 follicular lymphoma|stage i grade 1 follicular lymphoma
569895|NCT01137825|stage I grade 2 follicular lymphoma|stage i grade 2 follicular lymphoma
569896|NCT01137825|stage I grade 3 follicular lymphoma|stage i grade 3 follicular lymphoma
569897|NCT01137825|stage I mantle cell lymphoma|stage i mantle cell lymphoma
569898|NCT01137825|stage I marginal zone lymphoma|stage i marginal zone lymphoma
569899|NCT01137825|stage I small lymphocytic lymphoma|stage i small lymphocytic lymphoma
569900|NCT01137825|noncontiguous stage II adult Burkitt lymphoma|noncontiguous stage ii adult burkitt lymphoma
569901|NCT01137825|noncontiguous stage II adult diffuse large cell lymphoma|noncontiguous stage ii adult diffuse large cell lymphoma
569902|NCT01137825|noncontiguous stage II adult diffuse mixed cell lymphoma|noncontiguous stage ii adult diffuse mixed cell lymphoma
569903|NCT01137825|noncontiguous stage II adult diffuse small cleaved cell lymphoma|noncontiguous stage ii adult diffuse small cleaved cell lymphoma
569904|NCT01137825|noncontiguous stage II adult immunoblastic large cell lymphoma|noncontiguous stage ii adult immunoblastic large cell lymphoma
569905|NCT01137825|noncontiguous stage II adult lymphoblastic lymphoma|noncontiguous stage ii adult lymphoblastic lymphoma
569906|NCT01137825|noncontiguous stage II grade 1 follicular lymphoma|noncontiguous stage ii grade 1 follicular lymphoma
569907|NCT01137825|noncontiguous stage II grade 2 follicular lymphoma|noncontiguous stage ii grade 2 follicular lymphoma
569908|NCT01137825|noncontiguous stage II grade 3 follicular lymphoma|noncontiguous stage ii grade 3 follicular lymphoma
569909|NCT01137825|noncontiguous stage II mantle cell lymphoma|noncontiguous stage ii mantle cell lymphoma
569910|NCT01137825|noncontiguous stage II marginal zone lymphoma|noncontiguous stage ii marginal zone lymphoma
569911|NCT01137825|noncontiguous stage II small lymphocytic lymphoma|noncontiguous stage ii small lymphocytic lymphoma
569912|NCT01137825|stage III adult Burkitt lymphoma|stage iii adult burkitt lymphoma
569913|NCT01137825|stage III adult diffuse large cell lymphoma|stage iii adult diffuse large cell lymphoma
569914|NCT01137825|stage III adult diffuse mixed cell lymphoma|stage iii adult diffuse mixed cell lymphoma
569915|NCT01137825|stage III adult diffuse small cleaved cell lymphoma|stage iii adult diffuse small cleaved cell lymphoma
569916|NCT01137825|stage III adult immunoblastic large cell lymphoma|stage iii adult immunoblastic large cell lymphoma
569917|NCT01137825|stage III adult lymphoblastic lymphoma|stage iii adult lymphoblastic lymphoma
569918|NCT01137825|stage III grade 1 follicular lymphoma|stage iii grade 1 follicular lymphoma
569919|NCT01137825|stage III grade 2 follicular lymphoma|stage iii grade 2 follicular lymphoma
569920|NCT01137825|stage III grade 3 follicular lymphoma|stage iii grade 3 follicular lymphoma
569921|NCT01137825|stage III mantle cell lymphoma|stage iii mantle cell lymphoma
569922|NCT01137825|stage III marginal zone lymphoma|stage iii marginal zone lymphoma
569923|NCT01137825|stage III small lymphocytic lymphoma|stage iii small lymphocytic lymphoma
569924|NCT01137825|stage IV adult Burkitt lymphoma|stage iv adult burkitt lymphoma
569925|NCT01137825|stage IV adult diffuse large cell lymphoma|stage iv adult diffuse large cell lymphoma
569926|NCT01137825|stage IV adult diffuse mixed cell lymphoma|stage iv adult diffuse mixed cell lymphoma
569927|NCT01137825|stage IV adult diffuse small cleaved cell lymphoma|stage iv adult diffuse small cleaved cell lymphoma
569928|NCT01137825|stage IV adult immunoblastic large cell lymphoma|stage iv adult immunoblastic large cell lymphoma
569929|NCT01137825|stage IV adult lymphoblastic lymphoma|stage iv adult lymphoblastic lymphoma
569930|NCT01137825|stage IV grade 1 follicular lymphoma|stage iv grade 1 follicular lymphoma
569931|NCT01137825|stage IV grade 2 follicular lymphoma|stage iv grade 2 follicular lymphoma
569932|NCT01137825|stage IV grade 3 follicular lymphoma|stage iv grade 3 follicular lymphoma
569933|NCT01137825|stage IV mantle cell lymphoma|stage iv mantle cell lymphoma
569934|NCT01137825|stage IV marginal zone lymphoma|stage iv marginal zone lymphoma
569935|NCT01137825|stage IV small lymphocytic lymphoma|stage iv small lymphocytic lymphoma
569936|NCT01137825|recurrent adult Burkitt lymphoma|recurrent adult burkitt lymphoma
569937|NCT01137825|recurrent adult diffuse large cell lymphoma|recurrent adult diffuse large cell lymphoma
569938|NCT01137825|recurrent adult diffuse mixed cell lymphoma|recurrent adult diffuse mixed cell lymphoma
569939|NCT01137825|recurrent adult diffuse small cleaved cell lymphoma|recurrent adult diffuse small cleaved cell lymphoma
569940|NCT01137825|recurrent adult grade III lymphomatoid granulomatosis|recurrent adult grade iii lymphomatoid granulomatosis
569941|NCT01137825|recurrent adult immunoblastic large cell lymphoma|recurrent adult immunoblastic large cell lymphoma
569942|NCT01137825|recurrent adult lymphoblastic lymphoma|recurrent adult lymphoblastic lymphoma
569943|NCT01137825|recurrent grade 1 follicular lymphoma|recurrent grade 1 follicular lymphoma
569944|NCT01137825|recurrent grade 2 follicular lymphoma|recurrent grade 2 follicular lymphoma
569945|NCT01137825|recurrent grade 3 follicular lymphoma|recurrent grade 3 follicular lymphoma
569946|NCT01137825|recurrent mantle cell lymphoma|recurrent mantle cell lymphoma
569947|NCT01137825|recurrent marginal zone lymphoma|recurrent marginal zone lymphoma
569948|NCT01137825|recurrent small lymphocytic lymphoma|recurrent small lymphocytic lymphoma
569949|NCT01137825|intraocular lymphoma|intraocular lymphoma
569950|NCT01137825|post-transplant lymphoproliferative disorder|post-transplant lymphoproliferative disorder
569951|NCT01137825|chronic eosinophilic leukemia|chronic eosinophilic leukemia
569952|NCT01137825|chronic neutrophilic leukemia|chronic neutrophilic leukemia
569953|NCT01137825|primary myelofibrosis|primary myelofibrosis
569954|NCT01137825|essential thrombocythemia|essential thrombocythemia
569955|NCT01137825|polycythemia vera|polycythemia vera
569956|NCT01137825|extramedullary plasmacytoma|extramedullary plasmacytoma
569957|NCT01137825|isolated plasmacytoma of bone|isolated plasmacytoma of bone
569958|NCT01137825|stage I multiple myeloma|stage i multiple myeloma
569959|NCT01137825|stage II multiple myeloma|stage ii multiple myeloma
569960|NCT01137825|stage III multiple myeloma|stage iii multiple myeloma
569961|NCT01137825|primary systemic amyloidosis|primary systemic amyloidosis
569962|NCT01137825|refractory multiple myeloma|refractory multiple myeloma
569963|NCT01137825|de novo myelodysplastic syndromes|de novo myelodysplastic syndromes
569964|NCT01137825|previously treated myelodysplastic syndromes|previously treated myelodysplastic syndromes
569965|NCT01137825|secondary myelodysplastic syndromes|secondary myelodysplastic syndromes
569966|NCT01137825|myelodysplastic/myeloproliferative neoplasm, unclassifiable|myelodysplastic/myeloproliferative neoplasm, unclassifiable
569967|NCT01137812|Canagliflozin|canagliflozin
569968|NCT01137812|Sitagliptin (Januvia)|sitagliptin (januvia)
569969|NCT01137812|Metformin|metformin
569970|NCT01137812|Sulphonylurea|sulphonylurea
569971|NCT01137812|Hemoglobin A1c|hemoglobin a1c
569972|NCT01137812|Type 2 diabetes mellitus|type 2 diabetes mellitus
569973|NCT01137799|symptomatic treatment|symptomatic treatment
569974|NCT01137799|cognition|cognition
569975|NCT01137799|cognitive deficits|cognitive deficits
569976|NCT01137799|schizophrenia|schizophrenia
569977|NCT01137799|Alzheimer's Disease|alzheimer's disease
569978|NCT01137773|SAH (Subarachnoid Hemorrhage)|sah (subarachnoid hemorrhage)
569979|NCT01137773|Brain Hemorrhage|brain hemorrhage
569980|NCT01137773|Traumatic Brain Injury|traumatic brain injury
569981|NCT01137773|SAH|sah
569982|NCT01137773|ICH|ich
569983|NCT01137760|adults|adults
569984|NCT01137760|fiber|fiber
569985|NCT01137760|cold|cold
569986|NCT01137760|flu|flu
569987|NCT01137760|stress|stress
569988|NCT01137760|microbiota|microbiota
569989|NCT01137747|carfilzomib|carfilzomib
569990|NCT01137747|acute myeloid leukemia|acute myeloid leukemia
569991|NCT01137747|acute lymphoblastic leukemia|acute lymphoblastic leukemia
569992|NCT01137747|phase I|phase i
569993|NCT01137734|Heart Diseases|heart diseases
569994|NCT01137734|Heart Valve Diseases|heart valve diseases
569995|NCT01137734|Cardiovascular Diseases|cardiovascular diseases
569996|NCT01137721|magnetic resonance imaging|magnetic resonance imaging
569997|NCT01137721|sickle cell disease|sickle cell disease
569998|NCT01137721|hydroxyurea therapy|hydroxyurea therapy
569999|NCT01137708|drug interactions|drug interactions
570000|NCT01137708|CYP3A|cyp3a
570001|NCT01137708|oral contraceptive|oral contraceptive
570002|NCT01137708|anti-rheumatic agents|anti-rheumatic agents
570003|NCT01137695|pramlintide|pramlintide
570004|NCT01137695|glucose|glucose
570005|NCT01137695|type 2 diabetes mellitus|type 2 diabetes mellitus
570006|NCT01137695|amylin|amylin
570007|NCT01137682|Acromegaly|acromegaly
570008|NCT01137682|hormone disorder|hormone disorder
570009|NCT01137682|growth hormone|growth hormone
570010|NCT01137682|insulin like growth factor-1|insulin like growth factor-1
570011|NCT01137682|pituitary tumor|pituitary tumor
570012|NCT01137682|pasireotide|pasireotide
570013|NCT01137682|SOM230|som230
570014|NCT01137669|immunocompromised,parent protocol,shingles,varicella-zoster virus,ZOSTAVAX®|immunocompromised,parent protocol,shingles,varicella-zoster virus,zostavax®
570015|NCT01137656|Blood storage|blood storage
570016|NCT01137656|Blood transfusion|blood transfusion
570017|NCT01137656|Aged blood|aged blood
570018|NCT01137656|Blood Forearm|blood forearm
570019|NCT01137656|Storage lesion in blood|storage lesion in blood
570020|NCT01137643|accelerated phase chronic myelogenous leukemia|accelerated phase chronic myelogenous leukemia
570021|NCT01137643|acute undifferentiated leukemia|acute undifferentiated leukemia
570022|NCT01137643|adult acute lymphoblastic leukemia in remission|adult acute lymphoblastic leukemia in remission
570023|NCT01137643|adult acute myeloid leukemia in remission|adult acute myeloid leukemia in remission
570024|NCT01137643|adult acute myeloid leukemia with 11q23 (MLL) abnormalities|adult acute myeloid leukemia with 11q23 (mll) abnormalities
570025|NCT01137643|adult acute myeloid leukemia with inv(16)(p13;q22)|adult acute myeloid leukemia with inv(16)(p13;q22)
570026|NCT01137643|adult acute myeloid leukemia with t(15;17)(q22;q12)|adult acute myeloid leukemia with t(15;17)(q22;q12)
570245|NCT01137292|voriconazole|voriconazole
570027|NCT01137643|adult acute myeloid leukemia with t(16;16)(p13;q22)|adult acute myeloid leukemia with t(16;16)(p13;q22)
570028|NCT01137643|adult acute myeloid leukemia with t(8;21)(q22;q22)|adult acute myeloid leukemia with t(8;21)(q22;q22)
570029|NCT01137643|atypical chronic myeloid leukemia, BCR-ABL negative|atypical chronic myeloid leukemia, bcr-abl negative
570030|NCT01137643|blastic phase chronic myelogenous leukemia|blastic phase chronic myelogenous leukemia
570031|NCT01137643|mast cell leukemia|mast cell leukemia
570032|NCT01137643|meningeal chronic myelogenous leukemia|meningeal chronic myelogenous leukemia
570033|NCT01137643|progressive hairy cell leukemia, initial treatment|progressive hairy cell leukemia, initial treatment
570034|NCT01137643|prolymphocytic leukemia|prolymphocytic leukemia
570035|NCT01137643|recurrent adult acute lymphoblastic leukemia|recurrent adult acute lymphoblastic leukemia
570036|NCT01137643|recurrent adult acute myeloid leukemia|recurrent adult acute myeloid leukemia
570037|NCT01137643|recurrent adult T-cell leukemia/lymphoma|recurrent adult t-cell leukemia/lymphoma
570038|NCT01137643|refractory chronic lymphocytic leukemia|refractory chronic lymphocytic leukemia
570039|NCT01137643|refractory hairy cell leukemia|refractory hairy cell leukemia
570040|NCT01137643|relapsing chronic myelogenous leukemia|relapsing chronic myelogenous leukemia
570041|NCT01137643|secondary acute myeloid leukemia|secondary acute myeloid leukemia
570042|NCT01137643|stage 0 chronic lymphocytic leukemia|stage 0 chronic lymphocytic leukemia
570043|NCT01137643|stage I adult T-cell leukemia/lymphoma|stage i adult t-cell leukemia/lymphoma
570044|NCT01137643|stage I chronic lymphocytic leukemia|stage i chronic lymphocytic leukemia
570045|NCT01137643|stage II adult T-cell leukemia/lymphoma|stage ii adult t-cell leukemia/lymphoma
570046|NCT01137643|stage II chronic lymphocytic leukemia|stage ii chronic lymphocytic leukemia
570047|NCT01137643|stage III adult T-cell leukemia/lymphoma|stage iii adult t-cell leukemia/lymphoma
570048|NCT01137643|stage III chronic lymphocytic leukemia|stage iii chronic lymphocytic leukemia
570049|NCT01137643|stage IV adult T-cell leukemia/lymphoma|stage iv adult t-cell leukemia/lymphoma
570050|NCT01137643|stage IV chronic lymphocytic leukemia|stage iv chronic lymphocytic leukemia
570051|NCT01137643|T-cell large granular lymphocyte leukemia|t-cell large granular lymphocyte leukemia
570052|NCT01137643|untreated adult acute lymphoblastic leukemia|untreated adult acute lymphoblastic leukemia
570053|NCT01137643|untreated adult acute myeloid leukemia|untreated adult acute myeloid leukemia
570054|NCT01137643|untreated hairy cell leukemia|untreated hairy cell leukemia
570055|NCT01137643|recurrent adult Hodgkin lymphoma|recurrent adult hodgkin lymphoma
570056|NCT01137643|stage I adult Hodgkin lymphoma|stage i adult hodgkin lymphoma
570057|NCT01137643|stage II adult Hodgkin lymphoma|stage ii adult hodgkin lymphoma
570058|NCT01137643|stage III adult Hodgkin lymphoma|stage iii adult hodgkin lymphoma
570059|NCT01137643|stage IV adult Hodgkin lymphoma|stage iv adult hodgkin lymphoma
570060|NCT01137643|anaplastic large cell lymphoma|anaplastic large cell lymphoma
570061|NCT01137643|angioimmunoblastic T-cell lymphoma|angioimmunoblastic t-cell lymphoma
570062|NCT01137643|cutaneous B-cell non-Hodgkin lymphoma|cutaneous b-cell non-hodgkin lymphoma
570063|NCT01137643|recurrent cutaneous T-cell non-Hodgkin lymphoma|recurrent cutaneous t-cell non-hodgkin lymphoma
570064|NCT01137643|stage I cutaneous T-cell non-Hodgkin lymphoma|stage i cutaneous t-cell non-hodgkin lymphoma
570065|NCT01137643|stage II cutaneous T-cell non-Hodgkin lymphoma|stage ii cutaneous t-cell non-hodgkin lymphoma
710871|NCT00587483|cardiopulmonary bypass|cardiopulmonary bypass
570066|NCT01137643|stage III cutaneous T-cell non-Hodgkin lymphoma|stage iii cutaneous t-cell non-hodgkin lymphoma
570067|NCT01137643|stage IV cutaneous T-cell non-Hodgkin lymphoma|stage iv cutaneous t-cell non-hodgkin lymphoma
570068|NCT01137643|recurrent mycosis fungoides/Sezary syndrome|recurrent mycosis fungoides/sezary syndrome
570069|NCT01137643|stage I mycosis fungoides/Sezary syndrome|stage i mycosis fungoides/sezary syndrome
570070|NCT01137643|stage II mycosis fungoides/Sezary syndrome|stage ii mycosis fungoides/sezary syndrome
570071|NCT01137643|stage III mycosis fungoides/Sezary syndrome|stage iii mycosis fungoides/sezary syndrome
570072|NCT01137643|stage IV mycosis fungoides/Sezary syndrome|stage iv mycosis fungoides/sezary syndrome
570073|NCT01137643|adult grade III lymphomatoid granulomatosis|adult grade iii lymphomatoid granulomatosis
570074|NCT01137643|adult nasal type extranodal NK/T-cell lymphoma|adult nasal type extranodal nk/t-cell lymphoma
570075|NCT01137643|Waldenstrom macroglobulinemia|waldenstrom macroglobulinemia
570076|NCT01137643|extranodal marginal zone B-cell lymphoma of mucosa-associated lymphoid tissue|extranodal marginal zone b-cell lymphoma of mucosa-associated lymphoid tissue
570293|NCT01136980|Esophagitis|esophagitis
570077|NCT01137643|nodal marginal zone B-cell lymphoma|nodal marginal zone b-cell lymphoma
570078|NCT01137643|splenic marginal zone lymphoma|splenic marginal zone lymphoma
570079|NCT01137643|contiguous stage II adult Burkitt lymphoma|contiguous stage ii adult burkitt lymphoma
570080|NCT01137643|contiguous stage II adult diffuse large cell lymphoma|contiguous stage ii adult diffuse large cell lymphoma
570081|NCT01137643|contiguous stage II adult diffuse mixed cell lymphoma|contiguous stage ii adult diffuse mixed cell lymphoma
570082|NCT01137643|contiguous stage II adult diffuse small cleaved cell lymphoma|contiguous stage ii adult diffuse small cleaved cell lymphoma
570083|NCT01137643|contiguous stage II adult immunoblastic large cell lymphoma|contiguous stage ii adult immunoblastic large cell lymphoma
570084|NCT01137643|contiguous stage II adult lymphoblastic lymphoma|contiguous stage ii adult lymphoblastic lymphoma
570085|NCT01137643|contiguous stage II grade 1 follicular lymphoma|contiguous stage ii grade 1 follicular lymphoma
570086|NCT01137643|contiguous stage II grade 2 follicular lymphoma|contiguous stage ii grade 2 follicular lymphoma
570087|NCT01137643|contiguous stage II grade 3 follicular lymphoma|contiguous stage ii grade 3 follicular lymphoma
570088|NCT01137643|contiguous stage II mantle cell lymphoma|contiguous stage ii mantle cell lymphoma
570089|NCT01137643|contiguous stage II marginal zone lymphoma|contiguous stage ii marginal zone lymphoma
570090|NCT01137643|contiguous stage II small lymphocytic lymphoma|contiguous stage ii small lymphocytic lymphoma
570091|NCT01137643|stage I adult Burkitt lymphoma|stage i adult burkitt lymphoma
570092|NCT01137643|stage I adult diffuse large cell lymphoma|stage i adult diffuse large cell lymphoma
570093|NCT01137643|stage I adult diffuse mixed cell lymphoma|stage i adult diffuse mixed cell lymphoma
570094|NCT01137643|stage I adult diffuse small cleaved cell lymphoma|stage i adult diffuse small cleaved cell lymphoma
570095|NCT01137643|stage I adult immunoblastic large cell lymphoma|stage i adult immunoblastic large cell lymphoma
570096|NCT01137643|stage I adult lymphoblastic lymphoma|stage i adult lymphoblastic lymphoma
570097|NCT01137643|stage I grade 1 follicular lymphoma|stage i grade 1 follicular lymphoma
570098|NCT01137643|stage I grade 2 follicular lymphoma|stage i grade 2 follicular lymphoma
570099|NCT01137643|stage I grade 3 follicular lymphoma|stage i grade 3 follicular lymphoma
570100|NCT01137643|stage I mantle cell lymphoma|stage i mantle cell lymphoma
570101|NCT01137643|stage I marginal zone lymphoma|stage i marginal zone lymphoma
570102|NCT01137643|stage I small lymphocytic lymphoma|stage i small lymphocytic lymphoma
570103|NCT01137643|noncontiguous stage II adult Burkitt lymphoma|noncontiguous stage ii adult burkitt lymphoma
570104|NCT01137643|noncontiguous stage II adult diffuse large cell lymphoma|noncontiguous stage ii adult diffuse large cell lymphoma
570105|NCT01137643|noncontiguous stage II adult diffuse mixed cell lymphoma|noncontiguous stage ii adult diffuse mixed cell lymphoma
570106|NCT01137643|noncontiguous stage II adult diffuse small cleaved cell lymphoma|noncontiguous stage ii adult diffuse small cleaved cell lymphoma
570107|NCT01137643|noncontiguous stage II adult immunoblastic large cell lymphoma|noncontiguous stage ii adult immunoblastic large cell lymphoma
570108|NCT01137643|noncontiguous stage II adult lymphoblastic lymphoma|noncontiguous stage ii adult lymphoblastic lymphoma
570109|NCT01137643|noncontiguous stage II grade 1 follicular lymphoma|noncontiguous stage ii grade 1 follicular lymphoma
570110|NCT01137643|noncontiguous stage II grade 2 follicular lymphoma|noncontiguous stage ii grade 2 follicular lymphoma
570111|NCT01137643|noncontiguous stage II grade 3 follicular lymphoma|noncontiguous stage ii grade 3 follicular lymphoma
570112|NCT01137643|noncontiguous stage II mantle cell lymphoma|noncontiguous stage ii mantle cell lymphoma
570113|NCT01137643|noncontiguous stage II marginal zone lymphoma|noncontiguous stage ii marginal zone lymphoma
570114|NCT01137643|noncontiguous stage II small lymphocytic lymphoma|noncontiguous stage ii small lymphocytic lymphoma
570115|NCT01137643|stage III adult Burkitt lymphoma|stage iii adult burkitt lymphoma
570116|NCT01137643|stage III adult diffuse large cell lymphoma|stage iii adult diffuse large cell lymphoma
570117|NCT01137643|stage III adult diffuse mixed cell lymphoma|stage iii adult diffuse mixed cell lymphoma
570118|NCT01137643|stage III adult diffuse small cleaved cell lymphoma|stage iii adult diffuse small cleaved cell lymphoma
570119|NCT01137643|stage III adult immunoblastic large cell lymphoma|stage iii adult immunoblastic large cell lymphoma
570120|NCT01137643|stage III adult lymphoblastic lymphoma|stage iii adult lymphoblastic lymphoma
570121|NCT01137643|stage III grade 1 follicular lymphoma|stage iii grade 1 follicular lymphoma
570122|NCT01137643|stage III grade 2 follicular lymphoma|stage iii grade 2 follicular lymphoma
570123|NCT01137643|stage III grade 3 follicular lymphoma|stage iii grade 3 follicular lymphoma
570124|NCT01137643|stage III mantle cell lymphoma|stage iii mantle cell lymphoma
570125|NCT01137643|stage III marginal zone lymphoma|stage iii marginal zone lymphoma
570126|NCT01137643|stage III small lymphocytic lymphoma|stage iii small lymphocytic lymphoma
570127|NCT01137643|stage IV adult Burkitt lymphoma|stage iv adult burkitt lymphoma
570128|NCT01137643|stage IV adult diffuse large cell lymphoma|stage iv adult diffuse large cell lymphoma
570129|NCT01137643|stage IV adult diffuse mixed cell lymphoma|stage iv adult diffuse mixed cell lymphoma
570130|NCT01137643|stage IV adult diffuse small cleaved cell lymphoma|stage iv adult diffuse small cleaved cell lymphoma
570131|NCT01137643|stage IV adult immunoblastic large cell lymphoma|stage iv adult immunoblastic large cell lymphoma
570132|NCT01137643|stage IV adult lymphoblastic lymphoma|stage iv adult lymphoblastic lymphoma
570133|NCT01137643|stage IV grade 1 follicular lymphoma|stage iv grade 1 follicular lymphoma
570134|NCT01137643|stage IV grade 2 follicular lymphoma|stage iv grade 2 follicular lymphoma
570135|NCT01137643|stage IV grade 3 follicular lymphoma|stage iv grade 3 follicular lymphoma
570136|NCT01137643|stage IV mantle cell lymphoma|stage iv mantle cell lymphoma
570137|NCT01137643|stage IV marginal zone lymphoma|stage iv marginal zone lymphoma
570138|NCT01137643|stage IV small lymphocytic lymphoma|stage iv small lymphocytic lymphoma
570139|NCT01137643|recurrent adult Burkitt lymphoma|recurrent adult burkitt lymphoma
570140|NCT01137643|recurrent adult diffuse large cell lymphoma|recurrent adult diffuse large cell lymphoma
570141|NCT01137643|recurrent adult diffuse mixed cell lymphoma|recurrent adult diffuse mixed cell lymphoma
570142|NCT01137643|recurrent adult diffuse small cleaved cell lymphoma|recurrent adult diffuse small cleaved cell lymphoma
570143|NCT01137643|recurrent adult grade III lymphomatoid granulomatosis|recurrent adult grade iii lymphomatoid granulomatosis
570144|NCT01137643|recurrent adult immunoblastic large cell lymphoma|recurrent adult immunoblastic large cell lymphoma
570145|NCT01137643|recurrent adult lymphoblastic lymphoma|recurrent adult lymphoblastic lymphoma
570146|NCT01137643|recurrent grade 1 follicular lymphoma|recurrent grade 1 follicular lymphoma
570147|NCT01137643|recurrent grade 2 follicular lymphoma|recurrent grade 2 follicular lymphoma
570148|NCT01137643|recurrent grade 3 follicular lymphoma|recurrent grade 3 follicular lymphoma
570149|NCT01137643|recurrent mantle cell lymphoma|recurrent mantle cell lymphoma
570150|NCT01137643|recurrent marginal zone lymphoma|recurrent marginal zone lymphoma
570151|NCT01137643|recurrent small lymphocytic lymphoma|recurrent small lymphocytic lymphoma
570152|NCT01137643|intraocular lymphoma|intraocular lymphoma
570153|NCT01137643|post-transplant lymphoproliferative disorder|post-transplant lymphoproliferative disorder
570154|NCT01137643|chronic eosinophilic leukemia|chronic eosinophilic leukemia
570155|NCT01137643|chronic neutrophilic leukemia|chronic neutrophilic leukemia
570156|NCT01137643|primary myelofibrosis|primary myelofibrosis
570157|NCT01137643|essential thrombocythemia|essential thrombocythemia
570158|NCT01137643|polycythemia vera|polycythemia vera
570159|NCT01137643|extramedullary plasmacytoma|extramedullary plasmacytoma
570160|NCT01137643|isolated plasmacytoma of bone|isolated plasmacytoma of bone
570161|NCT01137643|stage I multiple myeloma|stage i multiple myeloma
570162|NCT01137643|stage II multiple myeloma|stage ii multiple myeloma
570163|NCT01137643|stage III multiple myeloma|stage iii multiple myeloma
570164|NCT01137643|primary systemic amyloidosis|primary systemic amyloidosis
570165|NCT01137643|refractory multiple myeloma|refractory multiple myeloma
570166|NCT01137643|de novo myelodysplastic syndromes|de novo myelodysplastic syndromes
570167|NCT01137643|previously treated myelodysplastic syndromes|previously treated myelodysplastic syndromes
570168|NCT01137643|secondary myelodysplastic syndromes|secondary myelodysplastic syndromes
570169|NCT01137643|myelodysplastic/myeloproliferative neoplasm, unclassifiable|myelodysplastic/myeloproliferative neoplasm, unclassifiable
570170|NCT01137643|aplastic anemia|aplastic anemia
570171|NCT01137630|seborrhoeic dermatitis|seborrhoeic dermatitis
570172|NCT01137630|scalp|scalp
570173|NCT01137630|K40a|k40a
570174|NCT01137630|K40b|k40b
570175|NCT01137617|spinal cord stimualtor|spinal cord stimualtor
570176|NCT01137591|Acetaminophen|acetaminophen
570177|NCT01137591|Acetylcysteine|acetylcysteine
570178|NCT01137591|Antidotes|antidotes
570179|NCT01137565|Amgen|amgen
570180|NCT01137565|Adolescent|adolescent
570181|NCT01137565|Safety|safety
570182|NCT01137552|First-In-Human|first-in-human
570183|NCT01137552|Dose Escalation|dose escalation
570184|NCT01137552|Dose Expansion|dose expansion
570185|NCT01137552|Advance Solid Tumors|advance solid tumors
570186|NCT01137552|Anti-Angiopoietin|anti-angiopoietin
570187|NCT01137552|Advance Malignancy|advance malignancy
570188|NCT01137552|Cancer|cancer
570189|NCT01137552|Oncology|oncology
570190|NCT01137552|Oncology Patients|oncology patients
570191|NCT01137552|Phase 1|phase 1
570192|NCT01137552|Clinical Trial|clinical trial
570193|NCT01137552|Tumors|tumors
570194|NCT01137552|Solid Tumors|solid tumors
570195|NCT01137552|Angiogenesis Inhibitors|angiogenesis inhibitors
570196|NCT01137539|urinary incontinence|urinary incontinence
570197|NCT01137539|stress urinary incontinence|stress urinary incontinence
570198|NCT01137539|mid-urethral slings|mid-urethral slings
570199|NCT01137539|Tension-free vaginal taping|tension-free vaginal taping
570200|NCT01137539|TVT|tvt
570201|NCT01137513|Chest Pain|chest pain
570202|NCT01137513|Acute coronary syndrome|acute coronary syndrome
570203|NCT01137513|AMI|ami
570204|NCT01137487|mechanical ventilation|mechanical ventilation
570205|NCT01137487|enteral nutrition|enteral nutrition
570206|NCT01137487|Ventilation-Associated Pneumonia|ventilation-associated pneumonia
570207|NCT01137487|residual gastric volume measurement|residual gastric volume measurement
570208|NCT01137487|vomiting|vomiting
570209|NCT01137487|gastro-oesophageal reflux|gastro-oesophageal reflux
570210|NCT01137487|early enteral nutrition|early enteral nutrition
570211|NCT01137487|Intensive care unit|intensive care unit
570212|NCT01137487|Enteral Feeding|enteral feeding
570213|NCT01137474|Diabetes Mellitus, Type 2|diabetes mellitus, type 2
570214|NCT01137474|Diabetes Mellitus|diabetes mellitus
570215|NCT01137474|Endocrine System Diseases|endocrine system diseases
570216|NCT01137474|Glucose Metabolism Disorders|glucose metabolism disorders
570217|NCT01137474|Metabolic Diseases|metabolic diseases
570218|NCT01137474|Angiotensin Receptor Antagonists|angiotensin receptor antagonists
570219|NCT01137474|Angiotensin-Converting Enzyme Inhibitors|angiotensin-converting enzyme inhibitors
570220|NCT01137474|Hypoglycemic Agents|hypoglycemic agents
570221|NCT01137474|Pharmacologic Actions|pharmacologic actions
570222|NCT01137474|Physiological Effects of Drugs|physiological effects of drugs
570223|NCT01137461|Female infertility with indication of oocyte reception|female infertility with indication of oocyte reception
570224|NCT01137448|Psoriasis|psoriasis
570225|NCT01137448|Obesity|obesity
570226|NCT01137435|Adacel|adacel
570227|NCT01137435|Diphtheria|diphtheria
570228|NCT01137435|Tetanus|tetanus
570229|NCT01137435|Pertussis|pertussis
570230|NCT01137383|Hepatitis C|hepatitis c
570231|NCT01137331|seborrhoeic eczema|seborrhoeic eczema
570232|NCT01137331|scalp|scalp
570233|NCT01137331|dandruff|dandruff
570234|NCT01137331|K301|k301
570235|NCT01137331|K40|k40
570236|NCT01137318|ADHD|adhd
570237|NCT01137318|Impairment|impairment
570238|NCT01137318|Treatment|treatment
570239|NCT01137318|Cognitive Remediation|cognitive remediation
570240|NCT01137318|Behavioral Parent Training|behavioral parent training
570241|NCT01137305|Virtual reality|virtual reality
570242|NCT01137305|surgical training|surgical training
570243|NCT01137305|Health Care [N]|health care [n]
570244|NCT01137292|observational study|observational study
570246|NCT01137292|high-risk patients|high-risk patients
570247|NCT01137266|chronic pain osteo-arthritis in one or both knees, adults|chronic pain osteo-arthritis in one or both knees, adults
570248|NCT01137253|Nitric Oxide|nitric oxide
570249|NCT01137253|Autonomic Nervous System|autonomic nervous system
570250|NCT01137240|subjects suffering from mitochondrial disorders with one or more gastrointestinal symptoms would be the focus of the study|subjects suffering from mitochondrial disorders with one or more gastrointestinal symptoms would be the focus of the study
570251|NCT01137227|Physical activity|physical activity
570252|NCT01137227|Epidemiology|epidemiology
570253|NCT01137227|Questionnaire|questionnaire
570254|NCT01137227|Cross-sectional study|cross-sectional study
570255|NCT01137214|complex sleep apnea|complex sleep apnea
570256|NCT01137201|Small bowel obstruction|small bowel obstruction
570257|NCT01137201|Laparoscopic gastric bypass|laparoscopic gastric bypass
570258|NCT01137201|Internal Hernia|internal hernia
570259|NCT01137201|Mesenteric defect|mesenteric defect
570260|NCT01137201|Morbid obesity|morbid obesity
570261|NCT01137175|Rickettsioses|rickettsioses
570262|NCT01137175|Scrub Typhus|scrub typhus
570263|NCT01137175|Q fever|q fever
570264|NCT01137175|Typhus fever|typhus fever
570265|NCT01137175|Spotted fever|spotted fever
570266|NCT01137175|Rickettsioses reported cases|rickettsioses reported cases
570267|NCT01137149|Adolescent Depression|adolescent depression
570268|NCT01137149|Treatment of depression in adolescents|treatment of depression in adolescents
570269|NCT01137149|Behavioral activation treatment for depressed adolescents|behavioral activation treatment for depressed adolescents
570270|NCT01137123|esophageal squamous cell carcinoma|esophageal squamous cell carcinoma
570271|NCT01137110|Subarachnoid Hemorrhage|subarachnoid hemorrhage
570272|NCT01137110|Seizure Prophylaxis|seizure prophylaxis
570273|NCT01137110|Levetiracetam|levetiracetam
570274|NCT01137045|rabies vaccine|rabies vaccine
570275|NCT01137045|vero cells|vero cells
570276|NCT01137045|serology|serology
570277|NCT01137045|safety|safety
570278|NCT01137032|Psoriasis|psoriasis
570279|NCT01137032|Atopic Dermatitis|atopic dermatitis
570280|NCT01137019|Drug-eluting stents|drug-eluting stents
570281|NCT01137019|Tomography, Optical Coherence|tomography, optical coherence
570282|NCT01137006|Melanoma|melanoma
570283|NCT01137006|Phase I|phase i
570284|NCT01137006|antibody|antibody
570285|NCT01137006|melanin|melanin
570286|NCT01137006|tyrosinase related protein 1|tyrosinase related protein 1
570287|NCT01137006|glycoprotein|glycoprotein
570288|NCT01137006|20D7S|20d7s
570289|NCT01136993|Stroke|stroke
570290|NCT01136993|Thrombolysis|thrombolysis
570291|NCT01136993|Telestroke|telestroke
570292|NCT01136980|GERD|gerd
570294|NCT01136980|Fundoplication|fundoplication
570295|NCT01136980|Anti-reflux surgery|anti-reflux surgery
570296|NCT01136980|PPI dependent|ppi dependent
570297|NCT01136928|Antiretroviral therapy|antiretroviral therapy
570298|NCT01136928|American ginseng|american ginseng
570299|NCT01136928|Efavirenz|efavirenz
570300|NCT01136928|Cytochrome P450 enzymes|cytochrome p450 enzymes
570301|NCT01136928|Complementary and Alternative Medicine|complementary and alternative medicine
570302|NCT01136928|Herbal|herbal
570303|NCT01136928|Pharmacikinetics|pharmacikinetics
570304|NCT01136928|Healthy volunteers|healthy volunteers
570305|NCT01136902|Diabetes Mellitus|diabetes mellitus
570306|NCT01136902|Retinal Vessels|retinal vessels
570307|NCT01136902|Physiology|physiology
570308|NCT01136889|PFMT|pfmt
570309|NCT01136889|Vaginal pessary|vaginal pessary
570310|NCT01136889|Pelvic Organ Prolapse|pelvic organ prolapse
570311|NCT01136863|hypertension|hypertension
570312|NCT01136863|felodipine|felodipine
570313|NCT01136863|moderate to high risk patients|moderate to high risk patients
570314|NCT01136850|Plasmodium falciparum|plasmodium falciparum
570315|NCT01136850|Plasmodium vivax|plasmodium vivax
570316|NCT01136850|azithromycin|azithromycin
570317|NCT01136850|sulphadoxine pyrimethamine|sulphadoxine pyrimethamine
570318|NCT01136850|low birth weight|low birth weight
570319|NCT01136850|haemoglobin|haemoglobin
570320|NCT01136850|Chlamydia trachomatis|chlamydia trachomatis
570321|NCT01136850|Neisseria gonorrhoeae|neisseria gonorrhoeae
570322|NCT01136850|Treponema pallidum|treponema pallidum
570323|NCT01136824|Sarcoma|sarcoma
570324|NCT01136824|questionnaire|questionnaire
570325|NCT01136824|doxorubicin plus ifosfamide (AI)|doxorubicin plus ifosfamide (ai)
570326|NCT01136798|slow wave sleep|slow wave sleep
570327|NCT01136798|exenatide and sleep|exenatide and sleep
570328|NCT01136759|Prevention|prevention
570329|NCT01136759|Microbicide|microbicide
570330|NCT01136759|Mother-to-Child-Transmission|mother-to-child-transmission
570331|NCT01136759|Pregnancy|pregnancy
570332|NCT01136746|Hyperglycemia|hyperglycemia
570333|NCT01136746|Diabetes|diabetes
570334|NCT01136746|Hospital|hospital
570335|NCT01136746|Diabetic|diabetic
570336|NCT01136733|Unresectable advanced or metastatic renal cell carcinoma|unresectable advanced or metastatic renal cell carcinoma
570337|NCT01136681|Anonymised Electronic Cohort|anonymised electronic cohort
570338|NCT01136681|Record Linkage|record linkage
570339|NCT01136681|Routine Data|routine data
570340|NCT01136681|Environment|environment
570341|NCT01136681|Childhood Obesity|childhood obesity
570342|NCT01136681|Low birth weight|low birth weight
570343|NCT01136681|Premature birth|premature birth
570344|NCT01136668|pediatrics|pediatrics
570345|NCT01136668|Transversus Abdominis Plane Block|transversus abdominis plane block
570346|NCT01136668|Ostomy Surgery|ostomy surgery
570347|NCT01136668|Anesthesia|anesthesia
570348|NCT01136668|Regional Anesthetic|regional anesthetic
570349|NCT01136655|asthmatic children|asthmatic children
570350|NCT01136655|Symbicort|symbicort
570351|NCT01136655|Foradil|foradil
570352|NCT01136642|Nicotine|nicotine
570353|NCT01136642|Nicotine Nasal Spray|nicotine nasal spray
570354|NCT01136642|Attention|attention
570355|NCT01136642|Smoking|smoking
570356|NCT01136629|Hyper-pigmented spots|hyper-pigmented spots
570357|NCT01136629|Lentigines|lentigines
570358|NCT01136629|Mealsma|mealsma
570359|NCT01136629|RNA extraction|rna extraction
570360|NCT01136629|Isolation of Keratinocytes|isolation of keratinocytes
570361|NCT01136629|Isolation of Melanocytes|isolation of melanocytes
570362|NCT01136616|Nasal fracture|nasal fracture
570363|NCT01136616|Nasal buttresses|nasal buttresses
570364|NCT01136616|Septal deviation|septal deviation
570365|NCT01136616|Nasal morphology|nasal morphology
570366|NCT01136616|CT Scan|ct scan
570367|NCT01136603|Abdominal wall defects|abdominal wall defects
570368|NCT01136603|Inflammation reactions|inflammation reactions
570369|NCT01136603|Amount of tissue ingrowth|amount of tissue ingrowth
570370|NCT01136603|Adhesion formation|adhesion formation
570371|NCT01136603|Shrinkage profiles of the implant|shrinkage profiles of the implant
570372|NCT01136590|Spinal deformity correction|spinal deformity correction
570373|NCT01136590|Surgical bleeding|surgical bleeding
570374|NCT01136590|Transfusion practice|transfusion practice
570375|NCT01136590|Spinal Fusion|spinal fusion
570376|NCT01136590|Antifibrinolytic Agents|antifibrinolytic agents
570377|NCT01136590|Hemorrhage|hemorrhage
570378|NCT01136590|Blood Transfusion|blood transfusion
570379|NCT01136577|Jaundice|jaundice
570380|NCT01136577|Hyperbilirubinemia|hyperbilirubinemia
570381|NCT01136577|Phototherapy|phototherapy
570382|NCT01136577|term newborn|term newborn
570384|NCT01136577|Fluorescent lamps|fluorescent lamps
570385|NCT01136564|paricalcitol|paricalcitol
570386|NCT01136564|vitamin d|vitamin d
570387|NCT01136564|kidney disease|kidney disease
570388|NCT01136564|renin|renin
570389|NCT01136564|proteinuria|proteinuria
570390|NCT01136551|Pharmacokinetic profile of controlled release formulation of Huperzine A|pharmacokinetic profile of controlled release formulation of huperzine a
711462|NCT00584597|Homeopathic Medication|homeopathic medication
724445|NCT00530270|ACS|acs
570391|NCT01136551|Bioequivalence of Huperzine A IR formulation and CR formulation|bioequivalence of huperzine a ir formulation and cr formulation
570392|NCT01136538|Bioequivalence|bioequivalence
570393|NCT01136538|Crossover|crossover
570394|NCT01136538|Valacyclovir Hydrochloride|valacyclovir hydrochloride
570395|NCT01136525|Bioequivalence|bioequivalence
570396|NCT01136525|Crossover|crossover
570397|NCT01136525|Valacyclovir Hydrochloride|valacyclovir hydrochloride
570398|NCT01136512|metformin|metformin
570399|NCT01136512|vitamin B12|vitamin b12
570400|NCT01136512|type 2 diabetes|type 2 diabetes
570401|NCT01136512|methylmalonic acid|methylmalonic acid
570402|NCT01136512|deficiency|deficiency
570403|NCT01136499|Sarcoma|sarcoma
570404|NCT01136499|Safety|safety
570405|NCT01136499|Efficacy|efficacy
570406|NCT01136499|PANOBINOSTAT|panobinostat
570407|NCT01136486|head trauma; traumatic brain injury|head trauma; traumatic brain injury
570408|NCT01136473|congenital cataract|congenital cataract
570409|NCT01136473|aphakic|aphakic
570410|NCT01136473|pseudophakic glaucoma|pseudophakic glaucoma
570411|NCT01136473|pediatric patients|pediatric patients
570412|NCT01136460|Primary congenital glaucoma|primary congenital glaucoma
570413|NCT01136460|neonatal|neonatal
570414|NCT01136460|Genotype correlation|genotype correlation
570415|NCT01136460|Phenotype correlation|phenotype correlation
570416|NCT01136447|Brachial plexus|brachial plexus
570417|NCT01136447|Ultrasound|ultrasound
570418|NCT01136421|COPD exacerbation|copd exacerbation
570419|NCT01136421|Magnesium sulfate|magnesium sulfate
570420|NCT01136421|Ipratropium bromide|ipratropium bromide
570421|NCT01136421|Emergency departement|emergency departement
570422|NCT01136395|Kidney Transplantation|kidney transplantation
570423|NCT01136395|Rituximab|rituximab
570424|NCT01136395|Living Donor|living donor
570425|NCT01136395|ABO Incompatible (ABOi) Transplantation|abo incompatible (aboi) transplantation
570426|NCT01136395|Immunology|immunology
570427|NCT01136395|Cytomegalovirus (CMV)|cytomegalovirus (cmv)
570428|NCT01136395|Epstein Barr virus (EBV)|epstein barr virus (ebv)
570429|NCT01136395|Polyomavirus|polyomavirus
570430|NCT01136382|asthma, children, budesonide pMDI|asthma, children, budesonide pmdi
570431|NCT01136369|metastasis|metastasis
570432|NCT01136369|molecular pathology|molecular pathology
570433|NCT01136356|opioid pharmacology|opioid pharmacology
570434|NCT01136356|buprenorphine|buprenorphine
570435|NCT01136356|morphine|morphine
570436|NCT01136356|withdrawal|withdrawal
570437|NCT01136356|human research|human research
570438|NCT01136343|women|women
570439|NCT01136343|middle age|middle age
570440|NCT01136343|risk factor|risk factor
570441|NCT01136330|Myotonic dystrophy|myotonic dystrophy
570443|NCT01136330|Sudden death|sudden death
570444|NCT01136330|Respiratory failure|respiratory failure
570445|NCT01136304|Gaucher disease|gaucher disease
570446|NCT01136304|Imiglucerase|imiglucerase
570447|NCT01136304|Cerezyme|cerezyme
570448|NCT01136304|Severity score|severity score
570449|NCT01136291|pregnancy|pregnancy
570450|NCT01136291|obesity|obesity
570451|NCT01136291|physical exercise|physical exercise
570452|NCT01136291|quality of life|quality of life
570453|NCT01136278|MDMA|mdma
570454|NCT01136278|norepinephrine|norepinephrine
570455|NCT01136278|alpha2 receptor|alpha2 receptor
570456|NCT01136278|Ecstasy|ecstasy
570457|NCT01136278|stimulant|stimulant
570458|NCT01136265|dual-time PET/CT|dual-time pet/ct
570459|NCT01136265|sentinel node|sentinel node
570460|NCT01136239|COPD|copd
570461|NCT01136239|N-acetylcysteine|n-acetylcysteine
570462|NCT01136239|airtrapping|airtrapping
570463|NCT01136239|airway resistance|airway resistance
570464|NCT01136239|antioxidant|antioxidant
570465|NCT01136226|Prostate Cancer|prostate cancer
570466|NCT01136200|Surgical and medical wards|surgical and medical wards
570467|NCT01136200|Adults|adults
570468|NCT01136200|Antimicrobial therapy|antimicrobial therapy
570469|NCT01136187|Myocardial infarction|myocardial infarction
570470|NCT01136187|Primary percutaneous coronary intervention|primary percutaneous coronary intervention
570471|NCT01136187|Radial|radial
570472|NCT01136187|Bleeding|bleeding
570473|NCT01136161|LTBI (Latent Tuberculosis Infection)|ltbi (latent tuberculosis infection)
570474|NCT01136161|TB (Tuberculosis)|tb (tuberculosis)
570475|NCT01136161|Vaccine|vaccine
570476|NCT01136148|Mental Health|mental health
570477|NCT01136148|Aged|aged
570478|NCT01136148|Hospitals, general|hospitals, general
570479|NCT01136148|Dementia|dementia
570480|NCT01136148|Delirium|delirium
570481|NCT01136148|Dementia and confusion|dementia and confusion
570482|NCT01136135|Heart transplant rejection|heart transplant rejection
570483|NCT01136135|cardiac MRI|cardiac mri
570484|NCT01136135|diagnosis|diagnosis
570485|NCT01136096|diabetes|diabetes
570486|NCT01136096|physical activity|physical activity
570487|NCT01136096|adiponectin|adiponectin
570488|NCT01136096|metabolic risks|metabolic risks
570489|NCT01136096|exercise|exercise
570490|NCT01136096|primary prevention|primary prevention
570491|NCT01136083|Tumor|tumor
570492|NCT01136083|Angiogenesis|angiogenesis
570493|NCT01136083|Exercise training|exercise training
570494|NCT01136083|VEGF|vegf
570495|NCT01136083|Myostatin|myostatin
570496|NCT01136070|Psychological Functioning in Burn Patients|psychological functioning in burn patients
570497|NCT01136044|tensor fasciae latae|tensor fasciae latae
570498|NCT01136044|septocutaneous perforators|septocutaneous perforators
570499|NCT01136031|advanced gastric cancer|advanced gastric cancer
570500|NCT01136031|1st-line failure|1st-line failure
570501|NCT01136005|receptor, epidermal growth factor|receptor, epidermal growth factor
570502|NCT01136005|skin reactions|skin reactions
570503|NCT01136005|quality of life|quality of life
570504|NCT01136005|adherence|adherence
570505|NCT01135966|COPD|copd
570506|NCT01135966|Whole Body Vibration training|whole body vibration training
570507|NCT01135966|Conventional resistance training|conventional resistance training
570508|NCT01135953|Brain excitation|brain excitation
570509|NCT01135953|transcranial Direct Stimulation|transcranial direct stimulation
570510|NCT01135953|administration pattern|administration pattern
570511|NCT01135940|neuromuscular scoliosis|neuromuscular scoliosis
570512|NCT01135940|dermabond|dermabond
570513|NCT01135940|infection|infection
570514|NCT01135940|wound closure|wound closure
570515|NCT01135914|DME|dme
570516|NCT01135914|visual impairment|visual impairment
570517|NCT01135914|diabetes|diabetes
570518|NCT01135914|macular edema|macular edema
570519|NCT01135914|diabetic macular edema|diabetic macular edema
570520|NCT01135914|ranibizumab|ranibizumab
570521|NCT01135914|laser|laser
570522|NCT01135914|photocoagulation|photocoagulation
570523|NCT01135914|retinopathy|retinopathy
570524|NCT01135914|retina|retina
570525|NCT01135901|prevention|prevention
570526|NCT01135901|public health|public health
570527|NCT01135901|community health services|community health services
570528|NCT01135901|Norway|norway
570529|NCT01135888|hypohidrotic ectodermal dysplasia|hypohidrotic ectodermal dysplasia
570530|NCT01135888|exertional hyperthermia|exertional hyperthermia
570531|NCT01135888|cooling device|cooling device
570532|NCT01135875|GBM|gbm
570533|NCT01135875|Brain Tumor|brain tumor
570534|NCT01135875|Brain Neoplasm|brain neoplasm
570535|NCT01135875|Control|control
570536|NCT01135875|Normal Control|normal control
570537|NCT01135875|Volunteer|volunteer
570538|NCT01135836|Shoulder pain|shoulder pain
570539|NCT01135836|Gynecologic laparoscopic surgery|gynecologic laparoscopic surgery
570540|NCT01135836|Nausea|nausea
570541|NCT01135836|Vomiting|vomiting
570542|NCT01135836|Abdominal fullness|abdominal fullness
570543|NCT01135810|healthy subjects|healthy subjects
570544|NCT01135771|glucose monitoring|glucose monitoring
570545|NCT01135771|diabetes|diabetes
571624|NCT01131247|CLL|cll
570546|NCT01135771|glucose monitoring in patients with diabetes|glucose monitoring in patients with diabetes
570547|NCT01135758|depression, ketamine, fMRI|depression, ketamine, fmri
570548|NCT01135732|late development cholangiocarcinoma|late development cholangiocarcinoma
570550|NCT01135719|Hyperopia|hyperopia
570551|NCT01135719|Astigmatism|astigmatism
570552|NCT01135719|PRK|prk
570553|NCT01135719|LASIK|lasik
570554|NCT01135706|Pulmonary Hypertension|pulmonary hypertension
570555|NCT01135706|Fractal dimension|fractal dimension
570556|NCT01135693|Section 136|section 136
570557|NCT01135693|Mental Health Act 1983|mental health act 1983
570558|NCT01135693|Police|police
570559|NCT01135693|Detention|detention
570560|NCT01135693|Failure of community care|failure of community care
570561|NCT01135667|clopidogrel|clopidogrel
570562|NCT01135667|prasugrel|prasugrel
570563|NCT01135667|low responder|low responder
570564|NCT01135667|multiplate|multiplate
570565|NCT01135667|verify now|verify now
570566|NCT01135654|alcohol dependence|alcohol dependence
570567|NCT01135654|unhealthy drinking|unhealthy drinking
570568|NCT01135654|SBIRT|sbirt
570569|NCT01135641|Adult patients (≥18 years)|adult patients (≥18 years)
570570|NCT01135641|first allogeneic stem cell transplantation|first allogeneic stem cell transplantation
570571|NCT01135641|first episode of chronic GVHD requiring systemic immunosuppressive therapy|first episode of chronic gvhd requiring systemic immunosuppressive therapy
570572|NCT01135628|Hepatic cirrhosis|hepatic cirrhosis
570573|NCT01135628|Minimal hepatic encephalopathy|minimal hepatic encephalopathy
570574|NCT01135628|Hyperproteic and fiber-rich diet|hyperproteic and fiber-rich diet
570575|NCT01135628|Lactobacillus reuteri|lactobacillus reuteri
570576|NCT01135628|Psychometric Hepatic Encephalopathy Score (PHES)|psychometric hepatic encephalopathy score (phes)
570577|NCT01135628|Critical Flicker Frequency (CFF)|critical flicker frequency (cff)
570578|NCT01135615|FGF-23, endothelial dysfunction, sevelamer|fgf-23, endothelial dysfunction, sevelamer
570579|NCT01135602|Alcohol dependence|alcohol dependence
570580|NCT01135602|Alcoholism|alcoholism
570581|NCT01135602|Topiramate|topiramate
570582|NCT01135589|pediatric|pediatric
570583|NCT01135589|adolescent|adolescent
570584|NCT01135589|micafungin|micafungin
570585|NCT01135576|Ferric pyrophosphate|ferric pyrophosphate
570586|NCT01135576|Fortification|fortification
570587|NCT01135576|Fruit juice|fruit juice
570588|NCT01135576|Functional food|functional food
570589|NCT01135576|Bioavailability|bioavailability
570590|NCT01135576|iron status|iron status
570591|NCT01135576|Women|women
570592|NCT01135576|iron-deficiency anemia|iron-deficiency anemia
570593|NCT01135563|pediatrics|pediatrics
570594|NCT01135563|Solid Tumors|solid tumors
570595|NCT01135563|CNS Tumors|cns tumors
570596|NCT01135563|Vinblastine|vinblastine
570597|NCT01135563|Sirolimus|sirolimus
570598|NCT01135563|Recurrent|recurrent
570599|NCT01135563|Refractory|refractory
570600|NCT01135550|Pediatrics|pediatrics
570601|NCT01135550|Vomiting|vomiting
570602|NCT01135550|Headache|headache
570603|NCT01135550|Radiation Therapy|radiation therapy
570604|NCT01135537|allogeneic hematopoietic stem cell transplantation|allogeneic hematopoietic stem cell transplantation
570605|NCT01135537|pharmacokinetics|pharmacokinetics
570606|NCT01135537|pediatrics|pediatrics
570607|NCT01135524|Osteoarthritis|osteoarthritis
570608|NCT01135524|Opioid|opioid
570609|NCT01135524|Transdermal|transdermal
570610|NCT01135511|Dry eye|dry eye
570611|NCT01135472|NEXIUM|nexium
570612|NCT01135472|HEALTHY VOLUNTEERS|healthy volunteers
570613|NCT01135472|BLOOD DRAW|blood draw
570614|NCT01135472|to measure gastrin levels in healthy volunteers while taking nexium|to measure gastrin levels in healthy volunteers while taking nexium
570615|NCT01135459|Lupus|lupus
570616|NCT01135433|Diabetes mellitus|diabetes mellitus
570617|NCT01135433|Metformin|metformin
570618|NCT01135433|ASP1941|asp1941
570619|NCT01135407|Parkinson's disease|parkinson's disease
570620|NCT01135407|Deep brain stimulation|deep brain stimulation
570621|NCT01135407|Subthalamic nucleus|subthalamic nucleus
570622|NCT01135407|Levodopa|levodopa
570623|NCT01135407|Selective visual attention|selective visual attention
570624|NCT01135407|Basal ganglia diseases|basal ganglia diseases
570625|NCT01135394|Pioglitazone|pioglitazone
570626|NCT01135394|Type 2 diabetes|type 2 diabetes
570627|NCT01135394|Insulin sensitivity|insulin sensitivity
570628|NCT01135394|Healthy adults|healthy adults
570629|NCT01135394|Thiazolidinediones|thiazolidinediones
570630|NCT01135394|Pharmacogenetics|pharmacogenetics
570631|NCT01135381|care transitions|care transitions
570632|NCT01135381|information technology|information technology
570633|NCT01135368|GERD|gerd
570634|NCT01135368|Gastroesophageal Reflux Disease|gastroesophageal reflux disease
570635|NCT01135368|Drug Therapy|drug therapy
570636|NCT01135342|Insomnia|insomnia
570637|NCT01135342|Weight loss|weight loss
570638|NCT01135342|Adults|adults
570639|NCT01135329|Lymphoma|lymphoma
570640|NCT01135329|Hodgkin's lymphoma|hodgkin's lymphoma
570641|NCT01135329|Non hodgkin's lymphoma|non hodgkin's lymphoma
570642|NCT01135329|Leukemia|leukemia
570643|NCT01135329|Acute myeloid leukemia (AML)|acute myeloid leukemia (aml)
570644|NCT01135329|Acute lymphoblastic leukemia(ALL)|acute lymphoblastic leukemia(all)
570645|NCT01135329|Chronic myeloid leukemia (CML)|chronic myeloid leukemia (cml)
570646|NCT01135329|Chronic Myelomonocytic (CMML)|chronic myelomonocytic (cmml)
570647|NCT01135329|Myelodysplastic syndrome (MDS)|myelodysplastic syndrome (mds)
570648|NCT01135329|High-risk acute leukemia in first remission|high-risk acute leukemia in first remission
570649|NCT01135329|Relapsed leukemia in remission|relapsed leukemia in remission
570650|NCT01135329|Cyclophosphamide|cyclophosphamide
570651|NCT01135329|High-dose cyclophosphamide|high-dose cyclophosphamide
570652|NCT01135329|Fludarabine|fludarabine
570653|NCT01135329|Busulfan|busulfan
570654|NCT01135329|Allogeneic|allogeneic
570655|NCT01135329|Nonmyeloablative|nonmyeloablative
570656|NCT01135329|Reduced intensity|reduced intensity
570657|NCT01135329|Haploidentical|haploidentical
570658|NCT01135329|Bone marrow transplant (BMT)|bone marrow transplant (bmt)
570659|NCT01135316|NSF, Ablavar, Kidney Disease, Magnetic Resonance Imaging (MRI),|nsf, ablavar, kidney disease, magnetic resonance imaging (mri),
570660|NCT01135303|Sleep Apnea Syndromes|sleep apnea syndromes
570661|NCT01135303|Polysomnography|polysomnography
570662|NCT01135303|Holter ECG|holter ecg
570663|NCT01135303|Thoracic impedance|thoracic impedance
570664|NCT01135303|Heart rate variability|heart rate variability
570665|NCT01135290|The management of post-treatment symptoms for subjects that had either a medium grade chemical peel or fractional resurfacing|the management of post-treatment symptoms for subjects that had either a medium grade chemical peel or fractional resurfacing
570666|NCT01135251|Neuropathic pain|neuropathic pain
570667|NCT01135251|AIDS|aids
570668|NCT01135251|Dimiracetam|dimiracetam
570669|NCT01135251|Treatment related painful neuropathy in AIDS patients|treatment related painful neuropathy in aids patients
570670|NCT01135238|adrenalectomy|adrenalectomy
570671|NCT01135238|metastasis|metastasis
570672|NCT01135238|morbidity|morbidity
570673|NCT01135238|mortality|mortality
570674|NCT01135238|survival|survival
570675|NCT01135225|Drug-eluting stent|drug-eluting stent
570676|NCT01135225|Percutaneous coronary intervention|percutaneous coronary intervention
570677|NCT01135225|Stent implantation|stent implantation
570678|NCT01135225|Evolution Stent System|evolution stent system
570679|NCT01135225|Biodegradable polymer coating|biodegradable polymer coating
570680|NCT01135225|Feasibility study|feasibility study
570681|NCT01135212|Hypertension|hypertension
570682|NCT01135212|ARB|arb
570683|NCT01135212|Fimasartan|fimasartan
570684|NCT01135173|Smoking Cessation, Waterpipe|smoking cessation, waterpipe
570685|NCT01135160|weight bearing|weight bearing
570686|NCT01135160|pain|pain
570687|NCT01135160|total hip arthroplasty|total hip arthroplasty
570688|NCT01135160|total knee arthroplasty|total knee arthroplasty
570689|NCT01135160|weight bearing after TKA or THA|weight bearing after tka or tha
570690|NCT01135108|Analgesics. Non-narcotic / therapeutic use|analgesics. non-narcotic / therapeutic use
570691|NCT01135108|Spinal Cord Injuries|spinal cord injuries
570692|NCT01135108|Pain|pain
570693|NCT01135108|Pain measurement / drug effect|pain measurement / drug effect
570694|NCT01135108|Pain postoperative / drug therapy|pain postoperative / drug therapy
570695|NCT01135095|Myocardial perfusion|myocardial perfusion
570696|NCT01135095|Low radiation dose|low radiation dose
570697|NCT01135095|Single photon emission computed tomography|single photon emission computed tomography
570698|NCT01135082|immunogenicity|immunogenicity
570699|NCT01135082|safety|safety
570700|NCT01135082|Pneumococcal conjugate vaccine|pneumococcal conjugate vaccine
570701|NCT01135082|HIV infected children|hiv infected children
570702|NCT01135082|objective of this study is to assess the safety and immunogenicity of a 7 - valent PCV vaccine among HIV - infected compared with HIV - exposed children|objective of this study is to assess the safety and immunogenicity of a 7 - valent pcv vaccine among hiv - infected compared with hiv - exposed children
570703|NCT01135056|Hepatocellular Carcinoma|hepatocellular carcinoma
570704|NCT01135056|Randomized|randomized
570705|NCT01135056|Open-label|open-label
570706|NCT01135056|Multi-Centre|multi-centre
570707|NCT01135056|Phase III|phase iii
570708|NCT01135056|Sorafenib|sorafenib
570709|NCT01135056|SIR-Spheres|sir-spheres
570710|NCT01135043|acceptable sputum|acceptable sputum
570711|NCT01135043|AFB culture|afb culture
570712|NCT01135043|pulmonary tuberculosis|pulmonary tuberculosis
570713|NCT01135030|total knee arthroplasty|total knee arthroplasty
570714|NCT01135004|pneumothorax|pneumothorax
570715|NCT01135004|thoracoscopy|thoracoscopy
570716|NCT01135004|pathogenesis|pathogenesis
570717|NCT01135004|blebs|blebs
570718|NCT01135004|surgery|surgery
570719|NCT01134991|rosacea|rosacea
570720|NCT01134991|topical|topical
570721|NCT01134991|minocycline|minocycline
570722|NCT01134991|foam|foam
570723|NCT01134991|phase II|phase ii
570724|NCT01134978|repeated measures design|repeated measures design
570725|NCT01134978|random assignment to groups|random assignment to groups
570726|NCT01134952|sirolimus|sirolimus
570727|NCT01134952|everolimus|everolimus
570728|NCT01134952|mycophenolic acid|mycophenolic acid
570729|NCT01134952|hepatitis C virus|hepatitis c virus
570730|NCT01134952|tacrolimus|tacrolimus
570731|NCT01134952|viral load|viral load
570732|NCT01134926|Retained products of conception|retained products of conception
570733|NCT01134926|residua|residua
570735|NCT01134926|expectant management|expectant management
570736|NCT01134913|ACS|acs
570737|NCT01134913|Acute Coronary Syndrome|acute coronary syndrome
570738|NCT01134913|Emergency Department|emergency department
570739|NCT01134900|Medication Errors|medication errors
570740|NCT01134900|Adverse Drug Events|adverse drug events
570741|NCT01134900|Decision Support Systems, Clinical|decision support systems, clinical
570742|NCT01134887|hypertension|hypertension
570743|NCT01134887|physician-patient relations|physician-patient relations
570744|NCT01134887|communication|communication
570745|NCT01134861|stage II non-small cell lung cancer|stage ii non-small cell lung cancer
570746|NCT01134861|stage IIIA non-small cell lung cancer|stage iiia non-small cell lung cancer
570747|NCT01134861|stage IIIB non-small cell lung cancer|stage iiib non-small cell lung cancer
570748|NCT01134848|Bile ducts|bile ducts
570749|NCT01134848|Sphincter of Oddi|sphincter of oddi
570750|NCT01134848|Pancreatic ducts|pancreatic ducts
570751|NCT01134822|Idiopathic Pulmonary Fibrosis|idiopathic pulmonary fibrosis
570752|NCT01134822|IPF|ipf
570753|NCT01134822|Lung Fibrosis|lung fibrosis
570754|NCT01134822|Biomarkers|biomarkers
570755|NCT01134809|Major abdominal surgery|major abdominal surgery
570756|NCT01134770|Prenatal Substance Use|prenatal substance use
570757|NCT01134770|Cocaine|cocaine
570758|NCT01134770|Cigarette Smoking|cigarette smoking
570759|NCT01134770|Mothers|mothers
570760|NCT01134770|Pregnant women|pregnant women
570761|NCT01134770|Smoking Mothers|smoking mothers
570762|NCT01134757|EAR|ear
570763|NCT01134757|LAR|lar
570764|NCT01134757|BHR|bhr
570765|NCT01134757|house dust mite|house dust mite
570766|NCT01134757|alternaria|alternaria
570767|NCT01134744|CXray|cxray
570768|NCT01134731|depression|depression
570769|NCT01134731|suicidality|suicidality
570770|NCT01134731|Major Depressive Disorder, current episode, with suicidality|major depressive disorder, current episode, with suicidality
570771|NCT01134718|TMC435-TiDP16-C119|tmc435-tidp16-c119
570772|NCT01134718|TMC435-C119|tmc435-c119
570773|NCT01134718|TMC435|tmc435
570774|NCT01134718|Protease inhibitor|protease inhibitor
570775|NCT01134718|HCV|hcv
570776|NCT01134718|Hepatitis C|hepatitis c
570777|NCT01134718|Bioavailability|bioavailability
570778|NCT01134692|Patients with cirrhosis who have large esophageal varices with No history of upper GI bleeding in the past|patients with cirrhosis who have large esophageal varices with no history of upper gi bleeding in the past
570779|NCT01134679|Drug Eluting Stent|drug eluting stent
570780|NCT01134679|Clopidogrel|clopidogrel
570781|NCT01134679|Aspirin|aspirin
570782|NCT01134666|Colorectal neoplasms|colorectal neoplasms
570783|NCT01134666|Intestinal neoplasms|intestinal neoplasms
570784|NCT01134666|Neoplasms|neoplasms
570785|NCT01134666|cetuximab|cetuximab
570786|NCT01134666|Erbitux|erbitux
570787|NCT01134653|Acute ankle sprain in children and young adults|acute ankle sprain in children and young adults
570788|NCT01134640|metastatic colorectal cancer|metastatic colorectal cancer
570789|NCT01134640|mCRC|mcrc
570790|NCT01134640|post marketing surveillance|post marketing surveillance
570791|NCT01134640|Erbitux|erbitux
570792|NCT01134640|Cetuximab|cetuximab
570793|NCT01134640|KRAS|kras
570794|NCT01134627|Multiple Sclerosis, Relapsing-Remitting|multiple sclerosis, relapsing-remitting
570795|NCT01134627|Interferon-β|interferon-β
570796|NCT01134627|Rebif®|rebif®
570797|NCT01134627|Minocycline|minocycline
570798|NCT01134601|Rectal Cancer|rectal cancer
570799|NCT01134601|Radiation Therapy|radiation therapy
570800|NCT01134601|Capecitabine|capecitabine
570801|NCT01134601|AZD6244|azd6244
570802|NCT01134575|Relapsed|relapsed
570803|NCT01134575|Refractory|refractory
570804|NCT01134575|Acute Lymphoblastic Leukemia|acute lymphoblastic leukemia
570806|NCT01134575|Burkitt's lymphoma|burkitt's lymphoma
570807|NCT01134575|Lymphoblastic lymphoma|lymphoblastic lymphoma
570808|NCT01134575|CMC-544|cmc-544
570809|NCT01134575|Inotuzumab Ozogamycin|inotuzumab ozogamycin
570810|NCT01134575|Rituxan|rituxan
570811|NCT01134575|Rituximab|rituximab
570812|NCT01134562|Clinical Trial, Phase 1|clinical trial, phase 1
570813|NCT01134562|Renal Dialysis|renal dialysis
570814|NCT01134562|Secondary Hyperparathyroidism|secondary hyperparathyroidism
570815|NCT01134562|Parathyroid hormone|parathyroid hormone
570816|NCT01134536|Pain, Postoperative|pain, postoperative
570817|NCT01134536|Postoperative Pain|postoperative pain
570818|NCT01134536|Tapentadol|tapentadol
570819|NCT01134536|NUCYNTA|nucynta
570820|NCT01134536|CG5503|cg5503
570821|NCT01134536|R331333|r331333
570822|NCT01134536|Pharmacokinetics|pharmacokinetics
570823|NCT01134536|Postsurgical pain|postsurgical pain
570824|NCT01134536|Children|children
570825|NCT01134536|Adolescents|adolescents
570826|NCT01134523|positive lymph node|positive lymph node
570827|NCT01134510|Kidney transplantation|kidney transplantation
570828|NCT01134484|autologous stem cell transplantation|autologous stem cell transplantation
570829|NCT01134484|complete remission|complete remission
570830|NCT01134484|bortezomib|bortezomib
570831|NCT01134484|thalidomide|thalidomide
570832|NCT01134484|progression free survival|progression free survival
570833|NCT01134484|induction and consolidation therapy|induction and consolidation therapy
570834|NCT01134458|cardiovascular disease|cardiovascular disease
570835|NCT01134445|Arthroplasty|arthroplasty
570836|NCT01134445|Replacement|replacement
570838|NCT01134445|Conservative|conservative
570839|NCT01134445|Anatomic|anatomic
570840|NCT01134445|Cementless|cementless
570841|NCT01134432|autoimmune hemolytic anemia|autoimmune hemolytic anemia
570842|NCT01134432|hemolytic anemia|hemolytic anemia
570843|NCT01134432|Rituximab|rituximab
570844|NCT01134432|Treatment of autoimmune hemolytic anemia|treatment of autoimmune hemolytic anemia
570845|NCT01134432|warm antibody dependant autoimmune hemolytic anemia|warm antibody dependant autoimmune hemolytic anemia
570846|NCT01134419|Patient Safety|patient safety
570847|NCT01134419|Medical Errors|medical errors
570848|NCT01134419|Handoff|handoff
570849|NCT01134419|Sign-out|sign-out
570850|NCT01134419|Resident|resident
570851|NCT01134419|Intern|intern
570852|NCT01134419|Graduate Medical Education|graduate medical education
570853|NCT01134406|Osteoarthritis|osteoarthritis
570854|NCT01134406|knee|knee
570855|NCT01134380|Percutaneous coronary intervention|percutaneous coronary intervention
570856|NCT01134380|Acute coronary syndrome|acute coronary syndrome
570857|NCT01134380|Dual antiplatelet therapy|dual antiplatelet therapy
570858|NCT01134380|clopidogrel/prasugrel|clopidogrel/prasugrel
570859|NCT01134380|genotyping|genotyping
570860|NCT01134380|stent|stent
570861|NCT01134380|compliance|compliance
570862|NCT01134367|gastroesophageal reflux disease (GERD)|gastroesophageal reflux disease (gerd)
570863|NCT01134354|Validation study|validation study
570864|NCT01134354|Outcome Measures|outcome measures
570865|NCT01134354|Patient Outcomes Assessment|patient outcomes assessment
570866|NCT01134354|Patient expectations|patient expectations
570867|NCT01134354|Physician patient relationship|physician patient relationship
570868|NCT01134341|Relapsed|relapsed
570869|NCT01134341|Refractory|refractory
570870|NCT01134315|Evaluating incidence of hypercalcemia in pediatric patients|evaluating incidence of hypercalcemia in pediatric patients
570871|NCT01134302|Hybrid|hybrid
570872|NCT01134302|Norwood|norwood
570873|NCT01134302|congenital heart disease|congenital heart disease
570874|NCT01134302|single ventricle|single ventricle
570875|NCT01134289|complex regional pain syndrome|complex regional pain syndrome
570876|NCT01134289|lumbar sympathetic blockade|lumbar sympathetic blockade
570877|NCT01134289|photoplethysmography|photoplethysmography
570878|NCT01134289|diagnostic lumbar sympathetic blockade|diagnostic lumbar sympathetic blockade
570879|NCT01134263|Dengue Fever|dengue fever
570880|NCT01134263|Dengue Hemorrhagic Fever|dengue hemorrhagic fever
570881|NCT01134263|CYD Dengue Vaccine|cyd dengue vaccine
570882|NCT01134263|Lot Consistency|lot consistency
570883|NCT01134250|Interleukin, IL2, F16, monoclonal, antibody, cytokine Paclitaxel, breast cancer,solid tumour|interleukin, il2, f16, monoclonal, antibody, cytokine paclitaxel, breast cancer,solid tumour
570884|NCT01134250|metastatic melanoma, non-small cell lung cancer (NSCLC)|metastatic melanoma, non-small cell lung cancer (nsclc)
570885|NCT01134237|non-surgical rate|non-surgical rate
570886|NCT01134198|Cocaine Dependence|cocaine dependence
570887|NCT01134185|Two groups of 8 hepatically impaired subjects, one group of 8 matched healthy subjects|two groups of 8 hepatically impaired subjects, one group of 8 matched healthy subjects
570888|NCT01134172|Sociodemographic|sociodemographic
570889|NCT01134172|Ethnicity|ethnicity
570890|NCT01134172|Work-related|work-related
570891|NCT01134172|Health system|health system
570892|NCT01134172|QOL|qol
570893|NCT01134172|Questionnaires|questionnaires
570894|NCT01134172|10-071|10-071
570895|NCT01134146|Intensity Modulated Radiotherapy|intensity modulated radiotherapy
570896|NCT01134146|IMRT|imrt
570897|NCT01134146|Malignant Pleural Mesothelioma|malignant pleural mesothelioma
570898|NCT01134146|Radical Pleurectomy|radical pleurectomy
570899|NCT01134146|Decortication|decortication
570900|NCT01134146|PD|pd
570901|NCT01134146|pleurectomy|pleurectomy
570902|NCT01134146|lung surgery|lung surgery
570903|NCT01134146|pleura|pleura
570904|NCT01134094|Undisplaced|undisplaced
570905|NCT01134094|Ankle Fracture|ankle fracture
570906|NCT01134094|Weber B|weber b
570907|NCT01134081|gum|gum
570908|NCT01134081|recession|recession
570909|NCT01134068|D-dimer|d-dimer
570910|NCT01134068|Pulmonary embolism|pulmonary embolism
570911|NCT01134068|Diagnostic strategy|diagnostic strategy
570912|NCT01134068|Safety of ruling PE with and age-adjusted DD cut-off|safety of ruling pe with and age-adjusted dd cut-off
570913|NCT01134055|ranibizumab|ranibizumab
570914|NCT01134055|wet AMD|wet amd
570915|NCT01134055|MD7110852|md7110852
570916|NCT01134055|age related macular degeneration|age related macular degeneration
570917|NCT01134055|age-related macular degeneration|age-related macular degeneration
570918|NCT01134055|macular degeneration|macular degeneration
570919|NCT01134055|pazopanib|pazopanib
570920|NCT01134042|Fluticasone propionate|fluticasone propionate
570921|NCT01134042|asthma|asthma
570922|NCT01134042|vilanterol|vilanterol
570923|NCT01134042|GW642444|gw642444
570924|NCT01134042|Fluticasone furoate|fluticasone furoate
570925|NCT01134029|obesity|obesity
570926|NCT01134029|weight management and cardiovascular risk factors|weight management and cardiovascular risk factors
570927|NCT01134016|Lung cancer|lung cancer
570928|NCT01134016|NSCLC|nsclc
570929|NCT01134003|Gynecare Prolift|gynecare prolift
570930|NCT01134003|Pelvic organ prolapse|pelvic organ prolapse
570931|NCT01134003|forming a large database of women who have recieve Gynecare prolift system|forming a large database of women who have recieve gynecare prolift system
570932|NCT01133964|Dairy proteins|dairy proteins
570933|NCT01133964|Appetite regulation|appetite regulation
570934|NCT01133964|Energy expenditure|energy expenditure
570935|NCT01133951|Helicobacter Infections|helicobacter infections
570936|NCT01133951|Helicobacter pylori|helicobacter pylori
570937|NCT01133951|Drug Therapy|drug therapy
570938|NCT01133951|Precancerous Conditions|precancerous conditions
570939|NCT01133951|Stomach Neoplasms|stomach neoplasms
570940|NCT01133951|Incidence|incidence
570941|NCT01133925|Coronary Artery Disease|coronary artery disease
570942|NCT01133925|Percutaneous Coronary Intervention|percutaneous coronary intervention
570943|NCT01133925|Drug Eluting Stent|drug eluting stent
570944|NCT01133925|Optical Coherence Tomography|optical coherence tomography
570945|NCT01133925|Thrombosi|thrombosi
570946|NCT01133925|Long lesions in native vessels requiring overlap|long lesions in native vessels requiring overlap
570947|NCT01133912|Patients with HER2 Positive Operable Breast Cancer|patients with her2 positive operable breast cancer
570948|NCT01133899|strength, anaerobic performance, recovery, ergogenic|strength, anaerobic performance, recovery, ergogenic
570949|NCT01133860|inherited thrombocytopenia|inherited thrombocytopenia
570950|NCT01133860|MYH9 mutations|myh9 mutations
570951|NCT01133860|eltrombopag|eltrombopag
570952|NCT01133834|meningococcal disease|meningococcal disease
570953|NCT01133834|cytokines|cytokines
570954|NCT01133821|Bipolar II Disorder|bipolar ii disorder
570955|NCT01133821|Bipolar II Depression|bipolar ii depression
570956|NCT01133821|Psychotherapy|psychotherapy
570957|NCT01133821|IPSRT|ipsrt
570958|NCT01133821|Seroquel|seroquel
570959|NCT01133821|Quetiapine|quetiapine
570960|NCT01133821|Placebo|placebo
570961|NCT01133821|Sugar Pill|sugar pill
570962|NCT01133808|diarrhea|diarrhea
570963|NCT01133808|childhood|childhood
570964|NCT01133808|rotavirus|rotavirus
570965|NCT01133808|vaccine|vaccine
570966|NCT01133808|Nicaragua|nicaragua
570967|NCT01133795|cirrhosis|cirrhosis
570968|NCT01133795|renal failure|renal failure
570969|NCT01133795|hepatorenal syndrome|hepatorenal syndrome
570970|NCT01133795|albumine|albumine
570971|NCT01133795|midodrine|midodrine
570972|NCT01133769|Clavicle fracture|clavicle fracture
570973|NCT01133769|fixation|fixation
570974|NCT01133769|polytrauma|polytrauma
570975|NCT01133769|Clavicle fracture patients with chest injury|clavicle fracture patients with chest injury
570976|NCT01133743|Lenalidomide|lenalidomide
570977|NCT01133743|Dexamethasone|dexamethasone
570978|NCT01133743|Immunomodulatory Drugs(IMiD™)|immunomodulatory drugs(imid™)
570979|NCT01133743|Thalidomide analogues|thalidomide analogues
570980|NCT01133730|supraclavicular nerve block|supraclavicular nerve block
570981|NCT01133730|regional anesthesia|regional anesthesia
570982|NCT01133730|transversalis fascia plane block|transversalis fascia plane block
570983|NCT01133730|ultrasound guided|ultrasound guided
570984|NCT01133730|opioid consumption|opioid consumption
570985|NCT01133730|iliac crest bone harvest|iliac crest bone harvest
570986|NCT01133730|hand surgery|hand surgery
570987|NCT01133730|wrist surgery|wrist surgery
570988|NCT01133730|Upper limb surgery combined with iliac crest bone harvest.|upper limb surgery combined with iliac crest bone harvest.
570989|NCT01133717|Sleep Apnea|sleep apnea
570990|NCT01133717|Cerebrovascular Reactivity|cerebrovascular reactivity
570991|NCT01133704|asymptomatic metastatic hormone-refractory prostate cancer|asymptomatic metastatic hormone-refractory prostate cancer
570992|NCT01133691|gastric emptying|gastric emptying
570993|NCT01133691|children|children
570994|NCT01133691|gastric fluid volume|gastric fluid volume
570995|NCT01133691|preoperative fasting|preoperative fasting
570996|NCT01133678|Squamous Cell Carcinoma|squamous cell carcinoma
570997|NCT01133665|Head and Neck, Squamous Cell|head and neck, squamous cell
570998|NCT01133665|Recurrent or metastatic squamous cell or undifferentiated carcinoma of the head and neck that is not amenable to curative therapy|recurrent or metastatic squamous cell or undifferentiated carcinoma of the head and neck that is not amenable to curative therapy
570999|NCT01133652|Venipuncture|venipuncture
571000|NCT01133652|Randomized Controlled Trial|randomized controlled trial
571001|NCT01133652|Intravenous access|intravenous access
571002|NCT01133652|Children|children
571003|NCT01133652|Pediatric Emergency Department|pediatric emergency department
571004|NCT01133652|Peripheral intravenous catheterization|peripheral intravenous catheterization
571005|NCT01133652|Catheterization, Peripheral Phlebotomy|catheterization, peripheral phlebotomy
571006|NCT01133587|Schizophrenia|schizophrenia
571007|NCT01133587|bipolar disorder|bipolar disorder
571008|NCT01133587|Long term care|long term care
571009|NCT01133587|patient admission|patient admission
571010|NCT01133574|Healthy volunteers|healthy volunteers
571011|NCT01133574|SLV354|slv354
571012|NCT01133574|Phase I|phase i
571013|NCT01133574|SRDT|srdt
571014|NCT01133561|psoriasis|psoriasis
571015|NCT01133561|insulin resistance|insulin resistance
571016|NCT01133561|metabolic syndrome|metabolic syndrome
571017|NCT01133561|pioglitazone|pioglitazone
571719|NCT01130948|sleep|sleep
571018|NCT01133561|randomized control trial|randomized control trial
571019|NCT01133548|testosterone, hypogonadal, males|testosterone, hypogonadal, males
571020|NCT01133522|AMG145|amg145
571021|NCT01133522|Multiple Dose|multiple dose
571022|NCT01133522|Statin|statin
571023|NCT01133522|Ascending|ascending
571024|NCT01133496|Bioequivalence|bioequivalence
571025|NCT01133496|Alendronate Sodium|alendronate sodium
571026|NCT01133496|crossover|crossover
571027|NCT01133483|Bioequivalence|bioequivalence
571028|NCT01133483|Fexofenadine Hydrochloride + Pseudoephedrine Hydrochloride|fexofenadine hydrochloride + pseudoephedrine hydrochloride
571029|NCT01133470|Bioequivalence|bioequivalence
571030|NCT01133470|Fexofenadine Hydrochloride + Pseudoephedrine Hydrochloride|fexofenadine hydrochloride + pseudoephedrine hydrochloride
571031|NCT01133457|Bioequivalence,Finasteride,Crossover|bioequivalence,finasteride,crossover
571032|NCT01133444|Bioequivalence,Finasteride,Crossover|bioequivalence,finasteride,crossover
571033|NCT01133431|CKD-501|ckd-501
571034|NCT01133431|Glimepiride|glimepiride
571035|NCT01133431|Placebo|placebo
571036|NCT01133431|Healthy male volunteer|healthy male volunteer
571037|NCT01133431|Pharmacokinetic|pharmacokinetic
571038|NCT01133431|Metabolite|metabolite
571039|NCT01133392|insulin|insulin
571040|NCT01133392|lispro|lispro
571041|NCT01133366|ISIS301012|isis301012
571042|NCT01133366|antisense|antisense
571043|NCT01133366|ApoB (Apolipoprotein B)|apob (apolipoprotein b)
571044|NCT01133366|LDL (low density lipoprotein)|ldl (low density lipoprotein)
571045|NCT01133366|mipomersen|mipomersen
571046|NCT01133340|RADIOTHERAPY|radiotherapy
571047|NCT01133340|CT simulation|ct simulation
571048|NCT01133340|MRI simulation|mri simulation
571049|NCT01133340|Endoscopic clip placement|endoscopic clip placement
571050|NCT01133340|Rectal cancer|rectal cancer
571051|NCT01133340|Accuracy of MRI Simulation for target delineation and planning|accuracy of mri simulation for target delineation and planning
571052|NCT01133327|Carotid Artery Stenting|carotid artery stenting
571053|NCT01133327|High Risk patient|high risk patient
571054|NCT01133327|Carotid artery stenosis|carotid artery stenosis
571055|NCT01133327|stroke|stroke
571056|NCT01133327|Carotid artery disease|carotid artery disease
571057|NCT01133327|ASTI study|asti study
571058|NCT01133327|Adapt Carotid Stent system|adapt carotid stent system
571059|NCT01133327|FilterWire EZ Embolic Protection System|filterwire ez embolic protection system
571060|NCT01133301|Borderline Personality Disorder|borderline personality disorder
571061|NCT01133301|Dissociation|dissociation
571062|NCT01133301|Naltrexone|naltrexone
571063|NCT01133249|total hip|total hip
571064|NCT01133236|Salt restriction|salt restriction
571065|NCT01133236|Fluid restriction|fluid restriction
571066|NCT01133236|Congestion|congestion
571067|NCT01133236|Heart Failure|heart failure
571068|NCT01133223|Stroke, mecanical thrombectomy|stroke, mecanical thrombectomy
571069|NCT01133210|hypertriglyceridemia|hypertriglyceridemia
571070|NCT01133210|triglyceride|triglyceride
571071|NCT01133210|cholesterol|cholesterol
571072|NCT01133210|Maraviroc|maraviroc
571073|NCT01133197|thumb|thumb
571074|NCT01133197|arthritis|arthritis
571075|NCT01133197|Impact of thumb arthritis on health|impact of thumb arthritis on health
571076|NCT01133184|HBV transmission PreS1/PreS2/S HBV vaccine|hbv transmission pres1/pres2/s hbv vaccine
571077|NCT01133171|Cardiovascular Disease|cardiovascular disease
571078|NCT01133171|Stroke|stroke
571079|NCT01133158|Follicular non-Hodgkin's lymphoma relapse refractory|follicular non-hodgkin's lymphoma relapse refractory
571080|NCT01133145|composite tissue allotransplantation|composite tissue allotransplantation
571081|NCT01133145|hand transplantation|hand transplantation
571082|NCT01133145|knee transplantation|knee transplantation
571083|NCT01133145|face transplantation|face transplantation
571084|NCT01133132|Colon cancer patients who have completed treatment|colon cancer patients who have completed treatment
571085|NCT01133119|cardiac catheterization|cardiac catheterization
571086|NCT01133119|local anesthetic|local anesthetic
571087|NCT01133119|pain experienced post-operatively|pain experienced post-operatively
571088|NCT01133119|pediatric patients|pediatric patients
571089|NCT01133106|stroke recovery|stroke recovery
571090|NCT01133106|quality of life|quality of life
571091|NCT01133093|Cardiovascular risk factors|cardiovascular risk factors
571092|NCT01133093|Nutritional assessment|nutritional assessment
571093|NCT01133093|Epidemiology|epidemiology
571094|NCT01133067|lung cancer|lung cancer
571095|NCT01133067|followup|followup
571096|NCT01133067|physical follow up|physical follow up
571097|NCT01133067|telephonic followup|telephonic followup
571098|NCT01133054|Coronary Vessel Anomalies|coronary vessel anomalies
571099|NCT01133028|Attention Deficit Hyperactivity Disorder (ADHD)|attention deficit hyperactivity disorder (adhd)
571101|NCT01133015|IVUS|ivus
571102|NCT01133015|MLA|mla
571103|NCT01132989|Patients with cutaneous T cell lymphoma|patients with cutaneous t cell lymphoma
571104|NCT01132976|Personality disorders|personality disorders
571105|NCT01132976|Personal Concerns Inventory|personal concerns inventory
571106|NCT01132976|Non completion|non completion
571107|NCT01132937|Diffusion/Perfusion-MRI|diffusion/perfusion-mri
571108|NCT01132937|Magnetic Resonance Imaging (MRI)|magnetic resonance imaging (mri)
571109|NCT01132937|Stroke|stroke
571110|NCT01132937|Brain Imaging|brain imaging
571111|NCT01132937|Brain Injuries|brain injuries
571112|NCT01132937|Traumatic Brain Injury|traumatic brain injury
571113|NCT01132937|TBI|tbi
571114|NCT01132924|Early Pregnancy|early pregnancy
571115|NCT01132924|Gestational Age|gestational age
571116|NCT01132924|Fecundability|fecundability
571117|NCT01132924|Ovulation|ovulation
571118|NCT01132924|Recall|recall
571119|NCT01132911|Solid Tumors|solid tumors
571120|NCT01132911|Maximum Tolerated Dose|maximum tolerated dose
571121|NCT01132911|Lymphoma|lymphoma
571122|NCT01132911|Dose Escalation|dose escalation
571123|NCT01132911|Pharmacokinetics|pharmacokinetics
571124|NCT01132911|Pediatric Cancer|pediatric cancer
571125|NCT01132911|Solid Tumor|solid tumor
571126|NCT01132911|Sarcoma|sarcoma
571127|NCT01132911|Wilms Tumor|wilms tumor
571128|NCT01132911|Neuroblastoma|neuroblastoma
571129|NCT01132898|Traumatic Brain Injury|traumatic brain injury
571130|NCT01132898|Biomarkers|biomarkers
571131|NCT01132898|Functional Level|functional level
571132|NCT01132898|DTI|dti
571133|NCT01132898|Neuropsychological Assessment|neuropsychological assessment
571134|NCT01132885|MRI|mri
571135|NCT01132885|Developmental|developmental
571136|NCT01132885|Genetic abnormalities in chromosome 7q11.23.|genetic abnormalities in chromosome 7q11.23.
571137|NCT01132885|Duplication|duplication
571138|NCT01132885|Brain|brain
571139|NCT01132885|Williams Syndrome|williams syndrome
571140|NCT01132885|Children|children
571141|NCT01132885|Healthy Volunteer|healthy volunteer
571142|NCT01132885|HV|hv
571143|NCT01132872|Serotonin 1A Receptor|serotonin 1a receptor
571144|NCT01132872|Positron Emission Tomograhy (PET)|positron emission tomograhy (pet)
571145|NCT01132872|Dosimetry|dosimetry
571146|NCT01132872|Healthy Volunteer|healthy volunteer
571147|NCT01132872|HV|hv
571148|NCT01132859|Specimen Collection|specimen collection
571149|NCT01132859|Mucosal Immunity|mucosal immunity
571150|NCT01132859|Immune Responses|immune responses
571151|NCT01132859|Immunity|immunity
571152|NCT01132859|Vaccines|vaccines
571153|NCT01132859|Healthy Volunteer|healthy volunteer
571154|NCT01132859|HV|hv
571155|NCT01132833|thromboembolism|thromboembolism
571156|NCT01132833|stage I multiple myeloma|stage i multiple myeloma
571157|NCT01132833|stage II multiple myeloma|stage ii multiple myeloma
571158|NCT01132833|stage III multiple myeloma|stage iii multiple myeloma
571159|NCT01132807|stage I adult Hodgkin lymphoma|stage i adult hodgkin lymphoma
571160|NCT01132807|stage II adult Hodgkin lymphoma|stage ii adult hodgkin lymphoma
571161|NCT01132794|Pain relief and sedation condition|pain relief and sedation condition
571162|NCT01132781|rhinosinusitis|rhinosinusitis
571163|NCT01132781|asthma|asthma
571164|NCT01132781|allergic rhinitis|allergic rhinitis
571165|NCT01132781|theophylline|theophylline
571166|NCT01132755|gastric|gastric
571167|NCT01132755|pancreas|pancreas
571168|NCT01132755|laparoscopy|laparoscopy
571169|NCT01132755|peritoneal lavage|peritoneal lavage
571170|NCT01132755|10-011|10-011
571171|NCT01132755|gastric and pancreatic cancer|gastric and pancreatic cancer
571172|NCT01132742|Malnutrition|malnutrition
571173|NCT01132742|children|children
571174|NCT01132742|Hospital Stay|hospital stay
571175|NCT01132742|Screening Tools|screening tools
571176|NCT01132742|Anthropometry|anthropometry
571177|NCT01132690|gaucher disease|gaucher disease
571178|NCT01132690|pediatric|pediatric
571179|NCT01132677|OA of Knee|oa of knee
571180|NCT01132677|Osteoarthritis of Knee|osteoarthritis of knee
571181|NCT01132677|Viscosupplementation and Osteoarthritis|viscosupplementation and osteoarthritis
571182|NCT01132677|Viscosupplementation and OA|viscosupplementation and oa
571183|NCT01132677|Hyaluronic Acid|hyaluronic acid
571184|NCT01132677|Corticosteroid injection versus hyaluronic acid|corticosteroid injection versus hyaluronic acid
571185|NCT01132677|Synvisc One and Knee OA|synvisc one and knee oa
571186|NCT01132677|viscosupplementation and knee pain|viscosupplementation and knee pain
571187|NCT01132677|knee Pain from OA|knee pain from oa
571188|NCT01132664|HER2|her2
571189|NCT01132664|BKM120|bkm120
571190|NCT01132664|PIK3|pik3
571191|NCT01132664|metastatic breast cancer|metastatic breast cancer
571192|NCT01132664|brain metastases|brain metastases
571193|NCT01132664|Herceptin|herceptin
571194|NCT01132664|trastuzumab|trastuzumab
571195|NCT01132664|capecitabine|capecitabine
571196|NCT01132664|open-label|open-label
571197|NCT01132664|maximum tolerated dose|maximum tolerated dose
571198|NCT01132664|Phase I/Phase ll|phase i/phase ll
571199|NCT01132651|eczema|eczema
571200|NCT01132651|itch|itch
571201|NCT01132651|pruritus|pruritus
571202|NCT01132651|head|head
571203|NCT01132651|neck|neck
571204|NCT01132638|Gastroesophageal|gastroesophageal
571205|NCT01132638|Pantoprazole|pantoprazole
571206|NCT01132638|erosive|erosive
571207|NCT01132638|Erosive GERD grades A-D, acc. to Los Angeles classification|erosive gerd grades a-d, acc. to los angeles classification
571208|NCT01132625|HSP90|hsp90
571209|NCT01132625|molecular chaperone|molecular chaperone
571210|NCT01132625|advanced solid tumors|advanced solid tumors
571211|NCT01132625|Japan|japan
571720|NCT01130948|sleep apnea|sleep apnea
571212|NCT01132612|Chronic plaque-type psoriasis|chronic plaque-type psoriasis
571213|NCT01132612|AIN457|ain457
571214|NCT01132612|dermatology|dermatology
571215|NCT01132612|Moderate to severe chronic plaque-type psoriasis|moderate to severe chronic plaque-type psoriasis
571216|NCT01132599|stage IV prostate cancer|stage iv prostate cancer
571217|NCT01132560|ductal breast carcinoma in situ|ductal breast carcinoma in situ
571218|NCT01132547|cachexia|cachexia
571219|NCT01132547|weight changes|weight changes
571220|NCT01132547|nausea and vomiting|nausea and vomiting
571221|NCT01132547|alveolar childhood rhabdomyosarcoma|alveolar childhood rhabdomyosarcoma
571222|NCT01132547|anaplastic osteosarcoma|anaplastic osteosarcoma
571223|NCT01132547|childhood alveolar soft-part sarcoma|childhood alveolar soft-part sarcoma
571224|NCT01132547|childhood angiosarcoma|childhood angiosarcoma
571225|NCT01132547|childhood epithelioid sarcoma|childhood epithelioid sarcoma
571226|NCT01132547|childhood fibrosarcoma|childhood fibrosarcoma
571227|NCT01132547|childhood gliosarcoma|childhood gliosarcoma
571228|NCT01132547|childhood leiomyosarcoma|childhood leiomyosarcoma
571229|NCT01132547|childhood liposarcoma|childhood liposarcoma
571230|NCT01132547|childhood neurofibrosarcoma|childhood neurofibrosarcoma
571231|NCT01132547|childhood synovial sarcoma|childhood synovial sarcoma
571232|NCT01132547|chondrosarcoma|chondrosarcoma
571233|NCT01132547|chondrosarcomatous osteosarcoma|chondrosarcomatous osteosarcoma
571234|NCT01132547|clear cell sarcoma of the kidney|clear cell sarcoma of the kidney
571235|NCT01132547|embryonal childhood rhabdomyosarcoma|embryonal childhood rhabdomyosarcoma
571236|NCT01132547|embryonal-botryoid childhood rhabdomyosarcoma|embryonal-botryoid childhood rhabdomyosarcoma
571237|NCT01132547|endometrial stromal sarcoma|endometrial stromal sarcoma
571238|NCT01132547|extraosseous Ewing sarcoma|extraosseous ewing sarcoma
571239|NCT01132547|peripheral primitive neuroectodermal tumor|peripheral primitive neuroectodermal tumor
571240|NCT01132547|fibrosarcomatous osteosarcoma|fibrosarcomatous osteosarcoma
571241|NCT01132547|localized Ewing sarcoma|localized ewing sarcoma
571242|NCT01132547|localized osteosarcoma|localized osteosarcoma
571243|NCT01132547|mast cell sarcoma|mast cell sarcoma
571244|NCT01132547|metastatic childhood soft tissue sarcoma|metastatic childhood soft tissue sarcoma
571245|NCT01132547|metastatic Ewing sarcoma|metastatic ewing sarcoma
571246|NCT01132547|metastatic osteosarcoma|metastatic osteosarcoma
571247|NCT01132547|mixed childhood rhabdomyosarcoma|mixed childhood rhabdomyosarcoma
571248|NCT01132547|mixed osteosarcoma|mixed osteosarcoma
571249|NCT01132547|nonmetastatic childhood soft tissue sarcoma|nonmetastatic childhood soft tissue sarcoma
571250|NCT01132547|osteoblastic osteosarcoma|osteoblastic osteosarcoma
571251|NCT01132547|ovarian carcinosarcoma|ovarian carcinosarcoma
571252|NCT01132547|ovarian sarcoma|ovarian sarcoma
571253|NCT01132547|pleomorphic childhood rhabdomyosarcoma|pleomorphic childhood rhabdomyosarcoma
571254|NCT01132547|previously treated childhood rhabdomyosarcoma|previously treated childhood rhabdomyosarcoma
571255|NCT01132547|previously untreated childhood rhabdomyosarcoma|previously untreated childhood rhabdomyosarcoma
571256|NCT01132547|recurrent adult soft tissue sarcoma|recurrent adult soft tissue sarcoma
571257|NCT01132547|recurrent childhood gliosarcoma|recurrent childhood gliosarcoma
571258|NCT01132547|recurrent childhood rhabdomyosarcoma|recurrent childhood rhabdomyosarcoma
571259|NCT01132547|recurrent childhood soft tissue sarcoma|recurrent childhood soft tissue sarcoma
571260|NCT01132547|recurrent Ewing sarcoma|recurrent ewing sarcoma
571261|NCT01132547|recurrent osteosarcoma|recurrent osteosarcoma
571262|NCT01132547|recurrent uterine sarcoma|recurrent uterine sarcoma
571263|NCT01132547|small intestine leiomyosarcoma|small intestine leiomyosarcoma
571264|NCT01132547|stage I uterine sarcoma|stage i uterine sarcoma
571265|NCT01132547|stage II uterine sarcoma|stage ii uterine sarcoma
571266|NCT01132547|stage III uterine sarcoma|stage iii uterine sarcoma
571267|NCT01132547|stage IV uterine sarcoma|stage iv uterine sarcoma
571268|NCT01132547|telangiectatic osteosarcoma|telangiectatic osteosarcoma
571269|NCT01132547|untreated childhood gliosarcoma|untreated childhood gliosarcoma
571270|NCT01132547|uterine carcinosarcoma|uterine carcinosarcoma
571271|NCT01132547|uterine leiomyosarcoma|uterine leiomyosarcoma
571272|NCT01132547|localized resectable neuroblastoma|localized resectable neuroblastoma
571273|NCT01132547|localized unresectable neuroblastoma|localized unresectable neuroblastoma
571274|NCT01132547|recurrent neuroblastoma|recurrent neuroblastoma
571275|NCT01132547|regional neuroblastoma|regional neuroblastoma
571276|NCT01132547|stage 4S neuroblastoma|stage 4s neuroblastoma
571277|NCT01132547|recurrent Wilms tumor|recurrent wilms tumor
571278|NCT01132547|childhood kidney tumors|childhood kidney tumors
571279|NCT01132547|stage III Wilms tumor|stage iii wilms tumor
571280|NCT01132547|stage IV Wilms tumor|stage iv wilms tumor
571281|NCT01132547|childhood hepatoblastoma|childhood hepatoblastoma
571282|NCT01132547|childhood extracranial germ cell tumor|childhood extracranial germ cell tumor
571283|NCT01132547|childhood extragonadal germ cell tumor|childhood extragonadal germ cell tumor
571284|NCT01132547|childhood gonadal germ cell tumor|childhood gonadal germ cell tumor
571285|NCT01132547|childhood malignant ovarian germ cell tumor|childhood malignant ovarian germ cell tumor
571286|NCT01132547|childhood malignant testicular germ cell tumor|childhood malignant testicular germ cell tumor
571287|NCT01132547|recurrent childhood malignant germ cell tumor|recurrent childhood malignant germ cell tumor
571288|NCT01132547|recurrent extragonadal germ cell tumor|recurrent extragonadal germ cell tumor
571435|NCT01132209|incisional hernia|incisional hernia
571289|NCT01132547|recurrent extragonadal non-seminomatous germ cell tumor|recurrent extragonadal non-seminomatous germ cell tumor
571290|NCT01132547|recurrent malignant testicular germ cell tumor|recurrent malignant testicular germ cell tumor
571291|NCT01132547|recurrent ovarian germ cell tumor|recurrent ovarian germ cell tumor
571292|NCT01132547|stage III extragonadal non-seminomatous germ cell tumor|stage iii extragonadal non-seminomatous germ cell tumor
571293|NCT01132547|stage III malignant testicular germ cell tumor|stage iii malignant testicular germ cell tumor
571294|NCT01132547|stage IIIA ovarian germ cell tumor|stage iiia ovarian germ cell tumor
571295|NCT01132547|stage IIIB ovarian germ cell tumor|stage iiib ovarian germ cell tumor
571296|NCT01132547|stage IIIC ovarian germ cell tumor|stage iiic ovarian germ cell tumor
571297|NCT01132547|stage IV extragonadal non-seminomatous germ cell tumor|stage iv extragonadal non-seminomatous germ cell tumor
571298|NCT01132547|stage IV ovarian germ cell tumor|stage iv ovarian germ cell tumor
571299|NCT01132547|recurrent childhood medulloblastoma|recurrent childhood medulloblastoma
571300|NCT01132547|untreated childhood medulloblastoma|untreated childhood medulloblastoma
571301|NCT01132547|childhood ependymoblastoma|childhood ependymoblastoma
571302|NCT01132547|childhood infratentorial ependymoma|childhood infratentorial ependymoma
571303|NCT01132547|newly diagnosed childhood ependymoma|newly diagnosed childhood ependymoma
571304|NCT01132547|recurrent childhood ependymoma|recurrent childhood ependymoma
571305|NCT01132547|recurrent childhood subependymal giant cell astrocytoma|recurrent childhood subependymal giant cell astrocytoma
571306|NCT01132547|untreated childhood subependymal giant cell astrocytoma|untreated childhood subependymal giant cell astrocytoma
571307|NCT01132547|peripheral primitive neuroectodermal tumor of the kidney|peripheral primitive neuroectodermal tumor of the kidney
571308|NCT01132547|childhood supratentorial primitive neuroectodermal tumor|childhood supratentorial primitive neuroectodermal tumor
725664|NCT00525785|Gastric|gastric
571309|NCT01132547|recurrent childhood brain stem glioma|recurrent childhood brain stem glioma
571310|NCT01132547|recurrent childhood brain tumor|recurrent childhood brain tumor
571311|NCT01132547|untreated childhood brain stem glioma|untreated childhood brain stem glioma
571312|NCT01132547|recurrent childhood anaplastic astrocytoma|recurrent childhood anaplastic astrocytoma
571313|NCT01132547|recurrent childhood anaplastic oligoastrocytoma|recurrent childhood anaplastic oligoastrocytoma
571314|NCT01132547|recurrent childhood anaplastic oligodendroglioma|recurrent childhood anaplastic oligodendroglioma
571315|NCT01132547|stage I childhood anaplastic large cell lymphoma|stage i childhood anaplastic large cell lymphoma
571316|NCT01132547|stage II childhood anaplastic large cell lymphoma|stage ii childhood anaplastic large cell lymphoma
571317|NCT01132547|stage III childhood anaplastic large cell lymphoma|stage iii childhood anaplastic large cell lymphoma
571318|NCT01132547|stage IV childhood anaplastic large cell lymphoma|stage iv childhood anaplastic large cell lymphoma
571319|NCT01132547|untreated childhood anaplastic astrocytoma|untreated childhood anaplastic astrocytoma
571320|NCT01132547|untreated childhood anaplastic oligoastrocytoma|untreated childhood anaplastic oligoastrocytoma
571321|NCT01132547|untreated childhood anaplastic oligodendroglioma|untreated childhood anaplastic oligodendroglioma
571322|NCT01132547|childhood high-grade cerebellar astrocytoma|childhood high-grade cerebellar astrocytoma
571323|NCT01132547|childhood low-grade cerebellar astrocytoma|childhood low-grade cerebellar astrocytoma
571324|NCT01132547|recurrent childhood astrocytoma|recurrent childhood astrocytoma
571325|NCT01132547|other tumor of glial origin|other tumor of glial origin
571326|NCT01132547|recurrent childhood cerebellar astrocytoma|recurrent childhood cerebellar astrocytoma
571327|NCT01132547|recurrent childhood cerebral astrocytoma|recurrent childhood cerebral astrocytoma
571328|NCT01132547|recurrent childhood diffuse astrocytoma|recurrent childhood diffuse astrocytoma
571329|NCT01132547|recurrent childhood fibrillary astrocytoma|recurrent childhood fibrillary astrocytoma
571330|NCT01132547|recurrent childhood gemistocytic astrocytoma|recurrent childhood gemistocytic astrocytoma
571331|NCT01132547|recurrent childhood oligoastrocytoma|recurrent childhood oligoastrocytoma
571332|NCT01132547|recurrent childhood pilocytic astrocytoma|recurrent childhood pilocytic astrocytoma
571333|NCT01132547|recurrent childhood pilomyxoid astrocytoma|recurrent childhood pilomyxoid astrocytoma
571334|NCT01132547|recurrent childhood pleomorphic xanthoastrocytoma|recurrent childhood pleomorphic xanthoastrocytoma
571335|NCT01132547|recurrent childhood protoplasmic astrocytoma|recurrent childhood protoplasmic astrocytoma
571336|NCT01132547|untreated childhood cerebellar astrocytoma|untreated childhood cerebellar astrocytoma
571337|NCT01132547|untreated childhood cerebral astrocytoma|untreated childhood cerebral astrocytoma
571338|NCT01132547|untreated childhood diffuse astrocytoma|untreated childhood diffuse astrocytoma
571339|NCT01132547|untreated childhood fibrillary astrocytoma|untreated childhood fibrillary astrocytoma
571340|NCT01132547|untreated childhood gemistocytic astrocytoma|untreated childhood gemistocytic astrocytoma
571341|NCT01132547|untreated childhood oligoastrocytoma|untreated childhood oligoastrocytoma
571342|NCT01132547|untreated childhood pilocytic astrocytoma|untreated childhood pilocytic astrocytoma
571343|NCT01132547|untreated childhood pilomyxoid astrocytoma|untreated childhood pilomyxoid astrocytoma
571344|NCT01132547|untreated childhood pleomorphic xanthoastrocytoma|untreated childhood pleomorphic xanthoastrocytoma
571345|NCT01132547|untreated childhood protoplasmic astrocytoma|untreated childhood protoplasmic astrocytoma
571346|NCT01132547|recurrent childhood gliomatosis cerebri|recurrent childhood gliomatosis cerebri
571347|NCT01132547|recurrent childhood oligodendroglioma|recurrent childhood oligodendroglioma
571348|NCT01132547|recurrent childhood visual pathway|recurrent childhood visual pathway
571349|NCT01132547|hypothalamic glioma|hypothalamic glioma
571350|NCT01132547|recurrent childhood visual pathway glioma|recurrent childhood visual pathway glioma
571351|NCT01132547|untreated childhood gliomatosis cerebri|untreated childhood gliomatosis cerebri
571352|NCT01132547|untreated childhood oligodendroglioma|untreated childhood oligodendroglioma
571353|NCT01132547|untreated childhood visual pathway|untreated childhood visual pathway
571354|NCT01132547|untreated childhood visual pathway glioma|untreated childhood visual pathway glioma
571355|NCT01132547|recurrent childhood giant cell glioblastoma|recurrent childhood giant cell glioblastoma
571356|NCT01132547|recurrent childhood glioblastoma|recurrent childhood glioblastoma
571357|NCT01132547|untreated childhood giant cell glioblastoma|untreated childhood giant cell glioblastoma
571358|NCT01132547|untreated childhood glioblastoma|untreated childhood glioblastoma
571359|NCT01132547|childhood choroid plexus tumor|childhood choroid plexus tumor
571360|NCT01132547|childhood grade I meningioma|childhood grade i meningioma
571361|NCT01132547|childhood grade II meningioma|childhood grade ii meningioma
571362|NCT01132547|childhood grade III meningioma|childhood grade iii meningioma
571363|NCT01132547|minimally differentiated myeloid leukemia (M0)|minimally differentiated myeloid leukemia (m0)
571364|NCT01132547|myeloblastic leukemia with maturation (M2)|myeloblastic leukemia with maturation (m2)
571365|NCT01132547|myeloblastic leukemia without maturation (M1)|myeloblastic leukemia without maturation (m1)
571366|NCT01132547|childhood acute myelomonocytic leukemia (M4)|childhood acute myelomonocytic leukemia (m4)
571367|NCT01132547|childhood acute promyelocytic leukemia (M3)|childhood acute promyelocytic leukemia (m3)
571368|NCT01132547|recurrent childhood acute myeloid leukemia|recurrent childhood acute myeloid leukemia
571369|NCT01132547|untreated childhood acute myeloid leukemia|untreated childhood acute myeloid leukemia
571370|NCT01132547|other myeloid malignancies|other myeloid malignancies
571371|NCT01132547|childhood acute monoblastic leukemia (M5a)|childhood acute monoblastic leukemia (m5a)
571372|NCT01132547|childhood acute monocytic leukemia (M5b)|childhood acute monocytic leukemia (m5b)
571373|NCT01132547|childhood acute erythroleukemia (M6)|childhood acute erythroleukemia (m6)
571374|NCT01132547|childhood acute megakaryocytic leukemia (M7)|childhood acute megakaryocytic leukemia (m7)
571375|NCT01132547|unspecified childhood solid tumor|unspecified childhood solid tumor
571377|NCT01132534|NBI|nbi
571378|NCT01132534|AFI|afi
571379|NCT01132534|Videoendoscopy|videoendoscopy
571380|NCT01132534|Narrow Band Imaging|narrow band imaging
571381|NCT01132534|Autofluorescence Imaging|autofluorescence imaging
571382|NCT01132521|ulinastatin|ulinastatin
571383|NCT01132521|severe acute pancreatitis|severe acute pancreatitis
571384|NCT01132508|Tibial plateau fracture|tibial plateau fracture
571385|NCT01132508|Orthopaedic Trauma Association (OTA) B2 B3 C3|orthopaedic trauma association (ota) b2 b3 c3
571386|NCT01132508|Bone Void|bone void
571387|NCT01132495|Stable angina|stable angina
571388|NCT01132495|angina pectoris|angina pectoris
571389|NCT01132495|PCI|pci
571390|NCT01132495|FAME|fame
571391|NCT01132495|FAME II|fame ii
571392|NCT01132495|FFR|ffr
571393|NCT01132495|Fractional Flow Reserve|fractional flow reserve
571394|NCT01132495|Pressure wire|pressure wire
571395|NCT01132482|Cystic fibrosis|cystic fibrosis
571396|NCT01132482|CFTR|cftr
571397|NCT01132482|Phosphodiesterase inhibitor|phosphodiesterase inhibitor
571398|NCT01132482|Nasal potential difference|nasal potential difference
571399|NCT01132482|Sweat test|sweat test
571400|NCT01132456|TARGET VESSEL REVASCULARIZATION (TVR)|target vessel revascularization (tvr)
571401|NCT01132456|MYOCARDIAL INFARCTION (MI)|myocardial infarction (mi)
571402|NCT01132456|TARGET VESSEL FAILURE (TVF)|target vessel failure (tvf)
571403|NCT01132456|TARGET LESION REVASCULARIZATION (TLR)|target lesion revascularization (tlr)
571404|NCT01132456|TARGET LESION FAILURE (TLF)|target lesion failure (tlf)
571405|NCT01132456|STENT THROMBOSIS|stent thrombosis
571406|NCT01132456|RESTENOTIC LESION|restenotic lesion
571407|NCT01132456|PERCUTANEOUS CORONARY INTERVENTION (PCI)|percutaneous coronary intervention (pci)
571408|NCT01132456|LONG LESION|long lesion
571409|NCT01132456|DUAL VESSEL|dual vessel
571410|NCT01132430|ADHERENCE|adherence
571411|NCT01132430|ASTHMA CONTROL|asthma control
571412|NCT01132430|ASTHMA QUALITY OF LIFE|asthma quality of life
571413|NCT01132430|MOTIVATIONAL INTERVIEWING|motivational interviewing
571414|NCT01132417|Tigecycline, MDR|tigecycline, mdr
571415|NCT01132417|Patient infected with multidrug resistance bacteria|patient infected with multidrug resistance bacteria
571416|NCT01132391|anal fissure|anal fissure
571417|NCT01132391|nitroglycerin|nitroglycerin
571418|NCT01132391|medical treatment|medical treatment
571419|NCT01132378|Total knee arthroplasty|total knee arthroplasty
571420|NCT01132365|knee arthroplasty|knee arthroplasty
571421|NCT01132352|Bioavailability|bioavailability
571422|NCT01132352|Crossover|crossover
571423|NCT01132352|Levetiracetam|levetiracetam
571424|NCT01132339|Adverse reactions to Gadolinium-based contrast agents.|adverse reactions to gadolinium-based contrast agents.
571425|NCT01132339|Adverse reactions to Iodine-basedcontrast agents.|adverse reactions to iodine-basedcontrast agents.
571426|NCT01132326|Symptomatic NOH|symptomatic noh
571427|NCT01132287|Contact lens wear|contact lens wear
571428|NCT01132287|lubricant eye drops|lubricant eye drops
571429|NCT01132274|Supraventricular arrhythmia catheter ablation|supraventricular arrhythmia catheter ablation
571430|NCT01132248|schistosomiasis, schistosoma haematobium|schistosomiasis, schistosoma haematobium
571431|NCT01132222|Bioequivalence|bioequivalence
571432|NCT01132222|Crossover|crossover
571433|NCT01132222|Ibuprofen and Pseudoephedrine|ibuprofen and pseudoephedrine
571436|NCT01132209|woundinfection|woundinfection
571437|NCT01132209|burst abdomen|burst abdomen
571438|NCT01132209|pain|pain
571439|NCT01132196|Bioequivalence|bioequivalence
571440|NCT01132196|Crossover|crossover
571441|NCT01132196|Divalproex Sodium|divalproex sodium
571442|NCT01132170|Bioequivalence|bioequivalence
571443|NCT01132170|Crossover|crossover
571444|NCT01132170|Divalproex Sodium|divalproex sodium
571445|NCT01132157|Healthy Kidney Donors and Their Recipients with End Stage Renal Disease|healthy kidney donors and their recipients with end stage renal disease
571446|NCT01132144|Reproductive Techniques|reproductive techniques
571447|NCT01132144|Embryo Implantation|embryo implantation
571448|NCT01132144|Endometrium|endometrium
571449|NCT01132144|Ultrasonography|ultrasonography
571450|NCT01132131|Urinary tract infection|urinary tract infection
571451|NCT01132131|Cystitis|cystitis
571452|NCT01132131|Bacteruria|bacteruria
571453|NCT01132118|rheumatoid arthritis|rheumatoid arthritis
571454|NCT01132118|insulin resistance|insulin resistance
571455|NCT01132118|hydroxychloroquine|hydroxychloroquine
571456|NCT01132118|cholesterol|cholesterol
571457|NCT01132092|Evoked Potentials, Adult, Hearing Loss|evoked potentials, adult, hearing loss
571458|NCT01132079|atopic dermatitis|atopic dermatitis
571459|NCT01132079|barrier function|barrier function
571460|NCT01132079|pimecrolimus|pimecrolimus
571461|NCT01132066|swallowing|swallowing
571462|NCT01132066|stroke|stroke
571463|NCT01132053|JC Virus|jc virus
571464|NCT01132040|Bioequivalence|bioequivalence
571465|NCT01132040|Crossover|crossover
571466|NCT01132040|Primidone|primidone
571467|NCT01132027|Bioavailability, crossover, tacrolimus|bioavailability, crossover, tacrolimus
571468|NCT01132014|Subjects with recurrent ovarian, fallopian tube or primary peritoneal cancer,|subjects with recurrent ovarian, fallopian tube or primary peritoneal cancer,
571469|NCT01132014|from whom solid tumor or ascites have been harvested and are available and|from whom solid tumor or ascites have been harvested and are available and
571470|NCT01132014|sufficient for tumorlysate preparation;and whose largest tumor nodule is 4.5|sufficient for tumorlysate preparation;and whose largest tumor nodule is 4.5
571471|NCT01132014|cm. Subjects may have undergone chemotherapy or other therapy following|cm. subjects may have undergone chemotherapy or other therapy following
571472|NCT01132014|tumor harvesting and prior to enrollment.|tumor harvesting and prior to enrollment.
571473|NCT01131988|Bioavailability, crossover, tacrolimus|bioavailability, crossover, tacrolimus
571474|NCT01131975|Bioequivalence|bioequivalence
571475|NCT01131975|Crossover|crossover
571476|NCT01131975|Lamotrigine (chewable, dispersible)|lamotrigine (chewable, dispersible)
571477|NCT01131962|esophageal varices|esophageal varices
571478|NCT01131962|hematemesis|hematemesis
571479|NCT01131962|endoscopy|endoscopy
571480|NCT01131949|Bioequivalence|bioequivalence
571481|NCT01131949|Crossover|crossover
571482|NCT01131949|Lamotrigine (chewable, dispersible)|lamotrigine (chewable, dispersible)
571483|NCT01131936|Bioequivalence|bioequivalence
571484|NCT01131936|Amlodipine Besylate|amlodipine besylate
571485|NCT01131923|Bioequivalence|bioequivalence
571486|NCT01131923|Amlodipine Besylate|amlodipine besylate
571487|NCT01131910|Rheumatoid arthritis|rheumatoid arthritis
571488|NCT01131910|TBE-vaccine|tbe-vaccine
571489|NCT01131910|Immunosuppression|immunosuppression
571490|NCT01131897|Bioavailability|bioavailability
571491|NCT01131897|Crossover|crossover
571492|NCT01131897|Levetiracetam|levetiracetam
571493|NCT01131884|ASIA A or ASIA B Spinal Cord Injury|asia a or asia b spinal cord injury
571494|NCT01131871|obesity|obesity
571495|NCT01131871|overweight|overweight
571496|NCT01131832|Cholesterol, Plant sterols, Non-response, SNPs,|cholesterol, plant sterols, non-response, snps,
571497|NCT01131819|Trans-tibial Amputation|trans-tibial amputation
571498|NCT01131806|chronic obstructive pulmonary disease|chronic obstructive pulmonary disease
571499|NCT01131806|lung function change FEV1 FVC|lung function change fev1 fvc
571500|NCT01131806|acute exacerbation|acute exacerbation
571501|NCT01131806|life quality questionnaire|life quality questionnaire
571502|NCT01131793|Coronary Artery Chronic Total Occlusion In-Stent|coronary artery chronic total occlusion in-stent
571503|NCT01131780|Bioequivalence|bioequivalence
571504|NCT01131780|Crossover|crossover
571505|NCT01131780|Ibuprofen and Pseudoephedrine|ibuprofen and pseudoephedrine
571506|NCT01131767|Bioequivalence|bioequivalence
571507|NCT01131767|Crossover|crossover
571508|NCT01131767|Naproxen Sodium and Pseudoephedrine Hydrochloride|naproxen sodium and pseudoephedrine hydrochloride
571509|NCT01131754|Peripheral venous catheter complications|peripheral venous catheter complications
571510|NCT01131754|PVC occlusion|pvc occlusion
571511|NCT01131754|PVC phlebitis|pvc phlebitis
571512|NCT01131741|anesthesia, general|anesthesia, general
571513|NCT01131741|blood pressure|blood pressure
571514|NCT01131741|epinephrine|epinephrine
571515|NCT01131741|heart rate|heart rate
571516|NCT01131741|injections, intravenous|injections, intravenous
571517|NCT01131728|Bioequivalence|bioequivalence
571518|NCT01131728|Crossover|crossover
571519|NCT01131728|Naproxen Sodium and Pseudoephedrine Hydrochloride|naproxen sodium and pseudoephedrine hydrochloride
571520|NCT01131715|Qualitetive interview|qualitetive interview
571521|NCT01131715|Coronary heart disease (CHD)|coronary heart disease (chd)
571522|NCT01131715|Patient experience|patient experience
571523|NCT01131715|Patient perception|patient perception
571524|NCT01131702|Bioequivalence|bioequivalence
571525|NCT01131702|Crossover|crossover
571526|NCT01131702|Ranitidine|ranitidine
571527|NCT01131689|metastatic HCC|metastatic hcc
571528|NCT01131663|Infants, aerosol, acceptance, face mask, drug delivery|infants, aerosol, acceptance, face mask, drug delivery
571529|NCT01131650|Prevalence of diabetic retinopathy|prevalence of diabetic retinopathy
571530|NCT01131650|Diabetes|diabetes
571531|NCT01131650|Retinopathy|retinopathy
571532|NCT01131650|Prevalence|prevalence
571533|NCT01131650|Population|population
571534|NCT01131637|chronic heart failure|chronic heart failure
571535|NCT01131637|rhNRG-1|rhnrg-1
571536|NCT01131637|mortality|mortality
571537|NCT01131624|Iron deficiency|iron deficiency
571538|NCT01131611|Spinal Stenosis|spinal stenosis
571539|NCT01131611|Rehabilitation|rehabilitation
571540|NCT01131611|Physical Therapy (specialty)|physical therapy (specialty)
571541|NCT01131611|Cognitive Behavior Therapy|cognitive behavior therapy
571542|NCT01131611|Behavioral Research|behavioral research
571543|NCT01131598|ALI|ali
571544|NCT01131598|SDRA|sdra
571545|NCT01131585|Diabetic macular edema|diabetic macular edema
571546|NCT01131585|DME|dme
571547|NCT01131585|Proliferative diabetic retinopathy|proliferative diabetic retinopathy
571548|NCT01131585|PDR|pdr
571549|NCT01131585|ranibizumab|ranibizumab
571550|NCT01131585|laser|laser
571551|NCT01131559|bipolar disorder|bipolar disorder
571552|NCT01131559|manic depression|manic depression
571553|NCT01131559|depression|depression
571554|NCT01131559|Bipolar I or II|bipolar i or ii
571555|NCT01131546|Essential Hypertension|essential hypertension
571556|NCT01131546|Levamlodipine Besylate|levamlodipine besylate
571557|NCT01131546|Amlodipine Maleate|amlodipine maleate
571558|NCT01131520|SBIRT|sbirt
571559|NCT01131520|Drug abuse|drug abuse
571560|NCT01131507|Exocrine Pancreatic Insufficiency|exocrine pancreatic insufficiency
571561|NCT01131507|Infants with CF|infants with cf
571562|NCT01131494|Parkinson's disease|parkinson's disease
571563|NCT01131494|Dysphagia|dysphagia
571564|NCT01131494|Treatment|treatment
571565|NCT01131481|cataracts,glistenings,intraocular lenses.|cataracts,glistenings,intraocular lenses.
571566|NCT01131468|ototoxicity|ototoxicity
571567|NCT01131468|aminoglycoside|aminoglycoside
571568|NCT01131468|vancomycine|vancomycine
571569|NCT01131468|peritoneal dialysis|peritoneal dialysis
571570|NCT01131468|peritonitis|peritonitis
571571|NCT01131442|immune|immune
571572|NCT01131429|mutation analysis|mutation analysis
571573|NCT01131429|first-line|first-line
571574|NCT01131429|second-line|second-line
571575|NCT01131429|targeted therapy|targeted therapy
571576|NCT01131403|IL-1α, skin care; baby wet wipes; full-term newborn; skin barrier function|il-1α, skin care; baby wet wipes; full-term newborn; skin barrier function
571577|NCT01131377|mechanical ventilation weaning phase patients with metabolic alkalosis|mechanical ventilation weaning phase patients with metabolic alkalosis
571578|NCT01131364|Interleukin|interleukin
571579|NCT01131364|IL2|il2
571580|NCT01131364|F16|f16
571581|NCT01131364|monoclonal|monoclonal
571582|NCT01131364|antibody|antibody
571583|NCT01131364|cytokine|cytokine
571584|NCT01131364|doxorubicin|doxorubicin
571585|NCT01131364|breast cancer|breast cancer
571586|NCT01131364|solid tumour|solid tumour
571587|NCT01131364|Phase I: Advanced Solid Tumour Patients|phase i: advanced solid tumour patients
571588|NCT01131364|Phase II: Breast Cancer Patients Amenable to anthracyclin Therapy|phase ii: breast cancer patients amenable to anthracyclin therapy
571589|NCT01131351|MDR-TB|mdr-tb
571590|NCT01131351|Dose Escalation|dose escalation
571591|NCT01131351|Phase II|phase ii
571592|NCT01131351|Open Label|open label
571593|NCT01131351|Non Controlled|non controlled
571594|NCT01131351|Pulmonary Multidrug-Resistant Tuberculosis (MDR TB)|pulmonary multidrug-resistant tuberculosis (mdr tb)
571595|NCT01131325|Philadelphia chromosome positive|philadelphia chromosome positive
571596|NCT01131325|Ph+|ph+
571597|NCT01131325|chronic myelogenous leukemia chronic phase|chronic myelogenous leukemia chronic phase
571598|NCT01131325|CML-CP|cml-cp
571599|NCT01131325|low imatinib trough levels|low imatinib trough levels
571600|NCT01131312|Cervix|cervix
571601|NCT01131312|CIN|cin
571602|NCT01131312|HPV|hpv
571603|NCT01131312|Triage|triage
571604|NCT01131312|ASCUS/LSIL|ascus/lsil
571605|NCT01131312|Pap Smear|pap smear
571606|NCT01131312|HPV Test|hpv test
571607|NCT01131299|HDL|hdl
571608|NCT01131299|Cholesterol|cholesterol
571609|NCT01131299|Lipoproteins|lipoproteins
571610|NCT01131299|Serum Lipids|serum lipids
571611|NCT01131299|Alpha-Cyclodextrin|alpha-cyclodextrin
571612|NCT01131299|Atherosclerosis|atherosclerosis
571613|NCT01131299|Heart Disease|heart disease
571614|NCT01131273|buprenorphine injecting|buprenorphine injecting
571615|NCT01131273|opiate dependence|opiate dependence
571616|NCT01131273|HIV risk|hiv risk
571617|NCT01131273|treatment outcome|treatment outcome
571618|NCT01131273|opiate dependence with buprenorphine injecting|opiate dependence with buprenorphine injecting
571619|NCT01131260|STAN|stan
571620|NCT01131260|Fetal monitoring|fetal monitoring
571621|NCT01131260|Fetal acidosis|fetal acidosis
571622|NCT01131260|Fetal heart rate monitoring|fetal heart rate monitoring
571623|NCT01131260|Perinatology|perinatology
571625|NCT01131247|bendamustine|bendamustine
571626|NCT01131247|ofatumumab|ofatumumab
571627|NCT01131247|blood cancer|blood cancer
571628|NCT01131247|leukemia|leukemia
571629|NCT01131247|lymphoma|lymphoma
571630|NCT01131247|lymphocyte|lymphocyte
571631|NCT01131247|refractory|refractory
571632|NCT01131247|Advanced|advanced
571633|NCT01131247|relapsed|relapsed
571634|NCT01131247|hematologic|hematologic
571635|NCT01131247|hematology|hematology
571636|NCT01131247|antibody|antibody
571637|NCT01131247|non-Hodgkin lymphoma|non-hodgkin lymphoma
571638|NCT01131247|small lymphocytic lymphoma|small lymphocytic lymphoma
571639|NCT01131247|nevada cancer institute|nevada cancer institute
571640|NCT01131247|cephalon|cephalon
571641|NCT01131247|Glaxosmithkline|glaxosmithkline
571642|NCT01131221|contiguous stage II grade 1 follicular lymphoma|contiguous stage ii grade 1 follicular lymphoma
571643|NCT01131221|contiguous stage II grade 2 follicular lymphoma|contiguous stage ii grade 2 follicular lymphoma
571644|NCT01131221|contiguous stage II grade 3 follicular lymphoma|contiguous stage ii grade 3 follicular lymphoma
571645|NCT01131221|noncontiguous stage II grade 1 follicular lymphoma|noncontiguous stage ii grade 1 follicular lymphoma
571646|NCT01131221|noncontiguous stage II grade 2 follicular lymphoma|noncontiguous stage ii grade 2 follicular lymphoma
571647|NCT01131221|noncontiguous stage II grade 3 follicular lymphoma|noncontiguous stage ii grade 3 follicular lymphoma
571648|NCT01131221|stage III grade 1 follicular lymphoma|stage iii grade 1 follicular lymphoma
571649|NCT01131221|stage III grade 2 follicular lymphoma|stage iii grade 2 follicular lymphoma
571650|NCT01131221|stage III grade 3 follicular lymphoma|stage iii grade 3 follicular lymphoma
571651|NCT01131221|stage IV grade 1 follicular lymphoma|stage iv grade 1 follicular lymphoma
571652|NCT01131221|stage IV grade 2 follicular lymphoma|stage iv grade 2 follicular lymphoma
571653|NCT01131221|stage IV grade 3 follicular lymphoma|stage iv grade 3 follicular lymphoma
571654|NCT01131208|contiguous stage II adult diffuse large cell lymphoma|contiguous stage ii adult diffuse large cell lymphoma
571655|NCT01131208|noncontiguous stage II adult diffuse large cell lymphoma|noncontiguous stage ii adult diffuse large cell lymphoma
571656|NCT01131208|recurrent adult diffuse large cell lymphoma|recurrent adult diffuse large cell lymphoma
571657|NCT01131208|stage I adult diffuse large cell lymphoma|stage i adult diffuse large cell lymphoma
571658|NCT01131208|stage III adult diffuse large cell lymphoma|stage iii adult diffuse large cell lymphoma
571659|NCT01131208|stage IV adult diffuse large cell lymphoma|stage iv adult diffuse large cell lymphoma
571660|NCT01131195|HER2-negative breast cancer|her2-negative breast cancer
571661|NCT01131195|recurrent breast cancer|recurrent breast cancer
571662|NCT01131195|stage IIIB breast cancer|stage iiib breast cancer
571663|NCT01131195|stage IIIC breast cancer|stage iiic breast cancer
571664|NCT01131195|stage IV breast cancer|stage iv breast cancer
571665|NCT01131169|Myeloma|myeloma
571666|NCT01131169|Busulfan|busulfan
571667|NCT01131169|Melphalan|melphalan
571668|NCT01131169|Fludarabine|fludarabine
571669|NCT01131169|T-Cell|t-cell
571670|NCT01131169|Stem Cell Transplantation|stem cell transplantation
571671|NCT01131169|10-051|10-051
571672|NCT01131156|postpartum|postpartum
571673|NCT01131156|smoking|smoking
571674|NCT01131156|relapse|relapse
571675|NCT01131156|breastfeeding|breastfeeding
571676|NCT01131143|Urban community centers|urban community centers
571677|NCT01131143|Obesity|obesity
571678|NCT01131143|Obesity counseling|obesity counseling
571679|NCT01131143|Low-cost intervention|low-cost intervention
571680|NCT01131130|Contact lens|contact lens
571681|NCT01131117|healthy|healthy
571682|NCT01131117|women|women
571683|NCT01131117|pregnancy|pregnancy
571684|NCT01131104|NAION|naion
571685|NCT01131065|Hepatitis B|hepatitis b
571686|NCT01131065|HBV|hbv
571687|NCT01131065|Orthotopic liver transplantation|orthotopic liver transplantation
571688|NCT01131065|Liver transplantation|liver transplantation
571689|NCT01131065|Recurrence|recurrence
571690|NCT01131065|Reinfection|reinfection
571691|NCT01131065|Protective titers|protective titers
571692|NCT01131065|HBsAb|hbsab
571693|NCT01131065|Hepatitis B virus immune globulin|hepatitis b virus immune globulin
571694|NCT01131065|Niuliva|niuliva
571695|NCT01131052|elderly populations|elderly populations
571696|NCT01131052|diabetes|diabetes
571697|NCT01131039|Ovarian Cancer|ovarian cancer
571698|NCT01131026|Helicobacter pylori|helicobacter pylori
571699|NCT01131026|levofloxacin|levofloxacin
571700|NCT01131026|amoxicillin|amoxicillin
571701|NCT01131026|lansoprazole|lansoprazole
571702|NCT01131026|efficacy|efficacy
571703|NCT01131026|safety|safety
571704|NCT01131026|triple therapy|triple therapy
571705|NCT01130987|resident|resident
571706|NCT01130987|intern|intern
571707|NCT01130987|patient safety|patient safety
571708|NCT01130987|medical error|medical error
571709|NCT01130987|time motion|time motion
571710|NCT01130987|handoff|handoff
571711|NCT01130987|sign-out|sign-out
571712|NCT01130987|Resident Workflow|resident workflow
571713|NCT01130987|Resident Communications|resident communications
571714|NCT01130961|Advanced NSCLC|advanced nsclc
571715|NCT01130961|Gefitinib|gefitinib
571716|NCT01130961|Thai patient|thai patient
571717|NCT01130948|hypoxia|hypoxia
571718|NCT01130948|altitude|altitude
571721|NCT01130948|periodic breathing|periodic breathing
571722|NCT01130948|vigilance|vigilance
571723|NCT01130948|psychomotor|psychomotor
571724|NCT01130948|endothelial function|endothelial function
571725|NCT01130935|GERD|gerd
571726|NCT01130935|gastric and duodenal ulcers|gastric and duodenal ulcers
571727|NCT01130935|NSAID therapy|nsaid therapy
571728|NCT01130922|Roux-and-Y gastric bypass surgery|roux-and-y gastric bypass surgery
571729|NCT01130922|stable body weight|stable body weight
571730|NCT01130909|Healthy|healthy
571731|NCT01130909|Effect of a single dose on gamma-band qEEG|effect of a single dose on gamma-band qeeg
571732|NCT01130896|MRI, pacemakers, Defibrillator|mri, pacemakers, defibrillator
571733|NCT01130883|acute tracheitis|acute tracheitis
571734|NCT01130883|acute tracheobronchitis or acute bronchitis|acute tracheobronchitis or acute bronchitis
571735|NCT01130883|acute exacerbation of chronic bronchitis|acute exacerbation of chronic bronchitis
571736|NCT01130883|mild community-acquired pneumonia|mild community-acquired pneumonia
571737|NCT01130870|Fecal incontinence|fecal incontinence
571738|NCT01130870|Sacral nerve stimulation|sacral nerve stimulation
571739|NCT01130870|Quality of life|quality of life
571740|NCT01130870|DR15.9 Incontinentia alva|dr15.9 incontinentia alva
571741|NCT01130818|Safety|safety
571742|NCT01130818|Tolerability|tolerability
571743|NCT01130818|Pharmacokinetics|pharmacokinetics
571744|NCT01130818|Bioavailability (solid vs solution, fasting vs fed)|bioavailability (solid vs solution, fasting vs fed)
571745|NCT01130818|Young healthy subjects|young healthy subjects
571746|NCT01130818|Elderly healthy subjects|elderly healthy subjects
571747|NCT01130805|gastric cancer pazopanib capecitabine, oxaliplatin|gastric cancer pazopanib capecitabine, oxaliplatin
571748|NCT01130805|Metastatic or recurrent gastric cancer|metastatic or recurrent gastric cancer
571749|NCT01130792|rotavirus|rotavirus
571750|NCT01130792|cryptosporidium|cryptosporidium
571751|NCT01130792|probiotics|probiotics
571752|NCT01130792|intestinal function|intestinal function
571753|NCT01130792|immune response|immune response
571754|NCT01130779|Non-small Cell Lung Cancer|non-small cell lung cancer
571755|NCT01130779|Erlotinib|erlotinib
571756|NCT01130779|brain metastasis|brain metastasis
571757|NCT01130766|Non-small Cell Lung Cancer|non-small cell lung cancer
571758|NCT01130766|Asymptomatic brain metastasis|asymptomatic brain metastasis
571759|NCT01130766|Stereotactic radiosurgery (SRS)|stereotactic radiosurgery (srs)
571760|NCT01130740|Osteoarthritis|osteoarthritis
571761|NCT01130740|Exercise|exercise
571762|NCT01130740|Diet|diet
571763|NCT01130740|Coping Skills|coping skills
571764|NCT01130740|Education, Medical|education, medical
571765|NCT01130727|diabetes mellitus|diabetes mellitus
571766|NCT01130727|diabetic nephropathy|diabetic nephropathy
571767|NCT01130727|hypertension|hypertension
571768|NCT01130727|green tea|green tea
571769|NCT01130727|cocoa|cocoa
571770|NCT01130727|polyphenol|polyphenol
571771|NCT01130727|nitric oxide|nitric oxide
571772|NCT01130714|inflammation|inflammation
571773|NCT01130714|chemotherapy|chemotherapy
571774|NCT01130714|lung cancer|lung cancer
571775|NCT01130701|Pancreatic Cancer|pancreatic cancer
571776|NCT01130701|Neoadjuvant|neoadjuvant
571777|NCT01130701|Panitumumab|panitumumab
571778|NCT01130701|Capecitabine|capecitabine
571779|NCT01130688|Leukemia|leukemia
571780|NCT01130688|Zileuton|zileuton
571781|NCT01130688|myeloproliferative neoplasm|myeloproliferative neoplasm
571782|NCT01130662|acute myeloid leukemia|acute myeloid leukemia
571783|NCT01130662|AML|aml
571784|NCT01130662|Relapsed AML|relapsed aml
571785|NCT01130662|Refractory AML|refractory aml
571786|NCT01130649|Epilepsy|epilepsy
571787|NCT01130649|Tracking|tracking
571788|NCT01130649|Electronic diary|electronic diary
571789|NCT01130636|oseltamivir carboxylate|oseltamivir carboxylate
571790|NCT01130636|oseltamivir phosphate|oseltamivir phosphate
571791|NCT01130636|Tamiflu pharmacokinetics in lactating women with influenza|tamiflu pharmacokinetics in lactating women with influenza
571792|NCT01130623|VEGF Inhibitor|vegf inhibitor
571793|NCT01130623|Maximum Tolerated Dose|maximum tolerated dose
571794|NCT01130623|Dose Escalation|dose escalation
571795|NCT01130623|Pharmacokinetics|pharmacokinetics
571796|NCT01130623|Antitumor Activity|antitumor activity
571797|NCT01130623|Pediatric Cancer|pediatric cancer
571798|NCT01130623|Solid Tumor|solid tumor
571799|NCT01130623|Sarcoma|sarcoma
571800|NCT01130623|Neuroblastoma|neuroblastoma
571801|NCT01130623|Wilms Tumor|wilms tumor
571802|NCT01130623|Osteosarcoma|osteosarcoma
571803|NCT01130623|Brain Tumor|brain tumor
571804|NCT01130610|preoperative period|preoperative period
571805|NCT01130610|preoperative care|preoperative care
571806|NCT01130610|anesthesia|anesthesia
571807|NCT01130610|program evaluation|program evaluation
571808|NCT01130597|HF|hf
571809|NCT01130597|Heart failure|heart failure
571810|NCT01130597|hyperkalemia|hyperkalemia
571811|NCT01130597|chronic kidney disease|chronic kidney disease
571812|NCT01130597|prevention of hyperkalemia in heart failure participants|prevention of hyperkalemia in heart failure participants
571813|NCT01130584|Cancer Patients|cancer patients
571814|NCT01130558|type 2 diabetes mellitus|type 2 diabetes mellitus
571815|NCT01130558|basal-bolus insulin|basal-bolus insulin
572104|NCT01129050|Adults|adults
571816|NCT01130558|insulin ordering|insulin ordering
571817|NCT01130545|Healthy Volunteer|healthy volunteer
571818|NCT01130545|Magnetic Resonance Imaging|magnetic resonance imaging
571819|NCT01130545|Gadolinium|gadolinium
571820|NCT01130545|HV|hv
571821|NCT01130532|Erectile Dysfunction|erectile dysfunction
571822|NCT01130532|ED|ed
571823|NCT01130532|Impotence|impotence
571824|NCT01130519|Immunotherapy|immunotherapy
571825|NCT01130519|Biomarker|biomarker
571826|NCT01130519|Kidney Cancer|kidney cancer
571827|NCT01130519|Renal Cell Cancer|renal cell cancer
571828|NCT01130519|Hereditary Leiomyomatosis and Renal Cell Cancer|hereditary leiomyomatosis and renal cell cancer
571829|NCT01130519|HLRCC|hlrcc
571830|NCT01130467|Attention Deficit Disorders with Hyperactivity|attention deficit disorders with hyperactivity
571831|NCT01130467|Attention Deficit Disorder|attention deficit disorder
571832|NCT01130467|Event related potential|event related potential
710872|NCT00587483|reperfusion ventricular fibrillation|reperfusion ventricular fibrillation
571833|NCT01130454|Unfavorable effect of environmental factors, stressors|unfavorable effect of environmental factors, stressors
571834|NCT01130441|adolescent behavior|adolescent behavior
571835|NCT01130441|harm reduction|harm reduction
571836|NCT01130428|Mechanical stimulation|mechanical stimulation
571837|NCT01130428|Vibration platform|vibration platform
571838|NCT01130428|Bone metabolism|bone metabolism
571839|NCT01130428|ATP release|atp release
571840|NCT01130415|Sacral neuromodulation|sacral neuromodulation
571841|NCT01130415|Screening|screening
571842|NCT01130415|Percutaneous nerve evaluation|percutaneous nerve evaluation
571843|NCT01130415|Tined lead|tined lead
571844|NCT01130402|age|age
571845|NCT01130402|lymphadenopathy|lymphadenopathy
571846|NCT01130402|fine needle aspiration|fine needle aspiration
571847|NCT01130402|sonography|sonography
571848|NCT01130389|ONJ|onj
571849|NCT01130376|Immune based therapy|immune based therapy
571850|NCT01130376|Therapeutic vaccination|therapeutic vaccination
571851|NCT01130376|cytokine therapy|cytokine therapy
571852|NCT01130376|HIV therapeutic vaccine|hiv therapeutic vaccine
571853|NCT01130363|Proton Pump Inhibitor|proton pump inhibitor
571854|NCT01130363|Gastric carcinoid tumors|gastric carcinoid tumors
571855|NCT01130363|Gastric cancer|gastric cancer
571856|NCT01130363|Fundic Gland Polyps|fundic gland polyps
571857|NCT01130324|VIBATIV|vibativ
571858|NCT01130324|telavancin|telavancin
571859|NCT01130324|Pregnancy|pregnancy
571860|NCT01130324|Registry|registry
571861|NCT01130298|testosterone,|testosterone,
571862|NCT01130298|Pharmacokinetics|pharmacokinetics
571863|NCT01130298|replacement,|replacement,
571864|NCT01130298|therapy|therapy
571865|NCT01130285|Lung Cancer|lung cancer
571866|NCT01130272|Irritable bowel syndrome with diarrhea|irritable bowel syndrome with diarrhea
571867|NCT01130272|Irritable bowel syndrome|irritable bowel syndrome
571868|NCT01130272|Diarrhea predominant irritable bowel syndrome|diarrhea predominant irritable bowel syndrome
571869|NCT01130272|Colonic diseases|colonic diseases
571870|NCT01130272|Colonic diseases, functional|colonic diseases, functional
571871|NCT01130272|Digestive system disease|digestive system disease
571872|NCT01130272|Gastrointestinal disease|gastrointestinal disease
571873|NCT01130272|Intestinal disease|intestinal disease
571874|NCT01130272|Colonic pseudo-obstruction|colonic pseudo-obstruction
571875|NCT01130272|Diarrhea|diarrhea
571876|NCT01130272|Signs and Symptoms, Digestive|signs and symptoms, digestive
571877|NCT01130259|mTNBC|mtnbc
571878|NCT01130259|triple negative breast cancer|triple negative breast cancer
571879|NCT01130259|metastatic triple negative breast cancer|metastatic triple negative breast cancer
571880|NCT01130259|metastatic breast cancer that is ER-, PR-, and HER2-negative|metastatic breast cancer that is er-, pr-, and her2-negative
571881|NCT01130233|rectal cancer|rectal cancer
571882|NCT01130220|Brain Tumor|brain tumor
571883|NCT01130220|Brain Neoplasm|brain neoplasm
571884|NCT01130207|Obesity|obesity
571885|NCT01130207|Diabetes|diabetes
571886|NCT01130207|Periodontal disease|periodontal disease
571887|NCT01130194|follicular lymphoma|follicular lymphoma
571888|NCT01130194|radioimmunotherapy|radioimmunotherapy
571889|NCT01130194|rituximab|rituximab
571890|NCT01130194|C-MOPP-R|c-mopp-r
571891|NCT01130194|autologous transplant|autologous transplant
571892|NCT01130155|Antimalarials|antimalarials
571893|NCT01130155|Diagnosis|diagnosis
571894|NCT01130155|Access to treatment|access to treatment
571895|NCT01130155|Quality of care|quality of care
571896|NCT01130129|Flavonoids|flavonoids
571897|NCT01130129|Platelets|platelets
571898|NCT01130103|PTSD|ptsd
571899|NCT01130103|anxiety disorders|anxiety disorders
571900|NCT01130103|trauma|trauma
571901|NCT01130077|Pediatric glioma|pediatric glioma
571902|NCT01130077|Vaccine therapy|vaccine therapy
571903|NCT01130064|Asthma|asthma
571904|NCT01130064|QAX576|qax576
571905|NCT01130051|bioavailability|bioavailability
571906|NCT01130038|Characteristic of play|characteristic of play
571907|NCT01130038|DCD|dcd
571908|NCT01130038|children|children
571909|NCT01130038|Typical Development|typical development
571910|NCT01130038|Whether there are any differences in the issue of Characteristic of play between Children with DCD and Children with Typical Development|whether there are any differences in the issue of characteristic of play between children with dcd and children with typical development
571911|NCT01130012|Gestational diabetes mellitus|gestational diabetes mellitus
571912|NCT01130012|Lifestyle intervention|lifestyle intervention
571913|NCT01130012|Oral glucose tolerance test|oral glucose tolerance test
571914|NCT01130012|Insulin treatment|insulin treatment
571915|NCT01130012|Pregnancy outcomes|pregnancy outcomes
571916|NCT01129999|smoking cessation, CBT, hypnotherapy|smoking cessation, cbt, hypnotherapy
571917|NCT01129986|venous ulcer Dermastream|venous ulcer dermastream
571918|NCT01129973|speech and language|speech and language
571919|NCT01129973|phonoaudiology|phonoaudiology
571920|NCT01129973|marketing|marketing
571921|NCT01129960|Diabetic Neuropathic Pain|diabetic neuropathic pain
571922|NCT01129934|Low Back Pain,|low back pain,
571923|NCT01129934|Emergency medicine,|emergency medicine,
571924|NCT01129934|Promethazine,|promethazine,
571925|NCT01129934|Morphine,|morphine,
571926|NCT01129934|Pain relief|pain relief
571927|NCT01129921|Lumbar Spine Stenosis|lumbar spine stenosis
571928|NCT01129921|Decompression|decompression
571929|NCT01129908|oral health in children with celiac disease|oral health in children with celiac disease
571930|NCT01129882|Schizophrenia|schizophrenia
571931|NCT01129869|Survey|survey
571932|NCT01129869|Perception|perception
571933|NCT01129869|Perception of Clinical Research Participation|perception of clinical research participation
571934|NCT01129869|Research Participant Perception|research participant perception
571935|NCT01129856|Dry eye|dry eye
571936|NCT01129856|Keratoconjunctivitis sicca|keratoconjunctivitis sicca
571937|NCT01129856|Iontophoresis|iontophoresis
571938|NCT01129856|Ophthalmic drug delivery|ophthalmic drug delivery
571939|NCT01129856|EGP-437|egp-437
571940|NCT01129856|Dexamethasone phosphate|dexamethasone phosphate
571941|NCT01129843|anemia|anemia
571942|NCT01129843|iron deficiency|iron deficiency
571943|NCT01129843|nutritional|nutritional
571944|NCT01129843|iron supplementation|iron supplementation
571945|NCT01129843|cluster randomized control trial|cluster randomized control trial
571946|NCT01129830|ovarian reserve|ovarian reserve
571947|NCT01129830|FSH|fsh
571948|NCT01129830|anti-mullerian hormone|anti-mullerian hormone
571949|NCT01129830|estradiol|estradiol
571950|NCT01129830|oocyte|oocyte
571951|NCT01129830|IVF|ivf
571952|NCT01129830|embryo transfer|embryo transfer
571953|NCT01129817|Cognitive Functional Therapy|cognitive functional therapy
571954|NCT01129817|Manual Therapy and Exercise|manual therapy and exercise
571955|NCT01129817|Chronic Low Back Pain|chronic low back pain
571956|NCT01129817|Randomized Controlled Trial|randomized controlled trial
571957|NCT01129817|Subclassification|subclassification
571958|NCT01129804|Alcohol dependence|alcohol dependence
571959|NCT01129804|Network Support|network support
571960|NCT01129804|Cognitive-behavioral treatment|cognitive-behavioral treatment
571961|NCT01129804|Relapse prevention|relapse prevention
571962|NCT01129804|Consequences of drinking|consequences of drinking
571963|NCT01129804|Social network development|social network development
571964|NCT01129791|Lactose intolerance|lactose intolerance
571965|NCT01129791|Dairy products|dairy products
571966|NCT01129791|Raw milk|raw milk
571967|NCT01129791|Adults|adults
571968|NCT01129765|Nasal suction|nasal suction
571969|NCT01129765|Nasal aspiration|nasal aspiration
571970|NCT01129765|Nasal saline irrigation|nasal saline irrigation
571971|NCT01129765|Nasal lavage|nasal lavage
571972|NCT01129739|Bone Marrow Disease|bone marrow disease
571973|NCT01129739|MDS-RA|mds-ra
571974|NCT01129739|MDS-RARS|mds-rars
571975|NCT01129739|Umbilical Cord/placenta-Derived MSC|umbilical cord/placenta-derived msc
571976|NCT01129739|Transplant|transplant
571977|NCT01129726|Transillumination-guided|transillumination-guided
571978|NCT01129726|Fiberoptic Intubation|fiberoptic intubation
571979|NCT01129726|time|time
571980|NCT01129726|success rate|success rate
571981|NCT01129726|intubation|intubation
571982|NCT01129713|GERD|gerd
571983|NCT01129713|Acid Reflux|acid reflux
571984|NCT01129713|Heartburn|heartburn
571985|NCT01129713|Regurgitation|regurgitation
571986|NCT01129713|Indigestion|indigestion
571987|NCT01129700|rectal cancer, short-course, chemoradiotherapy|rectal cancer, short-course, chemoradiotherapy
571988|NCT01129648|Hyperuricemia, gout|hyperuricemia, gout
571989|NCT01129635|Heart failure|heart failure
571990|NCT01129635|Cardiac resynchronization therapy|cardiac resynchronization therapy
571991|NCT01129635|Regional left ventricular dyssynchrony|regional left ventricular dyssynchrony
571992|NCT01129635|CRT|crt
571993|NCT01129622|Letrozole|letrozole
571994|NCT01129622|Breast MRI|breast mri
571995|NCT01129622|Postmenopausal women|postmenopausal women
571996|NCT01129609|Post-approval observation of patients being treated according to the indications for use for the Talent Converter Stent Graft|post-approval observation of patients being treated according to the indications for use for the talent converter stent graft
571997|NCT01129583|Botulinum Toxin|botulinum toxin
571998|NCT01129583|Elbow Stiffness|elbow stiffness
571999|NCT01129544|Severe combined immunodeficiency|severe combined immunodeficiency
572000|NCT01129544|SCID|scid
572001|NCT01129544|XSCID|xscid
572002|NCT01129544|SCID-X1|scid-x1
572003|NCT01129518|meningococcal serogroup C|meningococcal serogroup c
572004|NCT01129518|vaccine|vaccine
572005|NCT01129518|conjugate|conjugate
572006|NCT01129505|pregnancy|pregnancy
572007|NCT01129505|intervention|intervention
572008|NCT01129505|exercise|exercise
572009|NCT01129505|nutrition|nutrition
572010|NCT01129505|infants|infants
572011|NCT01129492|Autoimmune Thyroiditis, Laser, Therapy, Thyroid, Ultrasound|autoimmune thyroiditis, laser, therapy, thyroid, ultrasound
572012|NCT01129479|Aphasia|aphasia
572013|NCT01129479|treatment|treatment
572014|NCT01129479|cholinesterase inhibitor|cholinesterase inhibitor
572015|NCT01129479|stroke|stroke
572016|NCT01129453|Salmonella|salmonella
572017|NCT01129453|Vaccine|vaccine
572018|NCT01129440|Children|children
572019|NCT01129440|Fluoride varnish|fluoride varnish
572020|NCT01129440|Glass ionomer sealant|glass ionomer sealant
572021|NCT01129440|Prevention|prevention
572022|NCT01129401|methamphetamine|methamphetamine
572023|NCT01129401|men who have sex with men|men who have sex with men
572024|NCT01129401|HIV/AIDS|hiv/aids
572025|NCT01129362|Pertussis|pertussis
572026|NCT01129362|Whooping Cough|whooping cough
572027|NCT01129362|Pertussis Vaccine|pertussis vaccine
572028|NCT01129349|Solid Tumors|solid tumors
572029|NCT01129336|HER2-negative|her2-negative
572030|NCT01129336|HER2|her2
572031|NCT01129336|Metastatic breast cancer|metastatic breast cancer
572032|NCT01129336|First Line breast cancer|first line breast cancer
572033|NCT01129336|Second Line breast cancer|second line breast cancer
572034|NCT01129336|Breast cancer|breast cancer
572035|NCT01129336|Metastatic|metastatic
572036|NCT01129336|Stage IV breast cancer|stage iv breast cancer
572037|NCT01129336|Progression free survival|progression free survival
572038|NCT01129336|PFS|pfs
572039|NCT01129336|Circulating Tumor Cells|circulating tumor cells
572040|NCT01129336|CTCs|ctcs
572041|NCT01129336|Zoledronic acid|zoledronic acid
572042|NCT01129336|HER2-negative metastatic breast cancer patients without bone metastasis|her2-negative metastatic breast cancer patients without bone metastasis
572043|NCT01129323|Anemia, Severe, Aplastic, Reduced-Intensity, Allogeneic, Stem, Cell, Transplantation|anemia, severe, aplastic, reduced-intensity, allogeneic, stem, cell, transplantation
572044|NCT01129310|irinotecan|irinotecan
572045|NCT01129310|capecitabine|capecitabine
572046|NCT01129310|oxaliplatin|oxaliplatin
572047|NCT01129310|health-related quality of life|health-related quality of life
572048|NCT01129310|gastroesophageal(GE) junction adenocarcinoma|gastroesophageal(ge) junction adenocarcinoma
572049|NCT01129297|Obesity|obesity
572050|NCT01129297|surgery|surgery
572051|NCT01129297|genetic expression|genetic expression
572052|NCT01129297|collection of samples|collection of samples
572053|NCT01129284|Treatment Resistance|treatment resistance
572054|NCT01129284|Nephrotic Syndrome|nephrotic syndrome
572055|NCT01129284|Focal Segmental Glomerulosclerosis|focal segmental glomerulosclerosis
572056|NCT01129284|lipoid nephrosis|lipoid nephrosis
572057|NCT01129284|Membranous nephropathy|membranous nephropathy
572058|NCT01129284|IgA nephropathy|iga nephropathy
572059|NCT01129284|proteinuria|proteinuria
572060|NCT01129258|phase 1|phase 1
572061|NCT01129258|safety and tolerability|safety and tolerability
572062|NCT01129258|pharmacokinetics|pharmacokinetics
572063|NCT01129258|PK|pk
572064|NCT01129258|pharmacodynamics|pharmacodynamics
572065|NCT01129258|PD|pd
572066|NCT01129258|type 2 diabetes mellitus|type 2 diabetes mellitus
572067|NCT01129245|Celebrex|celebrex
572068|NCT01129245|prostoglandin inhibitor|prostoglandin inhibitor
572069|NCT01129245|ovulation|ovulation
572070|NCT01129245|emergency contraception|emergency contraception
572071|NCT01129232|insulin|insulin
572072|NCT01129219|Strength|strength
572073|NCT01129219|Function|function
572074|NCT01129219|Mobility|mobility
572075|NCT01129206|Gastroesophageal Cancer|gastroesophageal cancer
572076|NCT01129206|Gastroesophageal Carcinoma|gastroesophageal carcinoma
572077|NCT01129206|Adenocarcinoma|adenocarcinoma
572078|NCT01129180|T-Cell Lymphoma|t-cell lymphoma
572079|NCT01129167|Pancreatic adenocarcinoma|pancreatic adenocarcinoma
572080|NCT01129167|Local invasion by pancreatic adenocarcinoma|local invasion by pancreatic adenocarcinoma
572081|NCT01129167|Recurrence of pancreatic cancer|recurrence of pancreatic cancer
572082|NCT01129167|Surgical resection of pancreatic cancer|surgical resection of pancreatic cancer
572083|NCT01129154|Squamous cell carcinoma|squamous cell carcinoma
572084|NCT01129141|Tinnitus|tinnitus
572085|NCT01129141|Traumatic Brain Injury Counseling|traumatic brain injury counseling
572086|NCT01129141|Counseling|counseling
572087|NCT01129141|Education|education
572088|NCT01129141|Evaluation studies|evaluation studies
572089|NCT01129141|Quality of health care|quality of health care
572090|NCT01129128|Echinacea|echinacea
572091|NCT01129128|immune modulation|immune modulation
572092|NCT01129128|prevention|prevention
572093|NCT01129089|Acceptability|acceptability
572094|NCT01129089|Lipid-based nutrient supplements|lipid-based nutrient supplements
572095|NCT01129089|Micronutrient powder|micronutrient powder
572096|NCT01129089|Malnutrition|malnutrition
572097|NCT01129076|Thalassemia Major|thalassemia major
572098|NCT01129076|Stigma|stigma
572099|NCT01129076|Singapore|singapore
572100|NCT01129076|Qualitative|qualitative
572101|NCT01129050|Fish oil|fish oil
572102|NCT01129050|Omega-3 fatty acids|omega-3 fatty acids
572103|NCT01129050|Metabolic syndrome|metabolic syndrome
572105|NCT01129037|Oncology|oncology
572106|NCT01129024|Splenectomy|splenectomy
572107|NCT01129024|Low Platelet Count|low platelet count
572108|NCT01129024|Thrombopoiesis|thrombopoiesis
572109|NCT01129024|Thrombocytopaenia|thrombocytopaenia
572110|NCT01129024|Idiopathic Thrombocytopenic Purpura|idiopathic thrombocytopenic purpura
572111|NCT01129024|Immune Thrombocytopenia (ITP)|immune thrombocytopenia (itp)
572112|NCT01129024|Thrombotic Thrombocytopenic Purpura (ITP)|thrombotic thrombocytopenic purpura (itp)
572113|NCT01129024|Hematologic Disease|hematologic disease
572114|NCT01129024|Auto-immune Thrombocytopenic Purpura|auto-immune thrombocytopenic purpura
572115|NCT01129024|S-888711|s-888711
726809|NCT00521729|Thyroid|thyroid
572116|NCT01129024|Blood Platelet Disorders|blood platelet disorders
572117|NCT01129024|Relapsed Persistent or Chronic ITP|relapsed persistent or chronic itp
572118|NCT01129024|ITP|itp
572119|NCT01129011|NSAID|nsaid
572120|NCT01129011|gastric ulcers|gastric ulcers
572121|NCT01129011|Vimovo|vimovo
572122|NCT01129011|Esomeprazole|esomeprazole
572123|NCT01129011|Naproxen|naproxen
572124|NCT01128998|Sorafenib|sorafenib
572125|NCT01128998|S1|s1
572126|NCT01128998|Advanced Solid Tumors|advanced solid tumors
572127|NCT01128998|RD|rd
572128|NCT01128998|MTD|mtd
572129|NCT01128998|DLT|dlt
572130|NCT01128998|PK|pk
572131|NCT01128998|PG|pg
572132|NCT01128998|Biomarker|biomarker
572133|NCT01128985|Canagliflozin|canagliflozin
572134|NCT01128985|Placebo|placebo
572135|NCT01128985|Type 2 diabetes mellitus|type 2 diabetes mellitus
572136|NCT01128985|Pharmacokinetic|pharmacokinetic
572137|NCT01128985|Pharmacodynamic|pharmacodynamic
572138|NCT01128972|enamel erosion|enamel erosion
572139|NCT01128972|tooth remineralization|tooth remineralization
572140|NCT01128972|tooth erosion|tooth erosion
572141|NCT01128959|Epilepsy|epilepsy
572142|NCT01128959|Intravenous Carbamazepine|intravenous carbamazepine
572143|NCT01128959|Oral Carbamazepine|oral carbamazepine
572144|NCT01128946|Enamel remineralization|enamel remineralization
572145|NCT01128946|Fluoride|fluoride
572146|NCT01128946|caries|caries
572147|NCT01128933|Fractional flow reserve|fractional flow reserve
572148|NCT01128933|Revascularization|revascularization
572149|NCT01128933|Prognosis|prognosis
572150|NCT01128933|Hemodynamics|hemodynamics
572151|NCT01128933|Hypertension|hypertension
572152|NCT01128920|bacterial infections|bacterial infections
572153|NCT01128920|skin infections|skin infections
572154|NCT01128920|HIV|hiv
572155|NCT01128920|Hepatitis C|hepatitis c
572156|NCT01128920|risk reduction intervention|risk reduction intervention
572157|NCT01128907|Invasive Aspergillosis in neutropenic patients|invasive aspergillosis in neutropenic patients
572158|NCT01128894|GSK716155|gsk716155
572159|NCT01128894|liraglutide|liraglutide
572160|NCT01128894|albiglutide|albiglutide
572161|NCT01128894|open-label|open-label
572162|NCT01128868|Reverse oblique intertrochanteric fractures|reverse oblique intertrochanteric fractures
572163|NCT01128868|Reverse oblique subtrochanteric fractures|reverse oblique subtrochanteric fractures
572164|NCT01128855|Duchenne|duchenne
572165|NCT01128855|Duchenne Muscular Dystrophy|duchenne muscular dystrophy
572166|NCT01128855|DMD|dmd
572167|NCT01128855|968|968
572168|NCT01128842|Neratinib|neratinib
572169|NCT01128842|Capecitabine|capecitabine
572170|NCT01128842|Combination|combination
572171|NCT01128842|Solid Tumor|solid tumor
572172|NCT01128829|obesity|obesity
572173|NCT01128829|diabetes|diabetes
572174|NCT01128829|artificial sweeteners|artificial sweeteners
572175|NCT01128816|obstructive sleep apnea|obstructive sleep apnea
572176|NCT01128816|central sleep apnea|central sleep apnea
572177|NCT01128816|heart failure|heart failure
572178|NCT01128816|congestive heart failure|congestive heart failure
572179|NCT01128816|adaptive servo ventilation|adaptive servo ventilation
572180|NCT01128816|ASV|asv
572181|NCT01128803|Hepatocellular carcinoma|hepatocellular carcinoma
572182|NCT01128803|immunotherapy|immunotherapy
572183|NCT01128803|alpha foetoprotein|alpha foetoprotein
572184|NCT01128803|dendritic cells|dendritic cells
572185|NCT01128790|exercise|exercise
572186|NCT01128790|remote ischemic preconditioning|remote ischemic preconditioning
572187|NCT01128790|heart failure|heart failure
572188|NCT01128790|left ventricular dysfunction|left ventricular dysfunction
572189|NCT01128777|depression|depression
572190|NCT01128777|anxiety|anxiety
572191|NCT01128777|family conflict|family conflict
572192|NCT01128777|behavior problems|behavior problems
572193|NCT01128751|Cognition|cognition
572194|NCT01128751|Neuroprotection|neuroprotection
572195|NCT01128751|Cardiopulmonary bypass|cardiopulmonary bypass
572196|NCT01128751|Aortic valve replacement|aortic valve replacement
572197|NCT01128751|Micro-emboli|micro-emboli
572198|NCT01128738|Neuromuscular Agents|neuromuscular agents
572199|NCT01128738|Botulinum Toxin Type A|botulinum toxin type a
572200|NCT01128738|Sweating|sweating
572201|NCT01128738|Sweat Gland Disease|sweat gland disease
572202|NCT01128738|Axillary Hyperhidrosis|axillary hyperhidrosis
572203|NCT01128738|Skin Disease|skin disease
572204|NCT01128699|Ahmed valve|ahmed valve
572205|NCT01128699|Neovascular Glaucoma|neovascular glaucoma
572206|NCT01128699|Uveitic glaucoma|uveitic glaucoma
572207|NCT01128699|Failed glaucoma|failed glaucoma
572208|NCT01128699|VEGF-A|vegf-a
572209|NCT01128699|Intraocular pressure|intraocular pressure
572210|NCT01128699|Subconjunctival Avastin|subconjunctival avastin
572211|NCT01128686|retrospective|retrospective
572212|NCT01128686|naïve Chronic Hepatitis B (CHB) patients|naïve chronic hepatitis b (chb) patients
572213|NCT01128686|cohort study|cohort study
572214|NCT01128686|lamivudine|lamivudine
572215|NCT01128673|Hypoxic Ischemic encephalopathy|hypoxic ischemic encephalopathy
572216|NCT01128673|Magnet resonance imaging|magnet resonance imaging
572217|NCT01128673|Selective Head cooling|selective head cooling
572218|NCT01128673|Therapeutic hypothermia|therapeutic hypothermia
572219|NCT01128660|Prescription, General practitioner, Pharmacy|prescription, general practitioner, pharmacy
572220|NCT01128634|Verapamil|verapamil
572221|NCT01128634|Anticholinergic, β2 agonist|anticholinergic, β2 agonist
572222|NCT01128634|P-GP|p-gp
572223|NCT01128634|LABA|laba
572224|NCT01128634|Muscarinic Receptor Antagonist|muscarinic receptor antagonist
572225|NCT01128634|LAMA|lama
572226|NCT01128621|Pharmacokinetics|pharmacokinetics
572227|NCT01128621|Glucose|glucose
572228|NCT01128621|Safety|safety
572229|NCT01128621|Male|male
572230|NCT01128621|Female|female
572231|NCT01128621|Metformin|metformin
572232|NCT01128621|Pharmacodynamics|pharmacodynamics
572233|NCT01128621|Tolerability|tolerability
572234|NCT01128621|Type II Diabetes|type ii diabetes
572235|NCT01128608|GERD|gerd
572236|NCT01128608|Heartburn|heartburn
572237|NCT01128608|Acid Reflux|acid reflux
572238|NCT01128595|allergen challenge|allergen challenge
572239|NCT01128595|early asthmatic response|early asthmatic response
572240|NCT01128595|mild asthma|mild asthma
572241|NCT01128595|late asthmatic response|late asthmatic response
572242|NCT01128582|GERD|gerd
572243|NCT01128582|Insomnia|insomnia
572244|NCT01128582|Acid Reflux|acid reflux
572245|NCT01128582|Heartburn|heartburn
572246|NCT01128569|mild asthma|mild asthma
572247|NCT01128569|allergen challenge|allergen challenge
572248|NCT01128569|early asthmatic response|early asthmatic response
572249|NCT01128556|allergic conjunctivitis|allergic conjunctivitis
572250|NCT01128556|histamine skin testing|histamine skin testing
572251|NCT01128543|lapatinib|lapatinib
572252|NCT01128543|breast cancer|breast cancer
572253|NCT01128530|cSSSI|csssi
572254|NCT01128530|complicated skin and skin structure infections|complicated skin and skin structure infections
572255|NCT01128530|acute bacterial skin and skin structure infections|acute bacterial skin and skin structure infections
572256|NCT01128530|abscess|abscess
572257|NCT01128530|cellulitis|cellulitis
572258|NCT01128530|bacterial infections|bacterial infections
572259|NCT01128530|anti-bacterial agents|anti-bacterial agents
572260|NCT01128530|anti-infective agents|anti-infective agents
572261|NCT01128530|skin diseases, infectious|skin diseases, infectious
572262|NCT01128530|skin diseases|skin diseases
572263|NCT01128530|wound infection|wound infection
572264|NCT01128517|Maternal education|maternal education
572265|NCT01128517|Complementary food|complementary food
572266|NCT01128517|Infant growth|infant growth
572267|NCT01128478|Acute pancreatitis|acute pancreatitis
572268|NCT01128478|Enteral nutrition|enteral nutrition
572269|NCT01128478|Pancreas rest|pancreas rest
572270|NCT01128465|propofol|propofol
572271|NCT01128465|awake craniotomy|awake craniotomy
572272|NCT01128465|patients requiring an awake craniotomy for brain tumor/lesion resection|patients requiring an awake craniotomy for brain tumor/lesion resection
572273|NCT01128452|Treatment-Resistant Depression|treatment-resistant depression
572274|NCT01128439|Pneumococcal conjugate vaccine|pneumococcal conjugate vaccine
572275|NCT01128426|Pneumococcal conjugate vaccine|pneumococcal conjugate vaccine
572276|NCT01128413|Shock|shock
572277|NCT01128413|Resuscitation|resuscitation
572278|NCT01128413|Hemodynamics|hemodynamics
572279|NCT01128413|Emergencies|emergencies
572280|NCT01128413|Critical Care|critical care
572281|NCT01128413|Lactic Acid|lactic acid
572282|NCT01128413|Plasma volume|plasma volume
572283|NCT01128400|obesity|obesity
572284|NCT01128400|orlistat|orlistat
572285|NCT01128400|taste perception|taste perception
572286|NCT01128387|esophageal cancer|esophageal cancer
572287|NCT01128387|Locally advanced esophageal cancer|locally advanced esophageal cancer
572288|NCT01128374|Periodontal disease|periodontal disease
572289|NCT01128374|Nonsurgical therapy|nonsurgical therapy
572290|NCT01128374|Type 2 Diabetes Mellitus|type 2 diabetes mellitus
572291|NCT01128374|Bacterial burden|bacterial burden
572292|NCT01128374|Gene polymorphisms|gene polymorphisms
572293|NCT01128348|asthma|asthma
572294|NCT01128348|adherence|adherence
572295|NCT01128348|quality of life|quality of life
572296|NCT01128348|health literacy|health literacy
572297|NCT01128348|health disparities|health disparities
572298|NCT01128335|Liver transplantation|liver transplantation
572299|NCT01128335|HCV-negative recipient|hcv-negative recipient
572300|NCT01128335|deceased donor|deceased donor
572301|NCT01128335|sotrastaurin|sotrastaurin
572302|NCT01128335|oran transplantation|oran transplantation
572303|NCT01128335|tacrolimus|tacrolimus
572304|NCT01128322|CKD-828|ckd-828
572305|NCT01128322|Hypertension|hypertension
572306|NCT01128322|Primary Hypertension|primary hypertension
572307|NCT01128322|S-Amlodipine|s-amlodipine
572308|NCT01128322|Telmisartan|telmisartan
572309|NCT01128322|Amlodipine|amlodipine
572310|NCT01128322|Factorial|factorial
572311|NCT01128322|Phase 2|phase 2
572312|NCT01128296|high risk stage IIb or III adenocarcinoma of the pancreas|high risk stage iib or iii adenocarcinoma of the pancreas
572313|NCT01128283|Sepsis|sepsis
572314|NCT01128283|organ failure|organ failure
572315|NCT01128283|cytokines|cytokines
572316|NCT01128283|clotting factors|clotting factors
572317|NCT01128270|Dichloroacetate|dichloroacetate
572318|NCT01128270|Chloral Hydrate|chloral hydrate
572319|NCT01128270|Metabolism|metabolism
572320|NCT01128244|oral contraceptives|oral contraceptives
572321|NCT01128244|Vitamin B6|vitamin b6
572322|NCT01128244|birth control pills|birth control pills
572323|NCT01128244|amino acids|amino acids
572324|NCT01128244|Vitamin B6 deficiency|vitamin b6 deficiency
572325|NCT01128244|Vitamin B6 deficiency in women on oral contraceptives|vitamin b6 deficiency in women on oral contraceptives
572326|NCT01128218|Brain Neoplasms|brain neoplasms
572327|NCT01128218|5-ALA|5-ala
572328|NCT01128218|Aminolevulinic acid|aminolevulinic acid
572329|NCT01128218|Fluorescence|fluorescence
572330|NCT01128218|Gliomas|gliomas
572331|NCT01128218|Glioblastoma|glioblastoma
572332|NCT01128218|Surgery|surgery
572333|NCT01128205|diabetes|diabetes
572334|NCT01128205|cardiovascular risk factors|cardiovascular risk factors
572335|NCT01128205|blood pressure|blood pressure
572336|NCT01128205|blood lipid|blood lipid
572337|NCT01128205|blood glucose|blood glucose
572338|NCT01128166|Heart Failure|heart failure
572339|NCT01128166|Decompensation|decompensation
572340|NCT01128166|Cardiac Resynchronization Therapy|cardiac resynchronization therapy
572341|NCT01128153|Type 2 Diabetes|type 2 diabetes
572342|NCT01128153|Inadequate Glycaemic Control|inadequate glycaemic control
572343|NCT01128153|Saxagliptin|saxagliptin
572344|NCT01128153|Metformin|metformin
572345|NCT01128153|Sulfonylurea|sulfonylurea
572346|NCT01128153|Triple Oral Therapy|triple oral therapy
572347|NCT01128140|motivational enhancement therapy|motivational enhancement therapy
572348|NCT01128127|knowledge translation|knowledge translation
572349|NCT01128127|prescription|prescription
572350|NCT01128127|primary care|primary care
572351|NCT01128127|NSAID|nsaid
572352|NCT01128127|PPI|ppi
572353|NCT01128127|Gastrointestinal damage|gastrointestinal damage
572354|NCT01128127|Inappropriate prescription|inappropriate prescription
572355|NCT01128114|Acute bipolar mania|acute bipolar mania
572356|NCT01128114|Seroquel XR|seroquel xr
572357|NCT01128114|Quetiapine fumarate|quetiapine fumarate
572358|NCT01128114|Add-on therapy|add-on therapy
572359|NCT01128101|spironolactone|spironolactone
572360|NCT01128101|chronic kidney disease|chronic kidney disease
572361|NCT01128101|dialysis|dialysis
572362|NCT01128101|LHV|lhv
572363|NCT01128088|Enhanced recovery program in laparoscopic surgery|enhanced recovery program in laparoscopic surgery
572364|NCT01128075|RebiSmart|rebismart
572365|NCT01128075|Rebif|rebif
572366|NCT01128075|Adherence|adherence
572367|NCT01128075|Multidose|multidose
572368|NCT01128075|Relapsing Multiple Sclerosis|relapsing multiple sclerosis
572369|NCT01128075|RMS|rms
572370|NCT01128062|Canthaxanthin retinopathy|canthaxanthin retinopathy
572371|NCT01128049|Aqueous deficient dry eye (ADDE)|aqueous deficient dry eye (adde)
572372|NCT01128049|Meibomium Gland Dysfunction (MGD)|meibomium gland dysfunction (mgd)
572373|NCT01128049|Normal/Control (Non Dry Eye)|normal/control (non dry eye)
572374|NCT01128036|Congestive Heart failure|congestive heart failure
572375|NCT01128036|Cardiomyopathy|cardiomyopathy
572376|NCT01128023|myocardial perfusion imaging|myocardial perfusion imaging
572377|NCT01128023|rubidium-82|rubidium-82
572378|NCT01128023|medical isotope production|medical isotope production
572379|NCT01128023|Positron emission tomography|positron emission tomography
572380|NCT01128023|clinically useful|clinically useful
572381|NCT01127984|pacemaker|pacemaker
572382|NCT01127984|pocket haematoma|pocket haematoma
572383|NCT01127984|antiplatelet therapy|antiplatelet therapy
572384|NCT01127984|fibrin glue|fibrin glue
572385|NCT01127971|patients|patients
572386|NCT01127971|receiving|receiving
572387|NCT01127971|irradiation|irradiation
572388|NCT01127971|device|device
572389|NCT01127971|External Beam|external beam
572390|NCT01127958|In-stent restenosis|in-stent restenosis
572391|NCT01127958|Minimal lumen diameter|minimal lumen diameter
572392|NCT01127958|Drug eluting balloon|drug eluting balloon
572393|NCT01127958|Drug eluting stent|drug eluting stent
572394|NCT01127932|Cognitive Behavioral Therapy|cognitive behavioral therapy
572395|NCT01127919|Exercise|exercise
572396|NCT01127919|Activity|activity
572397|NCT01127919|Adherence|adherence
572398|NCT01127919|Genetics|genetics
572399|NCT01127906|Healthy Volunteers|healthy volunteers
572400|NCT01127906|cross-over|cross-over
572401|NCT01127906|randomized|randomized
572402|NCT01127906|placebo and active controlled|placebo and active controlled
572403|NCT01127906|heat pain|heat pain
572404|NCT01127906|UVB-Induced pain model|uvb-induced pain model
572405|NCT01127893|Musculoskeletal Diseases|musculoskeletal diseases
572406|NCT01127893|Joint Diseases|joint diseases
572407|NCT01127893|Arthritis|arthritis
572408|NCT01127893|Rheumatic Diseases|rheumatic diseases
572409|NCT01127880|Traumatic Hemopneumothorax|traumatic hemopneumothorax
572410|NCT01127880|Thoracotomy|thoracotomy
572411|NCT01127880|Antibiotics|antibiotics
572412|NCT01127854|kidney stone|kidney stone
572413|NCT01127854|urolithiasis|urolithiasis
572414|NCT01127854|calcium oxalate kidney stone|calcium oxalate kidney stone
572415|NCT01127854|calcium oxalate stone|calcium oxalate stone
572416|NCT01127854|calcium oxalate|calcium oxalate
572417|NCT01127828|IBS (Irritable Bowel Syndrome)|ibs (irritable bowel syndrome)
572418|NCT01127828|Probiotic yoghurt|probiotic yoghurt
572419|NCT01127828|Symptom severity|symptom severity
572420|NCT01127815|Peritoneal washing cytology|peritoneal washing cytology
572421|NCT01127815|pancreatic cancer|pancreatic cancer
572422|NCT01127815|peritoneal metastasis|peritoneal metastasis
572423|NCT01127815|anoikis|anoikis
572424|NCT01127815|to determine the relationship between PWC results and clinicopathologic parameters of pancreatic cancers|to determine the relationship between pwc results and clinicopathologic parameters of pancreatic cancers
572425|NCT01127815|to identify the predictive value of PWC and postoperative drainage cytology on the peritoneal recurrence or outcomes|to identify the predictive value of pwc and postoperative drainage cytology on the peritoneal recurrence or outcomes
572426|NCT01127815|to dissect the molecular mechanism of peritoneal recurrence, especially on the PWC-inducing peritoneal seeding process.|to dissect the molecular mechanism of peritoneal recurrence, especially on the pwc-inducing peritoneal seeding process.
572427|NCT01127802|CABG|cabg
572428|NCT01127802|functional status|functional status
572429|NCT01127802|symptoms distress|symptoms distress
572430|NCT01127802|quality of life|quality of life
572431|NCT01127802|the trajectory of functional status|the trajectory of functional status
572432|NCT01127802|the changes of symptoms distress|the changes of symptoms distress
572433|NCT01127802|the changes of quality of life|the changes of quality of life
572434|NCT01127776|patient after bi-trimalleolar fracture of ankle|patient after bi-trimalleolar fracture of ankle
572435|NCT01127763|metastatic|metastatic
572436|NCT01127763|breast|breast
572437|NCT01127763|cancer|cancer
572438|NCT01127750|Relapsing multiple sclerosis|relapsing multiple sclerosis
572439|NCT01127750|MS|ms
572440|NCT01127750|safety|safety
572441|NCT01127750|tolerability|tolerability
572442|NCT01127750|health outcomes|health outcomes
572443|NCT01127737|SCCs|sccs
572444|NCT01127737|Squamous Cell Carcinoma|squamous cell carcinoma
572445|NCT01127737|Skin Self Exam|skin self exam
572446|NCT01127737|SSE|sse
572447|NCT01127737|Organ Transplant|organ transplant
572448|NCT01127737|Performance of SSE with our written educational intervention|performance of sse with our written educational intervention
572449|NCT01127737|Time after organ transplantation to deliver intervention|time after organ transplantation to deliver intervention
572450|NCT01127737|Evaluate internation information|evaluate internation information
572451|NCT01127724|Vitamin B12|vitamin b12
572452|NCT01127724|Aphthous stomatitis|aphthous stomatitis
572453|NCT01127724|Cobalamin|cobalamin
572454|NCT01127724|Doses|doses
572455|NCT01127685|weight bearing|weight bearing
572456|NCT01127685|acl|acl
572457|NCT01127672|plantar fasciitis|plantar fasciitis
572458|NCT01127672|PRP|prp
572459|NCT01127672|platelet rich plasma|platelet rich plasma
572460|NCT01127659|diabetes|diabetes
572461|NCT01127659|hypogonadism|hypogonadism
572462|NCT01127659|obesity|obesity
572463|NCT01127659|testosterone|testosterone
572464|NCT01127659|insulin sensitivity|insulin sensitivity
572465|NCT01127659|inflammation|inflammation
572466|NCT01127620|Allergic Rhinoconjunctivitis|allergic rhinoconjunctivitis
572467|NCT01127620|Persistent allergic rhinitis|persistent allergic rhinitis
572468|NCT01127620|Hay fever|hay fever
572469|NCT01127620|Allergic Rhinitis|allergic rhinitis
572470|NCT01127620|Sneezing|sneezing
572471|NCT01127620|Nasal congestion|nasal congestion
572472|NCT01127620|Rhinorrhea|rhinorrhea
572473|NCT01127620|Nasal itching|nasal itching
572474|NCT01127620|Ocular itching|ocular itching
572475|NCT01127620|Ocular tearing|ocular tearing
572476|NCT01127620|Antihistamine|antihistamine
572477|NCT01127607|parenting|parenting
572478|NCT01127594|Melanoma|melanoma
572479|NCT01127581|Misoprostol vaginal insert|misoprostol vaginal insert
572480|NCT01127581|Dinoprostone vaginal insert|dinoprostone vaginal insert
572481|NCT01127581|Cervidil|cervidil
572482|NCT01127581|Cervical ripening|cervical ripening
572483|NCT01127581|Induction of labor|induction of labor
572484|NCT01127581|Rate of cesarean section|rate of cesarean section
572485|NCT01127568|Post-Traumatic Stress Disorders|post-traumatic stress disorders
572486|NCT01127568|Posttraumatic Stress Disorders|posttraumatic stress disorders
572487|NCT01127568|PTSD|ptsd
572488|NCT01127568|Stress Disorder, Post Traumatic|stress disorder, post traumatic
572489|NCT01127568|Stress Disorders, Posttraumatic|stress disorders, posttraumatic
572490|NCT01127568|Chronic Post Traumatic Stress Disorder|chronic post traumatic stress disorder
572491|NCT01127555|Biliary Tract Cancer|biliary tract cancer
572492|NCT01127555|Salvage therapy|salvage therapy
572493|NCT01127555|FOLFOX|folfox
572494|NCT01127516|Susceptibility testing|susceptibility testing
572495|NCT01127516|Antimicrobial stewardship|antimicrobial stewardship
572496|NCT01127503|Patients with velocardiofacial syndrome and psychosis|patients with velocardiofacial syndrome and psychosis
572497|NCT01127477|Hypovolemia, surgical blood loss|hypovolemia, surgical blood loss
572498|NCT01127464|HIV-1|hiv-1
572499|NCT01127464|HIV preventative vaccine|hiv preventative vaccine
572500|NCT01127464|Healthy Volunteers|healthy volunteers
572501|NCT01127451|Neoplasms|neoplasms
572502|NCT01127438|Monitored anesthesia care sedation|monitored anesthesia care sedation
572503|NCT01127425|nursing hours|nursing hours
572504|NCT01127425|length of hospital stay|length of hospital stay
572505|NCT01127425|reconvalescence|reconvalescence
572506|NCT01127425|colorectal surgery|colorectal surgery
572507|NCT01127425|laparoscopic|laparoscopic
572508|NCT01127425|sigmoid neoplasms|sigmoid neoplasms
572509|NCT01127412|overweight|overweight
572510|NCT01127412|physical activity|physical activity
572511|NCT01127412|infancy|infancy
572512|NCT01127412|body composition|body composition
572513|NCT01127412|motor development|motor development
572514|NCT01127412|motor activity|motor activity
572515|NCT01127373|Breast|breast
572516|NCT01127373|Radiation|radiation
572517|NCT01127373|Multi-Beam Intensity-Modulated Radiation|multi-beam intensity-modulated radiation
572518|NCT01127373|post mastectomy|post mastectomy
572519|NCT01127373|post partial mastectomy|post partial mastectomy
572520|NCT01127373|node-positive breast cancer|node-positive breast cancer
572521|NCT01127373|10-025|10-025
572522|NCT01127360|Anti-VEGF|anti-vegf
572523|NCT01127360|Ranibizumab|ranibizumab
572524|NCT01127360|Bevacizumab|bevacizumab
572525|NCT01127360|exudative|exudative
572526|NCT01127360|macular degeneration|macular degeneration
572527|NCT01127334|Dyssynchrony|dyssynchrony
572528|NCT01127334|Cardiac resynchronization therapy|cardiac resynchronization therapy
572529|NCT01127321|Systemic lupus erythematosus|systemic lupus erythematosus
572530|NCT01127321|SLE|sle
572531|NCT01127321|MEDI-570|medi-570
572532|NCT01127308|Absorption|absorption
572533|NCT01127308|Distribution|distribution
572534|NCT01127308|Metabolism|metabolism
572535|NCT01127308|and Excretion|and excretion
572536|NCT01127308|Mass Balance|mass balance
572537|NCT01127308|Metabolic Profile|metabolic profile
572538|NCT01127308|Radiolabel Study|radiolabel study
572539|NCT01127295|Pharmacokinetics|pharmacokinetics
572540|NCT01127295|Pharmacogenetic|pharmacogenetic
572541|NCT01127295|tamoxifen|tamoxifen
572542|NCT01127295|anti-aromatases|anti-aromatases
572543|NCT01127295|breast cancer|breast cancer
572544|NCT01127295|pharmacodynamy|pharmacodynamy
572545|NCT01127295|Observance|observance
572546|NCT01127282|influenza|influenza
572547|NCT01127282|vitamin|vitamin
572548|NCT01127282|improvement of symptom|improvement of symptom
572549|NCT01127243|Hysterectomy|hysterectomy
572550|NCT01127243|laparoscopy|laparoscopy
572551|NCT01127243|day-case surgery|day-case surgery
572552|NCT01127243|quality of life|quality of life
572553|NCT01127243|Ambulatory Surgical Procedures|ambulatory surgical procedures
572554|NCT01127230|ADRC|adrc
572555|NCT01127230|adipocyte derived regenerative cells|adipocyte derived regenerative cells
572556|NCT01127230|stem cells|stem cells
572557|NCT01127230|liposuction|liposuction
572558|NCT01127230|Cytori|cytori
572559|NCT01127230|Celution|celution
572560|NCT01127230|Lipoaspirate is obtained from patients who have opted for liposuction and consent to donate the lipoasirate for this study, which would otherwise be discarded.|lipoaspirate is obtained from patients who have opted for liposuction and consent to donate the lipoasirate for this study, which would otherwise be discarded.
572561|NCT01127217|amlodipine|amlodipine
572562|NCT01127217|losartan|losartan
572563|NCT01127217|hypertension|hypertension
572564|NCT01127217|stage 2|stage 2
572565|NCT01127204|HIV|hiv
572566|NCT01127204|Antiretroviral therapy|antiretroviral therapy
572567|NCT01127204|Infant|infant
572568|NCT01127204|Sub Saharian Africa|sub saharian africa
572569|NCT01127191|military exercises|military exercises
572570|NCT01127191|neuromuscular fatigue|neuromuscular fatigue
572571|NCT01127191|physiological responses|physiological responses
572572|NCT01127191|biomechanical responses|biomechanical responses
572573|NCT01127191|simulated military effort|simulated military effort
572574|NCT01127191|high load carriage|high load carriage
572575|NCT01127191|Healthy voluntary|healthy voluntary
572576|NCT01127152|Noradrenalin relays|noradrenalin relays
572577|NCT01127152|Automatic relays|automatic relays
572578|NCT01127152|Manual relays|manual relays
572579|NCT01127152|Hypotension|hypotension
572580|NCT01127152|Intensive care unit|intensive care unit
572581|NCT01127139|Essential hypertension|essential hypertension
572582|NCT01127113|Myocardial infarction|myocardial infarction
572583|NCT01127113|Magnetic resonance imaging|magnetic resonance imaging
572584|NCT01127113|Nanoparticles|nanoparticles
572585|NCT01127113|Mononuclear cells|mononuclear cells
572586|NCT01127113|Cell tracking|cell tracking
572587|NCT01127100|neuropathic pain|neuropathic pain
572588|NCT01127100|gabapentin|gabapentin
572589|NCT01127100|transdermal fentanyl matrix|transdermal fentanyl matrix
572590|NCT01127100|multicenter|multicenter
572591|NCT01127100|non-inferiority trial|non-inferiority trial
572592|NCT01127087|Hyperoxaluria|hyperoxaluria
572593|NCT01127087|Oxazyme|oxazyme
572594|NCT01127087|oxalate|oxalate
572595|NCT01127087|enteric hyperoxaluria|enteric hyperoxaluria
572596|NCT01127074|metastatic breast cancer|metastatic breast cancer
727417|NCT00519311|RCT|rct
572597|NCT01127074|breast cancer stage IV|breast cancer stage iv
572598|NCT01127074|vaccination|vaccination
572599|NCT01127074|CD80|cd80
572600|NCT01127074|immunotherapy|immunotherapy
572601|NCT01127061|Hypertrophic Cardiomyopathy|hypertrophic cardiomyopathy
572602|NCT01127061|Exercise|exercise
572603|NCT01127061|Oxygen consumption|oxygen consumption
572604|NCT01127048|bronchitis|bronchitis
572605|NCT01127048|coughing|coughing
572606|NCT01127048|children|children
572607|NCT01127048|Ivy|ivy
572608|NCT01127048|Hedera helix L.|hedera helix l.
572609|NCT01127035|allergic rhinitis|allergic rhinitis
572610|NCT01127035|alternaria alternata|alternaria alternata
572611|NCT01127035|symptom score|symptom score
572612|NCT01127022|Pregnancy|pregnancy
572613|NCT01127022|Lactation|lactation
572614|NCT01127022|Choline|choline
572615|NCT01127022|Cognition|cognition
572616|NCT01127022|Biomarkers|biomarkers
572617|NCT01126996|MenC conjugate vaccine|menc conjugate vaccine
572618|NCT01126996|Healthy children previously vaccinated against MenC|healthy children previously vaccinated against menc
572619|NCT01126970|reduced calorie diet|reduced calorie diet
572620|NCT01126970|orlistat|orlistat
572621|NCT01126970|velneperit|velneperit
572622|NCT01126944|heart failure|heart failure
572623|NCT01126944|resynchronization|resynchronization
572624|NCT01126944|left ventricular assist device|left ventricular assist device
572625|NCT01126931|Crohn disease|crohn disease
572626|NCT01126931|Involuntary weight loss in cancer|involuntary weight loss in cancer
572627|NCT01126931|IgA nephropathy|iga nephropathy
572628|NCT01126931|Depression with reduced appetite|depression with reduced appetite
572629|NCT01126918|Eating Disorders|eating disorders
572630|NCT01126918|Obesity|obesity
572631|NCT01126918|Body Dissatisfaction|body dissatisfaction
572632|NCT01126918|Female|female
572633|NCT01126905|Reticulated Haemoglobin Equivalent|reticulated haemoglobin equivalent
572634|NCT01126905|Functional Iron Deficiency|functional iron deficiency
572635|NCT01126905|Response to therapy|response to therapy
572636|NCT01126905|Iron deficiency|iron deficiency
572637|NCT01126892|Advanced Disease,|advanced disease,
572638|NCT01126892|Resistance,|resistance,
572639|NCT01126892|Intolerance|intolerance
572640|NCT01126866|advanced colorectal carcinoma|advanced colorectal carcinoma
572641|NCT01126866|CRC|crc
572642|NCT01126866|UICC Stages IV|uicc stages iv
572643|NCT01126866|liver and/or lung only metastases|liver and/or lung only metastases
572644|NCT01126853|Immunization|immunization
572645|NCT01126853|Immunity|immunity
572646|NCT01126853|Prevention|prevention
572647|NCT01126840|Lynch Syndrome|lynch syndrome
572648|NCT01126840|Families|families
572649|NCT01126840|Quality of life|quality of life
572650|NCT01126840|QOL|qol
572651|NCT01126840|First-degree relatives|first-degree relatives
572652|NCT01126840|Questionnaire|questionnaire
572653|NCT01126840|Interview|interview
572654|NCT01126827|Bipolar Disorder|bipolar disorder
572655|NCT01126827|Mood Disorders|mood disorders
572656|NCT01126827|Residual Symptoms|residual symptoms
572657|NCT01126827|Depression|depression
572658|NCT01126827|Mania|mania
572659|NCT01126827|Hypomania|hypomania
572660|NCT01126827|Bipolar|bipolar
572661|NCT01126827|Bipolar I|bipolar i
572662|NCT01126827|Bipolar II|bipolar ii
572663|NCT01126814|Gleevec|gleevec
572664|NCT01126814|c-kit|c-kit
572665|NCT01126814|aml|aml
572666|NCT01126775|Systematic prevention, stroke, vascular dementia, silent strokes, cerebral microangiopathy.|systematic prevention, stroke, vascular dementia, silent strokes, cerebral microangiopathy.
572667|NCT01126762|Docosahexaenoic acid|docosahexaenoic acid
572668|NCT01126762|fish|fish
572669|NCT01126762|pregnancy|pregnancy
572670|NCT01126762|methylmercury|methylmercury
572671|NCT01126762|n-3 polyunsaturated fatty acid|n-3 polyunsaturated fatty acid
572672|NCT01126749|Locally Advanced or Metastatic Bladder Cancer, including other transitional cell cancers of the urothelium (prostate, urethra, ureter, and renal pelvis)|locally advanced or metastatic bladder cancer, including other transitional cell cancers of the urothelium (prostate, urethra, ureter, and renal pelvis)
572673|NCT01126736|neoplams|neoplams
572674|NCT01126736|lung neoplasms|lung neoplasms
572675|NCT01126736|Stage IIIB|stage iiib
572676|NCT01126736|IV Nonsquamous Non Small Cell Lung Cancer|iv nonsquamous non small cell lung cancer
572677|NCT01126710|infiltration|infiltration
572678|NCT01126710|extravasation|extravasation
572679|NCT01126710|optical monitoring|optical monitoring
572680|NCT01126697|Cardiac|cardiac
572681|NCT01126697|Muscular Dystrophy|muscular dystrophy
572682|NCT01126697|Randomized|randomized
572683|NCT01126684|essential hypertension|essential hypertension
572684|NCT01126671|vitamin D|vitamin d
572685|NCT01126658|pressure-volume curve|pressure-volume curve
572686|NCT01126658|intracranial pressure|intracranial pressure
572687|NCT01126658|volume pressure response|volume pressure response
572688|NCT01126658|pressure-volume relationship|pressure-volume relationship
572689|NCT01126658|mathematical model|mathematical model
572690|NCT01126645|Liver|liver
572691|NCT01126645|HCC|hcc
572692|NCT01126632|Colonoscopy|colonoscopy
572693|NCT01126619|Psoriasis|psoriasis
572694|NCT01126567|Phase 1 Clinical Trials, Cerebrospinal Fluid, Biomarker|phase 1 clinical trials, cerebrospinal fluid, biomarker
572695|NCT01126554|Prognostic value|prognostic value
572696|NCT01126528|Vitamin D|vitamin d
572697|NCT01126528|cholecalciferol|cholecalciferol
572698|NCT01126528|Micronutrients|micronutrients
572699|NCT01126528|Developing countries|developing countries
572700|NCT01126528|Bangladesh|bangladesh
572701|NCT01126528|Infant, Newborn|infant, newborn
572702|NCT01126528|Reproductive Health|reproductive health
572703|NCT01126528|Infant, Newborn, Diseases|infant, newborn, diseases
572704|NCT01126528|Perinatology|perinatology
572705|NCT01126528|Immunology|immunology
572706|NCT01126528|cathelicidin|cathelicidin
572707|NCT01126528|Maternal Nutrition Physiology|maternal nutrition physiology
572708|NCT01126515|brain injury|brain injury
572709|NCT01126515|sequelae|sequelae
572710|NCT01126515|stroke|stroke
572711|NCT01126515|anoxia|anoxia
572712|NCT01126515|trauma|trauma
572713|NCT01126476|Adults with non-CNS recurrent tumors who have been previously irradiated|adults with non-cns recurrent tumors who have been previously irradiated
572714|NCT01126476|and have a tumor recurrence in or near prior radiation fields|and have a tumor recurrence in or near prior radiation fields
572715|NCT01126463|Hepatocellular carcinomas|hepatocellular carcinomas
572716|NCT01126463|lipiodol|lipiodol
572717|NCT01126463|rhenium|rhenium
572718|NCT01126463|Non operable Hepatocellular carcinomas|non operable hepatocellular carcinomas
572719|NCT01126450|recurrent colon cancer|recurrent colon cancer
572720|NCT01126450|recurrent rectal cancer|recurrent rectal cancer
572721|NCT01126424|Anti-muscarinics|anti-muscarinics
572722|NCT01126424|Anti-cholinergics|anti-cholinergics
572723|NCT01126424|Cognition|cognition
572724|NCT01126424|Solifenacin|solifenacin
572725|NCT01126411|pulmonary hypertension|pulmonary hypertension
572726|NCT01126411|autoantibodies|autoantibodies
572727|NCT01126411|immunoadsorption|immunoadsorption
572728|NCT01126411|immunoglobulin substitution|immunoglobulin substitution
572729|NCT01126411|right ventricular function|right ventricular function
572730|NCT01126385|Spinal Diseases|spinal diseases
572731|NCT01126385|Bone strength|bone strength
572732|NCT01126385|Transpedicular fixation|transpedicular fixation
572733|NCT01126385|Dorsal instrumentation|dorsal instrumentation
572734|NCT01126385|DensiProbe|densiprobe
572735|NCT01126372|Prostaglandin-dependent Congenital Heart Disease|prostaglandin-dependent congenital heart disease
572736|NCT01126372|Prematurity|prematurity
572737|NCT01126372|Feeding intolerances|feeding intolerances
572738|NCT01126372|Necrotizing Enterocolitis|necrotizing enterocolitis
572739|NCT01126372|Regional Oxygen Saturation|regional oxygen saturation
572740|NCT01126372|Near Infrared Spectroscopy|near infrared spectroscopy
572741|NCT01126372|Somanetics INVOS Oxyalert|somanetics invos oxyalert
572742|NCT01126359|Wound Vacuum Assisted Dressings|wound vacuum assisted dressings
572743|NCT01126359|Lidocaine|lidocaine
572744|NCT01126359|Dressing change|dressing change
572745|NCT01126359|Pain management|pain management
572746|NCT01126359|palliative care|palliative care
572747|NCT01126333|Nephrotoxicity, Kidney Transplantation, Graft Survival|nephrotoxicity, kidney transplantation, graft survival
572748|NCT01126333|Kidney transplant survival.|kidney transplant survival.
572749|NCT01126320|VAP|vap
572750|NCT01126307|refractory epilepsy- greater than 4 seizures in 2 month baseline period|refractory epilepsy- greater than 4 seizures in 2 month baseline period
572751|NCT01126294|lumbar laminectomy, melatonin, perioperative, pain, anxiety, analgesia, VAS score|lumbar laminectomy, melatonin, perioperative, pain, anxiety, analgesia, vas score
572752|NCT01126268|Eczema|eczema
572753|NCT01126268|Atopic dermatitis|atopic dermatitis
572754|NCT01126268|Infection|infection
572755|NCT01126268|Impetigo|impetigo
572756|NCT01126268|Folliculitis|folliculitis
572757|NCT01126255|vulvar lichen sclerosus|vulvar lichen sclerosus
572758|NCT01126255|progesterone|progesterone
572759|NCT01126255|clobetasol|clobetasol
572760|NCT01126255|randomized controlled trial|randomized controlled trial
572761|NCT01126242|Ankle|ankle
572762|NCT01126242|ligament injuries|ligament injuries
572763|NCT01126242|non-surgical treatment|non-surgical treatment
572764|NCT01126242|tape|tape
572765|NCT01126242|brace|brace
572766|NCT01126242|orthotic device|orthotic device
572767|NCT01126242|bandage|bandage
572768|NCT01126242|cost-effectiveness|cost-effectiveness
572769|NCT01126242|randomized trial|randomized trial
572770|NCT01126229|Resveratrol|resveratrol
572771|NCT01126229|Grape|grape
572772|NCT01126229|Aging|aging
572773|NCT01126229|functional MRI (fMRI)|functional mri (fmri)
572774|NCT01126229|Anti-Aging therapeutic|anti-aging therapeutic
572775|NCT01126229|Oxidative Stress|oxidative stress
572776|NCT01126229|Functional Performance|functional performance
572777|NCT01126216|Radiochemotherapy|radiochemotherapy
572778|NCT01126216|head and neck cancer|head and neck cancer
572779|NCT01126216|Paclitaxel|paclitaxel
572780|NCT01126216|Cisplatin|cisplatin
572781|NCT01126216|5-FU|5-fu
572782|NCT01126203|Pseudoexfoliation|pseudoexfoliation
572783|NCT01126203|Glaucoma|glaucoma
573082|NCT01124812|L19|l19
572784|NCT01126203|Ocular Hypertension|ocular hypertension
572785|NCT01126203|SLT|slt
572786|NCT01126203|Selective Laser Trabeculoplasy (SLT)|selective laser trabeculoplasy (slt)
572787|NCT01126203|Argon Laser Trabeculoplasty (ALT)|argon laser trabeculoplasty (alt)
572788|NCT01126177|asthma|asthma
572789|NCT01126164|parents|parents
572790|NCT01126164|peer|peer
572791|NCT01126164|basics|basics
572792|NCT01126164|college student drinking|college student drinking
572793|NCT01126151|drinking|drinking
572794|NCT01126151|alcohol consequences|alcohol consequences
572795|NCT01126138|unresectable|unresectable
572796|NCT01126138|locally advanced|locally advanced
572797|NCT01126138|metastatic|metastatic
572798|NCT01126138|breast cancer|breast cancer
572799|NCT01126125|iodine|iodine
572800|NCT01126125|infant|infant
572801|NCT01126125|breastfeeding|breastfeeding
572802|NCT01126125|deficiency|deficiency
572803|NCT01126112|advanced colorectal cancer; K-RAS; panitumumab|advanced colorectal cancer; k-ras; panitumumab
572804|NCT01126112|advanced Wild Type K-RAS colorectal cancer|advanced wild type k-ras colorectal cancer
572805|NCT01126099|double-blind|double-blind
572806|NCT01126099|treatment|treatment
572807|NCT01126099|prazosin|prazosin
572808|NCT01126099|Disruptive behaviors in Alzheimer's Disease|disruptive behaviors in alzheimer's disease
572809|NCT01126073|niacin/laropiprant|niacin/laropiprant
572810|NCT01126073|endothelial function|endothelial function
572811|NCT01126060|Neck dissection|neck dissection
572812|NCT01126047|Lung Diseases|lung diseases
572813|NCT01126034|Metoclopramide|metoclopramide
572814|NCT01126034|Randomized Controlled Trial|randomized controlled trial
572815|NCT01126021|Senior citizens|senior citizens
572816|NCT01126021|mental acuity|mental acuity
572817|NCT01126021|memory|memory
572818|NCT01126008|locally advanced Squamous cell carcinoma|locally advanced squamous cell carcinoma
572819|NCT01125995|limited disease|limited disease
572820|NCT01125969|diabetes|diabetes
572821|NCT01125969|glucose|glucose
572822|NCT01125969|peer mentor|peer mentor
572823|NCT01125969|incentives|incentives
572824|NCT01125969|behavioral economics|behavioral economics
572825|NCT01125969|cost-effectiveness|cost-effectiveness
572826|NCT01125956|Diabetes|diabetes
572827|NCT01125956|Diabetes mellitus|diabetes mellitus
572828|NCT01125956|HbA1c|hba1c
572829|NCT01125930|rosacea|rosacea
572830|NCT01125930|tretinoin|tretinoin
572831|NCT01125930|atralin|atralin
572832|NCT01125917|Low back pain|low back pain
572833|NCT01125917|Opioid|opioid
572834|NCT01125917|Transdermal|transdermal
572835|NCT01125904|Crizotinib|crizotinib
572836|NCT01125891|gemcitabine hydrochloride|gemcitabine hydrochloride
572837|NCT01125891|Gemzar|gemzar
572838|NCT01125891|ON 01910.Na|on 01910.na
572839|NCT01125878|satiety|satiety
572840|NCT01125878|appetite|appetite
572841|NCT01125878|fiber|fiber
572842|NCT01125878|starch|starch
572843|NCT01125878|nutrition|nutrition
572844|NCT01125865|Malignant hilar stricture|malignant hilar stricture
572845|NCT01125852|Peptic ulcer hemorrhage|peptic ulcer hemorrhage
572846|NCT01125852|Peptic ulcer bleeding|peptic ulcer bleeding
572847|NCT01125852|Angiographic embolization|angiographic embolization
572848|NCT01125852|Arterial embolization|arterial embolization
572849|NCT01125852|Angiography|angiography
572850|NCT01125839|osteomyelitis|osteomyelitis
572851|NCT01125839|16S rRNA|16s rrna
572852|NCT01125839|spine|spine
572853|NCT01125839|Magnetic resonance imaging|magnetic resonance imaging
572854|NCT01125800|Recurrent,|recurrent,
572855|NCT01125800|refractory,|refractory,
572856|NCT01125800|medulloblastoma,|medulloblastoma,
572857|NCT01125800|rhabdomyosarcoma,|rhabdomyosarcoma,
572858|NCT01125800|neuroblastoma,|neuroblastoma,
572859|NCT01125800|hepatoblastoma,|hepatoblastoma,
572860|NCT01125800|astrocytoma,|astrocytoma,
572861|NCT01125800|children,|children,
572862|NCT01125800|pediatric,|pediatric,
572863|NCT01125800|hedgehog pathway inhibitor, adult|hedgehog pathway inhibitor, adult
572864|NCT01125787|CLL|cll
572865|NCT01125787|bendamustine|bendamustine
572866|NCT01125787|ofatumumab|ofatumumab
572867|NCT01125787|blood cancer|blood cancer
572868|NCT01125787|leukemia|leukemia
572869|NCT01125787|lymphocyte|lymphocyte
572870|NCT01125787|hematology|hematology
572871|NCT01125787|non-Hodgkin lymphoma|non-hodgkin lymphoma
572872|NCT01125787|small lymphocytic lymphoma|small lymphocytic lymphoma
572873|NCT01125787|nevada cancer institute|nevada cancer institute
572874|NCT01125787|cephalon|cephalon
572875|NCT01125787|Glaxosmithkline|glaxosmithkline
572876|NCT01125774|Menstrually related migraine|menstrually related migraine
572877|NCT01125774|migraine|migraine
572878|NCT01125774|Premenstrual migraine|premenstrual migraine
572879|NCT01125761|Allergic dermatitis|allergic dermatitis
572880|NCT01125722|Urinary Incontinence|urinary incontinence
572881|NCT01125722|Overactive Bladder|overactive bladder
572882|NCT01125722|Frequency|frequency
572883|NCT01125722|Urgency|urgency
572884|NCT01125709|Neuromuscular disease|neuromuscular disease
572885|NCT01125709|Duchenne|duchenne
572886|NCT01125709|Muscular Dystrophy|muscular dystrophy
572887|NCT01125709|DMD|dmd
572888|NCT01125709|Strength assessment|strength assessment
572889|NCT01125709|CINRG Quantitative Measurement System|cinrg quantitative measurement system
572890|NCT01125709|CQMS|cqms
572891|NCT01125709|Hand Held Myometry|hand held myometry
572892|NCT01125709|HHM|hhm
572893|NCT01125696|mother-to-child transmission|mother-to-child transmission
572894|NCT01125696|HIV|hiv
572895|NCT01125696|Hepatitis B|hepatitis b
572896|NCT01125696|Pregnant women|pregnant women
572897|NCT01125696|Tenofovir|tenofovir
572898|NCT01125696|Infants|infants
572899|NCT01125683|Phase II|phase ii
572900|NCT01125683|Alzheimer's disease|alzheimer's disease
572901|NCT01125683|EEG|eeg
572902|NCT01125683|cognition|cognition
572903|NCT01125683|pharmacodynamic|pharmacodynamic
572904|NCT01125670|YM150|ym150
572905|NCT01125670|Food effect|food effect
572906|NCT01125657|YM150|ym150
572907|NCT01125657|bioequivalence study|bioequivalence study
572908|NCT01125644|necrotic pulmonary infections|necrotic pulmonary infections
572909|NCT01125631|Alzheimer's disease|alzheimer's disease
572910|NCT01125631|amyloid|amyloid
572911|NCT01125631|antibody|antibody
572912|NCT01125631|Japanese|japanese
572913|NCT01125618|child mortality|child mortality
572914|NCT01125618|intervention|intervention
572915|NCT01125618|Poverty|poverty
572916|NCT01125618|Africa|africa
572917|NCT01125618|Millennium Development Goal|millennium development goal
572918|NCT01125618|Millennium Development Goals|millennium development goals
572919|NCT01125605|PASCONAL|pasconal
572920|NCT01125605|nervousness|nervousness
572921|NCT01125605|nervosity|nervosity
572922|NCT01125605|sleep disorder|sleep disorder
572923|NCT01125592|assess the ability of the IonCleanse machine to remove heavy metals through the feet|assess the ability of the ioncleanse machine to remove heavy metals through the feet
572924|NCT01125579|nervousness|nervousness
572925|NCT01125579|restlessness|restlessness
572926|NCT01125579|depression|depression
572927|NCT01125579|affective disorder|affective disorder
572928|NCT01125540|Allergic conjunctivitis|allergic conjunctivitis
572929|NCT01125527|Haemophilus influenzae type b (Hib)|haemophilus influenzae type b (hib)
572930|NCT01125527|Vaccine|vaccine
572931|NCT01125527|Anti PRP antibody|anti prp antibody
572932|NCT01125514|Heart failure,|heart failure,
572933|NCT01125514|aliskiren,|aliskiren,
572934|NCT01125514|furosemide,|furosemide,
572935|NCT01125514|diuretic efficacy,|diuretic efficacy,
572936|NCT01125514|interaction|interaction
572937|NCT01125488|Maintenance therapy|maintenance therapy
572938|NCT01125488|LNG-IUS|lng-ius
572939|NCT01125488|recurrence,endometriosis|recurrence,endometriosis
572940|NCT01125488|Recurrence|recurrence
572941|NCT01125475|Relapsing Remitting Multiple Sclerosis|relapsing remitting multiple sclerosis
572942|NCT01125475|RebiSmart|rebismart
572943|NCT01125475|Rebif|rebif
572944|NCT01125475|Adherence|adherence
572945|NCT01125462|Ovulation Induction|ovulation induction
572946|NCT01125462|Infertility|infertility
572947|NCT01125462|Gonal-f|gonal-f
572948|NCT01125462|FertiQoL|fertiqol
572949|NCT01125462|Quality of Life|quality of life
572950|NCT01125449|ascorbic acid|ascorbic acid
572951|NCT01125449|vitamin C|vitamin c
572952|NCT01125449|antioxidants|antioxidants
572953|NCT01125449|vitamins|vitamins
572954|NCT01125423|Female|female
572955|NCT01125423|age 18 to 70|age 18 to 70
572956|NCT01125410|Fluomizin|fluomizin
572957|NCT01125410|Dequalinium chloride|dequalinium chloride
572958|NCT01125410|Bacterial vaginosis|bacterial vaginosis
572959|NCT01125410|vaginal therapy|vaginal therapy
572960|NCT01125397|bariatric surgery|bariatric surgery
572961|NCT01125397|behavioral weight management|behavioral weight management
572962|NCT01125397|psychosocial outcomes following bariatric surgery|psychosocial outcomes following bariatric surgery
572963|NCT01125371|Hazardous alcohol use|hazardous alcohol use
572964|NCT01125371|Binge drinking|binge drinking
572965|NCT01125371|High risk sexual behaviors|high risk sexual behaviors
572966|NCT01125371|HIV risk reduction|hiv risk reduction
572967|NCT01125345|hydrophobic acrylic|hydrophobic acrylic
572968|NCT01125345|PCO|pco
572969|NCT01125345|posterior capsule opacification|posterior capsule opacification
572970|NCT01125345|hydrophilic acrylic IO|hydrophilic acrylic io
572971|NCT01125306|Drug consumption|drug consumption
572972|NCT01125306|The Xal-Ease device|the xal-ease device
572973|NCT01125306|Patient's compliance|patient's compliance
572974|NCT01125306|Using a novel Pfizer-Pharmacia device to facilitate the Xalatan/Xalacom instillation and to avoid loss of eye drops|using a novel pfizer-pharmacia device to facilitate the xalatan/xalacom instillation and to avoid loss of eye drops
572975|NCT01125293|everolimus|everolimus
572976|NCT01125293|rituximab|rituximab
572977|NCT01125293|bortezomib|bortezomib
572978|NCT01125293|RAD001|rad001
572979|NCT01125293|Rituxan|rituxan
572980|NCT01125293|Velcade|velcade
572981|NCT01125280|Small bowel occlusion|small bowel occlusion
572982|NCT01125280|Conservative treatment for small bowel occlusion|conservative treatment for small bowel occlusion
572983|NCT01125280|Surgical treatment for small bowel occlusion|surgical treatment for small bowel occlusion
572984|NCT01125280|Small bowel resection|small bowel resection
572985|NCT01125280|Score of severity of small bowel occlusion|score of severity of small bowel occlusion
572986|NCT01125267|medication adherence|medication adherence
572987|NCT01125267|schizophrenia|schizophrenia
572988|NCT01125267|Mexican American|mexican american
572989|NCT01125267|multifamily groups|multifamily groups
572990|NCT01125254|thalassemia major|thalassemia major
572991|NCT01125254|calcium channel blockade|calcium channel blockade
572992|NCT01125254|magnetic resonance imaging|magnetic resonance imaging
572993|NCT01125241|wuling capsule|wuling capsule
572994|NCT01125241|epilepsy|epilepsy
572995|NCT01125241|depression|depression
572996|NCT01125241|superiority clinical research|superiority clinical research
572997|NCT01125228|HIV|hiv
572998|NCT01125215|Painful diabetic neuropathy|painful diabetic neuropathy
572999|NCT01125215|Capsaicin|capsaicin
573000|NCT01125215|Nanoparticle|nanoparticle
573001|NCT01125215|Quantitative Sensory Testing|quantitative sensory testing
573002|NCT01125202|Intervention studies|intervention studies
573003|NCT01125202|Computers, handheld|computers, handheld
573004|NCT01125202|Randomized controlled trial|randomized controlled trial
573005|NCT01125202|Sodium, dietary|sodium, dietary
573006|NCT01125176|CLL|cll
573007|NCT01125163|very low birth weight infants|very low birth weight infants
573008|NCT01125163|anemia|anemia
573009|NCT01125163|iron supplementation|iron supplementation
573010|NCT01125150|diffuse reflectance spectroscopy|diffuse reflectance spectroscopy
573011|NCT01125137|Keloid|keloid
573012|NCT01125137|MMP|mmp
573013|NCT01125137|Matrix metalloproteinase|matrix metalloproteinase
573014|NCT01125137|dermatology|dermatology
573015|NCT01125124|Pleurodesis|pleurodesis
573016|NCT01125124|Malignant pleural effusion|malignant pleural effusion
573017|NCT01125124|Silver Nitrate|silver nitrate
573018|NCT01125124|Pain|pain
573019|NCT01125098|COPD|copd
573020|NCT01125098|PRO-CT|pro-ct
573021|NCT01125098|antibiotics|antibiotics
573022|NCT01125085|I131|i131
573023|NCT01125085|L19|l19
573024|NCT01125085|antibody|antibody
573025|NCT01125085|monoclonal|monoclonal
573026|NCT01125085|multiple brain metastasis|multiple brain metastasis
573027|NCT01125085|tumor targeting|tumor targeting
573028|NCT01125085|radioimmunotherapy|radioimmunotherapy
573029|NCT01125085|Patients with brain metastases of solid tumors (>1), who are not amenable for surgical excision or stereotactic radiosurgery.|patients with brain metastases of solid tumors (>1), who are not amenable for surgical excision or stereotactic radiosurgery.
573030|NCT01125072|chest pain|chest pain
573031|NCT01125072|echocardiography|echocardiography
573032|NCT01125072|strain imaging|strain imaging
573033|NCT01125059|hydromorphone|hydromorphone
573034|NCT01125059|lumbar posterior spinal fusion|lumbar posterior spinal fusion
573035|NCT01125059|lumbosacral spondylosis|lumbosacral spondylosis
573036|NCT01125059|Spinal Fusion|spinal fusion
573037|NCT01125033|Dialysis, Restless legs syndrome, Ascorbic acid, Vitamin E|dialysis, restless legs syndrome, ascorbic acid, vitamin e
573038|NCT01125007|Dental plaque|dental plaque
573039|NCT01125007|Gingival abrasion|gingival abrasion
573040|NCT01125007|toothbrushing|toothbrushing
573041|NCT01124994|Barrett's oesophagus|barrett's oesophagus
573042|NCT01124994|High grade intraepithelial neoplasia (HGIEN)|high grade intraepithelial neoplasia (hgien)
573043|NCT01124981|Fibrinogen concentrate|fibrinogen concentrate
573044|NCT01124981|Coagulopathy|coagulopathy
573045|NCT01124968|User-Computer Interface|user-computer interface
573046|NCT01124968|Office Visits|office visits
573047|NCT01124968|Primary Health Care|primary health care
573048|NCT01124968|Patient Satisfaction|patient satisfaction
573049|NCT01124968|Job Satisfaction|job satisfaction
573050|NCT01124968|Health Services Research|health services research
573051|NCT01124955|treatment|treatment
573052|NCT01124955|acupuncture|acupuncture
573053|NCT01124955|spine|spine
573054|NCT01124929|Intestinal tuberculosis|intestinal tuberculosis
573055|NCT01124929|Tuberculous peritonitis|tuberculous peritonitis
573056|NCT01124929|Abdominal tuberculosis|abdominal tuberculosis
573057|NCT01124916|incontinence|incontinence
573058|NCT01124916|prolapse|prolapse
573059|NCT01124916|Abdominal sacrocolpopexy|abdominal sacrocolpopexy
573060|NCT01124903|dehydration|dehydration
573061|NCT01124903|hypohydration|hypohydration
573062|NCT01124903|diagnostic accuracy|diagnostic accuracy
573063|NCT01124903|biological variation|biological variation
573064|NCT01124903|hydration assessment|hydration assessment
573065|NCT01124903|body mass|body mass
573066|NCT01124903|osmolality|osmolality
573067|NCT01124903|plasma|plasma
573068|NCT01124903|saliva|saliva
573069|NCT01124903|urine|urine
573070|NCT01124890|acute myocardial infarction|acute myocardial infarction
573071|NCT01124890|thrombolysis|thrombolysis
573072|NCT01124890|percutaneous coronary interention|percutaneous coronary interention
573073|NCT01124877|Children and Adolescents with Bipolar I Disorder (manic or mixed)|children and adolescents with bipolar i disorder (manic or mixed)
573074|NCT01124864|Non-small-cell lung cancer|non-small-cell lung cancer
573075|NCT01124864|HSP90|hsp90
573076|NCT01124864|2nd to 3rd line treatment|2nd to 3rd line treatment
573077|NCT01124851|Sleep disorder|sleep disorder
573078|NCT01124838|Uveitis|uveitis
573079|NCT01124825|Anesthesia induction and maintenance|anesthesia induction and maintenance
573080|NCT01124825|Surgery|surgery
573081|NCT01124812|I131|i131
573083|NCT01124812|antibody|antibody
573084|NCT01124812|monoclonal|monoclonal
573085|NCT01124812|NSCLC|nsclc
573086|NCT01124812|lung|lung
573087|NCT01124812|tumor targeting|tumor targeting
573088|NCT01124812|radioimmunotherapy|radioimmunotherapy
573089|NCT01124812|Patients with newly diagnosed inoperable, locally-advanced (stage III) NSCLC|patients with newly diagnosed inoperable, locally-advanced (stage iii) nsclc
573090|NCT01124799|Hepatitis C virus|hepatitis c virus
573091|NCT01124799|TMC435-TiDP16-C125|tmc435-tidp16-c125
573092|NCT01124799|TMC435-C125|tmc435-c125
573093|NCT01124799|TMC435|tmc435
573094|NCT01124799|TMC435350|tmc435350
573095|NCT01124799|protease inhibitor|protease inhibitor
573096|NCT01124799|HCV|hcv
573097|NCT01124799|Hepatitis C|hepatitis c
573098|NCT01124799|photosensitivity|photosensitivity
573099|NCT01124799|phototoxicity|phototoxicity
573100|NCT01124786|cancer|cancer
573101|NCT01124786|metastatic|metastatic
573102|NCT01124786|pancreatic|pancreatic
573103|NCT01124786|pancreas|pancreas
573104|NCT01124786|adenocarcinoma|adenocarcinoma
573105|NCT01124786|gemcitabine|gemcitabine
573106|NCT01124786|human equilibrative nucleoside transporter-1 (hENT1)|human equilibrative nucleoside transporter-1 (hent1)
573107|NCT01124786|CO-1.01|co-1.01
573108|NCT01124786|CO-101|co-101
573109|NCT01124786|CO101|co101
573110|NCT01124786|Stage 4|stage 4
573111|NCT01124786|Stage IV|stage iv
573112|NCT01124773|cognition|cognition
573113|NCT01124773|memory|memory
573114|NCT01124773|hormone therapy|hormone therapy
573115|NCT01124760|open label|open label
573116|NCT01124760|2-consecutive-group|2-consecutive-group
573117|NCT01124760|2-period|2-period
573118|NCT01124760|1-sequence crossover study|1-sequence crossover study
573119|NCT01124747|ASP1585|asp1585
573120|NCT01124747|Healthy Volunteers|healthy volunteers
573121|NCT01124734|Metastatic melanoma|metastatic melanoma
573122|NCT01124721|Cognitive training|cognitive training
573123|NCT01124708|ADHD|adhd
573124|NCT01124708|Attention Deficit Hyperactive Disorder|attention deficit hyperactive disorder
573125|NCT01124695|estrogen receptor-positive breast cancer|estrogen receptor-positive breast cancer
573126|NCT01124695|male breast cancer|male breast cancer
573127|NCT01124695|progesterone receptor-positive breast cancer|progesterone receptor-positive breast cancer
573128|NCT01124695|recurrent breast cancer|recurrent breast cancer
573129|NCT01124695|stage IV breast cancer|stage iv breast cancer
573130|NCT01124682|adenocarcinoma of the bladder|adenocarcinoma of the bladder
573131|NCT01124682|squamous cell carcinoma of the bladder|squamous cell carcinoma of the bladder
573132|NCT01124682|transitional cell carcinoma of the bladder|transitional cell carcinoma of the bladder
573133|NCT01124682|recurrent bladder cancer|recurrent bladder cancer
573134|NCT01124682|stage II bladder cancer|stage ii bladder cancer
573135|NCT01124682|stage III bladder cancer|stage iii bladder cancer
573136|NCT01124682|stage IV bladder cancer|stage iv bladder cancer
573137|NCT01124669|recurrent non-small cell lung cancer|recurrent non-small cell lung cancer
573138|NCT01124669|stage IIIB non-small cell lung cancer|stage iiib non-small cell lung cancer
573139|NCT01124669|stage IV non-small cell lung cancer|stage iv non-small cell lung cancer
573140|NCT01124656|angiotensin II receptor blocker|angiotensin ii receptor blocker
573141|NCT01124656|thiazolidinediones|thiazolidinediones
573142|NCT01124656|combination|combination
573143|NCT01124656|Actos|actos
573144|NCT01124656|HbA1c|hba1c
573145|NCT01124656|Type 2 diabetes|type 2 diabetes
573146|NCT01124656|Drug Therapy|drug therapy
573147|NCT01124656|Hypertension|hypertension
573148|NCT01124643|Agalsidase alfa|agalsidase alfa
573149|NCT01124643|Alpha-Galactosidase|alpha-galactosidase
573150|NCT01124643|Replagal|replagal
573151|NCT01124643|Enzyme Replacement Therapy|enzyme replacement therapy
573152|NCT01124617|Chronic pain|chronic pain
573153|NCT01124617|Diabetic Neuropathic Pain|diabetic neuropathic pain
573154|NCT01124617|Neuralgia, Postherpetic|neuralgia, postherpetic
573155|NCT01124617|Tapentadol hydrochloride extended-release|tapentadol hydrochloride extended-release
573156|NCT01124617|JNS024ER|jns024er
573157|NCT01124617|Placebo|placebo
573158|NCT01124604|Pain|pain
573159|NCT01124604|Low Back Pain|low back pain
573160|NCT01124604|Back Pain|back pain
573161|NCT01124604|Osteoarthritis, Knee|osteoarthritis, knee
573162|NCT01124604|Tapentadol|tapentadol
573163|NCT01124604|Tapentadol Hydrochloride Extended Release|tapentadol hydrochloride extended release
573164|NCT01124578|Ventilators, Mechanical|ventilators, mechanical
573165|NCT01124565|Lateral Canthal Lines|lateral canthal lines
573166|NCT01124565|Crow's Feet|crow's feet
573167|NCT01124565|Facial Wrinkles|facial wrinkles
573168|NCT01124552|Lateral Canthal Lines|lateral canthal lines
573169|NCT01124552|Crow's Feet Wrinkles|crow's feet wrinkles
573170|NCT01124552|Facial Wrinkles|facial wrinkles
573171|NCT01124539|Adult Patients|adult patients
573172|NCT01124539|Recurrence of Glioblastoma Multiforme|recurrence of glioblastoma multiforme
573173|NCT01124539|Recurrence of GBM|recurrence of gbm
573174|NCT01124539|Gliosarcoma|gliosarcoma
573175|NCT01124526|R F C treatment in patients with Non Hodgkin Lymphoma|r f c treatment in patients with non hodgkin lymphoma
573176|NCT01124513|Melanin Index|melanin index
573177|NCT01124513|Fitzpatrick Skin Phototype|fitzpatrick skin phototype
573178|NCT01124513|Videodermoscopy|videodermoscopy
573179|NCT01124513|Spectrophotometry|spectrophotometry
573180|NCT01124500|methylphenidate|methylphenidate
573181|NCT01124500|transdermal patch|transdermal patch
573182|NCT01124500|placebo|placebo
573183|NCT01124500|fatigue|fatigue
573184|NCT01124500|10-020|10-020
573185|NCT01124487|fat|fat
573186|NCT01124487|inflammation|inflammation
573187|NCT01124487|lipids|lipids
573188|NCT01124487|total cholesterol|total cholesterol
573189|NCT01124487|Triglycerides|triglycerides
573190|NCT01124487|insulin sensitivity|insulin sensitivity
573191|NCT01124461|Malignant Brain Tumors|malignant brain tumors
573192|NCT01124461|Cancer of the Brain|cancer of the brain
573193|NCT01124435|Carboplatin plus Celecoxib|carboplatin plus celecoxib
573194|NCT01124435|Pre-treated Recurrent Ovarian Cancer Patients|pre-treated recurrent ovarian cancer patients
573195|NCT01124435|The antitumor activity and potential adverse effects|the antitumor activity and potential adverse effects
573196|NCT01124435|tumor response rate|tumor response rate
573197|NCT01124435|toxicity|toxicity
573198|NCT01124435|progression free survival|progression free survival
573199|NCT01124435|duration of response|duration of response
573200|NCT01124435|quality of life|quality of life
573201|NCT01124422|endurance shuttle walk test|endurance shuttle walk test
573202|NCT01124422|chronic obstructive pulmonary disease|chronic obstructive pulmonary disease
573203|NCT01124422|fluticasone propionate|fluticasone propionate
573204|NCT01124422|dyspnea|dyspnea
573205|NCT01124422|exercise endurance time|exercise endurance time
573206|NCT01124422|tiotropium|tiotropium
573207|NCT01124422|salmeterol|salmeterol
573208|NCT01124422|exercise inspiratory capacity|exercise inspiratory capacity
573209|NCT01124422|quality of life|quality of life
573210|NCT01124409|IGRT|igrt
573211|NCT01124409|3DCRT|3dcrt
573212|NCT01124409|EPID|epid
573213|NCT01124409|CBCT|cbct
573214|NCT01124409|HNSCC|hnscc
573215|NCT01124383|Glycine absorption|glycine absorption
573216|NCT01124383|Operative hysteroscopy|operative hysteroscopy
573217|NCT01124383|Endometrial resection|endometrial resection
573218|NCT01124383|General anesthesia|general anesthesia
573219|NCT01124383|Local anesthesia|local anesthesia
573220|NCT01124370|Sleep Disordered Breathing|sleep disordered breathing
573221|NCT01124370|Cheyne Stokes Respiration|cheyne stokes respiration
573222|NCT01124370|Periodic Breathing|periodic breathing
573223|NCT01124370|Sleep Apnea|sleep apnea
573224|NCT01124370|Central Sleep Apnea|central sleep apnea
573225|NCT01124357|Heavy menstrual bleeding|heavy menstrual bleeding
573226|NCT01124357|menorrhagia|menorrhagia
573227|NCT01124357|ThermachoiceTM|thermachoicetm
573228|NCT01124357|NovaSureTM|novasuretm
573229|NCT01124357|Endometrail Ablation|endometrail ablation
573230|NCT01124331|prospective meta-analysis|prospective meta-analysis
573231|NCT01124331|preterm infant|preterm infant
573232|NCT01124331|pulse oximetry|pulse oximetry
573233|NCT01124331|oxygen saturation|oxygen saturation
573234|NCT01124318|Lactofiltrum|lactofiltrum
573235|NCT01124318|atopic dermatitis|atopic dermatitis
573236|NCT01124318|itching|itching
573237|NCT01124318|Dermatological Index of Life Quality|dermatological index of life quality
573238|NCT01124318|SCORAD|scorad
573239|NCT01124318|Behavioral Rating Scores|behavioral rating scores
573240|NCT01124305|Total Knee Arthroplasty|total knee arthroplasty
573241|NCT01124305|Instrumentation|instrumentation
573242|NCT01124292|Disability|disability
573243|NCT01124292|Quadriplegia|quadriplegia
573244|NCT01124292|Paralysis|paralysis
573245|NCT01124292|Assistive technology|assistive technology
573246|NCT01124292|Quality of life|quality of life
573247|NCT01124292|Computer access|computer access
573248|NCT01124292|Wheeled mobility|wheeled mobility
573249|NCT01124279|Amgen|amgen
573250|NCT01124279|Healthy|healthy
573251|NCT01124279|Adult|adult
573252|NCT01124266|polyp|polyp
573253|NCT01124266|adenoma|adenoma
573254|NCT01124266|screening|screening
573255|NCT01124266|colonoscopy|colonoscopy
573256|NCT01124266|diagnosis|diagnosis
573257|NCT01124253|adjuvant therapy|adjuvant therapy
573258|NCT01124253|non-small cell lung cancer|non-small cell lung cancer
573259|NCT01124253|vinorelbine|vinorelbine
573260|NCT01124253|cisplatin|cisplatin
573261|NCT01124253|recombinant human endostatin|recombinant human endostatin
573262|NCT01124253|endostar|endostar
573263|NCT01124240|Glioblastoma Multiforme|glioblastoma multiforme
573264|NCT01124227|Congestive Heart Failure|congestive heart failure
573265|NCT01124227|Peritoneal Dialysis|peritoneal dialysis
573266|NCT01124227|Symptomatic improvement|symptomatic improvement
573267|NCT01124227|Renal function|renal function
573268|NCT01124214|Barrett's|barrett's
573270|NCT01124214|esophageal cancer|esophageal cancer
573271|NCT01124214|esophageal dysplasia|esophageal dysplasia
728263|NCT00515554|PET|pet
573272|NCT01124201|low back pain|low back pain
573273|NCT01124201|clinical trial|clinical trial
573274|NCT01124201|stabilization|stabilization
573275|NCT01124201|muscle stretching exercises|muscle stretching exercises
573276|NCT01124201|exercise therapy|exercise therapy
573277|NCT01124188|Geriatric psychiatry|geriatric psychiatry
573278|NCT01124188|Aged|aged
573279|NCT01124188|Elderly|elderly
573280|NCT01124188|Venlafaxine|venlafaxine
573281|NCT01124188|Self efficacy|self efficacy
573282|NCT01124188|Pain|pain
573283|NCT01124188|Psychotherapy|psychotherapy
573284|NCT01124188|Effexor|effexor
573285|NCT01124175|Bioequivalence|bioequivalence
573286|NCT01124175|Healthy Subjects|healthy subjects
573287|NCT01124162|Bioequivalence|bioequivalence
573288|NCT01124162|Healthy Subjects|healthy subjects
573289|NCT01124136|Chronic Heart Failure|chronic heart failure
573290|NCT01124136|Neurostimulation|neurostimulation
573291|NCT01124123|Pharmacokinetics|pharmacokinetics
573292|NCT01124123|Oral bioavailability|oral bioavailability
573293|NCT01124123|absorption|absorption
573294|NCT01124123|AUC|auc
573295|NCT01124123|Bioequivalence|bioequivalence
573296|NCT01124123|Bioavailability study|bioavailability study
573297|NCT01124110|Operating Engineers|operating engineers
573298|NCT01124110|Smoking Cessation|smoking cessation
573299|NCT01124097|post herpetic neuralgia|post herpetic neuralgia
573300|NCT01124071|Korean Diet|korean diet
573301|NCT01124058|restarting warfarin|restarting warfarin
573302|NCT01124058|time to therapeutic INR|time to therapeutic inr
573303|NCT01124045|Pediatric|pediatric
573304|NCT01124045|Cataracts|cataracts
573305|NCT01124045|Inflammation|inflammation
573306|NCT01124045|Durezol|durezol
573307|NCT01124045|Pred Forte|pred forte
573308|NCT01124045|Difluprednate|difluprednate
573309|NCT01124045|Prednisolone|prednisolone
573310|NCT01124019|Women undergoing screening mammography will be chosen if they are between the ages of 40 and 65.|women undergoing screening mammography will be chosen if they are between the ages of 40 and 65.
573311|NCT01123993|Thai traditional music|thai traditional music
573312|NCT01123993|dementia|dementia
573313|NCT01123993|Cognitive function|cognitive function
573314|NCT01123993|behavioural problem|behavioural problem
573315|NCT01123993|sleep quality|sleep quality
573316|NCT01123993|psychological health|psychological health
573317|NCT01123993|quality of sleep|quality of sleep
573318|NCT01123967|nicotine replacement therapy|nicotine replacement therapy
573319|NCT01123967|smoking cessation|smoking cessation
573320|NCT01123967|tobacco dependent|tobacco dependent
573321|NCT01123954|Seasonal influenza|seasonal influenza
573322|NCT01123954|Vaccine|vaccine
573323|NCT01123941|Typhoid fever|typhoid fever
573324|NCT01123941|Glycoconjugate vaccine|glycoconjugate vaccine
573325|NCT01123941|Carrier protein|carrier protein
573326|NCT01123941|Immunogenicity|immunogenicity
573327|NCT01123928|cataract|cataract
573328|NCT01123928|counseling|counseling
573329|NCT01123928|surgical uptake|surgical uptake
573330|NCT01123928|follow-up|follow-up
573331|NCT01123915|HIV|hiv
573332|NCT01123915|Therapeutic|therapeutic
573333|NCT01123915|Immunotherapy|immunotherapy
573334|NCT01123915|Acquired Immunodeficiency Syndrome|acquired immunodeficiency syndrome
573335|NCT01123915|Virus Diseases|virus diseases
573336|NCT01123915|Lentivirus Infections|lentivirus infections
573337|NCT01123915|Human Immunodeficiency Virus|human immunodeficiency virus
573338|NCT01123902|Breathlessness|breathlessness
573339|NCT01123902|Dyspnea|dyspnea
573340|NCT01123902|Hand-held fan|hand-held fan
573341|NCT01123902|Palliative Care|palliative care
573342|NCT01123889|subacromial impingement|subacromial impingement
573343|NCT01123889|partial thickness rotator cuff|partial thickness rotator cuff
573344|NCT01123889|PRP|prp
573345|NCT01123889|platelet rich plasma|platelet rich plasma
573346|NCT01123876|Gastric Cancer|gastric cancer
573347|NCT01123863|Neuro cognitive deficits;|neuro cognitive deficits;
573348|NCT01123863|Brigance pre-school screen;|brigance pre-school screen;
573349|NCT01123850|CopiOs|copios
573350|NCT01123850|Degenerative spondylolisthesis,|degenerative spondylolisthesis,
573351|NCT01123850|stenosis with instability, or|stenosis with instability, or
573352|NCT01123850|degenerative disc disease as diagnosed by radicular signs and/or imaging studies|degenerative disc disease as diagnosed by radicular signs and/or imaging studies
573353|NCT01123824|healthy subjects|healthy subjects
573354|NCT01123811|adenocarcinoma|adenocarcinoma
573355|NCT01123811|gastric cancer|gastric cancer
573356|NCT01123811|esophagogastric junction cancer|esophagogastric junction cancer
573357|NCT01123798|near infrared spectroscopy|near infrared spectroscopy
573358|NCT01123798|lower extremity injury|lower extremity injury
573359|NCT01123785|glaucoma|glaucoma
573360|NCT01123785|ocular hypertension|ocular hypertension
573361|NCT01123785|adenosine agonist|adenosine agonist
573362|NCT01123785|eye drop|eye drop
573363|NCT01123785|primary open angle glaucoma|primary open angle glaucoma
573364|NCT01123772|adenosine agonist|adenosine agonist
573365|NCT01123772|eye drop|eye drop
573366|NCT01123772|elderly volunteer|elderly volunteer
573367|NCT01123772|older healthy volunteer|older healthy volunteer
573368|NCT01123759|Fish|fish
573369|NCT01123759|mercury|mercury
573370|NCT01123759|omega-3 fatty acids|omega-3 fatty acids
573371|NCT01123759|infant|infant
573372|NCT01123759|brain development|brain development
573373|NCT01123759|pregnancy|pregnancy
573374|NCT01123759|nursing mother|nursing mother
573375|NCT01123759|dietary recommendations|dietary recommendations
573376|NCT01123759|Hair mercury|hair mercury
573377|NCT01123759|Blood mercury|blood mercury
573378|NCT01123759|Recommendations for pregnant or nursing women|recommendations for pregnant or nursing women
573379|NCT01123759|Infant brain health|infant brain health
573380|NCT01123746|Seizure|seizure
573381|NCT01123746|electrolyte|electrolyte
573382|NCT01123746|risk factor|risk factor
573383|NCT01123733|Baby-friendly hospitals|baby-friendly hospitals
573384|NCT01123733|Non baby-friendly hospitals|non baby-friendly hospitals
573385|NCT01123733|Breastfeeding|breastfeeding
573386|NCT01123733|Ten steps for successful breastfeeding|ten steps for successful breastfeeding
573387|NCT01123707|Major Depressive Disorder|major depressive disorder
573388|NCT01123707|MDD|mdd
573389|NCT01123707|Depression|depression
573390|NCT01123694|xeroderma pigmentosum|xeroderma pigmentosum
573391|NCT01123694|quality of life|quality of life
573392|NCT01123694|DLQI|dlqi
573393|NCT01123694|CDLQI|cdlqi
573394|NCT01123681|Respiration, Artificial|respiration, artificial
573395|NCT01123681|Pneumonia, Ventilator-Associated|pneumonia, ventilator-associated
573396|NCT01123681|Critical Illness|critical illness
573397|NCT01123668|Smoking|smoking
573398|NCT01123668|ADHD|adhd
573399|NCT01123668|Nicotine|nicotine
573400|NCT01123668|Methylphenidate|methylphenidate
573401|NCT01123668|function Magnetic Resonance Imaging|function magnetic resonance imaging
573402|NCT01123668|Neurobiological basis of abstinence-induced deficits in response inhibition|neurobiological basis of abstinence-induced deficits in response inhibition
573403|NCT01123642|post-traumatic stress disorder|post-traumatic stress disorder
573404|NCT01123642|depressive disorder|depressive disorder
573405|NCT01123642|alcoholism|alcoholism
573406|NCT01123642|Longitudinal studies|longitudinal studies
573407|NCT01123642|readjustment|readjustment
573408|NCT01123616|surgical site infection|surgical site infection
573409|NCT01123616|elective colorectal surgery|elective colorectal surgery
573410|NCT01123616|level of surgical site infection|level of surgical site infection
573411|NCT01123616|complication of surgical site infection|complication of surgical site infection
573412|NCT01123616|type of changed bandage|type of changed bandage
573413|NCT01123616|frequency of bandage changing|frequency of bandage changing
573414|NCT01123603|frequency|frequency
573415|NCT01123603|women|women
573416|NCT01123603|fibroids|fibroids
573417|NCT01123603|uterine artery embolization|uterine artery embolization
573418|NCT01123603|myomectomy|myomectomy
573419|NCT01123603|hysterectomy|hysterectomy
573420|NCT01123590|Thymoma|thymoma
573421|NCT01123590|Autoimmune diseases|autoimmune diseases
573422|NCT01123590|Immunodeficiency|immunodeficiency
573423|NCT01123577|Self Blood Pressure Monitoring|self blood pressure monitoring
573424|NCT01123577|SBPM|sbpm
573425|NCT01123577|Randomized Control Trial|randomized control trial
573426|NCT01123577|Hypertension (HTN)|hypertension (htn)
573427|NCT01123577|Cardiovascular Disease (CVD)|cardiovascular disease (cvd)
573428|NCT01123577|HTN|htn
573429|NCT01123577|CVD|cvd
573430|NCT01123564|macular edema secondary to retinal vein occlusion|macular edema secondary to retinal vein occlusion
573431|NCT01123551|Nebulized morphine|nebulized morphine
573432|NCT01123551|Intravenous morphine|intravenous morphine
573433|NCT01123551|Post traumatic|post traumatic
573434|NCT01123551|Pain|pain
573435|NCT01123551|Emergency department|emergency department
573436|NCT01123512|Vertebral Compression Fracture|vertebral compression fracture
573437|NCT01123512|Kyphoplasty|kyphoplasty
573438|NCT01123512|Spine|spine
573439|NCT01123512|Vertebral Body Compression Fracture|vertebral body compression fracture
573440|NCT01123512|Back Pain|back pain
573441|NCT01123499|G-CSF|g-csf
573442|NCT01123499|Plerixafor|plerixafor
573443|NCT01123499|Mozobil|mozobil
573444|NCT01123499|Apheresis|apheresis
573445|NCT01123499|Healthy Volunteer|healthy volunteer
573446|NCT01123499|HV|hv
573447|NCT01123486|Intravenous opioids|intravenous opioids
573448|NCT01123486|Patient Controlled Analgesia|patient controlled analgesia
573449|NCT01123486|volunteer pharmacokinetic-pharmacodynamic study|volunteer pharmacokinetic-pharmacodynamic study
573450|NCT01123473|adenocarcinoma of the gastroesophageal junction|adenocarcinoma of the gastroesophageal junction
573451|NCT01123473|adenocarcinoma of the stomach|adenocarcinoma of the stomach
573452|NCT01123473|stage IIIA gastric cancer|stage iiia gastric cancer
573453|NCT01123473|stage IIIB gastric cancer|stage iiib gastric cancer
573454|NCT01123473|stage IIIC gastric cancer|stage iiic gastric cancer
573455|NCT01123473|stage IV gastric cancer|stage iv gastric cancer
573456|NCT01123460|non-small cell lung cancer|non-small cell lung cancer
573457|NCT01123434|prostate cancer|prostate cancer
573458|NCT01123434|adjuvant|adjuvant
573459|NCT01123434|hormonal|hormonal
573460|NCT01123421|osteoporosis|osteoporosis
573461|NCT01123421|fracture risk|fracture risk
573462|NCT01123421|aging|aging
573463|NCT01123421|tibia|tibia
573464|NCT01123421|sonometer|sonometer
573465|NCT01123421|ultrasound|ultrasound
573466|NCT01123421|BMD|bmd
573467|NCT01123421|bone mineral density|bone mineral density
573468|NCT01123421|DXA|dxa
573469|NCT01123421|3D-HRpQT|3d-hrpqt
573470|NCT01123421|waveform profiles|waveform profiles
573471|NCT01123408|schizophrenia|schizophrenia
573472|NCT01123408|aggression|aggression
573473|NCT01123408|clozapine|clozapine
573474|NCT01123408|olanzapine|olanzapine
573475|NCT01123395|bioavailability|bioavailability
573477|NCT01123382|Shoulder pain|shoulder pain
573478|NCT01123382|Electrical stimulation|electrical stimulation
573479|NCT01123382|Neuromuscular stimulation|neuromuscular stimulation
573480|NCT01123382|Intramuscular stimulation|intramuscular stimulation
573481|NCT01123369|Sickle Cell Disease|sickle cell disease
573482|NCT01123356|Relapsed chronic lymphocytic leukemia|relapsed chronic lymphocytic leukemia
573483|NCT01123343|limbal relaxing incision|limbal relaxing incision
573484|NCT01123343|LRI|lri
573485|NCT01123343|capsulorhexis|capsulorhexis
573486|NCT01123343|surgical guidance|surgical guidance
573487|NCT01123343|3d visualization|3d visualization
573488|NCT01123317|Schizophrenia|schizophrenia
573489|NCT01123317|PET|pet
573490|NCT01123317|Oxytocin|oxytocin
573491|NCT01123304|melanoma|melanoma
573492|NCT01123291|follow-up coronary angiography|follow-up coronary angiography
573493|NCT01123278|Adiponectin|adiponectin
573494|NCT01123278|Resistin|resistin
573495|NCT01123278|Adipocytes|adipocytes
573496|NCT01123278|Testosterone|testosterone
573497|NCT01123278|Aging|aging
573498|NCT01123278|HOMA-IR|homa-ir
573499|NCT01123278|Insulin|insulin
573500|NCT01123278|Hypogonadism|hypogonadism
573501|NCT01123278|Metabolic Syndrome|metabolic syndrome
573502|NCT01123278|Obesity|obesity
573503|NCT01123278|Erectile Dysfunction|erectile dysfunction
573504|NCT01123265|PsA|psa
573505|NCT01123265|methotrexate|methotrexate
573506|NCT01123265|Anti-TNF|anti-tnf
573507|NCT01123265|TNF|tnf
573508|NCT01123265|DC-Stamp|dc-stamp
573509|NCT01123252|Lactobacillus casei|lactobacillus casei
573510|NCT01123239|Healthcare Disparities|healthcare disparities
573511|NCT01123213|pelvic organ prolapse|pelvic organ prolapse
573512|NCT01123213|pessary fitting|pessary fitting
573513|NCT01123187|diabetes type 1|diabetes type 1
573514|NCT01123187|kidney transplantation|kidney transplantation
573515|NCT01123187|islet|islet
573516|NCT01123187|hypoglycemia|hypoglycemia
573517|NCT01123174|Suicide|suicide
573518|NCT01123174|case management algorithm|case management algorithm
573519|NCT01123174|suicidal behaviors|suicidal behaviors
573520|NCT01123174|prevention of suicide|prevention of suicide
573521|NCT01123161|Hypothermia|hypothermia
573522|NCT01123161|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action
573523|NCT01123161|Cerebral Infarction|cerebral infarction
573524|NCT01123161|Hematologic Agents|hematologic agents
573525|NCT01123161|Stroke|stroke
573526|NCT01123161|Nervous System Diseases|nervous system diseases
573527|NCT01123161|Vascular Diseases|vascular diseases
573528|NCT01123161|Tissue Plasminogen Activator|tissue plasminogen activator
573529|NCT01123161|Central Nervous System Diseases|central nervous system diseases
573530|NCT01123161|Fibrinolytic Agents|fibrinolytic agents
573531|NCT01123161|Cardiovascular Agents|cardiovascular agents
573532|NCT01123161|Body Temperature Changes|body temperature changes
573533|NCT01123161|Brain Diseases|brain diseases
573534|NCT01123161|Cerebrovascular Disorders|cerebrovascular disorders
573535|NCT01123161|Pharmacologic Actions|pharmacologic actions
573536|NCT01123161|Signs and Symptoms|signs and symptoms
573537|NCT01123161|Fibrin Modulating Agents|fibrin modulating agents
573538|NCT01123161|Therapeutic Uses|therapeutic uses
573539|NCT01123161|Brain Ischemia|brain ischemia
573540|NCT01123161|Cardiovascular Diseases|cardiovascular diseases
573541|NCT01123161|Brain Infarction|brain infarction
573542|NCT01123161|Plasminogen|plasminogen
573543|NCT01123161|cooling|cooling
573544|NCT01123161|tPA|tpa
573545|NCT01123161|thrombolysis|thrombolysis
573546|NCT01123148|Brain computer interface|brain computer interface
573547|NCT01123148|wheelchair control|wheelchair control
573548|NCT01123135|urodynamic stress incontinence|urodynamic stress incontinence
573549|NCT01123135|postmenopausal women|postmenopausal women
573550|NCT01123109|nulliparous women|nulliparous women
573551|NCT01123096|Stress urinary incontinence|stress urinary incontinence
573552|NCT01123083|new onset type 1 diabetes|new onset type 1 diabetes
573553|NCT01123083|juvenile diabetes|juvenile diabetes
573554|NCT01123083|T1DM|t1dm
573555|NCT01123083|Type 1 diabetes|type 1 diabetes
573556|NCT01123057|keratoconus|keratoconus
573557|NCT01123057|collagen cross-linking|collagen cross-linking
573558|NCT01123057|LASIK ectasia|lasik ectasia
573559|NCT01123057|keratoconus,lasik ectasia|keratoconus,lasik ectasia
573560|NCT01123018|Memory Loss|memory loss
573561|NCT01122992|Limbal relaxing incision|limbal relaxing incision
573562|NCT01122992|Astigmatic correction|astigmatic correction
573563|NCT01122992|Phacoemulsification surgery|phacoemulsification surgery
573564|NCT01122992|Chinese eyes|chinese eyes
573565|NCT01122966|trabeculectomy|trabeculectomy
573566|NCT01122953|Bioequivalence|bioequivalence
573567|NCT01122953|EPAMIN|epamin
573568|NCT01122953|PHENYTOIN|phenytoin
573569|NCT01122940|Bioequivalence|bioequivalence
573570|NCT01122940|Phenytoin|phenytoin
573571|NCT01122940|Epamin|epamin
573572|NCT01122927|schizophrenia|schizophrenia
573573|NCT01122927|adolescent|adolescent
573574|NCT01122927|bipolar|bipolar
573575|NCT01122914|Kineret|kineret
573576|NCT01122914|Anakinra|anakinra
573577|NCT01122914|Atopic Dermatitis|atopic dermatitis
573578|NCT01122914|Eczema|eczema
573579|NCT01122914|Allergic Disease|allergic disease
573580|NCT01122862|tooth plaque|tooth plaque
573581|NCT01122849|trouble with sleep|trouble with sleep
573582|NCT01122849|night time nasal congestion|night time nasal congestion
573583|NCT01122836|Massage|massage
573584|NCT01122836|Chronic Neck Pain|chronic neck pain
573585|NCT01122836|Dosing Study|dosing study
573586|NCT01122823|Chronic Disease Self-Management Program (CDSMP)|chronic disease self-management program (cdsmp)
573587|NCT01122810|Diagnostic accuracy of coronary angiography|diagnostic accuracy of coronary angiography
573588|NCT01122810|Transplant heart patients|transplant heart patients
573589|NCT01122810|X-Ray and contrast agent exposure|x-ray and contrast agent exposure
573590|NCT01122810|Coronary stenosis|coronary stenosis
573591|NCT01122797|PNPLA3|pnpla3
573592|NCT01122797|fibrosis|fibrosis
573593|NCT01122797|cirrhosis|cirrhosis
573594|NCT01122797|alcoholic liver disease|alcoholic liver disease
573595|NCT01122784|Plague|plague
573596|NCT01122784|Vaccine|vaccine
573597|NCT01122771|visceral leishmaniasis|visceral leishmaniasis
573598|NCT01122771|phase III|phase iii
573599|NCT01122771|randomised ccontrolled trial|randomised ccontrolled trial
573600|NCT01122771|Bangladesh|bangladesh
573601|NCT01122771|Combination treatment|combination treatment
573602|NCT01122771|Ambisome|ambisome
573603|NCT01122771|miltefosine|miltefosine
573604|NCT01122771|paromomycin|paromomycin
573605|NCT01122758|Cohort|cohort
573606|NCT01122758|COPD|copd
573607|NCT01122758|Natural history|natural history
573608|NCT01122758|Phenotyping|phenotyping
573609|NCT01122758|Smoking|smoking
573610|NCT01122745|continuous block|continuous block
573611|NCT01122745|single shot|single shot
573612|NCT01122745|interscalene|interscalene
573613|NCT01122745|rotator cuff surgery|rotator cuff surgery
573614|NCT01122732|nerve block|nerve block
573615|NCT01122732|continuous catheter|continuous catheter
573616|NCT01122732|shoulder surgery|shoulder surgery
573617|NCT01122732|pain control after total shoulder arthroplasty|pain control after total shoulder arthroplasty
573618|NCT01122719|Optima|optima
573619|NCT01122719|Tacrolimus|tacrolimus
573620|NCT01122719|Drug eluting stent|drug eluting stent
573621|NCT01122706|tai ji|tai ji
573622|NCT01122706|psychosocial stress|psychosocial stress
573623|NCT01122706|primary prevention|primary prevention
573624|NCT01122706|Trier Social Stress Test|trier social stress test
573625|NCT01122706|salivary cortisol|salivary cortisol
573626|NCT01122706|salivary alpha amylase|salivary alpha amylase
573627|NCT01122706|heart rate variability|heart rate variability
573628|NCT01122706|stress management|stress management
573629|NCT01122693|Regional Anesthesia|regional anesthesia
573630|NCT01122693|Pain Medicine|pain medicine
573631|NCT01122693|Ultrasound|ultrasound
573632|NCT01122693|Nerve Blocks|nerve blocks
573633|NCT01122667|Renal Insufficiency|renal insufficiency
573634|NCT01122641|Insulin resistance|insulin resistance
573635|NCT01122641|incretins|incretins
573636|NCT01122641|DPP4 inhibitors|dpp4 inhibitors
573637|NCT01122641|vildagliptin|vildagliptin
573638|NCT01122641|microcirculation|microcirculation
573639|NCT01122628|Distal Radial Fracture|distal radial fracture
573640|NCT01122628|Volar Locking Plate|volar locking plate
573641|NCT01122615|Kidney|kidney
573642|NCT01122615|metastatic renal cell carcinoma|metastatic renal cell carcinoma
573643|NCT01122615|RCC|rcc
573644|NCT01122615|Sunitinib|sunitinib
573645|NCT01122615|Sunitinib Malate|sunitinib malate
573646|NCT01122615|Sutent|sutent
573647|NCT01122615|Temsirolimus|temsirolimus
573648|NCT01122615|Torisel|torisel
573649|NCT01122602|Aspirin|aspirin
573650|NCT01122589|Smoking Abstinence|smoking abstinence
573651|NCT01122589|Smoking Cessation|smoking cessation
573652|NCT01122576|Intra Ocular Lens|intra ocular lens
573653|NCT01122576|Ocular surgery|ocular surgery
573654|NCT01122576|Phacoemulsification|phacoemulsification
573655|NCT01122563|OABSS|oabss
573656|NCT01122563|IPSS|ipss
573657|NCT01122563|PPBC|ppbc
573658|NCT01122563|3-day micturition diary|3-day micturition diary
573659|NCT01122563|Solifenacin|solifenacin
573660|NCT01122550|OABSS|oabss
573661|NCT01122550|IPSS|ipss
573662|NCT01122550|PPBC|ppbc
573663|NCT01122550|3-day micturition diary|3-day micturition diary
573664|NCT01122537|Meningitis|meningitis
573665|NCT01122537|infection|infection
573666|NCT01122537|cerebrospinal fluid|cerebrospinal fluid
573667|NCT01122537|procalcitonin|procalcitonin
573668|NCT01122537|adenosine deaminase|adenosine deaminase
573669|NCT01122524|Trisomy 21|trisomy 21
573670|NCT01122472|lenalidomide (Revlimid)|lenalidomide (revlimid)
573671|NCT01122472|diffuse large B-cell lymphoma|diffuse large b-cell lymphoma
573672|NCT01122472|phase III study|phase iii study
573673|NCT01122472|after R-CHOP|after r-chop
573674|NCT01122472|Maintenance treatment|maintenance treatment
573675|NCT01122472|Maintenance|maintenance
573676|NCT01122459|Perioperative intravenous fluids|perioperative intravenous fluids
573677|NCT01122446|Alum-GAD|alum-gad
573678|NCT01122446|Type 1 diabetes|type 1 diabetes
573679|NCT01122446|prevention|prevention
573680|NCT01122446|immune tolerance|immune tolerance
573681|NCT01122446|glucose tolerance|glucose tolerance
573682|NCT01122446|glutamate decarboxylase autoantibodies|glutamate decarboxylase autoantibodies
573683|NCT01122433|difficult airway|difficult airway
573684|NCT01122433|indirect laryngoscopy|indirect laryngoscopy
573685|NCT01122433|C-MAC video laryngoscope|c-mac video laryngoscope
573686|NCT01122420|Obesity|obesity
573687|NCT01122394|stroke|stroke
573688|NCT01122394|recurrence|recurrence
573689|NCT01122394|blood pressure|blood pressure
573690|NCT01122394|prevention|prevention
573691|NCT01122381|headache, migraine|headache, migraine
573692|NCT01122381|depression|depression
573693|NCT01122381|disability evaluation|disability evaluation
573694|NCT01122381|weight gain|weight gain
573695|NCT01122368|mycoses|mycoses
573696|NCT01122368|Micafungin|micafungin
573697|NCT01122368|intra-abdominal surgery|intra-abdominal surgery
573698|NCT01122368|invasive fungal infection|invasive fungal infection
573699|NCT01122368|intra-abdominal infection|intra-abdominal infection
573700|NCT01122342|Testosterone|testosterone
573701|NCT01122342|Vaginal administration|vaginal administration
573702|NCT01122342|Aromatase inhibitors|aromatase inhibitors
573703|NCT01122329|dementia|dementia
573704|NCT01122316|Heart Failure|heart failure
573705|NCT01122316|Diabetes|diabetes
573706|NCT01122316|Metformin|metformin
573707|NCT01122303|Autologous serum eye drops|autologous serum eye drops
573708|NCT01122303|EGF|egf
573709|NCT01122303|TGF-β1|tgf-β1
573710|NCT01122303|TGF-β2|tgf-β2
573711|NCT01122303|Fibronectin|fibronectin
573712|NCT01122303|Stevens-Johnson syndrome|stevens-johnson syndrome
573713|NCT01122303|Dry eye|dry eye
573714|NCT01122290|Emotional eating|emotional eating
573715|NCT01122290|Eating in the absence of hunger|eating in the absence of hunger
573716|NCT01122290|emotion induction|emotion induction
573717|NCT01122277|Volume therapy|volume therapy
573718|NCT01122277|Fluid therapy|fluid therapy
573719|NCT01122277|Patients in ICU|patients in icu
573720|NCT01122264|Erectile Dysfunction|erectile dysfunction
573721|NCT01122251|hypertension|hypertension
573722|NCT01122251|lercanidipine|lercanidipine
573723|NCT01122251|valsartan|valsartan
573724|NCT01122238|Smoking|smoking
573725|NCT01122238|Smoking Cessation|smoking cessation
573726|NCT01122238|Motivation|motivation
573727|NCT01122238|Nicotine Dependence|nicotine dependence
573728|NCT01122225|septic shock|septic shock
573729|NCT01122225|medical intensive care|medical intensive care
573730|NCT01122212|intracerebral hemorrhage|intracerebral hemorrhage
573731|NCT01122212|ct scans|ct scans
573732|NCT01122212|protein s100|protein s100
573733|NCT01122212|inpatient treatment|inpatient treatment
573734|NCT01122186|Medication Adherence|medication adherence
573735|NCT01122186|Methamphetamine Use|methamphetamine use
573736|NCT01122186|Sexual Risk|sexual risk
573737|NCT01122186|Poly-substance Use|poly-substance use
573738|NCT01122186|HIV|hiv
573739|NCT01122186|Treatment|treatment
573740|NCT01122186|Motivational Interviewing|motivational interviewing
573741|NCT01122186|Cognitive Behavioral Skills Training|cognitive behavioral skills training
573742|NCT01122186|Men Who Have Sex With Men|men who have sex with men
573743|NCT01122173|Atrial Fibrillation|atrial fibrillation
573744|NCT01122173|Robotic Control|robotic control
573745|NCT01122173|Remote Control|remote control
573746|NCT01122160|anthocyanin|anthocyanin
573747|NCT01122160|omeprazole|omeprazole
573748|NCT01122160|Prilosec|prilosec
573749|NCT01122160|gastric pH|gastric ph
573750|NCT01122160|proton pump inhibitor|proton pump inhibitor
573751|NCT01122160|PPI|ppi
573752|NCT01122160|nutrition|nutrition
573753|NCT01122147|Aphthous stomatitis; Herbal medicines; Matricaria Chamomilla|aphthous stomatitis; herbal medicines; matricaria chamomilla
573754|NCT01122134|severe|severe
573755|NCT01122134|malaria|malaria
573756|NCT01122134|artesunate|artesunate
573757|NCT01122134|intravenous|intravenous
573758|NCT01122121|Drug Therapy|drug therapy
573759|NCT01122121|Radiotherapy|radiotherapy
573760|NCT01122108|Bile Acid Sequestrant|bile acid sequestrant
573761|NCT01122108|Resin|resin
573762|NCT01122108|Lipids|lipids
573763|NCT01122108|Glucose|glucose
573764|NCT01122108|Cholesterol|cholesterol
573765|NCT01122108|Diabetes Mellitus|diabetes mellitus
573766|NCT01122108|Bile Acid Sequestrant Acceptability Scale|bile acid sequestrant acceptability scale
573767|NCT01122095|Psoriasis|psoriasis
573768|NCT01122095|Cardiovascular risk|cardiovascular risk
573769|NCT01122082|energy intake|energy intake
573770|NCT01122082|energy expenditure|energy expenditure
573771|NCT01122082|macronutrient selection|macronutrient selection
573772|NCT01122056|Multiple Sclerosis|multiple sclerosis
573773|NCT01122056|b1b-interferon|b1b-interferon
573774|NCT01122056|Fatigue|fatigue
573775|NCT01122056|Exercise|exercise
573776|NCT01122043|Endoglide|endoglide
573777|NCT01122043|Endothelial Keratoplasty|endothelial keratoplasty
573778|NCT01122043|Donor Insertion|donor insertion
573779|NCT01122043|DSAEK|dsaek
573780|NCT01122043|Corneal Transplant|corneal transplant
573884|NCT01121588|neoplasm malignant|neoplasm malignant
573781|NCT01122043|Patients with Bullous Keratopathy|patients with bullous keratopathy
573782|NCT01122030|Chronic pain|chronic pain
573783|NCT01122030|Opioid physical dependence|opioid physical dependence
573784|NCT01121991|Infertility|infertility
573785|NCT01121991|Ovarian Stimulation|ovarian stimulation
573786|NCT01121991|Luveris|luveris
573787|NCT01121991|Lutropin alpha|lutropin alpha
573788|NCT01121991|Controlled ovarian stimulation|controlled ovarian stimulation
573789|NCT01121991|Reproductive techniques, assisted|reproductive techniques, assisted
573790|NCT01121978|macular tractional maculopathy|macular tractional maculopathy
573791|NCT01121978|pathologic myopia|pathologic myopia
573792|NCT01121965|macular hole|macular hole
573793|NCT01121965|impending macular hole|impending macular hole
573794|NCT01121965|stage 1 macular hole|stage 1 macular hole
573795|NCT01121952|Ankle joint|ankle joint
573796|NCT01121952|Talo-crural joint|talo-crural joint
573797|NCT01121952|Vertical jump|vertical jump
573798|NCT01121952|Chiropractic manipulation (HVLA)|chiropractic manipulation (hvla)
573799|NCT01121952|ROM|rom
573800|NCT01121952|Proprioception|proprioception
573801|NCT01121952|Pain|pain
573802|NCT01121939|advanced neuroendocrine|advanced neuroendocrine
573803|NCT01121939|Gastrointestinal|gastrointestinal
573804|NCT01121939|Bevacizumab|bevacizumab
573805|NCT01121939|Avastin|avastin
573806|NCT01121939|Pertuzumab|pertuzumab
573807|NCT01121939|Omnitarg|omnitarg
573808|NCT01121939|2C4|2c4
573809|NCT01121939|Sandostatin|sandostatin
573810|NCT01121939|Octreotide|octreotide
573811|NCT01121926|Healthy subjects|healthy subjects
573812|NCT01121926|Bioavailability|bioavailability
573813|NCT01121926|Pharmacokinetics|pharmacokinetics
573814|NCT01121926|Trazodone|trazodone
573815|NCT01121926|Steady-state|steady-state
573816|NCT01121913|Healthy subjects|healthy subjects
573817|NCT01121900|Healthy subjects|healthy subjects
573818|NCT01121887|smoking cessation|smoking cessation
573819|NCT01121887|telephone counselling|telephone counselling
573820|NCT01121887|motivational interviewing|motivational interviewing
573821|NCT01121887|treatment integrity|treatment integrity
573822|NCT01121887|Tobacco Smoking|tobacco smoking
573823|NCT01121874|CMC arthritis|cmc arthritis
573824|NCT01121874|thumb carpometacarpal arthritis|thumb carpometacarpal arthritis
573825|NCT01121874|basal joint arthritis|basal joint arthritis
573826|NCT01121874|thumb CMC arthritis|thumb cmc arthritis
573827|NCT01121861|efficacy|efficacy
573828|NCT01121861|safety|safety
573829|NCT01121861|predictability|predictability
573830|NCT01121861|stability|stability
573831|NCT01121861|toric IOL|toric iol
573832|NCT01121861|refractive astigmatism|refractive astigmatism
573833|NCT01121861|phacoemulsification|phacoemulsification
573834|NCT01121822|Influenza|influenza
573835|NCT01121822|Influenza vaccine|influenza vaccine
573836|NCT01121822|Influenza virus|influenza virus
573837|NCT01121822|Intramuscular|intramuscular
573838|NCT01121809|Raltegravir|raltegravir
573839|NCT01121809|etravirine|etravirine
573840|NCT01121809|pharmacokinetics|pharmacokinetics
573841|NCT01121809|intracellular|intracellular
573842|NCT01121757|relapsed|relapsed
573843|NCT01121757|refractory|refractory
573844|NCT01121757|lymphoma|lymphoma
573845|NCT01121757|follicular|follicular
573846|NCT01121757|marginal zone|marginal zone
573847|NCT01121744|Coronary Artery Disease|coronary artery disease
573848|NCT01121744|Drug Eluting Stents (DES)|drug eluting stents (des)
573849|NCT01121744|Pharmacokinetic (PK)|pharmacokinetic (pk)
573850|NCT01121731|Chronic Hepatitis C Viral Infection|chronic hepatitis c viral infection
573851|NCT01121731|Interferon alfa-5|interferon alfa-5
573852|NCT01121731|Interferon|interferon
573853|NCT01121718|lymph node|lymph node
573854|NCT01121705|genotype 3|genotype 3
573855|NCT01121705|Combination treatment|combination treatment
573856|NCT01121705|Short treatment|short treatment
573857|NCT01121692|Couples|couples
573858|NCT01121692|Alcohol use|alcohol use
573859|NCT01121692|HIV risk|hiv risk
573860|NCT01121692|Outreach|outreach
573861|NCT01121679|Older patients|older patients
573862|NCT01121679|Aged, 80 and Over|aged, 80 and over
573863|NCT01121679|Cardiology|cardiology
573864|NCT01121666|Assisted reproductive treatment|assisted reproductive treatment
573865|NCT01121666|Superovulation|superovulation
573866|NCT01121666|Follitropin alfa|follitropin alfa
573867|NCT01121666|r-hFSH|r-hfsh
573868|NCT01121666|AFOLIA|afolia
573869|NCT01121653|Neuropathic pain, magnesium|neuropathic pain, magnesium
573870|NCT01121640|Ovarian Cancer|ovarian cancer
573871|NCT01121640|Screening|screening
573872|NCT01121640|Biomarkers|biomarkers
573873|NCT01121627|Computerized Cognitive training|computerized cognitive training
573874|NCT01121627|Quality of life|quality of life
573875|NCT01121627|Gait Function|gait function
573876|NCT01121627|Executive Function|executive function
573877|NCT01121614|Harmonic scalpel|harmonic scalpel
573878|NCT01121614|ultrasonic scalpel|ultrasonic scalpel
573879|NCT01121614|LOTUS|lotus
573880|NCT01121614|LigaSure|ligasure
573881|NCT01121614|vessel sealing|vessel sealing
573882|NCT01121614|burst pressure|burst pressure
573883|NCT01121614|collateral damage|collateral damage
573885|NCT01121588|lymphoma|lymphoma
573886|NCT01121588|neuroblastoma|neuroblastoma
573887|NCT01121588|Crizotinib|crizotinib
573888|NCT01121588|anaplastic lymphoma kinase|anaplastic lymphoma kinase
573889|NCT01121588|ALK|alk
573890|NCT01121575|Phase 1 acquired resistance to erlotinib or gefitinib cMET inhibitor EGFR inhibitor panHER inhibitor combination trial Crizotinib|phase 1 acquired resistance to erlotinib or gefitinib cmet inhibitor egfr inhibitor panher inhibitor combination trial crizotinib
573891|NCT01121562|Neuroendocrine tumors|neuroendocrine tumors
573892|NCT01121549|Prospective|prospective
573893|NCT01121549|non-comparative|non-comparative
573894|NCT01121549|NIS|nis
573895|NCT01121549|600|600
573896|NCT01121549|postmenopausal|postmenopausal
573897|NCT01121549|hormone-receptor|hormone-receptor
573898|NCT01121549|positive|positive
573899|NCT01121549|EBC|ebc
573900|NCT01121549|tamoxifen|tamoxifen
573901|NCT01121549|current medical practice.|current medical practice.
573902|NCT01121536|Bipolar I Disorder|bipolar i disorder
573903|NCT01121523|Prematurity|prematurity
573904|NCT01121523|massage|massage
573905|NCT01121523|stress|stress
573906|NCT01121523|parenting|parenting
573907|NCT01121523|infancy|infancy
573908|NCT01121523|sleep|sleep
573909|NCT01121523|intervention|intervention
573910|NCT01121510|vascular closure device|vascular closure device
573911|NCT01121497|Sedation|sedation
573912|NCT01121497|Cognitive decline|cognitive decline
573913|NCT01121497|Physostigmine|physostigmine
573914|NCT01121497|Colonoscopy|colonoscopy
573915|NCT01121471|diabetes|diabetes
573916|NCT01121471|conjugated linoleic acid|conjugated linoleic acid
573917|NCT01121458|pulmonary artery|pulmonary artery
573918|NCT01121458|vascular resistance|vascular resistance
573919|NCT01121445|Sleep apnea|sleep apnea
573920|NCT01121445|CPAP|cpap
573921|NCT01121445|Saline irrigation|saline irrigation
573922|NCT01121419|Neuroblastoma|neuroblastoma
573923|NCT01121419|IMP3|imp3
573924|NCT01121419|Prognosis|prognosis
573925|NCT01121380|Healthy|healthy
573926|NCT01121380|Volunteers|volunteers
573927|NCT01121367|emphysema; pulmonary fibrosis;chemokine;sputum|emphysema; pulmonary fibrosis;chemokine;sputum
573928|NCT01121354|Cefazolin|cefazolin
573929|NCT01121354|Caphalosporin|caphalosporin
573930|NCT01121354|antibiotic|antibiotic
573931|NCT01121354|gram positive|gram positive
573932|NCT01121354|Infection control|infection control
573933|NCT01121341|Endoscopic vein harvesting|endoscopic vein harvesting
573934|NCT01121341|Saphenous vein|saphenous vein
573935|NCT01121341|Conventional vein harvesting|conventional vein harvesting
573936|NCT01121328|Preterm neonates.|preterm neonates.
573937|NCT01121328|Autologous cord blood transfusion.|autologous cord blood transfusion.
573938|NCT01121315|Epidemiological|epidemiological
573939|NCT01121315|Diabetes|diabetes
573940|NCT01121315|Glucose Lowering Drug Treatment in Primary care|glucose lowering drug treatment in primary care
573941|NCT01121315|CVD|cvd
573942|NCT01121302|AZD5213|azd5213
573943|NCT01121302|Phase 1|phase 1
573944|NCT01121302|Safety|safety
573945|NCT01121263|coronary arteriosclerosis|coronary arteriosclerosis
573946|NCT01121263|coronary heart disease|coronary heart disease
573947|NCT01121263|coronary artery bypass|coronary artery bypass
573948|NCT01121263|coronary artery bypass, off-pump|coronary artery bypass, off-pump
573949|NCT01121263|coronary angiography|coronary angiography
573950|NCT01121263|drug-eluting stents|drug-eluting stents
573951|NCT01121250|Combat disorders|combat disorders
573952|NCT01121250|Spouses|spouses
573953|NCT01121250|Support|support
573954|NCT01121250|Military personnel|military personnel
573955|NCT01121237|chronic kidney disease|chronic kidney disease
573956|NCT01121237|end-stage renal disease|end-stage renal disease
573957|NCT01121237|renal anaemia|renal anaemia
573958|NCT01121237|epoetin alfa|epoetin alfa
573959|NCT01121224|Saphenous vein graft|saphenous vein graft
573960|NCT01121224|Percutaneous coronary intervention|percutaneous coronary intervention
573962|NCT01121211|Testosterone|testosterone
573963|NCT01121211|Hormones|hormones
573964|NCT01121211|Mental Health|mental health
573965|NCT01121198|Food effect|food effect
573966|NCT01121185|Hepatitis C virus (HCV)|hepatitis c virus (hcv)
573967|NCT01121185|Liver transplantation|liver transplantation
573968|NCT01121185|Human Monoclonal Antibody|human monoclonal antibody
573969|NCT01121146|Osteolysis|osteolysis
573970|NCT01121146|Polyethylene|polyethylene
573971|NCT01121146|Crosslinked Polyethylene|crosslinked polyethylene
573972|NCT01121146|Total Hip Replacement|total hip replacement
573973|NCT01121146|CT|ct
573974|NCT01121120|Lymphoma, Non-Hodgkin|lymphoma, non-hodgkin
573975|NCT01121120|Hodgkin Disease|hodgkin disease
573976|NCT01121120|Multiple myeloma|multiple myeloma
573977|NCT01121120|Peripheral Blood Stem Cell Transplant|peripheral blood stem cell transplant
573978|NCT01121120|Autologous Peripheral Blood Stem Cell Transplant|autologous peripheral blood stem cell transplant
573979|NCT01121120|Limited re-infusion of CD34+ cells|limited re-infusion of cd34+ cells
573980|NCT01121107|Heart Failure|heart failure
573981|NCT01121107|Decompensated Heart Failure|decompensated heart failure
573982|NCT01121107|Acute Decompensated Heart Failure|acute decompensated heart failure
574081|NCT01120535|Vena Cava|vena cava
573983|NCT01121107|Hemodynamic Monitoring|hemodynamic monitoring
573984|NCT01121107|Implantable Pressure Monitor|implantable pressure monitor
573985|NCT01121107|Left Atrial Pressure Monitoring|left atrial pressure monitoring
573986|NCT01121094|Liver, spleen , T2* , MRI, fetus|liver, spleen , t2* , mri, fetus
573987|NCT01121081|Male or female subjects|male or female subjects
573988|NCT01121081|≥18 to ≤75 years of age|≥18 to ≤75 years of age
573989|NCT01121081|who have a diagnosis of plaque or guttate psoriasis|who have a diagnosis of plaque or guttate psoriasis
573990|NCT01121068|IGRA|igra
573991|NCT01121068|variability|variability
573992|NCT01121068|Long-term variability of IGRA|long-term variability of igra
573993|NCT01121055|Fiberoptic Bronchoscopy|fiberoptic bronchoscopy
573994|NCT01121055|Patient|patient
573995|NCT01121055|Satisfaction|satisfaction
573996|NCT01121055|Lorazepam|lorazepam
573997|NCT01121016|NAEB, chronic cough, montelukast, induced sputum|naeb, chronic cough, montelukast, induced sputum
573998|NCT01121003|Fructose|fructose
573999|NCT01121003|VLDL-triglycerides|vldl-triglycerides
574000|NCT01121003|de novo lipogenesis|de novo lipogenesis
574001|NCT01121003|Human metabolism|human metabolism
574002|NCT01120990|Blood pressure measuring devices|blood pressure measuring devices
574003|NCT01120990|Essential Hypertension|essential hypertension
574004|NCT01120990|Automated blood pressure measurement|automated blood pressure measurement
574005|NCT01120951|Respiratory rate R8 Anaxsys|respiratory rate r8 anaxsys
574006|NCT01120938|AIrways, Patency, Infant death|airways, patency, infant death
574007|NCT01120925|Cirrhotic|cirrhotic
574008|NCT01120925|Stem Cells|stem cells
574009|NCT01120925|Bone marrow stem cells|bone marrow stem cells
574010|NCT01120925|Decompensate Cirrhotic Patients|decompensate cirrhotic patients
574011|NCT01120912|oral insulin|oral insulin
574012|NCT01120899|Diabetic Macular Edema|diabetic macular edema
574013|NCT01120899|Microglia|microglia
574014|NCT01120899|Minocycline|minocycline
574015|NCT01120899|Diabetes|diabetes
574016|NCT01120886|Ion channelopathy,|ion channelopathy,
574017|NCT01120886|Still birth|still birth
574018|NCT01120886|Sudden death|sudden death
574019|NCT01120873|Hyperglycemia|hyperglycemia
574020|NCT01120873|dyslipidemia|dyslipidemia
574021|NCT01120873|Hypertension|hypertension
574022|NCT01120873|Obesity|obesity
574023|NCT01120860|Cognitive Aging|cognitive aging
574024|NCT01120860|Apolipoproteins E|apolipoproteins e
574025|NCT01120860|Magnetic Resonance Imaging|magnetic resonance imaging
574026|NCT01120834|diffuse large b cell lymphoma|diffuse large b cell lymphoma
574027|NCT01120821|PV|pv
574028|NCT01120769|Myocardial Infarction|myocardial infarction
574029|NCT01120769|Percutaneous Coronary Intervention|percutaneous coronary intervention
574030|NCT01120769|Acetaminophen|acetaminophen
574031|NCT01120769|Lipid Peroxidation|lipid peroxidation
574032|NCT01120756|executive dysfunction|executive dysfunction
574033|NCT01120756|brain injury|brain injury
574034|NCT01120756|attention|attention
574035|NCT01120756|rehabilitation|rehabilitation
574036|NCT01120743|liver failure|liver failure
574037|NCT01120743|cytokines|cytokines
574038|NCT01120743|hemodynamic instability|hemodynamic instability
574039|NCT01120717|QVA149|qva149
574040|NCT01120717|COPD|copd
574041|NCT01120717|combination bronchodilator|combination bronchodilator
574042|NCT01120704|Smoking|smoking
574043|NCT01120704|Smoking Cessation|smoking cessation
574044|NCT01120704|Adherence|adherence
574045|NCT01120704|Nicotine|nicotine
574046|NCT01120704|Motivation|motivation
574047|NCT01120691|QVA149|qva149
574048|NCT01120691|NVA237|nva237
574049|NCT01120691|COPD|copd
574050|NCT01120691|exacerbation|exacerbation
574051|NCT01120691|combination bronchodilator|combination bronchodilator
574052|NCT01120678|cytokines|cytokines
574053|NCT01120678|late-onset neonatal sepsis|late-onset neonatal sepsis
574054|NCT01120678|neonatal sepsis|neonatal sepsis
574055|NCT01120678|diagnosis of sepsis|diagnosis of sepsis
574056|NCT01120678|bacteremia|bacteremia
574057|NCT01120678|blood culture|blood culture
574058|NCT01120678|clinical sepsis|clinical sepsis
574059|NCT01120665|women's health|women's health
574060|NCT01120665|hormone replacement therapy|hormone replacement therapy
574061|NCT01120665|exercise|exercise
574062|NCT01120613|Nocturnal Hypertension|nocturnal hypertension
574063|NCT01120613|Nondipping|nondipping
574064|NCT01120613|Renal Transplant|renal transplant
574065|NCT01120613|Chronotherapy|chronotherapy
574066|NCT01120587|Deglutition|deglutition
574067|NCT01120587|Fluoroscopy|fluoroscopy
574068|NCT01120574|Nocturnal hypercapnic response to oxygen|nocturnal hypercapnic response to oxygen
574069|NCT01120574|Home mechanical ventilation|home mechanical ventilation
574070|NCT01120574|COPD|copd
574071|NCT01120561|TDM-1 EAP|tdm-1 eap
574072|NCT01120561|T-DM1 EAP|t-dm1 eap
574073|NCT01120561|TDM1 EAP|tdm1 eap
574074|NCT01120561|Trastuzumab-MCC-DM1 EAP|trastuzumab-mcc-dm1 eap
574075|NCT01120561|Trastuzumab emtansine|trastuzumab emtansine
574076|NCT01120561|EAP|eap
574077|NCT01120561|T-PAS|t-pas
574078|NCT01120548|CARDIAC REHABILITATION|cardiac rehabilitation
574079|NCT01120548|Nocturnal Ventilation|nocturnal ventilation
574080|NCT01120548|Apnea hypopnea index is > 15/h|apnea hypopnea index is > 15/h
574082|NCT01120535|Vena Cava Filter|vena cava filter
574083|NCT01120535|Pulmonary Embolism|pulmonary embolism
574084|NCT01120535|Venous Thromboembolism|venous thromboembolism
574085|NCT01120535|Risk of Pulmonary Embolism|risk of pulmonary embolism
574086|NCT01120522|Vena Cava|vena cava
574087|NCT01120522|Vena Cava Filter|vena cava filter
574088|NCT01120522|Pulmonary Embolism|pulmonary embolism
574089|NCT01120522|Venous Thromboembolism|venous thromboembolism
574090|NCT01120522|Risk of Pulmonary Embolism|risk of pulmonary embolism
574091|NCT01120509|Vena Cava|vena cava
574092|NCT01120509|Vena Cava Filter|vena cava filter
574093|NCT01120509|Pulmonary Embolism|pulmonary embolism
574094|NCT01120509|Venous Thromboembolism|venous thromboembolism
574095|NCT01120509|Risk of Pulmonary Embolism|risk of pulmonary embolism
574096|NCT01120496|Hypertonic saline solution, bronchiolitis, RSV|hypertonic saline solution, bronchiolitis, rsv
574097|NCT01120483|mortality|mortality
574098|NCT01120483|functional status|functional status
574099|NCT01120470|Castration Resistant|castration resistant
574100|NCT01120470|Prostate Cancer|prostate cancer
574101|NCT01120470|OGX-427|ogx-427
574102|NCT01120444|Diabetes|diabetes
574103|NCT01120444|Insulin|insulin
574104|NCT01120444|Blood Glucose|blood glucose
574105|NCT01120431|dehydration|dehydration
574106|NCT01120431|fluid therapy|fluid therapy
574107|NCT01120431|hyaluronoglucosaminidase|hyaluronoglucosaminidase
574108|NCT01120431|hyaluronidase|hyaluronidase
574109|NCT01120431|hypodermoclysis|hypodermoclysis
574110|NCT01120431|clysis|clysis
574111|NCT01120431|subcutaneous hydration|subcutaneous hydration
574112|NCT01120431|subcutaneous rehydration|subcutaneous rehydration
574113|NCT01120431|hyaluronan|hyaluronan
574114|NCT01120431|rHuPH20|rhuph20
574115|NCT01120431|pediatric|pediatric
574116|NCT01120431|ORT|ort
574117|NCT01120418|Endothelial cell density|endothelial cell density
574118|NCT01120418|screening|screening
574119|NCT01120405|Xenon|xenon
574120|NCT01120405|Cardiac safety|cardiac safety
574121|NCT01120405|Cardiovascular risk|cardiovascular risk
574122|NCT01120405|Non cardiac surgery|non cardiac surgery
574123|NCT01120405|Atherosclerotic vascular surgery|atherosclerotic vascular surgery
574124|NCT01120392|Parkinson's disease|parkinson's disease
574125|NCT01120392|Physical therapy|physical therapy
574126|NCT01120392|Virtual Reality|virtual reality
574127|NCT01120392|Quality of life|quality of life
574128|NCT01120392|Motor performance|motor performance
574129|NCT01120379|drug eluting stents|drug eluting stents
574130|NCT01120379|Stents|stents
574131|NCT01120379|Angioplasty|angioplasty
574132|NCT01120379|Stent thrombosis|stent thrombosis
574133|NCT01120353|Childhood cancer|childhood cancer
574134|NCT01120353|Young Children|young children
574135|NCT01120353|Adults|adults
574136|NCT01120301|stroke|stroke
574137|NCT01120288|Anti-Angiogenesis|anti-angiogenesis
574138|NCT01120288|Targeted Therapy|targeted therapy
574139|NCT01120288|HIF|hif
574140|NCT01120288|Antisense|antisense
574141|NCT01120288|VEGF|vegf
574142|NCT01120288|Cancer|cancer
574143|NCT01120288|Solid Tumor|solid tumor
574144|NCT01120288|Liver Metastasis|liver metastasis
574145|NCT01120262|recurrent prostate cancer|recurrent prostate cancer
574146|NCT01120262|stage IV prostate cancer|stage iv prostate cancer
574147|NCT01120249|stage I renal cell cancer|stage i renal cell cancer
574148|NCT01120249|stage II renal cell cancer|stage ii renal cell cancer
574149|NCT01120249|stage III renal cell cancer|stage iii renal cell cancer
574150|NCT01120249|clear cell renal cell carcinoma|clear cell renal cell carcinoma
574151|NCT01120249|papillary renal cell carcinoma|papillary renal cell carcinoma
574152|NCT01120210|Heart Failure|heart failure
574153|NCT01120210|Cardiac Failure|cardiac failure
574154|NCT01120197|randomized controlled trial|randomized controlled trial
574155|NCT01120197|osteoporosis|osteoporosis
574156|NCT01120197|moderate-intensity circuit exercises|moderate-intensity circuit exercises
574157|NCT01120197|balance|balance
574158|NCT01120197|health-related quality of life|health-related quality of life
574159|NCT01120171|Breast cancer|breast cancer
574160|NCT01120171|Elderly|elderly
574161|NCT01120171|Chemotherapy|chemotherapy
574162|NCT01120171|Cardiotoxicity|cardiotoxicity
729344|NCT00511927|heart|heart
574163|NCT01120158|Breast cancer|breast cancer
574164|NCT01120158|Elderly|elderly
574165|NCT01120158|Chemotherapy|chemotherapy
574166|NCT01120158|Anti-angiogenesis therapy|anti-angiogenesis therapy
574167|NCT01120145|Malaria|malaria
574168|NCT01120145|Pregnancy|pregnancy
574169|NCT01120145|Sulphadoxine-pyrimethamine|sulphadoxine-pyrimethamine
574170|NCT01120106|levosimendan|levosimendan
574171|NCT01120106|pediatric cardiac surgery|pediatric cardiac surgery
574172|NCT01120106|low cardiac output syndrome|low cardiac output syndrome
574173|NCT01120106|transposition of the great arteries|transposition of the great arteries
574174|NCT01120093|COPD|copd
574175|NCT01120080|Smoking|smoking
574176|NCT01120080|Tobacco|tobacco
574177|NCT01120080|Drinking|drinking
574178|NCT01120067|Psychology|psychology
574179|NCT01120067|Pain|pain
574180|NCT01120067|Veterans|veterans
574181|NCT01120067|Stress Disorders, Post-Traumatic|stress disorders, post-traumatic
574281|NCT01119612|Pregnancy|pregnancy
574182|NCT01120054|Traumatic Brain Injury|traumatic brain injury
574183|NCT01120054|Homelessness|homelessness
574184|NCT01120028|Kidney transplantation|kidney transplantation
574185|NCT01120028|Alemtuzumab|alemtuzumab
574186|NCT01120028|Sirolimus|sirolimus
574187|NCT01120028|Basiliximab|basiliximab
574188|NCT01120028|Tacrolimus|tacrolimus
574189|NCT01120028|Campath-1H|campath-1h
574190|NCT01120015|OA|oa
574191|NCT01120015|knee|knee
574192|NCT01120002|mild to moderate Alzheimer's Disease|mild to moderate alzheimer's disease
574193|NCT01119989|hepatic fat content|hepatic fat content
574194|NCT01119989|hepatic de novo lipogenesis|hepatic de novo lipogenesis
574195|NCT01119963|Preterm delivery|preterm delivery
574196|NCT01119950|COPD|copd
574197|NCT01119937|COPD|copd
574198|NCT01119937|NVA237|nva237
574199|NCT01119924|Mirtazapine|mirtazapine
574200|NCT01119924|Smilon|smilon
574201|NCT01119924|Depression|depression
574202|NCT01119924|Pain|pain
574203|NCT01119911|Blood sampling|blood sampling
574204|NCT01119911|Venipuncture|venipuncture
574205|NCT01119911|Peripheral venous catheter|peripheral venous catheter
574206|NCT01119911|Complete blood count|complete blood count
574207|NCT01119911|Basic chemistry|basic chemistry
574208|NCT01119911|Hemolysis|hemolysis
574209|NCT01119911|Peripheral venous catheter replaces venipuncture.|peripheral venous catheter replaces venipuncture.
574333|NCT01119404|Arterial Elasticity|arterial elasticity
574210|NCT01119911|Peripheral venous catheter blood sampling reduces pain.|peripheral venous catheter blood sampling reduces pain.
574211|NCT01119898|Osteoarthritis|osteoarthritis
574212|NCT01119898|Arthritis|arthritis
574213|NCT01119898|NSAIDs|nsaids
574214|NCT01119898|Topical NSAID|topical nsaid
574215|NCT01119898|Diclofenac|diclofenac
574216|NCT01119898|PENNSAID|pennsaid
574217|NCT01119885|chronic pain|chronic pain
574218|NCT01119885|fentanyl matrix|fentanyl matrix
574219|NCT01119885|arthritis|arthritis
574220|NCT01119885|osteoarthritis|osteoarthritis
574221|NCT01119872|Positive-Pressure Respiration|positive-pressure respiration
574222|NCT01119872|Respiration, Artificial|respiration, artificial
574223|NCT01119846|Tolerability|tolerability
574224|NCT01119846|Pharmacokinetics|pharmacokinetics
574225|NCT01119846|Safety|safety
574226|NCT01119846|Pharmacodynamics|pharmacodynamics
574227|NCT01119846|Glucose|glucose
574228|NCT01119833|Sickle Cell Disease|sickle cell disease
574229|NCT01119820|elective obstetric or gynecologic surgery|elective obstetric or gynecologic surgery
574230|NCT01119807|Intraosseous infusion|intraosseous infusion
574231|NCT01119807|Emergency Medical Services|emergency medical services
574232|NCT01119794|B-cell small lymphocytic lymphoma|b-cell small lymphocytic lymphoma
574233|NCT01119794|marginal zone lymphoma|marginal zone lymphoma
574234|NCT01119794|follicular lymphoma|follicular lymphoma
574235|NCT01119794|mantle cell lymphoma|mantle cell lymphoma
574236|NCT01119794|Waldenström macroglobulinemia.|waldenström macroglobulinemia.
574237|NCT01119794|Low Grade B cell Non-Hodgkins Lymphoma|low grade b cell non-hodgkins lymphoma
574239|NCT01119768|Nexium|nexium
574240|NCT01119768|Phase IV|phase iv
574241|NCT01119768|Co-diagnosed NERD|co-diagnosed nerd
574242|NCT01119755|TREATMENT OF HYPERTENSION|treatment of hypertension
574243|NCT01119742|Tinea Pedis|tinea pedis
574244|NCT01119742|Interdigital|interdigital
574245|NCT01119729|Cardiac Diseases • HIV-Infection • AIDS • Antiretroviral Therapy|cardiac diseases • hiv-infection • aids • antiretroviral therapy
574246|NCT01119716|Atrial Fibrillation|atrial fibrillation
574247|NCT01119716|Afib|afib
574248|NCT01119716|cardioversion|cardioversion
574249|NCT01119716|normal sinus rhythm|normal sinus rhythm
574250|NCT01119716|arrhythmia|arrhythmia
574251|NCT01119716|AF|af
574252|NCT01119703|Vaccine Hyporesponse|vaccine hyporesponse
574253|NCT01119690|Dietary|dietary
574254|NCT01119690|Cross-Over Study|cross-over study
574255|NCT01119690|Lipids|lipids
574256|NCT01119690|Rapeseed oil|rapeseed oil
574257|NCT01119690|Butter|butter
574258|NCT01119690|Milk Fat|milk fat
574259|NCT01119690|Unsaturated Fat|unsaturated fat
729502|NCT00511368|HIV|hiv
574260|NCT01119690|Saturated Fat|saturated fat
574261|NCT01119690|Oxidized LDL|oxidized ldl
574262|NCT01119690|Platelet Function|platelet function
574263|NCT01119690|Arterial Elasticity|arterial elasticity
574264|NCT01119664|Adult subjects with malignant pleural mesothelioma who present for first (front) line or second line chemotherapy,|adult subjects with malignant pleural mesothelioma who present for first (front) line or second line chemotherapy,
574265|NCT01119651|Healthy Volunteer Subjects|healthy volunteer subjects
574266|NCT01119638|Alzheimer's disease|alzheimer's disease
574267|NCT01119638|BPSD|bpsd
574268|NCT01119638|escitalopram|escitalopram
574269|NCT01119638|Risperidone|risperidone
574270|NCT01119638|Agitation|agitation
574271|NCT01119638|Psychosis|psychosis
574272|NCT01119638|Dementia|dementia
574273|NCT01119638|Elderly|elderly
574274|NCT01119625|safety|safety
574275|NCT01119625|Streptococcus pneumoniae|streptococcus pneumoniae
574276|NCT01119625|immunogenicity|immunogenicity
574277|NCT01119625|Pneumococcal conjugate vaccine|pneumococcal conjugate vaccine
574278|NCT01119625|Haemophilus influenzae|haemophilus influenzae
574279|NCT01119612|Malaria|malaria
574280|NCT01119612|Iron|iron
574282|NCT01119612|Anemia|anemia
574283|NCT01119612|Birth Weight|birth weight
574284|NCT01119586|B-cell adult acute lymphoblastic leukemia|b-cell adult acute lymphoblastic leukemia
574285|NCT01119586|B-cell childhood acute lymphoblastic leukemia|b-cell childhood acute lymphoblastic leukemia
574286|NCT01119586|untreated adult acute lymphoblastic leukemia|untreated adult acute lymphoblastic leukemia
574287|NCT01119586|untreated childhood acute lymphoblastic leukemia|untreated childhood acute lymphoblastic leukemia
574288|NCT01119573|stage I endometrial carcinoma|stage i endometrial carcinoma
574289|NCT01119573|stage III endometrial carcinoma|stage iii endometrial carcinoma
574290|NCT01119547|Musculoskeletal Diseases|musculoskeletal diseases
574291|NCT01119547|Osteoarthritis|osteoarthritis
574292|NCT01119547|Joint Diseases|joint diseases
574293|NCT01119547|Arthritis|arthritis
574294|NCT01119547|Rheumatic Diseases|rheumatic diseases
574295|NCT01119534|Cough treatment|cough treatment
574296|NCT01119521|South Africa,tuberculosis,vaccine|south africa,tuberculosis,vaccine
574297|NCT01119508|Advanced|advanced
574298|NCT01119508|Inoperable|inoperable
574299|NCT01119508|Melanoma|melanoma
574300|NCT01119508|Ipilimumab|ipilimumab
574301|NCT01119508|MDX010|mdx010
574302|NCT01119508|BMS-734016|bms-734016
574303|NCT01119508|Temozolomide|temozolomide
574304|NCT01119508|Temodar|temodar
574305|NCT01119508|TMZ|tmz
574306|NCT01119508|skin|skin
574307|NCT01119508|mucosal|mucosal
574308|NCT01119482|Serogroup A meningococcal vaccine|serogroup a meningococcal vaccine
574309|NCT01119482|meningococcal carriage|meningococcal carriage
574310|NCT01119482|incidence|incidence
574311|NCT01119482|prevalence|prevalence
574312|NCT01119469|Hypochondriasis|hypochondriasis
574313|NCT01119469|Health Anxiety|health anxiety
574314|NCT01119469|randomized controlled trial|randomized controlled trial
574315|NCT01119469|Cognitive Therapy|cognitive therapy
574316|NCT01119469|Exposure Therapy|exposure therapy
574317|NCT01119456|Tumors|tumors
574318|NCT01119456|Macrophage stimulating 1 receptor, human|macrophage stimulating 1 receptor, human
574319|NCT01119456|RON protein|ron protein
574320|NCT01119456|RON receptor protein tyrosine kinase|ron receptor protein tyrosine kinase
574321|NCT01119430|major depression|major depression
574322|NCT01119430|DU 125530|du 125530
574323|NCT01119430|Treatment depression|treatment depression
574324|NCT01119430|Latency antidepressant|latency antidepressant
574325|NCT01119417|supine Hypertension|supine hypertension
574326|NCT01119417|autonomic failure|autonomic failure
574327|NCT01119417|BQ123|bq123
574328|NCT01119417|BQ-123|bq-123
574329|NCT01119417|endothelin|endothelin
574330|NCT01119404|Metabolic Syndrome|metabolic syndrome
574331|NCT01119404|Coronary Heart Disease|coronary heart disease
574332|NCT01119404|Erectile Dysfunction|erectile dysfunction
574334|NCT01119404|Oxidized Low Density Lipoprotein|oxidized low density lipoprotein
574335|NCT01119404|Cardiovascular Diseases|cardiovascular diseases
574336|NCT01119404|Risk Assessment|risk assessment
574337|NCT01119404|Endothelial Dysfunction|endothelial dysfunction
574338|NCT01119404|Diabetes Mellitus|diabetes mellitus
574339|NCT01119404|Surrogate Markers|surrogate markers
574340|NCT01119404|Risk Factors|risk factors
574341|NCT01119391|IVF|ivf
574342|NCT01119391|Lifestyle habits|lifestyle habits
574343|NCT01119378|Post menopausal|post menopausal
574344|NCT01119378|Vitamin D sufficiency|vitamin d sufficiency
574345|NCT01119378|Calcium absorption efficiency|calcium absorption efficiency
574346|NCT01119378|Dual isotope technique|dual isotope technique
574347|NCT01119365|Healthy controls|healthy controls
574348|NCT01119352|Safety|safety
574349|NCT01119352|tolerability|tolerability
574350|NCT01119352|PK|pk
574351|NCT01119352|healthy|healthy
574352|NCT01119352|overweight|overweight
574353|NCT01119352|obese|obese
574354|NCT01119339|psoriasis|psoriasis
574355|NCT01119339|topical|topical
574356|NCT01119339|psoriasis plaques test|psoriasis plaques test
574357|NCT01119326|scar prevention|scar prevention
574358|NCT01119326|healing|healing
574359|NCT01119326|tissue|tissue
574360|NCT01119326|AFT|aft
574361|NCT01119326|scar analysis|scar analysis
574362|NCT01119300|Venous Thromboembolism (VTE)|venous thromboembolism (vte)
574363|NCT01119300|Atrial Fibrillation (AF)|atrial fibrillation (af)
574364|NCT01119287|Conjunctivitis|conjunctivitis
574365|NCT01119287|ocular allergy|ocular allergy
574366|NCT01119261|Venous thromboembolism (VTE)|venous thromboembolism (vte)
574367|NCT01119261|Atrial fibrillation (AF)|atrial fibrillation (af)
574368|NCT01119248|Children MRI General Anesthesia|children mri general anesthesia
574369|NCT01119235|Pharmacokinetics|pharmacokinetics
574370|NCT01119235|tablet performance|tablet performance
574371|NCT01119235|healthy volunteers|healthy volunteers
574372|NCT01119235|open label|open label
574373|NCT01119222|Cold pain methodology|cold pain methodology
574374|NCT01119222|Healthy male volunteers|healthy male volunteers
574375|NCT01119222|gabapentin|gabapentin
574376|NCT01119222|Diphenhydramine|diphenhydramine
574377|NCT01119222|morphine|morphine
574378|NCT01119209|Hip fracture|hip fracture
574379|NCT01119209|intertrochanteric|intertrochanteric
574380|NCT01119196|Peritoneal Dialysis|peritoneal dialysis
574935|NCT01117506|CHD|chd
574381|NCT01119196|Insulin resistance|insulin resistance
574382|NCT01119183|Patient understanding and counseling|patient understanding and counseling
574383|NCT01119170|nutrition|nutrition
574384|NCT01119170|infant formula|infant formula
574385|NCT01119170|probiotics|probiotics
574386|NCT01119157|influenza vaccine|influenza vaccine
574387|NCT01119157|cellular immune response|cellular immune response
574388|NCT01119157|humoral immune response|humoral immune response
574389|NCT01119144|Orbital|orbital
574390|NCT01119144|fractures|fractures
574391|NCT01119144|enophthalmos|enophthalmos
574392|NCT01119144|diplopia|diplopia
574393|NCT01119144|eye|eye
574394|NCT01119131|Vitamin D|vitamin d
574395|NCT01119131|Parkinson disease|parkinson disease
574396|NCT01119131|accidental falls|accidental falls
574397|NCT01119118|Metastatic|metastatic
574398|NCT01119118|castrate-resistant prostate cancer|castrate-resistant prostate cancer
574399|NCT01119118|bone metastasis|bone metastasis
574400|NCT01119105|acute bacterial skin and skin structure infection|acute bacterial skin and skin structure infection
574401|NCT01119105|bacteria|bacteria
574402|NCT01119092|Ankle Sprain|ankle sprain
574403|NCT01119092|Joint Mobilization|joint mobilization
574404|NCT01119092|Manual Therapy|manual therapy
574405|NCT01119092|Range of Motion|range of motion
574406|NCT01119079|labor pain|labor pain
574407|NCT01119079|epidural|epidural
574408|NCT01119066|Leukemia|leukemia
574409|NCT01119066|Multiple Myeloma|multiple myeloma
574410|NCT01119066|radiation|radiation
574411|NCT01119066|Thiotepa|thiotepa
574412|NCT01119066|cyclophosphamide|cyclophosphamide
574413|NCT01119066|fludarabine|fludarabine
574414|NCT01119066|Clofarabine|clofarabine
574415|NCT01119066|CliniMACS device|clinimacs device
574416|NCT01119066|GCSF|gcsf
574417|NCT01119066|10-050|10-050
574418|NCT01119053|VNS|vns
574419|NCT01119053|Depression|depression
574420|NCT01119053|Personality-Disorder|personality-disorder
574421|NCT01119053|Stimulation|stimulation
574422|NCT01119040|Dislodged PEG tube|dislodged peg tube
574423|NCT01119040|NOTES|notes
574424|NCT01119027|Laparoscopic Colectomy|laparoscopic colectomy
574425|NCT01119027|Colorectal Skills Training|colorectal skills training
574426|NCT01119014|Aripiprazole|aripiprazole
574427|NCT01119014|Quetiapine|quetiapine
574428|NCT01119014|Psychosis|psychosis
574429|NCT01119014|Child|child
574430|NCT01119014|Adolescent|adolescent
574431|NCT01118988|Peer Support|peer support
574432|NCT01118988|Social Support|social support
574433|NCT01118988|Chronic Pain|chronic pain
574434|NCT01118988|Behavioral Interventions for Pain|behavioral interventions for pain
574435|NCT01118988|Adolescents|adolescents
574436|NCT01118988|Children|children
574437|NCT01118988|Pediatric|pediatric
574438|NCT01118988|Mentorship|mentorship
574439|NCT01118988|Complementary and Alternative Medicine|complementary and alternative medicine
574440|NCT01118988|CAM|cam
574441|NCT01118988|Pain|pain
574442|NCT01118988|Pain Management|pain management
574443|NCT01118988|Behavioral|behavioral
574444|NCT01118975|lapatinib ditosylate|lapatinib ditosylate
574445|NCT01118975|Zolinza (vorinostat)|zolinza (vorinostat)
574446|NCT01118975|Cancer Stem Cells|cancer stem cells
574447|NCT01118962|Primary Generalized Tonic-Clonic (PGTC) Seizures|primary generalized tonic-clonic (pgtc) seizures
574448|NCT01118962|Absence Seizures|absence seizures
574449|NCT01118962|Myoclonic Seizures|myoclonic seizures
574450|NCT01118962|Idiopathic Generalized Epilepsy (IGE)|idiopathic generalized epilepsy (ige)
574451|NCT01118949|Primary Generalized Tonic-Clonic (PGTC) Seizures|primary generalized tonic-clonic (pgtc) seizures
574452|NCT01118949|Absence Seizures|absence seizures
574453|NCT01118949|Myoclonic Seizures|myoclonic seizures
574454|NCT01118949|Idiopathic Generalized Epilepsy (IGE)|idiopathic generalized epilepsy (ige)
574455|NCT01118936|Chronic Obstructive Pulmonary Disease|chronic obstructive pulmonary disease
574456|NCT01118936|Daily magnesium supplement|daily magnesium supplement
574457|NCT01118936|EQ-5D|eq-5d
574458|NCT01118923|Bronchial challenge test|bronchial challenge test
574459|NCT01118923|Hyperreactivity|hyperreactivity
574460|NCT01118923|PD20 for metacholine|pd20 for metacholine
574461|NCT01118923|Daily magnesium supplement|daily magnesium supplement
574462|NCT01118910|Intertrigo|intertrigo
574463|NCT01118910|Vusion|vusion
574464|NCT01118897|Gall bladder|gall bladder
574465|NCT01118897|Pancreatic cancers|pancreatic cancers
574466|NCT01118897|Tomotherapy|tomotherapy
574467|NCT01118884|Midazolam|midazolam
574468|NCT01118884|Nitrous oxide|nitrous oxide
574469|NCT01118884|Behaviour management|behaviour management
574470|NCT01118871|Treatment experienced|treatment experienced
574471|NCT01118858|CYP2D6|cyp2d6
574472|NCT01118858|CYP3A4|cyp3a4
574473|NCT01118858|cytochrome P450|cytochrome p450
574474|NCT01118858|children|children
574475|NCT01118858|pediatrics|pediatrics
574476|NCT01118858|dextromethorphan|dextromethorphan
574477|NCT01118858|phenotype|phenotype
574478|NCT01118858|genotype|genotype
574479|NCT01118845|Non-Hodgkin's lymphoma|non-hodgkin's lymphoma
574480|NCT01118845|Lymphoma, Large B-Cell|lymphoma, large b-cell
574688|NCT01118208|Medication adherence|medication adherence
574481|NCT01118845|Diffuse, Mantle cell lymphoma, Lymphoma|diffuse, mantle cell lymphoma, lymphoma
574482|NCT01118845|Follicular, Lymphoma|follicular, lymphoma
574483|NCT01118845|Large B-Cell, Diffuse|large b-cell, diffuse
574484|NCT01118832|Thermography|thermography
574485|NCT01118819|Phase I|phase i
574486|NCT01118819|Metastatic Disease|metastatic disease
574487|NCT01118819|Solid Tumor|solid tumor
574488|NCT01118819|Malignancy|malignancy
574489|NCT01118819|Metastases|metastases
574490|NCT01118819|Clinical trial|clinical trial
574491|NCT01118819|Hypoxia|hypoxia
574492|NCT01118819|Necrosis|necrosis
574493|NCT01118780|GAD|gad
574494|NCT01118780|Generalized Anxiety Disorder|generalized anxiety disorder
574495|NCT01118780|Anxiety|anxiety
574496|NCT01118767|Adherence|adherence
574497|NCT01118767|Appointment|appointment
574498|NCT01118767|Cell Phone|cell phone
574499|NCT01118767|Cellular Phone|cellular phone
574500|NCT01118767|Clinic|clinic
574501|NCT01118767|Computers|computers
574502|NCT01118767|Controlled Clinical Trials, Randomized|controlled clinical trials, randomized
574503|NCT01118767|HIV/AIDS|hiv/aids
574504|NCT01118767|Health Informatics|health informatics
574505|NCT01118767|Health behavior|health behavior
574506|NCT01118767|Information Technology|information technology
574507|NCT01118767|Internet|internet
574508|NCT01118767|Intervention|intervention
574509|NCT01118767|Medication|medication
574510|NCT01118767|Patient Satisfaction|patient satisfaction
574511|NCT01118767|Patient Self-Report|patient self-report
574512|NCT01118767|Patients|patients
574513|NCT01118767|Peru|peru
574514|NCT01118767|Phone|phone
574515|NCT01118767|Public Health|public health
574516|NCT01118767|Public Health Informatics|public health informatics
574517|NCT01118767|Randomized|randomized
574518|NCT01118767|Randomized Controlled Clinical Trials|randomized controlled clinical trials
574519|NCT01118767|Randomized Controlled Trials|randomized controlled trials
574520|NCT01118767|Research|research
574521|NCT01118767|Secondary Prevention|secondary prevention
574522|NCT01118767|Self-Report|self-report
574523|NCT01118767|Sex Behavior|sex behavior
574524|NCT01118767|Sexual Behavior|sexual behavior
574525|NCT01118767|Sexually Transmitted Diseases|sexually transmitted diseases
574526|NCT01118767|Sexually Transmitted Infection|sexually transmitted infection
574527|NCT01118767|Survey Instrument|survey instrument
574528|NCT01118767|Surveys|surveys
574529|NCT01118767|Telephone|telephone
574530|NCT01118767|Telephone, Cellular|telephone, cellular
574531|NCT01118767|Text|text
574532|NCT01118767|Unprotected Sex|unprotected sex
574533|NCT01118767|Viral Load result|viral load result
574534|NCT01118767|Vulnerable Populations|vulnerable populations
574535|NCT01118767|WWW|www
574536|NCT01118767|anti-retroviral therapy|anti-retroviral therapy
574537|NCT01118767|consumer informatics|consumer informatics
574538|NCT01118767|evidence base|evidence base
574539|NCT01118767|follow-up|follow-up
574540|NCT01118767|medication adherence|medication adherence
574541|NCT01118767|medication compliance|medication compliance
574542|NCT01118767|randomization|randomization
574543|NCT01118767|randomized controlled study|randomized controlled study
574544|NCT01118767|randomized trial|randomized trial
574545|NCT01118767|randomly assigned|randomly assigned
574546|NCT01118767|safer sex|safer sex
574547|NCT01118767|treatment adherence|treatment adherence
574548|NCT01118767|user centered design|user centered design
574549|NCT01118767|web|web
574550|NCT01118767|world wide web|world wide web
574551|NCT01118754|Santen|santen
574552|NCT01118754|Dry|dry
574553|NCT01118754|Eye|eye
574554|NCT01118741|Rising PSA|rising psa
729848|NCT00510016|infants|infants
574555|NCT01118741|Recurrent Non Metastatic Prostate Cancer|recurrent non metastatic prostate cancer
574556|NCT01118715|distal radius fracture|distal radius fracture
574557|NCT01118715|post-traumatic carpal tunnel syndrome|post-traumatic carpal tunnel syndrome
574558|NCT01118715|complex regional pain syndrome|complex regional pain syndrome
574559|NCT01118715|compression glove|compression glove
574560|NCT01118715|edema glove|edema glove
574561|NCT01118702|Pharmacokinetic|pharmacokinetic
574562|NCT01118702|Methylphenidate|methylphenidate
574563|NCT01118702|Novo-methylphenidate ER-C|novo-methylphenidate er-c
574564|NCT01118702|Ritalin-SR|ritalin-sr
574565|NCT01118702|CONCERTA|concerta
574566|NCT01118702|Plasma profile|plasma profile
574567|NCT01118676|locally advanced non small cell lung cancer (NSCLC), locally advanced, Phase I, Cilengitide, concomitant radiochemotherapy|locally advanced non small cell lung cancer (nsclc), locally advanced, phase i, cilengitide, concomitant radiochemotherapy
574568|NCT01118663|Acetaminophen overdose; induced hepatotoxicity, liver injury|acetaminophen overdose; induced hepatotoxicity, liver injury
574569|NCT01118650|Inattention|inattention
574570|NCT01118650|Hyperactivity|hyperactivity
574571|NCT01118650|Impulsivity|impulsivity
574572|NCT01118637|trichotillomania|trichotillomania
574573|NCT01118637|self-help|self-help
574574|NCT01118637|web-based|web-based
574575|NCT01118637|habit reversal|habit reversal
574576|NCT01118637|behavior therapy|behavior therapy
574577|NCT01118624|Female|female
574578|NCT01118624|Advanced|advanced
574579|NCT01118624|Metastatic|metastatic
574827|NCT01117909|arthritis|arthritis
574580|NCT01118611|unspecified adult solid tumor, protocol specific|unspecified adult solid tumor, protocol specific
574581|NCT01118598|PCOS|pcos
574582|NCT01118585|GERD|gerd
574583|NCT01118585|Esophagitis|esophagitis
574584|NCT01118585|Fundoplication|fundoplication
574585|NCT01118585|Anti-reflux surgery|anti-reflux surgery
574586|NCT01118585|PPI dependent|ppi dependent
574587|NCT01118572|Celecoxib|celecoxib
574589|NCT01118572|Pain|pain
574590|NCT01118572|Surgery|surgery
574591|NCT01118572|NSAIDs|nsaids
574592|NCT01118559|YM150|ym150
574593|NCT01118559|Food effect|food effect
574594|NCT01118559|Healthy volunteer|healthy volunteer
574595|NCT01118546|aspirin|aspirin
574596|NCT01118546|coronary artery disease|coronary artery disease
574597|NCT01118546|hypersensitivity|hypersensitivity
574598|NCT01118546|Platelet aggregation|platelet aggregation
574599|NCT01118533|Intubation|intubation
574600|NCT01118533|Sore throat|sore throat
574601|NCT01118533|Blades|blades
574602|NCT01118533|Laryngoscopy|laryngoscopy
574603|NCT01118533|Morbidity|morbidity
574604|NCT01118520|abdominal aortic aneurysm|abdominal aortic aneurysm
574605|NCT01118520|ACE Inhibition|ace inhibition
574606|NCT01118507|Trisomy of chromosome 21 diagnosis|trisomy of chromosome 21 diagnosis
574607|NCT01118507|first trimester of pregnancy|first trimester of pregnancy
574608|NCT01118507|maternal blood|maternal blood
574609|NCT01118507|High output shotgun sequencing|high output shotgun sequencing
574611|NCT01118494|RAS|ras
574612|NCT01118494|AGT|agt
574613|NCT01118481|Coronary stenosis|coronary stenosis
574614|NCT01118481|Wave intensity analysis|wave intensity analysis
574615|NCT01118481|Instantaneous Flow Reserve|instantaneous flow reserve
574616|NCT01118481|iFR|ifr
574617|NCT01118481|Fractional Flow Reserve|fractional flow reserve
574618|NCT01118468|Competitive Flow|competitive flow
574619|NCT01118468|Coronary artery bypass|coronary artery bypass
574620|NCT01118468|Wave Intensity Analysis|wave intensity analysis
574621|NCT01118442|Aortic Stenosis|aortic stenosis
574622|NCT01118442|Coronary Flow|coronary flow
574623|NCT01118442|Wave Intensity Analysis|wave intensity analysis
574624|NCT01118429|hyperhidrosis|hyperhidrosis
574625|NCT01118429|axillary|axillary
574626|NCT01118429|osmidrosis|osmidrosis
574627|NCT01118429|oxybutynin|oxybutynin
574628|NCT01118416|sexual risk|sexual risk
574629|NCT01118416|substance use|substance use
574630|NCT01118416|HIV|hiv
574631|NCT01118416|prevention|prevention
574632|NCT01118416|intervention|intervention
574633|NCT01118416|Motivational Enhancement Therapy|motivational enhancement therapy
574634|NCT01118416|young men who have sex with men|young men who have sex with men
574635|NCT01118403|Ventilator associated pneumonia|ventilator associated pneumonia
574636|NCT01118403|Coma|coma
574637|NCT01118403|Brain Injuries|brain injuries
574638|NCT01118403|Intensive care units|intensive care units
574639|NCT01118403|antibiotic prophylaxis|antibiotic prophylaxis
574640|NCT01118390|telangiectasias|telangiectasias
574641|NCT01118390|leg|leg
574642|NCT01118390|sclerotherapy|sclerotherapy
574643|NCT01118390|laser|laser
574644|NCT01118390|glycose|glycose
574645|NCT01118364|Social circumstances|social circumstances
574646|NCT01118325|Stable Coronary Artery Disease|stable coronary artery disease
574647|NCT01118325|Platelet Aggregation|platelet aggregation
574648|NCT01118312|Asthma|asthma
574649|NCT01118312|Rhinitis|rhinitis
574650|NCT01118312|Sinusitis|sinusitis
574651|NCT01118312|Chronic|chronic
574652|NCT01118312|ACRC|acrc
574653|NCT01118312|STAN|stan
730029|NCT00509678|Rituxan|rituxan
574654|NCT01118312|Nasal steroid|nasal steroid
574655|NCT01118312|Mometasone|mometasone
574656|NCT01118312|Nasal spray|nasal spray
574657|NCT01118299|ACP|acp
574658|NCT01118299|Atrial Fibrillation|atrial fibrillation
574659|NCT01118299|AF|af
574660|NCT01118299|A Fib|a fib
574661|NCT01118299|Stroke|stroke
574662|NCT01118299|Coumadin|coumadin
574663|NCT01118299|Warfarin|warfarin
574664|NCT01118299|Dabigatran|dabigatran
574665|NCT01118299|Pradaxa|pradaxa
574666|NCT01118299|Blood thinning medication|blood thinning medication
574667|NCT01118299|Left atrial appendage|left atrial appendage
574668|NCT01118299|LAA|laa
574669|NCT01118286|Hypertension|hypertension
574670|NCT01118286|Drug therapy, combination|drug therapy, combination
574671|NCT01118273|Naproxen sodium|naproxen sodium
574672|NCT01118273|Diphenhydramine|diphenhydramine
574673|NCT01118273|Drugs, Investigational|drugs, investigational
574674|NCT01118260|prostata hyperplasia|prostata hyperplasia
574675|NCT01118260|transurethral resection|transurethral resection
574676|NCT01118260|TIVA|tiva
574677|NCT01118260|spinal anaesthesia|spinal anaesthesia
574678|NCT01118247|Uncemented THA|uncemented tha
574679|NCT01118247|alumina-on-alumina|alumina-on-alumina
574680|NCT01118247|survival|survival
574681|NCT01118247|HHS|hhs
574682|NCT01118247|Patient satisfaction|patient satisfaction
574683|NCT01118234|CLL|cll
574684|NCT01118234|Rituximab|rituximab
574685|NCT01118234|Maintenance|maintenance
574686|NCT01118221|oxidant stress|oxidant stress
574687|NCT01118221|exercise|exercise
574689|NCT01118208|Accidental overdose|accidental overdose
574690|NCT01118208|Deliberate overdose|deliberate overdose
574691|NCT01118208|Suicide, attempted|suicide, attempted
574692|NCT01118182|Traumatic Brain Injury|traumatic brain injury
574693|NCT01118182|Veterans|veterans
574694|NCT01118182|Psychiatric Disorders|psychiatric disorders
574695|NCT01118182|Suicide|suicide
574696|NCT01118169|Personal values|personal values
574697|NCT01118169|Suicidal thoughts|suicidal thoughts
574698|NCT01118156|Suicide Nomenclature|suicide nomenclature
574699|NCT01118130|Genetics|genetics
574700|NCT01118130|genomics|genomics
574701|NCT01118130|Multiple Sclerosis|multiple sclerosis
574702|NCT01118130|beta-interferons|beta-interferons
574703|NCT01118117|atherosclerotic stenosis|atherosclerotic stenosis
574704|NCT01118117|occlusions|occlusions
574705|NCT01118117|Superficial Femoral Artery|superficial femoral artery
574706|NCT01118117|SFA|sfa
574707|NCT01118091|Immunotherapy|immunotherapy
574708|NCT01118091|Metastatic Melanoma|metastatic melanoma
574709|NCT01118091|Randomized|randomized
574710|NCT01118091|Cell Therapy|cell therapy
574711|NCT01118091|Skin Cancer|skin cancer
574712|NCT01118091|Melanoma|melanoma
574713|NCT01118065|anaplastic thyroid cancer|anaplastic thyroid cancer
574714|NCT01118065|recurrent thyroid cancer|recurrent thyroid cancer
574715|NCT01118065|stage III follicular thyroid cancer|stage iii follicular thyroid cancer
574716|NCT01118065|stage III papillary thyroid cancer|stage iii papillary thyroid cancer
574717|NCT01118065|stage IV follicular thyroid cancer|stage iv follicular thyroid cancer
574718|NCT01118065|stage IV papillary thyroid cancer|stage iv papillary thyroid cancer
574719|NCT01118065|thyroid gland medullary carcinoma|thyroid gland medullary carcinoma
574720|NCT01118039|localized transitional cell cancer of the renal pelvis and ureter|localized transitional cell cancer of the renal pelvis and ureter
574721|NCT01118039|metastatic transitional cell cancer of the renal pelvis and ureter|metastatic transitional cell cancer of the renal pelvis and ureter
574722|NCT01118039|recurrent transitional cell cancer of the renal pelvis and ureter|recurrent transitional cell cancer of the renal pelvis and ureter
574723|NCT01118039|transitional cell carcinoma of the bladder|transitional cell carcinoma of the bladder
574724|NCT01118039|distal urethral cancer|distal urethral cancer
574725|NCT01118039|proximal urethral cancer|proximal urethral cancer
574726|NCT01118039|recurrent urethral cancer|recurrent urethral cancer
574727|NCT01118039|recurrent bladder cancer|recurrent bladder cancer
574728|NCT01118039|stage IV bladder cancer|stage iv bladder cancer
574729|NCT01118039|stage III bladder cancer|stage iii bladder cancer
574730|NCT01118039|urethral cancer associated with invasive bladder cancer|urethral cancer associated with invasive bladder cancer
574731|NCT01118039|stage III urethral cancer|stage iii urethral cancer
574732|NCT01118039|stage IV urethral cancer|stage iv urethral cancer
574733|NCT01118026|stage I adult Hodgkin lymphoma|stage i adult hodgkin lymphoma
574734|NCT01118026|stage II adult Hodgkin lymphoma|stage ii adult hodgkin lymphoma
574735|NCT01118026|adult favorable prognosis Hodgkin lymphoma|adult favorable prognosis hodgkin lymphoma
574736|NCT01118026|adult lymphocyte depletion Hodgkin lymphoma|adult lymphocyte depletion hodgkin lymphoma
574737|NCT01118026|adult lymphocyte predominant Hodgkin lymphoma|adult lymphocyte predominant hodgkin lymphoma
574738|NCT01118026|adult mixed cellularity Hodgkin lymphoma|adult mixed cellularity hodgkin lymphoma
574739|NCT01118026|adult nodular sclerosis Hodgkin lymphoma|adult nodular sclerosis hodgkin lymphoma
574740|NCT01118026|adult unfavorable prognosis Hodgkin lymphoma|adult unfavorable prognosis hodgkin lymphoma
574741|NCT01118013|adult acute myeloid leukemia with 11q23 (MLL) abnormalities|adult acute myeloid leukemia with 11q23 (mll) abnormalities
574742|NCT01118013|adult acute myeloid leukemia with inv(16)(p13;q22)|adult acute myeloid leukemia with inv(16)(p13;q22)
574743|NCT01118013|adult acute myeloid leukemia with t(15;17)(q22;q12)|adult acute myeloid leukemia with t(15;17)(q22;q12)
574744|NCT01118013|adult acute myeloid leukemia with t(16;16)(p13;q22)|adult acute myeloid leukemia with t(16;16)(p13;q22)
574745|NCT01118013|adult acute myeloid leukemia with t(8;21)(q22;q22)|adult acute myeloid leukemia with t(8;21)(q22;q22)
574746|NCT01118013|juvenile myelomonocytic leukemia|juvenile myelomonocytic leukemia
574747|NCT01118013|prolymphocytic leukemia|prolymphocytic leukemia
574748|NCT01118013|recurrent adult acute myeloid leukemia|recurrent adult acute myeloid leukemia
574749|NCT01118013|recurrent adult T-cell leukemia/lymphoma|recurrent adult t-cell leukemia/lymphoma
574750|NCT01118013|recurrent childhood acute myeloid leukemia|recurrent childhood acute myeloid leukemia
574751|NCT01118013|refractory chronic lymphocytic leukemia|refractory chronic lymphocytic leukemia
574752|NCT01118013|recurrent adult Hodgkin lymphoma|recurrent adult hodgkin lymphoma
574753|NCT01118013|recurrent adult Burkitt lymphoma|recurrent adult burkitt lymphoma
574754|NCT01118013|recurrent adult diffuse large cell lymphoma|recurrent adult diffuse large cell lymphoma
574755|NCT01118013|recurrent adult diffuse mixed cell lymphoma|recurrent adult diffuse mixed cell lymphoma
574756|NCT01118013|recurrent adult diffuse small cleaved cell lymphoma|recurrent adult diffuse small cleaved cell lymphoma
574757|NCT01118013|recurrent adult grade III lymphomatoid granulomatosis|recurrent adult grade iii lymphomatoid granulomatosis
574758|NCT01118013|recurrent adult immunoblastic large cell lymphoma|recurrent adult immunoblastic large cell lymphoma
574759|NCT01118013|recurrent adult lymphoblastic lymphoma|recurrent adult lymphoblastic lymphoma
574760|NCT01118013|recurrent childhood grade III lymphomatoid granulomatosis|recurrent childhood grade iii lymphomatoid granulomatosis
574761|NCT01118013|recurrent childhood large cell lymphoma|recurrent childhood large cell lymphoma
574762|NCT01118013|recurrent childhood lymphoblastic lymphoma|recurrent childhood lymphoblastic lymphoma
574763|NCT01118013|recurrent childhood small noncleaved cell lymphoma|recurrent childhood small noncleaved cell lymphoma
574764|NCT01118013|recurrent cutaneous T-cell non-Hodgkin lymphoma|recurrent cutaneous t-cell non-hodgkin lymphoma
574765|NCT01118013|recurrent mycosis fungoides/Sezary syndrome|recurrent mycosis fungoides/sezary syndrome
574766|NCT01118013|recurrent grade 1 follicular lymphoma|recurrent grade 1 follicular lymphoma
574767|NCT01118013|recurrent grade 2 follicular lymphoma|recurrent grade 2 follicular lymphoma
574768|NCT01118013|recurrent grade 3 follicular lymphoma|recurrent grade 3 follicular lymphoma
574769|NCT01118013|recurrent mantle cell lymphoma|recurrent mantle cell lymphoma
574770|NCT01118013|recurrent marginal zone lymphoma|recurrent marginal zone lymphoma
574771|NCT01118013|recurrent small lymphocytic lymphoma|recurrent small lymphocytic lymphoma
574772|NCT01118013|recurrent/refractory childhood Hodgkin lymphoma|recurrent/refractory childhood hodgkin lymphoma
574773|NCT01118013|childhood diffuse large cell lymphoma|childhood diffuse large cell lymphoma
574774|NCT01118013|childhood grade III lymphomatoid granulomatosis|childhood grade iii lymphomatoid granulomatosis
574775|NCT01118013|childhood immunoblastic large cell lymphoma|childhood immunoblastic large cell lymphoma
574776|NCT01118013|childhood nasal type extranodal NK/T-cell lymphoma|childhood nasal type extranodal nk/t-cell lymphoma
574777|NCT01118013|post-transplant lymphoproliferative disorder|post-transplant lymphoproliferative disorder
574778|NCT01118013|stage I multiple myeloma|stage i multiple myeloma
574779|NCT01118013|stage II multiple myeloma|stage ii multiple myeloma
574780|NCT01118013|stage III multiple myeloma|stage iii multiple myeloma
574781|NCT01118013|refractory multiple myeloma|refractory multiple myeloma
574782|NCT01118013|de novo myelodysplastic syndromes|de novo myelodysplastic syndromes
574783|NCT01118013|previously treated myelodysplastic syndromes|previously treated myelodysplastic syndromes
574784|NCT01118013|secondary myelodysplastic syndromes|secondary myelodysplastic syndromes
574785|NCT01118013|childhood myelodysplastic syndromes|childhood myelodysplastic syndromes
574786|NCT01118013|recurrent childhood anaplastic large cell lymphoma|recurrent childhood anaplastic large cell lymphoma
574787|NCT01118013|adult acute myelomonocytic leukemia (M4)|adult acute myelomonocytic leukemia (m4)
574788|NCT01118013|childhood acute myelomonocytic leukemia (M4)|childhood acute myelomonocytic leukemia (m4)
574789|NCT01118013|adult acute minimally differentiated myeloid leukemia (M0)|adult acute minimally differentiated myeloid leukemia (m0)
574790|NCT01118013|childhood acute minimally differentiated myeloid leukemia (M0)|childhood acute minimally differentiated myeloid leukemia (m0)
574791|NCT01118013|adult acute myeloblastic leukemia without maturation (M1)|adult acute myeloblastic leukemia without maturation (m1)
574792|NCT01118013|childhood acute myeloblastic leukemia without maturation (M1)|childhood acute myeloblastic leukemia without maturation (m1)
574793|NCT01118013|adult acute myeloblastic leukemia with maturation (M2)|adult acute myeloblastic leukemia with maturation (m2)
574794|NCT01118013|childhood acute myeloblastic leukemia with maturation (M2)|childhood acute myeloblastic leukemia with maturation (m2)
574795|NCT01118013|adult acute promyelocytic leukemia (M3)|adult acute promyelocytic leukemia (m3)
574796|NCT01118013|childhood acute promyelocytic leukemia (M3)|childhood acute promyelocytic leukemia (m3)
574797|NCT01118013|adult acute monoblastic leukemia (M5a)|adult acute monoblastic leukemia (m5a)
574798|NCT01118013|adult acute monocytic leukemia (M5b)|adult acute monocytic leukemia (m5b)
574799|NCT01118013|childhood acute monoblastic leukemia (M5a)|childhood acute monoblastic leukemia (m5a)
574800|NCT01118013|childhood acute monocytic leukemia (M5b)|childhood acute monocytic leukemia (m5b)
574801|NCT01118013|adult erythroleukemia (M6a)|adult erythroleukemia (m6a)
574802|NCT01118013|adult pure erythroid leukemia (M6b)|adult pure erythroid leukemia (m6b)
574803|NCT01118013|childhood acute erythroleukemia (M6)|childhood acute erythroleukemia (m6)
574804|NCT01118013|adult acute megakaryoblastic leukemia (M7)|adult acute megakaryoblastic leukemia (m7)
574805|NCT01118013|childhood acute megakaryocytic leukemia (M7)|childhood acute megakaryocytic leukemia (m7)
574806|NCT01118013|childhood Burkitt lymphoma|childhood burkitt lymphoma
574807|NCT01118013|atypical chronic myeloid leukemia, BCR-ABL1 negative|atypical chronic myeloid leukemia, bcr-abl1 negative
574808|NCT01118013|chronic myelomonocytic leukemia|chronic myelomonocytic leukemia
574809|NCT01118013|cutaneous B-cell non-Hodgkin lymphoma|cutaneous b-cell non-hodgkin lymphoma
574810|NCT01118013|extranodal marginal zone B-cell lymphoma of mucosa-associated lymphoid tissue|extranodal marginal zone b-cell lymphoma of mucosa-associated lymphoid tissue
574811|NCT01118013|nodal marginal zone B-cell lymphoma|nodal marginal zone b-cell lymphoma
574812|NCT01118013|splenic marginal zone lymphoma|splenic marginal zone lymphoma
574813|NCT01118013|myelodysplastic/myeloproliferative neoplasm, unclassifiable|myelodysplastic/myeloproliferative neoplasm, unclassifiable
574814|NCT01118000|ischemic preconditioning,serum proteins,human|ischemic preconditioning,serum proteins,human
574815|NCT01117987|Pulmonary arterial hypertension, imatinib, 6MWD, pulmonary hypertension|pulmonary arterial hypertension, imatinib, 6mwd, pulmonary hypertension
574816|NCT01117961|Excessive gestational weight gain|excessive gestational weight gain
574817|NCT01117935|IMRT|imrt
574818|NCT01117935|prostate cancer|prostate cancer
574819|NCT01117935|radiation therapy|radiation therapy
574820|NCT01117935|external beam|external beam
574821|NCT01117935|recurrent prostate cancer|recurrent prostate cancer
574822|NCT01117922|preterm birth|preterm birth
574823|NCT01117922|interconceptional intervention|interconceptional intervention
574824|NCT01117922|pregnancy outcomes|pregnancy outcomes
574825|NCT01117909|ankle sprain|ankle sprain
574826|NCT01117909|athletic injury|athletic injury
574829|NCT01117896|Rescuer fatigue|rescuer fatigue
574830|NCT01117896|Chest Compression effectiveness|chest compression effectiveness
574831|NCT01117883|Perfusion pressures|perfusion pressures
574832|NCT01117883|central venous pressure|central venous pressure
574833|NCT01117883|cardiac output|cardiac output
574834|NCT01117883|CPR|cpr
574835|NCT01117883|cardiac arrest|cardiac arrest
574836|NCT01117883|Leaning|leaning
574837|NCT01117883|incomplete release|incomplete release
574838|NCT01117870|chronic|chronic
574839|NCT01117870|pain|pain
574840|NCT01117870|lumbar|lumbar
574841|NCT01117870|Radicular|radicular
574842|NCT01117831|Diabetes mellitus|diabetes mellitus
574843|NCT01117805|Asthma|asthma
574844|NCT01117779|kidney tumors|kidney tumors
574845|NCT01117779|renal tumors|renal tumors
574846|NCT01117779|renal cell carcinoma|renal cell carcinoma
574847|NCT01117779|kidney lesions|kidney lesions
574848|NCT01117779|renal lesions|renal lesions
574849|NCT01117779|cryoablation|cryoablation
574850|NCT01117779|cryotherapy|cryotherapy
574851|NCT01117779|cryosurgery|cryosurgery
574852|NCT01117766|Methodology|methodology
574853|NCT01117766|Quantitative Sensory Testing|quantitative sensory testing
574854|NCT01117766|Neuropathies Pain|neuropathies pain
574855|NCT01117766|Pregabalin|pregabalin
574856|NCT01117740|Malignant Pleural Effusions|malignant pleural effusions
574857|NCT01117740|MPE|mpe
574858|NCT01117740|Lungs|lungs
574859|NCT01117740|Quality of Life|quality of life
574860|NCT01117740|M. D. Anderson Symptom Inventory|m. d. anderson symptom inventory
574861|NCT01117740|MDASI|mdasi
574862|NCT01117740|Indwelling Pleural Catheters|indwelling pleural catheters
574863|NCT01117740|Thoracoscopic Pleurodesis|thoracoscopic pleurodesis
574864|NCT01117740|Symptom burden|symptom burden
574865|NCT01117740|Pleurodesis efficacy|pleurodesis efficacy
574866|NCT01117740|Complications|complications
574867|NCT01117740|Health care resource utilization|health care resource utilization
574868|NCT01117714|Lung cancer|lung cancer
574869|NCT01117714|Lung neoplasm|lung neoplasm
574870|NCT01117714|Pulmonary cancer|pulmonary cancer
574871|NCT01117714|Pulmonary neoplasm|pulmonary neoplasm
574872|NCT01117714|Lung cancer staging|lung cancer staging
574873|NCT01117688|Ureteroscopy|ureteroscopy
574874|NCT01117675|Telemedicine|telemedicine
574875|NCT01117675|Home care|home care
574876|NCT01117675|Chronic HIV infection|chronic hiv infection
574877|NCT01117675|HIV-infected patients|hiv-infected patients
574878|NCT01117662|transplantation|transplantation
574879|NCT01117662|acute rejection|acute rejection
574880|NCT01117662|kidney|kidney
574881|NCT01117649|PVR|pvr
574882|NCT01117649|HES 130|hes 130
574883|NCT01117649|pancreatic head|pancreatic head
574884|NCT01117649|goal-directed|goal-directed
574885|NCT01117649|intraoperative PVR in elective surgery of the pancreatic head|intraoperative pvr in elective surgery of the pancreatic head
574886|NCT01117636|Aspirin|aspirin
574887|NCT01117623|Oncology patients with advanced disease|oncology patients with advanced disease
574888|NCT01117623|BAY73-4506|bay73-4506
574889|NCT01117610|pain|pain
574890|NCT01117610|preemptive|preemptive
574891|NCT01117610|postoperative|postoperative
574892|NCT01117610|epidural injection|epidural injection
574893|NCT01117610|laminectomy|laminectomy
574894|NCT01117597|Healthy subjects|healthy subjects
574895|NCT01117584|Type 2 diabetes|type 2 diabetes
574896|NCT01117584|ASP1941|asp1941
574897|NCT01117584|diabetes|diabetes
574898|NCT01117584|metformin|metformin
574899|NCT01117571|knee|knee
574900|NCT01117571|osteoarthritis|osteoarthritis
574901|NCT01117571|unicompartmental|unicompartmental
574902|NCT01117571|arthroplasty|arthroplasty
574903|NCT01117571|knee resurfacing|knee resurfacing
574904|NCT01117571|Conformis|conformis
574905|NCT01117571|patient specific|patient specific
574906|NCT01117558|PCOS,|pcos,
574907|NCT01117558|DM,|dm,
574908|NCT01117558|Hypertension,|hypertension,
574909|NCT01117558|CVD|cvd
574910|NCT01117545|veterans,|veterans,
574911|NCT01117545|PTSD,|ptsd,
574912|NCT01117545|EFT (Emotional Freedom Techniques),|eft (emotional freedom techniques),
574913|NCT01117545|depression,|depression,
574914|NCT01117545|anxiety|anxiety
574915|NCT01117532|students,|students,
574916|NCT01117532|depression,|depression,
574917|NCT01117532|group therapy,|group therapy,
574918|NCT01117532|EFT (Emotional Freedom Techniques),|eft (emotional freedom techniques),
574919|NCT01117532|energy psychology|energy psychology
574920|NCT01117519|fluid and volume management|fluid and volume management
574921|NCT01117519|acid-base balance|acid-base balance
574922|NCT01117519|goal-directed therapy|goal-directed therapy
574923|NCT01117519|transoesophageal doppler|transoesophageal doppler
574924|NCT01117506|Angina Pectoris|angina pectoris
574925|NCT01117506|Myocardial Ischemia|myocardial ischemia
574926|NCT01117506|Molecular Genetics|molecular genetics
574927|NCT01117506|Atherosclerosis|atherosclerosis
574928|NCT01117506|Corus CAD|corus cad
574929|NCT01117506|ASGES|asges
574930|NCT01117506|Age/Sex/Gene Expression Score|age/sex/gene expression score
574931|NCT01117506|Gene Expression|gene expression
574933|NCT01117506|CAD|cad
574934|NCT01117506|CVD|cvd
574936|NCT01117506|Precision Medicine|precision medicine
574937|NCT01117506|Clinical Validity|clinical validity
574938|NCT01117506|Myocardial Perfusion Imaging|myocardial perfusion imaging
574939|NCT01117506|Coronary Artery Disease|coronary artery disease
574940|NCT01117506|Chest Pain|chest pain
574941|NCT01117506|Cardiovascular Disease|cardiovascular disease
574942|NCT01117506|Coronary Heart Disease|coronary heart disease
574943|NCT01117506|MPI|mpi
574944|NCT01117506|COMPASS|compass
574945|NCT01117480|Moderate Rheumatoid Arthritis|moderate rheumatoid arthritis
574946|NCT01117480|Rheumatoid Arthritis|rheumatoid arthritis
574947|NCT01117480|Severe Rheumatoid Arthritis|severe rheumatoid arthritis
574948|NCT01117480|Adalimumab|adalimumab
574949|NCT01117480|Clinical Effectiveness|clinical effectiveness
574950|NCT01117467|Simulation|simulation
574951|NCT01117467|Learning|learning
574952|NCT01117467|Medical Students|medical students
574953|NCT01117467|Empathy|empathy
574954|NCT01117467|Anxiety|anxiety
574955|NCT01117454|Catecholaminergic Polymorphic Ventricular Tachycardia|catecholaminergic polymorphic ventricular tachycardia
574956|NCT01117454|implantable cardioverter-defibrillator|implantable cardioverter-defibrillator
574957|NCT01117454|flecainide|flecainide
574958|NCT01117428|Advanced solid tumors|advanced solid tumors
574959|NCT01117428|Metastatic colorectal Cancer|metastatic colorectal cancer
574960|NCT01117415|Gall Bladder|gall bladder
574961|NCT01117415|Cholecystectomy|cholecystectomy
574962|NCT01117402|recurrent carcinoma cervix|recurrent carcinoma cervix
574963|NCT01117402|Vault carcinoma|vault carcinoma
574964|NCT01117402|Tomotherapy|tomotherapy
574965|NCT01117402|Brachytherapy|brachytherapy
574966|NCT01117389|Human Papillomavirus Vaccination|human papillomavirus vaccination
574967|NCT01117389|Childhood cancer survivors|childhood cancer survivors
574968|NCT01117389|cervical cancer|cervical cancer
574969|NCT01117389|sexually transmitted infection|sexually transmitted infection
574970|NCT01117376|Gastroparesis|gastroparesis
574971|NCT01117376|Erythromycin|erythromycin
574972|NCT01117376|Methylnaltrexone|methylnaltrexone
574973|NCT01117376|ICU|icu
574974|NCT01117363|Appetite whole grain|appetite whole grain
574975|NCT01117337|Hernia, laparoscopic, recurrence, pain, inguinal|hernia, laparoscopic, recurrence, pain, inguinal
574976|NCT01117324|Bone density|bone density
574977|NCT01117324|infant of diabetic mother|infant of diabetic mother
574978|NCT01117324|large birth weight|large birth weight
574979|NCT01117311|Vagus|vagus
574980|NCT01117311|Diabetes|diabetes
574981|NCT01117311|Obesity|obesity
574982|NCT01117298|Raynaud's phenomenon|raynaud's phenomenon
574983|NCT01117298|ischemic ulcers|ischemic ulcers
574984|NCT01117298|digital ulcers|digital ulcers
574985|NCT01117298|digital infarcts|digital infarcts
574986|NCT01117298|gangrene|gangrene
574987|NCT01117298|vasodilators|vasodilators
574988|NCT01117298|endothelial dysfunction|endothelial dysfunction
574989|NCT01117298|scleroderma|scleroderma
574990|NCT01117285|Occupational Therapy|occupational therapy
574991|NCT01117285|Evidence-Based Practice|evidence-based practice
574992|NCT01117285|Continuing Education|continuing education
574993|NCT01117285|utilization|utilization
574994|NCT01117285|Guideline|guideline
574995|NCT01117285|Dementia|dementia
574996|NCT01117285|Guideline implementation|guideline implementation
574997|NCT01117272|PCOS|pcos
574998|NCT01117272|hyperprolactinemia|hyperprolactinemia
574999|NCT01117272|obesity|obesity
575000|NCT01117272|hyperandrogenic|hyperandrogenic
575001|NCT01117246|bone metastasis|bone metastasis
575002|NCT01117246|pain palliation|pain palliation
575003|NCT01117233|Healthy volunteers|healthy volunteers
575004|NCT01117233|PK|pk
575005|NCT01117233|PD|pd
575006|NCT01117233|safety and toleration|safety and toleration
575007|NCT01117220|pediatric|pediatric
575008|NCT01117220|bipolar|bipolar
575009|NCT01117181|Alzheimer's disease|alzheimer's disease
575010|NCT01117181|Apathy|apathy
575011|NCT01117181|Methylphenidate|methylphenidate
575012|NCT01117181|Dopaminergic agents|dopaminergic agents
575013|NCT01117181|Apathy Evaluation Scale|apathy evaluation scale
575014|NCT01117181|Dementia|dementia
575015|NCT01117168|Children's Oncology Group|children's oncology group
575016|NCT01117168|Pediatric Oncology|pediatric oncology
575017|NCT01117168|Pediatric Cancer|pediatric cancer
575018|NCT01117168|Registration|registration
575019|NCT01117168|Leukemia|leukemia
575020|NCT01117168|Brain Tumor|brain tumor
575021|NCT01117168|Sarcoma|sarcoma
575022|NCT01117155|Brain Tumor|brain tumor
575023|NCT01117155|Imaging|imaging
575024|NCT01117155|FLT|flt
575025|NCT01117155|FDG|fdg
575026|NCT01117155|Spectroscopy|spectroscopy
575027|NCT01117155|Glioma|glioma
575028|NCT01117155|Glioblastoma Multiforme|glioblastoma multiforme
575029|NCT01117155|Astrocytoma|astrocytoma
575030|NCT01117142|CLL (Chronic Lymphocytic Leukemia)|cll (chronic lymphocytic leukemia)
575031|NCT01117142|Monoclonal B Cell Lymphocytosis|monoclonal b cell lymphocytosis
575032|NCT01117142|Small Lymphocytic Lymphoma|small lymphocytic lymphoma
575033|NCT01117142|Mantle Cell Lymphoma|mantle cell lymphoma
575034|NCT01117142|Cellular Proliferation|cellular proliferation
575035|NCT01117142|Chronic Lymphocytic Leukemia|chronic lymphocytic leukemia
575036|NCT01117142|CLL|cll
575037|NCT01117142|Monoclonal B-Cell Lymphocytosis|monoclonal b-cell lymphocytosis
575038|NCT01117142|MBL|mbl
575039|NCT01117142|SLL|sll
575040|NCT01117142|MCL|mcl
575041|NCT01117142|Healthy Volunteer|healthy volunteer
575042|NCT01117142|HV|hv
575043|NCT01117103|Type 2 diabetes|type 2 diabetes
575044|NCT01117103|Diabetes Mellitus|diabetes mellitus
575045|NCT01117103|Glucophage|glucophage
575046|NCT01117103|Metformin|metformin
575047|NCT01117090|Feasibility|feasibility
575048|NCT01117090|SynchroMed II|synchromed ii
575049|NCT01117090|Intrathecal catheter|intrathecal catheter
575050|NCT01117090|Baclofen|baclofen
575051|NCT01117077|liver transplantation|liver transplantation
575052|NCT01117077|aspergillus infection|aspergillus infection
575053|NCT01117077|interleukin-17|interleukin-17
575054|NCT01117077|Treg cell|treg cell
575055|NCT01117077|immune tolerance|immune tolerance
575056|NCT01117064|Sleep Apnea|sleep apnea
575057|NCT01117064|OSA|osa
575058|NCT01117064|CPAP|cpap
575059|NCT01117051|Opioid induced constipation/prucalopride chronic non-cancer pain|opioid induced constipation/prucalopride chronic non-cancer pain
575060|NCT01117051|Subjects with chronic non-cancer pain suffering from OIC|subjects with chronic non-cancer pain suffering from oic
575061|NCT01117038|ED|ed
575062|NCT01117038|Erectile Dysfunction|erectile dysfunction
575063|NCT01117025|Resistant hypertension|resistant hypertension
575064|NCT01117025|Atrial Fibrillation|atrial fibrillation
575065|NCT01117025|Percutaneous renal denervation|percutaneous renal denervation
575066|NCT01116986|Smoking|smoking
575067|NCT01116986|Smoking Cessation|smoking cessation
575068|NCT01116986|Nicotine|nicotine
575069|NCT01116973|CVP monitoring compared with peripheral monitoring|cvp monitoring compared with peripheral monitoring
575070|NCT01116960|P4P|p4p
575071|NCT01116947|Hypoalbuminemia|hypoalbuminemia
575072|NCT01116947|Hyperphosphatemia|hyperphosphatemia
575073|NCT01116947|Phosphorus|phosphorus
575074|NCT01116947|Protein|protein
575075|NCT01116947|CKD|ckd
575076|NCT01116947|Dialysis|dialysis
575077|NCT01116947|Meals|meals
575078|NCT01116947|Lanthanum|lanthanum
575079|NCT01116947|End-Stage Renal Disease (ESRD)|end-stage renal disease (esrd)
575080|NCT01116947|Dietary Protein Intake (DPI)|dietary protein intake (dpi)
575081|NCT01116947|Dietary Phosphorus Binding (DPB)|dietary phosphorus binding (dpb)
575082|NCT01116947|Protein-Energy Wasting (PEW)|protein-energy wasting (pew)
575083|NCT01116947|Sources of Dietary Phosphorus|sources of dietary phosphorus
575084|NCT01116934|blood culture, IL-1β, IL-6, IL-8, IP-10, interferon-gamma|blood culture, il-1β, il-6, il-8, ip-10, interferon-gamma
575085|NCT01116921|laryngeal mask airway|laryngeal mask airway
575086|NCT01116921|surfactant|surfactant
575087|NCT01116921|respiratory distress syndrome|respiratory distress syndrome
575088|NCT01116921|neonate|neonate
575089|NCT01116908|Diarrhea|diarrhea
575090|NCT01116908|Water|water
575091|NCT01116908|Household Water Treatment|household water treatment
575092|NCT01116908|HIV|hiv
575093|NCT01116908|Infant Health|infant health
575094|NCT01116895|Psoriasis Vulgaris|psoriasis vulgaris
575095|NCT01116895|Systemic|systemic
575096|NCT01116895|Anti-psoriatic|anti-psoriatic
575097|NCT01116882|PCI|pci
575098|NCT01116882|heart disease|heart disease
575099|NCT01116882|ischemic heart disease|ischemic heart disease
575100|NCT01116869|MBC|mbc
575101|NCT01116869|Healthy|healthy
575102|NCT01116869|Benign disease|benign disease
575103|NCT01116869|Confirmed metastatic breast cancer patient with at least one measurable solid tumor according to the RECIST guideline|confirmed metastatic breast cancer patient with at least one measurable solid tumor according to the recist guideline
575104|NCT01116869|Medical examinations detect no breast benign and malignant tumors|medical examinations detect no breast benign and malignant tumors
575105|NCT01116869|Benign Breast Disease|benign breast disease
575106|NCT01116869|Pathology diagnosed breast benign tumor disease|pathology diagnosed breast benign tumor disease
575107|NCT01116856|Exercise|exercise
575108|NCT01116856|Training|training
575109|NCT01116856|Obesity|obesity
575110|NCT01116856|Overweight|overweight
575111|NCT01116856|Body composition|body composition
575112|NCT01116856|Lipidic profile|lipidic profile
575113|NCT01116856|Nutrition|nutrition
575114|NCT01116856|Polymorphisms|polymorphisms
575115|NCT01116843|Oral cavity cancer|oral cavity cancer
575116|NCT01116843|No prior treatment|no prior treatment
575117|NCT01116817|Long-term Lopinavir/ritonavir monotherapy|long-term lopinavir/ritonavir monotherapy
575118|NCT01116817|neurocognitive performance|neurocognitive performance
575119|NCT01116817|ultrasensitive CSF-viraemia|ultrasensitive csf-viraemia
575120|NCT01116804|Primary liver cancer|primary liver cancer
575121|NCT01116791|cytoreductive surgery|cytoreductive surgery
575122|NCT01116791|peritoneal chemotherapy|peritoneal chemotherapy
575123|NCT01116791|cisplatin|cisplatin
575124|NCT01116791|cancer|cancer
575125|NCT01116791|gastric|gastric
575126|NCT01116791|biliary|biliary
575127|NCT01116791|pancreas|pancreas
575128|NCT01116791|peritoneal metastases|peritoneal metastases
575129|NCT01116791|liver metastases|liver metastases
575130|NCT01116791|peritoneal carcinomatosis from upper gastrointestinal cancer|peritoneal carcinomatosis from upper gastrointestinal cancer
575741|NCT01114750|diabetes|diabetes
575131|NCT01116778|perennial allergic rhinitis|perennial allergic rhinitis
575132|NCT01116778|probiotics|probiotics
575133|NCT01116778|Lactobacillus paracasei GMNL-32 (eN-Lac®)|lactobacillus paracasei gmnl-32 (en-lac®)
575134|NCT01116778|efficacy and safety|efficacy and safety
575135|NCT01116765|preterm infants born between 26 to 29 weeks of gestation age.|preterm infants born between 26 to 29 weeks of gestation age.
575136|NCT01116752|Intensive Care|intensive care
575137|NCT01116752|Critical care|critical care
575138|NCT01116752|Glycemic Control|glycemic control
575139|NCT01116752|Hypoglycemia|hypoglycemia
575140|NCT01116752|Hyperglycemia|hyperglycemia
575141|NCT01116752|Insulin treatment|insulin treatment
575142|NCT01116752|Organ Function|organ function
575143|NCT01116752|PELOD|pelod
575144|NCT01116752|Outcomes|outcomes
575145|NCT01116752|Pediatrics|pediatrics
575146|NCT01116713|Mastectomy|mastectomy
575147|NCT01116713|Breast cancer|breast cancer
575148|NCT01116713|Postoperative pain|postoperative pain
575149|NCT01116713|Postoperative nausea and vomiting|postoperative nausea and vomiting
575150|NCT01116700|Epilepsy|epilepsy
575151|NCT01116700|Dexmedetomidine|dexmedetomidine
575152|NCT01116700|Seizure|seizure
575153|NCT01116674|Intensive critical care, glycemic control, hypoglycemia, hyperglycemia , insulin treatment, intensive care outcomes, pediatrics|intensive critical care, glycemic control, hypoglycemia, hyperglycemia , insulin treatment, intensive care outcomes, pediatrics
575154|NCT01116661|glioma|glioma
575155|NCT01116661|high grade glioma, low grade glioma|high grade glioma, low grade glioma
575156|NCT01116635|chemoembolization|chemoembolization
575157|NCT01116635|drug eluting microsphere|drug eluting microsphere
575158|NCT01116635|hepato|hepato
575159|NCT01116635|embolotherapy|embolotherapy
575160|NCT01116635|downstage|downstage
575161|NCT01116622|Aerodigestive|aerodigestive
575162|NCT01116622|Targretin|targretin
575163|NCT01116622|Tarceva|tarceva
575164|NCT01116609|Phenylalanine|phenylalanine
575165|NCT01116609|Palmitate|palmitate
575166|NCT01116609|hyperinsulinemic-euglycemic-clamp|hyperinsulinemic-euglycemic-clamp
575167|NCT01116609|Effects of epinephrine in healthy volunteers|effects of epinephrine in healthy volunteers
575168|NCT01116596|Glutathione|glutathione
575169|NCT01116596|Paracetamol|paracetamol
575170|NCT01116596|elderly people|elderly people
575171|NCT01116583|Gabapentin|gabapentin
575172|NCT01116583|Thoracotomy|thoracotomy
575173|NCT01116583|Pain, Postoperative|pain, postoperative
575174|NCT01116583|Analgesia|analgesia
575175|NCT01116583|Recovery of Function|recovery of function
575176|NCT01116583|Quality of Life|quality of life
575177|NCT01116570|Muscular Dystrophy|muscular dystrophy
575178|NCT01116570|Facioscapulohumeral|facioscapulohumeral
575179|NCT01116570|Physical training|physical training
575180|NCT01116570|Exercise|exercise
575181|NCT01116557|radiofrequency|radiofrequency
575182|NCT01116557|ablation|ablation
575183|NCT01116557|atrial fibrillation|atrial fibrillation
575184|NCT01116557|CARTO|carto
575185|NCT01116557|THERMOCOOL|thermocool
575186|NCT01116557|LASSO|lasso
575187|NCT01116557|PVAC|pvac
575188|NCT01116544|AMES device|ames device
575189|NCT01116544|Cerebrovascular Accident|cerebrovascular accident
575190|NCT01116544|Chronic Stroke|chronic stroke
575191|NCT01116544|Rehabilitation|rehabilitation
575192|NCT01116544|Upper Extremity|upper extremity
575193|NCT01116544|Biofeedback|biofeedback
575194|NCT01116531|Pharmacokinetics|pharmacokinetics
575195|NCT01116531|Pharmacodynamics|pharmacodynamics
575196|NCT01116531|Interaction|interaction
575197|NCT01116531|tramadol|tramadol
575198|NCT01116531|duloxetine|duloxetine
575199|NCT01116531|pregabalin|pregabalin
575200|NCT01116505|Celiac disease|celiac disease
575201|NCT01116505|Endomysial antibodies|endomysial antibodies
575202|NCT01116505|Gluten-free diet|gluten-free diet
575203|NCT01116505|Screen-detected|screen-detected
575204|NCT01116505|Asymptomatic|asymptomatic
575205|NCT01116505|Bone mineral density|bone mineral density
575206|NCT01116492|SILS|sils
575207|NCT01116492|Inflammatory reaction|inflammatory reaction
575208|NCT01116492|a-defensins|a-defensins
575209|NCT01116492|SILS vs standard laparoscopic cholecystectomy|sils vs standard laparoscopic cholecystectomy
575210|NCT01116479|Anaemia, transfusion, cancer, chemotherapy, Quality of life|anaemia, transfusion, cancer, chemotherapy, quality of life
575211|NCT01116453|dysmenorrhea|dysmenorrhea
575212|NCT01116453|acupuncture|acupuncture
575213|NCT01116453|randomized controlled trial|randomized controlled trial
575214|NCT01116440|Menstrual pain|menstrual pain
575215|NCT01116440|Refractory endometriosis|refractory endometriosis
575216|NCT01116440|Pelvic pain|pelvic pain
575218|NCT01116427|multiple sclerosis|multiple sclerosis
575219|NCT01116427|relapsing-remitting multiple sclerosis|relapsing-remitting multiple sclerosis
575220|NCT01116427|RRMS|rrms
575221|NCT01116401|Hot Flashes|hot flashes
575222|NCT01116401|Sleep disturbance|sleep disturbance
575223|NCT01116401|Lupron|lupron
575224|NCT01116401|Menopause|menopause
575225|NCT01116388|Autism|autism
575226|NCT01116388|Gastrointestinal Disorders|gastrointestinal disorders
575227|NCT01116388|Food Allergy|food allergy
575228|NCT01116388|Gluten free, casein free diet|gluten free, casein free diet
575229|NCT01116388|Diarrhea|diarrhea
575230|NCT01116388|Constipation|constipation
575231|NCT01116388|Reflux|reflux
575232|NCT01116388|Abdominal pain|abdominal pain
575233|NCT01116388|Pain after eating|pain after eating
575234|NCT01116388|Self injurious behavior|self injurious behavior
575235|NCT01116375|Obesity|obesity
575236|NCT01116375|OSA|osa
575237|NCT01116375|PAP therapy|pap therapy
575238|NCT01116362|ulna|ulna
575239|NCT01116362|median|median
575240|NCT01116362|repair|repair
575241|NCT01116362|primary|primary
575242|NCT01116349|humeral diaphysis fracture|humeral diaphysis fracture
575243|NCT01116349|plate and screws for humeral diaphysis fracture|plate and screws for humeral diaphysis fracture
575244|NCT01116349|nailing for humerus diaphysis fracture|nailing for humerus diaphysis fracture
575245|NCT01116349|Hanging Support System|hanging support system
575246|NCT01116336|Pre-cancerous conditions|pre-cancerous conditions
575247|NCT01116336|Head and neck tumors|head and neck tumors
575248|NCT01116336|Cancer of head and neck|cancer of head and neck
575249|NCT01116323|Adverse events|adverse events
575250|NCT01116323|Adverse effects|adverse effects
575251|NCT01116323|Emergency Service, Hospital|emergency service, hospital
575252|NCT01116323|Emergency department|emergency department
575253|NCT01116323|Crowding|crowding
575254|NCT01116310|Hot flushes|hot flushes
575255|NCT01116310|Hot flashes|hot flashes
575256|NCT01116310|menopause|menopause
575257|NCT01116310|postmenopause|postmenopause
575258|NCT01116310|Soy isoflavones|soy isoflavones
575259|NCT01116310|Red clover|red clover
575260|NCT01116310|Equol|equol
575261|NCT01116297|breast reconstruction|breast reconstruction
575262|NCT01116297|breast cancer|breast cancer
575263|NCT01116297|near infrared imaging|near infrared imaging
575264|NCT01116284|Weight Loss|weight loss
575265|NCT01116284|Obesity|obesity
575266|NCT01116284|Gastric Bypass|gastric bypass
575267|NCT01116271|colorectal|colorectal
575268|NCT01116271|second line therapy|second line therapy
575269|NCT01116271|K-ras or B-raf mutations|k-ras or b-raf mutations
575270|NCT01116271|response rate|response rate
575271|NCT01116271|Progression Free Survival|progression free survival
575272|NCT01116258|Safety|safety
575273|NCT01116245|Cervical Intraepithelial Neoplasia Stage 2/3|cervical intraepithelial neoplasia stage 2/3
575274|NCT01116232|graft versus host disease|graft versus host disease
575275|NCT01116232|accelerated phase chronic myelogenous leukemia|accelerated phase chronic myelogenous leukemia
575276|NCT01116232|adult acute lymphoblastic leukemia in remission|adult acute lymphoblastic leukemia in remission
575277|NCT01116232|adult acute myeloid leukemia in remission|adult acute myeloid leukemia in remission
575278|NCT01116232|adult acute myeloid leukemia with 11q23 (MLL) abnormalities|adult acute myeloid leukemia with 11q23 (mll) abnormalities
575279|NCT01116232|adult acute myeloid leukemia with inv(16)(p13;q22)|adult acute myeloid leukemia with inv(16)(p13;q22)
575280|NCT01116232|adult acute myeloid leukemia with t(15;17)(q22;q12)|adult acute myeloid leukemia with t(15;17)(q22;q12)
575281|NCT01116232|adult acute myeloid leukemia with t(16;16)(p13;q22)|adult acute myeloid leukemia with t(16;16)(p13;q22)
575282|NCT01116232|adult acute myeloid leukemia with t(8;21)(q22;q22)|adult acute myeloid leukemia with t(8;21)(q22;q22)
575283|NCT01116232|atypical chronic myeloid leukemia, BCR-ABL negative|atypical chronic myeloid leukemia, bcr-abl negative
575284|NCT01116232|blastic phase chronic myelogenous leukemia|blastic phase chronic myelogenous leukemia
575285|NCT01116232|chronic myelomonocytic leukemia|chronic myelomonocytic leukemia
575286|NCT01116232|chronic phase chronic myelogenous leukemia|chronic phase chronic myelogenous leukemia
575287|NCT01116232|meningeal chronic myelogenous leukemia|meningeal chronic myelogenous leukemia
575288|NCT01116232|progressive hairy cell leukemia, initial treatment|progressive hairy cell leukemia, initial treatment
575289|NCT01116232|prolymphocytic leukemia|prolymphocytic leukemia
575290|NCT01116232|recurrent adult acute lymphoblastic leukemia|recurrent adult acute lymphoblastic leukemia
575291|NCT01116232|recurrent adult acute myeloid leukemia|recurrent adult acute myeloid leukemia
575292|NCT01116232|recurrent adult T-cell leukemia/lymphoma|recurrent adult t-cell leukemia/lymphoma
575293|NCT01116232|refractory chronic lymphocytic leukemia|refractory chronic lymphocytic leukemia
575294|NCT01116232|refractory hairy cell leukemia|refractory hairy cell leukemia
575295|NCT01116232|relapsing chronic myelogenous leukemia|relapsing chronic myelogenous leukemia
575296|NCT01116232|stage I adult T-cell leukemia/lymphoma|stage i adult t-cell leukemia/lymphoma
575297|NCT01116232|stage I chronic lymphocytic leukemia|stage i chronic lymphocytic leukemia
575298|NCT01116232|stage II adult T-cell leukemia/lymphoma|stage ii adult t-cell leukemia/lymphoma
575299|NCT01116232|stage II chronic lymphocytic leukemia|stage ii chronic lymphocytic leukemia
575300|NCT01116232|stage III adult T-cell leukemia/lymphoma|stage iii adult t-cell leukemia/lymphoma
575301|NCT01116232|stage III chronic lymphocytic leukemia|stage iii chronic lymphocytic leukemia
575302|NCT01116232|stage IV adult T-cell leukemia/lymphoma|stage iv adult t-cell leukemia/lymphoma
575303|NCT01116232|stage IV chronic lymphocytic leukemia|stage iv chronic lymphocytic leukemia
575304|NCT01116232|T-cell large granular lymphocyte leukemia|t-cell large granular lymphocyte leukemia
575305|NCT01116232|untreated adult acute lymphoblastic leukemia|untreated adult acute lymphoblastic leukemia
575306|NCT01116232|untreated adult acute myeloid leukemia|untreated adult acute myeloid leukemia
575307|NCT01116232|untreated hairy cell leukemia|untreated hairy cell leukemia
575308|NCT01116232|recurrent adult Hodgkin lymphoma|recurrent adult hodgkin lymphoma
575309|NCT01116232|stage I adult Hodgkin lymphoma|stage i adult hodgkin lymphoma
575310|NCT01116232|stage II adult Hodgkin lymphoma|stage ii adult hodgkin lymphoma
575311|NCT01116232|stage III adult Hodgkin lymphoma|stage iii adult hodgkin lymphoma
575312|NCT01116232|stage IV adult Hodgkin lymphoma|stage iv adult hodgkin lymphoma
575313|NCT01116232|anaplastic large cell lymphoma|anaplastic large cell lymphoma
575314|NCT01116232|angioimmunoblastic T-cell lymphoma|angioimmunoblastic t-cell lymphoma
575315|NCT01116232|cutaneous B-cell non-Hodgkin lymphoma|cutaneous b-cell non-hodgkin lymphoma
575316|NCT01116232|recurrent cutaneous T-cell non-Hodgkin lymphoma|recurrent cutaneous t-cell non-hodgkin lymphoma
575317|NCT01116232|stage I cutaneous T-cell non-Hodgkin lymphoma|stage i cutaneous t-cell non-hodgkin lymphoma
575318|NCT01116232|stage II cutaneous T-cell non-Hodgkin lymphoma|stage ii cutaneous t-cell non-hodgkin lymphoma
575319|NCT01116232|stage III cutaneous T-cell non-Hodgkin lymphoma|stage iii cutaneous t-cell non-hodgkin lymphoma
575320|NCT01116232|stage IV cutaneous T-cell non-Hodgkin lymphoma|stage iv cutaneous t-cell non-hodgkin lymphoma
575321|NCT01116232|recurrent mycosis fungoides/Sezary syndrome|recurrent mycosis fungoides/sezary syndrome
575322|NCT01116232|stage I mycosis fungoides/Sezary syndrome|stage i mycosis fungoides/sezary syndrome
575323|NCT01116232|stage II mycosis fungoides/Sezary syndrome|stage ii mycosis fungoides/sezary syndrome
575324|NCT01116232|stage III mycosis fungoides/Sezary syndrome|stage iii mycosis fungoides/sezary syndrome
575325|NCT01116232|stage IV mycosis fungoides/Sezary syndrome|stage iv mycosis fungoides/sezary syndrome
575326|NCT01116232|adult grade III lymphomatoid granulomatosis|adult grade iii lymphomatoid granulomatosis
575327|NCT01116232|adult nasal type extranodal NK/T-cell lymphoma|adult nasal type extranodal nk/t-cell lymphoma
575328|NCT01116232|Waldenstrom macroglobulinemia|waldenstrom macroglobulinemia
575329|NCT01116232|extranodal marginal zone B-cell lymphoma of mucosa-associated lymphoid tissue|extranodal marginal zone b-cell lymphoma of mucosa-associated lymphoid tissue
575330|NCT01116232|nodal marginal zone B-cell lymphoma|nodal marginal zone b-cell lymphoma
575331|NCT01116232|splenic marginal zone lymphoma|splenic marginal zone lymphoma
575332|NCT01116232|contiguous stage II adult Burkitt lymphoma|contiguous stage ii adult burkitt lymphoma
575333|NCT01116232|contiguous stage II adult diffuse large cell lymphoma|contiguous stage ii adult diffuse large cell lymphoma
575334|NCT01116232|contiguous stage II adult diffuse mixed cell lymphoma|contiguous stage ii adult diffuse mixed cell lymphoma
575335|NCT01116232|contiguous stage II adult diffuse small cleaved cell lymphoma|contiguous stage ii adult diffuse small cleaved cell lymphoma
575336|NCT01116232|contiguous stage II adult immunoblastic large cell lymphoma|contiguous stage ii adult immunoblastic large cell lymphoma
575337|NCT01116232|contiguous stage II adult lymphoblastic lymphoma|contiguous stage ii adult lymphoblastic lymphoma
575338|NCT01116232|contiguous stage II grade 1 follicular lymphoma|contiguous stage ii grade 1 follicular lymphoma
575339|NCT01116232|contiguous stage II grade 2 follicular lymphoma|contiguous stage ii grade 2 follicular lymphoma
575340|NCT01116232|contiguous stage II grade 3 follicular lymphoma|contiguous stage ii grade 3 follicular lymphoma
575341|NCT01116232|contiguous stage II mantle cell lymphoma|contiguous stage ii mantle cell lymphoma
575342|NCT01116232|contiguous stage II marginal zone lymphoma|contiguous stage ii marginal zone lymphoma
575343|NCT01116232|contiguous stage II small lymphocytic lymphoma|contiguous stage ii small lymphocytic lymphoma
575344|NCT01116232|stage I adult Burkitt lymphoma|stage i adult burkitt lymphoma
575345|NCT01116232|stage I adult diffuse large cell lymphoma|stage i adult diffuse large cell lymphoma
575346|NCT01116232|stage I adult diffuse mixed cell lymphoma|stage i adult diffuse mixed cell lymphoma
575347|NCT01116232|stage I adult diffuse small cleaved cell lymphoma|stage i adult diffuse small cleaved cell lymphoma
575348|NCT01116232|stage I adult immunoblastic large cell lymphoma|stage i adult immunoblastic large cell lymphoma
575349|NCT01116232|stage I adult lymphoblastic lymphoma|stage i adult lymphoblastic lymphoma
575350|NCT01116232|stage I grade 1 follicular lymphoma|stage i grade 1 follicular lymphoma
575351|NCT01116232|stage I grade 2 follicular lymphoma|stage i grade 2 follicular lymphoma
575352|NCT01116232|stage I grade 3 follicular lymphoma|stage i grade 3 follicular lymphoma
575353|NCT01116232|stage I mantle cell lymphoma|stage i mantle cell lymphoma
575354|NCT01116232|stage I marginal zone lymphoma|stage i marginal zone lymphoma
575355|NCT01116232|stage I small lymphocytic lymphoma|stage i small lymphocytic lymphoma
575356|NCT01116232|noncontiguous stage II adult Burkitt lymphoma|noncontiguous stage ii adult burkitt lymphoma
575357|NCT01116232|noncontiguous stage II adult diffuse large cell lymphoma|noncontiguous stage ii adult diffuse large cell lymphoma
575358|NCT01116232|noncontiguous stage II adult diffuse mixed cell lymphoma|noncontiguous stage ii adult diffuse mixed cell lymphoma
575359|NCT01116232|noncontiguous stage II adult diffuse small cleaved cell lymphoma|noncontiguous stage ii adult diffuse small cleaved cell lymphoma
575360|NCT01116232|noncontiguous stage II adult immunoblastic large cell lymphoma|noncontiguous stage ii adult immunoblastic large cell lymphoma
575361|NCT01116232|noncontiguous stage II adult lymphoblastic lymphoma|noncontiguous stage ii adult lymphoblastic lymphoma
575362|NCT01116232|noncontiguous stage II grade 1 follicular lymphoma|noncontiguous stage ii grade 1 follicular lymphoma
575363|NCT01116232|noncontiguous stage II grade 2 follicular lymphoma|noncontiguous stage ii grade 2 follicular lymphoma
575364|NCT01116232|noncontiguous stage II grade 3 follicular lymphoma|noncontiguous stage ii grade 3 follicular lymphoma
575365|NCT01116232|noncontiguous stage II mantle cell lymphoma|noncontiguous stage ii mantle cell lymphoma
575366|NCT01116232|noncontiguous stage II marginal zone lymphoma|noncontiguous stage ii marginal zone lymphoma
575367|NCT01116232|noncontiguous stage II small lymphocytic lymphoma|noncontiguous stage ii small lymphocytic lymphoma
575368|NCT01116232|stage III adult Burkitt lymphoma|stage iii adult burkitt lymphoma
575369|NCT01116232|stage III adult diffuse large cell lymphoma|stage iii adult diffuse large cell lymphoma
575370|NCT01116232|stage III adult diffuse mixed cell lymphoma|stage iii adult diffuse mixed cell lymphoma
575371|NCT01116232|stage III adult diffuse small cleaved cell lymphoma|stage iii adult diffuse small cleaved cell lymphoma
575372|NCT01116232|stage III adult immunoblastic large cell lymphoma|stage iii adult immunoblastic large cell lymphoma
575373|NCT01116232|stage III adult lymphoblastic lymphoma|stage iii adult lymphoblastic lymphoma
575374|NCT01116232|stage III grade 1 follicular lymphoma|stage iii grade 1 follicular lymphoma
575375|NCT01116232|stage III grade 2 follicular lymphoma|stage iii grade 2 follicular lymphoma
575376|NCT01116232|stage III grade 3 follicular lymphoma|stage iii grade 3 follicular lymphoma
575377|NCT01116232|stage III mantle cell lymphoma|stage iii mantle cell lymphoma
575378|NCT01116232|stage III marginal zone lymphoma|stage iii marginal zone lymphoma
575379|NCT01116232|stage III small lymphocytic lymphoma|stage iii small lymphocytic lymphoma
575380|NCT01116232|stage IV adult Burkitt lymphoma|stage iv adult burkitt lymphoma
575381|NCT01116232|stage IV adult diffuse large cell lymphoma|stage iv adult diffuse large cell lymphoma
575382|NCT01116232|stage IV adult diffuse mixed cell lymphoma|stage iv adult diffuse mixed cell lymphoma
575383|NCT01116232|stage IV adult diffuse small cleaved cell lymphoma|stage iv adult diffuse small cleaved cell lymphoma
575384|NCT01116232|stage IV adult immunoblastic large cell lymphoma|stage iv adult immunoblastic large cell lymphoma
575385|NCT01116232|stage IV adult lymphoblastic lymphoma|stage iv adult lymphoblastic lymphoma
575386|NCT01116232|stage IV grade 1 follicular lymphoma|stage iv grade 1 follicular lymphoma
575387|NCT01116232|stage IV grade 2 follicular lymphoma|stage iv grade 2 follicular lymphoma
575388|NCT01116232|stage IV grade 3 follicular lymphoma|stage iv grade 3 follicular lymphoma
575389|NCT01116232|stage IV mantle cell lymphoma|stage iv mantle cell lymphoma
575390|NCT01116232|stage IV marginal zone lymphoma|stage iv marginal zone lymphoma
575391|NCT01116232|stage IV small lymphocytic lymphoma|stage iv small lymphocytic lymphoma
575392|NCT01116232|recurrent adult Burkitt lymphoma|recurrent adult burkitt lymphoma
575393|NCT01116232|recurrent adult diffuse large cell lymphoma|recurrent adult diffuse large cell lymphoma
575394|NCT01116232|recurrent adult diffuse mixed cell lymphoma|recurrent adult diffuse mixed cell lymphoma
575395|NCT01116232|recurrent adult diffuse small cleaved cell lymphoma|recurrent adult diffuse small cleaved cell lymphoma
575396|NCT01116232|recurrent adult grade III lymphomatoid granulomatosis|recurrent adult grade iii lymphomatoid granulomatosis
575397|NCT01116232|recurrent adult immunoblastic large cell lymphoma|recurrent adult immunoblastic large cell lymphoma
575398|NCT01116232|recurrent adult lymphoblastic lymphoma|recurrent adult lymphoblastic lymphoma
575399|NCT01116232|recurrent grade 1 follicular lymphoma|recurrent grade 1 follicular lymphoma
710873|NCT00587483|ventricular fibrillation|ventricular fibrillation
575400|NCT01116232|recurrent grade 2 follicular lymphoma|recurrent grade 2 follicular lymphoma
575401|NCT01116232|recurrent grade 3 follicular lymphoma|recurrent grade 3 follicular lymphoma
575402|NCT01116232|recurrent mantle cell lymphoma|recurrent mantle cell lymphoma
575403|NCT01116232|recurrent marginal zone lymphoma|recurrent marginal zone lymphoma
575404|NCT01116232|recurrent small lymphocytic lymphoma|recurrent small lymphocytic lymphoma
575405|NCT01116232|intraocular lymphoma|intraocular lymphoma
575406|NCT01116232|post-transplant lymphoproliferative disorder|post-transplant lymphoproliferative disorder
575407|NCT01116232|chronic eosinophilic leukemia|chronic eosinophilic leukemia
575408|NCT01116232|chronic neutrophilic leukemia|chronic neutrophilic leukemia
575409|NCT01116232|primary myelofibrosis|primary myelofibrosis
575410|NCT01116232|stage I multiple myeloma|stage i multiple myeloma
575411|NCT01116232|stage II multiple myeloma|stage ii multiple myeloma
575412|NCT01116232|stage III multiple myeloma|stage iii multiple myeloma
575413|NCT01116232|refractory multiple myeloma|refractory multiple myeloma
575414|NCT01116232|de novo myelodysplastic syndromes|de novo myelodysplastic syndromes
575415|NCT01116232|previously treated myelodysplastic syndromes|previously treated myelodysplastic syndromes
575416|NCT01116232|myelodysplastic/myeloproliferative neoplasm, unclassifiable|myelodysplastic/myeloproliferative neoplasm, unclassifiable
575417|NCT01116219|adenocarcinoma of the lung|adenocarcinoma of the lung
575418|NCT01116219|bronchoalveolar cell lung cancer|bronchoalveolar cell lung cancer
575419|NCT01116219|large cell lung cancer|large cell lung cancer
575420|NCT01116219|stage IV non-small cell lung cancer|stage iv non-small cell lung cancer
575421|NCT01116219|recurrent non-small cell lung cancer|recurrent non-small cell lung cancer
575422|NCT01116206|Constipation|constipation
575423|NCT01116206|Prucalopride|prucalopride
575424|NCT01116206|Resolor|resolor
575425|NCT01116193|antileukemic therapy|antileukemic therapy
575426|NCT01116193|lymphoblastic leukemia|lymphoblastic leukemia
575427|NCT01116193|lenalidomide|lenalidomide
575428|NCT01116193|dexamethasone|dexamethasone
575429|NCT01116180|Type 1 diabetes|type 1 diabetes
575430|NCT01116180|Hypoglycaemia|hypoglycaemia
575431|NCT01116180|genetic susceptibility|genetic susceptibility
575432|NCT01116180|Renin angiotensin system activity|renin angiotensin system activity
575433|NCT01116167|Polycystic Ovary Syndrome|polycystic ovary syndrome
575434|NCT01116141|rheumatoid arthritis|rheumatoid arthritis
575435|NCT01116141|MTX|mtx
575436|NCT01116141|CH-405|ch-405
575437|NCT01116141|antifolates|antifolates
575438|NCT01116128|relapsed/refractory myeloma patients|relapsed/refractory myeloma patients
575439|NCT01116128|Progression free survival|progression free survival
575440|NCT01116128|Overall survival|overall survival
575441|NCT01116128|dasatinib|dasatinib
575442|NCT01116115|Term Infants|term infants
575443|NCT01116115|Intestine flora|intestine flora
575444|NCT01116115|Stool characteristics|stool characteristics
575445|NCT01116102|dehydration|dehydration
575446|NCT01116102|fluid therapy|fluid therapy
575447|NCT01116102|hyaluronoglucosaminidase|hyaluronoglucosaminidase
575448|NCT01116102|hyaluronidase|hyaluronidase
575449|NCT01116102|hypodermoclysis|hypodermoclysis
575451|NCT01116102|subcutaneous hydration|subcutaneous hydration
575452|NCT01116102|subcutaneous rehydration|subcutaneous rehydration
575453|NCT01116102|hyaluronan|hyaluronan
575454|NCT01116102|rHuPH20|rhuph20
575455|NCT01116089|Cystic fibrosis, tobramycin,nebulizer, PK|cystic fibrosis, tobramycin,nebulizer, pk
575456|NCT01116063|COPD, Pulmonary hypertension|copd, pulmonary hypertension
575457|NCT01116037|Diseased Heart Valve, Replacement, Aortic, Stentless|diseased heart valve, replacement, aortic, stentless
575458|NCT01116024|Diseased Heart Valve, Replacement, Aortic|diseased heart valve, replacement, aortic
575459|NCT01116011|Phase I|phase i
575460|NCT01116011|Japanese Healthy volunteer|japanese healthy volunteer
575461|NCT01115998|cerebral palsy|cerebral palsy
575462|NCT01115998|wheelchair|wheelchair
575463|NCT01115998|disabled children|disabled children
575464|NCT01115985|ASP1585|asp1585
575465|NCT01115985|Drug-drug interaction|drug-drug interaction
575466|NCT01115985|Atorvastatin|atorvastatin
575467|NCT01115985|Healthy volunteer|healthy volunteer
575468|NCT01115972|ASP1585|asp1585
575469|NCT01115972|Drug-drug interaction|drug-drug interaction
575470|NCT01115972|valsartan|valsartan
575471|NCT01115972|Healthy volunteer|healthy volunteer
575472|NCT01115946|ASP1585|asp1585
575473|NCT01115946|Drug-drug interaction|drug-drug interaction
575474|NCT01115946|enalapril|enalapril
575475|NCT01115946|Healthy volunteer|healthy volunteer
575476|NCT01115933|drug eluting stents|drug eluting stents
575477|NCT01115933|small vessel|small vessel
575478|NCT01115933|Stents|stents
575479|NCT01115933|Everolimus|everolimus
575480|NCT01115933|Angioplasty|angioplasty
575481|NCT01115920|Drug Safety|drug safety
575482|NCT01115920|Clinical Trial, Phase I|clinical trial, phase i
575483|NCT01115920|Nontherapeutic Human Experimentation|nontherapeutic human experimentation
575484|NCT01115920|Heading Pharmacokinetics|heading pharmacokinetics
575485|NCT01115920|Phase I Safety and Tolerability|phase i safety and tolerability
575486|NCT01115907|Aortic|aortic
575487|NCT01115907|Valve replacement|valve replacement
575488|NCT01115894|problem drinking|problem drinking
575489|NCT01115894|alcohol|alcohol
575490|NCT01115881|To examine the relationship between signal strength and macular thickness measured by stratus OCT|to examine the relationship between signal strength and macular thickness measured by stratus oct
575491|NCT01115855|Double-blind|double-blind
575492|NCT01115855|eplerenone|eplerenone
575493|NCT01115855|Japanese|japanese
575494|NCT01115842|Vitamin D|vitamin d
575495|NCT01115842|Acute coronary syndrome|acute coronary syndrome
575496|NCT01115842|inflammatory cytokines|inflammatory cytokines
575497|NCT01115803|Advanced Cancer|advanced cancer
575498|NCT01115803|Metastatic Cancer|metastatic cancer
575499|NCT01115803|Non-Small Cell Lung Cancer|non-small cell lung cancer
575500|NCT01115803|Renal Cell Carcinoma|renal cell carcinoma
575501|NCT01115803|Neuroendocrine Tumors|neuroendocrine tumors
575502|NCT01115777|Pediatric patients|pediatric patients
575503|NCT01115777|treated with|treated with
575504|NCT01115777|radiation therapy|radiation therapy
575505|NCT01115777|for brain tumors|for brain tumors
575506|NCT01115777|and non-CNS malignancies|and non-cns malignancies
575507|NCT01115764|diastolic dysfunction|diastolic dysfunction
575508|NCT01115751|Advanced Cancer|advanced cancer
575509|NCT01115751|Metastatic Cancer|metastatic cancer
575510|NCT01115751|Solid Tumors|solid tumors
575511|NCT01115738|Plavix, Effient|plavix, effient
575512|NCT01115725|Follitropin alfa|follitropin alfa
575513|NCT01115725|Fertilization in vitro|fertilization in vitro
575514|NCT01115725|Intracytoplasmic sperm injection|intracytoplasmic sperm injection
575515|NCT01115725|Reproductive techniques, assisted|reproductive techniques, assisted
575516|NCT01115712|Healthy Volunteers|healthy volunteers
575517|NCT01115699|Depression|depression
575519|NCT01115660|stroke|stroke
575520|NCT01115660|patient education|patient education
575521|NCT01115660|medication adherence|medication adherence
575522|NCT01115647|Malnutrition|malnutrition
575523|NCT01115647|Nutritional intervention|nutritional intervention
575524|NCT01115647|Behavioural intervention|behavioural intervention
575525|NCT01115647|Burkina Faso|burkina faso
575526|NCT01115647|Cluster randomize trial|cluster randomize trial
575527|NCT01115634|Fibroblast|fibroblast
575528|NCT01115634|Cell transplantation|cell transplantation
575529|NCT01115634|Facial deformities|facial deformities
575530|NCT01115608|Preventive Health Services|preventive health services
575531|NCT01115595|Allergic rhinitis|allergic rhinitis
575532|NCT01115595|Allergen injection immunotherapy|allergen injection immunotherapy
575533|NCT01115595|Efficacy|efficacy
575534|NCT01115582|Inborn Errors|inborn errors
575535|NCT01115582|Bile Acid|bile acid
575536|NCT01115582|Pediatrics|pediatrics
575537|NCT01115582|Liver Disease|liver disease
575538|NCT01115569|chronic pain|chronic pain
575539|NCT01115504|Thiamine|thiamine
575540|NCT01115504|heart failure|heart failure
575541|NCT01115478|Malaria|malaria
575542|NCT01115478|Low birth weight|low birth weight
575543|NCT01115478|Anemia|anemia
575544|NCT01115478|Perinatal mortality|perinatal mortality
575545|NCT01115478|Vitamin A|vitamin a
575546|NCT01115478|Zinc|zinc
575547|NCT01115465|Stress Urinary Incontinence|stress urinary incontinence
575548|NCT01115465|silicone elastomer|silicone elastomer
575549|NCT01115452|potassium nitrate|potassium nitrate
575550|NCT01115452|tooth sensitivity|tooth sensitivity
575551|NCT01115452|dentin sensitivity|dentin sensitivity
575552|NCT01115439|falciparum malaria|falciparum malaria
575553|NCT01115439|artemisinin combination treatments|artemisinin combination treatments
575554|NCT01115413|teenage|teenage
575555|NCT01115413|pregnancy|pregnancy
575556|NCT01115413|obstetrical risk|obstetrical risk
575557|NCT01115400|Abdominal Wall Hernia|abdominal wall hernia
575558|NCT01115400|quality of life|quality of life
575559|NCT01115387|Age-related macular degeneration|age-related macular degeneration
575560|NCT01115387|AMD|amd
575561|NCT01115387|Genetic risk|genetic risk
575562|NCT01115387|Environmental risk factors|environmental risk factors
575563|NCT01115387|Complex genetic disorder|complex genetic disorder
575564|NCT01115387|Age-related maculopathy|age-related maculopathy
575565|NCT01115387|Risk modeling|risk modeling
575566|NCT01115387|Smoking|smoking
575567|NCT01115387|Light exposure|light exposure
575568|NCT01115387|Sleep apnea|sleep apnea
575569|NCT01115387|Fundus Photography|fundus photography
575570|NCT01115387|Macula|macula
575571|NCT01115387|Drusen|drusen
575572|NCT01115387|Wet AMD|wet amd
575573|NCT01115387|Dry AMD|dry amd
575574|NCT01115387|Geographic atrophy|geographic atrophy
575575|NCT01115387|Vitamins & supplements|vitamins & supplements
575576|NCT01115361|family planning|family planning
575577|NCT01115361|postpartum|postpartum
575578|NCT01115361|immunization|immunization
575579|NCT01115361|integration|integration
575580|NCT01115361|Contraceptive behavior|contraceptive behavior
575581|NCT01115335|neonatal male circumcision|neonatal male circumcision
575582|NCT01115335|Gomco|gomco
575583|NCT01115335|Plastibell|plastibell
575584|NCT01115335|Mogen|mogen
575585|NCT01115335|Safety|safety
575586|NCT01115335|Uptake|uptake
731303|NCT00505401|HIV|hiv
575587|NCT01115335|Acceptability|acceptability
575588|NCT01115335|Feasibility|feasibility
575589|NCT01115335|Zambia|zambia
575590|NCT01115322|Healthy volunteer study|healthy volunteer study
575591|NCT01115322|phototoxicity|phototoxicity
575592|NCT01115309|Sinusitis|sinusitis
575593|NCT01115296|Helicobacter Pylori|helicobacter pylori
575594|NCT01115296|gastritis|gastritis
575595|NCT01115296|Probiotics|probiotics
575596|NCT01115296|Lactobacillus Reuteri|lactobacillus reuteri
575597|NCT01115283|amblyopia treatment|amblyopia treatment
575598|NCT01115283|neural plasticity|neural plasticity
575599|NCT01115283|perceptual learning|perceptual learning
575600|NCT01115283|vision therapy|vision therapy
575601|NCT01115283|spatial vision|spatial vision
575602|NCT01115283|video games|video games
575603|NCT01115283|occlusion therapy|occlusion therapy
575604|NCT01115270|Normal Pressure Hydrocephalus|normal pressure hydrocephalus
575605|NCT01115257|severe proliferative diabetic retinopathy|severe proliferative diabetic retinopathy
575606|NCT01115257|vitrectomy|vitrectomy
575607|NCT01115257|panretinalphotocoagulation|panretinalphotocoagulation
575608|NCT01115244|Dermatitis herpetiformis|dermatitis herpetiformis
575609|NCT01115244|Dapsone|dapsone
575610|NCT01115231|Age-Related Macular Degeneration|age-related macular degeneration
575611|NCT01115231|Age-Related Maculopathies|age-related maculopathies
575612|NCT01115231|Age-Related Maculopathy|age-related maculopathy
575613|NCT01115231|Macular Dystrophy|macular dystrophy
575614|NCT01115231|Maculopathies, Age-Related|maculopathies, age-related
575615|NCT01115231|Maculopathy, Age-Related|maculopathy, age-related
575616|NCT01115218|Glaucoma|glaucoma
575617|NCT01115205|Exercise, Walking, Type 2 diabetes, Therapy|exercise, walking, type 2 diabetes, therapy
575618|NCT01115179|propofol|propofol
575619|NCT01115179|inflammation|inflammation
575620|NCT01115179|perioperative|perioperative
575621|NCT01115179|lipids|lipids
575622|NCT01115179|Apolipoprotein A-I|apolipoprotein a-i
575623|NCT01115166|blood volume|blood volume
575624|NCT01115153|Acute appendicitis|acute appendicitis
575625|NCT01115153|Antibiotic prophylaxis|antibiotic prophylaxis
575626|NCT01115153|Wound infection|wound infection
575627|NCT01115153|Nosocomial infection|nosocomial infection
575629|NCT01115140|Metformin|metformin
575630|NCT01115140|PCOS|pcos
575631|NCT01115140|Pregnancy|pregnancy
575632|NCT01115140|Trophoblastic invasion|trophoblastic invasion
575633|NCT01115140|Uterine artery velocimetry|uterine artery velocimetry
575634|NCT01115127|pre-menopause|pre-menopause
575635|NCT01115127|melatonin|melatonin
575636|NCT01115127|myo-inositol|myo-inositol
575637|NCT01115101|pain after cesarean|pain after cesarean
575638|NCT01115101|visual analog scale|visual analog scale
575639|NCT01115101|oxycodon|oxycodon
575640|NCT01115101|piritramid|piritramid
575641|NCT01115075|Leptin|leptin
575642|NCT01115075|Changes in leptin may precede the|changes in leptin may precede the
575643|NCT01115075|phasing of oscillations of dietary fat intake|phasing of oscillations of dietary fat intake
575644|NCT01115062|Pain|pain
575645|NCT01115062|Children|children
575646|NCT01115062|Local anesthetics|local anesthetics
575647|NCT01115036|glioblastoma|glioblastoma
575648|NCT01115036|recurrent|recurrent
575649|NCT01115036|surgical resection|surgical resection
575650|NCT01115023|iron deficiency anemia|iron deficiency anemia
575651|NCT01115023|dietary intervention|dietary intervention
575652|NCT01115023|To evaluate a cheap and sustainable dietary intervention to improve the iron status of the entire family of the index case of non-severe iron deficiency anemia.|to evaluate a cheap and sustainable dietary intervention to improve the iron status of the entire family of the index case of non-severe iron deficiency anemia.
575653|NCT01115010|intubation rate|intubation rate
575654|NCT01115010|intubation time|intubation time
575655|NCT01115010|stiffening device|stiffening device
575656|NCT01115010|stiffening wire|stiffening wire
575657|NCT01114997|Lidocaine Infusion|lidocaine infusion
575658|NCT01114997|Esmolol Infusion|esmolol infusion
575659|NCT01114997|Anesthetic adjuvant|anesthetic adjuvant
575660|NCT01114997|Abdominal surgery|abdominal surgery
575661|NCT01114997|Pain management|pain management
575662|NCT01114997|Hemodynamic stability|hemodynamic stability
575663|NCT01114997|Perioperative outcomes|perioperative outcomes
575664|NCT01114984|Pain management|pain management
575665|NCT01114984|Radical mastectomy|radical mastectomy
575666|NCT01114984|Breast surgery|breast surgery
575667|NCT01114984|post-operative pain|post-operative pain
575668|NCT01114971|Labetalol|labetalol
575669|NCT01114971|Esmolol|esmolol
575670|NCT01114971|Fentanyl|fentanyl
575671|NCT01114971|Anesthetic adjuvant|anesthetic adjuvant
575672|NCT01114971|Ambulatory surgery|ambulatory surgery
575673|NCT01114971|Outpatient surgery|outpatient surgery
575674|NCT01114971|Pain management|pain management
575675|NCT01114971|Hemodynamic stability|hemodynamic stability
575676|NCT01114971|Perioperative outcomes|perioperative outcomes
575677|NCT01114958|Lung cancer|lung cancer
575678|NCT01114958|Non-small cell lung cancer|non-small cell lung cancer
575679|NCT01114958|Small-cell lung cancer|small-cell lung cancer
575680|NCT01114958|Lung metastases|lung metastases
575681|NCT01114958|Metastatic cancer|metastatic cancer
575682|NCT01114958|Stage IIIA|stage iiia
575683|NCT01114958|Stage IIIB|stage iiib
575684|NCT01114958|Stage III|stage iii
575685|NCT01114958|Stage 3|stage 3
575686|NCT01114945|Direct Laryngoscopy|direct laryngoscopy
575687|NCT01114945|Video-Mac|video-mac
575688|NCT01114945|GlideScope|glidescope
575689|NCT01114945|McGrath|mcgrath
575690|NCT01114945|Laryngoscopy|laryngoscopy
575691|NCT01114945|Bariatrics|bariatrics
575692|NCT01114945|Glottic view|glottic view
575693|NCT01114945|Airway intubating devices|airway intubating devices
575694|NCT01114945|Tracheal intubation|tracheal intubation
575695|NCT01114932|pre-oxygenation|pre-oxygenation
575696|NCT01114932|body mass index|body mass index
575697|NCT01114932|end-tidal O2|end-tidal o2
575698|NCT01114932|anesthesia induction|anesthesia induction
575699|NCT01114919|Problem drinking|problem drinking
575700|NCT01114919|Alcohol dependence|alcohol dependence
575701|NCT01114919|Alcohol abuse|alcohol abuse
575702|NCT01114919|Internet based intervention|internet based intervention
575703|NCT01114919|Treatment|treatment
575704|NCT01114919|Alcohol Use Disorders Identification Test|alcohol use disorders identification test
575705|NCT01114906|Asthma|asthma
575706|NCT01114906|Resource use|resource use
575707|NCT01114880|ankylosing spondylitis|ankylosing spondylitis
575708|NCT01114880|China|china
575709|NCT01114867|ultrasound|ultrasound
575710|NCT01114867|penis length|penis length
575711|NCT01114867|corpus cavernosum|corpus cavernosum
575712|NCT01114867|length of fetal penis and fetal corpus cavernosum|length of fetal penis and fetal corpus cavernosum
575713|NCT01114841|Healthy Volunteer Subjects|healthy volunteer subjects
575714|NCT01114828|Cirrhosis|cirrhosis
575715|NCT01114828|ascites|ascites
575716|NCT01114828|Tolvaptan|tolvaptan
575717|NCT01114828|OPC-41061|opc-41061
575718|NCT01114815|CADASIL|cadasil
575719|NCT01114815|cerebral|cerebral
575720|NCT01114815|autosomal dominant|autosomal dominant
575721|NCT01114815|arteriopathy|arteriopathy
575722|NCT01114815|subcortical infarcts|subcortical infarcts
575723|NCT01114815|leukoencephalopathy|leukoencephalopathy
575724|NCT01114802|Cancer survivors|cancer survivors
575725|NCT01114802|Anxiety|anxiety
575726|NCT01114802|Depression|depression
575727|NCT01114802|Technology Assisted|technology assisted
575728|NCT01114802|Internet|internet
575729|NCT01114789|chronic renal failure|chronic renal failure
575730|NCT01114789|hemodialysis|hemodialysis
575731|NCT01114789|obesity|obesity
575732|NCT01114789|proteolysis|proteolysis
575733|NCT01114763|Metabolic Syndrome|metabolic syndrome
575734|NCT01114763|Oxidized Low Density Lipoprotein|oxidized low density lipoprotein
575735|NCT01114763|Arterial Elasticity|arterial elasticity
575736|NCT01114763|Diabetes Mellitus|diabetes mellitus
575737|NCT01114763|Cardiovascular Diseases|cardiovascular diseases
575738|NCT01114750|blood glucose|blood glucose
575739|NCT01114750|blood insulin|blood insulin
575740|NCT01114750|dextran|dextran
575742|NCT01114750|hyperglycemia|hyperglycemia
575743|NCT01114750|hypoglycemia|hypoglycemia
575744|NCT01114750|oral delivery|oral delivery
575745|NCT01114750|portal delivery|portal delivery
575746|NCT01114737|Phenylketonuria|phenylketonuria
575747|NCT01114737|PKU|pku
575748|NCT01114737|Kuvan|kuvan
575749|NCT01114737|Sapropterin dihydrochloride|sapropterin dihydrochloride
575750|NCT01114737|Neuropsychiatric disorder|neuropsychiatric disorder
575751|NCT01114737|ADHD|adhd
575752|NCT01114724|Thoracic dissection|thoracic dissection
575753|NCT01114724|Endovascular aortic repair|endovascular aortic repair
575754|NCT01114711|Menstrual Migraine|menstrual migraine
575755|NCT01114711|Frova|frova
575756|NCT01114711|Imaging|imaging
575757|NCT01114711|fMRI|fmri
575758|NCT01114711|Pain|pain
575759|NCT01114698|Depression|depression
575760|NCT01114698|Major Depressive Disorder|major depressive disorder
575761|NCT01114698|Venlafaxine XR (EFFEXOR XR)|venlafaxine xr (effexor xr)
575762|NCT01114698|26489112|26489112
575763|NCT01114698|JNJ26489112|jnj26489112
575764|NCT01114672|Pruritis in hemodialysis patients|pruritis in hemodialysis patients
575765|NCT01114672|25-Vitamin D in chronic kidney disease|25-vitamin d in chronic kidney disease
575766|NCT01114646|Hemiarthroplasty|hemiarthroplasty
575767|NCT01114646|Cemented|cemented
575768|NCT01114646|Press Fit|press fit
575769|NCT01114646|Mortality|mortality
575770|NCT01114646|Morbidity|morbidity
575771|NCT01114646|Functional Status|functional status
575772|NCT01114646|Displaced femoral neck fracture|displaced femoral neck fracture
575773|NCT01114633|PCOS|pcos
575774|NCT01114633|Acne|acne
575775|NCT01114633|Hirsutism|hirsutism
575776|NCT01114620|elderly|elderly
575777|NCT01114620|post-marketing|post-marketing
575778|NCT01114620|H1N1|h1n1
575779|NCT01114620|Clinical trial|clinical trial
575780|NCT01114620|pandemic influenza|pandemic influenza
575781|NCT01114607|GSK1605786|gsk1605786
575782|NCT01114607|relative bioavailability|relative bioavailability
575783|NCT01114607|CCR9 receptor antagonist|ccr9 receptor antagonist
710874|NCT00587483|amiodarone|amiodarone
575784|NCT01114594|Chronic Kidney Disease (CKD)|chronic kidney disease (ckd)
575785|NCT01114594|Autosomal Dominant Polycystic Kidney Disease (ADPKD)|autosomal dominant polycystic kidney disease (adpkd)
575786|NCT01114581|Acute Respiratory Infection|acute respiratory infection
575787|NCT01114581|Mucociliary|mucociliary
575788|NCT01114581|Cough Clearance|cough clearance
575789|NCT01114581|Guaifenesin|guaifenesin
575790|NCT01114568|Relative Bioavailability|relative bioavailability
575791|NCT01114568|Pharmacokinetics|pharmacokinetics
575792|NCT01114568|Pharmacodynamics|pharmacodynamics
575793|NCT01114555|Bevacizumab|bevacizumab
575794|NCT01114555|Irinotecan|irinotecan
575795|NCT01114555|Temozolomide|temozolomide
575796|NCT01114555|10-015|10-015
575797|NCT01114529|de novo renal allograft recipients|de novo renal allograft recipients
575798|NCT01114529|renal allograft function|renal allograft function
575799|NCT01114529|CNI-free regimen|cni-free regimen
575800|NCT01114516|cervical insufficiency|cervical insufficiency
575801|NCT01114503|GSK2136525|gsk2136525
575802|NCT01114503|Pharmacodynamics|pharmacodynamics
575803|NCT01114503|Safety|safety
575804|NCT01114503|Otelixizumab|otelixizumab
575805|NCT01114503|Thyroid eye disease|thyroid eye disease
575806|NCT01114503|Graves' ophthalmopathy|graves' ophthalmopathy
575807|NCT01114503|Repeat dose|repeat dose
575808|NCT01114503|Intravenous infusion|intravenous infusion
575809|NCT01114503|Tolerability|tolerability
575810|NCT01114503|EUGOGO|eugogo
575811|NCT01114490|Hepatic Insufficiency|hepatic insufficiency
575812|NCT01114477|Transcranial magnetic stimulation|transcranial magnetic stimulation
575813|NCT01114477|TMS|tms
575814|NCT01114477|Observational study|observational study
575815|NCT01114477|Major Depression|major depression
575816|NCT01114464|Breast cancer|breast cancer
575817|NCT01114464|Ovarian reserve|ovarian reserve
575818|NCT01114464|Anti-Mullerian Hormone (AMH)|anti-mullerian hormone (amh)
575819|NCT01114464|Chemotherapy|chemotherapy
575820|NCT01114451|Cesarean delivery|cesarean delivery
575821|NCT01114451|Obesity|obesity
575822|NCT01114451|Skin staples|skin staples
575823|NCT01114451|Wound complications|wound complications
575824|NCT01114425|tolerability of post exposure to HIV infection prophylaxis|tolerability of post exposure to hiv infection prophylaxis
575825|NCT01114412|focus groups|focus groups
575826|NCT01114412|overactive bladder|overactive bladder
575827|NCT01114412|bladder sensations|bladder sensations
575828|NCT01114399|Cardiovascular Disease|cardiovascular disease
575829|NCT01114399|Cardiovascular Disease risk (mild to moderate)|cardiovascular disease risk (mild to moderate)
575830|NCT01114399|Cholesterol|cholesterol
575831|NCT01114399|Ambulatory blood pressure|ambulatory blood pressure
575832|NCT01114399|Arterial Stiffness|arterial stiffness
575833|NCT01114386|Smoking|smoking
575834|NCT01114386|Dyspnea|dyspnea
575835|NCT01114386|Cough|cough
575836|NCT01114386|Exercise|exercise
575837|NCT01114373|Melatonin|melatonin
575838|NCT01114373|Hypertension|hypertension
575839|NCT01114373|Blood Pressure|blood pressure
575840|NCT01114373|Cardiovascular|cardiovascular
575841|NCT01114373|Sleep|sleep
575842|NCT01114373|Nighttime|nighttime
575843|NCT01114373|Nocturnal|nocturnal
575844|NCT01114373|Catecholamines|catecholamines
575845|NCT01114373|Sympathetic Nervous System|sympathetic nervous system
575846|NCT01114373|Endothelial Function|endothelial function
575847|NCT01114373|African American|african american
575848|NCT01114360|Melatonin|melatonin
575849|NCT01114360|Hypertension|hypertension
575850|NCT01114360|Blood Pressure|blood pressure
575851|NCT01114360|Cardiovascular|cardiovascular
575852|NCT01114360|Sleep|sleep
575853|NCT01114360|Nighttime|nighttime
575854|NCT01114360|Nocturnal|nocturnal
575855|NCT01114360|Catecholamines|catecholamines
575856|NCT01114360|Sympathetic Nervous System|sympathetic nervous system
575857|NCT01114360|Endothelial function|endothelial function
575858|NCT01114360|African American|african american
575859|NCT01114321|Idiopathic Parkinson's disease|idiopathic parkinson's disease
575860|NCT01114321|Glucose intolerance|glucose intolerance
575861|NCT01114321|Diabetes|diabetes
575862|NCT01114321|OGTT|ogtt
575863|NCT01114321|Patient with an Idiopathic Parkinson's disease|patient with an idiopathic parkinson's disease
575864|NCT01114308|opioid dependence|opioid dependence
575865|NCT01114308|opioid addiction|opioid addiction
575866|NCT01114308|buprenorphine|buprenorphine
575867|NCT01114308|implant|implant
575868|NCT01114308|methadone|methadone
575869|NCT01114308|heroin|heroin
575870|NCT01114308|suboxone|suboxone
575871|NCT01114308|opioid pain medication|opioid pain medication
575872|NCT01114308|opioid withdrawal|opioid withdrawal
575873|NCT01114295|overt|overt
575874|NCT01114295|obscure|obscure
575875|NCT01114295|gastrointestinal|gastrointestinal
575876|NCT01114295|bleeding|bleeding
575877|NCT01114295|hemorrhage|hemorrhage
575878|NCT01114269|Coronary Artery Disease|coronary artery disease
575879|NCT01114269|Sudden Cardiac Death|sudden cardiac death
575880|NCT01114269|Myocardial Infarction|myocardial infarction
575881|NCT01114269|Percutaneous Coronary Intervention|percutaneous coronary intervention
731735|NCT00504088|CLI|cli
575882|NCT01114269|Implantable Cardiac Defibrillator|implantable cardiac defibrillator
575883|NCT01114230|Advanced Renal Cell Carcinoma|advanced renal cell carcinoma
575884|NCT01114230|Advanced Kidney Cancer|advanced kidney cancer
575885|NCT01114230|AGS-16M8F|ags-16m8f
575886|NCT01114217|Iron deficiency anemia|iron deficiency anemia
575887|NCT01114217|Feraheme|feraheme
575888|NCT01114217|Ferumoxytol|ferumoxytol
575889|NCT01114217|IDA|ida
575890|NCT01114204|Iron deficiency anemia|iron deficiency anemia
575891|NCT01114204|Feraheme|feraheme
575892|NCT01114204|ferumoxytol|ferumoxytol
575893|NCT01114204|iron sucrose|iron sucrose
575894|NCT01114204|Venofer|venofer
575895|NCT01114204|IDA|ida
575896|NCT01114178|questionnaire|questionnaire
575897|NCT01114178|peripheral artery disease|peripheral artery disease
575898|NCT01114178|exercise|exercise
575899|NCT01114165|Neutropenia|neutropenia
575900|NCT01114165|Febrile Neutropenia|febrile neutropenia
575901|NCT01114165|Sepsis|sepsis
575902|NCT01114165|Polymerase Chain Reaction|polymerase chain reaction
575903|NCT01114152|AZD9742|azd9742
575904|NCT01114152|Japanese Healthy Volunteers|japanese healthy volunteers
575905|NCT01114152|Phase I|phase i
575906|NCT01114152|Single and Multiple Ascending Dose|single and multiple ascending dose
575907|NCT01114139|Iron deficiency anemia|iron deficiency anemia
575908|NCT01114139|Feraheme|feraheme
575909|NCT01114139|ferumoxytol|ferumoxytol
575910|NCT01114139|IDA|ida
575911|NCT01114126|Neu-P11|neu-p11
575912|NCT01114126|Insomnia|insomnia
575913|NCT01114126|PSG|psg
575914|NCT01114126|safety|safety
575915|NCT01114113|IBS-D|ibs-d
575916|NCT01114113|Post meal Diarrhea|post meal diarrhea
575917|NCT01114113|Trigger meals|trigger meals
575918|NCT01114100|chest pain|chest pain
575919|NCT01114100|panic attacks|panic attacks
575920|NCT01114100|palpitations|palpitations
575921|NCT01114100|depression|depression
575922|NCT01114100|panic disorder|panic disorder
575923|NCT01114100|depressive disorder|depressive disorder
575924|NCT01114100|non cardiac chest pain|non cardiac chest pain
575925|NCT01114087|Spermatogenesis|spermatogenesis
575926|NCT01114087|Inhibitors of tyrosine kinase|inhibitors of tyrosine kinase
575927|NCT01114087|Fragmentation of the spermatic DNA|fragmentation of the spermatic dna
575928|NCT01114074|Thrombosis|thrombosis
575929|NCT01114074|Blood coagulation|blood coagulation
575930|NCT01114074|Perfusion flow experiments|perfusion flow experiments
575931|NCT01114074|Factor XII|factor xii
575932|NCT01114074|Factor XI|factor xi
575933|NCT01114074|Prekallikrein|prekallikrein
575934|NCT01114074|High molecular weight kininogen|high molecular weight kininogen
575935|NCT01114061|diabetes|diabetes
575936|NCT01114061|postprandial glucose level|postprandial glucose level
575937|NCT01114061|insulin pharmacodynamics|insulin pharmacodynamics
575938|NCT01114061|Insulin Pharmacokinetics|insulin pharmacokinetics
575939|NCT01114048|age under 65|age under 65
575940|NCT01114048|Previous untreated|previous untreated
575941|NCT01114035|intestinal epithelial dysplasia|intestinal epithelial dysplasia
575942|NCT01114035|characterization phenotypic|characterization phenotypic
575943|NCT01114035|genetic study|genetic study
575944|NCT01114035|"or  tufting enteropathy "|"or  tufting enteropathy "
575945|NCT01114022|Acute respiratory failure|acute respiratory failure
575946|NCT01114009|recruitment maneuvers|recruitment maneuvers
575947|NCT01114009|ARDS|ards
575948|NCT01114009|lung protective strategy|lung protective strategy
575949|NCT01114009|ARDS, Human|ards, human
575950|NCT01113996|Obesity|obesity
575951|NCT01113996|Gastric by-pass|gastric by-pass
575952|NCT01113996|Body composition|body composition
575953|NCT01113996|Nutrition|nutrition
575954|NCT01113996|Physical activity|physical activity
575955|NCT01113983|SAPIEN XT Valve, Cardiovascular Disease, Valvular Heart Disease, Aortic Stenosis, Heart Valve Therapy, Transapical, Transcatheter, Transfemoral|sapien xt valve, cardiovascular disease, valvular heart disease, aortic stenosis, heart valve therapy, transapical, transcatheter, transfemoral
575956|NCT01113970|breast cancer|breast cancer
575957|NCT01113970|Indibulin|indibulin
575958|NCT01113970|unresectable, locally advanced breast cancer|unresectable, locally advanced breast cancer
575959|NCT01113957|Ovarian Cancer|ovarian cancer
575960|NCT01113931|Chlamydia|chlamydia
575961|NCT01113918|Obesity,|obesity,
575962|NCT01113918|PCOS,|pcos,
575963|NCT01113918|HA,|ha,
575964|NCT01113918|CVD|cvd
575965|NCT01113905|Fatigue|fatigue
575966|NCT01113905|Breast Cancer|breast cancer
575967|NCT01113879|rehabilitation|rehabilitation
575968|NCT01113879|aphasia|aphasia
575969|NCT01113879|exercise|exercise
575970|NCT01113879|BDNF|bdnf
575971|NCT01113853|asthma|asthma
575972|NCT01113853|exhaled nitric oxide|exhaled nitric oxide
575973|NCT01113853|lung function|lung function
575974|NCT01113840|elderly|elderly
575975|NCT01113840|heart failure|heart failure
575976|NCT01113840|exercise|exercise
575977|NCT01113840|diastolic dysfunction|diastolic dysfunction
575978|NCT01113827|Olive|olive
575979|NCT01113827|antioxidant|antioxidant
575980|NCT01113827|exercise|exercise
575981|NCT01113827|inflammation|inflammation
575982|NCT01113827|recovery|recovery
575983|NCT01113827|Healthy men|healthy men
575984|NCT01113801|Chronic Kidney Disease|chronic kidney disease
575985|NCT01113801|Diabetic Kidney Disease|diabetic kidney disease
575986|NCT01113801|End-Stage Renal Disease|end-stage renal disease
575987|NCT01113801|Transforming Growth Factor beta 1 Monoclonal Antibody|transforming growth factor beta 1 monoclonal antibody
575988|NCT01113801|Type 1 Diabetes|type 1 diabetes
575989|NCT01113801|Type 2 Diabetes|type 2 diabetes
575990|NCT01113788|atrial flutter, tricuspid isthmus, ablation|atrial flutter, tricuspid isthmus, ablation
575991|NCT01113775|pulmonary embolism|pulmonary embolism
575992|NCT01113775|computed tomography|computed tomography
575993|NCT01113762|Arthroplasty, Replacement, Hip|arthroplasty, replacement, hip
575994|NCT01113762|Bone Density|bone density
575995|NCT01113762|Rehabilitation|rehabilitation
575996|NCT01113762|T-Lymphocytes|t-lymphocytes
575997|NCT01113762|Chromium Alloys|chromium alloys
575998|NCT01113749|Dementia|dementia
575999|NCT01113749|Nutrition|nutrition
576000|NCT01113749|Feeding|feeding
576001|NCT01113736|Ileostomy|ileostomy
576002|NCT01113736|Stenosis|stenosis
576003|NCT01113736|Surgical Wound Dehiscence|surgical wound dehiscence
576004|NCT01113736|Peritoneal|peritoneal
576005|NCT01113736|Colorectal Surgery|colorectal surgery
576006|NCT01113723|C-MAC|c-mac
576007|NCT01113723|Fiberoptic bronchoscope|fiberoptic bronchoscope
576008|NCT01113723|Laryngoscopy|laryngoscopy
576009|NCT01113723|Cervical spine injury|cervical spine injury
576010|NCT01113723|Glottic view|glottic view
576011|NCT01113723|Tracheal intubation|tracheal intubation
576012|NCT01113710|Rotigotine|rotigotine
576013|NCT01113710|Neupro®|neupro®
576014|NCT01113710|Restless Legs Syndrome|restless legs syndrome
576015|NCT01113697|allergen challenge|allergen challenge
576016|NCT01113697|blood draw|blood draw
576017|NCT01113697|gene expression analysis|gene expression analysis
576018|NCT01113697|protein analysis|protein analysis
576019|NCT01113697|genetics|genetics
576020|NCT01113671|Diabetes Mellitus type 2|diabetes mellitus type 2
576021|NCT01113671|Haptoglobin phenotype|haptoglobin phenotype
576022|NCT01113671|Vitamin E|vitamin e
576023|NCT01113658|negative pressure wound therapy|negative pressure wound therapy
576024|NCT01113658|NPWT|npwt
576025|NCT01113658|Spiracur|spiracur
576026|NCT01113658|SNaP Wound Care System|snap wound care system
576027|NCT01113645|Decompressive craniectomy|decompressive craniectomy
576028|NCT01113645|Cranioplasty|cranioplasty
576029|NCT01113645|Cerebral blood flow|cerebral blood flow
576030|NCT01113645|Cerebral hemodynamic|cerebral hemodynamic
576031|NCT01113645|Neurological-cognitive test GOS, FAB, MMSE,|neurological-cognitive test gos, fab, mmse,
576032|NCT01113645|Transcranial Doppler|transcranial doppler
576033|NCT01113632|Chronic Lymphocytic Leukemia|chronic lymphocytic leukemia
576034|NCT01113632|Small Lymphocytic Lymphoma|small lymphocytic lymphoma
576035|NCT01113632|Ofatumumab|ofatumumab
576036|NCT01113619|lactose maldigestion|lactose maldigestion
576037|NCT01113619|dairy intolerance|dairy intolerance
576038|NCT01113619|intolerance to milk|intolerance to milk
576039|NCT01113619|intolerance to dairy|intolerance to dairy
576040|NCT01113619|milk intolerance|milk intolerance
576041|NCT01113619|GI disorder|gi disorder
576042|NCT01113619|lactose metabolism|lactose metabolism
576043|NCT01113619|GI symptoms after dairy ingestion|gi symptoms after dairy ingestion
576044|NCT01113606|Moderate to severe facial photo damage|moderate to severe facial photo damage
576045|NCT01113606|Periocular or perioral fine wrinkles|periocular or perioral fine wrinkles
576046|NCT01113593|COPD|copd
576047|NCT01113567|Hepatic Encephalopathy|hepatic encephalopathy
576048|NCT01113567|Liver Cirrhosis|liver cirrhosis
576049|NCT01113567|Disaccharides|disaccharides
576050|NCT01113567|Lactose|lactose
576051|NCT01113567|Quality of Life|quality of life
576052|NCT01113541|Ziprasidone|ziprasidone
576053|NCT01113541|Bipolar Disorder|bipolar disorder
576054|NCT01113541|Metabolic Syndrome|metabolic syndrome
576055|NCT01113528|Bone allograft|bone allograft
576056|NCT01113528|IL-1|il-1
576057|NCT01113528|IL-10|il-10
576058|NCT01113528|periodontal regeneration|periodontal regeneration
576059|NCT01113528|omega-3|omega-3
576060|NCT01113528|aspirin|aspirin
576061|NCT01113515|Diabetic foot ulcer|diabetic foot ulcer
576062|NCT01113515|Diabetic wound|diabetic wound
576063|NCT01113515|chronic non healing ulcer|chronic non healing ulcer
576064|NCT01113476|Advanced Malignancies|advanced malignancies
576065|NCT01113476|Nab-paclitaxel|nab-paclitaxel
576066|NCT01113476|Gemcitabine|gemcitabine
576067|NCT01113476|Bevacizumab|bevacizumab
576068|NCT01113463|Brain Tumor|brain tumor
576069|NCT01113463|Central Nervous System|central nervous system
576071|NCT01113463|Glioblastoma Multiforme|glioblastoma multiforme
576072|NCT01113463|GBM|gbm
576073|NCT01113463|TPI 287|tpi 287
576074|NCT01113463|Radiation Therapy|radiation therapy
576075|NCT01113463|Temozolomide|temozolomide
576076|NCT01113463|Chemotherapy|chemotherapy
576077|NCT01113463|taxanes|taxanes
576078|NCT01113450|hearing, newborn, screening|hearing, newborn, screening
576079|NCT01113437|Bronchial Asthma|bronchial asthma
576080|NCT01113437|Allergy|allergy
576081|NCT01113424|Smoking Cessation|smoking cessation
576082|NCT01113424|Nicotine pharmacokinetics|nicotine pharmacokinetics
576083|NCT01113411|humerus fracture|humerus fracture
576084|NCT01113411|locked plate|locked plate
576085|NCT01113398|glioblastoma multiforme|glioblastoma multiforme
576086|NCT01113398|gliosarcoma|gliosarcoma
576087|NCT01113398|malignant glioma|malignant glioma
576088|NCT01113398|glioma|glioma
576089|NCT01113398|Avastin|avastin
576090|NCT01113398|bevacizumab|bevacizumab
576091|NCT01113398|AMG 102|amg 102
576092|NCT01113398|rilotumumab|rilotumumab
576093|NCT01113398|recurrent|recurrent
576094|NCT01113398|Duke|duke
576095|NCT01113398|Pro00022491|pro00022491
576096|NCT01113385|Nephrotic syndrome|nephrotic syndrome
576097|NCT01113385|Focal Segmental glomerulosclerosis|focal segmental glomerulosclerosis
576098|NCT01113385|FSGS|fsgs
576099|NCT01113385|Minimal change|minimal change
576100|NCT01113385|Steroid resistant|steroid resistant
576101|NCT01113385|Pediatric|pediatric
576102|NCT01113385|Proteinuria|proteinuria
576103|NCT01113385|Galactose|galactose
576104|NCT01113385|FSPF|fspf
576105|NCT01113372|Coronary, Disease|coronary, disease
576106|NCT01113359|HCMV infection|hcmv infection
576107|NCT01113359|Hypertension|hypertension
576108|NCT01113359|The Potential Link Between HCMV Infection and Essential Hypertension|the potential link between hcmv infection and essential hypertension
576109|NCT01113346|enterosorbent|enterosorbent
576110|NCT01113346|sorbent|sorbent
576111|NCT01113346|gastrointestinal decontamination|gastrointestinal decontamination
576112|NCT01113346|viral diarrhea|viral diarrhea
576113|NCT01113346|rotavirus|rotavirus
576114|NCT01113346|Filtrum|filtrum
576115|NCT01113346|Filtrum-STI|filtrum-sti
576116|NCT01113346|lignin|lignin
576117|NCT01113320|Safinamide - Parkinson's disease - Levodopa induced dyskinesia|safinamide - parkinson's disease - levodopa induced dyskinesia
576118|NCT01113320|Advanced idiopathic PD patients treated with L-dopa and suffering from temporally predictable L-dopa induced peak-dose dyskinesia.|advanced idiopathic pd patients treated with l-dopa and suffering from temporally predictable l-dopa induced peak-dose dyskinesia.
576119|NCT01113307|Chronic ulcers|chronic ulcers
576120|NCT01113307|pressure ulcers|pressure ulcers
576121|NCT01113307|venous ulcers|venous ulcers
576122|NCT01113307|diabetic foot ulcers|diabetic foot ulcers
576123|NCT01113307|post operative ulcers|post operative ulcers
576124|NCT01113307|hard to heal ulcers|hard to heal ulcers
576125|NCT01113281|Tuberculosis|tuberculosis
576126|NCT01113281|Vaccine|vaccine
576127|NCT01113281|Live Vaccine|live vaccine
576128|NCT01113281|rBCG|rbcg
576129|NCT01113268|Patient collection|patient collection
576130|NCT01113268|Cardiac remodelling|cardiac remodelling
576131|NCT01113268|Echography|echography
576132|NCT01113268|Magnetic Resonance Imaging|magnetic resonance imaging
576133|NCT01113268|Gene polymorphisms|gene polymorphisms
576134|NCT01113268|Biomarkers|biomarkers
576135|NCT01113255|VENTILATORS|ventilators
576136|NCT01113255|BENCH EVALUATION|bench evaluation
576137|NCT01113255|MECHANICAL VENTILATION|mechanical ventilation
576138|NCT01113242|Parkinson Disease Dementia|parkinson disease dementia
576139|NCT01113242|Observational|observational
576140|NCT01113242|Case control|case control
576141|NCT01113242|Neuropsychological assessment|neuropsychological assessment
576142|NCT01113229|Post Partum Haemorrhage,|post partum haemorrhage,
576143|NCT01113229|oxytocin,|oxytocin,
576144|NCT01113229|misoprostol,|misoprostol,
576145|NCT01113229|prevention,|prevention,
576146|NCT01113229|delivery.|delivery.
576147|NCT01113216|CF|cf
576148|NCT01113216|CFRD|cfrd
576149|NCT01113216|Diabetes|diabetes
576150|NCT01113216|Genetic Modifiers|genetic modifiers
576151|NCT01113203|resistance training|resistance training
576152|NCT01113203|blood pressure|blood pressure
576153|NCT01113203|hemodynamics|hemodynamics
576154|NCT01113203|autonomic|autonomic
576155|NCT01113203|Elderly Subjects|elderly subjects
576156|NCT01113177|Mandibular growth temporomandibular arthritis|mandibular growth temporomandibular arthritis
576157|NCT01113164|ondansetron|ondansetron
576158|NCT01113164|sertraline|sertraline
576159|NCT01113164|lab studies|lab studies
576160|NCT01113164|alcoholism|alcoholism
576161|NCT01113164|alcohol dependence|alcohol dependence
576162|NCT01113151|Steroid-resistant|steroid-resistant
576163|NCT01113151|Severe asthmatics|severe asthmatics
576164|NCT01113151|Annual symptoms|annual symptoms
576165|NCT01113151|Daily magnesium supplement|daily magnesium supplement
576166|NCT01113151|ACT (asthma control test)|act (asthma control test)
576167|NCT01113138|Clearance|clearance
576168|NCT01113138|Half-life|half-life
576169|NCT01113138|Absorption fraction|absorption fraction
576170|NCT01113138|Pharmacokinetics|pharmacokinetics
576171|NCT01113125|hypertrophic scar|hypertrophic scar
576172|NCT01113125|keloid|keloid
576173|NCT01113125|central venous catheter|central venous catheter
576174|NCT01113125|children|children
576175|NCT01113125|cancer|cancer
576176|NCT01113112|Ovarian Neoplasms|ovarian neoplasms
576177|NCT01113086|Parkinson|parkinson
576178|NCT01113086|Transcranial direct current stimulation|transcranial direct current stimulation
732005|NCT00503230|Latino|latino
576179|NCT01113086|Motor function|motor function
576180|NCT01113086|Cognitive function|cognitive function
576181|NCT01113086|Affective function|affective function
576182|NCT01113073|pulse pressure variation|pulse pressure variation
576183|NCT01113073|hemodynamic monitoring|hemodynamic monitoring
576184|NCT01113073|fluid responsiveness|fluid responsiveness
576185|NCT01113073|mechanical ventilation|mechanical ventilation
576186|NCT01113073|fluid therapy|fluid therapy
576187|NCT01113060|Coronary Artery Disease|coronary artery disease
576188|NCT01113060|Aspirin|aspirin
576189|NCT01113060|Secondary Prevention|secondary prevention
576190|NCT01113047|Hypertension|hypertension
576191|NCT01113047|Aliskiren|aliskiren
576192|NCT01113047|Amlodipine|amlodipine
576193|NCT01113034|Asthma|asthma
576194|NCT01113034|Bronchiectasis|bronchiectasis
576195|NCT01113008|Myocardial Reperfusion Injury/mortality|myocardial reperfusion injury/mortality
576196|NCT01113008|Coronary angioplasty|coronary angioplasty
576197|NCT01113008|Reperfusion|reperfusion
576198|NCT01113008|Myocardial Reperfusion Injury/prevention & control|myocardial reperfusion injury/prevention & control
576199|NCT01112995|Probiotic|probiotic
576200|NCT01112995|Lactobacillus|lactobacillus
576201|NCT01112995|Antibiotic resistance|antibiotic resistance
576202|NCT01112982|Gout|gout
576203|NCT01112982|Synovial pannus|synovial pannus
576204|NCT01112982|Magnetic resonance imaging|magnetic resonance imaging
576205|NCT01112969|Internet-based supportive coaching|internet-based supportive coaching
576206|NCT01112969|guided self-help|guided self-help
576207|NCT01112969|Caregivers|caregivers
576208|NCT01112969|Brain Injury|brain injury
576209|NCT01112969|Caregiver Burden|caregiver burden
576210|NCT01112969|Coping|coping
576211|NCT01112969|Stress|stress
576212|NCT01112969|Depression|depression
576213|NCT01112956|HSV-2|hsv-2
576214|NCT01112956|HSV-1|hsv-1
576215|NCT01112956|Sensitivity|sensitivity
576216|NCT01112956|Specificity|specificity
576217|NCT01112956|Testing algorithm|testing algorithm
576218|NCT01112956|Test evaluation|test evaluation
576219|NCT01112943|Acupuncture, Pulmonary Rehabilitation, Inflammation, COPD|acupuncture, pulmonary rehabilitation, inflammation, copd
576220|NCT01112930|essential fatty acids|essential fatty acids
576221|NCT01112930|DHA|dha
576222|NCT01112930|preschool children|preschool children
576223|NCT01112930|docosahexanoic acid (DHA)|docosahexanoic acid (dha)
576224|NCT01112904|essential fatty acids|essential fatty acids
576225|NCT01112904|DHA status|dha status
576226|NCT01112904|preschool children|preschool children
576227|NCT01112904|gestation|gestation
576228|NCT01112891|Vitamin D|vitamin d
576229|NCT01112891|Infant|infant
576230|NCT01112891|Lactation|lactation
576231|NCT01112891|Dose-Response|dose-response
576232|NCT01112878|Shoulder arthroscopy|shoulder arthroscopy
576233|NCT01112878|Knee arthroscopy|knee arthroscopy
576234|NCT01112878|Clonidine|clonidine
576235|NCT01112878|Gabapentin|gabapentin
576236|NCT01112878|Pain management|pain management
576237|NCT01112878|Ambulatory surgery|ambulatory surgery
576238|NCT01112878|Perioperative outcome|perioperative outcome
576239|NCT01112878|Analgesia|analgesia
576240|NCT01112865|Growth Hormone Deficiency|growth hormone deficiency
576241|NCT01112865|Somatropin|somatropin
576242|NCT01112865|Injection Pen|injection pen
576243|NCT01112865|Medical Device|medical device
576244|NCT01112865|Cross Over Study|cross over study
576245|NCT01112865|Preference|preference
576246|NCT01112865|Convenience|convenience
576247|NCT01112865|Children|children
576248|NCT01112865|Dyads|dyads
576249|NCT01112865|Adults|adults
576250|NCT01112852|control of bleed|control of bleed
576251|NCT01112839|Overweight|overweight
576252|NCT01112839|Obese|obese
576253|NCT01112839|Breast cancer survivors|breast cancer survivors
576254|NCT01112839|Weight loss|weight loss
576255|NCT01112839|Exercise|exercise
576256|NCT01112839|Physical activity|physical activity
576257|NCT01112826|triple-negative breast cancer|triple-negative breast cancer
576258|NCT01112826|metronomic chemotherapy|metronomic chemotherapy
576259|NCT01112826|capecitabine (xeloda)|capecitabine (xeloda)
576261|NCT01112813|lithium|lithium
576262|NCT01112813|MRI|mri
576263|NCT01112813|gray matter|gray matter
576264|NCT01112800|Anthracycline|anthracycline
576265|NCT01112800|Cardiac Muscle Injury|cardiac muscle injury
576266|NCT01112800|Doxorubicin|doxorubicin
576267|NCT01112800|Doppler Imaging|doppler imaging
576268|NCT01112800|Intermediate non-rhabdomyosarcoma soft tissue sarcomas|intermediate non-rhabdomyosarcoma soft tissue sarcomas
576269|NCT01112800|High-risk non-rhabdomyosarcoma soft tissue sarcomas|high-risk non-rhabdomyosarcoma soft tissue sarcomas
576270|NCT01112787|Healthy Volunteer Subjects|healthy volunteer subjects
576271|NCT01112774|Transcranial direct current stimulation|transcranial direct current stimulation
576272|NCT01112774|Spinal cord injury|spinal cord injury
576273|NCT01112774|Chronic pain|chronic pain
576274|NCT01112774|Brain excitability|brain excitability
576275|NCT01112761|Athletes|athletes
576276|NCT01112761|Multiple Concussions|multiple concussions
576277|NCT01112761|Transcranial Stimulation|transcranial stimulation
576278|NCT01112748|Focal neuropathic pain|focal neuropathic pain
576279|NCT01112735|Abdominoplasty|abdominoplasty
576280|NCT01112735|Flap adherence in subjects undergoing abdominoplasty to eliminate dead space and reduce seroma/hematoma formation|flap adherence in subjects undergoing abdominoplasty to eliminate dead space and reduce seroma/hematoma formation
576281|NCT01112722|honeybee toxin|honeybee toxin
576282|NCT01112722|Apitox|apitox
576283|NCT01112722|pain|pain
576284|NCT01112722|inflammation|inflammation
576285|NCT01112722|osteoarthritis|osteoarthritis
576286|NCT01112722|Apitoxin|apitoxin
576287|NCT01112709|Diabetes|diabetes
576288|NCT01112709|Prediabetes|prediabetes
576289|NCT01112709|Resistance training|resistance training
576290|NCT01112709|behavior|behavior
576291|NCT01112709|behavioral change theory|behavioral change theory
576292|NCT01112696|diabetes|diabetes
576293|NCT01112696|glucose sensor|glucose sensor
576294|NCT01112696|CGM|cgm
576295|NCT01112683|Down syndrome|down syndrome
576296|NCT01112683|Trisomy 21|trisomy 21
576297|NCT01112683|Pattern Recognition Memory (PRM)|pattern recognition memory (prm)
576298|NCT01112683|Paired Associates Learning (PAL)|paired associates learning (pal)
576299|NCT01112683|California Verbal Learning Test (CVLT)|california verbal learning test (cvlt)
576300|NCT01112683|Test of Reception of Grammar (TROG-II)|test of reception of grammar (trog-ii)
576301|NCT01112683|Peabody Picture Vocabulary Test (PPVT-III)|peabody picture vocabulary test (ppvt-iii)
576302|NCT01112683|Scales of Independent Behavior revised (SIB-R)|scales of independent behavior revised (sib-r)
576303|NCT01112670|Healthy volunteers|healthy volunteers
576304|NCT01112657|Multiple Sclerosis|multiple sclerosis
576305|NCT01112657|Clinical isolated syndrome|clinical isolated syndrome
576306|NCT01112657|Demyelination|demyelination
576307|NCT01112631|NSCLC,|nsclc,
576308|NCT01112631|PORT,|port,
576309|NCT01112631|Quality of Life,|quality of life,
576310|NCT01112631|Pulmonary function after RT|pulmonary function after rt
576311|NCT01112618|Infertility|infertility
576312|NCT01112618|Reproductive technologies, Assisted|reproductive technologies, assisted
576313|NCT01112618|r-hFSH|r-hfsh
576314|NCT01112618|r-hLH|r-hlh
576315|NCT01112618|Pergoveris|pergoveris
576316|NCT01112605|achilles tendon|achilles tendon
576317|NCT01112605|sural nerve|sural nerve
576318|NCT01112605|distance|distance
576319|NCT01112605|US|us
576320|NCT01112605|ultrasound|ultrasound
576321|NCT01112605|Distance between Sural nerve and the Achilles tendon|distance between sural nerve and the achilles tendon
576322|NCT01112592|NETs|nets
576323|NCT01112592|Infections|infections
576324|NCT01112592|Neutrophil function|neutrophil function
576325|NCT01112553|Acute Migraine|acute migraine
576326|NCT01112553|Treximet|treximet
576327|NCT01112553|Imaging|imaging
576328|NCT01112553|fMRI|fmri
576329|NCT01112553|Pain|pain
576330|NCT01112553|Heat Stimulus|heat stimulus
576331|NCT01112540|to evaluate the anal. efficacy of IV morph. vs. place. for elderly presenting to the ED with UAP and determine if it has an impact on diag. accu. and phy. exam|to evaluate the anal. efficacy of iv morph. vs. place. for elderly presenting to the ed with uap and determine if it has an impact on diag. accu. and phy. exam
576332|NCT01112527|PF-00299804|pf-00299804
576333|NCT01112514|ICG|icg
576334|NCT01112514|indocyanine green|indocyanine green
576335|NCT01112501|Diagnosis|diagnosis
576336|NCT01112501|Dementia|dementia
576337|NCT01112501|Imaging|imaging
576338|NCT01112488|stroke|stroke
576339|NCT01112488|patient engagement programme|patient engagement programme
576340|NCT01112488|community rehabilitation|community rehabilitation
576341|NCT01112488|new carer|new carer
576342|NCT01112462|Nasal congestion, Headache|nasal congestion, headache
576343|NCT01112449|selenium|selenium
576344|NCT01112449|oxidative stress|oxidative stress
576345|NCT01112449|prostate cancer|prostate cancer
576346|NCT01112449|PSA|psa
576347|NCT01112449|glucose|glucose
576348|NCT01112436|Pain|pain
576349|NCT01112436|preemptive|preemptive
576350|NCT01112436|Postoperative|postoperative
576351|NCT01112436|delirium|delirium
576352|NCT01112410|Bronchiectasis|bronchiectasis
576353|NCT01112410|Hypertonic saline|hypertonic saline
576354|NCT01112397|Jak2|jak2
576355|NCT01112397|cancer|cancer
576356|NCT01112397|jak 1|jak 1
576357|NCT01112397|stat 3|stat 3
576358|NCT01112397|Phase 1|phase 1
576359|NCT01112371|scars after abdominal Caesarean section|scars after abdominal caesarean section
576360|NCT01112358|Lutropin alfa|lutropin alfa
576361|NCT01112358|Fertilization in vitro|fertilization in vitro
576362|NCT01112358|Intracytoplasmic sperm injection|intracytoplasmic sperm injection
576363|NCT01112358|Reproductive techniques, assisted|reproductive techniques, assisted
576364|NCT01112345|Multiple Sclerosis, Relapsing-Remitting|multiple sclerosis, relapsing-remitting
576365|NCT01112345|Interferon-beta|interferon-beta
576366|NCT01112319|COLD HOT or Electrotherapy treatment|cold hot or electrotherapy treatment
576367|NCT01112306|Open-label|open-label
576368|NCT01112306|PAH|pah
576369|NCT01112306|Pulmonary Arterial Hypertension|pulmonary arterial hypertension
710875|NCT00587483|lidocaine|lidocaine
576370|NCT01112293|Subjects who have pleural malignant mesothelioma|subjects who have pleural malignant mesothelioma
576371|NCT01112280|Colorectal neoplasm|colorectal neoplasm
576372|NCT01112280|Colonoscopy|colonoscopy
576373|NCT01112280|chromoendoscopy|chromoendoscopy
576374|NCT01112280|cap-assisted colonoscopy|cap-assisted colonoscopy
576375|NCT01112267|Chronic low back pain|chronic low back pain
576376|NCT01112267|Tramadol Hydrochloride (HCl)|tramadol hydrochloride (hcl)
576377|NCT01112267|acetaminophen|acetaminophen
576378|NCT01112254|Ductal Carcinoma In Situ (DCIS) breast cancer|ductal carcinoma in situ (dcis) breast cancer
576379|NCT01112241|Obliterative bronchiolitis|obliterative bronchiolitis
576380|NCT01112241|Bronchodilator responsiveness|bronchodilator responsiveness
576381|NCT01112241|Partial forced expiratory flow|partial forced expiratory flow
576382|NCT01112241|Lung volumes|lung volumes
576383|NCT01112215|SLE|sle
576384|NCT01112215|non-renal manifestations|non-renal manifestations
576385|NCT01112202|direct thrombin inhibitors|direct thrombin inhibitors
576386|NCT01112202|Dabigatran|dabigatran
576387|NCT01112202|Coagulation parameters|coagulation parameters
576388|NCT01112189|Lymphedema|lymphedema
576389|NCT01112189|Stem cells|stem cells
576390|NCT01112189|Mastectomy|mastectomy
576391|NCT01112189|Breast Cancer|breast cancer
576392|NCT01112176|Strain|strain
576393|NCT01112176|Ejection fraction|ejection fraction
576394|NCT01112176|Diastolic function|diastolic function
576395|NCT01112163|ischemic heart disease|ischemic heart disease
576396|NCT01112150|Edema|edema
576397|NCT01112150|Heart failure|heart failure
576398|NCT01112150|Pulmonary hypertension|pulmonary hypertension
576399|NCT01112150|Edema in legs|edema in legs
576400|NCT01112124|Typical|typical
576401|NCT01112124|Development|development
576402|NCT01112124|Microwave|microwave
576403|NCT01112124|Children|children
576404|NCT01112124|Behavior|behavior
576405|NCT01112085|Diabetic macular edema|diabetic macular edema
576406|NCT01112085|Ranibizumab|ranibizumab
576407|NCT01112072|keratoconus|keratoconus
576408|NCT01112072|corneal ectasia|corneal ectasia
576409|NCT01112072|collagen crosslinking|collagen crosslinking
576410|NCT01112072|riboflavin|riboflavin
576411|NCT01112072|cornea|cornea
576412|NCT01112072|ultraviolet|ultraviolet
576413|NCT01112059|cystic fibrosis|cystic fibrosis
576414|NCT01112046|Early colorectal neoplasms|early colorectal neoplasms
576415|NCT01112033|biliverdin reductase|biliverdin reductase
576416|NCT01112033|BLVRA|blvra
576417|NCT01112033|hepatitis C|hepatitis c
576418|NCT01112033|HCV|hcv
576419|NCT01112033|peripheral blood mononuclear cells|peripheral blood mononuclear cells
576420|NCT01112033|PBMC|pbmc
576421|NCT01112033|liver|liver
576422|NCT01112033|genetic polymorphisms|genetic polymorphisms
576423|NCT01112020|Chlorhexidine digluconate (CHG)|chlorhexidine digluconate (chg)
576424|NCT01112020|Biopatch Protective Disk|biopatch protective disk
576425|NCT01112020|Tegaderm CHG IV (intravenous) Securement Dressing|tegaderm chg iv (intravenous) securement dressing
576426|NCT01112020|parachloroaniline (PCA)|parachloroaniline (pca)
576427|NCT01112020|No condition being studied.|no condition being studied.
576428|NCT01112020|Assessing components of CHG-containing dressings after use.|assessing components of chg-containing dressings after use.
576429|NCT01112007|Insulin Resistance|insulin resistance
576430|NCT01112007|Hypertension|hypertension
576431|NCT01112007|Blood pressure|blood pressure
576432|NCT01112007|Aldosterone|aldosterone
576433|NCT01112007|Renin|renin
576434|NCT01111994|hyperpigmentation|hyperpigmentation
576435|NCT01111981|alopecia|alopecia
576436|NCT01111981|CCCA - Central Centrifugal Cicatricial Alopecia|ccca - central centrifugal cicatricial alopecia
576437|NCT01111968|vaccine|vaccine
576438|NCT01111968|pandemic influenza A|pandemic influenza a
576439|NCT01111968|adjuvant|adjuvant
576440|NCT01111968|safety|safety
576441|NCT01111942|head and neck cancer|head and neck cancer
576442|NCT01111942|chemotherapy|chemotherapy
576443|NCT01111942|radiation|radiation
576444|NCT01111929|Emergency contraception|emergency contraception
576445|NCT01111929|pregnancy during breastfeeding|pregnancy during breastfeeding
576446|NCT01111929|Lactational amenorrhea Method|lactational amenorrhea method
576447|NCT01111929|unplanned pregnancy|unplanned pregnancy
576448|NCT01111877|ear tubes|ear tubes
576449|NCT01111877|ear drainage|ear drainage
576450|NCT01111877|ear infection|ear infection
576451|NCT01111877|ear drops|ear drops
576452|NCT01111877|tympanostomy tubes|tympanostomy tubes
576453|NCT01111877|Pediatric patients|pediatric patients
576454|NCT01111851|NK1-receptor occupancy|nk1-receptor occupancy
576455|NCT01111838|STA-9090|sta-9090
576456|NCT01111838|colon|colon
576457|NCT01111838|rectal|rectal
576458|NCT01111838|10-029|10-029
576459|NCT01111825|HKI-272 (NERATINIB)|hki-272 (neratinib)
576460|NCT01111825|TEMSIROLIMUS (CCI-779)|temsirolimus (cci-779)
576461|NCT01111825|HER2-Amplified|her2-amplified
576462|NCT01111825|Triple-negative|triple-negative
576463|NCT01111825|invasive adenocarcinoma|invasive adenocarcinoma
576464|NCT01111825|10-005|10-005
576465|NCT01111825|Nerlynx|nerlynx
576466|NCT01111825|PB-272|pb-272
576467|NCT01111812|overweight|overweight
576468|NCT01111812|obese|obese
576469|NCT01111812|children|children
576470|NCT01111812|weighing|weighing
576471|NCT01111812|weight|weight
576472|NCT01111799|endometrial biopsy|endometrial biopsy
576473|NCT01111799|implantation|implantation
576474|NCT01111799|uterine receptivity|uterine receptivity
576475|NCT01111799|infertility|infertility
576476|NCT01111799|controled ovarian hyperstimulation|controled ovarian hyperstimulation
576477|NCT01111799|intra uterine insemination|intra uterine insemination
576478|NCT01111786|scleroderma|scleroderma
576479|NCT01111786|skin|skin
576480|NCT01111786|tightness|tightness
576481|NCT01111786|durometer|durometer
576482|NCT01111773|Patellar tendonitis|patellar tendonitis
576483|NCT01111760|cardiovascular disease|cardiovascular disease
576484|NCT01111760|heart CT scan|heart ct scan
576485|NCT01111760|CT scan|ct scan
576486|NCT01111760|pulmonary embolisms|pulmonary embolisms
576487|NCT01111760|aortography|aortography
576488|NCT01111747|platelet-rich plasma|platelet-rich plasma
576489|NCT01111747|patellar ligament|patellar ligament
576490|NCT01111747|regeneration|regeneration
576491|NCT01111747|growth substances|growth substances
576492|NCT01111734|self harm|self harm
576493|NCT01111734|self injury|self injury
576494|NCT01111734|self mutilation|self mutilation
576495|NCT01111734|N-Acetylcysteine|n-acetylcysteine
576496|NCT01111734|adolescents|adolescents
576497|NCT01111734|impulse control disorder|impulse control disorder
576498|NCT01111734|borderline personality disorder|borderline personality disorder
576499|NCT01111734|fMRI|fmri
576500|NCT01111721|Sexually Transmitted Diseases|sexually transmitted diseases
576501|NCT01111721|HIV Infections|hiv infections
576502|NCT01111721|Genital Diseases, Female|genital diseases, female
576503|NCT01111721|Acquired Immunodeficiency Syndrome|acquired immunodeficiency syndrome
576504|NCT01111721|Risk Reduction Behavior|risk reduction behavior
576505|NCT01111721|HIV prevention|hiv prevention
576506|NCT01111695|wound healing|wound healing
576507|NCT01111695|granulation tissue|granulation tissue
576508|NCT01111695|Varicose Ulcer|varicose ulcer
576509|NCT01111682|traumatic brain injury|traumatic brain injury
576510|NCT01111682|hypertonic saline therapy|hypertonic saline therapy
576511|NCT01111682|intracranial pressure|intracranial pressure
576512|NCT01111669|Functional Endoscopic Sinus Surgery|functional endoscopic sinus surgery
576513|NCT01111669|Tranexamic Acid|tranexamic acid
576514|NCT01111656|Multi-center|multi-center
576515|NCT01111656|randomized|randomized
576516|NCT01111656|prospective|prospective
576517|NCT01111656|parallel-group|parallel-group
576518|NCT01111656|rater-blinded|rater-blinded
576519|NCT01111656|RR-MS|rr-ms
576520|NCT01111630|chronic renal failure|chronic renal failure
576521|NCT01111630|Anaemia|anaemia
576522|NCT01111604|Colonic Neoplasms|colonic neoplasms
576523|NCT01111604|Rectal Neoplasms|rectal neoplasms
576524|NCT01111604|Adenocarcinoma|adenocarcinoma
576525|NCT01111604|Antibodies, Monoclonal|antibodies, monoclonal
576526|NCT01111591|Cyclooxygenase-2 inhibitor (Celecoxib)|cyclooxygenase-2 inhibitor (celecoxib)
576527|NCT01111591|Extrahepatic bile duct cancer|extrahepatic bile duct cancer
576528|NCT01111591|Pancreas cancer|pancreas cancer
576529|NCT01111565|Major Depressive Disorder|major depressive disorder
576531|NCT01111565|Depression|depression
576532|NCT01111552|Major Depressive Disorder|major depressive disorder
576533|NCT01111552|MDD|mdd
576534|NCT01111552|Depression|depression
576535|NCT01111539|Major Depressive Disorder|major depressive disorder
576536|NCT01111539|MDD|mdd
576537|NCT01111539|Depression|depression
576538|NCT01111526|Graft versus host disease|graft versus host disease
576539|NCT01111526|GVHD|gvhd
576540|NCT01111526|allogeneic transplant|allogeneic transplant
576541|NCT01111526|acute GVHD|acute gvhd
576542|NCT01111526|chronic GVHD|chronic gvhd
576543|NCT01111513|knee surgery|knee surgery
576544|NCT01111513|total knee arthroplasty|total knee arthroplasty
576545|NCT01111513|total knee replacement|total knee replacement
576546|NCT01111513|ropivacaine|ropivacaine
576547|NCT01111513|femoral nerve block|femoral nerve block
576548|NCT01111487|COPD|copd
576549|NCT01111487|Electromyography|electromyography
576550|NCT01111487|Inspiratory muscles|inspiratory muscles
576551|NCT01111474|dentin hypersensitivity|dentin hypersensitivity
576552|NCT01111474|cyanoacrylate|cyanoacrylate
576553|NCT01111474|laser|laser
576554|NCT01111461|Advanced Endometrial Cancer|advanced endometrial cancer
576555|NCT01111448|Myelodysplastic Syndromes of all IPSS subgroups|myelodysplastic syndromes of all ipss subgroups
576556|NCT01111422|Antioxidant|antioxidant
576557|NCT01111422|Epithelial to Mesenchymal Transition|epithelial to mesenchymal transition
576558|NCT01111422|peritoneal fibrosis|peritoneal fibrosis
576559|NCT01111422|Peritoneal Dialysis, Continuous Ambulatory|peritoneal dialysis, continuous ambulatory
576560|NCT01111396|ALL|all
576561|NCT01111396|GMALL 2003|gmall 2003
576562|NCT01111396|Chemotherapy|chemotherapy
576563|NCT01111396|Hippocampus|hippocampus
576564|NCT01111383|cystic fibrosis|cystic fibrosis
576565|NCT01111383|P. aeruginosa|p. aeruginosa
576566|NCT01111383|tobramycin|tobramycin
576567|NCT01111370|diabetes mellitus requiring insulin|diabetes mellitus requiring insulin
576568|NCT01111357|Rheumatoid Arthritis|rheumatoid arthritis
576569|NCT01111357|Rheumatoid Arthritis according to ACR criteria of diagnosis|rheumatoid arthritis according to acr criteria of diagnosis
576570|NCT01111344|Dietary supplement|dietary supplement
576571|NCT01111344|Anogenital warts|anogenital warts
576572|NCT01111344|Viusid|viusid
576573|NCT01111344|Glizigen|glizigen
576574|NCT01111305|Filariasis|filariasis
576575|NCT01111305|Post-Treatment Reactions|post-treatment reactions
576576|NCT01111305|Monoclonal Antibody|monoclonal antibody
576577|NCT01111305|Loa Loa|loa loa
576578|NCT01111305|Loiasis|loiasis
576579|NCT01111266|in vivo KUF|in vivo kuf
576580|NCT01111266|ß2M|ß2m
576581|NCT01111266|leptin|leptin
576582|NCT01111253|multicenter randomized, open label, clinical trial|multicenter randomized, open label, clinical trial
576583|NCT01111253|acute uncomplicated (mild) diverticulitis|acute uncomplicated (mild) diverticulitis
576584|NCT01111253|treatment strategies|treatment strategies
576585|NCT01111253|management of diverticulitis|management of diverticulitis
576586|NCT01111253|antibiotics|antibiotics
576587|NCT01111253|observation and supportive care|observation and supportive care
576588|NCT01111253|cost analysis|cost analysis
576589|NCT01111253|economic evaluation|economic evaluation
576590|NCT01111240|Humira|humira
576591|NCT01111240|Long-term safety and effectiveness|long-term safety and effectiveness
576592|NCT01111240|Psoriatic Arthritis|psoriatic arthritis
576593|NCT01111227|cytokines|cytokines
576594|NCT01111227|propofol|propofol
576595|NCT01111227|isoflurane|isoflurane
576596|NCT01111227|flow cytometry|flow cytometry
576597|NCT01111227|Types of General Anesthesia|types of general anesthesia
576598|NCT01111214|Invasive Pneumococcal Disease (IPD)|invasive pneumococcal disease (ipd)
576599|NCT01111214|pneumococcal serotypes|pneumococcal serotypes
576600|NCT01111201|Autologous Bone Marrow Transplant|autologous bone marrow transplant
576601|NCT01111201|Breast|breast
576602|NCT01111201|Lymphoma|lymphoma
576603|NCT01111201|International travel|international travel
576604|NCT01111201|questionnaire|questionnaire
576605|NCT01111201|Hematopoietic Stem Cell Transplant (HSCT) recipients|hematopoietic stem cell transplant (hsct) recipients
576606|NCT01111175|Locally recurrent breast cancer|locally recurrent breast cancer
576607|NCT01111162|HIV|hiv
576608|NCT01111162|H1N1 vaccination|h1n1 vaccination
576609|NCT01111162|HIV infected individuals|hiv infected individuals
576610|NCT01111149|Schizophrenia|schizophrenia
576611|NCT01111149|Smoking cessation|smoking cessation
576612|NCT01111149|Varenicline|varenicline
576613|NCT01111149|Bupropion|bupropion
576614|NCT01111136|Urticaria|urticaria
576615|NCT01111136|Hives|hives
576616|NCT01111136|Stress|stress
576617|NCT01111123|plaque psoriasis|plaque psoriasis
576618|NCT01111123|lac-hydrin|lac-hydrin
576619|NCT01111123|ammonium lactate|ammonium lactate
576620|NCT01111123|Ultravate|ultravate
576621|NCT01111123|halobetasol propionate|halobetasol propionate
576622|NCT01111123|weekend only application|weekend only application
576623|NCT01111123|topical therapy|topical therapy
576624|NCT01111123|topical corticosteroid|topical corticosteroid
576625|NCT01111123|class I steroid|class i steroid
576626|NCT01111097|Brain tumors, Glioblastoma and DCA|brain tumors, glioblastoma and dca
576627|NCT01111097|Brain tumor,Glioblastoma recurrent|brain tumor,glioblastoma recurrent
576628|NCT01111084|Ovulation induction|ovulation induction
576629|NCT01111084|Ovarian Hyperstimulation Syndrome|ovarian hyperstimulation syndrome
576630|NCT01111084|Pregnancy|pregnancy
576631|NCT01111084|Fertility|fertility
576632|NCT01111071|hospital variation|hospital variation
576633|NCT01111071|30 day mortality|30 day mortality
576634|NCT01111071|in hospital mortality|in hospital mortality
577214|NCT01108757|catheter|catheter
576635|NCT01111071|acute coronary syndrome|acute coronary syndrome
576636|NCT01111071|myocardial infarction|myocardial infarction
576637|NCT01111071|unstable angina|unstable angina
576638|NCT01111071|hospital performance|hospital performance
576639|NCT01111071|trends|trends
576640|NCT01111058|Squamous Cell Cancer|squamous cell cancer
576641|NCT01111032|Treadmill|treadmill
576642|NCT01111032|Exercise|exercise
576643|NCT01111032|Cancer|cancer
576644|NCT01111032|Validity|validity
576645|NCT01111032|Reliability|reliability
576646|NCT01111019|Hypochondroplasia|hypochondroplasia
576647|NCT01111019|Skeletal dysplasia|skeletal dysplasia
576648|NCT01111019|Growth|growth
576649|NCT01111019|Growth Hormone|growth hormone
576650|NCT01111019|Recombinant-human Growth Hormone|recombinant-human growth hormone
576651|NCT01111006|Electronic toilet|electronic toilet
576652|NCT01111006|Bidet|bidet
576653|NCT01111006|Anorectal resting pressure|anorectal resting pressure
576654|NCT01110993|Multiple Sclerosis, Interferon-beta 1-a|multiple sclerosis, interferon-beta 1-a
576655|NCT01110980|Head and Neck neoplasms|head and neck neoplasms
576656|NCT01110980|Radiotherapy|radiotherapy
576657|NCT01110980|Diet counselling|diet counselling
576658|NCT01110980|Swallow therapy|swallow therapy
576659|NCT01110980|Food intake|food intake
576660|NCT01110941|S-1|s-1
576661|NCT01110941|leucovorin|leucovorin
576662|NCT01110941|oxaliplatin|oxaliplatin
576663|NCT01110941|colorectal cancer|colorectal cancer
576664|NCT01110941|SOL|sol
576665|NCT01110941|unresectable or recurrent colorectal cancer|unresectable or recurrent colorectal cancer
576666|NCT01110902|Agomelatine|agomelatine
576667|NCT01110902|Major Depressive Disorder|major depressive disorder
576668|NCT01110902|MDD|mdd
576669|NCT01110902|depression|depression
576670|NCT01110889|Agomelatine|agomelatine
576671|NCT01110889|Major Depressive Disorder|major depressive disorder
576672|NCT01110889|MDD|mdd
576673|NCT01110889|depression|depression
576674|NCT01110876|Recurrent Glioblastoma Multiforme|recurrent glioblastoma multiforme
576675|NCT01110876|GBM|gbm
576676|NCT01110876|Brain|brain
576677|NCT01110876|Central Nervous Center|central nervous center
576678|NCT01110876|Malignant glioma|malignant glioma
576679|NCT01110876|Glioblastoma multiforme|glioblastoma multiforme
576680|NCT01110876|Gliosarcoma|gliosarcoma
576681|NCT01110876|Anaplastic astrocytoma|anaplastic astrocytoma
576682|NCT01110876|Anaplastic oligodendroglioma|anaplastic oligodendroglioma
576683|NCT01110876|Anaplastic oligoastrocytoma|anaplastic oligoastrocytoma
576684|NCT01110876|Vorinostat|vorinostat
576685|NCT01110876|SAHA|saha
576686|NCT01110876|Suberoylanilide Hydroxamic Acid|suberoylanilide hydroxamic acid
576687|NCT01110876|MSK-390|msk-390
576688|NCT01110876|Zolinza|zolinza
576689|NCT01110876|Erlotinib|erlotinib
576690|NCT01110876|Erlotinib Hydrochloride|erlotinib hydrochloride
576691|NCT01110876|OSI-774|osi-774
576692|NCT01110876|Tarceva|tarceva
576693|NCT01110876|Temozolomide|temozolomide
576694|NCT01110876|Temodar|temodar
576695|NCT01110863|Chronic Lymphocytic Leukemia|chronic lymphocytic leukemia
576696|NCT01110850|Chronic Lymphocytic Leukemia|chronic lymphocytic leukemia
576697|NCT01110837|Allergic rhinitis|allergic rhinitis
576698|NCT01110837|Allergen|allergen
576699|NCT01110824|Prevention|prevention
576700|NCT01110824|ventricular dysfunction|ventricular dysfunction
576701|NCT01110824|chemotherapy|chemotherapy
576702|NCT01110824|acute myeloid leukemia|acute myeloid leukemia
576703|NCT01110824|precursor-cell lymphoblastic leukemia|precursor-cell lymphoblastic leukemia
576704|NCT01110824|multiple myeloma|multiple myeloma
576705|NCT01110824|lymphoma|lymphoma
576706|NCT01110824|ejection fraction|ejection fraction
576707|NCT01110824|Autologous hematopoietic stem cell transplantation|autologous hematopoietic stem cell transplantation
576708|NCT01110811|GERD|gerd
576709|NCT01110811|Esophagitis|esophagitis
576710|NCT01110811|Fundoplication|fundoplication
576711|NCT01110811|Anti-reflux surgery|anti-reflux surgery
576712|NCT01110811|PPI dependent|ppi dependent
576713|NCT01110798|perioperative/postoperative complications|perioperative/postoperative complications
576714|NCT01110798|gastrointestinal complications|gastrointestinal complications
576715|NCT01110798|adenocarcinoma of the rectum|adenocarcinoma of the rectum
576716|NCT01110798|stage I rectal cancer|stage i rectal cancer
576717|NCT01110798|stage II rectal cancer|stage ii rectal cancer
576718|NCT01110798|stage III rectal cancer|stage iii rectal cancer
576719|NCT01110785|recurrent colon cancer|recurrent colon cancer
576720|NCT01110785|stage III colon cancer|stage iii colon cancer
576721|NCT01110785|stage IV colon cancer|stage iv colon cancer
576722|NCT01110785|recurrent rectal cancer|recurrent rectal cancer
576723|NCT01110785|stage III rectal cancer|stage iii rectal cancer
576724|NCT01110785|stage IV rectal cancer|stage iv rectal cancer
576725|NCT01110772|Surgical site infection|surgical site infection
576726|NCT01110772|Skin preparation|skin preparation
576727|NCT01110772|Cost analysis|cost analysis
576728|NCT01110759|pain management|pain management
576729|NCT01110759|ambulatory surgery|ambulatory surgery
576730|NCT01110759|opioid|opioid
576731|NCT01110759|local anesthesia|local anesthesia
576732|NCT01110759|hand surgery|hand surgery
576733|NCT01110759|postoperative pain|postoperative pain
576734|NCT01110733|Non-Hodgkins Lymphoma|non-hodgkins lymphoma
576735|NCT01110733|Non-Hodgkin's Lymphoma|non-hodgkin's lymphoma
576736|NCT01110733|Lymphoma|lymphoma
576737|NCT01110707|Reproductive technology, Assisted|reproductive technology, assisted
576738|NCT01110707|Recombinant human follicle stimulating hormone (r-hFSH)|recombinant human follicle stimulating hormone (r-hfsh)
576739|NCT01110707|Recombinant leutinizing hormone (r-hLH)|recombinant leutinizing hormone (r-hlh)
576740|NCT01110707|Ovulation induction|ovulation induction
576741|NCT01110707|Infertility|infertility
576742|NCT01110694|Idiopathic pulmonary fibrosis|idiopathic pulmonary fibrosis
576743|NCT01110694|Interstitial lung disease|interstitial lung disease
576744|NCT01110694|Prognosis|prognosis
576745|NCT01110694|Biomarkers|biomarkers
576746|NCT01110694|Mortality|mortality
576747|NCT01110694|Acute exacerbations|acute exacerbations
576748|NCT01110668|Unresectable|unresectable
576749|NCT01110668|metastatic gastrointestinal stromal tumor|metastatic gastrointestinal stromal tumor
576750|NCT01110668|disease progression|disease progression
576751|NCT01110668|progression-free survival|progression-free survival
576752|NCT01110655|Exercise-associated hyponatremia|exercise-associated hyponatremia
576753|NCT01110655|Randomized treatment trial|randomized treatment trial
576754|NCT01110655|Endurance runners|endurance runners
576755|NCT01110629|Chronic kidney disease not on dialysis|chronic kidney disease not on dialysis
576756|NCT01110629|Lanthanum carbonate|lanthanum carbonate
576757|NCT01110616|EEG Standardization|eeg standardization
576758|NCT01110603|Cancer|cancer
576759|NCT01110603|Advanced Solid Tumors|advanced solid tumors
576760|NCT01110590|Erectile Dysfunction|erectile dysfunction
576761|NCT01110577|MRI|mri
576762|NCT01110577|Hepatic Steatosis Study|hepatic steatosis study
576763|NCT01110564|Chronic Obstructive Pulmonary Disease|chronic obstructive pulmonary disease
576764|NCT01110564|daily symptom variability|daily symptom variability
576765|NCT01110564|effects of symptom on morning activities|effects of symptom on morning activities
576766|NCT01110551|Dengue, vaccine, flavivirus|dengue, vaccine, flavivirus
576767|NCT01110525|Phase I|phase i
576768|NCT01110525|Drug-drug interaction|drug-drug interaction
576769|NCT01110525|Oral contraceptives|oral contraceptives
576770|NCT01110525|AZD 1981|azd 1981
576771|NCT01110512|Improvement of CVI parameters|improvement of cvi parameters
576772|NCT01110447|Hepatic Encephalopathy, probiotics|hepatic encephalopathy, probiotics
576773|NCT01110421|Doripenem|doripenem
576774|NCT01110421|Child, Hospitalized|child, hospitalized
576775|NCT01110421|Cefepime|cefepime
576776|NCT01110421|Infusions, Intravenous|infusions, intravenous
576777|NCT01110421|Severe community acquired pneumonia|severe community acquired pneumonia
576778|NCT01110421|Nosocomial pneumonia|nosocomial pneumonia
576779|NCT01110421|Ventilator associated pneumonia|ventilator associated pneumonia
576780|NCT01110408|Antibiotic|antibiotic
576781|NCT01110408|Child, Hospitalized|child, hospitalized
576782|NCT01110408|Complicated Urinary Tract Infection|complicated urinary tract infection
576783|NCT01110408|Pyelonephritis|pyelonephritis
576784|NCT01110408|Doripenem|doripenem
576785|NCT01110408|Cefepime|cefepime
576786|NCT01110382|Anti-Infective Agents|anti-infective agents
576787|NCT01110382|Doripenem|doripenem
576788|NCT01110382|Meropenem|meropenem
576789|NCT01110382|Child, Hospitalized|child, hospitalized
576790|NCT01110382|Complicated Intra-Abdominal Infections|complicated intra-abdominal infections
576791|NCT01110369|sarcopenia|sarcopenia
576792|NCT01110369|frail elderly|frail elderly
576793|NCT01110369|protein drink|protein drink
576794|NCT01110369|resistance exercise|resistance exercise
576795|NCT01110369|Skeletal muscle mass|skeletal muscle mass
576796|NCT01110369|muscle mass in elderly|muscle mass in elderly
576797|NCT01110343|parent stress|parent stress
576798|NCT01110343|parent coping|parent coping
576799|NCT01110343|parent anxiety|parent anxiety
576800|NCT01110343|parent health|parent health
576801|NCT01110343|parent depression|parent depression
576802|NCT01110330|Tinea Pedis|tinea pedis
576803|NCT01110330|Ketoconazole (NIZORAL)|ketoconazole (nizoral)
576804|NCT01110330|Antifungal Agents|antifungal agents
576805|NCT01110330|Miconazole (DAKTARIN)|miconazole (daktarin)
576806|NCT01110317|Paliperidone palmitate|paliperidone palmitate
576807|NCT01110317|R092670PSY1001|r092670psy1001
576808|NCT01110317|Pharmacokinetics|pharmacokinetics
576809|NCT01110317|Risperdal (CONSTA)|risperdal (consta)
576810|NCT01110317|Risperidone, Paliperidone|risperidone, paliperidone
576811|NCT01110304|acromio-clavicular joint dislocation|acromio-clavicular joint dislocation
576812|NCT01110304|type III acromio-clavicular joint dislocation|type iii acromio-clavicular joint dislocation
576813|NCT01110304|joint dislocation|joint dislocation
576814|NCT01110304|clavicle hook plate|clavicle hook plate
576815|NCT01110291|docetaxel toxicity|docetaxel toxicity
576816|NCT01110291|CYP3A activity|cyp3a activity
576817|NCT01110291|CYP3A5|cyp3a5
576818|NCT01110291|MDR1|mdr1
576819|NCT01110291|peroral midazolam|peroral midazolam
576820|NCT01110278|Urge Urinary Incontinence|urge urinary incontinence
576821|NCT01110278|Magnetic Resonance Imaging|magnetic resonance imaging
576822|NCT01110278|Diffusion Tensor Imaging|diffusion tensor imaging
576823|NCT01110278|Brain Connectivity|brain connectivity
576824|NCT01110278|Bladder Control|bladder control
576825|NCT01110278|fMRI|fmri
576826|NCT01110252|Chronic Obstructive Pulmonary Disease|chronic obstructive pulmonary disease
576827|NCT01110252|Emphysema|emphysema
576828|NCT01110252|Cell therapy|cell therapy
576829|NCT01110252|Bone marrow mononuclear cells|bone marrow mononuclear cells
576830|NCT01110252|stem cells|stem cells
576831|NCT01110239|limb preconditioning|limb preconditioning
576832|NCT01110239|remote preconditioning|remote preconditioning
576833|NCT01110239|ischemic preconditioning|ischemic preconditioning
576834|NCT01110226|non small cell lung cancer|non small cell lung cancer
576835|NCT01110226|small cell lung cancer|small cell lung cancer
576836|NCT01110226|Platinum Responsive|platinum responsive
576837|NCT01110226|solid tumor malignancies|solid tumor malignancies
576838|NCT01110213|Aging|aging
576839|NCT01110213|physical activity|physical activity
576840|NCT01110213|diet|diet
576841|NCT01110213|goal setting|goal setting
576842|NCT01110200|Hospitalization|hospitalization
576843|NCT01110200|Exacerbations of COPD|exacerbations of copd
576844|NCT01110200|Chronic Obstructive Pulmonary Disease (COPD)|chronic obstructive pulmonary disease (copd)
576845|NCT01110187|Lacosamide|lacosamide
576846|NCT01110187|Fosphenytoin|fosphenytoin
576847|NCT01110187|traumatic brain injury|traumatic brain injury
576848|NCT01110187|Glasgow coma scale|glasgow coma scale
576849|NCT01110187|Disability Rating Scale|disability rating scale
576850|NCT01110187|Resource Utilization Questionnaire|resource utilization questionnaire
576851|NCT01110187|Continuous EEG|continuous eeg
576852|NCT01110187|seizures|seizures
576853|NCT01110161|Abdominal Fat|abdominal fat
576854|NCT01110161|Visceral Fat|visceral fat
576855|NCT01110161|Subcutaneous Fat|subcutaneous fat
576856|NCT01110161|Dual-energy x-ray absorptiometry|dual-energy x-ray absorptiometry
576857|NCT01110161|DXA|dxa
576858|NCT01110161|Computed Tomography|computed tomography
576859|NCT01110161|CT|ct
576860|NCT01110161|Body Mass Index|body mass index
576861|NCT01110161|Body composition|body composition
576862|NCT01110161|Percent fat|percent fat
576863|NCT01110161|Waist circumference|waist circumference
576864|NCT01110161|Hip circumference|hip circumference
576865|NCT01110148|skin biopsy|skin biopsy
576866|NCT01110148|informed consent|informed consent
576867|NCT01110148|patient education|patient education
576868|NCT01110148|video education|video education
576869|NCT01110148|patients requiring skin biopsies|patients requiring skin biopsies
576870|NCT01110122|Muscle recovery|muscle recovery
576871|NCT01110122|Intermittent exercise|intermittent exercise
576872|NCT01110122|Whey protein|whey protein
576873|NCT01110122|Soccer|soccer
576874|NCT01110109|Adult|adult
576875|NCT01110109|Surgery|surgery
576876|NCT01110109|Endotracheal Tube|endotracheal tube
576877|NCT01110109|Ventilator|ventilator
576878|NCT01110109|Pneumonia|pneumonia
576879|NCT01110109|Suctioning|suctioning
576880|NCT01110096|Obesity|obesity
576881|NCT01110096|Child|child
576882|NCT01110096|Parent|parent
576883|NCT01110096|Family|family
576884|NCT01110083|Phase 1|phase 1
576885|NCT01110083|advanced solid tumors|advanced solid tumors
576886|NCT01110083|refractory to standard therapy|refractory to standard therapy
576887|NCT01110083|Patients with solid tumors, either refractory to standard therapy or for which no effective standard therapy is available|patients with solid tumors, either refractory to standard therapy or for which no effective standard therapy is available
576888|NCT01110070|articular|articular
576889|NCT01110070|cartilage|cartilage
576890|NCT01110070|microfracture|microfracture
576891|NCT01110070|knee pain|knee pain
576892|NCT01110070|cartilage repair|cartilage repair
576893|NCT01110070|Subjects with an articular cartilage defect in the knee.|subjects with an articular cartilage defect in the knee.
576894|NCT01110057|p38 kinase inhibitor|p38 kinase inhibitor
576895|NCT01110057|male and female|male and female
576896|NCT01110057|patients|patients
576897|NCT01110044|Neonatal vaccination|neonatal vaccination
576898|NCT01110031|Chronic lymphocytic leukemia|chronic lymphocytic leukemia
576899|NCT01110031|Cardiac Repolarization (QTc)|cardiac repolarization (qtc)
576900|NCT01110018|Tolerability|tolerability
576901|NCT01110018|COPD|copd
576902|NCT01110018|Safety|safety
576903|NCT01110018|Muscarinic receptor (mAChR) antagonist|muscarinic receptor (machr) antagonist
576904|NCT01110018|GSK573719|gsk573719
576905|NCT01110018|Healthy subjects|healthy subjects
576906|NCT01110018|Pharmacokinetics|pharmacokinetics
576907|NCT01110018|IV study|iv study
576908|NCT01110005|D5LR|d5lr
576909|NCT01110005|glucose containing IV solution|glucose containing iv solution
576910|NCT01110005|LR|lr
576911|NCT01110005|non glucose IV solution|non glucose iv solution
576912|NCT01109992|coronary artery disease|coronary artery disease
576913|NCT01109992|exercise|exercise
576914|NCT01109992|regadenoson|regadenoson
576915|NCT01109992|positron emission tomography|positron emission tomography
576916|NCT01109979|Cardiovascular, vascular|cardiovascular, vascular
576917|NCT01109966|Allergy|allergy
576918|NCT01109966|Cow's Milk|cow's milk
576919|NCT01109966|Infants|infants
576920|NCT01109966|Food Allergy|food allergy
576921|NCT01109953|Lung|lung
576922|NCT01109953|PET/CT scan|pet/ct scan
576923|NCT01109953|10-054|10-054
576924|NCT01109940|Ankylosing spondylitis|ankylosing spondylitis
576925|NCT01109940|IgG1K monoclonal antibody|igg1k monoclonal antibody
576926|NCT01109940|Interleukin -17A neutralizing|interleukin -17a neutralizing
576927|NCT01109914|Renal transplantation|renal transplantation
576928|NCT01109914|Immunosuppression|immunosuppression
576929|NCT01109914|ETEC|etec
576930|NCT01109914|Dukoral|dukoral
576931|NCT01109914|Vaccination|vaccination
576932|NCT01109914|Immunity, Humoral|immunity, humoral
576933|NCT01109901|Cubital tunnel,subcutaneous transposition,submuscular|cubital tunnel,subcutaneous transposition,submuscular
576934|NCT01109862|Femoral neck fractures|femoral neck fractures
576935|NCT01109862|Hip fractures|hip fractures
576936|NCT01109862|Elderly|elderly
576937|NCT01109862|Total hip arthroplasty|total hip arthroplasty
576938|NCT01109862|Bipolar hemiarthroplasty|bipolar hemiarthroplasty
576939|NCT01109849|ADHD|adhd
576940|NCT01109849|growth|growth
576942|NCT01109849|stimulant medication|stimulant medication
576943|NCT01109836|prevention|prevention
576944|NCT01109836|cognitive decline|cognitive decline
576945|NCT01109836|post-stroke dementia|post-stroke dementia
576946|NCT01109836|life-style intervention|life-style intervention
576947|NCT01109836|vascular risk factors|vascular risk factors
576948|NCT01109836|polyintervention|polyintervention
576949|NCT01109836|multifactorial treatment|multifactorial treatment
576950|NCT01109823|Patients hospitalized at Intensive Care Unit treated with levofloxacin IV|patients hospitalized at intensive care unit treated with levofloxacin iv
576951|NCT01109784|coronary angioplasty|coronary angioplasty
576952|NCT01109784|clopidogrel resistance|clopidogrel resistance
576953|NCT01109784|prasugrel|prasugrel
576954|NCT01109771|Ventral hernia|ventral hernia
576955|NCT01109758|Fenofibrate|fenofibrate
576956|NCT01109758|Gene Expression|gene expression
576957|NCT01109758|DNA methylation|dna methylation
576958|NCT01109745|Asthma|asthma
576959|NCT01109745|health-related quality of life|health-related quality of life
576960|NCT01109745|patient-centred care|patient-centred care
576961|NCT01109719|Protocol|protocol
576962|NCT01109719|Critical pathway|critical pathway
576963|NCT01109719|Intensive care units|intensive care units
576964|NCT01109706|Acute coronary syndrome|acute coronary syndrome
576965|NCT01109706|PCSK9|pcsk9
576966|NCT01109706|cardiovascular safety|cardiovascular safety
576967|NCT01109667|Thromboplastin, Prothrombin, Diagnostic Reagent Kits, International Normalized Ratio, Laboratory Tests.|thromboplastin, prothrombin, diagnostic reagent kits, international normalized ratio, laboratory tests.
576968|NCT01109654|Fertilization in Vitro|fertilization in vitro
576969|NCT01109654|Reproductive Techniques, Assisted|reproductive techniques, assisted
576970|NCT01109654|Follicle Stimulating Hormone|follicle stimulating hormone
576971|NCT01109654|Cetrotide|cetrotide
576972|NCT01109654|Gonal-f|gonal-f
576973|NCT01109628|sarcopenia|sarcopenia
576974|NCT01109628|frail elderly|frail elderly
576975|NCT01109628|protein drink|protein drink
576976|NCT01109628|skeletal muscle mass|skeletal muscle mass
576977|NCT01109628|muscle mass in elderly|muscle mass in elderly
576978|NCT01109615|Colorectal cancer|colorectal cancer
576979|NCT01109615|Metastatic colorectal cancer|metastatic colorectal cancer
576980|NCT01109615|Treatment resistant|treatment resistant
576981|NCT01109615|Chemotherapy refractory|chemotherapy refractory
576982|NCT01109615|KRAS mutation|kras mutation
576983|NCT01109602|Stroke|stroke
576984|NCT01109602|accidental falls|accidental falls
576985|NCT01109602|Yoga|yoga
576986|NCT01109602|Blood pressure|blood pressure
576987|NCT01109602|Range of Motion|range of motion
576988|NCT01109602|Rehabilitation|rehabilitation
576989|NCT01109602|Exercise|exercise
576990|NCT01109602|balance|balance
576991|NCT01109602|quality of life|quality of life
576992|NCT01109602|mobility|mobility
576993|NCT01109589|antibiotics|antibiotics
576994|NCT01109589|prescriptions|prescriptions
576995|NCT01109589|pregnancy|pregnancy
576996|NCT01109589|children|children
576997|NCT01109576|deafness-blindness|deafness-blindness
576998|NCT01109576|pilot study|pilot study
576999|NCT01109576|self management education|self management education
577000|NCT01109576|dual sensory loss|dual sensory loss
577001|NCT01109576|rehabilitation|rehabilitation
577002|NCT01109576|peer support groups|peer support groups
577003|NCT01109576|age related|age related
577004|NCT01109563|cannabis use disorder|cannabis use disorder
577005|NCT01109563|marijuana|marijuana
577006|NCT01109563|motivational enhancement treatment|motivational enhancement treatment
577007|NCT01109563|cognitive behavioral treatment|cognitive behavioral treatment
577008|NCT01109563|continuing care|continuing care
577009|NCT01109537|Restless Legs Syndrome (RLS)|restless legs syndrome (rls)
577010|NCT01109537|GABA|gaba
577011|NCT01109537|Glutamate|glutamate
577012|NCT01109537|Magnetic Resonance Spectroscopy|magnetic resonance spectroscopy
577013|NCT01109498|LPLD|lpld
577014|NCT01109498|Lipoprotein Lipase Deficiency|lipoprotein lipase deficiency
577015|NCT01109498|Chylomicronaemia|chylomicronaemia
577016|NCT01109498|Genetherapy|genetherapy
577017|NCT01109498|AAV|aav
577018|NCT01109498|Alipogene Tiparvovec|alipogene tiparvovec
577019|NCT01109498|AMT-011|amt-011
577020|NCT01109498|Lipoprotein Lipase|lipoprotein lipase
577021|NCT01109485|Allergic conjunctivitis|allergic conjunctivitis
577022|NCT01109459|preschool|preschool
577023|NCT01109459|screening|screening
577024|NCT01109459|cluster randomized|cluster randomized
577025|NCT01109459|physician practice patterns|physician practice patterns
577026|NCT01109459|behavior|behavior
577027|NCT01109459|knowledge|knowledge
577028|NCT01109459|attitudes|attitudes
577029|NCT01109459|guideline adherence|guideline adherence
577030|NCT01109446|Lateral Epicondylitis|lateral epicondylitis
577031|NCT01109446|Tennis Elbow|tennis elbow
577032|NCT01109446|Epicondylitis Lateralis|epicondylitis lateralis
577033|NCT01109433|Behcet's Disease|behcet's disease
577034|NCT01109433|Intermediate Uveitis|intermediate uveitis
577035|NCT01109433|Uveitis|uveitis
577036|NCT01109433|Immunogenetics|immunogenetics
577037|NCT01109420|Hereditary Cancer|hereditary cancer
577038|NCT01109420|Susceptibility Gene(s) for Thyroid Cancer|susceptibility gene(s) for thyroid cancer
577039|NCT01109420|Screening at Risk Family Members|screening at risk family members
577040|NCT01109420|Inherited Thyroid Cancer|inherited thyroid cancer
577041|NCT01109420|Thyroid Cancer|thyroid cancer
577042|NCT01109407|Plasma Cell Neoplasm|plasma cell neoplasm
577043|NCT01109407|Natural History|natural history
577044|NCT01109407|Translational Studies|translational studies
577045|NCT01109407|Gene Expression Profiling|gene expression profiling
577046|NCT01109407|Protein Markers|protein markers
577047|NCT01109407|Smoldering Myeloma|smoldering myeloma
577048|NCT01109407|SMM|smm
577049|NCT01109407|Monoclonal Gammopathy of Undetermined Significance|monoclonal gammopathy of undetermined significance
577050|NCT01109407|MGUS|mgus
577051|NCT01109394|Genomics|genomics
577052|NCT01109394|Proteomics|proteomics
577053|NCT01109394|Tissue Repository|tissue repository
577054|NCT01109394|Omics|omics
577055|NCT01109394|Cell Lines|cell lines
577056|NCT01109394|Pediatric Cancer|pediatric cancer
577057|NCT01109394|Solid Tumor|solid tumor
577058|NCT01109394|Sarcoma|sarcoma
577059|NCT01109394|Kidney Cancer|kidney cancer
577060|NCT01109394|Neuroblastoma|neuroblastoma
577061|NCT01109381|bacterial infections|bacterial infections
577062|NCT01109381|anti-infective agents|anti-infective agents
577063|NCT01109381|gastrointestinal agents|gastrointestinal agents
577064|NCT01109381|antibacterial agents|antibacterial agents
577065|NCT01109381|omeprazole|omeprazole
577066|NCT01109381|lauric acid|lauric acid
577067|NCT01109381|n-acetylcysteine|n-acetylcysteine
577068|NCT01109381|helicobacter infections|helicobacter infections
577069|NCT01109381|helicobacter pylori|helicobacter pylori
577070|NCT01109381|non-antibiotic treatment|non-antibiotic treatment
577071|NCT01109368|Autosomal Dominant Familial Hypercholesterolemia|autosomal dominant familial hypercholesterolemia
577072|NCT01109355|PEEP|peep
577073|NCT01109355|Patients with hemorrhage stroke under mechanical ventilation|patients with hemorrhage stroke under mechanical ventilation
577074|NCT01109342|HIV Prevention|hiv prevention
577075|NCT01109342|Vaccine|vaccine
577076|NCT01109342|Recombinant Adenovirus-5|recombinant adenovirus-5
577077|NCT01109342|HIV Preventative Vaccine|hiv preventative vaccine
577078|NCT01109329|Vaccine|vaccine
577079|NCT01109303|ankle fracture with syndesmotic ligament rupture|ankle fracture with syndesmotic ligament rupture
577080|NCT01109303|ankle syndesmosis rupture|ankle syndesmosis rupture
577081|NCT01109264|Chronic Lymphocytic Leukemia|chronic lymphocytic leukemia
577082|NCT01109264|Bendamustine Hydrochloride|bendamustine hydrochloride
577083|NCT01109264|Chlorambucil|chlorambucil
577084|NCT01109238|Refractory Neuroblastoma|refractory neuroblastoma
577085|NCT01109238|Relapsed Neuroblastoma|relapsed neuroblastoma
577086|NCT01109225|aldosterone|aldosterone
577087|NCT01109225|myocardial infarction|myocardial infarction
577088|NCT01109225|cardiac remodeling|cardiac remodeling
577089|NCT01109212|Type 2-Diabetic Nephrophaty|type 2-diabetic nephrophaty
577090|NCT01109212|bindarit|bindarit
577091|NCT01109212|albuminuria|albuminuria
577092|NCT01109212|MCP-1|mcp-1
577093|NCT01109199|viscous|viscous
577094|NCT01109199|fibre|fibre
577095|NCT01109199|polysaccharide|polysaccharide
577096|NCT01109199|appetite|appetite
577097|NCT01109199|hunger|hunger
577098|NCT01109199|satiety|satiety
577099|NCT01109199|weight management|weight management
577100|NCT01109186|patient with a kidney transplantation since less than 30 days|patient with a kidney transplantation since less than 30 days
577101|NCT01109160|azithromycin|azithromycin
577102|NCT01109160|lymphocytic bronchitis or bronchiolitis|lymphocytic bronchitis or bronchiolitis
577103|NCT01109160|lung transplantation|lung transplantation
577104|NCT01109160|acute allograft rejection|acute allograft rejection
577105|NCT01109160|chronic allograft rejection|chronic allograft rejection
577106|NCT01109160|bronchiolitis obliterans syndrome|bronchiolitis obliterans syndrome
577107|NCT01109147|Schizophrenic Disorders|schizophrenic disorders
577108|NCT01109147|Schizophrenia|schizophrenia
577109|NCT01109147|Affect|affect
577110|NCT01109147|Emotional Blunting|emotional blunting
577111|NCT01109134|primary angioplasty|primary angioplasty
577112|NCT01109134|tirofiban|tirofiban
577113|NCT01109134|microcirculation|microcirculation
577114|NCT01109121|Moderate to severe gout|moderate to severe gout
577115|NCT01109121|Hyperuricemia|hyperuricemia
577116|NCT01109108|pneumococcal vaccine|pneumococcal vaccine
577117|NCT01109108|nasopharyngeal carriage|nasopharyngeal carriage
577118|NCT01109095|Glioblastoma Multiforme (GBM)|glioblastoma multiforme (gbm)
577120|NCT01109095|CMV|cmv
577121|NCT01109095|Brain Cancer|brain cancer
577122|NCT01109095|Autologous HER2.CAR CMV-specific cytotoxic CTL|autologous her2.car cmv-specific cytotoxic ctl
577123|NCT01109095|CMV-specific cytotoxic CTL|cmv-specific cytotoxic ctl
577124|NCT01109082|Scoliosis|scoliosis
577125|NCT01109082|gait|gait
577126|NCT01109082|posture|posture
577127|NCT01109082|balance|balance
577128|NCT01109069|PCI-32765|pci-32765
577129|NCT01109069|Lymphoma, B-Cell|lymphoma, b-cell
577130|NCT01109069|Leukemia, Lymphoid|leukemia, lymphoid
577131|NCT01109069|Leukemia, B-Cell|leukemia, b-cell
577132|NCT01109069|Bruton's Tyrosine Kinase|bruton's tyrosine kinase
577133|NCT01109043|Hypertension|hypertension
577134|NCT01109043|Bisoprolol|bisoprolol
577135|NCT01109043|Antihypertensive drugs|antihypertensive drugs
577136|NCT01109043|Blood pressure|blood pressure
577137|NCT01109043|Quality of life|quality of life
577138|NCT01109043|Diabetes|diabetes
577139|NCT01109043|Ketohexokinase|ketohexokinase
577140|NCT01109030|Major depressive disorder|major depressive disorder
577141|NCT01109030|pioglitazone|pioglitazone
577142|NCT01109030|double blind|double blind
577143|NCT01109030|placebo controlled|placebo controlled
577144|NCT01109004|Symptomatic Multiple Myeloma|symptomatic multiple myeloma
577145|NCT01109004|Lenalidomide|lenalidomide
577146|NCT01109004|Anti-Myeloma Agents|anti-myeloma agents
577147|NCT01109004|Hematologic Disorders|hematologic disorders
577148|NCT01109004|Maintenance Therapy|maintenance therapy
577149|NCT01109004|Progression|progression
577150|NCT01109004|Autologous Transplant|autologous transplant
577151|NCT01109004|RVD Consolidation|rvd consolidation
577152|NCT01108991|Chronic obstructive pulmonary disease|chronic obstructive pulmonary disease
577153|NCT01108991|Randomized controlled trial|randomized controlled trial
577154|NCT01108991|Self-management support|self-management support
577155|NCT01108991|Physical activity|physical activity
577156|NCT01108978|Type 2 Diabetes Mellitus|type 2 diabetes mellitus
577157|NCT01108978|Cardiovascular Disease|cardiovascular disease
577158|NCT01108978|hypercholesterolemia|hypercholesterolemia
577159|NCT01108965|Hydrocephalus|hydrocephalus
577160|NCT01108965|Shunt Dysfunction|shunt dysfunction
577161|NCT01108965|Shunt Flow|shunt flow
577162|NCT01108952|Chemotherapy|chemotherapy
577163|NCT01108952|Memory|memory
577164|NCT01108952|Methotrexate|methotrexate
577165|NCT01108952|Glucocorticoids|glucocorticoids
577166|NCT01108952|Trauma|trauma
577167|NCT01108952|pediatric oncology|pediatric oncology
577168|NCT01108952|traumatization|traumatization
577169|NCT01108939|Malaria, Iron absorption, Iron utilization, Benin|malaria, iron absorption, iron utilization, benin
577170|NCT01108913|COPD|copd
577171|NCT01108900|Erectile Dysfunction udenafil sildenafil treatment satisfaction|erectile dysfunction udenafil sildenafil treatment satisfaction
577172|NCT01108887|Multiple Sclerosis, Relapsing-Remitting|multiple sclerosis, relapsing-remitting
577173|NCT01108887|RebiSmart|rebismart
577174|NCT01108887|Rebif|rebif
577175|NCT01108887|Interferon beta-1a|interferon beta-1a
577176|NCT01108874|Cesarean section|cesarean section
577177|NCT01108874|Hypotension|hypotension
577178|NCT01108874|Metaraminol|metaraminol
577179|NCT01108874|Vasoconstrictor Agents|vasoconstrictor agents
577180|NCT01108874|Adult|adult
577181|NCT01108874|Female|female
577182|NCT01108874|Pregnancy|pregnancy
577183|NCT01108874|Anesthesia, Obstetrical/adverse effects|anesthesia, obstetrical/adverse effects
577184|NCT01108874|Anesthesia,Spinal|anesthesia,spinal
577185|NCT01108874|Blood Pressure/drug effects|blood pressure/drug effects
577186|NCT01108874|Nausea|nausea
577187|NCT01108874|Vomiting|vomiting
577188|NCT01108861|Peripheral Vascular Disease|peripheral vascular disease
577189|NCT01108861|In-stent restenosis|in-stent restenosis
577190|NCT01108861|Endoprosthesis|endoprosthesis
577191|NCT01108861|Plain old balloon angioplasty|plain old balloon angioplasty
577192|NCT01108848|C1-esterase Inhibitor|c1-esterase inhibitor
577193|NCT01108848|Hereditary angioedema|hereditary angioedema
577194|NCT01108848|Acute HAE attack|acute hae attack
577195|NCT01108835|COPD|copd
577196|NCT01108835|Comprehensive care|comprehensive care
577197|NCT01108783|Rhinitis|rhinitis
577198|NCT01108783|Allergic|allergic
577199|NCT01108783|Seasonal|seasonal
577200|NCT01108783|Hay Fever|hay fever
577201|NCT01108783|Pollen Allergy|pollen allergy
577202|NCT01108783|Pollinosis|pollinosis
577203|NCT01108783|Rhinoconjunctivitis|rhinoconjunctivitis
577204|NCT01108783|Sneezing|sneezing
577205|NCT01108783|Nasal itching|nasal itching
577206|NCT01108783|Nasal Congestion|nasal congestion
577207|NCT01108783|Rhinorrhea|rhinorrhea
577208|NCT01108783|Ocular itching|ocular itching
577209|NCT01108783|Ocular redness|ocular redness
577210|NCT01108783|Tearing|tearing
577211|NCT01108770|HED|hed
577212|NCT01108770|XLHED|xlhed
577213|NCT01108770|Hypohidrotic Ectodermal Dysplasia|hypohidrotic ectodermal dysplasia
577215|NCT01108757|urinary tract infection|urinary tract infection
577216|NCT01108744|clinical trial|clinical trial
577217|NCT01108744|mannitol|mannitol
577218|NCT01108744|intracranial pressure (ICP)|intracranial pressure (icp)
577219|NCT01108744|hypertonic saline|hypertonic saline
577220|NCT01108744|cerebral edema|cerebral edema
577221|NCT01108744|traumatic brain injury (TBI)|traumatic brain injury (tbi)
577222|NCT01108718|Mattress|mattress
577223|NCT01108718|Tempur-Pedic|tempur-pedic
577224|NCT01108718|Fibromyalgia|fibromyalgia
577225|NCT01108718|Sleep patterns|sleep patterns
577226|NCT01108692|atrial fibrillation|atrial fibrillation
577227|NCT01108692|supraventricular arrhythmia|supraventricular arrhythmia
577228|NCT01108692|antithrombotic treatment|antithrombotic treatment
577229|NCT01108692|antiarrhythmic drugs|antiarrhythmic drugs
577230|NCT01108692|medical reaction time|medical reaction time
577231|NCT01108692|telecardiology|telecardiology
577232|NCT01108692|early detection|early detection
577233|NCT01108692|holters memories|holters memories
577234|NCT01108692|Pacemaker|pacemaker
577235|NCT01108666|Stage IIIA or IIIB NSCLC|stage iiia or iiib nsclc
577236|NCT01108653|Cardiovascular diseases|cardiovascular diseases
577237|NCT01108653|Heart diseases|heart diseases
577238|NCT01108653|Myocardial infarction|myocardial infarction
577239|NCT01108653|Rehabilitation|rehabilitation
577240|NCT01108653|Health Economy|health economy
577241|NCT01108653|Randomized controlled trials|randomized controlled trials
577242|NCT01108653|Non ST Elevation Myocardial Infarction (NSTEMI)|non st elevation myocardial infarction (nstemi)
577243|NCT01108653|Cost analysis|cost analysis
577244|NCT01108653|Sick-leave|sick-leave
577245|NCT01108653|Quality of Life|quality of life
577246|NCT01108614|Methadone maintenance treatment|methadone maintenance treatment
577247|NCT01108614|drug users|drug users
577248|NCT01108614|heroin|heroin
577249|NCT01108614|HIV|hiv
577250|NCT01108614|HCV|hcv
577251|NCT01108614|Syphilis|syphilis
577252|NCT01108614|HSV-2|hsv-2
577253|NCT01108601|Ringer's|ringer's
577254|NCT01108601|lactate|lactate
577255|NCT01108601|cisplatin|cisplatin
577256|NCT01108601|ototoxicity|ototoxicity
577257|NCT01108601|hearing loss|hearing loss
577258|NCT01108575|Mechanical ventilation|mechanical ventilation
577259|NCT01108575|mechanical ventilation weaning|mechanical ventilation weaning
577260|NCT01108575|inspiratory muscle strength training|inspiratory muscle strength training
577261|NCT01108575|Patients admitted to a surgical intensive care unit who are expected to receive mechanical ventilation for more than three days.|patients admitted to a surgical intensive care unit who are expected to receive mechanical ventilation for more than three days.
577262|NCT01108562|postoperative pain management|postoperative pain management
577263|NCT01108549|Fibromyalgia|fibromyalgia
577264|NCT01108549|Chronic Fatigue Syndrome|chronic fatigue syndrome
577265|NCT01108549|D-ribose|d-ribose
577266|NCT01108549|fatigue|fatigue
577267|NCT01108536|prosthetics|prosthetics
577268|NCT01108536|socket comfort|socket comfort
577269|NCT01108536|amputation stump|amputation stump
577270|NCT01108536|amputee rehabilitation|amputee rehabilitation
577271|NCT01108523|Moisture Associated Skin Damage|moisture associated skin damage
577272|NCT01108510|Treatment Naive|treatment naive
577273|NCT01108510|HIV 1 Infected|hiv 1 infected
577274|NCT01108484|Cancer survivors, exercise, diet, emotional support|cancer survivors, exercise, diet, emotional support
577275|NCT01108471|cesarean section; hemoglobin; postpartum hemorrhage;|cesarean section; hemoglobin; postpartum hemorrhage;
577276|NCT01108445|cancer|cancer
577277|NCT01108445|kidney cancer|kidney cancer
577278|NCT01108445|sutent|sutent
577279|NCT01108445|everolimus|everolimus
577280|NCT01108445|renal cancer|renal cancer
577281|NCT01108445|papillary renal cell|papillary renal cell
577282|NCT01108445|chromophobe renal cell|chromophobe renal cell
577283|NCT01108445|papillary|papillary
577284|NCT01108445|chromophobe|chromophobe
577285|NCT01108432|Tobacco cessation counseling|tobacco cessation counseling
577286|NCT01108419|healthy adults|healthy adults
577287|NCT01108406|Hearing Loss|hearing loss
577288|NCT01108406|Unilateral Hearing Loss|unilateral hearing loss
577289|NCT01108406|Single Sided Deafness|single sided deafness
577290|NCT01108393|Obsessive Compulsive Disorder|obsessive compulsive disorder
577291|NCT01108393|Agomelatine|agomelatine
577292|NCT01108380|Liver cirrhosis|liver cirrhosis
577293|NCT01108380|liver regeneration|liver regeneration
577294|NCT01108380|liver volume|liver volume
577295|NCT01108380|liver function|liver function
577296|NCT01108380|hepatocellular carcinoma, extensive|hepatocellular carcinoma, extensive
577297|NCT01108380|hepatectomy|hepatectomy
577298|NCT01108328|viscous|viscous
577299|NCT01108328|fibre|fibre
577300|NCT01108328|polysaccharide|polysaccharide
577301|NCT01108328|blood glucose|blood glucose
577302|NCT01108328|postprandial|postprandial
577303|NCT01108328|appetite|appetite
577304|NCT01108328|hunger|hunger
577305|NCT01108328|satiety|satiety
577306|NCT01108315|Patient Reported Outcomes (PRO)|patient reported outcomes (pro)
577307|NCT01108315|Web-based|web-based
577308|NCT01108315|Phone-based|phone-based
577309|NCT01108315|Breast Cancer|breast cancer
577310|NCT01108302|uterotonic|uterotonic
577311|NCT01108302|oxytocin|oxytocin
577312|NCT01108302|randomized trial|randomized trial
577313|NCT01108302|India|india
577314|NCT01108302|community|community
577315|NCT01108302|hemorrhage|hemorrhage
577316|NCT01108289|hemorrhage|hemorrhage
577317|NCT01108289|uterotonic|uterotonic
577318|NCT01108289|oxytocin|oxytocin
577319|NCT01108289|blood loss|blood loss
577320|NCT01108289|community|community
577321|NCT01108289|Ghana|ghana
577322|NCT01108289|randomized trial|randomized trial
577323|NCT01108237|Arthroplasties, Knee Replacement|arthroplasties, knee replacement
577324|NCT01108237|Arthroplasties, Replacement, Knee|arthroplasties, replacement, knee
577325|NCT01108237|Arthroplasty, Knee Replacement|arthroplasty, knee replacement
577326|NCT01108237|Knee Replacement Arthroplasties|knee replacement arthroplasties
577327|NCT01108237|Knee Replacement Arthroplasty|knee replacement arthroplasty
577328|NCT01108237|Knee Replacement, Total|knee replacement, total
577329|NCT01108237|Replacement Arthroplasties, Knee|replacement arthroplasties, knee
733452|NCT00499239|MM|mm
577330|NCT01108237|Replacement Arthroplasty, Knee|replacement arthroplasty, knee
577331|NCT01108237|Replacement, Total Knee|replacement, total knee
577332|NCT01108237|Total Knee Replacement|total knee replacement
577333|NCT01108224|Quality of life|quality of life
577334|NCT01108224|Coping|coping
577335|NCT01108224|Social relations|social relations
577336|NCT01108224|Survival|survival
577337|NCT01108224|Psychotherapy|psychotherapy
577338|NCT01108211|Adolescent Idiopathic Scoliosis|adolescent idiopathic scoliosis
577339|NCT01108211|AIS|ais
577340|NCT01108211|Vibration Therapy|vibration therapy
577341|NCT01108211|Low bone mass|low bone mass
577342|NCT01108211|osteopenia|osteopenia
577343|NCT01108198|phimosis,|phimosis,
577344|NCT01108198|non-retractable foreskin|non-retractable foreskin
577345|NCT01108198|topical steroids|topical steroids
577346|NCT01108198|children|children
577347|NCT01108185|treatment with Klacid®SR|treatment with klacid®sr
577348|NCT01108185|tracheitis|tracheitis
577349|NCT01108185|tracheobronchitis|tracheobronchitis
577350|NCT01108185|bronchitis|bronchitis
577351|NCT01108185|chronic bronchitis|chronic bronchitis
577352|NCT01108185|community-acquired pneumonia|community-acquired pneumonia
577353|NCT01108133|Posttraumatic Stress Disorder|posttraumatic stress disorder
577354|NCT01108133|Traumatic Memories|traumatic memories
577355|NCT01108133|fMRI|fmri
577356|NCT01108120|diabetic foot ulcer|diabetic foot ulcer
577357|NCT01108120|artery mini-pump|artery mini-pump
577358|NCT01108120|continuous infusion of urokinase|continuous infusion of urokinase
577359|NCT01108120|femoral artery|femoral artery
577360|NCT01108107|Colon cancer|colon cancer
577361|NCT01108107|Neoadjuvant treatment|neoadjuvant treatment
577362|NCT01108107|KRAS mutation|kras mutation
577363|NCT01108107|BRAF mutation|braf mutation
577364|NCT01108107|PIK3CA mutation|pik3ca mutation
577365|NCT01108107|Possibly avoid chemotherapy after operation|possibly avoid chemotherapy after operation
577366|NCT01108081|Sleep apnea|sleep apnea
577367|NCT01108081|Sleep symptoms|sleep symptoms
577368|NCT01108081|Quality of Life|quality of life
577369|NCT01108068|Osteoporosis-pseudoglioma syndrome, OPPG, LRP5 mutation|osteoporosis-pseudoglioma syndrome, oppg, lrp5 mutation
577370|NCT01108029|Parkinson's disease|parkinson's disease
577371|NCT01108029|Freezing of Gait|freezing of gait
577372|NCT01108029|Memantine|memantine
577373|NCT01108029|NMDA receptor|nmda receptor
577374|NCT01108029|glutamate|glutamate
577375|NCT01108029|No Dementia|no dementia
577376|NCT01107964|Dry Eye Syndrome|dry eye syndrome
577377|NCT01107964|Recent Diagnosis of Dry Eye Syndrome|recent diagnosis of dry eye syndrome
577378|NCT01107951|Rituximab|rituximab
577379|NCT01107951|Dexamethasone|dexamethasone
577380|NCT01107951|Low-dose|low-dose
577381|NCT01107951|ITP|itp
577382|NCT01107938|GERD|gerd
577383|NCT01107925|Platelet function|platelet function
577384|NCT01107912|Platelet function|platelet function
577385|NCT01107899|Acute Coronary Syndromes|acute coronary syndromes
577386|NCT01107899|Angina|angina
577387|NCT01107899|Platelet Function|platelet function
577388|NCT01107899|Coronary Angiography|coronary angiography
577389|NCT01107899|Clinical Symptoms of Angina|clinical symptoms of angina
577390|NCT01107899|Positive Stress Test|positive stress test
577391|NCT01107886|Risk of cardiovascular disease and death in patients with type 2 diabetes mellitus|risk of cardiovascular disease and death in patients with type 2 diabetes mellitus
577392|NCT01107873|Twenty (ASA status I) unpremedicated children, ages 1 to 5 yr old|twenty (asa status i) unpremedicated children, ages 1 to 5 yr old
577393|NCT01107847|electrical impedance tomography|electrical impedance tomography
577394|NCT01107847|EIT|eit
577395|NCT01107847|acute lung injury|acute lung injury
577396|NCT01107847|regional lung opening pressure|regional lung opening pressure
577397|NCT01107847|regional lung closing pressure|regional lung closing pressure
577398|NCT01107834|HIV|hiv
577399|NCT01107834|heart function|heart function
577400|NCT01107834|HAART|haart
577401|NCT01107834|in utero|in utero
577402|NCT01107834|children|children
577403|NCT01107821|Pressure sores grade III and IV|pressure sores grade iii and iv
577404|NCT01107821|Traumatic wounds with considerable soft tissue loss|traumatic wounds with considerable soft tissue loss
577405|NCT01107821|Wounds after necrotizing fasciitis|wounds after necrotizing fasciitis
577406|NCT01107821|Abdominal wounds|abdominal wounds
577407|NCT01107808|Adolescents|adolescents
577408|NCT01107808|African American|african american
577409|NCT01107808|Female|female
577410|NCT01107782|sildenafil|sildenafil
577411|NCT01107782|FGR|fgr
577412|NCT01107743|Hypertension|hypertension
577413|NCT01107743|Angina pectoris|angina pectoris
577414|NCT01107743|Hypercholesterolemia|hypercholesterolemia
577415|NCT01107743|Familial hypercholesterolemia|familial hypercholesterolemia
577416|NCT01107743|Japanese|japanese
577417|NCT01107743|caduet|caduet
577418|NCT01107743|Regulatory Post Marketing Commitment Plan|regulatory post marketing commitment plan
577419|NCT01107730|Atrial fibrillation|atrial fibrillation
577420|NCT01107730|Cardiac valve repair|cardiac valve repair
577421|NCT01107730|Aneurysm repair|aneurysm repair
577422|NCT01107730|CABG|cabg
577423|NCT01107730|On-pump|on-pump
577424|NCT01107730|Cardiac surgery|cardiac surgery
577425|NCT01107730|Vitamin C|vitamin c
577426|NCT01107717|type 2 diabetes|type 2 diabetes
577427|NCT01107717|new onset|new onset
577428|NCT01107717|combination therapy|combination therapy
577429|NCT01107717|new onset type 2 diabetes|new onset type 2 diabetes
577430|NCT01107704|Intensive Care Units|intensive care units
577431|NCT01107704|Surrogates|surrogates
577432|NCT01107704|Family Members|family members
577433|NCT01107704|Physicians|physicians
577434|NCT01107704|Critically Ill|critically ill
577435|NCT01107704|Depression|depression
577436|NCT01107704|Anxiety|anxiety
577437|NCT01107704|Emotional|emotional
577438|NCT01107704|Support|support
577439|NCT01107704|Multi-faceted communication|multi-faceted communication
577440|NCT01107704|Grief|grief
577441|NCT01107704|Prognosis|prognosis
577442|NCT01107704|Family Support Counselor|family support counselor
577443|NCT01107691|resistance and weight loss training|resistance and weight loss training
577444|NCT01107678|YMCA; Preventative child obesity|ymca; preventative child obesity
577445|NCT01107665|pazopanib|pazopanib
577446|NCT01107665|paclitaxel|paclitaxel
577447|NCT01107665|melanoma|melanoma
577448|NCT01107639|stage IIB esophageal cancer|stage iib esophageal cancer
577449|NCT01107639|adenocarcinoma of the esophagus|adenocarcinoma of the esophagus
577450|NCT01107639|adenocarcinoma of the gastroesophageal junction|adenocarcinoma of the gastroesophageal junction
577451|NCT01107639|squamous cell carcinoma of the esophagus|squamous cell carcinoma of the esophagus
577452|NCT01107639|stage IIIA esophageal cancer|stage iiia esophageal cancer
577453|NCT01107639|stage IIIB esophageal cancer|stage iiib esophageal cancer
577454|NCT01107639|stage IIIC esophageal cancer|stage iiic esophageal cancer
577455|NCT01107626|recurrent non-small cell lung cancer|recurrent non-small cell lung cancer
577456|NCT01107626|stage IIIB non-small cell lung cancer|stage iiib non-small cell lung cancer
577457|NCT01107626|stage IV non-small cell lung cancer|stage iv non-small cell lung cancer
577458|NCT01107626|adenocarcinoma of the lung|adenocarcinoma of the lung
577459|NCT01107626|bronchoalveolar cell lung cancer|bronchoalveolar cell lung cancer
577460|NCT01107626|large cell lung cancer|large cell lung cancer
577461|NCT01107613|opinion leader|opinion leader
577462|NCT01107613|COPD|copd
577463|NCT01107613|Emergency Department|emergency department
577464|NCT01107613|relapse|relapse
577465|NCT01107613|follow-up|follow-up
577466|NCT01107613|evidence-based guidelines|evidence-based guidelines
577467|NCT01107613|Exacerbation of COPD|exacerbation of copd
577468|NCT01107600|Dental Implants, Single-Tooth|dental implants, single-tooth
577469|NCT01107600|Bone Regeneration|bone regeneration
577470|NCT01107600|Dental Restoration|dental restoration
577471|NCT01107600|Socket preservation|socket preservation
577472|NCT01107587|Human rotavirus vaccine|human rotavirus vaccine
577473|NCT01107574|Chronic Pain, tenderpoints, insomnia, mood disorder, fatigue|chronic pain, tenderpoints, insomnia, mood disorder, fatigue
577474|NCT01107561|cricothyroidotomy|cricothyroidotomy
577475|NCT01107561|intubation|intubation
577476|NCT01107561|airway|airway
577477|NCT01107561|emergency medicine|emergency medicine
577478|NCT01107561|education|education
577479|NCT01107535|Synagis (palivizumab) immunoprophylaxis|synagis (palivizumab) immunoprophylaxis
577480|NCT01107535|Respiratory syncytial virus infection|respiratory syncytial virus infection
577481|NCT01107535|Preterm infants|preterm infants
577482|NCT01107509|Renal cell carcinoma|renal cell carcinoma
577483|NCT01107509|Metastatic|metastatic
577484|NCT01107509|everolimus|everolimus
577485|NCT01107509|neo-adjuvant|neo-adjuvant
577486|NCT01107509|biomarkers|biomarkers
577487|NCT01107509|nephrectomy|nephrectomy
577488|NCT01107509|Locally advanced clear cell renal carcinoma|locally advanced clear cell renal carcinoma
577489|NCT01107509|Metastatic clear cell renal carcinoma|metastatic clear cell renal carcinoma
577490|NCT01107509|Clear Cell Renal Carcinoma|clear cell renal carcinoma
577491|NCT01107483|endotoxaemia|endotoxaemia
577492|NCT01107470|Infertility IVF ART|infertility ivf art
577493|NCT01107457|Moderate|moderate
577494|NCT01107457|Severe|severe
577495|NCT01107457|Plaque|plaque
577496|NCT01107457|Chronic|chronic
577497|NCT01107431|glucose|glucose
577498|NCT01107431|insulin|insulin
577499|NCT01107431|L-arabinose|l-arabinose
577500|NCT01107431|Chromium|chromium
577501|NCT01107366|lupiae techinque|lupiae techinque
577502|NCT01107366|aortic aneurism|aortic aneurism
577503|NCT01107366|aortic dissection|aortic dissection
577504|NCT01107327|cancer|cancer
577505|NCT01107301|ADHD|adhd
577506|NCT01107288|Aged|aged
577507|NCT01107288|Balance|balance
577508|NCT01107288|Dual-task|dual-task
577509|NCT01107288|Exercise|exercise
577510|NCT01107288|Falls|falls
577511|NCT01107288|Gait|gait
577512|NCT01107288|Music|music
577513|NCT01107275|Rabies|rabies
577514|NCT01107275|PCECV|pcecv
577515|NCT01107275|pre-exposure immunization|pre-exposure immunization
577516|NCT01107275|intradermal|intradermal
577517|NCT01107275|children|children
577518|NCT01107262|H5N1 Subtype|h5n1 subtype
577519|NCT01107262|Avian viruses|avian viruses
577520|NCT01107262|Highly pathogenic avian influenza (HPAI)|highly pathogenic avian influenza (hpai)
577521|NCT01107249|esophageal|esophageal
577522|NCT01107249|stenting|stenting
577523|NCT01107249|perforations|perforations
577524|NCT01107249|gastric|gastric
577525|NCT01107249|esophageal stenting|esophageal stenting
577526|NCT01107236|Healthy subjects|healthy subjects
577527|NCT01107223|Antibiotic|antibiotic
577528|NCT01107223|Prescribing behaviour|prescribing behaviour
577529|NCT01107223|Guidelines|guidelines
577530|NCT01107223|Respiratory tract infections|respiratory tract infections
577531|NCT01107223|Non-antibiotic prescription|non-antibiotic prescription
577532|NCT01107210|stroke|stroke
577533|NCT01107210|physical fitness|physical fitness
577534|NCT01107210|evolution|evolution
577535|NCT01107210|determinants|determinants
577536|NCT01107197|Pressure ulcers|pressure ulcers
577537|NCT01107197|Healing|healing
577538|NCT01107197|Malnutrition|malnutrition
577539|NCT01107197|Nutritional support|nutritional support
577540|NCT01107197|Micronutrients|micronutrients
577541|NCT01107184|Remote ischemic conditioning|remote ischemic conditioning
577542|NCT01107184|CABG surgery|cabg surgery
577543|NCT01107184|Atrial fibrillation|atrial fibrillation
577544|NCT01107184|Coronary Artery Bypass|coronary artery bypass
577545|NCT01107184|Ischemic Preconditioning|ischemic preconditioning
577546|NCT01107171|Tang-min-ling pills;|tang-min-ling pills;
577547|NCT01107171|overweight type 2 diabetes mellitus;|overweight type 2 diabetes mellitus;
577548|NCT01107171|blood glucose|blood glucose
577549|NCT01107171|Traditional Chinese Medicine|traditional chinese medicine
577550|NCT01107171|Clinical Trial|clinical trial
577551|NCT01107171|Intervention Studies|intervention studies
577552|NCT01107145|Plasmodium|plasmodium
577553|NCT01107145|Vivax|vivax
577554|NCT01107145|Malaria|malaria
577555|NCT01107145|Pregnancy|pregnancy
577556|NCT01107145|Brazil|brazil
577557|NCT01107145|Treatment|treatment
577558|NCT01107119|Frail elderly|frail elderly
577559|NCT01107119|Chronic illness|chronic illness
577560|NCT01107119|Integrated care model|integrated care model
577561|NCT01107119|Clinical pathways|clinical pathways
577562|NCT01107119|Home care services|home care services
577563|NCT01107106|Contraceptive Methods|contraceptive methods
577564|NCT01107106|Female Contraception|female contraception
577565|NCT01107080|breast cancer|breast cancer
577566|NCT01107080|breast carcinoma in situ|breast carcinoma in situ
577567|NCT01107080|ductal breast carcinoma in situ|ductal breast carcinoma in situ
577568|NCT01107080|invasive carcinoma|invasive carcinoma
577569|NCT01107080|invasive ductal carcinoma|invasive ductal carcinoma
577570|NCT01107080|invasive lobular carcinoma|invasive lobular carcinoma
577571|NCT01107067|hypogonadism|hypogonadism
577572|NCT01107067|paraoxonase|paraoxonase
577573|NCT01107067|Hipogonadism|hipogonadism
577574|NCT01107054|QTC|qtc
577575|NCT01107041|Depression|depression
577576|NCT01107041|Technology Assisted|technology assisted
577577|NCT01107041|Mobile Phone|mobile phone
577578|NCT01107028|Idiopathic pulmonary fibrosis|idiopathic pulmonary fibrosis
577579|NCT01107028|Dyspnea|dyspnea
577580|NCT01107028|Functional capacity|functional capacity
577581|NCT01107028|Quality of life|quality of life
577582|NCT01107015|Diabetes|diabetes
577583|NCT01107015|Glucose control|glucose control
577584|NCT01107015|Diabetes monitoring|diabetes monitoring
577585|NCT01107015|Care management|care management
577586|NCT01107015|Electronic communication|electronic communication
577587|NCT01107015|Mobile phone technology|mobile phone technology
577588|NCT01107015|Self care|self care
577589|NCT01107002|infertility|infertility
577590|NCT01107002|Embryo transfer|embryo transfer
577591|NCT01106976|PET|pet
577592|NCT01106976|acetylcholine|acetylcholine
577593|NCT01106963|knee|knee
577594|NCT01106963|tibial fractures|tibial fractures
577595|NCT01106963|pain|pain
577596|NCT01106963|osteosynthesis|osteosynthesis
577597|NCT01106963|intramedullary nailing|intramedullary nailing
577598|NCT01106950|acute myelogenous leukemia|acute myelogenous leukemia
577599|NCT01106950|primary acute myelogenous leukemia|primary acute myelogenous leukemia
577600|NCT01106950|secondary acute myelogenous leukemia|secondary acute myelogenous leukemia
577601|NCT01106950|relapsed acute myelogenous leukemia|relapsed acute myelogenous leukemia
577602|NCT01106924|Probiotics, Weight control, Body composition|probiotics, weight control, body composition
578078|NCT01105000|HPV vaccine|hpv vaccine
577603|NCT01106911|digital breast tomosynthesis|digital breast tomosynthesis
577604|NCT01106911|baseline screening mammography|baseline screening mammography
577605|NCT01106911|recall rates|recall rates
577606|NCT01106885|Diabetes|diabetes
577607|NCT01106885|Depression|depression
577608|NCT01106885|Telephone Care Management|telephone care management
577609|NCT01106885|Medication Care Management (MCM)|medication care management (mcm)
577610|NCT01106885|Cognitive Behavioral Therapy (CBT)|cognitive behavioral therapy (cbt)
577611|NCT01106872|Sarcoma|sarcoma
577612|NCT01106872|Soft Tissue Sarcoma|soft tissue sarcoma
577613|NCT01106872|Locally Advanced Sarcoma|locally advanced sarcoma
577614|NCT01106872|Unresectable Sarcoma|unresectable sarcoma
577615|NCT01106872|Metastatic Sarcoma|metastatic sarcoma
577616|NCT01106872|Valproic Acid|valproic acid
577617|NCT01106872|Bevacizumab|bevacizumab
577618|NCT01106872|Histone Deacetylase Inhibitor|histone deacetylase inhibitor
577619|NCT01106859|insomnia|insomnia
577620|NCT01106846|Ketamine|ketamine
577621|NCT01106846|Anesthesia|anesthesia
577622|NCT01106846|Pain|pain
577623|NCT01106846|Outpatient surgery|outpatient surgery
577624|NCT01106833|Chronic Graft-versus-Host Disease (cGVHD)|chronic graft-versus-host disease (cgvhd)
577625|NCT01106794|diffuse intrinsic pontine glioma|diffuse intrinsic pontine glioma
577626|NCT01106794|DIPG|dipg
577627|NCT01106794|childhood brainstem glioma|childhood brainstem glioma
577628|NCT01106794|pediatric brainstem glioma|pediatric brainstem glioma
577629|NCT01106794|brainstem glioma|brainstem glioma
577630|NCT01106794|BSG|bsg
577631|NCT01106781|EGFR mutation test|egfr mutation test
577632|NCT01106781|NSCLC|nsclc
577633|NCT01106781|Non-Interventional Study|non-interventional study
577634|NCT01106781|EGFR mutation status|egfr mutation status
577635|NCT01106768|oral health needs|oral health needs
577636|NCT01106768|children|children
577637|NCT01106768|attention deficit disorder with or without hyperactivity|attention deficit disorder with or without hyperactivity
577638|NCT01106755|kinematic|kinematic
577639|NCT01106755|hemiparesis|hemiparesis
577640|NCT01106755|gait|gait
577641|NCT01106755|Body weight support|body weight support
577642|NCT01106755|Functional electrical stimulation|functional electrical stimulation
577643|NCT01106742|Inflammatory|inflammatory
577644|NCT01106742|AbM|abm
577645|NCT01106742|IBD|ibd
577646|NCT01106729|Flavonoids|flavonoids
577647|NCT01106729|Anthocyanin|anthocyanin
577648|NCT01106729|Cyanidin 3 glucoside|cyanidin 3 glucoside
577649|NCT01106729|Acute feeding trial|acute feeding trial
577650|NCT01106729|Stable isotope|stable isotope
577651|NCT01106729|Metabolism|metabolism
577652|NCT01106729|Clearance|clearance
577653|NCT01106729|Bioavailability|bioavailability
577654|NCT01106729|Pharmacokinetics|pharmacokinetics
577655|NCT01106716|Lidocaine|lidocaine
577656|NCT01106716|Lignocaine|lignocaine
577657|NCT01106716|Analgesics. Non-narcotic / therapeutic use|analgesics. non-narcotic / therapeutic use
577658|NCT01106716|Neuralgia, Postherpetic|neuralgia, postherpetic
577659|NCT01106716|Pain|pain
577660|NCT01106716|Pain measurement / drug effect|pain measurement / drug effect
577661|NCT01106716|Pain postoperative / drug therapy|pain postoperative / drug therapy
577662|NCT01106716|PHN|phn
577663|NCT01106703|atopy, IgE|atopy, ige
577664|NCT01106690|Canagliflozin|canagliflozin
577665|NCT01106690|Placebo|placebo
577666|NCT01106690|Sitagliptin (Januvia)|sitagliptin (januvia)
577667|NCT01106690|Metformin|metformin
577668|NCT01106690|Pioglitazone (Actos)|pioglitazone (actos)
577669|NCT01106690|Hemoglobin A1c|hemoglobin a1c
577670|NCT01106690|Type 2 diabetes mellitus|type 2 diabetes mellitus
577671|NCT01106677|Type 2 diabetes mellitus|type 2 diabetes mellitus
577672|NCT01106677|Canagliflozin|canagliflozin
577673|NCT01106677|Placebo|placebo
577674|NCT01106677|Sitagliptin|sitagliptin
577675|NCT01106677|Januvia|januvia
577676|NCT01106677|Metformin Immediate Release (IR)|metformin immediate release (ir)
577677|NCT01106677|Hemoglobin A1c|hemoglobin a1c
577678|NCT01106664|ONO-7746|ono-7746
577679|NCT01106664|Healthy adult subjects|healthy adult subjects
577680|NCT01106651|Canagliflozin|canagliflozin
577681|NCT01106651|Placebo|placebo
577682|NCT01106651|Hemoglobin A1c|hemoglobin a1c
577683|NCT01106651|Bone|bone
577684|NCT01106651|Type 2 diabetes mellitus|type 2 diabetes mellitus
577685|NCT01106638|HIV|hiv
577686|NCT01106638|AIDS|aids
577687|NCT01106638|Smoking|smoking
577688|NCT01106638|Tobacco|tobacco
577689|NCT01106638|Cessation|cessation
577690|NCT01106638|Tobacco use in persons living with HIV/AIDS|tobacco use in persons living with hiv/aids
577691|NCT01106625|Canagliflozin|canagliflozin
577692|NCT01106625|Placebo|placebo
577693|NCT01106625|Metformin|metformin
577694|NCT01106625|Sulphonylurea|sulphonylurea
577695|NCT01106625|Hemoglobin A1c|hemoglobin a1c
577696|NCT01106625|Type 2 diabetes mellitus|type 2 diabetes mellitus
577697|NCT01106612|randomized controlled trial|randomized controlled trial
577698|NCT01106612|controlled clinical trial|controlled clinical trial
577699|NCT01106612|comparative effectiveness research|comparative effectiveness research
577700|NCT01106612|chest pain|chest pain
577701|NCT01106612|angina pectoris|angina pectoris
578174|NCT01104532|sitagliptin|sitagliptin
577702|NCT01106612|non-invasive cardiac imaging|non-invasive cardiac imaging
577703|NCT01106612|nuclear stress testing|nuclear stress testing
577704|NCT01106612|coronary CT angiography|coronary ct angiography
577705|NCT01106612|coronary catheterization|coronary catheterization
577706|NCT01106612|coronary revascularization|coronary revascularization
577707|NCT01106586|HIV 1 Infection|hiv 1 infection
577708|NCT01106586|Treatment Naive|treatment naive
577709|NCT01106573|Diabetes Mellitus|diabetes mellitus
577710|NCT01106573|Arteriosclerosis|arteriosclerosis
577711|NCT01106573|Intima media thickness|intima media thickness
577712|NCT01106573|arterial stiffness|arterial stiffness
577713|NCT01106573|pulsewave velocity|pulsewave velocity
577714|NCT01106573|fibulin-1|fibulin-1
577715|NCT01106547|abdominal hysterectomy|abdominal hysterectomy
577716|NCT01106547|glucocorticoids|glucocorticoids
577717|NCT01106547|rehabilitation|rehabilitation
577718|NCT01106547|postoperative pain|postoperative pain
577719|NCT01106547|analgetics|analgetics
577720|NCT01106534|drug eluting stents|drug eluting stents
577722|NCT01106534|Angioplasty|angioplasty
577723|NCT01106534|Stent thrombosis|stent thrombosis
577724|NCT01106534|antiplatelet treatment|antiplatelet treatment
577725|NCT01106521|Infiltrating ductal carcinoma|infiltrating ductal carcinoma
577726|NCT01106521|Brachytherapy|brachytherapy
577727|NCT01106508|Advanced solid tumors|advanced solid tumors
577728|NCT01106508|recurrent or refractory medulloblastoma|recurrent or refractory medulloblastoma
577729|NCT01106508|locally advanced or metastatic basal cell carcinoma|locally advanced or metastatic basal cell carcinoma
577730|NCT01106508|hedgehog pathway inhibitor|hedgehog pathway inhibitor
577731|NCT01106495|Atherosclerosis|atherosclerosis
577732|NCT01106495|Vascular Endothelium|vascular endothelium
577733|NCT01106495|Counterpulsation, External|counterpulsation, external
577734|NCT01106482|TBE|tbe
577735|NCT01106482|Tick Borne Encephalitis|tick borne encephalitis
577736|NCT01106469|Healthy Volunteers|healthy volunteers
577737|NCT01106469|Healthy|healthy
577738|NCT01106469|JNJ-41443532|jnj-41443532
577739|NCT01106469|Pharmacokinetics|pharmacokinetics
577740|NCT01106443|Indeterminate thyroid nodule|indeterminate thyroid nodule
577741|NCT01106443|fine needle aspirate biopsy|fine needle aspirate biopsy
577742|NCT01106443|thyroidectomy|thyroidectomy
577743|NCT01106443|central lymph node dissection|central lymph node dissection
577744|NCT01106430|ADHD|adhd
577745|NCT01106417|Cervical Degenerative Disc Disease|cervical degenerative disc disease
577746|NCT01106417|Degenerative Spondylolisthesis|degenerative spondylolisthesis
577747|NCT01106417|Spinal Stenosis|spinal stenosis
577748|NCT01106417|Stem cells|stem cells
577749|NCT01106417|Adult Stem Cells|adult stem cells
577750|NCT01106417|Anterior cervical discectomy and Fusion (ACDF)|anterior cervical discectomy and fusion (acdf)
577751|NCT01106417|Anterior Cervical Plate Fixation|anterior cervical plate fixation
577752|NCT01106391|Abdominal aortic aneurysm|abdominal aortic aneurysm
577753|NCT01106391|AAA|aaa
577754|NCT01106391|Safety|safety
577755|NCT01106391|Performance|performance
577756|NCT01106391|Stent graft system|stent graft system
577757|NCT01106391|First in Human|first in human
577758|NCT01106391|Endovascular repair|endovascular repair
577759|NCT01106378|Coronary artery disease|coronary artery disease
577760|NCT01106378|drug-eluting stents|drug-eluting stents
577761|NCT01106378|sirolimus-eluting coronary stents|sirolimus-eluting coronary stents
577762|NCT01106365|multiple sclerosis|multiple sclerosis
577763|NCT01106365|fatigue|fatigue
577764|NCT01106365|depressivity|depressivity
577765|NCT01106365|repetitive deep transcranial magnetic stimulation|repetitive deep transcranial magnetic stimulation
577766|NCT01106352|The target population is patients with bone metastasis from castration-resistant prostate cancer intended for treatment with docetaxel|the target population is patients with bone metastasis from castration-resistant prostate cancer intended for treatment with docetaxel
577767|NCT01106339|humans|humans
577768|NCT01106339|patients|patients
577769|NCT01106339|somatoform disorders|somatoform disorders
577770|NCT01106339|fibromyalgia|fibromyalgia
577771|NCT01106339|myofascial pain syndrome diffuse|myofascial pain syndrome diffuse
577772|NCT01106339|depression|depression
577773|NCT01106339|chronic fatigue syndrome|chronic fatigue syndrome
577774|NCT01106339|inflammation|inflammation
577775|NCT01106339|inflammatory response|inflammatory response
577776|NCT01106339|biomarkers|biomarkers
577777|NCT01106339|cytokines|cytokines
577778|NCT01106339|cell surface markers|cell surface markers
577779|NCT01106339|functional polymorphisms|functional polymorphisms
577780|NCT01106326|Asthma|asthma
577781|NCT01106248|tumor|tumor
577782|NCT01106209|premature infants|premature infants
577783|NCT01106209|polymorphonuclear leukocytes|polymorphonuclear leukocytes
577784|NCT01106209|PMNs|pmns
577785|NCT01106209|neutrophil extracellular traps|neutrophil extracellular traps
577786|NCT01106209|NET formation|net formation
577787|NCT01106209|necrotizing enterocolitis|necrotizing enterocolitis
577788|NCT01106196|Influenza, Human|influenza, human
577789|NCT01106196|Influenza, Human/complications|influenza, human/complications
577790|NCT01106196|Myocardial infarction/etiology|myocardial infarction/etiology
577791|NCT01106196|Cardiovascular Diseases/mortality|cardiovascular diseases/mortality
577792|NCT01106157|Autoimmune, Diabetes Mellitus, Glucose Metabolism|autoimmune, diabetes mellitus, glucose metabolism
577793|NCT01106079|Early psoriatic arthritis|early psoriatic arthritis
577794|NCT01106079|Tight control|tight control
577795|NCT01106079|Intensive management|intensive management
577796|NCT01106053|Binge eating disorder|binge eating disorder
577797|NCT01106053|Food craving|food craving
577798|NCT01106053|Obesity|obesity
577799|NCT01106053|Pramipexole|pramipexole
577800|NCT01106053|Mirapex|mirapex
577801|NCT01106053|Binge|binge
577802|NCT01106040|Lymphoseek|lymphoseek
577803|NCT01106040|Breast Cancer|breast cancer
577804|NCT01106040|Melanoma|melanoma
577805|NCT01106040|Experimental|experimental
577806|NCT01106014|pulmonary arterial hypertension|pulmonary arterial hypertension
577807|NCT01106014|PAH|pah
577808|NCT01106001|total hip arthroplasty|total hip arthroplasty
577809|NCT01106001|periarticular injection|periarticular injection
577810|NCT01106001|pain|pain
577811|NCT01105988|GBM|gbm
577812|NCT01105988|PET scans|pet scans
577813|NCT01105988|MRI scans|mri scans
577814|NCT01105975|Dyslipidemias|dyslipidemias
577815|NCT01105975|Mixed dyslipidemia|mixed dyslipidemia
577816|NCT01105975|Hypercholesterolemia|hypercholesterolemia
577817|NCT01105975|Atherosclerosis|atherosclerosis
577818|NCT01105975|Atorvastatin|atorvastatin
577819|NCT01105975|Simvastatin|simvastatin
577820|NCT01105975|Rosuvastatin|rosuvastatin
577821|NCT01105975|Metabolic Diseases|metabolic diseases
577822|NCT01105975|Antilipemic Agents|antilipemic agents
577823|NCT01105975|Enzyme Inhibitors|enzyme inhibitors
577824|NCT01105975|Anticholesteremic Agents|anticholesteremic agents
577825|NCT01105975|Cholesteryl Ester Transfer Protein Inhibitors|cholesteryl ester transfer protein inhibitors
577826|NCT01105975|Cholesteryl Ester|cholesteryl ester
577827|NCT01105975|Lipid Metabolism Disorders|lipid metabolism disorders
577828|NCT01105962|traumatic|traumatic
577829|NCT01105962|brain|brain
577830|NCT01105962|injury|injury
577831|NCT01105962|post-traumatic|post-traumatic
577832|NCT01105962|stress|stress
577833|NCT01105962|hyperbaric|hyperbaric
577834|NCT01105962|oxygen|oxygen
577835|NCT01105962|HBOT|hbot
577836|NCT01105962|TBI|tbi
577837|NCT01105962|PTSD|ptsd
577838|NCT01105949|nasal patency|nasal patency
577839|NCT01105949|acoustic rhinometry|acoustic rhinometry
577840|NCT01105949|nasal strip|nasal strip
577841|NCT01105936|osteoarthritis|osteoarthritis
577842|NCT01105936|pain|pain
577843|NCT01105936|paracetamol|paracetamol
577844|NCT01105936|Blood-Oxygen-Level-Dependent functional magnetic resonance imaging|blood-oxygen-level-dependent functional magnetic resonance imaging
577845|NCT01105910|Dry Eye, Post Menopausal dry eye|dry eye, post menopausal dry eye
577846|NCT01105897|endometriosis|endometriosis
577847|NCT01105897|deep endometriosis|deep endometriosis
577848|NCT01105897|surgery|surgery
577849|NCT01105897|laparoscopy|laparoscopy
577850|NCT01105897|chronic pain|chronic pain
577851|NCT01105897|quality of life|quality of life
577852|NCT01105897|sexual function|sexual function
577853|NCT01105897|complications|complications
577854|NCT01105897|recurrence|recurrence
577855|NCT01105884|Wound healing, type 2 diabetes, diabetic foot ulcers, different dressings|wound healing, type 2 diabetes, diabetic foot ulcers, different dressings
577856|NCT01105871|Pain relief|pain relief
577857|NCT01105858|Diabetes Mellitus|diabetes mellitus
577858|NCT01105858|Obesity|obesity
577859|NCT01105858|Diabetic Complications|diabetic complications
577860|NCT01105858|Genetics|genetics
577861|NCT01105858|Molecular Profiling|molecular profiling
577862|NCT01105845|Motor Learning|motor learning
577863|NCT01105845|Genetic Analysis|genetic analysis
577864|NCT01105845|BDNF|bdnf
577865|NCT01105845|Parkinson Disease|parkinson disease
577866|NCT01105845|Movement Disorders|movement disorders
577867|NCT01105845|Dystonia|dystonia
577868|NCT01105845|Healthy Volunteer|healthy volunteer
577869|NCT01105845|HV|hv
577870|NCT01105832|Teriparatide|teriparatide
577871|NCT01105832|fracture healing|fracture healing
577872|NCT01105832|proximal humeral fractures|proximal humeral fractures
577873|NCT01105819|Probiotics|probiotics
577874|NCT01105819|Lactobacillus plantarum 299|lactobacillus plantarum 299
577875|NCT01105819|Ventilator-associated pneumonia VAP|ventilator-associated pneumonia vap
577876|NCT01105819|Chlorhexidine|chlorhexidine
577877|NCT01105819|Tracheal secretions|tracheal secretions
577878|NCT01105819|Oropharyngeal secretions|oropharyngeal secretions
577879|NCT01105806|advance directive|advance directive
577880|NCT01105806|CPR Intervention|cpr intervention
577881|NCT01105806|Video|video
577882|NCT01105806|Narrative|narrative
577883|NCT01105806|10-043|10-043
577884|NCT01105793|cyclic mastalgia|cyclic mastalgia
577885|NCT01105793|cyclic breast pain|cyclic breast pain
577886|NCT01105793|fibrocystic breast disease|fibrocystic breast disease
577887|NCT01105780|Healthy Volunteers|healthy volunteers
577888|NCT01105780|Healthy|healthy
577889|NCT01105780|Japanese|japanese
577890|NCT01105780|Pharmacokinetics|pharmacokinetics
577891|NCT01105780|JNJ-41443532|jnj-41443532
577892|NCT01105767|Staphylococcus aureus|staphylococcus aureus
577893|NCT01105767|MRSA Skin Infection|mrsa skin infection
577894|NCT01105767|Staphylococcal Skin Infections|staphylococcal skin infections
577895|NCT01105767|Chlorhexidine gluconate|chlorhexidine gluconate
577896|NCT01105741|Crohn's disease|crohn's disease
577897|NCT01105741|Adalimumab|adalimumab
577898|NCT01105741|Metabolome|metabolome
577899|NCT01105728|Gastric subepitelial mass|gastric subepitelial mass
577900|NCT01105728|Endoscopic full thickness resection|endoscopic full thickness resection
577901|NCT01105715|Rheumatoid Arthritis|rheumatoid arthritis
577903|NCT01105715|Cardiovascular disease|cardiovascular disease
577904|NCT01105702|brain tumor|brain tumor
577905|NCT01105702|brain cancer|brain cancer
577906|NCT01105702|glioma|glioma
577907|NCT01105689|Urine Calcium to Creatinine Ratio|urine calcium to creatinine ratio
577908|NCT01105689|Hypocalciuria|hypocalciuria
577909|NCT01105689|Infants|infants
577910|NCT01105689|Toddlers|toddlers
577911|NCT01105676|vascular malformation|vascular malformation
577912|NCT01105676|vascular anomalies|vascular anomalies
577913|NCT01105676|abnormalities of growth|abnormalities of growth
577914|NCT01105676|overgrowth|overgrowth
577915|NCT01105676|subjects with vascular malformations abnormalities of growth.|subjects with vascular malformations abnormalities of growth.
577916|NCT01105663|sedated|sedated
577917|NCT01105663|intubated|intubated
577918|NCT01105663|mechanically ventilated|mechanically ventilated
577919|NCT01105663|pediatric|pediatric
577920|NCT01105663|lung injury|lung injury
577921|NCT01105650|recurrent ovarian cancer|recurrent ovarian cancer
577922|NCT01105650|recurrent fallopian tube cancer|recurrent fallopian tube cancer
577923|NCT01105650|recurrent primary peritoneal cancer|recurrent primary peritoneal cancer
577924|NCT01105650|refractory ovarian cancer|refractory ovarian cancer
577925|NCT01105650|refractory fallopian tube cancer|refractory fallopian tube cancer
577926|NCT01105650|refractory peritoneal cancer|refractory peritoneal cancer
577927|NCT01105650|metastatic breast cancer|metastatic breast cancer
577928|NCT01105637|burn injuries|burn injuries
577929|NCT01105637|exercise|exercise
577930|NCT01105611|HIV|hiv
577931|NCT01105611|Hepatitis C|hepatitis c
577932|NCT01105611|Co-infection|co-infection
577933|NCT01105611|Intravenous drug users|intravenous drug users
577934|NCT01105611|Treatment-naïve|treatment-naïve
577935|NCT01105611|Methadone|methadone
577936|NCT01105585|Cataracts|cataracts
577937|NCT01105585|aspheric|aspheric
577938|NCT01105585|IOL|iol
577939|NCT01105585|ocular aberrations|ocular aberrations
577940|NCT01105572|Congestive Heart Failure|congestive heart failure
577941|NCT01105559|Diphtheria|diphtheria
577942|NCT01105559|Tetanus|tetanus
577943|NCT01105559|Whooping cough|whooping cough
577944|NCT01105559|Hepatitis B|hepatitis b
577945|NCT01105559|Poliomyelitis|poliomyelitis
577946|NCT01105559|Diphtheria-Tetanus-acellular Pertussis Vaccines|diphtheria-tetanus-acellular pertussis vaccines
577947|NCT01105546|hemophilia A|hemophilia a
577948|NCT01105546|inhibitors|inhibitors
577949|NCT01105546|prophylaxis|prophylaxis
577950|NCT01105546|immune tolerance induction|immune tolerance induction
577951|NCT01105533|VGEF inhibitor|vgef inhibitor
577952|NCT01105533|Anti angiogenesis|anti angiogenesis
577953|NCT01105533|Advanced Solid Tumors|advanced solid tumors
577954|NCT01105520|Intraspinal processes (tumor or vascular malformation AVM)|intraspinal processes (tumor or vascular malformation avm)
577955|NCT01105507|Canakinumab|canakinumab
577956|NCT01105507|Cryopyrin-associated periodic syndromes|cryopyrin-associated periodic syndromes
577957|NCT01105507|Familial Cold Autoinflammatory Syndrome (FCAS)|familial cold autoinflammatory syndrome (fcas)
577958|NCT01105507|Familial Cold Urticaria (FCU)|familial cold urticaria (fcu)
577959|NCT01105507|Muckle-Wells Syndrome (MWS)|muckle-wells syndrome (mws)
577960|NCT01105507|Neonatal-Onset Multisystem Inflammatory Disease (NOMID)|neonatal-onset multisystem inflammatory disease (nomid)
577961|NCT01105507|Chronic Infantile Neurological|chronic infantile neurological
577962|NCT01105507|Cutaneous|cutaneous
577963|NCT01105507|Articular Syndrome (CINCA)|articular syndrome (cinca)
577964|NCT01105507|Treatment of patients diagnosed with CAPS (Cryopyrin associated periodic syndrome)|treatment of patients diagnosed with caps (cryopyrin associated periodic syndrome)
577965|NCT01105481|treatment-resistant schizophrenia|treatment-resistant schizophrenia
577966|NCT01105481|clozapine|clozapine
577967|NCT01105481|amisulpride|amisulpride
577968|NCT01105468|Breath gas analysis|breath gas analysis
577969|NCT01105468|Volatile components in exhaled breath|volatile components in exhaled breath
577970|NCT01105455|Randomized clinical trial|randomized clinical trial
577971|NCT01105455|Gestational diabetes|gestational diabetes
577972|NCT01105455|Carbohydrates|carbohydrates
577973|NCT01105455|Glycemic index|glycemic index
577974|NCT01105442|Post-operative pain treatment|post-operative pain treatment
577975|NCT01105442|Fast-track colonic surgery patients|fast-track colonic surgery patients
577976|NCT01105442|Surgery|surgery
577977|NCT01105416|Pediatric Emergency Department|pediatric emergency department
577978|NCT01105416|Parental monitoring|parental monitoring
577979|NCT01105416|Adolescent|adolescent
577980|NCT01105416|Parents|parents
577981|NCT01105416|Communication|communication
577982|NCT01105416|Alcohol Drinking|alcohol drinking
577983|NCT01105403|Hematopoietic stem cells|hematopoietic stem cells
577984|NCT01105403|Mobilisation|mobilisation
577985|NCT01105403|Autologous transplantation|autologous transplantation
577986|NCT01105364|recurrent renal cell cancer|recurrent renal cell cancer
577987|NCT01105364|stage IV renal cell cancer|stage iv renal cell cancer
577988|NCT01105364|liver metastases|liver metastases
577989|NCT01105351|Folate|folate
577990|NCT01105351|MTHFR|mthfr
734376|NCT00495768|HCV|hcv
577991|NCT01105351|Homocysteine|homocysteine
577992|NCT01105338|prostate cancer|prostate cancer
577993|NCT01105325|acute coronary syndrome|acute coronary syndrome
577994|NCT01105325|treatment compliance|treatment compliance
577995|NCT01105325|cardiac intensive care unit|cardiac intensive care unit
577996|NCT01105325|secondary prevention|secondary prevention
577997|NCT01105325|cardiac intensive care unit (CIC)|cardiac intensive care unit (cic)
577998|NCT01105325|compliance|compliance
577999|NCT01105325|intensive care|intensive care
578000|NCT01105312|male breast cancer|male breast cancer
578001|NCT01105312|estrogen receptor-negative breast cancer|estrogen receptor-negative breast cancer
578002|NCT01105312|estrogen receptor-positive breast cancer|estrogen receptor-positive breast cancer
578003|NCT01105312|HER2-negative breast cancer|her2-negative breast cancer
578004|NCT01105312|HER2-positive breast cancer|her2-positive breast cancer
578005|NCT01105312|progesterone receptor-negative breast cancer|progesterone receptor-negative breast cancer
578006|NCT01105312|progesterone receptor-positive breast cancer|progesterone receptor-positive breast cancer
578007|NCT01105312|triple-negative breast cancer|triple-negative breast cancer
578008|NCT01105312|recurrent breast cancer|recurrent breast cancer
578009|NCT01105312|stage IV breast cancer|stage iv breast cancer
578010|NCT01105299|bioequivalence|bioequivalence
578011|NCT01105299|anastrozole|anastrozole
578012|NCT01105299|Healthy subjects|healthy subjects
578013|NCT01105299|Antineoplastic Agents|antineoplastic agents
578014|NCT01105299|Therapeutic Uses|therapeutic uses
578015|NCT01105299|Enzyme Inhibitors|enzyme inhibitors
578016|NCT01105273|Aplastic anemia|aplastic anemia
578017|NCT01105273|Fludarabine|fludarabine
578018|NCT01105273|CD3±CD19 depletion|cd3±cd19 depletion
578019|NCT01105273|Haploidentical hematopoietic stem cell transplantation|haploidentical hematopoietic stem cell transplantation
578020|NCT01105260|early reconditioning program|early reconditioning program
578021|NCT01105260|spinal cord injury|spinal cord injury
578022|NCT01105260|early rehabilitation|early rehabilitation
578023|NCT01105260|wheelchair|wheelchair
578024|NCT01105247|PCI-32765|pci-32765
578025|NCT01105247|Lymphoma, B-Cell|lymphoma, b-cell
578026|NCT01105247|Leukemia, Lymphoid|leukemia, lymphoid
578027|NCT01105247|Leukemia, B-Cell|leukemia, b-cell
578028|NCT01105247|Bruton's Tyrosine Kinase|bruton's tyrosine kinase
578029|NCT01105234|Healthy volunteers|healthy volunteers
578030|NCT01105221|Acupuncture|acupuncture
578031|NCT01105221|Dry eye|dry eye
578032|NCT01105221|Artificial tear drop|artificial tear drop
578033|NCT01105221|Mixed method approach|mixed method approach
578034|NCT01105221|Qualitative study|qualitative study
578035|NCT01105221|Cost effectiveness analysis|cost effectiveness analysis
578036|NCT01105221|Tear cytokine analysis|tear cytokine analysis
578037|NCT01105195|DuraPrep|duraprep
578038|NCT01105195|ChloraPrep|chloraprep
578039|NCT01105195|Lumbar Spine|lumbar spine
578040|NCT01105182|Radiofrequency Ablation|radiofrequency ablation
578041|NCT01105169|Personalized prevention|personalized prevention
578042|NCT01105169|Colorectal cancer|colorectal cancer
578043|NCT01105169|Investigational Nutrigenetic Studies|investigational nutrigenetic studies
578044|NCT01105169|Magnesium|magnesium
578045|NCT01105169|Gene polymorphism|gene polymorphism
578046|NCT01105156|Gastric band|gastric band
578047|NCT01105156|Questionnaire|questionnaire
578048|NCT01105156|Post operative management|post operative management
578049|NCT01105156|Adjustment|adjustment
578050|NCT01105143|weight loss|weight loss
578051|NCT01105143|muscle mass|muscle mass
578052|NCT01105130|radiation toxicity|radiation toxicity
578053|NCT01105130|male erectile disorder|male erectile disorder
578054|NCT01105130|prostate cancer|prostate cancer
578055|NCT01105117|Pulmonary Arterial Hypertension|pulmonary arterial hypertension
578056|NCT01105117|PAH|pah
578057|NCT01105117|EPITOME-1|epitome-1
578058|NCT01105091|Pulmonary Arterial Hypertension|pulmonary arterial hypertension
578059|NCT01105091|PAH|pah
578060|NCT01105091|EPITOME-1|epitome-1
578061|NCT01105078|cardiopulmonary bypass flow rate outcome tissue perfusion oxygenation l/min/m2|cardiopulmonary bypass flow rate outcome tissue perfusion oxygenation l/min/m2
578062|NCT01105065|Normal Pressure Glaucoma|normal pressure glaucoma
578063|NCT01105052|Insomnia|insomnia
578064|NCT01105052|Co-morbid|co-morbid
578065|NCT01105052|CBT|cbt
578066|NCT01105052|Self-help|self-help
578067|NCT01105052|Bibliotherapy|bibliotherapy
578068|NCT01105039|Pain pattern|pain pattern
578069|NCT01105039|overall pain|overall pain
578070|NCT01105039|incisional pain|incisional pain
578071|NCT01105039|shoulder pain|shoulder pain
578072|NCT01105039|visceral pain|visceral pain
578073|NCT01105026|alveolar ridge preservation, bioactive glass, tooth extraction, graft material|alveolar ridge preservation, bioactive glass, tooth extraction, graft material
578074|NCT01105013|fungal infections|fungal infections
578075|NCT01105013|tinea|tinea
578076|NCT01105013|tonaftato|tonaftato
578077|NCT01105000|HPV|hpv
578079|NCT01104987|Ankylosing spondylitis|ankylosing spondylitis
578080|NCT01104987|spondarthritis|spondarthritis
578081|NCT01104987|Osteoporosis|osteoporosis
578082|NCT01104987|Bone mineral density|bone mineral density
578083|NCT01104987|Dual energy x-ray absorptiometry|dual energy x-ray absorptiometry
578084|NCT01104987|Quantitative computed tomography|quantitative computed tomography
578085|NCT01104974|HIV|hiv
578086|NCT01104974|HIV providers|hiv providers
578087|NCT01104974|Infectious Disease|infectious disease
578088|NCT01104974|HIV and pregnancy|hiv and pregnancy
578089|NCT01104961|Bacterial infection|bacterial infection
578090|NCT01104961|Loss of epithelial cells|loss of epithelial cells
578091|NCT01104922|Re-irradiation with Fractionated Stereotactic Radiosurgery for Head and Neck|re-irradiation with fractionated stereotactic radiosurgery for head and neck
578092|NCT01104909|Dry weight|dry weight
578093|NCT01104909|Blood Pressure|blood pressure
578094|NCT01104909|Chronic Kidney disease|chronic kidney disease
578095|NCT01104896|Cigarette|cigarette
578096|NCT01104896|tobacco|tobacco
578097|NCT01104896|mechanical ventilation|mechanical ventilation
578098|NCT01104896|nicotine|nicotine
578099|NCT01104883|Adductor-Canal-Blockade|adductor-canal-blockade
578100|NCT01104883|postoperative pain|postoperative pain
578101|NCT01104883|US-guided nerve block|us-guided nerve block
578102|NCT01104883|total knee arthroplasty|total knee arthroplasty
578103|NCT01104857|Respiratory muscle|respiratory muscle
578104|NCT01104857|Myosin|myosin
578105|NCT01104857|Mechanical ventilation|mechanical ventilation
578106|NCT01104844|dental pain|dental pain
578107|NCT01104844|Analgesia|analgesia
578108|NCT01104831|Tibial Plateau Fracture|tibial plateau fracture
578109|NCT01104831|AO/OTA 41|ao/ota 41
578110|NCT01104818|Sibling relationship quality|sibling relationship quality
578111|NCT01104818|Foster Care|foster care
578112|NCT01104818|Parent Management Training|parent management training
578113|NCT01104818|Mental health outcomes|mental health outcomes
578114|NCT01104805|Drug Abuse|drug abuse
578115|NCT01104805|Substance Abuse|substance abuse
578116|NCT01104805|Substance Use Disorder|substance use disorder
578117|NCT01104805|Addiction|addiction
578118|NCT01104805|Behavioral Treatment|behavioral treatment
578119|NCT01104792|Schizophrenia|schizophrenia
578120|NCT01104792|Acute schizophrenia|acute schizophrenia
578121|NCT01104792|Psychotropic drugs|psychotropic drugs
578122|NCT01104792|Antipsychotic agents|antipsychotic agents
578123|NCT01104792|Mental disorders|mental disorders
578124|NCT01104792|Dopamine agents|dopamine agents
578125|NCT01104792|Central nervous system agents|central nervous system agents
578126|NCT01104779|Schizophrenia|schizophrenia
578127|NCT01104779|Acute Schizophrenia|acute schizophrenia
578128|NCT01104779|Psychotropic Drugs|psychotropic drugs
578129|NCT01104779|Antipsychotic Agents|antipsychotic agents
578130|NCT01104779|Mental Disorders|mental disorders
578131|NCT01104779|Dopamine Agents|dopamine agents
578132|NCT01104779|Central Nervous System Agents|central nervous system agents
578133|NCT01104766|Schizophrenia|schizophrenia
578134|NCT01104766|Acute Schizophrenia|acute schizophrenia
578135|NCT01104766|Psychotropic Drugs|psychotropic drugs
578136|NCT01104766|Aripiprazole|aripiprazole
578137|NCT01104766|Antipsychotic Agents|antipsychotic agents
578138|NCT01104766|Mental Disorders|mental disorders
578139|NCT01104766|Dopamine Agents|dopamine agents
578140|NCT01104766|Central Nervous System Agents|central nervous system agents
578141|NCT01104727|SINGLE PORT SURGERY|single port surgery
578142|NCT01104727|LAPAROSCOPY, CHOLECYSTECTOMY|laparoscopy, cholecystectomy
578143|NCT01104701|Exenatide|exenatide
578144|NCT01104701|Amylin|amylin
578145|NCT01104701|Lilly|lilly
578146|NCT01104701|Byetta|byetta
578147|NCT01104701|Exenatide Once Weekly|exenatide once weekly
578148|NCT01104688|Abdominal Aortic Aneurysm|abdominal aortic aneurysm
578149|NCT01104688|Wall Stress|wall stress
578150|NCT01104688|Shear Stress|shear stress
578151|NCT01104688|Inflammation|inflammation
578152|NCT01104688|Magnetic Resonance Imaging|magnetic resonance imaging
578153|NCT01104675|ovarian|ovarian
578154|NCT01104675|platinum resistant ovarian cancer|platinum resistant ovarian cancer
578155|NCT01104649|Spinocerebellar ataxia|spinocerebellar ataxia
578156|NCT01104649|Friedreich ataxia|friedreich ataxia
578157|NCT01104623|ADHD|adhd
578158|NCT01104597|Healthy Asian Indians and Caucasians|healthy asian indians and caucasians
578159|NCT01104584|Breast Cancer|breast cancer
578160|NCT01104584|Gadobutrol-enhanced MRI|gadobutrol-enhanced mri
578161|NCT01104584|Mammography|mammography
578162|NCT01104584|Diagnostic Imaging|diagnostic imaging
578163|NCT01104571|HER2-positive breast cancer|her2-positive breast cancer
578164|NCT01104571|stage IA breast cancer|stage ia breast cancer
578165|NCT01104571|stage IB breast cancer|stage ib breast cancer
578166|NCT01104571|stage II breast cancer|stage ii breast cancer
578167|NCT01104571|stage IIIA breast cancer|stage iiia breast cancer
578168|NCT01104571|estrogen receptor-negative breast cancer|estrogen receptor-negative breast cancer
578169|NCT01104571|estrogen receptor-positive breast cancer|estrogen receptor-positive breast cancer
578170|NCT01104558|Bisoprolol|bisoprolol
578171|NCT01104558|Chronic Heart failure|chronic heart failure
578172|NCT01104532|ASP1941|asp1941
578173|NCT01104532|Januvia|januvia
578175|NCT01104480|Relapsing Polychondritis|relapsing polychondritis
578176|NCT01104480|Unremitting|unremitting
578177|NCT01104480|Inflammation|inflammation
578178|NCT01104480|IL6|il6
578179|NCT01104467|Acute Ischemic Stroke|acute ischemic stroke
578180|NCT01104467|Desmoteplase|desmoteplase
578181|NCT01104467|Japan|japan
578182|NCT01104467|Safety|safety
578183|NCT01104467|Stroke|stroke
578184|NCT01104467|Tolerability|tolerability
578185|NCT01104454|healthy pregnant women|healthy pregnant women
578186|NCT01104441|critical limb ischaemia|critical limb ischaemia
578187|NCT01104441|Aspirin resistance|aspirin resistance
578188|NCT01104428|Hench-schonlein purpura|hench-schonlein purpura
578189|NCT01104428|Renal damage|renal damage
578190|NCT01104428|Relapse|relapse
578191|NCT01104428|End event|end event
578192|NCT01104428|TCM syndrome|tcm syndrome
578193|NCT01104402|telemedicine|telemedicine
578194|NCT01104402|spirometer|spirometer
578195|NCT01104402|CF|cf
578196|NCT01104402|pulmonary|pulmonary
578197|NCT01104402|home monitoring|home monitoring
578198|NCT01104376|Cytochrome P450|cytochrome p450
578199|NCT01104376|CYP2B6|cyp2b6
578200|NCT01104376|Voriconazole|voriconazole
578201|NCT01104376|Efavirenz|efavirenz
578202|NCT01104376|Pharmacokinetics|pharmacokinetics
578203|NCT01104376|Drug-Interactions|drug-interactions
578204|NCT01104376|Pharmacogenetics|pharmacogenetics
578205|NCT01104376|Healthy volunteers|healthy volunteers
578206|NCT01104363|Dental implants|dental implants
578207|NCT01104350|Bladder|bladder
578208|NCT01104350|Radiotherapy|radiotherapy
578209|NCT01104350|Gemcitabine|gemcitabine
578210|NCT01104350|Chemotherapy|chemotherapy
578211|NCT01104350|10-031|10-031
578212|NCT01104337|paracetamol|paracetamol
578213|NCT01104337|warfarin|warfarin
578214|NCT01104337|drug interaction|drug interaction
578215|NCT01104337|pathogenic mechanism|pathogenic mechanism
578216|NCT01104324|bone health|bone health
578217|NCT01104324|Osteonecrosis|osteonecrosis
578218|NCT01104324|acute lymphoblastic leukemia|acute lymphoblastic leukemia
578219|NCT01104311|Blood Pressure|blood pressure
578220|NCT01104311|Atherosclerosis|atherosclerosis
578221|NCT01104311|Brain Ischemia|brain ischemia
578222|NCT01104298|metastatic STS|metastatic sts
578223|NCT01104298|Trabectedin|trabectedin
578224|NCT01104298|doxorrubicin|doxorrubicin
578225|NCT01104298|soft tissue sarcoma|soft tissue sarcoma
578226|NCT01104298|non operable sarcoma|non operable sarcoma
578227|NCT01104272|Ultrasound Treatment of Subcutaneous Adipose Tissue|ultrasound treatment of subcutaneous adipose tissue
578228|NCT01104246|Hypogonadism|hypogonadism
578229|NCT01104246|Testosterone|testosterone
578230|NCT01104246|Hormone replacement therapy|hormone replacement therapy
578231|NCT01104233|Video-assisted Thoracoscopic Surgery|video-assisted thoracoscopic surgery
578232|NCT01104233|Soft spreading|soft spreading
578233|NCT01104233|LAP Protector|lap protector
578234|NCT01104220|NAFLD|nafld
578235|NCT01104220|Obesity|obesity
578236|NCT01104220|Metabolic syndrome|metabolic syndrome
578237|NCT01104207|tinnitus|tinnitus
578238|NCT01104207|TMS|tms
578239|NCT01104207|transcranial magnetic stimulation|transcranial magnetic stimulation
578240|NCT01104194|depression|depression
578241|NCT01104194|cognition|cognition
578242|NCT01104194|heart rate variability|heart rate variability
578243|NCT01104194|omega-3 fatty acids|omega-3 fatty acids
578244|NCT01104194|Depression (in remission) (vulnerability to depression)|depression (in remission) (vulnerability to depression)
578245|NCT01104181|Anal HPV|anal hpv
578246|NCT01104181|Anal Dysplasia|anal dysplasia
578247|NCT01104181|Ana Cancer|ana cancer
578248|NCT01104168|diabetes|diabetes
578249|NCT01104168|elderly|elderly
578250|NCT01104168|nursing home resident|nursing home resident
578251|NCT01104155|NSCLC|nsclc
578252|NCT01104129|Pancreatic Cancer|pancreatic cancer
578253|NCT01104129|Intraductal Papillary Mucinous Neoplasm (IPMN)|intraductal papillary mucinous neoplasm (ipmn)
578254|NCT01104129|Stool-based digital melt curve (DMC) assay|stool-based digital melt curve (dmc) assay
578255|NCT01104129|Surgical resection for pancreatic cancer|surgical resection for pancreatic cancer
578256|NCT01104129|Hereditary Pancreatic Cancer Syndrome|hereditary pancreatic cancer syndrome
578257|NCT01104129|Genetic mutations linked to pancreatic cancer|genetic mutations linked to pancreatic cancer
578258|NCT01104116|Pancreatic Cancer|pancreatic cancer
578259|NCT01104116|Intraductal Papillary Mucinous Neoplasm|intraductal papillary mucinous neoplasm
578260|NCT01104116|Pre-cancerous pancreatic lesion|pre-cancerous pancreatic lesion
578261|NCT01104116|PET Scan|pet scan
578262|NCT01104116|Pancreatic Cancer Screening|pancreatic cancer screening
578263|NCT01104103|Catheterization, Peripheral|catheterization, peripheral
578264|NCT01104103|Disposable Equipment|disposable equipment
578265|NCT01104103|Emergency Medical Technicians|emergency medical technicians
578266|NCT01104103|Emergency Nursing|emergency nursing
578267|NCT01104090|C-MAC|c-mac
578268|NCT01104090|direct laryngoscopy|direct laryngoscopy
578269|NCT01104090|indirect laryngoscopy|indirect laryngoscopy
578270|NCT01104090|to determine the safety and efficacy of the C-MAC|to determine the safety and efficacy of the c-mac
578271|NCT01104077|Pancreatic Cancer|pancreatic cancer
734719|NCT00494520|Anomia|anomia
578272|NCT01104077|Family History|family history
578273|NCT01104077|Pre-cancerous lesion|pre-cancerous lesion
578274|NCT01104077|Intraductal Papillary Mucinous Neoplasm (IPMN)|intraductal papillary mucinous neoplasm (ipmn)
578275|NCT01104077|Intraductal Papillary Mucinous Neoplasm|intraductal papillary mucinous neoplasm
578276|NCT01104064|Stroke|stroke
578277|NCT01104038|physical activity|physical activity
578278|NCT01104038|cardiometabolic risk|cardiometabolic risk
578279|NCT01104038|children|children
578280|NCT01104025|hemophagocytic lymphohistiocytosis|hemophagocytic lymphohistiocytosis
578281|NCT01104025|hybrid immunotherapy|hybrid immunotherapy
578282|NCT01104025|dexamethasone|dexamethasone
578283|NCT01104025|Etoposide|etoposide
578284|NCT01104025|ATG,rabbit|atg,rabbit
578285|NCT01103999|spleen|spleen
578286|NCT01103986|health literacy|health literacy
578287|NCT01103986|consumer health information|consumer health information
578288|NCT01103986|patient education as topics/methods|patient education as topics/methods
578289|NCT01103986|patient participation|patient participation
578290|NCT01103973|IVF, Mind/Body|ivf, mind/body
578291|NCT01103947|Anesthesia induction|anesthesia induction
578292|NCT01103947|Facemask|facemask
578293|NCT01103947|surgery|surgery
578294|NCT01103921|sugar|sugar
578295|NCT01103921|fructose|fructose
578296|NCT01103921|glucose|glucose
578297|NCT01103921|HFCS|hfcs
578298|NCT01103921|metabolism|metabolism
578299|NCT01103908|cardiac output|cardiac output
578300|NCT01103908|cardiopulmonary bypass|cardiopulmonary bypass
578301|NCT01103908|ultrasound dilution|ultrasound dilution
578302|NCT01103895|cardiac output|cardiac output
578303|NCT01103895|cardiopulmonary bypass|cardiopulmonary bypass
578304|NCT01103895|ultrasound dilution|ultrasound dilution
578305|NCT01103856|HIV|hiv
578306|NCT01103856|adherence to care|adherence to care
578307|NCT01103856|retention in care|retention in care
578308|NCT01103856|patient navigation|patient navigation
578309|NCT01103843|Coronary artery disease|coronary artery disease
578310|NCT01103843|clopidogrel|clopidogrel
578311|NCT01103843|prasugrel|prasugrel
578312|NCT01103843|Verify Now|verify now
578313|NCT01103843|PRU measurements|pru measurements
578314|NCT01103843|Drug eluting stents (EDS)|drug eluting stents (eds)
578315|NCT01103843|P2Y12|p2y12
578316|NCT01103843|Platelet reactivity|platelet reactivity
578317|NCT01103830|P. falciparum Malaria, Eurartesim, ACT|p. falciparum malaria, eurartesim, act
578318|NCT01103817|Type 1 Diabetes|type 1 diabetes
578319|NCT01103817|Adolescents and Young Adults|adolescents and young adults
578320|NCT01103817|Vitamin D|vitamin d
578321|NCT01103817|Cardiovascular Disease|cardiovascular disease
578322|NCT01103804|GerdQ questionnaire|gerdq questionnaire
578323|NCT01103778|Chronic kidney disease|chronic kidney disease
578324|NCT01103778|IgA nephropathy|iga nephropathy
578325|NCT01103778|Velcade®|velcade®
578326|NCT01103778|Proteinuria|proteinuria
578327|NCT01103778|Bortezomib|bortezomib
578328|NCT01103778|Proteasome inhibitor|proteasome inhibitor
578329|NCT01103765|Post-dilatation|post-dilatation
578330|NCT01103765|noncompliant balloon|noncompliant balloon
578331|NCT01103765|optimal stent deployment of drug-eluting stent|optimal stent deployment of drug-eluting stent
578332|NCT01103765|Intravascular ultrasound (IVUS)|intravascular ultrasound (ivus)
578333|NCT01103765|Optimal stent deployment defined by intravascular ultrasound analysis|optimal stent deployment defined by intravascular ultrasound analysis
578334|NCT01103739|pharmacokinetics|pharmacokinetics
578335|NCT01103739|drug-drug interaction|drug-drug interaction
578336|NCT01103726|FDG-PET|fdg-pet
578337|NCT01103726|regional cerebral glucose metabolism|regional cerebral glucose metabolism
578338|NCT01103726|striatum|striatum
578339|NCT01103726|PDE10 inhibitor|pde10 inhibitor
578340|NCT01103713|P. falciparum malaria|p. falciparum malaria
578341|NCT01103713|asymptomatic parasitemia|asymptomatic parasitemia
578342|NCT01103713|parasitological clearance|parasitological clearance
578463|NCT01103219|VLBW|vlbw
578343|NCT01103713|Intermittent Preventive Treatment of Falciparum Malaria in Pregnant Women (IPTp)|intermittent preventive treatment of falciparum malaria in pregnant women (iptp)
578344|NCT01103700|Quality of dying and death of terminal cancer patients|quality of dying and death of terminal cancer patients
578345|NCT01103687|HIV Preventive Vaccine|hiv preventive vaccine
578346|NCT01103674|Paroxysmal Atrial Fibrillation|paroxysmal atrial fibrillation
578347|NCT01103674|AF|af
578348|NCT01103674|Atrial Fibrillation|atrial fibrillation
578349|NCT01103674|RF ablation|rf ablation
578350|NCT01103661|Longstanding Persistent Atrial Fibrillation|longstanding persistent atrial fibrillation
578351|NCT01103661|AF|af
578352|NCT01103661|Chronic AF|chronic af
578353|NCT01103661|RF Ablation|rf ablation
578354|NCT01103661|nContact Surgical|ncontact surgical
578355|NCT01103661|Therapy Cool Path Ablation Catheter|therapy cool path ablation catheter
578356|NCT01103661|St. Jude Medical|st. jude medical
578357|NCT01103648|Prediabetes|prediabetes
578358|NCT01103648|Statin|statin
578359|NCT01103648|Ezetimibe|ezetimibe
578360|NCT01103648|Pleiotropic effects|pleiotropic effects
578361|NCT01103648|Cardiometabolic risk|cardiometabolic risk
578362|NCT01103622|Diabetes|diabetes
578363|NCT01103622|Type 2|type 2
578364|NCT01103622|Digoxin|digoxin
578365|NCT01103622|drug-drug interaction|drug-drug interaction
578366|NCT01103609|Diabetes|diabetes
578367|NCT01103609|Type 2|type 2
578368|NCT01103609|Warfarin|warfarin
578369|NCT01103609|drug-drug interaction|drug-drug interaction
578370|NCT01103596|Evaluation of the impact of Kaletra on antiretroviral resistance|evaluation of the impact of kaletra on antiretroviral resistance
578371|NCT01103570|Laparoscopic cholecystectomy|laparoscopic cholecystectomy
578372|NCT01103570|Intra-operative cholangiography|intra-operative cholangiography
578373|NCT01103557|Papillary thyroid carcinoma with neck metastasis|papillary thyroid carcinoma with neck metastasis
578374|NCT01103557|neck dissection|neck dissection
578375|NCT01103544|TCCU|tccu
578376|NCT01103544|advanced TCCU|advanced tccu
578377|NCT01103544|metastatic TCCU|metastatic tccu
578378|NCT01103544|transitional cell carcinoma of the urothelium|transitional cell carcinoma of the urothelium
578379|NCT01103544|advanced transitional cell carcinoma of the urothelium|advanced transitional cell carcinoma of the urothelium
578380|NCT01103544|metastatic transitional cell carcinoma of the urothelium|metastatic transitional cell carcinoma of the urothelium
578381|NCT01103544|Cisplatinum failure|cisplatinum failure
578382|NCT01103544|Vinflunine|vinflunine
578383|NCT01103544|Javlor|javlor
578384|NCT01103544|daily routine|daily routine
578385|NCT01103544|concomitant antiemetic treatment|concomitant antiemetic treatment
578386|NCT01103544|concomitant antiobstipative treatment|concomitant antiobstipative treatment
578387|NCT01103544|concomitant antiobstipative diet|concomitant antiobstipative diet
578388|NCT01103544|patient compliance|patient compliance
578389|NCT01103544|quality of life|quality of life
578390|NCT01103544|non-interventional study|non-interventional study
578391|NCT01103544|Germany|germany
578392|NCT01103544|Advanced / metastatic TCCU after Cisplatinum-failure|advanced / metastatic tccu after cisplatinum-failure
578393|NCT01103531|Methamphetamine|methamphetamine
578394|NCT01103531|Methamphetamine Dependence|methamphetamine dependence
578395|NCT01103531|Methamphetamine Treatment|methamphetamine treatment
578396|NCT01103531|Aerobic Exercise|aerobic exercise
578397|NCT01103531|Resistance Exercise|resistance exercise
578398|NCT01103531|Brain Imaging|brain imaging
578399|NCT01103531|D2 and D3 receptor availability|d2 and d3 receptor availability
578400|NCT01103518|Menstrual irregularity|menstrual irregularity
578401|NCT01103518|Menstruation disturbances|menstruation disturbances
578402|NCT01103518|Hyperandrogenism|hyperandrogenism
578403|NCT01103505|AMD|amd
578404|NCT01103505|CNV|cnv
578405|NCT01103492|prostate cancer|prostate cancer
578406|NCT01103492|endometrial cancer|endometrial cancer
578407|NCT01103492|radiation proctitis|radiation proctitis
578408|NCT01103492|pelvic radiotherapy|pelvic radiotherapy
578409|NCT01103492|rectal bleeding|rectal bleeding
578410|NCT01103479|Early Detection of Cancer|early detection of cancer
578411|NCT01103479|Colorectal Cancer Screening|colorectal cancer screening
578412|NCT01103466|Ileostomy base plate|ileostomy base plate
578413|NCT01103453|MCI|mci
578414|NCT01103453|Executive Function|executive function
578415|NCT01103453|ADL|adl
578416|NCT01103453|Virtual Supermarket|virtual supermarket
578417|NCT01103440|Major Adverse Cardiovascular Event|major adverse cardiovascular event
578418|NCT01103440|MACE|mace
578419|NCT01103440|Death|death
578420|NCT01103440|MI|mi
578421|NCT01103440|CK MB greater 3x Normal|ck mb greater 3x normal
578422|NCT01103440|Urgent Revascularization|urgent revascularization
578423|NCT01103440|Stent Thrombosis|stent thrombosis
578424|NCT01103440|Bleeding|bleeding
578425|NCT01103427|smoking cessation|smoking cessation
578426|NCT01103427|telemedicine|telemedicine
578427|NCT01103427|smoking|smoking
578428|NCT01103427|prevention intervention|prevention intervention
578429|NCT01103427|internet-based|internet-based
578430|NCT01103427|text messages|text messages
578431|NCT01103427|behavioral|behavioral
578432|NCT01103414|Diabetes|diabetes
578433|NCT01103388|Rituximab|rituximab
578434|NCT01103388|Rituxan|rituxan
578435|NCT01103388|Lymphoma|lymphoma
578436|NCT01103388|High dose chemotherapy|high dose chemotherapy
578437|NCT01103388|Autologous transplantation|autologous transplantation
578438|NCT01103388|Autologous stem cell transplant|autologous stem cell transplant
578439|NCT01103388|ASCT|asct
578440|NCT01103336|Patients with chronic renal failure undergoing coronary angiography|patients with chronic renal failure undergoing coronary angiography
578441|NCT01103323|Metastatic Colorectal Cancer|metastatic colorectal cancer
578442|NCT01103310|Neoplasm|neoplasm
578443|NCT01103310|PET/CT diagnosis|pet/ct diagnosis
578444|NCT01103310|PET tracer|pet tracer
578445|NCT01103297|Distal radius fracture|distal radius fracture
578446|NCT01103297|Double row plate|double row plate
578447|NCT01103297|Volar approach|volar approach
578448|NCT01103297|DVR plate|dvr plate
578449|NCT01103297|Postoperative complications [MeSH]|postoperative complications [mesh]
578450|NCT01103284|beta-cells|beta-cells
578451|NCT01103284|autoimmune|autoimmune
578452|NCT01103284|Diabetes|diabetes
578453|NCT01103284|immunomodulation|immunomodulation
578454|NCT01103271|depression|depression
578455|NCT01103271|placebo effect|placebo effect
578456|NCT01103271|complementary therapies|complementary therapies
578457|NCT01103271|alternative therapies|alternative therapies
578458|NCT01103258|Incompetence of the great saphenous vein.|incompetence of the great saphenous vein.
578459|NCT01103245|Glucose|glucose
578460|NCT01103245|Insulin|insulin
578461|NCT01103232|Cross education|cross education
578462|NCT01103232|Muscle training|muscle training
578464|NCT01103219|nutrition|nutrition
578465|NCT01103219|vitamin A|vitamin a
578466|NCT01103219|long-chain unsaturated fatty acids|long-chain unsaturated fatty acids
578467|NCT01103219|growth|growth
578468|NCT01103219|cognitive functions|cognitive functions
578469|NCT01103219|Very low birth weight infants (birth weight below 1,500 grams).|very low birth weight infants (birth weight below 1,500 grams).
578470|NCT01103206|Parathyroid hormone|parathyroid hormone
578471|NCT01103206|Cinacalcet|cinacalcet
578472|NCT01103206|Primary hyperparathyroidism|primary hyperparathyroidism
578473|NCT01103206|Diagnosis|diagnosis
578474|NCT01103193|ASA class I/II patients, with surgery under general anesthesia|asa class i/ii patients, with surgery under general anesthesia
578475|NCT01103180|Selective Serotonin Reuptake Inhibitor|selective serotonin reuptake inhibitor
578476|NCT01103180|Escitalopram|escitalopram
578477|NCT01103180|Borderline Personality Disorder|borderline personality disorder
578478|NCT01103180|Major Depressive Disorder|major depressive disorder
578479|NCT01103180|Self-harm|self-harm
578480|NCT01103167|body composition|body composition
578481|NCT01103167|blood pressure|blood pressure
578482|NCT01103167|hemodialysis|hemodialysis
578483|NCT01103154|beta blocker|beta blocker
578484|NCT01103154|variceal rebleeding|variceal rebleeding
578485|NCT01103154|efficacy and safety in reducing variceal rebleeding|efficacy and safety in reducing variceal rebleeding
578486|NCT01103141|Vascular Surgical Procedures|vascular surgical procedures
578487|NCT01103141|Angioplasty|angioplasty
578488|NCT01103141|Radiology, Interventional|radiology, interventional
578489|NCT01103128|Pancreatic Cancer|pancreatic cancer
578490|NCT01103128|Pre-neoplastic lesions|pre-neoplastic lesions
578491|NCT01103128|Breast and Ovarian Cancer Syndrome|breast and ovarian cancer syndrome
578492|NCT01103128|BRCA1/2|brca1/2
578493|NCT01103128|Mouse model for pancreatic cancer|mouse model for pancreatic cancer
578494|NCT01103115|Adolescent Idiopathic Scoliosis|adolescent idiopathic scoliosis
578496|NCT01103115|low bone mass|low bone mass
578497|NCT01103115|osteopenia|osteopenia
578498|NCT01103115|bone health|bone health
578499|NCT01103115|bone density|bone density
578500|NCT01103102|Gingivitis|gingivitis
578501|NCT01103102|Biological Markers|biological markers
578502|NCT01103089|NSCLC|nsclc
578503|NCT01103089|EGFR|egfr
578504|NCT01103089|gefitinib|gefitinib
578505|NCT01103089|observational|observational
578506|NCT01103076|Immune dysfunction|immune dysfunction
578507|NCT01103076|Hemodialysis|hemodialysis
578508|NCT01103076|HBV|hbv
578509|NCT01103076|Vaccination|vaccination
578510|NCT01103076|Immune response|immune response
578511|NCT01103063|P. falciparum malaria|p. falciparum malaria
578512|NCT01103063|IPTp|iptp
578513|NCT01103050|Allergic inflammation|allergic inflammation
578514|NCT01103050|Seasonal rhinitis|seasonal rhinitis
578515|NCT01103037|Mild|mild
578516|NCT01103037|Moderate|moderate
578517|NCT01103037|Asthma|asthma
578518|NCT01103024|Active uveitis|active uveitis
578519|NCT01103024|intermediate uveitis|intermediate uveitis
578520|NCT01103024|panuveitis|panuveitis
578521|NCT01103024|posterior uveitis|posterior uveitis
578522|NCT01103024|uveitis|uveitis
578523|NCT01102998|Sleep complaints|sleep complaints
578524|NCT01102998|Brain Tumor Survivors|brain tumor survivors
578525|NCT01102985|exercise|exercise
578526|NCT01102985|physical activity|physical activity
578527|NCT01102985|intervention|intervention
578528|NCT01102985|cancer survivor|cancer survivor
578529|NCT01102972|HIV-1|hiv-1
578530|NCT01102972|HIV|hiv
578531|NCT01102959|EDUCATION|education
578532|NCT01102959|DIABETES MELLITUS|diabetes mellitus
578533|NCT01102959|ADOLESCENT|adolescent
578534|NCT01102959|DIABETIC DIET|diabetic diet
578535|NCT01102946|proliferative diabetic retinopathy|proliferative diabetic retinopathy
578536|NCT01102946|retinal neovascularization|retinal neovascularization
578537|NCT01102946|Angiogenesis Inhibitors|angiogenesis inhibitors
578538|NCT01102946|ranibizumab|ranibizumab
578539|NCT01102946|laser|laser
578540|NCT01102920|Obstructive sleep apnea|obstructive sleep apnea
578541|NCT01102920|Obesity|obesity
578542|NCT01102920|Behavioural medicine|behavioural medicine
578543|NCT01102920|Physical therapy|physical therapy
578544|NCT01102920|Health behaviour change|health behaviour change
578545|NCT01102920|Physical activity|physical activity
578546|NCT01102920|Eating habits|eating habits
578547|NCT01102907|Appetite|appetite
578548|NCT01102907|Satiety|satiety
578549|NCT01102907|Gastric Emptying Time|gastric emptying time
578550|NCT01102907|Food Intake|food intake
578551|NCT01102907|Food Form|food form
578552|NCT01102881|Healthy adults|healthy adults
578553|NCT01102829|Knee Joint|knee joint
578554|NCT01102829|Arthroplasty|arthroplasty
578555|NCT01102829|Replacement|replacement
578556|NCT01102829|Knee|knee
578557|NCT01102816|hemodialysis|hemodialysis
578558|NCT01102816|end-stage renal disease|end-stage renal disease
578559|NCT01102816|pain|pain
578560|NCT01102816|acupuncture|acupuncture
578561|NCT01102803|Phobias|phobias
578562|NCT01102803|Anxiety Disorders|anxiety disorders
578563|NCT01102803|D-Cycloserine|d-cycloserine
578564|NCT01102803|Phobic Disorders|phobic disorders
578565|NCT01102803|Mental Disorders|mental disorders
578567|NCT01102803|Acrophobia|acrophobia
578568|NCT01102790|HIT|hit
578569|NCT01102777|internet|internet
578570|NCT01102777|walking|walking
578571|NCT01102764|Anxiety Disorders: PTSD|anxiety disorders: ptsd
578572|NCT01102764|Prolong Exposure (PE)|prolong exposure (pe)
578573|NCT01102764|Telemedicine|telemedicine
578574|NCT01102764|cost effectiveness|cost effectiveness
578575|NCT01102764|deployment related problems|deployment related problems
578576|NCT01102764|mental health care delivery|mental health care delivery
578577|NCT01102751|fibroblast growth factor 23|fibroblast growth factor 23
578578|NCT01102751|Osteomalacia|osteomalacia
578579|NCT01102751|vitamin D|vitamin d
578580|NCT01102725|Colon Surgery|colon surgery
578581|NCT01102725|Rectal Surgery|rectal surgery
578582|NCT01102725|Colorectal Surgery|colorectal surgery
578583|NCT01102712|Emphysema|emphysema
578584|NCT01102712|COPD|copd
578585|NCT01102712|Lung Volume Reduction|lung volume reduction
578586|NCT01102712|BTVA|btva
578587|NCT01102699|Diabetes|diabetes
578588|NCT01102699|stem cells|stem cells
578589|NCT01102699|bone marrow|bone marrow
578590|NCT01102699|mobilization|mobilization
578591|NCT01102686|Late-onset GM2-gangliosidosis|late-onset gm2-gangliosidosis
578592|NCT01102686|pyrimethamine|pyrimethamine
578593|NCT01102673|phase 1|phase 1
578594|NCT01102673|safety and tolerability|safety and tolerability
578595|NCT01102673|PK|pk
578596|NCT01102673|T2DM|t2dm
578597|NCT01102673|type 2 diabetes mellitus|type 2 diabetes mellitus
578598|NCT01102660|Knee osteoarthritis|knee osteoarthritis
578599|NCT01102660|clinical trial|clinical trial
578600|NCT01102660|cross-over|cross-over
578601|NCT01102621|hearing loss|hearing loss
578602|NCT01102621|head and neck cancer|head and neck cancer
578603|NCT01102621|radiotherapy|radiotherapy
578604|NCT01102621|hearing complaint|hearing complaint
578605|NCT01102621|Hearing loss due to the exposure of radiotherapy|hearing loss due to the exposure of radiotherapy
578606|NCT01102608|sarcoma|sarcoma
578607|NCT01102608|ifosfamide|ifosfamide
578608|NCT01102595|Unresectable/inoperable glioblastomas|unresectable/inoperable glioblastomas
578609|NCT01102582|Parkinson's disease dementia, neuropsychiatric symptoms|parkinson's disease dementia, neuropsychiatric symptoms
578610|NCT01102569|Hereditary pancreatic cancer|hereditary pancreatic cancer
578611|NCT01102569|Breast and Ovarian Cancer Syndrome|breast and ovarian cancer syndrome
578612|NCT01102569|BRCA1/2|brca1/2
578613|NCT01102569|Ashkenazi Jewish patients|ashkenazi jewish patients
578614|NCT01102556|Pancreatic Cancer|pancreatic cancer
578615|NCT01102556|Pre-Neoplastic Lesions|pre-neoplastic lesions
578616|NCT01102556|Pancreatic Cancer Surgery|pancreatic cancer surgery
578617|NCT01102556|High-Risk for Pancreatic Cancer|high-risk for pancreatic cancer
578618|NCT01102556|Tissue and Blood Bank for Pancreatic Cancer|tissue and blood bank for pancreatic cancer
578619|NCT01102556|Pancreatic Cancer Questionnaire|pancreatic cancer questionnaire
578620|NCT01102543|pulmonary surfactant|pulmonary surfactant
578621|NCT01102543|Respiratory distress syndrome|respiratory distress syndrome
578622|NCT01102543|Newborn|newborn
578623|NCT01102543|prophylaxis|prophylaxis
578624|NCT01102517|NSCLC|nsclc
578625|NCT01102517|Clinical|clinical
578626|NCT01102517|Early-stage|early-stage
578627|NCT01102504|carotid atheroma|carotid atheroma
578628|NCT01102504|plaque vulnerability|plaque vulnerability
578629|NCT01102504|stroke risk|stroke risk
578630|NCT01102491|postoperative nausea and vomiting|postoperative nausea and vomiting
578631|NCT01102439|Clopidogrel|clopidogrel
578632|NCT01102439|Aspirin|aspirin
578633|NCT01102439|Interaction|interaction
578634|NCT01102426|Multiple Myeloma|multiple myeloma
578635|NCT01102426|Aplidin|aplidin
578636|NCT01102426|plitidepsin|plitidepsin
578637|NCT01102426|dexamethasone|dexamethasone
578638|NCT01102400|cancer|cancer
578639|NCT01102400|tumor|tumor
578640|NCT01102400|hepatocellular carcinoma|hepatocellular carcinoma
578641|NCT01102387|Candida infections in intertriginous areas|candida infections in intertriginous areas
578642|NCT01102374|Vitamin D Deficiency|vitamin d deficiency
578643|NCT01102374|Respiratory Infection|respiratory infection
578644|NCT01102374|Nursing Home Residents|nursing home residents
578645|NCT01102374|Geriatrics|geriatrics
578646|NCT01102374|Immunosenescence|immunosenescence
578647|NCT01102374|Prevention|prevention
578648|NCT01102348|Critically Ill|critically ill
578649|NCT01102348|Nutrition Therapy|nutrition therapy
578650|NCT01102348|Enteral Nutrition|enteral nutrition
578651|NCT01102335|hepatitis B virus|hepatitis b virus
578652|NCT01102335|Antiviral Agents|antiviral agents
578653|NCT01102335|Liver Neoplasms|liver neoplasms
578654|NCT01102335|Drug Toxicity|drug toxicity
578655|NCT01102335|Survival|survival
578656|NCT01102322|Acute respiratory distress syndrome|acute respiratory distress syndrome
578657|NCT01102309|cerebrovascular accident|cerebrovascular accident
578658|NCT01102309|hemiparesis|hemiparesis
578659|NCT01102309|recovery of function|recovery of function
578660|NCT01102309|rehabilitation|rehabilitation
578661|NCT01102309|robotics|robotics
578662|NCT01102309|subacute therapy|subacute therapy
578663|NCT01102309|training|training
578664|NCT01102296|hepatitis A vaccine|hepatitis a vaccine
578665|NCT01102296|male homosexual|male homosexual
578666|NCT01102296|HIV infection|hiv infection
578667|NCT01102296|male homosexuals who are seronegative for hepatitis A virus|male homosexuals who are seronegative for hepatitis a virus
578668|NCT01102283|Colonic obstruction|colonic obstruction
578669|NCT01102270|Obstructive sleep apnea|obstructive sleep apnea
578670|NCT01102270|Arousal threshold|arousal threshold
578671|NCT01102270|Sedative medication|sedative medication
578672|NCT01102270|upper airway|upper airway
578673|NCT01102257|Dry Eye Disease|dry eye disease
578675|NCT01102257|Keratoconjunctivitis Sicca|keratoconjunctivitis sicca
578676|NCT01102257|Omega-3|omega-3
578677|NCT01102244|blepharitis|blepharitis
578678|NCT01102244|moderate to severe chronic blepharitis|moderate to severe chronic blepharitis
578679|NCT01102218|Anemia, ESRD|anemia, esrd
578680|NCT01102192|Myasthenia gravis|myasthenia gravis
578681|NCT01102192|Thymoma|thymoma
578682|NCT01102192|T-cells|t-cells
578683|NCT01102192|Thymectomy|thymectomy
578684|NCT01102166|This study was conducted in healthy subjects|this study was conducted in healthy subjects
578685|NCT01102153|sudden cardiac arrest|sudden cardiac arrest
578686|NCT01102153|Hypothermia|hypothermia
578687|NCT01102153|Coolgard|coolgard
578688|NCT01102153|arctic sun|arctic sun
578689|NCT01102153|neurological outcome|neurological outcome
578690|NCT01102153|neuron specific enolase|neuron specific enolase
578691|NCT01102140|Cardiomyopathy|cardiomyopathy
578692|NCT01102140|Heart Failure|heart failure
578693|NCT01102127|elastography|elastography
578694|NCT01102127|thyroid nodule|thyroid nodule
578695|NCT01102127|fine-needle aspiration|fine-needle aspiration
578696|NCT01102114|Smoking Cessation|smoking cessation
578697|NCT01102114|NicVAX|nicvax
578698|NCT01102114|Smoking Vaccine|smoking vaccine
578699|NCT01102114|Smoking Abstinence|smoking abstinence
578700|NCT01102114|Smoking|smoking
578701|NCT01102114|Tobacco Cessation|tobacco cessation
578702|NCT01102101|Remifentanil|remifentanil
578703|NCT01102101|Hyperalgesia|hyperalgesia
578704|NCT01102101|Zoster|zoster
578705|NCT01102101|Postherpetic neuralgia|postherpetic neuralgia
578706|NCT01102088|Cancer|cancer
578707|NCT01102088|Gastroesophageal|gastroesophageal
578708|NCT01102088|Simultaneous Integrated Boost|simultaneous integrated boost
578709|NCT01102088|SIB|sib
578710|NCT01102088|5-Fluorouracil|5-fluorouracil
578711|NCT01102088|5-FU|5-fu
578712|NCT01102088|Adrucil|adrucil
578713|NCT01102088|Efudex|efudex
578714|NCT01102088|Docetaxel|docetaxel
578715|NCT01102088|Taxotere|taxotere
578716|NCT01102088|Radiation|radiation
578717|NCT01102088|chemoradiation|chemoradiation
578718|NCT01102075|Obesity|obesity
578719|NCT01102075|Electroacupuncture|electroacupuncture
578720|NCT01102075|Sham electroacupuncture|sham electroacupuncture
578721|NCT01102075|Waist circumference|waist circumference
578722|NCT01102075|Thickness of subcutaneous fat|thickness of subcutaneous fat
578723|NCT01102036|Transit time|transit time
578724|NCT01102036|constipation|constipation
578725|NCT01102036|gut regularity|gut regularity
578726|NCT01102036|defecation frequency|defecation frequency
578727|NCT01102036|Colonic transit time|colonic transit time
578728|NCT01102010|Blood transfusion|blood transfusion
578729|NCT01102010|Hip fracture|hip fracture
578730|NCT01102010|Elderly|elderly
578731|NCT01102010|Geriatrics|geriatrics
578732|NCT01102010|Hospitalization|hospitalization
578733|NCT01102010|Frail elderly|frail elderly
578734|NCT01101997|Lipolysis|lipolysis
578735|NCT01101997|Cryolipolysis|cryolipolysis
578736|NCT01101997|Fat Reduction|fat reduction
578737|NCT01101971|Education, Medical|education, medical
578738|NCT01101971|Students, Medical|students, medical
578739|NCT01101971|Gynecology|gynecology
578740|NCT01101971|Physical Examination|physical examination
578741|NCT01101971|Computer-Assisted Instruction|computer-assisted instruction
578742|NCT01101945|diabetes|diabetes
578743|NCT01101945|DPP4 inhibitor|dpp4 inhibitor
578744|NCT01101945|dutogliptin|dutogliptin
578745|NCT01101945|PHX1149|phx1149
578746|NCT01101932|Safety|safety
578747|NCT01101932|Tolerability|tolerability
578748|NCT01101932|Pharmacokinetics/Pharmacodynamics|pharmacokinetics/pharmacodynamics
578749|NCT01101932|Rheumatoid Arthritis|rheumatoid arthritis
578750|NCT01101932|healthy volunteers|healthy volunteers
578751|NCT01101919|Rheumatoid Arthritis|rheumatoid arthritis
578752|NCT01101906|HCC|hcc
578753|NCT01101906|OSI-906|osi-906
578754|NCT01101906|Hepatocellular Carcinoma|hepatocellular carcinoma
578755|NCT01101893|GSK2248761, raltegravir, drug interaction, pharmacokinetics|gsk2248761, raltegravir, drug interaction, pharmacokinetics
578756|NCT01101867|diabetes|diabetes
578757|NCT01101867|glucose|glucose
578758|NCT01101867|hospital|hospital
578759|NCT01101854|gene expression in wounds|gene expression in wounds
578760|NCT01101854|healing wounds|healing wounds
578761|NCT01101854|non-healing wounds|non-healing wounds
578762|NCT01101854|punch biopsy|punch biopsy
578763|NCT01101854|debridement|debridement
578764|NCT01101841|Vasomotor Symptoms|vasomotor symptoms
578765|NCT01101841|Menopause|menopause
578766|NCT01101841|Hot Flashes|hot flashes
578767|NCT01101841|Perimenopause|perimenopause
578768|NCT01101841|Nonhormonal therapies|nonhormonal therapies
578769|NCT01101841|Climacteric symptoms|climacteric symptoms
578770|NCT01101841|Mesafem|mesafem
578771|NCT01101841|Low-Dose Mesylate salt of Paroxetine (LDMP)|low-dose mesylate salt of paroxetine (ldmp)
578772|NCT01101815|Viral Loads|viral loads
578773|NCT01101815|Naltrexone|naltrexone
578774|NCT01101815|HIV Risk|hiv risk
578775|NCT01101815|Substance Abuse|substance abuse
578776|NCT01101802|SLE|sle
578777|NCT01101802|Atherosclerosis|atherosclerosis
578778|NCT01101802|Endothelial function|endothelial function
578779|NCT01101802|Mycophenolate mofetil|mycophenolate mofetil
578780|NCT01101789|surgical wound infection|surgical wound infection
578781|NCT01101789|triclosan-coated suture|triclosan-coated suture
578782|NCT01101776|Multiple Sclerosis, relapsing|multiple sclerosis, relapsing
578783|NCT01101776|Rebif New Formulation|rebif new formulation
578784|NCT01101776|Interferon beta-1a|interferon beta-1a
578785|NCT01101750|Gardasil|gardasil
578786|NCT01101750|HPV|hpv
578787|NCT01101750|transplant|transplant
578788|NCT01101750|adolescent|adolescent
578789|NCT01101750|prevention|prevention
578790|NCT01101750|vaccine|vaccine
578791|NCT01101750|immunogenicity|immunogenicity
578792|NCT01101750|vaccination|vaccination
578793|NCT01101737|Hypertension, clinical trial, nurse-led clinic, primary care|hypertension, clinical trial, nurse-led clinic, primary care
578794|NCT01101724|mild traumatic brain injury|mild traumatic brain injury
578795|NCT01101724|Concussion|concussion
578796|NCT01101724|postconcussive syndrome|postconcussive syndrome
578797|NCT01101698|Vitamin K|vitamin k
578798|NCT01101698|chronic kidney disease|chronic kidney disease
578799|NCT01101698|coronary artery calcification|coronary artery calcification
578800|NCT01101698|intima media thickness|intima media thickness
578801|NCT01101685|non-dysphoric|non-dysphoric
578802|NCT01101685|Dysphoric|dysphoric
578803|NCT01101672|Single port laparoscopic colectomy|single port laparoscopic colectomy
578804|NCT01101659|Activity of JNJ-40411813|activity of jnj-40411813
578805|NCT01101659|Challenge study|challenge study
578806|NCT01101646|Rabeprazole sodium|rabeprazole sodium
578807|NCT01101646|Pharmacokinetics|pharmacokinetics
578808|NCT01101646|Biological Availability|biological availability
578809|NCT01101646|Safety|safety
578810|NCT01101646|Adult|adult
578811|NCT01101633|Appetite|appetite
578812|NCT01101633|Energy intake|energy intake
578813|NCT01101633|gastric emptying|gastric emptying
578814|NCT01101633|well being|well being
578815|NCT01101633|Body weight|body weight
578816|NCT01101607|Pediatrics|pediatrics
578817|NCT01101607|Distal Forearm fractures|distal forearm fractures
578818|NCT01101607|Pediatric Emergency Medicine|pediatric emergency medicine
578819|NCT01101607|Pediatric Orthopedics|pediatric orthopedics
578820|NCT01101594|Treatment|treatment
578821|NCT01101594|Multiple Myeloma|multiple myeloma
578822|NCT01101594|Relapsed, refractory multiple myeloma|relapsed, refractory multiple myeloma
578823|NCT01101581|Diffuse Large cell NHL|diffuse large cell nhl
578824|NCT01101581|Mantle cell NHL|mantle cell nhl
578825|NCT01101581|Lymphoblastic lymphoma|lymphoblastic lymphoma
578826|NCT01101581|Diffuse mixed cell lymphoma|diffuse mixed cell lymphoma
578827|NCT01101581|Diffuse large cell lymphoma|diffuse large cell lymphoma
578828|NCT01101581|large noncleaved cell lymphoma|large noncleaved cell lymphoma
578829|NCT01101568|GSK1292263, rosuvastatin, simvastatin, pharmacokinetics, drug interaction|gsk1292263, rosuvastatin, simvastatin, pharmacokinetics, drug interaction
578830|NCT01101555|Rheumatoid arthritis|rheumatoid arthritis
578831|NCT01101555|repeat dose|repeat dose
578832|NCT01101555|pharmacodynamics|pharmacodynamics
578833|NCT01101555|pharmacokinetics|pharmacokinetics
578834|NCT01101555|subcutaneous|subcutaneous
578835|NCT01101555|safety|safety
578836|NCT01101555|Otelixizumab|otelixizumab
578837|NCT01101555|long term follow up|long term follow up
578838|NCT01101555|tolerability|tolerability
578839|NCT01101542|Post-marketing surveillance|post-marketing surveillance
578840|NCT01101542|Human papillomavirus|human papillomavirus
578841|NCT01101542|Korea|korea
578842|NCT01101542|Safety|safety
578843|NCT01101542|Prescribing Information|prescribing information
578844|NCT01101529|Chemotherapy-induced nausea and vomiting CINV|chemotherapy-induced nausea and vomiting cinv
578845|NCT01101503|Newly diagnosed type 2 diabetes|newly diagnosed type 2 diabetes
578846|NCT01101503|Endothelial dysfunction|endothelial dysfunction
578847|NCT01101503|Intensive therapy|intensive therapy
578848|NCT01101503|Metabolic Memorial Effect|metabolic memorial effect
578849|NCT01101490|To compare the change of cerebral oxygen saturation and blood flow between right and left side in lateral decubitus position during nephrectomy|to compare the change of cerebral oxygen saturation and blood flow between right and left side in lateral decubitus position during nephrectomy
578850|NCT01101477|Target-controlled infusion,|target-controlled infusion,
578851|NCT01101477|bronchoscopy,|bronchoscopy,
578852|NCT01101477|sedation,|sedation,
578853|NCT01101477|propofol|propofol
578854|NCT01101438|stage I breast cancer|stage i breast cancer
579161|NCT01100749|Hepatitis C|hepatitis c
578855|NCT01101438|stage II breast cancer|stage ii breast cancer
578856|NCT01101438|stage IIIA breast cancer|stage iiia breast cancer
578857|NCT01101438|stage IIIC breast cancer|stage iiic breast cancer
578858|NCT01101438|male breast cancer|male breast cancer
578859|NCT01101438|HER2-negative breast cancer|her2-negative breast cancer
578860|NCT01101438|estrogen receptor-positive breast cancer|estrogen receptor-positive breast cancer
578861|NCT01101438|HER2-positive breast cancer|her2-positive breast cancer
578862|NCT01101438|progesterone receptor-positive breast cancer|progesterone receptor-positive breast cancer
578863|NCT01101425|male|male
578864|NCT01101425|breast cancer|breast cancer
578865|NCT01101412|infection|infection
578866|NCT01101412|unspecified adult solid tumor, protocol specific|unspecified adult solid tumor, protocol specific
578867|NCT01101412|accelerated phase chronic myelogenous leukemia|accelerated phase chronic myelogenous leukemia
578868|NCT01101412|acute undifferentiated leukemia|acute undifferentiated leukemia
578869|NCT01101412|adult acute lymphoblastic leukemia in remission|adult acute lymphoblastic leukemia in remission
578870|NCT01101412|adult acute myeloid leukemia in remission|adult acute myeloid leukemia in remission
578871|NCT01101412|adult acute myeloid leukemia with 11q23 (MLL) abnormalities|adult acute myeloid leukemia with 11q23 (mll) abnormalities
578872|NCT01101412|adult acute myeloid leukemia with inv(16)(p13;q22)|adult acute myeloid leukemia with inv(16)(p13;q22)
578873|NCT01101412|adult acute myeloid leukemia with t(15;17)(q22;q12)|adult acute myeloid leukemia with t(15;17)(q22;q12)
578874|NCT01101412|adult acute myeloid leukemia with t(16;16)(p13;q22)|adult acute myeloid leukemia with t(16;16)(p13;q22)
578875|NCT01101412|adult acute myeloid leukemia with t(8;21)(q22;q22)|adult acute myeloid leukemia with t(8;21)(q22;q22)
578876|NCT01101412|atypical chronic myeloid leukemia, BCR-ABL negative|atypical chronic myeloid leukemia, bcr-abl negative
578877|NCT01101412|blastic phase chronic myelogenous leukemia|blastic phase chronic myelogenous leukemia
578878|NCT01101412|chronic myelomonocytic leukemia|chronic myelomonocytic leukemia
578879|NCT01101412|chronic phase chronic myelogenous leukemia|chronic phase chronic myelogenous leukemia
578880|NCT01101412|mast cell leukemia|mast cell leukemia
578881|NCT01101412|meningeal chronic myelogenous leukemia|meningeal chronic myelogenous leukemia
578882|NCT01101412|progressive hairy cell leukemia, initial treatment|progressive hairy cell leukemia, initial treatment
578883|NCT01101412|prolymphocytic leukemia|prolymphocytic leukemia
578884|NCT01101412|recurrent adult acute lymphoblastic leukemia|recurrent adult acute lymphoblastic leukemia
578885|NCT01101412|recurrent adult acute myeloid leukemia|recurrent adult acute myeloid leukemia
578886|NCT01101412|recurrent adult T-cell leukemia/lymphoma|recurrent adult t-cell leukemia/lymphoma
578887|NCT01101412|refractory chronic lymphocytic leukemia|refractory chronic lymphocytic leukemia
578888|NCT01101412|refractory hairy cell leukemia|refractory hairy cell leukemia
578889|NCT01101412|relapsing chronic myelogenous leukemia|relapsing chronic myelogenous leukemia
578890|NCT01101412|secondary acute myeloid leukemia|secondary acute myeloid leukemia
578891|NCT01101412|stage 0 chronic lymphocytic leukemia|stage 0 chronic lymphocytic leukemia
578892|NCT01101412|stage I adult T-cell leukemia/lymphoma|stage i adult t-cell leukemia/lymphoma
578893|NCT01101412|stage I chronic lymphocytic leukemia|stage i chronic lymphocytic leukemia
578894|NCT01101412|stage II adult T-cell leukemia/lymphoma|stage ii adult t-cell leukemia/lymphoma
578895|NCT01101412|stage II chronic lymphocytic leukemia|stage ii chronic lymphocytic leukemia
578896|NCT01101412|stage III adult T-cell leukemia/lymphoma|stage iii adult t-cell leukemia/lymphoma
578897|NCT01101412|stage III chronic lymphocytic leukemia|stage iii chronic lymphocytic leukemia
578898|NCT01101412|stage IV adult T-cell leukemia/lymphoma|stage iv adult t-cell leukemia/lymphoma
578899|NCT01101412|stage IV chronic lymphocytic leukemia|stage iv chronic lymphocytic leukemia
578900|NCT01101412|T-cell large granular lymphocyte leukemia|t-cell large granular lymphocyte leukemia
578901|NCT01101412|untreated adult acute lymphoblastic leukemia|untreated adult acute lymphoblastic leukemia
578902|NCT01101412|untreated adult acute myeloid leukemia|untreated adult acute myeloid leukemia
578903|NCT01101412|untreated hairy cell leukemia|untreated hairy cell leukemia
578904|NCT01101412|recurrent adult Hodgkin lymphoma|recurrent adult hodgkin lymphoma
578905|NCT01101412|stage I adult Hodgkin lymphoma|stage i adult hodgkin lymphoma
578906|NCT01101412|stage II adult Hodgkin lymphoma|stage ii adult hodgkin lymphoma
578907|NCT01101412|stage III adult Hodgkin lymphoma|stage iii adult hodgkin lymphoma
578908|NCT01101412|stage IV adult Hodgkin lymphoma|stage iv adult hodgkin lymphoma
578909|NCT01101412|anaplastic large cell lymphoma|anaplastic large cell lymphoma
578910|NCT01101412|angioimmunoblastic T-cell lymphoma|angioimmunoblastic t-cell lymphoma
578911|NCT01101412|cutaneous B-cell non-Hodgkin lymphoma|cutaneous b-cell non-hodgkin lymphoma
578912|NCT01101412|recurrent cutaneous T-cell non-Hodgkin lymphoma|recurrent cutaneous t-cell non-hodgkin lymphoma
578913|NCT01101412|stage I cutaneous T-cell non-Hodgkin lymphoma|stage i cutaneous t-cell non-hodgkin lymphoma
578914|NCT01101412|stage II cutaneous T-cell non-Hodgkin lymphoma|stage ii cutaneous t-cell non-hodgkin lymphoma
578915|NCT01101412|stage III cutaneous T-cell non-Hodgkin lymphoma|stage iii cutaneous t-cell non-hodgkin lymphoma
578916|NCT01101412|stage IV cutaneous T-cell non-Hodgkin lymphoma|stage iv cutaneous t-cell non-hodgkin lymphoma
578917|NCT01101412|recurrent mycosis fungoides/Sezary syndrome|recurrent mycosis fungoides/sezary syndrome
578918|NCT01101412|stage I mycosis fungoides/Sezary syndrome|stage i mycosis fungoides/sezary syndrome
578919|NCT01101412|stage II mycosis fungoides/Sezary syndrome|stage ii mycosis fungoides/sezary syndrome
578920|NCT01101412|stage III mycosis fungoides/Sezary syndrome|stage iii mycosis fungoides/sezary syndrome
579162|NCT01100749|Genotype 3|genotype 3
578921|NCT01101412|stage IV mycosis fungoides/Sezary syndrome|stage iv mycosis fungoides/sezary syndrome
578922|NCT01101412|adult grade III lymphomatoid granulomatosis|adult grade iii lymphomatoid granulomatosis
578923|NCT01101412|adult nasal type extranodal NK/T-cell lymphoma|adult nasal type extranodal nk/t-cell lymphoma
578924|NCT01101412|Waldenstrom macroglobulinemia|waldenstrom macroglobulinemia
578925|NCT01101412|extranodal marginal zone B-cell lymphoma of mucosa-associated lymphoid tissue|extranodal marginal zone b-cell lymphoma of mucosa-associated lymphoid tissue
578926|NCT01101412|nodal marginal zone B-cell lymphoma|nodal marginal zone b-cell lymphoma
578927|NCT01101412|splenic marginal zone lymphoma|splenic marginal zone lymphoma
578928|NCT01101412|contiguous stage II adult Burkitt lymphoma|contiguous stage ii adult burkitt lymphoma
578929|NCT01101412|contiguous stage II adult diffuse large cell lymphoma|contiguous stage ii adult diffuse large cell lymphoma
578930|NCT01101412|contiguous stage II adult diffuse mixed cell lymphoma|contiguous stage ii adult diffuse mixed cell lymphoma
578931|NCT01101412|contiguous stage II adult diffuse small cleaved cell lymphoma|contiguous stage ii adult diffuse small cleaved cell lymphoma
578932|NCT01101412|contiguous stage II adult immunoblastic large cell lymphoma|contiguous stage ii adult immunoblastic large cell lymphoma
578933|NCT01101412|contiguous stage II adult lymphoblastic lymphoma|contiguous stage ii adult lymphoblastic lymphoma
578934|NCT01101412|contiguous stage II grade 1 follicular lymphoma|contiguous stage ii grade 1 follicular lymphoma
579031|NCT01101360|port wine stains|port wine stains
578935|NCT01101412|contiguous stage II grade 2 follicular lymphoma|contiguous stage ii grade 2 follicular lymphoma
578936|NCT01101412|contiguous stage II grade 3 follicular lymphoma|contiguous stage ii grade 3 follicular lymphoma
578937|NCT01101412|contiguous stage II mantle cell lymphoma|contiguous stage ii mantle cell lymphoma
578938|NCT01101412|contiguous stage II marginal zone lymphoma|contiguous stage ii marginal zone lymphoma
578939|NCT01101412|contiguous stage II small lymphocytic lymphoma|contiguous stage ii small lymphocytic lymphoma
578940|NCT01101412|stage I adult Burkitt lymphoma|stage i adult burkitt lymphoma
578941|NCT01101412|stage I adult diffuse large cell lymphoma|stage i adult diffuse large cell lymphoma
578942|NCT01101412|stage I adult diffuse mixed cell lymphoma|stage i adult diffuse mixed cell lymphoma
578943|NCT01101412|stage I adult diffuse small cleaved cell lymphoma|stage i adult diffuse small cleaved cell lymphoma
578944|NCT01101412|stage I adult immunoblastic large cell lymphoma|stage i adult immunoblastic large cell lymphoma
578945|NCT01101412|stage I adult lymphoblastic lymphoma|stage i adult lymphoblastic lymphoma
578946|NCT01101412|stage I grade 1 follicular lymphoma|stage i grade 1 follicular lymphoma
578947|NCT01101412|stage I grade 2 follicular lymphoma|stage i grade 2 follicular lymphoma
578948|NCT01101412|stage I grade 3 follicular lymphoma|stage i grade 3 follicular lymphoma
578949|NCT01101412|stage I mantle cell lymphoma|stage i mantle cell lymphoma
578950|NCT01101412|stage I marginal zone lymphoma|stage i marginal zone lymphoma
578951|NCT01101412|stage I small lymphocytic lymphoma|stage i small lymphocytic lymphoma
578952|NCT01101412|noncontiguous stage II adult Burkitt lymphoma|noncontiguous stage ii adult burkitt lymphoma
578953|NCT01101412|noncontiguous stage II adult diffuse large cell lymphoma|noncontiguous stage ii adult diffuse large cell lymphoma
578954|NCT01101412|noncontiguous stage II adult diffuse mixed cell lymphoma|noncontiguous stage ii adult diffuse mixed cell lymphoma
578955|NCT01101412|noncontiguous stage II adult diffuse small cleaved cell lymphoma|noncontiguous stage ii adult diffuse small cleaved cell lymphoma
578956|NCT01101412|noncontiguous stage II adult immunoblastic large cell lymphoma|noncontiguous stage ii adult immunoblastic large cell lymphoma
578957|NCT01101412|noncontiguous stage II adult lymphoblastic lymphoma|noncontiguous stage ii adult lymphoblastic lymphoma
578958|NCT01101412|noncontiguous stage II grade 1 follicular lymphoma|noncontiguous stage ii grade 1 follicular lymphoma
578959|NCT01101412|noncontiguous stage II grade 2 follicular lymphoma|noncontiguous stage ii grade 2 follicular lymphoma
578960|NCT01101412|noncontiguous stage II grade 3 follicular lymphoma|noncontiguous stage ii grade 3 follicular lymphoma
578961|NCT01101412|noncontiguous stage II mantle cell lymphoma|noncontiguous stage ii mantle cell lymphoma
578962|NCT01101412|noncontiguous stage II marginal zone lymphoma|noncontiguous stage ii marginal zone lymphoma
578963|NCT01101412|noncontiguous stage II small lymphocytic lymphoma|noncontiguous stage ii small lymphocytic lymphoma
578964|NCT01101412|stage III adult Burkitt lymphoma|stage iii adult burkitt lymphoma
578965|NCT01101412|stage III adult diffuse large cell lymphoma|stage iii adult diffuse large cell lymphoma
578966|NCT01101412|stage III adult diffuse mixed cell lymphoma|stage iii adult diffuse mixed cell lymphoma
578967|NCT01101412|stage III adult diffuse small cleaved cell lymphoma|stage iii adult diffuse small cleaved cell lymphoma
710876|NCT00587483|cardiac surgery|cardiac surgery
578968|NCT01101412|stage III adult immunoblastic large cell lymphoma|stage iii adult immunoblastic large cell lymphoma
578969|NCT01101412|stage III adult lymphoblastic lymphoma|stage iii adult lymphoblastic lymphoma
578970|NCT01101412|stage III grade 1 follicular lymphoma|stage iii grade 1 follicular lymphoma
578971|NCT01101412|stage III grade 2 follicular lymphoma|stage iii grade 2 follicular lymphoma
578972|NCT01101412|stage III grade 3 follicular lymphoma|stage iii grade 3 follicular lymphoma
578973|NCT01101412|stage III mantle cell lymphoma|stage iii mantle cell lymphoma
578974|NCT01101412|stage III marginal zone lymphoma|stage iii marginal zone lymphoma
578975|NCT01101412|stage III small lymphocytic lymphoma|stage iii small lymphocytic lymphoma
578976|NCT01101412|stage IV adult Burkitt lymphoma|stage iv adult burkitt lymphoma
578977|NCT01101412|stage IV adult diffuse large cell lymphoma|stage iv adult diffuse large cell lymphoma
578978|NCT01101412|stage IV adult diffuse mixed cell lymphoma|stage iv adult diffuse mixed cell lymphoma
578979|NCT01101412|stage IV adult diffuse small cleaved cell lymphoma|stage iv adult diffuse small cleaved cell lymphoma
578980|NCT01101412|stage IV adult immunoblastic large cell lymphoma|stage iv adult immunoblastic large cell lymphoma
578981|NCT01101412|stage IV adult lymphoblastic lymphoma|stage iv adult lymphoblastic lymphoma
578982|NCT01101412|stage IV grade 1 follicular lymphoma|stage iv grade 1 follicular lymphoma
578983|NCT01101412|stage IV grade 2 follicular lymphoma|stage iv grade 2 follicular lymphoma
578984|NCT01101412|stage IV grade 3 follicular lymphoma|stage iv grade 3 follicular lymphoma
578985|NCT01101412|stage IV mantle cell lymphoma|stage iv mantle cell lymphoma
578986|NCT01101412|stage IV marginal zone lymphoma|stage iv marginal zone lymphoma
578987|NCT01101412|stage IV small lymphocytic lymphoma|stage iv small lymphocytic lymphoma
578988|NCT01101412|recurrent adult Burkitt lymphoma|recurrent adult burkitt lymphoma
578989|NCT01101412|recurrent adult diffuse large cell lymphoma|recurrent adult diffuse large cell lymphoma
578990|NCT01101412|recurrent adult diffuse mixed cell lymphoma|recurrent adult diffuse mixed cell lymphoma
578991|NCT01101412|recurrent adult diffuse small cleaved cell lymphoma|recurrent adult diffuse small cleaved cell lymphoma
578992|NCT01101412|recurrent adult grade III lymphomatoid granulomatosis|recurrent adult grade iii lymphomatoid granulomatosis
578993|NCT01101412|recurrent adult immunoblastic large cell lymphoma|recurrent adult immunoblastic large cell lymphoma
578994|NCT01101412|recurrent adult lymphoblastic lymphoma|recurrent adult lymphoblastic lymphoma
578995|NCT01101412|recurrent grade 1 follicular lymphoma|recurrent grade 1 follicular lymphoma
578996|NCT01101412|recurrent grade 2 follicular lymphoma|recurrent grade 2 follicular lymphoma
578997|NCT01101412|recurrent grade 3 follicular lymphoma|recurrent grade 3 follicular lymphoma
578998|NCT01101412|recurrent mantle cell lymphoma|recurrent mantle cell lymphoma
578999|NCT01101412|recurrent marginal zone lymphoma|recurrent marginal zone lymphoma
579000|NCT01101412|recurrent small lymphocytic lymphoma|recurrent small lymphocytic lymphoma
579001|NCT01101412|intraocular lymphoma|intraocular lymphoma
579002|NCT01101412|post-transplant lymphoproliferative disorder|post-transplant lymphoproliferative disorder
579003|NCT01101412|chronic eosinophilic leukemia|chronic eosinophilic leukemia
579004|NCT01101412|chronic neutrophilic leukemia|chronic neutrophilic leukemia
579005|NCT01101412|primary myelofibrosis|primary myelofibrosis
579006|NCT01101412|essential thrombocythemia|essential thrombocythemia
579007|NCT01101412|polycythemia vera|polycythemia vera
579008|NCT01101412|extramedullary plasmacytoma|extramedullary plasmacytoma
579009|NCT01101412|isolated plasmacytoma of bone|isolated plasmacytoma of bone
579010|NCT01101412|stage I multiple myeloma|stage i multiple myeloma
579011|NCT01101412|stage II multiple myeloma|stage ii multiple myeloma
579012|NCT01101412|stage III multiple myeloma|stage iii multiple myeloma
579013|NCT01101412|primary systemic amyloidosis|primary systemic amyloidosis
579014|NCT01101412|refractory multiple myeloma|refractory multiple myeloma
579015|NCT01101412|de novo myelodysplastic syndromes|de novo myelodysplastic syndromes
579016|NCT01101412|previously treated myelodysplastic syndromes|previously treated myelodysplastic syndromes
579017|NCT01101412|secondary myelodysplastic syndromes|secondary myelodysplastic syndromes
579018|NCT01101412|myelodysplastic/myeloproliferative neoplasm, unclassifiable|myelodysplastic/myeloproliferative neoplasm, unclassifiable
579019|NCT01101399|Anemia|anemia
579020|NCT01101399|Lymphoproliferative Disorders|lymphoproliferative disorders
579021|NCT01101399|Chemotherapy|chemotherapy
579022|NCT01101399|ferric carboxymaltose|ferric carboxymaltose
579023|NCT01101399|iron|iron
579024|NCT01101386|Voriconazole|voriconazole
579025|NCT01101386|SBECD|sbecd
579026|NCT01101386|pharmacokinetics|pharmacokinetics
579027|NCT01101386|Renal Failure|renal failure
579028|NCT01101373|Limbic surgery|limbic surgery
579029|NCT01101373|Stereotactic surgery|stereotactic surgery
579030|NCT01101373|Major Depressive Disorder: Treatment Refractory|major depressive disorder: treatment refractory
579032|NCT01101360|radiofrequency|radiofrequency
579033|NCT01101360|Pulse Dye Laser|pulse dye laser
579034|NCT01101334|NSCLC|nsclc
579035|NCT01101321|Healthy subjects|healthy subjects
579036|NCT01101321|Opioid|opioid
579037|NCT01101321|Healthy volunteers|healthy volunteers
579038|NCT01101308|Healthy subjects|healthy subjects
579039|NCT01101308|Opioid|opioid
579040|NCT01101308|Healthy volunteers|healthy volunteers
579041|NCT01101295|Immune Thrombocytopenia|immune thrombocytopenia
735868|NCT00489931|Healthy|healthy
579042|NCT01101295|Rituximab|rituximab
579043|NCT01101295|side effects|side effects
579044|NCT01101295|tolerance|tolerance
579045|NCT01101295|safety|safety
579046|NCT01101295|splenectomy|splenectomy
579047|NCT01101295|serum sickness|serum sickness
579048|NCT01101282|PEP|pep
579049|NCT01101282|exacerbation|exacerbation
579050|NCT01101282|physiotherapy|physiotherapy
579051|NCT01101282|airway clearance|airway clearance
579052|NCT01101282|sputum|sputum
579053|NCT01101282|physical Therapy modalities|physical therapy modalities
579054|NCT01101269|Diabetic nephropathy|diabetic nephropathy
579055|NCT01101243|Vitamin D|vitamin d
579056|NCT01101243|UVB|uvb
579057|NCT01101243|Frequency|frequency
579058|NCT01101243|Body surface area|body surface area
579059|NCT01101243|Dose-Response|dose-response
579060|NCT01101230|Cardiovascular disease|cardiovascular disease
579061|NCT01101230|cholesterol|cholesterol
579062|NCT01101230|low-density|low-density
579063|NCT01101230|lipoprotein|lipoprotein
579064|NCT01101230|high-density lipoprotein|high-density lipoprotein
579065|NCT01101230|triglycerides|triglycerides
579066|NCT01101217|hemocystein zinc renal failure|hemocystein zinc renal failure
579067|NCT01101191|Healthy subjects|healthy subjects
579068|NCT01101191|Opioid|opioid
579069|NCT01101191|Healthy volunteers|healthy volunteers
579070|NCT01101178|Healthy subjects|healthy subjects
579071|NCT01101178|Opioid|opioid
579072|NCT01101178|Healthy volunteers|healthy volunteers
579073|NCT01101165|Healthy subjects|healthy subjects
579074|NCT01101165|Opioid|opioid
579075|NCT01101165|Healthy volunteers|healthy volunteers
579076|NCT01101152|Antidepressant|antidepressant
579077|NCT01101152|healthy volunteers|healthy volunteers
579078|NCT01101152|desvenlafaxine succinate|desvenlafaxine succinate
579079|NCT01101152|norepinephrine reuptake|norepinephrine reuptake
579080|NCT01101152|serotonin reuptake|serotonin reuptake
579081|NCT01101152|tyramine test|tyramine test
579082|NCT01101126|Chronic obstructive pulmonary disease (COPD)|chronic obstructive pulmonary disease (copd)
579083|NCT01101126|Asthma|asthma
579084|NCT01101113|peritoneal dialysis|peritoneal dialysis
579085|NCT01101100|Psoriasis|psoriasis
579086|NCT01101087|Dialysis|dialysis
579087|NCT01101074|Swine Flu A (H1N1) vaccine|swine flu a (h1n1) vaccine
579088|NCT01101074|Adjuvanted flu egg derived|adjuvanted flu egg derived
579089|NCT01101074|Novel influenza A (H1N1): a new flu virus of swine origin|novel influenza a (h1n1): a new flu virus of swine origin
579090|NCT01101061|Amgen|amgen
579091|NCT01101061|Phase 1|phase 1
579092|NCT01101061|Postmenopausal|postmenopausal
579093|NCT01101061|Japanese|japanese
579094|NCT01101048|Amgen|amgen
579095|NCT01101048|Phase 1b|phase 1b
579096|NCT01101048|Postmenopausal|postmenopausal
579097|NCT01101048|Bone Mineral Density|bone mineral density
579098|NCT01101035|Cardiovascular Outcomes|cardiovascular outcomes
579099|NCT01101035|Heart Attack|heart attack
579100|NCT01101035|Stroke|stroke
579101|NCT01101035|Drug Therapy|drug therapy
579102|NCT01101035|Physiology|physiology
579103|NCT01101035|Hyperuricemia|hyperuricemia
579104|NCT01101035|Uric Acid|uric acid
579105|NCT01101009|Sevikar®|sevikar®
579106|NCT01101009|Central Arterial Blood Pressure|central arterial blood pressure
579107|NCT01100996|enteral nutrition|enteral nutrition
579108|NCT01100996|endotoxemia|endotoxemia
579109|NCT01100996|innate immunity|innate immunity
579110|NCT01100996|nutritional anti-inflammatory pathway|nutritional anti-inflammatory pathway
579111|NCT01100996|intestinal damage|intestinal damage
579112|NCT01100970|Caesarean section|caesarean section
579113|NCT01100970|cortisol|cortisol
579114|NCT01100970|stress|stress
579115|NCT01100970|unipolar electric needle|unipolar electric needle
579116|NCT01100970|bipolar electric needle|bipolar electric needle
579117|NCT01100944|Gene Expression|gene expression
579118|NCT01100944|HDAC Class I and II enzymes|hdac class i and ii enzymes
579119|NCT01100944|Thymoma|thymoma
579120|NCT01100944|Chemotherapy|chemotherapy
579121|NCT01100944|Hydroxamic Acid Deacetylase Inhibitor|hydroxamic acid deacetylase inhibitor
579122|NCT01100944|Thymic Cancer|thymic cancer
579123|NCT01100931|NSCLC|nsclc
579124|NCT01100931|Solid Tumors|solid tumors
579125|NCT01100931|YM155|ym155
579126|NCT01100931|Survivin|survivin
579127|NCT01100931|Non Small-Cell Lung Cancer|non small-cell lung cancer
579128|NCT01100931|Solid Tumor|solid tumor
579129|NCT01100918|Cardiac resynchronisation therapy|cardiac resynchronisation therapy
579130|NCT01100918|Tissue Doppler Imaging|tissue doppler imaging
579131|NCT01100918|Dyssynchrony|dyssynchrony
579132|NCT01100905|Iron|iron
579133|NCT01100905|Iron status|iron status
579134|NCT01100905|Iron deficiency|iron deficiency
579135|NCT01100905|Iron deficiency anemia|iron deficiency anemia
579136|NCT01100892|Pediatrics|pediatrics
579137|NCT01100892|Pancreas|pancreas
579138|NCT01100879|Anemia|anemia
579139|NCT01100879|Lymphoproliferative Disorders|lymphoproliferative disorders
579140|NCT01100879|Chemotherapy|chemotherapy
579141|NCT01100879|ferric carboxymaltose|ferric carboxymaltose
579142|NCT01100879|iron|iron
579143|NCT01100866|clinically localized Prostate Cancer|clinically localized prostate cancer
579144|NCT01100866|low and intermediate risk for relapse|low and intermediate risk for relapse
579145|NCT01100866|candidates for radical prostatectomy|candidates for radical prostatectomy
579146|NCT01100853|amphetamine dependence|amphetamine dependence
579147|NCT01100853|amphetamine injection|amphetamine injection
579148|NCT01100853|VIVITROL/VIVITROL placebo|vivitrol/vivitrol placebo
579149|NCT01100853|amphetamine craving|amphetamine craving
579150|NCT01100827|EGFR mutation status in patients with advanced stage adenocarcinoma NSCLC|egfr mutation status in patients with advanced stage adenocarcinoma nsclc
579151|NCT01100827|The association between EGFR mutation status and demographic data in advanced stage adenocarcinoma NSCLC patients.|the association between egfr mutation status and demographic data in advanced stage adenocarcinoma nsclc patients.
579152|NCT01100801|advanced|advanced
579153|NCT01100801|metastatic|metastatic
579154|NCT01100775|Galantamine|galantamine
579155|NCT01100775|Schizophrenia|schizophrenia
579156|NCT01100775|working memory|working memory
579157|NCT01100775|cognitive|cognitive
579158|NCT01100762|Parkinson's Disease|parkinson's disease
579159|NCT01100762|Cranial Electric Stimulation|cranial electric stimulation
579160|NCT01100762|Gait|gait
579163|NCT01100749|Demographics|demographics
579164|NCT01100749|Genetics|genetics
579165|NCT01100749|Metabolic status|metabolic status
579166|NCT01100736|Forearm Blood Flow|forearm blood flow
579167|NCT01100736|Vasodilation|vasodilation
579168|NCT01100736|Vasoconstriction|vasoconstriction
579169|NCT01100736|Endothelin System|endothelin system
579170|NCT01100736|Endothelin-1|endothelin-1
579171|NCT01100736|Endothelin-3|endothelin-3
579172|NCT01100736|Endothelin antagonists|endothelin antagonists
579173|NCT01100736|Bosentan|bosentan
579174|NCT01100736|Sitaxsentan|sitaxsentan
579175|NCT01100736|Endothelin|endothelin
579176|NCT01100736|Regional Blood Flow|regional blood flow
579177|NCT01100723|secondary hyperparathyroidism|secondary hyperparathyroidism
579178|NCT01100723|calcium|calcium
579179|NCT01100723|phosphorus|phosphorus
579180|NCT01100723|ESRD|esrd
579181|NCT01100723|CKD|ckd
579182|NCT01100723|mineral disorder|mineral disorder
579183|NCT01100710|Age Gender left ventricular mass high sensitive Troponin T|age gender left ventricular mass high sensitive troponin t
579184|NCT01100697|prenatal diagnosis|prenatal diagnosis
579185|NCT01100697|ultrasound|ultrasound
579186|NCT01100697|outcome|outcome
579187|NCT01100697|spina bifida|spina bifida
579188|NCT01100697|neural tube defect|neural tube defect
579189|NCT01100684|diarrhea predominant irritable bowel syndrome|diarrhea predominant irritable bowel syndrome
579190|NCT01100671|atherosclerosis|atherosclerosis
579191|NCT01100671|vascular inflammation|vascular inflammation
579192|NCT01100671|MDCT|mdct
579193|NCT01100671|18FDG-PET|18fdg-pet
579194|NCT01100606|Exocrine Pancreatic Insufficiency|exocrine pancreatic insufficiency
579195|NCT01100606|Infants with CF|infants with cf
579196|NCT01100593|Ultrasound|ultrasound
579197|NCT01100593|IV catheters|iv catheters
579198|NCT01100593|Extravasation|extravasation
579199|NCT01100580|Low-salt diet|low-salt diet
579200|NCT01100580|calciuria|calciuria
579201|NCT01100580|blood pressure|blood pressure
579202|NCT01100580|nephrolithiasis|nephrolithiasis
579203|NCT01100580|hypertension|hypertension
579204|NCT01100580|BMI|bmi
579205|NCT01100580|urinary stone risk factors|urinary stone risk factors
579206|NCT01100567|skeletal health|skeletal health
579207|NCT01100567|bone turnover|bone turnover
579208|NCT01100567|bone geometry|bone geometry
579209|NCT01100567|malnutrition|malnutrition
579210|NCT01100541|Therapeutic Hyperthermia|therapeutic hyperthermia
579211|NCT01100541|Thermotherapy|thermotherapy
579212|NCT01100541|Polymers|polymers
579213|NCT01100541|Castor Oil|castor oil
579214|NCT01100515|intoxication|intoxication
579215|NCT01100515|carbon monoxide|carbon monoxide
579216|NCT01100515|adults|adults
579217|NCT01100515|domestic accident|domestic accident
579218|NCT01100515|acute domestic carbon monoxide poisoning|acute domestic carbon monoxide poisoning
579219|NCT01100502|Antigens, CD30|antigens, cd30
579220|NCT01100502|Antibody-Drug Conjugate|antibody-drug conjugate
579221|NCT01100502|Antibodies, Monoclonal|antibodies, monoclonal
579222|NCT01100502|Disease, Hodgkin|disease, hodgkin
579223|NCT01100502|Drug Therapy|drug therapy
579224|NCT01100502|Hematologic Diseases|hematologic diseases
579225|NCT01100502|Immunotherapy|immunotherapy
579226|NCT01100502|Lymphoma|lymphoma
579227|NCT01100502|Monomethylauristatin E|monomethylauristatin e
579228|NCT01100476|Closure Device|closure device
579229|NCT01100476|endovascular procedures|endovascular procedures
579230|NCT01100476|sealing femoral arterial access|sealing femoral arterial access
579231|NCT01100476|Mynx M5|mynx m5
579232|NCT01100463|HFS, Hand-Foot Syndrome, Capecitabine, Breast Cancer|hfs, hand-foot syndrome, capecitabine, breast cancer
579233|NCT01100450|bariatric surgery|bariatric surgery
579234|NCT01100450|class III obesity|class iii obesity
579235|NCT01100450|resistance training|resistance training
579236|NCT01100450|strength|strength
579237|NCT01100450|fitness|fitness
579238|NCT01100437|opioid|opioid
579239|NCT01100437|morphine|morphine
579240|NCT01100437|naltrexone|naltrexone
579241|NCT01100437|withdrawal signs|withdrawal signs
579242|NCT01100437|withdrawal symptoms|withdrawal symptoms
579243|NCT01100424|Contact lenses|contact lenses
579244|NCT01100424|Contact lens solution|contact lens solution
579245|NCT01100424|Corneal staining|corneal staining
579246|NCT01100411|Contact lenses, myopia, lens geometry|contact lenses, myopia, lens geometry
579247|NCT01100398|Fatty liver disease|fatty liver disease
579248|NCT01100385|Healthy adults|healthy adults
579249|NCT01100372|recurrent ovarian epithelial cancer|recurrent ovarian epithelial cancer
579250|NCT01100372|recurrent fallopian tube cancer|recurrent fallopian tube cancer
579251|NCT01100372|recurrent primary peritoneal cavity cancer|recurrent primary peritoneal cavity cancer
579252|NCT01100359|endometrial clear cell carcinoma|endometrial clear cell carcinoma
579253|NCT01100359|recurrent endometrial carcinoma|recurrent endometrial carcinoma
579254|NCT01100359|stage IIIA endometrial carcinoma|stage iiia endometrial carcinoma
579255|NCT01100359|stage IIIB endometrial carcinoma|stage iiib endometrial carcinoma
579256|NCT01100359|stage IIIC endometrial carcinoma|stage iiic endometrial carcinoma
579257|NCT01100359|stage IVA endometrial carcinoma|stage iva endometrial carcinoma
579258|NCT01100359|stage IVB endometrial carcinoma|stage ivb endometrial carcinoma
579259|NCT01100346|Ovulation induction|ovulation induction
579260|NCT01100346|Intrauterine insemination|intrauterine insemination
579261|NCT01100346|Gonal-f|gonal-f
579262|NCT01100346|Controlled ovarian stimulation|controlled ovarian stimulation
579263|NCT01100346|Infertility|infertility
579264|NCT01100333|Infertility|infertility
579265|NCT01100333|Reproductive technologies, Assisted|reproductive technologies, assisted
579266|NCT01100333|r-hFSH|r-hfsh
579267|NCT01100333|Gonal-f|gonal-f
579268|NCT01100320|Healthy subjects|healthy subjects
579269|NCT01100320|Opioid|opioid
579270|NCT01100307|diabetic macular edema|diabetic macular edema
579271|NCT01100307|Macugen|macugen
579272|NCT01100307|sham-controlled study|sham-controlled study
579273|NCT01100294|Influenza|influenza
579274|NCT01100294|Pandemic vaccine|pandemic vaccine
579275|NCT01100294|Seasonal vaccine|seasonal vaccine
579276|NCT01100294|Prevention|prevention
579277|NCT01100294|Influenza vaccine|influenza vaccine
579278|NCT01100294|Influenza in humans|influenza in humans
579279|NCT01100294|Pandemic influenza in humans|pandemic influenza in humans
579280|NCT01100294|Influenza vaccine for children|influenza vaccine for children
579281|NCT01100281|prefrontal cortex|prefrontal cortex
579282|NCT01100268|Hoarding|hoarding
579283|NCT01100255|OCD|ocd
579284|NCT01100242|Renal Cell Carcinoma|renal cell carcinoma
579285|NCT01100242|metastatic renal cell cancer|metastatic renal cell cancer
579286|NCT01100242|kidney cancer|kidney cancer
579287|NCT01100216|smokeless tobacco|smokeless tobacco
579288|NCT01100216|nicotine|nicotine
579289|NCT01100216|snus|snus
579290|NCT01100216|snuff|snuff
579291|NCT01100216|chewing tobacco|chewing tobacco
579292|NCT01100216|oral tobacco|oral tobacco
579293|NCT01100203|aldosterone receptor inhibition|aldosterone receptor inhibition
579294|NCT01100203|arterial stiffness|arterial stiffness
579295|NCT01100203|ambulatory arterial stiffness index|ambulatory arterial stiffness index
579296|NCT01100190|Facelift|facelift
579297|NCT01100190|Rhytidectomy|rhytidectomy
579298|NCT01100190|Ptosis|ptosis
579299|NCT01100177|Patients with non resectable Glioblastoma who have only a|patients with non resectable glioblastoma who have only a
579300|NCT01100177|biopsy as surgical treatment|biopsy as surgical treatment
579301|NCT01100164|INSOMNIA|insomnia
579302|NCT01100164|FOR THE TREATMENT OF INSOMNIA|for the treatment of insomnia
579303|NCT01100151|Opioid-induced constipation|opioid-induced constipation
579304|NCT01100151|RDC-1036|rdc-1036
579305|NCT01100151|ALKS 37|alks 37
579306|NCT01100125|Diabetes|diabetes
579307|NCT01100125|Sitagliptin|sitagliptin
579308|NCT01100125|insulin|insulin
579309|NCT01100125|C-peptide|c-peptide
579310|NCT01100112|ulcerative colitis|ulcerative colitis
579311|NCT01100112|Budesonide|budesonide
579312|NCT01100099|Celiac disease.|celiac disease.
579313|NCT01100099|Food intolerance.|food intolerance.
579314|NCT01100099|Gluten intolerance without celiac disease.|gluten intolerance without celiac disease.
579315|NCT01100086|Healthy subjects|healthy subjects
579316|NCT01100086|Opioid|opioid
579317|NCT01100060|Azithromycin|azithromycin
579318|NCT01100060|chloroquine|chloroquine
579319|NCT01100060|microsphere|microsphere
579320|NCT01100060|pharmacokinetics|pharmacokinetics
579321|NCT01100060|bioavailability|bioavailability
579322|NCT01100047|Phase I|phase i
579323|NCT01100047|Japanese healthy volunteer|japanese healthy volunteer
579324|NCT01100047|AZD5069|azd5069
579325|NCT01100034|pediatric psoriasis|pediatric psoriasis
579326|NCT01100034|etanercept|etanercept
579327|NCT01100034|PASS|pass
579328|NCT01100034|safety|safety
579329|NCT01100034|effectiveness|effectiveness
579330|NCT01100008|Pulmonary arterial hypertension|pulmonary arterial hypertension
579331|NCT01100008|cardiac MRI (magnetic resonance imaging)|cardiac mri (magnetic resonance imaging)
579332|NCT01100008|severity|severity
579333|NCT01100008|prognosis|prognosis
579334|NCT01099995|domestic accident|domestic accident
579335|NCT01099995|coma|coma
579336|NCT01099995|carbon monoxide|carbon monoxide
579337|NCT01099995|intoxication|intoxication
579338|NCT01099995|acute domestic carbon monoxide poisoning|acute domestic carbon monoxide poisoning
579339|NCT01099982|Congestive Heart Failure|congestive heart failure
579340|NCT01099982|Left Ventricular Assist Device|left ventricular assist device
579341|NCT01099982|LVAD|lvad
579342|NCT01099982|Myocardium|myocardium
579343|NCT01099982|Remodeling|remodeling
579344|NCT01099982|Microvasculature|microvasculature
579345|NCT01099982|Fibrosis|fibrosis
579346|NCT01099982|Cardiac Transplant|cardiac transplant
579347|NCT01099969|Endotrol Endotracheal tube|endotrol endotracheal tube
579348|NCT01099969|Regular endotracheal tube|regular endotracheal tube
579349|NCT01099969|gliderite stylet|gliderite stylet
579350|NCT01099969|McGrath videolaryngoscope|mcgrath videolaryngoscope
579351|NCT01099969|Glidescope|glidescope
579352|NCT01099956|type 1 diabetes|type 1 diabetes
579353|NCT01099956|children|children
579354|NCT01099956|low grade inflammation|low grade inflammation
579355|NCT01099956|cytokine|cytokine
579356|NCT01099956|CRP|crp
579357|NCT01099930|immunoablation|immunoablation
579358|NCT01099930|stem cell transplantation|stem cell transplantation
579359|NCT01099917|MDS|mds
579360|NCT01099917|Maitake|maitake
579361|NCT01099917|mushroom|mushroom
579362|NCT01099917|09-094|09-094
579363|NCT01099878|Cycling Exercise|cycling exercise
579364|NCT01099878|Functional Electrical Stimulation|functional electrical stimulation
579365|NCT01099878|Stroke|stroke
579366|NCT01099852|dengue|dengue
579367|NCT01099852|fever|fever
579368|NCT01099852|dengue hemorrhagic fever|dengue hemorrhagic fever
579369|NCT01099852|dengue virus|dengue virus
579370|NCT01099852|Chikungunya virus|chikungunya virus
579371|NCT01099852|Zika Virus|zika virus
579372|NCT01099852|Joint pain|joint pain
579373|NCT01099839|ASP1941|asp1941
579374|NCT01099839|Miglitol|miglitol
579375|NCT01099826|colorectal cancer screening|colorectal cancer screening
579376|NCT01099826|tailored education|tailored education
579377|NCT01099826|motivational interview|motivational interview
579378|NCT01099826|patient education|patient education
579379|NCT01099813|Critical Illness|critical illness
579380|NCT01099813|Sepsis|sepsis
579381|NCT01099813|Duration|duration
579382|NCT01099813|Severity of Illness Scores|severity of illness scores
579383|NCT01099813|Trajectory|trajectory
579384|NCT01099800|asthma|asthma
579385|NCT01099800|health disparities|health disparities
579386|NCT01099800|illness representations|illness representations
579387|NCT01099800|CAM|cam
579388|NCT01099800|Latino|latino
579389|NCT01099748|Drug interaction|drug interaction
579390|NCT01099748|pharmacokinetics|pharmacokinetics
579391|NCT01099748|lersivirine|lersivirine
579392|NCT01099748|methadone|methadone
579393|NCT01099735|Bariatric Surgery|bariatric surgery
579394|NCT01099735|Sleep Apnea|sleep apnea
579395|NCT01099735|Gastroesophageal Reflux Disease|gastroesophageal reflux disease
579396|NCT01099735|GERD|gerd
579397|NCT01099722|moderate to severe persistent reversible asthma|moderate to severe persistent reversible asthma
579398|NCT01099709|healthy subjects|healthy subjects
579399|NCT01099709|opioid|opioid
579400|NCT01099696|abdominal discomfort and bloating|abdominal discomfort and bloating
579401|NCT01099644|Peritoneum|peritoneum
579402|NCT01099644|Desmoplastic Small Round Cell Tumors|desmoplastic small round cell tumors
579403|NCT01099644|Intraperitoneal Radioimmunotherapy|intraperitoneal radioimmunotherapy
579404|NCT01099644|131 I-8H9|131 i-8h9
579405|NCT01099644|09-090|09-090
579406|NCT01099631|Salmonella typhimurium|salmonella typhimurium
579407|NCT01099631|unresectable hepatic cancer|unresectable hepatic cancer
579408|NCT01099631|attenuated Salmonella typhimurium|attenuated salmonella typhimurium
579409|NCT01099631|IL-2|il-2
579410|NCT01099605|hemorrhoidectomy|hemorrhoidectomy
579411|NCT01099605|pain management|pain management
579412|NCT01099579|HIV, Pediatric|hiv, pediatric
579413|NCT01099566|human endotoxemia|human endotoxemia
579414|NCT01099566|tissue factor induced coagulation|tissue factor induced coagulation
579415|NCT01099566|platelet activation|platelet activation
579416|NCT01099566|thienopyridines|thienopyridines
579417|NCT01099553|Educational video|educational video
579418|NCT01099553|colonoscopy|colonoscopy
579419|NCT01099553|bowel preparation|bowel preparation
579420|NCT01099553|Bowel preparation for colonoscopy|bowel preparation for colonoscopy
579421|NCT01099540|neuroendocrine tumor|neuroendocrine tumor
579422|NCT01099527|gastric cancer|gastric cancer
579423|NCT01099527|refractory|refractory
579424|NCT01099527|metastatic|metastatic
579425|NCT01099501|Mechanical Ventilation|mechanical ventilation
579426|NCT01099488|Immunological assays|immunological assays
579427|NCT01099475|liver surgery|liver surgery
579428|NCT01099475|pringle manoeuvre|pringle manoeuvre
579429|NCT01099475|hepatocellular damage|hepatocellular damage
579430|NCT01099475|surgical complications|surgical complications
579431|NCT01099475|patients requiring liver surgery|patients requiring liver surgery
579432|NCT01099462|fever|fever
579433|NCT01099462|Ibuprofen|ibuprofen
579434|NCT01099449|neurotoxicity|neurotoxicity
579435|NCT01099449|neuropathy|neuropathy
579436|NCT01099449|chemotherapeutic agent toxicity|chemotherapeutic agent toxicity
579437|NCT01099449|stage II colon cancer|stage ii colon cancer
579438|NCT01099449|stage III colon cancer|stage iii colon cancer
579439|NCT01099449|stage IV colon cancer|stage iv colon cancer
579440|NCT01099449|stage II rectal cancer|stage ii rectal cancer
579441|NCT01099449|stage III rectal cancer|stage iii rectal cancer
579442|NCT01099449|stage IV rectal cancer|stage iv rectal cancer
579443|NCT01099449|adenocarcinoma of the colon|adenocarcinoma of the colon
579444|NCT01099449|adenocarcinoma of the rectum|adenocarcinoma of the rectum
579445|NCT01099436|HER2-negative breast cancer|her2-negative breast cancer
579446|NCT01099436|stage II breast cancer|stage ii breast cancer
579447|NCT01099436|stage IIIA breast cancer|stage iiia breast cancer
579448|NCT01099436|stage IIIB breast cancer|stage iiib breast cancer
579449|NCT01099436|stage IIIC breast cancer|stage iiic breast cancer
579450|NCT01099423|clear cell renal cell carcinoma|clear cell renal cell carcinoma
579451|NCT01099423|stage IV renal cell cancer|stage iv renal cell cancer
579452|NCT01099410|macrophages, alveolar|macrophages, alveolar
579453|NCT01099410|monocytes|monocytes
579454|NCT01099410|Receptor Protein-Tyrosine Kinases|receptor protein-tyrosine kinases
579455|NCT01099410|Humans|humans
579456|NCT01099410|Phagocytosis|phagocytosis
579457|NCT01099410|Lung|lung
579458|NCT01099410|in vitro|in vitro
579459|NCT01099397|Glucose|glucose
579460|NCT01099397|Glucose Tolerance Test|glucose tolerance test
579461|NCT01099397|Insulin Resistance|insulin resistance
579462|NCT01099397|Metabolic adverse effects|metabolic adverse effects
579463|NCT01099397|Hypertension|hypertension
579464|NCT01099397|Beta-blocker|beta-blocker
579465|NCT01099397|Atenolol|atenolol
579466|NCT01099397|Diuretic|diuretic
579467|NCT01099397|Hydrochlorothiazide|hydrochlorothiazide
579468|NCT01099397|Blood pressure|blood pressure
579469|NCT01099371|Knee|knee
579470|NCT01099371|Osteoarthritis|osteoarthritis
579471|NCT01099371|Exercise|exercise
579472|NCT01099358|Cancer of Head|cancer of head
579473|NCT01099358|Cancer of Head and Neck|cancer of head and neck
579474|NCT01099358|Cancer of Neck|cancer of neck
579475|NCT01099358|Cancer of the Head|cancer of the head
579476|NCT01099358|Cancer of the Head and Neck|cancer of the head and neck
579477|NCT01099358|Cancer of the Neck|cancer of the neck
579478|NCT01099358|Head and Neck Cancer|head and neck cancer
579479|NCT01099358|Head Cancer|head cancer
579480|NCT01099358|Head Neoplasms|head neoplasms
579481|NCT01099358|Head, Neck Neoplasms|head, neck neoplasms
579482|NCT01099358|Neck Cancer|neck cancer
579483|NCT01099358|Neck Neoplasms|neck neoplasms
579484|NCT01099358|Solid Neoplasm|solid neoplasm
579485|NCT01099358|Carcinoma|carcinoma
579486|NCT01099358|Sarcoma|sarcoma
579487|NCT01099345|OAB|oab
579488|NCT01099345|Nocturia|nocturia
579489|NCT01099345|Bladder function|bladder function
579490|NCT01099345|cystometry|cystometry
579491|NCT01099345|polysomnography|polysomnography
579492|NCT01099332|Alzheimer's disease|alzheimer's disease
579493|NCT01099332|Mild Cognitive Impairment|mild cognitive impairment
579494|NCT01099332|Copper metabolism|copper metabolism
579495|NCT01099332|Zinc metabolism|zinc metabolism
579496|NCT01099332|Ceruloplasmin|ceruloplasmin
579497|NCT01099319|Dietary supplement|dietary supplement
579498|NCT01099319|Renalof|renalof
579499|NCT01099319|gallstones|gallstones
579500|NCT01099319|elderly|elderly
579501|NCT01099293|Hepatic Encephalopathy|hepatic encephalopathy
579502|NCT01099293|Psychometric Hepatic Encephalopathy Score|psychometric hepatic encephalopathy score
579503|NCT01099293|Critical Flicker Frequency|critical flicker frequency
579504|NCT01099293|Cerebrovascular Reactivity|cerebrovascular reactivity
579505|NCT01099293|Endotoxemia|endotoxemia
579506|NCT01099293|Transcranial Doppler|transcranial doppler
579507|NCT01099293|Liver Cirrhosis|liver cirrhosis
579508|NCT01099280|induction of labor in term|induction of labor in term
579509|NCT01099280|premature rupture of membranes|premature rupture of membranes
579510|NCT01099280|dinoprostone|dinoprostone
579511|NCT01099280|oxytocin|oxytocin
579512|NCT01099267|MDS|mds
579513|NCT01099254|CVP|cvp
579514|NCT01099254|US|us
579515|NCT01099254|Trendelenburg position|trendelenburg position
579516|NCT01099254|Ultrasound|ultrasound
579517|NCT01099254|Head Down Tilt|head down tilt
579518|NCT01099241|CVP|cvp
579519|NCT01099241|US|us
579520|NCT01099241|Ultrasonography|ultrasonography
579521|NCT01099228|Neuroendocrine Tumor|neuroendocrine tumor
579522|NCT01099228|Imaging|imaging
579523|NCT01099215|peripheral artery disease|peripheral artery disease
579524|NCT01099215|percutaneous transluminal angioplasty|percutaneous transluminal angioplasty
579525|NCT01099215|stent|stent
579526|NCT01099215|balloon/stent|balloon/stent
579527|NCT01099215|superficial femoral artery|superficial femoral artery
579528|NCT01099202|Procrit|procrit
579529|NCT01099202|Acute Lymphocytic Leukemia|acute lymphocytic leukemia
579530|NCT01099202|Lymphoblastic Lymphoma|lymphoblastic lymphoma
579531|NCT01099202|Burkitt's|burkitt's
579532|NCT01099202|Chemotherapy|chemotherapy
579533|NCT01099202|Hyper-CVAD|hyper-cvad
579534|NCT01099202|augmented BFM|augmented bfm
579535|NCT01099202|Epoetin alfa|epoetin alfa
579536|NCT01099202|Epogen|epogen
579537|NCT01099202|Erythropoietin|erythropoietin
579538|NCT01099189|Histology|histology
579539|NCT01099189|Compliance|compliance
579540|NCT01099189|Dialysis|dialysis
579541|NCT01099189|Arteriovenous access fistula|arteriovenous access fistula
579542|NCT01099189|vein|vein
579543|NCT01099176|hyperlipidemia|hyperlipidemia
579544|NCT01099176|impaired fasting glycemia|impaired fasting glycemia
579545|NCT01099176|adipokines|adipokines
579546|NCT01099176|atorvastatin|atorvastatin
579547|NCT01099176|fenofibrate|fenofibrate
579548|NCT01099163|Diabetes mellitus|diabetes mellitus
579549|NCT01099163|CLA|cla
579550|NCT01099163|Antioxidant|antioxidant
579551|NCT01099163|Glycemic control|glycemic control
579552|NCT01099150|Platelets|platelets
579553|NCT01099150|Platelet aggregation|platelet aggregation
579554|NCT01099150|Platelet activation|platelet activation
579555|NCT01099150|Platelet function|platelet function
579556|NCT01099150|Light transmission aggregometry|light transmission aggregometry
579557|NCT01099150|Platelet Function Analyzer-100 (PFA-100)|platelet function analyzer-100 (pfa-100)
579558|NCT01099150|P-selectin|p-selectin
579559|NCT01099150|Fibrinogen receptor|fibrinogen receptor
579560|NCT01099150|Glycoprotein IIb-IIIa|glycoprotein iib-iiia
579561|NCT01099150|Chocolate|chocolate
579562|NCT01099150|Cocoa|cocoa
579563|NCT01099150|Flavan-3-ols|flavan-3-ols
579564|NCT01099150|Procyanidins|procyanidins
579565|NCT01099137|Diabetes|diabetes
579566|NCT01099137|Vildagliptin|vildagliptin
579567|NCT01099137|insulin|insulin
579568|NCT01099137|C-peptide|c-peptide
579569|NCT01099124|M2ES|m2es
579570|NCT01099124|NSCLC|nsclc
579571|NCT01099124|Phase I Trial|phase i trial
579572|NCT01099124|Advanced NSCLC|advanced nsclc
579573|NCT01099124|Recurrent NSCLC|recurrent nsclc
579574|NCT01099111|IBS|ibs
579575|NCT01099111|UC|uc
579576|NCT01099111|CD|cd
579577|NCT01099111|CRAP/CRC|crap/crc
579578|NCT01099098|People who have fibrosis or nodules in their upper lobe of the lung|people who have fibrosis or nodules in their upper lobe of the lung
579579|NCT01099085|gastric cancer, unresectable/metastatic|gastric cancer, unresectable/metastatic
579580|NCT01099072|ADHD|adhd
579581|NCT01099072|carnitine|carnitine
579582|NCT01099072|methylphenidate|methylphenidate
579583|NCT01099059|Attention-deficit/hyperactivity disorder|attention-deficit/hyperactivity disorder
579584|NCT01099059|Clinical Trial|clinical trial
579585|NCT01099059|Amantadine|amantadine
579586|NCT01099059|Methylphenidate|methylphenidate
579587|NCT01099046|Meniere's disease|meniere's disease
579588|NCT01099046|stress management|stress management
579589|NCT01099046|vasopressin|vasopressin
579590|NCT01099046|V2 receptor|v2 receptor
579591|NCT01099046|water intake|water intake
579592|NCT01099046|tympanic tubing|tympanic tubing
579593|NCT01099046|regular sleep under dark|regular sleep under dark
579594|NCT01099033|hiatal hernia|hiatal hernia
579595|NCT01099033|paraesophageal hernia|paraesophageal hernia
579596|NCT01099033|biologic mesh|biologic mesh
579597|NCT01099033|MMPs|mmps
579598|NCT01099033|Hiatal/Paraesophageal hernia|hiatal/paraesophageal hernia
579599|NCT01099020|Subjects receiving large volumes of Radiation|subjects receiving large volumes of radiation
579600|NCT01099007|Women|women
579601|NCT01099007|Menopause|menopause
579602|NCT01099007|Cardiovascular Disease|cardiovascular disease
579603|NCT01099007|Physical Activity|physical activity
579604|NCT01099007|Weight Loss|weight loss
579605|NCT01098994|Type 1 diabetes|type 1 diabetes
579606|NCT01098994|Haptoglobin genotype|haptoglobin genotype
579607|NCT01098994|HDL function|hdl function
579608|NCT01098994|Heart disease|heart disease
579609|NCT01098994|Feasibility of clinical trial|feasibility of clinical trial
579610|NCT01098955|Cancer|cancer
579611|NCT01098955|Smoking Cessation Treatment|smoking cessation treatment
579612|NCT01098955|Acceptance and Commitment Therapy|acceptance and commitment therapy
579613|NCT01098955|ACT Theory|act theory
579614|NCT01098955|Motivational and Behavioral Counseling|motivational and behavioral counseling
579615|NCT01098955|MBC|mbc
579616|NCT01098955|abstinence|abstinence
579617|NCT01098955|Varenicline|varenicline
579618|NCT01098955|Chantix|chantix
579619|NCT01098942|bariatric surgery|bariatric surgery
579620|NCT01098929|genes|genes
579621|NCT01098929|genetic|genetic
579622|NCT01098929|chromosome|chromosome
579623|NCT01098929|chromosome microarray|chromosome microarray
579624|NCT01098916|hospital at home|hospital at home
579625|NCT01098916|radiology at home|radiology at home
579626|NCT01098916|frail elderly|frail elderly
579627|NCT01098903|sunitinib|sunitinib
579628|NCT01098903|cancer|cancer
579629|NCT01098903|pharmacogenomics|pharmacogenomics
579630|NCT01098903|pharmacokinetics|pharmacokinetics
579631|NCT01098903|Patients who have a malignancy and are going to be treated with sunitinib|patients who have a malignancy and are going to be treated with sunitinib
579632|NCT01098903|doseindividualism|doseindividualism
579633|NCT01098877|Phase1|phase1
579634|NCT01098877|pharmacokinetics|pharmacokinetics
579635|NCT01098877|safety|safety
579636|NCT01098877|toleration|toleration
579637|NCT01098877|pharmacodynamics|pharmacodynamics
579638|NCT01098864|Behavior|behavior
579639|NCT01098864|Impulsivity|impulsivity
579640|NCT01098864|Transcranial Magnetic Stimulation|transcranial magnetic stimulation
579641|NCT01098851|Obstructive Sleep Apnea|obstructive sleep apnea
579642|NCT01098851|Pulse Oximetry|pulse oximetry
579643|NCT01098838|Cancer|cancer
579644|NCT01098838|adults|adults
579645|NCT01098838|solid tumor|solid tumor
579646|NCT01098838|apoptosis|apoptosis
579647|NCT01098838|programmed cell death|programmed cell death
579648|NCT01098838|LCL161|lcl161
579649|NCT01098825|vaccine hesitancy|vaccine hesitancy
579650|NCT01098825|vaccine refusal|vaccine refusal
579651|NCT01098812|Cataract, Intraocular lens|cataract, intraocular lens
579652|NCT01098799|Urotensin II,Chronic renal disease|urotensin ii,chronic renal disease
579653|NCT01098786|Influenza A|influenza a
579654|NCT01098786|H1N1 subtype|h1n1 subtype
579655|NCT01098786|Vaccine|vaccine
579656|NCT01098786|Adjuvant|adjuvant
579657|NCT01098786|Cell culture|cell culture
579658|NCT01098773|Weaning from mechanical ventilation|weaning from mechanical ventilation
579659|NCT01098773|BNP|bnp
579660|NCT01098773|Lung ultrasound|lung ultrasound
579661|NCT01098773|Echocardiography|echocardiography
579662|NCT01098760|Sorafenib|sorafenib
580035|NCT01097031|pediatric|pediatric
579663|NCT01098760|Hepatocellular Carcinoma (HCC)|hepatocellular carcinoma (hcc)
579664|NCT01098747|Pain following third molar extraction|pain following third molar extraction
579665|NCT01098734|non-steroid|non-steroid
579666|NCT01098734|anti-inflammatory|anti-inflammatory
579667|NCT01098734|skin disease|skin disease
579668|NCT01098734|topical cream|topical cream
579669|NCT01098734|small molecule|small molecule
579670|NCT01098734|atopic dermatitis|atopic dermatitis
579671|NCT01098734|eczema|eczema
579672|NCT01098721|plaque psoriasis|plaque psoriasis
579673|NCT01098721|skin diseases|skin diseases
579674|NCT01098721|anti-inflammatory|anti-inflammatory
579675|NCT01098721|non-steroid|non-steroid
579676|NCT01098721|topical cream|topical cream
579678|NCT01098708|non ambulatory|non ambulatory
579679|NCT01098695|parenting interventions|parenting interventions
579680|NCT01098695|Family Check-Up|family check-up
579681|NCT01098695|Early Intervention|early intervention
579682|NCT01098695|Self-Regulation|self-regulation
579683|NCT01098669|cancer survivor|cancer survivor
579684|NCT01098669|lymphedema|lymphedema
579685|NCT01098669|head and neck cancer|head and neck cancer
579686|NCT01098656|stage III mycosis fungoides/Sezary syndrome|stage iii mycosis fungoides/sezary syndrome
579687|NCT01098656|stage IV mycosis fungoides/Sezary syndrome|stage iv mycosis fungoides/sezary syndrome
579688|NCT01098656|stage II mycosis fungoides/Sezary syndrome|stage ii mycosis fungoides/sezary syndrome
579689|NCT01098656|stage II cutaneous T-cell non-Hodgkin lymphoma|stage ii cutaneous t-cell non-hodgkin lymphoma
579690|NCT01098656|stage III cutaneous T-cell non-Hodgkin lymphoma|stage iii cutaneous t-cell non-hodgkin lymphoma
579691|NCT01098656|stage IV cutaneous T-cell non-Hodgkin lymphoma|stage iv cutaneous t-cell non-hodgkin lymphoma
579692|NCT01098643|unspecified adult solid tumor, protocol specific|unspecified adult solid tumor, protocol specific
579693|NCT01098617|endoscopic sphincterotomy|endoscopic sphincterotomy
579694|NCT01098617|hemorrhage|hemorrhage
579695|NCT01098617|nonsteroidal antiinflammatory agents|nonsteroidal antiinflammatory agents
579696|NCT01098617|antiaggregants|antiaggregants
579697|NCT01098617|anticoagulants|anticoagulants
579698|NCT01098617|Endoscopic biliary sphincterotomy induced bleeding|endoscopic biliary sphincterotomy induced bleeding
579699|NCT01098591|meta-analysis|meta-analysis
579700|NCT01098591|stem cell|stem cell
579701|NCT01098591|cardiac|cardiac
579702|NCT01098591|remodeling|remodeling
579703|NCT01098591|MESS|mess
579704|NCT01098578|Posterior Epistaxis|posterior epistaxis
579705|NCT01098552|Prostate Cancer|prostate cancer
579706|NCT01098539|sitagliptin|sitagliptin
579707|NCT01098539|albiglutide|albiglutide
579708|NCT01098539|renal impairment|renal impairment
579709|NCT01098526|GSK1349572|gsk1349572
579710|NCT01098526|efavirenz|efavirenz
579711|NCT01098526|integrase|integrase
579712|NCT01098526|pharmacokinetics|pharmacokinetics
579713|NCT01098513|HIV|hiv
579714|NCT01098513|healthy|healthy
579715|NCT01098513|GSK1349572|gsk1349572
579716|NCT01098500|Liver function|liver function
579717|NCT01098500|Tyrosine Kinase Inhibitor|tyrosine kinase inhibitor
579718|NCT01098487|Immune (idiopathic) thrombocytopenic purpura (ITP)|immune (idiopathic) thrombocytopenic purpura (itp)
579719|NCT01098487|bone marrow fibers|bone marrow fibers
579720|NCT01098487|eltrombopag olamine|eltrombopag olamine
579721|NCT01098487|thrombopoietin receptor agonist|thrombopoietin receptor agonist
579722|NCT01098474|Tuberculosis vaccine|tuberculosis vaccine
579723|NCT01098461|dose-ranging|dose-ranging
579724|NCT01098461|pharmacokinetics|pharmacokinetics
579725|NCT01098461|GSK716155|gsk716155
579726|NCT01098461|Japan|japan
579727|NCT01098461|albiglutide|albiglutide
579728|NCT01098448|Amoxicillin|amoxicillin
579729|NCT01098448|antibiotics|antibiotics
579730|NCT01098448|chronic periodontitis|chronic periodontitis
579731|NCT01098448|local drug delivery|local drug delivery
579732|NCT01098448|metronidazol|metronidazol
579733|NCT01098448|randomized controlled trial|randomized controlled trial
579734|NCT01098448|subgingival scaling|subgingival scaling
579735|NCT01098448|surgery|surgery
579736|NCT01098448|tetracycline|tetracycline
579737|NCT01098448|moderate to advanced chronic periodontitis|moderate to advanced chronic periodontitis
579738|NCT01098435|Binge eating disorder|binge eating disorder
579739|NCT01098435|RDC-0313|rdc-0313
579740|NCT01098422|liver|liver
579741|NCT01098422|colorectal|colorectal
579742|NCT01098422|metastasis|metastasis
579743|NCT01098422|carcinoma|carcinoma
579744|NCT01098422|Yttrium-90|yttrium-90
579745|NCT01098422|microspheres|microspheres
579746|NCT01098409|sodium nitrite|sodium nitrite
579747|NCT01098409|coronary artery bypass surgery|coronary artery bypass surgery
579748|NCT01098409|cardioprotection|cardioprotection
579749|NCT01098409|myocardial injury|myocardial injury
579750|NCT01098396|parkinson disease|parkinson disease
579751|NCT01098396|gait|gait
579752|NCT01098383|Autism|autism
579753|NCT01098357|rhPDGF, diabetic foot ulcer,|rhpdgf, diabetic foot ulcer,
579754|NCT01098344|stage III pancreatic cancer|stage iii pancreatic cancer
579755|NCT01098344|stage IV pancreatic cancer|stage iv pancreatic cancer
579756|NCT01098344|duct cell adenocarcinoma of the pancreas|duct cell adenocarcinoma of the pancreas
579757|NCT01098331|stage I prostate cancer|stage i prostate cancer
579758|NCT01098331|stage IIB prostate cancer|stage iib prostate cancer
579759|NCT01098331|stage IIA prostate cancer|stage iia prostate cancer
579760|NCT01098318|Depression|depression
579761|NCT01098318|Antidepressant Therapy|antidepressant therapy
579762|NCT01098318|Herbal Treatment|herbal treatment
579763|NCT01098318|Rhodiola rosea|rhodiola rosea
579764|NCT01098318|Alternative Therapy|alternative therapy
579765|NCT01098305|nicotine smokeless tobacco chewing tobacco varenicline|nicotine smokeless tobacco chewing tobacco varenicline
579766|NCT01098292|Fibromyalgia|fibromyalgia
579767|NCT01098292|Irritable Bowel Syndrome|irritable bowel syndrome
579768|NCT01098292|Chronic Fatigue Syndrome|chronic fatigue syndrome
579769|NCT01098292|Interstitial Cystitis|interstitial cystitis
579770|NCT01098292|Chronic Prostatitis|chronic prostatitis
579771|NCT01098292|Urological Chronic Pelvic Pain|urological chronic pelvic pain
579772|NCT01098292|Painful Bladder Syndrome|painful bladder syndrome
579773|NCT01098279|Interstitial Cystitis|interstitial cystitis
579774|NCT01098279|Chronic Prostatitis|chronic prostatitis
579775|NCT01098279|Urological Chronic Pelvic Pain|urological chronic pelvic pain
579776|NCT01098279|Painful Bladder Syndrome|painful bladder syndrome
579777|NCT01098266|MPM|mpm
579778|NCT01098266|NGR-hTNF|ngr-htnf
579779|NCT01098266|NGR-hTNF plus BIC|ngr-htnf plus bic
580494|NCT01095575|Epidural|epidural
579780|NCT01098266|Randomized double-blind phase III study|randomized double-blind phase iii study
579781|NCT01098253|adherence|adherence
579782|NCT01098253|diabetes mellitus|diabetes mellitus
579783|NCT01098253|depression|depression
579784|NCT01098253|primary health care|primary health care
579785|NCT01098240|Antidepressant Augmentation|antidepressant augmentation
579786|NCT01098227|RSV Bronchiolitis|rsv bronchiolitis
579787|NCT01098227|Lower Respiratory Viral infection|lower respiratory viral infection
579788|NCT01098227|Exhaled Nitric Oxide|exhaled nitric oxide
579789|NCT01098214|Normal pregnancy|normal pregnancy
579790|NCT01098214|Amniotic fluid|amniotic fluid
579791|NCT01098214|Cytokines|cytokines
579792|NCT01098214|Biomarkers|biomarkers
579793|NCT01098201|Certolizumab|certolizumab
579794|NCT01098201|TNF|tnf
579795|NCT01098201|RA|ra
579796|NCT01098201|Cizmia|cizmia
579797|NCT01098175|laparotomy|laparotomy
579798|NCT01098175|thoracotomy|thoracotomy
579799|NCT01098175|peritoneal conditioning|peritoneal conditioning
579800|NCT01098175|humidification|humidification
579801|NCT01098175|temperature control|temperature control
579802|NCT01098162|Lacosamide|lacosamide
579803|NCT01098162|Vimpat®|vimpat®
579804|NCT01098162|Epilepsy|epilepsy
579805|NCT01098162|Partial-Onset Seizures|partial-onset seizures
579806|NCT01098162|Adjunctive therapy|adjunctive therapy
579807|NCT01098149|Haemodialysis treatment tolerance|haemodialysis treatment tolerance
579808|NCT01098149|acetate free biofiltration|acetate free biofiltration
579809|NCT01098149|frequency of hypotensive events during dialysis|frequency of hypotensive events during dialysis
579810|NCT01098149|nurse intervention during dialysis|nurse intervention during dialysis
579811|NCT01098136|Pelvic girdle pain|pelvic girdle pain
579812|NCT01098136|Chiropractic|chiropractic
579813|NCT01098136|Single-blinded|single-blinded
579814|NCT01098136|Outcome study|outcome study
579815|NCT01098084|Decitabine, chronic myelomonocytic leukemia|decitabine, chronic myelomonocytic leukemia
579816|NCT01098058|Adult attention deficit hyperactivity disorder|adult attention deficit hyperactivity disorder
579817|NCT01098058|cognitive-behavioural therapy|cognitive-behavioural therapy
579818|NCT01098058|randomised controlled trial|randomised controlled trial
579819|NCT01098045|HIV|hiv
579820|NCT01098045|fat redistribution|fat redistribution
579821|NCT01098045|brown adipose tissue|brown adipose tissue
579822|NCT01098045|PET|pet
579823|NCT01098032|Contrast media|contrast media
579824|NCT01098032|Kidney|kidney
579825|NCT01098032|Complication|complication
579826|NCT01098019|Notalgia paresthetica|notalgia paresthetica
579827|NCT01098019|Xeomin|xeomin
579828|NCT01098019|Botulinum Toxin A|botulinum toxin a
579829|NCT01098019|Pruritus|pruritus
579830|NCT01098019|Upper Back|upper back
579831|NCT01098019|Hyperpigmentation|hyperpigmentation
579832|NCT01098006|Immunological assays|immunological assays
579833|NCT01098006|Chronic hepatitis B|chronic hepatitis b
579834|NCT01097980|trazodone|trazodone
579835|NCT01097980|SSRI|ssri
579836|NCT01097980|sexual dysfunction|sexual dysfunction
579837|NCT01097980|5-HT2A polymorphism|5-ht2a polymorphism
579838|NCT01097967|Sleep disordered breathing|sleep disordered breathing
579839|NCT01097967|Continuous Positive Airway Pressure|continuous positive airway pressure
579840|NCT01097967|Sleep apnoea|sleep apnoea
579841|NCT01097967|Markers of atherosclerosis|markers of atherosclerosis
579842|NCT01097954|Exercise induced asthma|exercise induced asthma
579843|NCT01097954|Exercise induced bronchospasm|exercise induced bronchospasm
579844|NCT01097954|exhaled Nitric Oxide|exhaled nitric oxide
579845|NCT01097941|Influenza|influenza
579846|NCT01097941|H1N1|h1n1
579847|NCT01097915|PROP taste sensitivity|prop taste sensitivity
579848|NCT01097915|Gustin (CAVI) polymorphism|gustin (cavi) polymorphism
579849|NCT01097915|Salivary zinc|salivary zinc
579850|NCT01097915|BMI|bmi
579851|NCT01097915|Electrophysiological recording from the tongue|electrophysiological recording from the tongue
579852|NCT01097889|United Nations World Food Programme|united nations world food programme
579853|NCT01097889|blended food (CSB)|blended food (csb)
579854|NCT01097889|ready-to-use supplementary foods (RUSF)|ready-to-use supplementary foods (rusf)
579855|NCT01097889|Plumpy®|plumpy®
579856|NCT01097876|healthy volunteer|healthy volunteer
579857|NCT01097876|pharmacokinetic|pharmacokinetic
579858|NCT01097876|safety|safety
579859|NCT01097850|hand foot skin syndrome|hand foot skin syndrome
579860|NCT01097850|palmar plantar erythrodysesthesia|palmar plantar erythrodysesthesia
579861|NCT01097850|doxorubicin|doxorubicin
579862|NCT01097850|capecitabine|capecitabine
579863|NCT01097837|Epilepsy|epilepsy
579864|NCT01097837|Contraceptive|contraceptive
579865|NCT01097837|Birth Control|birth control
579866|NCT01097837|Seizure|seizure
579867|NCT01097837|This study is looking at the use of different birth control measures in women with epilepsy.|this study is looking at the use of different birth control measures in women with epilepsy.
579868|NCT01097811|Hepatic Encephalopathy|hepatic encephalopathy
579869|NCT01097811|Hypertension, Portal|hypertension, portal
579870|NCT01097811|Liver Cirrhosis|liver cirrhosis
579871|NCT01097811|Bacterial Overgrowth Syndrome|bacterial overgrowth syndrome
579872|NCT01097798|muscle injury|muscle injury
579873|NCT01097772|abdominal|abdominal
579874|NCT01097772|aortic|aortic
579875|NCT01097772|aneurysm|aneurysm
579876|NCT01097759|hemorrhoids|hemorrhoids
579877|NCT01097759|prolapsed|prolapsed
579878|NCT01097759|hemorrhoidectomy|hemorrhoidectomy
579879|NCT01097759|Hemorrhoidopexy|hemorrhoidopexy
579880|NCT01097759|LigaSure|ligasure
579881|NCT01097759|Stapled|stapled
579882|NCT01097720|Valproate|valproate
579883|NCT01097720|Lamotrigine|lamotrigine
579884|NCT01097720|Carbamazepine|carbamazepine
579885|NCT01097720|Anticonvulsant|anticonvulsant
579886|NCT01097720|Antiepileptic|antiepileptic
579887|NCT01097720|Teratogen|teratogen
579888|NCT01097720|Autism|autism
579889|NCT01097720|Developmental Delay|developmental delay
579890|NCT01097694|cKIT inhibition in Asthma|ckit inhibition in asthma
579891|NCT01097694|Efficacy of Imatinib in severe resistent asthma.|efficacy of imatinib in severe resistent asthma.
579892|NCT01097681|Urinary glucose excretion|urinary glucose excretion
579893|NCT01097681|Diabetes mellitus|diabetes mellitus
579894|NCT01097681|ASP1941|asp1941
579895|NCT01097668|Multiple sclerosis|multiple sclerosis
579896|NCT01097668|Immunomodulation|immunomodulation
579897|NCT01097668|Phase 1|phase 1
579898|NCT01097655|Tablets|tablets
579899|NCT01097655|Infection|infection
579900|NCT01097655|Non Nucleoside Reverse Transcriptase Inhibitor|non nucleoside reverse transcriptase inhibitor
579901|NCT01097655|Tolerability|tolerability
579902|NCT01097655|Viral load|viral load
579903|NCT01097655|Human immunodeficiency Virus|human immunodeficiency virus
579904|NCT01097655|Effectiveness|effectiveness
579905|NCT01097655|Treatment-naïve|treatment-naïve
579906|NCT01097603|Non-Invasive Blood Pressure|non-invasive blood pressure
579907|NCT01097590|ulcerative colitis|ulcerative colitis
579908|NCT01097590|leukapheresis treatment|leukapheresis treatment
579909|NCT01097577|photorefractive keratectomy|photorefractive keratectomy
579910|NCT01097577|excimer laser|excimer laser
579911|NCT01097577|PRK|prk
579912|NCT01097577|pain, postoperative|pain, postoperative
579913|NCT01097577|pregabalin|pregabalin
579914|NCT01097564|Genetic|genetic
579915|NCT01097564|Cerebral angiopathy|cerebral angiopathy
579916|NCT01097564|Retinal angiopathy|retinal angiopathy
579917|NCT01097564|COL4A1 gene|col4a1 gene
579918|NCT01097564|Infantile Cerebral Palsy|infantile cerebral palsy
579919|NCT01097564|Congenital porencephaly|congenital porencephaly
579920|NCT01097564|Congenital cataract|congenital cataract
579921|NCT01097564|Leukoencephalopathy|leukoencephalopathy
579922|NCT01097564|COL4A1 gene related cerebra-retinal angiopathy|col4a1 gene related cerebra-retinal angiopathy
579923|NCT01097551|Type 1 diabetes mellitus|type 1 diabetes mellitus
579924|NCT01097551|Diabetic retinopathy|diabetic retinopathy
579925|NCT01097551|Pathogenesis|pathogenesis
579926|NCT01097551|Dynamic Vessel Analyser|dynamic vessel analyser
579927|NCT01097551|Endothelial dysfunction|endothelial dysfunction
579928|NCT01097538|exercise|exercise
579929|NCT01097538|rehabilitation|rehabilitation
579930|NCT01097538|progressive multiple sclerosis|progressive multiple sclerosis
579931|NCT01097538|functional ability|functional ability
579932|NCT01097538|fatigue|fatigue
579933|NCT01097538|quality of life|quality of life
579934|NCT01097512|AS703569|as703569
579935|NCT01097512|MSC1992371A|msc1992371a
579936|NCT01097512|Aurora kinase inhibitor|aurora kinase inhibitor
579937|NCT01097512|Cancer treatable with gemcitabine|cancer treatable with gemcitabine
579938|NCT01097499|Dental implant initial stability|dental implant initial stability
579939|NCT01097499|Initial bone resorption post implant placement|initial bone resorption post implant placement
579940|NCT01097499|Analgesia effect of LED intervention|analgesia effect of led intervention
579941|NCT01097486|Cervical Degenerative Disc Disease|cervical degenerative disc disease
579942|NCT01097486|Degenerative Spondylolisthesis|degenerative spondylolisthesis
579943|NCT01097486|Spinal Stenosis|spinal stenosis
579944|NCT01097486|Stem cells|stem cells
579945|NCT01097486|Adult Stem Cells|adult stem cells
580036|NCT01097031|nursing|nursing
579946|NCT01097486|Anterior cervical discectomy and Fusion (ACDF)|anterior cervical discectomy and fusion (acdf)
579947|NCT01097486|Cervical Allograft Spacer|cervical allograft spacer
579948|NCT01097486|Anterior Cervical Plate Fixation|anterior cervical plate fixation
579949|NCT01097460|HER2/HER3|her2/her3
579950|NCT01097460|Bispecific Antibody|bispecific antibody
579951|NCT01097460|Breast Cancer|breast cancer
579952|NCT01097460|Advanced Breast Cancer|advanced breast cancer
579953|NCT01097460|Metastatic Breast Cancer|metastatic breast cancer
579954|NCT01097460|HER2 Positive Breast Cancer|her2 positive breast cancer
579955|NCT01097460|Trastuzumab|trastuzumab
579956|NCT01097460|Herceptin|herceptin
579957|NCT01097447|Diagnosis of keratoconus, post-LASIK ectasia, FFKC, or pellucid marginal degeneration|diagnosis of keratoconus, post-lasik ectasia, ffkc, or pellucid marginal degeneration
579958|NCT01097395|ribavirin|ribavirin
579959|NCT01097395|pharmacokinetics|pharmacokinetics
579960|NCT01097395|Hepatitis C virus|hepatitis c virus
579961|NCT01097343|Clopidogrel pharmacogenomics study|clopidogrel pharmacogenomics study
579962|NCT01097343|Performing genetic study looking at clopidogrel resistance|performing genetic study looking at clopidogrel resistance
579963|NCT01097330|Defibrillators, Implantable|defibrillators, implantable
579964|NCT01097330|Tachycardia, Ventricular|tachycardia, ventricular
579965|NCT01097330|Catheter Ablation|catheter ablation
579966|NCT01097330|Amiodarone|amiodarone
579967|NCT01097317|chemotherapeutic agent toxicity|chemotherapeutic agent toxicity
579968|NCT01097317|musculoskeletal complications|musculoskeletal complications
579969|NCT01097317|fatigue|fatigue
579970|NCT01097317|stage I non-small cell lung cancer|stage i non-small cell lung cancer
579971|NCT01097317|stage II non-small cell lung cancer|stage ii non-small cell lung cancer
579972|NCT01097317|stage IIIA non-small cell lung cancer|stage iiia non-small cell lung cancer
579973|NCT01097317|stage IIIB non-small cell lung cancer|stage iiib non-small cell lung cancer
579974|NCT01097317|stage IV non-small cell lung cancer|stage iv non-small cell lung cancer
579975|NCT01097317|recurrent non-small cell lung cancer|recurrent non-small cell lung cancer
579976|NCT01097278|breast cancer|breast cancer
579977|NCT01097278|ductal breast carcinoma in situ|ductal breast carcinoma in situ
579978|NCT01097278|lobular breast carcinoma in situ|lobular breast carcinoma in situ
579979|NCT01097278|BRCA1 mutation carrier|brca1 mutation carrier
579980|NCT01097278|BRCA2 mutation carrier|brca2 mutation carrier
579981|NCT01097265|stage I colon cancer|stage i colon cancer
579982|NCT01097265|stage II colon cancer|stage ii colon cancer
579983|NCT01097252|Cervical Neoplasm|cervical neoplasm
579984|NCT01097252|chemoradiation|chemoradiation
579985|NCT01097252|compliance|compliance
579986|NCT01097252|toxicity|toxicity
579987|NCT01097239|High Intensity Focused Ultrasound|high intensity focused ultrasound
579988|NCT01097239|HIFU|hifu
579989|NCT01097239|Rectal Cancer|rectal cancer
579990|NCT01097239|Sonablate 500|sonablate 500
579991|NCT01097239|Transrectal|transrectal
579992|NCT01097226|Dietary intervention|dietary intervention
579993|NCT01097226|bioavailability|bioavailability
579994|NCT01097226|Healthy volunteers|healthy volunteers
579995|NCT01097200|sacrocolpopexy|sacrocolpopexy
579996|NCT01097200|meshes|meshes
579997|NCT01097200|sacrospinous ligament|sacrospinous ligament
579998|NCT01097174|Glaucoma|glaucoma
579999|NCT01097174|Glaucoma device|glaucoma device
580000|NCT01097174|Glaucoma surgery|glaucoma surgery
580001|NCT01097174|Intraocular pressure|intraocular pressure
580002|NCT01097161|Stuttering|stuttering
580003|NCT01097161|Apraxia of speech|apraxia of speech
580004|NCT01097161|Motor control|motor control
580005|NCT01097161|Prosody|prosody
580006|NCT01097161|Pitch range|pitch range
580007|NCT01097161|Speech rate|speech rate
580008|NCT01097161|fluency disorders|fluency disorders
580009|NCT01097148|Obese|obese
580010|NCT01097148|Atracurium|atracurium
580011|NCT01097148|Cefazolin|cefazolin
580012|NCT01097148|Morfine|morfine
580013|NCT01097148|Nadroparin|nadroparin
580014|NCT01097122|bone|bone
580015|NCT01097122|motor neuron excitability|motor neuron excitability
580016|NCT01097122|forearm vibration|forearm vibration
580017|NCT01097122|mechanical loading|mechanical loading
580018|NCT01097122|muscle electrical activity|muscle electrical activity
580019|NCT01097109|Effect of Somatic Dysfunctions of Pelvis|effect of somatic dysfunctions of pelvis
580020|NCT01097109|Effect of Somatic Dysfunctions of Sacrum|effect of somatic dysfunctions of sacrum
580021|NCT01097109|Effect of Somatic Dysfunctions of Lower Lumbar Spine|effect of somatic dysfunctions of lower lumbar spine
580022|NCT01097109|Weight-Bearing|weight-bearing
580023|NCT01097096|Active immunization|active immunization
580024|NCT01097096|Alzheimer disease|alzheimer disease
580025|NCT01097096|Antibody|antibody
580026|NCT01097096|Central Nervous System Diseases|central nervous system diseases
580027|NCT01097096|Neurodegenerative diseases|neurodegenerative diseases
580028|NCT01097096|Vaccine|vaccine
580029|NCT01097083|Patients With Child-Pugh C Unresectable Hepatocellular Carcinoma|patients with child-pugh c unresectable hepatocellular carcinoma
580030|NCT01097083|Patients who are unfit for standard therapy|patients who are unfit for standard therapy
580031|NCT01097044|Erythropoietic Protoporphyria|erythropoietic protoporphyria
580032|NCT01097044|EPP|epp
580033|NCT01097044|Afamelanotide|afamelanotide
580034|NCT01097031|blood pressure|blood pressure
580037|NCT01097031|maintenance arterial catheter|maintenance arterial catheter
580038|NCT01097005|Mycobacterium Infections, Atypical|mycobacterium infections, atypical
580039|NCT01096992|Chronic lymphocytic leukemia|chronic lymphocytic leukemia
580040|NCT01096992|CLL|cll
580041|NCT01096992|Bendamustine|bendamustine
580042|NCT01096992|Fludarabine|fludarabine
580043|NCT01096992|Fludara|fludara
580044|NCT01096992|Fludarabine Phosphate|fludarabine phosphate
580045|NCT01096992|Rituximab|rituximab
580046|NCT01096992|Rituxan|rituxan
580047|NCT01096979|Subcutaneous Adipose Tissue Reduction|subcutaneous adipose tissue reduction
580048|NCT01096966|chronic low back pain|chronic low back pain
580049|NCT01096953|Attention Deficit Hyperactivity Disorder|attention deficit hyperactivity disorder
580050|NCT01096953|ADHD|adhd
580051|NCT01096953|attention deficit|attention deficit
580052|NCT01096940|Type 2 Diabetes Mellitus|type 2 diabetes mellitus
580053|NCT01096940|Glucose lowering|glucose lowering
580054|NCT01096927|Lower Abdominal Pain|lower abdominal pain
580055|NCT01096927|Right Iliac Fossa Pain|right iliac fossa pain
580056|NCT01096927|Acute Appendicitis|acute appendicitis
580057|NCT01096927|Antibiotic Therapy|antibiotic therapy
580058|NCT01096927|Conservative Management|conservative management
580059|NCT01096927|Appendectomy|appendectomy
580060|NCT01096927|Recurrence|recurrence
580061|NCT01096927|Length of hospital stay|length of hospital stay
580062|NCT01096927|Sick leave time|sick leave time
580063|NCT01096927|Short and Long Term Abdominal pain evaluation|short and long term abdominal pain evaluation
580064|NCT01096888|WIC|wic
580065|NCT01096888|Weight loss|weight loss
580066|NCT01096888|Overweight|overweight
580067|NCT01096888|Post Partum|post partum
580068|NCT01096888|Internet based weight loss intervention for Mothers in the WIC program.|internet based weight loss intervention for mothers in the wic program.
580069|NCT01096875|Endothelial progenitor cells|endothelial progenitor cells
580070|NCT01096875|Atorvastatin|atorvastatin
580071|NCT01096875|Coronary surgery|coronary surgery
580072|NCT01096862|ASP015K|asp015k
580073|NCT01096862|Psoriasis|psoriasis
580074|NCT01096849|urinary tract infection|urinary tract infection
580075|NCT01096849|UTI|uti
580076|NCT01096849|cUTI|cuti
580077|NCT01096849|pyelonephritis|pyelonephritis
580078|NCT01096849|AP|ap
580079|NCT01096849|ACHN-490|achn-490
580080|NCT01096836|resistance exercise|resistance exercise
580081|NCT01096836|body mass index|body mass index
580082|NCT01096836|hypertrophy|hypertrophy
580083|NCT01096836|endothelial function|endothelial function
580084|NCT01096836|blood lipids|blood lipids
580085|NCT01096823|Rheumatoid Arthritis|rheumatoid arthritis
580086|NCT01096823|Yoga|yoga
580087|NCT01096823|Adolescents|adolescents
580088|NCT01096823|Young Adults|young adults
580089|NCT01096810|Asymptomatic|asymptomatic
580090|NCT01096784|insulin-like growth factor|insulin-like growth factor
580091|NCT01096784|ROP|rop
580092|NCT01096784|IGF-I|igf-i
580093|NCT01096784|BPD|bpd
580094|NCT01096784|bronchopulmonary dysplasia|bronchopulmonary dysplasia
580095|NCT01096784|retinopathy of prematurity|retinopathy of prematurity
580096|NCT01096771|ARDS|ards
580097|NCT01096771|Parenteral|parenteral
580098|NCT01096771|Pharmaconutrition|pharmaconutrition
580099|NCT01096758|PKU|pku
580100|NCT01096758|phenylketonuria|phenylketonuria
580101|NCT01096758|adult|adult
580102|NCT01096758|patient|patient
580103|NCT01096758|development|development
580104|NCT01096758|nutritional deficiencies|nutritional deficiencies
580105|NCT01096758|neurological outcome|neurological outcome
580106|NCT01096758|psychological and neurological development|psychological and neurological development
580107|NCT01096758|comparison with healthy adults|comparison with healthy adults
580108|NCT01096758|longitudinal development|longitudinal development
580109|NCT01096758|quality of life|quality of life
580110|NCT01096745|Gemcitabine|gemcitabine
580111|NCT01096745|Cisplatin|cisplatin
580112|NCT01096745|S-1|s-1
580113|NCT01096745|bile duct cancer|bile duct cancer
580114|NCT01096732|Pancreatic|pancreatic
580115|NCT01096732|adenocarcinoma|adenocarcinoma
580116|NCT01096732|cancer|cancer
580117|NCT01096719|Weight|weight
580118|NCT01096719|Dietary intake|dietary intake
580119|NCT01096719|Energy Density|energy density
580120|NCT01096719|Behavioral|behavioral
580121|NCT01096719|Satiety|satiety
580122|NCT01096719|Deprivation|deprivation
580123|NCT01096719|Hunger|hunger
580124|NCT01096719|Fruit|fruit
580125|NCT01096719|Vegetable|vegetable
580126|NCT01096706|Urocortin 2|urocortin 2
580127|NCT01096706|Urocortin 3|urocortin 3
580128|NCT01096706|Nitric Oxide|nitric oxide
580129|NCT01096706|Plethysmography|plethysmography
580130|NCT01096706|Forearm blood flow|forearm blood flow
580131|NCT01096706|Vascular|vascular
580132|NCT01096706|Heart failure|heart failure
580133|NCT01096706|endothelium|endothelium
580134|NCT01096706|Cyclo-oxygenase pathway|cyclo-oxygenase pathway
580135|NCT01096706|EDHF|edhf
580136|NCT01096693|Urocortin 2|urocortin 2
580137|NCT01096693|Urocortin 3|urocortin 3
580138|NCT01096693|Astressin 2B|astressin 2b
580139|NCT01096693|forearm blood flow|forearm blood flow
580140|NCT01096693|plethysmography|plethysmography
580141|NCT01096693|vascular|vascular
580142|NCT01096693|heart failure|heart failure
580143|NCT01096667|type 2 diabetes|type 2 diabetes
580144|NCT01096667|hypertension|hypertension
580145|NCT01096667|ambulatory blood pressure monitoring|ambulatory blood pressure monitoring
580146|NCT01096654|endocrine hypertension|endocrine hypertension
580495|NCT01095575|Morphine|morphine
580147|NCT01096654|primary hyperaldosteronism|primary hyperaldosteronism
580148|NCT01096654|aldosterone|aldosterone
580149|NCT01096654|aldosterone-producing adenoma|aldosterone-producing adenoma
580150|NCT01096654|bilateral adrenal hyperplasia|bilateral adrenal hyperplasia
580151|NCT01096654|computed tomography|computed tomography
580152|NCT01096654|adrenal vein sampling|adrenal vein sampling
580153|NCT01096641|Fatigued disease-free Cancer Patients|fatigued disease-free cancer patients
580154|NCT01096641|cancer treatment finished > one year and < ten years ago|cancer treatment finished > one year and < ten years ago
580155|NCT01096628|adolescent|adolescent
580156|NCT01096628|low back pain|low back pain
580157|NCT01096628|chiropractic|chiropractic
580158|NCT01096628|exercise|exercise
580159|NCT01096615|Allergic rhinitis-Probiotic Lactobacillus paracasei LP-33-|allergic rhinitis-probiotic lactobacillus paracasei lp-33-
580160|NCT01096602|Dendritic Cell/AML vaccine|dendritic cell/aml vaccine
580161|NCT01096602|CT-011|ct-011
580162|NCT01096589|lymphoedema|lymphoedema
580163|NCT01096589|lymphedema|lymphedema
580164|NCT01096563|Phase I|phase i
580165|NCT01096563|Japanese healthy volunteer|japanese healthy volunteer
580166|NCT01096563|AZD9164|azd9164
580167|NCT01096550|opioid dependence|opioid dependence
580168|NCT01096550|outpatient treatment|outpatient treatment
580169|NCT01096550|intensive outpatient treatment|intensive outpatient treatment
580170|NCT01096537|incidence|incidence
580171|NCT01096537|young workers|young workers
580172|NCT01096537|occupations at risk|occupations at risk
580173|NCT01096537|public health|public health
580174|NCT01096537|epidemiology|epidemiology
580175|NCT01096537|polymorphisms|polymorphisms
580176|NCT01096537|gentic|gentic
580177|NCT01096524|Kneehab|kneehab
580178|NCT01096524|NMES|nmes
580179|NCT01096524|Total Knee Arthroplasty|total knee arthroplasty
580180|NCT01096524|Total Knee Replacement|total knee replacement
580181|NCT01096524|TKA|tka
580182|NCT01096524|Disuse atrophy|disuse atrophy
580183|NCT01096524|muscle hypertrophy|muscle hypertrophy
580184|NCT01096524|TKR|tkr
580185|NCT01096524|Atrophy Prevention|atrophy prevention
580186|NCT01096511|Moxifloxacin,|moxifloxacin,
580187|NCT01096511|cIAI|ciai
580188|NCT01096511|non-interventional|non-interventional
580189|NCT01096472|Tinea pedis|tinea pedis
580190|NCT01096459|spina|spina
580191|NCT01096459|bifida|bifida
580192|NCT01096459|restore|restore
580193|NCT01096459|urinary|urinary
580194|NCT01096459|function|function
580195|NCT01096459|nerve|nerve
580196|NCT01096459|reroute|reroute
580197|NCT01096433|Sleep apnea|sleep apnea
580198|NCT01096433|CPAP|cpap
580199|NCT01096433|Prostaglandins|prostaglandins
580200|NCT01096433|Circadian variations|circadian variations
580201|NCT01096420|chronic migraine|chronic migraine
580202|NCT01096420|acupuncture|acupuncture
580203|NCT01096420|Topiramate|topiramate
580204|NCT01096420|Randomized trial|randomized trial
580205|NCT01096407|pain|pain
580206|NCT01096407|arthralgia|arthralgia
580207|NCT01096407|unspecified adult solid tumor, protocol specific|unspecified adult solid tumor, protocol specific
580208|NCT01096394|stage III ovarian epithelial cancer|stage iii ovarian epithelial cancer
580209|NCT01096394|stage IV ovarian epithelial cancer|stage iv ovarian epithelial cancer
580210|NCT01096381|cardiovascular complications|cardiovascular complications
580211|NCT01096381|stage I breast cancer|stage i breast cancer
580212|NCT01096381|stage II breast cancer|stage ii breast cancer
580213|NCT01096381|stage IIIA breast cancer|stage iiia breast cancer
580214|NCT01096381|stage IIIB breast cancer|stage iiib breast cancer
580215|NCT01096381|stage IIIC breast cancer|stage iiic breast cancer
580216|NCT01096381|stage IV breast cancer|stage iv breast cancer
580217|NCT01096381|stage I colon cancer|stage i colon cancer
580218|NCT01096381|stage II colon cancer|stage ii colon cancer
580219|NCT01096381|stage III colon cancer|stage iii colon cancer
580220|NCT01096381|stage IV colon cancer|stage iv colon cancer
580221|NCT01096381|stage I rectal cancer|stage i rectal cancer
580222|NCT01096381|stage II rectal cancer|stage ii rectal cancer
580223|NCT01096381|stage III rectal cancer|stage iii rectal cancer
580224|NCT01096381|stage IV rectal cancer|stage iv rectal cancer
580225|NCT01096381|stage I non-small cell lung cancer|stage i non-small cell lung cancer
580226|NCT01096381|stage II non-small cell lung cancer|stage ii non-small cell lung cancer
580227|NCT01096381|stage IIIA non-small cell lung cancer|stage iiia non-small cell lung cancer
580228|NCT01096381|stage IIIB non-small cell lung cancer|stage iiib non-small cell lung cancer
580229|NCT01096381|stage IV non-small cell lung cancer|stage iv non-small cell lung cancer
580230|NCT01096381|unspecified adult solid tumor, protocol specific|unspecified adult solid tumor, protocol specific
580231|NCT01096381|recurrent squamous cell carcinoma of the hypopharynx|recurrent squamous cell carcinoma of the hypopharynx
580232|NCT01096381|stage IV squamous cell carcinoma of the hypopharynx|stage iv squamous cell carcinoma of the hypopharynx
580233|NCT01096381|recurrent squamous cell carcinoma of the larynx|recurrent squamous cell carcinoma of the larynx
580234|NCT01096381|stage IV squamous cell carcinoma of the larynx|stage iv squamous cell carcinoma of the larynx
580235|NCT01096381|recurrent verrucous carcinoma of the larynx|recurrent verrucous carcinoma of the larynx
580236|NCT01096381|stage IV verrucous carcinoma of the larynx|stage iv verrucous carcinoma of the larynx
580237|NCT01096381|recurrent adenoid cystic carcinoma of the oral cavity|recurrent adenoid cystic carcinoma of the oral cavity
580238|NCT01096381|recurrent mucoepidermoid carcinoma of the oral cavity|recurrent mucoepidermoid carcinoma of the oral cavity
580239|NCT01096381|recurrent verrucous carcinoma of the oral cavity|recurrent verrucous carcinoma of the oral cavity
580240|NCT01096381|stage IV adenoid cystic carcinoma of the oral cavity|stage iv adenoid cystic carcinoma of the oral cavity
580241|NCT01096381|stage IV mucoepidermoid carcinoma of the oral cavity|stage iv mucoepidermoid carcinoma of the oral cavity
580242|NCT01096381|stage IV verrucous carcinoma of the oral cavity|stage iv verrucous carcinoma of the oral cavity
580243|NCT01096381|recurrent basal cell carcinoma of the lip|recurrent basal cell carcinoma of the lip
580244|NCT01096381|recurrent squamous cell carcinoma of the lip and oral cavity|recurrent squamous cell carcinoma of the lip and oral cavity
580245|NCT01096381|stage IV basal cell carcinoma of the lip|stage iv basal cell carcinoma of the lip
580246|NCT01096381|stage IV squamous cell carcinoma of the lip and oral cavity|stage iv squamous cell carcinoma of the lip and oral cavity
580247|NCT01096381|metastatic squamous neck cancer with occult primary squamous cell carcinoma|metastatic squamous neck cancer with occult primary squamous cell carcinoma
580248|NCT01096381|recurrent metastatic squamous neck cancer with occult primary|recurrent metastatic squamous neck cancer with occult primary
580249|NCT01096381|untreated metastatic squamous neck cancer with occult primary|untreated metastatic squamous neck cancer with occult primary
580250|NCT01096381|recurrent lymphoepithelioma of the nasopharynx|recurrent lymphoepithelioma of the nasopharynx
580251|NCT01096381|recurrent squamous cell carcinoma of the nasopharynx|recurrent squamous cell carcinoma of the nasopharynx
580252|NCT01096381|stage IV lymphoepithelioma of the nasopharynx|stage iv lymphoepithelioma of the nasopharynx
580253|NCT01096381|stage IV squamous cell carcinoma of the nasopharynx|stage iv squamous cell carcinoma of the nasopharynx
580254|NCT01096381|recurrent lymphoepithelioma of the oropharynx|recurrent lymphoepithelioma of the oropharynx
580255|NCT01096381|recurrent squamous cell carcinoma of the oropharynx|recurrent squamous cell carcinoma of the oropharynx
580496|NCT01095575|Preoperative|preoperative
580256|NCT01096381|stage IV lymphoepithelioma of the oropharynx|stage iv lymphoepithelioma of the oropharynx
580257|NCT01096381|stage IV squamous cell carcinoma of the oropharynx|stage iv squamous cell carcinoma of the oropharynx
580258|NCT01096381|recurrent esthesioneuroblastoma of the paranasal sinus and nasal cavity|recurrent esthesioneuroblastoma of the paranasal sinus and nasal cavity
580259|NCT01096381|recurrent inverted papilloma of the paranasal sinus and nasal cavity|recurrent inverted papilloma of the paranasal sinus and nasal cavity
580260|NCT01096381|recurrent midline lethal granuloma of the paranasal sinus and nasal cavity|recurrent midline lethal granuloma of the paranasal sinus and nasal cavity
710877|NCT00587470|valve, mitral, regurgitation|valve, mitral, regurgitation
580261|NCT01096381|recurrent squamous cell carcinoma of the paranasal sinus and nasal cavity|recurrent squamous cell carcinoma of the paranasal sinus and nasal cavity
580262|NCT01096381|stage IV esthesioneuroblastoma of the paranasal sinus and nasal cavity|stage iv esthesioneuroblastoma of the paranasal sinus and nasal cavity
580263|NCT01096381|stage IV inverted papilloma of the paranasal sinus and nasal cavity|stage iv inverted papilloma of the paranasal sinus and nasal cavity
580264|NCT01096381|stage IV midline lethal granuloma of the paranasal sinus and nasal cavity|stage iv midline lethal granuloma of the paranasal sinus and nasal cavity
580265|NCT01096381|stage IV squamous cell carcinoma of the paranasal sinus and nasal cavity|stage iv squamous cell carcinoma of the paranasal sinus and nasal cavity
580266|NCT01096381|stage II ovarian epithelial cancer|stage ii ovarian epithelial cancer
580267|NCT01096381|stage III ovarian epithelial cancer|stage iii ovarian epithelial cancer
580268|NCT01096381|stage IV ovarian epithelial cancer|stage iv ovarian epithelial cancer
580269|NCT01096381|fallopian tube cancer|fallopian tube cancer
580270|NCT01096381|peritoneal cavity cancer|peritoneal cavity cancer
580271|NCT01096329|postmenopausal|postmenopausal
580272|NCT01096329|hormone replacement therapy|hormone replacement therapy
580273|NCT01096316|mood disorders|mood disorders
580274|NCT01096316|depressive disorder|depressive disorder
580275|NCT01096316|women|women
580276|NCT01096316|depression|depression
580277|NCT01096303|COPD|copd
580278|NCT01096303|pulmonary function|pulmonary function
580279|NCT01096303|tobacco and marihuana smoking|tobacco and marihuana smoking
580280|NCT01096290|constipation|constipation
580281|NCT01096290|lubiprostone|lubiprostone
580282|NCT01096290|healthy volunteers|healthy volunteers
580283|NCT01096264|Arterial stiffness|arterial stiffness
580284|NCT01096264|Pulse wave velocity|pulse wave velocity
580285|NCT01096264|Ultrafastecho|ultrafastecho
580286|NCT01096264|Supersonic shear imaging|supersonic shear imaging
580287|NCT01096251|Obesity|obesity
580288|NCT01096251|Binge Eating Disorder|binge eating disorder
580289|NCT01096251|Cognitive Behavioural Therapy|cognitive behavioural therapy
580290|NCT01096251|Brief Strategic Therapy|brief strategic therapy
580291|NCT01096251|Telepsychology|telepsychology
580292|NCT01096238|The immunogenicity of Influenza Virus Vaccine, AdimFlu-S (A/H1N1), in adults after half a year will be analyzed and discussed.|the immunogenicity of influenza virus vaccine, adimflu-s (a/h1n1), in adults after half a year will be analyzed and discussed.
580293|NCT01096225|the antibody response|the antibody response
580294|NCT01096225|T-cell response|t-cell response
580295|NCT01096225|S-OIV|s-oiv
580296|NCT01096225|vaccine|vaccine
580297|NCT01096225|Immunogenicity assessment|immunogenicity assessment
580298|NCT01096212|Efficacy|efficacy
580299|NCT01096212|Minimum alveolar concentration|minimum alveolar concentration
580300|NCT01096212|Safety|safety
580301|NCT01096212|Sevoflurane|sevoflurane
580302|NCT01096199|The purpose of the study is to evaluate the safety and feasibility of combining TS-1/CDDP with RAD001. Primary|the purpose of the study is to evaluate the safety and feasibility of combining ts-1/cddp with rad001. primary
580303|NCT01096199|Objectives|objectives
580304|NCT01096199|To determine the MTD/recommended phase II dose of TS-1/CDDP/RAD001 combination —To determine|to determine the mtd/recommended phase ii dose of ts-1/cddp/rad001 combination —to determine
580305|NCT01096199|the safety of TS-1/CDDP/RAD001 combination Secondary Objectives —To preliminarily describe any clinical activity in|the safety of ts-1/cddp/rad001 combination secondary objectives —to preliminarily describe any clinical activity in
580306|NCT01096199|platinum refractory disease|platinum refractory disease
580307|NCT01096199|To assess to effect of concurrent TS-1/CDDP on RAD001 pharmacokinetics —To explore|to assess to effect of concurrent ts-1/cddp on rad001 pharmacokinetics —to explore
580308|NCT01096199|the relationship of tumour biomarkers and treatment response|the relationship of tumour biomarkers and treatment response
580309|NCT01096186|motor Symptoms|motor symptoms
580310|NCT01096186|efficacy|efficacy
580311|NCT01096186|IPX066|ipx066
580312|NCT01096186|Parkinson's Disease|parkinson's disease
580313|NCT01096173|Sputum|sputum
580314|NCT01096173|chronic obstructive pulmonary disease|chronic obstructive pulmonary disease
580315|NCT01096160|Hypertension|hypertension
580316|NCT01096147|FBSS|fbss
580317|NCT01096147|chronic pain|chronic pain
580318|NCT01096147|leg pain|leg pain
580319|NCT01096147|low back pain|low back pain
580320|NCT01096147|spinal cord stimulation|spinal cord stimulation
580321|NCT01096121|Angiotensin-converting enzyme inhibitors (ACE)|angiotensin-converting enzyme inhibitors (ace)
580322|NCT01096121|Renal disease|renal disease
580323|NCT01096121|Microalbuminemia|microalbuminemia
580324|NCT01096108|Smoking cessation|smoking cessation
580325|NCT01096108|Quit smoking|quit smoking
580326|NCT01096108|Quit & Win|quit & win
580327|NCT01096095|SCA|sca
580328|NCT01096095|Spinocerebellar Ataxia|spinocerebellar ataxia
580329|NCT01096095|Sodium Phenylbutyrate|sodium phenylbutyrate
580330|NCT01096095|Machado-Joseph Disease|machado-joseph disease
580331|NCT01096095|Treatment|treatment
580332|NCT01096082|spinocerebellar ataxia|spinocerebellar ataxia
580333|NCT01096082|Treatment|treatment
580334|NCT01096082|Lithium carbonate|lithium carbonate
580335|NCT01096069|Rituximab, rheumatoid arthritis, CD55, CD59|rituximab, rheumatoid arthritis, cd55, cd59
580336|NCT01096056|Children|children
580337|NCT01096056|Influenza|influenza
580338|NCT01096056|Safety|safety
580339|NCT01096056|Immunogenicity|immunogenicity
580340|NCT01096056|Vaccine|vaccine
580341|NCT01096043|Heart Failure|heart failure
580342|NCT01096043|ADHF|adhf
580343|NCT01096030|Regorafenib|regorafenib
580344|NCT01096030|Advanced|advanced
580345|NCT01096030|Refractory solid tumors|refractory solid tumors
580346|NCT01096017|Terbutaline|terbutaline
580347|NCT01096017|Turbuhaler|turbuhaler
580348|NCT01096017|Efficacy|efficacy
580349|NCT01096017|Asthma|asthma
580350|NCT01096017|Japanese|japanese
580351|NCT01096017|salbutamol|salbutamol
580352|NCT01096017|Bricanyl|bricanyl
580353|NCT01096004|Pharmacodynamic method evaluation|pharmacodynamic method evaluation
580354|NCT01095991|Type 2 Diabetes Mellitus, Sitagliptin|type 2 diabetes mellitus, sitagliptin
580355|NCT01095978|Klacid SR|klacid sr
580356|NCT01095978|Clarithromycin|clarithromycin
580357|NCT01095978|Respiratory tract infections|respiratory tract infections
580358|NCT01095978|Bronchitis|bronchitis
580359|NCT01095978|Pneumonia|pneumonia
580360|NCT01095965|Nutrition education intervention|nutrition education intervention
580361|NCT01095965|Type 2 diabetes mellitus|type 2 diabetes mellitus
580362|NCT01095952|atrial fibrillation|atrial fibrillation
580363|NCT01095952|inappropriate shock|inappropriate shock
580364|NCT01095952|AV-node stimulation|av-node stimulation
580365|NCT01095952|ventricular arrhythmia|ventricular arrhythmia
580366|NCT01095939|Renal function consecutive to pre-eclampsia|renal function consecutive to pre-eclampsia
580367|NCT01095926|pharmacokinetic|pharmacokinetic
580368|NCT01095926|doxorubicin|doxorubicin
580369|NCT01095926|cancer|cancer
580370|NCT01095926|troponin|troponin
580371|NCT01095926|natriuretic peptide|natriuretic peptide
580372|NCT01095926|cardiotoxicity|cardiotoxicity
580373|NCT01095926|anthracyclines|anthracyclines
580374|NCT01095926|Ewing|ewing
580375|NCT01095926|ALL|all
580376|NCT01095913|Near-Infrared Imaging|near-infrared imaging
580377|NCT01095913|Fluorescent Dyes|fluorescent dyes
580378|NCT01095913|Lymph Node Mapping|lymph node mapping
580379|NCT01095913|Indocyanine green|indocyanine green
580380|NCT01095913|IC-Green|ic-green
580381|NCT01095913|nonradioactive optical imaging|nonradioactive optical imaging
580382|NCT01095913|fluorescent contrast agent|fluorescent contrast agent
580383|NCT01095913|ICG|icg
580384|NCT01095913|lymph nodes|lymph nodes
580385|NCT01095913|axillary nodal dissection|axillary nodal dissection
580386|NCT01095900|Pain after treatment|pain after treatment
580491|NCT01095601|TA-1790|ta-1790
580387|NCT01095900|healing of fissure after treatment|healing of fissure after treatment
580388|NCT01095900|continence scores after treatment|continence scores after treatment
580389|NCT01095887|ABO incompatibility|abo incompatibility
580390|NCT01095887|living donor kidney transplant|living donor kidney transplant
580391|NCT01095887|kidney transplant|kidney transplant
580392|NCT01095887|ABO blood type incompatible|abo blood type incompatible
580393|NCT01095874|myelodysplasia|myelodysplasia
580394|NCT01095874|allogeneic hematopoietic stem cell transplantation|allogeneic hematopoietic stem cell transplantation
580395|NCT01095874|Survival|survival
580396|NCT01095874|Transplantation|transplantation
580397|NCT01095861|endotracheal tube|endotracheal tube
580398|NCT01095848|vaccine|vaccine
580399|NCT01095848|cancer|cancer
580400|NCT01095848|ovarian|ovarian
580401|NCT01095848|breast|breast
580402|NCT01095848|prostate|prostate
580403|NCT01095848|tumor|tumor
580404|NCT01095848|Immunotherapy|immunotherapy
580405|NCT01095822|Diabetes|diabetes
580406|NCT01095822|Hypertension|hypertension
580407|NCT01095822|Platelets|platelets
580408|NCT01095822|Hemostasis|hemostasis
580409|NCT01095822|Aliskiren|aliskiren
580410|NCT01095822|Valsartan|valsartan
580411|NCT01095796|Treatment Naive|treatment naive
580412|NCT01095796|HIV 1 Infected|hiv 1 infected
580413|NCT01095783|low back pain|low back pain
580414|NCT01095783|physiotherapy|physiotherapy
580415|NCT01095783|hemodialysis|hemodialysis
580416|NCT01095783|end-stage renal disease|end-stage renal disease
580417|NCT01095770|Atrial Fibrillation|atrial fibrillation
580418|NCT01095770|Atrial Fibrillation Ablation|atrial fibrillation ablation
580419|NCT01095770|Atrial Fibrillation monitoring|atrial fibrillation monitoring
580420|NCT01095770|Ablation Frontiers|ablation frontiers
580421|NCT01095770|Reveal XT|reveal xt
580422|NCT01095770|LASSO|lasso
580423|NCT01095757|Myeloma|myeloma
580424|NCT01095757|Lymphoma|lymphoma
580425|NCT01095757|Stem cell transplantation|stem cell transplantation
580426|NCT01095744|PIB imaging,|pib imaging,
580427|NCT01095744|brain atrophy|brain atrophy
580428|NCT01095744|cognitive impairment|cognitive impairment
580429|NCT01095744|Pet imaging|pet imaging
580430|NCT01095744|Alzheimer's disease|alzheimer's disease
580431|NCT01095744|amyloid protein|amyloid protein
580432|NCT01095731|aneurysm|aneurysm
580433|NCT01095731|aneurysmal|aneurysmal
580434|NCT01095731|subarachnoid|subarachnoid
580435|NCT01095731|hemorrhage|hemorrhage
580436|NCT01095731|haemorrhage|haemorrhage
580437|NCT01095731|neuroprotection|neuroprotection
580438|NCT01095731|3-aminopropanal|3-aminopropanal
580439|NCT01095731|3AP|3ap
580440|NCT01095731|polyamine oxidase|polyamine oxidase
580441|NCT01095731|spermine|spermine
580442|NCT01095731|spermidine|spermidine
580443|NCT01095731|vasospasm|vasospasm
580444|NCT01095731|cerebral ischemia|cerebral ischemia
580445|NCT01095731|neurosurgery|neurosurgery
580446|NCT01095731|neurological intensive care unit|neurological intensive care unit
580447|NCT01095731|NICU|nicu
580448|NCT01095731|Tiopronin|tiopronin
580449|NCT01095731|Thiola|thiola
580450|NCT01095731|FDA|fda
580451|NCT01095731|Thiopronin|thiopronin
580452|NCT01095731|Thiosol|thiosol
580453|NCT01095731|Tioglis|tioglis
580454|NCT01095731|Acadione|acadione
580455|NCT01095731|Capen|capen
580456|NCT01095731|Captimer|captimer
580457|NCT01095731|Epatiol|epatiol
580458|NCT01095731|Vincol|vincol
580459|NCT01095731|Mucolysin|mucolysin
580460|NCT01095731|Sutilan|sutilan
580461|NCT01095731|Meprin|meprin
580462|NCT01095731|Thiolpropionamidoacetic acid|thiolpropionamidoacetic acid
580463|NCT01095731|Mercaptopropionyl glycine|mercaptopropionyl glycine
580464|NCT01095731|2 MPG|2 mpg
580465|NCT01095705|Hypnosis|hypnosis
580466|NCT01095705|Transesophageal Echocardiography|transesophageal echocardiography
580467|NCT01095705|Efficiency of Hypnosis|efficiency of hypnosis
580468|NCT01095692|Occult stress Incontinence,|occult stress incontinence,
580469|NCT01095692|Pelvic Organ Prolapse,|pelvic organ prolapse,
580470|NCT01095692|Prevention of stress urinary incontinence,|prevention of stress urinary incontinence,
580471|NCT01095692|Postoperative incontinence,|postoperative incontinence,
580472|NCT01095692|Sub-urethral tape|sub-urethral tape
580473|NCT01095679|CHEYNE Stokes respiration|cheyne stokes respiration
580474|NCT01095679|Periodic ventilation|periodic ventilation
580475|NCT01095679|baclofen|baclofen
580476|NCT01095679|hypoxia|hypoxia
580477|NCT01095679|healthy subject|healthy subject
580478|NCT01095640|acne|acne
580479|NCT01095640|adapalene|adapalene
580480|NCT01095640|Differin|differin
580481|NCT01095614|Women|women
580482|NCT01095614|Hormonal status|hormonal status
580483|NCT01095614|Exercise|exercise
580484|NCT01095614|Substrate utilization|substrate utilization
580485|NCT01095614|Women Hormonal Status (with oral contraception or without any contraception)|women hormonal status (with oral contraception or without any contraception)
580486|NCT01095601|avanafil|avanafil
580487|NCT01095601|absoprion|absoprion
580488|NCT01095601|bioavailability|bioavailability
580489|NCT01095601|food effect|food effect
580490|NCT01095601|dose-proportionality|dose-proportionality
580492|NCT01095601|Pharmacokinetics of avanafil|pharmacokinetics of avanafil
580493|NCT01095588|ED|ed
580497|NCT01095575|Postoperative|postoperative
580498|NCT01095575|Analgesia|analgesia
580499|NCT01095575|Tolerance|tolerance
580500|NCT01095575|Preoperative, Postoperative Analgesia|preoperative, postoperative analgesia
580501|NCT01095549|ankle-brachial index (ABI)|ankle-brachial index (abi)
580502|NCT01095549|brachial-ankle pulse wave velocity (baPWV)|brachial-ankle pulse wave velocity (bapwv)
580503|NCT01095549|far infrared therapy (FIR)|far infrared therapy (fir)
580504|NCT01095549|hemodialysis (HD)|hemodialysis (hd)
580505|NCT01095549|peripheral artery disease (PAD)|peripheral artery disease (pad)
580506|NCT01095549|Peripheral artery disease in hemodialysis|peripheral artery disease in hemodialysis
580507|NCT01095536|laparoscopic cholecystectomy, elective|laparoscopic cholecystectomy, elective
580508|NCT01095536|anesthesia, general|anesthesia, general
580509|NCT01095536|shoulder pain|shoulder pain
580510|NCT01095536|nausea|nausea
580511|NCT01095536|vomiting|vomiting
580512|NCT01095536|laparoscopic cholecystectomy|laparoscopic cholecystectomy
580513|NCT01095536|general anesthesia|general anesthesia
580514|NCT01095523|Colon Cancer|colon cancer
580515|NCT01095523|Rectal Cancer|rectal cancer
580516|NCT01095523|Peritoneal Perfusion|peritoneal perfusion
580517|NCT01095523|Metastatic Cancer|metastatic cancer
580518|NCT01095523|Recurrence|recurrence
580519|NCT01095523|Colorectal Cancer|colorectal cancer
580520|NCT01095510|CINRYZE|cinryze
580521|NCT01095510|C1 INH|c1 inh
580522|NCT01095510|HAE|hae
580523|NCT01095510|C1 inhibitor|c1 inhibitor
580524|NCT01095510|Pediatric|pediatric
580525|NCT01095510|PK/PD|pk/pd
580526|NCT01095497|HAE|hae
580527|NCT01095497|C1 inhibitor (C1INH)|c1 inhibitor (c1inh)
580528|NCT01095497|Subcutaneous|subcutaneous
580529|NCT01095484|Rotigotine|rotigotine
580530|NCT01095484|Neupro®|neupro®
580531|NCT01095471|7 valent Pneumococcal conjugate vaccine|7 valent pneumococcal conjugate vaccine
580532|NCT01095471|13 valent Pneumococcal conjugate vaccine|13 valent pneumococcal conjugate vaccine
580533|NCT01095471|PCV13|pcv13
580534|NCT01095471|PCV7|pcv7
580535|NCT01095458|Obesity|obesity
580536|NCT01095458|Phone vs Clinical methods|phone vs clinical methods
580537|NCT01095445|hepatitis C|hepatitis c
580538|NCT01095445|genotype 3|genotype 3
580539|NCT01095445|end of treatment response|end of treatment response
580540|NCT01095445|relapse rate|relapse rate
580541|NCT01095445|rapid virologic response|rapid virologic response
580542|NCT01095445|complete early virologic response|complete early virologic response
580543|NCT01095432|Colonoscopy|colonoscopy
580544|NCT01095432|Flexible Sigmoidoscopy|flexible sigmoidoscopy
580545|NCT01095419|massage therapy|massage therapy
580546|NCT01095419|sleep quality|sleep quality
580547|NCT01095419|coronary artery bypass grafting surgery|coronary artery bypass grafting surgery
580548|NCT01095419|Patients after Coronary Artery Bypass Graft Surgery|patients after coronary artery bypass graft surgery
580549|NCT01095406|Weaning|weaning
580550|NCT01095406|closed loop|closed loop
580551|NCT01095406|mechanical ventilation|mechanical ventilation
580552|NCT01095406|children|children
580553|NCT01095393|Certolizumab Pegol|certolizumab pegol
580554|NCT01095393|CZP|czp
580555|NCT01095393|Cimzia®|cimzia®
580556|NCT01095393|NDB|ndb
580557|NCT01095393|registry|registry
580558|NCT01095380|task-specific training|task-specific training
580559|NCT01095380|walking|walking
580560|NCT01095380|locomotion|locomotion
580561|NCT01095380|function|function
580562|NCT01095380|body weight support|body weight support
580563|NCT01095380|Individuals with motor-incomplete spinal cord injury|individuals with motor-incomplete spinal cord injury
580564|NCT01095367|Adhesion barrier sheets|adhesion barrier sheets
580565|NCT01095367|ovarian cancer|ovarian cancer
580566|NCT01095367|Advanced stage epithelial ovarian cancer|advanced stage epithelial ovarian cancer
580567|NCT01095354|pediatric|pediatric
580568|NCT01095354|lung ventilation inhomogeneity|lung ventilation inhomogeneity
580569|NCT01095341|hyperthyroidism|hyperthyroidism
580570|NCT01095341|tertiary hyperparathyroidism|tertiary hyperparathyroidism
580571|NCT01095341|palpation thyroiditis|palpation thyroiditis
580572|NCT01095341|parathyroidectomy|parathyroidectomy
580573|NCT01095341|thyroglobulin|thyroglobulin
580574|NCT01095341|rate of postoperative hyperthyroidism|rate of postoperative hyperthyroidism
580575|NCT01095328|Q fever|q fever
580576|NCT01095328|Pregnancy|pregnancy
580577|NCT01095328|Screening|screening
580578|NCT01095328|Cost-effectiveness|cost-effectiveness
580579|NCT01095289|electromyography|electromyography
580580|NCT01095289|laryngeal neoplasms|laryngeal neoplasms
580581|NCT01095289|masticatory muscles|masticatory muscles
580582|NCT01095276|Mechanical Ventilation|mechanical ventilation
580583|NCT01095276|Extubation|extubation
580584|NCT01095276|dornase alpha|dornase alpha
580585|NCT01095276|oxygenation|oxygenation
580586|NCT01095276|chest x ray|chest x ray
580587|NCT01095250|Active uveitis|active uveitis
580588|NCT01095250|intermediate uveitis|intermediate uveitis
580589|NCT01095250|panuveitis|panuveitis
580590|NCT01095250|posterior uveitis|posterior uveitis
580591|NCT01095250|uveitis|uveitis
581258|NCT01092546|Amyloid|amyloid
580592|NCT01095237|Peripheral Arterial Disease|peripheral arterial disease
580593|NCT01095237|Peripheral Vascular Disease|peripheral vascular disease
580594|NCT01095237|PAD|pad
580595|NCT01095237|vascular prosthesis|vascular prosthesis
580596|NCT01095237|revascularization|revascularization
580597|NCT01095237|patency|patency
580598|NCT01095237|blood vessel|blood vessel
580599|NCT01095237|Rutherford|rutherford
580600|NCT01095237|ABI|abi
580601|NCT01095237|Ankle Brachial Index|ankle brachial index
580602|NCT01095237|Vascular Graft|vascular graft
580603|NCT01095237|Carbothane|carbothane
580604|NCT01095237|ProEndoTecc|proendotecc
580605|NCT01095237|implantation|implantation
580606|NCT01095224|HIV Preventive Vaccine|hiv preventive vaccine
580607|NCT01095211|folic acid|folic acid
580608|NCT01095211|homocysteine|homocysteine
580609|NCT01095211|MMSE scores|mmse scores
580610|NCT01095211|methyl malonic acid|methyl malonic acid
580611|NCT01095211|betaine|betaine
580612|NCT01095198|vaginal self collection|vaginal self collection
580613|NCT01095198|human papillomavirus (hpv)|human papillomavirus (hpv)
580614|NCT01095198|cervical intraepithelial neoplasia|cervical intraepithelial neoplasia
580615|NCT01095172|Immunosuppression|immunosuppression
580616|NCT01095172|Rituximab|rituximab
580617|NCT01095172|B cell|b cell
580618|NCT01095159|TVTO|tvto
580619|NCT01095159|TVTSecur|tvtsecur
580620|NCT01095159|Mini sling|mini sling
580621|NCT01095159|stress urinary incontinence|stress urinary incontinence
580622|NCT01095146|MAS|mas
580623|NCT01095146|Hemophagocytosis|hemophagocytosis
580624|NCT01095146|Reactive HLH|reactive hlh
580625|NCT01095146|Macrophage activation syndrome|macrophage activation syndrome
580626|NCT01095146|Systemic onset juvenile idiopathic arthritis|systemic onset juvenile idiopathic arthritis
580627|NCT01095146|SoJIA|sojia
580628|NCT01095146|JIA|jia
580629|NCT01095133|Gastroesophageal reflux disease|gastroesophageal reflux disease
580630|NCT01095133|Heartburn|heartburn
580631|NCT01095107|Determining whether adjustments in the amounts of fat grams within the current inpatient protocol meal plans will lead to a change in the hospital stay duration|determining whether adjustments in the amounts of fat grams within the current inpatient protocol meal plans will lead to a change in the hospital stay duration
580632|NCT01095107|Alter their recovery by affecting vital signs|alter their recovery by affecting vital signs
580633|NCT01095107|Rate of weight change or need for supplemental feeds/medications|rate of weight change or need for supplemental feeds/medications
580634|NCT01095107|Effect gastrointestinal symptoms (bloating, gastroesophageal reflux, constipation, diarrhea, abdominal pain|effect gastrointestinal symptoms (bloating, gastroesophageal reflux, constipation, diarrhea, abdominal pain
711562|NCT00584038|contraceptive compliance|contraceptive compliance
580635|NCT01095107|And/or effect their perceived body image or cause any changes in their mood.|and/or effect their perceived body image or cause any changes in their mood.
580636|NCT01095094|adult brain tumor|adult brain tumor
580637|NCT01095094|adult anaplastic astrocytoma|adult anaplastic astrocytoma
580638|NCT01095094|adult anaplastic ependymoma|adult anaplastic ependymoma
580639|NCT01095094|adult anaplastic oligodendroglioma|adult anaplastic oligodendroglioma
580640|NCT01095094|adult brain stem glioma|adult brain stem glioma
580641|NCT01095094|adult giant cell glioblastoma|adult giant cell glioblastoma
580642|NCT01095094|adult glioblastoma|adult glioblastoma
580643|NCT01095094|adult gliosarcoma|adult gliosarcoma
580644|NCT01095094|adult mixed glioma|adult mixed glioma
580645|NCT01095094|recurrent adult brain tumor|recurrent adult brain tumor
580646|NCT01095042|HRV|hrv
580647|NCT01095042|emotion|emotion
580648|NCT01095042|cognition|cognition
580649|NCT01095042|stress|stress
580650|NCT01095042|cortisol|cortisol
580651|NCT01095042|Autonomic nervous system|autonomic nervous system
580652|NCT01095029|Positron emission tomography (PET)|positron emission tomography (pet)
580653|NCT01095029|Idiopathic Faecal Incontinence|idiopathic faecal incontinence
580654|NCT01095029|Bilateral Sacral Nerve Stimulation|bilateral sacral nerve stimulation
580655|NCT01095029|Sacral Nerve Stimulation|sacral nerve stimulation
580656|NCT01095029|Sacral Nervemodulation|sacral nervemodulation
580657|NCT01094990|crossover; double blinded; intrathecal chemotherapy; dexamethasone; ketamine;vomiting|crossover; double blinded; intrathecal chemotherapy; dexamethasone; ketamine;vomiting
580658|NCT01094977|Blood Loss and Transfusion|blood loss and transfusion
580659|NCT01094977|Craniosynostoses|craniosynostoses
580660|NCT01094977|Tranexamic Acid|tranexamic acid
580661|NCT01094977|Children|children
580662|NCT01094964|recurrent bladder cancer|recurrent bladder cancer
580663|NCT01094964|stage 0 bladder cancer|stage 0 bladder cancer
580664|NCT01094964|stage I bladder cancer|stage i bladder cancer
580665|NCT01094964|adenocarcinoma of the bladder|adenocarcinoma of the bladder
580666|NCT01094964|squamous cell carcinoma of the bladder|squamous cell carcinoma of the bladder
580667|NCT01094951|Depression|depression
580668|NCT01094938|Aortic aneurysm repair|aortic aneurysm repair
580669|NCT01094925|Cesarean section|cesarean section
580670|NCT01094925|Gabapentin|gabapentin
580671|NCT01094912|Cancer pain|cancer pain
580672|NCT01094899|diabetes|diabetes
580673|NCT01094899|osteopenia|osteopenia
580674|NCT01094899|neuropathy|neuropathy
580675|NCT01094899|foot|foot
580676|NCT01094899|AGE|age
580677|NCT01094886|Total Hip Replacement|total hip replacement
580678|NCT01094886|Total Knee Replacement|total knee replacement
580679|NCT01094886|Hip Implant|hip implant
580680|NCT01094886|Knee Implant|knee implant
580681|NCT01094886|Joint Prosthesis|joint prosthesis
580682|NCT01094886|Orthopedic Surgery|orthopedic surgery
580683|NCT01094886|Rivaroxaban|rivaroxaban
580684|NCT01094886|Xarelto|xarelto
580685|NCT01094886|Blood Clot|blood clot
580686|NCT01094873|Hepatitis C|hepatitis c
580687|NCT01094873|HCV|hcv
580688|NCT01094873|Adenovirus|adenovirus
580689|NCT01094873|Vaccine|vaccine
580690|NCT01094860|Relapsed/Refractory Lymphoid Malignancies|relapsed/refractory lymphoid malignancies
580691|NCT01094860|Chronic lymphocytic leukemia|chronic lymphocytic leukemia
580692|NCT01094860|CLL|cll
580693|NCT01094860|Small lymphocytic lymphoma|small lymphocytic lymphoma
580694|NCT01094860|SLL|sll
580695|NCT01094860|B-prolymphocytic leukemia|b-prolymphocytic leukemia
580696|NCT01094860|Follicular lymphoma|follicular lymphoma
580697|NCT01094860|Mantle cell lymphoma|mantle cell lymphoma
580698|NCT01094860|Lymphoplasmacytoid lymphoma|lymphoplasmacytoid lymphoma
580699|NCT01094860|Marginal zone lymphoma|marginal zone lymphoma
580700|NCT01094860|T-cell prolymphocytic leukemia|t-cell prolymphocytic leukemia
580701|NCT01094860|large granular lymphocyte leukemia|large granular lymphocyte leukemia
580702|NCT01094860|mycosis fungoides|mycosis fungoides
580703|NCT01094860|Sezary syndrome|sezary syndrome
580704|NCT01094860|peripheral T-cell lymphoma|peripheral t-cell lymphoma
580705|NCT01094860|Chemotherapy|chemotherapy
580706|NCT01094860|Monoclonal antibody therapy|monoclonal antibody therapy
580707|NCT01094860|T-cell or B-cell acute lymphoblastic leukemia (ALL)|t-cell or b-cell acute lymphoblastic leukemia (all)
580708|NCT01094860|Continuous Infusion Nelarabine|continuous infusion nelarabine
580709|NCT01094860|Arranon|arranon
580710|NCT01094821|Healthy volunteers|healthy volunteers
580711|NCT01094821|ATI-7505|ati-7505
580712|NCT01094821|Scintigraphy|scintigraphy
580713|NCT01094821|Gastrointestinal transit|gastrointestinal transit
580714|NCT01094808|pregabalin|pregabalin
580715|NCT01094808|motor|motor
580716|NCT01094808|sensation|sensation
580717|NCT01094808|colon|colon
580718|NCT01094808|pain|pain
580719|NCT01094808|gas|gas
580720|NCT01094782|Pain|pain
580721|NCT01094782|Pain management|pain management
580722|NCT01094756|Obesity|obesity
580723|NCT01094717|psoriasis|psoriasis
580724|NCT01094717|excimer|excimer
580725|NCT01094717|acitretin|acitretin
580726|NCT01094717|tazarotene|tazarotene
580727|NCT01094704|cystic fibrosis|cystic fibrosis
580728|NCT01094704|mucociliary clearance|mucociliary clearance
580729|NCT01094704|hypertonic saline|hypertonic saline
580730|NCT01094678|Peripheral Aterial Disease (PAD)|peripheral aterial disease (pad)
580731|NCT01094678|Peripheral Vascular Disease|peripheral vascular disease
580732|NCT01094678|Drug-Eluting Stent|drug-eluting stent
580733|NCT01094678|Drug-Coated Stent|drug-coated stent
580734|NCT01094678|Vascular Diseases|vascular diseases
580735|NCT01094678|Cardiovascular Diseases|cardiovascular diseases
580736|NCT01094652|Adolescent|adolescent
580737|NCT01094652|Whole grain|whole grain
580738|NCT01094652|Digestive health|digestive health
580739|NCT01094652|Dietary fiber|dietary fiber
580740|NCT01094652|Grain|grain
580741|NCT01094652|Microbiota|microbiota
580742|NCT01094652|Inflammation|inflammation
580743|NCT01094652|Mucosal Immunity|mucosal immunity
580744|NCT01094626|Pancreatic adenocarcinoma|pancreatic adenocarcinoma
580745|NCT01094626|Intraductal papillary mucinous neoplasm|intraductal papillary mucinous neoplasm
580746|NCT01094626|Imaging techniques|imaging techniques
580747|NCT01094626|Pancreatic surgical resection|pancreatic surgical resection
580748|NCT01094626|Synthetic human secretin|synthetic human secretin
580749|NCT01094613|Crohn's Disease|crohn's disease
580750|NCT01094613|Delayed Release|delayed release
580751|NCT01094613|Targeted Ileal Delivery|targeted ileal delivery
580752|NCT01094600|Pancreatic cancer|pancreatic cancer
580753|NCT01094600|Pancreatic resection|pancreatic resection
580754|NCT01094600|Synthetic human secretin|synthetic human secretin
580755|NCT01094600|Secretin-enhanced MRCP|secretin-enhanced mrcp
580756|NCT01094600|Endoscopic pancreatic function test|endoscopic pancreatic function test
580757|NCT01094600|Pancreatic exocrine insufficiency|pancreatic exocrine insufficiency
580758|NCT01094561|Family history of pancreatic cancer|family history of pancreatic cancer
580759|NCT01094561|Pancreatic adenocarcinoma|pancreatic adenocarcinoma
580760|NCT01094561|Imaging techniques|imaging techniques
580761|NCT01094561|Synthetic human secretin|synthetic human secretin
580762|NCT01094561|Pancreatic abnormalities|pancreatic abnormalities
580763|NCT01094561|Early detection and prevention|early detection and prevention
580764|NCT01094548|L-BLP25 liposome|l-blp25 liposome
580765|NCT01094548|Multiple myeloma|multiple myeloma
580766|NCT01094535|Pancreatic adenocarcinoma|pancreatic adenocarcinoma
580767|NCT01094535|Synthetic human secretin|synthetic human secretin
580768|NCT01094535|Secretin-enhanced MRCP|secretin-enhanced mrcp
580769|NCT01094535|Pancreatic insufficiency|pancreatic insufficiency
580770|NCT01094535|Endoscopic Pancreatic Function Test (ePFT)|endoscopic pancreatic function test (epft)
580771|NCT01094535|Endocrine pancreatic function test|endocrine pancreatic function test
580772|NCT01094535|Exocrine pancreatic function test|exocrine pancreatic function test
580773|NCT01094496|bladder cancer|bladder cancer
581927|NCT01089634|LVCM|lvcm
580774|NCT01094496|immunotherapy|immunotherapy
580775|NCT01094496|cystectomy|cystectomy
580776|NCT01094496|cancer vaccine|cancer vaccine
580777|NCT01094496|human chorionic gonadotropin|human chorionic gonadotropin
580778|NCT01094496|hCG|hcg
580779|NCT01094496|urogenital neoplasms|urogenital neoplasms
580780|NCT01094496|urinary bladder neoplasms|urinary bladder neoplasms
580781|NCT01094496|muscle invasive|muscle invasive
580782|NCT01094496|non-metastatic|non-metastatic
580783|NCT01094496|transitional cell (urothelial) bladder cancer|transitional cell (urothelial) bladder cancer
580784|NCT01094483|Thromboxane B2|thromboxane b2
580785|NCT01094470|gait|gait
580786|NCT01094470|ambulation|ambulation
580787|NCT01094470|kinematics|kinematics
580788|NCT01094457|antiplatelet therapy|antiplatelet therapy
580789|NCT01094457|clopidogrel low responsiveness|clopidogrel low responsiveness
580790|NCT01094457|acute coronary syndromes|acute coronary syndromes
580791|NCT01094457|percutaneous coronary intervention|percutaneous coronary intervention
580792|NCT01094457|cilostazol|cilostazol
580793|NCT01094444|Vitamin K3 lotion|vitamin k3 lotion
580794|NCT01094444|Cetuximab induced folliculitis|cetuximab induced folliculitis
580795|NCT01094431|Fever|fever
580796|NCT01094431|Etiology|etiology
580797|NCT01094431|Children under five years of age|children under five years of age
580798|NCT01094431|IMCI|imci
580799|NCT01094418|polyneuropathy|polyneuropathy
580800|NCT01094418|Nerve conduction study|nerve conduction study
580801|NCT01094418|Impaired glucose tolerance test|impaired glucose tolerance test
580802|NCT01094418|Diabetes mellitus|diabetes mellitus
580803|NCT01094405|NPC with persistent, recurrent or metastatic disease patients|npc with persistent, recurrent or metastatic disease patients
580804|NCT01094392|ALL|all
580805|NCT01094392|PEG-asparaginase|peg-asparaginase
580806|NCT01094392|prolonged treatment|prolonged treatment
580807|NCT01094392|Thrombosis|thrombosis
580808|NCT01094392|Central venous line|central venous line
580809|NCT01094392|Echocardiography|echocardiography
580810|NCT01094379|cholecystectomy|cholecystectomy
580811|NCT01094379|laparoscopic|laparoscopic
580812|NCT01094379|pain|pain
580813|NCT01094379|single incision|single incision
580814|NCT01094366|Paracervical Block|paracervical block
580815|NCT01094366|pain control|pain control
580816|NCT01094366|abortion|abortion
580817|NCT01094353|Urodynamic Stress urinary incontinence|urodynamic stress urinary incontinence
580818|NCT01094353|Minisling|minisling
580819|NCT01094353|Ophira™|ophira™
580820|NCT01094353|Unitape™|unitape™
580821|NCT01094327|focal segmental glomerulosclerosis|focal segmental glomerulosclerosis
580822|NCT01094301|electrical stimulation|electrical stimulation
580823|NCT01094301|neurostimulation|neurostimulation
580824|NCT01094301|neuromodulation|neuromodulation
580825|NCT01094301|shoulder pain|shoulder pain
580826|NCT01094301|post-stroke shoulder pain|post-stroke shoulder pain
580827|NCT01094301|hemiplegic shoulder pain|hemiplegic shoulder pain
580828|NCT01094275|drug resistance|drug resistance
580829|NCT01094275|gene polymorphism|gene polymorphism
580830|NCT01094262|Osteoarthritis pain of the knee|osteoarthritis pain of the knee
580831|NCT01094262|Osteoarthritis|osteoarthritis
580832|NCT01094262|Osteoarthritis, Knee|osteoarthritis, knee
580833|NCT01094262|Pain|pain
580834|NCT01094262|Arthralgia|arthralgia
580835|NCT01094262|Joint Pain|joint pain
580836|NCT01094262|JNJ-42160443|jnj-42160443
580837|NCT01094249|Paliperidone ER|paliperidone er
580838|NCT01094249|INVEGA|invega
580839|NCT01094249|Divalproex sodium|divalproex sodium
580840|NCT01094249|Depakote ER|depakote er
580841|NCT01094249|Valproic acid|valproic acid
580842|NCT01094249|Pharmacokinetics|pharmacokinetics
580843|NCT01094249|R076477BIM1004|r076477bim1004
580844|NCT01094236|behavior management|behavior management
580845|NCT01094236|academic performance|academic performance
580846|NCT01094236|playground supervision|playground supervision
580847|NCT01094236|harm reduction|harm reduction
580848|NCT01094236|Behavioral Research|behavioral research
580849|NCT01094223|Stimulant|stimulant
580850|NCT01094223|Addiction|addiction
580851|NCT01094223|Mindfulness|mindfulness
580852|NCT01094223|Treatment|treatment
580853|NCT01094210|Anti-erosion dental benefits|anti-erosion dental benefits
580854|NCT01094197|Transfusion-associated microchimerism|transfusion-associated microchimerism
580855|NCT01094197|Injuries|injuries
580856|NCT01094197|Leukocytes|leukocytes
580857|NCT01094171|poliomyelitis|poliomyelitis
580858|NCT01094171|diphtheria|diphtheria
580859|NCT01094171|Primary immunization|primary immunization
580860|NCT01094171|pertussis|pertussis
580861|NCT01094171|Children|children
580862|NCT01094171|tetanus|tetanus
580863|NCT01094158|NAFLD|nafld
580864|NCT01094158|NASH|nash
580865|NCT01094158|Fatty Liver|fatty liver
580866|NCT01094158|Metabolic Syndrome|metabolic syndrome
580867|NCT01094158|Endothelial Dysfunction|endothelial dysfunction
580868|NCT01094158|Insulin Resistance|insulin resistance
580869|NCT01094158|Liver Fat|liver fat
580870|NCT01094145|(light to moderate)|(light to moderate)
580871|NCT01094132|cervical cancer|cervical cancer
580872|NCT01094132|cervical intraepithelial neoplasia grade 1|cervical intraepithelial neoplasia grade 1
580873|NCT01094132|cervical intraepithelial neoplasia grade 2|cervical intraepithelial neoplasia grade 2
580874|NCT01094132|cervical intraepithelial neoplasia grade 3|cervical intraepithelial neoplasia grade 3
580875|NCT01094132|Nonmalignant Condition|nonmalignant condition
580876|NCT01094119|heated blanket|heated blanket
580877|NCT01094119|heated pad|heated pad
580878|NCT01094106|postoperative pain|postoperative pain
580879|NCT01094106|infiltration analgesia|infiltration analgesia
580880|NCT01094106|ropivacaine|ropivacaine
580881|NCT01094106|Caesarean Section|caesarean section
580882|NCT01094093|Amgen|amgen
580883|NCT01094093|AMG 139|amg 139
580884|NCT01094080|fully formula fed|fully formula fed
580885|NCT01094080|fully breast fed|fully breast fed
580886|NCT01094041|Gluten|gluten
580887|NCT01094041|Diarrhea or diarrhea predominant irritable bowel syndrome|diarrhea or diarrhea predominant irritable bowel syndrome
580888|NCT01094041|Colonic permeability|colonic permeability
580889|NCT01094041|Small bowel permeability|small bowel permeability
580890|NCT01094041|Colonic inflammatory response|colonic inflammatory response
580891|NCT01094041|Small bowel inflammatory response|small bowel inflammatory response
580892|NCT01094028|Blood loss in the third and fourth stage of labor and the duration of third stage of labor|blood loss in the third and fourth stage of labor and the duration of third stage of labor
580893|NCT01094015|hysteroscopy|hysteroscopy
580894|NCT01094015|local anaesthetic|local anaesthetic
580895|NCT01094015|pain relief|pain relief
580896|NCT01094015|gynecological pathology|gynecological pathology
580897|NCT01094002|OCCUPATIONAL THERAPY|occupational therapy
580898|NCT01094002|RANDOMISED CLINICAL TRIAL|randomised clinical trial
580899|NCT01094002|AGED|aged
580900|NCT01094002|PATIENT CARE|patient care
580901|NCT01093976|Skin Picking|skin picking
580902|NCT01093976|OCD|ocd
580903|NCT01093976|Trichotillomania|trichotillomania
580904|NCT01093976|Pathological Skin Picking|pathological skin picking
580905|NCT01093950|anthropometric|anthropometric
580906|NCT01093950|white light scanner|white light scanner
580907|NCT01093950|extraction profiles|extraction profiles
580908|NCT01093950|Body lipodystrophy|body lipodystrophy
580909|NCT01093937|Bipolar disorder|bipolar disorder
580910|NCT01093937|Bipolar-I|bipolar-i
580911|NCT01093937|Varenicline|varenicline
580912|NCT01093937|Champix|champix
580913|NCT01093937|Chantix|chantix
580914|NCT01093937|Nicotine|nicotine
580915|NCT01093937|Nicotinic receptor|nicotinic receptor
580916|NCT01093937|Nicotinic receptor dysregulation|nicotinic receptor dysregulation
580917|NCT01093937|Dopamine|dopamine
580918|NCT01093937|Acetylcholine|acetylcholine
580919|NCT01093937|Cigarette|cigarette
580920|NCT01093937|Smoking|smoking
580921|NCT01093937|Tobacco|tobacco
580922|NCT01093937|Dependence|dependence
580923|NCT01093937|Neuropsychological function|neuropsychological function
580924|NCT01093924|Behavioral weight loss maintenance intervention|behavioral weight loss maintenance intervention
580925|NCT01093924|Weight loss|weight loss
580926|NCT01093924|Weight loss maintenance|weight loss maintenance
580927|NCT01093911|Lupus|lupus
580928|NCT01093911|SLE|sle
580929|NCT01093859|acetylcholinesterase|acetylcholinesterase
580930|NCT01093846|uveitis|uveitis
580931|NCT01093833|Diabetes|diabetes
580932|NCT01093833|Type 1 diabetes|type 1 diabetes
580933|NCT01093833|Type 2 diabetes|type 2 diabetes
580934|NCT01093833|Diabetes mellitus|diabetes mellitus
580935|NCT01093833|Blood glucose|blood glucose
580936|NCT01093833|Continuous blood glucose monitoring|continuous blood glucose monitoring
580937|NCT01093833|CGM|cgm
580938|NCT01093820|acute myocardial infarction|acute myocardial infarction
580939|NCT01093820|continuous erythropoetin receptor activator|continuous erythropoetin receptor activator
580940|NCT01093820|Mircera|mircera
580941|NCT01093820|hemoglobin kinetics|hemoglobin kinetics
580942|NCT01093807|Hypertension|hypertension
580943|NCT01093807|Lercanidipine|lercanidipine
580944|NCT01093807|Calcium antagonist|calcium antagonist
580945|NCT01093807|Enalapril|enalapril
580946|NCT01093794|Type 2 Diabetes|type 2 diabetes
580947|NCT01093781|membranous nephropathy aliskiren proteinuria, glomerulonephritis|membranous nephropathy aliskiren proteinuria, glomerulonephritis
580948|NCT01093768|Oxytocin|oxytocin
580949|NCT01093768|Vasopressin|vasopressin
580950|NCT01093768|Autism|autism
580951|NCT01093768|Amygdala|amygdala
580952|NCT01093768|Social Cognition|social cognition
580953|NCT01093768|Autism Spectrum Disorders|autism spectrum disorders
580954|NCT01093768|ASD|asd
580955|NCT01093768|Healthy Volunteer|healthy volunteer
580956|NCT01093768|HV|hv
580957|NCT01093755|Barrett's Esophagus|barrett's esophagus
580958|NCT01093755|Radiofrequency ablation|radiofrequency ablation
580959|NCT01093755|Patients post-radiofrequency ablation for Barrett's Esophagus.|patients post-radiofrequency ablation for barrett's esophagus.
580960|NCT01093742|Healthy|healthy
580961|NCT01093729|Exendin-4|exendin-4
580962|NCT01093716|Alcohol dependence|alcohol dependence
580963|NCT01093716|Craving|craving
580964|NCT01093716|rTMS|rtms
580965|NCT01093716|Dorsolateral prefrontal cortex|dorsolateral prefrontal cortex
580966|NCT01093703|kidney transplantation|kidney transplantation
580967|NCT01093703|hypertension|hypertension
580968|NCT01093703|chronotherapy|chronotherapy
582220|NCT01088516|Aluvia|aluvia
580969|NCT01093703|graft function|graft function
580970|NCT01093703|circadian pattern|circadian pattern
580971|NCT01093690|chemotherapy induced nausea and vomiting, metoclopramide|chemotherapy induced nausea and vomiting, metoclopramide
580972|NCT01093612|HER2-positive breast cancer|her2-positive breast cancer
580973|NCT01093599|Smoking|smoking
580974|NCT01093599|Smoking cessation|smoking cessation
580975|NCT01093599|Nicotine|nicotine
580976|NCT01093599|Tobacco|tobacco
580977|NCT01093599|Mindfulness|mindfulness
580978|NCT01093599|Meditation|meditation
580979|NCT01093599|MBSR|mbsr
580980|NCT01093599|Mindfulness Training|mindfulness training
580981|NCT01093599|Behavioral Intervention|behavioral intervention
580982|NCT01093599|Nicotine Patch|nicotine patch
580983|NCT01093599|Quit Line|quit line
580984|NCT01093599|Phone counseling|phone counseling
580985|NCT01093573|Untreated myelodysplastic syndromes|untreated myelodysplastic syndromes
580986|NCT01093560|metabolic syndrome|metabolic syndrome
580987|NCT01093560|premenopausal women|premenopausal women
580988|NCT01093560|fat feeding|fat feeding
580989|NCT01093534|Vesicare|vesicare
580990|NCT01093534|Solifenacin|solifenacin
580991|NCT01093534|Detrusor Overactivity|detrusor overactivity
580992|NCT01093534|Urinary Nerve Growth Factor|urinary nerve growth factor
580993|NCT01093534|Overactive Bladder|overactive bladder
580994|NCT01093534|Bladder wall thickness|bladder wall thickness
580995|NCT01093521|IV Gallium|iv gallium
580996|NCT01093521|Gallium|gallium
580997|NCT01093521|Ganite|ganite
580998|NCT01093521|Cystic Fibrosis|cystic fibrosis
580999|NCT01093521|Gallium Infusion|gallium infusion
581000|NCT01093495|Nasal Continuous positive Airway pressure|nasal continuous positive airway pressure
581001|NCT01093495|Nasal Cannula|nasal cannula
581002|NCT01093495|CPAP|cpap
581003|NCT01093495|Premature|premature
581005|NCT01093495|HMD|hmd
581006|NCT01093495|NICU|nicu
581007|NCT01093482|mechanical ventilation|mechanical ventilation
581008|NCT01093482|epidemiology|epidemiology
581009|NCT01093482|outcomes|outcomes
581010|NCT01093482|mortality|mortality
581011|NCT01093482|weaning|weaning
581012|NCT01093482|sedation|sedation
711563|NCT00584038|educational intervention|educational intervention
581013|NCT01093482|non-invasive positive pressure ventilation|non-invasive positive pressure ventilation
581014|NCT01093469|Atopic Dermatitis|atopic dermatitis
581015|NCT01093469|Wake Forest|wake forest
581016|NCT01093469|Dermatology|dermatology
581017|NCT01093469|Skin|skin
581018|NCT01093469|Over-the-counter|over-the-counter
581019|NCT01093469|Moisturizer|moisturizer
581020|NCT01093469|Children|children
581021|NCT01093456|diurnal variation|diurnal variation
581022|NCT01093456|peritoneal dialysis|peritoneal dialysis
581023|NCT01093456|uremic retention solutes|uremic retention solutes
581024|NCT01093456|phosphorous|phosphorous
581025|NCT01093456|indoxyl sulfate|indoxyl sulfate
581026|NCT01093456|p-cresol sulfate|p-cresol sulfate
581027|NCT01093443|IVF|ivf
581028|NCT01093443|ICSI|icsi
581029|NCT01093443|GnRH antagonist|gnrh antagonist
581030|NCT01093443|pretreatment|pretreatment
581031|NCT01093430|Gynecological surgery|gynecological surgery
581032|NCT01093430|laparoscopic ports|laparoscopic ports
581033|NCT01093430|neuropathy|neuropathy
581034|NCT01093417|Vitamin D|vitamin d
581035|NCT01093417|Human Immunodeficiency Virus (HIV)|human immunodeficiency virus (hiv)
581036|NCT01093417|Complementary Therapies|complementary therapies
581037|NCT01093404|Heart disease|heart disease
581038|NCT01093404|Myocardial infarction|myocardial infarction
581039|NCT01093404|Angioplasty|angioplasty
581040|NCT01093404|Thrombus aspiration|thrombus aspiration
581041|NCT01093391|coronary artery|coronary artery
581042|NCT01093391|thrombosis|thrombosis
581043|NCT01093391|stent|stent
581044|NCT01093378|Infertility|infertility
581045|NCT01093378|Obesity|obesity
581046|NCT01093378|Dietary intake|dietary intake
581047|NCT01093378|Fertility|fertility
581048|NCT01093378|nutrition|nutrition
581049|NCT01093378|diet|diet
581050|NCT01093378|weight|weight
581051|NCT01093365|Schizophrenia|schizophrenia
581052|NCT01093365|Schizoaffective Disorder|schizoaffective disorder
581053|NCT01093365|Varenicline|varenicline
581054|NCT01093365|Champix|champix
581055|NCT01093365|Chantix|chantix
581056|NCT01093365|Nicotine|nicotine
581057|NCT01093365|Nicotinic receptor|nicotinic receptor
581058|NCT01093365|Dopamine|dopamine
581059|NCT01093365|Acetylcholine|acetylcholine
581060|NCT01093365|Cigarette|cigarette
581061|NCT01093365|Smoking|smoking
581062|NCT01093365|Tobacco|tobacco
581063|NCT01093365|Executive function|executive function
581064|NCT01093365|Working memory|working memory
581065|NCT01093365|Verbal memory|verbal memory
581066|NCT01093365|Cognitive function|cognitive function
581067|NCT01093365|Neuropsychological function|neuropsychological function
581068|NCT01093352|Alveolar-decortication|alveolar-decortication
581069|NCT01093352|Corticotomy assisted orthodontics|corticotomy assisted orthodontics
581070|NCT01093352|Palatally impacted canine|palatally impacted canine
581071|NCT01093352|Surgical exposure of canines|surgical exposure of canines
581072|NCT01093352|Velocity of tooth movement|velocity of tooth movement
581073|NCT01093339|GERD|gerd
581074|NCT01093339|SLEEP DEPRIVATION|sleep deprivation
581075|NCT01093339|APPETITE REGULATION|appetite regulation
581076|NCT01093339|GHRELIN|ghrelin
581077|NCT01093339|LEPTIN|leptin
581078|NCT01093274|colonoscopy|colonoscopy
581079|NCT01093274|Cathartics|cathartics
581080|NCT01093274|Sodium picosulfate|sodium picosulfate
581081|NCT01093274|Polyethylene Glycol|polyethylene glycol
581082|NCT01093261|trauma|trauma
581083|NCT01093261|trauma brain injury|trauma brain injury
581084|NCT01093261|multiple trauma|multiple trauma
581085|NCT01093261|head trauma|head trauma
581086|NCT01093261|hydrocortisone|hydrocortisone
581087|NCT01093261|fludrocortisone|fludrocortisone
581088|NCT01093261|glucocorticoid insufficiency related to ICU|glucocorticoid insufficiency related to icu
581089|NCT01093261|adrenal Insufficiency|adrenal insufficiency
581090|NCT01093261|pneumonia|pneumonia
581091|NCT01093261|intensive care unit|intensive care unit
581092|NCT01093261|shock|shock
581093|NCT01093261|neurological recovery|neurological recovery
581094|NCT01093235|cardiac toxicity|cardiac toxicity
581095|NCT01093235|perioperative/postoperative complications|perioperative/postoperative complications
581096|NCT01093235|HER2-negative breast cancer|her2-negative breast cancer
581097|NCT01093235|male breast cancer|male breast cancer
581098|NCT01093235|estrogen receptor-negative breast cancer|estrogen receptor-negative breast cancer
581099|NCT01093235|estrogen receptor-positive breast cancer|estrogen receptor-positive breast cancer
581100|NCT01093235|progesterone receptor-negative breast cancer|progesterone receptor-negative breast cancer
581101|NCT01093235|progesterone receptor-positive breast cancer|progesterone receptor-positive breast cancer
581102|NCT01093235|stage II breast cancer|stage ii breast cancer
581103|NCT01093235|stage IIIA breast cancer|stage iiia breast cancer
581104|NCT01093235|stage IIIB breast cancer|stage iiib breast cancer
581105|NCT01093235|inflammatory breast cancer|inflammatory breast cancer
581106|NCT01093209|Carpal Tunnel Syndrome|carpal tunnel syndrome
581107|NCT01093209|Interferential laser therapy|interferential laser therapy
581108|NCT01093209|Low-level laser therapy|low-level laser therapy
581109|NCT01093209|Neuropathic pain|neuropathic pain
581110|NCT01093209|Median nerve compression|median nerve compression
581111|NCT01093196|Multiple Myeloma|multiple myeloma
581112|NCT01093196|Elderly Patients|elderly patients
581113|NCT01093196|Diagnosis|diagnosis
581114|NCT01093196|Lenalidomide|lenalidomide
581115|NCT01093196|Prednisone|prednisone
581116|NCT01093196|Melphalan|melphalan
581117|NCT01093196|Dexamethasone|dexamethasone
581118|NCT01093196|Cyclophosphamide|cyclophosphamide
581119|NCT01093157|Kidney disease, Glomerulonephritis|kidney disease, glomerulonephritis
581120|NCT01093144|Delivery mode|delivery mode
581121|NCT01093144|pelvic measurement|pelvic measurement
581122|NCT01093131|Contrast induced nephropathy|contrast induced nephropathy
581123|NCT01093131|Percutaneous transluminal coronary angioplasty|percutaneous transluminal coronary angioplasty
581124|NCT01093131|chronic kidney disease|chronic kidney disease
581125|NCT01093131|Prevention|prevention
581126|NCT01093131|Equivalence|equivalence
581127|NCT01093118|Distal subungual onychomycosis|distal subungual onychomycosis
581128|NCT01093105|Leukodystrophy, Globoid Cell|leukodystrophy, globoid cell
581129|NCT01093105|Classic Globoid Cell Leukodystrophy|classic globoid cell leukodystrophy
581130|NCT01093105|Early-Onset Globoid Cell Leukodystrophy|early-onset globoid cell leukodystrophy
581131|NCT01093105|Globoid Cell Leukodystrophy|globoid cell leukodystrophy
581132|NCT01093105|Globoid Cell Leukoencephalopathy|globoid cell leukoencephalopathy
581133|NCT01093105|Infantile Globoid Cell Leukodystrophy|infantile globoid cell leukodystrophy
581134|NCT01093105|Late-Onset Globoid Cell Leukodystrophy|late-onset globoid cell leukodystrophy
581135|NCT01093105|Leukodystrophy, Globoid Cell, Classic|leukodystrophy, globoid cell, classic
581136|NCT01093105|Leukodystrophy, Globoid Cell, Early-Onset|leukodystrophy, globoid cell, early-onset
581137|NCT01093105|Leukodystrophy, Globoid Cell, Infantile|leukodystrophy, globoid cell, infantile
581138|NCT01093105|Leukodystrophy, Globoid Cell, Late-Onset|leukodystrophy, globoid cell, late-onset
581139|NCT01093105|Psychosine|psychosine
581140|NCT01093105|galactosylsphingosine (psychosine) beta-galactosidase|galactosylsphingosine (psychosine) beta-galactosidase
581141|NCT01093105|Psychosine-UDP galactosyltransferase|psychosine-udp galactosyltransferase
581142|NCT01093105|Krabbe Disease|krabbe disease
581143|NCT01093105|Krabbe Leukodystrophy|krabbe leukodystrophy
581144|NCT01093105|Krabbe's Disease|krabbe's disease
581145|NCT01093105|Krabbe's Leukodystrophy|krabbe's leukodystrophy
581146|NCT01093079|Renal tumor, RCC, Partial nephrectomy, Laparoscopy|renal tumor, rcc, partial nephrectomy, laparoscopy
581147|NCT01093066|urothelial carcinoma|urothelial carcinoma
581149|NCT01093066|chemotherapy|chemotherapy
581150|NCT01093053|Mind-Body Therapies|mind-body therapies
581151|NCT01093027|Essential Tremor|essential tremor
581152|NCT01093027|Cooling|cooling
581153|NCT01093027|Temperature|temperature
581154|NCT01093027|Patients with Essential Tremor involving the upper limbs with at least moderate tremor.|patients with essential tremor involving the upper limbs with at least moderate tremor.
581155|NCT01093014|Quadriceps Muscle|quadriceps muscle
581156|NCT01093014|RNA, Messenger|rna, messenger
581157|NCT01093014|Hypertrophy|hypertrophy
581158|NCT01093014|Electric Stimulation Therapy|electric stimulation therapy
581159|NCT01093001|Reduce Tricuspid Regurgitation|reduce tricuspid regurgitation
581160|NCT01093001|Reduce Right Ventricular pacing|reduce right ventricular pacing
581161|NCT01093001|Lead position|lead position
581162|NCT01093001|Lead size|lead size
581163|NCT01092988|Uterine Fibroids|uterine fibroids
581164|NCT01092988|Bleeding|bleeding
581165|NCT01092988|Pain|pain
581166|NCT01092988|Quality of life|quality of life
581167|NCT01092988|MR guided focused ultrasound|mr guided focused ultrasound
581168|NCT01092975|radiotherapy|radiotherapy
581169|NCT01092962|Children|children
581170|NCT01092962|Mycophenolate mofetil|mycophenolate mofetil
581171|NCT01092962|Cyclophosphamide|cyclophosphamide
581172|NCT01092962|Idiopathic nephrotic steroid sensitive syndrome|idiopathic nephrotic steroid sensitive syndrome
581173|NCT01092949|Placenta|placenta
581174|NCT01092949|perfusion|perfusion
581175|NCT01092949|MRI|mri
581176|NCT01092949|spin tagging|spin tagging
581177|NCT01092949|Gadolinium|gadolinium
581178|NCT01092949|placental insufficiency|placental insufficiency
581179|NCT01092949|urinary tract, sexual organs and pregnancy conditions|urinary tract, sexual organs and pregnancy conditions
581180|NCT01092936|Comparative fit index|comparative fit index
581181|NCT01092936|Movement Disorders' Society|movement disorders' society
581182|NCT01092936|Unified Parkinson's Disease Rating Scale|unified parkinson's disease rating scale
581183|NCT01092923|Nitrous Oxide|nitrous oxide
581184|NCT01092923|washin|washin
581185|NCT01092923|washout|washout
581186|NCT01092923|second gas effect|second gas effect
581187|NCT01092923|sevoflurane|sevoflurane
581188|NCT01092923|induction|induction
581189|NCT01092923|emergence|emergence
581190|NCT01092910|Sensorineural|sensorineural
581191|NCT01092910|Hearing Loss|hearing loss
581192|NCT01092884|melasma|melasma
581193|NCT01092884|sunscreen|sunscreen
581194|NCT01092884|polypodium leucotomos|polypodium leucotomos
581195|NCT01092858|Testosterone undecanoate|testosterone undecanoate
581196|NCT01092858|Hypogonadism|hypogonadism
581197|NCT01092845|Double-Blind|double-blind
581198|NCT01092845|Randomized|randomized
581199|NCT01092845|Placebo-Controlled|placebo-controlled
581200|NCT01092845|2-Way Crossover|2-way crossover
581201|NCT01092845|Polysomnographic Endpoints|polysomnographic endpoints
581202|NCT01092832|Invasive Candidiasis Candidemia Esophageal Candidiasis|invasive candidiasis candidemia esophageal candidiasis
581203|NCT01092819|acute ischemic stroke, large vessel occlusion, natural history, functional outcome|acute ischemic stroke, large vessel occlusion, natural history, functional outcome
581204|NCT01092806|tacrolimus|tacrolimus
581205|NCT01092806|pharmacokinetics|pharmacokinetics
581206|NCT01092806|formulations|formulations
581207|NCT01092806|once daily|once daily
581208|NCT01092806|twice daily|twice daily
581209|NCT01092806|renal transplant recipients|renal transplant recipients
581210|NCT01092806|Kidney transplantation|kidney transplantation
581211|NCT01092793|Fish oil|fish oil
581212|NCT01092793|Krill|krill
581213|NCT01092793|CAD|cad
581214|NCT01092767|Thoracic Aneurysm|thoracic aneurysm
581215|NCT01092767|Thoracic Transection|thoracic transection
581216|NCT01092767|Endovascular Aortic Repair|endovascular aortic repair
581217|NCT01092754|brain, spine, liver, MRI, Pediatric|brain, spine, liver, mri, pediatric
581218|NCT01092741|Leukemia|leukemia
581219|NCT01092741|Gleevec|gleevec
581220|NCT01092741|STI571|sti571
581221|NCT01092741|CML|cml
581222|NCT01092741|Chronic Myelogenous Leukemia|chronic myelogenous leukemia
581223|NCT01092728|Acral lentiginous melanoma|acral lentiginous melanoma
581224|NCT01092728|Mucosal melanoma|mucosal melanoma
581225|NCT01092728|Chronic sun-damaged melanoma|chronic sun-damaged melanoma
581226|NCT01092728|Surgically removed tumor|surgically removed tumor
581227|NCT01092728|biopsied|biopsied
581228|NCT01092728|Sprycel|sprycel
581229|NCT01092728|Dasatinib|dasatinib
581230|NCT01092715|Neck pain|neck pain
581231|NCT01092715|Spinal manipulation|spinal manipulation
581232|NCT01092715|Massage|massage
581233|NCT01092702|Tobacco Dependence|tobacco dependence
581234|NCT01092702|Smoking|smoking
581235|NCT01092702|Tobacco Cessation|tobacco cessation
581236|NCT01092689|heterocyclic amines|heterocyclic amines
581237|NCT01092689|PhIP|phip
581238|NCT01092689|Meat|meat
581239|NCT01092689|pancreas neoplasms|pancreas neoplasms
581240|NCT01092676|Pediatrics|pediatrics
581241|NCT01092676|Emergency|emergency
581242|NCT01092663|Colesevelam|colesevelam
581243|NCT01092663|type 2 diabetes|type 2 diabetes
581244|NCT01092663|sitagliptin|sitagliptin
581245|NCT01092663|glucose metabolism|glucose metabolism
581246|NCT01092650|Tobacco toxicants|tobacco toxicants
581247|NCT01092650|Polycyclic aromatic hydrocarbons|polycyclic aromatic hydrocarbons
581248|NCT01092650|Smoking|smoking
581249|NCT01092624|voiding dysfunction|voiding dysfunction
581250|NCT01092624|defecatory dysfunction|defecatory dysfunction
581251|NCT01092624|vaginal bulge symptoms|vaginal bulge symptoms
581252|NCT01092611|long-term follow-up study|long-term follow-up study
581253|NCT01092611|HIV-infected subjects|hiv-infected subjects
581254|NCT01092611|HIV therapeutic vaccine|hiv therapeutic vaccine
581255|NCT01092572|cystic fibrosis|cystic fibrosis
581256|NCT01092572|adult cystic fibrosis|adult cystic fibrosis
581257|NCT01092559|Diagnostic Techniques and Procedures|diagnostic techniques and procedures
581259|NCT01092546|Normal pressure hydrocephalus (NPH)|normal pressure hydrocephalus (nph)
581260|NCT01092546|Positron Emission Tomography (PET)|positron emission tomography (pet)
581261|NCT01092546|Standard uptake value ratios (SUVR)|standard uptake value ratios (suvr)
581262|NCT01092520|Gabapentin|gabapentin
581263|NCT01092520|Burn Injuries in Children|burn injuries in children
581264|NCT01092520|pruritus|pruritus
581265|NCT01092507|Encephalitis|encephalitis
581266|NCT01092507|Japanese Encephalitis|japanese encephalitis
581267|NCT01092507|Japanese Encephalitis Vaccines|japanese encephalitis vaccines
581268|NCT01092507|Infant|infant
581269|NCT01092494|Endometrioma recurrence|endometrioma recurrence
581270|NCT01092494|oral contraceptives|oral contraceptives
581271|NCT01092494|gonadotropin-releasing hormone agonist|gonadotropin-releasing hormone agonist
581272|NCT01092481|Adjuvant FOLFOX or CAPOX Therapy|adjuvant folfox or capox therapy
581273|NCT01092481|Stage II/III Colon Cancer|stage ii/iii colon cancer
581274|NCT01092481|Adjuvant Therapy|adjuvant therapy
581275|NCT01092468|cancer|cancer
581276|NCT01092468|reconstruction|reconstruction
581277|NCT01092468|free flap|free flap
581278|NCT01092468|surgery|surgery
581279|NCT01092455|End Stage Renal Disease|end stage renal disease
581280|NCT01092455|Renal Dialysis|renal dialysis
581281|NCT01092455|Hemodialysis therapy|hemodialysis therapy
581282|NCT01092455|Heparin|heparin
581283|NCT01092455|Citrasate|citrasate
581284|NCT01092455|Anticoagulant|anticoagulant
581285|NCT01092442|Pulmonary Valve|pulmonary valve
581286|NCT01092442|Right Ventricular Outflow Tract Reconstruction|right ventricular outflow tract reconstruction
581287|NCT01092442|Ross Procedure|ross procedure
581288|NCT01092429|CAD|cad
581289|NCT01092416|CAD|cad
581290|NCT01092416|Severely calcified lesion|severely calcified lesion
581291|NCT01092390|randomized trial|randomized trial
581292|NCT01092390|omega three fatty acids|omega three fatty acids
581293|NCT01092364|Young adults|young adults
581294|NCT01092351|urinary tract infection|urinary tract infection
581295|NCT01092351|nitrofurantoin|nitrofurantoin
581296|NCT01092338|Human Immunodeficiency Virus|human immunodeficiency virus
581297|NCT01092338|Acquired Immune Deficiency Syndrome|acquired immune deficiency syndrome
581298|NCT01092338|Vitamin D|vitamin d
581299|NCT01092338|HIV|hiv
581300|NCT01092338|Complementary therapies|complementary therapies
581301|NCT01092325|Heart Failure|heart failure
581302|NCT01092312|knee|knee
581303|NCT01092312|arthroplasty|arthroplasty
581304|NCT01092299|Phase I|phase i
581305|NCT01092299|Relative bioavailability|relative bioavailability
581306|NCT01092299|Pharmacokinetic study|pharmacokinetic study
581307|NCT01092299|AZD1446|azd1446
581308|NCT01092299|healthy volunteers|healthy volunteers
581309|NCT01092286|Knee injury|knee injury
581310|NCT01092286|ankle sprain|ankle sprain
581311|NCT01092286|anterior cruciate ligament|anterior cruciate ligament
581312|NCT01092286|adolescent|adolescent
581313|NCT01092286|soccer|soccer
581314|NCT01092286|basketball|basketball
581315|NCT01092286|prevention|prevention
581316|NCT01092273|Glaucoma and Ocular Hypertension|glaucoma and ocular hypertension
581317|NCT01092260|Glomerular Filtration Rate|glomerular filtration rate
581318|NCT01092260|Kidney disease|kidney disease
581319|NCT01092260|Child|child
581320|NCT01092260|Iohexol|iohexol
581321|NCT01092260|Cystatin C|cystatin c
581322|NCT01092260|Measurement of kidney function in children|measurement of kidney function in children
581323|NCT01092247|Patients with malignant tumors|patients with malignant tumors
581324|NCT01092234|Observational units|observational units
581325|NCT01092234|Length of stay (LOS)|length of stay (los)
581326|NCT01092234|Readmission|readmission
581327|NCT01092221|mania, allopurinol, add-on treatment|mania, allopurinol, add-on treatment
581328|NCT01092208|Autism|autism
581329|NCT01092208|iPS Cells|ips cells
581330|NCT01092208|Fibroblasts|fibroblasts
581331|NCT01092208|Gene Networks|gene networks
581332|NCT01092208|Tuberous Sclerosis|tuberous sclerosis
581333|NCT01092208|Healthy Volunteer|healthy volunteer
581334|NCT01092208|HV|hv
581335|NCT01092195|Women's Health|women's health
581336|NCT01092195|Genital Precancer|genital precancer
581337|NCT01092195|Stem Cell Donor|stem cell donor
581338|NCT01092195|Cervical Cytology|cervical cytology
581339|NCT01092195|Healthy Volunteers|healthy volunteers
581340|NCT01092195|Stem Cell Transplant|stem cell transplant
581341|NCT01092195|Healthy Volunteer|healthy volunteer
581342|NCT01092195|HV|hv
581343|NCT01092182|Microarray|microarray
581344|NCT01092182|Toxicity|toxicity
581345|NCT01092182|Therapeutic Index|therapeutic index
581346|NCT01092182|HIV Positive|hiv positive
581347|NCT01092182|HIV Negative|hiv negative
581348|NCT01092182|HIV Infections|hiv infections
581349|NCT01092156|Nipple pain during lactation|nipple pain during lactation
581350|NCT01092130|Heart failure|heart failure
581351|NCT01092130|Vitamin D|vitamin d
581352|NCT01092130|Plasma renin activity|plasma renin activity
581353|NCT01092130|Renin angiotensin system|renin angiotensin system
581354|NCT01092117|abdominal|abdominal
581355|NCT01092117|aortic|aortic
581356|NCT01092117|aneurysm|aneurysm
581357|NCT01092091|Neoplasm|neoplasm
582221|NCT01088516|Lopinavir|lopinavir
581358|NCT01092091|Hepatocellular Carcinoma|hepatocellular carcinoma
581359|NCT01092078|hypertension|hypertension
581360|NCT01092078|colon cancer screening|colon cancer screening
581361|NCT01092078|african american|african american
581363|NCT01092078|motivational interviewing|motivational interviewing
581364|NCT01092078|patient navigation|patient navigation
581365|NCT01092065|Parkinson's Disease|parkinson's disease
581366|NCT01092065|Dyskinesia|dyskinesia
581367|NCT01092065|Drug-induced|drug-induced
581368|NCT01092065|Levodopa|levodopa
581369|NCT01092065|L-dopa|l-dopa
581370|NCT01092052|Phase I study|phase i study
581371|NCT01092052|Advanced/Metastatic Solid Tumors|advanced/metastatic solid tumors
581372|NCT01092052|Cdc7 kinase inhibitor|cdc7 kinase inhibitor
581373|NCT01092039|Common Cold|common cold
581374|NCT01092039|Cold Virus|cold virus
581375|NCT01092039|Feeling sick|feeling sick
581376|NCT01092039|Influenza|influenza
581377|NCT01092000|Health Promotion, Dietary Guidelines, Physical Activity Guidelines|health promotion, dietary guidelines, physical activity guidelines
581378|NCT01091987|Insomnia|insomnia
581379|NCT01091974|Insomnia|insomnia
581380|NCT01091974|Fatigue|fatigue
581381|NCT01091974|QOL|qol
581382|NCT01091974|CBT|cbt
581383|NCT01091974|Breast cancer|breast cancer
581384|NCT01091974|Survivors|survivors
581385|NCT01091974|Chemotherapy|chemotherapy
581386|NCT01091961|ACE inhibitor|ace inhibitor
581387|NCT01091961|ARB|arb
581388|NCT01091961|Non-cardiac surgery|non-cardiac surgery
581389|NCT01091961|Perioperative|perioperative
581390|NCT01091961|Preoperative|preoperative
581391|NCT01091961|Hypotension|hypotension
581392|NCT01091961|Congestive heart failure|congestive heart failure
581393|NCT01091961|Hypertension|hypertension
581394|NCT01091961|Angiotensin-Converting Enzyme Inhibitors|angiotensin-converting enzyme inhibitors
581395|NCT01091961|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers
581396|NCT01091961|Perioperative Care|perioperative care
581397|NCT01091948|elective general surgery|elective general surgery
581398|NCT01091948|orotracheal intubation|orotracheal intubation
581399|NCT01091948|Patients would be eligible for inclusion if they were at least 18 years old and scheduled for elective surgery requiring orotracheal intubation.|patients would be eligible for inclusion if they were at least 18 years old and scheduled for elective surgery requiring orotracheal intubation.
581400|NCT01091935|Lidocaine,Intravenous Infusions,Neuropathic Pain,Side Effects|lidocaine,intravenous infusions,neuropathic pain,side effects
581401|NCT01091922|flavonoids|flavonoids
581402|NCT01091922|flavanols|flavanols
581403|NCT01091922|bacteria|bacteria
581404|NCT01091909|type 2 diabetes|type 2 diabetes
581405|NCT01091909|wound healing|wound healing
581406|NCT01091909|neutrophil count|neutrophil count
581407|NCT01091909|dental extraction|dental extraction
581408|NCT01091896|bevacizumab|bevacizumab
581409|NCT01091896|vitreous hemorrhage|vitreous hemorrhage
581410|NCT01091896|diabetes mellitus|diabetes mellitus
581411|NCT01091883|Bone cancer|bone cancer
581412|NCT01091883|Bone Metastases|bone metastases
581413|NCT01091883|pain palliation|pain palliation
581414|NCT01091883|metastasis|metastasis
581415|NCT01091883|breast cancer|breast cancer
581416|NCT01091883|lung cancer|lung cancer
581417|NCT01091883|prostate cancer|prostate cancer
581418|NCT01091883|cancer related pain|cancer related pain
581419|NCT01091883|tumors|tumors
581420|NCT01091870|Aneurysm|aneurysm
581421|NCT01091870|Vasospasm|vasospasm
581422|NCT01091870|sildenafil|sildenafil
581423|NCT01091870|Viagra|viagra
581424|NCT01091857|Exercise|exercise
581425|NCT01091857|Transdisciplinary|transdisciplinary
581426|NCT01091857|Physiology|physiology
581427|NCT01091857|Mood|mood
581428|NCT01091857|Motivation|motivation
581429|NCT01091844|voiding trial, urinary retention, catheterization|voiding trial, urinary retention, catheterization
581430|NCT01091844|Urinary retention after gynecologic surgery|urinary retention after gynecologic surgery
581431|NCT01091831|Multiple Myeloma|multiple myeloma
581432|NCT01091831|Lenalidomide|lenalidomide
581433|NCT01091831|High dose melphalan|high dose melphalan
581434|NCT01091831|Mobilization|mobilization
581435|NCT01091831|CD 34|cd 34
581436|NCT01091831|Newly Diagnosed patients|newly diagnosed patients
581437|NCT01091818|To see if sedation with dexmedetomidine results in faster emergence after end of intensive care treatment in children|to see if sedation with dexmedetomidine results in faster emergence after end of intensive care treatment in children
581438|NCT01091818|treatment|treatment
581439|NCT01091792|GBM|gbm
581440|NCT01091792|Grade IV|grade iv
581441|NCT01091792|glioma|glioma
581442|NCT01091779|Male patients scheduled to have spinal anaesthesia for TURP|male patients scheduled to have spinal anaesthesia for turp
581443|NCT01091766|local anaesthetics toxicity|local anaesthetics toxicity
581444|NCT01091766|heart arrhythmia|heart arrhythmia
581445|NCT01091766|heart rate|heart rate
581446|NCT01091766|heart conduction|heart conduction
581447|NCT01091766|regional anaesthesia|regional anaesthesia
581448|NCT01091766|paediatric anaesthesia|paediatric anaesthesia
581449|NCT01091766|cardio-vascular system|cardio-vascular system
581450|NCT01091766|prevention|prevention
581451|NCT01091753|Non-dipper HTN patient|non-dipper htn patient
581452|NCT01091740|Drug eluting stent|drug eluting stent
581453|NCT01091740|Tomography, optical coherence|tomography, optical coherence
581454|NCT01091727|Neurogenic|neurogenic
581455|NCT01091727|Detrusor|detrusor
581456|NCT01091727|Overactive|overactive
581457|NCT01091727|Overactivity|overactivity
581458|NCT01091727|Bladder|bladder
581459|NCT01091727|Spinal|spinal
581460|NCT01091727|Cord|cord
581461|NCT01091727|Injury|injury
581462|NCT01091701|Ischemic Cerebral Stroke|ischemic cerebral stroke
581463|NCT01091688|neonatal|neonatal
581464|NCT01091688|discharge planning|discharge planning
581465|NCT01091688|health transition|health transition
581466|NCT01091688|educational needs assessment|educational needs assessment
581467|NCT01091688|Intensive care, neonatal|intensive care, neonatal
581468|NCT01091675|ankylosing spondylitis|ankylosing spondylitis
581469|NCT01091675|biologic therapies|biologic therapies
581470|NCT01091675|ASAS|asas
581471|NCT01091675|ASASBIO|asasbio
581472|NCT01091675|etoricoxib|etoricoxib
581473|NCT01091675|NSAIDs|nsaids
581474|NCT01091675|COX-2 Inhibitor|cox-2 inhibitor
581475|NCT01091675|ARCOXIA 90 mg|arcoxia 90 mg
581476|NCT01091675|BASDAI Bath Ankylosing Spondylitis Disease Activity Index|basdai bath ankylosing spondylitis disease activity index
581477|NCT01091662|Seizures|seizures
581478|NCT01091662|Epilepsy|epilepsy
581479|NCT01091662|Anticonvulsant|anticonvulsant
581480|NCT01091662|Monotherapy|monotherapy
581481|NCT01091662|Historical control|historical control
581482|NCT01091649|Pharmacokinetics, Safety|pharmacokinetics, safety
581483|NCT01091623|improvement of exercise capacity in patients with COPD|improvement of exercise capacity in patients with copd
581484|NCT01091610|retrospective study|retrospective study
581485|NCT01091610|wounds and injuries/epidemiology|wounds and injuries/epidemiology
581486|NCT01091610|emergency medical technicians|emergency medical technicians
581487|NCT01091610|human|human
581488|NCT01091610|emergency medical services|emergency medical services
581489|NCT01091610|ambulance|ambulance
581490|NCT01091610|health personnel|health personnel
581491|NCT01091610|emergency medicine|emergency medicine
581492|NCT01091610|risk factors|risk factors
581493|NCT01091571|Adenosine|adenosine
581494|NCT01091571|Endotoxin|endotoxin
581495|NCT01091571|Innate Immunity|innate immunity
581496|NCT01091571|Dipyridamole|dipyridamole
581497|NCT01091558|ulcerative colitis|ulcerative colitis
581498|NCT01091558|colon cancer|colon cancer
581499|NCT01091558|endoscopy|endoscopy
581500|NCT01091558|screening|screening
581501|NCT01091545|breast cancer|breast cancer
581502|NCT01091545|screening|screening
581503|NCT01091545|sensitivity|sensitivity
581504|NCT01091545|tomosynthesis|tomosynthesis
581505|NCT01091519|Non-interventional study fesoterodine educational materials|non-interventional study fesoterodine educational materials
581506|NCT01091506|L-methylfolate|l-methylfolate
581507|NCT01091506|Deplin|deplin
581508|NCT01091506|schizophrenia|schizophrenia
581509|NCT01091506|folate|folate
581510|NCT01091506|folic acid|folic acid
581511|NCT01091506|homocysteine|homocysteine
581512|NCT01091506|methionine|methionine
581513|NCT01091506|MTHFR genotype|mthfr genotype
581514|NCT01091506|C677T mutation|c677t mutation
581515|NCT01091506|vitamin B6|vitamin b6
581516|NCT01091506|vitamin B12|vitamin b12
581517|NCT01091506|psychotic symptoms|psychotic symptoms
581518|NCT01091506|MTHFR C677T Polymorphism|mthfr c677t polymorphism
581519|NCT01091493|COPD|copd
581520|NCT01091480|Hypertrophic cardiomyopathy|hypertrophic cardiomyopathy
581521|NCT01091480|Observatory|observatory
581523|NCT01091467|Heart Failure|heart failure
581524|NCT01091467|Ejection Fraction|ejection fraction
581525|NCT01091467|Echocardiography|echocardiography
581526|NCT01091454|stage IV breast cancer|stage iv breast cancer
581527|NCT01091454|triple-negative breast cancer|triple-negative breast cancer
581528|NCT01091454|male breast cancer|male breast cancer
581529|NCT01091441|therapeutic education|therapeutic education
581530|NCT01091428|RECIST: Response Evaluation Criteria in Solid Tumors|recist: response evaluation criteria in solid tumors
581531|NCT01091428|OC: Ovarian Cancer|oc: ovarian cancer
581532|NCT01091428|GCIG: Gynecologic Cancer Intergroup|gcig: gynecologic cancer intergroup
581533|NCT01091428|Breast carcinoma (Phase 1)|breast carcinoma (phase 1)
581534|NCT01091428|Drug therapy|drug therapy
581535|NCT01091402|autologous serum skin test, IL-18|autologous serum skin test, il-18
581536|NCT01091389|Atrial Fibrillation|atrial fibrillation
581537|NCT01091389|Totally Thoracoscopic PV isolation|totally thoracoscopic pv isolation
581538|NCT01091376|Non-small cell lung cancer|non-small cell lung cancer
581539|NCT01091376|EGFR-TKI|egfr-tki
581540|NCT01091376|Erlotinib|erlotinib
581541|NCT01091376|Radiotherapy|radiotherapy
581542|NCT01091363|smoking cessation|smoking cessation
581543|NCT01091363|tobacco dependence treatment|tobacco dependence treatment
581544|NCT01091363|cultural adaptation|cultural adaptation
581545|NCT01091363|Asian Americans|asian americans
581546|NCT01091324|CKD, proteinuria, dextromethorphan, silymarin|ckd, proteinuria, dextromethorphan, silymarin
581547|NCT01091324|patients with 15 ml<eGFR< 60ml and 0.5 g/day<proteinuria<3g/day|patients with 15 ml<egfr< 60ml and 0.5 g/day<proteinuria<3g/day
581548|NCT01091311|Meibomian Gland Dysfunction|meibomian gland dysfunction
581549|NCT01091298|Safety of vaccine|safety of vaccine
581550|NCT01091272|healthy volunteer|healthy volunteer
581551|NCT01091272|safety|safety
581552|NCT01091272|pharmacokinetic|pharmacokinetic
581553|NCT01091259|antibody therapy|antibody therapy
581554|NCT01091259|chemotherapy|chemotherapy
581555|NCT01091259|biologic therapy|biologic therapy
581556|NCT01091259|combination therapy|combination therapy
581557|NCT01091233|Critically ill patients|critically ill patients
581558|NCT01091233|liver cirrhosis|liver cirrhosis
581559|NCT01091233|ascites requiring Paracentesis|ascites requiring paracentesis
581560|NCT01091220|certolizumab pegol|certolizumab pegol
581561|NCT01091220|Cimzia®|cimzia®
581562|NCT01091220|healthy male volunteers|healthy male volunteers
581563|NCT01091220|sperm|sperm
581564|NCT01091207|Sorafenib|sorafenib
581565|NCT01091207|GIST|gist
581566|NCT01091207|Refractory|refractory
581567|NCT01091207|advanced GIST failed after both imatinib and sunitinib|advanced gist failed after both imatinib and sunitinib
581568|NCT01091194|Heart Transplantation|heart transplantation
581569|NCT01091194|Aerobic Exercise|aerobic exercise
581570|NCT01091194|Exercise, Physical|exercise, physical
581571|NCT01091194|Exercise Test|exercise test
581572|NCT01091194|Treadmill Test|treadmill test
581573|NCT01091194|VO2 peak|vo2 peak
581574|NCT01091194|Muscle Strength|muscle strength
581575|NCT01091194|Quality of Life|quality of life
581576|NCT01091194|Reinnervation|reinnervation
581577|NCT01091194|Heart Rate|heart rate
581578|NCT01091194|Myocardial Function|myocardial function
581579|NCT01091181|Caesarean|caesarean
581580|NCT01091155|Colon Anastomosis|colon anastomosis
581581|NCT01091155|Rectum Anastomosis|rectum anastomosis
581582|NCT01091155|Intestine|intestine
581583|NCT01091155|Colorectal Surgery|colorectal surgery
581584|NCT01091155|Colorectal Anastomosis|colorectal anastomosis
581585|NCT01091129|hyperhidrosis|hyperhidrosis
581586|NCT01091116|Injections, Intra-Articular|injections, intra-articular
581587|NCT01091090|Smoking cessation|smoking cessation
581588|NCT01091090|Nicotine dependence|nicotine dependence
581589|NCT01091090|Chronic pain|chronic pain
581590|NCT01091077|dietary supplement|dietary supplement
581591|NCT01091051|Ustekinumab, Palmo-Plantar, Pustular Psoriasis, Pustulosis|ustekinumab, palmo-plantar, pustular psoriasis, pustulosis
581592|NCT01091038|Adverse drug events|adverse drug events
581593|NCT01091038|medical errors|medical errors
581594|NCT01091038|computerized physician order entry|computerized physician order entry
581595|NCT01091038|clinical decision support|clinical decision support
581596|NCT01091025|Adults|adults
581597|NCT01091025|Cystic Fibrosis Related Diabetes|cystic fibrosis related diabetes
581598|NCT01091025|Screening|screening
581599|NCT01091025|Oral glucose tolerance test|oral glucose tolerance test
581600|NCT01091025|Royal Brompton & Harefield Foundation Trust|royal brompton & harefield foundation trust
581601|NCT01090999|COPD|copd
581602|NCT01090999|Pulmonary Rehabilitation|pulmonary rehabilitation
581603|NCT01090986|Restrictive pulmonary disease with hypercapnic chronic respiratory failure.|restrictive pulmonary disease with hypercapnic chronic respiratory failure.
581604|NCT01090986|COPD patients who need NIV hypercapnic chronic respiratory failure.|copd patients who need niv hypercapnic chronic respiratory failure.
581605|NCT01090973|relapsed|relapsed
581606|NCT01090973|refractory|refractory
581607|NCT01090973|CLL|cll
581608|NCT01090973|chronic lymphocytic leukemia|chronic lymphocytic leukemia
581609|NCT01090973|MCL|mcl
581610|NCT01090973|mantle cell lymphoma|mantle cell lymphoma
581611|NCT01090934|Diagnosis|diagnosis
581612|NCT01090934|Partial Epilepsy|partial epilepsy
581613|NCT01090921|Multiple Myeloma|multiple myeloma
581614|NCT01090921|Bortezomib|bortezomib
581615|NCT01090921|Newly diagnosed|newly diagnosed
581616|NCT01090921|Newly diagnosed Multiple Myeloma|newly diagnosed multiple myeloma
581617|NCT01090895|Percutaneous Coronary Intervention|percutaneous coronary intervention
581618|NCT01090895|Vitamin C|vitamin c
581619|NCT01090895|Biomarkers|biomarkers
581620|NCT01090895|Magnetic Risonance|magnetic risonance
581621|NCT01090882|Local anaesthetic|local anaesthetic
581622|NCT01090882|Laparoscopic cholecystectomy|laparoscopic cholecystectomy
581623|NCT01090882|Pain scores|pain scores
581624|NCT01090882|Bupivocaine|bupivocaine
581625|NCT01090882|Day case surgery|day case surgery
581626|NCT01090856|Bifurcations|bifurcations
581627|NCT01090856|Drug eluting-stents|drug eluting-stents
581628|NCT01090856|Provisional stenting|provisional stenting
581629|NCT01090843|Obscure digestive bleeding (ODB)|obscure digestive bleeding (odb)
581630|NCT01090843|Chronic anaemia of unknown origin|chronic anaemia of unknown origin
581631|NCT01090843|Chronic diarrhoea|chronic diarrhoea
581632|NCT01090830|Non small cell lung cancer|non small cell lung cancer
581633|NCT01090830|Belinostat|belinostat
581634|NCT01090830|carboplatin|carboplatin
581635|NCT01090830|Paclitaxel|paclitaxel
581636|NCT01090830|Bevacizumab|bevacizumab
581637|NCT01090830|chemotherapy|chemotherapy
581638|NCT01090830|Maximum Tolerated Dose|maximum tolerated dose
581639|NCT01090830|Neoplasms, Pulmonary|neoplasms, pulmonary
581640|NCT01090830|Lung Cancer|lung cancer
581641|NCT01090830|Event Free Survival|event free survival
582222|NCT01088516|Africa|africa
581642|NCT01090830|Disease free survival|disease free survival
581643|NCT01090830|Progression Free Survival|progression free survival
581644|NCT01090830|Histone Deacetylase Inhibitors|histone deacetylase inhibitors
581645|NCT01090830|Treatment Efficacy|treatment efficacy
581646|NCT01090817|mesenchymal stromal cells|mesenchymal stromal cells
581647|NCT01090817|ileitis|ileitis
581648|NCT01090817|colitis|colitis
581649|NCT01090804|BreatheMAX breathing device|breathemax breathing device
581650|NCT01090804|Secretion clearance|secretion clearance
581651|NCT01090804|Ventilatory dependence|ventilatory dependence
581652|NCT01090804|Intubated patients|intubated patients
581653|NCT01090791|critically ill patient|critically ill patient
581654|NCT01090778|growth hormone deficiency|growth hormone deficiency
581655|NCT01090778|circadian variation|circadian variation
581656|NCT01090765|Prostate|prostate
581657|NCT01090765|Tumor|tumor
581658|NCT01090765|Cancer|cancer
581659|NCT01090765|Hormone|hormone
581660|NCT01090765|Androgen|androgen
581661|NCT01090765|Prostate Cancer|prostate cancer
581662|NCT01090752|diabetes|diabetes
581663|NCT01090752|blood pressure|blood pressure
581664|NCT01090752|pioglitazone|pioglitazone
581665|NCT01090752|sodium|sodium
581666|NCT01090752|insulin resistance, renal function, sodium, pioglitazone|insulin resistance, renal function, sodium, pioglitazone
581667|NCT01090739|Fecal incontinence|fecal incontinence
581668|NCT01090739|Accidental bowel leakage|accidental bowel leakage
581669|NCT01090739|Failure conservative therapy|failure conservative therapy
581670|NCT01090739|Women|women
581671|NCT01090739|Class III medical device|class iii medical device
581672|NCT01090739|Surgical mesh|surgical mesh
739294|NCT00476944|CAD|cad
581673|NCT01090700|TMC435-TiDP16-C112|tmc435-tidp16-c112
581674|NCT01090700|TMC435-C112|tmc435-c112
581675|NCT01090700|TMC435|tmc435
581676|NCT01090700|HCV|hcv
581677|NCT01090700|Hepatitis C|hepatitis c
581678|NCT01090687|breast cancer, CT scans, mammography|breast cancer, ct scans, mammography
581679|NCT01090674|Diaphragmatic force|diaphragmatic force
581680|NCT01090674|mobility|mobility
581681|NCT01090661|antisense|antisense
581682|NCT01090661|ApoB (Apolipoprotein B)|apob (apolipoprotein b)
581683|NCT01090661|LDL (low density lipoprotein)|ldl (low density lipoprotein)
581684|NCT01090661|thorough QT|thorough qt
581685|NCT01090648|TMC125HIV1083|tmc125hiv1083
581686|NCT01090648|TMC125|tmc125
581687|NCT01090648|HIV|hiv
581688|NCT01090648|Etravirine|etravirine
581689|NCT01090648|ETR|etr
581690|NCT01090648|Intelence|intelence
581691|NCT01090648|HIV Infections|hiv infections
581692|NCT01090635|Cervical Intraepithelial Neoplasia|cervical intraepithelial neoplasia
581693|NCT01090609|Coronary Stent|coronary stent
581694|NCT01090609|Cobalt-Chromium coronary stent|cobalt-chromium coronary stent
581695|NCT01090583|Cytokines|cytokines
581696|NCT01090583|Pregnancy|pregnancy
581697|NCT01090583|Cesarean|cesarean
581698|NCT01090544|COPD|copd
581699|NCT01090544|TNI|tni
581700|NCT01090544|PaCO2|paco2
581701|NCT01090492|Raynaud's phenomenon|raynaud's phenomenon
581702|NCT01090492|vasospasm|vasospasm
581703|NCT01090492|scleroderma|scleroderma
581704|NCT01090492|systemic sclerosis|systemic sclerosis
581705|NCT01090492|CREST|crest
581706|NCT01090492|phosphodiesterase inhibitor|phosphodiesterase inhibitor
581707|NCT01090479|Surgical site infections|surgical site infections
581708|NCT01090479|Chlorhexidine|chlorhexidine
581709|NCT01090479|Shoulder surgery|shoulder surgery
581710|NCT01090466|transitional cell carcinoma of the bladder|transitional cell carcinoma of the bladder
581711|NCT01090466|recurrent bladder cancer|recurrent bladder cancer
581712|NCT01090466|recurrent urethral cancer|recurrent urethral cancer
581713|NCT01090466|recurrent transitional cell cancer of the renal pelvis and ureter|recurrent transitional cell cancer of the renal pelvis and ureter
581714|NCT01090466|stage IV bladder cancer|stage iv bladder cancer
581715|NCT01090466|metastatic transitional cell cancer of the renal pelvis and ureter|metastatic transitional cell cancer of the renal pelvis and ureter
581833|NCT01089972|radial artery|radial artery
581716|NCT01090466|regional transitional cell cancer of the renal pelvis and ureter|regional transitional cell cancer of the renal pelvis and ureter
581717|NCT01090466|distal urethral cancer|distal urethral cancer
581718|NCT01090466|proximal urethral cancer|proximal urethral cancer
581719|NCT01090466|urethral cancer associated with invasive bladder cancer|urethral cancer associated with invasive bladder cancer
581720|NCT01090466|stage IV urethral cancer|stage iv urethral cancer
581721|NCT01090440|schizophrenia|schizophrenia
581722|NCT01090440|GSK1144814|gsk1144814
581723|NCT01090440|effect of food|effect of food
581724|NCT01090440|healthy subjects|healthy subjects
581725|NCT01090440|depressive disorder|depressive disorder
581726|NCT01090440|pharmacokinetics|pharmacokinetics
581727|NCT01090427|Ustekinumab|ustekinumab
581728|NCT01090427|Injection|injection
581729|NCT01090427|CNTO 1275|cnto 1275
581730|NCT01090427|Stelara|stelara
581731|NCT01090427|Pediatric psoriasis|pediatric psoriasis
581732|NCT01090427|Adolescents|adolescents
581733|NCT01090414|Idelalisib|idelalisib
581734|NCT01090414|Chronic lymphocytic leukemia (CLL)|chronic lymphocytic leukemia (cll)
581735|NCT01090414|Non-Hodgkin lymphoma (NHL)|non-hodgkin lymphoma (nhl)
581825|NCT01090037|Chronic Renal Failure|chronic renal failure
581736|NCT01090414|Phosphatidylinositol 3-kinase (PI3K)|phosphatidylinositol 3-kinase (pi3k)
581737|NCT01090388|Cross-sectional survey|cross-sectional survey
581738|NCT01090388|Health-related quality of life|health-related quality of life
581739|NCT01090388|Symptom management|symptom management
581740|NCT01090375|osteoarthritis|osteoarthritis
581741|NCT01090375|biochemical markers|biochemical markers
581742|NCT01090375|cartilage|cartilage
581743|NCT01090375|inflammation|inflammation
581744|NCT01090375|microdialysis|microdialysis
581745|NCT01090362|Atrial fibrillation|atrial fibrillation
581746|NCT01090362|Anticoagulation|anticoagulation
581747|NCT01090362|Stroke|stroke
581748|NCT01090362|Stroke prevention|stroke prevention
581749|NCT01090362|Health Economics|health economics
581750|NCT01090349|ICD, CRTD, Remote Care|icd, crtd, remote care
581751|NCT01090336|platelet aggregation inhibition|platelet aggregation inhibition
581752|NCT01090336|prasugrel|prasugrel
581753|NCT01090336|clopidogrel|clopidogrel
581755|NCT01090323|Deferasirox|deferasirox
581756|NCT01090323|ICL670A|icl670a
581757|NCT01090323|Iron chelators|iron chelators
581758|NCT01090323|Sickle Cell Disease|sickle cell disease
581759|NCT01090323|Transfusional Hemosiderosis|transfusional hemosiderosis
581760|NCT01090310|Quiescent uveitis|quiescent uveitis
581761|NCT01090310|intermediate uveitis|intermediate uveitis
581762|NCT01090310|panuveitis|panuveitis
581763|NCT01090310|posterior uveitis|posterior uveitis
581764|NCT01090310|uveitis|uveitis
581765|NCT01090310|NVS Definition: Words or phrases that best describe the protocol. Keywords help users find studies in the database.|nvs definition: words or phrases that best describe the protocol. keywords help users find studies in the database.
581766|NCT01090310|Avoid acronyms, abbreviations and trade names.|avoid acronyms, abbreviations and trade names.
581767|NCT01090310|Examples: Heart failure, aliskiren, heart attack, cardiovascular diseases|examples: heart failure, aliskiren, heart attack, cardiovascular diseases
581768|NCT01090310|Psoriasis, inflammatory skin disease, scaly patches|psoriasis, inflammatory skin disease, scaly patches
581769|NCT01090297|Obstructive Sleep Apnea Syndrome|obstructive sleep apnea syndrome
581770|NCT01090297|Blood pressure|blood pressure
581771|NCT01090297|Continuous Positive Airway Pressure|continuous positive airway pressure
581772|NCT01090284|Inguinal hernia|inguinal hernia
581773|NCT01090284|Immune system|immune system
581774|NCT01090284|Cytokines|cytokines
581775|NCT01090284|Prosthetic repair|prosthetic repair
581776|NCT01090284|Oxidative Stress|oxidative stress
581777|NCT01090271|Subacromial impingement syndrome|subacromial impingement syndrome
581778|NCT01090271|Muscle Strength|muscle strength
581779|NCT01090271|Resistance Training|resistance training
581780|NCT01090258|cardiac surgery|cardiac surgery
581781|NCT01090258|mechanical ventilation|mechanical ventilation
581782|NCT01090258|automation|automation
581783|NCT01090258|weaning|weaning
581784|NCT01090245|contingency management|contingency management
581785|NCT01090245|substance abuse treatment|substance abuse treatment
581786|NCT01090245|criminal justice populations|criminal justice populations
581787|NCT01090245|substance abuse treatment retention|substance abuse treatment retention
581788|NCT01090245|HIV prevention in criminal justice settings|hiv prevention in criminal justice settings
581789|NCT01090245|voucher based reinforcement therapy|voucher based reinforcement therapy
581790|NCT01090245|Parole treatment admission for substance abusing parolees|parole treatment admission for substance abusing parolees
581791|NCT01090245|Parole treatment retention for substance abusing parolees|parole treatment retention for substance abusing parolees
581792|NCT01090245|HIV testing and counseling for substance abusing parolees|hiv testing and counseling for substance abusing parolees
581793|NCT01090219|Inguinal Hernia|inguinal hernia
581794|NCT01090219|contraction of two different meshes in the repair of inguinal hernias in men|contraction of two different meshes in the repair of inguinal hernias in men
581795|NCT01090206|Hemophilia|hemophilia
581796|NCT01090206|Vitamin D|vitamin d
581797|NCT01090193|Obstructive jaundice|obstructive jaundice
581798|NCT01090193|kidney histopathology|kidney histopathology
581799|NCT01090193|lactulose|lactulose
581800|NCT01090180|PTSD|ptsd
581801|NCT01090180|combat|combat
581802|NCT01090180|stress disorders|stress disorders
581803|NCT01090180|veteran|veteran
581804|NCT01090154|Ulcerative colitis|ulcerative colitis
581805|NCT01090154|UC|uc
581806|NCT01090154|Inflammatory Bowel Disease|inflammatory bowel disease
581807|NCT01090141|Micafungin|micafungin
581808|NCT01090141|Body Weight|body weight
581809|NCT01090141|Anti-Infective Agents|anti-infective agents
581810|NCT01090141|Signs and Symptoms|signs and symptoms
581811|NCT01090141|Mycoses|mycoses
581812|NCT01090141|Therapeutic Uses|therapeutic uses
581813|NCT01090141|Antifungal Agents|antifungal agents
581814|NCT01090141|Overnutrition|overnutrition
581815|NCT01090141|Pharmacologic Actions|pharmacologic actions
581816|NCT01090076|Pressure Ulcer Wound|pressure ulcer wound
581817|NCT01090076|Specialized Amino Acid Mixture|specialized amino acid mixture
581818|NCT01090063|Palmar Plantar Psoriasis|palmar plantar psoriasis
581819|NCT01090050|Chronic Migraine|chronic migraine
581820|NCT01090050|Migraine|migraine
581821|NCT01090050|Treximet|treximet
581822|NCT01090050|naproxen|naproxen
581823|NCT01090050|sumatriptan|sumatriptan
581824|NCT01090037|ESRD|esrd
581826|NCT01090037|Prostaglandin|prostaglandin
581827|NCT01090037|Prostacyclin|prostacyclin
581828|NCT01090037|Asian Multinational Study|asian multinational study
581829|NCT01089998|Neoplasm|neoplasm
581830|NCT01089998|PET/CT diagnosis|pet/ct diagnosis
581831|NCT01089998|PET tracer|pet tracer
581832|NCT01089998|Inflammation|inflammation
581834|NCT01089972|ulnar artery|ulnar artery
581835|NCT01089972|catheterization|catheterization
581836|NCT01089972|regional blood flow|regional blood flow
581837|NCT01089959|Acid re-flux,GERD|acid re-flux,gerd
581838|NCT01089959|sleep related arousals due to GERD|sleep related arousals due to gerd
581839|NCT01089959|Treatment of acid reflux during sleep in patients with GERD.|treatment of acid reflux during sleep in patients with gerd.
581840|NCT01089946|Mobilization|mobilization
581841|NCT01089946|Hip arthroplasty|hip arthroplasty
581842|NCT01089946|cardiovascular|cardiovascular
581843|NCT01089933|Anesthesia|anesthesia
581844|NCT01089933|Local Anesthetics|local anesthetics
581845|NCT01089933|Analgesia|analgesia
581846|NCT01089933|Quality of life|quality of life
581847|NCT01089933|Paravertebral blocks|paravertebral blocks
581848|NCT01089933|Arm morbidity|arm morbidity
581849|NCT01089907|genomic|genomic
581850|NCT01089907|childhood|childhood
581851|NCT01089907|acute lymphoblastic leukemia|acute lymphoblastic leukemia
581852|NCT01089894|18F-FLT|18f-flt
581853|NCT01089894|PET|pet
581854|NCT01089894|non-small cell lung cancer|non-small cell lung cancer
581855|NCT01089894|cell proliferation|cell proliferation
581856|NCT01089894|therapeutic response|therapeutic response
581857|NCT01089894|18F-3'-fluoro-3'-deoxy-L-thymidine (18F-FLT)|18f-3'-fluoro-3'-deoxy-l-thymidine (18f-flt)
581858|NCT01089881|prostate cancer|prostate cancer
581859|NCT01089881|18F-fluorocholine|18f-fluorocholine
581860|NCT01089881|PET|pet
581861|NCT01089881|recurrence|recurrence
581862|NCT01089881|metastases|metastases
581863|NCT01089868|Glioblastoma multiforme|glioblastoma multiforme
581864|NCT01089868|Microsurgery|microsurgery
581865|NCT01089868|Stereotactic biopsy|stereotactic biopsy
581866|NCT01089868|Radiochemotherapy|radiochemotherapy
581867|NCT01089868|Temodar|temodar
581868|NCT01089868|FET PET|fet pet
581869|NCT01089868|Molecular imaging|molecular imaging
581870|NCT01089855|Neuropathic Pain|neuropathic pain
581871|NCT01089855|Brief Pain Inventory|brief pain inventory
581872|NCT01089855|DN4 questionnaire|dn4 questionnaire
581873|NCT01089855|ElectroCardioGram|electrocardiogram
581874|NCT01089842|Secondary Prevention|secondary prevention
581875|NCT01089842|Health Promotion|health promotion
581876|NCT01089842|Behavioral Medicine|behavioral medicine
581877|NCT01089842|Exercise Therapy|exercise therapy
581878|NCT01089829|CKD|ckd
581879|NCT01089829|Foot Ulceration|foot ulceration
581880|NCT01089829|Diabetes|diabetes
581881|NCT01089816|Influenza infections|influenza infections
581882|NCT01089816|Orthomyxoviridae infections|orthomyxoviridae infections
581883|NCT01089816|Influenza Human|influenza human
581884|NCT01089803|laryngectomy|laryngectomy
581885|NCT01089803|larynx|larynx
581886|NCT01089803|hypopharynx|hypopharynx
581887|NCT01089764|breast neoplasm|breast neoplasm
581888|NCT01089764|breast cancer|breast cancer
581889|NCT01089764|behavioral intervention|behavioral intervention
581890|NCT01089764|online support|online support
581891|NCT01089764|relationship distress|relationship distress
581892|NCT01089764|dyadic coping|dyadic coping
581893|NCT01089738|mulitple dose|mulitple dose
581894|NCT01089738|pharmacokinetics|pharmacokinetics
581895|NCT01089738|safety|safety
581896|NCT01089738|healthy elderly volunteers|healthy elderly volunteers
581897|NCT01089725|safety|safety
581898|NCT01089725|efficacy|efficacy
581899|NCT01089725|parallel group|parallel group
581900|NCT01089725|double-blind|double-blind
581901|NCT01089725|multicenter|multicenter
581902|NCT01089725|injection|injection
581903|NCT01089725|infusion|infusion
581904|NCT01089725|osteoarthritis|osteoarthritis
581905|NCT01089725|bridging|bridging
581906|NCT01089725|subcutaneous|subcutaneous
581907|NCT01089725|intravenous|intravenous
581908|NCT01089725|tanezumab|tanezumab
581909|NCT01089712|Infection|infection
581910|NCT01089712|Cardiac Surgery|cardiac surgery
581911|NCT01089712|Post Operative Cardiac Surgery Infection|post operative cardiac surgery infection
581912|NCT01089712|Management Practices|management practices
581913|NCT01089699|breast cancer|breast cancer
581914|NCT01089699|support groups|support groups
581915|NCT01089699|Primary diagnosis of breast cancer within the past three years.|primary diagnosis of breast cancer within the past three years.
581916|NCT01089686|Chronic Cerebrospinal Venous Insufficiency|chronic cerebrospinal venous insufficiency
581917|NCT01089673|retrospective data collection|retrospective data collection
581918|NCT01089660|Influenza|influenza
581919|NCT01089660|Pandemic Flu|pandemic flu
581920|NCT01089660|Swine-origin Influenza|swine-origin influenza
581921|NCT01089660|Inactivated split-virion vaccine|inactivated split-virion vaccine
581922|NCT01089647|OSA|osa
581923|NCT01089647|Medical treatment|medical treatment
581924|NCT01089634|LV measurement|lv measurement
581925|NCT01089634|CRT|crt
581926|NCT01089634|Concerto|concerto
581928|NCT01089634|LV threshold|lv threshold
581929|NCT01089634|new CRT|new crt
581930|NCT01089608|Azyter in patients affected by chronic blepharitis.|azyter in patients affected by chronic blepharitis.
581931|NCT01089595|Imatinib Resistance|imatinib resistance
581932|NCT01089595|GIST|gist
581933|NCT01089595|Advanced Disease|advanced disease
581934|NCT01089595|Nilotinib|nilotinib
581935|NCT01089582|non-interventional|non-interventional
581936|NCT01089582|mild to moderate Alzheimer's|mild to moderate alzheimer's
581937|NCT01089582|ARICEPT.|aricept.
581938|NCT01089569|diabetes|diabetes
581939|NCT01089569|continuous glucose monitoring|continuous glucose monitoring
581940|NCT01089569|exenatide|exenatide
581941|NCT01089569|insulin glargine|insulin glargine
581942|NCT01089543|dyspepsia|dyspepsia
581943|NCT01089543|rabeprazole|rabeprazole
581944|NCT01089543|Japan|japan
581945|NCT01089530|Fibrinogen|fibrinogen
581946|NCT01089530|Cholesterol|cholesterol
581947|NCT01089530|Cardiovascular risk factors|cardiovascular risk factors
581948|NCT01089530|Primary prevention|primary prevention
581949|NCT01089530|High levels fibrinogen|high levels fibrinogen
581950|NCT01089530|High plasma fibrinogen|high plasma fibrinogen
581951|NCT01089504|phenobarbital|phenobarbital
581952|NCT01089504|neonate|neonate
581953|NCT01089504|antiepileptic drugs|antiepileptic drugs
581954|NCT01089504|neurodevelopmental outcome|neurodevelopmental outcome
581955|NCT01089504|seizure|seizure
581956|NCT01089491|Low back pain|low back pain
581957|NCT01089491|Epiduroscopy|epiduroscopy
581958|NCT01089491|Cytology|cytology
581959|NCT01089491|Electrical stimulation|electrical stimulation
581960|NCT01089478|Back pain|back pain
581961|NCT01089478|Low back pain|low back pain
581962|NCT01089478|Cytology|cytology
581963|NCT01089478|Epiduroscopy|epiduroscopy
581964|NCT01089478|Pain|pain
581965|NCT01089478|Radiculopathy|radiculopathy
581966|NCT01089465|Bed bugs|bed bugs
581967|NCT01089465|Cimex|cimex
581968|NCT01089465|insects|insects
581969|NCT01089465|bites|bites
581970|NCT01089452|Mild to moderate hypertension|mild to moderate hypertension
581971|NCT01089439|Nitric oxide|nitric oxide
581972|NCT01089426|Pediatric patients with Parenteral Nutrition (PN) induced Liver Injury|pediatric patients with parenteral nutrition (pn) induced liver injury
581973|NCT01089400|influenza|influenza
581974|NCT01089400|H1N1|h1n1
581975|NCT01089400|lymphocytes|lymphocytes
581976|NCT01089400|T cell|t cell
581977|NCT01089400|CD4|cd4
581978|NCT01089400|CD8|cd8
581979|NCT01089400|cytokine|cytokine
581980|NCT01089400|serology|serology
581981|NCT01089400|broncho-alveolar lavage|broncho-alveolar lavage
581982|NCT01089400|acute respiratory distress syndrome|acute respiratory distress syndrome
581983|NCT01089400|ventilation|ventilation
581984|NCT01089400|intensive care unit|intensive care unit
581985|NCT01089387|radical prostatectomy|radical prostatectomy
581986|NCT01089374|Phyllodes|phyllodes
581987|NCT01089361|systemic inflammatory syndrome|systemic inflammatory syndrome
581988|NCT01089361|sepsis syndrome|sepsis syndrome
581989|NCT01089361|septic shock|septic shock
581990|NCT01089361|Cytokine|cytokine
581991|NCT01089361|Ketamine|ketamine
581992|NCT01089348|Vaginosis, Bacterial|vaginosis, bacterial
581993|NCT01089348|Prebiotics|prebiotics
581994|NCT01089348|Lactofiltrum|lactofiltrum
581995|NCT01089348|Therapy|therapy
581996|NCT01089335|Sentinel node|sentinel node
581997|NCT01089335|Thyroid cancer|thyroid cancer
581998|NCT01089335|Thyroid neoplasia|thyroid neoplasia
581999|NCT01089335|Follicular neoplasia|follicular neoplasia
582000|NCT01089322|SEVERE ASTHMA|severe asthma
582001|NCT01089322|RISK FACTORS|risk factors
582002|NCT01089322|CHARACTERIZATION|characterization
582003|NCT01089322|CLINICAL CONTROL|clinical control
582004|NCT01089322|INFLAMMATORY MARKERS|inflammatory markers
582005|NCT01089322|SEVERE|severe
582006|NCT01089322|CONTROL|control
582007|NCT01089309|Aldosterone Blockade|aldosterone blockade
582008|NCT01089309|Arterial elasticity|arterial elasticity
582009|NCT01089309|Glycemic control|glycemic control
582010|NCT01089296|Infants born preterm|infants born preterm
582011|NCT01089296|Early physiotherapy intervention|early physiotherapy intervention
582012|NCT01089296|Motor development|motor development
582013|NCT01089296|Parental participation|parental participation
582014|NCT01089296|Parental competency|parental competency
582015|NCT01089283|parkinson|parkinson
582016|NCT01089283|fdg pet-ct|fdg pet-ct
582017|NCT01089283|i123 dat scan|i123 dat scan
582018|NCT01089283|LRRK2|lrrk2
582019|NCT01089283|GBA|gba
582020|NCT01089283|parkinson patients with known genetic characteristic|parkinson patients with known genetic characteristic
582021|NCT01089270|Parkinson|parkinson
582022|NCT01089270|fdg pet-ct|fdg pet-ct
582023|NCT01089270|i123 dat scan|i123 dat scan
582024|NCT01089270|first degree relatives of diagnosed Parkinson patients|first degree relatives of diagnosed parkinson patients
582025|NCT01089270|with no clinical evidence of movement disorders|with no clinical evidence of movement disorders
582026|NCT01089257|Cardiovascular risks|cardiovascular risks
582027|NCT01089257|Oxidative stress|oxidative stress
582028|NCT01089257|Systemic inflammation|systemic inflammation
582029|NCT01089257|Endothelial function|endothelial function
582030|NCT01089257|Peripheral Arterial Tone|peripheral arterial tone
582031|NCT01089257|Positive Airway Pressure|positive airway pressure
582032|NCT01089244|Low grade glioma|low grade glioma
582033|NCT01089244|Astrocytoma|astrocytoma
582034|NCT01089244|Molecular imaging|molecular imaging
582035|NCT01089244|FET PET|fet pet
582036|NCT01089244|Therapy monitoring|therapy monitoring
582037|NCT01089244|Temodar|temodar
582038|NCT01089231|Hyperlipidemia|hyperlipidemia
582039|NCT01089231|coronary heart disease|coronary heart disease
582040|NCT01089231|gene expression|gene expression
582041|NCT01089231|fish oil|fish oil
582042|NCT01089231|DHA, EPA|dha, epa
582043|NCT01089218|bronchoscopy|bronchoscopy
582044|NCT01089218|post-bronchoscopy fever|post-bronchoscopy fever
582045|NCT01089218|pneumonia|pneumonia
582046|NCT01089218|cytokines|cytokines
582047|NCT01089218|amoxicillin/clavulanate|amoxicillin/clavulanate
582048|NCT01089218|prophylaxis|prophylaxis
582049|NCT01089153|human blood, urine and fecal samples|human blood, urine and fecal samples
582050|NCT01089140|pediatrics|pediatrics
582051|NCT01089140|scoliosis|scoliosis
582052|NCT01089140|tranexamic acid|tranexamic acid
582053|NCT01089140|Investigating non-idiopathic scoliosis|investigating non-idiopathic scoliosis
582054|NCT01089127|Indacaterol|indacaterol
582055|NCT01089127|COPD|copd
582056|NCT01089127|salmeterol|salmeterol
582057|NCT01089114|Cardiac Imaging|cardiac imaging
582058|NCT01089114|MR Spectroscopy|mr spectroscopy
582060|NCT01089114|Lipid Metabolism|lipid metabolism
582061|NCT01089114|HIV Infection|hiv infection
582062|NCT01089114|Cardiovascular Disease|cardiovascular disease
582063|NCT01089114|HIV Infections|hiv infections
582064|NCT01089088|recurrent urethral cancer|recurrent urethral cancer
582065|NCT01089088|recurrent transitional cell cancer of the renal pelvis and ureter|recurrent transitional cell cancer of the renal pelvis and ureter
582066|NCT01089088|metastatic transitional cell cancer of the renal pelvis and ureter|metastatic transitional cell cancer of the renal pelvis and ureter
582067|NCT01089088|regional transitional cell cancer of the renal pelvis and ureter|regional transitional cell cancer of the renal pelvis and ureter
582068|NCT01089088|posterior urethral cancer|posterior urethral cancer
582069|NCT01089088|urethral cancer associated with invasive bladder cancer|urethral cancer associated with invasive bladder cancer
582070|NCT01089088|transitional cell carcinoma of the bladder|transitional cell carcinoma of the bladder
582071|NCT01089088|stage IV bladder cancer|stage iv bladder cancer
582072|NCT01089088|recurrent bladder cancer|recurrent bladder cancer
582073|NCT01089088|anterior urethral cancer|anterior urethral cancer
582074|NCT01089075|neuropsychological effects of hydrocortisone replacement|neuropsychological effects of hydrocortisone replacement
582075|NCT01089062|Healthy volunteers|healthy volunteers
582076|NCT01089049|Urinary Estrogen Metabolites|urinary estrogen metabolites
582077|NCT01089049|2-OH Estrone|2-oh estrone
582078|NCT01089049|16-alpha-OH Estrone|16-alpha-oh estrone
582079|NCT01089049|Urinary 2/16a Estrogen Metabolite Ratio|urinary 2/16a estrogen metabolite ratio
582080|NCT01089036|ECMO|ecmo
582081|NCT01089036|cardiogenic shock|cardiogenic shock
582082|NCT01089036|ROS|ros
582083|NCT01089036|GPx|gpx
582084|NCT01089036|cytokines|cytokines
582085|NCT01088997|Persistent pulmonary hypertension of newborn|persistent pulmonary hypertension of newborn
582086|NCT01088997|PPHN|pphn
582087|NCT01088997|Persistent pulmonary hypertension|persistent pulmonary hypertension
582088|NCT01088997|Pulmonary hypertension|pulmonary hypertension
582089|NCT01088997|Pulmonary hypertension of newborn|pulmonary hypertension of newborn
582090|NCT01088958|Kenya|kenya
582091|NCT01088958|Child Nutrition Disorders|child nutrition disorders
582092|NCT01088958|Social marketing|social marketing
582093|NCT01088945|Infant, Premature, Diseases|infant, premature, diseases
582094|NCT01088932|Safety in Healthy Volunteers|safety in healthy volunteers
582095|NCT01088919|ASP1941|asp1941
582096|NCT01088919|Actos|actos
582097|NCT01088919|pioglitazone hydrochloride|pioglitazone hydrochloride
582098|NCT01088906|Phalcis|phalcis
582099|NCT01088906|BRCA1|brca1
582100|NCT01088906|RAP80|rap80
582101|NCT01088906|TS|ts
582102|NCT01088906|First line|first line
582103|NCT01088906|Non-squamous|non-squamous
582104|NCT01088893|everolimus|everolimus
582105|NCT01088893|neoadjuvant|neoadjuvant
582106|NCT01088893|m-TOR inhibitor|m-tor inhibitor
582107|NCT01088880|Familial Mediterranean Fever|familial mediterranean fever
582108|NCT01088880|canakinumab|canakinumab
582109|NCT01088880|colchicine resistance|colchicine resistance
582110|NCT01088867|Pain|pain
582111|NCT01088867|Acupuncture|acupuncture
582112|NCT01088867|DNIC|dnic
582113|NCT01088867|Electroacupuncture|electroacupuncture
582114|NCT01088828|MRI, clubfoot, CTEV, Congenital Talipes Equinovarus|mri, clubfoot, ctev, congenital talipes equinovarus
582115|NCT01088815|Adenocarcinoma|adenocarcinoma
582116|NCT01088815|Hedgehog|hedgehog
582117|NCT01088815|Neoplasms|neoplasms
582118|NCT01088815|Digestive System Diseases|digestive system diseases
582119|NCT01088815|Neoplasms by Site|neoplasms by site
582120|NCT01088815|Digestive System Neoplasms|digestive system neoplasms
582121|NCT01088815|Neoplasms by Histologic Type|neoplasms by histologic type
582122|NCT01088815|Pancreatic Neoplasms|pancreatic neoplasms
582123|NCT01088815|Pancreatic Diseases|pancreatic diseases
582124|NCT01088815|Carcinoma|carcinoma
582125|NCT01088802|Squamous Cell Carcinoma|squamous cell carcinoma
582126|NCT01088802|Oropharynx|oropharynx
582127|NCT01088789|Adenocarcinoma|adenocarcinoma
582128|NCT01088789|Cyclophosphamide|cyclophosphamide
582129|NCT01088789|Immunotherapy|immunotherapy
582130|NCT01088789|Neo-Adjuvant|neo-adjuvant
582131|NCT01088789|Pancreatic tumor vaccine|pancreatic tumor vaccine
582132|NCT01088789|GM-CSF|gm-csf
582133|NCT01088789|Randomize|randomize
582134|NCT01088776|CKD|ckd
582135|NCT01088776|hypertriglyceridemia|hypertriglyceridemia
582136|NCT01088776|Fatty Acid Supplementation|fatty acid supplementation
582137|NCT01088776|Children|children
582138|NCT01088776|Omega-3|omega-3
582139|NCT01088750|childhood nodular lymphocyte predominant Hodgkin lymphoma|childhood nodular lymphocyte predominant hodgkin lymphoma
582140|NCT01088750|stage I childhood Hodgkin lymphoma|stage i childhood hodgkin lymphoma
582141|NCT01088750|stage II childhood Hodgkin lymphoma|stage ii childhood hodgkin lymphoma
582142|NCT01088737|Lentigo maligna|lentigo maligna
582143|NCT01088737|melanoma|melanoma
582144|NCT01088737|imiquimod|imiquimod
582145|NCT01088737|prevention|prevention
582146|NCT01088711|Type 2 diabetes (T2D)|type 2 diabetes (t2d)
582147|NCT01088698|psoriasis|psoriasis
582148|NCT01088698|golimumab|golimumab
582149|NCT01088698|TNF-alpha inhibition|tnf-alpha inhibition
582150|NCT01088698|phototherapy|phototherapy
582151|NCT01088698|311-nm|311-nm
582152|NCT01088672|Stroke|stroke
582153|NCT01088672|Ischemic|ischemic
582154|NCT01088672|Thrombus|thrombus
582155|NCT01088672|Embolectomy|embolectomy
582156|NCT01088672|Thrombectomy|thrombectomy
582157|NCT01088672|Concentric|concentric
582158|NCT01088672|Embolus|embolus
582159|NCT01088672|Mechanical|mechanical
582160|NCT01088672|Trevo|trevo
582161|NCT01088646|capsule endoscopy|capsule endoscopy
582162|NCT01088646|small bowel disease|small bowel disease
582163|NCT01088646|inflammatory bowel disease|inflammatory bowel disease
582164|NCT01088646|Subjects indicated for EGD endoscopy|subjects indicated for egd endoscopy
582165|NCT01088633|COPD|copd
582166|NCT01088620|NSCLC|nsclc
582167|NCT01088620|Stage IIIb or IV|stage iiib or iv
582168|NCT01088620|Nonsquamous|nonsquamous
582169|NCT01088620|KRAS-Wildtype|kras-wildtype
582170|NCT01088607|Primary sclerosing cholangitis|primary sclerosing cholangitis
582171|NCT01088607|Autoimmune hepatitis|autoimmune hepatitis
582172|NCT01088607|Cholestatic liver disease|cholestatic liver disease
582173|NCT01088607|Cirrhosis|cirrhosis
582174|NCT01088607|Children|children
582175|NCT01088607|Primary Sclerosing Cholangitis/Autoimmune Hepatitis Overlap|primary sclerosing cholangitis/autoimmune hepatitis overlap
582176|NCT01088594|urinary sodium excretion|urinary sodium excretion
582177|NCT01088594|Pioglitazone|pioglitazone
582178|NCT01088594|Rosiglitazone|rosiglitazone
582179|NCT01088594|Methodological study|methodological study
582180|NCT01088581|hepatocellular carcinoma|hepatocellular carcinoma
582181|NCT01088581|hepatic arterial infusion chemotherapy|hepatic arterial infusion chemotherapy
582182|NCT01088581|5-fluorouracil|5-fluorouracil
582183|NCT01088581|cisplatin|cisplatin
582184|NCT01088581|adjuvant chemotherapy|adjuvant chemotherapy
582185|NCT01088581|hepatectomy|hepatectomy
582186|NCT01088568|Keratomileusis, laser in situ|keratomileusis, laser in situ
582187|NCT01088568|Phakic Intraocular Lenses|phakic intraocular lenses
582188|NCT01088568|myopia|myopia
582189|NCT01088568|astigmatism|astigmatism
582190|NCT01088568|Implantable Collamer Lens, Toric|implantable collamer lens, toric
582191|NCT01088555|nephrolithiasis|nephrolithiasis
582192|NCT01088555|calcium stones|calcium stones
582193|NCT01088555|kidney stones|kidney stones
582194|NCT01088555|hypercalciuria|hypercalciuria
582195|NCT01088555|sodium thiosulfate|sodium thiosulfate
582196|NCT01088555|Calcium containing kidney stones|calcium containing kidney stones
582197|NCT01088542|substance use|substance use
582198|NCT01088542|delinquency|delinquency
582199|NCT01088542|risky sexual behavior|risky sexual behavior
582200|NCT01088542|risk factors|risk factors
582201|NCT01088542|protective factors|protective factors
582202|NCT01088542|prevention|prevention
582203|NCT01088542|community coalitions|community coalitions
582204|NCT01088542|systems transformation|systems transformation
582205|NCT01088542|violence|violence
582206|NCT01088529|Neoadjuvant Prostate Cancer|neoadjuvant prostate cancer
582207|NCT01088529|Abiraterone Acetate|abiraterone acetate
582208|NCT01088529|LHRHa|lhrha
582209|NCT01088529|high risk prostate cancer|high risk prostate cancer
582210|NCT01088529|Radical prostatectomy|radical prostatectomy
582211|NCT01088529|Prednisone|prednisone
582212|NCT01088529|Luteinizing Hormone-Releasing Hormone|luteinizing hormone-releasing hormone
582213|NCT01088529|LHRH analogue|lhrh analogue
582214|NCT01088516|Human Immunodeficiency Virus|human immunodeficiency virus
582215|NCT01088516|Vertical Transmission|vertical transmission
582216|NCT01088516|Pregnancy|pregnancy
582217|NCT01088516|Breastfeeding|breastfeeding
582218|NCT01088516|Prevention of mother to child transmission|prevention of mother to child transmission
582219|NCT01088516|HAART|haart
582223|NCT01088516|Infectious Disease Transmission, Vertical|infectious disease transmission, vertical
582224|NCT01088490|Hydrogen sulfide|hydrogen sulfide
582225|NCT01088490|critically ill|critically ill
582226|NCT01088490|mortality|mortality
582227|NCT01088477|Acquired anti-hormonal resistant breast cancer|acquired anti-hormonal resistant breast cancer
582228|NCT01088464|Human Immunoglobulin Gamma-1 (IgG1)|human immunoglobulin gamma-1 (igg1)
582229|NCT01088464|Monoclonal Antibody (MAb)|monoclonal antibody (mab)
582230|NCT01088464|Epidermal Growth Factor Receptor (EGFR)|epidermal growth factor receptor (egfr)
582231|NCT01088464|Advanced Solid Tumors|advanced solid tumors
582232|NCT01088451|Diabetes Mellitus, Type 1|diabetes mellitus, type 1
582233|NCT01088451|Prandial Glycemia|prandial glycemia
582234|NCT01088451|Rapid Acting Insulin Analogue|rapid acting insulin analogue
582235|NCT01088451|Human Insulin|human insulin
582236|NCT01088438|medical education|medical education
582237|NCT01088438|decision making|decision making
582238|NCT01088438|diagnostic error|diagnostic error
582239|NCT01088438|contextualization|contextualization
582240|NCT01088425|vitrification|vitrification
582241|NCT01088425|2PN oocyte|2pn oocyte
582242|NCT01088425|maternal and infant health|maternal and infant health
582243|NCT01088425|embryo survival, clinical pregnancy rate|embryo survival, clinical pregnancy rate
582244|NCT01088425|mode of delivery|mode of delivery
582245|NCT01088425|injury during delivery|injury during delivery
582246|NCT01088425|infant development|infant development
582247|NCT01088425|infant morbidity|infant morbidity
582248|NCT01088425|slow- rate freezing|slow- rate freezing
582249|NCT01088347|TRAIL|trail
582250|NCT01088347|TRM1|trm1
582251|NCT01088347|advanced cervical cancer|advanced cervical cancer
582252|NCT01088347|mapatumumab|mapatumumab
582253|NCT01088347|Uterine cervical neoplasm|uterine cervical neoplasm
582254|NCT01088347|Radiotherapy|radiotherapy
582255|NCT01088347|Cisplatin|cisplatin
582256|NCT01088334|Idiopathic venous thromboembolism|idiopathic venous thromboembolism
582257|NCT01088334|Malignancy|malignancy
582258|NCT01088334|screening|screening
582259|NCT01088295|Metabolic|metabolic
582260|NCT01088295|HIV|hiv
582261|NCT01088295|Fat accumulation|fat accumulation
582262|NCT01088295|AIDS|aids
582263|NCT01088295|Metabolic abnormalities in HIV infection|metabolic abnormalities in hiv infection
582264|NCT01088295|HIV Infections|hiv infections
582265|NCT01088282|Diffractive multifocal IOL|diffractive multifocal iol
582266|NCT01088269|Blood Pressure Measurement|blood pressure measurement
582267|NCT01088269|Atrial Fibrillation|atrial fibrillation
582268|NCT01088269|Blood pressure measurement in atrial fibrillation|blood pressure measurement in atrial fibrillation
582269|NCT01088269|Atrial Fibrillation diagnosis|atrial fibrillation diagnosis
582270|NCT01088256|CRPS|crps
582271|NCT01088256|Morbus Sudeck|morbus sudeck
582272|NCT01088256|Causalgia|causalgia
582273|NCT01088256|Etoricoxib|etoricoxib
582274|NCT01088256|Polyneuropathy|polyneuropathy
582275|NCT01088256|post herpetic neuralgia|post herpetic neuralgia
582276|NCT01088256|peripheral nerve injury|peripheral nerve injury
582277|NCT01088256|radiculopathy|radiculopathy
582278|NCT01088256|Nervenverletzung|nervenverletzung
582279|NCT01088256|postherpetische Neuralgie|postherpetische neuralgie
582280|NCT01088256|COX-2-Inhibitor|cox-2-inhibitor
582281|NCT01088243|Berylliosis|berylliosis
582282|NCT01088243|Beryllium Disease|beryllium disease
582283|NCT01088230|hemiparesis|hemiparesis
582284|NCT01088230|robotics|robotics
582285|NCT01088230|stroke|stroke
582286|NCT01088230|Botox®|botox®
582287|NCT01088230|rehabilitation|rehabilitation
582288|NCT01088230|wrist spasticity|wrist spasticity
582289|NCT01088217|Idiopathic Pulmonary Fibrosis|idiopathic pulmonary fibrosis
582290|NCT01088217|Familial Pulmonary Fibrosis|familial pulmonary fibrosis
582291|NCT01088217|Idiopathic Interstitial Pneumonia|idiopathic interstitial pneumonia
582292|NCT01088217|Familial Interstitial Pneumonia|familial interstitial pneumonia
582293|NCT01088217|Pulmonary Fibrosis|pulmonary fibrosis
582294|NCT01088191|Acute Anterior Cruciate Ligament Injury|acute anterior cruciate ligament injury
582295|NCT01088191|Anterior Cruciate Ligament Reconstruction|anterior cruciate ligament reconstruction
582296|NCT01088191|Adult Stem Cells|adult stem cells
582297|NCT01088191|Mesenchymal precursor cells|mesenchymal precursor cells
582298|NCT01088178|Long-Acting Reversible Contraception|long-acting reversible contraception
582299|NCT01088178|Contraceptive Agents|contraceptive agents
582300|NCT01088178|Therapeutic Uses|therapeutic uses
582301|NCT01088178|Contraceptive Agents, Female|contraceptive agents, female
582302|NCT01088178|Reproductive Control Agents|reproductive control agents
582303|NCT01088178|Pharmacologic Actions|pharmacologic actions
582304|NCT01088178|Levonorgestrel|levonorgestrel
582305|NCT01088165|Psoriasis|psoriasis
582306|NCT01088165|Cardiovascular Diseases|cardiovascular diseases
582307|NCT01088165|Diabetes Mellitus, Type 2|diabetes mellitus, type 2
582308|NCT01088165|Adalimumab|adalimumab
582309|NCT01088165|Fumaric acid esters|fumaric acid esters
582310|NCT01088152|Celiac disease|celiac disease
582311|NCT01088152|Education|education
582312|NCT01088152|Sweden|sweden
582313|NCT01088152|Gluten-free diet|gluten-free diet
582314|NCT01088139|Nutritional support|nutritional support
582595|NCT01087203|tanezumab|tanezumab
582315|NCT01088139|Rehabilitation outcomes|rehabilitation outcomes
582316|NCT01088113|Tai Chi|tai chi
582317|NCT01088113|Qigong|qigong
582318|NCT01088113|Heart rate variability|heart rate variability
582319|NCT01088113|Near Infrared Spectroscopy|near infrared spectroscopy
582320|NCT01088113|blood pressure|blood pressure
582321|NCT01088100|POCD|pocd
582322|NCT01088100|clock-gene genotypes|clock-gene genotypes
582323|NCT01088100|HPER3|hper3
582324|NCT01088074|Total Knee Replacement|total knee replacement
582325|NCT01088074|Closure Methods|closure methods
582326|NCT01088048|CLL|cll
582327|NCT01088048|non-Hodgkin lymphoma (NHL)|non-hodgkin lymphoma (nhl)
582328|NCT01088048|mantle cell lymphoma (MCL)|mantle cell lymphoma (mcl)
582329|NCT01088048|phosphatidylinositol 3-kinase|phosphatidylinositol 3-kinase
582330|NCT01088048|bendamustine|bendamustine
582331|NCT01088048|CD20 mAb|cd20 mab
582332|NCT01088048|rituximab|rituximab
582333|NCT01088048|CAL-101|cal-101
582334|NCT01088048|Ofatumumab|ofatumumab
582335|NCT01088048|indolent non-Hodgkin lymphoma (iNHL)|indolent non-hodgkin lymphoma (inhl)
582336|NCT01088048|fludarabine|fludarabine
582337|NCT01088048|everolimus|everolimus
582338|NCT01088048|bortezomib|bortezomib
582339|NCT01088048|chlorambucil|chlorambucil
582340|NCT01088048|lenalidomide|lenalidomide
582341|NCT01088035|Childhood ependymoma|childhood ependymoma
582342|NCT01088035|Ependymoma|ependymoma
582343|NCT01088035|Survivin|survivin
582344|NCT01088022|the complete response (CR) rate defined as the number of patients with no emetic episodes and no rescue medication in the first 120 hours post-chemotherapy|the complete response (cr) rate defined as the number of patients with no emetic episodes and no rescue medication in the first 120 hours post-chemotherapy
582345|NCT01088009|chronic hepatitis B|chronic hepatitis b
582346|NCT01087996|Chronic Ischemic Left Ventricular|chronic ischemic left ventricular
582347|NCT01087983|Metastatic cancer|metastatic cancer
582348|NCT01087983|Lapatinib|lapatinib
582349|NCT01087983|Tykerb|tykerb
582350|NCT01087983|Metformin|metformin
582351|NCT01087983|Glucophage|glucophage
582352|NCT01087983|Sirolimus|sirolimus
582353|NCT01087983|Rapamune|rapamune
582354|NCT01087970|Pharynx|pharynx
582355|NCT01087970|Larynx|larynx
582356|NCT01087970|Nose|nose
582357|NCT01087970|Parathyroid|parathyroid
582358|NCT01087931|Local anesthetic|local anesthetic
582359|NCT01087931|Iliac crest bone harvest|iliac crest bone harvest
582360|NCT01087931|Patients undergoing spine surgery that require use of iliac crest bone autograft|patients undergoing spine surgery that require use of iliac crest bone autograft
582361|NCT01087918|ASIA C and D|asia c and d
582362|NCT01087905|Smoking|smoking
582363|NCT01087905|Smoking cessation|smoking cessation
582364|NCT01087905|Medication adherence|medication adherence
582365|NCT01087879|oral glucose tolerance test|oral glucose tolerance test
582366|NCT01087879|hormonal contraception|hormonal contraception
582367|NCT01087879|androgens|androgens
582368|NCT01087879|crp|crp
582369|NCT01087866|Gestational diabetes mellitus|gestational diabetes mellitus
582370|NCT01087866|treatment|treatment
582371|NCT01087866|metformin|metformin
582372|NCT01087853|Fluid Therapy|fluid therapy
582373|NCT01087853|Water Electrolyte Imbalance|water electrolyte imbalance
582374|NCT01087853|Acid Base Imbalance|acid base imbalance
582375|NCT01087853|Renal Circulation|renal circulation
582376|NCT01087853|Magnetic Resonance Imaging|magnetic resonance imaging
582377|NCT01087840|HIV|hiv
582378|NCT01087840|nonoccupational|nonoccupational
582379|NCT01087840|postexposure|postexposure
582380|NCT01087840|prophylaxis|prophylaxis
582381|NCT01087840|HIV Seronegativity|hiv seronegativity
582382|NCT01087827|oscillometric blood pressure|oscillometric blood pressure
582383|NCT01087827|cuff site|cuff site
582384|NCT01087827|forearm blood pressure|forearm blood pressure
582385|NCT01087827|upper arm blood pressure|upper arm blood pressure
582386|NCT01087827|anthropometric measurements|anthropometric measurements
582387|NCT01087827|tonometry|tonometry
582388|NCT01087827|site of blood pressure measurement|site of blood pressure measurement
582389|NCT01087827|measurement accuracy|measurement accuracy
582390|NCT01087814|efavirenz|efavirenz
582391|NCT01087814|Sustiva|sustiva
582392|NCT01087814|pharmacokinetics|pharmacokinetics
582393|NCT01087801|Genetic End Marker|genetic end marker
582394|NCT01087788|Certolizumab Pegol|certolizumab pegol
582395|NCT01087788|Cimzia|cimzia
582396|NCT01087762|Certolizumab Pegol|certolizumab pegol
582397|NCT01087762|Cimzia|cimzia
582398|NCT01087736|PTSD|ptsd
582399|NCT01087736|Alcohol abuse|alcohol abuse
582400|NCT01087736|Alcoholism|alcoholism
582401|NCT01087736|Topiramate|topiramate
582402|NCT01087736|Stress Disorder, Post Traumatic|stress disorder, post traumatic
582403|NCT01087736|Chronic Post-Traumatic Stress Disorder|chronic post-traumatic stress disorder
582404|NCT01087723|EUROMAX|euromax
582405|NCT01087723|STEMI|stemi
582406|NCT01087723|STE-ACS|ste-acs
582407|NCT01087723|UFH|ufh
582408|NCT01087723|bivalirudin|bivalirudin
582409|NCT01087723|PCI|pci
582410|NCT01087723|ambulance study|ambulance study
582411|NCT01087723|STE-MI participants|ste-mi participants
582412|NCT01087697|bladder cancer|bladder cancer
582413|NCT01087697|radical cystectomy|radical cystectomy
582414|NCT01087697|incontinent urinary diversion|incontinent urinary diversion
582415|NCT01087684|Glaucoma|glaucoma
582416|NCT01087684|laser trabeculoplasty|laser trabeculoplasty
582417|NCT01087684|intraocular pressure|intraocular pressure
582418|NCT01087632|Metabolic Syndrome Insulin-resistance Endothelial Function|metabolic syndrome insulin-resistance endothelial function
582419|NCT01087619|Hyperparathyroidism, primary|hyperparathyroidism, primary
582420|NCT01087619|Aged 66 years or older|aged 66 years or older
582421|NCT01087619|Mild hypercalcaemia|mild hypercalcaemia
582422|NCT01087619|Surgical Procedures, Elective|surgical procedures, elective
582423|NCT01087619|Indication|indication
582424|NCT01087619|Osteoporosis|osteoporosis
582425|NCT01087619|Cognitive function|cognitive function
582426|NCT01087619|Atherosclerosis|atherosclerosis
582427|NCT01087619|Follow-up|follow-up
582428|NCT01087619|Randomized trial|randomized trial
582429|NCT01087593|estrogen|estrogen
582430|NCT01087593|substitution|substitution
582431|NCT01087593|pain|pain
582432|NCT01087593|hormonal levels|hormonal levels
582433|NCT01087593|quantitative sensory testing|quantitative sensory testing
582434|NCT01087580|Prostate Cancer|prostate cancer
582435|NCT01087580|non metastatic prostate cancer|non metastatic prostate cancer
582436|NCT01087580|oligometastatic prostate cancer|oligometastatic prostate cancer
582437|NCT01087567|diabetes|diabetes
582438|NCT01087567|insulin|insulin
582439|NCT01087567|rescue therapy|rescue therapy
582440|NCT01087554|Advanced Cancer|advanced cancer
582441|NCT01087554|Sirolimus|sirolimus
582442|NCT01087554|Rapamune|rapamune
582443|NCT01087554|mTOR Inhibitor|mtor inhibitor
582444|NCT01087554|Histone Deacetylase Inhibitor|histone deacetylase inhibitor
582445|NCT01087554|Vorinostat|vorinostat
582446|NCT01087554|SAHA|saha
582447|NCT01087554|Suberoylanilide Hydroxamic Acid|suberoylanilide hydroxamic acid
582448|NCT01087554|MSK-390|msk-390
582449|NCT01087554|Zolinza|zolinza
582450|NCT01087554|Everolimus|everolimus
582451|NCT01087554|Afinitor|afinitor
582452|NCT01087554|Zortress|zortress
582453|NCT01087554|RAD001|rad001
582454|NCT01087554|Temsirolimus|temsirolimus
582455|NCT01087554|CCI-779|cci-779
582456|NCT01087554|Torisel|torisel
582457|NCT01087541|Patient's Safety|patient's safety
582458|NCT01087541|Diabetes mellitus|diabetes mellitus
582459|NCT01087541|Public Health for professionals|public health for professionals
582460|NCT01087541|Safety|safety
582461|NCT01087541|Public health|public health
582462|NCT01087528|Colonic Diseases|colonic diseases
582463|NCT01087528|bowel diseases|bowel diseases
582464|NCT01087528|large bowel diseases|large bowel diseases
582465|NCT01087489|pain|pain
582466|NCT01087489|discomfort|discomfort
582467|NCT01087489|anesthetic drugs|anesthetic drugs
582468|NCT01087489|topical drug administration|topical drug administration
582469|NCT01087489|injections, intraocular|injections, intraocular
582470|NCT01087489|lidocaine|lidocaine
582471|NCT01087489|intraocular pressure|intraocular pressure
582472|NCT01087489|keratopathy|keratopathy
582473|NCT01087476|oral mucositis|oral mucositis
582474|NCT01087476|chemotherapy|chemotherapy
582475|NCT01087476|acute leukemia|acute leukemia
582476|NCT01087476|salivary flow.|salivary flow.
582477|NCT01087450|Erythropoietin|erythropoietin
582478|NCT01087450|Sepsis|sepsis
582479|NCT01087450|Septic shock|septic shock
582480|NCT01087450|Orthogonal Polarization Spectroscopy|orthogonal polarization spectroscopy
582481|NCT01087450|Severe sepsis or Septic shock|severe sepsis or septic shock
582482|NCT01087437|Distraction osteogenesis|distraction osteogenesis
582483|NCT01087424|Diffuse Large B-Cell Lymphoma|diffuse large b-cell lymphoma
582484|NCT01087411|accelerometry|accelerometry
582485|NCT01087411|physical activity|physical activity
582486|NCT01087411|obesity|obesity
582487|NCT01087411|children|children
582488|NCT01087411|cardiovascular risk markers|cardiovascular risk markers
582489|NCT01087411|metabolic risk markers|metabolic risk markers
582490|NCT01087411|DXA|dxa
582491|NCT01087411|obesity prevention|obesity prevention
582492|NCT01087411|omega 3|omega 3
582493|NCT01087411|fish liver oil|fish liver oil
582494|NCT01087411|motivational interviewing|motivational interviewing
582495|NCT01087398|Osteopetrosis|osteopetrosis
582496|NCT01087398|HSCT|hsct
582497|NCT01087385|peripheral arterial occlusive disease|peripheral arterial occlusive disease
582498|NCT01087385|mortality|mortality
582499|NCT01087385|cardiovascular events|cardiovascular events
582500|NCT01087385|amputation|amputation
582501|NCT01087385|peripheral arterial revascularization|peripheral arterial revascularization
582502|NCT01087372|Stress hyperglycemia|stress hyperglycemia
582503|NCT01087372|Incretins|incretins
582504|NCT01087372|GLP-1|glp-1
582505|NCT01087372|GIP|gip
582506|NCT01087372|glucoregulatory hormones|glucoregulatory hormones
582507|NCT01087346|Risk Perception|risk perception
582508|NCT01087346|Obesity Risk|obesity risk
582509|NCT01087346|Healthy Volunteer|healthy volunteer
582510|NCT01087346|HV|hv
582511|NCT01087333|Cytotoxicity Assay|cytotoxicity assay
582512|NCT01087333|Neutralizing Antibodies|neutralizing antibodies
582513|NCT01087333|Apheresis|apheresis
582514|NCT01087333|Flow Cytometry|flow cytometry
582515|NCT01087333|Hemolytic Uremic Syndrome (HUS)|hemolytic uremic syndrome (hus)
582516|NCT01087320|Rare Disorders|rare disorders
582517|NCT01087320|Genetic Disorders|genetic disorders
582518|NCT01087320|Congenital Disorders|congenital disorders
582519|NCT01087320|Inherited Diseases|inherited diseases
582520|NCT01087307|Serum|serum
582521|NCT01087307|Urine Collection|urine collection
582522|NCT01087307|Saliva|saliva
582523|NCT01087307|Specimen Collection|specimen collection
582524|NCT01087294|CD19|cd19
582525|NCT01087294|Chimeric-Antigen-Receptor|chimeric-antigen-receptor
582526|NCT01087294|Gene Therapy|gene therapy
582527|NCT01087294|Adoptive T Cell Therapy|adoptive t cell therapy
582528|NCT01087294|Allogeneic Stem Cell Transplantation|allogeneic stem cell transplantation
582529|NCT01087281|Visual Attention|visual attention
582530|NCT01087281|Visual Cortex|visual cortex
582531|NCT01087281|Focal Lesions|focal lesions
582532|NCT01087281|Neurological Disorder|neurological disorder
582533|NCT01087281|Functional Magnetic Resonance Imaging (fMRI)|functional magnetic resonance imaging (fmri)
582534|NCT01087281|Focal Brain Lesion|focal brain lesion
582535|NCT01087281|Healthy Volunteer|healthy volunteer
582536|NCT01087281|HV|hv
582537|NCT01087268|gastrointestinal complications|gastrointestinal complications
582538|NCT01087268|radiation toxicity|radiation toxicity
582539|NCT01087268|long-term effects secondary to cancer therapy in adults|long-term effects secondary to cancer therapy in adults
582540|NCT01087268|stage I rectal cancer|stage i rectal cancer
582541|NCT01087268|stage II rectal cancer|stage ii rectal cancer
582542|NCT01087268|stage III rectal cancer|stage iii rectal cancer
582543|NCT01087268|stage I prostate cancer|stage i prostate cancer
582544|NCT01087268|stage IIB prostate cancer|stage iib prostate cancer
582545|NCT01087268|stage IIA prostate cancer|stage iia prostate cancer
582546|NCT01087268|stage III prostate cancer|stage iii prostate cancer
582547|NCT01087268|stage IV prostate cancer|stage iv prostate cancer
582548|NCT01087268|stage I bladder cancer|stage i bladder cancer
582549|NCT01087268|stage II bladder cancer|stage ii bladder cancer
582550|NCT01087268|stage III bladder cancer|stage iii bladder cancer
582551|NCT01087268|stage IV bladder cancer|stage iv bladder cancer
582552|NCT01087268|stage IA cervical cancer|stage ia cervical cancer
582553|NCT01087268|stage IB cervical cancer|stage ib cervical cancer
582554|NCT01087268|stage IIA cervical cancer|stage iia cervical cancer
582555|NCT01087268|stage IIB cervical cancer|stage iib cervical cancer
582556|NCT01087268|stage III cervical cancer|stage iii cervical cancer
582557|NCT01087268|stage I vaginal cancer|stage i vaginal cancer
582558|NCT01087268|stage II vaginal cancer|stage ii vaginal cancer
582559|NCT01087268|stage III vaginal cancer|stage iii vaginal cancer
582560|NCT01087268|stage I malignant testicular germ cell tumor|stage i malignant testicular germ cell tumor
582561|NCT01087268|stage II malignant testicular germ cell tumor|stage ii malignant testicular germ cell tumor
582562|NCT01087268|stage III malignant testicular germ cell tumor|stage iii malignant testicular germ cell tumor
582563|NCT01087268|stage I endometrial carcinoma|stage i endometrial carcinoma
582564|NCT01087268|stage II endometrial carcinoma|stage ii endometrial carcinoma
582565|NCT01087268|stage III endometrial carcinoma|stage iii endometrial carcinoma
582566|NCT01087268|stage I uterine sarcoma|stage i uterine sarcoma
582567|NCT01087268|stage II uterine sarcoma|stage ii uterine sarcoma
582568|NCT01087268|stage III uterine sarcoma|stage iii uterine sarcoma
582569|NCT01087268|stage IA ovarian epithelial cancer|stage ia ovarian epithelial cancer
582570|NCT01087268|stage IB ovarian epithelial cancer|stage ib ovarian epithelial cancer
582571|NCT01087268|stage IC ovarian epithelial cancer|stage ic ovarian epithelial cancer
582572|NCT01087268|stage IIA ovarian epithelial cancer|stage iia ovarian epithelial cancer
582573|NCT01087268|stage IIB ovarian epithelial cancer|stage iib ovarian epithelial cancer
582574|NCT01087268|stage IIC ovarian epithelial cancer|stage iic ovarian epithelial cancer
582575|NCT01087268|stage IIIA ovarian epithelial cancer|stage iiia ovarian epithelial cancer
582576|NCT01087268|stage IIIB ovarian epithelial cancer|stage iiib ovarian epithelial cancer
582577|NCT01087268|stage IIIC ovarian epithelial cancer|stage iiic ovarian epithelial cancer
582578|NCT01087268|stage IA ovarian germ cell tumor|stage ia ovarian germ cell tumor
582579|NCT01087268|stage IB ovarian germ cell tumor|stage ib ovarian germ cell tumor
582580|NCT01087268|stage IC ovarian germ cell tumor|stage ic ovarian germ cell tumor
582581|NCT01087268|stage IIA ovarian germ cell tumor|stage iia ovarian germ cell tumor
582582|NCT01087268|stage IIB ovarian germ cell tumor|stage iib ovarian germ cell tumor
582583|NCT01087268|stage IIC ovarian germ cell tumor|stage iic ovarian germ cell tumor
582584|NCT01087268|stage IIIA ovarian germ cell tumor|stage iiia ovarian germ cell tumor
582585|NCT01087268|stage IIIB ovarian germ cell tumor|stage iiib ovarian germ cell tumor
582586|NCT01087268|stage IIIC ovarian germ cell tumor|stage iiic ovarian germ cell tumor
582587|NCT01087255|Caregiver-based interventions|caregiver-based interventions
582588|NCT01087255|Chronic Kidney Disease|chronic kidney disease
582589|NCT01087255|Medication Adherence|medication adherence
582590|NCT01087242|Tang-min Lin pills|tang-min lin pills
582591|NCT01087242|type 2 diabetes|type 2 diabetes
582592|NCT01087242|liver and stomach heat retention|liver and stomach heat retention
582593|NCT01087242|Evaluate the safety and efficacy of Tang-min Lin pills|evaluate the safety and efficacy of tang-min lin pills
582594|NCT01087203|diabetic peripheral neuropathy|diabetic peripheral neuropathy
582596|NCT01087203|diabetic neuropathies|diabetic neuropathies
582597|NCT01087203|diabetic polyneuropathy|diabetic polyneuropathy
582598|NCT01087203|diabetic neuropathy painful|diabetic neuropathy painful
582600|NCT01087190|transplantation|transplantation
582601|NCT01087190|tuberculosis|tuberculosis
582602|NCT01087190|ELISPOT|elispot
582603|NCT01087190|isoniazid|isoniazid
582604|NCT01087177|Smoking|smoking
582605|NCT01087177|Tobacco|tobacco
582606|NCT01087177|Pediatrics|pediatrics
582607|NCT01087164|Vaccine acceptance|vaccine acceptance
582608|NCT01087164|human papillomavirus|human papillomavirus
582609|NCT01087164|brief messages|brief messages
582610|NCT01087164|social compliance|social compliance
740541|NCT00472381|DWI|dwi
582611|NCT01087164|Message sidedness|message sidedness
582612|NCT01087151|Rituxan|rituxan
582613|NCT01087151|Apoptosis|apoptosis
582614|NCT01087151|BCl-2|bcl-2
582615|NCT01087138|bone health|bone health
582616|NCT01087138|bone density|bone density
582617|NCT01087138|bone mass|bone mass
582618|NCT01087112|MIP|mip
582619|NCT01087112|RCT|rct
582620|NCT01087112|postnatal depression|postnatal depression
582621|NCT01087112|Mother-child relationship|mother-child relationship
582622|NCT01087086|Metabolic syndrome|metabolic syndrome
582623|NCT01087086|Oxidative stress|oxidative stress
582624|NCT01087086|Proinflammatory state|proinflammatory state
582625|NCT01087086|Insulin resistance|insulin resistance
582626|NCT01087086|Hypertension|hypertension
582627|NCT01087086|Dyslipidemia|dyslipidemia
582628|NCT01087086|Mediterranean diet|mediterranean diet
582629|NCT01087086|Glycemic index|glycemic index
582630|NCT01087086|Hypocaloric diet|hypocaloric diet
582631|NCT01087086|Hyperproteic diet|hyperproteic diet
582632|NCT01087086|Macronutrient distribution|macronutrient distribution
582633|NCT01087086|Antioxidant capacity of the diet|antioxidant capacity of the diet
582634|NCT01087086|Crononutrition|crononutrition
582635|NCT01087086|Dietary and psychological support|dietary and psychological support
582636|NCT01087086|Waist circumference|waist circumference
582637|NCT01087073|Healthcare Disparities|healthcare disparities
582638|NCT01087073|Health Care Quality Improvement|health care quality improvement
582639|NCT01087073|Shared Decision-Making|shared decision-making
582640|NCT01087073|Patient Education|patient education
582641|NCT01087073|Patient Activation|patient activation
582642|NCT01087073|Community Outreach|community outreach
582643|NCT01087073|Provider Training|provider training
582644|NCT01087047|Pregnancy|pregnancy
582645|NCT01087047|Upper airways|upper airways
582646|NCT01087047|Acoustic reflection method|acoustic reflection method
582647|NCT01087034|Infantile scoliosis|infantile scoliosis
582648|NCT01087034|bracing|bracing
582649|NCT01087034|acoustic reflection method|acoustic reflection method
582650|NCT01087034|EOS™|eos™
582651|NCT01087034|noninvasive|noninvasive
582652|NCT01087034|upper airways|upper airways
582653|NCT01087034|thoracic penetration index|thoracic penetration index
582654|NCT01087034|Idiopathic juvenile evolutive thoracic scoliosis|idiopathic juvenile evolutive thoracic scoliosis
582655|NCT01087008|Multiple Myeloma|multiple myeloma
582656|NCT01087008|Zoledronic acid|zoledronic acid
582657|NCT01086995|extubation|extubation
582658|NCT01086995|weaning|weaning
582659|NCT01086995|mechanical ventilation|mechanical ventilation
582660|NCT01086969|Meningococcal Infection|meningococcal infection
582661|NCT01086969|Meningitis, Bacterial|meningitis, bacterial
582662|NCT01086969|Menactra®|menactra®
582663|NCT01086956|patients of prostatic cancer aged more than 65 years|patients of prostatic cancer aged more than 65 years
582664|NCT01086917|Malaria Challenge|malaria challenge
582665|NCT01086917|Plasmodium falciparum|plasmodium falciparum
582666|NCT01086917|Controlled human malaria infection|controlled human malaria infection
582667|NCT01086917|PfSPZ Challenge|pfspz challenge
582668|NCT01086904|renal transplantation|renal transplantation
582669|NCT01086904|immunosuppression|immunosuppression
582670|NCT01086904|inflenza A (H1N1)|inflenza a (h1n1)
582671|NCT01086904|vaccine|vaccine
582672|NCT01086878|Antiretroviral Therapy, Highly Active|antiretroviral therapy, highly active
582673|NCT01086878|Trimethoprim-Sulfamethoxazole Combination|trimethoprim-sulfamethoxazole combination
582674|NCT01086878|anemia|anemia
582675|NCT01086878|neutropenia|neutropenia
582676|NCT01086878|safety|safety
582677|NCT01086878|hematologic toxicity|hematologic toxicity
582678|NCT01086865|inappetence|inappetence
582679|NCT01086865|apetiviton BC|apetiviton bc
582680|NCT01086852|Factor X deficiency|factor x deficiency
582681|NCT01086852|surgery|surgery
582682|NCT01086852|Factor X deficiency subjects requiring surgery|factor x deficiency subjects requiring surgery
582683|NCT01086839|Cystic Fibrosis|cystic fibrosis
582684|NCT01086839|chronic rhinosinusitis|chronic rhinosinusitis
582685|NCT01086813|Safety|safety
582686|NCT01086813|Tolerability|tolerability
582687|NCT01086813|Pharmacokinetics|pharmacokinetics
582688|NCT01086813|Sedation|sedation
582689|NCT01086787|Heart failure|heart failure
582690|NCT01086787|Bone marrow|bone marrow
582691|NCT01086787|Bone marrow mononuclear cells|bone marrow mononuclear cells
582692|NCT01086787|Surgery|surgery
582693|NCT01086787|Orthopedic surgery|orthopedic surgery
582694|NCT01086787|Cardiac surgery|cardiac surgery
582695|NCT01086774|Dry eye|dry eye
582696|NCT01086774|Tear Film Stability|tear film stability
582697|NCT01086735|hematological malignancy|hematological malignancy
582698|NCT01086735|allogeneic hematopoietic stem cell transplantation|allogeneic hematopoietic stem cell transplantation
582699|NCT01086735|donor lymphocyte infusion|donor lymphocyte infusion
582700|NCT01086735|antitumor immunotherapy|antitumor immunotherapy
582701|NCT01086735|graft-versus-tumor effect|graft-versus-tumor effect
582702|NCT01086735|gene therapy|gene therapy
582703|NCT01086735|relapse|relapse
582704|NCT01086735|adult|adult
582705|NCT01086709|Human Papillomavirus|human papillomavirus
582706|NCT01086709|Vaccine|vaccine
582707|NCT01086709|Crossover|crossover
582708|NCT01086709|Hepatitis A|hepatitis a
582709|NCT01086709|Hepatitis B|hepatitis b
582710|NCT01086696|PET Imaging|pet imaging
582711|NCT01086696|F-18 Paclitaxel (FPAC)|f-18 paclitaxel (fpac)
582712|NCT01086696|Breast Cancer|breast cancer
582713|NCT01086696|Lung Cancer|lung cancer
582714|NCT01086696|Renal and Adrenal Cancers|renal and adrenal cancers
582715|NCT01086696|Kidney Cancer|kidney cancer
582716|NCT01086696|Adrenal Cancer|adrenal cancer
582717|NCT01086683|neoplasms|neoplasms
582718|NCT01086683|rehabilitation|rehabilitation
582719|NCT01086683|intervention|intervention
582720|NCT01086683|quality of life|quality of life
582721|NCT01086683|lifestyle|lifestyle
582722|NCT01086670|Coordination|coordination
582723|NCT01086670|Neuroimaging|neuroimaging
582724|NCT01086670|Motion Analysis|motion analysis
582725|NCT01086670|Locomotor|locomotor
582726|NCT01086670|Cerebral Palsy|cerebral palsy
582727|NCT01086670|Pediatrics|pediatrics
582728|NCT01086657|Bird Flu|bird flu
582729|NCT01086657|Avian Influenza|avian influenza
582730|NCT01086657|Healthy|healthy
582731|NCT01086657|Immunity|immunity
582732|NCT01086657|Prevention|prevention
582733|NCT01086657|Healthy Volunteer|healthy volunteer
582734|NCT01086657|HV|hv
582735|NCT01086631|Autoimmune Retinopathy|autoimmune retinopathy
582736|NCT01086631|RITUXAN|rituxan
582737|NCT01086631|Rituximab|rituximab
582738|NCT01086631|Immunosuppression|immunosuppression
582739|NCT01086618|stage IV colon cancer|stage iv colon cancer
582740|NCT01086618|stage IV rectal cancer|stage iv rectal cancer
582741|NCT01086605|HER2-negative breast cancer|her2-negative breast cancer
582742|NCT01086605|male breast cancer|male breast cancer
582743|NCT01086605|recurrent breast cancer|recurrent breast cancer
582744|NCT01086605|stage IV breast cancer|stage iv breast cancer
582745|NCT01086605|stage IIIC breast cancer|stage iiic breast cancer
582746|NCT01086592|Aged|aged
582747|NCT01086592|Strength|strength
582748|NCT01086592|Balance|balance
582749|NCT01086592|Electrotherapy|electrotherapy
582750|NCT01086592|Quality of life|quality of life
582751|NCT01086579|paclitaxel PTCA drug-eluting balloon|paclitaxel ptca drug-eluting balloon
582752|NCT01086579|provisional spot stenting|provisional spot stenting
582753|NCT01086579|coronary artery disease|coronary artery disease
582754|NCT01086579|Late Lumen Loss|late lumen loss
582755|NCT01086579|Minimal lumen diameter|minimal lumen diameter
582756|NCT01086579|coronary artery disease in a small vessel|coronary artery disease in a small vessel
582757|NCT01086566|Influenza, H5N1, avian influenza, parent protocol|influenza, h5n1, avian influenza, parent protocol
582758|NCT01086553|Crohn´s disease|crohn´s disease
582759|NCT01086553|budesonide|budesonide
582760|NCT01086553|induction of remission|induction of remission
582761|NCT01086540|Pulmonary Arterial Hypertension (PAH)|pulmonary arterial hypertension (pah)
582762|NCT01086540|Autoimmune Disease|autoimmune disease
582763|NCT01086540|Systemic Scleroderma|systemic scleroderma
582764|NCT01086527|Pharmacogenetics|pharmacogenetics
582765|NCT01086527|Singulair|singulair
582766|NCT01086527|montelukast|montelukast
582767|NCT01086527|Leukotriene Antagonists|leukotriene antagonists
582768|NCT01086527|Anti-Asthmatic Agents|anti-asthmatic agents
582769|NCT01086527|Intestinal Absorption|intestinal absorption
582770|NCT01086527|pharmacokinetics|pharmacokinetics
582771|NCT01086527|absorption|absorption
582772|NCT01086527|biochemical transport|biochemical transport
582773|NCT01086527|Membrane Transport Proteins|membrane transport proteins
582774|NCT01086514|Breast|breast
582775|NCT01086514|mammography|mammography
582776|NCT01086514|MRI|mri
582777|NCT01086514|Digital Mammography|digital mammography
582778|NCT01086514|10-024|10-024
582779|NCT01086501|open, non-interventional|open, non-interventional
582780|NCT01086488|recurrent or persistent Nasopharyngeal Carcinoma|recurrent or persistent nasopharyngeal carcinoma
582781|NCT01086488|treatment of patients with squamous cell carcinoma of the head and neck|treatment of patients with squamous cell carcinoma of the head and neck
582782|NCT01086488|Foscan-PDT|foscan-pdt
582783|NCT01086488|Brachytherapy|brachytherapy
582784|NCT01086475|Autism Spectrum Disorder|autism spectrum disorder
582785|NCT01086475|D-cycloserine|d-cycloserine
582786|NCT01086475|Social Skills Training|social skills training
582787|NCT01086462|GSK2239633|gsk2239633
582788|NCT01086462|RADIOLABEL|radiolabel
582789|NCT01086462|PHARMACOKINETICS|pharmacokinetics
582790|NCT01086462|INTRAVENOUS|intravenous
582791|NCT01086462|MICRODOSE|microdose
582792|NCT01086449|safety|safety
582793|NCT01086449|Japanese|japanese
582794|NCT01086449|Herpes Zoster|herpes zoster
582795|NCT01086449|immunogenicity|immunogenicity
582796|NCT01086449|Herpes Zoster in healthy ethnic Japanese adults|herpes zoster in healthy ethnic japanese adults
582797|NCT01086449|Vaccine|vaccine
582798|NCT01086436|Human Rotavirus vaccine|human rotavirus vaccine
582799|NCT01086423|Infanrix-IPV+Hib|infanrix-ipv+hib
582800|NCT01086410|HPA axis|hpa axis
582801|NCT01086397|pneumococcal pneumonia|pneumococcal pneumonia
582802|NCT01086397|community-acquired pneumonia|community-acquired pneumonia
582803|NCT01086371|Multiple Sclerosis|multiple sclerosis
582804|NCT01086371|gait|gait
582805|NCT01086358|Productivity|productivity
582806|NCT01086358|Migraine|migraine
582807|NCT01086358|Treximet|treximet
582808|NCT01086358|Triptan|triptan
582809|NCT01086345|adult giant cell glioblastoma|adult giant cell glioblastoma
582810|NCT01086345|adult gliosarcoma|adult gliosarcoma
582811|NCT01086345|recurrent adult brain tumor|recurrent adult brain tumor
582812|NCT01086332|radiotherapy|radiotherapy
582813|NCT01086332|gemcitabine|gemcitabine
582814|NCT01086332|nelfinavir|nelfinavir
582815|NCT01086332|neoplasms|neoplasms
582816|NCT01086241|Tomography|tomography
582817|NCT01086241|Mammography|mammography
582818|NCT01086241|Breast Neoplasms|breast neoplasms
582819|NCT01086241|Prevention and Control|prevention and control
582820|NCT01086228|Drug eluting stents|drug eluting stents
582821|NCT01086228|Stents|stents
582822|NCT01086228|Angioplasty|angioplasty
582823|NCT01086202|irreparable rotator cuff tears|irreparable rotator cuff tears
582824|NCT01086163|Omacor|omacor
582825|NCT01086163|Simvastatin|simvastatin
582826|NCT01086163|Aspirin|aspirin
582827|NCT01086163|Platelet activity|platelet activity
582828|NCT01086163|Coronary artery disease|coronary artery disease
582829|NCT01086137|salivary biomarker|salivary biomarker
582830|NCT01086137|metabolic syndrome|metabolic syndrome
582831|NCT01086137|prediabetes|prediabetes
582832|NCT01086137|diabetes hypertension|diabetes hypertension
582833|NCT01086124|echocardiography|echocardiography
582834|NCT01086124|ST elevation myocardial infarction|st elevation myocardial infarction
582835|NCT01086124|Heart failure|heart failure
582836|NCT01086124|Coronary artery disease|coronary artery disease
582837|NCT01086124|Cardiovascular diseases|cardiovascular diseases
582838|NCT01086111|type 2 diabetes|type 2 diabetes
582839|NCT01086111|gastric bypass|gastric bypass
582840|NCT01086111|sleeve gastrectomy|sleeve gastrectomy
582841|NCT01086111|clamp study|clamp study
582842|NCT01086111|weight loss surgery|weight loss surgery
582843|NCT01086098|Pacemakers|pacemakers
582844|NCT01086098|Survival|survival
582845|NCT01086059|Autoimmune diseases|autoimmune diseases
582846|NCT01086059|adalimumab|adalimumab
582847|NCT01086059|pregnancy|pregnancy
582848|NCT01086059|birth defects|birth defects
582849|NCT01086059|TNF|tnf
582850|NCT01086059|Tumor necrosis factor|tumor necrosis factor
582851|NCT01086046|platelet|platelet
582852|NCT01086046|thrombozyme|thrombozyme
582853|NCT01086046|ASD|asd
582854|NCT01086046|Heparin|heparin
582855|NCT01086046|Enoxaparin|enoxaparin
582856|NCT01086033|Evaluation of safety and efficacy|evaluation of safety and efficacy
582857|NCT01086033|Adalimumab treatment|adalimumab treatment
582858|NCT01086033|Rheumatoid Arthritis|rheumatoid arthritis
582859|NCT01086020|IVUS|ivus
582860|NCT01086020|coronary plaque|coronary plaque
582861|NCT01086020|regression|regression
582862|NCT01086007|Groin hernia|groin hernia
582863|NCT01086007|chronic pain|chronic pain
582864|NCT01086007|Persistent postoperative pain|persistent postoperative pain
582865|NCT01086007|Laparoscopic inguinal herniotomy|laparoscopic inguinal herniotomy
582866|NCT01086007|Sexual dysfunction|sexual dysfunction
582867|NCT01085994|antibiotics|antibiotics
582868|NCT01085994|resistance|resistance
582869|NCT01085994|bio-marker|bio-marker
582870|NCT01085994|procalcitonin|procalcitonin
582871|NCT01085994|algorithm|algorithm
582872|NCT01085994|critically ill|critically ill
582873|NCT01085981|quantitative assessment of the effects of a topically|quantitative assessment of the effects of a topically
582874|NCT01085981|applied vasodilating cream to the clitoris using doppler|applied vasodilating cream to the clitoris using doppler
582875|NCT01085981|flow plethysmography|flow plethysmography
582876|NCT01085968|Parkinson's disease|parkinson's disease
582877|NCT01085968|Cognitive deficits|cognitive deficits
582878|NCT01085968|fMRI|fmri
582879|NCT01085968|neuro rehabilitation|neuro rehabilitation
582880|NCT01085968|Age Matched Controls|age matched controls
582881|NCT01085955|peripartum|peripartum
582882|NCT01085955|cardiomyopathy|cardiomyopathy
582883|NCT01085955|post pregnancy|post pregnancy
582884|NCT01085955|myocardial recovery|myocardial recovery
582885|NCT01085955|pregnant women with peripartum cardiomyopathy|pregnant women with peripartum cardiomyopathy
582886|NCT01085942|rotator cuff tear|rotator cuff tear
582887|NCT01085942|asymptomatic|asymptomatic
582888|NCT01085942|natural course|natural course
582889|NCT01085942|tear characteristics|tear characteristics
582890|NCT01085942|Asymptomatic rotator cuff tears|asymptomatic rotator cuff tears
582982|NCT01085604|physical therapy|physical therapy
582891|NCT01085942|Natural course of rotator cuff tears|natural course of rotator cuff tears
582892|NCT01085929|abscess|abscess
582893|NCT01085929|infection|infection
582894|NCT01085929|ultrasound guidance|ultrasound guidance
582895|NCT01085929|incision and drainage|incision and drainage
582896|NCT01085929|needle aspiration|needle aspiration
582897|NCT01085929|skin|skin
582898|NCT01085929|ultrasound|ultrasound
711564|NCT00584038|oral contraception|oral contraception
740904|NCT00471081|Safety|safety
582899|NCT01085916|prevalence of asthma and Rhinitis symptoms among secondary school students in Saudi Arabia|prevalence of asthma and rhinitis symptoms among secondary school students in saudi arabia
582900|NCT01085903|Spatial Neglect|spatial neglect
582901|NCT01085903|Dysphagia|dysphagia
582902|NCT01085903|Arousal|arousal
582903|NCT01085903|Modafinil|modafinil
582904|NCT01085903|Stroke|stroke
582905|NCT01085890|Blood Pressure|blood pressure
582906|NCT01085890|Life Style|life style
582907|NCT01085890|Body Mass Index|body mass index
582908|NCT01085890|Obesity, Abdominal|obesity, abdominal
582909|NCT01085890|Blood Chemical Analysis|blood chemical analysis
582910|NCT01085864|Lung Nodules|lung nodules
582911|NCT01085864|A need exists for non-invasive testing to aid in clinical decision-making for CT scan detected lung nodules of indeterminate etiology.|a need exists for non-invasive testing to aid in clinical decision-making for ct scan detected lung nodules of indeterminate etiology.
582912|NCT01085851|Sunburn|sunburn
582913|NCT01085851|Dexchlorpheniramine|dexchlorpheniramine
582914|NCT01085851|Lotion|lotion
582915|NCT01085851|Cream|cream
582916|NCT01085838|Erlotinib|erlotinib
582917|NCT01085838|myelodysplastic syndrome|myelodysplastic syndrome
582918|NCT01085825|induced abortion|induced abortion
582919|NCT01085825|termination of pregnancy|termination of pregnancy
582920|NCT01085825|manual vacuum aspiration|manual vacuum aspiration
582921|NCT01085825|electric vacuum aspiration|electric vacuum aspiration
582922|NCT01085799|Educational activities|educational activities
582923|NCT01085799|Cluster-randomized controlled trial|cluster-randomized controlled trial
582924|NCT01085799|Albendazole|albendazole
582925|NCT01085799|Deworming|deworming
582926|NCT01085799|School-age children|school-age children
582927|NCT01085799|Peru|peru
582928|NCT01085799|Ascaris lumbricoides|ascaris lumbricoides
582929|NCT01085799|Trichuris trichiura|trichuris trichiura
582930|NCT01085799|Hookworm|hookworm
582931|NCT01085799|STH infections|sth infections
582932|NCT01085799|Intestinal helminth infections|intestinal helminth infections
582933|NCT01085786|Helicobacter pylori infection|helicobacter pylori infection
582934|NCT01085773|HbA1c|hba1c
582935|NCT01085773|Type 2 Diabetes|type 2 diabetes
582936|NCT01085773|Lifestyle changes|lifestyle changes
582937|NCT01085773|Exercise|exercise
582938|NCT01085747|Chronic pancreatitis|chronic pancreatitis
582939|NCT01085747|Biliary stricture|biliary stricture
582940|NCT01085747|Endoscopic treatment|endoscopic treatment
582941|NCT01085747|SEMS|sems
582942|NCT01085721|allergic rhinitis|allergic rhinitis
582943|NCT01085721|viral infections of the upper respiratory tract|viral infections of the upper respiratory tract
582944|NCT01085721|dexchlorpheniramine|dexchlorpheniramine
582945|NCT01085721|pseudoephedrine|pseudoephedrine
582946|NCT01085721|guaifenesin|guaifenesin
582947|NCT01085708|Rabeprazole|rabeprazole
582948|NCT01085708|Japan|japan
582949|NCT01085708|healthy Japanese male|healthy japanese male
582950|NCT01085695|Rabeprazole|rabeprazole
582951|NCT01085695|Japan|japan
582952|NCT01085695|healthy Japanese male|healthy japanese male
582953|NCT01085682|Diabetes prevention|diabetes prevention
582954|NCT01085682|Lifestyle modification|lifestyle modification
582955|NCT01085682|Obesity|obesity
582956|NCT01085682|Impaired glucose tolerance|impaired glucose tolerance
582957|NCT01085682|Diet|diet
582958|NCT01085682|Physical activity|physical activity
582959|NCT01085669|Infection rate of VEPTR-Implants|infection rate of veptr-implants
582960|NCT01085669|VEPTR. Vertical Expandable|veptr. vertical expandable
582961|NCT01085669|Prosthetic Titanium Rib|prosthetic titanium rib
582962|NCT01085643|IBS|ibs
582963|NCT01085643|Lubiprostone|lubiprostone
582964|NCT01085643|Small Bowel|small bowel
582965|NCT01085643|High Resolution Manometry|high resolution manometry
582966|NCT01085643|Delayed Intestinal Transit|delayed intestinal transit
582967|NCT01085630|epithelial mesothelioma|epithelial mesothelioma
582968|NCT01085630|sarcomatous mesothelioma|sarcomatous mesothelioma
582969|NCT01085630|stage II malignant mesothelioma|stage ii malignant mesothelioma
582970|NCT01085630|stage III malignant mesothelioma|stage iii malignant mesothelioma
582971|NCT01085630|stage IV malignant mesothelioma|stage iv malignant mesothelioma
582972|NCT01085617|oral complications|oral complications
582973|NCT01085617|mucositis|mucositis
582974|NCT01085617|untreated adult acute lymphoblastic leukemia|untreated adult acute lymphoblastic leukemia
582975|NCT01085617|B-cell adult acute lymphoblastic leukemia|b-cell adult acute lymphoblastic leukemia
582976|NCT01085617|T-cell adult acute lymphoblastic leukemia|t-cell adult acute lymphoblastic leukemia
582977|NCT01085617|Philadelphia chromosome positive adult precursor acute lymphoblastic leukemia|philadelphia chromosome positive adult precursor acute lymphoblastic leukemia
582978|NCT01085604|low back pain|low back pain
582979|NCT01085604|clinical instability|clinical instability
582980|NCT01085604|neuromuscular control|neuromuscular control
582981|NCT01085604|core stabilization|core stabilization
582984|NCT01085591|Clostridium difficile Infection|clostridium difficile infection
582985|NCT01085591|Diarrhea|diarrhea
582986|NCT01085578|healthy male volunteers|healthy male volunteers
582987|NCT01085578|fasted and fed state|fasted and fed state
741035|NCT00470522|steroid|steroid
582988|NCT01085565|Bone cancer|bone cancer
582989|NCT01085565|Bone Metastases|bone metastases
582990|NCT01085565|pain palliation|pain palliation
582991|NCT01085565|metastasis|metastasis
582992|NCT01085565|breast cancer|breast cancer
582993|NCT01085565|lung cancer|lung cancer
582994|NCT01085565|prostate cancer|prostate cancer
582995|NCT01085565|cancer related pain|cancer related pain
582996|NCT01085565|tumors|tumors
582997|NCT01085552|NeoRecormon®|neorecormon®
582998|NCT01085552|Caucasian|caucasian
582999|NCT01085552|Japanese|japanese
583000|NCT01085552|Bioequivalence|bioequivalence
583001|NCT01085552|Ethnic|ethnic
583002|NCT01085539|neonatal intensive care|neonatal intensive care
583003|NCT01085539|infant pulse oximetry|infant pulse oximetry
583004|NCT01085526|basophil activity|basophil activity
583005|NCT01085526|plasma cells|plasma cells
583006|NCT01085526|IgE|ige
583007|NCT01085526|IgG1|igg1
583008|NCT01085526|IgG4|igg4
583009|NCT01085526|mast cells|mast cells
583010|NCT01085526|IgE receptor|ige receptor
583011|NCT01085526|allergic rhinoconjunctivitis|allergic rhinoconjunctivitis
583012|NCT01085526|grass pollen allergy|grass pollen allergy
583013|NCT01085513|intestinal abnormalities|intestinal abnormalities
583014|NCT01085500|laparoscopic|laparoscopic
583015|NCT01085500|totally extraperitoneal inguinal hernia repair|totally extraperitoneal inguinal hernia repair
583016|NCT01085487|Menorrhagia|menorrhagia
583017|NCT01085474|Asthma|asthma
583018|NCT01085474|Pharmaceutical intervention|pharmaceutical intervention
583019|NCT01085474|Effect of a pharmaceutical intervention on the level of control of the asthmatic patient|effect of a pharmaceutical intervention on the level of control of the asthmatic patient
583020|NCT01085448|low back pain|low back pain
583021|NCT01085448|core stabilization|core stabilization
583022|NCT01085448|physical therapy|physical therapy
583023|NCT01085435|ICD|icd
583024|NCT01085435|defibrillator|defibrillator
583025|NCT01085422|Prostate Cancer|prostate cancer
583026|NCT01085409|experienced utility|experienced utility
583027|NCT01085409|decision utility|decision utility
583028|NCT01085409|subjective well-being|subjective well-being
583029|NCT01085409|experience sampling method|experience sampling method
583030|NCT01085409|day reconstruction method|day reconstruction method
583031|NCT01085409|Quality of life|quality of life
583032|NCT01085396|Fiber Optic|fiber optic
583033|NCT01085396|Melanoma|melanoma
583034|NCT01085396|UV Exposure|uv exposure
583035|NCT01085383|Antipsychotic|antipsychotic
583036|NCT01085383|hyperprolactinemia|hyperprolactinemia
583037|NCT01085383|hypogonadism|hypogonadism
583038|NCT01085383|aripiprazole|aripiprazole
583039|NCT01085370|posttraumatic stress|posttraumatic stress
583040|NCT01085370|prevention|prevention
583041|NCT01085370|children|children
583042|NCT01085370|acute stress disorder due to burn injury or injuries associated with road traffic accidents|acute stress disorder due to burn injury or injuries associated with road traffic accidents
583043|NCT01085357|Glaucoma|glaucoma
583044|NCT01085357|Glaucoma device|glaucoma device
583045|NCT01085357|Glaucoma surgery|glaucoma surgery
583046|NCT01085357|Intraocular pressure|intraocular pressure
583047|NCT01085344|hemophilia, prophylaxis, cost effectiveness|hemophilia, prophylaxis, cost effectiveness
583048|NCT01085331|Mek Inhibitor|mek inhibitor
583049|NCT01085331|Metastatic Colorectal Cancer|metastatic colorectal cancer
583050|NCT01085331|K-Ras Mutation|k-ras mutation
583051|NCT01085331|Phase II|phase ii
583052|NCT01085331|Second line K-Ras mutated metastatic colorectal cancer|second line k-ras mutated metastatic colorectal cancer
583053|NCT01085305|Behavior problems|behavior problems
583054|NCT01085305|Parent-Child Interaction|parent-child interaction
583055|NCT01085305|Locus of control|locus of control
583056|NCT01085305|Psychiatric symptoms|psychiatric symptoms
583057|NCT01085305|Depressive symptoms|depressive symptoms
583058|NCT01085305|Attachment|attachment
583059|NCT01085279|fractional laser|fractional laser
583060|NCT01085279|melasma|melasma
583061|NCT01085279|topical bleaching|topical bleaching
583062|NCT01085253|Parkinson's|parkinson's
583063|NCT01085253|supranuclear palsy|supranuclear palsy
583064|NCT01085253|substantia nigra|substantia nigra
583065|NCT01085253|sub thalamic nucleus|sub thalamic nucleus
583066|NCT01085253|MRI|mri
583067|NCT01085227|Parkinson's disease|parkinson's disease
583068|NCT01085227|LRRK2|lrrk2
583069|NCT01085227|asymptomatic carriers|asymptomatic carriers
583070|NCT01085201|lexiscan|lexiscan
583071|NCT01085175|Heart Failure,|heart failure,
583072|NCT01085175|PET Imaging,|pet imaging,
583073|NCT01085175|Implantable Cardioverter-Defibrillator,|implantable cardioverter-defibrillator,
583074|NCT01085175|Sudden Cardiac Death|sudden cardiac death
583075|NCT01085162|Coronary Artery Disease|coronary artery disease
583076|NCT01085162|PET imaging|pet imaging
583077|NCT01085162|SPECT imaging|spect imaging
583078|NCT01085149|simvastatin|simvastatin
583079|NCT01085149|alveolar bone|alveolar bone
583080|NCT01085149|tooth extraction|tooth extraction
583081|NCT01085149|remodeling|remodeling
583082|NCT01085149|alveolar bone remodeling|alveolar bone remodeling
583083|NCT01085123|Migraine|migraine
583084|NCT01085123|ZOMIG® Rapimelt|zomig® rapimelt
583085|NCT01085110|Groin hernia|groin hernia
583086|NCT01085110|Chronic pain|chronic pain
583087|NCT01085110|QST|qst
583088|NCT01085110|Quantitative sensory testing|quantitative sensory testing
583089|NCT01085110|Persistent postoperative pain|persistent postoperative pain
583090|NCT01085110|Laparoscopic inguinal herniotomy|laparoscopic inguinal herniotomy
583091|NCT01085110|Postherniotomy Pain after laparoscopic inguinal herniotomy|postherniotomy pain after laparoscopic inguinal herniotomy
583092|NCT01085110|laparoscopic inguinal hernia repair|laparoscopic inguinal hernia repair
583093|NCT01085097|Systemic Lupus Erythematosus (SLE)|systemic lupus erythematosus (sle)
583094|NCT01085097|Lupus Nephritis|lupus nephritis
583095|NCT01085097|Laquinimod|laquinimod
583096|NCT01085084|Systemic Lupus Erythematosus (SLE)|systemic lupus erythematosus (sle)
583097|NCT01085084|Lupus Arthritis|lupus arthritis
583098|NCT01085084|Laquinimod|laquinimod
583099|NCT01085071|intensive care unit|intensive care unit
583100|NCT01085071|potassium|potassium
583101|NCT01085071|atrial fibrillation|atrial fibrillation
583102|NCT01085071|cardiac surgery|cardiac surgery
583103|NCT01085071|Critically ill patients post CABG and/or valvular surgery|critically ill patients post cabg and/or valvular surgery
583104|NCT01085071|Critically ill patients not post CABG and/or valvular surgery|critically ill patients not post cabg and/or valvular surgery
583105|NCT01085071|coronary artery bypass graft|coronary artery bypass graft
583106|NCT01085058|Lymphoproliferative diseases (Hodgkin's disease, non-Hodgkin's lymphomas, multiple myelomas) and high-dose therapy|lymphoproliferative diseases (hodgkin's disease, non-hodgkin's lymphomas, multiple myelomas) and high-dose therapy
583107|NCT01085045|COPD|copd
583108|NCT01085032|Smoking Cessation|smoking cessation
583109|NCT01085032|Substance Withdrawal Syndrome|substance withdrawal syndrome
583110|NCT01085032|Depression|depression
583111|NCT01085019|Endothelial function|endothelial function
583112|NCT01085019|Cardiovascular risk factors|cardiovascular risk factors
583113|NCT01085019|Spices|spices
583114|NCT01085019|Herbs|herbs
583115|NCT01085019|Antioxidant|antioxidant
583116|NCT01085006|cesarean delivery|cesarean delivery
583117|NCT01085006|Tranexamic acid|tranexamic acid
583118|NCT01085006|hemorrhage|hemorrhage
583119|NCT01085006|Spinal analgesia|spinal analgesia
583120|NCT01085006|1-the amount of hemorrhage during cesarean delivery|1-the amount of hemorrhage during cesarean delivery
583121|NCT01085006|2-the amount of hemorrhage in the first 2 hours of cesarean delivery|2-the amount of hemorrhage in the first 2 hours of cesarean delivery
583122|NCT01085006|3-the amount of hemorrhage in the first 24 hour after cesarean delivery|3-the amount of hemorrhage in the first 24 hour after cesarean delivery
583123|NCT01084993|Coronary artery stenting, transradial, intracoronary|coronary artery stenting, transradial, intracoronary
583124|NCT01084980|minimal change disease|minimal change disease
583125|NCT01084980|tacrolimus|tacrolimus
583126|NCT01084980|corticosteroid|corticosteroid
583127|NCT01084967|obesity|obesity
583128|NCT01084967|metabolic syndrome|metabolic syndrome
583129|NCT01084967|genetic risk markers|genetic risk markers
583130|NCT01084967|copy number variation|copy number variation
583131|NCT01084954|HIV validation helicase-dependent amplification|hiv validation helicase-dependent amplification
583132|NCT01084941|pregnancy|pregnancy
583133|NCT01084941|weight gain|weight gain
583134|NCT01084941|obesity|obesity
583135|NCT01084941|pregnancy and weight gain|pregnancy and weight gain
583136|NCT01084928|diabetes|diabetes
583137|NCT01084928|obesity|obesity
583138|NCT01084928|pre-diabetes|pre-diabetes
583139|NCT01084928|South Asian|south asian
583140|NCT01084915|Weight loss after SAGB VC band placement|weight loss after sagb vc band placement
583141|NCT01084902|POAG|poag
583142|NCT01084902|OH|oh
583143|NCT01084902|Xalatan|xalatan
583144|NCT01084902|Azopt|azopt
583145|NCT01084902|Primary Open Angle Study|primary open angle study
583146|NCT01084889|polypropylene mesh|polypropylene mesh
583147|NCT01084889|Prolapse|prolapse
583148|NCT01084889|Cystocele|cystocele
583149|NCT01084889|Surgical Mesh|surgical mesh
583150|NCT01084876|Herceptin|herceptin
583151|NCT01084876|metastatic breast cancer|metastatic breast cancer
583152|NCT01084876|CT-P6|ct-p6
583153|NCT01084863|Herceptin|herceptin
583154|NCT01084863|Her 2-positive|her 2-positive
583155|NCT01084863|metastatic breast cancer|metastatic breast cancer
583156|NCT01084863|CT-P6|ct-p6
583157|NCT01084850|Corneal endothelium|corneal endothelium
583158|NCT01084850|diabetes mellitus|diabetes mellitus
583159|NCT01084850|corneal thickness|corneal thickness
583160|NCT01084837|Multiple myeloma|multiple myeloma
583161|NCT01084837|Renal failure|renal failure
583162|NCT01084824|Warts|warts
583163|NCT01084824|Verruca vulgaris|verruca vulgaris
583164|NCT01084824|Liquid Nitrogen|liquid nitrogen
583165|NCT01084824|Cantharidin|cantharidin
583166|NCT01084824|combination treatment|combination treatment
583167|NCT01084798|Multiple sclerosis|multiple sclerosis
583168|NCT01084798|Expanded Disability Status Scale|expanded disability status scale
583169|NCT01084798|Sclerosis|sclerosis
583170|NCT01084785|Cancer|cancer
583171|NCT01084785|genomics|genomics
583172|NCT01084785|proteomics|proteomics
583173|NCT01084746|Colorectal Cancer Screening|colorectal cancer screening
583174|NCT01084746|Computer Interactive Intervention|computer interactive intervention
583175|NCT01084746|Predictors|predictors
583176|NCT01084746|Cost Effective Analysis|cost effective analysis
583177|NCT01084746|Transtheoretical Model|transtheoretical model
583299|NCT01084213|Placenta malaria|placenta malaria
583178|NCT01084707|Smoking Cessation, Nicotine pharmacokinetics|smoking cessation, nicotine pharmacokinetics
583180|NCT01084694|Caregiver|caregiver
583181|NCT01084694|Caregiver Burden|caregiver burden
583182|NCT01084694|Allogeneic Transplant|allogeneic transplant
583183|NCT01084694|Autologous Transplant|autologous transplant
583184|NCT01084694|Hematopoietic Stem Cell Transplantation|hematopoietic stem cell transplantation
583185|NCT01084681|SILK flow diverter, intracranial stents, intracranial aneurysms|silk flow diverter, intracranial stents, intracranial aneurysms
583186|NCT01084668|moderate to severe chronic plaque psoriasis|moderate to severe chronic plaque psoriasis
583187|NCT01084668|adalimumab|adalimumab
583188|NCT01084668|Psoriasis Area and Severity Index (PASI)|psoriasis area and severity index (pasi)
583189|NCT01084668|Disease Life Quality Index (DLQI)|disease life quality index (dlqi)
583190|NCT01084668|Nail Psoriasis Severity Index (NAPSI)|nail psoriasis severity index (napsi)
583191|NCT01084668|biologic disease modifying anti-rheumatic drug (BDMARD)|biologic disease modifying anti-rheumatic drug (bdmard)
583192|NCT01084668|antibodies|antibodies
583193|NCT01084668|monoclonals|monoclonals
583194|NCT01084642|Survey|survey
583195|NCT01084642|Sexual Health Issues|sexual health issues
583196|NCT01084642|10-034|10-034
583197|NCT01084629|Barrett's Esophagus|barrett's esophagus
583198|NCT01084629|Surveillance|surveillance
583199|NCT01084603|Smoking Cessation|smoking cessation
583200|NCT01084603|Nicotine pharmacokinetics|nicotine pharmacokinetics
583201|NCT01084590|Prevention|prevention
583202|NCT01084590|Obesity|obesity
583203|NCT01084590|Safety|safety
583204|NCT01084590|Unhealthy weight gain|unhealthy weight gain
583205|NCT01084590|Injury prevention|injury prevention
583206|NCT01084564|Cost-effectiveness analysis|cost-effectiveness analysis
583207|NCT01084564|Colombia|colombia
583208|NCT01084538|paricalcitol iv|paricalcitol iv
583209|NCT01084538|vitamin D|vitamin d
583210|NCT01084538|secondary hyperparathyroidism|secondary hyperparathyroidism
583211|NCT01084538|hemodialysis|hemodialysis
583212|NCT01084525|Meniere's Disease|meniere's disease
583213|NCT01084525|Vertigo|vertigo
583214|NCT01084525|Definitive vertigo|definitive vertigo
583215|NCT01084525|Vertigo episodes|vertigo episodes
583216|NCT01084525|Vertigo frequency|vertigo frequency
583217|NCT01084525|Tinnitus|tinnitus
583218|NCT01084525|Hearing loss|hearing loss
583219|NCT01084525|Aural Fullness|aural fullness
583220|NCT01084512|kinematic analysis,|kinematic analysis,
583221|NCT01084512|three-compartment model,|three-compartment model,
583222|NCT01084512|chest wall motion,|chest wall motion,
583223|NCT01084512|spinal cord injury.|spinal cord injury.
583224|NCT01084499|Healthy Subjects|healthy subjects
583225|NCT01084486|nonalcoholic fatty liver disease|nonalcoholic fatty liver disease
583226|NCT01084486|Pulse wave velocity|pulse wave velocity
583227|NCT01084486|augmentation index|augmentation index
583228|NCT01084486|metformin|metformin
583229|NCT01084473|Dexmedetomidine|dexmedetomidine
583230|NCT01084473|gastric emptying|gastric emptying
583231|NCT01084473|oro-cecal transit time|oro-cecal transit time
583232|NCT01084473|Sedation in intensive care|sedation in intensive care
583233|NCT01084473|Gastrointestinal effects of sedation|gastrointestinal effects of sedation
583234|NCT01084460|Gastrointestinal stromal tumor,endoscopic ultrasound,submucosal tumor|gastrointestinal stromal tumor,endoscopic ultrasound,submucosal tumor
583235|NCT01084447|obesity|obesity
583236|NCT01084447|gastroplasty|gastroplasty
583237|NCT01084447|respiratory muscle training|respiratory muscle training
583238|NCT01084447|muscle strength|muscle strength
583239|NCT01084447|physical therapy|physical therapy
583240|NCT01084421|Adolescents|adolescents
583241|NCT01084421|Parents|parents
583242|NCT01084421|Computer Based|computer based
583243|NCT01084421|Latino|latino
583244|NCT01084421|Sexual Communication|sexual communication
583245|NCT01084408|de-novo|de-novo
583246|NCT01084408|coronary stenoses|coronary stenoses
583247|NCT01084408|PEPCAD|pepcad
583248|NCT01084408|DEBonly|debonly
583249|NCT01084408|Paclitaxel|paclitaxel
583250|NCT01084395|Parent|parent
583251|NCT01084395|Adolescent|adolescent
583252|NCT01084395|Mexico|mexico
583253|NCT01084395|Safer Sex Communication|safer sex communication
583254|NCT01084395|Randomized Controlled Trial|randomized controlled trial
583255|NCT01084395|HIV/AIDS|hiv/aids
583256|NCT01084395|STD|std
583257|NCT01084395|Sexual Behavior|sexual behavior
583258|NCT01084382|Arthrospira platensis|arthrospira platensis
583259|NCT01084382|female HIV patient|female hiv patient
583260|NCT01084382|Yaounde|yaounde
583261|NCT01084382|Redox potential|redox potential
583262|NCT01084382|Life quality|life quality
583263|NCT01084382|female patient infected by HIV in Yaounde: Cameroon|female patient infected by hiv in yaounde: cameroon
583264|NCT01084369|Type 2 diabetes|type 2 diabetes
583265|NCT01084369|Hypogonadism|hypogonadism
583266|NCT01084369|Testosterone|testosterone
583267|NCT01084369|Endothelial dysfunction|endothelial dysfunction
583268|NCT01084356|CZT|czt
583269|NCT01084356|sentinel node|sentinel node
583270|NCT01084356|osseous processes|osseous processes
583271|NCT01084343|vaccination|vaccination
583272|NCT01084343|prophylaxis|prophylaxis
583273|NCT01084330|gastric cancer|gastric cancer
583274|NCT01084330|metastatic gastric cancer|metastatic gastric cancer
583275|NCT01084330|advanced gastric cancer|advanced gastric cancer
583276|NCT01084317|asthma|asthma
583277|NCT01084317|children|children
583278|NCT01084317|delay in asthma diagnosis|delay in asthma diagnosis
583279|NCT01084304|Pregnancy|pregnancy
583280|NCT01084304|Ovulation tests|ovulation tests
583281|NCT01084304|stress|stress
583282|NCT01084304|Wishing to become pregnant|wishing to become pregnant
583283|NCT01084291|Vaccine|vaccine
583284|NCT01084291|Dengue Hemorrhagic Fever|dengue hemorrhagic fever
583285|NCT01084265|Hypogonadism|hypogonadism
583286|NCT01084265|Recombinant human follicle stimulating hormone (r-hFSH)|recombinant human follicle stimulating hormone (r-hfsh)
583287|NCT01084265|Recombinant leutinizing hormone (r-hLH)|recombinant leutinizing hormone (r-hlh)
583288|NCT01084239|acute chest pain|acute chest pain
583289|NCT01084239|emergency department|emergency department
583290|NCT01084239|cardiac computed tomography|cardiac computed tomography
583291|NCT01084226|Rye fiber|rye fiber
583292|NCT01084226|Alkylresorcinols|alkylresorcinols
583293|NCT01084226|Plant sterols|plant sterols
583294|NCT01084226|Cholesterol|cholesterol
583295|NCT01084226|Antioxidant|antioxidant
583296|NCT01084226|Effects of plant sterols in rye bread on serum lipids|effects of plant sterols in rye bread on serum lipids
583297|NCT01084226|Effects of alkylresorcinols in rye fiber on LDL particles|effects of alkylresorcinols in rye fiber on ldl particles
583298|NCT01084213|Low birth weight|low birth weight
583300|NCT01084213|Anaemia|anaemia
583301|NCT01084213|Intermittent preventive treatment|intermittent preventive treatment
583302|NCT01084213|Intermittent screening and treatment|intermittent screening and treatment
583303|NCT01084213|Rapid diagnostic test|rapid diagnostic test
583304|NCT01084200|Postoperative pain|postoperative pain
583305|NCT01084200|Sevoflurane|sevoflurane
583306|NCT01084200|Propofol|propofol
583307|NCT01084200|Female|female
583308|NCT01084200|Elective gynaecological surgery|elective gynaecological surgery
583309|NCT01084200|Laparoscopic and hysteroscopic surgery|laparoscopic and hysteroscopic surgery
583310|NCT01084200|Female patients|female patients
583311|NCT01084200|Undergoing elective laparoscopic and hysteroscopic surgery|undergoing elective laparoscopic and hysteroscopic surgery
583312|NCT01084187|erectile dysfunction|erectile dysfunction
583313|NCT01084187|arterial hypertension|arterial hypertension
583314|NCT01084187|flow mediated vasodilation|flow mediated vasodilation
583315|NCT01084187|endothelial dysfunction|endothelial dysfunction
583316|NCT01084187|carotid intima media thickness|carotid intima media thickness
583317|NCT01084187|vardenafil|vardenafil
583318|NCT01084174|Peanut Allergy|peanut allergy
583319|NCT01084135|Clinical trial|clinical trial
583320|NCT01084135|Down syndrome|down syndrome
583321|NCT01084135|adolescents|adolescents
583322|NCT01084135|cognitive|cognitive
583323|NCT01084135|rivastigmine|rivastigmine
583324|NCT01084122|Intravenous iron sucrose|intravenous iron sucrose
583325|NCT01084122|Anemia|anemia
583326|NCT01084122|Transfusion|transfusion
583327|NCT01084109|Complementary feeding|complementary feeding
583328|NCT01084109|Infant growth|infant growth
583329|NCT01084109|Developing countries|developing countries
583330|NCT01084096|Antenatal Corticosteroids, Preterm Birth, Diffusion|antenatal corticosteroids, preterm birth, diffusion
583331|NCT01084083|human papilloma virus infection|human papilloma virus infection
583332|NCT01084083|stage III squamous cell carcinoma of the oropharynx|stage iii squamous cell carcinoma of the oropharynx
583333|NCT01084083|stage IV squamous cell carcinoma of the oropharynx|stage iv squamous cell carcinoma of the oropharynx
583334|NCT01084083|tongue cancer|tongue cancer
583335|NCT01084070|early feeding|early feeding
583336|NCT01084070|postoperative care|postoperative care
583337|NCT01084070|emergency surgery|emergency surgery
583338|NCT01084018|acute postoperative pain|acute postoperative pain
583339|NCT01084018|nursing intervention|nursing intervention
583340|NCT01083992|NAFLD|nafld
583341|NCT01083992|Galvus|galvus
583342|NCT01083992|vitamin D|vitamin d
583343|NCT01083966|Vestibular|vestibular
583344|NCT01083966|Schwannoma|schwannoma
583345|NCT01083966|earing-loss|earing-loss
583346|NCT01083966|brain-tumor|brain-tumor
583347|NCT01083966|Acoustic|acoustic
583348|NCT01083966|Neuroma|neuroma
583349|NCT01083953|end tidal concentration|end tidal concentration
583350|NCT01083927|Pterygium|pterygium
583351|NCT01083914|extracorporeal circulation, off-pump CABG|extracorporeal circulation, off-pump cabg
583352|NCT01083888|Pharmacokinetics|pharmacokinetics
583353|NCT01083888|Safety and tolerability|safety and tolerability
583354|NCT01083888|Plasma concentration|plasma concentration
583355|NCT01083888|ASP1517|asp1517
583356|NCT01083888|FG-4592|fg-4592
583357|NCT01083875|Radiation|radiation
583358|NCT01083875|mucositis|mucositis
583359|NCT01083875|head and neck carcinoma|head and neck carcinoma
583360|NCT01083875|oral rinse|oral rinse
583361|NCT01083875|amlexanox|amlexanox
741505|NCT00469144|MDS|mds
583362|NCT01083875|MuGard|mugard
583363|NCT01083862|Health literacy|health literacy
583364|NCT01083862|patient education|patient education
583365|NCT01083862|health behaviors|health behaviors
583366|NCT01083862|chronic disease management|chronic disease management
583367|NCT01083862|shared decision-making|shared decision-making
583368|NCT01083862|patient-centered decision making|patient-centered decision making
583369|NCT01083849|Observational study|observational study
583370|NCT01083849|Paricalcitol|paricalcitol
583371|NCT01083849|Treatment of Hyperparathyroidism|treatment of hyperparathyroidism
583372|NCT01083849|Chronic kidney disease stage 3, 4 and 5 (CKD stage 3, 4 and 5)|chronic kidney disease stage 3, 4 and 5 (ckd stage 3, 4 and 5)
583373|NCT01083849|Chronic Kidney Disease|chronic kidney disease
583374|NCT01083849|Zemplar|zemplar
583375|NCT01083849|sHPT|shpt
583376|NCT01083849|Secondary|secondary
583377|NCT01083823|Mental health telemetry|mental health telemetry
583378|NCT01083823|Mood telemetry|mood telemetry
583379|NCT01083823|Mood|mood
583380|NCT01083823|Bipolar disorder|bipolar disorder
583381|NCT01083823|Affective instability|affective instability
583382|NCT01083823|Cyclothymia|cyclothymia
583383|NCT01083823|Electronic diaries|electronic diaries
583384|NCT01083823|Mood diaries|mood diaries
583385|NCT01083823|Mood swings|mood swings
583386|NCT01083810|Human Immunodeficiency Virus|human immunodeficiency virus
583387|NCT01083810|Infection|infection
583388|NCT01083810|Kaletra|kaletra
583389|NCT01083810|Resistance|resistance
583390|NCT01083810|Mutations|mutations
583391|NCT01083810|alternative Therapy regimen|alternative therapy regimen
583392|NCT01083797|Sedation|sedation
583393|NCT01083797|Electroencephalography|electroencephalography
583394|NCT01083797|Dexmedetomidine|dexmedetomidine
583395|NCT01083797|Chloral hydrate|chloral hydrate
583396|NCT01083784|Cardiac arrest|cardiac arrest
583397|NCT01083784|Prophylactic anticonvulsant|prophylactic anticonvulsant
583398|NCT01083719|Glioblastoma|glioblastoma
583399|NCT01083719|FDG-PET|fdg-pet
583401|NCT01083693|Monoclonals|monoclonals
583402|NCT01083693|Antibodies|antibodies
583403|NCT01083693|Ankylosing Spondylitis|ankylosing spondylitis
583404|NCT01083693|Antirheumatic Agents|antirheumatic agents
583405|NCT01083693|Quality of Life|quality of life
583406|NCT01083693|Adalimumab|adalimumab
583407|NCT01083693|rheumatoid arthritis|rheumatoid arthritis
583408|NCT01083693|psoriatic arthritis|psoriatic arthritis
583409|NCT01083680|Routine clinical setting|routine clinical setting
583410|NCT01083680|Long-term efficacy and safety|long-term efficacy and safety
583411|NCT01083680|Crohn's Disease|crohn's disease
583412|NCT01083680|Humira®|humira®
583413|NCT01083680|Adalimumab|adalimumab
583414|NCT01083667|ALS|als
583415|NCT01083667|Familial ALS|familial als
583416|NCT01083667|SOD1 Gene Mutation|sod1 gene mutation
583417|NCT01083654|Smoking|smoking
583418|NCT01083654|Smoking cessation|smoking cessation
583419|NCT01083641|Breast Cancer|breast cancer
583420|NCT01083628|mhealth|mhealth
583421|NCT01083628|depression|depression
583422|NCT01083628|latinos|latinos
583423|NCT01083628|text messaging|text messaging
583424|NCT01083628|CBT|cbt
583425|NCT01083628|SMS|sms
583426|NCT01083615|CRPC patients with cancer related pain|crpc patients with cancer related pain
583427|NCT01083615|CRPC|crpc
583428|NCT01083615|HRPC|hrpc
583429|NCT01083602|Multiple Myeloma|multiple myeloma
583430|NCT01083602|Relapsed Multiple Myeloma|relapsed multiple myeloma
583431|NCT01083602|Refractory Multiple Myeloma|refractory multiple myeloma
583432|NCT01083589|Lung Cancer|lung cancer
583433|NCT01083589|Metastatic NSCLC|metastatic nsclc
583434|NCT01083589|Tumor|tumor
583435|NCT01083589|Imatinib Mesylate|imatinib mesylate
583436|NCT01083589|Gleevec|gleevec
583437|NCT01083589|Docetaxel|docetaxel
583438|NCT01083589|Taxotere|taxotere
583439|NCT01083576|leishmaniasis|leishmaniasis
583440|NCT01083576|cutaneous|cutaneous
583441|NCT01083576|WR 279,396|wr 279,396
583442|NCT01083576|paromomycin|paromomycin
583443|NCT01083576|gentamicin|gentamicin
583444|NCT01083576|pharmacokinetics|pharmacokinetics
583445|NCT01083576|safety|safety
583446|NCT01083576|efficacy|efficacy
583447|NCT01083563|TNF|tnf
583448|NCT01083563|CD20|cd20
583449|NCT01083563|RA|ra
583450|NCT01083550|thyroid carcinoma|thyroid carcinoma
583451|NCT01083550|thyroid cancer|thyroid cancer
583452|NCT01083550|therapeutic radioisotopes|therapeutic radioisotopes
583453|NCT01083550|radioactive iodine|radioactive iodine
583454|NCT01083537|malignant bowel obstruction|malignant bowel obstruction
583455|NCT01083537|ovarian cancer|ovarian cancer
583456|NCT01083537|Peritoneal cancer|peritoneal cancer
583457|NCT01083537|Fallopian Tube cancer|fallopian tube cancer
583458|NCT01083524|Pulmonary arterial hypertension|pulmonary arterial hypertension
583459|NCT01083524|Pulmonary hypertension|pulmonary hypertension
583460|NCT01083524|Dichloroacetate|dichloroacetate
583461|NCT01083524|Dichloroacetate Sodium|dichloroacetate sodium
583462|NCT01083524|DCA|dca
583463|NCT01083511|Influenza|influenza
583464|NCT01083511|Influenza A|influenza a
583465|NCT01083511|Influenza B|influenza b
583466|NCT01083511|Swine Influenza A/H1N1|swine influenza a/h1n1
583467|NCT01083511|Respiratory Virus|respiratory virus
583468|NCT01083498|Becker's nevus|becker's nevus
583469|NCT01083498|ablative fractional laser therapy|ablative fractional laser therapy
583470|NCT01083498|randomized controlled trial|randomized controlled trial
583471|NCT01083498|split-lesion design|split-lesion design
583472|NCT01083485|Oxycodone|oxycodone
583473|NCT01083485|Naloxone|naloxone
583474|NCT01083485|Postoperative pain|postoperative pain
583475|NCT01083485|Arthroplasty|arthroplasty
583476|NCT01083485|Efficacy|efficacy
583477|NCT01083472|dehiscence|dehiscence
583478|NCT01083472|laparotomy|laparotomy
583479|NCT01083472|Hernia repair|hernia repair
583480|NCT01083472|surgical wound|surgical wound
583481|NCT01083472|surgical mesh|surgical mesh
583482|NCT01083446|Encephalopathy|encephalopathy
583483|NCT01083446|Cirrhotics|cirrhotics
583484|NCT01083433|Continuous Glucose Monitor|continuous glucose monitor
583485|NCT01083433|Adherence|adherence
583486|NCT01083433|Adolescents|adolescents
583487|NCT01083433|Diabetes Education|diabetes education
583488|NCT01083420|Oral lichen planus|oral lichen planus
583489|NCT01083420|Minocycline|minocycline
583490|NCT01083420|Dexamethasone|dexamethasone
583491|NCT01083407|Oral care.|oral care.
583492|NCT01083407|Chlorhexidine.|chlorhexidine.
583493|NCT01083407|Pediatric Nursing|pediatric nursing
583494|NCT01083407|Intensive Care|intensive care
583495|NCT01083407|Nosocomial infection|nosocomial infection
583496|NCT01083407|Pneumonia|pneumonia
583497|NCT01083407|Oropharyngeal colonization|oropharyngeal colonization
583498|NCT01083407|Tracheal colonization|tracheal colonization
583499|NCT01083394|PTA|pta
583500|NCT01083394|paclitaxel|paclitaxel
583501|NCT01083394|restenosis|restenosis
583502|NCT01083381|Schizophrenia treatment MS14 randomized clinical trial|schizophrenia treatment ms14 randomized clinical trial
583503|NCT01083368|adenocarcinoma of the prostate|adenocarcinoma of the prostate
583504|NCT01083368|hormone-resistant prostate cancer|hormone-resistant prostate cancer
583505|NCT01083368|recurrent prostate cancer|recurrent prostate cancer
583506|NCT01083368|stage IV prostate cancer|stage iv prostate cancer
583507|NCT01083355|Variable ventilation|variable ventilation
583508|NCT01083355|Pressure regulated volume control ventilation|pressure regulated volume control ventilation
583509|NCT01083355|Airway pressure release ventilation|airway pressure release ventilation
583510|NCT01083342|primary CNS lymphoma|primary cns lymphoma
583511|NCT01083342|MTX: Methotrexate,Leucovorin|mtx: methotrexate,leucovorin
583512|NCT01083342|MVD: Methotrexate,Vincristine,Dexamethasone|mvd: methotrexate,vincristine,dexamethasone
583513|NCT01083342|VIA: VP-16 (Etoposide),Ifosfamide,Mesna, Cytarabine (ara-C)|via: vp-16 (etoposide),ifosfamide,mesna, cytarabine (ara-c)
583514|NCT01083342|Newly diagnosed primary CNS lymphoma patients|newly diagnosed primary cns lymphoma patients
583515|NCT01083329|nicotinic acid|nicotinic acid
583516|NCT01083329|lipolysis|lipolysis
583517|NCT01083329|training program|training program
583518|NCT01083329|adipose tissue inflammation|adipose tissue inflammation
583519|NCT01083329|obese|obese
583520|NCT01083316|Amyloid|amyloid
583521|NCT01083316|Amyloidosis|amyloidosis
583522|NCT01083316|AL Amyloidosis|al amyloidosis
583523|NCT01083316|Primary Amyloidosis|primary amyloidosis
583524|NCT01083316|Stem Cell Transplant|stem cell transplant
583525|NCT01083303|energy expenditure|energy expenditure
583526|NCT01083303|hypothermia|hypothermia
583527|NCT01083303|body temperature|body temperature
583528|NCT01083303|weaning|weaning
583529|NCT01083303|preterm infants|preterm infants
583530|NCT01083290|spironolactone|spironolactone
583531|NCT01083290|linearity of pharmacokinetics|linearity of pharmacokinetics
583532|NCT01083290|Healthy volunteers|healthy volunteers
583533|NCT01083277|oxygenation|oxygenation
583534|NCT01083277|ventilation|ventilation
583535|NCT01083277|tidal volume|tidal volume
583536|NCT01083277|patterns of breathing|patterns of breathing
583537|NCT01083277|variable ventilation|variable ventilation
583538|NCT01083277|mechanical ventilation|mechanical ventilation
583539|NCT01083264|Pharmacokinetics|pharmacokinetics
583540|NCT01083251|HBV|hbv
583541|NCT01083251|VITAMIN D|vitamin d
583542|NCT01083251|PEGITERFERON|pegiterferon
583543|NCT01083251|Telbivudine|telbivudine
583544|NCT01083238|pharmacokinetics|pharmacokinetics
583545|NCT01083238|fasting or after a high fat meal|fasting or after a high fat meal
583546|NCT01083238|adult|adult
583547|NCT01083238|elderly adult|elderly adult
583548|NCT01083238|COPD|copd
583549|NCT01083212|Type 2 Diabetes Mellitus|type 2 diabetes mellitus
583550|NCT01083212|Gemfibrozil|gemfibrozil
583551|NCT01083199|Prostate Cancer|prostate cancer
583552|NCT01083199|Radical Prostatectomy|radical prostatectomy
583553|NCT01083199|Vesico-Urethral Anastomosis|vesico-urethral anastomosis
583554|NCT01083186|Secondary Hyperparathyroidism|secondary hyperparathyroidism
583555|NCT01083186|Chronic Kidney Failure|chronic kidney failure
583556|NCT01083173|Postmarketing Drug Surveillance|postmarketing drug surveillance
583557|NCT01083173|HIV-1 infection|hiv-1 infection
583558|NCT01083173|Kaletra|kaletra
741764|NCT00468078|PET|pet
583559|NCT01083160|Rheumatoid Arthritis|rheumatoid arthritis
583560|NCT01083160|Anti-TNF|anti-tnf
583561|NCT01083160|Adalimumab|adalimumab
583562|NCT01083160|Infliximab|infliximab
583563|NCT01083160|Etanercept|etanercept
583564|NCT01083147|Intermediate AMD|intermediate amd
583565|NCT01083134|CAD|cad
583566|NCT01083121|Postmarketing Drug Surveillance|postmarketing drug surveillance
583567|NCT01083108|Behavioral Weight Loss Treatment|behavioral weight loss treatment
583568|NCT01083108|Bariatric Surgery|bariatric surgery
583569|NCT01083108|Diabetes Type II|diabetes type ii
583570|NCT01083108|Obesity|obesity
583571|NCT01083108|Adult|adult
583572|NCT01083108|Type 2 Diabetes|type 2 diabetes
583573|NCT01083095|Malaria|malaria
583574|NCT01083095|Sporozoite|sporozoite
583575|NCT01083095|Challenge Model|challenge model
583576|NCT01083095|Plasmodium vivax|plasmodium vivax
583577|NCT01083095|Human Volunteers|human volunteers
583578|NCT01083082|lifestyles|lifestyles
583579|NCT01083082|diet|diet
583580|NCT01083082|exercise|exercise
583581|NCT01083082|central blood pressure|central blood pressure
583582|NCT01083082|arterial stiffness|arterial stiffness
583583|NCT01083082|endothelial dysfunction|endothelial dysfunction
583584|NCT01083082|Healthy people|healthy people
583585|NCT01083069|Sudden cardiac arrest|sudden cardiac arrest
583586|NCT01083069|hypothermia|hypothermia
583587|NCT01083069|neurological outcome|neurological outcome
583588|NCT01083056|retina|retina
583589|NCT01083056|gliosis|gliosis
583590|NCT01083056|macula|macula
583591|NCT01083056|membrane|membrane
583592|NCT01083056|ILM|ilm
583593|NCT01083043|Glycemic Variability|glycemic variability
583594|NCT01083043|Endothelial Dysfunction|endothelial dysfunction
583595|NCT01083030|pAVK|pavk
583596|NCT01083030|PTA|pta
583597|NCT01083030|drug coated balloon|drug coated balloon
583598|NCT01083004|dye|dye
583599|NCT01083004|internal limiting membrane|internal limiting membrane
583600|NCT01083004|macular hole|macular hole
583601|NCT01083004|macular pucker|macular pucker
583602|NCT01082978|Quality of Life|quality of life
583603|NCT01082978|Health Care Quality and Safety|health care quality and safety
583604|NCT01082978|Randomized controlled trial|randomized controlled trial
583605|NCT01082965|ASL MRI|asl mri
583606|NCT01082965|perfusion|perfusion
583607|NCT01082965|cognition|cognition
583608|NCT01082965|donepezil|donepezil
583609|NCT01082965|alzheimer's disease|alzheimer's disease
583610|NCT01082965|translational medicine|translational medicine
583611|NCT01082939|Chronic lymphocytic leukemia|chronic lymphocytic leukemia
583612|NCT01082939|Refractory CLL|refractory cll
583613|NCT01082939|CFAR|cfar
583614|NCT01082939|Alemtuzumab|alemtuzumab
583615|NCT01082939|Campath-1H|campath-1h
583616|NCT01082939|Campath|campath
583617|NCT01082939|Cyclophosphamide|cyclophosphamide
583618|NCT01082939|Cytoxan|cytoxan
583619|NCT01082939|Neosar|neosar
583620|NCT01082939|Fludarabine|fludarabine
583621|NCT01082939|Fludara|fludara
583622|NCT01082939|Fludarabine Phosphate|fludarabine phosphate
583623|NCT01082939|Rituximab|rituximab
583624|NCT01082939|Rituxan|rituxan
583625|NCT01082939|CLL|cll
583626|NCT01082926|adult anaplastic astrocytoma|adult anaplastic astrocytoma
583627|NCT01082926|adult anaplastic ependymoma|adult anaplastic ependymoma
583628|NCT01082926|adult anaplastic meningioma|adult anaplastic meningioma
583629|NCT01082926|adult anaplastic oligodendroglioma|adult anaplastic oligodendroglioma
583630|NCT01082926|adult brain stem glioma|adult brain stem glioma
583631|NCT01082926|adult ependymoblastoma|adult ependymoblastoma
583632|NCT01082926|adult giant cell glioblastoma|adult giant cell glioblastoma
583633|NCT01082926|adult glioblastoma|adult glioblastoma
583634|NCT01082926|adult gliosarcoma|adult gliosarcoma
583635|NCT01082926|adult grade III meningioma|adult grade iii meningioma
583636|NCT01082926|adult meningeal hemangiopericytoma|adult meningeal hemangiopericytoma
583637|NCT01082926|adult mixed glioma|adult mixed glioma
583638|NCT01082926|adult pineal gland astrocytoma|adult pineal gland astrocytoma
583639|NCT01082926|recurrent adult brain tumor|recurrent adult brain tumor
583640|NCT01082926|Los Angeles|los angeles
583641|NCT01082900|Transient Tachypnea of the Newborn|transient tachypnea of the newborn
583642|NCT01082900|Elective Cesarean section|elective cesarean section
583643|NCT01082900|Late preterm|late preterm
583644|NCT01082900|CPAP|cpap
583645|NCT01082900|Delivery Room|delivery room
583646|NCT01082887|Immunotherapy TIL (Tumor Infiltrating Lymphocytes)|immunotherapy til (tumor infiltrating lymphocytes)
583647|NCT01082887|Intra-tumoral injection|intra-tumoral injection
583648|NCT01082887|Interferon gamma-adenovirus(Ad-IFNg)|interferon gamma-adenovirus(ad-ifng)
583649|NCT01082887|Metastatic melanoma|metastatic melanoma
583650|NCT01082887|A stage IIIc/IV metastatic melanoma with nodal relapse|a stage iiic/iv metastatic melanoma with nodal relapse
583651|NCT01082887|in transit metastasis|in transit metastasis
583652|NCT01082887|cutaneous unresectable metastases|cutaneous unresectable metastases
583653|NCT01082887|visceral metastases|visceral metastases
583654|NCT01082874|Randomized Controlled Trial|randomized controlled trial
583655|NCT01082874|Blinded|blinded
583656|NCT01082874|Clonidine|clonidine
583657|NCT01082874|acetyl-salicylic acid (ASA)|acetyl-salicylic acid (asa)
583658|NCT01082874|Perioperative vascular complications|perioperative vascular complications
583659|NCT01082874|Noncardiac surgery|noncardiac surgery
583660|NCT01082861|1998 female birth cohort eligible for HPV vaccination in 2011 within the Dutch NIP|1998 female birth cohort eligible for hpv vaccination in 2011 within the dutch nip
583661|NCT01082835|Chinese herbs|chinese herbs
583662|NCT01082822|cell sheet PDLSC periodontitis|cell sheet pdlsc periodontitis
583663|NCT01082809|advanced biliary tract carcinoma|advanced biliary tract carcinoma
583664|NCT01082809|Sunitinib|sunitinib
583665|NCT01082783|stroke-induced immunodepression|stroke-induced immunodepression
583666|NCT01082783|acute media infarct|acute media infarct
583667|NCT01082783|acute intracerebral bleeding|acute intracerebral bleeding
583668|NCT01082783|leucocytes|leucocytes
583669|NCT01082783|autoaggressive T-cells|autoaggressive t-cells
583670|NCT01082783|acute media infarct or acute intracerebral bleeding|acute media infarct or acute intracerebral bleeding
583671|NCT01082757|Colorectal neoplasms|colorectal neoplasms
583672|NCT01082757|metastasis|metastasis
583673|NCT01082757|colorectal cancer|colorectal cancer
583674|NCT01082744|Paravertebral Block|paravertebral block
583675|NCT01082744|Regional Anesthesia|regional anesthesia
583676|NCT01082744|Anesthetics Local|anesthetics local
583677|NCT01082744|Ropivacaine|ropivacaine
583678|NCT01082744|Sufentanil|sufentanil
583679|NCT01082744|Pain Postoperative|pain postoperative
583680|NCT01082744|Chronic Pain|chronic pain
583681|NCT01082744|Thoracic Surgery Video-Assisted.|thoracic surgery video-assisted.
583682|NCT01082731|Malaria|malaria
583683|NCT01082731|Plasmodium falciparum|plasmodium falciparum
583684|NCT01082731|Treatment|treatment
583685|NCT01082731|Brazil|brazil
583686|NCT01082718|Malaria|malaria
583687|NCT01082718|Pregnancy|pregnancy
583688|NCT01082718|Pharmacokinetics|pharmacokinetics
583689|NCT01082718|Brazil|brazil
583690|NCT01082705|malaria|malaria
583691|NCT01082705|treatment|treatment
583692|NCT01082705|artemisinin combination therapy|artemisinin combination therapy
583693|NCT01082705|Tanzania|tanzania
583694|NCT01082705|P. falciparum malaria in children age 6-59 months|p. falciparum malaria in children age 6-59 months
583695|NCT01082692|HIV Infection|hiv infection
583696|NCT01082692|DNA vaccine|dna vaccine
583697|NCT01082692|Electroporation|electroporation
583698|NCT01082692|HIV therapeutic vaccine|hiv therapeutic vaccine
583699|NCT01082679|opioid dependent|opioid dependent
583700|NCT01082679|methadone|methadone
583701|NCT01082679|Suboxone|suboxone
583702|NCT01082679|buprenorphine|buprenorphine
583703|NCT01082666|Cuff pressure|cuff pressure
583704|NCT01082666|microaspiration|microaspiration
583705|NCT01082666|pepsin|pepsin
583707|NCT01082666|Mechanical ventilation|mechanical ventilation
583708|NCT01082653|ALS|als
583709|NCT01082653|Lou Gehrig's Disease|lou gehrig's disease
583710|NCT01082640|Gout|gout
583711|NCT01082640|physiology|physiology
583712|NCT01082640|Hyperuricemia|hyperuricemia
583713|NCT01082640|Uric Acid|uric acid
583714|NCT01082640|Drug Therapy|drug therapy
583715|NCT01082627|Somatostatin small bowel obstruction|somatostatin small bowel obstruction
583716|NCT01082601|Catheter Ablation|catheter ablation
583717|NCT01082601|Atrial Fibrillation|atrial fibrillation
583718|NCT01082601|Congestive heart failure|congestive heart failure
583719|NCT01082588|schizophrenia|schizophrenia
583720|NCT01082588|pravastatin|pravastatin
583721|NCT01082588|inflammation|inflammation
583722|NCT01082588|cognition|cognition
583723|NCT01082588|antipsychotics|antipsychotics
583724|NCT01082588|cholesterol|cholesterol
583725|NCT01082575|Post Op Patients|post op patients
583726|NCT01082575|Continuous Pulse Oximetry Monitoring|continuous pulse oximetry monitoring
583727|NCT01082575|Major Surgery|major surgery
583728|NCT01082549|Patients with Previously Untreated Advanced Squamous Cell Lung Cancer|patients with previously untreated advanced squamous cell lung cancer
583729|NCT01082536|Pediatrics|pediatrics
583730|NCT01082536|Congenital heart disease|congenital heart disease
583731|NCT01082536|NIRS|nirs
583732|NCT01082536|Brain oxygenation|brain oxygenation
583733|NCT01082510|UFT|uft
583734|NCT01082510|BCG|bcg
583735|NCT01082497|Mindfulness|mindfulness
583736|NCT01082497|Stress|stress
583737|NCT01082497|Burnout|burnout
583738|NCT01082497|Ward atmosphere|ward atmosphere
583739|NCT01082497|Stress and burnout among staff, psychosocial atmosphere at the ward|stress and burnout among staff, psychosocial atmosphere at the ward
583740|NCT01082484|Healthy volunteers|healthy volunteers
583741|NCT01082484|iontophoresis|iontophoresis
583742|NCT01082471|Morphine 6-glucuronide|morphine 6-glucuronide
583743|NCT01082471|Morphine|morphine
583744|NCT01082471|Patient Controlled Analgesia|patient controlled analgesia
583745|NCT01082471|Post Operative Nausea and Vomiting|post operative nausea and vomiting
583746|NCT01082458|Patients scheduled to undergo thyroidectomy|patients scheduled to undergo thyroidectomy
583747|NCT01082445|stage C|stage c
583748|NCT01082445|grade 0 (Texas University)|grade 0 (texas university)
583749|NCT01082432|thumb|thumb
583750|NCT01082432|Ulnar collateral ligament|ulnar collateral ligament
583751|NCT01082432|superimposed electrical stimulation|superimposed electrical stimulation
583752|NCT01082432|stiffness|stiffness
583753|NCT01082432|adhesions|adhesions
583754|NCT01082419|Liver stiffness measurement|liver stiffness measurement
583755|NCT01082419|ARFI|arfi
583756|NCT01082419|fibrosis|fibrosis
583757|NCT01082419|hepatopathy|hepatopathy
583758|NCT01082393|vitiligo|vitiligo
583759|NCT01082380|radiolabeled|radiolabeled
583760|NCT01082380|healthy volunteers|healthy volunteers
583761|NCT01082367|Tobramycin Inhalation solution|tobramycin inhalation solution
583762|NCT01082367|Cystic fibrosis|cystic fibrosis
583763|NCT01082367|Lung disease|lung disease
583764|NCT01082367|anti-bacterial agents|anti-bacterial agents
583765|NCT01082354|Infant, Low birth weight|infant, low birth weight
583766|NCT01082354|Infant, Low birth height|infant, low birth height
583767|NCT01082354|Infant, Small for Gestational Age|infant, small for gestational age
583768|NCT01082341|GCP Good Clinical Practice|gcp good clinical practice
583769|NCT01082341|IFAT Indirect Immunofluorescence antibody test|ifat indirect immunofluorescence antibody test
583770|NCT01082341|MFA Membrane Feeding Assay|mfa membrane feeding assay
583771|NCT01082341|N Number (typically refers to subjects)|n number (typically refers to subjects)
583772|NCT01082341|RBC Red Blood Cells|rbc red blood cells
583773|NCT01082341|SOP Standard Operating Procedure|sop standard operating procedure
583774|NCT01082341|TBS Thick blood smear|tbs thick blood smear
583775|NCT01082341|P. Vivax|p. vivax
583776|NCT01082341|irradiated sporozoite vaccination.|irradiated sporozoite vaccination.
583777|NCT01082328|Phenylketonuria (PKU)|phenylketonuria (pku)
583778|NCT01082328|Hyperphenylalaninemia (HPA)|hyperphenylalaninemia (hpa)
583780|NCT01082328|Sapropterin dihydrochloride|sapropterin dihydrochloride
583781|NCT01082328|Kuvan responder|kuvan responder
583782|NCT01082328|Tetrahydrobiopterin (BH4)|tetrahydrobiopterin (bh4)
583783|NCT01082315|Colorectal cancer|colorectal cancer
583784|NCT01082315|Neoplasm metastasis|neoplasm metastasis
583785|NCT01082315|Cetuximab|cetuximab
583786|NCT01082315|Erbitux|erbitux
583787|NCT01082315|EGFR|egfr
583788|NCT01082302|green tea extract|green tea extract
583789|NCT01082302|Polyphenon E|polyphenon e
583790|NCT01082302|Pharmacokinetics|pharmacokinetics
583791|NCT01082289|Lurasidone|lurasidone
583792|NCT01082289|Schizophrenia|schizophrenia
583793|NCT01082289|Latuda|latuda
583794|NCT01082276|Rifampin DDI with Lurasidone HCl|rifampin ddi with lurasidone hcl
583795|NCT01082263|DDI study between Midazolam and Lurasidone HCl|ddi study between midazolam and lurasidone hcl
583796|NCT01082263|Male and Female|male and female
583797|NCT01082250|Bioequivalence|bioequivalence
583798|NCT01082250|Male/Female Patient|male/female patient
583799|NCT01082250|Reference/Test Formulation|reference/test formulation
583800|NCT01082250|Schizophrenia Patients|schizophrenia patients
583801|NCT01082237|Major Depressive Disorder|major depressive disorder
583803|NCT01082237|SSRI|ssri
583804|NCT01082224|adult primary hepatocellular carcinoma|adult primary hepatocellular carcinoma
583805|NCT01082224|localized unresectable adult primary liver cancer|localized unresectable adult primary liver cancer
583806|NCT01082224|recurrent adult primary liver cancer|recurrent adult primary liver cancer
583807|NCT01082211|invasive ductal breast carcinoma|invasive ductal breast carcinoma
583808|NCT01082211|medullary ductal breast carcinoma with lymphocytic infiltrate|medullary ductal breast carcinoma with lymphocytic infiltrate
583809|NCT01082211|invasive lobular breast carcinoma|invasive lobular breast carcinoma
583810|NCT01082211|tubular ductal breast carcinoma|tubular ductal breast carcinoma
583811|NCT01082211|mucinous ductal breast carcinoma|mucinous ductal breast carcinoma
583812|NCT01082211|ductal breast carcinoma in situ|ductal breast carcinoma in situ
583813|NCT01082211|lobular breast carcinoma in situ|lobular breast carcinoma in situ
583814|NCT01082211|recurrent breast cancer|recurrent breast cancer
583815|NCT01082198|stage III melanoma|stage iii melanoma
583816|NCT01082185|abdominal|abdominal
583817|NCT01082185|aortic|aortic
583818|NCT01082185|aneurysm|aneurysm
583819|NCT01082185|AAA|aaa
583820|NCT01082172|thoracic|thoracic
583821|NCT01082172|aortic|aortic
583822|NCT01082172|aneurysm|aneurysm
583823|NCT01082172|TAA|taa
583824|NCT01082159|Spinal Stenosis|spinal stenosis
583825|NCT01082159|Lumbar Spinal Stenosis|lumbar spinal stenosis
583826|NCT01082146|pharmacokinetics, lurasidone|pharmacokinetics, lurasidone
583827|NCT01082133|Fanconi Anemia|fanconi anemia
583828|NCT01082120|Type 2 Diabetes Mellitus|type 2 diabetes mellitus
583829|NCT01082120|Pioglitazone|pioglitazone
583830|NCT01082094|Ischemic heart failure|ischemic heart failure
583831|NCT01082094|Congestive heart failure|congestive heart failure
583832|NCT01082094|Stromal cell-derived factor 1|stromal cell-derived factor 1
583833|NCT01082094|SDF-1|sdf-1
583834|NCT01082094|Gene therapy|gene therapy
583835|NCT01082081|paracetamol|paracetamol
583836|NCT01082081|dental pain|dental pain
583837|NCT01082081|Post-surgical dental pain|post-surgical dental pain
583838|NCT01082068|HER2 negative|her2 negative
583839|NCT01082068|Hormone Receptor Positive|hormone receptor positive
583840|NCT01082068|Breast Neoplasms|breast neoplasms
583841|NCT01082055|Cardiac|cardiac
583842|NCT01082055|Dysrhythmia|dysrhythmia
583843|NCT01082055|Safety|safety
583844|NCT01082042|Balance, postural|balance, postural
583845|NCT01082042|Aged, over 70|aged, over 70
583846|NCT01082042|Exercise|exercise
583847|NCT01082042|Accidental falls|accidental falls
583848|NCT01082016|Sleep|sleep
583849|NCT01082016|Critical Illness|critical illness
583850|NCT01082016|Sleep promotion during recovery form illness|sleep promotion during recovery form illness
583851|NCT01082003|Capsular contractures in breast cancer patients|capsular contractures in breast cancer patients
583852|NCT01081977|Delayed cord clamping|delayed cord clamping
583853|NCT01081977|Ferritin|ferritin
583854|NCT01081977|Hemoglobin|hemoglobin
583855|NCT01081977|Neonatal anemia|neonatal anemia
583856|NCT01081977|Postpartum haemorrhage|postpartum haemorrhage
583857|NCT01081977|Neonatal jaundice|neonatal jaundice
583858|NCT01081964|pneumonia|pneumonia
583859|NCT01081964|Community acquired pneumonia of moderate severity|community acquired pneumonia of moderate severity
583860|NCT01081951|Poly(ADP ribose)|poly(adp ribose)
583861|NCT01081951|polymerisation (PARP)|polymerisation (parp)
583862|NCT01081951|Platinum sensitive|platinum sensitive
583863|NCT01081951|Advanced Serous Ovarian cancer|advanced serous ovarian cancer
583864|NCT01081951|olaparib|olaparib
583865|NCT01081951|PARP inhibitors|parp inhibitors
583866|NCT01081951|Platinum Sensitive Advanced Serous Ovarian Cancer|platinum sensitive advanced serous ovarian cancer
583867|NCT01081925|Congestive Heart Failure|congestive heart failure
583868|NCT01081925|Cardiac Failure|cardiac failure
583869|NCT01081912|chronic pain|chronic pain
583870|NCT01081912|back pain|back pain
583871|NCT01081899|dying patients|dying patients
583872|NCT01081899|cancer|cancer
583873|NCT01081899|hospital|hospital
583874|NCT01081899|Liverpool Care Pathways|liverpool care pathways
583875|NCT01081886|Total knee arthroplasty|total knee arthroplasty
583876|NCT01081886|PlasmaBlade|plasmablade
583877|NCT01081886|Electrosurgery|electrosurgery
583878|NCT01081886|PEAK Surgical|peak surgical
583879|NCT01081886|Medtronic Advanced Energy|medtronic advanced energy
583880|NCT01081886|Medtronic|medtronic
583881|NCT01081873|Multicenter study|multicenter study
583882|NCT01081860|Carpal tunnel syndrome|carpal tunnel syndrome
583883|NCT01081860|CTS|cts
583884|NCT01081860|Skinstiffness|skinstiffness
583885|NCT01081860|Jointstiffness|jointstiffness
583886|NCT01081847|Malaria|malaria
583887|NCT01081847|Synthetic peptides|synthetic peptides
583888|NCT01081847|Plasmodium vivax|plasmodium vivax
583889|NCT01081847|Human volunteers|human volunteers
583890|NCT01081834|Diabetes Mellitus, Type 2|diabetes mellitus, type 2
583891|NCT01081834|Canagliflozin|canagliflozin
583892|NCT01081834|Placebo|placebo
583893|NCT01081834|Hemoglobin A1c|hemoglobin a1c
583894|NCT01081834|Type 2 diabetes mellitus|type 2 diabetes mellitus
583895|NCT01081821|JNJ 39758979|jnj 39758979
583896|NCT01081821|Japanese descent|japanese descent
583897|NCT01081808|PhaseI|phasei
583898|NCT01081808|Solid Tumor|solid tumor
583899|NCT01081808|biomarkers|biomarkers
583900|NCT01081808|T cell|t cell
583901|NCT01081808|Cetuximab|cetuximab
583902|NCT01081808|Epidermal Growth Factor Receptor|epidermal growth factor receptor
583903|NCT01081808|Aldesleukin|aldesleukin
583904|NCT01081808|Lymphocytes|lymphocytes
583905|NCT01081808|Autologous|autologous
583906|NCT01081808|Recurrent|recurrent
583907|NCT01081808|Refractory|refractory
583908|NCT01081808|Metastatic|metastatic
583909|NCT01081808|Immunotherapy|immunotherapy
583910|NCT01081808|Antibodies|antibodies
583911|NCT01081808|Neoplasms by Site|neoplasms by site
583912|NCT01081808|Anti-Retroviral Agents|anti-retroviral agents
583913|NCT01081808|Therapeutic Uses|therapeutic uses
583914|NCT01081808|Anti-Infective Agents|anti-infective agents
583915|NCT01081808|Neoplasms by Histologic Type|neoplasms by histologic type
583916|NCT01081808|Antineoplastic Agents|antineoplastic agents
583917|NCT01081808|Antiviral Agents|antiviral agents
583918|NCT01081808|Pharmacologic Actions|pharmacologic actions
583919|NCT01081808|Carcinoma|carcinoma
583920|NCT01081808|Neoplasms|neoplasms
583921|NCT01081795|Topiramate|topiramate
583922|NCT01081795|Migraine|migraine
583923|NCT01081782|Multiple Sclerosis|multiple sclerosis
583924|NCT01081782|ONO-4641|ono-4641
583925|NCT01081769|Schizophrenia|schizophrenia
583926|NCT01081769|paliperidone palmitate|paliperidone palmitate
583927|NCT01081769|Invega|invega
583928|NCT01081769|Intramuscular injection|intramuscular injection
583929|NCT01081769|Oral antipsychotics|oral antipsychotics
583930|NCT01081769|Relapse|relapse
583931|NCT01081756|Reproductive technology; Assisted|reproductive technology; assisted
583932|NCT01081756|recombinant human chorionic hormone (r-hCG)|recombinant human chorionic hormone (r-hcg)
583933|NCT01081743|Alzheimer|alzheimer
583934|NCT01081743|Dementia|dementia
583935|NCT01081743|Mild to moderately severe|mild to moderately severe
583936|NCT01081743|New diagnosis|new diagnosis
583937|NCT01081743|Prevention of behavioural problems|prevention of behavioural problems
583938|NCT01081730|psoriasis|psoriasis
583939|NCT01081730|ustekinumab|ustekinumab
583940|NCT01081730|anti-TNF biologics|anti-tnf biologics
583941|NCT01081730|non-anti-TNF biologics|non-anti-tnf biologics
583942|NCT01081730|systemic non-biological treatments|systemic non-biological treatments
583943|NCT01081717|Rheumatoid arthritis|rheumatoid arthritis
583944|NCT01081717|psoriatic arthritis|psoriatic arthritis
583945|NCT01081717|ankylosing spondylitis|ankylosing spondylitis
583946|NCT01081717|golimumab|golimumab
583947|NCT01081717|anti-TNF biologics|anti-tnf biologics
583948|NCT01081717|non-anti-TNF biologics|non-anti-tnf biologics
583949|NCT01081717|non-biological treatments|non-biological treatments
583950|NCT01081704|Healthy volunteer|healthy volunteer
583951|NCT01081704|Chinese male|chinese male
583952|NCT01081704|Stelara|stelara
583953|NCT01081691|CNTO 5825|cnto 5825
583954|NCT01081691|Safety|safety
583955|NCT01081691|Phase I|phase i
583956|NCT01081691|Healthy adults|healthy adults
583957|NCT01081691|Healthy Atopic adults|healthy atopic adults
583958|NCT01081678|AMG 785|amg 785
583959|NCT01081678|Proximal Femur|proximal femur
583960|NCT01081678|Fracture Healing|fracture healing
583961|NCT01081678|Hip Fracture|hip fracture
583962|NCT01081665|Chronic Kidney Failure|chronic kidney failure
583963|NCT01081665|Secondary Hyperparathyroidism|secondary hyperparathyroidism
583964|NCT01081665|Paricalcitol IV treatment|paricalcitol iv treatment
583965|NCT01081665|Safety and efficacy assessment|safety and efficacy assessment
583966|NCT01081652|Fertilisation, In vitro|fertilisation, in vitro
583967|NCT01081652|Embryo transfer|embryo transfer
583968|NCT01081652|progesterone|progesterone
583969|NCT01081652|Reproductive technologies, Assisted|reproductive technologies, assisted
583970|NCT01081639|Follitropin alfa|follitropin alfa
583971|NCT01081639|Follitropin beta|follitropin beta
583972|NCT01081639|Fertilization, in vitro|fertilization, in vitro
583973|NCT01081639|Intracytoplasmic sperm injection|intracytoplasmic sperm injection
583974|NCT01081639|Assisted reproductive techniques|assisted reproductive techniques
583975|NCT01081639|Polycystic ovary syndrome|polycystic ovary syndrome
583976|NCT01081626|Infertility|infertility
583977|NCT01081626|Ovulation induction|ovulation induction
583978|NCT01081626|Gonal-f|gonal-f
583979|NCT01081626|Follitropin alpha|follitropin alpha
583980|NCT01081626|Polycystic ovarian syndrome|polycystic ovarian syndrome
583981|NCT01081626|Anovulatory infertility|anovulatory infertility
583982|NCT01081613|heat shock protein|heat shock protein
583983|NCT01081613|breast cancer|breast cancer
583984|NCT01081613|PET imaging|pet imaging
583985|NCT01081613|bevacizumab|bevacizumab
583986|NCT01081600|Heat shock protein|heat shock protein
583987|NCT01081600|breast cancer|breast cancer
583988|NCT01081600|PET imaging|pet imaging
583989|NCT01081600|trastuzumab|trastuzumab
583990|NCT01081587|Non MeSH terms:|non mesh terms:
583991|NCT01081587|Children|children
583992|NCT01081587|Malnutrition|malnutrition
583993|NCT01081587|Computer Clinical Decision Support System|computer clinical decision support system
583994|NCT01081587|Cluster randomized trial|cluster randomized trial
583995|NCT01081587|Healthcare workers|healthcare workers
583996|NCT01081587|Guideline adherence|guideline adherence
583997|NCT01081587|Patient safety|patient safety
583998|NCT01081587|MeSH terms:|mesh terms:
583999|NCT01081587|Nutrition Surveys|nutrition surveys
584000|NCT01081587|Secondary Prevention|secondary prevention
584001|NCT01081587|Pediatrics|pediatrics
584002|NCT01081587|Child Care|child care
584003|NCT01081587|Health Personnel|health personnel
584004|NCT01081587|Reminder Systems|reminder systems
584005|NCT01081587|Intervention Studies|intervention studies
584006|NCT01081587|Quality of Health Care|quality of health care
584007|NCT01081574|Allergic Rhinitis|allergic rhinitis
584008|NCT01081574|Seasonal Allergic Rhinitis|seasonal allergic rhinitis
584009|NCT01081574|Perennial Allergic Rhinitis|perennial allergic rhinitis
584010|NCT01081574|Urticaria|urticaria
584011|NCT01081574|Chronic Idiopathic Urticaria|chronic idiopathic urticaria
584012|NCT01081574|Allergy|allergy
584013|NCT01081574|Sneezing|sneezing
584014|NCT01081574|Nasal Itching|nasal itching
584015|NCT01081574|Rhinorrhea|rhinorrhea
584016|NCT01081574|Nasal Congestion|nasal congestion
584017|NCT01081574|Wheals|wheals
584018|NCT01081574|Hives|hives
584019|NCT01081574|Skin itching|skin itching
584020|NCT01081574|Flare|flare
584021|NCT01081574|Erythema|erythema
584022|NCT01081535|Pediatric patients (6 months-5 years) scheduled elective ureteroneocystostomy|pediatric patients (6 months-5 years) scheduled elective ureteroneocystostomy
584023|NCT01081509|adherence|adherence
584024|NCT01081509|early breast cancer|early breast cancer
584025|NCT01081509|Arimidex|arimidex
584026|NCT01081509|Therapy adherence|therapy adherence
584027|NCT01081496|EGFR mutation, Non-small cell lung carcinoma, Spain|egfr mutation, non-small cell lung carcinoma, spain
584028|NCT01081496|Evaluate the prevalence of EGFR mutation status in patients with newly diagnosed locally advanced or metastatic NSCLC|evaluate the prevalence of egfr mutation status in patients with newly diagnosed locally advanced or metastatic nsclc
584029|NCT01081483|Healthy Volunteers|healthy volunteers
584030|NCT01081483|HCV Infections|hcv infections
584031|NCT01081457|Parkinson's disease|parkinson's disease
584032|NCT01081457|deep brain stimulation|deep brain stimulation
584033|NCT01081457|GI motility|gi motility
584034|NCT01081444|repetitive transcranial stimulation|repetitive transcranial stimulation
584035|NCT01081431|Myelodysplastic Syndromes|myelodysplastic syndromes
584036|NCT01081431|MDS|mds
584037|NCT01081431|deletion 5q|deletion 5q
584038|NCT01081431|del 5q|del 5q
584039|NCT01081431|IPSS|ipss
584040|NCT01081431|low risk|low risk
584041|NCT01081431|intermediate-1 risk|intermediate-1 risk
584042|NCT01081431|GMIHO|gmiho
584043|NCT01081431|ClinAssess|clinassess
584044|NCT01081431|Germing|germing
584045|NCT01081431|Düsseldorf|düsseldorf
584046|NCT01081431|MDS-LE-MON-5|mds-le-mon-5
584047|NCT01081431|Lenalidomide|lenalidomide
584048|NCT01081431|Revlimid|revlimid
584049|NCT01081418|Schizophrenia, assertive community treatment, quetiapine|schizophrenia, assertive community treatment, quetiapine
584050|NCT01081405|ALLOGENEIC HEMATOPOIETIC CELL TRANSPLANTATION|allogeneic hematopoietic cell transplantation
584051|NCT01081405|TOTAL LYMPHOID IRRADIATION|total lymphoid irradiation
584052|NCT01081405|ANTI-THYMOCYTE GLOBULIN|anti-thymocyte globulin
584053|NCT01081392|LPS|lps
584054|NCT01081392|endotoxin|endotoxin
584055|NCT01081392|inflammatory markers|inflammatory markers
584056|NCT01081392|healthy volunteers|healthy volunteers
584057|NCT01081392|neutrophils in sputum|neutrophils in sputum
584058|NCT01081379|Cytomegalovirus Infections|cytomegalovirus infections
584059|NCT01081379|Pregnancy|pregnancy
584060|NCT01081379|T-Lymphocytes|t-lymphocytes
584061|NCT01081379|Transmission|transmission
584062|NCT01081353|Aspirin|aspirin
584063|NCT01081353|Acetylsalicylic Acid|acetylsalicylic acid
584064|NCT01081340|gestational weight gain|gestational weight gain
584065|NCT01081340|postpartum weight loss|postpartum weight loss
584066|NCT01081340|breastfeeding|breastfeeding
584067|NCT01081340|overfeeding|overfeeding
584068|NCT01081327|Atrial Fibrillation|atrial fibrillation
584069|NCT01081327|Warfarin|warfarin
584070|NCT01081327|Safety|safety
584071|NCT01081301|hope|hope
584072|NCT01081301|quality of life|quality of life
584073|NCT01081301|caregivers|caregivers
584074|NCT01081288|Breast cancer|breast cancer
584075|NCT01081288|Breast screening|breast screening
584076|NCT01081288|Mammography|mammography
584077|NCT01081288|Routine screening programme|routine screening programme
584078|NCT01081275|Multiple Sclerosis|multiple sclerosis
584079|NCT01081275|MS|ms
584080|NCT01081275|CI Therapy|ci therapy
584081|NCT01081275|CIMT|cimt
584082|NCT01081275|Constraint-Induced Movement Therapy|constraint-induced movement therapy
584083|NCT01081275|Complementary and Alternative Medicine|complementary and alternative medicine
584084|NCT01081275|CAM|cam
584085|NCT01081275|Physical Therapy|physical therapy
584086|NCT01081275|Occupational Therapy|occupational therapy
584087|NCT01081275|Relaxation|relaxation
584088|NCT01081275|Exercise|exercise
584089|NCT01081275|Massage|massage
584090|NCT01081275|Yoga|yoga
584091|NCT01081275|Pool Therapy|pool therapy
584092|NCT01081275|Aquatherapy|aquatherapy
584093|NCT01081275|Aquatic Therapy|aquatic therapy
584094|NCT01081249|psychotherapy|psychotherapy
584095|NCT01081236|liver cirrhosis|liver cirrhosis
584096|NCT01081236|intestinal permeability|intestinal permeability
584097|NCT01081236|microbiota|microbiota
584098|NCT01081236|complications|complications
584099|NCT01081223|Brain Neoplasms|brain neoplasms
584100|NCT01081223|Central Nervous System Neoplasms|central nervous system neoplasms
584101|NCT01081223|Brain Diseases|brain diseases
584102|NCT01081223|Neoplasms|neoplasms
584103|NCT01081223|Nervous System Neoplasms|nervous system neoplasms
584104|NCT01081223|Glioblastoma|glioblastoma
584105|NCT01081223|Astrocytoma|astrocytoma
584106|NCT01081223|Nervous System Diseases|nervous system diseases
584107|NCT01081223|Central Nervous System Diseases|central nervous system diseases
584108|NCT01081223|Glioma|glioma
584109|NCT01081223|Recurrent astrocytoma|recurrent astrocytoma
584110|NCT01081223|Recurrent glioma|recurrent glioma
584111|NCT01081223|Cancer vaccine|cancer vaccine
584112|NCT01081223|Immunotherapy|immunotherapy
584113|NCT01081223|Killer T cells|killer t cells
584114|NCT01081223|Activated T cells|activated t cells
584115|NCT01081223|GM-CSF|gm-csf
584116|NCT01081223|Low dose IL-2|low dose il-2
584117|NCT01081223|Activated lymphocytes|activated lymphocytes
584118|NCT01081210|Echocardiography|echocardiography
584119|NCT01081210|Heart failure|heart failure
584120|NCT01081210|Kidney|kidney
584121|NCT01081210|Lung|lung
584122|NCT01081210|Aorta|aorta
584123|NCT01081197|heart failure|heart failure
584124|NCT01081197|liver|liver
584125|NCT01081197|depression|depression
584126|NCT01081197|neuropathy|neuropathy
584127|NCT01081184|primary Sjögren syndrome|primary sjögren syndrome
584128|NCT01081184|neurotrophins|neurotrophins
584129|NCT01081184|B cell|b cell
584130|NCT01081184|sicca syndrome|sicca syndrome
584131|NCT01081184|T cell|t cell
584132|NCT01081119|adolescent|adolescent
584133|NCT01081119|middle school|middle school
584134|NCT01081119|prevention|prevention
584135|NCT01081119|alcohol|alcohol
584136|NCT01081119|cigarettes|cigarettes
584137|NCT01081119|marijuana|marijuana
584138|NCT01081106|Breast Cancer|breast cancer
584139|NCT01081093|Hypertrophic Cardiomyopathy Diastolic Ventricular Interaction|hypertrophic cardiomyopathy diastolic ventricular interaction
584140|NCT01081093|Biventricular Pacemaker cardiac surgery aortic valve replacement|biventricular pacemaker cardiac surgery aortic valve replacement
584141|NCT01081080|cardiac|cardiac
584142|NCT01081080|muscle|muscle
584143|NCT01081080|pediatric|pediatric
584144|NCT01081080|dystrophy|dystrophy
584145|NCT01081054|Diverticulitis|diverticulitis
584339|NCT01080118|Intubation|intubation
584146|NCT01081054|Not complicated diverticulitis|not complicated diverticulitis
584147|NCT01081028|Multiple Myeloma|multiple myeloma
584148|NCT01081028|MM|mm
584149|NCT01081028|disease registry|disease registry
584150|NCT01081028|Connect®|connect®
584151|NCT01081015|Chronic Lymphocytic Leukemia|chronic lymphocytic leukemia
584152|NCT01081015|CLL|cll
584153|NCT01081015|disease registry|disease registry
584154|NCT01081015|Connect™|connect™
584155|NCT01081002|Propofol|propofol
584156|NCT01081002|Conscious sedation|conscious sedation
584157|NCT01081002|Topical pharyngeal anesthesia|topical pharyngeal anesthesia
584158|NCT01081002|Anesthetics, Local|anesthetics, local
584159|NCT01081002|Gastrointestinal Endoscopy|gastrointestinal endoscopy
584160|NCT01080989|solomon islands|solomon islands
584161|NCT01080989|malaria|malaria
584162|NCT01080989|flavivirus|flavivirus
584163|NCT01080989|alphavirus|alphavirus
584164|NCT01080989|parasite|parasite
584165|NCT01080989|leptospirosis|leptospirosis
584166|NCT01080963|Prophylaxis|prophylaxis
584167|NCT01080963|Antibiotic|antibiotic
584168|NCT01080963|Sternotomy|sternotomy
584169|NCT01080963|Heart-Lung Machine|heart-lung machine
584171|NCT01080950|sepsis|sepsis
584172|NCT01080950|fever|fever
584173|NCT01080950|vitamin d|vitamin d
584174|NCT01080937|acute heart failure|acute heart failure
584175|NCT01080911|Spinal morphine|spinal morphine
584176|NCT01080911|Vaginal hysterectomy|vaginal hysterectomy
584177|NCT01080898|Age - Related Macular Degeneration|age - related macular degeneration
584178|NCT01080898|Optical Coherence Tomography|optical coherence tomography
584179|NCT01080898|Choroidal neovascularization|choroidal neovascularization
584180|NCT01080898|FLORESCEIN Angiography|florescein angiography
584181|NCT01080898|Fundus photographs|fundus photographs
584182|NCT01080885|Prevention|prevention
584183|NCT01080885|Prevention of unhealthy weight gain|prevention of unhealthy weight gain
584184|NCT01080872|acute coronary syndrome|acute coronary syndrome
584185|NCT01080872|coronary flow reserve|coronary flow reserve
584186|NCT01080872|OCT|oct
584187|NCT01080872|healing|healing
584188|NCT01080872|drug eluting stent|drug eluting stent
584189|NCT01080859|titanium|titanium
584190|NCT01080859|everolimus|everolimus
584191|NCT01080859|oct|oct
584192|NCT01080859|acute coronary syndrome|acute coronary syndrome
584193|NCT01080859|stent|stent
584194|NCT01080859|pci|pci
584195|NCT01080859|stenting|stenting
584196|NCT01080846|Primary postpartum hemorrhage|primary postpartum hemorrhage
584197|NCT01080846|PPH|pph
584198|NCT01080846|uterine atony|uterine atony
584199|NCT01080846|high fever|high fever
584200|NCT01080846|hyperpyrexia|hyperpyrexia
584201|NCT01080833|EMS|ems
584202|NCT01080833|ERCP|ercp
584203|NCT01080833|Training|training
584204|NCT01080833|Trainees|trainees
584205|NCT01080820|Healthy adult volunteers|healthy adult volunteers
584206|NCT01080820|Pharmacokinetics|pharmacokinetics
584207|NCT01080794|Parkinson's Disease|parkinson's disease
584208|NCT01080794|Depression|depression
584209|NCT01080794|Transcranial Magnetic Stimulation|transcranial magnetic stimulation
584210|NCT01080781|Cardiomyopathy|cardiomyopathy
584211|NCT01080781|Ephrin-B1 expression|ephrin-b1 expression
584212|NCT01080781|cell-cell junctions|cell-cell junctions
584213|NCT01080781|heart rate variability|heart rate variability
584214|NCT01080781|right appendage|right appendage
584215|NCT01080768|Pedal edema|pedal edema
584216|NCT01080768|hypertension|hypertension
584217|NCT01080768|aliskiren|aliskiren
584218|NCT01080768|amlodipine|amlodipine
584219|NCT01080755|Adult Growth Hormone Deficiency|adult growth hormone deficiency
584220|NCT01080755|Pituitary|pituitary
584221|NCT01080755|Saizen|saizen
584222|NCT01080755|Somatropin|somatropin
584223|NCT01080755|Growth Hormone|growth hormone
584224|NCT01080742|Hypertension|hypertension
584225|NCT01080742|Lodoz|lodoz
584226|NCT01080742|Bisoprolol|bisoprolol
584227|NCT01080742|Hydrochlorothiazide|hydrochlorothiazide
584228|NCT01080729|Ovulation induction|ovulation induction
584229|NCT01080729|Ovarian Hyperstimulation Syndrome|ovarian hyperstimulation syndrome
584230|NCT01080729|Multifollicular stimulation|multifollicular stimulation
584231|NCT01080729|Pregnancy|pregnancy
584232|NCT01080729|Sperm injections, intracytoplasmic|sperm injections, intracytoplasmic
584233|NCT01080729|Fertility|fertility
584234|NCT01080703|Lung Transplant|lung transplant
584235|NCT01080703|Quadriceps Strength|quadriceps strength
584236|NCT01080703|Quality of Life|quality of life
711565|NCT00584025|Parkinson's disease|parkinson's disease
584237|NCT01080703|Patients with pulmonary disease awaiting lung transplant.|patients with pulmonary disease awaiting lung transplant.
584238|NCT01080690|endosonography, right side abdominal pain|endosonography, right side abdominal pain
584239|NCT01080690|Endosonography (diagnostic value in right side abdominal pain)|endosonography (diagnostic value in right side abdominal pain)
584240|NCT01080664|AS703569|as703569
584241|NCT01080664|Aurora Kinase Inhibitor|aurora kinase inhibitor
584242|NCT01080664|Haematological malignancies|haematological malignancies
584243|NCT01080638|abciximab|abciximab
584244|NCT01080638|Myocardial Infarction|myocardial infarction
584245|NCT01080638|angioplasty|angioplasty
584246|NCT01080638|Platelet|platelet
584729|NCT01078467|HV|hv
584247|NCT01080625|postreperfusion syndrome|postreperfusion syndrome
584248|NCT01080625|phenylephrine|phenylephrine
584249|NCT01080625|epinephrine|epinephrine
584250|NCT01080625|liver transplantation|liver transplantation
584251|NCT01080612|pregabalin|pregabalin
584252|NCT01080612|pharmacokinetics|pharmacokinetics
584253|NCT01080612|bioavailability|bioavailability
584254|NCT01080599|obturator nerve block in TURB|obturator nerve block in turb
584255|NCT01080586|Bioequivalence study in healthy volunteers|bioequivalence study in healthy volunteers
584256|NCT01080573|Multiple sclerosis|multiple sclerosis
584257|NCT01080573|Rebif|rebif
584258|NCT01080573|Interferon beta-1a|interferon beta-1a
584259|NCT01080560|Bioequivalence study in healthy volunteers|bioequivalence study in healthy volunteers
584260|NCT01080534|Bioequivalence study in healthy volunteers|bioequivalence study in healthy volunteers
584261|NCT01080508|pressure pattern|pressure pattern
584262|NCT01080508|esophageal and tracheal ventilation.|esophageal and tracheal ventilation.
584263|NCT01080508|esophageal intubation.|esophageal intubation.
584264|NCT01080495|left ventricular function|left ventricular function
584265|NCT01080495|radial strain|radial strain
584266|NCT01080495|fractional shortening|fractional shortening
584267|NCT01080495|fractional area change|fractional area change
584268|NCT01080482|Bioequivalence study in healthy volunteers|bioequivalence study in healthy volunteers
584269|NCT01080469|Bioequivalence study in healthy volunteers|bioequivalence study in healthy volunteers
584270|NCT01080456|Bioequivalence study in healthy volunteers|bioequivalence study in healthy volunteers
584271|NCT01080443|Bioequivalence study in healthy volunteers|bioequivalence study in healthy volunteers
584272|NCT01080430|vestibular|vestibular
584273|NCT01080430|vertigo|vertigo
584274|NCT01080430|rehabilitation|rehabilitation
584275|NCT01080430|rotation|rotation
584276|NCT01080430|balance|balance
584277|NCT01080417|Bioequivalence study in healthy volunteers|bioequivalence study in healthy volunteers
584278|NCT01080404|Obstructive sleep apnea|obstructive sleep apnea
584279|NCT01080404|Obesity|obesity
584280|NCT01080404|Metabolism|metabolism
584281|NCT01080404|Bariatric surgery|bariatric surgery
584282|NCT01080404|CPAP|cpap
584283|NCT01080391|Multiple Myeloma|multiple myeloma
584284|NCT01080352|Prostate cancer|prostate cancer
584285|NCT01080352|palliative care|palliative care
584286|NCT01080352|antioxidants|antioxidants
584287|NCT01080352|ascorbic acid|ascorbic acid
584288|NCT01080352|rna expression|rna expression
584289|NCT01080339|insulin resistance|insulin resistance
584290|NCT01080339|cardiovascular risk|cardiovascular risk
584291|NCT01080339|physical activity|physical activity
584292|NCT01080339|child|child
584293|NCT01080326|ulcer repair surgery|ulcer repair surgery
584294|NCT01080326|transluminal omental patch|transluminal omental patch
584295|NCT01080300|Hot Flushes|hot flushes
584296|NCT01080300|Vasomotor Symptoms|vasomotor symptoms
584297|NCT01080300|Menopausal Hot Flashes|menopausal hot flashes
584298|NCT01080287|autonomic|autonomic
584299|NCT01080287|orthostatic|orthostatic
584300|NCT01080287|syncope|syncope
584301|NCT01080287|biopsy|biopsy
584302|NCT01080287|prevalence of autonomic dysfunction in migraineurs with orthostatic intolerance|prevalence of autonomic dysfunction in migraineurs with orthostatic intolerance
584303|NCT01080287|characterize autonomic findings utilizing neurocardiac testing, neurophysiological testing and skin biopsies to analyze autonomic fibers in the dermis|characterize autonomic findings utilizing neurocardiac testing, neurophysiological testing and skin biopsies to analyze autonomic fibers in the dermis
584304|NCT01080274|ergometry|ergometry
584305|NCT01080274|vitamin d|vitamin d
584306|NCT01080274|zinc|zinc
584307|NCT01080261|Atherosclerosis|atherosclerosis
584308|NCT01080261|Coronary Artery Disease|coronary artery disease
584309|NCT01080248|Pancreas|pancreas
584310|NCT01080235|quality improvement|quality improvement
584311|NCT01080235|geriatric care|geriatric care
584312|NCT01080235|residency training|residency training
584313|NCT01080222|VX-950|vx-950
584314|NCT01080196|Falling risk|falling risk
584315|NCT01080196|muscle conditioning|muscle conditioning
584316|NCT01080196|muscle size|muscle size
584317|NCT01080196|isometric strength|isometric strength
584318|NCT01080196|Incidence in falls|incidence in falls
584319|NCT01080183|Health-related quality of life|health-related quality of life
584320|NCT01080183|physical activity|physical activity
584321|NCT01080170|Aromatase Inhibitor|aromatase inhibitor
584322|NCT01080170|Anastrazole|anastrazole
584323|NCT01080170|Arimidex|arimidex
711566|NCT00584025|dyskinesia|dyskinesia
584324|NCT01080170|Heart disease|heart disease
584325|NCT01080170|Lipids|lipids
584326|NCT01080170|Body composition|body composition
584327|NCT01080170|Breast cancer.|breast cancer.
584328|NCT01080157|Diabetes|diabetes
584329|NCT01080157|Diabetes Screening|diabetes screening
584330|NCT01080157|Experimental Medical Device|experimental medical device
584331|NCT01080144|Cirrhosis|cirrhosis
584332|NCT01080144|TIPS (Transjugular intrahepatic portosystemic shunt)|tips (transjugular intrahepatic portosystemic shunt)
584333|NCT01080144|Encephalopathy|encephalopathy
584334|NCT01080131|Frequent flares|frequent flares
584335|NCT01080131|Gout|gout
584336|NCT01080131|Anti-interleukin-1β monoclonal antibody|anti-interleukin-1β monoclonal antibody
584337|NCT01080118|Teaching|teaching
584338|NCT01080118|Video Scope|video scope
584340|NCT01080105|Depression Prevention|depression prevention
584341|NCT01080105|Prevention|prevention
584342|NCT01080105|Major Depressive Disorder|major depressive disorder
584343|NCT01080105|Internet|internet
584344|NCT01080105|Technology Assisted|technology assisted
584345|NCT01080092|smokers|smokers
584346|NCT01080079|Onychomycosis|onychomycosis
584347|NCT01080066|Carcinoma|carcinoma
584348|NCT01080066|Squamous cell|squamous cell
584349|NCT01080066|Erbitux|erbitux
584350|NCT01080066|cetuximab|cetuximab
584351|NCT01080066|Head|head
584352|NCT01080066|Neck|neck
584353|NCT01080053|Multiple Sclerosis, Relapsing Remitting|multiple sclerosis, relapsing remitting
584354|NCT01080053|Sexual dysfunction|sexual dysfunction
584355|NCT01080040|Multiple Sclerosis, Relapsing Remitting|multiple sclerosis, relapsing remitting
584356|NCT01080040|Quality of life|quality of life
584357|NCT01080027|Multiple sclerosis|multiple sclerosis
584358|NCT01080027|Relapsing remitting|relapsing remitting
584359|NCT01080027|Rebif|rebif
584360|NCT01080014|Relapsing-remitting multiple sclerosis (RRMS)|relapsing-remitting multiple sclerosis (rrms)
584361|NCT01080014|primary progressive multiple sclerosis (PPMS)|primary progressive multiple sclerosis (ppms)
584362|NCT01080014|secondary progressive multiple sclerosis (SPMS)|secondary progressive multiple sclerosis (spms)
584363|NCT01080014|Multiple Sclerosis Functional Composite (MSFC)|multiple sclerosis functional composite (msfc)
584364|NCT01080014|Expanded Disability Status Scale (EDSS)|expanded disability status scale (edss)
584365|NCT01080001|Multiple sclerosis|multiple sclerosis
584366|NCT01080001|Multiple sclerosis, Relapsing-remitting|multiple sclerosis, relapsing-remitting
584367|NCT01080001|Expanded Disability Status Scale|expanded disability status scale
584368|NCT01080001|Fatigue|fatigue
584369|NCT01080001|Hamilton Depression Inventory|hamilton depression inventory
584370|NCT01080001|Depression|depression
584371|NCT01079988|Psoriasis|psoriasis
584372|NCT01079988|Discontinuation of efalizumab|discontinuation of efalizumab
584373|NCT01079988|Managing inflammatory recurrence|managing inflammatory recurrence
584374|NCT01079975|Multiple sclerosis|multiple sclerosis
584375|NCT01079975|Depression|depression
584376|NCT01079962|Bisoprolol|bisoprolol
584377|NCT01079962|Atenolol|atenolol
584378|NCT01079962|Hypertension|hypertension
584379|NCT01079962|Blood pressure|blood pressure
584380|NCT01079949|Infertility|infertility
584381|NCT01079949|Ovulation induction|ovulation induction
584382|NCT01079949|Luveris|luveris
584383|NCT01079949|Lutropin alfa|lutropin alfa
584384|NCT01079949|Controlled ovarian stimulation|controlled ovarian stimulation
584385|NCT01079949|Reproductive technologies, Assisted|reproductive technologies, assisted
584386|NCT01079936|Multiple Myeloma|multiple myeloma
584387|NCT01079936|Lenalidomide|lenalidomide
584388|NCT01079936|Revlimid|revlimid
584389|NCT01079936|Melphalan|melphalan
584390|NCT01079936|Alkeran|alkeran
584391|NCT01079936|Autologous stem cell transplantation|autologous stem cell transplantation
584392|NCT01079936|High-dose chemotherapy|high-dose chemotherapy
584393|NCT01079923|healthy volunteers|healthy volunteers
584394|NCT01079923|healthy subjects|healthy subjects
584395|NCT01079923|vitamin D|vitamin d
584396|NCT01079923|cholecalciferol|cholecalciferol
584397|NCT01079923|vitamin D3|vitamin d3
584398|NCT01079923|total vitamin D|total vitamin d
584399|NCT01079910|Plaque|plaque
584400|NCT01079910|Toothpaste|toothpaste
584401|NCT01079910|Gingivitis|gingivitis
584402|NCT01079897|Atopic dermatitis|atopic dermatitis
584403|NCT01079897|Ectoine|ectoine
584404|NCT01079897|Treatment|treatment
584405|NCT01079897|Atopiclair|atopiclair
584406|NCT01079897|Medical device|medical device
584407|NCT01079871|Sjogren's Syndrome|sjogren's syndrome
584408|NCT01079871|Dry Eye|dry eye
584409|NCT01079858|Meibomian Gland Dysfunction|meibomian gland dysfunction
584410|NCT01079858|Dry Eye|dry eye
584411|NCT01079845|Diet|diet
584412|NCT01079845|Nutrition|nutrition
584413|NCT01079845|Adolescent|adolescent
584414|NCT01079845|Young Adult|young adult
584415|NCT01079845|Overweight|overweight
584416|NCT01079845|Obesity|obesity
584417|NCT01079793|adenocarcinoma of the prostate|adenocarcinoma of the prostate
584418|NCT01079793|stage III prostate cancer|stage iii prostate cancer
584419|NCT01079780|mucinous adenocarcinoma of the colon|mucinous adenocarcinoma of the colon
584420|NCT01079780|recurrent colon cancer|recurrent colon cancer
584421|NCT01079780|signet ring adenocarcinoma of the colon|signet ring adenocarcinoma of the colon
584422|NCT01079780|stage III colon cancer|stage iii colon cancer
584423|NCT01079780|stage IV colon cancer|stage iv colon cancer
584424|NCT01079780|mucinous adenocarcinoma of the rectum|mucinous adenocarcinoma of the rectum
584425|NCT01079780|recurrent rectal cancer|recurrent rectal cancer
584426|NCT01079780|signet ring adenocarcinoma of the rectum|signet ring adenocarcinoma of the rectum
584427|NCT01079780|stage III rectal cancer|stage iii rectal cancer
584428|NCT01079780|stage IV rectal cancer|stage iv rectal cancer
584429|NCT01079767|adult primary hepatocellular carcinoma|adult primary hepatocellular carcinoma
584430|NCT01079767|advanced adult primary liver cancer|advanced adult primary liver cancer
584431|NCT01079767|localized unresectable adult primary liver cancer|localized unresectable adult primary liver cancer
584432|NCT01079767|recurrent adult primary liver cancer|recurrent adult primary liver cancer
584433|NCT01079754|Spinal morphine 0.05 mg|spinal morphine 0.05 mg
584434|NCT01079754|Spinal morphine|spinal morphine
584435|NCT01079741|Melanoma|melanoma
584436|NCT01079741|Skin Cancer|skin cancer
584437|NCT01079741|Adjuvant Therapy|adjuvant therapy
584438|NCT01079741|Oncogenesis|oncogenesis
584439|NCT01079741|LAGE|lage
584440|NCT01079741|Cancer Immunity|cancer immunity
584441|NCT01079741|Neoplasms|neoplasms
584442|NCT01079741|Immunogenicity|immunogenicity
584443|NCT01079741|Vaccine|vaccine
584444|NCT01079741|Immunotherapy|immunotherapy
584445|NCT01079728|ischemic stroke|ischemic stroke
584446|NCT01079728|stroke-associated pneumonia|stroke-associated pneumonia
584447|NCT01079728|prediction|prediction
584448|NCT01079728|immune and infection parameters|immune and infection parameters
584449|NCT01079715|Newborn|newborn
584450|NCT01079715|Retinal Diseases|retinal diseases
584451|NCT01079715|Angiogenesis Modulating Agents|angiogenesis modulating agents
584452|NCT01079715|Adrenergic beta-Antagonists|adrenergic beta-antagonists
584453|NCT01079689|basic science|basic science
584454|NCT01079689|healthy volunteers|healthy volunteers
584455|NCT01079650|children|children
584456|NCT01079637|Sella and Barrete Stage 0 1 or 2|sella and barrete stage 0 1 or 2
584457|NCT01079624|Incretin hormones|incretin hormones
584458|NCT01079624|Glucose-insulinotropic peptide|glucose-insulinotropic peptide
584459|NCT01079624|Glucagon-like peptide-1|glucagon-like peptide-1
584460|NCT01079624|Gastric emptying|gastric emptying
584461|NCT01079624|Appetite|appetite
584462|NCT01079624|Glucose disposal|glucose disposal
584463|NCT01079624|Gut hormones|gut hormones
584465|NCT01079598|RadioFrequency|radiofrequency
584466|NCT01079598|QOL|qol
584467|NCT01079572|osteoarthritis|osteoarthritis
584468|NCT01079572|arthroplasty|arthroplasty
584469|NCT01079572|web-based|web-based
584470|NCT01079572|electronic follow-up|electronic follow-up
584471|NCT01079559|total knee arthroplasty|total knee arthroplasty
584472|NCT01079559|infection|infection
584473|NCT01079559|antibiotic bone cement|antibiotic bone cement
584474|NCT01079546|HPV, Israel, Squamous cell carcinoma of head and neck|hpv, israel, squamous cell carcinoma of head and neck
584475|NCT01079533|Colorectal Neoplasms|colorectal neoplasms
584476|NCT01079533|Mass Screening|mass screening
584477|NCT01079533|Patient Compliance|patient compliance
584478|NCT01079533|Intervention Studies|intervention studies
584479|NCT01079533|Clinical Trial|clinical trial
584480|NCT01079520|Cancer|cancer
584481|NCT01079520|Lung Cancer|lung cancer
584482|NCT01079520|Ultrasound|ultrasound
584483|NCT01079520|Surgery|surgery
584484|NCT01079507|single nucleotide polymorphism|single nucleotide polymorphism
584485|NCT01079507|adult acute lymphoblastic leukemia|adult acute lymphoblastic leukemia
584486|NCT01079494|Uncontrolled blood pressure|uncontrolled blood pressure
584487|NCT01079481|Relapsed or Refractory Small Cell Lung Cancer|relapsed or refractory small cell lung cancer
584488|NCT01079481|Paclitaxel|paclitaxel
584489|NCT01079481|Everolimus|everolimus
584490|NCT01079468|Transient cognitive decline following orthopaedic surgery|transient cognitive decline following orthopaedic surgery
584491|NCT01079455|Coxarthrosis|coxarthrosis
584492|NCT01079455|Hip|hip
584493|NCT01079455|Infiltration|infiltration
584494|NCT01079455|Hyaluronic Acid|hyaluronic acid
584495|NCT01079455|Corticosterone|corticosterone
584496|NCT01079442|postoperative ileus after colonic resections|postoperative ileus after colonic resections
584497|NCT01079429|Monoclonal gammopathy of undetermined significance|monoclonal gammopathy of undetermined significance
584498|NCT01079429|MGUS|mgus
584499|NCT01079429|Smoldering myeloma|smoldering myeloma
584500|NCT01079429|SMM|smm
584501|NCT01079429|Multiple myeloma|multiple myeloma
584502|NCT01079416|Esophageal Capsule Endoscopy, Screening|esophageal capsule endoscopy, screening
584503|NCT01079390|acupuncture|acupuncture
584504|NCT01079390|osteoarthritis|osteoarthritis
584505|NCT01079390|fMRI|fmri
584506|NCT01079377|Adolescents|adolescents
584507|NCT01079377|Bariatric Surgery|bariatric surgery
584508|NCT01079377|Psychological Symptoms|psychological symptoms
584509|NCT01079377|Cognitive Behavioral Therapy|cognitive behavioral therapy
584510|NCT01079377|Telemedicine|telemedicine
584511|NCT01079377|Longitudinal|longitudinal
584512|NCT01079351|Epilepsy|epilepsy
584513|NCT01079351|Intravenous Carbamazepine|intravenous carbamazepine
584514|NCT01079351|Oral Carbamazepine|oral carbamazepine
584515|NCT01079338|sensitivity to caffeine|sensitivity to caffeine
584516|NCT01079325|Diabetic neuropathy|diabetic neuropathy
584517|NCT01079325|Diabetes Type 1 or 2|diabetes type 1 or 2
584518|NCT01079325|Moderately severe sensorimotor diabetic polyneuropathy|moderately severe sensorimotor diabetic polyneuropathy
584519|NCT01079312|ERCP|ercp
584520|NCT01079312|patient-controlled sedation|patient-controlled sedation
584521|NCT01079312|propofol|propofol
584522|NCT01079312|remifentanil|remifentanil
584523|NCT01079312|sedation level|sedation level
584524|NCT01079299|venous ulcer|venous ulcer
584525|NCT01079299|secondary lymphedema|secondary lymphedema
584526|NCT01079299|chronic lower leg ulceration|chronic lower leg ulceration
584527|NCT01079286|mTOR inhibition|mtor inhibition
584528|NCT01079286|advanced malignancies|advanced malignancies
584529|NCT01079286|pharmacokinetics|pharmacokinetics
584530|NCT01079286|Akt inhibition|akt inhibition
584656|NCT01078701|replication-deficient influenza virus|replication-deficient influenza virus
584531|NCT01079286|Advanced malignancies, including metastatic renal cell cancer|advanced malignancies, including metastatic renal cell cancer
584532|NCT01079273|Influenza|influenza
584533|NCT01079273|Vaccines|vaccines
584535|NCT01079273|Influenza Vaccines|influenza vaccines
584536|NCT01079260|Malnourished|malnourished
584537|NCT01079260|Elderly|elderly
584538|NCT01079260|Nutrition support|nutrition support
584539|NCT01079247|Burn|burn
584540|NCT01079247|Transfusion|transfusion
584541|NCT01079247|blood|blood
584542|NCT01079247|hemoglobin|hemoglobin
584543|NCT01079221|exercise|exercise
584544|NCT01079221|Knee extensor|knee extensor
584545|NCT01079208|infant formula, synbiotics, probiotics, nutrition|infant formula, synbiotics, probiotics, nutrition
584546|NCT01079195|Effectiveness and tolerability of Tarka|effectiveness and tolerability of tarka
584547|NCT01079195|Hypertensive patients|hypertensive patients
584548|NCT01079195|Diabetes mellitus|diabetes mellitus
584549|NCT01079195|Observational study|observational study
584550|NCT01079182|Daily practice|daily practice
584551|NCT01079182|Humira|humira
584552|NCT01079182|Efficacy|efficacy
584553|NCT01079182|Safety|safety
584554|NCT01079182|Ankylosing spondylitis|ankylosing spondylitis
584555|NCT01079169|urinary tract infection|urinary tract infection
584556|NCT01079169|prevention|prevention
584557|NCT01079169|rehabilitation|rehabilitation
584558|NCT01079169|spinal cord injury|spinal cord injury
584559|NCT01079143|De Novo renal transplantation|de novo renal transplantation
584560|NCT01079130|Indacaterol|indacaterol
584561|NCT01079130|asthma|asthma
584562|NCT01079130|salmeterol|salmeterol
584563|NCT01079117|Opiate|opiate
584564|NCT01079117|Methadone|methadone
584565|NCT01079117|Slow Release Oral Morphine (SORM)|slow release oral morphine (sorm)
584566|NCT01079117|Sevre-Long™|sevre-long™
584567|NCT01079104|Liver failure|liver failure
584568|NCT01079104|Hepatic insufficiency|hepatic insufficiency
584569|NCT01079104|Artificial liver|artificial liver
584570|NCT01079104|Albumin dialysis|albumin dialysis
584571|NCT01079091|Liver failure|liver failure
584572|NCT01079091|Hepatic insufficiency|hepatic insufficiency
584573|NCT01079091|Liver Cirrhosis|liver cirrhosis
584574|NCT01079091|Artificial liver|artificial liver
584575|NCT01079091|Albumin dialysis|albumin dialysis
584576|NCT01079078|Acetaminophen fed study|acetaminophen fed study
584577|NCT01079065|Famotidine tablets fasting study|famotidine tablets fasting study
584578|NCT01079052|Famotidine tablets fed study|famotidine tablets fed study
584579|NCT01079026|biomarker|biomarker
584580|NCT01079026|epidural steroid|epidural steroid
584581|NCT01079026|radiculopathy|radiculopathy
584583|NCT01079000|asthma|asthma
584584|NCT01079000|exacerbation|exacerbation
584585|NCT01079000|emergency department|emergency department
584586|NCT01079000|relapse|relapse
584587|NCT01078987|Nephrogenic Fibrosing Dermopathy (NFD)|nephrogenic fibrosing dermopathy (nfd)
584588|NCT01078987|Nephrogenic Systemic Fibrosis (NSF)|nephrogenic systemic fibrosis (nsf)
584589|NCT01078974|WM|wm
584590|NCT01078974|pomalidomide|pomalidomide
584591|NCT01078974|dexamethasone|dexamethasone
584592|NCT01078974|rituximab|rituximab
584593|NCT01078961|bortezomib|bortezomib
584594|NCT01078961|sorafenib|sorafenib
584595|NCT01078961|advanced melanoma|advanced melanoma
584596|NCT01078948|tDCS|tdcs
584597|NCT01078948|transcranial direct current stimulation|transcranial direct current stimulation
584598|NCT01078948|major depression|major depression
584599|NCT01078948|double-blind|double-blind
584600|NCT01078948|randomized|randomized
584601|NCT01078948|placebo-controlled|placebo-controlled
584602|NCT01078948|treatment|treatment
584603|NCT01078935|Crohn's disease activity index|crohn's disease activity index
584604|NCT01078935|CDAI|cdai
584605|NCT01078922|ofatumumab diffuse B cell non hodgkins lymphoma DLBCL|ofatumumab diffuse b cell non hodgkins lymphoma dlbcl
584606|NCT01078922|refractory DLBCL|refractory dlbcl
584607|NCT01078922|relapsed DLBCL|relapsed dlbcl
584608|NCT01078909|Cardiovascular disease|cardiovascular disease
584609|NCT01078909|Inflammation|inflammation
584610|NCT01078909|Fish Oil|fish oil
584611|NCT01078909|Omega-3 Fatty Acids|omega-3 fatty acids
584612|NCT01078909|LPS|lps
584613|NCT01078909|Endotoxin|endotoxin
584614|NCT01078883|Lung cancer|lung cancer
584615|NCT01078883|Respiratory muscle strength|respiratory muscle strength
584616|NCT01078883|Dyspnea|dyspnea
584617|NCT01078883|Functional capacity|functional capacity
584618|NCT01078870|Negative symptom|negative symptom
584619|NCT01078857|Chronic kidney disease|chronic kidney disease
584620|NCT01078857|Small-fiber neuropathy|small-fiber neuropathy
584621|NCT01078857|Skin biopsy|skin biopsy
584622|NCT01078857|Contact heat evoked potential|contact heat evoked potential
584623|NCT01078857|Autonomic neuropathy|autonomic neuropathy
584624|NCT01078857|Neuropathy in late stage chronic kidney disease|neuropathy in late stage chronic kidney disease
584625|NCT01078844|Autism|autism
584626|NCT01078844|Asperger's Disorder|asperger's disorder
584627|NCT01078844|Pervasive Developmental Disorder NOS|pervasive developmental disorder nos
584628|NCT01078844|Adult|adult
584629|NCT01078844|Memantine|memantine
584630|NCT01078818|Cardiac surgery|cardiac surgery
584631|NCT01078818|Extracorporeal circulation|extracorporeal circulation
584632|NCT01078818|Anaemia|anaemia
584633|NCT01078818|Intravenous iron|intravenous iron
584634|NCT01078818|Oral Iron|oral iron
584635|NCT01078779|Influenza|influenza
584636|NCT01078779|Prevention|prevention
584637|NCT01078779|Chloroquine|chloroquine
584638|NCT01078779|Randomised controlled trial|randomised controlled trial
584639|NCT01078779|Respiratory virus infection|respiratory virus infection
584640|NCT01078766|cerebral palsy|cerebral palsy
584641|NCT01078740|cystic fibrosis|cystic fibrosis
584642|NCT01078740|cystic fibrosis transmembrane conductance regulator|cystic fibrosis transmembrane conductance regulator
584643|NCT01078740|biomarkers|biomarkers
584644|NCT01078740|Intestinal Current Measurement|intestinal current measurement
584645|NCT01078727|Thermal Stimulation|thermal stimulation
584646|NCT01078727|Upper Extremity|upper extremity
584647|NCT01078727|Motor Recovery|motor recovery
584648|NCT01078727|Stroke|stroke
584649|NCT01078714|Autism|autism
584650|NCT01078714|Bumetanide|bumetanide
584651|NCT01078714|GABA|gaba
584652|NCT01078714|NKCC1|nkcc1
584653|NCT01078701|live attenuated flu vaccines|live attenuated flu vaccines
584654|NCT01078701|Influenza A (H1N1)|influenza a (h1n1)
584655|NCT01078701|intranasal application|intranasal application
584657|NCT01078688|Limitations of activities|limitations of activities
584658|NCT01078688|persistent asthma|persistent asthma
584659|NCT01078688|general practitioner|general practitioner
584660|NCT01078688|frequency of limitations of activities|frequency of limitations of activities
584661|NCT01078688|depending on gender and age-group|depending on gender and age-group
584662|NCT01078675|Familial Hypercholesterolaemia|familial hypercholesterolaemia
584663|NCT01078675|pediatric|pediatric
584664|NCT01078662|olaparib|olaparib
584665|NCT01078662|PARP inhibitors|parp inhibitors
584666|NCT01078662|genetic BRCA1 mutation|genetic brca1 mutation
584667|NCT01078662|BRCA2 mutation|brca2 mutation
584668|NCT01078662|solid tumour refractory|solid tumour refractory
584669|NCT01078649|cancer|cancer
584670|NCT01078649|solid tumors|solid tumors
584671|NCT01078649|lymphoma|lymphoma
584672|NCT01078649|smac mimetic|smac mimetic
584673|NCT01078649|IAP inhibitor|iap inhibitor
584674|NCT01078649|Phase I|phase i
584675|NCT01078649|Dose escalation|dose escalation
584676|NCT01078636|amyloid|amyloid
584677|NCT01078636|plaques|plaques
584678|NCT01078636|imaging|imaging
584679|NCT01078636|early detection|early detection
584680|NCT01078636|Amnestic MCI|amnestic mci
584681|NCT01078636|pre-dementia|pre-dementia
584682|NCT01078623|Bronchitis|bronchitis
584683|NCT01078623|Chronic|chronic
584684|NCT01078623|Emphysema|emphysema
584685|NCT01078610|Psoriatic Arthritis|psoriatic arthritis
584686|NCT01078610|Long-term Observation|long-term observation
584687|NCT01078610|Humira|humira
584688|NCT01078610|Safety|safety
584689|NCT01078610|Effectiveness|effectiveness
584690|NCT01078610|Quality of Life|quality of life
584691|NCT01078610|Work Productivity|work productivity
584692|NCT01078597|anti-MCV|anti-mcv
584693|NCT01078597|anti-CCP|anti-ccp
584694|NCT01078597|Biomarkers|biomarkers
584695|NCT01078597|Rheumatoid Arthritis|rheumatoid arthritis
584696|NCT01078584|Uncontrolled hypertension|uncontrolled hypertension
584697|NCT01078584|trandolapril|trandolapril
584698|NCT01078571|Rheumatoid Arthritis|rheumatoid arthritis
584699|NCT01078571|Biologic|biologic
584700|NCT01078571|Tumor Necrosis Factors blockers agents Monoclonal antibody|tumor necrosis factors blockers agents monoclonal antibody
584701|NCT01078558|Multicenter study|multicenter study
584702|NCT01078545|Prostate cancer|prostate cancer
584703|NCT01078545|Lower urinary tract symptoms|lower urinary tract symptoms
584704|NCT01078545|Hormonotherapy|hormonotherapy
584705|NCT01078545|LHRH analogue|lhrh analogue
584706|NCT01078545|Androgen deprivation therapy (ADT)|androgen deprivation therapy (adt)
584707|NCT01078532|medically complex diseases that increase cardiovascular risk|medically complex diseases that increase cardiovascular risk
584708|NCT01078519|Fever|fever
584709|NCT01078519|anesthesia|anesthesia
584710|NCT01078519|Labor|labor
584711|NCT01078506|Chinese|chinese
584712|NCT01078506|intracranial aneurysm|intracranial aneurysm
584713|NCT01078506|magnetic resonance imaging|magnetic resonance imaging
584714|NCT01078493|Platelet rich plasma|platelet rich plasma
584715|NCT01078493|PRP|prp
584716|NCT01078493|wrinkles|wrinkles
584717|NCT01078493|MyCells®|mycells®
584718|NCT01078493|CREATE|create
584719|NCT01078493|Life Source Medical Centre|life source medical centre
584720|NCT01078493|Dr Tan Kok leong|dr tan kok leong
584721|NCT01078480|Fracture|fracture
584722|NCT01078480|Collar bone|collar bone
584723|NCT01078467|Wound Healing|wound healing
584724|NCT01078467|Oral Wounds|oral wounds
584725|NCT01078467|Cutaneous Wounds|cutaneous wounds
584726|NCT01078467|Gene Array Analysis|gene array analysis
584727|NCT01078467|Proteomic Analysis|proteomic analysis
584728|NCT01078467|Healthy Volunteer|healthy volunteer
584730|NCT01078454|Melphalan|melphalan
584731|NCT01078454|Dexamethasone|dexamethasone
584732|NCT01078454|Bortezomib|bortezomib
584733|NCT01078454|Systemic Light-chain (AL) Amyloidosis|systemic light-chain (al) amyloidosis
584734|NCT01078441|Bortezomib|bortezomib
584735|NCT01078441|Liposomal Doxorubicin|liposomal doxorubicin
584736|NCT01078441|Dexamethasone|dexamethasone
584737|NCT01078441|Cyclophosphamide|cyclophosphamide
584738|NCT01078441|refractory multiple myeloma|refractory multiple myeloma
584739|NCT01078428|Hypertrophic scars|hypertrophic scars
584740|NCT01078428|Topical silicone gel|topical silicone gel
584741|NCT01078428|Scar thickness|scar thickness
584742|NCT01078428|Scar Color|scar color
584743|NCT01078428|Scar pliability|scar pliability
584744|NCT01078428|Scar appearance|scar appearance
584745|NCT01078415|HCC|hcc
584746|NCT01078415|Hepatocellular Carcinoma|hepatocellular carcinoma
584747|NCT01078415|Early Stage|early stage
584748|NCT01078415|Prospective|prospective
584749|NCT01078415|Multicenter|multicenter
584750|NCT01078415|Irreversible Electroporation (IRE)|irreversible electroporation (ire)
584751|NCT01078415|Electroporation|electroporation
584752|NCT01078415|Low Energy Direct Current|low energy direct current
584753|NCT01078415|LEDC|ledc
584754|NCT01078415|Nonthermal ablation|nonthermal ablation
584755|NCT01078415|NTIRE (nonthermal IRE)|ntire (nonthermal ire)
584756|NCT01078415|Ablation|ablation
584757|NCT01078415|Soft Tissue|soft tissue
584758|NCT01078402|Treatment compliance and tolerability of Humira in patients|treatment compliance and tolerability of humira in patients
584759|NCT01078402|Eastern European countries|eastern european countries
584760|NCT01078402|Rheumatoid Arthritis|rheumatoid arthritis
584761|NCT01078402|Psoriatic Arthritis|psoriatic arthritis
584762|NCT01078402|Adalimumab|adalimumab
584763|NCT01078402|Ankylosing Spondylitis|ankylosing spondylitis
584764|NCT01078402|Evaluation of clinical outcome|evaluation of clinical outcome
584765|NCT01078389|Gout|gout
584766|NCT01078389|Hyperuricemia|hyperuricemia
584767|NCT01078389|Uric Acid|uric acid
584768|NCT01078389|Drug Therapy|drug therapy
584769|NCT01078376|Pediatrics|pediatrics
584770|NCT01078376|Blood Pressure, High|blood pressure, high
584771|NCT01078376|Drug Therapy|drug therapy
584772|NCT01078363|Heart Transplantation|heart transplantation
584773|NCT01078350|Lymphoma|lymphoma
584774|NCT01078350|Hodgkin Disease|hodgkin disease
584775|NCT01078311|Patients with advanced hepatocellular cancer|patients with advanced hepatocellular cancer
584776|NCT01078298|smoking|smoking
584777|NCT01078298|smoking cessation|smoking cessation
584778|NCT01078298|smoking cessation in depressed subjects|smoking cessation in depressed subjects
584779|NCT01078285|Integrated program on adherence using counseling|integrated program on adherence using counseling
584780|NCT01078285|support services including cost-sharing where appropriate and educational materials mailed monthly.|support services including cost-sharing where appropriate and educational materials mailed monthly.
584781|NCT01078272|Coronary Atherosclerosis|coronary atherosclerosis
584782|NCT01078272|Percutaneous Coronary Intervention|percutaneous coronary intervention
584783|NCT01078272|Coronary Stenting|coronary stenting
584784|NCT01078272|Coronary Stenosis|coronary stenosis
584785|NCT01078272|Remote Ischemic Preconditioning|remote ischemic preconditioning
584787|NCT01078233|HIV|hiv
584788|NCT01078233|antiretroviral treatment|antiretroviral treatment
584789|NCT01078233|HIV Cohort|hiv cohort
584790|NCT01078233|Treatment|treatment
584791|NCT01078220|Human Papillomavirus (HPV)|human papillomavirus (hpv)
584792|NCT01078194|Weight regain|weight regain
584793|NCT01078194|Weight loss failure|weight loss failure
584794|NCT01078194|Gastric bypass|gastric bypass
584795|NCT01078181|gastric bypass|gastric bypass
584796|NCT01078181|banded gastric bypass|banded gastric bypass
584797|NCT01078181|weight loss|weight loss
584798|NCT01078181|weight regain|weight regain
584799|NCT01078181|bariatric surgery|bariatric surgery
584800|NCT01078168|Alzheimer`s Disease|alzheimer`s disease
584801|NCT01078155|Bone mineral density|bone mineral density
584802|NCT01078155|Bone turnover markers|bone turnover markers
584803|NCT01078155|Rheumatoid arthritis|rheumatoid arthritis
584804|NCT01078155|Osteoporosis|osteoporosis
584805|NCT01078142|temsirolimus|temsirolimus
584806|NCT01078142|bendamustine|bendamustine
584807|NCT01078142|rituximab|rituximab
584808|NCT01078142|mantle cell lymphoma|mantle cell lymphoma
584809|NCT01078142|follicular lymphoma|follicular lymphoma
584810|NCT01078129|cognitive deficits|cognitive deficits
584811|NCT01078116|Rheumatoid Arthritis|rheumatoid arthritis
584812|NCT01078116|Adalimumab treatment|adalimumab treatment
584813|NCT01078116|Evaluation of the patients' Health Related Quality of Life|evaluation of the patients' health related quality of life
584814|NCT01078116|Cost of the disease management|cost of the disease management
584815|NCT01078103|Diabetes Mellitus|diabetes mellitus
584816|NCT01078103|cornea endothelium|cornea endothelium
584817|NCT01078103|cell loss|cell loss
584818|NCT01078103|cataract surgery|cataract surgery
584819|NCT01078090|Safety|safety
584820|NCT01078090|Rheumatoid Arthritis|rheumatoid arthritis
584821|NCT01078090|Effectiveness|effectiveness
584822|NCT01078077|healthy females ages twentyfive through sixty|healthy females ages twentyfive through sixty
585253|NCT01076452|tremor|tremor
584823|NCT01078064|Gastroesophageal reflux disease, gastric motility|gastroesophageal reflux disease, gastric motility
584824|NCT01078051|chronic total occlusion|chronic total occlusion
584826|NCT01078051|medical therapy|medical therapy
584827|NCT01078038|Coronary Artery Disease|coronary artery disease
584828|NCT01078038|Stent|stent
584829|NCT01078025|transvaginal access for cholecystectomy|transvaginal access for cholecystectomy
584830|NCT01077999|chemoradiation|chemoradiation
584831|NCT01077999|panitumumab|panitumumab
584832|NCT01077999|esophageal cancer|esophageal cancer
584833|NCT01077999|Resectable squamous cell carcinoma, adenocarcinoma or undifferentiated carcinoma of the intrathoracic esophagus or gastro esophageal junction|resectable squamous cell carcinoma, adenocarcinoma or undifferentiated carcinoma of the intrathoracic esophagus or gastro esophageal junction
584834|NCT01077986|mTOR inhibition|mtor inhibition
584835|NCT01077986|EGFR inhibition|egfr inhibition
584836|NCT01077986|pancreatic cancer|pancreatic cancer
584837|NCT01077986|pharmacodynamics|pharmacodynamics
584838|NCT01077973|Headache|headache
584839|NCT01077960|Serostim|serostim
584840|NCT01077960|HARS|hars
584841|NCT01077947|low back pain|low back pain
584842|NCT01077947|spinal fusion|spinal fusion
584843|NCT01077947|Primarily axial low back pain|primarily axial low back pain
584844|NCT01077934|All Patients admitted to Grady Memorial Hospital with Unilateral Lower leg injury at risk for compartment syndrome|all patients admitted to grady memorial hospital with unilateral lower leg injury at risk for compartment syndrome
584845|NCT01077921|sickle|sickle
584846|NCT01077921|adhesion|adhesion
584847|NCT01077921|propranolol|propranolol
584848|NCT01077908|Adoptive cellular therapy|adoptive cellular therapy
584849|NCT01077908|Hematopoietic Stem Cell Transplantation|hematopoietic stem cell transplantation
584850|NCT01077895|Critically ill patients with positive fluid balance, IAH and AKI requiring RRT|critically ill patients with positive fluid balance, iah and aki requiring rrt
584851|NCT01077882|Moderate and severe psoriasis and atopic dermatitis|moderate and severe psoriasis and atopic dermatitis
584852|NCT01077869|oropharynx and lymph node metastases from an unknown primary tumor|oropharynx and lymph node metastases from an unknown primary tumor
584853|NCT01077856|congenital anomaly|congenital anomaly
584854|NCT01077856|pregnancy|pregnancy
584855|NCT01077856|GARDASIL®|gardasil®
584856|NCT01077856|Nordic|nordic
584857|NCT01077856|population-based|population-based
584858|NCT01077843|Ankylosing Spondylitis|ankylosing spondylitis
584859|NCT01077830|New Incidence of Cancer|new incidence of cancer
584860|NCT01077791|Schizophrenia|schizophrenia
584861|NCT01077791|social cognition|social cognition
584862|NCT01077791|theory of mind|theory of mind
584863|NCT01077791|cognitive therapy|cognitive therapy
584864|NCT01077791|therapeutic trial|therapeutic trial
584865|NCT01077791|magnetoencephalography (MEG)|magnetoencephalography (meg)
584866|NCT01077778|Magnetic Resonance Imaging/methods|magnetic resonance imaging/methods
584867|NCT01077778|Magnetic Resonance Angiography|magnetic resonance angiography
584868|NCT01077778|Perfusion Imaging|perfusion imaging
584869|NCT01077778|Pulmonary Embolism/diagnosis|pulmonary embolism/diagnosis
584870|NCT01077765|HIV-associated Lipodystrophy|hiv-associated lipodystrophy
584871|NCT01077765|Polyacrylamide hydrogel|polyacrylamide hydrogel
584872|NCT01077752|Pain, postoperative|pain, postoperative
584873|NCT01077752|Local infiltration|local infiltration
584874|NCT01077752|Hyperalgesia, postoperative|hyperalgesia, postoperative
584875|NCT01077752|Local anesthetic, ropivacaine, lidocaine|local anesthetic, ropivacaine, lidocaine
584876|NCT01077752|Colorectal laparoscopic surgery|colorectal laparoscopic surgery
584877|NCT01077752|Pain management after colorectal laparoscopic surgery|pain management after colorectal laparoscopic surgery
584878|NCT01077687|schizophrenia|schizophrenia
584879|NCT01077687|genome-wide association study (GWAS)|genome-wide association study (gwas)
584880|NCT01077687|single-nucleotide polymorphisms (SNPs)|single-nucleotide polymorphisms (snps)
584881|NCT01077687|Han Chinese population|han chinese population
584882|NCT01077687|trio families|trio families
584883|NCT01077687|Schizophrenia with trio families|schizophrenia with trio families
584884|NCT01077674|Electroencephalogram|electroencephalogram
584885|NCT01077674|Entropy|entropy
584886|NCT01077674|BIS|bis
743461|NCT00461864|hip|hip
584887|NCT01077674|Sevoflurane|sevoflurane
584888|NCT01077661|Nebivolol|nebivolol
584889|NCT01077661|PMS (post-marketing surveillance)|pms (post-marketing surveillance)
584890|NCT01077648|Breast Cancer|breast cancer
584891|NCT01077648|Treatment|treatment
584892|NCT01077648|Brain metastases|brain metastases
584893|NCT01077648|ErbB2 expression|erbb2 expression
584894|NCT01077635|HIV|hiv
584895|NCT01077635|Antiretroviral therapy|antiretroviral therapy
584896|NCT01077635|protease inbitor|protease inbitor
584897|NCT01077635|fosamprenavir|fosamprenavir
584898|NCT01077635|paediatrics|paediatrics
584899|NCT01077609|Intranasal steroids|intranasal steroids
584900|NCT01077609|beclometasone diproprionate|beclometasone diproprionate
584901|NCT01077609|steroid-related outcomes|steroid-related outcomes
584902|NCT01077596|Carcinogenicity|carcinogenicity
584903|NCT01077596|Case control|case control
584904|NCT01077596|Bupropion|bupropion
584905|NCT01077583|Pregnancy test|pregnancy test
584906|NCT01077583|Wishing to become pregnant|wishing to become pregnant
584907|NCT01077557|Combivir (Zidovudine+Lamivudine)|combivir (zidovudine+lamivudine)
584908|NCT01077557|Trizivir (Abacavir+Lamivudine+Zidovudine)|trizivir (abacavir+lamivudine+zidovudine)
584909|NCT01077557|Zidovudine|zidovudine
584910|NCT01077557|Epzicom (Abacavir+Lamivudine)|epzicom (abacavir+lamivudine)
584911|NCT01077557|Fracture|fracture
584912|NCT01077557|Amprenavir|amprenavir
584913|NCT01077557|human immunodeficiency virus (HIV) infection|human immunodeficiency virus (hiv) infection
584914|NCT01077557|antiretroviral (ARV) therapy|antiretroviral (arv) therapy
584915|NCT01077557|Lamivudine|lamivudine
584916|NCT01077557|incidence|incidence
584917|NCT01077557|Abacavir|abacavir
584918|NCT01077557|risk|risk
584919|NCT01077557|Fosamprenavir|fosamprenavir
584920|NCT01077544|Chronic Myeloid Leukemia|chronic myeloid leukemia
584921|NCT01077544|Acute Lymphoblastic Leukemia|acute lymphoblastic leukemia
584922|NCT01077544|Ph+ CML|ph+ cml
584923|NCT01077544|Ph+ ALL|ph+ all
584924|NCT01077544|pediatric|pediatric
584925|NCT01077544|nilotinib|nilotinib
584926|NCT01077544|imatinib|imatinib
584927|NCT01077544|chronic phase|chronic phase
584928|NCT01077544|accelerated phase|accelerated phase
584929|NCT01077544|newly diagnosed Ph+ CML|newly diagnosed ph+ cml
584930|NCT01077544|dasatinib|dasatinib
584931|NCT01077531|Rheumatoid arthritis|rheumatoid arthritis
584932|NCT01077531|intravenous infusion|intravenous infusion
584933|NCT01077531|long-term followup|long-term followup
584934|NCT01077518|Refractory|refractory
584935|NCT01077518|Safety|safety
584936|NCT01077518|Efficacy|efficacy
584937|NCT01077518|Rituximab refractory|rituximab refractory
584938|NCT01077518|Oncology|oncology
584939|NCT01077505|pharmacokinetics|pharmacokinetics
584940|NCT01077505|GSK716155|gsk716155
584941|NCT01077505|Brevicon|brevicon
584942|NCT01077505|albiglutide|albiglutide
584943|NCT01077505|healthy female volunteers|healthy female volunteers
584944|NCT01077505|oral contraceptive|oral contraceptive
584945|NCT01077492|lung cancer|lung cancer
584946|NCT01077492|mediastinal lymph nodes|mediastinal lymph nodes
584947|NCT01077492|TBNA|tbna
584948|NCT01077492|staging lung cancer|staging lung cancer
584949|NCT01077479|body fat mass gain|body fat mass gain
584950|NCT01077479|Insulin resistance|insulin resistance
584951|NCT01077466|Primary Progressive Multiple Sclerosis|primary progressive multiple sclerosis
584952|NCT01077466|Secondary Progressive Multiple Sclerosis|secondary progressive multiple sclerosis
584953|NCT01077466|Natalizumab|natalizumab
584954|NCT01077466|Treatment|treatment
584955|NCT01077466|Safety|safety
584956|NCT01077466|Efficacy|efficacy
584957|NCT01077466|Cerebrospinal fluid|cerebrospinal fluid
584958|NCT01077466|Osteopontin|osteopontin
584959|NCT01077440|cancer survivor|cancer survivor
584960|NCT01077440|stage III adult Burkitt lymphoma|stage iii adult burkitt lymphoma
584961|NCT01077440|stage III adult diffuse large cell lymphoma|stage iii adult diffuse large cell lymphoma
584962|NCT01077440|stage III adult diffuse mixed cell lymphoma|stage iii adult diffuse mixed cell lymphoma
584963|NCT01077440|stage III adult diffuse small cleaved cell lymphoma|stage iii adult diffuse small cleaved cell lymphoma
584964|NCT01077440|stage III adult Hodgkin lymphoma|stage iii adult hodgkin lymphoma
584965|NCT01077440|stage III adult immunoblastic large cell lymphoma|stage iii adult immunoblastic large cell lymphoma
584966|NCT01077440|stage III adult lymphoblastic lymphoma|stage iii adult lymphoblastic lymphoma
584967|NCT01077440|stage III grade 1 follicular lymphoma|stage iii grade 1 follicular lymphoma
584968|NCT01077440|stage III grade 2 follicular lymphoma|stage iii grade 2 follicular lymphoma
584969|NCT01077440|stage III grade 3 follicular lymphoma|stage iii grade 3 follicular lymphoma
584970|NCT01077440|stage III mantle cell lymphoma|stage iii mantle cell lymphoma
584971|NCT01077440|stage III marginal zone lymphoma|stage iii marginal zone lymphoma
584972|NCT01077440|stage III small lymphocytic lymphoma|stage iii small lymphocytic lymphoma
584973|NCT01077440|stage IV adult Burkitt lymphoma|stage iv adult burkitt lymphoma
584974|NCT01077440|stage IV adult diffuse large cell lymphoma|stage iv adult diffuse large cell lymphoma
711567|NCT00584025|levetiracetam|levetiracetam
743581|NCT00461422|IVF|ivf
584975|NCT01077440|stage IV adult diffuse mixed cell lymphoma|stage iv adult diffuse mixed cell lymphoma
584976|NCT01077440|stage IV adult diffuse small cleaved cell lymphoma|stage iv adult diffuse small cleaved cell lymphoma
584977|NCT01077440|stage IV adult Hodgkin lymphoma|stage iv adult hodgkin lymphoma
584978|NCT01077440|stage IV adult immunoblastic large cell lymphoma|stage iv adult immunoblastic large cell lymphoma
584979|NCT01077440|stage IV adult lymphoblastic lymphoma|stage iv adult lymphoblastic lymphoma
584980|NCT01077440|stage IV grade 1 follicular lymphoma|stage iv grade 1 follicular lymphoma
584981|NCT01077440|stage IV grade 2 follicular lymphoma|stage iv grade 2 follicular lymphoma
584982|NCT01077440|stage IV grade 3 follicular lymphoma|stage iv grade 3 follicular lymphoma
584983|NCT01077440|stage IV mantle cell lymphoma|stage iv mantle cell lymphoma
584984|NCT01077440|stage IV marginal zone lymphoma|stage iv marginal zone lymphoma
584985|NCT01077440|stage IV small lymphocytic lymphoma|stage iv small lymphocytic lymphoma
584986|NCT01077440|recurrent adult Burkitt lymphoma|recurrent adult burkitt lymphoma
584987|NCT01077440|recurrent adult diffuse large cell lymphoma|recurrent adult diffuse large cell lymphoma
584988|NCT01077440|recurrent adult diffuse mixed cell lymphoma|recurrent adult diffuse mixed cell lymphoma
584989|NCT01077440|recurrent adult diffuse small cleaved cell lymphoma|recurrent adult diffuse small cleaved cell lymphoma
584990|NCT01077440|recurrent adult Hodgkin lymphoma|recurrent adult hodgkin lymphoma
585254|NCT01076452|dyskinesia|dyskinesia
584991|NCT01077440|recurrent adult immunoblastic large cell lymphoma|recurrent adult immunoblastic large cell lymphoma
584992|NCT01077440|recurrent adult lymphoblastic lymphoma|recurrent adult lymphoblastic lymphoma
584993|NCT01077440|recurrent cutaneous T-cell non-Hodgkin lymphoma|recurrent cutaneous t-cell non-hodgkin lymphoma
584994|NCT01077440|recurrent grade 1 follicular lymphoma|recurrent grade 1 follicular lymphoma
584995|NCT01077440|recurrent grade 2 follicular lymphoma|recurrent grade 2 follicular lymphoma
584996|NCT01077440|recurrent grade 3 follicular lymphoma|recurrent grade 3 follicular lymphoma
584997|NCT01077440|recurrent mantle cell lymphoma|recurrent mantle cell lymphoma
584998|NCT01077440|recurrent marginal zone lymphoma|recurrent marginal zone lymphoma
584999|NCT01077440|recurrent small lymphocytic lymphoma|recurrent small lymphocytic lymphoma
585000|NCT01077440|recurrent mycosis fungoides/Sezary syndrome|recurrent mycosis fungoides/sezary syndrome
585001|NCT01077440|extranodal marginal zone B-cell lymphoma of mucosa-associated lymphoid tissue|extranodal marginal zone b-cell lymphoma of mucosa-associated lymphoid tissue
585002|NCT01077440|nodal marginal zone B-cell lymphoma|nodal marginal zone b-cell lymphoma
585003|NCT01077440|splenic marginal zone lymphoma|splenic marginal zone lymphoma
585004|NCT01077440|noncontiguous stage II adult Burkitt lymphoma|noncontiguous stage ii adult burkitt lymphoma
585005|NCT01077440|noncontiguous stage II adult diffuse large cell lymphoma|noncontiguous stage ii adult diffuse large cell lymphoma
585006|NCT01077440|noncontiguous stage II adult diffuse mixed cell lymphoma|noncontiguous stage ii adult diffuse mixed cell lymphoma
585007|NCT01077440|noncontiguous stage II adult diffuse small cleaved cell lymphoma|noncontiguous stage ii adult diffuse small cleaved cell lymphoma
585008|NCT01077440|noncontiguous stage II adult immunoblastic large cell lymphoma|noncontiguous stage ii adult immunoblastic large cell lymphoma
585009|NCT01077440|noncontiguous stage II adult lymphoblastic lymphoma|noncontiguous stage ii adult lymphoblastic lymphoma
585010|NCT01077440|noncontiguous stage II grade 1 follicular lymphoma|noncontiguous stage ii grade 1 follicular lymphoma
585011|NCT01077440|noncontiguous stage II grade 2 follicular lymphoma|noncontiguous stage ii grade 2 follicular lymphoma
585012|NCT01077440|noncontiguous stage II grade 3 follicular lymphoma|noncontiguous stage ii grade 3 follicular lymphoma
585013|NCT01077440|noncontiguous stage II mantle cell lymphoma|noncontiguous stage ii mantle cell lymphoma
585014|NCT01077440|noncontiguous stage II marginal zone lymphoma|noncontiguous stage ii marginal zone lymphoma
585015|NCT01077440|noncontiguous stage II small lymphocytic lymphoma|noncontiguous stage ii small lymphocytic lymphoma
585016|NCT01077440|accelerated phase chronic myelogenous leukemia|accelerated phase chronic myelogenous leukemia
585017|NCT01077440|adult acute lymphoblastic leukemia in remission|adult acute lymphoblastic leukemia in remission
585018|NCT01077440|adult acute myeloid leukemia in remission|adult acute myeloid leukemia in remission
585019|NCT01077440|adult acute myeloid leukemia with 11q23 (MLL) abnormalities|adult acute myeloid leukemia with 11q23 (mll) abnormalities
585020|NCT01077440|adult acute myeloid leukemia with inv(16)(p13;q22)|adult acute myeloid leukemia with inv(16)(p13;q22)
585021|NCT01077440|adult acute myeloid leukemia with t(15;17)(q22;q12)|adult acute myeloid leukemia with t(15;17)(q22;q12)
585022|NCT01077440|adult acute myeloid leukemia with t(16;16)(p13;q22)|adult acute myeloid leukemia with t(16;16)(p13;q22)
585023|NCT01077440|adult acute myeloid leukemia with t(8;21)(q22;q22)|adult acute myeloid leukemia with t(8;21)(q22;q22)
585024|NCT01077440|atypical chronic myeloid leukemia, BCR-ABL negative|atypical chronic myeloid leukemia, bcr-abl negative
585025|NCT01077440|blastic phase chronic myelogenous leukemia|blastic phase chronic myelogenous leukemia
585026|NCT01077440|chronic myelomonocytic leukemia|chronic myelomonocytic leukemia
585027|NCT01077440|chronic phase chronic myelogenous leukemia|chronic phase chronic myelogenous leukemia
585028|NCT01077440|recurrent adult acute lymphoblastic leukemia|recurrent adult acute lymphoblastic leukemia
585029|NCT01077440|recurrent adult acute myeloid leukemia|recurrent adult acute myeloid leukemia
585030|NCT01077440|refractory chronic lymphocytic leukemia|refractory chronic lymphocytic leukemia
585031|NCT01077440|refractory hairy cell leukemia|refractory hairy cell leukemia
585032|NCT01077440|relapsing chronic myelogenous leukemia|relapsing chronic myelogenous leukemia
585033|NCT01077440|secondary acute myeloid leukemia|secondary acute myeloid leukemia
585034|NCT01077440|stage III chronic lymphocytic leukemia|stage iii chronic lymphocytic leukemia
585035|NCT01077440|stage IV chronic lymphocytic leukemia|stage iv chronic lymphocytic leukemia
585036|NCT01077440|chronic eosinophilic leukemia|chronic eosinophilic leukemia
585037|NCT01077440|primary myelofibrosis|primary myelofibrosis
585038|NCT01077440|chronic neutrophilic leukemia|chronic neutrophilic leukemia
585039|NCT01077440|de novo myelodysplastic syndromes|de novo myelodysplastic syndromes
585040|NCT01077440|disseminated neuroblastoma|disseminated neuroblastoma
585041|NCT01077440|myelodysplastic/myeloproliferative neoplasm, unclassifiable|myelodysplastic/myeloproliferative neoplasm, unclassifiable
585042|NCT01077440|previously treated myelodysplastic syndromes|previously treated myelodysplastic syndromes
585043|NCT01077440|recurrent neuroblastoma|recurrent neuroblastoma
585044|NCT01077440|recurrent malignant testicular germ cell tumor|recurrent malignant testicular germ cell tumor
585045|NCT01077440|secondary myelodysplastic syndromes|secondary myelodysplastic syndromes
585046|NCT01077440|stage I multiple myeloma|stage i multiple myeloma
585047|NCT01077440|stage II multiple myeloma|stage ii multiple myeloma
585048|NCT01077440|stage III multiple myeloma|stage iii multiple myeloma
585049|NCT01077440|stage III malignant testicular germ cell tumor|stage iii malignant testicular germ cell tumor
585050|NCT01077440|refractory multiple myeloma|refractory multiple myeloma
585051|NCT01077427|pancreatic cancer|pancreatic cancer
585052|NCT01077427|adjuvant treatment|adjuvant treatment
585053|NCT01077427|hyperthermia|hyperthermia
585054|NCT01077414|Psychosocial Functioning|psychosocial functioning
585055|NCT01077414|Psychosocial Stress|psychosocial stress
585056|NCT01077414|Palliative Care|palliative care
585057|NCT01077414|Spirituality|spirituality
585058|NCT01077414|Cancer|cancer
585059|NCT01077401|Diabetic|diabetic
585060|NCT01077401|edema|edema
585062|NCT01077388|CVD|cvd
585063|NCT01077388|uncontrolled HTN|uncontrolled htn
585064|NCT01077375|Milnacipran|milnacipran
585065|NCT01077375|Duloxetine|duloxetine
585066|NCT01077375|Switch|switch
585067|NCT01077375|Forest Research Institute|forest research institute
585068|NCT01077362|Ustekinumab|ustekinumab
585069|NCT01077362|CNTO 1275|cnto 1275
585070|NCT01077362|Stelara|stelara
585071|NCT01077362|Psoriatic Arthritis|psoriatic arthritis
585072|NCT01077362|Psoriasis|psoriasis
585073|NCT01077362|TNF alpha|tnf alpha
585074|NCT01077349|Cardiac surgery|cardiac surgery
585075|NCT01077349|Shock|shock
585076|NCT01077349|Continuous Veno-Venous Haemofiltration|continuous veno-venous haemofiltration
585077|NCT01077349|Continuous Renal Replacement Therapy|continuous renal replacement therapy
585078|NCT01077349|Renal Insufficiency|renal insufficiency
585079|NCT01077349|Acute|acute
585080|NCT01077336|susceptibility testing|susceptibility testing
585081|NCT01077323|pancreatitis|pancreatitis
585082|NCT01077323|exenatide|exenatide
585083|NCT01077323|Byetta|byetta
585084|NCT01077323|Amylin|amylin
585085|NCT01077323|Lilly|lilly
585086|NCT01077310|HIV|hiv
585087|NCT01077310|Acquired Immunodeficiency Syndrome|acquired immunodeficiency syndrome
585088|NCT01077310|Alcohol dependence|alcohol dependence
585089|NCT01077310|CD4|cd4
585090|NCT01077310|HIV-1 RNA|hiv-1 rna
585091|NCT01077310|Alcohol treatment outcomes|alcohol treatment outcomes
585092|NCT01077284|Kidney Calculi|kidney calculi
585093|NCT01077284|Kidney Stones|kidney stones
585094|NCT01077284|Nephrolithiasis|nephrolithiasis
585095|NCT01077284|Drug Therapy|drug therapy
585096|NCT01077284|Uric Acid|uric acid
585097|NCT01077271|Premature infants|premature infants
585098|NCT01077271|Respiratory Syncytial Virus (RSV)|respiratory syncytial virus (rsv)
585099|NCT01077271|Compliance|compliance
585100|NCT01077271|Palivizumab|palivizumab
585101|NCT01077258|Safety|safety
585102|NCT01077258|Long-term observation|long-term observation
585103|NCT01077258|Routine Clinical Setting|routine clinical setting
585104|NCT01077258|Rheumatoid Arthritis|rheumatoid arthritis
585105|NCT01077258|Effectiveness|effectiveness
585106|NCT01077245|Clostridium difficile|clostridium difficile
585107|NCT01077245|Clostridium Infections|clostridium infections
585108|NCT01077245|Gram-Positive Bacterial Infections|gram-positive bacterial infections
585109|NCT01077245|Bacterial Infections|bacterial infections
585110|NCT01077245|Anti-Infective Agents|anti-infective agents
585111|NCT01077245|Clostridium butyricum|clostridium butyricum
585112|NCT01077245|Metronidazole|metronidazole
585113|NCT01077245|Vancomycin|vancomycin
585114|NCT01077245|Gastrointestinal Diseases|gastrointestinal diseases
585115|NCT01077245|Physiological Effects of Drugs|physiological effects of drugs
585116|NCT01077245|Colonic Diseases|colonic diseases
585117|NCT01077245|Enterocolitis, Pseudomembranous|enterocolitis, pseudomembranous
585118|NCT01077245|Intestinal Diseases|intestinal diseases
585119|NCT01077245|Enterocolitis|enterocolitis
585120|NCT01077245|Pharmacologic Actions|pharmacologic actions
585121|NCT01077245|Digestive System Diseases|digestive system diseases
585122|NCT01077245|Therapeutic Uses|therapeutic uses
585123|NCT01077245|Gastroenteritis|gastroenteritis
585124|NCT01077245|Colitis|colitis
585125|NCT01077245|Diarrhea|diarrhea
585126|NCT01077245|Probiotics|probiotics
585127|NCT01077245|Gastrointestinal Agents|gastrointestinal agents
585128|NCT01077232|Moderate to Severe Plaque Psoriasis|moderate to severe plaque psoriasis
585129|NCT01077232|Humira|humira
585130|NCT01077232|Safety|safety
585131|NCT01077232|Efficacy|efficacy
585132|NCT01077232|Work Productivity|work productivity
585133|NCT01077219|healthy female|healthy female
585134|NCT01077206|Aneurysm|aneurysm
585135|NCT01077206|statin|statin
585136|NCT01077206|subarachnoid hemorrhage|subarachnoid hemorrhage
585137|NCT01077193|Bariatric|bariatric
585138|NCT01077193|Obesity|obesity
585139|NCT01077167|Omecamtiv mecarbil|omecamtiv mecarbil
585140|NCT01077167|pharmacokinetics|pharmacokinetics
585141|NCT01077154|Early Stage Breast Cancer|early stage breast cancer
585142|NCT01077154|Bone Metastasis|bone metastasis
585143|NCT01077154|Adjuvant treatment|adjuvant treatment
585144|NCT01077154|Neoadjuvant treatment|neoadjuvant treatment
585145|NCT01077154|Denosumab|denosumab
585146|NCT01077154|Stage II breast cancer|stage ii breast cancer
585147|NCT01077154|Stage III breast cancer|stage iii breast cancer
585148|NCT01077154|Stage IIA breast cancer|stage iia breast cancer
585149|NCT01077154|Stage IIB breast cancer|stage iib breast cancer
585150|NCT01077154|Stage IIIA breast cancer|stage iiia breast cancer
585151|NCT01077154|Stage IIIB breast cancer|stage iiib breast cancer
585152|NCT01077154|Stage IIIC breast cancer|stage iiic breast cancer
585153|NCT01077154|Early breast cancer|early breast cancer
585154|NCT01077154|Breast Tumors|breast tumors
585155|NCT01077154|Breast Neoplasms|breast neoplasms
585156|NCT01077128|Psoriasis|psoriasis
585157|NCT01077128|Quality of life|quality of life
585158|NCT01077115|Cholecystectomy|cholecystectomy
585159|NCT01077115|Cholecystitis|cholecystitis
585160|NCT01077115|Laparoscopy|laparoscopy
585161|NCT01077115|Cholelithiasis|cholelithiasis
585162|NCT01077115|Operative trauma|operative trauma
585163|NCT01077102|COPD|copd
585164|NCT01077102|eccentric exercise training|eccentric exercise training
585165|NCT01077102|cycle ergometer|cycle ergometer
585166|NCT01077102|muscle function|muscle function
585167|NCT01077089|traumatic brain injury|traumatic brain injury
585168|NCT01077089|In-hospital transport|in-hospital transport
585169|NCT01077076|Gastric Acid|gastric acid
585170|NCT01077076|Human Experimentation|human experimentation
585171|NCT01077063|Pleurx catheter|pleurx catheter
585172|NCT01077063|malignant ascites|malignant ascites
585173|NCT01077024|Stimulant treatment|stimulant treatment
585174|NCT01077024|Smoking Cessation|smoking cessation
585175|NCT01077011|Dry eye|dry eye
585176|NCT01077011|artificial tears|artificial tears
585177|NCT01076998|Dry eye|dry eye
585178|NCT01076998|artificial tears|artificial tears
585179|NCT01076985|Human Immunodeficiency Virus|human immunodeficiency virus
585180|NCT01076972|Human Immunodeficiency Virus|human immunodeficiency virus
585181|NCT01076959|Rheumatoid Arthritis|rheumatoid arthritis
585182|NCT01076946|ballooning|ballooning
585183|NCT01076946|TLVBS|tlvbs
585184|NCT01076933|Borderline Personality Disorder|borderline personality disorder
585185|NCT01076933|Transcranial Magnetic Stimulation|transcranial magnetic stimulation
585186|NCT01076933|Neuropsychological Test|neuropsychological test
585187|NCT01076933|Randomised Control Trial|randomised control trial
585188|NCT01076907|colonoscopy|colonoscopy
585189|NCT01076907|polyps|polyps
585190|NCT01076894|pain|pain
585191|NCT01076894|thoracotomy|thoracotomy
585192|NCT01076894|pulmonary function|pulmonary function
585193|NCT01076894|epidural anesthesia|epidural anesthesia
585194|NCT01076894|intercostal nerve block|intercostal nerve block
585195|NCT01076868|vivax|vivax
585196|NCT01076868|malaria|malaria
585197|NCT01076868|relapse|relapse
585198|NCT01076842|Diabetes|diabetes
585199|NCT01076829|MDA|mda
585200|NCT01076829|Spice|spice
585201|NCT01076816|Patients with single-organ failure in need of mechanical ventilation|patients with single-organ failure in need of mechanical ventilation
585202|NCT01076803|Malignant intestinal obstruction in inoperable patients|malignant intestinal obstruction in inoperable patients
585203|NCT01076790|Nociception|nociception
585204|NCT01076790|Dexmedetomidine|dexmedetomidine
585205|NCT01076790|Electroencephalogram|electroencephalogram
585206|NCT01076790|Electromyogram|electromyogram
585207|NCT01076790|Entropy Index|entropy index
585208|NCT01076790|Bispectral Index|bispectral index
585209|NCT01076790|Electrocardiogram|electrocardiogram
585210|NCT01076790|Plethysmogram|plethysmogram
585211|NCT01076790|Heart|heart
585212|NCT01076790|Heart rate|heart rate
585213|NCT01076790|Heart rate variability|heart rate variability
585214|NCT01076790|Surgery|surgery
585215|NCT01076777|Panic disorder|panic disorder
585216|NCT01076777|Physical exercise|physical exercise
585217|NCT01076777|Cognitive-behavioral therapy|cognitive-behavioral therapy
585218|NCT01076777|Manualized|manualized
585219|NCT01076725|ProSeal LMA|proseal lma
585220|NCT01076725|standard insertion|standard insertion
585221|NCT01076725|rotational insertion|rotational insertion
585222|NCT01076699|abdominal pain|abdominal pain
585223|NCT01076699|bloating|bloating
585224|NCT01076699|diarrhea|diarrhea
585225|NCT01076699|irritable bowel|irritable bowel
585226|NCT01076686|Augmentation mammoplasty|augmentation mammoplasty
585227|NCT01076686|Breast augmentation|breast augmentation
585228|NCT01076686|Postoperative pain|postoperative pain
585229|NCT01076686|Analgesia|analgesia
585230|NCT01076660|Ischemic cardiomyopathy|ischemic cardiomyopathy
585231|NCT01076660|Nonischemic cardiomyopathy|nonischemic cardiomyopathy
585232|NCT01076660|Implantable cardioverter defibrillator|implantable cardioverter defibrillator
585233|NCT01076660|Sudden Cardiac Death|sudden cardiac death
585234|NCT01076660|Ventricular tachycardia|ventricular tachycardia
585235|NCT01076660|Ventricular fibrillation|ventricular fibrillation
585236|NCT01076608|primary care patients|primary care patients
585237|NCT01076595|Multiple sclerosis|multiple sclerosis
585238|NCT01076595|BetaPlus program|betaplus program
585239|NCT01076595|Recurrent/remittent multiple sclerosis patients|recurrent/remittent multiple sclerosis patients
585240|NCT01076595|Adherence to treatment regimen|adherence to treatment regimen
585241|NCT01076582|hormone withdrawal associated symptoms|hormone withdrawal associated symptoms
585242|NCT01076504|SCLC|sclc
585243|NCT01076504|Amrubicin|amrubicin
585244|NCT01076504|Carboplatin|carboplatin
585245|NCT01076504|Pegfilgrastim|pegfilgrastim
585246|NCT01076504|Neulasta|neulasta
585247|NCT01076478|Symmetric Diabetic Polyneuropathy|symmetric diabetic polyneuropathy
585248|NCT01076465|Heart failure|heart failure
585249|NCT01076465|Elderly|elderly
585250|NCT01076465|Disease management|disease management
585251|NCT01076452|Parkinson's Disease|parkinson's disease
585252|NCT01076452|levo-dopa|levo-dopa
585255|NCT01076452|subthalamic nucleus|subthalamic nucleus
585256|NCT01076452|globus pallidus|globus pallidus
585257|NCT01076426|probiotic|probiotic
585258|NCT01076426|peritoneal dialysis|peritoneal dialysis
585259|NCT01076426|peritonitis|peritonitis
585260|NCT01076426|nutrition status|nutrition status
585261|NCT01076413|gait|gait
585262|NCT01076413|exercise|exercise
585263|NCT01076413|skill-based|skill-based
585264|NCT01076413|aerobic|aerobic
585265|NCT01076387|Bladder|bladder
585266|NCT01076387|Cystectomy|cystectomy
585267|NCT01076387|Robotic|robotic
585268|NCT01076387|Open Radical|open radical
585269|NCT01076387|10-016|10-016
585270|NCT01076374|pacemaker|pacemaker
585271|NCT01076361|Epicardial|epicardial
585272|NCT01076361|Pacing Lead|pacing lead
585273|NCT01076348|Epicardial|epicardial
585274|NCT01076348|Pacing Lead|pacing lead
585275|NCT01076335|Neoadjuvant Hormonal Therapy|neoadjuvant hormonal therapy
585276|NCT01076335|Docetaxel|docetaxel
585277|NCT01076335|Taxotere|taxotere
585278|NCT01076335|Chemotherapy|chemotherapy
585279|NCT01076335|Radical Prostatectomy|radical prostatectomy
585280|NCT01076335|Node-positive Prostate Cancer|node-positive prostate cancer
585281|NCT01076335|Androgen-dependent prostate cancer|androgen-dependent prostate cancer
585282|NCT01076335|Lymph node metastases|lymph node metastases
585283|NCT01076309|cataract surgery|cataract surgery
585284|NCT01076309|tamsulosin|tamsulosin
585285|NCT01076309|endothelium cell|endothelium cell
585286|NCT01076283|baclofen|baclofen
585287|NCT01076283|alcoholism|alcoholism
585288|NCT01076283|urge|urge
585289|NCT01076283|craving|craving
585290|NCT01076283|alcohol drinking|alcohol drinking
585291|NCT01076283|biobehavioral mechanisms of baclofen in alcoholism|biobehavioral mechanisms of baclofen in alcoholism
585292|NCT01076257|brain damage|brain damage
585293|NCT01076257|constraint induced movement therapy|constraint induced movement therapy
585294|NCT01076257|kinematic|kinematic
585295|NCT01076257|function|function
585296|NCT01076257|outcome|outcome
585297|NCT01076257|Quality of life|quality of life
585298|NCT01076218|Continuous Glucose Monitoring|continuous glucose monitoring
585299|NCT01076218|Accuracy|accuracy
585300|NCT01076218|Continuous Glucose Error-Grid Analysis|continuous glucose error-grid analysis
585301|NCT01076205|Work Productivity|work productivity
585302|NCT01076205|Long-term Observation|long-term observation
585303|NCT01076205|Humira|humira
585304|NCT01076205|Quality of Life|quality of life
585305|NCT01076205|Rheumatoid Arthritis|rheumatoid arthritis
585306|NCT01076192|Moderate Psoriasis|moderate psoriasis
585307|NCT01076192|Psoriasis|psoriasis
585308|NCT01076192|Severe Psoriasis|severe psoriasis
585309|NCT01076192|Adalimumab|adalimumab
585310|NCT01076192|Effectiveness|effectiveness
585311|NCT01076192|Safety|safety
585312|NCT01076192|Clinical practice|clinical practice
585313|NCT01076179|Infection|infection
585314|NCT01076179|Rilpivirine|rilpivirine
585315|NCT01076179|CCR5 antagonists|ccr5 antagonists
585316|NCT01076179|Etravirine|etravirine
585317|NCT01076179|Human Immunodeficiency Virus|human immunodeficiency virus
585318|NCT01076179|Maraviroc|maraviroc
585319|NCT01076179|Safety and efficacy|safety and efficacy
585320|NCT01076179|Non nucleoside reverse transcriptase inhibitors (NNRTIs)|non nucleoside reverse transcriptase inhibitors (nnrtis)
585321|NCT01076179|Integrase inhibitors|integrase inhibitors
585322|NCT01076179|Raltegravir|raltegravir
744077|NCT00459524|Survey|survey
585323|NCT01076179|Kaletra|kaletra
585324|NCT01076166|Post-marketing observational study|post-marketing observational study
585325|NCT01076166|Lower respiratory tract infections|lower respiratory tract infections
585326|NCT01076166|Klacid Granules for Oral Suspension|klacid granules for oral suspension
585327|NCT01076153|Post-marketing observational study|post-marketing observational study
585328|NCT01076153|Upper or lower respiratory tract infection|upper or lower respiratory tract infection
585329|NCT01076153|Klacid MR|klacid mr
585330|NCT01076140|Hypertension as a result of bevacizumab therapy|hypertension as a result of bevacizumab therapy
585331|NCT01076101|SLE|sle
585332|NCT01076101|sister|sister
585333|NCT01076101|autoimmune disease|autoimmune disease
585334|NCT01076075|Type 2 Diabetes Mellitus|type 2 diabetes mellitus
585335|NCT01076062|Pregnancy Maintenance|pregnancy maintenance
585336|NCT01076062|Labor, Induced|labor, induced
585337|NCT01076062|spontaneous labor|spontaneous labor
585338|NCT01076062|cesarean delivery|cesarean delivery
585339|NCT01076036|ischemia|ischemia
585340|NCT01076036|stent|stent
585341|NCT01076023|Diabetes|diabetes
585342|NCT01076023|Cardiovascular disease|cardiovascular disease
585343|NCT01076023|Observational study|observational study
585344|NCT01076023|China|china
585345|NCT01075997|Diabetes Mellitus|diabetes mellitus
585346|NCT01075984|Antifungal Agents pharmacokinetics|antifungal agents pharmacokinetics
585347|NCT01075984|Mycoses prevention and control|mycoses prevention and control
585348|NCT01075971|Buprenorphine tablet|buprenorphine tablet
585349|NCT01075971|Fast dissolving tablet|fast dissolving tablet
585350|NCT01075971|Opioid dependant patients|opioid dependant patients
585351|NCT01075958|n-3 PUFAs|n-3 pufas
585352|NCT01075958|Fish oil|fish oil
585353|NCT01075958|Cognitive function|cognitive function
585354|NCT01075958|Healthy young adults|healthy young adults
585355|NCT01075945|antimalarials|antimalarials
585356|NCT01075945|ACTs|acts
585357|NCT01075945|Piperaquine|piperaquine
585358|NCT01075945|uncomplicated|uncomplicated
585359|NCT01075932|cerebral blood flow|cerebral blood flow
585360|NCT01075932|NIRS|nirs
585361|NCT01075932|n-3 PUFAs|n-3 pufas
585362|NCT01075932|fish oil|fish oil
585363|NCT01075932|cognitive function|cognitive function
585364|NCT01075919|n-3 PUFAs|n-3 pufas
585365|NCT01075919|Cognitive function|cognitive function
585366|NCT01075919|Healthy young adults|healthy young adults
585367|NCT01075919|Fish oil|fish oil
585368|NCT01075919|Mood|mood
585369|NCT01075906|pharmacokinetics|pharmacokinetics
585370|NCT01075893|Colorectal cancer|colorectal cancer
585371|NCT01075893|Stem cells|stem cells
585372|NCT01075893|Ulcerative colitis|ulcerative colitis
585373|NCT01075893|Polyps|polyps
585374|NCT01075880|Multiple Sclerosis, Relapsing-Remitting|multiple sclerosis, relapsing-remitting
585375|NCT01075880|Rebif|rebif
585376|NCT01075880|Interferon beta-1a|interferon beta-1a
585377|NCT01075854|Gonal-F|gonal-f
585378|NCT01075854|Multifollicular stimulation|multifollicular stimulation
585379|NCT01075854|Pregnancy|pregnancy
585380|NCT01075854|Ovarian hyperstimulation|ovarian hyperstimulation
585381|NCT01075854|In vitro fertilization|in vitro fertilization
585382|NCT01075854|Intracytoplasmic sperm injection|intracytoplasmic sperm injection
585383|NCT01075854|Infertility|infertility
585384|NCT01075841|Head and neck neoplasms|head and neck neoplasms
585385|NCT01075841|Carcinoma, squamous cell|carcinoma, squamous cell
585386|NCT01075841|Cetuximab|cetuximab
585387|NCT01075828|Head and Neck Neoplasms|head and neck neoplasms
585388|NCT01075828|Neoplasms, Squamous Cell|neoplasms, squamous cell
585389|NCT01075828|Cetuximab|cetuximab
585390|NCT01075815|Infertility|infertility
585391|NCT01075815|Ovulation induction|ovulation induction
585392|NCT01075815|Luveris|luveris
585393|NCT01075815|Controlled ovarian stimulation|controlled ovarian stimulation
585394|NCT01075815|Reproductive technologies, assisted|reproductive technologies, assisted
585395|NCT01075802|Breast cancer|breast cancer
585396|NCT01075802|Tamoxifen|tamoxifen
585397|NCT01075802|Endoxifen|endoxifen
585398|NCT01075802|polymorphism of CYP2D6|polymorphism of cyp2d6
585399|NCT01075789|Pain|pain
585400|NCT01075789|Discomfort|discomfort
585401|NCT01075789|Insertion|insertion
585402|NCT01075789|Nasogastric tube|nasogastric tube
585403|NCT01075763|Alzheimer's|alzheimer's
585404|NCT01075763|Dementia|dementia
585405|NCT01075763|Interferon beta-1a|interferon beta-1a
585406|NCT01075763|Rebif|rebif
585407|NCT01075750|hyperkalaemia|hyperkalaemia
585408|NCT01075750|metabolic acidosis|metabolic acidosis
585409|NCT01075750|renal transplantation|renal transplantation
585410|NCT01075750|normal saline|normal saline
585411|NCT01075750|elomel isoton|elomel isoton
585412|NCT01075750|fluid management in renal transplantation|fluid management in renal transplantation
585413|NCT01075737|Multiple sclerosis|multiple sclerosis
585414|NCT01075737|Sclerosis|sclerosis
585415|NCT01075737|Quality of life|quality of life
585416|NCT01075724|Perioperative Hypothermia Prevention|perioperative hypothermia prevention
585417|NCT01075724|Accidental Perioperative Hypothermia|accidental perioperative hypothermia
744202|NCT00458952|MIBG|mibg
585418|NCT01075711|Arthritis, Rheumatoid|arthritis, rheumatoid
585419|NCT01075711|Prednisone|prednisone
585420|NCT01075698|Type 2 Diabetes|type 2 diabetes
585421|NCT01075698|Cerebrovascular disease|cerebrovascular disease
585422|NCT01075698|Coronary Artery Disease|coronary artery disease
585423|NCT01075698|Chronic Kidney Disease|chronic kidney disease
585424|NCT01075698|Peripheral Artery Disease|peripheral artery disease
585425|NCT01075672|OCD|ocd
585426|NCT01075672|BDD|bdd
585427|NCT01075672|Tourette syndrome|tourette syndrome
585428|NCT01075672|trichotillomania|trichotillomania
585429|NCT01075672|Compulsive Skin Picking|compulsive skin picking
585430|NCT01075672|panic disorder|panic disorder
585431|NCT01075672|social phobia|social phobia
585432|NCT01075672|generalized anxiety disorder|generalized anxiety disorder
585433|NCT01075672|depression|depression
585434|NCT01075672|PTSD|ptsd
585435|NCT01075672|ADHD|adhd
585436|NCT01075672|eating disorder|eating disorder
585437|NCT01075672|Specific Phobia|specific phobia
585438|NCT01075659|Smoking Cessation|smoking cessation
585439|NCT01075659|VAS|vas
585440|NCT01075659|Urges to smoke|urges to smoke
585441|NCT01075646|postoperative pain|postoperative pain
585442|NCT01075646|wound infusion|wound infusion
585443|NCT01075646|local anesthesia|local anesthesia
585444|NCT01075633|FOBT|fobt
585445|NCT01075633|colonoscopy|colonoscopy
585446|NCT01075633|familiar risk|familiar risk
585447|NCT01075633|colorectal cancer|colorectal cancer
585448|NCT01075633|advanced adenoma|advanced adenoma
585449|NCT01075620|rotating platform|rotating platform
585450|NCT01075620|posterior stabilized|posterior stabilized
585451|NCT01075620|non-posterior stabilized|non-posterior stabilized
585452|NCT01075607|Lymph fluid collection|lymph fluid collection
585453|NCT01075594|Dyslipidemia|dyslipidemia
585454|NCT01075594|Target cholesterol|target cholesterol
585455|NCT01075594|Undertreatment|undertreatment
585456|NCT01075581|Hemodynamic instability|hemodynamic instability
585457|NCT01075581|Hemostasis|hemostasis
585458|NCT01075555|adult primary hepatocellular carcinoma|adult primary hepatocellular carcinoma
585459|NCT01075555|localized unresectable adult primary liver cancer|localized unresectable adult primary liver cancer
585460|NCT01075555|advanced adult primary liver cancer|advanced adult primary liver cancer
585461|NCT01075555|recurrent adult primary liver cancer|recurrent adult primary liver cancer
585462|NCT01075542|Corneal astigmatism|corneal astigmatism
585463|NCT01075542|Intraocular lens|intraocular lens
585464|NCT01075529|major depressive disorder, fluoxetine, Hamilton Rating Scale for Depression (HAM-D-17)|major depressive disorder, fluoxetine, hamilton rating scale for depression (ham-d-17)
585465|NCT01075516|Remote Monitoring|remote monitoring
585466|NCT01075516|ICD patients|icd patients
585467|NCT01075516|EQ-5D questionnaire|eq-5d questionnaire
585468|NCT01075516|remote follow up|remote follow up
585469|NCT01075503|Supraclavicular|supraclavicular
585470|NCT01075503|Interscalene|interscalene
585471|NCT01075503|Infraclavicular|infraclavicular
585472|NCT01075503|Brachial plexus block|brachial plexus block
585473|NCT01075503|Ropivacaine|ropivacaine
585474|NCT01075490|spinal anesthesia|spinal anesthesia
585475|NCT01075490|neonates|neonates
585476|NCT01075490|clonidine|clonidine
585477|NCT01075490|post operative apnea|post operative apnea
585478|NCT01075464|Solid Tumor|solid tumor
585479|NCT01075451|Staphylococcus aureus|staphylococcus aureus
585480|NCT01075451|Antimicrobial Stewardship|antimicrobial stewardship
585481|NCT01075451|Antibacterial resistance|antibacterial resistance
585482|NCT01075451|Vancomycin|vancomycin
585483|NCT01075438|ataxia telangiectasia|ataxia telangiectasia
585484|NCT01075438|Pneumococcal Vaccines|pneumococcal vaccines
585485|NCT01075425|leukemia|leukemia
585486|NCT01075425|acute leukemia|acute leukemia
585487|NCT01075425|chronic myelogenous leukemia|chronic myelogenous leukemia
585488|NCT01075425|myelodysplastic syndrome|myelodysplastic syndrome
585489|NCT01075425|relapsed acute leukemia|relapsed acute leukemia
585490|NCT01075425|refractory acute leukemia|refractory acute leukemia
585491|NCT01075425|belinostat|belinostat
585492|NCT01075425|bortezomib|bortezomib
585494|NCT01075425|PXD-101|pxd-101
585495|NCT01075412|Positron-Emission Tomography|positron-emission tomography
585496|NCT01075412|Radiotherapy, Intensity-Modulated|radiotherapy, intensity-modulated
585497|NCT01075399|[F 18]HX4|[f 18]hx4
585498|NCT01075399|HX4|hx4
585499|NCT01075399|Hypoxia|hypoxia
585500|NCT01075399|Head/Neck Cancer|head/neck cancer
585501|NCT01075399|Lung Cancer|lung cancer
585502|NCT01075399|Liver Cancer|liver cancer
585503|NCT01075399|Rectal Cancer|rectal cancer
585504|NCT01075399|Cervical Cancer|cervical cancer
585505|NCT01075399|HIF1 alpha|hif1 alpha
585506|NCT01075399|CAIX|caix
585507|NCT01075386|Hysterectomy|hysterectomy
585508|NCT01075386|Endometrial cancer|endometrial cancer
585509|NCT01075386|Benign|benign
585510|NCT01075386|Endocrine system|endocrine system
585511|NCT01075386|Tissue collection|tissue collection
585512|NCT01075373|early stage schizophrenia|early stage schizophrenia
585513|NCT01075373|drug naïve schizophrenia|drug naïve schizophrenia
711568|NCT00584025|keppra|keppra
585514|NCT01075373|treatment response|treatment response
585515|NCT01075373|Aripiprazole|aripiprazole
585516|NCT01075373|pharmacogenetics|pharmacogenetics
585517|NCT01075373|Disrupted-in-Schizophrenia 1 gene (DISC1)|disrupted-in-schizophrenia 1 gene (disc1)
585518|NCT01075373|Neuregulin 1 gene (NRG1)|neuregulin 1 gene (nrg1)
585519|NCT01075373|Dopamine receptor type 2 gene (DRD2)|dopamine receptor type 2 gene (drd2)
585520|NCT01075373|Catechol-O-Methyltransferase gene (COMT)|catechol-o-methyltransferase gene (comt)
585521|NCT01075373|neurocognitive function|neurocognitive function
585522|NCT01075373|event-related evoked potential (ERP)|event-related evoked potential (erp)
585523|NCT01075373|Niacin skin test|niacin skin test
585524|NCT01075373|plasma neurotransmitter level|plasma neurotransmitter level
585525|NCT01075373|plasma cytokine level|plasma cytokine level
585526|NCT01075373|plasma signaling protein level|plasma signaling protein level
585527|NCT01075373|AKT1 protein level in the peripheral lymphocytes|akt1 protein level in the peripheral lymphocytes
585528|NCT01075373|16-45 y/o|16-45 y/o
585529|NCT01075373|without mental retardation or epilepsy|without mental retardation or epilepsy
585530|NCT01075360|Neuroblastoma, MYCN, AHR|neuroblastoma, mycn, ahr
585531|NCT01075347|autoserum|autoserum
585532|NCT01075347|ocular surgery|ocular surgery
585533|NCT01075347|corneal epithelium healing|corneal epithelium healing
585534|NCT01075334|sperm|sperm
585535|NCT01075334|male infertility|male infertility
585536|NCT01075334|Carnitine|carnitine
585537|NCT01075334|food supplementation|food supplementation
585538|NCT01075334|insemination|insemination
585539|NCT01075308|hormone-resistant prostate cancer|hormone-resistant prostate cancer
585540|NCT01075308|recurrent prostate cancer|recurrent prostate cancer
585541|NCT01075308|stage IV prostate cancer|stage iv prostate cancer
585542|NCT01075308|stage III prostate cancer|stage iii prostate cancer
585543|NCT01075308|adenocarcinoma of the prostate|adenocarcinoma of the prostate
585544|NCT01075295|Schizophreniform Disorder|schizophreniform disorder
585545|NCT01075295|Schizophrenia, Schizoaffective disorder|schizophrenia, schizoaffective disorder
585546|NCT01075295|Bipolar I Disorder|bipolar i disorder
585547|NCT01075295|Bipolar II Disorder|bipolar ii disorder
585548|NCT01075295|Major Depressive Disorder with Psychotic Features,|major depressive disorder with psychotic features,
585549|NCT01075295|Substance-Induced Psychoses|substance-induced psychoses
585550|NCT01075295|Psychosis Not Otherwise Specified|psychosis not otherwise specified
585551|NCT01075295|antipsychotic|antipsychotic
585552|NCT01075295|weight gain|weight gain
585553|NCT01075295|body mass index|body mass index
585554|NCT01075295|BMI|bmi
585555|NCT01075295|waist circumference|waist circumference
585556|NCT01075295|WC|wc
585557|NCT01075295|coronary heart disease|coronary heart disease
585558|NCT01075295|CHD|chd
585559|NCT01075269|robotic thyroidectomy, comparative study, cosmetic result, postoperative neck discomfort, swallowing symptom|robotic thyroidectomy, comparative study, cosmetic result, postoperative neck discomfort, swallowing symptom
585560|NCT01075269|Robotic thyroidectomy, cosmetic effect, postoperative distress, surgical outcome|robotic thyroidectomy, cosmetic effect, postoperative distress, surgical outcome
585561|NCT01075256|sensitivity|sensitivity
585562|NCT01075256|occlusion|occlusion
585563|NCT01075243|dental pain|dental pain
585564|NCT01075243|paracetamol|paracetamol
585565|NCT01075243|Post-surgical dental pain|post-surgical dental pain
585566|NCT01075230|PRP, TKA, pain scale, hemoglobin, hematocrit, narcotics|prp, tka, pain scale, hemoglobin, hematocrit, narcotics
585567|NCT01075217|Peripheral arterial occlusive disease (PAOD)|peripheral arterial occlusive disease (paod)
585568|NCT01075204|Respiratory Tract Infection|respiratory tract infection
585569|NCT01075204|Clarithromycin|clarithromycin
585570|NCT01075204|Recovery|recovery
585571|NCT01075191|Viral load|viral load
585572|NCT01075191|Resistance|resistance
585573|NCT01075191|Double protease inhibitors|double protease inhibitors
585574|NCT01075191|Mutations|mutations
585575|NCT01075191|Immune system|immune system
585576|NCT01075191|Infection|infection
585577|NCT01075191|Nucleoside Reverse Transcriptase Inhibitors-free|nucleoside reverse transcriptase inhibitors-free
585578|NCT01075191|Human Immunodeficiency Virus|human immunodeficiency virus
585579|NCT01075178|Infection|infection
585580|NCT01075178|Arrhythmia|arrhythmia
585581|NCT01075178|Death|death
585582|NCT01075178|Palivizumab|palivizumab
585583|NCT01075178|Safety|safety
585584|NCT01075178|Hemodynamically Significant Congenital Heart Disease|hemodynamically significant congenital heart disease
585585|NCT01075178|Pediatric|pediatric
585586|NCT01075178|Observational|observational
585587|NCT01075165|silicone|silicone
585588|NCT01075165|burn scar|burn scar
585589|NCT01075165|hypertrophic scar|hypertrophic scar
585590|NCT01075165|keloid|keloid
585591|NCT01075165|scar assessment|scar assessment
585592|NCT01075165|abnormal scarring|abnormal scarring
585593|NCT01075165|Burn patients|burn patients
585594|NCT01075152|cryptococcal meningitis|cryptococcal meningitis
585595|NCT01075152|cryptococcus|cryptococcus
585596|NCT01075152|cryptococcosis|cryptococcosis
585597|NCT01075152|HIV|hiv
585598|NCT01075152|AIDS|aids
585599|NCT01075152|strategy|strategy
585600|NCT01075139|Motivational interviewing|motivational interviewing
585601|NCT01075139|Physical activity|physical activity
585602|NCT01075139|Diet|diet
585603|NCT01075126|bipolar affective disorder|bipolar affective disorder
585604|NCT01075126|African American|african american
585605|NCT01075126|antimanic|antimanic
585606|NCT01075126|lithium|lithium
585607|NCT01075126|depakote|depakote
585608|NCT01075113|adult primary hepatocellular carcinoma|adult primary hepatocellular carcinoma
585609|NCT01075113|advanced adult primary liver cancer|advanced adult primary liver cancer
585610|NCT01075113|recurrent adult primary liver cancer|recurrent adult primary liver cancer
585611|NCT01075100|metastatic|metastatic
585612|NCT01075100|breast|breast
585613|NCT01075100|cancer|cancer
585614|NCT01075087|TAP Block|tap block
585615|NCT01075087|Pain|pain
585616|NCT01075087|Obesity|obesity
585617|NCT01075087|Surgery|surgery
585618|NCT01075087|Laparoscopic Banding|laparoscopic banding
585619|NCT01075074|Pain|pain
585620|NCT01075074|TAP block|tap block
585621|NCT01075074|Laparoscopic|laparoscopic
585622|NCT01075074|Gynecologic|gynecologic
585623|NCT01075061|Congenital mirror movement, physiopathology, imaging, transcranial magnetic stimulation, candidate gene|congenital mirror movement, physiopathology, imaging, transcranial magnetic stimulation, candidate gene
585624|NCT01075048|Colorectal cancer|colorectal cancer
585625|NCT01075048|wild-type KRAS|wild-type kras
585626|NCT01075048|irinotecan|irinotecan
585627|NCT01075048|cetuximab|cetuximab
585628|NCT01075048|second-line therapy|second-line therapy
585629|NCT01075035|Traumatic Brain Injury|traumatic brain injury
585630|NCT01075035|TBI|tbi
585631|NCT01075035|Military|military
585632|NCT01075035|Imaging|imaging
585633|NCT01075035|MEG|meg
585634|NCT01075035|PET/CT|pet/ct
585635|NCT01075035|MRI|mri
585636|NCT01075035|fMRI|fmri
585637|NCT01075035|DTI|dti
585638|NCT01075035|SANIC|sanic
585639|NCT01075035|veteran|veteran
585640|NCT01075009|Antibiotics|antibiotics
585641|NCT01075009|Resistance|resistance
585642|NCT01075009|Epidemiology|epidemiology
585643|NCT01075009|Gram-negative bacteria|gram-negative bacteria
585644|NCT01075009|Epidemiology of antibiotic use|epidemiology of antibiotic use
585645|NCT01074996|Pancreatic cancer|pancreatic cancer
585646|NCT01074996|S-1|s-1
585647|NCT01074996|S-1 plus Leucovorin|s-1 plus leucovorin
585648|NCT01074996|second-line therapy|second-line therapy
585649|NCT01074983|Prehospital, Oxygen, Trauma, Hypoxemia|prehospital, oxygen, trauma, hypoxemia
585650|NCT01074970|PARP inhibition + breast cancer|parp inhibition + breast cancer
585651|NCT01074970|breast cancer|breast cancer
585652|NCT01074970|PARP inhibitor|parp inhibitor
585653|NCT01074970|Triple negative|triple negative
585654|NCT01074944|Gaucher disease|gaucher disease
585655|NCT01074944|Genz-112638|genz-112638
585656|NCT01074944|beta-glucosidase|beta-glucosidase
585657|NCT01074944|acid β-glucosidase|acid β-glucosidase
585658|NCT01074944|glucocerebrosidase|glucocerebrosidase
585659|NCT01074944|glucosylceramide|glucosylceramide
585660|NCT01074944|D-glucosyl-N-acylsphingosine glucohydrolase|d-glucosyl-n-acylsphingosine glucohydrolase
585661|NCT01074944|substrate reduction therapy|substrate reduction therapy
585662|NCT01074931|Lopinavir/ritonavir|lopinavir/ritonavir
585663|NCT01074918|Pre-hypertension|pre-hypertension
585664|NCT01074918|Hypertension|hypertension
585665|NCT01074905|vivax malaria|vivax malaria
585666|NCT01074905|artesunate|artesunate
585667|NCT01074905|chloroquine|chloroquine
585668|NCT01074905|primaquine|primaquine
585669|NCT01074905|relapse|relapse
585670|NCT01074892|endometrial hyperplasia treatment MPA per os LNG-IUD|endometrial hyperplasia treatment mpa per os lng-iud
585671|NCT01074879|Elderly|elderly
585672|NCT01074879|protein consumption|protein consumption
585673|NCT01074879|resistance exercise|resistance exercise
585674|NCT01074879|muscle mass|muscle mass
585675|NCT01074866|Mechanical ventilation|mechanical ventilation
585676|NCT01074866|Non invasive Ventilation|non invasive ventilation
585677|NCT01074866|Patient-ventilator interaction|patient-ventilator interaction
585678|NCT01074866|Pressure support|pressure support
585679|NCT01074866|Neurally adjusted ventilatory assist|neurally adjusted ventilatory assist
585680|NCT01074840|Food Hypersensitivity|food hypersensitivity
585681|NCT01074840|Hypersensitivity|hypersensitivity
585682|NCT01074840|Immune System Diseases|immune system diseases
585683|NCT01074840|Hypersensitivity, Immediate|hypersensitivity, immediate
585684|NCT01074840|Peanut Hypersensitivity|peanut hypersensitivity
585685|NCT01074840|Food Allergy|food allergy
585686|NCT01074827|Multiple Sclerosis|multiple sclerosis
585687|NCT01074827|Walking ability|walking ability
585688|NCT01074827|Strength|strength
585689|NCT01074827|Balance|balance
585690|NCT01074827|Treadmill walking|treadmill walking
585691|NCT01074814|Metastatic Breast Cancer|metastatic breast cancer
585692|NCT01074814|Molecular profiling|molecular profiling
585693|NCT01074801|Closed-loop systems|closed-loop systems
585694|NCT01074801|day-and-night glucose control|day-and-night glucose control
585695|NCT01074788|rehabilitation|rehabilitation
585696|NCT01074788|mind body therapy|mind body therapy
585697|NCT01074788|integrative medicine|integrative medicine
585698|NCT01074775|innate immunity|innate immunity
585699|NCT01074775|mycobacterium bovis|mycobacterium bovis
585700|NCT01074775|mucosal immunity|mucosal immunity
585701|NCT01074775|adaptive immunity|adaptive immunity
585702|NCT01074775|genomics|genomics
585703|NCT01074762|Diabetes mellitus|diabetes mellitus
585704|NCT01074762|Quality of health care|quality of health care
585705|NCT01074762|Health services research|health services research
585706|NCT01074749|AF|af
585707|NCT01074749|Automatic Mode Switch|automatic mode switch
585708|NCT01074749|FFRW|ffrw
585709|NCT01074749|paroxysmal AF|paroxysmal af
585710|NCT01074736|influenza A/H5N1|influenza a/h5n1
585711|NCT01074736|host genetic susceptibility|host genetic susceptibility
585712|NCT01074736|genotyping|genotyping
585713|NCT01074723|b-cryptoxanthin|b-cryptoxanthin
585714|NCT01074723|cholesterol|cholesterol
585715|NCT01074723|bone markers|bone markers
585716|NCT01074723|Osteoporosis|osteoporosis
585717|NCT01074723|cardiovascular risk|cardiovascular risk
585718|NCT01074723|post-menopausal women|post-menopausal women
585719|NCT01074697|Randomized Controlled Trial|randomized controlled trial
585720|NCT01074697|Serotonin Agonists|serotonin agonists
585721|NCT01074697|Dexamethasone|dexamethasone
585722|NCT01074697|Receptors, Neurokinin-1|receptors, neurokinin-1
585723|NCT01074697|Radiotherapy|radiotherapy
585724|NCT01074697|Cisplatin|cisplatin
585725|NCT01074697|Prevention & control|prevention & control
585726|NCT01074684|diagnosis|diagnosis
585727|NCT01074684|nodules|nodules
585728|NCT01074684|fine needle aspiration|fine needle aspiration
585729|NCT01074658|Advance|advance
585730|NCT01074658|Medtronic CoreValve System|medtronic corevalve system
585731|NCT01074658|International|international
585732|NCT01074658|Interventional|interventional
585733|NCT01074658|Post Market Study|post market study
585734|NCT01074645|Acute-on -chronic liver failure|acute-on -chronic liver failure
585735|NCT01074645|Reactivation of hepatitis B|reactivation of hepatitis b
585736|NCT01074645|Spontaneous reactivation of chronic hepatitis B presenting as to acute-on-chronic liver failure|spontaneous reactivation of chronic hepatitis b presenting as to acute-on-chronic liver failure
585737|NCT01074606|Cataract|cataract
585738|NCT01074593|PHARMACOKINETICS AND PHARMACODYNAMICS OF DRUG INTERFERON BETA-1A|pharmacokinetics and pharmacodynamics of drug interferon beta-1a
585739|NCT01074580|Crohn's disease|crohn's disease
585740|NCT01074580|sonography|sonography
585741|NCT01074580|contrast enhanced ultrasound|contrast enhanced ultrasound
585742|NCT01074554|sarcoidosis|sarcoidosis
585743|NCT01074554|mycobacteria|mycobacteria
585744|NCT01074554|cutaneous lesions|cutaneous lesions
585745|NCT01074541|Vitamin D|vitamin d
585746|NCT01074541|UVB|uvb
585747|NCT01074541|Dose-Response|dose-response
585748|NCT01074541|UV intensity|uv intensity
585749|NCT01074541|Skin cancer|skin cancer
585750|NCT01074528|cancer patients|cancer patients
585751|NCT01074528|relatives or partners of cancer patients|relatives or partners of cancer patients
585752|NCT01074515|COPD|copd
585753|NCT01074515|Depression|depression
585754|NCT01074515|Inflammation|inflammation
585755|NCT01074515|Genetics|genetics
585756|NCT01074515|Functioning|functioning
585757|NCT01074515|Dyspnea|dyspnea
585758|NCT01074515|Physical activity|physical activity
585759|NCT01074502|acne|acne
585760|NCT01074489|GDM|gdm
585761|NCT01074489|Gestational Diabetes|gestational diabetes
585762|NCT01074489|GTT|gtt
585763|NCT01074489|CGMS|cgms
585764|NCT01074476|Knee osteoarthritis|knee osteoarthritis
585765|NCT01074476|glucosamine|glucosamine
585766|NCT01074476|synovial fluid|synovial fluid
585767|NCT01074476|viscosity|viscosity
585768|NCT01074476|viscoelasticity|viscoelasticity
585769|NCT01074476|WOMAC|womac
585770|NCT01074463|Bioequivalence|bioequivalence
585771|NCT01074463|Healthy Subjects|healthy subjects
585772|NCT01074450|Bioequivalence|bioequivalence
585773|NCT01074450|Healthy Subjects|healthy subjects
585774|NCT01074424|stage IIB cervical cancer|stage iib cervical cancer
585775|NCT01074424|stage III cervical cancer|stage iii cervical cancer
585776|NCT01074424|stage IVA cervical cancer|stage iva cervical cancer
585777|NCT01074424|cervical adenocarcinoma|cervical adenocarcinoma
585778|NCT01074424|cervical adenosquamous cell carcinoma|cervical adenosquamous cell carcinoma
585779|NCT01074424|cervical squamous cell carcinoma|cervical squamous cell carcinoma
585780|NCT01074398|recurrent ovarian epithelial cancer|recurrent ovarian epithelial cancer
585781|NCT01074398|stage III ovarian epithelial cancer|stage iii ovarian epithelial cancer
585782|NCT01074398|stage IV ovarian epithelial cancer|stage iv ovarian epithelial cancer
585783|NCT01074398|fallopian tube cancer|fallopian tube cancer
585784|NCT01074398|peritoneal cavity cancer|peritoneal cavity cancer
585785|NCT01074385|Stage IV Colorectal Cancer|stage iv colorectal cancer
585786|NCT01074359|A3243G Mitochondrial DNA Point Mutation|a3243g mitochondrial dna point mutation
585787|NCT01074346|Multiple sclerosis|multiple sclerosis
585788|NCT01074346|Interferon-beta 1-a|interferon-beta 1-a
585789|NCT01074333|Colorectal cancer|colorectal cancer
585790|NCT01074333|Metastasis|metastasis
585791|NCT01074333|Cetuximab|cetuximab
585792|NCT01074333|Erbitux|erbitux
585793|NCT01074333|Epidermal growth factor receptor|epidermal growth factor receptor
585794|NCT01074320|breast cancer|breast cancer
585795|NCT01074320|aromatase inhibitors|aromatase inhibitors
585796|NCT01074320|musculoskeletal symptoms|musculoskeletal symptoms
585797|NCT01074307|Systolic heart failure|systolic heart failure
585798|NCT01074307|Bisoprolol|bisoprolol
585799|NCT01074307|Concor|concor
585800|NCT01074307|Echocardiogram|echocardiogram
585801|NCT01074294|Inattention|inattention
585802|NCT01074294|Hyperactivity|hyperactivity
585803|NCT01074294|Impulsivity|impulsivity
585804|NCT01074294|Distractibility|distractibility
585805|NCT01074294|Procrastination|procrastination
585806|NCT01074294|Disorganized|disorganized
585807|NCT01074294|ADHD|adhd
585808|NCT01074281|Hypertension|hypertension
585809|NCT01074281|Isolated systolic hypertonia|isolated systolic hypertonia
585810|NCT01074281|Eneas|eneas
585811|NCT01074255|Nausea|nausea
585812|NCT01074255|Vomiting|vomiting
585813|NCT01074255|Chemotherapy|chemotherapy
585814|NCT01074255|Post-chemotherapy|post-chemotherapy
585815|NCT01074242|Gastroenteritis rotavirus|gastroenteritis rotavirus
585816|NCT01074229|Pain|pain
585817|NCT01074229|Post Operative|post operative
585818|NCT01074229|Opioids|opioids
585819|NCT01074229|Laparoscopic|laparoscopic
585820|NCT01074229|Surgery|surgery
585821|NCT01074229|Hysterectomy|hysterectomy
585822|NCT01074216|Vitamin D|vitamin d
585823|NCT01074216|Vitamin D3|vitamin d3
585824|NCT01074216|colon cancer|colon cancer
585825|NCT01074216|rectum cancer|rectum cancer
585826|NCT01074216|Cholecalciferol|cholecalciferol
585827|NCT01074216|09-143|09-143
585828|NCT01074203|nitazoxanide|nitazoxanide
585829|NCT01074203|liver transplantation|liver transplantation
585830|NCT01074203|HCV recurrence|hcv recurrence
585831|NCT01074190|Epidural Labor Analgesia|epidural labor analgesia
585832|NCT01074190|Pain|pain
585833|NCT01074190|Infant|infant
585834|NCT01074190|Breastfeeding|breastfeeding
585835|NCT01074177|BIBW 2992|bibw 2992
585836|NCT01074177|NSCLC|nsclc
585837|NCT01074164|eczema|eczema
585838|NCT01074164|atopic dermatitis|atopic dermatitis
585839|NCT01074164|itch|itch
585840|NCT01074164|pruritus|pruritus
585841|NCT01074164|acupressure|acupressure
585842|NCT01074164|acupuncture|acupuncture
585843|NCT01074151|Pregnancy|pregnancy
585844|NCT01074151|pregnant|pregnant
585845|NCT01074151|Cymbalta|cymbalta
585846|NCT01074151|Pregnancy Outcomes|pregnancy outcomes
585847|NCT01074138|CPRC|cprc
585848|NCT01074125|Hyperphosphatemia|hyperphosphatemia
585849|NCT01074125|ESRD|esrd
585850|NCT01074125|Dialysis|dialysis
585851|NCT01074125|End Stage Renal Disease|end stage renal disease
585852|NCT01074125|Phosphorus|phosphorus
585853|NCT01074125|Renal|renal
585854|NCT01074125|Kidney|kidney
585855|NCT01074112|Ultrasound|ultrasound
585856|NCT01074112|Prehospital|prehospital
585857|NCT01074112|Trauma|trauma
585858|NCT01074112|EMS|ems
585859|NCT01074112|Paramedics|paramedics
585860|NCT01074112|Sonography|sonography
585861|NCT01074112|Ultrasonography|ultrasonography
585862|NCT01074112|Ambulance|ambulance
585863|NCT01074112|FAST|fast
585864|NCT01074112|EFAST|efast
585865|NCT01074086|RAD 001 in relapsed AML|rad 001 in relapsed aml
585866|NCT01074073|Lithium DDI with Lurasidone HCl|lithium ddi with lurasidone hcl
585867|NCT01074073|Male/Female, Schizophrenia Patients|male/female, schizophrenia patients
585868|NCT01074047|Acute Myeloid Leukemia|acute myeloid leukemia
585869|NCT01074047|Cytarabine|cytarabine
585870|NCT01074047|Vidaza|vidaza
585871|NCT01074047|azacitidine|azacitidine
585872|NCT01074047|Intensive Chemotherapy|intensive chemotherapy
585873|NCT01074047|Low Dose Cytarabine|low dose cytarabine
585874|NCT01074047|Celgene|celgene
585875|NCT01074021|Nimotuzumab|nimotuzumab
585876|NCT01074021|Nasopharyngeal cancer|nasopharyngeal cancer
585877|NCT01074021|chemoradiation|chemoradiation
585878|NCT01073995|Radiculopathy|radiculopathy
585879|NCT01073995|Sciatica|sciatica
585880|NCT01073995|Lumbar Disc Herniation|lumbar disc herniation
585881|NCT01073995|Surgical Alternative|surgical alternative
585882|NCT01073982|pain|pain
585883|NCT01073982|inflammation|inflammation
585884|NCT01073982|osteoarthritis|osteoarthritis
585885|NCT01073969|prebiotic study|prebiotic study
585886|NCT01073969|modulating colonic bacteria|modulating colonic bacteria
585887|NCT01073956|Subacromial Impingement Syndrome|subacromial impingement syndrome
585888|NCT01073956|Shoulder Pain|shoulder pain
585889|NCT01073956|Physical therapy|physical therapy
585890|NCT01073956|Electrotherapy|electrotherapy
585891|NCT01073956|Ultrasonic therapy|ultrasonic therapy
585892|NCT01073956|Medium-wave 448 kHz therapy|medium-wave 448 khz therapy
585893|NCT01073943|Bowel Preparation|bowel preparation
585894|NCT01073943|Colonoscopy|colonoscopy
585895|NCT01073930|Bowel Preparation|bowel preparation
585896|NCT01073930|Colonoscopy|colonoscopy
585897|NCT01073917|Ventilation|ventilation
585898|NCT01073917|General Anesthesia|general anesthesia
585899|NCT01073917|electrical impedance tomography|electrical impedance tomography
585900|NCT01073917|pressure support|pressure support
585901|NCT01073917|spontaneous breathing|spontaneous breathing
585902|NCT01073917|laryngeal mask|laryngeal mask
585903|NCT01073917|Patients who are scheduled for elective knee or ankle surgery|patients who are scheduled for elective knee or ankle surgery
585904|NCT01073891|Pharmacokinetics|pharmacokinetics
585905|NCT01073891|Bioavailability|bioavailability
585906|NCT01073891|Food effect|food effect
585907|NCT01073891|Oral liquid formulation|oral liquid formulation
585908|NCT01073878|Urinary Urge Incontinence|urinary urge incontinence
585909|NCT01073878|Urinary Stress Incontinence|urinary stress incontinence
585910|NCT01073878|Urinary Mixed Incontinence|urinary mixed incontinence
585911|NCT01073865|ZOLADEX|zoladex
585912|NCT01073865|Pre-menopausal|pre-menopausal
585913|NCT01073865|Oestrogen Receptor|oestrogen receptor
585914|NCT01073865|Advanced Breast Cancer|advanced breast cancer
585915|NCT01073865|Progression Free Survival|progression free survival
585916|NCT01073852|Chronic Urticaria|chronic urticaria
585917|NCT01073852|Hives|hives
585918|NCT01073852|Hydroxychloroquine|hydroxychloroquine
585919|NCT01073813|Minocycline|minocycline
585920|NCT01073813|Retinal nerve fibre layer thickness|retinal nerve fibre layer thickness
585921|NCT01073813|Macular volume|macular volume
585922|NCT01073813|Visual outcomes|visual outcomes
585923|NCT01073800|atorvastatin|atorvastatin
585924|NCT01073800|vascular occlusion|vascular occlusion
585925|NCT01073800|myocardial infarction|myocardial infarction
585926|NCT01073800|stroke|stroke
585927|NCT01073800|renal failure|renal failure
585928|NCT01073800|critically ill|critically ill
585929|NCT01073800|Vascular occlusive events among the critically ill|vascular occlusive events among the critically ill
585930|NCT01073787|migraine|migraine
585931|NCT01073787|headache|headache
585932|NCT01073787|pediatric|pediatric
585933|NCT01073787|children|children
585934|NCT01073787|Emergency Department|emergency department
585935|NCT01073774|breast cancer couples coping|breast cancer couples coping
585936|NCT01073748|Asthma|asthma
585937|NCT01073748|Acetaminophen|acetaminophen
585938|NCT01073748|paracetamol|paracetamol
585939|NCT01073748|FeNO|feno
585940|NCT01073748|Spirometry|spirometry
585941|NCT01073748|Lung function|lung function
586417|NCT01071759|Hemoglobin|hemoglobin
585942|NCT01073735|Needs assessment|needs assessment
585943|NCT01073735|Health-related needs|health-related needs
585944|NCT01073735|Childhood cancer survivors|childhood cancer survivors
585945|NCT01073722|thoracic surgery|thoracic surgery
585946|NCT01073722|one-lung ventilation|one-lung ventilation
585947|NCT01073722|double lumen tube|double lumen tube
585948|NCT01073722|endobronchial blocker|endobronchial blocker
585949|NCT01073709|Acetaminophen fasting study|acetaminophen fasting study
585950|NCT01073696|Sancuso|sancuso
585951|NCT01073696|granisetron|granisetron
585952|NCT01073696|Pharmacokinetics|pharmacokinetics
585953|NCT01073683|TPF|tpf
585954|NCT01073683|INDUCTION CHEMOTHERAPY|induction chemotherapy
585955|NCT01073683|LARYNX PRESERVATION|larynx preservation
585956|NCT01073683|SUPACRICOID LARYNGECTOMY|supacricoid laryngectomy
585957|NCT01073683|Stage 3 and 4 larynx cancer|stage 3 and 4 larynx cancer
585958|NCT01073670|NSAIDs|nsaids
585959|NCT01073670|bleeding|bleeding
585960|NCT01073670|thromboelastography|thromboelastography
585961|NCT01073670|cardiac surgery|cardiac surgery
585962|NCT01073670|Indomethacin|indomethacin
585963|NCT01073670|acetaminophen|acetaminophen
585964|NCT01073657|Rehabilitation|rehabilitation
585965|NCT01073644|imatinib resistant or intolerant|imatinib resistant or intolerant
585966|NCT01073631|voriconazole|voriconazole
585967|NCT01073631|Korea|korea
585968|NCT01073631|invasive fungal infection|invasive fungal infection
585969|NCT01073618|voriconazole|voriconazole
585970|NCT01073618|Korea|korea
585971|NCT01073618|invasive fungal infection|invasive fungal infection
585972|NCT01073605|Short height|short height
585973|NCT01073605|intra-uterine growth retardation|intra-uterine growth retardation
585974|NCT01073605|Genotonorm|genotonorm
585975|NCT01073605|continuous treatment|continuous treatment
585976|NCT01073605|intermittent treatment|intermittent treatment
585977|NCT01073592|HMP|hmp
585978|NCT01073592|CNV|cnv
585979|NCT01073592|AMD|amd
585980|NCT01073592|PHP|php
585981|NCT01073592|HPHP|hphp
585982|NCT01073592|FORESEE HOME|foresee home
585983|NCT01073579|Cryptogenic Infantile Spasms|cryptogenic infantile spasms
585984|NCT01073579|Cryptogenic West Syndrome|cryptogenic west syndrome
585985|NCT01073579|Hypsarrhythmia|hypsarrhythmia
585986|NCT01073579|Infantile Spasms|infantile spasms
585987|NCT01073579|Symptomatic Infantile Spasms|symptomatic infantile spasms
585988|NCT01073579|Symptomatic West Syndrome|symptomatic west syndrome
585989|NCT01073579|West Syndrome|west syndrome
585990|NCT01073579|Refractory Complex Partial Seizures|refractory complex partial seizures
585991|NCT01073579|Complex Partial Epilepsy|complex partial epilepsy
585992|NCT01073579|Complex Partial Seizure Disorder|complex partial seizure disorder
585993|NCT01073579|Cryptogenic Partial Complex Epilepsy|cryptogenic partial complex epilepsy
585994|NCT01073579|Disorder, Complex Partial Seizures|disorder, complex partial seizures
585995|NCT01073579|Epilepsy, Cryptogenic, Partial Complex|epilepsy, cryptogenic, partial complex
585996|NCT01073579|Epilepsy, Psychic Equivalent|epilepsy, psychic equivalent
585997|NCT01073579|Epilepsy, Psychomotor|epilepsy, psychomotor
585998|NCT01073579|Epilepsy, Symptomatic, Partial Complex|epilepsy, symptomatic, partial complex
585999|NCT01073579|Partial Complex Epilepsy, Cryptogenic|partial complex epilepsy, cryptogenic
586000|NCT01073579|Partial Complex Epilepsy, Symptomatic|partial complex epilepsy, symptomatic
586001|NCT01073579|Seizure Disorder, Complex Partial|seizure disorder, complex partial
586002|NCT01073579|Symptomatic Partial Complex Epilepsy|symptomatic partial complex epilepsy
586003|NCT01073566|Autoimmune Diseases|autoimmune diseases
586004|NCT01073566|Diabetes Mellitus|diabetes mellitus
586005|NCT01073566|Endocrine System Diseases|endocrine system diseases
586006|NCT01073566|Glucose Metabolism Disorders|glucose metabolism disorders
586007|NCT01073566|Immune System Diseases|immune system diseases
586008|NCT01073566|Insulin|insulin
586009|NCT01073566|Metabolic Diseases|metabolic diseases
586010|NCT01073527|Child, preschool|child, preschool
586011|NCT01073527|Pediatric emergency department|pediatric emergency department
586012|NCT01073514|Malignant biliary obstruction (MBO)|malignant biliary obstruction (mbo)
586013|NCT01073501|UREMIC PRURITUS|uremic pruritus
586014|NCT01073501|PREGABALIN|pregabalin
586015|NCT01073501|UP|up
586016|NCT01073488|Pregnancy|pregnancy
586017|NCT01073488|Maternal child health|maternal child health
586018|NCT01073488|Developing countries|developing countries
586019|NCT01073488|Stillbirth|stillbirth
586020|NCT01073488|Neonatal mortality|neonatal mortality
586021|NCT01073488|Maternal mortality|maternal mortality
586022|NCT01073488|Community intervention|community intervention
586023|NCT01073488|Community mobilization|community mobilization
586024|NCT01073488|Home-based Life Saving Skills|home-based life saving skills
586025|NCT01073475|Pregnancy|pregnancy
586026|NCT01073475|Maternal mortality|maternal mortality
586027|NCT01073475|Neonatal mortality|neonatal mortality
586028|NCT01073475|Stillbirth|stillbirth
586029|NCT01073475|Maternal Cause of Death|maternal cause of death
586030|NCT01073475|Neonatal Cause of Death|neonatal cause of death
586031|NCT01073462|Secondary Hyperparathyroidism (sHPT)|secondary hyperparathyroidism (shpt)
586032|NCT01073462|Paricalcitol|paricalcitol
586033|NCT01073462|Chronic kidney disease stage 5 (CKD stage 5)|chronic kidney disease stage 5 (ckd stage 5)
586034|NCT01073449|Cardiac devices|cardiac devices
586035|NCT01073449|In-Hospital Follow-up|in-hospital follow-up
586036|NCT01073449|Analytical|analytical
586037|NCT01073436|diagnosis of Ph+) CML in chronic phase.|diagnosis of ph+) cml in chronic phase.
586038|NCT01073436|prior therapy with interferon-alpha for at least 2 years, and achieved at least a partial cytogenetic response|prior therapy with interferon-alpha for at least 2 years, and achieved at least a partial cytogenetic response
586039|NCT01073436|receiving a TKI (imatinib mesylate, dasatinib, nilotinib)|receiving a tki (imatinib mesylate, dasatinib, nilotinib)
586040|NCT01073436|WBC ≤ 10 x 109/L.|wbc ≤ 10 x 109/l.
586041|NCT01073436|Platelet count < 450,000 x 109/L.|platelet count < 450,000 x 109/l.
586042|NCT01073436|No blasts or promyelocytes in peripheral blood.|no blasts or promyelocytes in peripheral blood.
586043|NCT01073436|No evidence of disease-related symptoms and extramedullary disease|no evidence of disease-related symptoms and extramedullary disease
586044|NCT01073436|complete cytogenetic response (CCyR) on a TKI for a minimum of 1 yr|complete cytogenetic response (ccyr) on a tki for a minimum of 1 yr
586045|NCT01073436|major molecular remission on a TKI for a minimum of 1 yr|major molecular remission on a tki for a minimum of 1 yr
586046|NCT01073436|18 years of age or older|18 years of age or older
586047|NCT01073436|ECOG performance status of 0-2 (Appendix 13.1)|ecog performance status of 0-2 (appendix 13.1)
586048|NCT01073436|Informed Consent|informed consent
586049|NCT01073423|HIV|hiv
586050|NCT01073423|sleep|sleep
586051|NCT01073423|insomnia|insomnia
586052|NCT01073423|yoga|yoga
586053|NCT01073423|music|music
586054|NCT01073397|Menopause|menopause
586055|NCT01073397|Hot Flashes|hot flashes
586056|NCT01073397|Vasomotor symptoms|vasomotor symptoms
586057|NCT01073397|Yoga|yoga
586058|NCT01073371|Liposome|liposome
586059|NCT01073371|Prilocaine|prilocaine
586060|NCT01073371|Dental anesthesia|dental anesthesia
586061|NCT01073358|resectable hepatic metastases of colorectal cancer|resectable hepatic metastases of colorectal cancer
586062|NCT01073345|Patients undergoing elective hepatic resection|patients undergoing elective hepatic resection
586063|NCT01073319|Methamphetamine|methamphetamine
586064|NCT01073319|Rivastigmine|rivastigmine
586065|NCT01073306|Vaccine|vaccine
586066|NCT01073306|Dengue Hemorrhagic Fever|dengue hemorrhagic fever
586067|NCT01073280|Cerebral and subarachnoid biopsy|cerebral and subarachnoid biopsy
586068|NCT01073280|flexible endoscopy|flexible endoscopy
586069|NCT01073280|Patients with neurological findings without diagnosis.|patients with neurological findings without diagnosis.
586070|NCT01073267|Stage IB-IIIA Mycosis fungoides|stage ib-iiia mycosis fungoides
586071|NCT01073267|Total Skin Electron Beam Therapy|total skin electron beam therapy
586072|NCT01073267|TSEBT|tsebt
586073|NCT01073241|benign prostatic hyperplasia|benign prostatic hyperplasia
586074|NCT01073241|Transurethral Resection of Prostate|transurethral resection of prostate
586075|NCT01073241|transurethral enucleation of prostate|transurethral enucleation of prostate
586076|NCT01073228|Alzheimer's disease|alzheimer's disease
586077|NCT01073228|Central Nervous System diseases|central nervous system diseases
586078|NCT01073228|Cognition|cognition
586079|NCT01073215|Adolescents|adolescents
586080|NCT01073215|Obesity|obesity
586081|NCT01073215|Weight Management|weight management
586082|NCT01073215|Family-based Lifestyle Modification|family-based lifestyle modification
586083|NCT01073189|Acute kidney injury|acute kidney injury
586084|NCT01073189|Fenoldopam mesylate|fenoldopam mesylate
586085|NCT01073189|Benephit catheter|benephit catheter
586086|NCT01073176|ADHD|adhd
586087|NCT01073176|Executive function|executive function
586088|NCT01073176|Preschool children|preschool children
586089|NCT01073176|Treatment|treatment
586090|NCT01073176|Memory|memory
586091|NCT01073176|Attention|attention
586092|NCT01073176|Training|training
586093|NCT01073176|Cognitive enhancement|cognitive enhancement
586094|NCT01073150|Tea Tree Oil|tea tree oil
586095|NCT01073150|Chronic Blepharitis|chronic blepharitis
586096|NCT01073137|diabetes|diabetes
586097|NCT01073072|bovine pericardium bioprosthesis|bovine pericardium bioprosthesis
586098|NCT01073072|contamination|contamination
586099|NCT01073072|hernia repair|hernia repair
586100|NCT01073072|abdominal wall reconstruction|abdominal wall reconstruction
586101|NCT01073072|Tutomesh|tutomesh
586102|NCT01073072|Tutopatch|tutopatch
586103|NCT01073072|Potentially Contaminated Hernia Repair|potentially contaminated hernia repair
586104|NCT01073072|Potentially Contaminated Abdominal Wall Reconstruction|potentially contaminated abdominal wall reconstruction
586105|NCT01073059|valproic acid|valproic acid
586106|NCT01073059|ertapenem|ertapenem
586107|NCT01073046|Naso-Gastric/Jejunal Tube|naso-gastric/jejunal tube
586108|NCT01073046|Sub-total Gastrectomy|sub-total gastrectomy
586109|NCT01073046|Gastric Cancer|gastric cancer
586110|NCT01073046|Decompression|decompression
586111|NCT01073046|Discomfort|discomfort
586112|NCT01073046|Complications|complications
586113|NCT01073033|pregnancy|pregnancy
586114|NCT01073033|lactation|lactation
586115|NCT01073033|oral supplement|oral supplement
586116|NCT01073033|probiotics|probiotics
586117|NCT01073033|early infections|early infections
586118|NCT01073020|Type 2 Diabetes Mellitus|type 2 diabetes mellitus
586119|NCT01073020|Obesity|obesity
586120|NCT01073020|Lifestyle|lifestyle
586121|NCT01073020|Bariatric Surgery|bariatric surgery
586122|NCT01073020|Laparoscopic Adjustable Gastric Band|laparoscopic adjustable gastric band
586123|NCT01073020|Laparoscopic Roux-en-Y Gastric Bypass|laparoscopic roux-en-y gastric bypass
586124|NCT01073007|Acute Stroke|acute stroke
586125|NCT01073007|tissue plasminogen activator|tissue plasminogen activator
586126|NCT01073007|simvastatin|simvastatin
586127|NCT01072994|Myocardium|myocardium
586128|NCT01072994|Phospholipid|phospholipid
586129|NCT01072994|Fish oil|fish oil
586130|NCT01072994|Cardiolipin|cardiolipin
586131|NCT01072994|Transplantation|transplantation
586132|NCT01072981|Pancreatic Cancer|pancreatic cancer
586133|NCT01072981|Vaccine Therapy|vaccine therapy
586134|NCT01072968|Multicenter|multicenter
586135|NCT01072968|Randomized|randomized
586136|NCT01072968|Double-blind|double-blind
586137|NCT01072968|Efficacy and safety study|efficacy and safety study
586138|NCT01072968|BF2.649 versus placebo|bf2.649 versus placebo
586139|NCT01072968|Patients suffering from Obstructive Sleep Apnea|patients suffering from obstructive sleep apnea
586140|NCT01072968|Complaining from Excessive Daytime Sleepiness|complaining from excessive daytime sleepiness
586141|NCT01072968|Refusing nasal Continuous Positive Airway Pressure|refusing nasal continuous positive airway pressure
586142|NCT01072942|Chronic Obstructive|chronic obstructive
586143|NCT01072942|Phase I|phase i
586144|NCT01072942|Pharmacokinetics|pharmacokinetics
586145|NCT01072942|Microbiology|microbiology
586146|NCT01072929|Bipolar I Disorder|bipolar i disorder
586147|NCT01072916|Colon, Irritable|colon, irritable
586148|NCT01072916|Microbiota|microbiota
586149|NCT01072903|inflammation|inflammation
586150|NCT01072903|colon, irritable|colon, irritable
586151|NCT01072903|Colonic Diseases, Functional|colonic diseases, functional
586152|NCT01072903|Irritable Bowel Syndrome|irritable bowel syndrome
586153|NCT01072890|Temsirolimus, Pazopanib|temsirolimus, pazopanib
586154|NCT01072877|Varicose Veins|varicose veins
586155|NCT01072864|Postmenopausal|postmenopausal
586156|NCT01072851|colorectal cancer screening|colorectal cancer screening
586157|NCT01072851|multimedia education|multimedia education
586158|NCT01072851|print education|print education
586159|NCT01072851|culturally competent|culturally competent
586160|NCT01072838|breast cancer|breast cancer
586161|NCT01072838|APBI|apbi
586162|NCT01072838|brachytherapy|brachytherapy
586163|NCT01072838|Contura|contura
586164|NCT01072812|Alzheimer's|alzheimer's
586165|NCT01072812|Amnestic Mild Cognitive Impairment|amnestic mild cognitive impairment
586166|NCT01072812|Pharmacokinetics|pharmacokinetics
586167|NCT01072812|Pharmacodynamics|pharmacodynamics
586168|NCT01072812|Biomarkers|biomarkers
586169|NCT01072799|A (H1N1)|a (h1n1)
586170|NCT01072786|Dengue Virus|dengue virus
586171|NCT01072786|Dengue Fever|dengue fever
586172|NCT01072786|Dengue Vaccine|dengue vaccine
586173|NCT01072786|Dengue Hemorrhagic Fever|dengue hemorrhagic fever
586174|NCT01072786|Dengue Shock Syndrome|dengue shock syndrome
586175|NCT01072760|Mallet finger|mallet finger
586176|NCT01072760|extensor tendon|extensor tendon
586177|NCT01072760|Kirschner wire|kirschner wire
586178|NCT01072760|Fracture Fixation|fracture fixation
586179|NCT01072734|Lupus|lupus
586180|NCT01072734|CXCR4 on leucocytes of patients with SLE|cxcr4 on leucocytes of patients with sle
586181|NCT01072734|Influenza vaccine|influenza vaccine
586182|NCT01072721|Liver|liver
586183|NCT01072721|Fibrosis|fibrosis
586184|NCT01072721|Elastometry|elastometry
586185|NCT01072721|FIBROSCANN|fibroscann
586186|NCT01072721|Children|children
586187|NCT01072708|Cystic fibrosis -diabetes - glucose tolerance - reversibility - oral glucose tolerance test - predictive factors|cystic fibrosis -diabetes - glucose tolerance - reversibility - oral glucose tolerance test - predictive factors
586188|NCT01072695|Hepatitis C|hepatitis c
586190|NCT01072695|GS-9256|gs-9256
586191|NCT01072695|GS-9190|gs-9190
586192|NCT01072695|Genotype 1|genotype 1
586193|NCT01072682|Acute Renal Failure|acute renal failure
586194|NCT01072682|Acute tubular necrosis|acute tubular necrosis
586195|NCT01072682|Continuous Renal Replacement Therapy|continuous renal replacement therapy
586196|NCT01072682|Selective cytopheretic device|selective cytopheretic device
586197|NCT01072669|Ambrisentan increases digital micro-vascular flow (measured by LDPI) in patients with Raynaud's phenomenon (RP) and digital ischemia secondary to SSc.|ambrisentan increases digital micro-vascular flow (measured by ldpi) in patients with raynaud's phenomenon (rp) and digital ischemia secondary to ssc.
586198|NCT01072643|Sedation|sedation
586199|NCT01072643|Pulmonary Hypertension|pulmonary hypertension
586200|NCT01072643|Pediatric|pediatric
586201|NCT01072643|Cardiac Catheterization|cardiac catheterization
586202|NCT01072643|Pulmonary Vascular Resistance|pulmonary vascular resistance
586203|NCT01072630|Bipolar I Disorder|bipolar i disorder
586204|NCT01072604|Aspirin|aspirin
586205|NCT01072604|Acetylsalicylic Acid|acetylsalicylic acid
586206|NCT01072591|anti-NGF|anti-ngf
586207|NCT01072591|OA|oa
586208|NCT01072591|pain|pain
586209|NCT01072578|Healthy volunteers|healthy volunteers
586210|NCT01072578|Inhibition of glucose re-absorption|inhibition of glucose re-absorption
586211|NCT01072578|diabetes|diabetes
586212|NCT01072578|dapagliflozin|dapagliflozin
586213|NCT01072565|Type 2 Diabetes|type 2 diabetes
586214|NCT01072565|A1c|a1c
586418|NCT01071759|Iron|iron
586215|NCT01072565|Continuous Glucose Monitoring|continuous glucose monitoring
586216|NCT01072565|Blood Glucose|blood glucose
586217|NCT01072552|recurrent wheezing|recurrent wheezing
586218|NCT01072552|asthma|asthma
586219|NCT01072552|preterm infants|preterm infants
586220|NCT01072552|palivizumab|palivizumab
586221|NCT01072552|atopic diseases|atopic diseases
586222|NCT01072539|infection|infection
586223|NCT01072539|Tygacil|tygacil
586224|NCT01072539|PMS|pms
586225|NCT01072526|Dry Eye Syndromes|dry eye syndromes
586226|NCT01072526|Lacrimal Apparatus Diseases|lacrimal apparatus diseases
586227|NCT01072513|Semen Analysis, Prostate Cancer, Proton Radiation|semen analysis, prostate cancer, proton radiation
586228|NCT01072500|Aging|aging
586229|NCT01072500|Physical Activity|physical activity
586230|NCT01072500|Exercise|exercise
586231|NCT01072500|Sedentary Lifestyle|sedentary lifestyle
586232|NCT01072500|Mobility|mobility
586233|NCT01072500|Disability|disability
586234|NCT01072500|Falls|falls
586235|NCT01072500|Cost effectiveness|cost effectiveness
586236|NCT01072500|Behavioral counseling|behavioral counseling
586237|NCT01072487|Safety|safety
586238|NCT01072487|Sedation|sedation
586239|NCT01072487|Gastrointestinal endoscopy|gastrointestinal endoscopy
586240|NCT01072487|Colonoscopy|colonoscopy
586241|NCT01072474|Safety|safety
586242|NCT01072474|Sedation|sedation
586243|NCT01072474|Gastrointestinal endoscopy|gastrointestinal endoscopy
586244|NCT01072474|Colonoscopy|colonoscopy
586245|NCT01072461|Cerebrovascular Accident|cerebrovascular accident
586246|NCT01072461|Robotics|robotics
586247|NCT01072461|Virtual Reality|virtual reality
586248|NCT01072461|Rehabilitation|rehabilitation
586249|NCT01072461|Neuroplasticity|neuroplasticity
586250|NCT01072448|COPD|copd
586251|NCT01072448|indacaterol|indacaterol
586252|NCT01072435|ERCP|ercp
586253|NCT01072435|patient-controlled sedation|patient-controlled sedation
586254|NCT01072435|target-controlled infusion|target-controlled infusion
586255|NCT01072435|propofol|propofol
586256|NCT01072435|Sedation with propofol for ERCP|sedation with propofol for ercp
586257|NCT01072435|Endoscopic Retrograde Cholangiopancreatography|endoscopic retrograde cholangiopancreatography
586258|NCT01072422|Smoking|smoking
586259|NCT01072422|Pulmonary Disease, Chronic Obstructive|pulmonary disease, chronic obstructive
586260|NCT01072422|Questionnaires|questionnaires
586261|NCT01072422|Nurses|nurses
586262|NCT01072422|Primary Health Care|primary health care
586263|NCT01072409|Speech perception ability in the CI alone condition|speech perception ability in the ci alone condition
711569|NCT00584012|Any cancer|any cancer
586264|NCT01072383|chronic plaque psoriasis|chronic plaque psoriasis
586265|NCT01072383|psoriasis vulgaris|psoriasis vulgaris
586266|NCT01072383|autoimmune disease|autoimmune disease
586267|NCT01072370|Umbilical Cord Blood|umbilical cord blood
586268|NCT01072370|Stem Cells|stem cells
586269|NCT01072370|Autologous Blood Transfusion|autologous blood transfusion
586270|NCT01072370|Cerebral Palsy|cerebral palsy
586271|NCT01072357|High-Risk Corneal Transplantation|high-risk corneal transplantation
586272|NCT01072357|Penetrating Keratoplasty|penetrating keratoplasty
586273|NCT01072357|Neovascularization|neovascularization
586274|NCT01072357|Corneal Blood Vessels|corneal blood vessels
586275|NCT01072357|Avastin|avastin
586276|NCT01072357|Bevacizumab|bevacizumab
586277|NCT01072357|Corneal Graft|corneal graft
586278|NCT01072344|Anxiety|anxiety
586279|NCT01072344|Chamomile|chamomile
586280|NCT01072344|Herbal Remedy|herbal remedy
586281|NCT01072344|Complementary and Alternative Medicine|complementary and alternative medicine
586282|NCT01072331|insulin resistance|insulin resistance
586283|NCT01072318|Breast cancer|breast cancer
586284|NCT01072318|extended adjuvant hormonal therapy|extended adjuvant hormonal therapy
586285|NCT01072318|letrozole|letrozole
586286|NCT01072318|Toremifene|toremifene
586287|NCT01072305|fluid restriction|fluid restriction
586288|NCT01072305|fluid therapy|fluid therapy
586289|NCT01072305|intraoperative care|intraoperative care
586290|NCT01072279|Malnutrition;|malnutrition;
586291|NCT01072279|Infant nutrition;|infant nutrition;
586292|NCT01072279|Fortified food|fortified food
586293|NCT01072279|Linear growth|linear growth
586294|NCT01072279|Cluster randomized controlled trials|cluster randomized controlled trials
586295|NCT01072279|Effectiveness|effectiveness
586296|NCT01072279|Impact evaluation studies|impact evaluation studies
586297|NCT01072279|Burundi|burundi
586298|NCT01072279|Guatemala|guatemala
586299|NCT01072266|Refractory, Advanced malignancies|refractory, advanced malignancies
586300|NCT01072227|Non-typeable Haemophilus Influenzae|non-typeable haemophilus influenzae
586301|NCT01072227|Acute Otitis Media|acute otitis media
586302|NCT01072227|Streptococcus Pneumoniae|streptococcus pneumoniae
586303|NCT01072227|Etiology|etiology
586304|NCT01072214|Pazopanib|pazopanib
586305|NCT01072214|Tolerability|tolerability
586306|NCT01072214|Pharmacokinetics|pharmacokinetics
586307|NCT01072214|GW786034|gw786034
586308|NCT01072214|Safety|safety
586309|NCT01072175|drug-drug interaction|drug-drug interaction
586310|NCT01072175|BRAF inhibitor|braf inhibitor
586311|NCT01072175|expansion cohorts|expansion cohorts
586312|NCT01072175|melanoma|melanoma
586313|NCT01072175|dose escalation|dose escalation
586314|NCT01072175|MEK inhibitor|mek inhibitor
586315|NCT01072162|healthy|healthy
586316|NCT01072162|powder for suspension|powder for suspension
586317|NCT01072162|tablets|tablets
586318|NCT01072162|bioavailibility|bioavailibility
586319|NCT01072162|eltrombopag|eltrombopag
586320|NCT01072149|COPD|copd
586321|NCT01072149|Safety|safety
586322|NCT01072149|FEV1|fev1
586323|NCT01072149|Efficacy|efficacy
586324|NCT01072136|mucopurulent cervicitis, chlamydia, gonorrhea, women|mucopurulent cervicitis, chlamydia, gonorrhea, women
586325|NCT01072110|Patients with diarrhea|patients with diarrhea
586326|NCT01072097|PCOS|pcos
586327|NCT01072097|Atorvastatin|atorvastatin
586328|NCT01072097|Androgens|androgens
586329|NCT01072097|Glucose metabolism|glucose metabolism
586330|NCT01072097|Inflammatory markers|inflammatory markers
586331|NCT01072084|food allergy|food allergy
586332|NCT01072084|confocal laser endoscope|confocal laser endoscope
586333|NCT01072084|diagnosis|diagnosis
586334|NCT01072084|Diagnosis of food allergy|diagnosis of food allergy
586335|NCT01072071|abdominal compartment syndrome|abdominal compartment syndrome
586336|NCT01072071|intra-abdominal pressure|intra-abdominal pressure
586337|NCT01072071|furosemide|furosemide
586338|NCT01072071|fluid balance|fluid balance
586339|NCT01072058|Infliximab|infliximab
586340|NCT01072058|Adalimumab|adalimumab
586341|NCT01072058|Etanercept|etanercept
586342|NCT01072058|Heart failure|heart failure
586343|NCT01072058|Diastolic disfunction|diastolic disfunction
586344|NCT01072058|TNF blocker|tnf blocker
586345|NCT01072058|Anti-TNF|anti-tnf
586346|NCT01072058|Echocardiography|echocardiography
586347|NCT01072058|Tissue doppler imaging|tissue doppler imaging
586348|NCT01072058|Brain Natriuretic Peptide|brain natriuretic peptide
586349|NCT01072058|NT-proBNP|nt-probnp
586350|NCT01072045|Hemangioma|hemangioma
586351|NCT01072045|Proliferative hemangioma|proliferative hemangioma
586352|NCT01072045|Treatment|treatment
586353|NCT01072045|Propranolol|propranolol
586354|NCT01072045|Corticosteroid|corticosteroid
586355|NCT01072032|EEG|eeg
586356|NCT01072032|Robotics (ankle)|robotics (ankle)
586357|NCT01072032|Motor-learning|motor-learning
586358|NCT01072032|Brain Plasticity|brain plasticity
586359|NCT01072006|TBI (Traumatic Brain Injury)|tbi (traumatic brain injury)
586360|NCT01072006|PTSD|ptsd
586361|NCT01072006|fMRI|fmri
586362|NCT01072006|attention|attention
586363|NCT01071993|prevention|prevention
586364|NCT01071993|nephropathy|nephropathy
586365|NCT01071967|Community Health Nursing|community health nursing
586366|NCT01071967|Nursing Care Management|nursing care management
586367|NCT01071967|Aged|aged
586368|NCT01071967|Aged, 80 and over|aged, 80 and over
586369|NCT01071967|Health Services for the Aged|health services for the aged
586370|NCT01071967|Geriatric Nursing|geriatric nursing
586371|NCT01071967|Geriatric Assessment|geriatric assessment
586372|NCT01071967|Longevity|longevity
586373|NCT01071967|Mortality|mortality
586374|NCT01071954|Immune thrombocytopenic Purpura|immune thrombocytopenic purpura
586375|NCT01071954|Pediatric|pediatric
586376|NCT01071954|Thrombocytopenia|thrombocytopenia
586377|NCT01071941|rRp450|rrp450
586378|NCT01071941|Herpes virus|herpes virus
586379|NCT01071941|Gene therapy|gene therapy
586380|NCT01071928|Advanced Urothelial Carcinoma|advanced urothelial carcinoma
586381|NCT01071902|ear tubes|ear tubes
586382|NCT01071902|ear drainage|ear drainage
586383|NCT01071902|ear infection|ear infection
586384|NCT01071902|ear drops|ear drops
586385|NCT01071902|acute otitis media|acute otitis media
586386|NCT01071889|Healthy Volunteers|healthy volunteers
586387|NCT01071876|Sleep disorder|sleep disorder
586388|NCT01071876|obstructive sleep apnea|obstructive sleep apnea
586389|NCT01071876|excessive daytime sleepiness|excessive daytime sleepiness
586390|NCT01071876|patients with OSA treated by CPAP presenting EDS|patients with osa treated by cpap presenting eds
586391|NCT01071850|ASP1941|asp1941
586392|NCT01071850|Metformin|metformin
586393|NCT01071850|Type 2 diabetes|type 2 diabetes
586394|NCT01071850|diabetes|diabetes
586395|NCT01071837|Glioblastoma Multiforme|glioblastoma multiforme
586396|NCT01071824|size|size
586397|NCT01071824|limb|limb
586398|NCT01071824|transverse coloplasty pouch|transverse coloplasty pouch
586399|NCT01071824|rectal resection|rectal resection
586400|NCT01071824|mesorectal excision|mesorectal excision
586401|NCT01071824|treatment outcome|treatment outcome
586402|NCT01071811|Randomized controlled trial|randomized controlled trial
586403|NCT01071811|Pedometer|pedometer
586404|NCT01071811|Physical activity|physical activity
586405|NCT01071811|Health measurement|health measurement
586406|NCT01071811|Self-rated health|self-rated health
586407|NCT01071811|Stress|stress
586408|NCT01071811|Sleep quality|sleep quality
586409|NCT01071785|Metabolic Syndrome|metabolic syndrome
586410|NCT01071785|diet|diet
586411|NCT01071785|fiber|fiber
586412|NCT01071785|Serum lipids|serum lipids
586413|NCT01071785|Albuminuria|albuminuria
586414|NCT01071759|Pregnancy|pregnancy
586415|NCT01071759|anemia|anemia
586416|NCT01071759|Helicobacter pylori|helicobacter pylori
586419|NCT01071759|Ferritin|ferritin
586420|NCT01071720|Healthy subjects|healthy subjects
586421|NCT01071707|IPF|ipf
586422|NCT01071707|Idiopathic Pulmonary Fibrosis|idiopathic pulmonary fibrosis
586423|NCT01071694|Multiple Sclerosis,|multiple sclerosis,
586424|NCT01071694|Relapsing-Remitting,|relapsing-remitting,
586425|NCT01071694|Interferon beta-1b,|interferon beta-1b,
586426|NCT01071694|Quality of life|quality of life
586427|NCT01071681|Arterial hypertension|arterial hypertension
586428|NCT01071668|onset of labor|onset of labor
586429|NCT01071668|metabolomics|metabolomics
586430|NCT01071668|vaginal secretions|vaginal secretions
586431|NCT01071668|urine|urine
586432|NCT01071668|blood|blood
586433|NCT01071655|colorectal cancer|colorectal cancer
586434|NCT01071655|Bevacizumab|bevacizumab
586435|NCT01071655|Oxaliplatin|oxaliplatin
586436|NCT01071655|Irinotecan|irinotecan
586437|NCT01071655|5FU|5fu
586438|NCT01071655|capecitabine|capecitabine
586439|NCT01071642|Change in eGFR from baseline to 72 hours following the exposure to the contrast.|change in egfr from baseline to 72 hours following the exposure to the contrast.
586440|NCT01071642|Rate of eGFR decrease>25% from the baseline|rate of egfr decrease>25% from the baseline
586441|NCT01071642|Length of hospitalization.|length of hospitalization.
586442|NCT01071642|Requirement of unplanned therapy for elevated blood pressure|requirement of unplanned therapy for elevated blood pressure
586443|NCT01071629|interval training|interval training
586444|NCT01071629|strength training|strength training
586445|NCT01071629|exercise capacity|exercise capacity
586446|NCT01071629|chronic heart failure|chronic heart failure
586447|NCT01071629|Cardiac rehabilitation|cardiac rehabilitation
586448|NCT01071616|Cannabinoids|cannabinoids
586449|NCT01071616|Oral Fluid|oral fluid
586450|NCT01071616|Pharmacokinetics|pharmacokinetics
586451|NCT01071616|Stability|stability
586452|NCT01071616|Smoked Cannabis|smoked cannabis
586453|NCT01071603|Biomarkers|biomarkers
586454|NCT01071603|Extrapulmonary TB|extrapulmonary tb
586455|NCT01071603|NTM|ntm
586456|NCT01071603|HRCT|hrct
586457|NCT01071603|MDRTB|mdrtb
586458|NCT01071603|Tuberculosis|tuberculosis
586459|NCT01071590|Parkinson's Disease|parkinson's disease
586460|NCT01071590|Sensory Input|sensory input
586461|NCT01071590|Gait|gait
586462|NCT01071590|Imagery|imagery
586463|NCT01071590|Parkinson Disease|parkinson disease
586464|NCT01071590|PD|pd
586465|NCT01071577|Bone Marrow Stromal Cells|bone marrow stromal cells
586466|NCT01071577|Mesenchymal Stem Cells|mesenchymal stem cells
586467|NCT01071577|Immune Modulation|immune modulation
586468|NCT01071577|Tissue Regeneration|tissue regeneration
586469|NCT01071551|Children|children
586470|NCT01071551|Obesity|obesity
586471|NCT01071551|Lifestyle|lifestyle
586472|NCT01071551|LSES|lses
586473|NCT01071551|Caries|caries
586474|NCT01071538|Depressive Disorder, Major|depressive disorder, major
586475|NCT01071538|Late-Life Depression|late-life depression
586476|NCT01071538|Geriatrics|geriatrics
586477|NCT01071538|Buprenorphine|buprenorphine
586478|NCT01071512|MRI|mri
586479|NCT01071512|OCT|oct
586480|NCT01071512|Tysabri|tysabri
586481|NCT01071512|Multiple Sclerosis|multiple sclerosis
586482|NCT01071512|cognition|cognition
586483|NCT01071499|pharmacokinetics|pharmacokinetics
586484|NCT01071499|pharmacogenetics|pharmacogenetics
586485|NCT01071499|morphine|morphine
586486|NCT01071499|children|children
586487|NCT01071486|Busulfan|busulfan
586488|NCT01071486|Glutathione S-transferase|glutathione s-transferase
586489|NCT01071486|Genetic polymorphism|genetic polymorphism
586490|NCT01071486|HVOD|hvod
586491|NCT01071486|GVHD|gvhd
586492|NCT01071473|Childhood cancer|childhood cancer
586493|NCT01071473|Anthracyclines|anthracyclines
586494|NCT01071473|Cardiomyopathy|cardiomyopathy
586495|NCT01071460|PAD|pad
586496|NCT01071447|Rheumatic diseases|rheumatic diseases
586497|NCT01071447|Biologic treatment|biologic treatment
586498|NCT01071447|Nurse-led|nurse-led
586499|NCT01071421|Sleep apnea syndrome|sleep apnea syndrome
586500|NCT01071421|community acquired pneumonia|community acquired pneumonia
586501|NCT01071421|prevalence|prevalence
586502|NCT01071408|chronic care model|chronic care model
586503|NCT01071408|stroke prevention|stroke prevention
586504|NCT01071408|health services research|health services research
586505|NCT01071395|Parkinson's disease|parkinson's disease
586506|NCT01071395|Dyskinesia|dyskinesia
586507|NCT01071395|Dyskinesia Rating Scales|dyskinesia rating scales
586508|NCT01071395|Amantadine|amantadine
586509|NCT01071395|Placebo|placebo
586510|NCT01071382|Aeromedical Evacuation|aeromedical evacuation
586511|NCT01071382|Repatriation|repatriation
586512|NCT01071356|methamphetamine|methamphetamine
586513|NCT01071356|motivational interviewing|motivational interviewing
586514|NCT01071343|muscular atrophy|muscular atrophy
586515|NCT01071343|recovery of function|recovery of function
586516|NCT01071343|rehabilitation|rehabilitation
586517|NCT01071343|Intensive care unit|intensive care unit
586518|NCT01071304|Relapsed or refractory advanced cancer, metastatic cancer, locally advanced cancer|relapsed or refractory advanced cancer, metastatic cancer, locally advanced cancer
586619|NCT01070784|Symbicort|symbicort
586519|NCT01071278|Lipid metabolism disorder|lipid metabolism disorder
586520|NCT01071252|Moderate to severe chronic plaque-type psoriasis|moderate to severe chronic plaque-type psoriasis
586521|NCT01071252|AIN457|ain457
586522|NCT01071252|dermatology|dermatology
586523|NCT01071239|Fanconi Anemia|fanconi anemia
586524|NCT01071239|Hematopoietic stem cell transplant|hematopoietic stem cell transplant
586525|NCT01071226|Malignant and non-malignant diseases|malignant and non-malignant diseases
586526|NCT01071226|Hematopoietic stem cell transplant|hematopoietic stem cell transplant
586527|NCT01071226|Peripheral blood progenitor cell transplant|peripheral blood progenitor cell transplant
586528|NCT01071226|CliniMACS device|clinimacs device
586529|NCT01071226|T cell depletion|t cell depletion
586530|NCT01071200|Reproductive Techniques, Assisted|reproductive techniques, assisted
586531|NCT01071200|Recombinant human follicle stimulating hormone (r-hFSH)|recombinant human follicle stimulating hormone (r-hfsh)
586532|NCT01071200|Recombinant leutinizing hormone (r-hLH)|recombinant leutinizing hormone (r-hlh)
586533|NCT01071187|alcohol dependence|alcohol dependence
586534|NCT01071187|addiction|addiction
586535|NCT01071187|alcohol|alcohol
586536|NCT01071187|relapse prevention|relapse prevention
586537|NCT01071174|HIV infections|hiv infections
586538|NCT01071174|Anti-HIV agents|anti-hiv agents
586539|NCT01071174|HIV-1|hiv-1
586540|NCT01071161|chronic cough|chronic cough
586541|NCT01071161|COPD|copd
586542|NCT01071161|Azithromycin|azithromycin
586543|NCT01071161|Zithromax|zithromax
586545|NCT01071148|Infertility|infertility
586546|NCT01071148|Gonal-f|gonal-f
586547|NCT01071148|Pergoveris|pergoveris
586548|NCT01071148|Luveris|luveris
586549|NCT01071122|Central blood pressure|central blood pressure
586550|NCT01071122|Nifedipine|nifedipine
586551|NCT01071122|Valsartan|valsartan
586552|NCT01071109|Therapeutic massage|therapeutic massage
586553|NCT01071109|massage|massage
586554|NCT01071109|inflammation|inflammation
586555|NCT01071109|fatigue|fatigue
586556|NCT01071109|insomnia|insomnia
586557|NCT01071109|radiation therapy|radiation therapy
586558|NCT01071109|breast cancer|breast cancer
586559|NCT01071109|Breast Cancer patients receiving radiation therapy|breast cancer patients receiving radiation therapy
586560|NCT01071096|Botox|botox
586561|NCT01071096|OnabotulinumtoxinA|onabotulinumtoxina
586562|NCT01071096|Chronic Migraine|chronic migraine
586563|NCT01071096|Calcitonin Gene-Related Peptide|calcitonin gene-related peptide
586564|NCT01071096|Saliva|saliva
586565|NCT01071083|MS|ms
586566|NCT01071070|Chronic Kidney Disease|chronic kidney disease
586567|NCT01071070|Secondary hyperparathyroidism|secondary hyperparathyroidism
586568|NCT01071057|opioid-induced pruritus|opioid-induced pruritus
586569|NCT01071057|naloxone|naloxone
586570|NCT01071044|Chronic Fatigue Syndrome|chronic fatigue syndrome
586571|NCT01071031|Safety|safety
586572|NCT01071031|Tolerability|tolerability
586573|NCT01071031|Immunogenicity|immunogenicity
586574|NCT01071031|Human Immunodeficiency Virus|human immunodeficiency virus
586575|NCT01071031|HIV-1|hiv-1
586576|NCT01071031|Vaccine|vaccine
586577|NCT01071031|CD4|cd4
586578|NCT01071031|Viral Load|viral load
586579|NCT01071031|HIV|hiv
586580|NCT01071018|locally advanced or metastatic solid tumors|locally advanced or metastatic solid tumors
586581|NCT01071005|Decrease serum levels of luteinizing hormone, FSH and Testosterone|decrease serum levels of luteinizing hormone, fsh and testosterone
586582|NCT01070966|Atherosclerosis|atherosclerosis
586583|NCT01070953|Hypercholesterolemia|hypercholesterolemia
586584|NCT01070940|L-NMMA|l-nmma
586585|NCT01070940|blood pressure|blood pressure
586586|NCT01070940|arterial stiffness|arterial stiffness
586587|NCT01070940|pulse wave velocity|pulse wave velocity
586588|NCT01070940|augmentation index|augmentation index
586589|NCT01070940|dose-response|dose-response
586590|NCT01070940|healthy subjects|healthy subjects
586591|NCT01070940|GFR|gfr
586592|NCT01070914|Cilia|cilia
586593|NCT01070914|Phenotyping|phenotyping
586594|NCT01070914|Diagnosis|diagnosis
586595|NCT01070914|Nitric Oxide|nitric oxide
586596|NCT01070914|Bronchiectasis|bronchiectasis
586597|NCT01070888|Asthma|asthma
586598|NCT01070888|Exercise Induced Asthma|exercise induced asthma
586599|NCT01070875|Antithrombotic prophylaxis|antithrombotic prophylaxis
586600|NCT01070862|multiple myeloma, treatment, first line|multiple myeloma, treatment, first line
586601|NCT01070849|exercise|exercise
586602|NCT01070849|physical activity|physical activity
586603|NCT01070836|JCV|jcv
586604|NCT01070836|Sample Collection|sample collection
586605|NCT01070836|PML|pml
586606|NCT01070836|Antibody|antibody
586607|NCT01070823|Sample Collection|sample collection
586608|NCT01070823|JCV|jcv
586609|NCT01070823|PML|pml
586610|NCT01070810|Septic Shock|septic shock
586611|NCT01070810|Sepsis|sepsis
586612|NCT01070797|Epstein-Barr virus|epstein-barr virus
586613|NCT01070797|CTL|ctl
586614|NCT01070797|cytotoxic T Lymphocytes|cytotoxic t lymphocytes
586615|NCT01070797|CMV|cmv
586616|NCT01070797|Adenovirus Infection|adenovirus infection
586617|NCT01070797|viral infection|viral infection
586618|NCT01070797|hematopoietic stem cell transplantation|hematopoietic stem cell transplantation
586620|NCT01070784|Safety|safety
586621|NCT01070784|Efficacy|efficacy
586622|NCT01070784|COPD|copd
586623|NCT01070784|Japanese|japanese
586624|NCT01070771|Pressure wire|pressure wire
586625|NCT01070771|Fractional flow reserve|fractional flow reserve
586626|NCT01070758|Congenital hyperinsulinism|congenital hyperinsulinism
586627|NCT01070758|Somatostatin analog|somatostatin analog
586628|NCT01070758|Lanreotide autogel|lanreotide autogel
586629|NCT01070758|Hypoglycemia|hypoglycemia
586630|NCT01070745|PDA|pda
586631|NCT01070745|Indomethacin|indomethacin
586632|NCT01070745|Ibuprofen|ibuprofen
586633|NCT01070732|Fever|fever
586634|NCT01070732|Infectious diseases|infectious diseases
586635|NCT01070732|Neoplasia|neoplasia
586636|NCT01070732|Pain|pain
586637|NCT01070732|cholecystectomy|cholecystectomy
586638|NCT01070732|Colectomy|colectomy
586639|NCT01070719|Multiple Sclerosis, relapsing forms|multiple sclerosis, relapsing forms
586640|NCT01070706|Patients with HER2- stage II/III breast cancer|patients with her2- stage ii/iii breast cancer
586641|NCT01070693|Inguinal hernia|inguinal hernia
586642|NCT01070693|Open mesh repair|open mesh repair
586643|NCT01070693|Long term outcome|long term outcome
586644|NCT01070693|Recurrence|recurrence
586645|NCT01070693|Discomfort|discomfort
586646|NCT01070680|ERCP|ercp
586647|NCT01070680|dexmedetomidine|dexmedetomidine
586648|NCT01070680|propofol|propofol
586649|NCT01070680|patient-controlled sedation|patient-controlled sedation
586650|NCT01070680|Chronic Alcoholic pancreatitis|chronic alcoholic pancreatitis
586651|NCT01070667|PAF|paf
586652|NCT01070667|AF|af
586653|NCT01070667|Dronedarone|dronedarone
586654|NCT01070667|AF Burden|af burden
586655|NCT01070667|AFB|afb
586656|NCT01070667|PPM|ppm
586657|NCT01070667|Permanent Pacemaker|permanent pacemaker
586658|NCT01070667|Atrial Fibrillation Burden in Paroxysmal Atrial Fibrillation|atrial fibrillation burden in paroxysmal atrial fibrillation
586659|NCT01070654|ARDS|ards
586660|NCT01070654|Recruitment Manoeuvres|recruitment manoeuvres
586661|NCT01070654|PEEP|peep
586662|NCT01070654|Cytokines|cytokines
586663|NCT01070654|Respiratory Insufficiency|respiratory insufficiency
586664|NCT01070641|CARVEDILOL|carvedilol
586665|NCT01070641|VARICEAL BAND LIGATION|variceal band ligation
586666|NCT01070641|PRIMARY PROPHYLAXIS|primary prophylaxis
586667|NCT01070628|Pharmacokinetic|pharmacokinetic
586668|NCT01070602|IFIS|ifis
586669|NCT01070589|Obesity|obesity
586670|NCT01070589|Growth hormone secretion|growth hormone secretion
586671|NCT01070589|Anaerobic exercise|anaerobic exercise
586672|NCT01070576|non union|non union
586673|NCT01070576|fracture|fracture
586674|NCT01070576|healing|healing
586675|NCT01070576|arginine|arginine
586676|NCT01070576|NO|no
586677|NCT01070563|Brain death|brain death
586678|NCT01070563|CT angiography|ct angiography
586679|NCT01070563|Ultrasonography, doppler, transcranial|ultrasonography, doppler, transcranial
586680|NCT01070537|Otolaryngology|otolaryngology
586681|NCT01070537|Equipment and Supplies|equipment and supplies
586682|NCT01070537|Intubation|intubation
586683|NCT01070511|Muscular Dystrophy|muscular dystrophy
586684|NCT01070511|Tadalafil|tadalafil
586685|NCT01070498|peanut hypersensitivity|peanut hypersensitivity
586686|NCT01070498|tree nut hypersensitivity|tree nut hypersensitivity
586687|NCT01070498|allergy|allergy
586688|NCT01070498|Trichuris suis|trichuris suis
586689|NCT01070498|hygiene hypothesis|hygiene hypothesis
586690|NCT01070498|treatment|treatment
586691|NCT01070498|clinical trial|clinical trial
586692|NCT01070498|food/adverse effect|food/adverse effect
586693|NCT01070498|peanut allergy (mild to moderate)|peanut allergy (mild to moderate)
586694|NCT01070498|tree nut allergy (mild to moderate)|tree nut allergy (mild to moderate)
586695|NCT01070472|labor induction at term using a titrated oral misoprostol solution|labor induction at term using a titrated oral misoprostol solution
586696|NCT01070459|Stroke aerobic exercise daily functioning rehabilitation|stroke aerobic exercise daily functioning rehabilitation
586697|NCT01070446|choline|choline
586698|NCT01070446|cystic fibrosis|cystic fibrosis
586699|NCT01070446|methyl metabolism|methyl metabolism
586700|NCT01070446|fatty acids|fatty acids
586701|NCT01070446|oxidative stress|oxidative stress
586702|NCT01070446|pulmonary function|pulmonary function
586703|NCT01070433|Diabetic Foot Ulcers (DFUs)|diabetic foot ulcers (dfus)
586704|NCT01070420|Adenosine|adenosine
586705|NCT01070420|Fractional flow reserve, Hyperemia|fractional flow reserve, hyperemia
586706|NCT01070420|Fractional Flow Reserve, Myocardial|fractional flow reserve, myocardial
586707|NCT01070407|Hepatitis C virus|hepatitis c virus
586708|NCT01070407|HCV|hcv
586709|NCT01070407|Adenovirus|adenovirus
586710|NCT01070407|Vaccine|vaccine
586711|NCT01070394|ADHD|adhd
586712|NCT01070394|Lisdexamfetamine Dimesylate|lisdexamfetamine dimesylate
586713|NCT01070394|Amphetamine|amphetamine
586714|NCT01070368|skin test|skin test
586715|NCT01070368|open wheat challenge|open wheat challenge
586716|NCT01070355|Colorectal Neoplasms|colorectal neoplasms
586717|NCT01070355|Fish Oils|fish oils
586718|NCT01070355|Fatty Acids, Omega-3|fatty acids, omega-3
586719|NCT01070355|Eicosapentaenoic Acid|eicosapentaenoic acid
586720|NCT01070355|Liver Metastases|liver metastases
586721|NCT01070355|Randomised Controlled Trial|randomised controlled trial
586722|NCT01070316|Epilepsy|epilepsy
586723|NCT01070316|Tuberous Sclerosis Complex|tuberous sclerosis complex
586724|NCT01070316|Everolimus|everolimus
586725|NCT01070316|RAD001|rad001
586726|NCT01070316|Mammalian Target of Rapamycin (MTOR)|mammalian target of rapamycin (mtor)
586727|NCT01070303|HUMIRA|humira
586728|NCT01070303|adalimumab|adalimumab
586729|NCT01070303|Inflammatory Bowel Disease|inflammatory bowel disease
586730|NCT01070290|gastric carcinoma|gastric carcinoma
586731|NCT01070290|Locally Advanced or Metastatic Gastric Cancer|locally advanced or metastatic gastric cancer
586732|NCT01070277|chronic diarrhea|chronic diarrhea
586733|NCT01070277|travelers|travelers
586734|NCT01070277|Parasites|parasites
586735|NCT01070277|albendazole|albendazole
586736|NCT01070277|tinidazole|tinidazole
586737|NCT01070264|Osteoarthritis|osteoarthritis
586738|NCT01070238|Isomaltulose|isomaltulose
586739|NCT01070238|Slow Released Carbohydrates|slow released carbohydrates
586740|NCT01070238|Postprandial Glucose Metabolism|postprandial glucose metabolism
586741|NCT01070238|Type 2 diabetes|type 2 diabetes
586742|NCT01070212|human, chewing, appetite,|human, chewing, appetite,
586743|NCT01070199|obese, liquid, solid, fitness, humans, appetite|obese, liquid, solid, fitness, humans, appetite
586744|NCT01070186|nephrectomy|nephrectomy
586745|NCT01070186|T1b|t1b
586746|NCT01070186|T2|t2
586747|NCT01070186|T3|t3
586748|NCT01070186|T4|t4
586749|NCT01070186|N1|n1
586750|NCT01070186|Kidney Cancer|kidney cancer
586751|NCT01070173|Ghrelin|ghrelin
586752|NCT01070173|short stature|short stature
586753|NCT01070173|failure to thrive|failure to thrive
586754|NCT01070160|Polycystic Ovarian Syndrome (PCOS)|polycystic ovarian syndrome (pcos)
586755|NCT01070160|Metformin|metformin
586756|NCT01070160|Endometrin|endometrin
586757|NCT01070147|asthma|asthma
586758|NCT01070147|emergency medicine|emergency medicine
586759|NCT01070147|medical informatics|medical informatics
586760|NCT01070147|computerized reminder systems|computerized reminder systems
586761|NCT01070121|Rheumatoid Arthritis|rheumatoid arthritis
586762|NCT01070121|RA|ra
586763|NCT01070121|Autoimmune Disease|autoimmune disease
586764|NCT01070121|Muscular Skeletal Disease|muscular skeletal disease
586765|NCT01070108|Preemption, ketamine, escalating, dose, pain, analgesia|preemption, ketamine, escalating, dose, pain, analgesia
586766|NCT01070082|adult ICU patients|adult icu patients
586767|NCT01070082|procedural pain|procedural pain
586768|NCT01070082|pain intensity|pain intensity
586769|NCT01070082|pain distress|pain distress
586770|NCT01070082|pain behaviors|pain behaviors
586771|NCT01070082|pain|pain
586772|NCT01070082|ICU procedures|icu procedures
586773|NCT01070069|Percutaneous|percutaneous
586774|NCT01070069|Preclose|preclose
586775|NCT01070069|Endologix|endologix
586776|NCT01070069|Abbott Vascular|abbott vascular
586777|NCT01070069|Endovascular|endovascular
586778|NCT01070069|PEVAR|pevar
586779|NCT01070069|Stent graft|stent graft
586780|NCT01070069|Suture mediated closure devices|suture mediated closure devices
586781|NCT01070056|Blood Pressure|blood pressure
586782|NCT01070056|Lifestyle Changes|lifestyle changes
586783|NCT01070056|African American|african american
586784|NCT01070043|Hypertension|hypertension
586785|NCT01070043|valsartan|valsartan
586786|NCT01070043|amlodipine|amlodipine
586787|NCT01070043|high blood pressure|high blood pressure
586788|NCT01070030|Stage II Hypertension, Aliskiren, Amlodipine, Hydrochlorothiazide|stage ii hypertension, aliskiren, amlodipine, hydrochlorothiazide
586789|NCT01070017|Peru|peru
586790|NCT01070017|DOT|dot
586791|NCT01070017|HIV|hiv
586792|NCT01070017|AIDS|aids
586793|NCT01070017|Community based|community based
586794|NCT01070017|social capital|social capital
586795|NCT01070004|sleepiness|sleepiness
586796|NCT01070004|driving|driving
586797|NCT01070004|countermeasures|countermeasures
586798|NCT01070004|coffee|coffee
586799|NCT01070004|blue light exposure|blue light exposure
586800|NCT01070004|physical activity|physical activity
586801|NCT01069991|Asthma|asthma
586802|NCT01069991|Adolescents|adolescents
586803|NCT01069991|Patient Education|patient education
586804|NCT01069991|Schools|schools
586805|NCT01069965|Type 2|type 2
586806|NCT01069952|Deep Brain Stimulation|deep brain stimulation
586807|NCT01069952|Treatment Refractory|treatment refractory
586808|NCT01069952|Neurosurgery|neurosurgery
586809|NCT01069952|Implantable Neurostimulator (INS)|implantable neurostimulator (ins)
586810|NCT01069952|Internal Capsule|internal capsule
586811|NCT01069939|Gastric ulcer|gastric ulcer
586812|NCT01069939|Duodenal ulcer|duodenal ulcer
586813|NCT01069939|Low-dose aspirin|low-dose aspirin
586814|NCT01069926|Diabetes|diabetes
586815|NCT01069913|Healthy Volunteer|healthy volunteer
586816|NCT01069900|Intra-abdominal infection|intra-abdominal infection
586817|NCT01069900|Pediatric infection|pediatric infection
586818|NCT01069887|febrile events|febrile events
586819|NCT01069887|invasive fungal infections|invasive fungal infections
586820|NCT01069887|hematological patients|hematological patients
586821|NCT01069874|Bone Density Conservation Agents|bone density conservation agents
587015|NCT01069133|cirrhosis|cirrhosis
586822|NCT01069874|Cholecalciferol|cholecalciferol
586823|NCT01069874|Communicable Diseases|communicable diseases
586824|NCT01069874|Growth Substances|growth substances
586825|NCT01069874|Housing for the Elderly|housing for the elderly
586826|NCT01069874|Infection|infection
586827|NCT01069874|Micronutrients|micronutrients
586828|NCT01069874|Pharmacologic Actions|pharmacologic actions
586829|NCT01069874|Physiological Effects of Drugs|physiological effects of drugs
586830|NCT01069874|Respiratory Tract Diseases|respiratory tract diseases
586831|NCT01069874|Vitamins|vitamins
586832|NCT01069874|Respiratory Tract Infections/prevention & control*|respiratory tract infections/prevention & control*
586833|NCT01069874|Vitamin D|vitamin d
586834|NCT01069861|PPHN|pphn
586835|NCT01069861|neonates|neonates
586836|NCT01069861|sildanefil IV|sildanefil iv
586837|NCT01069835|Non small cell lung cancer|non small cell lung cancer
586838|NCT01069835|EGFR mutation|egfr mutation
586839|NCT01069835|NSCLC|nsclc
586840|NCT01069822|Midazolam|midazolam
586841|NCT01069822|Pharmacokinetics|pharmacokinetics
586842|NCT01069796|triple negative|triple negative
586843|NCT01069796|metastatic|metastatic
586844|NCT01069796|breast cancer|breast cancer
586845|NCT01069796|First line chemotherapy|first line chemotherapy
586846|NCT01069783|dyslipidemia|dyslipidemia
586847|NCT01069783|cholesterol|cholesterol
586848|NCT01069783|LDL|ldl
586849|NCT01069770|Neoadjuvant Therapy|neoadjuvant therapy
586850|NCT01069770|Sunitinib|sunitinib
586851|NCT01069770|Clear Cell Renal Cell Carcinoma|clear cell renal cell carcinoma
586852|NCT01069770|Metastasis|metastasis
586853|NCT01069757|Advanced/recurrent non-small-cell lung cancer|advanced/recurrent non-small-cell lung cancer
586854|NCT01069705|Tobramycin Inhalation Powder|tobramycin inhalation powder
586855|NCT01069705|Cystic fibrosis|cystic fibrosis
586856|NCT01069705|Lung diseases|lung diseases
586857|NCT01069705|Anti-Bacterial Agents|anti-bacterial agents
586858|NCT01069705|Treatment of pulmonary infections with P. aeruginosa in cystic fibrosis patients|treatment of pulmonary infections with p. aeruginosa in cystic fibrosis patients
586859|NCT01069692|Chronic Kidney Disease|chronic kidney disease
586860|NCT01069692|Hemodialysis|hemodialysis
586861|NCT01069692|Hyperphosphatemia|hyperphosphatemia
710267|NCT00589563|stage III cutaneous T-cell non-Hodgkin lymphoma|stage iii cutaneous t-cell non-hodgkin lymphoma
746045|NCT00452660|MDS|mds
586862|NCT01069692|Hyperphosphatemia patients with chronic kidney disease on 3x/week hemodialysis|hyperphosphatemia patients with chronic kidney disease on 3x/week hemodialysis
586863|NCT01069666|atopic dermatitis|atopic dermatitis
586864|NCT01069666|Thai pediatricians|thai pediatricians
586865|NCT01069653|CDCA1|cdca1
586866|NCT01069653|KIF20A|kif20a
586867|NCT01069653|lung cancer|lung cancer
586868|NCT01069653|vaccine|vaccine
586869|NCT01069653|HLA-A*2402|hla-a*2402
586870|NCT01069640|URLC10|urlc10
586871|NCT01069640|lung cancer|lung cancer
586872|NCT01069640|vaccine|vaccine
586873|NCT01069640|HLA-A*0201|hla-a*0201
586874|NCT01069640|HLA-A*0206|hla-a*0206
586875|NCT01069614|Equipment and supplies|equipment and supplies
586876|NCT01069601|solid organ transplantation|solid organ transplantation
586877|NCT01069601|bone marrow transplantation|bone marrow transplantation
586878|NCT01069601|adults|adults
586879|NCT01069601|adults with solid organ transplantation|adults with solid organ transplantation
586880|NCT01069601|adults with bone marrow transplantation|adults with bone marrow transplantation
586881|NCT01069588|bioabsorbable screw|bioabsorbable screw
586882|NCT01069588|acl reconstruction|acl reconstruction
586883|NCT01069575|URLC10|urlc10
586884|NCT01069575|CDCA1|cdca1
586885|NCT01069575|KIF20A|kif20a
586886|NCT01069575|lung cancer|lung cancer
586887|NCT01069575|vaccine|vaccine
586888|NCT01069575|HLA-A*2402|hla-a*2402
586889|NCT01069562|closed loop control of anesthesia|closed loop control of anesthesia
586890|NCT01069562|isoflurane|isoflurane
586891|NCT01069562|open heart surgery|open heart surgery
586892|NCT01069549|Type 2 Diabetes Mellitus|type 2 diabetes mellitus
586893|NCT01069549|Diabetic Nephropathy|diabetic nephropathy
586894|NCT01069549|Angiotensin II type 1 receptor gene polymorphism|angiotensin ii type 1 receptor gene polymorphism
586895|NCT01069549|Acetyl coA carboxylase beta gene polymorphism.|acetyl coa carboxylase beta gene polymorphism.
586896|NCT01069536|metoclopramide|metoclopramide
586897|NCT01069536|akathisia|akathisia
586898|NCT01069536|nausea|nausea
586899|NCT01069536|vomiting|vomiting
586900|NCT01069536|antiemetic|antiemetic
586901|NCT01069536|improvement of nausea|improvement of nausea
586902|NCT01069523|Attention Deficit Disorder with Hyperactivity|attention deficit disorder with hyperactivity
586903|NCT01069523|Guanfacine|guanfacine
586904|NCT01069523|Event Related Potentials|event related potentials
586905|NCT01069497|Infection control|infection control
586906|NCT01069497|Urinary Tract Infections|urinary tract infections
586907|NCT01069497|Respiratory Tract Infections|respiratory tract infections
586908|NCT01069484|Randomized controlled trial|randomized controlled trial
586909|NCT01069484|Post partum pelvic floor muscle training|post partum pelvic floor muscle training
586910|NCT01069484|Urinary incontinence|urinary incontinence
586911|NCT01069484|Pelvic floor dysfunction|pelvic floor dysfunction
586912|NCT01069484|Pelvic floor muscle injury|pelvic floor muscle injury
586913|NCT01069484|Pelvic floor muscle strength|pelvic floor muscle strength
586914|NCT01069484|Pelvic floor muscle morphology|pelvic floor muscle morphology
586915|NCT01069471|S.dysenteriae|s.dysenteriae
586916|NCT01069471|Healthy volunteers|healthy volunteers
586917|NCT01069471|Conjugate vaccine|conjugate vaccine
586918|NCT01069471|Safety|safety
586919|NCT01069471|Immunogenicity|immunogenicity
586920|NCT01069471|Dose scaling|dose scaling
586921|NCT01069458|Dietary intervention|dietary intervention
586922|NCT01069458|Smoking cessation|smoking cessation
586923|NCT01069458|Body weight|body weight
586924|NCT01069445|diet|diet
586925|NCT01069445|probiotics|probiotics
586926|NCT01069445|inflammaging|inflammaging
586927|NCT01069445|oxidative stress|oxidative stress
586928|NCT01069445|gut microbiota|gut microbiota
586929|NCT01069445|food complements|food complements
586930|NCT01069432|Chronic Lymphocytic Leukemia|chronic lymphocytic leukemia
586931|NCT01069432|CLL|cll
586932|NCT01069432|Normal Volunteers|normal volunteers
586933|NCT01069419|Certolizumab Pegol|certolizumab pegol
586934|NCT01069419|Cimzia|cimzia
586935|NCT01069406|notch|notch
586936|NCT01069406|uterine|uterine
586937|NCT01069406|first|first
586938|NCT01069406|bleeding|bleeding
586939|NCT01069380|resting metabolic rate|resting metabolic rate
586940|NCT01069380|bed ridden, vegetative|bed ridden, vegetative
586941|NCT01069380|low conscious|low conscious
586942|NCT01069380|minimal conscious state|minimal conscious state
586943|NCT01069380|immobilized|immobilized
586944|NCT01069380|resting energy expenditure|resting energy expenditure
586945|NCT01069367|Influenza A|influenza a
586946|NCT01069367|H1N1 subtype|h1n1 subtype
586947|NCT01069367|Children/adolescent|children/adolescent
586948|NCT01069367|Vaccine|vaccine
586949|NCT01069367|Adjuvant|adjuvant
586950|NCT01069367|Cell culture|cell culture
586951|NCT01069354|Moderate to severe wrinkles and folds such as nasolabial folds|moderate to severe wrinkles and folds such as nasolabial folds
586952|NCT01069341|Rubeosis|rubeosis
586953|NCT01069341|Neovascularization of iris|neovascularization of iris
586954|NCT01069341|Proliferative diabetic retinopathy|proliferative diabetic retinopathy
586955|NCT01069341|PDR|pdr
586956|NCT01069341|Cataract|cataract
746097|NCT00452374|CLL|cll
586957|NCT01069328|Lung|lung
586958|NCT01069328|cancer|cancer
586959|NCT01069328|NSCLC|nsclc
586960|NCT01069315|open wound|open wound
586961|NCT01069315|solution|solution
586962|NCT01069315|pressure|pressure
586963|NCT01069315|randomized|randomized
586964|NCT01069302|Coronary artery disease|coronary artery disease
586965|NCT01069289|Symbicort|symbicort
586966|NCT01069289|Oxis|oxis
586967|NCT01069289|Chronic Obstructive Pulmonary Disease|chronic obstructive pulmonary disease
586968|NCT01069289|COPD|copd
586969|NCT01069289|Efficacy|efficacy
586970|NCT01069276|Stroke|stroke
586971|NCT01069276|prehospital ultrasound|prehospital ultrasound
586972|NCT01069263|Interstitial cystitis|interstitial cystitis
586973|NCT01069263|Painful bladder syndrome|painful bladder syndrome
586974|NCT01069263|Chronic pelvic pain|chronic pelvic pain
586975|NCT01069263|DMSO|dmso
586976|NCT01069263|Hyperbaric oxygen therapy|hyperbaric oxygen therapy
586977|NCT01069250|dynamic cerebrovascular autoregulation|dynamic cerebrovascular autoregulation
586978|NCT01069250|static cerebrovascular autoregulation|static cerebrovascular autoregulation
586979|NCT01069250|acute brain injury|acute brain injury
586980|NCT01069250|transcranial Doppler ultrasound|transcranial doppler ultrasound
586981|NCT01069250|critical care|critical care
586982|NCT01069237|contact lens wear|contact lens wear
586983|NCT01069237|multi-purpose solution|multi-purpose solution
586984|NCT01069237|corneal staining|corneal staining
586985|NCT01069224|rotator cuff|rotator cuff
586986|NCT01069224|synovial fluid|synovial fluid
586987|NCT01069224|proinflammatory cytokines|proinflammatory cytokines
586988|NCT01069211|Breast cancer, Letrozole|breast cancer, letrozole
586989|NCT01069211|postmenopause|postmenopause
586990|NCT01069211|hormone receptor positive breast cancer|hormone receptor positive breast cancer
586991|NCT01069198|Visceral leishmaniasis|visceral leishmaniasis
586992|NCT01069198|Kala-azar|kala-azar
586993|NCT01069198|Bangladesh|bangladesh
586994|NCT01069198|Malnutrition|malnutrition
586995|NCT01069198|Asymptomatic|asymptomatic
586996|NCT01069198|Albendazole|albendazole
586997|NCT01069198|Iron|iron
586998|NCT01069198|Zinc|zinc
586999|NCT01069198|Vitamin A|vitamin a
587000|NCT01069185|Unplanned extubation|unplanned extubation
587001|NCT01069185|Length of stay in PICU|length of stay in picu
587002|NCT01069185|Length of mechanical ventilation|length of mechanical ventilation
587003|NCT01069172|Cataract|cataract
587004|NCT01069172|Surgery, cataract extraction|surgery, cataract extraction
587005|NCT01069172|Optical devices, laser|optical devices, laser
587006|NCT01069159|Traumatic memory|traumatic memory
587007|NCT01069159|Traumatic memories|traumatic memories
587008|NCT01069159|Traumatic memories and associated symptoms|traumatic memories and associated symptoms
587009|NCT01069159|Posttraumatic Stress Disorder|posttraumatic stress disorder
587010|NCT01069159|PTSD|ptsd
587011|NCT01069146|sepsis,|sepsis,
587012|NCT01069146|septic shock,|septic shock,
587013|NCT01069146|therapeutic hypothermia|therapeutic hypothermia
587014|NCT01069133|minimal hepatic encephalopathy|minimal hepatic encephalopathy
587016|NCT01069133|complications|complications
587017|NCT01069120|Uterine Fibroids|uterine fibroids
587018|NCT01069107|community hospital|community hospital
587019|NCT01069107|alternative acute admissions|alternative acute admissions
587020|NCT01069094|Uterine fibroids|uterine fibroids
587021|NCT01069081|Metastasis Breast Cancer|metastasis breast cancer
587022|NCT01069081|Proton Pump Inhibitor|proton pump inhibitor
587023|NCT01069081|Chemotherapy|chemotherapy
587024|NCT01069081|Phase II study|phase ii study
587025|NCT01069081|TTP|ttp
587026|NCT01069068|To evaluate the effect of advancing Jaw on airway dimension|to evaluate the effect of advancing jaw on airway dimension
587027|NCT01069055|inguinal hernia|inguinal hernia
587028|NCT01069055|surgery|surgery
587029|NCT01069055|general anesthesia|general anesthesia
587030|NCT01069055|analgesia|analgesia
587031|NCT01069055|pre-emptive|pre-emptive
587032|NCT01069055|SF36|sf36
587033|NCT01069042|Rho kinase activity|rho kinase activity
587034|NCT01069042|Heart failure|heart failure
587035|NCT01069042|ACE inhibitor|ace inhibitor
587036|NCT01069042|LVEF change|lvef change
587037|NCT01069042|Rho kinase activity change|rho kinase activity change
587038|NCT01069029|Macular Hole|macular hole
587039|NCT01069029|Cataract surgery|cataract surgery
587040|NCT01069029|Vitreoretinal surgery|vitreoretinal surgery
587041|NCT01069029|Combined surgery|combined surgery
587042|NCT01069029|Idiopathic|idiopathic
587043|NCT01069016|Fecal Incontinence|fecal incontinence
587044|NCT01069016|Colorectal surgery|colorectal surgery
587045|NCT01069016|Sacral nerve stimulation|sacral nerve stimulation
587046|NCT01069016|Pudendal nerve stimulation|pudendal nerve stimulation
587047|NCT01069003|Heart Disease|heart disease
587048|NCT01069003|Cardiovascular Disease|cardiovascular disease
587049|NCT01069003|Platelet Aggregation Inhibitors|platelet aggregation inhibitors
587050|NCT01069003|Dual Antiplatelet Therapy|dual antiplatelet therapy
587051|NCT01069003|Clopidogrel|clopidogrel
587052|NCT01069003|Prasugrel|prasugrel
587053|NCT01069003|Vascular Disease|vascular disease
587054|NCT01069003|Myocardial Ischemia|myocardial ischemia
587055|NCT01068990|pneumonia|pneumonia
587056|NCT01068951|type 1 diabetes|type 1 diabetes
587057|NCT01068951|mesenchymal stem cells|mesenchymal stem cells
587058|NCT01068951|intervention|intervention
587059|NCT01068938|visual field|visual field
587060|NCT01068938|perimetry|perimetry
587061|NCT01068938|glaucoma progression|glaucoma progression
587062|NCT01068938|grid|grid
587063|NCT01068938|POAG and glaucoma suspects with prostaglandin monotherapy|poag and glaucoma suspects with prostaglandin monotherapy
587064|NCT01068925|healthy volunteer|healthy volunteer
587065|NCT01068925|pharmacokinetics|pharmacokinetics
587066|NCT01068925|HIV, GSK1349572, tipranavir, ritonavir, drug interaction|hiv, gsk1349572, tipranavir, ritonavir, drug interaction
587067|NCT01068912|Influenza|influenza
587068|NCT01068899|healthy adults|healthy adults
587069|NCT01068899|healthy children|healthy children
587070|NCT01068886|Pancreaticoduodenectomy|pancreaticoduodenectomy
587071|NCT01068873|HIV|hiv
587072|NCT01068873|Protease Inhibitor|protease inhibitor
587073|NCT01068873|CCR5 Co-receptor Antagonist|ccr5 co-receptor antagonist
587074|NCT01068873|treatment naive|treatment naive
587075|NCT01068860|Type 2 Diabetes Mellitus|type 2 diabetes mellitus
587076|NCT01068860|canakinumab|canakinumab
587077|NCT01068860|Pre diabetic|pre diabetic
587078|NCT01068860|glucose intolerant|glucose intolerant
587079|NCT01068860|oral anti diabetic medication|oral anti diabetic medication
587080|NCT01068860|insulin treatment|insulin treatment
587081|NCT01068860|metabolic syndrome|metabolic syndrome
587082|NCT01068847|Opioid dependence|opioid dependence
587083|NCT01068847|methadone|methadone
587084|NCT01068847|opioid|opioid
587085|NCT01068834|Adherence|adherence
587086|NCT01068834|Statins|statins
587087|NCT01068834|Kinesin-like protein 6|kinesin-like protein 6
587088|NCT01068821|Slide|slide
587089|NCT01068821|Trendelenburg's position|trendelenburg's position
587090|NCT01068821|Postoperative|postoperative
587091|NCT01068821|neurologic complaints|neurologic complaints
587092|NCT01068808|Nonallergic rhinitis|nonallergic rhinitis
587093|NCT01068808|Allergic rhinitis|allergic rhinitis
587094|NCT01068808|Development|development
587095|NCT01068795|placental syndrome|placental syndrome
587096|NCT01068795|maternal thromboembolic event|maternal thromboembolic event
587097|NCT01068795|enoxaparin|enoxaparin
587098|NCT01068795|anti-factor Xa|anti-factor xa
587099|NCT01068782|Glioblastoma|glioblastoma
587100|NCT01068782|Glioma|glioma
587101|NCT01068782|Brain Cancer|brain cancer
587102|NCT01068782|Brain Tumor|brain tumor
587103|NCT01068782|Astrocytoma|astrocytoma
587104|NCT01068769|regorafenib|regorafenib
587105|NCT01068769|GIST|gist
587106|NCT01068691|aortic dissection|aortic dissection
587107|NCT01068691|ambulatory blood pressure|ambulatory blood pressure
587108|NCT01068691|obstructive sleep apnea syndrome|obstructive sleep apnea syndrome
587109|NCT01068691|patients undergoing surgery for a dissection of the thoracic aorta|patients undergoing surgery for a dissection of the thoracic aorta
587110|NCT01068613|COPD|copd
587111|NCT01068613|Long acting muscarinic antagonist|long acting muscarinic antagonist
587112|NCT01068600|COPD|copd
587113|NCT01068600|Indacaterol|indacaterol
587114|NCT01068587|recurrent non-small cell lung cancer|recurrent non-small cell lung cancer
587115|NCT01068587|stage IIIA non-small cell lung cancer|stage iiia non-small cell lung cancer
587116|NCT01068587|stage IIIB non-small cell lung cancer|stage iiib non-small cell lung cancer
587117|NCT01068587|stage IV non-small cell lung cancer|stage iv non-small cell lung cancer
587118|NCT01068574|Acute illnesses in children under five|acute illnesses in children under five
587119|NCT01068561|Retinitis pigmentosa|retinitis pigmentosa
587120|NCT01068561|stem cell|stem cell
587121|NCT01068561|bone marrow|bone marrow
587122|NCT01068535|metabolic syndrome|metabolic syndrome
587123|NCT01068535|MetS|mets
587124|NCT01068535|premenopausal women|premenopausal women
587125|NCT01068535|vascular risk|vascular risk
587126|NCT01068535|atherosclerosis detection|atherosclerosis detection
587127|NCT01068522|Intracranial pressure|intracranial pressure
587128|NCT01068522|Intracranial pressure monitoring|intracranial pressure monitoring
587129|NCT01068522|Head injury|head injury
587130|NCT01068509|Cvac|cvac
587131|NCT01068483|Advanced solid tumors|advanced solid tumors
587132|NCT01068483|Breast Cancer|breast cancer
587133|NCT01068483|Colon Cancer|colon cancer
587134|NCT01068483|Ovarian Cancer|ovarian cancer
587135|NCT01068483|Endometrium cancer|endometrium cancer
587136|NCT01068470|Interleukin-2|interleukin-2
587137|NCT01068470|Melanoma|melanoma
587138|NCT01068470|Kidney Cancer|kidney cancer
587139|NCT01068470|Lymphokine Activated Killer cells|lymphokine activated killer cells
587140|NCT01068457|persistent pain|persistent pain
587141|NCT01068457|neuropathic pain|neuropathic pain
587142|NCT01068457|Thoracic Surgery, Video Assisted|thoracic surgery, video assisted
587143|NCT01068457|Chronic Pain|chronic pain
587144|NCT01068444|NASH|nash
587145|NCT01068444|Pioglitazone|pioglitazone
587146|NCT01068444|Treatment|treatment
587147|NCT01068431|lymphedema|lymphedema
587148|NCT01068431|conservative treatment|conservative treatment
587149|NCT01068431|compression therapy|compression therapy
587150|NCT01068431|interface pressure|interface pressure
587151|NCT01068418|Obesity|obesity
587152|NCT01068418|Renin Angiotensin System|renin angiotensin system
587153|NCT01068418|Vitamin D deficiency|vitamin d deficiency
587154|NCT01068418|Hypertension|hypertension
587155|NCT01068392|relapsed|relapsed
587156|NCT01068392|marginal zone B-cell lymphoma|marginal zone b-cell lymphoma
587157|NCT01068392|oxaliplatin|oxaliplatin
587158|NCT01068392|prednisolone|prednisolone
587159|NCT01068379|rhegmatogenous retinal detachment|rhegmatogenous retinal detachment
587160|NCT01068379|cryopexy|cryopexy
587161|NCT01068379|photocoagulation|photocoagulation
587162|NCT01068366|Nickel Allergic Syndrome|nickel allergic syndrome
587163|NCT01068366|Septal Closure Devices|septal closure devices
587164|NCT01068353|Alzheimer's disease|alzheimer's disease
587165|NCT01068353|Dementia|dementia
587166|NCT01068353|TNF-alpha|tnf-alpha
587167|NCT01068353|Etanercept|etanercept
587168|NCT01068340|Adhesions|adhesions
587169|NCT01068340|Small Bowel Obstruction|small bowel obstruction
587170|NCT01068340|Ileus|ileus
587171|NCT01068314|Endothelium|endothelium
587172|NCT01068314|Vasodilatation|vasodilatation
587173|NCT01068314|Vein|vein
587174|NCT01068314|Compliance|compliance
587175|NCT01068314|Arteriovenous shunt, surgical|arteriovenous shunt, surgical
587176|NCT01068301|Allogeneic Stem Cell transplantation|allogeneic stem cell transplantation
587177|NCT01068301|Plerixafor|plerixafor
587178|NCT01068301|Acute Lymphoblastic leukemia|acute lymphoblastic leukemia
587179|NCT01068301|Acute Myeloid leukemia|acute myeloid leukemia
587180|NCT01068301|Chronic Myeloid leukemia|chronic myeloid leukemia
587181|NCT01068301|Myelodysplastic Syndrome|myelodysplastic syndrome
587182|NCT01068301|Non-Hodgkin's Lymphoma|non-hodgkin's lymphoma
587183|NCT01068301|Other Leukemia|other leukemia
587184|NCT01068288|laparoscopic appendectomy|laparoscopic appendectomy
587185|NCT01068288|open appendectomy|open appendectomy
587186|NCT01068288|expectant management|expectant management
587187|NCT01068288|paediatric|paediatric
587188|NCT01068275|anterior cruciate ligament|anterior cruciate ligament
587189|NCT01068275|pain, postoperative|pain, postoperative
587190|NCT01068275|peripheral nerve catheter|peripheral nerve catheter
587191|NCT01068275|nerve block|nerve block
587192|NCT01068275|Children undergoing anterior cruciate ligament repair|children undergoing anterior cruciate ligament repair
587193|NCT01068249|Advanced|advanced
587194|NCT01068249|Recurrent|recurrent
587195|NCT01068249|Progressive|progressive
587196|NCT01068249|Endometrial Cancer|endometrial cancer
587197|NCT01068249|Letrozole|letrozole
587198|NCT01068249|RAD001|rad001
587199|NCT01068249|Afinitor|afinitor
587200|NCT01068249|Everolimus|everolimus
587201|NCT01068249|Femara|femara
587202|NCT01068236|Teen girls|teen girls
587203|NCT01068236|weightloss|weightloss
587204|NCT01068236|healthy lifestyle|healthy lifestyle
587205|NCT01068236|yoga|yoga
587206|NCT01068236|Weight loss and healthy lifestyle|weight loss and healthy lifestyle
587207|NCT01068223|Cetirizine, CR016609|cetirizine, cr016609
587208|NCT01068210|Exercise Intervention|exercise intervention
587209|NCT01068210|Lung Cancer|lung cancer
587210|NCT01068210|15-215|15-215
587211|NCT01068197|Low Glycemic Load diet|low glycemic load diet
587212|NCT01068197|Low Glycemic Index diet|low glycemic index diet
587213|NCT01068197|Low Fat diet|low fat diet
587214|NCT01068197|Obese Hispanic American children and adolescents|obese hispanic american children and adolescents
587215|NCT01068197|At risk for type 2 diabetes mellitus|at risk for type 2 diabetes mellitus
587216|NCT01068184|AZD6553|azd6553
587217|NCT01068184|Chronic|chronic
587218|NCT01068184|obstructive|obstructive
587219|NCT01068184|pulmonary|pulmonary
587220|NCT01068184|lung|lung
587221|NCT01068184|respiratory disease|respiratory disease
587222|NCT01068184|placebo-controlled|placebo-controlled
587223|NCT01068184|COPD|copd
587224|NCT01068184|Healthy Volunteers|healthy volunteers
587225|NCT01068184|COPD Patients|copd patients
587226|NCT01068171|diabetes|diabetes
587227|NCT01068171|foot ulcers|foot ulcers
587228|NCT01068171|off-loading|off-loading
587229|NCT01068171|collagen|collagen
587230|NCT01068171|Wagner 1|wagner 1
587231|NCT01068158|Head lice infestation|head lice infestation
587232|NCT01068158|Pediculus humanus capitis|pediculus humanus capitis
587233|NCT01068145|COPD|copd
587234|NCT01068132|Colorectal Neoplasms|colorectal neoplasms
587235|NCT01068132|KRAS|kras
587236|NCT01068132|PTEN|pten
587237|NCT01068119|Acute coronary syndrome|acute coronary syndrome
587238|NCT01068119|percutaneous coronary angioplasty|percutaneous coronary angioplasty
587239|NCT01068119|Troponin negative|troponin negative
587240|NCT01068119|cardiac|cardiac
587241|NCT01068080|fatty acid metabolism|fatty acid metabolism
587242|NCT01068080|insulin resistance|insulin resistance
587243|NCT01068080|cardiac death|cardiac death
587244|NCT01068080|hemodialysis|hemodialysis
587245|NCT01068080|normal coronary arteries|normal coronary arteries
587246|NCT01068080|Predictive values of impaired myocardial fatty acid metabolism or insulin resistance for cardiac death of hemodialysis patients with normal coronary arteries|predictive values of impaired myocardial fatty acid metabolism or insulin resistance for cardiac death of hemodialysis patients with normal coronary arteries
587247|NCT01068054|vernal keratoconjunctivitis|vernal keratoconjunctivitis
587248|NCT01068054|FK-506|fk-506
587249|NCT01068054|tacrolimus|tacrolimus
587250|NCT01068054|cyclosporine|cyclosporine
587251|NCT01068054|children|children
587252|NCT01068028|Healthy volunteer study|healthy volunteer study
587253|NCT01068015|MSM|msm
587254|NCT01068015|Intervention|intervention
587255|NCT01068015|Popular Opinion Leader|popular opinion leader
587256|NCT01068015|Male Circumcision|male circumcision
587257|NCT01068015|HIV|hiv
587258|NCT01068015|Syphilis|syphilis
587259|NCT01068015|HSV-2|hsv-2
587260|NCT01068002|Hypertension Pregnancy|hypertension pregnancy
587261|NCT01067989|metronomic chemotherapy|metronomic chemotherapy
587262|NCT01067989|anti-angiogenic effect|anti-angiogenic effect
587263|NCT01067989|Breast cancer|breast cancer
587264|NCT01067976|Breast Cancer|breast cancer
587265|NCT01067976|Gadobutrol-enhanced MRI|gadobutrol-enhanced mri
587266|NCT01067976|Mammography|mammography
587267|NCT01067963|self-care|self-care
587268|NCT01067963|self-management|self-management
587269|NCT01067963|health behavior change|health behavior change
587270|NCT01067963|motivational interviewing|motivational interviewing
587271|NCT01067963|computer assisted learning|computer assisted learning
587272|NCT01067950|isolated pancreas transplant|isolated pancreas transplant
587273|NCT01067950|intensive insulin therapy|intensive insulin therapy
587274|NCT01067937|Appendicitis|appendicitis
587275|NCT01067937|children|children
587276|NCT01067924|Type 2 diabetes, motivational interviewing, physical activity maintenance, physical activity adherence|type 2 diabetes, motivational interviewing, physical activity maintenance, physical activity adherence
587277|NCT01067911|Postprandial lipids|postprandial lipids
587278|NCT01067911|test meal|test meal
587279|NCT01067911|fatty acids|fatty acids
587280|NCT01067898|vitamin D supplementation|vitamin d supplementation
587281|NCT01067898|cholecalciferol|cholecalciferol
587282|NCT01067898|PTH|pth
587283|NCT01067898|bone turnover markers|bone turnover markers
587284|NCT01067898|elderly women|elderly women
587285|NCT01067885|Nitinol Stent|nitinol stent
587286|NCT01067885|Superficial femoral artery|superficial femoral artery
587287|NCT01067885|SFA|sfa
587288|NCT01067885|Angioplasty|angioplasty
587289|NCT01067885|peripheral artery disease|peripheral artery disease
587290|NCT01067885|peripheral artery obstructive disease|peripheral artery obstructive disease
587291|NCT01067885|PAOD|paod
587292|NCT01067885|PAD|pad
587293|NCT01067885|Peripheral Vascular Disease|peripheral vascular disease
587294|NCT01067859|Heart Failure|heart failure
587295|NCT01067846|cocaine dependence|cocaine dependence
587296|NCT01067846|relapse prevention|relapse prevention
587297|NCT01067846|computerized cognitive behavioral therapy (CBT)|computerized cognitive behavioral therapy (cbt)
587298|NCT01067846|D-cycloserine (DCS)|d-cycloserine (dcs)
587299|NCT01067833|atrial fibrillation|atrial fibrillation
587300|NCT01067833|AF|af
587301|NCT01067820|ApolipoproteinA1|apolipoproteina1
587302|NCT01067820|HDL-C|hdl-c
587303|NCT01067820|Atherosclerosis|atherosclerosis
587304|NCT01067807|Pharmacokinetics|pharmacokinetics
587305|NCT01067794|Metastatic|metastatic
587306|NCT01067794|Advanced|advanced
587307|NCT01067794|Stage IIIB-IV|stage iiib-iv
587308|NCT01067794|daily|daily
587309|NCT01067794|hospital|hospital
587310|NCT01067794|practice|practice
587311|NCT01067794|setting|setting
587312|NCT01067781|Prevention of Travelers' Diarrhea|prevention of travelers' diarrhea
587313|NCT01067768|Urinary Tract Infections|urinary tract infections
587314|NCT01067768|Catheter-associated urinary tract infections|catheter-associated urinary tract infections
587315|NCT01067768|Prevention and control|prevention and control
587316|NCT01067768|Controlled clinical trial|controlled clinical trial
587317|NCT01067755|navigation|navigation
587318|NCT01067755|bronchoscopy|bronchoscopy
587319|NCT01067755|lymphadenopathy|lymphadenopathy
587320|NCT01067742|Mucolipidosis, retinal dystrophy, mucolipin-1,|mucolipidosis, retinal dystrophy, mucolipin-1,
587321|NCT01067742|lysosomal storage disease, gastrin, mental retardation,|lysosomal storage disease, gastrin, mental retardation,
587322|NCT01067742|dysmyelination, dysplastic corpus callosum,corneal clouding|dysmyelination, dysplastic corpus callosum,corneal clouding
587323|NCT01067729|Burn|burn
587324|NCT01067729|Superficial burns|superficial burns
587325|NCT01067729|Partial thickness burns|partial thickness burns
587326|NCT01067729|Rate of healing|rate of healing
587327|NCT01067729|Infection rate|infection rate
587328|NCT01067729|Pain perception|pain perception
587329|NCT01067729|Non adherence|non adherence
587330|NCT01067729|Scarring|scarring
587331|NCT01067703|remote ischaemic preconditioning, cardiac surgery|remote ischaemic preconditioning, cardiac surgery
587332|NCT01067690|classical Kaposi's sarcoma|classical kaposi's sarcoma
587333|NCT01067690|chemotherapy|chemotherapy
587334|NCT01067690|indinavir|indinavir
587335|NCT01067690|HIV protease inhibitor|hiv protease inhibitor
587336|NCT01067690|Advanced classical (non HIV-associated) Kaposi's sarcoma|advanced classical (non hiv-associated) kaposi's sarcoma
587337|NCT01067677|PONV|ponv
587338|NCT01067677|Post operative nausea and vomiting|post operative nausea and vomiting
587339|NCT01067677|rescue emetic therapy|rescue emetic therapy
587340|NCT01067599|Biomarkers of tobacco exposure|biomarkers of tobacco exposure
587341|NCT01067599|Smokeless Tobacco|smokeless tobacco
587342|NCT01067586|Smokeless Tobacco|smokeless tobacco
587343|NCT01067586|Biomarkers of tobacco exposure|biomarkers of tobacco exposure
587344|NCT01067573|MS|ms
587345|NCT01067573|Serum Leptin Levels during relapse|serum leptin levels during relapse
587346|NCT01067573|Multiple sclerosis|multiple sclerosis
587347|NCT01067573|relapse|relapse
587348|NCT01067560|Glucose|glucose
587349|NCT01067560|CSF|csf
587350|NCT01067560|Cesarean section, spinal anesthesia|cesarean section, spinal anesthesia
587351|NCT01067560|Nova Stat Strip|nova stat strip
587352|NCT01067560|Abbott Precision Xtra|abbott precision xtra
587353|NCT01067560|Roche Accucheck Inform 2|roche accucheck inform 2
587354|NCT01067547|Iron deficiency|iron deficiency
587355|NCT01067547|Inflammatory Bowel Disease|inflammatory bowel disease
587356|NCT01067547|Crohn's Disease|crohn's disease
587357|NCT01067547|Ulcerative colitis|ulcerative colitis
587358|NCT01067521|Relapsing Remitting Multiple Sclerosis|relapsing remitting multiple sclerosis
587359|NCT01067521|Glatiramer Acetate|glatiramer acetate
587360|NCT01067495|stroke|stroke
587361|NCT01067495|rehabilitation|rehabilitation
587362|NCT01067495|exercise|exercise
587363|NCT01067495|walking|walking
587364|NCT01067495|risk factors|risk factors
587365|NCT01067482|OCT|oct
587366|NCT01067482|spectral domain cirrus|spectral domain cirrus
587367|NCT01067482|glaucoma|glaucoma
587368|NCT01067482|glaucoma suspect|glaucoma suspect
587369|NCT01067482|normal population|normal population
587370|NCT01067469|CNS|cns
587371|NCT01067469|Central Nervous System|central nervous system
587372|NCT01067469|malignant brain tumor|malignant brain tumor
587373|NCT01067469|Recurrent Glioblastoma Multiforme|recurrent glioblastoma multiforme
587374|NCT01067469|GBM|gbm
587375|NCT01067469|Bevacizumab|bevacizumab
587376|NCT01067469|Lomustine|lomustine
587377|NCT01067469|CCNU|ccnu
587378|NCT01067443|Phase II|phase ii
587379|NCT01067443|Randomised clinical trial|randomised clinical trial
587380|NCT01067443|Visceral Leishmaniasis|visceral leishmaniasis
587381|NCT01067430|Rheumatoid Arthritis|rheumatoid arthritis
587382|NCT01067430|Etoricoxib|etoricoxib
587383|NCT01067430|Diclofenac|diclofenac
587384|NCT01067430|Pain|pain
587385|NCT01067430|Stiffness|stiffness
587386|NCT01067417|Hydroxychloroquine|hydroxychloroquine
587387|NCT01067417|Chloroquine|chloroquine
587388|NCT01067417|HIV Infection|hiv infection
587389|NCT01067417|Acquired Immunodeficiency Syndrome|acquired immunodeficiency syndrome
587390|NCT01067417|Immune Activation|immune activation
587391|NCT01067417|inflammation|inflammation
587392|NCT01067417|treatment naive|treatment naive
587393|NCT01067417|disease progression|disease progression
587394|NCT01067404|Influenza vaccines|influenza vaccines
587395|NCT01067404|Infant|infant
587396|NCT01067404|Dose-Response relationship, immunologic|dose-response relationship, immunologic
587397|NCT01067391|Hypotension in SCI males|hypotension in sci males
587398|NCT01067391|Erectile Dysfunction|erectile dysfunction
587399|NCT01067378|Interdisciplinary Health Team|interdisciplinary health team
587400|NCT01067378|Training|training
587401|NCT01067365|Secondary Hypogonadism|secondary hypogonadism
587402|NCT01067352|Infant, small for gestational age|infant, small for gestational age
587403|NCT01067352|Growth hormone|growth hormone
587404|NCT01067352|Saizen|saizen
587405|NCT01067339|coronary endothelial dysfunction|coronary endothelial dysfunction
587406|NCT01067339|coronary vasospasm|coronary vasospasm
587407|NCT01067326|Endothelial Dysfunction|endothelial dysfunction
587408|NCT01067326|Endothelial Function|endothelial function
587409|NCT01067326|Tekturna|tekturna
587410|NCT01067326|Endothelial Peripheral Arterial Tomography (EndoPAT)|endothelial peripheral arterial tomography (endopat)
587411|NCT01067326|Progenitor Cells|progenitor cells
587412|NCT01067326|renin inhibition|renin inhibition
587413|NCT01067326|endothelial progenitor cells|endothelial progenitor cells
587414|NCT01067326|early atherosclerosis|early atherosclerosis
587415|NCT01067313|Intensive Care Unit|intensive care unit
587416|NCT01067313|continuous hemodialysis|continuous hemodialysis
587417|NCT01067313|continuous hemofiltration|continuous hemofiltration
587418|NCT01067313|High Cut-off membrane|high cut-off membrane
587419|NCT01067313|"Enhanced middle molecule clearance membrane"|"enhanced middle molecule clearance membrane"
587420|NCT01067313|Septic shock|septic shock
587421|NCT01067313|Acute kidney injury|acute kidney injury
587422|NCT01067313|Blood purification|blood purification
587423|NCT01067313|Renal replacement therapy|renal replacement therapy
587424|NCT01067300|young|young
587425|NCT01067300|acute leukemia in remission|acute leukemia in remission
587426|NCT01067300|Children or young adults (< 35 years) with acute leukemia in remission|children or young adults (< 35 years) with acute leukemia in remission
587427|NCT01067287|dendritic cell fusion vaccine|dendritic cell fusion vaccine
587428|NCT01067287|CT-011|ct-011
587429|NCT01067287|autologous stem cell transplant|autologous stem cell transplant
587430|NCT01067274|Acute Myeloid Leukemia|acute myeloid leukemia
587431|NCT01067274|Aged of 65 to 79 years|aged of 65 to 79 years
587432|NCT01067274|Older Patients with Acute Myeloblastic Leukemia|older patients with acute myeloblastic leukemia
587433|NCT01067261|Nerve stimulation|nerve stimulation
587434|NCT01067261|TMNS|tmns
587435|NCT01067261|Prostatectomy|prostatectomy
587436|NCT01067261|Prevention|prevention
587437|NCT01067261|Restoration|restoration
587438|NCT01067261|Treatment|treatment
587439|NCT01067261|Vibration|vibration
587440|NCT01067261|Non-invasive|non-invasive
587441|NCT01067248|COPD|copd
587442|NCT01067248|Osteoporosis|osteoporosis
587443|NCT01067248|Pathophysiology|pathophysiology
587444|NCT01067248|Mechanism|mechanism
587445|NCT01067248|Bone markers|bone markers
587446|NCT01067248|Bone turnover|bone turnover
587447|NCT01067248|Protein turnover|protein turnover
587448|NCT01067248|Ageing|ageing
587449|NCT01067248|Endocrinology|endocrinology
587450|NCT01067248|Vitamin D|vitamin d
587451|NCT01067235|Narcolespy|narcolespy
587452|NCT01067235|Cataplexy|cataplexy
587453|NCT01067235|Excesssive daytime Sleepiness|excesssive daytime sleepiness
587454|NCT01067235|Sleep Disorders|sleep disorders
587455|NCT01067235|Sleep attacks|sleep attacks
587456|NCT01067235|Orphan Drug|orphan drug
587457|NCT01067235|Pitolisant|pitolisant
587458|NCT01067222|Narcolepsy|narcolepsy
587459|NCT01067222|Excessive daytime Sleepiness|excessive daytime sleepiness
587460|NCT01067222|Cataplexy|cataplexy
587461|NCT01067222|Sleep Disorders|sleep disorders
587462|NCT01067222|Sleep attacks|sleep attacks
587463|NCT01067222|Orphan Drug|orphan drug
587464|NCT01067222|Pitolisant|pitolisant
587465|NCT01067209|Reversal of Obesity-related and Diabetic Cardiomyopathy|reversal of obesity-related and diabetic cardiomyopathy
587466|NCT01067196|Proton Radiation|proton radiation
587467|NCT01067196|Central Nervous System (CNS) Tumors|central nervous system (cns) tumors
587468|NCT01067196|Brain|brain
587469|NCT01067196|Spine|spine
587470|NCT01067196|Cancer|cancer
587471|NCT01067196|Radiation Therapy (RT)|radiation therapy (rt)
587472|NCT01067183|stress reduction|stress reduction
587473|NCT01067183|physician wellness|physician wellness
587474|NCT01067170|Hemodialysis|hemodialysis
587475|NCT01067170|Intradialytic hypotension|intradialytic hypotension
587476|NCT01067157|Obesity|obesity
587477|NCT01067157|overweight|overweight
587478|NCT01067157|childhood|childhood
587479|NCT01067157|adolescence|adolescence
587480|NCT01067157|inpatient therapy|inpatient therapy
587481|NCT01067157|lifestyle intervention|lifestyle intervention
587482|NCT01067157|cardiovascular risk|cardiovascular risk
587483|NCT01067157|gene-lifestyle-interaction|gene-lifestyle-interaction
587484|NCT01067157|Obesity and associated cardiovascular risk in childhood and adolescence,|obesity and associated cardiovascular risk in childhood and adolescence,
587485|NCT01067157|health behaviour|health behaviour
587486|NCT01067131|Candida albicans|candida albicans
587487|NCT01067131|Fungal vaginal infection|fungal vaginal infection
587488|NCT01067131|Vulvovaginal candidiasis|vulvovaginal candidiasis
587489|NCT01067131|Candidose|candidose
587490|NCT01067131|Vaccine|vaccine
587491|NCT01067131|Virosome|virosome
587492|NCT01067105|Perennial allergic rhinitis|perennial allergic rhinitis
587493|NCT01067105|allergic rhinitis|allergic rhinitis
587494|NCT01067105|ciclesonide|ciclesonide
587495|NCT01067079|Rabies vaccine|rabies vaccine
587496|NCT01067079|Long-term Immunogenicity|long-term immunogenicity
587497|NCT01067066|TPI 287|tpi 287
587498|NCT01067066|microtubule inhibitor|microtubule inhibitor
587499|NCT01067066|Temozolomide|temozolomide
587500|NCT01067066|Temodar|temodar
587501|NCT01067066|cytotoxic agent|cytotoxic agent
587502|NCT01067066|unresectable Stage III|unresectable stage iii
587503|NCT01067066|Stage IV|stage iv
587504|NCT01067066|Metastatic Melanoma|metastatic melanoma
587505|NCT01067053|Bevacizumab|bevacizumab
587506|NCT01067053|Capecitabine|capecitabine
587507|NCT01067053|Oxaliplatin|oxaliplatin
587508|NCT01067053|Metastatic colorectal cancer|metastatic colorectal cancer
587509|NCT01067027|Colic|colic
587510|NCT01067027|Colic in Breast-fed Infants|colic in breast-fed infants
587511|NCT01067014|Lumbar spinal stenosis|lumbar spinal stenosis
587512|NCT01067014|Decompression|decompression
587513|NCT01067014|Lumbar spinal decompression|lumbar spinal decompression
587514|NCT01067014|Lumbar spinal decompressive surgery|lumbar spinal decompressive surgery
587515|NCT01066988|lipid layer thickness|lipid layer thickness
587516|NCT01066975|loaded backpack|loaded backpack
587517|NCT01066975|unloaded backpack|unloaded backpack
587518|NCT01066962|HIV-infected antiretroviral naïve subjects|hiv-infected antiretroviral naïve subjects
587519|NCT01066949|hemodialysis|hemodialysis
587520|NCT01066949|behavior change|behavior change
587521|NCT01066949|patient adherence|patient adherence
587522|NCT01066949|self management|self management
587523|NCT01066923|firefighter|firefighter
587524|NCT01066923|heat stress|heat stress
587525|NCT01066923|platelet activation|platelet activation
587526|NCT01066923|aspirin|aspirin
587527|NCT01066910|Obesity|obesity
587528|NCT01066910|Childhood Obesity|childhood obesity
587529|NCT01066910|Exercise|exercise
587530|NCT01066910|Nutrition|nutrition
587531|NCT01066871|Knee cartilage injury|knee cartilage injury
587532|NCT01066871|fibroblast growth factor 18|fibroblast growth factor 18
587533|NCT01066871|FGF18|fgf18
587534|NCT01066858|tenofovir|tenofovir
587535|NCT01066858|renal and bone toxicity|renal and bone toxicity
587536|NCT01066858|pregnancy|pregnancy
587537|NCT01066858|breastfeeding|breastfeeding
587538|NCT01066858|mother to child transmission|mother to child transmission
587539|NCT01066832|Drug-eluting balloon|drug-eluting balloon
587540|NCT01066832|Paclitaxel|paclitaxel
587541|NCT01066832|DIOR|dior
587542|NCT01066832|short term registry|short term registry
587543|NCT01066832|Valentines Trial|valentines trial
587544|NCT01066832|Drug-eluting balloon treatment of in-stent restenosis|drug-eluting balloon treatment of in-stent restenosis
587545|NCT01066780|cochlear implant|cochlear implant
587546|NCT01066780|adults|adults
587547|NCT01066780|HiResolution|hiresolution
587548|NCT01066780|Fidelity 120|fidelity 120
587549|NCT01066780|listening benefits|listening benefits
587550|NCT01066780|noise|noise
587551|NCT01066780|cochlear implant benefit|cochlear implant benefit
587552|NCT01066741|Epidermoid carcinoma|epidermoid carcinoma
587553|NCT01066741|Hypopharynx|hypopharynx
587554|NCT01066741|Oropharynx|oropharynx
587555|NCT01066741|Oral cavity|oral cavity
587556|NCT01066741|Oral mucosa|oral mucosa
587557|NCT01066741|Cavum|cavum
587558|NCT01066741|Severe Oral mucositis|severe oral mucositis
587559|NCT01066741|Radiotherapy|radiotherapy
587560|NCT01066741|Phytotherapy|phytotherapy
587561|NCT01066728|apnea|apnea
587562|NCT01066728|premature|premature
587563|NCT01066728|infant|infant
587564|NCT01066728|prematurity|prematurity
587565|NCT01066715|Diabetes|diabetes
587566|NCT01066715|Type 2|type 2
587567|NCT01066715|Mellitus|mellitus
587568|NCT01066689|kidney transplantation, acute humoral rejection, rituximab|kidney transplantation, acute humoral rejection, rituximab
587570|NCT01066663|SLL|sll
587571|NCT01066663|relapsed|relapsed
587572|NCT01066663|pyrimethamine|pyrimethamine
587573|NCT01066650|TWENTE|twente
587574|NCT01066650|randomized study|randomized study
587575|NCT01066650|stent|stent
587576|NCT01066650|coronary stent|coronary stent
587577|NCT01066650|drug-eluting stent|drug-eluting stent
587578|NCT01066650|Zotarolimus|zotarolimus
587579|NCT01066650|Everolimus|everolimus
587580|NCT01066650|Xience V|xience v
587581|NCT01066650|Endeavor Resolute|endeavor resolute
587582|NCT01066650|head to head comparison|head to head comparison
587583|NCT01066650|real world patients|real world patients
587584|NCT01066650|target vessel failure|target vessel failure
587585|NCT01066650|investigator initiated study|investigator initiated study
587586|NCT01066650|coronary artery disease|coronary artery disease
587587|NCT01066650|coronary arteries|coronary arteries
587588|NCT01066650|atherosclerosis|atherosclerosis
587589|NCT01066650|non inferiority|non inferiority
587590|NCT01066637|Heart transplant patients|heart transplant patients
587591|NCT01066624|Mucositis|mucositis
587592|NCT01066624|Multiple myeloma|multiple myeloma
587593|NCT01066624|Autologous hematopoietic stem cell transplantation|autologous hematopoietic stem cell transplantation
587594|NCT01066611|Allergic Rhinitis|allergic rhinitis
587595|NCT01066611|Allergy|allergy
587596|NCT01066611|Phosphatidylinositol 3-kinase|phosphatidylinositol 3-kinase
587597|NCT01066598|graft versus host disease|graft versus host disease
587598|NCT01066598|chronic graft versus host disease|chronic graft versus host disease
587599|NCT01066598|cGVHD|cgvhd
587600|NCT01066585|Head lice|head lice
587601|NCT01066585|Pediculus humanus capitis|pediculus humanus capitis
587602|NCT01066546|Delirium|delirium
587603|NCT01066546|Dementia|dementia
587604|NCT01066546|Amnestic|amnestic
587605|NCT01066546|Cognitive Disorders|cognitive disorders
587606|NCT01066546|Mental Disorders|mental disorders
587607|NCT01066546|Nervous System Diseases|nervous system diseases
587608|NCT01066546|Central Nervous System Diseases|central nervous system diseases
587609|NCT01066533|MTA|mta
587610|NCT01066533|NEC|nec
587611|NCT01066533|Immunohistochemistry|immunohistochemistry
587612|NCT01066533|fibronectin|fibronectin
587613|NCT01066533|tenascin|tenascin
587614|NCT01066520|ankle sprain|ankle sprain
587615|NCT01066520|traumeel|traumeel
587616|NCT01066520|diclofenac|diclofenac
587617|NCT01066520|antiinflammatory|antiinflammatory
587618|NCT01066520|time to normal function|time to normal function
587619|NCT01066507|Her2|her2
587620|NCT01066507|FISH|fish
587621|NCT01066507|Breast cancer|breast cancer
587622|NCT01066507|Amplification|amplification
587623|NCT01066494|AML|aml
587624|NCT01066494|Pgp|pgp
587625|NCT01066494|MDR|mdr
587626|NCT01066494|sAML|saml
587627|NCT01066494|AS1413|as1413
587628|NCT01066494|Amonafide|amonafide
587629|NCT01066481|Alzheimer's disease|alzheimer's disease
587630|NCT01066481|clinical trial|clinical trial
587631|NCT01066481|memory loss|memory loss
587632|NCT01066481|investigational drug|investigational drug
587633|NCT01066481|neurodegenerative disease|neurodegenerative disease
587634|NCT01066481|dementia|dementia
587635|NCT01066468|Chronic myeloid leukemia|chronic myeloid leukemia
587636|NCT01066468|CML|cml
587637|NCT01066468|Philadelphia chromosome positive|philadelphia chromosome positive
587638|NCT01066468|acute lymphoblastic leukemia|acute lymphoblastic leukemia
587639|NCT01066468|PhGlivec,|phglivec,
587640|NCT01066468|Gleevec,|gleevec,
587641|NCT01066468|hypereosinophilic syndrome,|hypereosinophilic syndrome,
587642|NCT01066468|HES,|hes,
587643|NCT01066468|chronic eosinophilic leukemia,|chronic eosinophilic leukemia,
587644|NCT01066468|CEL,|cel,
587645|NCT01066468|myelodysplastic syndrome,|myelodysplastic syndrome,
587646|NCT01066468|MDS,|mds,
587647|NCT01066468|myeloproliferative disease,|myeloproliferative disease,
587648|NCT01066468|MPD+ ALL|mpd+ all
587649|NCT01066455|Cardiac|cardiac
587650|NCT01066455|Muscular Dystrophy|muscular dystrophy
587651|NCT01066455|Prospective|prospective
587652|NCT01066455|Pediatric|pediatric
587653|NCT01066455|Echocardiogram|echocardiogram
587654|NCT01066442|Excessive Daytime Sleepiness (EDS)|excessive daytime sleepiness (eds)
587655|NCT01066442|Parkinson's Disease|parkinson's disease
587656|NCT01066429|poor-prognosis diffuse large B-cell lymphoma|poor-prognosis diffuse large b-cell lymphoma
587657|NCT01066429|dose-adjusted|dose-adjusted
587658|NCT01066429|R-EDOCH-14|r-edoch-14
587659|NCT01066429|rituximab|rituximab
587660|NCT01066429|age-adjusted IPI|age-adjusted ipi
587661|NCT01066429|toxicity|toxicity
587662|NCT01066403|schizophrenia|schizophrenia
587663|NCT01066403|cognitive deficits|cognitive deficits
587664|NCT01066403|dopamine|dopamine
587665|NCT01066403|dopamine agonists|dopamine agonists
587666|NCT01066403|prefrontal cortex|prefrontal cortex
587667|NCT01066403|D1 specific modulation|d1 specific modulation
587668|NCT01066403|pergolide|pergolide
587669|NCT01066403|executive control|executive control
587670|NCT01066403|working memory|working memory
587671|NCT01066403|Influence of pergolide on cognition in Schizophrenia|influence of pergolide on cognition in schizophrenia
587672|NCT01066403|D1-specific modulation of prefrontal functions|d1-specific modulation of prefrontal functions
587673|NCT01066403|Influence of pergolide on psychopathology and depression|influence of pergolide on psychopathology and depression
587674|NCT01066403|Influence of pergolide on extrapyramidal symptoms|influence of pergolide on extrapyramidal symptoms
587675|NCT01066390|stage IIIC/IV melanoma|stage iiic/iv melanoma
587676|NCT01066377|prebiotic|prebiotic
587677|NCT01066377|probiotic|probiotic
587678|NCT01066377|influenza|influenza
587679|NCT01066377|vaccination|vaccination
587680|NCT01066377|ageing|ageing
587681|NCT01066377|immunosenescence|immunosenescence
587682|NCT01066364|NASH|nash
587683|NCT01066364|NAFLD|nafld
587684|NCT01066364|Steatohepatitis|steatohepatitis
587685|NCT01066364|Nonalcoholic|nonalcoholic
587686|NCT01066364|Fatty Liver Disease|fatty liver disease
587687|NCT01066351|acute kidney injury|acute kidney injury
587688|NCT01066351|erythropoietin|erythropoietin
587689|NCT01066351|cardiac surgery|cardiac surgery
587690|NCT01066338|SNP array|snp array
587691|NCT01066338|prognosis|prognosis
587692|NCT01066338|acute myeloid leukemia|acute myeloid leukemia
587693|NCT01066338|normal karyotype|normal karyotype
587694|NCT01066338|acute myeloid leukemia with normal karyotype|acute myeloid leukemia with normal karyotype
587695|NCT01066325|Sit-n-Reach Test|sit-n-reach test
587696|NCT01066325|Flexibility|flexibility
587697|NCT01066325|Hamstring|hamstring
587698|NCT01066325|Mindbody|mindbody
587699|NCT01066325|Complementary and Alternative Medicine|complementary and alternative medicine
587700|NCT01066325|Neuro Emotional Technique (NET)|neuro emotional technique (net)
587701|NCT01066312|Muscle testing|muscle testing
587702|NCT01066312|Kinesiology|kinesiology
587703|NCT01066312|Muscles|muscles
587704|NCT01066312|Complementary and Alternative Medicine|complementary and alternative medicine
587705|NCT01066312|Practitioner Experience|practitioner experience
587706|NCT01066312|This study is actually not a randomised controlled trial,|this study is actually not a randomised controlled trial,
587707|NCT01066312|but an assessment of diagnostic test accuracy. We will be|but an assessment of diagnostic test accuracy. we will be
587708|NCT01066312|looking at the accuracy of MMT to distinguish congruent from|looking at the accuracy of mmt to distinguish congruent from
587709|NCT01066312|incongruent statements under varying levels of blinding.|incongruent statements under varying levels of blinding.
587710|NCT01066299|oxytocin|oxytocin
587711|NCT01066299|psychophysiology|psychophysiology
587712|NCT01066299|startle|startle
587713|NCT01066299|anxiety|anxiety
587714|NCT01066299|emotion|emotion
587715|NCT01066299|physiology|physiology
587716|NCT01066286|genome wide SNP-array|genome wide snp-array
587717|NCT01066286|micro-cytogenetic lesion|micro-cytogenetic lesion
587718|NCT01066286|KIT mutation|kit mutation
587719|NCT01066286|core binding factor|core binding factor
587720|NCT01066286|acute myeloid leukemia|acute myeloid leukemia
710268|NCT00589563|stage IV adult Hodgkin lymphoma|stage iv adult hodgkin lymphoma
747099|NCT00448396|EPO|epo
587721|NCT01066286|The Approval status was changed from Pending to Approved.|the approval status was changed from pending to approved.
587722|NCT01066260|Probiotics|probiotics
587723|NCT01066260|Energy balance|energy balance
587724|NCT01066247|spinal anesthesia|spinal anesthesia
587725|NCT01066247|heart rate variability|heart rate variability
587726|NCT01066247|premedication|premedication
587727|NCT01066247|heart rate|heart rate
587728|NCT01066247|blood pressure|blood pressure
587729|NCT01066234|Microscopic N2 Non-small Cell Lung Cancer|microscopic n2 non-small cell lung cancer
587730|NCT01066234|Paclitaxel|paclitaxel
587731|NCT01066234|Carboplatin|carboplatin
587732|NCT01066234|Cisplatin|cisplatin
587733|NCT01066221|clostridium difficile|clostridium difficile
587734|NCT01066208|Classification criteria|classification criteria
587735|NCT01066208|Diagnostic criteria|diagnostic criteria
587736|NCT01066195|Non-Small Cell Lung Cancer|non-small cell lung cancer
587737|NCT01066195|Never-Smoker and Adenocarcinoma patients|never-smoker and adenocarcinoma patients
587738|NCT01066195|Pemetrexed (ALIMTA)|pemetrexed (alimta)
587739|NCT01066195|Gefitinib (IRESSA®)|gefitinib (iressa®)
587740|NCT01066182|DHA|dha
587741|NCT01066182|Learning|learning
587742|NCT01066182|Reading|reading
587743|NCT01066182|Memory|memory
587744|NCT01066182|Children|children
587745|NCT01066182|Omega 3|omega 3
587746|NCT01066182|Education|education
587747|NCT01066182|Learning and behaviour in children|learning and behaviour in children
587748|NCT01066169|Pandemic Influenza A/H1N1|pandemic influenza a/h1n1
587749|NCT01066169|HIV|hiv
587750|NCT01066169|Antibodies|antibodies
587751|NCT01066169|Replicaton|replicaton
587752|NCT01066156|Post-traumatic Stress Disorder|post-traumatic stress disorder
587753|NCT01066156|PTSD|ptsd
587754|NCT01066156|Seroquel|seroquel
587755|NCT01066156|fMRI|fmri
587756|NCT01066143|Seroquel|seroquel
587757|NCT01066143|Generalized Anxiety Disorder|generalized anxiety disorder
587758|NCT01066143|fMRI|fmri
587759|NCT01066130|Diabetes Mellitus|diabetes mellitus
587760|NCT01066130|Arthritis, Rheumatoid|arthritis, rheumatoid
587761|NCT01066130|psychosocial aspects|psychosocial aspects
587762|NCT01066130|Patient Adherence|patient adherence
587763|NCT01066130|Social Work|social work
587764|NCT01066130|Coping Behavior|coping behavior
587765|NCT01066130|Coping Skills|coping skills
587766|NCT01066130|Adaptation, Psychological|adaptation, psychological
587767|NCT01066117|urinary incontinent|urinary incontinent
587768|NCT01066091|Inflammatory response|inflammatory response
587769|NCT01066091|High-fat meal|high-fat meal
587770|NCT01066091|cytokines|cytokines
587771|NCT01066091|Body composition|body composition
587772|NCT01066078|heart failure - congestive|heart failure - congestive
587773|NCT01066078|Cardiovascular imaging agents/Techniques]|cardiovascular imaging agents/techniques]
587774|NCT01066078|Echocardiography|echocardiography
587775|NCT01066078|Other diagnostic testing|other diagnostic testing
587776|NCT01066078|Other Treatment|other treatment
587777|NCT01066078|Recipients of cardiac resynchronization therapy systems|recipients of cardiac resynchronization therapy systems
587778|NCT01066065|cardiovascular disease|cardiovascular disease
587779|NCT01066065|HIV|hiv
587780|NCT01066065|metabolic disorder|metabolic disorder
587781|NCT01066065|HIV naive patients initiating HAART with Raltegravir or boosted Darunavir|hiv naive patients initiating haart with raltegravir or boosted darunavir
587782|NCT01066052|Growth hormone|growth hormone
587783|NCT01066052|Turner syndrome|turner syndrome
587784|NCT01066052|r-hGH|r-hgh
587785|NCT01066052|early treatment|early treatment
587786|NCT01066039|Bisoprolol|bisoprolol
587787|NCT01066039|Hypertension|hypertension
587788|NCT01066039|Diabetes mellitus, Type II|diabetes mellitus, type ii
587789|NCT01066039|Blood pressure|blood pressure
587790|NCT01066039|Glycemic level|glycemic level
587791|NCT01066026|metallic cannula|metallic cannula
587792|NCT01066026|Hyaluronic acid|hyaluronic acid
587793|NCT01066013|Antimicrobial De escalation|antimicrobial de escalation
587794|NCT01066013|Meropenem|meropenem
587795|NCT01066013|Piperacillin tazobactam|piperacillin tazobactam
587796|NCT01066013|Medical patients|medical patients
587797|NCT01066013|Appropriate use|appropriate use
587798|NCT01066013|Cost savings|cost savings
587799|NCT01066013|Antimicrobial De-escalation strategy|antimicrobial de-escalation strategy
587800|NCT01065974|Nutritional Intake|nutritional intake
587801|NCT01065974|Psychosocial Outcome|psychosocial outcome
587802|NCT01065961|anterior|anterior
587803|NCT01065961|cervical|cervical
587804|NCT01065961|fusion|fusion
587805|NCT01065961|swallowing|swallowing
587806|NCT01065961|Swallowing after anterior cervical discectomy and fusion|swallowing after anterior cervical discectomy and fusion
587807|NCT01065961|Bony fusion rates post anterior cervical discectomy and fusion|bony fusion rates post anterior cervical discectomy and fusion
587808|NCT01065948|subcutaneous glucose monitoring|subcutaneous glucose monitoring
587809|NCT01065948|diabetes|diabetes
587810|NCT01065948|fluorescence|fluorescence
587811|NCT01065948|affinity|affinity
587812|NCT01065948|biosensor|biosensor
587813|NCT01065948|type I Diabetes|type i diabetes
587814|NCT01065948|type II diabetes|type ii diabetes
587815|NCT01065935|ALN-RSV01|aln-rsv01
587816|NCT01065935|RSV|rsv
587817|NCT01065935|Respiratory Syncytial Virus|respiratory syncytial virus
587818|NCT01065896|spinal cord injury|spinal cord injury
587819|NCT01065896|coronary artery disease|coronary artery disease
587820|NCT01065857|Colonoscopy, Preparation, Evacuating, Bowel Cleansing.|colonoscopy, preparation, evacuating, bowel cleansing.
587821|NCT01065844|Nelfinavir|nelfinavir
587822|NCT01065831|motivational interviewing, lay health advisers|motivational interviewing, lay health advisers
587823|NCT01065818|Esophageal cancer|esophageal cancer
587824|NCT01065818|Non-small cell lung cancer|non-small cell lung cancer
587825|NCT01065818|FLT-PET|flt-pet
587826|NCT01065818|Chemoradiotherapy|chemoradiotherapy
587827|NCT01065805|18F-FLT|18f-flt
587828|NCT01065805|Positive Emission Tomography|positive emission tomography
587829|NCT01065805|Cancer|cancer
587830|NCT01065792|HIV Infection|hiv infection
587831|NCT01065766|Diabetes Mellitus|diabetes mellitus
587832|NCT01065766|Non-Insulin-Dependent|non-insulin-dependent
587833|NCT01065753|Rho kinase|rho kinase
587834|NCT01065753|Brain-derived neurotrophic factor|brain-derived neurotrophic factor
587835|NCT01065740|Peripheral arterial disease|peripheral arterial disease
587836|NCT01065740|Patient education|patient education
587837|NCT01065740|Physical activity coaching|physical activity coaching
587838|NCT01065740|Lifestyle modifications|lifestyle modifications
587839|NCT01065740|Walking capacity|walking capacity
587840|NCT01065740|6 minutes walking test|6 minutes walking test
587841|NCT01065727|Reemitting aggressive multiple sclerosis|reemitting aggressive multiple sclerosis
587842|NCT01065714|Transepidermal water loss|transepidermal water loss
587843|NCT01065714|Epidermal barrier|epidermal barrier
587844|NCT01065714|Skin hydration|skin hydration
587845|NCT01065688|distal gastrectomy|distal gastrectomy
587846|NCT01065688|Billroth-I reconstruction|billroth-i reconstruction
587847|NCT01065688|gastric cancer|gastric cancer
587849|NCT01065675|Medication Reconciliation|medication reconciliation
587850|NCT01065675|Emergency Department|emergency department
587851|NCT01065675|Nurse|nurse
587852|NCT01065675|Pharmacist|pharmacist
587853|NCT01065675|Certified Pharmacy Technician|certified pharmacy technician
587854|NCT01065675|Medication reconciliation: inpatients admitted from the ED|medication reconciliation: inpatients admitted from the ed
587855|NCT01065662|AZD2171|azd2171
587856|NCT01065662|temsirolimus|temsirolimus
587857|NCT01065662|advanced gynecological malignancies|advanced gynecological malignancies
587858|NCT01065649|reflux disease|reflux disease
587859|NCT01065649|heartburn|heartburn
587860|NCT01065623|Phase I|phase i
587861|NCT01065623|Dose escalation|dose escalation
587862|NCT01065623|Immunoconjugate|immunoconjugate
587863|NCT01065597|electroconvulsive therapy|electroconvulsive therapy
587864|NCT01065597|seizure|seizure
587865|NCT01065597|nonconvulsive|nonconvulsive
587866|NCT01065597|subconvulsive|subconvulsive
587867|NCT01065597|major depression|major depression
587868|NCT01065597|bipolar disorder|bipolar disorder
587869|NCT01065584|liver transplantation|liver transplantation
587870|NCT01065584|Patients undergoing liver transplantation|patients undergoing liver transplantation
587871|NCT01065571|relapse|relapse
587872|NCT01065571|carrageenan|carrageenan
587873|NCT01065571|inflammation|inflammation
587874|NCT01065558|Ecopipam|ecopipam
587875|NCT01065558|Lesch-Nyhan Disease|lesch-nyhan disease
587876|NCT01065558|Safety|safety
587877|NCT01065558|Self-Injurious Behavior|self-injurious behavior
587878|NCT01065545|leukemia|leukemia
587879|NCT01065532|Restenosis|restenosis
587880|NCT01065532|PCI|pci
587881|NCT01065532|Drug-eluting stent|drug-eluting stent
587882|NCT01065532|Drug-eluting balloon|drug-eluting balloon
587883|NCT01065532|Optical Coherence Tomography|optical coherence tomography
587884|NCT01065519|Coronary stent|coronary stent
587885|NCT01065519|Optical coherence tomography|optical coherence tomography
587886|NCT01065519|Intravascular ultrasound|intravascular ultrasound
587887|NCT01065480|Training|training
587888|NCT01065480|Substance Abuse|substance abuse
587889|NCT01065480|Counseling|counseling
587890|NCT01065480|Motivational Interviewing|motivational interviewing
587891|NCT01065467|LBH589|lbh589
587892|NCT01065467|panobinostat|panobinostat
587893|NCT01065454|Pulmonary Hypertension|pulmonary hypertension
587894|NCT01065454|Left ventricular dysfunction|left ventricular dysfunction
587895|NCT01065441|breast cancer|breast cancer
587896|NCT01065441|colorectal cancer|colorectal cancer
587897|NCT01065441|prostate cancer|prostate cancer
587898|NCT01065441|melanoma|melanoma
587899|NCT01065441|ovarian cancer|ovarian cancer
587900|NCT01065441|GI cancer|gi cancer
587901|NCT01065441|Sarcoma|sarcoma
587902|NCT01065441|Renal Cell Carcinoma|renal cell carcinoma
587903|NCT01065428|neuromechanical efficiency|neuromechanical efficiency
587904|NCT01065428|neuroventilatory efficiency|neuroventilatory efficiency
587905|NCT01065428|weaning|weaning
587906|NCT01065428|Respiration, Artificial|respiration, artificial
587907|NCT01065415|Magnetic Resonance Imaging/Positron Emission Tomography|magnetic resonance imaging/positron emission tomography
587908|NCT01065415|Whole body imaging|whole body imaging
587909|NCT01065415|Non-small cell lung cancer|non-small cell lung cancer
587910|NCT01065415|staging|staging
587911|NCT01065415|Diagnostic accuracy|diagnostic accuracy
587912|NCT01065402|Diabetes mellitus|diabetes mellitus
587913|NCT01065402|continuous glucose monitoring system (CGMS)|continuous glucose monitoring system (cgms)
587914|NCT01065389|Intradialysis|intradialysis
587915|NCT01065389|Resistance training|resistance training
587916|NCT01065389|Protein Catabolic Rate|protein catabolic rate
587917|NCT01065389|Urea kinetics|urea kinetics
587918|NCT01065389|Quality of life|quality of life
587919|NCT01065389|VO2 max|vo2 max
587920|NCT01065376|IVF|ivf
587921|NCT01065376|OHSS|ohss
587922|NCT01065376|cabergoline|cabergoline
587923|NCT01065363|Hepatitis B virus DNA|hepatitis b virus dna
587924|NCT01065363|Metabolic factor|metabolic factor
587925|NCT01065363|Body mass index|body mass index
587926|NCT01065363|Obesity|obesity
587927|NCT01065363|Insulin resistance|insulin resistance
587928|NCT01065363|Lifestyle factor|lifestyle factor
587929|NCT01065363|Preventive Medicine|preventive medicine
587930|NCT01065363|Health Promotion|health promotion
587931|NCT01065350|ketofol|ketofol
587932|NCT01065350|hemodynamics|hemodynamics
587933|NCT01065350|propofol|propofol
587934|NCT01065350|anesthesia|anesthesia
587935|NCT01065337|peripheral arterial occlusion disease (PAD)|peripheral arterial occlusion disease (pad)
587936|NCT01065337|diabetic foot|diabetic foot
587937|NCT01065337|critical limb ischemia (CLI)|critical limb ischemia (cli)
587938|NCT01065337|stem cell therapy|stem cell therapy
587939|NCT01065324|balloon|balloon
587940|NCT01065324|enteroscopy|enteroscopy
587941|NCT01065324|bacteremia|bacteremia
587942|NCT01065311|Depressive Disorder|depressive disorder
587943|NCT01065311|Psychotherapy|psychotherapy
587944|NCT01065285|Influenza|influenza
587945|NCT01065285|autoimmune diseases|autoimmune diseases
587946|NCT01065285|vaccination|vaccination
587947|NCT01065285|H1N1|h1n1
587948|NCT01065272|Dexamethasone|dexamethasone
587949|NCT01065272|Bronchiolitis|bronchiolitis
587950|NCT01065259|attention deficit hyperactivity disorder|attention deficit hyperactivity disorder
587951|NCT01065259|executive function|executive function
587952|NCT01065259|OROS MPH|oros mph
587953|NCT01065259|atomoxetine|atomoxetine
587954|NCT01065246|malignant ascites|malignant ascites
587955|NCT01065246|second cycle|second cycle
587956|NCT01065246|trifunctional|trifunctional
587957|NCT01065220|Serotonin Transporter|serotonin transporter
587958|NCT01065220|Hormone therapy|hormone therapy
587959|NCT01065220|Gender Dysphoria|gender dysphoria
587960|NCT01065220|Transsexualism|transsexualism
587961|NCT01065181|shoulder|shoulder
587962|NCT01065181|posterior inferior glenohumeral ligament|posterior inferior glenohumeral ligament
587963|NCT01065181|posterior capsule|posterior capsule
587964|NCT01065181|capsular contracture|capsular contracture
587965|NCT01065181|baseball|baseball
587966|NCT01065181|throwing injury|throwing injury
587967|NCT01065168|endometriosis|endometriosis
587968|NCT01065168|endometrioma|endometrioma
587969|NCT01065168|antimullerian hormone|antimullerian hormone
587970|NCT01065168|cystectomy|cystectomy
587971|NCT01065142|Heart Failure|heart failure
587972|NCT01065142|Patient Education as Topic|patient education as topic
587973|NCT01065142|Primary Health Care|primary health care
587974|NCT01065142|Quality of Life|quality of life
587975|NCT01065116|Malaria|malaria
587976|NCT01065103|STEMI|stemi
587977|NCT01065103|Primary angioplasty|primary angioplasty
587978|NCT01065103|Non-culprit vessel at STEMI|non-culprit vessel at stemi
587979|NCT01065103|Fractional Flow Reserve|fractional flow reserve
587980|NCT01065103|ST-elevation myocardial infarction|st-elevation myocardial infarction
587981|NCT01065103|Fractional Flow Reserve in non-culprit vessel at STEMI|fractional flow reserve in non-culprit vessel at stemi
587982|NCT01065090|Capacity for Work Questionnaire|capacity for work questionnaire
587983|NCT01065090|exercise|exercise
587984|NCT01065090|AVONEX|avonex
587985|NCT01065090|SDMT: Symbol Digit Modalities Test|sdmt: symbol digit modalities test
587986|NCT01065090|FSMC: Fatigue Scale for Motor and Cognitive functions|fsmc: fatigue scale for motor and cognitive functions
587987|NCT01065090|effects of exercise|effects of exercise
587988|NCT01065090|EDSS: Expanded Disability Status Scale|edss: expanded disability status scale
587989|NCT01065077|Heart Failure|heart failure
587990|NCT01065064|Multifocal IOL|multifocal iol
587991|NCT01065064|ReSTOR IOL|restor iol
587992|NCT01065051|Pulmonary Hypertension|pulmonary hypertension
587993|NCT01065051|Left ventricular dysfunction|left ventricular dysfunction
587994|NCT01065025|4SC-205|4sc-205
587995|NCT01065025|Solid tumors|solid tumors
587996|NCT01065025|Lymphomas|lymphomas
587997|NCT01065025|Phase I|phase i
587998|NCT01064999|Neoadjuvant chemotherapy|neoadjuvant chemotherapy
587999|NCT01064999|locally advanced rectal cancer|locally advanced rectal cancer
588000|NCT01064999|intensity-modulated radiation therapy|intensity-modulated radiation therapy
588001|NCT01064999|pathological complete response|pathological complete response
588002|NCT01064986|Immune System|immune system
588003|NCT01064973|autism|autism
588004|NCT01064960|Neoplasms, Connective and Soft Tissue|neoplasms, connective and soft tissue
588005|NCT01064960|Neoplasms, Muscle Tissue|neoplasms, muscle tissue
588006|NCT01064960|Neoplasms|neoplasms
588007|NCT01064960|Myofibroma|myofibroma
588008|NCT01064960|Neoplasms by Histologic Type|neoplasms by histologic type
588009|NCT01064960|Connective Tissue Diseases|connective tissue diseases
588010|NCT01064960|Neoplasms, Connective Tissue|neoplasms, connective tissue
588011|NCT01064960|Leiomyoma|leiomyoma
588012|NCT01064934|coronary heart disease|coronary heart disease
588013|NCT01064934|cerebrovascular disease|cerebrovascular disease
588014|NCT01064934|peripheral arterial disease|peripheral arterial disease
588015|NCT01064934|atherosclerosis|atherosclerosis
588016|NCT01064934|hyperlipoproteinemia|hyperlipoproteinemia
588017|NCT01064921|oropharyngeal cancer|oropharyngeal cancer
588018|NCT01064921|recurrent squamous cell carcinoma of the oropharynx|recurrent squamous cell carcinoma of the oropharynx
588019|NCT01064908|Endarterectomy, Carotid|endarterectomy, carotid
588020|NCT01064908|Carotid stenosis|carotid stenosis
588021|NCT01064908|Oxygen mask|oxygen mask
588022|NCT01064895|Benephit|benephit
588023|NCT01064895|Acute Kidney Injury|acute kidney injury
588024|NCT01064895|Acute Renal Failure|acute renal failure
588025|NCT01064895|Contrast Induced Nephropathy|contrast induced nephropathy
588026|NCT01064895|Chronic Kidney Disease|chronic kidney disease
588027|NCT01064869|Adherence|adherence
588028|NCT01064869|Asthma|asthma
588029|NCT01064869|medication|medication
588030|NCT01064856|peripheral spondyloarthritis|peripheral spondyloarthritis
588031|NCT01064856|adalimumab|adalimumab
588032|NCT01064856|humira|humira
588033|NCT01064843|Edentulous|edentulous
588034|NCT01064843|Edentulism|edentulism
588035|NCT01064843|Lower denture|lower denture
588036|NCT01064843|Mini dental implant|mini dental implant
588037|NCT01064843|Imtec MDI|imtec mdi
588038|NCT01064843|Denture stabilization|denture stabilization
588039|NCT01064843|Case success rate of overdentures stabilized by MDI|case success rate of overdentures stabilized by mdi
588040|NCT01064843|General satisfaction of patients with this treatment|general satisfaction of patients with this treatment
588041|NCT01064843|Oral health-related quality of life of these patients|oral health-related quality of life of these patients
588042|NCT01064843|Cost estimates|cost estimates
588043|NCT01064830|brittle nail|brittle nail
588044|NCT01064817|glaucoma, trabeculectomy|glaucoma, trabeculectomy
588045|NCT01064791|Renal transplantation|renal transplantation
588046|NCT01064778|Glycemic Index|glycemic index
588047|NCT01064778|Brain|brain
588048|NCT01064778|Intake Regulation|intake regulation
588049|NCT01064778|Weight Loss|weight loss
588050|NCT01064778|Hunger|hunger
588051|NCT01064778|Diet|diet
588052|NCT01064765|Heart failure|heart failure
588053|NCT01064765|Self management|self management
588054|NCT01064765|cognitive dysfunction|cognitive dysfunction
588055|NCT01064765|Self management of heart failure|self management of heart failure
588056|NCT01064752|Minocycline|minocycline
588057|NCT01064752|HIV-1|hiv-1
588058|NCT01064752|Immune activation|immune activation
588059|NCT01064752|Cerebrospinal fluid|cerebrospinal fluid
588060|NCT01064752|Observational|observational
588061|NCT01064739|Healthy Volunteers|healthy volunteers
588062|NCT01064739|Fava bean consumption|fava bean consumption
588063|NCT01064739|L-Dopa content in Fava Beans|l-dopa content in fava beans
588064|NCT01064739|Sodium|sodium
588065|NCT01064739|Potassium|potassium
588066|NCT01064739|Electrolyte Balance|electrolyte balance
588067|NCT01064739|Natriuresis|natriuresis
588068|NCT01064726|Allergic Rhinitis Nasal Allergen Challenge Inflammatory Markers|allergic rhinitis nasal allergen challenge inflammatory markers
588069|NCT01064713|Tesetaxel|tesetaxel
588070|NCT01064713|Second-line therapy|second-line therapy
588071|NCT01064713|Metastatic melanoma|metastatic melanoma
588072|NCT01064713|Normal serum LDH|normal serum ldh
588073|NCT01064700|Anxiety|anxiety
588074|NCT01064700|Phototherapy|phototherapy
588075|NCT01064700|Psychic Anxiety|psychic anxiety
588076|NCT01064674|renal transplantation|renal transplantation
588077|NCT01064674|cardiovascular morbidity|cardiovascular morbidity
588078|NCT01064674|evaluation before renal transplantation|evaluation before renal transplantation
588079|NCT01064661|Probiotics|probiotics
588080|NCT01064661|abdominal pain|abdominal pain
588081|NCT01064661|abdominal discomfort|abdominal discomfort
588082|NCT01064661|bloating|bloating
588083|NCT01064661|Functional Bowel Disorders|functional bowel disorders
588084|NCT01064635|stage IA breast cancer|stage ia breast cancer
588085|NCT01064635|stage IB breast cancer|stage ib breast cancer
588086|NCT01064635|stage II breast cancer|stage ii breast cancer
588087|NCT01064635|stage IIIA breast cancer|stage iiia breast cancer
588088|NCT01064635|stage IIIB breast cancer|stage iiib breast cancer
588089|NCT01064635|stage IIIC breast cancer|stage iiic breast cancer
588090|NCT01064596|obesity|obesity
588091|NCT01064596|fondaparinux|fondaparinux
588092|NCT01064596|surgery|surgery
588093|NCT01064596|anti-Xa activity|anti-xa activity
588094|NCT01064570|Acute Promyelocytic Leukemia|acute promyelocytic leukemia
588096|NCT01064557|Acute promyelocytic Leukemia|acute promyelocytic leukemia
588097|NCT01064544|Sleep problems|sleep problems
588098|NCT01064544|melatonin|melatonin
588099|NCT01064544|mood|mood
588100|NCT01064544|Hemodialysis|hemodialysis
588101|NCT01064518|Lateral Canthal Lines|lateral canthal lines
588102|NCT01064518|Crow's Feet Wrinkles|crow's feet wrinkles
588103|NCT01064518|Facial Wrinkles|facial wrinkles
588104|NCT01064505|Ocular Neuroprotection|ocular neuroprotection
588105|NCT01064505|ocular neuroprotectant|ocular neuroprotectant
588106|NCT01064505|NAION|naion
588107|NCT01064505|NAAION|naaion
588108|NCT01064505|Non-arteritic ischemic optic neuropathy|non-arteritic ischemic optic neuropathy
588109|NCT01064505|Non-arteritic anterior ischemic optic neuropathy|non-arteritic anterior ischemic optic neuropathy
588110|NCT01064505|chronic optic nerve atrophy|chronic optic nerve atrophy
588111|NCT01064505|optic nerve atrophy|optic nerve atrophy
588112|NCT01064505|retinal degeneration|retinal degeneration
588113|NCT01064505|optic neuritis|optic neuritis
588114|NCT01064505|end stage glaucoma|end stage glaucoma
588115|NCT01064505|Leber's hereditary optic neuropathy|leber's hereditary optic neuropathy
588116|NCT01064466|SCLC|sclc
588117|NCT01064466|Etoposide|etoposide
588118|NCT01064466|SNP|snp
588119|NCT01064466|Topo|topo
588120|NCT01064466|CYP|cyp
588121|NCT01064466|Genotype|genotype
588122|NCT01064466|Oncology|oncology
588123|NCT01064466|Genetics|genetics
588124|NCT01064466|Lung|lung
588125|NCT01064466|Cancer|cancer
588126|NCT01064453|Menopause|menopause
588127|NCT01064453|Menopausal symptoms|menopausal symptoms
588128|NCT01064453|Prevention of osteoporosis in menopausal women|prevention of osteoporosis in menopausal women
588129|NCT01064453|Estrogen deficiency symptoms|estrogen deficiency symptoms
588130|NCT01064453|Hormone replacement therapy|hormone replacement therapy
588131|NCT01064440|Painful legs|painful legs
588132|NCT01064440|Ischemic legs|ischemic legs
588133|NCT01064440|Treatment for Claudication|treatment for claudication
588134|NCT01064440|Gene therapy|gene therapy
588135|NCT01064427|breast cancer|breast cancer
588136|NCT01064427|fatigue|fatigue
588137|NCT01064427|adjuvant chemotherapy|adjuvant chemotherapy
588138|NCT01064427|quality of life|quality of life
588139|NCT01064414|Canagliflozin|canagliflozin
588140|NCT01064414|JNJ 28431754|jnj 28431754
588141|NCT01064414|Placebo|placebo
588142|NCT01064414|Sodium-Glucose Transporter 2|sodium-glucose transporter 2
588143|NCT01064414|hemoglobin A1c protein, Blood Glucose|hemoglobin a1c protein, blood glucose
588144|NCT01064414|reduced kidney function, Type 2 diabetes mellitus|reduced kidney function, type 2 diabetes mellitus
588145|NCT01064388|Safety|safety
588146|NCT01064375|DNA vaccine|dna vaccine
588147|NCT01064375|Electroporation|electroporation
588148|NCT01064362|Haemorrhage|haemorrhage
588149|NCT01064362|Thromboprophylaxis|thromboprophylaxis
588150|NCT01064349|ErbB2+ breast cancer|erbb2+ breast cancer
588151|NCT01064349|ErbB2 treatment|erbb2 treatment
588152|NCT01064349|brain metastases|brain metastases
588153|NCT01064336|Thrombocytopenia|thrombocytopenia
588154|NCT01064336|Pregnancy|pregnancy
588155|NCT01064323|intermittent pneumatic leg compression|intermittent pneumatic leg compression
588156|NCT01064323|nitric oxide|nitric oxide
588157|NCT01064323|vascular endothelial cells|vascular endothelial cells
588158|NCT01064323|IPC|ipc
588159|NCT01064323|EECP|eecp
588160|NCT01064323|atherosclerosis|atherosclerosis
588161|NCT01064310|renal cell carcinoma|renal cell carcinoma
588162|NCT01064310|Votrient|votrient
588163|NCT01064310|cancer|cancer
588164|NCT01064310|pazopanib|pazopanib
588165|NCT01064310|patient preference|patient preference
588166|NCT01064310|quality of life|quality of life
588167|NCT01064297|Pregnancy registry|pregnancy registry
588168|NCT01064297|Major congenital malformations|major congenital malformations
588169|NCT01064297|Pregnancy outcomes|pregnancy outcomes
588170|NCT01064297|Pregnancy|pregnancy
588171|NCT01064297|First trimester|first trimester
588172|NCT01064297|Lamotrigine|lamotrigine
588173|NCT01064284|Hemophilia A|hemophilia a
588174|NCT01064284|Factor VIII inhibitors|factor viii inhibitors
588175|NCT01064284|vWF/FVIII|vwf/fviii
588176|NCT01064284|rFVIII|rfviii
588177|NCT01064258|treatment|treatment
588178|NCT01064258|CPAP|cpap
588179|NCT01064258|sleep apnea|sleep apnea
588180|NCT01064245|Asthma|asthma
588181|NCT01064245|Cough Variant Asthma|cough variant asthma
588182|NCT01064245|Mannitol|mannitol
588183|NCT01064245|Methacholine|methacholine
588184|NCT01064245|Cough|cough
588185|NCT01064245|Hypersensitivity|hypersensitivity
588186|NCT01064219|hCG|hcg
588187|NCT01064219|Treg cells|treg cells
588188|NCT01064219|implantation|implantation
588189|NCT01064219|pinopodes|pinopodes
588190|NCT01064219|endometrium|endometrium
588191|NCT01064206|thrombangiitis obliterans|thrombangiitis obliterans
588192|NCT01064206|Buerger's disease|buerger's disease
588193|NCT01064206|atheromatous arteritis|atheromatous arteritis
588194|NCT01064206|psychiatric disorders|psychiatric disorders
588195|NCT01064206|personality disorders|personality disorders
588196|NCT01064206|addictive profile|addictive profile
588197|NCT01064206|addiction|addiction
588198|NCT01064206|tobacco|tobacco
588199|NCT01064206|cannabis|cannabis
588200|NCT01064193|In Vitro Fertilization|in vitro fertilization
588201|NCT01064193|biopsy|biopsy
588202|NCT01064193|pregnancy|pregnancy
588203|NCT01064193|Implantation|implantation
588204|NCT01064193|Embryo|embryo
588205|NCT01064193|first or second IVF tentative|first or second ivf tentative
588206|NCT01064167|Tranexamic Acid|tranexamic acid
588207|NCT01064167|off-pump coronary Artery Bypass|off-pump coronary artery bypass
588208|NCT01064141|Dengue Fever|dengue fever
588209|NCT01064141|Dengue Hemorrhagic Fever|dengue hemorrhagic fever
588210|NCT01064141|CYD Dengue Vaccine|cyd dengue vaccine
588211|NCT01064141|Toddlers|toddlers
588212|NCT01064128|Single-port|single-port
588213|NCT01064128|Laparoscopy|laparoscopy
588214|NCT01064128|Hysterectomy|hysterectomy
588215|NCT01064128|Pain|pain
588216|NCT01064128|Cosmesis|cosmesis
588217|NCT01064128|Analgesics|analgesics
588218|NCT01064089|HSP990|hsp990
588219|NCT01064089|HSP90|hsp90
588220|NCT01064089|Japan/Korea|japan/korea
588221|NCT01064089|Phase I|phase i
588222|NCT01064089|advanced solid tumors|advanced solid tumors
588223|NCT01064089|dose escalation|dose escalation
588224|NCT01064089|maximum tolerated dose|maximum tolerated dose
588225|NCT01064089|MTD|mtd
588226|NCT01064089|Japanese paatients|japanese paatients
588227|NCT01064089|Korean patients|korean patients
588228|NCT01064076|ICD, defibrillator|icd, defibrillator
588229|NCT01064050|tumoral obstruction of the main stem bronchus|tumoral obstruction of the main stem bronchus
588230|NCT01064050|bronchoscopy|bronchoscopy
588231|NCT01064050|silicone stent|silicone stent
588232|NCT01064037|Heart Failure|heart failure
588233|NCT01064024|uUTI|uuti
588234|NCT01064024|Pain or burning associated with Uncomplicated Urinary Tract Infections|pain or burning associated with uncomplicated urinary tract infections
588235|NCT01063998|Renal cell|renal cell
588236|NCT01063998|Carcinoma|carcinoma
588237|NCT01063998|Biomarkers|biomarkers
588238|NCT01063985|Skin testing for mouse allergies|skin testing for mouse allergies
588239|NCT01063959|Laparoscopic Sleeve Gastrectomy|laparoscopic sleeve gastrectomy
588240|NCT01063959|Laparoscopic Gastric Bypass|laparoscopic gastric bypass
588241|NCT01063933|influenza, Peramivir, children, pharmacokinetic, pharmacodynamic|influenza, peramivir, children, pharmacokinetic, pharmacodynamic
588242|NCT01063920|LT-NS001|lt-ns001
588243|NCT01063920|Gastric Ulcers|gastric ulcers
588244|NCT01063920|NSAID|nsaid
588245|NCT01063920|Osteoarthritis|osteoarthritis
588246|NCT01063920|Naproxen|naproxen
588247|NCT01063907|Leukemia|leukemia
588248|NCT01063907|Immunoproliferative Disorder|immunoproliferative disorder
588249|NCT01063907|Neoplasma by Histologic Type|neoplasma by histologic type
588250|NCT01063907|Immune System Diseases|immune system diseases
588251|NCT01063907|Hematologic Diseases|hematologic diseases
588252|NCT01063907|Blood Protein Disorders|blood protein disorders
588253|NCT01063907|Paraproteinemias|paraproteinemias
588254|NCT01063907|Multiple Myeloma|multiple myeloma
588255|NCT01063907|Hematologic Disorders|hematologic disorders
588256|NCT01063907|Leukemia, Chronic, B-cell|leukemia, chronic, b-cell
588257|NCT01063907|Leukemia, B-cell|leukemia, b-cell
588258|NCT01063907|Leukemia, Chronic|leukemia, chronic
588259|NCT01063907|Neoplasms, Plasma Cell|neoplasms, plasma cell
588260|NCT01063907|Monoclonal Gammopathy of unknown significance (MGUS)|monoclonal gammopathy of unknown significance (mgus)
588261|NCT01063881|Sexual Dysfunction, physiological|sexual dysfunction, physiological
588262|NCT01063881|R096769|r096769
588263|NCT01063881|Dapoxetine|dapoxetine
588264|NCT01063881|Phase 3b|phase 3b
588265|NCT01063881|Premature Ejaculation|premature ejaculation
588266|NCT01063868|Diabetic neuropathy|diabetic neuropathy
588267|NCT01063868|Painful|painful
588268|NCT01063868|Polyneuropathy|polyneuropathy
588269|NCT01063868|Peripheral neuropathy|peripheral neuropathy
588270|NCT01063855|Erectile Dysfunction|erectile dysfunction
588271|NCT01063855|Sexual Dysfunction|sexual dysfunction
588272|NCT01063855|Dapoxetine hydrochloride|dapoxetine hydrochloride
588273|NCT01063855|PRILIGY|priligy
588274|NCT01063855|Premature ejaculation|premature ejaculation
588275|NCT01063855|Serotonin Uptake Inhibitors|serotonin uptake inhibitors
588276|NCT01063855|Sildenafil (Viagra)|sildenafil (viagra)
588277|NCT01063855|Vardenafil (Levitra)|vardenafil (levitra)
588278|NCT01063855|Tadalafil (Cialis)|tadalafil (cialis)
588279|NCT01063842|Drop-out rate|drop-out rate
588280|NCT01063842|Osteoarthritis|osteoarthritis
588281|NCT01063842|Tolerability|tolerability
588282|NCT01063842|Tramadol|tramadol
588283|NCT01063842|Acetaminophen|acetaminophen
588284|NCT01063829|HCMV|hcmv
588285|NCT01063816|PARP Inhibitors|parp inhibitors
588286|NCT01063803|Open-label|open-label
588287|NCT01063803|Long-term safety study of ATN-103 in RA|long-term safety study of atn-103 in ra
588288|NCT01063790|Post-operative pain|post-operative pain
588289|NCT01063790|inguinal hernia repair surgery|inguinal hernia repair surgery
588290|NCT01063790|Patient education|patient education
588291|NCT01063777|Hip Osteoarthritis, Exercise therapy, Patient Education|hip osteoarthritis, exercise therapy, patient education
588292|NCT01063764|Keppra|keppra
588293|NCT01063764|Levetiracetam|levetiracetam
588294|NCT01063764|Children|children
588295|NCT01063764|Epilepsy|epilepsy
588296|NCT01063764|Partial Seizures|partial seizures
588297|NCT01063751|Osteoarthritis|osteoarthritis
588298|NCT01063751|Traumatic arthritis|traumatic arthritis
588299|NCT01063751|Avascular Necrosis|avascular necrosis
588300|NCT01063738|Rehabilitation|rehabilitation
588301|NCT01063738|Intensive Care|intensive care
588302|NCT01063738|Critical illness|critical illness
588303|NCT01063738|Physiotherapy|physiotherapy
588304|NCT01063738|Nutritional supplementation|nutritional supplementation
588305|NCT01063725|menopause|menopause
588306|NCT01063725|hot flashes|hot flashes
588307|NCT01063725|vasomotor symptoms|vasomotor symptoms
588308|NCT01063725|femarelle|femarelle
588309|NCT01063725|soy extract|soy extract
588310|NCT01063725|SERM|serm
588311|NCT01063712|Ductus|ductus
588312|NCT01063712|Patent ductus Arterious|patent ductus arterious
588313|NCT01063712|"Nit-Occlud® PDA-R"|"nit-occlud® pda-r"
588314|NCT01063712|Interventional closure of PDA|interventional closure of pda
588315|NCT01063712|Percutaneous closure|percutaneous closure
588316|NCT01063699|biliary atresia - laparoscopy - kasai - portoenterostomy|biliary atresia - laparoscopy - kasai - portoenterostomy
588317|NCT01063686|Pregnancy|pregnancy
588318|NCT01063673|Running, overuse injury, limits humans|running, overuse injury, limits humans
588319|NCT01063660|Treosulfan|treosulfan
588320|NCT01063660|Fludarabine|fludarabine
588321|NCT01063660|ATG|atg
588322|NCT01063660|AML|aml
588323|NCT01063647|Treosulfan|treosulfan
588324|NCT01063647|Allogeneic stem cell transplantation|allogeneic stem cell transplantation
588325|NCT01063647|Conditioning therapy|conditioning therapy
588326|NCT01063634|malignant biliary obstruction|malignant biliary obstruction
588327|NCT01063634|viaduct|viaduct
588328|NCT01063634|self-expandable metal stents|self-expandable metal stents
588329|NCT01063595|Octaplas LG|octaplas lg
588330|NCT01063595|Octaplas SD|octaplas sd
588331|NCT01063582|echocardiogram|echocardiogram
588332|NCT01063582|electrocardiographic|electrocardiographic
588333|NCT01063582|risk factors|risk factors
588334|NCT01063582|noise|noise
588335|NCT01063569|Addison's disease|addison's disease
588336|NCT01063569|Glucocorticoid treatment|glucocorticoid treatment
588337|NCT01063569|Continuous subcutaneous hydrocortisone infusion|continuous subcutaneous hydrocortisone infusion
588338|NCT01063569|CSHI|cshi
588339|NCT01063569|Quality of Life|quality of life
588340|NCT01063569|Sleep|sleep
588341|NCT01063556|end-stage renal disease hemodialysis donepezil hydrochloride pharmacokinetics Cross-Over Study|end-stage renal disease hemodialysis donepezil hydrochloride pharmacokinetics cross-over study
588342|NCT01063543|fondaparinux|fondaparinux
588343|NCT01063543|orthopedic surgery|orthopedic surgery
588344|NCT01063543|patients with major orthopedic surgery|patients with major orthopedic surgery
588345|NCT01063530|FLuoride|fluoride
588346|NCT01063530|Dental Sensitivity|dental sensitivity
588347|NCT01063530|Abfraction|abfraction
588348|NCT01063530|Cervical lesions|cervical lesions
588349|NCT01063517|Poly(ADP ribose)|poly(adp ribose)
588350|NCT01063517|polymerase (PARP)|polymerase (parp)
588351|NCT01063517|Gastric cancer|gastric cancer
588352|NCT01063517|olaparib|olaparib
588353|NCT01063517|PARP inhibitor|parp inhibitor
588354|NCT01063517|ATM AZD2281|atm azd2281
588355|NCT01063517|Ku0059436|ku0059436
588356|NCT01063517|Homologous Recombination deficiency (HRD)|homologous recombination deficiency (hrd)
588357|NCT01063517|Recurrent gastric cancer|recurrent gastric cancer
588358|NCT01063517|metastatic gastric cancer|metastatic gastric cancer
588359|NCT01063491|coronary artery bypass graft surgery|coronary artery bypass graft surgery
588360|NCT01063491|bypass grafts|bypass grafts
588361|NCT01063491|angiography|angiography
588362|NCT01063491|percutaneous coronary intervention|percutaneous coronary intervention
588363|NCT01063491|coronary imaging|coronary imaging
588364|NCT01063491|coronary artery bypass graft surgery, bypass graft patency|coronary artery bypass graft surgery, bypass graft patency
588365|NCT01063478|Non-Small Cell|non-small cell
588366|NCT01063478|Lung Cancer|lung cancer
588367|NCT01063478|Unresectable advanced NSCLC|unresectable advanced nsclc
588368|NCT01063465|Achilles|achilles
588369|NCT01063465|Tendon|tendon
588370|NCT01063465|weightbearing|weightbearing
588371|NCT01063452|Urinary Catheterization|urinary catheterization
588372|NCT01063452|Urinary Tract Infections|urinary tract infections
588373|NCT01063439|DLBCL|dlbcl
588374|NCT01063439|NHL|nhl
588375|NCT01063426|Statin|statin
588376|NCT01063426|Vein|vein
588377|NCT01063413|Behavioral Research|behavioral research
588378|NCT01063413|Community-Based Participatory Research|community-based participatory research
588379|NCT01063387|cervical cancer,semaphorin 4C (Sema4C),|cervical cancer,semaphorin 4c (sema4c),
588380|NCT01063387|Prophylactic Irradiation|prophylactic irradiation
588381|NCT01063348|N-Acetyl Cysteine|n-acetyl cysteine
588382|NCT01063348|Picking|picking
588383|NCT01063348|Impulse Control Disorder|impulse control disorder
588384|NCT01063348|Obsessive Compulsive Disorder|obsessive compulsive disorder
588385|NCT01063335|CB1 Receptor|cb1 receptor
588386|NCT01063335|Schizophrenia|schizophrenia
588387|NCT01063335|Positron Emission Tomography (PET)|positron emission tomography (pet)
588388|NCT01063335|Healthy Volunteers|healthy volunteers
588389|NCT01063335|HV|hv
747841|NCT00446082|SOM230|som230
588390|NCT01063322|Mitral Regurgitation|mitral regurgitation
588391|NCT01063322|Echocardiography|echocardiography
588392|NCT01063322|Cardiac Magnetic Resonance|cardiac magnetic resonance
588393|NCT01063322|Regurgitant Volume|regurgitant volume
588394|NCT01063322|Mitral Valve Regurgitation|mitral valve regurgitation
588395|NCT01063309|Chronic Granulomatous Disease (CGD)|chronic granulomatous disease (cgd)
588396|NCT01063309|Atherosclerosis|atherosclerosis
588397|NCT01063309|Inflammatory Bowel Disease|inflammatory bowel disease
588398|NCT01063309|Immune Deficiencies|immune deficiencies
588399|NCT01063309|Immune System Deficiences|immune system deficiences
588400|NCT01063309|Chronic Granulomatous Disease|chronic granulomatous disease
588401|NCT01063309|CGD|cgd
588402|NCT01063296|cervical cancer|cervical cancer
588403|NCT01063283|Non-squamous Non-Small Cell Lung Cancer|non-squamous non-small cell lung cancer
588404|NCT01063283|Bevacizumab|bevacizumab
588405|NCT01063283|Ambulatory Blood Pressure Monitoring|ambulatory blood pressure monitoring
588406|NCT01063270|Hidradenitis Suppurativa|hidradenitis suppurativa
588407|NCT01063270|Antibiotics|antibiotics
588408|NCT01063270|Laser|laser
588409|NCT01063257|Myelodysplastic Syndrome|myelodysplastic syndrome
588410|NCT01063244|pregnancy|pregnancy
588411|NCT01063244|induction of Labor|induction of labor
588412|NCT01063244|Cervical ripening|cervical ripening
588413|NCT01063244|Foley balloon|foley balloon
588414|NCT01063231|Colonic Diseases|colonic diseases
588415|NCT01063231|bowel diseases|bowel diseases
588416|NCT01063218|Dermatitis, Atopic|dermatitis, atopic
588417|NCT01063218|Corticoids, topic|corticoids, topic
588418|NCT01063218|Corticosteroids|corticosteroids
588419|NCT01063205|Methamphetamine|methamphetamine
588420|NCT01063205|NAC|nac
588421|NCT01063205|N-acetylcysteine|n-acetylcysteine
588422|NCT01063192|Locally Advanced Pancreatic Cancer|locally advanced pancreatic cancer
588423|NCT01063179|Elderly patients|elderly patients
588424|NCT01063179|Bortezomib|bortezomib
588425|NCT01063179|Thalidomide|thalidomide
588426|NCT01063153|ADHD|adhd
588427|NCT01063153|Adults|adults
588428|NCT01063153|Electroencephalography (EEG)|electroencephalography (eeg)
588429|NCT01063153|Concerta|concerta
588430|NCT01063140|Rabies Immune Globulin|rabies immune globulin
588431|NCT01063140|Source Plasma Donors|source plasma donors
588432|NCT01063140|Booster Immunization|booster immunization
588433|NCT01063127|Morbid obesity|morbid obesity
588434|NCT01063127|Insulin resistance|insulin resistance
588435|NCT01063127|Euglycemic clamp|euglycemic clamp
588436|NCT01063114|proton beam radiation|proton beam radiation
588437|NCT01063088|Prophylaxis of seasonal influenza in adults|prophylaxis of seasonal influenza in adults
588438|NCT01063075|Cancer of Head|cancer of head
588439|NCT01063075|Cancer of Head and Neck|cancer of head and neck
588440|NCT01063075|Cancer of Neck|cancer of neck
588441|NCT01063075|Head and Neck Cancer|head and neck cancer
588442|NCT01063075|Head Cancer|head cancer
588443|NCT01063075|Head Neoplasms|head neoplasms
588444|NCT01063075|Head, Neck Neoplasms|head, neck neoplasms
588445|NCT01063075|Neck Cancer|neck cancer
588446|NCT01063075|Neck Neoplasms|neck neoplasms
588447|NCT01063075|Solid Neoplasm|solid neoplasm
588448|NCT01063075|Carcinoma|carcinoma
588449|NCT01063075|Sarcoma|sarcoma
588450|NCT01063010|sepsis|sepsis
588451|NCT01063010|septic shock|septic shock
588452|NCT01063010|Bevacizumab|bevacizumab
588453|NCT01063010|Avastin|avastin
588454|NCT01062984|Renal Replacement Therapy|renal replacement therapy
588455|NCT01062971|Open-angle glaucoma|open-angle glaucoma
588456|NCT01062971|Ocular hypertension|ocular hypertension
588457|NCT01062971|POAG|poag
588458|NCT01062971|Treatment|treatment
588459|NCT01062958|Neevo|neevo
588460|NCT01062958|Neevo DHA|neevo dha
588461|NCT01062958|L-methylfolate|l-methylfolate
588462|NCT01062958|anemia during pregnancy|anemia during pregnancy
588463|NCT01062958|folic acid|folic acid
588464|NCT01062958|vitamin B12|vitamin b12
588465|NCT01062958|prenatal vitamins|prenatal vitamins
588466|NCT01062958|hemoglobin|hemoglobin
588467|NCT01062958|iron deficiency|iron deficiency
588468|NCT01062958|Pregnancy|pregnancy
588469|NCT01062945|Cocaine|cocaine
588470|NCT01062945|Doxazosin|doxazosin
588471|NCT01062932|Cycloserine|cycloserine
588472|NCT01062932|Nicotine|nicotine
588473|NCT01062932|Smoking|smoking
588474|NCT01062906|intravenous lidocaine|intravenous lidocaine
588475|NCT01062906|postoperative pain|postoperative pain
588476|NCT01062906|laparoscopic surgery|laparoscopic surgery
588477|NCT01062906|opioids|opioids
588478|NCT01062906|opioids side-effects|opioids side-effects
588479|NCT01062893|labor pain treatment|labor pain treatment
588480|NCT01062893|duration analgesia|duration analgesia
588481|NCT01062893|Analgesic duration with normal saline injection.|analgesic duration with normal saline injection.
588482|NCT01062893|Analgesic duration without normal saline injection|analgesic duration without normal saline injection
588483|NCT01062867|Anaesthetic|anaesthetic
588484|NCT01062854|snoring, sleep disordered breathing, polysomnography, sleep fragmentation|snoring, sleep disordered breathing, polysomnography, sleep fragmentation
588485|NCT01062841|Long-Term Care|long-term care
588486|NCT01062841|Nursing Homes|nursing homes
588487|NCT01062841|Infection Control|infection control
588488|NCT01062841|Multi-drug resistant pathogens|multi-drug resistant pathogens
588489|NCT01062841|Long-term care residents with in-dwelling devices|long-term care residents with in-dwelling devices
588490|NCT01062828|Prematurity|prematurity
588491|NCT01062828|Necrotizing Enterocolitis|necrotizing enterocolitis
588492|NCT01062828|Feeding Intolerance|feeding intolerance
588493|NCT01062815|PNALD|pnald
588494|NCT01062815|PNAC|pnac
588495|NCT01062815|Parenteral Nutrition-Associated Cholestasis|parenteral nutrition-associated cholestasis
588496|NCT01062815|Congenital Anomalies of Gastrointestinal Tract|congenital anomalies of gastrointestinal tract
588497|NCT01062789|lung biopsy|lung biopsy
588498|NCT01062789|computed tomograph|computed tomograph
588499|NCT01062789|respiratory motion|respiratory motion
588500|NCT01062789|Controlling respiratory motion in CT guided lung biopsies|controlling respiratory motion in ct guided lung biopsies
588501|NCT01062789|biopsy|biopsy
588502|NCT01062776|dehydration|dehydration
588503|NCT01062776|fluid therapy|fluid therapy
588504|NCT01062776|pharmacokinetics|pharmacokinetics
588505|NCT01062776|hemoglobin|hemoglobin
588506|NCT01062763|hypertension|hypertension
588507|NCT01062763|spironolactone|spironolactone
588508|NCT01062763|antihypertensive treatment|antihypertensive treatment
588509|NCT01062763|Type-2 diabetes|type-2 diabetes
588510|NCT01062750|Liver Cirrhosis|liver cirrhosis
588511|NCT01062724|Cholestasis|cholestasis
588512|NCT01062724|TPN|tpn
588513|NCT01062724|Neonates|neonates
588514|NCT01062724|Primene|primene
588515|NCT01062724|Trophamine|trophamine
588516|NCT01062724|Methionine|methionine
588517|NCT01062724|Cysteine|cysteine
588518|NCT01062724|Taurine|taurine
588519|NCT01062724|Total Parenteral Nutrition|total parenteral nutrition
588520|NCT01062711|sarcopenia|sarcopenia
588521|NCT01062711|muscle|muscle
588522|NCT01062711|protein|protein
588523|NCT01062711|muscle protein synthesis|muscle protein synthesis
588524|NCT01062711|muscle protein breakdown|muscle protein breakdown
588525|NCT01062711|whey|whey
588526|NCT01062711|soy|soy
588527|NCT01062711|casein|casein
588528|NCT01062711|dose response|dose response
588529|NCT01062711|resistance exercise|resistance exercise
588530|NCT01062711|unilateral|unilateral
588531|NCT01062711|knee extension|knee extension
588532|NCT01062711|whole body protein|whole body protein
588533|NCT01062698|mechanical Thrombectomy|mechanical thrombectomy
588534|NCT01062698|CVA (Cerebrovascular Accident)|cva (cerebrovascular accident)
588535|NCT01062698|Cerebrovascular Accident, Acute|cerebrovascular accident, acute
588536|NCT01062685|septic shock|septic shock
588537|NCT01062685|sepsis|sepsis
588538|NCT01062685|St02|st02
588539|NCT01062685|Near Infrared Spectroscopy|near infrared spectroscopy
588540|NCT01062685|NIRS|nirs
588541|NCT01062672|plasticity|plasticity
588542|NCT01062672|reorganization|reorganization
588543|NCT01062672|cortical|cortical
588544|NCT01062672|fMRI|fmri
588545|NCT01062672|rehabilitation|rehabilitation
588546|NCT01062659|HCV|hcv
588547|NCT01062659|hepatitis C virus|hepatitis c virus
588548|NCT01062659|CHC|chc
588549|NCT01062659|chronic hepatitis c|chronic hepatitis c
588550|NCT01062659|interferon|interferon
588551|NCT01062659|ribavirin|ribavirin
588552|NCT01062659|Hepatitis, Viral, Human|hepatitis, viral, human
588553|NCT01062659|Anti-Infective Agents|anti-infective agents
588554|NCT01062659|peginterferon alfa-2a|peginterferon alfa-2a
588555|NCT01062659|peginterferon alfa-2b|peginterferon alfa-2b
588556|NCT01062646|music therapy|music therapy
588557|NCT01062646|multimodal psychotherapy|multimodal psychotherapy
588558|NCT01062646|children|children
588559|NCT01062646|anxiety disorders|anxiety disorders
588560|NCT01062646|pediatric anxiety|pediatric anxiety
588561|NCT01062633|dental caries|dental caries
588562|NCT01062633|prevention|prevention
588563|NCT01062633|dietary supplements|dietary supplements
588564|NCT01062607|bipolar disorders|bipolar disorders
588565|NCT01062607|everyday setting|everyday setting
588566|NCT01062607|treatment adherence|treatment adherence
588567|NCT01062607|global|global
588568|NCT01062581|Recipient|recipient
588569|NCT01062581|Donor|donor
588570|NCT01062581|Organ Transplant|organ transplant
588571|NCT01062581|Registry|registry
588572|NCT01062581|University of Minnesota|university of minnesota
588573|NCT01062568|adolescents|adolescents
588574|NCT01062568|puberty|puberty
588575|NCT01062568|androgens|androgens
588576|NCT01062568|hyperandrogenemia|hyperandrogenemia
588577|NCT01062529|GH signalling|gh signalling
588578|NCT01062529|insulin resistance|insulin resistance
588579|NCT01062529|somatostatin|somatostatin
588580|NCT01062529|acromegaly|acromegaly
588581|NCT01062516|acute coronary syndrome|acute coronary syndrome
588582|NCT01062516|acute myocardial infarction|acute myocardial infarction
588583|NCT01062516|percutaneous coronary intervention|percutaneous coronary intervention
588584|NCT01062516|aspirin|aspirin
588585|NCT01062516|clopidogrel|clopidogrel
588586|NCT01062516|esomeprazole|esomeprazole
588587|NCT01062516|famotidine|famotidine
588588|NCT01062516|platelet function|platelet function
588589|NCT01062503|Cancer|cancer
588590|NCT01062503|Prostate|prostate
588591|NCT01062503|metastatic|metastatic
588592|NCT01062490|Treosulfan|treosulfan
588593|NCT01062490|MDS|mds
588594|NCT01062490|allogeneic stem cell transplantation|allogeneic stem cell transplantation
588595|NCT01062490|leukemia|leukemia
588596|NCT01062490|Conditioning|conditioning
588597|NCT01062477|Diphtheria Tetanus Pertussis Haemophilus Influenzae Type B|diphtheria tetanus pertussis haemophilus influenzae type b
588598|NCT01062451|Methamphetamine|methamphetamine
588599|NCT01062451|Perindopril|perindopril
588600|NCT01062451|Candesartan|candesartan
588601|NCT01062451|Angiotensin receptor blocker|angiotensin receptor blocker
588602|NCT01062451|ACE Inhibitor|ace inhibitor
588603|NCT01062438|localized osteosarcoma|localized osteosarcoma
588604|NCT01062438|metastatic osteosarcoma|metastatic osteosarcoma
588605|NCT01062399|adult glioblastoma|adult glioblastoma
588606|NCT01062399|adult giant cell glioblastoma|adult giant cell glioblastoma
588607|NCT01062399|adult gliosarcoma|adult gliosarcoma
588608|NCT01062386|prevalence|prevalence
588609|NCT01062386|transmission|transmission
588610|NCT01062386|knowledge|knowledge
588611|NCT01062386|attitude|attitude
588612|NCT01062386|practice|practice
588613|NCT01062373|Premature Newborns|premature newborns
588614|NCT01062373|Human Milk|human milk
588615|NCT01062373|DHA|dha
588616|NCT01062373|Mother-child|mother-child
588617|NCT01062360|Sore Throat|sore throat
588618|NCT01062360|Upper Respiratory Tract Infections|upper respiratory tract infections
588619|NCT01062360|Nasal Congestion|nasal congestion
588620|NCT01062347|To identify a new bio-marker for zinc status|to identify a new bio-marker for zinc status
588621|NCT01062334|Anastomotic leakage after LAR|anastomotic leakage after lar
588622|NCT01062321|Hepatitis E Virus|hepatitis e virus
588623|NCT01062321|Cytokines|cytokines
588624|NCT01062321|Pregnancy|pregnancy
588625|NCT01062308|Stroke|stroke
588626|NCT01062308|Taping|taping
588627|NCT01062308|Pain|pain
588628|NCT01062308|Shoulder Injury|shoulder injury
588629|NCT01062295|passenger,|passenger,
588630|NCT01062295|sleep,|sleep,
588631|NCT01062295|rest,|rest,
588632|NCT01062282|Pulmonary Hypertension|pulmonary hypertension
588633|NCT01062269|Bile acid sequestrant|bile acid sequestrant
588634|NCT01062269|Resin|resin
588635|NCT01062269|Cholesterol|cholesterol
588636|NCT01062269|Diabetes mellitus|diabetes mellitus
588637|NCT01062269|Lipids|lipids
588638|NCT01062269|Glucose|glucose
588639|NCT01062269|Bile Acid Sequestrant Acceptability Scale (BASA)validation study|bile acid sequestrant acceptability scale (basa)validation study
588640|NCT01062256|Cough assessment in upper respiratory infection|cough assessment in upper respiratory infection
588641|NCT01062256|guaifenesin|guaifenesin
588642|NCT01062256|honey|honey
588643|NCT01062243|brain injury|brain injury
588644|NCT01062243|family treatment|family treatment
588645|NCT01062230|Cancer|cancer
588646|NCT01062230|Hematologic malignancy|hematologic malignancy
588647|NCT01062204|Skin Graft donor sites|skin graft donor sites
588648|NCT01062191|hydrogel|hydrogel
588649|NCT01062191|dressing|dressing
588650|NCT01062191|burn|burn
588651|NCT01062191|joint|joint
588652|NCT01062178|Small renal Mass|small renal mass
588653|NCT01062178|Contrast Enhanced Ultrasound|contrast enhanced ultrasound
588654|NCT01062178|Renal Cell Carcinoma|renal cell carcinoma
588655|NCT01062178|noninvasive diagnosis of RCC|noninvasive diagnosis of rcc
588656|NCT01062165|Echinocandin|echinocandin
588657|NCT01062165|Obesity|obesity
588658|NCT01062165|Pharmacokinetics|pharmacokinetics
588659|NCT01062165|Pharmacodynamics|pharmacodynamics
588660|NCT01062165|Fungal infection|fungal infection
588661|NCT01062152|Hematology|hematology
588662|NCT01062152|MDS|mds
588663|NCT01062152|Myelodysplastic Syndrome|myelodysplastic syndrome
588664|NCT01062152|Low risk MDS|low risk mds
588665|NCT01062152|Patients with non-deletion(5q)|patients with non-deletion(5q)
588666|NCT01062152|Non-deletion 5q|non-deletion 5q
588667|NCT01062152|Non del(5q)|non del(5q)
588668|NCT01062152|Revlimid|revlimid
588669|NCT01062152|lenalidomide|lenalidomide
588670|NCT01062152|Telintra|telintra
588671|NCT01062152|ezatiostat hydrochloride|ezatiostat hydrochloride
588672|NCT01062152|ezatiostat|ezatiostat
588673|NCT01062152|TLK199|tlk199
588674|NCT01062152|Glutathione|glutathione
588675|NCT01062152|Glutathione analog|glutathione analog
588676|NCT01062152|Glutathione Transferase|glutathione transferase
588677|NCT01062152|Glutathione Transferase inhibitor|glutathione transferase inhibitor
588678|NCT01062152|Glutathione Transferase P1-1 inhibitor|glutathione transferase p1-1 inhibitor
588679|NCT01062152|GSTp1-1 inhibitor|gstp1-1 inhibitor
588680|NCT01062152|Apoptosis|apoptosis
588681|NCT01062152|Differentiation|differentiation
588682|NCT01062152|Enzyme inhibitor|enzyme inhibitor
588683|NCT01062126|Pacemaker|pacemaker
588684|NCT01062126|Advanced Features|advanced features
588685|NCT01062126|Clinical Outcomes|clinical outcomes
588686|NCT01062113|Acute pain after oral surgery lateral mandibular Impacted third molar tooth extraction|acute pain after oral surgery lateral mandibular impacted third molar tooth extraction
588687|NCT01062100|breast cancer|breast cancer
588688|NCT01062100|molecular breast imaging|molecular breast imaging
588689|NCT01062100|MRI|mri
588690|NCT01062100|gamma camera|gamma camera
588691|NCT01062087|postoperative pain|postoperative pain
588692|NCT01062087|tubal ligation|tubal ligation
588693|NCT01062087|local anesthetic|local anesthetic
588694|NCT01062061|Varicella|varicella
588695|NCT01062035|Advanced colon polyp|advanced colon polyp
588696|NCT01062035|Adenomatous colon polyp|adenomatous colon polyp
588697|NCT01062035|Adenoma, villous colon polyp|adenoma, villous colon polyp
588698|NCT01062035|Advanced colorectal adenomas|advanced colorectal adenomas
588699|NCT01062035|Colonic neoplasms|colonic neoplasms
588700|NCT01062035|High grade dysplasia|high grade dysplasia
588701|NCT01062035|Telomere blood testing|telomere blood testing
588702|NCT01062022|intervention|intervention
588703|NCT01062022|combat wounded|combat wounded
588704|NCT01062022|family|family
588705|NCT01062022|Focus-CI|focus-ci
588706|NCT01061996|Ulcerative Colitis|ulcerative colitis
588707|NCT01061983|Deep brain stimulation|deep brain stimulation
588708|NCT01061983|Treatment refractory|treatment refractory
588709|NCT01061983|Ventral internal capsule/ventral striatum|ventral internal capsule/ventral striatum
588710|NCT01061983|Neurosurgery|neurosurgery
588711|NCT01061983|Neuroimaging|neuroimaging
588712|NCT01061970|Hypogonadism|hypogonadism
588713|NCT01061970|Chronic Obstructive Pulmonary Disease|chronic obstructive pulmonary disease
588714|NCT01061970|COPD|copd
588715|NCT01061957|Treatment outcome|treatment outcome
588716|NCT01061957|HIV treatment|hiv treatment
588717|NCT01061944|biopsy|biopsy
588718|NCT01061944|tumor biopsy|tumor biopsy
588719|NCT01061944|genetic studies|genetic studies
588720|NCT01061931|MRI|mri
588721|NCT01061931|left-sided atrial catheter ablation|left-sided atrial catheter ablation
588722|NCT01061931|paroxysmal atrial fibrillation|paroxysmal atrial fibrillation
588723|NCT01061931|cryoballoon technique|cryoballoon technique
588724|NCT01061931|mesh ablator catheter|mesh ablator catheter
588725|NCT01061931|stroke|stroke
588726|NCT01061931|silent stroke|silent stroke
588727|NCT01061931|major complications|major complications
588728|NCT01061918|Compare the visual outcomes with bilateral implantation of Tecnis MF and ReSTOR IOLs 6 months post cataract surgery.|compare the visual outcomes with bilateral implantation of tecnis mf and restor iols 6 months post cataract surgery.
588729|NCT01061905|health behavior|health behavior
588730|NCT01061905|behavioral economics|behavioral economics
588731|NCT01061905|calorie labeling|calorie labeling
588732|NCT01061905|exercise|exercise
588733|NCT01061879|umbilical cord|umbilical cord
588734|NCT01061879|umbilical cord blood collection|umbilical cord blood collection
588735|NCT01061879|pregnancy|pregnancy
588736|NCT01061866|Thalidomide|thalidomide
588737|NCT01061866|Antiepileptic drugs|antiepileptic drugs
588738|NCT01061866|Refractory epilepsy|refractory epilepsy
588739|NCT01061866|Sedative drugs|sedative drugs
588740|NCT01061853|Oral lichen planus|oral lichen planus
588741|NCT01061853|chronic inflammatory|chronic inflammatory
588742|NCT01061853|mucous membranes|mucous membranes
588743|NCT01061853|erosive lesions|erosive lesions
588744|NCT01061840|Ewings Sarcoma|ewings sarcoma
588745|NCT01061840|Non Small Cell Lung Cancer|non small cell lung cancer
588746|NCT01061840|Liver Cancer|liver cancer
588747|NCT01061827|GMS-package;dementia;depression|gms-package;dementia;depression
588748|NCT01061814|ApoB (Apolipoprotein B)|apob (apolipoprotein b)
588749|NCT01061814|LDL (low density lipoprotein)|ldl (low density lipoprotein)
588750|NCT01061814|mipomersen|mipomersen
588751|NCT01061814|ISIS301012|isis301012
588752|NCT01061814|antisense|antisense
588753|NCT01061801|caregivers|caregivers
588754|NCT01061801|cancer|cancer
588755|NCT01061801|emotion|emotion
588756|NCT01061801|protective buffering|protective buffering
588757|NCT01061788|Phase I|phase i
588758|NCT01061788|Solid Tumor|solid tumor
588759|NCT01061788|AMG 479|amg 479
588760|NCT01061788|Panitumumab|panitumumab
588761|NCT01061788|Everolimus|everolimus
588762|NCT01061788|RAD001|rad001
588763|NCT01061788|Duke|duke
588764|NCT01061788|Subjects with refractory advanced solid tumors|subjects with refractory advanced solid tumors
588765|NCT01061788|non-small cell lung cancer|non-small cell lung cancer
588766|NCT01061775|Hypothalamic Obesity|hypothalamic obesity
588767|NCT01061775|Exenatide|exenatide
588768|NCT01061775|Byetta|byetta
588769|NCT01061775|Craniopharyngioma|craniopharyngioma
588770|NCT01061762|Treatment adherence|treatment adherence
588771|NCT01061762|Low literacy skills|low literacy skills
588772|NCT01061762|HIV treatment|hiv treatment
588773|NCT01061710|Smoking|smoking
588774|NCT01061710|smoking cessation|smoking cessation
588775|NCT01061710|Japanese|japanese
588776|NCT01061710|varenicline|varenicline
588777|NCT01061710|retreatment|retreatment
588778|NCT01061710|Regulatory Post Marketing Commitment Plan|regulatory post marketing commitment plan
588779|NCT01061684|fatty liver disease|fatty liver disease
588780|NCT01061684|NASH|nash
588781|NCT01061684|NAFLD|nafld
588782|NCT01061684|non-alcoholic steatohepatitis|non-alcoholic steatohepatitis
588783|NCT01061671|Chronic Obstructive Pulmonary Disease|chronic obstructive pulmonary disease
588784|NCT01061671|COPD|copd
748290|NCT00445679|MDD|mdd
588785|NCT01061671|Exacerbation|exacerbation
588786|NCT01061671|Lung function|lung function
588787|NCT01061671|Cardiovascular|cardiovascular
588788|NCT01061671|Smoking|smoking
588789|NCT01061671|Statins|statins
588790|NCT01061671|Simvastatin|simvastatin
588791|NCT01061645|MDT and DLT|mdt and dlt
588792|NCT01061632|deadlift|deadlift
588793|NCT01061632|motor control|motor control
588794|NCT01061632|exercises|exercises
588795|NCT01061632|pain|pain
588796|NCT01061632|function|function
588797|NCT01061632|functional capacity|functional capacity
588798|NCT01061619|prediagnostic symptoms|prediagnostic symptoms
588799|NCT01061619|sentinel events|sentinel events
588800|NCT01061619|pathway to diagnosis|pathway to diagnosis
588801|NCT01061593|TB|tb
588802|NCT01061593|MDR-TB|mdr-tb
588803|NCT01061593|XDR-TB|xdr-tb
588804|NCT01061593|TB/HIV|tb/hiv
588805|NCT01061580|Bone Marrow Concentrate|bone marrow concentrate
588806|NCT01061580|CABG|cabg
588807|NCT01061580|Cardiac|cardiac
588808|NCT01061580|Stem Cell|stem cell
588809|NCT01061554|Bioavailability|bioavailability
588810|NCT01061554|Eicosapentaenoic acid|eicosapentaenoic acid
588811|NCT01061554|Docosahexaenoic acid|docosahexaenoic acid
588812|NCT01061554|Soft gel capsules|soft gel capsules
588813|NCT01061554|Gastric stable emulsion|gastric stable emulsion
588814|NCT01061554|Omega-3|omega-3
588815|NCT01061554|Tri-glycerides|tri-glycerides
588816|NCT01061554|Marine phospholipids|marine phospholipids
588817|NCT01061541|Pertussis|pertussis
588818|NCT01061541|Tetanus|tetanus
588819|NCT01061541|Hiberix™|hiberix™
588820|NCT01061541|Hepatitis B|hepatitis b
588821|NCT01061541|DTPw-HBV vaccine|dtpw-hbv vaccine
588822|NCT01061541|Tritanrix™-HepB|tritanrix™-hepb
588823|NCT01061541|Haemophilus influenzae type b|haemophilus influenzae type b
588824|NCT01061541|Diphtheria|diphtheria
588825|NCT01061541|Hib vaccine|hib vaccine
588826|NCT01061528|cigarette smoking|cigarette smoking
588827|NCT01061528|smoking cessation|smoking cessation
588828|NCT01061528|nicotine dependence|nicotine dependence
588829|NCT01061502|Burns|burns
588830|NCT01061502|Wounds and Injuries|wounds and injuries
588831|NCT01061502|Skin Grafts, Bioelectric|skin grafts, bioelectric
588832|NCT01061502|Grafting, skin|grafting, skin
588833|NCT01061489|neuroplasticity|neuroplasticity
588834|NCT01061489|Mild Cognitive Impairment (MCI)|mild cognitive impairment (mci)
588835|NCT01061489|Alzheimer|alzheimer
588836|NCT01061489|sensory-cognitive training|sensory-cognitive training
588837|NCT01061489|physical fitness|physical fitness
588838|NCT01061476|sleep apnea|sleep apnea
588839|NCT01061476|treatment|treatment
588840|NCT01061476|collapsibility|collapsibility
588841|NCT01061476|expiratory nasal resistance|expiratory nasal resistance
588842|NCT01061463|Radiation cataracts|radiation cataracts
588843|NCT01061463|Lens opacities|lens opacities
588844|NCT01061463|X-rays|x-rays
588845|NCT01061463|Interventional Cardiologists|interventional cardiologists
588846|NCT01061463|Electrophysiologists|electrophysiologists
588847|NCT01061450|Diastolic dysfunction|diastolic dysfunction
588848|NCT01061450|hypertension|hypertension
588849|NCT01061450|Statins|statins
588850|NCT01061450|ACE inhibitor|ace inhibitor
588851|NCT01061450|Echocardiography|echocardiography
588852|NCT01061437|H. pylori|h. pylori
588853|NCT01061424|pediatric asthma|pediatric asthma
588854|NCT01061398|cardiac ct|cardiac ct
588855|NCT01061398|stress testing|stress testing
588856|NCT01061398|coronary artery disease|coronary artery disease
588858|NCT01061359|Breast Cancer|breast cancer
588859|NCT01061359|Neoadjuvant Treatment|neoadjuvant treatment
588860|NCT01061359|Chemotherapy|chemotherapy
588861|NCT01061359|Adjuvant|adjuvant
588862|NCT01061359|Epirubicin|epirubicin
588863|NCT01061346|Fructose|fructose
588864|NCT01061346|Glucose|glucose
588865|NCT01061320|Alpha-Tocopherol (Vitamin E)|alpha-tocopherol (vitamin e)
588866|NCT01061320|Contrast induced nephropathy|contrast induced nephropathy
588867|NCT01061320|Chronic kidney disease|chronic kidney disease
588868|NCT01061320|Coronary procedures|coronary procedures
588869|NCT01061307|Fe deficiency, Zn deficiency, vitamin A deficiency|fe deficiency, zn deficiency, vitamin a deficiency
588870|NCT01061294|Assess the efficacy, predictability and safety of the Advanced CustomVue™ iLASIK procedure.|assess the efficacy, predictability and safety of the advanced customvue™ ilasik procedure.
588871|NCT01061281|Aphakia following refractive lensectomy to treat presbyopia|aphakia following refractive lensectomy to treat presbyopia
588872|NCT01061268|Relief of dry eye symptoms following implantation of TMF IOL|relief of dry eye symptoms following implantation of tmf iol
588874|NCT01061255|Cortisol|cortisol
588875|NCT01061255|Clinical reasoning|clinical reasoning
588876|NCT01061255|Ambulatory setting|ambulatory setting
588877|NCT01061255|Medical students|medical students
588878|NCT01061255|Year 6 medical students|year 6 medical students
588879|NCT01061242|Neurocognitive function|neurocognitive function
588880|NCT01061242|Sleep quality|sleep quality
588881|NCT01061242|Critical care|critical care
588882|NCT01061242|Quality Assurance, health care|quality assurance, health care
588883|NCT01061216|Diabetes|diabetes
588884|NCT01061216|Insulin Therapy|insulin therapy
588885|NCT01061216|Blood Glucose|blood glucose
588886|NCT01061216|Basal insulin|basal insulin
588887|NCT01061216|Diabetics|diabetics
588888|NCT01061203|Rhinitis|rhinitis
588889|NCT01061203|allergic|allergic
588890|NCT01061203|Seasonal|seasonal
588891|NCT01061203|grass|grass
588892|NCT01061203|Asthma|asthma
588893|NCT01061190|Stroke|stroke
588894|NCT01061177|Leukemia|leukemia
588895|NCT01061177|myeloid|myeloid
588896|NCT01061177|myelogenous|myelogenous
588897|NCT01061177|chronic BCR-ABL positive|chronic bcr-abl positive
588898|NCT01061177|Nilotinib|nilotinib
588899|NCT01061177|Philadelphia chromosome|philadelphia chromosome
588900|NCT01061177|CML in chronic phase|cml in chronic phase
588901|NCT01061151|Mother to Child Transmission|mother to child transmission
588902|NCT01061151|HIV Infection|hiv infection
588903|NCT01061151|HAART|haart
588904|NCT01061151|Maternal Health|maternal health
588905|NCT01061151|Breastfeeding|breastfeeding
588906|NCT01061151|Perinatal transmission|perinatal transmission
588907|NCT01061138|breast cancer|breast cancer
588908|NCT01061138|screening mammograms|screening mammograms
588909|NCT01061138|breast biopsy|breast biopsy
588910|NCT01061125|atrial fibrillation|atrial fibrillation
588911|NCT01061125|implantable loop recorder|implantable loop recorder
588912|NCT01061125|TTM|ttm
588913|NCT01061112|Drug Interactions|drug interactions
588914|NCT01061112|Genetics|genetics
588915|NCT01061112|CYP2C9|cyp2c9
588916|NCT01061112|Healthy Volunteers|healthy volunteers
588917|NCT01061099|Type II or Type III Osteogenesis imperfecta|type ii or type iii osteogenesis imperfecta
588918|NCT01061099|OI|oi
588919|NCT01061099|Mesenchymal Stromal Cells|mesenchymal stromal cells
588920|NCT01061099|MSC|msc
588921|NCT01061086|Acute Coronary Syndromes|acute coronary syndromes
588922|NCT01061086|Epidemiology|epidemiology
588923|NCT01061086|Management of disease|management of disease
588924|NCT01061086|Outcomes|outcomes
588925|NCT01061086|Greece|greece
588926|NCT01061060|Prostaglandin I2|prostaglandin i2
588927|NCT01061060|Beraprost Na|beraprost na
588928|NCT01061060|Endothelial cell function|endothelial cell function
588929|NCT01061047|patients infected with a bacteria sensible to ertapeneme|patients infected with a bacteria sensible to ertapeneme
588930|NCT01061034|pharmacokinetics|pharmacokinetics
588931|NCT01061034|aspirin|aspirin
588932|NCT01061034|proton pump inhiditor|proton pump inhiditor
588933|NCT01061021|HIV prevention|hiv prevention
588934|NCT01061021|Treatment adherence|treatment adherence
588935|NCT01061021|Treatment for Prevention|treatment for prevention
588936|NCT01061008|Exercise; arteriovenous fistula; chronic kidney disease|exercise; arteriovenous fistula; chronic kidney disease
588937|NCT01060995|Informed Consent|informed consent
588938|NCT01060995|Oral Health|oral health
588939|NCT01060995|Patient Decision-making|patient decision-making
588940|NCT01060982|Primary hyperparathyroidism|primary hyperparathyroidism
588941|NCT01060982|High Intensity Focused Ultrasound|high intensity focused ultrasound
588942|NCT01060982|Parathyroid tumor|parathyroid tumor
588943|NCT01060982|Parathyroid hormone|parathyroid hormone
588944|NCT01060982|Calcium|calcium
588945|NCT01060969|Acute Mountain Sickness|acute mountain sickness
588946|NCT01060969|travellers|travellers
588947|NCT01060969|Acetazolamide|acetazolamide
588948|NCT01060969|Tadalafil|tadalafil
588949|NCT01060969|Acute Mountain Sickness assessed by Lake Louise score|acute mountain sickness assessed by lake louise score
588950|NCT01060969|High altitude pulmonary edema|high altitude pulmonary edema
588951|NCT01060969|High altitude cerebral edema|high altitude cerebral edema
588952|NCT01060956|Urinary tract infection with two bacteria in culture|urinary tract infection with two bacteria in culture
588953|NCT01060943|injectable collagen filler|injectable collagen filler
588954|NCT01060943|correction of wrinkles and folds|correction of wrinkles and folds
588955|NCT01060943|enrolled : 73|enrolled : 73
588956|NCT01060943|withdrawal : 4|withdrawal : 4
588957|NCT01060943|ongoing : 0|ongoing : 0
588958|NCT01060943|completed : 69|completed : 69
588959|NCT01060930|Nitric oxide|nitric oxide
588960|NCT01060930|Diesel exhaust|diesel exhaust
588961|NCT01060930|Air pollution|air pollution
588962|NCT01060930|Cardiac output|cardiac output
588963|NCT01060930|Healthy volunteers|healthy volunteers
588964|NCT01060917|diabetes|diabetes
588965|NCT01060904|Antibodies, Monoclonal|antibodies, monoclonal
588966|NCT01060904|Antibody-Drug Conjugate|antibody-drug conjugate
588967|NCT01060904|Antigens, CD30|antigens, cd30
588968|NCT01060904|Disease, Hodgkin|disease, hodgkin
588969|NCT01060904|Hematologic Diseases|hematologic diseases
588970|NCT01060904|Immunotherapy|immunotherapy
588971|NCT01060904|Lymphoma|lymphoma
588972|NCT01060904|monomethyl auristatin E|monomethyl auristatin e
588973|NCT01060891|patients infected with with multiresistant gram-negative bacteria|patients infected with with multiresistant gram-negative bacteria
588974|NCT01060878|Early-stage|early-stage
588975|NCT01060865|hypertension|hypertension
588976|NCT01060865|aliskiren|aliskiren
588977|NCT01060865|Blood Pressure Monitoring, Ambulatory|blood pressure monitoring, ambulatory
588978|NCT01060839|counseling|counseling
588979|NCT01060826|acute pancreatits|acute pancreatits
748493|NCT00445341|MCL|mcl
588980|NCT01060813|cirrhosis|cirrhosis
588981|NCT01060813|exercise|exercise
588982|NCT01060813|leucin|leucin
588983|NCT01060813|glutamine synthetase|glutamine synthetase
588984|NCT01060800|Chiari|chiari
588985|NCT01060800|Chiari Type I|chiari type i
588986|NCT01060800|Chiari Type I Malformation|chiari type i malformation
588987|NCT01060800|Familial Chiari|familial chiari
588988|NCT01060774|Bupivacaine|bupivacaine
588989|NCT01060774|Inflammation|inflammation
588990|NCT01060774|Pain|pain
588991|NCT01060774|Local Anesthetic|local anesthetic
588992|NCT01060774|peripheral sensitization|peripheral sensitization
588993|NCT01060761|cancer|cancer
588994|NCT01060761|Rehabilitation program (patient and a relative together)|rehabilitation program (patient and a relative together)
588995|NCT01060761|counselling|counselling
588996|NCT01060761|retreat weekend|retreat weekend
588997|NCT01060748|Vaccination|vaccination
588998|NCT01060748|Challenge|challenge
588999|NCT01060748|Diarrhea|diarrhea
589000|NCT01060748|ETEC illness|etec illness
589001|NCT01060748|Travelers diarrhea|travelers diarrhea
589002|NCT01060748|ETEC|etec
589003|NCT01060748|Enterotoxigenic E.coli|enterotoxigenic e.coli
589004|NCT01060735|Vitamin D|vitamin d
589005|NCT01060735|pregnancy|pregnancy
589006|NCT01060735|children|children
589007|NCT01060735|bone|bone
589008|NCT01060735|quantitative ultrasound|quantitative ultrasound
589009|NCT01060735|Healthy pregnant women|healthy pregnant women
589010|NCT01060722|Healthy Male Volunteers|healthy male volunteers
589011|NCT01060709|Carbon dioxide|carbon dioxide
589012|NCT01060709|TcC02|tcc02
589013|NCT01060709|Hypoventilation|hypoventilation
589014|NCT01060709|endoscopic|endoscopic
589015|NCT01060709|elective colonoscopy and requiring sedation|elective colonoscopy and requiring sedation
589016|NCT01060696|Infertility|infertility
589017|NCT01060696|Saline infusion sonohysterography|saline infusion sonohysterography
589018|NCT01060696|Pain|pain
589019|NCT01060696|Hyoscine|hyoscine
589020|NCT01060696|Mefenamic acid|mefenamic acid
589021|NCT01060696|women|women
589022|NCT01060683|hemoglobin|hemoglobin
589023|NCT01060683|Coagulation variables|coagulation variables
589024|NCT01060683|blood chemistry|blood chemistry
589025|NCT01060683|Blood gas analysis|blood gas analysis
589026|NCT01060670|Foot Ulcer|foot ulcer
589027|NCT01060670|Diabetic|diabetic
589028|NCT01060670|Wound Healing|wound healing
589029|NCT01060670|Integra Dermal Regeneration Template|integra dermal regeneration template
589030|NCT01060670|Full Thickness|full thickness
589031|NCT01060670|Neuropathic|neuropathic
589032|NCT01060670|Omnigraft|omnigraft
589033|NCT01060657|X-ray Computed Tomography|x-ray computed tomography
589034|NCT01060657|Coronary vessels|coronary vessels
589035|NCT01060657|Radiation dosage|radiation dosage
589036|NCT01060644|Maxillary Sinus|maxillary sinus
589037|NCT01060644|Bone Augmentation|bone augmentation
589038|NCT01060644|Dental Implant|dental implant
589039|NCT01060644|Sinus Membrane|sinus membrane
589040|NCT01060631|bispectral index|bispectral index
589041|NCT01060631|lesions|lesions
589042|NCT01060631|consciousness|consciousness
589043|NCT01060605|islet transplantation|islet transplantation
589044|NCT01060605|insulin independence|insulin independence
589045|NCT01060605|C-peptide secretion|c-peptide secretion
589046|NCT01060592|Gastric Band|gastric band
589047|NCT01060592|LapBand|lapband
589048|NCT01060592|Bariatric Surgery|bariatric surgery
589049|NCT01060579|Glaucoma|glaucoma
589050|NCT01060553|Post-traumatic stress disorders|post-traumatic stress disorders
589051|NCT01060553|Acupuncture|acupuncture
589052|NCT01060553|Quality of life|quality of life
589053|NCT01060553|sleep disorder|sleep disorder
589054|NCT01060540|genetic screening|genetic screening
589055|NCT01060527|irritable bowel syndrome,protease activity,China|irritable bowel syndrome,protease activity,china
589056|NCT01060514|Lung cancer|lung cancer
589057|NCT01060514|Breast cancer|breast cancer
589058|NCT01060501|rectal cancer|rectal cancer
589059|NCT01060501|adjuvant chemoradiotherapy|adjuvant chemoradiotherapy
589060|NCT01060501|5-FU, interferon-alpha|5-fu, interferon-alpha
589061|NCT01060501|Locally advanced resectable rectal cancer (UICC stage II and III)|locally advanced resectable rectal cancer (uicc stage ii and iii)
589062|NCT01060488|GH secretion tests|gh secretion tests
589063|NCT01060488|adverse effects|adverse effects
589064|NCT01060488|adult growth hormone deficiency|adult growth hormone deficiency
589065|NCT01060488|growth-hormone releasing hormone and arginine test|growth-hormone releasing hormone and arginine test
589066|NCT01060488|insulin tolerance test|insulin tolerance test
589067|NCT01060488|GHRH + Arginine test|ghrh + arginine test
589068|NCT01060475|Transplant|transplant
589069|NCT01060462|Defervescence rate|defervescence rate
589070|NCT01060462|Defervescence timing|defervescence timing
589071|NCT01060462|Itraconazole|itraconazole
589072|NCT01060449|cardiac resynchronization therapy|cardiac resynchronization therapy
589073|NCT01060449|congestive heart failure|congestive heart failure
589074|NCT01060436|sleep apnea|sleep apnea
589075|NCT01060436|sleep disordered breathing|sleep disordered breathing
748552|NCT00445081|WLQ|wlq
589076|NCT01060436|CPAP|cpap
589077|NCT01060436|BiPAP|bipap
589078|NCT01060436|treatment outcomes|treatment outcomes
589079|NCT01060423|colorectal|colorectal
589080|NCT01060423|liver metastasis|liver metastasis
589081|NCT01060423|KRAS wildtype|kras wildtype
589082|NCT01060423|chemoembolization|chemoembolization
589083|NCT01060423|irinotecan eluting beads|irinotecan eluting beads
589084|NCT01060410|Myelosuppression|myelosuppression
589085|NCT01060410|Infection|infection
589086|NCT01060410|Nausea|nausea
589087|NCT01060397|Alcohol|alcohol
589088|NCT01060397|nurse|nurse
589089|NCT01060397|alcohol dependence|alcohol dependence
589090|NCT01060397|acute hospital|acute hospital
589091|NCT01060397|brief interventions|brief interventions
589092|NCT01060371|Spinocerebellar Ataxia|spinocerebellar ataxia
589093|NCT01060371|Natural History|natural history
589094|NCT01060371|Genetic Modifiers|genetic modifiers
589095|NCT01060371|DNA testing|dna testing
589096|NCT01060358|lumbar spine|lumbar spine
589097|NCT01060358|low back pain|low back pain
589098|NCT01060345|DCIS|dcis
589099|NCT01060293|Heart Failure|heart failure
589100|NCT01060293|Dopamine|dopamine
589101|NCT01060293|Furosemide|furosemide
589102|NCT01060293|Worsening Renal Function|worsening renal function
589103|NCT01060293|Hypokalemia|hypokalemia
589104|NCT01060293|Outcomes|outcomes
589105|NCT01060293|Prognosis|prognosis
589106|NCT01060280|low back pain|low back pain
589107|NCT01060280|physiotherapy|physiotherapy
589108|NCT01060280|exercise|exercise
589109|NCT01060280|active management|active management
589110|NCT01060254|Interstitial cystitis (IC) and/or painful bladder syndrome (PBS)-related pain|interstitial cystitis (ic) and/or painful bladder syndrome (pbs)-related pain
589111|NCT01060254|Moderate to severe chronic bladder pain|moderate to severe chronic bladder pain
589112|NCT01060254|JNJ-42160443|jnj-42160443
589113|NCT01060241|Remote Blood Glucose Monitoring System, Type 2 Diabetes|remote blood glucose monitoring system, type 2 diabetes
589114|NCT01060228|Paliperidone ER|paliperidone er
589115|NCT01060228|INVEGA|invega
589116|NCT01060228|Divalproex sodium|divalproex sodium
589117|NCT01060228|Depakote ER|depakote er
589118|NCT01060228|Pharmacokinetics|pharmacokinetics
589119|NCT01060228|Valproic Acid|valproic acid
589120|NCT01060228|Human Experimentation|human experimentation
589121|NCT01060215|effusion|effusion
589122|NCT01060215|osteoarthritis|osteoarthritis
589123|NCT01060215|knee|knee
589124|NCT01060202|Multiple Myeloma|multiple myeloma
589125|NCT01060202|Bortezomib|bortezomib
589126|NCT01060202|Velcade|velcade
589127|NCT01060202|QoL|qol
589128|NCT01060202|Proteasome inhibitor|proteasome inhibitor
589129|NCT01060202|EORTC QLQ C30|eortc qlq c30
589130|NCT01060202|EQ 5D|eq 5d
589131|NCT01060189|ulinastatin|ulinastatin
589132|NCT01060189|tranexamic acid|tranexamic acid
589133|NCT01060189|cardiac surgery procedures|cardiac surgery procedures
589134|NCT01060189|hemostasis|hemostasis
589135|NCT01060176|tranexamic acid|tranexamic acid
589136|NCT01060176|cardiac surgery procedures|cardiac surgery procedures
589137|NCT01060176|hemostasis|hemostasis
589138|NCT01060163|Clopidogrel|clopidogrel
589139|NCT01060163|Tranexamic Acid|tranexamic acid
589140|NCT01060163|Cardiac Surgical Procedures|cardiac surgical procedures
589141|NCT01060163|Hemostasis|hemostasis
589142|NCT01060150|Attention Deficit Hyperactivity Disorder|attention deficit hyperactivity disorder
589143|NCT01060150|Methylphenidate hydrochloride|methylphenidate hydrochloride
589144|NCT01060150|Methylphenidate|methylphenidate
589145|NCT01060150|CONCERTA|concerta
589146|NCT01060137|fentanyl matrix|fentanyl matrix
589147|NCT01060124|Pain; Cancer|pain; cancer
589148|NCT01060124|TTS-Fentanyl D-trans|tts-fentanyl d-trans
589149|NCT01060124|Durogesic D-trans|durogesic d-trans
589150|NCT01060111|Migraine|migraine
589151|NCT01060111|Topiramate|topiramate
589152|NCT01060111|Propranolol|propranolol
589153|NCT01060085|Breast Cancer|breast cancer
589154|NCT01060059|diabetes; exenatide; Byetta; basal insulin; Amylin; Lilly|diabetes; exenatide; byetta; basal insulin; amylin; lilly
589155|NCT01060046|biologic mesh|biologic mesh
589156|NCT01060046|ventral hernia repair|ventral hernia repair
589157|NCT01060046|breast reconstruction|breast reconstruction
589158|NCT01060046|MMPs|mmps
589159|NCT01060033|Squamous cell cervical cancer|squamous cell cervical cancer
589160|NCT01060020|Aortic valve stenosis|aortic valve stenosis
589161|NCT01060020|Sildenafil|sildenafil
589162|NCT01060020|Phosphodiesterase inhibitors|phosphodiesterase inhibitors
589251|NCT01059669|Diabetes|diabetes
589163|NCT01060020|Hypertension, Pulmonary|hypertension, pulmonary
589164|NCT01059994|fatigue|fatigue
589165|NCT01059994|aging|aging
589166|NCT01059968|bone density|bone density
589167|NCT01059968|energy availability|energy availability
589168|NCT01059968|menstrual status|menstrual status
589169|NCT01059968|female|female
589170|NCT01059968|adolescent|adolescent
589171|NCT01059955|scleritis|scleritis
589172|NCT01059955|anterior scleritis|anterior scleritis
589173|NCT01059955|nodular anterior scleritis|nodular anterior scleritis
589174|NCT01059955|diffuse anterior scleritis|diffuse anterior scleritis
589175|NCT01059942|communication barriers|communication barriers
589176|NCT01059942|clinical competence|clinical competence
589177|NCT01059942|medical education|medical education
589178|NCT01059942|internship and residency|internship and residency
589179|NCT01059942|hospitalist|hospitalist
589180|NCT01059942|Quality Assurance, Healthcare|quality assurance, healthcare
589181|NCT01059942|Patient Care|patient care
589182|NCT01059942|Internal Medicine|internal medicine
589183|NCT01059929|Hypnotics and Sedatives|hypnotics and sedatives
589184|NCT01059929|Respiration, Artificial|respiration, artificial
589185|NCT01059929|Ventilators, Mechanical|ventilators, mechanical
589186|NCT01059929|Critical care|critical care
589187|NCT01059929|Intensive care|intensive care
589188|NCT01059929|Physical therapy|physical therapy
589189|NCT01059929|Occupational therapy|occupational therapy
589190|NCT01059929|Sedative medications|sedative medications
589191|NCT01059903|Rotigotine|rotigotine
589192|NCT01059903|Neupro®|neupro®
589193|NCT01059903|Transdermal Patch|transdermal patch
589194|NCT01059877|dementia alzheimers frontotemporal lyme,|dementia alzheimers frontotemporal lyme,
589195|NCT01059877|lewy body cognitive impairment|lewy body cognitive impairment
589196|NCT01059864|cholesterol|cholesterol
589197|NCT01059864|lipids|lipids
589198|NCT01059864|rheumatoid arthritis|rheumatoid arthritis
589199|NCT01059864|CP-690|cp-690
589200|NCT01059864|550|550
589201|NCT01059838|pediatrics|pediatrics
589202|NCT01059838|cochlear implant|cochlear implant
589203|NCT01059825|Phase 2|phase 2
589204|NCT01059825|safety and efficacy study with ertugliflozin (PF-04971729, MK-8835)|safety and efficacy study with ertugliflozin (pf-04971729, mk-8835)
589205|NCT01059825|Type 2 diabetes mellitus|type 2 diabetes mellitus
589206|NCT01059786|Monoclonal Antibody|monoclonal antibody
589207|NCT01059786|Purine Analog|purine analog
589208|NCT01059786|Soluble CD25|soluble cd25
589209|NCT01059786|Minimal Residual Disease MRD|minimal residual disease mrd
589210|NCT01059786|CD20|cd20
589211|NCT01059786|Hairy Cell Leukemia|hairy cell leukemia
589212|NCT01059773|Psoriasis|psoriasis
589213|NCT01059773|Ustekinumab|ustekinumab
589214|NCT01059773|Stelara|stelara
589215|NCT01059773|Methotrexate|methotrexate
589216|NCT01059773|Biologic|biologic
589217|NCT01059760|Fasting|fasting
589218|NCT01059760|Short-term starvation|short-term starvation
589219|NCT01059760|Diet|diet
589220|NCT01059760|Coronary artery disease|coronary artery disease
589221|NCT01059734|adult acute myeloid leukemia with 11q23 (MLL) abnormalities|adult acute myeloid leukemia with 11q23 (mll) abnormalities
589222|NCT01059734|adult acute myeloid leukemia with del(5q)|adult acute myeloid leukemia with del(5q)
589223|NCT01059734|adult acute myeloid leukemia with inv(16)(p13;q22)|adult acute myeloid leukemia with inv(16)(p13;q22)
589224|NCT01059734|adult acute myeloid leukemia with t(16;16)(p13;q22)|adult acute myeloid leukemia with t(16;16)(p13;q22)
589225|NCT01059734|adult acute myeloid leukemia with t(8;21)(q22;q22)|adult acute myeloid leukemia with t(8;21)(q22;q22)
589226|NCT01059734|recurrent adult acute myeloid leukemia|recurrent adult acute myeloid leukemia
589227|NCT01059734|untreated adult acute myeloid leukemia|untreated adult acute myeloid leukemia
589228|NCT01059734|adult erythroleukemia (M6a)|adult erythroleukemia (m6a)
589229|NCT01059734|adult pure erythroid leukemia (M6b)|adult pure erythroid leukemia (m6b)
589230|NCT01059734|adult acute monoblastic leukemia (M5a)|adult acute monoblastic leukemia (m5a)
589231|NCT01059734|adult acute monocytic leukemia (M5b)|adult acute monocytic leukemia (m5b)
589232|NCT01059734|adult acute myeloblastic leukemia with maturation (M2)|adult acute myeloblastic leukemia with maturation (m2)
589233|NCT01059734|adult acute myeloblastic leukemia without maturation (M1)|adult acute myeloblastic leukemia without maturation (m1)
589234|NCT01059734|adult acute myelomonocytic leukemia (M4)|adult acute myelomonocytic leukemia (m4)
589235|NCT01059734|secondary acute myeloid leukemia|secondary acute myeloid leukemia
589236|NCT01059734|adult acute minimally differentiated myeloid leukemia (M0)|adult acute minimally differentiated myeloid leukemia (m0)
589237|NCT01059734|adult acute megakaryoblastic leukemia (M7)|adult acute megakaryoblastic leukemia (m7)
589238|NCT01059721|Centralisation|centralisation
589239|NCT01059721|Patella dislocation|patella dislocation
589240|NCT01059721|Open epiphyses|open epiphyses
589241|NCT01059721|Malalignment syndrome|malalignment syndrome
589242|NCT01059721|Relapse rate|relapse rate
589243|NCT01059708|outcomes carbon monoxide poisoning children pediatric|outcomes carbon monoxide poisoning children pediatric
589244|NCT01059695|cervical cancer|cervical cancer
589245|NCT01059695|retrospective|retrospective
589246|NCT01059695|quality of life|quality of life
589247|NCT01059695|treatment|treatment
589248|NCT01059669|Chronic pancreatitis|chronic pancreatitis
589249|NCT01059669|Pain|pain
589250|NCT01059669|Exocrine insufficiency|exocrine insufficiency
589252|NCT01059669|Nutrition|nutrition
589253|NCT01059669|Ultrasound|ultrasound
589254|NCT01059656|Dermatofibrosarcoma|dermatofibrosarcoma
589255|NCT01059656|Pazopanib¨|pazopanib¨
589256|NCT01059656|Phase II|phase ii
589257|NCT01059630|follicular|follicular
589258|NCT01059630|follicular lymphoma|follicular lymphoma
589259|NCT01059617|Pandemic|pandemic
589260|NCT01059617|GSK Bio's influenza vaccine GSK2340274A|gsk bio's influenza vaccine gsk2340274a
589261|NCT01059617|H1N1|h1n1
589262|NCT01059617|Influenza|influenza
589263|NCT01059604|pregnancy outcomes|pregnancy outcomes
589264|NCT01059604|pregnancy|pregnancy
589265|NCT01059604|first trimester|first trimester
589266|NCT01059604|Sumatriptan|sumatriptan
589267|NCT01059604|major congenital malformations|major congenital malformations
589268|NCT01059604|naratriptan|naratriptan
589269|NCT01059604|sumatriptan-naproxen combination|sumatriptan-naproxen combination
589270|NCT01059604|pregnancy registry|pregnancy registry
589271|NCT01059591|NK1 antagonist and SSRI|nk1 antagonist and ssri
589272|NCT01059591|Healthy subjects|healthy subjects
589273|NCT01059591|Safety|safety
589274|NCT01059591|First time in Human|first time in human
589275|NCT01059578|Nk1 Antagonist and SSRI|nk1 antagonist and ssri
589276|NCT01059578|Safety|safety
589277|NCT01059578|First Time in Humans|first time in humans
589278|NCT01059578|Healthy Subjects|healthy subjects
589279|NCT01059565|Cystic Fibrosis|cystic fibrosis
589280|NCT01059565|Aztreonam Lysine|aztreonam lysine
589281|NCT01059565|lung infection|lung infection
589282|NCT01059565|Burkholderia|burkholderia
589283|NCT01059565|CFQ-R|cfq-r
589284|NCT01059565|inhaled antibiotic|inhaled antibiotic
589285|NCT01059552|lung cancer|lung cancer
589286|NCT01059552|locally advanced lung cancer|locally advanced lung cancer
589287|NCT01059539|Mania|mania
589288|NCT01059539|Acute mania|acute mania
589289|NCT01059539|Bipolar I disorder|bipolar i disorder
589290|NCT01059526|HAE|hae
589291|NCT01059513|T1c|t1c
589292|NCT01059513|T2a|t2a
589293|NCT01059513|T2b|t2b
589294|NCT01059500|Computer-derived, quantitative pretest probability (PTP)|computer-derived, quantitative pretest probability (ptp)
589295|NCT01059500|Overtesting|overtesting
589296|NCT01059500|Radiation|radiation
589297|NCT01059500|Intravenous Contrast|intravenous contrast
589298|NCT01059500|Anticoagulation|anticoagulation
589299|NCT01059487|Traditional Chinese Medicine|traditional chinese medicine
589300|NCT01059487|Acupuncture|acupuncture
589301|NCT01059474|DMPS|dmps
589302|NCT01059474|mercury|mercury
589303|NCT01059461|Hypoxic Ischemic Encephalopathy (HIE)|hypoxic ischemic encephalopathy (hie)
589304|NCT01059461|Perinatal Asphyxia|perinatal asphyxia
589305|NCT01059461|Nerve growth factor|nerve growth factor
589306|NCT01059461|Cerebrolysin|cerebrolysin
589307|NCT01059461|Cerebral palsy|cerebral palsy
589308|NCT01059448|Amgen|amgen
589309|NCT01059448|RA|ra
589310|NCT01059448|AMG 827|amg 827
589311|NCT01059448|20090061|20090061
589312|NCT01059435|Amgen|amgen
589313|NCT01059435|First in Human|first in human
589314|NCT01059435|Postmenopausal|postmenopausal
589315|NCT01059435|Phase 1|phase 1
589316|NCT01059409|Meniscal Allografts|meniscal allografts
589317|NCT01059409|Osteoarthritis|osteoarthritis
589318|NCT01059383|Gastroesophageal Reflux|gastroesophageal reflux
589319|NCT01059383|GERD|gerd
589320|NCT01059383|Nocturnal GERD|nocturnal gerd
589321|NCT01059383|Heartburn|heartburn
589322|NCT01059383|Nighttime Heartburn|nighttime heartburn
589323|NCT01059370|Autonomic dysfunction|autonomic dysfunction
589324|NCT01059370|Spinal cord injured|spinal cord injured
589325|NCT01059370|Neurogenic bowel|neurogenic bowel
589326|NCT01059370|Neurogenic bladder|neurogenic bladder
589327|NCT01059344|Mesalamine|mesalamine
589328|NCT01059344|Asacol|asacol
589329|NCT01059344|Ulcerative colitis|ulcerative colitis
589330|NCT01059344|induction therapy|induction therapy
589331|NCT01059344|acute disease|acute disease
589332|NCT01059344|mild to moderate|mild to moderate
589333|NCT01059344|Active Ulcerative Colitis (mild to moderate)|active ulcerative colitis (mild to moderate)
589334|NCT01059331|Kidney|kidney
589335|NCT01059318|Lymphangioleiomyomatosis,|lymphangioleiomyomatosis,
589336|NCT01059318|High Resolution CT scan,|high resolution ct scan,
589337|NCT01059318|chest x-ray,|chest x-ray,
589338|NCT01059318|6 minute walk test,|6 minute walk test,
589339|NCT01059318|pulse oximetry,|pulse oximetry,
589340|NCT01059318|renal MRI,|renal mri,
589341|NCT01059318|Pikometer|pikometer
589342|NCT01059305|Erlotinib|erlotinib
589343|NCT01059305|Erlotinib Hydrochloride|erlotinib hydrochloride
589344|NCT01059305|OSI-774|osi-774
589345|NCT01059305|Tarceva|tarceva
589346|NCT01059305|Squamous cell carcinoma of the skin|squamous cell carcinoma of the skin
589347|NCT01059305|Aggressive cutaneous squamous cell carcinoma|aggressive cutaneous squamous cell carcinoma
589348|NCT01059305|CSCC|cscc
589349|NCT01059305|Local surgery|local surgery
589350|NCT01059305|Radiation therapy|radiation therapy
589351|NCT01059305|Epidermal growth factor receptor|epidermal growth factor receptor
589352|NCT01059305|EGFR|egfr
589353|NCT01059305|Small Molecule Tyrosine Kinase Inhibitor|small molecule tyrosine kinase inhibitor
589553|NCT01058512|chronic HCV|chronic hcv
589354|NCT01059292|we have complieted party research|we have complieted party research
589355|NCT01059279|Familial Mediterranean fever|familial mediterranean fever
589356|NCT01059279|Cytokines|cytokines
589357|NCT01059279|Inflammatory proteins|inflammatory proteins
589358|NCT01059279|MEFV|mefv
589359|NCT01059279|mutations|mutations
748933|NCT00443651|Rituxan|rituxan
589360|NCT01059279|Heat Intolerance|heat intolerance
589361|NCT01059279|Heat Tolerance Test|heat tolerance test
589362|NCT01059266|immunotherapy|immunotherapy
589363|NCT01059266|grass pollen|grass pollen
589364|NCT01059266|seasonal allergy|seasonal allergy
589365|NCT01059266|dose tolerability|dose tolerability
589366|NCT01059253|Falls|falls
589367|NCT01059253|Balance|balance
589368|NCT01059253|Elderly|elderly
589369|NCT01059253|Aged|aged
589370|NCT01059240|Survival Motor Neuron 1 (SMN1)|survival motor neuron 1 (smn1)
589371|NCT01059240|Survival Motor Neuron 2 (SMN2)|survival motor neuron 2 (smn2)
589372|NCT01059240|Spinal Muscular Atrophy (SMA)|spinal muscular atrophy (sma)
589373|NCT01059240|SMN Copy Number in Mali|smn copy number in mali
589374|NCT01059240|Spinal Muscular Antrophy|spinal muscular antrophy
589375|NCT01059240|SMA|sma
589376|NCT01059227|Treatment|treatment
589377|NCT01059227|Anxiety|anxiety
589378|NCT01059227|Fear|fear
589379|NCT01059227|Fear Potentiated Startle|fear potentiated startle
589380|NCT01059227|Healthy Volunteer|healthy volunteer
589381|NCT01059227|HV|hv
589382|NCT01059214|Acute Myocardial Infarction|acute myocardial infarction
589383|NCT01059214|Reperfusion|reperfusion
589384|NCT01059214|MRI|mri
589385|NCT01059214|Heart Attack|heart attack
589386|NCT01059201|Autism Spectrum Disorder|autism spectrum disorder
589387|NCT01059201|Cholesterol|cholesterol
589388|NCT01059201|Exome Sequencing|exome sequencing
589389|NCT01059201|Autistic Spectrum Disorder|autistic spectrum disorder
589390|NCT01059201|ASD|asd
589391|NCT01059188|stage IIIB non-small cell lung cancer|stage iiib non-small cell lung cancer
589392|NCT01059188|adenocarcinoma of the lung|adenocarcinoma of the lung
589393|NCT01059188|adenosquamous cell lung cancer|adenosquamous cell lung cancer
589394|NCT01059188|large cell lung cancer|large cell lung cancer
589395|NCT01059188|squamous cell lung cancer|squamous cell lung cancer
589396|NCT01059175|Heart failure|heart failure
589397|NCT01059175|Cardiac resynchronization therapy|cardiac resynchronization therapy
589398|NCT01059175|Biventricular stimulation|biventricular stimulation
589399|NCT01059175|Multisite stimulation|multisite stimulation
589400|NCT01059175|Non responders|non responders
589401|NCT01059162|Glaucoma Surgery|glaucoma surgery
589402|NCT01059162|Filtering Surgery|filtering surgery
589403|NCT01059162|Non Penetrating glaucoma surgery|non penetrating glaucoma surgery
589404|NCT01059149|Rehabilitation|rehabilitation
589405|NCT01059149|Transcranial magnetic stimulation|transcranial magnetic stimulation
589406|NCT01059149|Brain magnetic stimulation|brain magnetic stimulation
589407|NCT01059149|Repetitive|repetitive
589408|NCT01059149|Stroke|stroke
589409|NCT01059149|Subacute|subacute
589410|NCT01059136|Myocardial infarction|myocardial infarction
589411|NCT01059136|Outcome|outcome
589412|NCT01059136|Aldosterone|aldosterone
589413|NCT01059136|Spironolactone|spironolactone
589414|NCT01059123|Amoxicillin|amoxicillin
589415|NCT01059123|Erysipelas|erysipelas
589416|NCT01059123|Short course|short course
589417|NCT01059110|Occlusive dressings|occlusive dressings
589418|NCT01059110|Salicylate ointment|salicylate ointment
589419|NCT01059110|Cryotherapy|cryotherapy
589420|NCT01059110|Topical 5-fluoro-uracil|topical 5-fluoro-uracil
589421|NCT01059110|Imiquimod|imiquimod
589422|NCT01059110|Randomized clinical trial|randomized clinical trial
589423|NCT01059110|Plantar warts|plantar warts
589424|NCT01059084|HIV|hiv
589425|NCT01059084|Valacyclovir|valacyclovir
589426|NCT01059084|Valtrex®|valtrex®
589427|NCT01059071|Refractory Neuroblastoma|refractory neuroblastoma
589428|NCT01059071|Relapsed neuroblastoma|relapsed neuroblastoma
589429|NCT01059058|MI Paste Plus|mi paste plus
589430|NCT01059058|Fluoride Varnish|fluoride varnish
589431|NCT01059058|CPP-ACP|cpp-acp
589432|NCT01059058|White Spot Lesions|white spot lesions
589433|NCT01059058|Remineralization|remineralization
589434|NCT01059058|Orthodontic Treatment|orthodontic treatment
589435|NCT01059019|Refractive Surgery|refractive surgery
589436|NCT01059019|PRK|prk
589437|NCT01059019|Photorefractive Keratectomy|photorefractive keratectomy
589438|NCT01059019|Omega 3 Fatty Acids|omega 3 fatty acids
589439|NCT01059019|Cornea|cornea
589440|NCT01059006|Reflective Surgery|reflective surgery
589441|NCT01059006|Presbyopia|presbyopia
589442|NCT01059006|PresbyLASIK|presbylasik
589443|NCT01058993|neutropenia|neutropenia
589444|NCT01058993|myelokathexis|myelokathexis
589445|NCT01058993|WHIM syndrome|whim syndrome
589446|NCT01058993|AMD 3100|amd 3100
589447|NCT01058993|plerixafor|plerixafor
589448|NCT01058993|Myelokathexis syndrome|myelokathexis syndrome
589449|NCT01058993|Neutropenia due to mutations of CXCR-4|neutropenia due to mutations of cxcr-4
589450|NCT01058980|catheter ablation|catheter ablation
589451|NCT01058980|atrial fibrillation|atrial fibrillation
589452|NCT01058980|adenosine|adenosine
589453|NCT01058967|Code III trauma (highest acuity)|code iii trauma (highest acuity)
589454|NCT01058967|Life Flight aeromedical ambulance service|life flight aeromedical ambulance service
589455|NCT01058941|Alzheimer's disease|alzheimer's disease
589456|NCT01058941|fish oil|fish oil
589457|NCT01058941|lipoic acid|lipoic acid
589458|NCT01058928|Tracheal tube|tracheal tube
589459|NCT01058928|Size|size
589460|NCT01058915|ST-Segment Elevation Myocardial Infarction|st-segment elevation myocardial infarction
589461|NCT01058902|Non small cell lung cancer|non small cell lung cancer
589462|NCT01058902|survival|survival
589463|NCT01058902|aspirin|aspirin
589464|NCT01058889|Diabetes mellitus Type 2|diabetes mellitus type 2
589465|NCT01058889|Telemedicine|telemedicine
589466|NCT01058889|Insulin|insulin
589467|NCT01058876|Smoking|smoking
589468|NCT01058876|nicotine|nicotine
589469|NCT01058837|Sudden Cardiac Death|sudden cardiac death
589470|NCT01058837|Implantable Cardioverter Defibrillator|implantable cardioverter defibrillator
589471|NCT01058837|Ventricular Fibrillation|ventricular fibrillation
589472|NCT01058824|Bioequivalence|bioequivalence
589473|NCT01058824|Lincomycin Hydrocloride|lincomycin hydrocloride
589474|NCT01058811|lung cancer|lung cancer
589475|NCT01058798|Neuroblastoma|neuroblastoma
589476|NCT01058798|B4GALNT3|b4galnt3
589477|NCT01058798|Prognosis|prognosis
589478|NCT01058785|Gene therapy|gene therapy
589479|NCT01058785|Flow cytometry|flow cytometry
589480|NCT01058785|Immunoenzyme technique|immunoenzyme technique
589481|NCT01058785|Laboratory biomarker analysis|laboratory biomarker analysis
589482|NCT01058785|Tumor cell-derivative vaccine therapy|tumor cell-derivative vaccine therapy
589483|NCT01058772|Induced Labour|induced labour
589484|NCT01058772|Expectant Management|expectant management
589485|NCT01058772|C-section rate|c-section rate
589486|NCT01058772|Maternal Outcomes|maternal outcomes
589487|NCT01058772|Neonatal Outcomes|neonatal outcomes
589488|NCT01058759|non-small cell lung cancer|non-small cell lung cancer
589489|NCT01058759|NSCLC|nsclc
589490|NCT01058759|Enoxaparin|enoxaparin
589491|NCT01058759|Locally Advanced or Metastatic Non-small Cell Lung Cancer stadium IIIb/IV|locally advanced or metastatic non-small cell lung cancer stadium iiib/iv
589492|NCT01058746|pancreas|pancreas
589493|NCT01058746|surgery|surgery
589494|NCT01058746|Pancreaticoduodenectomy|pancreaticoduodenectomy
589495|NCT01058746|Central Pancreatectomy|central pancreatectomy
589496|NCT01058746|Distal Pancreatectomy|distal pancreatectomy
589497|NCT01058746|resection|resection
589498|NCT01058746|IV fluids|iv fluids
589499|NCT01058746|09-185|09-185
589500|NCT01058733|semi-automatic response system (SARS)|semi-automatic response system (sars)
589501|NCT01058733|Diabetes Mellitus|diabetes mellitus
589502|NCT01058733|Internet|internet
589503|NCT01058733|ubiquitous health care system|ubiquitous health care system
589504|NCT01058720|Vitamin D|vitamin d
589505|NCT01058720|Supplementation|supplementation
589506|NCT01058720|Adolescence|adolescence
589507|NCT01058707|Solid tumors, MLN0128, TORC1/2 inhibitors|solid tumors, mln0128, torc1/2 inhibitors
589508|NCT01058694|Mobile phones,|mobile phones,
589509|NCT01058694|Medication Adherence|medication adherence
589510|NCT01058694|Micro-Electrical-Mechanical Systems|micro-electrical-mechanical systems
589511|NCT01058694|HIV Infections|hiv infections
589512|NCT01058681|LH pulsatility|lh pulsatility
589513|NCT01058681|GnRH regulation|gnrh regulation
589514|NCT01058681|isocaloric nutrition|isocaloric nutrition
589515|NCT01058681|hypercaloric nutrition|hypercaloric nutrition
589516|NCT01058681|euglycemic clamps|euglycemic clamps
589517|NCT01058681|hyperinsulinemic clamps|hyperinsulinemic clamps
589518|NCT01058681|testosterone|testosterone
589520|NCT01058681|leptine|leptine
589521|NCT01058681|ghrelin|ghrelin
589522|NCT01058681|PYY|pyy
589523|NCT01058681|CCK|cck
589524|NCT01058681|GLP-1|glp-1
589525|NCT01058681|GIP|gip
589526|NCT01058681|cortisol|cortisol
589527|NCT01058668|Acute Mania|acute mania
589528|NCT01058668|Bipolar I Disorder|bipolar i disorder
589529|NCT01058655|Colorectal Cancer|colorectal cancer
589530|NCT01058642|pain|pain
589531|NCT01058642|delta opioid receptor agonist|delta opioid receptor agonist
589532|NCT01058629|Hybrid|hybrid
589533|NCT01058629|contact lens|contact lens
589534|NCT01058629|myopia|myopia
589535|NCT01058629|hyperopia|hyperopia
589536|NCT01058629|near sighted|near sighted
589537|NCT01058629|astigmatism|astigmatism
589538|NCT01058629|far sighted|far sighted
589539|NCT01058603|Infertility|infertility
589540|NCT01058603|Cell Culture|cell culture
589541|NCT01058603|AECC|aecc
589542|NCT01058603|Endocell|endocell
589543|NCT01058603|IVF|ivf
589544|NCT01058590|Inflammation|inflammation
589545|NCT01058590|Adenotonsillectomy|adenotonsillectomy
589546|NCT01058577|diabetes|diabetes
589547|NCT01058564|GERD|gerd
589548|NCT01058551|Sleep Apnea|sleep apnea
589549|NCT01058551|Atrial Fibrillation|atrial fibrillation
589550|NCT01058538|Interleukin, IL2, monoclonal, antibody, cytokine, tumour targeting, solid tumours, dose finding, renal cell carcinoma, fusion protein, RCC,|interleukin, il2, monoclonal, antibody, cytokine, tumour targeting, solid tumours, dose finding, renal cell carcinoma, fusion protein, rcc,
589551|NCT01058538|L19|l19
589552|NCT01058512|hepatitis C|hepatitis c
589554|NCT01058512|viral HCV|viral hcv
589555|NCT01058512|genotype 1|genotype 1
589556|NCT01058512|failed treatment with pegylated interferon plus ribavirin|failed treatment with pegylated interferon plus ribavirin
749176|NCT00443131|Malaria|malaria
589557|NCT01058499|Chronic Obstructive Pulmonary Disease|chronic obstructive pulmonary disease
589558|NCT01058499|COPD|copd
589559|NCT01058486|Chronic Disease Management|chronic disease management
589560|NCT01058486|Physical Activity|physical activity
589561|NCT01058486|Self-efficacy|self-efficacy
589562|NCT01058486|Self management|self management
589563|NCT01058473|Sickle Cell Disease|sickle cell disease
589564|NCT01058473|Pain|pain
589565|NCT01058473|Assessment|assessment
589566|NCT01058460|Cervical Intraepithelial Neoplasia, Grade III|cervical intraepithelial neoplasia, grade iii
589567|NCT01058460|Cervical Intraepithelial Neoplasia, Grade II|cervical intraepithelial neoplasia, grade ii
589568|NCT01058447|ADME|adme
589569|NCT01058447|Healthy volunteers|healthy volunteers
589570|NCT01058434|Multiple myeloma|multiple myeloma
589571|NCT01058434|relapsed|relapsed
589572|NCT01058434|refractory|refractory
589573|NCT01058434|t(4;14)|t(4;14)
589574|NCT01058434|FGFR3|fgfr3
589575|NCT01058421|mechanical ventilation|mechanical ventilation
589576|NCT01058421|acute respiratory failure|acute respiratory failure
589577|NCT01058421|physical therapy|physical therapy
589578|NCT01058421|critical illness neuropathy|critical illness neuropathy
589579|NCT01058421|critical illness myopathy|critical illness myopathy
589580|NCT01058408|advanced head and neck cancer|advanced head and neck cancer
589581|NCT01058408|cisplatin|cisplatin
589582|NCT01058408|RAD001|rad001
589583|NCT01058408|radiation|radiation
589584|NCT01058408|HNSCC|hnscc
589585|NCT01058395|Traumatic Brain Injury|traumatic brain injury
589586|NCT01058395|Minocycline|minocycline
589587|NCT01058395|Outcome|outcome
589588|NCT01058382|FET|fet
589589|NCT01058382|Progesterone Support|progesterone support
589590|NCT01058382|Frozen Embryo Transfer|frozen embryo transfer
589591|NCT01058356|antibiotics associated colitis|antibiotics associated colitis
589592|NCT01058356|lactobacilli|lactobacilli
589593|NCT01058356|probiotics|probiotics
589594|NCT01058356|prevention|prevention
589595|NCT01058356|pulmonary infection|pulmonary infection
589596|NCT01058356|Prevention of antibiotics associated colitis|prevention of antibiotics associated colitis
589597|NCT01058356|the role of probiotics for prevention of antibiotics associated colitis|the role of probiotics for prevention of antibiotics associated colitis
589598|NCT01058356|the lactobacilli effect for antibiotics associated colitis|the lactobacilli effect for antibiotics associated colitis
589599|NCT01058356|antibiotic associated colitis on pulmonary infectious disease|antibiotic associated colitis on pulmonary infectious disease
589600|NCT01058343|SLE|sle
589601|NCT01058330|Neurofibromatosis type 1|neurofibromatosis type 1
589602|NCT01058330|NF1|nf1
589603|NCT01058317|respiratory, papilloma, pediatric, juvenile|respiratory, papilloma, pediatric, juvenile
589604|NCT01058304|osteoarthritis|osteoarthritis
589605|NCT01058304|knee|knee
589606|NCT01058304|physical therapy (specialty)|physical therapy (specialty)
589607|NCT01058304|veterans|veterans
589608|NCT01058278|Glaucoma|glaucoma
589609|NCT01058278|Ocular Hypertension|ocular hypertension
589610|NCT01058278|Intraocular Pressure|intraocular pressure
589611|NCT01058278|Trabeculectomy|trabeculectomy
589612|NCT01058239|bortezomib|bortezomib
589613|NCT01058239|rituximab|rituximab
589614|NCT01058239|PTLD|ptld
589615|NCT01058239|EBV|ebv
589616|NCT01058239|transplantation|transplantation
589617|NCT01058226|Experimental malaria challenge|experimental malaria challenge
589618|NCT01058213|COPD|copd
589619|NCT01058213|Pulmonary rehabilitation|pulmonary rehabilitation
589620|NCT01058213|Resistance Training|resistance training
589621|NCT01058213|Aerobic Training|aerobic training
589622|NCT01058213|Dyspnea|dyspnea
589623|NCT01058174|Prophylaxis|prophylaxis
589624|NCT01058174|Liver transplantation|liver transplantation
589625|NCT01058174|Invasive Fungal Infection|invasive fungal infection
589626|NCT01058174|Micafungin|micafungin
589627|NCT01058174|Prevention|prevention
589628|NCT01058174|Mycoses|mycoses
589629|NCT01058161|wrist and hand cartilage abnormalities in inflammatory and chronic rheumatisms|wrist and hand cartilage abnormalities in inflammatory and chronic rheumatisms
589630|NCT01058148|Cervical Cancer Screening|cervical cancer screening
589631|NCT01058148|Cervical Precancer|cervical precancer
589632|NCT01058148|Self-Collection|self-collection
589633|NCT01058148|Cytology|cytology
589634|NCT01058148|Human Papilloma Virus (HPV)|human papilloma virus (hpv)
589635|NCT01058135|insulin resistance|insulin resistance
589636|NCT01058135|dietary fiber|dietary fiber
589637|NCT01058135|resistant starch|resistant starch
589638|NCT01058122|Adverse drug reactions in patients on the oncology ward|adverse drug reactions in patients on the oncology ward
589639|NCT01058109|bone health, bone density, bone mass|bone health, bone density, bone mass
589640|NCT01058096|Acute Mania|acute mania
589641|NCT01058096|Bipolar I Disorder|bipolar i disorder
589642|NCT01058070|GERD|gerd
589643|NCT01058057|atorvastatin|atorvastatin
589644|NCT01058057|percutaneous coronary intervention|percutaneous coronary intervention
589645|NCT01058057|periprocedural myocardial infarction|periprocedural myocardial infarction
589842|NCT01057264|Gemzar|gemzar
589646|NCT01058057|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors
589647|NCT01058044|Cancer, Sunitinib, capecitabine, anastrozole, letrozole|cancer, sunitinib, capecitabine, anastrozole, letrozole
589648|NCT01058044|adherence, anticancer treatment|adherence, anticancer treatment
589649|NCT01058018|Cholesterol|cholesterol
589650|NCT01058018|High density lipoprotein|high density lipoprotein
589651|NCT01058018|Atherosclerosis|atherosclerosis
589652|NCT01058018|ApolipoproteinA1|apolipoproteina1
589653|NCT01058018|Stable angina artery disease|stable angina artery disease
589654|NCT01058005|MS|ms
589655|NCT01057979|exercise|exercise
589656|NCT01057979|college students|college students
589657|NCT01057979|Sedentary college students|sedentary college students
589658|NCT01057966|Bioavailability|bioavailability
589659|NCT01057966|Ocular Vitamins|ocular vitamins
589660|NCT01057953|Colo-Rectal Cancer|colo-rectal cancer
589661|NCT01057914|Randomized controlled trial|randomized controlled trial
589662|NCT01057914|Malnutrition|malnutrition
589663|NCT01057914|Aged|aged
589664|NCT01057914|Aged 80 and over|aged 80 and over
589665|NCT01057914|Nutrition therapy|nutrition therapy
589666|NCT01057888|Immunization status for:|immunization status for:
589667|NCT01057888|Tdap|tdap
589668|NCT01057888|Menactra|menactra
589669|NCT01057888|HPV (if female)|hpv (if female)
589670|NCT01057888|Well child care visit|well child care visit
589671|NCT01057862|Naltrexone|naltrexone
589672|NCT01057862|Pathological Gambling|pathological gambling
589673|NCT01057862|Opioid Antagonist|opioid antagonist
589674|NCT01057849|schizophrenia|schizophrenia
589675|NCT01057849|first episode|first episode
589676|NCT01057849|atypical antipsychotics|atypical antipsychotics
589677|NCT01057849|psychosocial intervention|psychosocial intervention
589678|NCT01057849|outcome|outcome
589679|NCT01057849|effectiveness|effectiveness
589680|NCT01057823|aged|aged
589681|NCT01057823|sleep deprivation|sleep deprivation
589682|NCT01057823|actigraphy|actigraphy
589683|NCT01057823|ambulatory monitoring|ambulatory monitoring
589684|NCT01057797|COPD|copd
589685|NCT01057797|Pulmonary rehabilitation|pulmonary rehabilitation
589686|NCT01057797|Self-efficacy|self-efficacy
589687|NCT01057797|Muscle strength|muscle strength
589688|NCT01057797|Dyspnea|dyspnea
589689|NCT01057797|Exercise adherence|exercise adherence
589690|NCT01057784|obesity|obesity
589691|NCT01057784|bariatric|bariatric
589692|NCT01057784|surgery|surgery
589693|NCT01057784|sleeve|sleeve
589694|NCT01057784|gastric bypass|gastric bypass
589695|NCT01057784|vitamin D|vitamin d
589696|NCT01057784|quality of life|quality of life
589697|NCT01057784|body composition|body composition
589698|NCT01057784|bone density|bone density
589699|NCT01057784|adolescent|adolescent
589700|NCT01057784|child|child
589701|NCT01057784|teenager|teenager
589702|NCT01057784|fertility|fertility
589703|NCT01057784|offspring|offspring
589704|NCT01057784|biomarker|biomarker
589705|NCT01057784|epigenome|epigenome
589706|NCT01057784|gene expression|gene expression
589707|NCT01057771|meditation|meditation
589708|NCT01057771|exercise|exercise
589709|NCT01057771|immunity|immunity
589710|NCT01057771|respiratory infection|respiratory infection
589711|NCT01057771|influenza|influenza
589712|NCT01057771|flu shot|flu shot
589713|NCT01057771|immunomodulation|immunomodulation
589714|NCT01057758|Suspicion of ventilator-associated pneumonia|suspicion of ventilator-associated pneumonia
589715|NCT01057745|woman|woman
589716|NCT01057745|chemotherapy|chemotherapy
589717|NCT01057745|radiation|radiation
589718|NCT01057745|fertility preservation|fertility preservation
589719|NCT01057745|cryobank|cryobank
589720|NCT01057719|cross-over design|cross-over design
589721|NCT01057719|mixed model|mixed model
589722|NCT01057719|multiple sclerosis|multiple sclerosis
589723|NCT01057719|physical performance measures|physical performance measures
589724|NCT01057719|physical therapy|physical therapy
589725|NCT01057719|the Bobath concept|the bobath concept
589726|NCT01057719|warm climate|warm climate
589727|NCT01057719|6-minute walk test|6-minute walk test
589728|NCT01057706|chiropractic|chiropractic
589729|NCT01057706|exercise|exercise
589730|NCT01057706|seniors|seniors
589731|NCT01057693|Diabetic peripheral neuropathy|diabetic peripheral neuropathy
589732|NCT01057693|Lyrica|lyrica
589733|NCT01057693|pregabalin|pregabalin
589734|NCT01057693|pain|pain
589735|NCT01057680|Bone|bone
589736|NCT01057680|Muscle|muscle
589737|NCT01057680|Strength|strength
589738|NCT01057680|Kidney|kidney
589739|NCT01057680|Liver|liver
589740|NCT01057680|Creatine|creatine
589741|NCT01057654|Cholesterol|cholesterol
589742|NCT01057641|PIDLSS, Spacer|pidlss, spacer
589743|NCT01057628|Blood glucose|blood glucose
589744|NCT01057628|ASP1941|asp1941
589745|NCT01057628|Diabetes mellitus|diabetes mellitus
589746|NCT01057615|Asthma|asthma
589747|NCT01057615|Exercise-Induced Bronchoconstriction|exercise-induced bronchoconstriction
589748|NCT01057615|Inflammation|inflammation
589749|NCT01057615|Airway|airway
589750|NCT01057615|Fish Oil|fish oil
589751|NCT01057615|Ascorbic Acid|ascorbic acid
589752|NCT01057602|Dementia|dementia
589753|NCT01057602|Screening Tests|screening tests
589754|NCT01057602|Cognition|cognition
589755|NCT01057602|Memory|memory
589756|NCT01057602|MOST|most
589757|NCT01057589|Pharynx|pharynx
589758|NCT01057589|Larynx|larynx
589759|NCT01057589|Cervical esophagus|cervical esophagus
589760|NCT01057589|Nose|nose
589761|NCT01057589|Thyroid Gland|thyroid gland
589762|NCT01057589|Parathyroid Gland|parathyroid gland
589763|NCT01057576|bioactives|bioactives
589764|NCT01057576|insulin|insulin
589765|NCT01057576|botanicals|botanicals
589766|NCT01057563|Coronary artery disease|coronary artery disease
589767|NCT01057563|Neointimal hyperplasia|neointimal hyperplasia
589768|NCT01057563|Drug-eluting balloon|drug-eluting balloon
589769|NCT01057563|Optical coherence tomography|optical coherence tomography
589770|NCT01057550|Stress urinary Incontinence|stress urinary incontinence
589771|NCT01057550|autologous slings|autologous slings
589772|NCT01057550|slings|slings
589773|NCT01057550|tvt|tvt
589774|NCT01057550|grafts|grafts
589775|NCT01057550|surgery|surgery
589776|NCT01057537|Polypill|polypill
589777|NCT01057537|Red Heart Pill|red heart pill
589778|NCT01057537|Cardiovascular disease|cardiovascular disease
589779|NCT01057537|Adherence|adherence
589780|NCT01057537|Secondary prevention|secondary prevention
589781|NCT01057524|Airway clearance|airway clearance
589782|NCT01057524|Cystic fibrosis|cystic fibrosis
589783|NCT01057524|High frequency chest wall oscillation|high frequency chest wall oscillation
589784|NCT01057511|Crinone|crinone
589785|NCT01057511|progesterone|progesterone
589786|NCT01057511|endometrial progesterone concentration|endometrial progesterone concentration
589787|NCT01057485|Atrial Fibrillation|atrial fibrillation
589788|NCT01057485|Ablation|ablation
589789|NCT01057472|Repeatability of measurements|repeatability of measurements
589790|NCT01057459|Stage II Grade 1 Contiguous Follicular Lymphoma|stage ii grade 1 contiguous follicular lymphoma
589791|NCT01057459|Stage II Grade 1 Non-Contiguous Follicular Lymphoma|stage ii grade 1 non-contiguous follicular lymphoma
589792|NCT01057459|Stage II Grade 2 Contiguous Follicular Lymphoma|stage ii grade 2 contiguous follicular lymphoma
589793|NCT01057459|Stage II Grade 2 Non-Contiguous Follicular Lymphoma|stage ii grade 2 non-contiguous follicular lymphoma
589794|NCT01057459|Stage II Grade 3 Contiguous Follicular Lymphoma|stage ii grade 3 contiguous follicular lymphoma
589795|NCT01057459|Stage II Grade 3 Non-Contiguous Follicular Lymphoma|stage ii grade 3 non-contiguous follicular lymphoma
589796|NCT01057459|stage III grade 1 follicular lymphoma|stage iii grade 1 follicular lymphoma
589797|NCT01057459|stage III grade 2 follicular lymphoma|stage iii grade 2 follicular lymphoma
589798|NCT01057459|stage III grade 3 follicular lymphoma|stage iii grade 3 follicular lymphoma
589799|NCT01057459|stage IV grade 1 follicular lymphoma|stage iv grade 1 follicular lymphoma
589800|NCT01057459|stage IV grade 2 follicular lymphoma|stage iv grade 2 follicular lymphoma
589801|NCT01057459|stage IV grade 3 follicular lymphoma|stage iv grade 3 follicular lymphoma
589802|NCT01057446|Colonoscopy preparation|colonoscopy preparation
589803|NCT01057446|sennoside|sennoside
589804|NCT01057446|sodium phosphate|sodium phosphate
589805|NCT01057446|the aim is to assess the bowel cleansing effects of two different agents|the aim is to assess the bowel cleansing effects of two different agents
589806|NCT01057433|Healthy Volunteers|healthy volunteers
589807|NCT01057407|Hyperphosphatemia|hyperphosphatemia
589808|NCT01057407|hemodialysis|hemodialysis
589809|NCT01057407|CKD|ckd
589810|NCT01057407|ASP1585|asp1585
589811|NCT01057394|Atrial Fibrillation|atrial fibrillation
589812|NCT01057381|Adenotonsillectomy|adenotonsillectomy
589813|NCT01057381|Postoperative analgesia|postoperative analgesia
589814|NCT01057381|Pediatrics|pediatrics
589815|NCT01057355|Intraductal papillary mucinous neoplasm|intraductal papillary mucinous neoplasm
589816|NCT01057355|Mucinous cystic neoplasm|mucinous cystic neoplasm
589817|NCT01057355|Endoscopic ultrasound|endoscopic ultrasound
589818|NCT01057355|Endoscopic retrograde cholangiopancreatography|endoscopic retrograde cholangiopancreatography
589819|NCT01057355|Pancreatic cyst|pancreatic cyst
589820|NCT01057355|Pancreas cyst|pancreas cyst
589821|NCT01057355|Alcohol|alcohol
589822|NCT01057342|extensive stage small cell lung cancer|extensive stage small cell lung cancer
589823|NCT01057329|TDM|tdm
589824|NCT01057329|Drug|drug
589825|NCT01057329|Psychopharmacology|psychopharmacology
589826|NCT01057329|children|children
589827|NCT01057329|adolescents|adolescents
589828|NCT01057303|childhood acute myeloid leukemia/other myeloid malignancies|childhood acute myeloid leukemia/other myeloid malignancies
589829|NCT01057290|childhood acute myeloid leukemia/other myeloid malignancies|childhood acute myeloid leukemia/other myeloid malignancies
589830|NCT01057277|Head and Neck Cancer|head and neck cancer
589831|NCT01057277|Advanced Inoperable Head & Neck Cancer|advanced inoperable head & neck cancer
589832|NCT01057264|Liver|liver
589833|NCT01057264|Cancer|cancer
589834|NCT01057264|Hepatic arterial infusion|hepatic arterial infusion
589835|NCT01057264|HAI|hai
589836|NCT01057264|Abraxane|abraxane
589837|NCT01057264|Nab-Paclitaxel|nab-paclitaxel
589838|NCT01057264|Paclitaxel|paclitaxel
589839|NCT01057264|ABI-007|abi-007
589840|NCT01057264|Gemcitabine|gemcitabine
589841|NCT01057264|Gemcitabine Hydrochloride|gemcitabine hydrochloride
589843|NCT01057264|Bevacizumab|bevacizumab
589844|NCT01057264|Avastin|avastin
589845|NCT01057264|Anti-VEGF monoclonal antibody|anti-vegf monoclonal antibody
589846|NCT01057264|rhuMAb-VEGF|rhumab-vegf
589847|NCT01057264|Filgrastim|filgrastim
589848|NCT01057264|G-CSF|g-csf
589849|NCT01057264|Neupogen|neupogen
589850|NCT01057251|Nebivolol|nebivolol
589851|NCT01057251|Bystolic TM|bystolic tm
589852|NCT01057251|Hypertension|hypertension
589853|NCT01057251|Stage 2 Hypertension|stage 2 hypertension
589854|NCT01057238|mechanical ventilation|mechanical ventilation
589855|NCT01057238|critical care|critical care
589856|NCT01057212|advanced or metastatic non-squamous non-small cell lung cancer (NSCLC)|advanced or metastatic non-squamous non-small cell lung cancer (nsclc)
589857|NCT01057199|adult acute myeloid leukemia|adult acute myeloid leukemia
589858|NCT01057199|childhood acute myeloid leukemia/other myeloid malignancies|childhood acute myeloid leukemia/other myeloid malignancies
589859|NCT01057173|Heart Valve Disease|heart valve disease
589860|NCT01057173|Heart Valve Prosthesis|heart valve prosthesis
589861|NCT01057173|Heart Valve Prosthesis Implantation|heart valve prosthesis implantation
589862|NCT01057173|Randomized Controlled Trial|randomized controlled trial
589863|NCT01057121|HIV Infections|hiv infections
589864|NCT01057108|Hyperphosphatemia|hyperphosphatemia
589865|NCT01057108|chronic kidney disease|chronic kidney disease
589866|NCT01057108|salivary phosphorus|salivary phosphorus
589867|NCT01057095|adult acute myeloid leukemia with inv(16)(p13;q22)|adult acute myeloid leukemia with inv(16)(p13;q22)
589868|NCT01057095|adult acute myeloid leukemia with 11q23 (MLL) abnormalities|adult acute myeloid leukemia with 11q23 (mll) abnormalities
589869|NCT01057095|adult acute myeloid leukemia with del(5q)|adult acute myeloid leukemia with del(5q)
589870|NCT01057095|adult acute myeloid leukemia with t(16;16)(p13;q22)|adult acute myeloid leukemia with t(16;16)(p13;q22)
589871|NCT01057095|adult acute myeloid leukemia in remission|adult acute myeloid leukemia in remission
589872|NCT01057095|recurrent adult acute myeloid leukemia|recurrent adult acute myeloid leukemia
589873|NCT01057095|untreated adult acute myeloid leukemia|untreated adult acute myeloid leukemia
589874|NCT01057095|childhood acute myeloid leukemia in remission|childhood acute myeloid leukemia in remission
589875|NCT01057095|recurrent childhood acute myeloid leukemia|recurrent childhood acute myeloid leukemia
589876|NCT01057095|untreated childhood acute myeloid leukemia and other myeloid malignancies|untreated childhood acute myeloid leukemia and other myeloid malignancies
589877|NCT01057082|Sarcopenia|sarcopenia
589878|NCT01057082|Aging|aging
589879|NCT01057082|Muscle|muscle
589880|NCT01057082|Dietary Supplement|dietary supplement
589881|NCT01057082|HMB|hmb
589882|NCT01057082|Arginine|arginine
589883|NCT01057082|Glutamine|glutamine
589884|NCT01057069|Neo adjuvant|neo adjuvant
589885|NCT01057069|Triple negative|triple negative
589886|NCT01057069|primary tumor over 2 cm and/or positive lymphnodes|primary tumor over 2 cm and/or positive lymphnodes
589887|NCT01057056|patients in a sub-acute geriatric rehabilitation department|patients in a sub-acute geriatric rehabilitation department
589888|NCT01057043|Osteoarthritis|osteoarthritis
589889|NCT01057017|colorectal cancer|colorectal cancer
589890|NCT01057004|heart failure|heart failure
589891|NCT01056978|palliative care unit|palliative care unit
589892|NCT01056978|bleeding|bleeding
589893|NCT01056978|thromboembolic|thromboembolic
589894|NCT01056978|hemorrhagic risk|hemorrhagic risk
589895|NCT01056978|antithrombotic prophylaxis|antithrombotic prophylaxis
589896|NCT01056965|Frontotemporal Dementia|frontotemporal dementia
589897|NCT01056965|Corticobasal Degeneration|corticobasal degeneration
589898|NCT01056965|Progressive Nonfluent Aphasia|progressive nonfluent aphasia
589899|NCT01056965|Progressive Supranuclear Palsy|progressive supranuclear palsy
589900|NCT01056965|FTLD|ftld
589901|NCT01056965|FTD|ftd
589902|NCT01056965|PNFA|pnfa
589903|NCT01056965|CBD|cbd
589904|NCT01056965|PSP|psp
589905|NCT01056965|Predicted tauopathies, including:|predicted tauopathies, including:
589906|NCT01056965|Progressive Supranuclear Palsy (PSP)|progressive supranuclear palsy (psp)
589907|NCT01056965|(CBS)|(cbs)
589908|NCT01056965|Progressive Nonfluent Aphasia (PNFA)|progressive nonfluent aphasia (pnfa)
589909|NCT01056939|Ventilatory care, children, intensive care, NAVA|ventilatory care, children, intensive care, nava
589910|NCT01056939|Children needing ventilatory care|children needing ventilatory care
589911|NCT01056926|smoking|smoking
589912|NCT01056926|nicotine|nicotine
589913|NCT01056926|Effects of nicotine and non-nicotine factors on continuous working memory.|effects of nicotine and non-nicotine factors on continuous working memory.
589914|NCT01056926|Effects of nicotine and non-nicotine factors on cue reactivity.|effects of nicotine and non-nicotine factors on cue reactivity.
589915|NCT01056926|Use of nicotine patches, placebo patches, and denicotinized cigarettes.|use of nicotine patches, placebo patches, and denicotinized cigarettes.
589916|NCT01056926|memory|memory
589917|NCT01056913|anastomotic leakage|anastomotic leakage
589918|NCT01056913|bleeding from the anastomotic region|bleeding from the anastomotic region
589919|NCT01056913|anastomotic stenosis|anastomotic stenosis
589920|NCT01056900|articular cartilage defects|articular cartilage defects
589921|NCT01056900|ACI|aci
589922|NCT01056900|Autologous Chondrocyte Implantation|autologous chondrocyte implantation
589923|NCT01056900|Knee joint|knee joint
589924|NCT01056900|chondron|chondron
589925|NCT01056887|diabetes insipidus|diabetes insipidus
589926|NCT01056887|primary polydipsia|primary polydipsia
589927|NCT01056887|copeptin|copeptin
589928|NCT01056887|Utility of plasma copeptin in differential diagnosis of polyuria/ polydipsia while performing a traditional deprivation test|utility of plasma copeptin in differential diagnosis of polyuria/ polydipsia while performing a traditional deprivation test
589929|NCT01056874|Maraviroc|maraviroc
589930|NCT01056874|Digoxin|digoxin
589931|NCT01056874|P-glycoprotein|p-glycoprotein
589932|NCT01056874|Pharmacokinetics|pharmacokinetics
589933|NCT01056874|Drug Interaction|drug interaction
589934|NCT01056874|HIV|hiv
589935|NCT01056861|cervical dystonia|cervical dystonia
589936|NCT01056861|torticollis|torticollis
589937|NCT01056861|Botulinum toxin|botulinum toxin
589938|NCT01056861|magnetoencephalography|magnetoencephalography
589939|NCT01056861|MEG|meg
589940|NCT01056861|cortical organizational changes detected by MEG after botulinum toxin in patients with torticollis, correlating with improvement in the symptoms|cortical organizational changes detected by meg after botulinum toxin in patients with torticollis, correlating with improvement in the symptoms
589941|NCT01056848|Euvolemic Hyponatremia|euvolemic hyponatremia
589942|NCT01056848|Hypervolemic Hyponatremia|hypervolemic hyponatremia
589943|NCT01056848|SIADH|siadh
589944|NCT01056848|Serum Sodium|serum sodium
589945|NCT01056809|Colorectal cancer|colorectal cancer
589946|NCT01056809|Metastases|metastases
589947|NCT01056809|Treatment strategies|treatment strategies
589948|NCT01056809|Colorectal cancer with synchronous metastases|colorectal cancer with synchronous metastases
589949|NCT01056796|compression anastomosis|compression anastomosis
589950|NCT01056796|Colorectal cancer|colorectal cancer
589951|NCT01056796|Low anterior resection|low anterior resection
589952|NCT01056796|Radiated to the pelvic area|radiated to the pelvic area
589953|NCT01056796|Radiotherapy|radiotherapy
589954|NCT01056783|EoE|eoe
589955|NCT01056770|Smallpox vaccine efficacy|smallpox vaccine efficacy
589956|NCT01056757|metastatic breast cancer|metastatic breast cancer
589957|NCT01056757|ribavirin|ribavirin
589958|NCT01056757|eIF4E|eif4e
589959|NCT01056744|coronary stent|coronary stent
589960|NCT01056744|optical coherence tomography|optical coherence tomography
589961|NCT01056744|drug-eluting|drug-eluting
589962|NCT01056744|neointimal proliferation|neointimal proliferation
589963|NCT01056731|high blood pressure|high blood pressure
589964|NCT01056731|aliskiren|aliskiren
589965|NCT01056731|hydrochlorothiazide|hydrochlorothiazide
589966|NCT01056731|control rate|control rate
589967|NCT01056718|Diastolic Function|diastolic function
589968|NCT01056718|Nebivolol|nebivolol
589969|NCT01056705|Inactivated Poliomyelitis Vaccine|inactivated poliomyelitis vaccine
589970|NCT01056705|Sabin Strains|sabin strains
589971|NCT01056705|poliomyelitis|poliomyelitis
589972|NCT01056692|Asthma|asthma
589973|NCT01056692|bronchial allergen challenge|bronchial allergen challenge
589974|NCT01056692|sputum eosinophiilia|sputum eosinophiilia
589975|NCT01056653|father-child relations|father-child relations
589976|NCT01056653|paternal behaviour|paternal behaviour
589977|NCT01056653|early intervention|early intervention
589978|NCT01056653|child-rearing|child-rearing
589979|NCT01056640|telemonitoring|telemonitoring
589980|NCT01056640|usual care|usual care
589981|NCT01056640|elderly|elderly
589982|NCT01056640|hospitalization|hospitalization
589983|NCT01056640|Emergency room visits|emergency room visits
589984|NCT01056601|insulinoma|insulinoma
589985|NCT01056601|cancer of pancreas|cancer of pancreas
589986|NCT01056601|neoplasms, pancreas|neoplasms, pancreas
589987|NCT01056601|alpha-cell tumor|alpha-cell tumor
589988|NCT01056601|glucagonoma|glucagonoma
589989|NCT01056601|beta-cell tumor|beta-cell tumor
589990|NCT01056601|somatostatinoma|somatostatinoma
589991|NCT01056588|adolescent smoking|adolescent smoking
589992|NCT01056588|Contingency management|contingency management
589993|NCT01056588|Quit smoking|quit smoking
589994|NCT01056562|Prostate|prostate
589995|NCT01056562|GU|gu
589996|NCT01056562|Urological Oncology|urological oncology
589997|NCT01056549|Intestinal lipoprotein|intestinal lipoprotein
589998|NCT01056549|Apo B48 and apoB100|apo b48 and apob100
589999|NCT01056549|Pancreatic clamp|pancreatic clamp
590000|NCT01056549|GLP-1 agonist|glp-1 agonist
590001|NCT01056536|Travel|travel
590002|NCT01056536|casual sexual relationships|casual sexual relationships
590003|NCT01056536|condoms|condoms
590004|NCT01056536|Structured intervention|structured intervention
590005|NCT01056523|AML|aml
590006|NCT01056497|diabetes|diabetes
590007|NCT01056497|alpha lipoic acid|alpha lipoic acid
590008|NCT01056497|endoplasmic reticulum (ER) stress|endoplasmic reticulum (er) stress
590009|NCT01056497|insulin secretion|insulin secretion
590010|NCT01056497|insulin sensitivity|insulin sensitivity
590011|NCT01056484|Alcohol Dependence|alcohol dependence
590012|NCT01056484|Alcoholism|alcoholism
590013|NCT01056484|Substance Use Disorders|substance use disorders
590014|NCT01056484|Substance Abuse|substance abuse
590015|NCT01056471|Multiple Sclerosis|multiple sclerosis
590016|NCT01056471|Mesenchymal Stem Cells|mesenchymal stem cells
590017|NCT01056471|Autologous|autologous
590018|NCT01056458|acupressure|acupressure
590019|NCT01056458|perimenopause|perimenopause
590020|NCT01056458|menopause|menopause
590021|NCT01056458|anxiety|anxiety
590022|NCT01056458|life quality|life quality
590023|NCT01056458|insomnia|insomnia
590024|NCT01056445|Carotid artery stenting|carotid artery stenting
590025|NCT01056445|Hemodynamic Instability|hemodynamic instability
590026|NCT01056445|Valsalva Ratio|valsalva ratio
590027|NCT01056432|osteoporosis, bone fracture risk, bone ultrasonometry|osteoporosis, bone fracture risk, bone ultrasonometry
590028|NCT01056419|Graves' ophthalmopathy|graves' ophthalmopathy
590029|NCT01056419|Total thyroidectomy|total thyroidectomy
590030|NCT01056419|Anti-thyroid drug treatment|anti-thyroid drug treatment
590031|NCT01056419|Clinical activity score|clinical activity score
590032|NCT01056406|Pregnancy|pregnancy
590033|NCT01056406|Overweight|overweight
590034|NCT01056406|Obese|obese
590035|NCT01056406|Nutrition intervention|nutrition intervention
590036|NCT01056393|HIV|hiv
590037|NCT01056380|influenza|influenza
590038|NCT01056380|influenza like illness|influenza like illness
590039|NCT01056367|Resistant hypertension|resistant hypertension
590040|NCT01056367|Type-II-Diabetes Mellitus|type-ii-diabetes mellitus
590041|NCT01056367|Arterial stiffness|arterial stiffness
590042|NCT01056367|Ventricular function|ventricular function
590043|NCT01056354|Influenza|influenza
590044|NCT01056354|respiratory virus|respiratory virus
590045|NCT01056354|pandemic|pandemic
590046|NCT01056354|swine flu|swine flu
590047|NCT01056354|infection|infection
590048|NCT01056354|MERS-CoV|mers-cov
590049|NCT01056354|SARS-CoV|sars-cov
590050|NCT01056341|Infantile Hemangioma|infantile hemangioma
590051|NCT01056341|Propranolol|propranolol
590052|NCT01056315|Analgesia|analgesia
590053|NCT01056315|Diabetic Neuropathy|diabetic neuropathy
590054|NCT01056315|Neuropathic pain|neuropathic pain
590055|NCT01056315|Painful|painful
590056|NCT01056315|Chronic pain|chronic pain
590057|NCT01056302|Reconstructive surgical procedures|reconstructive surgical procedures
590058|NCT01056302|visuohaptic|visuohaptic
590059|NCT01056276|Multiple Myeloma|multiple myeloma
590060|NCT01056276|Bendamustine|bendamustine
590061|NCT01056276|Bortezomib|bortezomib
590062|NCT01056276|Dexamethasone|dexamethasone
590063|NCT01056263|retrospective trial|retrospective trial
590064|NCT01056263|5-year survival|5-year survival
590065|NCT01056263|metastatic renal cancer cell|metastatic renal cancer cell
590066|NCT01056250|cholelithiasis|cholelithiasis
590067|NCT01056224|skull pin insertion|skull pin insertion
590068|NCT01056224|remifentanil|remifentanil
590069|NCT01056224|short acting opioid|short acting opioid
590070|NCT01056224|craniotomy|craniotomy
590071|NCT01056224|cervical spine surgery|cervical spine surgery
590072|NCT01056224|hemodynamic changes|hemodynamic changes
590073|NCT01056224|dose requirement|dose requirement
590074|NCT01056224|age related|age related
590075|NCT01056198|Diabetic Foot Ulcers|diabetic foot ulcers
590076|NCT01056198|Diabetic Foot Wounds|diabetic foot wounds
590077|NCT01056185|influenza|influenza
590078|NCT01056185|flu|flu
590079|NCT01056185|swine flu|swine flu
590080|NCT01056185|respiratory virus|respiratory virus
590081|NCT01056185|hospitalization|hospitalization
590082|NCT01056185|MERS-CoV|mers-cov
590083|NCT01056185|SARS-CoV|sars-cov
590084|NCT01056172|Chronic hepatitis C|chronic hepatitis c
590085|NCT01056172|Genotype 2|genotype 2
590086|NCT01056172|Rapid virologic response|rapid virologic response
590087|NCT01056172|Sustained virologic response|sustained virologic response
590088|NCT01056172|Peginterferon alfa-2a|peginterferon alfa-2a
590089|NCT01056172|Ribavirin|ribavirin
590090|NCT01056159|asthma|asthma
590091|NCT01056159|dry powder inhaler|dry powder inhaler
590092|NCT01056159|short-acting beta2-agonist|short-acting beta2-agonist
590093|NCT01056159|SABA|saba
590094|NCT01056159|bronchoconstriction|bronchoconstriction
590095|NCT01056159|bronchodilation|bronchodilation
590096|NCT01056159|bronchodilator|bronchodilator
590097|NCT01056159|metered dose inhaler|metered dose inhaler
590098|NCT01056146|TBI|tbi
590099|NCT01056146|intracranial edema|intracranial edema
590100|NCT01056146|brain edema|brain edema
590101|NCT01056146|craniocerebral trauma|craniocerebral trauma
590102|NCT01056146|head injury|head injury
590103|NCT01056146|brain hemorrhage, traumatic|brain hemorrhage, traumatic
590104|NCT01056146|subdural hematoma|subdural hematoma
590105|NCT01056146|brain concussion|brain concussion
590106|NCT01056146|head injuries, closed|head injuries, closed
590107|NCT01056146|epidural hematoma|epidural hematoma
590108|NCT01056146|extra-axial hemorrhage|extra-axial hemorrhage
590109|NCT01056146|cortical contusion|cortical contusion
590110|NCT01056146|Additional relevant MeSH terms:|additional relevant mesh terms:
590111|NCT01056146|Nervous System Diseases|nervous system diseases
590112|NCT01056146|Wounds and Injuries|wounds and injuries
590113|NCT01056146|Disorders of Environmental Origin|disorders of environmental origin
590114|NCT01056146|Central Nervous System Diseases|central nervous system diseases
590115|NCT01056146|Trauma, Nervous System|trauma, nervous system
590116|NCT01056146|Brain Diseases|brain diseases
590117|NCT01056146|Brain Injuries|brain injuries
590118|NCT01056133|non-alcoholic fatty liver disease|non-alcoholic fatty liver disease
590119|NCT01056133|non-alcoholic steatohepatitis|non-alcoholic steatohepatitis
590218|NCT01055652|Type 2 diabetes mellitus|type 2 diabetes mellitus
590219|NCT01055652|Japanese|japanese
590120|NCT01056107|Constipation, Irritable Bowel Syndrome (IBS), Glucagon Like Peptide analogue|constipation, irritable bowel syndrome (ibs), glucagon like peptide analogue
590121|NCT01056081|COPD|copd
590122|NCT01056081|inspiratory muscles|inspiratory muscles
590123|NCT01056081|diaphragm|diaphragm
590124|NCT01056055|Ankle|ankle
590125|NCT01056055|Chronic lateral instability|chronic lateral instability
590126|NCT01056055|Modified Brostrom procedure|modified brostrom procedure
590127|NCT01056055|Suture anchor|suture anchor
590128|NCT01056055|Bone tunnel|bone tunnel
590129|NCT01056042|pelvic pain|pelvic pain
590130|NCT01056042|postoperative|postoperative
590131|NCT01056042|medical therapy|medical therapy
590132|NCT01056029|Solid Tumors|solid tumors
590133|NCT01056016|ADHD|adhd
590134|NCT01056003|gastric inlet patch|gastric inlet patch
590135|NCT01056003|prevalence|prevalence
590136|NCT01056003|globus sensations|globus sensations
590137|NCT01055990|pandemic influenza A (H1N1) 2009|pandemic influenza a (h1n1) 2009
590138|NCT01055990|blood fix treatment|blood fix treatment
590139|NCT01055990|influenza A (H1N1) 2009 monovalent vaccine|influenza a (h1n1) 2009 monovalent vaccine
590140|NCT01055990|effectiveness|effectiveness
590141|NCT01055990|immunogenicity|immunogenicity
590142|NCT01055990|safety|safety
590143|NCT01055977|statin therapy|statin therapy
590144|NCT01055977|treatment goal|treatment goal
590145|NCT01055977|dyslipidaemia|dyslipidaemia
590146|NCT01055951|Insulin pumps|insulin pumps
590147|NCT01055951|Diabetes|diabetes
590148|NCT01055912|Congestive Heart Failure|congestive heart failure
590149|NCT01055912|Volume Overload|volume overload
590150|NCT01055899|RA|ra
590151|NCT01055886|PTSD|ptsd
590152|NCT01055886|smoking cessation|smoking cessation
590153|NCT01055886|nicotine patch|nicotine patch
590154|NCT01055873|immune status|immune status
590155|NCT01055873|adolescents or young adults infected|adolescents or young adults infected
590156|NCT01055873|impact of viral replication|impact of viral replication
590157|NCT01055860|uterine Prolapse|uterine prolapse
590158|NCT01055860|vaginal prolapse|vaginal prolapse
590159|NCT01055860|mesh erosion|mesh erosion
590160|NCT01055860|urinary incontinence|urinary incontinence
590161|NCT01055860|bowel symptoms|bowel symptoms
590162|NCT01055847|cystic fibrosis|cystic fibrosis
590163|NCT01055847|CF|cf
590164|NCT01055847|aztreonam|aztreonam
590165|NCT01055847|lung infection|lung infection
590166|NCT01055847|Pseudomonas aeruginosa|pseudomonas aeruginosa
590167|NCT01055834|Insomnia|insomnia
590168|NCT01055834|primary insomnia|primary insomnia
590169|NCT01055834|insomnia associated with psychiatric or physical disorder(s)|insomnia associated with psychiatric or physical disorder(s)
590170|NCT01055821|Hepatitis C|hepatitis c
590171|NCT01055821|Vaccine|vaccine
590172|NCT01055821|HCVac|hcvac
590173|NCT01055821|MVA-HCV|mva-hcv
590174|NCT01055808|Insulin|insulin
590175|NCT01055808|ITR-QOL|itr-qol
590176|NCT01055808|DTSQ|dtsq
590177|NCT01055808|Diabetes Mellitus, Type 2|diabetes mellitus, type 2
590178|NCT01055782|Colonoscopy|colonoscopy
590179|NCT01055782|Endoguide|endoguide
590180|NCT01055782|Pain perception|pain perception
590181|NCT01055782|Colonoscopy to the coecum (success rate)|colonoscopy to the coecum (success rate)
590182|NCT01055782|Patient's perception of pain|patient's perception of pain
590183|NCT01055782|Duration of successful colonoscopies|duration of successful colonoscopies
590184|NCT01055769|Bio-equivalence|bio-equivalence
590185|NCT01055769|Linezolid OS|linezolid os
590186|NCT01055769|Linezolid tablet|linezolid tablet
590187|NCT01055756|Reduction of signs and symptoms and enhanced nasal flow|reduction of signs and symptoms and enhanced nasal flow
590188|NCT01055756|Nasal Flow|nasal flow
590189|NCT01055743|Fluorouracil Implants|fluorouracil implants
590190|NCT01055743|Hepatocellular carcinoma|hepatocellular carcinoma
590191|NCT01055743|Radical resection|radical resection
590192|NCT01055730|Pulmonary rehabilitation|pulmonary rehabilitation
590193|NCT01055730|Exercise therapy|exercise therapy
590194|NCT01055730|Interstitial lung disease|interstitial lung disease
590195|NCT01055730|Pulmonary fibrosis|pulmonary fibrosis
590196|NCT01055730|Mobility limitation|mobility limitation
590197|NCT01055730|Dyspnea|dyspnea
590198|NCT01055730|Mental health|mental health
590199|NCT01055717|avenanthramide|avenanthramide
590200|NCT01055717|enriched|enriched
590201|NCT01055717|oat|oat
590202|NCT01055717|phytochemical|phytochemical
590203|NCT01055717|bioavailability|bioavailability
590204|NCT01055704|Methylnaltrexone|methylnaltrexone
590205|NCT01055704|Codeine|codeine
590206|NCT01055704|Gastrointestinal motility|gastrointestinal motility
590207|NCT01055704|Colonic transit|colonic transit
590208|NCT01055691|healthy volunteers|healthy volunteers
590209|NCT01055691|bioequivalence|bioequivalence
590210|NCT01055691|dapagliflozin|dapagliflozin
590211|NCT01055691|metformin|metformin
590212|NCT01055678|breast cancer|breast cancer
590213|NCT01055678|ductal breast carcinoma in situ|ductal breast carcinoma in situ
590214|NCT01055678|breast cancer in situ|breast cancer in situ
590215|NCT01055678|invasive carcinoma|invasive carcinoma
590216|NCT01055678|invasive ductal carcinoma|invasive ductal carcinoma
590217|NCT01055678|invasive lobular carcinoma|invasive lobular carcinoma
590220|NCT01055652|phase 1|phase 1
590221|NCT01055652|safety|safety
590222|NCT01055652|dapagliflozin|dapagliflozin
590223|NCT01055652|Pharmacokinetics|pharmacokinetics
590224|NCT01055652|Drug-drug Interaction|drug-drug interaction
590225|NCT01055652|voglibose|voglibose
590226|NCT01055639|Chronic Pain|chronic pain
590227|NCT01055639|Acceptance and Commitment Therapy (ACT)|acceptance and commitment therapy (act)
590228|NCT01055626|Body mass index|body mass index
590229|NCT01055626|Body fat|body fat
590230|NCT01055626|Obesity|obesity
590231|NCT01055626|Overweight|overweight
590232|NCT01055626|Diabetes Mellitus, Type 2|diabetes mellitus, type 2
590233|NCT01055626|Air displacement plethysmography|air displacement plethysmography
590234|NCT01055600|eltrombopag|eltrombopag
590235|NCT01055600|pharmacokinetics|pharmacokinetics
590236|NCT01055600|PROMACTA|promacta
590237|NCT01055600|lactation|lactation
590238|NCT01055600|milk-only study|milk-only study
590239|NCT01055587|major abdominal surgery|major abdominal surgery
590240|NCT01055587|severe burn injury|severe burn injury
590241|NCT01055587|infection|infection
590242|NCT01055587|diagnostic|diagnostic
590243|NCT01055574|lumbar disc arthroplasty|lumbar disc arthroplasty
590244|NCT01055574|total disc replacement|total disc replacement
590245|NCT01055574|ProDisc L|prodisc l
590246|NCT01055574|anterior lumbar interbody fusion|anterior lumbar interbody fusion
590247|NCT01055574|lumbar spine surgery outcomes|lumbar spine surgery outcomes
590248|NCT01055561|Acupuncture|acupuncture
590249|NCT01055561|Behavioral and Psychological Symptoms of Dementia|behavioral and psychological symptoms of dementia
590250|NCT01055561|BPSD|bpsd
590251|NCT01055561|MMSE|mmse
590252|NCT01055561|BEHAVE-AD|behave-ad
590253|NCT01055561|The Questionnaire of Acupuncture Events|the questionnaire of acupuncture events
590254|NCT01055561|healthy volunteers|healthy volunteers
590255|NCT01055548|Preterm|preterm
590256|NCT01055548|Perinatal|perinatal
590257|NCT01055548|Ultrasound|ultrasound
590258|NCT01055548|Cerebral palsy|cerebral palsy
590259|NCT01055548|Anxiety|anxiety
590260|NCT01055548|Parents|parents
590261|NCT01055522|Interleukin, IL2, monoclonal, antibody, cytokine, Dacarbazine, metastatic, melanoma, tumor targeting, Dose definition|interleukin, il2, monoclonal, antibody, cytokine, dacarbazine, metastatic, melanoma, tumor targeting, dose definition
590262|NCT01055522|, L19|, l19
590263|NCT01055509|Social Adjustment|social adjustment
590264|NCT01055509|Quality of life|quality of life
590265|NCT01055509|Recurrence|recurrence
590266|NCT01055509|Hospitalization|hospitalization
590267|NCT01055496|Non-Hodgkin's lymphoma|non-hodgkin's lymphoma
590268|NCT01055483|Acute myeloid leukemia|acute myeloid leukemia
590269|NCT01055483|AML|aml
590270|NCT01055483|relapsed acute myeloid leukemia|relapsed acute myeloid leukemia
590271|NCT01055483|refractory acute myeloid leukemia|refractory acute myeloid leukemia
590272|NCT01055431|iron|iron
590273|NCT01055431|bioavailability|bioavailability
590274|NCT01055431|status|status
590275|NCT01055431|deficiency|deficiency
590276|NCT01055431|anaemia|anaemia
590277|NCT01055431|functional foods|functional foods
590278|NCT01055431|child bearing|child bearing
590279|NCT01055418|Vitamin C|vitamin c
590280|NCT01055418|Cognitive performance|cognitive performance
590281|NCT01055418|Cerebral blood flow|cerebral blood flow
590282|NCT01055418|Trans cranial doppler|trans cranial doppler
590283|NCT01055418|Near infrared spectroscopy|near infrared spectroscopy
590284|NCT01055405|Exercise tolerance|exercise tolerance
590285|NCT01055405|COPD|copd
590286|NCT01055405|Pulmonary hypertension|pulmonary hypertension
590287|NCT01055405|Sildenafil|sildenafil
590288|NCT01055392|mild cognitive impairment|mild cognitive impairment
590289|NCT01055392|Alzheimer's disease|alzheimer's disease
590290|NCT01055392|Lithium|lithium
590291|NCT01055392|disease-modification|disease-modification
590292|NCT01055392|cognition|cognition
590293|NCT01055392|early Alzheimer`s disease|early alzheimer`s disease
590294|NCT01055379|Rasagiline|rasagiline
590295|NCT01055379|Depressive Symptoms|depressive symptoms
590296|NCT01055379|Cognition|cognition
590297|NCT01055366|Open angle glaucoma|open angle glaucoma
590298|NCT01055366|OAG|oag
590299|NCT01055366|Elazop|elazop
590300|NCT01055366|Azarga|azarga
590301|NCT01055366|Brinzolamide/Timolol combination|brinzolamide/timolol combination
590302|NCT01055353|Target organs damage|target organs damage
590303|NCT01055353|hypertensive patients|hypertensive patients
590304|NCT01055340|Ketogenesis|ketogenesis
590305|NCT01055340|Glucose-Dependent Insulin Secretion|glucose-dependent insulin secretion
590306|NCT01055340|Graded Glucose Infusion|graded glucose infusion
590307|NCT01055340|Oxyntomodulin|oxyntomodulin
590308|NCT01055327|Isolated oral clefts|isolated oral clefts
590309|NCT01055327|lamotrigine|lamotrigine
590310|NCT01055327|EUROCAT|eurocat
590311|NCT01055327|congenital malformations|congenital malformations
590312|NCT01055327|anti-epileptic drugs|anti-epileptic drugs
590313|NCT01055301|stage I multiple myeloma|stage i multiple myeloma
590314|NCT01055301|stage II multiple myeloma|stage ii multiple myeloma
590315|NCT01055301|stage III multiple myeloma|stage iii multiple myeloma
590316|NCT01055275|iliac aneurysm|iliac aneurysm
590317|NCT01055275|aortic aneurysm|aortic aneurysm
590318|NCT01055275|endovascular grafts|endovascular grafts
590319|NCT01055262|Safety|safety
590320|NCT01055262|tolerability|tolerability
590321|NCT01055262|heatwrap|heatwrap
590322|NCT01055262|lower back|lower back
590323|NCT01055262|healthy subjects|healthy subjects
590324|NCT01055249|UVB|uvb
590325|NCT01055249|pain|pain
590326|NCT01055249|inflammation|inflammation
590327|NCT01055249|model|model
590328|NCT01055249|healthy volunteers|healthy volunteers
590329|NCT01055249|Ultraviolet radiation (UVR) induced pain and inflammation in healthy volunteers|ultraviolet radiation (uvr) induced pain and inflammation in healthy volunteers
590330|NCT01055236|sedation|sedation
590331|NCT01055223|thiazolidinediones|thiazolidinediones
590332|NCT01055223|rosiglitazone|rosiglitazone
590333|NCT01055223|amiloride|amiloride
590334|NCT01055223|pioglitazone|pioglitazone
590335|NCT01055223|fracture|fracture
590336|NCT01055223|Spironolactone|spironolactone
590337|NCT01055210|Heart Failure|heart failure
590338|NCT01055210|Pacemakers|pacemakers
590339|NCT01055197|extensive stage small cell lung cancer|extensive stage small cell lung cancer
590340|NCT01055184|Influenza|influenza
590341|NCT01055184|H1N1|h1n1
590342|NCT01055171|alcohol dependence|alcohol dependence
590343|NCT01055171|PTSD|ptsd
590344|NCT01055171|propanolol|propanolol
590345|NCT01055171|craving|craving
590346|NCT01055171|beta-block|beta-block
590347|NCT01055171|cue exposure|cue exposure
590348|NCT01055171|addiction|addiction
590349|NCT01055171|memory|memory
590350|NCT01055171|trauma|trauma
590351|NCT01055171|addictive behavior|addictive behavior
590352|NCT01055158|HIV|hiv
590353|NCT01055145|Multidrug-resistant TB, sensitive to levofloxacin and moxifloxacin|multidrug-resistant tb, sensitive to levofloxacin and moxifloxacin
590354|NCT01055106|bacterial vaginosis|bacterial vaginosis
590355|NCT01055106|vaginal infection|vaginal infection
590356|NCT01055106|vaginal discharge|vaginal discharge
590357|NCT01055106|vaginal disease|vaginal disease
590358|NCT01055093|diabetes mellitus|diabetes mellitus
590359|NCT01055093|prospective observational study|prospective observational study
590360|NCT01055093|diabetic complications|diabetic complications
590361|NCT01055080|type 1 diabetes|type 1 diabetes
590362|NCT01055080|beta-cell autoantibodies|beta-cell autoantibodies
590363|NCT01055080|cow's milk formula|cow's milk formula
590364|NCT01055080|bovine insulin|bovine insulin
590365|NCT01055054|bariatrics|bariatrics
590366|NCT01055015|total knee arthroplasty|total knee arthroplasty
590367|NCT01055002|Health male volunteers|health male volunteers
590368|NCT01055002|Male volunteers aged 18-45 years|male volunteers aged 18-45 years
590369|NCT01055002|Non-smokers and in good health|non-smokers and in good health
590370|NCT01054989|Healthy adults|healthy adults
590371|NCT01054989|Insulin sensitivity|insulin sensitivity
590372|NCT01054976|Alzheimer's disease|alzheimer's disease
590373|NCT01054976|Galantamine|galantamine
590374|NCT01054976|Dementia|dementia
590375|NCT01054963|early inflammatory arthritis|early inflammatory arthritis
590376|NCT01054963|chronic disease|chronic disease
590377|NCT01054963|peer support|peer support
590378|NCT01054963|peer mentor|peer mentor
590379|NCT01054963|peer counselling|peer counselling
590380|NCT01054937|4SC-203|4sc-203
590381|NCT01054937|Phase I|phase i
590382|NCT01054937|single dose|single dose
590383|NCT01054937|healthy volunteers|healthy volunteers
590384|NCT01054911|GIST|gist
590385|NCT01054911|gastrointestinal stromal tumor|gastrointestinal stromal tumor
590386|NCT01054911|gastrointestinal stomach tumor|gastrointestinal stomach tumor
590387|NCT01054911|Sunitinib|sunitinib
590388|NCT01054898|depression|depression
590389|NCT01054898|spouse abuse|spouse abuse
590390|NCT01054898|intervention studies|intervention studies
590391|NCT01054885|COPD|copd
590392|NCT01054885|Chronic Obstructive Pulmonary Disease|chronic obstructive pulmonary disease
590393|NCT01054885|Efficacy|efficacy
590394|NCT01054885|FEV1|fev1
590395|NCT01054885|Safety|safety
590396|NCT01054872|HIV Seronegativity|hiv seronegativity
590397|NCT01054872|HIV Preventive Vaccine|hiv preventive vaccine
590398|NCT01054846|Bicycle helmet|bicycle helmet
590399|NCT01054820|FLECTORÂ® Patch|flectorâ® patch
590400|NCT01054820|acute back strain|acute back strain
590401|NCT01054794|Gastroparesis|gastroparesis
590402|NCT01054794|Gastric Electrical Stimulation|gastric electrical stimulation
590403|NCT01054781|Diffuse Large B-Cell Lymphoma (DLBCL)|diffuse large b-cell lymphoma (dlbcl)
590404|NCT01054781|rituximab|rituximab
590405|NCT01054781|CHOP|chop
590406|NCT01054768|Antioxidant|antioxidant
590407|NCT01054768|Inflammation|inflammation
590408|NCT01054768|Sickle Cell Disease|sickle cell disease
590409|NCT01054768|Oxidative Stress|oxidative stress
590410|NCT01054768|Cytokines|cytokines
590411|NCT01054768|anti-inflammatory|anti-inflammatory
590412|NCT01054768|Acetylcarnitine|acetylcarnitine
590413|NCT01054729|Chronic Hepatitis C infection Genotype 1|chronic hepatitis c infection genotype 1
590414|NCT01054729|HCV|hcv
590415|NCT01054729|GT1|gt1
590416|NCT01054729|GT 1|gt 1
590417|NCT01054716|RhD negative|rhd negative
590418|NCT01054716|RhD disease|rhd disease
590419|NCT01054716|fetal nucleic acid|fetal nucleic acid
590420|NCT01054716|fetal DNA|fetal dna
590421|NCT01054716|cell free fetal DNA|cell free fetal dna
590422|NCT01054716|Fetal RHD genotype|fetal rhd genotype
590423|NCT01054690|Catheterization|catheterization
590424|NCT01054690|Urinary Tract Infection|urinary tract infection
590425|NCT01054690|Elective Surgery|elective surgery
590426|NCT01054677|Infections in nursing homes|infections in nursing homes
590427|NCT01054677|especially urinary tract infections|especially urinary tract infections
590428|NCT01054664|liver enzymes|liver enzymes
590429|NCT01054664|peripheral mononuclear blood cells|peripheral mononuclear blood cells
590430|NCT01054664|hemodialysis|hemodialysis
590431|NCT01054664|hepatitis C|hepatitis c
590433|NCT01054651|Schistosoma mansoni|schistosoma mansoni
590434|NCT01054651|Praziquantel|praziquantel
590435|NCT01054651|Artesunate + Sulfamethoxypyrazine/pyrimethamine|artesunate + sulfamethoxypyrazine/pyrimethamine
590436|NCT01054651|Randomized open-label controlled clinical trial|randomized open-label controlled clinical trial
590437|NCT01054638|amprenavir|amprenavir
590438|NCT01054638|fosamprenavir|fosamprenavir
590439|NCT01054638|HIV|hiv
590440|NCT01054638|HAART treatment|haart treatment
590441|NCT01054638|Epzicom|epzicom
590442|NCT01054638|Trizivir|trizivir
590443|NCT01054638|Combivir|combivir
590444|NCT01054638|zidovudine|zidovudine
590445|NCT01054638|lamivudine|lamivudine
590446|NCT01054638|cardiovascular disease|cardiovascular disease
590447|NCT01054638|HIV Infections|hiv infections
590448|NCT01054625|Squamous Cell Carcinoma of the Head and Neck|squamous cell carcinoma of the head and neck
590449|NCT01054625|Head and Neck Cancer|head and neck cancer
590450|NCT01054625|Head and Neck Neoplasms|head and neck neoplasms
590451|NCT01054625|anti-EGFr monoclonal antibody|anti-egfr monoclonal antibody
590452|NCT01054625|Zalutumumab|zalutumumab
590453|NCT01054612|Histology|histology
590454|NCT01054612|Immunohistochemical|immunohistochemical
590455|NCT01054612|Gene Expression|gene expression
590456|NCT01054612|Tissue Sectioning|tissue sectioning
590457|NCT01054599|epilepsy|epilepsy
590458|NCT01054599|memory|memory
590459|NCT01054599|memantine|memantine
590460|NCT01054599|localization related epilepsy|localization related epilepsy
590461|NCT01054599|focal epilepsy|focal epilepsy
590462|NCT01054586|antiretroviral therapy|antiretroviral therapy
590463|NCT01054586|hepatic impairment|hepatic impairment
590464|NCT01054586|HIV|hiv
590465|NCT01054573|Hepatitis C, Chronic|hepatitis c, chronic
590466|NCT01054573|Telaprevir|telaprevir
590467|NCT01054573|Roll-over study|roll-over study
590468|NCT01054560|Ischemic Stroke|ischemic stroke
590469|NCT01054560|SOLITAIRE™ Device|solitaire™ device
590470|NCT01054560|SOLITAIRE™|solitaire™
590471|NCT01054560|MERCI® Device|merci® device
590472|NCT01054560|MERCI®|merci®
590473|NCT01054560|Stroke|stroke
590474|NCT01054560|Ischemic|ischemic
590475|NCT01054560|Mechanical Thrombectomy|mechanical thrombectomy
590476|NCT01054560|Brain|brain
590477|NCT01054560|Brain Clot|brain clot
590478|NCT01054560|Brain Artery Revascularization|brain artery revascularization
590479|NCT01054560|Recanalization|recanalization
590480|NCT01054560|Brain Stroke|brain stroke
590481|NCT01054560|Clot Retriever|clot retriever
590482|NCT01054560|Device|device
590483|NCT01054560|Neurosurgery|neurosurgery
590484|NCT01054560|Neurovascular Intervention|neurovascular intervention
590485|NCT01054560|Interventional Neuroradiology|interventional neuroradiology
590486|NCT01054560|Brain study|brain study
590487|NCT01054560|neurovascular clinical trial|neurovascular clinical trial
590488|NCT01054547|topical anesthetic|topical anesthetic
590489|NCT01054547|liposomal ropivacaine|liposomal ropivacaine
590490|NCT01054547|dentistry|dentistry
590491|NCT01054534|urinary incontinence|urinary incontinence
590492|NCT01054521|radiofrequency turbinate reduction|radiofrequency turbinate reduction
590493|NCT01054521|nasal obstruction|nasal obstruction
590494|NCT01054521|Temperature-controlled radiofrequency|temperature-controlled radiofrequency
590495|NCT01054521|Bipolar radiofrequency|bipolar radiofrequency
590496|NCT01054521|chronic rhinitis.|chronic rhinitis.
590497|NCT01054495|Acupuncture|acupuncture
590498|NCT01054495|Sham acupuncture|sham acupuncture
590499|NCT01054495|Laser|laser
590500|NCT01054495|Methodology|methodology
590501|NCT01054495|Control intervention|control intervention
590502|NCT01054495|Pilot|pilot
711570|NCT00584012|Breast cancer|breast cancer
750396|NCT00439361|Mesna|mesna
590503|NCT01054495|Nausea and vomiting in early pregnancy|nausea and vomiting in early pregnancy
590504|NCT01054495|Patient's experience of different acu-stimulation|patient's experience of different acu-stimulation
590505|NCT01054495|Blinding in acupuncture research|blinding in acupuncture research
590506|NCT01054482|Neoadjuvant chemotherapy|neoadjuvant chemotherapy
590507|NCT01054482|neoadjuvant chemoradiotherapy|neoadjuvant chemoradiotherapy
590508|NCT01054469|nephrectomy|nephrectomy
590509|NCT01054456|LEC|lec
590510|NCT01054456|Low Emetogenic Chemotherapy|low emetogenic chemotherapy
590511|NCT01054456|Nausea and Vomiting|nausea and vomiting
590512|NCT01054456|Nausea|nausea
590513|NCT01054456|Vomiting|vomiting
590514|NCT01054456|Anti- emetic|anti- emetic
590515|NCT01054443|Blood Platelet Disorders|blood platelet disorders
590516|NCT01054443|Immune Thrombocytopenia (ITP)|immune thrombocytopenia (itp)
590517|NCT01054443|Low Platelet Count|low platelet count
590518|NCT01054443|Thrombocytopaenia|thrombocytopaenia
590519|NCT01054443|S-888711|s-888711
590520|NCT01054443|Splenectomy|splenectomy
590521|NCT01054443|Thrombopoiesis|thrombopoiesis
590522|NCT01054443|Hematologic Disease|hematologic disease
590523|NCT01054443|Auto-immune thrombocytopenic Purpura|auto-immune thrombocytopenic purpura
590524|NCT01054443|Relapsed Persistent or Chronic ITP|relapsed persistent or chronic itp
590525|NCT01054443|Idiopathic Thrombocytopenic Purpura|idiopathic thrombocytopenic purpura
590526|NCT01054443|Thrombotic Thrombocytopenic Purpura (TTP)|thrombotic thrombocytopenic purpura (ttp)
590527|NCT01054430|Avanafil|avanafil
590528|NCT01054430|Hepatic|hepatic
590529|NCT01054430|Erectile Dysfunction|erectile dysfunction
590530|NCT01054430|Impairment|impairment
590531|NCT01054417|Appendicitis|appendicitis
590532|NCT01054417|Laparoscopy|laparoscopy
590533|NCT01054417|Appendectomy|appendectomy
590534|NCT01054404|Brain Swelling|brain swelling
590535|NCT01054404|Brain Edema|brain edema
590536|NCT01054404|Dehydration|dehydration
590537|NCT01054352|Seasonal allergies|seasonal allergies
590538|NCT01054352|Allergic rhinitis|allergic rhinitis
590539|NCT01054339|Alpha-1 antitrypsin deficiency|alpha-1 antitrypsin deficiency
590540|NCT01054339|Adeno-associated virus vector|adeno-associated virus vector
590541|NCT01054339|AAV|aav
590542|NCT01054339|Gene therapy|gene therapy
590543|NCT01054339|Human gene transfer|human gene transfer
590544|NCT01054326|arthroscopic subacromial decompression|arthroscopic subacromial decompression
590545|NCT01054326|exercise|exercise
590546|NCT01054326|physical therapy|physical therapy
590547|NCT01054326|rotator cuff|rotator cuff
590548|NCT01054326|shoulder impingement syndrome|shoulder impingement syndrome
590549|NCT01054326|Subacromial impingement after arthroscopic subacromial decompression|subacromial impingement after arthroscopic subacromial decompression
590550|NCT01054313|Advanced Malignancies|advanced malignancies
590551|NCT01054313|Taxotere|taxotere
590552|NCT01054313|Docetaxel|docetaxel
590553|NCT01054313|Rapamycin|rapamycin
590554|NCT01054313|Sirolimus|sirolimus
590555|NCT01054313|Rapamune|rapamune
590556|NCT01054313|Prednisone|prednisone
590557|NCT01054313|Resistant to standard therapy|resistant to standard therapy
590558|NCT01054274|esophageal cancer|esophageal cancer
590559|NCT01054274|dysphagia|dysphagia
590560|NCT01054274|stent|stent
590561|NCT01054274|brachytherapy|brachytherapy
590562|NCT01054261|avanafil, renal, impairment, TA-1790|avanafil, renal, impairment, ta-1790
590563|NCT01054248|pregnancy, malaria, artemisinin, vivax, falciparum|pregnancy, malaria, artemisinin, vivax, falciparum
590564|NCT01054235|prenatal care|prenatal care
590565|NCT01054235|community-based randomized controlled trial|community-based randomized controlled trial
590566|NCT01054235|perinatal mortality|perinatal mortality
590567|NCT01054235|China|china
590568|NCT01054222|overactive bladder idiopathic|overactive bladder idiopathic
590569|NCT01054222|elderly fesoterodine SOFIA Portugal extension study|elderly fesoterodine sofia portugal extension study
590570|NCT01054209|Inadvertent Peri-operative Hypothermia|inadvertent peri-operative hypothermia
590571|NCT01054209|Shivering|shivering
590572|NCT01054209|Caesarean Section|caesarean section
590573|NCT01054209|Elective|elective
590574|NCT01054209|Warming Mattress|warming mattress
590575|NCT01054209|Regional Anaesthesia|regional anaesthesia
590576|NCT01054183|respiratory failure, intubation, GlideScope, pediatric|respiratory failure, intubation, glidescope, pediatric
590577|NCT01054170|Chronic|chronic
590578|NCT01054170|obstructive|obstructive
590579|NCT01054170|pulmonary|pulmonary
590580|NCT01054170|lung|lung
590581|NCT01054170|respiratory disease|respiratory disease
590582|NCT01054170|efficacy|efficacy
590583|NCT01054170|placebo-controlled|placebo-controlled
590584|NCT01054170|COPD|copd
590585|NCT01054170|FEV1|fev1
590586|NCT01054170|St Georges Respiratory Questionnaire|st georges respiratory questionnaire
590587|NCT01054170|Computed Tomography|computed tomography
590588|NCT01054170|MSCT|msct
590589|NCT01054144|Newly Diagnosed Standard Risk Multiple Myeloma|newly diagnosed standard risk multiple myeloma
590590|NCT01054144|Senior Adults|senior adults
590591|NCT01054131|peer support|peer support
590592|NCT01054131|peer mentor|peer mentor
750598|NCT00438854|CLL|cll
590593|NCT01054131|self-management|self-management
590594|NCT01054131|early inflammatory arthritis|early inflammatory arthritis
590595|NCT01054131|chronic disease|chronic disease
590596|NCT01054118|Type 2 Diabetes Mellitus|type 2 diabetes mellitus
590597|NCT01054105|Pulmonary hypertension|pulmonary hypertension
590598|NCT01054105|genes|genes
590599|NCT01054105|mutation|mutation
590600|NCT01054105|drug therapy|drug therapy
590601|NCT01054092|Blood glucose|blood glucose
590602|NCT01054092|ASP1941|asp1941
590603|NCT01054092|Food effect|food effect
590604|NCT01054092|Diabetes mellitus|diabetes mellitus
590605|NCT01054066|Chronic Kidney Disease|chronic kidney disease
590606|NCT01054066|Cardiovascular Disease|cardiovascular disease
590607|NCT01054066|Hypertension|hypertension
590608|NCT01054066|Anemia|anemia
590609|NCT01054053|Neisseria meningitidis B:14, P1-7, 16|neisseria meningitidis b:14, p1-7, 16
590610|NCT01054053|Serum bactericidal activity|serum bactericidal activity
590611|NCT01054053|Menbvac|menbvac
590612|NCT01054040|cardiovascular disease, portion plate|cardiovascular disease, portion plate
590613|NCT01054027|Retinopathy of Prematurity (ROP)|retinopathy of prematurity (rop)
590614|NCT01054027|Eye exams|eye exams
590615|NCT01054027|Premature infants|premature infants
590616|NCT01054027|cyclomydril|cyclomydril
590617|NCT01054014|CR016795|cr016795
590618|NCT01054001|prostate cancer|prostate cancer
590619|NCT01054001|prostatectomy|prostatectomy
590620|NCT01054001|erectile dysfunction|erectile dysfunction
590621|NCT01053988|Safety|safety
590622|NCT01053988|Chronic Obstructive Pulmonary Disease|chronic obstructive pulmonary disease
590623|NCT01053988|Efficacy|efficacy
590624|NCT01053988|FEV1|fev1
590625|NCT01053988|COPD|copd
590626|NCT01053975|RSR|rsr
590627|NCT01053975|SECG|secg
590628|NCT01053975|SPECT|spect
590629|NCT01053975|QCA|qca
590630|NCT01053975|SCAD|scad
590631|NCT01053962|Chronic Idiopathic Constipation|chronic idiopathic constipation
590632|NCT01053962|Constipation|constipation
590633|NCT01053962|Irritable Bowel Syndrome|irritable bowel syndrome
590634|NCT01053949|Multiple myeloma|multiple myeloma
590635|NCT01053949|dexamethasone|dexamethasone
590636|NCT01053949|pomalidomide|pomalidomide
590637|NCT01053949|response|response
590638|NCT01053949|safety|safety
590639|NCT01053936|Chronic Kidney Disease|chronic kidney disease
590640|NCT01053936|Type 2 diabetes|type 2 diabetes
590641|NCT01053936|Diabetic Nephropathy|diabetic nephropathy
590642|NCT01053923|Perianal Cancer|perianal cancer
590643|NCT01053923|Anal Cancer|anal cancer
590644|NCT01053923|MRI scan|mri scan
590645|NCT01053897|GBT009|gbt009
590646|NCT01053897|incisional scar|incisional scar
590647|NCT01053897|breast reconstruction|breast reconstruction
590648|NCT01053884|Invasive Candidiasis|invasive candidiasis
590649|NCT01053884|invasive fungal disease|invasive fungal disease
590650|NCT01053884|Anidulafungin|anidulafungin
590651|NCT01053871|normal|normal
590652|NCT01053858|bevacizumab,triamcinolone, intravitreal injection|bevacizumab,triamcinolone, intravitreal injection
590653|NCT01053845|Neuropathic pain|neuropathic pain
590654|NCT01053832|ventricular pace suppression|ventricular pace suppression
590655|NCT01053832|pacemaker|pacemaker
590656|NCT01053832|efficacy|efficacy
590657|NCT01053832|safety|safety
590658|NCT01053832|support of intrinsic heart rhythm|support of intrinsic heart rhythm
590659|NCT01053819|psoriasis|psoriasis
590660|NCT01053819|melanoma|melanoma
590661|NCT01053819|non-melanoma skin cancer|non-melanoma skin cancer
590662|NCT01053819|etanercept|etanercept
590663|NCT01053819|Enbrel|enbrel
590664|NCT01053806|MDS|mds
590665|NCT01053806|Lenalidomide|lenalidomide
590666|NCT01053806|5-Azacytidine.|5-azacytidine.
590667|NCT01053806|ORR|orr
590668|NCT01053806|PFS|pfs
590669|NCT01053806|myelodysplastic syndrome.High risk.|myelodysplastic syndrome.high risk.
590670|NCT01053793|Glycemic index|glycemic index
590671|NCT01053793|Anthocyanin|anthocyanin
590672|NCT01053793|Potato|potato
590673|NCT01053793|Polyphenol|polyphenol
590674|NCT01053780|Intercessory Prayer, pregnants|intercessory prayer, pregnants
590675|NCT01053767|Group B streptococcus|group b streptococcus
590676|NCT01053767|GBS|gbs
590677|NCT01053767|Vaccine|vaccine
590921|NCT01052779|Chronic kidney disease|chronic kidney disease
590678|NCT01053754|adrenocortical insufficiency|adrenocortical insufficiency
590679|NCT01053754|prolonged corticotherapy|prolonged corticotherapy
590680|NCT01053715|Hemophilia|hemophilia
590681|NCT01053715|Quality of Life|quality of life
590682|NCT01053689|Bioequivalence, Glimepiride, Crossover|bioequivalence, glimepiride, crossover
590683|NCT01053676|Hyperphosphatemia|hyperphosphatemia
590685|NCT01053676|Granule|granule
590686|NCT01053676|Healthy volunteers|healthy volunteers
590687|NCT01053650|Healthy volunteers|healthy volunteers
590688|NCT01053650|Open / hidden|open / hidden
590689|NCT01053650|Placebo effect|placebo effect
590690|NCT01053637|lacerations|lacerations
590691|NCT01053637|sutures|sutures
590692|NCT01053637|pediatrics|pediatrics
590693|NCT01053637|child|child
590694|NCT01053637|pain|pain
590695|NCT01053637|Anxiety|anxiety
590696|NCT01053624|Tracheostomy and thoracic surgery|tracheostomy and thoracic surgery
590697|NCT01053624|postoperative complications|postoperative complications
590698|NCT01053624|pulmonary surgical procedures|pulmonary surgical procedures
590699|NCT01053624|respiratory failure|respiratory failure
590700|NCT01053611|composite variability index|composite variability index
590701|NCT01053611|bispectral index|bispectral index
590702|NCT01053611|pain|pain
590703|NCT01053598|Mycobacterium tuberculosis|mycobacterium tuberculosis
590704|NCT01053598|Nitrate Reductase Assay|nitrate reductase assay
590705|NCT01053598|NRA|nra
590706|NCT01053598|REMA|rema
590707|NCT01053598|RETA|reta
590708|NCT01053598|Rezazurine|rezazurine
590709|NCT01053585|Gastro-esophageal junction, reflux, insertion angle, magnetic resonance imaging, manometry|gastro-esophageal junction, reflux, insertion angle, magnetic resonance imaging, manometry
590710|NCT01053572|Chronic low back pain|chronic low back pain
590711|NCT01053572|Post lumbar laminectomy syndrome|post lumbar laminectomy syndrome
590712|NCT01053572|Lower extremity pain|lower extremity pain
590713|NCT01053572|Local anesthetic|local anesthetic
590714|NCT01053572|Steroid|steroid
590715|NCT01053572|Percutaneous lumbar adhesiolysis|percutaneous lumbar adhesiolysis
590716|NCT01053559|Crohn's|crohn's
590717|NCT01053559|Inflammatory Bowel Disease|inflammatory bowel disease
590718|NCT01053533|Chinese herbal medicines|chinese herbal medicines
590719|NCT01053533|pandemic H1N1 influenza|pandemic h1n1 influenza
590720|NCT01053533|effectiveness|effectiveness
590721|NCT01053533|safety|safety
590722|NCT01053507|Headache|headache
590723|NCT01053507|Post-traumatic headache|post-traumatic headache
590724|NCT01053507|Brain injury|brain injury
590725|NCT01053507|Cognitive impairment|cognitive impairment
590726|NCT01053468|breast cancer|breast cancer
590727|NCT01053468|physical activity|physical activity
590728|NCT01053468|quality of life|quality of life
590729|NCT01053468|theory of planned behavior|theory of planned behavior
590730|NCT01053468|behavior change|behavior change
590731|NCT01053468|health promotion|health promotion
590732|NCT01053455|Non-invasive ventilation|non-invasive ventilation
590733|NCT01053455|SiPAP|sipap
590734|NCT01053455|CPAP|cpap
590735|NCT01053455|low birth weight infants|low birth weight infants
590736|NCT01053455|respiratory distress syndrome|respiratory distress syndrome
590737|NCT01053442|iron absorption|iron absorption
590738|NCT01053442|stable isotopes|stable isotopes
590739|NCT01053442|NaFeEDTA|nafeedta
590740|NCT01053442|Non-transferrin-bound iron (NTBI)|non-transferrin-bound iron (ntbi)
590741|NCT01053442|Hepcidin|hepcidin
590742|NCT01053429|Regulatory Post-Marketing Surveillance|regulatory post-marketing surveillance
590743|NCT01053429|Regulatory Pharmacovigilance|regulatory pharmacovigilance
590744|NCT01053429|ziprasidone|ziprasidone
590745|NCT01053416|glaucoma|glaucoma
590746|NCT01053416|pigmentary glaucoma|pigmentary glaucoma
590747|NCT01053416|laser iridotomy|laser iridotomy
590748|NCT01053403|MDMA|mdma
590749|NCT01053403|Ecstasy|ecstasy
590750|NCT01053403|MDMA effect on sleep|mdma effect on sleep
590751|NCT01053403|MDMA effect on water homeostasis|mdma effect on water homeostasis
590752|NCT01053403|MDMA effect on neurocognitive function|mdma effect on neurocognitive function
590753|NCT01053403|Recreational Drug Use|recreational drug use
590754|NCT01053403|Drug Abuse|drug abuse
590755|NCT01053390|gallbladder neoplasmas|gallbladder neoplasmas
590756|NCT01053390|Gallbladder Neoplasms,Advanced Stage,Chemotherapy,Somatostatin|gallbladder neoplasms,advanced stage,chemotherapy,somatostatin
590757|NCT01053377|Influenza|influenza
590758|NCT01053377|Tamiflu|tamiflu
590759|NCT01053377|Osteltamivir|osteltamivir
590760|NCT01053377|Transmission|transmission
590761|NCT01053377|Prevention|prevention
590762|NCT01053377|Resistance|resistance
590763|NCT01053377|Post-Exposure Profylaxe|post-exposure profylaxe
590764|NCT01053338|Bioequivalence,Ibuprofen Diphenhydramine Citrate,Crossover|bioequivalence,ibuprofen diphenhydramine citrate,crossover
590765|NCT01053325|Malaria|malaria
590766|NCT01053325|Pregnancy|pregnancy
590767|NCT01053325|Prevention|prevention
590769|NCT01053325|Sub-Sahara Africa|sub-sahara africa
590770|NCT01053312|Amyloid|amyloid
590771|NCT01053312|NPH Normal pressure hydrocephalus|nph normal pressure hydrocephalus
590772|NCT01053312|PET Positron Emission Tomography|pet positron emission tomography
590773|NCT01053312|SUVR Standard uptake value ratios|suvr standard uptake value ratios
590774|NCT01053299|Developmental dysplasia of the hip (DDH)|developmental dysplasia of the hip (ddh)
590775|NCT01053299|newborn|newborn
590776|NCT01053299|universal screening|universal screening
590777|NCT01053299|Universal ultrasound-screening for DDH in newborns|universal ultrasound-screening for ddh in newborns
590778|NCT01053299|The accuracy of ultrasound-recording of the hip in newborns|the accuracy of ultrasound-recording of the hip in newborns
590779|NCT01053286|Dysphagia|dysphagia
590780|NCT01053286|Globus|globus
590781|NCT01053286|Gastroesophageal reflux|gastroesophageal reflux
590782|NCT01053273|Low back pain|low back pain
590783|NCT01053273|Post lumbar laminectomy syndrome|post lumbar laminectomy syndrome
590784|NCT01053273|Lumbar spinal stenosis|lumbar spinal stenosis
711571|NCT00584012|Lovastatin|lovastatin
590785|NCT01053273|Local anesthetic steroid|local anesthetic steroid
590786|NCT01053273|Lumbar transforaminal epidural injection|lumbar transforaminal epidural injection
590787|NCT01053273|Percutaneous epidural adhesiolysis|percutaneous epidural adhesiolysis
590788|NCT01053273|Caudal epidural injection|caudal epidural injection
590789|NCT01053260|Contingency Management|contingency management
590790|NCT01053260|Weight Loss|weight loss
590791|NCT01053247|Atopic Dermatitis|atopic dermatitis
590792|NCT01053234|Hyperglycaemia|hyperglycaemia
590793|NCT01053234|Postprandial|postprandial
590794|NCT01053234|Type 2 diabetes|type 2 diabetes
590795|NCT01053234|Cardiovascular risk markers|cardiovascular risk markers
590796|NCT01053221|mycophenolate|mycophenolate
590797|NCT01053221|living donor|living donor
590798|NCT01053208|Bioequivalence,Ibuprofen Diphenhydramine Citrate,Crossover|bioequivalence,ibuprofen diphenhydramine citrate,crossover
590799|NCT01053195|Diabetes|diabetes
590800|NCT01053195|prevention|prevention
590801|NCT01053195|intervention|intervention
590802|NCT01053182|esophageal cancer|esophageal cancer
590803|NCT01053182|postoperative complications|postoperative complications
590804|NCT01053182|diaphragm|diaphragm
590805|NCT01053182|pulmonary function|pulmonary function
590806|NCT01053169|Coagulopathy|coagulopathy
590807|NCT01053169|Perioperative bleeding|perioperative bleeding
590808|NCT01053169|Prothrombin complex|prothrombin complex
590809|NCT01053169|Liver disease|liver disease
590810|NCT01053156|Fragile X syndrome|fragile x syndrome
590811|NCT01053156|minocycline|minocycline
590812|NCT01053156|targeted treatment|targeted treatment
590813|NCT01053143|Influenza|influenza
590814|NCT01053143|Pandemic Influenza|pandemic influenza
590815|NCT01053143|Swine-Origin Influenza A/H1N1 Non-adjuvanted Vaccine|swine-origin influenza a/h1n1 non-adjuvanted vaccine
590816|NCT01053143|Influenza A Virus, H1N1 subtype|influenza a virus, h1n1 subtype
590818|NCT01053130|obesity|obesity
590819|NCT01053130|bariatric surgery|bariatric surgery
590820|NCT01053130|chronic kidney disease|chronic kidney disease
590821|NCT01053130|weight loss|weight loss
590822|NCT01053130|exercise|exercise
590823|NCT01053117|central venous catheter|central venous catheter
590824|NCT01053117|arteriovenous fistula|arteriovenous fistula
590825|NCT01053117|hemodialysis|hemodialysis
590826|NCT01053117|vascular access|vascular access
590827|NCT01053117|dialysis|dialysis
590828|NCT01053104|Colorectal cancer|colorectal cancer
590829|NCT01053104|Breast cancer|breast cancer
590830|NCT01053104|Capecitabine|capecitabine
590831|NCT01053104|Docetaxel|docetaxel
590832|NCT01053104|Mobile phone|mobile phone
590833|NCT01053104|Toxicity|toxicity
590834|NCT01053104|Metastatic|metastatic
590835|NCT01053091|exercise-base rehabilitation|exercise-base rehabilitation
590836|NCT01053091|diastolic heart failure|diastolic heart failure
590837|NCT01053091|cardiovascular function|cardiovascular function
590838|NCT01053091|aerobic fitness|aerobic fitness
590839|NCT01053078|Type 1 diabetes|type 1 diabetes
590840|NCT01053078|Hypoglycemia unawareness|hypoglycemia unawareness
590841|NCT01053078|low blood sugar|low blood sugar
590842|NCT01053065|Atherosclerosis|atherosclerosis
590843|NCT01053065|Macrophages|macrophages
590844|NCT01053065|Carotid arteries|carotid arteries
590845|NCT01053065|Statin|statin
590846|NCT01053052|Patency Tests, Fallopian Tubes|patency tests, fallopian tubes
590847|NCT01053052|Hysterosalpingography|hysterosalpingography
590848|NCT01053052|Sonography, Medical|sonography, medical
590849|NCT01053026|Angiotensin receptor II antagonist|angiotensin receptor ii antagonist
590850|NCT01053013|macrobead|macrobead
590851|NCT01053013|biological|biological
590852|NCT01053013|mouse cells|mouse cells
590853|NCT01053000|ACTINIC KERATOSES|actinic keratoses
590854|NCT01053000|HAND|hand
590855|NCT01053000|FOREARM|forearm
590856|NCT01052987|Gout|gout
590857|NCT01052987|Hyperuricemia|hyperuricemia
590858|NCT01052974|femoral neck fracture|femoral neck fracture
590859|NCT01052974|analgesia|analgesia
590860|NCT01052961|severe influenza|severe influenza
590861|NCT01052961|hospitalized adults|hospitalized adults
590862|NCT01052961|oseltamivir treatment|oseltamivir treatment
590863|NCT01052948|dopamine agonists|dopamine agonists
590864|NCT01052948|cabergoline|cabergoline
590865|NCT01052948|Parkinson's disease|parkinson's disease
590866|NCT01052948|hyperprolactinemia|hyperprolactinemia
590867|NCT01052948|epidemiology|epidemiology
590868|NCT01052948|cardiac valvulopathy|cardiac valvulopathy
590869|NCT01052935|Group B streptococcus|group b streptococcus
590870|NCT01052935|GBS|gbs
590871|NCT01052935|Vaccine|vaccine
590872|NCT01052922|Colorectal Neoplasms|colorectal neoplasms
590873|NCT01052922|Mass Screening|mass screening
590874|NCT01052922|Population Surveillance|population surveillance
590875|NCT01052922|Randomized controlled trial|randomized controlled trial
590876|NCT01052922|Occult Blood|occult blood
590877|NCT01052922|Colonoscopy|colonoscopy
590878|NCT01052922|Sigmoidoscopy|sigmoidoscopy
590879|NCT01052922|Health Behavior|health behavior
590880|NCT01052909|Bioequivalence, Glimepiride, Crossover|bioequivalence, glimepiride, crossover
590881|NCT01052896|Dyspepsia|dyspepsia
590882|NCT01052896|Functional|functional
590883|NCT01052883|TMC114-TiDP3-C182|tmc114-tidp3-c182
590884|NCT01052883|TMC114-C182|tmc114-c182
590885|NCT01052883|TMC114|tmc114
590886|NCT01052883|HIV|hiv
590887|NCT01052883|HIV Infections|hiv infections
590888|NCT01052870|pharmacogenomics, androgen receptor gene, androgen sensitivity, CAG repeats, androgenetic alopecia|pharmacogenomics, androgen receptor gene, androgen sensitivity, cag repeats, androgenetic alopecia
590889|NCT01052870|Pharmacogenomics in treatment for androgenetic alopecia in women|pharmacogenomics in treatment for androgenetic alopecia in women
590890|NCT01052857|to evaluate acupuncture as possible alternative treatment for induction of labor|to evaluate acupuncture as possible alternative treatment for induction of labor
590891|NCT01052857|Induction|induction
590892|NCT01052857|treatment|treatment
590893|NCT01052857|posterm|posterm
590894|NCT01052844|Vomiting|vomiting
590895|NCT01052844|Antiemetics|antiemetics
590896|NCT01052844|Dexamethasone|dexamethasone
590897|NCT01052844|Cisplatin|cisplatin
590898|NCT01052844|Antineoplastic combined chemotherapy protocols|antineoplastic combined chemotherapy protocols
590899|NCT01052831|Compulsive Gambling|compulsive gambling
590900|NCT01052831|Compulsive Buying|compulsive buying
590901|NCT01052831|Compulsive Shopping|compulsive shopping
590902|NCT01052831|Compulsive Eating|compulsive eating
590903|NCT01052831|Hypersexuality|hypersexuality
590904|NCT01052831|Dopamine Agonists|dopamine agonists
590905|NCT01052831|Mirapex|mirapex
590906|NCT01052831|Pramipexole|pramipexole
590907|NCT01052831|Requip|requip
590908|NCT01052831|Ropinirole|ropinirole
590909|NCT01052831|Impulse Control Disorders|impulse control disorders
590910|NCT01052818|Non small-cell lung cancer|non small-cell lung cancer
590911|NCT01052818|Circulating tumor cells|circulating tumor cells
590912|NCT01052818|Carcinoembryonic antigen|carcinoembryonic antigen
590913|NCT01052818|Cytokeratin|cytokeratin
590914|NCT01052805|nerve|nerve
590915|NCT01052805|myelinated nerve|myelinated nerve
590916|NCT01052805|unmyelinated nerve|unmyelinated nerve
590917|NCT01052792|Bioequivalence|bioequivalence
590918|NCT01052792|Naproxen|naproxen
590919|NCT01052792|crossover|crossover
590920|NCT01052779|Iron deficiency anemia|iron deficiency anemia
590922|NCT01052779|Feraheme|feraheme
590923|NCT01052779|Ferumoxytol|ferumoxytol
590924|NCT01052779|Iron sucrose|iron sucrose
590925|NCT01052779|IDA|ida
590926|NCT01052779|CKD|ckd
590927|NCT01052779|Venofer|venofer
590928|NCT01052766|lung cancer|lung cancer
590929|NCT01052766|PET Scan|pet scan
590930|NCT01052766|CT Scan|ct scan
590931|NCT01052766|BH-PET scan|bh-pet scan
590932|NCT01052766|09-134|09-134
590933|NCT01052753|Attention-deficit/hyperactivity disorder|attention-deficit/hyperactivity disorder
590934|NCT01052753|executive function|executive function
590935|NCT01052753|endophenotype|endophenotype
590936|NCT01052753|dopaminergic system|dopaminergic system
590937|NCT01052753|noradrenergic system|noradrenergic system
590938|NCT01052753|candidate gene|candidate gene
590939|NCT01052753|Family-based association study|family-based association study
590940|NCT01052740|Breast Cancer|breast cancer
590941|NCT01052740|Mammography|mammography
590942|NCT01052740|Screening|screening
590943|NCT01052727|Laparoscopic Cholecystectomy|laparoscopic cholecystectomy
590944|NCT01052727|quality of life|quality of life
590945|NCT01052714|Antipsychotic|antipsychotic
590946|NCT01052714|Bipolar|bipolar
590947|NCT01052714|Diabetes|diabetes
590948|NCT01052714|Mental Illness|mental illness
590949|NCT01052714|Nutrition|nutrition
590950|NCT01052714|Obesity|obesity
590951|NCT01052714|Schizoaffective|schizoaffective
590952|NCT01052714|Schizophrenia|schizophrenia
590953|NCT01052714|Weight Gain|weight gain
590954|NCT01052714|Weight Loss|weight loss
590955|NCT01052688|Down syndrome, aneuploidy, amniocentesis, chorionic villus sampling, Trisomy|down syndrome, aneuploidy, amniocentesis, chorionic villus sampling, trisomy
590956|NCT01052675|Drug and substance problematic use, abuse or dependence|drug and substance problematic use, abuse or dependence
590957|NCT01052662|Drug Abuse|drug abuse
590958|NCT01052649|MNC subpopulations|mnc subpopulations
590959|NCT01052649|Gene Expression|gene expression
590960|NCT01052649|Metabolomics|metabolomics
590961|NCT01052649|Immunological Status|immunological status
590962|NCT01052636|Hip fracture|hip fracture
590963|NCT01052636|Intervention program|intervention program
590964|NCT01052636|Elderly|elderly
590965|NCT01052623|GH/IGF-1|gh/igf-1
590966|NCT01052623|Ataxia telangiectasia (AT)|ataxia telangiectasia (at)
590967|NCT01052623|IGF-1 Generation Test|igf-1 generation test
590968|NCT01052623|Growth hormone|growth hormone
590969|NCT01052610|SLIT|slit
590970|NCT01052610|bronchial asthma|bronchial asthma
590971|NCT01052610|allergic rhinitis|allergic rhinitis
590972|NCT01052597|Type 2 diabetes|type 2 diabetes
590973|NCT01052597|Metabolic syndrome|metabolic syndrome
590974|NCT01052597|cardiovascular risk|cardiovascular risk
590975|NCT01052584|malaria|malaria
590976|NCT01052584|therapeutic efficacy|therapeutic efficacy
590977|NCT01052584|in vivo|in vivo
590978|NCT01052584|artemether lumefantrine|artemether lumefantrine
590979|NCT01052584|coartem|coartem
590980|NCT01052584|chloroquine|chloroquine
590981|NCT01052584|Plasmodium falciparum|plasmodium falciparum
590982|NCT01052584|Plasmodium vivax|plasmodium vivax
590983|NCT01052571|Chronic low back pain|chronic low back pain
590984|NCT01052571|Lumbar disc herniation|lumbar disc herniation
590985|NCT01052571|Lower extremity pain|lower extremity pain
590986|NCT01052571|Lumbar radiculitis|lumbar radiculitis
590987|NCT01052571|Local anesthetic|local anesthetic
590988|NCT01052571|Steroid|steroid
590989|NCT01052571|Lumbar transforaminal epidural injection|lumbar transforaminal epidural injection
590990|NCT01052558|Open angle|open angle
590991|NCT01052558|Glaucoma|glaucoma
590992|NCT01052558|Cataract|cataract
590993|NCT01052558|Surgery|surgery
590994|NCT01052558|Intraocular Pressure|intraocular pressure
590995|NCT01052545|urinary tract infection|urinary tract infection
590996|NCT01052545|urinary catheter|urinary catheter
590997|NCT01052545|bacteriuria|bacteriuria
590998|NCT01052545|clinical guidelines|clinical guidelines
590999|NCT01052545|audit-feedback|audit-feedback
591000|NCT01052545|guidelines implementation|guidelines implementation
591001|NCT01052532|Mitral Regurgitation|mitral regurgitation
591002|NCT01052532|LV remodeling|lv remodeling
591003|NCT01052532|Reactive nitrogen species|reactive nitrogen species
591004|NCT01052532|Cardiac MRI|cardiac mri
591595|NCT01050101|Satiety|satiety
591005|NCT01052532|Adrenergic overdrive|adrenergic overdrive
591006|NCT01052519|Obesity|obesity
591007|NCT01052519|Esophageal Doppler monitoring|esophageal doppler monitoring
591008|NCT01052519|tissue oxygen tension|tissue oxygen tension
591009|NCT01052506|Human volunteers|human volunteers
591010|NCT01052493|obesity|obesity
591011|NCT01052493|pancreatic polypeptide|pancreatic polypeptide
591012|NCT01052493|gut hormones|gut hormones
591013|NCT01052480|Antiviral|antiviral
591014|NCT01052480|Anti-Influenza Immune Plasma|anti-influenza immune plasma
591015|NCT01052480|Emerging Infectious Disease|emerging infectious disease
591016|NCT01052480|Swine Flu|swine flu
591017|NCT01052454|hot flashes|hot flashes
591018|NCT01052454|mindfulness|mindfulness
591019|NCT01052454|stress|stress
591020|NCT01052441|CCTA|ccta
591021|NCT01052441|Coronary Artery Stenosis|coronary artery stenosis
591022|NCT01052441|Iodinated Contrast|iodinated contrast
591023|NCT01052441|Invasive Coronary Angiography|invasive coronary angiography
591024|NCT01052428|Chronic MR|chronic mr
591025|NCT01052428|Volume Overload|volume overload
591026|NCT01052428|Beta-1 receptor blocker|beta-1 receptor blocker
591027|NCT01052428|LV remodelling, LV dimensions|lv remodelling, lv dimensions
591028|NCT01052428|LV systolic function|lv systolic function
591029|NCT01052428|LV diastolic dysfunction|lv diastolic dysfunction
591030|NCT01052428|Cardiac MRI|cardiac mri
591032|NCT01052415|Stigma|stigma
591033|NCT01052415|POL|pol
591034|NCT01052415|Service providers|service providers
591035|NCT01052415|China|china
591036|NCT01052415|Universal precaution|universal precaution
591037|NCT01052389|Schizophrenia|schizophrenia
591038|NCT01052389|Pragmatic RCT|pragmatic rct
591039|NCT01052389|Aripiprazole|aripiprazole
591040|NCT01052389|Olanzapine|olanzapine
591041|NCT01052389|Haloperidol|haloperidol
591042|NCT01052389|Metabolic syndrome|metabolic syndrome
591043|NCT01052389|Drug discontinuation|drug discontinuation
591044|NCT01052376|nflammatory bowel diseases (IBD)|nflammatory bowel diseases (ibd)
591045|NCT01052376|Familial adenomatous polyposis (FAP)|familial adenomatous polyposis (fap)
591046|NCT01052363|CNS tumors|cns tumors
591047|NCT01052350|Parkinson disease|parkinson disease
591048|NCT01052350|PET imaging|pet imaging
591049|NCT01052350|PIB|pib
591050|NCT01052350|dementia|dementia
591051|NCT01052311|Coronary artery disease|coronary artery disease
591052|NCT01052311|Endothelial function|endothelial function
591053|NCT01052311|Platelet function|platelet function
591054|NCT01052311|Statins|statins
591055|NCT01052311|Niacin|niacin
591056|NCT01052298|Ciprofloxacin|ciprofloxacin
591057|NCT01052298|Inhalation|inhalation
591058|NCT01052298|Pharmacokinetics|pharmacokinetics
591059|NCT01052298|Safety|safety
591060|NCT01052298|Tolerability|tolerability
591061|NCT01052298|COPD|copd
591062|NCT01052285|Transversus abdominis plane block|transversus abdominis plane block
591063|NCT01052272|Diabetes|diabetes
591064|NCT01052272|Acute MI|acute mi
591065|NCT01052272|Ang II type-1 receptor blockade (AT1RB)|ang ii type-1 receptor blockade (at1rb)
591066|NCT01052272|LV remodeling|lv remodeling
591067|NCT01052272|ACE inhibitor therapy|ace inhibitor therapy
591068|NCT01052272|XO inhibitor, Allopurinol|xo inhibitor, allopurinol
591069|NCT01052272|Systolic dysfunction|systolic dysfunction
591070|NCT01052272|Diastolic dysfunction|diastolic dysfunction
591071|NCT01052272|LV dimensions|lv dimensions
591072|NCT01052272|Cardiac MRI|cardiac mri
591073|NCT01052259|Chronic rejection|chronic rejection
591074|NCT01052259|Kidney|kidney
591075|NCT01052259|Transplantation|transplantation
591076|NCT01052259|Immunosuppressive|immunosuppressive
591077|NCT01052246|acne vulgaris|acne vulgaris
591078|NCT01052246|laser surgery|laser surgery
591079|NCT01052246|pulsed dye lasers|pulsed dye lasers
591080|NCT01052246|benzoyl peroxidase|benzoyl peroxidase
591081|NCT01052246|clindamycin|clindamycin
591082|NCT01052246|randomized controlled trial|randomized controlled trial
591083|NCT01052233|Sham-surgery|sham-surgery
591084|NCT01052233|Development of osteoarthritis|development of osteoarthritis
591085|NCT01052233|Randomized, double-blinded, placebo-controlled|randomized, double-blinded, placebo-controlled
591086|NCT01052220|Hypertension|hypertension
591087|NCT01052220|Blood Pressure|blood pressure
591088|NCT01052220|End Stage Renal Disease|end stage renal disease
591089|NCT01052220|Hemodialysis|hemodialysis
591090|NCT01052220|Interdialytic Weight Gain|interdialytic weight gain
591091|NCT01052220|Self-Regulation|self-regulation
591092|NCT01052207|Biological Response Modifiers|biological response modifiers
591093|NCT01052207|Endocrinology|endocrinology
591094|NCT01052207|Hormone Dysfunction|hormone dysfunction
591095|NCT01052207|Hormones|hormones
591096|NCT01052207|Neuroendocrinology|neuroendocrinology
591097|NCT01052194|Rheumatoid Arthritis|rheumatoid arthritis
591098|NCT01052181|Vitamin D|vitamin d
591099|NCT01052181|Insulin sensitivity|insulin sensitivity
591100|NCT01052181|Centrally obese|centrally obese
591101|NCT01052168|simulation|simulation
591102|NCT01052168|simulators|simulators
591103|NCT01052168|motion metrics|motion metrics
591104|NCT01052168|performance metrics|performance metrics
591105|NCT01052168|skills training|skills training
591106|NCT01052168|proficiency|proficiency
591107|NCT01052168|laparoscopic|laparoscopic
591108|NCT01052155|Controlled substances|controlled substances
591109|NCT01052155|Opioids|opioids
591110|NCT01052155|Benzodiazepines|benzodiazepines
591111|NCT01052155|Illicit drugs|illicit drugs
591112|NCT01052155|Immunoassay drug testing|immunoassay drug testing
591113|NCT01052155|Point of care (POC) testing|point of care (poc) testing
591114|NCT01052155|Liquid Chromatography Tandem Mass Spectometry|liquid chromatography tandem mass spectometry
591115|NCT01052142|Melanoma|melanoma
591116|NCT01052142|Cancer vaccines|cancer vaccines
591117|NCT01052129|Bioequivalence|bioequivalence
591118|NCT01052129|Naproxen|naproxen
591119|NCT01052129|crossover|crossover
591120|NCT01052116|Asthma|asthma
591122|NCT01052116|Supplement|supplement
591123|NCT01052116|ACRC|acrc
591124|NCT01052116|SOYA|soya
591125|NCT01052090|HCV|hcv
591126|NCT01052077|OPC-34712|opc-34712
591127|NCT01052077|Major Depressive Disorder|major depressive disorder
591128|NCT01052077|Adjunctive Treatment|adjunctive treatment
591129|NCT01052064|Children|children
591130|NCT01052064|ADHD|adhd
591131|NCT01052064|rTMS|rtms
591132|NCT01052064|Safety|safety
591133|NCT01052038|Sore throat|sore throat
591134|NCT01052038|Dexamethasone|dexamethasone
591135|NCT01052038|Pain|pain
591136|NCT01052012|Postoperative pain|postoperative pain
591137|NCT01052012|Post-operative pain|post-operative pain
591138|NCT01052012|Opioid|opioid
591139|NCT01052012|Laparoscopic surgery|laparoscopic surgery
591140|NCT01052012|Bupivacaine|bupivacaine
591141|NCT01052012|Local anesthetic|local anesthetic
591142|NCT01051999|Glutamine|glutamine
591143|NCT01051986|coronary artery bypass|coronary artery bypass
591144|NCT01051986|off-pump surgery|off-pump surgery
591145|NCT01051986|composite graft|composite graft
591146|NCT01051986|saphenous vein|saphenous vein
591147|NCT01051986|internal thoracic artery|internal thoracic artery
591148|NCT01051973|Cognitive behavior therapy|cognitive behavior therapy
591149|NCT01051973|exposure|exposure
591150|NCT01051973|stress management|stress management
591151|NCT01051960|Systemic Sclerosis|systemic sclerosis
591152|NCT01051960|connective tissue disease|connective tissue disease
591153|NCT01051960|Shortness of breath|shortness of breath
591154|NCT01051960|Pulmonary Hypertension|pulmonary hypertension
591155|NCT01051947|Nebivolol|nebivolol
591156|NCT01051947|Metoprolol|metoprolol
591157|NCT01051947|central aortic pressure|central aortic pressure
591158|NCT01051947|hypertension|hypertension
591159|NCT01051934|Recombinant Immunotoxin|recombinant immunotoxin
591160|NCT01051934|Monoclonal Antibody|monoclonal antibody
591161|NCT01051934|Pseudomonas Exotoxin|pseudomonas exotoxin
591162|NCT01051934|Targeted Therapy|targeted therapy
591163|NCT01051934|Lung Cancer|lung cancer
591164|NCT01051934|Non-Small Cell Lung Cancer|non-small cell lung cancer
591165|NCT01051921|HCV|hcv
591166|NCT01051921|Null Responder|null responder
591167|NCT01051895|Cervical intra-epithelial neoplasia|cervical intra-epithelial neoplasia
591168|NCT01051895|Colposcopy|colposcopy
591169|NCT01051895|HPV DNA testing|hpv dna testing
591170|NCT01051895|treatment failure|treatment failure
591171|NCT01051882|Mesenchymal Stromal Cells (MSC)|mesenchymal stromal cells (msc)
591172|NCT01051882|Amyotrophic Lateral Sclerosis (ALS)|amyotrophic lateral sclerosis (als)
591173|NCT01051882|Neuroprotection|neuroprotection
591174|NCT01051882|Neurodegeneration|neurodegeneration
591175|NCT01051882|Stem cells|stem cells
591176|NCT01051882|ALS|als
591177|NCT01051869|distal humerus|distal humerus
591178|NCT01051869|fractures|fractures
591179|NCT01051869|ulnar nerve|ulnar nerve
591180|NCT01051869|simple decompression|simple decompression
711572|NCT00584012|Docetaxel|docetaxel
591181|NCT01051869|anterior transposition|anterior transposition
591182|NCT01051843|Maternal Breastfeeding|maternal breastfeeding
591183|NCT01051843|Orofacial Difficulties|orofacial difficulties
591184|NCT01051843|Rooming-in|rooming-in
591185|NCT01051843|Speech and Language Therapy|speech and language therapy
591186|NCT01051817|relapsing-remitting multiple sclerosis|relapsing-remitting multiple sclerosis
591187|NCT01051817|RRMS|rrms
591188|NCT01051804|Dry eye|dry eye
591189|NCT01051804|Visual Performance|visual performance
591190|NCT01051791|RAD001|rad001
591191|NCT01051791|Everolimus|everolimus
591192|NCT01051778|Recurrent abortion|recurrent abortion
591193|NCT01051778|Antiphospholipid syndrome|antiphospholipid syndrome
591194|NCT01051778|unfractionated heparin|unfractionated heparin
591195|NCT01051778|Low Molecular Weight Heparin|low molecular weight heparin
591196|NCT01051752|Nontuberculous mycobacterial diseases|nontuberculous mycobacterial diseases
591197|NCT01051752|pharmacokinetics|pharmacokinetics
591198|NCT01051752|pharmacodynamics|pharmacodynamics
591199|NCT01051739|vision testing|vision testing
591200|NCT01051739|perimetry|perimetry
591201|NCT01051739|glaucoma|glaucoma
591202|NCT01051739|test variability|test variability
591203|NCT01051726|aromatherapy|aromatherapy
591204|NCT01051726|childbirth|childbirth
591205|NCT01051726|Obstetrics|obstetrics
591206|NCT01051726|Labour|labour
591207|NCT01051726|Complementary Medicine|complementary medicine
591208|NCT01051726|delivery, obstetric|delivery, obstetric
591209|NCT01051713|obesity|obesity
591210|NCT01051713|behavioraladherence|behavioraladherence
591211|NCT01051713|weight loss|weight loss
591212|NCT01051713|smartphone|smartphone
591213|NCT01051700|repeat-dose|repeat-dose
591214|NCT01051700|pharmacokinetics|pharmacokinetics
591215|NCT01051700|choroidal neovascularization|choroidal neovascularization
591216|NCT01051700|safety|safety
591217|NCT01051700|GW786034|gw786034
591218|NCT01051700|tolerability|tolerability
591219|NCT01051700|age-related macular degeneration|age-related macular degeneration
591220|NCT01051700|stem cell growth factor|stem cell growth factor
591221|NCT01051700|pazopanib|pazopanib
591222|NCT01051700|platelet derived growth factor|platelet derived growth factor
591223|NCT01051700|vascular endothelial growth factor|vascular endothelial growth factor
591224|NCT01051687|vitiligo|vitiligo
591225|NCT01051674|Obesity|obesity
591226|NCT01051674|Type 2 diabetes|type 2 diabetes
591227|NCT01051674|Fiber|fiber
591228|NCT01051674|Dietary fiber|dietary fiber
591229|NCT01051674|Low-carbohydrate diet|low-carbohydrate diet
591230|NCT01051674|High protein diet|high protein diet
591231|NCT01051661|Influenza|influenza
591232|NCT01051661|H1N1|h1n1
591233|NCT01051661|Pandemic|pandemic
591234|NCT01051648|Triamcinolone acetenoide|triamcinolone acetenoide
591235|NCT01051648|anterior vitrectomy|anterior vitrectomy
591236|NCT01051648|presence of vitreous in the anterior chamber.|presence of vitreous in the anterior chamber.
591237|NCT01051648|effect of triamcinolone injection on IOP,intraocular infection|effect of triamcinolone injection on iop,intraocular infection
591238|NCT01051635|DNA Repair|dna repair
591239|NCT01051635|DNA Damage|dna damage
591240|NCT01051635|Advanced Cancer|advanced cancer
591241|NCT01051635|Advanced Malignancies|advanced malignancies
591242|NCT01051635|Topoisomerase Inhibitor|topoisomerase inhibitor
591243|NCT01051622|PBMC (Peripheral Blood Mononuclear Cells)|pbmc (peripheral blood mononuclear cells)
591244|NCT01051622|Crohn's Disease|crohn's disease
591245|NCT01051622|SPECT (Single Photon Emission Computerized Tomography)|spect (single photon emission computerized tomography)
591246|NCT01051609|Post Menopausal|post menopausal
591247|NCT01051609|Breast Cancer|breast cancer
591248|NCT01051596|metastatic|metastatic
591249|NCT01051596|colorectal cancer|colorectal cancer
591250|NCT01051583|Neovascular glaucoma|neovascular glaucoma
591251|NCT01051583|diode laser|diode laser
591252|NCT01051583|cyclophotocoagulation|cyclophotocoagulation
591253|NCT01051583|Avastin|avastin
591254|NCT01051570|hormone-resistant prostate cancer|hormone-resistant prostate cancer
591255|NCT01051570|recurrent prostate cancer|recurrent prostate cancer
591256|NCT01051570|stage IV prostate cancer|stage iv prostate cancer
591257|NCT01051570|adenocarcinoma of the prostate|adenocarcinoma of the prostate
591258|NCT01051544|ITI|iti
591259|NCT01051544|HAEMOPHILIA A|haemophilia a
591260|NCT01051544|INHIBITORS|inhibitors
591261|NCT01051544|VWF/FVIII Concentrates|vwf/fviii concentrates
591262|NCT01051531|Schizophrenia|schizophrenia
591263|NCT01051531|R092670|r092670
591264|NCT01051531|Paliperidone palmitate|paliperidone palmitate
591265|NCT01051531|Diagnostic and Statistical Manual of Mental Disorders, 4th Edition|diagnostic and statistical manual of mental disorders, 4th edition
591266|NCT01051531|Intramuscular injection|intramuscular injection
591267|NCT01051505|Phase I|phase i
591268|NCT01051505|multiple ascending dose|multiple ascending dose
591269|NCT01051505|Safety|safety
591270|NCT01051505|Tolerability|tolerability
591271|NCT01051505|Healthy Volunteer|healthy volunteer
591272|NCT01051479|PET Positron emission tomography|pet positron emission tomography
591273|NCT01051479|CT X-ray computed tomography|ct x-ray computed tomography
711678|NCT00583557|RA|ra
711679|NCT00583544|Healthy|healthy
591274|NCT01051479|Patients with Locally Advanced Esophageal Cancer|patients with locally advanced esophageal cancer
591275|NCT01051440|lisdexamfetamine|lisdexamfetamine
591276|NCT01051440|vyvanse|vyvanse
591277|NCT01051440|bipolar disorder|bipolar disorder
591278|NCT01051440|depression|depression
591279|NCT01051440|stimulant|stimulant
591280|NCT01051440|magnetic resonance spectroscopy|magnetic resonance spectroscopy
591281|NCT01051440|functional magnetic resonance imaging|functional magnetic resonance imaging
591282|NCT01051440|neuropsychological testing|neuropsychological testing
591283|NCT01051427|Nasal packing|nasal packing
591284|NCT01051427|Haemostatic matrix|haemostatic matrix
591285|NCT01051427|Epistaxis control|epistaxis control
591286|NCT01051388|The efficacy of PPI|the efficacy of ppi
591287|NCT01051388|Patients receiving low-dose aspirin for vascular protection|patients receiving low-dose aspirin for vascular protection
591288|NCT01051375|anorexia nervosa|anorexia nervosa
591289|NCT01051375|bulimia nervosa|bulimia nervosa
591290|NCT01051375|EDNOS|ednos
591291|NCT01051362|Advanced Non-small Cell Lung Cancer|advanced non-small cell lung cancer
591292|NCT01051362|Pegylated liposomal doxorubicin|pegylated liposomal doxorubicin
591293|NCT01051362|Carboplatin|carboplatin
591294|NCT01051362|Chemotherapy|chemotherapy
591295|NCT01051349|MS|ms
591296|NCT01051349|Multiple Sclerosis|multiple sclerosis
591297|NCT01051336|TARIS Placebo|taris placebo
591298|NCT01051336|Bladder|bladder
591299|NCT01051336|Interstitial Cystitis|interstitial cystitis
591596|NCT01050101|Fiber|fiber
591300|NCT01051336|Normal Healthy Volunteers|normal healthy volunteers
591301|NCT01051297|Obstructive sleep apnea|obstructive sleep apnea
591302|NCT01051297|venous thrombosis|venous thrombosis
591303|NCT01051297|pulmonary embolism|pulmonary embolism
591304|NCT01051297|venous thromboembolism|venous thromboembolism
591305|NCT01051284|Pancreas|pancreas
591306|NCT01051284|Newly diagnosed|newly diagnosed
591307|NCT01051284|Cyberknife|cyberknife
591308|NCT01051284|Gemcitabine|gemcitabine
591309|NCT01051271|metoclopramide|metoclopramide
591310|NCT01051271|akathisia|akathisia
591311|NCT01051271|midazolam|midazolam
591312|NCT01051271|diphenhydramine|diphenhydramine
591313|NCT01051271|metoclopramide induced akathisia|metoclopramide induced akathisia
591314|NCT01051258|Polymeric Lung Volume Reduction (PLVR)|polymeric lung volume reduction (plvr)
591315|NCT01051258|Biologic Lung Volume Reduction (BLVR)|biologic lung volume reduction (blvr)
591316|NCT01051258|AeriSeal|aeriseal
591317|NCT01051258|treatment|treatment
591318|NCT01051258|device|device
591319|NCT01051258|breathing|breathing
591320|NCT01051258|COPD|copd
591321|NCT01051258|emphysema|emphysema
591322|NCT01051258|heterogeneous|heterogeneous
591323|NCT01051258|homogeneous|homogeneous
591324|NCT01051258|Pathologic Processes|pathologic processes
591325|NCT01051258|Respiratory Tract Diseases|respiratory tract diseases
591326|NCT01051258|Lung Diseases|lung diseases
591327|NCT01051258|Pulmonary Disease, Chronic Obstructive|pulmonary disease, chronic obstructive
591328|NCT01051245|Diabetes Mellitus, Type 2 [C18.452.394.750.149]|diabetes mellitus, type 2 [c18.452.394.750.149]
591329|NCT01051245|Case Management [N04.590.233.624.250]|case management [n04.590.233.624.250]
591330|NCT01051245|Disease Management [N04.590.607]|disease management [n04.590.607]
591331|NCT01051245|Diabetes Complications [C19.246.099]|diabetes complications [c19.246.099]
591332|NCT01051232|filibuvir|filibuvir
591333|NCT01051232|pharmacokinetics|pharmacokinetics
591334|NCT01051232|Japanese|japanese
591335|NCT01051232|Asian|asian
591336|NCT01051219|Losartan|losartan
591337|NCT01051219|Liver fibrosis|liver fibrosis
591338|NCT01051219|Nonalcoholic steatohepatitis|nonalcoholic steatohepatitis
591339|NCT01051193|Seizures|seizures
591340|NCT01051193|oxcarbazepine|oxcarbazepine
591341|NCT01051193|child|child
591342|NCT01051180|HEMORRHOIDS|hemorrhoids
591343|NCT01051180|TREATMENT|treatment
591344|NCT01051180|PILES|piles
591345|NCT01051180|BLEEDING|bleeding
591346|NCT01051180|HALO|halo
591347|NCT01051154|Docosahexaenoic acid|docosahexaenoic acid
591348|NCT01051154|Nutritional status|nutritional status
591349|NCT01051154|Acute lymphoblastic leukemia|acute lymphoblastic leukemia
591350|NCT01051154|Long chain polyunsaturated fatty acids|long chain polyunsaturated fatty acids
591351|NCT01051154|n-3 fatty acids|n-3 fatty acids
591352|NCT01051154|Remission-induction phase|remission-induction phase
591353|NCT01051141|alcohol use|alcohol use
591354|NCT01051141|brief intervention|brief intervention
591355|NCT01051141|risk behaviors|risk behaviors
591356|NCT01051128|neurological disorders|neurological disorders
591357|NCT01051128|multiple sclerosis|multiple sclerosis
591358|NCT01051128|stroke|stroke
591359|NCT01051128|cerebral palsy|cerebral palsy
591360|NCT01051128|spinal cord|spinal cord
591361|NCT01051128|brain injuries|brain injuries
591362|NCT01051128|neurodegenerative diseases|neurodegenerative diseases
591363|NCT01051115|CLL|cll
591364|NCT01051115|refractory|refractory
591365|NCT01051115|dasatinib|dasatinib
591366|NCT01051115|fludarabine|fludarabine
591367|NCT01051089|type 2 diabetes mellitus|type 2 diabetes mellitus
591368|NCT01051089|lifestyle modification|lifestyle modification
591369|NCT01051076|ITI|iti
591370|NCT01051076|Haemophilia A|haemophilia a
591371|NCT01051076|Inhibitors|inhibitors
591372|NCT01051076|Failed ITI|failed iti
591373|NCT01051076|VWF/FVIII concentrates|vwf/fviii concentrates
591374|NCT01051063|adult|adult
591375|NCT01051063|WT1|wt1
591376|NCT01051063|ASCI|asci
591377|NCT01051063|complete remission with incomplete blood count recovery|complete remission with incomplete blood count recovery
591378|NCT01051063|partial remission|partial remission
591379|NCT01051063|post-induction therapy|post-induction therapy
591380|NCT01051063|tumor antigen|tumor antigen
591381|NCT01051063|Acute Myeloid Leukemia|acute myeloid leukemia
591382|NCT01051063|Immunotherapy|immunotherapy
591383|NCT01051050|Evidence based medicine|evidence based medicine
591384|NCT01051050|Improving surgical residents skills and application of EBM in surgical practice|improving surgical residents skills and application of ebm in surgical practice
591385|NCT01051037|lung tumors|lung tumors
591386|NCT01051037|central airways|central airways
591387|NCT01051024|Dietary supplement|dietary supplement
591388|NCT01051024|Diamel|diamel
591389|NCT01051024|Polycystic Ovary Syndrome|polycystic ovary syndrome
591390|NCT01051024|Female Infertility|female infertility
591391|NCT01050998|Rheumatoid Arthritis|rheumatoid arthritis
591392|NCT01050998|Mavrilimumab|mavrilimumab
591393|NCT01050998|CAM-3001|cam-3001
591394|NCT01050985|advanced cancer|advanced cancer
591395|NCT01050985|temsirolimus|temsirolimus
591396|NCT01050985|capecitabine|capecitabine
591397|NCT01050972|Headache|headache
591597|NCT01050101|Nutrition|nutrition
591398|NCT01050972|Cervical Pain|cervical pain
591399|NCT01050972|Cognitive treatment|cognitive treatment
591400|NCT01050972|Relaxation|relaxation
591401|NCT01050972|Exercise|exercise
591402|NCT01050946|Unrelated Umbilical Cord Blood Transplant(UCB)|unrelated umbilical cord blood transplant(ucb)
591403|NCT01050946|CD34+ Selected mismatched related donor|cd34+ selected mismatched related donor
591404|NCT01050946|Haploidentical donor|haploidentical donor
591405|NCT01050946|hematopoietic stem cell transplantation(HSCT)|hematopoietic stem cell transplantation(hsct)
591406|NCT01050946|ALL|all
591407|NCT01050946|Leukemia, Lymphocytic, Acute|leukemia, lymphocytic, acute
591408|NCT01050946|AML|aml
591409|NCT01050946|Leukemia, Myelocytic, Acute|leukemia, myelocytic, acute
591410|NCT01050946|CML|cml
591411|NCT01050946|Leukemia, Myeloid, Chronic|leukemia, myeloid, chronic
591412|NCT01050946|NHL|nhl
591413|NCT01050946|Lymphoma, Non-Hodgkin|lymphoma, non-hodgkin
591414|NCT01050946|HL|hl
591415|NCT01050946|Lymphoma, Hodgkins|lymphoma, hodgkins
591416|NCT01050933|Healthy volunteer|healthy volunteer
591417|NCT01050907|leishmaniasis|leishmaniasis
591418|NCT01050907|cutaneous disease|cutaneous disease
591419|NCT01050907|mucosal disease|mucosal disease
591420|NCT01050907|miltefosine|miltefosine
591421|NCT01050894|osteoarthritis|osteoarthritis
591548|NCT01050387|vitamin D homeostasis|vitamin d homeostasis
591422|NCT01050881|blood donor notification|blood donor notification
591423|NCT01050881|emotional response|emotional response
591424|NCT01050881|variant Creutzfeldt-Jacob Disease|variant creutzfeldt-jacob disease
591425|NCT01050855|Non-malignant diseases|non-malignant diseases
591426|NCT01050855|Immune deficiencies|immune deficiencies
591427|NCT01050855|Hemoglobinopathies|hemoglobinopathies
591428|NCT01050855|Reduced Intensity Conditioning(RIC)|reduced intensity conditioning(ric)
591429|NCT01050829|Magnetic resonance imaging|magnetic resonance imaging
591430|NCT01050829|Tumor|tumor
591431|NCT01050829|Contrast media|contrast media
591432|NCT01050829|Gadobutrol|gadobutrol
591433|NCT01050816|articular cartilage defects|articular cartilage defects
591434|NCT01050816|ACI|aci
591435|NCT01050816|ankle joint|ankle joint
591436|NCT01050816|chondron|chondron
591437|NCT01050803|Diabetes Mellitus|diabetes mellitus
591438|NCT01050803|Intervention studies|intervention studies
591439|NCT01050803|Program effectiveness|program effectiveness
591440|NCT01050790|stage I multiple myeloma|stage i multiple myeloma
591441|NCT01050790|stage II multiple myeloma|stage ii multiple myeloma
591442|NCT01050790|stage III multiple myeloma|stage iii multiple myeloma
591443|NCT01050777|Cutaneous Leishmaniasis caused by l. tropica|cutaneous leishmaniasis caused by l. tropica
591444|NCT01050751|Bioavailability|bioavailability
591445|NCT01050751|Bioequivalence|bioequivalence
591446|NCT01050751|Lersivirine|lersivirine
591447|NCT01050751|UK-453|uk-453
591448|NCT01050751|061|061
591449|NCT01050751|Pharmacokinetics|pharmacokinetics
591450|NCT01050725|proteome|proteome
591451|NCT01050725|biomarkers|biomarkers
591452|NCT01050725|radiotherapy|radiotherapy
591453|NCT01050725|cancer|cancer
591454|NCT01050699|critical illness|critical illness
591455|NCT01050699|sleep|sleep
591456|NCT01050699|polysomnography|polysomnography
591457|NCT01050699|inflammatory cytokines|inflammatory cytokines
591458|NCT01050699|dexmedetomidine|dexmedetomidine
591459|NCT01050699|acute lung injury|acute lung injury
591460|NCT01050699|acute respiratory distress syndrome|acute respiratory distress syndrome
591461|NCT01050699|midazolam|midazolam
591462|NCT01050699|fentanyl|fentanyl
591463|NCT01050699|cytokines|cytokines
591464|NCT01050686|ileostomy reversal|ileostomy reversal
591465|NCT01050686|subcutaneous drain|subcutaneous drain
591466|NCT01050686|hospital stay|hospital stay
591467|NCT01050686|postoperative wound infection|postoperative wound infection
591468|NCT01050686|patients with elective ileostomy reversal|patients with elective ileostomy reversal
591469|NCT01050673|VERSAJET hydro-surgical debridement|versajet hydro-surgical debridement
591470|NCT01050673|traumatic wound|traumatic wound
591471|NCT01050660|Parenteral nutrition associated liver disease|parenteral nutrition associated liver disease
591472|NCT01050660|Direct bilirubin|direct bilirubin
591473|NCT01050660|Intravenous fat emulsion|intravenous fat emulsion
591474|NCT01050660|Very low birth weight infants|very low birth weight infants
591475|NCT01050660|PNAC|pnac
591476|NCT01050634|Aromatase inhibitor|aromatase inhibitor
591477|NCT01050634|Switch after Tamoxifen|switch after tamoxifen
591478|NCT01050634|Quality of Life|quality of life
591479|NCT01050634|Safety|safety
591480|NCT01050621|ascorbic acid|ascorbic acid
591481|NCT01050621|vitamin C|vitamin c
591482|NCT01050621|antioxidants|antioxidants
591483|NCT01050621|redox therapy|redox therapy
591484|NCT01050621|cytotoxic chemotherapy|cytotoxic chemotherapy
591485|NCT01050608|Alcohol Rub|alcohol rub
591486|NCT01050608|Hand Hygiene|hand hygiene
591487|NCT01050608|Provider Feedback|provider feedback
591488|NCT01050608|Health Care Associated Infections|health care associated infections
591489|NCT01050595|Intensive Care Unit|intensive care unit
591490|NCT01050595|Constipation|constipation
591491|NCT01050595|Bowel Management|bowel management
591492|NCT01050582|Schizophrenia|schizophrenia
591493|NCT01050582|Bipolar Disorder|bipolar disorder
591494|NCT01050582|Autistic Disorder|autistic disorder
591495|NCT01050582|Conduct and Other Disruptive Behavior Disorders|conduct and other disruptive behavior disorders
591496|NCT01050582|Risperidone|risperidone
591497|NCT01050582|RISPERDAL|risperdal
591498|NCT01050582|Antipsychotic Agents|antipsychotic agents
591499|NCT01050582|Prolactin|prolactin
591500|NCT01050582|Pediatrics|pediatrics
591501|NCT01050569|Smoking Cessation|smoking cessation
591502|NCT01050569|Nicotine Free Cigarettes|nicotine free cigarettes
591503|NCT01050556|arsenic|arsenic
591504|NCT01050556|folate|folate
591505|NCT01050556|folic acid|folic acid
591506|NCT01050556|creatine|creatine
591507|NCT01050556|arsenicosis|arsenicosis
591508|NCT01050556|nutrition|nutrition
591509|NCT01050530|Cirrhosis|cirrhosis
591510|NCT01050530|ascites|ascites
591511|NCT01050530|Tolvaptan|tolvaptan
591512|NCT01050530|OPC-41061|opc-41061
591513|NCT01050491|asthma|asthma
591514|NCT01050491|airway remodeling|airway remodeling
591515|NCT01050491|airway obstruction|airway obstruction
591516|NCT01050478|acute agitation|acute agitation
591517|NCT01050478|aggression|aggression
591518|NCT01050478|psychosis|psychosis
591519|NCT01050478|paliperidone extended release|paliperidone extended release
591520|NCT01050465|HIV|hiv
591521|NCT01050465|Knee pain|knee pain
591522|NCT01050465|Colonoscopy|colonoscopy
591523|NCT01050465|Mammography|mammography
591524|NCT01050465|Vaccination|vaccination
591525|NCT01050439|Allogeneic Stem Cell Transplant|allogeneic stem cell transplant
591526|NCT01050439|Unrelated donor|unrelated donor
591527|NCT01050439|Cord blood donor|cord blood donor
591528|NCT01050413|Thymidine Kinase 1 activity|thymidine kinase 1 activity
591529|NCT01050413|diagnosis|diagnosis
591530|NCT01050413|prognosis|prognosis
591531|NCT01050413|follow-up|follow-up
591532|NCT01050400|CYP2D6|cyp2d6
591533|NCT01050400|Genetic Polymorphism|genetic polymorphism
591534|NCT01050400|codeine|codeine
591535|NCT01050400|breastfeeding|breastfeeding
591536|NCT01050387|Vitamin D Deficiency|vitamin d deficiency
591537|NCT01050387|VDD|vdd
591538|NCT01050387|Vitamin D Supplementation|vitamin d supplementation
591539|NCT01050387|Vitamin D Binding Protein|vitamin d binding protein
591540|NCT01050387|DBP|dbp
591541|NCT01050387|Nutritional rickets|nutritional rickets
591542|NCT01050387|rickets|rickets
591543|NCT01050387|25hydroxyvitamin D|25hydroxyvitamin d
591544|NCT01050387|25OHD|25ohd
591545|NCT01050387|1,25OH2D|1,25oh2d
591546|NCT01050387|vitamin D metabolites|vitamin d metabolites
591547|NCT01050387|PTH|pth
591549|NCT01050361|To reduce perioperative morbidity and mortality associated with congestive heart failure for non-cardiac surgeries|to reduce perioperative morbidity and mortality associated with congestive heart failure for non-cardiac surgeries
591550|NCT01050322|receptor HER two positive|receptor her two positive
591551|NCT01050322|lapatinib|lapatinib
591552|NCT01050322|metastatic breast cancer|metastatic breast cancer
591553|NCT01050296|Neuroblastoma|neuroblastoma
591554|NCT01050296|Retinoblastoma|retinoblastoma
591555|NCT01050296|Osteosarcoma|osteosarcoma
591556|NCT01050296|Rhabdomyosarcoma|rhabdomyosarcoma
591557|NCT01050296|Ewing sarcoma|ewing sarcoma
591558|NCT01050296|Non-rhabdomyosarcoma soft tissue sarcoma|non-rhabdomyosarcoma soft tissue sarcoma
591559|NCT01050296|Adrenocortical tumors|adrenocortical tumors
591560|NCT01050296|Liver malignancies|liver malignancies
591561|NCT01050283|Advanced pancreatic adenocarcinoma|advanced pancreatic adenocarcinoma
591562|NCT01050244|Soy protein|soy protein
591563|NCT01050244|Milk protein|milk protein
591564|NCT01050244|Neuropathic pain|neuropathic pain
591565|NCT01050231|stroke|stroke
591566|NCT01050231|cerebrovascular accident|cerebrovascular accident
591567|NCT01050231|robot|robot
591568|NCT01050218|Diabetic Peripheral Neuropathy|diabetic peripheral neuropathy
591569|NCT01050205|Diabetes Prevention|diabetes prevention
591570|NCT01050205|Cardiovascular Risk Reduction|cardiovascular risk reduction
591571|NCT01050205|Lifestyle Intervention|lifestyle intervention
591572|NCT01050205|Group Lifestyle Balance|group lifestyle balance
591573|NCT01050192|Prematurity|prematurity
591574|NCT01050192|Nutrition|nutrition
591575|NCT01050192|Breast Feeding|breast feeding
591576|NCT01050179|chemosensitivity|chemosensitivity
591577|NCT01050166|islet transplantation|islet transplantation
591578|NCT01050166|magnetic resonance|magnetic resonance
591579|NCT01050166|Type 1 DM|type 1 dm
591580|NCT01050153|Prevention of venous thromboembolism|prevention of venous thromboembolism
591581|NCT01050140|fructose|fructose
591582|NCT01050140|fatty liver disease|fatty liver disease
591583|NCT01050140|diet|diet
591584|NCT01050127|Pharmacokinetics|pharmacokinetics
591585|NCT01050127|Pharmacodynamics|pharmacodynamics
591586|NCT01050127|Drug Safety|drug safety
591587|NCT01050127|Phase 1 Clinical Trial|phase 1 clinical trial
591588|NCT01050114|Botulinum Toxin|botulinum toxin
591589|NCT01050114|Oxybutynin|oxybutynin
591590|NCT01050114|Overactive Bladder|overactive bladder
591591|NCT01050114|Spinal Cord Injury|spinal cord injury
591592|NCT01050114|Urinary Incontinence|urinary incontinence
591593|NCT01050114|Nerve Growth Factor|nerve growth factor
591594|NCT01050114|Urine Biomarkers|urine biomarkers
591598|NCT01050101|Pre- and post-menopausal women|pre- and post-menopausal women
591599|NCT01050101|overweight|overweight
591600|NCT01050088|clubfoot|clubfoot
591601|NCT01050088|casting|casting
591602|NCT01050088|ponseti|ponseti
591603|NCT01050088|discomfort|discomfort
591604|NCT01050075|male breast cancer|male breast cancer
591605|NCT01050075|neurotoxicity|neurotoxicity
591606|NCT01050075|recurrent breast cancer|recurrent breast cancer
591607|NCT01050036|Leukemia, Myeloid|leukemia, myeloid
591608|NCT01050036|Primary complete remission|primary complete remission
591609|NCT01050036|Favorable karyotype|favorable karyotype
591610|NCT01050036|Autologous hematopoietic cell transplantation|autologous hematopoietic cell transplantation
591611|NCT01050036|Hematopoietic cell transplantation|hematopoietic cell transplantation
591612|NCT01050023|venous stasis ulcer|venous stasis ulcer
591613|NCT01050023|wound healing|wound healing
591614|NCT01050023|Provant Wound Closure System|provant wound closure system
591615|NCT01050023|radiofrequency|radiofrequency
591616|NCT01050023|Provant|provant
591617|NCT01050023|pain relief|pain relief
591618|NCT01050010|rheumatoid arthritis|rheumatoid arthritis
591619|NCT01050010|clinical remission|clinical remission
591620|NCT01050010|synovitis|synovitis
591621|NCT01050010|dedicated extremity MRI|dedicated extremity mri
591622|NCT01049997|Non ST Elevation Myocardial Infarction (NSTEMI)|non st elevation myocardial infarction (nstemi)
591623|NCT01049997|Elderly|elderly
591624|NCT01049997|Frailty|frailty
591625|NCT01049984|Parkinson's Disease|parkinson's disease
591626|NCT01049984|UPDRS|updrs
591627|NCT01049984|Clinical Global Evaluation Illness Severity score|clinical global evaluation illness severity score
591628|NCT01049984|Clinical Global Evaluation Improvement|clinical global evaluation improvement
591629|NCT01049984|B-SIT|b-sit
591630|NCT01049984|SCOPA - Sleep Daytime Sleepiness|scopa - sleep daytime sleepiness
591631|NCT01049984|PDQ -39|pdq -39
591632|NCT01049984|SCOPA - Cognition|scopa - cognition
591633|NCT01049984|Levodopa|levodopa
591634|NCT01049984|rasagiline|rasagiline
591635|NCT01049984|Dopamine Agonist Therapy|dopamine agonist therapy
591636|NCT01049984|monoamine oxidase type B inhibitor|monoamine oxidase type b inhibitor
591637|NCT01049971|colorectal surgery|colorectal surgery
591638|NCT01049971|wound infection|wound infection
591639|NCT01049971|wound protector|wound protector
591640|NCT01049971|laparoscopy|laparoscopy
591641|NCT01049971|surgical site infection after laparoscopic colorectal surgery with minilaparotomy|surgical site infection after laparoscopic colorectal surgery with minilaparotomy
591642|NCT01049958|asynchrony|asynchrony
591643|NCT01049958|mechanical ventilation|mechanical ventilation
591644|NCT01049958|blunt trauma|blunt trauma
591645|NCT01049932|HIV|hiv
591646|NCT01049932|Human Immunodeficiency Virus (HIV)|human immunodeficiency virus (hiv)
591647|NCT01049932|HIV Seronegativity|hiv seronegativity
591648|NCT01049919|Critical Limb Ischemia|critical limb ischemia
591649|NCT01049919|Peripheral Arterial Disease|peripheral arterial disease
591650|NCT01049919|Peripheral Vascular Disease|peripheral vascular disease
591651|NCT01049919|CLI|cli
591652|NCT01049919|PAD|pad
591653|NCT01049919|PVD|pvd
591654|NCT01049919|Angiogenesis|angiogenesis
591655|NCT01049919|Stem Cells|stem cells
591656|NCT01049919|Cell Therapy|cell therapy
591657|NCT01049919|Limb Salvage|limb salvage
591658|NCT01049919|Amputation|amputation
591659|NCT01049919|Leg Pain|leg pain
591660|NCT01049906|foot surgery|foot surgery
591661|NCT01049906|ankle surgery|ankle surgery
591662|NCT01049906|Patients scheduled for foot and ankle surgery|patients scheduled for foot and ankle surgery
591663|NCT01049880|Ascorbic Acid|ascorbic acid
591664|NCT01049880|Gemcitabine|gemcitabine
591665|NCT01049854|unrelated donor transplant|unrelated donor transplant
591666|NCT01049854|CD34 selection|cd34 selection
591667|NCT01049841|pediatric|pediatric
591668|NCT01049841|children|children
591669|NCT01049841|perifosine|perifosine
591670|NCT01049841|temsirolimus|temsirolimus
591671|NCT01049841|recurrent|recurrent
591672|NCT01049841|progressive|progressive
591673|NCT01049841|09-124|09-124
591674|NCT01049828|Tinnitus|tinnitus
591675|NCT01049828|fcMRI|fcmri
591676|NCT01049828|Neural Connectivity|neural connectivity
591677|NCT01049828|Bother|bother
591678|NCT01049815|hemodialysis|hemodialysis
591679|NCT01049815|intimal media thickness|intimal media thickness
591680|NCT01049802|stroke|stroke
591681|NCT01049802|hemiplegia|hemiplegia
591682|NCT01049802|TMS|tms
591683|NCT01049789|youth|youth
591684|NCT01049789|HIV|hiv
591685|NCT01049789|Depression|depression
591686|NCT01049789|Cognitive Behavioral Therapy|cognitive behavioral therapy
591687|NCT01049789|Medication management|medication management
591688|NCT01049776|Lung Cancer Non Small Cell|lung cancer non small cell
591689|NCT01049763|obese adult|obese adult
591690|NCT01049763|non obese healthy volunteers|non obese healthy volunteers
591691|NCT01049763|oseltamivir carboxylate|oseltamivir carboxylate
591692|NCT01049763|pharmacokinetics|pharmacokinetics
591693|NCT01049763|healthy volunteers|healthy volunteers
591694|NCT01049750|type 2 diabetes mellitus|type 2 diabetes mellitus
591695|NCT01049750|male|male
591696|NCT01049750|erectile dysfunction|erectile dysfunction
591697|NCT01049724|Myopia|myopia
591698|NCT01049724|refractive surgery|refractive surgery
591699|NCT01049724|LASIK|lasik
591700|NCT01049724|PRK|prk
591701|NCT01049724|Lacritin|lacritin
591702|NCT01049724|Heparanase|heparanase
591703|NCT01049711|erythropoietin|erythropoietin
591704|NCT01049711|hemodialysis|hemodialysis
591705|NCT01049711|cost utility|cost utility
591706|NCT01049711|incremental cost-effectiveness ratio|incremental cost-effectiveness ratio
591707|NCT01049711|Quality adjusted life year|quality adjusted life year
591708|NCT01049711|quality of life|quality of life
591709|NCT01049698|Obesity|obesity
591710|NCT01049698|Overweight|overweight
591711|NCT01049698|Older adults|older adults
591712|NCT01049698|resistance training|resistance training
591713|NCT01049698|exercise|exercise
591714|NCT01049685|HIV|hiv
591715|NCT01049685|Antiretroviral Therapy, Highly Active|antiretroviral therapy, highly active
591716|NCT01049685|Efavirenz|efavirenz
591717|NCT01049685|Lopinavir|lopinavir
591718|NCT01049685|Comparative Effectiveness Research|comparative effectiveness research
591719|NCT01049685|Treatment Naive|treatment naive
591720|NCT01049659|pregnancy|pregnancy
591721|NCT01049659|iodine deficiency|iodine deficiency
591722|NCT01049659|neuropsychological development|neuropsychological development
591723|NCT01049646|renin-angiotensin system|renin-angiotensin system
591724|NCT01049646|apelin|apelin
591725|NCT01049646|systemic haemodynamics|systemic haemodynamics
591726|NCT01049633|Insulin dependence|insulin dependence
591727|NCT01049633|Hypoglycemia|hypoglycemia
591728|NCT01049633|Hypoglycemia unawareness|hypoglycemia unawareness
591729|NCT01049633|Islet transplantation|islet transplantation
591730|NCT01049620|XELOX|xelox
591731|NCT01049620|RAD001|rad001
591732|NCT01049620|phase 1|phase 1
591733|NCT01049607|Patients undergoing hepatic resection|patients undergoing hepatic resection
591734|NCT01049581|Gross motor function performance|gross motor function performance
591735|NCT01049581|pediatric aquatic therapy|pediatric aquatic therapy
591736|NCT01049581|spastic cerebral palsy|spastic cerebral palsy
591737|NCT01049568|HIV|hiv
591738|NCT01049568|Cell phone|cell phone
591739|NCT01049568|HAART|haart
591740|NCT01049555|alzheimer|alzheimer
591741|NCT01049555|apathy|apathy
591742|NCT01049555|actigraphy|actigraphy
591743|NCT01049542|Astressin 2B|astressin 2b
591744|NCT01049542|Forearm blood flow|forearm blood flow
591745|NCT01049542|vascular|vascular
591746|NCT01049542|plethysmography|plethysmography
591747|NCT01049542|heart failure|heart failure
591748|NCT01049529|Docosahexaenoic acid|docosahexaenoic acid
591749|NCT01049529|n-3 Long Chain Polyunsaturated Fatty Acids|n-3 long chain polyunsaturated fatty acids
591750|NCT01049529|omega 3 fatty acids|omega 3 fatty acids
591751|NCT01049529|neonates|neonates
591752|NCT01049529|clinical outcomes|clinical outcomes
591753|NCT01049529|critically ill patients|critically ill patients
591754|NCT01049529|Inflammatory and antiinflammatory cytokines|inflammatory and antiinflammatory cytokines
591755|NCT01049529|Length of intensive care stay|length of intensive care stay
591756|NCT01049516|Military|military
591757|NCT01049516|Combat|combat
591758|NCT01049516|Psychological Treatment|psychological treatment
591759|NCT01049516|Psychotherapy|psychotherapy
591760|NCT01049516|Trauma|trauma
591761|NCT01049516|Posttraumatic Stress|posttraumatic stress
591762|NCT01049516|Posttraumatic Stress Disorder|posttraumatic stress disorder
591763|NCT01049516|PTSD|ptsd
591764|NCT01049516|Prolonged Exposure|prolonged exposure
591765|NCT01049516|Exposure therapy|exposure therapy
591766|NCT01049516|Behavior Therapy|behavior therapy
591767|NCT01049516|Cognitive Behavior Therapy|cognitive behavior therapy
591768|NCT01049516|Post-Traumatic Stress Disorders|post-traumatic stress disorders
591769|NCT01049516|Stress Disorders, Post-traumatic|stress disorders, post-traumatic
591770|NCT01049503|Dentifrices|dentifrices
591771|NCT01049503|Fluoride|fluoride
591772|NCT01049503|Nails|nails
591773|NCT01049503|Plaque|plaque
591774|NCT01049490|Intradermal vaccination, H1N1, microneedle|intradermal vaccination, h1n1, microneedle
591775|NCT01049477|Pregnancy|pregnancy
591776|NCT01049477|Cesarean Section|cesarean section
591777|NCT01049464|Atrial fibrillation|atrial fibrillation
591778|NCT01049464|Hemodynamically unstable patients|hemodynamically unstable patients
591779|NCT01049464|Magnesium sulfate|magnesium sulfate
591780|NCT01049464|Septic shock|septic shock
591781|NCT01049464|Medical intensive care unit|medical intensive care unit
591782|NCT01049464|New onset atrial fibrillation|new onset atrial fibrillation
591783|NCT01049464|Critically ill patients|critically ill patients
591784|NCT01049451|Multiple Sclerosis|multiple sclerosis
591785|NCT01049451|ACTH|acth
591786|NCT01049451|Steroids|steroids
591787|NCT01049438|MRSA|mrsa
591788|NCT01049438|Methicillin Resistant Staphylococcus aureus|methicillin resistant staphylococcus aureus
591789|NCT01049438|Staphylococcus aureus|staphylococcus aureus
591790|NCT01049438|Skin Infections|skin infections
591791|NCT01049438|Body Decolonization|body decolonization
591792|NCT01049425|anthracycline-free|anthracycline-free
591793|NCT01049425|OncotypDX|oncotypdx
591794|NCT01049425|taxane|taxane
591795|NCT01049425|Her2 negative breast cancer|her2 negative breast cancer
591796|NCT01049386|intestinal permeability|intestinal permeability
591797|NCT01049386|health|health
591798|NCT01049386|sugar absorption|sugar absorption
591799|NCT01049386|intestinal permeability examined in different men (lean vs obese) and different conditions (no breakfast and high-fat breakfast)|intestinal permeability examined in different men (lean vs obese) and different conditions (no breakfast and high-fat breakfast)
591800|NCT01049373|low-back|low-back
591801|NCT01049373|pain|pain
591802|NCT01049373|chronic|chronic
591803|NCT01049373|constitution|constitution
591804|NCT01049373|diathesism|diathesism
591805|NCT01049373|homoeopathy|homoeopathy
591806|NCT01049373|fixed combination|fixed combination
591807|NCT01049373|herbal preparation|herbal preparation
591808|NCT01049373|chronic low back pain lasting more than 6 months|chronic low back pain lasting more than 6 months
591809|NCT01049360|Chronic Obstructive Pulmonary Disease|chronic obstructive pulmonary disease
591810|NCT01049360|COPD|copd
591811|NCT01049360|Chronic Bronchitis|chronic bronchitis
591812|NCT01049360|Emphysema|emphysema
591813|NCT01049360|Airflow Obstruction, Chronic|airflow obstruction, chronic
591814|NCT01049360|Chronic Airflow Obstruction|chronic airflow obstruction
591815|NCT01049360|Chronic Obstructive Airway Disease|chronic obstructive airway disease
591816|NCT01049360|Chronic Obstructive Lung Disease|chronic obstructive lung disease
591817|NCT01049347|depression|depression
591818|NCT01049321|Dietary Approach to Stop Hypertension|dietary approach to stop hypertension
591819|NCT01049321|weight|weight
591820|NCT01049321|coagulation|coagulation
591821|NCT01049321|DASH eating pattern.|dash eating pattern.
591822|NCT01049308|heart failure|heart failure
591823|NCT01049308|cognitive disorders|cognitive disorders
591824|NCT01049308|medication adherence|medication adherence
591825|NCT01049308|patient readmissions|patient readmissions
591826|NCT01049295|taxanes|taxanes
591827|NCT01049295|breast cancer|breast cancer
591828|NCT01049295|n3 fatty acids|n3 fatty acids
591829|NCT01049295|inflammation|inflammation
591830|NCT01049282|safety|safety
591831|NCT01049282|immunogenicity|immunogenicity
591832|NCT01049282|adjuvanted TB subunit vaccine|adjuvanted tb subunit vaccine
591833|NCT01049269|Body Scanning|body scanning
591834|NCT01049269|Body Fat|body fat
591835|NCT01049269|Body Volume|body volume
591836|NCT01049269|Obesity|obesity
591837|NCT01049269|No Conditions|no conditions
591838|NCT01049256|Periodic breathing|periodic breathing
591839|NCT01049256|Heart Failure|heart failure
591840|NCT01049256|Chemoreflex|chemoreflex
591841|NCT01049256|Chemosensitivity|chemosensitivity
591842|NCT01049243|Atopic Dermatitis|atopic dermatitis
591843|NCT01049243|Open-Label|open-label
591844|NCT01049243|Topical|topical
591845|NCT01049243|Cream|cream
591846|NCT01049243|Eczema|eczema
591847|NCT01049243|Vanos|vanos
591848|NCT01049230|proton beam radiation|proton beam radiation
591849|NCT01049230|CNS germ cell tumor|cns germ cell tumor
591850|NCT01049217|neuropathy|neuropathy
591851|NCT01049217|pain|pain
591852|NCT01049217|HIV-1|hiv-1
591853|NCT01049217|HIV Infections|hiv infections
591854|NCT01049204|HIV|hiv
591855|NCT01049204|HIV-1 Infections|hiv-1 infections
591856|NCT01049191|Osteoporosis|osteoporosis
591857|NCT01049191|Fracture|fracture
752155|NCT00433316|pain|pain
591858|NCT01049191|microMRI|micromri
591859|NCT01049191|Bone architecture|bone architecture
591860|NCT01049191|Bone matrix|bone matrix
591861|NCT01049191|Bone and Bones|bone and bones
591862|NCT01049191|Magnetic Resonance Imaging|magnetic resonance imaging
591863|NCT01049178|antioxidant enzymes|antioxidant enzymes
591864|NCT01049178|asthma|asthma
591865|NCT01049178|silymarin|silymarin
591866|NCT01049178|RCT|rct
591867|NCT01049152|Diabetes mellitus|diabetes mellitus
591868|NCT01049152|ESRD|esrd
591869|NCT01049152|CGM|cgm
591870|NCT01049152|Inflammation markers|inflammation markers
591871|NCT01049152|Hemodialysis|hemodialysis
591872|NCT01049152|Diabetic patients|diabetic patients
591873|NCT01049152|Nondiabetic patients|nondiabetic patients
591874|NCT01049152|All with ESRD|all with esrd
591875|NCT01049152|All undergone hemodialysis|all undergone hemodialysis
591876|NCT01049139|vaccination|vaccination
591877|NCT01049139|HIV prevention|hiv prevention
591878|NCT01049139|YMSM|ymsm
591879|NCT01049139|youth|youth
591880|NCT01049139|HIV Preventative Vaccine|hiv preventative vaccine
591881|NCT01049126|Late Stage|late stage
591882|NCT01049113|Lymphoma|lymphoma
591883|NCT01049113|B-cell Acute Lymphocytic Leukemia|b-cell acute lymphocytic leukemia
591884|NCT01049113|ALL|all
591885|NCT01049100|Surgical Staging|surgical staging
591886|NCT01049100|Cervical Cancer|cervical cancer
591887|NCT01049100|Chemoradiation|chemoradiation
591888|NCT01049100|Outcome|outcome
591889|NCT01049100|Toxicity|toxicity
591890|NCT01049087|plasma volume|plasma volume
591891|NCT01049087|technetium-labeled albumin|technetium-labeled albumin
591892|NCT01049087|radioiodine-labeled albumin|radioiodine-labeled albumin
591893|NCT01049087|Healthy volunteers|healthy volunteers
591894|NCT01049074|Low Back Pain|low back pain
591895|NCT01049074|Acupuncture|acupuncture
591896|NCT01049074|RCT|rct
591897|NCT01049061|Cancer|cancer
591898|NCT01049061|FRα|frα
591899|NCT01049048|Endothelial Function|endothelial function
591900|NCT01049048|Arterial stiffness|arterial stiffness
591901|NCT01049048|Vitamin D|vitamin d
591902|NCT01049035|Meningitis|meningitis
591903|NCT01049035|Meningococcal Infection|meningococcal infection
591904|NCT01049035|Neisseria meningitidis|neisseria meningitidis
591905|NCT01049035|Tetravalent Meningococcal Vaccine|tetravalent meningococcal vaccine
591906|NCT01049022|Pharmacokinetics|pharmacokinetics
591907|NCT01049009|Nitric Oxide|nitric oxide
591908|NCT01049009|Adrenergic beta-Antagonists|adrenergic beta-antagonists
591909|NCT01049009|Antihypertensive Agents|antihypertensive agents
591910|NCT01049009|Vasodilator Agents|vasodilator agents
591911|NCT01049009|Anti-Arrhythmia Agents|anti-arrhythmia agents
591912|NCT01049009|Sympatholytics|sympatholytics
591913|NCT01049009|Vascular Resistance|vascular resistance
591914|NCT01049009|Neurotransmitter Agents|neurotransmitter agents
591915|NCT01049009|Cardiovascular Diseases|cardiovascular diseases
591916|NCT01049009|Metoprolol succinate|metoprolol succinate
591917|NCT01049009|Therapeutic Uses|therapeutic uses
591918|NCT01049009|Metoprolol|metoprolol
591919|NCT01049009|Vascular Diseases|vascular diseases
591920|NCT01049009|Nebivolol|nebivolol
591921|NCT01049009|Cardiovascular Agents|cardiovascular agents
591922|NCT01049009|Endothelium-Dependent Relaxing Factors|endothelium-dependent relaxing factors
591923|NCT01048996|Acute Lung Injury|acute lung injury
591924|NCT01048996|Acute Respiratory Distress Syndrome|acute respiratory distress syndrome
591925|NCT01048996|Genetic Variability|genetic variability
591926|NCT01048996|Plasma Biomarkers|plasma biomarkers
591927|NCT01048996|Pediatrics|pediatrics
591928|NCT01048983|Lung Cancer|lung cancer
591929|NCT01048983|NSCLC|nsclc
591930|NCT01048983|Concurrent Chemoradiation Therapy|concurrent chemoradiation therapy
591931|NCT01048983|Side Effects|side effects
591932|NCT01048983|Armodafinil|armodafinil
591933|NCT01048983|Nuvigil|nuvigil
591934|NCT01048983|Bupropion|bupropion
591935|NCT01048983|Wellbutrin|wellbutrin
591936|NCT01048983|Wellbutrin SR|wellbutrin sr
591937|NCT01048983|Zyban|zyban
591938|NCT01048983|Curcumin|curcumin
591939|NCT01048983|Minocycline|minocycline
591940|NCT01048983|Dynacin|dynacin
591941|NCT01048983|Minocin|minocin
591942|NCT01048983|Minocin PAC|minocin pac
591943|NCT01048983|Myrac|myrac
591944|NCT01048983|Solodyn|solodyn
591945|NCT01048970|Lung cancer|lung cancer
591946|NCT01048970|Eicosapentaenoic acid oral supplementation|eicosapentaenoic acid oral supplementation
591947|NCT01048970|Weight loss|weight loss
591948|NCT01048970|Toxicity|toxicity
591949|NCT01048970|Body composition|body composition
591950|NCT01048970|Inflammatory response|inflammatory response
591951|NCT01048957|Nicotine|nicotine
591952|NCT01048957|Craving|craving
591953|NCT01048957|fMRI|fmri
591954|NCT01048957|EEG|eeg
591955|NCT01048957|Real Time fMRI Feedback|real time fmri feedback
591956|NCT01048944|Electroencephalography|electroencephalography
591957|NCT01048944|nicotine|nicotine
591958|NCT01048944|bupropion|bupropion
591959|NCT01048944|attention|attention
591960|NCT01048944|drug withdrawal symptoms|drug withdrawal symptoms
591961|NCT01048931|Single-port, laparoscopic-assisted, vaginal hysterectomy|single-port, laparoscopic-assisted, vaginal hysterectomy
591962|NCT01048918|Circulating tumor cells in breast cancer|circulating tumor cells in breast cancer
591963|NCT01048905|Pulmonary Hypertension|pulmonary hypertension
591964|NCT01048905|Sickle Cell Disease|sickle cell disease
591965|NCT01048905|Thalassemia|thalassemia
591966|NCT01048892|recurrent neuroblastoma|recurrent neuroblastoma
591967|NCT01048892|previously treated childhood rhabdomyosarcoma|previously treated childhood rhabdomyosarcoma
591968|NCT01048892|recurrent childhood rhabdomyosarcoma|recurrent childhood rhabdomyosarcoma
591969|NCT01048892|recurrent Wilms tumor and other childhood kidney tumors|recurrent wilms tumor and other childhood kidney tumors
591970|NCT01048892|recurrent retinoblastoma|recurrent retinoblastoma
591971|NCT01048892|recurrent adrenocortical carcinoma|recurrent adrenocortical carcinoma
591972|NCT01048892|recurrent gastrointestinal carcinoid tumor|recurrent gastrointestinal carcinoid tumor
591973|NCT01048879|oseltamivir|oseltamivir
591974|NCT01048879|influenza|influenza
591975|NCT01048879|continuous renal replacement therapy|continuous renal replacement therapy
591976|NCT01048879|extracorporeal membrane oxygenation|extracorporeal membrane oxygenation
591977|NCT01048879|pharmacokinetics|pharmacokinetics
591978|NCT01048866|pharyngitis|pharyngitis
591979|NCT01048866|swollen throat|swollen throat
591980|NCT01048866|difficulty swallowing|difficulty swallowing
591981|NCT01048853|Cervix|cervix
591982|NCT01048853|Stage IA2 or IB1 Carcinoma|stage ia2 or ib1 carcinoma
591983|NCT01048853|Conservative Surgery|conservative surgery
591984|NCT01048853|Cervix Cancer recurrence|cervix cancer recurrence
591985|NCT01048853|Quality of Life Factors|quality of life factors
591986|NCT01048853|Pelvic lymph nodes|pelvic lymph nodes
591987|NCT01048853|Pelvic Lymphadenectomy|pelvic lymphadenectomy
591988|NCT01048853|parametrium|parametrium
591989|NCT01048853|Cervical cone biopsy|cervical cone biopsy
591990|NCT01048853|Endocervical curettage|endocervical curettage
591991|NCT01048853|ECC|ecc
591992|NCT01048840|Gastroesophageal Reflux|gastroesophageal reflux
591993|NCT01048827|AML|aml
591994|NCT01048827|autologous transplant|autologous transplant
591995|NCT01048801|History of fever|history of fever
591996|NCT01048801|measured fever|measured fever
591997|NCT01048788|Cirrhosis|cirrhosis
591998|NCT01048788|ascites|ascites
591999|NCT01048788|Tolvaptan|tolvaptan
592000|NCT01048788|OPC-41061|opc-41061
592001|NCT01048775|bispectral index|bispectral index
592002|NCT01048775|cardiac surgery|cardiac surgery
592003|NCT01048775|asymmetry|asymmetry
592004|NCT01048762|pulmonary cancer|pulmonary cancer
592005|NCT01048762|radically operated|radically operated
592006|NCT01048762|exercise training|exercise training
592007|NCT01048762|dyspnea counseling|dyspnea counseling
592008|NCT01048762|quality of life|quality of life
592009|NCT01048762|physical therapy|physical therapy
592010|NCT01048749|Low back pain|low back pain
592011|NCT01048749|nerve root compression|nerve root compression
592012|NCT01048749|spinal height|spinal height
592013|NCT01048736|obesity|obesity
592014|NCT01048736|exercise|exercise
592015|NCT01048736|intensity|intensity
592016|NCT01048736|weight loss|weight loss
592017|NCT01048736|diet|diet
592018|NCT01048723|Soft Tissue|soft tissue
592019|NCT01048723|Retroperitoneal|retroperitoneal
592020|NCT01048723|resectable|resectable
592021|NCT01048710|Knee osteoarthritis|knee osteoarthritis
592022|NCT01048710|knee osteonecrosis|knee osteonecrosis
592023|NCT01048710|osteotomy|osteotomy
592024|NCT01048697|Obesity|obesity
592025|NCT01048697|Pharmacokinetics|pharmacokinetics
592026|NCT01048697|Pharmacodynamics|pharmacodynamics
592027|NCT01048697|Dose individualization|dose individualization
592028|NCT01048697|Tuberculosis|tuberculosis
592029|NCT01048684|Brain tumor|brain tumor
592030|NCT01048684|Intracranial pressure|intracranial pressure
592031|NCT01048671|HIV|hiv
592032|NCT01048658|Sevoflurane|sevoflurane
592033|NCT01048658|anesthesia|anesthesia
592034|NCT01048658|abortion|abortion
592035|NCT01048658|blood loss|blood loss
592036|NCT01048645|All-trans retinoic acid|all-trans retinoic acid
592037|NCT01048645|non-small cell lung cancer|non-small cell lung cancer
592038|NCT01048645|retinoic acid receptor beta|retinoic acid receptor beta
592039|NCT01048645|chemotherapy|chemotherapy
592040|NCT01048632|Neonates with HLHS or variant with plan to undergo Norwood Procedure|neonates with hlhs or variant with plan to undergo norwood procedure
592041|NCT01048619|Myelodysplastic Syndrome|myelodysplastic syndrome
592042|NCT01048619|MDS|mds
592043|NCT01048606|Postmenopause|postmenopause
592044|NCT01048606|Overweight|overweight
592045|NCT01048606|Women|women
592046|NCT01048606|Phytoestrogens|phytoestrogens
592047|NCT01048606|Exercise|exercise
592048|NCT01048606|Cardiovascular Diseases|cardiovascular diseases
592049|NCT01048606|Risk Factors|risk factors
592050|NCT01048606|Aging|aging
592051|NCT01048593|ocular inflammation cataract surgery|ocular inflammation cataract surgery
592052|NCT01048593|post cataract surgery inflammation|post cataract surgery inflammation
592053|NCT01048580|Perifosine|perifosine
592054|NCT01048580|Capecitabine|capecitabine
592055|NCT01048580|Colon Cancer|colon cancer
592056|NCT01048567|Antibiotics|antibiotics
592057|NCT01048567|Diarrhea|diarrhea
592058|NCT01048567|Clostridium difficile|clostridium difficile
592059|NCT01048567|Probiotics|probiotics
592060|NCT01048567|Prevention & control|prevention & control
592061|NCT01048554|Melanoma|melanoma
592062|NCT01048554|Brain mets|brain mets
592063|NCT01048554|Bevacizumab|bevacizumab
592064|NCT01048554|Temozolomide|temozolomide
592065|NCT01048554|Avastin|avastin
592066|NCT01048554|Temodar|temodar
592067|NCT01048554|Melanoma with brain mets|melanoma with brain mets
592068|NCT01048528|immune response to vaccines|immune response to vaccines
592069|NCT01048528|stress management|stress management
592070|NCT01048528|perceived risk for breast cancer|perceived risk for breast cancer
592071|NCT01048515|Caffeine|caffeine
592072|NCT01048515|Physiological Effects of Drugs|physiological effects of drugs
592073|NCT01048515|Central Nervous System Agents|central nervous system agents
592074|NCT01048502|healthy volunteer|healthy volunteer
592075|NCT01048476|AMD|amd
592076|NCT01048463|gastric cancer|gastric cancer
592077|NCT01048463|colorectal cancer|colorectal cancer
592078|NCT01048463|chemotherapy|chemotherapy
592079|NCT01048463|eicosapentaenoic acid|eicosapentaenoic acid
592080|NCT01048463|enteral nutrition|enteral nutrition
592081|NCT01048450|arthritis|arthritis
592082|NCT01048450|degeneration|degeneration
592083|NCT01048424|Urinary incontinence|urinary incontinence
592084|NCT01048424|Paced respiration|paced respiration
592085|NCT01048411|stroke rehabilitation|stroke rehabilitation
592086|NCT01048411|outcome|outcome
592087|NCT01048411|barthel-index|barthel-index
592088|NCT01048411|geriatrics|geriatrics
592089|NCT01048411|elderly|elderly
592090|NCT01048398|ceophalic version|ceophalic version
592091|NCT01048398|breech presentation|breech presentation
592092|NCT01048398|pregnancy|pregnancy
592093|NCT01048398|remifentanil|remifentanil
592094|NCT01048398|paracetamol|paracetamol
592095|NCT01048385|Mitochondrial dysfunction|mitochondrial dysfunction
592096|NCT01048385|Mitochondrial nutrients|mitochondrial nutrients
592097|NCT01048385|Aneuploidy|aneuploidy
592098|NCT01048385|Meiotic Spindle|meiotic spindle
592099|NCT01048385|Coenzyme Q10|coenzyme q10
592100|NCT01048385|Electron transfer chain|electron transfer chain
592101|NCT01048372|HIV|hiv
592102|NCT01048372|monoclonal antibody|monoclonal antibody
592103|NCT01048372|immune therapy|immune therapy
592104|NCT01048372|pathogenesis|pathogenesis
592105|NCT01048372|cytotoxic T lymphocyte|cytotoxic t lymphocyte
592106|NCT01048372|anti-CD4|anti-cd4
592107|NCT01048372|anti-self|anti-self
592108|NCT01048372|viral replication|viral replication
592109|NCT01048372|Acute Infection|acute infection
592110|NCT01048359|Drug abuse, injury, trauma, screening, brief intervention.|drug abuse, injury, trauma, screening, brief intervention.
592111|NCT01048346|employment, disabilities|employment, disabilities
592112|NCT01048333|Chronic Obstructive Pulmonary Disease|chronic obstructive pulmonary disease
592113|NCT01048333|Onset of effect|onset of effect
592114|NCT01048333|COPD|copd
592115|NCT01048333|Oxis Turbuhaler|oxis turbuhaler
592116|NCT01048320|pancreatic cancer|pancreatic cancer
592117|NCT01048320|toxicity|toxicity
592118|NCT01048320|chemotherapy|chemotherapy
592119|NCT01048320|dose finding|dose finding
592120|NCT01048307|prontosan|prontosan
592121|NCT01048307|wound cleansing|wound cleansing
592122|NCT01048307|wound irrigation|wound irrigation
592123|NCT01048307|phmb|phmb
592124|NCT01048307|polihexanide|polihexanide
592125|NCT01048307|betaine|betaine
592126|NCT01048294|Seasonal affective disorder|seasonal affective disorder
592127|NCT01048294|phototherapy|phototherapy
592128|NCT01048294|circadian rhythms|circadian rhythms
592129|NCT01048294|blue enriched light|blue enriched light
592130|NCT01048294|melanopsin|melanopsin
592131|NCT01048294|Primary disease: Seasonal Affective Disorder, winter type|primary disease: seasonal affective disorder, winter type
592132|NCT01048268|T1DM|t1dm
592133|NCT01048268|T2DM|t2dm
592134|NCT01048268|GIP|gip
592135|NCT01048268|Glucose-dependent insulinotropic polypeptide|glucose-dependent insulinotropic polypeptide
592136|NCT01048268|Incretin|incretin
592137|NCT01048216|colorectal liver cancer|colorectal liver cancer
592138|NCT01048216|metastatic|metastatic
592139|NCT01048216|radiation therapy|radiation therapy
592140|NCT01048203|14C ABR 215050 Metabolism and Mass Balance Study|14c abr 215050 metabolism and mass balance study
592141|NCT01048203|tasquinimod|tasquinimod
592142|NCT01048203|Metabolic pattern of 14C ABR-215050|metabolic pattern of 14c abr-215050
592143|NCT01048190|Inactivated Poliomyelitis Vaccine|inactivated poliomyelitis vaccine
592144|NCT01048190|Sabin Strains|sabin strains
592145|NCT01048190|poliomyelitis|poliomyelitis
592146|NCT01048177|vulvodynia|vulvodynia
592147|NCT01048177|interstitial cystitis|interstitial cystitis
592148|NCT01048177|pelvic pain|pelvic pain
592149|NCT01048164|Massage|massage
592150|NCT01048164|Relaxation|relaxation
592151|NCT01048151|Prostate|prostate
592152|NCT01048151|TNFerade Biologic|tnferade biologic
752491|NCT00432055|Adult|adult
592153|NCT01048138|Biperiden|biperiden
592154|NCT01048138|Post-traumatic Epilepsy|post-traumatic epilepsy
592155|NCT01048138|Traumatic Brain Injury|traumatic brain injury
592156|NCT01048125|Stress-induced cardiomyopathy|stress-induced cardiomyopathy
592157|NCT01048125|Takotsubo cardiomyopathy|takotsubo cardiomyopathy
592158|NCT01048112|campylobacter|campylobacter
592159|NCT01048112|gastroenteritis|gastroenteritis
592160|NCT01048112|challenge models|challenge models
592161|NCT01048099|Breast Cancer|breast cancer
592162|NCT01048099|Metastatic|metastatic
592163|NCT01048099|PRO Onc Assay|pro onc assay
592164|NCT01048099|FISH Testing|fish testing
592165|NCT01048099|HER Negative|her negative
592166|NCT01048099|HER Overexpression|her overexpression
592167|NCT01048099|HER Activation|her activation
592168|NCT01048086|neuroblastoma|neuroblastoma
592169|NCT01048086|neuroendocrine tumor|neuroendocrine tumor
592170|NCT01048086|NET|net
592171|NCT01048086|retinoic acid|retinoic acid
592172|NCT01048073|lower respiratory tract infection|lower respiratory tract infection
592173|NCT01048073|non influenza|non influenza
592174|NCT01048073|PCR assay|pcr assay
592175|NCT01048047|aliskiren|aliskiren
592176|NCT01048047|amlodipine|amlodipine
592177|NCT01048047|hypertension|hypertension
592178|NCT01048047|ankle-foot volume|ankle-foot volume
592179|NCT01048047|mild and moderate hypertension|mild and moderate hypertension
592180|NCT01048034|Myelodysplastic syndrome|myelodysplastic syndrome
592181|NCT01048034|Chronic myelomonocytic leukemia|chronic myelomonocytic leukemia
592182|NCT01048034|Transfusion therapy|transfusion therapy
592183|NCT01048034|Transfusion dependency|transfusion dependency
592184|NCT01048034|Hypomethylating therapy|hypomethylating therapy
592185|NCT01048034|Azacitidine|azacitidine
592186|NCT01048034|DNA-methylation|dna-methylation
592187|NCT01048034|Epigenetic modifications|epigenetic modifications
592188|NCT01048021|Measurement of lung mechanics (FEV1, FVC and PEF)|measurement of lung mechanics (fev1, fvc and pef)
592189|NCT01048008|Glioblastoma multiforme|glioblastoma multiforme
592190|NCT01048008|Advanced cancers|advanced cancers
592191|NCT01048008|Brain Neoplasms, Malignant, Primary|brain neoplasms, malignant, primary
592192|NCT01048008|Brain Tumor, Recurrent|brain tumor, recurrent
592193|NCT01048008|Advanced cancer|advanced cancer
592194|NCT01047982|gestational diabetes|gestational diabetes
592195|NCT01047982|macrosomia|macrosomia
592196|NCT01047982|hypertension in pregnancy|hypertension in pregnancy
592197|NCT01047982|HOMA-IR|homa-ir
592198|NCT01047982|obesity|obesity
592199|NCT01047969|locally invasive high-risk rectal adenocarcinoma|locally invasive high-risk rectal adenocarcinoma
592200|NCT01047956|Methadone|methadone
592201|NCT01047956|NAC|nac
592202|NCT01047956|opioids|opioids
592203|NCT01047930|Insomnia|insomnia
592204|NCT01047930|Smoking|smoking
592205|NCT01047930|Cue reactivity|cue reactivity
592206|NCT01047930|Exercise timing|exercise timing
592207|NCT01047930|Acute nicotine withdrawal|acute nicotine withdrawal
592208|NCT01047930|Mood disturbances|mood disturbances
592209|NCT01047930|Smoking abstinence|smoking abstinence
592210|NCT01047930|Exercise intensity|exercise intensity
592211|NCT01047930|Altered sleep|altered sleep
592212|NCT01047930|Exercise duration|exercise duration
592213|NCT01047930|Nonpharmacologic behavioral treatment|nonpharmacologic behavioral treatment
592214|NCT01047930|Smoking cessation|smoking cessation
592215|NCT01047930|Exercise Test|exercise test
592216|NCT01047930|Polysomnography|polysomnography
592217|NCT01047917|Meditation|meditation
592218|NCT01047917|Relaxation Therapy|relaxation therapy
592219|NCT01047917|Quality of Life|quality of life
592220|NCT01047865|Type 1 Diabetes (T1D)|type 1 diabetes (t1d)
592221|NCT01047865|Autoimmunity|autoimmunity
592222|NCT01047852|chronic respiratory disorders|chronic respiratory disorders
592223|NCT01047852|hypercapnic respiratory failure|hypercapnic respiratory failure
592224|NCT01047852|noninvasive ventilation|noninvasive ventilation
592225|NCT01047839|Pediatric|pediatric
592226|NCT01047839|Japanese Encephalitis Vaccine|japanese encephalitis vaccine
592227|NCT01047839|non-endemic countries|non-endemic countries
592228|NCT01047839|to assess immunogenicity of purified inactivated Japanese Encephalitis (JE) vaccine IC51|to assess immunogenicity of purified inactivated japanese encephalitis (je) vaccine ic51
592229|NCT01047826|Fractured Tibia|fractured tibia
592230|NCT01047826|Expert Tibial Nail|expert tibial nail
592231|NCT01047826|Minimally Invasive Plate Osteosynthesis (M.I.P.O)|minimally invasive plate osteosynthesis (m.i.p.o)
592232|NCT01047826|Intramedullary Nailing|intramedullary nailing
592233|NCT01047826|Locked Plate|locked plate
592234|NCT01047826|distal third|distal third
592235|NCT01047826|43-A|43-a
592236|NCT01047813|Cognitive performance|cognitive performance
592237|NCT01047813|Type 2 diabetes|type 2 diabetes
592238|NCT01047813|Blood glucose|blood glucose
592239|NCT01047800|Functional gastrointestinal disorder|functional gastrointestinal disorder
592240|NCT01047800|GERD|gerd
592241|NCT01047800|reflux|reflux
592242|NCT01047800|irritable bowel syndrome|irritable bowel syndrome
592243|NCT01047800|Functional dyspepsia|functional dyspepsia
592244|NCT01047800|postprandial fullness|postprandial fullness
592245|NCT01047800|counseling|counseling
592246|NCT01047800|service|service
592247|NCT01047787|Sleep apnea|sleep apnea
592248|NCT01047787|Cheyne-Stokes Respiration|cheyne-stokes respiration
592249|NCT01047787|Congestive Heart Failure|congestive heart failure
592250|NCT01047774|soy protein|soy protein
592251|NCT01047774|diet|diet
592252|NCT01047761|Myasthenia Gravis|myasthenia gravis
592253|NCT01047761|Exercise|exercise
592254|NCT01047761|Fitness|fitness
592255|NCT01047761|Body Composition|body composition
592256|NCT01047761|Physical Activity|physical activity
592257|NCT01047761|Pulmonary Function|pulmonary function
592258|NCT01047761|Balance|balance
592259|NCT01047748|abortion|abortion
592260|NCT01047735|21+ years old|21+ years old
592261|NCT01047735|Address|address
592262|NCT01047735|Adult|adult
592263|NCT01047735|Amputation|amputation
592264|NCT01047735|Area|area
592265|NCT01047735|Arm|arm
592266|NCT01047735|Atheroscleroses|atheroscleroses
592267|NCT01047735|Atherosclerosis|atherosclerosis
592268|NCT01047735|Atherosclerotic|atherosclerotic
592269|NCT01047735|Cardiovascular Disease|cardiovascular disease
592270|NCT01047735|Bariatrics|bariatrics
592271|NCT01047735|Behavior Conditioning Therapy|behavior conditioning therapy
592272|NCT01047735|Behavior Modification|behavior modification
592273|NCT01047735|Behavior Therapy|behavior therapy
592274|NCT01047735|Behavior Treatment|behavior treatment
592275|NCT01047735|Behavior or Life Style Modifications|behavior or life style modifications
592276|NCT01047735|Behavioral|behavioral
592277|NCT01047735|Behavioral Conditioning Therapy|behavioral conditioning therapy
592278|NCT01047735|Behavioral Modification|behavioral modification
592279|NCT01047735|Behavioral Therapy|behavioral therapy
592280|NCT01047735|Behavioral Treatment|behavioral treatment
592281|NCT01047735|Beta Cell|beta cell
592282|NCT01047735|Blindness|blindness
592283|NCT01047735|Blood Pressure, High|blood pressure, high
592284|NCT01047735|Blood Vessels|blood vessels
592285|NCT01047735|Body Composition|body composition
592286|NCT01047735|Body Weight decreased|body weight decreased
592287|NCT01047735|Cancers|cancers
592288|NCT01047735|Cardiac infarction|cardiac infarction
592289|NCT01047735|Cardiovascular Diseases|cardiovascular diseases
592290|NCT01047735|Care, Health|care, health
592291|NCT01047735|Cause of Death|cause of death
592292|NCT01047735|Cell Function|cell function
592293|NCT01047735|Cell Process|cell process
592294|NCT01047735|Cell physiology|cell physiology
592295|NCT01047735|Cellular Function|cellular function
592296|NCT01047735|Cellular Physiology|cellular physiology
592297|NCT01047735|Cellular Process|cellular process
592298|NCT01047735|Cessation of life|cessation of life
592299|NCT01047735|Clinical|clinical
592300|NCT01047735|Clinical Trials Design|clinical trials design
592301|NCT01047735|Communities|communities
592302|NCT01047735|Conditioning Therapy|conditioning therapy
592303|NCT01047735|Controlled Clinical Trials, Randomized|controlled clinical trials, randomized
592304|NCT01047735|Controlled Study|controlled study
592305|NCT01047735|Country|country
592306|NCT01047735|D-Glucose|d-glucose
592307|NCT01047735|Death|death
592308|NCT01047735|Decision Making|decision making
592309|NCT01047735|Dextrose|dextrose
592310|NCT01047735|Diabetes Mellitus|diabetes mellitus
592311|NCT01047735|Diabetes Mellitus, Adult-Onset|diabetes mellitus, adult-onset
592312|NCT01047735|Diabetes Mellitus, Ketosis-Resistant|diabetes mellitus, ketosis-resistant
592313|NCT01047735|Diabetes Mellitus, Non-Insulin-Dependent|diabetes mellitus, non-insulin-dependent
592314|NCT01047735|Diabetes Mellitus, Noninsulin Dependent|diabetes mellitus, noninsulin dependent
592315|NCT01047735|Diabetes Mellitus, Slow-Onset|diabetes mellitus, slow-onset
592316|NCT01047735|Diabetes Mellitus, Stable|diabetes mellitus, stable
592317|NCT01047735|Diabetes Mellitus, Type 2|diabetes mellitus, type 2
592318|NCT01047735|Diabetes Mellitus, Type II|diabetes mellitus, type ii
592319|NCT01047735|Diet|diet
592320|NCT01047735|Disease|disease
592321|NCT01047735|Disease remission|disease remission
592322|NCT01047735|Disorder|disorder
592323|NCT01047735|Drugs|drugs
592324|NCT01047735|Dysfunction|dysfunction
592325|NCT01047735|Effectiveness|effectiveness
592326|NCT01047735|Epidemic|epidemic
592327|NCT01047735|Functional disorder|functional disorder
592328|NCT01047735|Future|future
592329|NCT01047735|Gastric Bypass|gastric bypass
592330|NCT01047735|Glucose|glucose
592331|NCT01047735|Health|health
592332|NCT01047735|Healthcare|healthcare
592333|NCT01047735|Hepatic Disorder|hepatic disorder
592334|NCT01047735|Human, Adult|human, adult
592335|NCT01047735|Hypertension|hypertension
592336|NCT01047735|INFLM|inflm
592337|NCT01047735|Incidence|incidence
592338|NCT01047735|Inflammation|inflammation
592339|NCT01047735|Insulin Cell|insulin cell
592340|NCT01047735|Insulin Resistance|insulin resistance
592341|NCT01047735|Insulin Secreting Cell|insulin secreting cell
592342|NCT01047735|Intestinal|intestinal
592343|NCT01047735|Intestines|intestines
711680|NCT00583544|Healthy Volunteers|healthy volunteers
592344|NCT01047735|Intravenous Glucose Tolerance|intravenous glucose tolerance
592345|NCT01047735|Intravenous Glucose Tolerance Test|intravenous glucose tolerance test
592346|NCT01047735|Kidney Failure|kidney failure
592347|NCT01047735|Kidney Insufficiency|kidney insufficiency
592348|NCT01047735|Learning|learning
592349|NCT01047735|Life Style|life style
592350|NCT01047735|Life Style Modification|life style modification
592351|NCT01047735|Lifestyle|lifestyle
592352|NCT01047735|Link|link
592353|NCT01047735|Liver diseases|liver diseases
592354|NCT01047735|Longitudinal Studies|longitudinal studies
592355|NCT01047735|MODY|mody
592356|NCT01047735|Malignant Neoplasms|malignant neoplasms
592357|NCT01047735|Malignant Tumor|malignant tumor
592358|NCT01047735|Maturity-Onset Diabetes Mellitus|maturity-onset diabetes mellitus
592359|NCT01047735|Measures|measures
592360|NCT01047735|Medical|medical
592361|NCT01047735|Medication|medication
592362|NCT01047735|Metabolic|metabolic
592363|NCT01047735|Methods|methods
592364|NCT01047735|Modification|modification
592365|NCT01047735|Morbid Obesity|morbid obesity
592366|NCT01047735|Morbidity|morbidity
592367|NCT01047735|Morbidity - disease rate|morbidity - disease rate
592368|NCT01047735|Mortality|mortality
592369|NCT01047735|Mortality Vital Statistics|mortality vital statistics
592370|NCT01047735|Myocardial Infarct|myocardial infarct
592371|NCT01047735|Myocardial Infarction|myocardial infarction
592372|NCT01047735|NAFLD|nafld
592373|NCT01047735|NASH|nash
592374|NCT01047735|NIDDM|niddm
592375|NCT01047735|Non-Insulin Dependent Diabetes|non-insulin dependent diabetes
592376|NCT01047735|Non-Insulin-Dependent Diabetes Mellitus|non-insulin-dependent diabetes mellitus
592377|NCT01047735|Non-alcoholic steatohepatitis|non-alcoholic steatohepatitis
592378|NCT01047735|Obesity|obesity
592379|NCT01047735|Obesity, Morbid|obesity, morbid
592380|NCT01047735|Operation|operation
592381|NCT01047735|Operative Procedures|operative procedures
592382|NCT01047735|Operative Surgical Procedures|operative surgical procedures
592383|NCT01047735|Outcome|outcome
592384|NCT01047735|Outcome Measure|outcome measure
592385|NCT01047735|PROV|prov
592386|NCT01047735|Participant|participant
592387|NCT01047735|Patients|patients
592388|NCT01047735|Pharmaceutic Preparations|pharmaceutic preparations
592389|NCT01047735|Pharmaceutical Preparations|pharmaceutical preparations
592390|NCT01047735|Physical activity|physical activity
592391|NCT01047735|Physiopathology|physiopathology
592392|NCT01047735|Pilot Projects|pilot projects
592393|NCT01047735|Population|population
592394|NCT01047735|Procedures|procedures
592395|NCT01047735|Programs (PT)|programs (pt)
592396|NCT01047735|Programs [Publication Type]|programs [publication type]
592397|NCT01047735|Provider|provider
592398|NCT01047735|Psychosocial Factor|psychosocial factor
592399|NCT01047735|Public Health|public health
592400|NCT01047735|RMSN|rmsn
592401|NCT01047735|Randomized|randomized
592402|NCT01047735|Randomized Controlled Clinical Trials|randomized controlled clinical trials
592403|NCT01047735|Randomized Controlled Trials|randomized controlled trials
592404|NCT01047735|Remission|remission
592405|NCT01047735|Renal Failure|renal failure
592406|NCT01047735|Renal Insufficiency|renal insufficiency
592407|NCT01047735|Reporting|reporting
592408|NCT01047735|Resolution|resolution
592409|NCT01047735|Science|science
592410|NCT01047735|Severe obesity|severe obesity
592411|NCT01047735|Structure|structure
592412|NCT01047735|Subcellular Process|subcellular process
592413|NCT01047735|Surgical|surgical
592414|NCT01047735|Surgical Interventions|surgical interventions
592415|NCT01047735|Surgical Procedure|surgical procedure
592416|NCT01047735|T2D|t2d
592417|NCT01047735|T2DM|t2dm
592418|NCT01047735|Testing|testing
592419|NCT01047735|Type 2 diabetes|type 2 diabetes
592420|NCT01047735|Type II diabetes|type ii diabetes
592421|NCT01047735|United States|united states
592422|NCT01047735|Upper arm|upper arm
592423|NCT01047735|Vascular Hypertensive Disease|vascular hypertensive disease
592424|NCT01047735|Vascular Hypertensive Disorder|vascular hypertensive disorder
592425|NCT01047735|Weight|weight
592426|NCT01047735|Weight Loss|weight loss
592427|NCT01047735|Weight Reduction|weight reduction
592428|NCT01047735|Work|work
592429|NCT01047735|adiposity|adiposity
592430|NCT01047735|adult human (21+)|adult human (21+)
592431|NCT01047735|adult onset diabetes|adult onset diabetes
592432|NCT01047735|atheromatosis|atheromatosis
592433|NCT01047735|atherosclerotic vascular disease|atherosclerotic vascular disease
592434|NCT01047735|bariatric surgery|bariatric surgery
592435|NCT01047735|behavior intervention|behavior intervention
592436|NCT01047735|behavioral intervention|behavioral intervention
592437|NCT01047735|blood glucose regulation|blood glucose regulation
592438|NCT01047735|body weight loss|body weight loss
592439|NCT01047735|bowel|bowel
592440|NCT01047735|cardiac infarct|cardiac infarct
592441|NCT01047735|cardiovascular disorder|cardiovascular disorder
592442|NCT01047735|cardiovascular risk|cardiovascular risk
592443|NCT01047735|cardiovascular risk factor|cardiovascular risk factor
592444|NCT01047735|clinical practice|clinical practice
592445|NCT01047735|comparative effectiveness|comparative effectiveness
592446|NCT01047735|coronary attack|coronary attack
592447|NCT01047735|coronary infarct|coronary infarct
592448|NCT01047735|coronary infarction|coronary infarction
592449|NCT01047735|corpulence|corpulence
592450|NCT01047735|corpulency|corpulency
592451|NCT01047735|corpulentia|corpulentia
592452|NCT01047735|design|design
592453|NCT01047735|designing|designing
592454|NCT01047735|diabetes|diabetes
592455|NCT01047735|diabetic patient|diabetic patient
592456|NCT01047735|disease/disorder|disease/disorder
592457|NCT01047735|drug/agent|drug/agent
592458|NCT01047735|effective therapy|effective therapy
592459|NCT01047735|effectiveness research|effectiveness research
592460|NCT01047735|fitness|fitness
592461|NCT01047735|gastric banding|gastric banding
592462|NCT01047735|gastric bypass surgery|gastric bypass surgery
592463|NCT01047735|glucose control|glucose control
592464|NCT01047735|glucose homeostasis|glucose homeostasis
592465|NCT01047735|glucose metabolism|glucose metabolism
592466|NCT01047735|glucose regulation|glucose regulation
592467|NCT01047735|heart attack|heart attack
592468|NCT01047735|heart infarct|heart infarct
592469|NCT01047735|heart infarction|heart infarction
592470|NCT01047735|hepatopathy|hepatopathy
592471|NCT01047735|hyperpiesia|hyperpiesia
592472|NCT01047735|hyperpiesis|hyperpiesis
592473|NCT01047735|hypertensive disease|hypertensive disease
592474|NCT01047735|implantable gastric stimulation banding|implantable gastric stimulation banding
592475|NCT01047735|insulin resistant|insulin resistant
592476|NCT01047735|interest|interest
592477|NCT01047735|ketosis resistant diabetes|ketosis resistant diabetes
592478|NCT01047735|life style intervention|life style intervention
592479|NCT01047735|lifestyle intervention|lifestyle intervention
592480|NCT01047735|liver disorder|liver disorder
592481|NCT01047735|long-term study|long-term study
592482|NCT01047735|malignancy|malignancy
592483|NCT01047735|maturity onset diabetes|maturity onset diabetes
592484|NCT01047735|moderate obesity|moderate obesity
592485|NCT01047735|neoplasm/cancer|neoplasm/cancer
592486|NCT01047735|non-alcohol fatty liver|non-alcohol fatty liver
592487|NCT01047735|non-alcohol induced steatohepatitis|non-alcohol induced steatohepatitis
592488|NCT01047735|non-alcoholic fatty liver|non-alcoholic fatty liver
592489|NCT01047735|non-alcoholic steato-hepatitis|non-alcoholic steato-hepatitis
592490|NCT01047735|nonalcohol fatty liver|nonalcohol fatty liver
592491|NCT01047735|nonalcoholic fatty liver|nonalcoholic fatty liver
592492|NCT01047735|nonalcoholic steato-hepatitis|nonalcoholic steato-hepatitis
592493|NCT01047735|nonalcoholic steatohepatitis|nonalcoholic steatohepatitis
592495|NCT01047735|obese people|obese people
592496|NCT01047735|obese person|obese person
592497|NCT01047735|obese population|obese population
592498|NCT01047735|obesity surgery|obesity surgery
592499|NCT01047735|obesity, extreme|obesity, extreme
592500|NCT01047735|pathophysiology|pathophysiology
592501|NCT01047735|pilot study|pilot study
592502|NCT01047735|programs|programs
592503|NCT01047735|psychosocial|psychosocial
592504|NCT01047735|psychosocial variables|psychosocial variables
592505|NCT01047735|public health medicine (field)|public health medicine (field)
592506|NCT01047735|public health relevance|public health relevance
592507|NCT01047735|randomisation|randomisation
592508|NCT01047735|randomization|randomization
592509|NCT01047735|randomized controlled study|randomized controlled study
592510|NCT01047735|randomized trial|randomized trial
592511|NCT01047735|randomly assigned|randomly assigned
592512|NCT01047735|respiratory|respiratory
592513|NCT01047735|response|response
592514|NCT01047735|stomach bypass|stomach bypass
592515|NCT01047735|stomach stapling|stomach stapling
592516|NCT01047735|surgery|surgery
592517|NCT01047735|trial comparing|trial comparing
592518|NCT01047735|vascular|vascular
592519|NCT01047735|weight loss intervention|weight loss intervention
592520|NCT01047735|weight loss surgery|weight loss surgery
592521|NCT01047735|wt-loss|wt-loss
592522|NCT01047722|platelet function test|platelet function test
592523|NCT01047722|platelets|platelets
592524|NCT01047722|in vivo test|in vivo test
592525|NCT01047722|aspirin|aspirin
592526|NCT01047722|aspirin resistance|aspirin resistance
592527|NCT01047722|aspirin non-responsiveness|aspirin non-responsiveness
592528|NCT01047722|in-vivo|in-vivo
592529|NCT01047722|To assess the specificity and sensitivity of a novel in-vivo diagnostic test of platelet function|to assess the specificity and sensitivity of a novel in-vivo diagnostic test of platelet function
592530|NCT01047722|"To use this test to define and assess aspirin resistance"|"to use this test to define and assess aspirin resistance"
592531|NCT01047683|hypertriglyceridemia|hypertriglyceridemia
592532|NCT01047683|omega-3 fatty acids|omega-3 fatty acids
592533|NCT01047683|statin|statin
592534|NCT01047683|triglycerides|triglycerides
592535|NCT01047683|lipids|lipids
592536|NCT01047683|EPA|epa
592537|NCT01047683|docosahexaenoic acid|docosahexaenoic acid
592538|NCT01047683|fish|fish
592539|NCT01047683|fatty acids|fatty acids
592540|NCT01047683|fibrates|fibrates
592541|NCT01047683|niacin|niacin
592542|NCT01047683|lipid|lipid
752954|NCT00430313|CINV|cinv
592543|NCT01047683|atorvastatin|atorvastatin
592544|NCT01047683|Lovaza|lovaza
592545|NCT01047683|simvastatin|simvastatin
592546|NCT01047683|lovastatin|lovastatin
592547|NCT01047683|pravastatin|pravastatin
592548|NCT01047683|fluvastatin|fluvastatin
592549|NCT01047683|rosuvastatin|rosuvastatin
592550|NCT01047683|Trilipix|trilipix
592551|NCT01047683|Vytorin|vytorin
592552|NCT01047683|Simcor|simcor
592553|NCT01047683|Niaspan|niaspan
592554|NCT01047683|ezetimibe|ezetimibe
592555|NCT01047683|Zetia|zetia
592556|NCT01047683|ethyl-EPA|ethyl-epa
592557|NCT01047683|ethyl icosapentate|ethyl icosapentate
592558|NCT01047683|Crestor|crestor
592559|NCT01047683|Zocor|zocor
592560|NCT01047683|Lipitor|lipitor
592561|NCT01047683|LDL|ldl
592562|NCT01047683|HDL|hdl
592563|NCT01047683|cholesterol|cholesterol
592564|NCT01047683|dyslipidemia|dyslipidemia
592565|NCT01047683|VASCEPA|vascepa
592566|NCT01047683|icosapent ethyl|icosapent ethyl
592567|NCT01047670|sepsis, shock, adrenal insufficiency, hydrocortisone, children, paediatric intensive care.|sepsis, shock, adrenal insufficiency, hydrocortisone, children, paediatric intensive care.
592568|NCT01047670|number of days free of vasoactive support in 7 days|number of days free of vasoactive support in 7 days
592569|NCT01047670|days free of mechanical ventilation|days free of mechanical ventilation
592570|NCT01047670|PICU mortality|picu mortality
592571|NCT01047670|mortality among patient with inappropriate response to the ACTH test|mortality among patient with inappropriate response to the acth test
592572|NCT01047670|baseline cortisol/ PIM2 correlation|baseline cortisol/ pim2 correlation
592573|NCT01047657|Asthma|asthma
592574|NCT01047657|Obesity|obesity
592575|NCT01047657|weight loss|weight loss
592576|NCT01047644|port|port
592577|NCT01047644|catheter|catheter
592578|NCT01047644|infusion|infusion
592579|NCT01047644|flush|flush
592580|NCT01047644|cleanse|cleanse
592581|NCT01047644|chemotherapy|chemotherapy
592582|NCT01047618|venous thromboembolism|venous thromboembolism
592583|NCT01047605|qEEG|qeeg
592584|NCT01047605|herbal medicine|herbal medicine
592585|NCT01047605|cognitive function|cognitive function
592586|NCT01047605|Neurapas balance|neurapas balance
592587|NCT01047605|Pascoflair|pascoflair
592588|NCT01047605|hypericum|hypericum
592589|NCT01047605|passionflower|passionflower
592590|NCT01047605|valerian|valerian
592591|NCT01047605|Healthy volunteers|healthy volunteers
592592|NCT01047605|Influence on quantitative electro-encephalogram (qEEG).|influence on quantitative electro-encephalogram (qeeg).
592593|NCT01047592|Schizophrenia|schizophrenia
592594|NCT01047592|cognitive function|cognitive function
592595|NCT01047592|N-methyl-D-aspartate receptor|n-methyl-d-aspartate receptor
592596|NCT01047579|Alzheimer's Disease|alzheimer's disease
592597|NCT01047579|Rivastigmine transdermal|rivastigmine transdermal
592598|NCT01047579|caregiver preference|caregiver preference
592599|NCT01047553|Chronic Obstructive Pulmonary Disease|chronic obstructive pulmonary disease
592600|NCT01047553|COPD|copd
592601|NCT01047553|Japanese|japanese
592602|NCT01047553|Phase 3|phase 3
592603|NCT01047553|Safety|safety
592604|NCT01047553|OT|ot
592605|NCT01047553|Oxis|oxis
592606|NCT01047527|nicotine replacement therapy, smoking cessation, transdermal nicotine|nicotine replacement therapy, smoking cessation, transdermal nicotine
592607|NCT01047501|hypertriglyceridemia|hypertriglyceridemia
592608|NCT01047501|omega-3 fatty acids|omega-3 fatty acids
592609|NCT01047501|statin|statin
592610|NCT01047501|triglycerides|triglycerides
592611|NCT01047501|lipids|lipids
592612|NCT01047501|EPA|epa
592613|NCT01047501|docosahexaenoic acid|docosahexaenoic acid
592614|NCT01047501|fish|fish
592615|NCT01047501|fatty acids|fatty acids
592616|NCT01047501|fibrates|fibrates
592617|NCT01047501|niacin|niacin
592618|NCT01047501|lipid|lipid
592619|NCT01047501|atorvastatin|atorvastatin
592620|NCT01047501|Lovaza|lovaza
592621|NCT01047501|simvastatin|simvastatin
592622|NCT01047501|lovastatin|lovastatin
592623|NCT01047501|pravastatin|pravastatin
592624|NCT01047501|fluvastatin|fluvastatin
592625|NCT01047501|rosuvastatin|rosuvastatin
592626|NCT01047501|Trilipix|trilipix
592627|NCT01047501|Vytorin|vytorin
592628|NCT01047501|Simcor|simcor
592629|NCT01047501|Niaspan|niaspan
592630|NCT01047501|ezetimibe|ezetimibe
592631|NCT01047501|Zetia|zetia
592632|NCT01047501|ethyl-EPA|ethyl-epa
592633|NCT01047501|ethyl icosapentate|ethyl icosapentate
592634|NCT01047501|Crestor|crestor
592635|NCT01047501|Zocor|zocor
592636|NCT01047501|Lipitor|lipitor
592637|NCT01047501|LDL|ldl
592638|NCT01047501|HDL|hdl
592639|NCT01047501|cholesterol|cholesterol
592640|NCT01047501|dyslipidemia|dyslipidemia
592641|NCT01047501|VASCEPA|vascepa
592642|NCT01047501|icosapent ethyl|icosapent ethyl
592643|NCT01047488|polyneuropathy|polyneuropathy
592644|NCT01047488|neuropathic pain|neuropathic pain
592645|NCT01047488|treatment|treatment
592646|NCT01047475|MB-6|mb-6
592647|NCT01047475|FOLFOX4|folfox4
592648|NCT01047475|Metastatic Colorectal Cancer|metastatic colorectal cancer
592649|NCT01047449|saphenous vein graft patency|saphenous vein graft patency
592650|NCT01047449|fish oil supplementation|fish oil supplementation
592651|NCT01047449|coronary artery bypass surgery|coronary artery bypass surgery
592652|NCT01047449|coronary artery disease|coronary artery disease
592653|NCT01047436|Plasmodium infections|plasmodium infections
592654|NCT01047436|Remittent fever|remittent fever
592655|NCT01047436|Artemether|artemether
592656|NCT01047436|Artemisinins|artemisinins
592657|NCT01047436|quinine|quinine
592658|NCT01047436|Malaria|malaria
592659|NCT01047436|Protozoan Infections|protozoan infections
592660|NCT01047436|Anti-Infective Agents|anti-infective agents
592661|NCT01047436|Antiprotozoal Agents|antiprotozoal agents
592662|NCT01047436|Schistosomicides|schistosomicides
592663|NCT01047436|Pharmacologic Actions|pharmacologic actions
592664|NCT01047436|Malaria, Falciparum|malaria, falciparum
592665|NCT01047436|Antimalarials|antimalarials
592666|NCT01047436|Antiparasitic Agents|antiparasitic agents
592667|NCT01047436|Parasitic Diseases|parasitic diseases
592668|NCT01047436|sublingual|sublingual
592669|NCT01047423|Hypertension endothelial dysfunction statin prevention|hypertension endothelial dysfunction statin prevention
592670|NCT01047410|physical exercise training|physical exercise training
592671|NCT01047410|quality of life|quality of life
592672|NCT01047410|exercise capacity|exercise capacity
592673|NCT01047410|skeletal muscle strength|skeletal muscle strength
592674|NCT01047410|physical activity level|physical activity level
592675|NCT01047410|costeffectiveness|costeffectiveness
592676|NCT01047410|renal transplantation|renal transplantation
592677|NCT01047410|hemodialysis|hemodialysis
592678|NCT01047410|peritoneal dialysis|peritoneal dialysis
592679|NCT01047410|diet|diet
592680|NCT01047397|hemodialysis|hemodialysis
592681|NCT01047397|tolerability|tolerability
592682|NCT01047397|pharmacokinetics|pharmacokinetics
592683|NCT01047397|safety|safety
592684|NCT01047397|anemia|anemia
592685|NCT01047397|renal impairment|renal impairment
592686|NCT01047397|repeat dose|repeat dose
592687|NCT01047345|Cervical cancer|cervical cancer
592688|NCT01047345|Genital warts|genital warts
592689|NCT01047345|Human papillomavirus vaccine|human papillomavirus vaccine
592690|NCT01047345|GARDASIL™|gardasil™
592691|NCT01047319|Relapsing Multiple Sclerosis|relapsing multiple sclerosis
592692|NCT01047293|colorectal cancer|colorectal cancer
592693|NCT01047280|Conjugated linoleic acid|conjugated linoleic acid
592694|NCT01047280|Body weight|body weight
592695|NCT01047280|Body composition|body composition
592696|NCT01047280|Blood lipid profile|blood lipid profile
592894|NCT01046513|Nicotine|nicotine
592697|NCT01047280|Body inflammatory and oxidative status|body inflammatory and oxidative status
592698|NCT01047267|candidiasis|candidiasis
592699|NCT01047267|invasive fungal disease|invasive fungal disease
592700|NCT01047267|critically ill|critically ill
592701|NCT01047267|anidulafungin|anidulafungin
592702|NCT01047267|pharmacokinetics|pharmacokinetics
592703|NCT01047241|Painful medical procedures|painful medical procedures
592704|NCT01047215|schizophrenia|schizophrenia
592705|NCT01047215|bipolar|bipolar
592706|NCT01047215|aripiprazole|aripiprazole
592707|NCT01047215|quetiapine|quetiapine
592708|NCT01047189|Mild to moderate acne vulgaris|mild to moderate acne vulgaris
592709|NCT01047176|Statins|statins
592710|NCT01047176|Coronary Heart Disease|coronary heart disease
592711|NCT01047176|Percutaneous coronary intervention (PCI)|percutaneous coronary intervention (pci)
592712|NCT01047163|Muscle soreness|muscle soreness
592713|NCT01047163|Simvastatin|simvastatin
592715|NCT01047163|Muscle Atrophy|muscle atrophy
592716|NCT01047150|Myocardial Perfusion Imaging|myocardial perfusion imaging
592717|NCT01047150|Repeat studies|repeat studies
592718|NCT01047150|Tetrofosmin|tetrofosmin
592719|NCT01047150|Sestamibi|sestamibi
592720|NCT01047137|Urticaria|urticaria
592721|NCT01047137|Hives|hives
592722|NCT01047137|Stress|stress
592723|NCT01047137|Immune dysregulation|immune dysregulation
592724|NCT01047124|Depression|depression
592725|NCT01047124|Collaborative Care|collaborative care
592726|NCT01047124|Cognitive Behaviour Therapy|cognitive behaviour therapy
592727|NCT01047124|Mental Health Services|mental health services
592728|NCT01047124|Antidepressants|antidepressants
592729|NCT01047111|Esophageal Neoplasms|esophageal neoplasms
592730|NCT01047111|Esophagectomy|esophagectomy
592731|NCT01047098|Lactation|lactation
592732|NCT01047098|Breastfeeding|breastfeeding
592733|NCT01047098|Iron|iron
592734|NCT01047098|Oxidative stress|oxidative stress
592735|NCT01047098|Iron status and oxidative stress during lactation|iron status and oxidative stress during lactation
592736|NCT01047085|cholecystolithiasis|cholecystolithiasis
592737|NCT01047085|cholecystectomy|cholecystectomy
592738|NCT01047085|gastroesophageal reflux|gastroesophageal reflux
592739|NCT01047085|impedance pH|impedance ph
592740|NCT01047085|The relationship between cholecystolithiasis, cholecystectomy and gastroesophageal reflux by impedance pH-method.|the relationship between cholecystolithiasis, cholecystectomy and gastroesophageal reflux by impedance ph-method.
592741|NCT01047072|Scleroderma, systemic sclerosis, allogeneic hematopoietic stem cell transplantation|scleroderma, systemic sclerosis, allogeneic hematopoietic stem cell transplantation
592742|NCT01047059|NSCLC|nsclc
592743|NCT01047059|Lung Cancer|lung cancer
592744|NCT01047046|SNM device|snm device
592745|NCT01047046|Chart review of patients with surgical placed SNM device|chart review of patients with surgical placed snm device
592746|NCT01047033|Poverty|poverty
592747|NCT01047033|Global health|global health
592748|NCT01047033|International health|international health
592749|NCT01047033|Latin America|latin america
592750|NCT01047033|Peru|peru
592751|NCT01047033|Child health|child health
592752|NCT01047033|Microcredit|microcredit
592753|NCT01047033|Microenterprise|microenterprise
592754|NCT01047033|Microfinance|microfinance
592755|NCT01047020|Impairments of musculoskeletal Health;|impairments of musculoskeletal health;
592756|NCT01047020|Physical activity;|physical activity;
592757|NCT01047020|Motor Proficiency;|motor proficiency;
592758|NCT01047007|Head and Neck Cancer|head and neck cancer
592759|NCT01047007|Esophageal Cancer|esophageal cancer
592760|NCT01047007|Gastric Cancer|gastric cancer
592761|NCT01046981|Surgical site infections|surgical site infections
592762|NCT01046981|Prevention|prevention
592763|NCT01046981|Prophylaxis|prophylaxis
592764|NCT01046981|Tumescent|tumescent
592765|NCT01046981|Intravenous|intravenous
592766|NCT01046981|Antibiotic|antibiotic
592767|NCT01046981|Absorption|absorption
592768|NCT01046981|Pharmacokinetics|pharmacokinetics
592769|NCT01046981|Bioavailability|bioavailability
592770|NCT01046968|Obesity|obesity
592771|NCT01046968|metabolic syndrome|metabolic syndrome
592772|NCT01046968|C-reactive protein|c-reactive protein
592773|NCT01046968|Leptin|leptin
592774|NCT01046955|ESRD|esrd
592775|NCT01046942|Saphenous vein|saphenous vein
592776|NCT01046942|Antiplatelet therapy|antiplatelet therapy
592777|NCT01046942|Hypercoagulable|hypercoagulable
592778|NCT01046942|Clopidogrel resistance|clopidogrel resistance
592779|NCT01046942|Aspirin resistance|aspirin resistance
592780|NCT01046942|Clopidogrel|clopidogrel
592781|NCT01046942|Aspirin|aspirin
592782|NCT01046942|Saphenous vein graft disease|saphenous vein graft disease
592783|NCT01046942|TEG|teg
592784|NCT01046942|Thrombelastography|thrombelastography
592785|NCT01046942|Multiplate aggregometry|multiplate aggregometry
592786|NCT01046942|Multislice CT|multislice ct
592787|NCT01046942|Coronary artery bypass graft surgery|coronary artery bypass graft surgery
592788|NCT01046942|coagulation status|coagulation status
592789|NCT01046942|graft patency|graft patency
592790|NCT01046942|CABG|cabg
592791|NCT01046929|limonene|limonene
592792|NCT01046929|breast cancer|breast cancer
592793|NCT01046929|cancer prevention|cancer prevention
592794|NCT01046903|observational prolonged thromboprophylaxis|observational prolonged thromboprophylaxis
592795|NCT01046890|Darunavir|darunavir
592796|NCT01046890|Echinacea purpurea|echinacea purpurea
592797|NCT01046890|Interaction|interaction
592798|NCT01046890|Complementary Therapies|complementary therapies
592799|NCT01046864|Gastro-Intestinal Cancer, NOS|gastro-intestinal cancer, nos
592800|NCT01046838|Diastolic Heart Failure|diastolic heart failure
592801|NCT01046825|Lymphoma|lymphoma
592802|NCT01046825|Leukemia|leukemia
592803|NCT01046825|Non-Hodgkin's Lymphoma|non-hodgkin's lymphoma
592804|NCT01046812|questionnaire|questionnaire
592805|NCT01046812|halitosis|halitosis
592806|NCT01046812|caphosol|caphosol
592807|NCT01046812|Quality of life questionnaire assessing halitosis|quality of life questionnaire assessing halitosis
592808|NCT01046799|hepatitis B|hepatitis b
592809|NCT01046799|liver transplantation|liver transplantation
592810|NCT01046799|shortterm HBIg|shortterm hbig
592811|NCT01046799|lamivudine resistance|lamivudine resistance
592812|NCT01046786|spinal cord injury|spinal cord injury
592813|NCT01046786|cord blood mononuclear cell|cord blood mononuclear cell
592814|NCT01046786|Methylprednisolone|methylprednisolone
592815|NCT01046786|Lithium Carbonate|lithium carbonate
592816|NCT01046773|Children|children
592817|NCT01046773|Crohn's disease|crohn's disease
592818|NCT01046773|Vitamin D|vitamin d
592819|NCT01046760|epilepsy|epilepsy
592820|NCT01046760|language|language
592821|NCT01046760|childhood|childhood
592822|NCT01046760|praxis|praxis
592823|NCT01046747|external fixation|external fixation
592824|NCT01046747|pin tract infection|pin tract infection
592825|NCT01046747|self drilling|self drilling
592826|NCT01046734|Influenza|influenza
592827|NCT01046734|virus shedding|virus shedding
592828|NCT01046734|infection control|infection control
592829|NCT01046734|swine flu|swine flu
592830|NCT01046721|blood pressure|blood pressure
592831|NCT01046721|superior mesenteric artery blood flow|superior mesenteric artery blood flow
592832|NCT01046721|cardiovascular effects|cardiovascular effects
592833|NCT01046721|Exenatide|exenatide
592834|NCT01046708|IUI|iui
592835|NCT01046708|clomiphene citrate|clomiphene citrate
592836|NCT01046708|utrogestan|utrogestan
592837|NCT01046695|VATS|vats
592838|NCT01046695|Video-Assisted Thoracotomy|video-assisted thoracotomy
592839|NCT01046695|Thoracic Surgery, Video-Assisted|thoracic surgery, video-assisted
592840|NCT01046682|HIV|hiv
592841|NCT01046682|Endothelial dysfunction|endothelial dysfunction
592842|NCT01046682|Inflammation|inflammation
592843|NCT01046682|Insulin resistance|insulin resistance
592844|NCT01046656|nosocomial infection|nosocomial infection
592845|NCT01046656|diarrhea|diarrhea
592846|NCT01046656|Lactobacillus reuteri|lactobacillus reuteri
592847|NCT01046656|gastroenteritis|gastroenteritis
592848|NCT01046656|rotavirus|rotavirus
592849|NCT01046643|Women|women
592850|NCT01046643|Healthy|healthy
592851|NCT01046643|Menopausal|menopausal
592852|NCT01046643|Hormone treatment|hormone treatment
592853|NCT01046630|Phase I|phase i
592854|NCT01046630|BOLD signal|bold signal
592855|NCT01046630|fMRI|fmri
592856|NCT01046630|AZD6765|azd6765
592857|NCT01046630|BOLD signal measured by fMRI|bold signal measured by fmri
592858|NCT01046617|infantile colic|infantile colic
592859|NCT01046617|Lactobacillus reuteri|lactobacillus reuteri
592860|NCT01046617|duration of crying|duration of crying
592861|NCT01046604|mitral valve regurgitation|mitral valve regurgitation
592862|NCT01046604|omega 3 fatty acids|omega 3 fatty acids
592863|NCT01046604|fish oil|fish oil
592864|NCT01046604|cardiac|cardiac
592865|NCT01046604|mitochondria|mitochondria
592866|NCT01046604|apoptosis|apoptosis
592867|NCT01046604|human heart|human heart
592868|NCT01046591|Cleft Palate|cleft palate
592869|NCT01046591|Cleft Lip|cleft lip
592870|NCT01046591|Obstructive Sleep Apnea|obstructive sleep apnea
592871|NCT01046591|Sleep-Disordered Breathing|sleep-disordered breathing
592872|NCT01046591|Behavior|behavior
592873|NCT01046591|Learning|learning
592874|NCT01046578|Folliculogenesis|folliculogenesis
592875|NCT01046578|Letrozole|letrozole
592876|NCT01046578|Aromatase Inhibitor|aromatase inhibitor
592877|NCT01046578|Estrogen|estrogen
592878|NCT01046552|Choledocholithias|choledocholithias
592879|NCT01046552|Common bile duct stones|common bile duct stones
592880|NCT01046552|Endoscopic retrograde cholangiopancreatography|endoscopic retrograde cholangiopancreatography
592881|NCT01046552|endoscopic sphincterotomy|endoscopic sphincterotomy
592882|NCT01046552|Preoperative|preoperative
592883|NCT01046552|intraoperative|intraoperative
592884|NCT01046552|Laparoscopic common bile duct exploration|laparoscopic common bile duct exploration
592885|NCT01046526|Psychopathology|psychopathology
592886|NCT01046526|Nicotine Patch|nicotine patch
592887|NCT01046526|Eye Tracking|eye tracking
592888|NCT01046526|Attention|attention
592889|NCT01046526|Schizophrenic Participants|schizophrenic participants
592890|NCT01046513|Nicotinic Acetylcholine Receptors|nicotinic acetylcholine receptors
592891|NCT01046513|Neuroimaging|neuroimaging
592892|NCT01046513|Positron Emission Tomography (PET)|positron emission tomography (pet)
592893|NCT01046513|Alpha4beta2|alpha4beta2
592895|NCT01046513|Receptor Upregulation|receptor upregulation
592896|NCT01046500|insulin resistance|insulin resistance
592897|NCT01046500|body mass index|body mass index
592898|NCT01046500|myo-inositol|myo-inositol
592899|NCT01046500|serum triglycerides and cholesterol|serum triglycerides and cholesterol
592900|NCT01046500|blood pressure|blood pressure
592901|NCT01046500|metformin|metformin
592902|NCT01046487|dermatofibrosarcoma|dermatofibrosarcoma
592903|NCT01046487|cylindroma|cylindroma
592904|NCT01046487|choroid melanoma|choroid melanoma
592905|NCT01046487|gastrointestinal stroma tumor|gastrointestinal stroma tumor
592906|NCT01046487|chordoma|chordoma
592907|NCT01046487|ocular melanoma|ocular melanoma
592908|NCT01046487|conjunctival melanoma|conjunctival melanoma
592909|NCT01046487|malignant melanoma of the anus|malignant melanoma of the anus
592910|NCT01046487|gastric melanoma|gastric melanoma
592911|NCT01046487|desmoid tumor|desmoid tumor
592912|NCT01046474|school children|school children
592913|NCT01046474|body mass index|body mass index
592914|NCT01046474|sugar intake|sugar intake
592915|NCT01046474|beverage intake|beverage intake
592916|NCT01046461|Ramosetron|ramosetron
592917|NCT01046461|aprepitant|aprepitant
592918|NCT01046461|dexamethasone|dexamethasone
592920|NCT01046461|chemotherapy|chemotherapy
592921|NCT01046461|antiemetics|antiemetics
592922|NCT01046461|cisplatin|cisplatin
592923|NCT01046461|nausea|nausea
592924|NCT01046461|vomiting|vomiting
592925|NCT01046461|high dose cisplatin|high dose cisplatin
592926|NCT01046448|Children|children
592927|NCT01046448|chronic renal failure|chronic renal failure
592928|NCT01046448|chronic kidney disease|chronic kidney disease
592929|NCT01046448|cardiovascular disease|cardiovascular disease
593053|NCT01045876|Plasma Cortisol level|plasma cortisol level
592930|NCT01046448|cardiovascular morbidity|cardiovascular morbidity
592931|NCT01046448|left ventricular hypertrophy|left ventricular hypertrophy
592932|NCT01046448|carotid intima media thickness|carotid intima media thickness
592933|NCT01046448|arterial stiffness|arterial stiffness
592934|NCT01046448|pulse wave velocity|pulse wave velocity
592935|NCT01046448|augmentation index|augmentation index
592936|NCT01046448|left ventricular cardiac function|left ventricular cardiac function
592937|NCT01046448|progression|progression
592938|NCT01046448|genetic risk factors|genetic risk factors
592939|NCT01046448|vasculopathy|vasculopathy
592940|NCT01046448|cardiopathy|cardiopathy
592941|NCT01046448|whole genome analysis|whole genome analysis
592942|NCT01046448|haplotype analysis|haplotype analysis
592943|NCT01046448|SNP-screening|snp-screening
592944|NCT01046435|periodontitis|periodontitis
592945|NCT01046435|cardiovascular disease|cardiovascular disease
592946|NCT01046435|diabetes|diabetes
592947|NCT01046409|Coronary artery disease|coronary artery disease
592948|NCT01046409|Bifurcation|bifurcation
592949|NCT01046409|Myocardial infarction|myocardial infarction
592950|NCT01046409|Myocardial ischemia|myocardial ischemia
592951|NCT01046409|Collateral|collateral
592952|NCT01046383|NON-SMALL CELL LUNG CANCER PATIENTS|non-small cell lung cancer patients
592953|NCT01046383|WEIGHT LOSS|weight loss
592954|NCT01046383|QUALITY OF LIFE|quality of life
592955|NCT01046383|SURVIVAL|survival
592956|NCT01046383|CHEMOTHERAPY|chemotherapy
592957|NCT01046383|RADIOTHERAPY|radiotherapy
592958|NCT01046383|SURGERY|surgery
592959|NCT01046383|CYSTEINE-RICH WHEY PROTEIN ISOLATE|cysteine-rich whey protein isolate
592960|NCT01046383|IMN1207|imn1207
592961|NCT01046383|CANCER-RELATED WASTING (CACHEXIA)|cancer-related wasting (cachexia)
592962|NCT01046383|BODY WEIGHT|body weight
592963|NCT01046383|NUTRITIONAL PROTEIN SUPPLEMENT|nutritional protein supplement
592964|NCT01046357|First in human|first in human
592965|NCT01046357|Safety|safety
592966|NCT01046305|Chronic Myeloid Leukemia|chronic myeloid leukemia
592967|NCT01046305|CML|cml
592968|NCT01046305|Symptom Burden|symptom burden
592969|NCT01046305|M. D. Anderson Symptom Inventory|m. d. anderson symptom inventory
592970|NCT01046305|MDASI-CML|mdasi-cml
592971|NCT01046305|Severity|severity
592972|NCT01046305|Interference|interference
592973|NCT01046305|Questionnaire|questionnaire
592974|NCT01046305|Interview|interview
592975|NCT01046292|Gait, Ginkgo biloba, mild cognitive impairment|gait, ginkgo biloba, mild cognitive impairment
592976|NCT01046253|Bioequivalence|bioequivalence
592977|NCT01046253|Healthy Subjects|healthy subjects
592978|NCT01046240|chemotherapy|chemotherapy
592979|NCT01046240|emesis|emesis
592980|NCT01046240|palonosetron|palonosetron
592981|NCT01046227|Serology|serology
592982|NCT01046227|Monovalent inactivated H1N1 vaccine|monovalent inactivated h1n1 vaccine
592983|NCT01046227|Pediatric haemato-oncology patients|pediatric haemato-oncology patients
592984|NCT01046188|Education|education
592985|NCT01046188|Internet|internet
592986|NCT01046188|In vitro fertilization|in vitro fertilization
592987|NCT01046175|Respiratory complications|respiratory complications
592988|NCT01046175|respiratory insufficiency|respiratory insufficiency
592989|NCT01046175|respiratory therapy|respiratory therapy
592990|NCT01046162|Alprazolam|alprazolam
592991|NCT01046162|Tafil|tafil
592992|NCT01046162|Xanax|xanax
592993|NCT01046162|Bioequivalence|bioequivalence
592994|NCT01046162|Drug Kinetics|drug kinetics
592995|NCT01046149|Depression|depression
592996|NCT01046149|Depressive Symptoms|depressive symptoms
592997|NCT01046149|postmenopause|postmenopause
592998|NCT01046149|RSA biofeedback|rsa biofeedback
592999|NCT01046136|common cold|common cold
593000|NCT01046097|Pneumococcal vaccine|pneumococcal vaccine
593001|NCT01046084|Bioequivalence|bioequivalence
593002|NCT01046084|Healthy Subjects|healthy subjects
593003|NCT01046071|Transversus abdominis plane block, postoperative pain.|transversus abdominis plane block, postoperative pain.
593004|NCT01046058|TMC435-TiDP16-C113|tmc435-tidp16-c113
593005|NCT01046058|TMC435-C113|tmc435-c113
593006|NCT01046058|TMC435|tmc435
593007|NCT01046058|HCV|hcv
593008|NCT01046058|Protease Inhibitor|protease inhibitor
593009|NCT01046058|Hepatitis C|hepatitis c
593010|NCT01046045|mammalian target-of-rapamycin inhibitors|mammalian target-of-rapamycin inhibitors
593011|NCT01046045|chronic allograft dysfunction|chronic allograft dysfunction
593012|NCT01046045|everolimus|everolimus
593013|NCT01046045|calcineurin inhibitors|calcineurin inhibitors
593014|NCT01046032|Polycystic ovaries|polycystic ovaries
593015|NCT01046032|Ovarian stimulation|ovarian stimulation
593016|NCT01046032|IVF|ivf
593017|NCT01046032|Ovarian hyperstimulation|ovarian hyperstimulation
593018|NCT01046032|Metformin|metformin
593019|NCT01046019|DXA|dxa
593020|NCT01046019|Hip|hip
593021|NCT01046019|Arthroplasty|arthroplasty
593022|NCT01046006|lymphoma|lymphoma
593023|NCT01046006|Bortezomib|bortezomib
593024|NCT01046006|Rituximab|rituximab
593025|NCT01045993|Pilot Study to Assess Methodologies|pilot study to assess methodologies
593026|NCT01045980|Peritoneal dialysis|peritoneal dialysis
593027|NCT01045980|Impedance, bioelectric|impedance, bioelectric
593028|NCT01045980|Hypertrophy, left ventricular|hypertrophy, left ventricular
593029|NCT01045980|Fluid status|fluid status
593030|NCT01045980|Volume overload|volume overload
593031|NCT01045980|Congestive heart failure|congestive heart failure
593032|NCT01045980|Cardiovascular outcomes|cardiovascular outcomes
593033|NCT01045980|Randomized controlled trial|randomized controlled trial
593034|NCT01045967|Bioequivalence|bioequivalence
593035|NCT01045967|Healthy Subjects|healthy subjects
593036|NCT01045954|diabetes mellitus type 1|diabetes mellitus type 1
593037|NCT01045954|continuous glucose monitoring|continuous glucose monitoring
593038|NCT01045941|Distal Pancreas|distal pancreas
593039|NCT01045941|Adenocarcinoma|adenocarcinoma
593040|NCT01045941|Laparoscopic|laparoscopic
593041|NCT01045941|Gemcitabine|gemcitabine
593042|NCT01045915|Stage IIIB, stage IIIC or stage IV melanoma|stage iiib, stage iiic or stage iv melanoma
593043|NCT01045915|Progressive melanoma not responding to previous treatments|progressive melanoma not responding to previous treatments
593044|NCT01045902|Pulmonary Abscess|pulmonary abscess
593045|NCT01045902|Aspiration Pneumonia|aspiration pneumonia
593046|NCT01045889|HIV|hiv
593047|NCT01045889|non hodgkin lymphoma|non hodgkin lymphoma
593048|NCT01045889|peripheral blood stem cell transplantation|peripheral blood stem cell transplantation
593049|NCT01045876|Randomized controlled trial|randomized controlled trial
593050|NCT01045876|Dexamethasone|dexamethasone
593051|NCT01045876|Single dose|single dose
593052|NCT01045876|Preoperative|preoperative
593054|NCT01045863|volunteer|volunteer
593055|NCT01045850|coronary stents|coronary stents
593056|NCT01045850|non cardiac surgery|non cardiac surgery
593057|NCT01045850|cardiovascular complications|cardiovascular complications
593058|NCT01045850|hemorrhagic complications|hemorrhagic complications
593059|NCT01045850|antiplatelet agents|antiplatelet agents
593060|NCT01045850|bare metal stent|bare metal stent
593061|NCT01045850|drug eluting stent|drug eluting stent
593062|NCT01045850|surgery|surgery
593063|NCT01045837|Celiac disease, steroids, immunohistochemistry|celiac disease, steroids, immunohistochemistry
593064|NCT01045824|Schizophrenia|schizophrenia
593065|NCT01045824|DNA|dna
593066|NCT01045824|MRI|mri
593067|NCT01045811|Depression|depression
593068|NCT01045811|Depressive Symptoms|depressive symptoms
593069|NCT01045811|postmenopause|postmenopause
593070|NCT01045811|RSA biofeedback|rsa biofeedback
593071|NCT01045798|Candidiasis|candidiasis
593072|NCT01045798|Invasive Candidiasis|invasive candidiasis
593073|NCT01045798|Fungal Infection|fungal infection
593074|NCT01045798|Empirical Therapy|empirical therapy
593075|NCT01045785|aspirin resistance, platelet function assay, dialysis, end stage renal disease|aspirin resistance, platelet function assay, dialysis, end stage renal disease
593076|NCT01045772|Schnitler syndrome, Muckle-Wells syndrome, anti-IL-1|schnitler syndrome, muckle-wells syndrome, anti-il-1
593077|NCT01045759|VENOUS THROMBOSIS|venous thrombosis
593078|NCT01045759|ultrasonography|ultrasonography
593079|NCT01045759|intensive care unit|intensive care unit
593080|NCT01045746|whole-body vibration|whole-body vibration
593081|NCT01045746|stochastic resonance Therapy|stochastic resonance therapy
593082|NCT01045746|static balance|static balance
593083|NCT01045746|balance, mobility|balance, mobility
593084|NCT01045746|elderly, reaction time|elderly, reaction time
593085|NCT01045746|The focus of the study is effect of SRT on postural balance|the focus of the study is effect of srt on postural balance
593086|NCT01045733|Cataract|cataract
593087|NCT01045733|Toric|toric
593088|NCT01045733|IOL|iol
593089|NCT01045733|AcrySof|acrysof
593090|NCT01045733|LRI|lri
593091|NCT01045733|Astigmatism|astigmatism
593092|NCT01045720|Schizophrenia|schizophrenia
593093|NCT01045720|clozapine|clozapine
593094|NCT01045720|hypersalivation|hypersalivation
593095|NCT01045720|Suo Quan Wan|suo quan wan
593096|NCT01045720|Wu Lin San|wu lin san
593097|NCT01045694|Carpometacarpal Joints|carpometacarpal joints
593098|NCT01045694|Osteoarthritis|osteoarthritis
593099|NCT01045694|Basal thumb joint arthritis|basal thumb joint arthritis
593100|NCT01045694|Trapeziometacarpal arthritis|trapeziometacarpal arthritis
593101|NCT01045681|Multiple Myeloma|multiple myeloma
593102|NCT01045681|Elderly patients|elderly patients
593103|NCT01045681|first relapse|first relapse
593104|NCT01045681|refractory to first line therapy|refractory to first line therapy
593105|NCT01045681|Bendamustine Velcade Dexamethasone Association|bendamustine velcade dexamethasone association
593106|NCT01045655|Depression|depression
593107|NCT01045655|Perinatal care|perinatal care
593108|NCT01045655|Postpartum period|postpartum period
593109|NCT01045655|Pregnancy|pregnancy
593110|NCT01045655|Female|female
593111|NCT01045655|Low-income population|low-income population
593112|NCT01045642|Bioequivalence|bioequivalence
593113|NCT01045642|Omeprazole|omeprazole
593114|NCT01045642|Crossover|crossover
593115|NCT01045629|schizophrenia|schizophrenia
593116|NCT01045629|PANSS|panss
593117|NCT01045603|Instanyl|instanyl
593118|NCT01045603|non-interventional|non-interventional
593119|NCT01045603|breakthrough cancer pain|breakthrough cancer pain
593120|NCT01045603|BTP|btp
593121|NCT01045603|BTCP|btcp
593122|NCT01045603|Intranasal fentanyl spray|intranasal fentanyl spray
593123|NCT01045577|Severe Psoriasis|severe psoriasis
593124|NCT01045577|Kinase Inhibitor|kinase inhibitor
593125|NCT01045577|Masitinib|masitinib
593126|NCT01045564|Immunogenicity|immunogenicity
593127|NCT01045564|Vaccines|vaccines
593128|NCT01045564|H5N1|h5n1
593129|NCT01045564|Influenza|influenza
593130|NCT01045564|Pandemic|pandemic
593131|NCT01045564|Human|human
753696|NCT00427583|MPNST,|mpnst,
593132|NCT01045564|Avian|avian
593133|NCT01045564|Safety|safety
593134|NCT01045551|Inflammatory rosacea|inflammatory rosacea
593135|NCT01045551|Papules and pustules|papules and pustules
593136|NCT01045551|Moderate to severe erythema|moderate to severe erythema
593137|NCT01045551|Telangiectasia|telangiectasia
593138|NCT01045538|gastric cancer|gastric cancer
593139|NCT01045538|histone deacetylase inhibitor|histone deacetylase inhibitor
593140|NCT01045538|1st line chemotherapy|1st line chemotherapy
593141|NCT01045525|Phlebotomy|phlebotomy
593142|NCT01045525|Dysmetabolic liversiderosis|dysmetabolic liversiderosis
593143|NCT01045525|Hepatic Iron overload|hepatic iron overload
593144|NCT01045512|immunosenescence|immunosenescence
593145|NCT01045512|heart rate variability|heart rate variability
593146|NCT01045512|autonomic nervous system|autonomic nervous system
593147|NCT01045512|ageing|ageing
593148|NCT01045512|inflammatory/pathogen burden|inflammatory/pathogen burden
593149|NCT01045512|physical activity|physical activity
593150|NCT01045499|adolescent obesity surgery|adolescent obesity surgery
593151|NCT01045499|bariatric surgery|bariatric surgery
593152|NCT01045499|adjustable gastric banding|adjustable gastric banding
593153|NCT01045486|Atopic dermatitis|atopic dermatitis
593154|NCT01045486|Food allergy|food allergy
593155|NCT01045486|Probiotics|probiotics
593156|NCT01045473|MIS|mis
593157|NCT01045473|Minimally Invasive Spine Surgery|minimally invasive spine surgery
593158|NCT01045473|Fusion|fusion
593159|NCT01045473|Spine|spine
593160|NCT01045473|SMISS|smiss
593161|NCT01045460|multiple myeloma|multiple myeloma
593162|NCT01045434|Bioequivalence|bioequivalence
593163|NCT01045434|omeprazole|omeprazole
593164|NCT01045434|crossover|crossover
593165|NCT01045421|NSCLC|nsclc
593166|NCT01045421|SCLC|sclc
593167|NCT01045421|HNSCC|hnscc
593168|NCT01045408|Helicobacter pylori|helicobacter pylori
593169|NCT01045408|Berry extract|berry extract
593170|NCT01045408|Triple therapy|triple therapy
593171|NCT01045395|Algae|algae
593172|NCT01045395|Psoriasis|psoriasis
593173|NCT01045395|Lipid metabolism|lipid metabolism
593174|NCT01045395|Inflammation|inflammation
593175|NCT01045395|Oxidative stress|oxidative stress
593176|NCT01045382|HSC transplantation|hsc transplantation
593177|NCT01045382|HLA-mismatched|hla-mismatched
593178|NCT01045382|Mesenchymal stem cells|mesenchymal stem cells
593179|NCT01045382|GVHD|gvhd
593180|NCT01045382|co-infusion|co-infusion
593181|NCT01045369|HIV|hiv
593182|NCT01045369|Treatment Naive|treatment naive
593183|NCT01045343|heart failure|heart failure
593184|NCT01045343|home monitoring|home monitoring
593185|NCT01045343|integrated diagnostics|integrated diagnostics
593186|NCT01045343|Cardiac Resynchronization Therapy with Defibrillator (CRT D)|cardiac resynchronization therapy with defibrillator (crt d)
593187|NCT01045317|micro-dose|micro-dose
593188|NCT01045317|pharmacokinetics|pharmacokinetics
593189|NCT01045317|open label|open label
593190|NCT01045317|PF-04776548|pf-04776548
593191|NCT01045278|Hepatitis C patients|hepatitis c patients
593192|NCT01045278|Hepacivirus|hepacivirus
593193|NCT01045252|hemodynamics|hemodynamics
593194|NCT01045252|neonatal|neonatal
593195|NCT01045239|Diabetic macular edema|diabetic macular edema
593196|NCT01045239|Diabetic macular oedema|diabetic macular oedema
593197|NCT01045239|micropulse laser|micropulse laser
593198|NCT01045239|laser treatment|laser treatment
593199|NCT01045239|macular thickness|macular thickness
593200|NCT01045213|Chronic obstructive pulmonary disease|chronic obstructive pulmonary disease
593201|NCT01045213|COPD|copd
593202|NCT01045200|rectal cancer|rectal cancer
593203|NCT01045200|follow-up|follow-up
593204|NCT01045200|specialist nurse|specialist nurse
593205|NCT01045187|endometrial cancer|endometrial cancer
593206|NCT01045187|Uterine cancer|uterine cancer
593207|NCT01045187|electronic brachytherapy|electronic brachytherapy
593208|NCT01045187|Xoft|xoft
593209|NCT01045174|Asthma|asthma
593210|NCT01045174|Pediatric|pediatric
593211|NCT01045174|Emergency department|emergency department
593212|NCT01045174|Nebulizer|nebulizer
593213|NCT01045161|Chronic Obstructive Pulmonary Disease|chronic obstructive pulmonary disease
593214|NCT01045161|COPD|copd
593215|NCT01045161|Chronic Bronchitis|chronic bronchitis
593216|NCT01045161|Emphysema|emphysema
593217|NCT01045161|Airflow Obstruction, Chronic|airflow obstruction, chronic
593218|NCT01045161|Chronic Airflow Obstruction|chronic airflow obstruction
593219|NCT01045161|Chronic Obstructive Airway Disease|chronic obstructive airway disease
593220|NCT01045161|Chronic Obstructive Lung Disease|chronic obstructive lung disease
593221|NCT01045148|Prostatic Cancer|prostatic cancer
593222|NCT01045148|Prostatic Neoplasms|prostatic neoplasms
593223|NCT01045148|Prostate Neoplasms|prostate neoplasms
593224|NCT01045148|Cancer of the Prostate|cancer of the prostate
593225|NCT01045135|Pelvic organ prolapse|pelvic organ prolapse
593226|NCT01045135|Levator hiatus|levator hiatus
593227|NCT01045135|3 and 4 dimensional ultrasound|3 and 4 dimensional ultrasound
593228|NCT01045122|Obstructive Sleep Apnea|obstructive sleep apnea
593229|NCT01045109|prostate|prostate
593230|NCT01045109|cancer|cancer
593231|NCT01045109|vitamin D3|vitamin d3
593232|NCT01045109|early stage|early stage
593233|NCT01045109|active surveillance|active surveillance
593234|NCT01045096|Gastroesophageal Reflux|gastroesophageal reflux
593235|NCT01045096|Erosive Esophagitis|erosive esophagitis
593236|NCT01045096|Pharmacokinetics|pharmacokinetics
593237|NCT01045096|Pediatrics|pediatrics
593238|NCT01045096|Drug Therapy|drug therapy
593239|NCT01045070|periodontitis and coronary heart disease|periodontitis and coronary heart disease
593240|NCT01045057|voice prosthesis, larynx cancer, laryngectomy|voice prosthesis, larynx cancer, laryngectomy
593241|NCT01045044|Breast cancer|breast cancer
593242|NCT01045044|Magnetic Resonance Imaging|magnetic resonance imaging
593243|NCT01045044|Anthracycline based systemic chemotherapy|anthracycline based systemic chemotherapy
593244|NCT01045044|Tumor response|tumor response
593245|NCT01045044|Cognitive Impairment|cognitive impairment
593246|NCT01045044|Chemo Brain|chemo brain
593247|NCT01045031|cognitive function, aging, brain-derived neurotrophic factor|cognitive function, aging, brain-derived neurotrophic factor
593248|NCT01045018|colitis|colitis
593249|NCT01045018|ulcerative|ulcerative
593250|NCT01045018|ulcerative colitis|ulcerative colitis
593251|NCT01045005|Type 1 diabetes|type 1 diabetes
593252|NCT01045005|Endothelial dysfunction|endothelial dysfunction
593253|NCT01045005|Doppler Ultrasound Velocity Waveforms|doppler ultrasound velocity waveforms
593254|NCT01044992|Multi systemic atrophy|multi systemic atrophy
593255|NCT01044992|Parkinson Disease|parkinson disease
593256|NCT01044992|PET investigation|pet investigation
593257|NCT01044992|Motor control|motor control
593258|NCT01044992|levodopa|levodopa
593260|NCT01044992|Comparison with Parkinson disease and dopaminergic challenge.|comparison with parkinson disease and dopaminergic challenge.
593261|NCT01044979|Colloid osmotic pressure in interstitial fluid|colloid osmotic pressure in interstitial fluid
593262|NCT01044979|Colloid osmotic pressure in plasma|colloid osmotic pressure in plasma
593263|NCT01044979|Protein fractions in interstitial fluid|protein fractions in interstitial fluid
593264|NCT01044966|Glioblastoma|glioblastoma
593265|NCT01044966|Subventricular|subventricular
593266|NCT01044966|gliomagenesis|gliomagenesis
593267|NCT01044966|temozolomide|temozolomide
593268|NCT01044966|depocyt|depocyt
593269|NCT01044953|injury incidence|injury incidence
593270|NCT01044953|male professional soccer|male professional soccer
593271|NCT01044953|Change of injury incidence in professional soccer|change of injury incidence in professional soccer
593272|NCT01044940|Colloid Osmotic pressure in interstitial fluid|colloid osmotic pressure in interstitial fluid
593273|NCT01044940|Colloid Osmotic pressure in plasma|colloid osmotic pressure in plasma
593274|NCT01044940|Protein fractions in interstitial fluid|protein fractions in interstitial fluid
593275|NCT01044927|Chronic obstructive pulmonary disease|chronic obstructive pulmonary disease
593276|NCT01044927|telemedicine|telemedicine
593277|NCT01044927|COPD|copd
593278|NCT01044901|Sickle Cell Disease|sickle cell disease
593279|NCT01044901|Cardiac magnetic resonance imaging|cardiac magnetic resonance imaging
593280|NCT01044901|Coronary Disease|coronary disease
593281|NCT01044901|Pulmonary Hypertension|pulmonary hypertension
593282|NCT01044888|Heparin responsiveness|heparin responsiveness
593283|NCT01044888|Off-pump coronary artery bypass graft surgery|off-pump coronary artery bypass graft surgery
593284|NCT01044888|Risk factors|risk factors
593285|NCT01044888|Myocardial infarction|myocardial infarction
593286|NCT01044875|Diabetic retinopathy|diabetic retinopathy
593287|NCT01044875|Laser treatment|laser treatment
593288|NCT01044875|Complications|complications
593289|NCT01044875|Laser wavelength|laser wavelength
593290|NCT01044862|Pregnancy|pregnancy
593291|NCT01044862|Infertility|infertility
593292|NCT01044862|Ovarian stimulation|ovarian stimulation
593293|NCT01044862|Aromatase inhibitors|aromatase inhibitors
593294|NCT01044862|Follicle Stimulating Hormone|follicle stimulating hormone
593295|NCT01044849|Blood Pressure|blood pressure
593296|NCT01044836|Healthy volunteer|healthy volunteer
593297|NCT01044823|RA|ra
593298|NCT01044823|JRA|jra
593299|NCT01044810|HIV|hiv
593300|NCT01044810|efavirenz|efavirenz
593301|NCT01044810|nevirapine|nevirapine
593302|NCT01044810|allergy|allergy
593303|NCT01044810|rash|rash
593304|NCT01044810|Cohort Studies, Historical|cohort studies, historical
593305|NCT01044810|Retrospective Study|retrospective study
593306|NCT01044810|exanthem|exanthem
593307|NCT01044810|Antiretroviral Agents|antiretroviral agents
593308|NCT01044810|Highly Active Antiretroviral Therapy|highly active antiretroviral therapy
593309|NCT01044810|HAART|haart
593310|NCT01044810|treatment failure|treatment failure
593311|NCT01044797|Healthy Volunteer|healthy volunteer
593312|NCT01044797|Given Capsule Manipulation|given capsule manipulation
593313|NCT01044784|CRT|crt
593314|NCT01044771|HIV|hiv
593315|NCT01044771|Human immunodeficiency virus|human immunodeficiency virus
593316|NCT01044771|tenofovir|tenofovir
593317|NCT01044771|viread|viread
593318|NCT01044771|truvada|truvada
593319|NCT01044771|proteinuria|proteinuria
593320|NCT01044758|Mild Cognitive Impairment|mild cognitive impairment
593321|NCT01044758|Amnestic Mild Cognitive Impairment|amnestic mild cognitive impairment
593322|NCT01044758|Functional Magnetic Resonance Imaging|functional magnetic resonance imaging
593323|NCT01044758|Levetiracetam|levetiracetam
593324|NCT01044758|Keppra|keppra
593325|NCT01044758|Medial Temporal Lobe|medial temporal lobe
593326|NCT01044758|Memory Impairment|memory impairment
593327|NCT01044758|Alzheimer's Disease|alzheimer's disease
593328|NCT01044758|AD|ad
593329|NCT01044732|Colorectal|colorectal
593330|NCT01044732|Neoplasms|neoplasms
593331|NCT01044732|Adenomas|adenomas
593332|NCT01044732|Polyps|polyps
593333|NCT01044732|Miss rates|miss rates
593334|NCT01044732|Detection rates|detection rates
593335|NCT01044732|Colonoscope|colonoscope
593336|NCT01044732|Third Eye Retroscope|third eye retroscope
593337|NCT01044706|Bioequivalency|bioequivalency
593338|NCT01044693|supine Hypertension|supine hypertension
593339|NCT01044693|autonomic failure|autonomic failure
593340|NCT01044693|nitric oxide|nitric oxide
593341|NCT01044693|nebivolol|nebivolol
593342|NCT01044680|fiber|fiber
593343|NCT01044680|metabolic syndrome|metabolic syndrome
593344|NCT01044680|overweight|overweight
593345|NCT01044680|satiety|satiety
593346|NCT01044654|HIV|hiv
593347|NCT01044654|Treatment Experienced|treatment experienced
593348|NCT01044641|Colloid Osmotic pressure in interstitial fluid|colloid osmotic pressure in interstitial fluid
593349|NCT01044641|Colloid Osmotic pressure in plasma|colloid osmotic pressure in plasma
593350|NCT01044641|Protein fractions in interstitial fluid|protein fractions in interstitial fluid
593351|NCT01044628|COPD|copd
593352|NCT01044628|Oxygen therapy|oxygen therapy
593353|NCT01044628|Nocturnal|nocturnal
593354|NCT01044628|Desaturation|desaturation
593355|NCT01044628|INOX|inox
593356|NCT01044615|Mild Traumatic Brain Injury|mild traumatic brain injury
593357|NCT01044615|Concussion|concussion
593358|NCT01044615|Magnetic Resonance Imaging (MRI)|magnetic resonance imaging (mri)
593359|NCT01044615|Positron Emission Tomography(PET)|positron emission tomography(pet)
593360|NCT01044615|Computed Tomography (CT)|computed tomography (ct)
593361|NCT01044602|Obesity|obesity
593362|NCT01044602|Type 2 Diabetes Mellitus|type 2 diabetes mellitus
593363|NCT01044602|Roux-en-Y Gastric Bypass Surgery|roux-en-y gastric bypass surgery
593364|NCT01044576|Multiple Sclerosis|multiple sclerosis
593365|NCT01044563|Depression|depression
593366|NCT01044563|Depressive Symptoms|depressive symptoms
593367|NCT01044563|postmenopause|postmenopause
593368|NCT01044563|RSA biofeedback|rsa biofeedback
593369|NCT01044550|Diaphragm injury|diaphragm injury
593370|NCT01044550|Herniation|herniation
593371|NCT01044537|phase 1|phase 1
593372|NCT01044537|safety and tolerability|safety and tolerability
593373|NCT01044537|PK|pk
593374|NCT01044537|PD|pd
593375|NCT01044537|type 2 diabetes mellitus|type 2 diabetes mellitus
593376|NCT01044537|T2DM|t2dm
593377|NCT01044524|14C labeled ADME (Aborption Distribution Metabolism and Elimination) study|14c labeled adme (aborption distribution metabolism and elimination) study
593378|NCT01044524|Phase I|phase i
593379|NCT01044511|Esophageal cancer|esophageal cancer
593380|NCT01044511|Cardia cancer|cardia cancer
593381|NCT01044511|Health Related quality of Life|health related quality of life
593382|NCT01044511|SEMS|sems
593383|NCT01044511|Home visits|home visits
593384|NCT01044485|HER-2 positive advanced or metastatic breast cancer|her-2 positive advanced or metastatic breast cancer
593385|NCT01044485|dose escalation study|dose escalation study
593386|NCT01044485|lapatinib|lapatinib
593387|NCT01044485|docetaxel|docetaxel
593388|NCT01044472|CRT-D|crt-d
593389|NCT01044459|Chronic Obstructive Pulmonary Disease|chronic obstructive pulmonary disease
593390|NCT01044459|COPD|copd
593391|NCT01044459|Chronic Bronchitis|chronic bronchitis
593392|NCT01044459|Emphysema|emphysema
593393|NCT01044459|Airflow Obstruction, Chronic|airflow obstruction, chronic
593394|NCT01044459|Chronic Airflow Obstruction|chronic airflow obstruction
593395|NCT01044459|Chronic Obstructive Airway Disease|chronic obstructive airway disease
593396|NCT01044459|Chronic Obstructive Lung Disease|chronic obstructive lung disease
593397|NCT01044446|peritoneal dialysis|peritoneal dialysis
593398|NCT01044446|peritonitis|peritonitis
593399|NCT01044446|CAPD|capd
593400|NCT01044446|end-stage renal disease|end-stage renal disease
593401|NCT01044446|peritonitis outcome and ultrafiltration|peritonitis outcome and ultrafiltration
593402|NCT01044407|respiration|respiration
593403|NCT01044407|sleep apnea|sleep apnea
593404|NCT01044407|pacemaker|pacemaker
593405|NCT01044394|colonoscopy|colonoscopy
593406|NCT01044394|bowel preparation|bowel preparation
593407|NCT01044394|polyethylene glycol|polyethylene glycol
593408|NCT01044394|Quality in endoscopy|quality in endoscopy
593409|NCT01044394|Bowel Preparation for colonoscopy|bowel preparation for colonoscopy
593410|NCT01044381|Toenail|toenail
593411|NCT01044381|Fungal Infections|fungal infections
593413|NCT01044368|Remote Blood Glucose Monitoring System, Type 2 Diabetes|remote blood glucose monitoring system, type 2 diabetes
593414|NCT01044355|Resistant Hypertension|resistant hypertension
593415|NCT01044355|Obstructive Sleep Apnea|obstructive sleep apnea
593416|NCT01044355|24 Hour Blood Pressure|24 hour blood pressure
754075|NCT00426374|HIV|hiv
593417|NCT01044355|Arterial Stiffness|arterial stiffness
593418|NCT01044355|Insulin Resistance|insulin resistance
593419|NCT01044355|CPAP|cpap
593420|NCT01044355|APAP|apap
593421|NCT01044342|Healthy Volunteers|healthy volunteers
593422|NCT01044342|EEG|eeg
593423|NCT01044316|Haemophilus influenzae type b (Hib)|haemophilus influenzae type b (hib)
593424|NCT01044316|Vaccine|vaccine
593425|NCT01044316|Booster|booster
593426|NCT01044303|Kidney Transplantation|kidney transplantation
593427|NCT01044303|Mycophenolic Acid|mycophenolic acid
593428|NCT01044303|Donor-Specific Antibodies|donor-specific antibodies
593429|NCT01044303|Kidney Rejection|kidney rejection
593430|NCT01044290|quality of life|quality of life
593431|NCT01044290|end of life|end of life
593432|NCT01044290|self-disclosure|self-disclosure
593433|NCT01044290|palliative care|palliative care
593434|NCT01044277|glutathione|glutathione
593435|NCT01044277|gluthathione peroxidases|gluthathione peroxidases
593436|NCT01044277|GSH|gsh
593437|NCT01044264|Acne Vulgaris|acne vulgaris
593438|NCT01044264|bioequivalency|bioequivalency
593439|NCT01044264|clindamycin|clindamycin
593440|NCT01044264|benzoyl peroxide|benzoyl peroxide
593441|NCT01044251|Medication overuse headache|medication overuse headache
593442|NCT01044251|Rebound headache|rebound headache
593443|NCT01044251|Analgesic overuse headache|analgesic overuse headache
593444|NCT01044251|Transitional therapy|transitional therapy
593445|NCT01044251|Frovatriptan|frovatriptan
593446|NCT01044251|Migraine|migraine
593447|NCT01044238|methamphetamine|methamphetamine
593448|NCT01044238|methylphenidate|methylphenidate
593449|NCT01044238|clinical trial|clinical trial
593450|NCT01044238|random assignment|random assignment
593451|NCT01044238|double blind|double blind
593452|NCT01044238|abstinence|abstinence
593453|NCT01044238|reduction in methamphetamine use|reduction in methamphetamine use
593454|NCT01044225|newly diagnosed glioblastoma|newly diagnosed glioblastoma
593455|NCT01044212|Urogynecology|urogynecology
593456|NCT01044199|rabies|rabies
593457|NCT01044199|rabies vaccine|rabies vaccine
593458|NCT01044199|purified cultured embryo chicken rabies vaccine|purified cultured embryo chicken rabies vaccine
593459|NCT01044186|Deferasirox|deferasirox
593460|NCT01044186|ICL670A|icl670a
593461|NCT01044186|Iron chelators|iron chelators
593462|NCT01044186|Deferiprone|deferiprone
593463|NCT01044186|Transfusional hemosiderosis|transfusional hemosiderosis
593464|NCT01044186|Congenital aplastic anemia (Diamond Blackfan anemia)|congenital aplastic anemia (diamond blackfan anemia)
593465|NCT01044186|Red cell aplasia|red cell aplasia
593466|NCT01044186|Thalassemia|thalassemia
593467|NCT01044186|β thalassemia|β thalassemia
593468|NCT01044173|acute abdomen|acute abdomen
593469|NCT01044173|CT|ct
593470|NCT01044173|MRI|mri
593471|NCT01044173|fast imaging|fast imaging
593472|NCT01044160|cancer as trauma in children|cancer as trauma in children
593473|NCT01044160|PTG/PTSS/ PTSD in children with cancer vs healthy children|ptg/ptss/ ptsd in children with cancer vs healthy children
593474|NCT01044147|Obesity|obesity
593475|NCT01044147|Internet|internet
593476|NCT01044121|mattress|mattress
593477|NCT01044121|pain|pain
593478|NCT01044121|sleep|sleep
593479|NCT01044121|low back pain|low back pain
593480|NCT01044121|back|back
593481|NCT01044121|neck|neck
593482|NCT01044121|arousal|arousal
593483|NCT01044121|pillow|pillow
593484|NCT01044121|kingsdown|kingsdown
593485|NCT01044121|sleep to live|sleep to live
593486|NCT01044121|duke university|duke university
593487|NCT01044121|sleep to live institute|sleep to live institute
593488|NCT01044121|missouri|missouri
593489|NCT01044121|springfield|springfield
593490|NCT01044121|joplin|joplin
593491|NCT01044121|body diagnostic|body diagnostic
593492|NCT01044121|dormo diagnostic|dormo diagnostic
593493|NCT01044121|morning pain|morning pain
593494|NCT01044095|seasonal influenza vaccine|seasonal influenza vaccine
593495|NCT01044095|avian influenza H5N1|avian influenza h5n1
593496|NCT01044095|cross reactivity|cross reactivity
593497|NCT01044095|prime boost|prime boost
593498|NCT01044082|Postpartum haemorrhage|postpartum haemorrhage
593499|NCT01044082|Third stage of labour|third stage of labour
593500|NCT01044082|Controlled cord traction|controlled cord traction
593501|NCT01044082|Randomized controlled trial|randomized controlled trial
593502|NCT01044082|Prevention|prevention
593503|NCT01044069|Cyclophosphamide|cyclophosphamide
593504|NCT01044069|T cell|t cell
593505|NCT01044069|leukapheresis|leukapheresis
593506|NCT01044069|stem cell transplant|stem cell transplant
593507|NCT01044069|bone marrow transplant|bone marrow transplant
593508|NCT01044069|09-114|09-114
593509|NCT01044030|otitis media|otitis media
593510|NCT01044030|ear infection|ear infection
593511|NCT01043991|STEMI|stemi
593512|NCT01043991|AMI,|ami,
593513|NCT01043991|acute myocardial infarct|acute myocardial infarct
593514|NCT01043991|Epo|epo
593515|NCT01043991|Erythropoietin|erythropoietin
593516|NCT01043991|ischemia-reperfusion|ischemia-reperfusion
593517|NCT01043991|apoptosis|apoptosis
754180|NCT00425984|STI|sti
593518|NCT01043965|Diabetes Mellitus|diabetes mellitus
593519|NCT01043965|Myocardial perfusion imaging|myocardial perfusion imaging
593520|NCT01043965|Heart diseases|heart diseases
593521|NCT01043965|Echocardiography|echocardiography
593522|NCT01043965|Endothelium|endothelium
593523|NCT01043952|Propofol|propofol
593524|NCT01043952|Remifentanil|remifentanil
593525|NCT01043952|Bispectral Index Monitor|bispectral index monitor
593526|NCT01043939|childhood cancers|childhood cancers
593527|NCT01043939|cardiovascular disease|cardiovascular disease
593528|NCT01043939|childhood cancer survivor|childhood cancer survivor
593529|NCT01043926|Hepatic Insufficiency|hepatic insufficiency
593530|NCT01043913|Fatigue|fatigue
593531|NCT01043913|Breast Neoplasms|breast neoplasms
593532|NCT01043913|Quality of Life|quality of life
593533|NCT01043913|Paullinia|paullinia
593534|NCT01043900|Obsessive-Compulsive Disorder|obsessive-compulsive disorder
593535|NCT01043900|rTMS|rtms
593536|NCT01043900|Transcranial Magnetic Stimulation|transcranial magnetic stimulation
593537|NCT01043900|treatment|treatment
593538|NCT01043900|randomized controlled trials|randomized controlled trials
593539|NCT01043887|Healthy Volunteers|healthy volunteers
593540|NCT01043887|Hepatic Insufficiency|hepatic insufficiency
593541|NCT01043874|Chronic phase|chronic phase
593542|NCT01043874|Chronic myelogenous leukemia|chronic myelogenous leukemia
593543|NCT01043874|CML|cml
593544|NCT01043874|Philadelphia chromosome positive|philadelphia chromosome positive
593545|NCT01043874|Ph+|ph+
593546|NCT01043874|Nilotinib|nilotinib
593547|NCT01043874|CML-CP|cml-cp
593548|NCT01043874|Suboptimal molecular response|suboptimal molecular response
593549|NCT01043848|neurogenic detrusor overactivity|neurogenic detrusor overactivity
593550|NCT01043848|neuromodulation|neuromodulation
593551|NCT01043848|spinal cord injury|spinal cord injury
593552|NCT01043848|pudendal nerve stimulation|pudendal nerve stimulation
593553|NCT01043848|videocystometry|videocystometry
593554|NCT01043848|neurophysiology|neurophysiology
593555|NCT01043848|neuroplasticity|neuroplasticity
593556|NCT01043835|Stomach Neoplasm|stomach neoplasm
593557|NCT01043835|Laparoscopy|laparoscopy
593558|NCT01043835|gastrectomy|gastrectomy
593559|NCT01043822|Autism|autism
593560|NCT01043822|mental retardation|mental retardation
593561|NCT01043822|pain|pain
593562|NCT01043822|emotion|emotion
593563|NCT01043822|sensory profile|sensory profile
593564|NCT01043822|children|children
593565|NCT01043809|schools|schools
593566|NCT01043809|handwashing|handwashing
593567|NCT01043809|prevention and control|prevention and control
593568|NCT01043809|communicable diseases|communicable diseases
593569|NCT01043809|absenteeism|absenteeism
593570|NCT01043796|Insecticide treated wall liners|insecticide treated wall liners
593571|NCT01043796|Insecticide treated nets|insecticide treated nets
593572|NCT01043796|Incidence cohort|incidence cohort
593573|NCT01043783|Obesity|obesity
593574|NCT01043770|Metabolic syndrome|metabolic syndrome
593575|NCT01043770|Primary prevention|primary prevention
593576|NCT01043770|Diabetes|diabetes
593577|NCT01043770|Cardiovascular disease|cardiovascular disease
593578|NCT01043770|Patient education|patient education
593579|NCT01043757|Sedentary lifestyle|sedentary lifestyle
593580|NCT01043757|physical exercise|physical exercise
593581|NCT01043757|behavioral economics|behavioral economics
593582|NCT01043757|financial incentives|financial incentives
593584|NCT01043744|malaria|malaria
593585|NCT01043744|presumptive treatment|presumptive treatment
593586|NCT01043744|Integrated Management of Childhood Illness|integrated management of childhood illness
593587|NCT01043744|fever|fever
593588|NCT01043718|Obesity|obesity
593589|NCT01043718|Internet|internet
593590|NCT01043705|Pacemaker infection|pacemaker infection
593591|NCT01043705|Defibrillator infection|defibrillator infection
593592|NCT01043705|ICD infection|icd infection
593593|NCT01043705|CRT infection|crt infection
593594|NCT01043705|Cardiovascular implantable electronic device infection|cardiovascular implantable electronic device infection
593595|NCT01043705|Infection|infection
593596|NCT01043705|Pacemaker, Artificial|pacemaker, artificial
593597|NCT01043705|Defibrillators|defibrillators
593598|NCT01043692|Chronic Pain > 3 months|chronic pain > 3 months
593599|NCT01043692|Acupuncture|acupuncture
593600|NCT01043692|Acceptability|acceptability
593601|NCT01043692|Geriatrics|geriatrics
593602|NCT01043679|Bipolar, Mania|bipolar, mania
593603|NCT01043679|Utapine|utapine
593604|NCT01043679|Seroquel|seroquel
593605|NCT01043666|Micturition|micturition
593606|NCT01043666|YM178|ym178
593607|NCT01043666|Urinary incontinence|urinary incontinence
593608|NCT01043666|Frequency|frequency
593609|NCT01043666|Overactive Bladder|overactive bladder
593610|NCT01043666|Urgency|urgency
593611|NCT01043666|Urinary urge incontinence|urinary urge incontinence
593612|NCT01043653|recovery|recovery
593613|NCT01043653|serious mental illness|serious mental illness
593614|NCT01043640|inherited metabolic disorders|inherited metabolic disorders
593615|NCT01043614|Obesity|obesity
593616|NCT01043614|Obesity Prevention|obesity prevention
754304|NCT00425607|FTI|fti
593617|NCT01043614|Freshman women|freshman women
593618|NCT01043614|Freshman 15 weight gain|freshman 15 weight gain
593619|NCT01043614|Self efficacy|self efficacy
593620|NCT01043614|Activity and nutrition intervention|activity and nutrition intervention
593621|NCT01043614|Peer education|peer education
593622|NCT01043588|Surgery|surgery
593623|NCT01043588|Prostate|prostate
593624|NCT01043588|Laser 532 nm|laser 532 nm
593625|NCT01043588|Photo selective Vaporization of the Prostate (PVP)|photo selective vaporization of the prostate (pvp)
593626|NCT01043588|TransUrethral Resection of the Prostate (TURP)|transurethral resection of the prostate (turp)
593627|NCT01043588|Men health|men health
593628|NCT01043575|rifapentine, pharmacokinetics, pharmacodynamics, tuberculosis|rifapentine, pharmacokinetics, pharmacodynamics, tuberculosis
593629|NCT01043549|Gilles de la Tourette syndrome|gilles de la tourette syndrome
593630|NCT01043549|Tics|tics
593631|NCT01043549|Transcranial magnetic stimulation|transcranial magnetic stimulation
593632|NCT01043536|IMRT|imrt
593633|NCT01043536|Radiotherapy escalation dose|radiotherapy escalation dose
593634|NCT01043536|glioblastoma|glioblastoma
593635|NCT01043536|escalation radiotherapy dose|escalation radiotherapy dose
593636|NCT01043523|Liver neoplasms|liver neoplasms
593637|NCT01043523|Adenoma|adenoma
593638|NCT01043523|Liver cell carcinoma|liver cell carcinoma
593639|NCT01043523|Hepatocellular|hepatocellular
593640|NCT01043523|Liver abscess|liver abscess
593641|NCT01043484|Resectable rectal cancer|resectable rectal cancer
593642|NCT01043484|Radiotherapy|radiotherapy
593643|NCT01043484|Bevacizumab|bevacizumab
593644|NCT01043484|Capecitabine|capecitabine
593645|NCT01043471|Obesity|obesity
593646|NCT01043458|Pharmacokinetics|pharmacokinetics
593647|NCT01043445|GPR 119|gpr 119
593648|NCT01043445|GLP-1 secretion|glp-1 secretion
593649|NCT01043445|2-oleoyl-glycerol|2-oleoyl-glycerol
593650|NCT01043445|Dietary supplementation|dietary supplementation
593651|NCT01043432|Traumatic Brain Injury|traumatic brain injury
593652|NCT01043432|Suicide|suicide
593653|NCT01043432|Executive Function|executive function
593654|NCT01043419|Xenon Anesthesia|xenon anesthesia
593655|NCT01043419|LENOXe™ (xénon 100 % v/v) anesthesia|lenoxe™ (xénon 100 % v/v) anesthesia
593656|NCT01043419|Muscle Sympathetic Activity|muscle sympathetic activity
593657|NCT01043419|Baroreflex reagibility|baroreflex reagibility
593658|NCT01043406|Epilepsy|epilepsy
593659|NCT01043406|Seizures|seizures
593660|NCT01043406|Advisory|advisory
593661|NCT01043406|Prediction|prediction
593662|NCT01043393|Plaque psoriasis|plaque psoriasis
593663|NCT01043380|Heart Diseases|heart diseases
593664|NCT01043380|Hyperlipidemia|hyperlipidemia
593665|NCT01043380|Atorvastatin|atorvastatin
593666|NCT01043380|Ezetimibe|ezetimibe
593667|NCT01043380|Cardiovascular Diseases|cardiovascular diseases
593668|NCT01043380|Hypercholesterolemia|hypercholesterolemia
593669|NCT01043380|Coronary Artery Disease|coronary artery disease
593670|NCT01043380|Dyslipidemias|dyslipidemias
593671|NCT01043380|Intravascular Ultrasound|intravascular ultrasound
593672|NCT01043367|Depression|depression
593673|NCT01043367|Dietary supplement|dietary supplement
593674|NCT01043367|Deprexil|deprexil
593675|NCT01043354|cholesterol|cholesterol
593676|NCT01043354|diabetes|diabetes
593677|NCT01043354|adherence|adherence
593678|NCT01043341|HPV|hpv
593679|NCT01043341|vaccines|vaccines
593680|NCT01043341|knowledge|knowledge
593681|NCT01043341|attitude|attitude
593682|NCT01043328|human papillomavirus|human papillomavirus
593683|NCT01043328|nested PCR|nested pcr
593684|NCT01043328|saliva|saliva
593685|NCT01043328|serum|serum
593686|NCT01043328|oral tissues|oral tissues
593687|NCT01043315|Cognitive Function|cognitive function
593688|NCT01043315|Cognitive Impairment|cognitive impairment
593689|NCT01043315|Hospitalization|hospitalization
593690|NCT01043315|Cardiac Disease|cardiac disease
593691|NCT01043302|lymphoma, intestine, outcome, quality of life|lymphoma, intestine, outcome, quality of life
593692|NCT01043289|light therapy|light therapy
593693|NCT01043289|antepartum depression|antepartum depression
593694|NCT01043289|controlled trial|controlled trial
593695|NCT01043276|Healthy|healthy
593696|NCT01043250|schizophrenia|schizophrenia
593697|NCT01043250|atypical antipsychotics|atypical antipsychotics
593698|NCT01043250|appetite|appetite
593699|NCT01043250|eating behavior|eating behavior
593700|NCT01043237|acoustic|acoustic
593701|NCT01043237|digital|digital
593702|NCT01043237|sound|sound
593703|NCT01043237|vibration|vibration
593704|NCT01043237|coronary|coronary
593705|NCT01043237|auscultation|auscultation
593706|NCT01043237|artery|artery
593707|NCT01043237|diagnosis|diagnosis
593708|NCT01043211|Back Pain|back pain
593709|NCT01043211|Lidocaine|lidocaine
593710|NCT01043198|CGH array technology|cgh array technology
593711|NCT01043198|mental retardation|mental retardation
593712|NCT01043198|chromosomal abnormalities|chromosomal abnormalities
593713|NCT01043198|syndromic obesity|syndromic obesity
593714|NCT01043198|obesity|obesity
593715|NCT01043185|GERD|gerd
593716|NCT01043185|lesogaberan|lesogaberan
593717|NCT01043185|impedance|impedance
593718|NCT01043185|pH|ph
593719|NCT01043185|pharmacokinetics|pharmacokinetics
593720|NCT01043185|safety|safety
593721|NCT01043185|tolerability|tolerability
593722|NCT01043146|anti-beta1 adrenergic receptor|anti-beta1 adrenergic receptor
593723|NCT01043146|autoantibody|autoantibody
593724|NCT01043146|cyclic peptide|cyclic peptide
593725|NCT01043146|heart failure|heart failure
593726|NCT01043133|electronic medical records|electronic medical records
593727|NCT01043133|documentation templates|documentation templates
593728|NCT01043133|clinical encounter notes|clinical encounter notes
593729|NCT01043081|African American women who have sex with women|african american women who have sex with women
593730|NCT01043081|Sexually transmitted infections|sexually transmitted infections
593731|NCT01043081|Homosexuality|homosexuality
593732|NCT01043081|Human papillomavirus|human papillomavirus
593733|NCT01043081|Cervical intraepithelial neoplasia|cervical intraepithelial neoplasia
593734|NCT01043081|Herpes simplex virus types 1 and 2|herpes simplex virus types 1 and 2
593735|NCT01043081|Chlamydia|chlamydia
593736|NCT01043081|Gonorrhea|gonorrhea
593737|NCT01043081|Trichomoniasis|trichomoniasis
593738|NCT01043081|Bacterial vaginosis|bacterial vaginosis
593739|NCT01043081|Syphilis|syphilis
593740|NCT01043081|Human immunodeficiency virus|human immunodeficiency virus
593741|NCT01043068|cancer pain|cancer pain
593742|NCT01043068|opioid|opioid
593743|NCT01043068|guideline|guideline
593744|NCT01043055|Breast Cancer Screening|breast cancer screening
593745|NCT01043042|hypoglycemia among inpatients|hypoglycemia among inpatients
593746|NCT01043042|hyperglycemia among inpatients|hyperglycemia among inpatients
593747|NCT01043016|skin cancer|skin cancer
593748|NCT01043016|esophageal cancer|esophageal cancer
593749|NCT01043016|photodynamic therapy|photodynamic therapy
593750|NCT01042990|Stroke|stroke
593751|NCT01042990|Exercise|exercise
593752|NCT01042990|Balance|balance
593753|NCT01042990|Dynamic Gait|dynamic gait
593754|NCT01042990|Cardiovascular Fitness|cardiovascular fitness
593755|NCT01042977|dapagliflozin|dapagliflozin
593756|NCT01042977|diabetes|diabetes
593757|NCT01042977|cardiovascular disease|cardiovascular disease
593758|NCT01042964|platelet adhesion and aggregation|platelet adhesion and aggregation
593759|NCT01042964|acute coronary syndrome|acute coronary syndrome
593760|NCT01042964|myocardial infarction|myocardial infarction
593761|NCT01042964|stroke|stroke
593762|NCT01042964|inhibition of platelet adhesion to plaques|inhibition of platelet adhesion to plaques
593763|NCT01042964|collagen-induced platelet aggregation|collagen-induced platelet aggregation
593764|NCT01042951|safety|safety
593765|NCT01042951|immunogenicity|immunogenicity
593766|NCT01042951|Healthy Participants|healthy participants
593767|NCT01042938|Radiation dermatitis in breast cancer patients|radiation dermatitis in breast cancer patients
593768|NCT01042925|HER2 positive breast cancer|her2 positive breast cancer
593769|NCT01042925|breast cancer|breast cancer
593770|NCT01042925|breast tumors|breast tumors
593771|NCT01042925|human mammary carcinoma|human mammary carcinoma
593772|NCT01042912|diagnosis|diagnosis
593773|NCT01042912|carotid|carotid
593774|NCT01042912|artery|artery
593775|NCT01042912|disease|disease
593776|NCT01042912|auscultation|auscultation
593777|NCT01042912|sound|sound
593778|NCT01042899|TBI|tbi
593779|NCT01042899|intracranial edema|intracranial edema
593780|NCT01042899|brain edema|brain edema
593781|NCT01042899|craniocerebral trauma|craniocerebral trauma
593782|NCT01042899|head injury|head injury
593783|NCT01042899|brain hemorrhage, traumatic|brain hemorrhage, traumatic
593784|NCT01042899|subdural hematoma|subdural hematoma
593785|NCT01042899|brain concussion|brain concussion
593786|NCT01042899|head injuries, closed|head injuries, closed
593787|NCT01042899|epidural hematoma|epidural hematoma
593788|NCT01042899|extra-axial hemorrhage|extra-axial hemorrhage
593789|NCT01042899|cortical contusion|cortical contusion
593790|NCT01042899|wounds and injuries|wounds and injuries
593791|NCT01042899|disorders of environmental origin|disorders of environmental origin
593792|NCT01042899|trauma, nervous system|trauma, nervous system
593793|NCT01042899|brain injuries|brain injuries
593794|NCT01042886|Non-blind, randomized controlled trial|non-blind, randomized controlled trial
593795|NCT01042886|Pilot study|pilot study
593796|NCT01042873|Desensitization|desensitization
593797|NCT01042873|beta adrenergic receptors|beta adrenergic receptors
593798|NCT01042873|Healthy subjects|healthy subjects
593799|NCT01042860|macular pigment|macular pigment
593800|NCT01042860|lutein|lutein
593801|NCT01042860|age-related macular degeneration|age-related macular degeneration
593802|NCT01042860|AMD|amd
593803|NCT01042847|ovarian|ovarian
593804|NCT01042834|air pollution|air pollution
593805|NCT01042834|autonomic nervous system|autonomic nervous system
593806|NCT01042834|sleep apnea|sleep apnea
593807|NCT01042834|Heart rate variability|heart rate variability
593808|NCT01042834|Healthy volunteers|healthy volunteers
593809|NCT01042821|anal fistula|anal fistula
593810|NCT01042821|advancement flap|advancement flap
593811|NCT01042821|incontinence|incontinence
593812|NCT01042795|sunitinib|sunitinib
593813|NCT01042795|bladder neoplasm|bladder neoplasm
593814|NCT01042795|adjuvant treatment|adjuvant treatment
593815|NCT01042795|disease free survival|disease free survival
593816|NCT01042795|cystectomy|cystectomy
593817|NCT01042782|gastric cancer|gastric cancer
593818|NCT01042782|RAD001|rad001
593819|NCT01042782|Mitomycin C|mitomycin c
593820|NCT01042782|MTD|mtd
593821|NCT01042743|colon cancer|colon cancer
593822|NCT01042743|robot|robot
593823|NCT01042743|laparoscopy|laparoscopy
593824|NCT01042743|primary, right-side colon cancer|primary, right-side colon cancer
593825|NCT01042743|robot-assisted surgery|robot-assisted surgery
593826|NCT01042730|Pitavastatin|pitavastatin
593827|NCT01042730|Coronary Artery Disease|coronary artery disease
593828|NCT01042730|Cardiovascular Disease|cardiovascular disease
593829|NCT01042717|plerixafor|plerixafor
593830|NCT01042717|autologous transplantation|autologous transplantation
593831|NCT01042717|hematopoietic stem cell mobilization|hematopoietic stem cell mobilization
593832|NCT01042717|multiple myeloma|multiple myeloma
593833|NCT01042717|non-Hodgkins lymphoma|non-hodgkins lymphoma
593834|NCT01042704|Relapsed Myeloma|relapsed myeloma
593835|NCT01042704|Refractory Myeloma|refractory myeloma
593836|NCT01042665|Glaucoma|glaucoma
593837|NCT01042665|intraocular pressure|intraocular pressure
593838|NCT01042665|latanoprost|latanoprost
593839|NCT01042665|retinal ganglion cell|retinal ganglion cell
593840|NCT01042665|pattern electroretinogram|pattern electroretinogram
593841|NCT01042652|Methadone|methadone
593842|NCT01042652|HIV|hiv
593843|NCT01042652|Raltegravir|raltegravir
593844|NCT01042652|Antiretroviral|antiretroviral
593845|NCT01042652|Intravenous Drug User|intravenous drug user
593846|NCT01042652|Methadone Maintenance|methadone maintenance
593847|NCT01042652|Treatment Naive|treatment naive
593848|NCT01042639|osteopenia|osteopenia
593849|NCT01042639|very low birthweight infants|very low birthweight infants
593850|NCT01042639|bone speed of sound|bone speed of sound
593851|NCT01042639|quantitative ultrasound|quantitative ultrasound
593852|NCT01042626|Receptors, Calcium sensing|receptors, calcium sensing
593853|NCT01042626|Parathyroid Hormone|parathyroid hormone
593854|NCT01042613|AccuVein AV300 device;|accuvein av300 device;
593855|NCT01042613|Intravenous cannulation|intravenous cannulation
593856|NCT01042600|Respiratory distress syndrome|respiratory distress syndrome
593857|NCT01042600|Surfactant|surfactant
593858|NCT01042600|Tracheal intubation|tracheal intubation
593859|NCT01042600|Laryngeal mask airway|laryngeal mask airway
593860|NCT01042600|Newborn|newborn
593861|NCT01042587|bright light therapy|bright light therapy
593862|NCT01042587|circadian rhythm,|circadian rhythm,
593863|NCT01042587|entrainment|entrainment
593864|NCT01042574|intracranial hemorrhage (ICH)|intracranial hemorrhage (ich)
593865|NCT01042574|subarachnoid hemorrhage (SAH)|subarachnoid hemorrhage (sah)
593866|NCT01042574|intracranial monitoring|intracranial monitoring
593867|NCT01042574|external ventricular drain (ventriculostomy)|external ventricular drain (ventriculostomy)
593868|NCT01042574|hypertension|hypertension
593869|NCT01042561|vitamin d|vitamin d
593870|NCT01042561|prematurity|prematurity
593871|NCT01042561|25(OH)D|25(oh)d
593872|NCT01042561|infant|infant
593873|NCT01042561|CRP|crp
593874|NCT01042561|PTH|pth
593875|NCT01042548|Proteomics|proteomics
593876|NCT01042548|Breast Cancer Markers|breast cancer markers
593877|NCT01042548|Tissue Interstitial Fluid|tissue interstitial fluid
593878|NCT01042509|Chronic Graft vs Host Disease|chronic graft vs host disease
593879|NCT01042509|Alemtuzumab|alemtuzumab
593880|NCT01042509|Rituximab|rituximab
593881|NCT01042509|Low-dose|low-dose
593882|NCT01042509|Alemtuzumab and rituximab combination|alemtuzumab and rituximab combination
593883|NCT01042496|Bipolar|bipolar
593884|NCT01042496|depression|depression
593885|NCT01042483|active stage|active stage
593886|NCT01042483|labor|labor
593887|NCT01042483|progression|progression
593888|NCT01042483|pregnant women during active phases of labor|pregnant women during active phases of labor
593889|NCT01042470|pelvic organ prolapse|pelvic organ prolapse
593890|NCT01042470|pelvic floor dysfunction|pelvic floor dysfunction
593891|NCT01042470|biomechanics|biomechanics
593892|NCT01042470|aspiration device|aspiration device
593893|NCT01042470|connective tissue|connective tissue
593894|NCT01042457|trough level|trough level
593895|NCT01042457|therapeutic drug monitoring|therapeutic drug monitoring
593896|NCT01042457|Mycophenolate mofetil|mycophenolate mofetil
593897|NCT01042457|Mycophenolic acid|mycophenolic acid
593898|NCT01042457|lupus nephritis|lupus nephritis
593899|NCT01042444|Heart disease|heart disease
593900|NCT01042444|Embolic Protection Device|embolic protection device
593902|NCT01042444|SVG|svg
593903|NCT01042431|Nutritional status of ward patients and hospitalization outcome|nutritional status of ward patients and hospitalization outcome
593904|NCT01042418|satiety|satiety
593905|NCT01042418|grain structure|grain structure
593906|NCT01042418|rye|rye
593907|NCT01042392|Moderate systolic hypertension - adults - aliskiren -ramipril|moderate systolic hypertension - adults - aliskiren -ramipril
593908|NCT01042379|I-SPY 2|i-spy 2
593909|NCT01042379|Neoadjuvant|neoadjuvant
593910|NCT01042379|Breast|breast
593911|NCT01042379|Cancer|cancer
593912|NCT01042379|Neoplasm|neoplasm
593913|NCT01042379|Adaptive|adaptive
593914|NCT01042379|pCR|pcr
593915|NCT01042379|Pathologic Complete Response|pathologic complete response
593916|NCT01042379|Biomarkers signature|biomarkers signature
593917|NCT01042379|MRI Volume|mri volume
593918|NCT01042366|Melanoma|melanoma
593919|NCT01042340|nutrition|nutrition
593920|NCT01042340|geriatric|geriatric
593921|NCT01042340|supplement|supplement
593922|NCT01042340|energy|energy
593923|NCT01042327|solute clearances|solute clearances
593924|NCT01042288|Non-Small-Cell Lung Cancer|non-small-cell lung cancer
593925|NCT01042288|NSCLC|nsclc
593926|NCT01042288|Panitumumab|panitumumab
593927|NCT01042288|Vectibix|vectibix
593928|NCT01042288|Pemetrexed|pemetrexed
593929|NCT01042288|Alimta|alimta
593930|NCT01042288|Carboplatin|carboplatin
593931|NCT01042275|stress urinary incontinence|stress urinary incontinence
593932|NCT01042275|retropubic sling|retropubic sling
593933|NCT01042275|transobturator sling|transobturator sling
593934|NCT01042275|tension-free vaginal tape|tension-free vaginal tape
593935|NCT01042275|transobturator tape|transobturator tape
593936|NCT01042275|TVT|tvt
593937|NCT01042275|TVT-O|tvt-o
593938|NCT01042275|TOT|tot
593939|NCT01042275|REMEEX|remeex
593940|NCT01042275|IVS|ivs
593941|NCT01042262|Superoxide dismutase|superoxide dismutase
593942|NCT01042262|Oxygen|oxygen
593943|NCT01042262|Oxygen free radicals|oxygen free radicals
593944|NCT01042262|Labor and delivery|labor and delivery
593945|NCT01042249|PFMT|pfmt
593946|NCT01042249|Stroke|stroke
593947|NCT01042249|LUTS|luts
593948|NCT01042249|Men|men
593949|NCT01042236|Phase 2 stress urinary incontinence Fesoterodine|phase 2 stress urinary incontinence fesoterodine
593950|NCT01042223|Factors Predisposing or Causing|factors predisposing or causing
593951|NCT01042210|preeclampsia|preeclampsia
593952|NCT01042210|agouti-related peptide|agouti-related peptide
593953|NCT01042210|intrauterine growth|intrauterine growth
593954|NCT01042210|birth weight|birth weight
593955|NCT01042210|Intrauterine growth restriction due to preeclampsia|intrauterine growth restriction due to preeclampsia
593956|NCT01042197|Vitamin D|vitamin d
593957|NCT01042197|UVB|uvb
593958|NCT01042197|Dose-Response|dose-response
593959|NCT01042197|Body surface area|body surface area
593960|NCT01042184|H. pylori infected patients without prior eradication therapy|h. pylori infected patients without prior eradication therapy
593961|NCT01042158|Tadalafil|tadalafil
593962|NCT01042158|Ambrisentan|ambrisentan
593963|NCT01042158|Quality of Life|quality of life
593964|NCT01042145|Primary Care|primary care
593965|NCT01042145|Treatment|treatment
593966|NCT01042145|Croup|croup
593967|NCT01042145|Corticosteroids|corticosteroids
593968|NCT01042145|Prednisone|prednisone
593969|NCT01042145|Dexamethasone|dexamethasone
593970|NCT01042145|Randomized trial|randomized trial
593971|NCT01042132|intramedullary reaming|intramedullary reaming
593972|NCT01042132|inflammatory response|inflammatory response
593973|NCT01042132|human|human
593974|NCT01042132|femoral shaft fracture|femoral shaft fracture
593975|NCT01042132|Reamer-irrigator-aspirator|reamer-irrigator-aspirator
593976|NCT01042119|botulinum neurotoxin type A|botulinum neurotoxin type a
593977|NCT01042119|BoNT/A|bont/a
593978|NCT01042119|Botox|botox
593979|NCT01042119|overactive bladder syndrome|overactive bladder syndrome
593980|NCT01042106|diabetes|diabetes
593981|NCT01042093|Analgesia|analgesia
593982|NCT01042093|postoperative pain|postoperative pain
593983|NCT01042093|periarticular|periarticular
593984|NCT01042093|arthroplasty|arthroplasty
593985|NCT01042093|pain management|pain management
593986|NCT01042080|Mechanical ventilation|mechanical ventilation
593987|NCT01042080|Neurally adjusted ventilatory assist (NAVA)|neurally adjusted ventilatory assist (nava)
593988|NCT01042080|Acute respiratory failure|acute respiratory failure
593989|NCT01042080|Chronic obstructive pulmonary disease|chronic obstructive pulmonary disease
593990|NCT01042080|Weaning|weaning
593991|NCT01042080|Invasive mechanical ventilation|invasive mechanical ventilation
593992|NCT01042080|Positive Pressure support Ventilation|positive pressure support ventilation
593993|NCT01042067|warfarin|warfarin
593994|NCT01042067|genotyping|genotyping
593995|NCT01042067|vitamin K|vitamin k
593996|NCT01042067|dosing|dosing
593997|NCT01042067|adverse events|adverse events
593998|NCT01042067|initial phase of treatment|initial phase of treatment
593999|NCT01042067|algorithm|algorithm
594000|NCT01042054|Postoperative Care|postoperative care
594001|NCT01042054|Enhanced|enhanced
594002|NCT01042054|Recovery|recovery
594003|NCT01042054|Hepatectomy|hepatectomy
594004|NCT01042054|Analgesia|analgesia
594005|NCT01042028|Pancreas cancer|pancreas cancer
594006|NCT01042028|Everolimus|everolimus
594007|NCT01042028|Irinotecan|irinotecan
594008|NCT01042028|Cetuximab|cetuximab
594009|NCT01042028|Capecitabine|capecitabine
594010|NCT01042028|Oxaliplatin|oxaliplatin
594011|NCT01042028|Gemcitabine resistant pancreascancer|gemcitabine resistant pancreascancer
594012|NCT01042015|trauma|trauma
594013|NCT01042015|cardiac arrest|cardiac arrest
594014|NCT01042015|hemorrhagic shock|hemorrhagic shock
594015|NCT01042002|High intensity exercise|high intensity exercise
594016|NCT01042002|morbid obesity|morbid obesity
594017|NCT01042002|gastric bypass|gastric bypass
594018|NCT01041989|dementia|dementia
594019|NCT01041989|cognitive impairment|cognitive impairment
594020|NCT01041989|disability|disability
594021|NCT01041989|intervention|intervention
594022|NCT01041989|elderly|elderly
594023|NCT01041989|lifestyle counseling|lifestyle counseling
594024|NCT01041976|Veterans|veterans
594025|NCT01041976|Vocational Rehabilitation|vocational rehabilitation
594026|NCT01041963|ACEI|acei
594027|NCT01041963|ARB|arb
594028|NCT01041963|CAPD|capd
594029|NCT01041963|Peritoneal membrane transport|peritoneal membrane transport
594030|NCT01041950|intracerebral hemorrhage|intracerebral hemorrhage
594031|NCT01041950|intraventricular hemorrhage|intraventricular hemorrhage
594032|NCT01041950|hydrocephalus|hydrocephalus
594033|NCT01041950|Intracerebral hemorrhage with severe ventricular involvement and obstructive hydrocephalus|intracerebral hemorrhage with severe ventricular involvement and obstructive hydrocephalus
594034|NCT01041924|Sleep apnea|sleep apnea
594035|NCT01041924|Periodic breathing|periodic breathing
594036|NCT01041924|Heart Failure|heart failure
594037|NCT01041911|Hemorrhoids|hemorrhoids
594038|NCT01041898|osteocalcin|osteocalcin
594039|NCT01041898|insulin|insulin
594040|NCT01041898|body composition|body composition
594041|NCT01041898|bone mineral density|bone mineral density
594042|NCT01041898|Evaluate the effect of osteocalcin on bone mineral density|evaluate the effect of osteocalcin on bone mineral density
594043|NCT01041898|Evaluate the effect of osteocalcin on body fat distribution|evaluate the effect of osteocalcin on body fat distribution
594044|NCT01041898|Evaluate the effect of osteocalcin on insulin homeostasis|evaluate the effect of osteocalcin on insulin homeostasis
594045|NCT01041885|knee cartilage defect repair|knee cartilage defect repair
594046|NCT01041885|cartilage lesion|cartilage lesion
594047|NCT01041885|autologous chondrocyte|autologous chondrocyte
594048|NCT01041885|scaffold|scaffold
594049|NCT01041885|INSTRUCT|instruct
594050|NCT01041859|Diabetic Peripheral Neuropathy|diabetic peripheral neuropathy
594051|NCT01041859|Painful|painful
594052|NCT01041859|Polyneuropathy|polyneuropathy
594053|NCT01041859|Peripheral neuropathy|peripheral neuropathy
594054|NCT01041846|Myelodysplastic Syndrome|myelodysplastic syndrome
594055|NCT01041846|Dacogen|dacogen
594056|NCT01041846|Decitabine|decitabine
594057|NCT01041846|Epigenetic therapy|epigenetic therapy
594058|NCT01041846|Hypomethylating agent|hypomethylating agent
594059|NCT01041833|All-trans retinoic acid|all-trans retinoic acid
594060|NCT01041833|non-small cell lung cancer|non-small cell lung cancer
594061|NCT01041833|retinoic acid receptor beta|retinoic acid receptor beta
594062|NCT01041820|exercise|exercise
594063|NCT01041820|bone marrow adipose tissue|bone marrow adipose tissue
594064|NCT01041820|bone mineral density|bone mineral density
594065|NCT01041820|Children in the intervention condition will complete a supervised physical activity program 3 days/wk for 10 weeks|children in the intervention condition will complete a supervised physical activity program 3 days/wk for 10 weeks
594066|NCT01041820|Control treatment will be provided no intervention|control treatment will be provided no intervention
594067|NCT01041820|All participants will be instructed not to change their current dietary habits during the study period.|all participants will be instructed not to change their current dietary habits during the study period.
594068|NCT01041807|Hypertension|hypertension
594069|NCT01041794|body composition|body composition
594070|NCT01041794|fat distribution|fat distribution
594071|NCT01041794|exercise|exercise
594072|NCT01041794|diet|diet
594073|NCT01041781|adenocarcinoma of the lung|adenocarcinoma of the lung
594074|NCT01041781|adenosquamous cell lung cancer|adenosquamous cell lung cancer
594075|NCT01041781|large cell lung cancer|large cell lung cancer
594076|NCT01041781|squamous cell lung cancer|squamous cell lung cancer
594077|NCT01041781|recurrent non-small cell lung cancer|recurrent non-small cell lung cancer
594078|NCT01041781|stage IIIB non-small cell lung cancer|stage iiib non-small cell lung cancer
594079|NCT01041781|stage IV non-small cell lung cancer|stage iv non-small cell lung cancer
594080|NCT01041768|Type 2 Diabetes Mellitus|type 2 diabetes mellitus
594081|NCT01041755|Encephalopathy|encephalopathy
594082|NCT01041755|Cirrhosis|cirrhosis
594083|NCT01041716|Carbapenem|carbapenem
594084|NCT01041716|Klebsiella pneumoniae carbapenemase|klebsiella pneumoniae carbapenemase
594085|NCT01041716|Acinetobacter baumannii|acinetobacter baumannii
594086|NCT01041716|Pseudomonas aeruginosa|pseudomonas aeruginosa
594087|NCT01041690|Proliferative Diabetic Retinopathy|proliferative diabetic retinopathy
594088|NCT01041690|Vitrectomy|vitrectomy
594089|NCT01041690|Bevacizumab|bevacizumab
594090|NCT01041677|Obesity|obesity
594091|NCT01041677|Overweight|overweight
594092|NCT01041677|Body Weight|body weight
594093|NCT01041677|Body Size|body size
594094|NCT01041677|Nutritional and Metabolic Diseases|nutritional and metabolic diseases
594095|NCT01041664|nutrigenomics|nutrigenomics
594096|NCT01041664|admixture|admixture
594097|NCT01041664|Hispanic American|hispanic american
594098|NCT01041664|body composition|body composition
594099|NCT01041664|Association of diet and body composition|association of diet and body composition
711788|NCT00583011|Genetic amniocentesis|genetic amniocentesis
594100|NCT01041664|Association between genes and body composition|association between genes and body composition
594101|NCT01041664|Association between gen by diet interaction and body composition|association between gen by diet interaction and body composition
594102|NCT01041625|Lichen Planus|lichen planus
594103|NCT01041612|CBD|cbd
594104|NCT01041612|HBD|hbd
594105|NCT01041612|cancer of bile duct|cancer of bile duct
594106|NCT01041612|pancreatic cancer|pancreatic cancer
594107|NCT01041599|Diabetes Mellitus|diabetes mellitus
594108|NCT01041599|Hypertension|hypertension
594109|NCT01041599|Albuminuria|albuminuria
594110|NCT01041599|vascular stiffness|vascular stiffness
594111|NCT01041586|Emphysema|emphysema
594112|NCT01041586|COPD|copd
594113|NCT01041586|Lung Volume Reduction|lung volume reduction
594114|NCT01041586|BTVA|btva
594115|NCT01041573|Pediatric|pediatric
594116|NCT01041573|Japanese Encephalitis Vaccine|japanese encephalitis vaccine
594117|NCT01041573|endemic countries|endemic countries
594118|NCT01041573|to assess the systemic and local safety profile of purified inactivated Japanese Encephalitis Virus (JEV) vaccine IC51|to assess the systemic and local safety profile of purified inactivated japanese encephalitis virus (jev) vaccine ic51
594119|NCT01041560|Stroke|stroke
594120|NCT01041560|Tone|tone
594121|NCT01041560|Strength|strength
594122|NCT01041547|Insulin sensitivity|insulin sensitivity
594123|NCT01041547|Vascular function|vascular function
594124|NCT01041547|Flow-mediated dilation|flow-mediated dilation
594125|NCT01041547|Arterial stiffness|arterial stiffness
594126|NCT01041547|Glucose tolerance|glucose tolerance
594127|NCT01041547|Hypertension|hypertension
594128|NCT01041534|Adjustable gastric band, morbid obesity, bariatric surgery|adjustable gastric band, morbid obesity, bariatric surgery
594129|NCT01041521|HIV infection|hiv infection
594130|NCT01041521|Dyslipidemia|dyslipidemia
594131|NCT01041521|Elevated Triglyceride level|elevated triglyceride level
594132|NCT01041521|vascular function (BART)|vascular function (bart)
594133|NCT01041521|arterial stiffness|arterial stiffness
594134|NCT01041521|omega three fatty acids|omega three fatty acids
594135|NCT01041521|complementary therapies|complementary therapies
594136|NCT01041508|ALL|all
594137|NCT01041508|AML|aml
594138|NCT01041508|Recurrence|recurrence
594139|NCT01041508|Relapsed|relapsed
594140|NCT01041508|Stem Cell Transplant|stem cell transplant
594141|NCT01041508|Non-myeloablastive|non-myeloablastive
594142|NCT01041495|fibromyalgia|fibromyalgia
594143|NCT01041495|Pain|pain
594144|NCT01041495|Sleep|sleep
594145|NCT01041495|Fatigue|fatigue
594146|NCT01041482|sorafenib|sorafenib
594147|NCT01041482|renal cell carcinoma|renal cell carcinoma
594148|NCT01041482|disease free survival|disease free survival
594149|NCT01041482|Hand food skin reaction|hand food skin reaction
594150|NCT01041469|Down syndrome, Humans,Clinical study,Immunity, Autoimmunity,|down syndrome, humans,clinical study,immunity, autoimmunity,
594151|NCT01041456|complicated biliopancreatic diversion|complicated biliopancreatic diversion
594152|NCT01041456|failed biliopancreatic diversion|failed biliopancreatic diversion
594153|NCT01041456|revision gastric bypass|revision gastric bypass
594154|NCT01041456|conversion bariatric surgery|conversion bariatric surgery
594155|NCT01041456|revision bariatric surgery|revision bariatric surgery
594156|NCT01041456|re-operative bariatric surgery|re-operative bariatric surgery
594157|NCT01041456|malabsorptive syndrome|malabsorptive syndrome
594158|NCT01041456|protein malnutrition|protein malnutrition
594159|NCT01041456|metabolic bone disease|metabolic bone disease
594160|NCT01041430|Ambulatory Surgery|ambulatory surgery
594161|NCT01041430|Aged|aged
594162|NCT01041417|claudication|claudication
594163|NCT01041391|Surgical intervention vs Non-Surgical intervention|surgical intervention vs non-surgical intervention
594164|NCT01041378|Pediatric patients (6 months-5 years) scheduled elective day-case orchiopexy|pediatric patients (6 months-5 years) scheduled elective day-case orchiopexy
594165|NCT01041365|insulin sensitivity|insulin sensitivity
594166|NCT01041365|vascular function|vascular function
594167|NCT01041365|flow-mediated dilation|flow-mediated dilation
594168|NCT01041365|arterial stiffness|arterial stiffness
594169|NCT01041365|ethnicity|ethnicity
594170|NCT01041365|adolescents|adolescents
594172|NCT01041365|glucose tolerance|glucose tolerance
594173|NCT01041365|diabetes|diabetes
594174|NCT01041365|hypertension|hypertension
594175|NCT01041365|cardiovascular|cardiovascular
594176|NCT01041352|anaesthesia|anaesthesia
594177|NCT01041352|laryngeal mask|laryngeal mask
594178|NCT01041352|prone position|prone position
594179|NCT01041339|LpPLA2|lppla2
594180|NCT01041339|ST elevation|st elevation
594181|NCT01041339|acute pericarditis|acute pericarditis
594182|NCT01041326|prostatectomy|prostatectomy
594183|NCT01041326|radiation|radiation
594184|NCT01041326|neoadjuvant|neoadjuvant
594185|NCT01041313|Adjuvants, pharmaceuticals|adjuvants, pharmaceuticals
594186|NCT01041313|Receptors, N-Methyl-D-Aspartate|receptors, n-methyl-d-aspartate
594187|NCT01041313|Drug tolerance|drug tolerance
594188|NCT01041313|Pain Measurement|pain measurement
594189|NCT01041300|Transcranial Magnetic Stimulation|transcranial magnetic stimulation
594190|NCT01041300|TMS|tms
594191|NCT01041300|Motor Threashold|motor threashold
594192|NCT01041300|Multiway|multiway
594193|NCT01041300|Magstim Rapid 2|magstim rapid 2
594194|NCT01041300|Abductor policis brevis|abductor policis brevis
594195|NCT01041300|Figure 8 coil|figure 8 coil
594196|NCT01041300|Double cone coil|double cone coil
594197|NCT01041300|Circular coil|circular coil
594198|NCT01041300|Brainsway|brainsway
594199|NCT01041300|Healthy participants.|healthy participants.
594200|NCT01041274|Schizophrenia|schizophrenia
594201|NCT01041274|Citalopram|citalopram
594202|NCT01041274|First episode|first episode
594203|NCT01041274|fMRI|fmri
594204|NCT01041274|Cognitive behavioral therapy|cognitive behavioral therapy
594205|NCT01041274|Psychoeducation|psychoeducation
594206|NCT01041261|Laparoscopic gastric bypass surgery|laparoscopic gastric bypass surgery
594207|NCT01041261|Medical food|medical food
594208|NCT01041261|Body composition|body composition
594209|NCT01041261|Dietary intervention|dietary intervention
594210|NCT01041248|Relapsing Polychondritis|relapsing polychondritis
594211|NCT01041248|Single Patient Study|single patient study
594212|NCT01041248|Tocilizumab|tocilizumab
594213|NCT01041235|Solid Neoplasms|solid neoplasms
594214|NCT01041235|Carcinoma|carcinoma
594215|NCT01041235|Breast|breast
594216|NCT01041235|Ovarian|ovarian
594217|NCT01041235|Ovary|ovary
594218|NCT01041235|Pancreas|pancreas
594219|NCT01041235|Pancreatic|pancreatic
594220|NCT01041235|Lung|lung
594221|NCT01041235|NSCLC|nsclc
594222|NCT01041235|Non Small Cell Lung|non small cell lung
594223|NCT01041235|Prostate|prostate
594224|NCT01041235|Gastric|gastric
594225|NCT01041235|Head and Neck|head and neck
594226|NCT01041222|Familial ALS|familial als
594227|NCT01041222|ALS|als
594228|NCT01041222|SOD1 Protein|sod1 protein
594229|NCT01041222|ISIS 333611|isis 333611
594230|NCT01041222|SOD1Rx|sod1rx
594231|NCT01041209|Pneumonia|pneumonia
594232|NCT01041209|Children|children
594233|NCT01041196|obesity|obesity
594234|NCT01041196|ulcer disease|ulcer disease
594235|NCT01041196|marginal ulcer|marginal ulcer
594236|NCT01041196|perforation|perforation
594237|NCT01041196|abdominal pain|abdominal pain
594238|NCT01041196|bariatric surgery|bariatric surgery
594239|NCT01041196|weight loss surgery|weight loss surgery
594240|NCT01041183|Oral plus IV ramosetron may be more effective than|oral plus iv ramosetron may be more effective than
594241|NCT01041183|IV ramosetron and oral ramosetron for the prophylaxis of|iv ramosetron and oral ramosetron for the prophylaxis of
594242|NCT01041183|PONV after laparoscopic cholecystectomy|ponv after laparoscopic cholecystectomy
594243|NCT01041170|Rimonabant|rimonabant
594244|NCT01041170|fMRI|fmri
594245|NCT01041170|Alternative Matrices|alternative matrices
594246|NCT01041170|Brain Imaging|brain imaging
594247|NCT01041170|THC|thc
594248|NCT01041157|Torticollis|torticollis
594249|NCT01041157|Botulinum Toxins|botulinum toxins
594250|NCT01041144|Diabetes|diabetes
594251|NCT01041144|PDA|pda
594252|NCT01041144|Internet|internet
594253|NCT01041144|HbA1c|hba1c
594254|NCT01041131|Obesity|obesity
594255|NCT01041131|Obesity recidivism|obesity recidivism
594256|NCT01041131|Inadequate Initial Weight Loss|inadequate initial weight loss
594257|NCT01041131|Technical bariatric complications|technical bariatric complications
594258|NCT01041131|Complicated gastroplasty|complicated gastroplasty
594259|NCT01041131|Failed gastroplasty|failed gastroplasty
594260|NCT01041131|Gastroesophageal reflux disease|gastroesophageal reflux disease
594261|NCT01041131|Revisional gastric bypass|revisional gastric bypass
594262|NCT01041131|Conversion bariatric surgery|conversion bariatric surgery
594263|NCT01041131|Re-operative bariatric surgery|re-operative bariatric surgery
594264|NCT01041131|Technical complications of vertical gastroplasty|technical complications of vertical gastroplasty
594265|NCT01041131|Complicated vertical gastroplasty|complicated vertical gastroplasty
594266|NCT01041105|Obesity|obesity
594267|NCT01041105|Gastroesophageal Reflux Disease|gastroesophageal reflux disease
594268|NCT01041105|Nissen funduplication|nissen funduplication
594269|NCT01041105|Antireflux surgery|antireflux surgery
594270|NCT01041105|Revisional Gastric Bypass|revisional gastric bypass
594271|NCT01041105|Re-operative bariatric surgery|re-operative bariatric surgery
594272|NCT01041105|Bariatric surgery|bariatric surgery
594273|NCT01041105|Nissen|nissen
594274|NCT01041105|Conversion of Nissen to Gastric Bypass|conversion of nissen to gastric bypass
594275|NCT01041079|ulcer disease|ulcer disease
594276|NCT01041079|marginal ulcer|marginal ulcer
594277|NCT01041079|morbidity of gastric bypass|morbidity of gastric bypass
594278|NCT01041079|late morbidity of gastric bypass|late morbidity of gastric bypass
594279|NCT01041079|chronic abdominal pain|chronic abdominal pain
594280|NCT01041079|GI hemorrhage|gi hemorrhage
594281|NCT01041079|Perforation|perforation
594282|NCT01041079|Penetration|penetration
594283|NCT01041079|Obstruction|obstruction
594284|NCT01041066|patients who are intubated for general anesthesia|patients who are intubated for general anesthesia
594285|NCT01041040|Acute Myeloblastic Leukemia|acute myeloblastic leukemia
594286|NCT01041014|Limited English proficiency|limited english proficiency
594287|NCT01041014|Cost-effectiveness|cost-effectiveness
594288|NCT01041014|Emergency Departments|emergency departments
594289|NCT01041014|Language Discordance|language discordance
594290|NCT01041014|Satisfaction|satisfaction
594291|NCT01041014|Limited English proficient patients|limited english proficient patients
594292|NCT01041014|Spanish-speaking patients|spanish-speaking patients
594293|NCT01041001|Umbilical Cord Blood|umbilical cord blood
594294|NCT01041001|Mesenchymal Stem Cells|mesenchymal stem cells
594295|NCT01041001|cartilage injury|cartilage injury
594296|NCT01041001|osteoarthritis|osteoarthritis
594297|NCT01040988|Pacemaker|pacemaker
594298|NCT01040988|Implantable cardioverter-defibrillator|implantable cardioverter-defibrillator
594299|NCT01040962|neuropathy|neuropathy
594300|NCT01040962|diabetes|diabetes
594301|NCT01040949|smoking cessation|smoking cessation
594302|NCT01040949|pregnant Latinas|pregnant latinas
594303|NCT01040949|couples communication|couples communication
594304|NCT01040949|Latino community|latino community
594305|NCT01040949|couples communication in Latino couples|couples communication in latino couples
594306|NCT01040936|acute coronary syndrome|acute coronary syndrome
594307|NCT01040936|intervention|intervention
594308|NCT01040936|outcome|outcome
594309|NCT01040936|patients diagnosed ad Non-ST elevation ACS|patients diagnosed ad non-st elevation acs
594310|NCT01040936|patients received PCI therapy|patients received pci therapy
594311|NCT01040923|CAD|cad
594312|NCT01040923|Diagnostic|diagnostic
594313|NCT01040910|cannabis|cannabis
594314|NCT01040910|Crohn's disease|crohn's disease
594315|NCT01040910|Ulcerative colitis|ulcerative colitis
594316|NCT01040910|IBD|ibd
594317|NCT01040897|Obesity prevention|obesity prevention
594318|NCT01040897|Health Literacy|health literacy
594319|NCT01040897|Health Communication|health communication
594320|NCT01040858|cognitive strategy intervention|cognitive strategy intervention
594321|NCT01040858|cognitive disorders|cognitive disorders
594322|NCT01040845|healthy|healthy
594323|NCT01040845|pharmacokinetics|pharmacokinetics
594324|NCT01040845|drug-interaction|drug-interaction
594325|NCT01040832|Head and Neck Cancer|head and neck cancer
594326|NCT01040832|Recurrent or Metastatic Squamous Cell Carcinoma of the Head and Neck Cancer|recurrent or metastatic squamous cell carcinoma of the head and neck cancer
594327|NCT01040832|Cetuximab|cetuximab
594328|NCT01040832|EMD 1201081|emd 1201081
594329|NCT01040819|Diabetes Mellitus|diabetes mellitus
594330|NCT01040819|6-Ketoprostaglandin F1 alpha|6-ketoprostaglandin f1 alpha
594331|NCT01040819|15-epi-lipoxin A4|15-epi-lipoxin a4
594332|NCT01040819|Thiazolidinediones|thiazolidinediones
594333|NCT01040819|Pioglitazone|pioglitazone
594334|NCT01040806|Diabetes|diabetes
594335|NCT01040780|Efficacy|efficacy
594336|NCT01040780|Safety|safety
594337|NCT01040780|EGFR-TKI|egfr-tki
594338|NCT01040780|phase III|phase iii
594339|NCT01040780|NSCLC|nsclc
594340|NCT01040767|Ultrasound education|ultrasound education
594341|NCT01040767|Blended learning|blended learning
594342|NCT01040767|Distance education|distance education
594343|NCT01040767|Trauma ultrasound|trauma ultrasound
594344|NCT01040767|FAST|fast
594345|NCT01040741|Pandemic influenza A (H1N1) vaccine|pandemic influenza a (h1n1) vaccine
594346|NCT01040741|Adjuvanted|adjuvanted
594347|NCT01040715|Rheumatoid arthritis|rheumatoid arthritis
594348|NCT01040715|anti-drug antibodies|anti-drug antibodies
594349|NCT01040715|Rheumatoid arthritis with secondary loss of efficacy to anti-TNFa antagonists and anti-drug antibodies|rheumatoid arthritis with secondary loss of efficacy to anti-tnfa antagonists and anti-drug antibodies
594350|NCT01040676|Diabetes Mellitus|diabetes mellitus
594351|NCT01040676|Telephone|telephone
594352|NCT01040676|Nutrition Support|nutrition support
594353|NCT01040676|Automated|automated
594354|NCT01040676|Low English Proficiency|low english proficiency
594355|NCT01040676|Hispanic|hispanic
594356|NCT01040676|Latino|latino
594357|NCT01040637|Healthy subjects|healthy subjects
594358|NCT01040624|Prostate Cancer, Proton Radiation|prostate cancer, proton radiation
594359|NCT01040611|music therapy|music therapy
594360|NCT01040611|Tuberculosis|tuberculosis
594361|NCT01040611|anxiety|anxiety
594362|NCT01040611|physiological response|physiological response
594363|NCT01040598|Eosinophilic Esophagitis|eosinophilic esophagitis
594364|NCT01040598|Xolair|xolair
594365|NCT01040598|Omalizumab|omalizumab
594366|NCT01040598|Esophagitis|esophagitis
594367|NCT01040598|Eosinophils|eosinophils
594368|NCT01040598|monoclonal antibody|monoclonal antibody
594369|NCT01040585|cost effectiveness|cost effectiveness
594370|NCT01040585|linezolid|linezolid
594371|NCT01040585|ventilator acquired pneumonia|ventilator acquired pneumonia
594372|NCT01040585|central america|central america
594373|NCT01040572|Obesity recidivism|obesity recidivism
594374|NCT01040572|Weight Regain|weight regain
594375|NCT01040572|Weight recidivism|weight recidivism
594376|NCT01040572|Morbidity|morbidity
594377|NCT01040572|Complication|complication
594378|NCT01040572|Late complications|late complications
594379|NCT01040572|Revisional gastric bypass|revisional gastric bypass
594380|NCT01040572|Re-operative gastric bypass|re-operative gastric bypass
594381|NCT01040572|Revisional bariatric surgery|revisional bariatric surgery
594382|NCT01040572|Re-operative bariatric surgery|re-operative bariatric surgery
594383|NCT01040546|Obesity|obesity
594384|NCT01040546|Metabolic syndrome|metabolic syndrome
594385|NCT01040546|Weight control educational intervention|weight control educational intervention
594386|NCT01040546|Food intake|food intake
594387|NCT01040533|Failed jejunoileal bypass|failed jejunoileal bypass
594388|NCT01040533|Complicated jejunoileal bypass|complicated jejunoileal bypass
594389|NCT01040533|Revision gastric bypass|revision gastric bypass
594390|NCT01040533|Revisional surgery|revisional surgery
594391|NCT01040533|Reoperations|reoperations
594392|NCT01040533|Metabolic and nutritional complications|metabolic and nutritional complications
594393|NCT01040520|CT-based autopsy|ct-based autopsy
594394|NCT01040520|virtual autopsy|virtual autopsy
594395|NCT01040520|medical autopsy|medical autopsy
594396|NCT01040520|quality control|quality control
594397|NCT01040507|severe obesity|severe obesity
594398|NCT01040507|morbid obesity|morbid obesity
594399|NCT01040507|gastric bypass|gastric bypass
594400|NCT01040507|efficacy of gastric bypass|efficacy of gastric bypass
594401|NCT01040494|Aliskiren|aliskiren
594402|NCT01040494|Congestive heart failure|congestive heart failure
594403|NCT01040494|Central hemodynamics|central hemodynamics
594404|NCT01040481|Failed gastric bypass|failed gastric bypass
594405|NCT01040481|Malabsorptive distal gastric bypass|malabsorptive distal gastric bypass
594406|NCT01040481|Distal gastric bypass|distal gastric bypass
594407|NCT01040481|Malabsorptive gastric bypass|malabsorptive gastric bypass
594408|NCT01040481|Adding malabsorption|adding malabsorption
594409|NCT01040481|Increasing malabsorption|increasing malabsorption
594410|NCT01040481|Re-operative bariatric surgery|re-operative bariatric surgery
594411|NCT01040481|Revisional bariatric surgery|revisional bariatric surgery
594412|NCT01040481|Revisional gastric bypass|revisional gastric bypass
594413|NCT01040481|Reoperations|reoperations
594414|NCT01040481|Conversions|conversions
594415|NCT01040468|Type 2 Diabetes|type 2 diabetes
594416|NCT01040468|Bariatric Surgery|bariatric surgery
594417|NCT01040468|Roux-en-Y Gastric Bypass|roux-en-y gastric bypass
594418|NCT01040468|Gastric Banding|gastric banding
594419|NCT01040468|Obesity|obesity
594420|NCT01040468|Weight loss|weight loss
594421|NCT01040468|Insulin sensitivity|insulin sensitivity
594422|NCT01040468|GLP-1|glp-1
594423|NCT01040468|Meal Challenge|meal challenge
594424|NCT01040468|Euglycemic Clamp|euglycemic clamp
594425|NCT01040455|functional dyspepsia|functional dyspepsia
594426|NCT01040455|lansoprazole|lansoprazole
594427|NCT01040455|placebo effect|placebo effect
594428|NCT01040442|Postural Balance|postural balance
594429|NCT01040442|Aging|aging
594430|NCT01040442|Accidental Falls|accidental falls
594431|NCT01040442|Vibration|vibration
594432|NCT01040429|Adolescent|adolescent
594433|NCT01040429|Clonidine|clonidine
594434|NCT01040429|Autonomic nervous system|autonomic nervous system
594435|NCT01040429|Stress|stress
594436|NCT01040416|complicated marginal ulcer|complicated marginal ulcer
594437|NCT01040416|complex marginal ulcer|complex marginal ulcer
594438|NCT01040416|complication after gastric bypass|complication after gastric bypass
594439|NCT01040416|gastrointestinal hemorrhage|gastrointestinal hemorrhage
594440|NCT01040390|Acne Vulgaris|acne vulgaris
594441|NCT01040390|Homoeopathy|homoeopathy
594442|NCT01040390|Lappa Arctium|lappa arctium
594443|NCT01040377|Inadequate Initial Weight Loss|inadequate initial weight loss
594444|NCT01040377|Inadequate weight loss|inadequate weight loss
594445|NCT01040377|Poor weight loss|poor weight loss
594446|NCT01040377|Failed gastric bypass|failed gastric bypass
594447|NCT01040377|Revision gastric bypass|revision gastric bypass
594448|NCT01040364|Internal hernia|internal hernia
594449|NCT01040364|Mesocolic hernia|mesocolic hernia
594450|NCT01040364|Petersen´s hernia|petersen´s hernia
594451|NCT01040364|Jejunojejunostomy hernia|jejunojejunostomy hernia
594452|NCT01040364|Bowel obstruction|bowel obstruction
594453|NCT01040364|Ischemic bowel|ischemic bowel
594454|NCT01040364|Complication after gastric bypass|complication after gastric bypass
594455|NCT01040364|Re-operative bariatric surgery|re-operative bariatric surgery
594456|NCT01040364|Chronic pain after gastric bypass|chronic pain after gastric bypass
594457|NCT01040351|Infertility|infertility
594458|NCT01040351|Hydrosalpinx|hydrosalpinx
594459|NCT01040351|IVF-ET|ivf-et
594460|NCT01040338|Smoking|smoking
594461|NCT01040338|Tobacco|tobacco
594462|NCT01040338|Nicotine|nicotine
594463|NCT01040338|Dependence|dependence
594464|NCT01040338|Genetics|genetics
594465|NCT01040312|UGT1A1, irinotecan|ugt1a1, irinotecan
594466|NCT01040299|GangTrainer|gangtrainer
594467|NCT01040299|Gait Rehabilitation|gait rehabilitation
594468|NCT01040299|Cerebrovascular Disorders|cerebrovascular disorders
594469|NCT01040299|Robot assisted|robot assisted
594470|NCT01040299|Transcranial direct current stimulation|transcranial direct current stimulation
594471|NCT01040286|Subjects, age>21, with Chronic periodontal disease on natural teeth characterized by the presence of at least 2 teeth with periodontal|subjects, age>21, with chronic periodontal disease on natural teeth characterized by the presence of at least 2 teeth with periodontal
711789|NCT00583011|Fetal lung maturity|fetal lung maturity
594472|NCT01040286|pockets of 5-9 mm in depth demonstrating bleeding on probing without involving the|pockets of 5-9 mm in depth demonstrating bleeding on probing without involving the
594473|NCT01040286|apex of the tooth and confirmed by dental X-ray.|apex of the tooth and confirmed by dental x-ray.
594474|NCT01040260|tobacco use disorder|tobacco use disorder
594475|NCT01040247|Infertility|infertility
594476|NCT01040247|Low Responder|low responder
594477|NCT01040247|IVF|ivf
594478|NCT01040247|Embryo Transfer|embryo transfer
594479|NCT01040234|postoperative pain|postoperative pain
594480|NCT01040234|abdominal surgery|abdominal surgery
594481|NCT01040234|bilateral dual TAP block|bilateral dual tap block
594482|NCT01040221|Autism, Autism Spectrum Disorder|autism, autism spectrum disorder
594483|NCT01040221|ASD|asd
594484|NCT01040221|Trichuris Suis Ova|trichuris suis ova
594485|NCT01040221|TSO|tso
594486|NCT01040221|Treatment|treatment
594487|NCT01040221|Clinical Trial|clinical trial
594488|NCT01040195|ankylosing spondylitis|ankylosing spondylitis
594489|NCT01040195|undifferentiated spondyloarthropathy|undifferentiated spondyloarthropathy
594490|NCT01040195|spondyloarthropathy|spondyloarthropathy
594491|NCT01040195|inflammatory back pain|inflammatory back pain
594492|NCT01040195|methotrexate|methotrexate
594493|NCT01040195|sulfasalazine|sulfasalazine
594494|NCT01040195|hydroxychloroquine|hydroxychloroquine
594495|NCT01040182|ischemic stroke patients|ischemic stroke patients
594496|NCT01040143|Pneumococci|pneumococci
594497|NCT01040143|Streptococcus pneumoniae|streptococcus pneumoniae
594498|NCT01040117|Equilibrium|equilibrium
594499|NCT01040117|Rehabilitation|rehabilitation
594500|NCT01040117|Randomized Controlled Trial|randomized controlled trial
594501|NCT01040117|Postural instability|postural instability
594502|NCT01040117|Sensory-motor integration|sensory-motor integration
594503|NCT01040104|wound healing|wound healing
594504|NCT01040104|hypertrophic scar|hypertrophic scar
594505|NCT01040104|skin transplantation|skin transplantation
594506|NCT01040104|diabetes mellitus|diabetes mellitus
594507|NCT01040091|HIV Seronegativity|hiv seronegativity
594508|NCT01040091|Treatment Experienced|treatment experienced
594509|NCT01040065|Acromioclavicular joint arthritis|acromioclavicular joint arthritis
594510|NCT01040065|distal clavicle resection|distal clavicle resection
594511|NCT01040065|Mumford procedure|mumford procedure
594512|NCT01040052|Diphtheria|diphtheria
594513|NCT01040052|Tetanus|tetanus
594514|NCT01040052|Pertussis|pertussis
594515|NCT01040052|Adacel®|adacel®
594516|NCT01040039|HCV|hcv
594517|NCT01040039|HIV|hiv
594518|NCT01040013|LAPAROSCOPY,|laparoscopy,
594519|NCT01040013|LAPAROTOMY,|laparotomy,
594520|NCT01040013|OXYGENATION,|oxygenation,
594521|NCT01040013|ISCHEMIA-REPERFUSION INJURY|ischemia-reperfusion injury
594522|NCT01040000|NPC-1C|npc-1c
594523|NCT01040000|Monoclonal antibody|monoclonal antibody
594524|NCT01040000|Pancreatic Cancer|pancreatic cancer
594525|NCT01040000|Adenocarcinoma of the pancreas|adenocarcinoma of the pancreas
594526|NCT01040000|Ductal carcinoma of the pancreas|ductal carcinoma of the pancreas
594527|NCT01040000|Duct cell carcinomas, pancreas|duct cell carcinomas, pancreas
594528|NCT01040000|Carcinomas, pancreas duct cell|carcinomas, pancreas duct cell
594529|NCT01040000|Pancreas duct cell carcinoma|pancreas duct cell carcinoma
594530|NCT01040000|Pancreatic duct cell carcinoma|pancreatic duct cell carcinoma
594531|NCT01040000|Adenocarcinoma of the colon|adenocarcinoma of the colon
594532|NCT01040000|Adenocarcinoma of the rectum|adenocarcinoma of the rectum
594533|NCT01040000|Colorectal cancer|colorectal cancer
594534|NCT01040000|Colorectal tumor|colorectal tumor
594535|NCT01040000|Colorectal neoplasm|colorectal neoplasm
594536|NCT01039987|Autosomal dominant polycystic kidney disease|autosomal dominant polycystic kidney disease
594537|NCT01039987|ADPKD|adpkd
594538|NCT01039987|kidney|kidney
594539|NCT01039987|Biomarker|biomarker
594540|NCT01039987|MRI|mri
594541|NCT01039974|ketoconazole|ketoconazole
594542|NCT01039974|GSK962040|gsk962040
594543|NCT01039974|Drug-Drug Interaction|drug-drug interaction
594544|NCT01039974|Phase I|phase i
594545|NCT01039961|healthy volunteers|healthy volunteers
594546|NCT01039961|IV formulation study|iv formulation study
594547|NCT01039948|Neoplasms|neoplasms
594548|NCT01039948|Carcinoma|carcinoma
594549|NCT01039948|Carcinoma, Non-Small-Cell Lung|carcinoma, non-small-cell lung
594550|NCT01039948|Lung Neoplasms|lung neoplasms
594551|NCT01039948|Respiratory Tract Neoplasms|respiratory tract neoplasms
594552|NCT01039948|Neoplasms, Glandular and Epithelial|neoplasms, glandular and epithelial
594553|NCT01039948|Neoplasms by Histological Type|neoplasms by histological type
594554|NCT01039948|Thoracic Neoplasms|thoracic neoplasms
594555|NCT01039948|Neoplasms by Site|neoplasms by site
594556|NCT01039948|Lung Diseases|lung diseases
594557|NCT01039948|Respiratory Tract Diseases|respiratory tract diseases
594558|NCT01039948|Gefitinib|gefitinib
594559|NCT01039948|Antineoplastic Agents|antineoplastic agents
594560|NCT01039948|Therapeutic Uses|therapeutic uses
594561|NCT01039948|Pharmacologic Actions|pharmacologic actions
594562|NCT01039948|Protein Kinase Inhibitors|protein kinase inhibitors
594563|NCT01039948|Enzyme Inhibitors|enzyme inhibitors
594564|NCT01039948|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action
594565|NCT01039935|Odor Discrimination|odor discrimination
594566|NCT01039922|Neuroendocrine Tumors|neuroendocrine tumors
594567|NCT01039922|Registries|registries
594568|NCT01039883|Healthy Volunteers|healthy volunteers
594569|NCT01039870|postthoracotomy pain|postthoracotomy pain
594570|NCT01039857|Psychotherapy|psychotherapy
594571|NCT01039857|Depression|depression
594572|NCT01039857|Adjustment Disorders|adjustment disorders
594573|NCT01039857|Neuropsychology|neuropsychology
594574|NCT01039857|Rehabilitation|rehabilitation
594575|NCT01039857|Coping Skills|coping skills
594576|NCT01039857|Stroke|stroke
594577|NCT01039857|Caregivers|caregivers
594578|NCT01039844|LOC-paclitaxel Injection|loc-paclitaxel injection
594579|NCT01039844|metastatic Melanoma|metastatic melanoma
594580|NCT01039831|PIGD|pigd
594581|NCT01039831|tremor|tremor
594582|NCT01039831|falls|falls
594583|NCT01039831|white matter|white matter
594584|NCT01039818|Graves Disease|graves disease
594585|NCT01039818|Hyperthyroidism|hyperthyroidism
594586|NCT01039818|Radioiodine|radioiodine
594587|NCT01039818|Clinical trial|clinical trial
594588|NCT01039805|GSK962040|gsk962040
594589|NCT01039805|13C octanoic acid breath test|13c octanoic acid breath test
594590|NCT01039805|pharmacokinetics|pharmacokinetics
594591|NCT01039805|critically ill patients|critically ill patients
594592|NCT01039805|gut motility|gut motility
594593|NCT01039805|pharmacodynamics|pharmacodynamics
594594|NCT01039805|tolerability|tolerability
594595|NCT01039805|single dose|single dose
594596|NCT01039805|gastric emtpying|gastric emtpying
594597|NCT01039792|Autism|autism
594598|NCT01039792|Pervasive Developmental Disorders|pervasive developmental disorders
594599|NCT01039779|older fallers|older fallers
594600|NCT01039779|tai chi|tai chi
594601|NCT01039766|post traumatic stress disorder|post traumatic stress disorder
594602|NCT01039766|prevention|prevention
594603|NCT01039766|oxytocin|oxytocin
594604|NCT01039753|acute kidney injury|acute kidney injury
594605|NCT01039753|renal replacement therapy|renal replacement therapy
594606|NCT01039753|biomarkers|biomarkers
594607|NCT01039740|Pharmacogenomics|pharmacogenomics
594608|NCT01039740|Prediction of Mirtazapine response|prediction of mirtazapine response
594609|NCT01039740|Depressed patients|depressed patients
594610|NCT01039740|Mirtazapine response|mirtazapine response
594611|NCT01039740|Adverse event|adverse event
594612|NCT01039727|Pain [C10.597.617]|pain [c10.597.617]
594613|NCT01039714|Hypocalcemia|hypocalcemia
594614|NCT01039714|Hypoparathyroidism|hypoparathyroidism
594615|NCT01039714|Vitamin D deficiency|vitamin d deficiency
594616|NCT01039714|Total thyroidectomy|total thyroidectomy
594617|NCT01039714|calcium|calcium
594618|NCT01039714|PTH|pth
594619|NCT01039701|safety|safety
594620|NCT01039701|tolerability|tolerability
594621|NCT01039701|mild to moderate Alzheimer's disease|mild to moderate alzheimer's disease
594622|NCT01039701|To determine the safety and tolerability of AZD1446 vs Placebo given as an add-on treatment to Donepezil in patients with mild to moderate Alzheimer's disease|to determine the safety and tolerability of azd1446 vs placebo given as an add-on treatment to donepezil in patients with mild to moderate alzheimer's disease
594623|NCT01039688|oral JAK inhibitor|oral jak inhibitor
594624|NCT01039688|MTX|mtx
594625|NCT01039688|DMARD|dmard
594626|NCT01039688|clinical trial|clinical trial
594627|NCT01039688|joint diseases|joint diseases
594628|NCT01039688|autoimmune diseases|autoimmune diseases
594629|NCT01039688|anti-Inflammatory agents|anti-inflammatory agents
594630|NCT01039688|rheumatic diseases|rheumatic diseases
594631|NCT01039675|long-acting beta2-receptor agonist|long-acting beta2-receptor agonist
594632|NCT01039675|Safety and tolerability|safety and tolerability
594633|NCT01039675|pharmacodynamics|pharmacodynamics
594634|NCT01039675|pharmacokinetics|pharmacokinetics
594635|NCT01039675|long-acting muscarinic receptor antagonist|long-acting muscarinic receptor antagonist
594636|NCT01039675|COPD|copd
594637|NCT01039649|radiation|radiation
594638|NCT01039649|Tomography, Spiral Computed|tomography, spiral computed
594639|NCT01039649|Four-Dimensional Computed Tomography|four-dimensional computed tomography
594640|NCT01039649|Respiratory Function Tests|respiratory function tests
594641|NCT01039636|Beta-thalassemia|beta-thalassemia
594642|NCT01039636|Sickle cell anemia|sickle cell anemia
594643|NCT01039636|Transfusional iron overload|transfusional iron overload
594644|NCT01039636|Iron overload|iron overload
594645|NCT01039636|Iron chelation|iron chelation
594646|NCT01039623|Healthy volunteers|healthy volunteers
594647|NCT01039610|single dose|single dose
594648|NCT01039610|pharmacokinetics|pharmacokinetics
594649|NCT01039610|GSK945237|gsk945237
594650|NCT01039610|tolerability|tolerability
594651|NCT01039610|safety|safety
594652|NCT01039610|antibiotics|antibiotics
594653|NCT01039610|linezolid|linezolid
594654|NCT01039610|QTc|qtc
594655|NCT01039610|bacterial type II topoisomerase Inhibitors (BTI)|bacterial type ii topoisomerase inhibitors (bti)
594656|NCT01039610|moxifloxacin|moxifloxacin
594657|NCT01039610|repeat dose|repeat dose
594659|NCT01039597|Ulcerative colitis|ulcerative colitis
594660|NCT01039584|bioequivalence|bioequivalence
594661|NCT01039584|butoconazole|butoconazole
594662|NCT01039584|vulvovaginal|vulvovaginal
594663|NCT01039584|candidiasis|candidiasis
594664|NCT01039571|rotator cuff tear|rotator cuff tear
594665|NCT01039571|arthroscopic repair|arthroscopic repair
594666|NCT01039571|single row repair|single row repair
594667|NCT01039571|double row repair|double row repair
594668|NCT01039571|retear rate|retear rate
594669|NCT01039558|gastroesophageal reflux disease|gastroesophageal reflux disease
594670|NCT01039558|lansoprazole|lansoprazole
594671|NCT01039558|ecabet sodium|ecabet sodium
594672|NCT01039545|Urinary tract infections|urinary tract infections
594673|NCT01039545|Anti-bacterial agents|anti-bacterial agents
594674|NCT01039532|Type 2 diabetes mellitus|type 2 diabetes mellitus
594675|NCT01039532|Biphasic human insulin thrice a day|biphasic human insulin thrice a day
594676|NCT01039532|Basal bolus insulin|basal bolus insulin
594677|NCT01039519|G.I. Stromal Tumor|g.i. stromal tumor
594678|NCT01039519|GIST|gist
594679|NCT01039506|UGT1A1, irinotecan|ugt1a1, irinotecan
594680|NCT01039480|pharmacological biomarker|pharmacological biomarker
594681|NCT01039480|compliance monitoring|compliance monitoring
594682|NCT01039480|platelet aggregometry|platelet aggregometry
594683|NCT01039480|resistance|resistance
594684|NCT01039480|Platelet Aggregation Inhibitors|platelet aggregation inhibitors
594685|NCT01039480|Medication Non-Compliance|medication non-compliance
594686|NCT01039467|Managed Ventricular Pacing|managed ventricular pacing
594687|NCT01039454|Food Reward|food reward
594688|NCT01039454|fMRI|fmri
594689|NCT01039454|Obese|obese
594690|NCT01039454|Cognition|cognition
594691|NCT01039454|Food Addiction|food addiction
594692|NCT01039454|Behaviour|behaviour
594693|NCT01039454|Overweight|overweight
594694|NCT01039454|Food Reinforcement|food reinforcement
594695|NCT01039454|Metabolic endpoints|metabolic endpoints
594696|NCT01039428|hyperphosphatemia|hyperphosphatemia
594697|NCT01039428|hemodialysis|hemodialysis
594698|NCT01039428|chitosan|chitosan
594699|NCT01039415|marijuana|marijuana
594700|NCT01039415|marijuana abuse|marijuana abuse
594701|NCT01039415|marijuana dependence|marijuana dependence
594702|NCT01039415|cannabis|cannabis
594703|NCT01039415|substance-related disorder|substance-related disorder
594704|NCT01039415|abstinence|abstinence
594705|NCT01039402|cardiovascular risk|cardiovascular risk
594706|NCT01039402|France|france
594707|NCT01039402|Observational, descriptive study|observational, descriptive study
594708|NCT01039389|Coronary Artery Disease|coronary artery disease
594709|NCT01039389|Stable|stable
594710|NCT01039389|Coronary Collaterals|coronary collaterals
594711|NCT01039389|Therapeutic Collateral Promotion|therapeutic collateral promotion
594712|NCT01039389|Arteriogenesis|arteriogenesis
594713|NCT01039389|Bradycardia|bradycardia
594714|NCT01039376|maintenance therapy|maintenance therapy
594715|NCT01039376|anti-CD20 monoclonal antibody|anti-cd20 monoclonal antibody
594716|NCT01039376|ofatumumab|ofatumumab
594717|NCT01039363|Relapse or refractory acute myeloid leukemia|relapse or refractory acute myeloid leukemia
594718|NCT01039350|Myelodysplastic syndrome|myelodysplastic syndrome
594719|NCT01039337|osteoarthritis|osteoarthritis
594720|NCT01039337|manual therapy|manual therapy
594721|NCT01039337|manipulation|manipulation
594722|NCT01039337|hip school|hip school
594723|NCT01039337|chiropractic|chiropractic
594724|NCT01039337|patient education|patient education
594725|NCT01039324|Complex patients|complex patients
594726|NCT01039324|Care transitions|care transitions
594727|NCT01039324|Patient safety|patient safety
594728|NCT01039324|Patient care|patient care
594729|NCT01039324|Health Information Technology|health information technology
594730|NCT01039324|Health Information Exchange|health information exchange
594731|NCT01039324|Clinical Decision Support|clinical decision support
594732|NCT01039324|Care coordination|care coordination
594733|NCT01039324|Data sharing|data sharing
594734|NCT01039311|Lung|lung
594735|NCT01039311|cancer|cancer
594736|NCT01039311|bronchoscopy|bronchoscopy
594737|NCT01039311|optical|optical
594738|NCT01039311|coherence|coherence
594739|NCT01039311|tomography|tomography
594740|NCT01039298|Oral cancer|oral cancer
594741|NCT01039298|fluorescence visualization|fluorescence visualization
594742|NCT01039298|surgical margin|surgical margin
594743|NCT01039298|recurrence|recurrence
594744|NCT01039285|Very premature infant|very premature infant
594745|NCT01039285|Surfactant|surfactant
594746|NCT01039285|Respiratory Distress|respiratory distress
594747|NCT01039285|Bronchopulmonary Dysplasia|bronchopulmonary dysplasia
594748|NCT01039272|oral cancer|oral cancer
594749|NCT01039272|EBV|ebv
594750|NCT01039272|PCR|pcr
594751|NCT01039259|adolescent|adolescent
594752|NCT01039259|body piercing/adverse effects|body piercing/adverse effects
594753|NCT01039259|tongue piercing|tongue piercing
594754|NCT01039259|tongue/microbiology|tongue/microbiology
594755|NCT01039181|Vitamin D|vitamin d
594756|NCT01039181|Calcitriol|calcitriol
594757|NCT01039181|cholangiocarcinoma|cholangiocarcinoma
594758|NCT01039181|Clinical trial|clinical trial
594759|NCT01039168|Burnout|burnout
594760|NCT01039168|Sick leave|sick leave
594761|NCT01039168|Intervention study|intervention study
594762|NCT01039168|Prospective study|prospective study
594763|NCT01039168|Work|work
594764|NCT01039142|Psoriasis|psoriasis
594765|NCT01039129|Gallstones|gallstones
594766|NCT01039129|Appendicitis|appendicitis
594767|NCT01039129|Pelvic pain|pelvic pain
594768|NCT01039129|Peritoneal mass|peritoneal mass
594769|NCT01039116|obesity|obesity
594770|NCT01039116|nutrition|nutrition
594771|NCT01039116|type 2 diabetes|type 2 diabetes
594772|NCT01039116|community-based.|community-based.
594773|NCT01039103|PEG-liposomal prednisolone sodium phosphate|peg-liposomal prednisolone sodium phosphate
594774|NCT01039090|Not eligible for deep brain stimulation|not eligible for deep brain stimulation
594775|NCT01039090|Parkinsons's patients|parkinsons's patients
594776|NCT01039038|prostate|prostate
594777|NCT01039038|curietherapy|curietherapy
594778|NCT01039038|radiotherapy|radiotherapy
594779|NCT01039038|intermediate risk|intermediate risk
594780|NCT01039025|Myeloma|myeloma
594781|NCT01039025|Topotecan|topotecan
594782|NCT01039025|Hycamtin|hycamtin
594783|NCT01039025|Melphalan|melphalan
594784|NCT01039025|Alkeran|alkeran
594785|NCT01039025|Cyclophosphamide|cyclophosphamide
594786|NCT01039025|Cytoxan|cytoxan
594787|NCT01039025|Neosar|neosar
594788|NCT01039025|Stem Cell Harvest|stem cell harvest
594789|NCT01039025|Peripheral Blood Stem Cells|peripheral blood stem cells
594790|NCT01039012|bone mineral density|bone mineral density
594791|NCT01039012|osteoporosis|osteoporosis
594792|NCT01039012|exercise|exercise
594793|NCT01039012|bone remodeling|bone remodeling
594794|NCT01039012|biomotion analysis|biomotion analysis
594795|NCT01038999|Complementary Therapies|complementary therapies
594796|NCT01038986|chronic wound|chronic wound
594797|NCT01038986|refractory wound|refractory wound
594798|NCT01038986|CureXcell|curexcell
594799|NCT01038986|activated cell suspension|activated cell suspension
594800|NCT01038960|ICD, training|icd, training
594801|NCT01038934|Buccal Mucosa|buccal mucosa
594802|NCT01038934|DNA|dna
594803|NCT01038934|Polymerase Chain Reaction|polymerase chain reaction
594804|NCT01038921|Blood Pressure|blood pressure
594805|NCT01038921|Glucose levels|glucose levels
594806|NCT01038921|HDL levels|hdl levels
594807|NCT01038921|Triglyceride levels|triglyceride levels
594808|NCT01038921|Waist Circumference|waist circumference
594809|NCT01038908|sentinel lymph node biopsy (SLNB)|sentinel lymph node biopsy (slnb)
594810|NCT01038908|axillary lymph node dissection (ALND)|axillary lymph node dissection (alnd)
594811|NCT01038908|lymphatics|lymphatics
594812|NCT01038908|blue dye|blue dye
594813|NCT01038895|Hypertension|hypertension
594814|NCT01038895|type 2 diabetes|type 2 diabetes
594815|NCT01038895|aliskiren|aliskiren
594816|NCT01038895|ramipril|ramipril
594817|NCT01038895|microalbuminuria|microalbuminuria
594818|NCT01038895|blood pressure> 130/80 <180/105 mmHg at the end of the wash−out|blood pressure> 130/80 <180/105 mmhg at the end of the wash−out
594819|NCT01038895|type 2 diabetes mellitus well controlled by medication and / or|type 2 diabetes mellitus well controlled by medication and / or
594820|NCT01038895|compliance with diet (HbA1c <7%)|compliance with diet (hba1c <7%)
594821|NCT01038895|Microalbuminuria in the upper range of normal (> 200 <300 mg/24 h)|microalbuminuria in the upper range of normal (> 200 <300 mg/24 h)
594822|NCT01038882|sedation|sedation
594823|NCT01038882|midazolam|midazolam
594824|NCT01038882|flexible bronchoscopy|flexible bronchoscopy
594825|NCT01038882|tolerance|tolerance
594826|NCT01038843|VA106483|va106483
594827|NCT01038843|Nocturia|nocturia
594828|NCT01038843|males|males
594829|NCT01038843|nocturnal voids|nocturnal voids
594830|NCT01038843|anti-diuretic|anti-diuretic
594831|NCT01038843|hyponatraemia|hyponatraemia
594832|NCT01038817|tooth-decay|tooth-decay
594833|NCT01038817|prevention|prevention
594834|NCT01038817|fluoride-varnish|fluoride-varnish
594835|NCT01038817|institutionalised elderly people|institutionalised elderly people
594836|NCT01038804|Breast Cancer|breast cancer
594837|NCT01038804|Metastatic|metastatic
594838|NCT01038804|HER2 Negative|her2 negative
594839|NCT01038804|YM155|ym155
594840|NCT01038791|chronic hypercapnic respiratory failure|chronic hypercapnic respiratory failure
594842|NCT01038791|RTD|rtd
594843|NCT01038791|sleep architecture|sleep architecture
594844|NCT01038791|humidification|humidification
594845|NCT01038765|Recurrent Major Depressive Disorder|recurrent major depressive disorder
594846|NCT01038765|Mindfulness Based Cognitive Therapy|mindfulness based cognitive therapy
594847|NCT01038765|Randomized Controlled Trial|randomized controlled trial
594848|NCT01038752|NSCLC|nsclc
594849|NCT01038752|suramin|suramin
594850|NCT01038752|lung cancer|lung cancer
594851|NCT01038752|chemotherapy|chemotherapy
594852|NCT01038726|Healthy Aging|healthy aging
594853|NCT01038700|Circulating endothelial compartment|circulating endothelial compartment
594854|NCT01038700|microparticles|microparticles
594855|NCT01038700|endothelial progenitors cells|endothelial progenitors cells
594856|NCT01038700|circulating endothelial cells|circulating endothelial cells
594857|NCT01038700|transcriptome|transcriptome
594858|NCT01038700|aging|aging
594859|NCT01038700|Healthy volunteers|healthy volunteers
594860|NCT01038687|functional constipation|functional constipation
594861|NCT01038687|bile acid|bile acid
594862|NCT01038648|Sitagliptin|sitagliptin
594863|NCT01038648|Type 2 diabetes|type 2 diabetes
594864|NCT01038648|Prevention of type 2 diabetes|prevention of type 2 diabetes
594865|NCT01038635|5-Azacytidine|5-azacytidine
594866|NCT01038635|5-Aza|5-aza
594867|NCT01038635|Lenalidomide|lenalidomide
594868|NCT01038635|Revlimid|revlimid
594869|NCT01038635|CC-5103|cc-5103
594870|NCT01038635|Myelodysplastic Syndrome|myelodysplastic syndrome
594871|NCT01038635|MDS|mds
594872|NCT01038635|Acute Myelogenous Leukemia|acute myelogenous leukemia
594873|NCT01038635|AML|aml
594874|NCT01038622|L-arginine|l-arginine
594875|NCT01038622|Nasal NO|nasal no
594876|NCT01038622|Nosocomial infection|nosocomial infection
594877|NCT01038622|Immune function|immune function
594878|NCT01038622|HLA-DR expression|hla-dr expression
594879|NCT01038622|Critically ill|critically ill
594880|NCT01038622|Medical ICU patients|medical icu patients
594881|NCT01038609|Postoperative Pain|postoperative pain
594882|NCT01038596|osteoarthritis, mesenchymal stromal cells, proliferation|osteoarthritis, mesenchymal stromal cells, proliferation
594883|NCT01038583|Aspirin|aspirin
594884|NCT01038583|Prevention|prevention
594885|NCT01038583|Healthy|healthy
594886|NCT01038583|Over 70 years old|over 70 years old
594887|NCT01038583|ASPREE|aspree
594888|NCT01038583|Aspirin in Reducing Events in the Elderly|aspirin in reducing events in the elderly
594889|NCT01038583|Australia|australia
594890|NCT01038583|Functional disability|functional disability
594891|NCT01038583|Dementia|dementia
594892|NCT01038583|Heart Disease/ Stroke|heart disease/ stroke
594893|NCT01038583|Cancer|cancer
594894|NCT01038583|Bleeding|bleeding
594895|NCT01038570|Prader Willi syndrome|prader willi syndrome
594896|NCT01038570|adults|adults
594897|NCT01038570|social behaviour|social behaviour
594898|NCT01038570|stress|stress
594899|NCT01038570|anxiety|anxiety
594900|NCT01038570|psychological tests|psychological tests
594901|NCT01038557|frozen|frozen
594902|NCT01038557|red blood cells|red blood cells
594903|NCT01038557|transfusion|transfusion
594904|NCT01038557|trauma|trauma
594905|NCT01038544|Esophageal Cancer|esophageal cancer
594906|NCT01038544|Mediastinal lymph nodes|mediastinal lymph nodes
594907|NCT01038544|Staging|staging
594908|NCT01038544|EBUS|ebus
594909|NCT01038544|EUS|eus
594910|NCT01038544|Endobronchial Ultrasound|endobronchial ultrasound
594911|NCT01038544|Endoscopic Ultrasound|endoscopic ultrasound
594912|NCT01038531|Acute lung injury (ALI)|acute lung injury (ali)
594913|NCT01038531|Adult respiratory distress syndrome (ARDS)|adult respiratory distress syndrome (ards)
594914|NCT01038531|Low-tidal-volume strategy|low-tidal-volume strategy
594915|NCT01038531|ARDS Net|ards net
594916|NCT01038531|airway pressure release ventilation (APRV)|airway pressure release ventilation (aprv)
594917|NCT01038531|biomarkers of lung injury|biomarkers of lung injury
594918|NCT01038518|epidemiology|epidemiology
594919|NCT01038518|risk factors|risk factors
594920|NCT01038518|micronutrients|micronutrients
594921|NCT01038479|Xylitol|xylitol
594922|NCT01038479|Mutans streptococci|mutans streptococci
594923|NCT01038479|Maternal consumption|maternal consumption
594924|NCT01038479|Early childhood tooth decay|early childhood tooth decay
594925|NCT01038479|Early childhood caries|early childhood caries
594926|NCT01038479|Childsmile|childsmile
594927|NCT01038466|CHAT|chat
594928|NCT01038466|breast cancer|breast cancer
594929|NCT01038466|non interventional observational study|non interventional observational study
594930|NCT01038440|Omega 3 fatty acids|omega 3 fatty acids
594931|NCT01038440|Omega 3 Index|omega 3 index
594932|NCT01038440|Stearidonic acid (SDA)|stearidonic acid (sda)
594933|NCT01038440|Eicosapentaenoic acid (EPA)|eicosapentaenoic acid (epa)
594934|NCT01038440|Red blood cells|red blood cells
594935|NCT01038440|Lipids|lipids
594936|NCT01038440|Inflammation markers|inflammation markers
594937|NCT01038427|Rhinitis|rhinitis
594938|NCT01038427|Allergic|allergic
594939|NCT01038427|Seasonal|seasonal
594940|NCT01038427|Mometasone Furoate|mometasone furoate
594941|NCT01038427|Equivalence|equivalence
594942|NCT01038401|HIV infection|hiv infection
594943|NCT01038401|HAART|haart
594944|NCT01038401|Viral DNA test positive-10063306|viral dna test positive-10063306
594945|NCT01038401|Blood HIV RNA 10049826|blood hiv rna 10049826
594946|NCT01038401|Treatment Experienced|treatment experienced
594947|NCT01038388|Multiple Myeloma|multiple myeloma
594948|NCT01038375|hypertension|hypertension
594949|NCT01038375|stroke|stroke
594950|NCT01038375|adherence|adherence
594951|NCT01038362|endothelium|endothelium
594952|NCT01038362|almonds|almonds
594953|NCT01038362|dietary interventions|dietary interventions
594954|NCT01038362|coronary artery disease|coronary artery disease
594955|NCT01038336|Hearing Loss - Noise-Induced|hearing loss - noise-induced
594956|NCT01038336|Prevention|prevention
594957|NCT01038336|Computer-assisted instruction|computer-assisted instruction
594958|NCT01038323|Fibromyalgia|fibromyalgia
594960|NCT01038310|Parkinson´s disease|parkinson´s disease
594961|NCT01038310|FP-CIT-SPECT|fp-cit-spect
594962|NCT01038297|Scarring|scarring
594963|NCT01038284|Patient Education|patient education
594964|NCT01038284|Drug Toxicity|drug toxicity
594965|NCT01038271|palliative care|palliative care
594966|NCT01038258|neoadjuvant chemotherapy|neoadjuvant chemotherapy
594967|NCT01038245|Receptor Up-Regulation|receptor up-regulation
594968|NCT01038245|Smoking|smoking
594969|NCT01038245|Nicotine|nicotine
594970|NCT01038245|Neuroimaging|neuroimaging
594971|NCT01038232|Distress Tolerance|distress tolerance
594972|NCT01038232|Cocaine Dependence|cocaine dependence
594973|NCT01038232|Relapse|relapse
594974|NCT01038232|Limbic System|limbic system
594975|NCT01038232|Prefrontal Cortex|prefrontal cortex
594976|NCT01038232|Healthy Volunteer|healthy volunteer
594977|NCT01038232|HV|hv
594978|NCT01038219|fever|fever
594979|NCT01038219|children|children
594980|NCT01038219|SUBJECTIVE ASSESSMENT|subjective assessment
594981|NCT01038206|prevention|prevention
594982|NCT01038206|HIV|hiv
594983|NCT01038206|drugs|drugs
594984|NCT01038206|smoking|smoking
594985|NCT01038206|Hispanic|hispanic
594986|NCT01038206|Adolescent|adolescent
594987|NCT01038206|Familias Unidas|familias unidas
594988|NCT01038206|Parent-Preadolescent Training|parent-preadolescent training
594989|NCT01038206|parent-centered|parent-centered
594990|NCT01038206|unsafe sexual behavior|unsafe sexual behavior
594991|NCT01038206|efficacy|efficacy
594992|NCT01038206|intervention|intervention
594993|NCT01038193|Cognition, subarachnoid hemorrhage.|cognition, subarachnoid hemorrhage.
594994|NCT01038180|pacemaker|pacemaker
594995|NCT01038180|adverse effects|adverse effects
594996|NCT01038167|VX-950|vx-950
594997|NCT01038154|advanced esophageal cancer and stomach cancer|advanced esophageal cancer and stomach cancer
594998|NCT01038154|Pravastatin|pravastatin
594999|NCT01038154|Survival|survival
595000|NCT01038154|adverse effects|adverse effects
595001|NCT01038128|Bulimia nervosa|bulimia nervosa
595002|NCT01038128|Bulimia|bulimia
595003|NCT01038128|Body dysmorphic disorder|body dysmorphic disorder
595004|NCT01038128|Eating disorders|eating disorders
595005|NCT01038128|Body image|body image
595006|NCT01038128|Binge eating|binge eating
595007|NCT01038128|purging|purging
595008|NCT01038115|Catheter Ablation|catheter ablation
595009|NCT01038102|Obesity|obesity
595010|NCT01038102|Diabetes|diabetes
595011|NCT01038102|Insulin resistance|insulin resistance
595012|NCT01038102|Fatty liver|fatty liver
595013|NCT01038102|NAFLD|nafld
595014|NCT01038102|Steatosis|steatosis
595015|NCT01038102|Dietary fatty acids|dietary fatty acids
595016|NCT01038089|endothelium|endothelium
595017|NCT01038089|resveratrol|resveratrol
595018|NCT01038089|diabetes mellitus|diabetes mellitus
595019|NCT01038076|HIV|hiv
595020|NCT01038076|AIDS|aids
595021|NCT01038076|adherence|adherence
595022|NCT01038076|antiretroviral|antiretroviral
595023|NCT01038076|aCASI|acasi
595024|NCT01038076|HAART|haart
595025|NCT01038076|Complementary Therapies|complementary therapies
595026|NCT01038076|Adherence Care Manager|adherence care manager
595027|NCT01038050|Endothelial progenitor cell|endothelial progenitor cell
595028|NCT01038050|endothelial function(FMD)|endothelial function(fmd)
595029|NCT01038050|Gingko Biloba Extract|gingko biloba extract
595030|NCT01038050|Type 2 Diabetes mellitus|type 2 diabetes mellitus
595031|NCT01038050|Stable coronary artery disease|stable coronary artery disease
595032|NCT01038050|Endothelial progenitor cells Numbers|endothelial progenitor cells numbers
595033|NCT01038037|Lung Cancer|lung cancer
595034|NCT01038037|Non small cell lung cancer|non small cell lung cancer
595159|NCT01037595|pruritus|pruritus
595035|NCT01038037|Triple mutational status|triple mutational status
595036|NCT01038037|KRAS|kras
595037|NCT01038037|BRAF|braf
595038|NCT01038037|PI3K|pi3k
595039|NCT01038024|antioxidant supplement|antioxidant supplement
595040|NCT01037998|adenocarcinoma|adenocarcinoma
595041|NCT01037998|non-small-cell lung cancer|non-small-cell lung cancer
595042|NCT01037998|gefitinib|gefitinib
595043|NCT01037998|UFUR|ufur
595044|NCT01037985|Scarring|scarring
595045|NCT01037972|Galileo|galileo
595046|NCT01037972|Whole body vibration|whole body vibration
595047|NCT01037972|Osteoarthritis|osteoarthritis
595048|NCT01037972|Knee|knee
595049|NCT01037972|Physiotherapy|physiotherapy
595050|NCT01037959|severe cirrhosis|severe cirrhosis
595051|NCT01037959|Patients with severe cirrhosis|patients with severe cirrhosis
595052|NCT01037946|HIV|hiv
595053|NCT01037946|Family interventions|family interventions
595054|NCT01037946|Thailand|thailand
595055|NCT01037933|Cancer|cancer
595056|NCT01037933|Humor|humor
595057|NCT01037933|Distraction|distraction
595058|NCT01037933|Comedy|comedy
595059|NCT01037933|Chemotherapy|chemotherapy
595060|NCT01037907|Oral treatment for MS|oral treatment for ms
595061|NCT01037907|Oral drug for multiple sclerosis|oral drug for multiple sclerosis
595062|NCT01037907|Oral RRMS|oral rrms
595063|NCT01037907|Oral relapsing remitting multiple sclerosis|oral relapsing remitting multiple sclerosis
595064|NCT01037907|Gamma Linolenic Acid|gamma linolenic acid
595065|NCT01037907|GLA|gla
595066|NCT01037907|Fatty acid|fatty acid
595067|NCT01037907|Triglyceride|triglyceride
595068|NCT01037907|Structured lipid|structured lipid
595069|NCT01037907|MRI|mri
595070|NCT01037907|Magnetic resonance imaging|magnetic resonance imaging
595071|NCT01037907|gadolinium enhancing lesions|gadolinium enhancing lesions
595072|NCT01037907|expanded disability status scale|expanded disability status scale
595073|NCT01037907|EDSS|edss
595074|NCT01037907|Demyelination|demyelination
595075|NCT01037907|Remyelination|remyelination
595076|NCT01037907|TGFB1|tgfb1
595077|NCT01037907|Transforming growth factor beta 1|transforming growth factor beta 1
595078|NCT01037907|cytokines|cytokines
595079|NCT01037907|disease modifying therapy|disease modifying therapy
595080|NCT01037907|immunomodulator|immunomodulator
595081|NCT01037907|Anti inflammatory|anti inflammatory
595082|NCT01037907|Pro inflammatory|pro inflammatory
595083|NCT01037907|TNF alpha|tnf alpha
595084|NCT01037907|interleukin 1 beta|interleukin 1 beta
595085|NCT01037907|interferon gamma|interferon gamma
595086|NCT01037907|Fayaz Master|fayaz master
595087|NCT01037907|Omega 6|omega 6
595088|NCT01037907|Polyunsaturated fatty acid|polyunsaturated fatty acid
595089|NCT01037907|Cytokine balance|cytokine balance
595090|NCT01037907|Pleneva TM|pleneva tm
595091|NCT01037907|BGC20-0134|bgc20-0134
595092|NCT01037907|RRMS|rrms
595093|NCT01037894|Acupuncture,Intracerebral hemorrhage, Stroke|acupuncture,intracerebral hemorrhage, stroke
595094|NCT01037868|depression|depression
595095|NCT01037868|alcohol dependency syndrome|alcohol dependency syndrome
595096|NCT01037868|dual diagnosis|dual diagnosis
595097|NCT01037868|SMS text messages|sms text messages
595098|NCT01037855|Swine Flu H1N1 vaccine|swine flu h1n1 vaccine
595099|NCT01037855|Adjuvanted flu cell culture derived|adjuvanted flu cell culture derived
595100|NCT01037816|Ankle Sprain|ankle sprain
595101|NCT01037803|perioperative sublingual microcirculation SDF|perioperative sublingual microcirculation sdf
595102|NCT01037777|individuals at risk for SCA1, SCA2, SCA3, SCA6 and SCA7|individuals at risk for sca1, sca2, sca3, sca6 and sca7
595103|NCT01037764|acute lymphoid leukemia|acute lymphoid leukemia
595104|NCT01037764|primary complete remission|primary complete remission
595105|NCT01037764|secondary complete remission|secondary complete remission
595106|NCT01037764|postremission therapy|postremission therapy
595107|NCT01037764|allogeneic hematopoietic cell transplantation|allogeneic hematopoietic cell transplantation
595108|NCT01037751|Cancer|cancer
595109|NCT01037751|Symptom burden|symptom burden
595110|NCT01037751|M. D. Anderson Symptom Inventory|m. d. anderson symptom inventory
595111|NCT01037751|MDASI-Ovarian Cancer|mdasi-ovarian cancer
595112|NCT01037751|Symptoms|symptoms
595113|NCT01037751|Daily functioning|daily functioning
595114|NCT01037751|Symptom severity|symptom severity
595115|NCT01037751|Questionnaire|questionnaire
595116|NCT01037751|Interview|interview
595117|NCT01037738|ACL reconstruction|acl reconstruction
595118|NCT01037738|autologous conditioned serum|autologous conditioned serum
595119|NCT01037738|Orthokine|orthokine
595120|NCT01037738|osteoarthritis|osteoarthritis
595121|NCT01037738|interleukin receptor antagonist|interleukin receptor antagonist
595122|NCT01037738|growth factors|growth factors
595123|NCT01037738|WOMAC|womac
595124|NCT01037738|IKDC|ikdc
595125|NCT01037725|Healthy volunteer|healthy volunteer
595126|NCT01037725|first time in human|first time in human
595127|NCT01037725|food effect|food effect
595128|NCT01037712|Foetuses infection with CMV|foetuses infection with cmv
595129|NCT01037712|neurological handicap of infectious origin.|neurological handicap of infectious origin.
595130|NCT01037699|Ovarian stimulation|ovarian stimulation
595131|NCT01037699|In Vitro Fertilization|in vitro fertilization
595132|NCT01037699|Luteinizing Hormone|luteinizing hormone
595133|NCT01037699|GnRH antagonist|gnrh antagonist
595134|NCT01037699|Implantation rate in infertile patients undergoing In vitro fertilization and embryo transfer.|implantation rate in infertile patients undergoing in vitro fertilization and embryo transfer.
595135|NCT01037686|PD|pd
595136|NCT01037686|DBS|dbs
595137|NCT01037660|endothelium|endothelium
595333|NCT01036581|Drug Abuse|drug abuse
595138|NCT01037660|cardiovascular disease|cardiovascular disease
595139|NCT01037660|dietary fat|dietary fat
595140|NCT01037660|insulin resistance|insulin resistance
595141|NCT01037647|Type 2 diabetes|type 2 diabetes
595142|NCT01037647|Diabetic dyslipidemia|diabetic dyslipidemia
595143|NCT01037647|VLDL-TG kinetics|vldl-tg kinetics
595144|NCT01037647|VLDL-TG metabolism|vldl-tg metabolism
595145|NCT01037634|Avian Influenza|avian influenza
595146|NCT01037634|H1N1 Influenza|h1n1 influenza
595147|NCT01037634|Seasonal Influenza|seasonal influenza
595148|NCT01037621|Herpes simplex type 2|herpes simplex type 2
595149|NCT01037621|Hepatitis C virus|hepatitis c virus
595150|NCT01037621|Valacyclovir|valacyclovir
595151|NCT01037621|Herpes Simplex virus type 2 infection|herpes simplex virus type 2 infection
595153|NCT01037608|fMRI|fmri
595154|NCT01037608|Alternative Matrices|alternative matrices
595155|NCT01037608|Brain Imaging|brain imaging
595156|NCT01037608|THC|thc
595157|NCT01037595|hemodialysis|hemodialysis
595158|NCT01037595|turmeric|turmeric
595160|NCT01037569|Toxicological Screening|toxicological screening
595161|NCT01037569|Drugs|drugs
595162|NCT01037569|Alternative Matrices|alternative matrices
595163|NCT01037569|Urine|urine
595164|NCT01037569|Children|children
595166|NCT01037556|Acute Myeloid Leukemia|acute myeloid leukemia
595167|NCT01037556|Acute Myelogenous Leukemia|acute myelogenous leukemia
595168|NCT01037556|Refractory AML|refractory aml
595169|NCT01037556|Relapsed AML|relapsed aml
595170|NCT01037556|Refractory Acute Myeloid Leukemia|refractory acute myeloid leukemia
595171|NCT01037556|Relapsed Acute Myeloid Leukemia|relapsed acute myeloid leukemia
595172|NCT01037556|Refractory Acute Myelogenous Leukemia|refractory acute myelogenous leukemia
595173|NCT01037556|Relapsed Acute Myelogenous Leukemia|relapsed acute myelogenous leukemia
595174|NCT01037556|ALL|all
595175|NCT01037556|Acute Lymphocytic Leukemia|acute lymphocytic leukemia
595176|NCT01037556|Relapsed Acute Lymphocytic Leukemia|relapsed acute lymphocytic leukemia
595177|NCT01037556|Refractory Acute Lymphocytic Leukemia|refractory acute lymphocytic leukemia
595178|NCT01037556|Relapsed ALL|relapsed all
595179|NCT01037556|Refractory ALL|refractory all
595180|NCT01037530|ACE inhibitors|ace inhibitors
595181|NCT01037530|Intermittent claudication|intermittent claudication
595182|NCT01037530|Ramipril|ramipril
595183|NCT01037517|Myeloma|myeloma
595184|NCT01037517|Multiple Myeloma or Lymphoma Patients undergoing|multiple myeloma or lymphoma patients undergoing
595185|NCT01037517|mobilization for the purpose of autologous stem cell collection|mobilization for the purpose of autologous stem cell collection
595186|NCT01037504|safety|safety
595187|NCT01037504|tolerability|tolerability
595188|NCT01037504|healthy|healthy
595189|NCT01037504|inhalation|inhalation
595190|NCT01037504|Healthy volunteers|healthy volunteers
595191|NCT01037491|aspirin, clopidogrel, peptic ulcer, proton pump inhibitor, rabeprazole, ulcer bleeding|aspirin, clopidogrel, peptic ulcer, proton pump inhibitor, rabeprazole, ulcer bleeding
595192|NCT01037478|Hodgkin's Lymphoma|hodgkin's lymphoma
595193|NCT01037478|HDAC|hdac
595194|NCT01037478|4SC-201|4sc-201
595195|NCT01037478|Resminostat|resminostat
595196|NCT01037478|Phase II|phase ii
595197|NCT01037465|endothelium|endothelium
595198|NCT01037465|cell signaling|cell signaling
595199|NCT01037465|N-acetylcysteine|n-acetylcysteine
595200|NCT01037465|reactive oxygen species|reactive oxygen species
595201|NCT01037452|Heartburn|heartburn
595202|NCT01037452|antacid|antacid
595203|NCT01037452|PPI|ppi
595204|NCT01037452|Lansoprazole|lansoprazole
595205|NCT01037452|calcium carbonate|calcium carbonate
595206|NCT01037452|magnesium hydroxide|magnesium hydroxide
595207|NCT01037452|Relief of heartburn following ingestion of a heartburn-inducing meal|relief of heartburn following ingestion of a heartburn-inducing meal
595208|NCT01037426|SND Sinus Node Disease|snd sinus node disease
595209|NCT01037426|Falls|falls
595210|NCT01037426|Fractures|fractures
595211|NCT01037413|Scarring|scarring
595212|NCT01037400|Knee Replacement|knee replacement
595213|NCT01037400|Arthroplasty|arthroplasty
595214|NCT01037374|risk|risk
595215|NCT01037374|assessment|assessment
595216|NCT01037374|difficult|difficult
595217|NCT01037374|endotracheal|endotracheal
595218|NCT01037374|intubation|intubation
595219|NCT01037361|Children and Adolescents|children and adolescents
595220|NCT01037361|Motor Control|motor control
595221|NCT01037361|Movement-Related Potential|movement-related potential
595222|NCT01037361|Stereotypic Movement Disorder|stereotypic movement disorder
595223|NCT01037361|Electroencephalogram (EEG)|electroencephalogram (eeg)
595224|NCT01037348|Choroidal Neovascularisation|choroidal neovascularisation
595225|NCT01037348|Pathological Myopia|pathological myopia
595226|NCT01037335|bone graft|bone graft
595227|NCT01037335|pain|pain
595228|NCT01037335|chronic|chronic
595229|NCT01037322|crohn's disease|crohn's disease
595230|NCT01037322|ulcerative colitis|ulcerative colitis
595231|NCT01037322|cannabis|cannabis
595232|NCT01037322|cannabidiol|cannabidiol
595233|NCT01037296|catheter ablation|catheter ablation
595234|NCT01037296|robotic navigation|robotic navigation
595235|NCT01037283|Bipolar|bipolar
595236|NCT01037283|Depressed|depressed
595237|NCT01037270|Patients with conditions (PE, Afib, DVT) requiring ongoing INR measurements.|patients with conditions (pe, afib, dvt) requiring ongoing inr measurements.
595238|NCT01037231|hyperoxaluria|hyperoxaluria
595239|NCT01037231|oxalate|oxalate
595241|NCT01037192|outpatient|outpatient
595242|NCT01037192|skin and soft tissue infections|skin and soft tissue infections
595243|NCT01037192|vancomycin intravenous|vancomycin intravenous
595244|NCT01037153|Intravenous|intravenous
595245|NCT01037153|Rate of Delivery|rate of delivery
595246|NCT01037153|Dose Responses|dose responses
595247|NCT01037153|Variable Intervals|variable intervals
595248|NCT01037153|Multiple Rapid Injections|multiple rapid injections
595249|NCT01037127|GSK1120212|gsk1120212
595250|NCT01037127|BRAF Inhibitor|braf inhibitor
595251|NCT01037127|melanoma|melanoma
595252|NCT01037127|MEK Inhibitor|mek inhibitor
595253|NCT01037114|Hepatitis A and hepatitis B|hepatitis a and hepatitis b
595254|NCT01037101|acrophobia|acrophobia
595255|NCT01037101|virtual reality|virtual reality
595256|NCT01037101|exposure therapy|exposure therapy
595257|NCT01037101|In Vivo Exposure Therapy plus D-Cycloserine|in vivo exposure therapy plus d-cycloserine
595258|NCT01037101|In Vivo Exposure Therapy plus Placebo|in vivo exposure therapy plus placebo
595259|NCT01037101|Virtual Reality Exposure Therapy plus D-Cycloserine|virtual reality exposure therapy plus d-cycloserine
595260|NCT01037101|Virtual Reality Exposure Therapy plus Placebo|virtual reality exposure therapy plus placebo
595261|NCT01037101|Wait-List|wait-list
595262|NCT01037088|cannabis|cannabis
595263|NCT01037088|marijuana|marijuana
595264|NCT01037088|neuropathy|neuropathy
595265|NCT01037088|antinociception|antinociception
595266|NCT01037088|mood|mood
595267|NCT01037088|cognition|cognition
595268|NCT01037088|neuropathic pain|neuropathic pain
595269|NCT01037075|Schizophrenia|schizophrenia
595270|NCT01037075|Dual Diagnosis|dual diagnosis
595271|NCT01037075|Nicotine Nasal Spray|nicotine nasal spray
595272|NCT01037075|Drug Abuse/Dependence|drug abuse/dependence
595273|NCT01037075|Cognitive Processes|cognitive processes
595274|NCT01037049|Rectal Cancer|rectal cancer
595275|NCT01037049|6vs12|6vs12
595276|NCT01037049|6 vs 12|6 vs 12
595277|NCT01037049|Cancer|cancer
595278|NCT01037049|CRM|crm
595279|NCT01037049|Circumferential Resection Margin|circumferential resection margin
595280|NCT01037049|Quality of Life|quality of life
595281|NCT01037049|MRI|mri
595282|NCT01037049|Radiology|radiology
595283|NCT01037049|Abdominoperineal Excision|abdominoperineal excision
595284|NCT01037049|Anterior Resection|anterior resection
595285|NCT01037049|Surgery|surgery
595286|NCT01037049|Pathology|pathology
595287|NCT01037049|Radiotherapy|radiotherapy
595288|NCT01037036|Ocular Hypertension|ocular hypertension
595289|NCT01037036|Open-Angle Glaucoma|open-angle glaucoma
595290|NCT01037036|Xalatan|xalatan
595291|NCT01037036|IOP|iop
595292|NCT01037023|PMS (post-marketing surveillance)|pms (post-marketing surveillance)
595293|NCT01037023|Topotecan|topotecan
595294|NCT01036971|Physical Examination|physical examination
595295|NCT01036971|Medical Information|medical information
595296|NCT01036971|Assessment|assessment
595297|NCT01036971|Blood Work|blood work
595298|NCT01036971|Screening|screening
595299|NCT01036958|Pediatric cGVHD|pediatric cgvhd
595300|NCT01036958|Response Criteria|response criteria
595301|NCT01036958|Symptoms|symptoms
595302|NCT01036958|Quality of Life|quality of life
595303|NCT01036958|Graft-Versus-Host Disease|graft-versus-host disease
595304|NCT01036958|GVHD|gvhd
595305|NCT01036958|Pediatric GVHD|pediatric gvhd
595306|NCT01036854|Ondansetron, EUR-1025|ondansetron, eur-1025
595307|NCT01036841|MNE with nocturnal polyuria|mne with nocturnal polyuria
595308|NCT01036841|monosymptomatic nocturnal enuresis with nocturnal polyuria|monosymptomatic nocturnal enuresis with nocturnal polyuria
595309|NCT01036802|sickle cell disease|sickle cell disease
595310|NCT01036802|pulmonary hypertension|pulmonary hypertension
595311|NCT01036802|coagulation activation|coagulation activation
595312|NCT01036802|platelet activation|platelet activation
595313|NCT01036802|endothelial activation|endothelial activation
595314|NCT01036711|Attention|attention
595315|NCT01036711|Working Memory|working memory
595316|NCT01036711|Central Executive Processes|central executive processes
595317|NCT01036711|Response Preparation|response preparation
595318|NCT01036711|Cigarettes|cigarettes
595319|NCT01036685|Adolescents|adolescents
595320|NCT01036685|Affect|affect
595321|NCT01036685|fMRI|fmri
595322|NCT01036685|Task Development|task development
595323|NCT01036685|Cognition|cognition
595324|NCT01036659|acute angiotensin converting enzyme inhibitor angioedema|acute angiotensin converting enzyme inhibitor angioedema
595325|NCT01036646|Patients on stable OAT therapy for at least 3 months.|patients on stable oat therapy for at least 3 months.
595326|NCT01036633|mucositis|mucositis
595327|NCT01036594|Ketoconazole|ketoconazole
595328|NCT01036594|Dexamethasone|dexamethasone
595329|NCT01036581|Magnetic Resonance Imaging (MRI)|magnetic resonance imaging (mri)
595330|NCT01036581|Functional Brain Imaging|functional brain imaging
595331|NCT01036581|Magnetic Resonance Spectroscopy|magnetic resonance spectroscopy
595332|NCT01036581|Diffusion Tensor Imaging|diffusion tensor imaging
595334|NCT01036568|Psychosis|psychosis
595335|NCT01036568|Smooth Pursuit|smooth pursuit
595336|NCT01036568|Motion Perception|motion perception
595337|NCT01036568|Neurophysiology|neurophysiology
595338|NCT01036568|fMRI|fmri
595339|NCT01036529|Spinal Cord Stimulation|spinal cord stimulation
595340|NCT01036529|Decompression|decompression
595341|NCT01036529|Fusion with or without instrumentation|fusion with or without instrumentation
595342|NCT01036529|Discectomy|discectomy
595343|NCT01036529|Laminectomy|laminectomy
595344|NCT01036529|Laminotomy|laminotomy
595345|NCT01036529|Foraminotomy|foraminotomy
595346|NCT01036516|Drug Cues|drug cues
595347|NCT01036516|Dopamine Release|dopamine release
595348|NCT01036516|Psychomotor Stimulants|psychomotor stimulants
595349|NCT01036516|D2 Dopamine Receptor Subtype|d2 dopamine receptor subtype
595350|NCT01036516|Neuroimaging|neuroimaging
595351|NCT01036412|Chlorhexidine|chlorhexidine
595352|NCT01036412|Chlorhexidine Gel Therapy|chlorhexidine gel therapy
595353|NCT01036412|1% chlorhexidine gluconate gel|1% chlorhexidine gluconate gel
595354|NCT01036412|Cariogenic Oral Microflora|cariogenic oral microflora
595355|NCT01036412|Irradiated Head and Neck Cancer Patients|irradiated head and neck cancer patients
595356|NCT01036412|caries-forming organisms|caries-forming organisms
595357|NCT01036412|Radiation treatment|radiation treatment
595358|NCT01036412|Mouth Cancer|mouth cancer
595359|NCT01036412|Throat Cancer|throat cancer
595360|NCT01036412|Tooth decay|tooth decay
595361|NCT01036399|PTCL|ptcl
595362|NCT01036360|Obesity|obesity
595363|NCT01036360|Acute exercise|acute exercise
595364|NCT01036360|Intensity of exercise|intensity of exercise
595365|NCT01036360|Energy balance regulation|energy balance regulation
595366|NCT01036360|Appetite|appetite
595367|NCT01036308|dietary fibre|dietary fibre
595368|NCT01036308|legumes|legumes
595369|NCT01036308|lupin kernel fibre|lupin kernel fibre
595370|NCT01036308|soy fibre|soy fibre
595371|NCT01036308|bile acids|bile acids
595372|NCT01036308|short-chain fatty acids|short-chain fatty acids
595373|NCT01036308|cholesterol metabolism|cholesterol metabolism
595374|NCT01036308|Subjects|subjects
595375|NCT01036243|digestive tolerance|digestive tolerance
595376|NCT01036243|night sleep|night sleep
595377|NCT01036243|crying|crying
595378|NCT01036243|growth|growth
595379|NCT01036230|fMRI|fmri
595380|NCT01036230|Methylphenidate|methylphenidate
595381|NCT01036230|Taste|taste
595382|NCT01036230|Olfaction|olfaction
595383|NCT01036230|Addiction|addiction
595384|NCT01036217|Recruitment|recruitment
595385|NCT01036217|Adult|adult
595386|NCT01036217|Telephone|telephone
595387|NCT01036217|Selection|selection
595388|NCT01036217|Testing|testing
595389|NCT01036139|EDS in Parkinson's Disease|eds in parkinson's disease
595390|NCT01036126|Nicotine|nicotine
595391|NCT01036126|Cocaine|cocaine
595392|NCT01036126|N-Back|n-back
595393|NCT01036126|Craving|craving
595394|NCT01036126|Dependence|dependence
595395|NCT01036113|EZN-2208 (PEG-SN38)|ezn-2208 (peg-sn38)
595396|NCT01036087|Inflammatory Breast Cancer|inflammatory breast cancer
595397|NCT01036087|IBC|ibc
595398|NCT01036087|Primary breast carcinoma|primary breast carcinoma
595399|NCT01036087|HER2 negative overexpression|her2 negative overexpression
595400|NCT01036087|Panitumumab|panitumumab
595401|NCT01036087|Vectibix|vectibix
595402|NCT01036087|Nab-paclitaxel|nab-paclitaxel
595403|NCT01036087|Paclitaxel|paclitaxel
595404|NCT01036087|Abraxane|abraxane
595405|NCT01036087|Carboplatin|carboplatin
595406|NCT01036087|Paraplatin|paraplatin
595407|NCT01036087|PNC|pnc
595408|NCT01036087|5-fluorouracil|5-fluorouracil
595409|NCT01036087|5-FU|5-fu
595410|NCT01036087|Adrucil|adrucil
595411|NCT01036087|Efudex|efudex
595412|NCT01036087|Epirubicin|epirubicin
595413|NCT01036087|Ellence|ellence
595414|NCT01036087|Cyclophosphamide|cyclophosphamide
595415|NCT01036087|Cytoxan|cytoxan
595416|NCT01036087|Neosar|neosar
595417|NCT01036087|FEC|fec
595418|NCT01036074|Drug Abuse|drug abuse
595419|NCT01036074|Cocaine|cocaine
595420|NCT01036074|Cocaine Dependence|cocaine dependence
595421|NCT01036074|Functional MRI|functional mri
595422|NCT01036074|Pharmalogical MRI|pharmalogical mri
595423|NCT01036074|Conditioning|conditioning
595424|NCT01036061|compulsive discorders|compulsive discorders
595425|NCT01036061|addiction|addiction
595426|NCT01036048|saphenous vein graft|saphenous vein graft
595427|NCT01036048|stent|stent
595428|NCT01036035|Tolterodine|tolterodine
595429|NCT01036035|Over active Bladder (OAB)|over active bladder (oab)
595430|NCT01036035|Incontinence|incontinence
595431|NCT01036022|mesalazine|mesalazine
595432|NCT01036022|ulcerative colitis|ulcerative colitis
595433|NCT01036022|pharmacokinetics/dynamics|pharmacokinetics/dynamics
595434|NCT01036022|GSK1399686|gsk1399686
595435|NCT01036009|Hematologic|hematologic
595436|NCT01036009|Malignancy|malignancy
595437|NCT01036009|Leukemia|leukemia
595438|NCT01036009|Pre-leukemic|pre-leukemic
595439|NCT01036009|Allogeneic|allogeneic
595440|NCT01036009|Transplant|transplant
595441|NCT01036009|Pediatric|pediatric
595442|NCT01035996|Classical Conditioning|classical conditioning
595443|NCT01035996|fMRI|fmri
595444|NCT01035996|Schizophrenia|schizophrenia
595445|NCT01035996|TD Model|td model
595446|NCT01035996|Incentive Salience|incentive salience
595447|NCT01035983|menstrually associated migraine (MAM), Migraines,Menstrual Migraines, menstrually related migraines|menstrually associated migraine (mam), migraines,menstrual migraines, menstrually related migraines
595448|NCT01035944|Chronic wounds|chronic wounds
595449|NCT01035944|Chronic wound debridement|chronic wound debridement
595450|NCT01035944|Debridement|debridement
595451|NCT01035944|Bedside debridement|bedside debridement
595452|NCT01035944|Surgical debridement|surgical debridement
595453|NCT01035944|Wound debridement|wound debridement
595454|NCT01035944|Minimize bacterial re-colonization of wounds|minimize bacterial re-colonization of wounds
595455|NCT01035944|HemCon ChitoGauze Dressings|hemcon chitogauze dressings
595456|NCT01035944|HemCon Dressings|hemcon dressings
595457|NCT01035944|Chitosan-based dressings|chitosan-based dressings
595458|NCT01035788|PTSD|ptsd
595459|NCT01035788|mindfulness meditation|mindfulness meditation
595460|NCT01035788|cognitive behavior therapy|cognitive behavior therapy
595461|NCT01035788|relationship function|relationship function
595462|NCT01035788|couple therapy|couple therapy
595463|NCT01035775|Colonoscopy|colonoscopy
595464|NCT01035775|Adenoma detection|adenoma detection
595465|NCT01035775|Colorectal polyps|colorectal polyps
595466|NCT01035749|pandemic influenza|pandemic influenza
595467|NCT01035749|Clinical trial|clinical trial
595468|NCT01035749|H1N1|h1n1
595469|NCT01035749|children|children
595470|NCT01035723|Prefrontal Cortex|prefrontal cortex
595471|NCT01035723|Hippocampus|hippocampus
595472|NCT01035723|Amygdala|amygdala
595473|NCT01035723|MRI|mri
595474|NCT01035723|Cognitive Tasks|cognitive tasks
595475|NCT01035697|NICHD Neonatal Research Network|nichd neonatal research network
595476|NCT01035697|Very Low Birth Weight (VLBW)|very low birth weight (vlbw)
595477|NCT01035697|Extremely Low Birth Weight (ELBW)|extremely low birth weight (elbw)
595478|NCT01035697|Prematurity|prematurity
595479|NCT01035697|Pro-inflammatory cytokines|pro-inflammatory cytokines
595480|NCT01035697|Anti-inflammatory cytokines|anti-inflammatory cytokines
595481|NCT01035697|Interleukin-1 (IL-1β)|interleukin-1 (il-1β)
595482|NCT01035697|Interleukin-2 (IL-2)|interleukin-2 (il-2)
595483|NCT01035697|Interleukin-3 (IL-3)|interleukin-3 (il-3)
595484|NCT01035697|Interleukin-8 (IL-8)|interleukin-8 (il-8)
595485|NCT01035697|Interleukin-9 (IL-9)|interleukin-9 (il-9)
595486|NCT01035697|Tumor necrosis factor-α (TNF-α)|tumor necrosis factor-α (tnf-α)
595487|NCT01035697|Regulated upon Activation, Normal T-cell Expressed and Secreted (RANTES)|regulated upon activation, normal t-cell expressed and secreted (rantes)
595488|NCT01035658|Pazopanib|pazopanib
595489|NCT01035658|Doxil|doxil
595490|NCT01035658|Liposomal doxorubicin|liposomal doxorubicin
595491|NCT01035658|Advanced relapsed|advanced relapsed
595492|NCT01035658|platinum-sensitive|platinum-sensitive
595493|NCT01035658|platinum-resistant|platinum-resistant
595494|NCT01035645|First time in human|first time in human
595495|NCT01035645|Interleukin-18|interleukin-18
595496|NCT01035645|Healthy male subjects|healthy male subjects
595497|NCT01035645|Obese male subjects|obese male subjects
595498|NCT01035645|Monoclonal antibody|monoclonal antibody
595499|NCT01035645|Pharmacokinetics|pharmacokinetics
595500|NCT01035645|Tolerability|tolerability
595501|NCT01035645|Safety|safety
595502|NCT01035645|Pharmacodynamics|pharmacodynamics
595503|NCT01035632|Craving|craving
595504|NCT01035632|Incubation|incubation
595505|NCT01035632|Relapse|relapse
595506|NCT01035632|Smoking Cues|smoking cues
595507|NCT01035632|Cortisol|cortisol
595508|NCT01035619|onchocerciasis; river blindness; moxidectin; pediatric|onchocerciasis; river blindness; moxidectin; pediatric
595509|NCT01035606|attention|attention
595510|NCT01035606|rehabilitation|rehabilitation
595511|NCT01035606|training|training
595512|NCT01035606|functional MRI|functional mri
595513|NCT01035606|executive function|executive function
595514|NCT01035606|brain injury|brain injury
595515|NCT01035580|chemoprevention|chemoprevention
595516|NCT01035580|curcumin|curcumin
595517|NCT01035580|pharmacokinetics|pharmacokinetics
595518|NCT01035580|safety|safety
595519|NCT01035567|Multivessel coronary artery disease|multivessel coronary artery disease
595520|NCT01035567|Hybrid revascularization|hybrid revascularization
595521|NCT01035567|Coronary Artery Bypass Grafting|coronary artery bypass grafting
595522|NCT01035567|Percutaneous Coronary Interventions|percutaneous coronary interventions
595523|NCT01035567|Drug eluting stents|drug eluting stents
595524|NCT01035554|high blood pressure|high blood pressure
595525|NCT01035541|Major non-cardiac surgery,|major non-cardiac surgery,
595526|NCT01035541|hemodynamic management,|hemodynamic management,
595527|NCT01035541|PiCCO,|picco,
595528|NCT01035541|acute kidney injury,|acute kidney injury,
595529|NCT01035541|renal outcome|renal outcome
595530|NCT01035528|diastolic function, postmeal glucose, insulin glargine|diastolic function, postmeal glucose, insulin glargine
595531|NCT01035515|Healthy subjects|healthy subjects
595532|NCT01035502|Cancer|cancer
595533|NCT01035502|CP-4055|cp-4055
595534|NCT01035502|elacytarabine|elacytarabine
595535|NCT01035502|combination|combination
595536|NCT01035502|idarubicin|idarubicin
595537|NCT01035502|Acute myeloid leukaemia (AML)|acute myeloid leukaemia (aml)
595538|NCT01035489|Pacemaker treatment in heart failure|pacemaker treatment in heart failure
595539|NCT01035489|Cardiac resynchronization therapy|cardiac resynchronization therapy
595540|NCT01035489|DDD pacemakers|ddd pacemakers
595542|NCT01035476|nasal ventilation|nasal ventilation
595543|NCT01035476|data card recording|data card recording
595544|NCT01035450|Coronary stent|coronary stent
595545|NCT01035437|obstructing|obstructing
595546|NCT01035424|Batten Disease|batten disease
595547|NCT01035424|Late Infantile Neuronal Lipofuscinosis|late infantile neuronal lipofuscinosis
595548|NCT01035424|LINCL|lincl
595549|NCT01035411|COPD|copd
595550|NCT01035398|stage 0 esophageal cancer|stage 0 esophageal cancer
595551|NCT01035398|stage I esophageal cancer|stage i esophageal cancer
595552|NCT01035398|stage II esophageal cancer|stage ii esophageal cancer
595553|NCT01035398|stage III esophageal cancer|stage iii esophageal cancer
595554|NCT01035398|stage IV esophageal cancer|stage iv esophageal cancer
595555|NCT01035385|FOFLOX4|foflox4
595556|NCT01035385|resectable liver metastasis from colorectal cancer|resectable liver metastasis from colorectal cancer
595557|NCT01035372|healthy older people|healthy older people
595558|NCT01035359|radius|radius
595559|NCT01035359|fracture|fracture
595560|NCT01035359|wrist|wrist
595561|NCT01035359|external|external
595562|NCT01035359|fixation|fixation
595563|NCT01035359|volar|volar
595564|NCT01035359|plate|plate
595565|NCT01035359|DASH|dash
595566|NCT01035359|PRWE|prwe
595567|NCT01035346|Fever|fever
595568|NCT01035346|antipyretic|antipyretic
595569|NCT01035346|uncomplicated acute viral infection|uncomplicated acute viral infection
595570|NCT01035346|uncomplicated acute bacterial infections|uncomplicated acute bacterial infections
595571|NCT01035333|gastric bypass surgery|gastric bypass surgery
595572|NCT01035307|childhood acute myeloid leukemia in remission|childhood acute myeloid leukemia in remission
595573|NCT01035307|recurrent childhood acute myeloid leukemia|recurrent childhood acute myeloid leukemia
595574|NCT01035281|Diabetic Neuropathies|diabetic neuropathies
595575|NCT01035281|Neuropathic Pain|neuropathic pain
595576|NCT01035281|Cannabinoids|cannabinoids
595577|NCT01035281|Tree Number C10.668.829.300|tree number c10.668.829.300
595578|NCT01035268|breast cancer treated by conservative surgery|breast cancer treated by conservative surgery
595579|NCT01035255|chronic heart failure|chronic heart failure
595580|NCT01035255|cardiovascular death|cardiovascular death
595581|NCT01035255|hospitalization|hospitalization
595582|NCT01035255|outcome study|outcome study
595583|NCT01035255|BNP|bnp
595584|NCT01035255|KCCQ|kccq
595585|NCT01035255|eGFR|egfr
595586|NCT01035242|OCD|ocd
595587|NCT01035242|obsessions|obsessions
595588|NCT01035242|cognitive|cognitive
595589|NCT01035229|Hepatocellular carcinoma|hepatocellular carcinoma
595590|NCT01035229|randomized trial|randomized trial
595591|NCT01035229|medical treatment|medical treatment
595592|NCT01035229|RAD001|rad001
595593|NCT01035229|placebo|placebo
595594|NCT01035229|Advanced Hepatocellular Carcinoma (HCC)|advanced hepatocellular carcinoma (hcc)
595595|NCT01035216|Relapsed or Refractory B-Cell Chronic Lymphocytic Leukemia (B-CLL)|relapsed or refractory b-cell chronic lymphocytic leukemia (b-cll)
595596|NCT01035190|Preterm Infants|preterm infants
595597|NCT01035190|Inhaled Corticosteroids|inhaled corticosteroids
595598|NCT01035190|Bronchopulmonary Dysplasia|bronchopulmonary dysplasia
595599|NCT01035177|Bone Mineral Density (BMD);|bone mineral density (bmd);
595600|NCT01035177|Cortical bone;|cortical bone;
595601|NCT01035177|Hip fracture;|hip fracture;
595602|NCT01035177|Osteoporosis;|osteoporosis;
595603|NCT01035177|Quantitative Computed Tomography (QCT).|quantitative computed tomography (qct).
595604|NCT01035164|Alzheimer's Disease|alzheimer's disease
595605|NCT01035164|Diagnostic Imaging|diagnostic imaging
595606|NCT01035164|Neuroinflammation|neuroinflammation
595607|NCT01035164|PET Diagnosis|pet diagnosis
595608|NCT01035164|PET Tracer|pet tracer
595609|NCT01035151|randomized cluster design|randomized cluster design
595610|NCT01035151|tobacco cessation|tobacco cessation
595611|NCT01035151|smoking cessation|smoking cessation
595612|NCT01035151|African American|african american
595613|NCT01035125|Self-management|self-management
595614|NCT01035125|Self-efficacy|self-efficacy
595615|NCT01035125|Coping|coping
595616|NCT01035125|Health consumer|health consumer
595617|NCT01035125|Patient education|patient education
595618|NCT01035125|Health related quality of life|health related quality of life
595619|NCT01035099|Letrozole|letrozole
595620|NCT01035099|IVF (in vitro fertilization)|ivf (in vitro fertilization)
595621|NCT01035099|Cryopreservation|cryopreservation
595622|NCT01035099|Fertility Preservation|fertility preservation
595623|NCT01035099|Breast Cancer|breast cancer
595624|NCT01035086|dietary fibre|dietary fibre
595625|NCT01035086|lupin kernel fibre|lupin kernel fibre
595626|NCT01035086|bile acids|bile acids
595627|NCT01035086|cholesterol metabolism|cholesterol metabolism
595628|NCT01035086|blood lipids|blood lipids
595629|NCT01035086|hypercholesterolemia|hypercholesterolemia
595630|NCT01035086|fibre-enriched food|fibre-enriched food
595631|NCT01035086|moderate hypercholesterolemia|moderate hypercholesterolemia
595632|NCT01035047|Acute Coronary Syndrome|acute coronary syndrome
595633|NCT01035047|Chest pain|chest pain
595634|NCT01035047|Cardiac MRI|cardiac mri
595635|NCT01035047|Risk Stratification|risk stratification
595636|NCT01035047|Emergency Department|emergency department
595637|NCT01035008|pancreatic cysts|pancreatic cysts
595638|NCT01034982|COPD|copd
595639|NCT01034969|Hereditary angioedema|hereditary angioedema
595640|NCT01034956|Soft tissue filler|soft tissue filler
595641|NCT01034956|Dermal filler|dermal filler
595642|NCT01034956|Complications|complications
595643|NCT01034956|Patient satisfaction|patient satisfaction
595644|NCT01034943|radius|radius
595645|NCT01034943|fracture|fracture
595646|NCT01034943|wrist|wrist
595647|NCT01034943|external|external
595648|NCT01034943|fixation|fixation
595649|NCT01034943|volar|volar
595650|NCT01034943|plate|plate
595651|NCT01034943|DASH|dash
595652|NCT01034943|PRWE|prwe
595653|NCT01034930|MANDIBLE|mandible
595654|NCT01034930|IMPLANTS|implants
595655|NCT01034930|OVERDENTURE|overdenture
595656|NCT01034917|Active Comparator|active comparator
595657|NCT01034917|Placebo Comparator|placebo comparator
595658|NCT01034917|Sham Comparator|sham comparator
595659|NCT01034917|No intervention|no intervention
595660|NCT01034917|Other|other
595661|NCT01034917|Treatment Experienced|treatment experienced
595662|NCT01034904|Quality of Life|quality of life
595663|NCT01034904|HRQoL|hrqol
595664|NCT01034904|Hemophilia A|hemophilia a
595665|NCT01034904|Helixate FS|helixate fs
595666|NCT01034891|BRCA mutation|brca mutation
595667|NCT01034891|benign breast disease|benign breast disease
595668|NCT01034891|family history of breast cancer|family history of breast cancer
595669|NCT01034891|strong family history of breast cancer|strong family history of breast cancer
595670|NCT01034891|atypical ductal hyperplasia|atypical ductal hyperplasia
595671|NCT01034891|atypical lobular hyperplasia|atypical lobular hyperplasia
595672|NCT01034891|high risk for breast cancer|high risk for breast cancer
595673|NCT01034852|Atrial Fibrillation|atrial fibrillation
595674|NCT01034852|Maze|maze
595675|NCT01034852|Ablation|ablation
595676|NCT01034839|acute myeloid leukemia|acute myeloid leukemia
595677|NCT01034839|prognosis|prognosis
595678|NCT01034839|cytarabine|cytarabine
595679|NCT01034826|NGT, IGT, diabetes|ngt, igt, diabetes
595680|NCT01034813|contractures, range of motion, scar formation|contractures, range of motion, scar formation
595681|NCT01034800|HIV Positive|hiv positive
595682|NCT01034787|CP-675,206|cp-675,206
595683|NCT01034787|Immunotherapy|immunotherapy
595684|NCT01034787|AntiCTLA4|antictla4
595685|NCT01034787|Clinical Trial|clinical trial
595686|NCT01034787|Unresectable or Metastatic|unresectable or metastatic
595687|NCT01034774|Human volunteers|human volunteers
595688|NCT01034761|Electronic prescribing|electronic prescribing
595689|NCT01034761|Inappropriate medications|inappropriate medications
595690|NCT01034761|Patient safety|patient safety
595691|NCT01034761|Elderly patients in the hospital|elderly patients in the hospital
595692|NCT01034748|Radiolabelled|radiolabelled
595693|NCT01034748|Mass Balance|mass balance
595694|NCT01034748|Healthy Volunteers|healthy volunteers
595695|NCT01034748|Pharmacokinetics|pharmacokinetics
595696|NCT01034735|Saizen®|saizen®
595697|NCT01034735|bioequivalence|bioequivalence
595698|NCT01034735|recombinant human|recombinant human
595699|NCT01034735|Growth Hormone|growth hormone
595700|NCT01034735|treatment of growth failure in children|treatment of growth failure in children
595701|NCT01034735|growth hormone deficiency in adults|growth hormone deficiency in adults
595702|NCT01034722|Breast Milk|breast milk
595703|NCT01034722|Fat Globules|fat globules
595704|NCT01034709|Cytomegalovirus|cytomegalovirus
595705|NCT01034709|CMV|cmv
595706|NCT01034657|MDS|mds
595707|NCT01034657|bone marrow|bone marrow
595708|NCT01034657|anemia|anemia
595709|NCT01034657|cytopenia|cytopenia
595710|NCT01034657|transfusion dependance|transfusion dependance
595711|NCT01034657|EPO|epo
595712|NCT01034657|ESA|esa
595713|NCT01034657|erythropoietin|erythropoietin
595714|NCT01034657|LBH589|lbh589
595715|NCT01034657|Myelodysplastic Syndromes|myelodysplastic syndromes
595716|NCT01034657|hematopoietic improvement|hematopoietic improvement
595717|NCT01034657|IPSS Low|ipss low
595718|NCT01034657|IPSS Int-1|ipss int-1
595719|NCT01034657|HI-E|hi-e
595720|NCT01034657|HDAC Inhibitor|hdac inhibitor
595721|NCT01034657|HDAC-I|hdac-i
595722|NCT01034657|DAC-I|dac-i
595723|NCT01034657|Deacetylase-Inhibitor|deacetylase-inhibitor
595724|NCT01034657|Histone Deacetylase-Inhibitor|histone deacetylase-inhibitor
595725|NCT01034657|red blood cell transfusions|red blood cell transfusions
595726|NCT01034644|Biomarkers|biomarkers
595727|NCT01034644|Genetic markers|genetic markers
595728|NCT01034631|Metastatic Kidney Cancer|metastatic kidney cancer
595729|NCT01034631|BNC105P|bnc105p
595730|NCT01034618|Diabetes|diabetes
595731|NCT01034618|protein|protein
595732|NCT01034618|protein hydrolysate|protein hydrolysate
595733|NCT01034579|Biomarkers|biomarkers
595734|NCT01034579|Genetic markers|genetic markers
595735|NCT01034527|Anterior Cruciate Ligament|anterior cruciate ligament
595736|NCT01034527|Female Athlete|female athlete
595737|NCT01034527|Sports Injuries|sports injuries
595738|NCT01034527|Injury Prevention|injury prevention
595739|NCT01034501|periodontitis|periodontitis
595740|NCT01034501|photodynamic therapy|photodynamic therapy
595741|NCT01034475|acute myeloid leukemia|acute myeloid leukemia
595742|NCT01034475|acute lymphoblastic leukemia|acute lymphoblastic leukemia
595743|NCT01034475|multiple myeloma|multiple myeloma
595744|NCT01034475|chronic myeloid\ leukemia in blast phase|chronic myeloid\ leukemia in blast phase
595745|NCT01034462|Depression|depression
595746|NCT01034462|Major Depressive Disorder|major depressive disorder
595747|NCT01034449|allo graft|allo graft
595748|NCT01034449|cord blood|cord blood
595749|NCT01034449|expansion|expansion
595750|NCT01034449|reduced-intensity conditioning|reduced-intensity conditioning
595751|NCT01034423|Focus: health effects from omega-3 fatty acids, from fish oil with different quality|focus: health effects from omega-3 fatty acids, from fish oil with different quality
595752|NCT01034410|AS1411|as1411
595753|NCT01034410|AML|aml
595754|NCT01034410|relapsed|relapsed
595755|NCT01034410|refractory|refractory
595756|NCT01034410|aptamer|aptamer
595757|NCT01034410|nucleolin|nucleolin
595758|NCT01034384|fMRI|fmri
595759|NCT01034384|Smoking Withdrawal|smoking withdrawal
595760|NCT01034384|Imaging|imaging
595761|NCT01034384|Memory|memory
595762|NCT01034384|Mood|mood
595763|NCT01034371|Coronary Artery Disease; Hybrid Revascularization;|coronary artery disease; hybrid revascularization;
595764|NCT01034371|Percutaneous Coronary Intervention; Coronary Artery Bypass|percutaneous coronary intervention; coronary artery bypass
595765|NCT01034358|inflammatory bowel disease|inflammatory bowel disease
595766|NCT01034358|Crohn disease|crohn disease
595767|NCT01034358|ulcerative colitis|ulcerative colitis
595768|NCT01034358|Papillomavirus vaccines|papillomavirus vaccines
595769|NCT01034345|Sirolimus|sirolimus
595770|NCT01034345|Liver Transplantation|liver transplantation
595771|NCT01034345|Tolerance|tolerance
595772|NCT01034345|Immune responses|immune responses
595773|NCT01034345|Allograft tolerance|allograft tolerance
595774|NCT01034332|Esophageal cancer|esophageal cancer
595775|NCT01034332|Esophagectomy|esophagectomy
595776|NCT01034332|Paclitaxel|paclitaxel
595777|NCT01034332|Induction chemotherapy|induction chemotherapy
595778|NCT01034319|type 2 diabetes|type 2 diabetes
595779|NCT01034319|genetics|genetics
595780|NCT01034319|genetic counseling|genetic counseling
595781|NCT01034319|diabetes prevention|diabetes prevention
595782|NCT01034293|feeding frequency|feeding frequency
595783|NCT01034293|insulin metabolism|insulin metabolism
595784|NCT01034293|glucose metabolism|glucose metabolism
595785|NCT01034293|substrate partitioning|substrate partitioning
595786|NCT01034280|Down Syndrome|down syndrome
595787|NCT01034280|phenotype|phenotype
595788|NCT01034280|genotype|genotype
595789|NCT01034280|patient family|patient family
595790|NCT01034267|Depression|depression
595791|NCT01034267|Major Depressive Disorder|major depressive disorder
595792|NCT01034254|influenza|influenza
595793|NCT01034254|immunization|immunization
595794|NCT01034254|pregnancy|pregnancy
595795|NCT01034254|efficacy|efficacy
595796|NCT01034254|pertussis|pertussis
595797|NCT01034254|hepatitis E|hepatitis e
595798|NCT01034241|milk protein|milk protein
595799|NCT01034241|overweight|overweight
595800|NCT01034241|insulin metabolism|insulin metabolism
595801|NCT01034241|substrate partitioning|substrate partitioning
595802|NCT01034228|Diarrhoea|diarrhoea
595803|NCT01034228|L-isoleucine|l-isoleucine
595804|NCT01034228|children|children
595805|NCT01034228|ORS|ors
595806|NCT01034228|Antibacterial peptide|antibacterial peptide
595807|NCT01034215|Behavioral|behavioral
595808|NCT01034215|Quality of Life|quality of life
595809|NCT01034215|Breast Cancer|breast cancer
595810|NCT01034189|Esophageal cancer|esophageal cancer
595811|NCT01034189|Chemoradiotherapy|chemoradiotherapy
595812|NCT01034189|Paclitaxel|paclitaxel
595813|NCT01034189|Cetuximab|cetuximab
595814|NCT01034176|BK viremia|bk viremia
595815|NCT01034176|kidney transplantation|kidney transplantation
595816|NCT01034176|BK viremia in kidney transplant recipients|bk viremia in kidney transplant recipients
595817|NCT01034163|Phase III randomized|phase iii randomized
595818|NCT01034163|double blind|double blind
595819|NCT01034163|placebo controlled multi-center study|placebo controlled multi-center study
595820|NCT01034163|panobinostat|panobinostat
595821|NCT01034163|Hodgkin's lymphoma|hodgkin's lymphoma
595822|NCT01034163|at risk for relapse|at risk for relapse
595823|NCT01034163|autologous stem cell transplant|autologous stem cell transplant
595824|NCT01034137|Treat-to-target, tight control, strategy study, TCZ, MTX|treat-to-target, tight control, strategy study, tcz, mtx
595825|NCT01034124|warfarin|warfarin
595826|NCT01034124|midazolam|midazolam
595827|NCT01034124|cranberry juice|cranberry juice
595828|NCT01034124|pharmacokinetics|pharmacokinetics
595829|NCT01034098|Obesity|obesity
595830|NCT01034098|Postmenopausal women|postmenopausal women
595831|NCT01034098|Mechanical ventilatory constraints|mechanical ventilatory constraints
595920|NCT01033656|anakinra|anakinra
595832|NCT01034098|Dynamic lung volume|dynamic lung volume
595833|NCT01034098|Expiratory flow limitation|expiratory flow limitation
595834|NCT01034085|Nicotine|nicotine
595835|NCT01034085|Schizophrenia|schizophrenia
595836|NCT01034085|Cognition|cognition
595837|NCT01034085|Genes|genes
595838|NCT01034085|Smoking|smoking
595839|NCT01034085|Cigarette Smoking|cigarette smoking
595840|NCT01034046|Obesity|obesity
595841|NCT01034033|quality of life|quality of life
595842|NCT01034020|Nasal Spray|nasal spray
595843|NCT01034020|Attention Network Test|attention network test
595844|NCT01034020|Continuous Performance Test|continuous performance test
756949|NCT00416247|TMS|tms
595845|NCT01034020|Attentional Blink Test|attentional blink test
595846|NCT01034007|tissue engineered vascular graft|tissue engineered vascular graft
595847|NCT01033994|Knee osteoarthritis|knee osteoarthritis
595848|NCT01033994|Fibroblast growth factor 18|fibroblast growth factor 18
595849|NCT01033994|Sprifermin|sprifermin
595850|NCT01033981|cost effectiveness|cost effectiveness
595851|NCT01033981|Sunitinib Central America and Caribbean Metastatic Renal Cell Carcinoma|sunitinib central america and caribbean metastatic renal cell carcinoma
595852|NCT01033968|lasers|lasers
595853|NCT01033968|pain measurement|pain measurement
595854|NCT01033968|photocoagulation|photocoagulation
595855|NCT01033968|retina|retina
595856|NCT01033955|critical care|critical care
595857|NCT01033955|H1N1/influenza infection|h1n1/influenza infection
595858|NCT01033955|respiration|respiration
595859|NCT01033955|ventilation, artificial|ventilation, artificial
595860|NCT01033955|critically ill patients|critically ill patients
595861|NCT01033955|invasive mechanical ventilation|invasive mechanical ventilation
595862|NCT01033955|H1N1/influenza infection (suspected, probable or confirmed)|h1n1/influenza infection (suspected, probable or confirmed)
595863|NCT01033942|Pre-exposure prophylaxis|pre-exposure prophylaxis
595864|NCT01033942|HIV Prevention|hiv prevention
595865|NCT01033942|Truvada|truvada
595866|NCT01033942|Many Men, Many Voices|many men, many voices
595867|NCT01033942|Emtricitabine|emtricitabine
595868|NCT01033942|Tenofovir disoproxil fumarate|tenofovir disoproxil fumarate
595869|NCT01033942|Young men who have sex with men|young men who have sex with men
595870|NCT01033942|HIV Seronegativity|hiv seronegativity
595871|NCT01033929|tuberculosis|tuberculosis
595872|NCT01033929|ESAT-6|esat-6
595873|NCT01033929|CFP-10|cfp-10
595874|NCT01033929|skin test|skin test
595875|NCT01033929|diagnostic test|diagnostic test
595876|NCT01033916|Blood Glucose|blood glucose
595877|NCT01033916|Insulin/Administration and Dosage|insulin/administration and dosage
595878|NCT01033916|Coronary Artery Bypass|coronary artery bypass
595879|NCT01033903|Abortion, Spontaneous|abortion, spontaneous
595880|NCT01033903|Randomized Controlled Trial|randomized controlled trial
595881|NCT01033890|local anesthesia|local anesthesia
595882|NCT01033890|cochlear implant|cochlear implant
595883|NCT01033890|sedation|sedation
595884|NCT01033890|3 patients submitted to cochlear implant surgery with local anesthesia with sedation|3 patients submitted to cochlear implant surgery with local anesthesia with sedation
595885|NCT01033877|Immunisation, active|immunisation, active
595886|NCT01033812|Networks|networks
595887|NCT01033812|Index recruiter|index recruiter
595888|NCT01033799|Probiotic - Lactobacillus casei DN114-001|probiotic - lactobacillus casei dn114-001
595889|NCT01033799|dairy product - infections - shiftworkers|dairy product - infections - shiftworkers
595890|NCT01033799|Common infectious diseases,|common infectious diseases,
595891|NCT01033799|occuring in healthy subjects,|occuring in healthy subjects,
595892|NCT01033799|including upper respiratory tract infections (defined as rhinopharyngitis, sore throat, sinusitis and otitis),|including upper respiratory tract infections (defined as rhinopharyngitis, sore throat, sinusitis and otitis),
595893|NCT01033799|lower respiratory tract infections (defined as bronchitis,|lower respiratory tract infections (defined as bronchitis,
595894|NCT01033799|pneumopathy and flu and flu-like syndromes), and|pneumopathy and flu and flu-like syndromes), and
595895|NCT01033799|gastrointestinal tract infection defined as gastroenteritis.|gastrointestinal tract infection defined as gastroenteritis.
595896|NCT01033773|Type 2 diabetes mellitus|type 2 diabetes mellitus
595897|NCT01033773|Uncontrolled hyperglycemia|uncontrolled hyperglycemia
595898|NCT01033773|Emergency Department|emergency department
595899|NCT01033760|Primary HIV-1 infection|primary hiv-1 infection
595900|NCT01033760|antiretroviral treatment|antiretroviral treatment
595901|NCT01033760|HIV reservoirs|hiv reservoirs
595902|NCT01033760|HIV-DNA levels|hiv-dna levels
595903|NCT01033760|randomized|randomized
595904|NCT01033760|Treatment Naive|treatment naive
595905|NCT01033747|iron overload|iron overload
595906|NCT01033747|iron chelation therapy|iron chelation therapy
595907|NCT01033747|B-thalassemia|b-thalassemia
595908|NCT01033708|Psychotherapy|psychotherapy
595909|NCT01033708|PTSD|ptsd
595910|NCT01033708|Borderline personality disorders|borderline personality disorders
595911|NCT01033695|Endoscopy|endoscopy
595912|NCT01033695|Endoscopic Ultrasound|endoscopic ultrasound
595913|NCT01033695|Endoscopic Sonoelastography|endoscopic sonoelastography
595914|NCT01033695|Cancer|cancer
595915|NCT01033695|Interobserver agreement|interobserver agreement
595916|NCT01033669|Inhalation profiles|inhalation profiles
595917|NCT01033669|asthma|asthma
595918|NCT01033669|COPD|copd
595919|NCT01033656|adult-onset Still's disease|adult-onset still's disease
595921|NCT01033656|prednisolone|prednisolone
595922|NCT01033656|disease-modifying antirheumatic drug|disease-modifying antirheumatic drug
595923|NCT01033656|methotrexate|methotrexate
595924|NCT01033656|efficacy|efficacy
595925|NCT01033656|patients|patients
595926|NCT01033617|Stem cells|stem cells
595927|NCT01033617|Cellular therapy|cellular therapy
595928|NCT01033617|Myocardial repair|myocardial repair
595929|NCT01033591|Primary Health Care|primary health care
595930|NCT01033591|Family PractiCe|family practice
595931|NCT01033591|Hearth Failure|hearth failure
595932|NCT01033591|Exercise|exercise
595933|NCT01033591|Randomized Controlled Trials|randomized controlled trials
595934|NCT01033591|Multicenter Study|multicenter study
595935|NCT01033591|Quality of life|quality of life
595936|NCT01033565|Impaired sleep maintenance|impaired sleep maintenance
595937|NCT01033565|Autism Spectrum Disorders|autism spectrum disorders
595938|NCT01033565|Pediatric|pediatric
595939|NCT01033539|Survive|survive
595940|NCT01033539|safety|safety
595941|NCT01033539|lactobacillus Reuteri|lactobacillus reuteri
595942|NCT01033526|Symptomatic treatment of Common Cold symptoms|symptomatic treatment of common cold symptoms
595943|NCT01033487|Safety|safety
595944|NCT01033487|Pharmacokinetics|pharmacokinetics
595945|NCT01033487|Pharmacodynamics|pharmacodynamics
595946|NCT01033487|PF-03635659|pf-03635659
595947|NCT01033487|COPD|copd
595948|NCT01033474|Infertile Patients|infertile patients
595949|NCT01033461|probiotic|probiotic
595950|NCT01033461|lactobacillus paracasei|lactobacillus paracasei
595951|NCT01033461|calcium|calcium
595952|NCT01033461|faecal microbiota|faecal microbiota
595953|NCT01033461|cholesterol metabolism|cholesterol metabolism
595954|NCT01033435|Inflammation|inflammation
595955|NCT01033435|Oxidative stress|oxidative stress
595956|NCT01033435|HbA1c|hba1c
595957|NCT01033435|Hemodialysis|hemodialysis
595958|NCT01033422|Glaucoma|glaucoma
595959|NCT01033422|Ocular hypertension|ocular hypertension
595960|NCT01033422|Intraocular hypertension|intraocular hypertension
595961|NCT01033409|Salmonella Typhi|salmonella typhi
595962|NCT01033409|pneumonia|pneumonia
595963|NCT01033409|oral|oral
595964|NCT01033409|vaccine|vaccine
595965|NCT01033396|Allergic rhinitis Environmental exposure unit|allergic rhinitis environmental exposure unit
595966|NCT01033370|acute|acute
595967|NCT01033370|aortic|aortic
595968|NCT01033370|emergencies|emergencies
595969|NCT01033370|Aortic dissection|aortic dissection
595970|NCT01033357|dialysis|dialysis
595971|NCT01033357|hemodialysis|hemodialysis
595972|NCT01033357|neointimal hyperplasia|neointimal hyperplasia
595973|NCT01033344|Cat allergy|cat allergy
595974|NCT01033344|Rhinoconjunctivitis|rhinoconjunctivitis
595975|NCT01033344|Exposure chamber|exposure chamber
595976|NCT01033344|Immunotherapy|immunotherapy
595977|NCT01033344|Cat-PAD|cat-pad
595978|NCT01033331|Spinal Muscular atrophy|spinal muscular atrophy
595979|NCT01033331|Valproic acid|valproic acid
595980|NCT01033331|HMAS|hmas
595981|NCT01033331|MRC scale|mrc scale
595982|NCT01033318|Hypertension|hypertension
595983|NCT01033305|UC|uc
595984|NCT01033292|ovarian|ovarian
595985|NCT01033292|cancer|cancer
595986|NCT01033292|sensitive|sensitive
595987|NCT01033292|PARP|parp
595988|NCT01033292|recurrent|recurrent
595989|NCT01033292|platinum-resistant recurrent ovarian cancer|platinum-resistant recurrent ovarian cancer
595990|NCT01033279|Coaguchek|coaguchek
595991|NCT01033279|Portable coagulometer|portable coagulometer
595992|NCT01033279|Self-monitoring|self-monitoring
595993|NCT01033279|Coumadin|coumadin
595994|NCT01033279|Warfarin|warfarin
595995|NCT01033279|Quality of life|quality of life
595996|NCT01033279|Pharmacist|pharmacist
595997|NCT01033227|sickle cell disease|sickle cell disease
595998|NCT01033227|sickle cell anemia|sickle cell anemia
595999|NCT01033227|pain crisis|pain crisis
596000|NCT01033227|nitric oxide|nitric oxide
596001|NCT01033227|nitrite|nitrite
596002|NCT01033227|vaso occlusive crisis|vaso occlusive crisis
596003|NCT01033227|pain medication|pain medication
596004|NCT01033227|sickled cells|sickled cells
596005|NCT01033227|blood flow|blood flow
596006|NCT01033227|microcirculation|microcirculation
596007|NCT01033214|TAA|taa
596008|NCT01033214|Thoracic|thoracic
596009|NCT01033214|Descending Thoracic Aorta|descending thoracic aorta
596010|NCT01033214|TAArget|taarget
596011|NCT01033201|Lung rejection|lung rejection
596012|NCT01033188|double bundle|double bundle
596013|NCT01033188|hamstring graft|hamstring graft
596014|NCT01033188|ACL reconstruction|acl reconstruction
596015|NCT01033188|single bundle|single bundle
596016|NCT01033175|COPD|copd
596017|NCT01033175|anemia|anemia
596018|NCT01033175|exercise|exercise
596019|NCT01033175|cytokines|cytokines
596020|NCT01033175|erythropoietin|erythropoietin
596021|NCT01033123|ovarian|ovarian
596022|NCT01033123|cancer|cancer
596023|NCT01033123|sensitive|sensitive
596024|NCT01033123|PARP|parp
596025|NCT01033123|recurrent|recurrent
596026|NCT01033123|platinum-sensitive recurrent ovarian cancer|platinum-sensitive recurrent ovarian cancer
596027|NCT01033110|inactive|inactive
596028|NCT01033110|>45 years|>45 years
596029|NCT01033110|female|female
596030|NCT01033097|Dermatitis|dermatitis
596031|NCT01033097|inflammatory skin disease|inflammatory skin disease
596032|NCT01033097|itch|itch
596033|NCT01033097|eczema|eczema
596034|NCT01033084|Depressive Disorder, Major|depressive disorder, major
596035|NCT01033071|Hypertensive|hypertensive
757179|NCT00415402|CRP|crp
596036|NCT01033071|Blood Pressure, High|blood pressure, high
596037|NCT01033071|Cardiovascular disease|cardiovascular disease
596038|NCT01033071|Vascular Disease|vascular disease
596039|NCT01033071|Drug Therapy|drug therapy
596040|NCT01033058|STEMI|stemi
596041|NCT01033058|atorvastatin|atorvastatin
596043|NCT01033045|Hepatitis C|hepatitis c
596044|NCT01033045|Viral|viral
596045|NCT01033045|Non-A|non-a
596046|NCT01033045|Non-B|non-b
596047|NCT01033045|Parenterally-Transmitted|parenterally-transmitted
596048|NCT01033032|Metastatic Breast Cancer|metastatic breast cancer
596049|NCT01033032|Amrubicin|amrubicin
596050|NCT01033019|Basal cell carcinomas,|basal cell carcinomas,
596051|NCT01033019|sporadic,|sporadic,
596052|NCT01033019|superficial and nodular,|superficial and nodular,
596053|NCT01033019|skin|skin
596054|NCT01033006|Peripheral Nerves|peripheral nerves
596055|NCT01033006|Axillary Block|axillary block
596056|NCT01033006|MRI|mri
596057|NCT01032993|CoQ10|coq10
596058|NCT01032993|Statins|statins
596059|NCT01032993|Myalgia|myalgia
596060|NCT01032993|Muscle Pain|muscle pain
596061|NCT01032993|Muscle Weakness|muscle weakness
596062|NCT01032980|HUMENZA|humenza
596063|NCT01032980|PANENZA|panenza
596064|NCT01032980|Influenza|influenza
596065|NCT01032980|Swine-Origin Influenza A H1N1 Virus|swine-origin influenza a h1n1 virus
596066|NCT01032980|Influenza virus vaccines|influenza virus vaccines
596067|NCT01032967|squamous cell carcinoma|squamous cell carcinoma
596068|NCT01032967|esophagectomy|esophagectomy
596069|NCT01032967|chemoradiotherapy|chemoradiotherapy
596070|NCT01032967|chemoradiation|chemoradiation
596071|NCT01032967|Squamous cell carcinomas of the esophagus|squamous cell carcinomas of the esophagus
596072|NCT01032954|Botulinum Toxin|botulinum toxin
596073|NCT01032954|Rejuvenation|rejuvenation
596074|NCT01032954|Facial dynamic wrinkles|facial dynamic wrinkles
596075|NCT01032941|Portal Hypertension|portal hypertension
596076|NCT01032941|Portal Pressure Measurement|portal pressure measurement
596077|NCT01032941|VSL3|vsl3
596078|NCT01032941|Cirrhosis|cirrhosis
596079|NCT01032941|End Stage Liver Disease|end stage liver disease
596080|NCT01032941|Probiotics|probiotics
596081|NCT01032928|Swallowing|swallowing
596082|NCT01032928|Dysphagia|dysphagia
596083|NCT01032928|Breathing and swallowing|breathing and swallowing
596084|NCT01032928|Oropharyngeal cancer|oropharyngeal cancer
596085|NCT01032915|Quiescent uveitis|quiescent uveitis
596086|NCT01032915|intermediate uveitis|intermediate uveitis
596087|NCT01032915|panuveitis|panuveitis
596088|NCT01032915|posterior uveitis|posterior uveitis
596089|NCT01032915|uveitis|uveitis
596090|NCT01032902|Human immunodeficiency virus|human immunodeficiency virus
596091|NCT01032902|Rapid Test|rapid test
596092|NCT01032902|HIV|hiv
596093|NCT01032902|HIV Seronegativity|hiv seronegativity
596094|NCT01032876|Congenital Heart disease|congenital heart disease
596095|NCT01032876|Cardiopulmonary bypass|cardiopulmonary bypass
596096|NCT01032876|Neonatal brain injury|neonatal brain injury
596097|NCT01032876|Deep Hypothermic Circulatory Arrest|deep hypothermic circulatory arrest
596098|NCT01032876|Antegrade Cerebral Perfusion|antegrade cerebral perfusion
596099|NCT01032863|Chronic musculoskeletal pain|chronic musculoskeletal pain
596100|NCT01032863|Benign joint hypermobility syndrome|benign joint hypermobility syndrome
596101|NCT01032863|Fibromyalgia|fibromyalgia
596102|NCT01032850|INST 0820|inst 0820
596103|NCT01032850|sorafenib|sorafenib
596104|NCT01032850|capecitabine|capecitabine
596105|NCT01032850|hepatocellular carcinoma|hepatocellular carcinoma
596106|NCT01032850|lung|lung
596107|NCT01032850|nexavar|nexavar
596108|NCT01032850|xeloda|xeloda
596109|NCT01032850|liver cancer|liver cancer
596110|NCT01032824|Complementary Therapies|complementary therapies
596111|NCT01032811|ADHD, childhood cancer|adhd, childhood cancer
596112|NCT01032811|ADHD/Secondary ADHD Among Survivors of Childhood Cancer|adhd/secondary adhd among survivors of childhood cancer
596113|NCT01032785|Patent Foramen Ovale|patent foramen ovale
596114|NCT01032785|Patent Ductus Arteriosus|patent ductus arteriosus
596115|NCT01032785|PFO|pfo
596116|NCT01032785|PDA|pda
596117|NCT01032772|alcohol-exposed pregnancy|alcohol-exposed pregnancy
596118|NCT01032772|tobacco-exposed pregnancy|tobacco-exposed pregnancy
596119|NCT01032772|alcohol|alcohol
596120|NCT01032772|contraception|contraception
596121|NCT01032772|smoking|smoking
596122|NCT01032772|pregnancy|pregnancy
596123|NCT01032746|colon cancer|colon cancer
596124|NCT01032746|rectal cancer|rectal cancer
596125|NCT01032733|Weight Loss|weight loss
596126|NCT01032733|Physical Function|physical function
596127|NCT01032733|Oxidative Stress|oxidative stress
596128|NCT01032733|Inflammation|inflammation
596129|NCT01032720|ultrasound|ultrasound
596130|NCT01032720|osteoarthritis|osteoarthritis
596131|NCT01032720|knee|knee
596132|NCT01032720|corticosteroids|corticosteroids
596133|NCT01032720|intra-articular|intra-articular
596134|NCT01032720|injections|injections
596135|NCT01032694|Community-Acquired Pneumonia|community-acquired pneumonia
596136|NCT01032694|Azithromycin SR|azithromycin sr
596137|NCT01032694|Amoxiclav|amoxiclav
596138|NCT01032681|Solid tumor|solid tumor
596139|NCT01032681|B-Cell Non-Hodgkin Lymphoma|b-cell non-hodgkin lymphoma
596140|NCT01032681|Immunocytokine|immunocytokine
596141|NCT01032681|interleukin-2|interleukin-2
596142|NCT01032681|immunotherapy|immunotherapy
596143|NCT01032681|Metastatic or Locally Advanced Solid Tumors or B-Cell Non-Hodgkin Lymphoma|metastatic or locally advanced solid tumors or b-cell non-hodgkin lymphoma
596144|NCT01032668|percutaneous coronary intervention, clopidogrel resistance, ASA resistance|percutaneous coronary intervention, clopidogrel resistance, asa resistance
596145|NCT01032655|Helicobacter pylori|helicobacter pylori
596146|NCT01032655|sequential therapy|sequential therapy
596147|NCT01032655|susceptibility-driven|susceptibility-driven
596148|NCT01032655|rescue|rescue
596149|NCT01032655|levofloxacin|levofloxacin
596150|NCT01032655|clarithromycin|clarithromycin
596151|NCT01032655|salvage|salvage
596152|NCT01032655|treatment failure|treatment failure
596153|NCT01032655|those who fail from two standard eradication therapies|those who fail from two standard eradication therapies
596154|NCT01032642|infertility fallopian tubes|infertility fallopian tubes
596155|NCT01032629|Diabetes|diabetes
596156|NCT01032629|Type 2 diabetes mellitus|type 2 diabetes mellitus
596157|NCT01032629|Cardiovascular risk|cardiovascular risk
596158|NCT01032629|Cardiovascular outcomes|cardiovascular outcomes
596159|NCT01032629|Canagliflozin (JNJ-28431754)|canagliflozin (jnj-28431754)
596160|NCT01032629|Placebo|placebo
596161|NCT01032616|splanchnic bed|splanchnic bed
596162|NCT01032616|theronine and lysine metabolism uptake|theronine and lysine metabolism uptake
596163|NCT01032616|isotopes|isotopes
596164|NCT01032616|metabolism of two indispensable amino acids, threonine and lysine, by the splanchnic bed by Healthy Males|metabolism of two indispensable amino acids, threonine and lysine, by the splanchnic bed by healthy males
596166|NCT01032603|Exotropia|exotropia
596167|NCT01032603|Strabismus|strabismus
596168|NCT01032603|Intermittent exotropia|intermittent exotropia
596169|NCT01032590|weight changes|weight changes
596170|NCT01032590|cancer survivor|cancer survivor
596171|NCT01032590|stage I colon cancer|stage i colon cancer
596172|NCT01032590|stage II colon cancer|stage ii colon cancer
596173|NCT01032590|stage III colon cancer|stage iii colon cancer
596174|NCT01032590|stage I rectal cancer|stage i rectal cancer
596175|NCT01032590|stage II rectal cancer|stage ii rectal cancer
596176|NCT01032590|stage III rectal cancer|stage iii rectal cancer
596177|NCT01032577|ischemic cardiomyopathy|ischemic cardiomyopathy
596178|NCT01032577|nonischemic cardiomyopathy|nonischemic cardiomyopathy
596179|NCT01032577|implant|implant
596180|NCT01032577|bipolar sensing|bipolar sensing
596181|NCT01032577|extended bipolar sensing|extended bipolar sensing
596182|NCT01032564|estimate the interest of the measure of cervix elasticity degree by elastography in prediction of premature birth within a population of pregnant women|estimate the interest of the measure of cervix elasticity degree by elastography in prediction of premature birth within a population of pregnant women
596183|NCT01032551|Coronary Angiogram|coronary angiogram
596184|NCT01032551|Decision Aid|decision aid
596185|NCT01032551|Vascular Access|vascular access
596186|NCT01032551|Radial|radial
596187|NCT01032551|Femoral|femoral
596188|NCT01032538|Unicondylar Knee Replacement|unicondylar knee replacement
596189|NCT01032525|Crohn's Disease|crohn's disease
596190|NCT01032525|Ulcerative Colitis|ulcerative colitis
596191|NCT01032525|IBD|ibd
596192|NCT01032525|Inflammatory Bowel Disease in Monroe County, NY|inflammatory bowel disease in monroe county, ny
596193|NCT01032512|IMMUNE-ENHANCING|immune-enhancing
596194|NCT01032512|GLUTAMINE|glutamine
596195|NCT01032512|ARGININE|arginine
596196|NCT01032512|OMEGA 3 FATTY ACIDS|omega 3 fatty acids
596197|NCT01032512|ONCOLOGIC SURGERY|oncologic surgery
596198|NCT01032512|PREOPERATIVE NUTRITION|preoperative nutrition
596199|NCT01032499|Acne Vulgaris|acne vulgaris
596200|NCT01032499|Boil|boil
596201|NCT01032499|Taro Elixir|taro elixir
596202|NCT01032486|Rasagiline|rasagiline
596203|NCT01032486|Sleep|sleep
596204|NCT01032486|Sleepiness|sleepiness
596205|NCT01032486|Parkinson's Disease Sleep Scale|parkinson's disease sleep scale
596206|NCT01032486|Epworth Sleepiness Scale|epworth sleepiness scale
596207|NCT01032460|airway|airway
596208|NCT01032460|airway device|airway device
596209|NCT01032460|cervical spine immobilisation|cervical spine immobilisation
596210|NCT01032434|sertraline|sertraline
596211|NCT01032434|Polysomnograph|polysomnograph
596212|NCT01032421|women admitted to the In Vitro Fertilization unit|women admitted to the in vitro fertilization unit
596213|NCT01032408|Influenza A Virus|influenza a virus
596214|NCT01032408|Virus Diseases|virus diseases
596215|NCT01032408|Influenza, Human|influenza, human
596216|NCT01032408|HIV-1|hiv-1
596217|NCT01032408|Immunodeficiency Virus|immunodeficiency virus
596218|NCT01032408|H1N1|h1n1
596219|NCT01032408|HIV Infection|hiv infection
596220|NCT01032408|Immunogenicity|immunogenicity
596221|NCT01032408|safety|safety
596222|NCT01032408|tolerability|tolerability
596223|NCT01032395|H1N1|h1n1
596224|NCT01032395|Pulmonary Disease|pulmonary disease
596225|NCT01032395|Heart Disease|heart disease
596226|NCT01032395|Diabetes|diabetes
596227|NCT01032395|Influenza|influenza
596228|NCT01032395|immunogenicity|immunogenicity
757391|NCT00414700|Femoral|femoral
596229|NCT01032395|safety|safety
596230|NCT01032395|tolerability|tolerability
596231|NCT01032382|leishmaniasis|leishmaniasis
596232|NCT01032382|cutaneous|cutaneous
596233|NCT01032382|WR 279,396|wr 279,396
596234|NCT01032382|paromomycin|paromomycin
596235|NCT01032382|gentamicin|gentamicin
596236|NCT01032382|pharmacokinetics|pharmacokinetics
596237|NCT01032382|safety|safety
596238|NCT01032382|efficacy|efficacy
596239|NCT01032369|"Over-weight or obese subjects with learning disability who have completed Nitzan Onim two-year training program and live in housing within the community"|"over-weight or obese subjects with learning disability who have completed nitzan onim two-year training program and live in housing within the community"
596240|NCT01032356|Distal Radius fracture|distal radius fracture
596241|NCT01032343|Immunosuppression|immunosuppression
596242|NCT01032343|Ultraviolet radiation|ultraviolet radiation
596243|NCT01032343|Nickel|nickel
596244|NCT01032343|Contact hypersensitivity|contact hypersensitivity
596245|NCT01032330|intermittent exotropia|intermittent exotropia
596246|NCT01032330|IXT|ixt
596247|NCT01032330|natural history|natural history
596248|NCT01032330|occlusion therapy|occlusion therapy
596249|NCT01032330|occlusion|occlusion
596250|NCT01032330|patching|patching
596251|NCT01032330|strabismus|strabismus
596252|NCT01032330|strabismus treatment|strabismus treatment
596253|NCT01032330|stereoacuity|stereoacuity
596254|NCT01032330|motor alignment|motor alignment
596255|NCT01032317|Arrhythmia|arrhythmia
596256|NCT01032317|Electrophysiology|electrophysiology
596257|NCT01032317|Fibrillation|fibrillation
596258|NCT01032317|Tachycardia|tachycardia
596259|NCT01032317|Ablation|ablation
596260|NCT01032317|Atrial Fibrillation (AF)|atrial fibrillation (af)
596261|NCT01032317|Ischemic Ventricular Tachycardia (VT)|ischemic ventricular tachycardia (vt)
596262|NCT01032291|Colorectal cancer|colorectal cancer
596263|NCT01032291|Revlimid|revlimid
596264|NCT01032291|Lenalidomide|lenalidomide
596265|NCT01032291|Cetuximab|cetuximab
596266|NCT01032291|Erbitux|erbitux
596267|NCT01032291|KRAS|kras
596268|NCT01032278|cardiac toxicity|cardiac toxicity
596269|NCT01032278|unspecified adult solid tumor, protocol specific|unspecified adult solid tumor, protocol specific
596270|NCT01032265|female|female
596271|NCT01032265|stress urinary incontinence|stress urinary incontinence
596272|NCT01032265|treatment|treatment
596273|NCT01032265|pelvic floor muscle training|pelvic floor muscle training
596274|NCT01032265|cognitive behavioral therapy|cognitive behavioral therapy
596275|NCT01032265|internet|internet
596276|NCT01032265|life style|life style
596277|NCT01032265|pamphlet|pamphlet
596278|NCT01032265|eHealth|ehealth
596279|NCT01032252|fall prevention|fall prevention
596280|NCT01032252|general practitioners setting|general practitioners setting
596281|NCT01032252|implementation|implementation
596283|NCT01032252|community dwelling older adults|community dwelling older adults
596284|NCT01032252|exercise intervention|exercise intervention
596285|NCT01032239|Severe spasticity in post-stroke patients|severe spasticity in post-stroke patients
596286|NCT01032200|fatigue|fatigue
596287|NCT01032200|cognitive/functional effects|cognitive/functional effects
596288|NCT01032200|adult giant cell glioblastoma|adult giant cell glioblastoma
596289|NCT01032200|adult glioblastoma|adult glioblastoma
596290|NCT01032200|adult gliosarcoma|adult gliosarcoma
596291|NCT01032200|adult anaplastic astrocytoma|adult anaplastic astrocytoma
596292|NCT01032200|adult anaplastic oligodendroglioma|adult anaplastic oligodendroglioma
596293|NCT01032200|adult mixed glioma|adult mixed glioma
596294|NCT01032200|adult diffuse astrocytoma|adult diffuse astrocytoma
596295|NCT01032200|adult pilocytic astrocytoma|adult pilocytic astrocytoma
596296|NCT01032200|adult pineal gland astrocytoma|adult pineal gland astrocytoma
596297|NCT01032200|adult subependymal giant cell astrocytoma|adult subependymal giant cell astrocytoma
596298|NCT01032200|adult oligodendroglioma|adult oligodendroglioma
596299|NCT01032200|adult anaplastic ependymoma|adult anaplastic ependymoma
596300|NCT01032200|adult ependymoma|adult ependymoma
596301|NCT01032200|adult myxopapillary ependymoma|adult myxopapillary ependymoma
596302|NCT01032200|adult subependymoma|adult subependymoma
596303|NCT01032200|adult anaplastic meningioma|adult anaplastic meningioma
596304|NCT01032200|adult grade I meningioma|adult grade i meningioma
596305|NCT01032200|adult grade II meningioma|adult grade ii meningioma
596306|NCT01032200|adult grade III meningioma|adult grade iii meningioma
596307|NCT01032200|adult papillary meningioma|adult papillary meningioma
596308|NCT01032200|adult brain stem glioma|adult brain stem glioma
596309|NCT01032187|Visceral leishmaniasis|visceral leishmaniasis
596310|NCT01032187|Amphotericin B deoxycholate|amphotericin b deoxycholate
596311|NCT01032187|Meglumine antimoniate|meglumine antimoniate
596312|NCT01032187|Children|children
596313|NCT01032187|Brazil|brazil
596506|NCT01031563|Comorbidity|comorbidity
596314|NCT01032174|Azithromycin SR Amoxiclav 1000 mg Maxillary Sinusitis|azithromycin sr amoxiclav 1000 mg maxillary sinusitis
596315|NCT01032161|Delirium|delirium
596316|NCT01032161|Postoperative|postoperative
596317|NCT01032161|Non-cardiovascular surgery|non-cardiovascular surgery
596318|NCT01032161|Post-anaesthesia care unit|post-anaesthesia care unit
596319|NCT01032161|patients between 3 to 12 years old|patients between 3 to 12 years old
596320|NCT01032161|undergoing selective non-cardiac surgery|undergoing selective non-cardiac surgery
596321|NCT01032161|under general anesthesia|under general anesthesia
596322|NCT01032161|surgery|surgery
596323|NCT01032161|general anesthesia|general anesthesia
596324|NCT01032148|Recurrent|recurrent
596325|NCT01032148|Refractory|refractory
596326|NCT01032122|melanoma|melanoma
596327|NCT01032122|rituximab|rituximab
596328|NCT01032122|metastatic|metastatic
596329|NCT01032122|stage IIIc/IV|stage iiic/iv
596330|NCT01032122|stem cell|stem cell
596331|NCT01032122|overall survival|overall survival
596332|NCT01032122|disease free interval|disease free interval
596333|NCT01032122|anti-CD20 therapy|anti-cd20 therapy
596334|NCT01032083|SSRI antidepressant|ssri antidepressant
596335|NCT01032083|Negative symptoms|negative symptoms
596336|NCT01032083|Schizophrenia|schizophrenia
596337|NCT01032070|pediatric|pediatric
596338|NCT01032070|etoposide|etoposide
596339|NCT01032070|erlotinib|erlotinib
596340|NCT01032070|phase 2|phase 2
596341|NCT01032070|ependymoma|ependymoma
596342|NCT01032057|adenocarcinoma of the pancreas|adenocarcinoma of the pancreas
596343|NCT01032057|stage II pancreatic cancer|stage ii pancreatic cancer
596344|NCT01032057|stage III pancreatic cancer|stage iii pancreatic cancer
596345|NCT01032044|Barrett's esophagus|barrett's esophagus
596346|NCT01032044|EsoGastroDuodenoscopy|esogastroduodenoscopy
596347|NCT01032044|Barrett's carcinoma|barrett's carcinoma
596348|NCT01032044|adenocarcinoma|adenocarcinoma
596349|NCT01032044|Cellvizio|cellvizio
596350|NCT01032044|endomicroscopy|endomicroscopy
596351|NCT01032044|probe-based Confocal Laser Endomicroscopy|probe-based confocal laser endomicroscopy
596352|NCT01032044|pCLE|pcle
596353|NCT01032044|Radio-frequency ablation|radio-frequency ablation
596354|NCT01032044|Endoscopic mucosal resection|endoscopic mucosal resection
596355|NCT01032044|Photodynamic therapy|photodynamic therapy
596356|NCT01032031|Green tea|green tea
596357|NCT01032031|Vitamin C|vitamin c
596358|NCT01032031|Ultraviolet radiation|ultraviolet radiation
596359|NCT01032031|Inflammation|inflammation
596360|NCT01032031|Photoageing|photoageing
596361|NCT01032018|Acute coronary syndrome|acute coronary syndrome
596362|NCT01032018|Depression|depression
596363|NCT01032018|Satisfaction with care|satisfaction with care
596364|NCT01031992|Hereditary hemorrhagic telangiectasia|hereditary hemorrhagic telangiectasia
596365|NCT01031992|Rendu-Osler-Weber syndrome|rendu-osler-weber syndrome
596366|NCT01031992|Epistaxis|epistaxis
596367|NCT01031992|Nosebleeds|nosebleeds
596368|NCT01031992|Anemia|anemia
596369|NCT01031992|Tranexamic acid|tranexamic acid
596370|NCT01031992|Antifibrinolytics|antifibrinolytics
596371|NCT01031979|PTSD|ptsd
596372|NCT01031979|Prolonged Exposure|prolonged exposure
596373|NCT01031979|extinction|extinction
596374|NCT01031979|habituation|habituation
596375|NCT01031979|psychophysiology|psychophysiology
596376|NCT01031966|ESRD|esrd
596377|NCT01031953|nausea and vomiting|nausea and vomiting
596378|NCT01031953|unspecified adult solid tumor, protocol specific|unspecified adult solid tumor, protocol specific
596379|NCT01031927|obsessive compulsive disorder|obsessive compulsive disorder
596380|NCT01031927|sarcosine|sarcosine
596381|NCT01031927|glycine transporter I|glycine transporter i
596382|NCT01031927|NMDA receptor|nmda receptor
596383|NCT01031914|Paced Breathing|paced breathing
596384|NCT01031914|OSA|osa
596385|NCT01031914|sleep/wake detection|sleep/wake detection
596386|NCT01031901|Tuberous Sclerosis|tuberous sclerosis
596387|NCT01031901|Neurofibromatoses|neurofibromatoses
596388|NCT01031901|Angiofibroma|angiofibroma
596389|NCT01031901|Neurofibroma|neurofibroma
596390|NCT01031901|Sirolimus|sirolimus
596391|NCT01031888|Corneal re-epithelialization|corneal re-epithelialization
596392|NCT01031888|Topical insulin application|topical insulin application
596393|NCT01031888|pars planar vitrectomy|pars planar vitrectomy
596394|NCT01031888|diabetic retinopathy|diabetic retinopathy
596395|NCT01031888|penetrating keratoplasty|penetrating keratoplasty
596396|NCT01031875|recurrent bladder cancer|recurrent bladder cancer
596397|NCT01031875|stage IV bladder cancer|stage iv bladder cancer
596398|NCT01031875|recurrent urethral cancer|recurrent urethral cancer
596399|NCT01031875|distal urethral cancer|distal urethral cancer
596400|NCT01031875|proximal urethral cancer|proximal urethral cancer
596401|NCT01031875|urethral cancer associated with invasive bladder cancer|urethral cancer associated with invasive bladder cancer
596402|NCT01031875|metastatic transitional cell cancer of the renal pelvis and ureter|metastatic transitional cell cancer of the renal pelvis and ureter
596403|NCT01031875|recurrent transitional cell cancer of the renal pelvis and ureter|recurrent transitional cell cancer of the renal pelvis and ureter
596404|NCT01031875|stage IV urethral cancer|stage iv urethral cancer
596405|NCT01031862|healthy volunteer|healthy volunteer
596507|NCT01031563|Impulsivity|impulsivity
596406|NCT01031862|reverse cholesterol transport|reverse cholesterol transport
596407|NCT01031862|RCT|rct
757653|NCT00413556|Ig G4|ig g4
596408|NCT01031862|3H|3h
596409|NCT01031849|HIV 1 patients|hiv 1 patients
596410|NCT01031836|Systemic Lupus Erythematosus|systemic lupus erythematosus
596411|NCT01031836|Japanese|japanese
596412|NCT01031836|phase 2|phase 2
596413|NCT01031836|safety|safety
596414|NCT01031836|tolerability|tolerability
596415|NCT01031836|MEDI-545|medi-545
596416|NCT01031836|Autoimmune Disease|autoimmune disease
596417|NCT01031836|Immune System Diseases|immune system diseases
596418|NCT01031823|Autism Spectrum Disorder|autism spectrum disorder
596419|NCT01031810|Treatment Resistant depression|treatment resistant depression
596420|NCT01031810|Major Depression|major depression
596421|NCT01031810|MDD|mdd
596422|NCT01031810|Depression|depression
596423|NCT01031797|SLE|sle
596424|NCT01031797|Disease activity score|disease activity score
596425|NCT01031797|QT dispersion|qt dispersion
596426|NCT01031784|liver metastasis|liver metastasis
596427|NCT01031784|Liver tumors|liver tumors
596428|NCT01031784|microspheres|microspheres
596429|NCT01031784|holmium|holmium
596430|NCT01031784|toxicity|toxicity
596431|NCT01031771|Cerebral Palsy|cerebral palsy
596432|NCT01031771|Deglutition|deglutition
596433|NCT01031771|Deglutition disorders|deglutition disorders
596434|NCT01031771|Endoscopy|endoscopy
596435|NCT01031758|Low HDL|low hdl
596436|NCT01031758|High HDL|high hdl
596437|NCT01031758|HDL|hdl
596438|NCT01031758|Reverse Cholesterol Transport|reverse cholesterol transport
596439|NCT01031758|RCT|rct
596440|NCT01031758|healthy volunteer|healthy volunteer
596441|NCT01031758|3H|3h
596442|NCT01031758|Average HDL|average hdl
596443|NCT01031745|Complementary Therapies|complementary therapies
596444|NCT01031745|Drug Users|drug users
596445|NCT01031732|Minimally invasive|minimally invasive
596446|NCT01031732|Total hip arthroplasty|total hip arthroplasty
596447|NCT01031732|Functional outcome|functional outcome
596448|NCT01031732|To compare the surgical results of 4 MIS THA techniques|to compare the surgical results of 4 mis tha techniques
596449|NCT01031732|To investigate the functional outcomes of 4 MIS THA techniques|to investigate the functional outcomes of 4 mis tha techniques
596450|NCT01031732|To study the biochemical parameters after the MIS surgeries.|to study the biochemical parameters after the mis surgeries.
596451|NCT01031719|Influenza A Virus|influenza a virus
596452|NCT01031719|Virus Diseases|virus diseases
596453|NCT01031719|Influenza, Human|influenza, human
596454|NCT01031719|H1N1|h1n1
596455|NCT01031719|Immunogenicity|immunogenicity
596456|NCT01031719|safety|safety
596457|NCT01031719|tolerability|tolerability
596458|NCT01031719|tumors|tumors
596459|NCT01031719|oncology|oncology
596460|NCT01031706|Hypertonic Saline|hypertonic saline
596461|NCT01031706|Pediatrics|pediatrics
596462|NCT01031706|Cystic Fibrosis|cystic fibrosis
596463|NCT01031706|Mucociliary Clearance|mucociliary clearance
596464|NCT01031706|Lung Clearance Index|lung clearance index
596465|NCT01031693|Nicotine|nicotine
596466|NCT01031693|Cigarettes|cigarettes
596467|NCT01031693|Tobacco|tobacco
596468|NCT01031693|Transcranial Magnetic Stimulation (TMS)|transcranial magnetic stimulation (tms)
596469|NCT01031693|Cue-Induced Craving|cue-induced craving
596470|NCT01031693|Smoking|smoking
596471|NCT01031680|dapagliflozin|dapagliflozin
596472|NCT01031680|diabetes|diabetes
596473|NCT01031680|cardiovascular disease|cardiovascular disease
596474|NCT01031680|hypertension|hypertension
596475|NCT01031667|Patients treated with PCI with stent|patients treated with pci with stent
596476|NCT01031641|Patient-Reported Outcomes|patient-reported outcomes
596477|NCT01031641|Symptoms|symptoms
596478|NCT01031641|Instrument Development|instrument development
596479|NCT01031641|Adverse Events|adverse events
596480|NCT01031641|Questionnaire|questionnaire
596481|NCT01031641|Patient Reported Outcomes|patient reported outcomes
596482|NCT01031628|GIST|gist
596483|NCT01031628|Gastrointestinal stromal tumors|gastrointestinal stromal tumors
596484|NCT01031628|Exon 9|exon 9
596485|NCT01031628|Gleevec|gleevec
596486|NCT01031628|Imatinib blood levels|imatinib blood levels
596487|NCT01031615|School age children and adolescents exposed to a potentially traumatic event|school age children and adolescents exposed to a potentially traumatic event
596488|NCT01031602|Cancer|cancer
596489|NCT01031602|Gynecology|gynecology
596490|NCT01031602|Sexual Dysfunction|sexual dysfunction
596491|NCT01031602|Depression|depression
596492|NCT01031602|Anxiety|anxiety
596493|NCT01031602|Underserved|underserved
596494|NCT01031602|Minority|minority
596495|NCT01031602|Psychological distress|psychological distress
596496|NCT01031589|TMC278-TiDP15-C158|tmc278-tidp15-c158
596497|NCT01031589|TMC278-C158|tmc278-c158
596498|NCT01031589|TMC278|tmc278
596499|NCT01031589|HIV|hiv
596500|NCT01031589|Non-nucleoside reverse transcriptase inhibitor|non-nucleoside reverse transcriptase inhibitor
596501|NCT01031589|HIV Seronegativity|hiv seronegativity
596502|NCT01031576|Osteoarthritis, posture, knee|osteoarthritis, posture, knee
596503|NCT01031563|Risk Taking|risk taking
596504|NCT01031563|Schizophrenia|schizophrenia
596505|NCT01031563|Drug Abuse/Dependence|drug abuse/dependence
596508|NCT01031563|Drug Abuse|drug abuse
596509|NCT01031550|liver resection for liver disease|liver resection for liver disease
596510|NCT01031537|FSME-Immun|fsme-immun
596511|NCT01031537|TBEV|tbev
596512|NCT01031537|TBE Researcher|tbe researcher
596513|NCT01031537|Plavivirus|plavivirus
596514|NCT01031537|Anti-TBEV Levels|anti-tbev levels
596515|NCT01031537|Tic-Borne Encephalitis|tic-borne encephalitis
596516|NCT01031524|Plasmodium falciparum malaria|plasmodium falciparum malaria
596517|NCT01031511|High-Functioning Autistic Spectrum Disorder|high-functioning autistic spectrum disorder
596518|NCT01031511|Anxiety|anxiety
596519|NCT01031511|Cognitive Behavioural Therapy|cognitive behavioural therapy
596520|NCT01031511|Social Recreational|social recreational
596521|NCT01031511|Parent Stress|parent stress
596522|NCT01031498|Nausea|nausea
596523|NCT01031498|Vomiting|vomiting
596524|NCT01031498|CINV|cinv
596525|NCT01031498|Leukemia|leukemia
596526|NCT01031498|High-risk Myelodysplastic syndrome|high-risk myelodysplastic syndrome
596527|NCT01031498|AML|aml
596528|NCT01031498|Hematologic malignancies|hematologic malignancies
596529|NCT01031498|Hematologic Disorder|hematologic disorder
596530|NCT01031498|Continuous multi-day chemotherapy|continuous multi-day chemotherapy
596531|NCT01031498|High-dose cytarabine|high-dose cytarabine
596532|NCT01031498|Palonosetron|palonosetron
596533|NCT01031498|Aloxi|aloxi
596534|NCT01031498|Ondansetron|ondansetron
596535|NCT01031498|Zofran|zofran
596536|NCT01031485|hypertension|hypertension
596537|NCT01031485|blood pressure|blood pressure
596538|NCT01031485|milk peptides|milk peptides
596539|NCT01031485|bioactive peptides|bioactive peptides
596540|NCT01031485|randomized controlled trial|randomized controlled trial
596541|NCT01031472|HIV, relative bioavailability, food effect, GSK2248761, healthy subjects|hiv, relative bioavailability, food effect, gsk2248761, healthy subjects
596542|NCT01031472|HIV Seronegativity|hiv seronegativity
596543|NCT01031446|stage IV breast cancer|stage iv breast cancer
596544|NCT01031446|Human epidermal growth factor (HER2)-negative breast cancer|human epidermal growth factor (her2)-negative breast cancer
596545|NCT01031446|triple-negative breast cancer|triple-negative breast cancer
596546|NCT01031446|hormone-resistant breast cancer|hormone-resistant breast cancer
596547|NCT01031433|Tobacco Craving|tobacco craving
596548|NCT01031433|Virtual Reality|virtual reality
596549|NCT01031433|Schizophrenia|schizophrenia
596550|NCT01031433|Smoking|smoking
596551|NCT01031420|bladder|bladder
596552|NCT01031420|cancer|cancer
596553|NCT01031420|invasive|invasive
596554|NCT01031407|Adolescents and Adults|adolescents and adults
596555|NCT01031407|Autism|autism
596556|NCT01031407|Functional Magnetic Resonance Imaging (fMRI)|functional magnetic resonance imaging (fmri)
596557|NCT01031407|MEG|meg
596558|NCT01031407|Structural MRI|structural mri
596559|NCT01031407|HV|hv
596560|NCT01031407|Autism Spectrum Disorder|autism spectrum disorder
596561|NCT01031407|ASD|asd
596562|NCT01031407|Autistic Disorder|autistic disorder
596563|NCT01031407|Asperger Syndrome|asperger syndrome
596564|NCT01031407|Mental Retardation|mental retardation
596565|NCT01031407|Healthy Volunteer|healthy volunteer
596566|NCT01031394|exercise|exercise
596567|NCT01031394|resistance training|resistance training
596568|NCT01031381|Recurrent|recurrent
596569|NCT01031381|ovarian|ovarian
596570|NCT01031381|fallopian tube|fallopian tube
596571|NCT01031381|primary peritoneal|primary peritoneal
596572|NCT01031381|cancer|cancer
596573|NCT01031381|Recurrent ovarian, fallopian tube, primary peritoneal cancer|recurrent ovarian, fallopian tube, primary peritoneal cancer
596574|NCT01031355|Female Contraception|female contraception
596575|NCT01031355|Contraceptives, Oral|contraceptives, oral
596576|NCT01031342|Colonoscopy|colonoscopy
596577|NCT01031342|Gastrointestinal bleeding|gastrointestinal bleeding
596578|NCT01031316|Echocardiography|echocardiography
596579|NCT01031316|Infant, Premature|infant, premature
596580|NCT01031316|Infant, Very Low Birth Weight|infant, very low birth weight
596581|NCT01031303|Diphtheria|diphtheria
596582|NCT01031303|Tetanus|tetanus
596583|NCT01031303|Pertussis|pertussis
596584|NCT01031303|Poliomyelitis|poliomyelitis
596585|NCT01031303|PENTAXIM™|pentaxim™
596586|NCT01031303|TETRAXIM™|tetraxim™
596587|NCT01031290|Cue-Induced Craving|cue-induced craving
596588|NCT01031290|Cannabis|cannabis
596589|NCT01031290|Functional Magnetic Resonance Imaging (fMRI)|functional magnetic resonance imaging (fmri)
596590|NCT01031290|Repetitive TMS (rTMS)|repetitive tms (rtms)
596591|NCT01031290|Cannabis Craving|cannabis craving
596592|NCT01031277|Hypercholesterolemia|hypercholesterolemia
596593|NCT01031277|Update NCEP ATP111|update ncep atp111
596594|NCT01031277|Survey|survey
596595|NCT01031264|social drinkers|social drinkers
596596|NCT01031238|PEM Uptake Value|pem uptake value
596597|NCT01031238|PUV|puv
596598|NCT01031238|Standardized Uptake Value|standardized uptake value
596599|NCT01031238|SUV|suv
596600|NCT01031238|Malignancies of the Breast|malignancies of the breast
596601|NCT01031238|[18F]-FDG-PET/CT scanning|[18f]-fdg-pet/ct scanning
596602|NCT01031238|Tumor|tumor
596603|NCT01031238|positron emission tomography/computed tomography|positron emission tomography/computed tomography
596604|NCT01031238|PET/CT scan|pet/ct scan
596605|NCT01031225|Synta|synta
596606|NCT01031225|STA 9090|sta 9090
596607|NCT01031225|ganetespib)|ganetespib)
596608|NCT01031225|Lung Cancer|lung cancer
596609|NCT01031225|Non Small Cell Lung Cancer|non small cell lung cancer
596610|NCT01031225|NSCLC|nsclc
596611|NCT01031212|cancer|cancer
596612|NCT01031212|neoplasms|neoplasms
596613|NCT01031212|adult solid tumor|adult solid tumor
596614|NCT01031212|antineoplastic agents|antineoplastic agents
596615|NCT01031199|Multiple sclerosis|multiple sclerosis
596616|NCT01031199|Diagnostic imaging|diagnostic imaging
596617|NCT01031199|Neuroinflammation|neuroinflammation
596618|NCT01031199|PET diagnosis|pet diagnosis
596619|NCT01031199|PET tracer|pet tracer
596620|NCT01031186|healthy male volunteers|healthy male volunteers
596621|NCT01031186|GSK356278|gsk356278
596622|NCT01031186|first time in man|first time in man
596623|NCT01031186|major depressive disorder|major depressive disorder
596624|NCT01031173|α galactosidase A|α galactosidase a
596625|NCT01031173|glycosphingolipid storage disorder|glycosphingolipid storage disorder
596626|NCT01031173|agalsidase alfa|agalsidase alfa
596627|NCT01031173|enzyme replacement therapy|enzyme replacement therapy
596628|NCT01031173|Replagal|replagal
596629|NCT01031173|agalsidase beta|agalsidase beta
596630|NCT01031173|Fabrazyme|fabrazyme
596631|NCT01031160|Health Indicators|health indicators
596632|NCT01031160|Health Behaviors|health behaviors
596633|NCT01031160|Health Study|health study
596634|NCT01031160|Substance Abuse|substance abuse
596635|NCT01031160|Adolescence|adolescence
596636|NCT01031160|Obesity|obesity
596637|NCT01031147|Magnetic resonance angiography|magnetic resonance angiography
596638|NCT01031147|Intracranial aneurysm|intracranial aneurysm
596639|NCT01031147|Digital subtraction angiography|digital subtraction angiography
596640|NCT01031147|Volume rendering|volume rendering
596641|NCT01031121|Cigarette Smoking|cigarette smoking
596642|NCT01031121|Biomarkers|biomarkers
596643|NCT01031121|Nicotine|nicotine
596644|NCT01031121|Cotinine|cotinine
596645|NCT01031121|Metabolites|metabolites
596646|NCT01031095|percutaneous coronary intervention|percutaneous coronary intervention
596647|NCT01031095|low dose intracoronary heparin|low dose intracoronary heparin
596648|NCT01031069|Cervarix|cervarix
596649|NCT01031069|Gardasil|gardasil
596650|NCT01031069|Immunogenicity|immunogenicity
596651|NCT01031069|Cervical cancer|cervical cancer
596652|NCT01031069|Safety|safety
596653|NCT01031069|HPV vaccine|hpv vaccine
596654|NCT01031043|IEM|iem
596655|NCT01031030|stage I breast cancer|stage i breast cancer
596656|NCT01031030|stage II breast cancer|stage ii breast cancer
596657|NCT01031030|stage IIIA breast cancer|stage iiia breast cancer
596658|NCT01031030|stage IIIB breast cancer|stage iiib breast cancer
596659|NCT01031030|stage IIIC breast cancer|stage iiic breast cancer
596660|NCT01031017|twin pregnancies|twin pregnancies
596661|NCT01031017|preterm delivery|preterm delivery
596662|NCT01031017|progesterone|progesterone
596663|NCT01030991|Heart failure|heart failure
596664|NCT01030991|Ejection fraction|ejection fraction
596665|NCT01030991|Diastolic heart failure|diastolic heart failure
596666|NCT01030991|Diastolic dysfunction|diastolic dysfunction
596667|NCT01030991|Ventricular-arterial coupling|ventricular-arterial coupling
596668|NCT01030991|Exercise testing|exercise testing
596669|NCT01030991|Echocardiography|echocardiography
596670|NCT01030991|Tissue Doppler imaging|tissue doppler imaging
596671|NCT01030991|Arterial tonometry|arterial tonometry
596672|NCT01030991|Genetics|genetics
596673|NCT01030991|Epidemiology|epidemiology
596674|NCT01030978|Impaired Glucose Tolerance|impaired glucose tolerance
596675|NCT01030978|PreDiabetes|prediabetes
596676|NCT01030978|Diabetes Prevention|diabetes prevention
596677|NCT01030965|Chronic Bronchitis|chronic bronchitis
596678|NCT01030965|Anticholinergic|anticholinergic
596679|NCT01030965|Emphysema|emphysema
596680|NCT01030965|Long-acting muscarinic antagonist|long-acting muscarinic antagonist
596681|NCT01030965|COPD|copd
596682|NCT01030952|Diabetes Mellitus, Type 2|diabetes mellitus, type 2
596683|NCT01030952|Nateglinide|nateglinide
596684|NCT01030952|Acarbose|acarbose
596685|NCT01030952|glucose fluctuation|glucose fluctuation
596686|NCT01030939|Healthy volunteers|healthy volunteers
596687|NCT01030939|Men and women|men and women
596688|NCT01030939|adults and elderly|adults and elderly
596689|NCT01030939|repeat dose|repeat dose
596690|NCT01030913|Chronic Lymphocytic Leukemia|chronic lymphocytic leukemia
596691|NCT01030900|Immunosuppression|immunosuppression
596692|NCT01030900|Microenvironment|microenvironment
596693|NCT01030900|Hodgkin Lymphoma|hodgkin lymphoma
596694|NCT01030900|B-Cell Lymphoma|b-cell lymphoma
596695|NCT01030900|Microarray|microarray
596696|NCT01030900|Diffuse Large B-Cell Lymphoma|diffuse large b-cell lymphoma
596697|NCT01030887|Cancer|cancer
596698|NCT01030887|Exercise|exercise
596699|NCT01030887|Physical Activity|physical activity
758038|NCT00412477|HIV|hiv
596700|NCT01030887|Randomized controlled trial|randomized controlled trial
596701|NCT01030874|hypotension, orthostatic|hypotension, orthostatic
596702|NCT01030874|falls|falls
596703|NCT01030874|rehabilitation|rehabilitation
596704|NCT01030874|blood pressure|blood pressure
596705|NCT01030874|aging|aging
596706|NCT01030861|type 1 diabetes|type 1 diabetes
596707|NCT01030861|pre-diabetic|pre-diabetic
596708|NCT01030861|autoantibody positive|autoantibody positive
596709|NCT01030861|at risk for type 1 diabetes|at risk for type 1 diabetes
596710|NCT01030861|glucose intolerance|glucose intolerance
596711|NCT01030861|relatives of people with type 1 diabetes|relatives of people with type 1 diabetes
596712|NCT01030835|Screening Protocol|screening protocol
596713|NCT01030835|Comorbidity|comorbidity
596714|NCT01030835|Normal Controls|normal controls
596715|NCT01030835|Substance Use Disorders|substance use disorders
596716|NCT01030835|Substance Abuse Disorders|substance abuse disorders
596717|NCT01030822|Catch-up vaccination|catch-up vaccination
596718|NCT01030822|Safety|safety
596719|NCT01030822|Pneumococcal vaccine|pneumococcal vaccine
596720|NCT01030822|Pneumococcal disease|pneumococcal disease
596721|NCT01030822|Booster vaccination|booster vaccination
596722|NCT01030822|Immunogenicity|immunogenicity
596723|NCT01030809|Crohn's disease|crohn's disease
596724|NCT01030809|community based gastroenterology practices Canada and Belgium|community based gastroenterology practices canada and belgium
596725|NCT01030809|Cluster randomization controlled trial|cluster randomization controlled trial
596726|NCT01030809|Remission|remission
596727|NCT01030809|Corticosteroids|corticosteroids
596728|NCT01030809|Documented diagnosis of Crohn's disease|documented diagnosis of crohn's disease
596729|NCT01030770|Diabetes|diabetes
596730|NCT01030770|Vitreous Haemorrhages|vitreous haemorrhages
596731|NCT01030757|Liver Cancer|liver cancer
596732|NCT01030757|Metastatic Liver Cancer|metastatic liver cancer
596733|NCT01030757|Tomotherapy|tomotherapy
596734|NCT01030757|Stereotactic Body Radiation Therapy|stereotactic body radiation therapy
596735|NCT01030744|Gestational Diabetes|gestational diabetes
596736|NCT01030744|Self-Monitoring of Blood Glucose|self-monitoring of blood glucose
596737|NCT01030731|Renal Dialysis, Ceftobiprole|renal dialysis, ceftobiprole
596738|NCT01030731|Skin and soft tissue Infections|skin and soft tissue infections
596739|NCT01030731|Staphylococcal Skin Infections|staphylococcal skin infections
596740|NCT01030731|Streptococcal Infection|streptococcal infection
596741|NCT01030705|Bradycardia|bradycardia
596742|NCT01030705|pacemaker|pacemaker
596743|NCT01030692|Cocaine|cocaine
596744|NCT01030692|Rivastigmine|rivastigmine
596745|NCT01030692|Huperzine A|huperzine a
596746|NCT01030679|Diabetes Mellitus, type 2|diabetes mellitus, type 2
596747|NCT01030679|Glitazone|glitazone
596748|NCT01030666|periodontal regeneration|periodontal regeneration
596749|NCT01030666|radiographic bone fill|radiographic bone fill
596750|NCT01030666|infrabony defects|infrabony defects
596751|NCT01030666|randomized placebo-controlled clinical trial|randomized placebo-controlled clinical trial
596752|NCT01030666|guided tissue regeneration, periodontal|guided tissue regeneration, periodontal
596753|NCT01030653|Voriconazole|voriconazole
596754|NCT01030653|Pharmacokinetics|pharmacokinetics
596755|NCT01030653|Obese|obese
596756|NCT01030653|Healthy Volunteer|healthy volunteer
596757|NCT01030640|intraepidermal nerve fiber density|intraepidermal nerve fiber density
596758|NCT01030640|IENF|ienf
596759|NCT01030640|tanezumab|tanezumab
596760|NCT01030640|subcutaneous|subcutaneous
596761|NCT01030640|healthy volunteers|healthy volunteers
596762|NCT01030627|Eclampsia|eclampsia
596763|NCT01030627|Preeclampsia|preeclampsia
596764|NCT01030627|Magnesium sulfate|magnesium sulfate
596765|NCT01030614|Laparoscopic cholecystectomy,postoperative symptoms|laparoscopic cholecystectomy,postoperative symptoms
596766|NCT01030601|Diabetic|diabetic
596767|NCT01030601|Macular Edema|macular edema
596768|NCT01030601|Pseudophakic|pseudophakic
596769|NCT01030601|Dexamethasone|dexamethasone
596770|NCT01030601|Intravitreal|intravitreal
596771|NCT01030601|Cataract surgery|cataract surgery
596772|NCT01030575|NICHD Neonatal Research Network|nichd neonatal research network
596773|NCT01030575|Pharmacokinetics|pharmacokinetics
596774|NCT01030575|Inositol|inositol
596775|NCT01030575|Very Low Birth Weight (VLBW)|very low birth weight (vlbw)
596776|NCT01030575|Extremely Low Birth Weight (ELBW)|extremely low birth weight (elbw)
596777|NCT01030575|Prematurity|prematurity
596778|NCT01030562|adolescent|adolescent
596779|NCT01030562|children|children
596780|NCT01030562|HPV|hpv
596781|NCT01030562|human papillomavirus|human papillomavirus
596782|NCT01030562|vaccine|vaccine
596783|NCT01030562|women|women
596784|NCT01030549|cardiovascular magnetic resonance|cardiovascular magnetic resonance
596785|NCT01030549|ventricular volumes|ventricular volumes
596786|NCT01030549|ventricular function|ventricular function
596787|NCT01030549|Healthy normal individuals from 20 to 80 years of age|healthy normal individuals from 20 to 80 years of age
596788|NCT01030536|NHL|nhl
596789|NCT01030536|CLL|cll
596790|NCT01030497|Cancer|cancer
596791|NCT01030497|Cervical Lymph Node Metastases|cervical lymph node metastases
596792|NCT01030497|High-Resolution PET Imaging System|high-resolution pet imaging system
596793|NCT01030497|Upper Aerodigestive Tract|upper aerodigestive tract
596794|NCT01030497|Head|head
596795|NCT01030497|Neck|neck
596796|NCT01030497|HR PET Imaging System|hr pet imaging system
596797|NCT01030497|High-Resolution PET|high-resolution pet
596798|NCT01030497|PET/CT|pet/ct
596799|NCT01030497|PEMFlex Solo II|pemflex solo ii
596800|NCT01030497|positron emission tomography/computed tomography (PET/CT)|positron emission tomography/computed tomography (pet/ct)
596801|NCT01030484|NAFLD|nafld
596802|NCT01030484|NASH|nash
596803|NCT01030484|non-alcoholic steatohepatitis|non-alcoholic steatohepatitis
596804|NCT01030484|fatty liver disease|fatty liver disease
596805|NCT01030471|adolescents|adolescents
596806|NCT01030471|depression|depression
596807|NCT01030471|adherence|adherence
596808|NCT01030471|family functioning|family functioning
596809|NCT01030471|intervention|intervention
596810|NCT01030458|Blood pressure|blood pressure
596811|NCT01030458|Hypertension|hypertension
596812|NCT01030458|Blacks|blacks
596813|NCT01030458|Africa|africa
596814|NCT01030458|Blood pressure control|blood pressure control
596815|NCT01030458|Side-effects|side-effects
596816|NCT01030445|non-invasive cardiac output monitor|non-invasive cardiac output monitor
596817|NCT01030445|electrical velocimetry|electrical velocimetry
596818|NCT01030445|Aesculon|aesculon
596819|NCT01030445|Icon|icon
596820|NCT01030445|pediatrics|pediatrics
596821|NCT01030445|normal reference|normal reference
596822|NCT01030419|Aging|aging
596823|NCT01030419|Quality of Life|quality of life
596824|NCT01030419|Functional fitness|functional fitness
596825|NCT01030406|Abuse Liability|abuse liability
596826|NCT01030406|Abuse Prevention|abuse prevention
596827|NCT01030406|Abuse Resistance|abuse resistance
596828|NCT01030406|Abuse Deterrence|abuse deterrence
596829|NCT01030393|hCG|hcg
596830|NCT01030393|pregnancy|pregnancy
596831|NCT01030393|implantation|implantation
596832|NCT01030393|ICSI|icsi
596833|NCT01030393|IVF|ivf
596834|NCT01030380|Facial toning|facial toning
596835|NCT01030380|Facial lift|facial lift
596836|NCT01030380|Improve facial complexion|improve facial complexion
596837|NCT01030380|Improve facial tone|improve facial tone
596838|NCT01030380|Improve radiance of the face|improve radiance of the face
596839|NCT01030380|Reduce signs of facial aging|reduce signs of facial aging
596840|NCT01030380|firming, lift, tone face|firming, lift, tone face
596841|NCT01030367|Coronary artery disease|coronary artery disease
596842|NCT01030354|Satiety|satiety
596843|NCT01030354|Meal Replacements|meal replacements
596844|NCT01030354|High Protein|high protein
596845|NCT01030354|Standard Protein|standard protein
596846|NCT01030341|Diabetes|diabetes
596847|NCT01030341|Gastroparesis|gastroparesis
596848|NCT01030315|Erythropoietin|erythropoietin
596849|NCT01030315|Long-acting|long-acting
596850|NCT01030315|EPO|epo
596851|NCT01030302|Bortezomib retreatment|bortezomib retreatment
596852|NCT01030302|Velcade|velcade
596853|NCT01030302|Proteasome inhibitor|proteasome inhibitor
596854|NCT01030302|Bortezomib|bortezomib
596855|NCT01030289|food cravings|food cravings
596856|NCT01030250|Breast Cancer|breast cancer
596857|NCT01030250|Adjuvant Chemotherapy|adjuvant chemotherapy
596858|NCT01030237|Dry eye|dry eye
596859|NCT01030237|artificial tears|artificial tears
596860|NCT01030224|Healthy volunteer|healthy volunteer
596861|NCT01030224|First time in human|first time in human
596862|NCT01030211|Dengue|dengue
596863|NCT01030211|Platelet transfusion|platelet transfusion
596864|NCT01030211|Bleeding|bleeding
596865|NCT01030211|Prevention|prevention
596866|NCT01030185|ascites|ascites
596867|NCT01030185|liver cirrhosis|liver cirrhosis
596868|NCT01030159|Cancer Anemia Survey|cancer anemia survey
596869|NCT01030159|Thai National Cancer Institute|thai national cancer institute
596870|NCT01030133|Pain|pain
596871|NCT01030120|chronic idiopathic urticaria|chronic idiopathic urticaria
596872|NCT01030120|etanercept|etanercept
596873|NCT01030107|sleep|sleep
596874|NCT01030107|obesity|obesity
596875|NCT01030107|children|children
596876|NCT01030107|eating behaviors|eating behaviors
596877|NCT01030107|activity|activity
596878|NCT01030107|leptin|leptin
596879|NCT01030107|ghrelin|ghrelin
596880|NCT01030094|Topiramate|topiramate
596881|NCT01030094|Carbamazepine|carbamazepine
596882|NCT01030094|Valproic acid|valproic acid
596883|NCT01030094|Epilepsy|epilepsy
596884|NCT01030094|Bone mineral density|bone mineral density
596885|NCT01030094|Monotherapy|monotherapy
596886|NCT01030081|24 hour blood pressure|24 hour blood pressure
596887|NCT01030081|morning blood pressure surge|morning blood pressure surge
596888|NCT01030081|amlodipine|amlodipine
596889|NCT01030081|nifedipine GITS|nifedipine gits
596890|NCT01030068|Smoking Cessation|smoking cessation
596891|NCT01030068|Yoga|yoga
596892|NCT01030068|Wellness|wellness
596893|NCT01030068|Feasibility|feasibility
596894|NCT01030068|Smoking Cessation Therapy|smoking cessation therapy
596895|NCT01030055|Neoplasms|neoplasms
596896|NCT01030055|Cancer|cancer
596897|NCT01030055|Tumors|tumors
596898|NCT01030055|Administration, oral|administration, oral
596899|NCT01030055|Capsules|capsules
596900|NCT01030055|CHIR258|chir258
596901|NCT01030055|CHIR-258|chir-258
596902|NCT01030055|CHIR 258|chir 258
596903|NCT01030055|TKI258|tki258
596904|NCT01030055|TKI-258|tki-258
596905|NCT01030055|TKI 258|tki 258
596906|NCT01030055|Bioavailability|bioavailability
596907|NCT01030055|Food|food
596908|NCT01030042|metastatic|metastatic
596909|NCT01030042|colorectal cancer|colorectal cancer
596910|NCT01030042|two sequences therapy|two sequences therapy
596911|NCT01030029|auricular acupuncture|auricular acupuncture
596912|NCT01030029|postoperative pain|postoperative pain
596913|NCT01030029|opioid consumption|opioid consumption
596914|NCT01030029|laparoscopic surgery|laparoscopic surgery
596915|NCT01030029|ACUPUNCTURE THERAPY (IM) + EAR, EXTERNAL (IM)|acupuncture therapy (im) + ear, external (im)
596916|NCT01030016|resistance exercise|resistance exercise
596917|NCT01030016|beta-blockers|beta-blockers
596918|NCT01030016|blood pressure|blood pressure
596919|NCT01030003|Sleep-Disordered Breathing|sleep-disordered breathing
596920|NCT01030003|Snoring|snoring
596921|NCT01030003|Pregnancy|pregnancy
596922|NCT01030003|Fetal Growth Retardation|fetal growth retardation
596923|NCT01030003|Pre-Eclampsia|pre-eclampsia
596924|NCT01029990|participation|participation
596925|NCT01029990|mass screening|mass screening
596926|NCT01029990|cervical neoplasia|cervical neoplasia
596927|NCT01029990|health economics|health economics
596928|NCT01029990|cost-benefit|cost-benefit
596929|NCT01029964|Childhood obesity|childhood obesity
596930|NCT01029964|Age-dependent|age-dependent
596931|NCT01029964|Long-term treatment|long-term treatment
596932|NCT01029964|BMI SDS|bmi sds
596933|NCT01029964|Dropouts|dropouts
596934|NCT01029951|Chiropractic; osteopathic physicians; manipulation; neck pain; adverse effects; randomized clinical trial|chiropractic; osteopathic physicians; manipulation; neck pain; adverse effects; randomized clinical trial
596935|NCT01029951|Subacute non-specific neck pain|subacute non-specific neck pain
596936|NCT01029938|Intracranial aneurysms;|intracranial aneurysms;
596937|NCT01029938|Covered stent;|covered stent;
596938|NCT01029938|Coil embolization|coil embolization
596939|NCT01029925|metastatic breast cancer|metastatic breast cancer
596940|NCT01029925|lung cancer|lung cancer
596941|NCT01029925|Previously treated metastatic breast cancer|previously treated metastatic breast cancer
596942|NCT01029925|stage IIIb lung cancer|stage iiib lung cancer
596943|NCT01029925|stage IV lung cancer|stage iv lung cancer
596944|NCT01029912|Stroke|stroke
596945|NCT01029912|Hemiplegia|hemiplegia
596946|NCT01029912|Footdrop|footdrop
596947|NCT01029912|Electrical Stimulation|electrical stimulation
596948|NCT01029912|Motor Relearning|motor relearning
596949|NCT01029912|Neuroplasticity|neuroplasticity
596950|NCT01029899|Colonoscopy|colonoscopy
596951|NCT01029899|Force|force
596952|NCT01029899|Monitor|monitor
596953|NCT01029899|Endoscopist|endoscopist
596954|NCT01029899|Trainee|trainee
596955|NCT01029886|diabetes|diabetes
596956|NCT01029886|exenatide once weekly|exenatide once weekly
596957|NCT01029886|Byetta|byetta
596958|NCT01029886|liraglutide|liraglutide
596959|NCT01029886|Victoza|victoza
596960|NCT01029886|Amylin|amylin
596961|NCT01029886|Lilly|lilly
596962|NCT01029873|cancer|cancer
596963|NCT01029873|immunotherapy|immunotherapy
596964|NCT01029873|targeted|targeted
596965|NCT01029873|metastatic|metastatic
596966|NCT01029873|interleukin-2|interleukin-2
596967|NCT01029873|IL-2|il-2
596968|NCT01029873|Cisplatin|cisplatin
596969|NCT01029873|antitumor|antitumor
596970|NCT01029873|melanoma|melanoma
596972|NCT01029873|T-cell receptor|t-cell receptor
596974|NCT01029873|p53 gene|p53 gene
596975|NCT01029873|p53 tumor suppressor protein|p53 tumor suppressor protein
596976|NCT01029860|Hypertension|hypertension
596977|NCT01029860|Ambulatory measurement|ambulatory measurement
596978|NCT01029847|Patients with axial spondyloarthritis|patients with axial spondyloarthritis
596979|NCT01029834|BMI >85%for age and gender|bmi >85%for age and gender
596980|NCT01029821|Low-Molecular-Weight-Heparin|low-molecular-weight-heparin
596981|NCT01029821|Open Reduction and Internal Fixation|open reduction and internal fixation
596982|NCT01029821|Thromboprophylaxis|thromboprophylaxis
596983|NCT01029808|carriers of hemophilia|carriers of hemophilia
596984|NCT01029782|Cellulitis|cellulitis
596985|NCT01029782|Emergency Department|emergency department
596986|NCT01029782|Cefazolin|cefazolin
596987|NCT01029782|Probenecid|probenecid
596988|NCT01029782|Cephalexin|cephalexin
596989|NCT01029756|Pentax Airway Scope AWS S100|pentax airway scope aws s100
596990|NCT01029756|Pentax AWS|pentax aws
596991|NCT01029756|Macintosh|macintosh
596992|NCT01029756|Laryngoscope|laryngoscope
596993|NCT01029756|Video Laryngoscope|video laryngoscope
596994|NCT01029743|TKR (Total Knee Replacement)|tkr (total knee replacement)
596995|NCT01029743|THR (Total Hip Replacement)|thr (total hip replacement)
758480|NCT00410761|MTC|mtc
596996|NCT01029743|VTE (Venous Thromboembolism)|vte (venous thromboembolism)
596997|NCT01029743|LMWH (Low Molecular Weight Heparin)|lmwh (low molecular weight heparin)
596998|NCT01029743|VKA (Vitamin K antagonist)|vka (vitamin k antagonist)
596999|NCT01029730|Low grade lymphoma|low grade lymphoma
597000|NCT01029730|Previously untreated lymphoma|previously untreated lymphoma
597001|NCT01029730|Lymphoma first line|lymphoma first line
597002|NCT01029730|bendamustine|bendamustine
597003|NCT01029730|Treanda|treanda
597004|NCT01029730|bortezomib|bortezomib
597005|NCT01029730|Velcade|velcade
597006|NCT01029730|rituximab|rituximab
597007|NCT01029730|Rituxan|rituxan
597008|NCT01029717|Central Venous Catheters|central venous catheters
597009|NCT01029717|blood stream infection|blood stream infection
597010|NCT01029717|children, intensive care|children, intensive care
597011|NCT01029717|Heparin bonded|heparin bonded
597012|NCT01029717|antibiotic coated|antibiotic coated
597013|NCT01029717|Children in Paediatric Intensive Care Unit|children in paediatric intensive care unit
597014|NCT01029704|Diabetes Mellitus Type 2|diabetes mellitus type 2
597015|NCT01029691|Sleep disordered breathing|sleep disordered breathing
597016|NCT01029691|Preeclampsia|preeclampsia
597017|NCT01029691|Positive Airway Pressure|positive airway pressure
597018|NCT01029678|Locally advanced lung cancer|locally advanced lung cancer
597019|NCT01029678|Elderly patients|elderly patients
597020|NCT01029678|NSCLC|nsclc
597021|NCT01029665|Hernia, Diaphragmatic|hernia, diaphragmatic
597022|NCT01029665|Asthma|asthma
597023|NCT01029665|Feeding and Eating Disorders of Childhood|feeding and eating disorders of childhood
597024|NCT01029665|Growth & Development|growth & development
597025|NCT01029652|frequent flares|frequent flares
597026|NCT01029652|gout|gout
597027|NCT01029652|anti-interleukin-1β monoclonal antibody|anti-interleukin-1β monoclonal antibody
597028|NCT01029639|Pulsatile intravenous insulin|pulsatile intravenous insulin
597029|NCT01029639|Oral carbohydrate loading|oral carbohydrate loading
597030|NCT01029639|Respiratory Quotients|respiratory quotients
597031|NCT01029639|Hypoglycemia|hypoglycemia
597032|NCT01029639|Diabetes Mellitus, with complications|diabetes mellitus, with complications
597033|NCT01029600|Randomized study capsulotomy vs distention with steroid|randomized study capsulotomy vs distention with steroid
597034|NCT01029587|CAPS|caps
597035|NCT01029587|Kidney transplant|kidney transplant
597036|NCT01029587|Renal transplant|renal transplant
597037|NCT01029587|Catastrophic Antiphospholipid Antibody Syndrome|catastrophic antiphospholipid antibody syndrome
597038|NCT01029574|Rotator cuff lesions|rotator cuff lesions
597039|NCT01029574|Platelet rich plasma|platelet rich plasma
597040|NCT01029574|Arthroscopic repair|arthroscopic repair
597041|NCT01029561|Metabolic syndrome|metabolic syndrome
597042|NCT01029561|Insulin Resistance|insulin resistance
597043|NCT01029561|Adipokines|adipokines
597044|NCT01029561|Proinflammatory markers|proinflammatory markers
597045|NCT01029561|Obstructive Sleep Apnea Syndrome|obstructive sleep apnea syndrome
597046|NCT01029561|Continuous Positive Airway Pressure|continuous positive airway pressure
597047|NCT01029561|Obesity|obesity
597048|NCT01029561|Bariatric surgery|bariatric surgery
597049|NCT01029548|HIV|hiv
597050|NCT01029548|Therapeutic Vaccine|therapeutic vaccine
597051|NCT01029522|Dyslipidemia|dyslipidemia
597052|NCT01029509|Advanced Leukemia|advanced leukemia
597053|NCT01029509|Acute myeloid leukemia|acute myeloid leukemia
597054|NCT01029509|ALL|all
597055|NCT01029509|Chronic myeloid leukemia blast crisis|chronic myeloid leukemia blast crisis
597056|NCT01029509|CMS|cms
597057|NCT01029509|Acute lymphocytic leukemia|acute lymphocytic leukemia
597058|NCT01029509|Chronic lymphocytic leukemia|chronic lymphocytic leukemia
597059|NCT01029509|Myelodysplastic syndromes|myelodysplastic syndromes
597060|NCT01029509|MDS|mds
597061|NCT01029509|OPB 31121|opb 31121
597062|NCT01029496|umbilical CORD CLAMPING|umbilical cord clamping
597063|NCT01029496|Neonatal anemia|neonatal anemia
597064|NCT01029496|Omphalitis|omphalitis
597065|NCT01029483|Obesity|obesity
597066|NCT01029483|Weight loss|weight loss
597067|NCT01029483|low carbohydrate diets|low carbohydrate diets
597068|NCT01029483|high complex carbohydrate diets|high complex carbohydrate diets
597069|NCT01029483|Healthy adults|healthy adults
597070|NCT01029483|Body composition|body composition
597071|NCT01029483|Energy Expenditure|energy expenditure
597072|NCT01029470|Luveris|luveris
597073|NCT01029470|hyporesponse|hyporesponse
597074|NCT01029470|pituitary downregulation|pituitary downregulation
597075|NCT01029470|IVF|ivf
597076|NCT01029470|Infertility women|infertility women
597077|NCT01029444|Diabetes|diabetes
597078|NCT01029444|Pulsatile intravenous insulin|pulsatile intravenous insulin
597079|NCT01029444|Oral carbohydrate loading|oral carbohydrate loading
597080|NCT01029444|Respiratory Quotients|respiratory quotients
597081|NCT01029444|Hypoglycemia|hypoglycemia
597082|NCT01029444|Hyperglycemia|hyperglycemia
597083|NCT01029444|Diabetes Mellitus, with complications|diabetes mellitus, with complications
597084|NCT01029431|intubating laryngeal airway|intubating laryngeal airway
597085|NCT01029431|pediatric|pediatric
597086|NCT01029418|HCC|hcc
597087|NCT01029418|hepatocellular carcinoma|hepatocellular carcinoma
597088|NCT01029418|liver cancer|liver cancer
597089|NCT01029405|Topical|topical
597090|NCT01029405|Plaque type psoriasis|plaque type psoriasis
597091|NCT01029392|Diabetes|diabetes
597092|NCT01029392|Type I|type i
597093|NCT01029392|Newly Diagnosis Type I Diabetes Mellitus|newly diagnosis type i diabetes mellitus
597094|NCT01029379|propofol|propofol
597095|NCT01029379|depth of anesthesia|depth of anesthesia
597096|NCT01029379|pharmacogenetics|pharmacogenetics
597097|NCT01029379|Depth of anesthesia in correlation to plasma concentrations of propofol|depth of anesthesia in correlation to plasma concentrations of propofol
597098|NCT01029353|NICHD Neonatal Research Network|nichd neonatal research network
597099|NCT01029353|Very Low Birth Weight (VLBW)|very low birth weight (vlbw)
597100|NCT01029353|Extremely Low Birth Weight (ELBW)|extremely low birth weight (elbw)
597101|NCT01029353|Prematurity|prematurity
597102|NCT01029353|Laparotomy|laparotomy
597103|NCT01029353|Drainage|drainage
597104|NCT01029353|Isolated intestinal perforation|isolated intestinal perforation
597105|NCT01029353|Focal intestinal perforation|focal intestinal perforation
597106|NCT01029340|Hemophilia A|hemophilia a
597107|NCT01029340|Factor VIII|factor viii
597108|NCT01029340|Prophylaxis|prophylaxis
597109|NCT01029314|Thermometry|thermometry
597110|NCT01029301|Skin aging|skin aging
597111|NCT01029301|Skin Wrinkling|skin wrinkling
597112|NCT01029288|Diabetes|diabetes
597113|NCT01029288|Decision aid|decision aid
597114|NCT01029288|Cardiovascular risk|cardiovascular risk
597115|NCT01029288|Patient education|patient education
597116|NCT01029275|Acromegaly|acromegaly
597117|NCT01029275|pituitary adenoma|pituitary adenoma
597118|NCT01029275|octreotide|octreotide
597119|NCT01029275|transsphenoïdal surgery|transsphenoïdal surgery
597120|NCT01029275|GH|gh
597121|NCT01029275|IGF-1|igf-1
597122|NCT01029262|Myelodysplastic Syndromes|myelodysplastic syndromes
597123|NCT01029262|MDS|mds
597124|NCT01029262|transfusion dependent anemia|transfusion dependent anemia
597125|NCT01029262|Erythropoiesis stimulating agents|erythropoiesis stimulating agents
597126|NCT01029262|non-del 5q|non-del 5q
597127|NCT01029236|obesity|obesity
597128|NCT01029236|metabolism|metabolism
597129|NCT01029236|weight loss|weight loss
597130|NCT01029236|energy expenditure|energy expenditure
597131|NCT01029236|thermogenesis|thermogenesis
597132|NCT01029236|Metabolism-Boosting Beverages effect on REE|metabolism-boosting beverages effect on ree
597133|NCT01029236|Metabolism-Boosting Beverages effect on appetite|metabolism-boosting beverages effect on appetite
597134|NCT01029210|osteoporosis|osteoporosis
597135|NCT01029210|temporomandibular disorders|temporomandibular disorders
597136|NCT01029210|resonance magnetic|resonance magnetic
597137|NCT01029184|weaning|weaning
597138|NCT01029184|cereals|cereals
597139|NCT01029184|allergy|allergy
597140|NCT01029184|atopy|atopy
597141|NCT01029184|open allergenic test|open allergenic test
597142|NCT01029171|falls|falls
597143|NCT01029171|balance training|balance training
597144|NCT01029171|strength training|strength training
597145|NCT01029158|Healthy volunteers|healthy volunteers
597146|NCT01029158|Comparison of two formulations|comparison of two formulations
597147|NCT01029158|Improvement of scar appearance|improvement of scar appearance
597148|NCT01029145|Bipolar disorder|bipolar disorder
597149|NCT01029145|New occured episode: manic depressive or mixed|new occured episode: manic depressive or mixed
597150|NCT01029132|Alzheimer's disease|alzheimer's disease
597151|NCT01029132|Galantamine|galantamine
597152|NCT01029132|Treatment response|treatment response
597153|NCT01029132|Efficacy|efficacy
597154|NCT01029132|Adverse Event|adverse event
597155|NCT01029119|blood pressure|blood pressure
597156|NCT01029106|SUI|sui
597157|NCT01029106|Stress Urinary Incontinence|stress urinary incontinence
597158|NCT01029106|Patients with Stress Urinary Incontinence|patients with stress urinary incontinence
597159|NCT01029093|extremity with immobilisation|extremity with immobilisation
597160|NCT01029093|brain platicity|brain platicity
597161|NCT01029093|deprivation|deprivation
597162|NCT01029093|MRI|mri
597163|NCT01029080|Brain, blood flow|brain, blood flow
597164|NCT01029080|Measurement techniques, flow velocity waveform analysis|measurement techniques, flow velocity waveform analysis
597165|NCT01029080|Monitoring, intensive care|monitoring, intensive care
597166|NCT01029080|Sepsis|sepsis
597167|NCT01029080|transcranial doppler ultrasound (TCD)|transcranial doppler ultrasound (tcd)
597168|NCT01029080|Cerebrovascular autoregulation|cerebrovascular autoregulation
597169|NCT01029080|sepsis-associated delir|sepsis-associated delir
597170|NCT01029067|schizophrenia|schizophrenia
597171|NCT01029067|delusion|delusion
597172|NCT01029067|paranoia|paranoia
597173|NCT01029067|psychosis|psychosis
597174|NCT01029054|Multiple Myeloma|multiple myeloma
597175|NCT01029041|fibromyalgia, exercise, strength, stretch|fibromyalgia, exercise, strength, stretch
597176|NCT01029015|OAB|oab
597177|NCT01029015|Insomnia|insomnia
597178|NCT01029015|Bladder function|bladder function
597179|NCT01029015|cystometry|cystometry
597180|NCT01029015|polysomnography|polysomnography
597181|NCT01029002|Vitamin D|vitamin d
597182|NCT01029002|CKD|ckd
597183|NCT01029002|proteinuria|proteinuria
597184|NCT01028989|Polycystic Ovary Syndrome|polycystic ovary syndrome
597185|NCT01028989|Insulin|insulin
597186|NCT01028989|Diet|diet
597187|NCT01028989|Glycemic Load|glycemic load
597188|NCT01028976|randomized controlled trial|randomized controlled trial
597189|NCT01028976|primary prevention|primary prevention
597190|NCT01028976|Vitamin C|vitamin c
597191|NCT01028976|Antioxidants|antioxidants
597192|NCT01028976|C-reactive protein|c-reactive protein
597193|NCT01028976|inflammation|inflammation
597194|NCT01028976|anti-inflammatory agents|anti-inflammatory agents
597195|NCT01028976|obesity|obesity
597196|NCT01028950|YM150|ym150
597197|NCT01028950|Bleeding|bleeding
597198|NCT01028950|VTE|vte
597199|NCT01028950|FXa inhibitor|fxa inhibitor
597200|NCT01028950|Deep Vein Thrombosis|deep vein thrombosis
597201|NCT01028950|Venous thromboembolism|venous thromboembolism
597202|NCT01028937|Hyperopia correction|hyperopia correction
597203|NCT01028937|Laser vision correction|laser vision correction
597204|NCT01028937|Optimal keratoplasty|optimal keratoplasty
597205|NCT01028924|Thorough QTc-Study|thorough qtc-study
597206|NCT01028924|Short Bowel Syndrome|short bowel syndrome
597207|NCT01028924|Cardiac safety|cardiac safety
597208|NCT01028911|Phase 1 Alzheimer's disease Safety Tolerability Pharmacokinetics|phase 1 alzheimer's disease safety tolerability pharmacokinetics
597209|NCT01028898|IBS|ibs
597210|NCT01028898|proteomics|proteomics
597211|NCT01028898|fluorescent quantitation polymerase chain reaction|fluorescent quantitation polymerase chain reaction
597212|NCT01028898|Western blot|western blot
597213|NCT01028898|immunohistochemistry staining (IHC)|immunohistochemistry staining (ihc)
597214|NCT01028898|ATP content|atp content
597215|NCT01028898|micRNA|micrna
597216|NCT01028872|higher-order aberrations, contrast sensitivity|higher-order aberrations, contrast sensitivity
597217|NCT01028859|Tubulin polymerization inhibitor|tubulin polymerization inhibitor
597218|NCT01028859|CKD-516|ckd-516
597219|NCT01028859|Phase I|phase i
597220|NCT01028859|Vascular disrupting agent|vascular disrupting agent
597221|NCT01028859|DCE MRI|dce mri
597222|NCT01028846|Type 2 Diabetes|type 2 diabetes
597223|NCT01028833|power wheelchairs|power wheelchairs
597224|NCT01028833|power mobility|power mobility
597225|NCT01028833|young children|young children
597226|NCT01028820|autism|autism
597227|NCT01028820|asperger's|asperger's
597228|NCT01028820|repetitive|repetitive
597229|NCT01028820|restricted|restricted
597230|NCT01028820|compulsions|compulsions
597231|NCT01028807|Early feeding|early feeding
597232|NCT01028807|Bowel anastomosis|bowel anastomosis
597233|NCT01028807|Children|children
597234|NCT01028794|stroke|stroke
597235|NCT01028794|bone marrow|bone marrow
597236|NCT01028794|mononuclear cell|mononuclear cell
597237|NCT01028794|angiogenesis|angiogenesis
597238|NCT01028794|neurogenesis|neurogenesis
597239|NCT01028768|Renal impairment|renal impairment
597240|NCT01028768|Renal impairment study|renal impairment study
597241|NCT01028755|Maximum Tolerated Dose|maximum tolerated dose
597242|NCT01028742|Traumatic brain injury|traumatic brain injury
597243|NCT01028742|Hypopituitarism|hypopituitarism
597244|NCT01028742|Incidence|incidence
597245|NCT01028703|Chronic kidney disease|chronic kidney disease
597246|NCT01028703|left ventricular dysfunction|left ventricular dysfunction
597247|NCT01028703|diastolic dysfunction|diastolic dysfunction
597248|NCT01028703|hypertension|hypertension
597249|NCT01028690|Helicobacter pylori|helicobacter pylori
597250|NCT01028690|Eradication therapy|eradication therapy
597251|NCT01028690|Lactobacillus reuteri|lactobacillus reuteri
597252|NCT01028690|Dyspeptic symptoms|dyspeptic symptoms
597253|NCT01028677|oxytocin|oxytocin
597254|NCT01028677|social cognition|social cognition
597255|NCT01028677|social skill|social skill
597256|NCT01028677|social functioning|social functioning
597257|NCT01028677|paranoia|paranoia
597258|NCT01028677|psychotic symptoms|psychotic symptoms
597259|NCT01028677|schizophrenia|schizophrenia
597260|NCT01028677|social deficits|social deficits
597261|NCT01028677|intranasal administration|intranasal administration
597262|NCT01028664|Glaucoma and ocular hypertension patients|glaucoma and ocular hypertension patients
597263|NCT01028651|PAH|pah
597264|NCT01028651|Pulmonary Hypertension|pulmonary hypertension
597265|NCT01028651|Remodulin|remodulin
597266|NCT01028651|Treprostinil|treprostinil
597267|NCT01028651|Quality of Life|quality of life
597268|NCT01028638|VEGF imaging|vegf imaging
597269|NCT01028638|everolimus|everolimus
597270|NCT01028638|renal cell carcinoma|renal cell carcinoma
597272|NCT01028638|bevacizumab|bevacizumab
597273|NCT01028625|Heart failure|heart failure
597274|NCT01028625|Depression|depression
597275|NCT01028625|Self Care|self care
597276|NCT01028625|Cognitive behavior therapy|cognitive behavior therapy
597277|NCT01028599|Heart transplantation|heart transplantation
597278|NCT01028599|Exercise capacity|exercise capacity
597279|NCT01028599|Endothelial function|endothelial function
597280|NCT01028573|bowel preparation|bowel preparation
597281|NCT01028573|colonoscopy|colonoscopy
597282|NCT01028560|Wheezing|wheezing
597283|NCT01028560|Asthma|asthma
597284|NCT01028560|Allergy|allergy
597285|NCT01028560|Immunotherapy|immunotherapy
597286|NCT01028547|PONV|ponv
597287|NCT01028534|Continuous positive pressure ventilation|continuous positive pressure ventilation
597288|NCT01028534|Blood pressure|blood pressure
597289|NCT01028534|Oxygen desaturation index|oxygen desaturation index
597290|NCT01028534|Endothelial dysfunction|endothelial dysfunction
597291|NCT01028534|Patient reported measurement|patient reported measurement
597292|NCT01028521|First time in man, safety study, Cm3.1-AC100|first time in man, safety study, cm3.1-ac100
597293|NCT01028521|Male volunteer aged 18 to 50 years at Screening|male volunteer aged 18 to 50 years at screening
597294|NCT01028508|Depression|depression
597295|NCT01028508|ECT|ect
597296|NCT01028508|electroconvulsive therapy|electroconvulsive therapy
597297|NCT01028508|mood disorders|mood disorders
597298|NCT01028508|continuation ECT|continuation ect
597299|NCT01028508|continuation pharmacotherapy|continuation pharmacotherapy
597300|NCT01028508|geriatric|geriatric
597301|NCT01028508|elderly|elderly
597302|NCT01028508|lithium|lithium
597303|NCT01028508|venlafaxine|venlafaxine
597304|NCT01028495|AKT-1|akt-1
597305|NCT01028482|severity of depression measured by MADRS and CGI|severity of depression measured by madrs and cgi
597306|NCT01028456|Seizures|seizures
597307|NCT01028456|Light Therapy|light therapy
597308|NCT01028430|Chronic Lymphocytic Leukemia|chronic lymphocytic leukemia
597309|NCT01028417|subcentimetre nodules|subcentimetre nodules
597310|NCT01028365|Fertility|fertility
597311|NCT01028365|Trying to Conceive|trying to conceive
597312|NCT01028365|Trying to Get Pregnant|trying to get pregnant
597313|NCT01028365|Pregnancy|pregnancy
597314|NCT01028339|traumatic brain injury|traumatic brain injury
597315|NCT01028339|PtiO2|ptio2
597316|NCT01028339|Cerebral microdialysis|cerebral microdialysis
597317|NCT01028339|Osmotherapy|osmotherapy
597318|NCT01028339|hypertonic saline|hypertonic saline
597319|NCT01028339|mannitol|mannitol
597320|NCT01028326|Pneumococcal pneumonia vaccine|pneumococcal pneumonia vaccine
597321|NCT01028313|Chronic Graft-Versus-Host Disease|chronic graft-versus-host disease
597322|NCT01028313|GVHD|gvhd
597323|NCT01028313|LBH589|lbh589
597324|NCT01028313|Panobinostat|panobinostat
597325|NCT01028300|DDD|ddd
597326|NCT01028287|Diabetic Nephropathy|diabetic nephropathy
597327|NCT01028287|Nephrotic syndrome|nephrotic syndrome
597328|NCT01028274|Hypercholesterolemia|hypercholesterolemia
597329|NCT01028274|Hypertriglyceridemia|hypertriglyceridemia
597330|NCT01028274|Fish Oil|fish oil
597331|NCT01028274|Red Yeast Rice|red yeast rice
597332|NCT01028261|Obese|obese
597333|NCT01028261|Obesity|obesity
597334|NCT01028261|Overweight|overweight
597335|NCT01028248|Central Retinal Vein Occlusion|central retinal vein occlusion
597336|NCT01028248|Retinal Vein Occlusive disease|retinal vein occlusive disease
597337|NCT01028235|Eosinophilic Esophagitis|eosinophilic esophagitis
597338|NCT01028222|Melanoma|melanoma
597339|NCT01028222|AMN107|amn107
597340|NCT01028222|c-Kit|c-kit
597341|NCT01028222|c-Kit mutated metastatic and/or inoperable melanoma|c-kit mutated metastatic and/or inoperable melanoma
597342|NCT01028196|schizophrenia|schizophrenia
597343|NCT01028196|schizoaffective disorder|schizoaffective disorder
597344|NCT01028196|recurrent depression|recurrent depression
597345|NCT01028196|Bipolar disorders|bipolar disorders
597346|NCT01028183|therapeutics|therapeutics
597347|NCT01028183|safety|safety
597348|NCT01028183|maternal|maternal
597349|NCT01028183|neonatal|neonatal
597350|NCT01028170|Congestive Heart Failure|congestive heart failure
597351|NCT01028170|Renal Insufficiency|renal insufficiency
597352|NCT01028170|Cardio-renal Syndrome|cardio-renal syndrome
597353|NCT01028157|HIV|hiv
597354|NCT01028157|risk reduction|risk reduction
597355|NCT01028157|behavioral intervention|behavioral intervention
597356|NCT01028144|Exercise|exercise
597357|NCT01028144|Physical Activity|physical activity
597358|NCT01028144|Adolescent|adolescent
597359|NCT01028144|Minority Health|minority health
597360|NCT01028131|cigarette smoking|cigarette smoking
597361|NCT01028131|pregnancy|pregnancy
597362|NCT01028131|intervention|intervention
597363|NCT01028131|efficacy|efficacy
597364|NCT01028131|Motivational Interviewing|motivational interviewing
597365|NCT01028131|Contingency Management|contingency management
597366|NCT01028118|domestic and sexual violence|domestic and sexual violence
597367|NCT01028118|menopause|menopause
597368|NCT01028118|professional improvement|professional improvement
597369|NCT01028118|social support network|social support network
597370|NCT01028105|Preoperative screening|preoperative screening
597371|NCT01028105|MRSA|mrsa
597372|NCT01028105|Incidence|incidence
597373|NCT01028105|Postoperative infection|postoperative infection
597374|NCT01028105|Preoperative MRSA Screening Incidence|preoperative mrsa screening incidence
597375|NCT01028105|Postoperative MRSA Infection Rate|postoperative mrsa infection rate
597376|NCT01028079|Back Pain|back pain
597377|NCT01028079|Acute low back pain|acute low back pain
597378|NCT01028066|nutritional intervention|nutritional intervention
597379|NCT01028066|nutritional counseling|nutritional counseling
597380|NCT01028066|feeding behavior|feeding behavior
597381|NCT01028066|food consumption|food consumption
597382|NCT01028066|angioplasty|angioplasty
597383|NCT01028053|Mild Cognitive Impairment|mild cognitive impairment
597384|NCT01028053|Positron Emission Tomography|positron emission tomography
597385|NCT01028053|National Institute of Neurological and Communicative Disorders and Stroke|national institute of neurological and communicative disorders and stroke
597386|NCT01028053|Alzheimer's Disease and Related Disorders Association|alzheimer's disease and related disorders association
597387|NCT01028053|Assess Prognostic Usefulness of Flutemetamol Injection for Identifying Subjects who will Convert to Clinically Probable Alzheimer's Disease|assess prognostic usefulness of flutemetamol injection for identifying subjects who will convert to clinically probable alzheimer's disease
597388|NCT01028040|Phase I|phase i
597389|NCT01028040|AZD3043|azd3043
597390|NCT01028040|Japanese healthy volunteer|japanese healthy volunteer
597391|NCT01028027|Blepharokeratoconjunctivitis|blepharokeratoconjunctivitis
597392|NCT01027988|Retinal Microvascularisation|retinal microvascularisation
597393|NCT01027988|Fundus|fundus
597394|NCT01027988|mfERGs|mfergs
597395|NCT01027988|CHF|chf
597396|NCT01027988|Cardiovascular Disease|cardiovascular disease
597397|NCT01027988|Coronarography|coronarography
597398|NCT01027988|Macrovascularisation|macrovascularisation
597399|NCT01027988|The objectives are to assess if if any retinal vascular disorder in arterioles and venules can be predictive for cardiovascular morbidity and mortality|the objectives are to assess if if any retinal vascular disorder in arterioles and venules can be predictive for cardiovascular morbidity and mortality
597400|NCT01027975|laparoscopy|laparoscopy
597401|NCT01027975|fundoplication|fundoplication
597402|NCT01027975|Nissen|nissen
597403|NCT01027975|Thal|thal
597404|NCT01027975|children|children
597405|NCT01027975|operative treatment of gastro-oesophageal reflux disease in children|operative treatment of gastro-oesophageal reflux disease in children
597406|NCT01027962|Early Onset Psychosis|early onset psychosis
597407|NCT01027962|Laptop Computer|laptop computer
597408|NCT01027962|Brain Training|brain training
597409|NCT01027936|Healthy Volunteers|healthy volunteers
597410|NCT01027910|PCI-24781|pci-24781
597411|NCT01027910|doxorubicin|doxorubicin
597412|NCT01027897|Pharmacokinetics|pharmacokinetics
597413|NCT01027897|Pharmacodynamics|pharmacodynamics
597414|NCT01027897|Doripenem|doripenem
597415|NCT01027897|Trauma|trauma
597416|NCT01027897|sepsis|sepsis
597417|NCT01027897|Trauma patients with sepsis|trauma patients with sepsis
597418|NCT01027884|Idebenone|idebenone
597419|NCT01027884|Duchenne Muscular Dystrophy (DMD)|duchenne muscular dystrophy (dmd)
597420|NCT01027884|Respiratory function|respiratory function
597421|NCT01027884|Ambulatory and non-ambulatory patients|ambulatory and non-ambulatory patients
597422|NCT01027884|Subjects not using glucocorticoids|subjects not using glucocorticoids
597423|NCT01027858|exercise|exercise
597424|NCT01027858|aerobic exercise training|aerobic exercise training
597425|NCT01027858|vascular cognitive impairment|vascular cognitive impairment
597426|NCT01027858|Mild Sub-cortical Ischaemic Vascular Cognitive Impairment (SIVCI)|mild sub-cortical ischaemic vascular cognitive impairment (sivci)
597427|NCT01027845|Pneumococcal disease|pneumococcal disease
597428|NCT01027845|Immunogenicity|immunogenicity
597429|NCT01027845|Booster vaccination|booster vaccination
597430|NCT01027845|Pneumococcal vaccine|pneumococcal vaccine
597431|NCT01027845|Primary vaccination|primary vaccination
597432|NCT01027845|Safety|safety
597433|NCT01027832|tracheobronchitis|tracheobronchitis
597434|NCT01027819|Total knee arthroplasty|total knee arthroplasty
597435|NCT01027819|Mobile bearing|mobile bearing
597436|NCT01027819|Fixed bearing|fixed bearing
597437|NCT01027819|Range of motion|range of motion
597438|NCT01027819|Knee Society Score|knee society score
597439|NCT01027806|Children|children
597440|NCT01027806|Sleep|sleep
597441|NCT01027806|Obstructive Sleep Apnea|obstructive sleep apnea
597442|NCT01027793|Stretch marks|stretch marks
597443|NCT01027793|Striae|striae
597444|NCT01027793|Tretinoin|tretinoin
597445|NCT01027793|Superficial dermabrasion|superficial dermabrasion
597446|NCT01027780|Mindfulness-Based Stress Reduction|mindfulness-based stress reduction
597447|NCT01027780|MBSR|mbsr
597448|NCT01027780|Seniors|seniors
597449|NCT01027780|immune system|immune system
597450|NCT01027780|keyhole limpet hemocyanin (KLH)|keyhole limpet hemocyanin (klh)
597451|NCT01027767|Breast|breast
597452|NCT01027767|MBI|mbi
597453|NCT01027767|Molecular|molecular
597454|NCT01027767|Molecular Breast Imaging|molecular breast imaging
597455|NCT01027767|Dense breast tissue|dense breast tissue
597456|NCT01027767|Surgery|surgery
597457|NCT01027767|Radiation|radiation
597458|NCT01027767|BCT|bct
597459|NCT01027754|methadone maintenance|methadone maintenance
597460|NCT01027715|Neonatal Seizures|neonatal seizures
597461|NCT01027715|Neonatal encephalopathy|neonatal encephalopathy
597462|NCT01027702|Donor Lymphocyte Infusion|donor lymphocyte infusion
597463|NCT01027702|Immune Recovery|immune recovery
597464|NCT01027702|T cell depleted transplant|t cell depleted transplant
597465|NCT01027702|Mismatched related donor transplants|mismatched related donor transplants
597466|NCT01027702|Unrelated donor transplants|unrelated donor transplants
597467|NCT01027689|alprazolam|alprazolam
597468|NCT01027689|bioequivalence|bioequivalence
597469|NCT01027689|sublingual|sublingual
597470|NCT01027676|Gefitinib|gefitinib
597471|NCT01027676|Vorinostat|vorinostat
597472|NCT01027663|anemia|anemia
597473|NCT01027663|malaria|malaria
597474|NCT01027637|breast reconstruction|breast reconstruction
597475|NCT01027637|tissue expander|tissue expander
597476|NCT01027637|Alloderm|alloderm
597477|NCT01027637|tissue matrix|tissue matrix
597478|NCT01027624|Pan South African Survey on the Undertreatment of Hypercholesterolaemia|pan south african survey on the undertreatment of hypercholesterolaemia
597479|NCT01027611|Effectiveness of topical pain medicine for control of pain associated with intravitreal injections|effectiveness of topical pain medicine for control of pain associated with intravitreal injections
597480|NCT01027611|Eye discomfort|eye discomfort
597481|NCT01027598|Lung Cancer|lung cancer
597482|NCT01027598|Previously Treated Advanced Non Small Cell Lung Cancer|previously treated advanced non small cell lung cancer
597483|NCT01027598|Erlotinib|erlotinib
597484|NCT01027598|Pazopanib|pazopanib
597485|NCT01027572|Vegetative state|vegetative state
597486|NCT01027572|Minimally conscious state|minimally conscious state
597487|NCT01027572|Thalamic stimulation|thalamic stimulation
597488|NCT01027559|Major Depression|major depression
597489|NCT01027559|Functional Magnetic Resonance Imaging|functional magnetic resonance imaging
597490|NCT01027559|Emotional Circuitry|emotional circuitry
597491|NCT01027559|Cognitive Behavioral Therapy|cognitive behavioral therapy
597492|NCT01027546|perioperative blood loss, spinal surgery|perioperative blood loss, spinal surgery
597493|NCT01027533|multifocal intraocular lens|multifocal intraocular lens
597494|NCT01027533|visual acuity|visual acuity
597495|NCT01027533|presbiopia|presbiopia
597496|NCT01027520|Hand burn|hand burn
597497|NCT01027520|skin graft|skin graft
597498|NCT01027520|coban dressing|coban dressing
597499|NCT01027520|range of motion|range of motion
597500|NCT01027494|ear tubes|ear tubes
597501|NCT01027494|ear drainage|ear drainage
597502|NCT01027494|ear infection|ear infection
597503|NCT01027494|ear drops|ear drops
597504|NCT01027494|tympanostomy tubes|tympanostomy tubes
597505|NCT01027481|lucentis, macular edema, branch retinal vein occlusion|lucentis, macular edema, branch retinal vein occlusion
597506|NCT01027468|bevacizumab, choroidal neovascularization|bevacizumab, choroidal neovascularization
597507|NCT01027442|Stereolithography|stereolithography
597508|NCT01027442|Dental implants,|dental implants,
597509|NCT01027442|Prosthetics|prosthetics
597510|NCT01027442|positioning-errors|positioning-errors
597511|NCT01027442|logistic regression analysis|logistic regression analysis
597512|NCT01027429|infant|infant
597513|NCT01027429|newborn|newborn
597514|NCT01027429|sepsis|sepsis
597515|NCT01027429|infection|infection
597516|NCT01027429|community|community
597517|NCT01027416|ER positive|er positive
597518|NCT01027416|Tamoxifen|tamoxifen
597519|NCT01027403|Heart failure|heart failure
597520|NCT01027403|Adult stem cells|adult stem cells
597521|NCT01027403|Circulating stem cells|circulating stem cells
597522|NCT01027403|Acute decompensated heart failure|acute decompensated heart failure
597523|NCT01027390|neck/shoulder|neck/shoulder
597524|NCT01027351|Children|children
597525|NCT01027351|Pre-school|pre-school
597526|NCT01027351|Meningococcal disease|meningococcal disease
597527|NCT01027351|Prevention|prevention
597528|NCT01027351|Vaccination|vaccination
597529|NCT01027325|Resistant Starch|resistant starch
597530|NCT01027325|Amylose|amylose
597531|NCT01027325|Amylopectin|amylopectin
597532|NCT01027325|LDL subclasses|ldl subclasses
597533|NCT01027325|Dietary carbohydrate|dietary carbohydrate
597534|NCT01027325|Postprandial insulinemia|postprandial insulinemia
597535|NCT01027312|Glaucoma|glaucoma
597536|NCT01027312|quality of life|quality of life
597537|NCT01027312|daily living activities|daily living activities
597538|NCT01027312|visual fields|visual fields
597539|NCT01027312|contrast sensitivity|contrast sensitivity
597540|NCT01027299|cardiac failure|cardiac failure
597541|NCT01027299|thoracic surgery|thoracic surgery
597542|NCT01027299|cardiac pacing, artificial|cardiac pacing, artificial
597543|NCT01027273|Stroke|stroke
597544|NCT01027273|Ischemic Stroke|ischemic stroke
597545|NCT01027273|Transient Ischemic Attack|transient ischemic attack
597546|NCT01027273|Stroke Recurrence Prevention|stroke recurrence prevention
597547|NCT01027273|Cerebrovascular Disorders|cerebrovascular disorders
597548|NCT01027273|Brain Ischemia|brain ischemia
597549|NCT01027273|Brain Infraction|brain infraction
597550|NCT01027273|Brain Diseases|brain diseases
597551|NCT01027273|Cerebral Infraction|cerebral infraction
597552|NCT01027273|Self-management|self-management
597553|NCT01027273|Peer-led|peer-led
597554|NCT01027273|Community Based|community based
597555|NCT01027247|Primary Glaucoma|primary glaucoma
597556|NCT01027234|Healthy volunteers|healthy volunteers
597557|NCT01027221|Low Dose Radiation|low dose radiation
597558|NCT01027221|pancreatic cancer|pancreatic cancer
597559|NCT01027221|Immunostimulation|immunostimulation
597560|NCT01027182|HIV|hiv
597561|NCT01027169|Hepatic impairment|hepatic impairment
597562|NCT01027169|Liver diseases|liver diseases
597563|NCT01027169|Pharmacokinetics|pharmacokinetics
597564|NCT01027169|To Investigate Pharmacokinetics of Safinamide in Subjects With Mild and Moderate Hepatic Impairment as Compared to Healthy Subjects With Normal Hepatic Function|to investigate pharmacokinetics of safinamide in subjects with mild and moderate hepatic impairment as compared to healthy subjects with normal hepatic function
597565|NCT01027156|Public Health|public health
597566|NCT01027156|Biochemistry|biochemistry
597567|NCT01027156|Ecological|ecological
597568|NCT01027143|Asthma|asthma
597569|NCT01027143|Obesity|obesity
597570|NCT01027143|Pharmacogenetics|pharmacogenetics
597571|NCT01027143|Nutrigenetics|nutrigenetics
597572|NCT01027117|Bioavailability|bioavailability
597573|NCT01027117|Revatio|revatio
597574|NCT01027117|Healthy Volunteers|healthy volunteers
597575|NCT01027104|injury prevention|injury prevention
597576|NCT01027104|firearms|firearms
597577|NCT01027104|training|training
597578|NCT01027104|counseling|counseling
597579|NCT01027104|medical education|medical education
597580|NCT01027104|safety|safety
597581|NCT01027104|anticipatory guidance|anticipatory guidance
597582|NCT01027104|Firearm injury prevention anticipatory guidance|firearm injury prevention anticipatory guidance
597583|NCT01027091|hypocalcemia|hypocalcemia
597584|NCT01027091|total thyroidectomy|total thyroidectomy
597585|NCT01027065|interleukin-7|interleukin-7
597586|NCT01027065|immune-based therapies|immune-based therapies
597587|NCT01027065|hepatitis B|hepatitis b
597588|NCT01027065|HBe negative|hbe negative
597589|NCT01027065|HBV vaccination|hbv vaccination
597590|NCT01027065|entecavir|entecavir
597591|NCT01027065|tenofovir|tenofovir
597592|NCT01027065|chronic hepatitis|chronic hepatitis
597593|NCT01027065|immune specific responses to HBV|immune specific responses to hbv
597594|NCT01027065|phase 1/2a|phase 1/2a
597595|NCT01027065|viral disease|viral disease
597596|NCT01027065|liver disease|liver disease
597598|NCT01027052|Spice|spice
597599|NCT01027039|primary open angle glaucoma|primary open angle glaucoma
597600|NCT01027039|pigmentary glaucoma|pigmentary glaucoma
597601|NCT01027039|exfoliative glaucoma|exfoliative glaucoma
597602|NCT01027039|angle closure glaucoma|angle closure glaucoma
597603|NCT01027039|low tension glaucoma|low tension glaucoma
597604|NCT01027026|Cost analysis|cost analysis
597605|NCT01027026|Safety|safety
597606|NCT01027026|Length of stay|length of stay
597607|NCT01027026|Randomized controlled trials|randomized controlled trials
597608|NCT01027026|Early discharge|early discharge
597609|NCT01027000|refractory chronic lymphocytic leukemia|refractory chronic lymphocytic leukemia
597610|NCT01027000|stage I chronic lymphocytic leukemia|stage i chronic lymphocytic leukemia
597611|NCT01027000|stage II chronic lymphocytic leukemia|stage ii chronic lymphocytic leukemia
597612|NCT01027000|stage III chronic lymphocytic leukemia|stage iii chronic lymphocytic leukemia
597613|NCT01027000|stage IV chronic lymphocytic leukemia|stage iv chronic lymphocytic leukemia
597614|NCT01027000|B-cell chronic lymphocytic leukemia|b-cell chronic lymphocytic leukemia
597615|NCT01027000|contiguous stage II small lymphocytic lymphoma|contiguous stage ii small lymphocytic lymphoma
597616|NCT01027000|noncontiguous stage II small lymphocytic lymphoma|noncontiguous stage ii small lymphocytic lymphoma
597617|NCT01027000|recurrent small lymphocytic lymphoma|recurrent small lymphocytic lymphoma
597618|NCT01027000|stage I small lymphocytic lymphoma|stage i small lymphocytic lymphoma
597619|NCT01027000|stage III small lymphocytic lymphoma|stage iii small lymphocytic lymphoma
597620|NCT01027000|stage IV small lymphocytic lymphoma|stage iv small lymphocytic lymphoma
597621|NCT01026974|Children|children
597622|NCT01026974|Pre-school|pre-school
597623|NCT01026974|Meningococcal disease|meningococcal disease
597624|NCT01026974|Prevention|prevention
597625|NCT01026974|Vaccination|vaccination
597626|NCT01026961|Safety|safety
597627|NCT01026961|heart rate|heart rate
597628|NCT01026961|systolic and diastolic blood pressure|systolic and diastolic blood pressure
597629|NCT01026961|arrhythmias|arrhythmias
597630|NCT01026948|Induction of labour|induction of labour
597631|NCT01026948|Intraprtum fetal monitoring|intraprtum fetal monitoring
597632|NCT01026935|open mesh repair|open mesh repair
597633|NCT01026935|sutured|sutured
597634|NCT01026935|non-sutured|non-sutured
597635|NCT01026935|pro-grip|pro-grip
597636|NCT01026935|postoperative pain|postoperative pain
597637|NCT01026922|antroduodenal manometry|antroduodenal manometry
597638|NCT01026922|gastric dysmotility|gastric dysmotility
597639|NCT01026922|intestinal dysmotility|intestinal dysmotility
597640|NCT01026883|hematocrit|hematocrit
597641|NCT01026883|layered resonant piezoelectric sensors|layered resonant piezoelectric sensors
597642|NCT01026844|erlotinib|erlotinib
597643|NCT01026844|tarceva|tarceva
597644|NCT01026844|hydroxychloroquine|hydroxychloroquine
597645|NCT01026844|NSCLC|nsclc
597646|NCT01026818|Erectile Dysfunction|erectile dysfunction
597647|NCT01026818|Radical Prostatectomy|radical prostatectomy
597648|NCT01026805|morcellator|morcellator
597649|NCT01026805|hysteroscope|hysteroscope
597650|NCT01026805|myomectomy|myomectomy
597651|NCT01026805|polypectomy|polypectomy
597652|NCT01026805|uterine fibroids|uterine fibroids
597653|NCT01026779|rotavirus|rotavirus
597654|NCT01026779|gastroenteritis|gastroenteritis
597655|NCT01026779|vaccine|vaccine
597656|NCT01026779|case-control study|case-control study
597657|NCT01026779|serotype|serotype
597658|NCT01026766|Hypothermia|hypothermia
597659|NCT01026766|Obesity|obesity
597660|NCT01026766|Heat and moisture exchanger|heat and moisture exchanger
597661|NCT01026766|Warming blanket|warming blanket
597662|NCT01026766|Warming fluids|warming fluids
597663|NCT01026766|Gynecological surgery|gynecological surgery
597664|NCT01026766|Intravenous anesthesia|intravenous anesthesia
597665|NCT01026766|Obese patients|obese patients
597666|NCT01026766|Non obese patients|non obese patients
597667|NCT01026753|colorectal cancer|colorectal cancer
597668|NCT01026753|screening|screening
597669|NCT01026753|fecal occult blood test|fecal occult blood test
597670|NCT01026753|randomized control trial|randomized control trial
597671|NCT01026753|primary care oncology|primary care oncology
597672|NCT01026753|web site|web site
597673|NCT01026753|provincial health contact center|provincial health contact center
597674|NCT01026740|Staphylococcal Skin Infections|staphylococcal skin infections
597675|NCT01026740|Streptococcal Infections|streptococcal infections
597676|NCT01026727|HIV Infections|hiv infections
597677|NCT01026727|Acquired Immunodeficiency Syndrome|acquired immunodeficiency syndrome
597678|NCT01026727|Virus Diseases|virus diseases
597679|NCT01026727|Sexually Transmitted Diseases, Viral|sexually transmitted diseases, viral
597680|NCT01026727|RNA Virus Infections|rna virus infections
597681|NCT01026727|Slow Virus Diseases|slow virus diseases
597682|NCT01026727|Immune System Diseases|immune system diseases
597683|NCT01026727|Sexually Transmitted Diseases|sexually transmitted diseases
597684|NCT01026727|Lentivirus Infections|lentivirus infections
597685|NCT01026727|Infection|infection
597686|NCT01026727|Retroviridae Infections|retroviridae infections
597687|NCT01026727|Immunologic Deficiency Syndromes|immunologic deficiency syndromes
597689|NCT01026727|treatment experienced|treatment experienced
597690|NCT01026727|bevirimat|bevirimat
597691|NCT01026701|Osteoblst effect|osteoblst effect
597692|NCT01026701|Velcade|velcade
597693|NCT01026701|Proteasome inhibitor|proteasome inhibitor
597694|NCT01026701|Bortezomib|bortezomib
597695|NCT01026701|Multjple Myeloma|multjple myeloma
597696|NCT01026688|Pragmatic randomized controlled trial|pragmatic randomized controlled trial
597697|NCT01026688|Cardiovascular risk reduction|cardiovascular risk reduction
597698|NCT01026688|Knowledge translation|knowledge translation
597699|NCT01026688|Clinical practice guidelines|clinical practice guidelines
597700|NCT01026662|Aesthetic dermatology|aesthetic dermatology
597701|NCT01026649|hematoma formation|hematoma formation
597702|NCT01026649|success rate|success rate
597703|NCT01026636|Staphylococcal Skin Infections|staphylococcal skin infections
597704|NCT01026636|Skin Infections|skin infections
597705|NCT01026636|Streptococcal Infections|streptococcal infections
597706|NCT01026610|Chronic hepatitis B|chronic hepatitis b
597707|NCT01026610|LB80380|lb80380
597708|NCT01026610|treatment-naive|treatment-naive
597709|NCT01026610|entecavir|entecavir
597710|NCT01026571|Bicuspid aortic valve|bicuspid aortic valve
597711|NCT01026558|Obesity, Ceftobiprole|obesity, ceftobiprole
597712|NCT01026558|Skin Infections|skin infections
597713|NCT01026558|Staphylococcal Skin Infections|staphylococcal skin infections
597714|NCT01026558|Bacterial Skin Infections|bacterial skin infections
597715|NCT01026558|Streptococcal Infection|streptococcal infection
597716|NCT01026545|safety|safety
597717|NCT01026545|tolerability|tolerability
597718|NCT01026545|pharmacokinetics|pharmacokinetics
597719|NCT01026545|multiple-dose|multiple-dose
597720|NCT01026545|macrolide|macrolide
597721|NCT01026506|c9,t11-CLA|c9,t11-cla
597722|NCT01026506|allergic bronchial asthma|allergic bronchial asthma
597723|NCT01026506|children and adolescents|children and adolescents
597724|NCT01026493|adult giant cell glioblastoma|adult giant cell glioblastoma
597725|NCT01026493|adult glioblastoma|adult glioblastoma
597726|NCT01026493|adult gliosarcoma|adult gliosarcoma
597727|NCT01026493|recurrent adult brain tumor|recurrent adult brain tumor
597728|NCT01026493|adult anaplastic astrocytoma|adult anaplastic astrocytoma
597729|NCT01026493|adult anaplastic ependymoma|adult anaplastic ependymoma
597730|NCT01026493|adult anaplastic oligodendroglioma|adult anaplastic oligodendroglioma
597731|NCT01026493|adult brain stem glioma|adult brain stem glioma
597732|NCT01026493|adult mixed glioma|adult mixed glioma
597733|NCT01026493|adult pineal gland astrocytoma|adult pineal gland astrocytoma
597734|NCT01026480|Ileal Pouch Anal Anastomosis|ileal pouch anal anastomosis
597735|NCT01026480|IPAA|ipaa
597736|NCT01026480|Pull through|pull through
597737|NCT01026480|IBD|ibd
597738|NCT01026480|Ulcerative colitis|ulcerative colitis
597739|NCT01026480|Familial adenomatous polyposis|familial adenomatous polyposis
597740|NCT01026480|FAP|fap
597741|NCT01026480|Hereditary nonpolyposis colorectal cancer|hereditary nonpolyposis colorectal cancer
597742|NCT01026480|HNPCC|hnpcc
597743|NCT01026454|HSV|hsv
597744|NCT01026454|HIV|hiv
597745|NCT01026441|Aesthetic|aesthetic
597746|NCT01026428|safinamide|safinamide
597747|NCT01026428|levodopa|levodopa
759366|NCT00407381|DME|dme
597748|NCT01026428|drug -drug interaction|drug -drug interaction
597749|NCT01026428|pharmacokinetics|pharmacokinetics
597750|NCT01026428|Patients diagnosed with idiopathic Parkinson's disease, levodopa-responsive, treated with a stable dose of levodopa/carbidopa|patients diagnosed with idiopathic parkinson's disease, levodopa-responsive, treated with a stable dose of levodopa/carbidopa
597751|NCT01026415|Antibody-Drug Conjugate|antibody-drug conjugate
597752|NCT01026415|Antigens, CD30|antigens, cd30
597753|NCT01026415|Disease, Hodgkin|disease, hodgkin
597754|NCT01026415|Lymphoma, Large-Cell, Anaplastic|lymphoma, large-cell, anaplastic
597755|NCT01026415|Lymphoma, Non-Hodgkin|lymphoma, non-hodgkin
597756|NCT01026415|monomethyl auristatin E|monomethyl auristatin e
597757|NCT01026415|Drug Therapy|drug therapy
597758|NCT01026415|Immunotherapy|immunotherapy
597759|NCT01026415|Hematologic Diseases|hematologic diseases
597760|NCT01026415|Lymphoma|lymphoma
597761|NCT01026415|Antibodies, Monoclonal|antibodies, monoclonal
597762|NCT01026402|Phase I|phase i
597763|NCT01026402|cancer|cancer
597764|NCT01026402|advanced solid malignancies|advanced solid malignancies
597765|NCT01026402|dose escalation|dose escalation
597766|NCT01026402|AZD2014|azd2014
597767|NCT01026402|mTor kinase inhibitor|mtor kinase inhibitor
597768|NCT01026402|safety|safety
597769|NCT01026402|pharmacokinetics|pharmacokinetics
597770|NCT01026389|MRA-Contrast agent comparison in peripheral disease|mra-contrast agent comparison in peripheral disease
597771|NCT01026376|Myelodysplastic Syndromes|myelodysplastic syndromes
597772|NCT01026376|Decitabine|decitabine
597773|NCT01026363|Vitamin D|vitamin d
597774|NCT01026363|Chronic Kidney Disease|chronic kidney disease
597775|NCT01026350|modulating immune response to flu antigen|modulating immune response to flu antigen
597776|NCT01026337|recurrent renal cell cancer|recurrent renal cell cancer
597777|NCT01026311|Coenzyme q10|coenzyme q10
597778|NCT01026311|statins|statins
597779|NCT01026311|myalgias|myalgias
597780|NCT01026311|anaerobic threshold|anaerobic threshold
597781|NCT01026311|athletic performance|athletic performance
597782|NCT01026298|asthma|asthma
597783|NCT01026298|obstructive sleep apnea|obstructive sleep apnea
597784|NCT01026298|severe asthma|severe asthma
597785|NCT01026298|OSA|osa
597786|NCT01026285|Risperdal Consta|risperdal consta
597787|NCT01026272|Endocannabinoid|endocannabinoid
597788|NCT01026272|Fish Oil|fish oil
597789|NCT01026272|Multiple Sclerosis|multiple sclerosis
597790|NCT01026272|Monocyte Migration|monocyte migration
597791|NCT01026259|Surgical site infection|surgical site infection
597792|NCT01026259|wound healing|wound healing
597793|NCT01026259|tissue oxygen|tissue oxygen
597794|NCT01026259|angiogenesis|angiogenesis
597795|NCT01026259|flow cytometry|flow cytometry
597796|NCT01026259|immunohistochemistry|immunohistochemistry
597797|NCT01026246|Ghana, malaria, vaccine, Plasmodium falciparum|ghana, malaria, vaccine, plasmodium falciparum
597798|NCT01026233|Antibodies, Monoclonal|antibodies, monoclonal
597799|NCT01026233|Antibody-Drug Conjugate|antibody-drug conjugate
597800|NCT01026233|Antigens, CD30|antigens, cd30
597801|NCT01026233|Disease, Hodgkin|disease, hodgkin
597802|NCT01026233|Drug Therapy|drug therapy
597803|NCT01026233|Hematologic Diseases|hematologic diseases
597804|NCT01026233|Immunotherapy|immunotherapy
597805|NCT01026233|Lymphoma|lymphoma
597806|NCT01026233|monomethylauristatin E|monomethylauristatin e
597807|NCT01026233|Lymphoma, Large-Cell, Anaplastic|lymphoma, large-cell, anaplastic
597808|NCT01026207|Diagnostic test|diagnostic test
597809|NCT01026207|polysomnography|polysomnography
597810|NCT01026207|Obstructive Sleep Apnea Syndrome|obstructive sleep apnea syndrome
597811|NCT01026207|Chronic Obstructive Pulmonary Disease|chronic obstructive pulmonary disease
597812|NCT01026194|insulin resistance|insulin resistance
597813|NCT01026155|Obese patients (BMI > 30 kg / m²)|obese patients (bmi > 30 kg / m²)
597814|NCT01026103|gastric bypass|gastric bypass
597815|NCT01026103|Gastric bypass surgery|gastric bypass surgery
597816|NCT01026077|Savella pregnant|savella pregnant
597817|NCT01026077|savella pregnancy|savella pregnancy
597818|NCT01026077|fibromyalgia pregnant|fibromyalgia pregnant
597819|NCT01026077|fibromyalgia pregnancy|fibromyalgia pregnancy
597820|NCT01026077|pregnancy registry savella|pregnancy registry savella
597821|NCT01026064|Macrolides|macrolides
597822|NCT01026064|Inflammation|inflammation
597823|NCT01026064|Azithromycin|azithromycin
597824|NCT01026064|Cantharidin induced skin blister model|cantharidin induced skin blister model
597825|NCT01026051|Cancer Vaccine, Immunotherapy, Melanoma|cancer vaccine, immunotherapy, melanoma
597826|NCT01026038|Pneumococcal vaccine 13-valent|pneumococcal vaccine 13-valent
597827|NCT01026025|lobectomy|lobectomy
597828|NCT01026025|segmentectomy|segmentectomy
597829|NCT01026025|pulmonary resection|pulmonary resection
597830|NCT01026012|Regadenoson|regadenoson
597831|NCT01026012|85% predicted heart rate|85% predicted heart rate
597832|NCT01026012|Myocardial perfusion stress testing|myocardial perfusion stress testing
597833|NCT01025999|RYGB|rygb
597834|NCT01025999|Gastrostomy tube|gastrostomy tube
597835|NCT01025999|DM|dm
597836|NCT01025999|Gastric Bypass|gastric bypass
597837|NCT01025960|colonoscopy|colonoscopy
597838|NCT01025960|adenoma detection|adenoma detection
597839|NCT01025960|polyps|polyps
597840|NCT01025947|Atrial fibrillation|atrial fibrillation
597841|NCT01025947|Cryptogenic stroke|cryptogenic stroke
597842|NCT01025947|Implantable loop recorder|implantable loop recorder
597843|NCT01025921|Tracheobronchitis|tracheobronchitis
597844|NCT01025921|pneumonia|pneumonia
597845|NCT01025921|inhaled antibiotics|inhaled antibiotics
597846|NCT01025921|colistin|colistin
597847|NCT01025921|Ventilator associated tracheobronchitis|ventilator associated tracheobronchitis
597848|NCT01025921|Ventilator associated pneumonia|ventilator associated pneumonia
597849|NCT01025908|psychotherapy|psychotherapy
597850|NCT01025908|panic disorder|panic disorder
597851|NCT01025908|anxiety|anxiety
597852|NCT01025908|behavior|behavior
597853|NCT01025908|cognition|cognition
597854|NCT01025895|arthroscopic surgical procedure|arthroscopic surgical procedure
597855|NCT01025882|adenocarcinoma of the pancreas|adenocarcinoma of the pancreas
597856|NCT01025882|stage I pancreatic cancer|stage i pancreatic cancer
597857|NCT01025882|stage II pancreatic cancer|stage ii pancreatic cancer
597858|NCT01025882|stage III pancreatic cancer|stage iii pancreatic cancer
597859|NCT01025856|liver fat|liver fat
597860|NCT01025856|postprandial lipids metabolism|postprandial lipids metabolism
597861|NCT01025856|diet|diet
597862|NCT01025856|exercise|exercise
597863|NCT01025856|type 2 diabetes|type 2 diabetes
597864|NCT01025830|HIV;Bioequivalence;Triomune|hiv;bioequivalence;triomune
597865|NCT01025817|Kidney transplant|kidney transplant
597866|NCT01025817|renal transplant|renal transplant
597867|NCT01025817|immunosuppression|immunosuppression
597868|NCT01025817|mycophenolate mofetil|mycophenolate mofetil
597869|NCT01025817|tacrolimus|tacrolimus
597870|NCT01025817|everolimus|everolimus
597871|NCT01025804|Interfant-06|interfant-06
597872|NCT01025804|Infant ALL|infant all
597873|NCT01025804|Asparaginase|asparaginase
597998|NCT01025310|eye movements|eye movements
597874|NCT01025804|Pharmacokinetics of asparaginase|pharmacokinetics of asparaginase
597875|NCT01025804|Antibody formation|antibody formation
597876|NCT01025778|Haploidentical hematopoietic stem cell transplantation|haploidentical hematopoietic stem cell transplantation
597877|NCT01025778|Graft versus host disease|graft versus host disease
597878|NCT01025778|Donor lymphocyte infusion|donor lymphocyte infusion
597879|NCT01025778|Graft versus leukemia effect|graft versus leukemia effect
597880|NCT01025778|Immunological recovery|immunological recovery
597881|NCT01025778|Bridge to transplant approach|bridge to transplant approach
597882|NCT01025778|Therapy resistant leukemia|therapy resistant leukemia
597883|NCT01025778|Hematological malignancy|hematological malignancy
597884|NCT01025752|chronic pain|chronic pain
597885|NCT01025752|cognitive behavior therapy|cognitive behavior therapy
597886|NCT01025752|low back pain|low back pain
597887|NCT01025739|Gastroesophageal Reflux Disease (GERD)|gastroesophageal reflux disease (gerd)
597888|NCT01025739|EsophyX|esophyx
597889|NCT01025713|Cystic Fibrosis|cystic fibrosis
597890|NCT01025713|CF|cf
597891|NCT01025713|Mucociliary Clearance|mucociliary clearance
597892|NCT01025713|Epithelial Sodium Channel Inhibitor|epithelial sodium channel inhibitor
597893|NCT01025713|ENaC Inhibitor|enac inhibitor
597894|NCT01025713|Airway Hydration|airway hydration
597895|NCT01025713|Amiloride|amiloride
597896|NCT01025700|Efficacy|efficacy
597897|NCT01025700|Marijuana|marijuana
597898|NCT01025700|Reduction|reduction
597899|NCT01025700|Craving|craving
597900|NCT01025687|girls|girls
597901|NCT01025687|obesity|obesity
597902|NCT01025687|television viewing|television viewing
597903|NCT01025687|puberty|puberty
597904|NCT01025674|School health program|school health program
597905|NCT01025674|Positive health behavior|positive health behavior
597906|NCT01025674|School-wide climate|school-wide climate
597907|NCT01025674|Mental health|mental health
597908|NCT01025674|Self-esteem|self-esteem
597909|NCT01025674|Social support|social support
597910|NCT01025674|Exercise|exercise
597911|NCT01025674|Nutrition|nutrition
597912|NCT01025674|Parent involvement|parent involvement
597913|NCT01025674|Community involvement|community involvement
597914|NCT01025661|chiropractic|chiropractic
597915|NCT01025661|hip osteoarthritis|hip osteoarthritis
597916|NCT01025661|hip arthroplasty|hip arthroplasty
597917|NCT01025661|pain|pain
597918|NCT01025661|activities of daily living.|activities of daily living.
597919|NCT01025648|Mild to Moderate Asthma|mild to moderate asthma
597920|NCT01025648|Dyspnea|dyspnea
597921|NCT01025648|Wheezing|wheezing
597922|NCT01025648|Status Asthmaticus|status asthmaticus
597923|NCT01025635|rosacea|rosacea
597924|NCT01025635|papulopustular|papulopustular
597925|NCT01025635|azelaic acid|azelaic acid
597926|NCT01025635|foam|foam
597927|NCT01025622|Stem Cells|stem cells
597928|NCT01025622|Liver Cirrhosis|liver cirrhosis
597929|NCT01025622|Cell Therapy|cell therapy
597930|NCT01025609|spinal cord injury|spinal cord injury
597931|NCT01025609|cardiovascular disease|cardiovascular disease
597932|NCT01025609|dietary patterns|dietary patterns
597933|NCT01025596|interleukin-7|interleukin-7
597934|NCT01025596|immune-based therapies|immune-based therapies
597935|NCT01025596|hepatitis C|hepatitis c
597936|NCT01025596|chronic hepatitis|chronic hepatitis
597937|NCT01025596|resistance to Peg-interferon and ribavirin bi-therapy|resistance to peg-interferon and ribavirin bi-therapy
597938|NCT01025596|immune specific responses to HCV|immune specific responses to hcv
597939|NCT01025596|phase 1|phase 1
597940|NCT01025596|viral disease|viral disease
597941|NCT01025596|liver disease|liver disease
597942|NCT01025583|acute gastroenteritis|acute gastroenteritis
597943|NCT01025583|intestinal infection|intestinal infection
597944|NCT01025583|intestinal fluid secretion|intestinal fluid secretion
597945|NCT01025583|intestinal microflora|intestinal microflora
597946|NCT01025583|treatment of childhood acute diarrhea|treatment of childhood acute diarrhea
597947|NCT01025570|pancreas|pancreas
597948|NCT01025570|pancreatic|pancreatic
597949|NCT01025570|bosutinib|bosutinib
597950|NCT01025570|SKI-606|ski-606
597951|NCT01025570|gemcitabine|gemcitabine
597952|NCT01025570|gemzar|gemzar
597953|NCT01025570|Patients with resected pancreatic cancer|patients with resected pancreatic cancer
597954|NCT01025557|Food intake|food intake
597955|NCT01025557|Blood glucose|blood glucose
597956|NCT01025557|Milk|milk
598057|NCT01025154|Cytarabine|cytarabine
597957|NCT01025544|Haemophilus influenzae type b (Hib)|haemophilus influenzae type b (hib)
597959|NCT01025544|Booster|booster
597960|NCT01025531|Hepatitis C|hepatitis c
597961|NCT01025518|Head and Neck Neoplasms|head and neck neoplasms
597962|NCT01025518|Resistance training|resistance training
597963|NCT01025518|Muscle mass|muscle mass
597964|NCT01025518|Functional capacity|functional capacity
597965|NCT01025505|Untreated Ph+ ALL unfit for intense therapy and allo SCT|untreated ph+ all unfit for intense therapy and allo sct
597966|NCT01025492|high density lipoprotein|high density lipoprotein
597967|NCT01025492|arterial compliance|arterial compliance
597968|NCT01025492|brachial artery flow-mediated dilatation|brachial artery flow-mediated dilatation
597969|NCT01025479|Osteoporosis|osteoporosis
597970|NCT01025479|Prostate cancer|prostate cancer
597971|NCT01025479|LHRH agonist and/or anti-androgen agent|lhrh agonist and/or anti-androgen agent
597972|NCT01025479|Korean prostate cancer|korean prostate cancer
597973|NCT01025453|thyroid|thyroid
597974|NCT01025453|follicular cell|follicular cell
597975|NCT01025453|papillary cell|papillary cell
597976|NCT01025453|Hurthle cell|hurthle cell
597977|NCT01025453|BAY 43-9006|bay 43-9006
597978|NCT01025453|Temsirolimus|temsirolimus
597979|NCT01025453|Sorafenib|sorafenib
597980|NCT01025453|09-148|09-148
597981|NCT01025427|HIV|hiv
597982|NCT01025427|HIV persistence|hiv persistence
597983|NCT01025427|HIV reservoirs|hiv reservoirs
597984|NCT01025414|pancreatic fistula|pancreatic fistula
597985|NCT01025401|epilepsy|epilepsy
597986|NCT01025401|seizures|seizures
597987|NCT01025401|movement|movement
597988|NCT01025388|Hypercholesterolemia|hypercholesterolemia
597989|NCT01025388|The study is focusing on the undertreatment of hypercholesterolemia|the study is focusing on the undertreatment of hypercholesterolemia
597990|NCT01025375|overweight|overweight
597991|NCT01025349|bevacizumab|bevacizumab
597992|NCT01025349|metastatic breast cancer|metastatic breast cancer
597993|NCT01025349|docetaxel|docetaxel
597994|NCT01025336|Antibody persistence|antibody persistence
597995|NCT01025323|Pre hypertension|pre hypertension
597996|NCT01025323|Lifestyle modification|lifestyle modification
597997|NCT01025323|DASH diet|dash diet
597999|NCT01025310|saccades|saccades
598000|NCT01025310|visual|visual
598001|NCT01025310|stress|stress
598002|NCT01025310|search coil|search coil
598003|NCT01025310|environment|environment
598004|NCT01025310|Saccadic eye movements|saccadic eye movements
598005|NCT01025310|Urban environment|urban environment
598006|NCT01025297|interleukin-7|interleukin-7
598007|NCT01025297|immune-based therapies|immune-based therapies
598008|NCT01025297|hepatitis C|hepatitis c
598009|NCT01025297|chronic hepatitis|chronic hepatitis
598010|NCT01025297|resistance to Peg-interferon and ribavirin bi-therapy|resistance to peg-interferon and ribavirin bi-therapy
598011|NCT01025297|immune specific responses to HCV|immune specific responses to hcv
598012|NCT01025297|phase 1/2a|phase 1/2a
598013|NCT01025297|viral disease|viral disease
598014|NCT01025297|liver disease|liver disease
598015|NCT01025271|meningitis|meningitis
598016|NCT01025258|Cystic Fibrosis|cystic fibrosis
598017|NCT01025258|Medication Adherence|medication adherence
598018|NCT01025258|Multidisciplinary Team|multidisciplinary team
598019|NCT01025258|Clinical Outcomes|clinical outcomes
598020|NCT01025245|Remifentanil induced postoperative hyperalgesia|remifentanil induced postoperative hyperalgesia
598021|NCT01025232|Antibodies, Monoclonal|antibodies, monoclonal
598022|NCT01025232|Immunologic Factors|immunologic factors
598023|NCT01025232|Eye Diseases|eye diseases
598024|NCT01025232|Retinal Degeneration|retinal degeneration
598025|NCT01025232|Macular Degeneration|macular degeneration
598026|NCT01025232|Pharmacologic Actions|pharmacologic actions
598027|NCT01025232|Retinal Diseases|retinal diseases
710269|NCT00589563|stage IV childhood Hodgkin lymphoma|stage iv childhood hodgkin lymphoma
598028|NCT01025219|Diagnosis of dependence on cocaine according to DSM-IV-TR criteria|diagnosis of dependence on cocaine according to dsm-iv-tr criteria
598029|NCT01025206|Multiple Myeloma|multiple myeloma
598030|NCT01025206|monoclonal antibody|monoclonal antibody
598031|NCT01025206|safety|safety
598032|NCT01025206|pharmacokinetic|pharmacokinetic
598033|NCT01025193|belimumab|belimumab
598034|NCT01025193|Benlysta|benlysta
598035|NCT01025193|LymphoStat B|lymphostat b
598036|NCT01025193|BLyS specific inhibitors|blys specific inhibitors
598037|NCT01025180|safety|safety
598038|NCT01025180|Procalcitonin|procalcitonin
598039|NCT01025180|PCT|pct
598040|NCT01025180|SOFA|sofa
598041|NCT01025180|Sepsis|sepsis
598042|NCT01025180|Antibiotic|antibiotic
598043|NCT01025180|Strategy|strategy
598044|NCT01025180|SIRS|sirs
598045|NCT01025180|severe sepsis without obvious infection|severe sepsis without obvious infection
598046|NCT01025167|cancer|cancer
598047|NCT01025167|enteral nutrition|enteral nutrition
598048|NCT01025167|omega-3-fatty acids|omega-3-fatty acids
598049|NCT01025154|Leukemia|leukemia
598050|NCT01025154|AML|aml
598051|NCT01025154|chemotherapy-naïve|chemotherapy-naïve
598052|NCT01025154|Clofarabine|clofarabine
598053|NCT01025154|Clofarex|clofarex
598054|NCT01025154|Clolar|clolar
598055|NCT01025154|Idarubicin|idarubicin
598056|NCT01025154|Idamycin|idamycin
598059|NCT01025154|Cytosar|cytosar
598060|NCT01025154|DepoCyt|depocyt
598061|NCT01025154|Cytosine Arabinosine Hydrochloride|cytosine arabinosine hydrochloride
598062|NCT01025141|MINISCREW|miniscrew
598063|NCT01025141|space extraction closure|space extraction closure
598064|NCT01025141|anchorage|anchorage
598065|NCT01025141|Orthodontic Treatment|orthodontic treatment
598066|NCT01025141|Extraction of 2 Maxillary Premolar|extraction of 2 maxillary premolar
598067|NCT01025141|closing of extraction space|closing of extraction space
598068|NCT01025141|patient aged from 12 to 50 years old|patient aged from 12 to 50 years old
598069|NCT01025115|Dietary supplement|dietary supplement
598070|NCT01025115|Diamel|diamel
598071|NCT01025115|Metabolic Syndrome|metabolic syndrome
598072|NCT01025089|Cetuximab|cetuximab
598073|NCT01025089|Cisplatin|cisplatin
598074|NCT01025089|Cyclophosphamide|cyclophosphamide
598075|NCT01025089|09-038|09-038
598076|NCT01025076|Enlarged gastric pouch and stoma|enlarged gastric pouch and stoma
598077|NCT01025076|Post bariatric surgery|post bariatric surgery
598078|NCT01025063|Spectral OCT|spectral oct
598079|NCT01025063|Choroidal Neovascularization|choroidal neovascularization
598080|NCT01025063|Lucentis|lucentis
598081|NCT01025063|Visudyne|visudyne
598082|NCT01025063|PDT|pdt
598083|NCT01025063|anti-VEGF|anti-vegf
598084|NCT01025050|Presbyopia|presbyopia
598085|NCT01025050|Intrastromal|intrastromal
598086|NCT01025050|Femtosecond Laser|femtosecond laser
598087|NCT01025050|minimal-invasive|minimal-invasive
598088|NCT01025050|INTRACOR|intracor
598089|NCT01025050|Enhance Near Visual Acuity|enhance near visual acuity
598090|NCT01025037|Rotator Cuff Tear, Large, Massive, Rotator, Cuff. Tear|rotator cuff tear, large, massive, rotator, cuff. tear
598091|NCT01025024|SNP|snp
598092|NCT01025024|single-nucleotide polymorphism|single-nucleotide polymorphism
598093|NCT01025024|glaucoma|glaucoma
598094|NCT01025024|primary open angle glaucoma|primary open angle glaucoma
598095|NCT01025011|retinal hemoglobin concentration|retinal hemoglobin concentration
598096|NCT01025011|non-invasive hemoglobin measurement|non-invasive hemoglobin measurement
598097|NCT01024998|Age-Related Macular Degeneration|age-related macular degeneration
598098|NCT01024998|AMD|amd
598099|NCT01024998|Wet AMD|wet amd
598100|NCT01024998|Neovascular AMD|neovascular amd
598101|NCT01024998|Ocular|ocular
598102|NCT01024998|Ocular gene therapy|ocular gene therapy
598103|NCT01024998|Subretinal neovascularization|subretinal neovascularization
598104|NCT01024985|optic neuritis|optic neuritis
598105|NCT01024985|longitudinally extensive transverse myelitis|longitudinally extensive transverse myelitis
598106|NCT01024985|retinal nerve fiber layer|retinal nerve fiber layer
598107|NCT01024985|macular thickness|macular thickness
598108|NCT01024959|Prostate Cancer|prostate cancer
598109|NCT01024959|Prostate Biopsy|prostate biopsy
598110|NCT01024959|PCA3|pca3
598111|NCT01024946|mesothelioma|mesothelioma
598112|NCT01024946|pleural|pleural
598113|NCT01024946|RAD001|rad001
598114|NCT01024946|Everolimus|everolimus
598115|NCT01024946|09-142|09-142
598116|NCT01024946|thoracic|thoracic
598117|NCT01024946|lung|lung
598118|NCT01024946|epithelioid|epithelioid
598119|NCT01024946|sarcomatoid|sarcomatoid
598120|NCT01024933|Hypertension|hypertension
598121|NCT01024933|High Blood Pressure|high blood pressure
598122|NCT01024894|interleukin-7|interleukin-7
598123|NCT01024894|immune-based therapies|immune-based therapies
598124|NCT01024894|hepatitis C|hepatitis c
598125|NCT01024894|chronic hepatitis|chronic hepatitis
598126|NCT01024894|resistance to Peg-interferon and ribavirin bitherapy|resistance to peg-interferon and ribavirin bitherapy
598127|NCT01024894|immune specific responses to HCV|immune specific responses to hcv
598128|NCT01024894|taiwan|taiwan
598129|NCT01024894|phase 1/2a|phase 1/2a
598130|NCT01024894|viral disease|viral disease
598131|NCT01024894|liver disease|liver disease
598132|NCT01024881|catheterization success rate|catheterization success rate
598133|NCT01024868|Transversus Abdominis Plane Block|transversus abdominis plane block
598134|NCT01024829|Non small cell lung cancer|non small cell lung cancer
598135|NCT01024829|Inoperable|inoperable
598137|NCT01024816|Metabolic Syndrome|metabolic syndrome
598138|NCT01024816|Restorative Yoga|restorative yoga
598139|NCT01024816|Stretching|stretching
598140|NCT01024816|Visceral adiposity|visceral adiposity
598141|NCT01024816|Randomized controlled trial|randomized controlled trial
598142|NCT01024803|Retina implant, Subretinal|retina implant, subretinal
598143|NCT01024803|Legal blindness|legal blindness
598144|NCT01024803|Genetic Diseases, Inborn|genetic diseases, inborn
598145|NCT01024803|Eye Diseases|eye diseases
598146|NCT01024803|Retinitis Pigmentosa|retinitis pigmentosa
598147|NCT01024803|Retinitis|retinitis
598148|NCT01024803|Retinal Degeneration|retinal degeneration
598149|NCT01024803|Eye Diseases, Hereditary|eye diseases, hereditary
598150|NCT01024803|Retinal Diseases|retinal diseases
598151|NCT01024777|cholecalciferol|cholecalciferol
598152|NCT01024777|multiple sclerosis|multiple sclerosis
598153|NCT01024777|vitamin D|vitamin d
598154|NCT01024777|D3|d3
598155|NCT01024764|HIV|hiv
598156|NCT01024764|Tat protein|tat protein
598157|NCT01024764|Preventive vaccine|preventive vaccine
598158|NCT01024725|A(H1N1)v influenza|a(h1n1)v influenza
598159|NCT01024725|vaccination|vaccination
598160|NCT01024725|pandemic|pandemic
598161|NCT01024712|recurrent non-small cell lung cancer|recurrent non-small cell lung cancer
598162|NCT01024712|stage IIIB non-small cell lung cancer|stage iiib non-small cell lung cancer
598163|NCT01024712|stage IV non-small cell lung cancer|stage iv non-small cell lung cancer
598164|NCT01024712|adenocarcinoma of the lung|adenocarcinoma of the lung
598165|NCT01024712|bronchoalveolar cell lung cancer|bronchoalveolar cell lung cancer
598166|NCT01024712|large cell lung cancer|large cell lung cancer
598167|NCT01024673|H1N1|h1n1
598168|NCT01024660|Patients with Mild to Moderate Alzheimer's Disease|patients with mild to moderate alzheimer's disease
598169|NCT01024634|Arterial stiffness|arterial stiffness
598170|NCT01024634|Endothelial function|endothelial function
598171|NCT01024634|Autonomic function|autonomic function
598172|NCT01024634|Inflammation|inflammation
598173|NCT01024621|gastric intestinal metaplasia|gastric intestinal metaplasia
598174|NCT01024621|Confocal laser endomicroscopy|confocal laser endomicroscopy
598176|NCT01024595|Tat protein|tat protein
598177|NCT01024582|breast cancer|breast cancer
598178|NCT01024582|invasive breast cancer|invasive breast cancer
598179|NCT01024582|adenocarcinoma of the breast|adenocarcinoma of the breast
598180|NCT01024569|Severe Mental Illness|severe mental illness
598181|NCT01024569|Recovery|recovery
598182|NCT01024569|Psychiatric Disability|psychiatric disability
598183|NCT01024569|Wellness|wellness
598184|NCT01024569|Peer Service|peer service
598185|NCT01024569|WRAP|wrap
598186|NCT01024556|HIV, HAART|hiv, haart
598187|NCT01024543|Angiotensin II|angiotensin ii
598188|NCT01024517|Safety|safety
598189|NCT01024517|Tolerability|tolerability
598190|NCT01024517|Pharmacokinetics|pharmacokinetics
598191|NCT01024504|Cancer|cancer
598192|NCT01024504|Colorectal cancer|colorectal cancer
598193|NCT01024504|Elderly|elderly
598194|NCT01024504|Chemotherapy|chemotherapy
598195|NCT01024504|Capecitabine|capecitabine
598196|NCT01024504|Oxaliplatin|oxaliplatin
598197|NCT01024504|Bevacizumab|bevacizumab
598198|NCT01024491|premature ejaculation|premature ejaculation
598199|NCT01024491|paroxetine|paroxetine
598200|NCT01024491|daily treatment|daily treatment
598201|NCT01024478|Coronary Artery|coronary artery
598202|NCT01024478|Magnetic Resonance Angiography|magnetic resonance angiography
598203|NCT01024478|Coronary Artery disease|coronary artery disease
598204|NCT01024478|Multicenter Trial|multicenter trial
598205|NCT01024478|Cardiac MRI|cardiac mri
598206|NCT01024465|obesity|obesity
598207|NCT01024465|intragastric balloon|intragastric balloon
598208|NCT01024452|anticoagulation|anticoagulation
598209|NCT01024452|warfarin|warfarin
598210|NCT01024452|computer systems|computer systems
598211|NCT01024452|international normalized ratio|international normalized ratio
598212|NCT01024452|nomograms|nomograms
598213|NCT01024426|Uganda|uganda
598214|NCT01024426|malaria|malaria
598215|NCT01024426|enhanced health facility-based care|enhanced health facility-based care
598216|NCT01024426|febrile illnesses|febrile illnesses
598217|NCT01024426|health services|health services
598218|NCT01024413|Thoracic Neoplasms|thoracic neoplasms
598219|NCT01024413|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action
598220|NCT01024413|Protein Kinase Inhibitors|protein kinase inhibitors
598221|NCT01024413|Respiratory Tract Diseases|respiratory tract diseases
598222|NCT01024413|Lung Neoplasms|lung neoplasms
598223|NCT01024413|Erlotinib|erlotinib
598224|NCT01024413|Gefitinib|gefitinib
598225|NCT01024413|Epidermal growth factor receptor genes|epidermal growth factor receptor genes
598226|NCT01024400|Influenza|influenza
598227|NCT01024400|Vaccine|vaccine
598228|NCT01024400|Pregnancy|pregnancy
598229|NCT01024387|AMG 479|amg 479
598230|NCT01024361|Preterm infants|preterm infants
598231|NCT01024361|Nasal CPAP|nasal cpap
598232|NCT01024361|Delivery room|delivery room
598233|NCT01024361|Newborn|newborn
598234|NCT01024348|Surgery, knee arthroscopy|surgery, knee arthroscopy
598235|NCT01024348|Pain, postoperative|pain, postoperative
598236|NCT01024348|tramadol, extended release|tramadol, extended release
598237|NCT01024335|opioid dependence|opioid dependence
598238|NCT01024335|naltrexone|naltrexone
598239|NCT01024335|vivitrol|vivitrol
598240|NCT01024335|dronabinol|dronabinol
598241|NCT01024335|marinol|marinol
598242|NCT01024322|Diagnosis of keratoconus, post-LASIK ectasia, FFKC, or pellucid marginal degeneration|diagnosis of keratoconus, post-lasik ectasia, ffkc, or pellucid marginal degeneration
598243|NCT01024309|total hip arthroplasty|total hip arthroplasty
598244|NCT01024283|Heat Shock Protein 90 Inhibitor (HSP90)|heat shock protein 90 inhibitor (hsp90)
598245|NCT01024283|Pharmacodynamic|pharmacodynamic
598246|NCT01024283|Blood|blood
598247|NCT01024283|Biopsy|biopsy
598248|NCT01024283|Solid malignancies|solid malignancies
598249|NCT01024270|endometrial pathology of uterus|endometrial pathology of uterus
598250|NCT01024270|operative hysteroscopy|operative hysteroscopy
598251|NCT01024270|efficacy of misoprostol per different routes|efficacy of misoprostol per different routes
598346|NCT01023776|Swine Flu|swine flu
598252|NCT01024257|beta-irradiation;conjunctival autograft;pterygium;recurrence; clinical trial|beta-irradiation;conjunctival autograft;pterygium;recurrence; clinical trial
598253|NCT01024205|clear cell renal cell carcinoma|clear cell renal cell carcinoma
598254|NCT01024205|stage IV renal cell cancer|stage iv renal cell cancer
598255|NCT01024179|Optical Coherence Tomography|optical coherence tomography
598256|NCT01024179|Coronary artery disease|coronary artery disease
598257|NCT01024179|Chronic total occlusion|chronic total occlusion
598258|NCT01024166|Cancer|cancer
598259|NCT01024166|Patient-Reported Outcomes Computer System|patient-reported outcomes computer system
598260|NCT01024166|PRO|pro
598261|NCT01024166|Palliative Care|palliative care
598262|NCT01024166|Symptoms|symptoms
598263|NCT01024166|Questionnaire|questionnaire
598264|NCT01024166|Patients|patients
598265|NCT01024166|Caregivers|caregivers
598266|NCT01024166|Palliative Care Physicians|palliative care physicians
598267|NCT01024166|Palliative Care Nurses|palliative care nurses
598268|NCT01024153|active video games|active video games
598269|NCT01024153|children|children
598270|NCT01024153|physical activity|physical activity
598271|NCT01024140|Posttraumatic Stress Disorder|posttraumatic stress disorder
598272|NCT01024140|Escitalopram|escitalopram
598273|NCT01024140|Efficacy|efficacy
598274|NCT01024114|MBI|mbi
598275|NCT01024114|Molecular Breast Imaging|molecular breast imaging
598276|NCT01024114|Breast Cancer|breast cancer
598277|NCT01024114|Positive Molecular Breast Imaging scan.|positive molecular breast imaging scan.
598278|NCT01024088|Guillain Barré syndrome|guillain barré syndrome
598279|NCT01024088|Swallowing disorders|swallowing disorders
598280|NCT01024088|Respiratory failure|respiratory failure
598281|NCT01024075|Chronic Rhinosinusitis|chronic rhinosinusitis
598282|NCT01024075|Endoscopic sinus surgery|endoscopic sinus surgery
598283|NCT01024075|Sinufoam|sinufoam
598284|NCT01024075|Dexamethasone|dexamethasone
598285|NCT01024075|For patients with Chronic Rhinosinusitis without nasal polyps|for patients with chronic rhinosinusitis without nasal polyps
598286|NCT01024075|Focus: Define the postoperative sinonasal mucosal healing status of 2 Sinufoam mixtures|focus: define the postoperative sinonasal mucosal healing status of 2 sinufoam mixtures
598287|NCT01024049|heart failure blood left ventricular dysfunction|heart failure blood left ventricular dysfunction
598288|NCT01024036|Multicentric Castleman's Disease|multicentric castleman's disease
598289|NCT01024036|MCD|mcd
598290|NCT01024036|CNTO 328|cnto 328
598291|NCT01024036|Best Supportive Care|best supportive care
598292|NCT01024036|Tumor|tumor
598293|NCT01024036|Symptomatic response|symptomatic response
598294|NCT01024036|Pharmacokinetics|pharmacokinetics
598295|NCT01024036|Interleukin-6|interleukin-6
598296|NCT01024036|IL6|il6
598297|NCT01024023|Early Walking Aid|early walking aid
598298|NCT01024023|Amputee|amputee
598299|NCT01024023|Trans-tibial|trans-tibial
598300|NCT01024023|Quality of life|quality of life
598301|NCT01023997|corneal thickness|corneal thickness
598302|NCT01023997|exfoliation|exfoliation
598303|NCT01023984|RECTAL NEOPLASMS|rectal neoplasms
598304|NCT01023945|ASP1941|asp1941
598305|NCT01023945|Diabetes mellitus|diabetes mellitus
598306|NCT01023945|Blood glucose|blood glucose
598307|NCT01023919|Optical coherence tomography|optical coherence tomography
598308|NCT01023919|Drug eluting stent|drug eluting stent
598309|NCT01023919|Coronary Artery Disease|coronary artery disease
598310|NCT01023919|Diabetes Mellitus|diabetes mellitus
598311|NCT01023906|Taste|taste
598312|NCT01023906|general Labeled Magnitude Scale|general labeled magnitude scale
598313|NCT01023906|Aging|aging
598314|NCT01023906|Chronic Disease Risk|chronic disease risk
598315|NCT01023906|Smell|smell
598316|NCT01023867|Alzheimer's disease|alzheimer's disease
598317|NCT01023867|Mixed Dementia|mixed dementia
598318|NCT01023867|Donepezil|donepezil
598319|NCT01023867|Efficacy|efficacy
598320|NCT01023867|Adverse Event|adverse event
598321|NCT01023854|Paravertebral block|paravertebral block
598322|NCT01023854|loco regional anesthesia|loco regional anesthesia
598323|NCT01023854|renal surgery|renal surgery
598324|NCT01023854|PCA morphine|pca morphine
598325|NCT01023828|K-RAS ONCOGENE MUTATION|k-ras oncogene mutation
598326|NCT01023828|NON-SMALL CELL LUNG CANCER|non-small cell lung cancer
598327|NCT01023828|WOOD SMOKE|wood smoke
598328|NCT01023815|Immunosuppression|immunosuppression
598329|NCT01023815|renal transplantation|renal transplantation
598330|NCT01023815|once-a-day regimen|once-a-day regimen
598331|NCT01023815|steroid withdrawal|steroid withdrawal
598332|NCT01023815|drug minimization|drug minimization
598333|NCT01023815|immunosuppression for prevention of acute rejections|immunosuppression for prevention of acute rejections
598334|NCT01023802|neoadjuvant therapy|neoadjuvant therapy
598335|NCT01023802|chemotherapy|chemotherapy
598336|NCT01023802|hormone therapy|hormone therapy
598337|NCT01023802|breast cancer|breast cancer
598338|NCT01023802|MBI|mbi
598339|NCT01023802|Molecular Breast Imaging|molecular breast imaging
598340|NCT01023789|Drug eluting stent|drug eluting stent
598341|NCT01023789|Stents|stents
598342|NCT01023789|Angioplasty|angioplasty
598343|NCT01023789|Bioabsorbable|bioabsorbable
598344|NCT01023789|Bioresorbable|bioresorbable
598345|NCT01023789|Scaffold|scaffold
598347|NCT01023776|H1N1|h1n1
598348|NCT01023763|Nursing homes|nursing homes
598349|NCT01023763|Intravenous|intravenous
598350|NCT01023763|Treatment|treatment
598351|NCT01023763|Patient trajectory|patient trajectory
598352|NCT01023763|Hospital admissions|hospital admissions
598353|NCT01023750|hypertriglyceridemia|hypertriglyceridemia
598354|NCT01023750|Triglycerides|triglycerides
598355|NCT01023750|HDL|hdl
598356|NCT01023750|Insulin resistance|insulin resistance
598357|NCT01023737|Malignant Solid Tumor|malignant solid tumor
598358|NCT01023737|Solid Tumor|solid tumor
598359|NCT01023737|Hydroxychloroquine|hydroxychloroquine
598360|NCT01023737|Vorinostat|vorinostat
598361|NCT01023711|Influenza|influenza
598362|NCT01023698|Diabetic retinopathy|diabetic retinopathy
598363|NCT01023698|Diabetic macular edema|diabetic macular edema
598364|NCT01023698|Panretinal photocoagulation|panretinal photocoagulation
598365|NCT01023685|Active immunization|active immunization
598366|NCT01023685|Alzheimer disease|alzheimer disease
598367|NCT01023685|Antibody|antibody
598368|NCT01023685|Central Nervous System diseases|central nervous system diseases
598492|NCT01023334|Anesthetics|anesthetics
598369|NCT01023685|Neurodegenerative diseases|neurodegenerative diseases
598370|NCT01023685|Vaccine|vaccine
598371|NCT01023672|Dementia with Lewy Bodies|dementia with lewy bodies
598372|NCT01023672|hypersomnolence|hypersomnolence
598373|NCT01023672|cognition|cognition
598374|NCT01023672|neuropsychiatric morbidity|neuropsychiatric morbidity
598375|NCT01023672|quality of life|quality of life
598376|NCT01023659|Smoking cessation|smoking cessation
598377|NCT01023659|Bupropion|bupropion
598378|NCT01023659|Varenicline|varenicline
598379|NCT01023659|Population-level|population-level
598380|NCT01023659|Mass distribution|mass distribution
598381|NCT01023659|Drug Therapy|drug therapy
598382|NCT01023646|Glycemic Index|glycemic index
598383|NCT01023646|Glycemic Load|glycemic load
598384|NCT01023646|Glucose|glucose
598385|NCT01023646|Insulin|insulin
598386|NCT01023646|Lipoproteins|lipoproteins
598387|NCT01023646|Free fatty acids|free fatty acids
598388|NCT01023633|to investigate the efficacy and feasibility of this novel treatment strategy in Chinese mCRC patients|to investigate the efficacy and feasibility of this novel treatment strategy in chinese mcrc patients
598389|NCT01023633|Primary Endpoint:DDC|primary endpoint:ddc
598390|NCT01023633|Secondary Endpoint:OS, RR,DCR, PFS,safety|secondary endpoint:os, rr,dcr, pfs,safety
598391|NCT01023620|HIV|hiv
598392|NCT01023620|Lipodystrophy|lipodystrophy
598393|NCT01023620|Lipoatrophy|lipoatrophy
598394|NCT01023620|Lipohypertrophy|lipohypertrophy
598395|NCT01023620|Human Immunodeficiency Virus|human immunodeficiency virus
598396|NCT01023607|optical coherence tomography|optical coherence tomography
598397|NCT01023607|intravascular ultrasound|intravascular ultrasound
598398|NCT01023607|Coronary artery disease|coronary artery disease
598399|NCT01023607|Hyperlipidemia|hyperlipidemia
598400|NCT01023594|Pancreatic fistula|pancreatic fistula
598401|NCT01023594|Pancreatic leakage|pancreatic leakage
598402|NCT01023594|Pancreatoduodenectomy|pancreatoduodenectomy
598403|NCT01023594|Pancreatic stent|pancreatic stent
598404|NCT01023581|Type 2 Diabetes mellitus|type 2 diabetes mellitus
598405|NCT01023581|Non-insulin dependent diabetes mellitus|non-insulin dependent diabetes mellitus
598406|NCT01023581|Drug Therapy|drug therapy
598407|NCT01023581|Hypoglycemia,|hypoglycemia,
598408|NCT01023581|Hyperglycemia|hyperglycemia
598409|NCT01023568|intubation|intubation
598410|NCT01023568|pediatric|pediatric
598411|NCT01023568|videolaryngoscope devices|videolaryngoscope devices
598412|NCT01023555|Bacteremia|bacteremia
760230|NCT00403494|IC|ic
598413|NCT01023555|Blood Cultures|blood cultures
598414|NCT01023555|Sepsis|sepsis
598415|NCT01023542|renal impairment|renal impairment
598416|NCT01023542|MELD>25|meld>25
598417|NCT01023542|Liver transplantation|liver transplantation
598418|NCT01023542|CNI-free|cni-free
598419|NCT01023542|Bottom-Up|bottom-up
598420|NCT01023542|Everolimus|everolimus
598421|NCT01023529|Prostatic Neoplasms|prostatic neoplasms
598422|NCT01023529|Rectal Neoplasms|rectal neoplasms
598423|NCT01023529|Palliative treatment|palliative treatment
598424|NCT01023529|Radiotherapy|radiotherapy
598425|NCT01023529|Quality of life|quality of life
598426|NCT01023516|Chronic|chronic
598427|NCT01023516|obstructive|obstructive
598428|NCT01023516|pulmonary|pulmonary
598429|NCT01023516|lung|lung
598430|NCT01023516|respiratory disease|respiratory disease
598431|NCT01023516|efficacy|efficacy
598432|NCT01023516|placebo-controlled|placebo-controlled
598433|NCT01023516|COPD|copd
598434|NCT01023516|FEV1|fev1
598435|NCT01023516|St Georges Respiratory Questionnaire|st georges respiratory questionnaire
598436|NCT01023503|Statins|statins
598437|NCT01023503|Dyslipidemia|dyslipidemia
598438|NCT01023503|Spain|spain
598439|NCT01023503|Rosuvastatin|rosuvastatin
598440|NCT01023503|Naive|naive
598441|NCT01023503|Switching|switching
598442|NCT01023503|New statins prescriptions in Spain (naive patients and switching)|new statins prescriptions in spain (naive patients and switching)
598443|NCT01023490|back pain|back pain
598444|NCT01023490|hypovitaminosis D|hypovitaminosis d
598643|NCT01022736|gabapentin|gabapentin
598445|NCT01023477|Carcinoma, Intraductal, Noninfiltrating|carcinoma, intraductal, noninfiltrating
598446|NCT01023477|Ductal Carcinoma In Situ|ductal carcinoma in situ
598447|NCT01023477|DCIS|dcis
598448|NCT01023477|Carcinoma, Intraductal|carcinoma, intraductal
598449|NCT01023477|Breast Cancer|breast cancer
598450|NCT01023477|Breast Tumors|breast tumors
598451|NCT01023477|chloroquine|chloroquine
598452|NCT01023477|autophagy|autophagy
598453|NCT01023477|Autophagic Cell Death|autophagic cell death
598454|NCT01023477|Autophagocytosis|autophagocytosis
598455|NCT01023477|Programmed Cell Death, Type II|programmed cell death, type ii
598456|NCT01023477|Autophagy, Cellular|autophagy, cellular
598457|NCT01023477|Autophagic Programmed Cell Death|autophagic programmed cell death
598458|NCT01023464|tear film break-up time|tear film break-up time
598459|NCT01023451|Pulmonary hypertension|pulmonary hypertension
598460|NCT01023451|Sickle cell disease|sickle cell disease
598461|NCT01023451|Pediatric patients|pediatric patients
598462|NCT01023451|Brain Natriuretic Peptide levels|brain natriuretic peptide levels
598463|NCT01023425|naive group|naive group
598464|NCT01023425|switching group|switching group
598465|NCT01023425|treatment response|treatment response
598466|NCT01023425|Efficacy|efficacy
598467|NCT01023425|Adverse event|adverse event
598468|NCT01023412|Immunonutrition|immunonutrition
598469|NCT01023412|cancer|cancer
598470|NCT01023412|GI cancer surgery|gi cancer surgery
598471|NCT01023386|YM155|ym155
598472|NCT01023386|Mass-balance|mass-balance
598473|NCT01023386|Phase I|phase i
598474|NCT01023386|Pharmacokinetics|pharmacokinetics
598475|NCT01023373|Angioplasty|angioplasty
598476|NCT01023373|Atherosclerotic reno vascular disease (ARVD)|atherosclerotic reno vascular disease (arvd)
598477|NCT01023373|Cardio- and cerebro- vascular comorbidity|cardio- and cerebro- vascular comorbidity
598478|NCT01023373|End stage renal disease (ERSD)|end stage renal disease (ersd)
598479|NCT01023373|kidney diseases|kidney diseases
598480|NCT01023373|High blood pressure|high blood pressure
598481|NCT01023373|Hypertension|hypertension
598482|NCT01023373|Ischemic nephropathy|ischemic nephropathy
598483|NCT01023373|Percutaneous transluminal renal artery stenting (PTRS)|percutaneous transluminal renal artery stenting (ptrs)
598484|NCT01023373|Randomized controlled trials|randomized controlled trials
598485|NCT01023373|Renal artery stenosis (RAS)|renal artery stenosis (ras)
598486|NCT01023373|Renal insufficiency|renal insufficiency
598487|NCT01023373|Vascular diseases|vascular diseases
598488|NCT01023347|NSCLC|nsclc
598489|NCT01023334|Topical analgesia|topical analgesia
598490|NCT01023334|FlACC Pain Scale|flacc pain scale
598491|NCT01023334|intracameral lignocaine|intracameral lignocaine
598493|NCT01023334|Physiological Effects of Drugs|physiological effects of drugs
598494|NCT01023334|Lidocaine|lidocaine
598495|NCT01023321|Safety|safety
598496|NCT01023321|Tolerability|tolerability
598497|NCT01023321|Pharmacokinetics|pharmacokinetics
598498|NCT01023308|Myeloma|myeloma
598499|NCT01023308|DACi|daci
598500|NCT01023308|Bortezomib|bortezomib
598501|NCT01023308|Combination|combination
598502|NCT01023308|Panobinostat|panobinostat
598503|NCT01023308|LBH589D|lbh589d
598504|NCT01023308|relapsed|relapsed
598505|NCT01023308|Velcade®|velcade®
598506|NCT01023295|Polypoidal Choroidal Vasculopathy|polypoidal choroidal vasculopathy
598507|NCT01023295|PCV|pcv
598508|NCT01023295|Polypoid|polypoid
598509|NCT01023295|oxigene|oxigene
598510|NCT01023295|VDA|vda
598511|NCT01023295|vascular disrupting agent|vascular disrupting agent
598512|NCT01023295|combretastatin|combretastatin
598513|NCT01023295|fosbretabulin|fosbretabulin
598514|NCT01023282|Parkinson's disease|parkinson's disease
598515|NCT01023282|Levodopa|levodopa
598516|NCT01023282|Dyskinesia|dyskinesia
598517|NCT01023282|ACR325|acr325
598518|NCT01023269|Neurogenic overactive bladder|neurogenic overactive bladder
598519|NCT01023269|Urinary incontinence due to incomplete spinal cord injury|urinary incontinence due to incomplete spinal cord injury
598520|NCT01023269|Neuromodulation|neuromodulation
598521|NCT01023269|Neuromodulation for treatment of neurogenic overactive bladder|neuromodulation for treatment of neurogenic overactive bladder
598522|NCT01023269|Patients with Urge urinary incontinence and detrusor overactivity|patients with urge urinary incontinence and detrusor overactivity
598523|NCT01023256|Rheumatoid arthritis|rheumatoid arthritis
598524|NCT01023256|GM-CSF|gm-csf
598525|NCT01023256|MOR103|mor103
598526|NCT01023243|foot exam|foot exam
598527|NCT01023243|health services|health services
598528|NCT01023243|practice improvement|practice improvement
598529|NCT01023243|quality|quality
598530|NCT01023243|preventive services|preventive services
598531|NCT01023243|Natural Language Processing|natural language processing
598532|NCT01023230|DV-601|dv-601
598533|NCT01023230|hepatitis B|hepatitis b
598534|NCT01023230|entecavir|entecavir
598535|NCT01023230|therapeutic vaccine|therapeutic vaccine
598536|NCT01023217|Chronic hepatitis B|chronic hepatitis b
598537|NCT01023217|lamivudine|lamivudine
598538|NCT01023217|adefovir|adefovir
598539|NCT01023217|entecavir|entecavir
598540|NCT01023191|Dialysis|dialysis
598541|NCT01023191|Peritoneal|peritoneal
598542|NCT01023191|Catheter|catheter
598543|NCT01023191|Surgery|surgery
598544|NCT01023165|Diabetes Mellitus|diabetes mellitus
598545|NCT01023165|Metabolic Integrity|metabolic integrity
598546|NCT01023165|Intravenous Bolus Insulin|intravenous bolus insulin
598547|NCT01023139|Adolescent|adolescent
598548|NCT01023139|Obesity|obesity
598549|NCT01023139|Pharmacotherapy|pharmacotherapy
598550|NCT01023139|Sibutramine|sibutramine
598551|NCT01023126|Obesity|obesity
598552|NCT01023126|Exercise|exercise
598553|NCT01023126|Psychotherapy|psychotherapy
598554|NCT01023113|Diabetic retinopathy|diabetic retinopathy
598555|NCT01023113|laser|laser
598556|NCT01023113|field loss|field loss
598557|NCT01023113|macular edema|macular edema
598558|NCT01023113|Visual field loss|visual field loss
598559|NCT01023100|taste study open label investigational drug oral therapy|taste study open label investigational drug oral therapy
598560|NCT01023074|MS|ms
598561|NCT01023074|CAP|cap
598562|NCT01023048|preimplantation diagnosis|preimplantation diagnosis
598563|NCT01023022|CareLink|carelink
598564|NCT01023022|Remote Monitoring|remote monitoring
598565|NCT01023022|Cardiac Pacemaker, Artificial|cardiac pacemaker, artificial
598566|NCT01023022|Implantable Cardioverter-Defibrillators|implantable cardioverter-defibrillators
598567|NCT01023009|Occlusion|occlusion
598568|NCT01023009|vitrectomy|vitrectomy
598569|NCT01023009|small gauge vitrectomy|small gauge vitrectomy
598570|NCT01023009|Postoperative occlusion|postoperative occlusion
598571|NCT01022996|Hodgkin's Lymphoma|hodgkin's lymphoma
598572|NCT01022996|Hodgkin Lymphoma|hodgkin lymphoma
598573|NCT01022996|Hodgkin's Disease|hodgkin's disease
598574|NCT01022996|Hodgkin Disease|hodgkin disease
598575|NCT01022996|Lymphoma|lymphoma
598576|NCT01022996|Lymphoproliferative Disorders|lymphoproliferative disorders
598577|NCT01022996|Neoplasms by Histological type|neoplasms by histological type
598578|NCT01022996|Lymphatic Diseases|lymphatic diseases
598579|NCT01022996|Hemic and Lymphatic Diseases|hemic and lymphatic diseases
598580|NCT01022996|Recurrent Lymphoma|recurrent lymphoma
598581|NCT01022996|Refractory Lymphoma|refractory lymphoma
598582|NCT01022996|Relapsed Lymphoma|relapsed lymphoma
598583|NCT01022996|Classical Hodgkin Lymphoma|classical hodgkin lymphoma
598584|NCT01022996|Classical Hodgkin's Disease|classical hodgkin's disease
598585|NCT01022996|Nodular sclerosing Hodgkin Lymphoma|nodular sclerosing hodgkin lymphoma
598586|NCT01022996|Mixed-cellularity Hodgkin Lymphoma|mixed-cellularity hodgkin lymphoma
598587|NCT01022996|Lymphocyte-rich Hodgkin Lymphoma|lymphocyte-rich hodgkin lymphoma
598588|NCT01022996|Lymphocyte depleted Hodgkin Lymphoma|lymphocyte depleted hodgkin lymphoma
598589|NCT01022970|Esophagitis|esophagitis
598590|NCT01022970|Digestive System Diseases|digestive system diseases
598591|NCT01022970|Esophageal disorder|esophageal disorder
598592|NCT01022970|Eosinophilic esophagitis|eosinophilic esophagitis
598593|NCT01022957|extra renal damages|extra renal damages
598594|NCT01022944|Serous otitis media|serous otitis media
598595|NCT01022944|Biofilm|biofilm
598596|NCT01022944|Adenoidectomy|adenoidectomy
598597|NCT01022944|Chronic otitis media|chronic otitis media
598598|NCT01022931|Influenza A H1N1|influenza a h1n1
598599|NCT01022931|Children|children
598600|NCT01022931|Epidemiology|epidemiology
598601|NCT01022931|Treatment|treatment
598602|NCT01022931|Oseltamivir|oseltamivir
598603|NCT01022931|Genetics|genetics
598604|NCT01022918|unresectable glioblastoma|unresectable glioblastoma
598605|NCT01022905|HIV infection|hiv infection
598606|NCT01022905|transplant|transplant
760434|NCT00402896|VEGFR|vegfr
598607|NCT01022905|rheumatic disease|rheumatic disease
598608|NCT01022905|cancer|cancer
598609|NCT01022905|children|children
598610|NCT01022892|Endovascular|endovascular
598611|NCT01022892|Abdominal|abdominal
598612|NCT01022892|Aortic|aortic
598613|NCT01022892|Aneurysm|aneurysm
598614|NCT01022892|Repair|repair
598615|NCT01022892|Surveillance|surveillance
598616|NCT01022892|EVAR|evar
598617|NCT01022892|CT|ct
598618|NCT01022892|Scan|scan
598619|NCT01022892|Endoleaks|endoleaks
598620|NCT01022892|Contrast|contrast
598621|NCT01022892|Enhanced|enhanced
598622|NCT01022892|Ultrasound|ultrasound
598623|NCT01022892|Definity|definity
598624|NCT01022892|AAA|aaa
598625|NCT01022892|imaging|imaging
598626|NCT01022892|No Endoleaks|no endoleaks
598627|NCT01022879|Pain scale of pain|pain scale of pain
598628|NCT01022866|falls|falls
598629|NCT01022866|older adults|older adults
598630|NCT01022827|stiff shoulder|stiff shoulder
598631|NCT01022827|massage|massage
598632|NCT01022827|muscle stiffness|muscle stiffness
598633|NCT01022775|Degenerative rotator cuff disease|degenerative rotator cuff disease
598634|NCT01022775|Impingement syndrome|impingement syndrome
598635|NCT01022775|Dynamic humeral centering|dynamic humeral centering
598636|NCT01022775|Randomized clinical trial|randomized clinical trial
598637|NCT01022749|inflammatory bowel disease (IBD)|inflammatory bowel disease (ibd)
598638|NCT01022749|immunosuppressed or non-immunosuppressed|immunosuppressed or non-immunosuppressed
598639|NCT01022749|influenza vaccine|influenza vaccine
598640|NCT01022749|antibody titers|antibody titers
598641|NCT01022749|seroprotective titers|seroprotective titers
598642|NCT01022749|vaccine-associated adverse events|vaccine-associated adverse events
598644|NCT01022736|pharmacokinetics|pharmacokinetics
598645|NCT01022736|visual analogue pain scale|visual analogue pain scale
598646|NCT01022736|cardiopulmonary bypass|cardiopulmonary bypass
598647|NCT01022723|Circulating tumor cells|circulating tumor cells
598648|NCT01022723|metastasis|metastasis
598649|NCT01022723|cancer|cancer
598650|NCT01022723|cell isolation|cell isolation
598651|NCT01022723|mircofludics|mircofludics
598652|NCT01022723|cell detection|cell detection
598653|NCT01022710|hearing loss|hearing loss
598654|NCT01022710|otoacoustic emissions|otoacoustic emissions
598655|NCT01022684|atherosclerosis|atherosclerosis
598656|NCT01022684|vascular inflammation|vascular inflammation
598657|NCT01022684|LpPLA2|lppla2
598658|NCT01022684|hsCRP|hscrp
598659|NCT01022684|MCP-1|mcp-1
598660|NCT01022684|18FDG-PET|18fdg-pet
598661|NCT01022671|Belotecan|belotecan
598662|NCT01022671|Camtobell inj|camtobell inj
598663|NCT01022671|NSCLC|nsclc
598664|NCT01022658|Insulin Therapy|insulin therapy
598665|NCT01022658|Vago-sympathetic activity|vago-sympathetic activity
598666|NCT01022658|arterial stiffness|arterial stiffness
598667|NCT01022658|endothelial function|endothelial function
598668|NCT01022645|Intrauterine device|intrauterine device
598669|NCT01022645|Gestational diabetes|gestational diabetes
598670|NCT01022645|Postpartum contraception|postpartum contraception
598671|NCT01022645|Postpartum birth control|postpartum birth control
598672|NCT01022632|Depression|depression
598673|NCT01022619|Sleep apnea|sleep apnea
598674|NCT01022619|high risk pregnancy|high risk pregnancy
598675|NCT01022619|fetal outcome|fetal outcome
598676|NCT01022619|cord blood|cord blood
598677|NCT01022580|nitric oxide|nitric oxide
598678|NCT01022580|surfactant|surfactant
598679|NCT01022580|bronchopulmonary dysplasia|bronchopulmonary dysplasia
598680|NCT01022580|BPD|bpd
598681|NCT01022580|prematurity|prematurity
598682|NCT01022580|neonates|neonates
598683|NCT01022580|iNO|ino
598684|NCT01022580|pulmonary outcome|pulmonary outcome
598685|NCT01022580|neurodevelopmental outcome|neurodevelopmental outcome
598686|NCT01022580|Infasurf|infasurf
598687|NCT01022580|lung function|lung function
598688|NCT01022580|Surfactant Dysfunction|surfactant dysfunction
598689|NCT01022528|Elective total abdominal hysterectomy (with or without salpingo-oophorectomy or minor bladder repair) or myomectomy|elective total abdominal hysterectomy (with or without salpingo-oophorectomy or minor bladder repair) or myomectomy
598690|NCT01022528|through a lower transverse or low midline incision under general anesthesia|through a lower transverse or low midline incision under general anesthesia
598691|NCT01022515|pheochromocytoma|pheochromocytoma
598692|NCT01022515|paraganglioma|paraganglioma
598693|NCT01022515|hypertension|hypertension
598694|NCT01022502|psoriasis, indigo naturalis|psoriasis, indigo naturalis
598695|NCT01022489|Schizophrenia, auditory hallucinations, TMS|schizophrenia, auditory hallucinations, tms
598696|NCT01022476|Pharmacokinetics|pharmacokinetics
598697|NCT01022476|Raltegravir|raltegravir
598698|NCT01022476|Immunosuppressive Agents|immunosuppressive agents
598699|NCT01022476|Severe hepatic insufficiency|severe hepatic insufficiency
598700|NCT01022476|Liver Transplantation|liver transplantation
598701|NCT01022476|Additional Keywords|additional keywords
598702|NCT01022476|HIV Infection|hiv infection
598703|NCT01022476|Hepatocarcinoma|hepatocarcinoma
598704|NCT01022476|Hepatitis C|hepatitis c
598705|NCT01022476|Hepatitis B|hepatitis b
598706|NCT01022450|rhabdomyolysis|rhabdomyolysis
598707|NCT01022450|myopathy|myopathy
598708|NCT01022450|acute renal failure|acute renal failure
598709|NCT01022450|neuroleptic malignant syndrome|neuroleptic malignant syndrome
598710|NCT01022450|Pharmaceutical Preparations|pharmaceutical preparations
598711|NCT01022450|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors
598712|NCT01022450|fibrates|fibrates
598713|NCT01022450|creatine kinase|creatine kinase
598714|NCT01022424|ADPKD|adpkd
598715|NCT01022424|Tolvaptan|tolvaptan
598716|NCT01022424|OPC-41061|opc-41061
598717|NCT01022411|brown rice|brown rice
598718|NCT01022411|white rice|white rice
598719|NCT01022411|diabetes risk|diabetes risk
598720|NCT01022398|Vitamin D3|vitamin d3
598721|NCT01022398|HMG-CoA reductase inhibitors (statin)-related myalgias|hmg-coa reductase inhibitors (statin)-related myalgias
598722|NCT01022359|haemodialysis|haemodialysis
598723|NCT01022359|vascular access|vascular access
598724|NCT01022359|central venous catheter|central venous catheter
598725|NCT01022346|Cervical intraepithelial neoplasia|cervical intraepithelial neoplasia
598726|NCT01022346|RO5217790|ro5217790
598727|NCT01022333|BRCA1|brca1
598728|NCT01022333|breast cancer|breast cancer
598729|NCT01022333|3,3'-di-indolylmethane|3,3'-di-indolylmethane
598730|NCT01022333|dietary intervention|dietary intervention
598731|NCT01022333|estrogen metabolites|estrogen metabolites
598732|NCT01022333|mRNA expression|mrna expression
598733|NCT01022333|BRCA1 protein|brca1 protein
598734|NCT01022333|Estrogen|estrogen
598735|NCT01022320|OSA|osa
598736|NCT01022320|Blood pressure|blood pressure
598737|NCT01022320|Lateral Pharyngoplasty|lateral pharyngoplasty
598738|NCT01022307|behavioral data acquisition|behavioral data acquisition
598739|NCT01022307|MRI|mri
598740|NCT01022294|children|children
598741|NCT01022294|analgesia|analgesia
598742|NCT01022294|dental treatment|dental treatment
598743|NCT01022294|inhalation|inhalation
598744|NCT01022281|Exfoliation|exfoliation
598745|NCT01022281|Scanning Laser Polarimetry|scanning laser polarimetry
598746|NCT01022281|Corneal Thickness|corneal thickness
598747|NCT01022268|Inflammation|inflammation
598748|NCT01022268|Children|children
598749|NCT01022268|Observational|observational
598750|NCT01022255|autologous vaccine|autologous vaccine
598751|NCT01022255|follicular lymphoma|follicular lymphoma
598752|NCT01022255|magnICON|magnicon
598753|NCT01022255|plant-made vaccines|plant-made vaccines
598754|NCT01022255|immune response|immune response
598755|NCT01022242|Surgical Adhesions|surgical adhesions
598756|NCT01022242|Post-surgical adhesions|post-surgical adhesions
598757|NCT01022242|Flexor tendon|flexor tendon
598758|NCT01022229|Attention Deficit Disorder|attention deficit disorder
598759|NCT01022229|Pediatrics|pediatrics
598760|NCT01022229|Attention|attention
598761|NCT01022229|Impulsivity|impulsivity
598762|NCT01022229|Complementary Therapies|complementary therapies
598763|NCT01022216|Wound|wound
598764|NCT01022216|Skin lesion|skin lesion
598765|NCT01022216|Antimicrobial|antimicrobial
598766|NCT01022216|Bioelectric|bioelectric
598767|NCT01022216|Diabetic foot|diabetic foot
598768|NCT01022216|Pressure Ulcer|pressure ulcer
598769|NCT01022203|Couples Therapy|couples therapy
598770|NCT01022203|PTSD|ptsd
598771|NCT01022190|Arthroplasty|arthroplasty
598772|NCT01022190|Hip|hip
598773|NCT01022190|Cemented|cemented
598774|NCT01022190|Heterotopic ossification|heterotopic ossification
598775|NCT01022190|Selective Cyclooxygenase-2 Inhibitors|selective cyclooxygenase-2 inhibitors
598776|NCT01022190|Arthroplasty, Replacement|arthroplasty, replacement
598777|NCT01022190|Hip Prosthesis|hip prosthesis
598778|NCT01022190|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors
598779|NCT01022164|fibrin glue|fibrin glue
598780|NCT01022164|vitrectomy|vitrectomy
598781|NCT01022164|safety and efficacy of fibrin glue|safety and efficacy of fibrin glue
598782|NCT01022151|Aminophylline|aminophylline
598783|NCT01022151|sevoflurane|sevoflurane
598784|NCT01022151|anaesthesia|anaesthesia
598785|NCT01022151|recovery|recovery
598786|NCT01022151|cognitive function|cognitive function
598787|NCT01022151|entropy|entropy
598788|NCT01022138|HER2-negative breast cancer|her2-negative breast cancer
598789|NCT01022138|stage IV breast cancer|stage iv breast cancer
598790|NCT01022138|recurrent breast cancer|recurrent breast cancer
598791|NCT01022125|TMC435-TiDP16-C121|tmc435-tidp16-c121
598792|NCT01022125|TMC435-C121|tmc435-c121
598793|NCT01022125|TMC435|tmc435
598794|NCT01022125|TMC435350|tmc435350
598795|NCT01022125|Protease inhibitor|protease inhibitor
598796|NCT01022125|HCV|hcv
598797|NCT01022125|Hepatitis C|hepatitis c
598798|NCT01022112|TA-7284|ta-7284
598799|NCT01022112|JNJ-28431754|jnj-28431754
598800|NCT01022112|Canagliflozin|canagliflozin
598801|NCT01022112|Type 2 diabetes mellitus|type 2 diabetes mellitus
598802|NCT01022112|Sodium Glucose Co-transporter (SGLT2 inhibitor)|sodium glucose co-transporter (sglt2 inhibitor)
598803|NCT01022099|Total Knee Arthroplasty|total knee arthroplasty
598804|NCT01022099|Navigation|navigation
598805|NCT01022086|Breast Cancer|breast cancer
598806|NCT01022086|Cardiotoxicity|cardiotoxicity
598807|NCT01022086|Trastuzumab|trastuzumab
598808|NCT01022086|Cardiac MRI|cardiac mri
598809|NCT01022073|Deep Brain Stimulation|deep brain stimulation
598810|NCT01022073|Subthalamic Nucleus|subthalamic nucleus
598811|NCT01022073|Globus Pallidus|globus pallidus
598812|NCT01022073|Parkinson Disease|parkinson disease
598813|NCT01022060|Dietary supplement|dietary supplement
598814|NCT01022060|Renalof|renalof
598815|NCT01022060|Recurrent calcic urolithiasis|recurrent calcic urolithiasis
598816|NCT01022060|Renal calculi|renal calculi
598817|NCT01022034|Rectal prolapse|rectal prolapse
598818|NCT01022034|mesh|mesh
598819|NCT01022034|recurrence|recurrence
598820|NCT01022021|non-Hodgkin's lymphoma|non-hodgkin's lymphoma
598821|NCT01022021|autologous stem cell transplant|autologous stem cell transplant
598822|NCT01022008|Exorbitism|exorbitism
598823|NCT01022008|Upper respiratory airways|upper respiratory airways
598824|NCT01022008|Osteodistraction|osteodistraction
598825|NCT01022008|Polysomnography|polysomnography
598826|NCT01021995|Safety of Echinacea in comparison to placebo|safety of echinacea in comparison to placebo
598827|NCT01021982|Pupillometer|pupillometer
598828|NCT01021982|Retinitis Pigmentosa|retinitis pigmentosa
598829|NCT01021982|Glaucoma|glaucoma
598830|NCT01021982|Objective perimetry|objective perimetry
598831|NCT01021956|Macular Degeneration|macular degeneration
598832|NCT01021956|Age Related Macular Degeneration|age related macular degeneration
598833|NCT01021956|Choroidal Neovascularization|choroidal neovascularization
598834|NCT01021956|AMD|amd
598835|NCT01021956|CNV|cnv
598836|NCT01021956|WST11|wst11
598837|NCT01021956|Stakel|stakel
598838|NCT01021956|Photodynamic therapy|photodynamic therapy
598839|NCT01021956|Vascular Targeted Photodynamic therapy|vascular targeted photodynamic therapy
598840|NCT01021956|VTP|vtp
598841|NCT01021943|calcineurin inhibitors|calcineurin inhibitors
598842|NCT01021943|fibrosis|fibrosis
598843|NCT01021943|spironolactone|spironolactone
598844|NCT01021943|Focus of the study is to assess if aldosterone blockade has an effect on interstitial fibrosis amongst kidney transplant recipients|focus of the study is to assess if aldosterone blockade has an effect on interstitial fibrosis amongst kidney transplant recipients
598845|NCT01021930|Optical coherence tomography|optical coherence tomography
598846|NCT01021930|Drug eluting stent|drug eluting stent
598847|NCT01021930|Coronary heart disease|coronary heart disease
598848|NCT01021930|Diabetes mellitus|diabetes mellitus
598849|NCT01021917|Obesity|obesity
598850|NCT01021917|Weight Loss|weight loss
598851|NCT01021917|Meal Replacements|meal replacements
598852|NCT01021904|Primary prevention|primary prevention
598853|NCT01021904|HPV Vaccination|hpv vaccination
598854|NCT01021904|HPV Infection|hpv infection
598855|NCT01021904|Cervical Cancer|cervical cancer
598856|NCT01021904|HPV Related Diseases|hpv related diseases
598857|NCT01021891|Technosphere® Insulin Inhalation Powder|technosphere® insulin inhalation powder
598858|NCT01021878|Peritoneal dialysis|peritoneal dialysis
598859|NCT01021878|Renal replacement therapy|renal replacement therapy
598860|NCT01021878|Dialysis solutions|dialysis solutions
598861|NCT01021878|Icodextrin|icodextrin
598862|NCT01021865|GLP-1|glp-1
598863|NCT01021865|Myocardial contrast echocardiography|myocardial contrast echocardiography
598864|NCT01021865|Myocardial perfusion|myocardial perfusion
598865|NCT01021839|renal dialysis|renal dialysis
598866|NCT01021839|bioprosthesis|bioprosthesis
598867|NCT01021839|arteriovenous shunt|arteriovenous shunt
598868|NCT01021839|surgical|surgical
598869|NCT01021826|knee replacement|knee replacement
598870|NCT01021826|hip replacement|hip replacement
598871|NCT01021826|hyperglycemia|hyperglycemia
598872|NCT01021826|diabetes|diabetes
598873|NCT01021826|osteoarthritis|osteoarthritis
598874|NCT01021800|Pancreatic tubular adenocarcinoma adjuvant setting|pancreatic tubular adenocarcinoma adjuvant setting
598875|NCT01021787|Sun Protection|sun protection
598876|NCT01021735|Rheumatoid|rheumatoid
598877|NCT01021735|Outcome|outcome
598878|NCT01021735|Cost effectiveness|cost effectiveness
598879|NCT01021735|Safety|safety
598880|NCT01021722|sphincter|sphincter
598881|NCT01021722|obstetric tears|obstetric tears
598882|NCT01021722|long-term follow-up|long-term follow-up
598883|NCT01021709|depression|depression
598884|NCT01021709|direct current stimulation|direct current stimulation
598885|NCT01021709|extracephalic electrode|extracephalic electrode
598886|NCT01021696|Dementia|dementia
598887|NCT01021696|Nursing home|nursing home
598888|NCT01021696|Pain treatment|pain treatment
598889|NCT01021696|Pain assessment|pain assessment
598890|NCT01021696|Agitation|agitation
598891|NCT01021683|Hematological neoplasms|hematological neoplasms
598892|NCT01021683|Neutropenia|neutropenia
598893|NCT01021683|Fever|fever
598894|NCT01021683|Itraconazole|itraconazole
598895|NCT01021683|Sporanox|sporanox
598896|NCT01021683|Antifungal prophylaxis|antifungal prophylaxis
598897|NCT01021683|Defeverscence|defeverscence
598898|NCT01021670|Dapoxetine hydrochloride|dapoxetine hydrochloride
598899|NCT01021670|Priligy|priligy
598900|NCT01021670|Premature ejaculation|premature ejaculation
598901|NCT01021670|Non-dapoxetine hydrochloride treatment(s)|non-dapoxetine hydrochloride treatment(s)
598902|NCT01021657|Glaucoma|glaucoma
598903|NCT01021657|Tenon's Capsule|tenon's capsule
598904|NCT01021657|Lipid profile|lipid profile
598905|NCT01021657|Assessment of lipid profile in Tenon's capsule in patients with Glaucoma|assessment of lipid profile in tenon's capsule in patients with glaucoma
598906|NCT01021644|APOE|apoe
598907|NCT01021644|Apolipoprotein E|apolipoprotein e
598908|NCT01021644|Cognition Disorders|cognition disorders
598909|NCT01021644|Neurocognition|neurocognition
598910|NCT01021631|Cardiac surgery|cardiac surgery
598911|NCT01021631|Strategies of transfusion|strategies of transfusion
598912|NCT01021631|Red blood cells|red blood cells
598913|NCT01021631|Liberal|liberal
598914|NCT01021631|Restrictive|restrictive
598915|NCT01021631|Anemia|anemia
598916|NCT01021605|hypercapnic respiratory failure, COPD, ARDS|hypercapnic respiratory failure, copd, ards
598917|NCT01021592|Velcade|velcade
598918|NCT01021592|QoL|qol
598919|NCT01021592|Proteasome inhibitor|proteasome inhibitor
598920|NCT01021592|Bortezomib|bortezomib
598921|NCT01021592|EORTC QLQ C30|eortc qlq c30
598922|NCT01021592|EQ 5D|eq 5d
598923|NCT01021579|Polycystic ovary syndrome|polycystic ovary syndrome
598924|NCT01021579|Metformin|metformin
598925|NCT01021579|Simvastatin|simvastatin
598926|NCT01021566|Opiate addiction|opiate addiction
598927|NCT01021566|Withdrawal symptoms|withdrawal symptoms
598928|NCT01021566|hemoperfusion|hemoperfusion
598929|NCT01021566|hemodialysis|hemodialysis
598930|NCT01021566|methadone|methadone
598931|NCT01021553|Proof of Concept|proof of concept
598932|NCT01021553|Double Blind|double blind
598933|NCT01021540|Nephritis,Nephropathy|nephritis,nephropathy
598934|NCT01021514|sRAGE|srage
598935|NCT01021514|SUV|suv
598936|NCT01021514|TBR|tbr
598937|NCT01021514|FDG PET CT|fdg pet ct
598938|NCT01021514|Type 2 DM|type 2 dm
598939|NCT01021501|nifedipine controlled release tablets|nifedipine controlled release tablets
598940|NCT01021501|hypertensive|hypertensive
598941|NCT01021501|chronic maintenance hemodialysis|chronic maintenance hemodialysis
598942|NCT01021501|Pharmacokinetics|pharmacokinetics
598943|NCT01021488|Thrombosis|thrombosis
598944|NCT01021488|Vein|vein
598945|NCT01021488|Statin|statin
598946|NCT01021488|Prevention|prevention
598947|NCT01021475|Functional Dyspepsia, Visceral Manipulation|functional dyspepsia, visceral manipulation
598948|NCT01021449|schizophrenia, BDNF, DNA methylation, histone modification|schizophrenia, bdnf, dna methylation, histone modification
598949|NCT01021436|Pneumonia|pneumonia
598950|NCT01021436|Gram-negative bacteria|gram-negative bacteria
598951|NCT01021423|Mantle Cell Lymphoma|mantle cell lymphoma
598952|NCT01021423|Non-Hodgkin's Lymphoma|non-hodgkin's lymphoma
598953|NCT01021423|CC-5013|cc-5013
598954|NCT01021423|Revlimid|revlimid
598955|NCT01021423|Lenalidomide|lenalidomide
598956|NCT01021410|acetaminophen|acetaminophen
598957|NCT01021410|paracetamol|paracetamol
598958|NCT01021410|protein adduct|protein adduct
598959|NCT01021410|healthy volunteer|healthy volunteer
598960|NCT01021410|acetaminophen-protein adduct formation|acetaminophen-protein adduct formation
598961|NCT01021397|Respiratory Tract Infection|respiratory tract infection
598962|NCT01021384|Depression,|depression,
598963|NCT01021384|Early Intervention,|early intervention,
598964|NCT01021384|Behavior Disorder,|behavior disorder,
598965|NCT01021384|Parenting Skills,|parenting skills,
598966|NCT01021384|Children with Special Health Care Needs,|children with special health care needs,
598967|NCT01021384|Developmental Disabilities,|developmental disabilities,
598968|NCT01021384|Family Support Programs|family support programs
598969|NCT01021371|HRQOL|hrqol
598970|NCT01021371|Rehabilitation|rehabilitation
598971|NCT01021371|Cancer Patients|cancer patients
598972|NCT01021371|General Practice|general practice
598973|NCT01021332|Vesomni|vesomni
598974|NCT01021332|Solifenacin succinate|solifenacin succinate
598975|NCT01021332|EC905|ec905
598976|NCT01021332|Tamsulosin hydrochloride OCAS|tamsulosin hydrochloride ocas
598977|NCT01021332|Treatment|treatment
598978|NCT01021332|Lower Urinary Tract Symptoms|lower urinary tract symptoms
598979|NCT01021332|Benign Prostatic Hyperplasia|benign prostatic hyperplasia
598980|NCT01021319|ischemic stroke|ischemic stroke
598981|NCT01021319|thrombolysis|thrombolysis
598982|NCT01021319|magnetic resonance imaging|magnetic resonance imaging
598983|NCT01021319|diffusion weighted imaging|diffusion weighted imaging
598984|NCT01021319|fluid attenuated inversion recovery|fluid attenuated inversion recovery
598985|NCT01021319|time window|time window
598986|NCT01021293|Poliorix|poliorix
598987|NCT01021293|IPV|ipv
598988|NCT01021280|Bartter syndrome,|bartter syndrome,
598989|NCT01021280|parathyroid hormone,|parathyroid hormone,
598990|NCT01021280|calcium sensing receptor,|calcium sensing receptor,
598991|NCT01021280|ROMK channel|romk channel
598992|NCT01021280|Barttin gene|barttin gene
598993|NCT01021280|PTH response to hypo- and hypercalcemia|pth response to hypo- and hypercalcemia
598994|NCT01021267|sexual dysfunctions|sexual dysfunctions
598995|NCT01021267|benign prostatic hyperplasia|benign prostatic hyperplasia
598996|NCT01021267|saw palmetto|saw palmetto
598997|NCT01021228|Liver resection|liver resection
598998|NCT01021228|Continuous volatile anesthesia|continuous volatile anesthesia
598999|NCT01021228|Continuous intravenous anesthesia|continuous intravenous anesthesia
599000|NCT01021228|Preconditioning volatile anesthesia|preconditioning volatile anesthesia
599001|NCT01021228|Comparing three groups of anesthesia during the liver surgery according to their benefit on liver and outcome.|comparing three groups of anesthesia during the liver surgery according to their benefit on liver and outcome.
599002|NCT01021215|Cancer Prevention|cancer prevention
599003|NCT01021215|Smoking-related lung disease|smoking-related lung disease
599004|NCT01021215|Smoking|smoking
599005|NCT01021215|Celecoxib|celecoxib
599006|NCT01021215|Celebrex|celebrex
599007|NCT01021215|Zileuton|zileuton
599008|NCT01021215|Zyflo CR|zyflo cr
599009|NCT01021215|Prevention|prevention
599010|NCT01021202|tracheostomy|tracheostomy
599011|NCT01021202|tracheotomy|tracheotomy
599012|NCT01021202|dilational|dilational
599013|NCT01021202|dilatative|dilatative
599014|NCT01021202|critical care|critical care
599015|NCT01021202|intensive care|intensive care
599016|NCT01021202|COPD|copd
599017|NCT01021202|chronic obstructive pulmonary disease|chronic obstructive pulmonary disease
599018|NCT01021202|lung disease|lung disease
599019|NCT01021202|pneumonia|pneumonia
599020|NCT01021202|prospective study|prospective study
599021|NCT01021202|questionnaire|questionnaire
599022|NCT01021202|quality of life|quality of life
599023|NCT01021202|outcome|outcome
599024|NCT01021202|mortality|mortality
599025|NCT01021189|safety|safety
599026|NCT01021189|tolerability|tolerability
599027|NCT01021189|AZD1446|azd1446
599028|NCT01021189|AD|ad
599029|NCT01021189|Japanese|japanese
599030|NCT01021176|Food Intake|food intake
599031|NCT01021176|Hunger|hunger
599032|NCT01021176|Lidocaine|lidocaine
599033|NCT01021176|Nose|nose
599034|NCT01021176|smell|smell
599035|NCT01021137|vestibular function tests|vestibular function tests
599036|NCT01021137|postural balance|postural balance
599037|NCT01021137|neuroimaging|neuroimaging
599038|NCT01021124|tuberculosis|tuberculosis
599039|NCT01021124|bone marrow transplant|bone marrow transplant
599040|NCT01021124|diagnosis|diagnosis
599041|NCT01021098|influenza|influenza
599042|NCT01021098|illness|illness
599043|NCT01021098|active-duty|active-duty
599044|NCT01021098|virus|virus
599045|NCT01021098|flu|flu
599046|NCT01021098|military|military
599047|NCT01021098|Influenza-like-illnesses|influenza-like-illnesses
599048|NCT01021085|Assisted Reproductive Technology|assisted reproductive technology
599049|NCT01021085|circulating cell free fetal DNA|circulating cell free fetal dna
599050|NCT01021085|First trimester|first trimester
599051|NCT01021059|Biological Effects of rhIL-15|biological effects of rhil-15
599052|NCT01021059|Estimate Antitumor Activity|estimate antitumor activity
599053|NCT01021059|rhIL-15 Pharmacokinetics|rhil-15 pharmacokinetics
599054|NCT01021059|Dose and Safety Determination of IL-15|dose and safety determination of il-15
599055|NCT01021059|Kidney Cancer|kidney cancer
599056|NCT01021059|Melanoma|melanoma
599057|NCT01021059|Renal Cell Cancer|renal cell cancer
599058|NCT01021046|deep anterior lamellar keratoplasty|deep anterior lamellar keratoplasty
599059|NCT01021046|rejection|rejection
599060|NCT01021046|high risk patients|high risk patients
599061|NCT01021046|acellular corneal tissue|acellular corneal tissue
599062|NCT01021033|Ischemia|ischemia
599063|NCT01021033|Hemorrhage|hemorrhage
599064|NCT01021033|Rehabilitation|rehabilitation
599065|NCT01021033|Stroke|stroke
599066|NCT01021020|bioequivalence|bioequivalence
599067|NCT01021020|fasting|fasting
599068|NCT01021020|fed|fed
599069|NCT01021020|healthy|healthy
599070|NCT01020994|Superficial infected eczema|superficial infected eczema
599071|NCT01020994|Superinfected eczema|superinfected eczema
599072|NCT01020981|OEF/OIF|oef/oif
599073|NCT01020981|Peer Group|peer group
599074|NCT01020981|Veterans|veterans
599075|NCT01020968|Ischemic Dilated Cardiomyopathy|ischemic dilated cardiomyopathy
599076|NCT01020968|Non-Ischemic Dilated Cardiomyopathy|non-ischemic dilated cardiomyopathy
599077|NCT01020968|ixmyelocel-T|ixmyelocel-t
599078|NCT01020955|GH and IGF-I|gh and igf-i
599079|NCT01020955|growth hormone deficiency and IGT or diabetes|growth hormone deficiency and igt or diabetes
599080|NCT01020942|ischemia|ischemia
599081|NCT01020942|myocardial infarction|myocardial infarction
599082|NCT01020942|prognosis|prognosis
599083|NCT01020942|pretreatment|pretreatment
599084|NCT01020942|electroacupuncture|electroacupuncture
599085|NCT01020942|stents|stents
599086|NCT01020942|troponin|troponin
599087|NCT01020942|percutaneous coronary intervention|percutaneous coronary intervention
599088|NCT01020916|Induced hypothermia|induced hypothermia
599089|NCT01020916|Mild induced hypothermia|mild induced hypothermia
599090|NCT01020916|Therapeutic hypothermia|therapeutic hypothermia
599091|NCT01020916|Cardiac arrest|cardiac arrest
599092|NCT01020916|Out-of-hospital cardiac arrest|out-of-hospital cardiac arrest
599093|NCT01020916|Mortality|mortality
599094|NCT01020916|Neurological function|neurological function
599095|NCT01020916|Randomised clinical trial|randomised clinical trial
599096|NCT01020890|GERD diagnosis|gerd diagnosis
599097|NCT01020890|GERD-Q|gerd-q
599098|NCT01020890|GERD patients' characteristics|gerd patients' characteristics
599099|NCT01020890|GERD|gerd
599100|NCT01020877|Bioequivalence|bioequivalence
599101|NCT01020877|Healthy Subjects|healthy subjects
599102|NCT01020877|Healthy, Normal Subjects|healthy, normal subjects
599103|NCT01020864|Platinum-resistent head and neck cancer|platinum-resistent head and neck cancer
599104|NCT01020864|Cetuximab|cetuximab
599105|NCT01020864|Carboplatin|carboplatin
599106|NCT01020864|Navelbine|navelbine
599107|NCT01020864|Phase II trial|phase ii trial
599108|NCT01020864|Combination chemotherapy|combination chemotherapy
599109|NCT01020851|hypertension|hypertension
599110|NCT01020851|stroke|stroke
599111|NCT01020851|cholesterol|cholesterol
599112|NCT01020851|adherence|adherence
599113|NCT01020838|Florbetaben|florbetaben
599114|NCT01020838|Amyloid beta-protein|amyloid beta-protein
599115|NCT01020838|Alzheimer's disease|alzheimer's disease
599116|NCT01020825|Complex perianal fistula|complex perianal fistula
599117|NCT01020825|Adipose-derived adult stem cells|adipose-derived adult stem cells
599118|NCT01020825|Fibrin glue|fibrin glue
599119|NCT01020799|Depression|depression
599120|NCT01020786|Non-squamous|non-squamous
599121|NCT01020773|extubation,Respiration, Artificial|extubation,respiration, artificial
599122|NCT01020760|Macular hole|macular hole
599123|NCT01020760|Vitrectomy|vitrectomy
599124|NCT01020760|Prone posturing|prone posturing
599125|NCT01020734|adult acute myeloid leukemia with 11q23 (MLL) abnormalities|adult acute myeloid leukemia with 11q23 (mll) abnormalities
599126|NCT01020734|adult acute myeloid leukemia with del(5q)|adult acute myeloid leukemia with del(5q)
599127|NCT01020734|adult acute myeloid leukemia with t(16;16)(p13;q22)|adult acute myeloid leukemia with t(16;16)(p13;q22)
599128|NCT01020734|recurrent adult acute myeloid leukemia|recurrent adult acute myeloid leukemia
599129|NCT01020734|adult acute myeloid leukemia in remission|adult acute myeloid leukemia in remission
599130|NCT01020734|childhood acute myeloid leukemia in remission|childhood acute myeloid leukemia in remission
599131|NCT01020734|recurrent childhood acute myeloid leukemia|recurrent childhood acute myeloid leukemia
599132|NCT01020734|adult acute minimally differentiated myeloid leukemia (M0)|adult acute minimally differentiated myeloid leukemia (m0)
599133|NCT01020734|childhood acute minimally differentiated myeloid leukemia (M0)|childhood acute minimally differentiated myeloid leukemia (m0)
599134|NCT01020734|adult acute myeloblastic leukemia without maturation (M1)|adult acute myeloblastic leukemia without maturation (m1)
599135|NCT01020734|childhood acute myeloblastic leukemia without maturation (M1)|childhood acute myeloblastic leukemia without maturation (m1)
599136|NCT01020734|adult acute myeloblastic leukemia with maturation (M2)|adult acute myeloblastic leukemia with maturation (m2)
599137|NCT01020734|childhood acute myeloblastic leukemia with maturation (M2)|childhood acute myeloblastic leukemia with maturation (m2)
599138|NCT01020734|adult acute myelomonocytic leukemia (M4)|adult acute myelomonocytic leukemia (m4)
599139|NCT01020734|childhood acute myelomonocytic leukemia (M4)|childhood acute myelomonocytic leukemia (m4)
599140|NCT01020734|adult acute monoblastic leukemia (M5a)|adult acute monoblastic leukemia (m5a)
599141|NCT01020734|adult acute monocytic leukemia (M5b)|adult acute monocytic leukemia (m5b)
599142|NCT01020734|childhood acute monoblastic leukemia (M5a)|childhood acute monoblastic leukemia (m5a)
599143|NCT01020734|childhood acute monocytic leukemia (M5b)|childhood acute monocytic leukemia (m5b)
599144|NCT01020734|adult erythroleukemia (M6a)|adult erythroleukemia (m6a)
599145|NCT01020734|adult pure erythroid leukemia (M6b)|adult pure erythroid leukemia (m6b)
599146|NCT01020734|childhood acute erythroleukemia (M6)|childhood acute erythroleukemia (m6)
599147|NCT01020734|adult acute megakaryoblastic leukemia (M7)|adult acute megakaryoblastic leukemia (m7)
599148|NCT01020734|childhood acute megakaryocytic leukemia (M7)|childhood acute megakaryocytic leukemia (m7)
599149|NCT01020721|CYP1B1 gene|cyp1b1 gene
599151|NCT01020695|EEG|eeg
599152|NCT01020695|QEEG|qeeg
599153|NCT01020695|LORETA|loreta
599154|NCT01020682|apathy|apathy
599155|NCT01020682|parkinson|parkinson
599156|NCT01020682|agonist dopaminergic|agonist dopaminergic
599157|NCT01020669|fMRI|fmri
599158|NCT01020669|Prenatal Drug Exposure|prenatal drug exposure
599159|NCT01020669|Decision Making|decision making
599160|NCT01020669|Working Memory|working memory
599161|NCT01020669|Vulnerability|vulnerability
599162|NCT01020656|anticoagulant agents|anticoagulant agents
599163|NCT01020656|antiplatelet agents|antiplatelet agents
599164|NCT01020656|vitreoretinal surgery|vitreoretinal surgery
599165|NCT01020656|Patients suffered from retinal detachment|patients suffered from retinal detachment
599166|NCT01020630|adenocarcinoma of stomach|adenocarcinoma of stomach
599167|NCT01020630|adenocarcinoma of lower oesophagus|adenocarcinoma of lower oesophagus
599168|NCT01020630|sunitinib|sunitinib
599169|NCT01020630|FOLFIRI|folfiri
599170|NCT01020604|BMI|bmi
599171|NCT01020604|Prostate cancer|prostate cancer
599172|NCT01020604|Recurrence|recurrence
599173|NCT01020591|knee osteoarthritis|knee osteoarthritis
599174|NCT01020591|manual therapy|manual therapy
599175|NCT01020591|osteopathy|osteopathy
599176|NCT01020552|APHIA II|aphia ii
599177|NCT01020552|AIDS, Population, and Health Integrated Assistance project|aids, population, and health integrated assistance project
599178|NCT01020552|DCF|dcf
599179|NCT01020552|data collection forms|data collection forms
599180|NCT01020552|FDA|fda
599181|NCT01020552|Federal Drug Administration|federal drug administration
599182|NCT01020552|FP|fp
599183|NCT01020552|family planning|family planning
599184|NCT01020552|IRB|irb
599185|NCT01020552|Institutional Review Board|institutional review board
599186|NCT01020552|PAC|pac
599187|NCT01020552|postabortion care|postabortion care
599188|NCT01020552|To document the ESD PAC svc pkg including the provision of services, client satisfaction with those services and provider attitudes towards PAC services|to document the esd pac svc pkg including the provision of services, client satisfaction with those services and provider attitudes towards pac services
599189|NCT01020552|To examine any differences in implementation of the ESD PAC services package for youth and adult clients|to examine any differences in implementation of the esd pac services package for youth and adult clients
599190|NCT01020552|To assess the usefulness of five Youth-Friendly PAC Job Aids developed by ESD|to assess the usefulness of five youth-friendly pac job aids developed by esd
599191|NCT01020539|Allogeneic Stem Cell Transplantation|allogeneic stem cell transplantation
599192|NCT01020539|Targeted Immune Therapy|targeted immune therapy
599193|NCT01020539|Acute Myelogenous Leukemia|acute myelogenous leukemia
599194|NCT01020539|Myelodysplastic Syndrome|myelodysplastic syndrome
599195|NCT01020539|Juvenile Myelomonocytic Leukemia|juvenile myelomonocytic leukemia
599196|NCT01020539|AML|aml
599197|NCT01020539|MDS|mds
599198|NCT01020539|JMML|jmml
599199|NCT01020474|juvenile primary fibromyalgia syndrome|juvenile primary fibromyalgia syndrome
599200|NCT01020474|pediatric fibromyalgia|pediatric fibromyalgia
599201|NCT01020474|pregabalin|pregabalin
599202|NCT01020474|and Lyrica|and lyrica
599203|NCT01020448|Locally advanced or metastatic Prostate Cancer|locally advanced or metastatic prostate cancer
599204|NCT01020435|Hypertension|hypertension
599205|NCT01020422|breast hypertrophy|breast hypertrophy
599206|NCT01020422|mammaplasty|mammaplasty
599207|NCT01020422|sexuality|sexuality
599208|NCT01020422|depression|depression
599209|NCT01020409|cardiac surgery|cardiac surgery
599210|NCT01020409|cardiopulmonary bypass|cardiopulmonary bypass
599211|NCT01020409|acute lung injury|acute lung injury
599212|NCT01020409|acute respiratory distress syndrome|acute respiratory distress syndrome
599213|NCT01020409|acute kidney injury|acute kidney injury
599214|NCT01020409|atrial fibrillation|atrial fibrillation
599215|NCT01020409|postoperative psychosis|postoperative psychosis
599216|NCT01020409|myocardial infarct|myocardial infarct
599217|NCT01020409|sepsis|sepsis
599218|NCT01020396|Bioequivalence|bioequivalence
599219|NCT01020396|Metronidazole|metronidazole
599220|NCT01020396|Vaginosis|vaginosis
599221|NCT01020370|Patients with RRMS who are participating in the CARE MS I and CARE MS II|patients with rrms who are participating in the care ms i and care ms ii
599222|NCT01020357|preterm infants|preterm infants
599223|NCT01020357|very low birthweight|very low birthweight
599224|NCT01020357|apnea of prematurity|apnea of prematurity
599225|NCT01020357|methylxanthines|methylxanthines
599226|NCT01020357|sleep disturbance|sleep disturbance
599227|NCT01020357|obstructive sleep apnea syndrome|obstructive sleep apnea syndrome
599228|NCT01020357|polysomnography|polysomnography
599229|NCT01020357|sleep disruption|sleep disruption
599231|NCT01020318|Traumatic Brain Injury|traumatic brain injury
599232|NCT01020318|TBI|tbi
599233|NCT01020318|Brain Injuries|brain injuries
599234|NCT01020279|muscle pain|muscle pain
599235|NCT01020279|model|model
599236|NCT01020266|brain protection|brain protection
599237|NCT01020266|cardiac surgery|cardiac surgery
599238|NCT01020266|heart valve replacement|heart valve replacement
599239|NCT01020266|electroacupuncture|electroacupuncture
599240|NCT01020266|pretreatment|pretreatment
599241|NCT01020266|preconditioning|preconditioning
599242|NCT01020266|Thoracic Surgery|thoracic surgery
599243|NCT01020253|bisphosphonate, vitamin D3|bisphosphonate, vitamin d3
599244|NCT01020253|Total Hip arthroplasty|total hip arthroplasty
599245|NCT01020240|Immediate puerperium|immediate puerperium
599246|NCT01020240|physiotherapy in postpartum|physiotherapy in postpartum
599247|NCT01020240|cesarean complications|cesarean complications
599248|NCT01020227|Postoperative Care|postoperative care
599249|NCT01020227|Quality of Life|quality of life
599250|NCT01020227|Integrative Medicine|integrative medicine
599251|NCT01020227|Coronary Artery Bypass Graft Surgery|coronary artery bypass graft surgery
599252|NCT01020201|Anesthesia, General|anesthesia, general
599253|NCT01020201|Elective Gynecological Operation|elective gynecological operation
599254|NCT01020201|Chinese female patient|chinese female patient
599255|NCT01020201|Adult|adult
599256|NCT01020175|allogeneic transplantation|allogeneic transplantation
599257|NCT01020175|Leukemia|leukemia
599258|NCT01020175|GvHD|gvhd
599259|NCT01020175|MDS|mds
599260|NCT01020162|Chronic pelvic pain|chronic pelvic pain
599261|NCT01020162|ilioinguinal nerve entrapment|ilioinguinal nerve entrapment
599262|NCT01020162|randomized study|randomized study
599263|NCT01020162|Chronic pelvic pain in women|chronic pelvic pain in women
599264|NCT01020149|Nerve transsection|nerve transsection
599265|NCT01020136|Bioequivalence Pharmacokinetics|bioequivalence pharmacokinetics
599266|NCT01020123|Type II Diabetes Mellitus|type ii diabetes mellitus
599267|NCT01020123|metformin|metformin
599268|NCT01020123|glipizide|glipizide
599269|NCT01020110|perfusion chamber|perfusion chamber
599270|NCT01020110|thrombus D-Dimer|thrombus d-dimer
599271|NCT01020110|HUVEC|huvec
599272|NCT01020084|Saliva|saliva
599273|NCT01020084|Mastication|mastication
599274|NCT01020084|Communication|communication
599275|NCT01020071|iridotomy|iridotomy
599276|NCT01020071|iridoplasty|iridoplasty
599277|NCT01020071|angle closure glaucoma|angle closure glaucoma
599278|NCT01020045|HIV|hiv
599279|NCT01020045|Osteopenia|osteopenia
599280|NCT01020045|Osteoporosis|osteoporosis
599281|NCT01020032|Music therapy|music therapy
599282|NCT01020032|Pain|pain
599283|NCT01020032|Anxiety|anxiety
599284|NCT01020032|Depression|depression
599285|NCT01020032|Controlled randomized trial|controlled randomized trial
599286|NCT01020019|Cannabis Dependence|cannabis dependence
599287|NCT01020019|Marijuana Dependence|marijuana dependence
599288|NCT01020019|Marinol|marinol
599289|NCT01020019|Lofexidine|lofexidine
599290|NCT01020006|PCI-27483|pci-27483
599291|NCT01020006|Factor VIIa|factor viia
599292|NCT01020006|Gemcitabine|gemcitabine
599293|NCT01020006|4 months life expectancy|4 months life expectancy
599294|NCT01020006|Pharmacyclics|pharmacyclics
599295|NCT01020006|Locally Advanced|locally advanced
599296|NCT01020006|Metastatic disease|metastatic disease
599297|NCT01019993|Thoracotomy|thoracotomy
599298|NCT01019993|one lung ventilation|one lung ventilation
599299|NCT01019993|HFPPV|hfppv
599300|NCT01019993|right ventricular function.|right ventricular function.
599301|NCT01019980|Antipyretics|antipyretics
599302|NCT01019980|fever|fever
599303|NCT01019980|diclofenac|diclofenac
599304|NCT01019980|acetaminophen|acetaminophen
599305|NCT01019980|children|children
599306|NCT01019980|acute upper respiratory tract infections|acute upper respiratory tract infections
599307|NCT01019967|Children and Adolescents|children and adolescents
599308|NCT01019967|Obsessive-Compulsive Disorder|obsessive-compulsive disorder
599309|NCT01019967|Magnetic Resonance Spectroscopy|magnetic resonance spectroscopy
599310|NCT01019967|Autism|autism
599311|NCT01019967|OCD|ocd
599312|NCT01019967|Obsessive Compulsive Disorder|obsessive compulsive disorder
599313|NCT01019941|Docetaxel|docetaxel
599314|NCT01019941|CKD-810|ckd-810
599315|NCT01019941|Taxotere inj.|taxotere inj.
599316|NCT01019941|Advanced Solid cancer|advanced solid cancer
599317|NCT01019941|Pharmacokinetic evaluation|pharmacokinetic evaluation
599318|NCT01019928|GERD|gerd
599319|NCT01019928|patient|patient
599320|NCT01019928|esophagus|esophagus
599321|NCT01019928|pain|pain
599322|NCT01019915|CRT|crt
599323|NCT01019915|heart failure|heart failure
599324|NCT01019915|left bundle branch block|left bundle branch block
599325|NCT01019915|skeletal muscle|skeletal muscle
599326|NCT01019915|cytokines|cytokines
599327|NCT01019915|VO2|vo2
599328|NCT01019915|pgc1alpha|pgc1alpha
599329|NCT01019902|iron|iron
599330|NCT01019902|pregnancy|pregnancy
599331|NCT01019902|adolescents|adolescents
599332|NCT01019902|auditory brainstem responses|auditory brainstem responses
599333|NCT01019902|anemia|anemia
599334|NCT01019902|neonate|neonate
599335|NCT01019889|upper respiratory tract infections|upper respiratory tract infections
599336|NCT01019889|herbal medicine|herbal medicine
599337|NCT01019876|Bone marrow Failure|bone marrow failure
599338|NCT01019876|Fanconi|fanconi
599339|NCT01019876|SCID|scid
599340|NCT01019850|disseminated neuroblastoma|disseminated neuroblastoma
599341|NCT01019850|localized unresectable neuroblastoma|localized unresectable neuroblastoma
599342|NCT01019850|recurrent neuroblastoma|recurrent neuroblastoma
599343|NCT01019850|regional neuroblastoma|regional neuroblastoma
599344|NCT01019837|Vaccine|vaccine
599345|NCT01019824|nerve compression|nerve compression
599346|NCT01019824|compression radiculopathy|compression radiculopathy
599347|NCT01019824|post-traumatic/post-surgical lumbar radiculopathy|post-traumatic/post-surgical lumbar radiculopathy
599348|NCT01019811|Cross-finger flap|cross-finger flap
599349|NCT01019811|finger injuries|finger injuries
599350|NCT01019811|fingertip reconstruction|fingertip reconstruction
599351|NCT01019811|proper digital artery|proper digital artery
599352|NCT01019811|proper digital nerve.|proper digital nerve.
599353|NCT01019798|non small cell lung cancer|non small cell lung cancer
599354|NCT01019798|sunitinib|sunitinib
599355|NCT01019798|docetaxel|docetaxel
599356|NCT01019785|Pregnancy rate (pos test, live fetus at 12 weeks, baby home)|pregnancy rate (pos test, live fetus at 12 weeks, baby home)
599357|NCT01019785|Pregnancy complication (Pregnancy hypertension, SGA, diab)|pregnancy complication (pregnancy hypertension, sga, diab)
599358|NCT01019785|Thrombin generation|thrombin generation
599359|NCT01019759|Atrial fibrillation|atrial fibrillation
599360|NCT01019759|cardiac surgery|cardiac surgery
599361|NCT01019759|ablation|ablation
599362|NCT01019759|pulmonary veins|pulmonary veins
599363|NCT01019746|Hypnosis with propofol|hypnosis with propofol
599364|NCT01019733|Hypoxia|hypoxia
599365|NCT01019733|Ischemia|ischemia
599366|NCT01019733|Brain|brain
599367|NCT01019733|Children|children
599368|NCT01019733|Cerebral Palsy|cerebral palsy
599369|NCT01019707|crystal meth|crystal meth
599370|NCT01019707|methamphetamine|methamphetamine
599371|NCT01019707|substance abuse|substance abuse
599372|NCT01019681|Cord blood injection in peripheral vascular disease|cord blood injection in peripheral vascular disease
599373|NCT01019668|chorioretinopathy|chorioretinopathy
599374|NCT01019668|photodynamic therapy|photodynamic therapy
599375|NCT01019668|reduced fluence|reduced fluence
599376|NCT01019668|reduced dose|reduced dose
599377|NCT01019655|thrombophilia|thrombophilia
599378|NCT01019655|pregnancy|pregnancy
599379|NCT01019655|heparin|heparin
599380|NCT01019642|vitamin D|vitamin d
599381|NCT01019642|diabetes|diabetes
599382|NCT01019642|C-reactive protein|c-reactive protein
599383|NCT01019642|insulin resistance|insulin resistance
599384|NCT01019629|Fabry, Fabry Disease, Alpha-galactosidase A deficiency, GLA gene, mutations|fabry, fabry disease, alpha-galactosidase a deficiency, gla gene, mutations
599385|NCT01019603|Acne|acne
599386|NCT01019551|Controlled viremia|controlled viremia
599387|NCT01019551|Viral reservoirs|viral reservoirs
599388|NCT01019551|Virus eradication|virus eradication
599389|NCT01019551|Therapeutic intensification|therapeutic intensification
599390|NCT01019551|Immunointervention|immunointervention
599391|NCT01019538|Oxygen|oxygen
599392|NCT01019538|Hypoxemia|hypoxemia
599393|NCT01019538|Air travel|air travel
599394|NCT01019525|respiration|respiration
599395|NCT01019525|respiratory disorders|respiratory disorders
599396|NCT01019525|Otolaryngology|otolaryngology
599397|NCT01019525|Otorhinolaryngology|otorhinolaryngology
599398|NCT01019525|Posture|posture
599399|NCT01019499|human|human
599400|NCT01019499|intervention|intervention
599401|NCT01019499|blood pressure|blood pressure
599402|NCT01019499|cardiovascular risk factors|cardiovascular risk factors
599403|NCT01019499|polyphenols|polyphenols
599404|NCT01019499|bioavailability|bioavailability
599405|NCT01019486|Myocardial blood flow|myocardial blood flow
599406|NCT01019486|Cardiac magnetic resonance imaging|cardiac magnetic resonance imaging
599407|NCT01019486|Myocardial perfusion imaging|myocardial perfusion imaging
599408|NCT01019486|Coronary artery flow reserve|coronary artery flow reserve
599409|NCT01019486|Regadenoson|regadenoson
599410|NCT01019473|Huntington's disease|huntington's disease
599411|NCT01019473|Chorea|chorea
599412|NCT01019473|Dyskinesia|dyskinesia
599413|NCT01019460|Small intestine|small intestine
599414|NCT01019460|Magnetic resonance imaging|magnetic resonance imaging
599415|NCT01019460|Computed tomography scanning|computed tomography scanning
599416|NCT01019460|Capsule endoscopy|capsule endoscopy
599417|NCT01019447|Surgical site infection|surgical site infection
599418|NCT01019447|Antimicrobial triclosan-coated polyglactin 910 suture|antimicrobial triclosan-coated polyglactin 910 suture
599419|NCT01019447|Length of hospital stay|length of hospital stay
599420|NCT01019447|SSI|ssi
599421|NCT01019434|adult glioblastoma|adult glioblastoma
599422|NCT01019421|Cognition|cognition
599423|NCT01019408|Clinical Trial|clinical trial
599424|NCT01019408|Chloroquine|chloroquine
599425|NCT01019408|Refugees|refugees
599426|NCT01019408|Afghanistan|afghanistan
599427|NCT01019408|Pakistan|pakistan
599428|NCT01019395|Gram Positive Infection|gram positive infection
599429|NCT01019395|Concurrent Antibiotic Treatment|concurrent antibiotic treatment
599430|NCT01019382|pancreatic|pancreatic
599431|NCT01019382|carcinoma|carcinoma
599432|NCT01019382|cancer|cancer
599433|NCT01019382|fish|fish
599434|NCT01019382|alternative|alternative
599435|NCT01019369|Contraception|contraception
599436|NCT01019369|Medroxyprogesterone 17-acetate|medroxyprogesterone 17-acetate
599437|NCT01019369|Self administration|self administration
599438|NCT01019356|PCOS|pcos
599439|NCT01019343|Magnetic Resonance Imaging (MRI)|magnetic resonance imaging (mri)
599440|NCT01019343|Magnetoencephalogram|magnetoencephalogram
599441|NCT01019343|Electroencephalogram (EEG)|electroencephalogram (eeg)
599442|NCT01019343|Transcranial Magnetic Stimulation (TMS)|transcranial magnetic stimulation (tms)
599443|NCT01019343|Motor Deficit|motor deficit
599444|NCT01019343|Dystonia|dystonia
599445|NCT01019343|Movement Disorder|movement disorder
599446|NCT01019343|Parkinson Disease|parkinson disease
599447|NCT01019343|PD|pd
599448|NCT01019343|Tourette Syndrome|tourette syndrome
599449|NCT01019343|TS|ts
599450|NCT01019343|Tic Disorder|tic disorder
599451|NCT01019330|radial vs femoral|radial vs femoral
599452|NCT01019330|radial artery cardiac catheterization|radial artery cardiac catheterization
599453|NCT01019317|Acute Myelogenous Leukemia|acute myelogenous leukemia
599454|NCT01019317|High-Risk Myelodysplastic Syndrome|high-risk myelodysplastic syndrome
599455|NCT01019317|Chronic myeloid leukemia|chronic myeloid leukemia
599456|NCT01019317|CML|cml
599457|NCT01019317|Blast crisis|blast crisis
599458|NCT01019317|Cytarabine|cytarabine
599459|NCT01019317|Ara-C|ara-c
599460|NCT01019317|Cytosar|cytosar
599461|NCT01019317|DepoCyt|depocyt
599462|NCT01019317|Cytosine arabinosine hydrochloride|cytosine arabinosine hydrochloride
599463|NCT01019317|Arabinosine Hydrochloride|arabinosine hydrochloride
599464|NCT01019317|Fludarabine|fludarabine
599465|NCT01019317|Fludarabine Phosphate|fludarabine phosphate
599466|NCT01019317|Fludara|fludara
599467|NCT01019317|Gemtuzumab Ozogamicin|gemtuzumab ozogamicin
599468|NCT01019317|Mylotarg|mylotarg
599469|NCT01019291|Indoor pollutants|indoor pollutants
599470|NCT01019265|Norspan patch|norspan patch
599471|NCT01019265|Buprenorphine transdermal patch (BTDS)|buprenorphine transdermal patch (btds)
599472|NCT01019265|efficacy|efficacy
599473|NCT01019265|buprenorphine|buprenorphine
599474|NCT01019252|Adolescent|adolescent
599475|NCT01019252|ADHD|adhd
599476|NCT01019239|Non-faeculant|non-faeculant
599477|NCT01019239|Perforated|perforated
599478|NCT01019239|Diverticulitis|diverticulitis
599479|NCT01019226|myocardium|myocardium
599480|NCT01019226|Magnetic resonance imaging|magnetic resonance imaging
599481|NCT01019213|His-pacing|his-pacing
599482|NCT01019200|psoriasis|psoriasis
599483|NCT01019200|heart disease|heart disease
599484|NCT01019200|cardiovascular disease|cardiovascular disease
599485|NCT01019200|hyperlipidemia|hyperlipidemia
599486|NCT01019161|Acute Myeloid Leukaemia (AML)|acute myeloid leukaemia (aml)
599487|NCT01019161|AML|aml
599488|NCT01019161|AZD1152|azd1152
599489|NCT01019161|Pharmacokinetics|pharmacokinetics
599490|NCT01019135|Women|women
599491|NCT01019135|Cardiac Care Facilities|cardiac care facilities
599492|NCT01019135|Patient satisfaction|patient satisfaction
599493|NCT01019135|Patient participation|patient participation
599494|NCT01019135|Patient compliance|patient compliance
599495|NCT01019135|Randomized Control Trial|randomized control trial
599496|NCT01019135|Coronary artery bypass|coronary artery bypass
599497|NCT01019135|Angioplasty, transluminal, percutaneous coronary|angioplasty, transluminal, percutaneous coronary
599498|NCT01019109|scoliosis|scoliosis
599499|NCT01019096|iron|iron
599500|NCT01019096|pregnancy|pregnancy
599501|NCT01019096|heme iron|heme iron
599502|NCT01019096|non-heme iron|non-heme iron
599503|NCT01019096|stable isotopes|stable isotopes
599504|NCT01019096|women/adolescents|women/adolescents
599505|NCT01019083|Cholera|cholera
599506|NCT01019083|Typhoid|typhoid
599507|NCT01019083|Oral Vaccine|oral vaccine
599508|NCT01019083|Immune response|immune response
599509|NCT01019083|Vaccine Evaluation|vaccine evaluation
599510|NCT01019083|Nutrition|nutrition
599511|NCT01019083|Child Health|child health
599512|NCT01019057|DDD|ddd
599513|NCT01019057|decompression|decompression
599514|NCT01019057|spinous process plate|spinous process plate
599515|NCT01019044|HIV|hiv
599516|NCT01019044|Viral reservoirs|viral reservoirs
599517|NCT01019044|Viral load|viral load
599518|NCT01019018|subtenon block|subtenon block
599519|NCT01019005|post-operative analgesia|post-operative analgesia
599520|NCT01019005|opioid|opioid
599521|NCT01019005|catheter|catheter
599522|NCT01019005|tibial nerve block|tibial nerve block
599523|NCT01018992|PTSD|ptsd
599524|NCT01018992|Anxiety Disorder|anxiety disorder
599525|NCT01018992|Corticotropin releasing factor|corticotropin releasing factor
599526|NCT01018992|Women|women
599527|NCT01018927|Cardiac MR (CMR)|cardiac mr (cmr)
599528|NCT01018927|Early Myocardial Infiltration|early myocardial infiltration
599529|NCT01018927|Amyloid|amyloid
599530|NCT01018927|Light Chain Deposition Disease|light chain deposition disease
599531|NCT01018927|Multiple Myeloma|multiple myeloma
599532|NCT01018914|Prograf|prograf
599533|NCT01018914|Advagraf|advagraf
599534|NCT01018914|Myfortic|myfortic
599535|NCT01018888|Cornea|cornea
599536|NCT01018888|Transplantation, Cornea|transplantation, cornea
599537|NCT01018888|Keratoplasty|keratoplasty
599538|NCT01018888|Grafting, Corneal|grafting, corneal
599539|NCT01018849|Vitamin D|vitamin d
599540|NCT01018849|Cardiac Catheterization|cardiac catheterization
599541|NCT01018849|Cardiovascular event|cardiovascular event
599542|NCT01018849|Cardiovascular Disease|cardiovascular disease
599543|NCT01018836|tumors metastatic to brain|tumors metastatic to brain
599544|NCT01018836|unspecified adult solid tumor, protocol specific|unspecified adult solid tumor, protocol specific
599545|NCT01018810|Psoriasis|psoriasis
599546|NCT01018797|INTRASTROMAL CORNEAL RING|intrastromal corneal ring
599547|NCT01018797|ASTIGMATISM|astigmatism
599548|NCT01018797|POSTKERATOPLASTY|postkeratoplasty
599549|NCT01018797|EYES|eyes
599550|NCT01018797|To evaluate the clinical outcomes of ICRS implantation to correct high-degree astigmatism on eyes with prior penetrating keratoplasty (PK)|to evaluate the clinical outcomes of icrs implantation to correct high-degree astigmatism on eyes with prior penetrating keratoplasty (pk)
599551|NCT01018784|Cancer|cancer
599552|NCT01018784|Mesothelin-positive|mesothelin-positive
599553|NCT01018771|actifuse|actifuse
599554|NCT01018771|INFUSE|infuse
599555|NCT01018771|InductOs|inductos
599556|NCT01018771|DDD|ddd
599557|NCT01018771|Degenerative disc disease|degenerative disc disease
599558|NCT01018771|PLF|plf
599559|NCT01018771|posterolateral lumbar fusion|posterolateral lumbar fusion
599560|NCT01018771|bone substitute|bone substitute
599561|NCT01018771|bone graft|bone graft
599562|NCT01018771|synthetic bone substitute|synthetic bone substitute
599563|NCT01018771|spinal surgery|spinal surgery
599564|NCT01018758|Non-Hodgkin's lymphoma|non-hodgkin's lymphoma
599565|NCT01018758|Quality of life|quality of life
599566|NCT01018758|Chemotherapy toxicity|chemotherapy toxicity
599567|NCT01018758|aggressive Non Hodgkin's Lymphomas treated with moderately emetogenic chemotherapy|aggressive non hodgkin's lymphomas treated with moderately emetogenic chemotherapy
599568|NCT01018732|Meningococcal|meningococcal
599569|NCT01018732|ACWY|acwy
599570|NCT01018732|Conjugate Vaccine|conjugate vaccine
599571|NCT01018732|Meningitis|meningitis
599572|NCT01018732|Adolescents|adolescents
599573|NCT01018732|Persistence|persistence
599574|NCT01018719|breast cancer radiotherapy cardiotoxicity multidetector CT|breast cancer radiotherapy cardiotoxicity multidetector ct
599575|NCT01018719|Radiotherapy|radiotherapy
599576|NCT01018706|Primary pci|primary pci
599577|NCT01018706|Stent|stent
599578|NCT01018706|Medical Hystory|medical hystory
599579|NCT01018706|Antiplatelet therapy|antiplatelet therapy
599580|NCT01018706|Compliance|compliance
599581|NCT01018693|Seasonal allergic rhinitis,|seasonal allergic rhinitis,
599582|NCT01018693|late phase response,|late phase response,
599583|NCT01018693|alutard avanz,|alutard avanz,
599584|NCT01018693|immunotherapy,|immunotherapy,
599585|NCT01018693|visual analogue scale,|visual analogue scale,
599586|NCT01018693|mini rhinitis quality of life,|mini rhinitis quality of life,
599587|NCT01018693|immune modulation|immune modulation
599588|NCT01018667|Heart Failure|heart failure
599589|NCT01018667|clinical trial|clinical trial
599590|NCT01018667|biventricular pacing|biventricular pacing
599591|NCT01018667|cardiac device|cardiac device
599592|NCT01018654|Substance Abuse|substance abuse
599593|NCT01018654|Substance Addiction|substance addiction
599594|NCT01020708|colitis|colitis
599595|NCT01020708|inflammatory bowel disease|inflammatory bowel disease
599596|NCT01020708|ulcerative colitis|ulcerative colitis
599597|NCT01020708|rectal administration|rectal administration
599598|NCT01020708|enema|enema
599599|NCT01020708|mesalamine|mesalamine
599718|NCT01018056|OCD|ocd
599600|NCT01020487|Reduction of parathyroid hormone levels in pediatric patients with Chronic Kidney Disease Stage 3 and 4|reduction of parathyroid hormone levels in pediatric patients with chronic kidney disease stage 3 and 4
599601|NCT01020292|Adult subjects with a diagnosis of Grade IV Glioma|adult subjects with a diagnosis of grade iv glioma
599602|NCT01020097|Stage 1 squamous cell carcinoma of the larynx|stage 1 squamous cell carcinoma of the larynx
599697|NCT01018134|Topical corticosteroids|topical corticosteroids
599698|NCT01018134|Plaque psoriasis|plaque psoriasis
599699|NCT01018121|Behavioral Treatment|behavioral treatment
599603|NCT01019954|Adults with premalignant head and neck tumors and adults who have Carcinoma in situ of the head and neck in whom standard therapy is not indicated|adults with premalignant head and neck tumors and adults who have carcinoma in situ of the head and neck in whom standard therapy is not indicated
599604|NCT01019122|cerebral palsy|cerebral palsy
599605|NCT01019122|DEXA scan|dexa scan
599606|NCT01019122|bone density|bone density
599607|NCT01018641|Staphylococcus aureus|staphylococcus aureus
599608|NCT01018641|Vaccine|vaccine
599609|NCT01018615|chronic hepatitis C|chronic hepatitis c
599610|NCT01018615|silymarin|silymarin
599611|NCT01018615|green tea catechins|green tea catechins
599612|NCT01018615|green tea extract|green tea extract
599613|NCT01018615|pharmacokinetics|pharmacokinetics
599614|NCT01018615|antioxidant activity|antioxidant activity
599615|NCT01018589|Post surgical scars|post surgical scars
599616|NCT01018589|Epidermic burn|epidermic burn
599617|NCT01018589|Cicatrix cream|cicatrix cream
599618|NCT01018576|delayed cord clamping|delayed cord clamping
599619|NCT01018576|premature infants|premature infants
599620|NCT01018576|hypothermia|hypothermia
599621|NCT01018576|anemia|anemia
599622|NCT01018576|intraventricular hemorrhage|intraventricular hemorrhage
599623|NCT01018576|Anemia in premature infants|anemia in premature infants
599624|NCT01018563|Extension study|extension study
599625|NCT01018563|Epithelial ovarian cancer|epithelial ovarian cancer
599626|NCT01018537|Multiple Sclerosis|multiple sclerosis
599627|NCT01018537|NARCOMS|narcoms
599628|NCT01018537|Global Patient Registry|global patient registry
599629|NCT01018524|position of the mesh|position of the mesh
599630|NCT01018524|recurrence rate|recurrence rate
599631|NCT01018524|surgical procedure|surgical procedure
599632|NCT01018524|long time outcome|long time outcome
599633|NCT01018511|EC905|ec905
599634|NCT01018511|Solifenacin succinate|solifenacin succinate
599635|NCT01018511|Tamsulosin hydrochloride OCAS|tamsulosin hydrochloride ocas
599636|NCT01018511|Treatment|treatment
599637|NCT01018511|Benign Prostatic Hyperplasia|benign prostatic hyperplasia
599638|NCT01018511|Vesomni|vesomni
599639|NCT01018511|Lower Urinary Tract Symptoms|lower urinary tract symptoms
599640|NCT01018498|Irritable Bowel Syndrome|irritable bowel syndrome
599641|NCT01018498|Children|children
599642|NCT01018472|cyanotic heart disease|cyanotic heart disease
599643|NCT01018472|congenital heart disease|congenital heart disease
599644|NCT01018472|intestinal microbiota|intestinal microbiota
599645|NCT01018472|probiotics|probiotics
599646|NCT01018459|malaria, vaccine, Burkina Faso|malaria, vaccine, burkina faso
599647|NCT01018446|Hematopoietic stem cell transplantation with busulfan based conditioning|hematopoietic stem cell transplantation with busulfan based conditioning
599648|NCT01018433|self-injury|self-injury
599649|NCT01018433|non-suicidal self-injury|non-suicidal self-injury
599650|NCT01018433|deliberate self-harm|deliberate self-harm
599651|NCT01018433|self-mutilation|self-mutilation
599652|NCT01018420|healthy|healthy
599653|NCT01018394|tobacco dependence|tobacco dependence
599654|NCT01018394|tobacco reduction|tobacco reduction
599655|NCT01018394|chewing tobacco|chewing tobacco
599656|NCT01018394|snuff|snuff
599657|NCT01018394|moist snuff|moist snuff
599658|NCT01018381|HCC|hcc
599659|NCT01018381|HBV|hbv
599660|NCT01018381|MGN-3|mgn-3
599661|NCT01018381|BioBran|biobran
599662|NCT01018381|Alternative Therapy|alternative therapy
599663|NCT01018355|Patent foramen ovale|patent foramen ovale
599664|NCT01018355|PFO|pfo
599665|NCT01018355|Stroke|stroke
599666|NCT01018355|TIA|tia
599667|NCT01018355|Percutaneus closure|percutaneus closure
599668|NCT01018355|Intervention|intervention
599669|NCT01018329|Adult Brain Tumor|adult brain tumor
599670|NCT01018316|preoxygenation|preoxygenation
599671|NCT01018316|UMOX|umox
599672|NCT01018303|cystic fibrosis|cystic fibrosis
599673|NCT01018303|vitamins|vitamins
599674|NCT01018303|antioxidants|antioxidants
599675|NCT01018303|anthropometric measurements|anthropometric measurements
599676|NCT01018303|pulmonary function|pulmonary function
599677|NCT01018264|Overactive bladder|overactive bladder
599678|NCT01018264|Urinary incontinence|urinary incontinence
599679|NCT01018264|Urinary frequency|urinary frequency
599680|NCT01018264|Parkinson's disease|parkinson's disease
599681|NCT01018212|Cutaneous Groves|cutaneous groves
599682|NCT01018199|C-reactive protein|c-reactive protein
599683|NCT01018199|procalcitonin|procalcitonin
599684|NCT01018199|community-acquired pneumonia|community-acquired pneumonia
599685|NCT01018199|antibiotic therapy|antibiotic therapy
599686|NCT01018160|Rabeprazole sodium|rabeprazole sodium
599687|NCT01018160|Gastroesophageal Reflux|gastroesophageal reflux
599688|NCT01018160|GERD|gerd
599689|NCT01018160|Observational|observational
599690|NCT01018147|stage IIIA non-small cell lung cancer|stage iiia non-small cell lung cancer
599691|NCT01018147|stage IIIB non-small cell lung cancer|stage iiib non-small cell lung cancer
599692|NCT01018147|stage IA non-small cell lung cancer|stage ia non-small cell lung cancer
599693|NCT01018147|stage IB non-small cell lung cancer|stage ib non-small cell lung cancer
599694|NCT01018147|stage IIA non-small cell lung cancer|stage iia non-small cell lung cancer
599695|NCT01018147|stage IIB non-small cell lung cancer|stage iib non-small cell lung cancer
599696|NCT01018134|Psoriasis|psoriasis
599700|NCT01018121|Preschool Children|preschool children
599701|NCT01018121|Obesity Treatment|obesity treatment
599702|NCT01018069|Acute|acute
599703|NCT01018069|myeloid|myeloid
599704|NCT01018069|leukemia|leukemia
599705|NCT01018069|antisense|antisense
599706|NCT01018069|chemotherapy|chemotherapy
599707|NCT01018069|idarubicin|idarubicin
599708|NCT01018069|cytarabine|cytarabine
599709|NCT01018069|Patients with AML, except those with APL (acute promyelocytic leukemia), failing a single standard dose cytarabine based frontline induction regimen.|patients with aml, except those with apl (acute promyelocytic leukemia), failing a single standard dose cytarabine based frontline induction regimen.
599710|NCT01018056|Tourette syndrome|tourette syndrome
599711|NCT01018056|glutamatergic therapy|glutamatergic therapy
599712|NCT01018056|D-serine|d-serine
599713|NCT01018056|riluzole|riluzole
599714|NCT01018056|glutamate|glutamate
599715|NCT01018056|glutamate agonist|glutamate agonist
599716|NCT01018056|glutamate antagonist|glutamate antagonist
599717|NCT01018056|Tourette syndrome treatment study|tourette syndrome treatment study
599719|NCT01018056|tics|tics
599720|NCT01018043|Cancer Anemia Survey|cancer anemia survey
599721|NCT01018043|Chulalongkorn hospital|chulalongkorn hospital
599722|NCT01018030|uncomplicated acute rhinosinusitis|uncomplicated acute rhinosinusitis
599723|NCT01018030|fluticasone furoate|fluticasone furoate
599724|NCT01018030|sinusitis|sinusitis
599725|NCT01018004|stage IB melanoma|stage ib melanoma
599726|NCT01018004|stage II melanoma|stage ii melanoma
599727|NCT01017991|infants|infants
599728|NCT01017991|formula|formula
599729|NCT01017991|probiotic|probiotic
599730|NCT01017991|crying|crying
599731|NCT01017965|Type 1 diabetes|type 1 diabetes
599732|NCT01017952|Safety|safety
599733|NCT01017952|COPD|copd
599734|NCT01017952|FEV1|fev1
599735|NCT01017952|Efficacy|efficacy
599736|NCT01017939|Prostate neoplasms|prostate neoplasms
599737|NCT01017939|Metastatic castration resistant prostate cancer|metastatic castration resistant prostate cancer
599738|NCT01017939|Metastatic castration refractory prostate cancer|metastatic castration refractory prostate cancer
599739|NCT01017939|Prostate cancer|prostate cancer
599740|NCT01017939|Abiraterone acetate|abiraterone acetate
599741|NCT01017939|CB7630|cb7630
599742|NCT01017926|Triazolam bioequivalence|triazolam bioequivalence
599743|NCT01017913|rehabilitation|rehabilitation
599744|NCT01017913|electrotherapy|electrotherapy
599745|NCT01017913|back pain|back pain
599746|NCT01017900|surgery|surgery
599747|NCT01017900|manual rupture|manual rupture
599748|NCT01017900|dorsal carpal ganglion|dorsal carpal ganglion
599749|NCT01017887|laparoscopy|laparoscopy
599750|NCT01017887|airseal|airseal
599751|NCT01017887|carbon dioxide|carbon dioxide
599752|NCT01017887|insufflation|insufflation
599753|NCT01017887|pneumoperitoneum|pneumoperitoneum
599754|NCT01017861|Temporal summation|temporal summation
599755|NCT01017861|Venipuncture pain|venipuncture pain
599756|NCT01017848|diabetes|diabetes
599757|NCT01017848|urine pH|urine ph
599758|NCT01017848|insulin resistance|insulin resistance
599759|NCT01017848|metabolic syndrome|metabolic syndrome
599760|NCT01017848|development of diabetes|development of diabetes
599761|NCT01017835|statins|statins
599762|NCT01017835|isolated hypertension|isolated hypertension
599763|NCT01017835|atherosclerosis|atherosclerosis
599764|NCT01017835|lipid profile|lipid profile
599765|NCT01017822|adenocarcinoma of the pancreas|adenocarcinoma of the pancreas
599766|NCT01017822|stage III pancreatic cancer|stage iii pancreatic cancer
599767|NCT01017809|ovarian|ovarian
599768|NCT01017809|chemotherapy|chemotherapy
599769|NCT01017809|nausea|nausea
599770|NCT01017796|Contrast induced nephropathy|contrast induced nephropathy
599771|NCT01017770|Uncomplicated malaria|uncomplicated malaria
599772|NCT01017757|Interstitial lung disease|interstitial lung disease
599773|NCT01017757|Immunosuppressive therapy|immunosuppressive therapy
599774|NCT01017757|Renal transplant|renal transplant
599775|NCT01017744|Anesthetic Conserving Device|anesthetic conserving device
599776|NCT01017744|Anaconda®|anaconda®
599777|NCT01017744|Sevoflurane|sevoflurane
599778|NCT01017744|Remifentanil|remifentanil
599779|NCT01017744|Sedation|sedation
599780|NCT01017744|Pressure support ventilation|pressure support ventilation
599781|NCT01017744|Work of breathing|work of breathing
599782|NCT01017744|Intrinsic positive end expiratory pressure|intrinsic positive end expiratory pressure
599783|NCT01017744|Ventilatory dead space|ventilatory dead space
599784|NCT01017744|Intensive care|intensive care
599785|NCT01017744|Weaning of mechanical ventilation|weaning of mechanical ventilation
599786|NCT01017744|Ventilated ICU patients in PSV|ventilated icu patients in psv
599787|NCT01017744|No more in acute state|no more in acute state
599788|NCT01017744|No respiratory distress|no respiratory distress
599789|NCT01017744|Sedated by intravenous remifentanil|sedated by intravenous remifentanil
599790|NCT01017744|In light sedation as define by a Richmond Agitation Sedation Scale (RASS) of - 1 to - 2.|in light sedation as define by a richmond agitation sedation scale (rass) of - 1 to - 2.
599791|NCT01017731|Advanced Solid tumor|advanced solid tumor
599792|NCT01017731|Antibodies, Monoclonal|antibodies, monoclonal
599794|NCT01017731|Metastatic|metastatic
599795|NCT01017731|Malignant|malignant
599796|NCT01017718|Diabetes mellitus type I|diabetes mellitus type i
599797|NCT01017718|nerve conduction velocity|nerve conduction velocity
599798|NCT01017718|Young score|young score
599799|NCT01017718|long term vascular complications|long term vascular complications
599800|NCT01017666|Healthy Volunteer|healthy volunteer
599801|NCT01017653|Panitumumab|panitumumab
599802|NCT01017653|Vectibix|vectibix
599803|NCT01017653|Irinotecan|irinotecan
599804|NCT01017653|CPT-11|cpt-11
599805|NCT01017653|Camptosar|camptosar
599806|NCT01017653|Malignant glioma|malignant glioma
599807|NCT01017653|Glioblastoma multiforme|glioblastoma multiforme
599808|NCT01017653|Gliosarcoma|gliosarcoma
599809|NCT01017653|Duke|duke
599810|NCT01017653|Vredenburgh|vredenburgh
599811|NCT01017653|Pro00015447|pro00015447
599812|NCT01017627|ESRD|esrd
599813|NCT01017627|Anemia|anemia
599814|NCT01017627|Hospitalizations|hospitalizations
599815|NCT01017627|Mortality|mortality
599816|NCT01017614|Inflammatory Bowel Disease|inflammatory bowel disease
599817|NCT01017614|Iron deficiency|iron deficiency
599818|NCT01017614|Iron deficiency anaemia|iron deficiency anaemia
599819|NCT01017614|Anaemia|anaemia
599820|NCT01017601|extensive stage small cell lung cancer|extensive stage small cell lung cancer
599821|NCT01017588|lumbar support|lumbar support
599822|NCT01017588|rubber tapper|rubber tapper
599823|NCT01017562|To clarify the 18F-fluoride uptake patterns associated with aseptic or septic loosening|to clarify the 18f-fluoride uptake patterns associated with aseptic or septic loosening
599824|NCT01017549|Stage I|stage i
599825|NCT01017549|Stage II|stage ii
599826|NCT01017549|Breast|breast
599827|NCT01017549|Cancer|cancer
599828|NCT01017536|HIV|hiv
599829|NCT01017536|Tuberculosis|tuberculosis
599830|NCT01017536|Vaccine|vaccine
599831|NCT01017523|diabetes|diabetes
599832|NCT01017523|relationship|relationship
599833|NCT01017523|social support|social support
599834|NCT01017523|telemedicine|telemedicine
599835|NCT01017497|Brain Metastases|brain metastases
599836|NCT01017484|blood pressure|blood pressure
599837|NCT01017484|DASH diet|dash diet
599838|NCT01017484|hypertension|hypertension
599839|NCT01017471|carpal tunnel syndrome|carpal tunnel syndrome
599840|NCT01017471|surgery|surgery
599841|NCT01017471|PSU retractor|psu retractor
599842|NCT01017471|carpal tunnel syndrome who failed to conservative treatment|carpal tunnel syndrome who failed to conservative treatment
599843|NCT01017458|Healthy Adults|healthy adults
599844|NCT01017445|osteoarthritis, exercise|osteoarthritis, exercise
599845|NCT01017419|hearing aids|hearing aids
599846|NCT01017419|counseling|counseling
599847|NCT01017406|plantar fasciitis|plantar fasciitis
599848|NCT01017406|heel cushion|heel cushion
599849|NCT01017406|treatment|treatment
599850|NCT01017393|preemptive epidural ketamine|preemptive epidural ketamine
599851|NCT01017393|prevention of chronic post-thoracotomy pain|prevention of chronic post-thoracotomy pain
599852|NCT01017380|preemptive analgesia|preemptive analgesia
599853|NCT01017380|cruciate ligament|cruciate ligament
599854|NCT01017367|RA|ra
599855|NCT01017367|inflammatory joint disease|inflammatory joint disease
599856|NCT01017354|vitamin D|vitamin d
599857|NCT01017354|function|function
599858|NCT01017354|falls|falls
599859|NCT01017354|25-hydroxyvitamin D|25-hydroxyvitamin d
599860|NCT01017354|disability|disability
599861|NCT01017341|hip fracture|hip fracture
599862|NCT01017341|back support|back support
599863|NCT01017328|infants and children undergoing surgery with general anesthesia|infants and children undergoing surgery with general anesthesia
599864|NCT01017315|baby talcum|baby talcum
599865|NCT01017315|pruritus|pruritus
599866|NCT01017315|cast|cast
599867|NCT01017276|Hyperphosphatemia|hyperphosphatemia
599868|NCT01017276|Peritoneal dialysis|peritoneal dialysis
599869|NCT01017276|CKD|ckd
599870|NCT01017276|ASP1585|asp1585
599871|NCT01017263|ADHD|adhd
599872|NCT01017263|Glucose Intolerance|glucose intolerance
599873|NCT01017263|Obesity|obesity
599874|NCT01017263|Vyvanse|vyvanse
599875|NCT01017250|Recurrent|recurrent
599876|NCT01017237|Dexmedetomidine sedation|dexmedetomidine sedation
599877|NCT01017237|Oral surgery sedation|oral surgery sedation
599878|NCT01017237|Dexmedetomidine amnesia|dexmedetomidine amnesia
599879|NCT01017211|Pain|pain
599880|NCT01017211|Electromyography|electromyography
599881|NCT01017211|Acupuncture|acupuncture
599882|NCT01017211|Randomized controlled trial|randomized controlled trial
599883|NCT01017211|Rehabilitation|rehabilitation
599884|NCT01017159|Polyradiculoneuropathy, Chronic Inflammatory Demyelinating|polyradiculoneuropathy, chronic inflammatory demyelinating
599885|NCT01017159|Subcutaneous immunoglobulin|subcutaneous immunoglobulin
599886|NCT01017146|Ance|ance
599887|NCT01017120|Acne|acne
599888|NCT01017107|acute pancreatitis|acute pancreatitis
599889|NCT01017107|treatment|treatment
599890|NCT01017107|organ failure|organ failure
599891|NCT01017107|activated protein c|activated protein c
599892|NCT01017094|Pin-site infection|pin-site infection
599893|NCT01017094|silversulfadiazine|silversulfadiazine
599894|NCT01017094|open fracture|open fracture
599988|NCT01016756|Brain malformation|brain malformation
599895|NCT01017094|open tibial fracture underwent external fixator|open tibial fracture underwent external fixator
599896|NCT01017081|physiotherapy|physiotherapy
599897|NCT01017081|children|children
599898|NCT01017081|clinical trial|clinical trial
599899|NCT01017068|GLAUCOMA|glaucoma
599900|NCT01017042|healthy|healthy
599901|NCT01017042|blood levels|blood levels
599902|NCT01017003|healthy|healthy
599903|NCT01017003|pharmacokinetics|pharmacokinetics
599904|NCT01016990|recurrent adult Hodgkin lymphoma|recurrent adult hodgkin lymphoma
599905|NCT01016990|recurrent adult Burkitt lymphoma|recurrent adult burkitt lymphoma
599906|NCT01016990|recurrent adult diffuse large cell lymphoma|recurrent adult diffuse large cell lymphoma
599907|NCT01016990|recurrent adult diffuse mixed cell lymphoma|recurrent adult diffuse mixed cell lymphoma
599908|NCT01016990|recurrent adult lymphoblastic lymphoma|recurrent adult lymphoblastic lymphoma
599909|NCT01016990|recurrent grade 3 follicular lymphoma|recurrent grade 3 follicular lymphoma
599910|NCT01016990|recurrent mantle cell lymphoma|recurrent mantle cell lymphoma
599911|NCT01016990|recurrent grade 1 follicular lymphoma|recurrent grade 1 follicular lymphoma
599912|NCT01016990|recurrent grade 2 follicular lymphoma|recurrent grade 2 follicular lymphoma
599913|NCT01016990|recurrent marginal zone lymphoma|recurrent marginal zone lymphoma
599914|NCT01016990|recurrent small lymphocytic lymphoma|recurrent small lymphocytic lymphoma
599915|NCT01016990|refractory chronic lymphocytic leukemia|refractory chronic lymphocytic leukemia
599916|NCT01016990|recurrent cutaneous T-cell non-Hodgkin lymphoma|recurrent cutaneous t-cell non-hodgkin lymphoma
599917|NCT01016990|peripheral T-cell lymphoma|peripheral t-cell lymphoma
599918|NCT01016990|AIDS-related peripheral/systemic lymphoma|aids-related peripheral/systemic lymphoma
599919|NCT01016990|AIDS-related diffuse large cell lymphoma|aids-related diffuse large cell lymphoma
599920|NCT01016990|AIDS-related immunoblastic large cell lymphoma|aids-related immunoblastic large cell lymphoma
599921|NCT01016990|AIDS-related small noncleaved cell lymphoma|aids-related small noncleaved cell lymphoma
599922|NCT01016990|AIDS-related diffuse mixed cell lymphoma|aids-related diffuse mixed cell lymphoma
599923|NCT01016990|AIDS-related diffuse small cleaved cell lymphoma|aids-related diffuse small cleaved cell lymphoma
599924|NCT01016990|AIDS-related lymphoblastic lymphoma|aids-related lymphoblastic lymphoma
599925|NCT01016990|Waldenström macroglobulinemia|waldenström macroglobulinemia
599926|NCT01016964|Androgenetic Alopecia|androgenetic alopecia
599927|NCT01016964|Hair Loss|hair loss
599928|NCT01016964|Female Pattern Baldness|female pattern baldness
599929|NCT01016951|Phase I|phase i
599930|NCT01016951|Safety study|safety study
599931|NCT01016951|AZD9164|azd9164
599932|NCT01016925|femoral perineural catheter|femoral perineural catheter
599933|NCT01016925|tunnelization|tunnelization
599934|NCT01016925|complication|complication
599935|NCT01016925|colonization|colonization
599936|NCT01016925|infection|infection
599937|NCT01016899|Electronic|electronic
599938|NCT01016899|Brachytherapy|brachytherapy
599939|NCT01016899|Nonmelanoma|nonmelanoma
599940|NCT01016899|cancer|cancer
599941|NCT01016886|trastuzumab|trastuzumab
599942|NCT01016886|cardiac MRI|cardiac mri
599943|NCT01016886|beta-blocker|beta-blocker
599944|NCT01016886|biomarkers|biomarkers
599945|NCT01016886|angiotensin converting enzyme inhibitor|angiotensin converting enzyme inhibitor
599946|NCT01016886|cardiotoxicity|cardiotoxicity
599947|NCT01016886|HER2 positive|her2 positive
599948|NCT01016873|Oraya|oraya
599949|NCT01016873|Oraya Therapeutics, Inc.|oraya therapeutics, inc.
599950|NCT01016873|low voltage stereotactic radiotherapy|low voltage stereotactic radiotherapy
599951|NCT01016873|radiotherapy|radiotherapy
599952|NCT01016873|IRay|iray
599953|NCT01016873|Ranibizumab|ranibizumab
599954|NCT01016873|Lucentis|lucentis
599955|NCT01016873|AMD|amd
599956|NCT01016873|Macular Degeneration|macular degeneration
599957|NCT01016873|xray|xray
599958|NCT01016873|radiation|radiation
599959|NCT01016873|x ray|x ray
599960|NCT01016873|external beam radiation|external beam radiation
599961|NCT01016873|radiosurgery|radiosurgery
599962|NCT01016860|OSI-906, irinotecan, colorectal cancer|osi-906, irinotecan, colorectal cancer
599963|NCT01016834|migraine|migraine
599964|NCT01016834|treatment satisfaction|treatment satisfaction
599965|NCT01016821|Oxycodone|oxycodone
599966|NCT01016821|Labour pain|labour pain
599967|NCT01016821|Pregnancy|pregnancy
599968|NCT01016821|Pregnant women|pregnant women
599969|NCT01016808|Bunionectomy|bunionectomy
599970|NCT01016808|Opioids|opioids
599971|NCT01016795|SCF|scf
599972|NCT01016795|Priming|priming
599973|NCT01016795|Mobilization|mobilization
599974|NCT01016795|Lymphoma|lymphoma
599975|NCT01016795|Clinical Trial|clinical trial
599976|NCT01016782|Inflammatory Rosacea|inflammatory rosacea
599977|NCT01016782|Rosacea|rosacea
599978|NCT01016769|Paclitaxel|paclitaxel
599979|NCT01016769|Carboplatin|carboplatin
599980|NCT01016769|Temsirolimus|temsirolimus
599981|NCT01016769|Head and Neck|head and neck
599982|NCT01016769|recurrent and/or metastatic|recurrent and/or metastatic
599983|NCT01016769|09-131|09-131
599984|NCT01016756|PHACE syndrome|phace syndrome
599985|NCT01016756|Hemangioma|hemangioma
599986|NCT01016756|Coarctation of aorta|coarctation of aorta
599987|NCT01016756|Dandy Walker|dandy walker
599989|NCT01016756|Eye anomaly|eye anomaly
599990|NCT01016756|Sternal malformation|sternal malformation
599991|NCT01016756|Genetic analysis|genetic analysis
599992|NCT01016756|Cerebral artery anomaly|cerebral artery anomaly
599993|NCT01016743|parkinson|parkinson
599994|NCT01016743|rTMS|rtms
599995|NCT01016717|clopidogrel|clopidogrel
599996|NCT01016717|platelet function|platelet function
599997|NCT01016717|omeprazole|omeprazole
599998|NCT01016717|pantoprazole|pantoprazole
599999|NCT01016717|coronary disease|coronary disease
600000|NCT01016665|Breast cancer|breast cancer
600001|NCT01016665|Short Term|short term
600002|NCT01016665|Homontherapy|homontherapy
600003|NCT01016665|aromatase inhibitor|aromatase inhibitor
600004|NCT01016665|Short term hormonetherapy in breast cancer|short term hormonetherapy in breast cancer
600005|NCT01016639|Stomach cancer|stomach cancer
600006|NCT01016639|Gall bladder cancer|gall bladder cancer
600007|NCT01016639|Bile ductus cancer|bile ductus cancer
600008|NCT01016639|Pancreas cancer|pancreas cancer
600009|NCT01016639|Colorectal cancer|colorectal cancer
600010|NCT01016639|Chemo radiotherapy|chemo radiotherapy
600011|NCT01016639|Phase I-II|phase i-ii
600012|NCT01016639|Oxaliplatin|oxaliplatin
600013|NCT01016639|Capecitabine|capecitabine
600014|NCT01016639|Response|response
600015|NCT01016626|Pharmacokinetics|pharmacokinetics
600016|NCT01016626|Healthy volunteers|healthy volunteers
600017|NCT01016626|Mycophenolate Mofetil|mycophenolate mofetil
600018|NCT01016613|chronic kidney disease|chronic kidney disease
600019|NCT01016613|glomerulonephritis|glomerulonephritis
600020|NCT01016613|proteinuria|proteinuria
600021|NCT01016613|nephrotic syndrome|nephrotic syndrome
600022|NCT01016613|nephropathy|nephropathy
600023|NCT01016613|biobank|biobank
600024|NCT01016587|symptoms|symptoms
600025|NCT01016587|dyspnea|dyspnea
600026|NCT01016587|pain|pain
600027|NCT01016587|fatigue|fatigue
600028|NCT01016587|anxiety|anxiety
600029|NCT01016587|depression|depression
600030|NCT01016587|sleeplessness|sleeplessness
600031|NCT01016587|genetic markers|genetic markers
600032|NCT01016587|immune markers|immune markers
600033|NCT01016587|COPD|copd
600034|NCT01016587|Quality of Life|quality of life
600035|NCT01016548|Lymphoma|lymphoma
600036|NCT01016548|Multiple myeloma|multiple myeloma
600037|NCT01016548|Leukemia, Lymphocytic, Chronic, B-Cell|leukemia, lymphocytic, chronic, b-cell
600038|NCT01016548|Influenza A Virus, H1N1 Subtype|influenza a virus, h1n1 subtype
600039|NCT01016548|Influenza Vaccines|influenza vaccines
600040|NCT01016548|Bone Marrow Transplantation|bone marrow transplantation
600041|NCT01016535|Family Health Program|family health program
600042|NCT01016535|Hygiene|hygiene
600043|NCT01016535|Child Health|child health
600044|NCT01016522|ALS|als
600045|NCT01016522|Ketogenic Diet|ketogenic diet
600046|NCT01016509|restenosis|restenosis
600047|NCT01016509|insulin|insulin
600048|NCT01016509|hyperglycemia|hyperglycemia
600049|NCT01016496|Cerebral Palsy|cerebral palsy
600050|NCT01016496|Mirror neurons|mirror neurons
600051|NCT01016496|hemiplegia|hemiplegia
600052|NCT01016496|action observation therapy|action observation therapy
600053|NCT01016496|children affected by hemiplegia as a consequence of Cerebral Palsy|children affected by hemiplegia as a consequence of cerebral palsy
600054|NCT01016483|MEK inhibitor|mek inhibitor
600055|NCT01016483|cancer|cancer
600056|NCT01016483|pancreatic Adenocarcinoma|pancreatic adenocarcinoma
600057|NCT01016483|metastatic|metastatic
600058|NCT01016483|chemo-naive|chemo-naive
600059|NCT01016483|phase II|phase ii
600060|NCT01016457|Diabetes Mellitus|diabetes mellitus
600061|NCT01016444|asthma|asthma
600062|NCT01016444|albuterol|albuterol
600063|NCT01016444|B2AR receptors|b2ar receptors
600064|NCT01016444|Acute asthma responsive and unresponsive to albuterol|acute asthma responsive and unresponsive to albuterol
600065|NCT01016431|cardiac pacing|cardiac pacing
600066|NCT01016431|heart failure|heart failure
600067|NCT01016431|oxygen consumption|oxygen consumption
600068|NCT01016431|ventricular dysfunction|ventricular dysfunction
600069|NCT01016431|left, exercise tolerance|left, exercise tolerance
600070|NCT01016431|chronotropic incompetence|chronotropic incompetence
600071|NCT01016431|pacemaker programming|pacemaker programming
600072|NCT01016418|NASH|nash
600073|NCT01016418|fatty liver disease|fatty liver disease
600074|NCT01016418|colostrum|colostrum
600075|NCT01016405|Dry eye|dry eye
600076|NCT01016405|incidence and severity|incidence and severity
600077|NCT01016405|cataract surgery|cataract surgery
600078|NCT01016392|Observational post-authorization safety study on Kuvan®.|observational post-authorization safety study on kuvan®.
600079|NCT01016379|untreated childhood acute lymphoblastic leukemia|untreated childhood acute lymphoblastic leukemia
600080|NCT01016379|recurrent childhood acute lymphoblastic leukemia|recurrent childhood acute lymphoblastic leukemia
600081|NCT01016366|Friedreich's Ataxia|friedreich's ataxia
600082|NCT01016366|FRDA|frda
600083|NCT01016366|Neurodegenerative|neurodegenerative
600084|NCT01016366|Erythropoietin|erythropoietin
600085|NCT01016366|Carbamylated|carbamylated
600086|NCT01016366|Neuroprotection|neuroprotection
600087|NCT01016366|Frataxin|frataxin
600088|NCT01016353|ABThera|abthera
600089|NCT01016353|Barker's Vacuum Packing Technique|barker's vacuum packing technique
600090|NCT01016340|Male Oligoasthenospermia|male oligoasthenospermia
600092|NCT01016327|Phase I study|phase i study
600093|NCT01016327|Advanced Solid Tumors|advanced solid tumors
600094|NCT01016327|Cdc7 kinase inhibitor|cdc7 kinase inhibitor
600095|NCT01016288|EUS-FNA|eus-fna
600096|NCT01016288|22 Gauge Needle|22 gauge needle
600097|NCT01016288|25 Gauge Needle|25 gauge needle
600098|NCT01016275|To obtain the first iliac long-term results for a patient cohort treated with nitinol stents only|to obtain the first iliac long-term results for a patient cohort treated with nitinol stents only
600099|NCT01016262|Ulcerative proctitis|ulcerative proctitis
600100|NCT01016262|Proctocolitis|proctocolitis
600101|NCT01016262|Inflammatory Bowel Disease|inflammatory bowel disease
600102|NCT01016262|Gastrointestinal Diseases|gastrointestinal diseases
600103|NCT01016262|Colonic Diseases|colonic diseases
600104|NCT01016262|Mesalamine|mesalamine
600105|NCT01016262|5-ASA|5-asa
600106|NCT01016249|Bronchiolitis, Viral|bronchiolitis, viral
600107|NCT01016249|An acute inflammation of the upper RESPIRATORY TRACT|an acute inflammation of the upper respiratory tract
600108|NCT01016223|Eosinophilic esophagitis|eosinophilic esophagitis
600109|NCT01016223|Beclomethasone|beclomethasone
600110|NCT01016223|Ultrasensitive CRP|ultrasensitive crp
600111|NCT01016210|pregnancy|pregnancy
600112|NCT01016210|IVF|ivf
600113|NCT01016197|Soft tissue mallet finger|soft tissue mallet finger
600114|NCT01016184|Quality of life|quality of life
600115|NCT01016158|Umbilical cord serum|umbilical cord serum
600116|NCT01016158|Recurrent corneal erosion|recurrent corneal erosion
600117|NCT01016145|Schizophrenia|schizophrenia
600118|NCT01016145|predictors of response|predictors of response
600119|NCT01016145|antipsychotics|antipsychotics
600120|NCT01016145|18-45 years old|18-45 years old
600121|NCT01016145|non-refractory|non-refractory
600122|NCT01016106|eczema|eczema
600123|NCT01016106|atopic dermatitis|atopic dermatitis
600124|NCT01016106|dry skin|dry skin
600125|NCT01016106|ichthyosis vulgaris|ichthyosis vulgaris
600126|NCT01016093|Thalassemia|thalassemia
600127|NCT01016093|BMT|bmt
600128|NCT01016093|HSCT|hsct
600129|NCT01016080|glutathione|glutathione
600130|NCT01016080|melanin|melanin
600131|NCT01016080|whitening|whitening
600132|NCT01016080|UV spots|uv spots
600133|NCT01016080|skin pigment|skin pigment
600134|NCT01016067|Tibia|tibia
600135|NCT01016067|Tibial|tibial
600136|NCT01016067|Fracture|fracture
600137|NCT01016067|Nonunion|nonunion
600138|NCT01016067|delayed|delayed
600139|NCT01016067|healing|healing
600140|NCT01016067|iliac|iliac
600141|NCT01016067|crest|crest
600142|NCT01016067|autograft|autograft
600143|NCT01016067|INFUSE|infuse
600144|NCT01016067|MASTERGRAFT|mastergraft
600145|NCT01016067|Fixation|fixation
600146|NCT01016067|Internal|internal
600147|NCT01016054|Clinical Trial, Phase1|clinical trial, phase1
600148|NCT01016054|Combination Drug Therapy|combination drug therapy
600149|NCT01016054|pharmacokinetics|pharmacokinetics
600150|NCT01016054|safety|safety
600151|NCT01016054|Ovarian|ovarian
600152|NCT01016041|drug-eluting stent|drug-eluting stent
600153|NCT01016041|stable angina|stable angina
600154|NCT01016041|ACS|acs
600155|NCT01016041|MACE|mace
600156|NCT01016041|safety|safety
600157|NCT01016041|stent thrombosis|stent thrombosis
600158|NCT01016028|Cancer|cancer
600159|NCT01016028|Colorectum Cancer|colorectum cancer
600160|NCT01016028|Colorectal disease|colorectal disease
600161|NCT01016028|neuropathic symptom tool|neuropathic symptom tool
600162|NCT01016028|chemotherapy-induced peripheral neuropathy|chemotherapy-induced peripheral neuropathy
600163|NCT01016028|CIPN|cipn
600164|NCT01016028|Pain|pain
600165|NCT01016028|Quantitative Sensory Testing|quantitative sensory testing
600166|NCT01016028|QST|qst
600167|NCT01016028|symptom measurement tools|symptom measurement tools
600168|NCT01016028|platinum agents|platinum agents
600169|NCT01016028|cisplatin|cisplatin
600170|NCT01016028|oxaliplatin|oxaliplatin
600171|NCT01016028|taxanes|taxanes
600172|NCT01016028|bortezomib|bortezomib
600173|NCT01015989|HIV treatment|hiv treatment
600174|NCT01015989|ART adherence|art adherence
600175|NCT01015989|Using new technology to improve adherence|using new technology to improve adherence
600176|NCT01015989|CARE+|care+
600177|NCT01015989|HIV-1 viral loads|hiv-1 viral loads
600178|NCT01015976|Gastric Bypass|gastric bypass
600179|NCT01015976|Sertraline|sertraline
600180|NCT01015976|Pharmacokinetics|pharmacokinetics
600181|NCT01015963|recurrent breast cancer|recurrent breast cancer
600182|NCT01015963|stage IIIA breast cancer|stage iiia breast cancer
600183|NCT01015963|stage IIIB breast cancer|stage iiib breast cancer
600184|NCT01015963|stage IIIC breast cancer|stage iiic breast cancer
600185|NCT01015963|stage IV breast cancer|stage iv breast cancer
600186|NCT01015963|extensive stage small cell lung cancer|extensive stage small cell lung cancer
600187|NCT01015963|recurrent small cell lung cancer|recurrent small cell lung cancer
600188|NCT01015963|recurrent non-small cell lung cancer|recurrent non-small cell lung cancer
600189|NCT01015963|stage IIIA non-small cell lung cancer|stage iiia non-small cell lung cancer
600190|NCT01015963|stage IIIB non-small cell lung cancer|stage iiib non-small cell lung cancer
600191|NCT01015963|stage IV non-small cell lung cancer|stage iv non-small cell lung cancer
600192|NCT01015963|stage IV bladder cancer|stage iv bladder cancer
600193|NCT01015963|recurrent bladder cancer|recurrent bladder cancer
600194|NCT01015963|stage III bladder cancer|stage iii bladder cancer
600195|NCT01015963|recurrent lymphoepithelioma of the nasopharynx|recurrent lymphoepithelioma of the nasopharynx
600196|NCT01015963|recurrent squamous cell carcinoma of the nasopharynx|recurrent squamous cell carcinoma of the nasopharynx
600197|NCT01015963|stage III lymphoepithelioma of the nasopharynx|stage iii lymphoepithelioma of the nasopharynx
600198|NCT01015963|stage III squamous cell carcinoma of the nasopharynx|stage iii squamous cell carcinoma of the nasopharynx
600199|NCT01015963|stage IV lymphoepithelioma of the nasopharynx|stage iv lymphoepithelioma of the nasopharynx
600200|NCT01015963|stage IV squamous cell carcinoma of the nasopharynx|stage iv squamous cell carcinoma of the nasopharynx
600201|NCT01015963|pulmonary carcinoid tumor|pulmonary carcinoid tumor
600202|NCT01015963|recurrent basal cell carcinoma of the lip|recurrent basal cell carcinoma of the lip
600203|NCT01015963|recurrent squamous cell carcinoma of the lip and oral cavity|recurrent squamous cell carcinoma of the lip and oral cavity
600204|NCT01015963|stage III basal cell carcinoma of the lip|stage iii basal cell carcinoma of the lip
600205|NCT01015963|stage III squamous cell carcinoma of the lip and oral cavity|stage iii squamous cell carcinoma of the lip and oral cavity
600206|NCT01015963|stage IV basal cell carcinoma of the lip|stage iv basal cell carcinoma of the lip
600207|NCT01015963|stage IV squamous cell carcinoma of the lip and oral cavity|stage iv squamous cell carcinoma of the lip and oral cavity
600208|NCT01015963|recurrent adenoid cystic carcinoma of the oral cavity|recurrent adenoid cystic carcinoma of the oral cavity
600209|NCT01015963|recurrent mucoepidermoid carcinoma of the oral cavity|recurrent mucoepidermoid carcinoma of the oral cavity
600210|NCT01015963|recurrent verrucous carcinoma of the oral cavity|recurrent verrucous carcinoma of the oral cavity
600211|NCT01015963|stage III adenoid cystic carcinoma of the oral cavity|stage iii adenoid cystic carcinoma of the oral cavity
600212|NCT01015963|stage III mucoepidermoid carcinoma of the oral cavity|stage iii mucoepidermoid carcinoma of the oral cavity
600213|NCT01015963|stage III verrucous carcinoma of the oral cavity|stage iii verrucous carcinoma of the oral cavity
600214|NCT01015963|stage IV adenoid cystic carcinoma of the oral cavity|stage iv adenoid cystic carcinoma of the oral cavity
600215|NCT01015963|stage IV mucoepidermoid carcinoma of the oral cavity|stage iv mucoepidermoid carcinoma of the oral cavity
600216|NCT01015963|stage IV verrucous carcinoma of the oral cavity|stage iv verrucous carcinoma of the oral cavity
600217|NCT01015963|recurrent lymphoepithelioma of the oropharynx|recurrent lymphoepithelioma of the oropharynx
600218|NCT01015963|recurrent squamous cell carcinoma of the oropharynx|recurrent squamous cell carcinoma of the oropharynx
600219|NCT01015963|stage III lymphoepithelioma of the oropharynx|stage iii lymphoepithelioma of the oropharynx
600220|NCT01015963|stage III squamous cell carcinoma of the oropharynx|stage iii squamous cell carcinoma of the oropharynx
600221|NCT01015963|stage IV lymphoepithelioma of the oropharynx|stage iv lymphoepithelioma of the oropharynx
600222|NCT01015963|stage IV squamous cell carcinoma of the oropharynx|stage iv squamous cell carcinoma of the oropharynx
600223|NCT01015963|recurrent squamous cell carcinoma of the hypopharynx|recurrent squamous cell carcinoma of the hypopharynx
600224|NCT01015963|stage III squamous cell carcinoma of the hypopharynx|stage iii squamous cell carcinoma of the hypopharynx
600225|NCT01015963|stage IV squamous cell carcinoma of the hypopharynx|stage iv squamous cell carcinoma of the hypopharynx
600226|NCT01015963|recurrent squamous cell carcinoma of the larynx|recurrent squamous cell carcinoma of the larynx
600227|NCT01015963|recurrent verrucous carcinoma of the larynx|recurrent verrucous carcinoma of the larynx
600228|NCT01015963|stage III squamous cell carcinoma of the larynx|stage iii squamous cell carcinoma of the larynx
600229|NCT01015963|stage III verrucous carcinoma of the larynx|stage iii verrucous carcinoma of the larynx
600230|NCT01015963|stage IV squamous cell carcinoma of the larynx|stage iv squamous cell carcinoma of the larynx
600231|NCT01015963|stage IV verrucous carcinoma of the larynx|stage iv verrucous carcinoma of the larynx
600232|NCT01015963|recurrent esthesioneuroblastoma of the paranasal sinus and nasal cavity|recurrent esthesioneuroblastoma of the paranasal sinus and nasal cavity
600233|NCT01015963|recurrent inverted papilloma of the paranasal sinus and nasal cavity|recurrent inverted papilloma of the paranasal sinus and nasal cavity
600234|NCT01015963|recurrent midline lethal granuloma of the paranasal sinus and nasal cavity|recurrent midline lethal granuloma of the paranasal sinus and nasal cavity
600235|NCT01015963|recurrent squamous cell carcinoma of the paranasal sinus and nasal cavity|recurrent squamous cell carcinoma of the paranasal sinus and nasal cavity
600236|NCT01015963|stage III esthesioneuroblastoma of the paranasal sinus and nasal cavity|stage iii esthesioneuroblastoma of the paranasal sinus and nasal cavity
600237|NCT01015963|stage III inverted papilloma of the paranasal sinus and nasal cavity|stage iii inverted papilloma of the paranasal sinus and nasal cavity
600238|NCT01015963|stage III midline lethal granuloma of the paranasal sinus and nasal cavity|stage iii midline lethal granuloma of the paranasal sinus and nasal cavity
600239|NCT01015963|stage III squamous cell carcinoma of the paranasal sinus and nasal cavity|stage iii squamous cell carcinoma of the paranasal sinus and nasal cavity
600240|NCT01015963|stage IV esthesioneuroblastoma of the paranasal sinus and nasal cavity|stage iv esthesioneuroblastoma of the paranasal sinus and nasal cavity
600241|NCT01015963|stage IV inverted papilloma of the paranasal sinus and nasal cavity|stage iv inverted papilloma of the paranasal sinus and nasal cavity
600242|NCT01015963|stage IV midline lethal granuloma of the paranasal sinus and nasal cavity|stage iv midline lethal granuloma of the paranasal sinus and nasal cavity
600342|NCT01015612|Aortic Valve Insufficiency|aortic valve insufficiency
600243|NCT01015963|stage IV squamous cell carcinoma of the paranasal sinus and nasal cavity|stage iv squamous cell carcinoma of the paranasal sinus and nasal cavity
600244|NCT01015963|recurrent salivary gland cancer|recurrent salivary gland cancer
600245|NCT01015963|stage III salivary gland cancer|stage iii salivary gland cancer
600246|NCT01015963|stage IV salivary gland cancer|stage iv salivary gland cancer
600247|NCT01015963|recurrent metastatic squamous neck cancer with occult primary|recurrent metastatic squamous neck cancer with occult primary
600248|NCT01015963|unspecified adult solid tumor, protocol specific|unspecified adult solid tumor, protocol specific
600249|NCT01015963|tongue cancer|tongue cancer
600250|NCT01015937|diabetes|diabetes
600251|NCT01015937|nephropathy|nephropathy
600252|NCT01015937|turmeric|turmeric
600253|NCT01015937|serum IL8|serum il8
600254|NCT01015937|serum TGFb|serum tgfb
600255|NCT01015937|serumINF|seruminf
600256|NCT01015937|urinary IL8|urinary il8
600257|NCT01015937|urine TGFb|urine tgfb
600258|NCT01015924|clavicle|clavicle
600259|NCT01015924|TEN|ten
600260|NCT01015924|Plate osteosynthesis|plate osteosynthesis
600261|NCT01015924|displaced|displaced
600262|NCT01015924|ESIN|esin
600263|NCT01015924|displaced midshaft clavicular fractures|displaced midshaft clavicular fractures
600264|NCT01015911|Antibodies, Monoclonal|antibodies, monoclonal
600265|NCT01015911|Antibody-Drug Conjugate|antibody-drug conjugate
600266|NCT01015911|Antigens, CD70|antigens, cd70
600267|NCT01015911|Lymphoma, Non-Hodgkin|lymphoma, non-hodgkin
600268|NCT01015911|Carcinoma, Renal Cell|carcinoma, renal cell
600269|NCT01015911|Immunotherapy|immunotherapy
600270|NCT01015911|Drug Therapy|drug therapy
600271|NCT01015911|monomethylauristatin F|monomethylauristatin f
600272|NCT01015898|basal cell carcinoma|basal cell carcinoma
600273|NCT01015898|photodynamic therapy|photodynamic therapy
600274|NCT01015898|photo chemotherapy|photo chemotherapy
600275|NCT01015898|basal cell epithelioma|basal cell epithelioma
600276|NCT01015872|sleep apnea syndrome|sleep apnea syndrome
600277|NCT01015872|CPAP|cpap
600278|NCT01015872|prostanoids|prostanoids
600279|NCT01015859|AV conduction|av conduction
600280|NCT01015859|Atrial fibrillation|atrial fibrillation
600281|NCT01015846|Core|core
600282|NCT01015846|Redcord|redcord
600283|NCT01015846|RUSI|rusi
600284|NCT01015846|low back|low back
600285|NCT01015820|Pancreatic Cancer|pancreatic cancer
600286|NCT01015820|Duodenum|duodenum
600287|NCT01015820|Spectroscopy|spectroscopy
600288|NCT01015820|Fiberoptic probe|fiberoptic probe
600289|NCT01015820|4D-ELF|4d-elf
600290|NCT01015807|postoperative|postoperative
600291|NCT01015807|hyperalgesia|hyperalgesia
600292|NCT01015807|pain|pain
600293|NCT01015807|transversus abdominis plane block|transversus abdominis plane block
600294|NCT01015807|TAP block|tap block
600295|NCT01015807|cesarean section|cesarean section
600296|NCT01015781|Tinnitus|tinnitus
600297|NCT01015781|Counseling|counseling
600298|NCT01015781|Education|education
600299|NCT01015781|Rehabilitation of hearing impaired|rehabilitation of hearing impaired
600300|NCT01015781|Triage|triage
600301|NCT01015781|Evaluation studies|evaluation studies
600302|NCT01015781|Quality of health care|quality of health care
600303|NCT01015768|corneal staining|corneal staining
600304|NCT01015768|barrier function|barrier function
600305|NCT01015768|contact lenses|contact lenses
600306|NCT01015768|contact lens care solutions|contact lens care solutions
600307|NCT01015768|contact lens material and care solution bioincompatibility|contact lens material and care solution bioincompatibility
600308|NCT01015755|thirst palliation and intensive care unit|thirst palliation and intensive care unit
600309|NCT01015755|thirst intensity and distress|thirst intensity and distress
600310|NCT01015755|predictors of thirst|predictors of thirst
600311|NCT01015742|AML|aml
600313|NCT01015742|CML|cml
600314|NCT01015729|Bioequivalence|bioequivalence
600315|NCT01015729|ASA|asa
600316|NCT01015729|Esomeprazole|esomeprazole
600317|NCT01015729|peptic ulcer disease|peptic ulcer disease
600318|NCT01015729|pH measurements|ph measurements
600319|NCT01015716|Weight loss|weight loss
600320|NCT01015716|Physical activity|physical activity
600321|NCT01015716|Cognitive Behavioral Training|cognitive behavioral training
600322|NCT01015703|Vaccine, hypertension|vaccine, hypertension
600323|NCT01015690|unexplained infertility|unexplained infertility
600324|NCT01015690|hCG|hcg
600325|NCT01015690|early pregnancy loss|early pregnancy loss
600326|NCT01015651|nociception, intraoperative, baroreflex|nociception, intraoperative, baroreflex
600327|NCT01015638|Healthy volunteers|healthy volunteers
600328|NCT01015625|breast cancer|breast cancer
600329|NCT01015625|ABCSG|abcsg
600330|NCT01015625|POSYTIVE|posytive
600331|NCT01015625|growth factor|growth factor
600332|NCT01015625|median survival|median survival
600333|NCT01015625|surgery on demand|surgery on demand
600334|NCT01015625|surgical therapy|surgical therapy
600335|NCT01015625|blood specimen|blood specimen
600336|NCT01015625|tissue specimen|tissue specimen
600337|NCT01015625|VEGF|vegf
600338|NCT01015625|TGF|tgf
600339|NCT01015625|circulating tumor cells|circulating tumor cells
600340|NCT01015625|stem cells|stem cells
600341|NCT01015612|Aortic Valve Stenosis|aortic valve stenosis
600343|NCT01015599|Obesity prevention|obesity prevention
600344|NCT01015599|after-school|after-school
600345|NCT01015599|physical activity|physical activity
600346|NCT01015599|fruit|fruit
600347|NCT01015599|vegetable|vegetable
600348|NCT01015599|children|children
600349|NCT01015586|Alcohol|alcohol
600350|NCT01015586|Bipolar Disorder|bipolar disorder
600351|NCT01015586|Manic depression|manic depression
600352|NCT01015586|Addiction|addiction
600353|NCT01015586|Alcoholism|alcoholism
600354|NCT01015586|Cognitive impairment|cognitive impairment
600355|NCT01015586|Executive function|executive function
600356|NCT01015586|Anxiety|anxiety
600357|NCT01015586|Depression|depression
600358|NCT01015586|Mania|mania
600359|NCT01015586|Affective disorder|affective disorder
600360|NCT01015586|Psychosis|psychosis
600361|NCT01015586|Carbohydrate deficient transferrin|carbohydrate deficient transferrin
600362|NCT01015586|Gammaglutamyltransferase|gammaglutamyltransferase
600363|NCT01015586|California Verbal Learning Test|california verbal learning test
600364|NCT01015586|Montgomery Asberg Depression Rating Scale|montgomery asberg depression rating scale
600365|NCT01015586|Young Mania Rating Scale|young mania rating scale
600366|NCT01015586|Timeline Follow Back|timeline follow back
600367|NCT01015560|bone metastases|bone metastases
600368|NCT01015560|unspecified adult solid tumor, protocol specific|unspecified adult solid tumor, protocol specific
600369|NCT01015547|juvenile idiopathic arthritis|juvenile idiopathic arthritis
600370|NCT01015547|polyarthritis|polyarthritis
600371|NCT01015547|combination therapy|combination therapy
600372|NCT01015547|biologic agents|biologic agents
600373|NCT01015547|TNF antagonists|tnf antagonists
600374|NCT01015547|infliximab|infliximab
600375|NCT01015534|Brain metastases|brain metastases
600376|NCT01015534|Temozolomide|temozolomide
600377|NCT01015534|Whole-brain radiotherapy|whole-brain radiotherapy
600378|NCT01015534|Phase II trial|phase ii trial
600379|NCT01015521|breast cancer|breast cancer
600380|NCT01015508|Weight loss and maintenance|weight loss and maintenance
600381|NCT01015508|body composition|body composition
600382|NCT01015508|energy expenditure|energy expenditure
600383|NCT01015508|adipogenic capacity|adipogenic capacity
600384|NCT01015508|physical activity|physical activity
600385|NCT01015495|angioid streaks|angioid streaks
600387|NCT01015495|intra vitreal ranibizumab|intra vitreal ranibizumab
600388|NCT01015482|Sunburn|sunburn
600389|NCT01015482|Remifentanil|remifentanil
600390|NCT01015482|Hyperalgesia|hyperalgesia
600391|NCT01015469|bariatric|bariatric
600392|NCT01015469|surgery|surgery
600393|NCT01015469|obesity|obesity
600394|NCT01015469|Roux-en-Y|roux-en-y
600395|NCT01015469|gastric|gastric
600396|NCT01015469|medical device|medical device
600397|NCT01015469|bypass|bypass
600398|NCT01015469|adiposity|adiposity
600399|NCT01015469|GaBP-Ring|gabp-ring
600400|NCT01015469|BMI|bmi
600401|NCT01015469|banded|banded
600402|NCT01015469|laparoscopic|laparoscopic
600403|NCT01015456|lupus nephritis|lupus nephritis
600404|NCT01015456|mycophenolate sodium|mycophenolate sodium
600405|NCT01015456|cyclophosphamide|cyclophosphamide
600406|NCT01015443|Non-Small Cell Lung Carcinoma|non-small cell lung carcinoma
600407|NCT01015443|Tecemotide|tecemotide
600408|NCT01015443|L-BLP25|l-blp25
600409|NCT01015443|Cyclophosphamide|cyclophosphamide
600410|NCT01015443|placebo controlled|placebo controlled
600411|NCT01015443|Non-Small Cell Lung Cancer|non-small cell lung cancer
600412|NCT01015417|Acute lithiasic cholecystitis|acute lithiasic cholecystitis
600413|NCT01015417|Cholecystectomy|cholecystectomy
600414|NCT01015417|Postoperative antibiotherapy|postoperative antibiotherapy
600415|NCT01015417|Surgical site infection|surgical site infection
600416|NCT01015417|Remote surgical site infection|remote surgical site infection
600417|NCT01015404|Trafermin|trafermin
600418|NCT01015404|Periodontitis|periodontitis
600419|NCT01015391|T2|t2
600420|NCT01015391|AZA|aza
600421|NCT01015391|remission|remission
600422|NCT01015391|Crohn's disease|crohn's disease
600423|NCT01015378|Recurrent sigmoid diverticulitis|recurrent sigmoid diverticulitis
600424|NCT01015378|diverticulitis|diverticulitis
600425|NCT01015378|Colon|colon
600426|NCT01015378|sigmoid|sigmoid
600427|NCT01015378|recurrence|recurrence
600428|NCT01015365|Chronic infected hip arthroplasty|chronic infected hip arthroplasty
600429|NCT01015365|Fast-track|fast-track
600430|NCT01015365|One-stage cementless revision|one-stage cementless revision
600431|NCT01015352|Myelodysplastic Syndromes|myelodysplastic syndromes
600432|NCT01015326|EGFRI|egfri
600433|NCT01015326|HRQL|hrql
600434|NCT01015326|Quality of Life|quality of life
600435|NCT01015326|Development of a standardized HRQL instrument for anti-EGFR therapy induced|development of a standardized hrql instrument for anti-egfr therapy induced
600436|NCT01015313|sodium, hypertension, volume overload|sodium, hypertension, volume overload
600437|NCT01015300|Hemangioblastoma|hemangioblastoma
600438|NCT01015300|Von Hippel Lindau|von hippel lindau
600439|NCT01015300|VHL|vhl
600440|NCT01015300|lesion|lesion
600441|NCT01015300|EGFR|egfr
600442|NCT01015287|Acute Coronary Syndromes|acute coronary syndromes
600443|NCT01015287|Heart Disease|heart disease
600444|NCT01015287|Percutaneous Coronary Intervention|percutaneous coronary intervention
600445|NCT01015287|P2Y12|p2y12
600446|NCT01015287|NSTEMI|nstemi
600448|NCT01015261|BMT|bmt
600449|NCT01015261|Chemotherapy|chemotherapy
600450|NCT01015261|Allogenic|allogenic
600451|NCT01015248|CD 20 positive|cd 20 positive
600452|NCT01015235|Ketorolac / therapeutic use|ketorolac / therapeutic use
600453|NCT01015235|Analgesics. Non-narcotic / therapeutic use|analgesics. non-narcotic / therapeutic use
600454|NCT01015235|Arthroplasty, replacement hip|arthroplasty, replacement hip
600455|NCT01015235|Arthroplasty, replacement knee|arthroplasty, replacement knee
600456|NCT01015235|Pain measurement / drug effect|pain measurement / drug effect
600457|NCT01015235|Pain postoperative / drug therapy|pain postoperative / drug therapy
600458|NCT01015222|Advanced Malignancies|advanced malignancies
600459|NCT01015222|Metastatic cancer|metastatic cancer
600460|NCT01015222|Bevacizumab|bevacizumab
600461|NCT01015222|Avastin|avastin
600462|NCT01015222|Dasatinib|dasatinib
600463|NCT01015222|Sprycel|sprycel
600464|NCT01015222|Paclitaxel|paclitaxel
600465|NCT01015222|Taxol|taxol
600466|NCT01015209|Dry eye syndromes|dry eye syndromes
600467|NCT01015196|acute myeloid leukemia in first complete remission|acute myeloid leukemia in first complete remission
600468|NCT01015183|Mucositis|mucositis
600469|NCT01015183|Bone Marrow Transplantation|bone marrow transplantation
600470|NCT01015183|BMT|bmt
600471|NCT01015183|HSCT|hsct
600472|NCT01015170|smoking cessation|smoking cessation
600473|NCT01015170|nicotine addiction|nicotine addiction
600474|NCT01015170|Zyban|zyban
600475|NCT01015170|bupropion hydrochloride|bupropion hydrochloride
600476|NCT01015157|Gastric bypass|gastric bypass
600477|NCT01015157|staple line reinforcement|staple line reinforcement
600478|NCT01015157|outcomes|outcomes
600479|NCT01015157|per and postoperative blood loss|per and postoperative blood loss
600480|NCT01015144|atorvastatin|atorvastatin
600481|NCT01015144|dilated cardiomyopathy|dilated cardiomyopathy
600482|NCT01015144|heart failure|heart failure
600483|NCT01015144|inflammation|inflammation
600484|NCT01015105|patients with hip fracture|patients with hip fracture
600485|NCT01015092|HIV|hiv
600486|NCT01015092|Cardiovascular|cardiovascular
600487|NCT01015092|Coronary hear disease|coronary hear disease
600488|NCT01015092|HAART|haart
600489|NCT01015092|antiretroviral|antiretroviral
600490|NCT01015079|Pap smear screening|pap smear screening
600491|NCT01015066|drug dependence|drug dependence
600492|NCT01015066|substance abuse|substance abuse
600493|NCT01015066|substance use disorders|substance use disorders
600494|NCT01015066|buprenorphine|buprenorphine
600495|NCT01015066|naltrexone|naltrexone
600496|NCT01015066|adolescents|adolescents
600497|NCT01015053|postoperative pain|postoperative pain
600498|NCT01015053|pediatric|pediatric
600499|NCT01015053|umbilical hernia|umbilical hernia
600500|NCT01015053|ropivacaine|ropivacaine
600501|NCT01015053|rectus sheath block|rectus sheath block
600502|NCT01015053|regional block|regional block
600503|NCT01015053|ultrasound-guided regional block|ultrasound-guided regional block
600504|NCT01015053|local infiltration|local infiltration
600505|NCT01015053|ambulatory surgery|ambulatory surgery
600506|NCT01015040|solifenacin succinate|solifenacin succinate
600507|NCT01015040|VESIcare|vesicare
600508|NCT01015040|Healthy Volunteers|healthy volunteers
600509|NCT01015014|Gram negative|gram negative
600510|NCT01015014|bacteria|bacteria
600511|NCT01015014|infection|infection
600512|NCT01015001|refractory schizophrenia|refractory schizophrenia
600513|NCT01015001|rTMS|rtms
600514|NCT01015001|auditory hallucinations|auditory hallucinations
600515|NCT01014988|pandemic|pandemic
600516|NCT01014988|seasonal influenza|seasonal influenza
600517|NCT01014988|Influenza B virus|influenza b virus
600518|NCT01014988|H1N1|h1n1
600519|NCT01014988|zanamivir|zanamivir
600520|NCT01014988|Influenza A virus, H1N1 Subtype|influenza a virus, h1n1 subtype
600521|NCT01014988|Relenza|relenza
600522|NCT01014988|influenza|influenza
600523|NCT01014988|neuraminidase inhibitor|neuraminidase inhibitor
600524|NCT01014975|stroke|stroke
600525|NCT01014975|plasmin|plasmin
600526|NCT01014975|thrombus|thrombus
600527|NCT01014975|ischemic|ischemic
600528|NCT01014975|middle cerebral artery|middle cerebral artery
600529|NCT01014975|thrombolysis|thrombolysis
600530|NCT01014975|intra-arterial|intra-arterial
600531|NCT01014975|fibrin|fibrin
600532|NCT01014962|Pharmacokinetic|pharmacokinetic
600533|NCT01014962|tolerability|tolerability
600534|NCT01014962|multiple escalating doses|multiple escalating doses
600535|NCT01014936|Phase 1|phase 1
600536|NCT01014936|advanced solid tumors|advanced solid tumors
600537|NCT01014936|refractory to standard therapy|refractory to standard therapy
600538|NCT01014923|motor vehicle|motor vehicle
600539|NCT01014923|accidents, traffic|accidents, traffic
600540|NCT01014923|prevention and control|prevention and control
600541|NCT01014910|Bronchiolitis|bronchiolitis
600542|NCT01014910|Hypoxia|hypoxia
600543|NCT01014910|Pulse|pulse
600544|NCT01014910|Oximetry|oximetry
600545|NCT01014910|Hospitalized|hospitalized
600546|NCT01014897|stroke|stroke
600547|NCT01014897|recovery|recovery
600548|NCT01014897|tDCS|tdcs
600549|NCT01014897|direct current|direct current
600550|NCT01014897|electric stimulation|electric stimulation
600551|NCT01014871|Forehead Wrinkles Toxin|forehead wrinkles toxin
600552|NCT01014858|Parkinson's disease|parkinson's disease
600553|NCT01014858|mild dementia|mild dementia
600554|NCT01014858|donepezil|donepezil
600555|NCT01014858|NIHR HTA|nihr hta
600556|NCT01014845|hepatitis E|hepatitis e
600557|NCT01014845|vaccine|vaccine
600558|NCT01014845|efficacy|efficacy
600559|NCT01014832|Diabetes, insulin.|diabetes, insulin.
600560|NCT01014819|Dermacorder|dermacorder
600561|NCT01014819|Electric field|electric field
600562|NCT01014819|basal cell carcinoma|basal cell carcinoma
600563|NCT01014819|Gorlin Syndrome|gorlin syndrome
600564|NCT01014793|Acromegaly resistant|acromegaly resistant
600565|NCT01014793|combined-treatment|combined-treatment
600566|NCT01014793|dopamine agonist|dopamine agonist
600567|NCT01014780|dry eye|dry eye
600568|NCT01014780|tear film|tear film
600569|NCT01014780|thickness|thickness
600570|NCT01014780|artificial tears|artificial tears
600571|NCT01014767|Choroid Plexus Tumors|choroid plexus tumors
600572|NCT01014767|Brain Tumor|brain tumor
600573|NCT01014767|Chemotherapy|chemotherapy
600574|NCT01014767|Etoposide|etoposide
600575|NCT01014767|Carboplatin|carboplatin
600576|NCT01014767|Vincristine|vincristine
600577|NCT01014767|Cyclophosphamide|cyclophosphamide
600578|NCT01014767|Methotrexate|methotrexate
600579|NCT01014767|Doxorubicin|doxorubicin
600580|NCT01014767|Cisplatin|cisplatin
600581|NCT01014767|Dactinomycin|dactinomycin
600582|NCT01014767|temozolomide|temozolomide
600583|NCT01014767|irinotecan|irinotecan
600584|NCT01014767|Pediatrics|pediatrics
600585|NCT01014741|Atrial Fibrillation|atrial fibrillation
600586|NCT01014741|Catheter Ablation|catheter ablation
600587|NCT01014741|Complex Fractionate Electrograms|complex fractionate electrograms
600588|NCT01014715|Breast Cancer|breast cancer
600589|NCT01014702|Cataract|cataract
600590|NCT01014702|Capsulotomy|capsulotomy
600591|NCT01014702|Capsulorrhexis|capsulorrhexis
600592|NCT01014702|lens fragmentation|lens fragmentation
600593|NCT01014702|phacoemulsification|phacoemulsification
600594|NCT01014689|acne vulgaris|acne vulgaris
600595|NCT01014676|Costs and Cost Analysis|costs and cost analysis
600596|NCT01014663|Parkinson's disease|parkinson's disease
600597|NCT01014663|exercise|exercise
600598|NCT01014663|training program|training program
600599|NCT01014663|rehabilitation|rehabilitation
600600|NCT01014663|boxing|boxing
600601|NCT01014650|glycine site partial agonist|glycine site partial agonist
600602|NCT01014650|normal volunteers|normal volunteers
600603|NCT01014650|safety in normal volunteers|safety in normal volunteers
600604|NCT01014637|Dermatomycoses|dermatomycoses
600605|NCT01014637|Infection|infection
600606|NCT01014637|Mycoses|mycoses
600607|NCT01014637|Nail diseases|nail diseases
600608|NCT01014637|Ski diseases|ski diseases
600609|NCT01014637|Skin diseases/infectious|skin diseases/infectious
600610|NCT01014624|thienopyridine|thienopyridine
600611|NCT01014624|pharmacologic action|pharmacologic action
600612|NCT01014624|prasugrel|prasugrel
600613|NCT01014624|clopidogrel|clopidogrel
600614|NCT01014611|Heart failure|heart failure
600615|NCT01014611|Skeletal muscle|skeletal muscle
600616|NCT01014611|Calcium|calcium
600617|NCT01014611|Ryanodine receptor|ryanodine receptor
600618|NCT01014611|Mitochondria|mitochondria
600619|NCT01014611|Exercise training|exercise training
600620|NCT01014611|Muscle biopsy|muscle biopsy
600621|NCT01014611|Healthy volunteers|healthy volunteers
600622|NCT01014585|Milnacipran|milnacipran
600623|NCT01014585|Pain|pain
600624|NCT01014585|Durability of Effect|durability of effect
600625|NCT01014585|Loss of Therapeutic Response|loss of therapeutic response
600626|NCT01014585|Fatigue|fatigue
600627|NCT01014585|Forest Research Institute|forest research institute
600628|NCT01014585|Savella ®|savella ®
600629|NCT01014572|Clinical Trials, Phase II|clinical trials, phase ii
600630|NCT01014572|Exercise|exercise
600631|NCT01014572|Exercise Tolerance|exercise tolerance
600632|NCT01014572|Aging|aging
600633|NCT01014559|Constipation|constipation
600634|NCT01014559|Oxycodone|oxycodone
600635|NCT01014559|Oxycodone hydrochloride|oxycodone hydrochloride
600636|NCT01014559|Naloxone hydrochloride|naloxone hydrochloride
600637|NCT01014559|Naloxone|naloxone
600638|NCT01014533|Alcoholism|alcoholism
600639|NCT01014533|Alcohol dependence|alcohol dependence
600640|NCT01014533|Insomnia|insomnia
600641|NCT01014533|Dim light melatonin onset|dim light melatonin onset
600642|NCT01014533|Gabapentin|gabapentin
600643|NCT01014520|Lumbar|lumbar
600644|NCT01014520|Diskectomy|diskectomy
600645|NCT01014520|Laminectomy|laminectomy
600646|NCT01014481|HIV|hiv
600647|NCT01014481|tuberculosis|tuberculosis
600648|NCT01014481|antiretroviral treatment|antiretroviral treatment
600649|NCT01014481|timing|timing
600650|NCT01014468|ranibizumab|ranibizumab
600651|NCT01014468|bevacizumab|bevacizumab
600652|NCT01014468|AMD|amd
600653|NCT01014468|Complications|complications
600654|NCT01014468|Visual acuity|visual acuity
600655|NCT01014468|OCt|oct
600656|NCT01014468|Age Macular Degeneration|age macular degeneration
600657|NCT01014455|surgery|surgery
600658|NCT01014429|Phase I dose escalation study|phase i dose escalation study
600659|NCT01014429|Advanced or metastatic solid tumors|advanced or metastatic solid tumors
600660|NCT01014429|PLK 1 inhibitor|plk 1 inhibitor
600661|NCT01014429|Adult patients|adult patients
600662|NCT01014416|Healthy Korean male|healthy korean male
600663|NCT01014403|venous thromboembolism|venous thromboembolism
600664|NCT01014403|enoxaparin|enoxaparin
600665|NCT01014403|traumatic brain injury|traumatic brain injury
600666|NCT01014403|Venous thromboembolism prophylaxis after traumatic brain injury|venous thromboembolism prophylaxis after traumatic brain injury
600667|NCT01014390|benign biliary strictures secondary to chronic pancreatitis/post abdominal surgery/post liver transplant|benign biliary strictures secondary to chronic pancreatitis/post abdominal surgery/post liver transplant
600668|NCT01014364|Acute lung injury|acute lung injury
600669|NCT01014364|Acute respiratory distress syndrome|acute respiratory distress syndrome
600670|NCT01014364|corticosteroids|corticosteroids
600671|NCT01014364|inflammation|inflammation
600672|NCT01014351|Metastatic Melanoma|metastatic melanoma
600673|NCT01014351|Everolimus|everolimus
600674|NCT01014351|Paclitaxel|paclitaxel
600675|NCT01014351|Carboplatin|carboplatin
600676|NCT01014312|Depression|depression
600677|NCT01014299|Intubation|intubation
600678|NCT01014299|Hypoxemia|hypoxemia
600679|NCT01014299|Mechanical ventilation|mechanical ventilation
600680|NCT01014299|Recruitment maneuver|recruitment maneuver
600681|NCT01014299|Acute lung injury|acute lung injury
600682|NCT01014299|Bacterial translocation|bacterial translocation
600683|NCT01014299|Hypoxemic ICU patients requiring invasive mechanical ventilation|hypoxemic icu patients requiring invasive mechanical ventilation
600684|NCT01014273|Acute Coronary Syndrome|acute coronary syndrome
600685|NCT01014273|PCI|pci
600686|NCT01014273|Percutaneous Coronary Intervention|percutaneous coronary intervention
600687|NCT01014273|Radial Access|radial access
600688|NCT01014260|Inflammatory markers of cardiovascular disease|inflammatory markers of cardiovascular disease
600689|NCT01014247|Moxifloxacin|moxifloxacin
600690|NCT01014234|Immunosuppressive Agents|immunosuppressive agents
600691|NCT01014234|Immune system regulation|immune system regulation
600692|NCT01014234|Regulatory T cells|regulatory t cells
600693|NCT01014234|Rapamycin|rapamycin
600694|NCT01014234|Tolerance|tolerance
600695|NCT01014221|acupuncture|acupuncture
600696|NCT01014221|carpal tunnel syndrome|carpal tunnel syndrome
600697|NCT01014221|CTS|cts
600698|NCT01014221|steroid|steroid
600699|NCT01014221|global symptom score (GSS)|global symptom score (gss)
600700|NCT01014208|The All Ireland Cooperative Oncology Research Group|the all ireland cooperative oncology research group
600701|NCT01014208|GELTAMO|geltamo
600702|NCT01014208|National Cancer Research Institute Lymphoma Clinical Studies Group|national cancer research institute lymphoma clinical studies group
600703|NCT01014208|Genmab|genmab
600704|NCT01014208|ofatumumab|ofatumumab
600705|NCT01014208|Japan Clinical Oncology Group|japan clinical oncology group
600706|NCT01014208|Oncology|oncology
600707|NCT01014208|Polish Lymphoma Research Group|polish lymphoma research group
600708|NCT01014208|Salvage chemotherapy|salvage chemotherapy
600709|NCT01014208|refractory|refractory
600710|NCT01014208|HOVON|hovon
600711|NCT01014208|DVD|dvd
600712|NCT01014208|relapsed|relapsed
600713|NCT01014208|safety|safety
600714|NCT01014208|efficacy|efficacy
600715|NCT01014208|DHAP|dhap
600716|NCT01014208|rituximab|rituximab
600717|NCT01014208|Autologous Stem Cell Transplant|autologous stem cell transplant
600718|NCT01014208|Dutch-Belgian Cooperative Trial Group for Hematology-Oncology|dutch-belgian cooperative trial group for hematology-oncology
600719|NCT01014208|Grupo Espanol de Linfomas|grupo espanol de linfomas
600720|NCT01014208|Nordic Lymphoma Group|nordic lymphoma group
600721|NCT01014195|Acute Lymphoblastic Leukemia|acute lymphoblastic leukemia
600722|NCT01014195|Neurocognitive function|neurocognitive function
600723|NCT01014195|ADHD|adhd
600724|NCT01014195|brain imaging|brain imaging
600725|NCT01014195|genetic polymorphisms|genetic polymorphisms
600726|NCT01014195|Psychopathology and neurocognitive Impairment in Leukemia Survivors|psychopathology and neurocognitive impairment in leukemia survivors
600727|NCT01014182|Early PCI|early pci
600728|NCT01014182|Myocardial Infarction|myocardial infarction
600729|NCT01014182|Thrombolysis|thrombolysis
600730|NCT01014182|Optimal revascularization therapy in STEMI patients|optimal revascularization therapy in stemi patients
600731|NCT01014169|Health education|health education
600732|NCT01014169|Sudden Infant Death|sudden infant death
600733|NCT01014169|Breast Feeding|breast feeding
600734|NCT01014169|Infant Equipment|infant equipment
600735|NCT01014156|pulmonary embolism|pulmonary embolism
600736|NCT01014156|vasoconstriction|vasoconstriction
600737|NCT01014156|right ventricular dysfunction|right ventricular dysfunction
600738|NCT01014156|epoprostenol|epoprostenol
600739|NCT01014156|acute pulmonary embolism with right ventricular dysfunction|acute pulmonary embolism with right ventricular dysfunction
600740|NCT01014130|Non Small Cell Lung Cancer|non small cell lung cancer
600741|NCT01014130|Hypofractionated|hypofractionated
600742|NCT01014130|Stereotactic Radiotherapy|stereotactic radiotherapy
600743|NCT01014104|Ovarian hyper stimulation syndrome|ovarian hyper stimulation syndrome
600744|NCT01014104|Methylprednisolone|methylprednisolone
600745|NCT01014104|IVF|ivf
600746|NCT01014091|influenza infection|influenza infection
600747|NCT01014091|GSK Bio's influenza vaccine GSK2340272A|gsk bio's influenza vaccine gsk2340272a
600748|NCT01014065|sunitinib|sunitinib
600749|NCT01014065|cardiac MRI|cardiac mri
600750|NCT01014065|maximal exercise testing|maximal exercise testing
600751|NCT01014065|biomarkers|biomarkers
600752|NCT01014065|pharmacokinetics|pharmacokinetics
600753|NCT01014026|Mass Screening|mass screening
600754|NCT01014026|Polymerase Chain Reaction|polymerase chain reaction
600755|NCT01014026|Vaginal Smears|vaginal smears
600756|NCT01013987|HIV-1|hiv-1
600757|NCT01013987|triple class failure|triple class failure
600758|NCT01013987|Maraviroc|maraviroc
600759|NCT01013987|Raltegravir|raltegravir
600760|NCT01013987|Darunavir/ritonavir|darunavir/ritonavir
600761|NCT01013987|Maraviroc with raltegravir and darunavir/ritonavir|maraviroc with raltegravir and darunavir/ritonavir
600762|NCT01013961|chronic lymphocytic leukemia|chronic lymphocytic leukemia
600763|NCT01013961|small lymphocytic lymphoma|small lymphocytic lymphoma
600764|NCT01013961|CLL|cll
600765|NCT01013961|elderly|elderly
600766|NCT01013961|low dose rituximab|low dose rituximab
600767|NCT01013961|alemtuzumab|alemtuzumab
600768|NCT01013961|monoclonal antibodies|monoclonal antibodies
600769|NCT01013948|Spirometry|spirometry
600770|NCT01013948|Bronchitis|bronchitis
600771|NCT01013948|COPD|copd
600772|NCT01013948|Chronic Obstructive Pulmonary Disease (COPD)|chronic obstructive pulmonary disease (copd)
600773|NCT01013948|Emphysema|emphysema
600774|NCT01013948|Chronic Bronchitis|chronic bronchitis
600775|NCT01013935|HIV treatment|hiv treatment
600776|NCT01013935|ART adherence|art adherence
600777|NCT01013935|Using new technology to improve adherence|using new technology to improve adherence
600778|NCT01013935|CARE+|care+
600779|NCT01013935|HIV-1 viral loads|hiv-1 viral loads
600780|NCT01013922|COPD|copd
600781|NCT01013922|COPD-6|copd-6
600782|NCT01013922|Spirometry|spirometry
600783|NCT01013922|VC|vc
600784|NCT01013922|FEV|fev
600785|NCT01013922|FEV1|fev1
600786|NCT01013909|Bifonazole|bifonazole
600787|NCT01013909|Terbinafine|terbinafine
600788|NCT01013909|Reduced treatment duration|reduced treatment duration
600789|NCT01013909|Efficacy|efficacy
600790|NCT01013909|Safety|safety
600791|NCT01013909|Athlete's foot|athlete's foot
600792|NCT01013909|Moderate severity|moderate severity
600793|NCT01013883|systolic dysfunction|systolic dysfunction
600794|NCT01013883|diastolic dysfunction|diastolic dysfunction
600795|NCT01013883|mortality|mortality
600796|NCT01013883|treatment|treatment
600797|NCT01013883|heart rate|heart rate
600798|NCT01013870|mild traumatic brain injury|mild traumatic brain injury
600799|NCT01013870|post-concussion syndrome|post-concussion syndrome
600800|NCT01013870|acute stress disorder|acute stress disorder
600801|NCT01013870|post-traumatic stress disorder|post-traumatic stress disorder
600802|NCT01013870|atorvastatin|atorvastatin
600803|NCT01013844|skin self-examination|skin self-examination
600804|NCT01013844|SSE|sse
600805|NCT01013844|melanoma|melanoma
600806|NCT01013805|Rectal Cancer|rectal cancer
600807|NCT01013805|Chemotherapy|chemotherapy
600808|NCT01013805|Radiotherapy|radiotherapy
600809|NCT01013792|Diabetic|diabetic
600810|NCT01013792|Foot|foot
600811|NCT01013792|Ulcer|ulcer
600812|NCT01013792|Neuropathic|neuropathic
600813|NCT01013792|Tegaderm Matrix Dressing|tegaderm matrix dressing
600814|NCT01013792|DFU|dfu
600815|NCT01013792|Wound Care|wound care
600816|NCT01013792|PHI|phi
600817|NCT01013779|Merkel Cell Cancer|merkel cell cancer
600818|NCT01013779|PET scanning|pet scanning
600819|NCT01013766|GSK1362885|gsk1362885
600820|NCT01013766|Pharmacodynamics|pharmacodynamics
600821|NCT01013766|Safety|safety
600822|NCT01013766|Pharmacokinetics|pharmacokinetics
600823|NCT01013766|T2DM|t2dm
600824|NCT01013766|Tolerability|tolerability
600825|NCT01013740|Neoplasms, Breast|neoplasms, breast
600826|NCT01013727|Volunteers|volunteers
600827|NCT01013727|healthy subjects|healthy subjects
600828|NCT01013714|Sudden cardiac death|sudden cardiac death
600829|NCT01013714|Ventricular tachycardia|ventricular tachycardia
600830|NCT01013714|Ventricular fibrillation|ventricular fibrillation
600831|NCT01013714|Cardiomyopathy|cardiomyopathy
600832|NCT01013714|Internal cardiac defibrillator shocks|internal cardiac defibrillator shocks
600833|NCT01013714|Internal cardiac defibrillator therapies|internal cardiac defibrillator therapies
600834|NCT01013701|nasal polyps|nasal polyps
600835|NCT01013701|nasal steroid|nasal steroid
600836|NCT01013701|fluticasone furoate|fluticasone furoate
600837|NCT01013688|Radiofrequency ablation|radiofrequency ablation
600838|NCT01013688|Maze|maze
600839|NCT01013688|Atrial fibrillation|atrial fibrillation
600840|NCT01013675|influenza|influenza
600841|NCT01013675|active-controlled|active-controlled
600842|NCT01013675|Phase 2|phase 2
600843|NCT01013662|septic shock|septic shock
600844|NCT01013662|glycemic control|glycemic control
600846|NCT01013662|lipid metabolism|lipid metabolism
600847|NCT01013662|septic patients|septic patients
600848|NCT01013623|melanoma|melanoma
600849|NCT01013623|stage IV|stage iv
600850|NCT01013623|resectable|resectable
600851|NCT01013623|surgery|surgery
600852|NCT01013623|medical therapy|medical therapy
600853|NCT01013610|Healthy Elderly Volunteers|healthy elderly volunteers
600854|NCT01013597|thyroid|thyroid
600855|NCT01013597|medullary|medullary
600856|NCT01013597|differentiated|differentiated
600857|NCT01013597|radioiodine-resistant|radioiodine-resistant
600858|NCT01013597|LBH589|lbh589
600859|NCT01013597|panobinostat|panobinostat
600860|NCT01013584|vitamin D|vitamin d
600861|NCT01013558|fetal pain|fetal pain
600862|NCT01013558|intrauterine|intrauterine
600863|NCT01013558|needling|needling
600864|NCT01013545|joint engagement|joint engagement
600865|NCT01013545|augmentative communication (AAC)|augmentative communication (aac)
600866|NCT01013545|enhanced milieu training|enhanced milieu training
600867|NCT01013545|autism spectrum disorder|autism spectrum disorder
600868|NCT01013545|language|language
600869|NCT01013532|Ischemic Stroke|ischemic stroke
600870|NCT01013532|Intracranial Hemorrhage|intracranial hemorrhage
600871|NCT01013532|Cilostazol|cilostazol
600872|NCT01013532|Probucol|probucol
600873|NCT01013506|estrogen receptor-positive breast cancer|estrogen receptor-positive breast cancer
600874|NCT01013506|progesterone receptor-positive breast cancer|progesterone receptor-positive breast cancer
600875|NCT01013506|stage IV breast cancer|stage iv breast cancer
600876|NCT01013506|recurrent breast cancer|recurrent breast cancer
600877|NCT01013493|breastfeeding|breastfeeding
600878|NCT01013493|myopia|myopia
600879|NCT01013493|nearsightedness|nearsightedness
600880|NCT01013493|children|children
600881|NCT01013480|Fragile X Syndrome|fragile x syndrome
600882|NCT01013467|blood pressure|blood pressure
600883|NCT01013467|control|control
600884|NCT01013467|adherence|adherence
600885|NCT01013467|behaviour|behaviour
600886|NCT01013454|varenicline percutaneous transcutaneous topical transdermal transdermal delivery system patch|varenicline percutaneous transcutaneous topical transdermal transdermal delivery system patch
600887|NCT01013441|Chronic Lymphocytic Leukemia|chronic lymphocytic leukemia
600888|NCT01013428|Traumatic Rupture of Tendon|traumatic rupture of tendon
600889|NCT01013415|HIV-1|hiv-1
600890|NCT01013402|Hypoglycemia|hypoglycemia
600891|NCT01013402|Home Blood Glucose Monitoring|home blood glucose monitoring
600892|NCT01013402|Subjects are being investigated for the integrity of|subjects are being investigated for the integrity of
600893|NCT01013402|pituitary-adrenal functions by insulin hypoglycemia test.|pituitary-adrenal functions by insulin hypoglycemia test.
600894|NCT01013389|actifuse|actifuse
600895|NCT01013389|INFUSE|infuse
600896|NCT01013389|InductOs|inductos
600897|NCT01013389|DDD|ddd
600898|NCT01013389|degenerative disk disease|degenerative disk disease
600899|NCT01013389|PLIF|plif
600900|NCT01013389|PITF|pitf
600901|NCT01013389|PLF|plf
600902|NCT01013389|poterolateral lumber fusion|poterolateral lumber fusion
600903|NCT01013389|Bone substitute|bone substitute
600904|NCT01013389|bone graft|bone graft
600905|NCT01013389|synthetic bone substitute|synthetic bone substitute
600906|NCT01013363|abortion|abortion
600907|NCT01013363|first trimester|first trimester
600908|NCT01013363|suction aspiration|suction aspiration
600909|NCT01013363|vacuum aspiration|vacuum aspiration
600910|NCT01013363|music|music
600911|NCT01013363|anesthesia|anesthesia
600912|NCT01013363|analgesia|analgesia
600913|NCT01013363|anxiolytic|anxiolytic
600914|NCT01013363|pain|pain
600915|NCT01013363|anxiety|anxiety
600916|NCT01013363|blood pressure|blood pressure
600917|NCT01013363|heart rate|heart rate
600918|NCT01013363|satisfaction|satisfaction
600919|NCT01013350|Multiple Sclerosis|multiple sclerosis
600920|NCT01013350|Cladribine|cladribine
600921|NCT01013350|PREMIERE|premiere
600922|NCT01013350|Observational study|observational study
600923|NCT01013324|endometrial cancer|endometrial cancer
600924|NCT01013324|endometrial carcinoma|endometrial carcinoma
600925|NCT01013324|carcinoma of the endometrium|carcinoma of the endometrium
600926|NCT01013324|cancer of the endometrium|cancer of the endometrium
600927|NCT01013311|Implantable Cardioverter-Defibrillator (ICD)- pre-existing|implantable cardioverter-defibrillator (icd)- pre-existing
600928|NCT01013298|percutaneous tracheostomy|percutaneous tracheostomy
600929|NCT01013298|paratracheal insertion|paratracheal insertion
600930|NCT01013298|tracheal injury|tracheal injury
600931|NCT01013298|transtracheal needle|transtracheal needle
600932|NCT01013298|ventilatory parameters|ventilatory parameters
600933|NCT01013285|adult giant cell glioblastoma|adult giant cell glioblastoma
600934|NCT01013285|adult gliosarcoma|adult gliosarcoma
600935|NCT01013285|adult glioblastoma|adult glioblastoma
600936|NCT01013272|entecavir|entecavir
600937|NCT01013272|lamivudine|lamivudine
600938|NCT01013272|sequential therapy|sequential therapy
600939|NCT01013259|E.coli|e.coli
600940|NCT01013259|Mutaflor|mutaflor
600941|NCT01013259|grass pollen|grass pollen
600942|NCT01013259|rhinoconjunctivitis|rhinoconjunctivitis
600943|NCT01013259|rhinoconjunctivitis caused by grass pollen|rhinoconjunctivitis caused by grass pollen
600944|NCT01013246|Video games|video games
600945|NCT01013246|Energy balance|energy balance
600946|NCT01013246|Metabolism|metabolism
600947|NCT01013246|Appetite control|appetite control
600948|NCT01013233|cognitive dysfunction chemotherapy|cognitive dysfunction chemotherapy
600949|NCT01013220|depression|depression
600950|NCT01013220|depression care management|depression care management
600951|NCT01013220|financing|financing
600952|NCT01013220|absenteeism|absenteeism
600953|NCT01013220|presenteeism|presenteeism
600954|NCT01013220|employer decisions to purchase health care benefits|employer decisions to purchase health care benefits
600955|NCT01013207|CPAP compliance|cpap compliance
600956|NCT01013194|Liver cirrhosis|liver cirrhosis
600957|NCT01013194|Fetal stem cells|fetal stem cells
600958|NCT01013194|Stem cell transplantation|stem cell transplantation
600959|NCT01013194|Liver transplant candidate|liver transplant candidate
600960|NCT01013181|Immune Thrombopenia|immune thrombopenia
600961|NCT01013181|Thrombocytopenia|thrombocytopenia
600962|NCT01013181|romiplostim|romiplostim
763533|NCT00390845|P38|p38
600963|NCT01013181|compassionate program|compassionate program
600964|NCT01013168|OncoSorb|oncosorb
600965|NCT01013168|immune apheresis|immune apheresis
600966|NCT01013168|sTNF-R1|stnf-r1
600967|NCT01013168|sTNF-R2|stnf-r2
600968|NCT01013168|sIL-2R|sil-2r
600969|NCT01013168|TNF|tnf
600970|NCT01013142|COPD|copd
600971|NCT01013129|hereditary prostate cancer|hereditary prostate cancer
600972|NCT01013129|prostate cancer|prostate cancer
600973|NCT01013090|Epidural anesthesia|epidural anesthesia
600974|NCT01013090|Spinal anesthesia|spinal anesthesia
600975|NCT01013090|Combined spinal-epidural anesthesia|combined spinal-epidural anesthesia
600976|NCT01013090|Fluid therapy|fluid therapy
600977|NCT01013090|Crystalloid|crystalloid
600978|NCT01013090|Colloid|colloid
600979|NCT01013077|functional vision|functional vision
600980|NCT01013077|contrast sensitivity|contrast sensitivity
600981|NCT01013077|aberrometry|aberrometry
600982|NCT01013077|reading ability|reading ability
600983|NCT01013064|Erythropoietin|erythropoietin
600984|NCT01013064|Long acting|long acting
600985|NCT01013064|EPO|epo
600986|NCT01013051|obesity|obesity
600987|NCT01013051|gastric bypass|gastric bypass
600988|NCT01013051|metformin|metformin
600989|NCT01013051|pharmacokinetics|pharmacokinetics
600990|NCT01013051|absorption|absorption
600991|NCT01013038|myocardial infarction|myocardial infarction
600992|NCT01013038|percutaneous coronary intervention|percutaneous coronary intervention
600993|NCT01013038|thrombus aspiration|thrombus aspiration
600994|NCT01013025|prostate cancer|prostate cancer
600995|NCT01013025|implant retrieval|implant retrieval
600996|NCT01013012|highly susceptible patients following spine surgery|highly susceptible patients following spine surgery
600997|NCT01012999|acute pain, intranasal, sufentanil,|acute pain, intranasal, sufentanil,
600998|NCT01012999|Acute pain control with an intranasal opiate|acute pain control with an intranasal opiate
600999|NCT01012973|Macular Edema|macular edema
601000|NCT01012973|Central Retinal Vein Occlusion|central retinal vein occlusion
601001|NCT01012973|CRVO|crvo
601002|NCT01012973|VEGF Trap-Eye|vegf trap-eye
601003|NCT01012973|best-corrected visual acuity|best-corrected visual acuity
601004|NCT01012960|methylnaltrexone|methylnaltrexone
601005|NCT01012960|upper esophageal sphincter|upper esophageal sphincter
601006|NCT01012960|lower esophageal sphincter|lower esophageal sphincter
601007|NCT01012960|high resolution solid state manometry|high resolution solid state manometry
601008|NCT01012960|opioid induced pharyngeal and esophageal dysfunction|opioid induced pharyngeal and esophageal dysfunction
601009|NCT01012947|MMSE|mmse
601010|NCT01012947|activity|activity
601011|NCT01012921|GBR|gbr
601012|NCT01012921|GTR|gtr
601013|NCT01012921|Dental Implant surgery|dental implant surgery
601014|NCT01012869|Coronary chronic total occlusions|coronary chronic total occlusions
601015|NCT01012856|depressive episode|depressive episode
601016|NCT01012856|psychotherapy|psychotherapy
601017|NCT01012856|cognitive therapy|cognitive therapy
601018|NCT01012856|emotional processing|emotional processing
601019|NCT01012856|RCT|rct
601020|NCT01012856|exposure|exposure
601021|NCT01012856|dual process model|dual process model
601022|NCT01012856|Implicit Association Test|implicit association test
601023|NCT01012856|mechanism of change|mechanism of change
601024|NCT01012843|Perianal|perianal
601025|NCT01012843|Abscess|abscess
601026|NCT01012843|Fistulae in ano|fistulae in ano
601027|NCT01012843|Antibiotic|antibiotic
601028|NCT01012843|Anorectal|anorectal
601029|NCT01012830|Schizophrenia|schizophrenia
601030|NCT01012830|Cognitive Disorders|cognitive disorders
601031|NCT01012830|Dementia|dementia
601032|NCT01012830|Huperzine A|huperzine a
601033|NCT01012830|HupA|hupa
601034|NCT01012804|stage IV colon cancer|stage iv colon cancer
601035|NCT01012804|recurrent colon cancer|recurrent colon cancer
601036|NCT01012791|Zumba exercise|zumba exercise
601037|NCT01012791|ApoE|apoe
601038|NCT01012778|Performance impairment|performance impairment
601039|NCT01012778|Yoga|yoga
601040|NCT01012778|Meditation|meditation
601041|NCT01012778|Peer mediated|peer mediated
601042|NCT01012765|COPD|copd
601043|NCT01012765|indacaterol|indacaterol
601044|NCT01012765|QAB149|qab149
601045|NCT01012765|inspiratory capacity|inspiratory capacity
601046|NCT01012739|asthma|asthma
601047|NCT01012739|QAB149|qab149
601048|NCT01012739|indacaterol|indacaterol
601049|NCT01012739|pulmonary function|pulmonary function
601050|NCT01012713|Psoriasis|psoriasis
601051|NCT01012713|Excimer|excimer
601052|NCT01012713|Laser|laser
601053|NCT01012713|Clobex|clobex
601054|NCT01012713|Vectical|vectical
601055|NCT01012713|clobetasol spray|clobetasol spray
601056|NCT01012713|calcitriol|calcitriol
601057|NCT01012713|Generalized plaque type psoriasis|generalized plaque type psoriasis
601058|NCT01012674|carotid or vertebral artery disease|carotid or vertebral artery disease
601059|NCT01012674|Contrast agent|contrast agent
601061|NCT01012661|Moderate to severe wrinkles and folds such as nasolabial folds|moderate to severe wrinkles and folds such as nasolabial folds
601062|NCT01012635|spinal cord injury|spinal cord injury
601063|NCT01012635|chronic pain|chronic pain
601064|NCT01012622|Attention Deficit Hyperactivity Disorder|attention deficit hyperactivity disorder
601065|NCT01012622|Methylphenidate Hydrochloride|methylphenidate hydrochloride
601066|NCT01012609|high-grade astrocytomas|high-grade astrocytomas
601067|NCT01012609|newly diagnosed diffuse pontine tumors|newly diagnosed diffuse pontine tumors
601068|NCT01012609|External beam radiation therapy|external beam radiation therapy
601069|NCT01012609|cetuximab|cetuximab
601070|NCT01012609|irinotecan|irinotecan
601072|NCT01012596|Natural Family Planning Methods|natural family planning methods
601073|NCT01012596|Ovulation Detection|ovulation detection
601074|NCT01012596|Cervix Mucus|cervix mucus
601075|NCT01012596|Intention|intention
601076|NCT01012596|Behavior|behavior
601077|NCT01012596|Birth Control|birth control
601078|NCT01012596|Contraception|contraception
601079|NCT01012596|Pregnancy|pregnancy
601080|NCT01012596|Fertility|fertility
601081|NCT01012583|Optical coherence tomography|optical coherence tomography
601082|NCT01012583|Drug eluting stent|drug eluting stent
601083|NCT01012583|Biodegradable polymer|biodegradable polymer
601084|NCT01012583|Intimal|intimal
601085|NCT01012583|Coverage|coverage
601086|NCT01012583|assess intimal hyperplasia of drug eluting stent with biodegradable polymer|assess intimal hyperplasia of drug eluting stent with biodegradable polymer
601087|NCT01012557|H1N1v|h1n1v
601088|NCT01012557|vaccine|vaccine
601089|NCT01012557|pregnant|pregnant
601090|NCT01012557|women|women
601091|NCT01012557|Assess whether the adjuvanted vaccine offers a meaningful benefit in pregnant women in terms of immune response over the non-adjuvanted vaccine.|assess whether the adjuvanted vaccine offers a meaningful benefit in pregnant women in terms of immune response over the non-adjuvanted vaccine.
601092|NCT01012557|Assess the persistence of immune response over a 15 month time period after one single vaccination of the pregnant mother.|assess the persistence of immune response over a 15 month time period after one single vaccination of the pregnant mother.
601093|NCT01012557|Assess whether the immune response to H1N1 in pregnant women is different from that of non-pregnant women of similar age.|assess whether the immune response to h1n1 in pregnant women is different from that of non-pregnant women of similar age.
601094|NCT01012557|Gain insight on safety of the Novartis egg-based MF59 adjuvanted H1N1 vaccine Focetria in pregnant women and their babies.|gain insight on safety of the novartis egg-based mf59 adjuvanted h1n1 vaccine focetria in pregnant women and their babies.
601095|NCT01012557|Assess the maternally transferred specific antibodies against H1N1v in the newborn|assess the maternally transferred specific antibodies against h1n1v in the newborn
601096|NCT01012557|Passive immunity transferred to the infant.|passive immunity transferred to the infant.
601097|NCT01012544|clopidogrel|clopidogrel
601098|NCT01012544|pharmacokinetics|pharmacokinetics
601099|NCT01012544|platelet function tests|platelet function tests
601100|NCT01012544|platelet reactivity|platelet reactivity
601101|NCT01012518|percutaneous tracheostomy|percutaneous tracheostomy
601102|NCT01012518|paratracheal insertion|paratracheal insertion
601103|NCT01012518|tracheal injury|tracheal injury
601104|NCT01012518|transtracheal needle|transtracheal needle
601105|NCT01012518|ventilatory parameters|ventilatory parameters
601106|NCT01012492|cancer|cancer
601107|NCT01012492|leukemia|leukemia
601108|NCT01012492|transplant|transplant
601109|NCT01012492|bone marrow|bone marrow
601110|NCT01012479|Blood Pressure|blood pressure
601111|NCT01012479|Blood Pressure, High|blood pressure, high
601112|NCT01012479|Drug Therapy|drug therapy
601113|NCT01012466|pregnancy|pregnancy
601114|NCT01012466|birth|birth
601115|NCT01012466|labor|labor
601116|NCT01012466|labor pain|labor pain
601117|NCT01012466|catastrophizing|catastrophizing
601118|NCT01012453|Hand eczema|hand eczema
601119|NCT01012453|Hand dermatitis|hand dermatitis
601120|NCT01012453|Occupational skin disease|occupational skin disease
601121|NCT01012453|skindisease in health care workers|skindisease in health care workers
601122|NCT01012453|occupational hand dermatitis|occupational hand dermatitis
601123|NCT01012453|occupational hand eczema|occupational hand eczema
601124|NCT01012427|Kidney|kidney
601125|NCT01012427|Cryoablation|cryoablation
601126|NCT01012427|09-108|09-108
601127|NCT01012414|Vitamin D|vitamin d
601128|NCT01012414|Coronary Artery Disease (CAD)|coronary artery disease (cad)
601129|NCT01012414|Chronic Kidney Disease (CKD)|chronic kidney disease (ckd)
601130|NCT01012401|Lung cancer|lung cancer
601131|NCT01012401|Quality of life|quality of life
601132|NCT01012401|Communication with physician|communication with physician
601133|NCT01012388|Moderate to severe wrinkles and folds such as nasolabial folds|moderate to severe wrinkles and folds such as nasolabial folds
601134|NCT01012375|Adult ADHD|adult adhd
601135|NCT01012362|Solid tumor malignancy|solid tumor malignancy
601136|NCT01012362|breast cancer|breast cancer
601137|NCT01012362|lung cancer|lung cancer
601138|NCT01012362|colon cancer|colon cancer
601139|NCT01012362|pancreatic cancer|pancreatic cancer
601140|NCT01012362|head and neck cancer|head and neck cancer
601141|NCT01012362|kidney cancer|kidney cancer
601142|NCT01012362|sarcoma|sarcoma
601143|NCT01012362|hepatocellular cancer|hepatocellular cancer
710270|NCT00589563|stage IV cutaneous T-cell non-Hodgkin lymphoma|stage iv cutaneous t-cell non-hodgkin lymphoma
763875|NCT00389493|OCD|ocd
601144|NCT01012336|efficacy and safety of Aprepitant/Ramosetron/Dexamethasone in ovary cancer patients with taxol and carboplatin|efficacy and safety of aprepitant/ramosetron/dexamethasone in ovary cancer patients with taxol and carboplatin
601146|NCT01012310|pharmacokinetics safety tolerability multiple dosing|pharmacokinetics safety tolerability multiple dosing
601147|NCT01012284|Moderate Hepatic Impairment|moderate hepatic impairment
601148|NCT01012284|Tuberculosis|tuberculosis
601149|NCT01012284|TMC207|tmc207
601150|NCT01012284|Mycobacterial adenosine triphosphate (ATP)-synthase|mycobacterial adenosine triphosphate (atp)-synthase
601151|NCT01012271|Wrist abnormalities|wrist abnormalities
601152|NCT01012258|antitumor activity|antitumor activity
601153|NCT01012258|safety|safety
601154|NCT01012258|cetuximab in combination with radiotherapy|cetuximab in combination with radiotherapy
601155|NCT01012258|locally advanced squamous cell head & neck carcinoma|locally advanced squamous cell head & neck carcinoma
601156|NCT01012245|Xchange|xchange
601157|NCT01012245|Xalatan|xalatan
601158|NCT01012245|Xalacom|xalacom
601159|NCT01012245|Betablocker|betablocker
601160|NCT01012245|observational|observational
601161|NCT01012245|longterm|longterm
601162|NCT01012232|total knee arthroplasty|total knee arthroplasty
601163|NCT01012232|postoperative pain|postoperative pain
601164|NCT01012206|Children|children
601165|NCT01012206|Overweight|overweight
601166|NCT01012206|Obesity|obesity
601167|NCT01012206|Food habits|food habits
601168|NCT01012206|Dietary assessment|dietary assessment
601169|NCT01012206|Physical activity|physical activity
601170|NCT01012193|adjunctive cilostazol|adjunctive cilostazol
601171|NCT01012193|high-MD clopidogrel|high-md clopidogrel
601172|NCT01012193|CYP 2C19 polymorphism|cyp 2c19 polymorphism
601173|NCT01012193|high risk patients|high risk patients
601174|NCT01012180|Bipolar Disorder|bipolar disorder
601175|NCT01012180|Adaptation|adaptation
601176|NCT01012180|Parents|parents
601177|NCT01012180|Risk|risk
601178|NCT01012180|Coping|coping
601179|NCT01012180|Survey|survey
601180|NCT01012167|Schizophrenia, oxytocin, galantamine|schizophrenia, oxytocin, galantamine
601181|NCT01012128|Temporal Artery Thermometer|temporal artery thermometer
601182|NCT01012128|Temperature|temperature
601183|NCT01012128|Preterm Infants|preterm infants
601184|NCT01012115|Histones|histones
601185|NCT01012115|organ failure|organ failure
601186|NCT01012115|sepsis|sepsis
601187|NCT01012102|EMD 640744|emd 640744
601188|NCT01012102|Montanide|montanide
601189|NCT01012102|Advanced solid tumours|advanced solid tumours
601190|NCT01012089|Hemodialysis|hemodialysis
601191|NCT01012089|Peritoneal dialysis|peritoneal dialysis
601192|NCT01012089|Daptomycin|daptomycin
601193|NCT01012089|Pharmacokinetics|pharmacokinetics
601194|NCT01012076|maternal synchrony|maternal synchrony
601195|NCT01012076|parent-child|parent-child
601196|NCT01012076|parent child play|parent child play
601197|NCT01012076|social communication|social communication
601198|NCT01012063|iron|iron
601199|NCT01012063|erythropoietin|erythropoietin
601200|NCT01012063|hemoglobin|hemoglobin
601201|NCT01012063|Total knee replacement arthroplasty|total knee replacement arthroplasty
601202|NCT01012050|Asthma|asthma
601203|NCT01012050|status asthmatics|status asthmatics
601204|NCT01012011|Carcinoma, Hepatocellular|carcinoma, hepatocellular
601205|NCT01012011|Carcinoma, Renal Cell|carcinoma, renal cell
601206|NCT01011998|CML|cml
601207|NCT01011998|Chronic Myelogenous leukemia|chronic myelogenous leukemia
601208|NCT01011998|INST 0901|inst 0901
601209|NCT01011998|imatinib|imatinib
601210|NCT01011998|valproic acid|valproic acid
601211|NCT01011998|Gleevec|gleevec
601212|NCT01011985|end stage renal disease|end stage renal disease
601213|NCT01011985|inflammation|inflammation
601214|NCT01011985|vascular access|vascular access
601215|NCT01011985|hemodialysis|hemodialysis
601216|NCT01011972|Dose escalation|dose escalation
601217|NCT01011972|XMT-1107|xmt-1107
601218|NCT01011972|1107|1107
601219|NCT01011972|Tumor|tumor
601220|NCT01011972|Phase 1|phase 1
601221|NCT01011972|Fumagillol|fumagillol
601222|NCT01011972|PHF|phf
601223|NCT01011972|Fleximer|fleximer
601224|NCT01011972|cancer|cancer
601225|NCT01011972|maximum tolerated dose|maximum tolerated dose
601226|NCT01011972|MTD|mtd
601227|NCT01011920|newly diagnosed primary central nervous system lymphoma|newly diagnosed primary central nervous system lymphoma
601228|NCT01011894|Lenalidomide|lenalidomide
601229|NCT01011894|CLL|cll
601230|NCT01011894|09-045|09-045
601231|NCT01011881|pleuritis|pleuritis
601232|NCT01011881|empyema|empyema
601233|NCT01011881|procalcitonin|procalcitonin
601234|NCT01011829|methamphetamine|methamphetamine
601235|NCT01011829|crystal meth|crystal meth
601236|NCT01011829|addiction|addiction
601237|NCT01011829|los angeles|los angeles
601238|NCT01011829|medication|medication
601239|NCT01011829|meth|meth
601240|NCT01011816|intervertebral disk|intervertebral disk
601241|NCT01011803|Deglutition|deglutition
601242|NCT01011803|Phonation|phonation
601243|NCT01011790|Healing Rhythms™|healing rhythms™
601244|NCT01011790|Meditation|meditation
763889|NCT00389467|MRI|mri
601245|NCT01011790|Biofeedback|biofeedback
601246|NCT01011790|Stress|stress
601247|NCT01011777|bladder exstrophy epispadias complex|bladder exstrophy epispadias complex
601248|NCT01011777|urinary incontinence|urinary incontinence
601249|NCT01011777|muscle derive cell therapy|muscle derive cell therapy
601250|NCT01011777|stem cells|stem cells
601251|NCT01011764|social networks|social networks
601252|NCT01011764|friendships|friendships
601253|NCT01011764|autism spectrum disorder|autism spectrum disorder
601254|NCT01011751|Drug Therapy|drug therapy
601255|NCT01011712|Genetics|genetics
601256|NCT01011712|Virus|virus
601257|NCT01011712|Defense|defense
601258|NCT01011712|Immunity|immunity
601259|NCT01011712|Immunodeficiency|immunodeficiency
601260|NCT01011712|Respiratory Viruses|respiratory viruses
601261|NCT01011712|Herpesvirus|herpesvirus
601262|NCT01011712|Cytomegalovirus|cytomegalovirus
601263|NCT01011712|Human Papillomavirus|human papillomavirus
601264|NCT01011712|Adenovirus|adenovirus
601265|NCT01011699|nicotinamide|nicotinamide
601266|NCT01011699|sevelamer hydrochloride|sevelamer hydrochloride
601267|NCT01011699|phosphatemia|phosphatemia
601268|NCT01011699|cinacalcet|cinacalcet
601269|NCT01011699|dyslipidemia|dyslipidemia
601270|NCT01011699|vascular calcification|vascular calcification
601271|NCT01011699|bone mass loss|bone mass loss
601272|NCT01011673|headache|headache
601273|NCT01011673|tension-type headache|tension-type headache
601274|NCT01011660|hypertension|hypertension
601275|NCT01011660|cardiovascular risk factors|cardiovascular risk factors
601276|NCT01011660|drugs intervention|drugs intervention
601277|NCT01011660|lipid-lowering therapy|lipid-lowering therapy
601278|NCT01011660|50-79 years of age|50-79 years of age
601279|NCT01011660|sign|sign
601280|NCT01011660|the informed|the informed
601281|NCT01011660|consent|consent
601282|NCT01011660|forms|forms
601283|NCT01011634|abortion|abortion
601284|NCT01011634|uterine aspiration|uterine aspiration
601285|NCT01011634|pain control|pain control
601286|NCT01011621|Prednisolone acetate|prednisolone acetate
601287|NCT01011621|Betamethasone valerate|betamethasone valerate
601288|NCT01011595|lung cancer|lung cancer
601289|NCT01011595|mediastinoscopy|mediastinoscopy
601290|NCT01011595|mediastinal lymph nodes|mediastinal lymph nodes
601291|NCT01011595|staging|staging
601292|NCT01011595|EBUS|ebus
601293|NCT01011595|EUS|eus
601294|NCT01011595|Endobronchial Ultrasound|endobronchial ultrasound
601295|NCT01011595|Endoscopic Ultrasound|endoscopic ultrasound
601296|NCT01011582|To evaluate biomarkers that cause critical illness in patients with novel H1N1 influenza and with seasonal influenza.|to evaluate biomarkers that cause critical illness in patients with novel h1n1 influenza and with seasonal influenza.
601297|NCT01011569|difference|difference
601298|NCT01011556|Age Related Osteoporosis|age related osteoporosis
601299|NCT01011556|Senile Osteoporosis|senile osteoporosis
601300|NCT01011543|pulmonary tuberculosis|pulmonary tuberculosis
601301|NCT01011543|negative sputum exam|negative sputum exam
601302|NCT01011543|induced sputum|induced sputum
601303|NCT01011543|endoscopy|endoscopy
601304|NCT01011530|Melanoma|melanoma
601305|NCT01011517|muscadine grapes|muscadine grapes
601306|NCT01011517|endothelial function|endothelial function
601307|NCT01011491|Obesity|obesity
601308|NCT01011491|Weight loss|weight loss
601309|NCT01011491|meal replacements|meal replacements
601310|NCT01011491|inflammation|inflammation
601311|NCT01011491|oxidative stress|oxidative stress
601312|NCT01011491|visceral fat|visceral fat
601313|NCT01011478|adenomatous polyp|adenomatous polyp
601314|NCT01011478|stage I colon cancer|stage i colon cancer
601315|NCT01011478|stage II colon cancer|stage ii colon cancer
601316|NCT01011478|adenocarcinoma of the colon|adenocarcinoma of the colon
601317|NCT01011465|Stress|stress
601318|NCT01011465|Oxytocin|oxytocin
601319|NCT01011465|Social Support|social support
601320|NCT01011465|Resilience|resilience
601321|NCT01011452|Acute Asthma Exacerbation|acute asthma exacerbation
601322|NCT01011452|Montelukast|montelukast
601323|NCT01011452|Management of acute asthma exacerbation|management of acute asthma exacerbation
601324|NCT01011439|B3 and C malignant thymoma|b3 and c malignant thymoma
601325|NCT01011426|laxative|laxative
601326|NCT01011426|postoperative care|postoperative care
601327|NCT01011426|ob-Gyn population|ob-gyn population
601328|NCT01011426|post-operative patients|post-operative patients
601329|NCT01011426|obstetrical and gynecological surgery|obstetrical and gynecological surgery
601330|NCT01011413|HIV|hiv
601331|NCT01011413|ART|art
601332|NCT01011413|Efavirenz|efavirenz
601333|NCT01011413|Dose reduction|dose reduction
601334|NCT01011400|clitoris|clitoris
601335|NCT01011387|Diabetic foot ulcers|diabetic foot ulcers
601336|NCT01011374|Retinal vein occlusion|retinal vein occlusion
601337|NCT01011374|Ranibizumab|ranibizumab
601338|NCT01011374|Lucentis|lucentis
601339|NCT01011374|Depression|depression
601340|NCT01011348|Gulf War Illness|gulf war illness
601341|NCT01011348|Coenzyme Q10|coenzyme q10
601342|NCT01011348|Quality of Life|quality of life
601343|NCT01011348|Fatigue|fatigue
601344|NCT01011348|oxidative stress|oxidative stress
601345|NCT01011335|Staphylococcus aureus|staphylococcus aureus
601346|NCT01011335|Skin and soft tissue infection|skin and soft tissue infection
601347|NCT01011335|Methicillin-resistant Staphylococcus aureus|methicillin-resistant staphylococcus aureus
601348|NCT01011335|Recombinant alpha-toxoid (rAT)|recombinant alpha-toxoid (rat)
601349|NCT01011335|Recombinant LukS subunit of Panton-Valentine Leukocidin (rLukS-PV)|recombinant luks subunit of panton-valentine leukocidin (rluks-pv)
601350|NCT01011309|Leishmaniasis|leishmaniasis
601351|NCT01011309|vaccine|vaccine
601352|NCT01011309|immunotherapy|immunotherapy
601353|NCT01011283|MDS|mds
601354|NCT01011283|Myelodysplastic Syndromes|myelodysplastic syndromes
601355|NCT01011270|Back pain|back pain
601356|NCT01011270|postural balance|postural balance
601357|NCT01011270|RDM|rdm
601358|NCT01011270|industrial operators|industrial operators
601359|NCT01011257|CAD|cad
601360|NCT01011231|Gamma Knife radiosurgery|gamma knife radiosurgery
601361|NCT01011231|recurrent glioma|recurrent glioma
601362|NCT01011231|MRI|mri
601363|NCT01011231|Spectroscopy|spectroscopy
601364|NCT01011231|Recurrent grade IV glioma (glioblastoma), with two additional exploratory arms for patients with recurrent grade II and grade III gliomas|recurrent grade iv glioma (glioblastoma), with two additional exploratory arms for patients with recurrent grade ii and grade iii gliomas
601365|NCT01011205|Immunosuppression|immunosuppression
601366|NCT01011205|Liver|liver
601367|NCT01011205|Transplant|transplant
601368|NCT01011205|Advagraf|advagraf
601369|NCT01011192|Intravenous anesthesia|intravenous anesthesia
601370|NCT01011192|propofol|propofol
601371|NCT01011192|pharmacokinetic model|pharmacokinetic model
601372|NCT01011192|Monitoring|monitoring
601373|NCT01011192|bispectral index.|bispectral index.
601374|NCT01011179|Teens Taking Charge|teens taking charge
601375|NCT01011179|Managing Arthritis Online|managing arthritis online
601376|NCT01011179|juvenile idiopathic arthritis|juvenile idiopathic arthritis
601377|NCT01011179|internet|internet
601378|NCT01011179|self-management|self-management
601379|NCT01011166|Chronic Hepatitis C|chronic hepatitis c
601380|NCT01011166|HepC|hepc
601381|NCT01011166|Hep C|hep c
601382|NCT01011140|Parenteral Hydration|parenteral hydration
601383|NCT01011140|Latin American Association for Palliative Care|latin american association for palliative care
601384|NCT01011140|ALCP|alcp
601385|NCT01011140|Spanish Society for Palliative Care|spanish society for palliative care
601386|NCT01011140|SECPAL|secpal
601387|NCT01011140|Online survey|online survey
601388|NCT01011140|Palliative care|palliative care
601389|NCT01011140|Physicians' attitudes|physicians' attitudes
601390|NCT01011140|End of life|end of life
601391|NCT01011140|Latin America|latin america
601392|NCT01011140|Spain|spain
601393|NCT01011127|Statins|statins
601394|NCT01011127|Insulin resistance|insulin resistance
601395|NCT01011114|hypophosphatemia|hypophosphatemia
601396|NCT01011114|hyperparathyroidism|hyperparathyroidism
601397|NCT01011114|renal transplant|renal transplant
601398|NCT01011101|Saccadic Eye Movements|saccadic eye movements
601399|NCT01011101|Schizophrenia|schizophrenia
601400|NCT01011101|Healthy Volunteer|healthy volunteer
601401|NCT01011101|HV|hv
601402|NCT01011088|Paternity|paternity
601403|NCT01011088|Psychology|psychology
601404|NCT01011088|Risk factor|risk factor
601405|NCT01011075|Lung cancer,|lung cancer,
601406|NCT01011075|Non-small cell lung cancer|non-small cell lung cancer
601407|NCT01011075|NSCLC|nsclc
601408|NCT01011075|Metastatic|metastatic
601409|NCT01011075|Gleevec|gleevec
601410|NCT01011075|elderly|elderly
601411|NCT01011062|Adipose tissue|adipose tissue
601412|NCT01011062|Adipokines|adipokines
601413|NCT01011049|Influenza|influenza
601414|NCT01011049|Fluzone Vaccine|fluzone vaccine
601415|NCT01011049|Intradermal Injections|intradermal injections
601416|NCT01011049|Adults|adults
601417|NCT01011036|healthy study subjects, no disease|healthy study subjects, no disease
601418|NCT01011023|Bowel anastomosis|bowel anastomosis
601419|NCT01011023|nasogastric tube|nasogastric tube
601420|NCT01011023|children|children
601421|NCT01011010|adult primary hepatocellular carcinoma|adult primary hepatocellular carcinoma
601422|NCT01011010|localized unresectable adult primary liver cancer|localized unresectable adult primary liver cancer
601423|NCT01011010|recurrent adult primary liver cancer|recurrent adult primary liver cancer
601424|NCT01010997|AMD, CNV|amd, cnv
602693|NCT01006096|efficacy|efficacy
601425|NCT01010984|metastatic melanoma|metastatic melanoma
601426|NCT01010984|stage IV melanoma|stage iv melanoma
601427|NCT01010984|metastatic melanoma to the liver|metastatic melanoma to the liver
601428|NCT01010971|Mountain Cedar|mountain cedar
601429|NCT01010945|erlotinib|erlotinib
601430|NCT01010945|nab-paclitaxel|nab-paclitaxel
601431|NCT01010945|gemcitabine|gemcitabine
601432|NCT01010945|Adenocarcinoma|adenocarcinoma
601433|NCT01010945|Advanced Pancreatic Cancer|advanced pancreatic cancer
601434|NCT01010945|Phase 1b|phase 1b
601435|NCT01010932|carotid or vertebral artery disease|carotid or vertebral artery disease
601436|NCT01010932|Contrast agent|contrast agent
601437|NCT01010932|MRA|mra
601438|NCT01010893|pandemic|pandemic
601439|NCT01010893|prevention|prevention
601440|NCT01010893|influenza|influenza
601441|NCT01010893|infection|infection
601442|NCT01010893|influenza vaccine|influenza vaccine
601443|NCT01010893|vaccine|vaccine
601444|NCT01010893|influenza in humans|influenza in humans
601445|NCT01010880|Multiple Myeloma|multiple myeloma
601446|NCT01010880|CXCR4|cxcr4
601447|NCT01010880|Stem Cells|stem cells
601448|NCT01010880|Mobilization|mobilization
601449|NCT01010880|Transplantation|transplantation
601450|NCT01010880|Chemotherapy|chemotherapy
601451|NCT01010867|Probiotics|probiotics
601452|NCT01010867|Hematopoietic Stem Cell Transplantation|hematopoietic stem cell transplantation
601453|NCT01010867|Pediatrics|pediatrics
601454|NCT01010854|breast cancer|breast cancer
601455|NCT01010854|advanced|advanced
601456|NCT01010854|local|local
601457|NCT01010841|Metabolic syndrome|metabolic syndrome
601458|NCT01010841|Serum lipid|serum lipid
601459|NCT01010841|Dietary intervention|dietary intervention
601460|NCT01010841|Lifestyle modification|lifestyle modification
601461|NCT01010841|Glycemic load|glycemic load
601462|NCT01010841|Phytochemical|phytochemical
601463|NCT01010841|Hops|hops
601464|NCT01010841|Acacia|acacia
601465|NCT01010841|Mediterranean diet|mediterranean diet
601466|NCT01010841|Kinase modulator|kinase modulator
601467|NCT01010815|ulcerative colitis|ulcerative colitis
601468|NCT01010815|gut microbiome|gut microbiome
601469|NCT01010815|metagenomics|metagenomics
601470|NCT01010802|Neuroprotection|neuroprotection
601471|NCT01010802|Parkinson Disease|parkinson disease
601472|NCT01010802|Erythropoietin|erythropoietin
601473|NCT01010776|Schizophrenia|schizophrenia
601474|NCT01010776|Paliperidone|paliperidone
601475|NCT01010750|ADHD|adhd
601476|NCT01010737|Multimeric|multimeric
601477|NCT01010737|Vaccine|vaccine
601478|NCT01010737|Influenza|influenza
601479|NCT01010737|elderly|elderly
601480|NCT01010737|phase 1/2|phase 1/2
601481|NCT01010737|safety|safety
601482|NCT01010737|efficacy|efficacy
601483|NCT01010737|tolerability|tolerability
601484|NCT01010737|reactogenicity|reactogenicity
601485|NCT01010737|Montanide|montanide
601486|NCT01010737|hemagglutinin inhibition|hemagglutinin inhibition
601487|NCT01010737|HAI|hai
601488|NCT01010737|TIV|tiv
601489|NCT01010711|migraine|migraine
601490|NCT01010711|children|children
601491|NCT01010711|dietary supplement|dietary supplement
601492|NCT01010711|q10|q10
601493|NCT01010711|prevention|prevention
601494|NCT01010698|cimetidine|cimetidine
601495|NCT01010698|acyclovir|acyclovir
601496|NCT01010698|pharmacokinetics|pharmacokinetics
601497|NCT01010698|excipient|excipient
601498|NCT01010698|formulation|formulation
601499|NCT01010685|Natural Orifice Transluminal Endoscopic Surgery (NOTES)|natural orifice transluminal endoscopic surgery (notes)
601500|NCT01010685|Transgastric surgery|transgastric surgery
601501|NCT01010685|Surgical Procedures, Minimally Invasive|surgical procedures, minimally invasive
601502|NCT01010659|Dacryocystorhinostomy|dacryocystorhinostomy
601503|NCT01010646|hepatitis C|hepatitis c
601504|NCT01010646|viral kinetics|viral kinetics
601505|NCT01010646|antiviral response|antiviral response
601506|NCT01010646|Genotype 1 or 4|genotype 1 or 4
601507|NCT01010620|screening|screening
601508|NCT01010620|research participation|research participation
601509|NCT01010620|substance abuse|substance abuse
601510|NCT01010620|Schizophrenia|schizophrenia
601511|NCT01010620|nicotine|nicotine
601512|NCT01010620|Healthy|healthy
601513|NCT01010620|cigarettes|cigarettes
601514|NCT01010620|smoking|smoking
601515|NCT01010620|marijuana|marijuana
601516|NCT01010620|cocaine|cocaine
601517|NCT01010581|Rheumatoid Arthritis|rheumatoid arthritis
601518|NCT01010581|SC12267|sc12267
601519|NCT01010581|4SC-101|4sc-101
601520|NCT01010581|Methotrexate|methotrexate
601521|NCT01010581|Phase II|phase ii
601522|NCT01010568|CLL|cll
601523|NCT01010568|SLL|sll
601524|NCT01010568|Bendamustine|bendamustine
601525|NCT01010568|Ofatumumab|ofatumumab
601526|NCT01010542|Single dose psoriasis study|single dose psoriasis study
601527|NCT01010529|Occupational Therapy|occupational therapy
601528|NCT01010529|Parkinson's Disease|parkinson's disease
601529|NCT01010529|Feasibility|feasibility
601530|NCT01010529|Effectiveness|effectiveness
601531|NCT01010529|RCT|rct
601532|NCT01010529|Activities of daily living|activities of daily living
601533|NCT01010529|Participation|participation
601534|NCT01010529|Caregiver's Burden|caregiver's burden
601535|NCT01010490|PACHYMETRY|pachymetry
601536|NCT01010490|CELL LOSS|cell loss
601537|NCT01010490|SAFETY|safety
601538|NCT01010490|EFFICACY|efficacy
601539|NCT01010490|PHACOEMULSIFICATION|phacoemulsification
601540|NCT01010490|Intraoperative complications|intraoperative complications
601541|NCT01010490|CLOCK TIME|clock time
601542|NCT01010490|FLUID USED|fluid used
601543|NCT01010490|CORNEAL THICKNESS|corneal thickness
601544|NCT01010490|ENDOTHELIUM CELL LOSS|endothelium cell loss
601545|NCT01010477|smoking cessation|smoking cessation
601546|NCT01010477|schizophrenia|schizophrenia
601547|NCT01010477|nicotine nasal spray|nicotine nasal spray
601548|NCT01010477|behavioral counseling|behavioral counseling
601549|NCT01010464|Adhesions|adhesions
601550|NCT01010464|Open abdomen|open abdomen
601551|NCT01010464|Laparotomy|laparotomy
601552|NCT01010451|pulpotomy|pulpotomy
601553|NCT01010451|pulpectomy|pulpectomy
601554|NCT01010451|primary teeth|primary teeth
601555|NCT01010451|dental care for children|dental care for children
601556|NCT01010438|sleep studies|sleep studies
601557|NCT01010438|sleep apnea|sleep apnea
601558|NCT01010438|OSA|osa
601559|NCT01010438|Referred for sleep studies by a medical professional|referred for sleep studies by a medical professional
601560|NCT01010412|Ultrasound|ultrasound
601561|NCT01010412|Nerve blocks|nerve blocks
601562|NCT01010412|Upper extremity|upper extremity
601563|NCT01010399|HIV|hiv
601564|NCT01010399|triglycerides|triglycerides
601565|NCT01010399|fosamprenavir|fosamprenavir
601566|NCT01010386|Pregnancy|pregnancy
601567|NCT01010386|Infertility|infertility
601568|NCT01010386|Physiologic Oxygen Tension|physiologic oxygen tension
601569|NCT01010386|Atmospheric Oxygen Tension|atmospheric oxygen tension
601570|NCT01010373|Primary Acute Myeloid Leukemia (AML) and Myelodysplastic Syndrome (MDS) induced AML.|primary acute myeloid leukemia (aml) and myelodysplastic syndrome (mds) induced aml.
601571|NCT01010360|celiac ganglia|celiac ganglia
601572|NCT01010347|fractures|fractures
601573|NCT01010347|casting|casting
601574|NCT01010347|splinting|splinting
601575|NCT01010347|pediatrics|pediatrics
601576|NCT01010334|INST 0813|inst 0813
601577|NCT01010334|Standard of Care|standard of care
601578|NCT01010321|skin lesion suspect as BCC or SCC or others|skin lesion suspect as bcc or scc or others
601579|NCT01010308|infantile hemangioma|infantile hemangioma
601580|NCT01010308|nadolol|nadolol
601581|NCT01010295|NHL of the ocular adnexae|nhl of the ocular adnexae
601582|NCT01010256|To evaluate the phosphate and tension homolog deleted on chromosome ten (PTEN) protein level in leukemia cells from patients with CMML.|to evaluate the phosphate and tension homolog deleted on chromosome ten (pten) protein level in leukemia cells from patients with cmml.
601583|NCT01010256|To identify the PTEN genetic defect in patients with deficient PTEN protein levels.|to identify the pten genetic defect in patients with deficient pten protein levels.
601584|NCT01010256|To evaluate the role of PTEN deregulation in CMML pathogenesis.|to evaluate the role of pten deregulation in cmml pathogenesis.
601585|NCT01010243|multiple myeloma|multiple myeloma
601586|NCT01010243|anti-inflammatory|anti-inflammatory
601587|NCT01010243|relapsed|relapsed
601588|NCT01010243|refractory|refractory
601589|NCT01010243|progressive|progressive
601590|NCT01010230|Childhood cancer survivors|childhood cancer survivors
601591|NCT01010217|Hematologic Neoplasms|hematologic neoplasms
601592|NCT01010217|Blood Disorders|blood disorders
601593|NCT01010217|Blood Cancer|blood cancer
601594|NCT01010217|Transplantation, Blood And Marrow|transplantation, blood and marrow
601595|NCT01010217|Acute myelogenous leukemia|acute myelogenous leukemia
601596|NCT01010217|Myelodysplastic syndrome|myelodysplastic syndrome
601597|NCT01010217|Acute lymphocytic leukemia|acute lymphocytic leukemia
601598|NCT01010217|Aplastic anemia|aplastic anemia
601599|NCT01010217|Chronic myelogenous leukemia|chronic myelogenous leukemia
601600|NCT01010217|Chronic lymphocytic leukemia|chronic lymphocytic leukemia
601601|NCT01010217|Myeloproliferative disease|myeloproliferative disease
601602|NCT01010217|Hodgkin's disease|hodgkin's disease
601603|NCT01010217|Non-Hodgkin's lymphoma|non-hodgkin's lymphoma
601604|NCT01010217|Multiple myeloma|multiple myeloma
601605|NCT01010217|Cyclophosphamide|cyclophosphamide
601606|NCT01010217|Fludarabine|fludarabine
601607|NCT01010217|Melphalan|melphalan
601608|NCT01010217|Mesna|mesna
601609|NCT01010217|Rituximab|rituximab
601610|NCT01010217|Tacrolimus|tacrolimus
601611|NCT01010217|Prograf|prograf
601612|NCT01010217|Mycofenolate mofetil|mycofenolate mofetil
601614|NCT01010217|CellCept|cellcept
601615|NCT01010217|G-CSF|g-csf
601616|NCT01010217|Filgrastim|filgrastim
601617|NCT01010217|Neupogen|neupogen
601618|NCT01010204|Varenicline|varenicline
601619|NCT01010204|Chantix|chantix
601620|NCT01010204|Smoking|smoking
601621|NCT01010204|Bipolar Disorder|bipolar disorder
601622|NCT01010191|irritable bowel syndrome|irritable bowel syndrome
601623|NCT01010191|no organic digestive disease|no organic digestive disease
601624|NCT01010178|COPD|copd
601625|NCT01010178|Macrolid|macrolid
601626|NCT01010178|reversibility|reversibility
601627|NCT01010178|Theophylline|theophylline
601628|NCT01010178|Corticosteroids|corticosteroids
601629|NCT01010178|symptoms PFT|symptoms pft
601630|NCT01010165|acute arthritis|acute arthritis
601631|NCT01010165|bacteria|bacteria
601632|NCT01010165|crystal arthritis|crystal arthritis
601633|NCT01010165|proteomic|proteomic
601634|NCT01010165|SELDI-TOF|seldi-tof
601635|NCT01010113|infants|infants
601636|NCT01010113|prebiotics|prebiotics
601637|NCT01010113|probiotics|probiotics
601638|NCT01010113|safety|safety
601639|NCT01010100|Metabolic Disease|metabolic disease
601640|NCT01010100|IGT Impaired Glucose Tolerance|igt impaired glucose tolerance
601641|NCT01010087|patients admitted to ICU|patients admitted to icu
601642|NCT01010074|retina, Parkinson's disease, ganglion cell, pupillary|retina, parkinson's disease, ganglion cell, pupillary
601643|NCT01010048|ESWL|eswl
601644|NCT01010048|urinary calculus|urinary calculus
601645|NCT01010048|drugs treat|drugs treat
601646|NCT01010035|type 2 diabetes mellitus|type 2 diabetes mellitus
601647|NCT01010035|dyslipidemia|dyslipidemia
601648|NCT01010035|kinetics|kinetics
601649|NCT01010022|hypovolemia|hypovolemia
601650|NCT01010022|surgical blood loss|surgical blood loss
601651|NCT01010022|orthopedic procedures|orthopedic procedures
601652|NCT01010022|Treatment of reduced circulating blood volume (hypovolemia) including massive hemorrhage|treatment of reduced circulating blood volume (hypovolemia) including massive hemorrhage
601653|NCT01010009|resveratrol|resveratrol
601654|NCT01010009|cerebral blood flow|cerebral blood flow
601655|NCT01010009|NIRS|nirs
601656|NCT01010009|cognitive performance|cognitive performance
601657|NCT01009996|Coronary bifurcation lesions|coronary bifurcation lesions
601658|NCT01009983|triple-negative breast cancer|triple-negative breast cancer
601659|NCT01009970|Diffuse Large B-Cell Lymphoma|diffuse large b-cell lymphoma
601660|NCT01009957|ADPKD|adpkd
601661|NCT01009957|CKD|ckd
601662|NCT01009957|Renal disease progression|renal disease progression
601663|NCT01009957|Everolimus|everolimus
601664|NCT01009944|High blood pressure|high blood pressure
601665|NCT01009931|Acute Myelogenous Leukemia|acute myelogenous leukemia
601666|NCT01009931|Relapsed AML|relapsed aml
601667|NCT01009931|Refractory AML|refractory aml
601668|NCT01009918|cardiac toxicity|cardiac toxicity
601669|NCT01009918|HER2-positive breast cancer|her2-positive breast cancer
601670|NCT01009918|recurrent breast cancer|recurrent breast cancer
601671|NCT01009918|stage IA breast cancer|stage ia breast cancer
601672|NCT01009918|stage IB breast cancer|stage ib breast cancer
601673|NCT01009918|stage II breast cancer|stage ii breast cancer
601674|NCT01009918|stage IIIA breast cancer|stage iiia breast cancer
601675|NCT01009918|stage IIIB breast cancer|stage iiib breast cancer
601676|NCT01009918|stage IIIC breast cancer|stage iiic breast cancer
601677|NCT01009918|male breast cancer|male breast cancer
601678|NCT01009879|rheumatoid arthritis|rheumatoid arthritis
601679|NCT01009879|B lymphocytes|b lymphocytes
601680|NCT01009866|Malignant brain tumor|malignant brain tumor
601681|NCT01009866|GBM|gbm
601682|NCT01009866|recurrent brain tumor|recurrent brain tumor
601683|NCT01009866|Supratentorial malignant brain tumor|supratentorial malignant brain tumor
601684|NCT01009866|astrocytomas|astrocytomas
601685|NCT01009866|ependymomas|ependymomas
601686|NCT01009866|Residual, progressive, or recurrent supratentorial malignant brain tumor based on imaging studies with measurable|residual, progressive, or recurrent supratentorial malignant brain tumor based on imaging studies with measurable
601687|NCT01009866|disease (>0.5cm).|disease (>0.5cm).
601688|NCT01009840|Multiple Myeloma|multiple myeloma
601689|NCT01009840|Bone marrow transplant|bone marrow transplant
601690|NCT01009840|Stem cell transplant|stem cell transplant
601691|NCT01009840|Busulfan|busulfan
601692|NCT01009840|Bortezomib|bortezomib
601693|NCT01009827|Medication adherence|medication adherence
601694|NCT01009827|Substance use|substance use
601695|NCT01009827|Sexual risk behaviors|sexual risk behaviors
601696|NCT01009814|HIV, HIV attachment inhibitor, attachment inhibitor|hiv, hiv attachment inhibitor, attachment inhibitor
601697|NCT01009801|adult primary hepatocellular carcinoma|adult primary hepatocellular carcinoma
601698|NCT01009801|recurrent adult primary liver cancer|recurrent adult primary liver cancer
601699|NCT01009801|localized resectable adult primary liver cancer|localized resectable adult primary liver cancer
601700|NCT01009788|ABT-888|abt-888
601701|NCT01009788|temozolomide|temozolomide
601702|NCT01009788|TMZ|tmz
601703|NCT01009775|Melanoma, Stage III|melanoma, stage iii
601704|NCT01009775|Melanoma, Stage IV|melanoma, stage iv
601705|NCT01009775|YM 155|ym 155
601706|NCT01009775|Metastatic Melanoma|metastatic melanoma
601707|NCT01009762|VACCINE|vaccine
601708|NCT01009762|THERAPY|therapy
601709|NCT01009762|CELLULAR IMMUNITY|cellular immunity
601710|NCT01009762|IMMUNITY|immunity
601711|NCT01009749|HAART|haart
601712|NCT01009749|HIV|hiv
601713|NCT01009749|Adherence|adherence
601714|NCT01009736|stage I prostate cancer|stage i prostate cancer
601715|NCT01009736|stage IIB prostate cancer|stage iib prostate cancer
601716|NCT01009736|stage IIA prostate cancer|stage iia prostate cancer
601717|NCT01009736|stage III prostate cancer|stage iii prostate cancer
601718|NCT01009736|stage IV prostate cancer|stage iv prostate cancer
601719|NCT01009723|Preterm delivery|preterm delivery
601720|NCT01009723|preterm labor|preterm labor
602694|NCT01006083|Aspirin|aspirin
601721|NCT01009723|maternal-fetal care|maternal-fetal care
601722|NCT01009723|maternal serum screening biomarkers|maternal serum screening biomarkers
601723|NCT01009723|alphafetoprotein|alphafetoprotein
601724|NCT01009723|AFP|afp
601725|NCT01009723|human chorionic gonadotropin|human chorionic gonadotropin
601726|NCT01009723|hCG|hcg
601727|NCT01009723|unconjugated estriol|unconjugated estriol
601728|NCT01009723|Inhibin A|inhibin a
601729|NCT01009723|pregnancy associated plasma protein|pregnancy associated plasma protein
601730|NCT01009723|PAPP-A|papp-a
601731|NCT01009723|maternal screening|maternal screening
601732|NCT01009684|Contraception|contraception
601733|NCT01009684|Estradiol valerate|estradiol valerate
601734|NCT01009671|knee osteoarthritis|knee osteoarthritis
601735|NCT01009658|Gastrointestinal motility|gastrointestinal motility
601736|NCT01009658|Gastroesophageal reflux|gastroesophageal reflux
601737|NCT01009658|Gastric emptying|gastric emptying
601738|NCT01009658|Sodium glutamate|sodium glutamate
601739|NCT01009658|Lower esophageal sphincter|lower esophageal sphincter
601740|NCT01009645|education|education
601741|NCT01009645|vaccination|vaccination
601742|NCT01009645|preventive service|preventive service
601743|NCT01009645|Prevention & Control|prevention & control
601744|NCT01009619|Bronchiolitis Obliterans Syndrome|bronchiolitis obliterans syndrome
601745|NCT01009619|Acute allograft Rejection|acute allograft rejection
601746|NCT01009619|Lymphocytic bronchiolitis|lymphocytic bronchiolitis
601747|NCT01009619|Respiratory infection|respiratory infection
601748|NCT01009619|Survival|survival
601749|NCT01009619|Mortality|mortality
601750|NCT01009619|Pulmonary function|pulmonary function
601751|NCT01009619|FEV1|fev1
601752|NCT01009619|Broncho-alveolar lavage|broncho-alveolar lavage
601753|NCT01009619|Neutrophils|neutrophils
601754|NCT01009619|Interleukin|interleukin
601755|NCT01009619|Culture|culture
601756|NCT01009619|Azithromycin|azithromycin
601757|NCT01009606|Out-of-hospital|out-of-hospital
601758|NCT01009606|Emergency|emergency
601759|NCT01009606|Cardiac arrest|cardiac arrest
601760|NCT01009606|Post-traumatic stress disorder|post-traumatic stress disorder
601761|NCT01009593|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action
601762|NCT01009593|Antineoplastic Agents|antineoplastic agents
601763|NCT01009593|Growth Substances|growth substances
601764|NCT01009593|Physiological Effects of Drugs|physiological effects of drugs
601765|NCT01009593|Enzyme Inhibitors|enzyme inhibitors
601766|NCT01009593|Angiogenesis Inhibitors|angiogenesis inhibitors
601767|NCT01009593|Inhibitors, Angiogenesis|inhibitors, angiogenesis
601768|NCT01009593|Protein Kinase Inhibitors|protein kinase inhibitors
601769|NCT01009593|Pharmacologic Actions|pharmacologic actions
601770|NCT01009593|Growth Inhibitors|growth inhibitors
601771|NCT01009593|Angiogenesis Modulating Agents|angiogenesis modulating agents
601772|NCT01009593|Sorafenib|sorafenib
601773|NCT01009567|OHSS|ohss
601774|NCT01009554|Mouthwashes|mouthwashes
601775|NCT01009541|pregabalin pharmacokinetics bioavailability bioequivalence|pregabalin pharmacokinetics bioavailability bioequivalence
601776|NCT01009528|Quality of care|quality of care
601777|NCT01009528|General Practice|general practice
601778|NCT01009528|Electronic Feedback System|electronic feedback system
601779|NCT01009515|metastatic|metastatic
601780|NCT01009515|melanoma|melanoma
601781|NCT01009515|skin cancer|skin cancer
601782|NCT01009515|paclitaxel|paclitaxel
601783|NCT01009515|carboplatin|carboplatin
601784|NCT01009515|temozolomide|temozolomide
601785|NCT01009476|Dementia|dementia
601786|NCT01009476|Galantamine|galantamine
601787|NCT01009476|Cholinesterase inhibitors|cholinesterase inhibitors
601788|NCT01009476|Nootropic agents|nootropic agents
601789|NCT01009476|Alzheimer|alzheimer
601790|NCT01009476|Vascular dementia|vascular dementia
601791|NCT01009476|Cognitive symptoms|cognitive symptoms
601792|NCT01009476|Behavioural symptoms|behavioural symptoms
601793|NCT01009476|Care giving times|care giving times
601794|NCT01009463|COPD|copd
601795|NCT01009463|Safety|safety
601796|NCT01009463|FEV1|fev1
601797|NCT01009463|Efficacy|efficacy
601798|NCT01009450|cirrhotic liver, gall bladder stone|cirrhotic liver, gall bladder stone
601799|NCT01009437|HER2-negative breast cancer|her2-negative breast cancer
601800|NCT01009437|HER2-positive breast cancer|her2-positive breast cancer
601801|NCT01009437|estrogen receptor-positive breast cancer|estrogen receptor-positive breast cancer
601802|NCT01009437|triple-negative breast cancer|triple-negative breast cancer
601803|NCT01009437|stage I breast cancer|stage i breast cancer
601804|NCT01009437|stage II breast cancer|stage ii breast cancer
601805|NCT01009437|stage IIIA breast cancer|stage iiia breast cancer
601806|NCT01009437|stage IIIB breast cancer|stage iiib breast cancer
601807|NCT01009437|stage IIIC breast cancer|stage iiic breast cancer
601808|NCT01009437|stage IV breast cancer|stage iv breast cancer
601809|NCT01009437|ductal breast carcinoma in situ|ductal breast carcinoma in situ
601810|NCT01009398|Anesthesia and Analgesia|anesthesia and analgesia
601811|NCT01009398|Regional anesthesia|regional anesthesia
601812|NCT01009398|Thoracic Paravertebral block|thoracic paravertebral block
601813|NCT01009398|Catheter location|catheter location
601814|NCT01009385|cervical|cervical
601815|NCT01009385|epidural|epidural
601816|NCT01009385|epidural pressure|epidural pressure
601817|NCT01009385|monitoring|monitoring
601818|NCT01009372|surgeon's physiology|surgeon's physiology
601819|NCT01009372|stress response|stress response
601820|NCT01009372|break scheme|break scheme
601821|NCT01009359|Alzheimers disease|alzheimers disease
601822|NCT01009359|Diagnostic imaging|diagnostic imaging
601823|NCT01009359|PET/CT diagnosis|pet/ct diagnosis
601824|NCT01009359|PET tracer|pet tracer
601825|NCT01009333|urgency frequency|urgency frequency
601826|NCT01009333|urinary urge incontinence|urinary urge incontinence
601827|NCT01009333|InterStim Therapy|interstim therapy
601828|NCT01009320|Pacemaker|pacemaker
601829|NCT01009320|Magnets|magnets
601830|NCT01009320|Drape|drape
601831|NCT01009320|Ferrite|ferrite
601832|NCT01009320|Magnetic field|magnetic field
601833|NCT01009320|Pacemaker interference|pacemaker interference
601834|NCT01009307|adult anaplastic astrocytoma|adult anaplastic astrocytoma
601835|NCT01009307|adult diffuse astrocytoma|adult diffuse astrocytoma
601836|NCT01009307|adult pilocytic astrocytoma|adult pilocytic astrocytoma
601837|NCT01009307|adult subependymal giant cell astrocytoma|adult subependymal giant cell astrocytoma
601838|NCT01009307|adult anaplastic ependymoma|adult anaplastic ependymoma
601839|NCT01009307|adult ependymoma|adult ependymoma
601840|NCT01009307|adult myxopapillary ependymoma|adult myxopapillary ependymoma
601841|NCT01009307|adult subependymoma|adult subependymoma
601842|NCT01009307|adult anaplastic oligodendroglioma|adult anaplastic oligodendroglioma
601843|NCT01009307|adult oligodendroglioma|adult oligodendroglioma
601844|NCT01009307|adult brain stem glioma|adult brain stem glioma
601845|NCT01009307|adult giant cell glioblastoma|adult giant cell glioblastoma
601846|NCT01009307|adult glioblastoma|adult glioblastoma
601847|NCT01009307|recurrent adult brain tumor|recurrent adult brain tumor
601848|NCT01009307|adult gliosarcoma|adult gliosarcoma
601849|NCT01009307|adult mixed glioma|adult mixed glioma
601850|NCT01009307|adult pineal gland astrocytoma|adult pineal gland astrocytoma
601851|NCT01009307|adult ependymoblastoma|adult ependymoblastoma
601852|NCT01009307|adult medulloblastoma|adult medulloblastoma
601853|NCT01009307|adult supratentorial primitive neuroectodermal tumor (PNET)|adult supratentorial primitive neuroectodermal tumor (pnet)
601854|NCT01009307|adult pineoblastoma|adult pineoblastoma
601855|NCT01009307|adult pineocytoma|adult pineocytoma
601856|NCT01009294|Duchenne muscular dystrophy|duchenne muscular dystrophy
601857|NCT01009294|Becker muscular dystrophy|becker muscular dystrophy
601858|NCT01009294|Nonsense mutation|nonsense mutation
601859|NCT01009294|Premature stop codon|premature stop codon
601860|NCT01009294|DMD|dmd
601861|NCT01009294|BMD|bmd
601862|NCT01009294|Ataluren|ataluren
601863|NCT01009294|PTC124|ptc124
601864|NCT01009281|Crohn's Disease|crohn's disease
601865|NCT01009281|Crohns|crohns
601866|NCT01009281|Bowel disease|bowel disease
601867|NCT01009281|digestive disorders|digestive disorders
601868|NCT01009281|auto immune|auto immune
601869|NCT01009281|diarrhea|diarrhea
601870|NCT01009281|Inflammatory Bowel Disease (IBD)|inflammatory bowel disease (ibd)
601871|NCT01009281|gastrointestinal diseases|gastrointestinal diseases
601872|NCT01009281|digestive system diseases|digestive system diseases
601873|NCT01009281|Antibody|antibody
601874|NCT01009281|IL 17|il 17
601875|NCT01009281|anti IL-17|anti il-17
601876|NCT01009281|monoclonal antibody|monoclonal antibody
601877|NCT01009281|Crohn's Disease (Chron's, CD)|crohn's disease (chron's, cd)
601878|NCT01009255|Alzheimer's disease|alzheimer's disease
601879|NCT01009255|placebo controlled|placebo controlled
601880|NCT01009255|randomised|randomised
601881|NCT01009255|Histamine|histamine
601882|NCT01009255|H3 Antagonist|h3 antagonist
601883|NCT01009255|double blind|double blind
601884|NCT01009255|Cognition|cognition
601885|NCT01009242|CDP6038|cdp6038
601886|NCT01009216|Pharmacokinetics|pharmacokinetics
601887|NCT01009216|Pharmacology|pharmacology
601888|NCT01009216|Drug Safety|drug safety
601889|NCT01009216|Phase 1 Clinical Trials|phase 1 clinical trials
601890|NCT01009203|squamous cell carcinoma|squamous cell carcinoma
601891|NCT01009203|head|head
601892|NCT01009203|neck|neck
601893|NCT01009203|aerodigestive|aerodigestive
601894|NCT01009190|Dose finding PARPi Chemotherapy|dose finding parpi chemotherapy
601895|NCT01009177|Melanoma|melanoma
601896|NCT01009177|Metastatic|metastatic
601897|NCT01009177|DTIC|dtic
601898|NCT01009177|Bosentan|bosentan
601899|NCT01009151|telemonitoring|telemonitoring
601900|NCT01009151|internet|internet
601901|NCT01009151|home monitoring system|home monitoring system
601902|NCT01009151|heart failure|heart failure
601903|NCT01009151|self management plan|self management plan
601904|NCT01009151|web portal|web portal
601905|NCT01009138|Subthreshold Depression|subthreshold depression
601906|NCT01009138|Diabetes-related Distress|diabetes-related distress
601907|NCT01009138|Minor Depression|minor depression
601908|NCT01009138|Light affective Disorder|light affective disorder
601909|NCT01009138|Subclinical depressive Symptoms|subclinical depressive symptoms
601910|NCT01009138|Diabetes mellitus|diabetes mellitus
601911|NCT01009138|Late Complications|late complications
601912|NCT01009138|Markers of Inflammation|markers of inflammation
601913|NCT01009125|questionnaires|questionnaires
601914|NCT01009125|health care surveys/methods|health care surveys/methods
601915|NCT01009125|motivation|motivation
601916|NCT01009125|living donors|living donors
601917|NCT01009125|living kidney donation|living kidney donation
601918|NCT01009112|Sleep|sleep
601919|NCT01009112|Sleep Disorder|sleep disorder
601920|NCT01009112|Veterans|veterans
601921|NCT01009112|Active Duty|active duty
601922|NCT01009112|OEF|oef
601923|NCT01009112|OIF|oif
601924|NCT01009112|PTSD|ptsd
601925|NCT01009099|pulmonary disease|pulmonary disease
601926|NCT01009099|COPD|copd
601927|NCT01009086|Arthritis, Psoriatic|arthritis, psoriatic
601928|NCT01009086|Ustekinumab|ustekinumab
601929|NCT01009086|CNTO 1275|cnto 1275
601930|NCT01009086|Stelara|stelara
601931|NCT01009086|Psoriasis|psoriasis
601932|NCT01009060|H3 Antagonist|h3 antagonist
601933|NCT01009060|Schizophrenia|schizophrenia
601934|NCT01009060|double blind|double blind
601935|NCT01009060|Histamine|histamine
601936|NCT01009060|randomised|randomised
601937|NCT01009060|placebo controlled|placebo controlled
601938|NCT01009060|Cognition|cognition
601939|NCT01009047|Schizophrenia|schizophrenia
601940|NCT01009047|Paliperidone|paliperidone
601941|NCT01009047|Aripiprazole|aripiprazole
601942|NCT01009021|pain|pain
601943|NCT01009021|retinal photocoagulation|retinal photocoagulation
601944|NCT01009021|potassium diclofenac|potassium diclofenac
601945|NCT01009008|cancer|cancer
601946|NCT01009008|breast cancer|breast cancer
601947|NCT01009008|mastectomy|mastectomy
601948|NCT01009008|breast reconstruction|breast reconstruction
601949|NCT01009008|reconstruction|reconstruction
601950|NCT01009008|tissue expansion|tissue expansion
601951|NCT01009008|two-stage breast reconstruction|two-stage breast reconstruction
601952|NCT01009008|tissue expander|tissue expander
601953|NCT01009008|AeroForm|aeroform
601954|NCT01009008|AirXpander|airxpander
601955|NCT01008995|psoriasis|psoriasis
601956|NCT01008995|asian patients|asian patients
601957|NCT01008995|Chinese|chinese
601958|NCT01008995|ustekinumab|ustekinumab
601959|NCT01008995|CNTO 1275|cnto 1275
601960|NCT01008995|Stelara|stelara
601961|NCT01008982|Belimumab,Sjögren's Syndrome.|belimumab,sjögren's syndrome.
601962|NCT01008982|Have a diagnosis of primary SS according to the updated American European Consensus Group Criteria|have a diagnosis of primary ss according to the updated american european consensus group criteria
601963|NCT01008969|Prostate|prostate
601964|NCT01008969|SPECT/CT|spect/ct
601965|NCT01008956|Influenza|influenza
601966|NCT01008956|H1N1|h1n1
601967|NCT01008956|Pandemic|pandemic
601968|NCT01008956|GSK Bio's influenza vaccine GSK2340274A|gsk bio's influenza vaccine gsk2340274a
601969|NCT01008930|Peripheral Tumors|peripheral tumors
601971|NCT01008930|Leg|leg
601972|NCT01008930|Head|head
601973|NCT01008930|Neck|neck
601974|NCT01008930|HR PET Imaging System|hr pet imaging system
601975|NCT01008930|High-Resolution PET|high-resolution pet
601976|NCT01008930|PET/CT|pet/ct
601977|NCT01008930|PEMFlex Solo II|pemflex solo ii
601978|NCT01008930|positron emission tomography/computed tomography (PET/CT)|positron emission tomography/computed tomography (pet/ct)
601979|NCT01008917|Hepatocellular carcinoma|hepatocellular carcinoma
601980|NCT01008917|HCC|hcc
601981|NCT01008917|Liver cancer|liver cancer
601982|NCT01008917|Hepatoma|hepatoma
601983|NCT01008904|cancer survivor|cancer survivor
601984|NCT01008904|hot flashes|hot flashes
601985|NCT01008904|breast cancer|breast cancer
601986|NCT01008904|unspecified adult solid tumor, protocol specific|unspecified adult solid tumor, protocol specific
601987|NCT01008852|rheumatoid arthritis|rheumatoid arthritis
601988|NCT01008852|seropositive|seropositive
601989|NCT01008852|methotrexate|methotrexate
601990|NCT01008839|study sarcopenia, which muscle becomes weaker with age|study sarcopenia, which muscle becomes weaker with age
601991|NCT01008826|sulforaphane|sulforaphane
601992|NCT01008826|pharmacokinetics|pharmacokinetics
601993|NCT01008813|HIV infection|hiv infection
601994|NCT01008813|adjuvanted and non-adjuvanted A(H1N1)v influenza vaccine|adjuvanted and non-adjuvanted a(h1n1)v influenza vaccine
601995|NCT01008813|immunogenicity|immunogenicity
601996|NCT01008813|safety|safety
601997|NCT01008800|Autism Spectrum Disorder|autism spectrum disorder
601998|NCT01008800|language|language
601999|NCT01008800|social|social
602000|NCT01008800|toddlers|toddlers
602001|NCT01008787|Cancer Prevention|cancer prevention
602002|NCT01008787|Focus Group|focus group
602003|NCT01008787|Interview|interview
602004|NCT01008787|Physical Activity|physical activity
602005|NCT01008787|African American women|african american women
602006|NCT01008787|Exercise|exercise
602007|NCT01008787|Exercise habits|exercise habits
602008|NCT01008787|Health behavior|health behavior
602009|NCT01008761|Pre-school child|pre-school child
602010|NCT01008761|Wheezy episode|wheezy episode
602011|NCT01008748|Smoking|smoking
602012|NCT01008748|Latinos|latinos
602013|NCT01008748|Mexican American|mexican american
602014|NCT01008748|Spanish-speaking smokers|spanish-speaking smokers
602015|NCT01008748|Ecological momentary assessment|ecological momentary assessment
602016|NCT01008748|Nicotine patch|nicotine patch
602017|NCT01008748|Smoking cessation counseling|smoking cessation counseling
602018|NCT01008748|Questionnaire|questionnaire
602019|NCT01008748|EMA|ema
602020|NCT01008722|Atrial Fibrillation|atrial fibrillation
602021|NCT01008722|Ablation|ablation
602022|NCT01008696|Reflux esophagitis|reflux esophagitis
602023|NCT01008696|Rabeprazole|rabeprazole
602024|NCT01008696|Lansoprazole|lansoprazole
602025|NCT01008683|Stem cell and and heart transplant patients who will receive pandemic H1N1 influenza vaccinations|stem cell and and heart transplant patients who will receive pandemic h1n1 influenza vaccinations
602026|NCT01008670|Cardiac resynchronization therapy|cardiac resynchronization therapy
602027|NCT01008657|Radiofrequency-Extranodular-Multipolar ablation|radiofrequency-extranodular-multipolar ablation
602028|NCT01008657|Recurrence|recurrence
602029|NCT01008644|carbon dioxide|carbon dioxide
602030|NCT01008644|ventilation|ventilation
602031|NCT01008644|gender|gender
602032|NCT01008644|osmolality|osmolality
602033|NCT01008644|menstruation cycle|menstruation cycle
602034|NCT01008631|renal failure|renal failure
602035|NCT01008631|sodium Thiosulfate|sodium thiosulfate
602036|NCT01008631|pharmakokinetic|pharmakokinetic
602037|NCT01008618|Chronic pain|chronic pain
602038|NCT01008618|Osteoarthritis|osteoarthritis
602039|NCT01008618|Low back pain|low back pain
602040|NCT01008618|Fentanyl|fentanyl
602041|NCT01008618|JNS020QD|jns020qd
602042|NCT01008618|Patch, transdermal|patch, transdermal
602043|NCT01008618|Opioid analgesics|opioid analgesics
602044|NCT01008605|Erectile Dysfunction|erectile dysfunction
602045|NCT01008592|dermatographism, levocetirizine (Xyzal)|dermatographism, levocetirizine (xyzal)
602046|NCT01008592|chronic idiopathic urticaria, dermatographism|chronic idiopathic urticaria, dermatographism
602047|NCT01008579|Patient Reported Outcome Measures|patient reported outcome measures
602048|NCT01008579|falls|falls
602049|NCT01008579|older adults|older adults
602050|NCT01008553|Postherpetic Neuralgia|postherpetic neuralgia
602051|NCT01008553|Complex Regional Pain Syndromes (CRPS)|complex regional pain syndromes (crps)
602052|NCT01008553|Postoperative Pain|postoperative pain
602053|NCT01008553|Fentanyl|fentanyl
602054|NCT01008553|Patch, transdermal|patch, transdermal
602055|NCT01008553|Opioid analgesics|opioid analgesics
602056|NCT01008540|cytomegalovirus|cytomegalovirus
602057|NCT01008540|resistance|resistance
602058|NCT01008540|transplantation|transplantation
602059|NCT01008540|Patient coming to an French transplantation center for solid organ or bone marrow transplant, with information and signed consent|patient coming to an french transplantation center for solid organ or bone marrow transplant, with information and signed consent
602060|NCT01008527|skin|skin
602061|NCT01008527|cutaneous|cutaneous
602062|NCT01008527|immunotherapy|immunotherapy
602063|NCT01008527|immunology|immunology
602064|NCT01008527|dose escalation|dose escalation
602065|NCT01008514|ductal breast carcinoma in situ|ductal breast carcinoma in situ
602066|NCT01008514|stage IA breast cancer|stage ia breast cancer
602067|NCT01008514|stage IB breast cancer|stage ib breast cancer
602068|NCT01008514|stage II breast cancer|stage ii breast cancer
602069|NCT01008501|hydatidiform moles|hydatidiform moles
602070|NCT01008501|complete hydatidiform moles|complete hydatidiform moles
602071|NCT01008501|partial hydatidiform moles|partial hydatidiform moles
602072|NCT01008501|Molar pregnancy|molar pregnancy
602073|NCT01008501|NLRP7|nlrp7
602074|NCT01008501|pregnancy wastage|pregnancy wastage
602075|NCT01008501|imprinting|imprinting
602076|NCT01008501|sporadic hydatidiform moles|sporadic hydatidiform moles
602077|NCT01008501|recurrent hydatidiform moles|recurrent hydatidiform moles
602078|NCT01008488|colonic diverticulitis|colonic diverticulitis
602079|NCT01008488|diverticular disease|diverticular disease
602080|NCT01008488|antibiotic therapy|antibiotic therapy
602081|NCT01008475|EMD 525797|emd 525797
602082|NCT01008475|Cetuximab|cetuximab
602083|NCT01008475|Irinotecan|irinotecan
602084|NCT01008475|metastatic colorectal cancer|metastatic colorectal cancer
602085|NCT01008449|Staples|staples
602086|NCT01008449|Sutures|sutures
602087|NCT01008449|Cesarean Delivery|cesarean delivery
602088|NCT01008449|Wound|wound
602089|NCT01008449|Skin Closure|skin closure
602090|NCT01008449|Wound infection|wound infection
602091|NCT01008449|Wound disruption|wound disruption
602092|NCT01008436|Ability of topical drug to reduce acute and overall bleeding as well as blood transfusions|ability of topical drug to reduce acute and overall bleeding as well as blood transfusions
602093|NCT01008423|Proctitis|proctitis
602094|NCT01008423|Proctosigmoiditis|proctosigmoiditis
602095|NCT01008423|Ulcerative|ulcerative
602096|NCT01008423|Salix|salix
602097|NCT01008423|Budesonide foam|budesonide foam
602098|NCT01008423|Budesonide|budesonide
602099|NCT01008423|Rectal|rectal
602100|NCT01008423|Gastrointestinal|gastrointestinal
602101|NCT01008423|Colitis|colitis
602102|NCT01008423|UC|uc
602103|NCT01008423|UP|up
602104|NCT01008423|UPS|ups
602105|NCT01008423|Additional relevant MeSH terms:|additional relevant mesh terms:
602106|NCT01008423|Proctocolitis|proctocolitis
602107|NCT01008423|Ulcer|ulcer
602108|NCT01008423|Colitis, Ulcerative|colitis, ulcerative
602109|NCT01008423|Gastroenteritis|gastroenteritis
602695|NCT01006083|Plavix|plavix
602110|NCT01008423|Gastrointestinal Diseases|gastrointestinal diseases
602111|NCT01008423|Digestive System Diseases|digestive system diseases
602112|NCT01008423|Rectal Diseases|rectal diseases
602113|NCT01008423|Intestinal Diseases|intestinal diseases
602114|NCT01008423|Colonic Diseases|colonic diseases
602115|NCT01008423|Sigmoid Diseases|sigmoid diseases
602116|NCT01008423|Pathologic Processes|pathologic processes
602117|NCT01008423|Inflammatory Bowel Diseases|inflammatory bowel diseases
602118|NCT01008423|Bronchodilator Agents|bronchodilator agents
602119|NCT01008423|Autonomic Agents|autonomic agents
602120|NCT01008423|Peripheral Nervous System Agents|peripheral nervous system agents
602121|NCT01008423|Physiological Effects of Drugs|physiological effects of drugs
602122|NCT01008423|Pharmacologic Actions|pharmacologic actions
602123|NCT01008423|Anti-Asthmatic Agents|anti-asthmatic agents
602124|NCT01008423|Respiratory System Agents|respiratory system agents
602125|NCT01008423|Therapeutic Uses|therapeutic uses
602126|NCT01008423|Glucocorticoids|glucocorticoids
602127|NCT01008423|Hormones|hormones
602128|NCT01008423|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists
602129|NCT01008423|Anti-Inflammatory Agents|anti-inflammatory agents
602130|NCT01008410|Proctitis|proctitis
602131|NCT01008410|Proctosigmoiditis|proctosigmoiditis
602132|NCT01008410|Ulcerative|ulcerative
602133|NCT01008410|Salix|salix
602134|NCT01008410|Budesonide foam|budesonide foam
602135|NCT01008410|Budesonide|budesonide
602136|NCT01008410|Rectal|rectal
602137|NCT01008410|Gastrointestinal|gastrointestinal
602138|NCT01008410|Colitis|colitis
602140|NCT01008410|UP|up
602141|NCT01008410|UPS|ups
602142|NCT01008410|Additional relevant MeSH terms:|additional relevant mesh terms:
602143|NCT01008410|Proctocolitis|proctocolitis
602144|NCT01008410|Ulcer|ulcer
602145|NCT01008410|Colitis, Ulcerative|colitis, ulcerative
602146|NCT01008410|Gastroenteritis|gastroenteritis
602147|NCT01008410|Gastrointestinal Diseases|gastrointestinal diseases
602148|NCT01008410|Digestive System Diseases|digestive system diseases
602149|NCT01008410|Rectal Diseases|rectal diseases
602150|NCT01008410|Intestinal Diseases|intestinal diseases
602151|NCT01008410|Colonic Diseases|colonic diseases
602152|NCT01008410|Sigmoid Diseases|sigmoid diseases
602153|NCT01008410|Pathologic Processes|pathologic processes
602154|NCT01008410|Inflammatory Bowel Diseases|inflammatory bowel diseases
602155|NCT01008410|Bronchodilator Agents|bronchodilator agents
602156|NCT01008410|Autonomic Agents|autonomic agents
602157|NCT01008410|Peripheral Nervous System Agents|peripheral nervous system agents
602158|NCT01008410|Physiological Effects of Drugs|physiological effects of drugs
602159|NCT01008410|Pharmacologic Actions|pharmacologic actions
602160|NCT01008410|Anti-Asthmatic Agents|anti-asthmatic agents
602161|NCT01008410|Respiratory System Agents|respiratory system agents
602162|NCT01008410|Therapeutic Uses|therapeutic uses
602163|NCT01008410|Glucocorticoids|glucocorticoids
602164|NCT01008410|Hormones|hormones
602165|NCT01008410|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists
602166|NCT01008410|Anti-Inflammatory Agents|anti-inflammatory agents
602167|NCT01008397|Rhinitis, Allergic, Seasonal|rhinitis, allergic, seasonal
602168|NCT01008371|Obesity|obesity
602169|NCT01008371|Cholecystokinin|cholecystokinin
602170|NCT01008371|Oxytocin|oxytocin
602171|NCT01008371|Satiety|satiety
602172|NCT01008371|Gastric emptying|gastric emptying
602173|NCT01008371|Anxiety|anxiety
602174|NCT01008371|Depression|depression
602175|NCT01008371|Panic Disorder|panic disorder
602176|NCT01008332|House Dust Mite Allergy|house dust mite allergy
602177|NCT01008332|Immunotherapy|immunotherapy
602178|NCT01008332|Rhinoconjunctivitis|rhinoconjunctivitis
602179|NCT01008332|Toleromune HDM|toleromune hdm
602180|NCT01008319|Anovulation|anovulation
602181|NCT01008319|Ovulation induction|ovulation induction
602182|NCT01008306|Cardiorespiratory fitness|cardiorespiratory fitness
602183|NCT01008306|physical activity|physical activity
602184|NCT01008306|hypertension|hypertension
602185|NCT01008306|overweight and obesity|overweight and obesity
602186|NCT01008306|metabolic syndrome|metabolic syndrome
602187|NCT01008306|Body composition|body composition
602188|NCT01008241|Hospice|hospice
602189|NCT01008241|End of Life|end of life
602190|NCT01008241|Knowledge|knowledge
602191|NCT01008241|Attitudes|attitudes
602192|NCT01008241|Opinions|opinions
602193|NCT01008241|Advanced Care Planning|advanced care planning
602194|NCT01008241|Death and Dying|death and dying
602195|NCT01008241|Communication|communication
602196|NCT01008241|Knowledge and Attitudes of South Florida Residents on Hospice Care|knowledge and attitudes of south florida residents on hospice care
602197|NCT01008228|spontaneous|spontaneous
602198|NCT01008228|primary|primary
602199|NCT01008228|first episode|first episode
602200|NCT01008215|INR Control|inr control
602201|NCT01008215|Warfarin dosing|warfarin dosing
602202|NCT01008215|Family physicians|family physicians
602203|NCT01008215|Cluster randomization|cluster randomization
602204|NCT01008176|Hypertension|hypertension
602205|NCT01008176|Sleep|sleep
765116|NCT00385034|IPV|ipv
602206|NCT01008176|Blood Pressure|blood pressure
602207|NCT01008176|Inflammatory Markers|inflammatory markers
602208|NCT01008150|breast cancer|breast cancer
602209|NCT01008150|neoadjuvant|neoadjuvant
602210|NCT01008150|neratinib|neratinib
602211|NCT01008150|paclitaxel|paclitaxel
602212|NCT01008150|trastuzumab|trastuzumab
602213|NCT01008150|doxorubicin|doxorubicin
602214|NCT01008150|cyclophosphamide|cyclophosphamide
602215|NCT01008124|Benign Paroxysmal Positional Vertigo|benign paroxysmal positional vertigo
602216|NCT01008124|BPPV|bppv
602218|NCT01008124|BPPN|bppn
602219|NCT01008124|Vertigo|vertigo
602220|NCT01008111|regeneration|regeneration
602221|NCT01008111|tissue survival|tissue survival
602222|NCT01008111|biological processes|biological processes
602223|NCT01008111|connective tissue|connective tissue
602224|NCT01008111|tissue|tissue
602225|NCT01008098|Posttraumatic Stress Disorder|posttraumatic stress disorder
602226|NCT01008098|Escitalopram|escitalopram
602227|NCT01008098|Magnetic Resonance Imaging|magnetic resonance imaging
602228|NCT01008098|BDNF|bdnf
602229|NCT01008085|STEMI|stemi
602230|NCT01008085|self-expandable|self-expandable
602231|NCT01008085|balloon-expandable|balloon-expandable
602232|NCT01008046|Polycystic ovary syndrome|polycystic ovary syndrome
602233|NCT01008046|clomiphene resistance|clomiphene resistance
602234|NCT01008046|metformin|metformin
602235|NCT01008046|N-acetyl cysteine|n-acetyl cysteine
602236|NCT01008020|tea catechin extracts|tea catechin extracts
602237|NCT01008020|influenza infection|influenza infection
602238|NCT01008020|prophylaxis|prophylaxis
602239|NCT01008020|supplements|supplements
602240|NCT01008020|adults over 20 years old|adults over 20 years old
602241|NCT01008020|both men and women|both men and women
602242|NCT01008007|Viusid|viusid
602243|NCT01008007|Dietary supplements|dietary supplements
602244|NCT01008007|Acute fever|acute fever
602245|NCT01008007|Viral etiology|viral etiology
602246|NCT01007994|Nocturnal hypertension|nocturnal hypertension
602247|NCT01007994|Pediatric|pediatric
602248|NCT01007994|Renal Transplant|renal transplant
602249|NCT01007994|Pulse Wave Velocity|pulse wave velocity
602250|NCT01007994|Echocardiogram|echocardiogram
602251|NCT01007994|Pediatric Renal Transplant Recipient|pediatric renal transplant recipient
602252|NCT01007968|solid tumors|solid tumors
602253|NCT01007968|hepatic function|hepatic function
602254|NCT01007968|advanced|advanced
602255|NCT01007968|panobinostat|panobinostat
602256|NCT01007929|ADME|adme
602257|NCT01007929|safety|safety
602258|NCT01007929|oral solution|oral solution
602259|NCT01007890|ChemoFX|chemofx
602260|NCT01007890|Operable|operable
602261|NCT01007890|Breast|breast
602262|NCT01007890|Cancer|cancer
602263|NCT01007890|Measurable|measurable
602264|NCT01007890|Disease|disease
602265|NCT01008163|diabetes|diabetes
602266|NCT01007942|Metastatic breast cancer|metastatic breast cancer
602267|NCT01007942|locally advanced breast cancer|locally advanced breast cancer
602268|NCT01007942|HER2/neu positive breast cancer|her2/neu positive breast cancer
602269|NCT01007942|HER2/neu over-expressing|her2/neu over-expressing
602270|NCT01007942|progressive-free survival (PFS)|progressive-free survival (pfs)
602271|NCT01007942|over survival (OS)|over survival (os)
602272|NCT01007942|bolero|bolero
602273|NCT01007942|bolero 3|bolero 3
602274|NCT01007942|Breast cancer|breast cancer
602275|NCT01007942|everolimus|everolimus
602276|NCT01007942|HER+|her+
602277|NCT01007942|vinorelbine|vinorelbine
602278|NCT01007942|herceptin|herceptin
602279|NCT01007942|trastuzumab|trastuzumab
602280|NCT01007942|RAD001|rad001
602281|NCT01007877|sleepiness|sleepiness
602282|NCT01007877|driving|driving
602283|NCT01007864|Parkinson|parkinson
602284|NCT01007864|piribedil|piribedil
602285|NCT01007864|vigilance|vigilance
602286|NCT01007864|dopamine agonist|dopamine agonist
602287|NCT01007864|cognition|cognition
602288|NCT01007851|GnRH agonist|gnrh agonist
602289|NCT01007851|GnRH antagonist|gnrh antagonist
602290|NCT01007851|IVF|ivf
602291|NCT01007851|ICSI|icsi
602292|NCT01007851|assisted reproduction|assisted reproduction
602293|NCT01007851|luteal phase|luteal phase
602294|NCT01007838|Progressive Resistance Training/Exercise|progressive resistance training/exercise
602295|NCT01007838|Muscle wasting|muscle wasting
602296|NCT01007838|Chronic Kidney Disease|chronic kidney disease
602297|NCT01007786|Pediatric Hydrocephalus|pediatric hydrocephalus
602298|NCT01007786|Ultrasound Guided Surgery|ultrasound guided surgery
602299|NCT01007773|Dexmedetomidine|dexmedetomidine
602300|NCT01007773|Intracranial Pressure|intracranial pressure
602301|NCT01007773|Traumatic Brain Injury|traumatic brain injury
602302|NCT01007760|Tobacco smoke|tobacco smoke
602303|NCT01007760|Oxidative stress|oxidative stress
602304|NCT01007760|Endothelial Function|endothelial function
602305|NCT01007760|Atherosclerosis|atherosclerosis
602306|NCT01007760|Arterial Stiffness|arterial stiffness
602307|NCT01007760|Microvascular Function|microvascular function
602308|NCT01007747|Geranium oil|geranium oil
602309|NCT01007747|Neuropathy|neuropathy
602310|NCT01007734|Quality of life|quality of life
602311|NCT01007734|COPD patients|copd patients
602312|NCT01007734|Evaluation According to Gender the Determining Independent Factors of Quality of Life Related to Respiratory Status of Patient With Moderate to Severe COPD|evaluation according to gender the determining independent factors of quality of life related to respiratory status of patient with moderate to severe copd
602313|NCT01007695|breast cancer|breast cancer
602314|NCT01007682|intrusive memories|intrusive memories
602315|NCT01007669|Physical activity|physical activity
602316|NCT01007656|healthy adult subjects|healthy adult subjects
602317|NCT01007656|safety evaluation|safety evaluation
602318|NCT01007656|GD Antrodia camphorata|gd antrodia camphorata
602319|NCT01007643|anterior knee pain|anterior knee pain
602320|NCT01007643|adolescents|adolescents
602321|NCT01007643|female|female
602322|NCT01007643|interactive video games|interactive video games
602323|NCT01007643|patellofemoral syndrome|patellofemoral syndrome
602324|NCT01007643|treatment|treatment
602325|NCT01007643|compliance|compliance
602326|NCT01007643|home exercises|home exercises
602327|NCT01007630|Parkinson's|parkinson's
602328|NCT01007630|Parkinsons|parkinsons
602329|NCT01007630|Parkinson|parkinson
602330|NCT01007630|Parkinson's Disease|parkinson's disease
602331|NCT01007630|PD|pd
602332|NCT01007630|Rasagiline|rasagiline
602333|NCT01007630|Azilect|azilect
602334|NCT01007630|Olfactory|olfactory
602335|NCT01007630|Sense of Smell|sense of smell
602336|NCT01007630|UPSIT|upsit
602337|NCT01007617|Children|children
602338|NCT01007617|Cancer|cancer
602339|NCT01007617|Mucositis|mucositis
602340|NCT01007617|Laser|laser
602341|NCT01007617|Prevention|prevention
602342|NCT01007617|Chemotherapy|chemotherapy
602343|NCT01007617|Children with malignancies receiving chemotherapy and/or radiotherapy inducing severe mucositis|children with malignancies receiving chemotherapy and/or radiotherapy inducing severe mucositis
602344|NCT01007604|claudication|claudication
602345|NCT01007604|pneumatic compression device|pneumatic compression device
602346|NCT01007578|Paclitaxel|paclitaxel
602347|NCT01007578|Paclitaxel-coated balloon catheters|paclitaxel-coated balloon catheters
602348|NCT01007578|Peripheral arterial occlusive disease (PAOD)|peripheral arterial occlusive disease (paod)
602349|NCT01007578|Plasma levels|plasma levels
602350|NCT01007578|Femoral artery|femoral artery
602351|NCT01007578|Popliteal artery|popliteal artery
602352|NCT01007578|Peripheral arterial disease (PAD) including stenotic or occluded femoro-popliteal arteries due to atherosclerosis|peripheral arterial disease (pad) including stenotic or occluded femoro-popliteal arteries due to atherosclerosis
602353|NCT01007565|periarticular injection|periarticular injection
602354|NCT01007552|Biliary Duct Cancer|biliary duct cancer
602355|NCT01007552|Cancer of the Gallbladder|cancer of the gallbladder
602356|NCT01007552|Adenocarcinoma of the Gall Bladder|adenocarcinoma of the gall bladder
602357|NCT01007552|Adenocarcinoma of the Biliary Ducts|adenocarcinoma of the biliary ducts
602358|NCT01007552|Cholangiocarcinoma|cholangiocarcinoma
602359|NCT01007552|Extrahepatic cholangiocarcinoma|extrahepatic cholangiocarcinoma
602360|NCT01007526|Extranodal Lymphoma|extranodal lymphoma
602361|NCT01007526|Natural killer cell|natural killer cell
602362|NCT01007526|T cell|t cell
602363|NCT01007526|Radiotherapy|radiotherapy
602364|NCT01007526|Chemotherapy|chemotherapy
602365|NCT01007513|Prematurity|prematurity
602366|NCT01007513|Inflammation|inflammation
602367|NCT01007513|Transvaginal ultrasound|transvaginal ultrasound
602368|NCT01007513|Vaginal secretion|vaginal secretion
602369|NCT01007513|Inflammatory process|inflammatory process
602370|NCT01007513|Neonatal morbidity|neonatal morbidity
602371|NCT01007500|Postoperative nausea and vomiting after video-assisted thoracoscopic surgery|postoperative nausea and vomiting after video-assisted thoracoscopic surgery
602372|NCT01007487|Plastic wound protector|plastic wound protector
602373|NCT01007487|Plastic wound retractor|plastic wound retractor
602374|NCT01007487|Bacterial translocation|bacterial translocation
602375|NCT01007487|Surgical site infection|surgical site infection
602376|NCT01007487|Abdominal surgery|abdominal surgery
602377|NCT01007487|Wound infection|wound infection
602378|NCT01007461|Acute Myocardial Infarction (AMI)|acute myocardial infarction (ami)
602379|NCT01007461|STEMI|stemi
602380|NCT01007461|Acute ST-Segment Elevation Myocardial Infraction (STEMI)|acute st-segment elevation myocardial infraction (stemi)
602381|NCT01007448|CTCL|ctcl
602382|NCT01007448|bexarotene|bexarotene
602383|NCT01007448|Targretin|targretin
602384|NCT01007448|Refractory Cutaneous T-cell Lymphoma|refractory cutaneous t-cell lymphoma
602385|NCT01007448|cutaneous T-cell Lymphoma|cutaneous t-cell lymphoma
602386|NCT01007448|MF|mf
602387|NCT01007448|Mycoses fungoides|mycoses fungoides
602388|NCT01007422|unspecified adult solid tumor, protocol specific|unspecified adult solid tumor, protocol specific
602389|NCT01007422|pain|pain
602390|NCT01007409|To assess food effect on the pharmacokinetics of fimasartan in healthy male volunteers|to assess food effect on the pharmacokinetics of fimasartan in healthy male volunteers
602391|NCT01007396|Interferon-gamma release assay|interferon-gamma release assay
602392|NCT01007383|Safety and tolerability of LEO 27847|safety and tolerability of leo 27847
602393|NCT01007370|tracheal intubation|tracheal intubation
602394|NCT01007370|supraglottic airway devices|supraglottic airway devices
602395|NCT01007344|flaxseed|flaxseed
602396|NCT01007344|hypercholesterolemia|hypercholesterolemia
602397|NCT01007344|children|children
602398|NCT01007331|Infants|infants
602399|NCT01007331|Atopic Dermatitis|atopic dermatitis
602400|NCT01007331|SCORAD|scorad
602401|NCT01007331|IgE|ige
602402|NCT01007331|Eosinophil Cation Protein|eosinophil cation protein
602403|NCT01007331|Calprotectin|calprotectin
602404|NCT01007331|Intestinal microflora|intestinal microflora
602405|NCT01007292|Non-Hodgkin's Lymphoma|non-hodgkin's lymphoma
602406|NCT01007292|relapsed|relapsed
602407|NCT01007292|CD20-Positive|cd20-positive
602408|NCT01007292|YM155|ym155
602409|NCT01007279|Percutaneous angioplasty|percutaneous angioplasty
602410|NCT01007279|Myocardial Infarction|myocardial infarction
602411|NCT01007266|Type 2 Diabetes Mellitus|type 2 diabetes mellitus
602412|NCT01007266|Adolescents|adolescents
602413|NCT01007266|Pediatric|pediatric
602414|NCT01007266|Patient Partner|patient partner
602415|NCT01007266|Buddy|buddy
602416|NCT01007266|Obesity|obesity
602417|NCT01007266|Type 2 Diabetes|type 2 diabetes
602418|NCT01007240|head and neck carcinoma|head and neck carcinoma
602419|NCT01007240|obturators|obturators
602420|NCT01007240|maxillectomy|maxillectomy
602421|NCT01007240|soft liner|soft liner
602422|NCT01007240|nano particles|nano particles
602423|NCT01007240|antibacterial properties|antibacterial properties
602424|NCT01007240|patients post maxillectomy|patients post maxillectomy
602425|NCT01007214|Prostate cancer|prostate cancer
602426|NCT01007214|Prostatectomy|prostatectomy
602427|NCT01007201|Influenza|influenza
602428|NCT01007201|H1N1|h1n1
602429|NCT01007201|vaccine|vaccine
602430|NCT01007201|Immunogenicity|immunogenicity
602431|NCT01007188|almond|almond
602432|NCT01007188|nuts|nuts
602433|NCT01007188|energy value|energy value
602434|NCT01007188|cardiovascular disease|cardiovascular disease
602435|NCT01007188|phytonutrient|phytonutrient
602436|NCT01007188|gene expression|gene expression
602437|NCT01007188|energy value of almonds|energy value of almonds
602438|NCT01007188|energy|energy
602439|NCT01007175|TNF inhibitor|tnf inhibitor
602440|NCT01007175|Multiple ascending dose study|multiple ascending dose study
602441|NCT01007149|Severe asthma,|severe asthma,
602442|NCT01007149|non-atopic,|non-atopic,
602443|NCT01007149|omalizumab|omalizumab
602444|NCT01007136|tDCS|tdcs
602445|NCT01007136|stroke|stroke
602446|NCT01007136|functional MRI|functional mri
602447|NCT01007136|TMS|tms
602448|NCT01007123|Chronic idiopathic constipation|chronic idiopathic constipation
602449|NCT01007123|A3309|a3309
602450|NCT01007110|DHA|dha
602451|NCT01007097|Diabetes Mellitus, Non Insulin Dependent|diabetes mellitus, non insulin dependent
602452|NCT01007097|Diabetes Mellitus, Type II|diabetes mellitus, type ii
602453|NCT01007097|Type 2 Diabetes Mellitus|type 2 diabetes mellitus
602454|NCT01007097|Drug Therapy|drug therapy
602455|NCT01007084|pain|pain
602456|NCT01007084|trauma|trauma
602457|NCT01007084|propranolol|propranolol
602458|NCT01007058|Urinary Bladder|urinary bladder
602459|NCT01007058|Non-muscle-invasive transitional cell carcinoma|non-muscle-invasive transitional cell carcinoma
602460|NCT01007058|Intact bladder|intact bladder
602461|NCT01007058|Intravesical Bladder Cancer Therapy|intravesical bladder cancer therapy
602462|NCT01007058|Tumor Recurrence|tumor recurrence
602463|NCT01007058|Surrogate markers of response|surrogate markers of response
602464|NCT01007058|BCG|bcg
602465|NCT01007058|Bacillus Calmette Guérin|bacillus calmette guérin
602466|NCT01007058|Interferon-alfa-2b|interferon-alfa-2b
602467|NCT01007058|IFN-alfa-2b|ifn-alfa-2b
602468|NCT01007058|Interferon|interferon
602469|NCT01007058|Fluorescence in situ hybridization|fluorescence in situ hybridization
602470|NCT01007058|FISH|fish
602471|NCT01007045|deep vein thrombosis|deep vein thrombosis
602472|NCT01007045|venous thromboembolic disorders|venous thromboembolic disorders
602473|NCT01007045|diagnostic ultrasound|diagnostic ultrasound
602474|NCT01007032|anti-IGF-IR|anti-igf-ir
602475|NCT01007032|monoclonal|monoclonal
602476|NCT01007032|solid tumor|solid tumor
602477|NCT01007032|insulin-like growth factor|insulin-like growth factor
602478|NCT01007019|Safety, tolerability and PK/PD|safety, tolerability and pk/pd
602479|NCT01007006|Telepharmacy Robotic Medicine Delivery Unit|telepharmacy robotic medicine delivery unit
602480|NCT01007006|Brain Injuries|brain injuries
602481|NCT01007006|Stress Disorders|stress disorders
602482|NCT01007006|Combat disorders|combat disorders
602483|NCT01007006|Polytrauma|polytrauma
602484|NCT01007006|Adherence|adherence
602485|NCT01006967|balance|balance
602486|NCT01006967|accidental falls|accidental falls
602487|NCT01006967|physical therapy|physical therapy
602488|NCT01006967|ActiveStep|activestep
602489|NCT01006967|older adults|older adults
602490|NCT01006954|Poor responder|poor responder
602491|NCT01006954|Flare up|flare up
602492|NCT01006954|Micro dose GnRH agonist flare up|micro dose gnrh agonist flare up
602493|NCT01006954|IVF/ICSI|ivf/icsi
602494|NCT01006941|Multiple sclerosis|multiple sclerosis
602495|NCT01006941|safety|safety
602496|NCT01006941|MRI|mri
602497|NCT01006941|immunological|immunological
602498|NCT01006941|Helminths|helminths
602499|NCT01006941|Trichuris suis|trichuris suis
602500|NCT01006928|Subjective health feeling|subjective health feeling
602501|NCT01006928|NICU|nicu
602502|NCT01006928|team support|team support
602503|NCT01006915|Diabetic sensorimotor polyneuropathy|diabetic sensorimotor polyneuropathy
602504|NCT01006902|Elderly|elderly
602505|NCT01006902|Function|function
602506|NCT01006902|Oncologic therapy|oncologic therapy
602507|NCT01006902|Functional change with chemotherapy|functional change with chemotherapy
602508|NCT01006876|coumadin|coumadin
602509|NCT01006876|peri-procedural thromboembolism|peri-procedural thromboembolism
602510|NCT01006876|RFCA|rfca
602511|NCT01006876|high risk atrial fibrillation|high risk atrial fibrillation
602512|NCT01006863|Ephedrine|ephedrine
602513|NCT01006863|phenylephrine|phenylephrine
602514|NCT01006863|hypotension|hypotension
602515|NCT01006863|propofol|propofol
602516|NCT01006863|anesthesia|anesthesia
602517|NCT01006863|cardiac valve surgery|cardiac valve surgery
602518|NCT01006837|trauma patients|trauma patients
602519|NCT01006837|severe injury|severe injury
602520|NCT01006837|ISS ≥9|iss ≥9
602521|NCT01006824|Capsule endoscopy|capsule endoscopy
602522|NCT01006824|gastrointestinal hemorrhage|gastrointestinal hemorrhage
602523|NCT01006811|West syndrome|west syndrome
602524|NCT01006811|Hypsarrhythmia|hypsarrhythmia
602525|NCT01006798|Virus Diseases|virus diseases
602526|NCT01006798|Respiratory Tract Diseases|respiratory tract diseases
602527|NCT01006798|Vaccine|vaccine
602528|NCT01006785|Breast Cancer|breast cancer
602529|NCT01006785|DLBS 1425|dlbs 1425
602530|NCT01006785|Cancer|cancer
602531|NCT01006785|Advanced/Metastatic (Stage IIIB/IV) Breast Cancer|advanced/metastatic (stage iiib/iv) breast cancer
602532|NCT01006772|Stroke|stroke
602533|NCT01006772|Ankle Foot Orthosis|ankle foot orthosis
602534|NCT01006772|Walking Speed|walking speed
602535|NCT01006772|Gait|gait
602536|NCT01006772|Rehabilitation|rehabilitation
602537|NCT01006772|Hemiplegia|hemiplegia
602538|NCT01006759|Leprosy|leprosy
602539|NCT01006759|Disability Evaluation|disability evaluation
602540|NCT01006759|Quality of Life|quality of life
602541|NCT01006759|Sensation|sensation
602542|NCT01006746|Remote monitoring|remote monitoring
602543|NCT01006746|Defibrillators|defibrillators
602544|NCT01006746|Survey|survey
602545|NCT01006746|Indication for ICD (primary and secondary prevention)|indication for icd (primary and secondary prevention)
602546|NCT01006733|pharmacogenetics|pharmacogenetics
602547|NCT01006733|arthroplasty|arthroplasty
602548|NCT01006733|VKORC1|vkorc1
602549|NCT01006733|thromboembolism|thromboembolism
602550|NCT01006733|warfarin|warfarin
602551|NCT01006720|Residual neuromuscular block|residual neuromuscular block
602552|NCT01006720|post-operative residual curarization|post-operative residual curarization
602553|NCT01006720|PORC|porc
602554|NCT01006720|sugammadex|sugammadex
602555|NCT01006720|neostigmine|neostigmine
602556|NCT01006694|depression|depression
602557|NCT01006694|collaborative care|collaborative care
602558|NCT01006694|Vietnam|vietnam
602559|NCT01006694|behavioral activation|behavioral activation
602560|NCT01006681|rheumatoid|rheumatoid
602561|NCT01006681|SLE|sle
602562|NCT01006681|Psoriatic arthritis|psoriatic arthritis
602563|NCT01006681|Ankylosing|ankylosing
602564|NCT01006681|Influenza H1N1|influenza h1n1
602565|NCT01006681|Vaccine|vaccine
602566|NCT01006681|Vaccination against H1N1 in rheumatic diseases|vaccination against h1n1 in rheumatic diseases
602567|NCT01006668|Neonates|neonates
602568|NCT01006668|Intensive care|intensive care
602569|NCT01006668|Endotracheal intubation|endotracheal intubation
602570|NCT01006668|Neonates in intensive care|neonates in intensive care
602571|NCT01006655|asthma|asthma
602572|NCT01006655|preschool children|preschool children
602573|NCT01006655|bronchial hyperresponsiveness|bronchial hyperresponsiveness
602574|NCT01006655|beclometasone dipropionate - HFA|beclometasone dipropionate - hfa
602575|NCT01006655|Qvar|qvar
602576|NCT01006655|Adenosine Challenge test|adenosine challenge test
602577|NCT01006629|Efficacy of palivizumab|efficacy of palivizumab
602578|NCT01006629|Respiratory syncytial virus (RSV) infection|respiratory syncytial virus (rsv) infection
602579|NCT01006629|Prevention of severe RSV infection|prevention of severe rsv infection
602580|NCT01006629|Preterm infants|preterm infants
602581|NCT01006629|Infants with bronchopulmonary dysplasia|infants with bronchopulmonary dysplasia
602582|NCT01006629|Infants with hemodynamically significant congenital heart disease|infants with hemodynamically significant congenital heart disease
602583|NCT01006603|Type 2 Diabetes Mellitus|type 2 diabetes mellitus
602584|NCT01006603|elderly patients|elderly patients
602585|NCT01006603|saxagliptin|saxagliptin
602586|NCT01006603|randomised|randomised
602587|NCT01006603|double-blind|double-blind
602588|NCT01006590|Type 2 Diabetes Mellitus|type 2 diabetes mellitus
602589|NCT01006590|Saxagliptin|saxagliptin
602590|NCT01006590|Randomised|randomised
602591|NCT01006590|Double-blind|double-blind
602592|NCT01006577|rectal cancer|rectal cancer
602593|NCT01006577|side-to-end anastomosis|side-to-end anastomosis
602594|NCT01006577|colon J pouch|colon j pouch
602595|NCT01006577|fecal incontinence|fecal incontinence
602596|NCT01006577|anorectal function|anorectal function
602597|NCT01006577|Are there differences between side-to-end anastomosis and colon J pouch in|are there differences between side-to-end anastomosis and colon j pouch in
603256|NCT01003782|ERCP|ercp
602598|NCT01006577|bowel function (fecal incontinence, frequency of bowel movements, rectal urgency, incomplete evacuation)|bowel function (fecal incontinence, frequency of bowel movements, rectal urgency, incomplete evacuation)
602599|NCT01006577|quality of life|quality of life
602600|NCT01006577|postoperative complications|postoperative complications
602601|NCT01006577|operation time/ institutional costs|operation time/ institutional costs
602602|NCT01006564|Magnetic Resonance Imaging|magnetic resonance imaging
602603|NCT01006564|Prostate Cancer|prostate cancer
602604|NCT01006564|Magnetic Resonance Spectroscopy|magnetic resonance spectroscopy
602605|NCT01006564|Radiotherapy planning|radiotherapy planning
602606|NCT01006551|Schizophrenia Spectrum Disorders|schizophrenia spectrum disorders
602607|NCT01006538|Wet Age-related Macular Degeneration|wet age-related macular degeneration
602608|NCT01006538|Predominantly classic|predominantly classic
602609|NCT01006538|Minimally classic|minimally classic
602610|NCT01006538|Occult with no classic|occult with no classic
602611|NCT01006538|Retinal Angiomatous Proliferation (RAP) lesions|retinal angiomatous proliferation (rap) lesions
602612|NCT01006499|neonatal sepsis|neonatal sepsis
602613|NCT01006499|pentoxyfilline|pentoxyfilline
602614|NCT01006499|pentaglobin|pentaglobin
602615|NCT01006499|biomarker|biomarker
602616|NCT01006499|To reduce mortality in neonatal sepsis|to reduce mortality in neonatal sepsis
602617|NCT01006486|Oral anticoagulants|oral anticoagulants
602618|NCT01006486|Warfarin|warfarin
602619|NCT01006486|Anticoagulation clinic|anticoagulation clinic
602620|NCT01006486|Thrombosis|thrombosis
602621|NCT01006486|Hemorrhage|hemorrhage
602622|NCT01006473|Chagas Disease|chagas disease
602623|NCT01006473|Chagas Cardiomyopathy|chagas cardiomyopathy
602624|NCT01006473|Exercise Movement Techniques|exercise movement techniques
602625|NCT01006460|Quality of life and subjective well-being in middle aged women|quality of life and subjective well-being in middle aged women
602626|NCT01006447|tai chi|tai chi
602627|NCT01006447|exercise|exercise
602628|NCT01006447|older adults|older adults
602629|NCT01006447|exercise persistence|exercise persistence
602630|NCT01006434|Stroke|stroke
602631|NCT01006434|Thrombolysis|thrombolysis
602632|NCT01006421|phototherapy|phototherapy
602633|NCT01006421|Gingko biloba|gingko biloba
602634|NCT01006421|repigmentation|repigmentation
602635|NCT01006408|Neuropathy|neuropathy
602636|NCT01006395|Prostate Cancer|prostate cancer
602637|NCT01006395|Androgen deprivation|androgen deprivation
602638|NCT01006395|Bone Health|bone health
602639|NCT01006395|Insulin resistance|insulin resistance
602640|NCT01006395|Men with nonmetastatic prostate cancer receiving androgen deprivation|men with nonmetastatic prostate cancer receiving androgen deprivation
602641|NCT01006369|stage IV colon cancer|stage iv colon cancer
602642|NCT01006369|stage IV rectal cancer|stage iv rectal cancer
602643|NCT01006369|recurrent colon cancer|recurrent colon cancer
602644|NCT01006369|recurrent rectal cancer|recurrent rectal cancer
602645|NCT01006356|Hydromorphone hydrochloride Oral Osmotic System|hydromorphone hydrochloride oral osmotic system
602646|NCT01006356|Jurnista|jurnista
602647|NCT01006317|Maternal health services|maternal health services
602648|NCT01006317|utilization|utilization
602649|NCT01006317|education|education
602650|NCT01006317|randomized controlled trial|randomized controlled trial
602651|NCT01006317|cost|cost
602652|NCT01006317|clinical skills|clinical skills
602653|NCT01006317|rural China|rural china
602654|NCT01006304|JNJ-39439335|jnj-39439335
602655|NCT01006304|Placebo|placebo
602656|NCT01006304|Pain|pain
602657|NCT01006304|Pain Measurements|pain measurements
602658|NCT01006304|Adults|adults
602660|NCT01006278|biomarker|biomarker
602661|NCT01006278|knee arthroscopy|knee arthroscopy
602662|NCT01006278|pain|pain
602663|NCT01006252|metastatic|metastatic
602664|NCT01006252|second-line|second-line
602665|NCT01006239|Cancer|cancer
602666|NCT01006213|Motivational Intervention|motivational intervention
602667|NCT01006200|granulation tissue|granulation tissue
602668|NCT01006200|benign|benign
602669|NCT01006200|tracheal stenosis|tracheal stenosis
602670|NCT01006200|ultraflex|ultraflex
602671|NCT01006200|COPD|copd
602672|NCT01006187|Analgesics|analgesics
602673|NCT01006187|Influenza|influenza
602674|NCT01006187|Vapocoolant|vapocoolant
602675|NCT01006187|vaccination|vaccination
602676|NCT01006187|pain|pain
602677|NCT01006148|Metopic Craniosynostosis|metopic craniosynostosis
602678|NCT01006122|Randomized|randomized
602679|NCT01006122|double-blind|double-blind
602680|NCT01006122|placebo-controlled|placebo-controlled
602681|NCT01006122|crossover study of PF-03654746 in Excessive Daytime Sleepiness associated with Narcolepsy|crossover study of pf-03654746 in excessive daytime sleepiness associated with narcolepsy
602682|NCT01006109|MEG|meg
602683|NCT01006109|Repetitive TMS (rTMS)|repetitive tms (rtms)
602684|NCT01006109|Decision-Making|decision-making
602685|NCT01006109|Healthy Volunteers|healthy volunteers
602686|NCT01006109|HV|hv
602687|NCT01006109|Healthy Volunteer|healthy volunteer
602688|NCT01006096|Psoriasis|psoriasis
602689|NCT01006096|double-blind|double-blind
602690|NCT01006096|randomized|randomized
602691|NCT01006096|placebo-controlled|placebo-controlled
602692|NCT01006096|erlotinib|erlotinib
602696|NCT01006083|antiplatelet therapy|antiplatelet therapy
602697|NCT01006083|Hemorrhage|hemorrhage
602698|NCT01006083|ischemic events|ischemic events
602699|NCT01006070|multiple myeloma|multiple myeloma
602700|NCT01006070|spinal disease|spinal disease
602701|NCT01006044|Glioblastoma multiforme, vaccine, dendritic cells, glioma|glioblastoma multiforme, vaccine, dendritic cells, glioma
602702|NCT01006031|Liver cirrhosis|liver cirrhosis
602703|NCT01006031|Hepatitis C virus|hepatitis c virus
602704|NCT01006031|HIV infection|hiv infection
602705|NCT01006031|Pegylated interferon alfa-2a|pegylated interferon alfa-2a
602706|NCT01006031|Ribavirin|ribavirin
602707|NCT01006031|Treatment experienced|treatment experienced
602708|NCT01006018|Prediabetic State|prediabetic state
602709|NCT01006005|HIV|hiv
602710|NCT01006005|Treatment experienced|treatment experienced
602711|NCT01005992|Scars secondary to injuries to tissues caused by contact with physical (heat, electricity) o chemical agent.|scars secondary to injuries to tissues caused by contact with physical (heat, electricity) o chemical agent.
602712|NCT01005979|Leukemia, Lymphocytic, Chronic, B-Cell|leukemia, lymphocytic, chronic, b-cell
602713|NCT01005979|Chronic Lymphocytic Leukemia|chronic lymphocytic leukemia
602714|NCT01005979|Lymphoma, Small Lymphocytic|lymphoma, small lymphocytic
602715|NCT01005979|Lymphoma|lymphoma
602716|NCT01005979|Leukemia|leukemia
602717|NCT01005966|remineralization|remineralization
602718|NCT01005966|enamel|enamel
602719|NCT01005966|in situ|in situ
602720|NCT01005966|fluoride|fluoride
602721|NCT01005966|caries|caries
602722|NCT01005953|Autism|autism
602723|NCT01005953|Behavioral Observations|behavioral observations
602724|NCT01005953|Electronic diaries|electronic diaries
602725|NCT01005953|Professionals treating children 3-10 with lower functioning autism|professionals treating children 3-10 with lower functioning autism
602726|NCT01005940|Sleep Apnea Syndromes|sleep apnea syndromes
602727|NCT01005940|Insulin Resistance|insulin resistance
602728|NCT01005940|Mandibular advancement device|mandibular advancement device
602729|NCT01005927|Calcium|calcium
602730|NCT01005927|Bone and Bones|bone and bones
602731|NCT01005927|Girls|girls
602732|NCT01005927|Bone Mineralization|bone mineralization
602733|NCT01005927|Fiber|fiber
602734|NCT01005927|Fructooligosaccharide|fructooligosaccharide
602735|NCT01005927|Female|female
602736|NCT01005927|Healthy|healthy
602737|NCT01005927|Adolescents|adolescents
602738|NCT01005914|adults|adults
602739|NCT01005914|Philadelphia chromosome precursor ALL,|philadelphia chromosome precursor all,
602740|NCT01005914|T-cell ALL|t-cell all
602741|NCT01005914|untreated ALL|untreated all
602742|NCT01005901|COPD|copd
602743|NCT01005901|NVA|nva
602744|NCT01005901|FEV1|fev1
602745|NCT01005888|Hereditary angioedema|hereditary angioedema
602746|NCT01005888|HAE|hae
602747|NCT01005888|C1 esterase inhibitor (human)|c1 esterase inhibitor (human)
602748|NCT01005888|C1INH-nf|c1inh-nf
602749|NCT01005875|Hepatocellular carcinoma|hepatocellular carcinoma
602750|NCT01005875|HCC|hcc
602751|NCT01005875|Liver Cancer|liver cancer
602752|NCT01005875|adult primary hepatocellular carcinoma|adult primary hepatocellular carcinoma
602753|NCT01005862|Alzheimer's disease antibody leucine ABeta|alzheimer's disease antibody leucine abeta
602754|NCT01005849|Probiotics|probiotics
602755|NCT01005849|Traveler's diarrhea|traveler's diarrhea
602756|NCT01005849|Prevention|prevention
602757|NCT01005836|Cognitive behavioral therapy|cognitive behavioral therapy
602758|NCT01005836|Anxiety treatment|anxiety treatment
602759|NCT01005836|Depression treatment|depression treatment
602760|NCT01005836|Child treatment|child treatment
602761|NCT01005836|Usual care|usual care
602762|NCT01005797|Renal Cancer|renal cancer
602763|NCT01005797|Non Small Cell Lung Cancer (NSCLC)|non small cell lung cancer (nsclc)
602764|NCT01005797|Solid Tumor|solid tumor
602765|NCT01005797|Soft tissue sarcoma|soft tissue sarcoma
602766|NCT01005797|Sorafenib|sorafenib
602767|NCT01005797|Panobinostat|panobinostat
602768|NCT01005784|GnRH antagonists|gnrh antagonists
602769|NCT01005771|Secondarily infected traumatic lesions|secondarily infected traumatic lesions
602770|NCT01005758|untreated adult acute lymphoblastic leukemia|untreated adult acute lymphoblastic leukemia
602771|NCT01005758|Philadelphia chromosome positive adult precursor acute lymphoblastic leukemia|philadelphia chromosome positive adult precursor acute lymphoblastic leukemia
602772|NCT01005758|L1 adult acute lymphoblastic leukemia|l1 adult acute lymphoblastic leukemia
602773|NCT01005758|L2 adult acute lymphoblastic leukemia|l2 adult acute lymphoblastic leukemia
602774|NCT01005758|T-cell adult acute lymphoblastic leukemia|t-cell adult acute lymphoblastic leukemia
602775|NCT01005745|skin|skin
602776|NCT01005745|adoptive cell therapy|adoptive cell therapy
602777|NCT01005745|tumor-infiltrating lymphocytes (TIL)|tumor-infiltrating lymphocytes (til)
602778|NCT01005745|lymphodepletion|lymphodepletion
602779|NCT01005732|hypertrophic|hypertrophic
602780|NCT01005732|scar|scar
602781|NCT01005732|burn|burn
602782|NCT01005732|cicatrix|cicatrix
602783|NCT01005732|pressure|pressure
602784|NCT01005732|garment|garment
602785|NCT01005693|unspecified adult solid tumor, protocol specific|unspecified adult solid tumor, protocol specific
602786|NCT01005667|Nulliparous women in spontaneous labor|nulliparous women in spontaneous labor
602787|NCT01005654|Gene Expression|gene expression
602788|NCT01005654|Epigenetic (methylation)|epigenetic (methylation)
602789|NCT01005654|Tissues Histological Evaluations|tissues histological evaluations
602790|NCT01005654|Establishment of Tumor Cell Lines|establishment of tumor cell lines
602791|NCT01005654|Metabolite and Protein Expression|metabolite and protein expression
602792|NCT01005654|Adrenal Cancer|adrenal cancer
602793|NCT01005654|Endocrine Tumor|endocrine tumor
602794|NCT01005654|Thyroid Cancer|thyroid cancer
602795|NCT01005641|advanced breast cancer|advanced breast cancer
602796|NCT01005641|hormone-responsive|hormone-responsive
602797|NCT01005641|metastatic breast cancer|metastatic breast cancer
602798|NCT01005628|Bortezomib postmarketing surveillance|bortezomib postmarketing surveillance
602799|NCT01005628|Korea bortezomib PMS|korea bortezomib pms
602800|NCT01005602|Digoxin|digoxin
602801|NCT01005602|Pharmacokinetics|pharmacokinetics
602802|NCT01005602|Dosing|dosing
602803|NCT01005602|Heart Failure|heart failure
602804|NCT01005589|Neonatal sepsis|neonatal sepsis
602805|NCT01005589|Necrotizing enterocolitis|necrotizing enterocolitis
602806|NCT01005589|CD64 antigen|cd64 antigen
602807|NCT01005589|Receptors, IgG|receptors, igg
602808|NCT01005576|Thalassemia|thalassemia
602809|NCT01005576|Alemtuzumab|alemtuzumab
602810|NCT01005576|Hematopoietic cell transplant|hematopoietic cell transplant
602811|NCT01005576|non-myeloablative|non-myeloablative
602812|NCT01005550|Unilateral spinal anaesthesia|unilateral spinal anaesthesia
602813|NCT01005550|Hypobaric anaesthesia|hypobaric anaesthesia
602814|NCT01005550|Ropivacaine|ropivacaine
602815|NCT01005550|Traumatic hip surgery|traumatic hip surgery
602816|NCT01005537|stage IV melanoma|stage iv melanoma
602817|NCT01005524|brain computer interface|brain computer interface
602818|NCT01005524|P3Speller|p3speller
602819|NCT01005524|P300|p300
602820|NCT01005524|Event Related potential|event related potential
602821|NCT01005524|tetraplegia|tetraplegia
602822|NCT01005524|Guillain barre syndrome|guillain barre syndrome
602823|NCT01005524|Feasibility|feasibility
602824|NCT01005524|Speed of spelling|speed of spelling
602825|NCT01005524|Accuracy|accuracy
602826|NCT01005511|Bruxism|bruxism
602827|NCT01005498|Low carbohydrate diet. Dietary treatment of diabetes mellitus.|low carbohydrate diet. dietary treatment of diabetes mellitus.
602828|NCT01005498|Diabetes mellitus type 2 and dietary treatment.|diabetes mellitus type 2 and dietary treatment.
602829|NCT01005485|Myocardial Infarction (MI)|myocardial infarction (mi)
602830|NCT01005485|Circulating Endothelial Cells (CEC)|circulating endothelial cells (cec)
602831|NCT01005485|Control Group A: (Vascular Surgery)|control group a: (vascular surgery)
602832|NCT01005485|Control Group B: (Healthy controls)|control group b: (healthy controls)
602833|NCT01005472|stage III melanoma|stage iii melanoma
602834|NCT01005472|stage IV melanoma|stage iv melanoma
602835|NCT01005472|recurrent melanoma|recurrent melanoma
602836|NCT01005472|ciliary body and choroid melanoma, medium/large size|ciliary body and choroid melanoma, medium/large size
602837|NCT01005472|extraocular extension melanoma|extraocular extension melanoma
602838|NCT01005472|iris melanoma|iris melanoma
602839|NCT01005472|metastatic intraocular melanoma|metastatic intraocular melanoma
602840|NCT01005472|recurrent intraocular melanoma|recurrent intraocular melanoma
602841|NCT01005459|labor pain|labor pain
602842|NCT01005459|combined spinal epidural labor analgesia|combined spinal epidural labor analgesia
602843|NCT01005459|CSE analgesia|cse analgesia
602844|NCT01005459|labor analgesia|labor analgesia
602845|NCT01005433|dexmedetomidine|dexmedetomidine
602846|NCT01005433|stress response|stress response
602847|NCT01005433|cesarean delivery|cesarean delivery
602848|NCT01005420|Insulin Sensitivity|insulin sensitivity
602849|NCT01005420|Pre-diabetes|pre-diabetes
602850|NCT01005420|Diabetes|diabetes
602851|NCT01005420|Blueberries|blueberries
602852|NCT01005420|Anthocyanins|anthocyanins
602853|NCT01005407|HBV vaccine|hbv vaccine
602854|NCT01005407|Hepatitis B vaccine|hepatitis b vaccine
602855|NCT01005407|Hepatitis B|hepatitis b
602856|NCT01005407|Hepatitis|hepatitis
602858|NCT01005407|Prevention & Control|prevention & control
602859|NCT01005407|Healthy|healthy
602860|NCT01005407|Healthy volunteers|healthy volunteers
602861|NCT01005381|Calcium|calcium
602862|NCT01005381|Vitamin D|vitamin d
602863|NCT01005381|Particle Size|particle size
602864|NCT01005381|Adolescents|adolescents
602865|NCT01005381|Bone|bone
602866|NCT01005381|Osteoporosis|osteoporosis
602867|NCT01005368|chronic lymphocytic leukemia|chronic lymphocytic leukemia
602868|NCT01005355|Solid tumor|solid tumor
602869|NCT01005355|recombinant human IgG1|recombinant human igg1
602870|NCT01005355|MAB|mab
602871|NCT01005355|monoclonal antibody|monoclonal antibody
765999|NCT00381433|HCV|hcv
602872|NCT01005355|VEGFR 2|vegfr 2
602873|NCT01005355|human vascular endothelial growth factor receptor 2|human vascular endothelial growth factor receptor 2
602874|NCT01005342|gene expression|gene expression
602875|NCT01005342|oats|oats
602876|NCT01005342|rye|rye
602877|NCT01005342|sugar beet fiber|sugar beet fiber
602878|NCT01005342|glucose|glucose
602879|NCT01005342|insulin|insulin
602880|NCT01005342|triglyceride|triglyceride
602881|NCT01005342|decreased postprandial glucose|decreased postprandial glucose
602882|NCT01005342|decreased postprandial insulin|decreased postprandial insulin
602883|NCT01005342|glycemic index|glycemic index
602884|NCT01005316|cohort study|cohort study
602885|NCT01005316|allo-antibodies|allo-antibodies
602886|NCT01005316|allosensitization|allosensitization
602887|NCT01005303|Heart Failure|heart failure
602888|NCT01005303|Micronutrients|micronutrients
602889|NCT01005303|Vitamin D|vitamin d
602890|NCT01005303|Inflammation|inflammation
602891|NCT01005303|Oxidative Stress|oxidative stress
602892|NCT01005303|Quality of Life|quality of life
602893|NCT01005303|Physical Functioning|physical functioning
602894|NCT01005290|cardiovascular|cardiovascular
602895|NCT01005290|fixed|fixed
602896|NCT01005290|dose|dose
602897|NCT01005290|combination|combination
602898|NCT01005290|pill|pill
602899|NCT01005290|hypertension|hypertension
602900|NCT01005277|childhood acute lymphoblastic leukemia in remission|childhood acute lymphoblastic leukemia in remission
602901|NCT01005277|recurrent childhood acute lymphoblastic leukemia|recurrent childhood acute lymphoblastic leukemia
602902|NCT01005277|childhood acute myeloid leukemia in remission|childhood acute myeloid leukemia in remission
602903|NCT01005277|childhood acute myeloid leukemia/other myeloid malignancies|childhood acute myeloid leukemia/other myeloid malignancies
602904|NCT01005277|recurrent childhood acute myeloid leukemia|recurrent childhood acute myeloid leukemia
602905|NCT01005277|secondary acute myeloid leukemia|secondary acute myeloid leukemia
602906|NCT01005277|adult acute myeloid leukemia with inv(16)(p13;q22)|adult acute myeloid leukemia with inv(16)(p13;q22)
602907|NCT01005277|adult acute myeloid leukemia with t(15;17)(q22;q12)|adult acute myeloid leukemia with t(15;17)(q22;q12)
602908|NCT01005277|adult acute myeloid leukemia with t(8;21)(q22;q22)|adult acute myeloid leukemia with t(8;21)(q22;q22)
602909|NCT01005264|diabetic foot|diabetic foot
602910|NCT01005264|neuropathic plantar ulcer|neuropathic plantar ulcer
602911|NCT01005264|ulcer healing|ulcer healing
602912|NCT01005264|non-removable total contact cast|non-removable total contact cast
602913|NCT01005264|removable cast walker|removable cast walker
602914|NCT01005251|GERD treatment|gerd treatment
602915|NCT01005251|Acid and non-acid Reflux|acid and non-acid reflux
602916|NCT01005251|Heartburn|heartburn
602917|NCT01005251|Regurgitation|regurgitation
602918|NCT01005251|Add-on treatment to PPI|add-on treatment to ppi
602919|NCT01005225|Solid tumor|solid tumor
602920|NCT01005225|prostate cancer|prostate cancer
602921|NCT01005225|colon cancer|colon cancer
602922|NCT01005212|EVAR|evar
602923|NCT01005212|Ultrasounds|ultrasounds
602924|NCT01005212|AAA|aaa
602925|NCT01005212|endoleaks after endovascular repair of AAA|endoleaks after endovascular repair of aaa
602926|NCT01005199|adult primary hepatocellular carcinoma|adult primary hepatocellular carcinoma
602927|NCT01005199|localized unresectable adult primary liver cancer|localized unresectable adult primary liver cancer
602928|NCT01005173|Acetaminophen|acetaminophen
602929|NCT01005173|APAP|apap
602930|NCT01005160|Mellitus, type 2|mellitus, type 2
602931|NCT01005160|pharmacokinetic evaluation|pharmacokinetic evaluation
602932|NCT01005160|drug interaction between CKD-501 and metformin|drug interaction between ckd-501 and metformin
602933|NCT01005147|tranexamic acid|tranexamic acid
602934|NCT01005147|upper GI bleeding|upper gi bleeding
602935|NCT01005147|blood transfusion|blood transfusion
602936|NCT01005147|GI bleeding|gi bleeding
602937|NCT01005108|Hot Flashes for Breast Cancer Patients|hot flashes for breast cancer patients
602938|NCT01005082|Low salt diet, idiopathic hypercalciuria, calcium stone formers|low salt diet, idiopathic hypercalciuria, calcium stone formers
602939|NCT01005082|Calcium stone formers with idiopathic hypercalciuria|calcium stone formers with idiopathic hypercalciuria
602940|NCT01005069|diabetes mellitus|diabetes mellitus
602941|NCT01005069|DLBS-32|dlbs-32
602942|NCT01005069|fasting plasma glucose|fasting plasma glucose
602943|NCT01005069|insulin resistance|insulin resistance
602944|NCT01005043|non-resectable osteosarcoma|non-resectable osteosarcoma
602945|NCT01005043|heavy ion radiotherapy|heavy ion radiotherapy
602946|NCT01005043|particle therapy|particle therapy
602947|NCT01005043|safety|safety
602948|NCT01005043|toxicity|toxicity
602949|NCT01005043|survival|survival
602950|NCT01005043|radiotherapy|radiotherapy
602951|NCT01005030|Parkinson Disease|parkinson disease
602952|NCT01005030|blood|blood
602953|NCT01005030|plasma|plasma
602954|NCT01005030|metabolomics|metabolomics
602955|NCT01005030|spectroscopy|spectroscopy
602956|NCT01005030|oxidative stress.|oxidative stress.
602957|NCT01005017|Radiofrequent ablation|radiofrequent ablation
602958|NCT01005017|Percutaneous radiofrequent therapy|percutaneous radiofrequent therapy
602959|NCT01005004|PMD|pmd
602960|NCT01005004|stem cells|stem cells
602961|NCT01005004|Pelizaeus-Merzbacher Disease|pelizaeus-merzbacher disease
602962|NCT01005004|human stem cells|human stem cells
602963|NCT01005004|central nervous system stem cells|central nervous system stem cells
602964|NCT01004965|untreated adult acute lymphoblastic leukemia|untreated adult acute lymphoblastic leukemia
602965|NCT01004965|untreated adult acute myeloid leukemia|untreated adult acute myeloid leukemia
602966|NCT01004965|adult acute myeloid leukemia with 11q23 (MLL) abnormalities|adult acute myeloid leukemia with 11q23 (mll) abnormalities
602967|NCT01004965|adult acute myeloid leukemia with inv(16)(p13;q22)|adult acute myeloid leukemia with inv(16)(p13;q22)
602968|NCT01004965|adult acute myeloid leukemia with t(15;17)(q22;q12)|adult acute myeloid leukemia with t(15;17)(q22;q12)
602969|NCT01004965|adult acute myeloid leukemia with t(16;16)(p13;q22)|adult acute myeloid leukemia with t(16;16)(p13;q22)
602970|NCT01004965|adult acute myeloid leukemia with t(8;21)(q22;q22)|adult acute myeloid leukemia with t(8;21)(q22;q22)
602971|NCT01004952|Skin|skin
602972|NCT01004952|Sunscreen|sunscreen
602973|NCT01004952|UVR Protection|uvr protection
602974|NCT01004952|09-137|09-137
602975|NCT01004939|prophylaxis|prophylaxis
602976|NCT01004939|venous thromboembolism|venous thromboembolism
602977|NCT01004939|postpartum|postpartum
602978|NCT01004939|fondaparinux|fondaparinux
602979|NCT01004939|pregnancy|pregnancy
602980|NCT01004926|Unilateral trans-tibial amputees|unilateral trans-tibial amputees
602981|NCT01004913|Benign paroxysmal positional vertigo|benign paroxysmal positional vertigo
602982|NCT01004913|Vestibular evoked myogenic potentials|vestibular evoked myogenic potentials
602983|NCT01004913|Sacculo-colic reflex|sacculo-colic reflex
602984|NCT01004900|Glaucoma, Angle Closure|glaucoma, angle closure
602985|NCT01004900|Selective laser trabeculoplasty|selective laser trabeculoplasty
602986|NCT01004900|Primary Angle Closure Disease|primary angle closure disease
602987|NCT01004887|adult anaplastic astrocytoma|adult anaplastic astrocytoma
602988|NCT01004887|adult giant cell glioblastoma|adult giant cell glioblastoma
602989|NCT01004887|adult gliosarcoma|adult gliosarcoma
602990|NCT01004887|childhood high-grade cerebellar astrocytoma|childhood high-grade cerebellar astrocytoma
602991|NCT01004887|childhood high-grade cerebral astrocytoma|childhood high-grade cerebral astrocytoma
602992|NCT01004874|malignant glioma|malignant glioma
602993|NCT01004874|glioblastoma|glioblastoma
602994|NCT01004874|gliosarcoma|gliosarcoma
602995|NCT01004874|Avastin|avastin
602996|NCT01004874|bevacizumab|bevacizumab
602997|NCT01004874|Topotecan|topotecan
602998|NCT01004874|Hycamtin|hycamtin
602999|NCT01004874|Temozolomide|temozolomide
603000|NCT01004874|Temodar|temodar
603001|NCT01004874|Pro00019960|pro00019960
603002|NCT01004874|Vredenburgh|vredenburgh
603003|NCT01004874|Duke|duke
603004|NCT01004874|Desjardins|desjardins
603005|NCT01004861|PVNS|pvns
603006|NCT01004848|Pre-diabetes|pre-diabetes
603007|NCT01004848|pre-diabetic state|pre-diabetic state
603008|NCT01004848|community-based participatory research|community-based participatory research
603009|NCT01004848|overweight|overweight
603010|NCT01004848|weight loss intervention, peer-led lifestyle education|weight loss intervention, peer-led lifestyle education
603011|NCT01004835|migraine|migraine
603012|NCT01004822|Treatment Non-Randomized Single Group Assignment Safety Study Neoplasms Carcinoma Cancer Malignancy|treatment non-randomized single group assignment safety study neoplasms carcinoma cancer malignancy
603013|NCT01004809|Dutasteride|dutasteride
603014|NCT01004796|breast cancer|breast cancer
603015|NCT01004783|stage I Wilms tumor|stage i wilms tumor
603016|NCT01004783|stage II Wilms tumor|stage ii wilms tumor
603017|NCT01004783|epithelial predominant Wilms tumor|epithelial predominant wilms tumor
603018|NCT01004770|CECT - Contrast-enhanced computed tomography|cect - contrast-enhanced computed tomography
603019|NCT01004770|HCG - Human Chorionic Gonadotropin|hcg - human chorionic gonadotropin
603020|NCT01004770|HU - Hounsfield Units|hu - hounsfield units
603021|NCT01004770|Patient Safety|patient safety
603022|NCT01004770|Tolerance|tolerance
603023|NCT01004770|Pharmacokinetic|pharmacokinetic
603024|NCT01004757|diastolic function|diastolic function
603025|NCT01004757|postmeal glucose|postmeal glucose
603026|NCT01004757|insulin resistance|insulin resistance
603027|NCT01004757|low carb diet|low carb diet
603028|NCT01004757|type 2 diabetes|type 2 diabetes
603029|NCT01004744|Postmenopausal women|postmenopausal women
603030|NCT01004744|ER+|er+
603031|NCT01004744|Estrogen positive|estrogen positive
603032|NCT01004744|PR+|pr+
603033|NCT01004744|Progesterone positive|progesterone positive
603034|NCT01004731|EGFr|egfr
603035|NCT01004731|cetuximab|cetuximab
603036|NCT01004731|gemcitabine|gemcitabine
603037|NCT01004731|carboplatin|carboplatin
603038|NCT01004731|NSCLC|nsclc
603039|NCT01004705|cardiovascular|cardiovascular
603040|NCT01004705|fixed|fixed
603041|NCT01004705|dose|dose
603042|NCT01004705|combination|combination
603043|NCT01004705|pill|pill
603044|NCT01004705|LDL|ldl
603045|NCT01004705|cholesterol|cholesterol
603046|NCT01004666|Breast cancer|breast cancer
603047|NCT01004666|Scintimammography|scintimammography
603048|NCT01004666|CZT|czt
603049|NCT01004666|High-risk|high-risk
603050|NCT01004640|chronic myelogenous leukemia|chronic myelogenous leukemia
603051|NCT01004627|fistula|fistula
603052|NCT01004627|ultrasound|ultrasound
603053|NCT01004627|angioaccess|angioaccess
603054|NCT01004627|preoperative vein mapping|preoperative vein mapping
603055|NCT01004627|Haemodialysis|haemodialysis
603056|NCT01004627|Angioaccess surgery|angioaccess surgery
603057|NCT01004601|pretreated failure advanced stage IIIb/IV NSCLC|pretreated failure advanced stage iiib/iv nsclc
603058|NCT01004588|elderly|elderly
603059|NCT01004588|sarcopenia|sarcopenia
603060|NCT01004588|protein drink|protein drink
603061|NCT01004588|resistance training|resistance training
603062|NCT01004575|stents|stents
603063|NCT01004575|bare metal stents|bare metal stents
603064|NCT01004562|breast cancer|breast cancer
603356|NCT01003340|asthma|asthma
603065|NCT01004549|Patients who have previously undergone bilateral intraocular lens implantation|patients who have previously undergone bilateral intraocular lens implantation
603066|NCT01004523|childhood low-grade cerebellar astrocytoma|childhood low-grade cerebellar astrocytoma
603067|NCT01004523|childhood low-grade cerebral astrocytoma|childhood low-grade cerebral astrocytoma
603068|NCT01004523|childhood mixed glioma|childhood mixed glioma
603069|NCT01004523|adult mixed glioma|adult mixed glioma
603070|NCT01004523|adult diffuse astrocytoma|adult diffuse astrocytoma
603071|NCT01004523|childhood oligodendroglioma|childhood oligodendroglioma
603072|NCT01004523|adult oligodendroglioma|adult oligodendroglioma
603073|NCT01004510|malignant pleural effusion|malignant pleural effusion
603074|NCT01004510|non small cell lung cancer|non small cell lung cancer
603075|NCT01004497|Acute lymphoblastic leukemia, adult, dasatinib|acute lymphoblastic leukemia, adult, dasatinib
603076|NCT01004484|non-patients|non-patients
603077|NCT01004484|non-diarrhea functional bowel symptoms|non-diarrhea functional bowel symptoms
603078|NCT01004458|fibromyalgia|fibromyalgia
603079|NCT01004458|cognitive behavioral therapy|cognitive behavioral therapy
603081|NCT01004458|pain|pain
603082|NCT01004458|stress|stress
603083|NCT01004458|type A behavior|type a behavior
603084|NCT01004445|Pneumonia|pneumonia
603085|NCT01004445|Adjunctive treatment|adjunctive treatment
603086|NCT01004445|Gram-negative bacteria|gram-negative bacteria
603087|NCT01004432|humira, remicade|humira, remicade
603088|NCT01004432|rheumatoid arthritis|rheumatoid arthritis
603089|NCT01004432|enbrel failure|enbrel failure
603090|NCT01004432|humira failure|humira failure
603091|NCT01004432|arthritis|arthritis
603092|NCT01004432|enbrel|enbrel
603093|NCT01004419|non small cell lung cancer|non small cell lung cancer
603094|NCT01004419|vandetanib|vandetanib
603095|NCT01004419|ZD6474|zd6474
603096|NCT01004419|fulvestrant|fulvestrant
603097|NCT01004419|faslodex|faslodex
603098|NCT01004419|phase 1|phase 1
603099|NCT01004406|plaque|plaque
603100|NCT01004406|LDL|ldl
603101|NCT01004406|statin|statin
603102|NCT01004406|endothelial|endothelial
603103|NCT01004406|apheresis|apheresis
603104|NCT01004406|acute coronary syndrome|acute coronary syndrome
603105|NCT01004393|Methylnaltrexone|methylnaltrexone
603106|NCT01004393|Constipation|constipation
603107|NCT01004393|Narcotic Antagonists|narcotic antagonists
603108|NCT01004393|Analgesics, Opioid|analgesics, opioid
603109|NCT01004393|Neoplasms|neoplasms
603110|NCT01004380|Epithelial Ovarian Cancer|epithelial ovarian cancer
603111|NCT01004380|Ovarian Cancer|ovarian cancer
603112|NCT01004367|Promoting healthy lifestyles in adolescents in Ecuador to prevent overweight|promoting healthy lifestyles in adolescents in ecuador to prevent overweight
603113|NCT01004354|Psychiatric illnesses|psychiatric illnesses
603114|NCT01004354|Vitamin D deficiency|vitamin d deficiency
603115|NCT01004354|Obesity|obesity
603116|NCT01004341|pediatric obesity|pediatric obesity
603117|NCT01004341|parenting style|parenting style
603118|NCT01004341|feeding style|feeding style
603119|NCT01004341|behavioral skills|behavioral skills
603120|NCT01004341|parenting skills|parenting skills
603121|NCT01004341|family meals|family meals
603122|NCT01004328|patient safety|patient safety
603123|NCT01004328|care transitions|care transitions
603124|NCT01004328|therapeutic monitoring|therapeutic monitoring
603125|NCT01004328|skilled nursing facilities|skilled nursing facilities
603126|NCT01004328|Adverse outcomes after discharge from a SNF to home|adverse outcomes after discharge from a snf to home
603127|NCT01004315|Overactive bladder|overactive bladder
603128|NCT01004315|Frequency|frequency
603129|NCT01004315|Micturition|micturition
603130|NCT01004315|Urgency|urgency
603131|NCT01004315|Urge urinary incontinence|urge urinary incontinence
603132|NCT01004315|OAB|oab
603133|NCT01004302|Obsessive-compulsive disorder|obsessive-compulsive disorder
603134|NCT01004302|Radiosurgery|radiosurgery
603135|NCT01004302|Psychosurgery|psychosurgery
603136|NCT01004302|Treatment outcome|treatment outcome
603137|NCT01004302|Randomized Controlled Trials|randomized controlled trials
603138|NCT01004289|Acute myocardial infarction|acute myocardial infarction
603139|NCT01004289|Primary percutaneous coronary intervention|primary percutaneous coronary intervention
603140|NCT01004289|Postconditioning|postconditioning
603141|NCT01004276|primary health care|primary health care
603142|NCT01004276|delivery of health care|delivery of health care
603143|NCT01004276|smoking cessation|smoking cessation
603144|NCT01004276|chronic disease|chronic disease
603145|NCT01004276|disease management|disease management
603146|NCT01004276|pilot projects|pilot projects
603147|NCT01004263|acute migraine with or without aura in adolescents|acute migraine with or without aura in adolescents
603148|NCT01004237|insulin resistance|insulin resistance
603149|NCT01004237|hypertensive|hypertensive
603150|NCT01004237|hypercholesterolemic patients|hypercholesterolemic patients
603151|NCT01004224|advanced solid tumors|advanced solid tumors
603152|NCT01004224|lung cancer|lung cancer
603153|NCT01004224|bladder cancer|bladder cancer
603154|NCT01004224|BGJ398|bgj398
603155|NCT01004224|FGFR|fgfr
603156|NCT01004224|kinase inhibitor|kinase inhibitor
603157|NCT01004224|advanced solid malignancies|advanced solid malignancies
603158|NCT01004211|bladder cancer|bladder cancer
603159|NCT01004211|recurrence|recurrence
603160|NCT01004198|Trauma|trauma
603161|NCT01004198|Hemorrhage|hemorrhage
603162|NCT01004198|Hemorrhagic shock|hemorrhagic shock
603163|NCT01004198|Lactic acidosis|lactic acidosis
603164|NCT01004198|Oxygen carriers|oxygen carriers
603165|NCT01004198|Oxygen therapeutics|oxygen therapeutics
603166|NCT01004198|Hemoglobin solutions|hemoglobin solutions
603167|NCT01004198|Hemoglobin substitutes|hemoglobin substitutes
603168|NCT01004198|Red cell substitutes|red cell substitutes
603169|NCT01004198|PEG-hemoglobin|peg-hemoglobin
603170|NCT01004172|carboplatin|carboplatin
603171|NCT01004172|bevacizumab|bevacizumab
603172|NCT01004159|Colorectal cancer|colorectal cancer
603173|NCT01004159|KRAS wild type tumors|kras wild type tumors
603174|NCT01004146|incentive spirometry|incentive spirometry
603175|NCT01004146|bariatric surgery|bariatric surgery
603176|NCT01004146|obesity|obesity
603177|NCT01004133|Age 80 or older|age 80 or older
603178|NCT01004133|No chronic disease|no chronic disease
603179|NCT01004094|children|children
603180|NCT01004094|video games|video games
603181|NCT01004094|internet|internet
603182|NCT01004094|parents|parents
603183|NCT01004094|fruit|fruit
603184|NCT01004094|vegetable|vegetable
603185|NCT01004094|implementation intention|implementation intention
603186|NCT01004094|goal setting|goal setting
603187|NCT01004094|fruit and vegetable consumption|fruit and vegetable consumption
603188|NCT01004094|obesity prevention|obesity prevention
603189|NCT01004094|cancer prevention|cancer prevention
603190|NCT01004081|Cancer of Breast|cancer of breast
603191|NCT01004081|Cancer of the Breast|cancer of the breast
603192|NCT01004068|Clomiphene|clomiphene
603193|NCT01004068|Diet|diet
603194|NCT01004068|Exercise|exercise
603195|NCT01004068|Infertility|infertility
603196|NCT01004068|PCOS|pcos
603197|NCT01004068|Physical activity|physical activity
603198|NCT01004068|Treatment|treatment
603199|NCT01004055|Wound|wound
603200|NCT01004055|Skin lesion|skin lesion
603201|NCT01004055|Antimicrobial|antimicrobial
603202|NCT01004055|Bioelectric|bioelectric
603203|NCT01004042|Depression|depression
603204|NCT01004042|Botulinum toxin|botulinum toxin
603205|NCT01004042|Glabella|glabella
603206|NCT01004042|Quality of life|quality of life
603207|NCT01004042|Self-steem|self-steem
603209|NCT01004029|hydroxyprogesterone caproate|hydroxyprogesterone caproate
603210|NCT01004029|preterm birth|preterm birth
603211|NCT01004029|progesterone|progesterone
603212|NCT01004029|women with a singleton pregnancy aged 18 years or older with a history of a previous singleton spontaneous preterm delivery|women with a singleton pregnancy aged 18 years or older with a history of a previous singleton spontaneous preterm delivery
603213|NCT01004016|Spinocerebellar degeneration|spinocerebellar degeneration
603214|NCT01004016|Thyrotropin-Releasing Hormone (TRH)|thyrotropin-releasing hormone (trh)
603215|NCT01004016|SCD|scd
603216|NCT01003990|Treatment experienced|treatment experienced
603217|NCT01003964|NON-SMALL CELL LUNG CANCER|non-small cell lung cancer
603218|NCT01003964|excision repair cross-complementing 1|excision repair cross-complementing 1
603219|NCT01003964|Gemcitabine and cisplatin|gemcitabine and cisplatin
603220|NCT01003964|Irinotecan and cisplatin|irinotecan and cisplatin
603221|NCT01003964|Pemetrexed|pemetrexed
603222|NCT01003964|Docetaxel|docetaxel
603223|NCT01003964|advanced NSCLC|advanced nsclc
603224|NCT01003951|Lymphedema|lymphedema
603225|NCT01003951|Acupuncture|acupuncture
603226|NCT01003951|09-136|09-136
603227|NCT01003938|chemotherapy|chemotherapy
603228|NCT01003938|combination therapy|combination therapy
603229|NCT01003938|targeted therapy|targeted therapy
603230|NCT01003938|second-line|second-line
603231|NCT01003925|Knee pain, osteoarthritis, non-surgical treatment, age 65+|knee pain, osteoarthritis, non-surgical treatment, age 65+
603232|NCT01003912|Lysosomal Storage Diseases|lysosomal storage diseases
603233|NCT01003912|Inborn Errors of Metabolism|inborn errors of metabolism
603234|NCT01003912|Krabbe|krabbe
603235|NCT01003912|Infantile metachromatic leukodystrophy disease|infantile metachromatic leukodystrophy disease
603236|NCT01003912|MLD|mld
603237|NCT01003912|Tay Sachs|tay sachs
603238|NCT01003912|Sandhoff|sandhoff
603239|NCT01003912|GM2 gangliosidoses|gm2 gangliosidoses
766500|NCT00379210|MMT|mmt
603240|NCT01003912|Pelizaeus-Merzbacher disease|pelizaeus-merzbacher disease
603241|NCT01003912|PMD|pmd
603242|NCT01003886|post marketing surveillance Filipino benign prostatic hyperplasia BPH Doxazosin GITS|post marketing surveillance filipino benign prostatic hyperplasia bph doxazosin gits
603243|NCT01003873|morbid obesity|morbid obesity
603244|NCT01003873|bariatric surgery|bariatric surgery
603245|NCT01003873|lifestyle intervention|lifestyle intervention
603246|NCT01003873|endocannabinoids system|endocannabinoids system
603247|NCT01003860|postoperative analgesia|postoperative analgesia
603248|NCT01003847|Insulin resistance|insulin resistance
603249|NCT01003834|substance use|substance use
603250|NCT01003834|drug use|drug use
603251|NCT01003834|drug abuse|drug abuse
603252|NCT01003782|cholangitis|cholangitis
603253|NCT01003782|antibiotic|antibiotic
603254|NCT01003782|bacteriobilia|bacteriobilia
603255|NCT01003782|bile|bile
603257|NCT01003756|Preoperative|preoperative
603258|NCT01003756|Exercise|exercise
603259|NCT01003756|Joint Replacement|joint replacement
603260|NCT01003756|Hip|hip
603261|NCT01003756|Knee|knee
603262|NCT01003730|Intraoperative protective ventilation strategies|intraoperative protective ventilation strategies
603263|NCT01003691|Phase 1b Advanced Dry Age-Related Macular Degeneration RN6G|phase 1b advanced dry age-related macular degeneration rn6g
603264|NCT01003678|Myelodysplastic syndrome|myelodysplastic syndrome
603265|NCT01003678|Clofarabine|clofarabine
603266|NCT01003678|low-dose oral clofarabine|low-dose oral clofarabine
603267|NCT01003678|intermediate risk Myelodysplastic syndrome|intermediate risk myelodysplastic syndrome
603268|NCT01003678|high risk Myelodysplastic syndrome|high risk myelodysplastic syndrome
603269|NCT01003652|goiter|goiter
603270|NCT01003639|papilledema|papilledema
603271|NCT01003639|vision loss|vision loss
603272|NCT01003639|headache|headache
603273|NCT01003639|obesity|obesity
603274|NCT01003639|women|women
603275|NCT01003639|diplopia|diplopia
603276|NCT01003639|tinnitus|tinnitus
603277|NCT01003626|Advanced cutaneous melanoma|advanced cutaneous melanoma
603278|NCT01003626|Tumor Pressure|tumor pressure
603279|NCT01003626|Tumor IFP|tumor ifp
603280|NCT01003626|Interstitial Fluid Pressure|interstitial fluid pressure
603281|NCT01003626|IFP|ifp
603282|NCT01003626|Transducer-tipped catheter Mikro-Tip SPC-320|transducer-tipped catheter mikro-tip spc-320
603283|NCT01003626|Transducer Millar|transducer millar
603284|NCT01003626|Power Lab 8/30 amplifier|power lab 8/30 amplifier
603285|NCT01003613|Tranilast|tranilast
603286|NCT01003613|fibrin glue|fibrin glue
603287|NCT01003613|primary pterygium|primary pterygium
603288|NCT01003613|conjunctival autograft|conjunctival autograft
603289|NCT01003600|Survivorship|survivorship
603290|NCT01003600|Quality of Life|quality of life
603291|NCT01003600|Questionnaire|questionnaire
603292|NCT01003600|09-133|09-133
603293|NCT01003587|India|india
603294|NCT01003587|evidence-based policy|evidence-based policy
603295|NCT01003587|knowledge translation|knowledge translation
603296|NCT01003587|disease control priorities|disease control priorities
603297|NCT01003587|decision-makers|decision-makers
603298|NCT01003587|health spending|health spending
603299|NCT01003587|health services delivery|health services delivery
603300|NCT01003587|maternal and child health|maternal and child health
603301|NCT01003587|policy making|policy making
603302|NCT01003587|delivery of health care|delivery of health care
603303|NCT01003574|cardiovascular health outcomes in cancer survivors|cardiovascular health outcomes in cancer survivors
603304|NCT01003561|ultrasonographic exam on upper and lower extremities|ultrasonographic exam on upper and lower extremities
603305|NCT01003548|Embryo culture|embryo culture
603306|NCT01003548|IVF|ivf
603307|NCT01003548|Microfluidics|microfluidics
603308|NCT01003548|infertility|infertility
603309|NCT01003535|Parkinson´s disease|parkinson´s disease
603310|NCT01003535|Acetylcholine receptors|acetylcholine receptors
603311|NCT01003522|Bronchial stents|bronchial stents
603312|NCT01003522|Airway obstruction|airway obstruction
603313|NCT01003522|Non-small cell lung cancer|non-small cell lung cancer
603314|NCT01003509|inguinal|inguinal
603315|NCT01003509|hernia|hernia
603316|NCT01003509|new|new
603317|NCT01003509|repair|repair
603318|NCT01003509|modified shouldice|modified shouldice
603319|NCT01003509|double|double
603320|NCT01003496|Cocaine|cocaine
603321|NCT01003496|crack|crack
603322|NCT01003496|heroin|heroin
603323|NCT01003496|non-prescribed opioids|non-prescribed opioids
603324|NCT01003496|contingency management|contingency management
603325|NCT01003496|community reinforcement approach|community reinforcement approach
603326|NCT01003496|facilitated therapeutic alliance|facilitated therapeutic alliance
603327|NCT01003496|chronic disease treatment models|chronic disease treatment models
603328|NCT01003483|metformin|metformin
603329|NCT01003483|orlistat|orlistat
603330|NCT01003483|pcos|pcos
603331|NCT01003483|obese|obese
603332|NCT01003470|cerebral infarction|cerebral infarction
603333|NCT01003470|Paralysis|paralysis
603334|NCT01003470|acupuncture|acupuncture
603335|NCT01003470|rehabilitation|rehabilitation
603336|NCT01003470|trial|trial
603337|NCT01003444|Muscle biopsy Malonyl CoA Biomarker assay|muscle biopsy malonyl coa biomarker assay
603338|NCT01003418|GSK2340272A|gsk2340272a
603339|NCT01003418|H1N1 pandemic influenza|h1n1 pandemic influenza
603340|NCT01003405|Overactive bladder|overactive bladder
603341|NCT01003405|Frequency|frequency
603342|NCT01003405|Micturition|micturition
603343|NCT01003405|Urgency|urgency
603344|NCT01003405|Urge urinary incontinence|urge urinary incontinence
603345|NCT01003405|OAB|oab
603346|NCT01003392|Coronary artery disease|coronary artery disease
603347|NCT01003392|Coffee|coffee
603348|NCT01003392|Heart system|heart system
603349|NCT01003379|cognitive dysfunction|cognitive dysfunction
603350|NCT01003379|schizophrenia|schizophrenia
603351|NCT01003379|Phase 2|phase 2
603352|NCT01003366|safety during central venous catheterization|safety during central venous catheterization
603353|NCT01003353|Stroke|stroke
603354|NCT01003353|Strength training|strength training
603355|NCT01003353|exercise therapy|exercise therapy
603357|NCT01003340|children|children
603358|NCT01003340|community health workers|community health workers
603359|NCT01003340|home intervention|home intervention
603360|NCT01003327|laryngeal mask, leak pressure|laryngeal mask, leak pressure
603361|NCT01003327|leak pressure|leak pressure
603362|NCT01003314|Vaccine|vaccine
603363|NCT01003314|Safety|safety
603364|NCT01003314|Immunogenicity|immunogenicity
603365|NCT01003314|Protection|protection
603366|NCT01003314|Sporozoite challenge|sporozoite challenge
603367|NCT01003301|cat allergy|cat allergy
603368|NCT01003288|H1N1 pandemic vaccine immunogenicity safety|h1n1 pandemic vaccine immunogenicity safety
603369|NCT01003288|Health employees|health employees
603370|NCT01003275|Chronic kidney disease|chronic kidney disease
603371|NCT01003275|Vitamin D|vitamin d
603372|NCT01003275|Paricalcitol|paricalcitol
603373|NCT01003275|Placebo|placebo
603374|NCT01003275|Kidney|kidney
603375|NCT01003275|Renal|renal
603376|NCT01003275|Oxidative Stress|oxidative stress
603377|NCT01003275|Immune cell function|immune cell function
603378|NCT01003275|Glucose|glucose
603379|NCT01003275|Glucose tolerance|glucose tolerance
603380|NCT01003262|Observation Unit|observation unit
603381|NCT01003262|Emergency Department|emergency department
603382|NCT01003249|over distention of bladder|over distention of bladder
603383|NCT01003249|Dysfunctional voiding|dysfunctional voiding
603384|NCT01003249|dysfunctional elimination syndrome|dysfunctional elimination syndrome
603385|NCT01003236|Diabetic nephropathy|diabetic nephropathy
603386|NCT01003236|Type II Diabetes|type ii diabetes
603387|NCT01003236|Milk Thistle extract|milk thistle extract
603388|NCT01003236|Silymarin|silymarin
603389|NCT01003223|phosphorus|phosphorus
603390|NCT01003223|dialysis|dialysis
603391|NCT01003223|PhosLo|phoslo
603392|NCT01003223|CKD stage V|ckd stage v
603393|NCT01003210|otitis media|otitis media
603394|NCT01003210|children|children
603395|NCT01003210|homeopathy|homeopathy
603396|NCT01003197|Development|development
603397|NCT01003197|Validation|validation
603398|NCT01003197|Prediction Score|prediction score
603399|NCT01003197|Complication|complication
603400|NCT01003197|Liver resection|liver resection
603401|NCT01003197|develop and validate a score to predict serious complications following liver resection using pre-operative risk factors.|develop and validate a score to predict serious complications following liver resection using pre-operative risk factors.
603402|NCT01003184|diabetes|diabetes
603403|NCT01003184|exenatide once weekly|exenatide once weekly
603404|NCT01003184|Byetta|byetta
603405|NCT01003184|insulin detemir|insulin detemir
603406|NCT01003184|Levemir|levemir
603407|NCT01003184|Amylin|amylin
603408|NCT01003184|Lilly|lilly
603409|NCT01003171|Pharmacokinetics|pharmacokinetics
603411|NCT01003171|MCS|mcs
603412|NCT01003171|Benign Prostatic Hyperplasia|benign prostatic hyperplasia
603413|NCT01003171|Multi-Carotenoids|multi-carotenoids
603414|NCT01003171|Healthy subjects|healthy subjects
603415|NCT01003158|Cancer|cancer
603416|NCT01003158|tumour|tumour
603417|NCT01003158|metastatic|metastatic
603418|NCT01003158|breast cancer|breast cancer
603419|NCT01003145|Influenza|influenza
603420|NCT01003145|vaccine|vaccine
603421|NCT01003145|Immunogenicity|immunogenicity
603422|NCT01003132|Psychosis|psychosis
603423|NCT01003132|Distress|distress
603424|NCT01003132|Mindfulness|mindfulness
603425|NCT01003132|Acceptance|acceptance
603426|NCT01003132|Values|values
603427|NCT01003119|Alcohol addiction|alcohol addiction
603428|NCT01003119|Alcohol treatment|alcohol treatment
603429|NCT01003119|Alcohol recovery|alcohol recovery
603430|NCT01003119|Post residential treatment DSM-IV diagnosis of alcohol dependence|post residential treatment dsm-iv diagnosis of alcohol dependence
603431|NCT01003106|RVO|rvo
603432|NCT01003106|BRVO|brvo
603433|NCT01003106|CRVO|crvo
603434|NCT01003106|Vein occlusion|vein occlusion
603435|NCT01003093|Tuberculosis|tuberculosis
603436|NCT01003093|Vaccine|vaccine
603437|NCT01003093|Ag85B|ag85b
603438|NCT01003093|ESAT-6|esat-6
603439|NCT01003093|IC31|ic31
711790|NCT00583011|Pain control|pain control
603440|NCT01003080|The evaluation of hemostasis during total knee arthroplasty using the aquamantys device.|the evaluation of hemostasis during total knee arthroplasty using the aquamantys device.
603441|NCT01003054|Leukemia|leukemia
603442|NCT01003054|CML|cml
603443|NCT01003054|Busulfan|busulfan
603444|NCT01003054|Busulfex|busulfex
603445|NCT01003054|Myleran|myleran
603446|NCT01003054|Cyclophosphamide|cyclophosphamide
603447|NCT01003054|Cytoxan|cytoxan
603448|NCT01003054|Neosar|neosar
603449|NCT01003054|Imatinib Mesylate|imatinib mesylate
603450|NCT01003054|Gleevec|gleevec
603451|NCT01003054|Autologous Stem Cell Transplantation|autologous stem cell transplantation
603452|NCT01003054|Stem Cell Transplant|stem cell transplant
603453|NCT01003041|healthy normal infants|healthy normal infants
603454|NCT01003028|Total intravenous anesthesia|total intravenous anesthesia
603455|NCT01003028|Maximum plasma concentration of remifentanil|maximum plasma concentration of remifentanil
603456|NCT01003015|HCC|hcc
603457|NCT01003015|Safety|safety
603458|NCT01003015|BAY73-4506|bay73-4506
603459|NCT01003002|Parkinson's disease|parkinson's disease
603460|NCT01003002|Dyskinesia|dyskinesia
603461|NCT01003002|Movement Disorders|movement disorders
603462|NCT01002989|ankle brachial index|ankle brachial index
603463|NCT01002989|WatchBP Office|watchbp office
603464|NCT01002989|oscillometric measurement|oscillometric measurement
603465|NCT01002937|Biomarkers|biomarkers
603466|NCT01002937|Prognosis response to treatment|prognosis response to treatment
603467|NCT01002937|Renal cancer|renal cancer
603469|NCT01002924|Adenocarcinoma|adenocarcinoma
603470|NCT01002924|Phase II|phase ii
603471|NCT01002924|Lung|lung
603472|NCT01002924|Non-small cell lung cancer|non-small cell lung cancer
603473|NCT01002924|NSCLC|nsclc
603474|NCT01002924|extension|extension
603475|NCT01002924|EC145|ec145
603476|NCT01002924|Prior exposure to EC145|prior exposure to ec145
603477|NCT01002911|Device procedure|device procedure
603478|NCT01002911|pacemaker|pacemaker
603479|NCT01002911|ICD|icd
603480|NCT01002911|antibiotics|antibiotics
603481|NCT01002898|HIV-1 RNA|hiv-1 rna
603482|NCT01002898|Treatment experienced|treatment experienced
603483|NCT01002885|Infertility|infertility
603484|NCT01002885|FSH Receptor Polymorphisms|fsh receptor polymorphisms
603485|NCT01002872|FGF23|fgf23
603486|NCT01002872|CKD|ckd
603487|NCT01002872|Fosrenol|fosrenol
603488|NCT01002872|Hyperphosphatemia|hyperphosphatemia
603489|NCT01002859|Coronary artery bypass graft surgery (CABG)|coronary artery bypass graft surgery (cabg)
603490|NCT01002859|Cardiopulmonary Bypass (CPB)|cardiopulmonary bypass (cpb)
603491|NCT01002859|Cyclosporine|cyclosporine
603492|NCT01002859|ischaemia reperfusion|ischaemia reperfusion
603493|NCT01002846|Efficacy|efficacy
603494|NCT01002846|Acupuncture|acupuncture
603495|NCT01002846|Hypertension|hypertension
603496|NCT01002833|Plasmodium falciparum|plasmodium falciparum
603497|NCT01002833|Malaria|malaria
603498|NCT01002820|Epileptic Seizures|epileptic seizures
603499|NCT01002820|Seizure Disorder|seizure disorder
603500|NCT01002820|Seizures|seizures
603501|NCT01002820|Convulsions|convulsions
603502|NCT01002820|Anticonvulsant|anticonvulsant
603503|NCT01002820|Anticonvulsive|anticonvulsive
603504|NCT01002820|Antiepileptic|antiepileptic
603505|NCT01002820|Ganaxolone|ganaxolone
603506|NCT01002794|Degenerative meniscal tear|degenerative meniscal tear
603507|NCT01002794|Arthroscopy|arthroscopy
603508|NCT01002794|Exercise therapy|exercise therapy
603509|NCT01002781|Tocilizumab Still|tocilizumab still
603510|NCT01002742|GVHD|gvhd
603511|NCT01002729|Oseltamivir Pharmacokinetics Obesity|oseltamivir pharmacokinetics obesity
603512|NCT01002729|Oseltamivir Pharmacokinetics in Obesity|oseltamivir pharmacokinetics in obesity
603513|NCT01002716|rheumatoid influenza vaccine cell immunity|rheumatoid influenza vaccine cell immunity
603514|NCT01002703|Lenalidomide|lenalidomide
603515|NCT01002703|Bendamustine|bendamustine
603516|NCT01002703|Multiple Myeloma|multiple myeloma
603517|NCT01002703|Myeloma|myeloma
603518|NCT01002703|Revlimid|revlimid
603519|NCT01002703|Phase I/II|phase i/ii
603520|NCT01002703|refractory Myeloma|refractory myeloma
603521|NCT01002703|relapsed Myeloma|relapsed myeloma
603522|NCT01002690|Asthma|asthma
603523|NCT01002690|Allergen challenge|allergen challenge
603524|NCT01002690|Airway responsiveness|airway responsiveness
603525|NCT01002690|Prostaglandins|prostaglandins
603526|NCT01002690|Eicosanoids|eicosanoids
603527|NCT01002677|brain injury|brain injury
603528|NCT01002677|traumatic brain injury|traumatic brain injury
603529|NCT01002677|training|training
603530|NCT01002677|teaching|teaching
603531|NCT01002677|curriculum|curriculum
603532|NCT01002664|Benign Prostatic Hyperplasia|benign prostatic hyperplasia
603533|NCT01002664|Multi-carotenoids|multi-carotenoids
603534|NCT01002664|MCS-2|mcs-2
603535|NCT01002664|Lower Urinary Tract Symptoms|lower urinary tract symptoms
603536|NCT01002664|International prostate symptom scores|international prostate symptom scores
603537|NCT01002651|gastrointestinal health|gastrointestinal health
603538|NCT01002651|healthy subjects|healthy subjects
710271|NCT00589563|anaplastic large cell lymphoma|anaplastic large cell lymphoma
711791|NCT00583011|Pregnancy|pregnancy
766883|NCT00378534|CML|cml
603539|NCT01002625|Double-Blind Randomized Placebo-Controlled 2-Way Crossover Polysomnographic Endpoints|double-blind randomized placebo-controlled 2-way crossover polysomnographic endpoints
603540|NCT01002612|Nutritional status|nutritional status
603541|NCT01002612|Thai HIV-infected children|thai hiv-infected children
603542|NCT01002599|bariatric surgery|bariatric surgery
603543|NCT01002599|morbidly obese|morbidly obese
603544|NCT01002599|BMI >35|bmi >35
603545|NCT01002599|CPAP|cpap
603546|NCT01002599|Venturi|venturi
603547|NCT01002599|Boussignac|boussignac
603548|NCT01002599|Ventilation|ventilation
603549|NCT01002599|Pulmonary function|pulmonary function
603550|NCT01002599|Morbidly Obese Patients undergoing bariatric surgery|morbidly obese patients undergoing bariatric surgery
603551|NCT01002586|Alzheimer's dementia|alzheimer's dementia
603552|NCT01002586|Wii-Fit|wii-fit
603553|NCT01002586|Walking|walking
603554|NCT01002586|Falls|falls
603555|NCT01002573|Pediatric|pediatric
603556|NCT01002573|Fever|fever
603557|NCT01002560|Melanoma|melanoma
603558|NCT01002560|Novel Prognostic Markers|novel prognostic markers
603559|NCT01002547|steatohepatitis|steatohepatitis
603560|NCT01002547|type 2 diabetes|type 2 diabetes
603561|NCT01002547|fatty liver|fatty liver
603562|NCT01002534|Cystic Fibrosis|cystic fibrosis
603563|NCT01002534|Vardenafil|vardenafil
603564|NCT01002534|Nasal instillation|nasal instillation
603565|NCT01002534|Nasal Potential difference|nasal potential difference
603566|NCT01002521|Diabetes|diabetes
603567|NCT01002521|vascular|vascular
603568|NCT01002521|haptoglobin|haptoglobin
603569|NCT01002521|tumor|tumor
603570|NCT01002521|necrosis|necrosis
603571|NCT01002521|factor|factor
603572|NCT01002521|alpha|alpha
603573|NCT01002521|traps|traps
603574|NCT01002521|impaired|impaired
603575|NCT01002521|wound|wound
603576|NCT01002521|healing|healing
603577|NCT01002521|Impaired wound healing in patients with diabetes mellitus|impaired wound healing in patients with diabetes mellitus
603578|NCT01002508|influenza vaccine scleroderma immunogenicity safety|influenza vaccine scleroderma immunogenicity safety
603579|NCT01002495|myocardial|myocardial
603580|NCT01002495|ischemia|ischemia
603581|NCT01002495|coronary disease|coronary disease
603582|NCT01002495|angina|angina
603583|NCT01002482|Hyperglycemia|hyperglycemia
603584|NCT01002482|Hypoglycemia|hypoglycemia
603585|NCT01002482|Intensive Care Unit|intensive care unit
603586|NCT01002482|Glucose Control|glucose control
603587|NCT01002482|Insulin|insulin
603588|NCT01002482|Computer Protocol|computer protocol
603589|NCT01002482|Metabolic Disorders|metabolic disorders
603590|NCT01002469|isotope ratio measurement|isotope ratio measurement
603591|NCT01002469|urea cycle|urea cycle
603592|NCT01002469|13C acetate|13c acetate
603593|NCT01002469|Healthy adults|healthy adults
603594|NCT01002456|Adrenergic beta-Antagonists|adrenergic beta-antagonists
603595|NCT01002456|Guideline Adherence|guideline adherence
603596|NCT01002456|Drug Prescriptions|drug prescriptions
603597|NCT01002456|target dose|target dose
603598|NCT01002443|Helicobacter pylori|helicobacter pylori
603599|NCT01002443|glandular atrophy|glandular atrophy
603600|NCT01002443|intestinal metaplasia|intestinal metaplasia
603601|NCT01002443|subtotal gastrectomy|subtotal gastrectomy
603602|NCT01002443|gastric cancer|gastric cancer
603603|NCT01002443|Precancerous lesion of gastric cancer|precancerous lesion of gastric cancer
603604|NCT01002430|Myocardial ischemia|myocardial ischemia
603605|NCT01002430|Refractory angina pectoris|refractory angina pectoris
603606|NCT01002430|Vascular endothelial growth factor|vascular endothelial growth factor
603607|NCT01002430|Gene therapy|gene therapy
603608|NCT01002430|Perfusion|perfusion
603609|NCT01002417|Benign Prostatic Hyperplasia|benign prostatic hyperplasia
603610|NCT01002417|Multi-carotenoids|multi-carotenoids
603611|NCT01002417|MCS-2|mcs-2
603612|NCT01002417|Lower Urinary Tract Symptoms|lower urinary tract symptoms
603613|NCT01002417|International prostate symptom scores|international prostate symptom scores
603614|NCT01002404|ERCP|ercp
603615|NCT01002404|deep biliary cannulation|deep biliary cannulation
603616|NCT01002404|guide wire cannulation|guide wire cannulation
603617|NCT01002404|post-ERCP pancreatitis|post-ercp pancreatitis
603618|NCT01002404|Success of deep biliary cannulation|success of deep biliary cannulation
603619|NCT01002404|Rate of post-ERCP pancreatitis|rate of post-ercp pancreatitis
603620|NCT01002404|Time used to deep biliary cannulation|time used to deep biliary cannulation
603621|NCT01002391|breast hypertrophy|breast hypertrophy
603622|NCT01002391|mammaplasty|mammaplasty
603623|NCT01002391|bandages|bandages
603624|NCT01002391|surgical site infection|surgical site infection
603625|NCT01002391|skin colonization|skin colonization
603626|NCT01002352|obesity|obesity
603627|NCT01002352|bariatric|bariatric
603628|NCT01002352|BOLD|bold
603629|NCT01002352|weightloss|weightloss
603630|NCT01002352|database|database
603631|NCT01002352|data registry|data registry
603632|NCT01002326|Pediatric|pediatric
603633|NCT01002326|Body Dysmorphic Disorder|body dysmorphic disorder
603634|NCT01002326|BDD|bdd
603635|NCT01002326|CBT|cbt
603636|NCT01002326|Cognitive-Behavioral Therapy|cognitive-behavioral therapy
603637|NCT01002300|Social Cognition|social cognition
603638|NCT01002300|Oxytocin|oxytocin
603639|NCT01002274|Benign Prostatic Hyperplasia|benign prostatic hyperplasia
603640|NCT01002274|BPH|bph
603641|NCT01002274|MCS-2|mcs-2
603642|NCT01002274|Multi-Carotenoids|multi-carotenoids
603643|NCT01002274|Lower Urinary Tract Symptoms|lower urinary tract symptoms
603644|NCT01002274|International prostate symptom score|international prostate symptom score
603645|NCT01002261|Galactose|galactose
603646|NCT01002261|PET/CT|pet/ct
603647|NCT01002261|Liver physiology|liver physiology
603648|NCT01002261|Liver pathophysiology|liver pathophysiology
603649|NCT01002248|Multiple Myeloma|multiple myeloma
603650|NCT01002248|Relapsed multiple myeloma|relapsed multiple myeloma
603651|NCT01002248|Refractory multiple myeloma|refractory multiple myeloma
603652|NCT01002248|Relapsed refractory multiple myeloma|relapsed refractory multiple myeloma
603653|NCT01002235|Diabetic|diabetic
603654|NCT01002235|Neuropathy|neuropathy
603655|NCT01002235|peripheral|peripheral
603656|NCT01002235|diabetes|diabetes
603657|NCT01002222|Benign Prostatic Hyperplasia|benign prostatic hyperplasia
603658|NCT01002222|MCS-2|mcs-2
603659|NCT01002222|Multi-Carotenoids|multi-carotenoids
603660|NCT01002222|Lower Urinary Tract Symptoms|lower urinary tract symptoms
603661|NCT01002222|International prostate symptom score|international prostate symptom score
603662|NCT01002209|Diabetes|diabetes
603663|NCT01002209|Vascular Surgery|vascular surgery
603664|NCT01002209|Hyperbaric oxygen|hyperbaric oxygen
603665|NCT01002209|Surgical complications|surgical complications
603666|NCT01002209|Wound complication|wound complication
603667|NCT01002209|Randomized|randomized
603668|NCT01002209|Controlled|controlled
603669|NCT01002196|Selective Mutism|selective mutism
603670|NCT01002196|Intervention|intervention
603671|NCT01002183|Malaria|malaria
603672|NCT01002183|Plasmodium falciparum|plasmodium falciparum
603673|NCT01002183|acute uncomplicated|acute uncomplicated
603674|NCT01002170|Tuberculosis|tuberculosis
603675|NCT01002170|Cycloserine|cycloserine
603676|NCT01002170|Pharmacokinetics|pharmacokinetics
603677|NCT01002157|Coronary Artery Calcification|coronary artery calcification
603678|NCT01002157|Vitamin K|vitamin k
603679|NCT01002157|Trial|trial
603680|NCT01002157|Treatment|treatment
603681|NCT01002131|Digital Volume Tomography|digital volume tomography
603682|NCT01002131|Cone Beam CT|cone beam ct
603683|NCT01002131|impacted and supernumerary teeth|impacted and supernumerary teeth
603684|NCT01002131|dental and maxillofacial radiology|dental and maxillofacial radiology
603685|NCT01002118|heart rate variability|heart rate variability
603686|NCT01002118|Dialysis|dialysis
603687|NCT01002105|Baclofen|baclofen
603688|NCT01002105|Alcohol|alcohol
603689|NCT01002105|Baclofen as add-on to standard treatment of alcohol|baclofen as add-on to standard treatment of alcohol
603690|NCT01002092|Osteosarcoma|osteosarcoma
603691|NCT01002092|Endostar|endostar
603692|NCT01002092|Chemotherapy|chemotherapy
603693|NCT01002066|Fever|fever
603694|NCT01002066|Malaria|malaria
603695|NCT01002066|RDT|rdt
603696|NCT01002066|IMCI|imci
603697|NCT01002066|Children<5 years of age|children<5 years of age
603698|NCT01002066|ACT|act
603699|NCT01002053|diabetes|diabetes
603700|NCT01002053|neuropathy|neuropathy
603701|NCT01002053|ankle block|ankle block
603702|NCT01002053|regional anesthesia|regional anesthesia
603703|NCT01002053|ultrasound|ultrasound
603704|NCT01002053|nerve localization|nerve localization
603705|NCT01002053|Nerve localization in patients undergoing foot surgery and having ankle block|nerve localization in patients undergoing foot surgery and having ankle block
603706|NCT01002040|HIV|hiv
603707|NCT01002040|vaccine,|vaccine,
603708|NCT01002040|H1N1|h1n1
603709|NCT01002040|influenza|influenza
603710|NCT01002040|H1N1 Influenza vaccine|h1n1 influenza vaccine
603711|NCT01002040|Arepanrix|arepanrix
603712|NCT01002040|Pandemic|pandemic
603713|NCT01002040|H1N1 2009 Influenza|h1n1 2009 influenza
603714|NCT01002040|HIV preventive vaccine|hiv preventive vaccine
603715|NCT01002027|Postnatal Depression|postnatal depression
603716|NCT01002027|CBT-Counselling|cbt-counselling
603717|NCT01002027|Primary care|primary care
603718|NCT01002014|Breast Cancer|breast cancer
603719|NCT01002014|Skin Sparing Mastectomy|skin sparing mastectomy
603720|NCT01002014|Breast Cancer Prophylaxis|breast cancer prophylaxis
603721|NCT01002014|Nipple Sparing Mastectomy|nipple sparing mastectomy
603722|NCT01002014|Nipple Areolar Complex|nipple areolar complex
603723|NCT01002014|Mastectomy|mastectomy
603724|NCT01002014|Breast Reconstruction|breast reconstruction
603725|NCT01002014|Local recurrence following nipple sparing mastectomy|local recurrence following nipple sparing mastectomy
603726|NCT01002014|Cosmetic outcomes following nipple sparing mastectomy|cosmetic outcomes following nipple sparing mastectomy
603727|NCT01002014|Complications following nipple sparing mastectomy|complications following nipple sparing mastectomy
603728|NCT01001988|Encephalitis|encephalitis
603729|NCT01001988|Japanese Encephalitis|japanese encephalitis
603730|NCT01001988|Japanese Encephalitis Chimeric Virus Vaccine|japanese encephalitis chimeric virus vaccine
603731|NCT01001988|Toddlers|toddlers
603732|NCT01001975|Sunscreens|sunscreens
603733|NCT01001962|Hypertension in type II diabetes|hypertension in type ii diabetes
603734|NCT01001962|Cardiovascular morbidity and mortality|cardiovascular morbidity and mortality
603735|NCT01001936|PHASE 1 SKI-606 Solid tumor|phase 1 ski-606 solid tumor
603736|NCT01001897|IUD insertion|iud insertion
603737|NCT01001897|nulliparous women|nulliparous women
603738|NCT01001897|contraception|contraception
603739|NCT01001884|caregiver, psychoeducational, colon|caregiver, psychoeducational, colon
603740|NCT01001871|Iron deficiency anemia|iron deficiency anemia
603741|NCT01001871|Sprinkles®|sprinkles®
603742|NCT01001871|micronutrients|micronutrients
603743|NCT01001871|malaria incidence|malaria incidence
603744|NCT01001871|iron supplement|iron supplement
603745|NCT01001858|OSA|osa
603746|NCT01001858|CPAP compliance|cpap compliance
603747|NCT01001858|nurse domiciliary led|nurse domiciliary led
603748|NCT01001858|sleep disease|sleep disease
603749|NCT01001845|hemodialysis|hemodialysis
603750|NCT01001845|oxidative stress|oxidative stress
603751|NCT01001845|plasma malondialdehyde|plasma malondialdehyde
603752|NCT01001845|Glutathion peroxidase|glutathion peroxidase
603753|NCT01001780|Graft versus Host Disease|graft versus host disease
603754|NCT01001780|Allogeneic Hematopoietic Stem Cell Transplant|allogeneic hematopoietic stem cell transplant
603755|NCT01001767|Omega-3 Fatty Acids|omega-3 fatty acids
603756|NCT01001767|HIV|hiv
603757|NCT01001767|Heart Disease|heart disease
603758|NCT01001767|Treatment experienced|treatment experienced
603759|NCT01001754|Hepatitis C|hepatitis c
603760|NCT01001754|Hepatitis C, Chronic|hepatitis c, chronic
603761|NCT01001754|PEGylated recombinant interleukin 29|pegylated recombinant interleukin 29
603762|NCT01001754|PEG-interferon lambda|peg-interferon lambda
603763|NCT01001754|Interleukin 29|interleukin 29
603764|NCT01001754|Virus|virus
603765|NCT01001754|Infection|infection
603766|NCT01001754|Liver Diseases|liver diseases
603767|NCT01001741|HIV|hiv
603768|NCT01001741|Antiretrovirals|antiretrovirals
603769|NCT01001741|Adherence|adherence
603770|NCT01001741|Text messaging|text messaging
603771|NCT01001741|Antiretroviral adherence|antiretroviral adherence
603772|NCT01001741|Treatment experienced|treatment experienced
603773|NCT01001728|Breast Cancer|breast cancer
603774|NCT01001728|Radiotherapy|radiotherapy
603775|NCT01001728|Prone position|prone position
603776|NCT01001702|Open Label|open label
603777|NCT01001702|Aripiprazole|aripiprazole
603778|NCT01001689|Pregnancy|pregnancy
603779|NCT01001689|Preventive health care|preventive health care
603780|NCT01001689|Fitness|fitness
603781|NCT01001689|Nutrition|nutrition
603782|NCT01001689|Obesity|obesity
603783|NCT01001689|Diabetes|diabetes
603784|NCT01001689|Weight gain|weight gain
603785|NCT01001676|renal failure|renal failure
603786|NCT01001676|Restenosis|restenosis
603787|NCT01001676|Dialysis access|dialysis access
603788|NCT01001676|Paclitaxel|paclitaxel
603789|NCT01001676|Angioplasty|angioplasty
603790|NCT01001676|Intimal hyperplasia|intimal hyperplasia
603791|NCT01001663|CAG|cag
603792|NCT01001650|Malaria Vaccine|malaria vaccine
603793|NCT01001650|Plasmodium falciparum|plasmodium falciparum
603794|NCT01001637|curcumin|curcumin
603795|NCT01001637|alzheimer's|alzheimer's
603796|NCT01001637|longVida|longvida
603797|NCT01001637|dementia|dementia
603798|NCT01001624|Cosmetic|cosmetic
603799|NCT01001624|Facial cream|facial cream
603800|NCT01001624|Melasma|melasma
603801|NCT01001624|Melanil|melanil
603802|NCT01001611|Diabetes Mellitus, Type 2|diabetes mellitus, type 2
603803|NCT01001611|glitazone|glitazone
603804|NCT01001611|Type II Diabetes|type ii diabetes
603805|NCT01001611|Hypolipidemic|hypolipidemic
603806|NCT01001611|oral hypoglycemic agent|oral hypoglycemic agent
603807|NCT01001585|mitochondrial disease|mitochondrial disease
603808|NCT01001585|sevoflurane|sevoflurane
603809|NCT01001585|mitochondrial disease and sevoflurane sensitivity|mitochondrial disease and sevoflurane sensitivity
603810|NCT01001572|Blood pressure|blood pressure
603811|NCT01001572|hypertension|hypertension
603812|NCT01001572|Exforge|exforge
603813|NCT01001572|valsartan/amlodipine|valsartan/amlodipine
603814|NCT01001559|Depression|depression
603815|NCT01001559|Combination therapy|combination therapy
603816|NCT01001559|antidepressant|antidepressant
603817|NCT01001559|Deplin|deplin
603818|NCT01001559|folate|folate
603819|NCT01001559|methylfolate|methylfolate
603820|NCT01001546|Veterans|veterans
603821|NCT01001546|Smoking cessation|smoking cessation
603822|NCT01001546|Operation Enduring Freedom|operation enduring freedom
603823|NCT01001546|Operation Iraqi Freedom|operation iraqi freedom
603824|NCT01001533|Electrical Cardiometry|electrical cardiometry
603825|NCT01001533|Dexmedetomidine|dexmedetomidine
603826|NCT01001533|ICON|icon
603827|NCT01001533|bio-impedance|bio-impedance
603828|NCT01001533|cardiac monitor|cardiac monitor
603829|NCT01001520|Genetics|genetics
603830|NCT01001520|Nicotine|nicotine
603831|NCT01001520|Cognition|cognition
603832|NCT01001520|fMRI|fmri
603833|NCT01001507|Family planning|family planning
603834|NCT01001507|HIV|hiv
603835|NCT01001507|Integrated services|integrated services
603836|NCT01001507|Unintended pregnancy|unintended pregnancy
603837|NCT01001507|Kenya|kenya
603838|NCT01001494|Chronic Obstructive Pulmonary Disease|chronic obstructive pulmonary disease
603839|NCT01001494|antimuscarinic|antimuscarinic
603840|NCT01001494|COPD|copd
603841|NCT01001481|Treatment review|treatment review
603842|NCT01001481|Schizophrenia|schizophrenia
603843|NCT01001481|Observational|observational
603844|NCT01001481|Prospective studies|prospective studies
603845|NCT01001481|Australia|australia
603846|NCT01001468|Psoriasis|psoriasis
603847|NCT01001455|BP|bp
603848|NCT01001442|Multiple myeloma|multiple myeloma
603849|NCT01001442|Relapsed|relapsed
603850|NCT01001442|Refractory|refractory
603851|NCT01001429|sedation for vitreoretinal surgery|sedation for vitreoretinal surgery
603852|NCT01001390|Acute Lymphoblastic leukemia|acute lymphoblastic leukemia
603853|NCT01001377|Panitumumab|panitumumab
603854|NCT01001377|Vectibix|vectibix
603855|NCT01001377|Colon Cancer|colon cancer
603856|NCT01001377|Colorectal Cancer|colorectal cancer
603857|NCT01001377|Rectal Cancer|rectal cancer
603858|NCT01001377|Cetuximab|cetuximab
603859|NCT01001377|Erbitux|erbitux
603860|NCT01001377|Metastatic|metastatic
603861|NCT01001351|Chronic Kidney Disease|chronic kidney disease
603862|NCT01001351|Arteriovenous Grafts (AVG)|arteriovenous grafts (avg)
603863|NCT01001351|Hemodialysis|hemodialysis
603864|NCT01001351|Vascular Access|vascular access
603865|NCT01001351|Dialysis|dialysis
603866|NCT01001351|Graft|graft
603867|NCT01001351|Access|access
603868|NCT01001351|vonapanitase|vonapanitase
603869|NCT01001351|kidney|kidney
603870|NCT01001351|renal|renal
603871|NCT01001325|influenza|influenza
603872|NCT01001325|vaccine|vaccine
603873|NCT01001325|observer blind|observer blind
603874|NCT01001312|Heart Failure|heart failure
603875|NCT01001312|Therapeutics|therapeutics
603876|NCT01001312|Blood volume|blood volume
603877|NCT01001286|dropout youth in low income communities in Amman, Jordan|dropout youth in low income communities in amman, jordan
603878|NCT01001273|Pancreas Transplantation|pancreas transplantation
603879|NCT01001273|Kidney Transplantation|kidney transplantation
603880|NCT01001273|Organ Transplantation|organ transplantation
603881|NCT01001273|Pancreas and Simultaneous Pancreas/Kidney Transplant Recipients|pancreas and simultaneous pancreas/kidney transplant recipients
603882|NCT01001260|Prostaglandins|prostaglandins
603883|NCT01001260|vascular injury|vascular injury
603884|NCT01001247|TMC278-TiDP6-C154|tmc278-tidp6-c154
603885|NCT01001247|TMC278-C154|tmc278-c154
603886|NCT01001247|TMC278|tmc278
603887|NCT01001247|Healthy volunteers|healthy volunteers
603888|NCT01001247|omeprazole|omeprazole
603889|NCT01001247|proton pump inhibitor|proton pump inhibitor
603890|NCT01001247|HIV|hiv
603891|NCT01001208|Etanercept|etanercept
603892|NCT01001208|Methotrexate|methotrexate
603893|NCT01001208|Psoriasis|psoriasis
603894|NCT01001182|observational|observational
603895|NCT01001182|non-interventional|non-interventional
603896|NCT01001182|prospective|prospective
603897|NCT01001169|GSK Bio's influenza vaccine GSK2340274A|gsk bio's influenza vaccine gsk2340274a
603898|NCT01001169|influenza infection|influenza infection
603899|NCT01001156|Aged|aged
603900|NCT01001156|Breathing Muscles|breathing muscles
603901|NCT01001156|Strength Muscles|strength muscles
603902|NCT01001156|Institution of long Permanence for elderly|institution of long permanence for elderly
603903|NCT01001130|avamys|avamys
603904|NCT01001130|Allergic Rhinitis|allergic rhinitis
603905|NCT01001130|post marketing surveillance|post marketing surveillance
603906|NCT01001130|Seasonal Allergic Rhinitis|seasonal allergic rhinitis
603907|NCT01001130|Perennial Allergic Rhinitis (PAR)|perennial allergic rhinitis (par)
603908|NCT01001117|Cataract|cataract
603909|NCT01001117|Capsulotomy|capsulotomy
603910|NCT01001117|Capsulorrhexis|capsulorrhexis
603911|NCT01001117|Phacoemulsification|phacoemulsification
603912|NCT01001104|Metabolic Diseases|metabolic diseases
603913|NCT01001104|Glucose Metabolism Disorders|glucose metabolism disorders
603914|NCT01001104|Diabetes|diabetes
603915|NCT01001104|GLP-1|glp-1
603916|NCT01001104|Lilly|lilly
603917|NCT01001091|Conjunctivitis|conjunctivitis
603918|NCT01001091|conjunctival inflammation|conjunctival inflammation
603919|NCT01001091|ocular allergies|ocular allergies
603920|NCT01001078|supraglottic airway devices|supraglottic airway devices
603921|NCT01001078|I-Gel|i-gel
603922|NCT01001078|Supreme Laryngeal mask airway|supreme laryngeal mask airway
603923|NCT01001078|Airway leak pressure|airway leak pressure
603924|NCT01001078|peak airway pressure|peak airway pressure
603925|NCT01001052|Healthy|healthy
603926|NCT01001052|bioavailability|bioavailability
603927|NCT01001039|chronic sinusitis|chronic sinusitis
603928|NCT01001039|facial pain|facial pain
603929|NCT01001026|vaccine|vaccine
603930|NCT01001026|H1N1|h1n1
603931|NCT01001026|influenza|influenza
603932|NCT01001026|H1N1 influenza vaccine|h1n1 influenza vaccine
603933|NCT01001026|pandemic|pandemic
603934|NCT01000987|alcohol|alcohol
603935|NCT01000987|reactivity|reactivity
603936|NCT01000987|smoking cessation medications|smoking cessation medications
603937|NCT01000974|primary vaccination course|primary vaccination course
603938|NCT01000974|Haemophilus influenzae type b|haemophilus influenzae type b
603939|NCT01000974|infants, children|infants, children
603940|NCT01000974|booster vaccination|booster vaccination
603941|NCT01000974|immunogenicity|immunogenicity
603942|NCT01000974|safety|safety
603943|NCT01000974|Gram-negative bacterial infections|gram-negative bacterial infections
603944|NCT01000974|vaccines, conjugate|vaccines, conjugate
603945|NCT01000961|cystinosis|cystinosis
603946|NCT01000961|cysteamine|cysteamine
603947|NCT01000961|inheritable disease|inheritable disease
603948|NCT01000961|orphan disease|orphan disease
603949|NCT01000961|CTNS protein, human|ctns protein, human
603950|NCT01000961|metabolic disease|metabolic disease
603951|NCT01000961|nephropathic cystinosis|nephropathic cystinosis
603952|NCT01000948|Prostate cancer|prostate cancer
603953|NCT01000948|Castration resistant|castration resistant
603954|NCT01000948|Chemotherapy resistant|chemotherapy resistant
603955|NCT01000948|Endothelial receptor A inhibitor|endothelial receptor a inhibitor
603956|NCT01000948|ZD4054|zd4054
603957|NCT01000935|Rotator Cuff Decompression Repair|rotator cuff decompression repair
603958|NCT01000922|Mealtime Insulin|mealtime insulin
603959|NCT01000922|Rapid acting insulin|rapid acting insulin
603960|NCT01000922|Ultra fast VIAject|ultra fast viaject
603961|NCT01000922|prandial insulin|prandial insulin
603963|NCT01000896|cancer|cancer
603964|NCT01000896|solid tumors|solid tumors
603965|NCT01000896|advanced solid malignancies|advanced solid malignancies
603966|NCT01000896|NSCLC|nsclc
603967|NCT01000896|epithelial ovarian cancer|epithelial ovarian cancer
603968|NCT01000896|dose escalation|dose escalation
603969|NCT01000896|combination treatment|combination treatment
603970|NCT01000896|src inhibitor|src inhibitor
603971|NCT01000896|Japanese|japanese
603972|NCT01000883|stage IIIA breast cancer|stage iiia breast cancer
603973|NCT01000883|stage IIIB breast cancer|stage iiib breast cancer
603974|NCT01000883|stage IIIC breast cancer|stage iiic breast cancer
603975|NCT01000883|stage IV breast cancer|stage iv breast cancer
603976|NCT01000883|recurrent breast cancer|recurrent breast cancer
603977|NCT01000857|controlled-release tablet|controlled-release tablet
603978|NCT01000857|repeat dose|repeat dose
603979|NCT01000857|immediate-release tablet|immediate-release tablet
603980|NCT01000857|paroxetine|paroxetine
603981|NCT01000857|safety|safety
603982|NCT01000857|crossover|crossover
603983|NCT01000857|pharmacokinetics|pharmacokinetics
603984|NCT01000857|steady-state|steady-state
603985|NCT01000857|Japanese healthy male volunteers|japanese healthy male volunteers
603986|NCT01000857|tolerance|tolerance
603987|NCT01000844|Hemophilia|hemophilia
603988|NCT01000844|Joint|joint
603989|NCT01000844|Cartilage|cartilage
603990|NCT01000844|Damage|damage
603991|NCT01000844|Prophylaxis|prophylaxis
603992|NCT01000844|Factor VIII|factor viii
603993|NCT01000844|FVIII|fviii
603994|NCT01000844|Disease|disease
603995|NCT01000844|Arthropathy|arthropathy
603996|NCT01000831|vaccine|vaccine
603997|NCT01000831|influenza|influenza
603998|NCT01000831|H1N1 influenza vaccine|h1n1 influenza vaccine
603999|NCT01000831|influenza vaccine|influenza vaccine
604000|NCT01000831|Arepanrix|arepanrix
604001|NCT01000818|Treatment experienced|treatment experienced
604002|NCT01000779|Non Cirrhotic Portal Hypertension, secondary prophylaxis|non cirrhotic portal hypertension, secondary prophylaxis
604003|NCT01000740|EAP|eap
604004|NCT01000740|Long term survival (3 years)|long term survival (3 years)
604005|NCT01000740|Gefitinib|gefitinib
604006|NCT01000740|efficacy|efficacy
604007|NCT01000727|Atherosclerosis|atherosclerosis
604008|NCT01000727|Heart disease|heart disease
604009|NCT01000727|Cardiovascular disease|cardiovascular disease
604010|NCT01000727|Lp-PLA2 inhibitor|lp-pla2 inhibitor
604011|NCT01000727|The TIMI Study Group|the timi study group
604012|NCT01000727|Coronary Heart Disease (CHD)|coronary heart disease (chd)
604013|NCT01000727|Acute Coronary Syndrome (ACS)|acute coronary syndrome (acs)
604014|NCT01000701|Inflammation|inflammation
604015|NCT01000701|ACS|acs
604016|NCT01000701|Prevention|prevention
604017|NCT01000701|Education|education
604018|NCT01000701|Clinical management|clinical management
604019|NCT01000675|aneurysm|aneurysm
604020|NCT01000675|coils|coils
604021|NCT01000662|whole breast radiotherapy|whole breast radiotherapy
604022|NCT01000662|tumor bed boost|tumor bed boost
604023|NCT01000649|V1a agonist|v1a agonist
604024|NCT01000636|Renal transplant patients|renal transplant patients
604025|NCT01000636|Actinic Keratoses|actinic keratoses
604026|NCT01000636|Metvix PDT|metvix pdt
604027|NCT01000636|Field cancerisation|field cancerisation
604028|NCT01000636|Gene expression|gene expression
604029|NCT01000597|pharmacokinetics|pharmacokinetics
604030|NCT01000597|serum cortisol|serum cortisol
604031|NCT01000597|pharmacodynamics|pharmacodynamics
604032|NCT01000597|fluticasone furoate|fluticasone furoate
604033|NCT01000597|healthy Caucasian, Japanese, Korean and Chinese subjects|healthy caucasian, japanese, korean and chinese subjects
604034|NCT01000584|vaccine|vaccine
604035|NCT01000584|H1N1|h1n1
604036|NCT01000584|influenza|influenza
604037|NCT01000584|H1N1 influenza vaccine|h1n1 influenza vaccine
604038|NCT01000584|influenza vaccine|influenza vaccine
604039|NCT01000584|seasonal Influenza|seasonal influenza
604040|NCT01000571|H1N1 pandemic flu|h1n1 pandemic flu
604041|NCT01000558|non-Hodgkin lymphoma|non-hodgkin lymphoma
604042|NCT01000545|Diabetes Mellitus|diabetes mellitus
604043|NCT01000545|Chronic Kidney Disease|chronic kidney disease
604044|NCT01000545|Glycosaminoglycans|glycosaminoglycans
604045|NCT01000545|Sulodexide|sulodexide
604046|NCT01000545|Macroalbuminuria|macroalbuminuria
604047|NCT01000545|Safety and Efficacy|safety and efficacy
604048|NCT01000532|steroid, leads, threshold, pacemaker|steroid, leads, threshold, pacemaker
604049|NCT01000519|Diabetes mellitus|diabetes mellitus
604050|NCT01000519|Randomized control trial|randomized control trial
604051|NCT01000519|Exercise|exercise
604052|NCT01000519|Hemoglobin A, Glycosylated|hemoglobin a, glycosylated
604053|NCT01000506|Dose-ranging|dose-ranging
604054|NCT01000506|Safety|safety
604055|NCT01000506|Pharmacodynamics|pharmacodynamics
604056|NCT01000506|eosinophils|eosinophils
604057|NCT01000506|SB-240563|sb-240563
604058|NCT01000506|Efficacy|efficacy
604059|NCT01000506|Severe refractory asthma|severe refractory asthma
604060|NCT01000506|mepolizumab|mepolizumab
604061|NCT01000506|Placebo|placebo
604062|NCT01000493|efficacy|efficacy
604063|NCT01000493|double-blind|double-blind
604064|NCT01000493|Clinician Administered PTSD Scale|clinician administered ptsd scale
604065|NCT01000493|placebo|placebo
604066|NCT01000493|Sleep|sleep
604067|NCT01000493|safety|safety
604068|NCT01000493|CAPS|caps
604069|NCT01000493|neurokinin-1 antagonist|neurokinin-1 antagonist
604070|NCT01000493|orvepitant|orvepitant
604071|NCT01000493|PTSD|ptsd
604072|NCT01000493|randomized|randomized
604073|NCT01000493|Post traumatic stress disorder|post traumatic stress disorder
604074|NCT01000493|Phase II|phase ii
604075|NCT01000467|PK assessment for healthy male volunteer|pk assessment for healthy male volunteer
604076|NCT01000467|Healthy male subjects aged 20 to 40 years|healthy male subjects aged 20 to 40 years
604077|NCT01000441|Rheumatoid arthritis with inadequate response to 1 anti-TNF|rheumatoid arthritis with inadequate response to 1 anti-tnf
604078|NCT01000428|NSCLC|nsclc
604079|NCT01000428|Tarceva|tarceva
604080|NCT01000428|Positron emission technology|positron emission technology
604081|NCT01000428|FLT|flt
604082|NCT01000428|FDG|fdg
604083|NCT01000415|Stage Ib2-early IIb of cervical cancer|stage ib2-early iib of cervical cancer
604084|NCT01000415|Neoadjuvant chemotherapy|neoadjuvant chemotherapy
604085|NCT01000415|Cisplatin plus gemcitabine|cisplatin plus gemcitabine
604086|NCT01000415|Radical hysterectomy with pelvic lymphadenectomy|radical hysterectomy with pelvic lymphadenectomy
604087|NCT01000415|Quality of life|quality of life
604088|NCT01000415|Stage Ib2-IIb of cervical cancer patients|stage ib2-iib of cervical cancer patients
604089|NCT01000402|Bipolar Disorder|bipolar disorder
604090|NCT01000402|Attention-Deficit/Hyperactivity Disorder|attention-deficit/hyperactivity disorder
604091|NCT01000402|Genetics|genetics
604092|NCT01000402|Environmental Factors|environmental factors
604093|NCT01000402|Family Factors|family factors
604094|NCT01000376|Cancer|cancer
604095|NCT01000376|solid tumors|solid tumors
604096|NCT01000350|orthostatic intolerance|orthostatic intolerance
604097|NCT01000350|exercise capacity|exercise capacity
604098|NCT01000350|tachycardia|tachycardia
604099|NCT01000350|POTS|pots
604100|NCT01000337|Liver Apoptosis|liver apoptosis
604101|NCT01000324|Hepatitis A|hepatitis a
604102|NCT01000324|Hepatitis B|hepatitis b
604103|NCT01000311|MenACWY conjugate vaccine in infants|menacwy conjugate vaccine in infants
604104|NCT01000311|Meningococcal vaccine in infants|meningococcal vaccine in infants
604105|NCT01000311|MenACWY|menacwy
604106|NCT01000246|mammacarcinoma|mammacarcinoma
604107|NCT01000246|breastcancer|breastcancer
604108|NCT01000246|chemotherapy|chemotherapy
604109|NCT01000246|heart failure|heart failure
604110|NCT01000246|influenza virus vaccine|influenza virus vaccine
604111|NCT01000233|PATOLOGIC CALCIFICATION|patologic calcification
604112|NCT01000233|AORTIC VALVE STENOSIS|aortic valve stenosis
604113|NCT01000233|INOSITOL HEXAPHOSPHATE|inositol hexaphosphate
604114|NCT01000207|Influenza A|influenza a
604115|NCT01000207|H1N1 subtype|h1n1 subtype
604116|NCT01000207|Children/adolescent|children/adolescent
604117|NCT01000207|Vaccine|vaccine
604118|NCT01000207|Adjuvant|adjuvant
604119|NCT01000194|postprandial|postprandial
604120|NCT01000194|gene expression profiles|gene expression profiles
604121|NCT01000194|microarray|microarray
604122|NCT01000168|Brain Injury|brain injury
604123|NCT01000168|Rehabilitation|rehabilitation
604124|NCT01000168|Treadmill therapy|treadmill therapy
604125|NCT01000155|fetal hemoglobin|fetal hemoglobin
604126|NCT01000155|vorinostat|vorinostat
604127|NCT01000155|HDAC inhibitor|hdac inhibitor
604128|NCT01000155|SAHA|saha
604129|NCT01000142|Osteopathic|osteopathic
604130|NCT01000142|Manipulation|manipulation
604131|NCT01000142|Preventative|preventative
604132|NCT01000142|Elderly|elderly
604133|NCT01000142|Nursing Home|nursing home
604134|NCT01000142|Prevention: General Health Status|prevention: general health status
604135|NCT01000129|Radiotherapy|radiotherapy
604136|NCT01000129|Bladder cancer|bladder cancer
604137|NCT01000129|Adaptive planning|adaptive planning
604138|NCT01000116|Tapp|tapp
604139|NCT01000116|Early pain|early pain
604140|NCT01000116|well-being|well-being
604141|NCT01000116|Seroma|seroma
604142|NCT01000116|Haematoma|haematoma
604143|NCT01000116|Fibrin glue|fibrin glue
604144|NCT01000116|tacks|tacks
604145|NCT01000103|Stroke|stroke
604146|NCT01000103|Visuospatial neglect|visuospatial neglect
604147|NCT01000103|Visuospatial extinction|visuospatial extinction
604148|NCT01000103|Transcranial Magnetic Stimulation (TMS)|transcranial magnetic stimulation (tms)
604149|NCT01000103|Non-invasive brain stimulation|non-invasive brain stimulation
604150|NCT01000103|Neuromodulation|neuromodulation
604151|NCT01000103|Brain parietal cortex|brain parietal cortex
604152|NCT01000103|Neurological sequels|neurological sequels
604153|NCT01000103|Cognitive rehabilitation|cognitive rehabilitation
604154|NCT01000090|Acromegaly|acromegaly
604155|NCT01000090|Somatostatin analogues|somatostatin analogues
604156|NCT01000090|Treatment|treatment
604157|NCT01000077|Regenerative Medicine|regenerative medicine
604158|NCT01000077|Tissue Collection|tissue collection
604159|NCT01000077|Cell Culture Systems|cell culture systems
604160|NCT01000077|Routine Surgery|routine surgery
604161|NCT01000064|Traumatic Brain Injury|traumatic brain injury
604162|NCT01000064|Attention Deficit|attention deficit
604163|NCT01000064|TBI|tbi
604164|NCT01000051|Transplant Thrombocytopenia|transplant thrombocytopenia
604165|NCT01000051|Hematopoietic cell transplantation|hematopoietic cell transplantation
604166|NCT01000051|HCT|hct
604167|NCT01000051|Low platelet count|low platelet count
604168|NCT01000051|Bleeding|bleeding
604169|NCT01000051|Blood clot|blood clot
604170|NCT01000051|Stem Cell Transplant|stem cell transplant
604171|NCT01000051|Blood And Marrow Transplantation|blood and marrow transplantation
604172|NCT01000051|Eltrombopag|eltrombopag
604173|NCT01000051|Promacta|promacta
604174|NCT01000038|Wii-Fit|wii-fit
604175|NCT01000038|Assisted living|assisted living
604176|NCT01000038|Alzheimer's dementia|alzheimer's dementia
604177|NCT01000025|stage IIIB non-small cell lung cancer|stage iiib non-small cell lung cancer
604178|NCT01000025|stage IV non-small cell lung cancer|stage iv non-small cell lung cancer
604179|NCT01000025|recurrent non-small cell lung cancer|recurrent non-small cell lung cancer
604180|NCT00999999|Craniotomy outcome|craniotomy outcome
604181|NCT00999999|CSF leakage|csf leakage
604182|NCT00999999|Dural sealant|dural sealant
604183|NCT00999960|Laparoscopy|laparoscopy
604184|NCT00999960|Prostate|prostate
604185|NCT00999960|Cancer|cancer
604186|NCT00999960|Learning|learning
604187|NCT00999960|Simulation|simulation
604188|NCT00999960|Simulator|simulator
604189|NCT00999947|genetics|genetics
604190|NCT00999947|mutation screening|mutation screening
604191|NCT00999947|phenotype-genotype analysis|phenotype-genotype analysis
604192|NCT00999947|desmosomal genes|desmosomal genes
604193|NCT00999921|Fibrocystic Breast Disease|fibrocystic breast disease
604194|NCT00999921|Fibroadenoma|fibroadenoma
604195|NCT00999921|Mastalgia|mastalgia
604196|NCT00999908|COPD|copd
604197|NCT00999908|indacaterol|indacaterol
604198|NCT00999908|tiotropium|tiotropium
604199|NCT00999895|Schizophrenia|schizophrenia
604200|NCT00999895|Switch of antipsychotic treatment|switch of antipsychotic treatment
604201|NCT00999895|Outcome evaluation|outcome evaluation
604202|NCT00999895|monotherapy|monotherapy
604203|NCT00999895|Greece|greece
604204|NCT00999882|mTor Kinase Inhibitor|mtor kinase inhibitor
604205|NCT00999882|Phase I/II|phase i/ii
604206|NCT00999882|Dose escalation|dose escalation
604207|NCT00999882|Hepatocellular carcinoma (HCC)|hepatocellular carcinoma (hcc)
604208|NCT00999882|Asia|asia
604209|NCT00999882|HCC|hcc
604210|NCT00999882|Safety and pharmacokinetics|safety and pharmacokinetics
604211|NCT00999869|Newly diagnosed|newly diagnosed
604212|NCT00999869|Alopecia areata|alopecia areata
604213|NCT00999869|Botulinum toxin A|botulinum toxin a
604214|NCT00999869|Corticosteroid|corticosteroid
604215|NCT00999869|Intralesional injection|intralesional injection
604216|NCT00999856|medical device,|medical device,
604217|NCT00999856|sub-conjunctival insert|sub-conjunctival insert
604218|NCT00999856|photometer|photometer
604219|NCT00999856|fluorescence|fluorescence
604220|NCT00999856|subconjunctival interstitial fluid glucose|subconjunctival interstitial fluid glucose
604221|NCT00999856|non-invasive measurement|non-invasive measurement
604222|NCT00999843|Sorafenib|sorafenib
604223|NCT00999843|Three-dimensional conformal radiation therapy|three-dimensional conformal radiation therapy
604224|NCT00999843|Intensity-modulated radiation therapy|intensity-modulated radiation therapy
604225|NCT00999843|Transcatheter arterial chemoembolization|transcatheter arterial chemoembolization
710272|NCT00589563|angioimmunoblastic T-cell lymphoma|angioimmunoblastic t-cell lymphoma
604226|NCT00999817|Drug-Drug interaction Study CYP2D6 inhibition Healthy Subjects|drug-drug interaction study cyp2d6 inhibition healthy subjects
604227|NCT00999804|Locally Advanced Breast Cancer Neoadjuvant Endocrine|locally advanced breast cancer neoadjuvant endocrine
604228|NCT00999778|Autism|autism
604229|NCT00999778|Social and Communication Deficits in Autism|social and communication deficits in autism
604230|NCT00999778|Parent and Caregiver interventions with children with Autism|parent and caregiver interventions with children with autism
604231|NCT00999778|Autism Spectrum Disorder|autism spectrum disorder
604232|NCT00999778|ASD|asd
604233|NCT00999765|Bipolar Disorder|bipolar disorder
604234|NCT00999765|Bipolar Depression|bipolar depression
604235|NCT00999765|Mindfulness-Based Cognitive Therapy|mindfulness-based cognitive therapy
604236|NCT00999765|MBCT|mbct
604237|NCT00999765|Maintenance|maintenance
604238|NCT00999765|Euthymic|euthymic
604239|NCT00999765|Efficacy|efficacy
604240|NCT00999765|Feasibility|feasibility
604241|NCT00999752|Hypertension|hypertension
604242|NCT00999752|African Americans|african americans
604243|NCT00999752|Arterial Stiffness|arterial stiffness
604244|NCT00999752|Vascular Resistance|vascular resistance
604245|NCT00999739|pneumococcal vaccines|pneumococcal vaccines
604246|NCT00999739|HIV|hiv
604247|NCT00999739|antibody response|antibody response
604248|NCT00999739|antibody affinity|antibody affinity
604249|NCT00999739|Antibody formation|antibody formation
604250|NCT00999739|Phagocytosis|phagocytosis
604251|NCT00999713|Acute Lung Injury|acute lung injury
604252|NCT00999713|Cancer|cancer
604253|NCT00999713|Pediatrics|pediatrics
604254|NCT00999700|Locally advanced HNSCC|locally advanced hnscc
604255|NCT00999700|Chemo-radiation|chemo-radiation
604256|NCT00999700|Induction chemotherapy|induction chemotherapy
604257|NCT00999700|Stage III/IV|stage iii/iv
604258|NCT00999700|Unresectable disease|unresectable disease
604259|NCT00999687|Nail psoriasis|nail psoriasis
604260|NCT00999687|Indigo naturalis|indigo naturalis
604261|NCT00999674|Exercise|exercise
604262|NCT00999648|Tinnitus|tinnitus
604263|NCT00999648|Myofascial Trigger Points|myofascial trigger points
604264|NCT00999648|Myofascial Pain Syndrome|myofascial pain syndrome
604265|NCT00999648|Controlled Clinical Trial|controlled clinical trial
604266|NCT00999635|Insoles|insoles
604267|NCT00999635|Prevention of Ulceration|prevention of ulceration
604268|NCT00999635|Diabetic Foot|diabetic foot
604269|NCT00999635|Neuropathic|neuropathic
604270|NCT00999622|infection|infection
604271|NCT00999622|adult anaplastic astrocytoma|adult anaplastic astrocytoma
604272|NCT00999622|adult anaplastic oligodendroglioma|adult anaplastic oligodendroglioma
604273|NCT00999622|adult giant cell glioblastoma|adult giant cell glioblastoma
604274|NCT00999622|adult gliosarcoma|adult gliosarcoma
604275|NCT00999622|adult oligodendroglioma|adult oligodendroglioma
604276|NCT00999622|adult glioblastoma|adult glioblastoma
604398|NCT00999193|Fracture|fracture
604277|NCT00999622|adult diffuse astrocytoma|adult diffuse astrocytoma
604278|NCT00999622|adult pilocytic astrocytoma|adult pilocytic astrocytoma
604279|NCT00999622|adult pineal gland astrocytoma|adult pineal gland astrocytoma
604280|NCT00999622|adult subependymal giant cell astrocytoma|adult subependymal giant cell astrocytoma
604281|NCT00999609|Adeno-associated virus|adeno-associated virus
604282|NCT00999609|AAV|aav
604283|NCT00999609|Leber congenital amaurosis|leber congenital amaurosis
604284|NCT00999609|RPE65|rpe65
604285|NCT00999609|Gene therapy|gene therapy
604286|NCT00999609|Gene transfer|gene transfer
604287|NCT00999609|voretigene neparvovec-rzyl|voretigene neparvovec-rzyl
604288|NCT00999609|Retinitis pigmentosa|retinitis pigmentosa
604289|NCT00999596|Breast Cancer|breast cancer
604290|NCT00999596|Digital Mammography|digital mammography
604291|NCT00999583|Cardiac arrest|cardiac arrest
604292|NCT00999583|erythropoietin|erythropoietin
604293|NCT00999583|post-anoxic encephalopathy|post-anoxic encephalopathy
604294|NCT00999583|neuroprotective drugs|neuroprotective drugs
604295|NCT00999570|outcome|outcome
604296|NCT00999570|quality of life|quality of life
604297|NCT00999570|total knee arthroplasty|total knee arthroplasty
604298|NCT00999570|clinical outcome scores post total knee arthroplasty|clinical outcome scores post total knee arthroplasty
604299|NCT00999570|quality of life scores post total knee arthroplasty|quality of life scores post total knee arthroplasty
604300|NCT00999557|breast cancer|breast cancer
604301|NCT00999557|male breast cancer|male breast cancer
604302|NCT00999557|alopecia|alopecia
604303|NCT00999544|opioid|opioid
604304|NCT00999544|oxycodone|oxycodone
604305|NCT00999544|NK1 antagonist|nk1 antagonist
604306|NCT00999544|aprepitant|aprepitant
604307|NCT00999544|intranasal|intranasal
604308|NCT00999544|abuse|abuse
604309|NCT00999531|Cystic Fibrosis|cystic fibrosis
604310|NCT00999531|CF|cf
604311|NCT00999531|Mucociliary Clearance|mucociliary clearance
604312|NCT00999531|Epithelial Sodium Channel Inhibitor|epithelial sodium channel inhibitor
604313|NCT00999531|ENaC Inhibitor|enac inhibitor
604314|NCT00999531|Airway Hydration|airway hydration
604315|NCT00999531|Amiloride|amiloride
710273|NCT00589563|Burkitt lymphoma|burkitt lymphoma
711792|NCT00583011|High risk pregnancy|high risk pregnancy
604316|NCT00999518|Randomized double blind placebo-controlled parallel-group dose-range finding interstitial cystitis efficacy pain urinary symptoms safety|randomized double blind placebo-controlled parallel-group dose-range finding interstitial cystitis efficacy pain urinary symptoms safety
604317|NCT00999505|Schizophrenia|schizophrenia
604318|NCT00999505|Amantadine|amantadine
604319|NCT00999505|Residual symptoms|residual symptoms
604320|NCT00999492|Tecnis Multifocal|tecnis multifocal
604321|NCT00999492|Patients scheduled for cataract or lens replacement surgery with implantation of multifocal intraocular lenses|patients scheduled for cataract or lens replacement surgery with implantation of multifocal intraocular lenses
604322|NCT00999453|LDL-cholesterol|ldl-cholesterol
604323|NCT00999453|Prevalent peritoneal dialysis patients with hypercholesterolemia|prevalent peritoneal dialysis patients with hypercholesterolemia
604324|NCT00999440|Chronic Pain|chronic pain
604325|NCT00999440|Methadone|methadone
604326|NCT00999440|Perceived Sleep|perceived sleep
604327|NCT00999440|QTc|qtc
604328|NCT00999427|Povidone-iodine|povidone-iodine
604329|NCT00999427|prostate cancer|prostate cancer
604330|NCT00999427|biopsy|biopsy
604331|NCT00999427|transrectal ultrasound|transrectal ultrasound
604332|NCT00999427|urinary tract infection|urinary tract infection
604333|NCT00999427|fever|fever
604334|NCT00999427|sepsis|sepsis
604335|NCT00999427|antisepsis|antisepsis
604336|NCT00999427|prevention|prevention
604337|NCT00999427|complications|complications
604338|NCT00999414|MM|mm
604339|NCT00999388|Lifestyle|lifestyle
604340|NCT00999388|Environment|environment
604341|NCT00999388|Neurodegenerative Diseases|neurodegenerative diseases
604342|NCT00999388|Elderly|elderly
604343|NCT00999388|Public Health|public health
604344|NCT00999388|PD|pd
604345|NCT00999388|Parkinson Disease|parkinson disease
604346|NCT00999375|Type 1 Diabetes|type 1 diabetes
604347|NCT00999375|Diet|diet
604348|NCT00999375|Behavioral Intervention|behavioral intervention
604349|NCT00999375|Children|children
604350|NCT00999375|Adolescents|adolescents
604351|NCT00999362|calcineurin activity|calcineurin activity
604352|NCT00999362|real-time PCR|real-time pcr
604353|NCT00999362|Gene expression of calcineurin|gene expression of calcineurin
604354|NCT00999362|T-lymphocytes|t-lymphocytes
604355|NCT00999362|interferon-gamma|interferon-gamma
604356|NCT00999362|Pharmacodynamics|pharmacodynamics
604357|NCT00999362|Pharmacokinetics|pharmacokinetics
604358|NCT00999362|tacrolimus|tacrolimus
604359|NCT00999362|western blot|western blot
604360|NCT00999362|Hoechst|hoechst
604361|NCT00999349|iron overload condition|iron overload condition
604362|NCT00999349|regular desferrioxamine administration|regular desferrioxamine administration
604363|NCT00999349|receiving continuous blood transfusions|receiving continuous blood transfusions
604364|NCT00999336|Betrixaban|betrixaban
604365|NCT00999336|Renal impairment|renal impairment
604366|NCT00999336|Healthy|healthy
604367|NCT00999336|Kidney dysfunction|kidney dysfunction
604368|NCT00999310|Klinefelter syndrome|klinefelter syndrome
604369|NCT00999310|Neuropsychology|neuropsychology
604370|NCT00999310|Neuroradiology|neuroradiology
604371|NCT00999310|Genetics|genetics
604372|NCT00999297|thermogenesis|thermogenesis
604373|NCT00999297|respiratory quotient|respiratory quotient
604374|NCT00999297|fat oxidation|fat oxidation
604375|NCT00999284|ZK200775 is tested for its effects on vision on healthy probands.|zk200775 is tested for its effects on vision on healthy probands.
604376|NCT00999271|Glucose-dependent insulinotropic polypeptide|glucose-dependent insulinotropic polypeptide
604377|NCT00999271|gastric emptying|gastric emptying
604378|NCT00999271|appetite|appetite
604379|NCT00999271|energy intake|energy intake
604380|NCT00999271|lipid metabolism|lipid metabolism
604381|NCT00999258|glomerular filtration rate|glomerular filtration rate
604382|NCT00999258|chronic allograft nephropathy|chronic allograft nephropathy
604383|NCT00999258|Kidney transplantation|kidney transplantation
604384|NCT00999258|African American|african american
604385|NCT00999232|erythromycin|erythromycin
604386|NCT00999232|prokinetics|prokinetics
604387|NCT00999232|nasojejunal tubes|nasojejunal tubes
604388|NCT00999232|Bengmark feeding tube|bengmark feeding tube
604389|NCT00999232|post-pyloric feeding|post-pyloric feeding
604390|NCT00999232|pancreatitis|pancreatitis
604391|NCT00999232|Non-critically ill patients having pancreatitis who require jejunal enteral nutrition|non-critically ill patients having pancreatitis who require jejunal enteral nutrition
604392|NCT00999219|FK199B|fk199b
604393|NCT00999219|Zolpidem|zolpidem
604394|NCT00999206|Influenza|influenza
604395|NCT00999206|Vaccine|vaccine
604396|NCT00999206|CHMP criteria|chmp criteria
604397|NCT00999193|Shoulder|shoulder
604399|NCT00999193|Locking Plate|locking plate
604400|NCT00999193|Hemiarthroplasty|hemiarthroplasty
604401|NCT00999193|Conservative|conservative
604402|NCT00999193|Comminuted Proximal Humerus Fracture|comminuted proximal humerus fracture
604403|NCT00999180|Botulinum Toxin|botulinum toxin
604404|NCT00999180|Rehabilitation|rehabilitation
604405|NCT00999180|Stroke|stroke
604406|NCT00999167|Cirrhosis|cirrhosis
604407|NCT00999167|Episodic Hepatic Encephalopathy|episodic hepatic encephalopathy
604408|NCT00999167|HE|he
604409|NCT00999167|HPN-100|hpn-100
604410|NCT00999167|GT4P|gt4p
604411|NCT00999167|glycerol phenylbutyrate|glycerol phenylbutyrate
604412|NCT00999154|Energy Expenditure|energy expenditure
604413|NCT00999154|Dietary Intake|dietary intake
604414|NCT00999154|Physical Activity|physical activity
604415|NCT00999154|Body Weight Regulation|body weight regulation
604416|NCT00999154|Sedentary|sedentary
604417|NCT00999154|HV|hv
604418|NCT00999154|Healthy Volunteer|healthy volunteer
604419|NCT00999128|PI3K inhibitor|pi3k inhibitor
604420|NCT00999128|PI3 kinase|pi3 kinase
604421|NCT00999128|PI3 kinase inhibitor|pi3 kinase inhibitor
604422|NCT00999115|Rectovaginal Fistula|rectovaginal fistula
604423|NCT00999115|Crohn Disease|crohn disease
604424|NCT00999115|Allogenic|allogenic
604425|NCT00999115|Adipose-Derived Stem Cells|adipose-derived stem cells
604426|NCT00999102|hypertension|hypertension
604427|NCT00999102|beta blockers|beta blockers
604428|NCT00999102|Metoprolol|metoprolol
604429|NCT00999102|blood pressure, high|blood pressure, high
604430|NCT00999102|antihypertensive agents|antihypertensive agents
604431|NCT00999102|vascular resistance|vascular resistance
604432|NCT00999102|adrenergic beta-receptor blockaders|adrenergic beta-receptor blockaders
604433|NCT00999102|beta-Adrenergic blockers|beta-adrenergic blockers
604434|NCT00999102|beta-Adrenergic Blocking Agents|beta-adrenergic blocking agents
604435|NCT00999102|beta-Adrenergic Receptor Blockaders|beta-adrenergic receptor blockaders
604436|NCT00999102|beta-Blockers, Adrenergic|beta-blockers, adrenergic
604437|NCT00999102|Bystolic|bystolic
604438|NCT00999102|Nebivolol|nebivolol
604439|NCT00999102|Nebivololum|nebivololum
604440|NCT00999102|Nebivololum [Latin]|nebivololum [latin]
604441|NCT00999102|R65,824|r65,824
604442|NCT00999102|Beloc- Zok|beloc- zok
604443|NCT00999102|H 93/26 succinate|h 93/26 succinate
604444|NCT00999102|Metoprolol succinate|metoprolol succinate
604445|NCT00999102|Seloken ZOC|seloken zoc
604446|NCT00999102|Selozok|selozok
604447|NCT00999102|Spesicor Dos|spesicor dos
604448|NCT00999102|Toprol XL|toprol xl
604449|NCT00999102|Toprol-XL|toprol-xl
604450|NCT00999102|UNII-TH25PD4CCB|unii-th25pd4ccb
604451|NCT00999089|Coronary disease|coronary disease
604452|NCT00999089|Coronary artery bypass grafting|coronary artery bypass grafting
604453|NCT00999089|Cardiopulmonary bypass|cardiopulmonary bypass
604454|NCT00999089|Extracorporeal circulation|extracorporeal circulation
604455|NCT00999089|Cardioplegia|cardioplegia
604456|NCT00999089|Off pump|off pump
604457|NCT00999063|GerdQ|gerdq
604458|NCT00999050|type two diabetes|type two diabetes
604459|NCT00999050|gastric bypass surgery|gastric bypass surgery
604460|NCT00999050|overweight or moderately obese|overweight or moderately obese
604461|NCT00999011|critical care|critical care
604462|NCT00999011|inflammatory biomarkers|inflammatory biomarkers
604463|NCT00999011|cytokines|cytokines
604464|NCT00999011|mechanical ventilation|mechanical ventilation
604465|NCT00999011|activity|activity
604466|NCT00999011|mobility therapy|mobility therapy
604467|NCT00999011|More than 48 hours of mechanical ventilation|more than 48 hours of mechanical ventilation
604468|NCT00998998|iron deficiency anemia|iron deficiency anemia
604469|NCT00998998|infant behavior|infant behavior
604470|NCT00998998|infant development|infant development
604471|NCT00998972|kidney graft,|kidney graft,
604472|NCT00998972|delayed graft function|delayed graft function
604473|NCT00998972|N-acetylcysteine|n-acetylcysteine
604474|NCT00998959|Depression|depression
604475|NCT00998959|Major Depression|major depression
604476|NCT00998946|Relapsed|relapsed
604477|NCT00998946|Refractory|refractory
604478|NCT00998946|Non-Hodgkin's|non-hodgkin's
604479|NCT00998933|Testosterone replacement therapy|testosterone replacement therapy
604480|NCT00998920|Healthy volunteers|healthy volunteers
604481|NCT00998907|Open Abdominal Surgery|open abdominal surgery
604482|NCT00998907|Fascial Closure|fascial closure
604483|NCT00998894|BIS|bis
604484|NCT00998894|MAC|mac
604485|NCT00998894|MAP|map
604486|NCT00998881|insulin resistance|insulin resistance
604487|NCT00998868|Rotator Cuff|rotator cuff
604488|NCT00998868|Tendinopathy|tendinopathy
604489|NCT00998868|ultrasonography|ultrasonography
604490|NCT00998855|Exercise in obesity|exercise in obesity
604491|NCT00998842|ECG|ecg
604492|NCT00998842|EKG|ekg
604493|NCT00998842|healthy subjects|healthy subjects
604494|NCT00998842|electrocardiography, ambulatory|electrocardiography, ambulatory
604495|NCT00998829|psoriasis|psoriasis
604496|NCT00998829|psoriatic arthritis|psoriatic arthritis
604497|NCT00998829|epidemiology|epidemiology
604498|NCT00998829|prevalence|prevalence
604499|NCT00998816|thoracotomy|thoracotomy
604500|NCT00998816|chronic|chronic
604501|NCT00998816|pain|pain
604502|NCT00998816|pregabalin|pregabalin
604503|NCT00998816|Lyrica|lyrica
604504|NCT00998803|Influenza virus|influenza virus
604505|NCT00998790|Urinary Incontinence, Stress|urinary incontinence, stress
604506|NCT00998790|Intrinsic sphincter deficiency|intrinsic sphincter deficiency
604507|NCT00998790|Secondary|secondary
604508|NCT00998790|TUR|tur
604509|NCT00998790|TURP|turp
604510|NCT00998790|Radical prostatectomy|radical prostatectomy
604511|NCT00998790|Open prostatectomy|open prostatectomy
604512|NCT00998790|Post-suprapubic prostatectomy|post-suprapubic prostatectomy
604513|NCT00998777|tubing program|tubing program
604514|NCT00998777|shoulder strengthening|shoulder strengthening
604515|NCT00998777|injury prevention|injury prevention
604516|NCT00998764|antibody|antibody
604517|NCT00998764|immunotherapy|immunotherapy
604518|NCT00998751|cKIT inhibitor|ckit inhibitor
604519|NCT00998751|GIST|gist
604520|NCT00998712|gestational diabetes mellitus|gestational diabetes mellitus
604521|NCT00998712|pregnancy|pregnancy
604522|NCT00998712|cardiovascular disease risk|cardiovascular disease risk
604523|NCT00998699|Diabetes|diabetes
604524|NCT00998699|Type 1|type 1
604525|NCT00998686|diabetes|diabetes
604526|NCT00998686|DPP4 inhibitor|dpp4 inhibitor
604527|NCT00998686|dutogliptin|dutogliptin
604528|NCT00998673|Silica gel fiber|silica gel fiber
604529|NCT00998673|Chronic venous leg ulcers|chronic venous leg ulcers
604530|NCT00998673|Venous ulcer|venous ulcer
604531|NCT00998673|Stasis ulcer|stasis ulcer
604532|NCT00998673|Varicose ulcer|varicose ulcer
604533|NCT00998660|Parkinson's disease|parkinson's disease
604534|NCT00998660|Essential Tremor|essential tremor
604535|NCT00998660|Dystonia (where indication is approved)|dystonia (where indication is approved)
604536|NCT00998660|Deep brain stimulation|deep brain stimulation
604537|NCT00998660|Activa RC|activa rc
604538|NCT00998647|modified ultrafiltration|modified ultrafiltration
604539|NCT00998647|cardiac surgery|cardiac surgery
604540|NCT00998647|ROTEM|rotem
604541|NCT00998647|Multiple Electrode Aggregometry|multiple electrode aggregometry
604542|NCT00998634|SCA2|sca2
604543|NCT00998634|Lithium|lithium
604544|NCT00998621|Hepatitis C, Chronic|hepatitis c, chronic
604545|NCT00998621|HIV Infection|hiv infection
604546|NCT00998621|Medication Adherence|medication adherence
604648|NCT00998192|carboplatin|carboplatin
604547|NCT00998621|Questionnaire Design|questionnaire design
604548|NCT00998621|Treatment experienced|treatment experienced
604549|NCT00998595|Diabetes, Gestational|diabetes, gestational
604550|NCT00998595|Postpartum Period|postpartum period
604551|NCT00998595|Reproductive Health Services|reproductive health services
604552|NCT00998595|Health Promotion|health promotion
604553|NCT00998595|Health Personnel|health personnel
604554|NCT00998582|Cardiovascular Disease|cardiovascular disease
604555|NCT00998582|HIV Infection|hiv infection
604556|NCT00998582|Abacavir|abacavir
604557|NCT00998582|Artery Elasticity|artery elasticity
604558|NCT00998582|Treatment experienced|treatment experienced
604559|NCT00998556|Peripartum cardiomyopathy|peripartum cardiomyopathy
604560|NCT00998556|Bromocriptine|bromocriptine
604561|NCT00998543|Smallpox Vaccinia Virus Smallpox Vaccine Variola Virus|smallpox vaccinia virus smallpox vaccine variola virus
604562|NCT00998530|Trichomonas vaginalis|trichomonas vaginalis
604563|NCT00998530|trichomoniasis|trichomoniasis
604564|NCT00998530|MLST|mlst
604565|NCT00998530|Multilocus sequence typing|multilocus sequence typing
604566|NCT00998517|Malnutrition|malnutrition
604567|NCT00998517|Supplemental Food|supplemental food
604568|NCT00998517|CSB++|csb++
604569|NCT00998517|Supplementary Plumpy|supplementary plumpy
604570|NCT00998504|impaired fat oxidation|impaired fat oxidation
604571|NCT00998504|fat accumulation|fat accumulation
604572|NCT00998504|mitochondrial dysfunction|mitochondrial dysfunction
604573|NCT00998504|mitochondrial biogenesis|mitochondrial biogenesis
604574|NCT00998465|Obesity|obesity
604575|NCT00998465|Hypertension|hypertension
604576|NCT00998465|Salt sensitivity|salt sensitivity
604577|NCT00998465|Laparoscopic gastric bypass|laparoscopic gastric bypass
604578|NCT00998465|Bariatric surgery|bariatric surgery
604579|NCT00998452|Weight|weight
604580|NCT00998452|Diet|diet
604581|NCT00998452|Physical Activity|physical activity
604582|NCT00998452|Veterans|veterans
604583|NCT00998452|MOVE! Program|move! program
604584|NCT00998439|in stent restenosis|in stent restenosis
604585|NCT00998439|paclitaxel coated balloon catheter|paclitaxel coated balloon catheter
604586|NCT00998439|pepcad|pepcad
604587|NCT00998439|drug eluting balloon|drug eluting balloon
604588|NCT00998426|hepatitis B immune globulin|hepatitis b immune globulin
604589|NCT00998426|HBIG|hbig
604590|NCT00998426|HepaGam B|hepagam b
604591|NCT00998426|orthotopic liver transplant|orthotopic liver transplant
604592|NCT00998413|asthma|asthma
604593|NCT00998413|overweight|overweight
604594|NCT00998413|obesity|obesity
604595|NCT00998413|children|children
604596|NCT00998400|Cognitive-behavioral treatment|cognitive-behavioral treatment
604597|NCT00998400|Well-being therapy|well-being therapy
604598|NCT00998400|Depression|depression
604599|NCT00998400|Demoralization|demoralization
604600|NCT00998400|Acute coronary syndrome|acute coronary syndrome
604601|NCT00998361|Sarcoma|sarcoma
604602|NCT00998361|allogeneic|allogeneic
604603|NCT00998361|Hemopoietic stem cell transplant|hemopoietic stem cell transplant
604604|NCT00998348|parenting|parenting
604605|NCT00998348|diet|diet
604606|NCT00998348|physical activity|physical activity
604607|NCT00998348|family|family
604608|NCT00998348|home|home
604609|NCT00998348|child|child
604610|NCT00998335|Type 2 diabetes mellitus|type 2 diabetes mellitus
604611|NCT00998335|Insulin therapy|insulin therapy
604612|NCT00998335|Detemir (Levemir)|detemir (levemir)
604613|NCT00998335|Aspart (Novolog)|aspart (novolog)
604614|NCT00998335|Hepatic steatosis|hepatic steatosis
604615|NCT00998322|metastatic|metastatic
604616|NCT00998322|pancreatic|pancreatic
604617|NCT00998322|adenocarcinoma|adenocarcinoma
604618|NCT00998322|REOLYSIN|reolysin
604619|NCT00998322|chemotherapy|chemotherapy
604620|NCT00998322|gemcitabine|gemcitabine
604621|NCT00998309|skin infection|skin infection
604622|NCT00998309|soft tissue infection|soft tissue infection
604623|NCT00998309|sexually-transmitted infection|sexually-transmitted infection
604624|NCT00998309|infection oral|infection oral
604625|NCT00998309|Regulatory Post Marketing Commitment Plan|regulatory post marketing commitment plan
604627|NCT00998257|Contraception|contraception
604628|NCT00998257|Premenstrual Dysphoric Disorder|premenstrual dysphoric disorder
604629|NCT00998257|PMDD|pmdd
604630|NCT00998257|Acne|acne
604631|NCT00998244|low carbohydrate|low carbohydrate
604632|NCT00998244|low fat|low fat
604633|NCT00998244|diet|diet
604634|NCT00998244|overweight|overweight
604635|NCT00998244|GERD|gerd
604636|NCT00998244|gastroesophageal reflux disease|gastroesophageal reflux disease
604637|NCT00998244|acid reflux|acid reflux
604638|NCT00998244|heartburn|heartburn
604639|NCT00998218|Sudden Cardiac Death|sudden cardiac death
604640|NCT00998218|Arrythmias|arrythmias
604641|NCT00998218|Triggered activity|triggered activity
604642|NCT00998218|left ventricular dysfunction|left ventricular dysfunction
604643|NCT00998192|carcinoma|carcinoma
604644|NCT00998192|squamous cell|squamous cell
604645|NCT00998192|lung|lung
604646|NCT00998192|REOLYSIN|reolysin
604647|NCT00998192|chemotherapy|chemotherapy
604649|NCT00998192|paclitaxel|paclitaxel
604650|NCT00998192|Carcinoma, Squamous Cell of the Lung|carcinoma, squamous cell of the lung
604651|NCT00998179|TENS|tens
604652|NCT00998179|acupuncture|acupuncture
604653|NCT00998179|FEV1|fev1
604654|NCT00998179|Normal Healthy subjects|normal healthy subjects
604655|NCT00998166|NSCLC|nsclc
604656|NCT00998153|substance use|substance use
604657|NCT00998153|PTSD|ptsd
604658|NCT00998153|risky behaviors|risky behaviors
604659|NCT00998153|revictimization|revictimization
604660|NCT00998140|resuscitation|resuscitation
604661|NCT00998140|sudden death|sudden death
604662|NCT00998140|cardiopulmonary resuscitation|cardiopulmonary resuscitation
604663|NCT00998140|emergency medical services|emergency medical services
604664|NCT00998140|termination of resuscitation|termination of resuscitation
604665|NCT00998140|ventricular fibrillation|ventricular fibrillation
604666|NCT00998140|out-of-hospital cardiac arrest|out-of-hospital cardiac arrest
604667|NCT00998140|asystole|asystole
604668|NCT00998140|medical futility|medical futility
604669|NCT00998140|withdrawing treatment|withdrawing treatment
604670|NCT00998140|transportation of patients|transportation of patients
604671|NCT00998140|health expenditures|health expenditures
604672|NCT00998140|healthcare costs|healthcare costs
604673|NCT00998127|Dual Anti-Platelet Therapy|dual anti-platelet therapy
604674|NCT00998127|Non-adherence|non-adherence
604675|NCT00998127|MACE|mace
604676|NCT00998127|NACE|nace
604677|NCT00998114|Early Cardiac Diastolic Dysfunction|early cardiac diastolic dysfunction
604678|NCT00998114|Aerobic Exercise|aerobic exercise
604679|NCT00998114|Weight Reduction|weight reduction
604680|NCT00998101|stage IIIB non-small cell lung cancer|stage iiib non-small cell lung cancer
604681|NCT00998101|stage IV non-small cell lung cancer|stage iv non-small cell lung cancer
604682|NCT00998101|recurrent non-small cell lung cancer|recurrent non-small cell lung cancer
604683|NCT00998088|Blood management|blood management
604684|NCT00998088|Orthopedic surgery|orthopedic surgery
604685|NCT00998088|elective|elective
604686|NCT00998088|randomized study|randomized study
604687|NCT00998088|adults|adults
604688|NCT00998088|hip replacement|hip replacement
604689|NCT00998088|knee replacement|knee replacement
604690|NCT00998075|Bioequivalence|bioequivalence
604691|NCT00998075|ASA|asa
604692|NCT00998075|Esomeprazole|esomeprazole
604693|NCT00998075|peptic ulcer disease|peptic ulcer disease
604694|NCT00998075|primary cardiovascular protection|primary cardiovascular protection
604695|NCT00998075|healthy volunteers|healthy volunteers
604696|NCT00998062|Dyslipaemia|dyslipaemia
604697|NCT00998062|atherosclerosis risk|atherosclerosis risk
604698|NCT00998062|increased hsCRP|increased hscrp
604699|NCT00998062|inflammatory and oxidative status in the Spanish population|inflammatory and oxidative status in the spanish population
604700|NCT00998036|TNBC|tnbc
604701|NCT00998036|Temsirolimus|temsirolimus
604702|NCT00998036|Erlotinib|erlotinib
604703|NCT00998036|Cisplatin|cisplatin
604704|NCT00998036|Breast Cancer|breast cancer
604705|NCT00998023|Angiogram|angiogram
604706|NCT00998023|Catheter Angiogram|catheter angiogram
604707|NCT00998010|adult giant cell glioblastoma|adult giant cell glioblastoma
604708|NCT00998010|adult glioblastoma|adult glioblastoma
604709|NCT00998010|adult gliosarcoma|adult gliosarcoma
604710|NCT00997997|Skin Diseases, Bacterial|skin diseases, bacterial
604711|NCT00997997|Product Surveillance|product surveillance
604712|NCT00997997|Postmarketing|postmarketing
604713|NCT00997984|ADHD|adhd
604714|NCT00997971|Hydrolysed rice protein formula|hydrolysed rice protein formula
604715|NCT00997971|Cow's milk protein allergy|cow's milk protein allergy
604716|NCT00997971|Infant formula|infant formula
604717|NCT00997971|Gastrointestinal tolerance|gastrointestinal tolerance
604718|NCT00997945|Phase I, advanced solid malignancies, advance solid tumour|phase i, advanced solid malignancies, advance solid tumour
604719|NCT00997945|advanced cancer|advanced cancer
604720|NCT00997945|ZD4054 (Zibotentan)|zd4054 (zibotentan)
604721|NCT00997945|china|china
604722|NCT00997945|PK|pk
604723|NCT00997945|pharmacokinetics|pharmacokinetics
604724|NCT00997932|levonorgestrel releasing intrauterine device|levonorgestrel releasing intrauterine device
604725|NCT00997932|levonorgestrel releasing intrauterine contraception|levonorgestrel releasing intrauterine contraception
604726|NCT00997932|unintended pregnancy prevention|unintended pregnancy prevention
604727|NCT00997932|postpartum contraception|postpartum contraception
604728|NCT00997906|stage III lymphoepithelioma of the nasopharynx|stage iii lymphoepithelioma of the nasopharynx
604729|NCT00997906|stage III squamous cell carcinoma of the nasopharynx|stage iii squamous cell carcinoma of the nasopharynx
604730|NCT00997906|stage IV lymphoepithelioma of the nasopharynx|stage iv lymphoepithelioma of the nasopharynx
604731|NCT00997906|stage IV squamous cell carcinoma of the nasopharynx|stage iv squamous cell carcinoma of the nasopharynx
604732|NCT00997893|menopause|menopause
604733|NCT00997893|hot flashes|hot flashes
604734|NCT00997893|soy|soy
604735|NCT00997893|estrogen|estrogen
604736|NCT00997893|anxiety|anxiety
604737|NCT00997880|rosuvastatin|rosuvastatin
604738|NCT00997867|Pain|pain
604739|NCT00997867|Surgery|surgery
604740|NCT00997867|Catheter|catheter
604741|NCT00997867|Nerve Block|nerve block
604742|NCT00997867|Popliteal|popliteal
604743|NCT00997867|Sciatic|sciatic
604744|NCT00997867|Femoral|femoral
604745|NCT00997867|Interscalene|interscalene
604746|NCT00997867|UCSD|ucsd
604747|NCT00997867|Moderate-to-severe pain|moderate-to-severe pain
604748|NCT00997867|Perineural Catheter|perineural catheter
604749|NCT00997867|Orthopedic Surgery|orthopedic surgery
604750|NCT00997854|Feeding|feeding
604751|NCT00997854|Intolerance|intolerance
604752|NCT00997854|Preterm|preterm
604753|NCT00997854|Bolus|bolus
604754|NCT00997841|POC|poc
604755|NCT00997841|ROTEM|rotem
604756|NCT00997841|Multiplate|multiplate
604757|NCT00997841|bleeding tendency|bleeding tendency
604758|NCT00997841|coagulation management|coagulation management
604759|NCT00997841|amount of transfused red blood cell concentrates,|amount of transfused red blood cell concentrates,
604760|NCT00997841|FFP|ffp
604761|NCT00997841|platelet concentrates|platelet concentrates
604762|NCT00997841|rate of rethoracotomy|rate of rethoracotomy
604763|NCT00997841|ventilation time|ventilation time
604764|NCT00997828|Coronary Artery Disease|coronary artery disease
604765|NCT00997828|stent|stent
604766|NCT00997828|coronary artery bypass graft surgery|coronary artery bypass graft surgery
604767|NCT00997828|multivessel coronary artery disease|multivessel coronary artery disease
604768|NCT00997815|Recalcitrant|recalcitrant
604769|NCT00997815|Alopecia totalis|alopecia totalis
604770|NCT00997815|Alopecia universalis|alopecia universalis
604771|NCT00997815|Botulinum toxin A|botulinum toxin a
604772|NCT00997802|Computed Tomographic Colonography|computed tomographic colonography
604773|NCT00997802|Colonic Polyps|colonic polyps
604774|NCT00997802|Colonic Neoplasms|colonic neoplasms
604902|NCT00997269|statin|statin
604775|NCT00997802|Computer Aided Diagnosis|computer aided diagnosis
604776|NCT00997789|Rebamipide|rebamipide
604777|NCT00997789|Bioequivalence|bioequivalence
604778|NCT00997789|ABCB1 genetic polymorphisms|abcb1 genetic polymorphisms
604779|NCT00997776|Hip Fracture|hip fracture
604780|NCT00997776|Exercise|exercise
604781|NCT00997776|Rehabilitation|rehabilitation
604782|NCT00997776|Functional Performance|functional performance
604783|NCT00997763|stenting, XIENCE V, CYPHER|stenting, xience v, cypher
604784|NCT00997750|ACS|acs
604785|NCT00997750|Acute Coronary Syndrome|acute coronary syndrome
604786|NCT00997750|NSAID|nsaid
604787|NCT00997750|Lornoxicam|lornoxicam
604788|NCT00997750|Xefocam|xefocam
604789|NCT00997737|incentive spirometry|incentive spirometry
604790|NCT00997737|diaphragm mobility|diaphragm mobility
604791|NCT00997737|ultrasound|ultrasound
604792|NCT00997737|diaphragmatic breathing|diaphragmatic breathing
604793|NCT00997724|assisted-VATS (video-assisted thoracoscopic surgery)|assisted-vats (video-assisted thoracoscopic surgery)
604794|NCT00997724|sleeve lobectomy|sleeve lobectomy
604795|NCT00997724|bronchoplasty|bronchoplasty
604796|NCT00997711|Diabetes|diabetes
604797|NCT00997711|death|death
604798|NCT00997711|MI|mi
604799|NCT00997711|TVR|tvr
604800|NCT00997698|Intracranial aneurysm|intracranial aneurysm
604801|NCT00997698|Magnetic resonance angiography|magnetic resonance angiography
604802|NCT00997698|Epidemiology|epidemiology
604803|NCT00997685|XELOX|xelox
604804|NCT00997685|potentially resectable liver metastasis from CRC|potentially resectable liver metastasis from crc
604805|NCT00997672|MSA|msa
604806|NCT00997672|Lithium|lithium
604807|NCT00997672|Lithium carbonate|lithium carbonate
604808|NCT00997672|MSA-P|msa-p
604809|NCT00997672|MSA-C|msa-c
604810|NCT00997659|chromium picolinate|chromium picolinate
604811|NCT00997659|insulin resistance|insulin resistance
604812|NCT00997659|obesity|obesity
604813|NCT00997646|Performance|performance
604814|NCT00997646|hospitalist|hospitalist
604815|NCT00997646|ward|ward
604816|NCT00997646|hospitalization|hospitalization
604817|NCT00997633|Intraperitoneal volume|intraperitoneal volume
604818|NCT00997633|peritoneal carcinomatosis|peritoneal carcinomatosis
604819|NCT00997633|cytoreductive surgery|cytoreductive surgery
604820|NCT00997633|SPECT|spect
604821|NCT00997633|intraperitoneal chemotherapy|intraperitoneal chemotherapy
604822|NCT00997620|Hay Fever|hay fever
604823|NCT00997620|Daytime somnolence|daytime somnolence
604824|NCT00997620|Cognition|cognition
604825|NCT00997607|Vaccine|vaccine
604826|NCT00997594|adrenal gland|adrenal gland
604827|NCT00997581|Gout|gout
604828|NCT00997568|transesophageal|transesophageal
604829|NCT00997568|transducer|transducer
604830|NCT00997568|TEE|tee
604831|NCT00997555|inhalation|inhalation
604832|NCT00997555|bronchoscopy|bronchoscopy
604833|NCT00997555|burn|burn
604834|NCT00997555|pneumonia|pneumonia
604835|NCT00997529|Stem cell transplant|stem cell transplant
604836|NCT00997529|Non-myeloablative|non-myeloablative
604837|NCT00997529|Metastatic Solid Tumor|metastatic solid tumor
604838|NCT00997529|Donor Leukocyte Infusion|donor leukocyte infusion
604839|NCT00997516|Laparoscopy|laparoscopy
604840|NCT00997516|Appendicitis|appendicitis
604841|NCT00997516|Single-incision laparoscopic surgery|single-incision laparoscopic surgery
604842|NCT00997516|SILS|sils
604843|NCT00997490|depression|depression
604844|NCT00997490|HAMD 21|hamd 21
604845|NCT00997490|anxiety|anxiety
604846|NCT00997490|HAMA|hama
604847|NCT00997490|Hypericum|hypericum
604848|NCT00997490|Valerian|valerian
604849|NCT00997490|Passionflower|passionflower
604850|NCT00997490|F32.0|f32.0
604851|NCT00997490|F33.0|f33.0
604852|NCT00997477|aerolizer|aerolizer
604853|NCT00997477|formoterol|formoterol
604854|NCT00997477|budesonide|budesonide
604855|NCT00997477|asthma|asthma
604856|NCT00997451|Medically unexplained chronic fatigue|medically unexplained chronic fatigue
604857|NCT00997451|Chronic fatigue syndrome|chronic fatigue syndrome
604858|NCT00997451|Cognitive-behavior therapy|cognitive-behavior therapy
604859|NCT00997451|Self-management|self-management
604860|NCT00997451|Primary care|primary care
604861|NCT00997451|Nurses|nurses
604862|NCT00997451|Economic analysis|economic analysis
604863|NCT00997451|Cost effectiveness|cost effectiveness
604864|NCT00997451|One year follow-up|one year follow-up
604865|NCT00997425|wandering|wandering
604866|NCT00997425|subjective exit barriers|subjective exit barriers
604867|NCT00997399|Ph I|ph i
604868|NCT00997399|panobinostat (DACi)|panobinostat (daci)
604869|NCT00997399|PK & safety|pk & safety
604870|NCT00997399|solid tumors|solid tumors
604871|NCT00997399|varying renal function|varying renal function
604872|NCT00997399|advanced|advanced
604873|NCT00997386|Hematologic malignancies|hematologic malignancies
604874|NCT00997386|lymphoma, leukemia, MDS (myelodysplastic syndrome)|lymphoma, leukemia, mds (myelodysplastic syndrome)
604875|NCT00997386|reduced-intensity preparative regimen|reduced-intensity preparative regimen
604876|NCT00997386|allogeneic peripheral blood stem cell transplant|allogeneic peripheral blood stem cell transplant
604877|NCT00997386|myelofibrosis or other myeloproliferative syndromes|myelofibrosis or other myeloproliferative syndromes
604878|NCT00997373|Endometrial Cancer|endometrial cancer
604879|NCT00997373|Endometrial Carcinoma|endometrial carcinoma
604880|NCT00997373|Aromatase Inhibitor|aromatase inhibitor
604881|NCT00997373|Letrozole|letrozole
604882|NCT00997373|Femara|femara
604883|NCT00997360|Phase 1|phase 1
604884|NCT00997360|Maximum tolerated dose|maximum tolerated dose
604885|NCT00997360|Solid tumors|solid tumors
604886|NCT00997334|erlotinib|erlotinib
604887|NCT00997334|EGFR mutation|egfr mutation
604888|NCT00997334|NSCLC|nsclc
604889|NCT00997321|ketamine|ketamine
604890|NCT00997321|propofol|propofol
604891|NCT00997321|procedural sedation|procedural sedation
604892|NCT00997321|moderate procedural sedation in the ED|moderate procedural sedation in the ed
604893|NCT00997308|AZD1446|azd1446
604894|NCT00997308|to investigate safety and tolerability in Healthy subjects during 4 weeks of administration|to investigate safety and tolerability in healthy subjects during 4 weeks of administration
604895|NCT00997295|low flow gas|low flow gas
604896|NCT00997295|Heat and moisture exchanger|heat and moisture exchanger
604897|NCT00997295|Humidity|humidity
604898|NCT00997295|Temperature|temperature
604899|NCT00997295|Core temperature|core temperature
604900|NCT00997295|Women|women
604901|NCT00997269|CoQ-10|coq-10
604903|NCT00997269|muscle pain|muscle pain
604904|NCT00997269|cardiovascular|cardiovascular
604905|NCT00997256|sleep-EEG|sleep-eeg
604906|NCT00997256|sleep architecture|sleep architecture
604907|NCT00997256|sleep duration|sleep duration
604908|NCT00997256|sleep continuity|sleep continuity
604909|NCT00997256|REM-sleep|rem-sleep
604910|NCT00997256|vigilance|vigilance
604911|NCT00997256|well-being|well-being
604912|NCT00997256|Healthy volunteers|healthy volunteers
604913|NCT00997243|de novo myelodysplastic syndromes|de novo myelodysplastic syndromes
604914|NCT00997243|secondary myelodysplastic syndromes|secondary myelodysplastic syndromes
604915|NCT00997243|chronic myelomonocytic leukemia|chronic myelomonocytic leukemia
604916|NCT00997243|refractory anemia with excess blasts in transformation|refractory anemia with excess blasts in transformation
604917|NCT00997243|refractory anemia with excess blasts|refractory anemia with excess blasts
604918|NCT00997243|refractory anemia with ringed sideroblasts|refractory anemia with ringed sideroblasts
604919|NCT00997243|refractory anemia|refractory anemia
604920|NCT00997243|refractory cytopenia with multilineage dysplasia|refractory cytopenia with multilineage dysplasia
604921|NCT00997230|EGFR mutation ,newly diagnosed NSCLC, locally advanced or metastatic NSCLC|egfr mutation ,newly diagnosed nsclc, locally advanced or metastatic nsclc
604923|NCT00997217|cardiac surgery|cardiac surgery
604924|NCT00997217|ischemic preconditioning|ischemic preconditioning
604925|NCT00997217|cardiac surgical procedures|cardiac surgical procedures
604926|NCT00997204|HAE|hae
604927|NCT00997204|Type I HAE|type i hae
604928|NCT00997204|Type II HAE|type ii hae
604929|NCT00997191|Bevacizumab|bevacizumab
604930|NCT00997191|Diabetes|diabetes
604931|NCT00997191|Intravitreal|intravitreal
604932|NCT00997191|Macular edema|macular edema
604933|NCT00997191|triamcinolone|triamcinolone
604934|NCT00997191|VEGF|vegf
604935|NCT00997178|Diabetes|diabetes
604936|NCT00997178|Diabetes Mellitus|diabetes mellitus
604937|NCT00997178|Periodontal Disease|periodontal disease
604938|NCT00997178|Periodontitis|periodontitis
604939|NCT00997178|Glycosylated Hemoglobin|glycosylated hemoglobin
604940|NCT00997178|HbA1c|hba1c
604941|NCT00997165|fatty liver|fatty liver
605207|NCT00996242|L-lysine|l-lysine
604942|NCT00997165|adipose tissue|adipose tissue
604943|NCT00997152|Diabetes|diabetes
604944|NCT00997139|healthcare|healthcare
604945|NCT00997139|staphylococcus aureus|staphylococcus aureus
604946|NCT00997139|nasal|nasal
604947|NCT00997126|propofol|propofol
604948|NCT00997126|alfentanil|alfentanil
604949|NCT00997126|nitrous oxide|nitrous oxide
604950|NCT00997126|moderate procedural sedation|moderate procedural sedation
604951|NCT00997126|Moderate Procedural Sedation in the Emergency Department|moderate procedural sedation in the emergency department
604952|NCT00997113|propofol|propofol
604953|NCT00997113|alfentanil|alfentanil
604954|NCT00997113|procedural sedation|procedural sedation
604955|NCT00997113|stress biomarkers|stress biomarkers
604956|NCT00997113|Deep procedural sedation in the ED|deep procedural sedation in the ed
604957|NCT00997100|Systemic Lupus Erythematosus (SLE)|systemic lupus erythematosus (sle)
604958|NCT00997100|ABR-215757|abr-215757
604959|NCT00997100|Change in Biomarkers|change in biomarkers
604960|NCT00997087|OCD|ocd
604961|NCT00997074|pain after abortion|pain after abortion
604962|NCT00997074|abortion|abortion
604963|NCT00997035|Fungal Infections|fungal infections
604964|NCT00997035|Eye Disease|eye disease
604965|NCT00997035|Fungal Keratitis|fungal keratitis
604966|NCT00997035|Visual Acuity|visual acuity
604967|NCT00997022|HCC|hcc
604968|NCT00997022|High-risk Hepatocellular Cancer|high-risk hepatocellular cancer
604969|NCT00997009|EGFR|egfr
604970|NCT00997009|chemotherapy|chemotherapy
604971|NCT00996996|Radioimmunotherapy|radioimmunotherapy
604972|NCT00996996|Anti-B1 Antibody and Iodine-131 Anti-B1 Antibody|anti-b1 antibody and iodine-131 anti-b1 antibody
604973|NCT00996996|Tositumomab and Iodine I 131 Tositumomab|tositumomab and iodine i 131 tositumomab
604974|NCT00996996|non-Hodgkin's Lymphoma|non-hodgkin's lymphoma
604975|NCT00996996|Bexxar|bexxar
604976|NCT00996970|HIV|hiv
604977|NCT00996970|H1N1|h1n1
604978|NCT00996970|Influenza|influenza
604979|NCT00996970|Vaccination|vaccination
604980|NCT00996970|Seroresponse|seroresponse
604981|NCT00996970|Immunogenicity|immunogenicity
604982|NCT00996970|Vaccine|vaccine
604983|NCT00996944|ropinirole|ropinirole
604984|NCT00996944|haemodialysis|haemodialysis
604985|NCT00996944|restless legs syndrome|restless legs syndrome
604986|NCT00996931|autistic spectrum disorder|autistic spectrum disorder
604987|NCT00996931|lenalidomide|lenalidomide
604988|NCT00996918|antibody|antibody
604989|NCT00996905|Epidural Analgesia|epidural analgesia
604990|NCT00996905|Ultrasound|ultrasound
604991|NCT00996905|Training, Inservice|training, inservice
604992|NCT00996892|GDC0941|gdc0941
604993|NCT00996892|GDC0973|gdc0973
604994|NCT00996892|MEK|mek
604995|NCT00996892|MEK Inhibitor|mek inhibitor
604996|NCT00996892|PI3K|pi3k
604997|NCT00996892|PI3K Inhibitor|pi3k inhibitor
604998|NCT00996892|PI3 Kinase|pi3 kinase
604999|NCT00996892|PI3 Kinase Inhibitor|pi3 kinase inhibitor
605000|NCT00996879|Human Volunteers|human volunteers
605001|NCT00996853|safety|safety
605002|NCT00996853|Influenza|influenza
605003|NCT00996853|vaccine|vaccine
605004|NCT00996853|reactogenicity|reactogenicity
605005|NCT00996853|swine flu|swine flu
605006|NCT00996840|dilmapimod|dilmapimod
605007|NCT00996840|p38|p38
605008|NCT00996840|SB-681323|sb-681323
605009|NCT00996840|Acute Lung Injury (ALI)|acute lung injury (ali)
605010|NCT00996840|Acute Respiratory Distress Syndrome (ARDS)|acute respiratory distress syndrome (ards)
605011|NCT00996827|Melanoma|melanoma
605012|NCT00996827|Skin cancer|skin cancer
605013|NCT00996827|Vitamin D|vitamin d
605014|NCT00996827|Vitamin D receptor|vitamin d receptor
605015|NCT00996827|Sunlight|sunlight
605016|NCT00996827|Cytokine|cytokine
605017|NCT00996814|Bioethics|bioethics
605018|NCT00996788|Patients suffering of dyspepsia due to chronic gastritis|patients suffering of dyspepsia due to chronic gastritis
605019|NCT00996775|Alcohol Consumption|alcohol consumption
605020|NCT00996762|bioequivalence, lapatinib, GW572016|bioequivalence, lapatinib, gw572016
605021|NCT00996736|Fungal Infections|fungal infections
605022|NCT00996736|Eye Disease|eye disease
605023|NCT00996736|Fungal Keratitis|fungal keratitis
605024|NCT00996736|Visual Acuity|visual acuity
605025|NCT00996710|Genome-wide|genome-wide
605026|NCT00996710|09-068|09-068
605027|NCT00996697|COPD (chronic obstructive pulmonary disease)|copd (chronic obstructive pulmonary disease)
605028|NCT00996684|Wet age related macular degeneration (AMD)|wet age related macular degeneration (amd)
605029|NCT00996684|Wet AMD|wet amd
605030|NCT00996684|Vitreomacular adhesion (VMA)|vitreomacular adhesion (vma)
605031|NCT00996684|Vitreomacular traction (VMT)|vitreomacular traction (vmt)
605032|NCT00996684|Neovascular age related macular degeneration|neovascular age related macular degeneration
605033|NCT00996671|focal adhesion kinase inhibitor|focal adhesion kinase inhibitor
605034|NCT00996671|healthy volunteers|healthy volunteers
605035|NCT00996671|first time in human|first time in human
605036|NCT00996645|Diabetes Mellitus, Type 2|diabetes mellitus, type 2
605037|NCT00996645|Coronary Artery Disease|coronary artery disease
605038|NCT00996645|Primary Health Care|primary health care
605039|NCT00996645|Feedback, Psychological|feedback, psychological
605040|NCT00996645|Quality Assurance, Health Care|quality assurance, health care
605041|NCT00996632|breast cancer|breast cancer
605042|NCT00996632|ultrasonic knife|ultrasonic knife
605043|NCT00996632|volume drainage|volume drainage
605044|NCT00996593|Tositumomab|tositumomab
605045|NCT00996593|radioimmunotherapy|radioimmunotherapy
605046|NCT00996593|rituximab|rituximab
605047|NCT00996593|anti-B1|anti-b1
605048|NCT00996593|I 131|i 131
605049|NCT00996593|Bexxar|bexxar
605050|NCT00996593|iodine|iodine
605051|NCT00996593|non-Hodgkin's lymphoma|non-hodgkin's lymphoma
605052|NCT00996580|Contraception|contraception
605053|NCT00996580|Oral contraceptives|oral contraceptives
605054|NCT00996567|Malignant mesothelioma|malignant mesothelioma
605055|NCT00996554|Hand-sutured colo-colonic and ileo-colonic anastomoses in elective surgery|hand-sutured colo-colonic and ileo-colonic anastomoses in elective surgery
605056|NCT00996541|Runaway youth|runaway youth
605057|NCT00996541|Homeless youth|homeless youth
605058|NCT00996541|Family intervention|family intervention
605059|NCT00996541|Family functioning|family functioning
605060|NCT00996541|HIV risk behavior|hiv risk behavior
605061|NCT00996541|HIV Seronegativity|hiv seronegativity
605062|NCT00996528|fetal alcohol syndrome|fetal alcohol syndrome
605063|NCT00996528|alcohol abuse|alcohol abuse
605064|NCT00996528|HIV|hiv
605065|NCT00996528|malnutrition|malnutrition
605066|NCT00996528|children|children
605067|NCT00996528|mentor mother|mentor mother
605068|NCT00996528|behavioral intervention|behavioral intervention
605069|NCT00996528|South Africa|south africa
605070|NCT00996528|Maternal alcohol use|maternal alcohol use
605071|NCT00996528|HIV-related transmission behaviors|hiv-related transmission behaviors
605072|NCT00996528|low birth weight babies and low-weight children|low birth weight babies and low-weight children
605073|NCT00996528|HIV Seronegativity|hiv seronegativity
605074|NCT00996515|Advanced Solid Tumor Malignancies|advanced solid tumor malignancies
605075|NCT00996515|Erlotinib|erlotinib
605076|NCT00996515|Vidaza|vidaza
605077|NCT00996515|Tarceva|tarceva
605078|NCT00996515|5-azacytidine|5-azacytidine
605079|NCT00996476|Hepatitis C|hepatitis c
605080|NCT00996476|Hepatitis C virus|hepatitis c virus
605081|NCT00996476|Interferon Alfa-2a|interferon alfa-2a
605082|NCT00996476|Ribavirin|ribavirin
605083|NCT00996476|Viral RNA|viral rna
605084|NCT00996450|brain tumour|brain tumour
605085|NCT00996437|vitreous|vitreous
605086|NCT00996437|hemorrhage|hemorrhage
605087|NCT00996437|proliferative|proliferative
605088|NCT00996437|diabetic|diabetic
605089|NCT00996437|retinopathy|retinopathy
605090|NCT00996437|intravitreal|intravitreal
605091|NCT00996437|ranibizumab|ranibizumab
605092|NCT00996437|Lucentis|lucentis
605093|NCT00996437|saline|saline
605094|NCT00996437|vitrectomy|vitrectomy
710274|NCT00589563|contiguous stage II adult Burkitt lymphoma|contiguous stage ii adult burkitt lymphoma
605095|NCT00996411|Healthy volunteers are being studied to evaluate the subject-rated, behavioral, and abuse liability effects of salvinorin A|healthy volunteers are being studied to evaluate the subject-rated, behavioral, and abuse liability effects of salvinorin a
605096|NCT00996398|Cryotherapy|cryotherapy
605097|NCT00996398|Joint Position Sense|joint position sense
605098|NCT00996398|Proprioception|proprioception
605099|NCT00996398|Pre Cooling|pre cooling
605100|NCT00996398|Knee Injury|knee injury
605101|NCT00996398|Physical Therapy Modalities|physical therapy modalities
605102|NCT00996398|Physical Therapy Techniques|physical therapy techniques
605103|NCT00996398|Weightbearing|weightbearing
605104|NCT00996398|NonWeightbearing|nonweightbearing
605105|NCT00996398|Randomised Control Trial|randomised control trial
605106|NCT00996385|Pleural Mesothelioma|pleural mesothelioma
605107|NCT00996385|Peritoneal Mesothelioma|peritoneal mesothelioma
605108|NCT00996359|adult acute myeloid leukemia with 11q23 (MLL) abnormalities|adult acute myeloid leukemia with 11q23 (mll) abnormalities
605109|NCT00996359|adult acute myeloid leukemia with inv(16)(p13;q22)|adult acute myeloid leukemia with inv(16)(p13;q22)
605110|NCT00996359|adult acute myeloid leukemia with t(15;17)(q22;q12)|adult acute myeloid leukemia with t(15;17)(q22;q12)
605111|NCT00996359|adult acute myeloid leukemia with t(16;16)(p13;q22)|adult acute myeloid leukemia with t(16;16)(p13;q22)
605112|NCT00996359|adult acute myeloid leukemia with t(8;21)(q22;q22)|adult acute myeloid leukemia with t(8;21)(q22;q22)
605113|NCT00996359|recurrent adult acute myeloid leukemia|recurrent adult acute myeloid leukemia
605114|NCT00996359|adult acute myeloid leukemia in remission|adult acute myeloid leukemia in remission
605115|NCT00996359|recurrent adult acute lymphoblastic leukemia|recurrent adult acute lymphoblastic leukemia
605116|NCT00996359|adult acute lymphoblastic leukemia in remission|adult acute lymphoblastic leukemia in remission
605117|NCT00996359|relapsing chronic myelogenous leukemia|relapsing chronic myelogenous leukemia
605118|NCT00996359|accelerated phase chronic myelogenous leukemia|accelerated phase chronic myelogenous leukemia
605119|NCT00996359|chronic phase chronic myelogenous leukemia|chronic phase chronic myelogenous leukemia
605120|NCT00996359|blastic phase chronic myelogenous leukemia|blastic phase chronic myelogenous leukemia
605121|NCT00996359|refractory chronic lymphocytic leukemia|refractory chronic lymphocytic leukemia
605122|NCT00996359|de novo myelodysplastic syndromes|de novo myelodysplastic syndromes
605123|NCT00996359|previously treated myelodysplastic syndromes|previously treated myelodysplastic syndromes
605124|NCT00996359|secondary myelodysplastic syndromes|secondary myelodysplastic syndromes
605125|NCT00996359|chronic myelomonocytic leukemia|chronic myelomonocytic leukemia
605126|NCT00996359|recurrent adult diffuse large cell lymphoma|recurrent adult diffuse large cell lymphoma
605127|NCT00996359|recurrent grade 1 follicular lymphoma|recurrent grade 1 follicular lymphoma
605128|NCT00996359|recurrent grade 2 follicular lymphoma|recurrent grade 2 follicular lymphoma
605129|NCT00996359|recurrent grade 3 follicular lymphoma|recurrent grade 3 follicular lymphoma
605130|NCT00996359|recurrent mantle cell lymphoma|recurrent mantle cell lymphoma
605131|NCT00996359|recurrent adult diffuse small cleaved cell lymphoma|recurrent adult diffuse small cleaved cell lymphoma
605132|NCT00996359|recurrent marginal zone lymphoma|recurrent marginal zone lymphoma
605133|NCT00996359|recurrent small lymphocytic lymphoma|recurrent small lymphocytic lymphoma
605134|NCT00996359|recurrent adult Burkitt lymphoma|recurrent adult burkitt lymphoma
605135|NCT00996359|recurrent adult diffuse mixed cell lymphoma|recurrent adult diffuse mixed cell lymphoma
605136|NCT00996359|recurrent adult immunoblastic large cell lymphoma|recurrent adult immunoblastic large cell lymphoma
605137|NCT00996359|recurrent adult lymphoblastic lymphoma|recurrent adult lymphoblastic lymphoma
605138|NCT00996359|recurrent adult T-cell leukemia/lymphoma|recurrent adult t-cell leukemia/lymphoma
605139|NCT00996359|recurrent cutaneous T-cell non-Hodgkin lymphoma|recurrent cutaneous t-cell non-hodgkin lymphoma
605140|NCT00996359|recurrent mycosis fungoides/Sezary syndrome|recurrent mycosis fungoides/sezary syndrome
605141|NCT00996359|adult nasal type extranodal NK/T-cell lymphoma|adult nasal type extranodal nk/t-cell lymphoma
605142|NCT00996359|peripheral T-cell lymphoma|peripheral t-cell lymphoma
605143|NCT00996359|hepatosplenic T-cell lymphoma|hepatosplenic t-cell lymphoma
605144|NCT00996359|anaplastic large cell lymphoma|anaplastic large cell lymphoma
605145|NCT00996359|extranodal marginal zone B-cell lymphoma of mucosa-associated lymphoid tissue|extranodal marginal zone b-cell lymphoma of mucosa-associated lymphoid tissue
605146|NCT00996359|nodal marginal zone B-cell lymphoma|nodal marginal zone b-cell lymphoma
605147|NCT00996359|splenic marginal zone lymphoma|splenic marginal zone lymphoma
605148|NCT00996359|recurrent adult Hodgkin lymphoma|recurrent adult hodgkin lymphoma
605149|NCT00996359|refractory multiple myeloma|refractory multiple myeloma
605150|NCT00996359|childhood acute myeloid leukemia in remission|childhood acute myeloid leukemia in remission
605151|NCT00996359|recurrent childhood acute myeloid leukemia|recurrent childhood acute myeloid leukemia
605152|NCT00996359|childhood acute lymphoblastic leukemia in remission|childhood acute lymphoblastic leukemia in remission
605153|NCT00996359|recurrent childhood acute lymphoblastic leukemia|recurrent childhood acute lymphoblastic leukemia
605154|NCT00996359|childhood diffuse large cell lymphoma|childhood diffuse large cell lymphoma
605155|NCT00996359|recurrent childhood large cell lymphoma|recurrent childhood large cell lymphoma
605156|NCT00996359|Burkitt lymphoma|burkitt lymphoma
605157|NCT00996359|childhood immunoblastic large cell lymphoma|childhood immunoblastic large cell lymphoma
605158|NCT00996359|angioimmunoblastic T-cell lymphoma|angioimmunoblastic t-cell lymphoma
605159|NCT00996359|recurrent childhood lymphoblastic lymphoma|recurrent childhood lymphoblastic lymphoma
605160|NCT00996359|recurrent childhood anaplastic large cell lymphoma|recurrent childhood anaplastic large cell lymphoma
605161|NCT00996359|recurrent childhood grade III lymphomatoid granulomatosis|recurrent childhood grade iii lymphomatoid granulomatosis
605162|NCT00996359|recurrent childhood small noncleaved cell lymphoma|recurrent childhood small noncleaved cell lymphoma
605163|NCT00996359|childhood nasal type extranodal NK/T-cell lymphoma|childhood nasal type extranodal nk/t-cell lymphoma
605164|NCT00996346|INST 0909|inst 0909
605165|NCT00996346|Irinotecan|irinotecan
605166|NCT00996346|Temsirolimus|temsirolimus
605167|NCT00996346|refractory sarcomas|refractory sarcomas
605168|NCT00996346|3066K1|3066k1
605169|NCT00996346|3066K1-1208|3066k1-1208
605170|NCT00996346|20091334|20091334
605171|NCT00996333|Stage IVB|stage ivb
605172|NCT00996320|Internship and Residency|internship and residency
605173|NCT00996320|Medical Errors|medical errors
605174|NCT00996320|Burnout, Professional|burnout, professional
605175|NCT00996320|Burnout|burnout
605176|NCT00996320|Depression|depression
605177|NCT00996320|Actigraphy|actigraphy
605178|NCT00996320|Personnel Staffing and Scheduling|personnel staffing and scheduling
605179|NCT00996320|Sleep Deprivation|sleep deprivation
605180|NCT00996320|Workload|workload
605181|NCT00996320|Humans|humans
605182|NCT00996320|Adult|adult
605183|NCT00996320|Male|male
605184|NCT00996320|Female|female
605185|NCT00996320|Intensive Care Units|intensive care units
605186|NCT00996320|Prospective Studies|prospective studies
605187|NCT00996320|Crossover Studies|crossover studies
605188|NCT00996320|Work Schedule Tolerance|work schedule tolerance
605189|NCT00996320|Disorders of Excessive Somnolence|disorders of excessive somnolence
605190|NCT00996320|Guideline Adherence|guideline adherence
605191|NCT00996320|Internal Medicine Education|internal medicine education
605192|NCT00996307|Swine Flu|swine flu
605193|NCT00996307|Flu|flu
605194|NCT00996307|Vaccine|vaccine
605195|NCT00996307|Children|children
605196|NCT00996307|Adjuvant|adjuvant
605197|NCT00996307|A/H1N1 2009 Influenza|a/h1n1 2009 influenza
605198|NCT00996281|Hypertensive|hypertensive
605199|NCT00996281|Blood Pressure, High|blood pressure, high
605200|NCT00996281|Cardiovascular disease|cardiovascular disease
605201|NCT00996281|Vascular Disease|vascular disease
605202|NCT00996281|Drug Therapy|drug therapy
605203|NCT00996268|hypertriglyceridemia|hypertriglyceridemia
605204|NCT00996268|GSK2212836|gsk2212836
605205|NCT00996268|relative bioavailability|relative bioavailability
605206|NCT00996242|Schizophrenia|schizophrenia
605208|NCT00996242|PANSS|panss
605209|NCT00996229|Diet|diet
605210|NCT00996229|elderly|elderly
605211|NCT00996229|cognition|cognition
605212|NCT00996229|prevention|prevention
605213|NCT00996229|cognitive decline|cognitive decline
605214|NCT00996229|Lifestyle|lifestyle
605215|NCT00996216|Peginterferon|peginterferon
605216|NCT00996216|Platelets|platelets
605217|NCT00996216|Ribavirin|ribavirin
605218|NCT00996216|Hepatitis C-related thrombocytopenia|hepatitis c-related thrombocytopenia
605219|NCT00996216|Thrombocytopenia|thrombocytopenia
605220|NCT00996216|Hepatitis C|hepatitis c
605221|NCT00996216|Thrombopoietin|thrombopoietin
605222|NCT00996190|transthoracic bioreactance|transthoracic bioreactance
605223|NCT00996190|noninvasive monitoring|noninvasive monitoring
605224|NCT00996190|vasopressor|vasopressor
605225|NCT00996190|blood pressure|blood pressure
605226|NCT00996177|Pain|pain
605227|NCT00996177|Patient-controlled analgesia|patient-controlled analgesia
605228|NCT00996177|Postoperative pain|postoperative pain
605229|NCT00996177|Transdermal fentanyl|transdermal fentanyl
605230|NCT00996177|Surgical pain|surgical pain
605231|NCT00996177|Opioid analgesics|opioid analgesics
605232|NCT00996151|Hypergonadism|hypergonadism
605233|NCT00996151|Testosterone Transfer|testosterone transfer
605234|NCT00996138|Influenza A|influenza a
605235|NCT00996138|H1N1 subtype|h1n1 subtype
605236|NCT00996138|Adult|adult
605237|NCT00996138|Vaccine|vaccine
605238|NCT00996138|Adjuvant|adjuvant
605239|NCT00996138|Swine-Origin Influenza A H1N1 Virus|swine-origin influenza a h1n1 virus
605240|NCT00996125|Immunogenicity|immunogenicity
605241|NCT00996125|Safety|safety
605242|NCT00996125|Human papillomavirus|human papillomavirus
605243|NCT00996125|China|china
605244|NCT00996125|HPV vaccine|hpv vaccine
605245|NCT00996112|primary health care|primary health care
605246|NCT00996099|continuous glucose monitoring|continuous glucose monitoring
605247|NCT00996099|intensive insulin therapy|intensive insulin therapy
605248|NCT00996099|critically ill|critically ill
605249|NCT00996099|cardiac surgery|cardiac surgery
605250|NCT00996099|hyperglycemia of critically ill|hyperglycemia of critically ill
605251|NCT00996073|Degenerative disc disease|degenerative disc disease
605252|NCT00996073|Spondylolisthesis|spondylolisthesis
605253|NCT00996073|Spinal stenosis|spinal stenosis
605254|NCT00996073|Stem cells|stem cells
605255|NCT00996073|Adult Stem Cells|adult stem cells
605256|NCT00996073|Spinal Fusion|spinal fusion
605257|NCT00996073|Lumbar Spinal Fusion|lumbar spinal fusion
605258|NCT00996073|TLIF|tlif
605259|NCT00996073|PLIF|plif
605260|NCT00996073|Mesoblast|mesoblast
605261|NCT00996060|Lung Cancer|lung cancer
605262|NCT00996060|Advanced Lung Cancer|advanced lung cancer
605263|NCT00996060|Unresectable Lung cancer|unresectable lung cancer
605264|NCT00996060|Previously treated lung cancer|previously treated lung cancer
605265|NCT00996047|untreated adult acute lymphoblastic leukemia|untreated adult acute lymphoblastic leukemia
605266|NCT00996047|accelerated phase chronic myelogenous leukemia|accelerated phase chronic myelogenous leukemia
605267|NCT00996047|acute undifferentiated leukemia|acute undifferentiated leukemia
605268|NCT00996047|adult acute lymphoblastic leukemia in remission|adult acute lymphoblastic leukemia in remission
605269|NCT00996047|adult acute myeloid leukemia in remission|adult acute myeloid leukemia in remission
605270|NCT00996047|adult acute myeloid leukemia with 11q23 (MLL) abnormalities|adult acute myeloid leukemia with 11q23 (mll) abnormalities
605271|NCT00996047|adult acute myeloid leukemia with inv(16)(p13;q22)|adult acute myeloid leukemia with inv(16)(p13;q22)
605272|NCT00996047|adult acute myeloid leukemia with t(15;17)(q22;q12)|adult acute myeloid leukemia with t(15;17)(q22;q12)
605273|NCT00996047|adult acute myeloid leukemia with t(16;16)(p13;q22)|adult acute myeloid leukemia with t(16;16)(p13;q22)
605274|NCT00996047|adult acute myeloid leukemia with t(8;21)(q22;q22)|adult acute myeloid leukemia with t(8;21)(q22;q22)
605275|NCT00996047|atypical chronic myeloid leukemia, BCR-ABL1 negative|atypical chronic myeloid leukemia, bcr-abl1 negative
605276|NCT00996047|blastic phase chronic myelogenous leukemia|blastic phase chronic myelogenous leukemia
605277|NCT00996047|childhood acute lymphoblastic leukemia in remission|childhood acute lymphoblastic leukemia in remission
605278|NCT00996047|childhood acute myeloid leukemia in remission|childhood acute myeloid leukemia in remission
605279|NCT00996047|childhood chronic myelogenous leukemia|childhood chronic myelogenous leukemia
605280|NCT00996047|chronic myelomonocytic leukemia|chronic myelomonocytic leukemia
605281|NCT00996047|chronic phase chronic myelogenous leukemia|chronic phase chronic myelogenous leukemia
605282|NCT00996047|juvenile myelomonocytic leukemia|juvenile myelomonocytic leukemia
605283|NCT00996047|mast cell leukemia|mast cell leukemia
605284|NCT00996047|meningeal chronic myelogenous leukemia|meningeal chronic myelogenous leukemia
605285|NCT00996047|progressive hairy cell leukemia, initial treatment|progressive hairy cell leukemia, initial treatment
605286|NCT00996047|prolymphocytic leukemia|prolymphocytic leukemia
605287|NCT00996047|recurrent adult acute lymphoblastic leukemia|recurrent adult acute lymphoblastic leukemia
605288|NCT00996047|recurrent adult acute myeloid leukemia|recurrent adult acute myeloid leukemia
605289|NCT00996047|recurrent childhood acute lymphoblastic leukemia|recurrent childhood acute lymphoblastic leukemia
605290|NCT00996047|recurrent childhood acute myeloid leukemia|recurrent childhood acute myeloid leukemia
605291|NCT00996047|refractory chronic lymphocytic leukemia|refractory chronic lymphocytic leukemia
605292|NCT00996047|refractory hairy cell leukemia|refractory hairy cell leukemia
605293|NCT00996047|relapsing chronic myelogenous leukemia|relapsing chronic myelogenous leukemia
605294|NCT00996047|secondary acute myeloid leukemia|secondary acute myeloid leukemia
605295|NCT00996047|stage I chronic lymphocytic leukemia|stage i chronic lymphocytic leukemia
605296|NCT00996047|stage II chronic lymphocytic leukemia|stage ii chronic lymphocytic leukemia
605297|NCT00996047|stage III chronic lymphocytic leukemia|stage iii chronic lymphocytic leukemia
605298|NCT00996047|stage IV chronic lymphocytic leukemia|stage iv chronic lymphocytic leukemia
605299|NCT00996047|T-cell large granular lymphocyte leukemia|t-cell large granular lymphocyte leukemia
605300|NCT00996047|untreated adult acute myeloid leukemia|untreated adult acute myeloid leukemia
605301|NCT00996047|untreated childhood acute lymphoblastic leukemia|untreated childhood acute lymphoblastic leukemia
605302|NCT00996047|untreated childhood acute myeloid leukemia and other myeloid malignancies|untreated childhood acute myeloid leukemia and other myeloid malignancies
605303|NCT00996047|untreated hairy cell leukemia|untreated hairy cell leukemia
605304|NCT00996047|childhood myelodysplastic syndromes|childhood myelodysplastic syndromes
605305|NCT00996047|de novo myelodysplastic syndromes|de novo myelodysplastic syndromes
605306|NCT00996047|previously treated myelodysplastic syndromes|previously treated myelodysplastic syndromes
605307|NCT00996047|secondary myelodysplastic syndromes|secondary myelodysplastic syndromes
605308|NCT00996047|myelodysplastic/myeloproliferative neoplasm, unclassifiable|myelodysplastic/myeloproliferative neoplasm, unclassifiable
605309|NCT00996047|myelodysplastic/myeloproliferative neoplasms|myelodysplastic/myeloproliferative neoplasms
605310|NCT00996034|Nicotine, SPECT, vaccine, receptor|nicotine, spect, vaccine, receptor
605311|NCT00996021|GSK1349572|gsk1349572
605312|NCT00996021|moxifloxacin|moxifloxacin
605313|NCT00996021|Avelox|avelox
605314|NCT00996021|QTc|qtc
605315|NCT00995982|Influenza|influenza
605316|NCT00995982|Healthy|healthy
605317|NCT00995982|Immunity|immunity
605318|NCT00995982|Preventive|preventive
605319|NCT00995982|Flu|flu
605320|NCT00995982|HV|hv
605321|NCT00995982|Healthy Volunteer|healthy volunteer
605322|NCT00995969|Mild to moderate psoriasis vulgaris|mild to moderate psoriasis vulgaris
605323|NCT00995956|Albumin|albumin
605324|NCT00995956|Mycophenolic acid|mycophenolic acid
605325|NCT00995956|IMPDH|impdh
605326|NCT00995956|Free fraction|free fraction
605327|NCT00995930|Atherosclerosis,|atherosclerosis,
605328|NCT00995930|Type 2 Diabetes Mellitus, T2DM,|type 2 diabetes mellitus, t2dm,
769089|NCT00371020|PVR|pvr
605329|NCT00995930|Cardiovascular Diseases, ACZ885, impaired glucose tolerance, IGT, Canakinumab|cardiovascular diseases, acz885, impaired glucose tolerance, igt, canakinumab
605330|NCT00995917|acupuncture|acupuncture
605331|NCT00995917|menstrual pain|menstrual pain
605332|NCT00995917|dysmenorrhea|dysmenorrhea
605333|NCT00995917|menstrual cramps|menstrual cramps
605334|NCT00995917|vitamin K1|vitamin k1
605335|NCT00995904|asthmatic children|asthmatic children
605336|NCT00995891|Laboratory Research Specimens|laboratory research specimens
605337|NCT00995891|Biologic Samples|biologic samples
605338|NCT00995891|Sample Collection|sample collection
605339|NCT00995891|Tissue Procurement|tissue procurement
605340|NCT00995891|HV|hv
605341|NCT00995891|Healthy Volunteer|healthy volunteer
605342|NCT00995878|Uterine fibroids|uterine fibroids
605343|NCT00995878|Fibroids|fibroids
605344|NCT00995878|Uterine leiomyomas|uterine leiomyomas
605345|NCT00995878|UAE|uae
605346|NCT00995878|UFE|ufe
605347|NCT00995878|Magnetic resonance guided focused ultrasound|magnetic resonance guided focused ultrasound
605348|NCT00995878|MRgFUS|mrgfus
605349|NCT00995878|Pelvic pain|pelvic pain
605350|NCT00995865|Prevention of yellow fever virus infection|prevention of yellow fever virus infection
605351|NCT00995852|Endoscopic lung volume reduction|endoscopic lung volume reduction
605352|NCT00995852|emphysema|emphysema
605353|NCT00995852|COPD|copd
605354|NCT00995852|Patients with bilateral heterogeneous pulmonary emphysema|patients with bilateral heterogeneous pulmonary emphysema
605355|NCT00995839|terlipressin|terlipressin
605356|NCT00995839|vasopressin|vasopressin
605357|NCT00995839|sepsis|sepsis
605358|NCT00995839|septic shock|septic shock
605359|NCT00995839|norepinephrine|norepinephrine
605360|NCT00995813|Intestinal failure|intestinal failure
605361|NCT00995813|Rotavirus vaccine|rotavirus vaccine
605362|NCT00995813|Infants|infants
605363|NCT00995800|Asthma|asthma
605364|NCT00995787|Type II diabetes mellitus|type ii diabetes mellitus
605365|NCT00995787|metformin|metformin
605366|NCT00995787|sulfonylurea|sulfonylurea
605367|NCT00995774|stroke|stroke
605368|NCT00995774|function|function
605369|NCT00995774|arm|arm
605370|NCT00995774|hand|hand
605371|NCT00995774|robotic|robotic
605372|NCT00995774|therapy|therapy
605373|NCT00995774|motor|motor
605374|NCT00995774|movement|movement
605375|NCT00995774|treatment|treatment
605376|NCT00995761|biweekly|biweekly
605377|NCT00995761|docetaxel|docetaxel
605378|NCT00995761|cisplatin|cisplatin
605379|NCT00995761|non-small cell lung cancer|non-small cell lung cancer
605380|NCT00995735|NOTES|notes
605381|NCT00995735|Natural Orifice Translumenal Endoscopic surgery|natural orifice translumenal endoscopic surgery
605382|NCT00995735|Cholecystectomy|cholecystectomy
605383|NCT00995735|Appendectomy|appendectomy
605384|NCT00995735|Endoscopy|endoscopy
605385|NCT00995735|Laparoscopy|laparoscopy
605386|NCT00995735|Minimally invasive surgery|minimally invasive surgery
605387|NCT00995735|clinical trials|clinical trials
605388|NCT00995722|Ocular myasthenia gravis|ocular myasthenia gravis
605389|NCT00995722|Prednisone|prednisone
605390|NCT00995722|Steroids|steroids
605391|NCT00995709|Behçet's disease,|behçet's disease,
605392|NCT00995709|intermediate uveitis|intermediate uveitis
605393|NCT00995709|panuveitis|panuveitis
605394|NCT00995709|posterior uveitis|posterior uveitis
605395|NCT00995709|uveitis|uveitis
605396|NCT00995696|Interactive Voice Response (IVR)|interactive voice response (ivr)
605397|NCT00995696|Antidepressant|antidepressant
605398|NCT00995683|intracranial hypertension|intracranial hypertension
605399|NCT00995683|neurological outcome|neurological outcome
605400|NCT00995683|osmotherapy|osmotherapy
605401|NCT00995670|hyperglycemia|hyperglycemia
605402|NCT00995670|statin|statin
605403|NCT00995670|blood vessels|blood vessels
605404|NCT00995670|ischemic preconditioning|ischemic preconditioning
605405|NCT00995670|Anesthesia, inhalational|anesthesia, inhalational
605406|NCT00995670|endothelium|endothelium
605407|NCT00995670|5% dextrose|5% dextrose
605408|NCT00995644|smoking|smoking
605409|NCT00995644|smoking cessation|smoking cessation
605410|NCT00995644|tobacco use cessation|tobacco use cessation
605411|NCT00995644|tobacco use disorder|tobacco use disorder
605412|NCT00995631|liposuction|liposuction
605413|NCT00995631|adipose tissue|adipose tissue
605414|NCT00995631|dietary fatty acids|dietary fatty acids
605415|NCT00995631|triglyceride storage|triglyceride storage
605416|NCT00995631|Normal healthy aging|normal healthy aging
605417|NCT00995618|Gout|gout
605418|NCT00995618|Hyperuricemia|hyperuricemia
605419|NCT00995592|nutrition|nutrition
605420|NCT00995592|child weight|child weight
605421|NCT00995592|undernourishment|undernourishment
605422|NCT00995592|mentor mother|mentor mother
605423|NCT00995592|South Africa|south africa
605424|NCT00995579|Physical Activity|physical activity
605425|NCT00995579|Energy Expenditure|energy expenditure
605426|NCT00995540|T1DM|t1dm
605427|NCT00995540|Regeneration|regeneration
605428|NCT00995540|Islet|islet
605429|NCT00995540|Beta cell|beta cell
605430|NCT00995540|INGAP Peptide|ingap peptide
605431|NCT00995527|Post Swine Flu Blood Samples|post swine flu blood samples
605432|NCT00995527|Biologic Sample Collection|biologic sample collection
605433|NCT00995527|Laboratory Research Samples|laboratory research samples
605434|NCT00995527|H1N1 Vaccine Samples|h1n1 vaccine samples
605435|NCT00995527|HV|hv
605436|NCT00995527|Healthy Volunteer|healthy volunteer
605437|NCT00995514|acute coronary syndrome|acute coronary syndrome
605438|NCT00995514|cardiovascular death|cardiovascular death
605439|NCT00995514|non-fatal MI|non-fatal mi
605440|NCT00995514|non-fatal stroke|non-fatal stroke
605441|NCT00995514|genetic testing|genetic testing
605442|NCT00995514|CYP2C19|cyp2c19
605443|NCT00995514|clopidogrel|clopidogrel
605444|NCT00995514|prasugrel|prasugrel
605445|NCT00995514|antiplatelet therapy|antiplatelet therapy
605446|NCT00995514|genotyping|genotyping
605447|NCT00995514|bleeding|bleeding
605448|NCT00995501|steroid administration|steroid administration
605449|NCT00995501|tight glucose control|tight glucose control
605450|NCT00995501|light anesthesiReducing inflammatory response to surgical stress|light anesthesireducing inflammatory response to surgical stress
605451|NCT00995501|a|a
605452|NCT00995488|Urothelial Cancer|urothelial cancer
605453|NCT00995488|ABI-007|abi-007
605454|NCT00995488|Bladder Cancer|bladder cancer
605455|NCT00995488|front-line|front-line
605456|NCT00995449|Rheumatoid Arthritis|rheumatoid arthritis
605457|NCT00995449|Biologics-Inadequate|biologics-inadequate
605458|NCT00995449|KB003|kb003
605459|NCT00995449|GM-CSF|gm-csf
605460|NCT00995436|Extractions|extractions
605461|NCT00995436|Anchorage supplementation|anchorage supplementation
605462|NCT00995423|Coronary Artery Disease|coronary artery disease
605463|NCT00995423|stent|stent
605464|NCT00995410|Subjects Who are at Risk for Developing Aspirin-ASA|subjects who are at risk for developing aspirin-asa
605465|NCT00995410|Subject must have a pre-existing condition for which aspirin is already indicated|subject must have a pre-existing condition for which aspirin is already indicated
605466|NCT00995410|Gastric Ulcers|gastric ulcers
605467|NCT00995397|Insect bites|insect bites
605468|NCT00995397|Dexchlorpheniramine|dexchlorpheniramine
605469|NCT00995397|Lotion|lotion
605470|NCT00995397|Cream|cream
605471|NCT00995371|Spinal Stenosis|spinal stenosis
605472|NCT00995371|Lumbar Spinal Stenosis|lumbar spinal stenosis
605473|NCT00995371|Laminotomy|laminotomy
605474|NCT00995371|Laminectomy|laminectomy
605475|NCT00995371|Spine Surgery|spine surgery
605476|NCT00995358|Epitope peptide|epitope peptide
605477|NCT00995358|CTL|ctl
605478|NCT00995358|Esophageal cancer|esophageal cancer
605479|NCT00995358|Vaccination|vaccination
605480|NCT00995345|Type 2 Diabetes|type 2 diabetes
605481|NCT00995345|Metformin|metformin
605482|NCT00995332|Acute myelogenous leukemia|acute myelogenous leukemia
605483|NCT00995332|all-trans retinoic acid|all-trans retinoic acid
605484|NCT00995332|valproic acid|valproic acid
605485|NCT00995332|cytarabine|cytarabine
605486|NCT00995332|Disease stabilization|disease stabilization
605487|NCT00995332|survival|survival
605488|NCT00995332|toxicity|toxicity
605490|NCT00995319|Mucositis|mucositis
605491|NCT00995319|Dysphagia|dysphagia
605492|NCT00995319|malnutrition|malnutrition
605493|NCT00995319|Xerostomia|xerostomia
605494|NCT00995319|saliva|saliva
605495|NCT00995319|tooth injuries|tooth injuries
605496|NCT00995306|Active comparator|active comparator
605497|NCT00995306|Active civamide cream, 0.075%|active civamide cream, 0.075%
605498|NCT00995306|Active civamide cream, 0.01%|active civamide cream, 0.01%
605499|NCT00995280|follicle flushing|follicle flushing
605500|NCT00995280|oocyte retrieval|oocyte retrieval
605501|NCT00995280|needle|needle
605502|NCT00995267|childhood obesity|childhood obesity
605503|NCT00995267|nutrition|nutrition
605504|NCT00995267|exercise|exercise
605505|NCT00995267|Alfred Adler|alfred adler
605506|NCT00995267|schoolchildren|schoolchildren
605507|NCT00995267|intervention study|intervention study
605508|NCT00995267|community-based trial|community-based trial
605509|NCT00995267|parent-child interaction|parent-child interaction
605510|NCT00995267|nutritional behaviors|nutritional behaviors
605511|NCT00995254|secondhand smoke|secondhand smoke
605512|NCT00995254|children|children
605513|NCT00995254|Chinese|chinese
605514|NCT00995254|respiratory symptoms|respiratory symptoms
605515|NCT00995254|household smoking policy|household smoking policy
605516|NCT00995254|Respiratory illnesses among children|respiratory illnesses among children
605517|NCT00995241|Raltegravir|raltegravir
605518|NCT00995241|intracellular concentration|intracellular concentration
605519|NCT00995241|plasmatic concentration|plasmatic concentration
605520|NCT00995241|HIV|hiv
605521|NCT00995241|Treatment experienced|treatment experienced
605522|NCT00995228|overhydration|overhydration
605523|NCT00995228|fluid restriction|fluid restriction
605524|NCT00995228|post-anesthesia care unit|post-anesthesia care unit
605525|NCT00995215|spinal cord injury|spinal cord injury
605526|NCT00995215|SCI|sci
605527|NCT00995215|paralysis|paralysis
605528|NCT00995215|cough|cough
605529|NCT00995215|cervical spinal cord injury|cervical spinal cord injury
605530|NCT00995215|thoracic spinal cord injury|thoracic spinal cord injury
605531|NCT00995202|stage II colon cancer|stage ii colon cancer
605532|NCT00995202|stage II rectal cancer|stage ii rectal cancer
605533|NCT00995202|stage III colon cancer|stage iii colon cancer
605534|NCT00995202|stage III rectal cancer|stage iii rectal cancer
605535|NCT00995202|adenocarcinoma of the colon|adenocarcinoma of the colon
605536|NCT00995202|adenocarcinoma of the rectum|adenocarcinoma of the rectum
605537|NCT00995189|contact lens wear|contact lens wear
605538|NCT00995189|multi-purpose solution|multi-purpose solution
605539|NCT00995189|corneal staining|corneal staining
605540|NCT00995176|Prevention|prevention
605541|NCT00995176|HIV|hiv
605542|NCT00995176|HIV seronegativity|hiv seronegativity
605543|NCT00995163|outcomes study|outcomes study
605544|NCT00995163|hemodialysis|hemodialysis
605545|NCT00995163|CKD-MBD|ckd-mbd
605546|NCT00995150|contraception|contraception
605547|NCT00995150|intrauterine|intrauterine
605548|NCT00995150|long-term|long-term
605549|NCT00995150|reversible|reversible
605550|NCT00995137|Relapsed or refractory B-Lineage ALL|relapsed or refractory b-lineage all
605551|NCT00995124|ovicide|ovicide
605552|NCT00995124|head lice infestation|head lice infestation
605553|NCT00995098|Acute severe pancreatitis|acute severe pancreatitis
605554|NCT00995098|nutritional support|nutritional support
605555|NCT00995098|enteral nutrition|enteral nutrition
605556|NCT00995098|parenteral nutrition|parenteral nutrition
605557|NCT00995085|ADHD|adhd
605558|NCT00995085|ADD|add
605559|NCT00995085|TOVA|tova
605560|NCT00995085|METADOXINE|metadoxine
605561|NCT00995072|sexual dysfunction|sexual dysfunction
605562|NCT00995072|female|female
605563|NCT00995072|hypertension|hypertension
605564|NCT00995072|high blood pressure|high blood pressure
605565|NCT00995072|beta blockers|beta blockers
605566|NCT00995072|metoprolol|metoprolol
605567|NCT00995072|nebivolol|nebivolol
605568|NCT00995072|Bystolic|bystolic
605569|NCT00995072|Toprol XL|toprol xl
605570|NCT00995059|stage I multiple myeloma|stage i multiple myeloma
605571|NCT00995059|stage II multiple myeloma|stage ii multiple myeloma
605572|NCT00995059|stage III multiple myeloma|stage iii multiple myeloma
605573|NCT00995046|Hemophilia A|hemophilia a
605574|NCT00995046|prophylaxis|prophylaxis
605575|NCT00995046|thrombin generation test (TGT)|thrombin generation test (tgt)
605576|NCT00995033|Smoking cessation|smoking cessation
605577|NCT00995033|Smoking lapse behavior|smoking lapse behavior
605578|NCT00995033|Smoking Relapse behavior|smoking relapse behavior
605579|NCT00995033|Varenicline|varenicline
605580|NCT00995033|Nicotine conjugate vaccine|nicotine conjugate vaccine
605581|NCT00995033|Medication effect on smoking lapse behavior|medication effect on smoking lapse behavior
605582|NCT00995020|Cone biopsy|cone biopsy
605583|NCT00995020|Conization|conization
605584|NCT00995020|Loop electrosurgical excisional procedures|loop electrosurgical excisional procedures
605585|NCT00995020|Large Loop Excision of Transformation Zone|large loop excision of transformation zone
605586|NCT00995020|Needle Excision of Transformation Zone|needle excision of transformation zone
605587|NCT00995020|Straight Wire Excision of Transformation Zone|straight wire excision of transformation zone
605588|NCT00995020|Electrosurgery|electrosurgery
605589|NCT00995007|Brain Tumor|brain tumor
605590|NCT00995007|Chemotherapy|chemotherapy
605591|NCT00995007|Antiangiogenesis|antiangiogenesis
605592|NCT00995007|Radiation|radiation
605593|NCT00995007|Progression|progression
605594|NCT00995007|Glioma|glioma
605595|NCT00995007|Glioblastoma Multiforme|glioblastoma multiforme
605596|NCT00994994|pediatric cardiac surgery|pediatric cardiac surgery
605597|NCT00994994|bleeding|bleeding
605598|NCT00994994|tranexamic acid|tranexamic acid
605599|NCT00994994|fibrinolysis|fibrinolysis
605600|NCT00994994|blood loss in pediatric cardiac surgery|blood loss in pediatric cardiac surgery
605601|NCT00994981|magnesium and reperfusion injury|magnesium and reperfusion injury
605602|NCT00994968|stage II breast cancer|stage ii breast cancer
605603|NCT00994968|stage III breast cancer|stage iii breast cancer
605605|NCT00994955|laser|laser
605606|NCT00994955|diabetic macular edema|diabetic macular edema
605607|NCT00994955|diabetes|diabetes
605608|NCT00994955|Clinically significant diabetic macular edema|clinically significant diabetic macular edema
605609|NCT00994929|biologic effects|biologic effects
605610|NCT00994929|von Willebrand disease|von willebrand disease
605611|NCT00994929|hemophilia|hemophilia
605612|NCT00994929|interleukin-11|interleukin-11
605613|NCT00994929|DDAVp|ddavp
605614|NCT00994916|Lambert-Eaton myasthenic syndrome|lambert-eaton myasthenic syndrome
605615|NCT00994916|3,4 diaminopyridine|3,4 diaminopyridine
605616|NCT00994903|Statin|statin
605617|NCT00994903|Colon|colon
605618|NCT00994903|Colorectal|colorectal
605619|NCT00994903|Intestinal Neoplasms|intestinal neoplasms
605620|NCT00994903|ERAS|eras
605621|NCT00994903|Perioperative Care|perioperative care
605622|NCT00994890|Double-blind safety|double-blind safety
605623|NCT00994825|levosimendan|levosimendan
605624|NCT00994825|cardiac surgery|cardiac surgery
605625|NCT00994825|cardiac anesthesia|cardiac anesthesia
605626|NCT00994825|mortality|mortality
605627|NCT00994825|survival|survival
605628|NCT00994825|inotropic drugs|inotropic drugs
605629|NCT00994812|Polycystic ovary syndrome|polycystic ovary syndrome
605630|NCT00994812|PCOS|pcos
605631|NCT00994812|Metformin|metformin
605632|NCT00994812|Miscarriage|miscarriage
605633|NCT00994812|Infertility|infertility
605634|NCT00994812|Complications of pregnancy|complications of pregnancy
605635|NCT00994786|treatment-resistant|treatment-resistant
605636|NCT00994786|refractory|refractory
605637|NCT00994786|obsessive compulsive disorder|obsessive compulsive disorder
605638|NCT00994786|Lyrica|lyrica
605639|NCT00994786|pregabalin|pregabalin
605640|NCT00994786|Serotonin Reuptake Inhibitor-Refractory Obsessive-Compulsive Disorder|serotonin reuptake inhibitor-refractory obsessive-compulsive disorder
605641|NCT00994773|Hepatitis B|hepatitis b
605642|NCT00994773|simvastatin|simvastatin
605643|NCT00994773|HBV DNA|hbv dna
605644|NCT00994760|intranasal fentanyl spray|intranasal fentanyl spray
605645|NCT00994747|infancy|infancy
605646|NCT00994747|nutrition|nutrition
605647|NCT00994747|protein hydrolysate formula|protein hydrolysate formula
605648|NCT00994747|flavor preferences|flavor preferences
605649|NCT00994747|food preferences|food preferences
605650|NCT00994747|growth|growth
605651|NCT00994747|emotional development|emotional development
605652|NCT00994747|mother-infant interaction|mother-infant interaction
605653|NCT00994747|infant temperament|infant temperament
605654|NCT00994747|feeding patterning|feeding patterning
605655|NCT00994747|taste receptor and obesity genotype|taste receptor and obesity genotype
605656|NCT00994747|sensitive period|sensitive period
605657|NCT00994721|Pancreatic Cancer|pancreatic cancer
605658|NCT00994695|Trivalent meningococcal polysaccharide vaccine|trivalent meningococcal polysaccharide vaccine
605659|NCT00994695|Children|children
605660|NCT00994695|Safety|safety
605661|NCT00994695|Immunogenicity|immunogenicity
605662|NCT00994695|To assess Safety of trivalent meningococcal polysaccharide vaccine in children|to assess safety of trivalent meningococcal polysaccharide vaccine in children
605663|NCT00994695|To assess the immunogenicity of the trivalent polysaccharide vaccine in children|to assess the immunogenicity of the trivalent polysaccharide vaccine in children
605664|NCT00994682|Additional relevant MeSH terms:|additional relevant mesh terms:
605665|NCT00994682|Hypoglycemic Agents|hypoglycemic agents
605666|NCT00994682|Physiological Effects of Drugs|physiological effects of drugs
605667|NCT00994682|Pharmacologic Actions|pharmacologic actions
605668|NCT00994682|Pioglitazone|pioglitazone
605669|NCT00994656|invasive procedures|invasive procedures
605670|NCT00994656|hypovolemia|hypovolemia
605671|NCT00994643|NHL|nhl
605672|NCT00994643|Non Hodgkin's Lymphoma|non hodgkin's lymphoma
605673|NCT00994643|Lymphoma|lymphoma
605674|NCT00994591|Nicotine|nicotine
605675|NCT00994591|Cotinine|cotinine
605676|NCT00994591|CYP2A6|cyp2a6
605677|NCT00994578|Advanced cancer|advanced cancer
605678|NCT00994565|Physical activity|physical activity
605679|NCT00994565|health behaviour|health behaviour
605680|NCT00994565|lifestyle|lifestyle
605681|NCT00994565|productivity|productivity
605682|NCT00994565|outcomes|outcomes
605683|NCT00994526|Colorectal cancer|colorectal cancer
605684|NCT00994526|Processed meat|processed meat
605685|NCT00994526|Calcium|calcium
605686|NCT00994526|Vitamin E|vitamin e
605687|NCT00994526|Preventive strategies|preventive strategies
605688|NCT00994513|Antioxidant|antioxidant
605689|NCT00994513|Obesity|obesity
605690|NCT00994487|Childhood Obesity|childhood obesity
605691|NCT00994487|Breastfeeding|breastfeeding
605692|NCT00994487|Bottle Feeding|bottle feeding
605693|NCT00994487|Dietary Intake|dietary intake
605694|NCT00994487|Preload|preload
605695|NCT00994487|Compensation|compensation
605696|NCT00994487|Parental Feeding Style|parental feeding style
605697|NCT00994474|Laser surgery|laser surgery
605698|NCT00994474|Profilometry|profilometry
605699|NCT00994474|Fitzpatrick wrinkle score|fitzpatrick wrinkle score
605700|NCT00994474|Patient Benefit Index|patient benefit index
605701|NCT00994474|Patient satisfaction|patient satisfaction
605702|NCT00994461|Endoscopy|endoscopy
605703|NCT00994448|Adolescents|adolescents
605704|NCT00994448|Methamphetamine abuse|methamphetamine abuse
605705|NCT00994448|Bupropion|bupropion
605706|NCT00994448|Addiction|addiction
605707|NCT00994448|Pharmacotherapy|pharmacotherapy
605708|NCT00994448|Cognitive Behavioral Therapy|cognitive behavioral therapy
605709|NCT00994448|Contingency Management|contingency management
605710|NCT00994448|Teens|teens
605711|NCT00994435|obesity|obesity
605712|NCT00994422|PEDICULUS HUMANUS CAPITIS|pediculus humanus capitis
605713|NCT00994422|Head Lice|head lice
605714|NCT00994409|Stroke|stroke
605715|NCT00994370|Pro-angiogenic markers|pro-angiogenic markers
605716|NCT00994370|SIRT|sirt
605717|NCT00994370|hepatic metastases|hepatic metastases
605718|NCT00994357|Real-time Continuous Glucose Monitoring|real-time continuous glucose monitoring
605719|NCT00994357|Macrosomia|macrosomia
605720|NCT00994344|Darunavir|darunavir
605721|NCT00994344|Lopinavir|lopinavir
605722|NCT00994344|Monotherapy|monotherapy
605723|NCT00994344|Antiretroviral simplification strategy|antiretroviral simplification strategy
605724|NCT00994344|HIV|hiv
605725|NCT00994344|Treatment experienced|treatment experienced
605726|NCT00994331|Percutaneous Coronary Intervention|percutaneous coronary intervention
605727|NCT00994331|Magnetic Navigation|magnetic navigation
605728|NCT00994331|Computed Tomography|computed tomography
605729|NCT00994318|Ferinject Iron Deficiency Anaemia Chronic Kidney Disease|ferinject iron deficiency anaemia chronic kidney disease
605730|NCT00994305|kidney transplantation|kidney transplantation
605731|NCT00994305|oxidative stress|oxidative stress
605732|NCT00994305|acetylcysteine|acetylcysteine
605733|NCT00994305|graft rejection|graft rejection
605734|NCT00994292|Factor Xa|factor xa
605735|NCT00994292|Anticoagulant|anticoagulant
605736|NCT00994292|YM150|ym150
605737|NCT00994292|Acute Coronary Syndrome|acute coronary syndrome
605738|NCT00994279|fatigue|fatigue
605739|NCT00994279|depression|depression
605740|NCT00994279|sleep disorders|sleep disorders
605741|NCT00994279|stage IA breast cancer|stage ia breast cancer
605742|NCT00994279|stage IB breast cancer|stage ib breast cancer
605743|NCT00994279|stage II breast cancer|stage ii breast cancer
605744|NCT00994279|stage IIIA breast cancer|stage iiia breast cancer
605745|NCT00994279|stage IIIB breast cancer|stage iiib breast cancer
605746|NCT00994279|stage IIIC breast cancer|stage iiic breast cancer
605747|NCT00994279|recurrent breast cancer|recurrent breast cancer
605748|NCT00994266|Type 2 diabetes|type 2 diabetes
605749|NCT00994266|Diamel|diamel
605750|NCT00994266|Dietary supplement|dietary supplement
605751|NCT00994227|electron microscopy|electron microscopy
605752|NCT00994227|internal limiting membrane|internal limiting membrane
605753|NCT00994227|macular disease|macular disease
605754|NCT00994227|optical coherence tomography|optical coherence tomography
605755|NCT00994188|Renal tumor|renal tumor
605756|NCT00994188|Ureteral tumor|ureteral tumor
605757|NCT00994188|Ureteral stricture|ureteral stricture
605758|NCT00994188|Restored kidney|restored kidney
605759|NCT00994188|Renal transplantation|renal transplantation
605760|NCT00994188|Family members|family members
605761|NCT00994175|Pioglitazone|pioglitazone
605762|NCT00994175|Severe, Refractory Asthma|severe, refractory asthma
605763|NCT00994175|Peroxisome Proliferator-Activated Receptor Gamma|peroxisome proliferator-activated receptor gamma
605764|NCT00994175|Airflow Obstruction|airflow obstruction
605765|NCT00994175|Airway Inflammation|airway inflammation
605766|NCT00994175|Asthma|asthma
605767|NCT00994162|NPWT|npwt
605768|NCT00994162|Gauze-based filler|gauze-based filler
605769|NCT00994162|Acute or Chronic Wounds|acute or chronic wounds
605770|NCT00994162|Efficacy|efficacy
605771|NCT00994149|Infants of Diabetic Mothers|infants of diabetic mothers
605772|NCT00994149|Hypoglycemia|hypoglycemia
605773|NCT00994149|Diazoxide|diazoxide
605774|NCT00994149|Large for Gestation Infants|large for gestation infants
605775|NCT00994136|Catheters, indwelling|catheters, indwelling
605776|NCT00994136|Catheterization, Central Venous|catheterization, central venous
605777|NCT00994136|Withdrawal occlusion|withdrawal occlusion
605778|NCT00994136|Heparin lock|heparin lock
605779|NCT00994123|Non-Small Cell Lung Cancer|non-small cell lung cancer
605780|NCT00994123|NSCLC|nsclc
605781|NCT00994123|Advanced Non-Small Cell Lung Cancer|advanced non-small cell lung cancer
605782|NCT00994123|Metastatic Non-Small Cell Lung Cancer|metastatic non-small cell lung cancer
605783|NCT00994123|Lung Cancer|lung cancer
605784|NCT00994123|Erlotinib|erlotinib
605785|NCT00994123|Tarceva|tarceva
605786|NCT00994123|MM-121|mm-121
605787|NCT00994123|ErbB3|erbb3
605788|NCT00994123|Her3|her3
605789|NCT00994123|Epidermal Growth Factor Receptor|epidermal growth factor receptor
605790|NCT00994123|anti-ErbB3 human monoclonal antibody|anti-erbb3 human monoclonal antibody
605791|NCT00994123|ErbB3 antagonist|erbb3 antagonist
605792|NCT00994110|PANCREAS|pancreas
605793|NCT00994110|Pasireotide|pasireotide
605794|NCT00994110|SOM230|som230
605795|NCT00994110|saline placebo|saline placebo
605796|NCT00994110|09-039|09-039
605797|NCT00994097|NGR-hTNF|ngr-htnf
605798|NCT00994097|Randomized controlled trial|randomized controlled trial
605799|NCT00994097|Gemcitabine|gemcitabine
605800|NCT00994097|Cisplatin|cisplatin
605801|NCT00994097|Pemetrexed|pemetrexed
605802|NCT00994097|Carcinoma, non-small cell lung|carcinoma, non-small cell lung
605803|NCT00994084|Obesity|obesity
605804|NCT00994084|Minority children|minority children
605805|NCT00994084|Community intervention program|community intervention program
605806|NCT00994084|Lifestyle changes|lifestyle changes
605807|NCT00994084|Physical activities|physical activities
605808|NCT00994084|Nutrition lessons|nutrition lessons
605809|NCT00994084|Behavior modification|behavior modification
605810|NCT00994071|Brain Tumor|brain tumor
605811|NCT00994071|CNC Tumor|cnc tumor
605812|NCT00994071|Pediatric|pediatric
605813|NCT00994071|PARP Inhibitor|parp inhibitor
605814|NCT00994071|Oral Chemotherapy|oral chemotherapy
605815|NCT00994058|Preterm Labor|preterm labor
605816|NCT00994058|Uterine Inhibitor|uterine inhibitor
605817|NCT00994058|Electro-Inhibition|electro-inhibition
605818|NCT00994045|Thoraco-Abdominal Aneurysm (TAAA)|thoraco-abdominal aneurysm (taaa)
605819|NCT00994045|Coagulopathy|coagulopathy
605820|NCT00994045|Fresh Frozen Plasma|fresh frozen plasma
605821|NCT00994045|Fibrinogen Concentrate|fibrinogen concentrate
605822|NCT00994032|vertebroplasty|vertebroplasty
605823|NCT00994032|disability evaluation|disability evaluation
605824|NCT00994032|outcome assessment|outcome assessment
605825|NCT00994032|pain measurement|pain measurement
605826|NCT00994019|HPV|hpv
605827|NCT00994019|oral cancer|oral cancer
605828|NCT00994019|young adults|young adults
605829|NCT00994006|Magnesium|magnesium
605830|NCT00994006|nutrition|nutrition
605831|NCT00994006|platelets|platelets
605832|NCT00994006|aggregation|aggregation
605833|NCT00993993|cleft palate|cleft palate
605834|NCT00993980|qigong|qigong
605835|NCT00993980|traditional chinese medicine|traditional chinese medicine
605836|NCT00993980|exercise therapy|exercise therapy
605837|NCT00993980|low back pain|low back pain
605838|NCT00993967|FRDA|frda
605839|NCT00993967|idebenone|idebenone
605840|NCT00993967|FRDA disease|frda disease
605841|NCT00993954|Nurse Treatment|nurse treatment
605842|NCT00993954|Pulled Elbow|pulled elbow
605843|NCT00993941|BMSC|bmsc
605844|NCT00993941|Stem cells|stem cells
605845|NCT00993941|Liver cirrhosis|liver cirrhosis
605846|NCT00993941|Transplantation|transplantation
605847|NCT00993928|psychosocial effects of cancer and its treatment|psychosocial effects of cancer and its treatment
605848|NCT00993928|fatigue|fatigue
605849|NCT00993928|sleep disorders|sleep disorders
605850|NCT00993928|cancer survivor|cancer survivor
605851|NCT00993915|Coronary Artery Disease|coronary artery disease
605852|NCT00993915|Hyperlipidemia|hyperlipidemia
605853|NCT00993915|Atorvastatin|atorvastatin
605854|NCT00993902|Double IUI|double iui
605855|NCT00993902|Intrauterine insemination|intrauterine insemination
605856|NCT00993902|Unexplained infertility|unexplained infertility
605857|NCT00993889|Virtual Reality Peds|virtual reality peds
605858|NCT00993876|Depression|depression
605859|NCT00993876|CREB|creb
605860|NCT00993876|cognitive performance|cognitive performance
605861|NCT00993876|psychotherapy|psychotherapy
605862|NCT00993876|SSRI|ssri
605863|NCT00993876|SNRI|snri
605864|NCT00993863|delta opioid agonist|delta opioid agonist
605865|NCT00993863|dental pain|dental pain
605866|NCT00993850|Bipolar disorder|bipolar disorder
605867|NCT00993850|Insomnia|insomnia
605868|NCT00993850|Sleep disturbance|sleep disturbance
605869|NCT00993850|Cognitive behavioral therapy|cognitive behavioral therapy
605870|NCT00993837|endoscopic thyroidectomy|endoscopic thyroidectomy
605871|NCT00993837|thyroid carcinoma|thyroid carcinoma
605872|NCT00993811|male circumcision|male circumcision
605873|NCT00993811|HIV|hiv
605874|NCT00993811|Africa|africa
605875|NCT00993811|HIV Seronegativity|hiv seronegativity
605876|NCT00993798|Post operative pain|post operative pain
605877|NCT00993798|Local anaesthesia|local anaesthesia
605878|NCT00993798|Postoperative pain after arthroscopic shoulder surgery|postoperative pain after arthroscopic shoulder surgery
605879|NCT00993759|common cold|common cold
605880|NCT00993759|rhinovirus|rhinovirus
605881|NCT00993759|prevention|prevention
605882|NCT00993746|Ultrasound guided infraclavicular brachial plexus block|ultrasound guided infraclavicular brachial plexus block
605883|NCT00993746|Bupivacaine|bupivacaine
605884|NCT00993746|Bupivacaine plus lidocaine|bupivacaine plus lidocaine
605885|NCT00993746|End stage renal disease|end stage renal disease
605886|NCT00993746|Arteriovenous fistula|arteriovenous fistula
605887|NCT00993733|hemodiafiltration|hemodiafiltration
605888|NCT00993733|cost|cost
605889|NCT00993733|dialysis solution|dialysis solution
605890|NCT00993733|acute renal failure|acute renal failure
605891|NCT00993733|intensive care unit|intensive care unit
605892|NCT00993720|patients with type 1 diabetes mellitus|patients with type 1 diabetes mellitus
605893|NCT00993707|Chronic Obstructive Pulmonary Disease (COPD)|chronic obstructive pulmonary disease (copd)
605894|NCT00993694|methemoglobinemia|methemoglobinemia
605895|NCT00993694|aplastic anemia|aplastic anemia
605896|NCT00993694|accelerated phase chronic myelogenous leukemia|accelerated phase chronic myelogenous leukemia
605897|NCT00993694|acute undifferentiated leukemia|acute undifferentiated leukemia
605898|NCT00993694|atypical chronic myeloid leukemia, BCR-ABL negative|atypical chronic myeloid leukemia, bcr-abl negative
605899|NCT00993694|blastic phase chronic myelogenous leukemia|blastic phase chronic myelogenous leukemia
605900|NCT00993694|childhood acute lymphoblastic leukemia in remission|childhood acute lymphoblastic leukemia in remission
605901|NCT00993694|childhood acute myeloid leukemia in remission|childhood acute myeloid leukemia in remission
605902|NCT00993694|childhood chronic myelogenous leukemia|childhood chronic myelogenous leukemia
605903|NCT00993694|chronic myelomonocytic leukemia|chronic myelomonocytic leukemia
605904|NCT00993694|chronic phase chronic myelogenous leukemia|chronic phase chronic myelogenous leukemia
605905|NCT00993694|juvenile myelomonocytic leukemia|juvenile myelomonocytic leukemia
605906|NCT00993694|mast cell leukemia|mast cell leukemia
605907|NCT00993694|meningeal chronic myelogenous leukemia|meningeal chronic myelogenous leukemia
711890|NCT00582686|Calcaneus Fractures|calcaneus fractures
605908|NCT00993694|progressive hairy cell leukemia, initial treatment|progressive hairy cell leukemia, initial treatment
605909|NCT00993694|prolymphocytic leukemia|prolymphocytic leukemia
605910|NCT00993694|recurrent childhood acute lymphoblastic leukemia|recurrent childhood acute lymphoblastic leukemia
605911|NCT00993694|recurrent childhood acute myeloid leukemia|recurrent childhood acute myeloid leukemia
605912|NCT00993694|refractory chronic lymphocytic leukemia|refractory chronic lymphocytic leukemia
605913|NCT00993694|refractory hairy cell leukemia|refractory hairy cell leukemia
605914|NCT00993694|relapsing chronic myelogenous leukemia|relapsing chronic myelogenous leukemia
605915|NCT00993694|secondary acute myeloid leukemia|secondary acute myeloid leukemia
605916|NCT00993694|stage 0 chronic lymphocytic leukemia|stage 0 chronic lymphocytic leukemia
605917|NCT00993694|stage I chronic lymphocytic leukemia|stage i chronic lymphocytic leukemia
605918|NCT00993694|stage II chronic lymphocytic leukemia|stage ii chronic lymphocytic leukemia
605919|NCT00993694|stage III chronic lymphocytic leukemia|stage iii chronic lymphocytic leukemia
605920|NCT00993694|stage IV chronic lymphocytic leukemia|stage iv chronic lymphocytic leukemia
605921|NCT00993694|T-cell large granular lymphocyte leukemia|t-cell large granular lymphocyte leukemia
605922|NCT00993694|AIDS-related diffuse large cell lymphoma|aids-related diffuse large cell lymphoma
605923|NCT00993694|AIDS-related diffuse mixed cell lymphoma|aids-related diffuse mixed cell lymphoma
605924|NCT00993694|AIDS-related diffuse small cleaved cell lymphoma|aids-related diffuse small cleaved cell lymphoma
605925|NCT00993694|AIDS-related immunoblastic large cell lymphoma|aids-related immunoblastic large cell lymphoma
605926|NCT00993694|AIDS-related lymphoblastic lymphoma|aids-related lymphoblastic lymphoma
605927|NCT00993694|AIDS-related peripheral/systemic lymphoma|aids-related peripheral/systemic lymphoma
605928|NCT00993694|AIDS-related primary CNS lymphoma|aids-related primary cns lymphoma
605929|NCT00993694|AIDS-related small noncleaved cell lymphoma|aids-related small noncleaved cell lymphoma
605930|NCT00993694|HIV-associated Hodgkin lymphoma|hiv-associated hodgkin lymphoma
605931|NCT00993694|recurrent/refractory childhood Hodgkin lymphoma|recurrent/refractory childhood hodgkin lymphoma
605932|NCT00993694|stage I childhood Hodgkin lymphoma|stage i childhood hodgkin lymphoma
605933|NCT00993694|stage II childhood Hodgkin lymphoma|stage ii childhood hodgkin lymphoma
605934|NCT00993694|stage IV childhood Hodgkin lymphoma|stage iv childhood hodgkin lymphoma
605935|NCT00993694|anaplastic large cell lymphoma|anaplastic large cell lymphoma
605936|NCT00993694|angioimmunoblastic T-cell lymphoma|angioimmunoblastic t-cell lymphoma
605937|NCT00993694|cutaneous B-cell non-Hodgkin lymphoma|cutaneous b-cell non-hodgkin lymphoma
605938|NCT00993694|recurrent cutaneous T-cell non-Hodgkin lymphoma|recurrent cutaneous t-cell non-hodgkin lymphoma
605939|NCT00993694|stage I cutaneous T-cell non-Hodgkin lymphoma|stage i cutaneous t-cell non-hodgkin lymphoma
605940|NCT00993694|stage II cutaneous T-cell non-Hodgkin lymphoma|stage ii cutaneous t-cell non-hodgkin lymphoma
605941|NCT00993694|stage III cutaneous T-cell non-Hodgkin lymphoma|stage iii cutaneous t-cell non-hodgkin lymphoma
605942|NCT00993694|stage IV cutaneous T-cell non-Hodgkin lymphoma|stage iv cutaneous t-cell non-hodgkin lymphoma
605943|NCT00993694|recurrent mycosis fungoides/Sezary syndrome|recurrent mycosis fungoides/sezary syndrome
605944|NCT00993694|stage I mycosis fungoides/Sezary syndrome|stage i mycosis fungoides/sezary syndrome
605945|NCT00993694|stage II mycosis fungoides/Sezary syndrome|stage ii mycosis fungoides/sezary syndrome
605946|NCT00993694|stage III mycosis fungoides/Sezary syndrome|stage iii mycosis fungoides/sezary syndrome
605947|NCT00993694|stage IV mycosis fungoides/Sezary syndrome|stage iv mycosis fungoides/sezary syndrome
605948|NCT00993694|Waldenstrom macroglobulinemia|waldenstrom macroglobulinemia
605949|NCT00993694|extranodal marginal zone B-cell lymphoma of mucosa-associated lymphoid tissue|extranodal marginal zone b-cell lymphoma of mucosa-associated lymphoid tissue
605950|NCT00993694|nodal marginal zone B-cell lymphoma|nodal marginal zone b-cell lymphoma
605951|NCT00993694|splenic marginal zone lymphoma|splenic marginal zone lymphoma
605952|NCT00993694|contiguous stage II grade 1 follicular lymphoma|contiguous stage ii grade 1 follicular lymphoma
605953|NCT00993694|contiguous stage II grade 2 follicular lymphoma|contiguous stage ii grade 2 follicular lymphoma
605954|NCT00993694|contiguous stage II grade 3 follicular lymphoma|contiguous stage ii grade 3 follicular lymphoma
605955|NCT00993694|contiguous stage II mantle cell lymphoma|contiguous stage ii mantle cell lymphoma
605956|NCT00993694|contiguous stage II marginal zone lymphoma|contiguous stage ii marginal zone lymphoma
605957|NCT00993694|contiguous stage II small lymphocytic lymphoma|contiguous stage ii small lymphocytic lymphoma
605958|NCT00993694|stage I grade 1 follicular lymphoma|stage i grade 1 follicular lymphoma
605959|NCT00993694|stage I grade 2 follicular lymphoma|stage i grade 2 follicular lymphoma
605960|NCT00993694|stage I grade 3 follicular lymphoma|stage i grade 3 follicular lymphoma
605961|NCT00993694|stage I mantle cell lymphoma|stage i mantle cell lymphoma
605962|NCT00993694|stage I marginal zone lymphoma|stage i marginal zone lymphoma
605963|NCT00993694|stage I small lymphocytic lymphoma|stage i small lymphocytic lymphoma
605964|NCT00993694|noncontiguous stage II grade 1 follicular lymphoma|noncontiguous stage ii grade 1 follicular lymphoma
605965|NCT00993694|noncontiguous stage II grade 2 follicular lymphoma|noncontiguous stage ii grade 2 follicular lymphoma
605966|NCT00993694|noncontiguous stage II grade 3 follicular lymphoma|noncontiguous stage ii grade 3 follicular lymphoma
605967|NCT00993694|noncontiguous stage II mantle cell lymphoma|noncontiguous stage ii mantle cell lymphoma
605968|NCT00993694|noncontiguous stage II marginal zone lymphoma|noncontiguous stage ii marginal zone lymphoma
605969|NCT00993694|noncontiguous stage II small lymphocytic lymphoma|noncontiguous stage ii small lymphocytic lymphoma
605970|NCT00993694|stage I childhood large cell lymphoma|stage i childhood large cell lymphoma
605971|NCT00993694|stage I childhood lymphoblastic lymphoma|stage i childhood lymphoblastic lymphoma
605972|NCT00993694|stage I childhood small noncleaved cell lymphoma|stage i childhood small noncleaved cell lymphoma
605973|NCT00993694|stage II childhood large cell lymphoma|stage ii childhood large cell lymphoma
605974|NCT00993694|stage II childhood lymphoblastic lymphoma|stage ii childhood lymphoblastic lymphoma
605975|NCT00993694|stage II childhood small noncleaved cell lymphoma|stage ii childhood small noncleaved cell lymphoma
605976|NCT00993694|stage III childhood large cell lymphoma|stage iii childhood large cell lymphoma
605977|NCT00993694|stage III childhood lymphoblastic lymphoma|stage iii childhood lymphoblastic lymphoma
605978|NCT00993694|stage III childhood small noncleaved cell lymphoma|stage iii childhood small noncleaved cell lymphoma
605979|NCT00993694|stage III grade 1 follicular lymphoma|stage iii grade 1 follicular lymphoma
605980|NCT00993694|stage III grade 2 follicular lymphoma|stage iii grade 2 follicular lymphoma
605981|NCT00993694|stage III grade 3 follicular lymphoma|stage iii grade 3 follicular lymphoma
605982|NCT00993694|stage III mantle cell lymphoma|stage iii mantle cell lymphoma
605983|NCT00993694|stage III marginal zone lymphoma|stage iii marginal zone lymphoma
605984|NCT00993694|stage III small lymphocytic lymphoma|stage iii small lymphocytic lymphoma
605985|NCT00993694|stage IV childhood large cell lymphoma|stage iv childhood large cell lymphoma
605986|NCT00993694|stage IV childhood lymphoblastic lymphoma|stage iv childhood lymphoblastic lymphoma
605987|NCT00993694|stage IV childhood small noncleaved cell lymphoma|stage iv childhood small noncleaved cell lymphoma
605988|NCT00993694|stage IV grade 1 follicular lymphoma|stage iv grade 1 follicular lymphoma
605989|NCT00993694|stage IV grade 2 follicular lymphoma|stage iv grade 2 follicular lymphoma
605990|NCT00993694|stage IV grade 3 follicular lymphoma|stage iv grade 3 follicular lymphoma
605991|NCT00993694|stage IV mantle cell lymphoma|stage iv mantle cell lymphoma
605992|NCT00993694|stage IV marginal zone lymphoma|stage iv marginal zone lymphoma
605993|NCT00993694|stage IV small lymphocytic lymphoma|stage iv small lymphocytic lymphoma
605994|NCT00993694|recurrent childhood grade III lymphomatoid granulomatosis|recurrent childhood grade iii lymphomatoid granulomatosis
605995|NCT00993694|recurrent childhood large cell lymphoma|recurrent childhood large cell lymphoma
605996|NCT00993694|recurrent childhood lymphoblastic lymphoma|recurrent childhood lymphoblastic lymphoma
605997|NCT00993694|recurrent childhood small noncleaved cell lymphoma|recurrent childhood small noncleaved cell lymphoma
605998|NCT00993694|recurrent grade 1 follicular lymphoma|recurrent grade 1 follicular lymphoma
605999|NCT00993694|recurrent grade 2 follicular lymphoma|recurrent grade 2 follicular lymphoma
606000|NCT00993694|recurrent grade 3 follicular lymphoma|recurrent grade 3 follicular lymphoma
606001|NCT00993694|recurrent mantle cell lymphoma|recurrent mantle cell lymphoma
606002|NCT00993694|recurrent marginal zone lymphoma|recurrent marginal zone lymphoma
606003|NCT00993694|recurrent small lymphocytic lymphoma|recurrent small lymphocytic lymphoma
606004|NCT00993694|Burkitt lymphoma|burkitt lymphoma
606005|NCT00993694|childhood diffuse large cell lymphoma|childhood diffuse large cell lymphoma
606006|NCT00993694|childhood grade III lymphomatoid granulomatosis|childhood grade iii lymphomatoid granulomatosis
606007|NCT00993694|childhood immunoblastic large cell lymphoma|childhood immunoblastic large cell lymphoma
606008|NCT00993694|childhood nasal type extranodal NK/T-cell lymphoma|childhood nasal type extranodal nk/t-cell lymphoma
606009|NCT00993694|intraocular lymphoma|intraocular lymphoma
606010|NCT00993694|primary central nervous system non-Hodgkin lymphoma|primary central nervous system non-hodgkin lymphoma
606492|NCT00991731|Faith based|faith based
606011|NCT00993694|post-transplant lymphoproliferative disorder|post-transplant lymphoproliferative disorder
606012|NCT00993694|chronic eosinophilic leukemia|chronic eosinophilic leukemia
606013|NCT00993694|chronic neutrophilic leukemia|chronic neutrophilic leukemia
606014|NCT00993694|primary myelofibrosis|primary myelofibrosis
606015|NCT00993694|essential thrombocythemia|essential thrombocythemia
606016|NCT00993694|polycythemia vera|polycythemia vera
606017|NCT00993694|extramedullary plasmacytoma|extramedullary plasmacytoma
606018|NCT00993694|isolated plasmacytoma of bone|isolated plasmacytoma of bone
606019|NCT00993694|stage I multiple myeloma|stage i multiple myeloma
606020|NCT00993694|stage II multiple myeloma|stage ii multiple myeloma
606021|NCT00993694|stage III multiple myeloma|stage iii multiple myeloma
606022|NCT00993694|primary systemic amyloidosis|primary systemic amyloidosis
606023|NCT00993694|refractory multiple myeloma|refractory multiple myeloma
606024|NCT00993694|de novo myelodysplastic syndromes|de novo myelodysplastic syndromes
606025|NCT00993694|previously treated myelodysplastic syndromes|previously treated myelodysplastic syndromes
606026|NCT00993694|secondary myelodysplastic syndromes|secondary myelodysplastic syndromes
606027|NCT00993694|myelodysplastic/myeloproliferative neoplasm, unclassifiable|myelodysplastic/myeloproliferative neoplasm, unclassifiable
606028|NCT00993694|childhood myelodysplastic syndromes|childhood myelodysplastic syndromes
606029|NCT00993694|recurrent childhood anaplastic large cell lymphoma|recurrent childhood anaplastic large cell lymphoma
606030|NCT00993694|stage I childhood anaplastic large cell lymphoma|stage i childhood anaplastic large cell lymphoma
606031|NCT00993694|stage II childhood anaplastic large cell lymphoma|stage ii childhood anaplastic large cell lymphoma
606032|NCT00993694|stage III childhood anaplastic large cell lymphoma|stage iii childhood anaplastic large cell lymphoma
606033|NCT00993694|stage IV childhood anaplastic large cell lymphoma|stage iv childhood anaplastic large cell lymphoma
606034|NCT00993694|stage III childhood Hodgkin lymphoma|stage iii childhood hodgkin lymphoma
606035|NCT00993681|Prevention of Travelers' Diarrhea|prevention of travelers' diarrhea
606036|NCT00993668|influenza|influenza
606037|NCT00993668|vaccine|vaccine
606038|NCT00993668|pneumococcal vaccine|pneumococcal vaccine
606039|NCT00993668|certolizumab pegol|certolizumab pegol
606040|NCT00993668|Cimzia|cimzia
606041|NCT00993655|peritoneal cavity cancer|peritoneal cavity cancer
606042|NCT00993655|fallopian tube cancer|fallopian tube cancer
606043|NCT00993655|stage II ovarian epithelial cancer|stage ii ovarian epithelial cancer
606044|NCT00993655|stage III ovarian epithelial cancer|stage iii ovarian epithelial cancer
606045|NCT00993655|stage IV ovarian epithelial cancer|stage iv ovarian epithelial cancer
606046|NCT00993655|malignant pleural effusion|malignant pleural effusion
606047|NCT00993655|ovarian clear cell cystadenocarcinoma|ovarian clear cell cystadenocarcinoma
606048|NCT00993655|ovarian clear cell tumor with proliferating activity|ovarian clear cell tumor with proliferating activity
606049|NCT00993642|estrogen receptor positive tamoxifen resistant breast cancer|estrogen receptor positive tamoxifen resistant breast cancer
606050|NCT00993629|PTSD|ptsd
606051|NCT00993629|Depression|depression
606052|NCT00993629|Neurosteroids|neurosteroids
606053|NCT00993603|Lifestyle|lifestyle
606054|NCT00993603|Diabetes Mellitus|diabetes mellitus
606055|NCT00993603|prevention/onset delay.|prevention/onset delay.
606056|NCT00993590|Persistent asthma|persistent asthma
606057|NCT00993590|Asthma related emergency room visits|asthma related emergency room visits
606058|NCT00993590|Asthma control, adolescents|asthma control, adolescents
606059|NCT00993590|Adherence, asthma control medications|adherence, asthma control medications
606060|NCT00993577|Stretching|stretching
606061|NCT00993577|Pain|pain
606062|NCT00993551|cleft palate|cleft palate
606063|NCT00993551|paediatric|paediatric
606064|NCT00993551|pediatric|pediatric
606065|NCT00993551|surgery|surgery
606066|NCT00993551|speech|speech
606067|NCT00993551|velopharyngeal|velopharyngeal
606068|NCT00993538|Leukaemia|leukaemia
606069|NCT00993538|Blood and marrow cells culture|blood and marrow cells culture
606070|NCT00993538|Cell growth|cell growth
606071|NCT00993538|Cell differentiation|cell differentiation
606072|NCT00993525|diabetic retinopathy|diabetic retinopathy
606073|NCT00993525|ranibizumab|ranibizumab
606074|NCT00993525|new vessels|new vessels
606075|NCT00993525|intravitreal injection|intravitreal injection
606076|NCT00993525|Persistent retina new vessels|persistent retina new vessels
606077|NCT00993512|photochemical internalisation|photochemical internalisation
606078|NCT00993512|photosensitiser|photosensitiser
606079|NCT00993512|cutaneous tumour|cutaneous tumour
606080|NCT00993512|sub-cutaneous tumour|sub-cutaneous tumour
606081|NCT00993512|dose escalation|dose escalation
606082|NCT00993486|Haploidentical stem cell transplantation|haploidentical stem cell transplantation
606083|NCT00993486|Graft-versus-host disease|graft-versus-host disease
606084|NCT00993486|Immune reconstitution|immune reconstitution
606085|NCT00993486|Alloreactive T-cells|alloreactive t-cells
606086|NCT00993486|Photodepletion|photodepletion
606087|NCT00993486|TH9402|th9402
606088|NCT00993486|Transplant related mortality|transplant related mortality
606089|NCT00993486|Hematologic malignancy|hematologic malignancy
606090|NCT00993460|Obesity|obesity
606091|NCT00993460|Insulin sensitivity|insulin sensitivity
606092|NCT00993460|Inflammation|inflammation
606093|NCT00993447|Dengue|dengue
606594|NCT00991406|Hemiplegia|hemiplegia
606094|NCT00993447|Dengue hemorrhagic fever|dengue hemorrhagic fever
606095|NCT00993447|Dengue virus|dengue virus
606096|NCT00993447|Dengue fever|dengue fever
606097|NCT00993447|Sanofi pasteur's CYD Dengue vaccine|sanofi pasteur's cyd dengue vaccine
606098|NCT00993434|Child|child
606099|NCT00993395|addiction|addiction
606100|NCT00993395|peer mentor|peer mentor
606101|NCT00993395|adherence|adherence
606102|NCT00993369|Prediction of neuro developmental delay|prediction of neuro developmental delay
606103|NCT00993356|Acromegaly|acromegaly
606104|NCT00993356|Macroadenomas|macroadenomas
606105|NCT00993356|Lanreotide|lanreotide
606106|NCT00993356|Transsphenoidal neurosurgery|transsphenoidal neurosurgery
606107|NCT00993356|Preoperative|preoperative
606108|NCT00993343|GVHD|gvhd
606109|NCT00993343|tacrolimus|tacrolimus
606110|NCT00993343|sirolimus|sirolimus
606111|NCT00993343|cyclosporine|cyclosporine
606112|NCT00993343|allogeneic|allogeneic
606113|NCT00993343|stem cell transplantation|stem cell transplantation
606114|NCT00993343|Relapse-free survival|relapse-free survival
606115|NCT00993330|macular pigment|macular pigment
606116|NCT00993330|to measure macular pigment in the retina|to measure macular pigment in the retina
606117|NCT00993317|CDP870|cdp870
606118|NCT00993317|Korea|korea
606119|NCT00993317|CIMZIA|cimzia
606120|NCT00993291|Parkinson's Disease|parkinson's disease
606121|NCT00993291|DBS|dbs
606122|NCT00993291|Frequency|frequency
606123|NCT00993291|Deep brain stimulation|deep brain stimulation
606124|NCT00993265|Trichotillomania|trichotillomania
606125|NCT00993265|Hair pulling|hair pulling
606126|NCT00993265|glutamate|glutamate
606127|NCT00993265|N-Acetylcysteine|n-acetylcysteine
606128|NCT00993265|Children|children
606129|NCT00993252|head injury|head injury
606130|NCT00993252|radiography|radiography
606131|NCT00993252|clinical impact|clinical impact
606132|NCT00993252|dissemination|dissemination
606133|NCT00993226|Postoperative pain|postoperative pain
606134|NCT00993226|Local anaesthesia|local anaesthesia
606135|NCT00993226|Postoperative pain after open abdominal hysterectomy surgery|postoperative pain after open abdominal hysterectomy surgery
606136|NCT00993213|fat mass|fat mass
606137|NCT00993213|body composition|body composition
606138|NCT00993200|Warfarin|warfarin
606139|NCT00993200|Pharmacogenetic|pharmacogenetic
606140|NCT00993161|Neuromuscular disorders|neuromuscular disorders
606141|NCT00993161|Evaluation|evaluation
606142|NCT00993161|Strength|strength
606143|NCT00993161|Upper limb|upper limb
606144|NCT00993148|Treatment naive|treatment naive
606145|NCT00993135|renal toxicity|renal toxicity
606146|NCT00993135|childhood acute lymphoblastic leukemia|childhood acute lymphoblastic leukemia
606147|NCT00993135|adult acute lymphoblastic leukemia|adult acute lymphoblastic leukemia
606148|NCT00993122|pre treatment|pre treatment
606149|NCT00993122|therapy compliance|therapy compliance
606150|NCT00993122|SVR|svr
606151|NCT00993122|sustained virological response|sustained virological response
606152|NCT00993122|TH1 TH2 ratio|th1 th2 ratio
606153|NCT00993109|Nifedipine GITS/OROS (Adalat®)|nifedipine gits/oros (adalat®)
606154|NCT00993109|Valsartan (Diovan®)|valsartan (diovan®)
606155|NCT00993109|Hypertension|hypertension
606156|NCT00993083|Influenza|influenza
606157|NCT00993083|Vaccine|vaccine
606158|NCT00993070|capsaicin|capsaicin
606159|NCT00993070|placebo|placebo
606160|NCT00993070|trial|trial
606161|NCT00993070|diabetic polyneuropathy|diabetic polyneuropathy
606162|NCT00993070|neuropathic pain|neuropathic pain
606163|NCT00993057|Euglycemia|euglycemia
606164|NCT00993057|craniotomy|craniotomy
606165|NCT00993057|neurosurgery|neurosurgery
606166|NCT00993057|hypoglycemia|hypoglycemia
606167|NCT00993057|insulin|insulin
606168|NCT00993031|HIV|hiv
606169|NCT00993031|Placental Malaria|placental malaria
606170|NCT00993031|Pregnancy|pregnancy
606171|NCT00993031|Uganda|uganda
606172|NCT00993031|Protease inhibitors|protease inhibitors
606173|NCT00993031|Trimethoprim-sulfamethoxazole|trimethoprim-sulfamethoxazole
606174|NCT00993031|Treatment experienced|treatment experienced
606175|NCT00993018|Diabetic Neuropathy|diabetic neuropathy
606176|NCT00993018|Diabetic painful neuropathy|diabetic painful neuropathy
606177|NCT00993018|JNJ-42160443|jnj-42160443
606178|NCT00993018|Neuropathic pain|neuropathic pain
606179|NCT00993018|Pain|pain
606180|NCT00993018|Pharmacokinetics|pharmacokinetics
606181|NCT00993005|Hypertrophic scars|hypertrophic scars
606182|NCT00993005|Keloids|keloids
606183|NCT00993005|Asian Gotu Kola|asian gotu kola
606184|NCT00993005|Asian Pennywort|asian pennywort
606185|NCT00992992|Cyclophosphamide, Doxorubicin, Vincristine, and Prednisone (CHOP)|cyclophosphamide, doxorubicin, vincristine, and prednisone (chop)
606186|NCT00992992|Tositumomab|tositumomab
606187|NCT00992992|Tositumomab and Iodine I-131 tostumomab|tositumomab and iodine i-131 tostumomab
606188|NCT00992992|Bexxar|bexxar
606189|NCT00992992|Iodine-131 Anti-B1 Antibody|iodine-131 anti-b1 antibody
606190|NCT00992992|Mantle Cell|mantle cell
606191|NCT00992992|radioimmunotherapy|radioimmunotherapy
606192|NCT00992979|Addiction|addiction
606193|NCT00992979|Anxiety|anxiety
606194|NCT00992979|Withdrawal|withdrawal
606195|NCT00992979|Psychoactive Drugs|psychoactive drugs
606196|NCT00992979|Therapeutic Massage|therapeutic massage
606197|NCT00992966|to acquire database of pneumonia cases in children|to acquire database of pneumonia cases in children
606198|NCT00992953|Virtual Reality|virtual reality
606199|NCT00992953|Post Traumatic Stress Disorder|post traumatic stress disorder
606200|NCT00992953|Combat|combat
606201|NCT00992953|Military|military
606202|NCT00992953|Major Depressive Disorder|major depressive disorder
606203|NCT00992953|Anxiety|anxiety
606204|NCT00992953|Virtual Reality Exposure with Stimulus Control|virtual reality exposure with stimulus control
606205|NCT00992953|Treatment as Usual|treatment as usual
606206|NCT00992940|awake craniotomy|awake craniotomy
606207|NCT00992940|patient-controlled sedation analgesia|patient-controlled sedation analgesia
606208|NCT00992940|anesthetist-controlled sedation analgesia|anesthetist-controlled sedation analgesia
606209|NCT00992940|remifentanil-propofol|remifentanil-propofol
606210|NCT00992940|tumour surgery|tumour surgery
606211|NCT00992927|Injections, Intra-Articular|injections, intra-articular
606212|NCT00992927|Range of Motion, Articular|range of motion, articular
606213|NCT00992927|Pain|pain
606214|NCT00992914|Hot flushes (vasomotor symptoms)|hot flushes (vasomotor symptoms)
606215|NCT00992901|gastric bypass surgery|gastric bypass surgery
606216|NCT00992901|glucose tolerance|glucose tolerance
606217|NCT00992901|Insulin response to meal ingestion|insulin response to meal ingestion
606218|NCT00992901|Gut hormone and neural response to meal ingestion|gut hormone and neural response to meal ingestion
606219|NCT00992888|Alcoholic Hepatitis|alcoholic hepatitis
606220|NCT00992888|Alcohol|alcohol
606221|NCT00992888|Endotoxin|endotoxin
606222|NCT00992888|LPS|lps
606223|NCT00992888|Liver dialysis|liver dialysis
606224|NCT00992888|Innate immunity|innate immunity
606225|NCT00992888|Toll Like receptors|toll like receptors
606226|NCT00992875|Healthy but stressed individuals|healthy but stressed individuals
606227|NCT00992849|Corneal neovascularization|corneal neovascularization
606228|NCT00992849|bevacizumab|bevacizumab
606229|NCT00992836|Influenza A Virus, H1N1 Subtype|influenza a virus, h1n1 subtype
606230|NCT00992836|Vaccine|vaccine
606231|NCT00992836|Children|children
606232|NCT00992836|Adolescents|adolescents
606233|NCT00992836|HIV-Infected|hiv-infected
606234|NCT00992836|Perinatal HIV Infection|perinatal hiv infection
606235|NCT00992836|Treatment experienced|treatment experienced
606236|NCT00992823|Iron|iron
606237|NCT00992823|anemia|anemia
606238|NCT00992823|supplementation|supplementation
606239|NCT00992823|preschoolers|preschoolers
606240|NCT00992823|prevalence|prevalence
606241|NCT00992823|preschoolers children from public day care centers|preschoolers children from public day care centers
606242|NCT00992810|upper limb|upper limb
606243|NCT00992810|hand|hand
606244|NCT00992810|arm|arm
606245|NCT00992810|surgery|surgery
606246|NCT00992810|supraclavicular nerve block|supraclavicular nerve block
606247|NCT00992810|brachial plexus nerve block|brachial plexus nerve block
606248|NCT00992810|ultrasound-guided regional anesthesia|ultrasound-guided regional anesthesia
606249|NCT00992797|Insulin resistance|insulin resistance
606250|NCT00992797|Insulin secretory dysfunction|insulin secretory dysfunction
606251|NCT00992797|Inflammation|inflammation
606252|NCT00992797|Vascular stiffness|vascular stiffness
606253|NCT00992784|Influenza Vaccines|influenza vaccines
606254|NCT00992784|GSK Bio's influenza vaccine GSK2186877A|gsk bio's influenza vaccine gsk2186877a
606255|NCT00992784|influenza infection|influenza infection
606256|NCT00992758|bone marrow|bone marrow
606257|NCT00992758|Radioimmunotherapy|radioimmunotherapy
606258|NCT00992758|non-Hodgkin's lymphoma|non-hodgkin's lymphoma
606259|NCT00992758|Bexxar|bexxar
606260|NCT00992758|anti-B1 antibody|anti-b1 antibody
606261|NCT00992758|tositumomab and iodine I-131 tositumomab|tositumomab and iodine i-131 tositumomab
606262|NCT00992758|NHL|nhl
606263|NCT00992758|tositumomab|tositumomab
606264|NCT00992745|prostate cancer|prostate cancer
606265|NCT00992745|imaging|imaging
606266|NCT00992745|metastases|metastases
606267|NCT00992745|PSMA|psma
606268|NCT00992745|ProstaScint®|prostascint®
606269|NCT00992719|H1N1, influenza A viruses, vaccine, pregnant women|h1n1, influenza a viruses, vaccine, pregnant women
606270|NCT00992706|palmar-plantar erythrodysesthesia|palmar-plantar erythrodysesthesia
606271|NCT00992706|stage IV breast cancer|stage iv breast cancer
606272|NCT00992706|male breast cancer|male breast cancer
606273|NCT00992693|Crimean-Congo Hemorrhagic Fever|crimean-congo hemorrhagic fever
606274|NCT00992693|Lassa Fever|lassa fever
606275|NCT00992693|CCHF|cchf
606276|NCT00992693|LF|lf
606277|NCT00992693|Viral Hemorrhagic Fever|viral hemorrhagic fever
606278|NCT00992693|VHF|vhf
606279|NCT00992693|Ribavirin|ribavirin
606280|NCT00992680|Lung Disease|lung disease
606281|NCT00992680|Chronic Airflow Obstruction|chronic airflow obstruction
606282|NCT00992680|Chronic Bronchitis|chronic bronchitis
606283|NCT00992680|Pulmonary Emphysema|pulmonary emphysema
606284|NCT00992680|Walk|walk
606285|NCT00992667|apocynin|apocynin
606286|NCT00992667|asthma|asthma
606287|NCT00992654|Open Label Access Program|open label access program
606288|NCT00992654|Treatment experienced|treatment experienced
606289|NCT00992641|Systems biology|systems biology
606290|NCT00992641|Nutrition|nutrition
606291|NCT00992641|Nordic diet|nordic diet
606292|NCT00992641|Dietary recommendations|dietary recommendations
606293|NCT00992641|Metabolic syndrome|metabolic syndrome
606294|NCT00992641|Features of metabolic syndrome|features of metabolic syndrome
606295|NCT00992628|GlideScope Video Laryngoscope|glidescope video laryngoscope
606296|NCT00992628|Macintosh Direct Laryngoscope|macintosh direct laryngoscope
606297|NCT00992628|Intubation|intubation
606298|NCT00992628|Applied Forces|applied forces
606299|NCT00992628|Elective surgery where endotracheal intubation required|elective surgery where endotracheal intubation required
606300|NCT00992589|Gastroesophageal Reflux|gastroesophageal reflux
606301|NCT00992589|Gastroesophageal Reflux Disease|gastroesophageal reflux disease
606302|NCT00992589|GERD|gerd
606303|NCT00992589|Proton Pump Inhibitor|proton pump inhibitor
606304|NCT00992589|PPI|ppi
606305|NCT00992589|Regurgitation|regurgitation
606306|NCT00992589|Infants|infants
606307|NCT00992589|AcipHex, PARIET|aciphex, pariet
606308|NCT00992589|ALFENCE|alfence
606309|NCT00992576|Confirmatory|confirmatory
606310|NCT00992576|Constipation|constipation
606311|NCT00992576|Pain|pain
606312|NCT00992576|Hydromorphone|hydromorphone
606313|NCT00992576|Naloxone|naloxone
606314|NCT00992563|wet age-related macular degeneration, exudative|wet age-related macular degeneration, exudative
606315|NCT00992550|hookah|hookah
606316|NCT00992550|cigarette|cigarette
606317|NCT00992550|smoking|smoking
606318|NCT00992524|Misoprostol|misoprostol
606319|NCT00992524|Labor, Obstetric|labor, obstetric
606320|NCT00992524|Labor, Induced|labor, induced
606321|NCT00992511|influenza infection|influenza infection
606322|NCT00992511|GSK Bio's influenza vaccine GSK2340272A|gsk bio's influenza vaccine gsk2340272a
606323|NCT00992498|COPD (Chronic Obstructive Pulmonary Disease)|copd (chronic obstructive pulmonary disease)
606324|NCT00992498|outpatients|outpatients
606325|NCT00992498|rehabilitation|rehabilitation
606326|NCT00992498|comorbidities|comorbidities
606327|NCT00992498|patient-centered outcome|patient-centered outcome
606328|NCT00992459|Urea Cycle Disorder (UCD)|urea cycle disorder (ucd)
606330|NCT00992459|hyperammonemia|hyperammonemia
606331|NCT00992459|Buphenyl (NaPBA)|buphenyl (napba)
606332|NCT00992459|glycerol phenylbutyrate (GPB)|glycerol phenylbutyrate (gpb)
606333|NCT00992459|Sodium Phenylbutyrate (NaPBA)|sodium phenylbutyrate (napba)
606334|NCT00992446|Autologous stem cell transplant|autologous stem cell transplant
606335|NCT00992446|NHL|nhl
606336|NCT00992446|maintenance therapy|maintenance therapy
606337|NCT00992433|influenza, H1N1, vaccine, human immunodeficiency virus|influenza, h1n1, vaccine, human immunodeficiency virus
606338|NCT00992420|thienopyridine|thienopyridine
606339|NCT00992420|platelets|platelets
606340|NCT00992420|CYP2C19|cyp2c19
606341|NCT00992420|clopidogrel|clopidogrel
606342|NCT00992420|platelet function tests|platelet function tests
606343|NCT00992420|platelet|platelet
606344|NCT00992420|genes|genes
606345|NCT00992420|cytochrome P450|cytochrome p450
606346|NCT00992420|single nucleotide polymorphisms|single nucleotide polymorphisms
606347|NCT00992420|Platelet Aggregation Inhibitors|platelet aggregation inhibitors
606348|NCT00992407|Schizophrenia|schizophrenia
606349|NCT00992407|Risperidone|risperidone
606350|NCT00992407|Risperdal|risperdal
606351|NCT00992394|Plaque psoriasis - etanercept - response maintenance|plaque psoriasis - etanercept - response maintenance
606352|NCT00992381|GI Pain|gi pain
606353|NCT00992381|healthy participants|healthy participants
606354|NCT00992381|Safety|safety
606355|NCT00992381|bioavailability|bioavailability
606356|NCT00992368|Quality-Adjusted Life Years:A measurement index|quality-adjusted life years:a measurement index
606357|NCT00992368|Cost-Benefit Analysis:A method of comparing costs|cost-benefit analysis:a method of comparing costs
606358|NCT00992368|Mammaplasty|mammaplasty
606359|NCT00992368|QALY|qaly
606360|NCT00992368|Health-related quality of life|health-related quality of life
606361|NCT00992368|Cost-effectiveness|cost-effectiveness
606362|NCT00992368|Breast|breast
606363|NCT00992355|Cataract|cataract
606364|NCT00992355|Phacoemulsification|phacoemulsification
606365|NCT00992355|Treatment duration|treatment duration
606366|NCT00992329|ciprofloxacin|ciprofloxacin
606367|NCT00992329|pharmacokinetics|pharmacokinetics
606368|NCT00992329|formulation|formulation
606369|NCT00992316|Inflammatory pain|inflammatory pain
606370|NCT00992303|unspecified adult solid tumor, protocol specific|unspecified adult solid tumor, protocol specific
606371|NCT00992290|cirrhosis|cirrhosis
606372|NCT00992290|hepatic encephalopathy|hepatic encephalopathy
606373|NCT00992290|complications|complications
606374|NCT00992290|probiotic|probiotic
606375|NCT00992290|lactobacillus GG|lactobacillus gg
606376|NCT00992264|Cigarette Smoking|cigarette smoking
606377|NCT00992264|Health Behavior|health behavior
606378|NCT00992264|Intervention Studies|intervention studies
606379|NCT00992264|Personal Communication|personal communication
606380|NCT00992251|prostate cancer|prostate cancer
606381|NCT00992225|Metastatic|metastatic
606382|NCT00992212|Pandemic influenza|pandemic influenza
606383|NCT00992212|vaccine|vaccine
606384|NCT00992199|intraperitoneal chemotherapy|intraperitoneal chemotherapy
606385|NCT00992199|cisplatin|cisplatin
606386|NCT00992199|fluorouracil|fluorouracil
606387|NCT00992199|advanced gastric cancer|advanced gastric cancer
606595|NCT00991406|walking|walking
606388|NCT00992186|Prostate cancer|prostate cancer
606389|NCT00992186|Infusion|infusion
606390|NCT00992186|Carlumab|carlumab
606391|NCT00992186|CNTO 888|cnto 888
606392|NCT00992173|Neuroblastoma|neuroblastoma
606393|NCT00992173|MIBG|mibg
606394|NCT00992173|Iobenguane|iobenguane
606395|NCT00992160|Polysomnography (PSG)|polysomnography (psg)
606396|NCT00992160|Adults|adults
606397|NCT00992160|Primary Insomnia|primary insomnia
606398|NCT00992134|Lymphoma, Mantle-Cell|lymphoma, mantle-cell
606399|NCT00992134|Bendamustine|bendamustine
606400|NCT00992134|Cytarabine|cytarabine
606401|NCT00992134|Rituximab|rituximab
606402|NCT00992134|Treatment|treatment
606403|NCT00992134|Combination chemotherapy|combination chemotherapy
606404|NCT00992121|pazopanib|pazopanib
606405|NCT00992121|Renal Cell Carcinoma|renal cell carcinoma
606406|NCT00992121|Kidney|kidney
606407|NCT00992121|cancer|cancer
606408|NCT00992121|bevacizumab|bevacizumab
606409|NCT00992108|Bruxism|bruxism
606410|NCT00992108|Myofascial pain|myofascial pain
606411|NCT00992108|EMG|emg
606412|NCT00992108|Ultrasound|ultrasound
710878|NCT00587457|Chronic Lymphocytic Leukemia|chronic lymphocytic leukemia
606413|NCT00992108|Masticatory myofascial face pain from bruxism and clenching|masticatory myofascial face pain from bruxism and clenching
606414|NCT00992082|Postoperative pain|postoperative pain
606415|NCT00992082|Local Infiltration Analgesia|local infiltration analgesia
606416|NCT00992082|Knee arthroplasty|knee arthroplasty
606417|NCT00992069|ARV|arv
606418|NCT00992069|Pharmacokinetics|pharmacokinetics
606419|NCT00992069|TMC207|tmc207
606420|NCT00992069|Efavirenz|efavirenz
606421|NCT00992043|creatine supplementation|creatine supplementation
606422|NCT00992043|exercise training|exercise training
606423|NCT00992017|Vaccine|vaccine
606424|NCT00992017|Pregnant|pregnant
606425|NCT00992017|Perinatal|perinatal
606426|NCT00992004|Osteoarthritis, Knee|osteoarthritis, knee
606427|NCT00992004|Osteoarthritis|osteoarthritis
606428|NCT00992004|Joint Diseases|joint diseases
606429|NCT00992004|Arthritis|arthritis
606430|NCT00992004|Rheumatic Diseases|rheumatic diseases
606431|NCT00991991|stage I melanoma|stage i melanoma
606432|NCT00991991|stage II melanoma|stage ii melanoma
606433|NCT00991991|stage III melanoma|stage iii melanoma
606434|NCT00991978|breast cancer|breast cancer
606435|NCT00991978|VEGF|vegf
606436|NCT00991978|Screening|screening
606437|NCT00991965|Alveolar Ridge Augmentation|alveolar ridge augmentation
606438|NCT00991965|Dental Implantation, Endosseous|dental implantation, endosseous
606439|NCT00991965|Osseointegration|osseointegration
606440|NCT00991965|Bone Morphogenetic Proteins|bone morphogenetic proteins
606441|NCT00991939|Immune thrombocytopenic purpura|immune thrombocytopenic purpura
606443|NCT00991939|Dexamethasone|dexamethasone
606444|NCT00991939|Prednisone|prednisone
606445|NCT00991926|obesity|obesity
606446|NCT00991926|GH/IGF-1 axis|gh/igf-1 axis
606447|NCT00991926|postprandial NEFA|postprandial nefa
606448|NCT00991913|Delirium|delirium
606449|NCT00991913|Postoperative|postoperative
606450|NCT00991913|Non-cardiovascular surgery|non-cardiovascular surgery
606451|NCT00991913|Post-anaesthesia care unit|post-anaesthesia care unit
606452|NCT00991887|Heterotopic Ossification|heterotopic ossification
606453|NCT00991887|Distal humerus Fracture-dislocations of the elbow|distal humerus fracture-dislocations of the elbow
606454|NCT00991887|Radiation Therapy|radiation therapy
606455|NCT00991874|Nitric oxide|nitric oxide
606456|NCT00991874|Asthma|asthma
606457|NCT00991874|Longitudinal studies|longitudinal studies
606458|NCT00991874|Child|child
606459|NCT00991861|Actinic Keratosis|actinic keratosis
606460|NCT00991861|AK|ak
606461|NCT00991861|NMSC|nmsc
606462|NCT00991848|Lidocaine;|lidocaine;
606463|NCT00991848|Fibromyalgia|fibromyalgia
606464|NCT00991848|signs|signs
606465|NCT00991848|symptoms|symptoms
606466|NCT00991822|open angle glaucoma|open angle glaucoma
606467|NCT00991822|timolol|timolol
606468|NCT00991822|dorzolamide|dorzolamide
606469|NCT00991809|opioid induced hyperalgesia|opioid induced hyperalgesia
606470|NCT00991783|Fimasartan|fimasartan
606471|NCT00991783|Drug interaction|drug interaction
606472|NCT00991770|Discomfort|discomfort
606473|NCT00991770|Port-a-Catheters|port-a-catheters
606474|NCT00991770|Complementary and Alternative Medicine|complementary and alternative medicine
606475|NCT00991770|Massage|massage
606476|NCT00991757|RWJ-333369|rwj-333369
606477|NCT00991757|Anticonvulsants|anticonvulsants
606478|NCT00991757|Antiepileptic drugs|antiepileptic drugs
606479|NCT00991757|Epilepsy, Focal|epilepsy, focal
606480|NCT00991757|Seizure Disorder|seizure disorder
606481|NCT00991744|Leukemia|leukemia
606482|NCT00991744|Central nervous system|central nervous system
606483|NCT00991744|Neurotoxicity|neurotoxicity
606484|NCT00991744|Liposomal cytarabine|liposomal cytarabine
606485|NCT00991744|Children|children
606486|NCT00991744|Acute lymphoblastic leukemia|acute lymphoblastic leukemia
606487|NCT00991744|Childhood acute lymphoblastic leukemia|childhood acute lymphoblastic leukemia
606488|NCT00991744|Intrathecal|intrathecal
606489|NCT00991744|Efficacy|efficacy
606490|NCT00991744|Safety|safety
606491|NCT00991731|Physical Activity|physical activity
606493|NCT00991731|Non faith based|non faith based
606494|NCT00991731|African American|african american
606496|NCT00991731|Pedometers|pedometers
606497|NCT00991718|GDC0449|gdc0449
606498|NCT00991705|Fimasartan, Atorvastatin|fimasartan, atorvastatin
606499|NCT00991692|Pediatric CI Therapy|pediatric ci therapy
606500|NCT00991692|ACQUIREc Therapy|acquirec therapy
606501|NCT00991692|Dosage|dosage
606502|NCT00991692|Occupational Therapy|occupational therapy
606503|NCT00991692|Physical Therapy|physical therapy
606504|NCT00991692|Cerebral Palsy|cerebral palsy
606505|NCT00991692|Hemiparesis|hemiparesis
606506|NCT00991679|Dry eye syndrome|dry eye syndrome
606507|NCT00991679|CXCL9 chemokine|cxcl9 chemokine
606508|NCT00991679|CXCL10 chemokine|cxcl10 chemokine
606509|NCT00991679|CXCL11 chemokine|cxcl11 chemokine
606510|NCT00991679|CXCR3 receptor|cxcr3 receptor
606511|NCT00991666|AMD|amd
606512|NCT00991666|rigidity|rigidity
606513|NCT00991666|pulsatile ocular blood flow|pulsatile ocular blood flow
606514|NCT00991666|Physiology of the eye|physiology of the eye
606515|NCT00991653|Weight|weight
606516|NCT00991653|Breast|breast
606517|NCT00991653|Cancer|cancer
606518|NCT00991627|Ephedrine|ephedrine
606519|NCT00991627|Adrenergic Agents|adrenergic agents
606520|NCT00991627|Central Nervous System Stimulants|central nervous system stimulants
606521|NCT00991627|Sympathomimetics|sympathomimetics
606522|NCT00991627|Vasoconstrictor Agents|vasoconstrictor agents
606523|NCT00991627|Bupivacaine|bupivacaine
606524|NCT00991627|Anesthetics, Local|anesthetics, local
606525|NCT00991627|Atropine|atropine
606526|NCT00991627|Adjuvants, Anesthesia|adjuvants, anesthesia
606527|NCT00991627|Anti-Arrhythmia Agents|anti-arrhythmia agents
606528|NCT00991627|Bronchodilator Agents|bronchodilator agents
606529|NCT00991627|Muscarinic Antagonists|muscarinic antagonists
606530|NCT00991627|Mydriatics|mydriatics
606531|NCT00991627|Parasympatholytics|parasympatholytics
606532|NCT00991627|Morphine|morphine
606533|NCT00991627|Analgesics, Opioid|analgesics, opioid
606534|NCT00991627|Narcotics|narcotics
606535|NCT00991627|Ringer's Lactate|ringer's lactate
606536|NCT00991627|Isotonic Solutions|isotonic solutions
606537|NCT00991627|Hypotension|hypotension
606538|NCT00991627|Blood pressure|blood pressure
606539|NCT00991627|Signs and Symptoms|signs and symptoms
606540|NCT00991627|Pregnancy|pregnancy
606541|NCT00991627|Anesthesia, Obstetrical|anesthesia, obstetrical
606542|NCT00991627|Inferior Vena Cava|inferior vena cava
606543|NCT00991601|liver|liver
606544|NCT00991601|pancreas|pancreas
606545|NCT00991601|cancer|cancer
606546|NCT00991601|tumor|tumor
606547|NCT00991601|FNAC|fnac
606548|NCT00991588|PCL|pcl
606549|NCT00991588|Posterolateral|posterolateral
606550|NCT00991575|Diabetes mellitus, type1|diabetes mellitus, type1
606551|NCT00991575|cardiovascular disease|cardiovascular disease
606552|NCT00991575|diabetes complications|diabetes complications
606553|NCT00991575|Glycation end products, advanced|glycation end products, advanced
606554|NCT00991562|relapsed or relapsed/refractory multiple myeloma|relapsed or relapsed/refractory multiple myeloma
606555|NCT00991549|overweight|overweight
606556|NCT00991549|obesity|obesity
606557|NCT00991549|glucose intolerance|glucose intolerance
606558|NCT00991549|pre-diabetes|pre-diabetes
606559|NCT00991523|resistance|resistance
606560|NCT00991523|exercise|exercise
606561|NCT00991523|protein|protein
606562|NCT00991523|recovery|recovery
606563|NCT00991510|renal transplantation|renal transplantation
606564|NCT00991510|mycophenolate mofetil|mycophenolate mofetil
606565|NCT00991510|pharmacokinetics|pharmacokinetics
606566|NCT00991510|immunosuppression|immunosuppression
606567|NCT00991497|varicose veins|varicose veins
606568|NCT00991497|foam sclerotherapy|foam sclerotherapy
606569|NCT00991497|compression bandaging|compression bandaging
606570|NCT00991497|duration|duration
606571|NCT00991484|ventral|ventral
606572|NCT00991484|inguinal|inguinal
606573|NCT00991484|hernia|hernia
606574|NCT00991484|inheritance|inheritance
606575|NCT00991484|genetics|genetics
606576|NCT00991471|Emergency Department Wait Times|emergency department wait times
606577|NCT00991471|Physician Nurse at Triage|physician nurse at triage
606578|NCT00991471|Overcrowding|overcrowding
606579|NCT00991471|CostEffectiveness|costeffectiveness
606580|NCT00991445|Unicompartmental knee arthroplasty|unicompartmental knee arthroplasty
606581|NCT00991445|Surgical exposure|surgical exposure
606582|NCT00991445|Minimal invasive surgery|minimal invasive surgery
606583|NCT00991445|Local Infiltration Analgesia|local infiltration analgesia
606584|NCT00991445|Knee Arthroplasty|knee arthroplasty
606585|NCT00991432|Alveolar Ridge Augmentation|alveolar ridge augmentation
606586|NCT00991432|Dental Implantation, Endosseous|dental implantation, endosseous
606587|NCT00991432|Osseointegration|osseointegration
606588|NCT00991432|Space Maintenance|space maintenance
606589|NCT00991432|Bone Morphogenetic Proteins|bone morphogenetic proteins
606590|NCT00991419|PET|pet
606591|NCT00991419|Alzheimer's disease|alzheimer's disease
606592|NCT00991419|diagnostic|diagnostic
606593|NCT00991406|Electric Stimulation|electric stimulation
606596|NCT00991393|Maxillary Sinus Augmentation|maxillary sinus augmentation
606597|NCT00991393|Dental Implantation|dental implantation
606598|NCT00991393|Osseointegration|osseointegration
606599|NCT00991393|Bone Morphogenetic Proteins|bone morphogenetic proteins
606600|NCT00991367|Post-surgical scars|post-surgical scars
606601|NCT00991367|Asian Gotu Kola|asian gotu kola
606602|NCT00991367|Asian Pennywort|asian pennywort
606603|NCT00991354|HIV Seronegativity|hiv seronegativity
606604|NCT00991354|HIV Preventive Vaccine|hiv preventive vaccine
606605|NCT00991341|Cardiac surgery|cardiac surgery
606606|NCT00991341|Red blood cell|red blood cell
606607|NCT00991341|Transfusion|transfusion
606608|NCT00991328|PD|pd
606609|NCT00991328|POCD|pocd
606610|NCT00991328|Post-op Delirium (PD)|post-op delirium (pd)
606611|NCT00991328|Post-op Cognitive Dysfunction (POCD)|post-op cognitive dysfunction (pocd)
606612|NCT00991315|prostate cancer|prostate cancer
606613|NCT00991302|Adherence|adherence
606614|NCT00991302|Behavioral Intervention|behavioral intervention
606615|NCT00991302|Antiretroviral Therapy|antiretroviral therapy
606616|NCT00991302|ART|art
606617|NCT00991302|Highly Active Antiretroviral Therapy|highly active antiretroviral therapy
606618|NCT00991302|HAART|haart
606619|NCT00991302|Treatment experienced|treatment experienced
606620|NCT00991289|Hepatitis C genotype 1|hepatitis c genotype 1
606621|NCT00991289|HCV treatment naive|hcv treatment naive
606622|NCT00991289|HCV/HIV coinfection|hcv/hiv coinfection
606623|NCT00991289|Antiretroviral|antiretroviral
606624|NCT00991289|Ribavirin|ribavirin
606625|NCT00991289|Pegylated Interferon alfa|pegylated interferon alfa
606626|NCT00991289|Nitazoxanide|nitazoxanide
606627|NCT00991276|restless legs syndrome RLS polysomnography PSG sleep disturbance patient reported outcome|restless legs syndrome rls polysomnography psg sleep disturbance patient reported outcome
606628|NCT00991263|stage II breast cancer|stage ii breast cancer
606629|NCT00991263|stage IIIA breast cancer|stage iiia breast cancer
606630|NCT00991250|Malignant melanoma|malignant melanoma
606631|NCT00991237|NRS|nrs
606632|NCT00991237|GPE|gpe
606633|NCT00991237|pain reduction|pain reduction
606634|NCT00991237|quality of life|quality of life
606635|NCT00991224|HIV|hiv
606636|NCT00991224|HIV therapeutic vaccine|hiv therapeutic vaccine
606637|NCT00991211|Comparison|comparison
606638|NCT00991211|Bendamustine + Rituximab|bendamustine + rituximab
606639|NCT00991211|CHOP + Rituximab|chop + rituximab
606640|NCT00991211|Progression free survival|progression free survival
606641|NCT00991211|Overall survival|overall survival
606642|NCT00991211|Toxicity|toxicity
606643|NCT00991211|Safety|safety
606644|NCT00991198|Topically dissolved oxygen|topically dissolved oxygen
606645|NCT00991198|inflammatory cutaneous disease|inflammatory cutaneous disease
606646|NCT00991198|rosacea|rosacea
606647|NCT00991198|acne vulgaris|acne vulgaris
606648|NCT00991198|atopic dermatitis|atopic dermatitis
606649|NCT00991198|seborrheic dermatitis|seborrheic dermatitis
606650|NCT00991198|photodamage|photodamage
606651|NCT00991185|Infections in Children|infections in children
606652|NCT00991172|sciatica|sciatica
606653|NCT00991172|sciatic pain|sciatic pain
606654|NCT00991172|pain|pain
606655|NCT00991172|back pain|back pain
606656|NCT00991159|Endocrinology; Hypercholesterolemia; Hyperlipidemia; Lipid Metabolism Disorders RN316 PF-04950615|endocrinology; hypercholesterolemia; hyperlipidemia; lipid metabolism disorders rn316 pf-04950615
606657|NCT00991146|CAPS|caps
606658|NCT00991146|FCAS|fcas
606659|NCT00991146|MWS|mws
606660|NCT00991146|NOMID|nomid
606661|NCT00991146|cryopyrin-associated periodic syndromes|cryopyrin-associated periodic syndromes
606662|NCT00991146|Familial Cold Autoinflammatory Syndrome|familial cold autoinflammatory syndrome
606663|NCT00991146|Muckle-Wells Syndrome|muckle-wells syndrome
606664|NCT00991146|Neonatal Onset Multisystem Inflammatory Disease|neonatal onset multisystem inflammatory disease
606665|NCT00991146|canakinumab|canakinumab
606666|NCT00991146|ACZ885|acz885
606667|NCT00991146|children|children
606668|NCT00991146|systemic autoinflammatory disease|systemic autoinflammatory disease
606669|NCT00991146|NALP-3|nalp-3
606670|NCT00991146|human monoclonal anti-human interleukin-1beta (IL-1beta)antibody|human monoclonal anti-human interleukin-1beta (il-1beta)antibody
606671|NCT00991146|autosomal dominant|autosomal dominant
606672|NCT00991146|familial autoinflammatory syndrome|familial autoinflammatory syndrome
606673|NCT00991107|phase I|phase i
606674|NCT00991107|safety|safety
606675|NCT00991107|tolerance|tolerance
606676|NCT00991107|insulin resistance|insulin resistance
606677|NCT00991107|obese|obese
606678|NCT00991094|Proton Therapy|proton therapy
606679|NCT00991094|Proton Therapy Treatment Plan|proton therapy treatment plan
606680|NCT00991094|Proton Dose Distributions|proton dose distributions
606681|NCT00991094|Side Effects|side effects
606682|NCT00991094|Symptoms|symptoms
606683|NCT00991094|Normal Tissue Toxicity|normal tissue toxicity
606684|NCT00991094|Dose Response Relationship|dose response relationship
606685|NCT00991081|pharmacogenetics|pharmacogenetics
606686|NCT00991081|genetic counseling|genetic counseling
606687|NCT00991081|genetic feedback|genetic feedback
606688|NCT00991081|nicotine replacement|nicotine replacement
606689|NCT00991081|bupropion|bupropion
606690|NCT00991081|smoking cessation|smoking cessation
606691|NCT00991081|primary care|primary care
606692|NCT00991081|telehealth|telehealth
606693|NCT00991081|motivational interviewing|motivational interviewing
606695|NCT00991068|Mild to moderate Carpal Tunnel Syndrome|mild to moderate carpal tunnel syndrome
606696|NCT00991042|Cytokines|cytokines
606697|NCT00991042|Low back pain|low back pain
606698|NCT00991042|Intervertebral disk displacement|intervertebral disk displacement
606699|NCT00991042|Interleukins|interleukins
606700|NCT00991042|Tumor necrosis factor-alpha|tumor necrosis factor-alpha
606701|NCT00991029|Transient Ischemic Attack|transient ischemic attack
606702|NCT00991029|TIA|tia
606703|NCT00991029|minor stroke|minor stroke
606704|NCT00991003|Colon Capsule Endoscopy|colon capsule endoscopy
606705|NCT00991003|Colorectal Cancer|colorectal cancer
606706|NCT00991003|Colonoscopy|colonoscopy
606707|NCT00990990|Safety tolerability pharmacokinetics (PK) pharmacodynamics whole blood activity (WBA) PNU-100480 linezolid pyrazinamide multiple dose|safety tolerability pharmacokinetics (pk) pharmacodynamics whole blood activity (wba) pnu-100480 linezolid pyrazinamide multiple dose
606708|NCT00990977|breast cancer|breast cancer
606709|NCT00990977|supportive care|supportive care
606710|NCT00990977|post-treatment|post-treatment
606711|NCT00990977|intervention|intervention
606712|NCT00990977|MBSR|mbsr
606713|NCT00990977|mindfulness|mindfulness
606714|NCT00990977|anxiety|anxiety
606715|NCT00990977|depression|depression
606716|NCT00990977|lifestyle|lifestyle
606717|NCT00990977|diet|diet
606718|NCT00990977|alcohol consumption|alcohol consumption
606719|NCT00990977|smoking|smoking
606720|NCT00990977|exercise|exercise
606721|NCT00990977|spirituality|spirituality
606722|NCT00990977|existential well-being|existential well-being
606723|NCT00990977|physical symptoms|physical symptoms
606724|NCT00990977|women|women
606725|NCT00990925|Obesity|obesity
606726|NCT00990925|Schizophrenia|schizophrenia
606727|NCT00990925|Schizoaffective disorder|schizoaffective disorder
606728|NCT00990925|weight loss|weight loss
606729|NCT00990899|hypertension|hypertension
606730|NCT00990899|obstructive sleep apnea|obstructive sleep apnea
606731|NCT00990899|pediatrics|pediatrics
606732|NCT00990886|Oxybutynin|oxybutynin
606733|NCT00990886|Ditropan|ditropan
606734|NCT00990886|Menopause Treatment|menopause treatment
606735|NCT00990886|Vasomotor symptoms|vasomotor symptoms
606736|NCT00990886|Hot Flashes|hot flashes
606737|NCT00990886|Non-hormonal therapy for Vasomotor symptoms|non-hormonal therapy for vasomotor symptoms
606738|NCT00990873|stage I non-small cell lung cancer|stage i non-small cell lung cancer
606739|NCT00990860|Combination of TACE With Sorafenib|combination of tace with sorafenib
606740|NCT00990834|Statin|statin
606741|NCT00990834|Myopathy|myopathy
606742|NCT00990834|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors
606743|NCT00990834|Atrogin-1|atrogin-1
606744|NCT00990795|open heart surgery|open heart surgery
606745|NCT00990795|cyclosporine|cyclosporine
606746|NCT00990795|myocardial protection|myocardial protection
606747|NCT00990769|Emergence delirium|emergence delirium
606748|NCT00990769|Bispectral Index|bispectral index
606749|NCT00990769|Depth of anesthesia|depth of anesthesia
606750|NCT00990743|Ocular hypertension|ocular hypertension
606751|NCT00990743|Glaucoma|glaucoma
606752|NCT00990743|Beta-blocker|beta-blocker
606753|NCT00990730|rheumatoid arthritis|rheumatoid arthritis
606754|NCT00990730|endothelial dysfunction|endothelial dysfunction
606755|NCT00990730|lipoproteins|lipoproteins
606756|NCT00990730|inflammation|inflammation
606757|NCT00990730|oxidative stress|oxidative stress
606758|NCT00990730|arterial stiffness|arterial stiffness
606759|NCT00990717|natural killer cells|natural killer cells
606760|NCT00990717|leukemia|leukemia
606761|NCT00990717|lymphoma|lymphoma
606762|NCT00990717|myeloma|myeloma
606763|NCT00990717|Hodgkin's disease|hodgkin's disease
606764|NCT00990717|cell therapy|cell therapy
606765|NCT00990704|Secondary hyperparathyroidism|secondary hyperparathyroidism
606766|NCT00990704|Hemodialysis|hemodialysis
606767|NCT00990704|paricalcitol|paricalcitol
606768|NCT00990704|maxacalcitol|maxacalcitol
606769|NCT00990691|Rett syndrome|rett syndrome
606770|NCT00990678|HIV-1|hiv-1
606771|NCT00990678|humans|humans
606772|NCT00990678|vitamin D|vitamin d
606773|NCT00990678|1-hydroxy-vitamin D|1-hydroxy-vitamin d
606774|NCT00990678|Rocaltrol|rocaltrol
606775|NCT00990678|calcium|calcium
606776|NCT00990678|complementary therapies|complementary therapies
606777|NCT00990665|CRT|crt
606778|NCT00990665|Heart Failure|heart failure
606779|NCT00990665|LV Leads|lv leads
606780|NCT00990652|brain tumor|brain tumor
606781|NCT00990639|hepatic fibrosis|hepatic fibrosis
606782|NCT00990639|angiotensin II blocking agents|angiotensin ii blocking agents
606783|NCT00990639|alcoholic liver disease|alcoholic liver disease
606784|NCT00990626|Seroquel XR|seroquel xr
606785|NCT00990626|schizophrenia relapse prevention|schizophrenia relapse prevention
606786|NCT00990613|percutaneous transcutaneous dimebon transdermal pharmacokinetics|percutaneous transcutaneous dimebon transdermal pharmacokinetics
606787|NCT00990600|adherence|adherence
606788|NCT00990600|Qol|qol
606789|NCT00990600|virologic efficacy|virologic efficacy
606790|NCT00990600|immunologic efficacy|immunologic efficacy
606791|NCT00990600|patients' preference|patients' preference
606792|NCT00990600|once-daily|once-daily
606793|NCT00990600|HAART|haart
606794|NCT00990600|treatment experienced|treatment experienced
606795|NCT00990587|relapsed and refractory hematologic malignancy|relapsed and refractory hematologic malignancy
606796|NCT00990587|ALL (acute lymphoid leukemia)|all (acute lymphoid leukemia)
606797|NCT00990587|CLL (chronic lymphoid leukemia)|cll (chronic lymphoid leukemia)
606798|NCT00990587|High risk myelodysplasia (MDS) with an IPSS (International Prognostic Scoring System) score >2.5|high risk myelodysplasia (mds) with an ipss (international prognostic scoring system) score >2.5
606799|NCT00990587|CML (chronic myelogenous leukemia) blast crisis|cml (chronic myelogenous leukemia) blast crisis
606800|NCT00990587|Relapsed or refractory acute myeloid leukemia (AML)|relapsed or refractory acute myeloid leukemia (aml)
606801|NCT00990548|Cardiac Caregivers|cardiac caregivers
606802|NCT00990548|Cardiac Patient Clinical Outcomes|cardiac patient clinical outcomes
606803|NCT00990548|Prevention of CVD|prevention of cvd
606804|NCT00990535|neuroendocrine tumors|neuroendocrine tumors
606805|NCT00990535|octreotide|octreotide
606806|NCT00990535|somatostatin analogues|somatostatin analogues
606807|NCT00990522|sharp debridment|sharp debridment
606808|NCT00990522|patients with full thickness wounds of greater than 30 days duration|patients with full thickness wounds of greater than 30 days duration
606809|NCT00990509|Primary ICH|primary ich
606810|NCT00990509|Albumin|albumin
606811|NCT00990509|MRI|mri
606812|NCT00990509|Neuroimaging outcome|neuroimaging outcome
606813|NCT00990509|Placebo-controlled|placebo-controlled
606814|NCT00990509|Phase II|phase ii
606815|NCT00990509|Blinded|blinded
606816|NCT00990509|Safety|safety
606817|NCT00990509|Acute ICH|acute ich
606818|NCT00990509|ICH|ich
606819|NCT00990509|Primary acute (< 48 hours) supratentorial ICH|primary acute (< 48 hours) supratentorial ich
606820|NCT00990496|Glioblastoma multiforme|glioblastoma multiforme
606821|NCT00990496|GBM|gbm
606822|NCT00990496|Cytomegalovirus|cytomegalovirus
606823|NCT00990496|CMV|cmv
606824|NCT00990496|Cytotoxic T lymphocyte|cytotoxic t lymphocyte
606825|NCT00990496|CTL|ctl
606826|NCT00990470|Transplantation|transplantation
606827|NCT00990470|Liver|liver
606828|NCT00990470|Endoscopy|endoscopy
606829|NCT00990470|Colonoscopy|colonoscopy
606830|NCT00990470|Gastroscopy|gastroscopy
606831|NCT00990457|Exercise|exercise
606832|NCT00990457|Weight loss diet|weight loss diet
606833|NCT00990457|Obesity|obesity
606834|NCT00990457|Overweight|overweight
606835|NCT00990457|Abdominal obesity|abdominal obesity
606836|NCT00990457|Cardiovascular function|cardiovascular function
606837|NCT00990457|Body composition|body composition
606838|NCT00990444|blood glucose|blood glucose
606839|NCT00990444|blood insulin|blood insulin
606840|NCT00990444|dextran|dextran
606841|NCT00990444|diabetes|diabetes
606842|NCT00990444|hyperglycemia|hyperglycemia
606843|NCT00990444|hypoglycemia|hypoglycemia
606844|NCT00990444|oral delivery|oral delivery
606845|NCT00990444|portal delivery|portal delivery
606846|NCT00990431|skin aging|skin aging
606847|NCT00990431|laser surgery|laser surgery
606848|NCT00990431|fractional photothermolysis|fractional photothermolysis
606849|NCT00990431|comparative study|comparative study
606850|NCT00990431|Ablative fractional treatment of peri-orbital rhytides|ablative fractional treatment of peri-orbital rhytides
606851|NCT00990418|Postoperative pain|postoperative pain
606852|NCT00990418|E-TRANS System, fentanyl HCl System|e-trans system, fentanyl hcl system
606853|NCT00990418|E-TRANSS (fentanyl HCl) System|e-transs (fentanyl hcl) system
606854|NCT00990418|Acute postoperative pain|acute postoperative pain
606855|NCT00990405|Rome III criteria|rome iii criteria
606856|NCT00990392|Blood stream infections|blood stream infections
606857|NCT00990392|Catheter related infections|catheter related infections
606858|NCT00990392|Central venous catheter related infections|central venous catheter related infections
606859|NCT00990392|Line sepsis|line sepsis
606860|NCT00990392|Topical antibiotics|topical antibiotics
606861|NCT00990392|Bacitracin|bacitracin
606862|NCT00990392|Polymixin|polymixin
606863|NCT00990392|Gramicidin|gramicidin
606864|NCT00990392|Polysporin Triple Therapy|polysporin triple therapy
606865|NCT00990392|Intensive care unit|intensive care unit
606866|NCT00990379|HIV|hiv
606867|NCT00990379|brain diseases|brain diseases
606868|NCT00990379|spinal fluid|spinal fluid
606869|NCT00990379|HIV positive|hiv positive
606870|NCT00990366|antireflux valve|antireflux valve
606871|NCT00990366|biliary obstruction|biliary obstruction
606872|NCT00990366|cholangitis|cholangitis
606873|NCT00990366|biliary stent|biliary stent
606874|NCT00990353|Spatial neglect|spatial neglect
606875|NCT00990353|hemineglect|hemineglect
606876|NCT00990353|stroke|stroke
606877|NCT00990353|cognition|cognition
606878|NCT00990353|prism adaptation|prism adaptation
606879|NCT00990353|Hierarchical linear modeling|hierarchical linear modeling
606880|NCT00990353|growth curve modeling|growth curve modeling
606881|NCT00990327|Coronary artery disease|coronary artery disease
606882|NCT00990327|Myocardial Perfusion Imaging|myocardial perfusion imaging
606883|NCT00990301|Healthy Subjects|healthy subjects
606884|NCT00990301|Bioequivalence|bioequivalence
606885|NCT00990288|To decrease blood loss during knee surgery|to decrease blood loss during knee surgery
606886|NCT00990262|acute chest pain|acute chest pain
606887|NCT00990262|emergency department|emergency department
606888|NCT00990262|cardiac computed tomography|cardiac computed tomography
606889|NCT00990249|Acute Lymphoblastic Leukemia|acute lymphoblastic leukemia
606890|NCT00990249|ALL|all
606891|NCT00990249|Acute lymphoblastic lymphoma|acute lymphoblastic lymphoma
606892|NCT00990249|acute biphenotypic leukemia|acute biphenotypic leukemia
606893|NCT00990249|Allogeneic hematopoietic cell transplantation|allogeneic hematopoietic cell transplantation
606894|NCT00990249|HCT|hct
606895|NCT00990249|Stem Cell Transplant|stem cell transplant
606896|NCT00990249|Treatment-related mortality|treatment-related mortality
606897|NCT00990249|Tyrosine kinase inhibitors|tyrosine kinase inhibitors
606898|NCT00990249|TKI|tki
606899|NCT00990249|Busulfan|busulfan
606900|NCT00990249|Busulfex|busulfex
606901|NCT00990249|Myleran|myleran
606902|NCT00990249|Clofarabine|clofarabine
606903|NCT00990249|Clolar|clolar
606904|NCT00990249|Clofarex|clofarex
606905|NCT00990249|Gleevec|gleevec
606906|NCT00990249|Imatinib Mesylate|imatinib mesylate
606907|NCT00990236|deep vein thrombosis|deep vein thrombosis
606908|NCT00990236|superficial venous thrombosis|superficial venous thrombosis
606909|NCT00990236|pulmonary embolus|pulmonary embolus
606910|NCT00990223|Eplerenone Aldosterone and Plasma Renin Activity responses Pharmacodynamics|eplerenone aldosterone and plasma renin activity responses pharmacodynamics
606911|NCT00990197|Pilot study|pilot study
606912|NCT00990197|Randomized clinical trial|randomized clinical trial
606913|NCT00990197|Smoking cessation|smoking cessation
606914|NCT00990197|Acute coronary syndrome|acute coronary syndrome
606915|NCT00990197|Transdermal nicotine patch|transdermal nicotine patch
606916|NCT00990184|Impaired Fasting Glucose|impaired fasting glucose
606917|NCT00990184|PreDiabetes|prediabetes
606918|NCT00990171|peritoneal Dialysis|peritoneal dialysis
606919|NCT00990171|wasting and malnutrition|wasting and malnutrition
606920|NCT00990171|nutrition status|nutrition status
606921|NCT00990171|bioelectrical impedance analysis|bioelectrical impedance analysis
606922|NCT00990171|body composition|body composition
606923|NCT00990158|Vitamin K1 (phytonadione)|vitamin k1 (phytonadione)
606924|NCT00990158|Randomized controlled trial|randomized controlled trial
606925|NCT00990158|Warfarin|warfarin
606926|NCT00990158|Coagulopathy|coagulopathy
606927|NCT00990158|Time in therapeutic range|time in therapeutic range
606928|NCT00990158|Bleeding|bleeding
606929|NCT00990158|Thrombosis|thrombosis
606930|NCT00990158|VKORC1 and CYP2C9 genotypes|vkorc1 and cyp2c9 genotypes
606931|NCT00990158|Time INR in therapeutic range|time inr in therapeutic range
606932|NCT00990132|COPD|copd
606933|NCT00990132|Respiratory failure|respiratory failure
606934|NCT00990132|Non-invasive ventilation|non-invasive ventilation
606935|NCT00990132|Home mechanical ventilation|home mechanical ventilation
606936|NCT00990119|high flow therapy|high flow therapy
606937|NCT00990119|high flow nasal cannula|high flow nasal cannula
606938|NCT00990119|chronic obstructive pulmonary disease|chronic obstructive pulmonary disease
606939|NCT00990119|respiratory insufficiency|respiratory insufficiency
606940|NCT00990106|posttraumatic stress disorder|posttraumatic stress disorder
606941|NCT00990106|PTSD|ptsd
606942|NCT00990106|nightmares|nightmares
606943|NCT00990106|prazosin|prazosin
606944|NCT00990106|sleep disturbance|sleep disturbance
606945|NCT00990106|combat trauma|combat trauma
606946|NCT00990067|MDMA|mdma
606947|NCT00990067|serotonin|serotonin
606948|NCT00990067|norepinephrine|norepinephrine
606949|NCT00990067|Ecstasy|ecstasy
606950|NCT00990067|stimulant|stimulant
606951|NCT00990054|Cytarabine,|cytarabine,
606952|NCT00990054|Daunorubicin,|daunorubicin,
606953|NCT00990054|De Novo,|de novo,
606954|NCT00990054|Acute Myeloid Leukemia,|acute myeloid leukemia,
606955|NCT00990054|AML|aml
606956|NCT00990041|periodontitis|periodontitis
606957|NCT00990041|find cytokines in blood of periodontal patients|find cytokines in blood of periodontal patients
606958|NCT00990028|moderate head injury|moderate head injury
606959|NCT00990028|rosuvastatin|rosuvastatin
606960|NCT00990028|statin|statin
606961|NCT00990028|amnesia|amnesia
606962|NCT00990028|orientation|orientation
606963|NCT00990015|Safety; tolerability; pharmacokinetics/pharmacodynamics|safety; tolerability; pharmacokinetics/pharmacodynamics
606964|NCT00989989|DME|dme
606965|NCT00989989|Diabetic|diabetic
606966|NCT00989989|macula|macula
606967|NCT00989989|edema|edema
606968|NCT00989989|ranibizumab|ranibizumab
606969|NCT00989989|REVEAL|reveal
606970|NCT00989976|Sleep|sleep
606971|NCT00989976|Diabetes Risk|diabetes risk
606972|NCT00989963|PAH|pah
606973|NCT00989950|daytrana|daytrana
606974|NCT00989950|sleep latency|sleep latency
606975|NCT00989950|adhd rating scales|adhd rating scales
606976|NCT00989950|ADHD|adhd
606977|NCT00989937|oxytocin|oxytocin
606978|NCT00989924|Diabetes mellitus|diabetes mellitus
606979|NCT00989924|Coronary heart disease|coronary heart disease
606980|NCT00989924|Magnetocardiography|magnetocardiography
607179|NCT00989131|Ovarian Cancer|ovarian cancer
606981|NCT00989911|Single ventricle congenital heart disease|single ventricle congenital heart disease
606982|NCT00989898|T1D, closed-loop systems, overnight hypoglycaemia|t1d, closed-loop systems, overnight hypoglycaemia
606983|NCT00989885|Evaluation|evaluation
606984|NCT00989885|Obstructive sleep apnea|obstructive sleep apnea
606985|NCT00989885|Polysomnography|polysomnography
606986|NCT00989872|Macrolides|macrolides
606987|NCT00989872|Antibiotics|antibiotics
606988|NCT00989872|Safety|safety
606989|NCT00989872|Tolerability|tolerability
606990|NCT00989872|Pharmacokinetics|pharmacokinetics
606991|NCT00989872|Phase I|phase i
606992|NCT00989872|MRSA/SSTI|mrsa/ssti
606993|NCT00989859|monitoring|monitoring
606994|NCT00989846|biomarker|biomarker
606995|NCT00989846|lung disease|lung disease
606996|NCT00989833|Exercise induced asthma|exercise induced asthma
606997|NCT00989833|Mild intermittent asthma|mild intermittent asthma
606998|NCT00989833|Exercise induced bronchoconstriction|exercise induced bronchoconstriction
606999|NCT00989820|osteoradionecrosis|osteoradionecrosis
607000|NCT00989820|mandible|mandible
607001|NCT00989820|radiotherapy|radiotherapy
607002|NCT00989820|hyperbaric oxygen therapy|hyperbaric oxygen therapy
607003|NCT00989807|CF|cf
607004|NCT00989807|Cystic fibrosis|cystic fibrosis
607005|NCT00989807|Pseudomonas aeruginosa|pseudomonas aeruginosa
607006|NCT00989807|EAP|eap
607007|NCT00989807|Expanded access|expanded access
607008|NCT00989807|AZLI|azli
607009|NCT00989807|Aztreonam lysine|aztreonam lysine
607010|NCT00989794|cartilage|cartilage
607011|NCT00989794|implantation|implantation
607012|NCT00989794|chondrocyte|chondrocyte
607013|NCT00989794|condyle|condyle
607014|NCT00989781|PCOS, Androgens, ovary, polycystic|pcos, androgens, ovary, polycystic
607015|NCT00989768|Botulinum toxin type A|botulinum toxin type a
607016|NCT00989768|field effects|field effects
607017|NCT00989768|dose-equivalence|dose-equivalence
607018|NCT00989768|anhydrotic action halos|anhydrotic action halos
607019|NCT00989755|Tobacco dependence treatment in primary health care setting|tobacco dependence treatment in primary health care setting
607020|NCT00989755|Fax to Quit|fax to quit
607021|NCT00989755|Fax to Quit plus Enhanced Academic Detailing|fax to quit plus enhanced academic detailing
607022|NCT00989755|Fax referral|fax referral
607023|NCT00989755|Quitline|quitline
607024|NCT00989742|lymphangioleiomatosis|lymphangioleiomatosis
607025|NCT00989742|LAM|lam
607026|NCT00989742|tuberous sclerosis|tuberous sclerosis
607027|NCT00989742|doxycycline|doxycycline
607028|NCT00989742|matrix metalloproteinases|matrix metalloproteinases
607029|NCT00989742|MMP|mmp
607030|NCT00989729|Endovascular Aortic Repair|endovascular aortic repair
607031|NCT00989729|Methylprednisolone|methylprednisolone
607032|NCT00989729|Systemic inflammatory response syndrome|systemic inflammatory response syndrome
607033|NCT00989703|Safety|safety
607034|NCT00989703|Tolerability|tolerability
607035|NCT00989703|Pharmacokinetics|pharmacokinetics
607036|NCT00989690|recurrent non-small cell lung cancer|recurrent non-small cell lung cancer
607037|NCT00989690|stage IIIB non-small cell lung cancer|stage iiib non-small cell lung cancer
607038|NCT00989690|stage IV non-small cell lung cancer|stage iv non-small cell lung cancer
607039|NCT00989664|non-Hodgkin's Lymphoma|non-hodgkin's lymphoma
607040|NCT00989664|radioimmunotherapy|radioimmunotherapy
607041|NCT00989664|NHL|nhl
607042|NCT00989664|Bexxar|bexxar
607043|NCT00989664|lymphoma|lymphoma
607044|NCT00989664|Tositumomab|tositumomab
607045|NCT00989625|migraine|migraine
607046|NCT00989625|single dose|single dose
607047|NCT00989625|healthy volunteer|healthy volunteer
607048|NCT00989625|adolescence|adolescence
607049|NCT00989625|pharmacokinetics|pharmacokinetics
607050|NCT00989612|influenza infection|influenza infection
607051|NCT00989612|GSK Biologicals' influenza vaccine GSK2340272A|gsk biologicals' influenza vaccine gsk2340272a
607052|NCT00989599|phlebitis|phlebitis
607053|NCT00989599|Chamomilla recutita|chamomilla recutita
607054|NCT00989599|Catheterization peripheral|catheterization peripheral
607055|NCT00989586|recurrent mantle cell lymphoma|recurrent mantle cell lymphoma
607056|NCT00989586|recurrent grade 1 follicular lymphoma|recurrent grade 1 follicular lymphoma
607057|NCT00989586|recurrent grade 2 follicular lymphoma|recurrent grade 2 follicular lymphoma
607058|NCT00989586|recurrent grade 3 follicular lymphoma|recurrent grade 3 follicular lymphoma
607059|NCT00989586|MALT lymphoma|malt lymphoma
607060|NCT00989586|nodal marginal zone B-cell lymphoma|nodal marginal zone b-cell lymphoma
607061|NCT00989586|splenic marginal zone lymphoma|splenic marginal zone lymphoma
607062|NCT00989586|recurrent marginal zone lymphoma|recurrent marginal zone lymphoma
607063|NCT00989586|Waldenstrom macroglobulinemia|waldenstrom macroglobulinemia
607064|NCT00989534|shift work|shift work
607065|NCT00989534|diabetes|diabetes
607066|NCT00989534|Affects of shift work and sleep loss on health|affects of shift work and sleep loss on health
607067|NCT00989521|Asthma|asthma
607068|NCT00989521|bronchial diseases|bronchial diseases
607069|NCT00989521|lung diseases|lung diseases
607070|NCT00989521|bronchitis|bronchitis
607071|NCT00989521|respiratory tract diseases|respiratory tract diseases
607072|NCT00989508|Perhexiline|perhexiline
607073|NCT00989508|Aortic Valve Stenosis|aortic valve stenosis
607074|NCT00989508|Hypertrophy, Left Ventricular|hypertrophy, left ventricular
607075|NCT00989508|Myocardial Reperfusion Injury|myocardial reperfusion injury
607076|NCT00989508|Cardiac Output, Low|cardiac output, low
607077|NCT00989508|Troponin|troponin
607078|NCT00989495|AIS|ais
607079|NCT00989456|chronic obstructive pulmonary disease|chronic obstructive pulmonary disease
607080|NCT00989456|Heart failure|heart failure
607081|NCT00989456|Stroke|stroke
607082|NCT00989456|quality of life|quality of life
607083|NCT00989456|self management education|self management education
607084|NCT00989456|physical exercise|physical exercise
607085|NCT00989456|primary health care|primary health care
607086|NCT00989443|Cervix Intraepithelial Neoplasia grades 2 and 3|cervix intraepithelial neoplasia grades 2 and 3
607087|NCT00989430|stroke|stroke
607088|NCT00989430|CVA|cva
607089|NCT00989430|cerebrovascular accident|cerebrovascular accident
607090|NCT00989430|rehabilitation|rehabilitation
607091|NCT00989417|Remote monitoring|remote monitoring
607092|NCT00989417|Defibrillators, Implantable|defibrillators, implantable
607093|NCT00989417|Home monitoring|home monitoring
607094|NCT00989417|Shock|shock
607095|NCT00989417|Implantable cardioverter-defibrillator Therapy|implantable cardioverter-defibrillator therapy
607096|NCT00989404|pk|pk
607097|NCT00989404|healthy subjects|healthy subjects
607098|NCT00989404|influenza virus|influenza virus
607099|NCT00989404|Safety|safety
607100|NCT00989404|pandemic|pandemic
607101|NCT00989391|Phase 1 multiple dose safety toleration pharmacokinetic|phase 1 multiple dose safety toleration pharmacokinetic
607102|NCT00989378|sleep|sleep
607103|NCT00989378|insulin|insulin
607104|NCT00989378|diabetes|diabetes
607105|NCT00989378|determine association between sleep characteristics and diabetes risk|determine association between sleep characteristics and diabetes risk
607106|NCT00989365|Aerobic Exercise|aerobic exercise
607107|NCT00989365|Exercise|exercise
607108|NCT00989352|PCNSL|pcnsl
607109|NCT00989352|Lymphoma|lymphoma
607110|NCT00989352|Methotrexate|methotrexate
607111|NCT00989352|Lomustine|lomustine
607112|NCT00989352|Procarbazine|procarbazine
607113|NCT00989352|Rituximab|rituximab
607114|NCT00989352|Elderly|elderly
607115|NCT00989352|Chemotherapy|chemotherapy
607116|NCT00989339|lipid emulsion|lipid emulsion
607117|NCT00989339|endothelial function|endothelial function
607118|NCT00989339|inflammatory markers|inflammatory markers
607119|NCT00989339|oxidative stress|oxidative stress
607120|NCT00989339|insulin sensitivity|insulin sensitivity
607121|NCT00989339|carbohydrate metabolism|carbohydrate metabolism
607122|NCT00989326|Remote monitoring|remote monitoring
607123|NCT00989326|Pacemaker|pacemaker
607124|NCT00989326|Follow up|follow up
607125|NCT00989326|Follow-up studies|follow-up studies
607126|NCT00989313|Peplin|peplin
607127|NCT00989313|Actinic keratosis|actinic keratosis
607128|NCT00989313|PEP005|pep005
607129|NCT00989300|Drug-Drug interaction|drug-drug interaction
607130|NCT00989300|Clopidogrel|clopidogrel
607131|NCT00989300|Rabeprazol|rabeprazol
607132|NCT00989300|Omeprazol|omeprazol
607133|NCT00989300|Pharmacodynamic Study|pharmacodynamic study
607134|NCT00989287|GSK Bio's influenza vaccine GSK2340272A|gsk bio's influenza vaccine gsk2340272a
607135|NCT00989287|influenza infection|influenza infection
607136|NCT00989274|Influenza|influenza
607137|NCT00989274|Vaccination|vaccination
607138|NCT00989274|Immunology|immunology
607139|NCT00989274|Immunogenicity|immunogenicity
607140|NCT00989274|Reactogenicity|reactogenicity
607141|NCT00989274|Safety|safety
607142|NCT00989274|Influenza vaccine|influenza vaccine
607143|NCT00989274|Immune response|immune response
607144|NCT00989274|Adverse effects|adverse effects
607145|NCT00989261|AML|aml
607146|NCT00989261|AC220|ac220
607147|NCT00989261|acute|acute
607148|NCT00989261|FLT3|flt3
607149|NCT00989261|inhibitor|inhibitor
607150|NCT00989261|kinase|kinase
607151|NCT00989261|leukemia|leukemia
607152|NCT00989261|leukaemia|leukaemia
607153|NCT00989261|myeloid|myeloid
607154|NCT00989261|relapsed|relapsed
607155|NCT00989261|refractory|refractory
607156|NCT00989248|Ergospirometry|ergospirometry
607157|NCT00989248|Cardiopulmonary Exercise Test|cardiopulmonary exercise test
607158|NCT00989248|Exercises|exercises
607159|NCT00989248|Immersion|immersion
607160|NCT00989235|NOS|nos
607161|NCT00989222|Distal radius fractures|distal radius fractures
607162|NCT00989222|Fractures of the distal radius|fractures of the distal radius
607163|NCT00989222|Volar plate|volar plate
607164|NCT00989222|External fixation|external fixation
607165|NCT00989209|facial paralysis|facial paralysis
607166|NCT00989209|asymmetry|asymmetry
607167|NCT00989209|myofunctional therapy|myofunctional therapy
607168|NCT00989209|botulinum toxin|botulinum toxin
607169|NCT00989209|facial evaluation|facial evaluation
607170|NCT00989183|Ovaries|ovaries
607171|NCT00989183|Reproductive Age|reproductive age
607172|NCT00989183|Oophorectomy|oophorectomy
607173|NCT00989157|Gastric Bypass|gastric bypass
607174|NCT00989157|Duloxetine|duloxetine
607175|NCT00989157|Cymbalta|cymbalta
607176|NCT00989157|Pharmacokinetics|pharmacokinetics
607177|NCT00989144|HIV seronegative|hiv seronegative
607178|NCT00989144|acute infection|acute infection
607180|NCT00989105|stage I prostate cancer|stage i prostate cancer
607181|NCT00989105|stage IIB prostate cancer|stage iib prostate cancer
607182|NCT00989105|stage IIA prostate cancer|stage iia prostate cancer
607183|NCT00989105|stage III prostate cancer|stage iii prostate cancer
607184|NCT00989105|stage IV prostate cancer|stage iv prostate cancer
607185|NCT00989105|recurrent prostate cancer|recurrent prostate cancer
607186|NCT00989092|anemia of cancer|anemia of cancer
607187|NCT00989092|darbepoetin alfa|darbepoetin alfa
607188|NCT00989092|Aranesp|aranesp
607189|NCT00989079|Single Ascending Dose Study in healthy subjects|single ascending dose study in healthy subjects
607190|NCT00989066|Xience V|xience v
607191|NCT00989066|stent|stent
607192|NCT00989066|coronary disease|coronary disease
607193|NCT00989053|depression|depression
607194|NCT00989053|anxiety|anxiety
607195|NCT00989053|stress|stress
607196|NCT00989053|antidepressant therapy|antidepressant therapy
607197|NCT00989053|SSRI|ssri
607198|NCT00989053|infertility|infertility
607199|NCT00989053|in vitro fertilization (IVF)|in vitro fertilization (ivf)
607200|NCT00989053|immunological factors|immunological factors
607201|NCT00989053|depressive and anxiety symptoms in women undergoing IVF treatment|depressive and anxiety symptoms in women undergoing ivf treatment
607202|NCT00989040|NPZ|npz
607203|NCT00989040|Pain|pain
607204|NCT00989027|Uterine contraction|uterine contraction
607205|NCT00989027|Dose-response|dose-response
607206|NCT00989027|Oxytocin pre-treatment|oxytocin pre-treatment
607207|NCT00989014|Erythematotelangiectatic|erythematotelangiectatic
607208|NCT00989014|Rosacea|rosacea
607209|NCT00989001|Atrial Fibrillation|atrial fibrillation
607210|NCT00989001|RSD1235|rsd1235
607211|NCT00989001|Vernakalant|vernakalant
607212|NCT00989001|conversion|conversion
607213|NCT00988988|Multiple Sclerosis|multiple sclerosis
607214|NCT00988988|AGEE|agee
607215|NCT00988988|histamine response|histamine response
607216|NCT00988962|pain|pain
607217|NCT00988962|opioids|opioids
607218|NCT00988949|Proof of mechanism study|proof of mechanism study
607219|NCT00988936|[F-18]RGD-K5|[f-18]rgd-k5
607220|NCT00988936|RGD-K5|rgd-k5
607221|NCT00988936|K5-101|k5-101
607222|NCT00988936|Avastin|avastin
607223|NCT00988936|angiogenesis|angiogenesis
607224|NCT00988936|anti-angiogenesis|anti-angiogenesis
607225|NCT00988936|chemotherapy|chemotherapy
607226|NCT00988936|breast cancer|breast cancer
607227|NCT00988936|colon cancer|colon cancer
607228|NCT00988936|rectal cancer|rectal cancer
607229|NCT00988936|lung cancer|lung cancer
607230|NCT00988936|non-squamous|non-squamous
607231|NCT00988936|non small cell|non small cell
607232|NCT00988910|Combined Oral Contraceptives|combined oral contraceptives
607233|NCT00988910|COC|coc
607234|NCT00988871|PICC (peripherally inserted central venous catheter)|picc (peripherally inserted central venous catheter)
607235|NCT00988871|CICC (centrally inserted central venous catheter|cicc (centrally inserted central venous catheter
607236|NCT00988871|CVP (central venous pressure)|cvp (central venous pressure)
607237|NCT00988871|LT (liver transplantation)|lt (liver transplantation)
607238|NCT00988871|agreement|agreement
607239|NCT00988845|dietary supplement|dietary supplement
607240|NCT00988845|indole 3 carbinol|indole 3 carbinol
607241|NCT00988845|estrogen|estrogen
607242|NCT00988806|Advanced heart failure|advanced heart failure
607243|NCT00988806|Levosimendan|levosimendan
607244|NCT00988806|Intermittent long-term infusions|intermittent long-term infusions
607245|NCT00988780|Immune reconstitution inflammatory syndrome|immune reconstitution inflammatory syndrome
607246|NCT00988780|CCR5 antagonist|ccr5 antagonist
607247|NCT00988780|Maraviroc|maraviroc
607248|NCT00988780|HIV|hiv
607249|NCT00988780|treatment naive|treatment naive
607250|NCT00988767|Hepatitis B|hepatitis b
607251|NCT00988767|DNA vaccine|dna vaccine
607252|NCT00988767|immunotherapy|immunotherapy
607253|NCT00988754|Obesity|obesity
607254|NCT00988754|childhood and adolescence|childhood and adolescence
607255|NCT00988754|school and family-based lifestyle intervention|school and family-based lifestyle intervention
607256|NCT00988754|cardiovascular risk|cardiovascular risk
607257|NCT00988754|Obesity and associated cardiovascular risk in childhood and adolescence,|obesity and associated cardiovascular risk in childhood and adolescence,
607258|NCT00988754|health behaviour|health behaviour
607259|NCT00988741|Unresectable|unresectable
607260|NCT00988741|Hepatocellular|hepatocellular
607261|NCT00988741|Carcinoma|carcinoma
607262|NCT00988702|Dan Tian Breathing|dan tian breathing
607263|NCT00988702|Physiological measurement|physiological measurement
607264|NCT00988702|progressive muscle relaxation|progressive muscle relaxation
607265|NCT00988702|Monitoring, Physiologic|monitoring, physiologic
607266|NCT00988689|starch|starch
607267|NCT00988689|carbohydrates|carbohydrates
607268|NCT00988689|blood glucose|blood glucose
607269|NCT00988689|food intake|food intake
607270|NCT00988689|satiety|satiety
607271|NCT00988689|appetite|appetite
607272|NCT00988663|electroconvulsive therapy|electroconvulsive therapy
607273|NCT00988663|memantine|memantine
607274|NCT00988663|cognitive function|cognitive function
607275|NCT00988663|memory|memory
607276|NCT00988650|Metabolic syndrome|metabolic syndrome
607475|NCT00987896|polypectomy|polypectomy
607277|NCT00988650|Mediterranean diet|mediterranean diet
607278|NCT00988650|Blood lipids|blood lipids
607279|NCT00988650|Coronary heart disease|coronary heart disease
607280|NCT00988650|Apolipoprotein|apolipoprotein
607281|NCT00988624|bioavailability pharmacokinetics Alzheimer's Disease Huntington Disease|bioavailability pharmacokinetics alzheimer's disease huntington disease
607282|NCT00988611|Reproductive aging|reproductive aging
607283|NCT00988598|phase 1 Alzheimer's disease donepezil|phase 1 alzheimer's disease donepezil
607284|NCT00988585|Heart Disease Risk Reduction|heart disease risk reduction
607285|NCT00988572|Wrist fractures|wrist fractures
607286|NCT00988572|Vestibular asymmetry|vestibular asymmetry
607287|NCT00988572|Vestibular rehabilitation|vestibular rehabilitation
607288|NCT00988572|Fall-related wrist fractures|fall-related wrist fractures
607289|NCT00988572|Patients 50 years or older|patients 50 years or older
607290|NCT00988559|high grade cervical dysplasia|high grade cervical dysplasia
607291|NCT00988559|treatment vaccine|treatment vaccine
607292|NCT00988559|therapeutic|therapeutic
607293|NCT00988559|HPV|hpv
607294|NCT00988559|DNA vaccine|dna vaccine
607295|NCT00988559|gene therapy|gene therapy
607296|NCT00988559|gene gun|gene gun
607297|NCT00988559|pre-cancerous|pre-cancerous
607298|NCT00988546|Disability Evaluation|disability evaluation
607299|NCT00988546|Joint Diseases|joint diseases
607300|NCT00988546|Joint Disability|joint disability
607301|NCT00988533|Head Lice|head lice
607302|NCT00988533|Pediculus|pediculus
607303|NCT00988520|Neuromuscular Blocking Agents|neuromuscular blocking agents
607304|NCT00988481|Bulimia Nervosa|bulimia nervosa
607305|NCT00988481|Topiramate|topiramate
607306|NCT00988481|Augmentation|augmentation
607307|NCT00988468|Knee Osteoarthritis|knee osteoarthritis
607308|NCT00988468|Manual Therapy|manual therapy
607309|NCT00988468|Therapeutic Exercise|therapeutic exercise
607310|NCT00988468|Ultrasound|ultrasound
607311|NCT00988468|Effusion|effusion
607312|NCT00988455|basal cell carcinoma|basal cell carcinoma
607313|NCT00988455|photodynamic therapy|photodynamic therapy
607314|NCT00988455|photo chemotherapy|photo chemotherapy
607315|NCT00988455|basal cell epithelioma|basal cell epithelioma
607316|NCT00988442|Adherence|adherence
607317|NCT00988442|Treatment|treatment
607318|NCT00988442|Adherence Intervention|adherence intervention
607319|NCT00988442|Telephone Intervention|telephone intervention
607320|NCT00988442|treatment experienced|treatment experienced
607321|NCT00988429|Refractory|refractory
607322|NCT00988429|partial|partial
607323|NCT00988429|epilepsy|epilepsy
607324|NCT00988429|efficacy|efficacy
607325|NCT00988429|eslicarbazepine|eslicarbazepine
607326|NCT00988429|safety|safety
607327|NCT00988416|IPMN|ipmn
607328|NCT00988390|mothers living with HIV|mothers living with hiv
607329|NCT00988390|family intervention|family intervention
607330|NCT00988390|family functioning|family functioning
607331|NCT00988390|conflict|conflict
607332|NCT00988390|Mental health|mental health
607333|NCT00988390|and physical health|and physical health
607334|NCT00988390|Family relationships (functioning and conflict)|family relationships (functioning and conflict)
607335|NCT00988377|whey protein|whey protein
607336|NCT00988377|subjective appetite|subjective appetite
607337|NCT00988377|shor-term food intake|shor-term food intake
607338|NCT00988377|blood glucose|blood glucose
607339|NCT00988364|Metabolic Syndrome|metabolic syndrome
607340|NCT00988364|LDL subfraction L5|ldl subfraction l5
607341|NCT00988364|The reduction of LDL Chol in patients with Metabolic Syndrome|the reduction of ldl chol in patients with metabolic syndrome
607342|NCT00988364|The prevalence of L5 in patients with Metabolic Syndrome|the prevalence of l5 in patients with metabolic syndrome
607343|NCT00988364|The reduction of L5 subfraction in patients with Metabolic Syndrome|the reduction of l5 subfraction in patients with metabolic syndrome
607344|NCT00988351|sleep apnea|sleep apnea
607345|NCT00988351|positive airway pressure|positive airway pressure
607346|NCT00988351|portable monitoring|portable monitoring
607347|NCT00988351|auto positive airway pressure|auto positive airway pressure
607348|NCT00988338|Trinity Evolution|trinity evolution
607349|NCT00988338|Arthrodesis|arthrodesis
607350|NCT00988338|Foot Fusion|foot fusion
607351|NCT00988338|Ankle Fusion|ankle fusion
607352|NCT00988338|Allograft|allograft
607353|NCT00988312|dendritic cells (DC)|dendritic cells (dc)
607354|NCT00988312|idiotype (Id)|idiotype (id)
607355|NCT00988312|immunotherapy|immunotherapy
607356|NCT00988299|older|older
607357|NCT00988299|NEAT|neat
607358|NCT00988299|exercise|exercise
607360|NCT00988299|energy expenditure|energy expenditure
607361|NCT00988273|Crohn's disease|crohn's disease
607362|NCT00988273|Ulcerative colitis|ulcerative colitis
607363|NCT00988273|dysplasia|dysplasia
607364|NCT00988247|Rhinitis, Allergic, Perennial|rhinitis, allergic, perennial
607365|NCT00988247|BDP-HFA|bdp-hfa
607366|NCT00988247|Hay fever|hay fever
607367|NCT00988247|Allergic rhinitis|allergic rhinitis
607368|NCT00988234|Lumbar plexus block|lumbar plexus block
607369|NCT00988234|sciatic nerve block|sciatic nerve block
607370|NCT00988234|position|position
607371|NCT00988234|ultrasound guidance|ultrasound guidance
607372|NCT00988234|elective lower limb surgery|elective lower limb surgery
607476|NCT00987896|NOTES|notes
607373|NCT00988208|Castrate-Resistant Prostate Cancer|castrate-resistant prostate cancer
607374|NCT00988208|Revlimid|revlimid
607375|NCT00988208|Lenalidomide|lenalidomide
607376|NCT00988195|Neoplasm|neoplasm
607377|NCT00988195|Hepatocellular Carcinoma|hepatocellular carcinoma
607378|NCT00988182|Whey protein|whey protein
607379|NCT00988182|Hydrolysate whey protein|hydrolysate whey protein
607380|NCT00988182|Blood glucose|blood glucose
607381|NCT00988182|Insulin|insulin
607382|NCT00988169|AT-101|at-101
607383|NCT00988169|erlotinib|erlotinib
607384|NCT00988169|Unresectable Stage IIIB|unresectable stage iiib
607385|NCT00988169|09-026|09-026
607386|NCT00988156|Epilepsy|epilepsy
607387|NCT00988156|Partial|partial
607388|NCT00988156|Refractory|refractory
607389|NCT00988156|Children|children
607390|NCT00988156|Adolescents|adolescents
607391|NCT00988156|Adjunctive|adjunctive
607392|NCT00988156|Randomised|randomised
607393|NCT00988156|Double-blind|double-blind
607394|NCT00988156|Placebo-controlled|placebo-controlled
607395|NCT00988156|Parallel-group|parallel-group
607396|NCT00988143|Influenza|influenza
607397|NCT00988143|Trivalent Influenza Virus Vaccine|trivalent influenza virus vaccine
607398|NCT00988143|Quadrivalent Influenza Virus Vaccine|quadrivalent influenza virus vaccine
607399|NCT00988130|sexual dysfunction|sexual dysfunction
607400|NCT00988130|stage I prostate cancer|stage i prostate cancer
607401|NCT00988130|stage IIB prostate cancer|stage iib prostate cancer
607402|NCT00988130|stage IIA prostate cancer|stage iia prostate cancer
607403|NCT00988130|stage III prostate cancer|stage iii prostate cancer
607404|NCT00988117|PDD|pdd
607405|NCT00988117|Parkinson's Disease with Dementia|parkinson's disease with dementia
607406|NCT00988117|rivastigmine|rivastigmine
607407|NCT00988117|rivastigmine patch|rivastigmine patch
607408|NCT00988117|open label|open label
607409|NCT00988117|Parkinson's Disease|parkinson's disease
607410|NCT00988117|Parkinsons Disease|parkinsons disease
607411|NCT00988117|memory|memory
607412|NCT00988117|Exelon|exelon
607413|NCT00988117|Exelon Patch|exelon patch
607414|NCT00988104|Behavior Therapy|behavior therapy
607415|NCT00988104|Randomized Controlled Trial|randomized controlled trial
607416|NCT00988078|metformin|metformin
607417|NCT00988078|Hyperandrogenism|hyperandrogenism
607418|NCT00988078|Metabolic Syndrome X|metabolic syndrome x
607419|NCT00988078|adolescents|adolescents
607420|NCT00988078|melatonin|melatonin
607421|NCT00988078|Polycystic Ovary Syndrome|polycystic ovary syndrome
607422|NCT00988078|Insulin Resistance|insulin resistance
607423|NCT00988078|Menstrual Cycle|menstrual cycle
607424|NCT00988052|Relapsing Multiple Sclerosis|relapsing multiple sclerosis
607425|NCT00988039|Human Immunodeficiency virus|human immunodeficiency virus
607426|NCT00988039|second line therapy|second line therapy
607427|NCT00988039|raltegravir|raltegravir
607428|NCT00988039|aluvia|aluvia
607429|NCT00988039|monotherapy|monotherapy
607430|NCT00988039|integrase inhibitor|integrase inhibitor
607431|NCT00988039|protease inhibitor|protease inhibitor
607432|NCT00988039|Randomized Controlled Trial|randomized controlled trial
607433|NCT00988013|total marrow irradiation|total marrow irradiation
607434|NCT00988013|intensity modulated radiation|intensity modulated radiation
607435|NCT00988013|leukemia|leukemia
607436|NCT00988013|hematologic diseases|hematologic diseases
607437|NCT00988000|outpatients|outpatients
607438|NCT00987987|hematological malignancy|hematological malignancy
607439|NCT00987987|allogeneic hematopoietic stem cell transplantation|allogeneic hematopoietic stem cell transplantation
607440|NCT00987987|donor lymphocyte infusion|donor lymphocyte infusion
607441|NCT00987987|antitumor immunotherapy|antitumor immunotherapy
607442|NCT00987987|graft-versus-tumor effect|graft-versus-tumor effect
607443|NCT00987987|regulatory T cells|regulatory t cells
607445|NCT00987974|ischemia reperfusion injury|ischemia reperfusion injury
607446|NCT00987974|endothelial dysfunction|endothelial dysfunction
607447|NCT00987974|statins|statins
607448|NCT00987974|rosuvastatin|rosuvastatin
607449|NCT00987974|atorvastatin|atorvastatin
607450|NCT00987974|placebo|placebo
607451|NCT00987974|ecto-5'-nucleotidase|ecto-5'-nucleotidase
607452|NCT00987974|flow mediated dilation|flow mediated dilation
607453|NCT00987961|opioid dependence|opioid dependence
607454|NCT00987961|suboxone|suboxone
607455|NCT00987961|HIV risk behavior|hiv risk behavior
607456|NCT00987948|HIV|hiv
607457|NCT00987948|dementia|dementia
607458|NCT00987948|High HIV DNA within CD14+ PBMCs|high hiv dna within cd14+ pbmcs
607459|NCT00987948|treatment experienced|treatment experienced
607460|NCT00987922|Stroke|stroke
607461|NCT00987922|Acute|acute
607462|NCT00987922|Infarction|infarction
607463|NCT00987922|Ischemic|ischemic
607464|NCT00987922|Thrombolysis|thrombolysis
607465|NCT00987922|Mild|mild
607466|NCT00987922|Hypothermia|hypothermia
607467|NCT00987909|Cat|cat
607468|NCT00987909|Allergy|allergy
607469|NCT00987909|Immunotherapy|immunotherapy
607470|NCT00987909|Sublingual|sublingual
607471|NCT00987909|Exposure chamber|exposure chamber
607472|NCT00987909|Safety|safety
607473|NCT00987909|Rhinoconjunctivitis|rhinoconjunctivitis
607474|NCT00987896|colonoscopy|colonoscopy
607477|NCT00987883|Nutritional Support|nutritional support
607478|NCT00987870|Stable plaque Psoriasis|stable plaque psoriasis
607479|NCT00987870|inflammatory skin|inflammatory skin
607480|NCT00987870|with or without arthritis|with or without arthritis
607481|NCT00987857|esophageal cancer|esophageal cancer
607482|NCT00987857|adenocarcinoma of the esophagus|adenocarcinoma of the esophagus
607483|NCT00987857|Barrett esophagus|barrett esophagus
607484|NCT00987831|SLE|sle
607485|NCT00987831|lupus|lupus
607486|NCT00987831|biomarkers|biomarkers
607487|NCT00987831|depomedrol|depomedrol
607488|NCT00987831|flare|flare
607489|NCT00987831|disease activity|disease activity
607490|NCT00987818|Biomarkers|biomarkers
607491|NCT00987818|Antibiotic therapy|antibiotic therapy
607492|NCT00987805|Functional dyspepsia|functional dyspepsia
607493|NCT00987805|Banhasasim-tang|banhasasim-tang
607494|NCT00987805|Gastrointestinal Symptom score|gastrointestinal symptom score
607495|NCT00987805|Visual Analogue Scale|visual analogue scale
607496|NCT00987805|Functional Dyspepsia-related Quality of Life|functional dyspepsia-related quality of life
607497|NCT00987805|Electrogastrography|electrogastrography
607498|NCT00987792|Community Acquired Pneumonia|community acquired pneumonia
607499|NCT00987779|Bioequivalence study|bioequivalence study
607500|NCT00987779|Food effect study|food effect study
607501|NCT00987779|Pharmacokinetics|pharmacokinetics
607502|NCT00987779|Gabapentin|gabapentin
607503|NCT00987766|advanced adult primary liver cancer|advanced adult primary liver cancer
607504|NCT00987766|stage III pancreatic cancer|stage iii pancreatic cancer
607505|NCT00987766|stage IV pancreatic cancer|stage iv pancreatic cancer
607506|NCT00987766|periampullary adenocarcinoma|periampullary adenocarcinoma
607507|NCT00987766|small intestine adenocarcinoma|small intestine adenocarcinoma
607508|NCT00987766|adenocarcinoma of the extrahepatic bile duct|adenocarcinoma of the extrahepatic bile duct
607509|NCT00987766|adenocarcinoma of the gallbladder|adenocarcinoma of the gallbladder
607510|NCT00987766|unresectable extrahepatic bile duct cancer|unresectable extrahepatic bile duct cancer
607511|NCT00987766|unresectable gallbladder cancer|unresectable gallbladder cancer
607512|NCT00987753|L-377202, prostate cancer, PSA|l-377202, prostate cancer, psa
607513|NCT00987740|hypercapnic respiratory failure, COPD|hypercapnic respiratory failure, copd
607514|NCT00987714|Organ Donors|organ donors
607515|NCT00987714|Recipients|recipients
607516|NCT00987701|Neurobehavior|neurobehavior
607517|NCT00987701|Development|development
607518|NCT00987701|Fluid management|fluid management
607519|NCT00987701|Neuraxial anesthesia|neuraxial anesthesia
607520|NCT00987688|trauma|trauma
607521|NCT00987688|Brain injury|brain injury
607522|NCT00987688|Pre-hospital|pre-hospital
607523|NCT00987688|cooling|cooling
607524|NCT00987675|stage I prostate cancer|stage i prostate cancer
607525|NCT00987675|stage IIB prostate cancer|stage iib prostate cancer
607526|NCT00987675|stage IIA prostate cancer|stage iia prostate cancer
607527|NCT00987675|stage III prostate cancer|stage iii prostate cancer
607528|NCT00987662|irbesartan|irbesartan
607529|NCT00987662|amlodipine|amlodipine
607530|NCT00987662|obesity|obesity
607531|NCT00987662|ambulatory blood pressure monitoring|ambulatory blood pressure monitoring
607532|NCT00987662|new onset diabetes|new onset diabetes
607533|NCT00987649|pelvic mass|pelvic mass
607534|NCT00987649|ovarian cancer|ovarian cancer
607535|NCT00987649|adnexal mass|adnexal mass
607536|NCT00987649|CA125|ca125
607537|NCT00987649|HE4|he4
607538|NCT00987636|Ewing Sarcoma|ewing sarcoma
607539|NCT00987636|localized|localized
607540|NCT00987636|disseminated|disseminated
607541|NCT00987636|metastases|metastases
607542|NCT00987636|bone|bone
607543|NCT00987636|soft tissue|soft tissue
607544|NCT00987610|Percutaneous coronary intervention|percutaneous coronary intervention
607545|NCT00987610|chronic total occlusion|chronic total occlusion
607546|NCT00987610|guidewire|guidewire
607547|NCT00987610|Angioplasty, Transluminal, Percutaneous Coronary|angioplasty, transluminal, percutaneous coronary
607548|NCT00987610|Angioplasty|angioplasty
607549|NCT00987610|Percutaneous Coronary|percutaneous coronary
607550|NCT00987597|Smoking|smoking
607551|NCT00987597|nicotine replacement|nicotine replacement
607552|NCT00987597|psychological behaviour|psychological behaviour
607553|NCT00987597|Smoking > 5 cigarettes per day|smoking > 5 cigarettes per day
607554|NCT00987597|Hospitalisation for acute coronary syndrome|hospitalisation for acute coronary syndrome
607555|NCT00987571|carpal tunnel syndrome|carpal tunnel syndrome
607556|NCT00987571|median nerve|median nerve
607557|NCT00987571|ultrasound|ultrasound
607558|NCT00987571|electrodiagnosis|electrodiagnosis
607559|NCT00987571|Normal subjects|normal subjects
607560|NCT00987558|Eslicarbazepine acetate|eslicarbazepine acetate
607561|NCT00987558|simvastatin|simvastatin
607562|NCT00987545|Keloids|keloids
607563|NCT00987545|recurrence|recurrence
607564|NCT00987532|preschool|preschool
607565|NCT00987532|participatory intervention|participatory intervention
607566|NCT00987532|cluster-randomization|cluster-randomization
607567|NCT00987532|children|children
607568|NCT00987532|obesity prevention|obesity prevention
607569|NCT00987519|acute bronchiolitis|acute bronchiolitis
607570|NCT00987519|acute gastroenteritis|acute gastroenteritis
608261|NCT00984880|Safety|safety
607571|NCT00987519|febrile convulsion|febrile convulsion
607572|NCT00987519|viral agents|viral agents
607573|NCT00987519|molecular methods|molecular methods
607574|NCT00987506|drug eluting stents|drug eluting stents
607575|NCT00987506|Stents|stents
607576|NCT00987506|Angioplasty|angioplasty
607577|NCT00987506|Chronic coronary occlusion|chronic coronary occlusion
607578|NCT00987506|Stent thrombosis|stent thrombosis
607579|NCT00987506|Vascular disease|vascular disease
607580|NCT00987506|Myocardial ischemia|myocardial ischemia
771988|NCT00360087|SCD|scd
607581|NCT00987506|Coronary artery stenosis|coronary artery stenosis
607582|NCT00987506|Coronary Disease|coronary disease
607583|NCT00987506|Coronary Artery Disease|coronary artery disease
607584|NCT00987506|Coronary Restenosis|coronary restenosis
607585|NCT00987493|recurrent adult diffuse large cell lymphoma|recurrent adult diffuse large cell lymphoma
607586|NCT00987493|recurrent grade 3 follicular lymphoma|recurrent grade 3 follicular lymphoma
607587|NCT00987480|Stem Cell Transplantation|stem cell transplantation
607588|NCT00987480|Anemia|anemia
607589|NCT00987480|Busulfan|busulfan
607590|NCT00987480|Cyclophosphamide|cyclophosphamide
607591|NCT00987480|Fludarabine|fludarabine
607592|NCT00987480|08-031|08-031
607593|NCT00987467|Atopic|atopic
607594|NCT00987467|Keratoconjunctivitis|keratoconjunctivitis
607595|NCT00987467|Restasis|restasis
607596|NCT00987467|Cyclosporine|cyclosporine
607597|NCT00987441|Neurobehavior|neurobehavior
607598|NCT00987441|Epidural analgesia|epidural analgesia
607599|NCT00987441|Local anesthetic|local anesthetic
607600|NCT00987441|Opioid|opioid
607601|NCT00987428|ERCP|ercp
607602|NCT00987428|EUS|eus
607603|NCT00987428|Pancreatitis biliary|pancreatitis biliary
607604|NCT00987428|Severe|severe
607605|NCT00987428|Interventional endoscopy|interventional endoscopy
607606|NCT00987428|Choledocolithiasis|choledocolithiasis
607607|NCT00987402|Surgery|surgery
607608|NCT00987402|hand scrubbing|hand scrubbing
607609|NCT00987402|post-operative infection|post-operative infection
607610|NCT00987402|surgical site infection|surgical site infection
607611|NCT00987402|surgical hand preparation|surgical hand preparation
607612|NCT00987402|plain soap and water|plain soap and water
607613|NCT00987402|alcohol-based hand rub|alcohol-based hand rub
607614|NCT00987402|Cost of surgical hand preparation agent|cost of surgical hand preparation agent
607615|NCT00987402|Side effects of use of hand preparation agent|side effects of use of hand preparation agent
607616|NCT00987389|Vasculitis|vasculitis
607617|NCT00987389|Granulomatosis with Polyangiitis|granulomatosis with polyangiitis
607618|NCT00987389|Microscopic Polyangiitis|microscopic polyangiitis
607619|NCT00987389|Wegener's|wegener's
607620|NCT00987389|ANCA-Associated Vasculitis|anca-associated vasculitis
607621|NCT00987389|GPA|gpa
607622|NCT00987389|MPA|mpa
607623|NCT00987389|Treatment|treatment
607624|NCT00987389|Plasma exchange|plasma exchange
607625|NCT00987389|Glucocorticoids|glucocorticoids
607626|NCT00987389|ANCA-Positive|anca-positive
607627|NCT00987363|critical limb ischemia (CLI)|critical limb ischemia (cli)
607628|NCT00987363|diabetic foot|diabetic foot
607629|NCT00987363|bone marrow derived mononuclear cells|bone marrow derived mononuclear cells
607630|NCT00987363|cell therapy|cell therapy
607631|NCT00987350|Jet Injector|jet injector
607632|NCT00987350|Vaccine|vaccine
607633|NCT00987350|Influenza|influenza
607634|NCT00987337|Hepatitis C Polymerase Inhibitor PF-00868554 Filibuvir|hepatitis c polymerase inhibitor pf-00868554 filibuvir
607635|NCT00987311|Probiotics|probiotics
607636|NCT00987311|intestinal immune system|intestinal immune system
607637|NCT00987311|human|human
607638|NCT00987311|healthy subjects|healthy subjects
607639|NCT00987311|dairy drink|dairy drink
607640|NCT00987311|Healthy adults|healthy adults
607641|NCT00987298|Abdominal Fat|abdominal fat
607642|NCT00987298|Visceral Fat|visceral fat
607643|NCT00987298|Subcutaneous Fat|subcutaneous fat
607644|NCT00987298|Dual-energy x-ray absorptiometry|dual-energy x-ray absorptiometry
607645|NCT00987298|DXA|dxa
607646|NCT00987298|Computed Tomography|computed tomography
607647|NCT00987298|CT|ct
607648|NCT00987298|Body Mass Index|body mass index
607649|NCT00987298|Body composition|body composition
607650|NCT00987298|Percent fat|percent fat
607651|NCT00987298|Waist circumference|waist circumference
607652|NCT00987298|Hip circumference|hip circumference
607653|NCT00987285|RE AIM model|re aim model
607654|NCT00987285|Type 2 Diabetes Mellitus|type 2 diabetes mellitus
607655|NCT00987285|Interactive voice recognition|interactive voice recognition
607656|NCT00987285|Computer Assisted Self Management|computer assisted self management
607657|NCT00987272|Allergies|allergies
607658|NCT00987272|Ocular|ocular
607659|NCT00987259|Myocardial infarction|myocardial infarction
607660|NCT00987259|Myocardial oedema|myocardial oedema
607661|NCT00987259|Magnetic resonance|magnetic resonance
607662|NCT00987246|Actinic Keratosis|actinic keratosis
607663|NCT00987246|AK|ak
607664|NCT00987246|NMSC|nmsc
607665|NCT00987246|Combination|combination
607666|NCT00987220|CSF Biomarkers Acetylcholine|csf biomarkers acetylcholine
607667|NCT00987207|Postconditioning|postconditioning
607668|NCT00987207|cyclosporine A|cyclosporine a
608982|NCT00982345|Quetiapine|quetiapine
607669|NCT00987207|myocardial ischemia|myocardial ischemia
607670|NCT00987207|cardiac surgery|cardiac surgery
607671|NCT00987207|aortic valvulopathy|aortic valvulopathy
607672|NCT00987194|HIV|hiv
607673|NCT00987194|rapid testing|rapid testing
607674|NCT00987194|HIV seronegativity|hiv seronegativity
607675|NCT00987181|Pulse wave velocity|pulse wave velocity
772170|NCT00359385|PTH|pth
607676|NCT00987181|Non contact|non contact
607677|NCT00987181|Non-invasive|non-invasive
607678|NCT00987181|Photoplethysmography|photoplethysmography
607679|NCT00987181|Doppler flow velocimetry|doppler flow velocimetry
607680|NCT00987168|Congenital Hyperinsulinism|congenital hyperinsulinism
607681|NCT00987168|Hypoglycemia,|hypoglycemia,
607682|NCT00987168|Sandostatine subcutaneous in 3 daily injections|sandostatine subcutaneous in 3 daily injections
607683|NCT00987168|Intramuscular injection of Sandostatine® LP per month|intramuscular injection of sandostatine® lp per month
607684|NCT00987155|Functional electrical stimulation cycling|functional electrical stimulation cycling
607685|NCT00987155|arm crank|arm crank
607686|NCT00987155|wheelchair|wheelchair
607687|NCT00987155|ergometry|ergometry
607688|NCT00987155|paraplegia|paraplegia
607689|NCT00987155|spinal cord injury|spinal cord injury
607690|NCT00987155|exercise testing|exercise testing
607691|NCT00987129|DHA|dha
607692|NCT00987129|EPA|epa
607693|NCT00987129|AMD|amd
607694|NCT00987129|drusen|drusen
607695|NCT00987129|omega-3 fatty acids|omega-3 fatty acids
607696|NCT00987129|omega6:omega3 ratio|omega6:omega3 ratio
607697|NCT00987116|Myasthenia gravis|myasthenia gravis
607698|NCT00987116|Steroids side effects|steroids side effects
607699|NCT00987116|Comparison of strategies for tapering steroids|comparison of strategies for tapering steroids
607700|NCT00987116|Generalized MG corresponding to grade III, IV or V of MGFA|generalized mg corresponding to grade iii, iv or v of mgfa
607701|NCT00987103|renal transplantation|renal transplantation
607702|NCT00987103|tacrolimus|tacrolimus
607703|NCT00987103|pharmacokinetics|pharmacokinetics
607704|NCT00987103|rectal|rectal
607705|NCT00987103|sublingual|sublingual
607706|NCT00987103|rectal administration|rectal administration
607707|NCT00987103|sublingual administration|sublingual administration
607708|NCT00987090|subjects developing symptoms of Alzheimer Disease|subjects developing symptoms of alzheimer disease
607709|NCT00987077|CSC|csc
607710|NCT00987077|SRT|srt
607711|NCT00987064|Protexo|protexo
607712|NCT00987064|Asthma|asthma
607713|NCT00987064|Temperature controlled Laminar Airflow|temperature controlled laminar airflow
607714|NCT00987064|Perennial allergy|perennial allergy
607715|NCT00987064|Quality of life|quality of life
607716|NCT00987064|MiniAQLQ|miniaqlq
607717|NCT00987064|FeNO|feno
607718|NCT00987064|FEV1|fev1
607719|NCT00987064|PEF|pef
607720|NCT00987051|sentinel node procedure|sentinel node procedure
607721|NCT00987051|radiocolloid|radiocolloid
607722|NCT00987051|patent blue|patent blue
607723|NCT00987038|drug interaction CYP3A4 glucocorticoids midazolam|drug interaction cyp3a4 glucocorticoids midazolam
607724|NCT00987025|hypertension|hypertension
607725|NCT00987025|telehealth|telehealth
607726|NCT00987025|nurse monitor|nurse monitor
607727|NCT00987025|nutrition center|nutrition center
607728|NCT00986999|HIV infected|hiv infected
607729|NCT00986999|treatment experienced|treatment experienced
607730|NCT00986986|Human immunodeficiency virus|human immunodeficiency virus
607731|NCT00986986|Low high density lipoprotein|low high density lipoprotein
607732|NCT00986986|Endothelial function|endothelial function
607733|NCT00986986|Flow-mediated vasodilation|flow-mediated vasodilation
607734|NCT00986973|PKU|pku
607735|NCT00986973|BH4|bh4
607736|NCT00986973|KUVAN|kuvan
607737|NCT00986973|PET scan|pet scan
607738|NCT00986973|Neurodevelopment|neurodevelopment
607739|NCT00986960|multiple sclerosis|multiple sclerosis
607740|NCT00986960|relapsing remitting|relapsing remitting
607741|NCT00986960|RRMS|rrms
607742|NCT00986921|Length of time for procedure to be completed|length of time for procedure to be completed
607743|NCT00986921|Need for additional dilation|need for additional dilation
607744|NCT00986921|Subject satisfaction with procedure|subject satisfaction with procedure
607745|NCT00986895|HPN-100|hpn-100
607746|NCT00986895|GT4P|gt4p
607747|NCT00986895|Glyceryl tri-(4-phenylbutyrate)|glyceryl tri-(4-phenylbutyrate)
607748|NCT00986882|Postoperative pain|postoperative pain
607749|NCT00986869|Safety|safety
607750|NCT00986869|Bronchoscopy|bronchoscopy
607751|NCT00986869|Pulmonary|pulmonary
607752|NCT00986869|Hypertension|hypertension
607753|NCT00986843|HM30181A|hm30181a
607754|NCT00986843|Irinotecan|irinotecan
607755|NCT00986843|MTD|mtd
607756|NCT00986843|DLT|dlt
607757|NCT00986830|Rhinosinusitis|rhinosinusitis
607758|NCT00986830|Balloon catheters|balloon catheters
607759|NCT00986830|Office treatment|office treatment
607760|NCT00986830|Otorhinolaryngologic Diseases|otorhinolaryngologic diseases
607761|NCT00986830|Respiratory Tract Infections|respiratory tract infections
607762|NCT00986830|Respiratory Tract Diseases|respiratory tract diseases
607763|NCT00986830|FinESS Sinus Treatment|finess sinus treatment
607764|NCT00986830|endoscopic sinus surgery|endoscopic sinus surgery
607765|NCT00986817|Refractory ascites|refractory ascites
608983|NCT00982345|fMRI|fmri
607766|NCT00986817|Cirrhosis Terlipressin|cirrhosis terlipressin
607767|NCT00986817|Paracentesis|paracentesis
607768|NCT00986791|risk reduction|risk reduction
772238|NCT00359164|AMD|amd
607769|NCT00986765|Fetal growth restriction|fetal growth restriction
607770|NCT00986765|Abruptio placentae|abruptio placentae
607771|NCT00986765|Perinatal death|perinatal death
607772|NCT00986752|stent|stent
607773|NCT00986752|atherectomy|atherectomy
607774|NCT00986752|paclitaxel-eluting balloon|paclitaxel-eluting balloon
607775|NCT00986739|Chronic pathologies|chronic pathologies
607776|NCT00986739|elderly|elderly
607777|NCT00986739|atmospheric pollution|atmospheric pollution
607778|NCT00986739|unplanned hospitalization|unplanned hospitalization
607779|NCT00986739|case-crossover|case-crossover
607780|NCT00986687|Oocyte cryopreservation|oocyte cryopreservation
607781|NCT00986687|vitrification|vitrification
607782|NCT00986674|Advanced Non-small Cell Lung Cancer|advanced non-small cell lung cancer
607783|NCT00986674|Carboplatin|carboplatin
607784|NCT00986674|Paclitaxel|paclitaxel
607785|NCT00986674|Cetuximab|cetuximab
607786|NCT00986674|IMC-A12|imc-a12
607787|NCT00986661|melanoma|melanoma
607788|NCT00986661|uveal|uveal
607789|NCT00986661|ocular|ocular
607790|NCT00986661|mUM|mum
607791|NCT00986661|mOM|mom
607792|NCT00986661|OM|om
607793|NCT00986661|UM|um
607794|NCT00986661|pancreatic|pancreatic
607795|NCT00986661|colon|colon
607796|NCT00986661|colorectal|colorectal
607797|NCT00986661|lung|lung
607798|NCT00986661|metastatic|metastatic
607799|NCT00986661|carcinoid|carcinoid
607800|NCT00986661|neuroendocrine|neuroendocrine
607801|NCT00986661|liver|liver
607803|NCT00986648|acute liver failure|acute liver failure
607804|NCT00986648|hepatic encephalopathy|hepatic encephalopathy
607805|NCT00986648|acetaminophen toxicity|acetaminophen toxicity
607806|NCT00986635|Activated partial thromboplastin time|activated partial thromboplastin time
607807|NCT00986635|Thrombin clotting Time|thrombin clotting time
607808|NCT00986635|Anti-Xa-activity|anti-xa-activity
607809|NCT00986635|Factor X-activity|factor x-activity
607810|NCT00986635|Factor XIII-activity|factor xiii-activity
607811|NCT00986635|Antithrombin (based on factor II)|antithrombin (based on factor ii)
607812|NCT00986635|Antithrombin (based on factor X<9|antithrombin (based on factor x<9
607813|NCT00986596|vitamin D|vitamin d
607814|NCT00986596|skeletal muscle|skeletal muscle
607815|NCT00986596|vitamin D receptor|vitamin d receptor
607816|NCT00986583|Succinylcholine|succinylcholine
607817|NCT00986583|Statins|statins
607818|NCT00986583|myalgias|myalgias
607819|NCT00986583|statins with succinylcholine and pain|statins with succinylcholine and pain
607820|NCT00986570|Botulinum Toxin A|botulinum toxin a
607821|NCT00986570|Wrinkles|wrinkles
607822|NCT00986557|cytomegalovirus infection|cytomegalovirus infection
607823|NCT00986557|graft versus host disease|graft versus host disease
607824|NCT00986544|Laparoscopy|laparoscopy
607825|NCT00986544|cholecystectomy|cholecystectomy
607826|NCT00986544|drainage|drainage
607827|NCT00986531|schizophrenia|schizophrenia
607828|NCT00986531|early phase trials|early phase trials
607829|NCT00986518|Advanced Colorectal Cancer|advanced colorectal cancer
607830|NCT00986518|Hepatic and/or lung metastasis|hepatic and/or lung metastasis
607831|NCT00986518|Adaptive autologous cell immunotherapy|adaptive autologous cell immunotherapy
607832|NCT00986518|T- regulatory lymphocyte depletion|t- regulatory lymphocyte depletion
607833|NCT00986518|Neo-adjuvant reduced intensity chemotherapeutic conditioning|neo-adjuvant reduced intensity chemotherapeutic conditioning
607834|NCT00986505|lidocaine|lidocaine
607835|NCT00986505|fibromyalgia|fibromyalgia
607836|NCT00986505|intravenous lidocaine|intravenous lidocaine
607837|NCT00986505|manifestations|manifestations
607838|NCT00986492|Sleep deprivation|sleep deprivation
607839|NCT00986492|Food intake|food intake
607840|NCT00986492|Motor activity|motor activity
607841|NCT00986492|Normal, healthy subjects|normal, healthy subjects
607842|NCT00986479|Patients|patients
607843|NCT00986466|exercise|exercise
607844|NCT00986466|falls|falls
607845|NCT00986466|physical functioning|physical functioning
607846|NCT00986466|vitamin D|vitamin d
607847|NCT00986466|mobility function|mobility function
607848|NCT00986466|neuromuscular functioning¨|neuromuscular functioning¨
607849|NCT00986466|quality of life|quality of life
607850|NCT00986466|number of fallers|number of fallers
607851|NCT00986466|fall-related injuries including bone fractures|fall-related injuries including bone fractures
607852|NCT00986466|bone mass|bone mass
607853|NCT00986453|Breast Reduction|breast reduction
607854|NCT00986453|PlasmaBlade|plasmablade
607855|NCT00986453|Electrosurgery|electrosurgery
607856|NCT00986453|PEAK Surgical|peak surgical
607857|NCT00986453|Medtronic Advanced Energy|medtronic advanced energy
607858|NCT00986453|Medtronic|medtronic
607859|NCT00986414|Parkinson Disease|parkinson disease
607860|NCT00986414|L-dopa|l-dopa
607861|NCT00986414|Levodopa|levodopa
607862|NCT00986414|dyskinesia|dyskinesia
607863|NCT00986401|Adults|adults
607864|NCT00986375|Randomized Controlled Trial|randomized controlled trial
607865|NCT00986375|evidence- and theory-based behavioral intervention|evidence- and theory-based behavioral intervention
608984|NCT00982345|pictures|pictures
607866|NCT00986375|expert system|expert system
607867|NCT00986375|stages of change|stages of change
607868|NCT00986375|motivational interviewing|motivational interviewing
607869|NCT00986375|tailoring|tailoring
607870|NCT00986375|Self Care|self care
607871|NCT00986375|Rehabilitation|rehabilitation
607872|NCT00986375|Expert Systems|expert systems
607873|NCT00986375|Behavior|behavior
607874|NCT00986375|Motivation|motivation
607875|NCT00986362|Safety in pediatrics|safety in pediatrics
607876|NCT00986349|Diabetes|diabetes
607877|NCT00986349|Weight Loss|weight loss
607878|NCT00986349|GI Dynamics|gi dynamics
607879|NCT00986349|EndoBarrier|endobarrier
607880|NCT00986336|topiramate|topiramate
607881|NCT00986336|risperidone, bipolar disorder|risperidone, bipolar disorder
607883|NCT00986323|Temperature controlled Laminar Airflow|temperature controlled laminar airflow
607884|NCT00986323|TLA|tla
607885|NCT00986323|Perennial allergy|perennial allergy
607886|NCT00986323|Quality of life|quality of life
607887|NCT00986323|Environmental control|environmental control
607888|NCT00986310|fluoxetine|fluoxetine
607889|NCT00986310|epilepsy|epilepsy
607890|NCT00986310|Prozac|prozac
607891|NCT00986297|recurrent non-small cell lung cancer|recurrent non-small cell lung cancer
607892|NCT00986297|stage II non-small cell lung cancer|stage ii non-small cell lung cancer
607893|NCT00986297|stage IIIA non-small cell lung cancer|stage iiia non-small cell lung cancer
607894|NCT00986297|stage IIIB non-small cell lung cancer|stage iiib non-small cell lung cancer
607895|NCT00986297|stage IV non-small cell lung cancer|stage iv non-small cell lung cancer
607896|NCT00986297|adenocarcinoma of the lung|adenocarcinoma of the lung
607897|NCT00986297|adenosquamous cell lung cancer|adenosquamous cell lung cancer
607898|NCT00986297|bronchoalveolar cell lung cancer|bronchoalveolar cell lung cancer
607899|NCT00986297|large cell lung cancer|large cell lung cancer
607900|NCT00986297|squamous cell lung cancer|squamous cell lung cancer
607901|NCT00986284|Non Small Cell Lung Cancer|non small cell lung cancer
607902|NCT00986284|Gefitinib|gefitinib
607903|NCT00986284|Neoadjuvant Therapy|neoadjuvant therapy
607904|NCT00986271|severe sepsis, intensive care units|severe sepsis, intensive care units
607905|NCT00986258|pain assessment|pain assessment
607906|NCT00986258|tapentadol|tapentadol
607907|NCT00986258|centrally acting analgesic|centrally acting analgesic
607908|NCT00986245|Parkinson disease|parkinson disease
607909|NCT00986245|Ropinirole|ropinirole
607910|NCT00986219|Asthma|asthma
607911|NCT00986219|Language|language
607912|NCT00986219|Symptoms,|symptoms,
607913|NCT00986219|Limitation of Daily activities|limitation of daily activities
607914|NCT00986219|Patients|patients
607915|NCT00986219|Physicians|physicians
607916|NCT00986219|Greece|greece
607917|NCT00986206|ovarian epithelial cancer|ovarian epithelial cancer
607918|NCT00986206|BRCA1 mutation carrier|brca1 mutation carrier
607919|NCT00986206|BRCA2 mutation carrier|brca2 mutation carrier
607920|NCT00986206|stage IA ovarian epithelial cancer|stage ia ovarian epithelial cancer
607921|NCT00986206|stage IB ovarian epithelial cancer|stage ib ovarian epithelial cancer
607922|NCT00986206|stage IC ovarian epithelial cancer|stage ic ovarian epithelial cancer
607923|NCT00986206|stage IIA ovarian epithelial cancer|stage iia ovarian epithelial cancer
607924|NCT00986206|stage IIB ovarian epithelial cancer|stage iib ovarian epithelial cancer
607925|NCT00986206|stage IIC ovarian epithelial cancer|stage iic ovarian epithelial cancer
607926|NCT00986206|stage IIIA ovarian epithelial cancer|stage iiia ovarian epithelial cancer
607927|NCT00986206|stage IIIB ovarian epithelial cancer|stage iiib ovarian epithelial cancer
607928|NCT00986206|stage IIIC ovarian epithelial cancer|stage iiic ovarian epithelial cancer
607929|NCT00986206|stage IV ovarian epithelial cancer|stage iv ovarian epithelial cancer
607930|NCT00986193|Aortic Valve Stenosis|aortic valve stenosis
607931|NCT00986193|Stent Valve|stent valve
607932|NCT00986193|Biological Aortic Valve Prosthesis|biological aortic valve prosthesis
607933|NCT00986180|Acute Low Back Pain|acute low back pain
607934|NCT00986180|Low Back Pain With Leg Pain Below The Knee|low back pain with leg pain below the knee
607935|NCT00986180|Radiculopathy, Oxycodone|radiculopathy, oxycodone
607936|NCT00986180|Tapentadol|tapentadol
607937|NCT00986180|NUCYNTA|nucynta
607938|NCT00986167|Psychosis|psychosis
607939|NCT00986167|Aggression|aggression
607940|NCT00986167|Acute|acute
607941|NCT00986167|Quetiapine XR|quetiapine xr
607942|NCT00986154|Recurrent Thrombosis|recurrent thrombosis
607943|NCT00986154|Recurrent Pulmonary Embolism|recurrent pulmonary embolism
607944|NCT00986154|Symptomatic Deep Vein Thrombosis|symptomatic deep vein thrombosis
607945|NCT00986154|Symptomatic Pulmonary Embolism|symptomatic pulmonary embolism
607946|NCT00986154|Venous Thromboembolism (VTE)|venous thromboembolism (vte)
607947|NCT00986128|Topiramate|topiramate
607948|NCT00986128|Lithium|lithium
607949|NCT00986128|Bipolar disorder|bipolar disorder
607950|NCT00986115|epilepsy|epilepsy
607951|NCT00986115|memory|memory
607952|NCT00986115|cognition|cognition
607953|NCT00986115|memantine|memantine
607954|NCT00986102|Carbapenem|carbapenem
607955|NCT00986102|Doripenem|doripenem
607956|NCT00986102|Doribax|doribax
710879|NCT00587457|Prolymphocytic Leukemia|prolymphocytic leukemia
772511|NCT00358202|nhap|nhap
607957|NCT00986102|Nosocomial pneumonia, Intra-abdominal infections|nosocomial pneumonia, intra-abdominal infections
607958|NCT00986102|Urinary tract infection|urinary tract infection
607959|NCT00986089|post-placental|post-placental
607960|NCT00986089|IUD|iud
607961|NCT00986089|Copper IUD|copper iud
607962|NCT00986089|cesarean section|cesarean section
607963|NCT00986089|immediate post-partum|immediate post-partum
607964|NCT00986089|continuation|continuation
607965|NCT00986076|Pediatric Cataract Surgery|pediatric cataract surgery
607966|NCT00986076|Low-Molecular weight Heparin|low-molecular weight heparin
607967|NCT00986076|Intraocular infusion|intraocular infusion
607968|NCT00986076|Anti-inflammatory effect|anti-inflammatory effect
607969|NCT00986063|Nevirapine induced rash|nevirapine induced rash
607970|NCT00986063|Hepatitis|hepatitis
607971|NCT00986063|Pharmacogenomics|pharmacogenomics
607972|NCT00986063|AIDS|aids
607973|NCT00986063|HIV|hiv
607974|NCT00986063|treatment naive|treatment naive
607975|NCT00986050|STEMI|stemi
607976|NCT00986050|DES|des
607977|NCT00986050|BMS|bms
607978|NCT00986050|abciximab|abciximab
607979|NCT00986037|Adverse events|adverse events
607980|NCT00986037|Pharmacokinetics|pharmacokinetics
607981|NCT00986024|Exercise therapy|exercise therapy
607982|NCT00986011|obesity|obesity
607983|NCT00986011|weight changes|weight changes
607984|NCT00986011|healthy, no evidence of disease|healthy, no evidence of disease
607985|NCT00985998|nimotuzumab|nimotuzumab
607986|NCT00985998|non-small cell lung cancer|non-small cell lung cancer
607987|NCT00985998|chemotherapy|chemotherapy
607988|NCT00985985|smoking cessation|smoking cessation
607989|NCT00985985|nicotine lozenge|nicotine lozenge
607990|NCT00985985|nicotine replacement therapy|nicotine replacement therapy
607991|NCT00985972|PHYSICAL ACTIVITY|physical activity
607992|NCT00985972|SCHOOL|school
607993|NCT00985972|NUTRITION|nutrition
607994|NCT00985972|EDUCATION|education
607995|NCT00985972|OVERWEIGHT|overweight
607996|NCT00985959|Multiple myeloma|multiple myeloma
607997|NCT00985959|Hematopoietic stem cell transplant|hematopoietic stem cell transplant
607998|NCT00985959|HSCT|hsct
607999|NCT00985959|Melphalan|melphalan
608000|NCT00985959|Prednisolone|prednisolone
608001|NCT00985959|Bortezomib|bortezomib
608002|NCT00985959|JNJ-26866138|jnj-26866138
608003|NCT00985933|Healthy normal volunteers|healthy normal volunteers
608004|NCT00985920|blood loss|blood loss
608005|NCT00985920|postoperative|postoperative
608006|NCT00985907|myeloma|myeloma
608007|NCT00985907|DMV|dmv
608008|NCT00985894|Teledermatology|teledermatology
608009|NCT00985894|Telemedicine|telemedicine
608010|NCT00985894|Atopic Dermatitis|atopic dermatitis
608011|NCT00985881|Artificial limbs|artificial limbs
608012|NCT00985881|Gait|gait
608013|NCT00985881|Posture|posture
608014|NCT00985881|Prosthesis|prosthesis
608015|NCT00985881|Vibration|vibration
608016|NCT00985868|unspecified childhood solid tumor, protocol specific|unspecified childhood solid tumor, protocol specific
608017|NCT00985842|Artificial limbs|artificial limbs
608018|NCT00985842|Gait|gait
608019|NCT00985842|Oximetry|oximetry
608020|NCT00985842|Prosthesis|prosthesis
608021|NCT00985842|Rehabilitation|rehabilitation
608022|NCT00985829|basal cell carcinoma|basal cell carcinoma
608023|NCT00985829|photodynamic therapy|photodynamic therapy
608024|NCT00985829|photo chemotherapy|photo chemotherapy
608025|NCT00985829|basal cell epithelioma|basal cell epithelioma
608026|NCT00985816|Preterm|preterm
608027|NCT00985816|newborns|newborns
608028|NCT00985816|Gastric|gastric
608029|NCT00985816|Motility|motility
608030|NCT00985816|Mucosal|mucosal
608031|NCT00985816|immunity|immunity
608032|NCT00985803|Systemic Lupus Erythematosus|systemic lupus erythematosus
608033|NCT00985803|Activity Physical|activity physical
608034|NCT00985803|Activity Disease,trials randomized|activity disease,trials randomized
608035|NCT00985790|vaccine|vaccine
608036|NCT00985790|Influenza|influenza
608037|NCT00985777|pancreas|pancreas
608038|NCT00985777|resectable|resectable
608039|NCT00985777|pancreatic tumor|pancreatic tumor
608040|NCT00985777|pancreatic ductal adenocarcinoma|pancreatic ductal adenocarcinoma
608041|NCT00985777|intraductal papillary mucinous neoplasm of the pancreas|intraductal papillary mucinous neoplasm of the pancreas
608042|NCT00985777|mucinous cystic neoplasm|mucinous cystic neoplasm
608043|NCT00985777|pancreatic exocrine neoplasia|pancreatic exocrine neoplasia
608044|NCT00985751|immunogenicity|immunogenicity
608045|NCT00985751|toddlers|toddlers
608046|NCT00985751|Pneumococcal vaccine|pneumococcal vaccine
608047|NCT00985751|Haemophilus influenzae|haemophilus influenzae
608048|NCT00985751|safety|safety
608049|NCT00985751|Streptococcus pneumoniae|streptococcus pneumoniae
608050|NCT00985751|Streptococcus Pneumoniae Vaccines|streptococcus pneumoniae vaccines
608051|NCT00985738|Prostate Cancer|prostate cancer
608052|NCT00985738|Early Stage Prostate Cancer|early stage prostate cancer
608053|NCT00985725|Major Depressive Disorder|major depressive disorder
608054|NCT00985699|non-Hodgkin lymphoma|non-hodgkin lymphoma
608055|NCT00985699|cutaneous B-cell non-Hodgkin lymphoma|cutaneous b-cell non-hodgkin lymphoma
608056|NCT00985699|extranodal marginal zone B-cell lymphoma of mucosa-associated lymphoid tissue|extranodal marginal zone b-cell lymphoma of mucosa-associated lymphoid tissue
608057|NCT00985699|nodal marginal zone B-cell lymphoma|nodal marginal zone b-cell lymphoma
608058|NCT00985686|e-mental health|e-mental health
608059|NCT00985686|Adolescent mental health|adolescent mental health
608060|NCT00985686|Spirituality|spirituality
608061|NCT00985673|GSK Bio's influenza vaccine GSK2340274A|gsk bio's influenza vaccine gsk2340274a
608062|NCT00985673|influenza infection|influenza infection
608063|NCT00985673|GSK Bio's influenza vaccine GSK2340273A|gsk bio's influenza vaccine gsk2340273a
608064|NCT00985647|HIV|hiv
608065|NCT00985647|HAART|haart
608066|NCT00985647|ART|art
608067|NCT00985647|Pharmacokinetic|pharmacokinetic
608068|NCT00985647|Healthy volunteers|healthy volunteers
608069|NCT00985647|3TC|3tc
608070|NCT00985647|Lamivudine|lamivudine
608071|NCT00985634|off pump bypass OPCAB|off pump bypass opcab
608072|NCT00985634|OPCAB|opcab
608073|NCT00985621|monoclonal antibody|monoclonal antibody
608074|NCT00985621|RN624|rn624
608075|NCT00985621|PF-04383119|pf-04383119
608076|NCT00985621|nerve growth factor|nerve growth factor
608077|NCT00985621|OA|oa
608078|NCT00985621|pain|pain
608079|NCT00985621|arthritis|arthritis
608080|NCT00985608|H pylori|h pylori
608081|NCT00985608|eradication therapy|eradication therapy
608082|NCT00985595|Adolescent|adolescent
608083|NCT00985595|substance abuse|substance abuse
608084|NCT00985582|Influenza A Virus (H1N1)|influenza a virus (h1n1)
608085|NCT00985569|Constipation|constipation
608086|NCT00985569|Nursing Home|nursing home
608087|NCT00985569|Quality Indicator|quality indicator
608088|NCT00985556|recurrent gastric cancer|recurrent gastric cancer
608089|NCT00985556|adenocarcinoma of the stomach|adenocarcinoma of the stomach
608090|NCT00985556|stage IIIA gastric cancer|stage iiia gastric cancer
608091|NCT00985556|stage IIIB gastric cancer|stage iiib gastric cancer
608092|NCT00985556|stage IIIC gastric cancer|stage iiic gastric cancer
608093|NCT00985556|stage IV gastric cancer|stage iv gastric cancer
608094|NCT00985543|HIV|hiv
608095|NCT00985543|ART|art
608096|NCT00985543|HAART|haart
608097|NCT00985543|Pharmacokinetics|pharmacokinetics
608098|NCT00985543|Lopinavir/ritonavir|lopinavir/ritonavir
608099|NCT00985543|Lower dose selection|lower dose selection
608100|NCT00985517|Parkinson's disease|parkinson's disease
608101|NCT00985517|Movement Disorders|movement disorders
608102|NCT00985517|Gene Therapy|gene therapy
608103|NCT00985517|Neurotrophic Factors|neurotrophic factors
608104|NCT00985517|GDNF|gdnf
608105|NCT00985517|Neurturin|neurturin
608106|NCT00985517|DBS|dbs
608107|NCT00985517|Dopamine|dopamine
608108|NCT00985504|Major Depressive Disorder|major depressive disorder
608109|NCT00985504|Apathy|apathy
608110|NCT00985504|Duloxetine Hydrochloride|duloxetine hydrochloride
608111|NCT00985504|SSRI|ssri
608112|NCT00985504|Escitalopram|escitalopram
608113|NCT00985491|obesity|obesity
608114|NCT00985478|First in Man|first in man
608115|NCT00985478|SLV342|slv342
608116|NCT00985478|Atherosclerosis|atherosclerosis
608117|NCT00985465|Booster vaccination|booster vaccination
608118|NCT00985465|Pneumococcal vaccine|pneumococcal vaccine
608119|NCT00985465|Catch-up vaccination|catch-up vaccination
608120|NCT00985465|Pneumococcal disease|pneumococcal disease
608121|NCT00985465|Safety|safety
608122|NCT00985465|Immunogenicity|immunogenicity
608123|NCT00985452|Medication|medication
608124|NCT00985452|Adherence|adherence
608125|NCT00985452|Hypertension|hypertension
608126|NCT00985426|chronic kidney disease|chronic kidney disease
608127|NCT00985426|kidney failure|kidney failure
608128|NCT00985426|kidney failure,chronic|kidney failure,chronic
608129|NCT00985426|chronic kidney failure|chronic kidney failure
608130|NCT00985426|hepatitis B virus (HBV) vaccine|hepatitis b virus (hbv) vaccine
608131|NCT00985426|hepatitis B vaccine|hepatitis b vaccine
608132|NCT00985426|hepatitis B|hepatitis b
608133|NCT00985426|hepatitis|hepatitis
608134|NCT00985426|HBV|hbv
608135|NCT00985426|prevention and control|prevention and control
608136|NCT00985426|dialysis|dialysis
608137|NCT00985413|Cockayne Syndrome|cockayne syndrome
608138|NCT00985413|pediatrics|pediatrics
608139|NCT00985413|growth|growth
608140|NCT00985413|hearing|hearing
608141|NCT00985413|Ageing|ageing
608142|NCT00985400|recurrent colon cancer|recurrent colon cancer
608143|NCT00985400|stage IV colon cancer|stage iv colon cancer
608144|NCT00985400|Gastrointestinal|gastrointestinal
608145|NCT00985400|Exercise|exercise
608146|NCT00985400|Relaxation|relaxation
608147|NCT00985400|Meditation|meditation
608148|NCT00985387|Solifenacin|solifenacin
608149|NCT00985387|Overactive bladder|overactive bladder
608150|NCT00985387|persistency of the treatment|persistency of the treatment
608151|NCT00985387|Vesicare|vesicare
608152|NCT00985348|Levetiracetam|levetiracetam
608153|NCT00985348|Healthy volunteers|healthy volunteers
608154|NCT00985348|Healthy Subjects|healthy subjects
608155|NCT00985322|Hemodialysis|hemodialysis
608156|NCT00985309|unsatisfactory|unsatisfactory
608157|NCT00985309|Pap smear|pap smear
608158|NCT00985296|Allergic rhinitis|allergic rhinitis
608159|NCT00985296|Allergic conjunctivitis|allergic conjunctivitis
608160|NCT00985283|prevention|prevention
608161|NCT00985283|older adults|older adults
608162|NCT00985283|function|function
608163|NCT00985283|participation|participation
608164|NCT00985283|life satisfaction|life satisfaction
608165|NCT00985283|self-rated health|self-rated health
608166|NCT00985244|COPD|copd
608167|NCT00985244|COPD exacerbation|copd exacerbation
608168|NCT00985244|macrolide|macrolide
608169|NCT00985244|diseae progression|diseae progression
608170|NCT00985244|bacterial colonisation|bacterial colonisation
608171|NCT00985218|infertility|infertility
608172|NCT00985218|embryo development|embryo development
608173|NCT00985205|Randomized Clinical Trial|randomized clinical trial
608174|NCT00985205|Glutamine|glutamine
608175|NCT00985205|Themal Burn Injuries|themal burn injuries
608176|NCT00985205|Nutrition|nutrition
608177|NCT00985205|Outcome Assessment|outcome assessment
608178|NCT00985205|Critical Care|critical care
608179|NCT00985205|Total Body Surface Area|total body surface area
608180|NCT00985192|adenocarcinoma of the esophagus|adenocarcinoma of the esophagus
608181|NCT00985192|adenocarcinoma of the stomach|adenocarcinoma of the stomach
608182|NCT00985192|recurrent esophageal cancer|recurrent esophageal cancer
608183|NCT00985192|stage III esophageal cancer|stage iii esophageal cancer
608184|NCT00985192|stage IV esophageal cancer|stage iv esophageal cancer
608185|NCT00985192|recurrent gastric cancer|recurrent gastric cancer
608186|NCT00985192|stage III gastric cancer|stage iii gastric cancer
608187|NCT00985192|stage IV gastric cancer|stage iv gastric cancer
608188|NCT00985179|Randomized Controlled Trial|randomized controlled trial
608189|NCT00985179|evidence- and theory-based behavioral intervention|evidence- and theory-based behavioral intervention
608190|NCT00985179|expert system|expert system
608191|NCT00985179|stages of change|stages of change
608192|NCT00985179|motivational interviewing|motivational interviewing
608193|NCT00985179|tailoring|tailoring
608194|NCT00985179|Self Care|self care
608195|NCT00985179|Expert Systems|expert systems
608196|NCT00985127|Hyperuricemia|hyperuricemia
608197|NCT00985127|Gout|gout
608198|NCT00985114|Type II Diabetes|type ii diabetes
608199|NCT00985114|Obesity|obesity
608200|NCT00985088|GSK Bio's influenza vaccine GSK2340274A|gsk bio's influenza vaccine gsk2340274a
608201|NCT00985088|influenza infection|influenza infection
608202|NCT00985088|GSK Bio's influenza vaccine GSK2340273A|gsk bio's influenza vaccine gsk2340273a
608203|NCT00985075|Allergic rhinitis|allergic rhinitis
608204|NCT00985075|Allergic conjunctivitis|allergic conjunctivitis
608205|NCT00985062|Folic Acid|folic acid
608206|NCT00985062|Homocysteine|homocysteine
608207|NCT00985062|Ovarian response|ovarian response
608208|NCT00985062|In Vitro Fertilization|in vitro fertilization
608209|NCT00985036|glioma|glioma
608210|NCT00985036|meningioma|meningioma
608211|NCT00985036|VEGF|vegf
608212|NCT00985023|Unstable|unstable
608213|NCT00985023|Lisfranc|lisfranc
608214|NCT00985023|fracture|fracture
608215|NCT00985023|dislocation|dislocation
608216|NCT00985023|midfoot|midfoot
608217|NCT00985010|hepatic encephalopathy|hepatic encephalopathy
608218|NCT00985010|hepatitis C|hepatitis c
608219|NCT00985010|manganese|manganese
608220|NCT00985010|mortality|mortality
608221|NCT00985010|prognosis.|prognosis.
608222|NCT00984997|Superior Sulcus Tumor|superior sulcus tumor
608223|NCT00984997|Lung Cancer|lung cancer
608224|NCT00984997|Non-Small Cell|non-small cell
608225|NCT00984997|Multimodality Treatment|multimodality treatment
608226|NCT00984997|Surgery|surgery
608227|NCT00984997|Segmentectomy|segmentectomy
608228|NCT00984997|Lobectomy|lobectomy
608229|NCT00984997|Cisplatin|cisplatin
608230|NCT00984997|CDDP|cddp
608231|NCT00984997|Etoposide|etoposide
608232|NCT00984997|VP-16|vp-16
608233|NCT00984997|VePesid|vepesid
608234|NCT00984997|Radiation Therapy|radiation therapy
608235|NCT00984997|Radiotherapy|radiotherapy
608236|NCT00984997|Chest Irradiation|chest irradiation
608237|NCT00984997|Prophylactic Cranial Irradiation|prophylactic cranial irradiation
608239|NCT00984971|Microbicides|microbicides
608240|NCT00984971|Tenofovir|tenofovir
608241|NCT00984971|HIV seronegativity|hiv seronegativity
608242|NCT00984945|pandemic vaccine|pandemic vaccine
608243|NCT00984945|influenza|influenza
608244|NCT00984945|H5N1|h5n1
608245|NCT00984945|Virus Like Particle (VLP)|virus like particle (vlp)
608246|NCT00984932|systemic sclerosis|systemic sclerosis
608247|NCT00984932|pulmonary hypertension|pulmonary hypertension
608248|NCT00984932|rosuvastatin|rosuvastatin
608249|NCT00984919|recurrent prostate cancer|recurrent prostate cancer
608250|NCT00984919|stage I prostate cancer|stage i prostate cancer
608251|NCT00984919|stage II prostate cancer|stage ii prostate cancer
608252|NCT00984919|stage III prostate cancer|stage iii prostate cancer
608253|NCT00984919|stage IV prostate cancer|stage iv prostate cancer
608254|NCT00984893|Osteoporosis|osteoporosis
608255|NCT00984893|Bone Mineral density|bone mineral density
608256|NCT00984893|fragility fractures|fragility fractures
608257|NCT00984893|zoledronic acid.|zoledronic acid.
608258|NCT00984893|Treatment|treatment
608259|NCT00984880|Sedation|sedation
608260|NCT00984880|anaesthesia|anaesthesia
608262|NCT00984880|Tolerability|tolerability
608263|NCT00984880|Pharmacokinetics|pharmacokinetics
608264|NCT00984880|Pharmacodynamics|pharmacodynamics
608265|NCT00984867|Dapagliflozin DPP IV inhibitor add on study|dapagliflozin dpp iv inhibitor add on study
608266|NCT00984867|Inadequate control|inadequate control
608267|NCT00984854|Cicatrix|cicatrix
608268|NCT00984854|Scar|scar
608269|NCT00984854|Wound-healing|wound-healing
608270|NCT00984854|Re-epithelialisation|re-epithelialisation
608271|NCT00984854|RN1004|rn1004
608272|NCT00984854|Mannose-6-phosphate|mannose-6-phosphate
608273|NCT00984854|M6P|m6p
608274|NCT00984854|Juvidex|juvidex
608275|NCT00984841|Diabetes Mellitus targeted mailing|diabetes mellitus targeted mailing
608276|NCT00984828|multiple myeloma|multiple myeloma
608277|NCT00984828|autologous stem cell transplantation|autologous stem cell transplantation
608278|NCT00984828|velcade|velcade
608279|NCT00984815|NSAID|nsaid
608280|NCT00984815|Chronic Pain|chronic pain
608281|NCT00984815|Osteoarthritis|osteoarthritis
608282|NCT00984815|Rheumatoid Arthritis|rheumatoid arthritis
608283|NCT00984789|Transdermal Patch|transdermal patch
608284|NCT00984789|Bleeding|bleeding
608285|NCT00984789|Pregnancy|pregnancy
608286|NCT00984776|coronary artery|coronary artery
608287|NCT00984776|MRI|mri
608288|NCT00984776|vessel wall imaging|vessel wall imaging
608289|NCT00984763|Malaria|malaria
608290|NCT00984763|Vaccine|vaccine
608291|NCT00984724|Smoking|smoking
608292|NCT00984724|Motivation and Problem Solving|motivation and problem solving
608293|NCT00984724|MAPS|maps
608294|NCT00984724|Low Income Smokers|low income smokers
608295|NCT00984724|HCHD community clinics|hchd community clinics
608296|NCT00984724|Telephone-based counseling|telephone-based counseling
608297|NCT00984698|Posttraumatic Stress Disorder|posttraumatic stress disorder
608298|NCT00984698|Depression|depression
608299|NCT00984698|Sleep Initiation and Maintenance Disorders|sleep initiation and maintenance disorders
608300|NCT00984698|Insomnia|insomnia
608301|NCT00984698|Psychotherapy, Group|psychotherapy, group
608302|NCT00984698|Cognitive Behavioral Therapy|cognitive behavioral therapy
608303|NCT00984698|Randomized Controlled Trial|randomized controlled trial
608304|NCT00984698|Veterans|veterans
608305|NCT00984698|Social Rhythms|social rhythms
608306|NCT00984672|Lumbar Degenerative Disease|lumbar degenerative disease
608307|NCT00984672|Bone Morphogenetic Protein|bone morphogenetic protein
608308|NCT00984672|TLIF|tlif
608309|NCT00984659|Pulmonary Disease, Chronic Obstructive|pulmonary disease, chronic obstructive
608310|NCT00984659|Dyspnea|dyspnea
608311|NCT00984646|Cicatrix|cicatrix
608312|NCT00984646|Scar|scar
608313|NCT00984646|Wound-healing|wound-healing
608314|NCT00984646|Prevascar|prevascar
608315|NCT00984646|Interleukin-10 (IL-10)|interleukin-10 (il-10)
608316|NCT00984646|Ilodecakin|ilodecakin
608317|NCT00984646|RN1003|rn1003
608318|NCT00984633|Neuromuscular Blocking Agents|neuromuscular blocking agents
608319|NCT00984607|Laparoscopic Gastric Band|laparoscopic gastric band
608320|NCT00984607|LAP BAND system|lap band system
608321|NCT00984594|allograft|allograft
608322|NCT00984594|knee injury|knee injury
608323|NCT00984594|cartilage injury|cartilage injury
608324|NCT00984581|Cicatrix|cicatrix
608325|NCT00984581|Scar|scar
608326|NCT00984581|Wound healing|wound healing
608327|NCT00984581|Avotermin|avotermin
608328|NCT00984581|TGF beta 3|tgf beta 3
608329|NCT00984581|Juvista|juvista
608330|NCT00984581|RN1001|rn1001
608331|NCT00984555|Biomarkers|biomarkers
608332|NCT00984555|Semen Exposure|semen exposure
608333|NCT00984542|recurrent small cell lung cancer|recurrent small cell lung cancer
608334|NCT00984529|Chronic heart failure|chronic heart failure
608335|NCT00984529|candesartan cilexetil|candesartan cilexetil
608336|NCT00984529|clinical signs|clinical signs
608337|NCT00984529|symptoms|symptoms
608338|NCT00984516|Cicatrix|cicatrix
608339|NCT00984516|Scar|scar
608340|NCT00984516|Wound-healing|wound-healing
608341|NCT00984516|Juvidex|juvidex
608342|NCT00984516|Mannose-6-phosphate|mannose-6-phosphate
608343|NCT00984516|M6P|m6p
608344|NCT00984516|RN1004|rn1004
608345|NCT00984503|Cicatrix|cicatrix
608346|NCT00984503|Scar|scar
608347|NCT00984503|Wound healing|wound healing
608348|NCT00984503|Avotermin|avotermin
608349|NCT00984503|TGF beta 3|tgf beta 3
608350|NCT00984503|Juvista|juvista
608351|NCT00984503|RN1001|rn1001
608352|NCT00984490|stage I breast cancer|stage i breast cancer
608353|NCT00984490|stage II breast cancer|stage ii breast cancer
608354|NCT00984477|Healthy volunteer|healthy volunteer
608355|NCT00984477|healthy subjects|healthy subjects
608356|NCT00984477|AZD5122|azd5122
608357|NCT00984477|single oral dose|single oral dose
608358|NCT00984477|phase 1|phase 1
608359|NCT00984477|Healthy volunteer phase 1 study|healthy volunteer phase 1 study
608360|NCT00984464|metastatic|metastatic
608361|NCT00984464|melanoma|melanoma
608362|NCT00984464|REOLYSIN|reolysin
608363|NCT00984464|chemotherapy|chemotherapy
608364|NCT00984464|carboplatin|carboplatin
608365|NCT00984464|paclitaxel|paclitaxel
608366|NCT00984451|Antibody Treatment|antibody treatment
608367|NCT00984451|Immune Therapy|immune therapy
608368|NCT00984451|Infectious Diseases|infectious diseases
608369|NCT00984451|IVIG|ivig
608370|NCT00984451|Plasma Apheresis|plasma apheresis
608371|NCT00984451|Influenza A|influenza a
608372|NCT00984451|Swine Flu|swine flu
608373|NCT00984399|vaginitis|vaginitis
608374|NCT00984399|Postmenopausal|postmenopausal
608375|NCT00984399|17-β estradiol|17-β estradiol
608376|NCT00984399|09-110|09-110
608377|NCT00984386|Cicatrix|cicatrix
608378|NCT00984386|Scar|scar
608379|NCT00984386|Wound-healing|wound-healing
608380|NCT00984386|Zesteem|zesteem
608381|NCT00984386|17β-Estradiol|17β-estradiol
608382|NCT00984386|RN1002|rn1002
608383|NCT00984373|Schizophrenia epidemiology|schizophrenia epidemiology
608384|NCT00984373|Schizophrenic patients' social and health characteristics|schizophrenic patients' social and health characteristics
608385|NCT00984360|Meth|meth
608386|NCT00984360|Methamphetamine Addiction|methamphetamine addiction
608387|NCT00984360|Methamphetamine Treatment|methamphetamine treatment
608388|NCT00984360|Naltrexone|naltrexone
608389|NCT00984360|Vivitrol|vivitrol
608390|NCT00984360|A118G|a118g
608391|NCT00984360|OPRM1|oprm1
608392|NCT00984347|nipple stimulation|nipple stimulation
608393|NCT00984347|Oxytocin|oxytocin
608394|NCT00984347|induction of labor|induction of labor
608395|NCT00984347|term pregnancies|term pregnancies
608396|NCT00984347|grandmultipara|grandmultipara
608397|NCT00984347|VBAC|vbac
608398|NCT00984347|PROM|prom
608399|NCT00984347|comparison of two methods for induction of labor|comparison of two methods for induction of labor
608400|NCT00984334|pain|pain
608401|NCT00984334|opioid|opioid
608402|NCT00984334|constipation|constipation
608403|NCT00984334|Subjects taking opioids for chronic non-cancer pain, who|subjects taking opioids for chronic non-cancer pain, who
608404|NCT00984334|experience symptoms of opioid induced constipation|experience symptoms of opioid induced constipation
608405|NCT00984321|Geriatric|geriatric
608406|NCT00984321|Elderly|elderly
608407|NCT00984321|Counseling|counseling
608408|NCT00984321|Depression|depression
608409|NCT00984321|Anxiety|anxiety
608410|NCT00984321|Intervention|intervention
608411|NCT00984321|Psychoeducational|psychoeducational
608412|NCT00984321|09-116|09-116
608413|NCT00984308|sleep apnea|sleep apnea
608414|NCT00984308|hypertension|hypertension
608415|NCT00984308|brain ischemia|brain ischemia
608416|NCT00984282|RAI-Refractory|rai-refractory
608417|NCT00984282|Differentiated|differentiated
608418|NCT00984282|Follicular|follicular
608419|NCT00984282|Papillary|papillary
608420|NCT00984282|Hurthle|hurthle
608421|NCT00984256|Malaria|malaria
608422|NCT00984256|Prophylaxis|prophylaxis
608423|NCT00984256|Atovaquone|atovaquone
608424|NCT00984256|Malarone|malarone
608425|NCT00984256|Challenge|challenge
608426|NCT00984243|lung cancer|lung cancer
608427|NCT00984230|Infant Formula|infant formula
608428|NCT00984230|Gut|gut
608429|NCT00984217|panitumumab|panitumumab
608430|NCT00984217|salivary gland malignancies|salivary gland malignancies
608431|NCT00984217|radiotherapy|radiotherapy
608432|NCT00984204|cavo-tricuspid dependent|cavo-tricuspid dependent
608433|NCT00984191|Papillary thyroid cancer|papillary thyroid cancer
608434|NCT00984191|99mTechnetium MIBI SPECT CT|99mtechnetium mibi spect ct
608435|NCT00984191|preoperative|preoperative
608436|NCT00984191|cervical lymphadenopathy|cervical lymphadenopathy
608437|NCT00984191|cervical metastasis|cervical metastasis
608438|NCT00984178|Reperfusion|reperfusion
608439|NCT00984178|acute myocardial infarction|acute myocardial infarction
608440|NCT00984178|stem cell therapy|stem cell therapy
608441|NCT00984178|GCSF|gcsf
608442|NCT00984178|bone marrow mononuclear cells|bone marrow mononuclear cells
608443|NCT00984178|magnetic resonance|magnetic resonance
608444|NCT00984165|Allotransplant|allotransplant
608445|NCT00984165|Relapse|relapse
608446|NCT00984165|Radiation|radiation
608447|NCT00984165|Donor Lymphocyte Infusion|donor lymphocyte infusion
608448|NCT00984165|Hematologic Malignancies|hematologic malignancies
608449|NCT00984165|Multiple Myeloma|multiple myeloma
608450|NCT00984165|Hodgkin Lymphoma|hodgkin lymphoma
608451|NCT00984165|Non-Hodgkin Lymphoma|non-hodgkin lymphoma
608452|NCT00984165|Chronic Lymphocytic Leukemia|chronic lymphocytic leukemia
608453|NCT00984152|HIV|hiv
608454|NCT00984152|Raltegravir|raltegravir
608455|NCT00984152|Women|women
608456|NCT00984152|Viral Suppression|viral suppression
608457|NCT00984152|Viral Reservoir|viral reservoir
608458|NCT00984152|Immune Parameters|immune parameters
608459|NCT00984152|Gut|gut
608460|NCT00984152|Genital Tract|genital tract
608461|NCT00984139|persistence|persistence
608462|NCT00984139|HBV|hbv
608463|NCT00984139|Long-term|long-term
608464|NCT00984139|Engerix™-B Kinder|engerix™-b kinder
608465|NCT00984139|Hepatitis B|hepatitis b
773064|NCT00356291|HIV|hiv
608466|NCT00984139|adolescent|adolescent
608467|NCT00984113|Elinogrel|elinogrel
608468|NCT00984113|Renal impairment|renal impairment
608469|NCT00984113|Healthy|healthy
608470|NCT00984113|Kidney dysfunction|kidney dysfunction
608471|NCT00984100|Cholelithiasis|cholelithiasis
608472|NCT00984100|Biliary dyskinesia|biliary dyskinesia
608473|NCT00984087|depression|depression
608474|NCT00984087|TMS|tms
608475|NCT00984087|adolescent|adolescent
608476|NCT00984087|transcranial magnetic stimulation|transcranial magnetic stimulation
608477|NCT00984087|MDD|mdd
608478|NCT00984087|Major depression|major depression
608479|NCT00984087|mood disorders|mood disorders
608480|NCT00984074|stage III salivary gland cancer|stage iii salivary gland cancer
608481|NCT00984074|recurrent squamous cell carcinoma of the hypopharynx|recurrent squamous cell carcinoma of the hypopharynx
608482|NCT00984074|stage I squamous cell carcinoma of the hypopharynx|stage i squamous cell carcinoma of the hypopharynx
608483|NCT00984074|stage II squamous cell carcinoma of the hypopharynx|stage ii squamous cell carcinoma of the hypopharynx
608484|NCT00984074|stage III squamous cell carcinoma of the hypopharynx|stage iii squamous cell carcinoma of the hypopharynx
608485|NCT00984074|recurrent squamous cell carcinoma of the larynx|recurrent squamous cell carcinoma of the larynx
608486|NCT00984074|recurrent verrucous carcinoma of the larynx|recurrent verrucous carcinoma of the larynx
608487|NCT00984074|stage I squamous cell carcinoma of the larynx|stage i squamous cell carcinoma of the larynx
608488|NCT00984074|stage I verrucous carcinoma of the larynx|stage i verrucous carcinoma of the larynx
608489|NCT00984074|stage II squamous cell carcinoma of the larynx|stage ii squamous cell carcinoma of the larynx
608490|NCT00984074|stage II verrucous carcinoma of the larynx|stage ii verrucous carcinoma of the larynx
608491|NCT00984074|stage III squamous cell carcinoma of the larynx|stage iii squamous cell carcinoma of the larynx
608492|NCT00984074|stage III verrucous carcinoma of the larynx|stage iii verrucous carcinoma of the larynx
608493|NCT00984074|recurrent adenoid cystic carcinoma of the oral cavity|recurrent adenoid cystic carcinoma of the oral cavity
608494|NCT00984074|recurrent mucoepidermoid carcinoma of the oral cavity|recurrent mucoepidermoid carcinoma of the oral cavity
608495|NCT00984074|recurrent verrucous carcinoma of the oral cavity|recurrent verrucous carcinoma of the oral cavity
608496|NCT00984074|stage I adenoid cystic carcinoma of the oral cavity|stage i adenoid cystic carcinoma of the oral cavity
608497|NCT00984074|stage I mucoepidermoid carcinoma of the oral cavity|stage i mucoepidermoid carcinoma of the oral cavity
608498|NCT00984074|stage I verrucous carcinoma of the oral cavity|stage i verrucous carcinoma of the oral cavity
608499|NCT00984074|stage II adenoid cystic carcinoma of the oral cavity|stage ii adenoid cystic carcinoma of the oral cavity
608500|NCT00984074|stage II mucoepidermoid carcinoma of the oral cavity|stage ii mucoepidermoid carcinoma of the oral cavity
608501|NCT00984074|stage II verrucous carcinoma of the oral cavity|stage ii verrucous carcinoma of the oral cavity
608502|NCT00984074|stage III adenoid cystic carcinoma of the oral cavity|stage iii adenoid cystic carcinoma of the oral cavity
608503|NCT00984074|stage III mucoepidermoid carcinoma of the oral cavity|stage iii mucoepidermoid carcinoma of the oral cavity
608504|NCT00984074|stage III verrucous carcinoma of the oral cavity|stage iii verrucous carcinoma of the oral cavity
608505|NCT00984074|stage I squamous cell carcinoma of the lip and oral cavity|stage i squamous cell carcinoma of the lip and oral cavity
608506|NCT00984074|stage II squamous cell carcinoma of the lip and oral cavity|stage ii squamous cell carcinoma of the lip and oral cavity
608507|NCT00984074|stage III squamous cell carcinoma of the lip and oral cavity|stage iii squamous cell carcinoma of the lip and oral cavity
608508|NCT00984074|recurrent basal cell carcinoma of the lip|recurrent basal cell carcinoma of the lip
608509|NCT00984074|recurrent squamous cell carcinoma of the lip and oral cavity|recurrent squamous cell carcinoma of the lip and oral cavity
608510|NCT00984074|stage I basal cell carcinoma of the lip|stage i basal cell carcinoma of the lip
608511|NCT00984074|stage II basal cell carcinoma of the lip|stage ii basal cell carcinoma of the lip
608512|NCT00984074|stage III basal cell carcinoma of the lip|stage iii basal cell carcinoma of the lip
608513|NCT00984074|recurrent metastatic squamous neck cancer with occult primary|recurrent metastatic squamous neck cancer with occult primary
608514|NCT00984074|untreated metastatic squamous neck cancer with occult primary|untreated metastatic squamous neck cancer with occult primary
608515|NCT00984074|recurrent lymphoepithelioma of the nasopharynx|recurrent lymphoepithelioma of the nasopharynx
608516|NCT00984074|recurrent squamous cell carcinoma of the nasopharynx|recurrent squamous cell carcinoma of the nasopharynx
608517|NCT00984074|stage I lymphoepithelioma of the nasopharynx|stage i lymphoepithelioma of the nasopharynx
608518|NCT00984074|stage I squamous cell carcinoma of the nasopharynx|stage i squamous cell carcinoma of the nasopharynx
608519|NCT00984074|stage II lymphoepithelioma of the nasopharynx|stage ii lymphoepithelioma of the nasopharynx
608520|NCT00984074|stage II squamous cell carcinoma of the nasopharynx|stage ii squamous cell carcinoma of the nasopharynx
608521|NCT00984074|stage III lymphoepithelioma of the nasopharynx|stage iii lymphoepithelioma of the nasopharynx
608522|NCT00984074|stage III squamous cell carcinoma of the nasopharynx|stage iii squamous cell carcinoma of the nasopharynx
608523|NCT00984074|recurrent lymphoepithelioma of the oropharynx|recurrent lymphoepithelioma of the oropharynx
608524|NCT00984074|recurrent squamous cell carcinoma of the oropharynx|recurrent squamous cell carcinoma of the oropharynx
608525|NCT00984074|stage I lymphoepithelioma of the oropharynx|stage i lymphoepithelioma of the oropharynx
608526|NCT00984074|stage I squamous cell carcinoma of the oropharynx|stage i squamous cell carcinoma of the oropharynx
608527|NCT00984074|stage II lymphoepithelioma of the oropharynx|stage ii lymphoepithelioma of the oropharynx
608528|NCT00984074|stage II squamous cell carcinoma of the oropharynx|stage ii squamous cell carcinoma of the oropharynx
608529|NCT00984074|stage III lymphoepithelioma of the oropharynx|stage iii lymphoepithelioma of the oropharynx
608530|NCT00984074|stage III squamous cell carcinoma of the oropharynx|stage iii squamous cell carcinoma of the oropharynx
608690|NCT00983658|Mild Allergic Asthma|mild allergic asthma
608531|NCT00984074|recurrent esthesioneuroblastoma of the paranasal sinus and nasal cavity|recurrent esthesioneuroblastoma of the paranasal sinus and nasal cavity
608532|NCT00984074|recurrent inverted papilloma of the paranasal sinus and nasal cavity|recurrent inverted papilloma of the paranasal sinus and nasal cavity
608533|NCT00984074|recurrent midline lethal granuloma of the paranasal sinus and nasal cavity|recurrent midline lethal granuloma of the paranasal sinus and nasal cavity
608534|NCT00984074|recurrent squamous cell carcinoma of the paranasal sinus and nasal cavity|recurrent squamous cell carcinoma of the paranasal sinus and nasal cavity
608535|NCT00984074|stage I esthesioneuroblastoma of the paranasal sinus and nasal cavity|stage i esthesioneuroblastoma of the paranasal sinus and nasal cavity
608536|NCT00984074|stage I inverted papilloma of the paranasal sinus and nasal cavity|stage i inverted papilloma of the paranasal sinus and nasal cavity
608537|NCT00984074|stage I midline lethal granuloma of the paranasal sinus and nasal cavity|stage i midline lethal granuloma of the paranasal sinus and nasal cavity
608538|NCT00984074|stage I squamous cell carcinoma of the paranasal sinus and nasal cavity|stage i squamous cell carcinoma of the paranasal sinus and nasal cavity
608539|NCT00984074|stage II esthesioneuroblastoma of the paranasal sinus and nasal cavity|stage ii esthesioneuroblastoma of the paranasal sinus and nasal cavity
608540|NCT00984074|stage II inverted papilloma of the paranasal sinus and nasal cavity|stage ii inverted papilloma of the paranasal sinus and nasal cavity
608541|NCT00984074|stage II midline lethal granuloma of the paranasal sinus and nasal cavity|stage ii midline lethal granuloma of the paranasal sinus and nasal cavity
608542|NCT00984074|stage II squamous cell carcinoma of the paranasal sinus and nasal cavity|stage ii squamous cell carcinoma of the paranasal sinus and nasal cavity
608543|NCT00984074|stage III esthesioneuroblastoma of the paranasal sinus and nasal cavity|stage iii esthesioneuroblastoma of the paranasal sinus and nasal cavity
608544|NCT00984074|stage III inverted papilloma of the paranasal sinus and nasal cavity|stage iii inverted papilloma of the paranasal sinus and nasal cavity
608545|NCT00984074|stage III midline lethal granuloma of the paranasal sinus and nasal cavity|stage iii midline lethal granuloma of the paranasal sinus and nasal cavity
608546|NCT00984074|stage III squamous cell carcinoma of the paranasal sinus and nasal cavity|stage iii squamous cell carcinoma of the paranasal sinus and nasal cavity
608547|NCT00984074|high-grade salivary gland mucoepidermoid carcinoma|high-grade salivary gland mucoepidermoid carcinoma
608548|NCT00984074|low-grade salivary gland mucoepidermoid carcinoma|low-grade salivary gland mucoepidermoid carcinoma
608549|NCT00984074|recurrent salivary gland cancer|recurrent salivary gland cancer
608550|NCT00984074|salivary gland acinic cell tumor|salivary gland acinic cell tumor
608551|NCT00984074|salivary gland adenocarcinoma|salivary gland adenocarcinoma
608552|NCT00984074|salivary gland adenoid cystic carcinoma|salivary gland adenoid cystic carcinoma
608553|NCT00984074|salivary gland anaplastic carcinoma|salivary gland anaplastic carcinoma
608554|NCT00984074|salivary gland malignant mixed cell type tumor|salivary gland malignant mixed cell type tumor
608555|NCT00984074|salivary gland poorly differentiated carcinoma|salivary gland poorly differentiated carcinoma
608556|NCT00984074|salivary gland squamous cell carcinoma|salivary gland squamous cell carcinoma
608557|NCT00984074|stage I salivary gland cancer|stage i salivary gland cancer
608558|NCT00984074|stage II salivary gland cancer|stage ii salivary gland cancer
608559|NCT00984074|tongue cancer|tongue cancer
608560|NCT00984061|healthy|healthy
608561|NCT00984061|pharmacokinetics|pharmacokinetics
608562|NCT00984061|drug-drug interaction|drug-drug interaction
608563|NCT00984048|Colorectal cancer|colorectal cancer
608564|NCT00984048|FOLFOX|folfox
608565|NCT00984048|FOLFIRI|folfiri
608566|NCT00984048|Avastin|avastin
608567|NCT00984048|Metastases|metastases
608568|NCT00984048|Liver|liver
608569|NCT00984048|Colon cancer|colon cancer
608570|NCT00984048|Biomarkers|biomarkers
608571|NCT00984048|Resistance|resistance
608572|NCT00984048|Biobanking|biobanking
608573|NCT00984048|Colorectal cancer with unresectable metastases to the liver|colorectal cancer with unresectable metastases to the liver
608574|NCT00984022|abscess|abscess
608575|NCT00984022|MRSA|mrsa
608576|NCT00984022|Aquacel dressing|aquacel dressing
608577|NCT00984022|Iodoform dressing|iodoform dressing
608578|NCT00984009|healthy|healthy
608579|NCT00984009|pharmacokinetics|pharmacokinetics
608580|NCT00984009|grapefruit juice|grapefruit juice
608581|NCT00984009|furanocoumarins|furanocoumarins
608582|NCT00984009|cytochrome p450 3A4|cytochrome p450 3a4
608583|NCT00983983|Amyotrophic Lateral Sclerosis|amyotrophic lateral sclerosis
608584|NCT00983983|ALS|als
608585|NCT00983983|Motor Neuron Disease|motor neuron disease
608586|NCT00983983|MND|mnd
608587|NCT00983983|Fat|fat
608588|NCT00983983|Lipid|lipid
608589|NCT00983983|Cholesterol|cholesterol
608590|NCT00983983|Omega-3 fatty acid|omega-3 fatty acid
608591|NCT00983983|Diet|diet
608592|NCT00983983|Tube feed|tube feed
608593|NCT00983983|Gastrostomy|gastrostomy
608594|NCT00983983|PEG|peg
608595|NCT00983983|Adults with Amyotrophic Lateral Sclerosis (ALS)|adults with amyotrophic lateral sclerosis (als)
608596|NCT00983970|Adolescents|adolescents
608597|NCT00983970|Obesity|obesity
608598|NCT00983970|Exercise|exercise
608599|NCT00983970|Music|music
608600|NCT00983970|Virtual Reality|virtual reality
608601|NCT00983944|contiguous stage II adult diffuse large cell lymphoma|contiguous stage ii adult diffuse large cell lymphoma
608602|NCT00983944|noncontiguous stage II adult diffuse large cell lymphoma|noncontiguous stage ii adult diffuse large cell lymphoma
608603|NCT00983944|stage I adult diffuse large cell lymphoma|stage i adult diffuse large cell lymphoma
608691|NCT00983658|Allergies|allergies
608604|NCT00983944|stage III adult diffuse large cell lymphoma|stage iii adult diffuse large cell lymphoma
608605|NCT00983944|stage IV adult diffuse large cell lymphoma|stage iv adult diffuse large cell lymphoma
608606|NCT00983944|childhood diffuse large cell lymphoma|childhood diffuse large cell lymphoma
608607|NCT00983944|stage I childhood large cell lymphoma|stage i childhood large cell lymphoma
608608|NCT00983944|stage II childhood large cell lymphoma|stage ii childhood large cell lymphoma
608609|NCT00983944|stage III childhood large cell lymphoma|stage iii childhood large cell lymphoma
608610|NCT00983944|stage IV childhood large cell lymphoma|stage iv childhood large cell lymphoma
608611|NCT00983931|healthy|healthy
608612|NCT00983931|adult|adult
608613|NCT00983931|colchicine|colchicine
608614|NCT00983931|cyclosporine|cyclosporine
608615|NCT00983931|blood levels over time|blood levels over time
608616|NCT00983905|healthy;|healthy;
608617|NCT00983905|adult;|adult;
608618|NCT00983905|blood levels over time|blood levels over time
608619|NCT00983892|Cancer|cancer
608620|NCT00983892|caregiver|caregiver
608621|NCT00983892|pain|pain
608622|NCT00983892|symptom|symptom
608623|NCT00983892|information technology|information technology
608624|NCT00983892|palliative care|palliative care
608625|NCT00983879|Infantile globoid cell leukodystrophy|infantile globoid cell leukodystrophy
608626|NCT00983879|GLD|gld
608627|NCT00983879|Krabbe disease|krabbe disease
608628|NCT00983879|Natural History Study|natural history study
608629|NCT00983853|VX-950|vx-950
608630|NCT00983853|INCIVEK|incivek
608631|NCT00983853|INCIVO|incivo
608632|NCT00983840|diet|diet
608633|NCT00983840|African-American families|african-american families
608634|NCT00983840|web-based|web-based
608635|NCT00983814|Attention Deficit Hyperactivity Disorder|attention deficit hyperactivity disorder
608636|NCT00983814|ADHD|adhd
608637|NCT00983814|Adult ADHD|adult adhd
608638|NCT00983814|Adult Attention Deficit Hyperactivity Disorder|adult attention deficit hyperactivity disorder
608639|NCT00983788|CPT II|cpt ii
608640|NCT00983788|VLCAD|vlcad
608641|NCT00983775|Pharmacokinetic profile|pharmacokinetic profile
608642|NCT00983775|Pharmacodynamic profile|pharmacodynamic profile
608643|NCT00983775|insulin|insulin
608644|NCT00983775|jet injector|jet injector
608645|NCT00983762|Knee osteoarthritis|knee osteoarthritis
608646|NCT00983762|Leg strength|leg strength
608647|NCT00983762|Functional outcomes|functional outcomes
608648|NCT00983762|Minimally Invasive Surgery Mini-Incision (MIS) TKA|minimally invasive surgery mini-incision (mis) tka
608649|NCT00983762|Unicompartmental knee arthroplasty|unicompartmental knee arthroplasty
608650|NCT00983762|Standard Para-patellar surgery TKA|standard para-patellar surgery tka
608651|NCT00983762|gait|gait
608652|NCT00983762|knee arthroplasty|knee arthroplasty
608653|NCT00983749|External Counterpulsation|external counterpulsation
608654|NCT00983749|Counterpulsation, Diastolic|counterpulsation, diastolic
608655|NCT00983749|Ultrasonography, Doppler, Transcranial|ultrasonography, doppler, transcranial
608656|NCT00983749|Blood Flow Velocity|blood flow velocity
608657|NCT00983749|Neurologic Deficit|neurologic deficit
608658|NCT00983723|Patient Foramen Ovale|patient foramen ovale
608659|NCT00983723|PFO|pfo
608660|NCT00983723|Stroke|stroke
608661|NCT00983723|Ischemic Brain Injury|ischemic brain injury
608662|NCT00983723|Neurovascular Disease|neurovascular disease
608663|NCT00983710|prostate neoplasms|prostate neoplasms
608664|NCT00983697|stage II squamous cell carcinoma of the larynx|stage ii squamous cell carcinoma of the larynx
608665|NCT00983697|stage II squamous cell carcinoma of the lip and oral cavity|stage ii squamous cell carcinoma of the lip and oral cavity
608666|NCT00983697|stage II squamous cell carcinoma of the oropharynx|stage ii squamous cell carcinoma of the oropharynx
608667|NCT00983697|stage III squamous cell carcinoma of the larynx|stage iii squamous cell carcinoma of the larynx
608668|NCT00983697|stage III squamous cell carcinoma of the lip and oral cavity|stage iii squamous cell carcinoma of the lip and oral cavity
608669|NCT00983697|stage III squamous cell carcinoma of the oropharynx|stage iii squamous cell carcinoma of the oropharynx
608670|NCT00983697|stage IV squamous cell carcinoma of the larynx|stage iv squamous cell carcinoma of the larynx
608671|NCT00983697|stage IV squamous cell carcinoma of the lip and oral cavity|stage iv squamous cell carcinoma of the lip and oral cavity
608672|NCT00983697|stage IV squamous cell carcinoma of the oropharynx|stage iv squamous cell carcinoma of the oropharynx
608673|NCT00983697|stage II verrucous carcinoma of the oral cavity|stage ii verrucous carcinoma of the oral cavity
608674|NCT00983697|stage III verrucous carcinoma of the oral cavity|stage iii verrucous carcinoma of the oral cavity
608675|NCT00983697|stage IV verrucous carcinoma of the oral cavity|stage iv verrucous carcinoma of the oral cavity
608676|NCT00983697|tongue cancer|tongue cancer
608677|NCT00983684|Neoplasms by Site|neoplasms by site
608678|NCT00983684|Breast Neoplasms|breast neoplasms
608679|NCT00983684|Breast Diseases|breast diseases
608680|NCT00983684|Breast Cancer|breast cancer
608681|NCT00983684|Cancer of Breast|cancer of breast
608682|NCT00983684|Cancer of the Breast|cancer of the breast
608683|NCT00983684|Carcinoma|carcinoma
608684|NCT00983671|Asthma|asthma
608685|NCT00983671|cystic fibrosis|cystic fibrosis
608686|NCT00983671|chronic lung disease|chronic lung disease
608687|NCT00983671|bronchopulmonary dysplasia|bronchopulmonary dysplasia
608688|NCT00983671|pneumonia|pneumonia
608689|NCT00983658|Anti-OX40L|anti-ox40l
608980|NCT00982345|Anxiety|anxiety
608692|NCT00983658|Allergic Asthma|allergic asthma
608693|NCT00983658|Adult Asthma|adult asthma
608694|NCT00983645|Kidney Transplantation|kidney transplantation
608695|NCT00983645|Immunosuppression|immunosuppression
608696|NCT00983632|vagus nerve stimulation|vagus nerve stimulation
608697|NCT00983632|heart rate|heart rate
608698|NCT00983632|systolic arterial pressure|systolic arterial pressure
608699|NCT00983619|Cancer|cancer
608700|NCT00983593|Mind Body Bridging|mind body bridging
608701|NCT00983593|Domestic Violence Offender Treatment|domestic violence offender treatment
608702|NCT00983593|Batterer Treatment|batterer treatment
608703|NCT00983554|testosterone|testosterone
608704|NCT00983554|insulin|insulin
608705|NCT00983554|obesity|obesity
608706|NCT00983554|aromatase|aromatase
608707|NCT00983554|5 alpha reductase|5 alpha reductase
608708|NCT00983541|intra or extrahepatic cholangiocarcinoma|intra or extrahepatic cholangiocarcinoma
608709|NCT00983541|liver cancer|liver cancer
608710|NCT00983541|liver|liver
608711|NCT00983541|HCC|hcc
608712|NCT00983541|EHCC|ehcc
608713|NCT00983528|cancer|cancer
608714|NCT00983528|lymphoblastic|lymphoblastic
608715|NCT00983528|leukemia|leukemia
608716|NCT00983502|Idiopathic Chronic Fatigue|idiopathic chronic fatigue
608717|NCT00983502|Chronic Fatigue Syndrome|chronic fatigue syndrome
608718|NCT00983502|Myalgic encephalomyelitis|myalgic encephalomyelitis
608719|NCT00983489|breast feeding|breast feeding
608720|NCT00983489|counselling|counselling
608721|NCT00983489|video demonstration|video demonstration
608722|NCT00983476|Randomized controlled trial|randomized controlled trial
608723|NCT00983476|Obesity|obesity
608724|NCT00983476|Comparative Effectiveness|comparative effectiveness
608725|NCT00983476|Clinical practice guidelines|clinical practice guidelines
608726|NCT00983476|Medical Informatics Computing|medical informatics computing
608727|NCT00983476|Services, Mental Health|services, mental health
608728|NCT00983476|Self-care|self-care
608729|NCT00983476|Psychotic disorders|psychotic disorders
608730|NCT00983476|Mental Health Care|mental health care
608731|NCT00983476|Veterans|veterans
608732|NCT00983463|Nonalcoholic fatty liver disease (NAFLD)|nonalcoholic fatty liver disease (nafld)
608733|NCT00983463|Nonalcoholic steatohepatitis (NASH)|nonalcoholic steatohepatitis (nash)
608734|NCT00983463|Obesity|obesity
608735|NCT00983463|Lipidomics|lipidomics
608736|NCT00983463|Proteomics|proteomics
608737|NCT00983424|Breast Cancer|breast cancer
608738|NCT00983411|non-invasive intermittent positive-pressure ventilation|non-invasive intermittent positive-pressure ventilation
608739|NCT00983411|work of breathing|work of breathing
608740|NCT00983411|Pulse transit time|pulse transit time
608741|NCT00983385|low back pain|low back pain
608742|NCT00983385|pain|pain
608743|NCT00983385|assessment|assessment
608744|NCT00983385|tapentadol|tapentadol
608745|NCT00983385|centrally acting analgesic|centrally acting analgesic
608746|NCT00983372|healthy; adult; volunteer; colchicine; diltiazem; blood levels over time|healthy; adult; volunteer; colchicine; diltiazem; blood levels over time
608747|NCT00983359|tumors metastatic to brain|tumors metastatic to brain
608748|NCT00983359|unspecified adult solid tumor, protocol specific|unspecified adult solid tumor, protocol specific
608749|NCT00983346|cancer|cancer
608750|NCT00983346|myeloma|myeloma
608751|NCT00983346|multiple myeloma|multiple myeloma
608752|NCT00983346|smoldering myeloma|smoldering myeloma
608753|NCT00983333|Health communication|health communication
608754|NCT00983333|Health literacy|health literacy
608755|NCT00983333|Patient|patient
608756|NCT00983333|Health Care Professional|health care professional
608757|NCT00983333|Satisfaction|satisfaction
608758|NCT00983320|Fibromyalgia|fibromyalgia
608760|NCT00983320|quetiapine|quetiapine
608761|NCT00983320|randomized placebo controlled trial|randomized placebo controlled trial
608762|NCT00983307|Radiation|radiation
608763|NCT00983307|Erlotinib|erlotinib
608764|NCT00983307|Tarceva|tarceva
608765|NCT00983294|blood levels over time;|blood levels over time;
608766|NCT00983294|colchicine;|colchicine;
608767|NCT00983294|azithromycin;|azithromycin;
608768|NCT00983294|healthy|healthy
608769|NCT00983281|Combat casualty care|combat casualty care
608770|NCT00983281|Hextend|hextend
608771|NCT00983281|Colloid|colloid
608772|NCT00983268|periampullary adenocarcinoma|periampullary adenocarcinoma
608773|NCT00983268|stage I pancreatic cancer|stage i pancreatic cancer
608774|NCT00983268|stage II pancreatic cancer|stage ii pancreatic cancer
608775|NCT00983268|stage III pancreatic cancer|stage iii pancreatic cancer
608776|NCT00983229|difficult airway|difficult airway
608777|NCT00983229|fibreoptic intubation|fibreoptic intubation
608778|NCT00983229|supraglottic airways|supraglottic airways
608779|NCT00983229|laryngeal mask airway|laryngeal mask airway
608780|NCT00983216|blood levels over time;|blood levels over time;
608781|NCT00983216|pharmacokinetics;|pharmacokinetics;
608782|NCT00983216|healthy adult;|healthy adult;
608783|NCT00983216|cytochrome p450|cytochrome p450
608784|NCT00983203|Dry eye|dry eye
608785|NCT00983203|artificial tears|artificial tears
608786|NCT00983190|HeartMate II|heartmate ii
608787|NCT00983190|BeneMACS|benemacs
608788|NCT00983190|LVAD|lvad
608789|NCT00983190|Thoratec Corporation|thoratec corporation
608790|NCT00983164|antiviral therapy|antiviral therapy
608791|NCT00983164|antioxidant therapy|antioxidant therapy
608792|NCT00983164|hepatitis C virus|hepatitis c virus
608793|NCT00983164|oxidative stress|oxidative stress
608794|NCT00983164|vitamin E|vitamin e
608795|NCT00983125|Labour|labour
608796|NCT00983125|Epidural analgesia|epidural analgesia
608797|NCT00983125|Clonidine|clonidine
608798|NCT00983125|Levobupivacaine|levobupivacaine
608799|NCT00983125|Opiates|opiates
608800|NCT00983125|Patient-controlled|patient-controlled
608801|NCT00983125|Active spontaneous labour requiring epidural analgesia|active spontaneous labour requiring epidural analgesia
608802|NCT00983112|Gonarthrosis|gonarthrosis
608803|NCT00983112|Knee prosthesis insertion|knee prosthesis insertion
608804|NCT00983112|Bleeding|bleeding
608805|NCT00983112|Undergoing a total knee prothesis surgery|undergoing a total knee prothesis surgery
608806|NCT00983112|knee prothesis surgery|knee prothesis surgery
608807|NCT00983112|Knee arthrosis|knee arthrosis
608808|NCT00983112|Thrombosis|thrombosis
608809|NCT00983086|Flavanones and vascular function|flavanones and vascular function
608810|NCT00983073|Osteoarthritis|osteoarthritis
608811|NCT00983073|Pain|pain
608812|NCT00983073|Assessment|assessment
608813|NCT00983073|Tapentadol|tapentadol
608814|NCT00983073|Centrally acting analgesic|centrally acting analgesic
608815|NCT00983073|Chronic pain due to osteoarthritis|chronic pain due to osteoarthritis
608816|NCT00983060|NIM811|nim811
608817|NCT00983060|chronic hepatitis|chronic hepatitis
608818|NCT00983060|chronic hepatitis C|chronic hepatitis c
608819|NCT00983060|chronic hepatitis C genotype-1|chronic hepatitis c genotype-1
608820|NCT00983060|HCV|hcv
608821|NCT00983060|HCV-1|hcv-1
608822|NCT00983060|relapser|relapser
608823|NCT00983047|Nimotuzumab|nimotuzumab
608824|NCT00983047|NSCLC|nsclc
608825|NCT00983047|Docetaxel|docetaxel
608826|NCT00983034|nephrotic syndrome|nephrotic syndrome
608827|NCT00983034|Helicobacter pylori infection|helicobacter pylori infection
608828|NCT00983034|proteinuria|proteinuria
608829|NCT00983034|membranous nephropathy|membranous nephropathy
608830|NCT00983008|Signs and Symptoms|signs and symptoms
608831|NCT00983008|Internship and Residency|internship and residency
608832|NCT00983008|Fatigue|fatigue
608833|NCT00983008|Medical Errors|medical errors
608834|NCT00983008|Burnout, Professional|burnout, professional
608835|NCT00983008|Actigraphy|actigraphy
608836|NCT00983008|Personnel Staffing and Scheduling|personnel staffing and scheduling
608837|NCT00983008|Workload|workload
608838|NCT00983008|Adult|adult
608839|NCT00983008|Intensive Care Units|intensive care units
608840|NCT00983008|Prospective Studies|prospective studies
608841|NCT00983008|Work Schedule Tolerance|work schedule tolerance
608842|NCT00983008|Disorders of Excessive Somnolence|disorders of excessive somnolence
608843|NCT00983008|Guideline Adherence|guideline adherence
608844|NCT00983008|Internal Medicine Education|internal medicine education
608845|NCT00982982|Schizophrenia|schizophrenia
608846|NCT00982982|Mental Disorders|mental disorders
608847|NCT00982982|Psychotic Disorders|psychotic disorders
608848|NCT00982982|Schizophrenia and Disorders with Psychotic Features|schizophrenia and disorders with psychotic features
608849|NCT00982982|Cannabis|cannabis
608850|NCT00982969|tuberculosis|tuberculosis
608851|NCT00982969|pneumonia|pneumonia
608852|NCT00982969|QuantiFERON-TB Gold in-tube|quantiferon-tb gold in-tube
608853|NCT00982969|Tuberculin skin test|tuberculin skin test
608854|NCT00982930|Tobramycin Inhalation Powder|tobramycin inhalation powder
608855|NCT00982930|Cystic fibrosis|cystic fibrosis
608856|NCT00982930|Lung diseases|lung diseases
608857|NCT00982930|Anti-Bacterial Agents|anti-bacterial agents
608858|NCT00982917|playground|playground
608859|NCT00982917|injury prevention|injury prevention
608860|NCT00982904|neglected disease|neglected disease
608861|NCT00982904|africa|africa
608862|NCT00982904|new drug|new drug
608863|NCT00982904|oral drug|oral drug
608864|NCT00982904|parasite|parasite
608865|NCT00982891|chronic obstructive pulmonary disease|chronic obstructive pulmonary disease
608866|NCT00982891|palliation|palliation
608867|NCT00982891|opioids|opioids
608868|NCT00982878|treatment experienced|treatment experienced
608869|NCT00982865|MEK inhibitor|mek inhibitor
608870|NCT00982865|Cancer|cancer
608871|NCT00982865|Solid tumors|solid tumors
608872|NCT00982852|Angioplasty|angioplasty
608873|NCT00982852|Coronary Vessels|coronary vessels
608874|NCT00982852|Heart Disease|heart disease
608875|NCT00982852|Cardiology|cardiology
608876|NCT00982852|Atherosclerosis|atherosclerosis
608877|NCT00982852|Catheterization|catheterization
608878|NCT00982826|Phase 1|phase 1
608879|NCT00982826|Single and Multiple Ascending Dose|single and multiple ascending dose
608880|NCT00982826|Food Effect|food effect
608881|NCT00982813|Periodontal disease|periodontal disease
608882|NCT00982813|Per-term delivery|per-term delivery
608883|NCT00982813|Sulcular bleeding index|sulcular bleeding index
608884|NCT00982813|Bacteriological gingival presence|bacteriological gingival presence
608885|NCT00982813|Cytokines|cytokines
608886|NCT00982813|Active periodontal disease with sulcular bleeding index|active periodontal disease with sulcular bleeding index
608981|NCT00982345|Seroquel|seroquel
608887|NCT00982813|Bacteriological sampling in periodontal pocketing|bacteriological sampling in periodontal pocketing
608888|NCT00982813|Cytokines in the periodontal pocketing|cytokines in the periodontal pocketing
608889|NCT00982800|gabapentin|gabapentin
608890|NCT00982800|opioid consumption|opioid consumption
608891|NCT00982800|analgesic|analgesic
608892|NCT00982800|anxiety|anxiety
608893|NCT00982800|quality of life|quality of life
608894|NCT00982787|Epilepsy|epilepsy
608895|NCT00982787|Seizures|seizures
608896|NCT00982787|Passiflora|passiflora
608897|NCT00982774|PKDL|pkdl
608898|NCT00982761|occupational drivers|occupational drivers
608899|NCT00982761|health status|health status
608900|NCT00982748|Fatigue|fatigue
608901|NCT00982748|Chemotherapy|chemotherapy
608902|NCT00982748|Yoga|yoga
608903|NCT00982748|Breathing|breathing
608904|NCT00982748|Cancer|cancer
608905|NCT00982748|Anxiety|anxiety
608906|NCT00982748|Pranayama|pranayama
608907|NCT00982748|Stress|stress
608908|NCT00982748|Fatigue-associated symptoms in chemotherapy patients|fatigue-associated symptoms in chemotherapy patients
608909|NCT00982748|Quality of life in chemotherapy patients|quality of life in chemotherapy patients
608910|NCT00982722|primary hyperparathyroidism|primary hyperparathyroidism
608911|NCT00982722|postoperative vitamin D supplementation|postoperative vitamin d supplementation
608912|NCT00982696|head and neck cancer|head and neck cancer
608913|NCT00982696|opioid growth factor|opioid growth factor
608914|NCT00982683|Surgery|surgery
608915|NCT00982683|Moon phases|moon phases
608916|NCT00982683|hemorrhage|hemorrhage
608917|NCT00982670|Metabolic syndrome|metabolic syndrome
608918|NCT00982670|Systemic lupus erythematosus|systemic lupus erythematosus
608919|NCT00982657|Phase Ib Phase II Advanced solid tumor Clear cell renal cancer Sunitinib plus / minus CVX-060|phase ib phase ii advanced solid tumor clear cell renal cancer sunitinib plus / minus cvx-060
608920|NCT00982631|temsirolimus (Torisel®)|temsirolimus (torisel®)
608921|NCT00982631|pegylated liposomal doxorubicin (PLD, Doxil®/ Caelyx®)|pegylated liposomal doxorubicin (pld, doxil®/ caelyx®)
608922|NCT00982579|HIV preventive vaccine|hiv preventive vaccine
608923|NCT00982553|Healthy Volunteers|healthy volunteers
608924|NCT00982540|empiric antifungal therapy|empiric antifungal therapy
608925|NCT00982540|preemptive antifungal therapy|preemptive antifungal therapy
608926|NCT00982540|febrile neutropenia|febrile neutropenia
608927|NCT00982540|risk stratification|risk stratification
608928|NCT00982540|invasive fungal infection|invasive fungal infection
608929|NCT00982527|cardiopulmonary bypass|cardiopulmonary bypass
608930|NCT00982527|pediatric cardiac surgery|pediatric cardiac surgery
608931|NCT00982527|acute renal failure|acute renal failure
608932|NCT00982527|renal biomarkers|renal biomarkers
608933|NCT00982527|fenoldopam|fenoldopam
608934|NCT00982527|Focus on optimization of perfusion during pediatric CPB|focus on optimization of perfusion during pediatric cpb
608935|NCT00982514|Asparaginase|asparaginase
608936|NCT00982514|thrombosis|thrombosis
608937|NCT00982514|ALL|all
608938|NCT00982514|central line|central line
608939|NCT00982501|(BMI 25-29,9 kg/m2)|(bmi 25-29,9 kg/m2)
608940|NCT00982475|pulmonary vein isolation|pulmonary vein isolation
608941|NCT00982475|robotic navigation|robotic navigation
608942|NCT00982475|atrial fibrillation|atrial fibrillation
608943|NCT00982462|cognition|cognition
608944|NCT00982462|vision|vision
608945|NCT00982462|immunology|immunology
608946|NCT00982462|DHA|dha
608947|NCT00982462|ARA|ara
608948|NCT00982462|infant|infant
608949|NCT00982462|nutrition|nutrition
608950|NCT00982449|EBV+ malignancies|ebv+ malignancies
608951|NCT00982449|KSHV+ malignancies|kshv+ malignancies
608952|NCT00982449|HIV-associated lymphomas|hiv-associated lymphomas
608953|NCT00982449|Hodgkin Lymphoma|hodgkin lymphoma
608954|NCT00982449|nonHodgkin Lymphoma or|nonhodgkin lymphoma or
608955|NCT00982449|nonHodgkins Lymphoproliferative Disease|nonhodgkins lymphoproliferative disease
608956|NCT00982449|Primary Effusion Lymphoma|primary effusion lymphoma
608957|NCT00982449|Kaposi's Sarcoma|kaposi's sarcoma
608958|NCT00982449|Gastric Cancer|gastric cancer
608959|NCT00982449|Nasopharyngeal Cancer|nasopharyngeal cancer
608960|NCT00982436|Combined Modality Therapy|combined modality therapy
608961|NCT00982436|Neoadjuvant Therapy|neoadjuvant therapy
608962|NCT00982436|Head and neck neoplasms|head and neck neoplasms
608963|NCT00982423|heart failure|heart failure
608964|NCT00982423|heart failure with and without kidney dysfunction|heart failure with and without kidney dysfunction
608965|NCT00982410|pain|pain
608966|NCT00982410|alcohol|alcohol
608967|NCT00982410|illicit drugs|illicit drugs
608968|NCT00982410|pain management|pain management
608969|NCT00982384|Chronic obstructive pulmonary disease|chronic obstructive pulmonary disease
608970|NCT00982384|Disease management|disease management
608971|NCT00982384|Pulmonary rehabilitation|pulmonary rehabilitation
608972|NCT00982384|Quality of life|quality of life
608973|NCT00982371|type 2 diabetes mellitus|type 2 diabetes mellitus
608974|NCT00982371|osteoporosis|osteoporosis
608975|NCT00982371|bone quality|bone quality
608976|NCT00982371|magnetic resonance imaging|magnetic resonance imaging
608977|NCT00982371|fracture|fracture
608978|NCT00982371|postmenopausal women >65 years old|postmenopausal women >65 years old
608979|NCT00982345|Depression|depression
608985|NCT00982332|polymyalgia rheumatica|polymyalgia rheumatica
608986|NCT00982319|Broccoli Sprout Extract|broccoli sprout extract
608987|NCT00982319|Breast Cancer|breast cancer
608989|NCT00982306|brief interventions|brief interventions
608990|NCT00982306|counseling|counseling
608991|NCT00982306|harmful/hazardous alcohol drinkers|harmful/hazardous alcohol drinkers
608992|NCT00982280|Osteoarthritis|osteoarthritis
608993|NCT00982280|pain assessment|pain assessment
608994|NCT00982280|tapentadol|tapentadol
608995|NCT00982280|centrally acting analgesic|centrally acting analgesic
608996|NCT00982267|cancer|cancer
608997|NCT00982254|Type 2 Diabetes|type 2 diabetes
608998|NCT00982254|Oral Insulin|oral insulin
608999|NCT00982254|Pharmacokinetics|pharmacokinetics
609000|NCT00982254|Pharmacodynamics|pharmacodynamics
609001|NCT00982241|OAB|oab
609002|NCT00982241|urine|urine
609003|NCT00982241|osmolality|osmolality
609004|NCT00982241|urge|urge
609005|NCT00982241|fluid intake|fluid intake
609006|NCT00982241|PPIUS|ppius
609007|NCT00982241|urge score|urge score
609008|NCT00982241|bladder|bladder
609009|NCT00982215|Paracetamol|paracetamol
609010|NCT00982215|per-oral mucosa PMB|per-oral mucosa pmb
609011|NCT00982215|No disease, healthy volunteers|no disease, healthy volunteers
609012|NCT00982202|PPAR-gamma|ppar-gamma
609013|NCT00982202|inflammation|inflammation
609014|NCT00982189|treatment experienced|treatment experienced
609015|NCT00982176|Anatomo-functional determinants|anatomo-functional determinants
609016|NCT00982176|cognitive impairment|cognitive impairment
609017|NCT00982176|coronary syndrome|coronary syndrome
609018|NCT00982176|brain MRI|brain mri
609019|NCT00982176|cerebral perfusion scintigraphy|cerebral perfusion scintigraphy
609020|NCT00982150|Talampanel|talampanel
609021|NCT00982150|Open-Label Study|open-label study
609022|NCT00982150|Amyotrophic Lateral Sclerosis|amyotrophic lateral sclerosis
609023|NCT00982137|Japanese Encephalitis|japanese encephalitis
609024|NCT00982137|Yellow Fever|yellow fever
609025|NCT00982137|ChimeriVax™-JE|chimerivax™-je
609026|NCT00982137|STAMARIL®|stamaril®
609027|NCT00982137|Adult|adult
609028|NCT00982124|Osteogenesis Imperfecta|osteogenesis imperfecta
609029|NCT00982124|Infants with moderate to severe Osteogenesis Imperfecta|infants with moderate to severe osteogenesis imperfecta
609030|NCT00982111|Nonsquamous|nonsquamous
609031|NCT00982111|Non Small Cell Lung Cancer|non small cell lung cancer
609032|NCT00982111|First line treatment|first line treatment
609033|NCT00982111|Monoclonal|monoclonal
609034|NCT00982111|Antibodies|antibodies
609035|NCT00982111|Epidermal Growth Factor Receptor (EGFR)|epidermal growth factor receptor (egfr)
609036|NCT00982098|Prostatectomy|prostatectomy
609037|NCT00982098|Prostatic cancer|prostatic cancer
609038|NCT00982098|Urinary incontinence|urinary incontinence
609039|NCT00982098|Exercise|exercise
609040|NCT00982098|Electric stimulation therapy|electric stimulation therapy
609041|NCT00982098|Counseling|counseling
609042|NCT00982085|Asthma|asthma
609043|NCT00982085|Allergic rhinitis|allergic rhinitis
609044|NCT00982085|Military|military
609045|NCT00982072|nephrotic minimal change tacrolimus prednisolone|nephrotic minimal change tacrolimus prednisolone
609046|NCT00982059|Colorectal cancer screening|colorectal cancer screening
609047|NCT00982059|Cancer survivor|cancer survivor
609048|NCT00982059|Radiation therapy|radiation therapy
609049|NCT00982046|contact lenses|contact lenses
609050|NCT00982046|disinfection solutions|disinfection solutions
609051|NCT00982046|contact lens care|contact lens care
609052|NCT00982033|Heart failure with normal ejection fraction|heart failure with normal ejection fraction
609053|NCT00982033|Elderly|elderly
609054|NCT00982020|safety|safety
609055|NCT00982020|schizophrenia|schizophrenia
609056|NCT00982020|bipolar I (manic or mixed)|bipolar i (manic or mixed)
609057|NCT00982020|adolescents|adolescents
609058|NCT00982020|weight management|weight management
609059|NCT00982007|IDA|ida
609060|NCT00981994|respiratory infection|respiratory infection
609061|NCT00981994|antimicrobial drugs|antimicrobial drugs
609062|NCT00981994|decision support|decision support
609063|NCT00981994|Adult patients|adult patients
609064|NCT00981981|humans|humans
609065|NCT00981981|randomized clinical trial|randomized clinical trial
609066|NCT00981981|dietary fiber|dietary fiber
609067|NCT00981981|nutrition|nutrition
609068|NCT00981981|beta-glucan|beta-glucan
609069|NCT00981981|oats|oats
609070|NCT00981981|LDL cholesterol|ldl cholesterol
609071|NCT00981981|coronary heart disease|coronary heart disease
609072|NCT00981955|Caffeine|caffeine
609073|NCT00981955|Ltheanine|ltheanine
609074|NCT00981955|Near Infrared Spectroscopy|near infrared spectroscopy
609075|NCT00981955|Cerebral Blood Flow|cerebral blood flow
609076|NCT00981955|Cognitive Function|cognitive function
609077|NCT00981955|Mood|mood
609078|NCT00981942|Nephrogenic systemic fibrosis|nephrogenic systemic fibrosis
609079|NCT00981942|Imatinib mesylate|imatinib mesylate
609080|NCT00981942|Glivec|glivec
609081|NCT00981942|Gleevec|gleevec
609082|NCT00981929|CYP2D6|cyp2d6
609083|NCT00981929|CYP2C9|cyp2c9
609084|NCT00981929|CYP2C19|cyp2c19
609085|NCT00981929|CYP1A2|cyp1a2
609086|NCT00981916|determination of depth to epidural space using ultrasound|determination of depth to epidural space using ultrasound
609087|NCT00981903|VTE in cancer patients|vte in cancer patients
609088|NCT00981890|Brain Metastases|brain metastases
609089|NCT00981890|Stereotactic radiosurgery|stereotactic radiosurgery
609090|NCT00981890|Sunitinib|sunitinib
609091|NCT00981890|Patients with Brain Metastases|patients with brain metastases
609092|NCT00981877|acute diarrhea|acute diarrhea
609093|NCT00981877|rotavirus|rotavirus
609094|NCT00981877|probiotic|probiotic
609095|NCT00981877|children|children
609096|NCT00981864|radiation therapy in breast cancer|radiation therapy in breast cancer
609097|NCT00981864|concurrent radiation|concurrent radiation
609098|NCT00981864|Breast cancer patients|breast cancer patients
609099|NCT00981851|intervention study|intervention study
609100|NCT00981851|interaction|interaction
609101|NCT00981851|COPD|copd
609102|NCT00981812|PET|pet
609103|NCT00981812|PEM|pem
609104|NCT00981812|Positron Emission Mammography|positron emission mammography
609105|NCT00981812|Breast Biopsy|breast biopsy
609106|NCT00981799|Relapse|relapse
609107|NCT00981799|T cell|t cell
609108|NCT00981799|Lymphoblastic|lymphoblastic
609109|NCT00981799|Leukemia|leukemia
609110|NCT00981799|Lymphoma|lymphoma
609111|NCT00981799|Nelarabine|nelarabine
609112|NCT00981799|TACL|tacl
609113|NCT00981799|NECTAR|nectar
609114|NCT00981786|24-hour IOP control|24-hour iop control
609115|NCT00981786|brinzolamide/timolol|brinzolamide/timolol
609116|NCT00981786|brimonidine/timolol|brimonidine/timolol
609117|NCT00981786|travoprost|travoprost
609118|NCT00981773|HIV switch|hiv switch
609119|NCT00981773|HIV|hiv
609120|NCT00981773|treatment experienced|treatment experienced
609121|NCT00981734|Aging|aging
609122|NCT00981734|functionality|functionality
609123|NCT00981734|life style|life style
609124|NCT00981734|To have more than sixty years|to have more than sixty years
609125|NCT00981721|Phase I|phase i
609126|NCT00981721|Advanced solid malignancies|advanced solid malignancies
609127|NCT00981721|Advanced solid tumour|advanced solid tumour
609128|NCT00981721|Advanced cancer|advanced cancer
609129|NCT00981721|Cediranib (RECENTIN™, AZD2171)|cediranib (recentin™, azd2171)
609130|NCT00981721|China|china
609131|NCT00981721|PK|pk
609132|NCT00981721|pharmacokinetics|pharmacokinetics
609133|NCT00981708|Amyloidosis|amyloidosis
609134|NCT00981708|lenalidomide|lenalidomide
609135|NCT00981708|newly diagnosed|newly diagnosed
609136|NCT00981708|relapsed|relapsed
609137|NCT00981708|primary systemic AL amyloidosis|primary systemic al amyloidosis
609138|NCT00981695|HIV|hiv
609139|NCT00981695|Vaccine|vaccine
609140|NCT00981695|MVA|mva
609141|NCT00981695|PMTCT|pmtct
609142|NCT00981695|HIV preventive vaccine|hiv preventive vaccine
609143|NCT00981695|HIV seronegativity|hiv seronegativity
609144|NCT00981682|decrease in the number of nocturic episodes for patients with nocturia|decrease in the number of nocturic episodes for patients with nocturia
609145|NCT00981669|brazilian pentavalent rotavirus vaccine|brazilian pentavalent rotavirus vaccine
609146|NCT00981669|safety|safety
609147|NCT00981669|tolerability|tolerability
609148|NCT00981669|immunogenicity|immunogenicity
609149|NCT00981656|stage I bladder cancer|stage i bladder cancer
609150|NCT00981656|transitional cell carcinoma of the bladder|transitional cell carcinoma of the bladder
609151|NCT00981643|Meditation|meditation
609152|NCT00981643|Multiple Sclerosis|multiple sclerosis
609153|NCT00981643|Peripheral Neuropathy|peripheral neuropathy
609154|NCT00981630|Japanese Encephalitis|japanese encephalitis
609155|NCT00981630|ChimeriVax™-JE Vaccine|chimerivax™-je vaccine
609156|NCT00981630|Adult|adult
609157|NCT00981604|SILS|sils
609158|NCT00981604|Laparoscopic Cholecystectomy|laparoscopic cholecystectomy
609159|NCT00981604|Children|children
609160|NCT00981591|Iloprost|iloprost
609161|NCT00981591|Nitric oxide|nitric oxide
609162|NCT00981591|Mechanical ventilator|mechanical ventilator
609163|NCT00981578|bone cancer|bone cancer
609164|NCT00981578|pain palliation|pain palliation
609165|NCT00981578|metastasis|metastasis
609166|NCT00981578|breast cancer|breast cancer
609167|NCT00981578|lung cancer|lung cancer
609168|NCT00981578|prostate cancer|prostate cancer
609169|NCT00981578|cancer related pain|cancer related pain
609170|NCT00981578|tumors|tumors
609171|NCT00981565|Carpal tunnel syndrome|carpal tunnel syndrome
609172|NCT00981565|CTS|cts
609173|NCT00981565|medianus impingement|medianus impingement
609174|NCT00981552|Cervix Cancer|cervix cancer
609175|NCT00981552|IMRT|imrt
609176|NCT00981552|Organ Motion|organ motion
609177|NCT00981552|Target Definition|target definition
609178|NCT00981539|The focus of this study is to determine whether it is beneficial to administer enemas before surgery|the focus of this study is to determine whether it is beneficial to administer enemas before surgery
609179|NCT00981526|Schizophrenia|schizophrenia
609180|NCT00981526|Cognition|cognition
609181|NCT00981526|Metabolism|metabolism
609182|NCT00981526|Antipsychotics|antipsychotics
609183|NCT00981526|Psychopathology|psychopathology
609184|NCT00981500|obesity|obesity
609185|NCT00981500|gastric bypass|gastric bypass
609186|NCT00981500|gastric banding|gastric banding
609187|NCT00981500|weight loss|weight loss
609188|NCT00981500|insulin sensitivity|insulin sensitivity
609189|NCT00981500|sleeve gastrectomy|sleeve gastrectomy
609190|NCT00981500|fibroblast growth factor 21|fibroblast growth factor 21
609191|NCT00981500|fibroblast growth factor 19|fibroblast growth factor 19
609192|NCT00981474|cardiac surgery; brain injury; cerebral autoregulation|cardiac surgery; brain injury; cerebral autoregulation
609193|NCT00981461|Andregenetic Alopecia|andregenetic alopecia
609194|NCT00981461|Hair Loss|hair loss
609195|NCT00981461|Female Pattern Baldness|female pattern baldness
609196|NCT00981448|zinc|zinc
609197|NCT00981448|diabetes|diabetes
609198|NCT00981448|genetics|genetics
609199|NCT00981435|Glaucoma|glaucoma
609200|NCT00981435|Trabeculoplasty|trabeculoplasty
609201|NCT00981435|Selective laser trabeculoplasty|selective laser trabeculoplasty
609202|NCT00981435|Intraocular pressure|intraocular pressure
609203|NCT00981422|glaucoma|glaucoma
609204|NCT00981422|immunology|immunology
609205|NCT00981422|immunophenotype|immunophenotype
609206|NCT00981409|Fondaparinux sodium|fondaparinux sodium
609207|NCT00981409|contrast-enhanced MDCT|contrast-enhanced mdct
609208|NCT00981409|Deep Vein Thrombosis|deep vein thrombosis
609209|NCT00981409|Pulmonary thromboembolism|pulmonary thromboembolism
609210|NCT00981396|smoking|smoking
609211|NCT00981396|EFT (Emotional Freedom Techniques)|eft (emotional freedom techniques)
609212|NCT00981396|CBT (cognitive behavior therapy)|cbt (cognitive behavior therapy)
609213|NCT00981396|cravings|cravings
609214|NCT00981396|trauma|trauma
609215|NCT00981383|Fatty Acids, Omega-3|fatty acids, omega-3
609216|NCT00981370|Sickle Cell Disease|sickle cell disease
609217|NCT00981370|Sickle Cell Anemia|sickle cell anemia
609218|NCT00981370|Iron Overload|iron overload
609219|NCT00981370|Chelation Therapy|chelation therapy
609220|NCT00981370|Iron overload from blood transfusions|iron overload from blood transfusions
609221|NCT00981370|Heart rate variability|heart rate variability
609222|NCT00981370|Autonomic dysfunction|autonomic dysfunction
609223|NCT00981357|Cross-over evaluate the efficacy of PF-04457845 in relieving pain due to osteoarthritis OA knee osteoarthritis of knee pain due to osteoarthritis|cross-over evaluate the efficacy of pf-04457845 in relieving pain due to osteoarthritis oa knee osteoarthritis of knee pain due to osteoarthritis
609224|NCT00981344|wheelchair|wheelchair
609225|NCT00981344|mobility disability|mobility disability
609226|NCT00981344|evidence based practice|evidence based practice
609227|NCT00981344|self help devices|self help devices
609228|NCT00981344|Veterans prescribed mobility aids|veterans prescribed mobility aids
609229|NCT00981331|Subtalar joint|subtalar joint
609230|NCT00981331|Musculoskeletal Manipulations|musculoskeletal manipulations
609231|NCT00981331|Manipulation, Chiropractic|manipulation, chiropractic
609232|NCT00981331|Ankle sprain|ankle sprain
609233|NCT00981331|Inversion sprain|inversion sprain
609234|NCT00981331|Range of motion, Articular|range of motion, articular
609235|NCT00981331|Quaternion|quaternion
609236|NCT00981331|Eigen analysis|eigen analysis
609237|NCT00981318|Acquired Immunodeficiency Syndrome|acquired immunodeficiency syndrome
609239|NCT00981318|AIDS|aids
609240|NCT00981318|treatment experienced|treatment experienced
609241|NCT00981305|dyspareunia|dyspareunia
609242|NCT00981305|breast cancer|breast cancer
609243|NCT00981305|sexual dysfunction|sexual dysfunction
609244|NCT00981305|vaginal lubricant|vaginal lubricant
609245|NCT00981292|Epigallocatechin Gallate|epigallocatechin gallate
609246|NCT00981292|cerebral blood flow|cerebral blood flow
609247|NCT00981292|Near Infrared spectroscopy|near infrared spectroscopy
609248|NCT00981292|Electroencephalography|electroencephalography
609249|NCT00981292|cognitive function|cognitive function
609250|NCT00981292|mood|mood
609251|NCT00981292|cerebro-electrical activity|cerebro-electrical activity
609252|NCT00981279|Health Profile|health profile
609253|NCT00981279|AIDS|aids
609254|NCT00981279|Health Promotion|health promotion
609255|NCT00981279|HIV|hiv
609256|NCT00981279|treatment experienced|treatment experienced
609257|NCT00981266|Augmentation|augmentation
609258|NCT00981266|Augmentation Revision|augmentation revision
609259|NCT00981253|Stress Management Training|stress management training
609260|NCT00981253|Cardiac Rehabilitation|cardiac rehabilitation
609261|NCT00981253|Stress|stress
609262|NCT00981253|Depression|depression
609263|NCT00981227|pain herpetic neuralgia|pain herpetic neuralgia
609264|NCT00981214|Cystic fibrosis|cystic fibrosis
609265|NCT00981214|Exocrine Pancreatic Insufficiency|exocrine pancreatic insufficiency
609266|NCT00981214|Zenpep-1009|zenpep-1009
609267|NCT00981201|Smoking|smoking
609268|NCT00981201|Cancer Prevention|cancer prevention
609269|NCT00981201|Celecoxib|celecoxib
609270|NCT00981201|Celebrex|celebrex
609271|NCT00981201|Placebo|placebo
609272|NCT00981175|Japanese Encephalitis|japanese encephalitis
609273|NCT00981175|Japanese Encephalitis Vaccines|japanese encephalitis vaccines
609274|NCT00981175|Adult|adult
609275|NCT00981136|Appendicitis|appendicitis
609276|NCT00981136|Appendectomy|appendectomy
609277|NCT00981136|Children|children
609278|NCT00981136|Laparoscopic|laparoscopic
609279|NCT00981136|SILS|sils
609280|NCT00981110|Surgical site infections (SSI)|surgical site infections (ssi)
609281|NCT00981110|Advanced antimicrobial dressing and clean surgery|advanced antimicrobial dressing and clean surgery
609282|NCT00981110|Hydrofibre dressing|hydrofibre dressing
609283|NCT00981097|HIV infection|hiv infection
609284|NCT00981097|HIV-associated Hodgkin lymphoma|hiv-associated hodgkin lymphoma
609285|NCT00981097|stage I adult Hodgkin lymphoma|stage i adult hodgkin lymphoma
609286|NCT00981097|stage II adult Hodgkin lymphoma|stage ii adult hodgkin lymphoma
609287|NCT00981097|stage III adult Hodgkin lymphoma|stage iii adult hodgkin lymphoma
609288|NCT00981097|stage IV adult Hodgkin lymphoma|stage iv adult hodgkin lymphoma
609289|NCT00981097|contiguous stage II adult Burkitt lymphoma|contiguous stage ii adult burkitt lymphoma
609290|NCT00981097|noncontiguous stage II adult Burkitt lymphoma|noncontiguous stage ii adult burkitt lymphoma
609291|NCT00981097|stage I adult Burkitt lymphoma|stage i adult burkitt lymphoma
609292|NCT00981097|stage III adult Burkitt lymphoma|stage iii adult burkitt lymphoma
609293|NCT00981097|stage IV adult Burkitt lymphoma|stage iv adult burkitt lymphoma
609294|NCT00981097|contiguous stage II adult diffuse large cell lymphoma|contiguous stage ii adult diffuse large cell lymphoma
609295|NCT00981097|noncontiguous stage II adult diffuse large cell lymphoma|noncontiguous stage ii adult diffuse large cell lymphoma
609296|NCT00981097|stage I adult diffuse large cell lymphoma|stage i adult diffuse large cell lymphoma
609297|NCT00981097|stage III adult diffuse large cell lymphoma|stage iii adult diffuse large cell lymphoma
609298|NCT00981097|stage IV adult diffuse large cell lymphoma|stage iv adult diffuse large cell lymphoma
609299|NCT00981097|contiguous stage II adult immunoblastic large cell lymphoma|contiguous stage ii adult immunoblastic large cell lymphoma
609300|NCT00981097|noncontiguous stage II adult immunoblastic large cell lymphoma|noncontiguous stage ii adult immunoblastic large cell lymphoma
609301|NCT00981097|stage I adult immunoblastic large cell lymphoma|stage i adult immunoblastic large cell lymphoma
609302|NCT00981097|stage III adult immunoblastic large cell lymphoma|stage iii adult immunoblastic large cell lymphoma
609303|NCT00981097|stage IV adult immunoblastic large cell lymphoma|stage iv adult immunoblastic large cell lymphoma
609304|NCT00981071|Tuberculosis|tuberculosis
609305|NCT00981071|QuantiFERON|quantiferon
609306|NCT00981071|Outbreak|outbreak
609307|NCT00981071|Conversion|conversion
609308|NCT00981058|Squamous|squamous
609309|NCT00981058|Non Small Cell Lung Cancer|non small cell lung cancer
609310|NCT00981058|First line treatment|first line treatment
609311|NCT00981058|Monoclonal|monoclonal
609312|NCT00981058|Antibodies|antibodies
609313|NCT00981058|Epidermal Growth Factor Receptor (EGFR)|epidermal growth factor receptor (egfr)
609315|NCT00981032|Aspirin|aspirin
609316|NCT00981032|Behavior|behavior
609317|NCT00981032|Cardiovascular Disease|cardiovascular disease
609318|NCT00981019|survival rates|survival rates
609319|NCT00981019|risk communication|risk communication
609320|NCT00981019|screening counselling|screening counselling
609321|NCT00981019|screening recommendation|screening recommendation
609322|NCT00981019|understanding of medical risk|understanding of medical risk
609323|NCT00981006|ischemic cardiomyopathy (ICM)|ischemic cardiomyopathy (icm)
609324|NCT00980993|Prostate|prostate
609325|NCT00980993|Motion|motion
609326|NCT00980993|Respiration|respiration
609327|NCT00980980|MRSA infection|mrsa infection
609328|NCT00980967|Lung transplantation|lung transplantation
609329|NCT00980967|Chronic lung rejection|chronic lung rejection
609330|NCT00980967|Obliterative bronchiolitis|obliterative bronchiolitis
609331|NCT00980967|Predictive factors|predictive factors
609332|NCT00980954|cervical adenocarcinoma|cervical adenocarcinoma
609333|NCT00980954|cervical adenosquamous cell carcinoma|cervical adenosquamous cell carcinoma
609334|NCT00980954|cervical squamous cell carcinoma|cervical squamous cell carcinoma
609335|NCT00980954|stage IA cervical cancer|stage ia cervical cancer
609336|NCT00980954|stage IB cervical cancer|stage ib cervical cancer
609337|NCT00980954|stage IIA cervical cancer|stage iia cervical cancer
609338|NCT00980941|starch|starch
609339|NCT00980941|carbohydrates|carbohydrates
609340|NCT00980941|blood glucose|blood glucose
609341|NCT00980941|food intake|food intake
609342|NCT00980941|satiety|satiety
609343|NCT00980941|appetite|appetite
609344|NCT00980915|Acute Lung Injury|acute lung injury
609345|NCT00980915|Acute Respiratory Distress Syndrome|acute respiratory distress syndrome
609346|NCT00980915|Respiratory Distress|respiratory distress
609347|NCT00980915|pneumonia|pneumonia
609348|NCT00980915|sepsis|sepsis
609349|NCT00980915|aspiration|aspiration
609350|NCT00980915|pancreatitis|pancreatitis
609351|NCT00980889|bile duct obstruction|bile duct obstruction
609352|NCT00980889|jaundice|jaundice
609353|NCT00980889|metal stent|metal stent
609354|NCT00980850|Flu vaccine|flu vaccine
609355|NCT00980850|H1N1 swine flu virus|h1n1 swine flu virus
609356|NCT00980850|Immunogenicity|immunogenicity
609357|NCT00980850|Reactogenicity|reactogenicity
609358|NCT00980824|cognitive behaviour therapy|cognitive behaviour therapy
609359|NCT00980824|self harm|self harm
609360|NCT00980824|personality disorder|personality disorder
609361|NCT00980824|complex comorbidity|complex comorbidity
609362|NCT00980824|mental health|mental health
609363|NCT00980798|Osteoarthritis|osteoarthritis
609364|NCT00980798|Strong pain killer|strong pain killer
609365|NCT00980798|Strong opioid|strong opioid
609366|NCT00980798|Low starting dose|low starting dose
609367|NCT00980798|Fewer side effects|fewer side effects
609368|NCT00980798|Physical functioning|physical functioning
609369|NCT00980798|Pain control|pain control
609370|NCT00980798|Quality of life|quality of life
609371|NCT00980798|Sleep quality|sleep quality
609372|NCT00980785|Alzheimer's Disease|alzheimer's disease
609373|NCT00980785|Hypertension|hypertension
609374|NCT00980759|Extended-field Irradiation (EFI)|extended-field irradiation (efi)
609375|NCT00980759|Cervical cancer|cervical cancer
609376|NCT00980759|Hypoxia|hypoxia
609377|NCT00980759|Carbonic anhydrase 9 (CA9)|carbonic anhydrase 9 (ca9)
609378|NCT00980759|locally advanced uterine cervical cancer|locally advanced uterine cervical cancer
609379|NCT00980746|pain diabetes neuropathy|pain diabetes neuropathy
609380|NCT00980733|Micronutrients|micronutrients
609381|NCT00980733|zinc|zinc
609382|NCT00980733|iron|iron
609383|NCT00980733|iodine|iodine
609384|NCT00980733|fortification|fortification
609385|NCT00980733|school children|school children
609386|NCT00980707|versican|versican
609387|NCT00980707|hyaluronan|hyaluronan
609388|NCT00980707|sputum|sputum
609389|NCT00980694|ubiquinol|ubiquinol
609390|NCT00980694|coenzyme Q10|coenzyme q10
609391|NCT00980694|Huntington disease|huntington disease
609392|NCT00980681|Renal disease|renal disease
609393|NCT00980681|Contrast agent|contrast agent
609395|NCT00980642|surgery|surgery
609396|NCT00980642|thermometer|thermometer
609397|NCT00980642|non-invasive|non-invasive
609398|NCT00980642|interoperative core temperature|interoperative core temperature
609399|NCT00980642|anesthesia|anesthesia
609400|NCT00980616|Arthroplasty, hip|arthroplasty, hip
609401|NCT00980616|blood losses|blood losses
609402|NCT00980616|pain|pain
609403|NCT00980616|local analgesia|local analgesia
609404|NCT00980616|epinephrine|epinephrine
609405|NCT00980616|Primary total hip arthroplasty|primary total hip arthroplasty
609406|NCT00980603|gastric cancer|gastric cancer
609407|NCT00980603|metastatic|metastatic
609408|NCT00980603|docetaxel|docetaxel
609409|NCT00980603|cisplatin|cisplatin
609410|NCT00980603|S-1|s-1
609411|NCT00980590|supine emergency intubations|supine emergency intubations
609412|NCT00980590|emergency intubations|emergency intubations
609413|NCT00980538|TMC125-TiDP35-C239|tmc125-tidp35-c239
609414|NCT00980538|TMC125-C239|tmc125-c239
609415|NCT00980538|TMC125|tmc125
609416|NCT00980538|HIV|hiv
609417|NCT00980538|Etravirine|etravirine
609418|NCT00980538|Intelence|intelence
609419|NCT00980538|IntelenceTM|intelencetm
609420|NCT00980525|healthy|healthy
609421|NCT00980512|behavior problems|behavior problems
609422|NCT00980512|parent training|parent training
609423|NCT00980512|foster care|foster care
609424|NCT00980486|Antibiotic Concentration|antibiotic concentration
609425|NCT00980486|Tissue|tissue
609426|NCT00980486|Obesity|obesity
609427|NCT00980486|Cesarean|cesarean
609428|NCT00980473|Primary Angle Closure Disease|primary angle closure disease
609429|NCT00980447|H5N1|h5n1
609430|NCT00980447|Vaccine|vaccine
609431|NCT00980447|Influenza H5N1|influenza h5n1
609432|NCT00980447|Avian influenza H5N1|avian influenza h5n1
609433|NCT00980447|Pandemic|pandemic
609434|NCT00980434|vertebral fracture|vertebral fracture
609435|NCT00980434|spinal cord injury|spinal cord injury
609436|NCT00980421|iron|iron
609437|NCT00980421|iron toxicity markers|iron toxicity markers
609438|NCT00980421|oxidative stress markers|oxidative stress markers
609439|NCT00980421|iron supplementation|iron supplementation
609440|NCT00980421|NTBI|ntbi
609441|NCT00980421|iron over load|iron over load
609442|NCT00980421|interleukin levels|interleukin levels
609443|NCT00980421|iron status|iron status
609444|NCT00980421|acut phase reactants|acut phase reactants
609445|NCT00980421|preschool children|preschool children
609446|NCT00980395|recurrent mantle cell lymphoma|recurrent mantle cell lymphoma
609447|NCT00980395|stage III mantle cell lymphoma|stage iii mantle cell lymphoma
609448|NCT00980395|stage IV mantle cell lymphoma|stage iv mantle cell lymphoma
609449|NCT00980395|recurrent marginal zone lymphoma|recurrent marginal zone lymphoma
609450|NCT00980395|stage III marginal zone lymphoma|stage iii marginal zone lymphoma
609451|NCT00980395|stage IV marginal zone lymphoma|stage iv marginal zone lymphoma
609452|NCT00980395|Waldenstrom macroglobulinemia|waldenstrom macroglobulinemia
609453|NCT00980395|recurrent small lymphocytic lymphoma|recurrent small lymphocytic lymphoma
609454|NCT00980395|stage III small lymphocytic lymphoma|stage iii small lymphocytic lymphoma
609455|NCT00980395|stage IV small lymphocytic lymphoma|stage iv small lymphocytic lymphoma
609456|NCT00980395|recurrent grade 1 follicular lymphoma|recurrent grade 1 follicular lymphoma
609457|NCT00980395|recurrent grade 2 follicular lymphoma|recurrent grade 2 follicular lymphoma
609458|NCT00980395|recurrent grade 3 follicular lymphoma|recurrent grade 3 follicular lymphoma
609459|NCT00980395|stage III grade 1 follicular lymphoma|stage iii grade 1 follicular lymphoma
609460|NCT00980395|stage III grade 2 follicular lymphoma|stage iii grade 2 follicular lymphoma
609461|NCT00980395|stage III grade 3 follicular lymphoma|stage iii grade 3 follicular lymphoma
609462|NCT00980395|stage IV grade 1 follicular lymphoma|stage iv grade 1 follicular lymphoma
609463|NCT00980395|stage IV grade 2 follicular lymphoma|stage iv grade 2 follicular lymphoma
609464|NCT00980395|stage IV grade 3 follicular lymphoma|stage iv grade 3 follicular lymphoma
609465|NCT00980395|extranodal marginal zone BCL mucosa assoc lymphoid tissue|extranodal marginal zone bcl mucosa assoc lymphoid tissue
609466|NCT00980395|nodal marginal zone B Cell lymphoma|nodal marginal zone b cell lymphoma
609467|NCT00980395|splenic marginal zone lymphoma|splenic marginal zone lymphoma
609468|NCT00980382|Stomach Neoplasms|stomach neoplasms
609469|NCT00980382|phase I/II|phase i/ii
609470|NCT00980382|Combination chemotherapy|combination chemotherapy
609471|NCT00980382|S-1|s-1
609472|NCT00980382|Docetaxel|docetaxel
609473|NCT00980369|Lateral internal sphincterotomy|lateral internal sphincterotomy
609474|NCT00980369|Anal fissure|anal fissure
609475|NCT00980369|Surgical technique|surgical technique
609476|NCT00980369|Incision|incision
609477|NCT00980369|Wound healing|wound healing
609478|NCT00980356|Diabetes Kidney transplantation|diabetes kidney transplantation
609479|NCT00980356|New onset diabetes mellitus after transplantation|new onset diabetes mellitus after transplantation
609480|NCT00980330|Hepatitis C|hepatitis c
609481|NCT00980330|Peginterferon alpha-2a|peginterferon alpha-2a
609482|NCT00980330|PegIFNalpha-2a|pegifnalpha-2a
609483|NCT00980330|RBV|rbv
609484|NCT00980330|Ribavirin|ribavirin
609485|NCT00980330|Placebo|placebo
609486|NCT00980330|TMC435-TIDP16-C206|tmc435-tidp16-c206
609487|NCT00980330|TMC435-C206|tmc435-c206
609488|NCT00980330|TMC435|tmc435
609489|NCT00980330|HCV|hcv
609490|NCT00980317|Renal tumor|renal tumor
609491|NCT00980317|Restored kidney|restored kidney
609492|NCT00980317|Renal transplantation|renal transplantation
609493|NCT00980317|Third party|third party
609494|NCT00980304|Diffuse large B cell lymphomas|diffuse large b cell lymphomas
609495|NCT00980278|sinus lift|sinus lift
609496|NCT00980278|tooth extraction|tooth extraction
609497|NCT00980278|dental implant|dental implant
609498|NCT00980252|Schizophrenia|schizophrenia
609499|NCT00980252|Cognitive Behavioral Therapy|cognitive behavioral therapy
609500|NCT00980252|Compliance|compliance
609501|NCT00980252|Medication Adherence|medication adherence
609502|NCT00980252|Psychotic Disorders|psychotic disorders
609503|NCT00980252|Mental Disorders|mental disorders
609504|NCT00980252|Outcomes|outcomes
609505|NCT00980252|Psychoeducation|psychoeducation
609506|NCT00980252|Adherence Attitudes|adherence attitudes
609507|NCT00980252|Intervention|intervention
609508|NCT00980252|Nonadherence|nonadherence
609509|NCT00980252|Schizophrenia and Disorders with Psychotic Features|schizophrenia and disorders with psychotic features
609510|NCT00980239|Solid Tumors|solid tumors
609511|NCT00980239|Liver|liver
609512|NCT00980239|hepatic arterial infusion|hepatic arterial infusion
609513|NCT00980239|HAI|hai
609514|NCT00980239|Bevacizumab|bevacizumab
609515|NCT00980239|Avastin|avastin
609516|NCT00980239|Cetuximab|cetuximab
609517|NCT00980239|Erbitux|erbitux
609518|NCT00980239|Irinotecan|irinotecan
609519|NCT00980239|Camptosar|camptosar
609520|NCT00980239|Oxaliplatin|oxaliplatin
609521|NCT00980239|Eloxatin|eloxatin
609522|NCT00980213|renal cell cancer|renal cell cancer
609523|NCT00980213|sunitinib|sunitinib
609524|NCT00980213|costs|costs
609525|NCT00980213|quality of life|quality of life
609526|NCT00980200|GW642444|gw642444
609527|NCT00980200|once daily dosing|once daily dosing
609528|NCT00980200|asthma|asthma
609529|NCT00980200|efficacy|efficacy
609530|NCT00980200|safety|safety
609531|NCT00980200|FEV1|fev1
609532|NCT00980187|blood tests|blood tests
609533|NCT00980187|cardiac function|cardiac function
609534|NCT00980187|endothelial function|endothelial function
609535|NCT00980187|arterial function|arterial function
609536|NCT00980174|men|men
609537|NCT00980174|male|male
609538|NCT00980174|denosumab|denosumab
609539|NCT00980174|BMD|bmd
609540|NCT00980174|lumbar spine|lumbar spine
609541|NCT00980174|ADAMO|adamo
609542|NCT00980174|The ADAMO Trial|the adamo trial
609543|NCT00980174|male osteoporosis|male osteoporosis
609544|NCT00980174|osteoporosis in men|osteoporosis in men
609545|NCT00980174|males with low bone mineral density|males with low bone mineral density
609546|NCT00980161|Hepatitis C|hepatitis c
609547|NCT00980161|Peginterferon|peginterferon
609548|NCT00980161|Ribavirin|ribavirin
609549|NCT00980161|MicroRNA|microrna
609550|NCT00980148|Chlamydia trachomatis, Chlamydia, Doxycycline, Azithromycin|chlamydia trachomatis, chlamydia, doxycycline, azithromycin
609551|NCT00980135|Sinecort|sinecort
609552|NCT00980135|Hydrocortison|hydrocortison
609553|NCT00980135|Mild atopic dermatitis|mild atopic dermatitis
609554|NCT00980135|Efficacy, safety|efficacy, safety
609555|NCT00980122|Advanced cancer patients dying in hospital receive aggressive cancer-specific therapy and supportive measures.|advanced cancer patients dying in hospital receive aggressive cancer-specific therapy and supportive measures.
609556|NCT00980109|Influenza Prophylaxis|influenza prophylaxis
609557|NCT00980109|Long Term|long term
609558|NCT00980109|Oral Oseltamivir|oral oseltamivir
609559|NCT00980109|Inhaled Zanamivir|inhaled zanamivir
609560|NCT00980083|GLP-1|glp-1
609561|NCT00980083|exendin(9-39)|exendin(9-39)
609562|NCT00980083|gastric emptying|gastric emptying
609563|NCT00980083|incretin|incretin
609564|NCT00980083|human|human
609565|NCT00980070|lumbar puncture positioning device|lumbar puncture positioning device
609566|NCT00980031|Aldosterone Blockade|aldosterone blockade
609567|NCT00980031|Aldosterone Receptor Blockers|aldosterone receptor blockers
609568|NCT00980031|cardiac chamber size|cardiac chamber size
609569|NCT00980031|wall thickness|wall thickness
609570|NCT00980031|left ventricular ejection fraction|left ventricular ejection fraction
609571|NCT00980031|left atrial volumes|left atrial volumes
609572|NCT00980031|diastolic function|diastolic function
609573|NCT00980018|CML|cml
609574|NCT00980018|Leukemia|leukemia
609575|NCT00980018|Tasigna|tasigna
609576|NCT00980018|nilotinib|nilotinib
609577|NCT00980018|AMN107|amn107
609578|NCT00980018|CML-CP|cml-cp
609579|NCT00980018|Chronic Phase|chronic phase
609580|NCT00980005|GSK Biologicals influenza vaccine GSK1557482A|gsk biologicals influenza vaccine gsk1557482a
609581|NCT00980005|influenza infection|influenza infection
609582|NCT00979979|Hepatitis C|hepatitis c
609583|NCT00979979|Genotype|genotype
609584|NCT00979979|Realtime PCR|realtime pcr
609585|NCT00979966|Locally advanced or metastatic non-clear cell renal cell cancer (ncc-RCC)|locally advanced or metastatic non-clear cell renal cell cancer (ncc-rcc)
609586|NCT00979953|delta opioid receptor agonist|delta opioid receptor agonist
609587|NCT00979953|osteoarthritis|osteoarthritis
609588|NCT00979953|pain|pain
609589|NCT00979940|atorvastatin|atorvastatin
609590|NCT00979940|clopidogrel|clopidogrel
609591|NCT00979940|percutaneous intervention|percutaneous intervention
609592|NCT00979940|periprocedural myonecrosis|periprocedural myonecrosis
609593|NCT00979927|Antisense|antisense
609594|NCT00979927|miR-122 antagonist|mir-122 antagonist
609595|NCT00979927|safety in healthy Volunteers|safety in healthy volunteers
609596|NCT00979927|Hepatitis C|hepatitis c
609597|NCT00979914|osteoarthritis|osteoarthritis
609598|NCT00979914|patient education|patient education
609599|NCT00979914|function|function
609600|NCT00979914|physio therapy|physio therapy
609601|NCT00979888|dyspnea|dyspnea
609602|NCT00979888|depression|depression
609603|NCT00979888|fatigue|fatigue
609604|NCT00979888|anxiety disorder|anxiety disorder
609605|NCT00979888|small cell lung cancer|small cell lung cancer
609606|NCT00979888|non-small cell lung cancer|non-small cell lung cancer
609607|NCT00979875|insulin|insulin
609608|NCT00979875|recombinant human hyaluronidase|recombinant human hyaluronidase
609609|NCT00979875|Healthy volunteers|healthy volunteers
609610|NCT00979849|safety|safety
609611|NCT00979849|tolerability|tolerability
609612|NCT00979849|healthy|healthy
609613|NCT00979849|inhalation|inhalation
609614|NCT00979836|venous|venous
609615|NCT00979836|ulcer|ulcer
609616|NCT00979836|phlebotonic|phlebotonic
609617|NCT00979836|calcium dobesilate|calcium dobesilate
609618|NCT00979836|clinical trial|clinical trial
609619|NCT00979810|PET scan|pet scan
609620|NCT00979810|CT scan|ct scan
609621|NCT00979810|09-060|09-060
609622|NCT00979810|CNS|cns
609623|NCT00979797|Community IMCI|community imci
609624|NCT00979797|C-IMCI|c-imci
609625|NCT00979797|CHW|chw
609626|NCT00979797|Children|children
609627|NCT00979797|Evaluation|evaluation
609628|NCT00979797|Behaviour|behaviour
609629|NCT00979797|Counselling|counselling
609630|NCT00979797|Under 5 mortality|under 5 mortality
609631|NCT00979797|Under 5 Nutrition|under 5 nutrition
609632|NCT00979784|obesity|obesity
609633|NCT00979784|primary care|primary care
609634|NCT00979771|GSK706769|gsk706769
609635|NCT00979771|Enbrel|enbrel
609636|NCT00979771|Rheumatoid Arthritis|rheumatoid arthritis
609637|NCT00979745|Erythropoietic Protoporphyria|erythropoietic protoporphyria
609638|NCT00979745|EPP|epp
609639|NCT00979745|Afamelanotide|afamelanotide
609640|NCT00979732|high blood pressure|high blood pressure
609641|NCT00979732|dietary supplements|dietary supplements
609642|NCT00979732|nutrition|nutrition
609643|NCT00979719|Randomized Controlled Trial|randomized controlled trial
609644|NCT00979719|evidence- and theory-based behavioral intervention|evidence- and theory-based behavioral intervention
609645|NCT00979719|expert system|expert system
609646|NCT00979719|stages of change|stages of change
609647|NCT00979719|motivational interviewing|motivational interviewing
609648|NCT00979719|tailoring|tailoring
609649|NCT00979719|Self Care|self care
609650|NCT00979719|Rehabilitation|rehabilitation
609651|NCT00979719|Expert Systems|expert systems
609652|NCT00979693|anxiety|anxiety
609653|NCT00979693|stage IV melanoma|stage iv melanoma
609654|NCT00979693|depression|depression
609655|NCT00979693|spirituality|spirituality
609656|NCT00979693|pain|pain
609657|NCT00979680|sphincter preservation|sphincter preservation
609658|NCT00979680|neoadjuvant therapy|neoadjuvant therapy
609659|NCT00979667|Upper respiratory tract infection|upper respiratory tract infection
609660|NCT00979667|Influenza A|influenza a
609661|NCT00979667|Human Swine Influenza|human swine influenza
609662|NCT00979654|Sifalimumab|sifalimumab
609663|NCT00979654|MEDI-545|medi-545
609664|NCT00979641|breast cancer|breast cancer
609665|NCT00979641|metastatic|metastatic
609666|NCT00979641|chemotherapy|chemotherapy
609667|NCT00979641|bevacizumab|bevacizumab
609668|NCT00979641|docetaxel|docetaxel
609669|NCT00979641|Phase II|phase ii
609670|NCT00979641|first line chemotherapy|first line chemotherapy
609671|NCT00979641|metastatic breast cancer patients|metastatic breast cancer patients
609672|NCT00979628|Type 2 Diabetes|type 2 diabetes
609673|NCT00979628|Inpatient Hyperglycemia|inpatient hyperglycemia
609674|NCT00979615|vasomotor rhinitis|vasomotor rhinitis
609675|NCT00979615|chronic non-allergic rhinitis|chronic non-allergic rhinitis
609676|NCT00979615|VMR|vmr
609677|NCT00979602|GSK Bio's influenza vaccine GSK2340274A|gsk bio's influenza vaccine gsk2340274a
609678|NCT00979602|Influenza Vaccines|influenza vaccines
609679|NCT00979602|GSK Bio's influenza vaccine GSK2340273A|gsk bio's influenza vaccine gsk2340273a
609680|NCT00979602|influenza infection|influenza infection
609681|NCT00979589|stroke|stroke
609682|NCT00979589|transient ischemic attack|transient ischemic attack
609683|NCT00979589|acute treatment|acute treatment
609684|NCT00979589|acute non-disabling cerebrovascular event|acute non-disabling cerebrovascular event
609685|NCT00979589|clopidogrel|clopidogrel
609686|NCT00979589|clopidogrel combined with ASA|clopidogrel combined with asa
609687|NCT00979589|recurrence of stroke and other vascular events|recurrence of stroke and other vascular events
609688|NCT00979563|HM30181AK|hm30181ak
609689|NCT00979563|Irinotecan tablet|irinotecan tablet
609690|NCT00979563|MTD|mtd
609691|NCT00979563|DLT|dlt
609692|NCT00979550|laser|laser
609693|NCT00979550|pediatric|pediatric
609694|NCT00979550|skin pigmentation|skin pigmentation
609695|NCT00979524|Depressive symptoms|depressive symptoms
609696|NCT00979524|Mental health services|mental health services
609697|NCT00979524|Adolescents|adolescents
609698|NCT00979524|Young adults|young adults
609699|NCT00979524|African-American|african-american
609700|NCT00979511|osteoporosis|osteoporosis
609701|NCT00979511|calcium|calcium
609702|NCT00979511|weight-bearing exercise|weight-bearing exercise
609703|NCT00979511|bone mass|bone mass
609704|NCT00979511|prepubertal girls|prepubertal girls
609705|NCT00979485|Pediatric IBD|pediatric ibd
609706|NCT00979485|Microparticles|microparticles
609707|NCT00979472|Solifenacin|solifenacin
609708|NCT00979472|Overactive bladder|overactive bladder
609709|NCT00979472|Micturition|micturition
609710|NCT00979472|Urinary urgency|urinary urgency
609711|NCT00979472|Vesicare|vesicare
609712|NCT00979446|Interactive phone-based intervention with written materials|interactive phone-based intervention with written materials
609713|NCT00979446|Older adults|older adults
609714|NCT00979446|Physical activity|physical activity
609715|NCT00979446|Cognitive stimulation|cognitive stimulation
609716|NCT00979446|Social engagement|social engagement
609717|NCT00979433|Extubation failure|extubation failure
609718|NCT00979433|Continuous positive airway pressure|continuous positive airway pressure
609719|NCT00979433|Bubble CPAP|bubble cpap
609720|NCT00979420|treatment experienced|treatment experienced
609721|NCT00979407|influenza infection|influenza infection
609722|NCT00979407|GSK Biologicals' influenza vaccine GSK2340272A and GSK2340274A|gsk biologicals' influenza vaccine gsk2340272a and gsk2340274a
609723|NCT00979394|Diabetes Care at GPs in Austria|diabetes care at gps in austria
609724|NCT00979394|Characteristic of diabetes patients at GPs in Austria|characteristic of diabetes patients at gps in austria
609725|NCT00979381|sunitinib|sunitinib
609726|NCT00979381|sorafenib|sorafenib
609727|NCT00979381|immune response|immune response
609728|NCT00979355|Whole body|whole body
609729|NCT00979355|SPECT|spect
609730|NCT00979342|morcellator|morcellator
609731|NCT00979342|hysteroscope|hysteroscope
609732|NCT00979342|myomectomy|myomectomy
609733|NCT00979342|polypectomy|polypectomy
609734|NCT00979342|uterine fibroids|uterine fibroids
609735|NCT00979342|uterine polyps|uterine polyps
609736|NCT00979342|local anesthetic|local anesthetic
609737|NCT00979342|cervical block|cervical block
609738|NCT00979342|pain management|pain management
609739|NCT00979329|sunitinib|sunitinib
609740|NCT00979329|sorafenib|sorafenib
609741|NCT00979329|fatigue|fatigue
609742|NCT00979329|depression|depression
609743|NCT00979329|quality of life|quality of life
609744|NCT00979329|metastatic RCC|metastatic rcc
609745|NCT00979329|colorectal cancer|colorectal cancer
609746|NCT00979329|GIST|gist
609747|NCT00979303|Pediatric|pediatric
609748|NCT00979303|Electrophysiology|electrophysiology
609749|NCT00979303|Ablation|ablation
609750|NCT00979303|Radiation|radiation
609751|NCT00979303|Devices|devices
609752|NCT00979303|SVT|svt
609753|NCT00979290|Fix-dose combination anti-TB drug|fix-dose combination anti-tb drug
609754|NCT00979290|adverse effect|adverse effect
609755|NCT00979290|efficiency|efficiency
609756|NCT00979264|Quality Improvement|quality improvement
609757|NCT00979251|Influenza|influenza
609758|NCT00979251|Immunocompromised|immunocompromised
609759|NCT00979251|HIV|hiv
609760|NCT00979251|History of transplant|history of transplant
609761|NCT00979238|Hemophilia B|hemophilia b
609762|NCT00979238|Factor IX Gene|factor ix gene
609763|NCT00979238|Factor IX Protein|factor ix protein
609764|NCT00979238|Vector|vector
609765|NCT00979225|health information technology|health information technology
609766|NCT00979225|clinical decision support|clinical decision support
609767|NCT00979225|medication management|medication management
609768|NCT00979225|medication adherence|medication adherence
609769|NCT00979212|stage IIIA non-small cell lung cancer|stage iiia non-small cell lung cancer
609770|NCT00979212|adenocarcinoma of the lung|adenocarcinoma of the lung
609771|NCT00979212|adenosquamous cell lung cancer|adenosquamous cell lung cancer
609772|NCT00979212|bronchoalveolar cell lung cancer|bronchoalveolar cell lung cancer
609773|NCT00979212|large cell lung cancer|large cell lung cancer
609774|NCT00979212|squamous cell lung cancer|squamous cell lung cancer
609776|NCT00979199|CAD|cad
609777|NCT00979199|Non invasive imaging|non invasive imaging
609778|NCT00979199|SPECT|spect
609779|NCT00979199|PET|pet
609780|NCT00979199|CMR|cmr
609781|NCT00979199|Echocardiography|echocardiography
609782|NCT00979186|transgastric cholecystectomy|transgastric cholecystectomy
609783|NCT00979173|malignant glioma|malignant glioma
609784|NCT00979173|glioblastoma multiforme|glioblastoma multiforme
609785|NCT00979173|gliosarcoma|gliosarcoma
609786|NCT00979173|anaplastic astrocytoma|anaplastic astrocytoma
609787|NCT00979173|anaplastic oligodendroglioma|anaplastic oligodendroglioma
609788|NCT00979173|anaplastic mixed glioma|anaplastic mixed glioma
609789|NCT00979173|Pro00018751|pro00018751
609790|NCT00979173|Duke|duke
609791|NCT00979173|Ambit|ambit
609792|NCT00979173|AC480|ac480
609793|NCT00979147|knee arthritis|knee arthritis
609794|NCT00979147|total knee arthroplasty|total knee arthroplasty
609795|NCT00979147|total knee replacement|total knee replacement
609796|NCT00979147|metal backed tibial component|metal backed tibial component
609797|NCT00979147|all-polyethylene tibia|all-polyethylene tibia
609798|NCT00979147|modular polished tibial baseplate|modular polished tibial baseplate
609799|NCT00979134|Cancer|cancer
609800|NCT00979134|Tumour|tumour
609801|NCT00979134|Advanced Solid Malignancies|advanced solid malignancies
609802|NCT00979134|FGFR|fgfr
609803|NCT00979134|Squamous NSCLC|squamous nsclc
609804|NCT00979134|Gastric adenocarcinoma|gastric adenocarcinoma
609805|NCT00979121|ALI|ali
609806|NCT00979121|Sepsis|sepsis
609807|NCT00979121|statin|statin
609808|NCT00979108|Radiculopathy|radiculopathy
609809|NCT00979108|Neck pain|neck pain
609810|NCT00979108|Physical therapy modalities|physical therapy modalities
609811|NCT00979108|Rehabilitation|rehabilitation
609812|NCT00979095|multiple hernia|multiple hernia
609813|NCT00979056|Traveller's diarrhoea|traveller's diarrhoea
609814|NCT00979056|Prevention|prevention
609815|NCT00979043|knee osteoarthritis|knee osteoarthritis
609816|NCT00979043|weight-loss|weight-loss
609817|NCT00979043|exercise|exercise
609818|NCT00979043|obesity|obesity
609819|NCT00979043|physical function|physical function
609820|NCT00979043|total mortality|total mortality
609821|NCT00979017|malignant glioma|malignant glioma
609822|NCT00979017|glioblastoma multiforme|glioblastoma multiforme
609823|NCT00979017|gliosarcoma|gliosarcoma
609824|NCT00979017|Avastin|avastin
609825|NCT00979017|bevacizumab|bevacizumab
609826|NCT00979017|Temodar|temodar
609827|NCT00979017|temozolomide|temozolomide
609828|NCT00979017|Irinotecan|irinotecan
609829|NCT00979017|CPT-11|cpt-11
609830|NCT00979017|Pro00019065|pro00019065
609831|NCT00979017|Vredenburgh|vredenburgh
609832|NCT00979017|Duke|duke
609833|NCT00979004|Photosensitivity|photosensitivity
609834|NCT00979004|Epilepsy|epilepsy
609835|NCT00979004|Seizures|seizures
609836|NCT00978991|Benign prostate hyperplasia|benign prostate hyperplasia
609837|NCT00978991|Erectile dysfunction|erectile dysfunction
609838|NCT00978965|kidney transplantation|kidney transplantation
609839|NCT00978965|immunosuppression|immunosuppression
710880|NCT00587457|Small Lymphocytic Lymphoma|small lymphocytic lymphoma
609840|NCT00978965|single nucleotide polymorphism|single nucleotide polymorphism
609841|NCT00978965|IMPDH|impdh
609842|NCT00978926|Anti-Vascular Endothelial growth factor|anti-vascular endothelial growth factor
609843|NCT00978913|dendritic cell|dendritic cell
609844|NCT00978913|cancervaccine|cancervaccine
609845|NCT00978913|breast cancer|breast cancer
609846|NCT00978913|malignant melanoma|malignant melanoma
609847|NCT00978913|Cyclophosphamide|cyclophosphamide
609848|NCT00978900|satiety peptides|satiety peptides
609849|NCT00978900|GLP-1|glp-1
609850|NCT00978900|PYY|pyy
609851|NCT00978900|ghrelin|ghrelin
609852|NCT00978900|appetite profile|appetite profile
609853|NCT00978900|Sweetening Agents|sweetening agents
609854|NCT00978887|Facial cream|facial cream
609855|NCT00978887|natural product|natural product
609856|NCT00978887|facial wrinkles|facial wrinkles
609857|NCT00978874|recurrent cervical cancer|recurrent cervical cancer
609858|NCT00978874|stage IB cervical cancer|stage ib cervical cancer
609859|NCT00978874|stage IIA cervical cancer|stage iia cervical cancer
609860|NCT00978874|stage IIB cervical cancer|stage iib cervical cancer
609861|NCT00978874|stage III cervical cancer|stage iii cervical cancer
609862|NCT00978874|stage IVA cervical cancer|stage iva cervical cancer
609863|NCT00978874|stage IVB cervical cancer|stage ivb cervical cancer
609864|NCT00978848|trichomonas|trichomonas
609865|NCT00978848|chlamydia|chlamydia
609866|NCT00978848|gonorrhea|gonorrhea
609867|NCT00978848|emergency contraception|emergency contraception
609868|NCT00978848|emergency contraception use|emergency contraception use
609869|NCT00978835|Diabetes|diabetes
609870|NCT00978835|Hypertension|hypertension
609871|NCT00978835|Physical Activity|physical activity
609872|NCT00978835|Diet|diet
609873|NCT00978835|Medication Adherence|medication adherence
609874|NCT00978822|Subarachnoid hemorrhage|subarachnoid hemorrhage
609875|NCT00978822|Hypertension|hypertension
609876|NCT00978822|brain Aneurysm|brain aneurysm
609877|NCT00978822|intracerebral hemorrhage|intracerebral hemorrhage
609878|NCT00978822|antihypertensive|antihypertensive
609879|NCT00978822|calcium channel blockers|calcium channel blockers
609880|NCT00978822|infusion|infusion
609881|NCT00978822|neurocritical care|neurocritical care
609882|NCT00978809|BPPV|bppv
609883|NCT00978809|postural stability|postural stability
609884|NCT00978809|Epley|epley
609885|NCT00978809|Semont|semont
609886|NCT00978796|Diabetes Mellitus|diabetes mellitus
609887|NCT00978796|Type 1 diabetes|type 1 diabetes
609888|NCT00978796|glucose variability|glucose variability
609889|NCT00978783|Phonation|phonation
609890|NCT00978783|Tracheostomy|tracheostomy
609891|NCT00978783|phonation valve|phonation valve
609892|NCT00978783|positive end expiratory pressure|positive end expiratory pressure
609893|NCT00978770|stage II breast cancer|stage ii breast cancer
609894|NCT00978770|stage IIIA breast cancer|stage iiia breast cancer
609895|NCT00978770|stage IIIB breast cancer|stage iiib breast cancer
609896|NCT00978770|stage IIIC breast cancer|stage iiic breast cancer
609897|NCT00978757|hepatectomy|hepatectomy
609898|NCT00978757|IL 6|il 6
609899|NCT00978757|organ failure|organ failure
609900|NCT00978757|ketamine|ketamine
609901|NCT00978757|Pringle|pringle
609902|NCT00978744|Clinical Health Record|clinical health record
609903|NCT00978744|Computerized Decision Support|computerized decision support
609904|NCT00978744|Patient Safety|patient safety
609905|NCT00978744|Resource Utilization|resource utilization
609906|NCT00978718|prostate cancer|prostate cancer
609907|NCT00978705|Keratinocyte Cell|keratinocyte cell
609908|NCT00978705|severe burn wound|severe burn wound
609909|NCT00978692|Myopia|myopia
609910|NCT00978692|Astigmatism|astigmatism
609911|NCT00978692|Orthokeratology|orthokeratology
609912|NCT00978692|Corneal thickness|corneal thickness
609913|NCT00978692|Corneal curvatures|corneal curvatures
609914|NCT00978692|Corneal biomechanics|corneal biomechanics
609915|NCT00978679|Children|children
609916|NCT00978679|Peripheral refraction|peripheral refraction
609917|NCT00978679|Aberration|aberration
609918|NCT00978679|Eyeball length|eyeball length
609919|NCT00978679|Myopic control|myopic control
609920|NCT00978679|Myopia|myopia
609921|NCT00978679|Corneal reshaping|corneal reshaping
609922|NCT00978679|Orthokeratology|orthokeratology
609923|NCT00978653|allopurinol|allopurinol
609924|NCT00978653|chronic kidney disease|chronic kidney disease
609925|NCT00978653|endothelial dysfunction|endothelial dysfunction
609926|NCT00978653|hyperuricemia|hyperuricemia
609927|NCT00978653|uric acid|uric acid
609928|NCT00978653|vascular endothelium|vascular endothelium
609929|NCT00978653|xanthine oxidase inhibitor|xanthine oxidase inhibitor
609930|NCT00978640|Sirt1 activity|sirt1 activity
609931|NCT00978601|post-operative analgesia|post-operative analgesia
609932|NCT00978601|early discharge,|early discharge,
609933|NCT00978601|fast recovery,|fast recovery,
609934|NCT00978601|minimally invasive myomectomy,|minimally invasive myomectomy,
609935|NCT00978601|laparoscopy,|laparoscopy,
609936|NCT00978601|laparoscopically assisted myomectomy|laparoscopically assisted myomectomy
609937|NCT00978601|patient discharge|patient discharge
609938|NCT00978601|Anesthesia Recovery Period|anesthesia recovery period
609939|NCT00978575|Iron treatment|iron treatment
609940|NCT00978575|Upper gastrointestinal bleeding|upper gastrointestinal bleeding
609941|NCT00978549|pain|pain
609942|NCT00978549|nausea and vomiting|nausea and vomiting
609943|NCT00978549|adenocarcinoma of the esophagus|adenocarcinoma of the esophagus
609944|NCT00978549|adenocarcinoma of the stomach|adenocarcinoma of the stomach
609945|NCT00978549|adenocarcinoma of the gastroesophageal junction|adenocarcinoma of the gastroesophageal junction
609946|NCT00978549|recurrent gastric cancer|recurrent gastric cancer
609947|NCT00978549|stage IIIA gastric cancer|stage iiia gastric cancer
609948|NCT00978549|stage IIIB gastric cancer|stage iiib gastric cancer
609949|NCT00978549|stage IIIC gastric cancer|stage iiic gastric cancer
609950|NCT00978549|stage IV gastric cancer|stage iv gastric cancer
609951|NCT00978549|recurrent esophageal cancer|recurrent esophageal cancer
609952|NCT00978549|stage IIIA esophageal cancer|stage iiia esophageal cancer
609953|NCT00978549|stage IIIB esophageal cancer|stage iiib esophageal cancer
609954|NCT00978549|stage IIIC esophageal cancer|stage iiic esophageal cancer
609955|NCT00978549|stage IV esophageal cancer|stage iv esophageal cancer
609956|NCT00978536|Multiple sclerosis|multiple sclerosis
609957|NCT00978536|cognitive deterioration|cognitive deterioration
609958|NCT00978536|biomarkers|biomarkers
609959|NCT00978536|cerebrospinal fluid|cerebrospinal fluid
609960|NCT00978536|Alzheimer disease|alzheimer disease
609961|NCT00978510|Tuberculosis|tuberculosis
609962|NCT00978510|Disease transmission|disease transmission
610267|NCT00977353|Depression|depression
609963|NCT00978510|Exposure to biological agents|exposure to biological agents
609964|NCT00978510|Health personnel|health personnel
609965|NCT00978484|PTSD|ptsd
609966|NCT00978484|Depression|depression
609967|NCT00978484|Anxiety|anxiety
609968|NCT00978484|Virtual Reality|virtual reality
609969|NCT00978484|Computer Therapy|computer therapy
609970|NCT00978484|Exposure Therapy|exposure therapy
609971|NCT00978484|Prolonged Exposure|prolonged exposure
609972|NCT00978484|Military Medicine|military medicine
609973|NCT00978484|Combat|combat
609974|NCT00978484|Iraq|iraq
609975|NCT00978484|Afghanistan|afghanistan
609976|NCT00978484|Air Force Personnel|air force personnel
609977|NCT00978484|Armed Forces Personnel|armed forces personnel
609978|NCT00978484|Army Personnel|army personnel
609979|NCT00978484|Coast Guard|coast guard
609980|NCT00978484|psychology|psychology
609981|NCT00978484|military psychiatry|military psychiatry
609982|NCT00978484|combat disorders|combat disorders
609983|NCT00978484|combat neurosis|combat neurosis
609984|NCT00978484|Marines|marines
609985|NCT00978484|Military|military
609986|NCT00978484|Navy Personnel|navy personnel
609987|NCT00978484|Sailors|sailors
609988|NCT00978484|Soldiers|soldiers
609989|NCT00978471|Conventional chemotherapy|conventional chemotherapy
609990|NCT00978471|cytapheresis|cytapheresis
609991|NCT00978471|Peripheral stem cell autograft|peripheral stem cell autograft
609992|NCT00978471|Surgical resection|surgical resection
609993|NCT00978471|Thiotepa|thiotepa
609994|NCT00978458|neurotoxicity|neurotoxicity
609995|NCT00978458|adult diffuse astrocytoma|adult diffuse astrocytoma
609996|NCT00978458|adult oligodendroglioma|adult oligodendroglioma
609997|NCT00978458|recurrent adult brain tumor|recurrent adult brain tumor
609998|NCT00978458|adult mixed glioma|adult mixed glioma
609999|NCT00978445|Systemic embolic events|systemic embolic events
610000|NCT00978445|Thromboembolic Complications with Atrial Fibrillation|thromboembolic complications with atrial fibrillation
610001|NCT00978445|Prophylaxis with Atrial Fibrillation|prophylaxis with atrial fibrillation
610002|NCT00978445|Mechanical Cardiac Valve Replacement|mechanical cardiac valve replacement
610003|NCT00978432|NHL|nhl
610004|NCT00978432|DLBCL|dlbcl
610005|NCT00978432|recurrent|recurrent
610006|NCT00978432|refractory|refractory
610007|NCT00978432|de novo|de novo
610008|NCT00978419|Statins|statins
610009|NCT00978419|Burns|burns
610010|NCT00978419|Sedatives|sedatives
610011|NCT00978419|Neurocognitive|neurocognitive
610012|NCT00978419|Septic|septic
610013|NCT00978419|Mortality|mortality
610014|NCT00978419|C Reactive Protein|c reactive protein
610015|NCT00978419|Septic shock|septic shock
610016|NCT00978419|Sedation|sedation
610017|NCT00978419|Neurocognitive function|neurocognitive function
610018|NCT00978406|Dietary Assessment Methods|dietary assessment methods
610019|NCT00978406|Measurement of Diet|measurement of diet
610020|NCT00978406|24-Hour Diet Recall|24-hour diet recall
610021|NCT00978406|Validation|validation
610022|NCT00978406|Feeding Study|feeding study
610023|NCT00978367|Cicatrix|cicatrix
610024|NCT00978367|Scar|scar
610025|NCT00978367|Avotermin|avotermin
610026|NCT00978367|Juvista|juvista
610027|NCT00978367|RN1001|rn1001
610028|NCT00978367|TGF beta 3|tgf beta 3
610029|NCT00978354|acute kidney injury|acute kidney injury
610030|NCT00978354|acute renal failure|acute renal failure
610031|NCT00978354|loop diuretic|loop diuretic
610032|NCT00978354|critical illness|critical illness
610033|NCT00978354|sepsis|sepsis
610034|NCT00978354|renal replacement therapy|renal replacement therapy
775142|NCT00348686|LVH|lvh
610035|NCT00978354|dialysis|dialysis
610036|NCT00978354|renal recovery|renal recovery
610037|NCT00978354|survival|survival
610038|NCT00978341|Clinical Trial Methodology study Neuropathic pain in Spinal cord injury patients Pain endpoints Crossover design|clinical trial methodology study neuropathic pain in spinal cord injury patients pain endpoints crossover design
610039|NCT00978328|Pain conditions|pain conditions
610040|NCT00978328|Oxycodone immediate release|oxycodone immediate release
610041|NCT00978328|Percocet®, Tylox®|percocet®, tylox®
610042|NCT00978328|Roxicodone®|roxicodone®
610043|NCT00978328|Registry|registry
610044|NCT00978328|Side effects|side effects
610045|NCT00978328|Observational|observational
610046|NCT00978328|Pain management|pain management
610047|NCT00978302|Cicatrix|cicatrix
610048|NCT00978302|Scar|scar
610049|NCT00978302|Wound healing|wound healing
610050|NCT00978302|Avotermin|avotermin
610051|NCT00978302|TGF beta 3|tgf beta 3
610052|NCT00978302|Juvista|juvista
610053|NCT00978302|RN1001|rn1001
610054|NCT00978289|obesity|obesity
610055|NCT00978289|gastric bypass surgery|gastric bypass surgery
610056|NCT00978276|Receptors|receptors
610057|NCT00978276|Immunohistochemistry|immunohistochemistry
610058|NCT00978276|Breast|breast
610059|NCT00978276|Over expression of Hormone receptors in carcinoma of the breast sues|over expression of hormone receptors in carcinoma of the breast sues
610060|NCT00978250|DNA Methylation|dna methylation
610061|NCT00978250|Advanced Cancer|advanced cancer
610062|NCT00978250|Methyltransferase Inhibitor|methyltransferase inhibitor
610063|NCT00978250|Epigenetics|epigenetics
610268|NCT00977353|Sarcosine|sarcosine
610064|NCT00978250|Gene Re-Expression|gene re-expression
610065|NCT00978250|Breast Cancer|breast cancer
610066|NCT00978250|Head and Neck Cancer|head and neck cancer
610067|NCT00978250|Lung Cancer|lung cancer
610068|NCT00978250|Non-Small Cell Lung Cancer|non-small cell lung cancer
610069|NCT00978250|Bladder Cancer|bladder cancer
610070|NCT00978237|HIV - Lipoatrophy|hiv - lipoatrophy
610071|NCT00978237|treatment experienced|treatment experienced
610072|NCT00978224|dietary supplement|dietary supplement
610073|NCT00978224|hemodialysis|hemodialysis
610074|NCT00978224|Chronic Inflammatory Syndrome|chronic inflammatory syndrome
610075|NCT00978224|Viusid|viusid
610076|NCT00978211|DOTATOC|dotatoc
610077|NCT00978211|somatostatin|somatostatin
610078|NCT00978211|radiopeptide|radiopeptide
610079|NCT00978211|Yttrium|yttrium
610080|NCT00978211|Lutetium|lutetium
610081|NCT00978211|neuroendocrine|neuroendocrine
610082|NCT00978211|cancer|cancer
610083|NCT00978198|Pharmacokinetics|pharmacokinetics
610084|NCT00978198|Safety and tolerability|safety and tolerability
610085|NCT00978198|Plasma concentration|plasma concentration
610086|NCT00978198|ASP1517|asp1517
610087|NCT00978198|FG-4592|fg-4592
610088|NCT00978185|nausea and vomiting|nausea and vomiting
610089|NCT00978185|anxiety disorder|anxiety disorder
610090|NCT00978185|unspecified adult solid tumor, protocol specific|unspecified adult solid tumor, protocol specific
610091|NCT00978159|esomeprazole|esomeprazole
610092|NCT00978159|famotidine|famotidine
610093|NCT00978159|aspirin|aspirin
610094|NCT00978159|dyspepsia|dyspepsia
610095|NCT00978133|Colectomy|colectomy
610096|NCT00978133|Closure|closure
610097|NCT00978133|Wound|wound
610098|NCT00978133|Dermabond|dermabond
610099|NCT00978133|Propen|propen
610100|NCT00978120|Influenza A Virus, H1N1 Subtype|influenza a virus, h1n1 subtype
610101|NCT00978120|Vaccine|vaccine
610102|NCT00978107|Hepatic tumors|hepatic tumors
610103|NCT00978107|Metastatic colorectal cancer|metastatic colorectal cancer
610104|NCT00978081|precancerous condition|precancerous condition
610105|NCT00978081|stage 0 hypopharyngeal cancer|stage 0 hypopharyngeal cancer
610106|NCT00978081|stage 0 laryngeal cancer|stage 0 laryngeal cancer
610107|NCT00978081|stage 0 lip and oral cavity cancer|stage 0 lip and oral cavity cancer
610108|NCT00978081|stage 0 nasopharyngeal cancer|stage 0 nasopharyngeal cancer
610109|NCT00978081|stage 0 oropharyngeal cancer|stage 0 oropharyngeal cancer
610110|NCT00978081|stage 0 paranasal sinus and nasal cavity cancer|stage 0 paranasal sinus and nasal cavity cancer
610111|NCT00978068|Pediatric HIV|pediatric hiv
610112|NCT00978068|Malaria|malaria
610113|NCT00978068|Uganda|uganda
610114|NCT00978068|Nevirapine|nevirapine
610115|NCT00978068|Zidovudine|zidovudine
610116|NCT00978068|Lamivudine|lamivudine
610117|NCT00978068|Lopinavir/ritonavir|lopinavir/ritonavir
610118|NCT00978068|Stavudine|stavudine
610119|NCT00978068|Efavirenz|efavirenz
610120|NCT00978068|HIV|hiv
610121|NCT00978029|immunotherapy|immunotherapy
610122|NCT00978016|GERD|gerd
610123|NCT00978003|Maltracking|maltracking
610124|NCT00978003|Anterior Knee Pain|anterior knee pain
610125|NCT00978003|Knee|knee
610126|NCT00977990|Skin Swab|skin swab
610127|NCT00977990|Self-Sample|self-sample
610128|NCT00977977|Nephrotic Syndrome|nephrotic syndrome
610129|NCT00977977|Renal Disease|renal disease
610130|NCT00977977|Autoimmune Diseases|autoimmune diseases
610131|NCT00977977|Clinical Trial|clinical trial
610132|NCT00977977|Proteinuria|proteinuria
610133|NCT00977964|Infant|infant
610134|NCT00977951|Cicatrix|cicatrix
610135|NCT00977951|Scar|scar
610136|NCT00977951|Avotermin|avotermin
610137|NCT00977951|Juvista|juvista
610138|NCT00977951|RN1001|rn1001
610139|NCT00977951|TGF beta 3|tgf beta 3
610140|NCT00977938|Acute Coronary Syndrome|acute coronary syndrome
610141|NCT00977938|Adverse event|adverse event
610142|NCT00977938|Antiplatelet therapy|antiplatelet therapy
610143|NCT00977938|Sirolimus|sirolimus
610144|NCT00977938|Everolimus|everolimus
610145|NCT00977938|Paclitaxel|paclitaxel
610146|NCT00977938|Zotarolimus|zotarolimus
610147|NCT00977938|Bare Metal Stent|bare metal stent
610148|NCT00977938|Drug Eluting Stent|drug eluting stent
610149|NCT00977938|Clinical Events Committee|clinical events committee
610150|NCT00977938|Dual antiplatelet therapy|dual antiplatelet therapy
610151|NCT00977938|Harvard Clinical Research Institute|harvard clinical research institute
610152|NCT00977938|Major Adverse Cardiac and Cerebral Event|major adverse cardiac and cerebral event
610153|NCT00977938|Major Bleeding|major bleeding
610154|NCT00977938|Myocardial infarction|myocardial infarction
610155|NCT00977938|Myocardial ischemia|myocardial ischemia
610156|NCT00977938|Percutaneous coronary intervention|percutaneous coronary intervention
610157|NCT00977938|Stent placement|stent placement
610158|NCT00977938|Stent Thrombosis|stent thrombosis
610159|NCT00977938|Thienopyridine|thienopyridine
610160|NCT00977938|Clopidogrel|clopidogrel
610161|NCT00977938|Prasugrel|prasugrel
610162|NCT00977925|Hemostasis|hemostasis
610163|NCT00977912|B. lactis|b. lactis
610164|NCT00977912|Preterm|preterm
610165|NCT00977912|Necrotizing Enterocolitis (NEC)|necrotizing enterocolitis (nec)
610166|NCT00977899|Plasmodium Falciparum|plasmodium falciparum
610167|NCT00977899|Alum Adsorbed|alum adsorbed
610168|NCT00977899|Ookinete Surface Protein|ookinete surface protein
610169|NCT00977899|Malaria Vaccine|malaria vaccine
610170|NCT00977899|Healthy Volunteer|healthy volunteer
610171|NCT00977899|HV|hv
610172|NCT00977860|Prostate|prostate
610173|NCT00977860|Stereotactic|stereotactic
610174|NCT00977860|Radiosurgery|radiosurgery
610175|NCT00977847|Family History|family history
610176|NCT00977847|Electronic Health Record|electronic health record
610177|NCT00977834|Geriatric Assessment|geriatric assessment
610178|NCT00977808|Artificial pancreas|artificial pancreas
610179|NCT00977808|Closed-Loop control|closed-loop control
610180|NCT00977795|Brain Neoplasms|brain neoplasms
610181|NCT00977795|5-ALA|5-ala
610182|NCT00977795|Aminolevulinic acid|aminolevulinic acid
610183|NCT00977795|Fluorescence|fluorescence
610184|NCT00977795|Gliomas|gliomas
610185|NCT00977795|Glioblastoma|glioblastoma
610186|NCT00977795|Surgery|surgery
610187|NCT00977769|cesarean delivery|cesarean delivery
610188|NCT00977769|blood pressure|blood pressure
610189|NCT00977769|cardiac output|cardiac output
610190|NCT00977756|Treatment|treatment
610191|NCT00977756|Children|children
610192|NCT00977756|Integrase Inhibitors|integrase inhibitors
610193|NCT00977756|Entry Inhibitors|entry inhibitors
610194|NCT00977756|Treatment Experienced|treatment experienced
610195|NCT00977730|Hepatitis|hepatitis
610196|NCT00977730|Fatty Liver|fatty liver
610197|NCT00977730|Non Alcoholic Steatohepatitis|non alcoholic steatohepatitis
610198|NCT00977730|Protandim|protandim
610199|NCT00977717|oxaliplatin|oxaliplatin
610200|NCT00977717|neuropathy|neuropathy
610201|NCT00977717|SNPs|snps
610202|NCT00977704|Correction of peri-oral wrinkles|correction of peri-oral wrinkles
610203|NCT00977691|Sickle Cell Anemia|sickle cell anemia
610204|NCT00977691|Peripheral Blood Stem Cell Transplantation|peripheral blood stem cell transplantation
610205|NCT00977691|Graft-Versus-Host Disease|graft-versus-host disease
610206|NCT00977691|Sirolimus (Rapamune )|sirolimus (rapamune )
610207|NCT00977691|Alemtuzumab (Campath )|alemtuzumab (campath )
610208|NCT00977691|Thalassemia|thalassemia
610209|NCT00977691|Sickle Cell Disease|sickle cell disease
610210|NCT00977678|open access gastroscopy|open access gastroscopy
610211|NCT00977652|fecal incontinence|fecal incontinence
610212|NCT00977626|Safety|safety
610213|NCT00977626|Tolerability|tolerability
610214|NCT00977626|Healthy|healthy
610215|NCT00977626|Pharmacokinetics|pharmacokinetics
610216|NCT00977626|Healthy volunteers|healthy volunteers
610217|NCT00977613|Treated Stage 2 and Stage 3 colorectal cancer|treated stage 2 and stage 3 colorectal cancer
610218|NCT00977600|Ammonul|ammonul
610219|NCT00977600|Sodium phenylacetate|sodium phenylacetate
610220|NCT00977600|sodium benzoate|sodium benzoate
610221|NCT00977600|Buphenyl|buphenyl
610222|NCT00977600|sodium phenylbutyrate|sodium phenylbutyrate
610223|NCT00977600|HPN-100|hpn-100
610224|NCT00977600|GT4P|gt4p
610225|NCT00977600|Glyceryl tri-(4-phenylbutyrate)|glyceryl tri-(4-phenylbutyrate)
610226|NCT00977600|Healthy Volunteers|healthy volunteers
610227|NCT00977587|irritable bowel syndrome|irritable bowel syndrome
610228|NCT00977587|faecal serine proteases|faecal serine proteases
610229|NCT00977561|Small Cell Lung Cancer|small cell lung cancer
610230|NCT00977561|Extensive stage disease|extensive stage disease
610231|NCT00977561|SCLC|sclc
610232|NCT00977561|IGF-1R inhibitor|igf-1r inhibitor
610233|NCT00977548|MDS|mds
610234|NCT00977548|blood diseases|blood diseases
610235|NCT00977548|bone marrow|bone marrow
610236|NCT00977548|hematopoietic|hematopoietic
610237|NCT00977548|leukemia|leukemia
610238|NCT00977522|schizophrenia negative symptoms adjunctive|schizophrenia negative symptoms adjunctive
610239|NCT00977509|genes|genes
610240|NCT00977509|mutation|mutation
610241|NCT00977509|non-small cell lung cancer|non-small cell lung cancer
610242|NCT00977509|cancer cells|cancer cells
610243|NCT00977496|hemodialysis|hemodialysis
610244|NCT00977496|microbiota|microbiota
610245|NCT00977496|Staphylococcus aureus|staphylococcus aureus
610246|NCT00977470|NSCLC|nsclc
610247|NCT00977470|HCQ|hcq
610248|NCT00977470|erlotinib|erlotinib
610249|NCT00977470|Tarceva|tarceva
610250|NCT00977457|stage I prostate cancer|stage i prostate cancer
610497|NCT00976404|Immunomodulation|immunomodulation
610251|NCT00977457|stage II prostate cancer|stage ii prostate cancer
610252|NCT00977457|stage III prostate cancer|stage iii prostate cancer
610253|NCT00977457|stage IV prostate cancer|stage iv prostate cancer
610255|NCT00977444|osteoarthritis|osteoarthritis
610256|NCT00977418|Healthy Aging|healthy aging
610257|NCT00977418|Exercise|exercise
610258|NCT00977418|Cognition|cognition
610259|NCT00977418|Cognitive Training|cognitive training
610260|NCT00977418|Keeping healthy seniors as mentally efficient as possible|keeping healthy seniors as mentally efficient as possible
610261|NCT00977405|Wound infection|wound infection
610262|NCT00977405|Gentamicin|gentamicin
610263|NCT00977405|Contaminated wounds|contaminated wounds
610264|NCT00977392|human papilloma virus infection|human papilloma virus infection
610265|NCT00977392|health status unknown|health status unknown
610266|NCT00977353|Major depressive disorder|major depressive disorder
610269|NCT00977353|N-methylglycine|n-methylglycine
610270|NCT00977353|NMDA|nmda
610271|NCT00977340|Chronic nightmare sufferers|chronic nightmare sufferers
610272|NCT00977340|nightmares|nightmares
610273|NCT00977340|Imagery Rehearsal Therapy IRT|imagery rehearsal therapy irt
610274|NCT00977340|sleep disturbance|sleep disturbance
610275|NCT00977340|treatment of nightmares|treatment of nightmares
610276|NCT00977340|confrontation|confrontation
610277|NCT00977340|People who suffer of chronic nightmares|people who suffer of chronic nightmares
610278|NCT00977327|Glioma|glioma
610279|NCT00977327|Intraoperative MR|intraoperative mr
610280|NCT00977327|Intraoperative Ultrasound|intraoperative ultrasound
610281|NCT00977327|resection|resection
610282|NCT00977327|Intraoperative navigation|intraoperative navigation
610283|NCT00977327|Extent of resection|extent of resection
610284|NCT00977314|Unilateral Hearing Loss|unilateral hearing loss
610285|NCT00977301|HIV infection|hiv infection
610286|NCT00977301|interaction|interaction
610287|NCT00977301|pharmacokinetics|pharmacokinetics
610288|NCT00977275|early stage invasive breast cancer|early stage invasive breast cancer
610289|NCT00977275|Partial breast irradiation|partial breast irradiation
610290|NCT00977275|interstitial implant|interstitial implant
610291|NCT00977262|fatty acids|fatty acids
610292|NCT00977262|peripheral blood mononuclear cells|peripheral blood mononuclear cells
610293|NCT00977262|inflammation|inflammation
610294|NCT00977262|nutrigenomics|nutrigenomics
610295|NCT00977249|long term nicotine gum use|long term nicotine gum use
610296|NCT00977249|varenicline|varenicline
610297|NCT00977249|adverse effects|adverse effects
610298|NCT00977236|children|children
610299|NCT00977236|corneal reshaping|corneal reshaping
610300|NCT00977236|myopia|myopia
610301|NCT00977236|myopia control|myopia control
610302|NCT00977236|orthokeratology|orthokeratology
610303|NCT00977223|Aldosterone|aldosterone
610304|NCT00977223|Substance P|substance p
610305|NCT00977223|Cortisol|cortisol
610306|NCT00977223|Aprepitant|aprepitant
610307|NCT00977223|Adrenal glands|adrenal glands
610308|NCT00977210|Phase 1|phase 1
610309|NCT00977210|oxi4503|oxi4503
610310|NCT00977210|oxigene|oxigene
610311|NCT00977210|cruk|cruk
610312|NCT00977210|solid tumors|solid tumors
610314|NCT00977210|vascular disrupting agent|vascular disrupting agent
610315|NCT00977184|Parkinson's Disease|parkinson's disease
610316|NCT00977184|Transcranial Magnetic Stimulation (TMS)|transcranial magnetic stimulation (tms)
610317|NCT00977184|Treatment Study|treatment study
610318|NCT00977184|PD|pd
610319|NCT00977184|Parkinson Disease|parkinson disease
610320|NCT00977171|chronic fatigue syndrome|chronic fatigue syndrome
610321|NCT00977171|CFS|cfs
610322|NCT00977171|neurally mediated hypotension|neurally mediated hypotension
610323|NCT00977171|NMH|nmh
610324|NCT00977171|neurogenic orthostatic hypotension|neurogenic orthostatic hypotension
610325|NCT00977171|NOH|noh
610326|NCT00977171|orthostatic hypotension|orthostatic hypotension
610327|NCT00977171|droxidopa|droxidopa
610328|NCT00977158|Cystic Fibrosis|cystic fibrosis
610329|NCT00977158|Microbiota|microbiota
610330|NCT00977158|upper respiratory tract|upper respiratory tract
610331|NCT00977158|16S rRNA sequence analysis|16s rrna sequence analysis
610332|NCT00977158|Staphylococcus aureus|staphylococcus aureus
775534|NCT00346762|HIV|hiv
610333|NCT00977158|Pseudomonas aeruginosa|pseudomonas aeruginosa
610334|NCT00977158|Burkholderia cepacia|burkholderia cepacia
610335|NCT00977158|Haemophilus influenzae|haemophilus influenzae
610336|NCT00977158|Streptococcus pneumoniae|streptococcus pneumoniae
610337|NCT00977145|melanoma|melanoma
610338|NCT00977145|peptide vaccine|peptide vaccine
610339|NCT00977145|interferon gamma|interferon gamma
610340|NCT00977145|immunotherapy|immunotherapy
610341|NCT00977132|Myelodysplastic Syndromes|myelodysplastic syndromes
610342|NCT00977132|Valproic acid|valproic acid
610343|NCT00977132|Lenalidomide|lenalidomide
610344|NCT00977119|breast cancer|breast cancer
610345|NCT00977119|capecitabine|capecitabine
610346|NCT00977093|Coronary artery disease|coronary artery disease
610347|NCT00977093|Cardiac magnetic resonance imaging|cardiac magnetic resonance imaging
610348|NCT00977093|single photon emission computed tomography|single photon emission computed tomography
610349|NCT00977093|invasive coronary angiography|invasive coronary angiography
610350|NCT00977080|Zemplar|zemplar
610351|NCT00977080|paricalcitol|paricalcitol
610352|NCT00977080|IMPACT SHPT|impact shpt
610353|NCT00977080|Hemodialysis|hemodialysis
610354|NCT00977080|Chronic Kidney Disease Stage 5|chronic kidney disease stage 5
610355|NCT00977067|GDC0152|gdc0152
610356|NCT00977067|IAP|iap
610357|NCT00977067|IAP Antagonist|iap antagonist
610358|NCT00977054|Hepatitis C|hepatitis c
610359|NCT00977054|Peginterferon alfa-2a|peginterferon alfa-2a
610360|NCT00977054|Ribavirin|ribavirin
610361|NCT00977054|Plasmapheresis|plasmapheresis
610362|NCT00977054|Genotype 1|genotype 1
610363|NCT00977041|Neurofeedback|neurofeedback
610364|NCT00977028|Tumescent|tumescent
610365|NCT00977028|Local Anesthesia|local anesthesia
610366|NCT00977028|Lidocaine|lidocaine
610367|NCT00977028|Dosage Maximum|dosage maximum
610368|NCT00977028|Subcutaneous infiltration|subcutaneous infiltration
610369|NCT00977028|maximum Safe mg per kg dosage of lidocaine|maximum safe mg per kg dosage of lidocaine
610370|NCT00977028|Tumescent Local Anesthesia|tumescent local anesthesia
610371|NCT00977002|noninvasive ventilation|noninvasive ventilation
610372|NCT00977002|extubation|extubation
610373|NCT00977002|Respiratory failure|respiratory failure
610374|NCT00977002|reintubation|reintubation
610375|NCT00976976|Resected advanced gastric cancer stage IIIB and IV|resected advanced gastric cancer stage iiib and iv
610377|NCT00976924|blood glucose|blood glucose
610378|NCT00976898|proton beam radiation|proton beam radiation
610379|NCT00976872|omega 3|omega 3
610380|NCT00976872|inflammation|inflammation
610381|NCT00976872|augmentation index|augmentation index
610382|NCT00976872|endothelial function|endothelial function
610383|NCT00976859|childhood sexual abuse|childhood sexual abuse
610384|NCT00976859|CSA|csa
610385|NCT00976859|posttraumatic stress disorder|posttraumatic stress disorder
610386|NCT00976859|PTSD, feeling of being polluted|ptsd, feeling of being polluted
610387|NCT00976859|mental pollution, mental contamination|mental pollution, mental contamination
610388|NCT00976859|feeling of being contaminated|feeling of being contaminated
610389|NCT00976859|sexual assault|sexual assault
610390|NCT00976859|disgust, shame|disgust, shame
610391|NCT00976846|hemodialysis|hemodialysis
610392|NCT00976846|on line|on line
610393|NCT00976846|postdilution|postdilution
610394|NCT00976846|high-flux dialyzer|high-flux dialyzer
610395|NCT00976846|hemodiafiltration|hemodiafiltration
610396|NCT00976833|Acute Respiratory Failure|acute respiratory failure
610397|NCT00976833|Early ICU Mobility|early icu mobility
610398|NCT00976833|Early Physical Therapy|early physical therapy
610399|NCT00976833|Critical Care|critical care
610400|NCT00976833|Intensive Care|intensive care
610401|NCT00976833|ICU|icu
610402|NCT00976820|influenza infection|influenza infection
610403|NCT00976820|Influenza Vaccines|influenza vaccines
610404|NCT00976820|GSK Bio's influenza vaccine GSK2340273A|gsk bio's influenza vaccine gsk2340273a
610405|NCT00976820|GSK Bio's influenza vaccine GSK2340274A|gsk bio's influenza vaccine gsk2340274a
610406|NCT00976807|critical care|critical care
610407|NCT00976807|intensive care|intensive care
610408|NCT00976807|weakness|weakness
610409|NCT00976807|myopathy|myopathy
610410|NCT00976807|paresis|paresis
610411|NCT00976807|rehabilitation|rehabilitation
610412|NCT00976794|BD I|bd i
610413|NCT00976768|Advanced gastric cancer|advanced gastric cancer
610414|NCT00976768|FOLFIRI|folfiri
610415|NCT00976755|adenocarcinoma of the prostate|adenocarcinoma of the prostate
610416|NCT00976755|hormone-resistant prostate cancer|hormone-resistant prostate cancer
610417|NCT00976755|stage III prostate cancer|stage iii prostate cancer
610418|NCT00976755|stage IV prostate cancer|stage iv prostate cancer
610419|NCT00976742|plasma lipoprotein lipids|plasma lipoprotein lipids
610420|NCT00976742|body composition|body composition
610421|NCT00976742|glucose tolerance|glucose tolerance
610422|NCT00976742|inflammation markers|inflammation markers
610423|NCT00976742|insulin sensitivity|insulin sensitivity
610424|NCT00976742|coagulation markers|coagulation markers
610425|NCT00976729|monocyte chemoattractant protein-1 (MCP-1)|monocyte chemoattractant protein-1 (mcp-1)
610426|NCT00976729|L-oligonucleotide aptamer|l-oligonucleotide aptamer
610427|NCT00976729|Spiegelmer|spiegelmer
610428|NCT00976716|posttraumatic pain|posttraumatic pain
610429|NCT00976703|cervical foley catheter|cervical foley catheter
610430|NCT00976690|Crohn's Disease|crohn's disease
610431|NCT00976690|Ileocolic resection|ileocolic resection
610432|NCT00976690|Endoscopic recurrence|endoscopic recurrence
610433|NCT00976690|Ileocolic or colon resection (>50cm)|ileocolic or colon resection (>50cm)
610434|NCT00976651|infertility|infertility
610435|NCT00976651|ICSI|icsi
610436|NCT00976651|hCG|hcg
610437|NCT00976651|infertility treatment|infertility treatment
610438|NCT00976638|Antimicrobial Resistant Bacteria|antimicrobial resistant bacteria
610439|NCT00976638|Hospital acquired infections|hospital acquired infections
610440|NCT00976638|Colonization|colonization
610441|NCT00976638|Bacteremia|bacteremia
610442|NCT00976638|MRSA|mrsa
610443|NCT00976638|VRE|vre
610444|NCT00976638|ESBL|esbl
610445|NCT00976638|Intensive Care|intensive care
610446|NCT00976638|ICU|icu
610447|NCT00976625|diastolic function|diastolic function
610448|NCT00976625|aortic regurgitation|aortic regurgitation
610449|NCT00976625|aortic valve replacement|aortic valve replacement
610450|NCT00976625|left ventricular hypertrophy|left ventricular hypertrophy
610451|NCT00976625|myocardial structure|myocardial structure
610452|NCT00976625|LV remodeling|lv remodeling
610453|NCT00976625|Muscular regression|muscular regression
610454|NCT00976625|LV fibrous tissue|lv fibrous tissue
610455|NCT00976612|Gastrointestinal stromal tumor|gastrointestinal stromal tumor
610456|NCT00976612|pharmacokinetics|pharmacokinetics
610457|NCT00976612|nilotinib|nilotinib
610458|NCT00976586|Incontinentia pigmenti|incontinentia pigmenti
610459|NCT00976586|recombination|recombination
610460|NCT00976586|IKBKG|ikbkg
610461|NCT00976586|IKBKGP|ikbkgp
610462|NCT00976573|Stage IV Skin Melanoma|stage iv skin melanoma
610463|NCT00976573|recurrent melanoma|recurrent melanoma
610464|NCT00976560|Lack of interest and energy|lack of interest and energy
610465|NCT00976560|Psychomotor retardation|psychomotor retardation
610466|NCT00976560|Cytokines|cytokines
610467|NCT00976560|Major Depressive disorder|major depressive disorder
610468|NCT00976547|tinnitus|tinnitus
610469|NCT00976547|depression|depression
610470|NCT00976547|audiometry|audiometry
610471|NCT00976547|measurement|measurement
610472|NCT00976534|Analgesic effect|analgesic effect
610473|NCT00976534|Peripheral Neuropathic pain|peripheral neuropathic pain
610474|NCT00976534|Posttraumatic Neuralgia (PTN)|posttraumatic neuralgia (ptn)
610475|NCT00976534|Postherpetic Neuralgia (PHN)|postherpetic neuralgia (phn)
610476|NCT00976508|advanced solid tumors cancer refractory cancer figitumumab pegvisomant|advanced solid tumors cancer refractory cancer figitumumab pegvisomant
610477|NCT00976482|Cardiovascular|cardiovascular
610478|NCT00976482|Pacemaker|pacemaker
610479|NCT00976482|Mortality|mortality
610480|NCT00976482|Physiologic pacing|physiologic pacing
610481|NCT00976456|lung cancer|lung cancer
610483|NCT00976456|elderly|elderly
610484|NCT00976456|non-squamous|non-squamous
610485|NCT00976456|Elderly patients at least 65 years old|elderly patients at least 65 years old
610486|NCT00976456|first line therapy|first line therapy
610487|NCT00976456|non-squamous non-small cell lung cancer stage IIIb or IV|non-squamous non-small cell lung cancer stage iiib or iv
610488|NCT00976443|Obesity|obesity
610489|NCT00976443|Gastric Emptying|gastric emptying
610490|NCT00976443|Satiation|satiation
610491|NCT00976443|Endosonography|endosonography
610492|NCT00976443|Endoscopy|endoscopy
610493|NCT00976443|Feeding Behavior|feeding behavior
610494|NCT00976430|Autologous Stem Cells.|autologous stem cells.
610495|NCT00976404|HIV-1 infection|hiv-1 infection
610496|NCT00976404|Treatment intensification|treatment intensification
610498|NCT00976404|HIV-rAd5 vaccine|hiv-rad5 vaccine
610499|NCT00976391|open-label|open-label
610500|NCT00976391|albiglutide|albiglutide
610501|NCT00976391|insulin glargine|insulin glargine
610502|NCT00976391|preprandial insulin|preprandial insulin
610503|NCT00976378|stromal cell-derived factor-1 (SDF-1)|stromal cell-derived factor-1 (sdf-1)
610504|NCT00976378|L-oligonucleotide aptamer|l-oligonucleotide aptamer
610505|NCT00976378|Spiegelmer|spiegelmer
610506|NCT00976365|Breast Cancer|breast cancer
610507|NCT00976352|Gene Therapy|gene therapy
610508|NCT00976352|Pompe Disease|pompe disease
610509|NCT00976352|Glycogen Storage Disease|glycogen storage disease
610510|NCT00976339|Breast cancer|breast cancer
610511|NCT00976339|Vitamin D|vitamin d
610512|NCT00976339|Premenopausal|premenopausal
610513|NCT00976313|thoracic epidural analgesia|thoracic epidural analgesia
610514|NCT00976313|urinary micturition|urinary micturition
610515|NCT00976313|thoracotomy|thoracotomy
610516|NCT00976300|SLE|sle
610517|NCT00976300|lupus nephritis|lupus nephritis
610518|NCT00976300|cyclosporine A|cyclosporine a
610519|NCT00976300|cyclophosphamide|cyclophosphamide
610520|NCT00976300|active proliferative lupus nephritis (class III or IV according to WHO)|active proliferative lupus nephritis (class iii or iv according to who)
610521|NCT00976287|Stem cells|stem cells
610522|NCT00976287|Liver cirrhosis|liver cirrhosis
610523|NCT00976287|Radiology|radiology
775818|NCT00345839|CKD|ckd
610524|NCT00976287|Interventional|interventional
610525|NCT00976287|Transplantation|transplantation
610526|NCT00976274|Korean red ginseng|korean red ginseng
610527|NCT00976274|metabolic syndrome|metabolic syndrome
610528|NCT00976274|blood pressure|blood pressure
610529|NCT00976274|arterial stiffness|arterial stiffness
610530|NCT00976274|inflammation|inflammation
610531|NCT00976274|oxidative stress|oxidative stress
610532|NCT00976261|type 2 diabetes|type 2 diabetes
610533|NCT00976261|single dose|single dose
610534|NCT00976261|3-O-methylglucose|3-o-methylglucose
610535|NCT00976261|healthy volunteer|healthy volunteer
610536|NCT00976261|repeat dose|repeat dose
610537|NCT00976248|everolimus|everolimus
610538|NCT00976248|RAD001|rad001
610539|NCT00976248|WM|wm
610540|NCT00976235|Macular Degeneration|macular degeneration
610541|NCT00976235|Visual Impairment|visual impairment
610542|NCT00976235|Quality of Life|quality of life
610543|NCT00976235|Telescope Prosthesis|telescope prosthesis
610544|NCT00976196|Aspirin|aspirin
610545|NCT00976196|Blood platelets|blood platelets
610546|NCT00976196|proteomics|proteomics
610547|NCT00976196|Platelet reactivity|platelet reactivity
610548|NCT00976183|ovarian cancer|ovarian cancer
610549|NCT00976183|gynecologic oncology|gynecologic oncology
610550|NCT00976183|vorinostat|vorinostat
610551|NCT00976183|treatment|treatment
610552|NCT00976170|Advanced or metastatic HCC|advanced or metastatic hcc
610553|NCT00976157|STREM-1|strem-1
610554|NCT00976157|BAL|bal
610555|NCT00976157|VAP|vap
610556|NCT00976144|safety|safety
610557|NCT00976144|LAMA|lama
610558|NCT00976144|pharmacodynamics|pharmacodynamics
610559|NCT00976144|tolerability|tolerability
610560|NCT00976144|Muscarinic receptor antagonist,|muscarinic receptor antagonist,
610561|NCT00976144|anticholinergic,|anticholinergic,
610562|NCT00976144|beta-2 agonist|beta-2 agonist
610563|NCT00976144|healthy Japanese subjects|healthy japanese subjects
610564|NCT00976144|LABA|laba
610657|NCT00975780|Pneumonia|pneumonia
610565|NCT00976144|Chronic Obstructive Pulmonary Disease (COPD)|chronic obstructive pulmonary disease (copd)
610566|NCT00976144|pharmacokinetics|pharmacokinetics
610567|NCT00976131|Breast Cancer|breast cancer
610568|NCT00976131|Early Stage Breast Cancer|early stage breast cancer
610569|NCT00976131|Complementary and Alternative Medicine|complementary and alternative medicine
610571|NCT00976118|Dementia of Alzheimer's type|dementia of alzheimer's type
610572|NCT00976118|mild to moderate Alzheimer's Disease|mild to moderate alzheimer's disease
610573|NCT00976105|Pharmacokinetics|pharmacokinetics
610574|NCT00976105|Pharmacodynamics|pharmacodynamics
610575|NCT00976105|Safety and tolerability|safety and tolerability
610576|NCT00976105|Repeat dose|repeat dose
610577|NCT00976105|Personality traits|personality traits
610578|NCT00976105|Fat mass|fat mass
610579|NCT00976105|Healthy volunteers|healthy volunteers
610580|NCT00976092|myocardial infarction|myocardial infarction
610581|NCT00976092|clopidogrel|clopidogrel
610582|NCT00976092|prasugrel|prasugrel
610583|NCT00976092|bivalirudin|bivalirudin
610584|NCT00976092|primary PCI|primary pci
610585|NCT00976079|Tibial femoral knee osteoarthritis|tibial femoral knee osteoarthritis
610586|NCT00976079|Osteoarthritis|osteoarthritis
610587|NCT00976066|Obesity|obesity
610588|NCT00976066|Naltrexone|naltrexone
610589|NCT00976066|Carfentanil|carfentanil
610590|NCT00976066|Receptor Occupancy|receptor occupancy
610591|NCT00976066|mu-opioid Receptor|mu-opioid receptor
610592|NCT00976066|PET (Positron Emission Tomography)|pet (positron emission tomography)
610593|NCT00976066|BOLD-fMRI|bold-fmri
610594|NCT00976053|Myocardial perfusion imaging|myocardial perfusion imaging
610595|NCT00976053|Single photon emission computed tomography|single photon emission computed tomography
610596|NCT00976053|Positron emission tomography|positron emission tomography
610597|NCT00976040|HIV-1|hiv-1
610598|NCT00976040|Africa|africa
610599|NCT00976040|Botswana|botswana
610600|NCT00976040|Highly active antiretroviral therapy|highly active antiretroviral therapy
610601|NCT00976040|treatment naive|treatment naive
610602|NCT00976027|Influenza|influenza
610603|NCT00976027|Respiratory Tract Infections|respiratory tract infections
610604|NCT00976027|Influenza-like illness|influenza-like illness
610605|NCT00976027|Elderly|elderly
610606|NCT00976027|Fluzone®|fluzone®
610607|NCT00976027|Efficacy|efficacy
610608|NCT00976001|Follow-up after stroke|follow-up after stroke
610609|NCT00975988|PMS (post-marketing surveillance)|pms (post-marketing surveillance)
610610|NCT00975988|TYKERB® tablets|tykerb® tablets
610611|NCT00975975|Paroxysmal nocturnal hemoglobinuria|paroxysmal nocturnal hemoglobinuria
610612|NCT00975975|severe aplastic anemia|severe aplastic anemia
610613|NCT00975975|Mantle cell|mantle cell
610614|NCT00975962|Stroke|stroke
610615|NCT00975962|Neuroprotection|neuroprotection
610616|NCT00975962|remote preconditioning|remote preconditioning
610617|NCT00975962|Salvage index (%): Difference in infarct growth (PWI-DWI)|salvage index (%): difference in infarct growth (pwi-dwi)
610618|NCT00975949|fluconazole prophylaxis|fluconazole prophylaxis
610619|NCT00975949|fungal colonization|fungal colonization
610620|NCT00975949|fungal infection|fungal infection
610621|NCT00975949|preterm infants|preterm infants
610622|NCT00975949|long term outcomes|long term outcomes
610623|NCT00975949|quality of life|quality of life
610624|NCT00975936|Microdose|microdose
610625|NCT00975936|Drug-Drug Interaction|drug-drug interaction
610626|NCT00975936|Ketoconazole|ketoconazole
610627|NCT00975936|Phase 0|phase 0
610628|NCT00975923|Quality Improvement|quality improvement
610629|NCT00975923|Critical Care|critical care
610630|NCT00975923|Collaboratives|collaboratives
610631|NCT00975923|Patient Safety|patient safety
610632|NCT00975923|Tool Kit|tool kit
610633|NCT00975910|Supratentorial Craniotomy|supratentorial craniotomy
610634|NCT00975897|adenocarcinoma of the colon|adenocarcinoma of the colon
610635|NCT00975897|recurrent colon cancer|recurrent colon cancer
610636|NCT00975897|stage III colon cancer|stage iii colon cancer
610637|NCT00975897|stage IV colon cancer|stage iv colon cancer
610638|NCT00975897|adenocarcinoma of the rectum|adenocarcinoma of the rectum
610639|NCT00975897|recurrent rectal cancer|recurrent rectal cancer
610640|NCT00975897|stage III rectal cancer|stage iii rectal cancer
610641|NCT00975897|stage IV rectal cancer|stage iv rectal cancer
610642|NCT00975884|GSK Bio's influenza vaccine GSK2340272A|gsk bio's influenza vaccine gsk2340272a
610643|NCT00975884|influenza infection|influenza infection
610644|NCT00975884|Influenza vaccine|influenza vaccine
610645|NCT00975871|Livedo vasculitis|livedo vasculitis
610646|NCT00975871|Genetic pleomorphism|genetic pleomorphism
610647|NCT00975858|Symptomatic Coronary Artery Disease Patients|symptomatic coronary artery disease patients
610648|NCT00975845|ACL|acl
610649|NCT00975845|Anterior Cruciate Ligament|anterior cruciate ligament
610650|NCT00975845|Torn tendon|torn tendon
610651|NCT00975845|ACL Repair|acl repair
610652|NCT00975845|ACL reconstruction|acl reconstruction
610653|NCT00975832|The independent effect of PCOS and obesity on adipose expression and plasma levels of adipocytokines|the independent effect of pcos and obesity on adipose expression and plasma levels of adipocytokines
610654|NCT00975793|Sepsis|sepsis
610655|NCT00975793|Severe sepsis|severe sepsis
610656|NCT00975793|Septic shock|septic shock
610658|NCT00975780|Lower respiratory tract infection|lower respiratory tract infection
610659|NCT00975780|Lower respiratory tract infection other than pneumonia|lower respiratory tract infection other than pneumonia
610660|NCT00975754|Inhalation|inhalation
610661|NCT00975754|lung deposition|lung deposition
610662|NCT00975741|Asthma|asthma
610663|NCT00975741|Mometasone furoate|mometasone furoate
610664|NCT00975741|Inhalation devices|inhalation devices
610665|NCT00975741|Forced expiratory volume|forced expiratory volume
610666|NCT00975728|Anti-oxidant|anti-oxidant
610667|NCT00975728|Açai|açai
610668|NCT00975728|Food supplement|food supplement
610669|NCT00975728|Sun protection|sun protection
610670|NCT00975728|Skin erythema prevention|skin erythema prevention
610671|NCT00975728|Anti-oxidant efficacy|anti-oxidant efficacy
610672|NCT00975728|Anti-age efficacy|anti-age efficacy
610673|NCT00975728|Skin photo-induced damage protection|skin photo-induced damage protection
610674|NCT00975715|Seizures|seizures
610675|NCT00975715|oxcarbazepine|oxcarbazepine
610676|NCT00975715|child|child
610677|NCT00975702|Remote ischemic preconditioning|remote ischemic preconditioning
610678|NCT00975702|deceased organ donors|deceased organ donors
610679|NCT00975702|ischemia reperfusion injury|ischemia reperfusion injury
610680|NCT00975702|Delayed graft function|delayed graft function
610681|NCT00975702|Clinical outcomes in kidney transplant recipients|clinical outcomes in kidney transplant recipients
610682|NCT00975702|Clinical outcomes in liver transplant recipients|clinical outcomes in liver transplant recipients
610683|NCT00975702|Clinical outcomes in pancreas transplant recipients|clinical outcomes in pancreas transplant recipients
610684|NCT00975689|Niemann-Pick Disease, Type C|niemann-pick disease, type c
610685|NCT00975689|Biomarkers|biomarkers
610686|NCT00975689|N-Acetyl Cysteine|n-acetyl cysteine
610687|NCT00975689|Oxidized Cholesterol|oxidized cholesterol
610688|NCT00975689|Neurodegeneration|neurodegeneration
610689|NCT00975689|NPC|npc
610690|NCT00975676|estrogen receptor-positive breast cancer|estrogen receptor-positive breast cancer
610691|NCT00975676|progesterone receptor-positive breast cancer|progesterone receptor-positive breast cancer
610692|NCT00975676|stage IA breast cancer|stage ia breast cancer
610693|NCT00975676|stage IB breast cancer|stage ib breast cancer
610694|NCT00975676|stage II breast cancer|stage ii breast cancer
610695|NCT00975676|stage IIIA breast cancer|stage iiia breast cancer
610696|NCT00975663|Lung transplantation|lung transplantation
610697|NCT00975663|heart-lung transplantation|heart-lung transplantation
610698|NCT00975663|therapeutic drug monitoring|therapeutic drug monitoring
610699|NCT00975663|tacrolimus|tacrolimus
610700|NCT00975663|mycophenolate|mycophenolate
610701|NCT00975663|immunosuppressant|immunosuppressant
610702|NCT00975663|pharmacokinetics|pharmacokinetics
610703|NCT00975650|Primary Hypogonadism|primary hypogonadism
610704|NCT00975650|Secondary Hypogonadism|secondary hypogonadism
610705|NCT00975611|schizophrenia|schizophrenia
610706|NCT00975611|schizoaffective disorder|schizoaffective disorder
610707|NCT00975611|paliperidone ER|paliperidone er
775995|NCT00345176|lutein|lutein
610708|NCT00975611|risperidone Consta|risperidone consta
610709|NCT00975611|prolactin|prolactin
610710|NCT00975611|hyperprolactinemia|hyperprolactinemia
610711|NCT00975572|Flu|flu
610712|NCT00975572|adjuvanted H1N1 vaccine|adjuvanted h1n1 vaccine
610713|NCT00975572|non-adjuvanted H1N1 vaccine|non-adjuvanted h1n1 vaccine
610714|NCT00975572|Immunogenictiy|immunogenictiy
610715|NCT00975572|Safety|safety
610716|NCT00975546|fertility|fertility
610717|NCT00975546|HIV discordant|hiv discordant
610718|NCT00975546|HIV|hiv
610719|NCT00975546|Infertility in HIV-discordant couples|infertility in hiv-discordant couples
610720|NCT00975546|HIV seronegativity|hiv seronegativity
610721|NCT00975533|type 2 diabetes mellitus|type 2 diabetes mellitus
610722|NCT00975533|obesity|obesity
610723|NCT00975520|Neurotropic|neurotropic
610724|NCT00975520|Melanoma|melanoma
610725|NCT00975520|Observation|observation
610726|NCT00975520|Radiation Therapy|radiation therapy
610727|NCT00975520|Relapse|relapse
610728|NCT00975494|pde5-inhibition|pde5-inhibition
610729|NCT00975494|sildenafil|sildenafil
610730|NCT00975494|LV diastolic function|lv diastolic function
610731|NCT00975494|heart failure patients|heart failure patients
610732|NCT00975481|oral single-dose 6-way crossover recreational drug users abuse potential pharmacodynamics safety|oral single-dose 6-way crossover recreational drug users abuse potential pharmacodynamics safety
610733|NCT00975468|pressure-controlled|pressure-controlled
610734|NCT00975468|volume-controlled|volume-controlled
610735|NCT00975468|one lung|one lung
610736|NCT00975468|ventilation|ventilation
610737|NCT00975468|lung injury|lung injury
610738|NCT00975468|thoracotomy|thoracotomy
610739|NCT00975442|Elbow|elbow
610740|NCT00975442|Tendinitis|tendinitis
610741|NCT00975442|Sports Medicine|sports medicine
610742|NCT00975442|Athletic injuries|athletic injuries
610743|NCT00975429|Prostatic Disease|prostatic disease
610744|NCT00975429|Genital neoplasm, male|genital neoplasm, male
610745|NCT00975429|Urogenital neoplasm|urogenital neoplasm
610746|NCT00975429|Genital disease,male|genital disease,male
610747|NCT00975429|Male urogenital disease|male urogenital disease
610748|NCT00975429|Neoplasms|neoplasms
610749|NCT00975429|Neoplasm by site|neoplasm by site
610750|NCT00975429|Prostatic neoplasm|prostatic neoplasm
610751|NCT00975429|Carcinoma|carcinoma
610752|NCT00975416|Drug Dependence|drug dependence
610753|NCT00975416|Cognitive Behavior|cognitive behavior
610754|NCT00975416|Oxytocin|oxytocin
610755|NCT00975416|Cocaine|cocaine
610756|NCT00975416|Heroin|heroin
610757|NCT00975416|fMRI|fmri
610758|NCT00975403|mild COPD|mild copd
610759|NCT00975403|dyspnea|dyspnea
610760|NCT00975403|exercise|exercise
610761|NCT00975403|respiratory mechanics|respiratory mechanics
610762|NCT00975403|COPD|copd
610763|NCT00975390|Glycogen|glycogen
610764|NCT00975390|Carbohydrate|carbohydrate
610765|NCT00975390|Protein|protein
610766|NCT00975390|Caffeine|caffeine
610767|NCT00975390|Post exercise muscle glycogen synthesis|post exercise muscle glycogen synthesis
610768|NCT00975390|Sports nutrition|sports nutrition
610769|NCT00975377|hair removal|hair removal
610770|NCT00975377|hair clipping|hair clipping
610771|NCT00975377|surgical site infection|surgical site infection
610772|NCT00975377|incisional infection|incisional infection
610773|NCT00975377|wound infection|wound infection
610774|NCT00975364|Folate|folate
610775|NCT00975364|Methylenetetrahydrofolate reductase|methylenetetrahydrofolate reductase
610776|NCT00975364|Speciation|speciation
610777|NCT00975364|Nutrient status|nutrient status
610778|NCT00975364|Bioavailability|bioavailability
610779|NCT00975364|Polymorphism, single nucleotide|polymorphism, single nucleotide
610780|NCT00975351|folates|folates
610781|NCT00975351|5-methyltetrahydrofolic acid|5-methyltetrahydrofolic acid
610782|NCT00975351|pharmacokinetics|pharmacokinetics
610783|NCT00975351|bioavailability|bioavailability
610784|NCT00975351|biotransformation|biotransformation
610785|NCT00975338|health care transition, young adults, rehabilitation|health care transition, young adults, rehabilitation
610786|NCT00975325|Bioequivalency|bioequivalency
610787|NCT00975312|lentigo|lentigo
610788|NCT00975312|hydroquinone|hydroquinone
610789|NCT00975312|tretinoin|tretinoin
610790|NCT00975312|fluocinolone acetonide|fluocinolone acetonide
610791|NCT00975299|Neoplasm|neoplasm
610792|NCT00975299|PET/CT diagnosis|pet/ct diagnosis
610793|NCT00975299|PET tracer|pet tracer
610794|NCT00975273|Asthma|asthma
610795|NCT00975273|Dyspnea|dyspnea
610796|NCT00975273|Paroxysmal|paroxysmal
610797|NCT00975273|Pulmonary|pulmonary
610798|NCT00975273|Respiratory hypersensitivity|respiratory hypersensitivity
610799|NCT00975273|Airway inflammation|airway inflammation
610800|NCT00975273|Airway obstruction|airway obstruction
610801|NCT00975273|Wheezing|wheezing
610802|NCT00975247|Quality Improvement|quality improvement
610803|NCT00975247|Colonoscopy|colonoscopy
610804|NCT00975247|Screening|screening
610805|NCT00975247|Colon Cancer|colon cancer
610806|NCT00975247|Polyp detection rates|polyp detection rates
610807|NCT00975247|Colonoscopy completion rates|colonoscopy completion rates
610808|NCT00975247|Scope Withdrawal time|scope withdrawal time
610809|NCT00975247|Reduce costs through improving bowel prep quality|reduce costs through improving bowel prep quality
610810|NCT00975234|Intra-lesion injection of autologous myoblasts|intra-lesion injection of autologous myoblasts
610811|NCT00975221|Primary hyperparathyroidism|primary hyperparathyroidism
610812|NCT00975221|Parathyroidectomy|parathyroidectomy
610813|NCT00975221|Hypercalcemia|hypercalcemia
610814|NCT00975208|Osteogenesis [G07.700.320.500.325.377.625.100.729]|osteogenesis [g07.700.320.500.325.377.625.100.729]
610815|NCT00975208|Tooth Eruption [G10.549.235.726]|tooth eruption [g10.549.235.726]
610816|NCT00975182|PI3K|pi3k
610817|NCT00975182|NSCLC|nsclc
610818|NCT00975182|Tarceva|tarceva
610819|NCT00975143|isotretinoin|isotretinoin
610820|NCT00975143|dermatology|dermatology
610821|NCT00975143|skin|skin
610822|NCT00975117|Dietary supplement|dietary supplement
610823|NCT00975117|male infertility|male infertility
610824|NCT00975117|spermatogenesis|spermatogenesis
610825|NCT00975104|Aging|aging
610826|NCT00975104|Frailty|frailty
610827|NCT00975104|Sedentary|sedentary
610828|NCT00975104|Immobilization|immobilization
610829|NCT00975104|Atrophy|atrophy
610830|NCT00975104|Muscle Wasting|muscle wasting
610831|NCT00975104|Physical Activity|physical activity
610832|NCT00975078|dexamethasone-suppression-test|dexamethasone-suppression-test
610833|NCT00975078|high dose glucocorticoid treatment|high dose glucocorticoid treatment
610834|NCT00975078|Population at Risk|population at risk
610835|NCT00975065|Galvus|galvus
610836|NCT00975039|Inoperable|inoperable
610837|NCT00975039|Inoperable Cholangiocarcinoma|inoperable cholangiocarcinoma
610838|NCT00975039|Non-resectable|non-resectable
610839|NCT00975039|Non-resectable Cholangiocarcinoma|non-resectable cholangiocarcinoma
610840|NCT00975039|Carcinoma|carcinoma
610841|NCT00975026|Massage|massage
610842|NCT00975026|Chair Massage|chair massage
610843|NCT00975026|Pain|pain
610844|NCT00975026|Discomfort|discomfort
610845|NCT00975026|Stretching|stretching
610846|NCT00975026|Stretching Exercises|stretching exercises
610847|NCT00975026|Sonographer|sonographer
610848|NCT00975026|Cardiac Sonographer|cardiac sonographer
610849|NCT00975013|Laparoscopic Gastric Bypass|laparoscopic gastric bypass
610850|NCT00975013|Morbid Obesity|morbid obesity
610851|NCT00975013|Bone Mineral Density|bone mineral density
610852|NCT00975000|Intervention|intervention
610853|NCT00975000|Cinacalcet|cinacalcet
610854|NCT00975000|Sensipar|sensipar
610855|NCT00975000|Mimpara|mimpara
610856|NCT00975000|hyperparathyroidism|hyperparathyroidism
610857|NCT00975000|calcium|calcium
610858|NCT00975000|osteodystrophy|osteodystrophy
610859|NCT00975000|hypercalcemia|hypercalcemia
610860|NCT00975000|renal|renal
610861|NCT00975000|transplant|transplant
610862|NCT00975000|acute rejection|acute rejection
610863|NCT00975000|kidney transplant failure|kidney transplant failure
610864|NCT00975000|hypophosphatemia|hypophosphatemia
610865|NCT00974987|adult giant cell glioblastoma|adult giant cell glioblastoma
610866|NCT00974987|adult glioblastoma|adult glioblastoma
610867|NCT00974987|adult gliosarcoma|adult gliosarcoma
610868|NCT00974974|Parkinson's Disease|parkinson's disease
610869|NCT00974961|Levobupivacaine|levobupivacaine
610870|NCT00974961|HRV|hrv
610871|NCT00974961|Spinal Anesthesia|spinal anesthesia
610872|NCT00974961|Responses of ANS to these two drugs|responses of ans to these two drugs
610873|NCT00974948|Pancreatic cancer|pancreatic cancer
610874|NCT00974948|Therapy|therapy
610875|NCT00974948|Neurolysis|neurolysis
610876|NCT00974935|Staphylococcal enterotoxin B, vaccine, Staphylococcus aureus, toxic shock syndrome|staphylococcal enterotoxin b, vaccine, staphylococcus aureus, toxic shock syndrome
610877|NCT00974922|Vitamin D|vitamin d
610878|NCT00974922|Hypertension|hypertension
610879|NCT00974909|Fecal incontinence|fecal incontinence
610880|NCT00974896|Advanced Solid Tumors|advanced solid tumors
610881|NCT00974896|AMG 479|amg 479
610882|NCT00974896|Amgen|amgen
610883|NCT00974896|Oncology|oncology
610884|NCT00974896|Phase 1b|phase 1b
610885|NCT00974883|ultrasound|ultrasound
610886|NCT00974883|GCA|gca
610887|NCT00974883|temporal arteritis|temporal arteritis
610888|NCT00974883|biopsy|biopsy
610889|NCT00974857|Hemodialysis|hemodialysis
610890|NCT00974857|Left Ventricular Hypertrophy|left ventricular hypertrophy
610891|NCT00974857|Body Composition Monitor|body composition monitor
610892|NCT00974844|posterior assisted levitation|posterior assisted levitation
610893|NCT00974844|Pars Plana|pars plana
610894|NCT00974844|Dropped nucleus|dropped nucleus
610895|NCT00974844|cataract|cataract
610896|NCT00974844|complication of|complication of
610897|NCT00974844|surgery|surgery
610898|NCT00974818|Bladder|bladder
610899|NCT00974818|Mitomycin C|mitomycin c
610900|NCT00974818|MMC|mmc
610901|NCT00974818|TheracysR Bacillus Calmette-Guerin|theracysr bacillus calmette-guerin
610902|NCT00974818|BCG|bcg
610903|NCT00974818|intravesical|intravesical
610904|NCT00974818|09-118|09-118
610905|NCT00974805|COPD|copd
610906|NCT00974805|Emphysema|emphysema
610907|NCT00974805|Bronchitis|bronchitis
610908|NCT00974792|stage III adult diffuse large cell lymphoma|stage iii adult diffuse large cell lymphoma
610909|NCT00974792|stage IV adult diffuse large cell lymphoma|stage iv adult diffuse large cell lymphoma
610910|NCT00974779|kidney failure chronic|kidney failure chronic
610911|NCT00974779|renal dialysis|renal dialysis
610912|NCT00974779|inflammation|inflammation
610913|NCT00974779|monocytes|monocytes
610914|NCT00974779|end stage renal disease on regular thrice weekly hemodialysis|end stage renal disease on regular thrice weekly hemodialysis
610915|NCT00974766|bronchial asthma|bronchial asthma
610916|NCT00974766|allergic bronchopulmonary aspergillosis|allergic bronchopulmonary aspergillosis
610917|NCT00974753|epiretinal membrane|epiretinal membrane
610918|NCT00974740|type 1 diabetes|type 1 diabetes
610919|NCT00974727|Childhood overweight|childhood overweight
610920|NCT00974727|Gardening|gardening
610921|NCT00974727|Summer weight gain|summer weight gain
610922|NCT00974714|chronic hypertension in pregnancy|chronic hypertension in pregnancy
610923|NCT00974701|symptoms of acute overt upper gastrointestinal hemorrhage|symptoms of acute overt upper gastrointestinal hemorrhage
610924|NCT00974688|Congenital|congenital
610925|NCT00974688|physical activity participation|physical activity participation
610926|NCT00974688|Moderate-to-vigorous physical activity|moderate-to-vigorous physical activity
610927|NCT00974675|Asthma|asthma
610928|NCT00974675|CAT-354|cat-354
610929|NCT00974675|Tralokinumab|tralokinumab
610930|NCT00974662|Non-Small Cell Lung Cancer|non-small cell lung cancer
610931|NCT00974662|Lung Cancer|lung cancer
610932|NCT00974662|NSCLC|nsclc
610933|NCT00974649|drop-out|drop-out
610934|NCT00974649|predictors of treatment continuation/discontinuation|predictors of treatment continuation/discontinuation
610935|NCT00974649|IVF/ICSI|ivf/icsi
610936|NCT00974649|infertility|infertility
610937|NCT00974649|counseling|counseling
610938|NCT00974649|psychology|psychology
610939|NCT00974649|Assisted Reproduction|assisted reproduction
610940|NCT00974649|Counselling|counselling
610941|NCT00974636|Kidney Disease|kidney disease
610942|NCT00974636|Albuminuria|albuminuria
610943|NCT00974636|Glomerular filtration rate|glomerular filtration rate
610944|NCT00974636|Volume status|volume status
610945|NCT00974636|Bioimpedance analysis|bioimpedance analysis
610946|NCT00974623|Bone growth substitute|bone growth substitute
610947|NCT00974623|Autograft|autograft
610948|NCT00974623|Allograft|allograft
610949|NCT00974623|Spine fusion|spine fusion
610950|NCT00974610|stage IV melanoma|stage iv melanoma
610951|NCT00974610|recurrent melanoma|recurrent melanoma
610952|NCT00974610|stage IV non-small cell lung cancer|stage iv non-small cell lung cancer
610953|NCT00974610|recurrent non-small cell lung cancer|recurrent non-small cell lung cancer
610954|NCT00974610|extensive stage small cell lung cancer|extensive stage small cell lung cancer
610955|NCT00974610|recurrent small cell lung cancer|recurrent small cell lung cancer
610956|NCT00974610|stage IV breast cancer|stage iv breast cancer
610957|NCT00974610|recurrent breast cancer|recurrent breast cancer
610958|NCT00974610|male breast cancer|male breast cancer
610959|NCT00974610|stage III pancreatic cancer|stage iii pancreatic cancer
610960|NCT00974610|stage IV pancreatic cancer|stage iv pancreatic cancer
610961|NCT00974610|recurrent pancreatic cancer|recurrent pancreatic cancer
610962|NCT00974610|stage IV colon cancer|stage iv colon cancer
610963|NCT00974610|recurrent colon cancer|recurrent colon cancer
610964|NCT00974610|stage IV rectal cancer|stage iv rectal cancer
610965|NCT00974610|recurrent rectal cancer|recurrent rectal cancer
610966|NCT00974597|burn|burn
610967|NCT00974597|donor site|donor site
610968|NCT00974597|treatment of burns|treatment of burns
610969|NCT00974597|Treatment of Donor Sites|treatment of donor sites
610970|NCT00974584|NSCLC|nsclc
610971|NCT00974584|PI3K|pi3k
610972|NCT00974584|Avastin|avastin
610973|NCT00974558|dyspnea|dyspnea
610974|NCT00974558|fan|fan
610975|NCT00974532|balance|balance
610976|NCT00974532|chronic kidney disease|chronic kidney disease
610977|NCT00974532|calcium|calcium
610978|NCT00974532|phosphorus|phosphorus
610979|NCT00974519|ADIS|adis
610980|NCT00974519|complementary therapies|complementary therapies
610981|NCT00974506|geriatric patients living in residential community (shared flats), multiple disease-conditions|geriatric patients living in residential community (shared flats), multiple disease-conditions
610982|NCT00974493|oral|oral
610983|NCT00974493|intravenous|intravenous
610984|NCT00974493|antibiotics|antibiotics
610985|NCT00974493|bone|bone
610986|NCT00974493|joint|joint
610987|NCT00974493|infection|infection
610988|NCT00974480|Skin|skin
610989|NCT00974480|Aging|aging
610990|NCT00974480|Rejuva-a|rejuva-a
610991|NCT00974480|Redermic|redermic
610992|NCT00974454|AIDS|aids
610993|NCT00974454|complementary therapies|complementary therapies
610994|NCT00974454|treatment experienced|treatment experienced
610995|NCT00974441|Bioequivalence|bioequivalence
610996|NCT00974428|Osteoarthritis|osteoarthritis
610997|NCT00974428|Disease of joints|disease of joints
610998|NCT00974428|Wobenzym® N|wobenzym® n
610999|NCT00974428|WOMAC pain score|womac pain score
611000|NCT00974428|Subject reported pain (VAS)|subject reported pain (vas)
611001|NCT00974415|BMI classification-overweight|bmi classification-overweight
611002|NCT00974402|Active duty|active duty
611003|NCT00974402|Afghanistan|afghanistan
611004|NCT00974402|Anger|anger
611005|NCT00974402|Anxiety|anxiety
611006|NCT00974402|Avoidance|avoidance
611007|NCT00974402|BAMC|bamc
611008|NCT00974402|Brooke Army Medical Center|brooke army medical center
611009|NCT00974402|Cognitive Behavioral Therapy|cognitive behavioral therapy
611010|NCT00974402|Combat|combat
611011|NCT00974402|Combat Disorder|combat disorder
611012|NCT00974402|Coping|coping
611013|NCT00974402|Counseling|counseling
611014|NCT00974402|Counselor|counselor
611015|NCT00974402|Deployment|deployment
611016|NCT00974402|Depression|depression
611017|NCT00974402|Exposure|exposure
611018|NCT00974402|Fear|fear
611019|NCT00974402|Feeling alone|feeling alone
611020|NCT00974402|Flashbacks|flashbacks
611021|NCT00974402|Guard|guard
611022|NCT00974402|Guilt|guilt
611023|NCT00974402|Hospitalization|hospitalization
611024|NCT00974402|Iraq|iraq
611025|NCT00974402|Mental Health|mental health
611026|NCT00974402|Military|military
611027|NCT00974402|Military member|military member
611028|NCT00974402|Military personnel|military personnel
611029|NCT00974402|Neuroses|neuroses
611030|NCT00974402|Nightmares|nightmares
611031|NCT00974402|OEF|oef
611032|NCT00974402|OIF|oif
611033|NCT00974402|Prolonged Exposure Therapy|prolonged exposure therapy
611034|NCT00974402|Psychiatric|psychiatric
611035|NCT00974402|Psychiatric medication|psychiatric medication
611036|NCT00974402|Psychological distress|psychological distress
611037|NCT00974402|Psychotherapy|psychotherapy
611038|NCT00974402|Reserve|reserve
611039|NCT00974402|Retired|retired
611040|NCT00974402|Sadness|sadness
611041|NCT00974402|Separated|separated
611042|NCT00974402|Sleeplessness|sleeplessness
611043|NCT00974402|Soldier|soldier
611044|NCT00974402|Stress|stress
611045|NCT00974402|Stress disorder|stress disorder
611046|NCT00974402|Stress management|stress management
611047|NCT00974402|STRONG STAR|strong star
611048|NCT00974402|Suicidal|suicidal
611049|NCT00974402|Suicide|suicide
611050|NCT00974402|Therapy|therapy
611051|NCT00974402|Trauma|trauma
611052|NCT00974402|Traumatic Event|traumatic event
611053|NCT00974402|Trouble Sleeping|trouble sleeping
611054|NCT00974402|Veteran|veteran
611055|NCT00974402|Veterans|veterans
611056|NCT00974402|War|war
611057|NCT00974402|WHMC|whmc
611058|NCT00974402|Wilford Hall Medical Center|wilford hall medical center
611059|NCT00974402|PTSD|ptsd
611060|NCT00974402|Posttraumatic Stress Disorders|posttraumatic stress disorders
611061|NCT00974389|stage III colon cancer|stage iii colon cancer
611062|NCT00974389|stage III rectal cancer|stage iii rectal cancer
611063|NCT00974389|stage IV colon cancer|stage iv colon cancer
611064|NCT00974389|stage IV rectal cancer|stage iv rectal cancer
611065|NCT00974389|recurrent colon cancer|recurrent colon cancer
611066|NCT00974389|recurrent rectal cancer|recurrent rectal cancer
611067|NCT00974376|Cannabis Treatment|cannabis treatment
611068|NCT00974376|Cannabis Use|cannabis use
611069|NCT00974376|Cannabis Dependence|cannabis dependence
611070|NCT00974376|Executive Functioning|executive functioning
611071|NCT00974376|Cognitive Deficits|cognitive deficits
611072|NCT00974363|meningococcal vaccine GSK 134612|meningococcal vaccine gsk 134612
611073|NCT00974350|Post-operative pain|post-operative pain
611074|NCT00974350|hernia surgery|hernia surgery
611075|NCT00974350|opioid|opioid
611076|NCT00974337|Adrenal insufficiency|adrenal insufficiency
611077|NCT00974337|cortisol|cortisol
611078|NCT00974337|preterm|preterm
611079|NCT00974337|shock|shock
611080|NCT00974337|neonate|neonate
611081|NCT00974324|peripheral T cell lymphoma|peripheral t cell lymphoma
611082|NCT00974324|chemotherapy|chemotherapy
611083|NCT00974324|anti-angiogeneses|anti-angiogeneses
611084|NCT00974311|Prostate Cancer|prostate cancer
611085|NCT00974311|Castration-resistant|castration-resistant
611086|NCT00974285|AIDS|aids
611087|NCT00974285|complementary therapies|complementary therapies
611088|NCT00974259|Hypoxia|hypoxia
611089|NCT00974259|Ischemia|ischemia
611090|NCT00974259|Intracranial hypertension|intracranial hypertension
611091|NCT00974259|Neurocritical care|neurocritical care
611092|NCT00974246|COPD|copd
611093|NCT00974246|Depression|depression
611094|NCT00974246|Nursing Home|nursing home
611095|NCT00974233|CLL|cll
611096|NCT00974233|SLL|sll
611097|NCT00974220|inhaled fentanyl|inhaled fentanyl
611098|NCT00974220|dyspnea|dyspnea
611099|NCT00974220|exercise|exercise
611100|NCT00974220|COPD|copd
611101|NCT00974194|Cholecystolithiasis|cholecystolithiasis
611102|NCT00974194|Cholecystectomy|cholecystectomy
611103|NCT00974194|Laparoscopic surgery|laparoscopic surgery
611104|NCT00974194|Single port|single port
611105|NCT00974168|pain|pain
611106|NCT00974168|radiation toxicity|radiation toxicity
611107|NCT00974168|spinal cord compression|spinal cord compression
611108|NCT00974168|unspecified adult solid tumor, protocol specific|unspecified adult solid tumor, protocol specific
611109|NCT00974155|Major|major
611110|NCT00974155|Depression|depression
611111|NCT00974155|Disorder|disorder
611112|NCT00974142|COPD|copd
611113|NCT00974142|Chronic Obstructive Pulmonary Disease|chronic obstructive pulmonary disease
611114|NCT00974142|Cyclosporine|cyclosporine
611115|NCT00974142|Oral Immunotherapy|oral immunotherapy
611116|NCT00974142|Advanced stage|advanced stage
611117|NCT00974103|low back pain|low back pain
611118|NCT00974103|pelvic pain|pelvic pain
611119|NCT00974103|pelvic girdle pain|pelvic girdle pain
611120|NCT00974103|post partum|post partum
611121|NCT00974090|insulin resistance|insulin resistance
611122|NCT00974077|recurrent depression,|recurrent depression,
611123|NCT00974077|mindfulness training|mindfulness training
611124|NCT00974077|attention|attention
611125|NCT00974077|Evoked EEG potentials|evoked eeg potentials
611126|NCT00974077|Relapse prevention in recurrent depression|relapse prevention in recurrent depression
611127|NCT00974064|COPD|copd
611128|NCT00974064|Lung disease|lung disease
611129|NCT00974064|Chronic bronchitis|chronic bronchitis
611130|NCT00974064|Emphysema|emphysema
611131|NCT00974064|Smoking|smoking
611132|NCT00974064|Smoking cessation|smoking cessation
611133|NCT00974064|Quit smoking|quit smoking
611134|NCT00974064|Healthy smoker|healthy smoker
611135|NCT00974064|Smoker|smoker
611136|NCT00974064|Non-smoker|non-smoker
611137|NCT00974051|Children|children
611138|NCT00974051|Exercise|exercise
611139|NCT00974051|Hypoglycemia|hypoglycemia
611140|NCT00974038|Bulimia Nervosa, EDNOS, Adolescents|bulimia nervosa, ednos, adolescents
611141|NCT00974012|Bioequivalence|bioequivalence
611142|NCT00973999|Botulinum Toxin|botulinum toxin
611143|NCT00973999|Saliva|saliva
611144|NCT00973999|Tracheostomy tube|tracheostomy tube
611145|NCT00973986|atorvastatin|atorvastatin
611146|NCT00973986|genetic polymorphisms|genetic polymorphisms
611147|NCT00973986|coronary heart disease|coronary heart disease
611148|NCT00973986|pharmacokinetics|pharmacokinetics
611149|NCT00973986|CYP3A|cyp3a
611150|NCT00973973|Pelvic Pain,NBI-56418,Endometriosis|pelvic pain,nbi-56418,endometriosis
611151|NCT00973947|stage I squamous cell carcinoma of the hypopharynx|stage i squamous cell carcinoma of the hypopharynx
611152|NCT00973947|stage II squamous cell carcinoma of the hypopharynx|stage ii squamous cell carcinoma of the hypopharynx
611153|NCT00973947|stage III squamous cell carcinoma of the hypopharynx|stage iii squamous cell carcinoma of the hypopharynx
611154|NCT00973947|stage IV squamous cell carcinoma of the hypopharynx|stage iv squamous cell carcinoma of the hypopharynx
611155|NCT00973947|stage I squamous cell carcinoma of the larynx|stage i squamous cell carcinoma of the larynx
611156|NCT00973947|stage I verrucous carcinoma of the larynx|stage i verrucous carcinoma of the larynx
611157|NCT00973947|stage II squamous cell carcinoma of the larynx|stage ii squamous cell carcinoma of the larynx
611158|NCT00973947|stage II verrucous carcinoma of the larynx|stage ii verrucous carcinoma of the larynx
611159|NCT00973947|stage III squamous cell carcinoma of the larynx|stage iii squamous cell carcinoma of the larynx
611160|NCT00973947|stage III verrucous carcinoma of the larynx|stage iii verrucous carcinoma of the larynx
611161|NCT00973947|stage IV squamous cell carcinoma of the larynx|stage iv squamous cell carcinoma of the larynx
611162|NCT00973947|stage IV verrucous carcinoma of the larynx|stage iv verrucous carcinoma of the larynx
611163|NCT00973947|stage I adenoid cystic carcinoma of the oral cavity|stage i adenoid cystic carcinoma of the oral cavity
611164|NCT00973947|stage I mucoepidermoid carcinoma of the oral cavity|stage i mucoepidermoid carcinoma of the oral cavity
611165|NCT00973947|stage I verrucous carcinoma of the oral cavity|stage i verrucous carcinoma of the oral cavity
611166|NCT00973947|stage II adenoid cystic carcinoma of the oral cavity|stage ii adenoid cystic carcinoma of the oral cavity
611167|NCT00973947|stage II mucoepidermoid carcinoma of the oral cavity|stage ii mucoepidermoid carcinoma of the oral cavity
611168|NCT00973947|stage II verrucous carcinoma of the oral cavity|stage ii verrucous carcinoma of the oral cavity
611169|NCT00973947|stage III adenoid cystic carcinoma of the oral cavity|stage iii adenoid cystic carcinoma of the oral cavity
611170|NCT00973947|stage III mucoepidermoid carcinoma of the oral cavity|stage iii mucoepidermoid carcinoma of the oral cavity
611171|NCT00973947|stage III verrucous carcinoma of the oral cavity|stage iii verrucous carcinoma of the oral cavity
611172|NCT00973947|stage IV adenoid cystic carcinoma of the oral cavity|stage iv adenoid cystic carcinoma of the oral cavity
611173|NCT00973947|stage IV mucoepidermoid carcinoma of the oral cavity|stage iv mucoepidermoid carcinoma of the oral cavity
611174|NCT00973947|stage IV verrucous carcinoma of the oral cavity|stage iv verrucous carcinoma of the oral cavity
611175|NCT00973947|stage I squamous cell carcinoma of the lip and oral cavity|stage i squamous cell carcinoma of the lip and oral cavity
611176|NCT00973947|stage II squamous cell carcinoma of the lip and oral cavity|stage ii squamous cell carcinoma of the lip and oral cavity
611177|NCT00973947|stage III squamous cell carcinoma of the lip and oral cavity|stage iii squamous cell carcinoma of the lip and oral cavity
611178|NCT00973947|stage IV squamous cell carcinoma of the lip and oral cavity|stage iv squamous cell carcinoma of the lip and oral cavity
611179|NCT00973947|stage I basal cell carcinoma of the lip|stage i basal cell carcinoma of the lip
611180|NCT00973947|stage II basal cell carcinoma of the lip|stage ii basal cell carcinoma of the lip
611181|NCT00973947|stage III basal cell carcinoma of the lip|stage iii basal cell carcinoma of the lip
611182|NCT00973947|stage IV basal cell carcinoma of the lip|stage iv basal cell carcinoma of the lip
611183|NCT00973947|metastatic squamous neck cancer with occult primary squamous cell carcinoma|metastatic squamous neck cancer with occult primary squamous cell carcinoma
611184|NCT00973947|untreated metastatic squamous neck cancer with occult primary|untreated metastatic squamous neck cancer with occult primary
611185|NCT00973947|stage I lymphoepithelioma of the nasopharynx|stage i lymphoepithelioma of the nasopharynx
611186|NCT00973947|stage I squamous cell carcinoma of the nasopharynx|stage i squamous cell carcinoma of the nasopharynx
611187|NCT00973947|stage II lymphoepithelioma of the nasopharynx|stage ii lymphoepithelioma of the nasopharynx
611188|NCT00973947|stage II squamous cell carcinoma of the nasopharynx|stage ii squamous cell carcinoma of the nasopharynx
611189|NCT00973947|stage III lymphoepithelioma of the nasopharynx|stage iii lymphoepithelioma of the nasopharynx
611190|NCT00973947|stage III squamous cell carcinoma of the nasopharynx|stage iii squamous cell carcinoma of the nasopharynx
611191|NCT00973947|stage IV lymphoepithelioma of the nasopharynx|stage iv lymphoepithelioma of the nasopharynx
611192|NCT00973947|stage IV squamous cell carcinoma of the nasopharynx|stage iv squamous cell carcinoma of the nasopharynx
611193|NCT00973947|stage I lymphoepithelioma of the oropharynx|stage i lymphoepithelioma of the oropharynx
611194|NCT00973947|stage I squamous cell carcinoma of the oropharynx|stage i squamous cell carcinoma of the oropharynx
611195|NCT00973947|stage II lymphoepithelioma of the oropharynx|stage ii lymphoepithelioma of the oropharynx
611196|NCT00973947|stage II squamous cell carcinoma of the oropharynx|stage ii squamous cell carcinoma of the oropharynx
611197|NCT00973947|stage III lymphoepithelioma of the oropharynx|stage iii lymphoepithelioma of the oropharynx
611198|NCT00973947|stage III squamous cell carcinoma of the oropharynx|stage iii squamous cell carcinoma of the oropharynx
611199|NCT00973947|stage IV lymphoepithelioma of the oropharynx|stage iv lymphoepithelioma of the oropharynx
611200|NCT00973947|stage IV squamous cell carcinoma of the oropharynx|stage iv squamous cell carcinoma of the oropharynx
611201|NCT00973947|stage I esthesioneuroblastoma of the paranasal sinus and nasal cavity|stage i esthesioneuroblastoma of the paranasal sinus and nasal cavity
611202|NCT00973947|stage I inverted papilloma of the paranasal sinus and nasal cavity|stage i inverted papilloma of the paranasal sinus and nasal cavity
611203|NCT00973947|stage I midline lethal granuloma of the paranasal sinus and nasal cavity|stage i midline lethal granuloma of the paranasal sinus and nasal cavity
611204|NCT00973947|stage I squamous cell carcinoma of the paranasal sinus and nasal cavity|stage i squamous cell carcinoma of the paranasal sinus and nasal cavity
611205|NCT00973947|stage II esthesioneuroblastoma of the paranasal sinus and nasal cavity|stage ii esthesioneuroblastoma of the paranasal sinus and nasal cavity
611206|NCT00973947|stage II inverted papilloma of the paranasal sinus and nasal cavity|stage ii inverted papilloma of the paranasal sinus and nasal cavity
611207|NCT00973947|stage II midline lethal granuloma of the paranasal sinus and nasal cavity|stage ii midline lethal granuloma of the paranasal sinus and nasal cavity
611208|NCT00973947|stage II squamous cell carcinoma of the paranasal sinus and nasal cavity|stage ii squamous cell carcinoma of the paranasal sinus and nasal cavity
611209|NCT00973947|stage III esthesioneuroblastoma of the paranasal sinus and nasal cavity|stage iii esthesioneuroblastoma of the paranasal sinus and nasal cavity
611210|NCT00973947|stage III inverted papilloma of the paranasal sinus and nasal cavity|stage iii inverted papilloma of the paranasal sinus and nasal cavity
611211|NCT00973947|stage III midline lethal granuloma of the paranasal sinus and nasal cavity|stage iii midline lethal granuloma of the paranasal sinus and nasal cavity
611212|NCT00973947|stage III squamous cell carcinoma of the paranasal sinus and nasal cavity|stage iii squamous cell carcinoma of the paranasal sinus and nasal cavity
611213|NCT00973947|stage IV esthesioneuroblastoma of the paranasal sinus and nasal cavity|stage iv esthesioneuroblastoma of the paranasal sinus and nasal cavity
611214|NCT00973947|stage IV inverted papilloma of the paranasal sinus and nasal cavity|stage iv inverted papilloma of the paranasal sinus and nasal cavity
611215|NCT00973947|stage IV midline lethal granuloma of the paranasal sinus and nasal cavity|stage iv midline lethal granuloma of the paranasal sinus and nasal cavity
611216|NCT00973947|stage IV squamous cell carcinoma of the paranasal sinus and nasal cavity|stage iv squamous cell carcinoma of the paranasal sinus and nasal cavity
611217|NCT00973947|stage I salivary gland cancer|stage i salivary gland cancer
611218|NCT00973947|stage II salivary gland cancer|stage ii salivary gland cancer
611219|NCT00973947|stage III salivary gland cancer|stage iii salivary gland cancer
611220|NCT00973947|stage IV salivary gland cancer|stage iv salivary gland cancer
611221|NCT00973947|recurrent lymphoepithelioma of the nasopharynx|recurrent lymphoepithelioma of the nasopharynx
611222|NCT00973947|recurrent lymphoepithelioma of the oropharynx|recurrent lymphoepithelioma of the oropharynx
611223|NCT00973947|recurrent squamous cell carcinoma of the hypopharynx|recurrent squamous cell carcinoma of the hypopharynx
611224|NCT00973947|recurrent squamous cell carcinoma of the nasopharynx|recurrent squamous cell carcinoma of the nasopharynx
611225|NCT00973947|recurrent squamous cell carcinoma of the oropharynx|recurrent squamous cell carcinoma of the oropharynx
611226|NCT00973947|recurrent squamous cell carcinoma of the larynx|recurrent squamous cell carcinoma of the larynx
611227|NCT00973947|recurrent verrucous carcinoma of the larynx|recurrent verrucous carcinoma of the larynx
611228|NCT00973947|recurrent squamous cell carcinoma of the lip and oral cavity|recurrent squamous cell carcinoma of the lip and oral cavity
611229|NCT00973947|recurrent basal cell carcinoma of the lip|recurrent basal cell carcinoma of the lip
611230|NCT00973947|recurrent adenoid cystic carcinoma of the oral cavity|recurrent adenoid cystic carcinoma of the oral cavity
611231|NCT00973947|recurrent mucoepidermoid carcinoma of the oral cavity|recurrent mucoepidermoid carcinoma of the oral cavity
611232|NCT00973947|recurrent verrucous carcinoma of the oral cavity|recurrent verrucous carcinoma of the oral cavity
611233|NCT00973947|recurrent metastatic squamous neck cancer with occult primary|recurrent metastatic squamous neck cancer with occult primary
611234|NCT00973947|recurrent esthesioneuroblastoma of the paranasal sinus and nasal cavity|recurrent esthesioneuroblastoma of the paranasal sinus and nasal cavity
611235|NCT00973947|recurrent inverted papilloma of the paranasal sinus and nasal cavity|recurrent inverted papilloma of the paranasal sinus and nasal cavity
611236|NCT00973947|recurrent midline lethal granuloma of the paranasal sinus and nasal cavity|recurrent midline lethal granuloma of the paranasal sinus and nasal cavity
611237|NCT00973947|recurrent squamous cell carcinoma of the paranasal sinus and nasal cavity|recurrent squamous cell carcinoma of the paranasal sinus and nasal cavity
611238|NCT00973947|recurrent salivary gland cancer|recurrent salivary gland cancer
611239|NCT00973921|Stent|stent
611240|NCT00973921|under-expansion|under-expansion
611241|NCT00973921|StentOp|stentop
611242|NCT00973921|StentOptimizer|stentoptimizer
611243|NCT00973921|IVUS|ivus
611244|NCT00973921|IC-PRO|ic-pro
611245|NCT00973921|image enhancement|image enhancement
611246|NCT00973908|Clostridium difficile associated diarrhoea|clostridium difficile associated diarrhoea
611247|NCT00973908|antibiotic associated diarrhoea|antibiotic associated diarrhoea
611248|NCT00973895|Influenza|influenza
611249|NCT00973895|Healthy|healthy
611250|NCT00973895|Immunity|immunity
611251|NCT00973895|Preventive|preventive
611252|NCT00973895|Pandemic|pandemic
611253|NCT00973882|Hormone resistant prostate cancer|hormone resistant prostate cancer
611254|NCT00973882|Neuro-endocrine marker|neuro-endocrine marker
611255|NCT00973882|Carboplatin-Etoposide combination|carboplatin-etoposide combination
611256|NCT00973882|Neuro-endocrine differentiation|neuro-endocrine differentiation
611257|NCT00973869|colon cancer|colon cancer
611258|NCT00973869|rectal cancer|rectal cancer
611259|NCT00973830|Changes in HbA1c|changes in hba1c
611260|NCT00973817|Hepatitis|hepatitis
611261|NCT00973817|AOCH|aoch
611262|NCT00973804|Reduced Intensity Conditioning|reduced intensity conditioning
611263|NCT00973804|Umbilical Cord Blood Transplant|umbilical cord blood transplant
611264|NCT00973804|Targeted Immune Depletion|targeted immune depletion
611265|NCT00973804|Leukemia|leukemia
611266|NCT00973804|Lymphoma|lymphoma
611267|NCT00973804|Multiple Myeloma|multiple myeloma
611268|NCT00973804|Non-Hodgkins Lymphoma|non-hodgkins lymphoma
611269|NCT00973804|Hodgkins Lymphoma|hodgkins lymphoma
611270|NCT00973791|Spinal anesthesia|spinal anesthesia
611271|NCT00973791|Fluid therapy|fluid therapy
611272|NCT00973778|Intensity Modulated Radiation Therapy|intensity modulated radiation therapy
611273|NCT00973778|Capecitabine|capecitabine
611274|NCT00973778|Resectable Rectal Carcinoma|resectable rectal carcinoma
611275|NCT00973765|abcess|abcess
611276|NCT00973765|MRSA|mrsa
611277|NCT00973765|cellulitis|cellulitis
611278|NCT00973765|antibiotics|antibiotics
611279|NCT00973765|uncomplicated abscesses|uncomplicated abscesses
611280|NCT00973752|ALL|all
611281|NCT00973739|NF-2|nf-2
611282|NCT00973739|NF-2 related tumors|nf-2 related tumors
611283|NCT00973739|Schwannoma, Acoustic, Bilateral|schwannoma, acoustic, bilateral
611284|NCT00973739|schwannomas|schwannomas
611285|NCT00973739|Neurilemmoma of other cranial and peripheral nerves|neurilemmoma of other cranial and peripheral nerves
611286|NCT00973739|NF2 related benign intracranial tumors including|nf2 related benign intracranial tumors including
611287|NCT00973739|NF2 related meningiomas|nf2 related meningiomas
611288|NCT00973739|NF2 related ependymomas|nf2 related ependymomas
611289|NCT00973739|NF2 related spinal neurofibromas|nf2 related spinal neurofibromas
611290|NCT00973739|NF2 related gliomas|nf2 related gliomas
611291|NCT00973713|Advanced cholangiocarcinoma|advanced cholangiocarcinoma
611292|NCT00973700|Swine Flu|swine flu
611293|NCT00973700|Flu|flu
611294|NCT00973700|Vaccine|vaccine
611295|NCT00973700|Adjuvant|adjuvant
611296|NCT00973687|pediatric|pediatric
611297|NCT00973687|dexamethasone|dexamethasone
611298|NCT00973687|management|management
611299|NCT00973687|corticosteroids|corticosteroids
611300|NCT00973687|asthma|asthma
611301|NCT00973661|Overweight|overweight
611302|NCT00973661|Diagnosis|diagnosis
611303|NCT00973661|Counseling|counseling
611304|NCT00973661|Medical Records Systems, Computerized|medical records systems, computerized
611305|NCT00973648|Tinnitus|tinnitus
611306|NCT00973648|Ringing in ears|ringing in ears
611307|NCT00973648|Functional connectivity MRI|functional connectivity mri
611308|NCT00973648|Voluntary control of tinnitus|voluntary control of tinnitus
611309|NCT00973635|education|education
611310|NCT00973635|web-based intervention|web-based intervention
611311|NCT00973635|patient care|patient care
611312|NCT00973622|Tobacco cessation|tobacco cessation
611313|NCT00973622|Tobacco dependence|tobacco dependence
611314|NCT00973622|Transcranial Magnetic Stimulation|transcranial magnetic stimulation
611315|NCT00973622|Nicotine Dependence|nicotine dependence
611316|NCT00973622|Delayed Discounting|delayed discounting
611317|NCT00973609|metastatic colorectal cancer|metastatic colorectal cancer
611318|NCT00973609|Bevacizumab|bevacizumab
611319|NCT00973609|Avastin®|avastin®
611320|NCT00973609|phase 3|phase 3
611321|NCT00973609|maintenance treatment|maintenance treatment
611322|NCT00973609|treatment pause|treatment pause
611323|NCT00973609|drug holiday|drug holiday
611324|NCT00973609|stage IV|stage iv
611325|NCT00973583|vitamin D|vitamin d
611326|NCT00973583|infection|infection
611327|NCT00973583|Vitamin D for the prevention of respiratory tract infections|vitamin d for the prevention of respiratory tract infections
611328|NCT00973570|tobacco cessation|tobacco cessation
611329|NCT00973570|evaluation|evaluation
611330|NCT00973570|epidémiology|epidémiology
611331|NCT00973570|adolescent|adolescent
611332|NCT00973570|apprentices|apprentices
611333|NCT00973557|bevacizumab|bevacizumab
611334|NCT00973544|breast reconstruction complications|breast reconstruction complications
611335|NCT00973544|drains|drains
611336|NCT00973544|silicone implant|silicone implant
611337|NCT00973531|Sleep Disordered Breathing|sleep disordered breathing
611338|NCT00973531|Sleep Apnea|sleep apnea
611339|NCT00973531|Hypertension|hypertension
611340|NCT00973531|Continuous Positive Airway Pressure|continuous positive airway pressure
611341|NCT00973518|Alzheimer's Disease|alzheimer's disease
611343|NCT00973518|Healthy Control|healthy control
611344|NCT00973505|Breast neoplasms|breast neoplasms
611345|NCT00973505|Aromatase inhibitors|aromatase inhibitors
611346|NCT00973505|Genetic polymorphisms|genetic polymorphisms
611347|NCT00973505|Arthralgia|arthralgia
611348|NCT00973505|Arthritis|arthritis
611349|NCT00973492|type 1 diabetes|type 1 diabetes
611350|NCT00973492|functional insulinotherapy|functional insulinotherapy
611351|NCT00973479|Arthritis, Rheumatoid|arthritis, rheumatoid
611352|NCT00973479|Active rheumatoid arthritis|active rheumatoid arthritis
611353|NCT00973479|Golimumab|golimumab
611354|NCT00973479|CNTO148|cnto148
611355|NCT00973479|Anti-TNFalpha monoclonal antibody|anti-tnfalpha monoclonal antibody
611356|NCT00973479|Methotrexate|methotrexate
611357|NCT00973479|Intravenous|intravenous
611358|NCT00973466|HIV-infection|hiv-infection
611359|NCT00973466|Neisseria gonorrhea|neisseria gonorrhea
611360|NCT00973466|Chlamydia trachomatis|chlamydia trachomatis
611361|NCT00973466|Herpes simplex virus|herpes simplex virus
611362|NCT00973466|prevalence|prevalence
611363|NCT00973453|non-seasonal allergy|non-seasonal allergy
611364|NCT00973453|house dust mite|house dust mite
611365|NCT00973453|immunotherapy|immunotherapy
611366|NCT00973453|dose tolerability|dose tolerability
611367|NCT00973440|geriatric assessment|geriatric assessment
611368|NCT00973427|NSCLC|nsclc
611369|NCT00973414|Combined epidural spinal anesthesia|combined epidural spinal anesthesia
611370|NCT00973414|Fluid therapy|fluid therapy
611371|NCT00973388|VX-950-TiDP24-C136|vx-950-tidp24-c136
611372|NCT00973388|VX-950-C136|vx-950-c136
611373|NCT00973388|VX-950|vx-950
611374|NCT00973388|HEPATITIS|hepatitis
611375|NCT00973388|Telaprevir|telaprevir
611376|NCT00973388|Moxifloxacin|moxifloxacin
611377|NCT00973388|ECG|ecg
611378|NCT00973388|QT|qt
611379|NCT00973388|QTc|qtc
611380|NCT00973375|Drug-eluting stent|drug-eluting stent
611381|NCT00973375|coronary restenosis|coronary restenosis
611382|NCT00973375|coronary thrombosis|coronary thrombosis
611383|NCT00973362|Cervix Cancer|cervix cancer
611384|NCT00973362|Cervical Intraepithelial Neoplasia (CIN)|cervical intraepithelial neoplasia (cin)
611385|NCT00973362|Human Papillomavirus Virus (HPV)|human papillomavirus virus (hpv)
611386|NCT00973362|APTIMA HPV Assay|aptima hpv assay
611387|NCT00973362|FDA-Approved HPV DNA Test|fda-approved hpv dna test
611388|NCT00973362|TIGRIS DTS (direct tube sampling) System|tigris dts (direct tube sampling) system
611389|NCT00973362|Clinical Sensitivity (%)|clinical sensitivity (%)
611390|NCT00973362|Clinical Specificity (%)|clinical specificity (%)
611391|NCT00973362|Positive Predictive Value [PPV] (%)|positive predictive value [ppv] (%)
611392|NCT00973362|Negative Predictive Value [NPV] (%)|negative predictive value [npv] (%)
611393|NCT00973362|Atypical Squamous Cells Undetermined Significance (ASC-US)|atypical squamous cells undetermined significance (asc-us)
611394|NCT00973362|Relative Risk|relative risk
611395|NCT00973349|Swine Flu|swine flu
611396|NCT00973349|Flu|flu
611397|NCT00973349|Vaccine|vaccine
611398|NCT00973349|Adults|adults
611399|NCT00973349|Elderly|elderly
611400|NCT00973349|Non-Elderly|non-elderly
611401|NCT00973349|Adjuvant|adjuvant
611402|NCT00973336|postoperative follow-up|postoperative follow-up
611403|NCT00973323|BAY59-7939|bay59-7939
611404|NCT00973323|Rivaroxaban|rivaroxaban
611405|NCT00973323|Non-valvular atrial fibrillation|non-valvular atrial fibrillation
611406|NCT00973323|Japanese Patients|japanese patients
611407|NCT00973323|Phase II|phase ii
611408|NCT00973310|Non-small-cell lung cancer|non-small-cell lung cancer
611409|NCT00973310|Radiation therapy|radiation therapy
611410|NCT00973310|Epidermal growth factor receptor|epidermal growth factor receptor
611411|NCT00973310|Tyrosine kinase inhibitor|tyrosine kinase inhibitor
611412|NCT00973297|Falls|falls
710275|NCT00589563|contiguous stage II adult diffuse large cell lymphoma|contiguous stage ii adult diffuse large cell lymphoma
777016|NCT00341484|HIV|hiv
611413|NCT00973284|Prevention of acute gastroenteritis due to infection with and experimental Norwalk Virus|prevention of acute gastroenteritis due to infection with and experimental norwalk virus
611414|NCT00973271|hypertriglyceridemia|hypertriglyceridemia
611415|NCT00973245|BAY59-7939|bay59-7939
611416|NCT00973245|Rivaroxaban|rivaroxaban
611417|NCT00973245|Non-valvular atrial fibrillation|non-valvular atrial fibrillation
611418|NCT00973245|Japanese Patients|japanese patients
611419|NCT00973245|Phase II|phase ii
611420|NCT00973232|Tramadol|tramadol
611421|NCT00973232|Acetaminophen|acetaminophen
611422|NCT00973232|combination|combination
611423|NCT00973232|pharmacokinetics|pharmacokinetics
611424|NCT00973232|bioavailability|bioavailability
611425|NCT00973232|Zaldiar|zaldiar
611426|NCT00973232|Ultracet|ultracet
611427|NCT00973232|fed|fed
611428|NCT00973232|fasted|fasted
611429|NCT00973232|single-dose|single-dose
611430|NCT00973232|multiple-dose|multiple-dose
611431|NCT00973232|healthy|healthy
611432|NCT00973232|volunteers|volunteers
611433|NCT00973232|Healthy volunteers|healthy volunteers
611434|NCT00973219|HBsAg loss|hbsag loss
611435|NCT00973219|HBsAg seroconversion|hbsag seroconversion
611436|NCT00973219|chronic hepatitis B|chronic hepatitis b
611437|NCT00973219|low viral load|low viral load
611438|NCT00973219|inactive carrier hepatitis B|inactive carrier hepatitis b
611439|NCT00973206|cardiovascular morbidity|cardiovascular morbidity
611440|NCT00973206|mortality community study|mortality community study
611441|NCT00973193|rectum|rectum
611442|NCT00973193|colorectal|colorectal
611443|NCT00973193|cancer|cancer
611444|NCT00973193|adenocarcinoma|adenocarcinoma
611445|NCT00973193|anti-EGFR|anti-egfr
611446|NCT00973193|monoclonal antibodies|monoclonal antibodies
611447|NCT00973193|neoadjuvant therapy|neoadjuvant therapy
611448|NCT00973193|preoperative radiotherapy|preoperative radiotherapy
611449|NCT00973180|Prescription medication understanding among diabetic and hypertension patients.|prescription medication understanding among diabetic and hypertension patients.
611450|NCT00973180|Prescription medication use among diabetic and hypertension patients.|prescription medication use among diabetic and hypertension patients.
611451|NCT00973180|Hemoglobin A1c changes among diabetic patients.|hemoglobin a1c changes among diabetic patients.
611452|NCT00973180|Blood pressure changes among hypertension patients.|blood pressure changes among hypertension patients.
611453|NCT00973167|Fracture rate|fracture rate
611454|NCT00973167|Fracture risks|fracture risks
611455|NCT00973154|Pneumonia|pneumonia
611456|NCT00973154|Corticosteroids|corticosteroids
611457|NCT00973154|clinical stability|clinical stability
611458|NCT00973141|Moderate to severe, osteoarthritis-related pain|moderate to severe, osteoarthritis-related pain
611459|NCT00973141|Osteoarthritis-related pain|osteoarthritis-related pain
611460|NCT00973141|Moderate to severe chronic pain|moderate to severe chronic pain
611461|NCT00973141|JNJ-42160443|jnj-42160443
611462|NCT00973089|Primary tooth|primary tooth
611463|NCT00973089|Caries, Dental|caries, dental
611464|NCT00973089|Alternative treatment|alternative treatment
611465|NCT00973076|Phase I, cancer|phase i, cancer
611466|NCT00973076|solid tumors|solid tumors
611467|NCT00973076|advanced solid malignancies|advanced solid malignancies
611468|NCT00973076|dose escalation|dose escalation
611469|NCT00973076|mTOR Kinase Inhibitor|mtor kinase inhibitor
611470|NCT00973076|Japanese|japanese
611471|NCT00973063|bacteremia|bacteremia
611472|NCT00973063|blood culture|blood culture
611473|NCT00973063|contamination|contamination
611474|NCT00973050|Bioequivalence|bioequivalence
611475|NCT00973037|Breast neoplasms|breast neoplasms
611476|NCT00973037|Tamoxifen|tamoxifen
611477|NCT00973037|Genotype|genotype
611478|NCT00973037|CYP2D6|cyp2d6
611479|NCT00973024|JNJ-42160443|jnj-42160443
611480|NCT00973024|Low back pain-related pain|low back pain-related pain
611481|NCT00973024|moderate to severe, chronic pain|moderate to severe, chronic pain
611482|NCT00973011|GA|ga
611483|NCT00972998|anal sphincter pressure|anal sphincter pressure
611484|NCT00972998|phenyephrine|phenyephrine
611485|NCT00972985|Healthy Control subjects|healthy control subjects
611486|NCT00972972|fruit polyphenols|fruit polyphenols
611487|NCT00972972|phytochemicals|phytochemicals
611488|NCT00972972|neurocognition|neurocognition
611489|NCT00972972|neuropsychology|neuropsychology
611490|NCT00972972|psychopharmacology|psychopharmacology
611491|NCT00972972|gene expression|gene expression
611492|NCT00972972|biochemistry|biochemistry
611493|NCT00972959|multiple myeloma|multiple myeloma
611494|NCT00972959|1-3 Prior Lines of Therapy|1-3 prior lines of therapy
611495|NCT00972959|bortezomib (Velcade)|bortezomib (velcade)
611496|NCT00972959|zoledronic acid (Zometa)|zoledronic acid (zometa)
611497|NCT00972959|Dexamethasone|dexamethasone
611498|NCT00972959|bone mineral density|bone mineral density
611499|NCT00972959|bone pain|bone pain
611500|NCT00972959|bone metabolism|bone metabolism
611501|NCT00972959|osteolytic lesions|osteolytic lesions
611502|NCT00972959|DEXA-scans|dexa-scans
611503|NCT00972959|X-ray radiography|x-ray radiography
611504|NCT00972946|MRI|mri
611505|NCT00972946|SPIO|spio
611506|NCT00972933|Immunogenicity Analysis|immunogenicity analysis
611507|NCT00972933|Biomarker Analysis|biomarker analysis
611508|NCT00972933|experimental|experimental
611509|NCT00972920|Transversus abdominis plane|transversus abdominis plane
611510|NCT00972920|Acute pain service|acute pain service
611511|NCT00972920|Ultrasound|ultrasound
611512|NCT00972907|anal fissure|anal fissure
611513|NCT00972907|pain|pain
611514|NCT00972907|nifedipine|nifedipine
611515|NCT00972894|Group B streptococcus|group b streptococcus
611516|NCT00972894|Polymerase chain reaction|polymerase chain reaction
611517|NCT00972894|PCR|pcr
611518|NCT00972894|Intrapartum screening|intrapartum screening
611519|NCT00972894|Risk factors|risk factors
611520|NCT00972894|arly onset Group B streptococcus infection|arly onset group b streptococcus infection
611521|NCT00972881|adenocarcinoma of the rectum|adenocarcinoma of the rectum
611522|NCT00972881|Locally advanced rectal cancer|locally advanced rectal cancer
611523|NCT00972868|Unidirectional mask|unidirectional mask
611524|NCT00972868|NPPV|nppv
611525|NCT00972868|COPD|copd
611526|NCT00972868|respiratory physiology|respiratory physiology
611527|NCT00972855|Bioequivalence|bioequivalence
611528|NCT00972842|PTCL|ptcl
611529|NCT00972842|Peripheral T-Cell Non-Hodgkin's Lymphoma|peripheral t-cell non-hodgkin's lymphoma
611530|NCT00972842|Vorinostat|vorinostat
611531|NCT00972842|Lenalidomid|lenalidomid
611532|NCT00972829|Hypercholesterolemia|hypercholesterolemia
611533|NCT00972816|Swine Flu|swine flu
611534|NCT00972816|Flu|flu
611535|NCT00972816|Vaccine|vaccine
611536|NCT00972816|Children|children
611537|NCT00972816|Adjuvant|adjuvant
611538|NCT00972803|gingivitis|gingivitis
611539|NCT00972803|dental plaque|dental plaque
611540|NCT00972803|mouthrinse|mouthrinse
611541|NCT00972790|brain tumor|brain tumor
611542|NCT00972790|un-ruptured aneurysm|un-ruptured aneurysm
611543|NCT00972790|arteriovenous malformation|arteriovenous malformation
611544|NCT00972790|epileptic focus|epileptic focus
611545|NCT00972790|supratentorial|supratentorial
611546|NCT00972764|Laryngomalacia|laryngomalacia
611547|NCT00972764|Factors Associated or Predisposing|factors associated or predisposing
611548|NCT00972751|stage II rectal cancer|stage ii rectal cancer
611549|NCT00972751|stage III rectal cancer|stage iii rectal cancer
611550|NCT00972751|adenocarcinoma of the rectum|adenocarcinoma of the rectum
611551|NCT00972725|Chloroquine|chloroquine
611552|NCT00972725|Human Immunodeficiency Virus|human immunodeficiency virus
611553|NCT00972712|Multiple Myeloma|multiple myeloma
611554|NCT00972699|Human Immunodeficiency Virus|human immunodeficiency virus
611555|NCT00972699|Acquired Immune Deficiency Syndrome|acquired immune deficiency syndrome
611556|NCT00972699|Tuberculosis|tuberculosis
611557|NCT00972699|Women|women
611558|NCT00972699|Pregnancy|pregnancy
611559|NCT00972699|Vertical Transmission of Human Immunodeficiency Virus|vertical transmission of human immunodeficiency virus
611560|NCT00972699|South Africa|south africa
611561|NCT00972699|Low Birth Weight|low birth weight
611562|NCT00972686|solid tumors|solid tumors
611563|NCT00972686|lymphoma|lymphoma
611564|NCT00972686|Phosphoinositide 3-kinase inhibitor|phosphoinositide 3-kinase inhibitor
611565|NCT00972660|Mesenchymal stem cell|mesenchymal stem cell
611566|NCT00972660|Efficacy|efficacy
611567|NCT00972660|Safety|safety
611568|NCT00972647|fracture|fracture
611569|NCT00972647|fixation|fixation
611570|NCT00972647|fluoroscopy|fluoroscopy
611571|NCT00972647|laser|laser
611572|NCT00972647|radiation|radiation
611573|NCT00972634|depression|depression
611574|NCT00972634|cachexia|cachexia
611575|NCT00972634|pain|pain
611576|NCT00972634|unspecified adult solid tumor, protocol specific|unspecified adult solid tumor, protocol specific
611577|NCT00972608|congenital heart disease|congenital heart disease
611578|NCT00972608|surgical planning|surgical planning
611579|NCT00972582|leucine intake|leucine intake
611580|NCT00972582|tolerable upper limit|tolerable upper limit
611581|NCT00972582|adults|adults
611582|NCT00972582|amino acid supplements|amino acid supplements
611583|NCT00972582|Excessive Leucine Intake|excessive leucine intake
611584|NCT00972569|BNP with or without PDE-V in heart failure|bnp with or without pde-v in heart failure
611585|NCT00972556|Mineral Trioxide Aggregate|mineral trioxide aggregate
611586|NCT00972556|Formocresol|formocresol
611587|NCT00972556|pulpotomy|pulpotomy
611588|NCT00972556|primary molar|primary molar
611589|NCT00972556|treatment outcome|treatment outcome
611590|NCT00972543|Moderate to severe chronic plaque psoriasis|moderate to severe chronic plaque psoriasis
611591|NCT00972543|palms and/or soles|palms and/or soles
611592|NCT00972543|with or without pustules|with or without pustules
611593|NCT00972530|rheumatoid arthritis|rheumatoid arthritis
611594|NCT00972530|treatment|treatment
611595|NCT00972517|GSK Bio's influenza vaccine GSK2340272A|gsk bio's influenza vaccine gsk2340272a
611596|NCT00972517|influenza infection|influenza infection
611597|NCT00972504|Proof of concept|proof of concept
611598|NCT00972465|nimotuzumab colorectal cancer chemotherapy|nimotuzumab colorectal cancer chemotherapy
611599|NCT00972452|Type II Diabetes|type ii diabetes
611600|NCT00972452|Insulin Resistance|insulin resistance
611601|NCT00972452|Exercise|exercise
611602|NCT00972452|Continuous Glucose Monitoring|continuous glucose monitoring
611603|NCT00972439|Oral Contraceptives|oral contraceptives
611604|NCT00972439|Breast Tissue|breast tissue
611605|NCT00972413|breast cancer|breast cancer
611606|NCT00972413|cone beam computed tomography|cone beam computed tomography
611607|NCT00972400|psychosocial effects of cancer and its treatment|psychosocial effects of cancer and its treatment
611608|NCT00972400|fatigue|fatigue
611609|NCT00972400|cancer survivor|cancer survivor
611610|NCT00972400|breast cancer|breast cancer
611611|NCT00972387|carbohydrate-protein|carbohydrate-protein
611612|NCT00972387|endurance exercise|endurance exercise
611613|NCT00972387|supplement|supplement
611614|NCT00972361|Adenoidectomy|adenoidectomy
611615|NCT00972361|Tonsillectomy|tonsillectomy
611616|NCT00972361|Ventilation Tubes|ventilation tubes
611617|NCT00972361|Preoperational screening|preoperational screening
611618|NCT00972361|Coagulation Profile|coagulation profile
611619|NCT00972361|Lupus anticoagulant|lupus anticoagulant
611620|NCT00972348|HIV|hiv
611621|NCT00972348|Personal Health Record|personal health record
611622|NCT00972348|Laboratory values: CD4 cells and HIV Viral load|laboratory values: cd4 cells and hiv viral load
611623|NCT00972348|Medication Reconciliation|medication reconciliation
611624|NCT00972335|Avastin|avastin
611625|NCT00972335|RAD001|rad001
611626|NCT00972335|Meningioma|meningioma
611627|NCT00972335|Bevacizumab|bevacizumab
611628|NCT00972335|Everolimus|everolimus
611629|NCT00972335|Brain|brain
611630|NCT00972309|Epotope-Enhanced TARP Peptide|epotope-enhanced tarp peptide
611631|NCT00972309|Prostate Cancer|prostate cancer
611632|NCT00972309|TARP Peptide-Pulsed Dendritic Cells|tarp peptide-pulsed dendritic cells
611633|NCT00972309|PSADT|psadt
611634|NCT00972309|HLA-A*0201|hla-a*0201
611635|NCT00972270|Arterial Occlusive Disease|arterial occlusive disease
611636|NCT00972270|Heart Diseases|heart diseases
611637|NCT00972270|Myocardial Ischemia|myocardial ischemia
611638|NCT00972270|Vascular Disease|vascular disease
611639|NCT00972270|Arteriosclerosis|arteriosclerosis
611640|NCT00972270|Ischemia|ischemia
611641|NCT00972257|24-hour IOP control|24-hour iop control
611642|NCT00972257|primary open-angle glaucoma|primary open-angle glaucoma
611643|NCT00972257|brimonidine/timolol|brimonidine/timolol
611644|NCT00972257|dorzolamide/timolol|dorzolamide/timolol
611645|NCT00972244|Type 2 diabetes mellitus|type 2 diabetes mellitus
611646|NCT00972244|Japanese|japanese
611647|NCT00972244|phase 2|phase 2
611648|NCT00972244|efficacy|efficacy
611649|NCT00972244|safety|safety
611650|NCT00972244|dapagliflozin|dapagliflozin
611651|NCT00972231|Thalassemia Major|thalassemia major
611652|NCT00972231|Thalassemia Intermedia|thalassemia intermedia
611653|NCT00972231|Sickle Cell Anemia|sickle cell anemia
611654|NCT00972231|Sickle Cell Thalassemia|sickle cell thalassemia
611655|NCT00972231|Iron Overload|iron overload
611656|NCT00972231|Growth Velocity|growth velocity
611657|NCT00972218|Spondyloarthritis|spondyloarthritis
611658|NCT00972218|Ankylosing Spondylitis|ankylosing spondylitis
611659|NCT00972218|Crohn's disease|crohn's disease
611660|NCT00972218|adalimumab|adalimumab
611661|NCT00972218|treatment|treatment
611662|NCT00972205|Pgp|pgp
611663|NCT00972205|Solid Tumors|solid tumors
611664|NCT00972205|Drug Resistance|drug resistance
611665|NCT00972205|Sestamibi|sestamibi
611666|NCT00972205|Cancer|cancer
611667|NCT00972205|Solid Tumor|solid tumor
611668|NCT00972192|HIV testing|hiv testing
611669|NCT00972192|HIV risk behavior|hiv risk behavior
611670|NCT00972192|access to care|access to care
611671|NCT00972179|healthy volunteers|healthy volunteers
611672|NCT00972153|Decrease in CFU density at surgery site|decrease in cfu density at surgery site
611673|NCT00972153|Decrease in airborne particulate at surgery site|decrease in airborne particulate at surgery site
611674|NCT00972140|Patients with stable COPD|patients with stable copd
611675|NCT00972101|Blood And Marrow Transplantation|blood and marrow transplantation
611676|NCT00972101|Leukemia|leukemia
611677|NCT00972101|Lymphoma|lymphoma
611678|NCT00972101|Pediatrics|pediatrics
611679|NCT00972101|Etoposide|etoposide
611680|NCT00972101|Expanded Cord Blood T Cells|expanded cord blood t cells
611681|NCT00972101|Filgrastim|filgrastim
611682|NCT00972101|Fludarabine|fludarabine
611683|NCT00972101|Melphalan|melphalan
611684|NCT00972101|Mycophenolate Mofetil|mycophenolate mofetil
611685|NCT00972101|Rituximab|rituximab
611686|NCT00972101|Tacrolimus|tacrolimus
611687|NCT00972101|Thiotepa|thiotepa
611688|NCT00972101|Thymoglobulin|thymoglobulin
611689|NCT00972101|Total Body Irradiation|total body irradiation
611690|NCT00972088|inflammation of the small bowel|inflammation of the small bowel
611691|NCT00972075|totally blind subjects|totally blind subjects
611692|NCT00972062|Subcutaneous injections|subcutaneous injections
611693|NCT00972062|Skin abnormalities|skin abnormalities
611695|NCT00972049|tolerability|tolerability
611696|NCT00972049|AZD2516|azd2516
611697|NCT00972049|pain|pain
611698|NCT00972049|Japanese|japanese
611699|NCT00972036|COLON|colon
611700|NCT00972036|LIVER|liver
611701|NCT00972036|RECTUM|rectum
611702|NCT00972036|SIR-Spheres|sir-spheres
611703|NCT00972036|09-030|09-030
611704|NCT00972023|triple-negative breast cancer|triple-negative breast cancer
611705|NCT00972023|stage I breast cancer|stage i breast cancer
611706|NCT00972023|stage II breast cancer|stage ii breast cancer
611707|NCT00972023|stage IIIA breast cancer|stage iiia breast cancer
611708|NCT00972023|stage IIIB breast cancer|stage iiib breast cancer
611709|NCT00972023|stage IIIC breast cancer|stage iiic breast cancer
611710|NCT00972010|Breast|breast
611711|NCT00972010|Cancer|cancer
611712|NCT00972010|Lumpectomies|lumpectomies
611713|NCT00972010|PlasmaBlade|plasmablade
611714|NCT00972010|Breast conservation therapy|breast conservation therapy
611715|NCT00971971|Hypotension|hypotension
611716|NCT00971971|Acute renal failure|acute renal failure
611717|NCT00971971|acute kidney injury|acute kidney injury
611718|NCT00971971|dialysis|dialysis
611719|NCT00971971|ICU|icu
611720|NCT00971958|HIV prevention|hiv prevention
611721|NCT00971958|infant, neonatal, male circumcision|infant, neonatal, male circumcision
611722|NCT00971932|Recurrent and/or metastatic|recurrent and/or metastatic
611723|NCT00971932|SCCHN|scchn
611724|NCT00971919|pain|pain
611725|NCT00971919|perioperative/postoperative complications|perioperative/postoperative complications
611726|NCT00971919|breast cancer in situ|breast cancer in situ
611727|NCT00971919|stage IA breast cancer|stage ia breast cancer
611728|NCT00971919|stage IB breast cancer|stage ib breast cancer
611729|NCT00971919|stage II breast cancer|stage ii breast cancer
611730|NCT00971919|stage IIIA breast cancer|stage iiia breast cancer
611731|NCT00971919|stage IIIB breast cancer|stage iiib breast cancer
611732|NCT00971919|stage IIIC breast cancer|stage iiic breast cancer
611733|NCT00971906|Pandemic influenza|pandemic influenza
611734|NCT00971906|Vaccine|vaccine
611735|NCT00971893|Acute Exacerbation of Bronchial Asthma Acute Asthma|acute exacerbation of bronchial asthma acute asthma
611736|NCT00971880|Blood transfusions|blood transfusions
611737|NCT00971880|Adverse events|adverse events
611738|NCT00971880|Hepatitis C|hepatitis c
611739|NCT00971880|HIV|hiv
611740|NCT00971854|Dystonia|dystonia
611741|NCT00971828|Myositis|myositis
611742|NCT00971828|polymyositis|polymyositis
611743|NCT00971828|dermatomyositis|dermatomyositis
611744|NCT00971815|HPA-axis|hpa-axis
611745|NCT00971815|fetal programming|fetal programming
611746|NCT00971789|Sirolimus|sirolimus
611747|NCT00971789|Cowden Syndrome|cowden syndrome
611748|NCT00971789|PTEN Mutation|pten mutation
611749|NCT00971789|Hamartoma Syndrome|hamartoma syndrome
611750|NCT00971776|Patient receiving AB5000 ventricle potentially recoverable|patient receiving ab5000 ventricle potentially recoverable
611751|NCT00971763|stage I adult diffuse large cell lymphoma|stage i adult diffuse large cell lymphoma
611752|NCT00971763|contiguous stage II adult diffuse large cell lymphoma|contiguous stage ii adult diffuse large cell lymphoma
611753|NCT00971763|noncontiguous stage II adult diffuse large cell lymphoma|noncontiguous stage ii adult diffuse large cell lymphoma
611754|NCT00971763|stage III adult diffuse large cell lymphoma|stage iii adult diffuse large cell lymphoma
611755|NCT00971763|stage IV adult diffuse large cell lymphoma|stage iv adult diffuse large cell lymphoma
611756|NCT00971750|ultrasonography|ultrasonography
611757|NCT00971750|gallbladder|gallbladder
611758|NCT00971750|cholelithiasis|cholelithiasis
611759|NCT00971750|laparoscopic|laparoscopic
611760|NCT00971750|gastric bypass|gastric bypass
611761|NCT00971750|obesity|obesity
611762|NCT00971750|bariatric surgery|bariatric surgery
611763|NCT00971737|stage IV breast cancer|stage iv breast cancer
611764|NCT00971737|male breast cancer|male breast cancer
611765|NCT00971724|Prednisolone|prednisolone
611766|NCT00971724|Glucocorticoids|glucocorticoids
611767|NCT00971711|IBS|ibs
611768|NCT00971711|irritable bowel syndrome|irritable bowel syndrome
611769|NCT00971711|abdominal pain|abdominal pain
611770|NCT00971711|urgency|urgency
611771|NCT00971711|bloating|bloating
611772|NCT00971711|diarrhea|diarrhea
611773|NCT00971698|Splenectomy|splenectomy
611774|NCT00971698|Thrombocytosis|thrombocytosis
611775|NCT00971698|Infections|infections
611776|NCT00971698|Spleen|spleen
611777|NCT00971698|Sickle Cell Thalassemia|sickle cell thalassemia
611778|NCT00971672|Infants|infants
611779|NCT00971672|Iron Deficiency|iron deficiency
611780|NCT00971672|Anemia|anemia
611781|NCT00971672|Healthy infants that attend the pediatric community clinics|healthy infants that attend the pediatric community clinics
611782|NCT00971659|type 2 diabetes|type 2 diabetes
611783|NCT00971646|overactive bladder|overactive bladder
611784|NCT00971646|self-consciousness|self-consciousness
611785|NCT00971646|perceptual urge sensation|perceptual urge sensation
611786|NCT00971620|Cutaneous Leiomyomas|cutaneous leiomyomas
611787|NCT00971620|Skin Pain|skin pain
611788|NCT00971620|Botox Therapy|botox therapy
611789|NCT00971620|Hereditary Leiomyomatosis|hereditary leiomyomatosis
611790|NCT00971620|Renal Cell Cancer|renal cell cancer
611791|NCT00971620|Cutaneous Leiomyoma|cutaneous leiomyoma
611792|NCT00971607|Acute myocardial infarction|acute myocardial infarction
611793|NCT00971607|Postconditioning|postconditioning
611794|NCT00971607|Sevoflurane|sevoflurane
611795|NCT00971594|weight loss|weight loss
611796|NCT00971594|glucose metabolism|glucose metabolism
611797|NCT00971568|Interstitial cystitis|interstitial cystitis
611798|NCT00971568|Painful bladder syndrome|painful bladder syndrome
611799|NCT00971555|Transient Hypothyroxinemia|transient hypothyroxinemia
611800|NCT00971555|Late Preterm Infants|late preterm infants
611801|NCT00971555|Total T4|total t4
611802|NCT00971555|TSH|tsh
611803|NCT00971555|Illness severity|illness severity
611804|NCT00971555|NICU|nicu
611805|NCT00971542|Pandemic influenza|pandemic influenza
611806|NCT00971542|Vaccine|vaccine
611807|NCT00971529|Smoking cessation|smoking cessation
611808|NCT00971529|tea filter|tea filter
611809|NCT00971516|diabetes|diabetes
611810|NCT00971516|implants|implants
611811|NCT00971516|cytokines|cytokines
611812|NCT00971503|Diabetes type 1|diabetes type 1
611813|NCT00971503|Adult Stem cells|adult stem cells
611814|NCT00971503|Local injection|local injection
611815|NCT00971503|Catheter delivery|catheter delivery
611816|NCT00971503|Bone marrow|bone marrow
611817|NCT00971490|COPD|copd
611818|NCT00971490|FEV1|fev1
611819|NCT00971490|beta endorphin|beta endorphin
611820|NCT00971490|SGRQ|sgrq
611821|NCT00971490|Acu-TENS|acu-tens
611822|NCT00971477|Teledermatology|teledermatology
611823|NCT00971477|Telemedicine|telemedicine
611824|NCT00971477|Psoriasis|psoriasis
611825|NCT00971464|AMD|amd
611826|NCT00971464|EV|ev
611827|NCT00971464|CCTV|cctv
611828|NCT00971464|Reading|reading
611829|NCT00971464|vision|vision
611830|NCT00971451|Anterior cruciate ligament|anterior cruciate ligament
611831|NCT00971451|ACL|acl
611832|NCT00971438|appendicitis|appendicitis
611833|NCT00971438|diagnosis|diagnosis
611834|NCT00971438|diagnostic imaging|diagnostic imaging
611835|NCT00971438|clinical scoring system|clinical scoring system
611836|NCT00971425|influenza infection|influenza infection
611837|NCT00971425|GSK Bio's influenza vaccine GSK2340272A|gsk bio's influenza vaccine gsk2340272a
611838|NCT00971386|Heart Failure|heart failure
611839|NCT00971373|antimicrobial|antimicrobial
611840|NCT00971373|epidemiology|epidemiology
611841|NCT00971373|bacteriology|bacteriology
611842|NCT00971373|CFU|cfu
611843|NCT00971360|conversion|conversion
611844|NCT00971360|cytokine|cytokine
611845|NCT00971360|inflammation|inflammation
611846|NCT00971347|obesity|obesity
611847|NCT00971347|overweight|overweight
611848|NCT00971347|weight loss|weight loss
611849|NCT00971347|randomized controlled trial|randomized controlled trial
611850|NCT00971347|chewing gum|chewing gum
611851|NCT00971334|Down Syndrome|down syndrome
611852|NCT00971334|Aneuploidy|aneuploidy
611853|NCT00971334|Amniocentesis|amniocentesis
611854|NCT00971334|CVS|cvs
611855|NCT00971321|influenza infection|influenza infection
611856|NCT00971321|GSK Bio's influenza vaccine GSK2340272A|gsk bio's influenza vaccine gsk2340272a
611857|NCT00971295|eslicarbazepine acetate|eslicarbazepine acetate
611858|NCT00971295|zebinix|zebinix
611859|NCT00971295|metformin|metformin
611860|NCT00971256|Bladder|bladder
611861|NCT00971256|Cancer|cancer
611862|NCT00971256|Cytology|cytology
611863|NCT00971243|Insulin resistance|insulin resistance
611864|NCT00971230|HIV|hiv
611865|NCT00971230|Human Immunodeficiency Virus|human immunodeficiency virus
611866|NCT00971217|Internet based Cognitive-Behavioural Intervention|internet based cognitive-behavioural intervention
611867|NCT00971217|Exercise Intervention|exercise intervention
611868|NCT00971217|Depression|depression
611869|NCT00971217|Perceived Social Support|perceived social support
611870|NCT00971217|Physical Self-Concept|physical self-concept
611871|NCT00971204|atrial fibrillation|atrial fibrillation
611872|NCT00971204|PAF|paf
611873|NCT00971191|Stage I - III surgical resection molecular change brief pre-operative exposure|stage i - iii surgical resection molecular change brief pre-operative exposure
611874|NCT00971178|Analgesia|analgesia
611875|NCT00971178|Dental pain|dental pain
611876|NCT00971178|Dexmedetomidine|dexmedetomidine
611877|NCT00971178|Pain|pain
611878|NCT00971178|Peripheral effects|peripheral effects
611879|NCT00971165|Hypertension|hypertension
611880|NCT00971165|Chlorthalidone|chlorthalidone
611881|NCT00971165|Amiloride|amiloride
611882|NCT00971165|Losartan|losartan
611883|NCT00971165|treatment|treatment
611884|NCT00971152|IVF|ivf
611885|NCT00971152|dose comparison of gonadotrophins|dose comparison of gonadotrophins
611886|NCT00971152|poor responder to ovarian stimulation|poor responder to ovarian stimulation
611887|NCT00971139|Online patient-provider communication|online patient-provider communication
611888|NCT00971139|Organizational change|organizational change
611889|NCT00971139|Symptom management|symptom management
611890|NCT00971126|hepatocellular carcinoma|hepatocellular carcinoma
611891|NCT00971100|Pandemic influenza|pandemic influenza
611892|NCT00971100|Vaccine|vaccine
611893|NCT00971087|Breast cancer|breast cancer
611894|NCT00971087|breast cancer screening|breast cancer screening
611895|NCT00971074|Arthralgia|arthralgia
611896|NCT00971074|Viscosupplementation|viscosupplementation
777720|NCT00339456|HIV|hiv
611897|NCT00971074|Knee|knee
611898|NCT00971074|Menisci, Tibial|menisci, tibial
611899|NCT00971074|Surgery, Outpatient|surgery, outpatient
611900|NCT00971061|Ahmed valve|ahmed valve
611901|NCT00971061|single-plate Molteno implant|single-plate molteno implant
611902|NCT00971061|refractory glaucoma|refractory glaucoma
611903|NCT00971061|surgical treatment|surgical treatment
611904|NCT00971048|pressure ulcers|pressure ulcers
611905|NCT00971048|PU|pu
611906|NCT00971048|diabetic foot ulcers|diabetic foot ulcers
611907|NCT00971048|DFU|dfu
611908|NCT00971048|Bates-Jensen Wound Assessment|bates-jensen wound assessment
611909|NCT00971035|MILR1444A|milr1444a
611910|NCT00971022|Low-income populations|low-income populations
611911|NCT00971022|Chronic health condition|chronic health condition
611912|NCT00971022|Prescription medication|prescription medication
611913|NCT00971022|Prescription drugs|prescription drugs
611914|NCT00971022|Discount generic prescription programs|discount generic prescription programs
611915|NCT00971022|Survey|survey
611916|NCT00971022|Awareness|awareness
611917|NCT00971022|Focus Group|focus group
611918|NCT00971022|Houston|houston
611919|NCT00971009|Symptom management|symptom management
611920|NCT00971009|Interactive Health Communication Application|interactive health communication application
611921|NCT00971009|Patient-provider communication|patient-provider communication
611922|NCT00971009|Health care costs|health care costs
611923|NCT00970996|Melanoma|melanoma
611924|NCT00970996|Abraxane|abraxane
611925|NCT00970996|Nab-paclitaxel|nab-paclitaxel
611926|NCT00970996|Paclitaxel (protein-bound)|paclitaxel (protein-bound)
611927|NCT00970996|ABI-007|abi-007
611928|NCT00970996|Cisplatin|cisplatin
611929|NCT00970996|Platinol-AQ|platinol-aq
611930|NCT00970996|Platinol|platinol
611931|NCT00970996|CDDP|cddp
611932|NCT00970996|Interleukin 2|interleukin 2
611933|NCT00970996|IL-2|il-2
611934|NCT00970996|Proleukin|proleukin
611935|NCT00970996|Intron A|intron a
611936|NCT00970996|Interferon alpha 2b|interferon alpha 2b
611937|NCT00970996|Interferon alfa-2b|interferon alfa-2b
611938|NCT00970996|Temodar|temodar
611939|NCT00970996|Temozolomide|temozolomide
611940|NCT00970970|Vascular endothelial growth factor|vascular endothelial growth factor
611941|NCT00970970|von Hippel Lindau disease|von hippel lindau disease
611942|NCT00970970|molecular imaging|molecular imaging
611943|NCT00970970|biomarker|biomarker
611944|NCT00970957|Macular edema|macular edema
611945|NCT00970957|Retinal Vein Occlusion|retinal vein occlusion
611946|NCT00970957|Bevacizumab|bevacizumab
611947|NCT00970944|Traumatic Brain Injury|traumatic brain injury
611948|NCT00970944|Rehabilitation|rehabilitation
611949|NCT00970944|Disorders of Consciousness|disorders of consciousness
611950|NCT00970944|Functional Outcome|functional outcome
611951|NCT00970944|Amantadine Hydrochloride|amantadine hydrochloride
611952|NCT00970931|hypertension|hypertension
611953|NCT00970931|diuretics|diuretics
611954|NCT00970918|Cardiovascular disease|cardiovascular disease
611955|NCT00970918|Carotid Intima Media Thickness|carotid intima media thickness
611956|NCT00970905|Radiation|radiation
611958|NCT00970905|Vomiting|vomiting
611959|NCT00970905|Ondansetron|ondansetron
611960|NCT00970905|Aprepitant|aprepitant
611961|NCT00970892|Anticoagulation|anticoagulation
611962|NCT00970892|warfarin|warfarin
611963|NCT00970892|VKORC1|vkorc1
611964|NCT00970892|CYP2C9|cyp2c9
611965|NCT00970892|thromboembolism|thromboembolism
611966|NCT00970892|pharmacogenetics|pharmacogenetics
611967|NCT00970879|malaria|malaria
611968|NCT00970879|pregnancy|pregnancy
611969|NCT00970879|HIV|hiv
611970|NCT00970879|prevention|prevention
611971|NCT00970879|cotrimoxazole|cotrimoxazole
611972|NCT00970879|mefloquine|mefloquine
611973|NCT00970866|multiple micronutrients|multiple micronutrients
612479|NCT00968747|NAFLD|nafld
611974|NCT00970866|home fortification|home fortification
611975|NCT00970866|complementary foods|complementary foods
611976|NCT00970866|infant feeding|infant feeding
611977|NCT00970866|lipid-based nutrient supplements|lipid-based nutrient supplements
611978|NCT00970853|Evaluate developmental outcomes|evaluate developmental outcomes
611979|NCT00970853|Evaluate child cognitive, academic, and behavioral outcomes|evaluate child cognitive, academic, and behavioral outcomes
611980|NCT00970840|Acceptability|acceptability
611981|NCT00970840|Supplements|supplements
611982|NCT00970840|Home-fortification|home-fortification
611983|NCT00970827|Coronary artery disease|coronary artery disease
611984|NCT00970827|PCI|pci
611985|NCT00970827|Postconditioning|postconditioning
611986|NCT00970827|Elective or urgent PCI|elective or urgent pci
611987|NCT00970814|Alcoholism|alcoholism
611988|NCT00970814|Alcohol Drinking|alcohol drinking
611989|NCT00970814|Alcoholic Intoxication|alcoholic intoxication
611990|NCT00970814|Alcohol Abuse|alcohol abuse
611991|NCT00970801|Atypical mycobacteria|atypical mycobacteria
611992|NCT00970775|Phase I|phase i
611993|NCT00970775|Japanese healthy volunteer|japanese healthy volunteer
611994|NCT00970775|AZD2423|azd2423
611995|NCT00970749|chlamydia|chlamydia
611996|NCT00970749|healthy women|healthy women
611997|NCT00970749|history of endocervical chlamydia|history of endocervical chlamydia
611998|NCT00970749|no history of endocervical chlamydia|no history of endocervical chlamydia
611999|NCT00970736|Motor cortex|motor cortex
612000|NCT00970736|Motor control|motor control
612001|NCT00970736|Neuroplasticity|neuroplasticity
612002|NCT00970736|Aging|aging
612003|NCT00970736|Swallowing|swallowing
612004|NCT00970723|Diabetic retinopathy|diabetic retinopathy
612005|NCT00970723|Macula edema|macula edema
612006|NCT00970723|Sleep apnea|sleep apnea
612007|NCT00970723|High blood pressure|high blood pressure
612008|NCT00970697|MARTORELL'S ULCER|martorell's ulcer
612009|NCT00970697|hydrogel|hydrogel
612010|NCT00970697|Hypertensive leg ulcer|hypertensive leg ulcer
612011|NCT00970684|recurrent non-small cell lung cancer|recurrent non-small cell lung cancer
612012|NCT00970684|stage IIIB non-small cell lung cancer|stage iiib non-small cell lung cancer
612013|NCT00970684|stage IV non-small cell lung cancer|stage iv non-small cell lung cancer
612014|NCT00970684|adenocarcinoma of the lung|adenocarcinoma of the lung
612015|NCT00970684|bronchoalveolar cell lung cancer|bronchoalveolar cell lung cancer
612016|NCT00970684|large cell lung cancer|large cell lung cancer
612017|NCT00970671|scar|scar
612018|NCT00970671|laser therapy|laser therapy
612019|NCT00970671|lasers, pulsed dye|lasers, pulsed dye
612020|NCT00970658|Plaster|plaster
612021|NCT00970658|injuries|injuries
612022|NCT00970658|regions miofasciais articulated|regions miofasciais articulated
612023|NCT00970658|Reducing signs, symptoms|reducing signs, symptoms
612024|NCT00970645|Non small cell lung cancer|non small cell lung cancer
612025|NCT00970645|mediastinum|mediastinum
612026|NCT00970645|endobronchial ultrasound fine needle aspiration|endobronchial ultrasound fine needle aspiration
612027|NCT00970645|endoscopic ultrasound|endoscopic ultrasound
612028|NCT00970645|mediastinoscopy|mediastinoscopy
612029|NCT00970645|surgical or minimally invasive evaluation of mediastinum|surgical or minimally invasive evaluation of mediastinum
612030|NCT00970645|NSCLC|nsclc
612031|NCT00970606|ARDS|ards
612032|NCT00970606|H1N1|h1n1
612033|NCT00970606|Influenza|influenza
612034|NCT00970606|Statin|statin
612035|NCT00970580|BIIB022|biib022
612036|NCT00970580|Stage IV|stage iv
612037|NCT00970580|Taxol|taxol
612038|NCT00970580|Stage IIIB|stage iiib
612039|NCT00970580|Carboplatin|carboplatin
612040|NCT00970580|Paclitaxel|paclitaxel
612041|NCT00970580|Non Small Cell Lung Cancer|non small cell lung cancer
612042|NCT00970580|Treatment Naive|treatment naive
612043|NCT00970580|Anti IGF1R|anti igf1r
612044|NCT00970580|NSCLC|nsclc
612045|NCT00970580|Open Label|open label
612046|NCT00970580|IGF1R|igf1r
612047|NCT00970580|Paraplatin|paraplatin
612048|NCT00970580|Cytotoxic|cytotoxic
612049|NCT00970580|Mitotic Inhibitor|mitotic inhibitor
612050|NCT00970580|Taxane|taxane
612051|NCT00970580|Alkylating agent|alkylating agent
612052|NCT00970567|therapy after positive ketone bodies in the blood|therapy after positive ketone bodies in the blood
612053|NCT00970567|timepoint of diagnosis|timepoint of diagnosis
612054|NCT00970567|timepoint of metabolic normalisation|timepoint of metabolic normalisation
612055|NCT00970554|Amblyopia|amblyopia
612056|NCT00970554|Telescopic magnification|telescopic magnification
612057|NCT00970554|Patching|patching
612058|NCT00970541|Cinnamon|cinnamon
612059|NCT00970541|PCOS|pcos
612060|NCT00970541|low blood sugar|low blood sugar
612061|NCT00970541|Insulin|insulin
612062|NCT00970541|Glucose|glucose
612063|NCT00970528|Oral Hypoglycemic Agent|oral hypoglycemic agent
612064|NCT00970515|Laparoscopy|laparoscopy
612065|NCT00970515|Incisional hernia|incisional hernia
612066|NCT00970515|Umbilical hernia|umbilical hernia
612067|NCT00970515|Mesh repair|mesh repair
612068|NCT00970515|Postoperative complications|postoperative complications
612069|NCT00970502|celecoxib|celecoxib
612070|NCT00970502|erlotinib|erlotinib
612071|NCT00970502|epidermal growth factor receptor|epidermal growth factor receptor
612072|NCT00970502|intensity-modulated radiotherapy|intensity-modulated radiotherapy
612073|NCT00970502|cyclooxygenase-2|cyclooxygenase-2
612074|NCT00970502|reirradiation|reirradiation
612075|NCT00970489|atrial fibrillation|atrial fibrillation
612076|NCT00970489|fish oil|fish oil
612077|NCT00970463|The GH-system and cardiac function|the gh-system and cardiac function
612078|NCT00970450|Paracetamol|paracetamol
612079|NCT00970450|Tropisetron|tropisetron
612080|NCT00970450|Central analgesic effect|central analgesic effect
612081|NCT00970450|Area of allodynia|area of allodynia
612082|NCT00970450|Secondary hyperalgesia|secondary hyperalgesia
612083|NCT00970398|Infant formula|infant formula
612084|NCT00970398|Bovine milk Osteopontin|bovine milk osteopontin
612085|NCT00970398|growth|growth
612086|NCT00970398|health|health
612087|NCT00970398|immune functions|immune functions
612088|NCT00970372|Coercion|coercion
612089|NCT00970359|thyroid|thyroid
612090|NCT00970359|metastases|metastases
612091|NCT00970359|AZD6244|azd6244
612092|NCT00970359|09-048|09-048
612093|NCT00970346|Digestive System Diseases|digestive system diseases
612094|NCT00970346|Genetic Diseases|genetic diseases
612095|NCT00970346|Inborn|inborn
612096|NCT00970346|Respiratory Tract Diseases|respiratory tract diseases
612097|NCT00970346|Cystic Fibrosis|cystic fibrosis
612098|NCT00970346|Lung Disease|lung disease
612099|NCT00970346|Pancreatic Diseases|pancreatic diseases
612100|NCT00970333|Alzheimer disease|alzheimer disease
612101|NCT00970333|Parkinson disease|parkinson disease
612102|NCT00970333|Multiple Sclerosis|multiple sclerosis
612103|NCT00970320|Anal Incontinence|anal incontinence
612104|NCT00970320|urinary incontinence|urinary incontinence
612105|NCT00970320|primiparas|primiparas
612106|NCT00970320|prevalence|prevalence
612107|NCT00970320|pelvic floor exercise treatment|pelvic floor exercise treatment
612108|NCT00970320|Quality of Life (QoL)|quality of life (qol)
612109|NCT00970294|diabetes|diabetes
612110|NCT00970268|COPD|copd
612111|NCT00970268|Chronic Obstructive Pulmonary Disease|chronic obstructive pulmonary disease
612112|NCT00970268|Chronic Bronchitis|chronic bronchitis
612113|NCT00970268|Emphysema|emphysema
612114|NCT00970268|Airflow Obstruction, Chronic|airflow obstruction, chronic
612115|NCT00970268|Chronic Airflow Obstruction|chronic airflow obstruction
612116|NCT00970268|Chronic Obstructive Airway Disease|chronic obstructive airway disease
612117|NCT00970268|Chronic Obstructive Lung Disease|chronic obstructive lung disease
612118|NCT00970255|Breastfeeding difficulties|breastfeeding difficulties
612119|NCT00970255|lingual frenulum|lingual frenulum
612120|NCT00970255|labial frenulum|labial frenulum
612121|NCT00970255|frenotomy|frenotomy
612122|NCT00970216|HBV DNA non-detectability|hbv dna non-detectability
612123|NCT00970203|Vaccine|vaccine
612124|NCT00970203|Androgen Ablation|androgen ablation
612125|NCT00970203|PSA Progression|psa progression
612126|NCT00970190|sinusitis|sinusitis
612127|NCT00970177|Pandemic influenza vaccine|pandemic influenza vaccine
612128|NCT00970151|Fetal Inflammation|fetal inflammation
612129|NCT00970151|Birth Outcome|birth outcome
612130|NCT00970151|Pregnancy|pregnancy
612131|NCT00970138|Progress free survival|progress free survival
612132|NCT00970138|Toxicity|toxicity
612133|NCT00970138|Response rate|response rate
612134|NCT00970138|Overall survival|overall survival
612135|NCT00970138|Quality of live|quality of live
612136|NCT00970125|advance care planning|advance care planning
612137|NCT00970125|cancer|cancer
612138|NCT00970112|pain|pain
612139|NCT00970112|pain assessment|pain assessment
612140|NCT00970086|measure of postoperative pain|measure of postoperative pain
612141|NCT00970086|children undergoing groin surgery|children undergoing groin surgery
612142|NCT00970073|calcineurin inhibitor delay|calcineurin inhibitor delay
612143|NCT00970073|Kidney|kidney
612144|NCT00970060|neuropathy|neuropathy
612145|NCT00970060|diabetes|diabetes
612146|NCT00970047|pregnant|pregnant
612147|NCT00970047|fetal sex determination|fetal sex determination
612148|NCT00970047|gender determination|gender determination
612149|NCT00970047|noninvasive test|noninvasive test
612150|NCT00970047|fetal DNA|fetal dna
612151|NCT00970034|Atrial fibrillation, apoptosis, oligonucleotide microarray|atrial fibrillation, apoptosis, oligonucleotide microarray
612152|NCT00970008|Osteoarthritis|osteoarthritis
612153|NCT00970008|Knee|knee
612154|NCT00969995|inflammation|inflammation
612155|NCT00969995|migraine|migraine
612156|NCT00969995|headache|headache
612157|NCT00969982|Pregnancy termination|pregnancy termination
612158|NCT00969982|abortion|abortion
612159|NCT00969982|medical abortion|medical abortion
612160|NCT00969982|2nd trimester|2nd trimester
612161|NCT00969982|mifepristone|mifepristone
612162|NCT00969982|misoprostol|misoprostol
612163|NCT00969969|First MTP Joint|first mtp joint
612164|NCT00969969|Hallux Rigidus|hallux rigidus
612165|NCT00969969|Hallux Limitus|hallux limitus
612166|NCT00969969|Cartilage Replacement|cartilage replacement
612167|NCT00969969|Osteoarthritis|osteoarthritis
612168|NCT00969969|First MTP Joint Osteoarthritis|first mtp joint osteoarthritis
612169|NCT00969969|Big Toe Pain|big toe pain
612275|NCT00969410|Liver neoplasms|liver neoplasms
612170|NCT00969956|Diabetes, Complication, Cardio-vascular disease|diabetes, complication, cardio-vascular disease
612171|NCT00969943|HPA axis|hpa axis
612172|NCT00969930|COMT|comt
612173|NCT00969930|ApoE|apoe
612174|NCT00969930|BDNF|bdnf
612175|NCT00969930|executive function|executive function
612176|NCT00969930|bipolar|bipolar
612177|NCT00969930|cognition|cognition
612178|NCT00969930|Cognitive deficits and Bipolar disease type I|cognitive deficits and bipolar disease type i
612179|NCT00969878|Cocaine Vaccine, TA-CD 09|cocaine vaccine, ta-cd 09
612180|NCT00969865|Atherosclerosis|atherosclerosis
612181|NCT00969852|Sertraline|sertraline
612182|NCT00969852|PET|pet
612183|NCT00969852|Serotonin receptor occupancy|serotonin receptor occupancy
612184|NCT00969852|PK-PD Model|pk-pd model
612185|NCT00969839|Fracture|fracture
612186|NCT00969839|Humerus|humerus
612187|NCT00969839|Intramedullary|intramedullary
612188|NCT00969839|Fixation|fixation
612189|NCT00969826|GCPGC|gcpgc
612190|NCT00969826|Pharmacokinetics|pharmacokinetics
612191|NCT00969826|Pharmacodynamics|pharmacodynamics
612192|NCT00969813|Hepatic impairment|hepatic impairment
612193|NCT00969800|Common cold|common cold
612194|NCT00969800|Influenza|influenza
612195|NCT00969800|Pneumonia|pneumonia
612196|NCT00969774|Face|face
612197|NCT00969774|Cephalometry|cephalometry
612198|NCT00969774|Anthropometry|anthropometry
612199|NCT00969774|Photography|photography
612200|NCT00969774|Diagnosis|diagnosis
612201|NCT00969774|Adult|adult
612202|NCT00969774|Morphology|morphology
612203|NCT00969774|Comparative Study|comparative study
612204|NCT00969735|Atrial fibrillation|atrial fibrillation
612205|NCT00969735|Catheter ablation|catheter ablation
612206|NCT00969735|Cryoenergy|cryoenergy
612207|NCT00969735|Implantable loop recorder|implantable loop recorder
612208|NCT00969735|Pulmonary vein|pulmonary vein
612209|NCT00969722|Neuroblastoma|neuroblastoma
612210|NCT00969722|3F8|3f8
612211|NCT00969722|Primary refractory|primary refractory
612212|NCT00969709|Depression|depression
612213|NCT00969709|Major Depressive Disorder|major depressive disorder
612214|NCT00969696|ability to learn, working memory|ability to learn, working memory
612215|NCT00969657|rectal cancer stage I-III|rectal cancer stage i-iii
612216|NCT00969657|concurrent chemoradiotherapie|concurrent chemoradiotherapie
612217|NCT00969657|response prediction|response prediction
612218|NCT00969631|Polycystic ovary syndrome|polycystic ovary syndrome
612219|NCT00969631|clomiphene resistance|clomiphene resistance
612220|NCT00969631|metformin|metformin
612221|NCT00969631|laparoscopic ovarian diathermy|laparoscopic ovarian diathermy
612222|NCT00969618|ADHD|adhd
612223|NCT00969605|weaning|weaning
612224|NCT00969605|adaptive support ventilation|adaptive support ventilation
612225|NCT00969605|COPD|copd
612226|NCT00969592|diabetes|diabetes
612227|NCT00969579|Cancer|cancer
612228|NCT00969579|Psychosocial Stress|psychosocial stress
612229|NCT00969579|Parenting|parenting
612230|NCT00969566|Diabetes|diabetes
612231|NCT00969566|Sitagliptin|sitagliptin
612232|NCT00969566|C-peptide|c-peptide
612233|NCT00969566|Glucagon|glucagon
612234|NCT00969540|Back Pain|back pain
612235|NCT00969540|Sleep|sleep
612236|NCT00969527|Oncoxin|oncoxin
612237|NCT00969527|Viusid|viusid
612238|NCT00969527|dietary supplements|dietary supplements
612239|NCT00969527|rheumatoid arthritis|rheumatoid arthritis
612240|NCT00969514|Robotic cystectomy|robotic cystectomy
612241|NCT00969514|Bladder|bladder
612242|NCT00969488|matern diet|matern diet
612243|NCT00969488|obese|obese
612244|NCT00969488|postpartum|postpartum
612245|NCT00969488|body weight change|body weight change
612246|NCT00969488|Women with overweight|women with overweight
612247|NCT00969475|scar revision|scar revision
612248|NCT00969475|intraoperative|intraoperative
612249|NCT00969475|fractional carbon dioxide laser|fractional carbon dioxide laser
612250|NCT00969462|Doxorubicin|doxorubicin
612251|NCT00969462|pharmacokinetics|pharmacokinetics
612252|NCT00969462|non-Hodgkin's lymphoma|non-hodgkin's lymphoma
612253|NCT00969462|response|response
612254|NCT00969462|association between response to chemotherapy|association between response to chemotherapy
612255|NCT00969462|myelosuppression degree|myelosuppression degree
612256|NCT00969462|doxorubicin pharmacokinetics|doxorubicin pharmacokinetics
612257|NCT00969449|Naproxen Sodium|naproxen sodium
612258|NCT00969436|Mumps|mumps
612259|NCT00969436|Immunogenicity|immunogenicity
612260|NCT00969436|Vaccines|vaccines
612261|NCT00969436|Safety|safety
612262|NCT00969436|Rubella|rubella
612263|NCT00969436|Combined Vaccine|combined vaccine
612264|NCT00969436|Varicella Vaccine|varicella vaccine
612265|NCT00969436|Children|children
612266|NCT00969436|Measles|measles
612267|NCT00969436|Humans|humans
612268|NCT00969423|persistent pain|persistent pain
612269|NCT00969423|neuropathic pain|neuropathic pain
612270|NCT00969423|Chronic Pain|chronic pain
612271|NCT00969423|VATS|vats
612272|NCT00969423|Primary spontaneous pneumothorax patients|primary spontaneous pneumothorax patients
612273|NCT00969410|Neoplasms|neoplasms
612274|NCT00969410|Neoplasm metastasis|neoplasm metastasis
612276|NCT00969410|Neoplastic processes|neoplastic processes
612277|NCT00969410|Pathologic processes|pathologic processes
612278|NCT00969410|Digestive system neoplasms|digestive system neoplasms
612279|NCT00969410|Neoplasms by site|neoplasms by site
612280|NCT00969410|Digestive system diseases|digestive system diseases
612281|NCT00969410|Liver diseases|liver diseases
612282|NCT00969397|Birthmark|birthmark
612283|NCT00969397|PWS|pws
612284|NCT00969384|Physical health|physical health
612285|NCT00969384|Mental illness|mental illness
612286|NCT00969384|prevention|prevention
612287|NCT00969384|Waist circumference|waist circumference
612288|NCT00969371|posterior chamber intraocular lens|posterior chamber intraocular lens
612289|NCT00969371|PCIOL|pciol
612290|NCT00969371|IOL|iol
612291|NCT00969345|Healthy Elderly Subjects|healthy elderly subjects
612292|NCT00969345|Respiratory Yoga Exercises|respiratory yoga exercises
612293|NCT00969345|Heart Rate Variability|heart rate variability
612294|NCT00969345|Baroreflex|baroreflex
612295|NCT00969345|Quality of Life|quality of life
612296|NCT00969332|liver|liver
612297|NCT00969332|Parenteral Nutrition|parenteral nutrition
612298|NCT00969332|fish oil|fish oil
612299|NCT00969332|Omegaven|omegaven
612300|NCT00969332|children|children
612301|NCT00969319|Octocog alfa|octocog alfa
612302|NCT00969319|Hemophilia A|hemophilia a
612303|NCT00969293|Macular Edema|macular edema
612304|NCT00969293|Occlusive retinal vascular disease|occlusive retinal vascular disease
612305|NCT00969293|Central Retinal Vein Occlusion|central retinal vein occlusion
612306|NCT00969293|CRVO|crvo
612307|NCT00969280|Acupuncture|acupuncture
612308|NCT00969280|Dry eye syndrome|dry eye syndrome
612309|NCT00969280|Ocular Surface Disease Index|ocular surface disease index
612310|NCT00969280|Schirmer test|schirmer test
612311|NCT00969280|Tear film Break-up time|tear film break-up time
612312|NCT00969267|ear acupuncture|ear acupuncture
612313|NCT00969267|obese|obese
612314|NCT00969267|obese women|obese women
612315|NCT00969267|women|women
612316|NCT00969254|Pílulas de Lussen|pílulas de lussen
612317|NCT00969254|Efficacy|efficacy
612318|NCT00969254|Safety|safety
612319|NCT00969254|Dysuria|dysuria
612320|NCT00969254|Symptomatic control|symptomatic control
612321|NCT00969241|saliva|saliva
612322|NCT00969241|free-radicals|free-radicals
612323|NCT00969241|periodontitis|periodontitis
612324|NCT00969228|Gastroenteritis|gastroenteritis
612325|NCT00969215|burn scar|burn scar
612326|NCT00969215|fractional carbon dioxide laser|fractional carbon dioxide laser
612327|NCT00969215|scar revision|scar revision
612328|NCT00969202|Prostate Cancer|prostate cancer
612329|NCT00969202|Cancer of the Prostate|cancer of the prostate
612330|NCT00969202|Prostate Tumor|prostate tumor
612331|NCT00969202|Novalis Tx|novalis tx
612332|NCT00969202|Novalis|novalis
612333|NCT00969202|Stereotactic Radiosurgery|stereotactic radiosurgery
612334|NCT00969202|Radiosurgery|radiosurgery
612335|NCT00969202|Radiation|radiation
612336|NCT00969189|anesthesia|anesthesia
612337|NCT00969189|child|child
612338|NCT00969189|infant|infant
612339|NCT00969189|laryngeal mask|laryngeal mask
612340|NCT00969176|pain|pain
612341|NCT00969176|fever|fever
612342|NCT00969176|neonate|neonate
612343|NCT00969176|preterm|preterm
612344|NCT00969176|term|term
612345|NCT00969176|newborn|newborn
612346|NCT00969163|Biomarkers of Skin Androgenization|biomarkers of skin androgenization
612347|NCT00969150|Major Depressive Disorder|major depressive disorder
612348|NCT00969150|Depression|depression
612349|NCT00969137|smoking, nicotine, cigarettes|smoking, nicotine, cigarettes
612350|NCT00969124|colonoscopy|colonoscopy
612351|NCT00969124|polyps|polyps
612352|NCT00969124|adenomas|adenomas
612353|NCT00969124|miss rates|miss rates
612354|NCT00969111|Proton Radiation, Prostate Cancer|proton radiation, prostate cancer
612355|NCT00969098|Histologically proven of Malignant pleural mesothelioma;|histologically proven of malignant pleural mesothelioma;
612356|NCT00969098|Patients not candidate to radical surgery;|patients not candidate to radical surgery;
612357|NCT00969098|Candidate to first-line pemetrexed-based chemotherapy;|candidate to first-line pemetrexed-based chemotherapy;
612358|NCT00969085|Cutaneous T-cell lymphoma|cutaneous t-cell lymphoma
612359|NCT00969085|Skin|skin
612360|NCT00969085|Mycosis fungoides|mycosis fungoides
612361|NCT00969085|MF|mf
612362|NCT00969085|Sézary syndrome|sézary syndrome
612363|NCT00969085|SS|ss
612364|NCT00969085|Curcumin|curcumin
612365|NCT00969085|Turmeric|turmeric
612366|NCT00969072|GI198745|gi198745
612367|NCT00969072|Long term extension study|long term extension study
612368|NCT00969072|BPH|bph
612369|NCT00969059|peripheral nerve injury|peripheral nerve injury
612370|NCT00969059|p38 kinase inhibitor|p38 kinase inhibitor
612371|NCT00969059|neuropathic pain|neuropathic pain
612372|NCT00969046|Colon cancer|colon cancer
612373|NCT00969046|MTD|mtd
612374|NCT00969046|DLT|dlt
612375|NCT00969046|EPO906|epo906
612376|NCT00969046|patupilone|patupilone
612377|NCT00969020|Length of stay|length of stay
612378|NCT00969020|Timed up and go|timed up and go
612379|NCT00968994|Wound Healing|wound healing
612380|NCT00968994|Wound Infection|wound infection
612381|NCT00968981|Hedgehog|hedgehog
612382|NCT00968981|BCC|bcc
612383|NCT00968981|basal cell carcinoma|basal cell carcinoma
612384|NCT00968968|carcinoma, breast lump, Pagets disease, breast cancer positive for human epidermal growth factor receptor 2, breast cancer progression, estrogen-receptor|carcinoma, breast lump, pagets disease, breast cancer positive for human epidermal growth factor receptor 2, breast cancer progression, estrogen-receptor
612385|NCT00968955|Postoperative acute pain|postoperative acute pain
612386|NCT00968955|Total hip arthroplasty|total hip arthroplasty
612387|NCT00968955|Local infiltration analgesia|local infiltration analgesia
612388|NCT00968942|Lateral Canthal Lines|lateral canthal lines
612389|NCT00968942|Crow's Feet|crow's feet
612390|NCT00968942|Facial Wrinkles|facial wrinkles
612391|NCT00968929|pulmonary embolism|pulmonary embolism
612392|NCT00968929|thrombolysis|thrombolysis
612393|NCT00968929|massive|massive
778311|NCT00337142|newborn|newborn
612394|NCT00968929|submassive|submassive
612395|NCT00968929|recombinant streptokinase|recombinant streptokinase
612396|NCT00968929|urokinase|urokinase
612397|NCT00968903|Hip arthroplasty|hip arthroplasty
612398|NCT00968903|Methylprednisolone|methylprednisolone
612399|NCT00968903|Post-operative pain|post-operative pain
612400|NCT00968890|GSK Bio's influenza vaccine GSK2340272A|gsk bio's influenza vaccine gsk2340272a
612401|NCT00968890|Influenza infection|influenza infection
612402|NCT00968877|Renal Insufficiency|renal insufficiency
612403|NCT00968877|Cholecalciferol|cholecalciferol
612404|NCT00968877|Kidney Disease|kidney disease
612405|NCT00968877|Kidney Failure|kidney failure
612406|NCT00968877|Vitamin D|vitamin d
612407|NCT00968877|Vitamin D Deficiency|vitamin d deficiency
612408|NCT00968877|Vitamin D3|vitamin d3
612409|NCT00968864|T cell depleted|t cell depleted
612410|NCT00968864|Matched unrelated donors|matched unrelated donors
612411|NCT00968864|Haplocompatible donors|haplocompatible donors
612412|NCT00968851|Schizophrenia|schizophrenia
612413|NCT00968851|Central nervous System Diseases|central nervous system diseases
612414|NCT00968851|Cognition|cognition
612415|NCT00968838|White Blood Cell Transfusion|white blood cell transfusion
612416|NCT00968838|Radiated Cells|radiated cells
612417|NCT00968838|Unradiated Cells|unradiated cells
612418|NCT00968838|Leukocyte Transfusions|leukocyte transfusions
612419|NCT00968838|Life-threatening Infections|life-threatening infections
612420|NCT00968825|Lateral Canthal Lines|lateral canthal lines
612421|NCT00968825|Crow's Feet|crow's feet
612422|NCT00968825|Facial Wrinkles|facial wrinkles
612423|NCT00968812|Diabetes|diabetes
612424|NCT00968812|Metformin|metformin
612425|NCT00968812|Glimepiride|glimepiride
612426|NCT00968812|Hemoglobin A1c|hemoglobin a1c
612427|NCT00968812|Type 2 diabetes mellitus|type 2 diabetes mellitus
612428|NCT00968812|Canagliflozin|canagliflozin
612429|NCT00968799|Ovarian Neoplasms|ovarian neoplasms
612430|NCT00968799|Recurrence|recurrence
612431|NCT00968799|Hyperthermia, Induced|hyperthermia, induced
612432|NCT00968799|Peritoneal Neoplasms|peritoneal neoplasms
612433|NCT00968799|recurrent epithelial ovarian cancer|recurrent epithelial ovarian cancer
612434|NCT00968799|recurrent fallopian tube carcinoma|recurrent fallopian tube carcinoma
612435|NCT00968786|hypertension|hypertension
612436|NCT00968786|type 2 diabetes|type 2 diabetes
612437|NCT00968786|home monitoring|home monitoring
612438|NCT00968773|inguinal hernia|inguinal hernia
612439|NCT00968773|mesh|mesh
612440|NCT00968773|hernia repair device|hernia repair device
612441|NCT00968760|CD19+ lymphoid malignancies|cd19+ lymphoid malignancies
612442|NCT00968760|non-Hodgkin's Lymphoma|non-hodgkin's lymphoma
612443|NCT00968760|NHL|nhl
612444|NCT00968760|small lymphocytic lymphoma|small lymphocytic lymphoma
612445|NCT00968760|SLL|sll
612446|NCT00968760|follicular lymphoma|follicular lymphoma
612447|NCT00968760|mantle cell lymphoma|mantle cell lymphoma
612448|NCT00968760|gene cell transfer|gene cell transfer
612449|NCT00968760|CD19-specific T cells|cd19-specific t cells
612450|NCT00968760|Stem Cell Transplant|stem cell transplant
612451|NCT00968760|T Cell Infusion|t cell infusion
612452|NCT00968760|Chemotherapy|chemotherapy
612453|NCT00968760|Leukapheresis|leukapheresis
612454|NCT00968760|BCNU|bcnu
612455|NCT00968760|carmustine|carmustine
612456|NCT00968760|Cytarabine|cytarabine
612457|NCT00968760|Etoposide|etoposide
612458|NCT00968760|Interleukin-2|interleukin-2
612459|NCT00968760|Proleukin|proleukin
612460|NCT00968760|Melphalan|melphalan
612461|NCT00968760|Rituximab|rituximab
612462|NCT00968760|T cell therapy|t cell therapy
612463|NCT00968747|Fasting|fasting
612464|NCT00968747|Fast|fast
612465|NCT00968747|healthy|healthy
612466|NCT00968747|diet|diet
612467|NCT00968747|study|study
612468|NCT00968747|manipulation|manipulation
612469|NCT00968747|dietary|dietary
612470|NCT00968747|FGF21|fgf21
612471|NCT00968747|Fibroblast growth factor|fibroblast growth factor
612472|NCT00968747|PTRF|ptrf
612473|NCT00968747|Polymerase 1 and transcript release factor|polymerase 1 and transcript release factor
612474|NCT00968747|adipose|adipose
612475|NCT00968747|fat|fat
612476|NCT00968747|blood|blood
612477|NCT00968747|inpatient|inpatient
612478|NCT00968747|outpatient|outpatient
612480|NCT00968747|metabolism|metabolism
612481|NCT00968734|Vitamin D|vitamin d
612482|NCT00968734|colecalciferol|colecalciferol
612483|NCT00968734|absorption by Vitamin D|absorption by vitamin d
612484|NCT00968721|Inflammatory bowel disease|inflammatory bowel disease
612485|NCT00968721|Crohn's disease|crohn's disease
612486|NCT00968721|Ulcerative colitis|ulcerative colitis
612487|NCT00968721|medication adherence|medication adherence
612488|NCT00968721|Decisional influences|decisional influences
612489|NCT00968708|Diabetes Mellitus - Type 2|diabetes mellitus - type 2
612490|NCT00968708|Diabetes Mellitus|diabetes mellitus
612491|NCT00968708|cardiovascular outcomes|cardiovascular outcomes
612492|NCT00968708|heart attack|heart attack
612493|NCT00968708|stroke|stroke
612494|NCT00968708|dipeptidyl-peptidase IV inhibitors|dipeptidyl-peptidase iv inhibitors
612495|NCT00968708|metabolic disorders|metabolic disorders
612496|NCT00968708|metabolic diseases|metabolic diseases
612497|NCT00968708|glucose metabolism disorders|glucose metabolism disorders
612498|NCT00968682|cardiac toxicity|cardiac toxicity
612499|NCT00968682|HER2-positive breast cancer|her2-positive breast cancer
612500|NCT00968682|stage IA breast cancer|stage ia breast cancer
612501|NCT00968682|stage IB breast cancer|stage ib breast cancer
612502|NCT00968682|stage II breast cancer|stage ii breast cancer
612503|NCT00968682|stage IIIA breast cancer|stage iiia breast cancer
612504|NCT00968682|stage IIIB breast cancer|stage iiib breast cancer
612505|NCT00968682|stage IIIC breast cancer|stage iiic breast cancer
612506|NCT00968656|Breast cancer|breast cancer
612507|NCT00968656|Head and Neck Cancer|head and neck cancer
612508|NCT00968656|Diffuse Large B-cell lymphoma|diffuse large b-cell lymphoma
612509|NCT00968656|Cellular proliferation|cellular proliferation
612510|NCT00968643|spinal cord compression|spinal cord compression
612511|NCT00968643|unspecified adult solid tumor, protocol specific|unspecified adult solid tumor, protocol specific
612512|NCT00968617|Anemia|anemia
612513|NCT00968604|Pancreatic Cancer|pancreatic cancer
612514|NCT00968604|Pancreas|pancreas
612515|NCT00968604|Liver|liver
612516|NCT00968604|Liver Tumor Biopsy|liver tumor biopsy
612517|NCT00968604|BikDD Nanoparticle|bikdd nanoparticle
612518|NCT00968604|C-VISA BikDD|c-visa bikdd
612519|NCT00968591|Hepatic insufficiency|hepatic insufficiency
612520|NCT00968591|liver disease|liver disease
612521|NCT00968591|cirrhosis|cirrhosis
612522|NCT00968591|pharmacokinetics|pharmacokinetics
612523|NCT00968578|Knee arthroplasty|knee arthroplasty
612524|NCT00968578|Methylprednisolone|methylprednisolone
612525|NCT00968578|Post-operative pain|post-operative pain
612526|NCT00968565|Heart Defects, Congenital|heart defects, congenital
612527|NCT00968565|Extracorporeal Membrane Oxygenation|extracorporeal membrane oxygenation
612528|NCT00968565|Citric Acid|citric acid
612529|NCT00968565|Heparin|heparin
612530|NCT00968565|Respiratory Insufficiency|respiratory insufficiency
612531|NCT00968552|Any Gastrointestinal problem that would require an endoscopically placed stent|any gastrointestinal problem that would require an endoscopically placed stent
612532|NCT00968539|GSK Bio's influenza vaccine GSK2340272A|gsk bio's influenza vaccine gsk2340272a
612533|NCT00968539|influenza infection|influenza infection
612534|NCT00968526|influenza infection|influenza infection
612535|NCT00968526|GSK Bio's influenza vaccine GSK2340272A|gsk bio's influenza vaccine gsk2340272a
612536|NCT00968513|Smoking Cessation, Inpatient Psychiatry, Stages of Change|smoking cessation, inpatient psychiatry, stages of change
612537|NCT00968500|Grief|grief
612538|NCT00968500|bereavement|bereavement
612539|NCT00968500|questionnaires|questionnaires
612540|NCT00968500|09-107|09-107
612541|NCT00968487|Lyophilized Plasma|lyophilized plasma
612542|NCT00968487|Fresh Frozen Plasma|fresh frozen plasma
612543|NCT00968487|Hemorrhage|hemorrhage
612544|NCT00968487|Coagulopathy|coagulopathy
612545|NCT00968487|Autologous|autologous
612546|NCT00968487|HemCon|hemcon
612547|NCT00968487|Plasmapheresis|plasmapheresis
612548|NCT00968487|Freeze Drying|freeze drying
612549|NCT00968487|Transfusion|transfusion
612550|NCT00968487|Resuscitation|resuscitation
612551|NCT00968487|Safety of Lyophilized Plasma in Normal, Healthy Volunteers|safety of lyophilized plasma in normal, healthy volunteers
612552|NCT00968461|Chronic lymphocytic leukemia|chronic lymphocytic leukemia
612553|NCT00968461|CLL|cll
612554|NCT00968461|PEITC|peitc
612555|NCT00968461|Phenethyl Isothiocyanate|phenethyl isothiocyanate
612556|NCT00968461|Fludarabine|fludarabine
612557|NCT00968448|respiratory muscle|respiratory muscle
612558|NCT00968448|breathing pattern|breathing pattern
612559|NCT00968448|exercise performance|exercise performance
612560|NCT00968435|bevacizumab|bevacizumab
612561|NCT00968435|cisplatin|cisplatin
612562|NCT00968435|cetuximab|cetuximab
612563|NCT00968435|radiation therapy|radiation therapy
612564|NCT00968435|Phase II|phase ii
612565|NCT00968435|09-083|09-083
612566|NCT00968422|Pharmacology|pharmacology
612567|NCT00968422|Drug Safety|drug safety
612568|NCT00968422|Phase 1 Clinical Trials|phase 1 clinical trials
612569|NCT00968422|Pharmacokinetics|pharmacokinetics
612570|NCT00968409|Breast Cancer|breast cancer
612571|NCT00968409|Hormone Receptor|hormone receptor
612572|NCT00968396|Myeloma|myeloma
612573|NCT00968396|Ex-Vivo Depletion of Myeloma Cells|ex-vivo depletion of myeloma cells
612574|NCT00968396|Peripheral Blood Progenitor Cell Grafts|peripheral blood progenitor cell grafts
612576|NCT00968396|Stem Cell Transplant|stem cell transplant
612577|NCT00968396|Bone marrow stem cells|bone marrow stem cells
612578|NCT00968396|Melphalan|melphalan
612579|NCT00968396|Alkeran|alkeran
612580|NCT00968396|Apheresis|apheresis
612581|NCT00968383|Acute Coronary Syndrome|acute coronary syndrome
612582|NCT00968383|Myocardial infarction|myocardial infarction
612583|NCT00968383|Infarct Related Artery|infarct related artery
612584|NCT00968383|Percutaneous Coronary Intervention|percutaneous coronary intervention
612585|NCT00968383|Medical treatment|medical treatment
612586|NCT00968383|Tissue Viability|tissue viability
612587|NCT00968383|Magnetic Resonance|magnetic resonance
612588|NCT00968370|Severe and very severe pneumonia|severe and very severe pneumonia
612589|NCT00968370|severe malnutrition|severe malnutrition
612590|NCT00968370|children|children
612591|NCT00968370|day-care management|day-care management
612592|NCT00968370|hospital management|hospital management
612593|NCT00968357|SCV-07|scv-07
612594|NCT00968357|relapsers|relapsers
612595|NCT00968357|Hepatitis C|hepatitis c
612596|NCT00968331|relapsed and refractory DLBCL|relapsed and refractory dlbcl
612597|NCT00968318|Tissue expander|tissue expander
612598|NCT00968318|seroma|seroma
612599|NCT00968318|extrusion|extrusion
612600|NCT00968318|lymphatics|lymphatics
612601|NCT00968318|deep fascia|deep fascia
612602|NCT00968318|Rate of seroma formation after excision of strip of deep fascia|rate of seroma formation after excision of strip of deep fascia
612603|NCT00968305|African American children with stable asthma|african american children with stable asthma
612604|NCT00968305|Asthma severity|asthma severity
612605|NCT00968305|Interleukin 13 from PHA stimulated PBMC|interleukin 13 from pha stimulated pbmc
612606|NCT00968305|Lung function (FEV1%)|lung function (fev1%)
612607|NCT00968305|Total serum IgE|total serum ige
612608|NCT00968305|Pediatrics|pediatrics
612609|NCT00968292|K3 Promoter prosthetic foot Tensegrity Prosthetics Jerome Rifkin|k3 promoter prosthetic foot tensegrity prosthetics jerome rifkin
612610|NCT00968279|Patients with atrial fibrillation|patients with atrial fibrillation
612611|NCT00968266|Adherence|adherence
612612|NCT00968266|Compliance|compliance
612613|NCT00968266|Rheumatoid Arthritis|rheumatoid arthritis
612614|NCT00968266|Intervention|intervention
612615|NCT00968266|Beliefs about medication|beliefs about medication
612616|NCT00968266|Motivational Interviewing|motivational interviewing
612617|NCT00968266|Medication adherence|medication adherence
612618|NCT00968266|Patient compliance|patient compliance
612619|NCT00968266|Intervention studies|intervention studies
612620|NCT00968253|Acute Lymphocytic Leukemia|acute lymphocytic leukemia
612621|NCT00968253|ALL|all
612622|NCT00968253|Hyper-CVAD|hyper-cvad
612623|NCT00968253|Everolimus|everolimus
612624|NCT00968253|6-mercaptopurine|6-mercaptopurine
612625|NCT00968253|Citrovorum|citrovorum
612626|NCT00968253|Cyclophosphamide|cyclophosphamide
612627|NCT00968253|Cytarabine|cytarabine
612628|NCT00968253|Dexamethasone|dexamethasone
612629|NCT00968253|Doxorubicin|doxorubicin
612630|NCT00968253|G-CSF|g-csf
612631|NCT00968253|Methotrexate|methotrexate
612632|NCT00968253|MESNA|mesna
612633|NCT00968253|Pegfilgrastim|pegfilgrastim
612634|NCT00968253|Prednisone|prednisone
612635|NCT00968253|RAD001|rad001
612636|NCT00968253|Solumedrol|solumedrol
612637|NCT00968253|Vincristine Sulfate|vincristine sulfate
612638|NCT00968240|GBM|gbm
612639|NCT00968240|AA|aa
612640|NCT00968240|AO|ao
612641|NCT00968240|Brain|brain
612642|NCT00968240|Tumors|tumors
612643|NCT00968240|Malignant|malignant
612644|NCT00968240|Glioblastoma|glioblastoma
612645|NCT00968240|Multiforme|multiforme
612646|NCT00968240|Anaplastic|anaplastic
612647|NCT00968240|Astrocytoma|astrocytoma
612648|NCT00968227|subarachnoid hemorrhage|subarachnoid hemorrhage
612649|NCT00968227|vasospasm|vasospasm
612650|NCT00968227|transfusion|transfusion
612651|NCT00968227|cerebral oxygen delivery|cerebral oxygen delivery
612652|NCT00968227|hemoglobin|hemoglobin
612653|NCT00968214|stage IA breast cancer|stage ia breast cancer
612654|NCT00968214|stage IB breast cancer|stage ib breast cancer
612655|NCT00968214|stage II breast cancer|stage ii breast cancer
612656|NCT00968214|stage IIIA breast cancer|stage iiia breast cancer
612657|NCT00968214|stage IIIB breast cancer|stage iiib breast cancer
612658|NCT00968214|stage IIIC breast cancer|stage iiic breast cancer
612659|NCT00968214|estrogen receptor-positive breast cancer|estrogen receptor-positive breast cancer
612660|NCT00968214|progesterone receptor-positive breast cancer|progesterone receptor-positive breast cancer
612661|NCT00968188|HIV Risk|hiv risk
612662|NCT00968188|Internet Intervention|internet intervention
612663|NCT00968188|Homosexuality, Male|homosexuality, male
612664|NCT00968188|HIV Seronegativity|hiv seronegativity
612665|NCT00968175|Ultrasound guided celiac plexus neurolysis|ultrasound guided celiac plexus neurolysis
612666|NCT00968175|CPN|cpn
612667|NCT00968175|Pancreatic Cancer|pancreatic cancer
612668|NCT00968175|Pain Management|pain management
612669|NCT00968162|Bone Marrow Transplant|bone marrow transplant
612670|NCT00968162|Sickle Cell Disease|sickle cell disease
612671|NCT00968136|refractory infantile spasms|refractory infantile spasms
612672|NCT00968110|Milk Allergy|milk allergy
612673|NCT00968097|Alzheimer' disease|alzheimer' disease
612674|NCT00968097|SPECT imaging|spect imaging
612675|NCT00968084|Diagnostic Work Up|diagnostic work up
612676|NCT00968084|Normal Volunteers|normal volunteers
612678|NCT00968084|Inflammatory Disease|inflammatory disease
612679|NCT00968084|Autoimmune Disease|autoimmune disease
612680|NCT00968084|Immunologic Disease|immunologic disease
612681|NCT00968084|Healthy Volunteer|healthy volunteer
612682|NCT00968071|Leukemia|leukemia
612683|NCT00968071|AML|aml
612684|NCT00968071|MDS|mds
612685|NCT00968071|High-Risk Myelodysplastic Syndrome|high-risk myelodysplastic syndrome
612686|NCT00968071|Decitabine|decitabine
612687|NCT00968071|5-aza-2 deoxycytidine|5-aza-2 deoxycytidine
612688|NCT00968071|Dacogen|dacogen
612689|NCT00968071|Gemtuzumab Ozogamicin|gemtuzumab ozogamicin
612690|NCT00968071|Mylotarg|mylotarg
612691|NCT00968058|Leak Pressure|leak pressure
612692|NCT00968058|Intubation, Endotracheal|intubation, endotracheal
612693|NCT00968058|Pediatric|pediatric
612694|NCT00968058|Temporal Variation|temporal variation
612695|NCT00968045|Fibrinogen|fibrinogen
612696|NCT00968045|Postoperative bleeding|postoperative bleeding
612697|NCT00968045|Transfusions|transfusions
612698|NCT00968045|CABG|cabg
612699|NCT00968032|PFO|pfo
612700|NCT00968032|Patent Foramen Ovale|patent foramen ovale
612701|NCT00968006|diabetes|diabetes
612702|NCT00968006|endothelium|endothelium
612703|NCT00968006|stem cells|stem cells
612704|NCT00967993|hyperphosphatemia|hyperphosphatemia
612705|NCT00967993|end-stage renal disease|end-stage renal disease
612706|NCT00967993|ESRD|esrd
612707|NCT00967993|hemodialysis|hemodialysis
612708|NCT00967993|diabetes|diabetes
612709|NCT00967993|dialysis|dialysis
612710|NCT00967980|pain|pain
612711|NCT00967980|Hip Resurfacing|hip resurfacing
612712|NCT00967980|catheter|catheter
612713|NCT00967980|nerve block|nerve block
612714|NCT00967980|UCSD|ucsd
612715|NCT00967980|hip surgery|hip surgery
612716|NCT00967980|psoas|psoas
612717|NCT00967980|femoral|femoral
612718|NCT00967980|ambulation|ambulation
612719|NCT00967980|hip flexion|hip flexion
612720|NCT00967980|infusion|infusion
612721|NCT00967967|control|control
612722|NCT00967967|symptoms|symptoms
612723|NCT00967954|stage IIB prostate cancer|stage iib prostate cancer
612724|NCT00967954|stage IIA prostate cancer|stage iia prostate cancer
612725|NCT00967954|stage III prostate cancer|stage iii prostate cancer
612726|NCT00967954|stage IV prostate cancer|stage iv prostate cancer
612727|NCT00967941|Vascular Surgery|vascular surgery
612728|NCT00967928|Stage IV or Recurrent Cervical cancer|stage iv or recurrent cervical cancer
612729|NCT00967915|Ankyloglossia|ankyloglossia
612730|NCT00967915|Tongue tie|tongue tie
612731|NCT00967915|Frenotomy|frenotomy
612732|NCT00967915|Frenulectomy|frenulectomy
612733|NCT00967915|Breast feeding|breast feeding
612734|NCT00967915|HATLFF|hatlff
612735|NCT00967915|IBFAT|ibfat
612736|NCT00967902|intracoronary stent|intracoronary stent
612737|NCT00967902|drug eluting stent|drug eluting stent
612738|NCT00967902|sirolimus|sirolimus
612739|NCT00967902|endothelial progenitor cells|endothelial progenitor cells
612740|NCT00967889|stage III prostate cancer|stage iii prostate cancer
612741|NCT00967889|stage IV prostate cancer|stage iv prostate cancer
612742|NCT00967889|recurrent prostate cancer|recurrent prostate cancer
612743|NCT00967876|Men or women of any ethnic group scheduled to undergo conventional coronary angiography for suspected coronary artery stent stenosis|men or women of any ethnic group scheduled to undergo conventional coronary angiography for suspected coronary artery stent stenosis
612744|NCT00967863|adenocarcinoma of the prostate|adenocarcinoma of the prostate
612745|NCT00967863|stage III prostate cancer|stage iii prostate cancer
612746|NCT00967863|stage IV prostate cancer|stage iv prostate cancer
612747|NCT00967850|High Myopia|high myopia
612748|NCT00967850|Bevacizumab|bevacizumab
612749|NCT00967850|Photodynamic therapy|photodynamic therapy
612750|NCT00967837|Diabetes with complications|diabetes with complications
612751|NCT00967837|Wound healing|wound healing
612752|NCT00967824|breast cancer|breast cancer
612753|NCT00967798|cystic fibrosis|cystic fibrosis
612754|NCT00967798|diabetes|diabetes
612755|NCT00967798|inflammation|inflammation
612756|NCT00967798|oxidative stress|oxidative stress
612757|NCT00967798|redox balance|redox balance
612758|NCT00967798|lung disease|lung disease
612759|NCT00967785|Neutropenia|neutropenia
612760|NCT00967785|Hypogammaglobulinemia|hypogammaglobulinemia
612761|NCT00967785|Myelokathexis|myelokathexis
612762|NCT00967785|Warts|warts
612763|NCT00967785|Immunodeficiency|immunodeficiency
612764|NCT00967772|Pharmacokinetics|pharmacokinetics
612765|NCT00967772|Safety|safety
612766|NCT00967772|tolerability|tolerability
612767|NCT00967759|common cold|common cold
612768|NCT00967759|treatment|treatment
612769|NCT00967759|inflammatory symptoms of superior air passages affection|inflammatory symptoms of superior air passages affection
612770|NCT00967694|Glaucoma|glaucoma
612771|NCT00967694|Nitrous oxide|nitrous oxide
612772|NCT00967668|Counseling|counseling
612773|NCT00967668|Veterans|veterans
612774|NCT00967668|Weight loss|weight loss
612775|NCT00967668|Physical activity|physical activity
612776|NCT00967668|Diet|diet
612777|NCT00967655|adenocarcinoma of the rectum|adenocarcinoma of the rectum
612778|NCT00967655|stage I rectal cancer|stage i rectal cancer
612779|NCT00967655|stage II rectal cancer|stage ii rectal cancer
612780|NCT00967655|stage III rectal cancer|stage iii rectal cancer
612781|NCT00967642|Patients with Diabetes Mellitus Submitted to Percutaneous Coronary Intervention with Stent|patients with diabetes mellitus submitted to percutaneous coronary intervention with stent
612782|NCT00967629|Diabetic nephropathy|diabetic nephropathy
612783|NCT00967629|CKD progression|ckd progression
612784|NCT00967629|AGEs|ages
612785|NCT00967629|oxidative stress|oxidative stress
612786|NCT00967629|dietary AGEs|dietary ages
612787|NCT00967616|metastatic|metastatic
612788|NCT00967616|colon|colon
612789|NCT00967616|rectum|rectum
612790|NCT00967616|combination|combination
612791|NCT00967616|chemotherapy|chemotherapy
612792|NCT00967603|adenocarcinoma of the pancreas|adenocarcinoma of the pancreas
612793|NCT00967603|stage IV pancreatic cancer|stage iv pancreatic cancer
612794|NCT00967564|Myelodysplastic Syndrome|myelodysplastic syndrome
612795|NCT00967564|Quality of Life|quality of life
612796|NCT00967564|Anemia|anemia
612797|NCT00967564|Epoetin alfa|epoetin alfa
612798|NCT00967564|Eprex|eprex
612799|NCT00967551|Diarrhea|diarrhea
612800|NCT00967551|Pneumonia|pneumonia
612801|NCT00967551|Upper respiratory infections|upper respiratory infections
612802|NCT00967551|Acute gastroenteritis|acute gastroenteritis
612803|NCT00967538|psoriasis|psoriasis
612804|NCT00967538|etanercept|etanercept
612805|NCT00967538|efficacy|efficacy
612806|NCT00967538|response|response
612807|NCT00967538|anti-TNF alpha|anti-tnf alpha
612808|NCT00967538|treatment efficacy|treatment efficacy
612809|NCT00967525|AML|aml
612810|NCT00967525|ALL|all
612811|NCT00967525|leukemia|leukemia
612812|NCT00967525|CML|cml
612813|NCT00967525|Myelodysplastic Syndrome|myelodysplastic syndrome
612814|NCT00967525|malignancies|malignancies
612815|NCT00967525|Undifferentiated leukemia|undifferentiated leukemia
612816|NCT00967525|High risk malignancies|high risk malignancies
612817|NCT00967512|Oligonucleotides, Antisense|oligonucleotides, antisense
612818|NCT00967512|Tumor Suppressor Protein p53|tumor suppressor protein p53
612819|NCT00967512|idarubicin|idarubicin
612820|NCT00967512|cytarabine|cytarabine
612821|NCT00967499|PONV|ponv
612822|NCT00967499|rescue|rescue
612823|NCT00967473|Astigmatism|astigmatism
612824|NCT00967473|cataract|cataract
612825|NCT00967473|corneal astigmatism|corneal astigmatism
612826|NCT00967473|IOL|iol
612827|NCT00967473|AcrySof|acrysof
612828|NCT00967460|Childhood obesity|childhood obesity
612829|NCT00967460|Children|children
612830|NCT00967460|Inactivity|inactivity
612831|NCT00967460|Physical activity|physical activity
612832|NCT00967460|Motor skills|motor skills
612833|NCT00967460|Motor fitness|motor fitness
612834|NCT00967460|Quality of life|quality of life
612835|NCT00967460|Nutrition|nutrition
612836|NCT00967460|Family|family
612837|NCT00967434|infarction|infarction
612838|NCT00967434|ischemia|ischemia
612839|NCT00967434|surgery|surgery
612840|NCT00967434|perioperative|perioperative
612841|NCT00967434|statins|statins
612842|NCT00967421|Driving|driving
612843|NCT00967421|DUI|dui
612844|NCT00967421|Driving simulation|driving simulation
612845|NCT00967421|Drugs|drugs
612846|NCT00967421|Ethanol|ethanol
612847|NCT00967408|Stroke|stroke
612848|NCT00967408|Antidepressive Agents,Second-Generation|antidepressive agents,second-generation
612849|NCT00967408|Treatment Outcome|treatment outcome
612850|NCT00967408|Rehabilitation|rehabilitation
612851|NCT00967382|Pregnancy|pregnancy
612852|NCT00967382|Thrombophilia|thrombophilia
612853|NCT00967382|High-risk pregnancy|high-risk pregnancy
612854|NCT00967382|LMWH prophylaxis|lmwh prophylaxis
612855|NCT00967382|Placenta mediated pregnancy complications|placenta mediated pregnancy complications
612856|NCT00967356|Healthy volunteers|healthy volunteers
612857|NCT00967343|Haploidentical stem cell transplantation|haploidentical stem cell transplantation
612858|NCT00967343|Graft-versus-host disease|graft-versus-host disease
612859|NCT00967343|Immune reconstitution|immune reconstitution
612860|NCT00967343|Alloreactive T-cells|alloreactive t-cells
612861|NCT00967343|Photodepletion|photodepletion
612862|NCT00967343|TH9402|th9402
612863|NCT00967343|Transplant related mortality|transplant related mortality
612864|NCT00967343|Hematologic malignancy|hematologic malignancy
612865|NCT00967317|Auris-Sedina|auris-sedina
612866|NCT00967317|Otitis|otitis
612867|NCT00967317|Efficacy|efficacy
612868|NCT00967317|Tolerability|tolerability
612869|NCT00967304|Unprovoked Venous thromboembolism|unprovoked venous thromboembolism
612870|NCT00967304|Clinical decision rule|clinical decision rule
612871|NCT00967304|Anticoagulants|anticoagulants
612872|NCT00967304|Recurrence|recurrence
612873|NCT00967304|Prognostic|prognostic
612874|NCT00967304|Risk stratification|risk stratification
612875|NCT00967291|acinar cell adenocarcinoma of the pancreas|acinar cell adenocarcinoma of the pancreas
612876|NCT00967291|duct cell adenocarcinoma of the pancreas|duct cell adenocarcinoma of the pancreas
612877|NCT00967291|stage IV pancreatic cancer|stage iv pancreatic cancer
612878|NCT00967291|recurrent pancreatic cancer|recurrent pancreatic cancer
612879|NCT00967278|OPCAB|opcab
612880|NCT00967278|pulmonary artery catheter|pulmonary artery catheter
612881|NCT00967278|esophageal doppler|esophageal doppler
612882|NCT00967278|hemodynamics|hemodynamics
612883|NCT00967265|Introduction seminar|introduction seminar
612884|NCT00967265|Psychoeducation|psychoeducation
612885|NCT00967265|Waiting list|waiting list
778903|NCT00334529|Flu|flu
612886|NCT00967265|Patient participation|patient participation
612887|NCT00967265|Mental disorders|mental disorders
612888|NCT00967252|surgery|surgery
612889|NCT00967252|inflammation|inflammation
612890|NCT00967252|infection|infection
612891|NCT00967252|statins|statins
612892|NCT00967239|ductal breast carcinoma in situ|ductal breast carcinoma in situ
612893|NCT00967239|invasive ductal breast carcinoma|invasive ductal breast carcinoma
612894|NCT00967239|invasive lobular breast carcinoma|invasive lobular breast carcinoma
612895|NCT00967239|invasive lobular breast carcinoma with predominant in situ component|invasive lobular breast carcinoma with predominant in situ component
612896|NCT00967226|hemangioma|hemangioma
612897|NCT00967200|adult anaplastic astrocytoma|adult anaplastic astrocytoma
612898|NCT00967200|adult diffuse astrocytoma|adult diffuse astrocytoma
612899|NCT00967200|adult glioblastoma|adult glioblastoma
612900|NCT00967200|adult giant cell glioblastoma|adult giant cell glioblastoma
612901|NCT00967200|adult gliosarcoma|adult gliosarcoma
612902|NCT00967200|adult pilocytic astrocytoma|adult pilocytic astrocytoma
612903|NCT00967200|adult pineal gland astrocytoma|adult pineal gland astrocytoma
612904|NCT00967200|adult subependymal giant cell astrocytoma|adult subependymal giant cell astrocytoma
612905|NCT00967200|adult brain stem glioma|adult brain stem glioma
612906|NCT00967200|adult choroid plexus tumor|adult choroid plexus tumor
612907|NCT00967200|adult craniopharyngioma|adult craniopharyngioma
612908|NCT00967200|adult ependymoblastoma|adult ependymoblastoma
612909|NCT00967200|adult medulloblastoma|adult medulloblastoma
612910|NCT00967200|adult supratentorial primitive neuroectodermal tumor (PNET)|adult supratentorial primitive neuroectodermal tumor (pnet)
612911|NCT00967200|adult anaplastic ependymoma|adult anaplastic ependymoma
612912|NCT00967200|adult ependymoma|adult ependymoma
612913|NCT00967200|adult myxopapillary ependymoma|adult myxopapillary ependymoma
612914|NCT00967200|adult subependymoma|adult subependymoma
612915|NCT00967200|meningeal melanocytoma|meningeal melanocytoma
612916|NCT00967200|adult meningeal hemangiopericytoma|adult meningeal hemangiopericytoma
612917|NCT00967200|adult grade I meningioma|adult grade i meningioma
612918|NCT00967200|adult grade II meningioma|adult grade ii meningioma
612919|NCT00967200|adult anaplastic meningioma|adult anaplastic meningioma
612920|NCT00967200|adult papillary meningioma|adult papillary meningioma
612921|NCT00967200|adult anaplastic oligodendroglioma|adult anaplastic oligodendroglioma
612922|NCT00967200|adult oligodendroglioma|adult oligodendroglioma
612923|NCT00967200|adult pineoblastoma|adult pineoblastoma
612924|NCT00967200|adult pineocytoma|adult pineocytoma
612925|NCT00967200|adult mixed glioma|adult mixed glioma
612926|NCT00967200|recurrent adult brain tumor|recurrent adult brain tumor
612927|NCT00967161|knee replacement motion analysis|knee replacement motion analysis
612928|NCT00967135|Thoracotomy|thoracotomy
612929|NCT00967135|Neuropathic pain|neuropathic pain
612930|NCT00967122|adjustment, hunger|adjustment, hunger
612931|NCT00967122|Hunger/satiety changes before and after gastric band adjustment|hunger/satiety changes before and after gastric band adjustment
612932|NCT00967109|Anemia|anemia
612933|NCT00967109|Tissue oxygenation|tissue oxygenation
612934|NCT00967109|Spine surgery|spine surgery
612935|NCT00967096|rifaximin|rifaximin
612936|NCT00967096|acute graft versus host disease|acute graft versus host disease
612937|NCT00967096|bone marrow transplant|bone marrow transplant
612938|NCT00967096|non-malignancy requiring BMT|non-malignancy requiring bmt
612939|NCT00967083|Quality of Life|quality of life
612940|NCT00967083|Questionnaires|questionnaires
612941|NCT00967083|Interviews|interviews
612942|NCT00967083|family members|family members
612943|NCT00967083|care givers|care givers
612944|NCT00967083|09-104|09-104
613065|NCT00966485|coronary stenting|coronary stenting
612945|NCT00967057|recurrent childhood acute lymphoblastic leukemia|recurrent childhood acute lymphoblastic leukemia
612946|NCT00967057|T-cell childhood acute lymphoblastic leukemia|t-cell childhood acute lymphoblastic leukemia
612947|NCT00967044|Relapsed or Refractory Lymphoma|relapsed or refractory lymphoma
612948|NCT00967044|Hodgkin's lymphoma|hodgkin's lymphoma
612949|NCT00967044|Non Hodgkin's Lymphoma|non hodgkin's lymphoma
612951|NCT00967044|LBH589|lbh589
612952|NCT00967044|Panobinostat|panobinostat
612953|NCT00967044|RAD001|rad001
612954|NCT00967044|Everolimus|everolimus
612955|NCT00967031|HER2-positive breast cancer|her2-positive breast cancer
612956|NCT00967031|male breast cancer|male breast cancer
612957|NCT00967031|stage IV breast cancer|stage iv breast cancer
612958|NCT00967031|tumors metastatic to brain|tumors metastatic to brain
612959|NCT00967018|Safety parameters|safety parameters
613153|NCT00966056|Mitomycin|mitomycin
612960|NCT00967018|ECG, blood and urine samples|ecg, blood and urine samples
612961|NCT00967018|general health state|general health state
612962|NCT00967005|N acetyl cysteine|n acetyl cysteine
612963|NCT00967005|Pathological gambling|pathological gambling
612964|NCT00967005|Nicotine dependence|nicotine dependence
612965|NCT00966992|Uterine Cervical Cancer|uterine cervical cancer
612966|NCT00966992|Cancer of Cervix|cancer of cervix
612967|NCT00966992|Cervix Cancer|cervix cancer
612968|NCT00966979|Osteoarthritis, Post-traumatic arthritis|osteoarthritis, post-traumatic arthritis
612969|NCT00966966|Alzheimer Disease|alzheimer disease
612970|NCT00966940|Glaucoma|glaucoma
612971|NCT00966940|IOP|iop
612972|NCT00966940|Travoprost|travoprost
612973|NCT00966927|quality of life|quality of life
612974|NCT00966927|functional independence|functional independence
612975|NCT00966927|spina bifid|spina bifid
612976|NCT00966888|stage II breast cancer|stage ii breast cancer
612977|NCT00966875|rheumatoid arthritis|rheumatoid arthritis
612978|NCT00966875|RA|ra
612979|NCT00966849|Randomized Controlled Trial|randomized controlled trial
612980|NCT00966849|Financial Support|financial support
612981|NCT00966849|Poverty|poverty
612982|NCT00966849|Child, Orphaned|child, orphaned
612983|NCT00966849|HIV|hiv
612984|NCT00966836|Heart Transplantation|heart transplantation
612985|NCT00966836|Cardiac Allograft Vasculopathy|cardiac allograft vasculopathy
612986|NCT00966836|Cytomegalovirus Infection|cytomegalovirus infection
612987|NCT00966836|Everolimus|everolimus
612988|NCT00966836|Valganciclovir|valganciclovir
612989|NCT00966836|Mycophenolate|mycophenolate
612990|NCT00966823|Diaphragm|diaphragm
612991|NCT00966823|Trachea|trachea
612992|NCT00966823|Lung development|lung development
612993|NCT00966823|Lung growth|lung growth
612994|NCT00966823|Tracheal occlusion|tracheal occlusion
612995|NCT00966823|ECMO|ecmo
612996|NCT00966823|Neonatal death|neonatal death
612997|NCT00966810|chronic myelocytic leukemia|chronic myelocytic leukemia
612998|NCT00966810|allogeneic stem cell transplantation|allogeneic stem cell transplantation
612999|NCT00966810|T cell depletion|t cell depletion
613000|NCT00966810|donor lymphocyte infusion|donor lymphocyte infusion
613001|NCT00966810|GvHD|gvhd
613002|NCT00966810|transplant related mortality|transplant related mortality
613003|NCT00966771|contraception|contraception
613004|NCT00966771|emergency contraception|emergency contraception
613005|NCT00966771|pregnancy prevention after unprotected intercourse|pregnancy prevention after unprotected intercourse
613006|NCT00966745|surgical field condition|surgical field condition
613007|NCT00966719|Jaundice|jaundice
613008|NCT00966719|Breastfeeding|breastfeeding
613009|NCT00966719|Infants|infants
613010|NCT00966706|adenocarcinoma of the pancreas|adenocarcinoma of the pancreas
613011|NCT00966706|stage III pancreatic cancer|stage iii pancreatic cancer
613012|NCT00966706|stage IV pancreatic cancer|stage iv pancreatic cancer
613013|NCT00966680|general anesthesia|general anesthesia
613014|NCT00966680|spinal anesthesia|spinal anesthesia
613015|NCT00966680|emergency cesarean delivery|emergency cesarean delivery
613016|NCT00966667|cancer survivor|cancer survivor
613017|NCT00966667|stage I colon cancer|stage i colon cancer
613018|NCT00966667|stage II colon cancer|stage ii colon cancer
613019|NCT00966667|stage III colon cancer|stage iii colon cancer
613020|NCT00966667|stage I rectal cancer|stage i rectal cancer
613021|NCT00966667|stage II rectal cancer|stage ii rectal cancer
613022|NCT00966667|stage III rectal cancer|stage iii rectal cancer
613023|NCT00966654|CABG|cabg
613024|NCT00966654|Cardiac Surgical Patient|cardiac surgical patient
613025|NCT00966628|pediatric|pediatric
613026|NCT00966628|dengue|dengue
613027|NCT00966628|hypertonic sodium lactate|hypertonic sodium lactate
613028|NCT00966628|fluid resuscitation|fluid resuscitation
613029|NCT00966628|Ringer's lactate|ringer's lactate
613030|NCT00966615|malnutrition|malnutrition
613031|NCT00966615|fluid status|fluid status
613032|NCT00966615|survival|survival
613033|NCT00966589|groin pain|groin pain
613034|NCT00966589|sportsman hernia|sportsman hernia
613035|NCT00966589|osteitis pubis|osteitis pubis
613036|NCT00966589|laparoscopic surgery|laparoscopic surgery
613037|NCT00966576|Glaucoma|glaucoma
613038|NCT00966576|IOP|iop
613039|NCT00966576|AZARGA|azarga
613040|NCT00966563|Mangafodipir|mangafodipir
613041|NCT00966563|Primary Percutaneous Coronary Intervention|primary percutaneous coronary intervention
613042|NCT00966563|Myocardial infarction|myocardial infarction
613043|NCT00966563|Troponin|troponin
613044|NCT00966563|CK-MB|ck-mb
613045|NCT00966563|Magnetic Resonance Imaging|magnetic resonance imaging
613046|NCT00966550|Tomato|tomato
613047|NCT00966550|Nutrition|nutrition
613048|NCT00966537|to study the clinical application of 3D/4D ultrasound for fetal scanning|to study the clinical application of 3d/4d ultrasound for fetal scanning
613049|NCT00966537|to study the clinical application of 3D/4D ultrasound for pelvic scanning;|to study the clinical application of 3d/4d ultrasound for pelvic scanning;
613050|NCT00966537|to demonstrate how to optimally display the different organs.|to demonstrate how to optimally display the different organs.
613051|NCT00966537|to correlate our findings with other diagnostic tools like MRI, CT;|to correlate our findings with other diagnostic tools like mri, ct;
613154|NCT00966056|Mitomycin c|mitomycin c
613052|NCT00966537|to correlate our findings with clinical outcome.|to correlate our findings with clinical outcome.
613053|NCT00966524|Endotracheal intubation|endotracheal intubation
613054|NCT00966511|lung cancer|lung cancer
613055|NCT00966511|lung resection|lung resection
613056|NCT00966511|lobectomy|lobectomy
613057|NCT00966511|pneumonectomy|pneumonectomy
613058|NCT00966511|lung function|lung function
613059|NCT00966511|perfusion|perfusion
613060|NCT00966498|malignancy|malignancy
779159|NCT00333632|Sleep|sleep
613061|NCT00966498|solid tumor|solid tumor
613062|NCT00966498|recurrent|recurrent
613063|NCT00966498|high risk|high risk
613064|NCT00966485|ASA resistance|asa resistance
613066|NCT00966485|platelet function|platelet function
613067|NCT00966485|laboratory ASA resistance|laboratory asa resistance
613068|NCT00966485|MACE|mace
613069|NCT00966485|Positive SPECT|positive spect
613070|NCT00966472|Rosuvastatin|rosuvastatin
613071|NCT00966472|Erlotinib|erlotinib
613072|NCT00966472|Squamous Cell Carcinoma|squamous cell carcinoma
613073|NCT00966472|Nom-Small Cell Lung Cancer|nom-small cell lung cancer
613074|NCT00966459|COPD|copd
613075|NCT00966446|MRSA; household; infection; colonization|mrsa; household; infection; colonization
613076|NCT00966433|Proseal™ LMA|proseal™ lma
613077|NCT00966433|children|children
613078|NCT00966433|ventilation|ventilation
613079|NCT00966433|general anesthesia|general anesthesia
613080|NCT00966433|Children under general anesthesia for outpatient surgery|children under general anesthesia for outpatient surgery
613081|NCT00966407|Metabolic Syndrome|metabolic syndrome
613082|NCT00966407|Obesity|obesity
613083|NCT00966407|Genetic risk markers|genetic risk markers
613084|NCT00966407|Single Nucleotide Polymorphisms|single nucleotide polymorphisms
613085|NCT00966407|Young adults|young adults
613086|NCT00966407|Fitness testing|fitness testing
613087|NCT00966394|ADHD, saliva, caries|adhd, saliva, caries
613088|NCT00966381|breastfeeding|breastfeeding
613089|NCT00966381|bone mineral density|bone mineral density
613090|NCT00966381|exercise|exercise
613091|NCT00966381|diet|diet
613092|NCT00966355|Cirrhosis, Esophagus Disorders, Varicose Veins|cirrhosis, esophagus disorders, varicose veins
613093|NCT00966342|vaccine|vaccine
613094|NCT00966342|influenza|influenza
613095|NCT00966342|influenza vaccine|influenza vaccine
613096|NCT00966342|pandemic preparedness|pandemic preparedness
613097|NCT00966329|Switching|switching
613098|NCT00966329|Maraviroc|maraviroc
613099|NCT00966329|Virological efficacy|virological efficacy
613100|NCT00966329|Lipid profile|lipid profile
613101|NCT00966329|Tropism|tropism
613102|NCT00966316|Acute Ischemic Stroke；clinical pathway;TCM；|acute ischemic stroke；clinical pathway;tcm；
613103|NCT00966303|rehabilitation|rehabilitation
613104|NCT00966303|dyspnea|dyspnea
613105|NCT00966303|strength|strength
613106|NCT00966290|anticoagulants|anticoagulants
613107|NCT00966290|management|management
613108|NCT00966290|anticoagulation clinics|anticoagulation clinics
613109|NCT00966290|randomized comparison|randomized comparison
613110|NCT00966277|Pancreas|pancreas
613111|NCT00966277|Primary venous thromboembolism|primary venous thromboembolism
613112|NCT00966277|VTE|vte
613113|NCT00966277|Chemotherapy|chemotherapy
613114|NCT00966277|Deep venous thrombosis|deep venous thrombosis
613115|NCT00966277|Pulmonary embolism|pulmonary embolism
613116|NCT00966277|Dalteparin|dalteparin
613117|NCT00966277|Fragmin|fragmin
613118|NCT00966277|Thromboprophylaxis|thromboprophylaxis
613119|NCT00966264|randomized controlled trial|randomized controlled trial
613120|NCT00966264|menorrhagia|menorrhagia
613121|NCT00966264|LNG-IUS|lng-ius
613122|NCT00966264|hysterectomy|hysterectomy
613123|NCT00966251|Primary Hepatocellular Carcinoma|primary hepatocellular carcinoma
613124|NCT00966238|influenza|influenza
613125|NCT00966238|vaccine|vaccine
613126|NCT00966199|blood pressure|blood pressure
613127|NCT00966199|aging|aging
613128|NCT00966199|cerebrovascular circulation|cerebrovascular circulation
613129|NCT00966199|hypertension|hypertension
613130|NCT00966186|ProSeal Laryngeal Mask Airway|proseal laryngeal mask airway
613131|NCT00966186|Rotational technique|rotational technique
613132|NCT00966186|Success rate|success rate
613133|NCT00966186|Postoperative complications|postoperative complications
613134|NCT00966160|treatment naive|treatment naive
613135|NCT00966134|mountain medicine|mountain medicine
613136|NCT00966134|ghrelin|ghrelin
613137|NCT00966134|growth hormone|growth hormone
613138|NCT00966134|hypoxia|hypoxia
613139|NCT00966134|physiology of hormonal adaptation to high altitude|physiology of hormonal adaptation to high altitude
613140|NCT00966121|Cirrhosis|cirrhosis
613141|NCT00966121|Esophagus Disorders|esophagus disorders
613142|NCT00966121|Varicose Veins|varicose veins
613143|NCT00966095|prostate cancer|prostate cancer
613144|NCT00966082|Cirrhosis|cirrhosis
613145|NCT00966082|Esophagus Disorders|esophagus disorders
613146|NCT00966082|Varicose Veins|varicose veins
613147|NCT00966069|Respiratory tract infections|respiratory tract infections
613148|NCT00966069|Viral infections|viral infections
613149|NCT00966069|Pediatrics|pediatrics
613150|NCT00966069|Specimen collection|specimen collection
613151|NCT00966056|Nasal adhesions|nasal adhesions
613152|NCT00966056|Nasal synechiae|nasal synechiae
613155|NCT00966056|Teflon|teflon
613156|NCT00966056|Splints|splints
613157|NCT00966056|Septal splints|septal splints
613158|NCT00966017|PET Scan|pet scan
613159|NCT00966004|Urge incontinence|urge incontinence
613160|NCT00966004|YM178|ym178
613161|NCT00966004|Overactive Bladder|overactive bladder
613162|NCT00966004|Urgency|urgency
779255|NCT00333138|MS|ms
613163|NCT00966004|Urinary incontinence|urinary incontinence
613164|NCT00966004|mirabegron|mirabegron
613165|NCT00966004|Micturition|micturition
613166|NCT00965991|Gestational diabetes|gestational diabetes
613167|NCT00965991|Metformin|metformin
613168|NCT00965991|Glyburide|glyburide
613169|NCT00965991|oral agents|oral agents
613170|NCT00965978|ONO-5920|ono-5920
613171|NCT00965978|YM529|ym529
613172|NCT00965978|Minodronic Acid|minodronic acid
613173|NCT00965978|Food Effect|food effect
613174|NCT00965965|health behavior|health behavior
613175|NCT00965965|randomized controlled trials|randomized controlled trials
613176|NCT00965965|self-efficacy|self-efficacy
613177|NCT00965965|patient education|patient education
613178|NCT00965965|comprehension|comprehension
613179|NCT00965965|mass screening|mass screening
613180|NCT00965965|prevention and control|prevention and control
613181|NCT00965926|Overactive Bladder|overactive bladder
613182|NCT00965926|Urinary incontinence|urinary incontinence
613183|NCT00965926|YM178|ym178
613184|NCT00965926|mirabegron|mirabegron
613185|NCT00965900|Cirrhosis|cirrhosis
613186|NCT00965900|Esophagus Disorders|esophagus disorders
613187|NCT00965900|Varicose Veins|varicose veins
613188|NCT00965874|Rapid Atrial Fibrillation|rapid atrial fibrillation
613189|NCT00965874|Magnesium Sulfate|magnesium sulfate
613190|NCT00965874|Cardiac arrhythmia|cardiac arrhythmia
613191|NCT00965861|Tissue Registry|tissue registry
613192|NCT00965861|Tissue Collection|tissue collection
613193|NCT00965861|Unknown Primary|unknown primary
613194|NCT00965861|Breast|breast
613195|NCT00965861|Lung|lung
613196|NCT00965861|Gastrointestinal|gastrointestinal
613197|NCT00965861|Bone Marrow Transplant|bone marrow transplant
613198|NCT00965861|Chronic Lymphocytic Leukemia|chronic lymphocytic leukemia
613199|NCT00965861|Central Nervous System|central nervous system
613200|NCT00965861|Head and Neck|head and neck
613201|NCT00965861|Melanoma|melanoma
613202|NCT00965861|Myelodysplastic syndrome|myelodysplastic syndrome
613203|NCT00965861|Multiple Myeloma|multiple myeloma
613204|NCT00965861|Lymphoma|lymphoma
613205|NCT00965861|Gynecologic|gynecologic
613206|NCT00965861|Genitourinary|genitourinary
613207|NCT00965861|Refractory Malignancy|refractory malignancy
613208|NCT00965848|Pneumonia, Ventilator-Associated|pneumonia, ventilator-associated
613209|NCT00965848|Intra-abdominal Infections|intra-abdominal infections
613210|NCT00965848|Urinary tract Infections|urinary tract infections
613211|NCT00965848|Doripenem|doripenem
613212|NCT00965848|Doribax|doribax
613213|NCT00965835|PET Scan|pet scan
613214|NCT00965822|URTI|urti
613215|NCT00965822|Natural Health Products|natural health products
613216|NCT00965796|Intravenous lidocaine|intravenous lidocaine
613217|NCT00965796|postoperative analgesia|postoperative analgesia
613218|NCT00965783|Sleep, Apnea, OSA, obese, middle-aged|sleep, apnea, osa, obese, middle-aged
613219|NCT00965770|abortion|abortion
613220|NCT00965770|intrauterine device|intrauterine device
613221|NCT00965770|cost-effectiveness|cost-effectiveness
613222|NCT00965744|Ligasure vessel sealing system|ligasure vessel sealing system
613223|NCT00965744|Azygoportal Disconnection|azygoportal disconnection
613224|NCT00965744|Splenectomy|splenectomy
613225|NCT00965744|Portal hypertension|portal hypertension
613226|NCT00965731|Lung Neoplasms|lung neoplasms
613227|NCT00965731|Crizotinib|crizotinib
613228|NCT00965718|advanced pancreatic cancer|advanced pancreatic cancer
613229|NCT00965705|Binge Eating Disorder|binge eating disorder
613230|NCT00965705|overeating|overeating
613231|NCT00965705|binge eating|binge eating
613232|NCT00965705|women|women
613233|NCT00965705|overweight|overweight
613234|NCT00965705|compulsive overeating|compulsive overeating
613235|NCT00965679|Cardiac CT|cardiac ct
613236|NCT00965679|Iodinated Radiocontrast|iodinated radiocontrast
613237|NCT00965679|Ionizing Radiation|ionizing radiation
613238|NCT00965679|Aortic Valve Stenosis|aortic valve stenosis
613239|NCT00965679|Percutaneous Aortic Valve Replacement|percutaneous aortic valve replacement
613240|NCT00965679|Heart Valve|heart valve
613241|NCT00965666|Fanconi Anemia|fanconi anemia
613242|NCT00965666|Hemic and Lymphatic Diseases|hemic and lymphatic diseases
613243|NCT00965666|Anti-Rheumatic Agents|anti-rheumatic agents
613244|NCT00965666|Anemia, Hypoplastic, Congenital|anemia, hypoplastic, congenital
613245|NCT00965666|DNA Repair-Deficiency Disorders|dna repair-deficiency disorders
613246|NCT00965666|Congenital, Hereditary, and|congenital, hereditary, and
613247|NCT00965666|Neonatal Diseases and Abnormalities|neonatal diseases and abnormalities
613248|NCT00965640|male pattern baldness|male pattern baldness
613249|NCT00965640|androgenetic alopecia|androgenetic alopecia
613250|NCT00965640|hair loss|hair loss
613251|NCT00965614|diagnose cardiac arrhythmia and CAD.|diagnose cardiac arrhythmia and cad.
613347|NCT00965302|Diabetes mellitus, Type 2|diabetes mellitus, type 2
613348|NCT00965302|Sleeve gastrectomy|sleeve gastrectomy
613252|NCT00965614|we'll try to establish the specific model to detect and diagnose cardiac arrhythmia and CAD.|we'll try to establish the specific model to detect and diagnose cardiac arrhythmia and cad.
613253|NCT00965601|Fibromyalgia|fibromyalgia
613254|NCT00965588|Alzheimer's disease|alzheimer's disease
613255|NCT00965588|amyloid beta|amyloid beta
613256|NCT00965588|vaccine|vaccine
613257|NCT00965575|epilepsy|epilepsy
613258|NCT00965575|sleep|sleep
613259|NCT00965575|seizures|seizures
613260|NCT00965575|cognition|cognition
613261|NCT00965562|Premenstrual syndrome|premenstrual syndrome
613262|NCT00965562|PMS|pms
613263|NCT00965562|calcium|calcium
613264|NCT00965536|Schizophrenia|schizophrenia
613265|NCT00965536|Bipolar Disorder|bipolar disorder
613266|NCT00965536|Manic Disorder|manic disorder
613267|NCT00965536|Register study|register study
613268|NCT00965536|Quetiapine|quetiapine
613269|NCT00965536|Quetiapine Prolong|quetiapine prolong
613270|NCT00965536|Seroquel|seroquel
613271|NCT00965536|Seroquel Prolong|seroquel prolong
613272|NCT00965536|Seroquel XR|seroquel xr
613273|NCT00965536|In-patient|in-patient
613274|NCT00965523|Cancer|cancer
613275|NCT00965523|breast cancer|breast cancer
613276|NCT00965523|neoplasm|neoplasm
613277|NCT00965523|E7389|e7389
613278|NCT00965523|Eribulin|eribulin
613279|NCT00965510|diabetes|diabetes
613280|NCT00965497|Amyotrophic Lateral Sclerosis|amyotrophic lateral sclerosis
613281|NCT00965497|ALS|als
613282|NCT00965497|Multiple Sclerosis|multiple sclerosis
613283|NCT00965497|MS|ms
613284|NCT00965497|Major Depression|major depression
613285|NCT00965497|Depression|depression
613286|NCT00965497|Major Depressive Disorder|major depressive disorder
613287|NCT00965497|antidepressants|antidepressants
613288|NCT00965497|Escitalopram|escitalopram
613289|NCT00965497|Lexapro|lexapro
613290|NCT00965484|Genotropin Medical device Patient reported outcome|genotropin medical device patient reported outcome
613291|NCT00965471|percutaneous coronary artery intervention|percutaneous coronary artery intervention
613292|NCT00965471|coronary artery bypass graft|coronary artery bypass graft
613293|NCT00965471|acute coronary syndrome|acute coronary syndrome
613294|NCT00965458|New-onset Type 1 Diabetes Mellitus|new-onset type 1 diabetes mellitus
613295|NCT00965458|New-onset T1DM|new-onset t1dm
613296|NCT00965458|New-onset T1D|new-onset t1d
613297|NCT00965458|Alefacept|alefacept
613298|NCT00965458|Amevive®|amevive®
613299|NCT00965445|isoprostanes|isoprostanes
613300|NCT00965445|mass spectrometry|mass spectrometry
613301|NCT00965406|acute coronary syndrome|acute coronary syndrome
613302|NCT00965406|glucose insulin potassium|glucose insulin potassium
613303|NCT00965393|Ischaemia reperfusion|ischaemia reperfusion
613304|NCT00965393|Platelet activation|platelet activation
613305|NCT00965393|Endothelial function|endothelial function
613306|NCT00965393|Remote ischaemic preconditioning|remote ischaemic preconditioning
613307|NCT00965393|Bradykinin|bradykinin
613308|NCT00965380|Trinity Evolution|trinity evolution
613309|NCT00965380|Symptomatic lumbar degenerative disc disease|symptomatic lumbar degenerative disc disease
613310|NCT00965380|Posterior lumbar interbody fusion|posterior lumbar interbody fusion
613311|NCT00965380|Transforaminal lumbar interbody fusion|transforaminal lumbar interbody fusion
613312|NCT00965367|POV tonsillectomy adenoidectomy acupuncture acupressure child|pov tonsillectomy adenoidectomy acupuncture acupressure child
613313|NCT00965367|Effectiveness of acupuncture on|effectiveness of acupuncture on
613314|NCT00965354|severe|severe
613315|NCT00965354|acute|acute
613316|NCT00965354|influenza|influenza
613317|NCT00965354|consortium|consortium
613318|NCT00965354|swine|swine
613319|NCT00965354|flu|flu
613320|NCT00965354|influenza A|influenza a
613321|NCT00965354|H1N1|h1n1
613322|NCT00965354|hospital|hospital
613323|NCT00965354|admission|admission
613324|NCT00965341|Cancer|cancer
613325|NCT00965341|Fatigue|fatigue
613326|NCT00965341|Testosterone Replacement Therapy|testosterone replacement therapy
613327|NCT00965341|Depo-Testosterone|depo-testosterone
613328|NCT00965341|Testosterone cypionate|testosterone cypionate
613329|NCT00965341|Testosterone enanthate|testosterone enanthate
613330|NCT00965341|Hypogonadic|hypogonadic
613331|NCT00965341|Functional Assessment of Cancer Therapy-Fatigue subscale|functional assessment of cancer therapy-fatigue subscale
613332|NCT00965341|FACIT-F|facit-f
613333|NCT00965328|anticoagulation|anticoagulation
613334|NCT00965328|hemofiltration|hemofiltration
613335|NCT00965328|acute kidney injury|acute kidney injury
613336|NCT00965328|heparin|heparin
613337|NCT00965328|hemostasis|hemostasis
613338|NCT00965328|nadroparin|nadroparin
613339|NCT00965328|anti-Xa|anti-xa
613340|NCT00965328|endogenous thrombin potential|endogenous thrombin potential
613341|NCT00965315|CV (cardiovascular)|cv (cardiovascular)
613342|NCT00965315|MI (myocardial infarction)|mi (myocardial infarction)
613343|NCT00965315|fenofibrate|fenofibrate
613344|NCT00965315|rosuvastatin|rosuvastatin
613345|NCT00965315|this trial is to test the hypothesis that the addition of fenofibrate on rosuvastatin would provide a further reduction in the time|this trial is to test the hypothesis that the addition of fenofibrate on rosuvastatin would provide a further reduction in the time
613346|NCT00965302|Obesity|obesity
614129|NCT00962715|Flu|flu
613349|NCT00965302|Metabolic surgery|metabolic surgery
613350|NCT00965289|Aggressive large B-cell lymphoma (DLBCL)|aggressive large b-cell lymphoma (dlbcl)
613351|NCT00965289|Intensive chemotherapy|intensive chemotherapy
613352|NCT00965289|Rituximab|rituximab
613353|NCT00965289|ASCT|asct
613354|NCT00965276|Adjuvant Therapy|adjuvant therapy
613355|NCT00965276|Paclitaxel|paclitaxel
613356|NCT00965276|Chemoresistance|chemoresistance
613357|NCT00965276|Serine/Threonine Kinase|serine/threonine kinase
613358|NCT00965276|Cell Survival|cell survival
613359|NCT00965276|Breast Cancer|breast cancer
613360|NCT00965263|Cocaine|cocaine
613361|NCT00965263|immunotherapy|immunotherapy
613362|NCT00965263|vaccination|vaccination
613363|NCT00965263|antibody|antibody
613364|NCT00965263|addiction|addiction
613365|NCT00965263|dependence|dependence
613366|NCT00965250|Thymic Malignancies|thymic malignancies
613367|NCT00965250|IMC-A12|imc-a12
613368|NCT00965250|Insulin-Like Growth Factor|insulin-like growth factor
613369|NCT00965224|AML (acute myeloid leukemia)|aml (acute myeloid leukemia)
613370|NCT00965224|CML (chronic myeloid leukemia)|cml (chronic myeloid leukemia)
613371|NCT00965224|MM (multiple myeloma)|mm (multiple myeloma)
613372|NCT00965211|Tourette's, OCD, dTMS, YGTSS, YBOCS, supplementary motor cortex|tourette's, ocd, dtms, ygtss, ybocs, supplementary motor cortex
613373|NCT00965211|Tourette's syndrome and Obsessive compulsive disorder|tourette's syndrome and obsessive compulsive disorder
613374|NCT00965198|Catheters, Indwelling|catheters, indwelling
613375|NCT00965198|Biofilms|biofilms
613376|NCT00965185|Cardiovascular Disease|cardiovascular disease
613377|NCT00965185|HIV|hiv
613378|NCT00965185|Atherosclerosis|atherosclerosis
613379|NCT00965185|Inflammation|inflammation
613380|NCT00965185|Statins|statins
613381|NCT00965185|treatment experienced|treatment experienced
613382|NCT00965172|Cancer|cancer
613383|NCT00965172|Mucositis|mucositis
613384|NCT00965172|Chemotherapy|chemotherapy
613385|NCT00965172|Caphosol|caphosol
613386|NCT00965172|Calcium phosphate|calcium phosphate
613387|NCT00965172|Sodium Bicarbonate|sodium bicarbonate
613388|NCT00965172|Baking Soda Solution|baking soda solution
613389|NCT00965172|Multi-cycle chemotherapy|multi-cycle chemotherapy
613390|NCT00965146|Osteoarthritis, traumatic arthritis, avascular necrosis|osteoarthritis, traumatic arthritis, avascular necrosis
613391|NCT00965120|Ischaemia reperfusion|ischaemia reperfusion
613392|NCT00965120|Bradykinin|bradykinin
613393|NCT00965120|Platelet activation|platelet activation
613394|NCT00965120|Endothelial function|endothelial function
613395|NCT00965068|Autism|autism
613396|NCT00965068|Autism Spectrum Disorder|autism spectrum disorder
613397|NCT00965068|Cholesterol|cholesterol
613398|NCT00965068|Smith-Lemli-Opitz Syndrome|smith-lemli-opitz syndrome
613399|NCT00965068|ASD|asd
613400|NCT00965068|Pervasive Developmental Disorder|pervasive developmental disorder
613401|NCT00965068|PPD-NOS|ppd-nos
613402|NCT00965042|Ceftobiprole|ceftobiprole
613403|NCT00965042|ZEVTERA|zevtera
613404|NCT00965042|ZEFTERA|zeftera
613405|NCT00965042|Intestinal Microflora|intestinal microflora
613406|NCT00965029|COPD|copd
613407|NCT00965029|Spirometry|spirometry
613408|NCT00965029|Weaning|weaning
613409|NCT00965016|Extracorporeal membrane oxygenation，induced hypothermia|extracorporeal membrane oxygenation，induced hypothermia
613410|NCT00964990|Moderate to severe chronic peripheral neuropathic pain|moderate to severe chronic peripheral neuropathic pain
613411|NCT00964990|Postherpetic neuralgia|postherpetic neuralgia
613412|NCT00964990|Post-traumatic neuralgia|post-traumatic neuralgia
613413|NCT00964990|Moderate to severe chronic pain|moderate to severe chronic pain
613414|NCT00964990|JNJ-42160443|jnj-42160443
613415|NCT00964977|pN1|pn1
613416|NCT00964977|head and neck cancer|head and neck cancer
613417|NCT00964977|radiation|radiation
613418|NCT00964977|prognosis|prognosis
613419|NCT00964977|comprehensive cohort design|comprehensive cohort design
613420|NCT00964951|H1N1, influenza A viruses, vaccine, elderly|h1n1, influenza a viruses, vaccine, elderly
613421|NCT00964938|Hemodynamic response|hemodynamic response
613422|NCT00964938|Cardiac resynchronization therapy|cardiac resynchronization therapy
613423|NCT00964886|chronic pain|chronic pain
613424|NCT00964886|back pain|back pain
613425|NCT00964886|antidepressants|antidepressants
613426|NCT00964873|Synta|synta
613427|NCT00964873|STA-9090|sta-9090
613428|NCT00964873|ganetespib|ganetespib
613429|NCT00964873|Hematologic Cancers|hematologic cancers
613430|NCT00964873|Acute Myeloid Leukemia|acute myeloid leukemia
613431|NCT00964873|Acute Lymphoblastic Leukemia|acute lymphoblastic leukemia
613432|NCT00964873|Blast-phase Chronic Myelogenous Leukemia|blast-phase chronic myelogenous leukemia
613433|NCT00964873|AML|aml
613434|NCT00964873|ALL|all
613435|NCT00964873|CML|cml
613436|NCT00964873|HSP90 Inhibitor|hsp90 inhibitor
613437|NCT00964847|hypertension|hypertension
613438|NCT00964847|cardiovascular disease|cardiovascular disease
613439|NCT00964847|yoga|yoga
613440|NCT00964821|stage III adult Burkitt lymphoma|stage iii adult burkitt lymphoma
613441|NCT00964821|stage III adult diffuse large cell lymphoma|stage iii adult diffuse large cell lymphoma
613442|NCT00964821|stage III adult diffuse mixed cell lymphoma|stage iii adult diffuse mixed cell lymphoma
613689|NCT00964106|drug interaction|drug interaction
710881|NCT00587457|Moxetumomab pasudotox|moxetumomab pasudotox
779634|NCT00331318|HV|hv
613443|NCT00964821|stage III adult diffuse small cleaved cell lymphoma|stage iii adult diffuse small cleaved cell lymphoma
613444|NCT00964821|stage III adult Hodgkin lymphoma|stage iii adult hodgkin lymphoma
613445|NCT00964821|stage III adult immunoblastic large cell lymphoma|stage iii adult immunoblastic large cell lymphoma
613446|NCT00964821|stage III adult lymphoblastic lymphoma|stage iii adult lymphoblastic lymphoma
613447|NCT00964821|stage III grade 1 follicular lymphoma|stage iii grade 1 follicular lymphoma
613448|NCT00964821|stage III grade 2 follicular lymphoma|stage iii grade 2 follicular lymphoma
613449|NCT00964821|stage III grade 3 follicular lymphoma|stage iii grade 3 follicular lymphoma
613450|NCT00964821|stage III mantle cell lymphoma|stage iii mantle cell lymphoma
613451|NCT00964821|stage III marginal zone lymphoma|stage iii marginal zone lymphoma
613452|NCT00964821|stage III small lymphocytic lymphoma|stage iii small lymphocytic lymphoma
613453|NCT00964821|stage IV adult Burkitt lymphoma|stage iv adult burkitt lymphoma
613454|NCT00964821|stage IV adult diffuse large cell lymphoma|stage iv adult diffuse large cell lymphoma
613455|NCT00964821|stage IV adult diffuse mixed cell lymphoma|stage iv adult diffuse mixed cell lymphoma
613456|NCT00964821|stage IV adult diffuse small cleaved cell lymphoma|stage iv adult diffuse small cleaved cell lymphoma
613457|NCT00964821|stage IV adult Hodgkin lymphoma|stage iv adult hodgkin lymphoma
613458|NCT00964821|stage IV adult immunoblastic large cell lymphoma|stage iv adult immunoblastic large cell lymphoma
613459|NCT00964821|stage IV adult lymphoblastic lymphoma|stage iv adult lymphoblastic lymphoma
613460|NCT00964821|stage IV grade 1 follicular lymphoma|stage iv grade 1 follicular lymphoma
613461|NCT00964821|stage IV grade 2 follicular lymphoma|stage iv grade 2 follicular lymphoma
613462|NCT00964821|stage IV grade 3 follicular lymphoma|stage iv grade 3 follicular lymphoma
613463|NCT00964821|stage IV mantle cell lymphoma|stage iv mantle cell lymphoma
613464|NCT00964821|stage IV marginal zone lymphoma|stage iv marginal zone lymphoma
613465|NCT00964821|stage IV small lymphocytic lymphoma|stage iv small lymphocytic lymphoma
613466|NCT00964821|recurrent adult Burkitt lymphoma|recurrent adult burkitt lymphoma
613467|NCT00964821|recurrent adult diffuse large cell lymphoma|recurrent adult diffuse large cell lymphoma
613468|NCT00964821|recurrent adult diffuse mixed cell lymphoma|recurrent adult diffuse mixed cell lymphoma
613469|NCT00964821|recurrent adult diffuse small cleaved cell lymphoma|recurrent adult diffuse small cleaved cell lymphoma
613470|NCT00964821|recurrent adult Hodgkin lymphoma|recurrent adult hodgkin lymphoma
613471|NCT00964821|recurrent adult immunoblastic large cell lymphoma|recurrent adult immunoblastic large cell lymphoma
613472|NCT00964821|recurrent adult lymphoblastic lymphoma|recurrent adult lymphoblastic lymphoma
613473|NCT00964821|recurrent childhood large cell lymphoma|recurrent childhood large cell lymphoma
613474|NCT00964821|recurrent cutaneous T-cell non-Hodgkin lymphoma|recurrent cutaneous t-cell non-hodgkin lymphoma
613475|NCT00964821|recurrent grade 1 follicular lymphoma|recurrent grade 1 follicular lymphoma
613476|NCT00964821|recurrent grade 2 follicular lymphoma|recurrent grade 2 follicular lymphoma
613477|NCT00964821|recurrent grade 3 follicular lymphoma|recurrent grade 3 follicular lymphoma
613478|NCT00964821|recurrent mantle cell lymphoma|recurrent mantle cell lymphoma
613479|NCT00964821|recurrent marginal zone lymphoma|recurrent marginal zone lymphoma
613480|NCT00964821|recurrent small lymphocytic lymphoma|recurrent small lymphocytic lymphoma
613481|NCT00964821|recurrent mycosis fungoides/Sezary syndrome|recurrent mycosis fungoides/sezary syndrome
613482|NCT00964821|extranodal marginal zone B-cell lymphoma of mucosa-associated lymphoid tissue|extranodal marginal zone b-cell lymphoma of mucosa-associated lymphoid tissue
613483|NCT00964821|nodal marginal zone B-cell lymphoma|nodal marginal zone b-cell lymphoma
613484|NCT00964821|splenic marginal zone lymphoma|splenic marginal zone lymphoma
613485|NCT00964821|noncontiguous stage II adult Burkitt lymphoma|noncontiguous stage ii adult burkitt lymphoma
613486|NCT00964821|noncontiguous stage II adult diffuse large cell lymphoma|noncontiguous stage ii adult diffuse large cell lymphoma
613487|NCT00964821|noncontiguous stage II adult diffuse mixed cell lymphoma|noncontiguous stage ii adult diffuse mixed cell lymphoma
613488|NCT00964821|noncontiguous stage II adult diffuse small cleaved cell lymphoma|noncontiguous stage ii adult diffuse small cleaved cell lymphoma
613489|NCT00964821|noncontiguous stage II adult immunoblastic large cell lymphoma|noncontiguous stage ii adult immunoblastic large cell lymphoma
613490|NCT00964821|noncontiguous stage II adult lymphoblastic lymphoma|noncontiguous stage ii adult lymphoblastic lymphoma
613491|NCT00964821|noncontiguous stage II grade 1 follicular lymphoma|noncontiguous stage ii grade 1 follicular lymphoma
613492|NCT00964821|noncontiguous stage II grade 2 follicular lymphoma|noncontiguous stage ii grade 2 follicular lymphoma
613493|NCT00964821|noncontiguous stage II grade 3 follicular lymphoma|noncontiguous stage ii grade 3 follicular lymphoma
613494|NCT00964821|noncontiguous stage II mantle cell lymphoma|noncontiguous stage ii mantle cell lymphoma
613495|NCT00964821|noncontiguous stage II marginal zone lymphoma|noncontiguous stage ii marginal zone lymphoma
613496|NCT00964821|noncontiguous stage II small lymphocytic lymphoma|noncontiguous stage ii small lymphocytic lymphoma
613497|NCT00964821|accelerated phase chronic myelogenous leukemia|accelerated phase chronic myelogenous leukemia
613498|NCT00964821|adult acute lymphoblastic leukemia in remission|adult acute lymphoblastic leukemia in remission
613499|NCT00964821|adult acute myeloid leukemia in remission|adult acute myeloid leukemia in remission
613500|NCT00964821|adult acute myeloid leukemia with 11q23 (MLL) abnormalities|adult acute myeloid leukemia with 11q23 (mll) abnormalities
613501|NCT00964821|adult acute myeloid leukemia with inv(16)(p13;q22)|adult acute myeloid leukemia with inv(16)(p13;q22)
613502|NCT00964821|adult acute myeloid leukemia with t(15;17)(q22;q12)|adult acute myeloid leukemia with t(15;17)(q22;q12)
613589|NCT00964626|stage IIIA ovarian epithelial cancer|stage iiia ovarian epithelial cancer
613503|NCT00964821|adult acute myeloid leukemia with t(16;16)(p13;q22)|adult acute myeloid leukemia with t(16;16)(p13;q22)
613504|NCT00964821|adult acute myeloid leukemia with t(8;21)(q22;q22)|adult acute myeloid leukemia with t(8;21)(q22;q22)
613505|NCT00964821|atypical chronic myeloid leukemia, BCR-ABL negative|atypical chronic myeloid leukemia, bcr-abl negative
613506|NCT00964821|blastic phase chronic myelogenous leukemia|blastic phase chronic myelogenous leukemia
613507|NCT00964821|chronic myelomonocytic leukemia|chronic myelomonocytic leukemia
613508|NCT00964821|chronic phase chronic myelogenous leukemia|chronic phase chronic myelogenous leukemia
613509|NCT00964821|recurrent adult acute lymphoblastic leukemia|recurrent adult acute lymphoblastic leukemia
613510|NCT00964821|recurrent adult acute myeloid leukemia|recurrent adult acute myeloid leukemia
613511|NCT00964821|refractory chronic lymphocytic leukemia|refractory chronic lymphocytic leukemia
613512|NCT00964821|refractory hairy cell leukemia|refractory hairy cell leukemia
613513|NCT00964821|relapsing chronic myelogenous leukemia|relapsing chronic myelogenous leukemia
613514|NCT00964821|secondary acute myeloid leukemia|secondary acute myeloid leukemia
613515|NCT00964821|stage III chronic lymphocytic leukemia|stage iii chronic lymphocytic leukemia
613516|NCT00964821|stage IV chronic lymphocytic leukemia|stage iv chronic lymphocytic leukemia
613517|NCT00964821|chronic eosinophilic leukemia|chronic eosinophilic leukemia
613518|NCT00964821|primary myelofibrosis|primary myelofibrosis
613519|NCT00964821|chronic neutrophilic leukemia|chronic neutrophilic leukemia
613520|NCT00964821|de novo myelodysplastic syndromes|de novo myelodysplastic syndromes
613521|NCT00964821|myelodysplastic/myeloproliferative neoplasm, unclassifiable|myelodysplastic/myeloproliferative neoplasm, unclassifiable
613522|NCT00964821|previously treated myelodysplastic syndromes|previously treated myelodysplastic syndromes
613523|NCT00964821|secondary myelodysplastic syndromes|secondary myelodysplastic syndromes
613524|NCT00964821|stage I multiple myeloma|stage i multiple myeloma
613525|NCT00964821|stage II multiple myeloma|stage ii multiple myeloma
613526|NCT00964821|stage III multiple myeloma|stage iii multiple myeloma
613527|NCT00964821|refractory multiple myeloma|refractory multiple myeloma
613528|NCT00964821|aplastic anemia|aplastic anemia
613529|NCT00964808|Hip fractures|hip fractures
613530|NCT00964808|Treatment Outcome|treatment outcome
613531|NCT00964808|Painkiller|painkiller
613532|NCT00964795|Eyes|eyes
613533|NCT00964795|Neovascular|neovascular
613534|NCT00964795|Macular Degeneration|macular degeneration
613535|NCT00964795|Retina|retina
613536|NCT00964795|AMD|amd
613537|NCT00964795|VEGF Trap-Eye|vegf trap-eye
613538|NCT00964795|Best Corrected Visual Acuity|best corrected visual acuity
613539|NCT00964782|Fontan|fontan
613540|NCT00964782|sildenafil|sildenafil
613541|NCT00964782|exercise capacity|exercise capacity
613542|NCT00964782|Patients with Fontan Circulation|patients with fontan circulation
613543|NCT00964769|Pneumococcal Vaccine|pneumococcal vaccine
613544|NCT00964769|Aged|aged
613545|NCT00964756|ovarian cancer|ovarian cancer
613546|NCT00964756|Recurrent ovarian cancer and other gynecologic cancers|recurrent ovarian cancer and other gynecologic cancers
613547|NCT00964743|Neurologic Oncology|neurologic oncology
613548|NCT00964743|Neoplastic Meningitis from solid tumors|neoplastic meningitis from solid tumors
613549|NCT00964743|Brain and Nervous System|brain and nervous system
613550|NCT00964743|Breast Cancer|breast cancer
613551|NCT00964730|Thorough QT Study|thorough qt study
613552|NCT00964730|Talampanel|talampanel
613553|NCT00964730|Cardiac Repolarizatiom|cardiac repolarizatiom
613554|NCT00964730|Healthy Volunteers|healthy volunteers
613555|NCT00964717|back pain|back pain
613556|NCT00964717|neck pain|neck pain
613557|NCT00964717|anxiety|anxiety
613558|NCT00964717|range of motion|range of motion
613559|NCT00964691|malaria|malaria
613560|NCT00964691|IPTp|iptp
613561|NCT00964691|Fansidar|fansidar
613562|NCT00964691|Intermittent Preventive Treatment in pregnancy|intermittent preventive treatment in pregnancy
613563|NCT00964691|pregnancy|pregnancy
613564|NCT00964691|prophylaxis|prophylaxis
613565|NCT00964691|Chloroquine|chloroquine
613566|NCT00964691|Anemia|anemia
613567|NCT00964691|Prevention|prevention
613568|NCT00964691|Placental malaria|placental malaria
613569|NCT00964691|Solomon Islands|solomon islands
613570|NCT00964691|Low birth weight|low birth weight
613571|NCT00964665|Hepatitis B,|hepatitis b,
613572|NCT00964665|Chronic,|chronic,
613573|NCT00964665|Hepatitis B e Antigens positive|hepatitis b e antigens positive
613574|NCT00964652|treadmill|treadmill
613575|NCT00964652|body load|body load
613576|NCT00964652|Parkinson's disease|parkinson's disease
613577|NCT00964652|gait|gait
613578|NCT00964639|Pain|pain
613579|NCT00964639|Postoperative|postoperative
613580|NCT00964639|Local infiltration analgesia|local infiltration analgesia
613581|NCT00964639|Cerebral palsy|cerebral palsy
613582|NCT00964639|r-FLACC|r-flacc
613583|NCT00964626|stage IA ovarian epithelial cancer|stage ia ovarian epithelial cancer
613584|NCT00964626|stage IB ovarian epithelial cancer|stage ib ovarian epithelial cancer
613585|NCT00964626|stage IC ovarian epithelial cancer|stage ic ovarian epithelial cancer
613586|NCT00964626|stage IIA ovarian epithelial cancer|stage iia ovarian epithelial cancer
613587|NCT00964626|stage IIB ovarian epithelial cancer|stage iib ovarian epithelial cancer
613588|NCT00964626|stage IIC ovarian epithelial cancer|stage iic ovarian epithelial cancer
613688|NCT00964106|probe drug|probe drug
613590|NCT00964626|stage IIIB ovarian epithelial cancer|stage iiib ovarian epithelial cancer
613591|NCT00964626|stage IIIC ovarian epithelial cancer|stage iiic ovarian epithelial cancer
613592|NCT00964626|stage IV ovarian epithelial cancer|stage iv ovarian epithelial cancer
613593|NCT00964613|Pars Plana|pars plana
613594|NCT00964613|Surgical Capsulotomy|surgical capsulotomy
613595|NCT00964613|Posterior capsule opacification|posterior capsule opacification
613596|NCT00964613|visual outcome|visual outcome
613597|NCT00964613|Complications|complications
613598|NCT00964600|transversus abdominis block|transversus abdominis block
613599|NCT00964600|postoperative pain|postoperative pain
613600|NCT00964600|cesarean|cesarean
613601|NCT00964587|diabetes self management education|diabetes self management education
613602|NCT00964587|problem-solving training|problem-solving training
613603|NCT00964587|health behavior change|health behavior change
613604|NCT00964587|health literacy|health literacy
613605|NCT00964548|vasospasm|vasospasm
613606|NCT00964548|subarachnoid hemorrhage|subarachnoid hemorrhage
613607|NCT00964548|neurocritical care|neurocritical care
613608|NCT00964548|dantrolene|dantrolene
613609|NCT00964548|vasorelaxation|vasorelaxation
613610|NCT00964522|Quality of life|quality of life
613611|NCT00964522|Breast Cancer|breast cancer
613612|NCT00964522|Nursing Care|nursing care
613613|NCT00964522|Education|education
613614|NCT00964522|Chemotherapy|chemotherapy
613615|NCT00964496|vascular malformation|vascular malformation
613616|NCT00964496|gastrointestinal bleeding|gastrointestinal bleeding
613617|NCT00964496|thalidomide|thalidomide
613618|NCT00964483|Hypertension|hypertension
613619|NCT00964470|Burn, donor site, skin graft, dressing, AWBAT™-D, XEROFORM™, GLUCAN II™|burn, donor site, skin graft, dressing, awbat™-d, xeroform™, glucan ii™
613620|NCT00964457|cetuximab|cetuximab
613621|NCT00964457|rectum cancer|rectum cancer
613622|NCT00964457|radiation|radiation
613623|NCT00964457|MRI|mri
613624|NCT00964444|Labor and delivery|labor and delivery
613625|NCT00964444|Vaginal delivery|vaginal delivery
613626|NCT00964379|Intra versus extraperitoneal colostomy|intra versus extraperitoneal colostomy
613627|NCT00964353|coumadine|coumadine
613628|NCT00964353|genotype|genotype
613629|NCT00964353|genes|genes
613630|NCT00964353|Warfarin|warfarin
613631|NCT00964327|TMC114-C201|tmc114-c201
613632|NCT00964327|TMC114|tmc114
613633|NCT00964327|HIV|hiv
613634|NCT00964327|darunavir|darunavir
613635|NCT00964314|advanced cancer|advanced cancer
613636|NCT00964314|TCM five elements music therapy|tcm five elements music therapy
613637|NCT00964314|quality of life (QOL)|quality of life (qol)
613638|NCT00964301|Asthma|asthma
613639|NCT00964301|Low-income|low-income
613640|NCT00964301|Quality of life|quality of life
613641|NCT00964301|Children|children
613642|NCT00964288|electrical hyperalgesia|electrical hyperalgesia
613643|NCT00964288|threshold tracking|threshold tracking
613644|NCT00964288|pain|pain
613645|NCT00964275|unspecified adult solid tumor, protocol specific|unspecified adult solid tumor, protocol specific
613646|NCT00964275|thromboembolism|thromboembolism
613647|NCT00964262|diabetes|diabetes
613648|NCT00964262|exenatide|exenatide
613649|NCT00964262|SR exenatide|sr exenatide
613650|NCT00964262|Peptron|peptron
613651|NCT00964236|sapropterin|sapropterin
613652|NCT00964236|Kuvan|kuvan
613653|NCT00964236|cognition|cognition
613654|NCT00964236|brain|brain
613655|NCT00964223|Acne vulgaris|acne vulgaris
613895|NCT00963417|stage IA breast cancer|stage ia breast cancer
613656|NCT00964210|Juvenile Idiopathic Arthritis|juvenile idiopathic arthritis
613657|NCT00964210|Inflammatory Bowel Disease|inflammatory bowel disease
613658|NCT00964210|Acute Lymphoblastic Leukemia|acute lymphoblastic leukemia
613659|NCT00964210|Chronic Renal Disease|chronic renal disease
613660|NCT00964210|Solid Organ Transplant|solid organ transplant
613661|NCT00964197|FemmeJock|femmejock
613662|NCT00964197|Pelvic Organ Prolapse|pelvic organ prolapse
613663|NCT00964184|Maturity onset diabetes of the young 3 protein, human|maturity onset diabetes of the young 3 protein, human
613664|NCT00964171|adenocarcinoma of the pancreas|adenocarcinoma of the pancreas
613665|NCT00964171|recurrent pancreatic cancer|recurrent pancreatic cancer
613666|NCT00964171|stage IV pancreatic cancer|stage iv pancreatic cancer
613667|NCT00964158|influenza infection|influenza infection
613668|NCT00964158|GSK Bio's influenza vaccine GSK2340272A|gsk bio's influenza vaccine gsk2340272a
613669|NCT00964145|Nulliparous women|nulliparous women
613670|NCT00964145|ultrasound|ultrasound
613671|NCT00964132|Non-Small Cell Lung Cancer|non-small cell lung cancer
613672|NCT00964132|NSCLC|nsclc
613673|NCT00964132|Rexinoid|rexinoid
613674|NCT00964132|NRX194204|nrx194204
613675|NCT00964132|Lung Cancer|lung cancer
613676|NCT00964132|RXR|rxr
613677|NCT00964106|inducer|inducer
613678|NCT00964106|midazolam|midazolam
613679|NCT00964106|inhibitor|inhibitor
613680|NCT00964106|rosiglitazone|rosiglitazone
613681|NCT00964106|dextromethorphan|dextromethorphan
613682|NCT00964106|caffeine|caffeine
613683|NCT00964106|cocktail|cocktail
613684|NCT00964106|pioglitazone|pioglitazone
613685|NCT00964106|omeprazole|omeprazole
613686|NCT00964106|CYP|cyp
613687|NCT00964106|rosuvastatin|rosuvastatin
613690|NCT00964106|flurbiprofen|flurbiprofen
613691|NCT00964093|premature|premature
613692|NCT00964093|infection|infection
613693|NCT00964093|central line|central line
613694|NCT00964093|very low birth weight|very low birth weight
613695|NCT00964093|silver alginate|silver alginate
613696|NCT00964093|Algidex|algidex
613697|NCT00964093|neonatal|neonatal
613698|NCT00964093|NICU|nicu
613699|NCT00964067|rehabilitation outcome|rehabilitation outcome
613700|NCT00964067|cardiac patients|cardiac patients
613701|NCT00964067|exercise intensity|exercise intensity
613702|NCT00964054|adolescents|adolescents
613703|NCT00964054|exercise|exercise
613704|NCT00964054|depression|depression
613705|NCT00964054|dose response|dose response
613706|NCT00964054|pilot study|pilot study
613707|NCT00964041|Cognitive Impairment|cognitive impairment
613708|NCT00964041|Neuroplasticity|neuroplasticity
613709|NCT00964041|D-cycloserine|d-cycloserine
613710|NCT00964041|N-methyl-D-aspartate (NMDA)|n-methyl-d-aspartate (nmda)
613711|NCT00964041|Anti-Bacterial Agents|anti-bacterial agents
613712|NCT00964041|Mental Disorders|mental disorders
613713|NCT00964041|Psychotic Disorders|psychotic disorders
613714|NCT00964041|Antitubercular Agents|antitubercular agents
613715|NCT00964041|Schizophrenia and Disorders with Psychotic Features|schizophrenia and disorders with psychotic features
613716|NCT00964041|Schizoaffective Disorder|schizoaffective disorder
613717|NCT00964028|Combined vaccine|combined vaccine
613718|NCT00964015|colloid fluid|colloid fluid
613719|NCT00964015|crystalloid fluid|crystalloid fluid
613720|NCT00964015|surgery|surgery
613721|NCT00964015|coronary artery bypass grafting|coronary artery bypass grafting
613722|NCT00964015|renal function|renal function
613723|NCT00964015|Patients undergoing coronary artery bypass surgery|patients undergoing coronary artery bypass surgery
613724|NCT00964002|recurrent prostate cancer|recurrent prostate cancer
613725|NCT00964002|stage IV prostate cancer|stage iv prostate cancer
613726|NCT00963989|Acute stroke|acute stroke
613727|NCT00963989|Large cerebral vessel occlusion|large cerebral vessel occlusion
613728|NCT00963989|Core infarct volume|core infarct volume
613729|NCT00963989|Penumbra System|penumbra system
613730|NCT00963989|Revascularization|revascularization
613731|NCT00963989|Intracerebral hemorrhage|intracerebral hemorrhage
613732|NCT00963989|mRS|mrs
613733|NCT00963989|NIHSS|nihss
613734|NCT00963989|Procedural serious adverse events|procedural serious adverse events
613735|NCT00963989|All cause mortality|all cause mortality
613736|NCT00963976|Stroke|stroke
613737|NCT00963976|Hypertension|hypertension
613738|NCT00963976|Cerebral Blood Flow|cerebral blood flow
613739|NCT00963976|CT Perfusion|ct perfusion
613740|NCT00963963|sexual health|sexual health
613741|NCT00963963|adolescent health|adolescent health
613742|NCT00963963|parent education|parent education
613743|NCT00963963|HIV Seronegativity|hiv seronegativity
613744|NCT00963963|treatment experienced|treatment experienced
613745|NCT00963950|cholecystectomy|cholecystectomy
613746|NCT00963937|adolescent|adolescent
613747|NCT00963937|sumatriptan|sumatriptan
613748|NCT00963937|children|children
613749|NCT00963937|migraine|migraine
613750|NCT00963924|Cognitive Impairment|cognitive impairment
613751|NCT00963924|Neuroplasticity|neuroplasticity
613752|NCT00963924|D-cycloserine|d-cycloserine
613753|NCT00963924|NMDA|nmda
613754|NCT00963924|Anti-Bacterial Agents|anti-bacterial agents
613755|NCT00963924|Mental Disorders|mental disorders
613756|NCT00963924|Psychotic Disorders|psychotic disorders
613757|NCT00963924|Antitubercular Agents|antitubercular agents
613758|NCT00963924|Schizophrenia and Disorders with Psychotic Features|schizophrenia and disorders with psychotic features
613759|NCT00963924|Schizoaffective Disorder|schizoaffective disorder
613760|NCT00963911|colon cancer|colon cancer
613761|NCT00963911|rectal cancer|rectal cancer
613762|NCT00963911|non-small cell lung cancer|non-small cell lung cancer
613763|NCT00963911|small cell lung cancer|small cell lung cancer
613764|NCT00963911|hypopharyngeal squamous cell carcinoma|hypopharyngeal squamous cell carcinoma
613765|NCT00963911|laryngeal squamous cell carcinoma|laryngeal squamous cell carcinoma
613766|NCT00963911|laryngeal verrucous carcinoma|laryngeal verrucous carcinoma
613767|NCT00963911|lip and oral cavity squamous cell carcinoma|lip and oral cavity squamous cell carcinoma
613768|NCT00963911|oral cavity verrucous carcinoma|oral cavity verrucous carcinoma
613769|NCT00963911|nasopharyngeal squamous cell carcinoma|nasopharyngeal squamous cell carcinoma
613770|NCT00963911|oropharyngeal squamous cell carcinoma|oropharyngeal squamous cell carcinoma
613771|NCT00963911|paranasal sinus and nasal cavity squamous cell carcinoma|paranasal sinus and nasal cavity squamous cell carcinoma
613772|NCT00963911|salivary gland squamous cell carcinoma|salivary gland squamous cell carcinoma
613773|NCT00963911|prostate cancer|prostate cancer
613774|NCT00963911|breast cancer|breast cancer
613775|NCT00963911|adult non-Hodgkin lymphoma|adult non-hodgkin lymphoma
613776|NCT00963898|Intravenous sedation|intravenous sedation
613777|NCT00963898|Target controlled infusion|target controlled infusion
613778|NCT00963898|Bispectral index|bispectral index
613779|NCT00963898|Dental treatment|dental treatment
613780|NCT00963898|Mental Retardation|mental retardation
613781|NCT00963898|Deep sedation|deep sedation
613872|NCT00963495|clioquinol|clioquinol
613782|NCT00963859|Robotic-assisted laparoscopic surgery|robotic-assisted laparoscopic surgery
613783|NCT00963859|Extended pelvic lymph node dissection|extended pelvic lymph node dissection
613784|NCT00963859|RA-PLND|ra-plnd
613785|NCT00963859|Second-look open lymph node dissection|second-look open lymph node dissection
613786|NCT00963859|O-PLND|o-plnd
613787|NCT00963859|Radical Cystectomy|radical cystectomy
613788|NCT00963859|Urinary diversion|urinary diversion
613789|NCT00963859|Bladder|bladder
613790|NCT00963846|schizophrenia|schizophrenia
613791|NCT00963846|cognition|cognition
613792|NCT00963846|functioning|functioning
613793|NCT00963833|Multiple Sclerosis|multiple sclerosis
613795|NCT00963833|Non-interventional|non-interventional
613796|NCT00963820|Relapsed multiple myeloma|relapsed multiple myeloma
613797|NCT00963820|Refractory multiple myeloma|refractory multiple myeloma
613798|NCT00963820|Drug therapy|drug therapy
613799|NCT00963794|Rectal cancer|rectal cancer
613800|NCT00963794|Population screening|population screening
613801|NCT00963794|Early detection|early detection
613802|NCT00963781|Coronary Artery Disease|coronary artery disease
613803|NCT00963781|Drug-Eluting Stents|drug-eluting stents
613804|NCT00963781|Coronary Thrombosis|coronary thrombosis
613805|NCT00963781|Platelet Aggregation Inhibitors|platelet aggregation inhibitors
613806|NCT00963781|Coronary Restenosis|coronary restenosis
613807|NCT00963768|Diabetes Mellitus, Type 2|diabetes mellitus, type 2
613808|NCT00963768|JNJ-28431754|jnj-28431754
613809|NCT00963768|Canagliflozin|canagliflozin
613810|NCT00963768|Sodium Glucose Co-transporter (SGLT2 inhibitor)|sodium glucose co-transporter (sglt2 inhibitor)
613811|NCT00963768|Pharmacokinetics|pharmacokinetics
613812|NCT00963768|Pharmacodynamics|pharmacodynamics
613813|NCT00963755|Imaging|imaging
613814|NCT00963755|Positron emission tomography|positron emission tomography
613815|NCT00963755|F-18-FCH|f-18-fch
613816|NCT00963755|Magnetic resonance imaging|magnetic resonance imaging
613817|NCT00963755|Magnetic resonance spectroscopy|magnetic resonance spectroscopy
613818|NCT00963742|cataract surgery|cataract surgery
613819|NCT00963742|IOL|iol
613820|NCT00963742|Intraocular lens|intraocular lens
613821|NCT00963729|estrogen receptor-positive breast cancer|estrogen receptor-positive breast cancer
613822|NCT00963729|recurrent breast cancer|recurrent breast cancer
613823|NCT00963729|stage II breast cancer|stage ii breast cancer
613824|NCT00963729|stage IIIA breast cancer|stage iiia breast cancer
613825|NCT00963729|stage IIIB breast cancer|stage iiib breast cancer
613826|NCT00963729|stage IIIC breast cancer|stage iiic breast cancer
613827|NCT00963716|endobronchial biopsy|endobronchial biopsy
613828|NCT00963716|bronchoscopy|bronchoscopy
613829|NCT00963716|interventional pulmonology|interventional pulmonology
613830|NCT00963677|Shikani optical stylet(SOS)|shikani optical stylet(sos)
613831|NCT00963677|difficult airways|difficult airways
613832|NCT00963677|intubation|intubation
613833|NCT00963664|melanoma|melanoma
613834|NCT00963664|malignant melanoma|malignant melanoma
613835|NCT00963664|interferon|interferon
613836|NCT00963664|interferon alfa-2b|interferon alfa-2b
613837|NCT00963664|Intron-A|intron-a
613838|NCT00963664|Intron A|intron a
613839|NCT00963664|Intron|intron
613840|NCT00963664|lovastatin|lovastatin
613841|NCT00963664|mevinolin|mevinolin
613842|NCT00963664|Mevacor|mevacor
613843|NCT00963664|statin|statin
613844|NCT00963664|HRI|hri
613845|NCT00963651|Pulmonary nodule, solitary|pulmonary nodule, solitary
613846|NCT00963651|Multiple pulmonary nodules|multiple pulmonary nodules
613847|NCT00963625|Blastocyst transfer|blastocyst transfer
613848|NCT00963625|endometrial receptivity|endometrial receptivity
613849|NCT00963625|IVF|ivf
613850|NCT00963625|in vitro fertilization|in vitro fertilization
613851|NCT00963625|embryo cryopreservation|embryo cryopreservation
613852|NCT00963612|Microvascular Invasion|microvascular invasion
613853|NCT00963612|Blood-Oxygen-Level Dependent Magnetic Resonance Imaging (BOLD MRI)|blood-oxygen-level dependent magnetic resonance imaging (bold mri)
613854|NCT00963560|ReSTOR +3|restor +3
613855|NCT00963547|Documented to be HER2+|documented to be her2+
613856|NCT00963534|Mantle cell lymphoma|mantle cell lymphoma
613857|NCT00963534|Lenalidomide|lenalidomide
613858|NCT00963534|Bendamustine|bendamustine
613859|NCT00963534|Rituximab|rituximab
613860|NCT00963534|Nordic Lymphoma Group|nordic lymphoma group
613861|NCT00963534|MTD for lenalidomide|mtd for lenalidomide
613862|NCT00963534|Untreated patients|untreated patients
613863|NCT00963534|Patients with mantle cell lymphoma, age over 65 years|patients with mantle cell lymphoma, age over 65 years
780295|NCT00328640|CVA|cva
613864|NCT00963521|adult acute myelomonocytic leukemia (M4)|adult acute myelomonocytic leukemia (m4)
613865|NCT00963521|adult acute monoblastic leukemia (M5a)|adult acute monoblastic leukemia (m5a)
613866|NCT00963521|adult acute monocytic leukemia (M5b)|adult acute monocytic leukemia (m5b)
613867|NCT00963521|adult acute myeloid leukemia in remission|adult acute myeloid leukemia in remission
613868|NCT00963521|adult acute myeloid leukemia with 11q23 (MLL) abnormalities|adult acute myeloid leukemia with 11q23 (mll) abnormalities
613869|NCT00963521|adult acute myeloid leukemia with inv(16)(p13;q22)|adult acute myeloid leukemia with inv(16)(p13;q22)
613870|NCT00963521|adult acute myeloid leukemia with t(16;16)(p13;q22)|adult acute myeloid leukemia with t(16;16)(p13;q22)
613871|NCT00963508|Head Lice|head lice
613873|NCT00963495|relapsed and refractory hematologic malignancy|relapsed and refractory hematologic malignancy
613874|NCT00963495|ALL|all
613875|NCT00963495|HD|hd
613876|NCT00963495|CLL|cll
613877|NCT00963495|High risk myelodysplasia (MDS) with an IPSS score >2.5|high risk myelodysplasia (mds) with an ipss score >2.5
613878|NCT00963495|CML blast crisis|cml blast crisis
613879|NCT00963495|Relapsed or refractory acute myeloid leukemia (AML)|relapsed or refractory acute myeloid leukemia (aml)
613880|NCT00963482|Smoking|smoking
613881|NCT00963482|Alcohol|alcohol
613882|NCT00963482|Outcome|outcome
613883|NCT00963482|Harm reduction|harm reduction
613884|NCT00963482|Alcohol drinking|alcohol drinking
613885|NCT00963482|Treatment outcome|treatment outcome
613886|NCT00963482|Treatment effectiveness|treatment effectiveness
613887|NCT00963443|Aspirin Complex|aspirin complex
613888|NCT00963443|Acetylsalicylic Acid|acetylsalicylic acid
613889|NCT00963443|Pseudoephedrine|pseudoephedrine
613890|NCT00963443|Common Cold|common cold
613891|NCT00963430|H1N1, influenza A viruses, pregnant women|h1n1, influenza a viruses, pregnant women
613892|NCT00963417|osteoporosis|osteoporosis
613893|NCT00963417|estrogen receptor-positive breast cancer|estrogen receptor-positive breast cancer
613894|NCT00963417|progesterone receptor-positive breast cancer|progesterone receptor-positive breast cancer
613896|NCT00963417|stage IB breast cancer|stage ib breast cancer
613897|NCT00963417|stage II breast cancer|stage ii breast cancer
613898|NCT00963417|stage IIIA breast cancer|stage iiia breast cancer
613899|NCT00963404|Image-guided Radiotherapy|image-guided radiotherapy
613900|NCT00963404|Fiducial marker|fiducial marker
613901|NCT00963404|Adverse effects|adverse effects
613902|NCT00963391|Health Production|health production
613903|NCT00963391|Government Policy; Regulation; Public Health|government policy; regulation; public health
613904|NCT00963391|Government Policy; Provision and Effects of Welfare Programs|government policy; provision and effects of welfare programs
613905|NCT00963391|Gastrointestinal diseases|gastrointestinal diseases
613906|NCT00963391|Respiratory Tract Infections|respiratory tract infections
613907|NCT00963391|Diarrhea|diarrhea
613908|NCT00963391|Ethanol|ethanol
613909|NCT00963391|Child, Preschool|child, preschool
613910|NCT00963391|Handwashing|handwashing
613911|NCT00963365|Phase 1|phase 1
613912|NCT00963365|Healthy volunteers|healthy volunteers
613913|NCT00963352|Colon cancer|colon cancer
613914|NCT00963352|Open surgery resection|open surgery resection
613915|NCT00963352|Laparoscopic surgery resection|laparoscopic surgery resection
613916|NCT00963352|Morbidity|morbidity
613917|NCT00963352|Mortality|mortality
613918|NCT00963352|Metastases|metastases
613919|NCT00963352|Oncology|oncology
613920|NCT00963352|Freedom of malignant disease recurrence|freedom of malignant disease recurrence
613921|NCT00963352|Safety of intervention open and laparoscopic|safety of intervention open and laparoscopic
613922|NCT00963352|Examination of adverse markers|examination of adverse markers
613923|NCT00963352|Development of metastases in lungs and other organs|development of metastases in lungs and other organs
613924|NCT00963339|AMD|amd
613925|NCT00963326|stage I squamous cell carcinoma of the hypopharynx|stage i squamous cell carcinoma of the hypopharynx
613926|NCT00963326|stage I squamous cell carcinoma of the larynx|stage i squamous cell carcinoma of the larynx
613927|NCT00963326|stage I squamous cell carcinoma of the nasopharynx|stage i squamous cell carcinoma of the nasopharynx
613928|NCT00963326|stage I squamous cell carcinoma of the oropharynx|stage i squamous cell carcinoma of the oropharynx
613929|NCT00963326|stage II squamous cell carcinoma of the hypopharynx|stage ii squamous cell carcinoma of the hypopharynx
613930|NCT00963326|stage II squamous cell carcinoma of the larynx|stage ii squamous cell carcinoma of the larynx
613931|NCT00963326|stage II squamous cell carcinoma of the nasopharynx|stage ii squamous cell carcinoma of the nasopharynx
613932|NCT00963326|stage II squamous cell carcinoma of the oropharynx|stage ii squamous cell carcinoma of the oropharynx
613933|NCT00963326|stage III squamous cell carcinoma of the hypopharynx|stage iii squamous cell carcinoma of the hypopharynx
613934|NCT00963326|stage III squamous cell carcinoma of the larynx|stage iii squamous cell carcinoma of the larynx
613935|NCT00963326|stage III squamous cell carcinoma of the nasopharynx|stage iii squamous cell carcinoma of the nasopharynx
613936|NCT00963326|stage III squamous cell carcinoma of the oropharynx|stage iii squamous cell carcinoma of the oropharynx
613937|NCT00963326|stage IV squamous cell carcinoma of the hypopharynx|stage iv squamous cell carcinoma of the hypopharynx
613938|NCT00963326|stage IV squamous cell carcinoma of the larynx|stage iv squamous cell carcinoma of the larynx
613939|NCT00963326|stage IV squamous cell carcinoma of the nasopharynx|stage iv squamous cell carcinoma of the nasopharynx
613940|NCT00963326|stage IV squamous cell carcinoma of the oropharynx|stage iv squamous cell carcinoma of the oropharynx
613941|NCT00963326|recurrent squamous cell carcinoma of the hypopharynx|recurrent squamous cell carcinoma of the hypopharynx
613942|NCT00963326|recurrent squamous cell carcinoma of the larynx|recurrent squamous cell carcinoma of the larynx
613943|NCT00963326|recurrent squamous cell carcinoma of the nasopharynx|recurrent squamous cell carcinoma of the nasopharynx
613944|NCT00963326|recurrent squamous cell carcinoma of the oropharynx|recurrent squamous cell carcinoma of the oropharynx
613945|NCT00963326|recurrent verrucous carcinoma of the oral cavity|recurrent verrucous carcinoma of the oral cavity
613946|NCT00963326|stage I verrucous carcinoma of the oral cavity|stage i verrucous carcinoma of the oral cavity
613947|NCT00963326|stage II verrucous carcinoma of the oral cavity|stage ii verrucous carcinoma of the oral cavity
614030|NCT00963092|stage III esophageal cancer|stage iii esophageal cancer
613948|NCT00963326|stage III verrucous carcinoma of the oral cavity|stage iii verrucous carcinoma of the oral cavity
613949|NCT00963326|stage IV verrucous carcinoma of the oral cavity|stage iv verrucous carcinoma of the oral cavity
613950|NCT00963326|recurrent verrucous carcinoma of the larynx|recurrent verrucous carcinoma of the larynx
613951|NCT00963326|stage I verrucous carcinoma of the larynx|stage i verrucous carcinoma of the larynx
613952|NCT00963326|stage II verrucous carcinoma of the larynx|stage ii verrucous carcinoma of the larynx
613953|NCT00963326|stage III verrucous carcinoma of the larynx|stage iii verrucous carcinoma of the larynx
613954|NCT00963326|stage IV verrucous carcinoma of the larynx|stage iv verrucous carcinoma of the larynx
613955|NCT00963326|tongue cancer|tongue cancer
613956|NCT00963313|Axial psoriatic arthritis|axial psoriatic arthritis
613957|NCT00963313|Adalimumab|adalimumab
613958|NCT00963313|Humira|humira
613959|NCT00963313|anti-TNF|anti-tnf
613960|NCT00963300|adenocarcinoma of the prostate|adenocarcinoma of the prostate
613961|NCT00963300|stage I prostate cancer|stage i prostate cancer
613962|NCT00963300|stage IIB prostate cancer|stage iib prostate cancer
613963|NCT00963300|stage IIA prostate cancer|stage iia prostate cancer
613964|NCT00963300|stage III prostate cancer|stage iii prostate cancer
613965|NCT00963300|stage IV prostate cancer|stage iv prostate cancer
613966|NCT00963287|alternative medicine|alternative medicine
613967|NCT00963287|traditional Chinese medicine|traditional chinese medicine
613968|NCT00963274|refractory chronic lymphocytic leukemia|refractory chronic lymphocytic leukemia
613969|NCT00963274|stage I chronic lymphocytic leukemia|stage i chronic lymphocytic leukemia
613970|NCT00963274|stage II chronic lymphocytic leukemia|stage ii chronic lymphocytic leukemia
613971|NCT00963274|stage III chronic lymphocytic leukemia|stage iii chronic lymphocytic leukemia
613972|NCT00963274|stage IV chronic lymphocytic leukemia|stage iv chronic lymphocytic leukemia
613973|NCT00963274|recurrent small lymphocytic lymphoma|recurrent small lymphocytic lymphoma
613974|NCT00963274|contiguous stage II small lymphocytic lymphoma|contiguous stage ii small lymphocytic lymphoma
613975|NCT00963274|noncontiguous stage II small lymphocytic lymphoma|noncontiguous stage ii small lymphocytic lymphoma
613976|NCT00963274|stage I small lymphocytic lymphoma|stage i small lymphocytic lymphoma
613977|NCT00963274|stage III small lymphocytic lymphoma|stage iii small lymphocytic lymphoma
613978|NCT00963274|stage IV small lymphocytic lymphoma|stage iv small lymphocytic lymphoma
613979|NCT00963274|adult nasal type extranodal NK/T-cell lymphoma|adult nasal type extranodal nk/t-cell lymphoma
613980|NCT00963274|anaplastic large cell lymphoma|anaplastic large cell lymphoma
613981|NCT00963274|angioimmunoblastic T-cell lymphoma|angioimmunoblastic t-cell lymphoma
613982|NCT00963274|extranodal marginal zone B-cell lymphoma of mucosa-associated lymphoid tissue|extranodal marginal zone b-cell lymphoma of mucosa-associated lymphoid tissue
613983|NCT00963274|hepatosplenic T-cell lymphoma|hepatosplenic t-cell lymphoma
613984|NCT00963274|nodal marginal zone B-cell lymphoma|nodal marginal zone b-cell lymphoma
613985|NCT00963274|peripheral T-cell lymphoma|peripheral t-cell lymphoma
613986|NCT00963261|melanoma|melanoma
613987|NCT00963261|interferon-a|interferon-a
613988|NCT00963261|quality of life|quality of life
613989|NCT00963261|psychological distress|psychological distress
613990|NCT00963261|depressive symptoms|depressive symptoms
613991|NCT00963261|side effects|side effects
613992|NCT00963248|EBV|ebv
613993|NCT00963248|PTLD|ptld
613994|NCT00963248|RTx|rtx
613995|NCT00963248|pediatric|pediatric
613996|NCT00963235|vaccine|vaccine
613997|NCT00963235|13-valent pneumococcal conjugate vaccine|13-valent pneumococcal conjugate vaccine
613998|NCT00963235|human immunodeficiency virus|human immunodeficiency virus
613999|NCT00963222|Atherosclerosis|atherosclerosis
614000|NCT00963222|Coronary Artery Disease|coronary artery disease
614001|NCT00963222|Vitamin A|vitamin a
614002|NCT00963222|CD4-Positive T-Lymphocytes|cd4-positive t-lymphocytes
614003|NCT00963222|Th1 Cells|th1 cells
614004|NCT00963222|Th2 Cells|th2 cells
614005|NCT00963209|endocrine sensitive|endocrine sensitive
614006|NCT00963209|breast cancer|breast cancer
614007|NCT00963209|tamoxifen|tamoxifen
614008|NCT00963209|genotyping|genotyping
614009|NCT00963209|phenotyping|phenotyping
614010|NCT00963209|Pharmacokinetics|pharmacokinetics
614011|NCT00963209|Endoxifen|endoxifen
614012|NCT00963183|Safety|safety
614013|NCT00963183|Tolerability|tolerability
614014|NCT00963183|Healthy|healthy
614015|NCT00963183|Inhalation|inhalation
614016|NCT00963157|H1N1, influenza A viruses, vaccine, elderly|h1n1, influenza a viruses, vaccine, elderly
614017|NCT00963144|Gerd Questionnaire|gerd questionnaire
614018|NCT00963131|Central serous chorioretinopathy,antioxidants|central serous chorioretinopathy,antioxidants
614019|NCT00963118|Angelica keiskei|angelica keiskei
614020|NCT00963118|Glycine max|glycine max
614021|NCT00963118|metabolic syndrome|metabolic syndrome
614022|NCT00963092|adenocarcinoma of the gastroesophageal junction|adenocarcinoma of the gastroesophageal junction
614023|NCT00963092|recurrent gastric cancer|recurrent gastric cancer
614024|NCT00963092|stage IV gastric cancer|stage iv gastric cancer
614025|NCT00963092|adenocarcinoma of the stomach|adenocarcinoma of the stomach
614026|NCT00963092|adenocarcinoma of the esophagus|adenocarcinoma of the esophagus
614027|NCT00963092|recurrent esophageal cancer|recurrent esophageal cancer
614028|NCT00963092|stage I esophageal cancer|stage i esophageal cancer
614029|NCT00963092|stage II esophageal cancer|stage ii esophageal cancer
614128|NCT00962715|TIV|tiv
614031|NCT00963092|stage IV esophageal cancer|stage iv esophageal cancer
614032|NCT00963092|stage IA gastric cancer|stage ia gastric cancer
614033|NCT00963092|stage IB gastric cancer|stage ib gastric cancer
614034|NCT00963092|stage IIA gastric cancer|stage iia gastric cancer
614035|NCT00963092|stage IIB gastric cancer|stage iib gastric cancer
614036|NCT00963092|stage IIIA gastric cancer|stage iiia gastric cancer
614037|NCT00963092|stage IIIB gastric cancer|stage iiib gastric cancer
614038|NCT00963092|stage IIIC gastric cancer|stage iiic gastric cancer
614039|NCT00963079|IVF|ivf
614040|NCT00963079|in vitro fertilization|in vitro fertilization
614041|NCT00963079|blastocyst transfer|blastocyst transfer
614042|NCT00963079|endometrial receptivity|endometrial receptivity
614043|NCT00963079|embryo cryopreservation|embryo cryopreservation
614044|NCT00963066|NAVA|nava
614045|NCT00963066|Acute Lung Injury|acute lung injury
614046|NCT00963066|Pressure Support Ventilation|pressure support ventilation
614047|NCT00963066|Intubation|intubation
614048|NCT00963066|Tracheostomy|tracheostomy
614049|NCT00963066|Mechanical ventilation|mechanical ventilation
614050|NCT00963053|dysmenorrhoea|dysmenorrhoea
614051|NCT00963053|dysmenorrhea|dysmenorrhea
614052|NCT00963053|pain|pain
614053|NCT00963053|pre-emptive|pre-emptive
614054|NCT00963040|intranasal oxytocin|intranasal oxytocin
614055|NCT00963040|acute headache treatment|acute headache treatment
614056|NCT00963040|chronic daily headache|chronic daily headache
614057|NCT00963027|Hypertension, Pulmonary|hypertension, pulmonary
614058|NCT00963027|Treprostinil|treprostinil
614059|NCT00963027|Pharmacokinetics|pharmacokinetics
614060|NCT00963027|Treprostinil Diethanolamine|treprostinil diethanolamine
614061|NCT00963027|Pulmonary Arterial Hypertension|pulmonary arterial hypertension
614062|NCT00963027|Esomeprazole|esomeprazole
614063|NCT00963001|Hypertension, Pulmonary|hypertension, pulmonary
614064|NCT00963001|Treprostinil|treprostinil
614065|NCT00963001|Pharmacokinetics|pharmacokinetics
614066|NCT00963001|Treprostinil Diethanolamine|treprostinil diethanolamine
614067|NCT00963001|Pulmonary Arterial Hypertension|pulmonary arterial hypertension
614068|NCT00962988|Cerebrovascular disease|cerebrovascular disease
614069|NCT00962988|stroke|stroke
614070|NCT00962988|Transient Ischemic Attack|transient ischemic attack
614071|NCT00962988|smoking cessation|smoking cessation
614072|NCT00962988|Pharmacotherapy|pharmacotherapy
614073|NCT00962962|Abnormal fasting glucose|abnormal fasting glucose
614074|NCT00962949|POTS|pots
614075|NCT00962949|Orthostatic intolerance|orthostatic intolerance
614076|NCT00962936|Chronic Hepatitis C|chronic hepatitis c
614077|NCT00962936|HCV Genotype I infection|hcv genotype i infection
614078|NCT00962936|Liver disease|liver disease
614079|NCT00962923|Systemic sclerosis|systemic sclerosis
614080|NCT00962923|Mesenchymal Stem Cells|mesenchymal stem cells
614081|NCT00962923|Transplantation|transplantation
614082|NCT00962910|Femoral Fractures|femoral fractures
614083|NCT00962910|Critical Pathway|critical pathway
614084|NCT00962910|Cluster Randomized Controlled Trial|cluster randomized controlled trial
614085|NCT00962910|Safety|safety
614086|NCT00962910|Efficiency|efficiency
614087|NCT00962897|atherosclerosis|atherosclerosis
614088|NCT00962897|covered stent|covered stent
614089|NCT00962897|percutaneous intervention|percutaneous intervention
614090|NCT00962897|stent|stent
614091|NCT00962897|angioplasty|angioplasty
614092|NCT00962884|Orthostatic hypotension|orthostatic hypotension
614093|NCT00962884|Breathing|breathing
614094|NCT00962884|Blood pressure|blood pressure
614095|NCT00962884|standing|standing
614096|NCT00962845|stage III melanoma|stage iii melanoma
614097|NCT00962845|stage IV melanoma|stage iv melanoma
614098|NCT00962832|rhuMAb IFNalpha|rhumab ifnalpha
614099|NCT00962832|SLE|sle
614100|NCT00962819|Mumps|mumps
614101|NCT00962819|Immunity|immunity
614102|NCT00962819|Vaccine|vaccine
614103|NCT00962819|Mumps antibodies|mumps antibodies
614104|NCT00962819|Mumps immunity|mumps immunity
614105|NCT00962806|Pediatric obesity|pediatric obesity
614106|NCT00962806|Insulin resistance|insulin resistance
614107|NCT00962806|Diabetes|diabetes
614108|NCT00962806|Mitochondria|mitochondria
614109|NCT00962793|latent tuberculosis prevalence of health care workers|latent tuberculosis prevalence of health care workers
614110|NCT00962780|vaccine|vaccine
614111|NCT00962780|13-valent pneumococcal conjugate vaccine|13-valent pneumococcal conjugate vaccine
614112|NCT00962780|23-valent pneumococcal polysaccharide vaccine|23-valent pneumococcal polysaccharide vaccine
614113|NCT00962780|human immunodeficiency virus|human immunodeficiency virus
614114|NCT00962767|Oncology comparison study|oncology comparison study
614115|NCT00962754|recording fluid balance|recording fluid balance
614116|NCT00962754|reliability|reliability
614117|NCT00962754|utility|utility
614118|NCT00962754|sick neonate|sick neonate
614119|NCT00962754|fluid balance|fluid balance
614120|NCT00962754|inpatient|inpatient
614121|NCT00962754|sick|sick
614122|NCT00962728|heart rate|heart rate
614123|NCT00962728|tachycardia|tachycardia
614124|NCT00962728|orthostatic intolerance|orthostatic intolerance
614125|NCT00962715|Leukemia|leukemia
614126|NCT00962715|CLL|cll
614127|NCT00962715|Influenza Vaccine Trivalent Inactivated|influenza vaccine trivalent inactivated
614130|NCT00962715|Pegasys|pegasys
614131|NCT00962715|Pegylated interferon|pegylated interferon
614132|NCT00962715|Roferon|roferon
614133|NCT00962715|Interferon|interferon
614134|NCT00962702|Exclusion|exclusion
614135|NCT00962702|Left Atrial Appendage|left atrial appendage
614136|NCT00962702|Surgical|surgical
614137|NCT00962702|Open chest|open chest
614138|NCT00962689|chronic rhinosinusitis|chronic rhinosinusitis
614139|NCT00962689|biofilm|biofilm
614140|NCT00962689|sinus tissue|sinus tissue
614141|NCT00962689|nasal secretions|nasal secretions
614142|NCT00962689|proteomics|proteomics
614143|NCT00962689|diagnosis|diagnosis
614144|NCT00962689|decreased antibiotics|decreased antibiotics
614145|NCT00962689|Develop a test to identify patients with sinusitis subtypes|develop a test to identify patients with sinusitis subtypes
614146|NCT00962676|suspicious of tuberculosis|suspicious of tuberculosis
614147|NCT00962676|immunocompromised patients|immunocompromised patients
614148|NCT00962650|abdominal adhesions|abdominal adhesions
614149|NCT00962650|diagnostic peritoneoscopy|diagnostic peritoneoscopy
614150|NCT00962650|Natural Orifice Transluminal Endoscopic Surgery|natural orifice transluminal endoscopic surgery
614151|NCT00962650|NOTES|notes
614152|NCT00962637|Secondary Hypogonadism|secondary hypogonadism
614153|NCT00962624|Meningococcal|meningococcal
614154|NCT00962624|Vaccine|vaccine
614155|NCT00962624|Meningitis|meningitis
614156|NCT00962611|Solid tumors|solid tumors
614157|NCT00962611|Advanced cancer|advanced cancer
614158|NCT00962598|Adolescents|adolescents
614159|NCT00962598|Major Depressive Disorder|major depressive disorder
614160|NCT00962598|Proton Magnetic Resonance Spectroscopy|proton magnetic resonance spectroscopy
614161|NCT00962598|Immune System Activation|immune system activation
614162|NCT00962598|Omega-3 Fatty Acids|omega-3 fatty acids
614163|NCT00962572|Outcomes|outcomes
614164|NCT00962572|Cancer|cancer
614165|NCT00962572|Radiotherapy|radiotherapy
614166|NCT00962572|Socio-economic|socio-economic
614167|NCT00962546|cerebral aneurysm|cerebral aneurysm
614168|NCT00962546|subarachnoid hemorrhage|subarachnoid hemorrhage
614169|NCT00962546|cerebral vasospasm|cerebral vasospasm
614170|NCT00962546|computed tomographic perfusion|computed tomographic perfusion
614171|NCT00962546|computed tomographic angiography|computed tomographic angiography
614172|NCT00962533|Chronic Hepatitis B|chronic hepatitis b
614173|NCT00962507|recurrent adult T-cell leukemia/lymphoma|recurrent adult t-cell leukemia/lymphoma
614174|NCT00962507|adult nasal type extranodal NK/T-cell lymphoma|adult nasal type extranodal nk/t-cell lymphoma
614175|NCT00962507|anaplastic large cell lymphoma|anaplastic large cell lymphoma
614176|NCT00962507|angioimmunoblastic T-cell lymphoma|angioimmunoblastic t-cell lymphoma
614177|NCT00962507|splenic marginal zone lymphoma|splenic marginal zone lymphoma
614178|NCT00962507|extranodal marginal zone B-cell lymphoma of mucosa-associated lymphoid tissue|extranodal marginal zone b-cell lymphoma of mucosa-associated lymphoid tissue
614179|NCT00962507|nodal marginal zone B-cell lymphoma|nodal marginal zone b-cell lymphoma
614180|NCT00962507|recurrent adult Hodgkin lymphoma|recurrent adult hodgkin lymphoma
614181|NCT00962507|recurrent adult Burkitt lymphoma|recurrent adult burkitt lymphoma
614182|NCT00962507|recurrent adult diffuse large cell lymphoma|recurrent adult diffuse large cell lymphoma
614183|NCT00962507|recurrent adult diffuse mixed cell lymphoma|recurrent adult diffuse mixed cell lymphoma
614184|NCT00962507|recurrent adult diffuse small cleaved cell lymphoma|recurrent adult diffuse small cleaved cell lymphoma
614185|NCT00962507|recurrent adult grade III lymphomatoid granulomatosis|recurrent adult grade iii lymphomatoid granulomatosis
614186|NCT00962507|recurrent adult immunoblastic large cell lymphoma|recurrent adult immunoblastic large cell lymphoma
614187|NCT00962507|recurrent adult lymphoblastic lymphoma|recurrent adult lymphoblastic lymphoma
614188|NCT00962507|recurrent cutaneous T-cell non-Hodgkin lymphoma|recurrent cutaneous t-cell non-hodgkin lymphoma
614189|NCT00962507|recurrent mycosis fungoides/Sezary syndrome|recurrent mycosis fungoides/sezary syndrome
614190|NCT00962507|recurrent grade 1 follicular lymphoma|recurrent grade 1 follicular lymphoma
614191|NCT00962507|recurrent grade 2 follicular lymphoma|recurrent grade 2 follicular lymphoma
710882|NCT00587444|heparin management|heparin management
614192|NCT00962507|recurrent grade 3 follicular lymphoma|recurrent grade 3 follicular lymphoma
614193|NCT00962507|recurrent mantle cell lymphoma|recurrent mantle cell lymphoma
614194|NCT00962507|recurrent marginal zone lymphoma|recurrent marginal zone lymphoma
614195|NCT00962507|recurrent small lymphocytic lymphoma|recurrent small lymphocytic lymphoma
614196|NCT00962507|cutaneous B-cell non-Hodgkin lymphoma|cutaneous b-cell non-hodgkin lymphoma
614197|NCT00962507|Waldenstrom macroglobulinemia|waldenstrom macroglobulinemia
614198|NCT00962507|refractory multiple myeloma|refractory multiple myeloma
614199|NCT00962468|Pulmonary Disease, Chronic Obstructive|pulmonary disease, chronic obstructive
614200|NCT00962468|Critical Pathway|critical pathway
614201|NCT00962468|Cluster Randomized Controlled Trial|cluster randomized controlled trial
614202|NCT00962468|Safety|safety
614203|NCT00962468|Efficiency|efficiency
614204|NCT00962455|Spirometry|spirometry
614205|NCT00962455|Family Practice|family practice
614206|NCT00962455|Randomized Controlled Trial|randomized controlled trial
614207|NCT00962455|Feedback|feedback
614208|NCT00962455|Intervention Studies|intervention studies
614209|NCT00962442|alcoholic hepatitis|alcoholic hepatitis
614210|NCT00962442|N-Acetylcysteine|n-acetylcysteine
614211|NCT00962442|enteral nutrition|enteral nutrition
614212|NCT00962442|oxidative stress|oxidative stress
614213|NCT00962442|severe acute alcoholic hepatitis|severe acute alcoholic hepatitis
614214|NCT00962429|neuropathy, lipoic acid|neuropathy, lipoic acid
614215|NCT00962416|Drug eluting stent|drug eluting stent
614216|NCT00962416|Biolimus|biolimus
614217|NCT00962416|Biodegradable stent|biodegradable stent
614218|NCT00962416|ST-elevation myocardial infarction|st-elevation myocardial infarction
614219|NCT00962416|Coronary artery disease|coronary artery disease
614220|NCT00962403|post traumatic stress disorder|post traumatic stress disorder
614221|NCT00962403|yoga|yoga
614222|NCT00962403|meditation|meditation
614223|NCT00962403|military|military
614224|NCT00962403|veteran|veteran
614225|NCT00962403|trauma|trauma
614226|NCT00962403|stress|stress
614227|NCT00962403|depression|depression
614228|NCT00962403|anxiety|anxiety
614229|NCT00962403|insomnia|insomnia
614230|NCT00962403|autonomic|autonomic
614231|NCT00962377|molecular expression testing|molecular expression testing
614232|NCT00962377|right ventricular endomyocardial biopsy|right ventricular endomyocardial biopsy
614233|NCT00962351|total hip replacement|total hip replacement
614234|NCT00962351|primary cementless total hip arthroplasty|primary cementless total hip arthroplasty
614235|NCT00962351|metal ion|metal ion
614236|NCT00962351|metal-on-metal|metal-on-metal
614237|NCT00962338|convalescence|convalescence
614238|NCT00962338|pain|pain
614239|NCT00962338|nausea|nausea
614240|NCT00962338|vomiting|vomiting
614241|NCT00962338|sexual dysfunction|sexual dysfunction
614242|NCT00962325|Physical activity|physical activity
614243|NCT00962325|Obesity|obesity
614244|NCT00962325|Bariatric surgery|bariatric surgery
614245|NCT00962325|Weight Loss|weight loss
614246|NCT00962312|adenocarcinoma of the pancreas|adenocarcinoma of the pancreas
614247|NCT00962312|recurrent pancreatic cancer|recurrent pancreatic cancer
614248|NCT00962312|stage IV pancreatic cancer|stage iv pancreatic cancer
614249|NCT00962299|Child|child
614250|NCT00962299|Wheezing|wheezing
614251|NCT00962299|Dyspnea|dyspnea
614252|NCT00962299|Inhaled corticosteroids|inhaled corticosteroids
614253|NCT00962286|Furosemide|furosemide
614254|NCT00962286|obesity|obesity
614255|NCT00962273|health personnel|health personnel
614256|NCT00962273|communicable diseases|communicable diseases
614257|NCT00962273|stress, psychological|stress, psychological
614258|NCT00962273|resilience, psychological|resilience, psychological
614259|NCT00962273|disaster planning|disaster planning
614260|NCT00962273|education|education
614261|NCT00962273|online|online
614262|NCT00962260|glucocerebrosidase|glucocerebrosidase
614263|NCT00962260|enzyme replacement therapy|enzyme replacement therapy
614264|NCT00962260|Gaucher disease|gaucher disease
614265|NCT00962260|plant cell culture|plant cell culture
614266|NCT00962260|splenomegaly|splenomegaly
614267|NCT00962260|hepatomegaly|hepatomegaly
614268|NCT00962260|anemia|anemia
614269|NCT00962260|thrombocytopenia|thrombocytopenia
614270|NCT00962247|physical activity|physical activity
614271|NCT00962247|relative reinforcing value|relative reinforcing value
614272|NCT00962247|sedentary behavior|sedentary behavior
614273|NCT00962247|obesity|obesity
614274|NCT00962234|Lipogenesis|lipogenesis
614275|NCT00962234|Lipolysis|lipolysis
614276|NCT00962234|Phospholipids|phospholipids
614277|NCT00962234|Body Composition|body composition
614278|NCT00962234|Nutritional Status|nutritional status
614279|NCT00962234|Lipid Metabolism|lipid metabolism
614280|NCT00962221|LDL lipoprotein subclasses in subclinical hypothyroidism|ldl lipoprotein subclasses in subclinical hypothyroidism
614281|NCT00962208|children|children
614282|NCT00962208|corneal reshaping|corneal reshaping
614283|NCT00962208|myopia|myopia
614284|NCT00962208|myopia control|myopia control
614285|NCT00962208|orthokeratology|orthokeratology
614286|NCT00962195|health|health
614287|NCT00962195|blood pressure|blood pressure
614288|NCT00962195|liver enzymes|liver enzymes
614289|NCT00962195|insulin resistance|insulin resistance
614290|NCT00962182|celiac disease|celiac disease
614291|NCT00962182|transglutaminase antibody|transglutaminase antibody
614292|NCT00962169|Guideline adherence|guideline adherence
614293|NCT00962169|Implementation|implementation
614294|NCT00962169|Physical therapy|physical therapy
614295|NCT00962169|Low back pain|low back pain
614296|NCT00962169|Health plan implementation|health plan implementation
614297|NCT00962156|Sepsis|sepsis
614298|NCT00962156|Shock|shock
614299|NCT00962156|Fluid therapy|fluid therapy
614300|NCT00962156|Plasma expanders|plasma expanders
614301|NCT00962143|Acute Achilles Tendon Tear|acute achilles tendon tear
614302|NCT00962143|Acute Achilles Tendon Repair|acute achilles tendon repair
614303|NCT00962130|tissue perfusion|tissue perfusion
614304|NCT00962130|reconstructive surgery|reconstructive surgery
614305|NCT00962130|continuous glucose monitoring|continuous glucose monitoring
614306|NCT00962117|Food Reinforcement|food reinforcement
614307|NCT00962117|Energy Intake|energy intake
614308|NCT00962117|Obesity|obesity
614309|NCT00962117|Dopamine|dopamine
614310|NCT00962104|ADHD|adhd
614311|NCT00962091|Drug therapy|drug therapy
614312|NCT00962078|COPD|copd
614313|NCT00962078|Pre-Lung-Transplantation|pre-lung-transplantation
614314|NCT00962078|Intervall versus continuous training|intervall versus continuous training
614315|NCT00962078|6 MWD|6 mwd
614316|NCT00962039|Abdominal Pain|abdominal pain
614317|NCT00962039|Anxiety|anxiety
614318|NCT00962026|Interleukin 1|interleukin 1
614319|NCT00962026|Type 1 diabetes mellitus|type 1 diabetes mellitus
614320|NCT00962026|Rilonacept|rilonacept
614321|NCT00962026|Arcalyst|arcalyst
614322|NCT00962000|Hemodialysis|hemodialysis
614323|NCT00962000|Dialysis, Renal|dialysis, renal
614324|NCT00961987|Maternity care|maternity care
614325|NCT00961987|Interprofessional collaboration|interprofessional collaboration
614326|NCT00961987|Continuity of Care|continuity of care
614327|NCT00961987|Integration|integration
614328|NCT00961974|type 1 diabetes|type 1 diabetes
614329|NCT00961974|hemoglobin A1c|hemoglobin a1c
614330|NCT00961974|family|family
614331|NCT00961974|involvement|involvement
614332|NCT00961974|responsibility|responsibility
614333|NCT00961974|conflict|conflict
614334|NCT00961974|quality of life|quality of life
614335|NCT00961974|children|children
614336|NCT00961961|Bipolar Disorder|bipolar disorder
614337|NCT00961961|Manic Depression|manic depression
614338|NCT00961961|Major Depressive Episode|major depressive episode
614339|NCT00961961|Mania|mania
614340|NCT00961961|Hypomania|hypomania
614341|NCT00961961|Long Term Treatment|long term treatment
614342|NCT00961948|Indigo carmine dye spraying|indigo carmine dye spraying
614343|NCT00961948|Narrow band imaging (NBI)|narrow band imaging (nbi)
614344|NCT00961948|Confocal Microscopy|confocal microscopy
614345|NCT00961935|bipolar disorder|bipolar disorder
614346|NCT00961935|child bipolar disorder|child bipolar disorder
614347|NCT00961935|adolescent bipolar disorder|adolescent bipolar disorder
614348|NCT00961935|pediatric bipolar disorder|pediatric bipolar disorder
614349|NCT00961935|fMRI|fmri
614350|NCT00961935|MRI|mri
614351|NCT00961935|EEG|eeg
614352|NCT00961935|neurocognitive tasks|neurocognitive tasks
614353|NCT00961922|childhood brain tumour survivors|childhood brain tumour survivors
614354|NCT00961896|Basal Cell Carcinoma|basal cell carcinoma
614355|NCT00961896|Gorlin Syndrome,|gorlin syndrome,
614356|NCT00961896|Gorlin-Goltz Syndrome,|gorlin-goltz syndrome,
614357|NCT00961896|Basal Cell Nevus Syndrome,|basal cell nevus syndrome,
614358|NCT00961896|Nevoid Basal Cell Carcinoma Syndrome,|nevoid basal cell carcinoma syndrome,
614359|NCT00961896|Basal Cell Carcinoma Nevus Syndrome|basal cell carcinoma nevus syndrome
614360|NCT00961883|HIV|hiv
614361|NCT00961883|Vaccine|vaccine
614362|NCT00961883|HIV Seronegativity|hiv seronegativity
614363|NCT00961883|Preventive Vaccine|preventive vaccine
614364|NCT00961870|bone|bone
614365|NCT00961870|motor neuron excitability|motor neuron excitability
614366|NCT00961870|forearm vibration|forearm vibration
614367|NCT00961870|Mechanical Loading|mechanical loading
614368|NCT00961831|Neoplasm|neoplasm
614369|NCT00961831|PET/CT diagnosis|pet/ct diagnosis
614370|NCT00961831|PET tracer|pet tracer
614371|NCT00961818|Voice|voice
614372|NCT00961818|Voice Quality|voice quality
614373|NCT00961818|Voice Training|voice training
614374|NCT00961818|Evaluation|evaluation
614375|NCT00961805|Fibromyalgia|fibromyalgia
614376|NCT00961805|Treatment|treatment
614377|NCT00961805|Dance|dance
614378|NCT00961805|Randomized controlled study|randomized controlled study
614379|NCT00961805|Exercise|exercise
614380|NCT00961753|PDA|pda
614381|NCT00961753|Ibuprofen|ibuprofen
614382|NCT00961753|Preterm|preterm
614383|NCT00961753|Neonate|neonate
614384|NCT00961740|Childhood Obesity|childhood obesity
614385|NCT00961740|CBT|cbt
614386|NCT00961740|Family|family
614387|NCT00961740|Lifestyle change|lifestyle change
614388|NCT00961727|Bedside Pews|bedside pews
710883|NCT00587431|Prostate|prostate
614389|NCT00961727|Credit Valley Hospital|credit valley hospital
614390|NCT00961727|The Bedside Paediatric Early Warning System|the bedside paediatric early warning system
614391|NCT00961727|clinically deteriorating|clinically deteriorating
614392|NCT00961714|VCF|vcf
614393|NCT00961688|PCOS|pcos
614394|NCT00961688|polycystic ovary syndrome|polycystic ovary syndrome
614395|NCT00961688|Polycystic ovarian syndrome|polycystic ovarian syndrome
614396|NCT00961688|infertility|infertility
614397|NCT00961688|ovulation|ovulation
614398|NCT00961675|otitis|otitis
614399|NCT00961675|acute|acute
614400|NCT00961675|externa|externa
614401|NCT00961675|ear|ear
614402|NCT00961649|Open-Angle Glaucoma|open-angle glaucoma
614403|NCT00961649|Ocular Hypertension|ocular hypertension
614404|NCT00961649|Brinzolamide|brinzolamide
614405|NCT00961649|Brimonidine|brimonidine
614406|NCT00961649|Intraocular Pressure|intraocular pressure
614407|NCT00961610|internet support|internet support
614408|NCT00961610|cancer|cancer
614409|NCT00961610|rehabilitation|rehabilitation
614410|NCT00961597|Meniscus|meniscus
614411|NCT00961597|Avascular region|avascular region
614412|NCT00961597|Platelet rich plasma|platelet rich plasma
614413|NCT00961571|colorectal cancer|colorectal cancer
614414|NCT00961571|sunitinib|sunitinib
614415|NCT00961571|capecitabine|capecitabine
614416|NCT00961558|varicocelectomy|varicocelectomy
614417|NCT00961558|male infertility|male infertility
614418|NCT00961558|clinical varicoceles|clinical varicoceles
614419|NCT00961558|randomized control trial|randomized control trial
614420|NCT00961532|intracerebral hemorrhage|intracerebral hemorrhage
614421|NCT00961532|platelets|platelets
614422|NCT00961506|cholecystectomy|cholecystectomy
614423|NCT00961506|gallbladder|gallbladder
614424|NCT00961506|laparoscopy|laparoscopy
614425|NCT00961506|laparoendoscopic|laparoendoscopic
614426|NCT00961467|Relapsed/ refractory Multiple Myeloma|relapsed/ refractory multiple myeloma
614427|NCT00961454|Major depressive disorder, anxiety disorders, treatments, photobiomodulation, near infra-red phototherapy, cerebral blood flow|major depressive disorder, anxiety disorders, treatments, photobiomodulation, near infra-red phototherapy, cerebral blood flow
614428|NCT00961441|Levetiracetam|levetiracetam
614429|NCT00961441|Epilepsy|epilepsy
614430|NCT00961441|Children|children
614431|NCT00961441|Adults|adults
614432|NCT00961428|Anorexia Nervosa|anorexia nervosa
614433|NCT00961428|Eating Disorders|eating disorders
614434|NCT00961428|Exercise|exercise
614435|NCT00961428|Physical Activity|physical activity
614436|NCT00961402|Exercise|exercise
614437|NCT00961402|PostParum Depression|postparum depression
614438|NCT00961389|delirium|delirium
614439|NCT00961389|critical care|critical care
614440|NCT00961389|risk factors|risk factors
614441|NCT00961389|prediction|prediction
614442|NCT00961389|inflammation|inflammation
614443|NCT00961376|melanoma|melanoma
614444|NCT00961376|unresectable stage III or IV melanoma|unresectable stage iii or iv melanoma
614445|NCT00961350|PA32540 is proposed for the secondary prevention of cardio- and cerebrovascular events in patients at risk for developing aspirin-associated gastric ulcers.|pa32540 is proposed for the secondary prevention of cardio- and cerebrovascular events in patients at risk for developing aspirin-associated gastric ulcers.
614446|NCT00961337|school children|school children
614447|NCT00961337|influenza vaccination|influenza vaccination
614448|NCT00961337|vaccine effectiveness|vaccine effectiveness
614449|NCT00961337|influenza attack rate|influenza attack rate
614450|NCT00961337|absenteeism|absenteeism
614451|NCT00961337|Influenza vaccine|influenza vaccine
614452|NCT00961311|Balloon|balloon
614453|NCT00961311|Angioplasty|angioplasty
614454|NCT00961311|Coronary Artery|coronary artery
614455|NCT00961311|PCI|pci
614456|NCT00961311|PTCA|ptca
614457|NCT00961311|Heart Disease|heart disease
614458|NCT00961311|Myocardial Ischemia|myocardial ischemia
614459|NCT00961298|IBS|ibs
614460|NCT00961298|Irritable Bowel Syndrome|irritable bowel syndrome
614461|NCT00961298|GAD|gad
614462|NCT00961298|Generalized Anxiety Disorder|generalized anxiety disorder
614463|NCT00961285|pharmacogenomics|pharmacogenomics
614464|NCT00961285|genotyping|genotyping
614465|NCT00961272|Pre-menopausal|pre-menopausal
614466|NCT00961272|Pharmacokinetics|pharmacokinetics
614467|NCT00961272|Raltegravir|raltegravir
614468|NCT00961272|Women|women
614469|NCT00961272|HIV-infected|hiv-infected
614470|NCT00961259|healthy|healthy
614471|NCT00961259|pharmacokinetics|pharmacokinetics
614472|NCT00961259|therapeutic equivalency|therapeutic equivalency
614473|NCT00961259|fenofibric acid|fenofibric acid
614474|NCT00961246|web based intervention|web based intervention
614475|NCT00961246|individually-tailored|individually-tailored
614476|NCT00961246|Chinese-American children|chinese-american children
614477|NCT00961246|compared the changes in physical activity level|compared the changes in physical activity level
614478|NCT00961246|changes in dietary intake|changes in dietary intake
614479|NCT00961246|changes in coping strategy used|changes in coping strategy used
614480|NCT00961246|changes in BMI|changes in bmi
614481|NCT00961233|eosinophilic esophagitis|eosinophilic esophagitis
614482|NCT00961194|Ketamine|ketamine
781142|NCT00325273|Asthma|asthma
614483|NCT00961194|pain|pain
614484|NCT00961194|neuropathic pain|neuropathic pain
614485|NCT00961194|chronic|chronic
614486|NCT00961181|paclitaxel|paclitaxel
614487|NCT00961181|in-stent restenosis|in-stent restenosis
614488|NCT00961181|BMS-ISR|bms-isr
614489|NCT00961181|DES-ISR|des-isr
614490|NCT00961181|drug eluting balloon|drug eluting balloon
614491|NCT00961168|Mechanical Ventilation|mechanical ventilation
614492|NCT00961155|asthma|asthma
614493|NCT00961155|children|children
614494|NCT00961155|EBC|ebc
614495|NCT00961155|exposure to tabacco|exposure to tabacco
614496|NCT00961155|antiasthma treatment|antiasthma treatment
614497|NCT00961142|Haploidentical Transplantation|haploidentical transplantation
614498|NCT00961142|CD3/CD19 Depletion|cd3/cd19 depletion
614499|NCT00961142|AML|aml
614500|NCT00961142|ALL|all
614501|NCT00961142|Reduced Intensity Conditioning|reduced intensity conditioning
614502|NCT00961129|colorectal cancer|colorectal cancer
614503|NCT00961129|needs|needs
614504|NCT00961129|survivors|survivors
614505|NCT00961129|any stage|any stage
614506|NCT00961116|healthy|healthy
614507|NCT00961116|pharmacokinetics|pharmacokinetics
614508|NCT00961116|therapeutic equivalency|therapeutic equivalency
614509|NCT00961116|fasting|fasting
614510|NCT00961116|procetofen|procetofen
614511|NCT00961116|fenofibric acid|fenofibric acid
614512|NCT00961103|spinal muscular atrophy|spinal muscular atrophy
614513|NCT00961103|motor development|motor development
614514|NCT00961103|orthoses|orthoses
614515|NCT00961090|Brain tumor|brain tumor
614516|NCT00961090|glioma|glioma
614517|NCT00961090|surgical resection|surgical resection
614518|NCT00961090|ALA|ala
614519|NCT00961090|ultraviolet light|ultraviolet light
614520|NCT00961077|elderly|elderly
614521|NCT00961077|S-1|s-1
614522|NCT00961077|Oxaliplatin|oxaliplatin
614523|NCT00961077|relapsed or metastatic gastric cancer|relapsed or metastatic gastric cancer
614524|NCT00961064|Hematopoeisis|hematopoeisis
614525|NCT00961064|Thrombocytopenia|thrombocytopenia
614526|NCT00961064|Autoimmunity|autoimmunity
614527|NCT00961064|Megakaryocytes|megakaryocytes
614528|NCT00961064|Bone Marrow Fibrosis|bone marrow fibrosis
614529|NCT00961064|Myelodysplastic Syndrome|myelodysplastic syndrome
614530|NCT00961064|MDS|mds
614531|NCT00961051|adapted contact lens wearers|adapted contact lens wearers
614532|NCT00961038|Ciprofloxacin|ciprofloxacin
614533|NCT00961038|Inhalation|inhalation
614534|NCT00961038|Pharmacokinetics|pharmacokinetics
614535|NCT00961038|Safety|safety
614536|NCT00961038|Tolerability|tolerability
614537|NCT00961038|COPD|copd
614538|NCT00961012|Randomized control trial|randomized control trial
614539|NCT00961012|pressure mapping|pressure mapping
614540|NCT00961012|High Fowler's position|high fowler's position
614541|NCT00961012|bed|bed
614542|NCT00961012|ventilation|ventilation
614543|NCT00961012|slow vital capacity|slow vital capacity
614544|NCT00961012|older adult population|older adult population
614545|NCT00961012|65 years and older|65 years and older
614546|NCT00960999|stage I non-small cell lung cancer|stage i non-small cell lung cancer
614547|NCT00960999|squamous cell lung cancer|squamous cell lung cancer
614548|NCT00960999|adenocarcinoma of the lung|adenocarcinoma of the lung
614549|NCT00960999|large cell lung cancer|large cell lung cancer
614550|NCT00960973|vitamin K|vitamin k
614551|NCT00960973|beta cell|beta cell
614552|NCT00960973|glucose metabolism|glucose metabolism
614553|NCT00960973|insulin resistance|insulin resistance
614554|NCT00960960|MBC|mbc
614555|NCT00960960|PI3K|pi3k
614556|NCT00960960|Avastin|avastin
614557|NCT00960960|Herceptin|herceptin
614558|NCT00960934|Osteoporosis|osteoporosis
614559|NCT00960934|Postmenopausal|postmenopausal
614560|NCT00960934|MK-5442|mk-5442
614561|NCT00960921|Pulmonary artery pressure|pulmonary artery pressure
614562|NCT00960921|Hypoxia|hypoxia
614563|NCT00960921|Iron|iron
614564|NCT00960921|Hypoxia-inducible factor|hypoxia-inducible factor
614565|NCT00960921|High altitude|high altitude
614566|NCT00960908|Zotarolimus|zotarolimus
614567|NCT00960908|Drug eluting stent|drug eluting stent
614568|NCT00960908|Endeavor Resolute|endeavor resolute
614569|NCT00960895|Lymphangioleiomyomatosis|lymphangioleiomyomatosis
614570|NCT00960895|Pulmonary hypertension|pulmonary hypertension
614571|NCT00960882|Pharmacokinetics|pharmacokinetics
614572|NCT00960882|Diabetes|diabetes
614573|NCT00960882|gastric tolerability|gastric tolerability
614574|NCT00960869|PA32540 is proposed for the secondary prevention of cardio- and cerebrovascular events in patients at risk for developing aspirin-associated gastric ulcers.|pa32540 is proposed for the secondary prevention of cardio- and cerebrovascular events in patients at risk for developing aspirin-associated gastric ulcers.
614575|NCT00960856|pharmacokinetics|pharmacokinetics
614576|NCT00960843|Morbid Obesity|morbid obesity
614577|NCT00960843|Gastric Banding|gastric banding
614578|NCT00960843|Bariatric Banding|bariatric banding
614579|NCT00960843|Swedish Adjustable Gastric Band|swedish adjustable gastric band
614580|NCT00960817|Normal coronary artery with slow blood flow|normal coronary artery with slow blood flow
781263|NCT00324753|cancer|cancer
614581|NCT00960804|OA|oa
614582|NCT00960791|Type II diabetes mellitus|type ii diabetes mellitus
614583|NCT00960791|absorption|absorption
614584|NCT00960791|distribution|distribution
614585|NCT00960791|metabolism|metabolism
614586|NCT00960791|excretion|excretion
614587|NCT00960791|14C-labelled|14c-labelled
614588|NCT00960778|gender|gender
614589|NCT00960778|nicotine dependence|nicotine dependence
614590|NCT00960778|nicotine replacement therapy|nicotine replacement therapy
614591|NCT00960778|extinction|extinction
614592|NCT00960778|denicotinized cigarettes|denicotinized cigarettes
614593|NCT00960765|Type 2 Diabetes Mellitus|type 2 diabetes mellitus
614594|NCT00960765|Gastric Bypass|gastric bypass
614595|NCT00960765|Gastric Banding|gastric banding
614596|NCT00960765|Endotoxin|endotoxin
614597|NCT00960752|gp100 peptide|gp100 peptide
614598|NCT00960752|MAGE-3 peptide|mage-3 peptide
614599|NCT00960752|R848|r848
614600|NCT00960752|Resiquimod|resiquimod
614601|NCT00960752|Toll Like Receptor|toll like receptor
614602|NCT00960752|TLR|tlr
614603|NCT00960752|T-cells|t-cells
614604|NCT00960752|Tumor|tumor
614605|NCT00960752|Metastatic|metastatic
614606|NCT00960752|Lesions|lesions
614607|NCT00960752|Injection Site|injection site
614608|NCT00960739|disseminated neuroblastoma|disseminated neuroblastoma
614609|NCT00960739|localized unresectable neuroblastoma|localized unresectable neuroblastoma
614610|NCT00960739|recurrent neuroblastoma|recurrent neuroblastoma
614611|NCT00960739|stage 4S neuroblastoma|stage 4s neuroblastoma
614612|NCT00960726|Leukemia|leukemia
614613|NCT00960726|NOV-002|nov-002
615632|NCT00956605|children|children
614614|NCT00960726|Myelodysplastic Syndrome|myelodysplastic syndrome
614615|NCT00960726|MDS|mds
614616|NCT00960713|observational cohort|observational cohort
614617|NCT00960713|rituximab|rituximab
614618|NCT00960713|off-label use|off-label use
614619|NCT00960713|auto-immunity|auto-immunity
614620|NCT00960713|cytopenia|cytopenia
614621|NCT00960700|MFlex|mflex
614622|NCT00960700|Multifocal|multifocal
614623|NCT00960700|630F|630f
614624|NCT00960687|healthy|healthy
614625|NCT00960687|pharmacokinetics|pharmacokinetics
614626|NCT00960687|therapeutic equivalency|therapeutic equivalency
614627|NCT00960661|diabetes|diabetes
614628|NCT00960661|exenatide|exenatide
614629|NCT00960661|Byetta|byetta
614630|NCT00960661|insulin lispro|insulin lispro
614631|NCT00960661|Humalog|humalog
614632|NCT00960661|insulin glargine|insulin glargine
614633|NCT00960661|Lantus|lantus
614634|NCT00960661|Amylin|amylin
614635|NCT00960661|Lilly|lilly
614636|NCT00960648|Everolimus|everolimus
614637|NCT00960648|Sirolimus|sirolimus
614638|NCT00960648|Drug eluting stent|drug eluting stent
614639|NCT00960635|new-onset|new-onset
614640|NCT00960622|treatment experienced|treatment experienced
614641|NCT00960609|Communicating veins|communicating veins
614642|NCT00960609|hepatic venous anastomosis|hepatic venous anastomosis
614643|NCT00960609|intra-operative ultrasonography|intra-operative ultrasonography
614644|NCT00960609|hepatic resection|hepatic resection
614645|NCT00960609|hepatic neoplasm|hepatic neoplasm
614646|NCT00960609|Primary and metastatic liver tumors|primary and metastatic liver tumors
614647|NCT00960596|educational intervention|educational intervention
614648|NCT00960596|asthma|asthma
614649|NCT00960596|Environmental Tobacco Smoke(ETS)|environmental tobacco smoke(ets)
614650|NCT00960596|children|children
614651|NCT00960583|Chronic low back pain|chronic low back pain
614652|NCT00960583|Multidisciplinary rehabilitation|multidisciplinary rehabilitation
614653|NCT00960583|Exercise|exercise
614654|NCT00960583|Cost-effectiveness|cost-effectiveness
614655|NCT00960570|healthy|healthy
614656|NCT00960570|adult|adult
614657|NCT00960570|efavirenz|efavirenz
614658|NCT00960570|fenofibric acid|fenofibric acid
614659|NCT00960570|blood levels|blood levels
614660|NCT00960557|hepatic tumor burden|hepatic tumor burden
614661|NCT00960557|liver cancer|liver cancer
614662|NCT00960557|liver carcinoma|liver carcinoma
614663|NCT00960557|carcinoma|carcinoma
614664|NCT00960557|hepatic cancer|hepatic cancer
614665|NCT00960557|hepatic carcinoma|hepatic carcinoma
614666|NCT00960557|VDA|vda
614667|NCT00960557|Vascular Disrupting Agent|vascular disrupting agent
614668|NCT00960544|Capecitabine|capecitabine
614669|NCT00960544|Xeloda|xeloda
614670|NCT00960544|Gene expression|gene expression
614671|NCT00960544|Pharmacokinetic testing|pharmacokinetic testing
614672|NCT00960544|PK sampling|pk sampling
614673|NCT00960544|DNA analysis|dna analysis
614674|NCT00960518|HBV-related unresectable HCC|hbv-related unresectable hcc
614675|NCT00960518|TACE|tace
614676|NCT00960518|adefovir|adefovir
614677|NCT00960518|recurrence rate|recurrence rate
614678|NCT00960505|Diet|diet
614679|NCT00960505|Coronary heart disease|coronary heart disease
614680|NCT00960505|Obesity|obesity
614681|NCT00960505|Weight loss|weight loss
614682|NCT00960505|Weight maintenance|weight maintenance
614683|NCT00960492|Astrocytic tumor|astrocytic tumor
710884|NCT00587431|Cancer|cancer
614684|NCT00960492|Glioblastoma with oligodendroglial components|glioblastoma with oligodendroglial components
614685|NCT00960466|Stress, Psychological|stress, psychological
614686|NCT00960466|Neoplasms/psychology|neoplasms/psychology
614687|NCT00960466|Psychology|psychology
614688|NCT00960440|randomized double-blind placebo-controlled investigational drug oral therapy safety and efficacy|randomized double-blind placebo-controlled investigational drug oral therapy safety and efficacy
614689|NCT00960427|adenocarcinoma of the rectum|adenocarcinoma of the rectum
614690|NCT00960427|stage II rectal cancer|stage ii rectal cancer
614691|NCT00960427|stage III rectal cancer|stage iii rectal cancer
614692|NCT00960414|obesity|obesity
614693|NCT00960414|randomized controlled trial|randomized controlled trial
614694|NCT00960414|weight loss|weight loss
614695|NCT00960414|metabolic syndrome|metabolic syndrome
614696|NCT00960401|coronary calcium scoring|coronary calcium scoring
614697|NCT00960401|breast cancer patients|breast cancer patients
614698|NCT00960401|radiation treatment|radiation treatment
614699|NCT00960375|smoking cessation|smoking cessation
614700|NCT00960375|serious mental illness|serious mental illness
614701|NCT00960349|Gastric cancer|gastric cancer
614702|NCT00960349|Japanese|japanese
614703|NCT00960349|PhI|phi
614704|NCT00960349|Safety and tolerability|safety and tolerability
614705|NCT00960349|Cediranib in combination with cisplatin plus a fluoropyrimidine|cediranib in combination with cisplatin plus a fluoropyrimidine
614706|NCT00960349|Cediranib|cediranib
614707|NCT00960349|Capecitabine|capecitabine
614708|NCT00960349|S-1|s-1
614709|NCT00960349|Cisplatin|cisplatin
614710|NCT00960349|Untreated locally advanced or metastatic unresectable gastric cancer (GC)|untreated locally advanced or metastatic unresectable gastric cancer (gc)
614711|NCT00960336|HER2-negative breast cancer|her2-negative breast cancer
615854|NCT00956371|ONO-7746|ono-7746
614712|NCT00960336|recurrent breast cancer|recurrent breast cancer
614713|NCT00960336|stage IV breast cancer|stage iv breast cancer
614714|NCT00960336|invasive ductal breast carcinoma|invasive ductal breast carcinoma
614715|NCT00960336|invasive lobular breast carcinoma|invasive lobular breast carcinoma
614716|NCT00960323|pharmacokinetics|pharmacokinetics
614717|NCT00960310|Treatment|treatment
614718|NCT00960297|Non-Small Cell Lung Cancer|non-small cell lung cancer
614720|NCT00960297|Preoperative chemotherapy|preoperative chemotherapy
614721|NCT00960297|Bevacizumab|bevacizumab
614722|NCT00960297|Avastin|avastin
614723|NCT00960284|stage IB pancreatic cancer|stage ib pancreatic cancer
614724|NCT00960284|stage II pancreatic cancer|stage ii pancreatic cancer
614725|NCT00960284|stage III pancreatic cancer|stage iii pancreatic cancer
614726|NCT00960284|adenocarcinoma of the pancreas|adenocarcinoma of the pancreas
614727|NCT00960271|Non-small cell lung cancer|non-small cell lung cancer
614728|NCT00960271|mediastinal lymph node|mediastinal lymph node
614729|NCT00960271|resectable|resectable
614730|NCT00960271|EBUS|ebus
614731|NCT00960271|stage IIIA|stage iiia
614732|NCT00960271|significant mediastinal lymph node at thoracic CT Scan|significant mediastinal lymph node at thoracic ct scan
614733|NCT00960258|Solid Tumors|solid tumors
614734|NCT00960232|vitamin D|vitamin d
614735|NCT00960232|blood pressure|blood pressure
614736|NCT00960232|lipids|lipids
614737|NCT00960232|infection|infection
614738|NCT00960232|depression|depression
614739|NCT00960193|blood levels over time|blood levels over time
614740|NCT00960193|colchicine|colchicine
614741|NCT00960193|seville orange juice|seville orange juice
614742|NCT00960193|pharmacokinetics|pharmacokinetics
614743|NCT00960167|HCC|hcc
614744|NCT00960167|radiotherapy|radiotherapy
614745|NCT00960167|dose escalation|dose escalation
614746|NCT00960167|Toxicity|toxicity
614747|NCT00960167|Local control|local control
614748|NCT00960154|Lumpectomy|lumpectomy
614749|NCT00960154|PlasmaBlade|plasmablade
614750|NCT00960154|Electrosurgery|electrosurgery
614751|NCT00960154|PEAK Surgical|peak surgical
614752|NCT00960154|Medtronic Advanced Energy|medtronic advanced energy
614753|NCT00960154|Medtronic|medtronic
614754|NCT00960115|NSCLC|nsclc
614755|NCT00960115|Stage III|stage iii
614756|NCT00960115|EMD531444|emd531444
614757|NCT00960115|L-BLP25|l-blp25
614758|NCT00960115|Cyclophosphamide|cyclophosphamide
614759|NCT00960115|Immunotherapy|immunotherapy
614760|NCT00960115|Tecemotide|tecemotide
614761|NCT00960102|cochlear implantation|cochlear implantation
614762|NCT00960102|hearing aid|hearing aid
614763|NCT00960089|Toenail|toenail
614764|NCT00960089|Fungus|fungus
614765|NCT00960089|Onychomycosis|onychomycosis
614766|NCT00960089|Dermatophyte|dermatophyte
614767|NCT00960076|T2DM|t2dm
614768|NCT00960076|Metformin|metformin
614769|NCT00960076|A1c|a1c
614770|NCT00960037|Vitamin D3|vitamin d3
614771|NCT00960037|obesity|obesity
614772|NCT00960037|cholecalciferol|cholecalciferol
614773|NCT00960024|Vocational rehabilitation|vocational rehabilitation
614774|NCT00960024|Severe mental illness|severe mental illness
614775|NCT00960024|Psychosis|psychosis
614776|NCT00960024|Mental Health|mental health
614777|NCT00960011|Inguinal hernia|inguinal hernia
614778|NCT00960011|mesh|mesh
614779|NCT00960011|progrip|progrip
614780|NCT00959998|Persistent Cancer-Related Fatigue|persistent cancer-related fatigue
614781|NCT00959985|compression sleeve|compression sleeve
614782|NCT00959985|compression bandage|compression bandage
614783|NCT00959972|Varenicline|varenicline
614784|NCT00959972|transdermal nicotine patch|transdermal nicotine patch
614785|NCT00959972|cardiovascular disease|cardiovascular disease
614786|NCT00959972|prevention|prevention
614787|NCT00959972|coronary heart disease|coronary heart disease
614788|NCT00959972|Smoking cessation|smoking cessation
614789|NCT00959959|CRPC|crpc
614790|NCT00959959|HRPC|hrpc
614791|NCT00959959|TOK-001|tok-001
614792|NCT00959959|ARMOR|armor
614793|NCT00959959|ARMOR1|armor1
614794|NCT00959946|Phase 1/2|phase 1/2
614795|NCT00959946|2-part study|2-part study
614796|NCT00959946|bosutinib and capecitabine|bosutinib and capecitabine
614797|NCT00959920|Indwelling bladder catheter|indwelling bladder catheter
614798|NCT00959920|Intermittent straight catheterization|intermittent straight catheterization
614799|NCT00959920|Labor and Delivery|labor and delivery
614800|NCT00959920|Time to delivery during labor|time to delivery during labor
614801|NCT00959907|Muscular activity|muscular activity
614802|NCT00959907|wrinkles in frontal area|wrinkles in frontal area
614803|NCT00959907|action halos|action halos
614804|NCT00959894|HIV|hiv
614805|NCT00959894|Infection|infection
614806|NCT00959894|Treatment Naive|treatment naive
614807|NCT00959894|Adults|adults
614808|NCT00959894|Once|once
614809|NCT00959894|Daily|daily
614810|NCT00959894|Etravirine|etravirine
614811|NCT00959894|HIV-1 Infection|hiv-1 infection
614812|NCT00959881|Alzheimer Disease|alzheimer disease
614813|NCT00959868|Bladder cancer|bladder cancer
614814|NCT00959868|Superficial bladder cancer (Ta or T1)|superficial bladder cancer (ta or t1)
614815|NCT00959868|Muscle invasive bladder cancer (T2)|muscle invasive bladder cancer (t2)
614816|NCT00959868|Transurethral resection|transurethral resection
614817|NCT00959868|Radical cystectomy|radical cystectomy
614818|NCT00959868|OGX-427|ogx-427
614819|NCT00959868|Antisense oligonucleotide|antisense oligonucleotide
614820|NCT00959868|Heat shock protein 27|heat shock protein 27
614821|NCT00959868|superficial bladder tumour (Ta or T1) or CIS prior to a transurethral resection|superficial bladder tumour (ta or t1) or cis prior to a transurethral resection
614822|NCT00959868|Muscle invasive (T2) bladder cancer prior to radical cystectomy|muscle invasive (t2) bladder cancer prior to radical cystectomy
614823|NCT00959855|COPD|copd
614824|NCT00959855|Pulmonary Rehabilitation|pulmonary rehabilitation
614825|NCT00959855|Inflammation|inflammation
614826|NCT00959855|Oxidative Stress|oxidative stress
614827|NCT00959855|Steps|steps
614828|NCT00959855|Free Living Activities|free living activities
614829|NCT00959855|Exacerbation|exacerbation
614830|NCT00959842|hypertriglyceridemia|hypertriglyceridemia
614831|NCT00959842|Omega-3 Fatty Acids|omega-3 fatty acids
614832|NCT00959842|Lipoprotein|lipoprotein
614833|NCT00959842|Statin|statin
614834|NCT00959842|Lovaza|lovaza
614835|NCT00959829|Communication|communication
614836|NCT00959829|Complementary Therapies|complementary therapies
614837|NCT00959829|Intensive Care|intensive care
614838|NCT00959829|Ethics|ethics
614839|NCT00959816|Volunteers|volunteers
614840|NCT00959803|Phase 1|phase 1
614841|NCT00959803|Pharmacokinetics|pharmacokinetics
614842|NCT00959803|Healthy Young Adult|healthy young adult
614843|NCT00959803|Japanese|japanese
614844|NCT00959803|Healthy Elderly|healthy elderly
614845|NCT00959803|Alzheimer disease|alzheimer disease
614846|NCT00959790|Health|health
614847|NCT00959790|Obesity|obesity
614848|NCT00959790|Oxidative stress|oxidative stress
614849|NCT00959790|Challenge concept|challenge concept
614850|NCT00959790|Vegetables|vegetables
614851|NCT00959751|migraine|migraine
614852|NCT00959738|loop ileostomy|loop ileostomy
614853|NCT00959738|quality of life|quality of life
614854|NCT00959738|morbidity|morbidity
614855|NCT00959738|Rectal Neoplasms|rectal neoplasms
614856|NCT00959725|Infliximab|infliximab
614857|NCT00959725|Diabetes|diabetes
614858|NCT00959725|Macular Edema|macular edema
614859|NCT00959699|coinfection|coinfection
614860|NCT00959699|protease inhibitor|protease inhibitor
614861|NCT00959699|HIV|hiv
614862|NCT00959686|Bendamustine refractory or relapsed T-cell lymphoma.|bendamustine refractory or relapsed t-cell lymphoma.
614863|NCT00959660|Diastolic heart failure|diastolic heart failure
614864|NCT00959660|Heart Failure|heart failure
614865|NCT00959660|Elderly|elderly
614866|NCT00959660|Obesity|obesity
614867|NCT00959647|Hedgehog pathway inhibitor|hedgehog pathway inhibitor
614868|NCT00959621|Habitual abortion|habitual abortion
614869|NCT00959621|recurrent abortion|recurrent abortion
614870|NCT00959621|hereditary and acquired|hereditary and acquired
614871|NCT00959621|thrombophilia|thrombophilia
614872|NCT00959621|preeclampsia|preeclampsia
614873|NCT00959621|premature birth|premature birth
614874|NCT00959621|miscarriage|miscarriage
614875|NCT00959621|stillbirth|stillbirth
614876|NCT00959621|LMWH (low molecular weigh heparin)|lmwh (low molecular weigh heparin)
614877|NCT00959621|ASA|asa
614878|NCT00959621|aspirin|aspirin
614879|NCT00959608|Weight Management in adults|weight management in adults
614880|NCT00959608|Reducing Health Disparities|reducing health disparities
614881|NCT00959595|Diabetes mellitus|diabetes mellitus
614882|NCT00959595|neuropathy|neuropathy
614883|NCT00959595|foot|foot
614884|NCT00959595|sensibility|sensibility
614885|NCT00959595|brain plasticity|brain plasticity
614886|NCT00959582|Relapsed ovarian cancer|relapsed ovarian cancer
614887|NCT00959569|esmolol|esmolol
614888|NCT00959569|cardiac surgery|cardiac surgery
614889|NCT00959569|cardiac anesthesia|cardiac anesthesia
614890|NCT00959569|mortality|mortality
614891|NCT00959569|beta blockers|beta blockers
614892|NCT00959569|beta-blockers|beta-blockers
614893|NCT00959569|cardiac protection|cardiac protection
614894|NCT00959556|recurrent breast cancer|recurrent breast cancer
614895|NCT00959556|stage IA breast cancer|stage ia breast cancer
614896|NCT00959556|stage IB breast cancer|stage ib breast cancer
614897|NCT00959556|stage II breast cancer|stage ii breast cancer
614898|NCT00959556|stage IIIA breast cancer|stage iiia breast cancer
614899|NCT00959556|stage IIIB breast cancer|stage iiib breast cancer
614900|NCT00959556|stage IIIC breast cancer|stage iiic breast cancer
614901|NCT00959556|stage IV breast cancer|stage iv breast cancer
614902|NCT00959530|complete dentures|complete dentures
614903|NCT00959530|patient satisfaction|patient satisfaction
614904|NCT00959530|treatment cost|treatment cost
614905|NCT00959517|Placebo controlled|placebo controlled
614906|NCT00959517|Efficacy|efficacy
614907|NCT00959517|Artemisinin-based combination therapy|artemisinin-based combination therapy
614908|NCT00959517|Primaquine|primaquine
614909|NCT00959517|Gametocytes|gametocytes
614910|NCT00959491|Colonoscopy|colonoscopy
614911|NCT00959491|Occult Blood|occult blood
614912|NCT00959491|Fecal|fecal
614913|NCT00959478|Carbon Monoxide (CO)|carbon monoxide (co)
616037|NCT00955630|Ranibizumab|ranibizumab
614914|NCT00959478|Carbon Monoxide Poisoning|carbon monoxide poisoning
614915|NCT00959478|Carbon Monoxide Alarm/Detector|carbon monoxide alarm/detector
614916|NCT00959478|Precaution Adoption Process Model (PAPM)|precaution adoption process model (papm)
614917|NCT00959478|Injury Prevention|injury prevention
614918|NCT00959478|Emergency Department|emergency department
614919|NCT00959452|Hypochondria|hypochondria
614920|NCT00959452|Cognitive behavioural therapy|cognitive behavioural therapy
614921|NCT00959452|Long term follow-up|long term follow-up
614922|NCT00959452|Psychosomatics|psychosomatics
614923|NCT00959452|Psychotherapy|psychotherapy
614924|NCT00959426|- Mutliple Ascending Dose Study in Overweight Subjects - Body Weight - Signs and Symptoms|- mutliple ascending dose study in overweight subjects - body weight - signs and symptoms
614925|NCT00959400|Fentanyl Transdermal|fentanyl transdermal
614926|NCT00959400|Pain|pain
614927|NCT00959400|Cancer|cancer
614928|NCT00959387|head and neck cancer|head and neck cancer
614929|NCT00959387|induction chemotherapy|induction chemotherapy
614930|NCT00959374|Abdominoplasty|abdominoplasty
614931|NCT00959374|Reduction Mammaplasty|reduction mammaplasty
614932|NCT00959374|Mastopexy|mastopexy
614933|NCT00959361|patient compliance|patient compliance
614934|NCT00959361|guidelines adherence|guidelines adherence
614935|NCT00959361|advance directive adherence|advance directive adherence
614936|NCT00959361|treatment refusal|treatment refusal
614937|NCT00959361|directly observed therapy|directly observed therapy
614938|NCT00959361|anti-retroviral agents|anti-retroviral agents
614939|NCT00959361|HIV seropositivity|hiv seropositivity
614940|NCT00959361|HIV infections|hiv infections
614941|NCT00959361|HIV|hiv
614942|NCT00959361|pharmaceutical services|pharmaceutical services
614943|NCT00959361|HIV-positives patients|hiv-positives patients
614944|NCT00959361|treatment experienced|treatment experienced
614945|NCT00959348|Asthma|asthma
614946|NCT00959348|Diabetes|diabetes
614947|NCT00959348|Impaired glucose tolerance|impaired glucose tolerance
614948|NCT00959348|Insulin resistance|insulin resistance
614949|NCT00959335|treatment|treatment
614950|NCT00959322|Capsulotomy|capsulotomy
614951|NCT00959309|pediatrics|pediatrics
614952|NCT00959309|media|media
614953|NCT00959309|MUPS|mups
614954|NCT00959296|Registry|registry
614955|NCT00959296|Pain|pain
614956|NCT00959296|Chronic Pain|chronic pain
614957|NCT00959296|Back Pain|back pain
614958|NCT00959296|Intractable Spasticity|intractable spasticity
614959|NCT00959296|Parkinson's Disease|parkinson's disease
614960|NCT00959296|Essential Tremor|essential tremor
614961|NCT00959296|Dystonia|dystonia
614962|NCT00959296|Implantable Pumps|implantable pumps
614963|NCT00959296|Incontinence|incontinence
614964|NCT00959257|Asthma|asthma
614965|NCT00959257|Inhaled corticosteroids|inhaled corticosteroids
614966|NCT00959257|Cardiovascular morbidities|cardiovascular morbidities
614967|NCT00959257|Systemic inflammation|systemic inflammation
614968|NCT00959244|ductal breast carcinoma in situ|ductal breast carcinoma in situ
614969|NCT00959244|stage I breast cancer|stage i breast cancer
614970|NCT00959244|stage II breast cancer|stage ii breast cancer
614971|NCT00959244|stage IIIA breast cancer|stage iiia breast cancer
614972|NCT00959244|stage IIIB breast cancer|stage iiib breast cancer
614973|NCT00959244|stage IIIC breast cancer|stage iiic breast cancer
614974|NCT00959244|stage IV breast cancer|stage iv breast cancer
614975|NCT00959231|hematopoietic/lymphoid cancer|hematopoietic/lymphoid cancer
614976|NCT00959218|Dronabinol|dronabinol
614977|NCT00959218|(-)trans-delta9-tetrahydrocannabinol|(-)trans-delta9-tetrahydrocannabinol
614978|NCT00959218|central neuropathic pain|central neuropathic pain
614979|NCT00959218|multiple sclerosis|multiple sclerosis
614980|NCT00959218|analgesic|analgesic
614981|NCT00959218|Central neuropathic pain related to multiple sclerosis|central neuropathic pain related to multiple sclerosis
614982|NCT00959179|CHF|chf
614983|NCT00959166|Acute hepatitis C|acute hepatitis c
614984|NCT00959166|HIV|hiv
614985|NCT00959166|Neurocognitive function|neurocognitive function
614986|NCT00959166|Neuroinflammation|neuroinflammation
614987|NCT00959153|Fragmenting of kidney stones|fragmenting of kidney stones
614988|NCT00959153|extracorporeal shockwave lithotripsy|extracorporeal shockwave lithotripsy
614989|NCT00959140|Allo PBSC|allo pbsc
614990|NCT00959140|HSCT|hsct
614991|NCT00959140|Bone Marrow Transplant|bone marrow transplant
614992|NCT00959140|Allogeneic Bone Marrow Transplant|allogeneic bone marrow transplant
614993|NCT00959140|Matched Related Donor Transplant|matched related donor transplant
614994|NCT00959140|MRD HSCT|mrd hsct
614995|NCT00959127|Colorectal Adenocarcinoma|colorectal adenocarcinoma
614996|NCT00959127|Colon Cancer|colon cancer
614997|NCT00959127|Rectal Cancer|rectal cancer
614998|NCT00959114|Celiac Disease|celiac disease
614999|NCT00959114|Coeliac Disease|coeliac disease
615000|NCT00959114|Celiac Sprue|celiac sprue
615001|NCT00959114|Keliakia|keliakia
615002|NCT00959075|Thiamin supplementation|thiamin supplementation
615003|NCT00959075|Thiamin deficiency|thiamin deficiency
615004|NCT00959075|Heart failure|heart failure
615005|NCT00959075|Improve heart function|improve heart function
615006|NCT00959075|Vitamin B1 supplementation|vitamin b1 supplementation
615007|NCT00959062|Pilot Study|pilot study
615008|NCT00959062|Randomized Controlled Trial|randomized controlled trial
615009|NCT00959062|Critically Ill|critically ill
615010|NCT00959062|Child|child
615011|NCT00959062|Pediatric|pediatric
615012|NCT00959062|Clonidine|clonidine
615013|NCT00959062|Sedation|sedation
615014|NCT00959023|stage I prostate cancer|stage i prostate cancer
615015|NCT00959023|stage IIB prostate cancer|stage iib prostate cancer
615016|NCT00959023|stage IIA prostate cancer|stage iia prostate cancer
615017|NCT00959023|stage III prostate cancer|stage iii prostate cancer
615018|NCT00959023|stage IV prostate cancer|stage iv prostate cancer
615019|NCT00959023|recurrent prostate cancer|recurrent prostate cancer
615020|NCT00959010|Omega 3|omega 3
615021|NCT00959010|Cystic Fibrosis|cystic fibrosis
615022|NCT00959010|Inflammatory markers|inflammatory markers
615023|NCT00958997|diabetes|diabetes
615024|NCT00958997|islet|islet
615025|NCT00958997|pancreas|pancreas
615026|NCT00958997|beta cell mass|beta cell mass
615027|NCT00958997|PET imaging|pet imaging
615028|NCT00958997|FPDTBZ|fpdtbz
615029|NCT00958997|arginine stimulus test|arginine stimulus test
615030|NCT00958984|pediatric|pediatric
615031|NCT00958984|solid organ transplant|solid organ transplant
615032|NCT00958984|hemoglobin|hemoglobin
615033|NCT00958971|Breast cancer|breast cancer
615034|NCT00958971|HER2 negative|her2 negative
615035|NCT00958971|FGFR1|fgfr1
615036|NCT00958958|Acute Coronary Syndrome|acute coronary syndrome
615037|NCT00958958|randomized cluster trial|randomized cluster trial
615038|NCT00958958|quality improvement|quality improvement
615039|NCT00958945|Postoperative Hematocrit|postoperative hematocrit
615040|NCT00958945|Postoperative Hemoglobin|postoperative hemoglobin
615041|NCT00958919|breathlessness intensity|breathlessness intensity
615042|NCT00958919|breathlessness unpleasantness|breathlessness unpleasantness
615043|NCT00958919|endorphins|endorphins
615044|NCT00958919|resistive breathing loads|resistive breathing loads
615045|NCT00958906|Infliximab|infliximab
615046|NCT00958906|Uveitis|uveitis
615047|NCT00958906|Macular Edema|macular edema
615048|NCT00958906|Intraocular Inflammation|intraocular inflammation
615049|NCT00958893|Uterine fibroids|uterine fibroids
615050|NCT00958867|Resistance exercise training|resistance exercise training
615051|NCT00958867|aerobic exercise training|aerobic exercise training
615052|NCT00958854|angioimmunoblastic T-cell lymphoma|angioimmunoblastic t-cell lymphoma
615053|NCT00958841|Rare tumors of neuroendocrine origin|rare tumors of neuroendocrine origin
615054|NCT00958841|NETs of the pancreatic|nets of the pancreatic
615055|NCT00958841|Pituitary NETs|pituitary nets
615056|NCT00958841|EAS Tumors|eas tumors
615057|NCT00958841|Nelson's Syndrome|nelson's syndrome
615058|NCT00958841|Pancreatic neoplasm|pancreatic neoplasm
615059|NCT00958841|pituitary neoplasm|pituitary neoplasm
615060|NCT00958841|Nelson Syndrome|nelson syndrome
615061|NCT00958841|ectopic ACTH syndrome|ectopic acth syndrome
615062|NCT00958841|pasireotide LAR|pasireotide lar
615063|NCT00958841|PNETs|pnets
615064|NCT00958841|PiNETS|pinets
615065|NCT00958815|vascular imaging|vascular imaging
615066|NCT00958815|diabetes|diabetes
615067|NCT00958815|rupture prone plaques|rupture prone plaques
615068|NCT00958815|HIV|hiv
615069|NCT00958815|treatment experienced|treatment experienced
615070|NCT00958802|tissue engineering|tissue engineering
615071|NCT00958776|Influenza|influenza
615072|NCT00958776|Hospitalized|hospitalized
615073|NCT00958776|Antiviral|antiviral
615074|NCT00958776|Flu|flu
615075|NCT00958763|HCV|hcv
615076|NCT00958763|Alcohol|alcohol
615077|NCT00958763|Methadone Maintained|methadone maintained
615078|NCT00958750|Androgenetic alopecia|androgenetic alopecia
615079|NCT00958750|female pattern hair loss|female pattern hair loss
615080|NCT00958737|stage III colon cancer|stage iii colon cancer
615081|NCT00958737|adenocarcinoma of the colon|adenocarcinoma of the colon
615082|NCT00958724|HKI-272|hki-272
615083|NCT00958724|Vinorelbine|vinorelbine
615084|NCT00958724|Combination|combination
615085|NCT00958724|Solid Tumor|solid tumor
615086|NCT00958724|Neratinib|neratinib
615087|NCT00958724|Nerlynx|nerlynx
615088|NCT00958724|PB-272|pb-272
615089|NCT00958685|ginger extract|ginger extract
615090|NCT00958685|ARDS|ards
615091|NCT00958685|enteral feeding|enteral feeding
615092|NCT00958685|mechanical ventilation|mechanical ventilation
615093|NCT00958685|ICU|icu
615094|NCT00958646|OMT|omt
615095|NCT00958646|biomarker|biomarker
615096|NCT00958646|Manipulation, osteopathic|manipulation, osteopathic
615097|NCT00958633|Bipolar I disorder|bipolar i disorder
615098|NCT00958633|Depression|depression
615099|NCT00958633|Antidepressant|antidepressant
615100|NCT00958620|Chronic Achilles Tendinopathy|chronic achilles tendinopathy
615101|NCT00958607|Caregivers|caregivers
615102|NCT00958607|Stroke|stroke
615103|NCT00958607|Social support|social support
615104|NCT00958607|Phase specific care|phase specific care
615105|NCT00958581|antifibrinolytics|antifibrinolytics
615106|NCT00958542|cerebral palsy|cerebral palsy
615107|NCT00958542|scoliosis|scoliosis
615108|NCT00958542|children|children
615109|NCT00958529|fiber|fiber
615110|NCT00958529|inulin|inulin
615111|NCT00958529|gastrointestinal tolerance|gastrointestinal tolerance
615112|NCT00958516|volunteers|volunteers
615113|NCT00958503|safety|safety
615114|NCT00958503|biomarker|biomarker
615115|NCT00958503|thiamphenicol|thiamphenicol
615116|NCT00958503|EAAT2|eaat2
615117|NCT00958477|Safety|safety
615118|NCT00958477|tolerability|tolerability
615119|NCT00958477|pharmacokinetics|pharmacokinetics
615120|NCT00958477|pharmacodynamics of EMD 525797|pharmacodynamics of emd 525797
615121|NCT00958477|prostate cancer patients|prostate cancer patients
615122|NCT00958464|MRI|mri
615123|NCT00958464|Perthes'disease|perthes'disease
615124|NCT00958464|hip|hip
615125|NCT00958464|cartilage|cartilage
615126|NCT00958451|Calcium|calcium
615127|NCT00958451|Vitamin D deficiency|vitamin d deficiency
615128|NCT00958451|Chronic Kidney disease|chronic kidney disease
615129|NCT00958438|Intercritical Gout|intercritical gout
615130|NCT00958438|Metabolism, Inborn Errors|metabolism, inborn errors
615131|NCT00958438|Allopurinol|allopurinol
615132|NCT00958438|Metabolic Diseases|metabolic diseases
615133|NCT00958438|Genetic Diseases, Inborn|genetic diseases, inborn
615134|NCT00958438|Musculoskeletal Diseases|musculoskeletal diseases
615135|NCT00958438|Joint Diseases|joint diseases
615136|NCT00958438|Arthritis|arthritis
615137|NCT00958438|Rheumatic Diseases|rheumatic diseases
615138|NCT00958438|Metabolic disorder|metabolic disorder
615139|NCT00958438|Purine-Pyrimidine Metabolism, Inborn Errors|purine-pyrimidine metabolism, inborn errors
615140|NCT00958438|Gout|gout
615141|NCT00958412|Endometriosis|endometriosis
615142|NCT00958412|Pelvic pain|pelvic pain
615143|NCT00958412|Oral progesterone blocker|oral progesterone blocker
615144|NCT00958399|satiety|satiety
615145|NCT00958399|fiber|fiber
615146|NCT00958399|food intake|food intake
615147|NCT00958399|gut hormones|gut hormones
615148|NCT00958399|visual analog scales|visual analog scales
615149|NCT00958399|microflora|microflora
615150|NCT00958386|colorectal cancer|colorectal cancer
615151|NCT00958386|Panitumumab|panitumumab
615152|NCT00958386|irinotecan|irinotecan
615153|NCT00958373|Scoliosis|scoliosis
615154|NCT00958373|adolescent idiopathic scoliosis|adolescent idiopathic scoliosis
615155|NCT00958373|spine curve|spine curve
615156|NCT00958373|pediatric|pediatric
615157|NCT00958373|mental health|mental health
615158|NCT00958373|screening|screening
615159|NCT00958360|vision, low|vision, low
615160|NCT00958334|Uterine fibroids|uterine fibroids
615161|NCT00958321|adenocarcinoma of the lung|adenocarcinoma of the lung
615162|NCT00958321|large cell lung cancer|large cell lung cancer
615163|NCT00958321|squamous cell lung cancer|squamous cell lung cancer
615164|NCT00958321|malignant pleural effusion|malignant pleural effusion
615165|NCT00958321|stage IIIA non-small cell lung cancer|stage iiia non-small cell lung cancer
615166|NCT00958321|stage IIIB non-small cell lung cancer|stage iiib non-small cell lung cancer
615167|NCT00958321|stage IA non-small cell lung cancer|stage ia non-small cell lung cancer
615168|NCT00958321|stage IB non-small cell lung cancer|stage ib non-small cell lung cancer
615169|NCT00958321|stage IIA non-small cell lung cancer|stage iia non-small cell lung cancer
615170|NCT00958321|stage IIB non-small cell lung cancer|stage iib non-small cell lung cancer
615171|NCT00958308|Probiotic|probiotic
615172|NCT00958308|Antibiotic-Associated Diarrhea (AAD) Prevention|antibiotic-associated diarrhea (aad) prevention
615173|NCT00958308|Clostridium Difficile-Associated Diarrhea (CDAD)Prevention|clostridium difficile-associated diarrhea (cdad)prevention
615174|NCT00958295|urinary tract infection|urinary tract infection
615175|NCT00958295|cystitis|cystitis
615176|NCT00958282|cocaine|cocaine
615177|NCT00958282|treatment|treatment
615178|NCT00958282|lisdexamfetamine|lisdexamfetamine
615179|NCT00958282|dependence|dependence
615180|NCT00958282|addiction|addiction
615181|NCT00958282|crack|crack
615182|NCT00958269|diabetes|diabetes
615183|NCT00958269|DPP4 inhibitor|dpp4 inhibitor
615184|NCT00958269|dutogliptin|dutogliptin
615185|NCT00958269|PHX1149|phx1149
615186|NCT00958256|Mantle Cell Lymphoma|mantle cell lymphoma
615187|NCT00958256|Lymphoma|lymphoma
615188|NCT00958256|Bortezomib|bortezomib
615189|NCT00958256|Velcade|velcade
615190|NCT00958256|Rituximab|rituximab
615191|NCT00958256|Rituxan|rituxan
615192|NCT00958256|Cyclophosphamide|cyclophosphamide
615193|NCT00958256|Cytoxan|cytoxan
615194|NCT00958256|Neosar|neosar
615195|NCT00958256|Mesna|mesna
615196|NCT00958256|Mesnex|mesnex
615197|NCT00958256|G-CSF|g-csf
615198|NCT00958256|Filgrastim|filgrastim
615199|NCT00958256|Neupogen|neupogen
615200|NCT00958230|endarterectomy|endarterectomy
615201|NCT00958230|dCell|dcell
615202|NCT00958230|Tissue Regenix Ltd|tissue regenix ltd
615203|NCT00958230|TRL|trl
615204|NCT00958230|Vascular Patch|vascular patch
615205|NCT00958230|Treatment|treatment
615206|NCT00958217|Depressive symptoms|depressive symptoms
615207|NCT00958217|Substance-related disorders|substance-related disorders
615208|NCT00958217|Posttraumatic stress disorders|posttraumatic stress disorders
615209|NCT00958217|Psychotherapy|psychotherapy
615210|NCT00958204|Depression|depression
615211|NCT00958204|rating scales|rating scales
615212|NCT00958204|RCT|rct
615213|NCT00958204|combination treatment|combination treatment
615214|NCT00958204|light therapy|light therapy
615215|NCT00958204|negative ion therapy|negative ion therapy
615216|NCT00958204|fluoxetine|fluoxetine
615217|NCT00958204|antidepressants|antidepressants
615218|NCT00958165|Treatment of PAF using EAS-AC|treatment of paf using eas-ac
615219|NCT00958152|VX-950|vx-950
615220|NCT00958152|VX-222|vx-222
615221|NCT00958152|STAT-C|stat-c
615222|NCT00958139|Lyme disease|lyme disease
615223|NCT00958139|tick|tick
615224|NCT00958100|raltegravir switch toxicity|raltegravir switch toxicity
615225|NCT00958100|treatment experienced|treatment experienced
615226|NCT00958061|CVD|cvd
615227|NCT00958048|Amyotrophic Lateral Sclerosis|amyotrophic lateral sclerosis
615228|NCT00958048|hypoventilation|hypoventilation
615229|NCT00957996|influenza|influenza
615230|NCT00957996|hospitalized|hospitalized
615231|NCT00957996|flu|flu
615232|NCT00957996|antiviral|antiviral
615233|NCT00957970|Stress shielding|stress shielding
615234|NCT00957970|Bone mineral density|bone mineral density
615235|NCT00957970|stemless femoral component|stemless femoral component
615236|NCT00957944|Rotigotine|rotigotine
615237|NCT00957944|Neupro®|neupro®
615238|NCT00957918|levodopa-induced dyskinesia|levodopa-induced dyskinesia
615239|NCT00957918|Parkinson's disease|parkinson's disease
615240|NCT00957918|parkinsonian|parkinsonian
615241|NCT00957918|levodopa-induced dyskinesias in Parkinson's disease|levodopa-induced dyskinesias in parkinson's disease
615242|NCT00957892|Healthy Infants|healthy infants
615243|NCT00957892|Satiation|satiation
615244|NCT00957892|Satiety|satiety
615245|NCT00957892|Intake Regulation|intake regulation
615246|NCT00957892|Infant Feeding|infant feeding
615247|NCT00957892|Infant Formula Feeding|infant formula feeding
615248|NCT00957879|Vitamin D|vitamin d
615249|NCT00957879|FGF23|fgf23
615250|NCT00957879|FGF-23|fgf-23
615251|NCT00957879|Phosphate|phosphate
615252|NCT00957866|The number of cases in the database thus far (4,477) is clearly sufficient to achieve meaningful results|the number of cases in the database thus far (4,477) is clearly sufficient to achieve meaningful results
615253|NCT00957853|Head and Neck Cancer|head and neck cancer
615254|NCT00957853|Squamous cell carcinoma of the head and neck|squamous cell carcinoma of the head and neck
615255|NCT00957853|HNSCC|hnscc
615256|NCT00957853|Cetuximab|cetuximab
615257|NCT00957853|IMC-A12|imc-a12
615258|NCT00957853|Tumor|tumor
615259|NCT00957853|Biomarkers|biomarkers
615260|NCT00957853|Phospho-AKT|phospho-akt
615261|NCT00957853|Surgical resection|surgical resection
615262|NCT00957840|Omaya reservoirs|omaya reservoirs
615263|NCT00957840|cerebral oxygenation|cerebral oxygenation
615264|NCT00957840|VP shunt|vp shunt
615265|NCT00957840|IVH|ivh
615266|NCT00957840|post hemorrhagic ventricular dilation (PVHD)|post hemorrhagic ventricular dilation (pvhd)
615267|NCT00957814|nutritional education|nutritional education
615268|NCT00957814|diet adherence|diet adherence
615269|NCT00957814|nutritional knowledge|nutritional knowledge
615270|NCT00957814|life quality|life quality
615271|NCT00957814|nutritional status|nutritional status
710885|NCT00587431|Docetaxel|docetaxel
710886|NCT00587431|03-076|03-076
615272|NCT00957814|impact of nutritional orientations by a systematic education program applied to outpatients with HF, in comparison to patients in a conventional treatment.|impact of nutritional orientations by a systematic education program applied to outpatients with hf, in comparison to patients in a conventional treatment.
615273|NCT00957801|Sarcopenia|sarcopenia
615274|NCT00957801|Aging muscle|aging muscle
615275|NCT00957801|Androgen|androgen
615276|NCT00957801|Cytokines|cytokines
615277|NCT00957801|Muscle metabolism|muscle metabolism
615278|NCT00957788|tinnitus|tinnitus
615279|NCT00957788|acouphenes|acouphenes
615280|NCT00957788|ear|ear
615281|NCT00957788|ringing|ringing
615282|NCT00957788|buzzing|buzzing
615283|NCT00957788|roaring|roaring
615284|NCT00957788|hissing|hissing
615285|NCT00957788|clicking|clicking
615286|NCT00957775|Substance Abuse Treatment|substance abuse treatment
615287|NCT00957775|Adolescents|adolescents
615288|NCT00957775|Substance-Related Disorders|substance-related disorders
615289|NCT00957775|Alcohol-Related Disorders|alcohol-related disorders
615290|NCT00957775|Marijuana Abuse|marijuana abuse
615291|NCT00957762|Body Composition|body composition
615292|NCT00957762|Glucose Tolerance|glucose tolerance
615293|NCT00957762|Insulin Sensitivity|insulin sensitivity
615294|NCT00957762|Metabolic Syndrome|metabolic syndrome
615295|NCT00957736|graft versus host disease|graft versus host disease
615296|NCT00957736|stage III adult Burkitt lymphoma|stage iii adult burkitt lymphoma
615297|NCT00957736|stage III adult diffuse large cell lymphoma|stage iii adult diffuse large cell lymphoma
615298|NCT00957736|stage III adult diffuse mixed cell lymphoma|stage iii adult diffuse mixed cell lymphoma
615299|NCT00957736|stage III adult diffuse small cleaved cell lymphoma|stage iii adult diffuse small cleaved cell lymphoma
615300|NCT00957736|stage III adult Hodgkin lymphoma|stage iii adult hodgkin lymphoma
615301|NCT00957736|stage III adult immunoblastic large cell lymphoma|stage iii adult immunoblastic large cell lymphoma
615302|NCT00957736|stage III adult lymphoblastic lymphoma|stage iii adult lymphoblastic lymphoma
615303|NCT00957736|stage III grade 1 follicular lymphoma|stage iii grade 1 follicular lymphoma
615304|NCT00957736|stage III grade 2 follicular lymphoma|stage iii grade 2 follicular lymphoma
615305|NCT00957736|stage III grade 3 follicular lymphoma|stage iii grade 3 follicular lymphoma
615306|NCT00957736|stage III mantle cell lymphoma|stage iii mantle cell lymphoma
615307|NCT00957736|stage III marginal zone lymphoma|stage iii marginal zone lymphoma
615308|NCT00957736|stage III small lymphocytic lymphoma|stage iii small lymphocytic lymphoma
615309|NCT00957736|stage IV adult Burkitt lymphoma|stage iv adult burkitt lymphoma
615310|NCT00957736|stage IV adult diffuse large cell lymphoma|stage iv adult diffuse large cell lymphoma
615311|NCT00957736|stage IV adult diffuse mixed cell lymphoma|stage iv adult diffuse mixed cell lymphoma
615312|NCT00957736|stage IV adult diffuse small cleaved cell lymphoma|stage iv adult diffuse small cleaved cell lymphoma
615313|NCT00957736|stage IV adult Hodgkin lymphoma|stage iv adult hodgkin lymphoma
615314|NCT00957736|stage IV adult immunoblastic large cell lymphoma|stage iv adult immunoblastic large cell lymphoma
615315|NCT00957736|stage IV adult lymphoblastic lymphoma|stage iv adult lymphoblastic lymphoma
615316|NCT00957736|stage IV grade 1 follicular lymphoma|stage iv grade 1 follicular lymphoma
615317|NCT00957736|stage IV grade 2 follicular lymphoma|stage iv grade 2 follicular lymphoma
615318|NCT00957736|stage IV grade 3 follicular lymphoma|stage iv grade 3 follicular lymphoma
615319|NCT00957736|stage IV mantle cell lymphoma|stage iv mantle cell lymphoma
615320|NCT00957736|stage IV marginal zone lymphoma|stage iv marginal zone lymphoma
615321|NCT00957736|stage IV small lymphocytic lymphoma|stage iv small lymphocytic lymphoma
615322|NCT00957736|recurrent adult Burkitt lymphoma|recurrent adult burkitt lymphoma
615323|NCT00957736|recurrent adult diffuse large cell lymphoma|recurrent adult diffuse large cell lymphoma
615324|NCT00957736|recurrent adult diffuse mixed cell lymphoma|recurrent adult diffuse mixed cell lymphoma
615325|NCT00957736|recurrent adult diffuse small cleaved cell lymphoma|recurrent adult diffuse small cleaved cell lymphoma
615326|NCT00957736|recurrent adult Hodgkin lymphoma|recurrent adult hodgkin lymphoma
615327|NCT00957736|recurrent adult immunoblastic large cell lymphoma|recurrent adult immunoblastic large cell lymphoma
615328|NCT00957736|recurrent adult lymphoblastic lymphoma|recurrent adult lymphoblastic lymphoma
615329|NCT00957736|recurrent childhood large cell lymphoma|recurrent childhood large cell lymphoma
615330|NCT00957736|recurrent childhood lymphoblastic lymphoma|recurrent childhood lymphoblastic lymphoma
615331|NCT00957736|recurrent childhood small noncleaved cell lymphoma|recurrent childhood small noncleaved cell lymphoma
615332|NCT00957736|recurrent cutaneous T-cell non-Hodgkin lymphoma|recurrent cutaneous t-cell non-hodgkin lymphoma
615333|NCT00957736|recurrent grade 1 follicular lymphoma|recurrent grade 1 follicular lymphoma
615334|NCT00957736|recurrent grade 2 follicular lymphoma|recurrent grade 2 follicular lymphoma
615335|NCT00957736|recurrent grade 3 follicular lymphoma|recurrent grade 3 follicular lymphoma
615336|NCT00957736|recurrent mantle cell lymphoma|recurrent mantle cell lymphoma
615337|NCT00957736|recurrent marginal zone lymphoma|recurrent marginal zone lymphoma
615338|NCT00957736|recurrent small lymphocytic lymphoma|recurrent small lymphocytic lymphoma
615339|NCT00957736|recurrent/refractory childhood Hodgkin lymphoma|recurrent/refractory childhood hodgkin lymphoma
615340|NCT00957736|recurrent mycosis fungoides/Sezary syndrome|recurrent mycosis fungoides/sezary syndrome
615341|NCT00957736|nodal marginal zone B-cell lymphoma|nodal marginal zone b-cell lymphoma
615342|NCT00957736|splenic marginal zone lymphoma|splenic marginal zone lymphoma
615343|NCT00957736|noncontiguous (NC) stage II adult Burkitt lymphoma|noncontiguous (nc) stage ii adult burkitt lymphoma
615344|NCT00957736|NC stage II adult diffuse large cell lymphoma|nc stage ii adult diffuse large cell lymphoma
615345|NCT00957736|NC stage II adult diffuse mixed cell lymphoma|nc stage ii adult diffuse mixed cell lymphoma
615346|NCT00957736|NC stage II adult diffuse small cleaved cell lymphoma|nc stage ii adult diffuse small cleaved cell lymphoma
615347|NCT00957736|NC stage II adult immunoblastic large cell lymphoma|nc stage ii adult immunoblastic large cell lymphoma
615348|NCT00957736|NC stage II adult lymphoblastic lymphoma|nc stage ii adult lymphoblastic lymphoma
615349|NCT00957736|NC stage II grade 1 follicular lymphoma|nc stage ii grade 1 follicular lymphoma
615350|NCT00957736|NC stage II grade 2 follicular lymphoma|nc stage ii grade 2 follicular lymphoma
615351|NCT00957736|NC stage II grade 3 follicular lymphoma|nc stage ii grade 3 follicular lymphoma
615352|NCT00957736|NC stage II mantle cell lymphoma|nc stage ii mantle cell lymphoma
615353|NCT00957736|NC stage II marginal zone lymphoma|nc stage ii marginal zone lymphoma
615354|NCT00957736|NC stage II small lymphocytic lymphoma|nc stage ii small lymphocytic lymphoma
615355|NCT00957736|accelerated phase chronic myelogenous leukemia|accelerated phase chronic myelogenous leukemia
615356|NCT00957736|adult acute lymphoblastic leukemia in remission|adult acute lymphoblastic leukemia in remission
615357|NCT00957736|adult acute myeloid leukemia in remission|adult acute myeloid leukemia in remission
615358|NCT00957736|adult acute myeloid leukemia with 11q23 (MLL) abnormalities|adult acute myeloid leukemia with 11q23 (mll) abnormalities
615359|NCT00957736|adult acute myeloid leukemia with inv(16)(p13;q22)|adult acute myeloid leukemia with inv(16)(p13;q22)
615360|NCT00957736|adult acute myeloid leukemia with t(15;17)(q22;q12)|adult acute myeloid leukemia with t(15;17)(q22;q12)
615361|NCT00957736|adult acute myeloid leukemia with t(16;16)(p13;q22)|adult acute myeloid leukemia with t(16;16)(p13;q22)
615362|NCT00957736|adult acute myeloid leukemia with t(8;21)(q22;q22)|adult acute myeloid leukemia with t(8;21)(q22;q22)
615363|NCT00957736|atypical chronic myeloid leukemia, BCR-ABL negative|atypical chronic myeloid leukemia, bcr-abl negative
615364|NCT00957736|blastic phase chronic myelogenous leukemia|blastic phase chronic myelogenous leukemia
615365|NCT00957736|childhood acute lymphoblastic leukemia in remission|childhood acute lymphoblastic leukemia in remission
615366|NCT00957736|childhood acute myeloid leukemia in remission|childhood acute myeloid leukemia in remission
616038|NCT00955630|OHS|ohs
615367|NCT00957736|childhood chronic myelogenous leukemia|childhood chronic myelogenous leukemia
615368|NCT00957736|chronic myelomonocytic leukemia|chronic myelomonocytic leukemia
615369|NCT00957736|chronic phase chronic myelogenous leukemia|chronic phase chronic myelogenous leukemia
615370|NCT00957736|juvenile myelomonocytic leukemia|juvenile myelomonocytic leukemia
615371|NCT00957736|recurrent adult acute lymphoblastic leukemia|recurrent adult acute lymphoblastic leukemia
615372|NCT00957736|recurrent adult acute myeloid leukemia|recurrent adult acute myeloid leukemia
615373|NCT00957736|recurrent childhood acute lymphoblastic leukemia|recurrent childhood acute lymphoblastic leukemia
615374|NCT00957736|recurrent childhood acute myeloid leukemia|recurrent childhood acute myeloid leukemia
615375|NCT00957736|refractory chronic lymphocytic leukemia|refractory chronic lymphocytic leukemia
615376|NCT00957736|refractory hairy cell leukemia|refractory hairy cell leukemia
615377|NCT00957736|relapsing chronic myelogenous leukemia|relapsing chronic myelogenous leukemia
615378|NCT00957736|secondary acute myeloid leukemia|secondary acute myeloid leukemia
615379|NCT00957736|stage III chronic lymphocytic leukemia|stage iii chronic lymphocytic leukemia
615380|NCT00957736|stage IV chronic lymphocytic leukemia|stage iv chronic lymphocytic leukemia
615381|NCT00957736|childhood myelodysplastic syndromes|childhood myelodysplastic syndromes
615382|NCT00957736|chronic eosinophilic leukemia|chronic eosinophilic leukemia
615383|NCT00957736|primary myelofibrosis|primary myelofibrosis
615384|NCT00957736|chronic neutrophilic leukemia|chronic neutrophilic leukemia
615385|NCT00957736|de novo myelodysplastic syndromes|de novo myelodysplastic syndromes
615386|NCT00957736|disseminated neuroblastoma|disseminated neuroblastoma
615387|NCT00957736|myelodysplastic/myeloproliferative neoplasm, unclassifiable|myelodysplastic/myeloproliferative neoplasm, unclassifiable
615388|NCT00957736|poor prognosis metastatic gestational trophoblastic tumor|poor prognosis metastatic gestational trophoblastic tumor
615389|NCT00957736|previously treated childhood rhabdomyosarcoma|previously treated childhood rhabdomyosarcoma
615390|NCT00957736|previously treated myelodysplastic syndromes|previously treated myelodysplastic syndromes
615391|NCT00957736|recurrent Wilms tumor and other childhood kidney tumors|recurrent wilms tumor and other childhood kidney tumors
615392|NCT00957736|recurrent childhood rhabdomyosarcoma|recurrent childhood rhabdomyosarcoma
615393|NCT00957736|recurrent neuroblastoma|recurrent neuroblastoma
615394|NCT00957736|recurrent ovarian epithelial cancer|recurrent ovarian epithelial cancer
615395|NCT00957736|recurrent ovarian germ cell tumor|recurrent ovarian germ cell tumor
615396|NCT00957736|recurrent malignant testicular germ cell tumor|recurrent malignant testicular germ cell tumor
615397|NCT00957736|secondary myelodysplastic syndromes|secondary myelodysplastic syndromes
615398|NCT00957736|stage I multiple myeloma|stage i multiple myeloma
615399|NCT00957736|stage II multiple myeloma|stage ii multiple myeloma
615400|NCT00957736|stage III multiple myeloma|stage iii multiple myeloma
615401|NCT00957736|stage II ovarian epithelial cancer|stage ii ovarian epithelial cancer
615402|NCT00957736|stage III ovarian epithelial cancer|stage iii ovarian epithelial cancer
615403|NCT00957736|stage IV ovarian epithelial cancer|stage iv ovarian epithelial cancer
615404|NCT00957736|stage III malignant testicular germ cell tumor|stage iii malignant testicular germ cell tumor
615405|NCT00957736|stage IIIA breast cancer|stage iiia breast cancer
615406|NCT00957736|stage IIIB breast cancer|stage iiib breast cancer
615407|NCT00957736|stage IIIC breast cancer|stage iiic breast cancer
615408|NCT00957736|stage IV breast cancer|stage iv breast cancer
615409|NCT00957736|refractory multiple myeloma|refractory multiple myeloma
615410|NCT00957710|progressive aphasia|progressive aphasia
615411|NCT00957710|semantic dementia|semantic dementia
615412|NCT00957710|neuroimaging|neuroimaging
615413|NCT00957710|treatment|treatment
615414|NCT00957710|errorless learning|errorless learning
615415|NCT00957697|Central Neuropathic Pain|central neuropathic pain
615416|NCT00957697|Central Post-Stroke Pain|central post-stroke pain
615417|NCT00957697|Stroke|stroke
615418|NCT00957697|Pain|pain
615419|NCT00957684|refractory|refractory
615420|NCT00957684|partial|partial
615421|NCT00957684|epilepsy|epilepsy
615422|NCT00957671|TBI|tbi
615423|NCT00957671|Traumatic Brain injury|traumatic brain injury
615424|NCT00957671|Growth hormone deficiency|growth hormone deficiency
615425|NCT00957671|Anterior pituitary hormone|anterior pituitary hormone
615426|NCT00957671|Recombinant human growth Hormone|recombinant human growth hormone
615427|NCT00957671|Genotropin|genotropin
615428|NCT00957658|Osteoarthritis|osteoarthritis
615429|NCT00957645|Central post-stroke pain|central post-stroke pain
615430|NCT00957645|post-stroke pain|post-stroke pain
615431|NCT00957645|shoulder pain|shoulder pain
615432|NCT00957619|pentoxyfilline|pentoxyfilline
615433|NCT00957619|liver regeneration|liver regeneration
615434|NCT00957619|major liver resection|major liver resection
615435|NCT00957619|reduction of the I/R injury|reduction of the i/r injury
615436|NCT00957606|Prostate cancer|prostate cancer
615437|NCT00957606|androgen deprivation therapy|androgen deprivation therapy
615438|NCT00957606|osteoporosis|osteoporosis
615439|NCT00957593|Induction of labor in term pregnancies|induction of labor in term pregnancies
615440|NCT00957593|Term pregnancy|term pregnancy
615441|NCT00957593|Cesarean delivery|cesarean delivery
615442|NCT00957580|MEK Inhibitor|mek inhibitor
615443|NCT00957580|Pimasertib|pimasertib
615444|NCT00957580|Acute Myeloid Leukemia|acute myeloid leukemia
615445|NCT00957580|Hematological Malignancies|hematological malignancies
615446|NCT00957580|Elderly Patients|elderly patients
615447|NCT00957580|Phase II|phase ii
615448|NCT00957541|NYHA Class III or IV|nyha class iii or iv
615449|NCT00957541|Implantable Cardiac Defibrillator|implantable cardiac defibrillator
615450|NCT00957541|Cardiac Resynchronization Therapy|cardiac resynchronization therapy
615451|NCT00957528|Low Normal Testosterone|low normal testosterone
615452|NCT00957528|Male|male
615453|NCT00957528|Aging|aging
615454|NCT00957489|Orthodontic treatment of Class II division 1 malocclusion|orthodontic treatment of class ii division 1 malocclusion
615455|NCT00957476|Pregnancy|pregnancy
615456|NCT00957476|Metabolic Diseases|metabolic diseases
615457|NCT00957476|Obesity|obesity
615458|NCT00957476|Fetal adiposity|fetal adiposity
615459|NCT00957476|Omega-3|omega-3
615460|NCT00957476|Inflammation|inflammation
615461|NCT00957476|Insulin Resistance|insulin resistance
615462|NCT00957463|endothelial function|endothelial function
615463|NCT00957450|cervix cancer|cervix cancer
615464|NCT00957450|intra-pelvic organ motion|intra-pelvic organ motion
615465|NCT00957450|cervical cancer and CBCT|cervical cancer and cbct
615466|NCT00957437|Phase 1|phase 1
615467|NCT00957437|healthy volunteer|healthy volunteer
615468|NCT00957437|male|male
615469|NCT00957437|pharmacokinetics|pharmacokinetics
615470|NCT00957437|AZD1305|azd1305
615471|NCT00957424|tobacco use disorder|tobacco use disorder
615472|NCT00957424|bladder cancer|bladder cancer
615473|NCT00957424|cervical cancer|cervical cancer
615474|NCT00957424|esophageal cancer|esophageal cancer
615475|NCT00957424|gastric cancer|gastric cancer
615476|NCT00957424|renal cell carcinoma|renal cell carcinoma
615477|NCT00957424|adult primary liver cancer|adult primary liver cancer
615478|NCT00957424|non-small cell lung cancer|non-small cell lung cancer
615479|NCT00957424|small cell lung cancer|small cell lung cancer
615480|NCT00957424|pancreatic cancer|pancreatic cancer
615481|NCT00957424|hypopharyngeal cancer|hypopharyngeal cancer
615482|NCT00957424|laryngeal cancer|laryngeal cancer
615483|NCT00957424|lip and oral cavity cancer|lip and oral cavity cancer
615484|NCT00957424|nasopharyngeal cancer|nasopharyngeal cancer
615485|NCT00957424|oropharyngeal cancer|oropharyngeal cancer
615486|NCT00957424|paranasal sinus and nasal cavity cancer|paranasal sinus and nasal cavity cancer
615487|NCT00957424|adult acute myeloid leukemia|adult acute myeloid leukemia
615488|NCT00957411|stage IB cervical cancer|stage ib cervical cancer
615489|NCT00957411|stage IIA cervical cancer|stage iia cervical cancer
615490|NCT00957411|stage IIB cervical cancer|stage iib cervical cancer
615491|NCT00957411|stage III cervical cancer|stage iii cervical cancer
615492|NCT00957411|cervical adenocarcinoma|cervical adenocarcinoma
615493|NCT00957411|cervical squamous cell carcinoma|cervical squamous cell carcinoma
615494|NCT00957398|Irritable Bowel Syndrome|irritable bowel syndrome
615495|NCT00957398|Irritable Bowel Syndrome subgroups|irritable bowel syndrome subgroups
615496|NCT00957398|Motility|motility
615497|NCT00957385|Leukemia|leukemia
615498|NCT00957385|Remission|remission
615499|NCT00957372|epilepsy|epilepsy
615500|NCT00957359|Cancer|cancer
615501|NCT00957359|Anxiety|anxiety
615502|NCT00957359|Depression|depression
615503|NCT00957359|Hallucinogens|hallucinogens
615504|NCT00957346|Pregnancy termination|pregnancy termination
615505|NCT00957346|abortion|abortion
615506|NCT00957346|medical abortion|medical abortion
615507|NCT00957346|2nd trimester|2nd trimester
615508|NCT00957346|mifepristone|mifepristone
615509|NCT00957346|misoprostol|misoprostol
615510|NCT00957333|ketamine|ketamine
615511|NCT00957333|bladder dysfunction|bladder dysfunction
615512|NCT00957333|bladder mucosa|bladder mucosa
615513|NCT00957333|mechanisms|mechanisms
615514|NCT00957320|leukemia|leukemia
615515|NCT00957320|cancer|cancer
615516|NCT00957320|oncology|oncology
615517|NCT00957320|sirolimus|sirolimus
615518|NCT00957320|ALL|all
615519|NCT00957281|Asthma|asthma
615520|NCT00957281|Systemic inflammation|systemic inflammation
615521|NCT00957281|Oxidative stress|oxidative stress
615522|NCT00957281|Cardiovascular morbidity|cardiovascular morbidity
615523|NCT00957281|Airway inflammation|airway inflammation
615524|NCT00957268|Type 2 diabetes mellitus|type 2 diabetes mellitus
615525|NCT00957268|Non-insulin dependent diabetes mellitus|non-insulin dependent diabetes mellitus
615526|NCT00957268|Drug therapy|drug therapy
615527|NCT00957268|Pediatrics|pediatrics
615528|NCT00957255|rotator cuff tear|rotator cuff tear
615529|NCT00957255|rotator cuff repair|rotator cuff repair
615530|NCT00957242|IPF|ipf
615531|NCT00957242|Warfarin|warfarin
615532|NCT00957216|adult onset ataxia|adult onset ataxia
615533|NCT00957203|Parkinson's disease|parkinson's disease
615534|NCT00957203|levodopa|levodopa
615535|NCT00957203|end of dose wearing off|end of dose wearing off
615536|NCT00957203|OFF time|off time
615537|NCT00957190|Ocular Hypertension|ocular hypertension
615538|NCT00957190|Open Angle Glaucoma|open angle glaucoma
615539|NCT00957164|Chronic pain|chronic pain
615540|NCT00957164|PTSD|ptsd
615541|NCT00957151|chronic pancreatitis|chronic pancreatitis
615542|NCT00957151|exocrine pancreatic insufficiency|exocrine pancreatic insufficiency
615543|NCT00957151|enzyme therapy|enzyme therapy
615544|NCT00957151|patients with chronic pancreatitis and exocrine pancreatic insufficiency|patients with chronic pancreatitis and exocrine pancreatic insufficiency
615545|NCT00957151|taking enzyme replacement therapy|taking enzyme replacement therapy
615546|NCT00957125|Localized primary breast cancer|localized primary breast cancer
615547|NCT00957125|Inflammatory breast cancer|inflammatory breast cancer
615548|NCT00957112|anxiety disorder|anxiety disorder
615549|NCT00957112|depression|depression
615550|NCT00957112|fatigue|fatigue
615551|NCT00957112|stage IA breast cancer|stage ia breast cancer
615552|NCT00957112|stage IB breast cancer|stage ib breast cancer
615553|NCT00957112|stage II breast cancer|stage ii breast cancer
615554|NCT00957112|stage IIIA breast cancer|stage iiia breast cancer
615555|NCT00957086|Phase III Adjuvant Concurrent Chemo-RT +/- nimotuzumab|phase iii adjuvant concurrent chemo-rt +/- nimotuzumab
615556|NCT00957073|Heart Failure|heart failure
615557|NCT00957073|Diastolic dysfunction|diastolic dysfunction
615558|NCT00957047|refractory|refractory
615559|NCT00957047|partial|partial
615560|NCT00957047|epilepsy|epilepsy
615561|NCT00957021|Knee|knee
615562|NCT00956982|Hepatitis C Virus Pegylated Interferon Ribavirin Older|hepatitis c virus pegylated interferon ribavirin older
615563|NCT00956969|headaches|headaches
615564|NCT00956969|stress management|stress management
615565|NCT00956969|assertiveness training|assertiveness training
615566|NCT00956969|relaxation training|relaxation training
615567|NCT00956969|emotional expression|emotional expression
615568|NCT00956956|An investigator and subject blinded (sponsor open)|an investigator and subject blinded (sponsor open)
615569|NCT00956956|multiple dose|multiple dose
615570|NCT00956956|dose escalation design with PF 04455242 and matching placebo.|dose escalation design with pf 04455242 and matching placebo.
615571|NCT00956943|nicotine dependence|nicotine dependence
615572|NCT00956943|nicotine replacement therapy|nicotine replacement therapy
615573|NCT00956943|transdermal nicotine|transdermal nicotine
615574|NCT00956943|nicotine metabolism|nicotine metabolism
615575|NCT00956943|high dose|high dose
615576|NCT00956930|advanced adult primary liver cancer|advanced adult primary liver cancer
615577|NCT00956930|localized unresectable adult primary liver cancer|localized unresectable adult primary liver cancer
615578|NCT00956930|recurrent adult primary liver cancer|recurrent adult primary liver cancer
615579|NCT00956930|adult primary hepatocellular carcinoma|adult primary hepatocellular carcinoma
615580|NCT00956904|Prostate Cancer|prostate cancer
615581|NCT00956904|Prostatectomy|prostatectomy
615582|NCT00956904|Transrectal Ultrasound|transrectal ultrasound
615583|NCT00956904|Tandem RALP|tandem ralp
615584|NCT00956891|short-term effects|short-term effects
615585|NCT00956891|long-term follow-up|long-term follow-up
615586|NCT00956891|liver failure patients|liver failure patients
615587|NCT00956891|autologous MSCs transplantation|autologous mscs transplantation
615588|NCT00956878|Cancer|cancer
615589|NCT00956878|Pain|pain
615591|NCT00956865|Glaucoma|glaucoma
615592|NCT00956865|Intervention|intervention
615593|NCT00956865|Follow up|follow up
615594|NCT00956839|Tropical calcific pancreatitis|tropical calcific pancreatitis
615595|NCT00956839|Tropical chronic pancreatitis|tropical chronic pancreatitis
615596|NCT00956839|Chronic pancreatitis|chronic pancreatitis
615597|NCT00956839|Vitamin D|vitamin d
615598|NCT00956839|Vitamin D deficiency|vitamin d deficiency
615599|NCT00956839|Cholecalciferol|cholecalciferol
615600|NCT00956839|Intramuscular vitamin D3|intramuscular vitamin d3
615601|NCT00956826|electrode vacuum delivery|electrode vacuum delivery
615602|NCT00956813|menopausal symptoms|menopausal symptoms
615603|NCT00956813|hot flashes|hot flashes
615604|NCT00956813|breast cancer|breast cancer
615605|NCT00956813|unspecified adult solid tumor, protocol specific|unspecified adult solid tumor, protocol specific
615606|NCT00956787|Myelodysplastic Syndrome|myelodysplastic syndrome
615607|NCT00956774|HSG|hsg
615608|NCT00956774|Cannula|cannula
615609|NCT00956774|HSG procedure|hsg procedure
615610|NCT00956774|infertility evaluation|infertility evaluation
615611|NCT00956761|Influenza vaccine|influenza vaccine
615612|NCT00956748|chronic suppurative otitis media with persistent otorrhea|chronic suppurative otitis media with persistent otorrhea
615613|NCT00956735|Cardiovascular Disease|cardiovascular disease
615614|NCT00956735|Type II Diabetes|type ii diabetes
615615|NCT00956735|Nutrition|nutrition
615616|NCT00956735|Pistachios|pistachios
615617|NCT00956735|Cardiovascular disease risk factors in adults with Type II diabetes|cardiovascular disease risk factors in adults with type ii diabetes
615618|NCT00956696|Epilepsy|epilepsy
615619|NCT00956696|mental retardation|mental retardation
615620|NCT00956683|infraclavicular nerve block ultrasound dual endpoint stimulation|infraclavicular nerve block ultrasound dual endpoint stimulation
615621|NCT00956657|Randomised Controlled Trial|randomised controlled trial
615622|NCT00956657|Adherence|adherence
615623|NCT00956657|Patient Participation|patient participation
615624|NCT00956631|Spinal Stenosis|spinal stenosis
615625|NCT00956631|Lumbar Spinal Stenosis|lumbar spinal stenosis
615626|NCT00956605|EEG-biofeedback|eeg-biofeedback
615627|NCT00956605|neurofeedback|neurofeedback
615628|NCT00956605|computer attention training systems|computer attention training systems
615629|NCT00956605|ADHD|adhd
615630|NCT00956605|ADD|add
615631|NCT00956605|child|child
615633|NCT00956592|Video laryngoscopy|video laryngoscopy
615634|NCT00956592|Intubation success|intubation success
615635|NCT00956592|Difficult airway|difficult airway
615636|NCT00956592|CMAC laryngoscope|cmac laryngoscope
615637|NCT00956579|autism|autism
615638|NCT00956579|autistic|autistic
615639|NCT00956579|sensory|sensory
615640|NCT00956579|MEG|meg
615641|NCT00956579|connectivity|connectivity
615642|NCT00956579|brain|brain
615643|NCT00956579|MRI|mri
615644|NCT00956579|language|language
615645|NCT00956579|developmental|developmental
615646|NCT00956579|neurodevelopmental|neurodevelopmental
615647|NCT00956579|aspergers|aspergers
615648|NCT00956579|asperger's|asperger's
615649|NCT00956579|coherence|coherence
615650|NCT00956553|HPV|hpv
615651|NCT00956553|Human Papilloma Virus|human papilloma virus
615652|NCT00956553|Cervical cancer vaccine|cervical cancer vaccine
615653|NCT00956540|Tracheostomy|tracheostomy
615654|NCT00956540|decannulation|decannulation
615655|NCT00956540|weaning|weaning
615656|NCT00956540|Tracheostomy Weaning|tracheostomy weaning
615657|NCT00956527|Adolescent|adolescent
615658|NCT00956527|Substance Use|substance use
615659|NCT00956527|Early Intervention|early intervention
615660|NCT00956527|Martial Arts|martial arts
615661|NCT00956527|Karate|karate
615662|NCT00956514|depression|depression
615663|NCT00956514|major depressive disorder|major depressive disorder
615664|NCT00956514|transcranial magnetic stimulation|transcranial magnetic stimulation
615665|NCT00956514|TMS|tms
615666|NCT00956514|EEG|eeg
615667|NCT00956514|electroencephalography|electroencephalography
615668|NCT00956514|Major Depression,|major depression,
615669|NCT00956501|fall|fall
615670|NCT00956501|balance|balance
615671|NCT00956488|Exercise for Amyotrophic lateral sclerosis|exercise for amyotrophic lateral sclerosis
615672|NCT00956475|anxiety disorder|anxiety disorder
615673|NCT00956475|long-term effects secondary to cancer therapy in adults|long-term effects secondary to cancer therapy in adults
615674|NCT00956475|fatigue|fatigue
615675|NCT00956475|pain|pain
615676|NCT00956475|psychosocial effects of cancer and its treatment|psychosocial effects of cancer and its treatment
615677|NCT00956475|cancer survivor|cancer survivor
615678|NCT00956475|accelerated phase chronic myelogenous leukemia|accelerated phase chronic myelogenous leukemia
615679|NCT00956475|acute undifferentiated leukemia|acute undifferentiated leukemia
615680|NCT00956475|adult acute lymphoblastic leukemia in remission|adult acute lymphoblastic leukemia in remission
615681|NCT00956475|adult acute myeloid leukemia in remission|adult acute myeloid leukemia in remission
615682|NCT00956475|adult acute myeloid leukemia with 11q23 (MLL) abnormalities|adult acute myeloid leukemia with 11q23 (mll) abnormalities
615683|NCT00956475|adult acute myeloid leukemia with inv(16)(p13;q22)|adult acute myeloid leukemia with inv(16)(p13;q22)
615684|NCT00956475|adult acute myeloid leukemia with t(15;17)(q22;q12)|adult acute myeloid leukemia with t(15;17)(q22;q12)
615685|NCT00956475|adult acute myeloid leukemia with t(16;16)(p13;q22)|adult acute myeloid leukemia with t(16;16)(p13;q22)
615686|NCT00956475|adult acute myeloid leukemia with t(8;21)(q22;q22)|adult acute myeloid leukemia with t(8;21)(q22;q22)
615687|NCT00956475|atypical chronic myeloid leukemia|atypical chronic myeloid leukemia
615688|NCT00956475|blastic phase chronic myelogenous leukemia|blastic phase chronic myelogenous leukemia
615689|NCT00956475|chronic myelomonocytic leukemia|chronic myelomonocytic leukemia
615690|NCT00956475|chronic phase chronic myelogenous leukemia|chronic phase chronic myelogenous leukemia
615691|NCT00956475|mast cell leukemia|mast cell leukemia
615692|NCT00956475|meningeal chronic myelogenous leukemia|meningeal chronic myelogenous leukemia
615693|NCT00956475|progressive hairy cell leukemia, initial treatment|progressive hairy cell leukemia, initial treatment
615694|NCT00956475|prolymphocytic leukemia|prolymphocytic leukemia
615695|NCT00956475|recurrent adult acute lymphoblastic leukemia|recurrent adult acute lymphoblastic leukemia
615696|NCT00956475|recurrent adult acute myeloid leukemia|recurrent adult acute myeloid leukemia
615697|NCT00956475|refractory chronic lymphocytic leukemia|refractory chronic lymphocytic leukemia
615698|NCT00956475|refractory hairy cell leukemia|refractory hairy cell leukemia
615699|NCT00956475|relapsing chronic myelogenous leukemia|relapsing chronic myelogenous leukemia
615700|NCT00956475|secondary acute myeloid leukemia|secondary acute myeloid leukemia
615701|NCT00956475|stage I chronic lymphocytic leukemia|stage i chronic lymphocytic leukemia
615702|NCT00956475|stage II chronic lymphocytic leukemia|stage ii chronic lymphocytic leukemia
615703|NCT00956475|stage III chronic lymphocytic leukemia|stage iii chronic lymphocytic leukemia
615704|NCT00956475|stage IV chronic lymphocytic leukemia|stage iv chronic lymphocytic leukemia
615705|NCT00956475|T-cell large granular lymphocyte leukemia|t-cell large granular lymphocyte leukemia
615706|NCT00956475|stage I adult Burkitt lymphoma|stage i adult burkitt lymphoma
615707|NCT00956475|stage I adult diffuse large cell lymphoma|stage i adult diffuse large cell lymphoma
615708|NCT00956475|stage I adult diffuse mixed cell lymphoma|stage i adult diffuse mixed cell lymphoma
615709|NCT00956475|stage I adult diffuse small cleaved cell lymphoma|stage i adult diffuse small cleaved cell lymphoma
615710|NCT00956475|stage I adult Hodgkin lymphoma|stage i adult hodgkin lymphoma
615711|NCT00956475|stage I adult immunoblastic large cell lymphoma|stage i adult immunoblastic large cell lymphoma
615712|NCT00956475|stage I adult lymphoblastic lymphoma|stage i adult lymphoblastic lymphoma
615713|NCT00956475|stage I adult T-cell leukemia/lymphoma|stage i adult t-cell leukemia/lymphoma
616039|NCT00955617|Dotarem|dotarem
615714|NCT00956475|stage I cutaneous T-cell non-Hodgkin lymphoma|stage i cutaneous t-cell non-hodgkin lymphoma
615715|NCT00956475|stage I grade 1 follicular lymphoma|stage i grade 1 follicular lymphoma
615716|NCT00956475|stage I grade 2 follicular lymphoma|stage i grade 2 follicular lymphoma
615717|NCT00956475|stage I grade 3 follicular lymphoma|stage i grade 3 follicular lymphoma
615718|NCT00956475|stage I mantle cell lymphoma|stage i mantle cell lymphoma
615719|NCT00956475|stage I marginal zone lymphoma|stage i marginal zone lymphoma
615720|NCT00956475|stage I small lymphocytic lymphoma|stage i small lymphocytic lymphoma
615721|NCT00956475|stage II adult Hodgkin lymphoma|stage ii adult hodgkin lymphoma
615722|NCT00956475|stage II adult T-cell leukemia/lymphoma|stage ii adult t-cell leukemia/lymphoma
615723|NCT00956475|stage II cutaneous T-cell non-Hodgkin lymphoma|stage ii cutaneous t-cell non-hodgkin lymphoma
615724|NCT00956475|stage III adult Burkitt lymphoma|stage iii adult burkitt lymphoma
615725|NCT00956475|stage III adult diffuse large cell lymphoma|stage iii adult diffuse large cell lymphoma
615726|NCT00956475|stage III adult diffuse mixed cell lymphoma|stage iii adult diffuse mixed cell lymphoma
615727|NCT00956475|stage III adult diffuse small cleaved cell lymphoma|stage iii adult diffuse small cleaved cell lymphoma
615728|NCT00956475|stage III adult Hodgkin lymphoma|stage iii adult hodgkin lymphoma
615729|NCT00956475|stage III adult immunoblastic large cell lymphoma|stage iii adult immunoblastic large cell lymphoma
615730|NCT00956475|stage III adult lymphoblastic lymphoma|stage iii adult lymphoblastic lymphoma
615731|NCT00956475|stage III adult T-cell leukemia/lymphoma|stage iii adult t-cell leukemia/lymphoma
615732|NCT00956475|stage III cutaneous T-cell non-Hodgkin lymphoma|stage iii cutaneous t-cell non-hodgkin lymphoma
615733|NCT00956475|stage III grade 1 follicular lymphoma|stage iii grade 1 follicular lymphoma
615734|NCT00956475|stage III grade 2 follicular lymphoma|stage iii grade 2 follicular lymphoma
615735|NCT00956475|stage III grade 3 follicular lymphoma|stage iii grade 3 follicular lymphoma
615736|NCT00956475|stage III mantle cell lymphoma|stage iii mantle cell lymphoma
615737|NCT00956475|stage III marginal zone lymphoma|stage iii marginal zone lymphoma
615738|NCT00956475|stage III small lymphocytic lymphoma|stage iii small lymphocytic lymphoma
615739|NCT00956475|stage IV adult Burkitt lymphoma|stage iv adult burkitt lymphoma
615740|NCT00956475|stage IV adult diffuse large cell lymphoma|stage iv adult diffuse large cell lymphoma
615741|NCT00956475|stage IV adult diffuse mixed cell lymphoma|stage iv adult diffuse mixed cell lymphoma
615742|NCT00956475|stage IV adult diffuse small cleaved cell lymphoma|stage iv adult diffuse small cleaved cell lymphoma
615743|NCT00956475|stage IV adult Hodgkin lymphoma|stage iv adult hodgkin lymphoma
615744|NCT00956475|stage IV adult immunoblastic large cell lymphoma|stage iv adult immunoblastic large cell lymphoma
615745|NCT00956475|stage IV adult lymphoblastic lymphoma|stage iv adult lymphoblastic lymphoma
615746|NCT00956475|stage IV adult T-cell leukemia/lymphoma|stage iv adult t-cell leukemia/lymphoma
615747|NCT00956475|stage IV cutaneous T-cell non-Hodgkin lymphoma|stage iv cutaneous t-cell non-hodgkin lymphoma
615748|NCT00956475|stage IV grade 1 follicular lymphoma|stage iv grade 1 follicular lymphoma
615749|NCT00956475|stage IV grade 2 follicular lymphoma|stage iv grade 2 follicular lymphoma
615750|NCT00956475|stage IV grade 3 follicular lymphoma|stage iv grade 3 follicular lymphoma
615751|NCT00956475|stage IV mantle cell lymphoma|stage iv mantle cell lymphoma
615752|NCT00956475|stage IV marginal zone lymphoma|stage iv marginal zone lymphoma
615753|NCT00956475|stage IV small lymphocytic lymphoma|stage iv small lymphocytic lymphoma
615754|NCT00956475|recurrent adult Burkitt lymphoma|recurrent adult burkitt lymphoma
615755|NCT00956475|recurrent adult diffuse large cell lymphoma|recurrent adult diffuse large cell lymphoma
615756|NCT00956475|recurrent adult diffuse mixed cell lymphoma|recurrent adult diffuse mixed cell lymphoma
615757|NCT00956475|recurrent adult diffuse small cleaved cell lymphoma|recurrent adult diffuse small cleaved cell lymphoma
615758|NCT00956475|recurrent adult grade III lymphomatoid granulomatosis|recurrent adult grade iii lymphomatoid granulomatosis
615759|NCT00956475|recurrent adult Hodgkin lymphoma|recurrent adult hodgkin lymphoma
615760|NCT00956475|recurrent adult immunoblastic large cell lymphoma|recurrent adult immunoblastic large cell lymphoma
615761|NCT00956475|recurrent adult lymphoblastic lymphoma|recurrent adult lymphoblastic lymphoma
615762|NCT00956475|recurrent adult T-cell leukemia/lymphoma|recurrent adult t-cell leukemia/lymphoma
615763|NCT00956475|recurrent cutaneous T-cell non-Hodgkin lymphoma|recurrent cutaneous t-cell non-hodgkin lymphoma
615764|NCT00956475|recurrent grade 1 follicular lymphoma|recurrent grade 1 follicular lymphoma
615765|NCT00956475|recurrent grade 2 follicular lymphoma|recurrent grade 2 follicular lymphoma
615766|NCT00956475|recurrent grade 3 follicular lymphoma|recurrent grade 3 follicular lymphoma
615767|NCT00956475|recurrent mantle cell lymphoma|recurrent mantle cell lymphoma
615768|NCT00956475|recurrent marginal zone lymphoma|recurrent marginal zone lymphoma
615769|NCT00956475|recurrent small lymphocytic lymphoma|recurrent small lymphocytic lymphoma
615770|NCT00956475|anaplastic large cell lymphoma|anaplastic large cell lymphoma
615771|NCT00956475|angioimmunoblastic T-cell lymphoma|angioimmunoblastic t-cell lymphoma
615772|NCT00956475|recurrent mycosis fungoides/Sezary syndrome|recurrent mycosis fungoides/sezary syndrome
615773|NCT00956475|stage I mycosis fungoides/Sezary syndrome|stage i mycosis fungoides/sezary syndrome
615774|NCT00956475|stage II mycosis fungoides/Sezary syndrome|stage ii mycosis fungoides/sezary syndrome
615775|NCT00956475|stage III mycosis fungoides/Sezary syndrome|stage iii mycosis fungoides/sezary syndrome
615776|NCT00956475|stage IV mycosis fungoides/Sezary syndrome|stage iv mycosis fungoides/sezary syndrome
615777|NCT00956475|adult grade III lymphomatoid granulomatosis|adult grade iii lymphomatoid granulomatosis
615853|NCT00956384|BRCA Mutation Carriers|brca mutation carriers
615778|NCT00956475|adult nasal type extranodal NK/T-cell lymphoma|adult nasal type extranodal nk/t-cell lymphoma
615779|NCT00956475|Waldenstrom macroglobulinemia|waldenstrom macroglobulinemia
615780|NCT00956475|extranodal marginal zone B-cell lymphoma of mucosa-associated lymphoid tissue|extranodal marginal zone b-cell lymphoma of mucosa-associated lymphoid tissue
615781|NCT00956475|nodal marginal zone B-cell lymphoma|nodal marginal zone b-cell lymphoma
615782|NCT00956475|splenic marginal zone lymphoma|splenic marginal zone lymphoma
615783|NCT00956475|contiguous stage II adult Burkitt lymphoma|contiguous stage ii adult burkitt lymphoma
615784|NCT00956475|contiguous stage II adult diffuse large cell lymphoma|contiguous stage ii adult diffuse large cell lymphoma
615895|NCT00956189|Prediction|prediction
615785|NCT00956475|contiguous stage II adult diffuse mixed cell lymphoma|contiguous stage ii adult diffuse mixed cell lymphoma
615786|NCT00956475|contiguous stage II adult diffuse small cleaved cell lymphoma|contiguous stage ii adult diffuse small cleaved cell lymphoma
615787|NCT00956475|contiguous stage II adult immunoblastic large cell lymphoma|contiguous stage ii adult immunoblastic large cell lymphoma
615788|NCT00956475|contiguous stage II adult lymphoblastic lymphoma|contiguous stage ii adult lymphoblastic lymphoma
615789|NCT00956475|contiguous stage II grade 1 follicular lymphoma|contiguous stage ii grade 1 follicular lymphoma
615790|NCT00956475|contiguous stage II grade 2 follicular lymphoma|contiguous stage ii grade 2 follicular lymphoma
615791|NCT00956475|contiguous stage II grade 3 follicular lymphoma|contiguous stage ii grade 3 follicular lymphoma
615792|NCT00956475|contiguous stage II mantle cell lymphoma|contiguous stage ii mantle cell lymphoma
615793|NCT00956475|contiguous stage II marginal zone lymphoma|contiguous stage ii marginal zone lymphoma
615794|NCT00956475|contiguous stage II small lymphocytic lymphoma|contiguous stage ii small lymphocytic lymphoma
615795|NCT00956475|noncontiguous stage II adult Burkitt lymphoma|noncontiguous stage ii adult burkitt lymphoma
615796|NCT00956475|noncontiguous stage II adult diffuse large cell lymphoma|noncontiguous stage ii adult diffuse large cell lymphoma
615797|NCT00956475|noncontiguous stage II adult diffuse mixed cell lymphoma|noncontiguous stage ii adult diffuse mixed cell lymphoma
615798|NCT00956475|noncontiguous stage II adult diffuse small cleaved cell lymphoma|noncontiguous stage ii adult diffuse small cleaved cell lymphoma
615799|NCT00956475|noncontiguous stage II adult immunoblastic large cell lymphoma|noncontiguous stage ii adult immunoblastic large cell lymphoma
615800|NCT00956475|noncontiguous stage II adult lymphoblastic lymphoma|noncontiguous stage ii adult lymphoblastic lymphoma
615801|NCT00956475|noncontiguous stage II grade 1 follicular lymphoma|noncontiguous stage ii grade 1 follicular lymphoma
615802|NCT00956475|noncontiguous stage II grade 2 follicular lymphoma|noncontiguous stage ii grade 2 follicular lymphoma
615803|NCT00956475|noncontiguous stage II grade 3 follicular lymphoma|noncontiguous stage ii grade 3 follicular lymphoma
615804|NCT00956475|noncontiguous stage II mantle cell lymphoma|noncontiguous stage ii mantle cell lymphoma
615805|NCT00956475|noncontiguous stage II marginal zone lymphoma|noncontiguous stage ii marginal zone lymphoma
615806|NCT00956475|noncontiguous stage II small lymphocytic lymphoma|noncontiguous stage ii small lymphocytic lymphoma
615807|NCT00956475|intraocular lymphoma|intraocular lymphoma
615808|NCT00956475|primary central nervous system lymphoma|primary central nervous system lymphoma
615809|NCT00956475|post-transplant lymphoproliferative disorder|post-transplant lymphoproliferative disorder
615810|NCT00956475|cutaneous B-cell non-Hodgkin lymphoma|cutaneous b-cell non-hodgkin lymphoma
615811|NCT00956475|small intestine lymphoma|small intestine lymphoma
615812|NCT00956462|intraocular pressure|intraocular pressure
615813|NCT00956462|Ahmed valve|ahmed valve
615814|NCT00956462|NSAIDS|nsaids
615815|NCT00956462|steroids|steroids
615816|NCT00956449|flu|flu
615817|NCT00956449|influenza|influenza
615818|NCT00956449|seasonal influenza|seasonal influenza
615819|NCT00956449|influenza vaccine antigen|influenza vaccine antigen
615820|NCT00956449|immunogenicity|immunogenicity
615821|NCT00956449|safety|safety
615822|NCT00956449|tolerability|tolerability
615823|NCT00956449|antibody response|antibody response
615824|NCT00956449|intra muscular|intra muscular
615825|NCT00956449|elderly|elderly
615826|NCT00956449|non-elderly|non-elderly
615827|NCT00956436|Liver Cancer|liver cancer
615828|NCT00956436|Hepatocellular Carcinoma|hepatocellular carcinoma
615829|NCT00956436|Sorafenib|sorafenib
615830|NCT00956436|HCC|hcc
615831|NCT00956436|BIIB022|biib022
615832|NCT00956436|Open-Label|open-label
615833|NCT00956436|IGF-1R|igf-1r
615834|NCT00956436|Nexavar|nexavar
615835|NCT00956423|obstructive sleep apnea|obstructive sleep apnea
615836|NCT00956423|exercise training|exercise training
615837|NCT00956423|aerobic exercise|aerobic exercise
615838|NCT00956423|resistance exercise|resistance exercise
615839|NCT00956410|Active immunization|active immunization
615840|NCT00956410|Alzheimer disease|alzheimer disease
615841|NCT00956410|Antibody|antibody
615842|NCT00956410|Central Nervous System Diseases|central nervous system diseases
615843|NCT00956410|Neurodegenerative diseases|neurodegenerative diseases
615844|NCT00956410|Vaccine|vaccine
615845|NCT00956397|Functional Dyspepsia|functional dyspepsia
615846|NCT00956397|Small Intestinal Bacterial Overgrowth|small intestinal bacterial overgrowth
615847|NCT00956397|chronic abdominal discomfort|chronic abdominal discomfort
615848|NCT00956384|Breast reconstruction|breast reconstruction
615849|NCT00956384|Early stage|early stage
615850|NCT00956384|Skin-saving mastectomy|skin-saving mastectomy
615851|NCT00956384|Prophylactic mastectomy|prophylactic mastectomy
615852|NCT00956384|Acellular dermal matrix|acellular dermal matrix
615855|NCT00956371|Healthy adult subjects|healthy adult subjects
615856|NCT00956358|bronchiolitis obliterans syndrome|bronchiolitis obliterans syndrome
615857|NCT00956332|Peripheral arterial disease (PAD)|peripheral arterial disease (pad)
615858|NCT00956332|Peripheral vascular disease (PVD)|peripheral vascular disease (pvd)
615859|NCT00956332|Critical limb ischemia (CLI)|critical limb ischemia (cli)
615860|NCT00956332|Cell therapy|cell therapy
615861|NCT00956332|Gene therapy|gene therapy
615862|NCT00956332|Endothelial cells|endothelial cells
615863|NCT00956332|Smooth muscle cells|smooth muscle cells
615864|NCT00956332|Angiogenesis|angiogenesis
615865|NCT00956332|Arteriogenesis|arteriogenesis
615866|NCT00956332|amputation|amputation
615867|NCT00956332|diabetic foot|diabetic foot
615868|NCT00956319|Insomnia|insomnia
615869|NCT00956319|Zolpidem|zolpidem
615870|NCT00956319|Estazolam|estazolam
615871|NCT00956306|Udenafil,DA-8159,hepatic impairment,healthy volunteers|udenafil,da-8159,hepatic impairment,healthy volunteers
615872|NCT00956280|The frequency and type of KRAS mutation in a sample of the Brazilian population with advanced NSCLC|the frequency and type of kras mutation in a sample of the brazilian population with advanced nsclc
615873|NCT00956280|KRAS mutation in population with advanced NSCLC|kras mutation in population with advanced nsclc
615874|NCT00956267|Polycystic ovary syndrome|polycystic ovary syndrome
615875|NCT00956267|clomiphene resistance|clomiphene resistance
615876|NCT00956267|letrozole|letrozole
615877|NCT00956267|Laparoscopic ovarian diathermy|laparoscopic ovarian diathermy
615878|NCT00956254|mucositis|mucositis
615879|NCT00956254|unspecified adult solid tumor, protocol specific|unspecified adult solid tumor, protocol specific
615880|NCT00956254|pain|pain
615881|NCT00956241|rectal cancer|rectal cancer
615882|NCT00956241|colonic pouch|colonic pouch
615883|NCT00956241|side-to-end anastomosis|side-to-end anastomosis
615884|NCT00956241|preoperative radiotherapy|preoperative radiotherapy
615885|NCT00956215|post operative|post operative
615886|NCT00956215|obese|obese
615887|NCT00956202|Influenza|influenza
615888|NCT00956202|Pandemic Flu|pandemic flu
615889|NCT00956202|Swine-origin A/H1N1 Influenza|swine-origin a/h1n1 influenza
615890|NCT00956202|Inactivated split-virion vaccine|inactivated split-virion vaccine
615891|NCT00956202|Adjuvant|adjuvant
615892|NCT00956189|Antipsychotic Agents|antipsychotic agents
615893|NCT00956189|Metabolic Syndrome X|metabolic syndrome x
615894|NCT00956189|Identification|identification
615896|NCT00956176|Cidofovir|cidofovir
615897|NCT00956176|Vistide|vistide
615898|NCT00956176|Adenovirus|adenovirus
615899|NCT00956176|BK virus infections|bk virus infections
615900|NCT00956176|HSCT|hsct
615901|NCT00956176|Hemorrhagic Cystitis|hemorrhagic cystitis
615902|NCT00956176|Foley catheter|foley catheter
615903|NCT00956176|Viral infection|viral infection
615904|NCT00956176|Bladder instillation|bladder instillation
615905|NCT00956176|Intravesical|intravesical
615906|NCT00956176|Transurethral catheter|transurethral catheter
615907|NCT00956176|Transplantation|transplantation
615908|NCT00956150|Chronic Multisymptom Complex|chronic multisymptom complex
615909|NCT00956150|Small Intestinal Bacterial Overgrowth|small intestinal bacterial overgrowth
615910|NCT00956150|Gulf War Syndrome|gulf war syndrome
615911|NCT00956150|Chronic Multisymptom Illness Complex|chronic multisymptom illness complex
615912|NCT00956137|spinal anesthesia|spinal anesthesia
615913|NCT00956137|ultrasound|ultrasound
615914|NCT00956137|palpation|palpation
615915|NCT00956137|knee|knee
615916|NCT00956137|hip|hip
615917|NCT00956137|surgery|surgery
615918|NCT00956137|intervertebral space|intervertebral space
615919|NCT00956111|Novel Influenza A/H1N1 Vaccine|novel influenza a/h1n1 vaccine
615920|NCT00956111|Immunogenictiy|immunogenictiy
615921|NCT00956111|Safety|safety
615922|NCT00956085|OCD|ocd
615923|NCT00956072|gastrointestinal stromal tumor|gastrointestinal stromal tumor
615924|NCT00956059|focal segmental glomerulosclerosis|focal segmental glomerulosclerosis
615925|NCT00956059|prednisone|prednisone
615926|NCT00956059|mycophenolate mofetil|mycophenolate mofetil
615927|NCT00956059|FK506|fk506
615928|NCT00956046|Influenza|influenza
615929|NCT00956046|Pandemic Flu|pandemic flu
615930|NCT00956046|Swine-origin A/H1N1 Influenza|swine-origin a/h1n1 influenza
615931|NCT00956046|Swine-origin Influenza Virus|swine-origin influenza virus
615932|NCT00956046|Infants|infants
615933|NCT00956033|Cancer|cancer
615934|NCT00956033|Peripheral Neuropathy|peripheral neuropathy
615935|NCT00956033|Bortezomib|bortezomib
615936|NCT00956020|platelet rich plasma|platelet rich plasma
615937|NCT00956020|fibrin matrix|fibrin matrix
615938|NCT00956020|dermal filler|dermal filler
615939|NCT00956007|stage III squamous cell carcinoma of the larynx|stage iii squamous cell carcinoma of the larynx
615940|NCT00956007|stage III verrucous carcinoma of the larynx|stage iii verrucous carcinoma of the larynx
615941|NCT00956007|stage IV squamous cell carcinoma of the larynx|stage iv squamous cell carcinoma of the larynx
615942|NCT00956007|stage IV verrucous carcinoma of the larynx|stage iv verrucous carcinoma of the larynx
615943|NCT00956007|stage III squamous cell carcinoma of the lip and oral cavity|stage iii squamous cell carcinoma of the lip and oral cavity
615944|NCT00956007|stage IV squamous cell carcinoma of the lip and oral cavity|stage iv squamous cell carcinoma of the lip and oral cavity
616040|NCT00955617|Gadovist|gadovist
615945|NCT00956007|stage III verrucous carcinoma of the oral cavity|stage iii verrucous carcinoma of the oral cavity
615946|NCT00956007|stage IV verrucous carcinoma of the oral cavity|stage iv verrucous carcinoma of the oral cavity
615947|NCT00956007|stage III squamous cell carcinoma of the oropharynx|stage iii squamous cell carcinoma of the oropharynx
615948|NCT00956007|stage IV squamous cell carcinoma of the oropharynx|stage iv squamous cell carcinoma of the oropharynx
615949|NCT00956007|tongue cancer|tongue cancer
615950|NCT00955968|HIV Infection|hiv infection
615952|NCT00955968|Maternal Health|maternal health
615953|NCT00955955|Depression|depression
615954|NCT00955955|Medical food|medical food
615955|NCT00955942|radiation toxicity|radiation toxicity
615956|NCT00955942|stage IIIA non-small cell lung cancer|stage iiia non-small cell lung cancer
615957|NCT00955942|stage IIIB non-small cell lung cancer|stage iiib non-small cell lung cancer
615958|NCT00955942|recurrent non-small cell lung cancer|recurrent non-small cell lung cancer
615959|NCT00955942|stage IV non-small cell lung cancer|stage iv non-small cell lung cancer
615960|NCT00955929|Penis|penis
615961|NCT00955929|PLACEBO|placebo
615962|NCT00955929|SILDENAFIL CITRATE|sildenafil citrate
615963|NCT00955929|TRIMIX|trimix
615964|NCT00955929|Bimix|bimix
615965|NCT00955929|Viagra|viagra
615966|NCT00955929|09-005|09-005
615967|NCT00955929|Erectile Dysfunction following Bilateral Nerve-Sparing|erectile dysfunction following bilateral nerve-sparing
615968|NCT00955916|relapsed|relapsed
615969|NCT00955916|refractory|refractory
615970|NCT00955916|acute|acute
615971|NCT00955916|myeloid|myeloid
615972|NCT00955916|AML|aml
615973|NCT00955916|CML|cml
615974|NCT00955916|blast crisis|blast crisis
615975|NCT00955903|glucose|glucose
615976|NCT00955903|insulin|insulin
615977|NCT00955903|lipids|lipids
615978|NCT00955903|C-reactive protein|c-reactive protein
615979|NCT00955903|adiponectin|adiponectin
615980|NCT00955903|leptin|leptin
615981|NCT00955903|TNF alpha|tnf alpha
615982|NCT00955903|IL-6|il-6
615983|NCT00955903|Quality of Life|quality of life
615984|NCT00955903|functional status|functional status
783170|NCT00317720|RAD001|rad001
615985|NCT00955890|cardioprotection|cardioprotection
615986|NCT00955890|anthracycline chemotherapy|anthracycline chemotherapy
615987|NCT00955890|breast cancer|breast cancer
615988|NCT00955877|extended-release epidural morphine|extended-release epidural morphine
615989|NCT00955877|DepoDur|depodur
615990|NCT00955877|Spastic Cerebral Palsy|spastic cerebral palsy
615991|NCT00955864|Cervix|cervix
615992|NCT00955864|Colposcope|colposcope
615993|NCT00955864|Polarized Light|polarized light
615994|NCT00955864|Cervix Structure|cervix structure
615995|NCT00955864|Collagen|collagen
615996|NCT00955864|HV|hv
615997|NCT00955864|Healthy Volunteer|healthy volunteer
615998|NCT00955864|Healthy Women|healthy women
615999|NCT00955825|allergic rhinoconjunctivitis|allergic rhinoconjunctivitis
616000|NCT00955812|OPB-31121|opb-31121
616001|NCT00955812|Advanced Solid Tumor|advanced solid tumor
616002|NCT00955812|STAT3|stat3
616003|NCT00955812|IL-6-induced STAT3 phosphorylation|il-6-induced stat3 phosphorylation
616004|NCT00955799|Subjective, Tinnitus|subjective, tinnitus
616005|NCT00955786|Solid Tumors|solid tumors
616006|NCT00955786|Lymphoma|lymphoma
616007|NCT00955786|G-Quadruplex|g-quadruplex
616008|NCT00955773|GSK1120212, everolimus, solid tumors, pancreatic cancer, non-small lung cancer, KRAS-mutant|gsk1120212, everolimus, solid tumors, pancreatic cancer, non-small lung cancer, kras-mutant
616009|NCT00955773|cancer|cancer
616010|NCT00955760|Healthy subjects|healthy subjects
616011|NCT00955734|wrist|wrist
616012|NCT00955734|fracture|fracture
616013|NCT00955734|motion|motion
616014|NCT00955734|surgery|surgery
616015|NCT00955721|Cholangiocarcinoma|cholangiocarcinoma
616016|NCT00955721|Biliary Tract Cancer|biliary tract cancer
616017|NCT00955721|Gallbladder Cancer|gallbladder cancer
616018|NCT00955695|adenocarcinoma of the lung|adenocarcinoma of the lung
616019|NCT00955695|adenosquamous cell lung cancer|adenosquamous cell lung cancer
616020|NCT00955695|bronchoalveolar cell lung cancer|bronchoalveolar cell lung cancer
616021|NCT00955695|large cell lung cancer|large cell lung cancer
616022|NCT00955695|squamous cell lung cancer|squamous cell lung cancer
616023|NCT00955695|stage IIIB non-small cell lung cancer|stage iiib non-small cell lung cancer
616024|NCT00955695|stage IV non-small cell lung cancer|stage iv non-small cell lung cancer
616025|NCT00955682|Meningococcal vaccine GSK134612|meningococcal vaccine gsk134612
616026|NCT00955669|mesenchymal stem cells|mesenchymal stem cells
616027|NCT00955669|mononuclear cells|mononuclear cells
616028|NCT00955656|Characteristics of medical practices|characteristics of medical practices
616029|NCT00955656|Practitioners providing care to children with asthma|practitioners providing care to children with asthma
616030|NCT00955656|Medically underserved and impoverished Arkansas Delta region|medically underserved and impoverished arkansas delta region
616031|NCT00955656|Characteristics of medical practices and practitioners|characteristics of medical practices and practitioners
616032|NCT00955656|Disadvantaged populations|disadvantaged populations
616033|NCT00955643|periodontitis|periodontitis
616034|NCT00955643|hyperbaric oxygen therapy|hyperbaric oxygen therapy
616035|NCT00955630|Histoplasmosis|histoplasmosis
616036|NCT00955630|Lucentis|lucentis
616041|NCT00955617|Peripheral arterial disease|peripheral arterial disease
616043|NCT00955604|Parkinson's Disease|parkinson's disease
616044|NCT00955604|Serotonin Toxicity|serotonin toxicity
616045|NCT00955604|Rasagiline|rasagiline
616046|NCT00955604|Antidepressants|antidepressants
616047|NCT00955604|Chart Review|chart review
616048|NCT00955604|Retrospective|retrospective
616049|NCT00955591|human papilloma virus infection|human papilloma virus infection
616050|NCT00955591|anal cancer|anal cancer
616051|NCT00955591|HIV infection|hiv infection
616052|NCT00955552|osteoarthritis (OA)|osteoarthritis (oa)
616053|NCT00955552|knee|knee
616054|NCT00955539|Heart Failure|heart failure
616055|NCT00955539|Cardiac resynchronization therapy|cardiac resynchronization therapy
616056|NCT00955539|Optimization|optimization
616057|NCT00955539|Viability|viability
616058|NCT00955539|Mechanical dyssynchrony|mechanical dyssynchrony
616059|NCT00955526|Parkinson's disease|parkinson's disease
616060|NCT00955526|levodopa|levodopa
616061|NCT00955526|end of dose wearing off|end of dose wearing off
616062|NCT00955526|OFF time|off time
616063|NCT00955513|Ankle sprain|ankle sprain
616064|NCT00955513|soft tissue injury|soft tissue injury
616065|NCT00955500|Hepatic encephalopathy|hepatic encephalopathy
616066|NCT00955500|Cirrhosis|cirrhosis
616067|NCT00955500|Proteins of the diet|proteins of the diet
616068|NCT00955500|Branched-chain amino acids|branched-chain amino acids
616069|NCT00955487|Premature Newborns|premature newborns
616070|NCT00955487|Inhaled Nitric Oxide|inhaled nitric oxide
616071|NCT00955448|Anterior pelvic organ prolapse|anterior pelvic organ prolapse
616072|NCT00955448|Surgical repair|surgical repair
616073|NCT00955448|Pelvic floor surgery|pelvic floor surgery
616074|NCT00955448|Randomized clinical trial|randomized clinical trial
616075|NCT00955435|adenocarcinoma of the prostate|adenocarcinoma of the prostate
616076|NCT00955435|stage I prostate cancer|stage i prostate cancer
616077|NCT00955435|stage IIB prostate cancer|stage iib prostate cancer
616078|NCT00955435|stage IIA prostate cancer|stage iia prostate cancer
616079|NCT00955435|stage III prostate cancer|stage iii prostate cancer
616080|NCT00955422|Diagnosis|diagnosis
616081|NCT00955422|Alzheimer's Disease|alzheimer's disease
616082|NCT00955422|Memory Disorder|memory disorder
616083|NCT00955422|Dementia|dementia
616084|NCT00955422|Alzheimer Disease|alzheimer disease
616085|NCT00955422|Memory Loss|memory loss
616086|NCT00955396|sodium channel blocker|sodium channel blocker
616087|NCT00955396|ambulatory blood pressure|ambulatory blood pressure
616088|NCT00955383|Japanese|japanese
616089|NCT00955370|Uncertainty|uncertainty
616090|NCT00955370|Undiagnosed|undiagnosed
616091|NCT00955370|Rare Diseases|rare diseases
616092|NCT00955370|Parents|parents
616093|NCT00955370|Multiple Abnormalities|multiple abnormalities
616094|NCT00955357|Epilepsy Treatment|epilepsy treatment
616095|NCT00955357|Anti-epileptic drugs|anti-epileptic drugs
616096|NCT00955357|Seizures|seizures
616097|NCT00955357|Vimpat|vimpat
616098|NCT00955344|colorectal cancer screening|colorectal cancer screening
616099|NCT00955344|American Board of Internal Medicine Maintenance of Certification program|american board of internal medicine maintenance of certification program
616100|NCT00955344|Currently enrolled in or plan to enroll in the American Board of Internal Medicine Maintenance of Certification program|currently enrolled in or plan to enroll in the american board of internal medicine maintenance of certification program
616101|NCT00955305|Non-Small Cell Lung Cancer|non-small cell lung cancer
616102|NCT00955305|cixutumumab|cixutumumab
616103|NCT00955292|Solid Tumors|solid tumors
616104|NCT00955292|Lymphoma|lymphoma
616105|NCT00955292|G-Quadruplex|g-quadruplex
616106|NCT00955279|Ustekinumab|ustekinumab
616107|NCT00955279|CNTO 1275|cnto 1275
616108|NCT00955279|Stelara|stelara
616109|NCT00955279|Golimumab|golimumab
616110|NCT00955279|CNTO 148|cnto 148
616111|NCT00955279|Simponi|simponi
616112|NCT00955279|Sarcoidosis|sarcoidosis
616113|NCT00955279|Sarcoid|sarcoid
616114|NCT00955279|Pulmonary Sarcoidosis|pulmonary sarcoidosis
616115|NCT00955279|Skin Sarcoidosis|skin sarcoidosis
616116|NCT00955266|Separation|separation
616117|NCT00955266|Cardiopulmonary bypass|cardiopulmonary bypass
616118|NCT00955266|Calcium chloride|calcium chloride
616119|NCT00955253|Neglect|neglect
616120|NCT00955253|Attention|attention
616121|NCT00955253|Vigilance|vigilance
616122|NCT00955253|Stroke|stroke
616123|NCT00955253|Hemineglect|hemineglect
616124|NCT00955253|Unilateral Neglect|unilateral neglect
616125|NCT00955253|Spatial Neglect|spatial neglect
616126|NCT00955240|stage II anal cancer|stage ii anal cancer
616127|NCT00955240|stage IIIA anal cancer|stage iiia anal cancer
616128|NCT00955240|stage IIIB anal cancer|stage iiib anal cancer
616129|NCT00955240|squamous cell carcinoma of the anus|squamous cell carcinoma of the anus
616130|NCT00955227|Omega-3 Fatty acid|omega-3 fatty acid
616131|NCT00955227|ALA (alpha linolenic acid)|ala (alpha linolenic acid)
616132|NCT00955227|Ezetimibe|ezetimibe
616133|NCT00955227|Flaxseed oil capsules|flaxseed oil capsules
616134|NCT00955214|TAXUS Liberté|taxus liberté
616135|NCT00955214|Small coronary artery disease|small coronary artery disease
616136|NCT00955214|Paclitaxel-eluting stent|paclitaxel-eluting stent
616137|NCT00955201|diabetes mellitus|diabetes mellitus
616138|NCT00955201|diabetic neuropathies|diabetic neuropathies
616139|NCT00955201|Aerobic Exercise|aerobic exercise
616140|NCT00955201|Exercise Therapy|exercise therapy
616141|NCT00955201|electromyography|electromyography
616142|NCT00955201|United States Veterans|united states veterans
616143|NCT00955188|colon cancer|colon cancer
616144|NCT00955188|rectal cancer|rectal cancer
616145|NCT00955175|stage I non-small cell lung cancer|stage i non-small cell lung cancer
616146|NCT00955175|stage II non-small cell lung cancer|stage ii non-small cell lung cancer
616147|NCT00955175|stage IIIA non-small cell lung cancer|stage iiia non-small cell lung cancer
616148|NCT00955175|stage IIIB non-small cell lung cancer|stage iiib non-small cell lung cancer
616149|NCT00955162|Substance Abuse, Intravenous|substance abuse, intravenous
616150|NCT00955162|Buprenorphine|buprenorphine
616151|NCT00955149|Primary sclerosing cholangitis|primary sclerosing cholangitis
616152|NCT00955149|Trisomy 7|trisomy 7
616153|NCT00955149|Cholangiocarcinoma|cholangiocarcinoma
616154|NCT00955149|Chemoprevention|chemoprevention
616155|NCT00955149|Erlotinib|erlotinib
616156|NCT00955136|ST elevated myocardial infarction|st elevated myocardial infarction
616157|NCT00955136|Acute coronary syndrome|acute coronary syndrome
616158|NCT00955136|MRX 801|mrx 801
616159|NCT00955136|Echocardiography|echocardiography
616160|NCT00955123|Inflammation|inflammation
616161|NCT00955123|Urea synthesis|urea synthesis
616162|NCT00955123|Catabolism|catabolism
616163|NCT00955123|Nitrogen balance|nitrogen balance
616164|NCT00955110|Opioid|opioid
616165|NCT00955110|Recreational|recreational
616166|NCT00955110|Oxymorphone|oxymorphone
616167|NCT00955110|Oxycodone|oxycodone
616168|NCT00955110|Extended Release|extended release
616169|NCT00955110|Healthy NonDependent Recreational Opioid Users|healthy nondependent recreational opioid users
616170|NCT00955097|Definity|definity
616171|NCT00955097|liver tumors|liver tumors
783432|NCT00316745|S-1|s-1
616172|NCT00955097|intra operative contrast|intra operative contrast
616173|NCT00955097|liver cancer|liver cancer
616174|NCT00955097|hepatic tumors|hepatic tumors
616175|NCT00955097|identify liver tumors|identify liver tumors
616176|NCT00955097|surgery liver tumors|surgery liver tumors
616177|NCT00955097|Patients with known hepatic tumors|patients with known hepatic tumors
616178|NCT00955071|exercise|exercise
616179|NCT00955071|physical activity|physical activity
616180|NCT00955071|diet|diet
616181|NCT00955071|metabolic risk|metabolic risk
616182|NCT00955071|visceral fat|visceral fat
616183|NCT00955071|Insulin Resistance|insulin resistance
616184|NCT00955058|PSA|psa
616185|NCT00955058|PCO|pco
616186|NCT00955058|PCOS|pcos
616187|NCT00955045|long-term tolerability and safety|long-term tolerability and safety
616188|NCT00955045|istradefylline treatment|istradefylline treatment
616189|NCT00955045|levodopa/carbidopa|levodopa/carbidopa
616190|NCT00955032|Parkinson's disease|parkinson's disease
616191|NCT00955032|Apathy|apathy
616192|NCT00955032|rTMS|rtms
616193|NCT00955032|Repetitive transcranial magnetic stimulation|repetitive transcranial magnetic stimulation
616194|NCT00955032|Depression|depression
616195|NCT00955019|Barrett's|barrett's
616196|NCT00955019|Esophagus|esophagus
616197|NCT00955019|Reflux|reflux
616198|NCT00955019|dysplasia|dysplasia
616199|NCT00955019|adenocarcinoma|adenocarcinoma
616200|NCT00955006|HIV Seronegativity|hiv seronegativity
616201|NCT00955006|HIV Preventive Vaccine|hiv preventive vaccine
616202|NCT00954993|Hepatitis C Virus (HCV)|hepatitis c virus (hcv)
616203|NCT00954993|Vaniprevir|vaniprevir
616204|NCT00954993|MK-7009|mk-7009
616205|NCT00954980|Varicose Veins|varicose veins
616206|NCT00954980|Superficial Thrombophlebitis|superficial thrombophlebitis
616207|NCT00954980|Deep Vein Thrombosis|deep vein thrombosis
616208|NCT00954980|Ulceration|ulceration
616209|NCT00954980|leg pain|leg pain
616210|NCT00954980|leg swelling|leg swelling
616211|NCT00954967|Diabetes Mellitus|diabetes mellitus
616212|NCT00954967|Smoking Cessation|smoking cessation
616213|NCT00954967|Primary Health Care|primary health care
616214|NCT00954967|Motivational Interview|motivational interview
616215|NCT00954954|Arthroplasty|arthroplasty
616216|NCT00954954|Replacement|replacement
616217|NCT00954954|Knee|knee
616218|NCT00954954|Range of Motion|range of motion
616219|NCT00954941|Hematologic Disorder|hematologic disorder
616220|NCT00954941|Acute myelogenous leukemia|acute myelogenous leukemia
616221|NCT00954941|AML|aml
616222|NCT00954941|High-risk myelodysplastic syndrome|high-risk myelodysplastic syndrome
616223|NCT00954941|HR-MDS|hr-mds
616224|NCT00954941|Chronic Myelogenous Leukemia|chronic myelogenous leukemia
616225|NCT00954941|CML|cml
616226|NCT00954941|Ondansetron|ondansetron
616227|NCT00954941|Zofran|zofran
616228|NCT00954941|Aprepitant|aprepitant
616229|NCT00954941|Emend|emend
616230|NCT00954941|L 754030|l 754030
616231|NCT00954941|MK 869|mk 869
616232|NCT00954941|Emesis|emesis
616233|NCT00954941|Nausea|nausea
616234|NCT00954941|Vomiting|vomiting
616235|NCT00954928|hand|hand
616236|NCT00954928|wrist|wrist
616237|NCT00954928|anticoagulation|anticoagulation
616238|NCT00954928|surgery|surgery
616239|NCT00954928|patients on anticoagulant medication|patients on anticoagulant medication
616240|NCT00954915|chronic plaque psoriasis|chronic plaque psoriasis
616241|NCT00954915|psoriatic arthritis|psoriatic arthritis
616242|NCT00954902|Spice|spice
616243|NCT00954902|responses to stress|responses to stress
616244|NCT00954902|Inflammatory|inflammatory
616245|NCT00954837|Thyroid cancer|thyroid cancer
616246|NCT00954837|thyroid FNA|thyroid fna
616247|NCT00954837|repeat FNA|repeat fna
616248|NCT00954837|thyroid screening|thyroid screening
616249|NCT00954837|thyroid ultrasonography|thyroid ultrasonography
616250|NCT00954837|FNA screening|fna screening
616251|NCT00954811|pregnancy|pregnancy
616252|NCT00954798|Influenza|influenza
616253|NCT00954798|Pandemic Flu|pandemic flu
616254|NCT00954798|Swine-origin Influenza|swine-origin influenza
616255|NCT00954798|Inactivated split-virion vaccine|inactivated split-virion vaccine
616256|NCT00954798|Adjuvant|adjuvant
616257|NCT00954798|Adult|adult
616258|NCT00954785|ankle|ankle
616259|NCT00954785|ligament|ligament
616260|NCT00954785|sprain|sprain
616261|NCT00954785|non-steroidal anti-inflammatory drugs|non-steroidal anti-inflammatory drugs
616262|NCT00954785|treatment|treatment
616263|NCT00954785|Acute ankle ligament sprain|acute ankle ligament sprain
616264|NCT00954772|Staged versus Simultaneous Bilateral DBS|staged versus simultaneous bilateral dbs
616265|NCT00954759|Infantile colic|infantile colic
616266|NCT00954759|Chiropractic|chiropractic
616267|NCT00954759|Manipulation|manipulation
616268|NCT00954759|Randomized controlled trial|randomized controlled trial
616269|NCT00954746|Advanced Dupuytren's Disease|advanced dupuytren's disease
616270|NCT00954746|Muscular Diseases|muscular diseases
616271|NCT00954746|Musculoskeletal Diseases|musculoskeletal diseases
783547|NCT00316264|RSV|rsv
616272|NCT00954746|Contracture Joint Diseases|contracture joint diseases
616273|NCT00954746|Connective Tissue Diseases|connective tissue diseases
616274|NCT00954746|Dupuytren's Contracture|dupuytren's contracture
616275|NCT00954733|Hysteroscopic surgery|hysteroscopic surgery
616276|NCT00954733|Hypoventilation|hypoventilation
616278|NCT00954733|Transcutaneous Co2 Monitor|transcutaneous co2 monitor
616280|NCT00954720|ALL|all
616281|NCT00954720|MDS|mds
616282|NCT00954720|iron overload|iron overload
616283|NCT00954707|Atherosclerosis|atherosclerosis
616284|NCT00954681|Cannabis|cannabis
616285|NCT00954681|quetiapine|quetiapine
616286|NCT00954668|Non-ST-elevation myocardial infarction|non-st-elevation myocardial infarction
616287|NCT00954668|angiography|angiography
616288|NCT00954668|percutaneous coronary intervention|percutaneous coronary intervention
616289|NCT00954668|timing|timing
616290|NCT00954655|gastrointestinal stromal tumor|gastrointestinal stromal tumor
616291|NCT00954642|Solid Tumor|solid tumor
616292|NCT00954642|Locally Advanced Solid Tumor|locally advanced solid tumor
616293|NCT00954642|Avastin|avastin
616294|NCT00954629|Osteoarthritis|osteoarthritis
616295|NCT00954629|Pain|pain
616296|NCT00954629|Knee|knee
616297|NCT00954616|Inappropriate Medications Associated|inappropriate medications associated
616298|NCT00954616|Alzheimer's disease|alzheimer's disease
616299|NCT00954603|delirium rating scale|delirium rating scale
616300|NCT00954603|clinical global improvement|clinical global improvement
616301|NCT00954603|extrapyramidal side effect|extrapyramidal side effect
616302|NCT00954577|obesity|obesity
616303|NCT00954577|diabetes|diabetes
616304|NCT00954577|exercise|exercise
616305|NCT00954577|education|education
616306|NCT00954577|child|child
616307|NCT00954564|arthralgia|arthralgia
616308|NCT00954564|stage I breast cancer|stage i breast cancer
616309|NCT00954564|stage II breast cancer|stage ii breast cancer
616310|NCT00954564|stage IIIA breast cancer|stage iiia breast cancer
616311|NCT00954525|Pancreatic Cancer|pancreatic cancer
616312|NCT00954512|Antibodies, neoplasm|antibodies, neoplasm
616313|NCT00954499|tactile stimulation|tactile stimulation
616314|NCT00954499|pain|pain
616315|NCT00954499|immunization|immunization
616316|NCT00954499|infant|infant
616317|NCT00954460|VPRIV|vpriv
616318|NCT00954460|Enzyme Replacement Therapy|enzyme replacement therapy
616319|NCT00954460|Gaucher disease|gaucher disease
616320|NCT00954460|glucocerebrosidase|glucocerebrosidase
616321|NCT00954460|beta-glucocerebrosidase|beta-glucocerebrosidase
616322|NCT00954460|Acid beta-glucocerebrosidase|acid beta-glucocerebrosidase
616323|NCT00954460|glucosylceramidase|glucosylceramidase
616324|NCT00954460|D-glucosyl-N-acylsphingosine glucohydrolase|d-glucosyl-n-acylsphingosine glucohydrolase
616325|NCT00954460|gene activation|gene activation
616326|NCT00954460|human|human
616327|NCT00954395|vitamin K antagonists, D-dimer,|vitamin k antagonists, d-dimer,
616328|NCT00954395|deep vein thrombosis, pulmonary embolism,|deep vein thrombosis, pulmonary embolism,
616329|NCT00954382|Down syndrome|down syndrome
616330|NCT00954382|IQ|iq
616331|NCT00954382|mental age|mental age
616332|NCT00954382|neuropsychological function|neuropsychological function
616333|NCT00954369|Alzheimer's disease|alzheimer's disease
616334|NCT00954369|AD|ad
616335|NCT00954369|W372|w372
616336|NCT00954369|W372000|w372000
616337|NCT00954369|[F-18]W372|[f-18]w372
616338|NCT00954369|exploratory|exploratory
616339|NCT00954369|imaging|imaging
616340|NCT00954356|Pain following 3rd molar/wisdom tooth extraction|pain following 3rd molar/wisdom tooth extraction
616341|NCT00954343|Foot Ulcers|foot ulcers
616342|NCT00954343|Extracorporeal Shockwave|extracorporeal shockwave
616343|NCT00954343|Chronic wound|chronic wound
616344|NCT00954330|rct, intervention, surgery, lateral ligament injury of the ankle|rct, intervention, surgery, lateral ligament injury of the ankle
616345|NCT00954330|REturn to pre-injury level|return to pre-injury level
616346|NCT00954317|epidural|epidural
616347|NCT00954317|labour analgesia|labour analgesia
616348|NCT00954304|Pgp inhibitor|pgp inhibitor
616349|NCT00954304|P-glycoprotein inhibitor|p-glycoprotein inhibitor
616350|NCT00954291|antinauseant and antiemetic|antinauseant and antiemetic
616351|NCT00954278|non small cell lung cancer|non small cell lung cancer
616352|NCT00954278|phase 1|phase 1
616353|NCT00954278|sorafenib|sorafenib
616354|NCT00954278|intrapatient dose escalation|intrapatient dose escalation
616355|NCT00954265|pregnancy occurence|pregnancy occurence
616356|NCT00954265|OHSS|ohss
616357|NCT00954161|First aid|first aid
616358|NCT00954161|Helping behaviour|helping behaviour
616359|NCT00954161|Health education|health education
616360|NCT00954161|Myocardial infarction|myocardial infarction
616361|NCT00954161|Emergencies|emergencies
616362|NCT00954148|cancer|cancer
616363|NCT00954148|colorectal|colorectal
616364|NCT00954148|head/neck|head/neck
616365|NCT00954148|lung|lung
616366|NCT00954148|PET/CT|pet/ct
616367|NCT00954135|neoadjuvant therapy, sorafenib, letrozolo, cyclophosphamide|neoadjuvant therapy, sorafenib, letrozolo, cyclophosphamide
616368|NCT00954122|Acute schizophrenia|acute schizophrenia
616369|NCT00954109|Insulin Resistance|insulin resistance
616370|NCT00954109|Type 2 Diabetes|type 2 diabetes
616371|NCT00954070|gastroesophageal reflux disease|gastroesophageal reflux disease
616372|NCT00954057|TED|ted
616373|NCT00954044|randomized clinical trial|randomized clinical trial
616374|NCT00954044|prostate cancer|prostate cancer
616375|NCT00954044|partnered exercise|partnered exercise
616376|NCT00954005|relapsed indolent lymphoma|relapsed indolent lymphoma
616377|NCT00954005|gemcitabine|gemcitabine
616378|NCT00954005|oxaliplatin|oxaliplatin
616379|NCT00954005|rituximab|rituximab
616380|NCT00953992|acute kidney disease|acute kidney disease
616381|NCT00953992|prognosis|prognosis
616382|NCT00953992|oxidative stress|oxidative stress
616383|NCT00953992|inflammation|inflammation
616384|NCT00953992|gene polymorphism|gene polymorphism
616385|NCT00953979|ankylosing spondylitis|ankylosing spondylitis
616386|NCT00953979|treatment|treatment
616387|NCT00953979|Sulfasalazine|sulfasalazine
616388|NCT00953979|kunxian capsule|kunxian capsule
616389|NCT00953914|pyridostigmine|pyridostigmine
616390|NCT00953914|autonomic modulation|autonomic modulation
616391|NCT00953914|diabetes mellitus|diabetes mellitus
616392|NCT00953914|heart rate variability|heart rate variability
616393|NCT00953888|Healthy volunteer|healthy volunteer
616394|NCT00953888|Single ascending dose|single ascending dose
616395|NCT00953888|Safety|safety
616396|NCT00953888|Tolerability|tolerability
616397|NCT00953888|Healthy volunteer study|healthy volunteer study
616398|NCT00953862|ADHD|adhd
616399|NCT00953862|Substance Use Disorder|substance use disorder
616400|NCT00953862|Residential Treatment Facility|residential treatment facility
616401|NCT00953849|Calcitriol|calcitriol
616402|NCT00953849|Celecoxib|celecoxib
616403|NCT00953849|Immunotherapy|immunotherapy
616404|NCT00953836|kinetics|kinetics
616405|NCT00953836|alkylresorcinol metabolites|alkylresorcinol metabolites
616406|NCT00953836|rye fiber|rye fiber
616407|NCT00953823|Thiamin supplementation|thiamin supplementation
616408|NCT00953823|Thiamin deficiency|thiamin deficiency
616409|NCT00953823|Heart failure|heart failure
616410|NCT00953823|Heart function|heart function
616411|NCT00953823|Vitamin B1 supplementation|vitamin b1 supplementation
616412|NCT00953810|heart failure|heart failure
616413|NCT00953810|education|education
616414|NCT00953810|non-pharmacological management|non-pharmacological management
616415|NCT00953810|prognosis|prognosis
616416|NCT00953797|Resistant Hypertension|resistant hypertension
616417|NCT00953797|Endothelial dysfunction|endothelial dysfunction
616418|NCT00953797|Enhanced External Counterpulsation|enhanced external counterpulsation
616419|NCT00953784|surgery|surgery
616420|NCT00953784|wound infections|wound infections
616421|NCT00953784|colorectal|colorectal
616422|NCT00953771|TTP|ttp
616423|NCT00953771|Thrombotic Thrombocytopenic Purpura|thrombotic thrombocytopenic purpura
616424|NCT00953758|Chronic Myeloid Leukemia Myelofibrosis Myelodysplastic Syndrome Acute myeloid Leukemia Hedgehog inhibitor|chronic myeloid leukemia myelofibrosis myelodysplastic syndrome acute myeloid leukemia hedgehog inhibitor
616425|NCT00953745|Depression|depression
616426|NCT00953745|Neuroimaging|neuroimaging
616427|NCT00953745|Aripiprazole|aripiprazole
616428|NCT00953745|Mood disorder|mood disorder
616429|NCT00953745|PET Scan|pet scan
616430|NCT00953745|fMRI|fmri
616431|NCT00953732|Peplin|peplin
616432|NCT00953732|Actinic keratosis|actinic keratosis
616433|NCT00953732|PEP005|pep005
616434|NCT00953719|Hip arthroplasty|hip arthroplasty
616435|NCT00953719|Acetabular cup|acetabular cup
616436|NCT00953719|Ceramic-on-polyethylene|ceramic-on-polyethylene
616437|NCT00953706|Fibrosis|fibrosis
616438|NCT00953706|Pancreatic Diseases|pancreatic diseases
616439|NCT00953706|Digestive System Diseases|digestive system diseases
616440|NCT00953706|Lung Diseases|lung diseases
616441|NCT00953706|Respiratory Tract Diseases|respiratory tract diseases
616442|NCT00953706|Genetic Diseases, Inborn|genetic diseases, inborn
616443|NCT00953706|Infant, Newborn, Diseases|infant, newborn, diseases
616444|NCT00953706|Pathologic Processes|pathologic processes
616445|NCT00953693|Induced pluripotent stem cells|induced pluripotent stem cells
616446|NCT00953693|Hepatic disorders|hepatic disorders
616447|NCT00953693|Eye disorders|eye disorders
616448|NCT00953693|Blood groups|blood groups
616449|NCT00953654|Generalized Anxiety Disorder|generalized anxiety disorder
616450|NCT00953654|Exercise Training|exercise training
616451|NCT00953654|Strength Training|strength training
616452|NCT00953654|Mental Health|mental health
616453|NCT00953641|Vaginal Misoprostol|vaginal misoprostol
616454|NCT00953641|Cervical ripening|cervical ripening
616455|NCT00953641|Endometrial biopsy|endometrial biopsy
616456|NCT00953628|endometrium|endometrium
616457|NCT00953628|histology|histology
616458|NCT00953628|pregnancy|pregnancy
616460|NCT00953615|Thalidomide|thalidomide
616461|NCT00953589|treatment naive|treatment naive
616462|NCT00953576|castration resistant prostate cancer|castration resistant prostate cancer
616463|NCT00953576|KHAD|khad
616464|NCT00953563|Venous Leg Ulcers|venous leg ulcers
616465|NCT00953537|stage IV breast cancer|stage iv breast cancer
616466|NCT00953524|Influenza|influenza
616467|NCT00953524|Pandemic Flu|pandemic flu
616468|NCT00953524|Swine-origin A/H1N1 Influenza|swine-origin a/h1n1 influenza
616469|NCT00953524|Adult|adult
616470|NCT00953511|esophagus|esophagus
616471|NCT00953511|chemoradiation|chemoradiation
616472|NCT00953511|excision repair cross-complementing gene|excision repair cross-complementing gene
616473|NCT00953511|polymorphism|polymorphism
616474|NCT00953511|response prediction|response prediction
616475|NCT00953498|diabetes|diabetes
616476|NCT00953498|glitazones|glitazones
616477|NCT00953498|HDL|hdl
616478|NCT00953485|Sjogren's Syndrome|sjogren's syndrome
616479|NCT00953485|Mesenchymal Stem Cells|mesenchymal stem cells
616480|NCT00953485|Transplantation|transplantation
616481|NCT00953472|hypertension treatment|hypertension treatment
616482|NCT00953459|extensive stage small cell lung cancer|extensive stage small cell lung cancer
616483|NCT00953459|recurrent small cell lung cancer|recurrent small cell lung cancer
616484|NCT00953446|metastatic renal cell carcinoma|metastatic renal cell carcinoma
616485|NCT00953446|ASL MRI|asl mri
616486|NCT00953446|sunitinib|sunitinib
616487|NCT00953446|AMG386|amg386
616488|NCT00953433|Intratracheal|intratracheal
616489|NCT00953420|nasopharyngeal carcinoma|nasopharyngeal carcinoma
616490|NCT00953420|Carboplatin|carboplatin
616491|NCT00953420|Docetaxel|docetaxel
616492|NCT00953420|Epstein-Barr Virus|epstein-barr virus
616493|NCT00953420|T Lymphocytes|t lymphocytes
616494|NCT00953420|EBV-CTLs|ebv-ctls
616495|NCT00953394|octreotide LAR|octreotide lar
616496|NCT00953394|neuroendocrine carcinoma|neuroendocrine carcinoma
616497|NCT00953394|metronomic 5fluorouracil|metronomic 5fluorouracil
616498|NCT00953381|Ilaprazole|ilaprazole
616499|NCT00953381|Proton pump inhibitor|proton pump inhibitor
616500|NCT00953381|Duodenal ulcer|duodenal ulcer
616501|NCT00953381|Acid suppression|acid suppression
616502|NCT00953381|Randomized trial|randomized trial
616503|NCT00953368|remote ischemic preconditioning|remote ischemic preconditioning
616504|NCT00953368|cognitive function|cognitive function
616505|NCT00953368|off-pump coronary artery bypass graft|off-pump coronary artery bypass graft
616506|NCT00953342|AEROBIC EXERCISE|aerobic exercise
616507|NCT00953342|ASTHMA CONTROL|asthma control
616508|NCT00953342|ASTHMA QUALITY OF LIFE|asthma quality of life
616509|NCT00953342|INFLAMMATION|inflammation
616510|NCT00953342|TREATMENT|treatment
616511|NCT00953303|heart failure|heart failure
616512|NCT00953303|prednisone|prednisone
616513|NCT00953303|cardiovascular mortality|cardiovascular mortality
616514|NCT00953303|renal function|renal function
616515|NCT00953290|Cellulite|cellulite
616516|NCT00953290|Adipose tissue|adipose tissue
616517|NCT00953290|Circumference|circumference
616518|NCT00953290|Reduction|reduction
616519|NCT00953290|Thigh|thigh
616520|NCT00953277|Nerve Repair|nerve repair
616521|NCT00953277|Erectile Function|erectile function
616522|NCT00953277|Prostate Cancer|prostate cancer
616523|NCT00953277|Robot Assisted Laparoscopic Prostatectomy|robot assisted laparoscopic prostatectomy
616524|NCT00953277|Continence|continence
616525|NCT00953251|high sensitive troponin T; non-STEMI; early detection.|high sensitive troponin t; non-stemi; early detection.
616526|NCT00953251|To detect non-STEMI in a cohort of patients with acute coronary syndrome|to detect non-stemi in a cohort of patients with acute coronary syndrome
616527|NCT00953225|prostate cancer|prostate cancer
616528|NCT00953225|vitamin D|vitamin d
616529|NCT00953212|atrial fibrillation|atrial fibrillation
616530|NCT00953212|cardiac surgery|cardiac surgery
616531|NCT00953212|open heart surgery|open heart surgery
616532|NCT00953199|endoscopic retrograde cholangiopancreatography|endoscopic retrograde cholangiopancreatography
616533|NCT00953199|ERCP|ercp
616534|NCT00953199|pancreatitis|pancreatitis
616535|NCT00953199|lidocaine|lidocaine
616536|NCT00953199|post-ERCP pancreatitis|post-ercp pancreatitis
616537|NCT00953186|Diabetes|diabetes
616538|NCT00953186|Foot ulcer|foot ulcer
616539|NCT00953186|Neuropathy|neuropathy
616540|NCT00953186|Ischemia|ischemia
616541|NCT00953160|Cellulite|cellulite
616542|NCT00953160|Adipose tissue|adipose tissue
616543|NCT00953160|Circumference|circumference
616544|NCT00953160|Reduction|reduction
616545|NCT00953160|Thigh|thigh
616546|NCT00953160|Abdomen|abdomen
616547|NCT00953160|Flank|flank
616548|NCT00953134|periconceptional|periconceptional
616549|NCT00953134|iron|iron
616550|NCT00953134|folic acid|folic acid
616551|NCT00953134|supplementation|supplementation
616552|NCT00953121|irinotecan|irinotecan
616553|NCT00953121|carboplatin|carboplatin
616554|NCT00953121|bevacizumab|bevacizumab
616555|NCT00953121|Avastin|avastin
616556|NCT00953095|Autism Spectrum Disorder|autism spectrum disorder
616557|NCT00953095|treatment|treatment
616558|NCT00953095|joint attention|joint attention
616559|NCT00953095|communication|communication
616560|NCT00953095|language|language
616561|NCT00953043|lubiprostone|lubiprostone
616562|NCT00953043|colon|colon
616563|NCT00953043|motility|motility
616564|NCT00953043|sensation|sensation
616565|NCT00953017|Efficacy of bowel cleansing|efficacy of bowel cleansing
616566|NCT00953017|Patient tolerability|patient tolerability
616567|NCT00953017|Amitiza|amitiza
616568|NCT00953017|Dulcolax|dulcolax
616569|NCT00953017|Miralax|miralax
616570|NCT00953017|Colonoscopy preparation|colonoscopy preparation
616571|NCT00953017|Bowel preparation|bowel preparation
616572|NCT00953017|Screening colonoscopy|screening colonoscopy
616573|NCT00953004|dietary fiber|dietary fiber
616574|NCT00953004|obesity|obesity
616575|NCT00953004|apparent energy digestibility|apparent energy digestibility
616576|NCT00952978|Ilaprazole|ilaprazole
616577|NCT00952978|Proton pump inhibitor|proton pump inhibitor
616578|NCT00952978|Duodenal ulcer|duodenal ulcer
616579|NCT00952978|Acid suppression|acid suppression
616580|NCT00952978|Randomized trial|randomized trial
616581|NCT00952965|BP|bp
616582|NCT00952939|ciliary body and choroid melanoma, small size|ciliary body and choroid melanoma, small size
616583|NCT00952939|iris melanoma|iris melanoma
616584|NCT00952939|intraocular melanoma|intraocular melanoma
616585|NCT00952939|ciliary body and choroid melanoma, medium/large size|ciliary body and choroid melanoma, medium/large size
616586|NCT00952926|Watchful Waiting|watchful waiting
616587|NCT00952926|Rectal cancer|rectal cancer
616588|NCT00952926|Observation|observation
616589|NCT00952926|Avoid operation|avoid operation
616590|NCT00952900|TMJMD|tmjmd
616591|NCT00952900|Acute Pain|acute pain
616592|NCT00952900|RDC/TMD|rdc/tmd
616593|NCT00952900|Community Treatment Clinics|community treatment clinics
616594|NCT00952900|RCT|rct
616595|NCT00952900|Evidence-Based Outcomes|evidence-based outcomes
616596|NCT00952900|Short- and long-term follow-up|short- and long-term follow-up
616597|NCT00952900|Biopsychosocial|biopsychosocial
616598|NCT00952900|Assessment and Treatment|assessment and treatment
616599|NCT00952900|Ability to read and write English|ability to read and write english
616600|NCT00952900|6 months' or less duration of TMD|6 months' or less duration of tmd
616601|NCT00952900|No other pain-related conditions|no other pain-related conditions
616602|NCT00952874|anal cancer|anal cancer
616603|NCT00952874|Molecular biology|molecular biology
616604|NCT00952874|HIV status|hiv status
616605|NCT00952874|HPV infection|hpv infection
616606|NCT00952874|Microsatellite instability|microsatellite instability
616607|NCT00952874|Biopsy proven Squamous Cell carcinoma of the Anus|biopsy proven squamous cell carcinoma of the anus
616608|NCT00952874|Squamous Cell carcinoma of the Anus|squamous cell carcinoma of the anus
616609|NCT00952861|Chronic obstructive pulmonary disease|chronic obstructive pulmonary disease
616610|NCT00952861|Infection|infection
616611|NCT00952861|Antibiotics|antibiotics
616612|NCT00952848|pain|pain
616613|NCT00952848|neurotoxicity|neurotoxicity
616614|NCT00952848|chemotherapeutic agent toxicity|chemotherapeutic agent toxicity
616615|NCT00952848|unspecified adult solid tumor, protocol specific|unspecified adult solid tumor, protocol specific
616616|NCT00952848|peripheral neuropathy|peripheral neuropathy
616617|NCT00952835|Asthma|asthma
616618|NCT00952835|rhinitis|rhinitis
616619|NCT00952835|EIB|eib
616620|NCT00952835|Exhaled Nitric oxide|exhaled nitric oxide
616621|NCT00952835|lung function|lung function
616622|NCT00952835|vitamin d|vitamin d
616623|NCT00952796|intra-abdominal infection|intra-abdominal infection
616624|NCT00952796|moxifloxacin|moxifloxacin
616625|NCT00952796|ampicillin/sulbactam|ampicillin/sulbactam
616626|NCT00952783|Peplin|peplin
616627|NCT00952783|Actinic keratosis|actinic keratosis
616628|NCT00952783|PEP005|pep005
616629|NCT00952770|Coronary artery disease|coronary artery disease
616630|NCT00952770|Coronary intervention|coronary intervention
616631|NCT00952770|intima-media thickness|intima-media thickness
616632|NCT00952757|APS-related hyperprolactinaemia|aps-related hyperprolactinaemia
616633|NCT00952757|Quetiapine|quetiapine
616634|NCT00952757|Schizophrenia|schizophrenia
616635|NCT00952757|Bipolar|bipolar
616636|NCT00952744|acute myocardial infarction|acute myocardial infarction
616637|NCT00952744|ST-segment elevation myocardial infarction|st-segment elevation myocardial infarction
616638|NCT00952744|STEMI|stemi
616639|NCT00952744|non-ST-segment elevation myocardial infarction|non-st-segment elevation myocardial infarction
616640|NCT00952744|NSTEMI|nstemi
616641|NCT00952744|unstable angina|unstable angina
616642|NCT00952744|unstable angina pectoris|unstable angina pectoris
616643|NCT00952744|UA|ua
616644|NCT00952744|UAP|uap
616645|NCT00952692|breast cancer|breast cancer
616646|NCT00952692|HER2|her2
616647|NCT00952692|Lapatinib|lapatinib
616648|NCT00952692|dHER2 ASCI|dher2 asci
616649|NCT00952692|overexpressing HER2|overexpressing her2
616650|NCT00952692|refractory to trastuzumab|refractory to trastuzumab
616651|NCT00952679|The investigators evaluated the new method by comparing lymph nodes defined by CT and traditional ways.|the investigators evaluated the new method by comparing lymph nodes defined by ct and traditional ways.
616652|NCT00952666|Prostate Cancer|prostate cancer
616653|NCT00952666|Transrectal Ultrasound Imaging of Prostate|transrectal ultrasound imaging of prostate
616654|NCT00952666|Neurovascular Bundles|neurovascular bundles
616655|NCT00952666|Robot Assisted Laparoscopic Radical Prostatectomy|robot assisted laparoscopic radical prostatectomy
784064|NCT00314418|time|time
616656|NCT00952653|depression|depression
616657|NCT00952640|vitamin A|vitamin a
616658|NCT00952640|post-partum|post-partum
616659|NCT00952640|infant|infant
616660|NCT00952640|acute phase response|acute phase response
616661|NCT00952627|Cardiac fibrosis|cardiac fibrosis
616662|NCT00952627|Diastolic dysfunction|diastolic dysfunction
616663|NCT00952627|Hypertension|hypertension
616664|NCT00952614|retinal vein occlusion|retinal vein occlusion
616665|NCT00952614|sustained drug delivery implant|sustained drug delivery implant
616666|NCT00952614|steroid|steroid
616667|NCT00952614|macular edema|macular edema
616668|NCT00952601|Tourette|tourette
616669|NCT00952601|Atkins|atkins
616670|NCT00952601|Ketosis|ketosis
616671|NCT00952601|Tic|tic
616672|NCT00952588|Acute Myeloid Leukaemia,|acute myeloid leukaemia,
616673|NCT00952588|AML|aml
616674|NCT00952575|Prevention of foeto-maternal allo-immunisation|prevention of foeto-maternal allo-immunisation
616675|NCT00952562|vitamin d|vitamin d
616676|NCT00952562|calcium|calcium
616677|NCT00952562|blood pressure|blood pressure
616678|NCT00952536|Randomised controlled trial|randomised controlled trial
616679|NCT00952536|Double blind fully masked|double blind fully masked
616680|NCT00952536|Dietary supplement|dietary supplement
616681|NCT00952523|acne|acne
616682|NCT00952523|irritation|irritation
616683|NCT00952523|objective sensory methods|objective sensory methods
616684|NCT00952510|Range of motion, articular|range of motion, articular
616685|NCT00952510|Cervical spine|cervical spine
616686|NCT00952497|Gastric Cancer|gastric cancer
616687|NCT00952497|Gastro-Esophageal Cancer|gastro-esophageal cancer
616688|NCT00952497|GE-Junction|ge-junction
616689|NCT00952497|Advanced Gastric Cancer|advanced gastric cancer
616690|NCT00952484|Hypophosphatasia|hypophosphatasia
616691|NCT00952484|HPP|hpp
616692|NCT00952484|Bone Disease|bone disease
616693|NCT00952484|Soft Bones|soft bones
616694|NCT00952484|Low Alkaline Phosphatase|low alkaline phosphatase
616695|NCT00952484|genetic metabolic disorder|genetic metabolic disorder
616696|NCT00952484|alkaline phosphatase|alkaline phosphatase
616697|NCT00952484|tissue non-specific alkaline phosphatase|tissue non-specific alkaline phosphatase
616698|NCT00952484|rickets|rickets
616699|NCT00952484|osteomalacia|osteomalacia
616700|NCT00952471|Asthma|asthma
616701|NCT00952471|Children|children
616702|NCT00952471|CPOE|cpoe
616703|NCT00952471|Decision Support|decision support
616704|NCT00952471|Framing|framing
616705|NCT00952471|Heuristic|heuristic
616706|NCT00952471|Order Sets|order sets
616707|NCT00952458|Safety|safety
616708|NCT00952458|Midazolam and propofol sedation|midazolam and propofol sedation
616709|NCT00952458|ERCP|ercp
616710|NCT00952458|Bispectral Index monitoring|bispectral index monitoring
616711|NCT00952432|Carpal Tunnel Syndrome|carpal tunnel syndrome
616712|NCT00952432|Multiple Excitability Test|multiple excitability test
616713|NCT00952432|Nerve Conduction Study|nerve conduction study
616714|NCT00952432|QtracW|qtracw
616715|NCT00952432|carbamazepine|carbamazepine
616716|NCT00952432|Acupuncture|acupuncture
616717|NCT00952419|Influenza|influenza
616718|NCT00952419|Pandemic Flu|pandemic flu
616719|NCT00952419|Swine-origin A/H1N1 Influenza|swine-origin a/h1n1 influenza
616720|NCT00952419|Children|children
616721|NCT00952406|Pelvic Floor Disorders|pelvic floor disorders
616722|NCT00952406|Sexual Function|sexual function
616723|NCT00952406|Incontinence|incontinence
616724|NCT00952406|Pelvic Organ Prolapse|pelvic organ prolapse
616725|NCT00952393|receptors nicotinic|receptors nicotinic
616726|NCT00952380|VTE|vte
616727|NCT00952354|Down syndrome|down syndrome
616728|NCT00952354|MLU|mlu
616729|NCT00952354|language development|language development
616730|NCT00952354|language assessment|language assessment
616731|NCT00952341|CINV|cinv
616732|NCT00952328|breastfeeding outcomes|breastfeeding outcomes
616733|NCT00952328|breastfeeding self-efficacy|breastfeeding self-efficacy
616734|NCT00952328|infant weight loss|infant weight loss
616735|NCT00952315|kidney stones|kidney stones
616736|NCT00952315|intracorporeal lithotriptors|intracorporeal lithotriptors
616737|NCT00952315|kidney stone removal|kidney stone removal
616738|NCT00952302|Hypoxia|hypoxia
616739|NCT00952302|Iron|iron
616740|NCT00952302|Hypoxia-Inducible Factor 1|hypoxia-inducible factor 1
616741|NCT00952302|Chronic mountain sickness|chronic mountain sickness
616742|NCT00952289|Myelofibrosis|myelofibrosis
616743|NCT00952289|Post-Polycythemia Vera Myelofibrosis|post-polycythemia vera myelofibrosis
616744|NCT00952289|Post-Essential Thrombocythemia Myelofibrosis|post-essential thrombocythemia myelofibrosis
616745|NCT00952276|Influenza Pandemic Flu Swine-origin A/H1N1 Influenza Adults|influenza pandemic flu swine-origin a/h1n1 influenza adults
616746|NCT00952263|Hepatitis C|hepatitis c
616747|NCT00952263|Phase I|phase i
616748|NCT00952263|Infusion|infusion
616749|NCT00952263|Pharmacokinetics|pharmacokinetics
616750|NCT00952263|MBL-HCV1|mbl-hcv1
616751|NCT00952263|Monoclonal antibody|monoclonal antibody
616752|NCT00952263|Safety Assessment|safety assessment
616753|NCT00952250|quality improvement|quality improvement
616754|NCT00952237|Autologous Peripheral Blood Stem Cell Transplant|autologous peripheral blood stem cell transplant
616755|NCT00952237|IL-2|il-2
616756|NCT00952237|GM-CSF|gm-csf
616757|NCT00952224|myocardial salvage|myocardial salvage
616758|NCT00952224|cardiovascular magnetic resonance|cardiovascular magnetic resonance
616759|NCT00952224|magnetic resonance imaging|magnetic resonance imaging
616760|NCT00952224|myocardial infarction|myocardial infarction
616761|NCT00952224|prognosis|prognosis
616762|NCT00952211|stroke|stroke
616763|NCT00952211|obstructive sleep apnea|obstructive sleep apnea
616764|NCT00952211|fatigue|fatigue
616765|NCT00952211|quality of life|quality of life
616766|NCT00952185|viral infection|viral infection
616767|NCT00952185|aplastic anemia|aplastic anemia
616768|NCT00952185|accelerated phase chronic myelogenous leukemia|accelerated phase chronic myelogenous leukemia
616769|NCT00952185|acute undifferentiated leukemia|acute undifferentiated leukemia
616770|NCT00952185|adult acute lymphoblastic leukemia in remission|adult acute lymphoblastic leukemia in remission
616771|NCT00952185|adult acute myeloid leukemia in remission|adult acute myeloid leukemia in remission
616772|NCT00952185|adult acute myeloid leukemia with 11q23 (MLL) abnormalities|adult acute myeloid leukemia with 11q23 (mll) abnormalities
616773|NCT00952185|adult acute myeloid leukemia with inv(16)(p13;q22)|adult acute myeloid leukemia with inv(16)(p13;q22)
616774|NCT00952185|adult acute myeloid leukemia with t(15;17)(q22;q12)|adult acute myeloid leukemia with t(15;17)(q22;q12)
616775|NCT00952185|adult acute myeloid leukemia with t(16;16)(p13;q22)|adult acute myeloid leukemia with t(16;16)(p13;q22)
616776|NCT00952185|adult acute myeloid leukemia with t(8;21)(q22;q22)|adult acute myeloid leukemia with t(8;21)(q22;q22)
616777|NCT00952185|atypical chronic myeloid leukemia, BCR-ABL negative|atypical chronic myeloid leukemia, bcr-abl negative
616778|NCT00952185|blastic phase chronic myelogenous leukemia|blastic phase chronic myelogenous leukemia
616779|NCT00952185|chronic myelomonocytic leukemia|chronic myelomonocytic leukemia
616780|NCT00952185|chronic phase chronic myelogenous leukemia|chronic phase chronic myelogenous leukemia
616781|NCT00952185|mast cell leukemia|mast cell leukemia
616782|NCT00952185|meningeal chronic myelogenous leukemia|meningeal chronic myelogenous leukemia
616783|NCT00952185|progressive hairy cell leukemia, initial treatment|progressive hairy cell leukemia, initial treatment
616784|NCT00952185|prolymphocytic leukemia|prolymphocytic leukemia
616785|NCT00952185|recurrent adult acute lymphoblastic leukemia|recurrent adult acute lymphoblastic leukemia
616786|NCT00952185|recurrent adult acute myeloid leukemia|recurrent adult acute myeloid leukemia
616787|NCT00952185|recurrent adult T-cell leukemia/lymphoma|recurrent adult t-cell leukemia/lymphoma
616788|NCT00952185|refractory chronic lymphocytic leukemia|refractory chronic lymphocytic leukemia
616789|NCT00952185|refractory hairy cell leukemia|refractory hairy cell leukemia
616790|NCT00952185|relapsing chronic myelogenous leukemia|relapsing chronic myelogenous leukemia
616791|NCT00952185|secondary acute myeloid leukemia|secondary acute myeloid leukemia
616792|NCT00952185|stage 0 chronic lymphocytic leukemia|stage 0 chronic lymphocytic leukemia
616793|NCT00952185|stage I adult T-cell leukemia/lymphoma|stage i adult t-cell leukemia/lymphoma
616794|NCT00952185|stage I chronic lymphocytic leukemia|stage i chronic lymphocytic leukemia
616795|NCT00952185|stage II adult T-cell leukemia/lymphoma|stage ii adult t-cell leukemia/lymphoma
616796|NCT00952185|stage II chronic lymphocytic leukemia|stage ii chronic lymphocytic leukemia
616797|NCT00952185|stage III adult T-cell leukemia/lymphoma|stage iii adult t-cell leukemia/lymphoma
616798|NCT00952185|stage III chronic lymphocytic leukemia|stage iii chronic lymphocytic leukemia
616799|NCT00952185|stage IV adult T-cell leukemia/lymphoma|stage iv adult t-cell leukemia/lymphoma
616800|NCT00952185|stage IV chronic lymphocytic leukemia|stage iv chronic lymphocytic leukemia
616801|NCT00952185|T-cell large granular lymphocyte leukemia|t-cell large granular lymphocyte leukemia
616802|NCT00952185|recurrent adult Hodgkin lymphoma|recurrent adult hodgkin lymphoma
616803|NCT00952185|stage I adult Hodgkin lymphoma|stage i adult hodgkin lymphoma
616804|NCT00952185|stage II adult Hodgkin lymphoma|stage ii adult hodgkin lymphoma
616805|NCT00952185|stage III adult Hodgkin lymphoma|stage iii adult hodgkin lymphoma
616806|NCT00952185|stage IV adult Hodgkin lymphoma|stage iv adult hodgkin lymphoma
616807|NCT00952185|anaplastic large cell lymphoma|anaplastic large cell lymphoma
616808|NCT00952185|angioimmunoblastic T-cell lymphoma|angioimmunoblastic t-cell lymphoma
616809|NCT00952185|cutaneous B-cell non-Hodgkin lymphoma|cutaneous b-cell non-hodgkin lymphoma
616810|NCT00952185|recurrent cutaneous T-cell non-Hodgkin lymphoma|recurrent cutaneous t-cell non-hodgkin lymphoma
616811|NCT00952185|stage I cutaneous T-cell non-Hodgkin lymphoma|stage i cutaneous t-cell non-hodgkin lymphoma
616812|NCT00952185|stage II cutaneous T-cell non-Hodgkin lymphoma|stage ii cutaneous t-cell non-hodgkin lymphoma
616813|NCT00952185|stage III cutaneous T-cell non-Hodgkin lymphoma|stage iii cutaneous t-cell non-hodgkin lymphoma
616814|NCT00952185|stage IV cutaneous T-cell non-Hodgkin lymphoma|stage iv cutaneous t-cell non-hodgkin lymphoma
616815|NCT00952185|recurrent mycosis fungoides/Sezary syndrome|recurrent mycosis fungoides/sezary syndrome
616816|NCT00952185|stage I mycosis fungoides/Sezary syndrome|stage i mycosis fungoides/sezary syndrome
616817|NCT00952185|stage II mycosis fungoides/Sezary syndrome|stage ii mycosis fungoides/sezary syndrome
616818|NCT00952185|stage III mycosis fungoides/Sezary syndrome|stage iii mycosis fungoides/sezary syndrome
616819|NCT00952185|stage IV mycosis fungoides/Sezary syndrome|stage iv mycosis fungoides/sezary syndrome
616820|NCT00952185|adult grade III lymphomatoid granulomatosis|adult grade iii lymphomatoid granulomatosis
616821|NCT00952185|adult nasal type extranodal NK/T-cell lymphoma|adult nasal type extranodal nk/t-cell lymphoma
616822|NCT00952185|Waldenstrom macroglobulinemia|waldenstrom macroglobulinemia
616823|NCT00952185|extranodal marginal zone B-cell lymphoma of mucosa-associated lymphoid tissue|extranodal marginal zone b-cell lymphoma of mucosa-associated lymphoid tissue
616824|NCT00952185|nodal marginal zone B-cell lymphoma|nodal marginal zone b-cell lymphoma
616825|NCT00952185|splenic marginal zone lymphoma|splenic marginal zone lymphoma
616826|NCT00952185|contiguous stage II adult Burkitt lymphoma|contiguous stage ii adult burkitt lymphoma
616827|NCT00952185|contiguous stage II adult diffuse large cell lymphoma|contiguous stage ii adult diffuse large cell lymphoma
616828|NCT00952185|contiguous stage II adult diffuse mixed cell lymphoma|contiguous stage ii adult diffuse mixed cell lymphoma
616829|NCT00952185|contiguous stage II adult diffuse small cleaved cell lymphoma|contiguous stage ii adult diffuse small cleaved cell lymphoma
616830|NCT00952185|contiguous stage II adult immunoblastic large cell lymphoma|contiguous stage ii adult immunoblastic large cell lymphoma
616831|NCT00952185|contiguous stage II adult lymphoblastic lymphoma|contiguous stage ii adult lymphoblastic lymphoma
616832|NCT00952185|contiguous stage II grade 1 follicular lymphoma|contiguous stage ii grade 1 follicular lymphoma
616833|NCT00952185|contiguous stage II grade 2 follicular lymphoma|contiguous stage ii grade 2 follicular lymphoma
616834|NCT00952185|contiguous stage II grade 3 follicular lymphoma|contiguous stage ii grade 3 follicular lymphoma
616835|NCT00952185|contiguous stage II mantle cell lymphoma|contiguous stage ii mantle cell lymphoma
616836|NCT00952185|contiguous stage II marginal zone lymphoma|contiguous stage ii marginal zone lymphoma
616837|NCT00952185|contiguous stage II small lymphocytic lymphoma|contiguous stage ii small lymphocytic lymphoma
616838|NCT00952185|stage I adult Burkitt lymphoma|stage i adult burkitt lymphoma
616839|NCT00952185|stage I adult diffuse large cell lymphoma|stage i adult diffuse large cell lymphoma
616840|NCT00952185|stage I adult diffuse mixed cell lymphoma|stage i adult diffuse mixed cell lymphoma
616841|NCT00952185|stage I adult diffuse small cleaved cell lymphoma|stage i adult diffuse small cleaved cell lymphoma
616842|NCT00952185|stage I adult immunoblastic large cell lymphoma|stage i adult immunoblastic large cell lymphoma
616843|NCT00952185|stage I adult lymphoblastic lymphoma|stage i adult lymphoblastic lymphoma
616844|NCT00952185|stage I grade 1 follicular lymphoma|stage i grade 1 follicular lymphoma
616845|NCT00952185|stage I grade 2 follicular lymphoma|stage i grade 2 follicular lymphoma
616846|NCT00952185|stage I grade 3 follicular lymphoma|stage i grade 3 follicular lymphoma
616847|NCT00952185|stage I mantle cell lymphoma|stage i mantle cell lymphoma
616848|NCT00952185|stage I marginal zone lymphoma|stage i marginal zone lymphoma
616849|NCT00952185|stage I small lymphocytic lymphoma|stage i small lymphocytic lymphoma
616850|NCT00952185|noncontiguous stage II adult Burkitt lymphoma|noncontiguous stage ii adult burkitt lymphoma
616851|NCT00952185|noncontiguous stage II adult diffuse large cell lymphoma|noncontiguous stage ii adult diffuse large cell lymphoma
616852|NCT00952185|noncontiguous stage II adult diffuse mixed cell lymphoma|noncontiguous stage ii adult diffuse mixed cell lymphoma
616853|NCT00952185|noncontiguous stage II adult diffuse small cleaved cell lymphoma|noncontiguous stage ii adult diffuse small cleaved cell lymphoma
616854|NCT00952185|noncontiguous stage II adult immunoblastic large cell lymphoma|noncontiguous stage ii adult immunoblastic large cell lymphoma
616855|NCT00952185|noncontiguous stage II adult lymphoblastic lymphoma|noncontiguous stage ii adult lymphoblastic lymphoma
616856|NCT00952185|noncontiguous stage II grade 1 follicular lymphoma|noncontiguous stage ii grade 1 follicular lymphoma
616857|NCT00952185|noncontiguous stage II grade 2 follicular lymphoma|noncontiguous stage ii grade 2 follicular lymphoma
616858|NCT00952185|noncontiguous stage II grade 3 follicular lymphoma|noncontiguous stage ii grade 3 follicular lymphoma
616859|NCT00952185|noncontiguous stage II mantle cell lymphoma|noncontiguous stage ii mantle cell lymphoma
616860|NCT00952185|noncontiguous stage II marginal zone lymphoma|noncontiguous stage ii marginal zone lymphoma
616861|NCT00952185|noncontiguous stage II small lymphocytic lymphoma|noncontiguous stage ii small lymphocytic lymphoma
616862|NCT00952185|stage III adult Burkitt lymphoma|stage iii adult burkitt lymphoma
616863|NCT00952185|stage III adult diffuse large cell lymphoma|stage iii adult diffuse large cell lymphoma
616864|NCT00952185|stage III adult diffuse mixed cell lymphoma|stage iii adult diffuse mixed cell lymphoma
616865|NCT00952185|stage III adult diffuse small cleaved cell lymphoma|stage iii adult diffuse small cleaved cell lymphoma
616941|NCT00952120|Skin graft|skin graft
616866|NCT00952185|stage III adult immunoblastic large cell lymphoma|stage iii adult immunoblastic large cell lymphoma
616867|NCT00952185|stage III adult lymphoblastic lymphoma|stage iii adult lymphoblastic lymphoma
616868|NCT00952185|stage III grade 1 follicular lymphoma|stage iii grade 1 follicular lymphoma
616869|NCT00952185|stage III grade 2 follicular lymphoma|stage iii grade 2 follicular lymphoma
616870|NCT00952185|stage III grade 3 follicular lymphoma|stage iii grade 3 follicular lymphoma
616871|NCT00952185|stage III mantle cell lymphoma|stage iii mantle cell lymphoma
616872|NCT00952185|stage III marginal zone lymphoma|stage iii marginal zone lymphoma
616873|NCT00952185|stage III small lymphocytic lymphoma|stage iii small lymphocytic lymphoma
616874|NCT00952185|stage IV adult Burkitt lymphoma|stage iv adult burkitt lymphoma
616875|NCT00952185|stage IV adult diffuse large cell lymphoma|stage iv adult diffuse large cell lymphoma
616876|NCT00952185|stage IV adult diffuse mixed cell lymphoma|stage iv adult diffuse mixed cell lymphoma
616877|NCT00952185|stage IV adult diffuse small cleaved cell lymphoma|stage iv adult diffuse small cleaved cell lymphoma
616878|NCT00952185|stage IV adult immunoblastic large cell lymphoma|stage iv adult immunoblastic large cell lymphoma
616879|NCT00952185|stage IV adult lymphoblastic lymphoma|stage iv adult lymphoblastic lymphoma
616880|NCT00952185|stage IV grade 1 follicular lymphoma|stage iv grade 1 follicular lymphoma
616881|NCT00952185|stage IV grade 2 follicular lymphoma|stage iv grade 2 follicular lymphoma
616882|NCT00952185|stage IV grade 3 follicular lymphoma|stage iv grade 3 follicular lymphoma
616883|NCT00952185|stage IV mantle cell lymphoma|stage iv mantle cell lymphoma
616884|NCT00952185|stage IV marginal zone lymphoma|stage iv marginal zone lymphoma
616885|NCT00952185|stage IV small lymphocytic lymphoma|stage iv small lymphocytic lymphoma
616886|NCT00952185|recurrent adult Burkitt lymphoma|recurrent adult burkitt lymphoma
616887|NCT00952185|recurrent adult diffuse large cell lymphoma|recurrent adult diffuse large cell lymphoma
616888|NCT00952185|recurrent adult diffuse mixed cell lymphoma|recurrent adult diffuse mixed cell lymphoma
616889|NCT00952185|recurrent adult diffuse small cleaved cell lymphoma|recurrent adult diffuse small cleaved cell lymphoma
616890|NCT00952185|recurrent adult grade III lymphomatoid granulomatosis|recurrent adult grade iii lymphomatoid granulomatosis
616891|NCT00952185|recurrent adult immunoblastic large cell lymphoma|recurrent adult immunoblastic large cell lymphoma
616892|NCT00952185|recurrent adult lymphoblastic lymphoma|recurrent adult lymphoblastic lymphoma
616893|NCT00952185|recurrent grade 1 follicular lymphoma|recurrent grade 1 follicular lymphoma
616894|NCT00952185|recurrent grade 2 follicular lymphoma|recurrent grade 2 follicular lymphoma
616895|NCT00952185|recurrent grade 3 follicular lymphoma|recurrent grade 3 follicular lymphoma
616896|NCT00952185|recurrent mantle cell lymphoma|recurrent mantle cell lymphoma
616897|NCT00952185|recurrent marginal zone lymphoma|recurrent marginal zone lymphoma
616898|NCT00952185|recurrent small lymphocytic lymphoma|recurrent small lymphocytic lymphoma
616899|NCT00952185|intraocular lymphoma|intraocular lymphoma
616900|NCT00952185|primary central nervous system non-Hodgkin lymphoma|primary central nervous system non-hodgkin lymphoma
616901|NCT00952185|primary central nervous system Hodgkin lymphoma|primary central nervous system hodgkin lymphoma
616902|NCT00952185|post-transplant lymphoproliferative disorder|post-transplant lymphoproliferative disorder
616903|NCT00952185|chronic eosinophilic leukemia|chronic eosinophilic leukemia
616904|NCT00952185|chronic neutrophilic leukemia|chronic neutrophilic leukemia
616905|NCT00952185|primary myelofibrosis|primary myelofibrosis
616906|NCT00952185|essential thrombocythemia|essential thrombocythemia
616907|NCT00952185|polycythemia vera|polycythemia vera
616908|NCT00952185|extramedullary plasmacytoma|extramedullary plasmacytoma
616909|NCT00952185|isolated plasmacytoma of bone|isolated plasmacytoma of bone
616910|NCT00952185|stage I multiple myeloma|stage i multiple myeloma
616911|NCT00952185|stage II multiple myeloma|stage ii multiple myeloma
616912|NCT00952185|stage III multiple myeloma|stage iii multiple myeloma
616913|NCT00952185|primary systemic amyloidosis|primary systemic amyloidosis
616914|NCT00952185|refractory multiple myeloma|refractory multiple myeloma
616915|NCT00952185|de novo myelodysplastic syndromes|de novo myelodysplastic syndromes
616916|NCT00952185|previously treated myelodysplastic syndromes|previously treated myelodysplastic syndromes
616917|NCT00952185|secondary myelodysplastic syndromes|secondary myelodysplastic syndromes
616918|NCT00952185|myelodysplastic/myeloproliferative neoplasm, unclassifiable|myelodysplastic/myeloproliferative neoplasm, unclassifiable
616919|NCT00952172|Stair stepping training|stair stepping training
616920|NCT00952172|OSAS|osas
616921|NCT00952172|cardiopulmonary fitness|cardiopulmonary fitness
616922|NCT00952172|sleep disturbance|sleep disturbance
616923|NCT00952172|Actigraphy|actigraphy
616924|NCT00952159|tramadol|tramadol
616925|NCT00952159|CYP2D6|cyp2d6
616926|NCT00952159|O-demethyl-tramadol|o-demethyl-tramadol
616927|NCT00952159|poor metabolizer|poor metabolizer
616928|NCT00952159|genotyping|genotyping
616929|NCT00952159|phenotyping|phenotyping
616930|NCT00952146|NOTES|notes
616931|NCT00952146|Transgastric|transgastric
616932|NCT00952146|Appendectomy|appendectomy
616933|NCT00952146|Safety|safety
616934|NCT00952146|Feasibility|feasibility
616935|NCT00952133|PONV|ponv
616936|NCT00952133|Outpatient surgery|outpatient surgery
616937|NCT00952133|Laparoscopic abdominal surgery|laparoscopic abdominal surgery
616938|NCT00952133|Laparoscopic gynecologic surgery|laparoscopic gynecologic surgery
616939|NCT00952120|Wound healing|wound healing
616940|NCT00952120|Negative pressure wound therapy|negative pressure wound therapy
616942|NCT00952107|breast cancer|breast cancer
616943|NCT00952107|breast reconstructive surgery|breast reconstructive surgery
616944|NCT00952107|flap assessment|flap assessment
616945|NCT00952094|Healthy volunteer|healthy volunteer
616946|NCT00952081|Hypertension|hypertension
616947|NCT00952081|Neurosurgery|neurosurgery
616948|NCT00952081|bloodpressure control|bloodpressure control
616949|NCT00952081|brain tumor resection|brain tumor resection
616950|NCT00952081|epilepsy focus resection|epilepsy focus resection
616951|NCT00952068|Back Pain|back pain
616952|NCT00952055|neopterin|neopterin
616953|NCT00952055|macrophage|macrophage
616954|NCT00952055|inflammation|inflammation
710887|NCT00587405|Watermelon Stomach|watermelon stomach
616955|NCT00952042|Tendinopathy, Achilles, Eccentric training, Heavy slow resistance training|tendinopathy, achilles, eccentric training, heavy slow resistance training
616956|NCT00952029|stage IV colon cancer|stage iv colon cancer
616957|NCT00952029|stage IV rectal cancer|stage iv rectal cancer
616958|NCT00952016|colorectal cancer|colorectal cancer
616959|NCT00952016|MSH2|msh2
616960|NCT00952016|metastatic|metastatic
616961|NCT00952003|Avastin|avastin
616962|NCT00952003|Campto|campto
616963|NCT00952003|Oxaliplatin|oxaliplatin
616964|NCT00952003|Taxotere|taxotere
616965|NCT00951977|End Stage Renal Disease (ESRD)|end stage renal disease (esrd)
616966|NCT00951977|Transplantation|transplantation
616967|NCT00951977|Living Kidney Donation|living kidney donation
616968|NCT00951977|Kidney Transplant|kidney transplant
616969|NCT00951938|Trinity Evolution|trinity evolution
616970|NCT00951938|Anterior Cervical Discectomy and Fusion|anterior cervical discectomy and fusion
616971|NCT00951938|Allograft|allograft
616972|NCT00951925|diagnostic bone marrow biopsies|diagnostic bone marrow biopsies
616973|NCT00951925|bone marrow harvesting for autologous BMT|bone marrow harvesting for autologous bmt
616974|NCT00951912|genistein|genistein
616975|NCT00951912|daidzein|daidzein
616976|NCT00951912|impaired glucose regulation|impaired glucose regulation
616977|NCT00951912|glucose metabolism|glucose metabolism
616978|NCT00951912|lipids metabolism|lipids metabolism
616979|NCT00951912|inflammation|inflammation
616980|NCT00951912|women|women
616981|NCT00951899|Incretins|incretins
616982|NCT00951899|colesevelam|colesevelam
616983|NCT00951899|hepatobiliary circulation|hepatobiliary circulation
616984|NCT00951886|Ataxia Teleangiectasia|ataxia teleangiectasia
616985|NCT00951886|Spirometry|spirometry
616986|NCT00951886|Respiratory rare diseases|respiratory rare diseases
616987|NCT00951860|Fullterm Birth|fullterm birth
616988|NCT00951860|Neonate|neonate
616989|NCT00951860|Prematurity|prematurity
616990|NCT00951860|Neurodevelopment|neurodevelopment
616991|NCT00951860|Autonomic Nervous System activity|autonomic nervous system activity
616992|NCT00951847|Oxcarbazepine oral suspension fed study|oxcarbazepine oral suspension fed study
616993|NCT00951834|Alzheimer´s Disease|alzheimer´s disease
616994|NCT00951834|Epigallocatechin-Gallate|epigallocatechin-gallate
616995|NCT00951834|Neuroprotection|neuroprotection
616996|NCT00951834|ADAS-COG|adas-cog
616997|NCT00951834|early stage of Alzheimer's Disease|early stage of alzheimer's disease
616998|NCT00951821|Suicidal Ideation|suicidal ideation
616999|NCT00951821|Suicide Attempts|suicide attempts
617000|NCT00951808|Anemia, Sickle Cell|anemia, sickle cell
617001|NCT00951808|Acute Chest Syndrome|acute chest syndrome
617002|NCT00951808|Secretory phospholipase A2(sPLA2)|secretory phospholipase a2(spla2)
617003|NCT00951795|HIV|hiv
617004|NCT00951795|AIDS|aids
617005|NCT00951795|CD4|cd4
617006|NCT00951782|COPD|copd
617007|NCT00951756|Dietary fat|dietary fat
617008|NCT00951756|Microbiome composition|microbiome composition
617009|NCT00951756|Controlled feeding experiment|controlled feeding experiment
617010|NCT00951743|AIDS|aids
617011|NCT00951743|HIV|hiv
617012|NCT00951743|mDAPTA|mdapta
617013|NCT00951730|Down Syndrome|down syndrome
617014|NCT00951730|Adult|adult
617015|NCT00951730|Children|children
617016|NCT00951730|Sleep apnea|sleep apnea
617017|NCT00951730|Sleep hypopnea|sleep hypopnea
617018|NCT00951730|Polysomnography|polysomnography
617019|NCT00951717|Postpartum Depressive Symptoms|postpartum depressive symptoms
617020|NCT00951717|Physical Symptoms|physical symptoms
617021|NCT00951717|Emotional Symptoms|emotional symptoms
617022|NCT00951717|Infant Colic|infant colic
617023|NCT00951717|Social Support|social support
617024|NCT00951717|Breastfeeding|breastfeeding
617025|NCT00951704|CPR|cpr
617026|NCT00951704|Tissue Perfusion|tissue perfusion
617027|NCT00951704|invasive arterial pressure|invasive arterial pressure
617028|NCT00951704|exhaled carbon dioxide|exhaled carbon dioxide
617029|NCT00951704|Quality of life|quality of life
617030|NCT00951704|Quality of chest compressions|quality of chest compressions
617031|NCT00951704|Epidemiology of sudden cardiac arrest(OHCA)|epidemiology of sudden cardiac arrest(ohca)
617032|NCT00951691|Elderly|elderly
617033|NCT00951691|Acute Medical Rehabilitation|acute medical rehabilitation
617034|NCT00951678|ultrasound|ultrasound
617035|NCT00951678|femoral vein|femoral vein
617036|NCT00951678|internal jugular vein|internal jugular vein
617037|NCT00951665|Trastuzumab DM1 (T-DM1)|trastuzumab dm1 (t-dm1)
617038|NCT00951665|Trastuzumab emtansine|trastuzumab emtansine
617039|NCT00951665|Armed Herceptin|armed herceptin
617040|NCT00951665|HER2|her2
617041|NCT00951665|HER2+|her2+
617042|NCT00951665|HER2 Positive Breast Cancer|her2 positive breast cancer
617043|NCT00951652|CBT|cbt
617044|NCT00951652|GAD|gad
617045|NCT00951652|Interpersonal Therapy|interpersonal therapy
617046|NCT00951652|Emotion-Focused Therapy|emotion-focused therapy
617047|NCT00951639|Cassia|cassia
617048|NCT00951639|Cinnamon|cinnamon
617049|NCT00951639|Blood Glucose|blood glucose
617050|NCT00951639|Endurance exercise|endurance exercise
617051|NCT00951639|Acute exercise|acute exercise
617052|NCT00951639|Overweight|overweight
617053|NCT00951639|Obesity|obesity
617054|NCT00951639|Women|women
617055|NCT00951626|psychosocial effects of cancer and its treatment|psychosocial effects of cancer and its treatment
617056|NCT00951626|therapy-related toxicity|therapy-related toxicity
617057|NCT00951626|stage III adult Burkitt lymphoma|stage iii adult burkitt lymphoma
617058|NCT00951626|stage III adult diffuse large cell lymphoma|stage iii adult diffuse large cell lymphoma
617059|NCT00951626|stage III adult diffuse mixed cell lymphoma|stage iii adult diffuse mixed cell lymphoma
617060|NCT00951626|stage III adult diffuse small cleaved cell lymphoma|stage iii adult diffuse small cleaved cell lymphoma
617061|NCT00951626|stage III adult Hodgkin lymphoma|stage iii adult hodgkin lymphoma
617062|NCT00951626|stage III adult immunoblastic large cell lymphoma|stage iii adult immunoblastic large cell lymphoma
617063|NCT00951626|stage III adult lymphoblastic lymphoma|stage iii adult lymphoblastic lymphoma
617064|NCT00951626|stage III grade 1 follicular lymphoma|stage iii grade 1 follicular lymphoma
617065|NCT00951626|stage III grade 2 follicular lymphoma|stage iii grade 2 follicular lymphoma
617066|NCT00951626|stage III grade 3 follicular lymphoma|stage iii grade 3 follicular lymphoma
617067|NCT00951626|stage III mantle cell lymphoma|stage iii mantle cell lymphoma
617068|NCT00951626|stage III marginal zone lymphoma|stage iii marginal zone lymphoma
617069|NCT00951626|stage III small lymphocytic lymphoma|stage iii small lymphocytic lymphoma
617070|NCT00951626|stage IV adult Burkitt lymphoma|stage iv adult burkitt lymphoma
617071|NCT00951626|stage IV adult diffuse large cell lymphoma|stage iv adult diffuse large cell lymphoma
617072|NCT00951626|stage IV adult diffuse mixed cell lymphoma|stage iv adult diffuse mixed cell lymphoma
617073|NCT00951626|stage IV adult diffuse small cleaved cell lymphoma|stage iv adult diffuse small cleaved cell lymphoma
617074|NCT00951626|stage IV adult Hodgkin lymphoma|stage iv adult hodgkin lymphoma
617075|NCT00951626|stage IV adult immunoblastic large cell lymphoma|stage iv adult immunoblastic large cell lymphoma
617076|NCT00951626|stage IV adult lymphoblastic lymphoma|stage iv adult lymphoblastic lymphoma
617077|NCT00951626|stage IV grade 1 follicular lymphoma|stage iv grade 1 follicular lymphoma
617078|NCT00951626|stage IV grade 2 follicular lymphoma|stage iv grade 2 follicular lymphoma
617079|NCT00951626|stage IV grade 3 follicular lymphoma|stage iv grade 3 follicular lymphoma
617080|NCT00951626|stage IV mantle cell lymphoma|stage iv mantle cell lymphoma
617081|NCT00951626|stage IV marginal zone lymphoma|stage iv marginal zone lymphoma
617082|NCT00951626|stage IV small lymphocytic lymphoma|stage iv small lymphocytic lymphoma
617083|NCT00951626|recurrent adult Burkitt lymphoma|recurrent adult burkitt lymphoma
617084|NCT00951626|recurrent adult diffuse large cell lymphoma|recurrent adult diffuse large cell lymphoma
617085|NCT00951626|recurrent adult diffuse mixed cell lymphoma|recurrent adult diffuse mixed cell lymphoma
617086|NCT00951626|recurrent adult diffuse small cleaved cell lymphoma|recurrent adult diffuse small cleaved cell lymphoma
617087|NCT00951626|recurrent adult Hodgkin lymphoma|recurrent adult hodgkin lymphoma
617088|NCT00951626|recurrent adult immunoblastic large cell lymphoma|recurrent adult immunoblastic large cell lymphoma
617089|NCT00951626|recurrent adult lymphoblastic lymphoma|recurrent adult lymphoblastic lymphoma
617090|NCT00951626|recurrent cutaneous T-cell non-Hodgkin lymphoma|recurrent cutaneous t-cell non-hodgkin lymphoma
617091|NCT00951626|recurrent grade 1 follicular lymphoma|recurrent grade 1 follicular lymphoma
617092|NCT00951626|recurrent grade 2 follicular lymphoma|recurrent grade 2 follicular lymphoma
617093|NCT00951626|recurrent grade 3 follicular lymphoma|recurrent grade 3 follicular lymphoma
617094|NCT00951626|recurrent mantle cell lymphoma|recurrent mantle cell lymphoma
617095|NCT00951626|recurrent marginal zone lymphoma|recurrent marginal zone lymphoma
617096|NCT00951626|recurrent small lymphocytic lymphoma|recurrent small lymphocytic lymphoma
617097|NCT00951626|recurrent mycosis fungoides/Sezary syndrome|recurrent mycosis fungoides/sezary syndrome
617098|NCT00951626|extranodal marginal zone B-cell lymphoma of mucosa-associated lymphoid tissue|extranodal marginal zone b-cell lymphoma of mucosa-associated lymphoid tissue
617099|NCT00951626|nodal marginal zone B-cell lymphoma|nodal marginal zone b-cell lymphoma
617100|NCT00951626|splenic marginal zone lymphoma|splenic marginal zone lymphoma
617101|NCT00951626|noncontiguous stage II adult Burkitt lymphoma|noncontiguous stage ii adult burkitt lymphoma
617102|NCT00951626|noncontiguous stage II adult diffuse large cell lymphoma|noncontiguous stage ii adult diffuse large cell lymphoma
617103|NCT00951626|noncontiguous stage II adult diffuse mixed cell lymphoma|noncontiguous stage ii adult diffuse mixed cell lymphoma
617104|NCT00951626|noncontiguous stage II adult diffuse small cleaved cell lymphoma|noncontiguous stage ii adult diffuse small cleaved cell lymphoma
617105|NCT00951626|noncontiguous stage II adult immunoblastic large cell lymphoma|noncontiguous stage ii adult immunoblastic large cell lymphoma
617106|NCT00951626|noncontiguous stage II adult lymphoblastic lymphoma|noncontiguous stage ii adult lymphoblastic lymphoma
617107|NCT00951626|noncontiguous stage II grade 1 follicular lymphoma|noncontiguous stage ii grade 1 follicular lymphoma
617108|NCT00951626|noncontiguous stage II grade 2 follicular lymphoma|noncontiguous stage ii grade 2 follicular lymphoma
617109|NCT00951626|noncontiguous stage II grade 3 follicular lymphoma|noncontiguous stage ii grade 3 follicular lymphoma
617110|NCT00951626|noncontiguous stage II mantle cell lymphoma|noncontiguous stage ii mantle cell lymphoma
617111|NCT00951626|noncontiguous stage II marginal zone lymphoma|noncontiguous stage ii marginal zone lymphoma
617112|NCT00951626|noncontiguous stage II small lymphocytic lymphoma|noncontiguous stage ii small lymphocytic lymphoma
710888|NCT00587405|Cryotherapy|cryotherapy
784804|NCT00311415|infant|infant
617113|NCT00951626|accelerated phase chronic myelogenous leukemia|accelerated phase chronic myelogenous leukemia
617114|NCT00951626|adult acute lymphoblastic leukemia in remission|adult acute lymphoblastic leukemia in remission
617115|NCT00951626|adult acute myeloid leukemia in remission|adult acute myeloid leukemia in remission
617116|NCT00951626|adult acute myeloid leukemia with 11q23 (MLL) abnormalities|adult acute myeloid leukemia with 11q23 (mll) abnormalities
617117|NCT00951626|adult acute myeloid leukemia with inv(16)(p13;q22)|adult acute myeloid leukemia with inv(16)(p13;q22)
617118|NCT00951626|adult acute myeloid leukemia with t(15;17)(q22;q12)|adult acute myeloid leukemia with t(15;17)(q22;q12)
617119|NCT00951626|adult acute myeloid leukemia with t(16;16)(p13;q22)|adult acute myeloid leukemia with t(16;16)(p13;q22)
617120|NCT00951626|adult acute myeloid leukemia with t(8;21)(q22;q22)|adult acute myeloid leukemia with t(8;21)(q22;q22)
617121|NCT00951626|atypical chronic myeloid leukemia, BCR-ABL negative|atypical chronic myeloid leukemia, bcr-abl negative
617122|NCT00951626|blastic phase chronic myelogenous leukemia|blastic phase chronic myelogenous leukemia
617123|NCT00951626|recurrent adult acute lymphoblastic leukemia|recurrent adult acute lymphoblastic leukemia
617124|NCT00951626|recurrent adult acute myeloid leukemia|recurrent adult acute myeloid leukemia
617125|NCT00951626|refractory chronic lymphocytic leukemia|refractory chronic lymphocytic leukemia
617126|NCT00951626|refractory hairy cell leukemia|refractory hairy cell leukemia
617127|NCT00951626|relapsing chronic myelogenous leukemia|relapsing chronic myelogenous leukemia
617128|NCT00951626|secondary acute myeloid leukemia|secondary acute myeloid leukemia
617129|NCT00951626|stage III chronic lymphocytic leukemia|stage iii chronic lymphocytic leukemia
617130|NCT00951626|stage IV chronic lymphocytic leukemia|stage iv chronic lymphocytic leukemia
617131|NCT00951626|chronic eosinophilic leukemia|chronic eosinophilic leukemia
617132|NCT00951626|primary myelofibrosis|primary myelofibrosis
617133|NCT00951626|chronic neutrophilic leukemia|chronic neutrophilic leukemia
617134|NCT00951626|de novo myelodysplastic syndromes|de novo myelodysplastic syndromes
617135|NCT00951626|myelodysplastic/myeloproliferative neoplasm, unclassifiable|myelodysplastic/myeloproliferative neoplasm, unclassifiable
617136|NCT00951626|previously treated myelodysplastic syndromes|previously treated myelodysplastic syndromes
617137|NCT00951626|secondary myelodysplastic syndromes|secondary myelodysplastic syndromes
617138|NCT00951626|refractory multiple myeloma|refractory multiple myeloma
617139|NCT00951613|small cell lung cancer|small cell lung cancer
617140|NCT00951613|carcinoma, lung|carcinoma, lung
617141|NCT00951613|Sensitive-relapsed or refractory-relapsed small cell lung cancer|sensitive-relapsed or refractory-relapsed small cell lung cancer
617142|NCT00951600|Oxcarbazepine oral suspension fasting study|oxcarbazepine oral suspension fasting study
617143|NCT00951587|Colonic Diseases|colonic diseases
617144|NCT00951574|thromboembolism|thromboembolism
617145|NCT00951574|cancer|cancer
617146|NCT00951574|chemotherapy|chemotherapy
617147|NCT00951574|low-molecular-weight-heparin|low-molecular-weight-heparin
617148|NCT00951574|nadroparin|nadroparin
617149|NCT00951561|Dysmenorrhea|dysmenorrhea
617150|NCT00951548|Probiotics|probiotics
617151|NCT00951548|VSL#3|vsl#3
617152|NCT00951548|Double-blind|double-blind
617153|NCT00951548|Placebo controlled|placebo controlled
617154|NCT00951535|stage I prostate cancer|stage i prostate cancer
617155|NCT00951535|stage IIB prostate cancer|stage iib prostate cancer
617156|NCT00951535|stage IIA prostate cancer|stage iia prostate cancer
617157|NCT00951535|stage III prostate cancer|stage iii prostate cancer
617158|NCT00951522|Cystic Fibrosis|cystic fibrosis
617159|NCT00951522|CF|cf
617160|NCT00951522|Mucociliary Clearance|mucociliary clearance
617161|NCT00951522|Epithelial Sodium Channel Inhibitor|epithelial sodium channel inhibitor
617162|NCT00951522|ENaC Inhibitor|enac inhibitor
617163|NCT00951522|Airway Hydration|airway hydration
617164|NCT00951522|Amiloride|amiloride
617165|NCT00951509|Electric power wheelchair driving|electric power wheelchair driving
617166|NCT00951509|rehabilitation|rehabilitation
617167|NCT00951509|driving assessments|driving assessments
617168|NCT00951483|Cardiovascular Biomarkers|cardiovascular biomarkers
617169|NCT00951483|Depression|depression
617170|NCT00951483|Quetiapine|quetiapine
617171|NCT00951470|Head and neck lymphedema|head and neck lymphedema
617172|NCT00951470|Complete Decongestive Therapy|complete decongestive therapy
617173|NCT00951470|CDT|cdt
617174|NCT00951470|Oral cavity cancer|oral cavity cancer
617175|NCT00951470|Oropharyngeal cancer|oropharyngeal cancer
617176|NCT00951457|CLL|cll
617177|NCT00951457|pretreated|pretreated
617178|NCT00951457|immune therapy|immune therapy
617179|NCT00951457|dose escalation|dose escalation
617180|NCT00951457|maintenance therapy|maintenance therapy
617181|NCT00951457|Bendamustine|bendamustine
617182|NCT00951457|Alemtuzumab|alemtuzumab
617183|NCT00951444|adenosquamous cell lung cancer|adenosquamous cell lung cancer
617184|NCT00951444|squamous cell lung cancer|squamous cell lung cancer
617185|NCT00951444|recurrent non-small cell lung cancer|recurrent non-small cell lung cancer
617186|NCT00951444|stage IIIB non-small cell lung cancer|stage iiib non-small cell lung cancer
617187|NCT00951444|stage IV non-small cell lung cancer|stage iv non-small cell lung cancer
617188|NCT00951431|Functional dyspepsia|functional dyspepsia
617189|NCT00951431|PPI|ppi
784965|NCT00310804|Flu|flu
617190|NCT00951431|postprandial fullness|postprandial fullness
617191|NCT00951431|delayed gastric emptying|delayed gastric emptying
617192|NCT00951418|clozapine|clozapine
617193|NCT00951418|schizophrenia|schizophrenia
617194|NCT00951418|cognition|cognition
617195|NCT00951418|t-wave morphology|t-wave morphology
617196|NCT00951392|Insulin sensitivity|insulin sensitivity
617197|NCT00951392|aging|aging
617198|NCT00951392|lipid metabolism|lipid metabolism
617199|NCT00951392|hyperinsulinemic clamp|hyperinsulinemic clamp
617200|NCT00951392|gene expression|gene expression
617201|NCT00951392|sirtuins|sirtuins
617202|NCT00951366|premature birth|premature birth
617203|NCT00951366|neonatal respiratory distress|neonatal respiratory distress
617204|NCT00951366|chronic lung disease|chronic lung disease
617205|NCT00951366|epidemiologicfactors|epidemiologicfactors
617206|NCT00951366|genetic factors|genetic factors
617207|NCT00951353|Transplantation|transplantation
617208|NCT00951353|Kidney Failure|kidney failure
617209|NCT00951353|End Stage Renal Disease|end stage renal disease
617210|NCT00951353|Pediatric|pediatric
617211|NCT00951340|CBT|cbt
617212|NCT00951340|Emotional-Focused Therapy|emotional-focused therapy
617213|NCT00951340|Interpersonal Therapy|interpersonal therapy
617214|NCT00951327|Primary sclerosing cholangitis|primary sclerosing cholangitis
617215|NCT00951314|Genetic Polymorphisms|genetic polymorphisms
617216|NCT00951314|Metabotropic Glutamate Receptors|metabotropic glutamate receptors
617217|NCT00951314|Positron Emission Tomograhy (PET)|positron emission tomograhy (pet)
617218|NCT00951314|Cocaine Dependence|cocaine dependence
617219|NCT00951314|Cue-Induced Craving|cue-induced craving
617220|NCT00951314|Drug Abuse|drug abuse
617221|NCT00951288|AMD|amd
617222|NCT00951288|Retinal Function|retinal function
617223|NCT00951288|Neuroprotection|neuroprotection
617224|NCT00951262|life review|life review
617225|NCT00951262|quality of life|quality of life
617226|NCT00951262|advanced cancer patients|advanced cancer patients
617227|NCT00951249|MSM|msm
617228|NCT00951249|HIV infections|hiv infections
617229|NCT00951249|HIV Seronegativity|hiv seronegativity
617230|NCT00951236|Trigger Finger|trigger finger
617231|NCT00951236|Trigger Thumb|trigger thumb
617232|NCT00951210|Peripheral Artery Disease|peripheral artery disease
617233|NCT00951210|Peripheral Vascular Disease|peripheral vascular disease
617234|NCT00951210|Critical limb ischemia|critical limb ischemia
617235|NCT00951210|PAD|pad
617236|NCT00951210|CLI|cli
617237|NCT00951197|dementia|dementia
617238|NCT00951197|Alzheimer's Disease|alzheimer's disease
617239|NCT00951197|diagnostic|diagnostic
617240|NCT00951197|biomarkers|biomarkers
617241|NCT00951197|neuroimaging|neuroimaging
617242|NCT00951197|PET|pet
617243|NCT00951197|MRI|mri
617244|NCT00951197|mild cognitive impairment|mild cognitive impairment
617245|NCT00951184|depression|depression
617246|NCT00951184|unspecified adult solid tumor, protocol specific|unspecified adult solid tumor, protocol specific
617247|NCT00951158|Conjugated Linoleic Acid|conjugated linoleic acid
617248|NCT00951158|Clarinol|clarinol
617249|NCT00951158|S14 Expression|s14 expression
617250|NCT00951132|Inflammation|inflammation
617251|NCT00951132|Atherosclerosis|atherosclerosis
617252|NCT00951132|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors
617253|NCT00951119|type 2 diabetes|type 2 diabetes
617254|NCT00951119|hypertension|hypertension
617255|NCT00951119|treatment|treatment
617256|NCT00951119|non-medical|non-medical
617257|NCT00951106|Peru|peru
617258|NCT00951106|Sulfadoxine-pyrimethamine|sulfadoxine-pyrimethamine
617259|NCT00951106|Drug resistance|drug resistance
617260|NCT00951093|GERD|gerd
617261|NCT00951093|Gastric bypass|gastric bypass
617262|NCT00951080|ulcer|ulcer
617263|NCT00951080|venous|venous
617264|NCT00951080|diabetic|diabetic
617265|NCT00951080|wounds and injuries|wounds and injuries
617266|NCT00951067|Lymphedema|lymphedema
617267|NCT00951067|Breast Cancer|breast cancer
617268|NCT00951067|Upper Extremity|upper extremity
617269|NCT00951067|Arm|arm
617270|NCT00951054|breast cancer|breast cancer
617271|NCT00951054|triple negative|triple negative
617272|NCT00951054|ER-negative|er-negative
617273|NCT00951054|PR-negative|pr-negative
617274|NCT00951054|HER2-negative|her2-negative
617275|NCT00951054|ER-, PR-, HER2- (Triple Negative) breast cancer|er-, pr-, her2- (triple negative) breast cancer
617276|NCT00951041|influenza infection|influenza infection
617277|NCT00951041|GSK Bio's influenza vaccine GSK2340272A|gsk bio's influenza vaccine gsk2340272a
617278|NCT00951028|Adherence|adherence
617279|NCT00951015|GSK1349572|gsk1349572
617280|NCT00951015|emtricitabine|emtricitabine
617281|NCT00951015|tenofovir|tenofovir
617282|NCT00951015|efavirenz|efavirenz
617283|NCT00951015|abacavir|abacavir
617284|NCT00951015|antiretroviral therapy naive|antiretroviral therapy naive
617285|NCT00951015|dose selection|dose selection
617286|NCT00951015|HIV-1 Infection|hiv-1 infection
617287|NCT00951015|integrase inhibitor|integrase inhibitor
617288|NCT00951015|HIV infection|hiv infection
785060|NCT00310401|hypoxia|hypoxia
617289|NCT00951015|once daily|once daily
617290|NCT00951015|lamivudine|lamivudine
617291|NCT00951002|anal fistula|anal fistula
617292|NCT00951002|acellular dermal matrix|acellular dermal matrix
617293|NCT00951002|treatment|treatment
617294|NCT00951002|postoperative complications|postoperative complications
617295|NCT00951002|recurrence|recurrence
617296|NCT00950989|Autoimmune Diseases|autoimmune diseases
617297|NCT00950989|Musculoskeletal Diseases|musculoskeletal diseases
617298|NCT00950989|Joint Diseases|joint diseases
617299|NCT00950989|Arthritis|arthritis
617300|NCT00950989|Connective Tissue Diseases|connective tissue diseases
617301|NCT00950989|Arthritis, Rheumatoid|arthritis, rheumatoid
617302|NCT00950989|Rheumatic Diseases|rheumatic diseases
617428|NCT00950482|Menopause|menopause
617303|NCT00950963|Diabetes, Nurse phone intervention, lipid control|diabetes, nurse phone intervention, lipid control
617304|NCT00950950|Amgen|amgen
617305|NCT00950950|Postmenopausal|postmenopausal
617306|NCT00950950|Bone Density|bone density
617307|NCT00950924|Hyperopia|hyperopia
617308|NCT00950924|Refractive Error|refractive error
617309|NCT00950924|Ocular Biometrics|ocular biometrics
617310|NCT00950924|Axial Length|axial length
617311|NCT00950924|Contact Lenses|contact lenses
617312|NCT00950924|Bifocal Contact Lenses|bifocal contact lenses
617313|NCT00950911|Bone metastases|bone metastases
617314|NCT00950911|Hormone-refractory prostate cancer|hormone-refractory prostate cancer
617315|NCT00950911|Multiple myeloma|multiple myeloma
617316|NCT00950911|Denosumab|denosumab
617317|NCT00950911|Breast cancer|breast cancer
617318|NCT00950911|20050103|20050103
617319|NCT00950911|20050136|20050136
617320|NCT00950911|20050244|20050244
617321|NCT00950911|Advanced cancer|advanced cancer
617322|NCT00950911|Tumor|tumor
617323|NCT00950911|Prostate cancer|prostate cancer
617324|NCT00950911|Zoledronic acid|zoledronic acid
617325|NCT00950898|coffee|coffee
617326|NCT00950898|caffeine|caffeine
617327|NCT00950898|glucose metabolism|glucose metabolism
617328|NCT00950898|insulin sensitivity|insulin sensitivity
617329|NCT00950898|diabetes|diabetes
617330|NCT00950885|sleep|sleep
617331|NCT00950885|alertness|alertness
617332|NCT00950885|performance|performance
617333|NCT00950885|vigilance|vigilance
617334|NCT00950885|circadian|circadian
617335|NCT00950859|treatment experienced|treatment experienced
617336|NCT00950859|HIV Infection|hiv infection
617337|NCT00950859|raltegravir resistance|raltegravir resistance
617338|NCT00950859|GSK1349572|gsk1349572
617339|NCT00950859|optimized background regimen|optimized background regimen
617340|NCT00950859|integrase inhibitor|integrase inhibitor
617341|NCT00950846|Congenital Pediatric Disorders|congenital pediatric disorders
617342|NCT00950846|Umbilical Cord Blood Transplant|umbilical cord blood transplant
617343|NCT00950846|Congenital Abnormalities|congenital abnormalities
617344|NCT00950846|Cord Blood Stem Cell Transplantation|cord blood stem cell transplantation
617345|NCT00950846|Busulfan|busulfan
617346|NCT00950846|Cytoxan|cytoxan
617347|NCT00950846|Cyclophosphamide|cyclophosphamide
617348|NCT00950846|Fludarabine|fludarabine
617349|NCT00950833|Catch-up vaccination|catch-up vaccination
617350|NCT00950833|Pneumococcal vaccine|pneumococcal vaccine
617351|NCT00950833|Immune memory|immune memory
617352|NCT00950833|Nasopharyngeal carriage|nasopharyngeal carriage
617353|NCT00950833|Immunogenicity|immunogenicity
617354|NCT00950833|Pneumococcal disease|pneumococcal disease
617355|NCT00950833|Safety|safety
617356|NCT00950820|Open-label|open-label
617357|NCT00950820|Phase-II-Study|phase-ii-study
617358|NCT00950820|Randomized|randomized
617359|NCT00950820|Metastatic|metastatic
617360|NCT00950820|Colorectal|colorectal
617361|NCT00950820|Cancer|cancer
617362|NCT00950820|Panitumumab|panitumumab
617363|NCT00950820|Vectibix®|vectibix®
617364|NCT00950820|second-line-treatment|second-line-treatment
617365|NCT00950820|KRAS|kras
617366|NCT00950807|Dose ranging|dose ranging
617367|NCT00950807|Chronic Bronchitis|chronic bronchitis
617368|NCT00950807|Long-acting muscarinic antagonist|long-acting muscarinic antagonist
617369|NCT00950807|cross-over|cross-over
617370|NCT00950807|COPD|copd
617371|NCT00950807|Emphysema|emphysema
617372|NCT00950807|Chronic Obstructive Pulmonary Disease (COPD)|chronic obstructive pulmonary disease (copd)
617373|NCT00950807|anticholinergic|anticholinergic
617374|NCT00950794|Long acting beta2-agonist|long acting beta2-agonist
617375|NCT00950781|Menopause|menopause
617376|NCT00950781|Cortisol|cortisol
617377|NCT00950781|ACTH|acth
617378|NCT00950768|Myeloma|myeloma
617379|NCT00950768|Melphalan|melphalan
617380|NCT00950768|Autologous transplantation|autologous transplantation
617381|NCT00950729|car driving simulator|car driving simulator
617382|NCT00950729|orthopedic leg immobilisation|orthopedic leg immobilisation
617383|NCT00950729|braking time|braking time
617384|NCT00950729|braking force|braking force
617385|NCT00950716|type II diabetes|type ii diabetes
617386|NCT00950716|peer support|peer support
617387|NCT00950716|empowerment|empowerment
617486|NCT00950274|Cell therapy|cell therapy
617487|NCT00950274|Bone marrow|bone marrow
617388|NCT00950703|Assessing the perceptions of Canadian Primary care physicians towards global Cardiovascular risk assessment.|assessing the perceptions of canadian primary care physicians towards global cardiovascular risk assessment.
617389|NCT00950690|observational safety study|observational safety study
617390|NCT00950677|Diabetes|diabetes
617391|NCT00950677|pramlintide|pramlintide
617392|NCT00950677|Symlin|symlin
617393|NCT00950677|exenatide|exenatide
617394|NCT00950677|byetta|byetta
617395|NCT00950677|glucagon|glucagon
617396|NCT00950677|gastric emptying|gastric emptying
617397|NCT00950664|cervical dystonia|cervical dystonia
617398|NCT00950664|botulinum toxin|botulinum toxin
617399|NCT00950638|AMD|amd
617400|NCT00950625|intraperitoneal analgesia|intraperitoneal analgesia
617401|NCT00950625|laparoscopic cholecystectomy|laparoscopic cholecystectomy
617402|NCT00950625|lignocaine|lignocaine
617403|NCT00950625|bupevacaine|bupevacaine
617404|NCT00950612|Tuberculosis vaccine|tuberculosis vaccine
617405|NCT00950586|Drug interaction|drug interaction
617406|NCT00950586|Saftey|saftey
617407|NCT00950586|Pharmacokinetics|pharmacokinetics
617408|NCT00950586|Cognition|cognition
617409|NCT00950573|cardiovascular disease|cardiovascular disease
617410|NCT00950573|endstage renal disease|endstage renal disease
617411|NCT00950547|Blood Transfusion|blood transfusion
617412|NCT00950547|Cell Saver|cell saver
617413|NCT00950547|Cardiac Surgery|cardiac surgery
617414|NCT00950547|Evaluate the efficacy of cell salvage CardioPAT routinely used in cardiac surgery in reducing blood transfusions.|evaluate the efficacy of cell salvage cardiopat routinely used in cardiac surgery in reducing blood transfusions.
617415|NCT00950521|Stroke|stroke
617416|NCT00950521|Stem Cell|stem cell
617417|NCT00950521|Cell Therapy|cell therapy
617418|NCT00950521|CD34 Stem cell|cd34 stem cell
617419|NCT00950521|Peripheral blood Stem cell|peripheral blood stem cell
617420|NCT00950495|Parallel design|parallel design
617421|NCT00950495|Oral appliance|oral appliance
617422|NCT00950495|Mandibular advancement device|mandibular advancement device
617423|NCT00950495|Continuous positive airway pressure|continuous positive airway pressure
617424|NCT00950495|Placebo|placebo
617425|NCT00950495|Therapy|therapy
617426|NCT00950495|Side-effects|side-effects
617427|NCT00950495|Compliance|compliance
617429|NCT00950482|Acupuncture|acupuncture
617430|NCT00950482|Hotflash|hotflash
617431|NCT00950469|high sensitive troponin T; cardiac necrosis; early detection; myoglobin; h-FABP|high sensitive troponin t; cardiac necrosis; early detection; myoglobin; h-fabp
617432|NCT00950469|early identification and risk stratification of patients with suspicious acute coronary syndrome|early identification and risk stratification of patients with suspicious acute coronary syndrome
617433|NCT00950443|Upper airway obstruction|upper airway obstruction
617434|NCT00950443|child|child
617435|NCT00950443|acoustic reflection method|acoustic reflection method
617436|NCT00950443|endoscopy|endoscopy
617437|NCT00950443|work of breathing|work of breathing
617438|NCT00950443|sleep study|sleep study
617439|NCT00950443|CT scan|ct scan
617440|NCT00950430|Imaging|imaging
617442|NCT00950430|PiB|pib
617443|NCT00950430|FDG|fdg
617444|NCT00950430|MCI|mci
617445|NCT00950430|Dementia|dementia
617446|NCT00950430|Alzheimer's Disease|alzheimer's disease
617447|NCT00950430|Brain Amyloid|brain amyloid
617448|NCT00950417|nimotuzumab esophageal chemo-radiotherapy|nimotuzumab esophageal chemo-radiotherapy
617449|NCT00950404|Bioavailability Pharmacokinetic Formulation|bioavailability pharmacokinetic formulation
617450|NCT00950391|peripheral nerve injury|peripheral nerve injury
617451|NCT00950391|peripheral nerve surgery|peripheral nerve surgery
617452|NCT00950391|nerve repair|nerve repair
617453|NCT00950391|nerve graft|nerve graft
617454|NCT00950378|edema|edema
617455|NCT00950378|blood supply|blood supply
617456|NCT00950378|lower legs|lower legs
617457|NCT00950378|venous stasis|venous stasis
617458|NCT00950365|recurrent non-small cell lung cancer|recurrent non-small cell lung cancer
617459|NCT00950365|stage IIIB non-small cell lung cancer|stage iiib non-small cell lung cancer
617460|NCT00950365|stage IV non-small cell lung cancer|stage iv non-small cell lung cancer
617461|NCT00950365|progressive or recurrent stage III or stage IV non-small cell lung cancer|progressive or recurrent stage iii or stage iv non-small cell lung cancer
617462|NCT00950352|methamphetamine|methamphetamine
617463|NCT00950352|Citicoline|citicoline
617464|NCT00950352|CDP-Choline|cdp-choline
617465|NCT00950352|Neuroimaging|neuroimaging
617466|NCT00950352|MRI|mri
617467|NCT00950352|Brain|brain
617468|NCT00950352|MRS|mrs
617469|NCT00950352|DTI|dti
617470|NCT00950339|GI bleeding|gi bleeding
617471|NCT00950339|clopidogrel|clopidogrel
617472|NCT00950339|aspirin|aspirin
617473|NCT00950339|prevention|prevention
617474|NCT00950339|angiography|angiography
617475|NCT00950326|osteoarthritis|osteoarthritis
617476|NCT00950326|hydrotherapy|hydrotherapy
617477|NCT00950326|affusion|affusion
617478|NCT00950326|conventional physiotherapy|conventional physiotherapy
617479|NCT00950326|comparison|comparison
617480|NCT00950313|Diabetes|diabetes
617481|NCT00950313|Screening|screening
617482|NCT00950313|Risk|risk
617483|NCT00950313|Self assessment|self assessment
785303|NCT00309738|KRE|kre
617484|NCT00950287|apnea-bradycardias|apnea-bradycardias
617485|NCT00950287|preterm infants|preterm infants
617488|NCT00950274|CD133|cd133
617489|NCT00950274|Bypass surgery|bypass surgery
617490|NCT00950274|Stem cells|stem cells
617491|NCT00950274|Myocardial infarction|myocardial infarction
617492|NCT00950274|Myocardial ischemia|myocardial ischemia
617493|NCT00950261|Cervical neoplasms|cervical neoplasms
617494|NCT00950261|Cisplatin|cisplatin
617495|NCT00950261|Concurrent Chemoradiation|concurrent chemoradiation
617496|NCT00950248|Idebenone|idebenone
617497|NCT00950248|Magnetic Resonance Imaging (MRI)|magnetic resonance imaging (mri)
617498|NCT00950248|Magnetic Resonance Spectroscopy|magnetic resonance spectroscopy
617499|NCT00950248|Mitochondrial Enhancer|mitochondrial enhancer
617500|NCT00950248|Multiple Sclerosis|multiple sclerosis
617501|NCT00950248|MS|ms
617502|NCT00950248|Primary Progressive Multiple Sclerosis|primary progressive multiple sclerosis
617503|NCT00950235|obese|obese
617504|NCT00950235|pregnant|pregnant
617505|NCT00950235|large for gestational age|large for gestational age
617506|NCT00950235|large for gestational age baby|large for gestational age baby
617507|NCT00950222|Intensive care unit|intensive care unit
617508|NCT00950222|Ventilator associated pneumonia|ventilator associated pneumonia
617509|NCT00950222|Gram negative bacilli infection|gram negative bacilli infection
617510|NCT00950222|Empirical antibiotic therapy|empirical antibiotic therapy
617511|NCT00950222|Pharmacokinetic / pharmacodynamic|pharmacokinetic / pharmacodynamic
617512|NCT00950222|Imipenem|imipenem
617513|NCT00950222|Amikacin|amikacin
617514|NCT00950222|Gram negative bacilli|gram negative bacilli
617515|NCT00950209|type 2 diabetic patients in the fed state|type 2 diabetic patients in the fed state
617516|NCT00950183|cryotherapy|cryotherapy
617517|NCT00950183|postoperative pain|postoperative pain
617518|NCT00950183|Iceman|iceman
617519|NCT00950183|primary first metatarsal osteotomy (PMO)|primary first metatarsal osteotomy (pmo)
617520|NCT00950183|lateral ankle ligament reconstruction (LAR)|lateral ankle ligament reconstruction (lar)
617521|NCT00950170|ReFacto AF|refacto af
617522|NCT00950170|factor VIII|factor viii
617523|NCT00950170|inhibitors|inhibitors
617524|NCT00950170|antibodies|antibodies
617525|NCT00950144|pain|pain
617526|NCT00950144|depression|depression
617527|NCT00950144|fatigue|fatigue
617528|NCT00950144|stage III colon cancer|stage iii colon cancer
617529|NCT00950144|stage IV colon cancer|stage iv colon cancer
617530|NCT00950144|recurrent colon cancer|recurrent colon cancer
617531|NCT00950144|stage III rectal cancer|stage iii rectal cancer
617532|NCT00950144|stage IV rectal cancer|stage iv rectal cancer
617533|NCT00950144|recurrent rectal cancer|recurrent rectal cancer
617534|NCT00950144|stage III pancreatic cancer|stage iii pancreatic cancer
617535|NCT00950144|stage IV pancreatic cancer|stage iv pancreatic cancer
617536|NCT00950144|recurrent pancreatic cancer|recurrent pancreatic cancer
617537|NCT00950144|adult primary hepatocellular carcinoma|adult primary hepatocellular carcinoma
617538|NCT00950144|advanced adult primary liver cancer|advanced adult primary liver cancer
617539|NCT00950144|localized unresectable adult primary liver cancer|localized unresectable adult primary liver cancer
617540|NCT00950144|recurrent adult primary liver cancer|recurrent adult primary liver cancer
617541|NCT00950118|Congenital Diaphragmatic Hernia (CDH)|congenital diaphragmatic hernia (cdh)
617542|NCT00950118|Genes|genes
617543|NCT00950118|Genetic|genetic
617544|NCT00950118|Genetic testing|genetic testing
617545|NCT00950118|exome sequencing|exome sequencing
617546|NCT00950118|genome sequencing|genome sequencing
617547|NCT00950118|RNAseq|rnaseq
617548|NCT00950105|CPSI2364|cpsi2364
617549|NCT00950105|Semapimod|semapimod
617550|NCT00950105|Anti TNF alpha|anti tnf alpha
617551|NCT00950105|Crohn's Disease|crohn's disease
617552|NCT00950105|Safety|safety
617553|NCT00950105|Tolerability|tolerability
617554|NCT00950105|Pharmacokinetics|pharmacokinetics
617555|NCT00950092|AF|af
617556|NCT00950092|atrial fibrillation|atrial fibrillation
617557|NCT00950092|ablation|ablation
617558|NCT00950092|surgical ablation|surgical ablation
617559|NCT00950092|afib|afib
617560|NCT00950092|coagulation|coagulation
617561|NCT00950092|RF|rf
617562|NCT00950092|epicardial|epicardial
617563|NCT00950092|Arrhythmias|arrhythmias
617564|NCT00950079|sodium bicarbonate|sodium bicarbonate
617565|NCT00950079|diabetes mellitus|diabetes mellitus
617566|NCT00950079|coronary angiography or intervention|coronary angiography or intervention
617567|NCT00950040|At-risk drinking|at-risk drinking
617568|NCT00950040|Type 2 diabetes|type 2 diabetes
617569|NCT00950040|Treatment adherence|treatment adherence
617570|NCT00950040|At-risk drinking among Type 2 diabetic patients|at-risk drinking among type 2 diabetic patients
617571|NCT00950014|Numeracy|numeracy
617572|NCT00949988|Chronic Lymphocytic Leukemia|chronic lymphocytic leukemia
617573|NCT00949988|CLL|cll
617574|NCT00949988|Dasatinib|dasatinib
617575|NCT00949988|Rituximab|rituximab
617576|NCT00949988|Relapsed|relapsed
617577|NCT00949988|Refractory|refractory
617578|NCT00949975|Chronic|chronic
617579|NCT00949975|Obstructive|obstructive
617580|NCT00949975|Pulmonary|pulmonary
617581|NCT00949975|Lung|lung
617582|NCT00949975|Respiratory disease|respiratory disease
617583|NCT00949975|Efficacy|efficacy
617584|NCT00949975|Safety and tolerability|safety and tolerability
617585|NCT00949975|Placebo-controlled|placebo-controlled
617586|NCT00949975|Pharmacokinetics|pharmacokinetics
617587|NCT00949975|COPD|copd
617588|NCT00949962|stage I prostate cancer|stage i prostate cancer
617589|NCT00949962|stage IIB prostate cancer|stage iib prostate cancer
617590|NCT00949962|stage IIA prostate cancer|stage iia prostate cancer
617591|NCT00949962|stage III prostate cancer|stage iii prostate cancer
617592|NCT00949936|Spine surgery|spine surgery
617593|NCT00949923|Postmenopausal women|postmenopausal women
617594|NCT00949923|Suspicious for breast ca|suspicious for breast ca
617595|NCT00949897|Adult Acquired Flatfoot|adult acquired flatfoot
617596|NCT00949897|Biofoam Porous Metal Implant|biofoam porous metal implant
617597|NCT00949897|Allograft Bone Wedge|allograft bone wedge
617598|NCT00949871|stage I breast cancer|stage i breast cancer
617599|NCT00949871|stage II breast cancer|stage ii breast cancer
617600|NCT00949871|stage IIIA breast cancer|stage iiia breast cancer
617601|NCT00949871|stage IIIB breast cancer|stage iiib breast cancer
617602|NCT00949871|stage IIIC breast cancer|stage iiic breast cancer
617603|NCT00949871|stage IV breast cancer|stage iv breast cancer
617604|NCT00949871|cancer survivor|cancer survivor
617605|NCT00949858|Sleep Disorders|sleep disorders
617606|NCT00949858|Obstructive Sleep Apnea|obstructive sleep apnea
617607|NCT00949858|Restless Leg Syndrome|restless leg syndrome
617608|NCT00949858|Insomnia|insomnia
617609|NCT00949858|Actigraphy|actigraphy
617610|NCT00949845|Effect of Inflammatory challenge on depressed mood|effect of inflammatory challenge on depressed mood
617611|NCT00949845|Effect of inflammatory challenge on social pain|effect of inflammatory challenge on social pain
617612|NCT00949832|rickets|rickets
617613|NCT00949832|calcium|calcium
617614|NCT00949832|vitamin D|vitamin d
617615|NCT00949832|nutrition|nutrition
617616|NCT00949832|child|child
617617|NCT00949819|Prostate Cancer|prostate cancer
617618|NCT00949819|Low risk|low risk
617619|NCT00949819|Gleason 6|gleason 6
617620|NCT00949819|Active surveillance|active surveillance
617621|NCT00949806|Botulinum toxin|botulinum toxin
617622|NCT00949793|Pathology|pathology
617623|NCT00949793|Microscopy, Confocal|microscopy, confocal
617624|NCT00949793|Microscopy, Fluorescence|microscopy, fluorescence
617625|NCT00949793|Intraoperative Procedures|intraoperative procedures
617626|NCT00949780|ABR|abr
617627|NCT00949780|Chloral Hydrate|chloral hydrate
617628|NCT00949780|Sedation|sedation
617629|NCT00949780|Children|children
617630|NCT00949754|honeybee venom|honeybee venom
617631|NCT00949754|osteoarthritis|osteoarthritis
617632|NCT00949754|pain|pain
617633|NCT00949754|knees|knees
617634|NCT00949728|Pterygium|pterygium
617635|NCT00949728|Autologous Transplantation|autologous transplantation
617636|NCT00949728|Conjunctiva|conjunctiva
617637|NCT00949728|Fibrin Tissue Adhesive|fibrin tissue adhesive
617638|NCT00949728|Recurrence|recurrence
617639|NCT00949715|Pacemaker|pacemaker
617640|NCT00949715|Implantable Pulse Generator (IPG)|implantable pulse generator (ipg)
617641|NCT00949715|AV Conduction Disturbance|av conduction disturbance
617642|NCT00949715|Selective Site Pacing|selective site pacing
617643|NCT00949689|adolescence|adolescence
617644|NCT00949689|insomnia|insomnia
617645|NCT00949689|depression|depression
617646|NCT00949689|sleep problems|sleep problems
617647|NCT00949689|cognitive therapy|cognitive therapy
617648|NCT00949663|Diabetes|diabetes
617649|NCT00949663|Blood Sugar|blood sugar
617650|NCT00949663|Xenin-25|xenin-25
617651|NCT00949663|GIP|gip
617652|NCT00949663|Insulin|insulin
617653|NCT00949637|obesity prevention|obesity prevention
617654|NCT00949637|girl scouts|girl scouts
617655|NCT00949637|physical activity|physical activity
617656|NCT00949637|family meals|family meals
617657|NCT00949637|fruits and vegetables|fruits and vegetables
617658|NCT00949637|health promotion|health promotion
617659|NCT00949624|PDGFr Inhibition;|pdgfr inhibition;
617660|NCT00949624|VEGFr inhibition;|vegfr inhibition;
617661|NCT00949624|targeted therapy|targeted therapy
617662|NCT00949611|Decision Aid|decision aid
617663|NCT00949611|Shared Decision Making|shared decision making
617664|NCT00949611|Shared Medical Decision Making|shared medical decision making
617665|NCT00949598|estrogen receptor-positive breast cancer|estrogen receptor-positive breast cancer
617666|NCT00949598|stage IA breast cancer|stage ia breast cancer
617667|NCT00949598|stage IB breast cancer|stage ib breast cancer
617668|NCT00949598|stage II breast cancer|stage ii breast cancer
617669|NCT00949598|stage IIIA breast cancer|stage iiia breast cancer
617670|NCT00949585|randomized, controlled feeding study;|randomized, controlled feeding study;
617671|NCT00949585|crossover design|crossover design
617672|NCT00949585|potassium intake|potassium intake
617673|NCT00949572|mucosal immunity|mucosal immunity
617674|NCT00949572|immunization|immunization
617675|NCT00949572|sublingual|sublingual
617676|NCT00949520|patients|patients
785521|NCT00308633|CAD|cad
617677|NCT00949520|functional evaluation|functional evaluation
617678|NCT00949520|known coronary artery lesion|known coronary artery lesion
617679|NCT00949494|knee osteoarthritis, synvisc, hyaluronan, dGEMRIC,cartilage|knee osteoarthritis, synvisc, hyaluronan, dgemric,cartilage
617680|NCT00949481|postpartum|postpartum
617978|NCT00948961|Hiltonol|hiltonol
617681|NCT00949481|family planning|family planning
617683|NCT00949481|immunization|immunization
617684|NCT00949481|pregnancy test|pregnancy test
617685|NCT00949468|Keratitis|keratitis
617686|NCT00949455|stage IV bladder cancer|stage iv bladder cancer
617687|NCT00949455|transitional cell carcinoma of the bladder|transitional cell carcinoma of the bladder
617688|NCT00949429|postoperative pain|postoperative pain
617689|NCT00949429|cardiac surgery|cardiac surgery
617690|NCT00949429|risk factors|risk factors
617691|NCT00949416|genetic|genetic
617692|NCT00949403|Non-Alcoholic Fatty Liver disease|non-alcoholic fatty liver disease
617693|NCT00949390|Advanced Cancer|advanced cancer
617694|NCT00949390|Advanced Malignancy|advanced malignancy
617695|NCT00949390|Complementary and Alternative Medicine|complementary and alternative medicine
617696|NCT00949390|CAM|cam
617697|NCT00949390|Investigational Cancer Therapeutics|investigational cancer therapeutics
617698|NCT00949390|Phase I Clinical Trials|phase i clinical trials
617699|NCT00949377|Constipation|constipation
617700|NCT00949377|opioid|opioid
617701|NCT00949364|Myeloproliferative Neoplasms|myeloproliferative neoplasms
617702|NCT00949364|Pomalidomide|pomalidomide
617703|NCT00949364|Fibrotic Stage|fibrotic stage
617704|NCT00949364|Patients with Myeloproliferative Neoplasms in Fibrotic Stage|patients with myeloproliferative neoplasms in fibrotic stage
617705|NCT00949351|ACEI, ARB, DN, aliskiren, proteinuria|acei, arb, dn, aliskiren, proteinuria
617706|NCT00949338|stage I prostate cancer|stage i prostate cancer
617707|NCT00949338|stage IIB prostate cancer|stage iib prostate cancer
617708|NCT00949338|stage IIA prostate cancer|stage iia prostate cancer
617709|NCT00949338|stage III prostate cancer|stage iii prostate cancer
617710|NCT00949338|stage IV prostate cancer|stage iv prostate cancer
617711|NCT00949338|recurrent prostate cancer|recurrent prostate cancer
617712|NCT00949325|osteosarcoma|osteosarcoma
617713|NCT00949325|soft tissue sarcoma|soft tissue sarcoma
617714|NCT00949325|rhabdomyosarcoma|rhabdomyosarcoma
617715|NCT00949325|leiomyosarcoma|leiomyosarcoma
617716|NCT00949325|Ewing's sarcoma|ewing's sarcoma
617717|NCT00949325|chondrosarcoma|chondrosarcoma
617718|NCT00949325|liposarcoma|liposarcoma
617719|NCT00949325|malignant fibrous histiocytoma|malignant fibrous histiocytoma
617720|NCT00949325|malignant peripheral nerve sheath tumor|malignant peripheral nerve sheath tumor
617721|NCT00949325|pleiomorphic sarcoma|pleiomorphic sarcoma
617722|NCT00949325|spindle cell sarcoma|spindle cell sarcoma
617723|NCT00949325|synovial sarcoma|synovial sarcoma
617724|NCT00949325|cancer stem cell|cancer stem cell
617725|NCT00949312|stage II colon cancer|stage ii colon cancer
617726|NCT00949286|Diabetes Mellitus, Type 2|diabetes mellitus, type 2
617727|NCT00949273|cylindrical abdominoperineal resection|cylindrical abdominoperineal resection
617728|NCT00949273|rectal cancer|rectal cancer
617729|NCT00949273|acellular dermal matrix|acellular dermal matrix
617730|NCT00949273|pelvic reconstruction|pelvic reconstruction
617731|NCT00949273|circumferential resection margin|circumferential resection margin
617732|NCT00949273|overall survival|overall survival
617733|NCT00949260|PIH|pih
617734|NCT00949260|pregnancy induced hypertension|pregnancy induced hypertension
617735|NCT00949260|pregnancy|pregnancy
617736|NCT00949260|bioimpedance|bioimpedance
617737|NCT00949260|noninvasive monitoring|noninvasive monitoring
617738|NCT00949260|Cardiac Output|cardiac output
617739|NCT00949260|Blood Pressure|blood pressure
617740|NCT00949247|stage I breast cancer|stage i breast cancer
617741|NCT00949247|stage II breast cancer|stage ii breast cancer
617742|NCT00949247|stage IIIA breast cancer|stage iiia breast cancer
617743|NCT00949247|stage IIIB breast cancer|stage iiib breast cancer
617744|NCT00949247|stage IIIC breast cancer|stage iiic breast cancer
617745|NCT00949247|HER2-positive breast cancer|her2-positive breast cancer
617746|NCT00949234|post exposure prophylaxis|post exposure prophylaxis
617747|NCT00949234|biomedical prevention|biomedical prevention
617748|NCT00949234|HIV seronegativity|hiv seronegativity
617749|NCT00949221|Type 1 diabetes|type 1 diabetes
617750|NCT00949221|Paediatric|paediatric
617751|NCT00949221|Real Time Continuous Glucose Monitoring|real time continuous glucose monitoring
617752|NCT00949221|Glycemic control|glycemic control
617753|NCT00949221|Therapeutic education|therapeutic education
617754|NCT00949208|Healthy people|healthy people
617755|NCT00949195|COPD|copd
617756|NCT00949195|healthy patients|healthy patients
617757|NCT00949195|PAP|pap
617758|NCT00949195|CPX|cpx
617759|NCT00949195|SSE|sse
617760|NCT00949195|hsCRP|hscrp
617761|NCT00949195|FMD|fmd
617762|NCT00949182|localized unresectable adult primary liver cancer|localized unresectable adult primary liver cancer
617763|NCT00949182|adult primary hepatocellular carcinoma|adult primary hepatocellular carcinoma
617764|NCT00949169|Atherosclerosis|atherosclerosis
785657|NCT00308009|Surgery|surgery
617765|NCT00949169|Carotid IMT|carotid imt
617766|NCT00949169|Multidetector CT|multidetector ct
617767|NCT00949169|Type 2 diabetes|type 2 diabetes
617768|NCT00949156|Craniopharyngiomas|craniopharyngiomas
617769|NCT00949156|Classification|classification
617770|NCT00949156|Membranous structure|membranous structure
617771|NCT00949156|Pituitary stalk|pituitary stalk
617772|NCT00949156|Obesity|obesity
617773|NCT00949156|panhypopituitarism|panhypopituitarism
617774|NCT00949143|wheelchair user|wheelchair user
617775|NCT00949117|malnutrition|malnutrition
617776|NCT00949117|weight changes|weight changes
617777|NCT00949117|childhood acute lymphoblastic leukemia in remission|childhood acute lymphoblastic leukemia in remission
617778|NCT00949117|recurrent childhood acute lymphoblastic leukemia|recurrent childhood acute lymphoblastic leukemia
617779|NCT00949117|untreated childhood acute lymphoblastic leukemia|untreated childhood acute lymphoblastic leukemia
617780|NCT00949117|childhood acute myeloid leukemia in remission|childhood acute myeloid leukemia in remission
617781|NCT00949117|recurrent childhood acute myeloid leukemia|recurrent childhood acute myeloid leukemia
617782|NCT00949117|untreated childhood acute myeloid leukemia|untreated childhood acute myeloid leukemia
617783|NCT00949117|other myeloid malignancies|other myeloid malignancies
617784|NCT00949117|stage I childhood Hodgkin lymphoma|stage i childhood hodgkin lymphoma
617785|NCT00949117|stage II childhood Hodgkin lymphoma|stage ii childhood hodgkin lymphoma
617786|NCT00949117|stage III childhood Hodgkin lymphoma|stage iii childhood hodgkin lymphoma
617787|NCT00949117|stage IV childhood Hodgkin lymphoma|stage iv childhood hodgkin lymphoma
617788|NCT00949117|recurrent/refractory childhood Hodgkin lymphoma|recurrent/refractory childhood hodgkin lymphoma
617789|NCT00949117|recurrent childhood anaplastic large cell lymphoma|recurrent childhood anaplastic large cell lymphoma
617790|NCT00949117|stage I childhood anaplastic large cell lymphoma|stage i childhood anaplastic large cell lymphoma
617791|NCT00949117|stage II childhood anaplastic large cell lymphoma|stage ii childhood anaplastic large cell lymphoma
617792|NCT00949117|stage III childhood anaplastic large cell lymphoma|stage iii childhood anaplastic large cell lymphoma
617793|NCT00949117|stage IV childhood anaplastic large cell lymphoma|stage iv childhood anaplastic large cell lymphoma
617794|NCT00949117|recurrent childhood grade III lymphomatoid granulomatosis|recurrent childhood grade iii lymphomatoid granulomatosis
617795|NCT00949117|childhood diffuse large cell lymphoma|childhood diffuse large cell lymphoma
617796|NCT00949117|childhood immunoblastic large cell lymphoma|childhood immunoblastic large cell lymphoma
617797|NCT00949117|recurrent childhood large cell lymphoma|recurrent childhood large cell lymphoma
617798|NCT00949117|stage I childhood large cell lymphoma|stage i childhood large cell lymphoma
617799|NCT00949117|stage II childhood large cell lymphoma|stage ii childhood large cell lymphoma
617800|NCT00949117|stage III childhood large cell lymphoma|stage iii childhood large cell lymphoma
617801|NCT00949117|stage IV childhood large cell lymphoma|stage iv childhood large cell lymphoma
617802|NCT00949117|recurrent childhood lymphoblastic lymphoma|recurrent childhood lymphoblastic lymphoma
617803|NCT00949117|stage I childhood lymphoblastic lymphoma|stage i childhood lymphoblastic lymphoma
617804|NCT00949117|stage II childhood lymphoblastic lymphoma|stage ii childhood lymphoblastic lymphoma
617805|NCT00949117|stage III childhood lymphoblastic lymphoma|stage iii childhood lymphoblastic lymphoma
617806|NCT00949117|stage IV childhood lymphoblastic lymphoma|stage iv childhood lymphoblastic lymphoma
617807|NCT00949117|childhood nasal type extranodal NK/T-cell lymphoma|childhood nasal type extranodal nk/t-cell lymphoma
617808|NCT00949117|childhood Burkitt lymphoma|childhood burkitt lymphoma
617809|NCT00949117|recurrent childhood small noncleaved cell lymphoma|recurrent childhood small noncleaved cell lymphoma
617810|NCT00949117|stage I childhood small noncleaved cell lymphoma|stage i childhood small noncleaved cell lymphoma
617811|NCT00949117|stage II childhood small noncleaved cell lymphoma|stage ii childhood small noncleaved cell lymphoma
617812|NCT00949117|stage III childhood small noncleaved cell lymphoma|stage iii childhood small noncleaved cell lymphoma
617813|NCT00949117|stage IV childhood small noncleaved cell lymphoma|stage iv childhood small noncleaved cell lymphoma
617814|NCT00949117|childhood myelodysplastic syndromes|childhood myelodysplastic syndromes
617815|NCT00949117|de novo myelodysplastic syndromes|de novo myelodysplastic syndromes
617816|NCT00949117|previously treated myelodysplastic syndromes|previously treated myelodysplastic syndromes
617817|NCT00949117|secondary myelodysplastic syndromes|secondary myelodysplastic syndromes
617818|NCT00949117|unspecified childhood solid tumor, protocol specific|unspecified childhood solid tumor, protocol specific
617819|NCT00949104|Sucrose|sucrose
617820|NCT00949104|pain|pain
617821|NCT00949104|neonate|neonate
617822|NCT00949104|preterm|preterm
617823|NCT00949104|orogastric tube|orogastric tube
617824|NCT00949091|Diabetes Mellitus, Non Insulin Dependent|diabetes mellitus, non insulin dependent
617825|NCT00949091|Diabetes Mellitus, Type II|diabetes mellitus, type ii
617826|NCT00949091|Type 2 Diabetes Mellitus|type 2 diabetes mellitus
617827|NCT00949091|Drug Therapy|drug therapy
617828|NCT00949078|peanut|peanut
617829|NCT00949078|allergy|allergy
617830|NCT00949065|complex regional pain syndrome|complex regional pain syndrome
617831|NCT00949065|sympathetic reflex dystrophy|sympathetic reflex dystrophy
617832|NCT00949065|intravenous immunoglobulins|intravenous immunoglobulins
617833|NCT00949065|autoimmune disease|autoimmune disease
617834|NCT00949052|cancer survivor|cancer survivor
617835|NCT00949052|stage III adult Burkitt lymphoma|stage iii adult burkitt lymphoma
617836|NCT00949052|stage III adult diffuse large cell lymphoma|stage iii adult diffuse large cell lymphoma
617837|NCT00949052|stage III adult diffuse mixed cell lymphoma|stage iii adult diffuse mixed cell lymphoma
617838|NCT00949052|stage III adult diffuse small cleaved cell lymphoma|stage iii adult diffuse small cleaved cell lymphoma
617839|NCT00949052|stage III adult Hodgkin lymphoma|stage iii adult hodgkin lymphoma
617840|NCT00949052|stage III adult immunoblastic large cell lymphoma|stage iii adult immunoblastic large cell lymphoma
617841|NCT00949052|stage III adult lymphoblastic lymphoma|stage iii adult lymphoblastic lymphoma
618370|NCT00947453|asthma|asthma
617842|NCT00949052|stage III grade 1 follicular lymphoma|stage iii grade 1 follicular lymphoma
617843|NCT00949052|stage III grade 2 follicular lymphoma|stage iii grade 2 follicular lymphoma
617844|NCT00949052|stage III grade 3 follicular lymphoma|stage iii grade 3 follicular lymphoma
617845|NCT00949052|stage III mantle cell lymphoma|stage iii mantle cell lymphoma
617846|NCT00949052|stage III marginal zone lymphoma|stage iii marginal zone lymphoma
617847|NCT00949052|stage III small lymphocytic lymphoma|stage iii small lymphocytic lymphoma
617848|NCT00949052|stage IV adult Burkitt lymphoma|stage iv adult burkitt lymphoma
617849|NCT00949052|stage IV adult diffuse large cell lymphoma|stage iv adult diffuse large cell lymphoma
617850|NCT00949052|stage IV adult diffuse mixed cell lymphoma|stage iv adult diffuse mixed cell lymphoma
617851|NCT00949052|stage IV adult diffuse small cleaved cell lymphoma|stage iv adult diffuse small cleaved cell lymphoma
617852|NCT00949052|stage IV adult Hodgkin lymphoma|stage iv adult hodgkin lymphoma
617853|NCT00949052|stage IV adult immunoblastic large cell lymphoma|stage iv adult immunoblastic large cell lymphoma
617854|NCT00949052|stage IV adult lymphoblastic lymphoma|stage iv adult lymphoblastic lymphoma
617855|NCT00949052|stage IV grade 1 follicular lymphoma|stage iv grade 1 follicular lymphoma
617856|NCT00949052|stage IV grade 2 follicular lymphoma|stage iv grade 2 follicular lymphoma
617857|NCT00949052|stage IV grade 3 follicular lymphoma|stage iv grade 3 follicular lymphoma
617858|NCT00949052|stage IV mantle cell lymphoma|stage iv mantle cell lymphoma
617859|NCT00949052|stage IV marginal zone lymphoma|stage iv marginal zone lymphoma
617860|NCT00949052|stage IV small lymphocytic lymphoma|stage iv small lymphocytic lymphoma
617861|NCT00949052|recurrent adult Burkitt lymphoma|recurrent adult burkitt lymphoma
617862|NCT00949052|recurrent adult diffuse large cell lymphoma|recurrent adult diffuse large cell lymphoma
617863|NCT00949052|recurrent adult diffuse mixed cell lymphoma|recurrent adult diffuse mixed cell lymphoma
617864|NCT00949052|recurrent adult diffuse small cleaved cell lymphoma|recurrent adult diffuse small cleaved cell lymphoma
617865|NCT00949052|recurrent adult Hodgkin lymphoma|recurrent adult hodgkin lymphoma
617866|NCT00949052|recurrent adult immunoblastic large cell lymphoma|recurrent adult immunoblastic large cell lymphoma
617867|NCT00949052|recurrent adult lymphoblastic lymphoma|recurrent adult lymphoblastic lymphoma
617868|NCT00949052|recurrent childhood large cell lymphoma|recurrent childhood large cell lymphoma
617869|NCT00949052|recurrent childhood lymphoblastic lymphoma|recurrent childhood lymphoblastic lymphoma
617870|NCT00949052|recurrent childhood small noncleaved cell lymphoma|recurrent childhood small noncleaved cell lymphoma
617871|NCT00949052|recurrent cutaneous T-cell non-Hodgkin lymphoma|recurrent cutaneous t-cell non-hodgkin lymphoma
617872|NCT00949052|recurrent grade 1 follicular lymphoma|recurrent grade 1 follicular lymphoma
617873|NCT00949052|recurrent grade 2 follicular lymphoma|recurrent grade 2 follicular lymphoma
617874|NCT00949052|recurrent grade 3 follicular lymphoma|recurrent grade 3 follicular lymphoma
617875|NCT00949052|recurrent mantle cell lymphoma|recurrent mantle cell lymphoma
617876|NCT00949052|recurrent marginal zone lymphoma|recurrent marginal zone lymphoma
617877|NCT00949052|recurrent small lymphocytic lymphoma|recurrent small lymphocytic lymphoma
617878|NCT00949052|recurrent/refractory childhood Hodgkin lymphoma|recurrent/refractory childhood hodgkin lymphoma
617879|NCT00949052|recurrent mycosis fungoides/Sezary syndrome|recurrent mycosis fungoides/sezary syndrome
617880|NCT00949052|extranodal marginal zone B-cell lymphoma of mucosa-associated lymphoid tissue|extranodal marginal zone b-cell lymphoma of mucosa-associated lymphoid tissue
617881|NCT00949052|nodal marginal zone B-cell lymphoma|nodal marginal zone b-cell lymphoma
617882|NCT00949052|splenic marginal zone lymphoma|splenic marginal zone lymphoma
617883|NCT00949052|noncontiguous stage II adult Burkitt lymphoma|noncontiguous stage ii adult burkitt lymphoma
617884|NCT00949052|noncontiguous stage II adult diffuse large cell lymphoma|noncontiguous stage ii adult diffuse large cell lymphoma
617885|NCT00949052|noncontiguous stage II adult diffuse mixed cell lymphoma|noncontiguous stage ii adult diffuse mixed cell lymphoma
617886|NCT00949052|noncontiguous stage II adult diffuse small cleaved cell lymphoma|noncontiguous stage ii adult diffuse small cleaved cell lymphoma
617887|NCT00949052|noncontiguous stage II adult immunoblastic large cell lymphoma|noncontiguous stage ii adult immunoblastic large cell lymphoma
617888|NCT00949052|noncontiguous stage II adult lymphoblastic lymphoma|noncontiguous stage ii adult lymphoblastic lymphoma
617889|NCT00949052|noncontiguous stage II grade 1 follicular lymphoma|noncontiguous stage ii grade 1 follicular lymphoma
617890|NCT00949052|noncontiguous stage II grade 2 follicular lymphoma|noncontiguous stage ii grade 2 follicular lymphoma
617891|NCT00949052|noncontiguous stage II grade 3 follicular lymphoma|noncontiguous stage ii grade 3 follicular lymphoma
617892|NCT00949052|noncontiguous stage II mantle cell lymphoma|noncontiguous stage ii mantle cell lymphoma
710889|NCT00587405|Argon Plasma Coagulation|argon plasma coagulation
617893|NCT00949052|noncontiguous stage II marginal zone lymphoma|noncontiguous stage ii marginal zone lymphoma
617894|NCT00949052|noncontiguous stage II small lymphocytic lymphoma|noncontiguous stage ii small lymphocytic lymphoma
617895|NCT00949052|accelerated phase chronic myelogenous leukemia|accelerated phase chronic myelogenous leukemia
617896|NCT00949052|adult acute lymphoblastic leukemia in remission|adult acute lymphoblastic leukemia in remission
617897|NCT00949052|adult acute myeloid leukemia in remission|adult acute myeloid leukemia in remission
617898|NCT00949052|adult acute myeloid leukemia with 11q23 (MLL) abnormalities|adult acute myeloid leukemia with 11q23 (mll) abnormalities
617899|NCT00949052|adult acute myeloid leukemia with inv(16)(p13;q22)|adult acute myeloid leukemia with inv(16)(p13;q22)
617900|NCT00949052|adult acute myeloid leukemia with t(15;17)(q22;q12)|adult acute myeloid leukemia with t(15;17)(q22;q12)
617901|NCT00949052|adult acute myeloid leukemia with t(16;16)(p13;q22)|adult acute myeloid leukemia with t(16;16)(p13;q22)
617979|NCT00948961|esophageal cancer|esophageal cancer
617902|NCT00949052|adult acute myeloid leukemia with t(8;21)(q22;q22)|adult acute myeloid leukemia with t(8;21)(q22;q22)
617903|NCT00949052|atypical chronic myeloid leukemia, BCR-ABL negative|atypical chronic myeloid leukemia, bcr-abl negative
617904|NCT00949052|blastic phase chronic myelogenous leukemia|blastic phase chronic myelogenous leukemia
617905|NCT00949052|childhood acute lymphoblastic leukemia in remission|childhood acute lymphoblastic leukemia in remission
617906|NCT00949052|childhood acute myeloid leukemia in remission|childhood acute myeloid leukemia in remission
617907|NCT00949052|childhood chronic myelogenous leukemia|childhood chronic myelogenous leukemia
617908|NCT00949052|chronic myelomonocytic leukemia|chronic myelomonocytic leukemia
617909|NCT00949052|chronic phase chronic myelogenous leukemia|chronic phase chronic myelogenous leukemia
617910|NCT00949052|juvenile myelomonocytic leukemia|juvenile myelomonocytic leukemia
617911|NCT00949052|recurrent adult acute lymphoblastic leukemia|recurrent adult acute lymphoblastic leukemia
617912|NCT00949052|recurrent adult acute myeloid leukemia|recurrent adult acute myeloid leukemia
617913|NCT00949052|recurrent childhood acute lymphoblastic leukemia|recurrent childhood acute lymphoblastic leukemia
617914|NCT00949052|recurrent childhood acute myeloid leukemia|recurrent childhood acute myeloid leukemia
617915|NCT00949052|refractory chronic lymphocytic leukemia|refractory chronic lymphocytic leukemia
617916|NCT00949052|refractory hairy cell leukemia|refractory hairy cell leukemia
617917|NCT00949052|relapsing chronic myelogenous leukemia|relapsing chronic myelogenous leukemia
617918|NCT00949052|secondary acute myeloid leukemia|secondary acute myeloid leukemia
617919|NCT00949052|stage III chronic lymphocytic leukemia|stage iii chronic lymphocytic leukemia
617920|NCT00949052|stage IV chronic lymphocytic leukemia|stage iv chronic lymphocytic leukemia
617921|NCT00949052|childhood myelodysplastic syndromes|childhood myelodysplastic syndromes
617922|NCT00949052|chronic eosinophilic leukemia|chronic eosinophilic leukemia
617923|NCT00949052|primary myelofibrosis|primary myelofibrosis
617924|NCT00949052|chronic neutrophilic leukemia|chronic neutrophilic leukemia
617925|NCT00949052|de novo myelodysplastic syndromes|de novo myelodysplastic syndromes
617926|NCT00949052|disseminated neuroblastoma|disseminated neuroblastoma
617927|NCT00949052|myelodysplastic/myeloproliferative neoplasm, unclassifiable|myelodysplastic/myeloproliferative neoplasm, unclassifiable
617928|NCT00949052|poor prognosis metastatic gestational trophoblastic tumor|poor prognosis metastatic gestational trophoblastic tumor
617929|NCT00949052|previously treated childhood rhabdomyosarcoma|previously treated childhood rhabdomyosarcoma
617930|NCT00949052|previously treated myelodysplastic syndromes|previously treated myelodysplastic syndromes
617931|NCT00949052|recurrent Wilms tumor and other childhood kidney tumors|recurrent wilms tumor and other childhood kidney tumors
617932|NCT00949052|recurrent childhood rhabdomyosarcoma|recurrent childhood rhabdomyosarcoma
617933|NCT00949052|recurrent neuroblastoma|recurrent neuroblastoma
617934|NCT00949052|recurrent ovarian epithelial cancer|recurrent ovarian epithelial cancer
617935|NCT00949052|recurrent ovarian germ cell tumor|recurrent ovarian germ cell tumor
617936|NCT00949052|recurrent malignant testicular germ cell tumor|recurrent malignant testicular germ cell tumor
617937|NCT00949052|secondary myelodysplastic syndromes|secondary myelodysplastic syndromes
617938|NCT00949052|stage I multiple myeloma|stage i multiple myeloma
617939|NCT00949052|stage II multiple myeloma|stage ii multiple myeloma
617940|NCT00949052|stage III multiple myeloma|stage iii multiple myeloma
617941|NCT00949052|stage II ovarian epithelial cancer|stage ii ovarian epithelial cancer
617942|NCT00949052|stage III ovarian epithelial cancer|stage iii ovarian epithelial cancer
617943|NCT00949052|stage IV ovarian epithelial cancer|stage iv ovarian epithelial cancer
617944|NCT00949052|stage III malignant testicular germ cell tumor|stage iii malignant testicular germ cell tumor
617945|NCT00949052|stage IIIA breast cancer|stage iiia breast cancer
617946|NCT00949052|stage IIIB breast cancer|stage iiib breast cancer
617947|NCT00949052|stage IIIC breast cancer|stage iiic breast cancer
617948|NCT00949052|stage IV breast cancer|stage iv breast cancer
617949|NCT00949052|refractory multiple myeloma|refractory multiple myeloma
617950|NCT00949026|Brain Cancer|brain cancer
617951|NCT00949026|Brain Neoplasms, Malignant|brain neoplasms, malignant
617952|NCT00949013|stage IA breast cancer|stage ia breast cancer
617953|NCT00949013|stage IB breast cancer|stage ib breast cancer
617954|NCT00949013|stage II breast cancer|stage ii breast cancer
617955|NCT00949013|stage IIIA breast cancer|stage iiia breast cancer
617956|NCT00949013|stage IIIB breast cancer|stage iiib breast cancer
786019|NCT00306605|fathers|fathers
617957|NCT00949013|stage IIIC breast cancer|stage iiic breast cancer
617958|NCT00948987|aspirin resistance|aspirin resistance
617959|NCT00948987|cardiovascular risk|cardiovascular risk
617960|NCT00948987|prostaglandins|prostaglandins
617961|NCT00948987|platelet inhibition|platelet inhibition
617962|NCT00948974|social anxiety|social anxiety
617963|NCT00948974|treatment|treatment
617964|NCT00948974|Cognitive Behavioral Therapy|cognitive behavioral therapy
617965|NCT00948974|Acceptance and Commitment Therapy|acceptance and commitment therapy
617966|NCT00948974|Cognitive Therapy|cognitive therapy
617967|NCT00948961|NYESO1|nyeso1
617968|NCT00948961|cancer vaccine|cancer vaccine
617969|NCT00948961|immunotherapy|immunotherapy
617970|NCT00948961|breast cancer|breast cancer
617971|NCT00948961|ovarian cancer|ovarian cancer
617972|NCT00948961|non-small cell lung cancer|non-small cell lung cancer
617973|NCT00948961|myeloma|myeloma
617974|NCT00948961|sarcoma|sarcoma
617975|NCT00948961|melanoma|melanoma
617976|NCT00948961|Resiquimod|resiquimod
617977|NCT00948961|Poly-ICLC|poly-iclc
617980|NCT00948961|bladder cancer|bladder cancer
617981|NCT00948961|chondrosarcoma|chondrosarcoma
617982|NCT00948961|adenocarcinoma|adenocarcinoma
617983|NCT00948935|Biliary Cancer|biliary cancer
617984|NCT00948935|Cholangiocarcinoma|cholangiocarcinoma
617985|NCT00948935|Panitumumab|panitumumab
617986|NCT00948922|multiple myeloma|multiple myeloma
617987|NCT00948922|myeloma|myeloma
617988|NCT00948922|myeloma proteins|myeloma proteins
617989|NCT00948922|autologous|autologous
617990|NCT00948922|allogeneic|allogeneic
617991|NCT00948922|G-CSR|g-csr
617992|NCT00948922|granulocyte colony-stimulating factor|granulocyte colony-stimulating factor
617993|NCT00948922|stem cell transplant|stem cell transplant
617994|NCT00948922|stem cell|stem cell
617995|NCT00948922|stem cell mobilization|stem cell mobilization
617996|NCT00948896|Chemoprevention|chemoprevention
617997|NCT00948896|Uganda|uganda
617998|NCT00948896|Malaria|malaria
617999|NCT00948896|Trimethoprim-sulfamethoxazole|trimethoprim-sulfamethoxazole
618000|NCT00948896|Sulfadoxine-pyrimethamine|sulfadoxine-pyrimethamine
618001|NCT00948896|Dihydroartemisinin-piperaquine|dihydroartemisinin-piperaquine
618002|NCT00948883|organ transplant|organ transplant
618003|NCT00948883|cancer|cancer
618004|NCT00948883|biobank|biobank
618005|NCT00948883|immunosuppressive drugs|immunosuppressive drugs
618006|NCT00948883|lymphoma|lymphoma
618007|NCT00948870|alternative medicine|alternative medicine
618008|NCT00948857|DHEA|dhea
618009|NCT00948857|POF|pof
618010|NCT00948857|Pregnancy|pregnancy
618011|NCT00948857|Ovarian Failure|ovarian failure
618012|NCT00948857|Otherwise Unexplained infertility|otherwise unexplained infertility
618013|NCT00948857|Ovarian aging|ovarian aging
618014|NCT00948844|falls|falls
618015|NCT00948844|Missteps|missteps
618016|NCT00948831|biologics|biologics
618017|NCT00948831|fusion rates|fusion rates
618018|NCT00948831|lumbar fusion|lumbar fusion
618019|NCT00948831|ALIF|alif
618020|NCT00948818|Irritable Bowel Syndrome|irritable bowel syndrome
618021|NCT00948818|Constipation|constipation
618022|NCT00948818|Linaclotide|linaclotide
618023|NCT00948805|corpus luteum rescue|corpus luteum rescue
618024|NCT00948805|Gonadotropin Releasing Hormone (GnRH agonist)|gonadotropin releasing hormone (gnrh agonist)
618025|NCT00948805|human Chorionic Gonadotropin (hCG)|human chorionic gonadotropin (hcg)
618026|NCT00948805|infertility|infertility
618027|NCT00948805|pregnancy rate|pregnancy rate
618028|NCT00948792|platelets|platelets
618029|NCT00948792|transfusion|transfusion
618030|NCT00948792|thrombocytopenia|thrombocytopenia
618031|NCT00948779|Patient education|patient education
618032|NCT00948779|Antibiotic|antibiotic
618033|NCT00948779|Child|child
618034|NCT00948779|Respiratory tract infection|respiratory tract infection
618035|NCT00948779|Patient satisfaction|patient satisfaction
618036|NCT00948779|Parental knowledge|parental knowledge
618037|NCT00948779|Adherence|adherence
618038|NCT00948766|Alzheimer's disease|alzheimer's disease
618039|NCT00948766|dementia|dementia
618040|NCT00948766|Alzheimer's type|alzheimer's type
618041|NCT00948753|Graft-versus-host disease|graft-versus-host disease
618042|NCT00948753|GVHD|gvhd
618043|NCT00948753|Maraviroc|maraviroc
618044|NCT00948753|non-myeloablative allogeneic stem-cell transplantation|non-myeloablative allogeneic stem-cell transplantation
618045|NCT00948753|Hematopoietic stem cell transplantation|hematopoietic stem cell transplantation
618046|NCT00948740|vitamin D|vitamin d
618047|NCT00948701|Breast cancer|breast cancer
618048|NCT00948701|Exercise|exercise
618049|NCT00948701|Physical activity|physical activity
618050|NCT00948701|Community volunteers|community volunteers
618051|NCT00948701|Peer mentors|peer mentors
618052|NCT00948701|Peer coaches|peer coaches
618053|NCT00948701|Social support|social support
618054|NCT00948688|Zolinza|zolinza
618055|NCT00948675|Advanced Non-Small Cell Lung Cancer of Nonsquamous Histology|advanced non-small cell lung cancer of nonsquamous histology
786149|NCT00306124|MCI|mci
618056|NCT00948675|Advanced Lung Cancer|advanced lung cancer
618057|NCT00948675|Non-Small Cell Lung Cancer|non-small cell lung cancer
618058|NCT00948675|Lung Cancer|lung cancer
618059|NCT00948662|Safety|safety
618060|NCT00948662|tolerability|tolerability
618061|NCT00948662|ascending single doses|ascending single doses
618062|NCT00948662|healthy subjects|healthy subjects
618063|NCT00948649|Varenicline, Working memory|varenicline, working memory
618064|NCT00948623|COPD|copd
618065|NCT00948623|physical activity|physical activity
618066|NCT00948623|pulmonary rehabilitation|pulmonary rehabilitation
618067|NCT00948623|counseling|counseling
618068|NCT00948610|Rheumatoid Arthritis|rheumatoid arthritis
618069|NCT00948597|propofol|propofol
618070|NCT00948597|elective surgical procedure|elective surgical procedure
618071|NCT00948597|Obese subjects|obese subjects
618072|NCT00948584|Diabetes Mellitus, Type 2|diabetes mellitus, type 2
618073|NCT00948584|Insulin dose titration system|insulin dose titration system
618074|NCT00948571|Vital capacity, FEV1, airway resistance|vital capacity, fev1, airway resistance
618075|NCT00948571|perioperative changes in lung function|perioperative changes in lung function
618076|NCT00948558|citrate anticoagulation|citrate anticoagulation
618077|NCT00948558|pharmacokinetic|pharmacokinetic
618078|NCT00948558|critically ill|critically ill
618079|NCT00948558|acute kidney failure|acute kidney failure
618080|NCT00948545|Autonomic nervous system|autonomic nervous system
618081|NCT00948545|Bariatric surgery|bariatric surgery
618082|NCT00948545|Observational study for individuals having bariatric surgery|observational study for individuals having bariatric surgery
618083|NCT00948532|degenerative disc disease|degenerative disc disease
618084|NCT00948532|lumbar spine|lumbar spine
618085|NCT00948532|XLIF|xlif
618086|NCT00948532|Degenerative conditions|degenerative conditions
618087|NCT00948519|Rhinosinusitis, sinusitis, chronic, nasal polyps, phototherapy, laser,laser therapy, antibiotic, safety laser, ICG, indocyanine green|rhinosinusitis, sinusitis, chronic, nasal polyps, phototherapy, laser,laser therapy, antibiotic, safety laser, icg, indocyanine green
618088|NCT00948519|Chronic Rhinosinusitis with or without nasal polyposis|chronic rhinosinusitis with or without nasal polyposis
618089|NCT00948493|diabetes|diabetes
618090|NCT00948493|insulin therapy|insulin therapy
618091|NCT00948480|autologous tumor cell vaccine|autologous tumor cell vaccine
618092|NCT00948480|metastatic melanoma|metastatic melanoma
618093|NCT00948480|sargramostim (GM-CSF)|sargramostim (gm-csf)
618094|NCT00948467|Advanced nonhematologic malignancies|advanced nonhematologic malignancies
618095|NCT00948467|Advanced metastatic melanoma|advanced metastatic melanoma
618096|NCT00948467|BRAF gene|braf gene
618097|NCT00948454|smoking|smoking
618098|NCT00948441|intestinal insufficiency|intestinal insufficiency
618099|NCT00948441|central venous catheter|central venous catheter
618100|NCT00948441|Catheter-Related Infections|catheter-related infections
618101|NCT00948441|pediatrics|pediatrics
618102|NCT00948441|ethanol|ethanol
618103|NCT00948428|actinic keratoses|actinic keratoses
618104|NCT00948428|imiquimod|imiquimod
618105|NCT00948428|therapeutic equivalence|therapeutic equivalence
618106|NCT00948428|bioequivalence|bioequivalence
618107|NCT00948415|Obesity|obesity
618108|NCT00948415|Weight loss|weight loss
618109|NCT00948415|Internet|internet
618110|NCT00948402|PED/PEA-15 protein|ped/pea-15 protein
618111|NCT00948402|PCOS|pcos
618112|NCT00948402|IR|ir
618113|NCT00948402|metformin|metformin
618114|NCT00948402|OCP|ocp
618115|NCT00948402|Oral Contraceptive|oral contraceptive
618116|NCT00948376|Natural history|natural history
618117|NCT00948376|IFT80|ift80
618118|NCT00948376|short ribs|short ribs
618119|NCT00948376|multivisceral involvement|multivisceral involvement
618120|NCT00948363|Kiwi fruits|kiwi fruits
618121|NCT00948363|Blood pressure|blood pressure
618122|NCT00948363|Endothelial function|endothelial function
618123|NCT00948363|Antioxidant capacity|antioxidant capacity
618124|NCT00948350|cervical instability|cervical instability
618125|NCT00948350|awake intubation|awake intubation
618126|NCT00948350|laryngeal anesthesia|laryngeal anesthesia
618127|NCT00948324|ype 2 diabetes mellitus, continuous subcutaneous insulin infusion,|ype 2 diabetes mellitus, continuous subcutaneous insulin infusion,
618128|NCT00948324|α-lipoic acid ,rosiglitazone ,metformin，therapy|α-lipoic acid ,rosiglitazone ,metformin，therapy
618129|NCT00948298|cardiovascular disease|cardiovascular disease
618130|NCT00948298|vitamin D|vitamin d
618131|NCT00948298|african american|african american
618132|NCT00948298|low vitamin D levels|low vitamin d levels
618133|NCT00948285|breast cancer|breast cancer
618134|NCT00948285|magnetic resonance imaging|magnetic resonance imaging
618135|NCT00948272|Rabies|rabies
618136|NCT00948272|Rabies virus|rabies virus
618137|NCT00948272|Purified Vero Rabies Vaccine|purified vero rabies vaccine
618138|NCT00948272|Serum Free|serum free
618139|NCT00948259|safety|safety
618140|NCT00948259|GSK inhibitor|gsk inhibitor
618141|NCT00948259|Alzheimer|alzheimer
618142|NCT00948233|Tobacco|tobacco
618143|NCT00948233|Smoking Cessation|smoking cessation
618144|NCT00948233|Prevention|prevention
618145|NCT00948233|Smokeless tobacco|smokeless tobacco
618146|NCT00948233|Habit|habit
618147|NCT00948220|HCV|hcv
618148|NCT00948220|hepatitis C virus|hepatitis c virus
618149|NCT00948220|CHC|chc
618150|NCT00948220|chronic hepatitis c|chronic hepatitis c
618151|NCT00948220|interferon|interferon
618152|NCT00948220|ribavirin|ribavirin
618153|NCT00948220|DEXA|dexa
618154|NCT00948220|BMD|bmd
618155|NCT00948220|bone mineral density|bone mineral density
618156|NCT00948220|osteoporosis|osteoporosis
618157|NCT00948220|osteopenia|osteopenia
618158|NCT00948220|osteodystrophy|osteodystrophy
618159|NCT00948220|osteodensitometry|osteodensitometry
618160|NCT00948220|Bone Density|bone density
618161|NCT00948220|Hepatitis, Viral, Human|hepatitis, viral, human
618162|NCT00948220|Anti-Infective Agents|anti-infective agents
618163|NCT00948220|peginterferon alfa-2a|peginterferon alfa-2a
618164|NCT00948207|Metastatic Cancer|metastatic cancer
618165|NCT00948207|Recurrent Cancer|recurrent cancer
618166|NCT00948207|Distributed Hematological Cancer|distributed hematological cancer
618167|NCT00948207|Advanced Cancer|advanced cancer
618168|NCT00948207|Terminal Cancer|terminal cancer
618169|NCT00948207|Stage III Cancer|stage iii cancer
618170|NCT00948207|Stage IV Cancer|stage iv cancer
618171|NCT00948194|Extended Donor Criteria|extended donor criteria
618172|NCT00948181|Epinephrine, Norepinephrine, normetanephrine|epinephrine, norepinephrine, normetanephrine
618173|NCT00948181|Catecholamine concentrations during surgery|catecholamine concentrations during surgery
618174|NCT00948168|T2DM|t2dm
618175|NCT00948168|exenatide|exenatide
618176|NCT00948168|HbA1c|hba1c
618177|NCT00948168|weight|weight
618178|NCT00948168|waist circumference|waist circumference
618179|NCT00948168|insulin sensitivity|insulin sensitivity
618180|NCT00948168|beta-cell function|beta-cell function
618181|NCT00948155|smoking|smoking
618182|NCT00948155|nicotine|nicotine
618183|NCT00948155|varenicline|varenicline
618184|NCT00948142|Acute Bacterial Skin and Skin Struction Infections; Bacterial Skin Diseases; Staphylococcal Skin Infections; MRSA|acute bacterial skin and skin struction infections; bacterial skin diseases; staphylococcal skin infections; mrsa
618185|NCT00948116|Diabetes mellitus|diabetes mellitus
618186|NCT00948116|Renal Impairment|renal impairment
618187|NCT00948116|Acute Kidney Injury|acute kidney injury
618188|NCT00948116|Coronary revascularisation|coronary revascularisation
618189|NCT00948116|eGFR <60ml/min|egfr <60ml/min
618190|NCT00948103|Nitrous Oxide|nitrous oxide
618191|NCT00948103|Administration, Intravesical Drug|administration, intravesical drug
618192|NCT00948103|Botulinum toxin|botulinum toxin
618193|NCT00948090|Hodgkin Lymphoma|hodgkin lymphoma
618194|NCT00948090|Non-Hodgkin's Lymphoma|non-hodgkin's lymphoma
618195|NCT00948090|Bone marrow transplant|bone marrow transplant
618196|NCT00948090|stem cell transplant|stem cell transplant
618197|NCT00948090|busulfan|busulfan
618198|NCT00948090|cyclophosphamide|cyclophosphamide
618199|NCT00948090|etoposide|etoposide
618200|NCT00948077|tuberculosis|tuberculosis
618201|NCT00948077|pharmacokinetic|pharmacokinetic
618202|NCT00948077|first-line drugs|first-line drugs
618203|NCT00948064|Leukemia|leukemia
618204|NCT00948064|Acute Myelogenous Leukemia|acute myelogenous leukemia
618205|NCT00948064|AML|aml
618206|NCT00948064|Myelodysplastic Syndrome|myelodysplastic syndrome
618207|NCT00948064|MDS|mds
618208|NCT00948064|Vorinostat|vorinostat
618209|NCT00948064|SAHA|saha
618210|NCT00948064|Suberoylanilide Hydroxamic Acid|suberoylanilide hydroxamic acid
618211|NCT00948064|MSK-390|msk-390
618212|NCT00948064|Zolinza|zolinza
618213|NCT00948064|Azacitidine|azacitidine
618214|NCT00948064|5-Azacitidine|5-azacitidine
618215|NCT00948064|5-Aza|5-aza
618216|NCT00948064|Vidaza|vidaza
618217|NCT00948064|5-AZC|5-azc
618218|NCT00948064|AZA-CR|aza-cr
618219|NCT00948064|Ladakamycin|ladakamycin
618220|NCT00948064|NSC-102816|nsc-102816
618221|NCT00948038|Inflammation|inflammation
618222|NCT00948038|Oxidative stress|oxidative stress
618223|NCT00948025|Peripheral Nerve Repair|peripheral nerve repair
618224|NCT00948025|Conduit|conduit
618225|NCT00948025|AVANCE|avance
618226|NCT00948025|Neuroma Resection|neuroma resection
618227|NCT00948025|Nerve Gap Repair|nerve gap repair
618228|NCT00948025|Digital Nerve Repair|digital nerve repair
618229|NCT00948012|Sickle Cell Anemia|sickle cell anemia
618230|NCT00948012|Pulmonary Hypertension|pulmonary hypertension
618231|NCT00948012|Exercise echocardiography|exercise echocardiography
618232|NCT00948012|Echocardiography|echocardiography
618233|NCT00947973|Attention Deficit Hyperactivity Disorder|attention deficit hyperactivity disorder
618234|NCT00947973|ADHD|adhd
618235|NCT00947973|School Based|school based
618236|NCT00947973|Intervention|intervention
618237|NCT00947973|Psychosocial|psychosocial
618238|NCT00947973|Academic Intervention|academic intervention
618239|NCT00947973|Behavioral|behavioral
618240|NCT00947960|Adult Polyglucosan Body Disease (APBD)|adult polyglucosan body disease (apbd)
618241|NCT00947960|Glycogen Brancher Enzyme (GBE1) Deficiency|glycogen brancher enzyme (gbe1) deficiency
618242|NCT00947947|condom use|condom use
618243|NCT00947947|HIV prevention|hiv prevention
618244|NCT00947947|African American|african american
618245|NCT00947947|Behavioral intervention|behavioral intervention
618246|NCT00947947|HIV Seronegativity|hiv seronegativity
618247|NCT00947934|Alzheimer disease,hypothalamus,Deep Brain Stimulation|alzheimer disease,hypothalamus,deep brain stimulation
618248|NCT00947921|Functional MItral regurgitation|functional mitral regurgitation
618249|NCT00947908|Hymenoptera venom allergy|hymenoptera venom allergy
618250|NCT00947908|Dendritic cells (DC)|dendritic cells (dc)
618251|NCT00947895|ACTH|acth
618252|NCT00947895|Acthar gel|acthar gel
618253|NCT00947895|adrenocorticotropin|adrenocorticotropin
618254|NCT00947895|methylprednisolone|methylprednisolone
618255|NCT00947895|solumedrol|solumedrol
618256|NCT00947895|MS|ms
618257|NCT00947895|multiple|multiple
618258|NCT00947895|sclerosis|sclerosis
618259|NCT00947895|relapse|relapse
618260|NCT00947895|exacerbation|exacerbation
618261|NCT00947895|sub-responsive|sub-responsive
618262|NCT00947895|IV|iv
618263|NCT00947856|Antibodies, Monoclonal|antibodies, monoclonal
618264|NCT00947856|Antibody-Drug Conjugate|antibody-drug conjugate
618265|NCT00947856|Antigens, CD30|antigens, cd30
618266|NCT00947856|Drug Therapy|drug therapy
618267|NCT00947856|Hematologic Diseases|hematologic diseases
618268|NCT00947856|Immunotherapy|immunotherapy
618269|NCT00947856|Monomethylauristatin E|monomethylauristatin e
618270|NCT00947843|CHD|chd
618271|NCT00947843|CHD equivalents|chd equivalents
618272|NCT00947830|CML|cml
618273|NCT00947830|intracellular imatinib level|intracellular imatinib level
618274|NCT00947830|OCT-1|oct-1
618275|NCT00947804|Acute Coronary Artery Syndrome Risk Stratification Score|acute coronary artery syndrome risk stratification score
618276|NCT00947791|Bipolar Disorder|bipolar disorder
618277|NCT00947791|Depression|depression
618278|NCT00947791|Treatment-Resistant|treatment-resistant
618279|NCT00947791|ketamine|ketamine
618280|NCT00947791|antidepressant|antidepressant
618281|NCT00947791|glutamate|glutamate
618282|NCT00947765|Tennis Elbow|tennis elbow
618283|NCT00947765|Epicondylitis, Lateral Humeral|epicondylitis, lateral humeral
618284|NCT00947752|Multiple Sclerosis|multiple sclerosis
618285|NCT00947752|Relapsing Remitting Multiple Sclerosis (RRMS)|relapsing remitting multiple sclerosis (rrms)
618286|NCT00947752|Glatiramer Acetate (GA)|glatiramer acetate (ga)
618287|NCT00947739|CZ|cz
618288|NCT00947739|Stehlin|stehlin
618289|NCT00947739|Lymphomas|lymphomas
618290|NCT00947713|Human chorionic gonadotropin|human chorionic gonadotropin
618291|NCT00947713|Clomiphene citrate|clomiphene citrate
618292|NCT00947713|chronic anovulation|chronic anovulation
618293|NCT00947713|Polycystic Ovary Syndrome|polycystic ovary syndrome
618294|NCT00947713|Follicolugenesis|follicolugenesis
618295|NCT00947700|Infants|infants
618296|NCT00947700|Risk markers|risk markers
618297|NCT00947700|ERP|erp
618298|NCT00947700|Parent child interaction|parent child interaction
618299|NCT00947700|Promoting First Relations|promoting first relations
618300|NCT00947700|Social Communication|social communication
618301|NCT00947687|influenza|influenza
618302|NCT00947687|healthy subject|healthy subject
618303|NCT00947687|virus inoculation|virus inoculation
618304|NCT00947687|symptom scores|symptom scores
618305|NCT00947687|viral shedding|viral shedding
618306|NCT00947687|bioaerosol output|bioaerosol output
618307|NCT00947674|Cellsorba EX|cellsorba ex
618308|NCT00947661|glaucoma latanoprost|glaucoma latanoprost
618309|NCT00947648|acute myelogenous leukemia|acute myelogenous leukemia
618310|NCT00947648|AML|aml
618311|NCT00947648|myelodysplastic syndrome|myelodysplastic syndrome
618312|NCT00947648|MDS|mds
618313|NCT00947648|Neutropenia|neutropenia
618314|NCT00947648|raw fruits and vegetables|raw fruits and vegetables
618315|NCT00947635|Type 1 diabetes|type 1 diabetes
618316|NCT00947635|Transplants|transplants
618317|NCT00947635|Immunosuppression|immunosuppression
618318|NCT00947635|Hyperlipidemia|hyperlipidemia
618319|NCT00947635|Nutrition Therapy|nutrition therapy
618320|NCT00947622|Fibromyalgia|fibromyalgia
618321|NCT00947622|Neuromodulation|neuromodulation
618322|NCT00947622|Transcranial Direct Current Stimulation|transcranial direct current stimulation
618323|NCT00947622|Occipital|occipital
618324|NCT00947609|Latent tuberculosis|latent tuberculosis
618325|NCT00947609|HIV|hiv
618326|NCT00947609|Children|children
618327|NCT00947609|Interferon gamma release assays|interferon gamma release assays
618328|NCT00947609|Thailand|thailand
618329|NCT00947609|QuantiFERON TB Gold In-tube|quantiferon tb gold in-tube
618330|NCT00947609|T-Spot.TB|t-spot.tb
618331|NCT00947596|Atropine|atropine
618332|NCT00947596|Aerosol|aerosol
618333|NCT00947596|Inhaler|inhaler
618334|NCT00947596|Dry Powder|dry powder
618335|NCT00947583|fusion rates|fusion rates
618336|NCT00947583|TLIF|tlif
618337|NCT00947583|Osteocel Plus|osteocel plus
618338|NCT00947583|biologics|biologics
618339|NCT00947583|lumbar fusion|lumbar fusion
618340|NCT00947570|Cognitive Behavioral Therapy|cognitive behavioral therapy
618341|NCT00947570|Functional Brain Imaging|functional brain imaging
618342|NCT00947570|Psychotherapy|psychotherapy
618343|NCT00947570|Treatment|treatment
618344|NCT00947570|Brain Imaging|brain imaging
618345|NCT00947544|Urea Cycle Disorder|urea cycle disorder
618346|NCT00947544|UCD|ucd
618347|NCT00947544|GT4P|gt4p
618348|NCT00947544|Buphenyl|buphenyl
618349|NCT00947544|hyperammonemia|hyperammonemia
618350|NCT00947544|sodium phenylbutyrate|sodium phenylbutyrate
618351|NCT00947518|chlorhexidine|chlorhexidine
618352|NCT00947518|preterm|preterm
618353|NCT00947518|newborn|newborn
618354|NCT00947518|skin condition|skin condition
618355|NCT00947518|temperature|temperature
618356|NCT00947518|skin flora|skin flora
618357|NCT00947505|Androgenetic alopecia|androgenetic alopecia
618358|NCT00947505|Hair loss|hair loss
618359|NCT00947505|Male Pattern baldness|male pattern baldness
618360|NCT00947492|Rheumatoid Arthritis patients|rheumatoid arthritis patients
618487|NCT00946933|acid-base balance|acid-base balance
618361|NCT00947492|treated with new immunosuppressive drugs : Orencia* (abatacept) and RoActemra* (tocilizumab).|treated with new immunosuppressive drugs : orencia* (abatacept) and roactemra* (tocilizumab).
618362|NCT00947479|obstructive sleep apnea|obstructive sleep apnea
618363|NCT00947479|pulse-wave velocity,|pulse-wave velocity,
618364|NCT00947479|acute kidney injury|acute kidney injury
618365|NCT00947479|biomarkers of acute kidney injury|biomarkers of acute kidney injury
618366|NCT00947466|Buprenorphine transdermal patch (BTDS)|buprenorphine transdermal patch (btds)
618367|NCT00947466|Moderate to severe mouth pain|moderate to severe mouth pain
618368|NCT00947466|Chemotherapy induced mucositis|chemotherapy induced mucositis
618369|NCT00947466|Pharmacokinetic|pharmacokinetic
618371|NCT00947453|montelukast|montelukast
618373|NCT00947440|Bioavailability|bioavailability
618374|NCT00947427|type 1 diabetes|type 1 diabetes
618375|NCT00947427|newly diagnosed T1D|newly diagnosed t1d
618376|NCT00947427|T1D|t1d
618377|NCT00947427|canakinumab|canakinumab
618378|NCT00947427|anti IL-1|anti il-1
618379|NCT00947414|cellulite; shockwave; microcirculation; skin|cellulite; shockwave; microcirculation; skin
618380|NCT00947401|Surgery, elective|surgery, elective
618381|NCT00947401|Fluids|fluids
618382|NCT00947401|Post Anesthesia Care Unit|post anesthesia care unit
618383|NCT00947401|PACU|pacu
618384|NCT00947401|Fluid management|fluid management
618385|NCT00947388|Refractory Chronic Lymphocytic Leukemia|refractory chronic lymphocytic leukemia
618386|NCT00947388|Bendamustine|bendamustine
618387|NCT00947388|Alemtuzumab|alemtuzumab
618388|NCT00947388|Phase I|phase i
618389|NCT00947388|CLL|cll
618390|NCT00947375|schizophrenia|schizophrenia
618391|NCT00947375|lamictal TM|lamictal tm
618392|NCT00947375|haloperidol decanoate|haloperidol decanoate
618393|NCT00947323|simvastatin|simvastatin
618394|NCT00947323|endothelial dysfunction|endothelial dysfunction
618395|NCT00947323|erectile dysfunction|erectile dysfunction
618396|NCT00947310|Inappropriate therapy|inappropriate therapy
618397|NCT00947310|ICD therapy|icd therapy
618398|NCT00947310|Primary prevention|primary prevention
618399|NCT00947297|Urea Cycle Disorder|urea cycle disorder
618400|NCT00947297|UCD|ucd
618401|NCT00947297|hyperammonemia|hyperammonemia
618402|NCT00947297|Buphenyl|buphenyl
618403|NCT00947297|Sodium Phenylbutyrate|sodium phenylbutyrate
618404|NCT00947271|STD|std
618405|NCT00947271|STI|sti
618406|NCT00947271|Sexual Behavior|sexual behavior
618407|NCT00947271|Prevention|prevention
618408|NCT00947271|HIV seronegativity|hiv seronegativity
618409|NCT00947258|Muscle Strength|muscle strength
618410|NCT00947258|Torque|torque
618411|NCT00947258|Muscle Stretching Exercises|muscle stretching exercises
618412|NCT00947258|Range of Motion|range of motion
618413|NCT00947232|major depressive disorder|major depressive disorder
618414|NCT00947232|physical activity|physical activity
618415|NCT00947232|aging with physical disability|aging with physical disability
618416|NCT00947232|motivational interviewing|motivational interviewing
618417|NCT00947219|Androgenetic Alopecia|androgenetic alopecia
618418|NCT00947219|Hair Loss|hair loss
618419|NCT00947219|Male Pattern Baldness|male pattern baldness
618420|NCT00947206|Chinese Americans|chinese americans
618421|NCT00947206|lay health worker outreach|lay health worker outreach
618422|NCT00947206|colorectal cancer screening|colorectal cancer screening
618423|NCT00947193|Hemophilia A|hemophilia a
618424|NCT00947193|Hemophilia B|hemophilia b
618425|NCT00947193|Factor VIII|factor viii
618426|NCT00947193|Factor IX|factor ix
618427|NCT00947193|FVIII|fviii
618428|NCT00947193|FIX|fix
618429|NCT00947193|Nonsense mutation|nonsense mutation
618430|NCT00947193|Premature stop codon|premature stop codon
618431|NCT00947193|HA|ha
618432|NCT00947193|HB|hb
618433|NCT00947193|PTC124|ptc124
618434|NCT00947193|Ataluren|ataluren
618435|NCT00947180|Biofeedback|biofeedback
618436|NCT00947180|Pelvic floor|pelvic floor
618437|NCT00947180|Levator ani syndrome|levator ani syndrome
618438|NCT00947180|Chronic proctalgia|chronic proctalgia
618439|NCT00947180|Electrogalvanic stimulation|electrogalvanic stimulation
618440|NCT00947180|Massage|massage
618441|NCT00947154|trichotillomania|trichotillomania
618442|NCT00947154|aripiprazole|aripiprazole
618443|NCT00947154|treatment|treatment
618444|NCT00947141|Optimising treatment of cytomegalovirus infection|optimising treatment of cytomegalovirus infection
618445|NCT00947128|Antiemetic|antiemetic
618446|NCT00947115|Cervical cancer|cervical cancer
618447|NCT00947115|HPV vaccine|hpv vaccine
618448|NCT00947102|pancreatic tubular adenocarcinoma|pancreatic tubular adenocarcinoma
618449|NCT00947102|gemcitabine|gemcitabine
618450|NCT00947102|gene expression|gene expression
618451|NCT00947102|immunological status|immunological status
618452|NCT00947102|serological status|serological status
618453|NCT00947102|pancreatic tubular adenocarcinoma adjuvant setting|pancreatic tubular adenocarcinoma adjuvant setting
618454|NCT00947089|ORC (oxidized regenerated cellulose)|orc (oxidized regenerated cellulose)
618455|NCT00947089|SSI (Surgical site infections)|ssi (surgical site infections)
618456|NCT00947076|Antidepressant|antidepressant
618457|NCT00947063|Antihistamine|antihistamine
618458|NCT00947050|CAD|cad
618459|NCT00947050|prompt physical exercise|prompt physical exercise
618460|NCT00947050|collateral function|collateral function
618461|NCT00947011|Healthy volunteers|healthy volunteers
618462|NCT00947011|GLP-1|glp-1
618463|NCT00947011|Januvia|januvia
618464|NCT00947011|Sitagliptin|sitagliptin
618465|NCT00946998|Chronic Kidney Disease|chronic kidney disease
618466|NCT00946998|Depression|depression
618467|NCT00946998|Antidepressants|antidepressants
618468|NCT00946998|randomized controlled trial|randomized controlled trial
618469|NCT00946998|treatment|treatment
618470|NCT00946998|Sertraline|sertraline
618471|NCT00946985|Schizophrenia|schizophrenia
618472|NCT00946985|Risperidone|risperidone
618473|NCT00946985|Risperdal|risperdal
618474|NCT00946985|Paliperidone Palmitate|paliperidone palmitate
618475|NCT00946985|Invega Sustenna|invega sustenna
618476|NCT00946972|Diabetes Mellitus, Type 2|diabetes mellitus, type 2
618477|NCT00946959|cardiac surgery|cardiac surgery
618478|NCT00946959|angioplasty|angioplasty
618479|NCT00946959|cognitive decline|cognitive decline
618480|NCT00946946|Randomized|randomized
618481|NCT00946946|Crohn's Disease|crohn's disease
618482|NCT00946946|Prevention|prevention
618483|NCT00946946|Azathioprine|azathioprine
618484|NCT00946946|mesalazine|mesalazine
618485|NCT00946946|mesalamine|mesalamine
618486|NCT00946946|TPMT|tpmt
618488|NCT00946933|ventilatory control|ventilatory control
618489|NCT00946933|dyspnea|dyspnea
618490|NCT00946933|exercise|exercise
618491|NCT00946933|modified rebreathing procedure|modified rebreathing procedure
618492|NCT00946933|Normal|normal
618493|NCT00946933|older|older
618494|NCT00946907|acute pericarditis|acute pericarditis
618495|NCT00946907|treatment|treatment
618496|NCT00946907|recurrence|recurrence
618497|NCT00946894|Total thyroidectomy|total thyroidectomy
618498|NCT00946894|Subtotal thyroidectomy|subtotal thyroidectomy
618499|NCT00946894|Dunhill operation|dunhill operation
618500|NCT00946894|Recurrent nodular goiter|recurrent nodular goiter
618501|NCT00946894|Completion thyroidectomy|completion thyroidectomy
618502|NCT00946894|Recurrent laryngeal nerve palsy|recurrent laryngeal nerve palsy
618503|NCT00946894|Hypoparathyroidism following thyroidectomy|hypoparathyroidism following thyroidectomy
618504|NCT00946894|Recurrent goiter|recurrent goiter
618505|NCT00946881|Prostatic disease|prostatic disease
618506|NCT00946881|genital neoplasm, male|genital neoplasm, male
618507|NCT00946881|Urogenital neoplasm|urogenital neoplasm
618508|NCT00946881|Genital disease|genital disease
618509|NCT00946881|male|male
618510|NCT00946881|Male urogenital disease|male urogenital disease
618511|NCT00946881|Neoplasms|neoplasms
618512|NCT00946881|Neoplasm by site|neoplasm by site
618513|NCT00946881|prostatic neoplasm|prostatic neoplasm
618514|NCT00946881|Carcinoma|carcinoma
618515|NCT00946868|intermittent claudication|intermittent claudication
618516|NCT00946868|metabolic syndrome|metabolic syndrome
618517|NCT00946855|soccer|soccer
618518|NCT00946855|laboratory|laboratory
618519|NCT00946855|reference|reference
618520|NCT00946855|exercise|exercise
618521|NCT00946855|variability|variability
618522|NCT00946855|season|season
618523|NCT00946855|elite athletes|elite athletes
618524|NCT00946855|Define reference blood parameters in elite athletes|define reference blood parameters in elite athletes
618525|NCT00946842|Healthy|healthy
618526|NCT00946842|Bioavailability|bioavailability
618527|NCT00946842|Relative bioavailability|relative bioavailability
618528|NCT00946842|TMC207|tmc207
618529|NCT00946842|Fed condition|fed condition
618530|NCT00946842|Fasted condition|fasted condition
618531|NCT00946803|Pain|pain
618532|NCT00946803|Fatigue|fatigue
618533|NCT00946803|Sleep|sleep
618534|NCT00946803|Cancer|cancer
618535|NCT00946803|Complementary therapies|complementary therapies
618536|NCT00946790|Immunosuppressant and Antirheumatic|immunosuppressant and antirheumatic
618537|NCT00946777|Dry Eye Signs|dry eye signs
618538|NCT00946777|barrier function|barrier function
618539|NCT00946764|Antidepressant|antidepressant
618540|NCT00946751|Anticonvulsant|anticonvulsant
618541|NCT00946738|Raynaud's phenomenon|raynaud's phenomenon
618542|NCT00946738|biofeedback|biofeedback
618543|NCT00946738|deep oscillation|deep oscillation
618544|NCT00946738|systemic sclerosis|systemic sclerosis
618545|NCT00946738|physiotherapy|physiotherapy
618546|NCT00946725|Angina (Chest Pain)|angina (chest pain)
618547|NCT00946725|Hypertension|hypertension
618548|NCT00946660|Contingency Management|contingency management
618549|NCT00946660|Drug Self-Administration|drug self-administration
618550|NCT00946647|Myelodysplastic Syndromes|myelodysplastic syndromes
618551|NCT00946647|Chronic Myelomonocytic Leukemia|chronic myelomonocytic leukemia
618552|NCT00946647|Acute Myeloid Leukemia|acute myeloid leukemia
618553|NCT00946647|hypomethylating therapy|hypomethylating therapy
618554|NCT00946647|deacetylase inhibitor|deacetylase inhibitor
618555|NCT00946647|MDS|mds
618556|NCT00946647|CMML|cmml
618557|NCT00946647|AML|aml
618558|NCT00946608|Antihistamine|antihistamine
618559|NCT00946595|Undetectable|undetectable
618560|NCT00946595|HIV infections|hiv infections
618561|NCT00946595|Monotherapy|monotherapy
618562|NCT00946595|Lopinavir/ritonavir|lopinavir/ritonavir
618563|NCT00946595|Protease inhibitor|protease inhibitor
618564|NCT00946595|Treatment experienced|treatment experienced
618565|NCT00946582|parenting management program|parenting management program
618566|NCT00946582|ADHD|adhd
618567|NCT00946569|Asthma|asthma
618568|NCT00946569|Persistent asthma|persistent asthma
618569|NCT00946569|Adults with persistent asthma|adults with persistent asthma
618570|NCT00946569|Chronic asthma|chronic asthma
618571|NCT00946569|JNJ-39758979|jnj-39758979
618572|NCT00946569|Placebo|placebo
618573|NCT00946556|herpes simplex virus type 2|herpes simplex virus type 2
618574|NCT00946556|HIV|hiv
618575|NCT00946556|genital immunology|genital immunology
618576|NCT00946556|CD4+ T cell|cd4+ t cell
618577|NCT00946556|valacyclovir|valacyclovir
618578|NCT00946556|HIV seronegativity|hiv seronegativity
618579|NCT00946543|stage IIB prostate cancer|stage iib prostate cancer
618580|NCT00946543|stage IIA prostate cancer|stage iia prostate cancer
618581|NCT00946543|stage III prostate cancer|stage iii prostate cancer
618582|NCT00946543|stage IV prostate cancer|stage iv prostate cancer
618583|NCT00946491|Typical Antipsychotic|typical antipsychotic
618584|NCT00946478|atopic dermatitis|atopic dermatitis
618586|NCT00946478|pimecrolimus|pimecrolimus
618587|NCT00946478|CASM981|casm981
618588|NCT00946478|immunity|immunity
618589|NCT00946478|cathelicidin|cathelicidin
618590|NCT00946478|antimicrobial peptide|antimicrobial peptide
618591|NCT00946478|eczema|eczema
618592|NCT00946452|Control|control
618593|NCT00946452|Satisfaction|satisfaction
618594|NCT00946439|training exercise gait|training exercise gait
618595|NCT00946413|CBT, Depressed and suicidal adolescents|cbt, depressed and suicidal adolescents
618596|NCT00946400|Heparin-induced thrombocytopenia|heparin-induced thrombocytopenia
618597|NCT00946400|HIT|hit
618598|NCT00946400|4Ts|4ts
618599|NCT00946400|Chong scale|chong scale
618600|NCT00946400|interobserver variability|interobserver variability
618601|NCT00946387|Antiemetic|antiemetic
618602|NCT00946374|Mantle-Cell-Lymphoma|mantle-cell-lymphoma
618603|NCT00946374|MCL|mcl
618604|NCT00946374|Non Hodgkin´s Lymphoma|non hodgkin´s lymphoma
618605|NCT00946374|NHL|nhl
618606|NCT00946374|Immunochemotherapy|immunochemotherapy
618607|NCT00946374|R-CHOP|r-chop
618608|NCT00946374|CHOP|chop
618609|NCT00946374|High-dose chemotherapy|high-dose chemotherapy
618610|NCT00946374|BEAM|beam
618611|NCT00946374|HD-BEAM|hd-beam
618612|NCT00946374|Autologous stem cell transplantation|autologous stem cell transplantation
618613|NCT00946374|Reduced conditioning regimen|reduced conditioning regimen
618614|NCT00946374|Unrelated donor|unrelated donor
618615|NCT00946374|Sibling donor|sibling donor
618616|NCT00946374|Total Body Irradiation|total body irradiation
618617|NCT00946374|TBI|tbi
618618|NCT00946374|Allogenic stem cell transplantation|allogenic stem cell transplantation
618619|NCT00946374|ABSCT|absct
618620|NCT00946374|ASCT|asct
618621|NCT00946374|Fludarabine+TBI|fludarabine+tbi
618622|NCT00946348|Dronabinol|dronabinol
618623|NCT00946348|Schizophrenia|schizophrenia
618624|NCT00946348|Dual Diagnosis|dual diagnosis
618625|NCT00946348|Substance Abuse|substance abuse
618626|NCT00946348|Cannabis Use Disorder|cannabis use disorder
618627|NCT00946322|post-traumatic stress disorder|post-traumatic stress disorder
618628|NCT00946322|alcohol-related disorders|alcohol-related disorders
618629|NCT00946322|substance use disorders|substance use disorders
618630|NCT00946322|couple therapy|couple therapy
618631|NCT00946296|Graves Disease|graves disease
618632|NCT00946283|stage III adult Burkitt lymphoma|stage iii adult burkitt lymphoma
618633|NCT00946283|stage III adult diffuse large cell lymphoma|stage iii adult diffuse large cell lymphoma
618634|NCT00946283|stage III adult diffuse mixed cell lymphoma|stage iii adult diffuse mixed cell lymphoma
618635|NCT00946283|stage III adult diffuse small cleaved cell lymphoma|stage iii adult diffuse small cleaved cell lymphoma
618636|NCT00946283|stage III adult Hodgkin lymphoma|stage iii adult hodgkin lymphoma
618637|NCT00946283|stage III adult immunoblastic large cell lymphoma|stage iii adult immunoblastic large cell lymphoma
618638|NCT00946283|stage III adult lymphoblastic lymphoma|stage iii adult lymphoblastic lymphoma
618639|NCT00946283|stage III grade 1 follicular lymphoma|stage iii grade 1 follicular lymphoma
618640|NCT00946283|stage III grade 2 follicular lymphoma|stage iii grade 2 follicular lymphoma
618641|NCT00946283|stage III grade 3 follicular lymphoma|stage iii grade 3 follicular lymphoma
618642|NCT00946283|stage III mantle cell lymphoma|stage iii mantle cell lymphoma
618643|NCT00946283|stage III marginal zone lymphoma|stage iii marginal zone lymphoma
618644|NCT00946283|stage III small lymphocytic lymphoma|stage iii small lymphocytic lymphoma
618645|NCT00946283|stage IV adult Burkitt lymphoma|stage iv adult burkitt lymphoma
618646|NCT00946283|stage IV adult diffuse large cell lymphoma|stage iv adult diffuse large cell lymphoma
618647|NCT00946283|stage IV adult diffuse mixed cell lymphoma|stage iv adult diffuse mixed cell lymphoma
618648|NCT00946283|stage IV adult diffuse small cleaved cell lymphoma|stage iv adult diffuse small cleaved cell lymphoma
618649|NCT00946283|stage IV adult Hodgkin lymphoma|stage iv adult hodgkin lymphoma
618650|NCT00946283|stage IV adult immunoblastic large cell lymphoma|stage iv adult immunoblastic large cell lymphoma
618651|NCT00946283|stage IV adult lymphoblastic lymphoma|stage iv adult lymphoblastic lymphoma
618652|NCT00946283|stage IV grade 1 follicular lymphoma|stage iv grade 1 follicular lymphoma
618653|NCT00946283|stage IV grade 2 follicular lymphoma|stage iv grade 2 follicular lymphoma
618654|NCT00946283|stage IV grade 3 follicular lymphoma|stage iv grade 3 follicular lymphoma
618655|NCT00946283|stage IV mantle cell lymphoma|stage iv mantle cell lymphoma
618656|NCT00946283|stage IV marginal zone lymphoma|stage iv marginal zone lymphoma
618657|NCT00946283|stage IV small lymphocytic lymphoma|stage iv small lymphocytic lymphoma
618658|NCT00946283|recurrent adult Burkitt lymphoma|recurrent adult burkitt lymphoma
618659|NCT00946283|recurrent adult diffuse large cell lymphoma|recurrent adult diffuse large cell lymphoma
618660|NCT00946283|recurrent adult diffuse mixed cell lymphoma|recurrent adult diffuse mixed cell lymphoma
618661|NCT00946283|recurrent adult diffuse small cleaved cell lymphoma|recurrent adult diffuse small cleaved cell lymphoma
618662|NCT00946283|recurrent adult Hodgkin lymphoma|recurrent adult hodgkin lymphoma
618663|NCT00946283|recurrent adult immunoblastic large cell lymphoma|recurrent adult immunoblastic large cell lymphoma
618664|NCT00946283|recurrent adult lymphoblastic lymphoma|recurrent adult lymphoblastic lymphoma
618665|NCT00946283|recurrent cutaneous T-cell non-Hodgkin lymphoma|recurrent cutaneous t-cell non-hodgkin lymphoma
618666|NCT00946283|recurrent grade 1 follicular lymphoma|recurrent grade 1 follicular lymphoma
618667|NCT00946283|recurrent grade 2 follicular lymphoma|recurrent grade 2 follicular lymphoma
618668|NCT00946283|recurrent grade 3 follicular lymphoma|recurrent grade 3 follicular lymphoma
618669|NCT00946283|recurrent mantle cell lymphoma|recurrent mantle cell lymphoma
618670|NCT00946283|recurrent marginal zone lymphoma|recurrent marginal zone lymphoma
618671|NCT00946283|recurrent small lymphocytic lymphoma|recurrent small lymphocytic lymphoma
618672|NCT00946283|recurrent mycosis fungoides/Sezary syndrome|recurrent mycosis fungoides/sezary syndrome
618673|NCT00946283|extranodal marginal zone B-cell lymphoma of mucosa-associated lymphoid tissue|extranodal marginal zone b-cell lymphoma of mucosa-associated lymphoid tissue
618674|NCT00946283|nodal marginal zone B-cell lymphoma|nodal marginal zone b-cell lymphoma
618675|NCT00946283|splenic marginal zone lymphoma|splenic marginal zone lymphoma
618676|NCT00946283|noncontiguous stage II adult Burkitt lymphoma|noncontiguous stage ii adult burkitt lymphoma
618677|NCT00946283|noncontiguous stage II adult diffuse large cell lymphoma|noncontiguous stage ii adult diffuse large cell lymphoma
618678|NCT00946283|noncontiguous stage II adult diffuse mixed cell lymphoma|noncontiguous stage ii adult diffuse mixed cell lymphoma
618679|NCT00946283|noncontiguous stage II adult diffuse small cleaved cell lymphoma|noncontiguous stage ii adult diffuse small cleaved cell lymphoma
618680|NCT00946283|noncontiguous stage II adult immunoblastic large cell lymphoma|noncontiguous stage ii adult immunoblastic large cell lymphoma
618681|NCT00946283|noncontiguous stage II adult lymphoblastic lymphoma|noncontiguous stage ii adult lymphoblastic lymphoma
618682|NCT00946283|noncontiguous stage II grade 1 follicular lymphoma|noncontiguous stage ii grade 1 follicular lymphoma
618683|NCT00946283|noncontiguous stage II grade 2 follicular lymphoma|noncontiguous stage ii grade 2 follicular lymphoma
618684|NCT00946283|noncontiguous stage II grade 3 follicular lymphoma|noncontiguous stage ii grade 3 follicular lymphoma
618685|NCT00946283|noncontiguous stage II mantle cell lymphoma|noncontiguous stage ii mantle cell lymphoma
618686|NCT00946283|noncontiguous stage II marginal zone lymphoma|noncontiguous stage ii marginal zone lymphoma
618687|NCT00946283|noncontiguous stage II small lymphocytic lymphoma|noncontiguous stage ii small lymphocytic lymphoma
618688|NCT00946283|accelerated phase chronic myelogenous leukemia|accelerated phase chronic myelogenous leukemia
618689|NCT00946283|adult acute lymphoblastic leukemia in remission|adult acute lymphoblastic leukemia in remission
618690|NCT00946283|adult acute myeloid leukemia in remission|adult acute myeloid leukemia in remission
618691|NCT00946283|adult acute myeloid leukemia with 11q23 (MLL) abnormalities|adult acute myeloid leukemia with 11q23 (mll) abnormalities
618692|NCT00946283|adult acute myeloid leukemia with inv(16)(p13;q22)|adult acute myeloid leukemia with inv(16)(p13;q22)
618693|NCT00946283|adult acute myeloid leukemia with t(15;17)(q22;q12)|adult acute myeloid leukemia with t(15;17)(q22;q12)
618694|NCT00946283|adult acute myeloid leukemia with t(16;16)(p13;q22)|adult acute myeloid leukemia with t(16;16)(p13;q22)
618695|NCT00946283|adult acute myeloid leukemia with t(8;21)(q22;q22)|adult acute myeloid leukemia with t(8;21)(q22;q22)
618696|NCT00946283|atypical chronic myeloid leukemia, BCR-ABL negative|atypical chronic myeloid leukemia, bcr-abl negative
618697|NCT00946283|blastic phase chronic myelogenous leukemia|blastic phase chronic myelogenous leukemia
618698|NCT00946283|chronic myelomonocytic leukemia|chronic myelomonocytic leukemia
618699|NCT00946283|chronic phase chronic myelogenous leukemia|chronic phase chronic myelogenous leukemia
618700|NCT00946283|recurrent adult acute lymphoblastic leukemia|recurrent adult acute lymphoblastic leukemia
618701|NCT00946283|recurrent adult acute myeloid leukemia|recurrent adult acute myeloid leukemia
618702|NCT00946283|refractory chronic lymphocytic leukemia|refractory chronic lymphocytic leukemia
618703|NCT00946283|refractory hairy cell leukemia|refractory hairy cell leukemia
618704|NCT00946283|relapsing chronic myelogenous leukemia|relapsing chronic myelogenous leukemia
618705|NCT00946283|secondary acute myeloid leukemia|secondary acute myeloid leukemia
618706|NCT00946283|stage III chronic lymphocytic leukemia|stage iii chronic lymphocytic leukemia
618707|NCT00946283|stage IV chronic lymphocytic leukemia|stage iv chronic lymphocytic leukemia
618708|NCT00946283|chronic eosinophilic leukemia|chronic eosinophilic leukemia
618709|NCT00946283|primary myelofibrosis|primary myelofibrosis
618710|NCT00946283|chronic neutrophilic leukemia|chronic neutrophilic leukemia
618711|NCT00946283|de novo myelodysplastic syndromes|de novo myelodysplastic syndromes
618712|NCT00946283|disseminated neuroblastoma|disseminated neuroblastoma
618713|NCT00946283|myelodysplastic/myeloproliferative neoplasm, unclassifiable|myelodysplastic/myeloproliferative neoplasm, unclassifiable
618714|NCT00946283|previously treated myelodysplastic syndromes|previously treated myelodysplastic syndromes
618715|NCT00946283|recurrent neuroblastoma|recurrent neuroblastoma
618716|NCT00946283|recurrent ovarian epithelial cancer|recurrent ovarian epithelial cancer
618717|NCT00946283|recurrent ovarian germ cell tumor|recurrent ovarian germ cell tumor
618718|NCT00946283|recurrent malignant testicular germ cell tumor|recurrent malignant testicular germ cell tumor
618719|NCT00946283|secondary myelodysplastic syndromes|secondary myelodysplastic syndromes
618720|NCT00946283|stage II multiple myeloma|stage ii multiple myeloma
618721|NCT00946283|stage III multiple myeloma|stage iii multiple myeloma
618822|NCT00945919|rotation|rotation
618722|NCT00946283|stage II ovarian epithelial cancer|stage ii ovarian epithelial cancer
618723|NCT00946283|stage III ovarian epithelial cancer|stage iii ovarian epithelial cancer
618724|NCT00946283|stage IV ovarian epithelial cancer|stage iv ovarian epithelial cancer
618725|NCT00946283|stage III malignant testicular germ cell tumor|stage iii malignant testicular germ cell tumor
618726|NCT00946283|stage IIIA breast cancer|stage iiia breast cancer
618727|NCT00946283|stage IIIB breast cancer|stage iiib breast cancer
618728|NCT00946283|stage IIIC breast cancer|stage iiic breast cancer
618729|NCT00946283|stage IV breast cancer|stage iv breast cancer
618730|NCT00946283|refractory multiple myeloma|refractory multiple myeloma
618731|NCT00946270|CC-4047|cc-4047
618732|NCT00946270|Pomalidomide|pomalidomide
618733|NCT00946270|polycythemia vera|polycythemia vera
618734|NCT00946270|essential thrombocythemia myelofibrosis|essential thrombocythemia myelofibrosis
618735|NCT00946257|Type 1 Diabetes Mellitus|type 1 diabetes mellitus
618736|NCT00946244|Early intervention|early intervention
618737|NCT00946244|Mother-child interaction|mother-child interaction
618738|NCT00946244|Neurodevelopment|neurodevelopment
618739|NCT00946244|Parenting|parenting
618740|NCT00946244|Prematurity|prematurity
618741|NCT00946244|Preschool age|preschool age
618742|NCT00946231|Heart Failure|heart failure
618744|NCT00946231|B-type natriuretic peptide|b-type natriuretic peptide
618745|NCT00946231|home testing|home testing
618746|NCT00946205|rectal prolapse|rectal prolapse
618747|NCT00946205|laparoscopic rectopexy|laparoscopic rectopexy
618748|NCT00946205|obstructed defecation|obstructed defecation
618749|NCT00946192|Amenorrhea|amenorrhea
618750|NCT00946192|Adolescent|adolescent
618751|NCT00946192|Endurance|endurance
618752|NCT00946192|Athletes|athletes
618753|NCT00946192|Females|females
618754|NCT00946192|Osteopenia|osteopenia
618755|NCT00946192|Osteoporosis|osteoporosis
618756|NCT00946192|Estrogen|estrogen
618757|NCT00946179|Influenza|influenza
618758|NCT00946179|Influenza virus vaccine|influenza virus vaccine
618759|NCT00946179|Split virion|split virion
618760|NCT00946166|pneumonia|pneumonia
618761|NCT00946166|statins|statins
618762|NCT00946166|cytokines|cytokines
618763|NCT00946153|Carcinoma|carcinoma
618764|NCT00946153|Hepatocellular|hepatocellular
618765|NCT00946140|Ovary|ovary
618766|NCT00946140|MRI|mri
618767|NCT00946140|08-132|08-132
618768|NCT00946127|Normal Pressure Hydrocephalus|normal pressure hydrocephalus
618769|NCT00946127|Communicating Hydrocephalus|communicating hydrocephalus
618770|NCT00946127|Gait disorder|gait disorder
618771|NCT00946127|Cognition|cognition
618772|NCT00946127|Shunt|shunt
618773|NCT00946127|Endoscopic Third Ventriculostomy.|endoscopic third ventriculostomy.
618774|NCT00946101|randomized, double-blind, placebo-controlled|randomized, double-blind, placebo-controlled
618775|NCT00946062|low vision|low vision
618776|NCT00946062|ophthalmology|ophthalmology
618777|NCT00946062|randomised controlled trial|randomised controlled trial
618778|NCT00946062|mobility|mobility
618779|NCT00946062|orientation|orientation
618780|NCT00946062|cane|cane
618781|NCT00946062|aged|aged
618782|NCT00946049|Checking clinical antibacterial effect of Vicryl Plus compared to conventional Vicryl in intraoral surgery|checking clinical antibacterial effect of vicryl plus compared to conventional vicryl in intraoral surgery
618783|NCT00946049|Bacteria|bacteria
618784|NCT00946023|lymphoma|lymphoma
618785|NCT00946023|non hodgkin lymphoma|non hodgkin lymphoma
618786|NCT00946023|allogeneic|allogeneic
787036|NCT00303433|Namenda|namenda
618787|NCT00946023|bone marrow transplantation|bone marrow transplantation
618788|NCT00946023|nonmyeloablative|nonmyeloablative
618789|NCT00946023|cyclophosphamide|cyclophosphamide
618790|NCT00946023|rituximab|rituximab
618791|NCT00946010|Hepatitis B|hepatitis b
618792|NCT00946010|Hepatitis C|hepatitis c
618793|NCT00946010|genotype|genotype
618794|NCT00946010|DNA level|dna level
618795|NCT00946010|RNA level|rna level
618796|NCT00946010|Taiwan|taiwan
618797|NCT00945997|misoprostol|misoprostol
618798|NCT00945997|mifepristone|mifepristone
618799|NCT00945997|medical abortion|medical abortion
618800|NCT00945997|randomised controlled trial|randomised controlled trial
618801|NCT00945984|Localized renal cell carcinoma|localized renal cell carcinoma
618802|NCT00945971|Attention Deficit Hyperactivity Disorder|attention deficit hyperactivity disorder
618803|NCT00945971|Catecholamine|catecholamine
618804|NCT00945971|Children|children
618805|NCT00945971|Physical Activity|physical activity
618806|NCT00945958|Glaucoma|glaucoma
618807|NCT00945958|Ocular hypertension|ocular hypertension
618808|NCT00945945|Osteoarthritis, Knee|osteoarthritis, knee
618809|NCT00945945|Pain|pain
618810|NCT00945932|asthma|asthma
618811|NCT00945932|GW870086X|gw870086x
618812|NCT00945932|Efficacy|efficacy
618813|NCT00945932|FEV1|fev1
618814|NCT00945932|repeat-dose|repeat-dose
618815|NCT00945919|Oral morphine|oral morphine
618816|NCT00945919|oxycodone|oxycodone
618817|NCT00945919|OPANA|opana
618818|NCT00945919|Oxymorphone|oxymorphone
618819|NCT00945919|pain|pain
618820|NCT00945919|nociceptive|nociceptive
618821|NCT00945919|neuropathic|neuropathic
618823|NCT00945919|titration|titration
618824|NCT00945919|mixed origin non-cancer pain|mixed origin non-cancer pain
618825|NCT00945906|Hereditary Factor XIII deficiency|hereditary factor xiii deficiency
618826|NCT00945906|Factor XIII|factor xiii
618827|NCT00945880|HCV|hcv
618828|NCT00945880|Hepatitis C|hepatitis c
618829|NCT00945880|Hepatitis|hepatitis
618830|NCT00945867|flecainide|flecainide
618831|NCT00945867|pharmacogenetics|pharmacogenetics
618832|NCT00945854|wholegrain cereals|wholegrain cereals
618833|NCT00945854|glycemic index|glycemic index
618834|NCT00945854|metabolic syndrome|metabolic syndrome
618835|NCT00945854|insulin sensitivity|insulin sensitivity
618836|NCT00945841|influenza vaccine|influenza vaccine
618837|NCT00945841|vaccine|vaccine
618838|NCT00945828|pediatric cancer, neurocognitive outcomes for pediatric cancer|pediatric cancer, neurocognitive outcomes for pediatric cancer
618839|NCT00945828|acute lymphoblastic leukemia|acute lymphoblastic leukemia
618840|NCT00945828|central nervous system tumors|central nervous system tumors
618841|NCT00945828|lymphoma|lymphoma
618842|NCT00945815|B-cell adult acute lymphoblastic leukemia|b-cell adult acute lymphoblastic leukemia
618843|NCT00945815|L1 adult acute lymphoblastic leukemia|l1 adult acute lymphoblastic leukemia
618844|NCT00945815|L2 adult acute lymphoblastic leukemia|l2 adult acute lymphoblastic leukemia
618845|NCT00945815|recurrent adult acute lymphoblastic leukemia|recurrent adult acute lymphoblastic leukemia
618846|NCT00945789|Asphyxia neonatorum|asphyxia neonatorum
618847|NCT00945789|Infants|infants
618848|NCT00945789|EEG|eeg
618849|NCT00945789|Brain MRI|brain mri
618850|NCT00945789|Nitric oxide|nitric oxide
618851|NCT00945776|OSA|osa
618852|NCT00945776|CPAP|cpap
618853|NCT00945763|Dental Pain|dental pain
618854|NCT00945737|hypercholesterolemia|hypercholesterolemia
618855|NCT00945737|cholesterol|cholesterol
618856|NCT00945737|soy|soy
618857|NCT00945711|dual diagnosis|dual diagnosis
618858|NCT00945698|Stunting|stunting
618859|NCT00945698|Growth failure|growth failure
618860|NCT00945698|Malnutrition|malnutrition
618861|NCT00945698|Lipid based nutrient supplement|lipid based nutrient supplement
618862|NCT00945698|LNS|lns
618863|NCT00945698|Prevention|prevention
618864|NCT00945698|Malawi|malawi
618865|NCT00945698|Sub-Saharan Africa|sub-saharan africa
618866|NCT00945698|Dietary supplementation|dietary supplementation
618867|NCT00945698|Efficacy|efficacy
618868|NCT00945685|Skin Aging|skin aging
618869|NCT00945685|Skin Wrinkling|skin wrinkling
618870|NCT00945672|Alzheimer's disease amyloid imaging antibody|alzheimer's disease amyloid imaging antibody
618871|NCT00945633|Obesity|obesity
618872|NCT00945633|unhealthy weight gain|unhealthy weight gain
618873|NCT00945620|Trans-abdominis block|trans-abdominis block
618874|NCT00945620|post-cesarean|post-cesarean
618875|NCT00945607|Complementary Medicine|complementary medicine
618876|NCT00945607|Alternative Medicine|alternative medicine
618877|NCT00945607|Breast Cancer|breast cancer
618878|NCT00945594|flexible cystoscopy|flexible cystoscopy
618879|NCT00945594|rigid cystoscopy|rigid cystoscopy
618880|NCT00945594|bladder|bladder
618881|NCT00945594|outcome assessment|outcome assessment
618882|NCT00945594|pain measurement|pain measurement
618883|NCT00945581|Healthy Elderly volunteers|healthy elderly volunteers
618884|NCT00945568|QOL|qol
618885|NCT00945568|liver|liver
618886|NCT00945555|Antibacterials|antibacterials
618887|NCT00945555|Classification of antibacterial agent|classification of antibacterial agent
618888|NCT00945555|Febrile neutropenia|febrile neutropenia
618889|NCT00945555|Turkey|turkey
618890|NCT00945542|Trauma|trauma
618891|NCT00945542|Coagulopathy|coagulopathy
618892|NCT00945542|Transfusion|transfusion
618893|NCT00945542|Plasma|plasma
618894|NCT00945542|Massive Transfusion|massive transfusion
618895|NCT00945529|Fontan|fontan
618896|NCT00945516|Metal stent|metal stent
618897|NCT00945516|Bile duct stricture|bile duct stricture
618898|NCT00945516|Stent migration|stent migration
618899|NCT00945516|Feasibility|feasibility
618900|NCT00945516|Safety|safety
618901|NCT00945516|Removability|removability
618902|NCT00945503|Glycine Tranporter|glycine tranporter
618903|NCT00945503|MRI|mri
618904|NCT00945503|PET|pet
618905|NCT00945490|Benign prostatic hyperplasia|benign prostatic hyperplasia
618906|NCT00945490|BPH|bph
618907|NCT00945490|Enlarged prostate|enlarged prostate
618908|NCT00945451|stage IIIA non-small cell lung cancer|stage iiia non-small cell lung cancer
618909|NCT00945451|stage IIIB non-small cell lung cancer|stage iiib non-small cell lung cancer
618910|NCT00945451|stage II non-small cell lung cancer|stage ii non-small cell lung cancer
618911|NCT00945438|Influenza|influenza
618912|NCT00945438|Influenza virus vaccine|influenza virus vaccine
618913|NCT00945438|Split virion|split virion
618914|NCT00945438|Intradermal|intradermal
618915|NCT00945425|Phase I|phase i
618916|NCT00945425|Volunteer|volunteer
618917|NCT00945412|microdebrider tonsillotomy|microdebrider tonsillotomy
618918|NCT00945412|Post-tonsillectomy hemorrhage|post-tonsillectomy hemorrhage
618919|NCT00945386|children|children
618920|NCT00945386|critically ill|critically ill
618921|NCT00945386|furosemide|furosemide
618922|NCT00945386|acoustic emission|acoustic emission
618923|NCT00945373|rosacea|rosacea
618924|NCT00945373|telangiectasias|telangiectasias
618925|NCT00945373|topical treatment|topical treatment
618926|NCT00945373|pulsed dye laser|pulsed dye laser
618927|NCT00945360|Leiomyoma|leiomyoma
618928|NCT00945360|perimenopause|perimenopause
618929|NCT00945360|aromatase inhibitor|aromatase inhibitor
618930|NCT00945347|Cystic fibrosis|cystic fibrosis
618931|NCT00945347|miglustat|miglustat
618932|NCT00945347|nasal instillation|nasal instillation
618933|NCT00945347|nasal potential difference|nasal potential difference
618934|NCT00945334|Constipation predominant Irritable Bowel Syndrome|constipation predominant irritable bowel syndrome
618935|NCT00945308|Primary PCI|primary pci
618936|NCT00945308|Acute myocardial infarction|acute myocardial infarction
618937|NCT00945308|Myocardial blush|myocardial blush
618938|NCT00945308|Primary coronary intervention in acute myocardial infarction|primary coronary intervention in acute myocardial infarction
618939|NCT00945308|focusing on the effect of the study drug on the immediate TIMI|focusing on the effect of the study drug on the immediate timi
618940|NCT00945308|flow at the infarct related artery and on the myocardial|flow at the infarct related artery and on the myocardial
618941|NCT00945308|perfusion evaluated by the TIMI myocardial perfusion grade or|perfusion evaluated by the timi myocardial perfusion grade or
618942|NCT00945308|blush|blush
618943|NCT00945295|Cerebrovascular Accident/Rehabilitation|cerebrovascular accident/rehabilitation
618944|NCT00945295|Muscle Spasticity|muscle spasticity
618945|NCT00945295|Botulinum Neurotoxin Type A|botulinum neurotoxin type a
618946|NCT00945295|Post-stroke focal upper limb spasticity|post-stroke focal upper limb spasticity
618947|NCT00945282|IDX12899|idx12899
618948|NCT00945282|adaptive|adaptive
618949|NCT00945282|monotherapy|monotherapy
618950|NCT00945282|pharmacokinetics|pharmacokinetics
618951|NCT00945282|Treatment-naive|treatment-naive
618952|NCT00945282|HIV-1|hiv-1
618953|NCT00945282|GSK2248761|gsk2248761
618954|NCT00945282|NNRTI|nnrti
618955|NCT00945282|HIV Infections|hiv infections
618956|NCT00945282|treatment naive|treatment naive
618957|NCT00945256|metabolism|metabolism
618958|NCT00945256|exercise|exercise
618959|NCT00945256|sodium nitroprusside|sodium nitroprusside
618960|NCT00945243|SCDD|scdd
618961|NCT00945230|Neurosurgical outcome|neurosurgical outcome
618962|NCT00945230|Actigraphy|actigraphy
618963|NCT00945230|Treatment Response Measurement|treatment response measurement
618964|NCT00945217|Atherogenic dyslipidemia|atherogenic dyslipidemia
618965|NCT00945217|Non-HDL-C|non-hdl-c
618966|NCT00945217|Postmenopausal women|postmenopausal women
618967|NCT00945217|SAH gene family|sah gene family
618968|NCT00945204|type 2 diabetes|type 2 diabetes
618969|NCT00945204|intermediate care|intermediate care
618970|NCT00945204|primary care|primary care
618971|NCT00945204|randomised controlled trial|randomised controlled trial
618972|NCT00945191|ovarian|ovarian
618973|NCT00945191|cancer|cancer
618974|NCT00945191|metastatic|metastatic
618975|NCT00945191|locally|locally
618976|NCT00945191|advanced|advanced
618977|NCT00945191|chemotherapy|chemotherapy
618978|NCT00945191|neoplasm|neoplasm
618979|NCT00945178|Safety|safety
618980|NCT00945178|Tolerability|tolerability
618981|NCT00945178|Healthy|healthy
618982|NCT00945178|Pharmacokinetics|pharmacokinetics
787295|NCT00302341|Dyspnea|dyspnea
618983|NCT00945165|Continuous Glucose Monitoring System|continuous glucose monitoring system
618984|NCT00945165|Exercise|exercise
618985|NCT00945152|Elimination of MRSA in open wounds|elimination of mrsa in open wounds
618986|NCT00945152|MRSA infected open wounds|mrsa infected open wounds
618987|NCT00945126|Allogeneic stem cell transplantation in pediatric patients|allogeneic stem cell transplantation in pediatric patients
618988|NCT00945126|CD3/CD19 depleted stem cells|cd3/cd19 depleted stem cells
618989|NCT00945126|malignant and non-malignant high risk diseases|malignant and non-malignant high risk diseases
618990|NCT00945113|pilot|pilot
618991|NCT00945113|stammer|stammer
618992|NCT00945113|stutter|stutter
618993|NCT00945113|children|children
618994|NCT00945113|randomised controlled trial|randomised controlled trial
618995|NCT00945113|RCT|rct
618996|NCT00945113|Speech and Language Therapy|speech and language therapy
618997|NCT00945113|Stuttering|stuttering
618998|NCT00945100|Amblyopia|amblyopia
618999|NCT00945100|patching|patching
619000|NCT00945100|occlusion|occlusion
619001|NCT00945087|bacteriophage|bacteriophage
619002|NCT00945087|bacteriophage preparation|bacteriophage preparation
619003|NCT00945087|bacterial infection|bacterial infection
619004|NCT00945087|antibiotic-resistant infection|antibiotic-resistant infection
619005|NCT00945087|multidrug-resistant bacteria|multidrug-resistant bacteria
619006|NCT00945087|MRSA|mrsa
619007|NCT00945074|Acupuncture|acupuncture
619008|NCT00945074|Moxibustion|moxibustion
619009|NCT00945074|Traditional Chinese Medicine|traditional chinese medicine
619010|NCT00945074|Complementary Medicine|complementary medicine
619011|NCT00945074|Irritable Bowel Syndrome|irritable bowel syndrome
619012|NCT00945074|IBS|ibs
619013|NCT00945061|ductal breast carcinoma in situ|ductal breast carcinoma in situ
619014|NCT00945061|recurrent breast cancer|recurrent breast cancer
619015|NCT00945061|invasive ductal breast carcinoma|invasive ductal breast carcinoma
619016|NCT00945061|medullary ductal breast carcinoma with lymphocytic infiltrate|medullary ductal breast carcinoma with lymphocytic infiltrate
619017|NCT00945061|mucinous ductal breast carcinoma|mucinous ductal breast carcinoma
619018|NCT00945061|papillary ductal breast carcinoma|papillary ductal breast carcinoma
619019|NCT00945061|tubular ductal breast carcinoma|tubular ductal breast carcinoma
619020|NCT00945061|male breast cancer|male breast cancer
619021|NCT00945022|General Surgery|general surgery
619022|NCT00944996|PACAP (Pituitary Adenylate Cyclase Activating Polypeptide)|pacap (pituitary adenylate cyclase activating polypeptide)
619023|NCT00944996|Major Depression|major depression
619024|NCT00944996|Receptors|receptors
619025|NCT00944996|Gene polymorphism|gene polymorphism
619026|NCT00944996|PACAP signaling system|pacap signaling system
619027|NCT00944996|Etiology of major depression|etiology of major depression
619028|NCT00944996|Mechanism of antidepressants action|mechanism of antidepressants action
619029|NCT00944996|PACAP receptors gene polymorphism|pacap receptors gene polymorphism
619030|NCT00944996|Pathogenesis of major depression|pathogenesis of major depression
619031|NCT00944996|Responsiveness to the antidepressant drugs|responsiveness to the antidepressant drugs
619032|NCT00944983|Hypertension|hypertension
619033|NCT00944983|Hypotension|hypotension
619034|NCT00944983|Clinical Validation|clinical validation
619035|NCT00944983|Blood Pressure Accuracy|blood pressure accuracy
619036|NCT00944983|ISO 81600 Standard|iso 81600 standard
619037|NCT00944983|British Hypertension Society|british hypertension society
619038|NCT00944983|European Society of Hypertension|european society of hypertension
619039|NCT00944983|International Protocol|international protocol
619040|NCT00944970|Coronary artery disease|coronary artery disease
619041|NCT00944970|Angina|angina
619042|NCT00944970|Anginal symptoms|anginal symptoms
619043|NCT00944970|Ischemic heart disease|ischemic heart disease
619044|NCT00944970|Ischemia|ischemia
619045|NCT00944970|Single photon emission computed tomography|single photon emission computed tomography
619046|NCT00944970|Pharmacologic stress|pharmacologic stress
619047|NCT00944970|Myocardial perfusion imaging|myocardial perfusion imaging
619048|NCT00944970|Suspected coronary artery disease|suspected coronary artery disease
619049|NCT00944970|known coronary artery disease|known coronary artery disease
619050|NCT00944970|typical or atypical anginal symptoms|typical or atypical anginal symptoms
619051|NCT00944957|Raltegravir|raltegravir
619052|NCT00944957|efavirenz|efavirenz
619053|NCT00944957|anxiety|anxiety
619054|NCT00944957|depression|depression
619055|NCT00944957|sleep quality|sleep quality
619056|NCT00944957|HIV|hiv
619057|NCT00944957|NNRTI|nnrti
619058|NCT00944957|Tritherapy|tritherapy
619059|NCT00944957|compliance|compliance
619060|NCT00944957|stocrin|stocrin
619061|NCT00944957|treatment experienced|treatment experienced
619062|NCT00944944|CORPUS UTERI,|corpus uteri,
619063|NCT00944944|ENDOMETRIUM|endometrium
619064|NCT00944944|FALLOPIAN TUBE|fallopian tube
619065|NCT00944944|OVARY|ovary
619066|NCT00944944|VAGINA|vagina
619067|NCT00944944|Lymphedema|lymphedema
619068|NCT00944944|Questionnaire|questionnaire
619069|NCT00944944|Quality of Life|quality of life
619070|NCT00944944|09-077|09-077
619071|NCT00944944|Fallopian Tubes|fallopian tubes
619072|NCT00944931|Cerebral Cortex|cerebral cortex
619073|NCT00944931|Cognition|cognition
619074|NCT00944931|Motor Cortex|motor cortex
619075|NCT00944931|Cognitive Enhancement|cognitive enhancement
619076|NCT00944931|Prefrontal Cortex|prefrontal cortex
619077|NCT00944931|Healthy Volunteer|healthy volunteer
619078|NCT00944918|Breast Cancer|breast cancer
619079|NCT00944879|HIV|hiv
619080|NCT00944879|vaccine|vaccine
619081|NCT00944879|prevention|prevention
619082|NCT00944879|HPV|hpv
619083|NCT00944879|adolescents|adolescents
619084|NCT00944853|zinc supplement|zinc supplement
619085|NCT00944853|prevention|prevention
619086|NCT00944853|zinc deficiency|zinc deficiency
619087|NCT00944853|plasma zinc concentration|plasma zinc concentration
619088|NCT00944840|Intermittent Preventive Treatment|intermittent preventive treatment
619089|NCT00944840|Home based management of malaria|home based management of malaria
619090|NCT00944827|Green Tea Extract|green tea extract
619091|NCT00944827|Catechins|catechins
619092|NCT00944827|Statin|statin
619093|NCT00944827|atorvastatin|atorvastatin
619094|NCT00944827|body composition|body composition
619095|NCT00944827|visceral fat|visceral fat
619096|NCT00944827|steatosis|steatosis
619097|NCT00944827|oxidative stress|oxidative stress
619098|NCT00944827|quality of life|quality of life
619099|NCT00944827|OGTT|ogtt
619100|NCT00944827|OGIS|ogis
619101|NCT00944827|ISI matsuda|isi matsuda
619102|NCT00944814|Lipid-based nutrient supplement|lipid-based nutrient supplement
619103|NCT00944814|Prevention of malnutrition|prevention of malnutrition
619104|NCT00944814|Prevention of micronutrient deficiencies|prevention of micronutrient deficiencies
619105|NCT00944814|Zinc|zinc
619106|NCT00944801|glioblastoma|glioblastoma
619107|NCT00944801|first-line|first-line
619108|NCT00944801|clinical trial|clinical trial
619109|NCT00944801|PEG-liposomal doxorubicin|peg-liposomal doxorubicin
619110|NCT00944801|temozolomide|temozolomide
619111|NCT00944801|radiotherapy|radiotherapy
619112|NCT00944801|phase 1|phase 1
619113|NCT00944801|phase 2|phase 2
619114|NCT00944788|physical activity|physical activity
619115|NCT00944788|aging|aging
619116|NCT00944788|inpatients|inpatients
619117|NCT00944788|quality of life|quality of life
619118|NCT00944788|depression|depression
619119|NCT00944775|Exercise|exercise
619120|NCT00944775|Dialysis|dialysis
619121|NCT00944775|Non-invasive cardiac measures|non-invasive cardiac measures
619122|NCT00944775|Exercise trained patients|exercise trained patients
619123|NCT00944775|Controls|controls
619124|NCT00944762|Stroke|stroke
619125|NCT00944749|H- ATG|h- atg
619126|NCT00944749|Anti -Thymocyte Globulin|anti -thymocyte globulin
619127|NCT00944749|Lymphocyte Immune Globulin|lymphocyte immune globulin
619128|NCT00944749|Aplastic Anemia|aplastic anemia
619129|NCT00944736|Crohn's Disease|crohn's disease
619130|NCT00944736|Pediatric|pediatric
619131|NCT00944736|VSL#3|vsl#3
619132|NCT00944736|Permeability|permeability
619133|NCT00944736|Probiotic|probiotic
619134|NCT00944736|Zonulin|zonulin
619135|NCT00944723|zinc fortification|zinc fortification
619136|NCT00944723|zinc supplementation|zinc supplementation
619137|NCT00944723|plasma zinc concentration|plasma zinc concentration
619138|NCT00944710|Amblyopia|amblyopia
619139|NCT00944710|atropine|atropine
619140|NCT00944710|Plano lens|plano lens
619141|NCT00944684|Chronic hepatitis C|chronic hepatitis c
619142|NCT00944684|Antiviral treatment|antiviral treatment
619143|NCT00944684|Ribavirin|ribavirin
619144|NCT00944684|Sustained virological response|sustained virological response
619145|NCT00944684|Hemolytic anemia|hemolytic anemia
619146|NCT00944684|Erythropoetin|erythropoetin
619147|NCT00944658|Ankylosing spondylitis|ankylosing spondylitis
619148|NCT00944658|Imaging|imaging
619149|NCT00944580|MAGE-A1|mage-a1
619150|NCT00944580|MAGE-A3|mage-a3
619151|NCT00944580|NY-ESO-1|ny-eso-1
619152|NCT00944580|antigen|antigen
619153|NCT00944580|vaccine|vaccine
619154|NCT00944580|dendritic cells|dendritic cells
619155|NCT00944580|immunohistochemistry|immunohistochemistry
619156|NCT00944580|immunology|immunology
619157|NCT00944567|Primary Mediastinal B-Cell Lymphoma|primary mediastinal b-cell lymphoma
619158|NCT00944567|Positron emission tomography|positron emission tomography
619159|NCT00944554|Relapse|relapse
619160|NCT00944554|Smoking Cessation|smoking cessation
619161|NCT00944554|Substance Abuse|substance abuse
619162|NCT00944541|maraviroc|maraviroc
619163|NCT00944541|immune restoration|immune restoration
619164|NCT00944541|treatment intensification|treatment intensification
619165|NCT00944528|Cancer of Breast|cancer of breast
619166|NCT00944528|Cancer of the Breast|cancer of the breast
619167|NCT00944528|Neoplasms, Breast|neoplasms, breast
619168|NCT00944528|Single dose radiation|single dose radiation
619169|NCT00944528|Radiotherapy|radiotherapy
619170|NCT00944528|Preoperative|preoperative
619171|NCT00944515|sinusitis|sinusitis
619172|NCT00944515|azithromycin|azithromycin
619173|NCT00944502|Neuralgy|neuralgy
619174|NCT00944502|Dexamethasone|dexamethasone
619175|NCT00944502|Complex Vitamins|complex vitamins
619176|NCT00944502|Injection|injection
787540|NCT00301886|pain|pain
619177|NCT00944502|Symptoms of neuralgy of various origins|symptoms of neuralgy of various origins
619178|NCT00944489|Hypertension|hypertension
619179|NCT00944489|Health-Related Quality of Life Adherence to the antihypertension treatment|health-related quality of life adherence to the antihypertension treatment
619180|NCT00944489|Ambulatory Patients|ambulatory patients
619181|NCT00944489|MINICHAL score|minichal score
619182|NCT00944489|Treatment Adherence Scale (MMAS)|treatment adherence scale (mmas)
619183|NCT00944489|Quality of life|quality of life
619184|NCT00944489|Adherence to treatment|adherence to treatment
619185|NCT00944476|Sarcoma|sarcoma
619186|NCT00944476|soft tissue|soft tissue
619187|NCT00944476|MRI|mri
619188|NCT00944476|Questionnaire|questionnaire
619189|NCT00944476|09-078|09-078
619190|NCT00944463|advanced pancreatic cancer|advanced pancreatic cancer
619191|NCT00944463|gemcitabine|gemcitabine
619192|NCT00944463|simvastatin|simvastatin
619193|NCT00944463|placebo|placebo
619194|NCT00944437|Ventilation, Mechanical|ventilation, mechanical
619195|NCT00944437|Positive-Pressure Respiration|positive-pressure respiration
619196|NCT00944437|Continuous Positive Airway Pressure|continuous positive airway pressure
619197|NCT00944424|Vitamin D in patients with metastatic breast cancer|vitamin d in patients with metastatic breast cancer
619198|NCT00944398|Zinc fortification|zinc fortification
619199|NCT00944398|Plasma zinc concentration|plasma zinc concentration
619200|NCT00944398|Assessment of zinc status|assessment of zinc status
619201|NCT00944372|Tumor|tumor
619202|NCT00944372|somatostatin receptor|somatostatin receptor
619203|NCT00944359|zinc supplementation|zinc supplementation
619204|NCT00944359|diarrhea management|diarrhea management
619205|NCT00944359|zinc deficiency|zinc deficiency
619206|NCT00944359|malaria|malaria
619207|NCT00944333|second generation DES|second generation des
619208|NCT00944333|clopidogrel|clopidogrel
619209|NCT00944333|dual platelet therapy|dual platelet therapy
619210|NCT00944333|patients with documented silent ischemia|patients with documented silent ischemia
619211|NCT00944333|unstable angina pectoris (Braunwald Classification)|unstable angina pectoris (braunwald classification)
619212|NCT00944333|Diagnosis of angina pectoris (CCS)|diagnosis of angina pectoris (ccs)
619214|NCT00944307|antiretroviral|antiretroviral
619215|NCT00944307|drug interaction|drug interaction
619216|NCT00944307|human immunodeficiency virus|human immunodeficiency virus
619217|NCT00944294|Coronary artery disease|coronary artery disease
619219|NCT00944294|Anginal symptoms|anginal symptoms
619220|NCT00944294|Ischemic heart disease|ischemic heart disease
619221|NCT00944294|Ischemia|ischemia
619222|NCT00944294|Single photon emission computed tomography|single photon emission computed tomography
619223|NCT00944294|Pharmacologic stress|pharmacologic stress
619224|NCT00944294|Myocardial perfusion imaging|myocardial perfusion imaging
619225|NCT00944294|typical or atypical anginal symptoms|typical or atypical anginal symptoms
619226|NCT00944294|Suspected coronary artery disease|suspected coronary artery disease
619227|NCT00944294|known coronary artery disease|known coronary artery disease
619228|NCT00944281|point-of-use fortification|point-of-use fortification
619229|NCT00944281|zinc supplement|zinc supplement
619230|NCT00944281|lipid-based nutrient supplement|lipid-based nutrient supplement
619231|NCT00944281|zinc deficiency|zinc deficiency
619232|NCT00944281|micronutrient deficiency|micronutrient deficiency
619233|NCT00944281|anemia|anemia
619234|NCT00944268|Passiflora, Crataegus and Salix|passiflora, crataegus and salix
619235|NCT00944268|Mild and Moderate anxiety|mild and moderate anxiety
619236|NCT00944268|Tablet|tablet
619237|NCT00944268|To evaluate the efficacy and tolerability of the combination|to evaluate the efficacy and tolerability of the combination
619238|NCT00944229|Heart Failure|heart failure
619239|NCT00944229|omega 3|omega 3
619240|NCT00944229|lovaza|lovaza
619241|NCT00944229|VO2 max|vo2 max
619242|NCT00944216|keratosis pilaris|keratosis pilaris
619243|NCT00944203|jellyfish|jellyfish
619244|NCT00944203|jellyfish venom|jellyfish venom
619245|NCT00944203|jellyfish dermatitis|jellyfish dermatitis
619246|NCT00944203|jellyfish stings|jellyfish stings
619247|NCT00944203|Ipomea pes-caprae|ipomea pes-caprae
619248|NCT00944190|pain|pain
619249|NCT00944190|fatigue|fatigue
619250|NCT00944190|depression|depression
619251|NCT00944190|cognitive difficulties|cognitive difficulties
619252|NCT00944190|self-management|self-management
619253|NCT00944151|pain|pain
619254|NCT00944151|UCSD|ucsd
619255|NCT00944151|catheter|catheter
619256|NCT00944151|nerve block|nerve block
619257|NCT00944151|hernia|hernia
619258|NCT00944151|post-surgery pain|post-surgery pain
619259|NCT00944151|abdominal pain|abdominal pain
619260|NCT00944151|pelvic pain|pelvic pain
619261|NCT00944151|Transversus abdominal plane|transversus abdominal plane
619262|NCT00944151|Hernia Repair|hernia repair
619263|NCT00944151|Transversus Abdominal Plane Block|transversus abdominal plane block
619264|NCT00944138|Obesity|obesity
619265|NCT00944138|meditation|meditation
619266|NCT00944138|chronic kidney disease|chronic kidney disease
619267|NCT00944112|Intensive care|intensive care
619268|NCT00944112|Blood Transfusion|blood transfusion
619269|NCT00944112|Anemia|anemia
619270|NCT00944099|intervention studies|intervention studies
619271|NCT00944099|feeding behavior|feeding behavior
619272|NCT00944099|eating frequency|eating frequency
619273|NCT00944099|weight loss|weight loss
619274|NCT00944099|dietary intake|dietary intake
619275|NCT00944086|Recruitment|recruitment
619276|NCT00944086|Oxygen Concentration|oxygen concentration
619277|NCT00944086|pneumoperitoneum|pneumoperitoneum
619278|NCT00944086|laparoscopy|laparoscopy
619279|NCT00944073|H1N1, influenza A viruses, vaccine, infants, children|h1n1, influenza a viruses, vaccine, infants, children
619280|NCT00944047|invasive breast cancer|invasive breast cancer
619281|NCT00944047|HER2|her2
619282|NCT00944047|primary breast cancer|primary breast cancer
619283|NCT00944047|neo-adjuvant therapy|neo-adjuvant therapy
619284|NCT00944047|Trastuzumab|trastuzumab
619285|NCT00944047|Nab-paclitaxel|nab-paclitaxel
619286|NCT00944034|Meningococcal meningitis|meningococcal meningitis
619287|NCT00944034|prevention|prevention
619288|NCT00944034|vaccination|vaccination
619289|NCT00944034|toddler|toddler
619290|NCT00944021|Early Bactericidal Activity|early bactericidal activity
619291|NCT00944021|EBA|eba
619292|NCT00944021|Pulmonary Tuberculosis|pulmonary tuberculosis
619293|NCT00944021|PA-824|pa-824
619294|NCT00944021|pretomanid|pretomanid
619295|NCT00944008|Acute Lymphoblastic Leukemia (ALL)|acute lymphoblastic leukemia (all)
619296|NCT00944008|Depocyte®|depocyte®
619297|NCT00944008|Neuromeningeal relapse|neuromeningeal relapse
619298|NCT00944008|Between 16 and 30 years old|between 16 and 30 years old
619299|NCT00944008|Standard risk|standard risk
619300|NCT00943995|End Stage Kidney Disease|end stage kidney disease
619301|NCT00943995|Kidney Failure|kidney failure
619302|NCT00943995|Short stature|short stature
619303|NCT00943995|Growth Hormone therapy|growth hormone therapy
619304|NCT00943982|Cystoid Macular Edema|cystoid macular edema
619305|NCT00943982|Intermediate Uveitis|intermediate uveitis
619306|NCT00943982|Uveitis|uveitis
619307|NCT00943982|OCT|oct
619308|NCT00943982|Interferon-Gamma (IFN-Gamma)|interferon-gamma (ifn-gamma)
619309|NCT00943969|obesity|obesity
619310|NCT00943969|gastric bypass|gastric bypass
619311|NCT00943969|morphine|morphine
619312|NCT00943969|pharmacokinetic|pharmacokinetic
619313|NCT00943969|absorption|absorption
619314|NCT00943956|stage III prostate cancer|stage iii prostate cancer
619315|NCT00943956|stage IV prostate cancer|stage iv prostate cancer
619316|NCT00943943|acute myelogenous leukemia|acute myelogenous leukemia
619317|NCT00943943|AML|aml
619318|NCT00943943|Leukemia|leukemia
619319|NCT00943943|myeloid leukemias|myeloid leukemias
619320|NCT00943943|mutated fms-like tyrosine kinase receptor-3|mutated fms-like tyrosine kinase receptor-3
619321|NCT00943943|FLT3 Mutations|flt3 mutations
619322|NCT00943943|G-CSF|g-csf
619323|NCT00943943|Granulocyte Colony Stimulating Factor|granulocyte colony stimulating factor
619324|NCT00943943|Filgrastim|filgrastim
619325|NCT00943943|Neupogen|neupogen
619326|NCT00943943|Plerixafor|plerixafor
619327|NCT00943943|Mobozil|mobozil
619328|NCT00943943|Sorafenib|sorafenib
619329|NCT00943943|BAY 43-9006|bay 43-9006
619330|NCT00943904|urinary leakage associated with urinary urgency|urinary leakage associated with urinary urgency
619331|NCT00943904|unable to fully empty bladder|unable to fully empty bladder
619332|NCT00943904|Comparison: Motor&Sensory Response to Interstim Stimulation|comparison: motor&sensory response to interstim stimulation
619333|NCT00943878|H1N1, influenza A viruses, vaccine, elderly, TIV|h1n1, influenza a viruses, vaccine, elderly, tiv
619334|NCT00943865|metabolic syndrome|metabolic syndrome
619335|NCT00943865|lifestyle|lifestyle
619336|NCT00943865|exercise|exercise
619337|NCT00943865|endothelial dysfunction|endothelial dysfunction
619338|NCT00943865|insulin sensitivity|insulin sensitivity
619339|NCT00943865|lipids|lipids
619340|NCT00943839|stage IV renal cell cancer|stage iv renal cell cancer
619341|NCT00943813|communication|communication
619342|NCT00943813|survey|survey
619343|NCT00943813|video|video
619344|NCT00943813|09-043|09-043
619345|NCT00943800|Appropriate candidate for transplantation|appropriate candidate for transplantation
619346|NCT00943800|An HLA-identical related or unrelated donor cannot be identified within an appropriate time frame.|an hla-identical related or unrelated donor cannot be identified within an appropriate time frame.
619347|NCT00943774|Physiology|physiology
619348|NCT00943774|Phenotype|phenotype
619349|NCT00943774|Genetics|genetics
619350|NCT00943774|Genomics|genomics
619351|NCT00943774|Stress|stress
619352|NCT00943774|Baroreflex|baroreflex
619353|NCT00943774|Blood Pressure|blood pressure
619354|NCT00943774|Arterial stiffness|arterial stiffness
619355|NCT00943761|hepatitis C|hepatitis c
619356|NCT00943735|Overactive Bladder Incontinence Adherence Behavioral interventions|overactive bladder incontinence adherence behavioral interventions
619357|NCT00943709|hyperglycemia|hyperglycemia
619358|NCT00943709|recurrent adult acute lymphoblastic leukemia|recurrent adult acute lymphoblastic leukemia
619359|NCT00943709|untreated adult acute lymphoblastic leukemia|untreated adult acute lymphoblastic leukemia
619360|NCT00943709|adult acute myeloid leukemia with 11q23 (MLL) abnormalities|adult acute myeloid leukemia with 11q23 (mll) abnormalities
619361|NCT00943709|adult acute myeloid leukemia with inv(16)(p13;q22)|adult acute myeloid leukemia with inv(16)(p13;q22)
619362|NCT00943709|adult acute myeloid leukemia with t(15;17)(q22;q12)|adult acute myeloid leukemia with t(15;17)(q22;q12)
619363|NCT00943709|adult acute myeloid leukemia with t(16;16)(p13;q22)|adult acute myeloid leukemia with t(16;16)(p13;q22)
619364|NCT00943709|adult acute myeloid leukemia with t(8;21)(q22;q22)|adult acute myeloid leukemia with t(8;21)(q22;q22)
619365|NCT00943709|recurrent adult acute myeloid leukemia|recurrent adult acute myeloid leukemia
619366|NCT00943709|untreated adult acute myeloid leukemia|untreated adult acute myeloid leukemia
619367|NCT00943670|MBC|mbc
619368|NCT00943670|TDM1|tdm1
619369|NCT00943670|Armed Herceptin|armed herceptin
619370|NCT00943670|Herceptin|herceptin
619371|NCT00943670|Trastuzumab emtansine|trastuzumab emtansine
619372|NCT00943644|MBI|mbi
619373|NCT00943644|Breast|breast
619374|NCT00943644|Breast Cancer|breast cancer
619375|NCT00943631|H1N1, influenza A viruses, vaccine, elderly|h1n1, influenza a viruses, vaccine, elderly
619376|NCT00943618|Smoking Cessation|smoking cessation
619377|NCT00943618|Nicotine Withdrawal|nicotine withdrawal
619378|NCT00943618|Smoking Reduction|smoking reduction
619379|NCT00943618|Varenicline|varenicline
619380|NCT00943618|Chantix|chantix
619381|NCT00943618|Bupropion|bupropion
619382|NCT00943618|Zyban|zyban
619383|NCT00943605|Mastectomy|mastectomy
619384|NCT00943605|PlasmaBlade|plasmablade
619385|NCT00943605|Electrosurgery|electrosurgery
619386|NCT00943605|PEAK Surgical|peak surgical
619387|NCT00943605|Medtronic Advanced Energy|medtronic advanced energy
619388|NCT00943605|Medtronic|medtronic
619389|NCT00943592|Melphalan|melphalan
619390|NCT00943592|Alemtuzumab|alemtuzumab
619391|NCT00943592|Clofarabine|clofarabine
619392|NCT00943579|autism|autism
619393|NCT00943579|autistic disorder|autistic disorder
619394|NCT00943579|tetrahydrobiopterin|tetrahydrobiopterin
619395|NCT00943579|sapropterin|sapropterin
619396|NCT00943579|treatment|treatment
619397|NCT00943566|Pain|pain
619398|NCT00943566|Cancer|cancer
619399|NCT00943566|Morphine|morphine
619400|NCT00943553|AML|aml
619401|NCT00943540|pharmacokinetics|pharmacokinetics
619402|NCT00943540|single dose|single dose
619403|NCT00943540|raltegravir|raltegravir
619404|NCT00943540|Treatment experienced|treatment experienced
619405|NCT00943527|Breast|breast
619406|NCT00943527|Menstrual Cycle|menstrual cycle
619407|NCT00943527|Breast Cancer|breast cancer
619408|NCT00943527|Hormone|hormone
619409|NCT00943527|MBI|mbi
619410|NCT00943527|Molecular Breast Imaging|molecular breast imaging
619411|NCT00943527|Breast Imaging|breast imaging
619412|NCT00943514|Variant Cystic Fibrosis|variant cystic fibrosis
619413|NCT00943514|Bronchopulmonary Mycosis|bronchopulmonary mycosis
619414|NCT00943514|Airway Infection Susceptibility|airway infection susceptibility
619415|NCT00943514|Chronic Respiratory Infection|chronic respiratory infection
619416|NCT00943514|Primary Ciliary Dyskinesia|primary ciliary dyskinesia
619417|NCT00943514|Bronchiectasis|bronchiectasis
619418|NCT00943488|influenza A viruses, H1N1, elderly|influenza a viruses, h1n1, elderly
619419|NCT00943475|DPNB, pain, hemodynamics effects, circumcision|dpnb, pain, hemodynamics effects, circumcision
619420|NCT00943449|Hepatocellular Carcinoma|hepatocellular carcinoma
619421|NCT00943449|Sorafenib|sorafenib
619422|NCT00943449|HDAC|hdac
619423|NCT00943449|4SC-201|4sc-201
619424|NCT00943449|Phase II|phase ii
619425|NCT00943449|Resminostat|resminostat
619426|NCT00943436|Exercise|exercise
619427|NCT00943436|Sedentary|sedentary
619428|NCT00943436|Energy Expenditure|energy expenditure
619429|NCT00943436|Energy Balance|energy balance
619430|NCT00943436|Macronutrient Intake|macronutrient intake
619431|NCT00943436|Energy and Macronutrient intake|energy and macronutrient intake
619432|NCT00943436|Exercise and Energy Balance|exercise and energy balance
619433|NCT00943423|stage I adult Hodgkin lymphoma|stage i adult hodgkin lymphoma
619434|NCT00943423|stage II adult Hodgkin lymphoma|stage ii adult hodgkin lymphoma
619435|NCT00943410|HER2-positive breast cancer|her2-positive breast cancer
619436|NCT00943410|inflammatory breast cancer|inflammatory breast cancer
619437|NCT00943410|recurrent breast cancer|recurrent breast cancer
619438|NCT00943410|stage IIIA breast cancer|stage iiia breast cancer
619439|NCT00943410|stage IIIB breast cancer|stage iiib breast cancer
619440|NCT00943410|stage IIIC breast cancer|stage iiic breast cancer
619441|NCT00943410|stage IV breast cancer|stage iv breast cancer
619442|NCT00943358|influenza|influenza
619443|NCT00943358|immunogenicity|immunogenicity
619444|NCT00943358|vaccine|vaccine
619445|NCT00943345|GI|gi
619446|NCT00943345|gastrointestinal|gastrointestinal
619447|NCT00943345|permeability|permeability
619448|NCT00943345|indometacin|indometacin
619449|NCT00943345|indomethacin|indomethacin
619450|NCT00943345|coeliac|coeliac
619451|NCT00943332|Orthopedic Procedures|orthopedic procedures
619452|NCT00943332|Fracture Fixation, Internal|fracture fixation, internal
619453|NCT00943332|Fracture Fixation, External|fracture fixation, external
619454|NCT00943332|femur fracture|femur fracture
619455|NCT00943332|pediatrics|pediatrics
619456|NCT00943319|Cancers of the blood|cancers of the blood
619457|NCT00943306|Homozygous|homozygous
619458|NCT00943306|Familial|familial
619459|NCT00943306|Hypercholesterolemia|hypercholesterolemia
619460|NCT00943306|MTP|mtp
619461|NCT00943306|Apheresis|apheresis
619462|NCT00943306|lomitapide|lomitapide
619463|NCT00943306|Homozygous Familial Hypercholesterolemia (HoFH)|homozygous familial hypercholesterolemia (hofh)
619464|NCT00943293|GVHD|gvhd
619465|NCT00943280|probability of patient participation in each of the Groups 1, 2 and 3.|probability of patient participation in each of the groups 1, 2 and 3.
619466|NCT00943280|Identification of factors predicting poor participation in screening for Barrett's esophagus.|identification of factors predicting poor participation in screening for barrett's esophagus.
619467|NCT00943267|Activated Protein C|activated protein c
619468|NCT00943267|Lipopolysaccharides|lipopolysaccharides
619469|NCT00943267|Inflammation, Pulmonary|inflammation, pulmonary
619470|NCT00943254|Metabolic Cardiovascular Syndrome|metabolic cardiovascular syndrome
619471|NCT00943241|Breast|breast
619472|NCT00943241|Breast Cancer|breast cancer
619473|NCT00943241|MBI|mbi
619474|NCT00943241|Molecular Breast Imaging|molecular breast imaging
619475|NCT00943241|Molecular Imaging|molecular imaging
619476|NCT00943228|Renal transplantation|renal transplantation
619477|NCT00943228|Adequate exposure|adequate exposure
619478|NCT00943228|Acute rejection|acute rejection
619479|NCT00943228|mycophenolate mofetil|mycophenolate mofetil
619480|NCT00943228|immunosuppression|immunosuppression
619481|NCT00943215|CALERIE II Follow-up|calerie ii follow-up
619482|NCT00943202|H1N1, influenza A viruses, TIV, vaccine, infants, children|h1n1, influenza a viruses, tiv, vaccine, infants, children
619483|NCT00943189|Fetal anomalies scan at the time of NT study|fetal anomalies scan at the time of nt study
619484|NCT00943176|Fatigue|fatigue
619485|NCT00943163|cyclorotation|cyclorotation
619486|NCT00943163|pupil|pupil
619487|NCT00943163|laser refractive surgery|laser refractive surgery
619488|NCT00943150|Abdominoplasty|abdominoplasty
619489|NCT00943150|PlasmaBlade|plasmablade
619490|NCT00943150|Electrosurgery|electrosurgery
619491|NCT00943150|PEAK Surgical|peak surgical
619492|NCT00943150|Medtronic Advanced Energy|medtronic advanced energy
619493|NCT00943150|Medtronic|medtronic
619494|NCT00943111|Gaucher disease,|gaucher disease,
619495|NCT00943111|Genz-112638,|genz-112638,
619496|NCT00943111|beta-glucosidase,|beta-glucosidase,
619497|NCT00943111|acid ß-glucosidase,|acid ß-glucosidase,
619498|NCT00943111|glucocerebrosidase,|glucocerebrosidase,
619499|NCT00943111|glucosylceramide,|glucosylceramide,
619500|NCT00943111|D-glucosyl-N-acylsphingosine glucohydrolase,|d-glucosyl-n-acylsphingosine glucohydrolase,
619501|NCT00943111|substrate reduction therapy|substrate reduction therapy
619502|NCT00943085|Early Signs of Bipolar Disorder|early signs of bipolar disorder
619503|NCT00943085|High Risk Youth|high risk youth
619504|NCT00943085|Adolescence|adolescence
619505|NCT00943085|Childhood|childhood
619506|NCT00943072|Macular edema|macular edema
619507|NCT00943072|Retinal vein occlusion|retinal vein occlusion
619508|NCT00943072|CRVO|crvo
619509|NCT00943072|VEGF Trap-Eye|vegf trap-eye
619510|NCT00943072|best-corrected visual acuity|best-corrected visual acuity
619511|NCT00943072|Regeneron|regeneron
619512|NCT00943072|COPERNICUS|copernicus
619513|NCT00943059|Mitochondrial function|mitochondrial function
619514|NCT00943059|Diabetes|diabetes
619515|NCT00943059|Cardiomyopathy|cardiomyopathy
619516|NCT00943059|insulin resistance|insulin resistance
619517|NCT00943059|lipid lowering|lipid lowering
619518|NCT00943059|triglycerides|triglycerides
619519|NCT00943059|Acipimox|acipimox
619520|NCT00943046|leads|leads
619521|NCT00943046|pacemaker|pacemaker
619522|NCT00943046|efficacy|efficacy
619523|NCT00943046|safety|safety
619524|NCT00943033|MBCT|mbct
619525|NCT00943033|Mindfulness-Based Cognitive Therapy|mindfulness-based cognitive therapy
619526|NCT00943033|Mindfulness|mindfulness
619527|NCT00943033|Meditation|meditation
619528|NCT00943033|Relapse Prevention|relapse prevention
619529|NCT00943033|Recurrent Depression|recurrent depression
619530|NCT00943033|Depression|depression
619531|NCT00943033|Major Depressive Disorder|major depressive disorder
619532|NCT00943020|Dietary supplement|dietary supplement
619533|NCT00943020|Carbohydrate loading|carbohydrate loading
619534|NCT00943020|Healthy volunteers|healthy volunteers
619535|NCT00943020|Anaesthesia|anaesthesia
619536|NCT00943020|Surgery|surgery
619537|NCT00943020|Glutamine|glutamine
619538|NCT00942994|Hypertension|hypertension
619539|NCT00942994|Aliskiren|aliskiren
619540|NCT00942994|Amlodipine|amlodipine
619541|NCT00942994|HCTZ|hctz
619542|NCT00942994|Systolic blood pressure|systolic blood pressure
619543|NCT00942994|Diastolic blood pressure|diastolic blood pressure
619544|NCT00942994|Stage II|stage ii
619545|NCT00942994|Combination|combination
619546|NCT00942981|PET Study|pet study
619547|NCT00942981|(18F) Fallypride|(18f) fallypride
619548|NCT00942981|(11C)NNC-112|(11c)nnc-112
619549|NCT00942981|Schizoaffective Disorder|schizoaffective disorder
619550|NCT00942981|Schizophrenia|schizophrenia
619551|NCT00942981|Healthy Volunteer|healthy volunteer
619552|NCT00942981|HV|hv
619553|NCT00942929|anorexia nervosa|anorexia nervosa
619554|NCT00942929|adolescents|adolescents
619555|NCT00942929|lung function tests|lung function tests
619556|NCT00942929|refeeding|refeeding
619557|NCT00942916|Make sure the difference of the serum inflammatory marker between the two groups|make sure the difference of the serum inflammatory marker between the two groups
619558|NCT00942903|HME|hme
619559|NCT00942903|Provox|provox
619560|NCT00942903|voice prosthesis|voice prosthesis
619561|NCT00942903|laryngectomy|laryngectomy
619562|NCT00942890|Case Management|case management
619563|NCT00942890|Amputation|amputation
619564|NCT00942890|Muscle strength|muscle strength
619565|NCT00942890|phantom limb pain|phantom limb pain
619566|NCT00942877|VEGF|vegf
619567|NCT00942877|Antiangiogenesis|antiangiogenesis
619568|NCT00942877|Tyrosine Kinase Inhibitor|tyrosine kinase inhibitor
619569|NCT00942877|Advanced Cancer|advanced cancer
619570|NCT00942877|Alveolar Soft Part Sarcoma|alveolar soft part sarcoma
619571|NCT00942877|Sarcoma|sarcoma
619572|NCT00942851|Dystonia|dystonia
619573|NCT00942851|Blepharospasm|blepharospasm
619574|NCT00942851|Botulinum Toxin|botulinum toxin
619575|NCT00942851|Treatment|treatment
619576|NCT00942851|Clinical Trial|clinical trial
619577|NCT00942851|Focal Dystonia|focal dystonia
619578|NCT00942838|Recurrent Ovarian Carcinoma|recurrent ovarian carcinoma
619579|NCT00942838|Cancer|cancer
619580|NCT00942825|NSCL|nscl
619581|NCT00942825|non-squamous non small cell lung cancer|non-squamous non small cell lung cancer
619582|NCT00942825|Lung Cancer|lung cancer
619583|NCT00942825|Lung|lung
619584|NCT00942825|non-squamous|non-squamous
619585|NCT00942825|metastatic|metastatic
619586|NCT00942825|pleural effusion|pleural effusion
619587|NCT00942825|Stage IIIb|stage iiib
619588|NCT00942825|Stage IV|stage iv
619589|NCT00942825|NSCLC|nsclc
619590|NCT00942812|Children|children
619591|NCT00942812|Recovery|recovery
619592|NCT00942812|Diarrhea Pack|diarrhea pack
619593|NCT00942812|Social Marketing|social marketing
619594|NCT00942799|Genz-644282|genz-644282
619595|NCT00942799|Topoisomerase I inhibitors|topoisomerase i inhibitors
619596|NCT00942799|Top1|top1
619597|NCT00942799|solid tumors|solid tumors
619598|NCT00942799|dose-escalation|dose-escalation
619599|NCT00942799|pharmacokinetic (PK)|pharmacokinetic (pk)
619600|NCT00942799|MTD (Maximum Tolerated Dose)|mtd (maximum tolerated dose)
619601|NCT00942799|oncology|oncology
619602|NCT00942799|cancer|cancer
619603|NCT00942786|natriuretic peptides|natriuretic peptides
619604|NCT00942786|emergency non-cardiac surgery|emergency non-cardiac surgery
619605|NCT00942773|Healthy volunteer|healthy volunteer
619606|NCT00942747|temsirolimus, primary CNS lymphoma, PCNSL, salvage treatment|temsirolimus, primary cns lymphoma, pcnsl, salvage treatment
619607|NCT00942734|Head and Neck|head and neck
619608|NCT00942734|Squamous Cell Carcinoma|squamous cell carcinoma
619609|NCT00942734|RAD001|rad001
619610|NCT00942734|Erlotinib|erlotinib
619611|NCT00942734|Everolimus|everolimus
619612|NCT00942734|OSI-774|osi-774
619613|NCT00942734|Tarceva|tarceva
619614|NCT00942721|Web-based Intervention|web-based intervention
619615|NCT00942721|CBT Treatment|cbt treatment
619616|NCT00942708|Pulmonary Arterial Hypertension|pulmonary arterial hypertension
619617|NCT00942708|Pulmonary Hypertension|pulmonary hypertension
619618|NCT00942695|pistachio|pistachio
619619|NCT00942695|nuts|nuts
619620|NCT00942695|energy value|energy value
619621|NCT00942695|cardiovascular disease|cardiovascular disease
619622|NCT00942695|phytonutrient|phytonutrient
619623|NCT00942695|gene expression|gene expression
619624|NCT00942695|energy value of pistachio nuts|energy value of pistachio nuts
619625|NCT00942682|sorafenib|sorafenib
619626|NCT00942682|RAD001|rad001
619627|NCT00942669|Sleep Apnea Syndrome|sleep apnea syndrome
619629|NCT00942669|SleepStrip OTC|sleepstrip otc
619630|NCT00942656|trans fatty acids|trans fatty acids
619631|NCT00942656|ruminant|ruminant
619632|NCT00942656|cardiovascular disease|cardiovascular disease
619633|NCT00942630|percutaneous|percutaneous
619634|NCT00942630|transhepatic|transhepatic
619635|NCT00942630|biliary|biliary
619636|NCT00942630|drainage|drainage
619637|NCT00942630|cholangioscopy|cholangioscopy
619638|NCT00942617|platelet aggregation|platelet aggregation
619639|NCT00942617|granule secretion|granule secretion
619640|NCT00942617|thromboxane production|thromboxane production
619641|NCT00942617|cyclooxygenase-1|cyclooxygenase-1
619642|NCT00942617|ATP release|atp release
619643|NCT00942617|aspirin resistance|aspirin resistance
619644|NCT00942617|platelet activation|platelet activation
619645|NCT00942617|flow cytometry|flow cytometry
619646|NCT00942617|Platelet aggregation in healthy volunteers|platelet aggregation in healthy volunteers
619647|NCT00942604|Peplin|peplin
619648|NCT00942604|Actinic keratosis|actinic keratosis
619649|NCT00942604|PEP005|pep005
619650|NCT00942591|multiple sclerosis|multiple sclerosis
619651|NCT00942591|interferon beta|interferon beta
619652|NCT00942591|atorvastatin|atorvastatin
619653|NCT00942578|Dual Antiangiogenic Combination Therapy for mCRPC|dual antiangiogenic combination therapy for mcrpc
619654|NCT00942578|Efficacy and Toxicity Profile|efficacy and toxicity profile
619655|NCT00942578|Single Stage Phase 2 With Early Stopping, Run In Phase For Toxicity|single stage phase 2 with early stopping, run in phase for toxicity
619656|NCT00942578|Correlative Measurements|correlative measurements
619657|NCT00942578|Overall Survival Assessment|overall survival assessment
619658|NCT00942578|Metastatic Prostate Cancer|metastatic prostate cancer
619659|NCT00942578|Prostate Cancer|prostate cancer
619660|NCT00942565|Open gynecological surgery|open gynecological surgery
619661|NCT00942539|Neonates|neonates
619662|NCT00942526|esophageal cancer|esophageal cancer
619663|NCT00942526|anastomotic leakage|anastomotic leakage
619664|NCT00942526|Prevention of anastomotic leakage after esophageal surgery|prevention of anastomotic leakage after esophageal surgery
619665|NCT00942513|substrate absorption|substrate absorption
619666|NCT00942513|substrate oxidation|substrate oxidation
619667|NCT00942513|glucose regulation|glucose regulation
619668|NCT00942513|whey protein|whey protein
619669|NCT00942513|soy protein|soy protein
619670|NCT00942513|sucrose|sucrose
619671|NCT00942513|fructose|fructose
619672|NCT00942513|lactose|lactose
619673|NCT00942500|Post-conditioning|post-conditioning
619674|NCT00942500|ST-elevation myocardial infarction|st-elevation myocardial infarction
619675|NCT00942500|Angioplasty, Transluminal, Percutaneous Coronary|angioplasty, transluminal, percutaneous coronary
619676|NCT00942487|arterial hypertension|arterial hypertension
619677|NCT00942474|The focus of the study is to assess the ability of the nerve access tool to facilitate nerve lead placement|the focus of the study is to assess the ability of the nerve access tool to facilitate nerve lead placement
619678|NCT00942461|a-defensins|a-defensins
619679|NCT00942461|TLRs|tlrs
619680|NCT00942461|Inflammatory Cytokines|inflammatory cytokines
619682|NCT00942461|No metastases|no metastases
619683|NCT00942461|No other obvious inflammation|no other obvious inflammation
619684|NCT00942461|No chronic diseases|no chronic diseases
619685|NCT00942435|YM150|ym150
619686|NCT00942435|Bleeding|bleeding
619687|NCT00942435|VTE|vte
619688|NCT00942435|FXa inhibitor|fxa inhibitor
619689|NCT00942435|Deep Vein Thrombosis|deep vein thrombosis
619690|NCT00942435|Venous thromboembolism|venous thromboembolism
619691|NCT00942422|monoclonal gammopathy of undetermined significance|monoclonal gammopathy of undetermined significance
619692|NCT00942422|smoldering multiple myeloma|smoldering multiple myeloma
619693|NCT00942396|Mammography|mammography
619694|NCT00942383|liver tumor|liver tumor
619695|NCT00942383|liver tumors|liver tumors
619696|NCT00942383|liver cancer|liver cancer
619697|NCT00942383|hepatocellular carcinoma|hepatocellular carcinoma
619698|NCT00942383|metastatic colorectal cancer|metastatic colorectal cancer
619699|NCT00942383|metastatic cancer to the liver|metastatic cancer to the liver
619700|NCT00942383|metastatic cancer|metastatic cancer
619701|NCT00942383|metastatic neuroendocrine cancer|metastatic neuroendocrine cancer
619702|NCT00942383|liver|liver
619703|NCT00942383|liver surgery|liver surgery
619704|NCT00942383|radiofrequency ablation|radiofrequency ablation
619705|NCT00942383|microwave ablation|microwave ablation
619706|NCT00942370|mechanography|mechanography
619707|NCT00942370|electromyography|electromyography
619708|NCT00942370|effort cough|effort cough
619709|NCT00942344|Amlodipine|amlodipine
619710|NCT00942344|Losartan|losartan
619711|NCT00942344|Hypertension|hypertension
619712|NCT00942318|Type 2 Diabetes Mellitus|type 2 diabetes mellitus
619713|NCT00942318|Continuous subcutaneous insulin infusion|continuous subcutaneous insulin infusion
619714|NCT00942318|Insulin external pump|insulin external pump
619715|NCT00942318|Multiple daily injections|multiple daily injections
619716|NCT00942318|Basal-bolus regimen|basal-bolus regimen
619717|NCT00942318|Education|education
619718|NCT00942305|Allogeneic stem cell transplant|allogeneic stem cell transplant
619719|NCT00942305|CMV seropositive (R+)|cmv seropositive (r+)
619720|NCT00942305|transplant|transplant
619721|NCT00942305|Allogeneic stem cell transplant recipients who were CMV seropositive (R+) at the time of transplant will be eligible for enrollment|allogeneic stem cell transplant recipients who were cmv seropositive (r+) at the time of transplant will be eligible for enrollment
619722|NCT00942292|Hepatic|hepatic
619723|NCT00942292|colorectal|colorectal
619724|NCT00942292|metastases|metastases
619725|NCT00942292|TPN|tpn
619726|NCT00942292|Fish oil|fish oil
619727|NCT00942253|RLS|rls
619728|NCT00942253|Muscle|muscle
619729|NCT00942253|Dialysis|dialysis
619730|NCT00942253|exercise|exercise
619731|NCT00942253|dopamine agonist|dopamine agonist
619732|NCT00942253|Sleep|sleep
619733|NCT00942227|Sciatica|sciatica
619734|NCT00942227|Radiculopathy|radiculopathy
619735|NCT00942227|Physical therapy modalities|physical therapy modalities
619736|NCT00942227|Rehabilitation|rehabilitation
619737|NCT00942214|Multiple sclerosis|multiple sclerosis
619738|NCT00942214|natalizumab|natalizumab
619739|NCT00942214|pharmacogenomics|pharmacogenomics
619740|NCT00942201|Asthma|asthma
619741|NCT00942201|Dexamethasone|dexamethasone
619742|NCT00942201|Emergency Department|emergency department
619743|NCT00942188|Diabetes|diabetes
619744|NCT00942188|Type 2 Diabetes|type 2 diabetes
619745|NCT00942175|Pharmacology|pharmacology
619746|NCT00942175|Stomach Ulcer|stomach ulcer
619747|NCT00942175|Esophagitis, Peptic|esophagitis, peptic
619748|NCT00942175|Zollinger-Ellison Syndrome|zollinger-ellison syndrome
619749|NCT00942175|Platelet function|platelet function
619750|NCT00942175|PPI|ppi
619751|NCT00942175|clopidogrel|clopidogrel
619752|NCT00942175|Pharmacokinetics and Pharmacodynamics|pharmacokinetics and pharmacodynamics
619753|NCT00942162|ASCI|asci
619754|NCT00942162|Melanoma|melanoma
619755|NCT00942162|Immunotherapeutic|immunotherapeutic
619756|NCT00942162|Tumor antigen|tumor antigen
619757|NCT00942162|PREDICT|predict
619758|NCT00942149|Infants|infants
619759|NCT00942149|Daptomycin|daptomycin
619760|NCT00942136|HIV|hiv
619761|NCT00942136|GSK1349572|gsk1349572
619762|NCT00942136|omeprazole|omeprazole
619763|NCT00942136|Prilosec|prilosec
619764|NCT00942136|supratherapeutic dose|supratherapeutic dose
619765|NCT00942136|pharmacokinetics|pharmacokinetics
619766|NCT00942136|drug interaction|drug interaction
619767|NCT00942136|HIV Infections|hiv infections
619768|NCT00942110|Postprandial glucose, lipid metabolism|postprandial glucose, lipid metabolism
619769|NCT00942110|humoral factors|humoral factors
619770|NCT00942097|Homeopathy|homeopathy
619771|NCT00942097|overweight|overweight
619772|NCT00942097|obesity|obesity
619773|NCT00942097|mental disorder|mental disorder
619774|NCT00942097|pregnancy|pregnancy
619775|NCT00942097|Overweight pregnant women with suspicious mental disorder|overweight pregnant women with suspicious mental disorder
619776|NCT00942084|HSV|hsv
619777|NCT00942084|Acyclovir|acyclovir
619778|NCT00942084|Pharmacokinetics|pharmacokinetics
619779|NCT00942084|Neonate|neonate
619780|NCT00942084|Premature|premature
619781|NCT00942084|Sepsis|sepsis
619782|NCT00942071|Influenza|influenza
619783|NCT00942071|Vaccine|vaccine
619784|NCT00942058|biological markers|biological markers
619785|NCT00942058|CA9 protein|ca9 protein
619786|NCT00942058|metastatic conventional renal cell cancer|metastatic conventional renal cell cancer
619787|NCT00942058|kidney cancer|kidney cancer
619788|NCT00942045|cervical spine|cervical spine
619789|NCT00942045|ACDF|acdf
619790|NCT00942045|biologics|biologics
619791|NCT00942045|fusion rates|fusion rates
619792|NCT00942019|BMI|bmi
619793|NCT00942019|obesity|obesity
619794|NCT00942019|CO|co
619795|NCT00942019|tobacco smoking|tobacco smoking
619796|NCT00942019|adolescents|adolescents
619797|NCT00942006|Lyme neuroborreliosis|lyme neuroborreliosis
619798|NCT00942006|Lyme borreliosis|lyme borreliosis
619799|NCT00942006|erythema migrans|erythema migrans
619800|NCT00942006|doxycycline treatment|doxycycline treatment
619801|NCT00942006|ceftriaxone treatment|ceftriaxone treatment
619802|NCT00942006|outcome|outcome
619803|NCT00942006|subjective symptoms|subjective symptoms
619804|NCT00941980|biologics|biologics
619805|NCT00941980|fusion rates|fusion rates
619806|NCT00941980|PLIF|plif
619807|NCT00941980|lumbar fusion|lumbar fusion
619808|NCT00941967|adult primary hepatocellular carcinoma|adult primary hepatocellular carcinoma
619809|NCT00941967|localized unresectable adult primary liver cancer|localized unresectable adult primary liver cancer
619810|NCT00941967|recurrent adult primary liver cancer|recurrent adult primary liver cancer
619811|NCT00941967|advanced adult primary liver cancer|advanced adult primary liver cancer
619812|NCT00941954|Physical activity|physical activity
619813|NCT00941954|Diabetes|diabetes
619814|NCT00941954|Prevention|prevention
619815|NCT00941954|Pedometer|pedometer
619816|NCT00941954|Walking|walking
619817|NCT00941954|Structured education|structured education
619818|NCT00941954|Randomized|randomized
619819|NCT00941954|Risk score|risk score
619820|NCT00941954|Impaired glucose regulation|impaired glucose regulation
619821|NCT00941941|Inguinal|inguinal
619823|NCT00941941|Hernia-repair|hernia-repair
619824|NCT00941941|Non-mesh|non-mesh
619825|NCT00941941|Mesh|mesh
619826|NCT00941941|Desarda|desarda
619827|NCT00941941|Lichtenstein|lichtenstein
619828|NCT00941928|Blood And Marrow Transplantation|blood and marrow transplantation
619829|NCT00941928|Relapsed Acute Lymphoblastic Leukemia|relapsed acute lymphoblastic leukemia
619830|NCT00941928|ALL|all
619831|NCT00941928|Leukemia|leukemia
619832|NCT00941928|Pediatrics|pediatrics
619833|NCT00941928|Haploidentical NK cells|haploidentical nk cells
619834|NCT00941928|Cyclophosphamide|cyclophosphamide
619835|NCT00941928|Cytoxan|cytoxan
619836|NCT00941928|Neosar|neosar
619837|NCT00941928|Epratuzumab|epratuzumab
619838|NCT00941928|Fludarabine|fludarabine
619839|NCT00941928|Fludarabine Phosphate|fludarabine phosphate
619840|NCT00941928|Fludara|fludara
619841|NCT00941928|Interleukin-2|interleukin-2
619842|NCT00941928|IL-2|il-2
619843|NCT00941928|Proleukin|proleukin
619844|NCT00941928|Low-dose interleukin|low-dose interleukin
619845|NCT00941928|Mesna|mesna
619846|NCT00941928|Mesnex|mesnex
619847|NCT00941928|Natural Killer Cells|natural killer cells
619848|NCT00941928|NK Cells Transplant|nk cells transplant
619849|NCT00941915|CaP|cap
619850|NCT00941915|SBRT|sbrt
619851|NCT00941915|Prostate|prostate
619852|NCT00941915|ExacTrac|exactrac
619853|NCT00941915|Calypso|calypso
619854|NCT00941915|IMRT|imrt
619855|NCT00941915|Radiation|radiation
619856|NCT00941915|Cancer of Prostate|cancer of prostate
619857|NCT00941915|Prostatic Neoplasms|prostatic neoplasms
619858|NCT00941902|human asialoglycoprotein receptor (ASGPR)|human asialoglycoprotein receptor (asgpr)
619859|NCT00941902|hepatocytes|hepatocytes
619860|NCT00941902|bariatric surgery|bariatric surgery
619861|NCT00941889|HIV|hiv
619862|NCT00941889|HPV|hpv
619863|NCT00941889|Anal condylomata|anal condylomata
619864|NCT00941889|Vaccine|vaccine
619865|NCT00941889|HIV positive patients|hiv positive patients
619866|NCT00941889|Anal condylomata or anal warts|anal condylomata or anal warts
619867|NCT00941876|AE|ae
619868|NCT00941876|adverse event|adverse event
619869|NCT00941876|AIDS|aids
619870|NCT00941876|acquired immunodeficiency syndrome|acquired immunodeficiency syndrome
619871|NCT00941876|ALT (SGPT)|alt (sgpt)
619872|NCT00941876|alanine aminotransferase|alanine aminotransferase
619873|NCT00941876|ART|art
619874|NCT00941876|antiretroviral therapy|antiretroviral therapy
619875|NCT00941876|AST (SGOT)|ast (sgot)
619876|NCT00941876|aspartate aminotransferase|aspartate aminotransferase
619877|NCT00941876|DCF|dcf
619878|NCT00941876|data collection forms|data collection forms
619879|NCT00941876|DMC|dmc
619880|NCT00941876|Data Monitoring Committee|data monitoring committee
619881|NCT00941876|FDA|fda
619882|NCT00941876|(U.S.) Food and Drug Administration|(u.s.) food and drug administration
619883|NCT00941876|GCP|gcp
619884|NCT00941876|Good Clinical Practice guidelines|good clinical practice guidelines
619885|NCT00941876|HB sAg|hb sag
619886|NCT00941876|Hepatitis B surface antigen|hepatitis b surface antigen
619887|NCT00941876|ICH|ich
619888|NCT00941876|International Conference of Harmonisation|international conference of harmonisation
619889|NCT00941876|IND|ind
619890|NCT00941876|Investigational New Drug Application|investigational new drug application
619891|NCT00941876|IRB|irb
619892|NCT00941876|Institutional Review Board|institutional review board
619893|NCT00941876|IU|iu
619894|NCT00941876|International units|international units
619895|NCT00941876|mg|mg
619896|NCT00941876|milligram(s)|milligram(s)
619897|NCT00941876|mm3|mm3
619898|NCT00941876|cubic millimeter(s)|cubic millimeter(s)
619899|NCT00941876|PCR|pcr
619900|NCT00941876|polymerase chain reaction|polymerase chain reaction
619901|NCT00941876|SAE|sae
619902|NCT00941876|serious adverse event|serious adverse event
619903|NCT00941876|µg|µg
619904|NCT00941876|microgram|microgram
619906|NCT00941876|upper limit of the normal range|upper limit of the normal range
619907|NCT00941876|WB|wb
619908|NCT00941876|Western Blot|western blot
619909|NCT00941876|To inform the Ministry of Health strategy for integrating FP and HIV/AIDS Care and Treatment Services in Tanzania|to inform the ministry of health strategy for integrating fp and hiv/aids care and treatment services in tanzania
619910|NCT00941876|HIV seronegativity|hiv seronegativity
619911|NCT00941863|Sorafenib|sorafenib
619912|NCT00941863|Advanced Solid Tumors|advanced solid tumors
619913|NCT00941863|Maximum tolerated dose|maximum tolerated dose
619914|NCT00941863|Carboplatin and paclitaxel chemotherapy combination|carboplatin and paclitaxel chemotherapy combination
619915|NCT00941850|Cardiac resynchronizton therapy|cardiac resynchronizton therapy
619916|NCT00941850|CRT|crt
619917|NCT00941850|Heart failure|heart failure
619918|NCT00941850|Dyssynchrony|dyssynchrony
619919|NCT00941850|Echocardiography|echocardiography
619920|NCT00941850|Pacemakers|pacemakers
619921|NCT00941850|Nonresponders|nonresponders
619922|NCT00941837|Palm olein|palm olein
619923|NCT00941837|homocsyteine|homocsyteine
619924|NCT00941837|Cholesterol|cholesterol
619925|NCT00941837|lipoproteins|lipoproteins
619926|NCT00941837|Interleukins|interleukins
619927|NCT00941837|CRP|crp
619928|NCT00941837|Blood Pressure|blood pressure
619929|NCT00941837|Total homocystein|total homocystein
619930|NCT00941837|Serum lipid profile|serum lipid profile
619931|NCT00941837|Serum apolipoproteins|serum apolipoproteins
619932|NCT00941837|Inflammatory markers|inflammatory markers
619933|NCT00941824|pharmacokinetic|pharmacokinetic
619934|NCT00941824|mycophénolate acid|mycophénolate acid
619935|NCT00941824|kidney transplantation|kidney transplantation
619936|NCT00941798|Asthma|asthma
619937|NCT00941798|LABA|laba
619938|NCT00941798|Safety|safety
619939|NCT00941785|Malaria|malaria
619940|NCT00941785|Intermittent Preventive Treatment|intermittent preventive treatment
619941|NCT00941785|IPTc|iptc
619942|NCT00941785|sIPTc|siptc
619943|NCT00941785|Burkina Faso|burkina faso
619944|NCT00941772|Nasogastric tube verification with ultrasonography|nasogastric tube verification with ultrasonography
619945|NCT00941772|ultrasonography|ultrasonography
619946|NCT00941759|Breast|breast
619947|NCT00941759|Blood and tissue collection|blood and tissue collection
619948|NCT00941759|Epidemiologic|epidemiologic
619949|NCT00941759|Questionnaire|questionnaire
619950|NCT00941759|TBCRC (Translational Breast Cancer Research Consortium)|tbcrc (translational breast cancer research consortium)
619951|NCT00941759|09-056|09-056
619952|NCT00941733|BTK|btk
619953|NCT00941733|CLI|cli
619954|NCT00941733|PTA|pta
619955|NCT00941720|stage I multiple myeloma|stage i multiple myeloma
619956|NCT00941720|stage II multiple myeloma|stage ii multiple myeloma
619957|NCT00941720|stage III multiple myeloma|stage iii multiple myeloma
619958|NCT00941707|Rheumatoid Arthritis|rheumatoid arthritis
619959|NCT00941707|JNJ-38518168|jnj-38518168
619960|NCT00941694|asthma|asthma
619961|NCT00941694|aged|aged
619962|NCT00941694|self care|self care
619963|NCT00941681|omecamtiv mecarbil|omecamtiv mecarbil
619964|NCT00941655|Gastric Carcinoma|gastric carcinoma
619965|NCT00941655|Chemotherapy|chemotherapy
619966|NCT00941655|Liver Tumors|liver tumors
619967|NCT00941655|Peritoneal Tumors|peritoneal tumors
619968|NCT00941655|Metastatic Gastric Cancer|metastatic gastric cancer
619969|NCT00941655|Stomach Cancer|stomach cancer
619970|NCT00941655|Gastric Cancer|gastric cancer
619971|NCT00941642|Nonalcoholic Fatty Liver Disease (NAFLD)|nonalcoholic fatty liver disease (nafld)
619972|NCT00941642|Lovaza|lovaza
619973|NCT00941642|Steatosis|steatosis
619974|NCT00941642|Non-Alcoholic steatohepatitis (NASH)|non-alcoholic steatohepatitis (nash)
619975|NCT00941629|PTSD|ptsd
619976|NCT00941629|Telemedicine|telemedicine
619977|NCT00941629|Clinical Trial|clinical trial
619978|NCT00941629|Psychotherapy|psychotherapy
619979|NCT00941616|Von Willebrand Disease|von willebrand disease
619980|NCT00941590|tick borne encephalitis|tick borne encephalitis
619981|NCT00941590|clinical outcome|clinical outcome
619982|NCT00941590|postencephalitic symptoms|postencephalitic symptoms
619983|NCT00941577|Hypersensitivity|hypersensitivity
619984|NCT00941577|Lung Diseases, Obstructive|lung diseases, obstructive
619985|NCT00941577|Immune System Diseases|immune system diseases
619986|NCT00941577|Respiratory Tract Diseases|respiratory tract diseases
619987|NCT00941577|Bronchial Diseases|bronchial diseases
619988|NCT00941577|Lung Diseases|lung diseases
619989|NCT00941577|Hypersensitivity, Immediate|hypersensitivity, immediate
619990|NCT00941577|Asthma|asthma
619991|NCT00941577|Respiratory Hypersensitivity|respiratory hypersensitivity
619992|NCT00941551|Thyroid lobectomy,|thyroid lobectomy,
619993|NCT00941551|prophylactic levothyroxine treatment,|prophylactic levothyroxine treatment,
619994|NCT00941551|recurrent nodular goiter,|recurrent nodular goiter,
619995|NCT00941551|iodine deficiency,|iodine deficiency,
619996|NCT00941551|long-term follow-up,|long-term follow-up,
619997|NCT00941551|completion thyroidectomy|completion thyroidectomy
619998|NCT00941538|nasopharyngeal cancer|nasopharyngeal cancer
619999|NCT00941538|screening|screening
620000|NCT00941538|biomarker|biomarker
620001|NCT00941538|early detection|early detection
620002|NCT00941538|epidemiological survey|epidemiological survey
620003|NCT00941525|Central corneal thickness|central corneal thickness
620004|NCT00941525|24hour fluctuation of intraocular pressure|24hour fluctuation of intraocular pressure
620005|NCT00941525|Open angle glaucoma|open angle glaucoma
620006|NCT00941525|Ocular hypertension|ocular hypertension
620007|NCT00941512|Colposcopy|colposcopy
620008|NCT00941499|Advanced Cancers|advanced cancers
620009|NCT00941499|Liver|liver
620010|NCT00941499|Oxaliplatin|oxaliplatin
620011|NCT00941499|Eloxatin|eloxatin
620012|NCT00941499|Bevacizumab|bevacizumab
620013|NCT00941499|Avastin|avastin
620014|NCT00941499|Anit-VEGF monoclonal antibody|anit-vegf monoclonal antibody
620015|NCT00941499|rhuMAb-VEGF|rhumab-vegf
620016|NCT00941499|5-fluorouracil|5-fluorouracil
620017|NCT00941499|5-FU|5-fu
620018|NCT00941499|Adrucil|adrucil
620019|NCT00941499|Efudex|efudex
620020|NCT00941499|Leucovorin|leucovorin
620021|NCT00941499|Citrovorum|citrovorum
620022|NCT00941499|Wellcovorin|wellcovorin
620023|NCT00941499|Cetuximab|cetuximab
620024|NCT00941499|C225|c225
620025|NCT00941499|Erbitux|erbitux
620026|NCT00941499|IMC-C225|imc-c225
620027|NCT00941473|Epidural Injection|epidural injection
620028|NCT00941473|Bone Density|bone density
620029|NCT00941460|progressive or recurrent glioblastoma|progressive or recurrent glioblastoma
620030|NCT00941460|temozolomide|temozolomide
620031|NCT00941460|dose intensification|dose intensification
620032|NCT00941460|comparison of two dosing regimens|comparison of two dosing regimens
620033|NCT00941447|Type 2 Diabetes|type 2 diabetes
620034|NCT00941447|Obesity|obesity
620035|NCT00941447|Self-Regulation|self-regulation
620036|NCT00941447|Self-Efficacy|self-efficacy
620037|NCT00941434|RUTF|rutf
620038|NCT00941434|SAM|sam
620039|NCT00941434|Nutributter|nutributter
620040|NCT00941382|sibutramine|sibutramine
620041|NCT00941382|metformin|metformin
620042|NCT00941382|obesity|obesity
620043|NCT00941356|MRSA nasal colonisation|mrsa nasal colonisation
620044|NCT00941356|Probiotics|probiotics
620045|NCT00941330|Breast, Male|breast, male
620046|NCT00941330|Breast, Female|breast, female
620047|NCT00941317|onychomycosis|onychomycosis
620048|NCT00941317|micro-drilling|micro-drilling
620049|NCT00941291|idiopathic macular hole|idiopathic macular hole
620050|NCT00941291|cataract|cataract
620051|NCT00941291|edema|edema
620052|NCT00941291|Reopening|reopening
620053|NCT00941265|treatment of anomia|treatment of anomia
620054|NCT00941265|levodopa|levodopa
620055|NCT00941265|"patient with aphasia hospitalised at the Service de neurorehabilitation with presence of anomia"|"patient with aphasia hospitalised at the service de neurorehabilitation with presence of anomia"
620056|NCT00941239|Metformin ER|metformin er
620057|NCT00941239|Pharmacokinetics|pharmacokinetics
620058|NCT00941239|Tolerability|tolerability
620059|NCT00941239|Healthy volunteers|healthy volunteers
620060|NCT00941226|Cerebral Palsy|cerebral palsy
620061|NCT00941226|Caregivers|caregivers
620062|NCT00941226|Quality of Life|quality of life
620063|NCT00941213|fractures of vertebral bodies Th10-L2|fractures of vertebral bodies th10-l2
620064|NCT00941213|(AO A1 with kyphosis, A2.3, B or C-type)|(ao a1 with kyphosis, a2.3, b or c-type)
620065|NCT00941187|pulmonary embolism|pulmonary embolism
620066|NCT00941187|pulmonary capillary blood volume|pulmonary capillary blood volume
620067|NCT00941187|double diffusion NO/CO method|double diffusion no/co method
620068|NCT00941174|(13C5) Calcium Leucovorin|(13c5) calcium leucovorin
620069|NCT00941174|Folate absorption across the large intestine|folate absorption across the large intestine
620070|NCT00941174|Folate Bioavailability|folate bioavailability
620071|NCT00941122|MRSA, VRE|mrsa, vre
620072|NCT00941109|MDS|mds
620073|NCT00941096|Glaucoma|glaucoma
620074|NCT00941096|Ocular Hypertension|ocular hypertension
620075|NCT00941096|Lumigan|lumigan
620076|NCT00941096|Ganfort|ganfort
620077|NCT00941083|Simplification from protease inhibitors to raltegravir|simplification from protease inhibitors to raltegravir
620078|NCT00941083|Treatment Experienced|treatment experienced
620079|NCT00941083|HIV-1 Infections|hiv-1 infections
620080|NCT00941044|non-invasive ventilation|non-invasive ventilation
620081|NCT00941044|diaphragm|diaphragm
620082|NCT00941044|electrical activity|electrical activity
620083|NCT00941044|neurally adjusted ventilatory assist|neurally adjusted ventilatory assist
620084|NCT00941044|volunteers|volunteers
620085|NCT00941031|Moderate to severe chronic plaque-type psoriasis|moderate to severe chronic plaque-type psoriasis
620086|NCT00941031|AIN457|ain457
620087|NCT00941031|dermatology|dermatology
620088|NCT00941018|Resolvins|resolvins
620089|NCT00941018|RvE1|rve1
620090|NCT00941018|Healthy volunteers|healthy volunteers
620091|NCT00940979|Integuseal microbial sealant|integuseal microbial sealant
620092|NCT00940979|Infection prophylaxis|infection prophylaxis
620093|NCT00940979|Postoperative wound infection|postoperative wound infection
620094|NCT00940979|Arterial bypass surgery|arterial bypass surgery
620095|NCT00940966|ADA diet|ada diet
620096|NCT00940966|low carbohydrate diet|low carbohydrate diet
620097|NCT00940966|Metabolic syndrome|metabolic syndrome
620098|NCT00940927|Albuterol|albuterol
620099|NCT00940927|Forced expiratory volume in one second|forced expiratory volume in one second
620100|NCT00940927|Dose at fifty percent of maximum effect|dose at fifty percent of maximum effect
620101|NCT00940927|Maximum effective dose|maximum effective dose
620102|NCT00940927|Metered dose inhaler|metered dose inhaler
620103|NCT00940927|Nebulizer|nebulizer
620104|NCT00940914|Parkinson's disease|parkinson's disease
620105|NCT00940914|pain|pain
620106|NCT00940914|dopamine transporters imaging|dopamine transporters imaging
620107|NCT00940901|priapism|priapism
620108|NCT00940901|sickle cell disease|sickle cell disease
620109|NCT00940901|sildenafil|sildenafil
620110|NCT00940901|phosphodiesterase type 5 inhibitor|phosphodiesterase type 5 inhibitor
620111|NCT00940888|ICD|icd
620112|NCT00940888|CRTD|crtd
620113|NCT00940888|Heart Failure|heart failure
620114|NCT00940888|DF4|df4
620115|NCT00940862|psoriasis|psoriasis
620116|NCT00940862|vascular inflammation|vascular inflammation
620117|NCT00940862|coronary atherosclerosis|coronary atherosclerosis
620118|NCT00940836|Anti-cold|anti-cold
620119|NCT00940836|Cold preparation|cold preparation
620120|NCT00940836|RCT|rct
620121|NCT00940823|Glaucoma Drainage Device|glaucoma drainage device
620122|NCT00940823|Aqueous Shunt Implant|aqueous shunt implant
620123|NCT00940823|Ahmed Valve|ahmed valve
620124|NCT00940823|Baerveldt Tube|baerveldt tube
620125|NCT00940823|Refractory Glaucoma|refractory glaucoma
620126|NCT00940797|diabetes|diabetes
620127|NCT00940797|Type 2|type 2
620128|NCT00940797|monotherapy|monotherapy
620129|NCT00940797|antidiabetics|antidiabetics
620130|NCT00940797|metformin|metformin
620131|NCT00940771|HIV|hiv
620132|NCT00940771|Lipids|lipids
620133|NCT00940771|Atazanavir|atazanavir
620134|NCT00940771|Pediatric|pediatric
620135|NCT00940771|treatment experienced|treatment experienced
620136|NCT00940745|HICH|hich
620137|NCT00940745|Suction drainages|suction drainages
620138|NCT00940745|TTAC|ttac
620139|NCT00940732|Help-seeking|help-seeking
620140|NCT00940732|Mental Health|mental health
620141|NCT00940732|Athletes|athletes
620142|NCT00940719|Multiple Sclerosis|multiple sclerosis
620143|NCT00940719|Regulatory T cell function|regulatory t cell function
620144|NCT00940719|Vitamin D|vitamin d
620145|NCT00940719|Vitamin D3|vitamin d3
620146|NCT00940719|25-hydroxyvitamin D|25-hydroxyvitamin d
620147|NCT00940706|Cerebral Palsy|cerebral palsy
620148|NCT00940706|Activity monitoring|activity monitoring
620149|NCT00940706|Treadmill|treadmill
620150|NCT00940706|Group training|group training
620151|NCT00940706|Physical active life style|physical active life style
620152|NCT00940693|Attention Deficit Disorder with Hyperactivity|attention deficit disorder with hyperactivity
620153|NCT00940693|Duloxetine|duloxetine
620154|NCT00940693|Adult|adult
620155|NCT00940693|ADDH|addh
620156|NCT00940693|ADHD|adhd
620157|NCT00940680|Amlodipine|amlodipine
620158|NCT00940680|Losartan|losartan
620159|NCT00940680|hypertension|hypertension
620160|NCT00940667|Amlodipine|amlodipine
620161|NCT00940667|Losartan|losartan
620162|NCT00940667|hypertension|hypertension
620163|NCT00940654|Fever|fever
620164|NCT00940654|Antipyretic|antipyretic
620165|NCT00940654|Infection|infection
620166|NCT00940654|Mortality|mortality
620167|NCT00940654|Cooling|cooling
620168|NCT00940654|Non steroid anti inflammatory drugs|non steroid anti inflammatory drugs
620169|NCT00940654|Acetaminophen|acetaminophen
620170|NCT00940654|Steroid|steroid
620171|NCT00940654|ICU|icu
620172|NCT00940654|Intensive care|intensive care
620173|NCT00940654|Critically ill|critically ill
620174|NCT00940641|Healthy Volunteer|healthy volunteer
620175|NCT00940615|traumatic brain injury|traumatic brain injury
620176|NCT00940615|aerobic exercise|aerobic exercise
620177|NCT00940615|Diffusion Tensor Imaging|diffusion tensor imaging
620178|NCT00940615|Neuropsychology|neuropsychology
620179|NCT00940615|Rehabilitation|rehabilitation
620180|NCT00940602|TELESTO|telesto
620181|NCT00940602|MDS Study|mds study
620182|NCT00940602|Myelodysplastic Syndromes|myelodysplastic syndromes
620183|NCT00940602|Myelodysplastic Syndromes (low-int-1 risk)|myelodysplastic syndromes (low-int-1 risk)
620184|NCT00940589|Alzheimer's Disease|alzheimer's disease
620185|NCT00940589|Acetylcholinesterase inhibitor|acetylcholinesterase inhibitor
620186|NCT00940589|cognitive function|cognitive function
620187|NCT00940589|Circadin|circadin
620188|NCT00940589|Sleep disturbances|sleep disturbances
620189|NCT00940576|mare's milk, Crohn's disease, ulcerative colitis, clinical|mare's milk, crohn's disease, ulcerative colitis, clinical
620190|NCT00940563|GIST|gist
620191|NCT00940563|imatinib|imatinib
620192|NCT00940563|advanced GIST|advanced gist
620193|NCT00940537|Obese|obese
620194|NCT00940537|MRS|mrs
620195|NCT00940537|hepatic triglyceride content|hepatic triglyceride content
620196|NCT00940537|MR spectroscopy|mr spectroscopy
620197|NCT00940524|Leukemia|leukemia
620198|NCT00940524|ALL|all
620199|NCT00940524|ALLOPURINOL|allopurinol
620200|NCT00940524|CARMUSTINE (BCNU)|carmustine (bcnu)
620201|NCT00940524|CYCLOPHOSPHAMIDE (CYTOXAN)|cyclophosphamide (cytoxan)
620202|NCT00940524|CYTARABINE (ARA-C)|cytarabine (ara-c)
620203|NCT00940524|DACTINOMYCIN|dactinomycin
620204|NCT00940524|DASATINIB|dasatinib
620205|NCT00940524|DEXAMETHASONE|dexamethasone
620206|NCT00940524|DOXORUBICIN/ADRIAMYCIN|doxorubicin/adriamycin
620207|NCT00940524|ETOPOSIDE (VP-16)|etoposide (vp-16)
620208|NCT00940524|MERCAPTOPURINE|mercaptopurine
620209|NCT00940524|METHOTREXATE|methotrexate
620210|NCT00940524|MITOXANTRONE|mitoxantrone
620211|NCT00940524|PEGASPERGASE|pegaspergase
620212|NCT00940524|VINCRISTINE|vincristine
620213|NCT00940511|All conditions faced by disabled Medicaid recipients|all conditions faced by disabled medicaid recipients
620214|NCT00940498|Phase 1|phase 1
620215|NCT00940498|Dose Finding|dose finding
620216|NCT00940498|Solid Tumors|solid tumors
620217|NCT00940498|Tumors|tumors
620218|NCT00940498|PF-05212384|pf-05212384
620219|NCT00940472|type 2 diabetes|type 2 diabetes
620220|NCT00940472|monotherapy|monotherapy
620221|NCT00940472|antidiabetics|antidiabetics
620222|NCT00940472|metformin|metformin
620223|NCT00940459|contact lenses|contact lenses
620224|NCT00940459|conjunctival staining|conjunctival staining
620225|NCT00940459|contact lens wear|contact lens wear
620226|NCT00940446|Insorb staples|insorb staples
620227|NCT00940446|Metal Staples|metal staples
620228|NCT00940433|Minimally invasive|minimally invasive
620229|NCT00940433|Inguinal hernia|inguinal hernia
620230|NCT00940433|Pro-peritoneal repair|pro-peritoneal repair
620231|NCT00940407|dry AMD|dry amd
620232|NCT00940407|light treatment|light treatment
620233|NCT00940407|ARMD|armd
620234|NCT00940407|photobiomodulation|photobiomodulation
620235|NCT00940407|macular|macular
620236|NCT00940407|eye disease|eye disease
620237|NCT00940407|ageing eye disease|ageing eye disease
620238|NCT00940394|mutual support group|mutual support group
620239|NCT00940394|psychoeducation group|psychoeducation group
620240|NCT00940394|family caregivers|family caregivers
620241|NCT00940394|schizophrenia|schizophrenia
620242|NCT00940381|Advanced Malignancies|advanced malignancies
620243|NCT00940381|Sirolimus|sirolimus
620244|NCT00940381|Rapamune|rapamune
620245|NCT00940381|Cetuximab|cetuximab
620246|NCT00940381|C225|c225
620247|NCT00940381|Erbitux|erbitux
620248|NCT00940381|IMC-225|imc-225
620249|NCT00940368|Nausea|nausea
620250|NCT00940368|Vomiting|vomiting
620251|NCT00940368|Chemotherapy|chemotherapy
620252|NCT00940355|COPD|copd
620253|NCT00940355|Health Status|health status
620254|NCT00940355|Intervention|intervention
620255|NCT00940355|Secondary prevention|secondary prevention
620256|NCT00940355|patient-tailored treatment|patient-tailored treatment
620257|NCT00940342|Chronic Lymphocytic Leukemia|chronic lymphocytic leukemia
620258|NCT00940342|Rituximab|rituximab
620259|NCT00940342|Leukemia|leukemia
620260|NCT00940342|Sargramostim|sargramostim
620261|NCT00940342|GM-CSF|gm-csf
620262|NCT00940329|Drug interactions|drug interactions
620263|NCT00940329|Pharmacodynamic interactions|pharmacodynamic interactions
620264|NCT00940329|Pharmacokinetic interactions|pharmacokinetic interactions
620265|NCT00940329|Formoterol|formoterol
620266|NCT00940329|Healthy subjects|healthy subjects
620267|NCT00940329|Phase I study|phase i study
620268|NCT00940329|Roflumilast|roflumilast
620269|NCT00940316|recurrent colon cancer|recurrent colon cancer
620270|NCT00940316|stage IV colon cancer|stage iv colon cancer
620271|NCT00940316|recurrent rectal cancer|recurrent rectal cancer
620272|NCT00940316|stage IV rectal cancer|stage iv rectal cancer
620273|NCT00940290|practice guideline as topic|practice guideline as topic
620274|NCT00940290|decision making|decision making
620275|NCT00940290|evidence based medicine|evidence based medicine
620276|NCT00940277|women couples counseling groups support intervention marriage|women couples counseling groups support intervention marriage
620277|NCT00940264|symptomatic cholecystolithiasis|symptomatic cholecystolithiasis
620278|NCT00940251|Ayurvedic formulation|ayurvedic formulation
620279|NCT00940251|type 2 diabetes mellitus|type 2 diabetes mellitus
620280|NCT00940251|secondary failure to oral hypoglycemic agents|secondary failure to oral hypoglycemic agents
620281|NCT00940251|antidiabetic|antidiabetic
620282|NCT00940225|Breast Cancer|breast cancer
620283|NCT00940225|Melanoma|melanoma
620284|NCT00940225|Stomach or Gastroesophageal Junction Carcinoma|stomach or gastroesophageal junction carcinoma
620285|NCT00940225|Hepatocellular Carcinoma (HCC)|hepatocellular carcinoma (hcc)
620286|NCT00940225|Small Cell Lung Cancer (SCLC)|small cell lung cancer (sclc)
620287|NCT00940225|Non-Small Cell Lung Cancer (NSCLC)|non-small cell lung cancer (nsclc)
620288|NCT00940225|Ovarian Cancer|ovarian cancer
620289|NCT00940225|Pancreatic Cancer|pancreatic cancer
620290|NCT00940225|Prostate Cancer|prostate cancer
620291|NCT00940212|Safety|safety
620292|NCT00940212|tolerability|tolerability
620293|NCT00940212|healthy|healthy
620294|NCT00940212|pharmacokinetics|pharmacokinetics
620295|NCT00940199|Breast cancer, sentinel lymph node mapping, biopsy|breast cancer, sentinel lymph node mapping, biopsy
620296|NCT00940173|xenotransplantation|xenotransplantation
620297|NCT00940173|type I diabetes|type i diabetes
620298|NCT00940173|porcine islets|porcine islets
620299|NCT00940160|Asthma|asthma
620300|NCT00940134|obesity|obesity
620301|NCT00940134|energy expenditure|energy expenditure
620302|NCT00940134|incretins|incretins
620303|NCT00940134|appetite regulation|appetite regulation
620305|NCT00940134|PYY|pyy
620306|NCT00940134|ad libitum energy intake|ad libitum energy intake
620307|NCT00940121|oral administration|oral administration
620308|NCT00940121|YM178|ym178
620309|NCT00940121|IV infusion|iv infusion
620310|NCT00940121|pharmacokinetics|pharmacokinetics
620311|NCT00940121|mirabegron|mirabegron
620312|NCT00940121|Healthy volunteer subjects|healthy volunteer subjects
620313|NCT00940095|Subarachnoid|subarachnoid
620314|NCT00940095|Aneurysmal|aneurysmal
620315|NCT00940095|surgical clipping|surgical clipping
620316|NCT00940095|PIVLAZ|pivlaz
620317|NCT00940095|vasospasm|vasospasm
620318|NCT00940095|cerebral vasospasm|cerebral vasospasm
620319|NCT00940095|clazosentan|clazosentan
620320|NCT00940095|Actelion|actelion
620321|NCT00940095|Hemorrhage|hemorrhage
620322|NCT00940082|Diabetes;|diabetes;
620323|NCT00940082|Echocardiography;|echocardiography;
620324|NCT00940082|High-sensitive C-reactive protein;|high-sensitive c-reactive protein;
620325|NCT00940082|homocysteine;|homocysteine;
620326|NCT00940082|TNF-α|tnf-α
620327|NCT00940069|TS|ts
620328|NCT00940069|polymorphism|polymorphism
620329|NCT00940069|lung cancer|lung cancer
620330|NCT00940069|adenocarcinoma|adenocarcinoma
620331|NCT00940069|pemetrexed|pemetrexed
620332|NCT00940056|Atrial fibrillation|atrial fibrillation
620333|NCT00940056|Ablation|ablation
620334|NCT00940056|Thoracoscopy|thoracoscopy
620335|NCT00940056|Atrial function|atrial function
620336|NCT00940043|bedside test|bedside test
620337|NCT00940043|interleukins|interleukins
620338|NCT00940043|inflammation|inflammation
620339|NCT00940043|vaginal secretions|vaginal secretions
620340|NCT00940030|Mechanical Bowel Preparation (MBP)|mechanical bowel preparation (mbp)
620341|NCT00940030|enema|enema
620342|NCT00940017|PK|pk
620343|NCT00940017|fungal infection|fungal infection
620344|NCT00940004|dendritic cell vaccination|dendritic cell vaccination
620345|NCT00940004|melanoma|melanoma
620346|NCT00940004|toll like receptor ligands|toll like receptor ligands
620347|NCT00940004|vaccines|vaccines
620348|NCT00939991|GBM|gbm
620349|NCT00939965|localized unresectable neuroblastoma|localized unresectable neuroblastoma
620350|NCT00939965|recurrent neuroblastoma|recurrent neuroblastoma
620351|NCT00939965|stage 4S neuroblastoma|stage 4s neuroblastoma
620352|NCT00939952|ertapenem|ertapenem
620353|NCT00939952|CAPD|capd
620354|NCT00939952|dialysis|dialysis
620355|NCT00939913|contrast nephropathy|contrast nephropathy
620356|NCT00939913|intravenous n-acetlycysteine|intravenous n-acetlycysteine
620357|NCT00939900|avascular necrosis of femoral head|avascular necrosis of femoral head
620358|NCT00939900|bisphosphonate|bisphosphonate
620359|NCT00939900|collapse|collapse
620360|NCT00939874|HIV+|hiv+
620361|NCT00939874|Raltegravir|raltegravir
620362|NCT00939874|Tenofovir|tenofovir
620363|NCT00939874|osteopenia|osteopenia
620364|NCT00939874|osteoporosis|osteoporosis
620365|NCT00939874|bone markers|bone markers
620366|NCT00939874|treatment experienced|treatment experienced
620367|NCT00939861|colorectal endometriosis, laparoscopy, laparotomy|colorectal endometriosis, laparoscopy, laparotomy
620368|NCT00939861|gynecologic and digestive symptoms|gynecologic and digestive symptoms
620369|NCT00939861|quality of life (SF-36 questionnaire)|quality of life (sf-36 questionnaire)
620370|NCT00939861|morbidity|morbidity
620371|NCT00939861|fertility|fertility
620372|NCT00939848|Disease-Free Survival|disease-free survival
620373|NCT00939757|Healthy volunteer subjects|healthy volunteer subjects
620374|NCT00939757|pharmacokinetics|pharmacokinetics
620375|NCT00939757|YM178|ym178
620376|NCT00939757|mirabegron|mirabegron
620377|NCT00939757|food|food
620378|NCT00939744|contractile activity|contractile activity
620379|NCT00939744|eicosanoids|eicosanoids
620380|NCT00939744|pregnant women|pregnant women
620381|NCT00939744|obstetrics complications|obstetrics complications
620382|NCT00939731|bioavailability, capsule, tablet, healthy volunteer|bioavailability, capsule, tablet, healthy volunteer
620383|NCT00939718|depression;vitamin B12;randomized control trial|depression;vitamin b12;randomized control trial
620384|NCT00939679|obesity|obesity
620385|NCT00939679|bariatric surgery|bariatric surgery
620386|NCT00939679|energy expenditure|energy expenditure
620387|NCT00939679|incretins|incretins
620388|NCT00939679|appetite regulation|appetite regulation
620389|NCT00939679|body composition|body composition
620390|NCT00939679|GLP-1|glp-1
620391|NCT00939666|Rectal cancer|rectal cancer
620392|NCT00939666|Chemoradiation|chemoradiation
620393|NCT00939666|Response|response
620394|NCT00939666|Wait-and-see policy|wait-and-see policy
620395|NCT00939666|Transanal endoscopic microsurgery|transanal endoscopic microsurgery
620396|NCT00939653|relapsed|relapsed
620397|NCT00939653|relapse|relapse
620398|NCT00939653|refractory|refractory
620399|NCT00939653|AML|aml
620400|NCT00939653|Acute myelogenous leukemia|acute myelogenous leukemia
620401|NCT00939653|Relapsed AML|relapsed aml
620402|NCT00939640|Diet|diet
620403|NCT00939640|Sodium|sodium
620404|NCT00939640|Hypertension|hypertension
620405|NCT00939640|Potassium|potassium
620406|NCT00939640|Antioxidants|antioxidants
620407|NCT00939640|congestive heart failure|congestive heart failure
620408|NCT00939640|Heart failure with normal ejection fraction|heart failure with normal ejection fraction
620409|NCT00939640|Heart failure with preserved systolic function|heart failure with preserved systolic function
620410|NCT00939601|Obstructive Sleep Apnea|obstructive sleep apnea
620411|NCT00939601|OSA|osa
620412|NCT00939601|Adherence|adherence
620413|NCT00939601|CPAP|cpap
620414|NCT00939601|Cognition|cognition
620415|NCT00939588|Aliskiren,|aliskiren,
620416|NCT00939588|hypertension,|hypertension,
620417|NCT00939588|renin-angiotensin-aldosterone system|renin-angiotensin-aldosterone system
620418|NCT00939575|preeclampsia, metabolomics, blood, urine|preeclampsia, metabolomics, blood, urine
620419|NCT00939562|Bioequivalence|bioequivalence
620420|NCT00939549|High dose cyclophosphamide|high dose cyclophosphamide
620421|NCT00939523|recurrent nonfunctioning adenoma|recurrent nonfunctioning adenoma
620422|NCT00939523|prolactinomas|prolactinomas
620423|NCT00939523|resistant pituitary tumors|resistant pituitary tumors
620424|NCT00939523|aggressive pituitary tumors|aggressive pituitary tumors
620425|NCT00939523|malignant pituitary adenomas|malignant pituitary adenomas
620426|NCT00939510|adenocarcinoma of the prostate|adenocarcinoma of the prostate
620427|NCT00939510|hormone-resistant prostate cancer|hormone-resistant prostate cancer
620428|NCT00939510|recurrent prostate cancer|recurrent prostate cancer
620429|NCT00939510|stage IV prostate cancer|stage iv prostate cancer
620430|NCT00939432|incontinence|incontinence
620431|NCT00939432|urinary|urinary
620432|NCT00939432|taboo|taboo
620433|NCT00939432|shame|shame
620434|NCT00939432|embarrassment|embarrassment
620435|NCT00939432|treatment|treatment
620436|NCT00939432|depression|depression
620437|NCT00939432|cancer|cancer
620438|NCT00939419|Tuberculosis care|tuberculosis care
620439|NCT00939419|community tuberculosis care|community tuberculosis care
620440|NCT00939419|Health facility based tuberculosis care|health facility based tuberculosis care
620441|NCT00939380|hematopoietic stem cell transplant|hematopoietic stem cell transplant
620442|NCT00939380|bone marrow transplant|bone marrow transplant
620443|NCT00939380|children|children
620444|NCT00939380|parents|parents
620445|NCT00939380|counseling|counseling
620446|NCT00939380|depression|depression
620447|NCT00939354|Asthma in subjects over the age of 65|asthma in subjects over the age of 65
620448|NCT00939341|Symbicort SMART|symbicort smart
620449|NCT00939328|B-cell chronic lymphocytic leukemia|b-cell chronic lymphocytic leukemia
620450|NCT00939328|refractory chronic lymphocytic leukemia|refractory chronic lymphocytic leukemia
620451|NCT00939315|Glioma, diagnosis|glioma, diagnosis
620452|NCT00939315|Imaging|imaging
620453|NCT00939315|Positron emission tomography|positron emission tomography
620454|NCT00939315|Magnetic resonance imaging|magnetic resonance imaging
620455|NCT00939315|Magnetic resonance spectroscopy|magnetic resonance spectroscopy
620456|NCT00939289|Continuous glucose monitoring|continuous glucose monitoring
620457|NCT00939276|cataract surgery|cataract surgery
620458|NCT00939276|macular edema|macular edema
620459|NCT00939276|prevention|prevention
620460|NCT00939263|deglutition disorders|deglutition disorders
620461|NCT00939263|esophageal diseases|esophageal diseases
620462|NCT00939263|eosinophilia|eosinophilia
620463|NCT00939250|Diabetes|diabetes
620464|NCT00939250|Depression|depression
620465|NCT00939250|Disease Self Management|disease self management
620466|NCT00939250|Measurement Based Care|measurement based care
620467|NCT00939237|Coronary heart disease|coronary heart disease
620468|NCT00939237|Carotid intima-media thickness|carotid intima-media thickness
620469|NCT00939237|Biomarkers|biomarkers
620470|NCT00939224|Near-infrared spectroscopy (NIRS)|near-infrared spectroscopy (nirs)
620471|NCT00939224|Regional oxygen saturation|regional oxygen saturation
620472|NCT00939224|Pediatrics|pediatrics
620473|NCT00939224|Cardiac catheterization|cardiac catheterization
620474|NCT00939224|Congenital heart disease|congenital heart disease
620475|NCT00939211|Chronic Obstructive Pulmonary Disease (COPD)|chronic obstructive pulmonary disease (copd)
620476|NCT00939211|efficacy|efficacy
620477|NCT00939211|safety|safety
620478|NCT00939211|inhalation|inhalation
620479|NCT00939211|long-acting muscarinic receptor antagonist (LAMA)|long-acting muscarinic receptor antagonist (lama)
620480|NCT00939198|Hookworm|hookworm
620481|NCT00939198|Allergy|allergy
620482|NCT00939198|Vaccine|vaccine
620483|NCT00939198|Skin Test|skin test
620484|NCT00939198|Immediate-type hypersensitivity to Na-ASP-2 hookworm antigen|immediate-type hypersensitivity to na-asp-2 hookworm antigen
620485|NCT00939185|Compliance and Safety Study in Children with Upper and Lower Respiratory Tract Infections|compliance and safety study in children with upper and lower respiratory tract infections
620486|NCT00939172|Advanced Refractory Solid Malignancies|advanced refractory solid malignancies
620487|NCT00939172|Solid tumor|solid tumor
620488|NCT00939172|Lymphoma|lymphoma
620489|NCT00939172|TTP607|ttp607
620490|NCT00939159|Low or Intermediate-1 Risk Myelodysplastic Syndrome|low or intermediate-1 risk myelodysplastic syndrome
620491|NCT00939159|MDS|mds
620492|NCT00939159|Cancer|cancer
620493|NCT00939159|LBH589|lbh589
620494|NCT00939146|self management|self management
620495|NCT00939146|quality of life|quality of life
620496|NCT00939146|end of life|end of life
620497|NCT00939133|acne|acne
620498|NCT00939133|tretinoin|tretinoin
620499|NCT00939133|isotretinoin|isotretinoin
620500|NCT00939133|recurrence|recurrence
620501|NCT00939133|Retin A micro|retin a micro
620502|NCT00939120|Benign prostatic hyperplasia (BPH)|benign prostatic hyperplasia (bph)
620503|NCT00939120|dutasteride|dutasteride
620504|NCT00939120|tolterodine ER|tolterodine er
620505|NCT00939107|low back pain|low back pain
620506|NCT00939107|Intervertebral disc|intervertebral disc
620507|NCT00939107|McKenzie|mckenzie
620508|NCT00939107|Physical Therapy|physical therapy
620509|NCT00939107|Spinal manipulation|spinal manipulation
620510|NCT00939107|Chiropractics|chiropractics
620511|NCT00939107|Patient education|patient education
620512|NCT00939107|Exercise therapy|exercise therapy
620513|NCT00939107|Random allocation|random allocation
620514|NCT00939094|Pain, Mechanical Hypersensitivity|pain, mechanical hypersensitivity
620515|NCT00939094|Allodynia|allodynia
620516|NCT00939094|Efficacy|efficacy
620517|NCT00939094|analgesia|analgesia
620518|NCT00939094|Neuropathic|neuropathic
620519|NCT00939081|Obesity|obesity
620520|NCT00939081|Women's health|women's health
620521|NCT00939081|Minority health|minority health
620522|NCT00939081|Obesity prevention|obesity prevention
620523|NCT00939068|Chronic hepatitis B, Telbivudine, Intrauterine transmission|chronic hepatitis b, telbivudine, intrauterine transmission
620524|NCT00939029|tobacco use|tobacco use
620525|NCT00939029|smokeless tobacco|smokeless tobacco
620526|NCT00939029|chewing tobacco|chewing tobacco
620527|NCT00939029|snuff|snuff
620528|NCT00939029|nicotine replacement|nicotine replacement
620529|NCT00939029|tobacco dependence|tobacco dependence
620530|NCT00939029|tobacco cessation|tobacco cessation
620531|NCT00939029|tobacco abstinence|tobacco abstinence
620532|NCT00939016|Dietary Assessment|dietary assessment
620533|NCT00939016|24-hour dietary recall|24-hour dietary recall
620534|NCT00939016|Dietary Restraint|dietary restraint
620535|NCT00939016|Social Desirability|social desirability
620536|NCT00939016|Portion estimation|portion estimation
620537|NCT00939016|Underreporting|underreporting
711891|NCT00582686|Iliac Crest Bone Grafting|iliac crest bone grafting
620538|NCT00938977|Obesity Hypoventilation syndrome|obesity hypoventilation syndrome
620539|NCT00938977|cytokines|cytokines
620540|NCT00938977|Adipokines|adipokines
620541|NCT00938977|continuous positive airway pressure|continuous positive airway pressure
620542|NCT00938977|bilevel support ventilation|bilevel support ventilation
620543|NCT00938977|Response to continuous positive airway pressure|response to continuous positive airway pressure
620544|NCT00938964|Cognition|cognition
620545|NCT00938951|Dry Eye|dry eye
620546|NCT00938951|Visual Performance|visual performance
620547|NCT00938938|risk communication|risk communication
620548|NCT00938938|medical reporting|medical reporting
620549|NCT00938938|Mass media|mass media
620550|NCT00938925|aggressive debridement|aggressive debridement
620551|NCT00938925|nail lacquer|nail lacquer
620552|NCT00938925|onychomycosis|onychomycosis
620553|NCT00938925|podiatry|podiatry
620554|NCT00938925|chiropody|chiropody
620555|NCT00938925|podiatry care|podiatry care
620556|NCT00938912|Lacosamide (VIMPAT)|lacosamide (vimpat)
620557|NCT00938899|TMC435350-TiDP16-C101|tmc435350-tidp16-c101
620558|NCT00938899|TMC435350-C101|tmc435350-c101
620559|NCT00938899|TMC435350|tmc435350
620560|NCT00938899|HCV|hcv
620561|NCT00938873|MBCT|mbct
620562|NCT00938873|identity|identity
620563|NCT00938873|depression|depression
620564|NCT00938873|recurrent|recurrent
620565|NCT00938873|homework|homework
620566|NCT00938860|Hepatitis C|hepatitis c
620567|NCT00938860|liver transplantation|liver transplantation
620568|NCT00938860|anti-viral therapy|anti-viral therapy
620569|NCT00938847|left ventricular dysfunction|left ventricular dysfunction
620570|NCT00938847|myocardial infarction|myocardial infarction
620571|NCT00938847|left ventricular dysfunction (LVDF) after acute myocardial infarction|left ventricular dysfunction (lvdf) after acute myocardial infarction
620572|NCT00938808|Osteoarthritis|osteoarthritis
620573|NCT00938808|Obesity|obesity
620574|NCT00938808|Weight loss|weight loss
620575|NCT00938808|Dietary instruction|dietary instruction
620576|NCT00938808|Formula diet|formula diet
620577|NCT00938808|Attention|attention
620578|NCT00938795|liver disease|liver disease
620579|NCT00938795|uncertainty|uncertainty
620580|NCT00938795|self management|self management
620581|NCT00938769|cancer|cancer
620582|NCT00938769|caregiver|caregiver
620583|NCT00938769|symptom|symptom
620584|NCT00938769|self management|self management
620585|NCT00938756|leptomeningeal metastases|leptomeningeal metastases
620586|NCT00938756|male breast cancer|male breast cancer
620587|NCT00938756|stage IV breast cancer|stage iv breast cancer
620588|NCT00938756|tumors metastatic to brain|tumors metastatic to brain
620589|NCT00938756|adult meningioma|adult meningioma
620590|NCT00938743|ADHD|adhd
620591|NCT00938743|adults|adults
620592|NCT00938743|driving performance|driving performance
620593|NCT00938743|atomoxetine|atomoxetine
620594|NCT00938730|Nonvalvular Atrial Fibrillation (NVAF)|nonvalvular atrial fibrillation (nvaf)
620595|NCT00938730|Factor Xa Inhibitor|factor xa inhibitor
620596|NCT00938730|Stroke|stroke
620597|NCT00938730|Thromboembolism|thromboembolism
620598|NCT00938730|Transient Ischemic attack|transient ischemic attack
620599|NCT00938730|Anticoagulants|anticoagulants
620600|NCT00938730|Prevention|prevention
620601|NCT00938730|YM150|ym150
620602|NCT00938730|Warfarin|warfarin
620603|NCT00938717|IBS|ibs
620604|NCT00938691|Scar|scar
620605|NCT00938691|Appearance|appearance
620606|NCT00938691|Spread|spread
620607|NCT00938678|Healthy volunteers|healthy volunteers
620608|NCT00938665|Alzheimer|alzheimer
620609|NCT00938665|Memory disorder|memory disorder
620610|NCT00938665|dementia|dementia
620611|NCT00938665|cognitive behavioral decline|cognitive behavioral decline
620612|NCT00938665|vascular dementia|vascular dementia
620613|NCT00938665|front temporal dementia|front temporal dementia
620614|NCT00938652|triple negative breast cancer|triple negative breast cancer
620615|NCT00938652|metastatic breast cancer|metastatic breast cancer
620616|NCT00938652|Triple negative metastatic breast cancer|triple negative metastatic breast cancer
620617|NCT00938626|refractory multiple myeloma|refractory multiple myeloma
620618|NCT00938626|stage I multiple myeloma|stage i multiple myeloma
620619|NCT00938626|stage II multiple myeloma|stage ii multiple myeloma
620620|NCT00938626|stage III multiple myeloma|stage iii multiple myeloma
620621|NCT00938613|SAR|sar
620622|NCT00938600|pharmacokinetics|pharmacokinetics
620623|NCT00938600|safety|safety
620624|NCT00938587|Rheumatoid Arthritis Glucocorticoids Prednisone|rheumatoid arthritis glucocorticoids prednisone
620625|NCT00938561|Chronic Kidney Disease|chronic kidney disease
620626|NCT00938561|Glomerular Filtration Rate|glomerular filtration rate
620627|NCT00938561|Kidney function|kidney function
620628|NCT00938561|Markers|markers
620629|NCT00938548|mastectomy|mastectomy
620630|NCT00938548|pain, postoperative|pain, postoperative
620631|NCT00938548|pregabalin|pregabalin
620632|NCT00938535|Obesity|obesity
620633|NCT00938535|Women's health|women's health
620634|NCT00938535|Minority health|minority health
620635|NCT00938535|Obesity prevention|obesity prevention
620636|NCT00938522|Cilostazol loading|cilostazol loading
712087|NCT00581789|non small cell lung cancer|non small cell lung cancer
620637|NCT00938522|Angioplasty, Transluminal, Percutaneous Coronary|angioplasty, transluminal, percutaneous coronary
620638|NCT00938509|IBUPROFEN|ibuprofen
620639|NCT00938509|CHILDREN|children
620640|NCT00938509|FEVER|fever
620641|NCT00938483|infant formula|infant formula
620642|NCT00938483|cow's milk allergy|cow's milk allergy
620643|NCT00938470|adenocarcinoma of the esophagus|adenocarcinoma of the esophagus
620644|NCT00938470|adenocarcinoma of the gastroesophageal junction|adenocarcinoma of the gastroesophageal junction
620645|NCT00938470|stage IIIA gastric cancer|stage iiia gastric cancer
620646|NCT00938470|stage IIIB gastric cancer|stage iiib gastric cancer
620647|NCT00938470|stage IIIC gastric cancer|stage iiic gastric cancer
620648|NCT00938470|stage IIIA esophageal cancer|stage iiia esophageal cancer
620649|NCT00938470|stage IIIB esophageal cancer|stage iiib esophageal cancer
620650|NCT00938470|stage IIIC esophageal cancer|stage iiic esophageal cancer
620651|NCT00938457|protocol specific|protocol specific
620652|NCT00938444|Patients with moderate to severe RA|patients with moderate to severe ra
620653|NCT00938431|Lacosamide|lacosamide
620654|NCT00938431|Vimpat|vimpat
620655|NCT00938431|Children|children
620656|NCT00938431|Epilepsy|epilepsy
620657|NCT00938431|Seizures|seizures
620658|NCT00938431|Anti-epileptic|anti-epileptic
620659|NCT00938405|type 1 diabetes mellitus|type 1 diabetes mellitus
620660|NCT00938405|colesevelam|colesevelam
620661|NCT00938405|LDL|ldl
620662|NCT00938405|cholesterol|cholesterol
620663|NCT00938405|A1c|a1c
620664|NCT00938405|target range glucose values|target range glucose values
620665|NCT00938392|influenza infection|influenza infection
620666|NCT00938392|GSK Bio's influenza vaccine GSK2186877A|gsk bio's influenza vaccine gsk2186877a
620667|NCT00938379|mosquito|mosquito
620668|NCT00938379|repellent|repellent
620669|NCT00938379|vector control|vector control
620670|NCT00938379|malaria|malaria
620671|NCT00938353|Moderate croup (Westley score 3-8)|moderate croup (westley score 3-8)
620672|NCT00938340|Cardiovascular Disease|cardiovascular disease
620673|NCT00938327|Gastroenteritis|gastroenteritis
620674|NCT00938301|healthy volunteer, first in human, safety and tolerability|healthy volunteer, first in human, safety and tolerability
620675|NCT00938288|Antithrombin|antithrombin
620676|NCT00938288|Thrombosis|thrombosis
620677|NCT00938288|Pharmacokinetics|pharmacokinetics
620678|NCT00938288|Hereditary Antithrombin Deficiency|hereditary antithrombin deficiency
620679|NCT00938288|Congenital Antithrombin Deficiency|congenital antithrombin deficiency
620680|NCT00938249|Moderately Elevated Serum Triglyceride|moderately elevated serum triglyceride
620681|NCT00938236|lung transplant|lung transplant
620682|NCT00938236|lung transplant recipient|lung transplant recipient
620683|NCT00938236|bronchiolitis obliterans syndrome|bronchiolitis obliterans syndrome
620684|NCT00938236|bronchiolitis obliterans|bronchiolitis obliterans
620685|NCT00938236|single lung transplant|single lung transplant
620686|NCT00938236|double lung transplant|double lung transplant
620687|NCT00938236|heart-lung transplant|heart-lung transplant
620688|NCT00938236|Aerosol|aerosol
620689|NCT00938223|melanoma|melanoma
620690|NCT00938223|peptide|peptide
620691|NCT00938223|vaccine|vaccine
620692|NCT00938223|adjuvant|adjuvant
620693|NCT00938223|advanced|advanced
620694|NCT00938210|Colonic surgery|colonic surgery
620695|NCT00938210|Postoperative care|postoperative care
620696|NCT00938210|Fatigue|fatigue
620697|NCT00938210|Physical function|physical function
620698|NCT00938210|Quality of life|quality of life
620699|NCT00938197|Fimasartan|fimasartan
620700|NCT00938197|Drug interaction|drug interaction
620701|NCT00938184|tolerance|tolerance
620702|NCT00938184|single dose|single dose
620703|NCT00938184|paroxetine|paroxetine
620704|NCT00938184|controlled-release tablet|controlled-release tablet
620705|NCT00938184|safety|safety
620706|NCT00938184|pharmacokinetics|pharmacokinetics
620707|NCT00938184|Japanese healthy male subjects|japanese healthy male subjects
620708|NCT00938171|Cytokine|cytokine
620709|NCT00938171|Anesthesia|anesthesia
620710|NCT00938171|Local anesthesia|local anesthesia
620711|NCT00938171|surgery|surgery
620712|NCT00938171|breast cancer|breast cancer
620713|NCT00938158|albiglutide|albiglutide
620714|NCT00938158|hemodialysis|hemodialysis
620715|NCT00938158|pharmacokinetics|pharmacokinetics
620716|NCT00938158|renal|renal
620717|NCT00938145|recurrent bladder cancer|recurrent bladder cancer
620718|NCT00938145|stage II bladder cancer|stage ii bladder cancer
620719|NCT00938145|stage III bladder cancer|stage iii bladder cancer
620720|NCT00938145|stage IV bladder cancer|stage iv bladder cancer
620721|NCT00938132|fimasartan|fimasartan
620722|NCT00938132|drug interaction|drug interaction
620723|NCT00938119|Cardiovascular disease|cardiovascular disease
620724|NCT00938119|Diabetes|diabetes
620725|NCT00938106|Intra-uterine Brachytherapy|intra-uterine brachytherapy
620726|NCT00938106|cervix cancer|cervix cancer
620727|NCT00938106|Patients suitable for intra-uterine brachytherapy for invasive carcinoma of the cervix.|patients suitable for intra-uterine brachytherapy for invasive carcinoma of the cervix.
620728|NCT00938067|Injuries, Trauma|injuries, trauma
620729|NCT00938054|Outcome|outcome
620730|NCT00938054|Autism|autism
712088|NCT00581789|sunitinib|sunitinib
620731|NCT00938054|Pervasive Developmental Disorder|pervasive developmental disorder
620732|NCT00938028|microbiome|microbiome
620733|NCT00938028|metabolome|metabolome
620734|NCT00938028|stool|stool
620735|NCT00938028|fecal samples|fecal samples
620736|NCT00938028|handling|handling
620737|NCT00938028|toddler|toddler
620738|NCT00938015|postmarketing surveillance|postmarketing surveillance
620739|NCT00938015|Enbrel|enbrel
620740|NCT00938015|psoriatic arthritis|psoriatic arthritis
620741|NCT00937989|ductal breast carcinoma in situ|ductal breast carcinoma in situ
620742|NCT00937989|lobular breast carcinoma in situ|lobular breast carcinoma in situ
620743|NCT00937989|male breast cancer|male breast cancer
620744|NCT00937989|stage I breast cancer|stage i breast cancer
620745|NCT00937989|stage II breast cancer|stage ii breast cancer
620746|NCT00937989|stage IIIA breast cancer|stage iiia breast cancer
620747|NCT00937989|stage IIIB breast cancer|stage iiib breast cancer
620748|NCT00937989|stage IIIC breast cancer|stage iiic breast cancer
620749|NCT00937976|Hemodialysis and peritoneal dialysis|hemodialysis and peritoneal dialysis
620750|NCT00937963|cholesterol|cholesterol
620751|NCT00937963|cardiovascular|cardiovascular
620752|NCT00937963|CVD|cvd
620753|NCT00937963|Triglycerides|triglycerides
620754|NCT00937963|Heart|heart
620755|NCT00937950|HPV|hpv
620756|NCT00937950|Papillomavirus|papillomavirus
620757|NCT00937950|Human papillomavirus|human papillomavirus
620758|NCT00937950|Cervical cancer|cervical cancer
620759|NCT00937950|HPV vaccine|hpv vaccine
620760|NCT00937924|EUS|eus
620761|NCT00937924|ERCP|ercp
620762|NCT00937924|Sedation Level|sedation level
620763|NCT00937924|Adverse Symptoms|adverse symptoms
620764|NCT00937924|Recovery time|recovery time
620765|NCT00937911|YM150|ym150
620766|NCT00937911|Bleeding|bleeding
620767|NCT00937911|Anticoagulant|anticoagulant
620768|NCT00937911|Venous thromboembolism|venous thromboembolism
620769|NCT00937911|FXa inhibitor|fxa inhibitor
620770|NCT00937898|lean beef|lean beef
620771|NCT00937898|cholesterol|cholesterol
620772|NCT00937898|lipids|lipids
620773|NCT00937898|diet intervention|diet intervention
620774|NCT00937885|Reminiscence|reminiscence
620775|NCT00937885|Nursing home staff|nursing home staff
620776|NCT00937885|Nursing home residents|nursing home residents
620777|NCT00937885|Elderly|elderly
620778|NCT00937846|Cognitive impairment|cognitive impairment
620779|NCT00937846|Schizophrenia|schizophrenia
620780|NCT00937846|Alzheimer's Disease|alzheimer's disease
620781|NCT00937846|PET|pet
620782|NCT00937833|prostate cancer|prostate cancer
620783|NCT00937833|prostatectomy|prostatectomy
620784|NCT00937833|incontinence|incontinence
620785|NCT00937820|YM150|ym150
620786|NCT00937820|Bleeding|bleeding
620787|NCT00937820|VTE|vte
620788|NCT00937820|FXa inhibitor|fxa inhibitor
620789|NCT00937820|Venous thromboembolism|venous thromboembolism
620790|NCT00937807|hemodynamic stability|hemodynamic stability
620791|NCT00937807|xenon|xenon
620792|NCT00937807|carotid surgery|carotid surgery
620793|NCT00937807|general anesthesia|general anesthesia
621156|NCT00936572|Microbiota|microbiota
620794|NCT00937781|stage III melanoma|stage iii melanoma
620795|NCT00937781|recurrent melanoma|recurrent melanoma
620796|NCT00937755|schizophrenia|schizophrenia
620797|NCT00937755|antipsychotics|antipsychotics
620798|NCT00937755|glucose homeostasis|glucose homeostasis
620799|NCT00937755|metabolic disturbance|metabolic disturbance
620800|NCT00937742|cardiovascular disease|cardiovascular disease
620801|NCT00937742|Lycopene|lycopene
620802|NCT00937742|Tomato|tomato
620803|NCT00937729|uncompliant patients with virological failure|uncompliant patients with virological failure
620804|NCT00937729|Treatment experienced|treatment experienced
620805|NCT00937716|schizophrenia|schizophrenia
620806|NCT00937716|treatment response|treatment response
620807|NCT00937716|risperidone|risperidone
620808|NCT00937716|functional magnetic resonance|functional magnetic resonance
620809|NCT00937716|functional magnetic spectroscopy|functional magnetic spectroscopy
620810|NCT00937690|melanoma|melanoma
620811|NCT00937690|cutaneous|cutaneous
620812|NCT00937690|imaging|imaging
620813|NCT00937677|Tysabri|tysabri
620814|NCT00937677|VWMTR|vwmtr
620815|NCT00937664|Phase I|phase i
620816|NCT00937664|cancer|cancer
620817|NCT00937664|solid tumors|solid tumors
620818|NCT00937664|advanced solid malignancies|advanced solid malignancies
620819|NCT00937664|dose escalation|dose escalation
620820|NCT00937664|combination treatment|combination treatment
620821|NCT00937664|CHK inhibitor|chk inhibitor
620822|NCT00937664|Japanese|japanese
620823|NCT00937651|Fimasartan|fimasartan
620824|NCT00937651|Essential Hypertension|essential hypertension
620825|NCT00937638|Metabolic syndrome|metabolic syndrome
620826|NCT00937638|Lean Beef|lean beef
620828|NCT00937612|Head and Neck Neoplasms|head and neck neoplasms
620829|NCT00937612|Chemotherapy|chemotherapy
620830|NCT00937612|Radiotherapy, Adjuvant|radiotherapy, adjuvant
620831|NCT00937612|Surgery|surgery
620832|NCT00937599|obese|obese
620833|NCT00937599|brazil nuts|brazil nuts
620834|NCT00937599|oxidative stress|oxidative stress
620835|NCT00937599|microcirculatory|microcirculatory
620836|NCT00937599|metabolic profile|metabolic profile
620837|NCT00937586|Metastatic Prostate Cancer|metastatic prostate cancer
620838|NCT00937586|Prostate Cancer Risk Assessment|prostate cancer risk assessment
620839|NCT00937573|stents|stents
620840|NCT00937573|mortality|mortality
620841|NCT00937573|revascularization|revascularization
620842|NCT00937573|stent thrombosis|stent thrombosis
620843|NCT00937573|Drug-Eluting Stents|drug-eluting stents
620844|NCT00937547|cervical cancer|cervical cancer
620845|NCT00937547|Human Papillomavirus Infection|human papillomavirus infection
620846|NCT00937534|Fimasartan|fimasartan
620847|NCT00937534|healthy elderly and young male volunteer|healthy elderly and young male volunteer
620848|NCT00937534|pharmacokinetic|pharmacokinetic
620849|NCT00937521|Immunogenicity|immunogenicity
620850|NCT00937521|Meningitis|meningitis
620851|NCT00937521|Antibody|antibody
620852|NCT00937521|Infants|infants
620853|NCT00937508|smoking|smoking
620854|NCT00937508|quitting|quitting
620855|NCT00937508|varenicline|varenicline
620856|NCT00937508|preoperative|preoperative
620857|NCT00937508|long term abstinence|long term abstinence
620858|NCT00937469|Social skills training for children with ADHD|social skills training for children with adhd
620859|NCT00937469|Children with ADHD|children with adhd
620860|NCT00937456|Esophagus|esophagus
620861|NCT00937456|Cancer|cancer
620862|NCT00937456|Surgery|surgery
620863|NCT00937456|Laparoscopy|laparoscopy
620864|NCT00937456|Randomized trial|randomized trial
620865|NCT00937456|Esophageal cancer deemed to be resectable|esophageal cancer deemed to be resectable
620866|NCT00937443|Physical Activity|physical activity
620867|NCT00937443|Cardiac Heart Failure|cardiac heart failure
620868|NCT00937443|Exercise Regimen|exercise regimen
620869|NCT00937443|Cardioreparative Factors|cardioreparative factors
620870|NCT00937430|Pelvic organ prolapse|pelvic organ prolapse
620871|NCT00937430|Bowel preparation|bowel preparation
620872|NCT00937417|unspecified adult solid tumor, protocol specific|unspecified adult solid tumor, protocol specific
620873|NCT00937417|recurrent non-small cell lung cancer|recurrent non-small cell lung cancer
620874|NCT00937417|stage IV non-small cell lung cancer|stage iv non-small cell lung cancer
620875|NCT00937417|stage IV breast cancer|stage iv breast cancer
620876|NCT00937417|recurrent squamous cell carcinoma of the hypopharynx|recurrent squamous cell carcinoma of the hypopharynx
620877|NCT00937417|stage IV squamous cell carcinoma of the hypopharynx|stage iv squamous cell carcinoma of the hypopharynx
620878|NCT00937417|recurrent squamous cell carcinoma of the larynx|recurrent squamous cell carcinoma of the larynx
620879|NCT00937417|recurrent verrucous carcinoma of the larynx|recurrent verrucous carcinoma of the larynx
620880|NCT00937417|stage IV squamous cell carcinoma of the larynx|stage iv squamous cell carcinoma of the larynx
620881|NCT00937417|stage IV verrucous carcinoma of the larynx|stage iv verrucous carcinoma of the larynx
620882|NCT00937417|recurrent adenoid cystic carcinoma of the oral cavity|recurrent adenoid cystic carcinoma of the oral cavity
620883|NCT00937417|recurrent mucoepidermoid carcinoma of the oral cavity|recurrent mucoepidermoid carcinoma of the oral cavity
620884|NCT00937417|recurrent squamous cell carcinoma of the lip and oral cavity|recurrent squamous cell carcinoma of the lip and oral cavity
620885|NCT00937417|recurrent verrucous carcinoma of the oral cavity|recurrent verrucous carcinoma of the oral cavity
620886|NCT00937417|recurrent basal cell carcinoma of the lip|recurrent basal cell carcinoma of the lip
620887|NCT00937417|stage IV adenoid cystic carcinoma of the oral cavity|stage iv adenoid cystic carcinoma of the oral cavity
620888|NCT00937417|stage IV basal cell carcinoma of the lip|stage iv basal cell carcinoma of the lip
620889|NCT00937417|stage IV mucoepidermoid carcinoma of the oral cavity|stage iv mucoepidermoid carcinoma of the oral cavity
620890|NCT00937417|stage IV squamous cell carcinoma of the lip and oral cavity|stage iv squamous cell carcinoma of the lip and oral cavity
620891|NCT00937417|stage IV verrucous carcinoma of the oral cavity|stage iv verrucous carcinoma of the oral cavity
620892|NCT00937417|recurrent metastatic squamous neck cancer with occult primary|recurrent metastatic squamous neck cancer with occult primary
620893|NCT00937417|recurrent lymphoepithelioma of the nasopharynx|recurrent lymphoepithelioma of the nasopharynx
620894|NCT00937417|recurrent squamous cell carcinoma of the nasopharynx|recurrent squamous cell carcinoma of the nasopharynx
620895|NCT00937417|stage IV lymphoepithelioma of the nasopharynx|stage iv lymphoepithelioma of the nasopharynx
620896|NCT00937417|stage IV squamous cell carcinoma of the nasopharynx|stage iv squamous cell carcinoma of the nasopharynx
620897|NCT00937417|recurrent lymphoepithelioma of the oropharynx|recurrent lymphoepithelioma of the oropharynx
620898|NCT00937417|recurrent squamous cell carcinoma of the oropharynx|recurrent squamous cell carcinoma of the oropharynx
620899|NCT00937417|stage IV lymphoepithelioma of the oropharynx|stage iv lymphoepithelioma of the oropharynx
620900|NCT00937417|stage IV squamous cell carcinoma of the oropharynx|stage iv squamous cell carcinoma of the oropharynx
620901|NCT00937417|recurrent esthesioneuroblastoma of the paranasal sinus and nasal cavity|recurrent esthesioneuroblastoma of the paranasal sinus and nasal cavity
620902|NCT00937417|recurrent inverted papilloma of the paranasal sinus and nasal cavity|recurrent inverted papilloma of the paranasal sinus and nasal cavity
620903|NCT00937417|recurrent midline lethal granuloma of the paranasal sinus and nasal cavity|recurrent midline lethal granuloma of the paranasal sinus and nasal cavity
620904|NCT00937417|recurrent squamous cell carcinoma of the paranasal sinus and nasal cavity|recurrent squamous cell carcinoma of the paranasal sinus and nasal cavity
620905|NCT00937417|stage IV esthesioneuroblastoma of the paranasal sinus and nasal cavity|stage iv esthesioneuroblastoma of the paranasal sinus and nasal cavity
620906|NCT00937417|stage IV inverted papilloma of the paranasal sinus and nasal cavity|stage iv inverted papilloma of the paranasal sinus and nasal cavity
620907|NCT00937417|stage IV midline lethal granuloma of the paranasal sinus and nasal cavity|stage iv midline lethal granuloma of the paranasal sinus and nasal cavity
620908|NCT00937417|stage IV squamous cell carcinoma of the paranasal sinus and nasal cavity|stage iv squamous cell carcinoma of the paranasal sinus and nasal cavity
620909|NCT00937417|recurrent salivary gland cancer|recurrent salivary gland cancer
620910|NCT00937417|stage IV salivary gland cancer|stage iv salivary gland cancer
620911|NCT00937417|anaplastic thyroid cancer|anaplastic thyroid cancer
620912|NCT00937417|stage IV follicular thyroid cancer|stage iv follicular thyroid cancer
620913|NCT00937417|insular thyroid cancer|insular thyroid cancer
620914|NCT00937417|stage IV papillary thyroid cancer|stage iv papillary thyroid cancer
620915|NCT00937417|recurrent thyroid cancer|recurrent thyroid cancer
620916|NCT00937417|thyroid gland medullary carcinoma|thyroid gland medullary carcinoma
620917|NCT00937417|recurrent prostate cancer|recurrent prostate cancer
620918|NCT00937417|hormone-resistant prostate cancer|hormone-resistant prostate cancer
620919|NCT00937417|recurrent breast cancer|recurrent breast cancer
620920|NCT00937417|stage IV prostate cancer|stage iv prostate cancer
620921|NCT00937417|male breast cancer|male breast cancer
620922|NCT00937404|IPV|ipv
620923|NCT00937391|MRI agents|mri agents
620924|NCT00937391|Magnevist|magnevist
620925|NCT00937365|Pregnancy|pregnancy
620926|NCT00937365|Pain|pain
620927|NCT00937365|Low back pain|low back pain
620928|NCT00937365|Pubic symphysis pain|pubic symphysis pain
620929|NCT00937365|CAM|cam
620930|NCT00937365|Complementary & Alternative Medicine|complementary & alternative medicine
620931|NCT00937365|Exercise|exercise
620932|NCT00937365|Chiropractic|chiropractic
620933|NCT00937365|Spinal manipulation|spinal manipulation
620934|NCT00937365|Adjustments|adjustments
620935|NCT00937365|Neuroemotional technique|neuroemotional technique
620936|NCT00937365|Mind body|mind body
620937|NCT00937365|Mind body therapy|mind body therapy
620938|NCT00937365|Attachment|attachment
620939|NCT00937365|Maternal Fetal relationship|maternal fetal relationship
620940|NCT00937365|Intrauterine attachment|intrauterine attachment
620941|NCT00937365|Heart rate variability|heart rate variability
620942|NCT00937365|VAS|vas
620943|NCT00937365|Visual analog scale|visual analog scale
620944|NCT00937365|Roland Morris Disability Index|roland morris disability index
620945|NCT00937352|Mild to moderate Alzheimer's disease|mild to moderate alzheimer's disease
620946|NCT00937339|cerebrovascular accident|cerebrovascular accident
620947|NCT00937339|bone|bone
620948|NCT00937339|muscle|muscle
620949|NCT00937339|vibration|vibration
620950|NCT00937287|HPV|hpv
620951|NCT00937287|African American|african american
620952|NCT00937287|Rural|rural
620953|NCT00937274|ETEC EPEC diarrhoea|etec epec diarrhoea
620954|NCT00937274|phage therapy|phage therapy
620955|NCT00937274|ORS|ors
620956|NCT00937248|Cone Beam CT in rectal cancer patients|cone beam ct in rectal cancer patients
620957|NCT00937248|Immobilizing rectal cancer patients|immobilizing rectal cancer patients
622342|NCT00931801|Raltegravir|raltegravir
620958|NCT00937248|Image guided radiotherapy in rectal cancer patients|image guided radiotherapy in rectal cancer patients
620959|NCT00937235|Smoking Cessation|smoking cessation
620960|NCT00937235|Anxiety|anxiety
620961|NCT00937235|Behavior Therapy|behavior therapy
620962|NCT00937235|Varenicline|varenicline
620963|NCT00937222|diabetes|diabetes
620964|NCT00937222|cholesterol|cholesterol
620965|NCT00937222|peanuts|peanuts
620966|NCT00937222|peanut butter|peanut butter
620967|NCT00937222|dietary intervention|dietary intervention
620968|NCT00937222|HDL cholesterol|hdl cholesterol
620969|NCT00937183|dendritic cell vaccine|dendritic cell vaccine
620970|NCT00937183|tumor cell lysate|tumor cell lysate
620971|NCT00937183|lymphoma|lymphoma
620972|NCT00937170|Total Knee Replacement|total knee replacement
620973|NCT00937170|Gender Specific Design|gender specific design
620974|NCT00937157|Inflammation|inflammation
620975|NCT00937157|Multiple Sclerosis|multiple sclerosis
620976|NCT00937157|Glatiramer Acetate|glatiramer acetate
620977|NCT00937157|Gd enhancing lesions|gd enhancing lesions
620978|NCT00937157|1.5T protocol|1.5t protocol
620979|NCT00937157|3T protocol|3t protocol
620980|NCT00937157|Magnetization transfer imaging (MTI)|magnetization transfer imaging (mti)
620981|NCT00937157|Lesion activity analysis|lesion activity analysis
620982|NCT00937157|Copaxone|copaxone
620983|NCT00937144|endothelial function|endothelial function
620984|NCT00937144|endothelial progenitor stem cells|endothelial progenitor stem cells
620985|NCT00937118|laparotomy|laparotomy
620986|NCT00937118|duodenal injury|duodenal injury
620987|NCT00937118|pancreatic injury|pancreatic injury
620988|NCT00937118|trauma|trauma
620989|NCT00937092|Heart Failure|heart failure
620990|NCT00937092|Dopamine|dopamine
620991|NCT00937092|Furosemide|furosemide
620992|NCT00937092|Worsening Renal Function|worsening renal function
620993|NCT00937092|Hypokalemia|hypokalemia
620994|NCT00937092|Outcomes|outcomes
620995|NCT00937092|Prognosis|prognosis
620996|NCT00937079|Glucagon-like peptide-1 receptor targeting|glucagon-like peptide-1 receptor targeting
620997|NCT00937079|Insulinoma imaging|insulinoma imaging
620998|NCT00937079|Exendin-4|exendin-4
620999|NCT00937079|molecular imaging|molecular imaging
621000|NCT00937066|Cost-effectiveness analysis|cost-effectiveness analysis
621001|NCT00937066|Symbicort|symbicort
621002|NCT00937053|Neutropenia|neutropenia
621003|NCT00937053|Transfusions|transfusions
621004|NCT00937053|Hemoglobin|hemoglobin
621005|NCT00937053|Bone marrow transplant|bone marrow transplant
621006|NCT00937053|Hematopoietic stem cell transplant|hematopoietic stem cell transplant
621007|NCT00937040|Osmotic Release Oral System (OROS®) Extended Release Methylphenidate HCl|osmotic release oral system (oros®) extended release methylphenidate hcl
621008|NCT00937040|CONCERTA® (OROS MPH)|concerta® (oros mph)
621009|NCT00937027|Antifolate|antifolate
621010|NCT00937027|Psoriasis|psoriasis
621011|NCT00937027|Antiinflammatory drug|antiinflammatory drug
621012|NCT00937027|Autoimmune disease|autoimmune disease
621013|NCT00937027|Treatment|treatment
621014|NCT00937014|infant formula|infant formula
621015|NCT00937014|growth|growth
621016|NCT00937014|weight|weight
621017|NCT00937001|myopathy|myopathy
621018|NCT00937001|respiratory failure|respiratory failure
621019|NCT00937001|cognitive impairment|cognitive impairment
621020|NCT00937001|delirium|delirium
621021|NCT00936988|Hyperparathyroidism, Primary|hyperparathyroidism, primary
621022|NCT00936988|cinacalcet|cinacalcet
621023|NCT00936962|Meningococcal C vaccine|meningococcal c vaccine
621024|NCT00936962|Meningitis study|meningitis study
621025|NCT00936962|Canadian vaccine schedule|canadian vaccine schedule
621026|NCT00936962|Prevention of Meningococcal C disease|prevention of meningococcal c disease
621027|NCT00936949|total hip arthroplasty|total hip arthroplasty
621028|NCT00936949|posterolateral|posterolateral
621029|NCT00936949|modified lateral|modified lateral
621030|NCT00936936|Testis|testis
621031|NCT00936936|Relapsed Testicular Cancer|relapsed testicular cancer
621032|NCT00936936|Bevacizumab|bevacizumab
621033|NCT00936936|Avastin|avastin
621034|NCT00936936|Anti-VEGF monoclonal antibody|anti-vegf monoclonal antibody
621035|NCT00936936|rhuMAb-VEGF|rhumab-vegf
621036|NCT00936936|Carboplatin|carboplatin
621037|NCT00936936|Paraplatin|paraplatin
621038|NCT00936936|Docetaxel|docetaxel
621039|NCT00936936|Taxotere|taxotere
621040|NCT00936936|Etoposide|etoposide
621041|NCT00936936|VePesid|vepesid
621042|NCT00936936|Gemcitabine|gemcitabine
621043|NCT00936936|Gemcitabine Hydrochloride|gemcitabine hydrochloride
621044|NCT00936936|Gemzar|gemzar
621045|NCT00936936|Ifosfamide|ifosfamide
621046|NCT00936936|Ifex|ifex
621047|NCT00936936|Melphalan|melphalan
621048|NCT00936936|Alkeran|alkeran
621049|NCT00936923|CAPD|capd
621050|NCT00936923|Diuretics|diuretics
621051|NCT00936923|Residual Renal Function|residual renal function
621052|NCT00936923|furosemide|furosemide
621053|NCT00936910|central line fungal infections|central line fungal infections
621054|NCT00936910|antifungal lock therapy|antifungal lock therapy
621055|NCT00936910|Ambisome lock therapy|ambisome lock therapy
621056|NCT00936884|Opioid Induced Constipation|opioid induced constipation
622343|NCT00931801|Tenofovir|tenofovir
621057|NCT00936871|lersivirine QT QTc ECG HIV NNRTI|lersivirine qt qtc ecg hiv nnrti
621058|NCT00936858|radioiodine refractory thyroid cancer|radioiodine refractory thyroid cancer
621059|NCT00936858|RAD001|rad001
621060|NCT00936832|stage IV rectal cancer|stage iv rectal cancer
621061|NCT00936832|adenocarcinoma of the rectum|adenocarcinoma of the rectum
621062|NCT00936832|liver metastases|liver metastases
621063|NCT00936832|lung metastases|lung metastases
621064|NCT00936819|Stent|stent
621065|NCT00936819|endothelial progenitor cells|endothelial progenitor cells
621066|NCT00936819|nitric oxide|nitric oxide
621067|NCT00936819|myocardial infarction|myocardial infarction
621069|NCT00936806|Intracranial tumor patients|intracranial tumor patients
621070|NCT00936793|Drug Interaction|drug interaction
621071|NCT00936793|Asthma|asthma
621072|NCT00936793|HIV|hiv
621073|NCT00936793|Beclomethasone|beclomethasone
621074|NCT00936793|Protease Inhibitors|protease inhibitors
621075|NCT00936793|HV|hv
621076|NCT00936793|Healthy Volunteer|healthy volunteer
621077|NCT00936793|HIV Infections|hiv infections
621078|NCT00936780|Coronary Artery Disease|coronary artery disease
621079|NCT00936780|Restenosis|restenosis
621080|NCT00936780|Stent thrombosis|stent thrombosis
621081|NCT00936780|Coronary stents|coronary stents
621082|NCT00936780|Angioplasty|angioplasty
621083|NCT00936780|Drug Eluting Stents (DES)|drug eluting stents (des)
621084|NCT00936767|falciparum malaria|falciparum malaria
621085|NCT00936767|artemisone|artemisone
621086|NCT00936767|artesunate|artesunate
621087|NCT00936767|resistance|resistance
621088|NCT00936754|Glycemic index|glycemic index
712089|NCT00581789|erlotinib|erlotinib
621089|NCT00936754|Reduction of glycemic index of ingested foods|reduction of glycemic index of ingested foods
621090|NCT00936741|Cushing's Disease|cushing's disease
621091|NCT00936741|Cushing's Syndrome|cushing's syndrome
621092|NCT00936741|Cushings|cushings
621093|NCT00936741|Pituitary|pituitary
621094|NCT00936741|ACTH|acth
621095|NCT00936741|Adrenocorticotropic hormone|adrenocorticotropic hormone
621096|NCT00936741|Ectopic|ectopic
621097|NCT00936741|Adrenal adenoma|adrenal adenoma
621098|NCT00936741|Adrenal carcinoma|adrenal carcinoma
621099|NCT00936741|Adrenal autonomy|adrenal autonomy
621100|NCT00936741|Cortisol|cortisol
621101|NCT00936741|Hypercortisolemia|hypercortisolemia
621102|NCT00936741|Cushingoid|cushingoid
621103|NCT00936741|Moon facies|moon facies
621104|NCT00936741|Dorsocervical fat|dorsocervical fat
621105|NCT00936741|Plethora|plethora
621106|NCT00936741|Hirsutism|hirsutism
621107|NCT00936741|Violaceous striae|violaceous striae
621108|NCT00936741|Hormone|hormone
621109|NCT00936741|Contraceptive|contraceptive
621110|NCT00936741|Endocrine|endocrine
621111|NCT00936741|Cushing Syndrome|cushing syndrome
621112|NCT00936741|Ectopic ACTH Secretion|ectopic acth secretion
621113|NCT00936715|prevention of chronic hepatitis B recurrence|prevention of chronic hepatitis b recurrence
621114|NCT00936715|post orthotopic liver transplant|post orthotopic liver transplant
621115|NCT00936715|prevention of chronic hepatitis B recurrence in patients who have undergone orthotopic liver transplant|prevention of chronic hepatitis b recurrence in patients who have undergone orthotopic liver transplant
621116|NCT00936702|Newly Diagnosed Carcinoma of Unknown Primary Origin|newly diagnosed carcinoma of unknown primary origin
621117|NCT00936702|Squamous Cell Carcinoma of Unknown Primary Origin|squamous cell carcinoma of unknown primary origin
621118|NCT00936702|Undifferentiated Carcinoma of Unknown Primary|undifferentiated carcinoma of unknown primary
621119|NCT00936702|newly diagnosed carcinoma of unknown primary|newly diagnosed carcinoma of unknown primary
621120|NCT00936689|Hepatocellular carcinoma;|hepatocellular carcinoma;
621121|NCT00936689|Chemoembolization;|chemoembolization;
621122|NCT00936689|DC-Beads.|dc-beads.
621123|NCT00936676|parkinson's|parkinson's
621124|NCT00936676|long-term effects|long-term effects
621125|NCT00936676|adagio|adagio
621126|NCT00936676|rasagiline|rasagiline
621127|NCT00936676|delayed start|delayed start
621128|NCT00936663|Diabetes|diabetes
621129|NCT00936663|Kidney Transplant|kidney transplant
621130|NCT00936663|Sitagliptin|sitagliptin
621131|NCT00936650|Hyperparathyroidism, Primary|hyperparathyroidism, primary
621132|NCT00936650|cinacalcet|cinacalcet
621133|NCT00936624|Persistent asthma|persistent asthma
621134|NCT00936611|LBH589|lbh589
621135|NCT00936611|WM|wm
621136|NCT00936611|panobinostat|panobinostat
621137|NCT00936611|relapsed|relapsed
621138|NCT00936611|waldenstrom|waldenstrom
621139|NCT00936611|macroglobulinemia|macroglobulinemia
621140|NCT00936598|Sleep|sleep
621141|NCT00936598|Endometrial Neoplasms|endometrial neoplasms
621142|NCT00936598|Pain|pain
621143|NCT00936585|Crohn's Disease|crohn's disease
621144|NCT00936585|Infusion|infusion
621145|NCT00936585|Anti IL-17 Monoclonal Antibody|anti il-17 monoclonal antibody
621146|NCT00936585|Placebo|placebo
621147|NCT00936585|Crohn Disease|crohn disease
621148|NCT00936585|Inflammatory Bowel Disease|inflammatory bowel disease
621149|NCT00936572|Probiotics|probiotics
621150|NCT00936572|La1|la1
621151|NCT00936572|BB536|bb536
621152|NCT00936572|Colorectal surgery|colorectal surgery
621153|NCT00936572|Intestinal immunity|intestinal immunity
621154|NCT00936572|Dendritic cells|dendritic cells
621155|NCT00936572|Lymphocyte|lymphocyte
621157|NCT00936559|rotator cuff tear repair|rotator cuff tear repair
621158|NCT00936559|open surgical technique|open surgical technique
621159|NCT00936559|safety|safety
621160|NCT00936520|Diabetic Macular Edema|diabetic macular edema
621161|NCT00936520|DME|dme
621162|NCT00936520|Pars Plana Vitrectomy|pars plana vitrectomy
621163|NCT00936520|Ocular Inflammation|ocular inflammation
621164|NCT00936507|energy density|energy density
621165|NCT00936507|portion size|portion size
621166|NCT00936507|child feeding|child feeding
621167|NCT00936494|obstructive sleep apnea|obstructive sleep apnea
621168|NCT00936494|sleep related breathing disorder|sleep related breathing disorder
621169|NCT00936494|snoring|snoring
621170|NCT00936494|disturbed sleeping|disturbed sleeping
621171|NCT00936494|open mouth breathing|open mouth breathing
621172|NCT00936494|upper airway resistance syndrome|upper airway resistance syndrome
621173|NCT00936481|OSA|osa
621174|NCT00936468|Elderly influenza vaccine|elderly influenza vaccine
621175|NCT00936455|telemedicine|telemedicine
621176|NCT00936455|telephone|telephone
621177|NCT00936455|outcomes|outcomes
621178|NCT00936442|Compliance|compliance
621179|NCT00936442|Early Breast Cancer|early breast cancer
621180|NCT00936429|Dengue fever|dengue fever
621181|NCT00936429|Dengue hemorrhagic fever|dengue hemorrhagic fever
621182|NCT00936429|Dengue shock syndrome|dengue shock syndrome
621183|NCT00936429|Vaccine|vaccine
621184|NCT00936429|Hawaii Biotech|hawaii biotech
621185|NCT00936416|Glomerular Filtration Rate|glomerular filtration rate
621186|NCT00936416|Renal Blood Flow|renal blood flow
621187|NCT00936416|MRI|mri
621188|NCT00936416|Inulin|inulin
621189|NCT00936416|Para-Aminohippuric Acid|para-aminohippuric acid
621190|NCT00936390|adenocarcinoma of the prostate|adenocarcinoma of the prostate
621191|NCT00936390|stage IIB prostate cancer|stage iib prostate cancer
621192|NCT00936390|stage IIA prostate cancer|stage iia prostate cancer
621193|NCT00936351|schizophrenia|schizophrenia
621194|NCT00936351|intervention studies|intervention studies
621195|NCT00936351|mindfulness meditation|mindfulness meditation
621196|NCT00936351|vocational rehabilitation|vocational rehabilitation
621197|NCT00936351|schizoaffective disorder|schizoaffective disorder
621198|NCT00936351|psychotic disorders|psychotic disorders
621199|NCT00936338|anterior disc displacement without reduction of temporomandibular disorders|anterior disc displacement without reduction of temporomandibular disorders
621200|NCT00936325|SCLS|scls
621201|NCT00936325|Systemic Capillary Leak Syndrome|systemic capillary leak syndrome
621202|NCT00936299|Adolescents|adolescents
621203|NCT00936299|Substance Use Disorder|substance use disorder
621204|NCT00936299|Attention Deficit Hyperactivity Disorder|attention deficit hyperactivity disorder
621205|NCT00936299|Cognitive Behavioral Therapy|cognitive behavioral therapy
621206|NCT00936286|Obstructive Sleep Apnea Syndrome|obstructive sleep apnea syndrome
621207|NCT00936286|Respiratory Muscle Training|respiratory muscle training
621208|NCT00936286|Normocapnic Hyperpnea|normocapnic hyperpnea
621209|NCT00936286|SpiroTiger|spirotiger
621210|NCT00936286|Polysomnography|polysomnography
621211|NCT00936273|Sleep apnea syndrome|sleep apnea syndrome
621212|NCT00936273|SAS|sas
621213|NCT00936273|double loop gain|double loop gain
621214|NCT00936273|DLI|dli
621215|NCT00936273|double loop index|double loop index
621216|NCT00936273|periodic breathing|periodic breathing
621217|NCT00936273|polysomnography|polysomnography
621218|NCT00936260|osteoporosis|osteoporosis
621219|NCT00936260|postmenopausal|postmenopausal
621220|NCT00936260|alendronate|alendronate
621221|NCT00936234|CAD|cad
621222|NCT00936234|diabetes|diabetes
621223|NCT00936234|SDF-1|sdf-1
621224|NCT00936234|endothelial function|endothelial function
621225|NCT00936221|BRAF mutation positive|braf mutation positive
621226|NCT00936221|advanced melanoma|advanced melanoma
621227|NCT00936221|Advanced cutaneous melanoma|advanced cutaneous melanoma
621228|NCT00936221|Unknown primary melanoma|unknown primary melanoma
621229|NCT00936195|HIV|hiv
621230|NCT00936195|pregnancy|pregnancy
621231|NCT00936195|breastfeeding|breastfeeding
621232|NCT00936195|PMTCT|pmtct
621233|NCT00936195|ARV treatment|arv treatment
621234|NCT00936195|treatment naive|treatment naive
621235|NCT00936169|Patients with at least one complex lesion suitable for implantation of a drug-eluting stent|patients with at least one complex lesion suitable for implantation of a drug-eluting stent
621236|NCT00936143|Spondylitis, Ankylosing|spondylitis, ankylosing
621237|NCT00936143|infliximab|infliximab
621238|NCT00936143|Antibodies, Monoclonal|antibodies, monoclonal
621239|NCT00936130|Roux-en-Y gastric bypass surgery|roux-en-y gastric bypass surgery
621240|NCT00936130|Sleeve gastrectomy (SGx) surgery|sleeve gastrectomy (sgx) surgery
621241|NCT00936130|Gastric banding (GBx) surgery|gastric banding (gbx) surgery
621242|NCT00936130|Low calorie diet program|low calorie diet program
621243|NCT00936117|Cancer of the Blood|cancer of the blood
621244|NCT00936117|Cancer of Bone Marrow|cancer of bone marrow
621245|NCT00936117|Acute Leukemia|acute leukemia
621246|NCT00936117|AML|aml
621247|NCT00936117|Fungal infection|fungal infection
621248|NCT00936117|Prophylaxis|prophylaxis
621249|NCT00936117|Posaconazole|posaconazole
621250|NCT00936117|SCH 56592|sch 56592
621251|NCT00936117|Noxafil|noxafil
621252|NCT00936117|Chemotherapy|chemotherapy
621253|NCT00936104|pancreas|pancreas
621254|NCT00936104|cancer|cancer
621255|NCT00936104|stem cell|stem cell
621256|NCT00936091|intestinal parasitic infections|intestinal parasitic infections
621257|NCT00936091|malnutrition|malnutrition
621258|NCT00936091|Anemia|anemia
621259|NCT00936078|kidney transplantation|kidney transplantation
621260|NCT00936078|cohort study|cohort study
621261|NCT00936078|qualitative research|qualitative research
621262|NCT00936078|health services research|health services research
621263|NCT00936078|hypertension|hypertension
621264|NCT00936065|Etanercept|etanercept
621265|NCT00936065|Acitretin|acitretin
621266|NCT00936065|Psoriasis|psoriasis
621267|NCT00936052|glioblastomas|glioblastomas
621268|NCT00936052|GBM|gbm
621269|NCT00936052|gliosarcoma|gliosarcoma
621270|NCT00936052|blastoma|blastoma
621271|NCT00936052|sarcoma|sarcoma
621272|NCT00936013|novel influenza A(H1N1)|novel influenza a(h1n1)
621273|NCT00936013|chinese medicinal herbs|chinese medicinal herbs
621274|NCT00936000|alcohol abuse|alcohol abuse
621275|NCT00936000|alveolar capillary permeability|alveolar capillary permeability
621276|NCT00935987|Primary Myelofibrosis|primary myelofibrosis
621277|NCT00935987|Post-Polycythemia Vera|post-polycythemia vera
621278|NCT00935987|Post-Essential Thrombocythemia|post-essential thrombocythemia
621279|NCT00935987|CYT387|cyt387
621280|NCT00935961|CISPLATIN|cisplatin
621281|NCT00935961|RAD001|rad001
621282|NCT00935961|TAXOTERE (DOCETAXEL)|taxotere (docetaxel)
621283|NCT00935961|09-028|09-028
712090|NCT00581789|phase 1|phase 1
621284|NCT00935961|Squamous Cell Carcinoma|squamous cell carcinoma
621285|NCT00935961|Local-Regional Advanced Head and Neck|local-regional advanced head and neck
621286|NCT00935948|hemorrhoids|hemorrhoids
621287|NCT00935948|hemorrhoidal disease|hemorrhoidal disease
621288|NCT00935948|water smartweed|water smartweed
621289|NCT00935948|hamamelis|hamamelis
621290|NCT00935948|RCT|rct
621291|NCT00935935|Treatment experienced|treatment experienced
621292|NCT00935922|Flaxseed|flaxseed
621293|NCT00935922|Weight loss|weight loss
621294|NCT00935922|Heart health|heart health
621295|NCT00935922|Diabetes|diabetes
621296|NCT00935909|IV cannulation|iv cannulation
621297|NCT00935896|Ventilator-associated lung injury|ventilator-associated lung injury
621298|NCT00935896|Tumor necrosis factor-alpha|tumor necrosis factor-alpha
621299|NCT00935896|Interleukin-8|interleukin-8
621300|NCT00935896|Mechanical ventilation|mechanical ventilation
621301|NCT00935896|Low tidal volume ventilation|low tidal volume ventilation
621302|NCT00935896|Normal lungs|normal lungs
621303|NCT00935883|Age Related macular Degeneration|age related macular degeneration
621304|NCT00935883|Macular Degeneration|macular degeneration
621305|NCT00935883|Drusen|drusen
621306|NCT00935883|Geographic atrophy|geographic atrophy
621307|NCT00935883|Eculizumab|eculizumab
621308|NCT00935883|Soliris|soliris
621309|NCT00935857|Balloon Enteroscopy|balloon enteroscopy
621310|NCT00935857|Looping|looping
621311|NCT00935844|Advanced solid tumors|advanced solid tumors
621312|NCT00935844|Lymphoma|lymphoma
621313|NCT00935831|Tolerability|tolerability
621314|NCT00935831|Safety|safety
621315|NCT00935831|Pharmacokinetics|pharmacokinetics
621316|NCT00935831|Pharmacodynamics|pharmacodynamics
621317|NCT00935818|smoking|smoking
621318|NCT00935818|nicotine|nicotine
621319|NCT00935818|tobacco|tobacco
621320|NCT00935818|dependence|dependence
621321|NCT00935818|cessation|cessation
621322|NCT00935818|abstinence|abstinence
621323|NCT00935805|Diabetes Mellitus|diabetes mellitus
621324|NCT00935805|Arterial Hypertension|arterial hypertension
621325|NCT00935805|Treatment|treatment
621326|NCT00935805|Primary Care|primary care
621327|NCT00935792|hematopoietic cancer|hematopoietic cancer
621328|NCT00935792|lymphoid cancer|lymphoid cancer
621329|NCT00935779|Stomach Neoplasms|stomach neoplasms
621330|NCT00935779|Peritoneum|peritoneum
621331|NCT00935766|Latinos Using Cardio Health Actions to Reduce Risk|latinos using cardio health actions to reduce risk
621332|NCT00935766|Omega three Fatty Acids|omega three fatty acids
621333|NCT00935766|Vascular Function and Inflammation|vascular function and inflammation
621334|NCT00935753|Lesch-Nyhan Disease|lesch-nyhan disease
621335|NCT00935753|self-mutilating behavior|self-mutilating behavior
621336|NCT00935740|thromboembolic disease|thromboembolic disease
621337|NCT00935740|thromboplastin|thromboplastin
621338|NCT00935740|hypercoagulability|hypercoagulability
621339|NCT00935740|congestive heart failure|congestive heart failure
621340|NCT00935727|renal transplant|renal transplant
621341|NCT00935727|ultrasound|ultrasound
621342|NCT00935727|elastography|elastography
621343|NCT00935714|Arm|arm
621344|NCT00935714|Lymphedema|lymphedema
621345|NCT00935714|Breast Cancer|breast cancer
621346|NCT00935714|Exercise|exercise
621347|NCT00935714|Breast Cancer related Lymphedema|breast cancer related lymphedema
621348|NCT00935701|Autism Spectrum Disorder|autism spectrum disorder
621349|NCT00935701|Acupressure|acupressure
621350|NCT00935701|Acupuncture|acupuncture
621351|NCT00935688|malaria|malaria
621352|NCT00935688|rapid diagnostic tests|rapid diagnostic tests
621353|NCT00935688|afghanistan|afghanistan
621354|NCT00935688|Non-specific fever|non-specific fever
621355|NCT00935675|Patients with head and neck squamous cell carcinomas|patients with head and neck squamous cell carcinomas
621356|NCT00935675|head and neck squamous cell carcinomas|head and neck squamous cell carcinomas
621357|NCT00935662|First time in man|first time in man
621358|NCT00935662|Safety study|safety study
621359|NCT00935662|AZD8329|azd8329
621360|NCT00935649|Toenail Fungus|toenail fungus
621361|NCT00935649|PinPointe|pinpointe
621362|NCT00935649|FootLaser|footlaser
621363|NCT00935649|Onychomycosis|onychomycosis
621364|NCT00935649|Fungal nails|fungal nails
621365|NCT00935636|Intubation|intubation
621366|NCT00935623|Malaria, Plasmodium vivax|malaria, plasmodium vivax
621367|NCT00935610|Elderly persons|elderly persons
621368|NCT00935610|Muscle function and strength|muscle function and strength
621369|NCT00935610|Body composition|body composition
621370|NCT00935610|Inflammatory cytokine levels|inflammatory cytokine levels
621371|NCT00935610|Cognitive functions|cognitive functions
621372|NCT00935610|Cysteine-rich whey protein isolate|cysteine-rich whey protein isolate
621373|NCT00935610|Immunocal|immunocal
621374|NCT00935610|Resistance training|resistance training
621375|NCT00935610|Improved muscle function|improved muscle function
621376|NCT00935610|Improved quality of life|improved quality of life
621377|NCT00935610|Aging processes|aging processes
621378|NCT00935610|Quality of life|quality of life
621379|NCT00935597|Relapsed Non-Hodgkin's Lymphoma|relapsed non-hodgkin's lymphoma
621380|NCT00935597|Hodgkin's Disease|hodgkin's disease
621381|NCT00935597|Multiple Myeloma|multiple myeloma
621382|NCT00935597|Chronic Lymphocytic Lymphoma|chronic lymphocytic lymphoma
621383|NCT00935597|Relapsed Non-Hodgkin's lymphoma (excluding follicular lymphoma and marginal zone lymphoma)|relapsed non-hodgkin's lymphoma (excluding follicular lymphoma and marginal zone lymphoma)
621384|NCT00935584|Communication|communication
621385|NCT00935584|Doctor-patient relations|doctor-patient relations
621386|NCT00935584|medical informatics|medical informatics
621387|NCT00935584|patient-centered care|patient-centered care
621388|NCT00935584|medical records systems, computerized|medical records systems, computerized
621389|NCT00935558|dendritic cell|dendritic cell
621390|NCT00935558|cancer vaccine|cancer vaccine
621391|NCT00935558|breast cancer|breast cancer
621392|NCT00935558|aromatase inhibitor|aromatase inhibitor
621393|NCT00935558|Zadaxin|zadaxin
621394|NCT00935545|Brain Tumors|brain tumors
621395|NCT00935545|High Grade|high grade
621396|NCT00935545|CNS|cns
621397|NCT00935532|diabetes; exenatide once weekly; Byetta; glargine; Lantus; Amylin; Lilly|diabetes; exenatide once weekly; byetta; glargine; lantus; amylin; lilly
621398|NCT00935519|total hip arthroplasty, ceramic, survival|total hip arthroplasty, ceramic, survival
621399|NCT00935493|guanfacine|guanfacine
621400|NCT00935493|aging|aging
621401|NCT00935493|cognitive aging|cognitive aging
621402|NCT00935493|prefrontal cognitive function|prefrontal cognitive function
621403|NCT00935493|executive function|executive function
621404|NCT00935493|prefrontal cortex|prefrontal cortex
621405|NCT00935480|HIV|hiv
621406|NCT00935480|INTEGRASE INHIBITOR|integrase inhibitor
621407|NCT00935480|Inhibitor on the lymphoid reservoir|inhibitor on the lymphoid reservoir
621408|NCT00935480|Residual HIV replication|residual hiv replication
621409|NCT00935480|treatment experienced|treatment experienced
621410|NCT00935454|hepatocyte matrix implantation|hepatocyte matrix implantation
621411|NCT00935454|endstage liver disease|endstage liver disease
621412|NCT00935454|liver cirrhosis|liver cirrhosis
621413|NCT00935454|impaired liver parenchyma|impaired liver parenchyma
621414|NCT00935454|improvement of liver function|improvement of liver function
621415|NCT00935441|Diabetes mellitus|diabetes mellitus
621416|NCT00935441|chronic care|chronic care
621417|NCT00935441|case management|case management
621418|NCT00935441|telemedicine|telemedicine
621419|NCT00935428|Equestrian injury|equestrian injury
621420|NCT00935428|Horse injury|horse injury
621421|NCT00935428|Trauma|trauma
621422|NCT00935428|Horse|horse
621423|NCT00935428|Equestrian|equestrian
621424|NCT00935415|asthma|asthma
621425|NCT00935415|exercise-induced bronchoconstriction|exercise-induced bronchoconstriction
621426|NCT00935415|montelukast|montelukast
621427|NCT00935415|clinical protection|clinical protection
621428|NCT00935415|children|children
621429|NCT00935415|time effect|time effect
621430|NCT00935402|Energy balance|energy balance
621431|NCT00935402|Weight management|weight management
621432|NCT00935402|Food intake|food intake
621433|NCT00935402|Energy expenditure|energy expenditure
621434|NCT00935376|Sleep Management|sleep management
621435|NCT00935376|Awareness Training Programs|awareness training programs
621436|NCT00935376|Mindfulness Meditation|mindfulness meditation
621437|NCT00935376|Mind Body Bridging|mind body bridging
621438|NCT00935363|glyburide|glyburide
621439|NCT00935363|pharmacokinetics|pharmacokinetics
621440|NCT00935363|pharmacodynamics|pharmacodynamics
621441|NCT00935363|drug interaction|drug interaction
621442|NCT00935363|Healthy Volunteers|healthy volunteers
621443|NCT00935350|viscous|viscous
621444|NCT00935350|fibre|fibre
621445|NCT00935350|polysaccharide|polysaccharide
621446|NCT00935350|blood glucose|blood glucose
621447|NCT00935350|postprandial|postprandial
621448|NCT00935337|Sleep problems|sleep problems
621449|NCT00935337|Awareness training program|awareness training program
621450|NCT00935337|Mind body bridging|mind body bridging
621451|NCT00935324|allo-SCT, GvHD, CK18-F|allo-sct, gvhd, ck18-f
621452|NCT00935298|Renal Transplantation|renal transplantation
621453|NCT00935298|Tacrolimus|tacrolimus
621454|NCT00935298|CYP3A5|cyp3a5
621455|NCT00935298|Genotyping|genotyping
621456|NCT00935285|Ventilator-associated pneumonia (VAP)|ventilator-associated pneumonia (vap)
621457|NCT00935285|Intensive care unit (ICU)|intensive care unit (icu)
621458|NCT00935285|Toll-like receptors|toll-like receptors
621459|NCT00935259|Hypercholesterolemia, Dyslipidemia, simvastatin, Zocor|hypercholesterolemia, dyslipidemia, simvastatin, zocor
621460|NCT00935246|Genomic devices|genomic devices
621461|NCT00935246|Prediction of Escitalopram Response|prediction of escitalopram response
621462|NCT00935246|Depressed Patients|depressed patients
621463|NCT00935233|ductal breast carcinoma in situ|ductal breast carcinoma in situ
621464|NCT00935207|Pain|pain
621465|NCT00935207|Pediatric Pain|pediatric pain
621466|NCT00935207|Pain Diary|pain diary
621467|NCT00935207|Pediatric Pain Measurement|pediatric pain measurement
621468|NCT00935207|Pain Measurement|pain measurement
621469|NCT00935194|Novel Influenza A(H1N1)|novel influenza a(h1n1)
621470|NCT00935194|Oseltamivir|oseltamivir
621471|NCT00935194|Chinese Medicinal Herbs|chinese medicinal herbs
621472|NCT00935181|COPD|copd
621473|NCT00935181|diaphragm|diaphragm
621474|NCT00935181|muscle|muscle
621475|NCT00935181|stretching|stretching
621476|NCT00935181|exercises|exercises
621477|NCT00935181|dyspnea|dyspnea
621478|NCT00935181|respiratory muscle stretching|respiratory muscle stretching
621479|NCT00935181|pulmonary rehabilitation|pulmonary rehabilitation
621480|NCT00935181|exercise training|exercise training
621481|NCT00935181|improved exercise capacity, dyspnea, quality of life|improved exercise capacity, dyspnea, quality of life
621482|NCT00935168|Intensive Care|intensive care
621483|NCT00935168|Fluid Resuscitation|fluid resuscitation
621484|NCT00935168|Saline|saline
621485|NCT00935168|Hydroxy-ethyl starch|hydroxy-ethyl starch
621486|NCT00935155|exercise therapy|exercise therapy
621487|NCT00935155|Knee arthroplasty|knee arthroplasty
621488|NCT00935155|Acupuncture Analgesia|acupuncture analgesia
621489|NCT00935155|Arthroplasty, Replacement, Knee|arthroplasty, replacement, knee
621490|NCT00935155|rehabilitation|rehabilitation
621491|NCT00935142|stage IV cancer with no treatment options|stage iv cancer with no treatment options
621492|NCT00935142|non-curative|non-curative
621493|NCT00935129|Treatment satisfaction|treatment satisfaction
621494|NCT00935129|OmniPod|omnipod
621495|NCT00935129|Insulin pump|insulin pump
621496|NCT00935129|diabetes|diabetes
621497|NCT00935103|Addiction|addiction
621498|NCT00935103|Psychoeducation|psychoeducation
621499|NCT00935103|Risk reduction behaviour|risk reduction behaviour
621500|NCT00935103|Drop in center (DIC)|drop in center (dic)
621501|NCT00935090|unspecified adult solid tumor, protocol specific|unspecified adult solid tumor, protocol specific
621502|NCT00935090|accelerated phase chronic myelogenous leukemia|accelerated phase chronic myelogenous leukemia
621503|NCT00935090|acute undifferentiated leukemia|acute undifferentiated leukemia
621504|NCT00935090|adult acute lymphoblastic leukemia in remission|adult acute lymphoblastic leukemia in remission
621505|NCT00935090|adult acute myeloid leukemia in remission|adult acute myeloid leukemia in remission
621506|NCT00935090|adult acute myeloid leukemia with 11q23 (MLL) abnormalities|adult acute myeloid leukemia with 11q23 (mll) abnormalities
621507|NCT00935090|adult acute myeloid leukemia with inv(16)(p13;q22)|adult acute myeloid leukemia with inv(16)(p13;q22)
621508|NCT00935090|adult acute myeloid leukemia with t(15;17)(q22;q12)|adult acute myeloid leukemia with t(15;17)(q22;q12)
621509|NCT00935090|adult acute myeloid leukemia with t(16;16)(p13;q22)|adult acute myeloid leukemia with t(16;16)(p13;q22)
621510|NCT00935090|adult acute myeloid leukemia with t(8;21)(q22;q22)|adult acute myeloid leukemia with t(8;21)(q22;q22)
621511|NCT00935090|atypical chronic myeloid leukemia, BCR-ABL negative|atypical chronic myeloid leukemia, bcr-abl negative
621512|NCT00935090|blastic phase chronic myelogenous leukemia|blastic phase chronic myelogenous leukemia
621513|NCT00935090|chronic myelomonocytic leukemia|chronic myelomonocytic leukemia
621514|NCT00935090|chronic phase chronic myelogenous leukemia|chronic phase chronic myelogenous leukemia
621515|NCT00935090|mast cell leukemia|mast cell leukemia
621516|NCT00935090|meningeal chronic myelogenous leukemia|meningeal chronic myelogenous leukemia
621517|NCT00935090|progressive hairy cell leukemia, initial treatment|progressive hairy cell leukemia, initial treatment
621518|NCT00935090|prolymphocytic leukemia|prolymphocytic leukemia
621519|NCT00935090|recurrent adult acute lymphoblastic leukemia|recurrent adult acute lymphoblastic leukemia
621520|NCT00935090|recurrent adult acute myeloid leukemia|recurrent adult acute myeloid leukemia
621521|NCT00935090|recurrent adult T-cell leukemia/lymphoma|recurrent adult t-cell leukemia/lymphoma
621522|NCT00935090|refractory chronic lymphocytic leukemia|refractory chronic lymphocytic leukemia
621523|NCT00935090|refractory hairy cell leukemia|refractory hairy cell leukemia
621524|NCT00935090|relapsing chronic myelogenous leukemia|relapsing chronic myelogenous leukemia
621525|NCT00935090|secondary acute myeloid leukemia|secondary acute myeloid leukemia
621526|NCT00935090|stage I adult T-cell leukemia/lymphoma|stage i adult t-cell leukemia/lymphoma
621527|NCT00935090|stage I chronic lymphocytic leukemia|stage i chronic lymphocytic leukemia
621748|NCT00934596|Cardiac de-airing|cardiac de-airing
621528|NCT00935090|stage II adult T-cell leukemia/lymphoma|stage ii adult t-cell leukemia/lymphoma
621529|NCT00935090|stage II chronic lymphocytic leukemia|stage ii chronic lymphocytic leukemia
621530|NCT00935090|stage III adult T-cell leukemia/lymphoma|stage iii adult t-cell leukemia/lymphoma
621531|NCT00935090|stage III chronic lymphocytic leukemia|stage iii chronic lymphocytic leukemia
621532|NCT00935090|stage IV adult T-cell leukemia/lymphoma|stage iv adult t-cell leukemia/lymphoma
621533|NCT00935090|stage IV chronic lymphocytic leukemia|stage iv chronic lymphocytic leukemia
621534|NCT00935090|T-cell large granular lymphocyte leukemia|t-cell large granular lymphocyte leukemia
621535|NCT00935090|untreated adult acute lymphoblastic leukemia|untreated adult acute lymphoblastic leukemia
621536|NCT00935090|untreated adult acute myeloid leukemia|untreated adult acute myeloid leukemia
621537|NCT00935090|untreated hairy cell leukemia|untreated hairy cell leukemia
621538|NCT00935090|recurrent adult Hodgkin lymphoma|recurrent adult hodgkin lymphoma
621539|NCT00935090|stage I adult Hodgkin lymphoma|stage i adult hodgkin lymphoma
621540|NCT00935090|stage II adult Hodgkin lymphoma|stage ii adult hodgkin lymphoma
621541|NCT00935090|stage III adult Hodgkin lymphoma|stage iii adult hodgkin lymphoma
621542|NCT00935090|stage IV adult Hodgkin lymphoma|stage iv adult hodgkin lymphoma
621543|NCT00935090|anaplastic large cell lymphoma|anaplastic large cell lymphoma
621544|NCT00935090|angioimmunoblastic T-cell lymphoma|angioimmunoblastic t-cell lymphoma
621545|NCT00935090|cutaneous B-cell non-Hodgkin lymphoma|cutaneous b-cell non-hodgkin lymphoma
621546|NCT00935090|recurrent cutaneous T-cell non-Hodgkin lymphoma|recurrent cutaneous t-cell non-hodgkin lymphoma
621547|NCT00935090|stage I cutaneous T-cell non-Hodgkin lymphoma|stage i cutaneous t-cell non-hodgkin lymphoma
621548|NCT00935090|stage II cutaneous T-cell non-Hodgkin lymphoma|stage ii cutaneous t-cell non-hodgkin lymphoma
621549|NCT00935090|stage III cutaneous T-cell non-Hodgkin lymphoma|stage iii cutaneous t-cell non-hodgkin lymphoma
621550|NCT00935090|stage IV cutaneous T-cell non-Hodgkin lymphoma|stage iv cutaneous t-cell non-hodgkin lymphoma
621551|NCT00935090|recurrent mycosis fungoides/Sezary syndrome|recurrent mycosis fungoides/sezary syndrome
621552|NCT00935090|stage I mycosis fungoides/Sezary syndrome|stage i mycosis fungoides/sezary syndrome
621553|NCT00935090|stage II mycosis fungoides/Sezary syndrome|stage ii mycosis fungoides/sezary syndrome
621554|NCT00935090|stage III mycosis fungoides/Sezary syndrome|stage iii mycosis fungoides/sezary syndrome
621555|NCT00935090|stage IV mycosis fungoides/Sezary syndrome|stage iv mycosis fungoides/sezary syndrome
621556|NCT00935090|adult grade III lymphomatoid granulomatosis|adult grade iii lymphomatoid granulomatosis
621557|NCT00935090|adult nasal type extranodal NK/T-cell lymphoma|adult nasal type extranodal nk/t-cell lymphoma
621558|NCT00935090|Waldenstrom macroglobulinemia|waldenstrom macroglobulinemia
621559|NCT00935090|extranodal marginal zone B-cell lymphoma of mucosa-associated lymphoid tissue|extranodal marginal zone b-cell lymphoma of mucosa-associated lymphoid tissue
621560|NCT00935090|nodal marginal zone B-cell lymphoma|nodal marginal zone b-cell lymphoma
621561|NCT00935090|splenic marginal zone lymphoma|splenic marginal zone lymphoma
621562|NCT00935090|contiguous stage II adult Burkitt lymphoma|contiguous stage ii adult burkitt lymphoma
621563|NCT00935090|contiguous stage II adult diffuse large cell lymphoma|contiguous stage ii adult diffuse large cell lymphoma
621564|NCT00935090|contiguous stage II adult diffuse mixed cell lymphoma|contiguous stage ii adult diffuse mixed cell lymphoma
621565|NCT00935090|contiguous stage II adult diffuse small cleaved cell lymphoma|contiguous stage ii adult diffuse small cleaved cell lymphoma
621566|NCT00935090|contiguous stage II adult immunoblastic large cell lymphoma|contiguous stage ii adult immunoblastic large cell lymphoma
621567|NCT00935090|contiguous stage II adult lymphoblastic lymphoma|contiguous stage ii adult lymphoblastic lymphoma
621568|NCT00935090|contiguous stage II grade 1 follicular lymphoma|contiguous stage ii grade 1 follicular lymphoma
621569|NCT00935090|contiguous stage II grade 2 follicular lymphoma|contiguous stage ii grade 2 follicular lymphoma
621570|NCT00935090|contiguous stage II grade 3 follicular lymphoma|contiguous stage ii grade 3 follicular lymphoma
621571|NCT00935090|contiguous stage II mantle cell lymphoma|contiguous stage ii mantle cell lymphoma
621572|NCT00935090|contiguous stage II marginal zone lymphoma|contiguous stage ii marginal zone lymphoma
621573|NCT00935090|contiguous stage II small lymphocytic lymphoma|contiguous stage ii small lymphocytic lymphoma
621574|NCT00935090|stage I adult Burkitt lymphoma|stage i adult burkitt lymphoma
621575|NCT00935090|stage I adult diffuse large cell lymphoma|stage i adult diffuse large cell lymphoma
621576|NCT00935090|stage I adult diffuse mixed cell lymphoma|stage i adult diffuse mixed cell lymphoma
621577|NCT00935090|stage I adult diffuse small cleaved cell lymphoma|stage i adult diffuse small cleaved cell lymphoma
621578|NCT00935090|stage I adult immunoblastic large cell lymphoma|stage i adult immunoblastic large cell lymphoma
621579|NCT00935090|stage I adult lymphoblastic lymphoma|stage i adult lymphoblastic lymphoma
621580|NCT00935090|stage I grade 1 follicular lymphoma|stage i grade 1 follicular lymphoma
621581|NCT00935090|stage I grade 2 follicular lymphoma|stage i grade 2 follicular lymphoma
621582|NCT00935090|stage I grade 3 follicular lymphoma|stage i grade 3 follicular lymphoma
621583|NCT00935090|stage I mantle cell lymphoma|stage i mantle cell lymphoma
621584|NCT00935090|stage I marginal zone lymphoma|stage i marginal zone lymphoma
621585|NCT00935090|stage I small lymphocytic lymphoma|stage i small lymphocytic lymphoma
621586|NCT00935090|noncontiguous stage II adult Burkitt lymphoma|noncontiguous stage ii adult burkitt lymphoma
621587|NCT00935090|noncontiguous stage II adult diffuse large cell lymphoma|noncontiguous stage ii adult diffuse large cell lymphoma
621588|NCT00935090|noncontiguous stage II adult diffuse mixed cell lymphoma|noncontiguous stage ii adult diffuse mixed cell lymphoma
621749|NCT00934596|CO2 insufflation|co2 insufflation
621750|NCT00934596|Air emboli|air emboli
621589|NCT00935090|noncontiguous stage II adult diffuse small cleaved cell lymphoma|noncontiguous stage ii adult diffuse small cleaved cell lymphoma
621590|NCT00935090|noncontiguous stage II adult immunoblastic large cell lymphoma|noncontiguous stage ii adult immunoblastic large cell lymphoma
621591|NCT00935090|noncontiguous stage II adult lymphoblastic lymphoma|noncontiguous stage ii adult lymphoblastic lymphoma
621592|NCT00935090|noncontiguous stage II grade 1 follicular lymphoma|noncontiguous stage ii grade 1 follicular lymphoma
621593|NCT00935090|noncontiguous stage II grade 2 follicular lymphoma|noncontiguous stage ii grade 2 follicular lymphoma
621594|NCT00935090|noncontiguous stage II grade 3 follicular lymphoma|noncontiguous stage ii grade 3 follicular lymphoma
621595|NCT00935090|noncontiguous stage II mantle cell lymphoma|noncontiguous stage ii mantle cell lymphoma
621596|NCT00935090|noncontiguous stage II marginal zone lymphoma|noncontiguous stage ii marginal zone lymphoma
621597|NCT00935090|noncontiguous stage II small lymphocytic lymphoma|noncontiguous stage ii small lymphocytic lymphoma
621598|NCT00935090|stage III adult Burkitt lymphoma|stage iii adult burkitt lymphoma
621599|NCT00935090|stage III adult diffuse large cell lymphoma|stage iii adult diffuse large cell lymphoma
621600|NCT00935090|stage III adult diffuse mixed cell lymphoma|stage iii adult diffuse mixed cell lymphoma
621601|NCT00935090|stage III adult diffuse small cleaved cell lymphoma|stage iii adult diffuse small cleaved cell lymphoma
621602|NCT00935090|stage III adult immunoblastic large cell lymphoma|stage iii adult immunoblastic large cell lymphoma
621603|NCT00935090|stage III adult lymphoblastic lymphoma|stage iii adult lymphoblastic lymphoma
621604|NCT00935090|stage III grade 1 follicular lymphoma|stage iii grade 1 follicular lymphoma
621605|NCT00935090|stage III grade 2 follicular lymphoma|stage iii grade 2 follicular lymphoma
621606|NCT00935090|stage III grade 3 follicular lymphoma|stage iii grade 3 follicular lymphoma
621607|NCT00935090|stage III mantle cell lymphoma|stage iii mantle cell lymphoma
621608|NCT00935090|stage III marginal zone lymphoma|stage iii marginal zone lymphoma
621609|NCT00935090|stage III small lymphocytic lymphoma|stage iii small lymphocytic lymphoma
621610|NCT00935090|stage IV adult Burkitt lymphoma|stage iv adult burkitt lymphoma
621611|NCT00935090|stage IV adult diffuse large cell lymphoma|stage iv adult diffuse large cell lymphoma
621612|NCT00935090|stage IV adult diffuse mixed cell lymphoma|stage iv adult diffuse mixed cell lymphoma
621613|NCT00935090|stage IV adult diffuse small cleaved cell lymphoma|stage iv adult diffuse small cleaved cell lymphoma
621614|NCT00935090|stage IV adult immunoblastic large cell lymphoma|stage iv adult immunoblastic large cell lymphoma
621615|NCT00935090|stage IV adult lymphoblastic lymphoma|stage iv adult lymphoblastic lymphoma
621616|NCT00935090|stage IV grade 1 follicular lymphoma|stage iv grade 1 follicular lymphoma
621617|NCT00935090|stage IV grade 2 follicular lymphoma|stage iv grade 2 follicular lymphoma
621618|NCT00935090|stage IV grade 3 follicular lymphoma|stage iv grade 3 follicular lymphoma
621619|NCT00935090|stage IV mantle cell lymphoma|stage iv mantle cell lymphoma
621620|NCT00935090|stage IV marginal zone lymphoma|stage iv marginal zone lymphoma
621621|NCT00935090|stage IV small lymphocytic lymphoma|stage iv small lymphocytic lymphoma
621622|NCT00935090|recurrent adult Burkitt lymphoma|recurrent adult burkitt lymphoma
621623|NCT00935090|recurrent adult diffuse large cell lymphoma|recurrent adult diffuse large cell lymphoma
621624|NCT00935090|recurrent adult diffuse mixed cell lymphoma|recurrent adult diffuse mixed cell lymphoma
621625|NCT00935090|recurrent adult diffuse small cleaved cell lymphoma|recurrent adult diffuse small cleaved cell lymphoma
621626|NCT00935090|recurrent adult grade III lymphomatoid granulomatosis|recurrent adult grade iii lymphomatoid granulomatosis
621627|NCT00935090|recurrent adult immunoblastic large cell lymphoma|recurrent adult immunoblastic large cell lymphoma
621628|NCT00935090|recurrent adult lymphoblastic lymphoma|recurrent adult lymphoblastic lymphoma
621629|NCT00935090|recurrent grade 1 follicular lymphoma|recurrent grade 1 follicular lymphoma
621630|NCT00935090|recurrent grade 2 follicular lymphoma|recurrent grade 2 follicular lymphoma
621631|NCT00935090|recurrent grade 3 follicular lymphoma|recurrent grade 3 follicular lymphoma
621632|NCT00935090|recurrent mantle cell lymphoma|recurrent mantle cell lymphoma
621633|NCT00935090|recurrent marginal zone lymphoma|recurrent marginal zone lymphoma
621634|NCT00935090|recurrent small lymphocytic lymphoma|recurrent small lymphocytic lymphoma
621635|NCT00935090|intraocular lymphoma|intraocular lymphoma
621636|NCT00935090|primary central nervous system non-Hodgkin lymphoma|primary central nervous system non-hodgkin lymphoma
621637|NCT00935090|primary central nervous system Hodgkin lymphoma|primary central nervous system hodgkin lymphoma
621638|NCT00935090|post-transplant lymphoproliferative disorder|post-transplant lymphoproliferative disorder
621639|NCT00935090|chronic eosinophilic leukemia|chronic eosinophilic leukemia
621640|NCT00935090|chronic neutrophilic leukemia|chronic neutrophilic leukemia
621641|NCT00935090|primary myelofibrosis|primary myelofibrosis
621642|NCT00935090|essential thrombocythemia|essential thrombocythemia
621643|NCT00935090|polycythemia vera|polycythemia vera
621644|NCT00935090|extramedullary plasmacytoma|extramedullary plasmacytoma
621645|NCT00935090|isolated plasmacytoma of bone|isolated plasmacytoma of bone
621646|NCT00935090|stage I multiple myeloma|stage i multiple myeloma
621647|NCT00935090|stage II multiple myeloma|stage ii multiple myeloma
621648|NCT00935090|stage III multiple myeloma|stage iii multiple myeloma
621649|NCT00935090|primary systemic amyloidosis|primary systemic amyloidosis
621650|NCT00935090|refractory multiple myeloma|refractory multiple myeloma
621651|NCT00935090|de novo myelodysplastic syndromes|de novo myelodysplastic syndromes
621652|NCT00935090|previously treated myelodysplastic syndromes|previously treated myelodysplastic syndromes
621653|NCT00935090|secondary myelodysplastic syndromes|secondary myelodysplastic syndromes
621654|NCT00935090|myelodysplastic/myeloproliferative neoplasm, unclassifiable|myelodysplastic/myeloproliferative neoplasm, unclassifiable
621655|NCT00935077|Hypertension|hypertension
621656|NCT00935077|Pharmacist Physician Collaborative Management of Hypertension|pharmacist physician collaborative management of hypertension
621657|NCT00935064|Diabetes|diabetes
621658|NCT00935051|type 1 diabetes|type 1 diabetes
621659|NCT00935051|type 2 diabetes|type 2 diabetes
621660|NCT00935051|Diabetic foot ulcer|diabetic foot ulcer
621661|NCT00935025|Phase I|phase i
621662|NCT00935025|Japanese healthy volunteer|japanese healthy volunteer
621663|NCT00935025|AZD1305|azd1305
621664|NCT00935025|Japanese and Caucasian|japanese and caucasian
621665|NCT00934986|Chronic Lymphocytic Leukemia|chronic lymphocytic leukemia
621666|NCT00934986|NK Cells|nk cells
621667|NCT00934973|irritable bowel syndrome|irritable bowel syndrome
621668|NCT00934973|treatment|treatment
621669|NCT00934960|vision|vision
621670|NCT00934960|Intraocular lenses|intraocular lenses
621671|NCT00934947|Burns|burns
621672|NCT00934947|Pain|pain
621673|NCT00934934|Candida|candida
621674|NCT00934934|ventilator associated pneumonia|ventilator associated pneumonia
621675|NCT00934934|respiratory tract infection|respiratory tract infection
621676|NCT00934934|antifungal|antifungal
621677|NCT00934934|biomarker|biomarker
621678|NCT00934921|Bioequivalence|bioequivalence
621679|NCT00934908|Zyprexa®|zyprexa®
621680|NCT00934908|Green Tea|green tea
621681|NCT00934908|ALL|all
621682|NCT00934895|stage IIIA breast cancer|stage iiia breast cancer
621683|NCT00934895|stage IIIB breast cancer|stage iiib breast cancer
621684|NCT00934895|stage IIIC breast cancer|stage iiic breast cancer
621685|NCT00934895|stage IV breast cancer|stage iv breast cancer
621686|NCT00934895|HER2-negative breast cancer|her2-negative breast cancer
621687|NCT00934895|recurrent breast cancer|recurrent breast cancer
621688|NCT00934882|Colorectal cancer|colorectal cancer
621689|NCT00934882|Targeted therapy|targeted therapy
621690|NCT00934882|Multi-kinase inhibitor|multi-kinase inhibitor
621691|NCT00934882|FOLFOX|folfox
621692|NCT00934882|FOLFIRI|folfiri
621693|NCT00934843|Cardiopulmonary Bypass (CPB)|cardiopulmonary bypass (cpb)
621694|NCT00934843|System Inflammatory Response|system inflammatory response
621695|NCT00934843|Low Cardiac Output Syndrome (LCOS) in Neonates|low cardiac output syndrome (lcos) in neonates
621696|NCT00934843|Methylprednisolone|methylprednisolone
621697|NCT00934843|Cardiopulmonary Bypass (CPB) in Neonates|cardiopulmonary bypass (cpb) in neonates
621698|NCT00934843|Glucocorticoid Use in Neonatal Cardiac Surgery|glucocorticoid use in neonatal cardiac surgery
621699|NCT00934843|Steroid|steroid
621700|NCT00934830|Antibiotic|antibiotic
621701|NCT00934830|Ultrasound|ultrasound
621702|NCT00934830|Efficacy|efficacy
621703|NCT00934830|Treatment|treatment
621704|NCT00934817|Volunteer|volunteer
621705|NCT00934804|refractive surgery|refractive surgery
621706|NCT00934791|Kidney Transplant|kidney transplant
621707|NCT00934791|Autosomal dominant polycystic kidney disease|autosomal dominant polycystic kidney disease
621708|NCT00934791|Polycystic liver disease|polycystic liver disease
621709|NCT00934778|Confocal microscopy|confocal microscopy
621710|NCT00934778|Endocytoscopy|endocytoscopy
621711|NCT00934778|Diffuse lung disease|diffuse lung disease
621712|NCT00934778|Minimally invasive|minimally invasive
621713|NCT00934778|Lung cancer and dysplasia|lung cancer and dysplasia
621714|NCT00934765|overweight, obesity, male, fertility|overweight, obesity, male, fertility
621715|NCT00934752|de novo stenotic lesions|de novo stenotic lesions
621716|NCT00934739|High-Risk Oral Cavity Cancer,|high-risk oral cavity cancer,
621717|NCT00934739|Anti-Angiogenesis|anti-angiogenesis
621718|NCT00934726|Quality of Life|quality of life
621719|NCT00934726|Patient satisfaction|patient satisfaction
621720|NCT00934726|Schizophrenia|schizophrenia
621721|NCT00934726|Investigate quality of life in schizophrenia|investigate quality of life in schizophrenia
621722|NCT00934713|montelukast, very young children, lung function tests|montelukast, very young children, lung function tests
621723|NCT00934700|perinatal asphyxia|perinatal asphyxia
621724|NCT00934700|encephalopathy|encephalopathy
621725|NCT00934700|neuroprotection|neuroprotection
621726|NCT00934687|depression|depression
621727|NCT00934687|depressive|depressive
621728|NCT00934687|botulinum|botulinum
621729|NCT00934687|botox|botox
621730|NCT00934674|Healthy Subjects|healthy subjects
621731|NCT00934661|hip resurfacing|hip resurfacing
621732|NCT00934661|hip arthroplasty|hip arthroplasty
621733|NCT00934635|D2-receptor occupancy|d2-receptor occupancy
621734|NCT00934635|Antipsychotic drugs|antipsychotic drugs
621735|NCT00934635|Paliperidone ER, Oral risperidone|paliperidone er, oral risperidone
621736|NCT00934635|Dopamine|dopamine
621737|NCT00934635|Fallypride|fallypride
621738|NCT00934635|Plasma concentration|plasma concentration
621739|NCT00934635|Therapeutic window, Healthy controls|therapeutic window, healthy controls
621740|NCT00934622|AcrySof|acrysof
621741|NCT00934622|ReSTOR|restor
621742|NCT00934622|Aspheric IOL|aspheric iol
621743|NCT00934622|Cataract|cataract
621744|NCT00934609|Exercise|exercise
621745|NCT00934609|heart failure|heart failure
621746|NCT00934609|dilated cardiomyopathy|dilated cardiomyopathy
621747|NCT00934609|Endurance training|endurance training
621751|NCT00934596|Trans cranial doppler|trans cranial doppler
621752|NCT00934596|Intraoperative echocardiography|intraoperative echocardiography
621753|NCT00934583|Bulimia Nervosa|bulimia nervosa
621754|NCT00934583|Binge Eating|binge eating
621755|NCT00934583|Binge-Eating Disorder|binge-eating disorder
621756|NCT00934570|Obesity|obesity
621757|NCT00934570|Metformin|metformin
621758|NCT00934570|Physical activity|physical activity
621759|NCT00934570|Cardiovascular health|cardiovascular health
621760|NCT00934544|Myelofibrosis|myelofibrosis
621761|NCT00934544|Post-Polycythemia Vera Myelofibrosis|post-polycythemia vera myelofibrosis
621762|NCT00934544|Post-Essential Thrombocythemia Myelofibrosis|post-essential thrombocythemia myelofibrosis
621763|NCT00934531|Mild Cognitive Impairment (MCI)|mild cognitive impairment (mci)
621764|NCT00934531|Falls|falls
621765|NCT00934531|donepezil|donepezil
621766|NCT00934531|gait variability|gait variability
712287|NCT00580814|methylphenidate|methylphenidate
621767|NCT00934518|Squamous cell carcinoma, Head and Neck cancer|squamous cell carcinoma, head and neck cancer
621768|NCT00934505|Positron-Emission Tomography|positron-emission tomography
621769|NCT00934505|PET Scan|pet scan
621770|NCT00934505|FDG|fdg
621771|NCT00934505|oesophageal cancer|oesophageal cancer
621772|NCT00934505|chemo-Radiation Oncology|chemo-radiation oncology
621773|NCT00934505|SUV|suv
621774|NCT00934492|Malnutrition|malnutrition
621775|NCT00934492|Wasting|wasting
621776|NCT00934492|Kwashiorkor|kwashiorkor
621777|NCT00934492|Immune deficiency|immune deficiency
621778|NCT00934492|Infection|infection
621779|NCT00934492|Prophylaxis|prophylaxis
621780|NCT00934492|Mortality|mortality
621781|NCT00934492|Kenya|kenya
621782|NCT00934479|Chronic Constipation|chronic constipation
621783|NCT00934479|Constipation Predominant Irritable Bowel Syndrome|constipation predominant irritable bowel syndrome
621784|NCT00934479|Intestinal Microecology|intestinal microecology
621785|NCT00934453|Healthy adult volunteers|healthy adult volunteers
621786|NCT00934453|Lactobacillus rhamnosus GG|lactobacillus rhamnosus gg
621787|NCT00934453|probiotic|probiotic
621788|NCT00934453|dietary supplement|dietary supplement
621789|NCT00934453|safety|safety
621790|NCT00934453|Safety Assessment|safety assessment
621791|NCT00934440|kidney cancer|kidney cancer
621792|NCT00934440|renal cell|renal cell
621793|NCT00934427|Raynaud's|raynaud's
621794|NCT00934427|scleroderma|scleroderma
621795|NCT00934427|nitroglycerin|nitroglycerin
621796|NCT00934427|MQX-503|mqx-503
621797|NCT00934427|treatment|treatment
621798|NCT00934401|FLT|flt
621799|NCT00934401|fluorolabeled thymidine|fluorolabeled thymidine
621800|NCT00934401|breast cancer|breast cancer
621801|NCT00934401|Positron-Emission Mammography|positron-emission mammography
621802|NCT00934388|Sportsmans groin, Gilmores groin|sportsmans groin, gilmores groin
621803|NCT00934375|Mild Cognitive Impairment|mild cognitive impairment
621804|NCT00934349|Comoro Island|comoro island
621805|NCT00934349|vit B1 intake|vit b1 intake
621806|NCT00934349|Thiamine status|thiamine status
621807|NCT00934349|Genetic factor|genetic factor
621808|NCT00934323|volunteer|volunteer
621809|NCT00934310|Patient Safety|patient safety
621810|NCT00934310|Team work|team work
621811|NCT00934310|Communication|communication
621812|NCT00934310|Ambulatory surgical patients|ambulatory surgical patients
621813|NCT00934297|MRI visible breast lesions that are occult under ultrasound|mri visible breast lesions that are occult under ultrasound
621814|NCT00934284|sciatic neuropathy|sciatic neuropathy
621815|NCT00934284|physical therapy|physical therapy
621816|NCT00934284|spinal injections|spinal injections
621817|NCT00934271|acromegaly|acromegaly
621818|NCT00934271|irradiation|irradiation
621819|NCT00934271|remission|remission
621820|NCT00934271|pituitary function|pituitary function
621821|NCT00934258|genes|genes
621822|NCT00934258|rosuvastatin|rosuvastatin
621823|NCT00934258|fenofibrate|fenofibrate
621824|NCT00934258|Cardiovascular (CV) diseases|cardiovascular (cv) diseases
621825|NCT00934258|dyslipidemia|dyslipidemia
621826|NCT00934258|metabolic syndrome|metabolic syndrome
621827|NCT00934258|identify genetic determinants of the wide range of interindividual variability in phenotypic and clinical response to the lipid-lowering drug classes|identify genetic determinants of the wide range of interindividual variability in phenotypic and clinical response to the lipid-lowering drug classes
621828|NCT00934258|identify genetic susceptibility to drug-related side effects.|identify genetic susceptibility to drug-related side effects.
621829|NCT00934245|Influenza|influenza
621830|NCT00934245|India|india
621831|NCT00934245|Children|children
621832|NCT00934245|Trivalent Influenza Vaccine (TIV)|trivalent influenza vaccine (tiv)
621833|NCT00934245|Inactivated poliovirus vaccine (IPV)|inactivated poliovirus vaccine (ipv)
621834|NCT00934245|Direct vaccine effectiveness|direct vaccine effectiveness
621835|NCT00934245|Indirect vaccine effectiveness|indirect vaccine effectiveness
621836|NCT00934232|cancer|cancer
621837|NCT00934232|myeloma|myeloma
621838|NCT00934219|hypertriglyceridemia|hypertriglyceridemia
621839|NCT00934219|triglycerides|triglycerides
621840|NCT00934219|familial hypertriglyceridemia|familial hypertriglyceridemia
621841|NCT00934206|Exercise|exercise
621842|NCT00934206|healthy subjects|healthy subjects
621843|NCT00934180|Bioequivalence|bioequivalence
622240|NCT00932269|Vaccination|vaccination
621844|NCT00934154|multiple myeloma|multiple myeloma
621845|NCT00934154|thalidomide|thalidomide
621846|NCT00934154|melphalan|melphalan
621847|NCT00934154|prednisolone|prednisolone
621848|NCT00934154|newly diagnosed|newly diagnosed
621849|NCT00934154|elderly|elderly
621850|NCT00934154|not eligible for transplantation|not eligible for transplantation
621851|NCT00934141|Organizational change|organizational change
621852|NCT00934141|process improvement|process improvement
621853|NCT00934141|addiction treatment|addiction treatment
621854|NCT00934141|cost effectiveness study|cost effectiveness study
621855|NCT00934128|Advanced Cancer|advanced cancer
621856|NCT00934128|Persistent Dyspnea|persistent dyspnea
621857|NCT00934128|Shortness of breath|shortness of breath
621858|NCT00934128|Specialized breathing devices|specialized breathing devices
621859|NCT00934128|Bilevel positive airway pressure device|bilevel positive airway pressure device
621860|NCT00934128|BIPAP|bipap
621861|NCT00934128|High flow oxygen delivery device|high flow oxygen delivery device
621862|NCT00934128|VapoTherm|vapotherm
621863|NCT00934128|Edmonton Symptom Assessment Scale|edmonton symptom assessment scale
621864|NCT00934128|ESAS|esas
621865|NCT00934115|To define the incidence, categories of infections by organ systems, etiologic agents and risk|to define the incidence, categories of infections by organ systems, etiologic agents and risk
621866|NCT00934037|Coronary Artery Disease|coronary artery disease
621867|NCT00934037|Computed Tomography|computed tomography
621868|NCT00934037|Myoperfusion|myoperfusion
621869|NCT00934037|Angiography|angiography
621870|NCT00934037|SPECT|spect
621871|NCT00934024|nicotine dependence|nicotine dependence
621872|NCT00934024|tobacco|tobacco
621873|NCT00934024|smoking|smoking
621874|NCT00934011|C-reactive protein|c-reactive protein
621875|NCT00934011|procalcitonin|procalcitonin
621876|NCT00934011|sepsis|sepsis
621877|NCT00934011|antibiotic therapy|antibiotic therapy
621878|NCT00933998|DPN|dpn
621879|NCT00933959|Sleep problems|sleep problems
621880|NCT00933959|Awareness training program|awareness training program
621881|NCT00933959|Mind body bridging|mind body bridging
621882|NCT00933920|Aliskiren,|aliskiren,
621883|NCT00933920|hypertension,|hypertension,
621884|NCT00933920|renin-angiotensin-aldosterone system,|renin-angiotensin-aldosterone system,
621885|NCT00933920|pharmacokinetics,|pharmacokinetics,
621886|NCT00933920|pharmacodynamics|pharmacodynamics
621887|NCT00933894|VX-950-TiDP24-C133|vx-950-tidp24-c133
621888|NCT00933894|VX-950-C133|vx-950-c133
621889|NCT00933894|VX950|vx950
621890|NCT00933894|HCV|hcv
621891|NCT00933894|telaprevir|telaprevir
621892|NCT00933894|escitalopram|escitalopram
621893|NCT00933881|GDM|gdm
621894|NCT00933868|A stroke that occurred three months to four years ago|a stroke that occurred three months to four years ago
621895|NCT00933855|Training Workshop|training workshop
621896|NCT00933855|Communication|communication
621897|NCT00933855|Questionnaires|questionnaires
621898|NCT00933855|Multiple Diseases|multiple diseases
621899|NCT00933829|absorbable sutures|absorbable sutures
621900|NCT00933829|non-absorbable sutures|non-absorbable sutures
621901|NCT00933829|wound management|wound management
621902|NCT00933816|sorafenib|sorafenib
621903|NCT00933816|intraarterial infusion chemotherapy|intraarterial infusion chemotherapy
621904|NCT00933816|Low dose FP|low dose fp
621905|NCT00933816|cisplatin|cisplatin
621906|NCT00933816|fluorouracil|fluorouracil
621907|NCT00933790|TB|tb
621908|NCT00933790|HIV|hiv
621909|NCT00933790|ARR|arr
621910|NCT00933790|Short course chemotherapy|short course chemotherapy
621911|NCT00933790|Drug resistance|drug resistance
621912|NCT00933751|central venous oxygen saturation|central venous oxygen saturation
621913|NCT00933751|oxygen transport|oxygen transport
621914|NCT00933751|physiologic monitoring|physiologic monitoring
621915|NCT00933751|tissue oxygenation|tissue oxygenation
621916|NCT00933751|Patients before high risk abdominal surgery|patients before high risk abdominal surgery
621917|NCT00933738|Patients needing OAT (Oral Anticoagulation Therapy)|patients needing oat (oral anticoagulation therapy)
621918|NCT00933725|menopausal syndrome|menopausal syndrome
621919|NCT00933725|TCM intervention|tcm intervention
621920|NCT00933673|NK/T cell lymphoma|nk/t cell lymphoma
621921|NCT00933673|DICE|dice
621922|NCT00933673|L-asparaginase|l-asparaginase
621923|NCT00933660|Education|education
621924|NCT00933660|Retention|retention
621925|NCT00933660|Retrieval|retrieval
621926|NCT00933647|Camellia sinensis|camellia sinensis
621927|NCT00933647|Ilex paraguariensis|ilex paraguariensis
621928|NCT00933647|Green tea|green tea
621929|NCT00933647|Yerba mate tea|yerba mate tea
621930|NCT00933647|Maté|maté
621931|NCT00933647|Dyslipidemia|dyslipidemia
621932|NCT00933647|Inflammation|inflammation
621933|NCT00933647|Obesity|obesity
621934|NCT00933634|atrial fibrillation|atrial fibrillation
621935|NCT00933634|electrical cardioversion|electrical cardioversion
621936|NCT00933634|pharmacological cardioversion|pharmacological cardioversion
621937|NCT00933608|subjective memory complaints|subjective memory complaints
621938|NCT00933608|cognitively healthy|cognitively healthy
621939|NCT00933608|family history|family history
621940|NCT00933608|AD|ad
621941|NCT00933595|HIV|hiv
621942|NCT00933595|Lung|lung
621943|NCT00933582|Osteoarthritis, Knee|osteoarthritis, knee
621944|NCT00933582|Knee Pain|knee pain
621945|NCT00933582|Pain Measurement|pain measurement
621946|NCT00933582|Naproxen|naproxen
621948|NCT00933582|Treatment Outcome|treatment outcome
621949|NCT00933556|infection|infection
621950|NCT00933556|probiotics|probiotics
621951|NCT00933543|Acne Vulgaris|acne vulgaris
621952|NCT00933543|Moderate to severe|moderate to severe
621953|NCT00933517|breast cancer, neoadjuvant therapies, chemotherapy, targeted therapy|breast cancer, neoadjuvant therapies, chemotherapy, targeted therapy
621954|NCT00933491|healthy|healthy
621955|NCT00933478|Patulous Eustachian Tube Dysfunction|patulous eustachian tube dysfunction
621956|NCT00933465|Fecal incontinence|fecal incontinence
621957|NCT00933452|duloxetine|duloxetine
621958|NCT00933452|pharmacokinetics|pharmacokinetics
621959|NCT00933452|antidepressant|antidepressant
621960|NCT00933452|antidepressive agents|antidepressive agents
621961|NCT00933452|depression|depression
621962|NCT00933452|psychotropic drugs|psychotropic drugs
621963|NCT00933452|safety|safety
621964|NCT00933452|Chinese|chinese
621965|NCT00933452|HAN|han
621966|NCT00933452|BDNF|bdnf
621967|NCT00933439|Depression|depression
621968|NCT00933439|Major Depressive Disorder|major depressive disorder
621969|NCT00933439|Cognitive Function|cognitive function
621970|NCT00933439|Psychosocial Function|psychosocial function
621971|NCT00933426|Castration-Resistant Prostate Cancer|castration-resistant prostate cancer
621972|NCT00933426|CRPC|crpc
621973|NCT00933426|Prostate|prostate
621974|NCT00933426|Lenalidomide|lenalidomide
621975|NCT00933426|Revlimid|revlimid
621976|NCT00933426|CC-5103|cc-5103
621977|NCT00933426|Paclitaxel|paclitaxel
621978|NCT00933426|Taxol|taxol
621979|NCT00933426|Taxanes|taxanes
621980|NCT00933400|Computed Tomography|computed tomography
621981|NCT00933400|CTA|cta
621982|NCT00933400|Cardiac CT|cardiac ct
621983|NCT00933400|CT|ct
621984|NCT00933400|Cardiac CTA|cardiac cta
621985|NCT00933400|Chest Pain|chest pain
621986|NCT00933400|Heart Attack|heart attack
621987|NCT00933400|Emergency Department|emergency department
621988|NCT00933400|Myocardial Infarction|myocardial infarction
621989|NCT00933400|Cost Effectiveness|cost effectiveness
621990|NCT00933400|Acute Coronary Event|acute coronary event
621991|NCT00933400|Heart Imaging|heart imaging
621992|NCT00933387|oral squamous cell carcinoma|oral squamous cell carcinoma
621993|NCT00933387|neoadjuvant bio-chemotherapy|neoadjuvant bio-chemotherapy
621994|NCT00933387|concurrent bio-radiotherapy|concurrent bio-radiotherapy
621995|NCT00933387|biomarker|biomarker
621996|NCT00933374|bladder cancer|bladder cancer
621998|NCT00933374|Paclitaxel|paclitaxel
621999|NCT00933361|Adult|adult
622000|NCT00933348|ulcer|ulcer
622001|NCT00933348|venous|venous
622002|NCT00933348|pressure|pressure
622003|NCT00933348|wound|wound
622004|NCT00933348|treatment|treatment
622005|NCT00933322|ruminant|ruminant
622006|NCT00933322|industrial|industrial
622007|NCT00933322|endothelial function|endothelial function
622008|NCT00933322|flow-mediated dilation|flow-mediated dilation
622009|NCT00933322|blood lipids|blood lipids
622010|NCT00933322|nutrition|nutrition
622011|NCT00933322|trans fatty acids|trans fatty acids
622012|NCT00933322|coronary disease|coronary disease
622013|NCT00933322|endothelial function of the brachial artery|endothelial function of the brachial artery
622014|NCT00933322|inflammation|inflammation
622015|NCT00933322|insulin resistancy|insulin resistancy
622016|NCT00933322|coagulation|coagulation
622017|NCT00933309|Breast|breast
622018|NCT00933309|Obese|obese
622019|NCT00933309|Obesity Treatment|obesity treatment
622020|NCT00933309|Exemestane|exemestane
622021|NCT00933309|Aromasin|aromasin
622022|NCT00933309|Metformin and Rosiglitazone|metformin and rosiglitazone
622023|NCT00933309|Avandamet|avandamet
622024|NCT00933309|Postmenopausal|postmenopausal
622025|NCT00933309|Hormone-sensitive|hormone-sensitive
622026|NCT00933309|Hormone-receptive-positive breast cancer|hormone-receptive-positive breast cancer
622027|NCT00933296|Schnitzler syndrome|schnitzler syndrome
622028|NCT00933296|Waldentsröm's disease|waldentsröm's disease
622029|NCT00933296|anakinra|anakinra
622030|NCT00933283|Healthy participants|healthy participants
622031|NCT00933283|Pharmacokinetics|pharmacokinetics
622032|NCT00933283|Pharmacodynamic|pharmacodynamic
622033|NCT00933283|Potential interaction|potential interaction
622034|NCT00933283|VX-950-TiDP24-C135|vx-950-tidp24-c135
622035|NCT00933283|VX-950|vx-950
622036|NCT00933283|Methadone|methadone
622037|NCT00933283|Telaprevir|telaprevir
622038|NCT00933283|Steady-state|steady-state
622039|NCT00933270|Superficial Femoral Artery or SFA|superficial femoral artery or sfa
622040|NCT00933244|Vitamin D|vitamin d
622041|NCT00933244|Cholecalciferol|cholecalciferol
622042|NCT00933244|Parathyroid Hormone|parathyroid hormone
622043|NCT00933244|Calcium Absorption|calcium absorption
622044|NCT00933244|Bone Mineral Density|bone mineral density
622045|NCT00933244|Muscle Function|muscle function
622046|NCT00933231|Tacrolimus|tacrolimus
622047|NCT00933231|Kidney Transplantation|kidney transplantation
622048|NCT00933231|Advagraf|advagraf
622049|NCT00933231|Immunosuppression|immunosuppression
622050|NCT00933231|Angiotensin-Converting Enzyme Inhibitors|angiotensin-converting enzyme inhibitors
622051|NCT00933179|Prevention of pregnancy|prevention of pregnancy
622052|NCT00933153|Elderly|elderly
622053|NCT00933153|Malnutrition|malnutrition
622054|NCT00933153|Oral Nutrition Supplement|oral nutrition supplement
622055|NCT00933153|Meals on Wheels|meals on wheels
622056|NCT00933140|HIV|hiv
622057|NCT00933140|women|women
622058|NCT00933140|anal cytology|anal cytology
622059|NCT00933127|contiguous stage II grade 1 follicular lymphoma|contiguous stage ii grade 1 follicular lymphoma
622060|NCT00933127|contiguous stage II grade 2 follicular lymphoma|contiguous stage ii grade 2 follicular lymphoma
712288|NCT00580814|PET|pet
712289|NCT00580801|Hepatitis C|hepatitis c
791101|NCT00290108|BIS|bis
622061|NCT00933127|contiguous stage II grade 3 follicular lymphoma|contiguous stage ii grade 3 follicular lymphoma
622062|NCT00933127|noncontiguous stage II grade 1 follicular lymphoma|noncontiguous stage ii grade 1 follicular lymphoma
622063|NCT00933127|noncontiguous stage II grade 2 follicular lymphoma|noncontiguous stage ii grade 2 follicular lymphoma
622064|NCT00933127|noncontiguous stage II grade 3 follicular lymphoma|noncontiguous stage ii grade 3 follicular lymphoma
622065|NCT00933127|stage III grade 1 follicular lymphoma|stage iii grade 1 follicular lymphoma
622066|NCT00933127|stage III grade 2 follicular lymphoma|stage iii grade 2 follicular lymphoma
622067|NCT00933127|stage III grade 3 follicular lymphoma|stage iii grade 3 follicular lymphoma
622068|NCT00933127|stage IV grade 1 follicular lymphoma|stage iv grade 1 follicular lymphoma
622069|NCT00933127|stage IV grade 2 follicular lymphoma|stage iv grade 2 follicular lymphoma
622070|NCT00933127|stage IV grade 3 follicular lymphoma|stage iv grade 3 follicular lymphoma
622071|NCT00933114|DCE MRI|dce mri
622072|NCT00933114|PET|pet
622073|NCT00933114|Perfusion|perfusion
622074|NCT00933114|Permeability|permeability
622075|NCT00933114|Cancer of the head and neck|cancer of the head and neck
622076|NCT00933114|Head, Neck neoplasms|head, neck neoplasms
622077|NCT00933088|adolescent coping strategies|adolescent coping strategies
622078|NCT00933088|stress response|stress response
622079|NCT00933088|breast cancer|breast cancer
622080|NCT00933049|Efficacy|efficacy
622081|NCT00933049|children|children
622082|NCT00933049|pneumonia|pneumonia
622083|NCT00933049|cotrimoxazole|cotrimoxazole
622084|NCT00933049|amoxicillin|amoxicillin
622085|NCT00933036|Osteoporosis|osteoporosis
622086|NCT00933036|VCF|vcf
622087|NCT00933036|PVA|pva
622088|NCT00933036|Vertebroplasty|vertebroplasty
622089|NCT00933036|Kyphoplasty|kyphoplasty
622090|NCT00933036|Vertebral fracture|vertebral fracture
622091|NCT00933036|Pathologic fracture|pathologic fracture
622092|NCT00933036|Vertebral augmentation|vertebral augmentation
622093|NCT00933010|metabolic syndrome|metabolic syndrome
622094|NCT00933010|lipids|lipids
622095|NCT00933010|waist circumference|waist circumference
622096|NCT00933010|HDL|hdl
622097|NCT00933010|hypertension|hypertension
622098|NCT00932997|psychosocial effects of cancer and its treatment|psychosocial effects of cancer and its treatment
622099|NCT00932997|stage I breast cancer|stage i breast cancer
622100|NCT00932997|stage II breast cancer|stage ii breast cancer
622101|NCT00932997|stage IIIA breast cancer|stage iiia breast cancer
622102|NCT00932997|cancer survivor|cancer survivor
622103|NCT00932958|Myocardial Infarction|myocardial infarction
622104|NCT00932919|Agoraphobia|agoraphobia
622105|NCT00932919|Cognitive therapy|cognitive therapy
622106|NCT00932919|Thought field therapy|thought field therapy
622107|NCT00932919|Psychotherapy research|psychotherapy research
622108|NCT00932906|Education|education
622109|NCT00932906|Retention|retention
622110|NCT00932906|Retrieval|retrieval
622111|NCT00932906|Self training|self training
622112|NCT00932893|Lung Neoplasms ALK gene crizotinib|lung neoplasms alk gene crizotinib
622113|NCT00932867|Arterial Hypertension|arterial hypertension
622114|NCT00932854|Mediastinal lymphadenopathy|mediastinal lymphadenopathy
622115|NCT00932854|EBUS|ebus
622116|NCT00932854|Bronchoscopy|bronchoscopy
622117|NCT00932854|Sarcoidosis|sarcoidosis
622118|NCT00932828|Peanut allergy|peanut allergy
622119|NCT00932802|Non-Interventional|non-interventional
622120|NCT00932802|Observational|observational
622121|NCT00932802|NIS|nis
622122|NCT00932802|Moxifloxacin|moxifloxacin
622123|NCT00932802|MXF|mxf
622124|NCT00932802|Avelox|avelox
622125|NCT00932802|AECB|aecb
622126|NCT00932750|Body composition|body composition
622127|NCT00932750|Weight loss|weight loss
622128|NCT00932750|Weight management|weight management
622129|NCT00932750|Beverages|beverages
622130|NCT00932750|Diet|diet
622131|NCT00932724|Metastatic|metastatic
622132|NCT00932724|Colorectal|colorectal
622133|NCT00932724|Cancer|cancer
622134|NCT00932724|refractory|refractory
622135|NCT00932724|Phase II|phase ii
622136|NCT00932724|randomised|randomised
622137|NCT00932724|double-blind|double-blind
622138|NCT00932724|controlled|controlled
622139|NCT00932724|multicenter|multicenter
622140|NCT00932724|CY-503|cy-503
622141|NCT00932724|Cytavis|cytavis
622142|NCT00932711|COPD|copd
622143|NCT00932698|Relapsed multiple myeloma|relapsed multiple myeloma
622241|NCT00932269|Immunity|immunity
622144|NCT00932698|Refractory multiple myeloma|refractory multiple myeloma
622145|NCT00932698|Ixazomib Proteasome inhibitor|ixazomib proteasome inhibitor
622146|NCT00932685|pediatric emergence agitation and pain|pediatric emergence agitation and pain
622147|NCT00932672|Prostate Cancer|prostate cancer
622148|NCT00932672|Atkins|atkins
622149|NCT00932659|End-Stage Renal Disease|end-stage renal disease
622150|NCT00932659|Hemodialysis|hemodialysis
622151|NCT00932659|Cardiac Arrhythmias|cardiac arrhythmias
622152|NCT00932633|neonatal brain injury|neonatal brain injury
622153|NCT00932633|congenital heart disease|congenital heart disease
622154|NCT00932633|magnetic resonance imaging|magnetic resonance imaging
622155|NCT00932633|cardiopulmonary bypass|cardiopulmonary bypass
622156|NCT00932633|neurodevelopmental outcome|neurodevelopmental outcome
622157|NCT00932620|hypercholesterolemia|hypercholesterolemia
622158|NCT00932620|statins|statins
622159|NCT00932620|simvastatin|simvastatin
622160|NCT00932620|ezetimibe|ezetimibe
622161|NCT00932620|LDL particles|ldl particles
622162|NCT00932607|seasonal|seasonal
622163|NCT00932607|rhinitis|rhinitis
622164|NCT00932607|rhinoconjunctivitis|rhinoconjunctivitis
622165|NCT00932607|birch pollen|birch pollen
622166|NCT00932607|immunotherapy|immunotherapy
622167|NCT00932607|sublingual|sublingual
622168|NCT00932594|Create the New Serial Treatment of TMD|create the new serial treatment of tmd
622169|NCT00932594|Promote the Classification of Biodynamics in the TMD|promote the classification of biodynamics in the tmd
622170|NCT00932594|Evaluate the Effect of Adjusting TMJ Treatment|evaluate the effect of adjusting tmj treatment
622171|NCT00932594|Establish the New Standard of the TMJ Treatment|establish the new standard of the tmj treatment
622172|NCT00932594|Invent New Device to Measure Pressure without Trauma|invent new device to measure pressure without trauma
622173|NCT00932581|Parkinson's Disease|parkinson's disease
622174|NCT00932581|Movement Disorders|movement disorders
622175|NCT00932581|Unified Parkinson's Disease Rating Scale|unified parkinson's disease rating scale
622176|NCT00932581|Short Parkinson's Evaluation Scale|short parkinson's evaluation scale
622177|NCT00932581|Scales for Outcomes in Parkinson's Disease|scales for outcomes in parkinson's disease
622178|NCT00932581|Motor Evaluation|motor evaluation
622179|NCT00932581|Schwab and England activities of daily living|schwab and england activities of daily living
622180|NCT00932581|Bradykinesia|bradykinesia
622181|NCT00932581|psychometrics|psychometrics
622182|NCT00932581|order effects|order effects
622183|NCT00932581|hoehn yahr aging|hoehn yahr aging
622184|NCT00932581|assessments|assessments
622185|NCT00932555|Octocog alfa|octocog alfa
622186|NCT00932555|Hemophilia A|hemophilia a
622187|NCT00932542|Hemorrhoidectomy|hemorrhoidectomy
622188|NCT00932529|Antipsychotic drugs|antipsychotic drugs
622189|NCT00932529|Treatment effectiveness|treatment effectiveness
622190|NCT00932529|Randomized controlled trial|randomized controlled trial
622191|NCT00932516|South Beach Diet™|south beach diet™
622192|NCT00932516|overweight|overweight
622193|NCT00932516|obesity|obesity
622194|NCT00932516|satiety|satiety
622195|NCT00932516|weight loss|weight loss
622196|NCT00932503|Vicryl plus|vicryl plus
622197|NCT00932503|wound infection|wound infection
622198|NCT00932503|coated suture material|coated suture material
622199|NCT00932503|open abdominal surgery|open abdominal surgery
622200|NCT00932503|transverse laparotomy|transverse laparotomy
622201|NCT00932451|Lung Neoplasms ALK gene Crizotinib|lung neoplasms alk gene crizotinib
622202|NCT00932438|colon cancer|colon cancer
622203|NCT00932438|liver metastases|liver metastases
622204|NCT00932425|Stroke|stroke
622205|NCT00932425|Cryptogenic|cryptogenic
622206|NCT00932425|Cardioembolic|cardioembolic
622207|NCT00932425|Atrial Fibrillation|atrial fibrillation
622208|NCT00932412|Younger Patients with Newly-Diagnosed Acute Myeloid Leukemia (AML).|younger patients with newly-diagnosed acute myeloid leukemia (aml).
622209|NCT00932386|Lower extremity surgery with tourniquet use|lower extremity surgery with tourniquet use
622210|NCT00932373|HER2-positive breast cancer|her2-positive breast cancer
622211|NCT00932373|MBC|mbc
622212|NCT00932373|Trastuzumab emtansine|trastuzumab emtansine
622213|NCT00932373|Herceptin|herceptin
622214|NCT00932373|T-DM1|t-dm1
622215|NCT00932360|Fibromyalgia|fibromyalgia
622216|NCT00932360|Transcutaneous Electrical Nerve Stimulation (TENS)|transcutaneous electrical nerve stimulation (tens)
622217|NCT00932347|Camellia sinensis|camellia sinensis
622218|NCT00932347|volatile sulfur compounds|volatile sulfur compounds
622219|NCT00932334|kidney|kidney
622220|NCT00932334|transplant|transplant
622221|NCT00932334|donation|donation
622222|NCT00932321|Contraception|contraception
622223|NCT00932295|tobacco|tobacco
622224|NCT00932295|cigarette|cigarette
622225|NCT00932295|nicotine|nicotine
622226|NCT00932282|Peanut|peanut
622227|NCT00932282|Allergy|allergy
622228|NCT00932282|Hypersensitivity|hypersensitivity
622229|NCT00932269|Diphtheria|diphtheria
622230|NCT00932269|Tetanus|tetanus
622231|NCT00932269|Pertussis|pertussis
622233|NCT00932269|Haemophilus influenzae type B|haemophilus influenzae type b
622234|NCT00932269|Hib|hib
622235|NCT00932269|Measles|measles
622236|NCT00932269|Mumps|mumps
622237|NCT00932269|Rubella|rubella
622238|NCT00932269|Hepatitis B|hepatitis b
622239|NCT00932269|Vaccine|vaccine
622242|NCT00932269|Vaccination program|vaccination program
622244|NCT00932269|ELISA|elisa
622245|NCT00932256|Rhinitis, Allergic, Seasonal|rhinitis, allergic, seasonal
622246|NCT00932243|bacteremia|bacteremia
622247|NCT00932243|sepsis|sepsis
622248|NCT00932243|Toll-Like-Receptors (TLRs)|toll-like-receptors (tlrs)
622249|NCT00932204|obsessive-compulsive disorder|obsessive-compulsive disorder
622250|NCT00932204|repetitive transcranial magnetic stimulation|repetitive transcranial magnetic stimulation
622251|NCT00932204|right dorsolateral prefrontal cortex|right dorsolateral prefrontal cortex
712290|NCT00580801|Telaprevir|telaprevir
791433|NCT00288587|CHF|chf
622252|NCT00932204|supplementary motor area (SMA)|supplementary motor area (sma)
622253|NCT00932191|Cataract|cataract
622254|NCT00932191|Corneal endothelial cell loss|corneal endothelial cell loss
622255|NCT00932191|Ultrasound power|ultrasound power
622256|NCT00932191|Corneal endothelium|corneal endothelium
622257|NCT00932178|Anxiety|anxiety
622258|NCT00932178|Worry|worry
622259|NCT00932178|nervousness|nervousness
622260|NCT00932178|Older Adult|older adult
622261|NCT00932152|advanced non-small cell lung cancer|advanced non-small cell lung cancer
622262|NCT00932152|postmenopausal|postmenopausal
622263|NCT00932152|bevacizumab|bevacizumab
622264|NCT00932152|fulvestrant|fulvestrant
622265|NCT00932152|anastrozole|anastrozole
622266|NCT00932139|Hypertension|hypertension
622267|NCT00932139|blood pressure|blood pressure
622268|NCT00932139|arrhythmias|arrhythmias
622269|NCT00932139|mild to moderate hypertension|mild to moderate hypertension
622270|NCT00932126|Phase 1 dose escalation dose finding pharmacokinetic and pharmacodynamic study|phase 1 dose escalation dose finding pharmacokinetic and pharmacodynamic study
622271|NCT00932113|tumor necrosis factor (TNF) inhibitor|tumor necrosis factor (tnf) inhibitor
622272|NCT00932113|tumor necrosis factor (TNF) blockade|tumor necrosis factor (tnf) blockade
622273|NCT00932113|Methotrexate|methotrexate
622274|NCT00932113|treatment|treatment
622275|NCT00932113|mechanism|mechanism
622276|NCT00932113|psoriasis|psoriasis
622277|NCT00932100|ACS|acs
622278|NCT00932100|Acute Coronary Syndrome|acute coronary syndrome
622279|NCT00932100|Catheterization|catheterization
622280|NCT00932087|Platelet function|platelet function
622281|NCT00932087|diabetes|diabetes
622282|NCT00932087|metabolic syndrome|metabolic syndrome
622283|NCT00932074|Atopic Dermatitis|atopic dermatitis
622284|NCT00932061|Fibromyalgia|fibromyalgia
622285|NCT00932061|Healthy controls|healthy controls
622286|NCT00932061|Acupuncture|acupuncture
622287|NCT00932061|Sham Acupuncture|sham acupuncture
622288|NCT00932061|fMRI|fmri
622289|NCT00932061|Biological marker|biological marker
622290|NCT00932048|Diabetes Mellitus|diabetes mellitus
622291|NCT00932048|Statins|statins
622292|NCT00932048|PET|pet
622293|NCT00932035|breast cancer|breast cancer
622294|NCT00932035|axillary mapping|axillary mapping
622295|NCT00932035|lymphedema|lymphedema
622296|NCT00932009|Human papillomavirus infection|human papillomavirus infection
622297|NCT00932009|Tanzanian men|tanzanian men
622298|NCT00932009|Prevalence|prevalence
622299|NCT00931996|schizophrenia|schizophrenia
622300|NCT00931996|antipsychotic|antipsychotic
622301|NCT00931996|risperidone|risperidone
622302|NCT00931983|Incomplete spinal cord injuries|incomplete spinal cord injuries
622303|NCT00931983|Walking|walking
622304|NCT00931983|Treadmill|treadmill
622305|NCT00931983|Training|training
622306|NCT00931970|Hemodialysis|hemodialysis
622307|NCT00931970|Peritoneal dialysis|peritoneal dialysis
622308|NCT00931970|Mortality|mortality
622309|NCT00931970|Prospective cohort|prospective cohort
622310|NCT00931970|Clinical study|clinical study
622311|NCT00931957|Etanercept|etanercept
622312|NCT00931957|Behcet's syndrome|behcet's syndrome
622313|NCT00931957|Behcet's Disease|behcet's disease
622314|NCT00931957|Ocular Lesions|ocular lesions
622315|NCT00931957|Uveitis|uveitis
622316|NCT00931957|Retinal Vasculitis|retinal vasculitis
622317|NCT00931944|ALS|als
622318|NCT00931944|Amyotrophic Lateral Sclerosis|amyotrophic lateral sclerosis
622319|NCT00931944|Lou Gehrig|lou gehrig
622320|NCT00931944|Lou Gehrig's|lou gehrig's
622321|NCT00931944|Lou Gehrig's disease|lou gehrig's disease
622322|NCT00931944|Motor Neuron Disease|motor neuron disease
622323|NCT00931944|Nervous System Diseases|nervous system diseases
622324|NCT00931944|KNS-760704|kns-760704
622325|NCT00931944|RTPB|rtpb
622326|NCT00931905|This study included workers exposed to lead.|this study included workers exposed to lead.
622327|NCT00931892|celiac disease|celiac disease
622328|NCT00931892|gluten challenge|gluten challenge
622329|NCT00931866|diclofenac|diclofenac
622330|NCT00931866|acute pain|acute pain
622331|NCT00931866|topical|topical
622332|NCT00931866|patch|patch
622333|NCT00931866|Acute Pain due to Mild to Moderate Soft Tissue Injury|acute pain due to mild to moderate soft tissue injury
622334|NCT00931840|EZN-2208 (PEG-SN38)|ezn-2208 (peg-sn38)
622335|NCT00931827|Contraception|contraception
622336|NCT00931814|Depression|depression
622337|NCT00931814|physical function|physical function
622338|NCT00931814|Quality of life|quality of life
622339|NCT00931801|AIDS|aids
622340|NCT00931801|HIV|hiv
622341|NCT00931801|Atazanavir|atazanavir
622344|NCT00931801|protease inhibitors|protease inhibitors
622345|NCT00931788|Management of hypertension and cholesterol|management of hypertension and cholesterol
622346|NCT00931788|stroke|stroke
622347|NCT00931788|TIA|tia
622348|NCT00931775|Major depressive disorder, citalopram, pindolol, HDRS|major depressive disorder, citalopram, pindolol, hdrs
622349|NCT00931762|Bone marrow|bone marrow
622350|NCT00931762|Myelofibrosis|myelofibrosis
622351|NCT00931762|JAK2mutation|jak2mutation
622352|NCT00931762|Post-Polycythemia Vera|post-polycythemia vera
622353|NCT00931762|Post-Essential Thrombocytopenia|post-essential thrombocytopenia
622354|NCT00931749|ultrasound therapy|ultrasound therapy
622355|NCT00931749|knee cartilage thickness|knee cartilage thickness
622356|NCT00931749|knee cartilage volume|knee cartilage volume
622357|NCT00931749|mild knee osteoarthritis|mild knee osteoarthritis
622358|NCT00931749|moderate knee osteoarthritis|moderate knee osteoarthritis
622359|NCT00931736|Tuberculosis|tuberculosis
622360|NCT00931723|Acute Mania|acute mania
622361|NCT00931723|Mania, Adults|mania, adults
622362|NCT00931723|Seroquel|seroquel
622363|NCT00931723|Acute Mania in Adult Patients|acute mania in adult patients
622364|NCT00931710|Hypertension|hypertension
622365|NCT00931710|combination therapy|combination therapy
622366|NCT00931710|valsartan|valsartan
622367|NCT00931710|cardiovascular diseases|cardiovascular diseases
622368|NCT00931697|Mefloquine|mefloquine
622369|NCT00931697|Malaria|malaria
622370|NCT00931697|(+) Mefloquine|(+) mefloquine
622371|NCT00931697|Pharmacokinetics|pharmacokinetics
622372|NCT00931671|Physical fitness|physical fitness
622373|NCT00931671|Cerebral circulation|cerebral circulation
622374|NCT00931671|Walking|walking
622375|NCT00931645|Chronic lymphocytic leukemia,|chronic lymphocytic leukemia,
622376|NCT00931645|autologous stem cell transplantation|autologous stem cell transplantation
622377|NCT00931632|Bronchopulmonary Dysplasia, BPD|bronchopulmonary dysplasia, bpd
622378|NCT00931619|Fluorine-18 Fluorodeoxyglucose|fluorine-18 fluorodeoxyglucose
622379|NCT00931619|Epilepsy|epilepsy
622380|NCT00931619|Epileptic Focus|epileptic focus
622381|NCT00931619|Temporal Lobe Epilepsy|temporal lobe epilepsy
622382|NCT00931619|Depression|depression
622383|NCT00931619|Major Depressive Disorder|major depressive disorder
622384|NCT00931619|Healthy Volunteer|healthy volunteer
622385|NCT00931619|HV|hv
622386|NCT00931606|anemia|anemia
622387|NCT00931606|metastatic|metastatic
622388|NCT00931606|breast|breast
622389|NCT00931606|cancer|cancer
622390|NCT00931593|Transient lower esophageal sphincter relaxation|transient lower esophageal sphincter relaxation
622391|NCT00931593|high resolution manometry|high resolution manometry
622392|NCT00931593|dentsleeve probe|dentsleeve probe
622393|NCT00931593|healthy volunteers|healthy volunteers
622394|NCT00931580|Vitamin D|vitamin d
622395|NCT00931580|Adolescent|adolescent
622396|NCT00931580|African American|african american
622397|NCT00931580|White|white
622398|NCT00931541|Safety|safety
622399|NCT00931541|Tolerability|tolerability
622400|NCT00931541|Healthy|healthy
622401|NCT00931528|sexual dysfunction|sexual dysfunction
622402|NCT00931528|stage IIB prostate cancer|stage iib prostate cancer
622403|NCT00931528|stage IIA prostate cancer|stage iia prostate cancer
622404|NCT00931528|adenocarcinoma of the prostate|adenocarcinoma of the prostate
622405|NCT00931515|DDD|ddd
622406|NCT00931502|Stent thrombosis|stent thrombosis
622407|NCT00931502|Acute Coronary Syndrome|acute coronary syndrome
622408|NCT00931502|ACS|acs
622409|NCT00931502|Stenting|stenting
622410|NCT00931502|Interventional Cardiology|interventional cardiology
622411|NCT00931502|Cardiology|cardiology
622412|NCT00931502|Cardiovascular Research|cardiovascular research
622413|NCT00931502|Registry|registry
622414|NCT00931489|Age Related Macular Degeneration|age related macular degeneration
622415|NCT00931489|Lucentis|lucentis
622416|NCT00931489|Ranibizumab|ranibizumab
622417|NCT00931489|Antibodies|antibodies
622418|NCT00931489|Retinal and RPE Autoimmunity|retinal and rpe autoimmunity
622419|NCT00931463|second line therapy|second line therapy
622420|NCT00931463|combination antiretroviral therapy|combination antiretroviral therapy
622421|NCT00931463|first-line failure|first-line failure
622422|NCT00931463|AIDS|aids
622423|NCT00931463|treatment experienced|treatment experienced
622424|NCT00931450|estrogen receptor-positive breast cancer|estrogen receptor-positive breast cancer
622425|NCT00931450|HER2-negative breast cancer|her2-negative breast cancer
622426|NCT00931450|stage IA breast cancer|stage ia breast cancer
622427|NCT00931450|stage IB breast cancer|stage ib breast cancer
622428|NCT00931450|stage II breast cancer|stage ii breast cancer
622429|NCT00931450|stage IIIA breast cancer|stage iiia breast cancer
622430|NCT00931450|stage IIIB breast cancer|stage iiib breast cancer
622431|NCT00931437|vitamin K|vitamin k
622432|NCT00931437|Bio-availability|bio-availability
622433|NCT00931424|Primary Chronic Venous Insufficiency|primary chronic venous insufficiency
622434|NCT00931424|surgery|surgery
622435|NCT00931424|reconstruction|reconstruction
622436|NCT00931424|valve|valve
622437|NCT00931411|Atopic Dermatitis|atopic dermatitis
622438|NCT00931411|Vitamin B3|vitamin b3
622439|NCT00931372|Insulin release|insulin release
622633|NCT00930501|AMH|amh
622440|NCT00931372|Diabetes mellitus type 2|diabetes mellitus type 2
622441|NCT00931372|GLP-1 agonist|glp-1 agonist
622442|NCT00931359|axillary|axillary
622443|NCT00931359|hyperhidrosis|hyperhidrosis
622444|NCT00931359|primary focal|primary focal
622445|NCT00931346|HIV|hiv
622446|NCT00931346|Human Immunodeficiency Virus|human immunodeficiency virus
622447|NCT00931333|Vertebroplasty|vertebroplasty
622448|NCT00931333|spine|spine
622449|NCT00931333|vertebra height|vertebra height
622450|NCT00931333|adverse events|adverse events
622451|NCT00931333|calcium phosphate bone cement|calcium phosphate bone cement
622452|NCT00931320|Ratio improvement|ratio improvement
622453|NCT00931320|LDL-C|ldl-c
622454|NCT00931320|HDL-C|hdl-c
622455|NCT00931320|Ratio of Low Density Lipoprotein Cholesterol to High Density Lipoprotein Cholesterol Improvement|ratio of low density lipoprotein cholesterol to high density lipoprotein cholesterol improvement
622456|NCT00931320|High Density Lipoprotein Cholesterol|high density lipoprotein cholesterol
622457|NCT00931281|Multiple Ascending Doses|multiple ascending doses
622458|NCT00931268|Lipoatrophy|lipoatrophy
622459|NCT00931268|Buttock treatment|buttock treatment
622460|NCT00931255|kidney transplant|kidney transplant
622461|NCT00931255|tacrolimus|tacrolimus
622462|NCT00931255|sirolimus|sirolimus
622463|NCT00931255|delayed graft function|delayed graft function
622464|NCT00931255|Graft survival|graft survival
622465|NCT00931255|Acute rejection|acute rejection
622466|NCT00931255|Chronic allograft nephropathy|chronic allograft nephropathy
622467|NCT00931242|eczema|eczema
622468|NCT00931242|dermatitis|dermatitis
622469|NCT00931242|TNF blockade|tnf blockade
622470|NCT00931242|PDE4 inhibitor|pde4 inhibitor
622471|NCT00931242|T cell inhibitor|t cell inhibitor
622472|NCT00931229|hepatitis B reactivation|hepatitis b reactivation
622473|NCT00931216|PMTCT|pmtct
622474|NCT00931216|Vertical transmission of HIV|vertical transmission of hiv
622475|NCT00931216|Pregnant women|pregnant women
622476|NCT00931216|Infant HIV testing|infant hiv testing
622477|NCT00931216|Kenya|kenya
622478|NCT00931216|AIDS|aids
622479|NCT00931164|phase I/II study|phase i/ii study
622480|NCT00931164|effects of sodium oxybate|effects of sodium oxybate
622481|NCT00931164|cohort of 6 children and young adults|cohort of 6 children and young adults
622483|NCT00931138|Acute Myeloid Leukemia in adults|acute myeloid leukemia in adults
622484|NCT00931138|Newly-diagnosed untreated AML|newly-diagnosed untreated aml
622485|NCT00931138|Patient aged 50 to 70 years|patient aged 50 to 70 years
622486|NCT00931125|Severe proliferative diabetic retinopathy|severe proliferative diabetic retinopathy
622487|NCT00931112|Peripheral Arterial Disease|peripheral arterial disease
622488|NCT00931112|Walking ability|walking ability
622489|NCT00931112|Quality of life|quality of life
622490|NCT00931112|Exercise training|exercise training
622491|NCT00931099|pregnancy|pregnancy
622492|NCT00931099|sleep disordered breathing|sleep disordered breathing
622493|NCT00931099|obstructive sleep apnea|obstructive sleep apnea
622494|NCT00931086|Rheumatoid Arthritis|rheumatoid arthritis
622495|NCT00931086|RA|ra
622496|NCT00931073|Drug Interactions|drug interactions
622497|NCT00931073|pharmacokinetics|pharmacokinetics
622498|NCT00931073|CYP2D6|cyp2d6
622499|NCT00931073|CYP2C19|cyp2c19
622500|NCT00931073|ketoconazole|ketoconazole
622501|NCT00931073|omeprazole|omeprazole
622502|NCT00931060|Ammonia|ammonia
622503|NCT00931060|Citric acid cycle|citric acid cycle
622504|NCT00931060|Branched Chain Amino Acids|branched chain amino acids
622505|NCT00931034|South Beach Diet™|south beach diet™
622506|NCT00931034|overweight|overweight
622507|NCT00931034|obesity|obesity
622508|NCT00931034|satiety|satiety
622509|NCT00931034|weight loss|weight loss
622510|NCT00931034|diabetes|diabetes
622511|NCT00931008|Locally Advanced or Metastatic Non-Small Cell Lung Cancer|locally advanced or metastatic non-small cell lung cancer
622512|NCT00930982|Ciprofloxacin|ciprofloxacin
622513|NCT00930982|Airway infection|airway infection
622514|NCT00930982|Bronchiectasis|bronchiectasis
622515|NCT00930969|Cardiac Ischemia|cardiac ischemia
622516|NCT00930969|ST segment elevated Myocardial Infarction (STEMI)|st segment elevated myocardial infarction (stemi)
622517|NCT00930969|Non-ST Segment elevated Myocardial Infarction (NSTEMI)|non-st segment elevated myocardial infarction (nstemi)
622518|NCT00930969|Implantable Cardioverter Defibrillator (ICD)|implantable cardioverter defibrillator (icd)
622519|NCT00930969|Cardiac Electrogram (EGM)|cardiac electrogram (egm)
622520|NCT00930969|Coronary Artery Disease (CAD)|coronary artery disease (cad)
622521|NCT00930956|Diabetes|diabetes
622522|NCT00930956|Obesity|obesity
622523|NCT00930956|Hyperglycemia|hyperglycemia
622524|NCT00930956|Dietary Fiber|dietary fiber
622525|NCT00930956|Wheat|wheat
622526|NCT00930956|Grain|grain
622527|NCT00930943|opioid tolerant|opioid tolerant
622528|NCT00930943|chronic pain|chronic pain
622529|NCT00930930|triple-negative breast cancer|triple-negative breast cancer
622530|NCT00930930|stage II breast cancer|stage ii breast cancer
622531|NCT00930930|stage IIIA breast cancer|stage iiia breast cancer
622532|NCT00930930|stage IIIB breast cancer|stage iiib breast cancer
622533|NCT00930930|stage IIIC breast cancer|stage iiic breast cancer
622534|NCT00930930|male breast cancer|male breast cancer
622535|NCT00930917|delivery room, polyethylene cap, preterm infant, temperature|delivery room, polyethylene cap, preterm infant, temperature
622536|NCT00930891|Extensive-Disease Small-Cell Lung Cancer|extensive-disease small-cell lung cancer
622537|NCT00930878|registry|registry
622538|NCT00930878|drug eluting coronary stent system|drug eluting coronary stent system
622539|NCT00930878|observational|observational
622540|NCT00930878|prospective|prospective
622541|NCT00930878|open-label|open-label
622542|NCT00930852|Migraine|migraine
622543|NCT00930852|Children|children
622544|NCT00930852|Primary headache disorders|primary headache disorders
622545|NCT00930852|Appetite|appetite
622546|NCT00930852|Obesity|obesity
622547|NCT00930852|Feeding Behavior|feeding behavior
622548|NCT00930839|Niacin|niacin
622549|NCT00930839|Prostaglandin D2|prostaglandin d2
622550|NCT00930839|Flushing|flushing
622551|NCT00930839|Nicotinic acid stimulated release of prostaglandin D2|nicotinic acid stimulated release of prostaglandin d2
622552|NCT00930826|The effect of bronchial asthma on school performance|the effect of bronchial asthma on school performance
622553|NCT00930813|Drug coated balloon|drug coated balloon
622554|NCT00930813|SFA disease|sfa disease
622555|NCT00930813|Femoropopliteal disease|femoropopliteal disease
622556|NCT00930813|Angioplasty|angioplasty
622557|NCT00930813|PAD|pad
622558|NCT00930813|Paclitaxel|paclitaxel
622559|NCT00930813|Tubulin modulators|tubulin modulators
622560|NCT00930813|Antineoplastic Agents|antineoplastic agents
622561|NCT00930813|Mitosis Modulators|mitosis modulators
622562|NCT00930813|Balloon angioplasty|balloon angioplasty
622563|NCT00930813|Local drug delivery|local drug delivery
622564|NCT00930813|Restenosis|restenosis
622565|NCT00930813|Drug-coated balloon|drug-coated balloon
622566|NCT00930800|Exercise capacity|exercise capacity
622567|NCT00930800|Physical activity|physical activity
622568|NCT00930800|Quality of life|quality of life
622569|NCT00930787|hernia repair, surgical mesh, co-morbidities|hernia repair, surgical mesh, co-morbidities
622570|NCT00930774|traumatic brain injury|traumatic brain injury
622571|NCT00930774|rehabilitation|rehabilitation
622572|NCT00930774|auditory processing disorder|auditory processing disorder
622573|NCT00930761|breast feeding|breast feeding
622574|NCT00930761|music therapy|music therapy
622575|NCT00930761|maternal welfare|maternal welfare
622576|NCT00930761|infant, newborn|infant, newborn
622577|NCT00930722|Quinapril non-interventional/observational study safety|quinapril non-interventional/observational study safety
622578|NCT00930709|Botulinum Toxin Type A|botulinum toxin type a
622579|NCT00930709|Exercise|exercise
622580|NCT00930709|Randomized Controlled Trial|randomized controlled trial
622581|NCT00930709|Muscle Stretching Exercises|muscle stretching exercises
622582|NCT00930709|Strength Training|strength training
622583|NCT00930709|Treatment Outcome|treatment outcome
622584|NCT00930696|endometriosis|endometriosis
622585|NCT00930696|abdominal lavage|abdominal lavage
622586|NCT00930696|bowel perforation|bowel perforation
622587|NCT00930696|discoid resection|discoid resection
622588|NCT00930696|laparoscopy|laparoscopy
622589|NCT00930670|ranitidine|ranitidine
622590|NCT00930670|pantoprazole|pantoprazole
622591|NCT00930670|esomeprazole|esomeprazole
622592|NCT00930670|omeprazole|omeprazole
622593|NCT00930670|atorvastatin|atorvastatin
622594|NCT00930670|rosuvastatin|rosuvastatin
622595|NCT00930670|statin|statin
622596|NCT00930670|clopidogrel resistance|clopidogrel resistance
622597|NCT00930670|antiplatelet therapy|antiplatelet therapy
622598|NCT00930670|coronary artery disease|coronary artery disease
622599|NCT00930670|percutaneous coronary intervention|percutaneous coronary intervention
622600|NCT00930670|stent|stent
622601|NCT00930670|clopidogrel|clopidogrel
622602|NCT00930670|proton pump inhibitors|proton pump inhibitors
622603|NCT00930670|drug interactions|drug interactions
622604|NCT00930670|drug resistance|drug resistance
622605|NCT00930670|genetic polymorphism|genetic polymorphism
622606|NCT00930657|Panic Disorder|panic disorder
622607|NCT00930657|Separation Anxiety|separation anxiety
622608|NCT00930657|Familial|familial
622609|NCT00930657|Risk|risk
622610|NCT00930657|Respiratory Physiology|respiratory physiology
622611|NCT00930644|short bowel syndrome|short bowel syndrome
622612|NCT00930644|parenteral nutrition|parenteral nutrition
622614|NCT00930644|HPN|hpn
622615|NCT00930644|TPN|tpn
622616|NCT00930644|SBS|sbs
622617|NCT00930631|CAD|cad
622618|NCT00930631|Pharmacokinetics|pharmacokinetics
622619|NCT00930631|BMS747158|bms747158
622620|NCT00930618|Prolonged pregnancy|prolonged pregnancy
622621|NCT00930618|Nulliparity|nulliparity
622622|NCT00930618|Cervical ripening|cervical ripening
622623|NCT00930618|Induced labor|induced labor
622624|NCT00930618|Cesarean section|cesarean section
622625|NCT00930592|Psoriasis|psoriasis
622626|NCT00930592|Metabolic Syndrome|metabolic syndrome
622627|NCT00930592|Cardiovascular Risk|cardiovascular risk
622628|NCT00930566|Allogeneic Hematopoietic Stem Cell Transplantation|allogeneic hematopoietic stem cell transplantation
622629|NCT00930566|Extracorporeal Photopheresis|extracorporeal photopheresis
622630|NCT00930553|Multiple Sclerosis|multiple sclerosis
622631|NCT00930501|chemotherapy|chemotherapy
622632|NCT00930501|cancer|cancer
622634|NCT00930501|gonadotoxicity|gonadotoxicity
622635|NCT00930501|ovarian reserve|ovarian reserve
622636|NCT00930501|patients exposed to chemotherapy|patients exposed to chemotherapy
622637|NCT00930488|Moxifloxacin|moxifloxacin
622638|NCT00930488|MXF|mxf
622639|NCT00930488|Avelox|avelox
622640|NCT00930488|Sinusitis|sinusitis
622641|NCT00930488|Acute bacterial sinusitis, ABS|acute bacterial sinusitis, abs
622642|NCT00930462|colonoscopy|colonoscopy
622643|NCT00930462|cap|cap
622644|NCT00930462|hood|hood
622645|NCT00930462|cecal intubation time|cecal intubation time
622646|NCT00930462|polyp detection rate|polyp detection rate
622647|NCT00930462|performance|performance
622648|NCT00930449|Pediatrics|pediatrics
622649|NCT00930449|Attention-Deficit Hyperactivity Disorder|attention-deficit hyperactivity disorder
622650|NCT00930449|Learning Disorder|learning disorder
622651|NCT00930449|Computerized Working Memory Training Program|computerized working memory training program
622652|NCT00930436|chronic kidney disease|chronic kidney disease
622653|NCT00930410|pancreas neoplasms|pancreas neoplasms
622654|NCT00930410|bile duct diseases|bile duct diseases
622655|NCT00930410|Cholangiopancreatography, Endoscopic Retrograde|cholangiopancreatography, endoscopic retrograde
622656|NCT00930410|ERCP|ercp
622657|NCT00930397|Pre-eclampsia|pre-eclampsia
622658|NCT00930397|UTERO-placental unit vascularization|utero-placental unit vascularization
622659|NCT00930397|Hypertension, pregnancy- induced|hypertension, pregnancy- induced
622660|NCT00930397|IUGR|iugr
622661|NCT00930397|Screening|screening
622662|NCT00930397|3D Doppler Ultrasound|3d doppler ultrasound
622663|NCT00930384|psoriasis|psoriasis
622664|NCT00930384|fatty liver|fatty liver
622665|NCT00930384|metabolic syndrome|metabolic syndrome
622666|NCT00930371|fatty liver|fatty liver
622667|NCT00930371|insulin resistance|insulin resistance
622668|NCT00930371|diet|diet
622669|NCT00930371|inflammation|inflammation
622670|NCT00930371|oxidative stress|oxidative stress
622671|NCT00930358|Sedation|sedation
622672|NCT00930358|Colonoscopy|colonoscopy
622673|NCT00930358|General anesthesia|general anesthesia
622674|NCT00930345|Renal cell carcinoma|renal cell carcinoma
622675|NCT00930345|Antiangiogenics|antiangiogenics
622676|NCT00930345|Biomarkers|biomarkers
622677|NCT00930345|Imagery|imagery
622678|NCT00930332|sleep disorders|sleep disorders
622679|NCT00930332|nausea and vomiting|nausea and vomiting
622680|NCT00930332|unspecified adult solid tumor, protocol specific|unspecified adult solid tumor, protocol specific
622681|NCT00930332|pain|pain
622682|NCT00930306|Chronic Pain|chronic pain
622683|NCT00930306|AZD2066|azd2066
622684|NCT00930293|Interpersonal Psychotherapy|interpersonal psychotherapy
622685|NCT00930280|stroke|stroke
622686|NCT00930280|brain attack|brain attack
622687|NCT00930280|hemorrhagic stroke|hemorrhagic stroke
622688|NCT00930280|risk factors|risk factors
622689|NCT00930267|fever|fever
622690|NCT00930267|children|children
622691|NCT00930267|cancer|cancer
622692|NCT00930267|leukemia|leukemia
622693|NCT00930267|stem cell transplantation|stem cell transplantation
622694|NCT00930267|infections in pediatric cancer patients presenting with fever during or following chemotherapy.|infections in pediatric cancer patients presenting with fever during or following chemotherapy.
622695|NCT00930254|pediatric nursing|pediatric nursing
622696|NCT00930254|peripheral catheterization|peripheral catheterization
622697|NCT00930254|ultrasonics|ultrasonics
622698|NCT00930254|intravenous infusions|intravenous infusions
622699|NCT00930241|Lung Transplantation|lung transplantation
622700|NCT00930241|Tacrolimus|tacrolimus
622701|NCT00930241|Deterioration of graft function|deterioration of graft function
622702|NCT00930228|Luteinizing hormone|luteinizing hormone
622703|NCT00930228|Testosterone|testosterone
622704|NCT00930215|Healthy volunteer|healthy volunteer
622705|NCT00930215|Japanese males|japanese males
622706|NCT00930215|homo-EM|homo-em
622707|NCT00930215|Bioequivalence study|bioequivalence study
622708|NCT00930202|Traumatic Brain Injury|traumatic brain injury
622709|NCT00930202|Conivaptan|conivaptan
622710|NCT00930202|Vaprisol|vaprisol
622711|NCT00930202|Sodium|sodium
622712|NCT00930189|age related macular degeneration|age related macular degeneration
622713|NCT00930163|Adult Asthma|adult asthma
622714|NCT00930150|Schizoaffective Disorder|schizoaffective disorder
622715|NCT00930137|Cardiovascular disease|cardiovascular disease
622716|NCT00930137|Trans fatty acids|trans fatty acids
622717|NCT00930137|Ruminant|ruminant
622718|NCT00930137|Blood lipids|blood lipids
622719|NCT00930137|Lipoproteins|lipoproteins
622720|NCT00930137|Women|women
622721|NCT00930124|cleft lip and palate|cleft lip and palate
622722|NCT00930124|distraction osteogenesis|distraction osteogenesis
622723|NCT00930124|conventional orthognathic surgery|conventional orthognathic surgery
622724|NCT00930124|stability|stability
622725|NCT00930124|morbidity|morbidity
622726|NCT00930124|soft tissue changes|soft tissue changes
622727|NCT00930124|psychological adjustment|psychological adjustment
622728|NCT00930124|speech changes|speech changes
622729|NCT00930124|velopharyngeal function|velopharyngeal function
622730|NCT00930111|inpatient|inpatient
622731|NCT00930111|hospitalists|hospitalists
622732|NCT00930111|residency|residency
622733|NCT00930111|job satisfaction|job satisfaction
622734|NCT00930111|burnout, professional|burnout, professional
622735|NCT00930111|professional practice|professional practice
622736|NCT00930111|medical education|medical education
622737|NCT00930098|acute lymphoblastic leukemia|acute lymphoblastic leukemia
622738|NCT00930098|clolar|clolar
622739|NCT00930098|evoltra|evoltra
622740|NCT00930098|clofarabine|clofarabine
622741|NCT00930098|refractory/relapsed acute leukemia|refractory/relapsed acute leukemia
622742|NCT00930098|pediatric acute leukemia|pediatric acute leukemia
622743|NCT00930085|sepsis|sepsis
622744|NCT00930085|septic shock|septic shock
622745|NCT00930059|Alzheimer's disease|alzheimer's disease
622746|NCT00930059|PF-04447943|pf-04447943
622747|NCT00930059|efficacy|efficacy
622748|NCT00930059|safety|safety
622749|NCT00930059|plasma concentrations|plasma concentrations
622750|NCT00930046|ropivacaine|ropivacaine
622751|NCT00930046|pediatric|pediatric
622752|NCT00930046|children|children
622753|NCT00930046|continuous|continuous
622754|NCT00930046|wound|wound
622755|NCT00930046|catheter|catheter
622756|NCT00930046|infusion|infusion
622757|NCT00930046|pyeloplasty|pyeloplasty
622758|NCT00930033|Nephrectomy,|nephrectomy,
622759|NCT00930033|metastatic renal cell carcinoma,|metastatic renal cell carcinoma,
622760|NCT00930033|sunitinib|sunitinib
622761|NCT00930020|ischemic stroke recovery|ischemic stroke recovery
622762|NCT00930020|minocycline|minocycline
622763|NCT00930020|neuroprotection|neuroprotection
622764|NCT00930020|acute stroke|acute stroke
622765|NCT00930007|Luteinizing hormone|luteinizing hormone
622766|NCT00930007|Puberty|puberty
622767|NCT00929994|cardiac rehab|cardiac rehab
622768|NCT00929981|Contact Dermatitis|contact dermatitis
622769|NCT00929981|Allergic Dermatitis|allergic dermatitis
622770|NCT00929968|Allergic rhinitis,|allergic rhinitis,
622771|NCT00929968|atopic patients,|atopic patients,
622772|NCT00929968|seasonal allergy,|seasonal allergy,
622773|NCT00929968|ragweed allergy|ragweed allergy
622774|NCT00929955|Anti inflammatory|anti inflammatory
622775|NCT00929955|Schizophrenia|schizophrenia
622776|NCT00929955|Simvastatin|simvastatin
622777|NCT00929955|ondansetron|ondansetron
622778|NCT00929942|lung transplantation|lung transplantation
622779|NCT00929942|bronchial stenosis|bronchial stenosis
622780|NCT00929942|biodegradable stent|biodegradable stent
622781|NCT00929929|Aging|aging
622782|NCT00929929|Functionality|functionality
622783|NCT00929929|Sarcopenia|sarcopenia
622784|NCT00929929|Leucine|leucine
622785|NCT00929929|Progressive resistance exercise|progressive resistance exercise
622786|NCT00929916|colonoscopy|colonoscopy
622787|NCT00929916|MoviPrep|moviprep
622788|NCT00929890|Obesity|obesity
622789|NCT00929890|Exercise|exercise
622790|NCT00929890|Diet|diet
622791|NCT00929890|Lifestyle|lifestyle
622792|NCT00929890|Vascular reactivity|vascular reactivity
622793|NCT00929890|Body composition|body composition
622794|NCT00929890|Lipids|lipids
622795|NCT00929890|Glucose|glucose
622796|NCT00929890|Insulin resistance|insulin resistance
622797|NCT00929838|Diabetes Mellitus, Type 2|diabetes mellitus, type 2
622798|NCT00929838|Diabetes Mellitus, Adult-Onset|diabetes mellitus, adult-onset
622799|NCT00929838|Diabetes Mellitus, Non-Insulin-Dependent|diabetes mellitus, non-insulin-dependent
622800|NCT00929838|African Americans|african americans
622801|NCT00929838|Blacks|blacks
622802|NCT00929838|Randomized Controlled Trial|randomized controlled trial
622803|NCT00929838|Controlled Clinical Trial|controlled clinical trial
622804|NCT00929838|Behavioral Research|behavioral research
622805|NCT00929838|Behavioral Medicine|behavioral medicine
622806|NCT00929825|Salivary stimulation|salivary stimulation
622807|NCT00929825|Transplantation of hematopoietic stem cells|transplantation of hematopoietic stem cells
622808|NCT00929825|Hyperboloid|hyperboloid
622809|NCT00929825|Transcutaneous Electrical Stimulation|transcutaneous electrical stimulation
622810|NCT00929812|obesity|obesity
622811|NCT00929812|food intake|food intake
622812|NCT00929812|glucagon|glucagon
622813|NCT00929812|ghrelin|ghrelin
622814|NCT00929812|glucose|glucose
622815|NCT00929812|insulin|insulin
622816|NCT00929786|Plasma levels isoniazid rifampicin pyrazinamide|plasma levels isoniazid rifampicin pyrazinamide
622817|NCT00929760|Chronic Kidney disease|chronic kidney disease
622818|NCT00929760|Nephrologists|nephrologists
622819|NCT00929760|Primary Care|primary care
622820|NCT00929760|Death|death
622821|NCT00929760|Renal Replacement Therapy|renal replacement therapy
622822|NCT00929760|Specialised renal care|specialised renal care
622823|NCT00929747|Cataract|cataract
622824|NCT00929747|Toric|toric
622826|NCT00929747|AcrySof, LRI|acrysof, lri
622827|NCT00929734|Inflammation|inflammation
622828|NCT00929734|Atherosclerosis|atherosclerosis
622829|NCT00929734|Hydroxymethylglutaryl-coenzyme A Reductase Inhibitors|hydroxymethylglutaryl-coenzyme a reductase inhibitors
622830|NCT00929721|CAP|cap
622831|NCT00929708|COPD|copd
622832|NCT00929708|Efficacy|efficacy
622833|NCT00929708|Safety|safety
622834|NCT00929708|Inhalation|inhalation
622835|NCT00929682|Labor|labor
622836|NCT00929682|Epidural analgesia|epidural analgesia
622837|NCT00929682|Local anesthetics|local anesthetics
792103|NCT00285662|SP|sp
622838|NCT00929682|Levobupivacaine|levobupivacaine
622839|NCT00929682|Opiates|opiates
622840|NCT00929682|Patient-controlled|patient-controlled
622841|NCT00929682|Active spontaneous labor requiring epidural analgesia|active spontaneous labor requiring epidural analgesia
622842|NCT00929669|pituitary tumor|pituitary tumor
622843|NCT00929669|endocrine|endocrine
622844|NCT00929656|Rehabilitation|rehabilitation
622845|NCT00929656|Neurophysiology|neurophysiology
622846|NCT00929656|Upper Extremity|upper extremity
622847|NCT00929643|health care costs|health care costs
622848|NCT00929643|Intra-Abdominal Infection|intra-abdominal infection
622849|NCT00929630|fibrin glue|fibrin glue
622850|NCT00929630|transsphincteric anal fistulas|transsphincteric anal fistulas
622851|NCT00929630|seton|seton
622852|NCT00929630|incontinence|incontinence
622977|NCT00929162|cancer|cancer
622853|NCT00929630|prospective randomised trial|prospective randomised trial
622854|NCT00929617|breast cancer|breast cancer
622855|NCT00929617|physical activity|physical activity
622856|NCT00929617|exercise|exercise
622857|NCT00929617|quality of life|quality of life
622858|NCT00929617|doubly labeled water|doubly labeled water
622859|NCT00929604|HIV|hiv
622860|NCT00929604|AIDS|aids
622861|NCT00929604|Zambia|zambia
622862|NCT00929604|viral load|viral load
622863|NCT00929604|antiretroviral therapy|antiretroviral therapy
622864|NCT00929604|cluster randomization|cluster randomization
622865|NCT00929604|ART monitoring|art monitoring
622866|NCT00929604|treatment failure|treatment failure
622867|NCT00929604|randomized clinical trial|randomized clinical trial
622868|NCT00929604|treatment naive|treatment naive
622869|NCT00929591|stage II breast cancer|stage ii breast cancer
622870|NCT00929591|stage IIIA breast cancer|stage iiia breast cancer
622871|NCT00929578|Psoriasis|psoriasis
622872|NCT00929578|T-lymphocytes|t-lymphocytes
622873|NCT00929578|Fluphenazine|fluphenazine
622874|NCT00929565|hemoptysis|hemoptysis
622875|NCT00929552|Blood pressure|blood pressure
622876|NCT00929552|Insulin sensitivity|insulin sensitivity
622877|NCT00929552|Blood lipid profile|blood lipid profile
622878|NCT00929539|Diabetes|diabetes
622879|NCT00929526|HPV vaccine|hpv vaccine
622880|NCT00929526|cervical intraepithelial neoplasia (CIN)|cervical intraepithelial neoplasia (cin)
622881|NCT00929526|including new onset of autoimmune disease [NOAD])|including new onset of autoimmune disease [noad])
622882|NCT00929526|new onset of chronic disease (NOCD)|new onset of chronic disease (nocd)
622883|NCT00929526|medically significant condition (MSC)|medically significant condition (msc)
622884|NCT00929487|contact lens wear|contact lens wear
622885|NCT00929487|contact lens solution|contact lens solution
622886|NCT00929487|corneal staining|corneal staining
622887|NCT00929461|omega-3 fatty acids|omega-3 fatty acids
622888|NCT00929461|lactate|lactate
622889|NCT00929461|surgery|surgery
622890|NCT00929461|gastric cancer|gastric cancer
622891|NCT00929461|address the effect of postoperative administration of omega-3 fatty acids on cellular hypoperfusion associated with major gastric surgery.|address the effect of postoperative administration of omega-3 fatty acids on cellular hypoperfusion associated with major gastric surgery.
622892|NCT00929448|Traumatic brain injury|traumatic brain injury
622893|NCT00929435|MRSA|mrsa
622894|NCT00929435|Contact isolation|contact isolation
622895|NCT00929435|Incidence|incidence
622896|NCT00929422|spinal cord injury|spinal cord injury
622897|NCT00929422|PET|pet
622898|NCT00929422|cerebral function|cerebral function
622899|NCT00929422|cortical reorganization|cortical reorganization
622900|NCT00929409|Postpartum anemia, iron-deficiency|postpartum anemia, iron-deficiency
622901|NCT00929396|Tuberculosis|tuberculosis
622902|NCT00929396|Vaccine|vaccine
622903|NCT00929396|Ag85B|ag85b
622904|NCT00929396|ESAT-6|esat-6
622905|NCT00929396|IC31|ic31
622906|NCT00929383|Intracranial Atherosclerosis|intracranial atherosclerosis
622907|NCT00929383|Stenosis|stenosis
622908|NCT00929383|ICAD|icad
622909|NCT00929383|atherosclerotic lesions|atherosclerotic lesions
622910|NCT00929383|stenting|stenting
622911|NCT00929370|Schizophrenia|schizophrenia
622912|NCT00929370|GSK1018921|gsk1018921
622913|NCT00929370|GlyT-1 inhibitor|glyt-1 inhibitor
622914|NCT00929370|Healthy Volunteers|healthy volunteers
622915|NCT00929370|CSF|csf
622916|NCT00929370|Patient|patient
622917|NCT00929370|Midazolam|midazolam
622918|NCT00929344|Alcohol|alcohol
622919|NCT00929344|Alcohol treatment|alcohol treatment
622920|NCT00929344|Alcoholism|alcoholism
622921|NCT00929344|Alcohol Abuse|alcohol abuse
622922|NCT00929344|Alcohol Dependence|alcohol dependence
622923|NCT00929331|Influenza|influenza
622924|NCT00929331|Fluviral®|fluviral®
622925|NCT00929305|chronic pain|chronic pain
622926|NCT00929305|neck|neck
622927|NCT00929305|shoulder|shoulder
622928|NCT00929305|musculoskeletal origin|musculoskeletal origin
622929|NCT00929292|Infant formula|infant formula
622930|NCT00929292|Alpha-lactalbumin|alpha-lactalbumin
622931|NCT00929292|Protein composition|protein composition
622932|NCT00929292|Colic|colic
622933|NCT00929292|Probiotics|probiotics
622934|NCT00929279|Acute coronary syndrome|acute coronary syndrome
622935|NCT00929279|Abciximab|abciximab
622936|NCT00929279|Bolus|bolus
622937|NCT00929279|Infusion|infusion
622938|NCT00929279|platelet inhibition|platelet inhibition
622939|NCT00929279|Non ST segment elevation acute coronary syndrome|non st segment elevation acute coronary syndrome
622940|NCT00929266|peripheral stem cells (PSC) donors|peripheral stem cells (psc) donors
622941|NCT00929266|cultured red blood cells|cultured red blood cells
622942|NCT00929266|In vivo half life|in vivo half life
622943|NCT00929253|Opioid Dependence|opioid dependence
622944|NCT00929253|Opiates|opiates
622945|NCT00929253|Hydrocodone|hydrocodone
622946|NCT00929253|Oxycodone|oxycodone
622947|NCT00929253|Oxycontin|oxycontin
622948|NCT00929253|Narcotic Abuse|narcotic abuse
622949|NCT00929227|Atherosclerosis|atherosclerosis
622950|NCT00929227|Myocardial Ischemia|myocardial ischemia
622951|NCT00929227|Diagnostic Testing|diagnostic testing
622952|NCT00929227|Cardiac Commuted Tomography|cardiac commuted tomography
622953|NCT00929227|Cardiac Magnetic Resonance Imaging|cardiac magnetic resonance imaging
622954|NCT00929227|Inconclusive Noninvasive Cardiac Stress Test|inconclusive noninvasive cardiac stress test
622955|NCT00929227|Cardiac Computed Tomography|cardiac computed tomography
622956|NCT00929227|Coronary Artery Disease|coronary artery disease
622957|NCT00929214|Breast Cancer|breast cancer
622958|NCT00929214|Metastasized|metastasized
622959|NCT00929214|Limited bone-only metastasis|limited bone-only metastasis
622960|NCT00929214|Local Therapy|local therapy
622961|NCT00929214|Radiation|radiation
622962|NCT00929214|Radiation Therapy|radiation therapy
622963|NCT00929214|RT|rt
622964|NCT00929214|Surgery|surgery
622965|NCT00929214|Standard Therapy|standard therapy
622966|NCT00929214|Chemotherapy|chemotherapy
622967|NCT00929214|Endocrine Therapy|endocrine therapy
622968|NCT00929188|Moderate to severe chronic, cancer-related pain related to an active cancer|moderate to severe chronic, cancer-related pain related to an active cancer
622969|NCT00929188|Cancer-related pain|cancer-related pain
622970|NCT00929188|Moderate to severe chronic pain|moderate to severe chronic pain
622971|NCT00929188|JNJ-42160443|jnj-42160443
622972|NCT00929175|Hypertension|hypertension
622973|NCT00929175|Resistant Hypertension|resistant hypertension
622974|NCT00929175|Sleep apnea syndrome|sleep apnea syndrome
622975|NCT00929175|Treatment|treatment
622976|NCT00929162|ovarian|ovarian
622978|NCT00929162|chemotherapy|chemotherapy
622979|NCT00929162|sensitive|sensitive
622980|NCT00929162|ZD4054|zd4054
622981|NCT00929136|Endotoxin|endotoxin
622982|NCT00929136|Insulin resistance|insulin resistance
622983|NCT00929136|Lipolysis|lipolysis
622984|NCT00929136|Proteolysis|proteolysis
622985|NCT00929136|Intracellular Insulin Signaling|intracellular insulin signaling
622986|NCT00929136|Regional effects of inflammation/endotoxin|regional effects of inflammation/endotoxin
622987|NCT00929123|manual therapy|manual therapy
622988|NCT00929123|carpal tunnel syndrome|carpal tunnel syndrome
622989|NCT00929123|central sensitization|central sensitization
622990|NCT00929110|COPD|copd
622991|NCT00929110|NVA237|nva237
622992|NCT00929110|glycopyrronium bromide|glycopyrronium bromide
622993|NCT00929097|Colorectal Neoplasms, (Hereditary Nonpolyposis)|colorectal neoplasms, (hereditary nonpolyposis)
622994|NCT00929097|Guideline|guideline
622995|NCT00929097|Health Plan Implementation|health plan implementation
622996|NCT00929097|Decision Support Techniques|decision support techniques
622997|NCT00929097|Risk assessment|risk assessment
622998|NCT00929097|Familial colorectal cancer risk|familial colorectal cancer risk
622999|NCT00929097|Risk assessment tool|risk assessment tool
623000|NCT00929084|Race Disparities|race disparities
623001|NCT00929084|Breast Cancer|breast cancer
623002|NCT00929084|Quality of Life|quality of life
623003|NCT00929084|Treatment Adherence|treatment adherence
623004|NCT00929071|wrinkles|wrinkles
623005|NCT00929071|dermal filler|dermal filler
623006|NCT00929071|collagen|collagen
623007|NCT00929071|soft tissue augmentation|soft tissue augmentation
623008|NCT00929071|lidocaine|lidocaine
623009|NCT00929071|aesthetic|aesthetic
623010|NCT00929045|Growth Hormone replacement|growth hormone replacement
623011|NCT00929045|subject 8 to 21|subject 8 to 21
623012|NCT00929045|moderate to severe traumatic brain injury|moderate to severe traumatic brain injury
623013|NCT00929045|growth hormone deficient|growth hormone deficient
623014|NCT00929032|Liver Transplantation|liver transplantation
623015|NCT00929032|Immunosystem of the Liver|immunosystem of the liver
623016|NCT00929032|Marginal and Non-marginal grafts|marginal and non-marginal grafts
623017|NCT00929019|uveal melanoma|uveal melanoma
623018|NCT00929019|chromosome 3|chromosome 3
623019|NCT00929019|high risk|high risk
623020|NCT00929019|immunotherapy|immunotherapy
623021|NCT00929019|adjuvant|adjuvant
623022|NCT00929019|high risk genetic profile|high risk genetic profile
623023|NCT00929019|loss of chromosome 3|loss of chromosome 3
623024|NCT00929006|hyperandrogenemia|hyperandrogenemia
623025|NCT00929006|pubertal|pubertal
623026|NCT00929006|polycystic ovary syndrome|polycystic ovary syndrome
623027|NCT00928993|actigraphy|actigraphy
623028|NCT00928993|polysomnography|polysomnography
623029|NCT00928993|pediatrics|pediatrics
623030|NCT00928993|sleep|sleep
623031|NCT00928993|To validate Actigraphy against polysomnography|to validate actigraphy against polysomnography
623032|NCT00928980|Recurrent Major Depressive Disorder|recurrent major depressive disorder
623033|NCT00928980|Mindfulness Based Cognitive Therapy|mindfulness based cognitive therapy
623034|NCT00928980|Cost-effectiveness|cost-effectiveness
623035|NCT00928980|Antidepressant medication|antidepressant medication
623036|NCT00928980|Randomized Controlled Trial|randomized controlled trial
623037|NCT00928967|Multiple Sclerosis|multiple sclerosis
623038|NCT00928967|Quality of life|quality of life
623039|NCT00928954|gabapentin|gabapentin
623040|NCT00928954|memantine|memantine
623041|NCT00928954|nystagmus|nystagmus
623042|NCT00928954|Drug treatment|drug treatment
623043|NCT00928941|PTSD|ptsd
623044|NCT00928941|rehabilitation|rehabilitation
623045|NCT00928928|Lipid peroxidation|lipid peroxidation
623046|NCT00928928|Protein peroxidation|protein peroxidation
623047|NCT00928928|DNA peroxidation|dna peroxidation
623048|NCT00928928|RNA peroxidation|rna peroxidation
623049|NCT00928928|Cytokines|cytokines
623050|NCT00928928|hsCRP|hscrp
623051|NCT00928928|Oxidative stress markers|oxidative stress markers
623052|NCT00928928|Open surgery|open surgery
623053|NCT00928928|Laparoscopic surgery|laparoscopic surgery
623054|NCT00928915|Intracranial Hemorrhages|intracranial hemorrhages
623055|NCT00928915|Vitamin-K antagonist|vitamin-k antagonist
623056|NCT00928915|Hemostatic treatment|hemostatic treatment
623057|NCT00928915|Prothrombin complex|prothrombin complex
623058|NCT00928915|Fresh frozen plasma|fresh frozen plasma
623059|NCT00928915|Intracranial Hemorrhages related to vitamin-K antagonist|intracranial hemorrhages related to vitamin-k antagonist
623060|NCT00928902|melanoma|melanoma
623061|NCT00928902|vaccine|vaccine
623062|NCT00928902|peptides|peptides
623063|NCT00928902|adjuvant|adjuvant
623064|NCT00928902|immunogenicity|immunogenicity
623065|NCT00928902|stage IIB, stage III or resected stage IV|stage iib, stage iii or resected stage iv
623066|NCT00928889|diabetes mellitus, type 2|diabetes mellitus, type 2
623067|NCT00928889|nateglinide|nateglinide
623068|NCT00928889|acarbose|acarbose
623069|NCT00928889|hyperglycemia|hyperglycemia
623070|NCT00928889|dyslipidemias|dyslipidemias
623071|NCT00928889|C-reactive protein|c-reactive protein
623072|NCT00928876|anakinra|anakinra
623073|NCT00928876|Diabetes mellitus, type 2|diabetes mellitus, type 2
623074|NCT00928876|Insulin resistance|insulin resistance
623075|NCT00928876|Interleukin-1beta|interleukin-1beta
623076|NCT00928863|haemorrhagia postpartum|haemorrhagia postpartum
623077|NCT00928863|implementation guidelines|implementation guidelines
623078|NCT00928863|maternal morbidity|maternal morbidity
623079|NCT00928863|management of obstetrics and trauma|management of obstetrics and trauma
623080|NCT00928850|Prostate|prostate
623081|NCT00928850|Radical Prostatectomy|radical prostatectomy
623082|NCT00928850|urethral irrigation|urethral irrigation
623083|NCT00928850|fascial suturing|fascial suturing
623084|NCT00928850|09-051|09-051
623085|NCT00928811|Simulect|simulect
623086|NCT00928811|de novo kidney transplant subjects|de novo kidney transplant subjects
623087|NCT00928811|calcineurin inhibitors|calcineurin inhibitors
623088|NCT00928811|Prograf|prograf
623089|NCT00928785|Tetanus Vaccine|tetanus vaccine
623090|NCT00928785|Tdap-IPV vaccine|tdap-ipv vaccine
623091|NCT00928772|Cranial Electro Stimulation|cranial electro stimulation
623092|NCT00928772|First Eye Cataract Surgery|first eye cataract surgery
623093|NCT00928772|Preoperative sedation|preoperative sedation
623094|NCT00928772|Perioperative sedation|perioperative sedation
623095|NCT00928759|Obesity|obesity
623096|NCT00928759|Polycystic Ovary Syndrome|polycystic ovary syndrome
623097|NCT00928733|Permeability|permeability
623098|NCT00928733|tight junctions|tight junctions
623099|NCT00928733|cytokines|cytokines
623100|NCT00928733|inflammatory bowel diseases|inflammatory bowel diseases
623101|NCT00928733|The effect of alcohol on the intestinal permeability may have major consequences on health.|the effect of alcohol on the intestinal permeability may have major consequences on health.
623102|NCT00928733|It's generally accepted that an increased intestinal permeability in alcoholic subjects lead|it's generally accepted that an increased intestinal permeability in alcoholic subjects lead
623103|NCT00928733|to translocation of bacterial endotoxins from the gut lumen into the portal vein and then to the liver.|to translocation of bacterial endotoxins from the gut lumen into the portal vein and then to the liver.
623104|NCT00928733|In the liver, endotoxins trigger the immune system and activate the resident macrophages, Kupffer cells.|in the liver, endotoxins trigger the immune system and activate the resident macrophages, kupffer cells.
623105|NCT00928733|Activation of Kupffer cells leads to production of chemokines (IL-8) and|activation of kupffer cells leads to production of chemokines (il-8) and
623106|NCT00928733|proinflammatory cytokines (IL-1, TNFα),resulting in hepatocytes damage, inflammation, fibrosis and finally cirrhosis.|proinflammatory cytokines (il-1, tnfα),resulting in hepatocytes damage, inflammation, fibrosis and finally cirrhosis.
623107|NCT00928720|fibromyalgia|fibromyalgia
623108|NCT00928720|pain|pain
623109|NCT00928720|sleep disturbance|sleep disturbance
623110|NCT00928720|fatigue|fatigue
623111|NCT00928720|depression|depression
623112|NCT00928720|functional magnetic resonance imaging|functional magnetic resonance imaging
623113|NCT00928707|Polycythemia Vera|polycythemia vera
623114|NCT00928707|GIVINOSTAT|givinostat
623115|NCT00928707|ITF2357|itf2357
623116|NCT00928655|apnea|apnea
623117|NCT00928655|sleep|sleep
623118|NCT00928655|altitude|altitude
623119|NCT00928655|hypoxia|hypoxia
623120|NCT00928655|treatment|treatment
623121|NCT00928655|CPAP|cpap
623122|NCT00928642|ovarian|ovarian
623123|NCT00928642|cancer|cancer
623124|NCT00928642|peritoneal|peritoneal
623125|NCT00928642|endometrioid|endometrioid
623126|NCT00928642|mucinous|mucinous
623127|NCT00928642|serous|serous
623128|NCT00928642|clear cell|clear cell
623129|NCT00928629|Peripheral Arterial Disease|peripheral arterial disease
623130|NCT00928629|Cardiovascular Disease|cardiovascular disease
623131|NCT00928629|Vascular Disease|vascular disease
623132|NCT00928616|hyperlipidemia|hyperlipidemia
623133|NCT00928616|plant sterols|plant sterols
623134|NCT00928616|monocytes|monocytes
623135|NCT00928603|prostate cancer|prostate cancer
623136|NCT00928603|therapy|therapy
623137|NCT00928590|open-angle glaucoma|open-angle glaucoma
623138|NCT00928590|ocular hypertension|ocular hypertension
623139|NCT00928590|pseudoexfoliation|pseudoexfoliation
623140|NCT00928590|pigment dispersion|pigment dispersion
623141|NCT00928577|Smallpox|smallpox
623142|NCT00928577|Smallpox Vaccine|smallpox vaccine
623143|NCT00928577|Vaccinia virus|vaccinia virus
623144|NCT00928577|Military|military
623145|NCT00928564|Pelvic floor muscle spasm|pelvic floor muscle spasm
623146|NCT00928564|Pelvic pain|pelvic pain
623147|NCT00928564|physical therapy|physical therapy
623148|NCT00928564|pudendal block|pudendal block
623149|NCT00928538|Female Contraception|female contraception
623150|NCT00928538|Home Visits|home visits
623151|NCT00928538|CONTRACEPTIVE AGENTS|contraceptive agents
623152|NCT00928538|CONTRACEPTIVE DEVICES|contraceptive devices
623153|NCT00928525|PDGFr alpha|pdgfr alpha
623154|NCT00928525|PDGFr beta|pdgfr beta
623155|NCT00928525|KIT|kit
623156|NCT00928512|Rheumatoid Arthritis, RA, ACR, inflammatory joints|rheumatoid arthritis, ra, acr, inflammatory joints
623157|NCT00928499|urge/frequency|urge/frequency
623158|NCT00928499|urge incontinence|urge incontinence
623159|NCT00928499|Interstim|interstim
623160|NCT00928499|after success Interstim planning IPG placement|after success interstim planning ipg placement
623161|NCT00928460|Electrocardiogram|electrocardiogram
623162|NCT00928460|Electrocardiography|electrocardiography
623163|NCT00928460|Perioperative care|perioperative care
623164|NCT00928460|Preoperative care|preoperative care
623165|NCT00928460|Preanesthesia Evaluation|preanesthesia evaluation
623166|NCT00928460|Acute Coronary Syndrome|acute coronary syndrome
623167|NCT00928460|Postoperative Myocardial Infarction|postoperative myocardial infarction
623168|NCT00928460|Myocardial ischaemia|myocardial ischaemia
623169|NCT00928460|Postoperative Cardiac Death|postoperative cardiac death
623170|NCT00928460|Intraoperative complications|intraoperative complications
623171|NCT00928460|Postoperative complications|postoperative complications
623172|NCT00928460|Cost-effectiveness analysis|cost-effectiveness analysis
623173|NCT00928447|rHuPH20|rhuph20
623174|NCT00928447|Recombinant Human hyaluronidase|recombinant human hyaluronidase
623175|NCT00928421|Varicose Veins|varicose veins
623176|NCT00928395|Urgent PC|urgent pc
623177|NCT00928395|Overactive Bladder|overactive bladder
623178|NCT00928395|SUmiT Trial|sumit trial
623179|NCT00928395|Overactive Urinary Bladder|overactive urinary bladder
623180|NCT00928382|Spinal Cord|spinal cord
623181|NCT00928382|Healthy Volunteer|healthy volunteer
623182|NCT00928382|Metastasis|metastasis
623183|NCT00928382|Samples|samples
623184|NCT00928382|Spinal Cord Vertebrae|spinal cord vertebrae
623185|NCT00928382|Cancer|cancer
623186|NCT00928382|HV|hv
623187|NCT00928356|Coronary Artery Disease|coronary artery disease
623188|NCT00928356|Robotic Coronary Artery Bypass Surgery|robotic coronary artery bypass surgery
623189|NCT00928356|Percutaneous Coronary Intervention|percutaneous coronary intervention
623190|NCT00928356|Hybrid Coronary Revascularization|hybrid coronary revascularization
623191|NCT00928343|Safety|safety
623192|NCT00928343|Tolerability|tolerability
623193|NCT00928343|Pharmacokinetics|pharmacokinetics
623194|NCT00928330|TDM-1|tdm-1
623195|NCT00928330|HER2|her2
623196|NCT00928330|HER2+|her2+
623197|NCT00928330|HER2+ Breast Cancer|her2+ breast cancer
623198|NCT00928330|HER-2|her-2
623199|NCT00928330|MBC|mbc
623200|NCT00928330|Trastuzumab emtansine|trastuzumab emtansine
623201|NCT00928304|Amyloid beta-protein|amyloid beta-protein
623202|NCT00928304|Down Syndrome|down syndrome
623203|NCT00928291|procalcitonin|procalcitonin
623204|NCT00928291|neutropenia|neutropenia
623205|NCT00928291|febrile neutropenia|febrile neutropenia
623206|NCT00928291|antibiotic therapy|antibiotic therapy
623207|NCT00928291|neutropenic patients|neutropenic patients
623208|NCT00928265|intracranial|intracranial
623209|NCT00928265|stenting|stenting
623210|NCT00928265|endovascular treatment|endovascular treatment
623211|NCT00928265|stent-assisted coiling|stent-assisted coiling
623212|NCT00928265|cerebrovascular disease|cerebrovascular disease
623213|NCT00928252|Hormone Refractory Prostate Cancer|hormone refractory prostate cancer
623214|NCT00928252|Castrate Resistant Prostate Cancer|castrate resistant prostate cancer
623705|NCT00926198|GABHS|gabhs
623215|NCT00928239|vaginal vault prolapse|vaginal vault prolapse
623216|NCT00928239|laparoscopic sacropexy|laparoscopic sacropexy
623217|NCT00928213|Preeclampsia|preeclampsia
623218|NCT00928213|IUGR|iugr
623219|NCT00928213|GH|gh
623220|NCT00928213|PP13|pp13
623221|NCT00928213|Doppler|doppler
623222|NCT00928213|placenta|placenta
623223|NCT00928213|PTD|ptd
623224|NCT00928213|Preterm delivery|preterm delivery
623225|NCT00928200|Relapsed|relapsed
623226|NCT00928200|Allergy|allergy
623227|NCT00928200|Erwinia|erwinia
623228|NCT00928200|Acute|acute
623229|NCT00928200|Lymphoblastic|lymphoblastic
623230|NCT00928200|Leukemia|leukemia
623231|NCT00928187|HIV|hiv
623232|NCT00928187|Second line treatment|second line treatment
623233|NCT00928187|WHO recommendations|who recommendations
623234|NCT00928187|Africa|africa
623235|NCT00928187|Treatment strategies|treatment strategies
623236|NCT00928187|treatment experienced|treatment experienced
623237|NCT00928174|Androgen insensitive prostate cancer|androgen insensitive prostate cancer
623238|NCT00928161|Reflux Disease|reflux disease
623239|NCT00928161|Acid-reflux|acid-reflux
623240|NCT00928161|Head and Neck Cancer|head and neck cancer
623241|NCT00928161|HNC|hnc
623242|NCT00928161|Radiation Therapy|radiation therapy
623243|NCT00928161|Mucositis|mucositis
623244|NCT00928161|Radiation-induced xerostomia|radiation-induced xerostomia
623245|NCT00928161|RIX|rix
623246|NCT00928161|Dry Mouth|dry mouth
623247|NCT00928161|Heartburn|heartburn
623248|NCT00928161|Dexlansoprazole|dexlansoprazole
623249|NCT00928161|Prevacid|prevacid
623250|NCT00928161|Prevacid Solu-Tab|prevacid solu-tab
623251|NCT00928161|GERD|gerd
623252|NCT00928109|eating disorders|eating disorders
623253|NCT00928109|couples therapy|couples therapy
623254|NCT00928096|Lymphoma|lymphoma
623255|NCT00928096|Radiotherapy|radiotherapy
623256|NCT00928096|Positron-Emission Tomography|positron-emission tomography
623257|NCT00928096|CT scan|ct scan
623258|NCT00928083|Phase I|phase i
623259|NCT00928083|Safety and tolerability|safety and tolerability
623260|NCT00928083|Pharmacokinetic|pharmacokinetic
623261|NCT00928083|synthetic peroxide|synthetic peroxide
623262|NCT00928083|trioxolane|trioxolane
623263|NCT00928083|treatment of erythrocytic stages of malaria|treatment of erythrocytic stages of malaria
623264|NCT00928070|Urgency Urinary Incontinence OAB|urgency urinary incontinence oab
623265|NCT00928057|Pen Needle|pen needle
623266|NCT00928057|Diabetes|diabetes
623267|NCT00928057|Insulin|insulin
623268|NCT00928057|Glycemic|glycemic
623269|NCT00928057|Pain|pain
623270|NCT00928057|Fructosamine|fructosamine
623271|NCT00928057|Leakage|leakage
623272|NCT00928057|Hypoglycemia|hypoglycemia
623273|NCT00928057|Hyperglycemia|hyperglycemia
623274|NCT00928018|allogeneic stem cell transplant|allogeneic stem cell transplant
623275|NCT00928018|reduced intensity conditioning|reduced intensity conditioning
623276|NCT00928018|graft versus host disease|graft versus host disease
623277|NCT00928018|GVHD|gvhd
623278|NCT00928018|RIC transplantation|ric transplantation
623279|NCT00928005|Weight loss diet|weight loss diet
623280|NCT00928005|Exercise training|exercise training
623281|NCT00928005|Type 2 diabetes|type 2 diabetes
623282|NCT00928005|Prediabetes|prediabetes
623283|NCT00928005|Cardiovascular health|cardiovascular health
623284|NCT00927966|RAD001|rad001
623285|NCT00927966|CP-751,871|cp-751,871
623286|NCT00927966|advanced sarcoma|advanced sarcoma
623287|NCT00927966|advanced malignant solid tumor|advanced malignant solid tumor
623288|NCT00927953|West Nile virus|west nile virus
623289|NCT00927953|WNV|wnv
623290|NCT00927953|Encephalitis|encephalitis
623291|NCT00927953|Meningitis|meningitis
623292|NCT00927953|Acute Flaccid Paralysis|acute flaccid paralysis
623293|NCT00927953|Monoclonal Antibody|monoclonal antibody
623294|NCT00927953|WNND|wnnd
623295|NCT00927953|West Nile Fever|west nile fever
623296|NCT00927953|WNF|wnf
623297|NCT00927940|TARGET VESSEL REVASCULARIZATION (TVR)|target vessel revascularization (tvr)
623298|NCT00927940|MYOCARDIAL INFARCTION (MI)|myocardial infarction (mi)
623299|NCT00927940|TARGET VESSEL FAILURE (TVF)|target vessel failure (tvf)
623300|NCT00927940|TARGET LESION REVASCULARIZATION (TLR)|target lesion revascularization (tlr)
623301|NCT00927940|TARGET LESION FAILURE (TLF)|target lesion failure (tlf)
623302|NCT00927940|STENT THROMBOSIS|stent thrombosis
623303|NCT00927940|RESTENOTIC LESION|restenotic lesion
623304|NCT00927940|PERCUTANEOUS CORONARY INTERVENTION (PCI)|percutaneous coronary intervention (pci)
623305|NCT00927901|QAB149|qab149
623306|NCT00927901|asthma|asthma
623307|NCT00927901|indacaterol salts (acetate, maleate, and xinafoate)|indacaterol salts (acetate, maleate, and xinafoate)
623308|NCT00927901|orally inhaled indacaterol salts|orally inhaled indacaterol salts
623309|NCT00927901|persistent asthma|persistent asthma
623310|NCT00927862|warfarin metabolism|warfarin metabolism
623311|NCT00927862|CYP2C9|cyp2c9
623312|NCT00927862|genotyping|genotyping
623313|NCT00927862|VKORC1|vkorc1
623314|NCT00927862|anticoagulation|anticoagulation
623315|NCT00927862|atrial fibrillation|atrial fibrillation
623316|NCT00927862|deep vein thrombosis|deep vein thrombosis
623317|NCT00927862|pulmonary embolism|pulmonary embolism
623318|NCT00927862|Patients initiating warfarin for thromboembolic conditions|patients initiating warfarin for thromboembolic conditions
623319|NCT00927849|anal hypertonia|anal hypertonia
623320|NCT00927849|sphincterotomy|sphincterotomy
623321|NCT00927849|incontinence|incontinence
623322|NCT00927849|manometry|manometry
623323|NCT00927810|Gout|gout
623324|NCT00927810|Gouty arthritis|gouty arthritis
623325|NCT00927810|Gout flares|gout flares
623326|NCT00927810|Anti-interleukin-1β monoclonal antibody|anti-interleukin-1β monoclonal antibody
623327|NCT00927797|immunochemotherapy|immunochemotherapy
623328|NCT00927797|Pentostatin|pentostatin
623329|NCT00927797|Cyclophosphamide|cyclophosphamide
623330|NCT00927797|Rituximab|rituximab
623331|NCT00927797|Maintenance|maintenance
623332|NCT00927797|indolent B-NHL|indolent b-nhl
623333|NCT00927797|B-CLL|b-cll
623334|NCT00927797|B-NHL|b-nhl
623335|NCT00927784|Mesenchymal Precursor Cells|mesenchymal precursor cells
623336|NCT00927784|Left Ventricular Assist Device|left ventricular assist device
623337|NCT00927784|LVAD|lvad
623338|NCT00927784|Congestive Heart Failure|congestive heart failure
623339|NCT00927784|Stem Cells|stem cells
623340|NCT00927771|melanosis|melanosis
623341|NCT00927771|melasma|melasma
623342|NCT00927771|azelaic acid|azelaic acid
623343|NCT00927771|hydroquinone|hydroquinone
623344|NCT00927745|Respiration Artificial|respiration artificial
623345|NCT00927745|Positive-Pressure Respiration|positive-pressure respiration
623346|NCT00927745|Critical Care|critical care
623347|NCT00927745|Intensive Care Units|intensive care units
623348|NCT00927732|Brugada|brugada
623349|NCT00927732|hydroquinidine|hydroquinidine
623350|NCT00927732|ventricular arrhythmia|ventricular arrhythmia
623351|NCT00927732|patients with Brugada syndrome, high cardiac arrhythmic risk and implanted with an implantable cardioverter defibrillator|patients with brugada syndrome, high cardiac arrhythmic risk and implanted with an implantable cardioverter defibrillator
623352|NCT00927719|Smallpox|smallpox
623353|NCT00927719|Smallpox Vaccine|smallpox vaccine
623354|NCT00927719|Vaccinia virus|vaccinia virus
623355|NCT00927719|Military|military
623356|NCT00927706|Assistive Technology|assistive technology
623357|NCT00927706|Mobility Limitation|mobility limitation
623358|NCT00927706|Physical Disability|physical disability
623359|NCT00927706|Caregiver|caregiver
623360|NCT00927706|Participation|participation
623361|NCT00927693|Atherosclerosis|atherosclerosis
623362|NCT00927693|Coronary Artery Disease|coronary artery disease
623363|NCT00927693|Cardiac Risk Factors|cardiac risk factors
623364|NCT00927693|Coronary Calcium Scan|coronary calcium scan
623365|NCT00927693|Prevention|prevention
623366|NCT00927680|Colorectal Cancer|colorectal cancer
623367|NCT00927680|Familial Colorectal Cancer|familial colorectal cancer
623368|NCT00927680|Genetics|genetics
623369|NCT00927680|Hispanics|hispanics
623370|NCT00927680|Lynch Syndrome|lynch syndrome
623371|NCT00927667|Hemophilia A|hemophilia a
623372|NCT00927667|Joint Status|joint status
623373|NCT00927667|Bleeds|bleeds
623374|NCT00927667|Magnetic Resonce Imaging|magnetic resonce imaging
623375|NCT00927654|Iloprost|iloprost
623376|NCT00927654|pulmonary hypertension|pulmonary hypertension
623377|NCT00927654|cardio pulmonary morbidity|cardio pulmonary morbidity
623378|NCT00927654|high risk cardiac surgical patients|high risk cardiac surgical patients
623379|NCT00927641|Ankle Sprain|ankle sprain
623380|NCT00927628|vitrectomy|vitrectomy
623381|NCT00927628|macular hole|macular hole
623382|NCT00927628|ILM peeling|ilm peeling
623383|NCT00927615|myocardial infarction|myocardial infarction
623384|NCT00927615|glycoprotein IIb/IIIa|glycoprotein iib/iiia
623385|NCT00927615|percutaneous coronary intervention|percutaneous coronary intervention
623386|NCT00927615|thrombus aspiration|thrombus aspiration
623387|NCT00927615|myocardial perfusion|myocardial perfusion
623388|NCT00927602|renal failure|renal failure
623389|NCT00927602|medical patient|medical patient
623390|NCT00927602|venous thromboembolism|venous thromboembolism
623391|NCT00927602|prophylaxis|prophylaxis
623392|NCT00927602|fondaparinux|fondaparinux
623393|NCT00927589|HER2+ Metastatic Cancer|her2+ metastatic cancer
623394|NCT00927589|HER2+ Locally Advanced Inoperable Cancer|her2+ locally advanced inoperable cancer
623395|NCT00927589|HER2+ Solid Malignancy|her2+ solid malignancy
623396|NCT00927576|cognitive training|cognitive training
623397|NCT00927576|neuroplasticity|neuroplasticity
623398|NCT00927576|cognitive impairment|cognitive impairment
623399|NCT00927576|recovery of function|recovery of function
623400|NCT00927576|memory|memory
623401|NCT00927576|attention|attention
623402|NCT00927563|Gambling|gambling
623403|NCT00927563|Addiction|addiction
623404|NCT00927550|resistant depression|resistant depression
623405|NCT00927550|lithium|lithium
623406|NCT00927550|RCT|rct
623407|NCT00927550|lithium therapy|lithium therapy
623408|NCT00927550|standard therapy|standard therapy
623409|NCT00927537|Hypertension|hypertension
623410|NCT00927524|Insulin analogs|insulin analogs
623411|NCT00927524|diabetes|diabetes
623412|NCT00927511|metastatic hormone-responsive breast cancer menopausal women|metastatic hormone-responsive breast cancer menopausal women
623413|NCT00927498|Acute myeloid Leukemia|acute myeloid leukemia
623706|NCT00926185|Dry Eye|dry eye
623414|NCT00927498|patient aged 50 to 70 years|patient aged 50 to 70 years
623415|NCT00927485|Familial Adenomatous Polyposis (FAP)|familial adenomatous polyposis (fap)
623416|NCT00927485|Curcumin|curcumin
623417|NCT00927485|Colorectal polyps|colorectal polyps
623418|NCT00927485|Duodenal polyps|duodenal polyps
623419|NCT00927472|Head Lice|head lice
623420|NCT00927459|cholesterol|cholesterol
623421|NCT00927459|coronary artery disease|coronary artery disease
623422|NCT00927446|esophageal cancer|esophageal cancer
623423|NCT00927446|head and neck cancer|head and neck cancer
623424|NCT00927446|narrow band imaging|narrow band imaging
623425|NCT00927446|endoscopy|endoscopy
623426|NCT00927446|screening|screening
623427|NCT00927433|Fatigue|fatigue
623428|NCT00927433|Cancer|cancer
623429|NCT00927433|Radiation therapy|radiation therapy
623430|NCT00927433|Chemotherapy|chemotherapy
623431|NCT00927433|Hormones|hormones
623432|NCT00927433|Surgery|surgery
623433|NCT00927433|Breast cancer|breast cancer
623434|NCT00927420|Bipolar disorder|bipolar disorder
623435|NCT00927420|adherence|adherence
623436|NCT00927420|treatment|treatment
623437|NCT00927420|real life practice|real life practice
623438|NCT00927407|Head Lice|head lice
623439|NCT00927394|Hypertension, Type II Diabetes, Aliskiren, Valsartan,|hypertension, type ii diabetes, aliskiren, valsartan,
623440|NCT00927394|Systolic blood pressure, Diastolic blood pressure,|systolic blood pressure, diastolic blood pressure,
623441|NCT00927394|Stage II, Combination|stage ii, combination
623442|NCT00927368|TKA|tka
623443|NCT00927368|total knee replacement|total knee replacement
623444|NCT00927355|pioglitazone|pioglitazone
623445|NCT00927355|human bone marrow stem cells|human bone marrow stem cells
623446|NCT00927355|adipocytes|adipocytes
623447|NCT00927355|osteoblasts|osteoblasts
623448|NCT00927355|bone mineral density|bone mineral density
623449|NCT00927355|adiponectin|adiponectin
623450|NCT00927355|leptin|leptin
623451|NCT00927355|CTX|ctx
623452|NCT00927355|P1NP|p1np
623453|NCT00927355|Osteocalcin|osteocalcin
623454|NCT00927342|Air leak|air leak
623455|NCT00927342|Thoracic Surgery|thoracic surgery
623456|NCT00927342|Sealants|sealants
623457|NCT00927329|Dermatophagoides|dermatophagoides
623458|NCT00927329|farinae|farinae
623459|NCT00927329|allergen|allergen
623460|NCT00927329|dust|dust
623461|NCT00927329|allergic|allergic
623462|NCT00927329|mite|mite
623463|NCT00927329|allergy|allergy
623464|NCT00927316|Report of Urinary Tract Infection episode|report of urinary tract infection episode
623465|NCT00927303|retinal thickness|retinal thickness
623466|NCT00927303|threshold algorithm|threshold algorithm
623467|NCT00927303|optical coherence tomography|optical coherence tomography
623468|NCT00927290|hepatitis C; insulin resistance; glitazones; pioglitazone; steatosis; viral kinetics; antiviral response|hepatitis c; insulin resistance; glitazones; pioglitazone; steatosis; viral kinetics; antiviral response
623469|NCT00927264|tobacco smoke exposure smoking|tobacco smoke exposure smoking
623470|NCT00927251|heart failure|heart failure
623471|NCT00927251|cardiac pacing|cardiac pacing
623472|NCT00927251|cardiac resynchronization therapy|cardiac resynchronization therapy
623473|NCT00927251|left ventricular lead|left ventricular lead
623474|NCT00927238|Single Level|single level
623475|NCT00927238|Lumbar Disc Disease|lumbar disc disease
623477|NCT00927199|High-Oleic Canola Oil|high-oleic canola oil
623478|NCT00927199|Flaxseed Oil|flaxseed oil
623479|NCT00927199|Monounsaturated Fatty Acids|monounsaturated fatty acids
623480|NCT00927199|Polyunsaturated Fatty Acids|polyunsaturated fatty acids
623481|NCT00927199|Alpha Linolenic Acid|alpha linolenic acid
623482|NCT00927199|Cardiovascular|cardiovascular
623483|NCT00927199|Hypercholesterolemia|hypercholesterolemia
623484|NCT00927199|Lipids|lipids
623485|NCT00927199|Inflammation|inflammation
623486|NCT00927199|Metabolism|metabolism
623487|NCT00927186|osteoporosis|osteoporosis
623488|NCT00927186|teriparatide|teriparatide
623489|NCT00927186|zoledronic acid|zoledronic acid
623490|NCT00927186|histomorphometry|histomorphometry
623491|NCT00927186|bone biopsy|bone biopsy
623492|NCT00927186|postmenopausal|postmenopausal
623493|NCT00927173|TMS|tms
623494|NCT00927173|Transcranial Magnetic Stimulation|transcranial magnetic stimulation
623495|NCT00927173|MDD|mdd
623496|NCT00927173|Major Depressive Disorder|major depressive disorder
623497|NCT00927160|Mobile Acute Care of the Elderly Unit|mobile acute care of the elderly unit
623498|NCT00927160|Geriatric Models of Care|geriatric models of care
623499|NCT00927147|head and neck cancer|head and neck cancer
623500|NCT00927147|boron neutron capture therapy|boron neutron capture therapy
623501|NCT00927147|cetuximab|cetuximab
623502|NCT00927147|epidermal growth factor receptor|epidermal growth factor receptor
623503|NCT00927147|safety|safety
623504|NCT00927147|efficacy|efficacy
623505|NCT00927147|survival|survival
623506|NCT00927134|Chronic Granulomatous Disease in children (=or< 18 years)|chronic granulomatous disease in children (=or< 18 years)
623507|NCT00927108|Adult Progenitor Stem cells|adult progenitor stem cells
623508|NCT00927108|Alzheimer's disease|alzheimer's disease
623509|NCT00927108|Parkinson's disease|parkinson's disease
623510|NCT00927108|Multiple sclerosis|multiple sclerosis
623511|NCT00927095|PMDD|pmdd
623512|NCT00927095|Oral contraceptives|oral contraceptives
623513|NCT00927095|steroid hormones|steroid hormones
623514|NCT00927095|neurosteroids|neurosteroids
623515|NCT00927069|Adalimumab|adalimumab
623516|NCT00927030|Autism|autism
623517|NCT00927030|children|children
623518|NCT00927030|sleep|sleep
623519|NCT00927030|insomnia|insomnia
623520|NCT00927017|Healthy volunteers|healthy volunteers
623521|NCT00927004|mechanical hyperalgesia|mechanical hyperalgesia
623522|NCT00927004|cold hyperalgesia|cold hyperalgesia
623523|NCT00927004|chronic pain|chronic pain
623524|NCT00926978|Thyroid|thyroid
623525|NCT00926978|I-124|i-124
623526|NCT00926965|tardive dyskinesia|tardive dyskinesia
623527|NCT00926965|neurocognitive function|neurocognitive function
623528|NCT00926952|Actinic keratoses|actinic keratoses
623529|NCT00926952|actinic keratosis|actinic keratosis
623530|NCT00926952|methylamonolevulinate|methylamonolevulinate
623531|NCT00926952|photodynamic therapy|photodynamic therapy
623532|NCT00926952|without occlusion|without occlusion
623533|NCT00926952|short incubation|short incubation
623534|NCT00926939|Cigarette|cigarette
623535|NCT00926939|Nicotine|nicotine
623536|NCT00926939|Smoking|smoking
623537|NCT00926939|Contingency Management|contingency management
623538|NCT00926939|Voucher reinforcement|voucher reinforcement
623539|NCT00926939|Smoking Abstinence|smoking abstinence
623540|NCT00926939|Internet-based treatment|internet-based treatment
623541|NCT00926926|Healthy volunteer|healthy volunteer
623542|NCT00926913|Macular Degeneration|macular degeneration
623543|NCT00926900|Alcoholism|alcoholism
623544|NCT00926900|D-cycloserine|d-cycloserine
623545|NCT00926900|extinction|extinction
623546|NCT00926900|cue-exposure|cue-exposure
623547|NCT00926874|ischaemic stroke|ischaemic stroke
623548|NCT00926874|acute coronary syndrome|acute coronary syndrome
623549|NCT00926874|obstructive sleep apnea syndrome|obstructive sleep apnea syndrome
623550|NCT00926874|brachial endothelial function|brachial endothelial function
623551|NCT00926874|blood pressure|blood pressure
623552|NCT00926874|aortic stiffness|aortic stiffness
623553|NCT00926861|age-related macular degeneration|age-related macular degeneration
623554|NCT00926861|detachment of the posterior hyaloid|detachment of the posterior hyaloid
623555|NCT00926861|AMD|amd
623556|NCT00926848|coronary heart disease|coronary heart disease
623557|NCT00926848|cardiac rehabilitation|cardiac rehabilitation
623558|NCT00926848|lifestyle change|lifestyle change
623559|NCT00926848|coronary artery bypass graft|coronary artery bypass graft
623560|NCT00926848|social support|social support
623561|NCT00926848|social cognitive learning theory|social cognitive learning theory
623562|NCT00926809|endoscopic mucosal resection|endoscopic mucosal resection
623563|NCT00926809|iatrogenic|iatrogenic
623564|NCT00926796|gonorrhea, gonococcal infections, Neisseria gonorrhoeae|gonorrhea, gonococcal infections, neisseria gonorrhoeae
623565|NCT00926783|paroxysmal|paroxysmal
623566|NCT00926783|persistent|persistent
623567|NCT00926783|targeted|targeted
623568|NCT00926783|generalized|generalized
623569|NCT00926783|CFAE|cfae
623570|NCT00926757|lymphoma|lymphoma
623571|NCT00926757|CD20|cd20
623572|NCT00926757|Hepatitis B virus|hepatitis b virus
623573|NCT00926757|reactivation|reactivation
623574|NCT00926757|Rituximab|rituximab
623575|NCT00926744|physical activity|physical activity
623576|NCT00926744|nutrition|nutrition
623577|NCT00926744|cardiovascular diseases|cardiovascular diseases
623578|NCT00926744|musculo-skeletal problems|musculo-skeletal problems
623579|NCT00926731|Acute Myeloid Leukaemia (AML)|acute myeloid leukaemia (aml)
623580|NCT00926718|BIS monitor|bis monitor
623581|NCT00926718|rocuronium|rocuronium
623582|NCT00926718|The effect of the neuromuscular blocking drug rocuronium on the response of the Composite Variability Index to laryngoscopy|the effect of the neuromuscular blocking drug rocuronium on the response of the composite variability index to laryngoscopy
623583|NCT00926705|Dexmedetomidine|dexmedetomidine
623584|NCT00926705|Fentanyl|fentanyl
623585|NCT00926705|Pain|pain
623586|NCT00926705|Pediatrics|pediatrics
623587|NCT00926692|B-cells|b-cells
623588|NCT00926692|CD5+|cd5+
623589|NCT00926692|B1 Cells|b1 cells
623590|NCT00926692|Healthy Controls|healthy controls
623591|NCT00926666|Ageing|ageing
623592|NCT00926666|Pain|pain
623593|NCT00926666|Pharmacology|pharmacology
623594|NCT00926666|Imaging|imaging
623595|NCT00926666|Anaesthesiology|anaesthesiology
623596|NCT00926666|Musculoskeletal disease|musculoskeletal disease
623597|NCT00926653|Geriatric Depression|geriatric depression
623598|NCT00926640|Solid Tumors|solid tumors
623599|NCT00926640|Histone deacetylase inhibitors|histone deacetylase inhibitors
623600|NCT00926640|EP &amp; Belinostat|ep &amp; belinostat
623601|NCT00926640|Phase I|phase i
623602|NCT00926640|SCLC|sclc
623603|NCT00926640|Small Cell Lung Cancer|small cell lung cancer
623604|NCT00926627|endothelin receptor antagonist|endothelin receptor antagonist
623605|NCT00926627|bosentan|bosentan
623606|NCT00926614|GT1|gt1
623607|NCT00926614|HCV|hcv
623608|NCT00926614|non responder|non responder
623609|NCT00926614|relapser|relapser
623610|NCT00926588|Pain|pain
623611|NCT00926588|Telecare|telecare
623612|NCT00926588|Collaborative care|collaborative care
623613|NCT00926575|BDP|bdp
623614|NCT00926575|orBec|orbec
623615|NCT00926575|GVHD|gvhd
623616|NCT00926575|beclomethasone dipropionate|beclomethasone dipropionate
623617|NCT00926575|bone marrow transplant|bone marrow transplant
623618|NCT00926575|hematopoietic cell transplant|hematopoietic cell transplant
623619|NCT00926575|HCT|hct
623620|NCT00926575|stem cell transplant|stem cell transplant
623621|NCT00926575|marrow transplant|marrow transplant
623622|NCT00926575|SCT|sct
623623|NCT00926575|beclomethasone 17,21-dipropionate|beclomethasone 17,21-dipropionate
623624|NCT00926562|Contrast Induced Nephropathy|contrast induced nephropathy
623625|NCT00926562|CIN|cin
623626|NCT00926562|Cardiac Catheterization|cardiac catheterization
623627|NCT00926549|spectral domain-OCT|spectral domain-oct
623628|NCT00926549|macular thickness|macular thickness
623629|NCT00926549|myopia|myopia
623630|NCT00926549|hypermetropia|hypermetropia
623631|NCT00926549|normal|normal
623632|NCT00926523|Pulmonary Hypertension|pulmonary hypertension
623633|NCT00926523|Pulmonary Arterial Hypertension|pulmonary arterial hypertension
623634|NCT00926523|Interstitial Lung Disease|interstitial lung disease
623635|NCT00926523|MIF|mif
623636|NCT00926497|antibiotic therapy|antibiotic therapy
623637|NCT00926497|early-onset sepsis|early-onset sepsis
623638|NCT00926497|interventions study|interventions study
623639|NCT00926497|procalcitonin|procalcitonin
623640|NCT00926497|term and near-term neonates|term and near-term neonates
623641|NCT00926484|Dentin hypersensitivity|dentin hypersensitivity
623642|NCT00926484|Tooth Mousse|tooth mousse
623643|NCT00926484|fluoride varnish|fluoride varnish
623644|NCT00926471|Autism|autism
623645|NCT00926471|Anxiety|anxiety
623646|NCT00926471|Autism Spectrum Disorders with Comorbid Anxiety|autism spectrum disorders with comorbid anxiety
623647|NCT00926458|stress echocardiography|stress echocardiography
623648|NCT00926458|coronary angiography|coronary angiography
623649|NCT00926458|coronary artery disease|coronary artery disease
623650|NCT00926445|Pain behavior|pain behavior
623651|NCT00926432|Balance|balance
623652|NCT00926432|Spine disorders|spine disorders
623653|NCT00926432|equilibrium|equilibrium
623654|NCT00926419|Varicella|varicella
623655|NCT00926419|Hepatitis A|hepatitis a
623656|NCT00926419|Vaccine|vaccine
623657|NCT00926419|Injector|injector
623658|NCT00926419|Fractional dose|fractional dose
623659|NCT00926419|Intradermal|intradermal
623660|NCT00926419|Children|children
623661|NCT00926406|Environmental lead exposure, maintenance hemodialysis; blood lead levels, EDTA chelating agents, malnutrition, anemia, inflammation, mortality.|environmental lead exposure, maintenance hemodialysis; blood lead levels, edta chelating agents, malnutrition, anemia, inflammation, mortality.
623662|NCT00926406|To determine whether lead chelation therapy improves the anemia, malnutrition, inflammation, morbidity or mortality in hemodialysis patients.|to determine whether lead chelation therapy improves the anemia, malnutrition, inflammation, morbidity or mortality in hemodialysis patients.
623663|NCT00926393|inpatient|inpatient
623664|NCT00926393|bipolar depression|bipolar depression
623665|NCT00926393|quetiapine|quetiapine
623666|NCT00926393|Seroquel IR|seroquel ir
623667|NCT00926393|Seroquel XR|seroquel xr
623668|NCT00926393|safety|safety
623669|NCT00926393|tolerability|tolerability
623670|NCT00926380|osteoporosis|osteoporosis
623671|NCT00926380|postmenopausal|postmenopausal
623672|NCT00926380|denosumab|denosumab
623673|NCT00926380|teriparatide|teriparatide
623674|NCT00926380|Forteo®|forteo®
623675|NCT00926380|DXA|dxa
623676|NCT00926380|Bone Mineral Density|bone mineral density
623677|NCT00926380|pQCT|pqct
623678|NCT00926367|Acne|acne
623679|NCT00926341|Metabolic syndrome|metabolic syndrome
623680|NCT00926341|inflammatory markers|inflammatory markers
623681|NCT00926341|Thiazolidinediones|thiazolidinediones
623682|NCT00926341|Angiotensin receptor blockers|angiotensin receptor blockers
623683|NCT00926328|Gingivitis and Plaque|gingivitis and plaque
623684|NCT00926315|Breast Neoplasms|breast neoplasms
623685|NCT00926315|Calcitriol|calcitriol
623686|NCT00926315|Postmenopausal|postmenopausal
623687|NCT00926315|Cell Proliferation|cell proliferation
623688|NCT00926315|Gene Expression Profiling|gene expression profiling
623689|NCT00926302|The bioequivalence of Levetiracetam vs. Keppra|the bioequivalence of levetiracetam vs. keppra
623690|NCT00926302|volunteer|volunteer
623691|NCT00926276|Gastroesophageal Reflux Disease (GERD)|gastroesophageal reflux disease (gerd)
623692|NCT00926276|Bronchopulmonary Dysplasia (BPD)|bronchopulmonary dysplasia (bpd)
623693|NCT00926276|Fundoplication|fundoplication
623694|NCT00926263|Pharmacokinetics|pharmacokinetics
623695|NCT00926263|Pharmacodynamics|pharmacodynamics
623696|NCT00926263|QTc interval prolongation|qtc interval prolongation
623697|NCT00926250|Sarcopenia|sarcopenia
623698|NCT00926237|Tinnitus|tinnitus
623699|NCT00926237|Transcranial Magnetic Stimulation|transcranial magnetic stimulation
623700|NCT00926237|TMS|tms
623701|NCT00926237|rTMS|rtms
623702|NCT00926224|Adult patients with chronic liver disease scheduled for a liver biopsy and a BMI superior or equal to 28 kg/m²|adult patients with chronic liver disease scheduled for a liver biopsy and a bmi superior or equal to 28 kg/m²
623703|NCT00926198|Upper airway infections|upper airway infections
623704|NCT00926198|pharyngotonsillitis|pharyngotonsillitis
623707|NCT00926185|ophthalmic delivery|ophthalmic delivery
623708|NCT00926172|Magnetic resonance angiography|magnetic resonance angiography
623709|NCT00926172|Intracranial aneurysm|intracranial aneurysm
623710|NCT00926172|cerebral aneurysm|cerebral aneurysm
623711|NCT00926172|unruptured aneurysm|unruptured aneurysm
623712|NCT00926172|Epidemiology|epidemiology
623713|NCT00926172|Magnetic Resonance Imaging|magnetic resonance imaging
623714|NCT00926159|Cardiomyopathies|cardiomyopathies
623715|NCT00926146|Hepatitis B and C|hepatitis b and c
623716|NCT00926146|HIV|hiv
623717|NCT00926146|nurse case management|nurse case management
623718|NCT00926146|HIV seronegativity|hiv seronegativity
623719|NCT00926120|Chronic Hepatitis C|chronic hepatitis c
623720|NCT00926081|Peripheral Artery Disease|peripheral artery disease
623721|NCT00926081|Quality of Life|quality of life
623722|NCT00926081|Outcome|outcome
623723|NCT00926081|Endothelial Progenitor Cells|endothelial progenitor cells
623724|NCT00926081|Microcirculation|microcirculation
623725|NCT00926068|Diabetes Mellitus|diabetes mellitus
623726|NCT00926068|Foot Ulcer|foot ulcer
623727|NCT00926068|DFU|dfu
623728|NCT00926068|Wound healing|wound healing
623729|NCT00926055|high risk patients in atherosclerosis|high risk patients in atherosclerosis
623730|NCT00926042|Healthy|healthy
623731|NCT00926042|volunteer|volunteer
623732|NCT00926042|Healthy controls|healthy controls
623733|NCT00926042|Normal controls|normal controls
623734|NCT00926016|Hepatitis C|hepatitis c
623735|NCT00926003|HIV|hiv
623736|NCT00926003|Children|children
623737|NCT00926003|Africa|africa
623738|NCT00926003|Neuropsychology|neuropsychology
623739|NCT00926003|cognitive rehabilitation|cognitive rehabilitation
623740|NCT00926003|computers|computers
623741|NCT00925990|HCV|hcv
623742|NCT00925990|interferon-naive|interferon-naive
623743|NCT00925977|treatment satisfaction|treatment satisfaction
623744|NCT00925977|insulin Glargine|insulin glargine
623745|NCT00925977|insulin Apidra|insulin apidra
623746|NCT00925977|NPH insulin|nph insulin
623747|NCT00925951|Persistent Non-specific Low Back Pain|persistent non-specific low back pain
623748|NCT00925951|wet cupping|wet cupping
623749|NCT00925951|cupping|cupping
623750|NCT00925951|Numerical Rating Scale|numerical rating scale
623751|NCT00925938|Hysteroscopy|hysteroscopy
623752|NCT00925938|Cervical priming|cervical priming
623753|NCT00925938|Cervical dilatation|cervical dilatation
623754|NCT00925938|Misoprostol|misoprostol
623755|NCT00925938|Endoscopy, uterine|endoscopy, uterine
623756|NCT00925925|Low birth weight|low birth weight
623757|NCT00925925|small for gestational age|small for gestational age
623758|NCT00925925|B-cell function|b-cell function
623759|NCT00925925|epigenetics|epigenetics
623760|NCT00925925|B1a|b1a
623761|NCT00925925|B1b|b1b
623762|NCT00925925|CD19|cd19
623763|NCT00925925|CD5|cd5
623764|NCT00925912|Hemorrhoidectomy|hemorrhoidectomy
623765|NCT00925912|perianal block|perianal block
623766|NCT00925912|local anesthesia|local anesthesia
623767|NCT00925912|spinal anesthesia|spinal anesthesia
623768|NCT00925899|Melatonin|melatonin
623769|NCT00925899|Palliative care|palliative care
623770|NCT00925899|Advanced cancer|advanced cancer
623771|NCT00925899|Symptoms|symptoms
623772|NCT00925899|Quality of life|quality of life
623773|NCT00925899|Randomized controlled trial|randomized controlled trial
623774|NCT00925886|Astigmatism|astigmatism
623775|NCT00925886|Cataract|cataract
623776|NCT00925873|Fludarabine|fludarabine
623777|NCT00925873|AML|aml
623778|NCT00925873|elderly patients|elderly patients
623779|NCT00925847|Amyotrophic lateral sclerosis|amyotrophic lateral sclerosis
623780|NCT00925847|Lithium|lithium
623781|NCT00925847|Survival|survival
623782|NCT00925834|Coronary angiography|coronary angiography
623783|NCT00925834|Placebo effect|placebo effect
623784|NCT00925834|Suggestion|suggestion
623785|NCT00925821|Allogeneic stem cell transplantation|allogeneic stem cell transplantation
623786|NCT00925821|Lenalidomide|lenalidomide
623787|NCT00925821|IMiD|imid
623788|NCT00925808|Unsuspected Venous Thromboembolism|unsuspected venous thromboembolism
623789|NCT00925808|VTE|vte
623790|NCT00925808|Routine Computed Tomography|routine computed tomography
623791|NCT00925808|CT Scans|ct scans
623792|NCT00925795|HIV|hiv
623793|NCT00925795|atherosclerosis|atherosclerosis
623794|NCT00925795|extra virgin olive oil|extra virgin olive oil
623795|NCT00925795|Alternative therapies|alternative therapies
623796|NCT00925795|Treatment experienced+|treatment experienced+
712393|NCT00580307|Nasal septum|nasal septum
623797|NCT00925782|autologous stem cell transplantation|autologous stem cell transplantation
623798|NCT00925756|HIV|hiv
623799|NCT00925756|low CD4 recovery|low cd4 recovery
623800|NCT00925756|Low CD4 recovery despite HIV control|low cd4 recovery despite hiv control
623801|NCT00925756|Treatment experienced|treatment experienced
623802|NCT00925743|Phase 1|phase 1
623803|NCT00925743|XRP6258|xrp6258
623804|NCT00925743|cisplatin|cisplatin
623805|NCT00925743|Antineoplastic Combined Chemotherapy Protocols|antineoplastic combined chemotherapy protocols
623806|NCT00925730|Atopic dermatitis|atopic dermatitis
623807|NCT00925730|AD|ad
623808|NCT00925730|pimecrolimus|pimecrolimus
623809|NCT00925730|blood|blood
623810|NCT00925730|absorption|absorption
623811|NCT00925730|systemic|systemic
623812|NCT00925717|ADA recommendation|ada recommendation
623813|NCT00925665|Intubation|intubation
623814|NCT00925665|Glidescope|glidescope
623815|NCT00925665|Macintosh|macintosh
623816|NCT00925665|Abscess|abscess
623817|NCT00925665|Difficult intubations in patients with odontogenic abscesses|difficult intubations in patients with odontogenic abscesses
623818|NCT00925652|CM|cm
623819|NCT00925652|bevacizumab|bevacizumab
623820|NCT00925652|cyclophosphamide|cyclophosphamide
623821|NCT00925652|methotrexate|methotrexate
623822|NCT00925652|exercise intervention|exercise intervention
623823|NCT00925652|diet intervention|diet intervention
623824|NCT00925639|phytoestrogen|phytoestrogen
623825|NCT00925639|coagulation|coagulation
623826|NCT00925639|menopause|menopause
623827|NCT00925639|ddimer|ddimer
623828|NCT00925639|antithrombin|antithrombin
623829|NCT00925639|hypercoagulation|hypercoagulation
623830|NCT00925613|Exchanging double lumen tube with laryngeal mask Proseal|exchanging double lumen tube with laryngeal mask proseal
623831|NCT00925613|Exchange double lumen tube with tracheal tube|exchange double lumen tube with tracheal tube
623832|NCT00925613|Exchange double lumen tube before emergence decrease cough|exchange double lumen tube before emergence decrease cough
623833|NCT00925613|thoracoscopy and postoperative respiratory complications|thoracoscopy and postoperative respiratory complications
623834|NCT00925613|thoracostomy and postoperative respiratory complications|thoracostomy and postoperative respiratory complications
623835|NCT00925613|postoperative cough|postoperative cough
623836|NCT00925613|postoperative respiratory complications|postoperative respiratory complications
623837|NCT00925613|laryngeal mask and postoperative respiratory complications|laryngeal mask and postoperative respiratory complications
623838|NCT00925600|Lens Opacification|lens opacification
623839|NCT00925600|Bone Loss|bone loss
623840|NCT00925600|Androgen Deprivation Therapy|androgen deprivation therapy
623841|NCT00925600|Non-metastatic prostate cancer|non-metastatic prostate cancer
623842|NCT00925587|CKD|ckd
623843|NCT00925587|Anemia|anemia
623844|NCT00925587|correction|correction
623845|NCT00925587|darbepoetin alfa|darbepoetin alfa
623846|NCT00925574|CNTO 1959|cnto 1959
623847|NCT00925574|Healthy Volunteers|healthy volunteers
623848|NCT00925574|Psoriasis|psoriasis
623849|NCT00925561|Coronary Artery Calcification|coronary artery calcification
623850|NCT00925548|Phase III trial|phase iii trial
623851|NCT00925548|randomized|randomized
623852|NCT00925548|cancer vaccine|cancer vaccine
623853|NCT00925548|MUC1|muc1
623854|NCT00925548|BLP25|blp25
623855|NCT00925548|advanced breast cancer|advanced breast cancer
623856|NCT00925548|postmenopausal breast cancer|postmenopausal breast cancer
623857|NCT00925548|immunotherapy of breast cancer|immunotherapy of breast cancer
623858|NCT00925548|Inoperable locally advanced, recurrent, or metastatic endocrine-sensitive Breast Cancer|inoperable locally advanced, recurrent, or metastatic endocrine-sensitive breast cancer
623859|NCT00925535|Pharmacokinetics HIV Tuberculosis Lersivirine UK-453|pharmacokinetics hiv tuberculosis lersivirine uk-453
623860|NCT00925535|061 Rifabutin|061 rifabutin
623861|NCT00925535|HIV Infections|hiv infections
623862|NCT00925509|upper digestive tract cancer|upper digestive tract cancer
623863|NCT00925509|implants|implants
623864|NCT00925509|implants insertion|implants insertion
623865|NCT00925509|radio-surgical guidance|radio-surgical guidance
623866|NCT00925509|accuracy of implants insertion|accuracy of implants insertion
623867|NCT00925509|cranial/facial radiotherapy or brachytherapy and/or microvascular fibula transfer.|cranial/facial radiotherapy or brachytherapy and/or microvascular fibula transfer.
623868|NCT00925509|Bone volume sufficient to support an implant|bone volume sufficient to support an implant
623869|NCT00925496|Omarthrosis shoulder joint|omarthrosis shoulder joint
623870|NCT00925483|left ventricular mass|left ventricular mass
623871|NCT00925483|cardiac MRI|cardiac mri
623872|NCT00925483|long dialysis|long dialysis
623873|NCT00925483|daily dialysis|daily dialysis
623874|NCT00925470|Target organs impairment|target organs impairment
623875|NCT00925470|High blood pressure|high blood pressure
623876|NCT00925470|Evaluation of target organs impairment on patients suffering from high blood pressure without known cardiovascular or renal disease|evaluation of target organs impairment on patients suffering from high blood pressure without known cardiovascular or renal disease
623877|NCT00925457|Serious ventricular arrhythmia|serious ventricular arrhythmia
623878|NCT00925457|Sudden cardiac death|sudden cardiac death
623879|NCT00925457|Domperidone|domperidone
623880|NCT00925457|Case-control study|case-control study
623881|NCT00925457|Saskatchewan residents|saskatchewan residents
623882|NCT00925457|Observational Study|observational study
623883|NCT00925444|Absorbable implants|absorbable implants
623884|NCT00925444|Humans|humans
623885|NCT00925444|Alginates|alginates
623886|NCT00925444|Pneumonectomy/methods|pneumonectomy/methods
623887|NCT00925444|Pneumonectomy/instrumentation|pneumonectomy/instrumentation
623888|NCT00925444|Surgical Stapling|surgical stapling
623889|NCT00925444|Thoracic surgery|thoracic surgery
623890|NCT00925444|Tissue Adhesives|tissue adhesives
623891|NCT00925444|Prospective studies|prospective studies
623892|NCT00925418|Neoplasm|neoplasm
623893|NCT00925418|breast Neoplasm|breast neoplasm
623894|NCT00925418|docetaxel|docetaxel
623895|NCT00925418|Glove|glove
623896|NCT00925405|Breast Cancer|breast cancer
623897|NCT00925405|Hodgkin's lymphoma|hodgkin's lymphoma
623898|NCT00925405|Mantle-field Irradiation|mantle-field irradiation
623899|NCT00925405|Mammogram|mammogram
623900|NCT00925405|Magnetic resonance imaging|magnetic resonance imaging
623901|NCT00925405|MRI Breast Cancer Screening|mri breast cancer screening
623902|NCT00925392|doripenem|doripenem
623903|NCT00925392|epithelial lining fluid|epithelial lining fluid
623904|NCT00925392|alveolar macrophages|alveolar macrophages
623905|NCT00925392|pharmacokinetics|pharmacokinetics
623906|NCT00925392|Healthy adult subjects|healthy adult subjects
623907|NCT00925366|Shoulder|shoulder
623908|NCT00925366|MRI|mri
623909|NCT00925366|MR arthrography|mr arthrography
623910|NCT00925366|CT arthrography|ct arthrography
623911|NCT00925366|Rotator cuff tear|rotator cuff tear
623912|NCT00925366|Arthroscopy|arthroscopy
623913|NCT00925353|lidocaine|lidocaine
623914|NCT00925353|pre-medication|pre-medication
623915|NCT00925353|mammography|mammography
623916|NCT00925353|pain|pain
623917|NCT00925353|safety|safety
623918|NCT00925340|Alcohol|alcohol
623919|NCT00925340|Substance Abuse|substance abuse
623920|NCT00925340|Adolescent|adolescent
623921|NCT00925340|Family functioning|family functioning
623922|NCT00925314|Stage III Melanoma|stage iii melanoma
623923|NCT00925314|Melanoma|melanoma
623924|NCT00925314|TLI|tli
623925|NCT00925314|Transgenic Lymphocyte Immunization|transgenic lymphocyte immunization
623926|NCT00925314|CB-10-01-02|cb-10-01-02
623927|NCT00925301|Amicus Therapeutics|amicus therapeutics
623928|NCT00925301|AT1001|at1001
623929|NCT00925301|Migalastat|migalastat
623930|NCT00925301|Pharmacokinetics|pharmacokinetics
623931|NCT00925301|Substrate|substrate
623932|NCT00925301|Galafold|galafold
623933|NCT00925288|Female sex worker|female sex worker
623934|NCT00925288|Peru|peru
623935|NCT00925288|Cervical infection|cervical infection
623936|NCT00925288|Cervical abnormality|cervical abnormality
623937|NCT00925288|Serum antibody|serum antibody
623938|NCT00925288|Vaccine acceptance|vaccine acceptance
623939|NCT00925288|Alternative schedule|alternative schedule
623940|NCT00925288|Viral infections|viral infections
623941|NCT00925288|Human papillomavirus vaccine|human papillomavirus vaccine
623942|NCT00925288|Human papillomavirus (HPV)|human papillomavirus (hpv)
623943|NCT00925288|non inferiority|non inferiority
623944|NCT00925275|Solid tumors|solid tumors
623945|NCT00925275|Refractory|refractory
623946|NCT00925275|Relapsed|relapsed
623947|NCT00925275|Radiation|radiation
623948|NCT00925275|Dosimetry|dosimetry
623949|NCT00925275|Radiopharmaceutical|radiopharmaceutical
623950|NCT00925275|Biodistribution|biodistribution
623951|NCT00925275|Pharmacokinetics|pharmacokinetics
623952|NCT00925275|Cancer|cancer
623953|NCT00925275|Phase I|phase i
623954|NCT00925262|mental health|mental health
623955|NCT00925262|randomized controlled trial|randomized controlled trial
623956|NCT00925262|torture|torture
623957|NCT00925249|rheumatoid arthritis|rheumatoid arthritis
623958|NCT00925249|RA|ra
623959|NCT00925249|TB|tb
623960|NCT00925249|tuberculosis|tuberculosis
623961|NCT00925249|anti-TNF therapy|anti-tnf therapy
623962|NCT00925249|biologic therapy|biologic therapy
623963|NCT00925249|quantiferon|quantiferon
623965|NCT00925249|Newly diagnosed rheumatoid arthritis (RA) in the Tricare system|newly diagnosed rheumatoid arthritis (ra) in the tricare system
623966|NCT00925236|MYH9 gene|myh9 gene
623967|NCT00925236|macrothrombocytopenia|macrothrombocytopenia
623968|NCT00925236|leukocyte inclusions|leukocyte inclusions
623969|NCT00925236|cataracts deafness|cataracts deafness
623970|NCT00925236|nephritis|nephritis
623971|NCT00925236|MYH9 Related Disorders|myh9 related disorders
623972|NCT00925223|IBS|ibs
623973|NCT00925223|BDNf|bdnf
623974|NCT00925223|visceral hypersensitivity|visceral hypersensitivity
623975|NCT00925210|Endobronchial ultrasound|endobronchial ultrasound
623976|NCT00925210|Electromagnetic Navigation Bronchoscopy|electromagnetic navigation bronchoscopy
623977|NCT00925210|Bronchoscopy|bronchoscopy
623978|NCT00925210|Ultrasonography|ultrasonography
623979|NCT00925197|anticoagulation|anticoagulation
623980|NCT00925197|fluindione|fluindione
623981|NCT00925197|patient self-testing|patient self-testing
623982|NCT00925197|coaguchek|coaguchek
623983|NCT00925197|inratio|inratio
623984|NCT00925197|Post operative antivitamin K therapy|post operative antivitamin k therapy
623985|NCT00925184|questionnaire, medical education, medical students.|questionnaire, medical education, medical students.
623986|NCT00925171|Chronic obstructive pulmonary disease|chronic obstructive pulmonary disease
623987|NCT00925171|Pulmonary rehabilitation|pulmonary rehabilitation
623988|NCT00925171|Chronic Respiratory Questionnaire|chronic respiratory questionnaire
623989|NCT00925158|Rhytidoplasty|rhytidoplasty
623990|NCT00925158|Video-Assisted Surgery|video-assisted surgery
623991|NCT00925158|Surgical instruments|surgical instruments
623992|NCT00925158|Dissection|dissection
623993|NCT00925158|Innovative therapies|innovative therapies
623994|NCT00925158|Face|face
623995|NCT00925158|Aging|aging
623996|NCT00925158|Premature aging|premature aging
623997|NCT00925158|Rejuvenation|rejuvenation
623998|NCT00925132|Metastatic|metastatic
623999|NCT00925132|Melanoma|melanoma
624000|NCT00925132|Epigenetic|epigenetic
624001|NCT00925132|Temozolomide|temozolomide
624002|NCT00925132|Decitabine|decitabine
624003|NCT00925132|Panobinostat|panobinostat
624004|NCT00925132|LBH589|lbh589
624005|NCT00925119|Diabetes|diabetes
624006|NCT00925119|Atenolol|atenolol
624007|NCT00925119|Genetic|genetic
624008|NCT00925106|Bioavailability, pharmacokinetics, celecoxib|bioavailability, pharmacokinetics, celecoxib
624009|NCT00925093|vancomycin|vancomycin
624010|NCT00925093|teicoplanin|teicoplanin
624011|NCT00925093|linezolid|linezolid
624012|NCT00925093|intravenous|intravenous
624013|NCT00925093|cerebrospinal fluid|cerebrospinal fluid
624014|NCT00925093|CSF|csf
624015|NCT00925093|pharmacokinetics|pharmacokinetics
624016|NCT00925093|penetration|penetration
624017|NCT00925093|blood-brain barrier|blood-brain barrier
624018|NCT00925093|Pharmacokinetics of three antibiotics in relation to cerebrospinal fluid|pharmacokinetics of three antibiotics in relation to cerebrospinal fluid
624019|NCT00925067|Inguinal hernia|inguinal hernia
624020|NCT00925067|Laparoscopic repair|laparoscopic repair
624021|NCT00925067|Prostheses|prostheses
624022|NCT00925067|Male fertility|male fertility
624023|NCT00925054|PKU|pku
624024|NCT00925054|PEG PAL|peg pal
624025|NCT00925054|BioMarin|biomarin
624026|NCT00924989|Adrenocortical carcinoma|adrenocortical carcinoma
624027|NCT00924989|OSI-906|osi-906
624028|NCT00924989|ACC|acc
624029|NCT00924989|GALACCTIC|galacctic
624030|NCT00924989|Insulin-like growth factor-1 receptor (IGF-1R)|insulin-like growth factor-1 receptor (igf-1r)
624031|NCT00924963|Pain of venipuncture or IV insertion|pain of venipuncture or iv insertion
624032|NCT00924950|Psoriasis|psoriasis
624033|NCT00924950|Plaque psoriasis, with bilateral symmetrical lesions.|plaque psoriasis, with bilateral symmetrical lesions.
624034|NCT00924950|A diagnosis of stable plaque-type psoriasis vulgaris|a diagnosis of stable plaque-type psoriasis vulgaris
624035|NCT00924950|with at least one pair of symmetric lesions on either|with at least one pair of symmetric lesions on either
624036|NCT00924950|the trunk, arms, or legs that would serve as target lesions.|the trunk, arms, or legs that would serve as target lesions.
624037|NCT00924937|Cardiovascular events|cardiovascular events
624038|NCT00924937|Blood pressure|blood pressure
624039|NCT00924937|Incidence of Cancer|incidence of cancer
624040|NCT00924937|Cognitive decline|cognitive decline
624041|NCT00924937|Mediterranean Diet|mediterranean diet
624042|NCT00924937|Secondary Prevention|secondary prevention
624043|NCT00924937|Low fat diet|low fat diet
624044|NCT00924924|health promotion|health promotion
624045|NCT00924924|prevention|prevention
624046|NCT00924924|worksite wellness|worksite wellness
624047|NCT00924924|behavior change|behavior change
624048|NCT00924924|healthy volunteers|healthy volunteers
624049|NCT00924911|GSK1322322, relative bioavailability, single dose, food effect, H2 blocker, healthy subjects, open label, PIB, tablet|gsk1322322, relative bioavailability, single dose, food effect, h2 blocker, healthy subjects, open label, pib, tablet
624050|NCT00924898|Acute HIV|acute hiv
624051|NCT00924898|HIV|hiv
624052|NCT00924898|Acute Infections|acute infections
624053|NCT00924898|Acute Infection|acute infection
624054|NCT00924885|Reproductive Medicine|reproductive medicine
624055|NCT00924885|Fertilization in Vitro|fertilization in vitro
624056|NCT00924885|Oocyte retrieval|oocyte retrieval
624057|NCT00924885|Local anaesthesia|local anaesthesia
624058|NCT00924885|Aspiration needle|aspiration needle
624059|NCT00924872|stroke|stroke
624060|NCT00924872|power wheelchair skills|power wheelchair skills
624061|NCT00924872|training|training
624062|NCT00924872|safety|safety
624063|NCT00924859|cerebral venous thrombosis|cerebral venous thrombosis
624064|NCT00924859|stroke|stroke
624065|NCT00924859|coagulation|coagulation
624066|NCT00924846|high frequency oscillatory ventilation|high frequency oscillatory ventilation
624067|NCT00924846|respiratory failure|respiratory failure
624068|NCT00924846|children|children
624069|NCT00924846|inhaled nitric oxide|inhaled nitric oxide
624070|NCT00924833|hypoxia|hypoxia
624071|NCT00924833|autonomic nervous system|autonomic nervous system
624072|NCT00924833|blood pressure|blood pressure
624073|NCT00924833|heart rate|heart rate
624074|NCT00924833|exercise|exercise
624075|NCT00924833|heart failure|heart failure
624076|NCT00924833|receptors, adrenergic, beta.|receptors, adrenergic, beta.
624077|NCT00924820|Neoplastic Meningitis|neoplastic meningitis
624078|NCT00924820|NM|nm
624079|NCT00924820|Advanced Cancers|advanced cancers
624080|NCT00924820|Brain Cancer|brain cancer
624081|NCT00924820|Advanced Cancer|advanced cancer
624082|NCT00924820|Brain Diseases|brain diseases
624083|NCT00924820|Central Nervous System Disorders|central nervous system disorders
624084|NCT00924820|CNS|cns
624085|NCT00924820|Bevacizumab|bevacizumab
624086|NCT00924820|Avastin|avastin
624087|NCT00924820|Anti-VEGF monoclonal antibody|anti-vegf monoclonal antibody
624088|NCT00924820|rhuMAb-VEGF|rhumab-vegf
624089|NCT00924820|Spinal Cord|spinal cord
624090|NCT00924820|meninges|meninges
624091|NCT00924820|cerebrospinal fluid|cerebrospinal fluid
624092|NCT00924820|CSF|csf
624093|NCT00924807|Prostate Cancer|prostate cancer
624397|NCT00923728|Cancer|cancer
624094|NCT00924807|Combined Androgen Blockade|combined androgen blockade
624095|NCT00924807|Radiotherapy|radiotherapy
624096|NCT00924807|Sorafenib|sorafenib
624097|NCT00924781|Anemia associated with chronic kidney disease (CKD)|anemia associated with chronic kidney disease (ckd)
624098|NCT00924781|Hemodialysis|hemodialysis
624099|NCT00924768|Otherwise healthy current cigarette smokers|otherwise healthy current cigarette smokers
624100|NCT00924768|current cigarette smokers|current cigarette smokers
624101|NCT00924755|Surgical mesh|surgical mesh
624102|NCT00924742|The PK of Tapimycin|the pk of tapimycin
624103|NCT00924742|volunteer|volunteer
624104|NCT00924690|Colon|colon
624105|NCT00924690|Cancer|cancer
624106|NCT00924690|Screening|screening
624107|NCT00924690|Prevention|prevention
624108|NCT00924690|Information|information
624109|NCT00924677|genicular nerve|genicular nerve
624110|NCT00924677|osteoarthritis|osteoarthritis
624111|NCT00924677|knee|knee
624112|NCT00924677|neurotomy|neurotomy
624113|NCT00924664|low back pain monoclonal antibody nerve growth factor|low back pain monoclonal antibody nerve growth factor
624114|NCT00924651|fatigue|fatigue
624115|NCT00924651|unspecified adult solid tumor, protocol specific|unspecified adult solid tumor, protocol specific
624116|NCT00924638|atrial fibrillation|atrial fibrillation
624117|NCT00924638|cryptogenic stroke|cryptogenic stroke
624118|NCT00924638|continuous monitoring|continuous monitoring
624119|NCT00924638|implantable loop recorder|implantable loop recorder
624120|NCT00924638|insertable cardiac monitor|insertable cardiac monitor
624121|NCT00924612|Primary hypogonadism|primary hypogonadism
624122|NCT00924612|Secondary hypogonadism|secondary hypogonadism
624123|NCT00924599|Recurring Gestational Diabetes|recurring gestational diabetes
624124|NCT00924599|Prevention|prevention
624125|NCT00924573|Glimepiride|glimepiride
624126|NCT00924573|Metformin|metformin
624127|NCT00924573|Combination Drug Therapy|combination drug therapy
624128|NCT00924560|Adolescents|adolescents
624129|NCT00924560|Bone Mineral Density|bone mineral density
624130|NCT00924560|Oral Contraceptive|oral contraceptive
624131|NCT00924547|Cystic Fibrosis|cystic fibrosis
624132|NCT00924547|Docosahexanoic Acid|docosahexanoic acid
624133|NCT00924547|DHA|dha
624134|NCT00924547|isoprostanes|isoprostanes
624135|NCT00924547|fatty acid|fatty acid
624136|NCT00924534|type 2 diabetes|type 2 diabetes
624137|NCT00924534|interventional|interventional
624138|NCT00924534|placebo|placebo
624139|NCT00924534|controlled|controlled
624140|NCT00924534|PK|pk
624141|NCT00924534|PD|pd
624142|NCT00924534|safety|safety
624143|NCT00924521|grains|grains
624144|NCT00924521|fiber|fiber
624145|NCT00924521|metabolic syndrome|metabolic syndrome
624146|NCT00924521|insulin|insulin
624147|NCT00924508|eczema|eczema
624148|NCT00924508|at least 3 patches of eczema|at least 3 patches of eczema
624149|NCT00924495|low back pain|low back pain
624150|NCT00924495|motor control|motor control
624151|NCT00924495|cortical regulation|cortical regulation
624152|NCT00924495|transcranial magnetic stimulation|transcranial magnetic stimulation
624153|NCT00924482|cardiac output|cardiac output
624154|NCT00924482|ECOM|ecom
624155|NCT00924482|Endotracheal Cardiac Output Monitor|endotracheal cardiac output monitor
624156|NCT00924482|Perioperative medical care|perioperative medical care
624157|NCT00924469|Prostate cancer|prostate cancer
624158|NCT00924469|Abiraterone acetate|abiraterone acetate
624159|NCT00924469|Leuprolide acetate|leuprolide acetate
624160|NCT00924469|Prednisone|prednisone
624161|NCT00924469|CB7630|cb7630
624162|NCT00924469|Testosterone|testosterone
624163|NCT00924456|Transcendental Meditation|transcendental meditation
624164|NCT00924456|blood pressure|blood pressure
624165|NCT00924456|psychological distress|psychological distress
624166|NCT00924456|high psychological distress|high psychological distress
624167|NCT00924443|acute myelogenous leukemia|acute myelogenous leukemia
624168|NCT00924443|acute myeloid leukemia|acute myeloid leukemia
624169|NCT00924443|clolar|clolar
624170|NCT00924443|evoltra|evoltra
624171|NCT00924443|clofarabine|clofarabine
624172|NCT00924443|untreated acute leukemia|untreated acute leukemia
624173|NCT00924443|adult acute leukemia|adult acute leukemia
624174|NCT00924430|Interaction SLV337 and simvastatin|interaction slv337 and simvastatin
624175|NCT00924430|Type 2 diabetes mellitus|type 2 diabetes mellitus
624176|NCT00924417|Pain associated with peripheral intravenous line placement|pain associated with peripheral intravenous line placement
624177|NCT00924404|Xylitol vs. Saline|xylitol vs. saline
624178|NCT00924404|nasal washes|nasal washes
624179|NCT00924404|sinusitis|sinusitis
624180|NCT00924391|cholesterol|cholesterol
624181|NCT00924391|plant sterols|plant sterols
624182|NCT00924391|cholesterol absorption|cholesterol absorption
624183|NCT00924365|Children|children
624184|NCT00924365|AIDS|aids
624185|NCT00924365|Toxicity|toxicity
624186|NCT00924365|Development|development
624187|NCT00924365|Puberty|puberty
624188|NCT00924365|HIV|hiv
624189|NCT00924365|Pediatrics|pediatrics
624190|NCT00924365|HIV Infections|hiv infections
624191|NCT00924352|Metastatic Breast Cancer|metastatic breast cancer
624192|NCT00924339|soy protein|soy protein
624193|NCT00924339|familial hypercholesterolaemia|familial hypercholesterolaemia
624194|NCT00924339|children and adolescents|children and adolescents
624195|NCT00924339|isoflavones|isoflavones
624196|NCT00924339|FH|fh
624197|NCT00924326|B Cell Malignancies|b cell malignancies
624198|NCT00924326|T Cell Persistence|t cell persistence
624199|NCT00924326|Immunotherapy|immunotherapy
624200|NCT00924326|Cell Transfer|cell transfer
624201|NCT00924326|Leukemia|leukemia
624202|NCT00924326|Chronic Lymphocytic Leukemia|chronic lymphocytic leukemia
624203|NCT00924326|CLL|cll
624204|NCT00924326|Lymphoma|lymphoma
624205|NCT00924313|Prostate Cancer|prostate cancer
624206|NCT00924313|MRI|mri
624207|NCT00924313|C-11 Acetate|c-11 acetate
624208|NCT00924313|PET|pet
624461|NCT00923481|Kidney Cancer|kidney cancer
624209|NCT00924300|feasibility of MEG in pediatric populations|feasibility of meg in pediatric populations
624210|NCT00924287|Metastatic Cancer|metastatic cancer
624211|NCT00924287|Tumor Regression|tumor regression
624212|NCT00924287|Immunotherapy|immunotherapy
624213|NCT00924287|Safety|safety
624214|NCT00924287|Cancer|cancer
624215|NCT00924261|hip|hip
624216|NCT00924261|gait|gait
624217|NCT00924261|walking|walking
624218|NCT00924261|falls|falls
624219|NCT00924261|stretching|stretching
624220|NCT00924261|Flexibility|flexibility
624221|NCT00924261|Aged|aged
624222|NCT00924248|Liver MRI|liver mri
624223|NCT00924209|Neoadjuvant|neoadjuvant
624224|NCT00924209|Stage IIIA (N2)|stage iiia (n2)
624225|NCT00924209|Cisplatin|cisplatin
624226|NCT00924209|Gemcitabine|gemcitabine
624227|NCT00924209|Bevacizumab|bevacizumab
624228|NCT00924209|Non-Small Cell Lung Cancer|non-small cell lung cancer
624229|NCT00924209|NSCLC|nsclc
624230|NCT00924196|Plexiform Neurofibroma|plexiform neurofibroma
624231|NCT00924196|Optic Pathway Tumor|optic pathway tumor
624232|NCT00924196|Neurofibroma|neurofibroma
624233|NCT00924196|Malignant Peripheral Nerve Sheath Tumor|malignant peripheral nerve sheath tumor
624234|NCT00924196|Volumetric MRI|volumetric mri
624235|NCT00924196|Neurofibromatosis Type 1|neurofibromatosis type 1
624236|NCT00924196|NF1|nf1
624237|NCT00924196|Optic Glioma|optic glioma
624238|NCT00924183|Depression|depression
624239|NCT00924183|Symptom scales|symptom scales
624240|NCT00924183|Symptom measures|symptom measures
624241|NCT00924183|Vancouver Semi-Structured Interview for Depression|vancouver semi-structured interview for depression
624242|NCT00924183|V-SID|v-sid
624243|NCT00924183|VSID|vsid
624244|NCT00924183|treatment-as-usual|treatment-as-usual
624245|NCT00924183|treatment as usual|treatment as usual
624246|NCT00924183|open-label|open-label
624247|NCT00924183|open label|open label
624248|NCT00924183|Major Depressive Episode|major depressive episode
624249|NCT00924183|MDE|mde
624250|NCT00924170|Immunotoxin|immunotoxin
624251|NCT00924170|CD25|cd25
624252|NCT00924170|Immunogenicity|immunogenicity
624253|NCT00924170|Neutralization|neutralization
624254|NCT00924170|Neutralizing Antibodies|neutralizing antibodies
624255|NCT00924170|Adult T-Cell Leukemia|adult t-cell leukemia
624256|NCT00924170|Leukemia|leukemia
624257|NCT00924170|ATL|atl
624258|NCT00924131|Late Effects|late effects
624259|NCT00924131|Radiation|radiation
624260|NCT00924131|Chemotherapy|chemotherapy
624261|NCT00924131|Hodgkin's Disease|hodgkin's disease
624262|NCT00924131|Lymphoma|lymphoma
624263|NCT00924131|Hodgkin Disease|hodgkin disease
624264|NCT00924118|Acute myocardial infarction|acute myocardial infarction
624265|NCT00924118|Reperfusion injury|reperfusion injury
624266|NCT00924118|Nitric oxide|nitric oxide
624267|NCT00924092|Immunotherapy|immunotherapy
624268|NCT00924092|Lung Cancer|lung cancer
624269|NCT00924092|Colorectal Cancer|colorectal cancer
624270|NCT00924092|Head and Neck Cancer|head and neck cancer
624271|NCT00924092|Prostate|prostate
624272|NCT00924092|Breast Cancer|breast cancer
624273|NCT00924079|Analysis of plasma concentration of nalbuphine|analysis of plasma concentration of nalbuphine
624274|NCT00924066|Ixabepilone|ixabepilone
624275|NCT00924066|BMS-247550|bms-247550
624276|NCT00924066|Ixempra|ixempra
624277|NCT00924066|Cervical Cancer|cervical cancer
624278|NCT00924066|Epothilone|epothilone
624279|NCT00924053|Diabetes Mellitus Type 2|diabetes mellitus type 2
624280|NCT00924040|BL22 in HCL after Immunotoxin|bl22 in hcl after immunotoxin
624281|NCT00924040|Hairy Cell Leukemia|hairy cell leukemia
624282|NCT00924040|Leukemia|leukemia
624283|NCT00924027|Radiation|radiation
624284|NCT00924027|Cancer|cancer
624285|NCT00924027|HDR|hdr
624286|NCT00924027|Brachytherapy|brachytherapy
624287|NCT00924027|Training|training
624288|NCT00924014|heart failure|heart failure
624289|NCT00924001|Clinical Response|clinical response
624290|NCT00924001|Immunotherapy|immunotherapy
624291|NCT00924001|Cancer|cancer
624292|NCT00924001|Cytokines|cytokines
624293|NCT00924001|Adoptive Cell Therapy|adoptive cell therapy
624294|NCT00924001|Melanoma|melanoma
624295|NCT00924001|Metastatic Melanoma|metastatic melanoma
624296|NCT00923988|Secondhand smoke|secondhand smoke
624297|NCT00923988|passive smoking|passive smoking
624298|NCT00923988|platelet function|platelet function
624299|NCT00923988|endothelial function|endothelial function
624300|NCT00923962|Basic science|basic science
624301|NCT00923962|Type 2 Diabetes mellitus|type 2 diabetes mellitus
624302|NCT00923962|Glucagon like peptid-1|glucagon like peptid-1
624303|NCT00923962|Coronary Bloodflow|coronary bloodflow
624304|NCT00923962|Metabolite uptake|metabolite uptake
624305|NCT00923949|NSCLC Stage Ia-IIb|nsclc stage ia-iib
624306|NCT00923949|Resectable NSCLC|resectable nsclc
624307|NCT00923949|Non-Small Cell Lung Cancer|non-small cell lung cancer
624308|NCT00923949|NSCLC|nsclc
624309|NCT00923936|Kaposi's Sarcoma|kaposi's sarcoma
624310|NCT00923936|HIV|hiv
624311|NCT00923936|Doxil|doxil
624312|NCT00923936|VEGF|vegf
624313|NCT00923936|Bevacizumab|bevacizumab
624314|NCT00923923|stress reactivity|stress reactivity
624315|NCT00923923|PTSD|ptsd
624316|NCT00923923|alcohol dependence|alcohol dependence
624317|NCT00923923|drinking|drinking
624318|NCT00923923|craving|craving
624319|NCT00923910|WT1 Peptide Dendritic Cell Vaccine|wt1 peptide dendritic cell vaccine
624320|NCT00923910|Hematologic Malignancies|hematologic malignancies
624321|NCT00923910|Relapse After Allogeneic Stem Cell Transplantation|relapse after allogeneic stem cell transplantation
624322|NCT00923910|Donor Lymphocyte Infusions|donor lymphocyte infusions
624323|NCT00923910|WT1-Positive|wt1-positive
624324|NCT00923910|Dendritic Cell Vaccine|dendritic cell vaccine
624325|NCT00923910|Tumor Immunotherapy|tumor immunotherapy
624326|NCT00923910|Allogeneic Adoptive Immunotherapy|allogeneic adoptive immunotherapy
624327|NCT00923910|Hodgkins Lymphoma|hodgkins lymphoma
624328|NCT00923910|Leukemia|leukemia
624329|NCT00923910|Acute Myelogenous Leukemia|acute myelogenous leukemia
624330|NCT00923910|AML|aml
624331|NCT00923910|Acute Lymphocytic Leukemia|acute lymphocytic leukemia
624332|NCT00923910|ALL|all
624333|NCT00923910|Chronic Myelogenous Leukemia|chronic myelogenous leukemia
624334|NCT00923910|CML|cml
624335|NCT00923910|Myelodysplasia Syndrome|myelodysplasia syndrome
624336|NCT00923910|Non-Hodgkin Lymphoma|non-hodgkin lymphoma
624337|NCT00923897|Hepatocellular Carcinoma|hepatocellular carcinoma
624338|NCT00923897|Hepatic Metastasis|hepatic metastasis
624339|NCT00923897|Palliative Radiation Therapy|palliative radiation therapy
624340|NCT00923897|Locally advanced HCC and Hepatic Metastasis|locally advanced hcc and hepatic metastasis
624341|NCT00923884|NSCLC|nsclc
624342|NCT00923884|Genotype|genotype
624343|NCT00923884|SCLC|sclc
624344|NCT00923884|Lung Cancer|lung cancer
624345|NCT00923884|Non-Small Cell Lung Cancer|non-small cell lung cancer
624346|NCT00923884|Small Cell Lung Cancer|small cell lung cancer
624347|NCT00923871|CBCT|cbct
624348|NCT00923871|Breast Cancer|breast cancer
624349|NCT00923858|Rotator Cuff|rotator cuff
624350|NCT00923858|Ultrasound|ultrasound
624351|NCT00923858|Pain|pain
624352|NCT00923858|Tear Progression|tear progression
624353|NCT00923845|Metastatic Renal Cell Carcinoma|metastatic renal cell carcinoma
624354|NCT00923845|Allogeneic Hematopoietic Stem Cell Transplant|allogeneic hematopoietic stem cell transplant
624355|NCT00923845|Th2 Cells|th2 cells
624356|NCT00923845|Sirolimus|sirolimus
624357|NCT00923845|Pentostatin|pentostatin
624358|NCT00923845|Kidney Cancer|kidney cancer
624359|NCT00923845|Renal Cell Carcinoma|renal cell carcinoma
624360|NCT00923845|Metastatic Renal Cell Cancer|metastatic renal cell cancer
624361|NCT00923832|Fungal Infections|fungal infections
624362|NCT00923832|PCR Assays|pcr assays
624363|NCT00923832|Cell Wall Derived Biomarkers|cell wall derived biomarkers
624364|NCT00923832|EORTC/MSG Definitions|eortc/msg definitions
624365|NCT00923832|Molecular Assays|molecular assays
624366|NCT00923832|Lung Fungal Infection|lung fungal infection
624367|NCT00923832|Invasive Pulmonary Fungal Infection|invasive pulmonary fungal infection
624368|NCT00923832|Invasive Pulmonary Aspegillosis|invasive pulmonary aspegillosis
624369|NCT00923832|Invasive Pulmonary Zycomycosis|invasive pulmonary zycomycosis
624370|NCT00923819|Adolescents|adolescents
624371|NCT00923819|Gastric Bypass|gastric bypass
624372|NCT00923819|Quality of Life|quality of life
624373|NCT00923819|Mental Health|mental health
624374|NCT00923819|Lifestyle|lifestyle
624375|NCT00923806|Metastatic Cancer|metastatic cancer
624376|NCT00923806|Tumor Regression|tumor regression
624377|NCT00923806|Safety|safety
624378|NCT00923806|Immunotherapy|immunotherapy
624379|NCT00923793|skull defects|skull defects
624380|NCT00923793|Hydroxylapatite implant|hydroxylapatite implant
624381|NCT00923793|Titanium implant|titanium implant
624382|NCT00923793|calotte defects without the possibility to be covered with the missing own bone|calotte defects without the possibility to be covered with the missing own bone
624383|NCT00923780|Tissue Acquisition|tissue acquisition
624384|NCT00923780|Gene Expression|gene expression
624385|NCT00923780|Class Predictor Model|class predictor model
624386|NCT00923780|Endocrine Tumor|endocrine tumor
624387|NCT00923741|Lung Cancer|lung cancer
624388|NCT00923741|Immunity|immunity
624389|NCT00923741|Clinical Response|clinical response
624390|NCT00923741|Cytokines|cytokines
624391|NCT00923741|Elispot Assay|elispot assay
624392|NCT00923741|Non-Small Cell Lung Cancer|non-small cell lung cancer
624393|NCT00923741|NSCLC|nsclc
624394|NCT00923728|AVN - 944|avn - 944
624395|NCT00923728|Phase I|phase i
624396|NCT00923728|Adult Solid Tumors|adult solid tumors
624398|NCT00923728|Solid Tumor|solid tumor
624399|NCT00923676|Hyperlipidemia|hyperlipidemia
624400|NCT00923676|LDL-cholesterol|ldl-cholesterol
624401|NCT00923676|HDL-cholesterol|hdl-cholesterol
624402|NCT00923676|triglycerides|triglycerides
624403|NCT00923676|IIEF|iief
624404|NCT00923676|FSFI|fsfi
624405|NCT00923676|Male and female sexual dysfunctions|male and female sexual dysfunctions
624406|NCT00923663|MALT lymphoma|malt lymphoma
624407|NCT00923663|Advanced or Helicobacter pylori-refractory MALT lymphoma|advanced or helicobacter pylori-refractory malt lymphoma
624408|NCT00923650|Informed Consent|informed consent
624409|NCT00923650|Pediatric Phase I Clinical Trials|pediatric phase i clinical trials
624410|NCT00923650|Assent|assent
624411|NCT00923650|Questionnaires|questionnaires
624412|NCT00923650|Osteosarcoma|osteosarcoma
624413|NCT00923650|Ewing's Sarcoma|ewing's sarcoma
624414|NCT00923650|Neuroblastoma|neuroblastoma
624415|NCT00923650|Brain Tumors|brain tumors
624416|NCT00923650|Leukemia|leukemia
624417|NCT00923637|Non small cell lung cancer|non small cell lung cancer
624418|NCT00923637|video assisted thoracic surgery|video assisted thoracic surgery
624419|NCT00923637|Adjuvant chemotherapy|adjuvant chemotherapy
624420|NCT00923637|Pemetrexed|pemetrexed
624421|NCT00923637|Oxaliplatin|oxaliplatin
624422|NCT00923624|electronic medical record|electronic medical record
624423|NCT00923624|antiretroviral medication adherence|antiretroviral medication adherence
624424|NCT00923611|Hypertension|hypertension
624425|NCT00923611|Fimasartan|fimasartan
624426|NCT00923598|TKA|tka
624427|NCT00923598|Bilateral|bilateral
624428|NCT00923598|Cleveland Clinic|cleveland clinic
624429|NCT00923598|UCSD|ucsd
624430|NCT00923598|Catheter|catheter
624431|NCT00923598|Nerve block|nerve block
624432|NCT00923598|Postoperative pain|postoperative pain
624433|NCT00923598|Femoral Catheter|femoral catheter
624434|NCT00923598|Bilateral Total Knee Arthroplasty|bilateral total knee arthroplasty
624435|NCT00923598|Bilateral Femoral Catheter|bilateral femoral catheter
624436|NCT00923572|Oral contraceptive|oral contraceptive
624437|NCT00923533|Fimasartan|fimasartan
624438|NCT00923533|Drug interaction|drug interaction
624439|NCT00923520|Solid Tumors|solid tumors
624440|NCT00923520|Phase I|phase i
624441|NCT00923520|Lymphoma|lymphoma
624442|NCT00923520|Dimethane Sulfonate (DMS612, NSC 281612)|dimethane sulfonate (dms612, nsc 281612)
624443|NCT00923520|Cancer|cancer
624444|NCT00923520|Solid Tumor|solid tumor
624445|NCT00923520|Renal Cell Cancer|renal cell cancer
624446|NCT00923520|Kidney Cancer|kidney cancer
624447|NCT00923520|Breast Cancer|breast cancer
624448|NCT00923520|Colon Cancer|colon cancer
624449|NCT00923520|Lung Disease|lung disease
624450|NCT00923520|Non-Hodgkin Lymphoma|non-hodgkin lymphoma
624451|NCT00923520|NHL|nhl
624452|NCT00923507|Chronic Lymphocytic Leukemia (CLL)|chronic lymphocytic leukemia (cll)
624453|NCT00923507|Monoclonal B Cell Lymphocytosis|monoclonal b cell lymphocytosis
624454|NCT00923507|Small Lymphocytic Lymphoma (SLL)|small lymphocytic lymphoma (sll)
624455|NCT00923507|Leukemia|leukemia
624456|NCT00923507|Lymphoma|lymphoma
624457|NCT00923494|Anesthesia|anesthesia
624458|NCT00923481|Multi-Kinase Inhibitor|multi-kinase inhibitor
624459|NCT00923481|Neoplasms|neoplasms
624460|NCT00923481|Advanced Cancer|advanced cancer
624462|NCT00923481|Liver Cancer|liver cancer
624463|NCT00923481|Pheochromocytoma|pheochromocytoma
624464|NCT00923481|Non-Small Cell Lung Cancer|non-small cell lung cancer
624465|NCT00923481|Colorectal Cancer|colorectal cancer
624466|NCT00923481|Head and Neck Cancer|head and neck cancer
624467|NCT00923468|Pharmacokinetics|pharmacokinetics
624468|NCT00923468|Phase I Trials|phase i trials
624469|NCT00923468|Children|children
624470|NCT00923468|Relaspsed Solid Tumors|relaspsed solid tumors
624471|NCT00923468|Relapsed Leukemia|relapsed leukemia
624472|NCT00923468|Relapsed Brain Tumors|relapsed brain tumors
624473|NCT00923442|Acute Lymphoblastic Leukemia|acute lymphoblastic leukemia
624474|NCT00923442|Acute Lymphocytic Leukemia|acute lymphocytic leukemia
624475|NCT00923442|Pediatric Blood Disorders|pediatric blood disorders
624476|NCT00923442|Hodgkins and non-Hodgkins lymphoma|hodgkins and non-hodgkins lymphoma
624477|NCT00923442|MDS|mds
624478|NCT00923429|Manual therapy|manual therapy
624479|NCT00923429|Low back pain|low back pain
624480|NCT00923429|Pain|pain
624481|NCT00923429|Return to work|return to work
624482|NCT00923416|Intra-Prostate Markers|intra-prostate markers
624483|NCT00923416|Transrectal Ultrasound|transrectal ultrasound
624484|NCT00923416|Prostate Cancer Patients|prostate cancer patients
624485|NCT00923403|plant sterols|plant sterols
624486|NCT00923403|diet|diet
624487|NCT00923403|soymilk|soymilk
624488|NCT00923403|cholesterol|cholesterol
624489|NCT00923390|Renal Cancer|renal cancer
624490|NCT00923390|Immunotherapy|immunotherapy
624491|NCT00923390|Clinical Response|clinical response
624492|NCT00923390|Toxicity|toxicity
624493|NCT00923390|Gene Therapy|gene therapy
624494|NCT00923390|Kidney Cancer|kidney cancer
624495|NCT00923377|Breast Cancer|breast cancer
624496|NCT00923377|Breast Cancer Prevention|breast cancer prevention
624497|NCT00923377|High Risk|high risk
625011|NCT00921440|stenosis|stenosis
624498|NCT00923377|Breast Stem Cells|breast stem cells
624499|NCT00923377|Mammographic Density|mammographic density
624500|NCT00923377|Breast Cancer Risk|breast cancer risk
624502|NCT00923364|Transplant|transplant
624503|NCT00923364|Immunodeficiency|immunodeficiency
624504|NCT00923364|Myelodysplasia|myelodysplasia
624505|NCT00923364|MonoMAC|monomac
624506|NCT00923351|Vaccine|vaccine
624507|NCT00923351|Immunotherapy|immunotherapy
624508|NCT00923351|Cancer|cancer
624509|NCT00923351|Chemotherapy|chemotherapy
624510|NCT00923351|Tumor Lysate/KLH Pulsed Dendritic Cell Vaccine|tumor lysate/klh pulsed dendritic cell vaccine
624511|NCT00923351|Neuroblastoma|neuroblastoma
624512|NCT00923351|Autologous Lymphocyte Infusion|autologous lymphocyte infusion
624513|NCT00923351|Ewing's Sarcoma|ewing's sarcoma
624514|NCT00923351|Rhabdomyosarcoma|rhabdomyosarcoma
624515|NCT00923338|fistula|fistula
624516|NCT00923338|vesico-vaginal fistula|vesico-vaginal fistula
624517|NCT00923325|Biomarker Analysis|biomarker analysis
624518|NCT00923325|Sarcomas|sarcomas
624519|NCT00923325|Ewing's Sarcoma|ewing's sarcoma
624520|NCT00923325|Osteosarcoma|osteosarcoma
624521|NCT00923325|Rhabdomyosarcoma|rhabdomyosarcoma
624522|NCT00923325|Synovial Sarcoma|synovial sarcoma
624523|NCT00923325|Other Sarcoma|other sarcoma
624524|NCT00923299|stage IV pancreatic cancer|stage iv pancreatic cancer
624525|NCT00923299|recurrent pancreatic cancer|recurrent pancreatic cancer
624526|NCT00923299|adenocarcinoma of the pancreas|adenocarcinoma of the pancreas
624527|NCT00923273|Pemetrexed|pemetrexed
624528|NCT00923273|Sirolimus|sirolimus
624529|NCT00923273|Non-Small Cell Lung Cancer|non-small cell lung cancer
624530|NCT00923273|Phase I/II|phase i/ii
624531|NCT00923273|mTOR Inhibitor|mtor inhibitor
624532|NCT00923273|NSCLC|nsclc
624533|NCT00923273|Lung Cancer|lung cancer
624534|NCT00923260|Omentectomy|omentectomy
624535|NCT00923260|metabolic syndrome|metabolic syndrome
624536|NCT00923260|acute phase reactants|acute phase reactants
624537|NCT00923247|Vandetanib|vandetanib
624538|NCT00923247|Bortezomib|bortezomib
624539|NCT00923247|Medullary Thyroid|medullary thyroid
624540|NCT00923247|Proteasome Inhibitor|proteasome inhibitor
624541|NCT00923247|Cancer|cancer
624542|NCT00923247|Solid Tumor|solid tumor
624543|NCT00923247|Thyroid Cancer|thyroid cancer
624544|NCT00923247|Medullary Thyroid Cancer|medullary thyroid cancer
624545|NCT00923234|monosomy 5|monosomy 5
624546|NCT00923234|del5q|del5q
624547|NCT00923234|lenalidomide|lenalidomide
624548|NCT00923234|azacitidine|azacitidine
624549|NCT00923221|Blood|blood
624550|NCT00923221|Prostate Cancer|prostate cancer
624551|NCT00923221|Genotyping|genotyping
624552|NCT00923195|Metastatic Melanoma|metastatic melanoma
624553|NCT00923195|Tumor Regression|tumor regression
624554|NCT00923195|Safety|safety
624555|NCT00923195|Immunotherapy|immunotherapy
624556|NCT00923182|Relapsed or Refractory Chronic Lymphocytic Leukemia,|relapsed or refractory chronic lymphocytic leukemia,
624557|NCT00923182|CLL|cll
624558|NCT00923169|Renal Cell|renal cell
624559|NCT00923169|Melanoma|melanoma
624560|NCT00923169|Monoclonal Antibodies|monoclonal antibodies
624561|NCT00923169|Phase I|phase i
624562|NCT00923169|TGF-B|tgf-b
624563|NCT00923156|Heart failure|heart failure
624564|NCT00923156|Systolic|systolic
624565|NCT00923156|Aliskiren|aliskiren
624566|NCT00923156|Ramipril|ramipril
624567|NCT00923156|Angiotensin II|angiotensin ii
624568|NCT00923156|Ang II|ang ii
624569|NCT00923156|Plasma Renin Activity|plasma renin activity
624570|NCT00923156|PRA|pra
624571|NCT00923156|Plasma Renin Concentration|plasma renin concentration
624572|NCT00923156|PR,|pr,
624573|NCT00923156|brain natriuretic peptide|brain natriuretic peptide
624574|NCT00923156|BNP|bnp
624575|NCT00923156|urinary aldosterone|urinary aldosterone
624576|NCT00923156|Escape|escape
624577|NCT00923156|Pharmacokinetic|pharmacokinetic
624578|NCT00923156|PK|pk
624579|NCT00923130|Renal Cell Carcinoma|renal cell carcinoma
624580|NCT00923130|Bevacizumab|bevacizumab
624581|NCT00923130|Ixabepilone|ixabepilone
624582|NCT00923130|Phase II|phase ii
624583|NCT00923117|Glioblastoma|glioblastoma
624584|NCT00923117|Chemotherapy|chemotherapy
624585|NCT00923117|Anti-Angiogenesis|anti-angiogenesis
624586|NCT00923117|Radiation|radiation
624587|NCT00923117|Brain Tumor|brain tumor
624588|NCT00923117|Malignant Glioma|malignant glioma
624589|NCT00923117|Glioblastoma Multiforme|glioblastoma multiforme
624590|NCT00923104|Radiation|radiation
624591|NCT00923104|Blister|blister
624592|NCT00923104|Healthy Volunteer|healthy volunteer
624593|NCT00923104|Samples|samples
624594|NCT00923104|Prostate Cancer|prostate cancer
624595|NCT00923104|Breast Cancer|breast cancer
624596|NCT00923104|HV|hv
624597|NCT00923091|triple combination|triple combination
624598|NCT00923091|parallel group|parallel group
624599|NCT00923091|dual combination|dual combination
624600|NCT00923078|schizophrenia|schizophrenia
624601|NCT00923078|cognitive remediation|cognitive remediation
624602|NCT00923078|rehabilitation|rehabilitation
624603|NCT00923078|electrophysiology|electrophysiology
624604|NCT00923078|neuropsychology|neuropsychology
624605|NCT00923065|Cancer|cancer
624606|NCT00923065|Oncology|oncology
624607|NCT00923065|Standard Care|standard care
624608|NCT00923052|Cancer Stem Cells|cancer stem cells
624609|NCT00923052|Biomarkers|biomarkers
624610|NCT00923052|Surgery|surgery
624611|NCT00923052|Solid Organ Cancers|solid organ cancers
624612|NCT00923052|Natural History|natural history
624613|NCT00923052|Cancer|cancer
624614|NCT00923052|Solid Organ Cancer|solid organ cancer
624615|NCT00923052|Liver Cancer|liver cancer
624616|NCT00923052|Colorectal Cancer|colorectal cancer
624617|NCT00923052|Breast Cancer|breast cancer
624618|NCT00923052|Gastric Cancer|gastric cancer
624619|NCT00923052|Pancreatic Ductal Cancer|pancreatic ductal cancer
624620|NCT00923039|The early origin of cardiovascular disease|the early origin of cardiovascular disease
624621|NCT00923026|Gene Therapy|gene therapy
624622|NCT00923026|Follow-Up|follow-up
624623|NCT00923026|Delayed Toxicity|delayed toxicity
624624|NCT00923026|Adenocarcinoma|adenocarcinoma
624625|NCT00923026|Melanoma|melanoma
624626|NCT00923026|Neuroendocrine Tumors|neuroendocrine tumors
624627|NCT00923026|Carcinoma|carcinoma
624628|NCT00923013|Hairy Cell Leukemia|hairy cell leukemia
624629|NCT00923013|Cladribine|cladribine
624630|NCT00923013|Rituximab|rituximab
624631|NCT00923013|Minimal Residual Disease|minimal residual disease
624632|NCT00923013|Leukemia|leukemia
624633|NCT00923000|Herb Drug|herb drug
624634|NCT00923000|volunteers|volunteers
624635|NCT00922987|lyrica pregabalin epilepsy partial seizures|lyrica pregabalin epilepsy partial seizures
624636|NCT00922974|spinal bone metastases|spinal bone metastases
624637|NCT00922974|pain|pain
624638|NCT00922961|brachytherapy, late cutaneous toxicity|brachytherapy, late cutaneous toxicity
624639|NCT00922948|Radiofrequency ablation|radiofrequency ablation
624640|NCT00922948|Cryosurgery|cryosurgery
624641|NCT00922948|Renal cancers|renal cancers
624642|NCT00922896|Gemcitabine|gemcitabine
624643|NCT00922896|Cisplatin|cisplatin
624644|NCT00922896|Erlotinib|erlotinib
624645|NCT00922883|Promacta|promacta
624646|NCT00922883|SAA|saa
624647|NCT00922883|Aplastic Anemia|aplastic anemia
624648|NCT00922883|Thrombocytopenia|thrombocytopenia
624649|NCT00922857|Respiratory Insufficiency|respiratory insufficiency
624650|NCT00922857|Muscular Atrophy|muscular atrophy
624651|NCT00922857|Respiratory rehabilitation|respiratory rehabilitation
624652|NCT00922844|hypotension|hypotension
624653|NCT00922844|low blood pressure|low blood pressure
624654|NCT00922844|vasopressor need|vasopressor need
624655|NCT00922831|Cognition, Affective MS symptoms|cognition, affective ms symptoms
624656|NCT00922818|Perineal|perineal
624657|NCT00922818|Prostatectomy|prostatectomy
624658|NCT00922818|Nerve|nerve
624659|NCT00922818|Anatomic|anatomic
624660|NCT00922818|Surgery|surgery
624661|NCT00922818|Neoplasms, Prostatic|neoplasms, prostatic
624662|NCT00922818|Prostate Cancer|prostate cancer
624663|NCT00922818|Prostate Neoplasms|prostate neoplasms
624664|NCT00922818|Prostatic Cancer|prostatic cancer
624665|NCT00922818|Prostate|prostate
624666|NCT00922818|Cancer|cancer
624667|NCT00922818|Recurrent|recurrent
624668|NCT00922805|Pediatrics, short bowel syndrome, soluble fiber|pediatrics, short bowel syndrome, soluble fiber
624669|NCT00922766|dalteparin non-ST segment elevated acute coronary syndromes|dalteparin non-st segment elevated acute coronary syndromes
624670|NCT00922753|Preoxygenation|preoxygenation
624671|NCT00922753|Inspiratory|inspiratory
624672|NCT00922753|Support|support
624673|NCT00922753|Healthy|healthy
624674|NCT00922753|EndtidalO2|endtidalo2
624675|NCT00922740|Nocturia|nocturia
624676|NCT00922740|Pharmacokinetics|pharmacokinetics
624677|NCT00922740|Pharmacodynamics|pharmacodynamics
624678|NCT00922740|Water-loading|water-loading
624679|NCT00922740|Elderly|elderly
624680|NCT00922740|Males|males
624681|NCT00922727|L. reuteri|l. reuteri
624682|NCT00922727|Cytokines|cytokines
624683|NCT00922727|Toll like receptors|toll like receptors
624684|NCT00922727|Healthy Adults|healthy adults
624685|NCT00922727|Probiotics|probiotics
624686|NCT00922714|Glutamine|glutamine
624687|NCT00922714|ICU patients|icu patients
624688|NCT00922714|Critically ill|critically ill
624689|NCT00922714|Nutrition|nutrition
624690|NCT00922701|Peritoneal dialysis|peritoneal dialysis
624691|NCT00922701|L-carnitine|l-carnitine
624692|NCT00922688|Dipeptide Alanyl-Glutamine|dipeptide alanyl-glutamine
624693|NCT00922688|Insulin sensitivity|insulin sensitivity
624694|NCT00922688|Intracellular signaling|intracellular signaling
624695|NCT00922688|Antioxidant/oxidant parameters|antioxidant/oxidant parameters
624696|NCT00922688|Lipolysis|lipolysis
624697|NCT00922688|Inflammatory response in the liver|inflammatory response in the liver
624698|NCT00922675|ST-elevation myocardial infarction|st-elevation myocardial infarction
624699|NCT00922662|coronary artery disease|coronary artery disease
624700|NCT00922662|chest pain|chest pain
624701|NCT00922662|CCTA|ccta
624702|NCT00922623|Nasolabial folds|nasolabial folds
624703|NCT00922597|Continuous infusion|continuous infusion
624704|NCT00922597|Surgery|surgery
624705|NCT00922597|Severe haemophilia A|severe haemophilia a
624706|NCT00922584|non-small cell lung cancer|non-small cell lung cancer
624707|NCT00922584|Sorafenib|sorafenib
624708|NCT00922584|targeted therapy|targeted therapy
624709|NCT00922571|Cataract|cataract
624710|NCT00922571|Femtosecond laser|femtosecond laser
624711|NCT00922558|tetra-axiametric posturography|tetra-axiametric posturography
624712|NCT00922558|postural control|postural control
624714|NCT00922558|children|children
624715|NCT00922545|Chronic obstructive pulmonary disease|chronic obstructive pulmonary disease
624716|NCT00922545|Quality of life|quality of life
624717|NCT00922545|Primary health care|primary health care
624718|NCT00922532|Hypoxic Respiratory Failure (HRF), Pulmonary Hypertension|hypoxic respiratory failure (hrf), pulmonary hypertension
624719|NCT00922519|Positron Emission Tomography|positron emission tomography
624720|NCT00922519|Sodium 18F-Fluoride|sodium 18f-fluoride
624721|NCT00922519|99mTc-MDP|99mtc-mdp
624722|NCT00922519|Bone Scan|bone scan
624723|NCT00922506|Overactive bladder|overactive bladder
624724|NCT00922506|Benign prostate hyperplasia|benign prostate hyperplasia
624725|NCT00922506|Doxazosin|doxazosin
624726|NCT00922506|Tolterodine|tolterodine
624727|NCT00922493|weaning|weaning
624728|NCT00922493|inspiratory muscle training|inspiratory muscle training
624729|NCT00922493|maximum inspiratory pressure (MIP)|maximum inspiratory pressure (mip)
624730|NCT00922493|index of Tobin (IT)|index of tobin (it)
624731|NCT00922493|intubated|intubated
624732|NCT00922493|intensive care unit|intensive care unit
624733|NCT00922493|elderly|elderly
624734|NCT00922480|Hypertension|hypertension
624735|NCT00922480|Losartan|losartan
624736|NCT00922454|patients will be matched based on AAA neck length and neck and iliac angulation|patients will be matched based on aaa neck length and neck and iliac angulation
624737|NCT00922441|Fimasartan|fimasartan
624738|NCT00922441|Essential Hypertension|essential hypertension
624739|NCT00922441|24hour ABPM|24hour abpm
624740|NCT00922441|Population PK|population pk
624741|NCT00922428|rheumatism|rheumatism
624742|NCT00922428|arthralgia|arthralgia
624743|NCT00922428|myalgia|myalgia
624744|NCT00922428|lumbago|lumbago
624745|NCT00922428|homoeopathy|homoeopathy
624746|NCT00922428|injection|injection
624747|NCT00922428|PASCOE-Agil HOM Injektopas|pascoe-agil hom injektopas
624748|NCT00922428|efficacy|efficacy
624749|NCT00922428|tolerability|tolerability
624750|NCT00922428|acceptance|acceptance
624751|NCT00922428|safety|safety
624752|NCT00922415|Crohn's disease|crohn's disease
624753|NCT00922415|calprotectin|calprotectin
624754|NCT00922402|Acute|acute
624755|NCT00922402|heart failure|heart failure
624756|NCT00922402|hyperglycemia|hyperglycemia
624757|NCT00922402|Acute heart failure with high levels of glycemia|acute heart failure with high levels of glycemia
624758|NCT00922389|Diabetes Complications|diabetes complications
624759|NCT00922389|Lower limb ischemia|lower limb ischemia
624760|NCT00922389|Adult stem cells|adult stem cells
624761|NCT00922389|peripheral blood stem cells|peripheral blood stem cells
624762|NCT00922376|Diabetes|diabetes
624763|NCT00922376|self- management|self- management
624764|NCT00922376|glycemic control|glycemic control
624765|NCT00922376|telehealth|telehealth
624766|NCT00922376|mhealth|mhealth
624767|NCT00922363|safety|safety
624768|NCT00922363|vaccine|vaccine
624769|NCT00922363|tuberculosis|tuberculosis
624770|NCT00922363|CAF01|caf01
624771|NCT00922363|Ag85B-ESAT-6|ag85b-esat-6
624772|NCT00922363|prevention|prevention
624773|NCT00922350|asthma|asthma
624774|NCT00922350|heliox|heliox
624775|NCT00922350|bronchodilators|bronchodilators
624776|NCT00922350|posture|posture
624777|NCT00922337|distal embolization|distal embolization
624778|NCT00922337|thrombotic lesions|thrombotic lesions
624779|NCT00922337|AMI|ami
624780|NCT00922337|ACS|acs
624781|NCT00922337|SVG|svg
624782|NCT00922324|Healthy volunteers|healthy volunteers
624783|NCT00922311|Proteinuria|proteinuria
624784|NCT00922285|psychosocial effects of cancer and its treatment|psychosocial effects of cancer and its treatment
624785|NCT00922285|health status unknown|health status unknown
624786|NCT00922272|Schizophrenia|schizophrenia
624787|NCT00922259|Flu|flu
624788|NCT00922259|Influenza|influenza
624789|NCT00922259|Vaccine|vaccine
624790|NCT00922259|Prevention|prevention
624791|NCT00922246|overuse injuries|overuse injuries
624792|NCT00922246|conscript|conscript
624793|NCT00922246|prevention|prevention
624794|NCT00922233|Contraception|contraception
624795|NCT00922220|low back pain|low back pain
624796|NCT00922220|spinal manipulation|spinal manipulation
624797|NCT00922220|central sensitization|central sensitization
624798|NCT00922220|manual therapy|manual therapy
624799|NCT00922194|Type 2 diabetes|type 2 diabetes
624800|NCT00922194|Obesity|obesity
624801|NCT00922194|Extended Release Metformin|extended release metformin
624802|NCT00922181|malignancy|malignancy
624803|NCT00922181|liver|liver
624804|NCT00922181|microwave|microwave
624805|NCT00922181|surgery|surgery
624806|NCT00922168|Sleep|sleep
624807|NCT00922168|apnea|apnea
624808|NCT00922168|obstructive|obstructive
624809|NCT00922168|central|central
624810|NCT00922155|endobronchial ultrasound|endobronchial ultrasound
624811|NCT00922155|guide sheath|guide sheath
624812|NCT00922155|peripheral pulmonary lesions|peripheral pulmonary lesions
624813|NCT00922129|Sirolimus|sirolimus
624814|NCT00922129|Calcineurin inhibitor|calcineurin inhibitor
624815|NCT00922129|prostate cancer|prostate cancer
624816|NCT00922103|Colitis, Ulcerative|colitis, ulcerative
624817|NCT00922103|Ileo Neo Rectal Anastomosis|ileo neo rectal anastomosis
624818|NCT00922103|Ileal Pouch Anal Anastomosis|ileal pouch anal anastomosis
624819|NCT00922103|Quality of Life|quality of life
624820|NCT00922103|functional results|functional results
624821|NCT00922103|reconstructive surgery|reconstructive surgery
624822|NCT00922103|surgery|surgery
624823|NCT00922090|Schizophrenia|schizophrenia
624824|NCT00922090|Seroquel XR|seroquel xr
624825|NCT00922090|CGI-CB|cgi-cb
624826|NCT00922090|SWN-K|swn-k
624827|NCT00922051|COPD|copd
624828|NCT00922051|FEV1|fev1
624829|NCT00922051|beta endorphin|beta endorphin
624830|NCT00922051|TENS|tens
624831|NCT00922051|acupuncture|acupuncture
624832|NCT00922025|NSCLC|nsclc
624833|NCT00922025|Male|male
624834|NCT00922025|Smoking Pattern|smoking pattern
624835|NCT00922025|Efficacy|efficacy
624836|NCT00922012|Electromagnetic Stimulation Therapy|electromagnetic stimulation therapy
624837|NCT00922012|Chronic Prostatitis|chronic prostatitis
624838|NCT00922012|Chronic Pelvic Pain Syndrome|chronic pelvic pain syndrome
624839|NCT00921999|Chickenpox|chickenpox
624840|NCT00921999|Shingles|shingles
624841|NCT00921999|Varicella|varicella
624842|NCT00921999|Zoster|zoster
624843|NCT00921999|Vaccine|vaccine
624844|NCT00921986|genetics|genetics
624845|NCT00921986|biorepository|biorepository
624846|NCT00921986|cardiac death|cardiac death
624847|NCT00921986|atrial fibrillation|atrial fibrillation
624848|NCT00921986|ventricular fibrillation|ventricular fibrillation
624849|NCT00921986|ventricular tachycardia|ventricular tachycardia
624850|NCT00921986|supraventricular tachycardias|supraventricular tachycardias
624851|NCT00921986|premature ventricular complexes|premature ventricular complexes
624852|NCT00921986|premature atrial complexes|premature atrial complexes
624853|NCT00921986|atrioventricular and intraventricular blocks|atrioventricular and intraventricular blocks
624854|NCT00921986|sinus node dysfunction|sinus node dysfunction
624855|NCT00921986|syncope|syncope
624856|NCT00921986|vasovagal reactivity|vasovagal reactivity
624857|NCT00921986|postural orthostatic tachycardia syndrome|postural orthostatic tachycardia syndrome
624858|NCT00921973|influenza|influenza
624859|NCT00921973|universal influenza vaccine|universal influenza vaccine
624860|NCT00921960|Left ventricular dysfunction|left ventricular dysfunction
624861|NCT00921960|Left ventricular systolic dysfunction|left ventricular systolic dysfunction
624862|NCT00921960|Left ventricular diastolic dysfunction|left ventricular diastolic dysfunction
624863|NCT00921960|Myocardial Infarction|myocardial infarction
624864|NCT00921960|Hypertension|hypertension
624865|NCT00921960|Diabetes|diabetes
624866|NCT00921960|Obesity|obesity
624867|NCT00921960|Dyslipidaemia|dyslipidaemia
624868|NCT00921960|Heart Failure|heart failure
624869|NCT00921960|Prevention|prevention
624870|NCT00921960|Screening|screening
624871|NCT00921960|Cardiovascular Risk Factors|cardiovascular risk factors
624872|NCT00921960|Echocardiography|echocardiography
624873|NCT00921960|Natriuretic Peptides|natriuretic peptides
624874|NCT00921947|influenza vaccine|influenza vaccine
624876|NCT00921947|Universal influenza vaccine|universal influenza vaccine
624877|NCT00921934|Herpes|herpes
624878|NCT00921934|Shingles|shingles
624879|NCT00921934|virus disease|virus disease
624880|NCT00921934|vitamin C|vitamin c
624881|NCT00921934|ascorbic acid|ascorbic acid
624882|NCT00921934|antioxidant|antioxidant
624883|NCT00921934|oxidative stress|oxidative stress
624884|NCT00921908|total hip arthroplasty|total hip arthroplasty
624885|NCT00921895|Pink Eye,|pink eye,
624886|NCT00921895|Viral conjunctivitis|viral conjunctivitis
624887|NCT00921895|Adenoviral conjunctivitis|adenoviral conjunctivitis
794576|NCT00276159|IRM|irm
624888|NCT00921895|Keratoconjunctivitis|keratoconjunctivitis
624889|NCT00921882|Type 2 diabetes|type 2 diabetes
624890|NCT00921882|Post-partum screening|post-partum screening
624891|NCT00921869|Cancer|cancer
624892|NCT00921869|Gastrointestinal Cancer|gastrointestinal cancer
624893|NCT00921856|Acetylcholine|acetylcholine
624894|NCT00921843|Pediatric patients undergoing surgery|pediatric patients undergoing surgery
624895|NCT00921830|ibuprofen|ibuprofen
624896|NCT00921830|healthy volunteers|healthy volunteers
624897|NCT00921830|bioavailability|bioavailability
624898|NCT00921830|pharmacokinetics|pharmacokinetics
624899|NCT00921830|suppository|suppository
624900|NCT00921817|healthy children|healthy children
624901|NCT00921804|Schizophrenia|schizophrenia
624902|NCT00921804|Hallucinations|hallucinations
624903|NCT00921804|Paranoia|paranoia
624904|NCT00921804|Inpatient schizophrenia clinical trial|inpatient schizophrenia clinical trial
624905|NCT00921791|Hypertension|hypertension
624906|NCT00921791|Blood pressure|blood pressure
624907|NCT00921791|Home Blood Pressure Monitoring|home blood pressure monitoring
624908|NCT00921791|Ambulatory Blood Pressure Monitoring|ambulatory blood pressure monitoring
624909|NCT00921791|Pharmaceutical care|pharmaceutical care
624910|NCT00921778|Laparoscopic supracervical hysterectomy|laparoscopic supracervical hysterectomy
624911|NCT00921778|Vaginal bleeding|vaginal bleeding
624912|NCT00921778|Patient satisfaction|patient satisfaction
624913|NCT00921778|vaginal bleeding after laparoscopic hysterectomy|vaginal bleeding after laparoscopic hysterectomy
624914|NCT00921765|Pain|pain
624915|NCT00921765|Naloxone|naloxone
624916|NCT00921765|Ketamine|ketamine
624917|NCT00921765|Third Molar|third molar
624918|NCT00921765|Surgery|surgery
624919|NCT00921752|Lipid therapy|lipid therapy
624920|NCT00921752|high CV risk|high cv risk
624921|NCT00921752|lipid goal attainment|lipid goal attainment
624922|NCT00921752|High cardiovascular risk patients|high cardiovascular risk patients
624923|NCT00921739|Non small cell lung cancer|non small cell lung cancer
624924|NCT00921739|Small cell lung cancer|small cell lung cancer
624925|NCT00921739|Thymoma unresectable|thymoma unresectable
624926|NCT00921739|Thymic carcinoma unresectable|thymic carcinoma unresectable
624927|NCT00921726|Drug Interaction|drug interaction
624928|NCT00921713|Early cancer care|early cancer care
624929|NCT00921700|Paracetamol|paracetamol
624930|NCT00921700|Acetaminophen|acetaminophen
624931|NCT00921700|Ibuprofen|ibuprofen
624932|NCT00921700|Pain|pain
624933|NCT00921700|Postoperative pain|postoperative pain
624934|NCT00921700|third molar|third molar
624935|NCT00921674|therapeutic equivalency|therapeutic equivalency
624936|NCT00921674|pharmacokinetics|pharmacokinetics
624937|NCT00921674|food|food
624938|NCT00921674|Healthy Volunteers|healthy volunteers
624939|NCT00921661|oxaliplatin|oxaliplatin
624940|NCT00921661|5-FU|5-fu
624941|NCT00921661|Folinic Acid|folinic acid
624943|NCT00921648|general paresis|general paresis
624944|NCT00921648|MRI|mri
624945|NCT00921648|neurosyphilis|neurosyphilis
624946|NCT00921635|Haemoglobin|haemoglobin
624947|NCT00921622|Blood pressure|blood pressure
624948|NCT00921622|Vitamin C|vitamin c
624949|NCT00921622|Vitamin D|vitamin d
624950|NCT00921609|Acromegaly|acromegaly
624951|NCT00921609|OGTT|ogtt
624952|NCT00921609|post-op|post-op
624953|NCT00921596|Surgical Procedures, Cardiac|surgical procedures, cardiac
624954|NCT00921596|Minimally Invasive Surgical Procedures|minimally invasive surgical procedures
624955|NCT00921596|Thoracoscopes|thoracoscopes
624956|NCT00921596|Cardiopulmonary Bypass|cardiopulmonary bypass
624957|NCT00921583|survival rate|survival rate
624958|NCT00921583|success rate|success rate
624959|NCT00921570|TWEAK|tweak
624960|NCT00921570|FMD|fmd
624961|NCT00921570|PTX3|ptx3
624962|NCT00921570|Valsartan|valsartan
624963|NCT00921570|Amlodipine|amlodipine
624964|NCT00921570|Renin Angiotensin System|renin angiotensin system
624965|NCT00921557|Bone mineral density|bone mineral density
624966|NCT00921544|ROP|rop
624967|NCT00921544|sucrose|sucrose
624968|NCT00921544|pain|pain
624969|NCT00921531|Hepatocellular carcinoma|hepatocellular carcinoma
624970|NCT00921531|thalidomide|thalidomide
624971|NCT00921531|TACE|tace
624972|NCT00921531|Child-Pugh Class A or B|child-pugh class a or b
624973|NCT00921518|Cardiac surgery|cardiac surgery
624974|NCT00921518|Sodium bicarbonate|sodium bicarbonate
624975|NCT00921518|Acute kidney injury|acute kidney injury
624976|NCT00921518|Saline|saline
624977|NCT00921505|Acetaminophen|acetaminophen
624978|NCT00921505|Ibuprofen|ibuprofen
624979|NCT00921505|Platelets|platelets
624980|NCT00921505|Leukocytes|leukocytes
624981|NCT00921505|Oxygen species|oxygen species
624982|NCT00921505|Humans|humans
624983|NCT00921505|Blood Platelets|blood platelets
624984|NCT00921505|Reactive Oxygen Species|reactive oxygen species
624985|NCT00921505|Platelet Activation|platelet activation
624986|NCT00921492|Luteinizing hormone|luteinizing hormone
624987|NCT00921492|Cortisol|cortisol
624988|NCT00921492|HPA axis|hpa axis
624989|NCT00921492|HPO axis|hpo axis
624990|NCT00921492|Ovulation|ovulation
624991|NCT00921492|Heart rate variability|heart rate variability
624992|NCT00921492|Psychological distress and quality of life|psychological distress and quality of life
624993|NCT00921479|third molar|third molar
624994|NCT00921479|quality of life|quality of life
624995|NCT00921479|postoperative swelling|postoperative swelling
624996|NCT00921479|postoperative pain|postoperative pain
624997|NCT00921479|Surgical Procedures, Operative|surgical procedures, operative
624998|NCT00921479|Postoperative Period|postoperative period
624999|NCT00921466|Evaluate the clinical content of the e-SSRS-IVR|evaluate the clinical content of the e-ssrs-ivr
625000|NCT00921453|Internet|internet
625001|NCT00921453|Information supply|information supply
625002|NCT00921453|Tailoring|tailoring
625003|NCT00921453|Patient empowerment|patient empowerment
625004|NCT00921453|Headaches|headaches
625005|NCT00921453|Meta-search|meta-search
625006|NCT00921453|Consumer Health Information|consumer health information
625007|NCT00921453|Information Services|information services
625008|NCT00921453|Information Storage and Retrieval|information storage and retrieval
625009|NCT00921453|Information Systems|information systems
625010|NCT00921440|coronary artery|coronary artery
625012|NCT00921427|Hemianopia|hemianopia
625013|NCT00921427|Rehabilitation|rehabilitation
625014|NCT00921427|Transcranial direct current stimulation|transcranial direct current stimulation
625015|NCT00921427|Visual field|visual field
625016|NCT00921414|Mantle cell lymphoma|mantle cell lymphoma
625017|NCT00921414|R DHAP|r dhap
625018|NCT00921414|ASCT|asct
625019|NCT00921414|Rituximab Maintenance|rituximab maintenance
625020|NCT00921388|Smoking Cessation|smoking cessation
625021|NCT00921388|Exercise|exercise
625022|NCT00921388|Postmenopausal women|postmenopausal women
625023|NCT00921388|CHANTIX|chantix
625024|NCT00921388|varenicline|varenicline
625025|NCT00921362|Schizophrenia|schizophrenia
625026|NCT00921349|Prophylaxis|prophylaxis
625027|NCT00921349|ligation|ligation
625028|NCT00921349|beta blockers|beta blockers
625029|NCT00921349|First bleeding rate|first bleeding rate
625030|NCT00921336|subjects with advanced Solid tumor who have not responded to standard therapy or for whom no standard therapy is available|subjects with advanced solid tumor who have not responded to standard therapy or for whom no standard therapy is available
625031|NCT00921323|Obesity|obesity
625032|NCT00921323|Physical activity|physical activity
625033|NCT00921323|pedometers|pedometers
625034|NCT00921323|children|children
625035|NCT00921310|Temsirolimus and pemetrexed for recurrent or refractory NSCLC|temsirolimus and pemetrexed for recurrent or refractory nsclc
625036|NCT00921297|Alzheimer's Disease|alzheimer's disease
625037|NCT00921297|vision impairment|vision impairment
625038|NCT00921297|cataract|cataract
625039|NCT00921297|quality of life|quality of life
625040|NCT00921297|retinal nerve fiber layer|retinal nerve fiber layer
625041|NCT00921271|Compartment syndrome|compartment syndrome
625042|NCT00921258|latent prostate cancer|latent prostate cancer
625043|NCT00921258|Patient with latent prostate cancer|patient with latent prostate cancer
625044|NCT00921258|PSA ≤ 10 ng/ml|psa ≤ 10 ng/ml
625045|NCT00921258|Clinical stage T1c or T2a|clinical stage t1c or t2a
625046|NCT00921258|Patient who accept just be control|patient who accept just be control
625047|NCT00921245|Overactive Bladder|overactive bladder
625048|NCT00921232|Life-ending patient|life-ending patient
625049|NCT00921232|caregiver|caregiver
625050|NCT00921219|therapeutic equivalency|therapeutic equivalency
625051|NCT00921219|pharmacokinetics|pharmacokinetics
625052|NCT00921219|food|food
625053|NCT00921219|Healthy volunteers|healthy volunteers
625054|NCT00921206|influenza|influenza
625055|NCT00921206|influenza vaccine|influenza vaccine
625056|NCT00921206|universal influenza vaccine|universal influenza vaccine
625057|NCT00921206|Matrix 2e protein|matrix 2e protein
625059|NCT00921206|Immune response|immune response
625060|NCT00921193|Prostate|prostate
625061|NCT00921193|fiducials|fiducials
625062|NCT00921193|radiation Therapy|radiation therapy
625063|NCT00921193|Tracking|tracking
625064|NCT00921193|Localization|localization
625065|NCT00921180|Hepatitis B, chronic|hepatitis b, chronic
625066|NCT00921180|Peginterferon alfa-2a|peginterferon alfa-2a
625067|NCT00921180|Entecavir|entecavir
625068|NCT00921167|Glioblastoma|glioblastoma
625069|NCT00921167|Astrocytoma|astrocytoma
625070|NCT00921167|Chemotherapy|chemotherapy
625071|NCT00921154|therapeutic equivalency|therapeutic equivalency
625072|NCT00921154|pharmacokinetics|pharmacokinetics
625073|NCT00921154|fasting|fasting
625074|NCT00921154|Healthy Volunteers|healthy volunteers
625075|NCT00921141|Implantable central venous access ports, cancer|implantable central venous access ports, cancer
625076|NCT00921128|Muscimol|muscimol
625077|NCT00921128|Convection-Enhanced Delivery|convection-enhanced delivery
625078|NCT00921128|Parkinson's Disease|parkinson's disease
625079|NCT00921128|Deep Brain Stimulation|deep brain stimulation
625080|NCT00921128|Parkinson Disease|parkinson disease
625082|NCT00921115|hormone receptor positive|hormone receptor positive
625083|NCT00921115|invasive breast cancer|invasive breast cancer
625084|NCT00921115|endocrine therapy|endocrine therapy
794745|NCT00275158|cGMP|cgmp
625085|NCT00921115|Anastrazole|anastrazole
625086|NCT00921115|Fulvestrant|fulvestrant
625087|NCT00921115|breast tumors|breast tumors
625088|NCT00921115|postmenopausal|postmenopausal
625089|NCT00921102|Atropine|atropine
625090|NCT00921102|Morphine|morphine
625091|NCT00921102|Analgesics, Opioid|analgesics, opioid
625092|NCT00921102|Antiemetics|antiemetics
625093|NCT00921089|Atherosclerosis|atherosclerosis
625094|NCT00921089|Cardiovascular disease|cardiovascular disease
625095|NCT00921089|Hemodialysis|hemodialysis
625096|NCT00921089|Inflammation|inflammation
625097|NCT00921089|Vascular calcification|vascular calcification
625098|NCT00921050|subclinical hypothyroidism|subclinical hypothyroidism
625099|NCT00921050|elderly|elderly
625100|NCT00921050|mild cognitive impairment|mild cognitive impairment
625101|NCT00921050|neuropsychological test|neuropsychological test
625102|NCT00921050|NEUROPSI|neuropsi
625103|NCT00921037|Neurofibromatosis Type 1|neurofibromatosis type 1
625104|NCT00921037|Morbus Recklinghausen|morbus recklinghausen
625105|NCT00921037|cutaneous neurofibromas|cutaneous neurofibromas
625106|NCT00921037|Erbium-YAG-Laser|erbium-yag-laser
625107|NCT00921037|Vaporisation|vaporisation
625108|NCT00921037|Thermal Necrosis|thermal necrosis
625109|NCT00921024|Complicated Urinary Tract Infection|complicated urinary tract infection
625110|NCT00921024|Pyelonephritis|pyelonephritis
625111|NCT00921024|Antimicrobial|antimicrobial
625112|NCT00921024|Cephalosporin|cephalosporin
625113|NCT00921024|Intravenous|intravenous
625114|NCT00921011|hypertension|hypertension
625115|NCT00921011|diabetes|diabetes
625116|NCT00921011|smoking|smoking
625117|NCT00921011|hyperlipidemia|hyperlipidemia
625118|NCT00921011|atherosclerosis risk|atherosclerosis risk
625119|NCT00920998|Z-338|z-338
625120|NCT00920998|YM443|ym443
625121|NCT00920998|healthy volunteers|healthy volunteers
625122|NCT00920985|Pregnancy prevention|pregnancy prevention
625123|NCT00920985|Female contraception|female contraception
625124|NCT00920985|Patch|patch
625125|NCT00920972|Bone marrow|bone marrow
625126|NCT00920972|Transplant|transplant
625127|NCT00920972|Transplantation|transplantation
625128|NCT00920972|Hematopoietic|hematopoietic
625129|NCT00920972|Umbilical cord|umbilical cord
625130|NCT00920972|Related|related
625131|NCT00920972|Unrelated|unrelated
625132|NCT00920972|Reduced|reduced
625133|NCT00920972|Non-myeloablative|non-myeloablative
625134|NCT00920972|Nonmyeloablative|nonmyeloablative
625135|NCT00920972|Non-malignant|non-malignant
625136|NCT00920972|Nonmalignant|nonmalignant
625137|NCT00920946|Huntington|huntington
625138|NCT00920946|Dimebon|dimebon
625139|NCT00920946|HD|hd
625140|NCT00920946|Huntingtin|huntingtin
625141|NCT00920933|Ozone challenge|ozone challenge
625142|NCT00920933|airway neutrophilia|airway neutrophilia
625143|NCT00920933|induced sputum|induced sputum
625144|NCT00920933|Healthy volunteers|healthy volunteers
625145|NCT00920920|3D-4D MRI-based Brachytherapy|3d-4d mri-based brachytherapy
625146|NCT00920920|Cervical Cancer|cervical cancer
625147|NCT00920920|Multicenter Clinical Study|multicenter clinical study
625148|NCT00920920|Locally advanced cervical cancer|locally advanced cervical cancer
625149|NCT00920881|Continuous glucose monitoring|continuous glucose monitoring
625150|NCT00920881|Accuracy|accuracy
625151|NCT00920881|Continuous glucose-error grid analysis|continuous glucose-error grid analysis
625152|NCT00920868|Phase I|phase i
625153|NCT00920868|Solid Tumor|solid tumor
625154|NCT00920868|Colorectal|colorectal
625155|NCT00920868|Dasatinib|dasatinib
625156|NCT00920868|Sprycel|sprycel
625157|NCT00920868|Bevacizumab|bevacizumab
625158|NCT00920868|Avastin|avastin
625159|NCT00920868|Oxaliplatin|oxaliplatin
625160|NCT00920868|Eloxatin|eloxatin
625161|NCT00920868|Capecitabine|capecitabine
625162|NCT00920868|Xeloda|xeloda
625163|NCT00920868|Duke|duke
625164|NCT00920868|Any Solid Tumor (Phase I)|any solid tumor (phase i)
625165|NCT00920868|Metastatic Colorectal Cancer (Expanded Cohort)|metastatic colorectal cancer (expanded cohort)
625166|NCT00920842|metabolic syndrome|metabolic syndrome
625167|NCT00920842|long-term effects secondary to cancer therapy in children|long-term effects secondary to cancer therapy in children
625168|NCT00920842|cardiovascular complications|cardiovascular complications
625169|NCT00920842|cancer survivor|cancer survivor
625170|NCT00920842|childhood acute lymphoblastic leukemia in remission|childhood acute lymphoblastic leukemia in remission
625171|NCT00920842|childhood acute myeloid leukemia in remission|childhood acute myeloid leukemia in remission
625172|NCT00920842|childhood chronic myelogenous leukemia|childhood chronic myelogenous leukemia
625173|NCT00920842|juvenile myelomonocytic leukemia|juvenile myelomonocytic leukemia
625174|NCT00920842|stage I chronic lymphocytic leukemia|stage i chronic lymphocytic leukemia
625175|NCT00920842|stage II chronic lymphocytic leukemia|stage ii chronic lymphocytic leukemia
625176|NCT00920842|stage III chronic lymphocytic leukemia|stage iii chronic lymphocytic leukemia
625177|NCT00920842|stage IV chronic lymphocytic leukemia|stage iv chronic lymphocytic leukemia
625178|NCT00920829|Alcohol Dependence|alcohol dependence
625179|NCT00920829|Alcoholism|alcoholism
625180|NCT00920829|Naltrexone|naltrexone
625181|NCT00920829|Substance Abuse|substance abuse
625182|NCT00920829|Genetics|genetics
625183|NCT00920816|Axitinib in First & Second Line Treatment of Patients With Metastatic Renal Cell Cancer|axitinib in first & second line treatment of patients with metastatic renal cell cancer
625184|NCT00920777|CBT|cbt
625185|NCT00920777|Fukuda criteria|fukuda criteria
625186|NCT00920777|Mental functioning|mental functioning
625187|NCT00920777|Physical functioning|physical functioning
625188|NCT00920764|CKD Stages 3&4|ckd stages 3&4
625189|NCT00920764|Endothelin antagonist|endothelin antagonist
625190|NCT00920764|Proteinuria|proteinuria
625191|NCT00920751|water infusion|water infusion
625192|NCT00920751|air insufflation|air insufflation
625193|NCT00920751|colonoscopy|colonoscopy
625194|NCT00920751|colorectal cancer screening|colorectal cancer screening
625195|NCT00920738|metabolic syndrome|metabolic syndrome
625196|NCT00920738|cancer survivor|cancer survivor
625197|NCT00920738|childhood soft tissue sarcoma|childhood soft tissue sarcoma
625198|NCT00920738|unspecified childhood solid tumor, protocol specific|unspecified childhood solid tumor, protocol specific
625199|NCT00920738|childhood acute lymphoblastic leukemia|childhood acute lymphoblastic leukemia
625200|NCT00920738|childhood chronic myelogenous leukemia|childhood chronic myelogenous leukemia
625201|NCT00920738|childhood Hodgkin lymphoma|childhood hodgkin lymphoma
625387|NCT00920088|NNRTI|nnrti
625202|NCT00920738|childhood non-Hodgkin lymphoma|childhood non-hodgkin lymphoma
625203|NCT00920738|childhood acute myeloid leukemia/other myeloid malignancies|childhood acute myeloid leukemia/other myeloid malignancies
625204|NCT00920738|chronic lymphocytic leukemia|chronic lymphocytic leukemia
625205|NCT00920738|childhood brain stem glioma|childhood brain stem glioma
625206|NCT00920738|childhood cerebellar astrocytoma|childhood cerebellar astrocytoma
625207|NCT00920738|childhood cerebral astrocytoma/malignant glioma|childhood cerebral astrocytoma/malignant glioma
625208|NCT00920738|childhood choroid plexus tumor|childhood choroid plexus tumor
625209|NCT00920738|childhood craniopharyngioma|childhood craniopharyngioma
625210|NCT00920738|childhood embryonal tumor|childhood embryonal tumor
625211|NCT00920738|childhood ependymoma|childhood ependymoma
625212|NCT00920738|childhood oligodendroglioma|childhood oligodendroglioma
625213|NCT00920738|childhood pineal parenchymal tumor|childhood pineal parenchymal tumor
625214|NCT00920738|childhood mixed glioma|childhood mixed glioma
625215|NCT00920738|childhood subependymal giant cell astrocytoma|childhood subependymal giant cell astrocytoma
625216|NCT00920738|childhood visual pathway and hypothalamic glioma|childhood visual pathway and hypothalamic glioma
625218|NCT00920712|chronic atrophic gastritis|chronic atrophic gastritis
625219|NCT00920712|Traditional Chinese Medicine|traditional chinese medicine
625220|NCT00920686|Migraine|migraine
625221|NCT00920686|aura|aura
625222|NCT00920673|child|child
625223|NCT00920647|enlarged adenoids|enlarged adenoids
625224|NCT00920647|hunters syndrome|hunters syndrome
625225|NCT00920647|enzyme replacement therapy|enzyme replacement therapy
625226|NCT00920647|hunter's syndrome|hunter's syndrome
625227|NCT00920647|mps society|mps society
625228|NCT00920647|Mucopolysaccharidosis (mps) 2|mucopolysaccharidosis (mps) 2
625229|NCT00920647|mps diagnosis|mps diagnosis
625230|NCT00920647|hunter disease|hunter disease
625231|NCT00920647|iduronate 2 sulfatase|iduronate 2 sulfatase
625232|NCT00920647|idursulfase|idursulfase
625233|NCT00920647|hunters disease|hunters disease
625234|NCT00920647|hunter's syndrome treatment|hunter's syndrome treatment
625235|NCT00920647|mucopolysaccharides|mucopolysaccharides
625236|NCT00920647|hunter syndrome treatment|hunter syndrome treatment
625237|NCT00920647|Mucopolysaccharidosis (mps) ii|mucopolysaccharidosis (mps) ii
625238|NCT00920647|elaprase|elaprase
625239|NCT00920647|hunter syndrome therapy|hunter syndrome therapy
625240|NCT00920647|lysosomal storage disease|lysosomal storage disease
625241|NCT00920647|hunter's disease|hunter's disease
625242|NCT00920647|Mucopolysaccharidosis(MPS) II|mucopolysaccharidosis(mps) ii
625243|NCT00920647|Mucopolysaccharidosis(MPS)2|mucopolysaccharidosis(mps)2
625244|NCT00920647|hunter's disease treatment|hunter's disease treatment
625245|NCT00920647|lysosomal storage disorder|lysosomal storage disorder
625246|NCT00920647|chronic ear infection|chronic ear infection
625247|NCT00920647|mps symptoms|mps symptoms
625248|NCT00920647|iduronate sulfatase|iduronate sulfatase
625249|NCT00920647|ert treatment|ert treatment
625250|NCT00920621|Asthma|asthma
625251|NCT00920621|Vitamin D|vitamin d
625252|NCT00920621|Randomized Control Trial|randomized control trial
625253|NCT00920608|AZD9056|azd9056
625254|NCT00920608|Pharmacokinetics|pharmacokinetics
625255|NCT00920608|interaction|interaction
625256|NCT00920608|Methotrexate|methotrexate
625257|NCT00920608|Rheumatoid Arthritis|rheumatoid arthritis
625258|NCT00920595|Cancer|cancer
625259|NCT00920582|Teplizumab|teplizumab
625260|NCT00920582|Protege|protege
625261|NCT00920582|Protege Encore|protege encore
625262|NCT00920582|MGA031|mga031
625263|NCT00920582|Monoclonal antibody|monoclonal antibody
625264|NCT00920582|Type 1 Diabetes Mellitus|type 1 diabetes mellitus
625265|NCT00920582|T1DM|t1dm
625266|NCT00920582|MacroGenics|macrogenics
625267|NCT00920582|Recent Onset Diabetes|recent onset diabetes
625268|NCT00920582|hOKT3γ1 (Ala-Ala)|hokt3γ1 (ala-ala)
625269|NCT00920582|Encore|encore
625270|NCT00920569|cardiac output|cardiac output
625271|NCT00920569|recirculation|recirculation
625272|NCT00920569|oxygenator blood volume|oxygenator blood volume
625273|NCT00920569|venoarterial extracorporeal membrane oxygenation|venoarterial extracorporeal membrane oxygenation
625274|NCT00920569|venovenous extracorporeal membrane oxygenation|venovenous extracorporeal membrane oxygenation
625275|NCT00920530|Screening|screening
625276|NCT00920530|real time PCR|real time pcr
625277|NCT00920530|Streptococcus agalactiae|streptococcus agalactiae
625278|NCT00920530|Pregnant women|pregnant women
625279|NCT00920504|Mesh: patient education as topic|mesh: patient education as topic
625280|NCT00920504|Mesh: neoplasms|mesh: neoplasms
625281|NCT00920504|Mesh: medication therapy management|mesh: medication therapy management
625282|NCT00920504|pain self management|pain self management
625283|NCT00920504|symptom management|symptom management
625284|NCT00920504|education of patients with pain from neoplasm metastases|education of patients with pain from neoplasm metastases
625285|NCT00920491|Chief complaint|chief complaint
625286|NCT00920491|non-specific symptoms|non-specific symptoms
625287|NCT00920491|general weakness / general deterioration|general weakness / general deterioration
625288|NCT00920491|risk assessment in ED patients with non-specific symptoms|risk assessment in ed patients with non-specific symptoms
625289|NCT00920478|Rheumatoid arthritis|rheumatoid arthritis
625290|NCT00920478|Musculoskeletal Ultrasound|musculoskeletal ultrasound
625291|NCT00920478|Synovitis|synovitis
625292|NCT00920478|DMARD|dmard
625293|NCT00920478|Etanercept|etanercept
625294|NCT00920478|Biomarkers|biomarkers
625295|NCT00920478|Undifferentiated Inflammatory Polyarthritis|undifferentiated inflammatory polyarthritis
625296|NCT00920452|implantable cardioverter defibrillator (ICD)|implantable cardioverter defibrillator (icd)
625297|NCT00920452|defibrillation leads, cardiac resynchronization therapy (CRT)|defibrillation leads, cardiac resynchronization therapy (crt)
625298|NCT00920439|Poliomyelitis Vaccines|poliomyelitis vaccines
625300|NCT00920426|HIV|hiv
625301|NCT00920426|naive|naive
625302|NCT00920426|Phase II|phase ii
625303|NCT00920426|integrase inhibitor|integrase inhibitor
625304|NCT00920426|GSK1265744|gsk1265744
625305|NCT00920426|newly diagnosed|newly diagnosed
625306|NCT00920426|pharmacokinetics|pharmacokinetics
625307|NCT00920426|AIDS|aids
625308|NCT00920426|integrase|integrase
625309|NCT00920426|HIV Infections|hiv infections
625310|NCT00920426|Treatment naive|treatment naive
625311|NCT00920387|Anxiety|anxiety
625312|NCT00920387|quality of life|quality of life
625313|NCT00920387|psychotherapy|psychotherapy
625314|NCT00920387|potentially fatal illness|potentially fatal illness
625315|NCT00920387|lysergic acid diethylamide|lysergic acid diethylamide
625316|NCT00920374|Influenza|influenza
625317|NCT00920348|Chronic obstructive pulmonary disease|chronic obstructive pulmonary disease
625318|NCT00920348|COPD|copd
625319|NCT00920348|Cohort study|cohort study
625320|NCT00920348|prospective longitudinal study|prospective longitudinal study
625321|NCT00920348|tissue bank|tissue bank
625322|NCT00920335|Adult intracranial ependymoma|adult intracranial ependymoma
625323|NCT00920322|Depression|depression
625324|NCT00920322|Transcranial Magnetic Stimulation|transcranial magnetic stimulation
625325|NCT00920309|Autosomal Dominant Polycystic Kidney Disease|autosomal dominant polycystic kidney disease
625326|NCT00920309|rapamycin|rapamycin
625327|NCT00920309|ADPKD|adpkd
625328|NCT00920296|drug interaction|drug interaction
625329|NCT00920296|integrase inhibitor|integrase inhibitor
625330|NCT00920283|Stents|stents
625331|NCT00920283|Bare Metal Stents|bare metal stents
625332|NCT00920283|PCI|pci
625333|NCT00920283|Coronary Artery Disease|coronary artery disease
625334|NCT00920283|Coronary Artery Stenosis|coronary artery stenosis
625335|NCT00920283|Stent Thrombosis|stent thrombosis
625336|NCT00920283|Vascular Disease|vascular disease
625337|NCT00920283|Myocardial Ischemia|myocardial ischemia
625338|NCT00920270|Hospital-Acquired Pneumonia|hospital-acquired pneumonia
625339|NCT00920270|Gram Negative Bacteria|gram negative bacteria
625340|NCT00920257|oncology|oncology
625341|NCT00920257|breast cancer|breast cancer
625342|NCT00920257|AKT inhibitor|akt inhibitor
625343|NCT00920257|first time in human|first time in human
625344|NCT00920257|lymphoma|lymphoma
625345|NCT00920257|endometrial cancer|endometrial cancer
625346|NCT00920257|GSK2141795|gsk2141795
625347|NCT00920257|solid tumors|solid tumors
625348|NCT00920244|Resuscitation|resuscitation
625349|NCT00920244|Cardiac arrest|cardiac arrest
625350|NCT00920244|State-transitions|state-transitions
625351|NCT00920244|Markov|markov
625352|NCT00920218|Vaccine|vaccine
625353|NCT00920218|Safety|safety
625354|NCT00920218|Herpes Zoster|herpes zoster
625355|NCT00920218|Immunogenicity|immunogenicity
625356|NCT00920218|Stem cell transplantation|stem cell transplantation
625357|NCT00920205|MPC-3100|mpc-3100
625358|NCT00920205|HSP90 inhibitor|hsp90 inhibitor
625359|NCT00920205|oral drug|oral drug
625360|NCT00920205|cancer|cancer
625361|NCT00920192|c-MET|c-met
625362|NCT00920192|VEGFR2|vegfr2
625363|NCT00920192|Advanced hepatocellular carcinoma|advanced hepatocellular carcinoma
710276|NCT00589563|contiguous stage II adult diffuse mixed cell lymphoma|contiguous stage ii adult diffuse mixed cell lymphoma
625364|NCT00920179|dry eye, in vivo confocal microscopy, inflammation, acinar unit density, lacrimal gland|dry eye, in vivo confocal microscopy, inflammation, acinar unit density, lacrimal gland
625365|NCT00920166|Infant formula|infant formula
625366|NCT00920166|Alpha-lactalbumin|alpha-lactalbumin
625367|NCT00920166|Symbiotic|symbiotic
625368|NCT00920166|Allergy|allergy
625369|NCT00920166|Gastrointestinal tolerance|gastrointestinal tolerance
625370|NCT00920166|Bacterial colonization|bacterial colonization
625371|NCT00920166|Faecal IgA analysis|faecal iga analysis
625372|NCT00920153|stage I adult Hodgkin lymphoma|stage i adult hodgkin lymphoma
625373|NCT00920153|stage II adult Hodgkin lymphoma|stage ii adult hodgkin lymphoma
625374|NCT00920153|stage III adult Hodgkin lymphoma|stage iii adult hodgkin lymphoma
625375|NCT00920153|stage IV adult Hodgkin lymphoma|stage iv adult hodgkin lymphoma
625376|NCT00920140|Oncology, GSK1120212, MEK inhibitor, hematological malignancies, AML|oncology, gsk1120212, mek inhibitor, hematological malignancies, aml
625377|NCT00920140|CMML|cmml
625378|NCT00920140|MDS|mds
625379|NCT00920127|AKL1|akl1
625380|NCT00920127|COPD|copd
625381|NCT00920101|atherosclerotic plaques|atherosclerotic plaques
625382|NCT00920101|hypercholesterolemia|hypercholesterolemia
625383|NCT00920101|HMG-CoA reductase inhibitor|hmg-coa reductase inhibitor
625384|NCT00920101|statin|statin
625385|NCT00920101|lipid-lowering therapy|lipid-lowering therapy
625386|NCT00920088|probes|probes
625388|NCT00920088|drug interaction|drug interaction
625389|NCT00920088|protease inhitibor|protease inhitibor
625390|NCT00920075|Juvenile Osteoporosis|juvenile osteoporosis
625391|NCT00920075|Bone Mineral Density|bone mineral density
625392|NCT00920075|Fosamax|fosamax
625393|NCT00920075|Dual Energy X-Ray Absorptiometry|dual energy x-ray absorptiometry
625394|NCT00920075|Fracture|fracture
625395|NCT00920062|recirculation|recirculation
625396|NCT00920062|ultrasound dilution|ultrasound dilution
625397|NCT00920062|venovenous extracorporeal membrane oxygenation|venovenous extracorporeal membrane oxygenation
625398|NCT00920049|Driving|driving
625399|NCT00920049|Injury|injury
625400|NCT00920049|Prevention|prevention
625401|NCT00920049|Intervention|intervention
625402|NCT00920049|Parents|parents
625403|NCT00920036|PTSD|ptsd
625404|NCT00920036|Combat|combat
625405|NCT00920036|Biofeedback|biofeedback
625406|NCT00920036|Psychophysiology|psychophysiology
625407|NCT00920023|SPIO MRI|spio mri
625408|NCT00920023|Feridex|feridex
625409|NCT00920010|non-small cell lung cancer|non-small cell lung cancer
625410|NCT00920010|small cell lung cancer|small cell lung cancer
625411|NCT00919997|human papilloma virus infection|human papilloma virus infection
625412|NCT00919997|HIV infection|hiv infection
625413|NCT00919997|HIV Infections|hiv infections
625414|NCT00919984|OVARIAN NEOPLASMS|ovarian neoplasms
625415|NCT00919984|ADJUVANT CHEMOTHERAPY|adjuvant chemotherapy
625416|NCT00919984|INTRAPERITONEAL CHEMOTHERAPY|intraperitoneal chemotherapy
625417|NCT00919971|Bi spectral Index|bi spectral index
625418|NCT00919971|Sedation depth monitoring|sedation depth monitoring
625419|NCT00919971|Out of hospital ventilated patients|out of hospital ventilated patients
625420|NCT00919958|Peripheral Artery Disease|peripheral artery disease
625421|NCT00919958|Peripheral Vascular Disease|peripheral vascular disease
625422|NCT00919958|Critical limb ischemia|critical limb ischemia
625423|NCT00919945|Neonates|neonates
625424|NCT00919945|Congenital Heart Disease|congenital heart disease
625425|NCT00919945|Postoperative Feeding|postoperative feeding
625426|NCT00919945|Splanchnic Blood Flow|splanchnic blood flow
625427|NCT00919932|Depression|depression
625428|NCT00919932|CBT|cbt
625429|NCT00919932|Texting|texting
625430|NCT00919932|SMS|sms
625431|NCT00919919|menopause|menopause
625432|NCT00919919|Endometrial Thickness|endometrial thickness
625433|NCT00919919|progesterone|progesterone
625434|NCT00919906|haptic|haptic
625435|NCT00919906|rehabilitation|rehabilitation
625436|NCT00919906|fine-motor skill|fine-motor skill
625437|NCT00919906|handwriting|handwriting
625438|NCT00919893|chronic prostatitis symptom index|chronic prostatitis symptom index
625439|NCT00919893|male|male
625440|NCT00919893|inflammatory|inflammatory
625441|NCT00919893|CP-CPPS|cp-cpps
625442|NCT00919893|Cernilton|cernilton
625443|NCT00919893|pelvic pain|pelvic pain
625444|NCT00919893|symptoms|symptoms
625445|NCT00919867|Normal, healthy volunteers (for this Phase 1 study)|normal, healthy volunteers (for this phase 1 study)
625446|NCT00919854|Human immunodeficiency virus 1|human immunodeficiency virus 1
625447|NCT00919854|HIV-1|hiv-1
625448|NCT00919854|Darunavir|darunavir
625449|NCT00919854|Ritonavir|ritonavir
625450|NCT00919854|Norvir|norvir
625451|NCT00919841|postpartum|postpartum
625452|NCT00919841|involution|involution
625453|NCT00919841|three-dimension sonography|three-dimension sonography
625454|NCT00919841|size of the uterus|size of the uterus
625455|NCT00919815|Leprosy|leprosy
625456|NCT00919815|Type 1 Reactions|type 1 reactions
625457|NCT00919815|Prednisolone|prednisolone
625458|NCT00919815|Ciclosporin|ciclosporin
625459|NCT00919802|Interstitial cystitis (IC)|interstitial cystitis (ic)
625460|NCT00919802|Oxytocin|oxytocin
625461|NCT00919802|Bladder|bladder
625462|NCT00919802|Void|void
625463|NCT00919776|Leprosy|leprosy
625464|NCT00919776|ENL|enl
625465|NCT00919776|Erythema Nodosum Leprosum|erythema nodosum leprosum
625466|NCT00919776|Prednisolone|prednisolone
625467|NCT00919776|Ciclosporin|ciclosporin
625468|NCT00919763|Atopic Dermatitis|atopic dermatitis
625469|NCT00919737|NPC-08|npc-08
625470|NCT00919737|carmustine|carmustine
625471|NCT00919737|nitrosourea|nitrosourea
625472|NCT00919737|safety|safety
625473|NCT00919724|AIDS|aids
625474|NCT00919724|Endothelial Function|endothelial function
625475|NCT00919724|Inflammation|inflammation
625476|NCT00919724|Immune Activation|immune activation
625477|NCT00919724|treatment naive|treatment naive
625478|NCT00919711|Menopausal Osteoporosis|menopausal osteoporosis
625479|NCT00919698|Hypnotics and Sedatives|hypnotics and sedatives
625480|NCT00919698|Respiration, Artificial|respiration, artificial
625481|NCT00919698|Ventilators, Mechanical|ventilators, mechanical
625482|NCT00919698|Critical care|critical care
625483|NCT00919698|Intensive care|intensive care
625484|NCT00919672|Irritable bowel syndrome|irritable bowel syndrome
625485|NCT00919672|Sacral nerve stimulation|sacral nerve stimulation
625486|NCT00919672|Motility|motility
625487|NCT00919672|Pain perception|pain perception
625488|NCT00919672|GSRS-IBS|gsrs-ibs
625489|NCT00919672|IBS-IS|ibs-is
625490|NCT00919659|parenteral nutrition|parenteral nutrition
625491|NCT00919659|cancer cachexia|cancer cachexia
625492|NCT00919659|pancreatic cancer|pancreatic cancer
625493|NCT00919633|hepatitis C|hepatitis c
625494|NCT00919633|HCV|hcv
625495|NCT00919633|genotype|genotype
625496|NCT00919633|sustained virological response|sustained virological response
625497|NCT00919633|rapid virological response|rapid virological response
625498|NCT00919633|interferon|interferon
625499|NCT00919620|Psychotic disorders|psychotic disorders
625500|NCT00919620|Psychoses|psychoses
625501|NCT00919607|quetiapine fumarate(SEROQUEL) extended-release(XR) China PK Study|quetiapine fumarate(seroquel) extended-release(xr) china pk study
625502|NCT00919607|pharmacokinetics parameters|pharmacokinetics parameters
625503|NCT00919594|Interpersonal Psychotherapy|interpersonal psychotherapy
625504|NCT00919594|Depression|depression
625505|NCT00919594|Mothers|mothers
625506|NCT00919581|Spinal cord injury|spinal cord injury
625507|NCT00919555|ALS Treatment|als treatment
625508|NCT00919555|Tretinoin|tretinoin
625509|NCT00919555|Pioglitazone HCL|pioglitazone hcl
625510|NCT00919555|Actos|actos
625511|NCT00919555|Tau levels|tau levels
625512|NCT00919555|ALS|als
625513|NCT00919542|Leprosy|leprosy
625514|NCT00919542|ENL|enl
625515|NCT00919542|Erythema Nodosum Leprosum|erythema nodosum leprosum
625516|NCT00919542|Prednisolone|prednisolone
625517|NCT00919542|Ciclosporin|ciclosporin
625518|NCT00919516|Bone marrow transplantation|bone marrow transplantation
625519|NCT00919516|Ischemia|ischemia
625520|NCT00919516|Neoangiogenesis|neoangiogenesis
625521|NCT00919516|Peripheral arterial disease|peripheral arterial disease
625522|NCT00919516|Stem cell therapy|stem cell therapy
625523|NCT00919503|nonmalignant diseases|nonmalignant diseases
625524|NCT00919503|nonmalignant inherited disorders|nonmalignant inherited disorders
625525|NCT00919503|primary immunodeficiency diseases|primary immunodeficiency diseases
625526|NCT00919503|primary immune deficiency disorders|primary immune deficiency disorders
625527|NCT00919503|chronic granulomatous|chronic granulomatous
625528|NCT00919503|disease|disease
625529|NCT00919503|IPEX syndrome|ipex syndrome
625530|NCT00919503|hemophagocytic lymphohistiocytosis|hemophagocytic lymphohistiocytosis
625531|NCT00919503|Wiskott Aldrich Syndrome|wiskott aldrich syndrome
625532|NCT00919503|bone marrow failure syndromes|bone marrow failure syndromes
625533|NCT00919503|Shwachman Diamond Syndrome|shwachman diamond syndrome
625534|NCT00919503|Dyskeratosis Congenita|dyskeratosis congenita
625535|NCT00919503|Diamond Blackfan Anemia|diamond blackfan anemia
625536|NCT00919503|inborn errors of metabolism|inborn errors of metabolism
625537|NCT00919503|metabolic diseases|metabolic diseases
625538|NCT00919503|hemoglobinopathies|hemoglobinopathies
625539|NCT00919503|sickle cell disease|sickle cell disease
625540|NCT00919503|thalassemia|thalassemia
625541|NCT00919503|reduced intensity transplantation|reduced intensity transplantation
625542|NCT00919503|hematopoietic cell transplantation|hematopoietic cell transplantation
625543|NCT00919503|bone marrow transplantation|bone marrow transplantation
625544|NCT00919503|umbilical cord blood transplantation|umbilical cord blood transplantation
625545|NCT00919490|Healthy Volunteers|healthy volunteers
625546|NCT00919477|Prostate cancer|prostate cancer
625547|NCT00919477|Casodex|casodex
625548|NCT00919477|Monotherapy|monotherapy
625549|NCT00919464|Compartment pressure|compartment pressure
625550|NCT00919464|compartment syndrome|compartment syndrome
625551|NCT00919464|femur fracture|femur fracture
625552|NCT00919451|Leprosy|leprosy
625553|NCT00919451|Type 1 Reaction|type 1 reaction
625554|NCT00919451|Prednisolone|prednisolone
625555|NCT00919451|Ciclosporin|ciclosporin
625556|NCT00919425|stage 0 chronic lymphocytic leukemia|stage 0 chronic lymphocytic leukemia
712394|NCT00580307|Deviated septum|deviated septum
625557|NCT00919425|stage I chronic lymphocytic leukemia|stage i chronic lymphocytic leukemia
625558|NCT00919425|stage II chronic lymphocytic leukemia|stage ii chronic lymphocytic leukemia
625559|NCT00919425|stage III chronic lymphocytic leukemia|stage iii chronic lymphocytic leukemia
625560|NCT00919425|stage IV chronic lymphocytic leukemia|stage iv chronic lymphocytic leukemia
625561|NCT00919425|recurrent adult acute myeloid leukemia|recurrent adult acute myeloid leukemia
625562|NCT00919425|recurrent adult acute lymphoblastic leukemia|recurrent adult acute lymphoblastic leukemia
625563|NCT00919425|relapsing chronic myelogenous leukemia|relapsing chronic myelogenous leukemia
625564|NCT00919425|refractory chronic lymphocytic leukemia|refractory chronic lymphocytic leukemia
625565|NCT00919425|chronic phase chronic myelogenous leukemia|chronic phase chronic myelogenous leukemia
625566|NCT00919425|accelerated phase chronic myelogenous leukemia|accelerated phase chronic myelogenous leukemia
625567|NCT00919425|blastic phase chronic myelogenous leukemia|blastic phase chronic myelogenous leukemia
625568|NCT00919425|meningeal chronic myelogenous leukemia|meningeal chronic myelogenous leukemia
625569|NCT00919425|untreated adult acute lymphoblastic leukemia|untreated adult acute lymphoblastic leukemia
625570|NCT00919425|untreated adult acute myeloid leukemia|untreated adult acute myeloid leukemia
625571|NCT00919425|adult acute myeloid leukemia with t(8;21)(q22;q22)|adult acute myeloid leukemia with t(8;21)(q22;q22)
625572|NCT00919425|adult acute myeloid leukemia with t(16;16)(p13;q22)|adult acute myeloid leukemia with t(16;16)(p13;q22)
625573|NCT00919425|adult acute myeloid leukemia with inv(16)(p13;q22)|adult acute myeloid leukemia with inv(16)(p13;q22)
625574|NCT00919425|adult acute myeloid leukemia with 11q23 (MLL) abnormalities|adult acute myeloid leukemia with 11q23 (mll) abnormalities
626533|NCT00915538|Aerochamber|aerochamber
625575|NCT00919425|adult acute myeloid leukemia with t(15;17)(q22;q12)|adult acute myeloid leukemia with t(15;17)(q22;q12)
625576|NCT00919425|adult acute lymphoblastic leukemia in remission|adult acute lymphoblastic leukemia in remission
625577|NCT00919425|childhood acute lymphoblastic leukemia in remission|childhood acute lymphoblastic leukemia in remission
625578|NCT00919425|adult acute myeloid leukemia in remission|adult acute myeloid leukemia in remission
625579|NCT00919425|childhood acute myeloid leukemia in remission|childhood acute myeloid leukemia in remission
625580|NCT00919425|recurrent childhood acute myeloid leukemia|recurrent childhood acute myeloid leukemia
625581|NCT00919425|untreated childhood acute myeloid leukemia and other myeloid malignancies|untreated childhood acute myeloid leukemia and other myeloid malignancies
625582|NCT00919425|recurrent childhood acute lymphoblastic leukemia|recurrent childhood acute lymphoblastic leukemia
625583|NCT00919425|untreated childhood acute lymphoblastic leukemia|untreated childhood acute lymphoblastic leukemia
625584|NCT00919425|childhood chronic myelogenous leukemia|childhood chronic myelogenous leukemia
625585|NCT00919425|de novo myelodysplastic syndromes|de novo myelodysplastic syndromes
625586|NCT00919425|previously treated myelodysplastic syndromes|previously treated myelodysplastic syndromes
625587|NCT00919425|secondary myelodysplastic syndromes|secondary myelodysplastic syndromes
625588|NCT00919425|secondary acute myeloid leukemia|secondary acute myeloid leukemia
625589|NCT00919425|atypical chronic myeloid leukemia, BCR-ABL1 negative|atypical chronic myeloid leukemia, bcr-abl1 negative
625590|NCT00919425|chronic myelomonocytic leukemia|chronic myelomonocytic leukemia
625591|NCT00919425|juvenile myelomonocytic leukemia|juvenile myelomonocytic leukemia
625592|NCT00919425|myelodysplastic/myeloproliferative neoplasm, unclassifiable|myelodysplastic/myeloproliferative neoplasm, unclassifiable
625593|NCT00919425|childhood myelodysplastic syndromes|childhood myelodysplastic syndromes
625594|NCT00919412|Non Invasive Biomarkers Preterm Delivery|non invasive biomarkers preterm delivery
625595|NCT00919399|breast cancer|breast cancer
625596|NCT00919399|locally advanced|locally advanced
625597|NCT00919399|Menopausal patient|menopausal patient
625598|NCT00919399|aromasin|aromasin
625599|NCT00919399|tamoxifen|tamoxifen
625600|NCT00919399|efficacy|efficacy
625601|NCT00919386|Ureteric Measurement|ureteric measurement
625602|NCT00919373|Catheter Ablation|catheter ablation
625603|NCT00919373|Defibrillators, Implantable|defibrillators, implantable
625604|NCT00919347|Cardiovascular Autonomic Neuropathy|cardiovascular autonomic neuropathy
625605|NCT00919347|Diabetic Autonomic Neuropathy|diabetic autonomic neuropathy
625606|NCT00919347|Autonomic Dysfunction|autonomic dysfunction
625607|NCT00919334|Myopia progression|myopia progression
625608|NCT00919334|Myopia control|myopia control
625609|NCT00919334|Simultaneous vision|simultaneous vision
625610|NCT00919334|Myopic defocus|myopic defocus
625611|NCT00919321|CLL|cll
625612|NCT00919321|PPV|ppv
625613|NCT00919321|PCV|pcv
625614|NCT00919308|Simulation|simulation
625615|NCT00919308|Invasive procedures|invasive procedures
625616|NCT00919295|Fibromyalgia syndrome|fibromyalgia syndrome
625617|NCT00919295|mirtazapine|mirtazapine
625618|NCT00919295|randomized controlled trial|randomized controlled trial
625619|NCT00919295|pilot study|pilot study
625620|NCT00919282|pancreatic cancer|pancreatic cancer
625621|NCT00919282|gemcitabine|gemcitabine
625622|NCT00919282|combination|combination
625623|NCT00919243|prednisone|prednisone
625624|NCT00919243|allopurinol|allopurinol
625625|NCT00919243|heart failure|heart failure
625626|NCT00919243|hyperuricemia|hyperuricemia
625627|NCT00919230|Hip fracture|hip fracture
625628|NCT00919230|iron therapy|iron therapy
625629|NCT00919230|anaemia|anaemia
795426|NCT00272519|HIV|hiv
625630|NCT00919217|Multiple Sclerosis|multiple sclerosis
625631|NCT00919217|MS|ms
625632|NCT00919217|Relapsing-remitting multiple sclerosis|relapsing-remitting multiple sclerosis
625633|NCT00919217|RR-MS|rr-ms
625634|NCT00919217|Women|women
625635|NCT00919204|AG-013736, axitinib, pharmacokinetics, healthy, Chinese|ag-013736, axitinib, pharmacokinetics, healthy, chinese
625636|NCT00919191|acne|acne
625637|NCT00919191|irritation|irritation
625638|NCT00919191|objective sensory methods|objective sensory methods
625639|NCT00919178|Dengue virus|dengue virus
625640|NCT00919178|Vaccine|vaccine
625641|NCT00919178|DEN4|den4
625642|NCT00919178|Dengue|dengue
625643|NCT00919165|carotid stenting|carotid stenting
625644|NCT00919165|cognitive function|cognitive function
625645|NCT00919165|pre and post stent|pre and post stent
625646|NCT00919165|severe carotid artery stenosis|severe carotid artery stenosis
625647|NCT00919152|stress ulcer prophylaxis|stress ulcer prophylaxis
625648|NCT00919152|intensive care|intensive care
625649|NCT00919152|Critically ill|critically ill
625650|NCT00919152|proton pump inhibitors|proton pump inhibitors
625651|NCT00919152|pharmacoeconomics|pharmacoeconomics
625652|NCT00919139|multiple myeloma|multiple myeloma
625653|NCT00919139|Waldenström macroglobulinemia|waldenström macroglobulinemia
625654|NCT00919139|monoclonal gammopathy of undetermined significance|monoclonal gammopathy of undetermined significance
625655|NCT00919139|primary systemic amyloidosis|primary systemic amyloidosis
625656|NCT00919126|Xenon in Anaesthesia|xenon in anaesthesia
625657|NCT00919113|Bladder Pain|bladder pain
625658|NCT00919113|GAG replacement therapy|gag replacement therapy
625659|NCT00919113|IC/PBS|ic/pbs
625660|NCT00919100|pediatric|pediatric
626632|NCT00915070|BQ-123|bq-123
625661|NCT00919100|venipuncture|venipuncture
625662|NCT00919100|pain|pain
625663|NCT00919100|vibration|vibration
625664|NCT00919100|vapocoolant|vapocoolant
625665|NCT00919074|Patients undergoing endoscopic retrograde cholangiopancreatography for the first time|patients undergoing endoscopic retrograde cholangiopancreatography for the first time
625666|NCT00919074|Particular focus on patients who meet predefined criteria for a difficult bile duct cannulation|particular focus on patients who meet predefined criteria for a difficult bile duct cannulation
625667|NCT00919061|GALL BLADDER|gall bladder
625668|NCT00919061|BILE DUCTS|bile ducts
625669|NCT00919061|BAY 43-9006|bay 43-9006
625670|NCT00919061|SORAFENIB|sorafenib
625671|NCT00919061|CISPLATIN|cisplatin
625672|NCT00919061|GEMCITABINE|gemcitabine
625673|NCT00919061|09-029|09-029
625674|NCT00919035|prostate cancer|prostate cancer
625675|NCT00919035|androgen-independent prostate cancer (AIPC) Prostate Cancer|androgen-independent prostate cancer (aipc) prostate cancer
625676|NCT00919022|Inoperable Prostate Cancer|inoperable prostate cancer
625677|NCT00919022|Erectile Dysfunction|erectile dysfunction
625678|NCT00919009|TACE|tace
625679|NCT00919009|Sorafenib|sorafenib
625680|NCT00918996|Cesarean Section|cesarean section
625681|NCT00918996|Bladder Flap|bladder flap
625682|NCT00918996|Operating time|operating time
625683|NCT00918983|Benign prostatic hyperplasia|benign prostatic hyperplasia
625684|NCT00918983|BPH|bph
625685|NCT00918983|Enlarged prostate|enlarged prostate
625686|NCT00918970|autonomous nervous system|autonomous nervous system
625687|NCT00918970|brain death|brain death
625688|NCT00918970|organs transplantation|organs transplantation
625689|NCT00918957|Tobramycin Inhalation Powder|tobramycin inhalation powder
625690|NCT00918957|Cystic fibrosis|cystic fibrosis
625691|NCT00918957|Lung diseases|lung diseases
625692|NCT00918957|Anti-Bacterial Agents|anti-bacterial agents
625693|NCT00918957|Treatment of infections with P. aeruginosa in cystic fibrosis subjects|treatment of infections with p. aeruginosa in cystic fibrosis subjects
625694|NCT00918944|clinical decision support tool|clinical decision support tool
625695|NCT00918944|electronic health record|electronic health record
625696|NCT00918944|control tool|control tool
625697|NCT00918944|spirometry|spirometry
625698|NCT00918944|quality of life survey|quality of life survey
625699|NCT00918944|provider survey|provider survey
625700|NCT00918931|Leukemia|leukemia
625701|NCT00918931|Systemic Mastocytosis|systemic mastocytosis
625702|NCT00918931|SM|sm
625703|NCT00918931|Obatoclax mesylate|obatoclax mesylate
625704|NCT00918931|GX15-070MS|gx15-070ms
625705|NCT00918918|Alcohol Consumption|alcohol consumption
625706|NCT00918918|High Density Lipoprotein (HDL)|high density lipoprotein (hdl)
625707|NCT00918918|lipopolysaccharides (LPS)|lipopolysaccharides (lps)
625708|NCT00918918|Apolipoproteins|apolipoproteins
625709|NCT00918918|Inflammation|inflammation
625710|NCT00918905|pervasive healthcare|pervasive healthcare
625711|NCT00918905|telecare|telecare
625712|NCT00918905|telemedicine|telemedicine
625713|NCT00918905|COPD|copd
625714|NCT00918892|breast cancer|breast cancer
625715|NCT00918892|estrogen receptor-negative breast cancer|estrogen receptor-negative breast cancer
625716|NCT00918892|estrogen receptor-positive breast cancer|estrogen receptor-positive breast cancer
625717|NCT00918892|progesterone receptor-negative breast cancer|progesterone receptor-negative breast cancer
712395|NCT00580307|Surgery|surgery
625718|NCT00918892|progesterone receptor-positive breast cancer|progesterone receptor-positive breast cancer
625719|NCT00918892|triple-negative breast cancer|triple-negative breast cancer
625720|NCT00918892|HER2-negative breast cancer|her2-negative breast cancer
625721|NCT00918892|HER2-positive breast cancer|her2-positive breast cancer
625722|NCT00918879|DPP-4 inhibitors|dpp-4 inhibitors
625723|NCT00918879|HbA1c|hba1c
625724|NCT00918879|Incretins|incretins
625725|NCT00918866|Phase 4|phase 4
625726|NCT00918866|DEFINITY®|definity®
625727|NCT00918866|hemodynamics|hemodynamics
625728|NCT00918866|pulmonary artery pressure|pulmonary artery pressure
625729|NCT00918853|pancreas|pancreas
625730|NCT00918853|adenocarcinoma|adenocarcinoma
625731|NCT00918840|HIV|hiv
625732|NCT00918840|Vaccine|vaccine
625733|NCT00918840|Immune Therapy|immune therapy
625734|NCT00918840|DermaVir|dermavir
625735|NCT00918840|Treatment experienced|treatment experienced
625736|NCT00918827|adenocarcinoma of the colon|adenocarcinoma of the colon
625737|NCT00918827|stage III colon cancer|stage iii colon cancer
625738|NCT00918801|T1DM|t1dm
625739|NCT00918801|MRI|mri
625740|NCT00918788|breast cancer|breast cancer
625741|NCT00918762|perioperative/postoperative complications|perioperative/postoperative complications
625742|NCT00918762|precancerous condition|precancerous condition
625743|NCT00918762|stage I squamous cell carcinoma of the hypopharynx|stage i squamous cell carcinoma of the hypopharynx
625744|NCT00918762|stage II squamous cell carcinoma of the hypopharynx|stage ii squamous cell carcinoma of the hypopharynx
625745|NCT00918762|stage III squamous cell carcinoma of the hypopharynx|stage iii squamous cell carcinoma of the hypopharynx
625746|NCT00918762|stage I squamous cell carcinoma of the larynx|stage i squamous cell carcinoma of the larynx
625747|NCT00918762|stage I verrucous carcinoma of the larynx|stage i verrucous carcinoma of the larynx
625748|NCT00918762|stage II squamous cell carcinoma of the larynx|stage ii squamous cell carcinoma of the larynx
626723|NCT00914784|TRALI|trali
625749|NCT00918762|stage II verrucous carcinoma of the larynx|stage ii verrucous carcinoma of the larynx
625750|NCT00918762|stage III squamous cell carcinoma of the larynx|stage iii squamous cell carcinoma of the larynx
625751|NCT00918762|stage III verrucous carcinoma of the larynx|stage iii verrucous carcinoma of the larynx
625752|NCT00918762|stage I lymphoepithelioma of the nasopharynx|stage i lymphoepithelioma of the nasopharynx
625753|NCT00918762|stage I squamous cell carcinoma of the nasopharynx|stage i squamous cell carcinoma of the nasopharynx
625754|NCT00918762|stage II lymphoepithelioma of the nasopharynx|stage ii lymphoepithelioma of the nasopharynx
625755|NCT00918762|stage II squamous cell carcinoma of the nasopharynx|stage ii squamous cell carcinoma of the nasopharynx
625756|NCT00918762|stage III lymphoepithelioma of the nasopharynx|stage iii lymphoepithelioma of the nasopharynx
625757|NCT00918762|stage III squamous cell carcinoma of the nasopharynx|stage iii squamous cell carcinoma of the nasopharynx
625758|NCT00918762|stage I lymphoepithelioma of the oropharynx|stage i lymphoepithelioma of the oropharynx
625759|NCT00918762|stage I squamous cell carcinoma of the oropharynx|stage i squamous cell carcinoma of the oropharynx
625760|NCT00918762|stage II lymphoepithelioma of the oropharynx|stage ii lymphoepithelioma of the oropharynx
625761|NCT00918762|stage II squamous cell carcinoma of the oropharynx|stage ii squamous cell carcinoma of the oropharynx
625762|NCT00918762|stage III lymphoepithelioma of the oropharynx|stage iii lymphoepithelioma of the oropharynx
625763|NCT00918762|stage III squamous cell carcinoma of the oropharynx|stage iii squamous cell carcinoma of the oropharynx
625764|NCT00918736|Ankle joint|ankle joint
625765|NCT00918736|Balance|balance
625766|NCT00918736|Hyaluronic acid|hyaluronic acid
625767|NCT00918736|Osteoarthritis|osteoarthritis
625768|NCT00918710|Squamous cell carcinoma of Oropharynx|squamous cell carcinoma of oropharynx
625769|NCT00918710|Human papillomavirus.|human papillomavirus.
625770|NCT00918710|Biological prognostic markers.|biological prognostic markers.
625771|NCT00918697|photorefractive keratectomy|photorefractive keratectomy
625772|NCT00918697|PRK|prk
625773|NCT00918697|alcohol-assisted debridement|alcohol-assisted debridement
625774|NCT00918697|mechanical debridement|mechanical debridement
625775|NCT00918697|confocal scan|confocal scan
625776|NCT00918697|confocal microscopy|confocal microscopy
625777|NCT00918684|Depression|depression
625778|NCT00918671|Headache|headache
625779|NCT00918671|Medication overuse|medication overuse
625780|NCT00918671|chronic|chronic
625781|NCT00918671|relapse|relapse
625782|NCT00918658|childhood chronic myelogenous leukemia|childhood chronic myelogenous leukemia
625783|NCT00918658|chronic myelogenous leukemia|chronic myelogenous leukemia
625784|NCT00918658|adult acute lymphoblastic leukemia|adult acute lymphoblastic leukemia
625785|NCT00918658|childhood acute lymphoblastic leukemia|childhood acute lymphoblastic leukemia
625786|NCT00918658|adult acute myeloid leukemia|adult acute myeloid leukemia
625787|NCT00918658|childhood acute myeloid leukemia/other myeloid malignancies|childhood acute myeloid leukemia/other myeloid malignancies
625788|NCT00918658|multiple myeloma|multiple myeloma
625789|NCT00918645|stage IV prostate cancer|stage iv prostate cancer
625790|NCT00918645|recurrent prostate cancer|recurrent prostate cancer
625791|NCT00918645|bone metastases|bone metastases
625792|NCT00918632|food-effect pharmacokinetics AG-013736 food fasting|food-effect pharmacokinetics ag-013736 food fasting
625793|NCT00918619|randomized,|randomized,
625794|NCT00918619|controlled,|controlled,
625795|NCT00918619|haemostatic agents,|haemostatic agents,
625796|NCT00918619|Sangustop,|sangustop,
625797|NCT00918619|Tachosil,|tachosil,
625798|NCT00918619|liver resection,|liver resection,
625799|NCT00918619|haemostasis|haemostasis
625800|NCT00918593|Metastases|metastases
625801|NCT00918593|Cutaneous|cutaneous
625802|NCT00918593|Ulcerating|ulcerating
625803|NCT00918593|Palliative|palliative
625804|NCT00918593|ulcerating metastases|ulcerating metastases
625805|NCT00918567|ADHD|adhd
625930|NCT00917917|Metabolic syndrome|metabolic syndrome
625806|NCT00918567|impact of atomoxetine with and and without behavior therapy at school and home|impact of atomoxetine with and and without behavior therapy at school and home
625807|NCT00918554|Sarcoid-associated uveitis|sarcoid-associated uveitis
625808|NCT00918554|Macular oedema|macular oedema
625809|NCT00918554|Methotrexate|methotrexate
625810|NCT00918554|Conventional corticosteroids sparing agent.|conventional corticosteroids sparing agent.
625811|NCT00918541|atherosclerotic disease|atherosclerotic disease
625812|NCT00918541|progression|progression
625813|NCT00918541|natural progression of atherosclerotic disease|natural progression of atherosclerotic disease
625814|NCT00918541|natural history of atherosclerosis at the level of the carotid artery as evaluated by MRI|natural history of atherosclerosis at the level of the carotid artery as evaluated by mri
625815|NCT00918528|Urethral stricture|urethral stricture
625816|NCT00918528|Mitomycin C|mitomycin c
625817|NCT00918528|Internal Urethrotomy|internal urethrotomy
625818|NCT00918515|Sedation|sedation
625819|NCT00918515|Anaesthesia|anaesthesia
625820|NCT00918515|Safety|safety
625821|NCT00918515|tolerability|tolerability
625822|NCT00918515|pharmacokinetics|pharmacokinetics
625823|NCT00918515|pharmacodynamics|pharmacodynamics
625824|NCT00918515|healthy male volunteers|healthy male volunteers
625825|NCT00918489|soft tissue sarcoma|soft tissue sarcoma
625826|NCT00918489|metastatic|metastatic
625827|NCT00918489|vorinostat|vorinostat
625828|NCT00918463|lymphoma|lymphoma
625829|NCT00918463|diffuse|diffuse
625830|NCT00918463|refractory|refractory
625831|NCT00918437|uvulopalatoplasty|uvulopalatoplasty
625832|NCT00918437|postoperative pain|postoperative pain
625833|NCT00918437|quality of life|quality of life
625834|NCT00918411|diarrhea|diarrhea
625835|NCT00918411|IBS|ibs
625836|NCT00918411|Colonic diseases|colonic diseases
625837|NCT00918411|YM060|ym060
625838|NCT00918385|hormone resistant prostate cancer|hormone resistant prostate cancer
625839|NCT00918385|castration resistant prostate cancer|castration resistant prostate cancer
625840|NCT00918385|hormone refractory prostate cancer|hormone refractory prostate cancer
625841|NCT00918385|metastatic prostate cancer|metastatic prostate cancer
625842|NCT00918385|hormonal therapy|hormonal therapy
625843|NCT00918385|antiandrogen therapy|antiandrogen therapy
625844|NCT00918385|androgen receptor|androgen receptor
625845|NCT00918385|nilutamide|nilutamide
625846|NCT00918385|dasatinib|dasatinib
625847|NCT00918385|genomics|genomics
625848|NCT00918385|genomic signature|genomic signature
625849|NCT00918385|genomic predictor|genomic predictor
625850|NCT00918385|genomic analysis|genomic analysis
625851|NCT00918385|genomic expression profile|genomic expression profile
625852|NCT00918372|MSCTA|mscta
625853|NCT00918372|Marathon runners|marathon runners
625854|NCT00918346|Ocular hypertension|ocular hypertension
625855|NCT00918320|Temozolomide|temozolomide
625856|NCT00918320|Topotecan|topotecan
625857|NCT00918320|paediatric solid tumours|paediatric solid tumours
625858|NCT00918320|Miscellaneous other solid tumours|miscellaneous other solid tumours
625859|NCT00918307|Tobacco Dependence|tobacco dependence
625860|NCT00918307|HIV infection|hiv infection
625861|NCT00918307|varenicline|varenicline
625862|NCT00918294|CRT|crt
625863|NCT00918294|heart failure|heart failure
625864|NCT00918294|optimization|optimization
625865|NCT00918294|Timing cycle optimization methods|timing cycle optimization methods
625866|NCT00918268|Influenza vaccine|influenza vaccine
625867|NCT00918255|Hidradenitis Suppurativa|hidradenitis suppurativa
625868|NCT00918255|Adalimumab|adalimumab
625869|NCT00918255|Nodule|nodule
625870|NCT00918255|Abscess|abscess
625871|NCT00918255|Fistula|fistula
625872|NCT00918255|Physicians Global Assessment|physicians global assessment
625873|NCT00918255|Hurley Stage|hurley stage
625874|NCT00918255|Sartorius Scale|sartorius scale
625875|NCT00918242|Coronary Heart Disease|coronary heart disease
625876|NCT00918242|computed tomography|computed tomography
625877|NCT00918242|prevalence of coronary artery disease|prevalence of coronary artery disease
625878|NCT00918229|Prostate|prostate
625879|NCT00918229|cancer|cancer
625880|NCT00918229|radiation|radiation
625881|NCT00918229|biodegradable implantable balloon|biodegradable implantable balloon
625882|NCT00918229|intrarectal balloon|intrarectal balloon
625883|NCT00918216|breast cancer|breast cancer
625884|NCT00918203|Lung neoplasms|lung neoplasms
625885|NCT00918203|IMC-3G3|imc-3g3
625886|NCT00918203|carboplatin|carboplatin
625887|NCT00918203|paclitaxel|paclitaxel
625888|NCT00918203|PDGFr|pdgfr
625889|NCT00918190|Postoperative nausea and vomiting|postoperative nausea and vomiting
625890|NCT00918190|Pediatric|pediatric
625891|NCT00918190|Strabismus|strabismus
625892|NCT00918190|Late onset postoperative nausea and vomiting|late onset postoperative nausea and vomiting
625893|NCT00918112|Parkinson's Disease|parkinson's disease
625894|NCT00918099|Mesh|mesh
625895|NCT00918099|vaginal prolapse|vaginal prolapse
625896|NCT00918099|Recurrence rate|recurrence rate
625897|NCT00918086|Vitamin D|vitamin d
625898|NCT00918086|Tuberculosis|tuberculosis
625899|NCT00918073|HIV infected smokers|hiv infected smokers
625900|NCT00918073|HIV|hiv
625901|NCT00918034|BPH|bph
625902|NCT00918034|LUTS|luts
625903|NCT00918034|talaporfin sodium|talaporfin sodium
625904|NCT00918008|URINARY BLADDER|urinary bladder
625905|NCT00918008|Bladder|bladder
625906|NCT00918008|Blood sample|blood sample
625907|NCT00918008|Lymph Nodes|lymph nodes
625908|NCT00917995|parastomal hernia|parastomal hernia
625909|NCT00917995|prophylactic mesh|prophylactic mesh
625910|NCT00917995|colostomy|colostomy
625911|NCT00917995|hernia|hernia
625912|NCT00917956|Lithium|lithium
625913|NCT00917956|IBM|ibm
625914|NCT00917956|InclusionIBM|inclusionibm
625915|NCT00917956|Myositis|myositis
625916|NCT00917943|smoking|smoking
625917|NCT00917943|pregnancy|pregnancy
625918|NCT00917943|counseling|counseling
625919|NCT00917943|prevention|prevention
625920|NCT00917943|tailored intervention|tailored intervention
625921|NCT00917943|postpartum|postpartum
625922|NCT00917943|women|women
625923|NCT00917943|cessation|cessation
625924|NCT00917930|exercise training|exercise training
625925|NCT00917930|functional recovery|functional recovery
625926|NCT00917930|heart diseases|heart diseases
625927|NCT00917930|altered glucose metabolism early after an acute cardiac event|altered glucose metabolism early after an acute cardiac event
625928|NCT00917930|non diabetes CAD patients|non diabetes cad patients
625929|NCT00917930|glycometabolic state|glycometabolic state
625931|NCT00917917|exercise training|exercise training
625932|NCT00917917|abdominal fat mass|abdominal fat mass
625933|NCT00917917|endothelial function|endothelial function
625934|NCT00917917|diastolic function|diastolic function
625935|NCT00917904|HIV Infections|hiv infections
625936|NCT00917904|Acquired Immunodeficiency Syndrome|acquired immunodeficiency syndrome
625937|NCT00917904|Healthy|healthy
625938|NCT00917904|HIV seronegativity|hiv seronegativity
625939|NCT00917891|HIV Infections|hiv infections
625940|NCT00917891|Acquired Immunodeficiency Syndrome|acquired immunodeficiency syndrome
625941|NCT00917891|Healthy|healthy
625942|NCT00917891|HIV seronegativity|hiv seronegativity
625943|NCT00917878|Milk|milk
625944|NCT00917878|Postprandial hyperlipidemia|postprandial hyperlipidemia
625945|NCT00917878|Postprandial inflammation|postprandial inflammation
625946|NCT00917878|Overweight|overweight
625947|NCT00917852|aorta|aorta
625948|NCT00917852|trauma|trauma
625949|NCT00917852|transection|transection
625950|NCT00917839|neuroprotection|neuroprotection
625951|NCT00917839|multiple sclerosis|multiple sclerosis
625952|NCT00917839|brain atrophy|brain atrophy
625953|NCT00917839|mr-spectroscopy|mr-spectroscopy
625954|NCT00917813|HIV|hiv
625955|NCT00917813|monoclonal antibody|monoclonal antibody
625956|NCT00917813|KD-247|kd-247
625957|NCT00917813|treatment naive|treatment naive
625958|NCT00917800|angiography|angiography
625959|NCT00917800|exercise testing|exercise testing
625960|NCT00917800|high frequency ECG|high frequency ecg
625961|NCT00917800|coronary artery disease|coronary artery disease
625962|NCT00917787|Asthma|asthma
625963|NCT00917774|gender specific knee|gender specific knee
625964|NCT00917774|osteoarthritis|osteoarthritis
625965|NCT00917774|total knee arthroplasty|total knee arthroplasty
625966|NCT00917761|Hepatitis B, chronic|hepatitis b, chronic
625967|NCT00917761|Peginterferon alfa-2a|peginterferon alfa-2a
625968|NCT00917761|Entecavir|entecavir
625969|NCT00917735|Green tea|green tea
625970|NCT00917735|Breast cancer|breast cancer
625971|NCT00917735|Prevention|prevention
625972|NCT00917735|COMT genotype|comt genotype
625973|NCT00917735|EGCG (Epigallocatechin gallate)|egcg (epigallocatechin gallate)
625974|NCT00917735|Mammographic density|mammographic density
625975|NCT00917735|Reproductive hormones|reproductive hormones
625976|NCT00917735|IGF axis proteins|igf axis proteins
625977|NCT00917735|Oxidative stress|oxidative stress
625978|NCT00917722|Parkinson's Disease|parkinson's disease
625979|NCT00917722|STN DBS|stn dbs
625980|NCT00917722|Deep Brain Stimulation|deep brain stimulation
625981|NCT00917709|dementia with Lewy bodies|dementia with lewy bodies
625982|NCT00917709|imaging|imaging
625983|NCT00917709|acetylcholine|acetylcholine
625984|NCT00917709|dopamine|dopamine
625985|NCT00917709|IBVM|ibvm
625986|NCT00917709|DATSCAN|datscan
625987|NCT00917670|trabecular meshwork|trabecular meshwork
625988|NCT00917670|electron microscopy|electron microscopy
625989|NCT00917657|photorefractive keratectomy|photorefractive keratectomy
625990|NCT00917657|hyperopia|hyperopia
625991|NCT00917657|radial keratotomy|radial keratotomy
625992|NCT00917657|refractive surgery|refractive surgery
712396|NCT00580307|Septoplasty|septoplasty
625993|NCT00917644|Bioqeuivalence, Pharmacokinetics, Atorvastatin|bioqeuivalence, pharmacokinetics, atorvastatin
625994|NCT00917631|Co-bedding|co-bedding
625995|NCT00917631|Procedural pain|procedural pain
625996|NCT00917631|Twin|twin
625997|NCT00917631|Comfort|comfort
625998|NCT00917631|RCT|rct
625999|NCT00917618|osteoarthritis|osteoarthritis
626000|NCT00917618|knee|knee
626001|NCT00917618|exercise|exercise
626002|NCT00917618|cycling|cycling
626003|NCT00917592|Diverticulitis|diverticulitis
626004|NCT00917579|Bioequivalence, pharmacokinetics, atorvastatin|bioequivalence, pharmacokinetics, atorvastatin
626005|NCT00917566|Airtraq|airtraq
626006|NCT00917566|Pediatric|pediatric
626007|NCT00917553|diabetic retinopathy|diabetic retinopathy
626008|NCT00917553|diabetes|diabetes
626009|NCT00917553|diabetic eye studies|diabetic eye studies
626010|NCT00917527|Subjects with family history of coronary heart disease|subjects with family history of coronary heart disease
626011|NCT00917514|Dosing Tool|dosing tool
626012|NCT00917514|Compliance|compliance
626013|NCT00917514|User Friendly|user friendly
626014|NCT00917514|Crohn's Disease|crohn's disease
626015|NCT00917514|Ulcerative Colitis|ulcerative colitis
626016|NCT00917501|Mania|mania
626017|NCT00917501|Adolescents at risk for Mania|adolescents at risk for mania
626018|NCT00917488|Allergen extract Standardization|allergen extract standardization
626019|NCT00917475|preterm infants|preterm infants
626020|NCT00917462|ESOPHAGUS|esophagus
626021|NCT00917462|BAY 43-9006 (SORAFENIB)|bay 43-9006 (sorafenib)
626022|NCT00917462|09-016|09-016
626023|NCT00917462|Nexavar®.|nexavar®.
626024|NCT00917449|Metabolic Syndrome|metabolic syndrome
626025|NCT00917449|Impaired glucose tolerance|impaired glucose tolerance
626026|NCT00917449|Type 2 diabetes mellitus|type 2 diabetes mellitus
626027|NCT00917449|Endothelial dysfunction|endothelial dysfunction
626028|NCT00917449|L-arginine|l-arginine
626029|NCT00917449|Insulin resistance|insulin resistance
626030|NCT00917423|Anorexia Nervosa|anorexia nervosa
626031|NCT00917423|Exercise|exercise
626032|NCT00917423|Physical Activity|physical activity
626033|NCT00917397|Traumatized refugee|traumatized refugee
626034|NCT00917397|treatment|treatment
626035|NCT00917397|antidepressants|antidepressants
626036|NCT00917397|psychotherapy|psychotherapy
626037|NCT00917397|PTSD in traumatized refugees|ptsd in traumatized refugees
626038|NCT00917384|IMC-1121B|imc-1121b
626039|NCT00917384|Monoclonal antibody (MAb)|monoclonal antibody (mab)
626040|NCT00917384|Vascular endothelial growth factor (VEGF)|vascular endothelial growth factor (vegf)
626041|NCT00917384|Human vascular endothelial growth factor receptor-2 (VEGFR-2)|human vascular endothelial growth factor receptor-2 (vegfr-2)
626042|NCT00917384|Platinum resistant|platinum resistant
626043|NCT00917384|platinum refractory|platinum refractory
626044|NCT00917384|Gastric|gastric
626045|NCT00917384|Gastroesophageal Junction Adenocarcinoma|gastroesophageal junction adenocarcinoma
626046|NCT00917384|metastatic|metastatic
626047|NCT00917384|Angiogenesis|angiogenesis
626048|NCT00917371|adults with attention-deficit hyperactivity disorder|adults with attention-deficit hyperactivity disorder
626049|NCT00917371|atomoxetine|atomoxetine
626050|NCT00917371|neuropsychological functioning|neuropsychological functioning
626051|NCT00917371|brain imaging studies|brain imaging studies
626052|NCT00917358|Hepatitis C|hepatitis c
626053|NCT00917358|Dialysis|dialysis
626054|NCT00917358|Interferon|interferon
626055|NCT00917345|ARC|arc
626057|NCT00917345|primary aldosteronism|primary aldosteronism
626058|NCT00917345|captopril test|captopril test
626059|NCT00917345|aldosterone-renin ratio|aldosterone-renin ratio
626060|NCT00917345|Primary aldosteronism (PA) than PRA and establish thresholds for the diagnosis using ARC.|primary aldosteronism (pa) than pra and establish thresholds for the diagnosis using arc.
626061|NCT00917332|pain|pain
626062|NCT00917332|childbirth|childbirth
626063|NCT00917332|relaxation|relaxation
626064|NCT00917332|guided imagery|guided imagery
626065|NCT00917332|VAS|vas
626066|NCT00917332|epidural|epidural
626067|NCT00917306|Peplin|peplin
626068|NCT00917306|Actinic keratosis|actinic keratosis
626069|NCT00917306|PEP005|pep005
626070|NCT00917293|Tardive Dyskinesia|tardive dyskinesia
626071|NCT00917293|Schizophrenia|schizophrenia
626072|NCT00917293|Pyridoxal 5'-phosphate|pyridoxal 5'-phosphate
626073|NCT00917280|Parkinson's Disease|parkinson's disease
626074|NCT00917267|diabetes|diabetes
626075|NCT00917267|exenatide|exenatide
626076|NCT00917267|once weekly|once weekly
626077|NCT00917267|Byetta|byetta
626078|NCT00917267|Amylin|amylin
626079|NCT00917267|Lilly|lilly
626080|NCT00917254|YM150|ym150
626081|NCT00917254|Thrombosis|thrombosis
626082|NCT00917254|VTE|vte
626083|NCT00917254|Knee Replacement|knee replacement
626084|NCT00917254|Anticoagulant|anticoagulant
626085|NCT00917254|FXa inhibitor|fxa inhibitor
626086|NCT00917241|Graves' disease|graves' disease
626087|NCT00917241|dexamethasone|dexamethasone
626088|NCT00917241|relapse|relapse
626089|NCT00917241|methimazole|methimazole
626090|NCT00917215|Asthma|asthma
626091|NCT00917215|Acupuncture|acupuncture
626092|NCT00917215|Pulmonary function|pulmonary function
626093|NCT00917215|Quality of life|quality of life
626094|NCT00917189|VCFS|vcfs
626095|NCT00917189|Chromosome 22q Deletion Syndrome|chromosome 22q deletion syndrome
626096|NCT00917189|Learning Disorders|learning disorders
626097|NCT00917163|coronary artery disease|coronary artery disease
626098|NCT00917163|restenosis|restenosis
626099|NCT00917163|stent thrombosis|stent thrombosis
626100|NCT00917163|coronary stents|coronary stents
626101|NCT00917163|angioplasty|angioplasty
626102|NCT00917163|drug eluting stents|drug eluting stents
626103|NCT00917150|chronic obstructive pulmonary disease|chronic obstructive pulmonary disease
626104|NCT00917150|COPD|copd
626105|NCT00917150|emphysema|emphysema
626106|NCT00917137|Lung cancer|lung cancer
626107|NCT00917137|Lung nodule|lung nodule
626108|NCT00917137|Transbronchial needle aspiration|transbronchial needle aspiration
626109|NCT00917137|Transbronchial lung biopsy|transbronchial lung biopsy
626110|NCT00917137|Bronchoscopy|bronchoscopy
626111|NCT00917124|cerebral oximetry|cerebral oximetry
626112|NCT00917124|NIRS|nirs
626113|NCT00917124|INVOS|invos
626114|NCT00917111|Randomized|randomized
626115|NCT00917111|Double-Blind|double-blind
626116|NCT00917111|Multi-Center|multi-center
626117|NCT00917111|Placebo-Controlled|placebo-controlled
626118|NCT00917111|Phase II|phase ii
626119|NCT00917111|Nasal Carbon Dioxide|nasal carbon dioxide
626120|NCT00917111|Carbon Dioxide|carbon dioxide
626121|NCT00917111|Efficacy|efficacy
626122|NCT00917111|Safety|safety
626123|NCT00917111|Total Nasal Symptom Score|total nasal symptom score
626124|NCT00917098|Behavior Therapy|behavior therapy
626125|NCT00917098|Supportive Counseling|supportive counseling
626126|NCT00917098|Child|child
626127|NCT00917098|Adolescent|adolescent
626128|NCT00917098|Hair Pulling|hair pulling
626129|NCT00917098|CBT|cbt
626130|NCT00917085|Preterm infant|preterm infant
626131|NCT00917085|Skin-to-skin contact|skin-to-skin contact
626132|NCT00917085|kangaroo care|kangaroo care
626133|NCT00917085|temperature|temperature
626134|NCT00917085|behavioral state|behavioral state
626135|NCT00917072|Clinical Handoff|clinical handoff
626136|NCT00917072|Medical Education|medical education
626137|NCT00917072|Simulation|simulation
626724|NCT00914784|Transfusion|transfusion
626138|NCT00917072|Residency and Internship|residency and internship
626139|NCT00917059|Major Depressive Disorder|major depressive disorder
626140|NCT00917059|SSRI|ssri
626141|NCT00917059|EEG|eeg
626142|NCT00917046|All-cause heart failure patients|all-cause heart failure patients
626143|NCT00917046|coronary artery disease etiology|coronary artery disease etiology
626144|NCT00917046|dilated cardiomyopathy etiology|dilated cardiomyopathy etiology
626145|NCT00917020|Randomized|randomized
626146|NCT00917020|Double-Blind|double-blind
626147|NCT00917020|Multi-Center|multi-center
626148|NCT00917020|Phase II|phase ii
626149|NCT00917020|Nasal Carbon Dioxide|nasal carbon dioxide
626150|NCT00917020|Carbon Dioxide|carbon dioxide
626151|NCT00917020|Efficacy|efficacy
626152|NCT00917020|Safety|safety
626153|NCT00917020|Total Nasal Symptom Score|total nasal symptom score
626154|NCT00917007|ABO incompatibility|abo incompatibility
626155|NCT00917007|hemolysis|hemolysis
626156|NCT00917007|jaundice|jaundice
626157|NCT00917007|hyperbilirubinemia|hyperbilirubinemia
626158|NCT00917007|newborn|newborn
626159|NCT00916994|Rotator Cuff Tear|rotator cuff tear
626160|NCT00916981|pseudarthrosis|pseudarthrosis
626161|NCT00916981|Treatment|treatment
626162|NCT00916981|osteoblast grafting|osteoblast grafting
626163|NCT00916981|cell therapy|cell therapy
626164|NCT00916981|nonunion|nonunion
626165|NCT00916968|Gender specific|gender specific
626166|NCT00916968|cruciate retaining|cruciate retaining
626167|NCT00916968|total knee arthroplasty|total knee arthroplasty
626168|NCT00916968|Bilateral Osteoarthritis of the knee joint|bilateral osteoarthritis of the knee joint
626169|NCT00916955|22q11.2 deletion syndrome|22q11.2 deletion syndrome
626170|NCT00916955|velo-cardio-facial syndrome|velo-cardio-facial syndrome
626171|NCT00916955|congenital anomalies|congenital anomalies
626172|NCT00916955|mental illness|mental illness
626173|NCT00916955|congenital heart disease|congenital heart disease
626174|NCT00916942|Tolerability study|tolerability study
626175|NCT00916916|Acromegaly|acromegaly
626176|NCT00916916|Lanreotide|lanreotide
626177|NCT00916903|Talus|talus
626178|NCT00916903|Neuroserpin|neuroserpin
626179|NCT00916903|mental retardation|mental retardation
626180|NCT00916903|epilepsy|epilepsy
626181|NCT00916903|FENIB|fenib
626182|NCT00916903|XLMR|xlmr
626183|NCT00916890|Opioid pharmacogenetics|opioid pharmacogenetics
626184|NCT00916890|Opioid pharmacokinetic|opioid pharmacokinetic
626185|NCT00916890|Long-term opioid treatment|long-term opioid treatment
626186|NCT00916890|Cancer pain|cancer pain
626187|NCT00916877|Prophylactic Cranial Irradiation|prophylactic cranial irradiation
626188|NCT00916877|Her-2-positive met breast cancer|her-2-positive met breast cancer
626189|NCT00916851|attention-deficit hyperactivity disorder|attention-deficit hyperactivity disorder
626190|NCT00916851|autism spectrum disorders|autism spectrum disorders
626191|NCT00916851|normally developing children and adolescents|normally developing children and adolescents
626192|NCT00916851|cognitive functions|cognitive functions
626193|NCT00916851|emotion/behaviors|emotion/behaviors
626194|NCT00916851|brain imaging|brain imaging
626195|NCT00916851|genotypes|genotypes
626196|NCT00916838|Type 1 Diabetes Mellitis|type 1 diabetes mellitis
626197|NCT00916838|MRI|mri
626198|NCT00916825|breast cancer|breast cancer
626199|NCT00916825|quality of life|quality of life
626200|NCT00916825|children of somatically ill parents|children of somatically ill parents
626201|NCT00916825|psychological adaptation|psychological adaptation
626202|NCT00916812|Difficult intubation|difficult intubation
626203|NCT00916812|Hyomental distance|hyomental distance
626204|NCT00916812|Obstetric|obstetric
626205|NCT00916812|Mallampati classification|mallampati classification
626206|NCT00916812|Thyromental distance|thyromental distance
626207|NCT00916812|Sternomental distance|sternomental distance
626208|NCT00916799|telehealth|telehealth
626209|NCT00916799|oximetry|oximetry
626210|NCT00916799|copd|copd
626211|NCT00916786|Attention-deficit/hyperactivity disorder|attention-deficit/hyperactivity disorder
626212|NCT00916786|pharmacogenetics|pharmacogenetics
626213|NCT00916786|molecular genetics|molecular genetics
626214|NCT00916786|medication response|medication response
626215|NCT00916773|Obstructive sleep apnea|obstructive sleep apnea
626216|NCT00916773|Airway inflammation|airway inflammation
626217|NCT00916773|Exercise-induced bronchoconstriction|exercise-induced bronchoconstriction
626218|NCT00916773|Continuous positive airway pressure|continuous positive airway pressure
626219|NCT00916760|allergic, rhinoconjunctivitis, Immunotherapy|allergic, rhinoconjunctivitis, immunotherapy
626220|NCT00916747|Progeria|progeria
626221|NCT00916734|McKenzie|mckenzie
626222|NCT00916734|thrust manipulation|thrust manipulation
626223|NCT00916734|clinical prediction rule|clinical prediction rule
626224|NCT00916721|Smoking cessation|smoking cessation
626225|NCT00916721|propranolol|propranolol
626226|NCT00916721|memory reconsolidation blockade|memory reconsolidation blockade
626227|NCT00916721|craving|craving
626228|NCT00916708|endometrial cancer|endometrial cancer
626229|NCT00916708|follow up|follow up
626230|NCT00916708|relapse|relapse
626231|NCT00916695|Stents|stents
626232|NCT00916695|Angioplasty|angioplasty
626233|NCT00916695|Coronary Artery Disease|coronary artery disease
626234|NCT00916695|Bifurcation Coronary Lesions|bifurcation coronary lesions
626235|NCT00916669|SCLC|sclc
626236|NCT00916669|enoxaparin sodium|enoxaparin sodium
626237|NCT00916669|cisplatin|cisplatin
626238|NCT00916669|etoposide|etoposide
626239|NCT00916656|Congenital fibrinogen deficiency|congenital fibrinogen deficiency
626240|NCT00916643|Hypercholesterolemia|hypercholesterolemia
626241|NCT00916643|FH|fh
626242|NCT00916643|LDL-C|ldl-c
626243|NCT00916643|CHD|chd
626244|NCT00916630|recurrent|recurrent
626245|NCT00916630|alimta|alimta
626246|NCT00916630|pemetrexed|pemetrexed
626247|NCT00916630|CNS lymphoma|cns lymphoma
626248|NCT00916630|Primary CNS lymphoma|primary cns lymphoma
626249|NCT00916630|Metastatic lymphoma to brain|metastatic lymphoma to brain
626250|NCT00916617|open-label|open-label
626251|NCT00916617|safety|safety
626252|NCT00916617|antibody|antibody
626253|NCT00916604|AZD1656|azd1656
626254|NCT00916604|Safety|safety
626255|NCT00916604|Pharmacokinetics|pharmacokinetics
626256|NCT00916604|Pharmacodynamic|pharmacodynamic
626257|NCT00916604|Multiple ascending doses|multiple ascending doses
626258|NCT00916604|Japanese|japanese
626259|NCT00916604|T2DM|t2dm
626260|NCT00916591|gastroesophageal reflux|gastroesophageal reflux
626261|NCT00916591|respiratory aspiration|respiratory aspiration
626262|NCT00916578|Advanced Inflammatory Breast Cancer|advanced inflammatory breast cancer
626263|NCT00916578|Non-Inflammatory Breast Cancer|non-inflammatory breast cancer
626264|NCT00916578|Capecitabine|capecitabine
626265|NCT00916578|Xeloda|xeloda
626266|NCT00916578|Concomitant Radiation|concomitant radiation
626267|NCT00916578|Radiation Therapy|radiation therapy
626268|NCT00916578|Radiotherapy|radiotherapy
626269|NCT00916578|Women|women
626270|NCT00916565|optimize nutritional content of infant formula|optimize nutritional content of infant formula
626271|NCT00916565|Infant|infant
626272|NCT00916552|Erythropoietin|erythropoietin
626273|NCT00916552|Epo|epo
626274|NCT00916552|depression|depression
626275|NCT00916552|bipolar disorder|bipolar disorder
626276|NCT00916552|cognition|cognition
626277|NCT00916552|cognitive function|cognitive function
626278|NCT00916552|antidepressant|antidepressant
626279|NCT00916526|Chronic cough|chronic cough
626280|NCT00916526|Inhaled corticosteroid treatment|inhaled corticosteroid treatment
626281|NCT00916526|Bronchial provocation test with mannitol|bronchial provocation test with mannitol
626282|NCT00916526|Methacholine|methacholine
626283|NCT00916513|Diabetes|diabetes
626284|NCT00916513|Treatment Satisfaction|treatment satisfaction
626285|NCT00916513|Quality of Life|quality of life
626286|NCT00916513|HbA1c levels and goals|hba1c levels and goals
796343|NCT00269048|CHD|chd
626287|NCT00916513|Healthcare resources consumption|healthcare resources consumption
626288|NCT00916500|CERVICAL CANCER, CONCURRENT CHEMORADIATION, CISPLATIN|cervical cancer, concurrent chemoradiation, cisplatin
626289|NCT00916461|First episode psychosis|first episode psychosis
626290|NCT00916461|Schizophrenia|schizophrenia
626291|NCT00916461|Minocycline|minocycline
626292|NCT00916461|neuroprotection|neuroprotection
626293|NCT00916461|First episode non affective psychosis|first episode non affective psychosis
626294|NCT00916461|With in first five years of illness|with in first five years of illness
626295|NCT00916448|Endotoxin|endotoxin
626296|NCT00916448|Bilirubin|bilirubin
626297|NCT00916448|Inflammation|inflammation
626298|NCT00916448|Sepsis|sepsis
626299|NCT00916448|Multi organ dysfunction syndrome|multi organ dysfunction syndrome
626300|NCT00916448|Oxidative Stress|oxidative stress
626301|NCT00916448|Heme oxygenase|heme oxygenase
626302|NCT00916435|Arrhythmia|arrhythmia
626303|NCT00916435|Cardiac Arrest|cardiac arrest
626304|NCT00916435|Cardiomyopathy|cardiomyopathy
626305|NCT00916435|Heart Failure|heart failure
626306|NCT00916422|Immunotherapy|immunotherapy
626307|NCT00916422|Allergoid|allergoid
626308|NCT00916422|Depigmented|depigmented
626309|NCT00916422|Polymerized|polymerized
626310|NCT00916422|Allergen-extract|allergen-extract
626311|NCT00916422|Rhinoconjunctivitis|rhinoconjunctivitis
626312|NCT00916409|Glioblastoma Multiforme|glioblastoma multiforme
626313|NCT00916409|Glioblastoma|glioblastoma
626314|NCT00916409|GBM|gbm
626315|NCT00916409|Brain tumor|brain tumor
626316|NCT00916409|Treatment|treatment
626317|NCT00916409|Minimal toxicity|minimal toxicity
626318|NCT00916409|Newly Diagnosed|newly diagnosed
626319|NCT00916409|TTFields|ttfields
626320|NCT00916409|Tumor Treating Fields|tumor treating fields
626321|NCT00916409|NovoCure|novocure
626322|NCT00916383|Skin Irritation|skin irritation
626323|NCT00916383|Donepezil Transdermal Patch System|donepezil transdermal patch system
626324|NCT00916383|Elderly|elderly
626325|NCT00916383|Alzheimer's subjects|alzheimer's subjects
626326|NCT00916383|Skin Irritation in elderly Alzheimer's subjects|skin irritation in elderly alzheimer's subjects
626327|NCT00916370|drug eluting stents|drug eluting stents
626328|NCT00916370|stents|stents
626329|NCT00916370|Angioplasty|angioplasty
626330|NCT00916370|myocardial ischemia|myocardial ischemia
626331|NCT00916370|coronary artery stenosis|coronary artery stenosis
626332|NCT00916370|Coronary Disease|coronary disease
626333|NCT00916370|Coronary Artery Disease|coronary artery disease
626334|NCT00916370|Coronary Restenosis|coronary restenosis
626335|NCT00916370|Long lesion|long lesion
626336|NCT00916357|recombinant human hyaluronidase PH20 (rHuPH20)|recombinant human hyaluronidase ph20 (rhuph20)
626337|NCT00916357|Insulin lispro|insulin lispro
626338|NCT00916357|Regular human insulin|regular human insulin
626339|NCT00916331|total knee replacement arthroplasty|total knee replacement arthroplasty
626340|NCT00916331|subcutaneous indwelling|subcutaneous indwelling
626341|NCT00916331|blood loss|blood loss
626342|NCT00916331|complications|complications
626343|NCT00916331|functional status|functional status
626344|NCT00916305|deafness noise tinnitus hearingloss|deafness noise tinnitus hearingloss
626345|NCT00916292|Diabetes|diabetes
626346|NCT00916292|dermal ulcers|dermal ulcers
626347|NCT00916279|Bare Metal In-Stent Restenosis|bare metal in-stent restenosis
626348|NCT00916279|Paclitaxel Coated Balloon Catheter|paclitaxel coated balloon catheter
626349|NCT00916279|Drug Coated Balloon|drug coated balloon
626350|NCT00916279|Coronary Artery Disease|coronary artery disease
626351|NCT00916266|Seizure frequency|seizure frequency
626352|NCT00916266|Hippocampal volume|hippocampal volume
626353|NCT00916266|Adverse effects|adverse effects
626354|NCT00916253|Sleep|sleep
626355|NCT00916253|real driving|real driving
626356|NCT00916253|simulated driving|simulated driving
626357|NCT00916253|MWT|mwt
626358|NCT00916240|Adolescents|adolescents
626359|NCT00916240|African American|african american
626360|NCT00916227|Low or Intermediate-1 Risk Myelodysplastic Syndrome|low or intermediate-1 risk myelodysplastic syndrome
626361|NCT00916201|schizophrenia|schizophrenia
626362|NCT00916188|Black Tea|black tea
626363|NCT00916188|Oxidative Stress|oxidative stress
626364|NCT00916188|Blood Lipids|blood lipids
626365|NCT00916188|Insulin Sensitivity|insulin sensitivity
626366|NCT00916175|hyperglycemia|hyperglycemia
626367|NCT00916175|overweight|overweight
626368|NCT00916175|functional food|functional food
626369|NCT00916175|aloe vera|aloe vera
626370|NCT00916175|cnidoscolus chayamansa|cnidoscolus chayamansa
626371|NCT00916162|aromatase inhibitor|aromatase inhibitor
626372|NCT00916149|Epilepsy|epilepsy
626373|NCT00916149|Cognition|cognition
626374|NCT00916149|Lamictal|lamictal
626375|NCT00916149|Lamotrigine|lamotrigine
626376|NCT00916149|Keppra|keppra
626377|NCT00916149|Levetiracetam|levetiracetam
626378|NCT00916136|Pre-operative Traction|pre-operative traction
626379|NCT00916136|Traction|traction
626380|NCT00916136|Proximal Femur Fracture|proximal femur fracture
626381|NCT00916136|Femoral Fractures|femoral fractures
626382|NCT00916136|Femoral Fracture|femoral fracture
626383|NCT00916136|Skeletal Traction|skeletal traction
626384|NCT00916136|Cutaneous Traction|cutaneous traction
626385|NCT00916123|castrate-resistant prostate cancer|castrate-resistant prostate cancer
626386|NCT00916123|CRPC|crpc
626387|NCT00916110|healthy subjects|healthy subjects
626388|NCT00916071|Bulimia Nervosa|bulimia nervosa
626389|NCT00916071|Eating Disorder NOS|eating disorder nos
626390|NCT00916071|Attention Deficit Hyperactivity Disorder|attention deficit hyperactivity disorder
626391|NCT00916071|ADHD|adhd
626392|NCT00916058|Multiple Myeloma|multiple myeloma
626393|NCT00916058|Autologous Stem Cell Transplant|autologous stem cell transplant
626394|NCT00916058|ASCT|asct
626395|NCT00916058|MM|mm
626396|NCT00916019|gene expression|gene expression
626397|NCT00916019|skeletal muscle|skeletal muscle
626398|NCT00916019|Healthy men|healthy men
626399|NCT00916006|Peplin|peplin
626400|NCT00916006|Actinic keratosis|actinic keratosis
626401|NCT00916006|PEP005|pep005
626402|NCT00915980|Meal-test|meal-test
626403|NCT00915980|reduced OGTT|reduced ogtt
626404|NCT00915980|gastric bypass surgery and glucose metabolism|gastric bypass surgery and glucose metabolism
626405|NCT00915980|Glucose metabolism before and after gastric bypass|glucose metabolism before and after gastric bypass
626406|NCT00915980|Different OGTT|different ogtt
626407|NCT00915980|New meal- test|new meal- test
626408|NCT00915967|Infection|infection
626409|NCT00915967|Vancomycin|vancomycin
626410|NCT00915967|Neurosurgery|neurosurgery
626411|NCT00915967|Stimulator|stimulator
626412|NCT00915967|Pump|pump
626413|NCT00915967|Deep Brain Stimulation|deep brain stimulation
626414|NCT00915967|Intrathecal Pump|intrathecal pump
626415|NCT00915954|Acromegaly|acromegaly
626416|NCT00915954|Type 2 diabetes mellitus|type 2 diabetes mellitus
626417|NCT00915954|recombinant human Insulin like growth factor 1 (IGF1)|recombinant human insulin like growth factor 1 (igf1)
626418|NCT00915954|oral glucose tolerance test|oral glucose tolerance test
626419|NCT00915915|Female contraception|female contraception
626420|NCT00915915|Ovulation inhibition|ovulation inhibition
626421|NCT00915889|psychosocial effects of cancer and its treatment|psychosocial effects of cancer and its treatment
626422|NCT00915889|stage IA cervical cancer|stage ia cervical cancer
626423|NCT00915889|stage IB cervical cancer|stage ib cervical cancer
626424|NCT00915889|stage IIA cervical cancer|stage iia cervical cancer
626425|NCT00915889|stage IIB cervical cancer|stage iib cervical cancer
626426|NCT00915889|stage III cervical cancer|stage iii cervical cancer
626427|NCT00915889|cancer survivor|cancer survivor
626428|NCT00915876|chronic kidney disease|chronic kidney disease
626429|NCT00915876|Vitamin D|vitamin d
626430|NCT00915863|pancreaticoduodenectomy|pancreaticoduodenectomy
626431|NCT00915863|pancreatic fistula|pancreatic fistula
626432|NCT00915863|reconstruction|reconstruction
626433|NCT00915863|isolated Roux-en-Y|isolated roux-en-y
626434|NCT00915837|DME|dme
626435|NCT00915824|Drug therapy|drug therapy
626436|NCT00915824|Prescribing|prescribing
626437|NCT00915824|Appropriateness|appropriateness
626438|NCT00915824|Randomized controlled trial|randomized controlled trial
626439|NCT00915824|STOPP/START criteria|stopp/start criteria
626440|NCT00915824|Appropriateness of prescribing in older patients|appropriateness of prescribing in older patients
626441|NCT00915824|Prescription Drugs|prescription drugs
626442|NCT00915811|Myelodysplastic Syndromes|myelodysplastic syndromes
626443|NCT00915811|Leukemia, Myeloid, Acute|leukemia, myeloid, acute
626444|NCT00915811|Haematopoietic stem cell transplantation|haematopoietic stem cell transplantation
626445|NCT00915811|Fludarabine|fludarabine
626446|NCT00915811|Busulphan|busulphan
626447|NCT00915811|Thymoglobuline|thymoglobuline
626448|NCT00915759|ProKera|prokera
626449|NCT00915759|Amniotic membrane|amniotic membrane
626450|NCT00915759|Photorefractive Keratectomy|photorefractive keratectomy
626451|NCT00915759|PRK|prk
626452|NCT00915759|time to re-epithelialization|time to re-epithelialization
626453|NCT00915746|Phase I|phase i
626454|NCT00915746|ketoconazole|ketoconazole
626455|NCT00915746|CYP3A4 inhibitor|cyp3a4 inhibitor
626456|NCT00915746|drug interaction|drug interaction
626457|NCT00915746|metabolism|metabolism
626458|NCT00915746|Healthly Volunteer|healthly volunteer
626459|NCT00915746|JNJ-31001074|jnj-31001074
626460|NCT00915733|acute myocardial infarction|acute myocardial infarction
626461|NCT00915733|inhibition of platelet aggregation|inhibition of platelet aggregation
626462|NCT00915733|triple antiplatelet therapy|triple antiplatelet therapy
626463|NCT00915733|high maintenance-dose clopidogrel.|high maintenance-dose clopidogrel.
626464|NCT00915733|CYP2C19 polymorphism|cyp2c19 polymorphism
626465|NCT00915733|High posttreatment platelet reactivity|high posttreatment platelet reactivity
626466|NCT00915733|Platelet Aggregation Inhibitors|platelet aggregation inhibitors
626467|NCT00915733|CYP2C19, human|cyp2c19, human
626468|NCT00915720|Atrial Fibrillation|atrial fibrillation
626469|NCT00915720|Surgical Ablation|surgical ablation
626470|NCT00915720|Implanted loop recorder|implanted loop recorder
626471|NCT00915720|Atrial Fibrillation Ablation|atrial fibrillation ablation
626472|NCT00915707|obesity|obesity
626473|NCT00915707|diabetes, risk|diabetes, risk
712397|NCT00580307|Turbinoplasty|turbinoplasty
626474|NCT00915707|obesity, diabetes risk related to sleep|obesity, diabetes risk related to sleep
626475|NCT00915694|adult giant cell glioblastoma|adult giant cell glioblastoma
626476|NCT00915694|adult gliosarcoma|adult gliosarcoma
626477|NCT00915694|adult glioblastoma|adult glioblastoma
626478|NCT00915681|amatoxin|amatoxin
626479|NCT00915681|amanita|amanita
626480|NCT00915681|mushroom poisoning|mushroom poisoning
626481|NCT00915681|hepatic failure|hepatic failure
626482|NCT00915681|milk thistle|milk thistle
626483|NCT00915681|Silibinin|silibinin
626484|NCT00915681|Legalon|legalon
626485|NCT00915668|Healthy women|healthy women
626486|NCT00915668|Non-childbearing potential|non-childbearing potential
626487|NCT00915668|Drug-drug interaction|drug-drug interaction
626488|NCT00915668|Oral contraceptive|oral contraceptive
626489|NCT00915668|OC|oc
626490|NCT00915668|Ovral-L|ovral-l
626491|NCT00915668|ethinyl estradiol|ethinyl estradiol
626492|NCT00915668|EE|ee
626493|NCT00915668|levonorgestrel|levonorgestrel
626494|NCT00915668|JNJ-31001074|jnj-31001074
626495|NCT00915655|HIV Infections|hiv infections
626496|NCT00915655|TMC114-TiDP29-C230|tmc114-tidp29-c230
626497|NCT00915655|TMC114-C230|tmc114-c230
626498|NCT00915655|TMC114|tmc114
626499|NCT00915655|HIV-1|hiv-1
626500|NCT00915655|Darunavir|darunavir
626501|NCT00915655|Ritonavir|ritonavir
626502|NCT00915655|NRTI|nrti
626503|NCT00915655|Treatment Naive|treatment naive
626504|NCT00915642|Obesity|obesity
626505|NCT00915642|Weight loss rate|weight loss rate
626506|NCT00915642|Sleep|sleep
626507|NCT00915642|Vigil|vigil
626508|NCT00915642|Metabolism|metabolism
626509|NCT00915642|Actigraphy|actigraphy
626510|NCT00915642|Normal|normal
626511|NCT00915603|Metastatic Breast Cancer|metastatic breast cancer
626512|NCT00915603|Paclitaxel|paclitaxel
626513|NCT00915603|Bevacizumab|bevacizumab
626514|NCT00915603|Everolimus|everolimus
626515|NCT00915577|Multiple Sclerosis|multiple sclerosis
626516|NCT00915577|interferon beta-1a|interferon beta-1a
626517|NCT00915577|Avonex|avonex
626518|NCT00915577|liquid Avonex|liquid avonex
626519|NCT00915564|Hepatitis C|hepatitis c
626520|NCT00915564|HCV|hcv
626521|NCT00915564|Hepatitis C Virus|hepatitis c virus
626522|NCT00915564|HCV negative|hcv negative
626523|NCT00915564|Protease inhibitor|protease inhibitor
626524|NCT00915564|Methadone|methadone
626525|NCT00915564|TMC435|tmc435
626526|NCT00915551|Peplin|peplin
626527|NCT00915551|Actinic keratosis|actinic keratosis
626528|NCT00915551|PEP005|pep005
626529|NCT00915538|Asthma|asthma
626530|NCT00915538|Formoterol|formoterol
626531|NCT00915538|LABA|laba
626532|NCT00915538|Symbicort|symbicort
626534|NCT00915512|Schizophrenia|schizophrenia
626535|NCT00915512|Paliperidone|paliperidone
626536|NCT00915512|Invega|invega
626537|NCT00915486|Diabetic|diabetic
626538|NCT00915486|ulcer|ulcer
626539|NCT00915486|topical|topical
626540|NCT00915486|PDGF|pdgf
626541|NCT00915486|GSoC|gsoc
626542|NCT00915460|Multiple Sclerosis|multiple sclerosis
626543|NCT00915460|Avonex|avonex
626544|NCT00915460|Interferon beta-1a|interferon beta-1a
626545|NCT00915460|patients at high risk to develop multiple sclerosis|patients at high risk to develop multiple sclerosis
626546|NCT00915447|Cat Allergic Rhinitis|cat allergic rhinitis
626547|NCT00915434|Healthy volunteer|healthy volunteer
626548|NCT00915434|Phase I|phase i
626549|NCT00915434|Non-childbearing potential|non-childbearing potential
626550|NCT00915434|JNJ-31001074|jnj-31001074
626551|NCT00915434|Food|food
626552|NCT00915434|Pharmacokinetics|pharmacokinetics
626553|NCT00915421|cardiac arrest|cardiac arrest
626554|NCT00915421|therapeutic hypothermia|therapeutic hypothermia
626555|NCT00915421|Postresuscitative disease|postresuscitative disease
626556|NCT00915408|Multiple Myeloma|multiple myeloma
626557|NCT00915408|Cyclophosphamide|cyclophosphamide
626558|NCT00915408|Dexamethasone|dexamethasone
626559|NCT00915408|Lenalidomide|lenalidomide
626560|NCT00915356|AZD1305|azd1305
626561|NCT00915356|intravenous cardioversion of Atrial Fibrillation|intravenous cardioversion of atrial fibrillation
626562|NCT00915343|Adrenal insufficiency|adrenal insufficiency
626563|NCT00915343|Primary adrenal insufficiency|primary adrenal insufficiency
626564|NCT00915343|Addison's disease|addison's disease
626565|NCT00915343|Hydrocortisone|hydrocortisone
626566|NCT00915343|Modified release|modified release
626567|NCT00915330|Transbronchial needle aspiration|transbronchial needle aspiration
626568|NCT00915330|Bronchoscopy|bronchoscopy
626569|NCT00915330|Rapid on-site cytopathologic evaluation|rapid on-site cytopathologic evaluation
626570|NCT00915330|Mediastinal lymphadenopathy|mediastinal lymphadenopathy
626571|NCT00915330|Hilar Lymphadenopathy|hilar lymphadenopathy
626572|NCT00915304|Clinical Decision Support System|clinical decision support system
626573|NCT00915304|Automatic reminder|automatic reminder
626574|NCT00915304|Primary care|primary care
626575|NCT00915304|Evidence-Based Medicine|evidence-based medicine
626576|NCT00915291|medical education|medical education
626577|NCT00915291|clinical decisionmaking|clinical decisionmaking
626578|NCT00915291|pharmaceutical marketing|pharmaceutical marketing
626579|NCT00915278|Neoplasms|neoplasms
626580|NCT00915278|monoclonal antibody|monoclonal antibody
626581|NCT00915278|PF-04605412|pf-04605412
626582|NCT00915278|advanced metastatic solid tumors|advanced metastatic solid tumors
626583|NCT00915265|Epidural analgesia|epidural analgesia
626584|NCT00915265|Continuous preperitoneal analgesia|continuous preperitoneal analgesia
626585|NCT00915265|Surgery|surgery
626586|NCT00915265|Open colorectal surgery|open colorectal surgery
626587|NCT00915265|Fast-track surgery|fast-track surgery
626588|NCT00915265|ERAS|eras
626589|NCT00915252|Acute Myeloid Leukemia|acute myeloid leukemia
626590|NCT00915252|azacitidine|azacitidine
626591|NCT00915252|elderly|elderly
626592|NCT00915252|demethylating agent|demethylating agent
626593|NCT00915252|flt3|flt3
626595|NCT00915239|volunteers|volunteers
626596|NCT00915226|Optic disk|optic disk
626597|NCT00915226|Regional blood flow|regional blood flow
626598|NCT00915226|Autoregulation|autoregulation
626599|NCT00915213|E. Coli|e. coli
626600|NCT00915213|Prostate Biopsy|prostate biopsy
626601|NCT00915200|Diabetic Nephropathies|diabetic nephropathies
626602|NCT00915200|Proteinuria|proteinuria
626603|NCT00915200|Renal Insufficiency, Chronic|renal insufficiency, chronic
626604|NCT00915200|Monocytes|monocytes
626605|NCT00915200|Oxidative stress|oxidative stress
626606|NCT00915200|Inflammation|inflammation
626607|NCT00915200|Antioxidants|antioxidants
626608|NCT00915200|Glutathione|glutathione
626609|NCT00915200|Silymarin|silymarin
626610|NCT00915200|Acetylcysteine|acetylcysteine
626611|NCT00915200|Dietary Supplements|dietary supplements
626612|NCT00915200|Complementary Therapies|complementary therapies
626613|NCT00915187|Vaccination, influenza prevention|vaccination, influenza prevention
626614|NCT00915174|drug-drug interaction study|drug-drug interaction study
626615|NCT00915161|ventilation|ventilation
626616|NCT00915161|oxygenation|oxygenation
626617|NCT00915148|Prolonged labor|prolonged labor
626618|NCT00915148|Ultrasound|ultrasound
626619|NCT00915148|Caeserian section|caeserian section
626620|NCT00915135|Insomnia|insomnia
626621|NCT00915135|Sleep Initiation and Maintenance Disorders|sleep initiation and maintenance disorders
626622|NCT00915135|Drug Therapy|drug therapy
626623|NCT00915122|IMRT treatment for Prostate cancer patients|imrt treatment for prostate cancer patients
626624|NCT00915122|Radiation treatment for prostate cancer|radiation treatment for prostate cancer
626625|NCT00915122|cancer of the prostate|cancer of the prostate
626626|NCT00915122|Patients with high risk adenocarcinoma of the prostate|patients with high risk adenocarcinoma of the prostate
626627|NCT00915109|amputees|amputees
626628|NCT00915109|lower limb|lower limb
626629|NCT00915096|Follicular Lymphoma|follicular lymphoma
626630|NCT00915096|PET|pet
626631|NCT00915096|GELA|gela
626633|NCT00915070|Optic Nerve Head Blood Flow|optic nerve head blood flow
626634|NCT00915070|Intraocular Pressure|intraocular pressure
626635|NCT00915070|Regional Blood Flow|regional blood flow
626636|NCT00915070|Ocular Physiology|ocular physiology
626637|NCT00915070|Optic Disk|optic disk
626638|NCT00915044|IBD|ibd
626639|NCT00915031|Robotic prostatectomy|robotic prostatectomy
626640|NCT00915031|Hypothermia|hypothermia
626641|NCT00915031|Potency|potency
626642|NCT00915018|ErbB-2 positive advanced breast cancer|erbb-2 positive advanced breast cancer
626643|NCT00915018|HKI-272|hki-272
626644|NCT00915018|Neratinib|neratinib
626645|NCT00915018|Nerlynx|nerlynx
626646|NCT00915018|HER2|her2
626647|NCT00915018|PB-272|pb-272
626648|NCT00915018|metastatic breast cancer|metastatic breast cancer
626649|NCT00915005|Locally-advanced non-small-cell lung carcinoma|locally-advanced non-small-cell lung carcinoma
626650|NCT00915005|NSCLC|nsclc
626651|NCT00915005|Lung Cancer|lung cancer
626652|NCT00915005|Image-Guided Adaptive Conformal Photon|image-guided adaptive conformal photon
626653|NCT00915005|Proton Therapy|proton therapy
626654|NCT00915005|Chemotherapy|chemotherapy
626655|NCT00915005|Treatment Related Pneumonitis|treatment related pneumonitis
626656|NCT00914992|optic disk|optic disk
626657|NCT00914992|regional blood flow|regional blood flow
626658|NCT00914992|autoregulation|autoregulation
626659|NCT00914979|Angiosculpt|angiosculpt
626660|NCT00914979|Bifurcation Lesion|bifurcation lesion
626661|NCT00914979|Side branch|side branch
626662|NCT00914979|IVUS|ivus
626663|NCT00914953|social isolation|social isolation
626664|NCT00914953|cooperative behavior|cooperative behavior
626665|NCT00914953|depression|depression
626666|NCT00914953|loneliness|loneliness
626667|NCT00914953|happiness|happiness
626668|NCT00914953|empathy|empathy
626669|NCT00914940|graft versus host disease|graft versus host disease
626670|NCT00914940|adult acute lymphoblastic leukemia in remission|adult acute lymphoblastic leukemia in remission
626671|NCT00914940|recurrent adult acute lymphoblastic leukemia|recurrent adult acute lymphoblastic leukemia
626672|NCT00914940|childhood acute lymphoblastic leukemia in remission|childhood acute lymphoblastic leukemia in remission
626673|NCT00914940|recurrent childhood acute lymphoblastic leukemia|recurrent childhood acute lymphoblastic leukemia
626674|NCT00914940|adult acute myeloid leukemia in remission|adult acute myeloid leukemia in remission
626675|NCT00914940|recurrent adult acute myeloid leukemia|recurrent adult acute myeloid leukemia
626676|NCT00914940|adult acute myeloid leukemia with 11q23 (MLL) abnormalities|adult acute myeloid leukemia with 11q23 (mll) abnormalities
626677|NCT00914940|adult acute myeloid leukemia with inv(16)(p13;q22)|adult acute myeloid leukemia with inv(16)(p13;q22)
626678|NCT00914940|adult acute myeloid leukemia with t(15;17)(q22;q12)|adult acute myeloid leukemia with t(15;17)(q22;q12)
626679|NCT00914940|adult acute myeloid leukemia with t(16;16)(p13;q22)|adult acute myeloid leukemia with t(16;16)(p13;q22)
626680|NCT00914940|adult acute myeloid leukemia with t(8;21)(q22;q22)|adult acute myeloid leukemia with t(8;21)(q22;q22)
626681|NCT00914940|childhood acute myeloid leukemia in remission|childhood acute myeloid leukemia in remission
626682|NCT00914940|recurrent childhood acute myeloid leukemia|recurrent childhood acute myeloid leukemia
626683|NCT00914940|childhood myelodysplastic syndromes|childhood myelodysplastic syndromes
626684|NCT00914940|previously treated myelodysplastic syndromes|previously treated myelodysplastic syndromes
626685|NCT00914940|refractory anemia with excess blasts|refractory anemia with excess blasts
626686|NCT00914940|de novo myelodysplastic syndromes|de novo myelodysplastic syndromes
626687|NCT00914940|secondary myelodysplastic syndromes|secondary myelodysplastic syndromes
626688|NCT00914927|Thrombocytopenia|thrombocytopenia
626689|NCT00914927|chronic liver disease|chronic liver disease
626691|NCT00914901|Doping|doping
626692|NCT00914901|Salmeterol|salmeterol
626693|NCT00914901|Beta-agonist|beta-agonist
626694|NCT00914901|Urine concentrations|urine concentrations
626695|NCT00914888|children|children
626696|NCT00914888|pediatry|pediatry
626697|NCT00914888|pneumonia|pneumonia
626698|NCT00914888|intra-abdominal|intra-abdominal
626699|NCT00914888|infection|infection
626700|NCT00914875|kidney function tests|kidney function tests
626701|NCT00914875|anti-inflammatory agents, non-steroidal|anti-inflammatory agents, non-steroidal
626702|NCT00914875|laparoscopic cholecystectomy|laparoscopic cholecystectomy
626703|NCT00914875|adult|adult
626704|NCT00914862|Sleep Initiation and Maintenance Disorders|sleep initiation and maintenance disorders
626705|NCT00914862|Drug Therapy|drug therapy
626706|NCT00914836|shoulder|shoulder
626707|NCT00914836|subacromion|subacromion
626708|NCT00914836|corticosteroid|corticosteroid
626709|NCT00914836|bursitis|bursitis
626710|NCT00914836|tendinitis|tendinitis
626711|NCT00914836|calcific tendonitis|calcific tendonitis
626712|NCT00914836|subacromial bursitis|subacromial bursitis
626713|NCT00914836|rotator cuff tendinitis|rotator cuff tendinitis
626714|NCT00914810|Chronic obstructive pulmonary disease|chronic obstructive pulmonary disease
626715|NCT00914810|Vitamin D|vitamin d
626716|NCT00914810|Cholecalciferol|cholecalciferol
626717|NCT00914810|Skeletal muscle|skeletal muscle
626718|NCT00914797|Asthma|asthma
626719|NCT00914797|Doping|doping
626720|NCT00914797|Beta agonist|beta agonist
626721|NCT00914797|Terbutaline|terbutaline
626722|NCT00914797|Pharmacokinetics|pharmacokinetics
626725|NCT00914784|dyspnea|dyspnea
626726|NCT00914784|pulmonary infiltrates|pulmonary infiltrates
626727|NCT00914771|Pandemic Influenza|pandemic influenza
626728|NCT00914771|H5N1|h5n1
626729|NCT00914771|Adults and Elderly|adults and elderly
626730|NCT00914771|antigen dose|antigen dose
626731|NCT00914758|multiple sclerosis|multiple sclerosis
626732|NCT00914758|cognition|cognition
626733|NCT00914758|cognitive functioning|cognitive functioning
626734|NCT00914758|Campath|campath
626735|NCT00914758|Rebif|rebif
626736|NCT00914758|alemtuzumab|alemtuzumab
626737|NCT00914758|interferon|interferon
626738|NCT00914732|IMVAMUNE®, smallpox, vaccine|imvamune®, smallpox, vaccine
626739|NCT00914719|sexual risk behavior among adolescents|sexual risk behavior among adolescents
626740|NCT00914719|alcohol and drug use among adolescents|alcohol and drug use among adolescents
626741|NCT00914706|Diabetes|diabetes
626742|NCT00914693|Fertility control|fertility control
626743|NCT00914693|Contraception|contraception
626744|NCT00914667|Overactive Bladder Urgency Frequency|overactive bladder urgency frequency
626745|NCT00914654|Asthma|asthma
626746|NCT00914654|Doping|doping
626747|NCT00914654|Formoterol|formoterol
626748|NCT00914654|Urinary concentrations|urinary concentrations
626749|NCT00914654|Beta-agonists|beta-agonists
626750|NCT00914641|formulation; sustained release; modified release; extended release|formulation; sustained release; modified release; extended release
626751|NCT00914628|high risk acute leukemia|high risk acute leukemia
626752|NCT00914628|HSV-TK|hsv-tk
626753|NCT00914628|Haploidentical HCT|haploidentical hct
626754|NCT00914628|GvHD|gvhd
626755|NCT00914628|GvL|gvl
626756|NCT00914628|Immunoreconstitution|immunoreconstitution
626757|NCT00914615|Stereotactic Body Radiation Therapy|stereotactic body radiation therapy
626758|NCT00914615|Liver Metastasis from colorectal cancer|liver metastasis from colorectal cancer
626759|NCT00914615|Patients with Liver Metastasis|patients with liver metastasis
626760|NCT00914576|Endotoxin, Escherichia Coli|endotoxin, escherichia coli
626761|NCT00914576|Retina|retina
626762|NCT00914576|Regional Blood Flow|regional blood flow
626763|NCT00914563|Burned shock|burned shock
626764|NCT00914563|Volume resuscitative patterns|volume resuscitative patterns
712398|NCT00580307|Contact point|contact point
626765|NCT00914563|Non-invasive hemodynamic monitoring|non-invasive hemodynamic monitoring
626766|NCT00914550|Pneumonia|pneumonia
626767|NCT00914550|Lung Infiltrates|lung infiltrates
626768|NCT00914550|Antibiotic discontinuation|antibiotic discontinuation
626769|NCT00914550|De-escalation therapy|de-escalation therapy
626770|NCT00914537|Anal Cancer|anal cancer
626771|NCT00914537|AIN|ain
626772|NCT00914537|HPV|hpv
626773|NCT00914537|Cytology|cytology
626774|NCT00914537|HIV|hiv
626775|NCT00914537|HIV Positive|hiv positive
626776|NCT00914524|Chronic Glomerulonephritis|chronic glomerulonephritis
626777|NCT00914524|Diabetic Nephropathy|diabetic nephropathy
626778|NCT00914524|Angiotensin II Receptor Blocker|angiotensin ii receptor blocker
626779|NCT00914524|Urinary Protein|urinary protein
626780|NCT00914511|Semen|semen
626781|NCT00914511|Sperm|sperm
626782|NCT00914511|Avanafil|avanafil
626783|NCT00914511|Pharmacokinetics|pharmacokinetics
626784|NCT00914511|Elderly|elderly
626785|NCT00914498|Xylocaine|xylocaine
626786|NCT00914498|Casarean section|casarean section
626787|NCT00914498|Post operative pain|post operative pain
626788|NCT00914498|Scar quality|scar quality
626789|NCT00914472|Preventing the thrombi formation|preventing the thrombi formation
626790|NCT00914459|hemophilia A|hemophilia a
626791|NCT00914446|Steatohepatitis|steatohepatitis
626792|NCT00914433|COPD|copd
626793|NCT00914420|OCT|oct
626794|NCT00914420|Reendothelialisation|reendothelialisation
626795|NCT00914420|Intrepide|intrepide
626796|NCT00914420|Trapidil|trapidil
626797|NCT00914420|Taxus|taxus
626798|NCT00914407|Ocular physiology|ocular physiology
626799|NCT00914394|L-NG-Monomethyl Arginine|l-ng-monomethyl arginine
626800|NCT00914394|Optic Nerve Head Blood Flow|optic nerve head blood flow
626801|NCT00914394|Intraocular Pressure|intraocular pressure
626802|NCT00914394|Regional Blood Flow|regional blood flow
626803|NCT00914394|Ocular Physiology|ocular physiology
626804|NCT00914394|Optic Disk|optic disk
626805|NCT00914381|Community reinforcement approach|community reinforcement approach
626806|NCT00914381|Contingency management|contingency management
626807|NCT00914381|12-step facilitation counseling|12-step facilitation counseling
626808|NCT00914381|Cocaine dependence|cocaine dependence
626809|NCT00914381|Women|women
626810|NCT00914368|Platelet Aggregation Inhibitors|platelet aggregation inhibitors
626811|NCT00914368|Aspirin|aspirin
626812|NCT00914368|Clopidogrel|clopidogrel
626813|NCT00914368|Pathologic Processes|pathologic processes
626814|NCT00914368|Disease|disease
626815|NCT00914368|Therapeutic Uses|therapeutic uses
626816|NCT00914368|Syndrome|syndrome
626817|NCT00914368|Hematologic Agents|hematologic agents
626818|NCT00914368|Cardiovascular Diseases|cardiovascular diseases
626819|NCT00914368|Pharmacologic Actions|pharmacologic actions
626820|NCT00914355|Hepatocellular Carcinoma|hepatocellular carcinoma
626821|NCT00914355|Stereotactic Body Radiation|stereotactic body radiation
626822|NCT00914355|Unresectable liver cancer|unresectable liver cancer
626823|NCT00914355|Patients with Hepatocellular Carcinoma|patients with hepatocellular carcinoma
626824|NCT00914342|Gerd|gerd
626825|NCT00914342|GerdQ questionnaire|gerdq questionnaire
626826|NCT00914342|work productivity|work productivity
626827|NCT00914342|Greece|greece
626828|NCT00914329|stress provoked|stress provoked
626829|NCT00914329|healthy volunteers|healthy volunteers
626830|NCT00914329|gelsemium|gelsemium
626831|NCT00914329|homeopathy|homeopathy
626832|NCT00914316|Lower leg claudication|lower leg claudication
626833|NCT00914316|Poor circulation of the leg muscles|poor circulation of the leg muscles
626834|NCT00914316|Cramping or discomfort in the lower legs|cramping or discomfort in the lower legs
626835|NCT00914316|Lower leg pain|lower leg pain
626836|NCT00914316|PAD (Peripheral arterial disease)|pad (peripheral arterial disease)
626837|NCT00914303|Safety|safety
626838|NCT00914303|tolerability|tolerability
626839|NCT00914303|healthy|healthy
626840|NCT00914303|Healthy volunteer study|healthy volunteer study
626841|NCT00914277|Rho-kinase inhibitor|rho-kinase inhibitor
626842|NCT00914277|male impotence|male impotence
626843|NCT00914264|chronic obstructive airway disease|chronic obstructive airway disease
626844|NCT00914264|obstructive sleep apnea|obstructive sleep apnea
626845|NCT00914264|continuous positive airway pressure|continuous positive airway pressure
626846|NCT00914251|endothelial|endothelial
626847|NCT00914251|metabolic syndrome|metabolic syndrome
626848|NCT00914251|hesperidin|hesperidin
626849|NCT00914238|Randomized clinical trial|randomized clinical trial
626850|NCT00914238|first episode psychosis of schizophrenia and schizotypal disorder|first episode psychosis of schizophrenia and schizotypal disorder
626851|NCT00914238|rehabilitation|rehabilitation
626852|NCT00914238|psychosocial|psychosocial
626853|NCT00914238|health service research|health service research
626854|NCT00914238|schizotypal Disorder|schizotypal disorder
626855|NCT00914225|Human immunodeficiency virus|human immunodeficiency virus
626856|NCT00914225|malaria|malaria
626857|NCT00914225|plasmodium falciparum|plasmodium falciparum
626858|NCT00914225|diarrhea|diarrhea
626859|NCT00914225|helminth|helminth
626860|NCT00914225|HIV|hiv
626861|NCT00914225|Treatment naive|treatment naive
626862|NCT00914199|PCI|pci
626863|NCT00914199|Bifurcation lesion|bifurcation lesion
626864|NCT00914186|Atopic Dermatitis|atopic dermatitis
626865|NCT00914186|Pruritus|pruritus
626866|NCT00914160|Anti-inflammatory|anti-inflammatory
626867|NCT00914147|unspecified adult solid tumor, protocol specific|unspecified adult solid tumor, protocol specific
626868|NCT00914134|Parkinson's disease|parkinson's disease
626869|NCT00914134|Autonomic nervous system|autonomic nervous system
626870|NCT00914134|Levodopa infusion|levodopa infusion
626871|NCT00914108|Preterm Infants|preterm infants
626872|NCT00914108|Developmental Care|developmental care
626873|NCT00914108|NIDCAP|nidcap
626874|NCT00914108|Intrauterine Growth Restriction|intrauterine growth restriction
626875|NCT00914108|APIB|apib
626876|NCT00914108|EEG|eeg
626877|NCT00914108|Neurobehavior|neurobehavior
626878|NCT00914095|Parkinson's disease|parkinson's disease
626879|NCT00914095|Freezing of Gait|freezing of gait
626880|NCT00914095|Methylphenidate|methylphenidate
626881|NCT00914095|Dopamine transporter inhibitor|dopamine transporter inhibitor
626882|NCT00914095|Noradrenaline|noradrenaline
626883|NCT00914082|Self hypnosis|self hypnosis
626884|NCT00914082|Hypnosis|hypnosis
626885|NCT00914082|mental training|mental training
626886|NCT00914082|antenatal training|antenatal training
626887|NCT00914082|pregnancy|pregnancy
626888|NCT00914082|pain control|pain control
626889|NCT00914082|Childbirth|childbirth
626890|NCT00914082|Analgesia|analgesia
626891|NCT00914043|fatigue|fatigue
626892|NCT00914043|HER2-negative breast cancer|her2-negative breast cancer
626893|NCT00914043|stage II breast cancer|stage ii breast cancer
626894|NCT00914043|stage IIIA breast cancer|stage iiia breast cancer
626895|NCT00914043|stage IIIB breast cancer|stage iiib breast cancer
626896|NCT00914030|Visual perception|visual perception
626897|NCT00914030|Local/global processing|local/global processing
626898|NCT00914030|Attention|attention
626899|NCT00914030|Visual priming|visual priming
626900|NCT00914030|Collinearity|collinearity
626901|NCT00914030|Grouping|grouping
626902|NCT00914017|Breast Cancer|breast cancer
626903|NCT00914017|Breast Cancer Prevention|breast cancer prevention
626904|NCT00914017|Mammographic Density|mammographic density
626905|NCT00914017|Breast Density|breast density
626906|NCT00914017|Breast Cancer Biomarkers|breast cancer biomarkers
626907|NCT00914004|Antidepressant|antidepressant
626908|NCT00913991|Nitric Oxide|nitric oxide
626909|NCT00913978|Normothermia|normothermia
626910|NCT00913978|Colorectal Surgery|colorectal surgery
626911|NCT00913978|Bair Huggers|bair huggers
626912|NCT00913978|VitaHeat|vitaheat
626913|NCT00913952|Antidepressant|antidepressant
626914|NCT00913939|Prostate Cancer|prostate cancer
626915|NCT00913939|HDR Brachytherapy|hdr brachytherapy
626916|NCT00913939|Prostate Brachytherapy|prostate brachytherapy
626917|NCT00913926|Climacteric symptoms|climacteric symptoms
626918|NCT00913913|Renal Cell Carcinoma|renal cell carcinoma
626919|NCT00913900|Arterial Occlusive Diseases|arterial occlusive diseases
626920|NCT00913900|Vascular Disease|vascular disease
626921|NCT00913887|Anti-Inflammatory|anti-inflammatory
626922|NCT00913861|endoscopy|endoscopy
626924|NCT00913861|non-pharmacological|non-pharmacological
626925|NCT00913848|Treatment of Epilepsy and Bipolar Disorder|treatment of epilepsy and bipolar disorder
626926|NCT00913835|Liposomal Doxorubicin|liposomal doxorubicin
626927|NCT00913835|IMC-3G3|imc-3g3
626928|NCT00913835|3G3|3g3
626929|NCT00913835|Platinum resistant|platinum resistant
626930|NCT00913835|Platinum refractory|platinum refractory
626931|NCT00913835|Ovary|ovary
626932|NCT00913835|Neoplasm|neoplasm
626933|NCT00913835|PDGFr|pdgfr
626934|NCT00913822|Antidepressant|antidepressant
626935|NCT00913809|Antidepressant|antidepressant
626936|NCT00913796|Renal transplantation|renal transplantation
626937|NCT00913796|Metabolic acidosis|metabolic acidosis
626938|NCT00913796|Physical capacity|physical capacity
626939|NCT00913796|Bone histology|bone histology
626940|NCT00913796|Bone histomorphometry|bone histomorphometry
626941|NCT00913796|Parathyroid function|parathyroid function
626942|NCT00913796|Calcium and phosphate metabolism|calcium and phosphate metabolism
626943|NCT00913783|Antidepressant|antidepressant
626944|NCT00913770|opioid dependence|opioid dependence
626945|NCT00913770|buprenorphine|buprenorphine
626946|NCT00913770|brief intervention|brief intervention
626947|NCT00913757|Hepatocellular Carcinoma|hepatocellular carcinoma
626948|NCT00913757|Liver Cancer|liver cancer
626949|NCT00913757|Chronic Liver Disease|chronic liver disease
626950|NCT00913757|Genome Wide Association Study|genome wide association study
626951|NCT00913757|Gene Expression Profiling|gene expression profiling
626952|NCT00913744|AMD|amd
626953|NCT00913731|Psychotic symptom assessments|psychotic symptom assessments
626954|NCT00913731|Observational assessments of patients with acute psychotic symptoms|observational assessments of patients with acute psychotic symptoms
626955|NCT00913705|NATCH|natch
626956|NCT00913705|LUNG|lung
626957|NCT00913705|OPERABLE NSCLC|operable nsclc
626958|NCT00913705|SURGERY PLUS ADJUVANT THERAPY|surgery plus adjuvant therapy
712399|NCT00580307|HIT-6|hit-6
626959|NCT00913705|SURGERY PLUS NEOADJUVANT THERAPY|surgery plus neoadjuvant therapy
626960|NCT00913692|Glutamine|glutamine
626961|NCT00913692|Herpes Labialis|herpes labialis
626962|NCT00913692|Herpes Simplex Virus|herpes simplex virus
626963|NCT00913692|Cold Sore|cold sore
626964|NCT00913679|osteonecrosis|osteonecrosis
626965|NCT00913679|femoral neck fracture|femoral neck fracture
626966|NCT00913679|implant fixation|implant fixation
626967|NCT00913679|implant failure|implant failure
626968|NCT00913679|periprosthetic bone mineral density|periprosthetic bone mineral density
626969|NCT00913679|gait function|gait function
626970|NCT00913679|gait analysis|gait analysis
626971|NCT00913679|patient recovery|patient recovery
626972|NCT00913666|Multiple Sclerosis|multiple sclerosis
626973|NCT00913653|Heart failure|heart failure
626974|NCT00913653|LCZ696|lcz696
626975|NCT00913640|Prospective Memory Performance|prospective memory performance
626976|NCT00913640|Prospective Memory Outcome|prospective memory outcome
626977|NCT00913640|Parkinson's Disease|parkinson's disease
626978|NCT00913627|Extended-release|extended-release
626979|NCT00913627|ibuprofen|ibuprofen
626980|NCT00913614|insomnia pediatric safety|insomnia pediatric safety
626981|NCT00913601|Idiopathic Fecal Incontinence|idiopathic fecal incontinence
626982|NCT00913601|Fecal Incontinence|fecal incontinence
626983|NCT00913601|Sacral Nerve Stimulation|sacral nerve stimulation
626984|NCT00913601|Sacral Nerve Neuromodulation|sacral nerve neuromodulation
626985|NCT00913575|neuromuscular training|neuromuscular training
626986|NCT00913575|preoperative exercise|preoperative exercise
626987|NCT00913575|physiotherapy|physiotherapy
626988|NCT00913575|total knee replacement|total knee replacement
626989|NCT00913575|knee osteoarthritis|knee osteoarthritis
626990|NCT00913562|Ocular Physiology|ocular physiology
626991|NCT00913562|Regional Blood Flow|regional blood flow
626992|NCT00913549|Antihistamine|antihistamine
626993|NCT00913536|Bladder Cancer|bladder cancer
626994|NCT00913536|Cone Beam CT|cone beam ct
626995|NCT00913536|On-line image guidance|on-line image guidance
626996|NCT00913536|Radiation therapy in bladder cancer patients|radiation therapy in bladder cancer patients
626997|NCT00913523|tampons|tampons
626998|NCT00913523|Glycerol Monolaurate|glycerol monolaurate
626999|NCT00913523|vaginal microflora|vaginal microflora
627000|NCT00913523|microbes|microbes
627001|NCT00913523|Vaginal Tampon|vaginal tampon
627002|NCT00913497|Type 1 diabetes mellitus in children|type 1 diabetes mellitus in children
627003|NCT00913497|insulin glulisine|insulin glulisine
627004|NCT00913497|insulin aspart|insulin aspart
627005|NCT00913497|post prandial|post prandial
627006|NCT00913484|Disulfiram|disulfiram
627007|NCT00913484|Buprenorphine|buprenorphine
627008|NCT00913484|Cocaine dependence|cocaine dependence
627009|NCT00913484|Opioid dependence|opioid dependence
627010|NCT00913484|Dopamine-Beta-Hydroxylase|dopamine-beta-hydroxylase
627011|NCT00913471|Spinal cord injury|spinal cord injury
627012|NCT00913471|SCI|sci
627013|NCT00913471|Neuropathic pain|neuropathic pain
627014|NCT00913471|Pain|pain
627015|NCT00913445|Appendicitis|appendicitis
627016|NCT00913445|appendicectomy|appendicectomy
627017|NCT00913445|stitches|stitches
627018|NCT00913445|wound healing|wound healing
627019|NCT00913445|cosmetic results|cosmetic results
627020|NCT00913432|rheumatoid arthritis|rheumatoid arthritis
627021|NCT00913432|methotrexate|methotrexate
627022|NCT00913432|DMARD|dmard
627023|NCT00913432|c-kit inhibitor|c-kit inhibitor
627024|NCT00913419|Antidepressant|antidepressant
627025|NCT00913406|Effect of lutein fortification growth healthy term infants|effect of lutein fortification growth healthy term infants
627026|NCT00913367|Type 2 Diabetes Mellitus|type 2 diabetes mellitus
627027|NCT00913354|infertility|infertility
627028|NCT00913354|ivf|ivf
627029|NCT00913354|acupuncture|acupuncture
627030|NCT00913328|Asthma|asthma
627031|NCT00913328|Airway responsiveness|airway responsiveness
627032|NCT00913328|Dose-response plateau|dose-response plateau
627033|NCT00913328|Montelukast|montelukast
627034|NCT00913328|Add-on to inhaled corticosteroids|add-on to inhaled corticosteroids
627035|NCT00913315|prostatitis|prostatitis
627036|NCT00913315|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists
627037|NCT00913315|tolterodine|tolterodine
627038|NCT00913302|Ankylosing Spondylitis|ankylosing spondylitis
627039|NCT00913302|Education|education
627040|NCT00913302|Physical fitness|physical fitness
627041|NCT00913289|Liver Cirrhosis|liver cirrhosis
627042|NCT00913263|Prostate cancer|prostate cancer
627043|NCT00913250|Multiple Sclerosis|multiple sclerosis
627044|NCT00913250|Interferon beta-1a|interferon beta-1a
627045|NCT00913237|Antidepressant|antidepressant
627046|NCT00913224|Anti-inflammatory|anti-inflammatory
627047|NCT00913198|Pancreas|pancreas
627048|NCT00913198|Advanced adenocarcinoma|advanced adenocarcinoma
627049|NCT00913198|CP-4126|cp-4126
627050|NCT00913185|Acne|acne
627051|NCT00913172|TB|tb
627052|NCT00913172|cost|cost
627053|NCT00913172|HEWs|hews
627054|NCT00913172|Cost-effectiveness|cost-effectiveness
627055|NCT00913172|treatment success rate|treatment success rate
627056|NCT00913159|Renal stones|renal stones
627057|NCT00913159|lithotripsy|lithotripsy
627058|NCT00913159|stone free rate|stone free rate
627059|NCT00913146|Management of fever|management of fever
627060|NCT00913146|Malaria|malaria
627061|NCT00913146|Malaria rapid diagnostic test|malaria rapid diagnostic test
627062|NCT00913146|Clinical trial|clinical trial
627063|NCT00913133|Anticoagulation|anticoagulation
627064|NCT00913133|Prophylaxis|prophylaxis
627065|NCT00913133|Desirudin|desirudin
627066|NCT00913133|Direct thrombin inhibitor|direct thrombin inhibitor
627067|NCT00913133|Heparin-induced thrombocytopenia|heparin-induced thrombocytopenia
627068|NCT00913120|YM150|ym150
627069|NCT00913120|FXa inhibitor|fxa inhibitor
627070|NCT00913120|Thrombosis|thrombosis
627071|NCT00913120|Anticoagulant|anticoagulant
627072|NCT00913120|Venous thromboembolism|venous thromboembolism
627073|NCT00913120|Arthroplasty, replacement, hip|arthroplasty, replacement, hip
627074|NCT00913107|Trigeminal Neuralgia|trigeminal neuralgia
627075|NCT00913107|Lamotrigine|lamotrigine
627076|NCT00913107|Carbamazepine|carbamazepine
627077|NCT00913107|Lamictal®|lamictal®
627078|NCT00913107|Tegretol®|tegretol®
627079|NCT00913094|Hypertension|hypertension
627080|NCT00913081|Skin|skin
627081|NCT00913081|pharmacology|pharmacology
627082|NCT00913081|metabolism|metabolism
627083|NCT00913081|lipid|lipid
627084|NCT00913068|radical prostatectomy|radical prostatectomy
627085|NCT00913055|S-LAR|s-lar
627086|NCT00913055|Octreotide|octreotide
627087|NCT00913055|Implant|implant
627088|NCT00913042|Febrile neutropenia|febrile neutropenia
627089|NCT00913042|Blood culture|blood culture
627090|NCT00913042|Bacteremia|bacteremia
627091|NCT00913042|Bacterial DNA testing|bacterial dna testing
627092|NCT00913029|primary open angle glaucoma (POAG)|primary open angle glaucoma (poag)
627093|NCT00913029|OAG|oag
627094|NCT00913029|glaucoma|glaucoma
627095|NCT00913016|hormonal therapy(letrozole)|hormonal therapy(letrozole)
627096|NCT00913016|postmenopausal breast cancer|postmenopausal breast cancer
627097|NCT00913016|quality of life|quality of life
627098|NCT00913003|Lidocaine|lidocaine
627099|NCT00913003|Mastectomy|mastectomy
627100|NCT00913003|Pain|pain
627101|NCT00912990|Pediatric|pediatric
627102|NCT00912977|Parkinsons disease|parkinsons disease
627103|NCT00912977|dyskinesia|dyskinesia
627104|NCT00912977|measurement|measurement
627105|NCT00912964|Urgency|urgency
627106|NCT00912964|YM178|ym178
627107|NCT00912964|Urinary incontinence|urinary incontinence
627108|NCT00912964|Mirabegron|mirabegron
627109|NCT00912964|Micturition|micturition
627110|NCT00912964|Frequency|frequency
627111|NCT00912964|Urinary urgency incontinence|urinary urgency incontinence
627112|NCT00912964|Overactive Bladder|overactive bladder
627113|NCT00912938|metastatic breast cancer|metastatic breast cancer
627114|NCT00912938|bone remodeling markers|bone remodeling markers
627115|NCT00912938|zoledronic acid|zoledronic acid
627116|NCT00912912|Genitourinary|genitourinary
627117|NCT00912912|Testis|testis
627118|NCT00912912|Refractory Germ Cell Tumors|refractory germ cell tumors
627119|NCT00912912|Advanced germ cell tumors|advanced germ cell tumors
627120|NCT00912912|GCTs|gcts
627121|NCT00912912|Sunitinib Malate|sunitinib malate
627122|NCT00912912|Sutent|sutent
627123|NCT00912912|SU011248|su011248
627124|NCT00912899|Refractory Multiple Myeloma|refractory multiple myeloma
627125|NCT00912899|CB3304|cb3304
627126|NCT00912899|Noscapine HCl|noscapine hcl
627127|NCT00912899|Multiple Myeloma|multiple myeloma
627128|NCT00912886|alzheimer|alzheimer
627129|NCT00912886|memory|memory
627130|NCT00912886|neurosteroids|neurosteroids
627131|NCT00912873|pain|pain
627132|NCT00912873|catheter|catheter
627133|NCT00912873|nerve block|nerve block
627134|NCT00912873|UCSD|ucsd
627135|NCT00912873|range of motion|range of motion
627136|NCT00912873|hip surgery|hip surgery
627137|NCT00912873|psoas compartment|psoas compartment
627138|NCT00912860|multiple sclerosis|multiple sclerosis
627139|NCT00912860|interferon beta-1a|interferon beta-1a
627140|NCT00912860|avonex|avonex
627141|NCT00912847|HBV carriers|hbv carriers
627142|NCT00912834|hematuria|hematuria
627143|NCT00912834|urinary tract infection|urinary tract infection
627144|NCT00912821|Renal Replacement Therapy|renal replacement therapy
627145|NCT00912821|Peritoneal dialysis|peritoneal dialysis
627146|NCT00912808|parkinsons disease|parkinsons disease
627147|NCT00912808|falling|falling
627148|NCT00912795|Smoking Cessation|smoking cessation
627149|NCT00912795|technology|technology
627150|NCT00912795|developing countries|developing countries
627151|NCT00912782|ESRD|esrd
627152|NCT00912782|Vitamin D|vitamin d
627153|NCT00912782|Arteriovenous Fistulae|arteriovenous fistulae
627154|NCT00912782|Dialysis Vascular Access|dialysis vascular access
627155|NCT00912769|Total knee replacement|total knee replacement
627156|NCT00912769|Subvastus|subvastus
627157|NCT00912769|Midvastus|midvastus
627158|NCT00912769|Isokinetic|isokinetic
627159|NCT00912769|Quadriceps|quadriceps
627160|NCT00912756|endovascular therapy|endovascular therapy
627161|NCT00912756|restenosis|restenosis
627162|NCT00912756|cilostazol|cilostazol
627163|NCT00912756|femoropopliteal artery lesions|femoropopliteal artery lesions
627164|NCT00912756|Chronic arteriosclerosis obliterans afflicting the femoropopliteal artery area|chronic arteriosclerosis obliterans afflicting the femoropopliteal artery area
627165|NCT00912743|Colorectal cancer|colorectal cancer
627166|NCT00912743|Olaparib|olaparib
627167|NCT00912743|MSI status|msi status
627168|NCT00912743|Stage IV|stage iv
627169|NCT00912743|Measurable Colorectal Cancer|measurable colorectal cancer
627170|NCT00912743|Stratified by MSI Status|stratified by msi status
627171|NCT00912730|melanoma|melanoma
627172|NCT00912730|imaging|imaging
627173|NCT00912730|sentinel node|sentinel node
627174|NCT00912730|biopsy|biopsy
627175|NCT00912704|Hemodialysis patients|hemodialysis patients
627176|NCT00912704|Kidney|kidney
627177|NCT00912704|Physician attitudes|physician attitudes
627178|NCT00912704|Family wishes|family wishes
627179|NCT00912704|30 numbers require maximum|30 numbers require maximum
627180|NCT00912691|Autism|autism
627181|NCT00912678|Kidney transplantation|kidney transplantation
627182|NCT00912678|Old for old kidney transplantation|old for old kidney transplantation
627183|NCT00912678|European senior program|european senior program
627184|NCT00912678|Calcineurin inhibitor free immunosuppression|calcineurin inhibitor free immunosuppression
627185|NCT00912665|Optic Nerve Head Blood Flow|optic nerve head blood flow
627186|NCT00912665|Intraocular Pressure|intraocular pressure
627187|NCT00912665|Regional Blood Flow|regional blood flow
627188|NCT00912665|Ocular Physiology|ocular physiology
627189|NCT00912665|Optic Disk|optic disk
627190|NCT00912652|obesity|obesity
627191|NCT00912652|rural health|rural health
627192|NCT00912652|exercise|exercise
627193|NCT00912639|recurrent breast cancer|recurrent breast cancer
627194|NCT00912639|Genexol-PM|genexol-pm
627195|NCT00912626|siblings|siblings
627196|NCT00912626|family|family
627197|NCT00912626|child behavior|child behavior
627198|NCT00912626|critical illness|critical illness
627199|NCT00912626|social support|social support
627200|NCT00912613|Critical illness|critical illness
627201|NCT00912613|ICU Diaries|icu diaries
627202|NCT00912613|Post Traumatic Stress Disorder|post traumatic stress disorder
627203|NCT00912613|Incidence|incidence
627204|NCT00912600|Intensive Care Units|intensive care units
627205|NCT00912600|Triage|triage
627206|NCT00912600|Aged, 80 and over|aged, 80 and over
627207|NCT00912600|Death|death
627208|NCT00912600|Activities of Daily Living|activities of daily living
627209|NCT00912600|Health Services Research|health services research
627210|NCT00912600|Health Care Quality, Access, and Evaluation|health care quality, access, and evaluation
627211|NCT00912574|Melanoma|melanoma
627212|NCT00912574|adjuvant|adjuvant
627213|NCT00912574|dendritic cells|dendritic cells
627214|NCT00912574|vaccine|vaccine
627215|NCT00912561|chronic brain ischaemia|chronic brain ischaemia
627216|NCT00912561|stroke prevention|stroke prevention
627217|NCT00912561|exercise|exercise
627218|NCT00912561|physical training|physical training
627219|NCT00912561|Chronic, extra- or intracranial stenoses of brain supplying arteries|chronic, extra- or intracranial stenoses of brain supplying arteries
627220|NCT00912548|premenopause|premenopause
627221|NCT00912548|ovarian function suppression|ovarian function suppression
627222|NCT00912548|tamoxifen|tamoxifen
627223|NCT00912535|Primary Anxiety Disorders|primary anxiety disorders
627224|NCT00912535|Mood Disorders with Comorbid Anxiety Symptoms|mood disorders with comorbid anxiety symptoms
627226|NCT00912522|TMS|tms
627227|NCT00912522|cognition|cognition
627228|NCT00912522|Motivation|motivation
627229|NCT00912522|Perception|perception
627230|NCT00912522|Decision making|decision making
627231|NCT00912509|infectious keratitis|infectious keratitis
627232|NCT00912509|cross linking|cross linking
627233|NCT00912509|corneal ulcer|corneal ulcer
627234|NCT00912509|corneal infection|corneal infection
627235|NCT00912509|collagen cross linking|collagen cross linking
627236|NCT00912496|Influenza, H5N1, vaccine, avian influenza|influenza, h5n1, vaccine, avian influenza
627237|NCT00912483|VTE|vte
627238|NCT00912470|genetic vascular risc factors|genetic vascular risc factors
627239|NCT00912470|ocular blood flow|ocular blood flow
627240|NCT00912470|progressive glaucoma|progressive glaucoma
627241|NCT00912457|sleep apnea|sleep apnea
627242|NCT00912457|donepezil|donepezil
627243|NCT00912457|pharmacological|pharmacological
627244|NCT00912457|cholinergic|cholinergic
627245|NCT00912444|Breast Neoplasms|breast neoplasms
627246|NCT00912444|Neoadjuvant|neoadjuvant
627247|NCT00912444|Chemotherapy|chemotherapy
627248|NCT00912444|Docetaxel|docetaxel
627249|NCT00912444|Cyclophosphamide|cyclophosphamide
627250|NCT00912444|Anthracycline|anthracycline
627251|NCT00912431|Healthy Volunteers|healthy volunteers
627252|NCT00912418|melanoma|melanoma
627253|NCT00912418|vaccine|vaccine
627254|NCT00912418|IL2 low dose|il2 low dose
627255|NCT00912405|Patients diagnosed with Chronic Sinusitis undergoing functional endoscopic surgery (FESS)|patients diagnosed with chronic sinusitis undergoing functional endoscopic surgery (fess)
627256|NCT00912366|VATS|vats
627257|NCT00912366|Lung cancer|lung cancer
627258|NCT00912366|NSCLC|nsclc
627259|NCT00912353|Phase I|phase i
627260|NCT00912353|Japanese healthy volunteer|japanese healthy volunteer
627261|NCT00912353|AZD7268|azd7268
627262|NCT00912340|Breast Cancer|breast cancer
627263|NCT00912327|Colorectal|colorectal
627264|NCT00912327|KRAS mutation|kras mutation
627265|NCT00912327|Stage IV|stage iv
627266|NCT00912327|Imprime PGG|imprime pgg
627267|NCT00912327|Cetuximab|cetuximab
627268|NCT00912327|Immunotherapy|immunotherapy
627269|NCT00912314|OAB|oab
627270|NCT00912314|overactive bladder|overactive bladder
627271|NCT00912314|ptns|ptns
627272|NCT00912314|posterior tibial nerve stimulation|posterior tibial nerve stimulation
627273|NCT00912314|percutaneous tibial nerve stimulation|percutaneous tibial nerve stimulation
627274|NCT00912301|chenodeoxycholate, IBS, transit, colon, constipation|chenodeoxycholate, ibs, transit, colon, constipation
627275|NCT00912288|Alzheimer disease moderate-to-severe memantine safety and efficacy|alzheimer disease moderate-to-severe memantine safety and efficacy
627276|NCT00912262|Analgesics|analgesics
627277|NCT00912262|Capsaicin|capsaicin
627278|NCT00912249|Horticulture Therapy|horticulture therapy
627279|NCT00912249|Psychiatric Rehabilitation|psychiatric rehabilitation
627280|NCT00912249|Nature-assisted psychotherapy|nature-assisted psychotherapy
627281|NCT00912249|Day Care|day care
627282|NCT00912236|Obesity|obesity
627283|NCT00912236|HDL|hdl
627284|NCT00912236|HDL functionality|hdl functionality
627285|NCT00912223|Follicular Non-Hodgkin's Lymphoma|follicular non-hodgkin's lymphoma
627286|NCT00912223|Hematopoietic Stem Cell Transplant (HSCT)|hematopoietic stem cell transplant (hsct)
627287|NCT00912223|Non-Myeloablative Transplant (NST)|non-myeloablative transplant (nst)
627288|NCT00912184|Kidney failure, acute|kidney failure, acute
627289|NCT00912184|Shock|shock
627290|NCT00912184|Toxins, biological|toxins, biological
627291|NCT00912184|Hemofiltration|hemofiltration
627292|NCT00912184|High cut off/super high flux membranes|high cut off/super high flux membranes
627293|NCT00912171|obstructive sleep apnea syndrome|obstructive sleep apnea syndrome
627294|NCT00912171|snoring|snoring
627295|NCT00912171|adenotonsillar hypertrophy|adenotonsillar hypertrophy
627296|NCT00912171|polysomnography|polysomnography
627297|NCT00912171|intranasal steroids|intranasal steroids
627298|NCT00912171|Anti-leukotrienes|anti-leukotrienes
627299|NCT00912158|CPE|cpe
627300|NCT00912158|CPAP|cpap
627301|NCT00912158|BiPAP|bipap
627302|NCT00912158|non invasive mechanical ventilation|non invasive mechanical ventilation
627303|NCT00912132|Fetal Growth|fetal growth
627304|NCT00912132|Pregnancy|pregnancy
627305|NCT00912119|craniofacial surgery|craniofacial surgery
627306|NCT00912119|pharmacokinetics|pharmacokinetics
627307|NCT00912119|cranial vault abnormalities|cranial vault abnormalities
627308|NCT00912119|homologous blood products|homologous blood products
627309|NCT00912119|wide scalp dissections|wide scalp dissections
627310|NCT00912119|transfusion requirements|transfusion requirements
627311|NCT00912106|osteoarthritis|osteoarthritis
627312|NCT00912106|HA|ha
627313|NCT00912106|synovial fluid|synovial fluid
627314|NCT00912106|lubrication|lubrication
627315|NCT00912093|HAE|hae
627316|NCT00912093|Type I HAE|type i hae
627317|NCT00912093|Type II HAE|type ii hae
627318|NCT00912080|genomic signature|genomic signature
627319|NCT00912080|lymph nodes|lymph nodes
627320|NCT00912080|no metastases|no metastases
627321|NCT00912054|OAG|oag
627322|NCT00912054|OH|oh
627323|NCT00912041|Brain computer interface|brain computer interface
627324|NCT00912041|Assistive device|assistive device
627325|NCT00912041|Environmental control|environmental control
627326|NCT00912041|Communication device|communication device
627327|NCT00912041|quadriplegia|quadriplegia
627328|NCT00912041|tetraplegia|tetraplegia
627329|NCT00911989|Obesity|obesity
627330|NCT00911989|Weight Loss|weight loss
627331|NCT00911976|Coronary artery bypass|coronary artery bypass
627332|NCT00911976|Stents|stents
627333|NCT00911976|Angioplasty, Transluminal, Percutaneous Coronary|angioplasty, transluminal, percutaneous coronary
627334|NCT00911976|Coronary Restenosis|coronary restenosis
627335|NCT00911976|Everolimus|everolimus
627336|NCT00911976|Saphenous vein grafts|saphenous vein grafts
627337|NCT00911963|VX-222|vx-222
627338|NCT00911937|incontinence OAB urgency nocturia|incontinence oab urgency nocturia
627339|NCT00911924|primary open angle glaucoma (POAG)|primary open angle glaucoma (poag)
627340|NCT00911924|OAG|oag
627341|NCT00911924|glaucoma|glaucoma
627342|NCT00911911|Breast cancer|breast cancer
627343|NCT00911911|Neo-adjuvant chemotherapy|neo-adjuvant chemotherapy
627344|NCT00911911|Proteomic|proteomic
627345|NCT00911911|Histological response|histological response
627346|NCT00911898|Her2 amplified solid tumors|her2 amplified solid tumors
627347|NCT00911898|Breast Cancer|breast cancer
627348|NCT00911898|Her3/ErbB3|her3/erbb3
627349|NCT00911898|Bispecific Antibody|bispecific antibody
627350|NCT00911885|Weight|weight
627351|NCT00911885|Diet|diet
627352|NCT00911885|Lipids|lipids
627353|NCT00911872|wrinkles|wrinkles
627354|NCT00911872|dermal filler|dermal filler
627355|NCT00911872|collagen|collagen
627356|NCT00911872|soft tissue augmentation|soft tissue augmentation
627357|NCT00911872|aesthetic|aesthetic
627358|NCT00911859|Multiple Myeloma|multiple myeloma
627359|NCT00911859|CNTO328|cnto328
627360|NCT00911859|Interleukin-6 (IL-6)|interleukin-6 (il-6)
627361|NCT00911859|Monoclonal antibody|monoclonal antibody
627362|NCT00911859|Anti-IL-6 monoclonal antibody|anti-il-6 monoclonal antibody
627363|NCT00911859|Bortezomib|bortezomib
627364|NCT00911859|Velcade|velcade
627365|NCT00911859|Melphalan|melphalan
627366|NCT00911859|Prednisone|prednisone
627367|NCT00911846|opioid dependence substitution buprenorphine methadone|opioid dependence substitution buprenorphine methadone
627368|NCT00911846|"substitution"|"substitution"
627369|NCT00911833|Trust|trust
627370|NCT00911807|Clinical Trial, Phase II|clinical trial, phase ii
627371|NCT00911807|Randomized Controlled Trial|randomized controlled trial
627372|NCT00911807|Multicenter Study|multicenter study
627373|NCT00911807|Cerebrolysin|cerebrolysin
627374|NCT00911807|Donepezil|donepezil
627375|NCT00911794|Dyspnea|dyspnea
627376|NCT00911794|Written Disclosure Therapy|written disclosure therapy
627377|NCT00911794|COPD|copd
627378|NCT00911794|Pulmonary Fibrosis|pulmonary fibrosis
627379|NCT00911794|Chronic Lung Diseases|chronic lung diseases
627380|NCT00911794|Pulmonary Rehabilitation|pulmonary rehabilitation
627381|NCT00911781|Infantile hemangioma|infantile hemangioma
627382|NCT00911768|Xerostomia|xerostomia
627383|NCT00911768|Panax ginseng(Korean Red Ginseng)|panax ginseng(korean red ginseng)
627384|NCT00911768|Visual Analogue Scale|visual analogue scale
627385|NCT00911768|Salivary Flow Rates|salivary flow rates
627386|NCT00911755|Laryngoscopy|laryngoscopy
627387|NCT00911755|Glidescope|glidescope
627388|NCT00911729|paraganglioma|paraganglioma
627389|NCT00911729|pheochromocytoma|pheochromocytoma
627390|NCT00911716|estrogen receptor-negative breast cancer|estrogen receptor-negative breast cancer
627391|NCT00911716|estrogen receptor-positive breast cancer|estrogen receptor-positive breast cancer
627392|NCT00911716|HER2-negative breast cancer|her2-negative breast cancer
627393|NCT00911716|stage IA breast cancer|stage ia breast cancer
627394|NCT00911716|stage IB breast cancer|stage ib breast cancer
627395|NCT00911716|stage II breast cancer|stage ii breast cancer
627396|NCT00911716|stage IIIA breast cancer|stage iiia breast cancer
627397|NCT00911716|male breast cancer|male breast cancer
627398|NCT00911690|Dementia|dementia
627399|NCT00911690|Alzheimers Disease|alzheimers disease
627400|NCT00911690|Cognitive Disorders|cognitive disorders
627401|NCT00911690|Tissue Banking|tissue banking
627402|NCT00911677|Delirium (MeSH Unique ID D003693)|delirium (mesh unique id d003693)
627403|NCT00911677|Cognition Disorders (MeSH Unique ID D003072)|cognition disorders (mesh unique id d003072)
627404|NCT00911677|Postoperative Complications (MeSH Unique ID D011183)|postoperative complications (mesh unique id d011183)
627405|NCT00911677|Apolipoproteins E (MeSH Unique ID D001057)|apolipoproteins e (mesh unique id d001057)
627406|NCT00911664|Vitamin D|vitamin d
627407|NCT00911664|HIV-Infected children|hiv-infected children
627408|NCT00911664|CD4 count|cd4 count
627409|NCT00911651|COPD|copd
627410|NCT00911651|salbutamol|salbutamol
627411|NCT00911651|ipratropium bromide|ipratropium bromide
627412|NCT00911651|computational fluid dynamics|computational fluid dynamics
627413|NCT00911651|functional imaging|functional imaging
627414|NCT00911651|central and peripheral airways|central and peripheral airways
627415|NCT00911638|Patient decision aids|patient decision aids
627416|NCT00911638|Patient preferences|patient preferences
627417|NCT00911638|Osteoarthritis|osteoarthritis
627418|NCT00911638|Joint replacement|joint replacement
627419|NCT00911638|Waiting times|waiting times
627420|NCT00911625|glargine|glargine
627421|NCT00911625|glulisine|glulisine
627422|NCT00911625|type 2 diabetes|type 2 diabetes
627423|NCT00911625|renal insufficiency|renal insufficiency
627424|NCT00911612|bile acid|bile acid
627425|NCT00911612|malabsorption|malabsorption
627426|NCT00911612|permeability|permeability
627427|NCT00911612|diarrhea|diarrhea
627429|NCT00911612|stool|stool
627430|NCT00911599|Individuals undergoing unilateral total hip replacement.|individuals undergoing unilateral total hip replacement.
627431|NCT00911573|pediatry|pediatry
627432|NCT00911573|children|children
627433|NCT00911573|skin|skin
627434|NCT00911573|bacteria|bacteria
627435|NCT00911573|MRSA|mrsa
627436|NCT00911560|BETA-D-GLUCAN|beta-d-glucan
627437|NCT00911560|OPT-821|opt-821
627438|NCT00911560|GD2-KLH|gd2-klh
627439|NCT00911560|GD3-KLH|gd3-klh
627440|NCT00911560|QS 21|qs 21
627441|NCT00911560|Vaccine|vaccine
627442|NCT00911560|05-075|05-075
627443|NCT00911547|chronic asthma|chronic asthma
627444|NCT00911534|Gastroesophageal Reflux Disease|gastroesophageal reflux disease
627445|NCT00911534|GERD|gerd
627446|NCT00911521|human papillomavirus|human papillomavirus
627447|NCT00911521|vaccine|vaccine
627448|NCT00911521|lupus|lupus
627449|NCT00911508|Atrial Fibrillation|atrial fibrillation
627450|NCT00911508|Left Atrial Ablation|left atrial ablation
627451|NCT00911508|Pulmonary Vein Isolation|pulmonary vein isolation
627452|NCT00911508|Catheter Ablation|catheter ablation
627453|NCT00911508|Antiarrhythmic Drug Therapy|antiarrhythmic drug therapy
627454|NCT00911495|Sickle Cell Disease|sickle cell disease
627455|NCT00911482|Type 2 Diabetes|type 2 diabetes
627456|NCT00911482|Dyslipidemia|dyslipidemia
627458|NCT00911482|Triglycerides|triglycerides
627459|NCT00911482|Tracers|tracers
627460|NCT00911469|Knee osteoarthritis|knee osteoarthritis
627461|NCT00911469|fibroblast growth factor 18|fibroblast growth factor 18
627462|NCT00911430|Staphylococcus Aureus (S. Areus)|staphylococcus aureus (s. areus)
627463|NCT00911430|Recurrent Staphylococcal Infection|recurrent staphylococcal infection
627464|NCT00911430|Atopic Dermatitis|atopic dermatitis
627465|NCT00911430|Immunodeficiency|immunodeficiency
627466|NCT00911430|Community Associated Staphylococcal Infection|community associated staphylococcal infection
627467|NCT00911430|Staphylococcal Infection|staphylococcal infection
627468|NCT00911430|Invasive Staphylococcal Infection|invasive staphylococcal infection
627469|NCT00911430|Staph Infection|staph infection
627470|NCT00911417|peripheral arterial disease|peripheral arterial disease
627471|NCT00911417|peripheral vascular disease|peripheral vascular disease
627472|NCT00911404|Gestational diabetes|gestational diabetes
627473|NCT00911404|Carbohydrate|carbohydrate
627474|NCT00911404|Diet|diet
627475|NCT00911404|Insulin|insulin
627476|NCT00911391|Doppler|doppler
627477|NCT00911391|Colectomy|colectomy
627478|NCT00911391|ERAS|eras
627479|NCT00911391|Fluid|fluid
627480|NCT00911391|Perioperative Care|perioperative care
627481|NCT00911378|weaning|weaning
627482|NCT00911378|mechanical ventilation|mechanical ventilation
627483|NCT00911365|voluntary participants|voluntary participants
627484|NCT00911365|75 years old or less|75 years old or less
627485|NCT00911352|Cryotherapy|cryotherapy
627486|NCT00911352|Hand toxicity|hand toxicity
627487|NCT00911352|Nail toxicity|nail toxicity
627488|NCT00911352|Infection control|infection control
627489|NCT00911326|HNSCC|hnscc
627490|NCT00911313|Polycystic ovary syndrome|polycystic ovary syndrome
627491|NCT00911313|clomiphene resistance|clomiphene resistance
627492|NCT00911313|letrozole|letrozole
627493|NCT00911300|Cardioversion, Electric|cardioversion, electric
627494|NCT00911300|Pathological Conditions, Sings and Symptoms|pathological conditions, sings and symptoms
627495|NCT00911300|Cardiovascular Diseases|cardiovascular diseases
627496|NCT00911300|Heart Diseases|heart diseases
627497|NCT00911300|Atrial Fibrillation|atrial fibrillation
627498|NCT00911300|Arrhythmias, Cardiac|arrhythmias, cardiac
627499|NCT00911300|Pathologic Processes|pathologic processes
627500|NCT00911300|Anticoagulants|anticoagulants
627501|NCT00911287|Chronic pain|chronic pain
627502|NCT00911287|Extended Release|extended release
627503|NCT00911287|Long-Acting Opioid|long-acting opioid
627504|NCT00911287|Opioid|opioid
627505|NCT00911287|Opioid-Naive|opioid-naive
627506|NCT00911287|Oxymorphone|oxymorphone
627507|NCT00911274|Bioequivalence|bioequivalence
627508|NCT00911274|Healthy Subjects|healthy subjects
627509|NCT00911261|Cancer Pain|cancer pain
627510|NCT00911261|Neuropathic Pain|neuropathic pain
627511|NCT00911261|Extended Release|extended release
627512|NCT00911261|Long-Acting Opioid|long-acting opioid
627513|NCT00911261|Oxymorphone|oxymorphone
627514|NCT00911248|Angiogenesis|angiogenesis
627515|NCT00911248|Neurofibromatosis|neurofibromatosis
627516|NCT00911248|Post-transcriptional control|post-transcriptional control
627518|NCT00911248|VEGF|vegf
627519|NCT00911235|The Effect Of Fluconazole On Pharmacokinetics Of Fesoterodine In Healthy Subjects|the effect of fluconazole on pharmacokinetics of fesoterodine in healthy subjects
627520|NCT00911222|antiemetic therapy|antiemetic therapy
627521|NCT00911222|emesis|emesis
627522|NCT00911222|vomiting|vomiting
627523|NCT00911222|nausea|nausea
627524|NCT00911222|moderately and highly emetogenic chemotherapy|moderately and highly emetogenic chemotherapy
627525|NCT00911222|cisplatin|cisplatin
627526|NCT00911222|carboplatin|carboplatin
627527|NCT00911222|oxaliplatin|oxaliplatin
627528|NCT00911222|anthracycline|anthracycline
627529|NCT00911222|cyclophosphamid|cyclophosphamid
627530|NCT00911209|Heart Disease|heart disease
627531|NCT00911209|Obesity|obesity
627532|NCT00911196|Prognosis|prognosis
627533|NCT00911196|Markers|markers
627534|NCT00911196|Expression analysis|expression analysis
627535|NCT00911196|Hepatocellular carcinoma|hepatocellular carcinoma
627536|NCT00911183|contiguous stage II adult diffuse large cell lymphoma|contiguous stage ii adult diffuse large cell lymphoma
627537|NCT00911183|noncontiguous stage II adult diffuse large cell lymphoma|noncontiguous stage ii adult diffuse large cell lymphoma
627538|NCT00911183|stage III adult diffuse large cell lymphoma|stage iii adult diffuse large cell lymphoma
627539|NCT00911183|stage IV adult diffuse large cell lymphoma|stage iv adult diffuse large cell lymphoma
627540|NCT00911170|adenocarcinoma of the colon or rectum|adenocarcinoma of the colon or rectum
627541|NCT00911170|febrile neutropenia|febrile neutropenia
627542|NCT00911170|Bevacizumab|bevacizumab
627543|NCT00911170|Avastin|avastin
627544|NCT00911170|5-fluorouracil, Oxaliplatin, Leucovorin (FOLFOX)|5-fluorouracil, oxaliplatin, leucovorin (folfox)
627545|NCT00911170|5-fluorouracil, Irinotecan, Leucovorin (FOLFIRI)|5-fluorouracil, irinotecan, leucovorin (folfiri)
627546|NCT00911157|Pulmonary thromboembolism|pulmonary thromboembolism
627547|NCT00911157|contrast-enhanced MDCT|contrast-enhanced mdct
627548|NCT00911157|Deep Vein Thrombosis|deep vein thrombosis
627549|NCT00911157|Fondaparinux sodium|fondaparinux sodium
627550|NCT00911144|Safety|safety
627551|NCT00911144|Pneumococcal vaccine|pneumococcal vaccine
627552|NCT00911144|Immunogenicity|immunogenicity
627553|NCT00911144|Pneumococcal disease|pneumococcal disease
627554|NCT00911144|Booster vaccination|booster vaccination
627555|NCT00911131|Small grade esophageal varices|small grade esophageal varices
627556|NCT00911131|capsule endoscopy|capsule endoscopy
627557|NCT00911131|PillCam ESO|pillcam eso
627558|NCT00911131|abdominal binder|abdominal binder
627559|NCT00911118|prostate|prostate
627560|NCT00911118|radiation|radiation
627561|NCT00911118|09-035|09-035
627562|NCT00911105|Multiple Myeloma|multiple myeloma
627563|NCT00911105|Non-interventional study|non-interventional study
627564|NCT00911105|Lenalidomide|lenalidomide
627565|NCT00911105|Dexamethasone|dexamethasone
627566|NCT00911105|Observational|observational
627567|NCT00911105|Time to progression|time to progression
627568|NCT00911105|Clinical routine|clinical routine
627569|NCT00911105|Germany|germany
627570|NCT00911105|Plasmacytoma|plasmacytoma
627571|NCT00911092|Oesophageal cancer|oesophageal cancer
627572|NCT00911092|exclusive concomitant radiochemotherapy|exclusive concomitant radiochemotherapy
627573|NCT00911079|Stage III, IV cervical cancer|stage iii, iv cervical cancer
627574|NCT00911079|Rising prostate specific antigen (PSA) after local therapy|rising prostate specific antigen (psa) after local therapy
627575|NCT00911053|melatonin|melatonin
627576|NCT00911053|sleep|sleep
627577|NCT00911053|blindness|blindness
627578|NCT00911053|blind individuals|blind individuals
627579|NCT00911027|Prostate|prostate
627580|NCT00911027|Cancer|cancer
627581|NCT00911027|Biopsy|biopsy
627582|NCT00911027|Guided|guided
627583|NCT00911027|Contrast|contrast
627584|NCT00911027|Enhanced|enhanced
627585|NCT00911027|SonoVue|sonovue
627586|NCT00911027|Suspicion of prostate cancer|suspicion of prostate cancer
627587|NCT00911001|Arthroplasty|arthroplasty
627588|NCT00911001|Antithrombotic prophylaxis treatment|antithrombotic prophylaxis treatment
627589|NCT00911001|Replacement|replacement
627590|NCT00911001|Knee|knee
627591|NCT00910988|healthy|healthy
627592|NCT00910988|sedentary|sedentary
627593|NCT00910988|men|men
627594|NCT00910988|acute effects of antipsychotic|acute effects of antipsychotic
627595|NCT00910988|blood sugar|blood sugar
627596|NCT00910988|insulin sensitivity|insulin sensitivity
627597|NCT00910975|Hepatitis C virus|hepatitis c virus
627598|NCT00910975|Real-time PCR|real-time pcr
627599|NCT00910975|Treatment|treatment
627600|NCT00910962|NSTEMI, acute coronary syndrome, p38 MAPK inhibitor, GW856553, percutaneous coronary intervention|nstemi, acute coronary syndrome, p38 mapk inhibitor, gw856553, percutaneous coronary intervention
627601|NCT00910949|persistent pain|persistent pain
627602|NCT00910949|neuropathic pain|neuropathic pain
627603|NCT00910949|Thoracotomy|thoracotomy
627604|NCT00910949|Chronic Pain|chronic pain
627605|NCT00910936|HIV|hiv
627606|NCT00910936|Exercise|exercise
627607|NCT00910936|Inflammation|inflammation
627608|NCT00910936|Quality of life|quality of life
627609|NCT00910936|Lipodystrophia|lipodystrophia
627610|NCT00910923|Diabetes Mellitus, Type 2|diabetes mellitus, type 2
627611|NCT00910897|Newly Diagnosed|newly diagnosed
627612|NCT00910897|multiple myeloma|multiple myeloma
627613|NCT00910897|induction|induction
627614|NCT00910897|Thalidomide|thalidomide
627615|NCT00910884|stage I breast cancer|stage i breast cancer
627616|NCT00910884|stage II breast cancer|stage ii breast cancer
627617|NCT00910884|stage IIIA breast cancer|stage iiia breast cancer
627618|NCT00910884|male breast cancer|male breast cancer
627619|NCT00910871|Tuberculosis|tuberculosis
627620|NCT00910871|TMC207-TiDP13-C209|tmc207-tidp13-c209
627621|NCT00910871|TMC207-C209|tmc207-c209
627622|NCT00910871|TMC207|tmc207
627624|NCT00910871|MDR-TB|mdr-tb
627625|NCT00910832|Dyschesia treatment|dyschesia treatment
627626|NCT00910832|Rehabilitation|rehabilitation
627627|NCT00910832|Dyschesia|dyschesia
627628|NCT00910819|Colorectal Cancer|colorectal cancer
627629|NCT00910819|Advanced Colorectal Cancer|advanced colorectal cancer
627630|NCT00910819|Epidemiology|epidemiology
627631|NCT00910819|Health Services Research|health services research
627632|NCT00910819|Germany|germany
627633|NCT00910819|Registry|registry
627634|NCT00910819|Palliative Care|palliative care
627635|NCT00910819|Palliative Treatment|palliative treatment
627636|NCT00910819|Adjuvant Drug Therapy|adjuvant drug therapy
627637|NCT00910819|Nutrition Assessment|nutrition assessment
627638|NCT00910819|Physical Activity|physical activity
627639|NCT00910806|TMC207-TiDP13-C117|tmc207-tidp13-c117
627640|NCT00910806|TMC207-C110|tmc207-c110
627641|NCT00910806|TMC207|tmc207
627642|NCT00910806|drug-drug interaction|drug-drug interaction
627643|NCT00910806|Tuberculosis|tuberculosis
627644|NCT00910806|HIV|hiv
627645|NCT00910806|nevirapine|nevirapine
627646|NCT00910806|open-label|open-label
627647|NCT00910806|Pharmacokinetics|pharmacokinetics
627648|NCT00910793|Asthma|asthma
627649|NCT00910793|Formoterol|formoterol
627650|NCT00910793|Beclomethasone Dipropionate|beclomethasone dipropionate
627651|NCT00910793|Computational Fluid Dynamics|computational fluid dynamics
627652|NCT00910793|Functional Imaging|functional imaging
627653|NCT00910793|Central and Peripheral Airways|central and peripheral airways
627654|NCT00910754|Prostate neoplasms|prostate neoplasms
627655|NCT00910754|Metastatic castration resistant prostate cancer|metastatic castration resistant prostate cancer
627656|NCT00910754|Abiraterone acetate|abiraterone acetate
627657|NCT00910754|CB7630|cb7630
627658|NCT00910741|pancreatic cancer|pancreatic cancer
627659|NCT00910741|Gemcitabine|gemcitabine
627660|NCT00910728|Primary Myelofibrosis (PMF)|primary myelofibrosis (pmf)
627661|NCT00910728|Post-Polycythaemia Vera/Essential Thrombocythaemia Myelofibrosis (Post-PV/ET MF)|post-polycythaemia vera/essential thrombocythaemia myelofibrosis (post-pv/et mf)
627662|NCT00910728|Myeloproliferative diseases|myeloproliferative diseases
627663|NCT00910728|Phase I|phase i
627664|NCT00910728|Phase II|phase ii
627665|NCT00910728|Bone marrow|bone marrow
627666|NCT00910715|erythema migrans|erythema migrans
627667|NCT00910715|Lyme borreliosis|lyme borreliosis
627668|NCT00910715|doxycycline treatment|doxycycline treatment
627669|NCT00910715|outcome|outcome
627670|NCT00910715|subjective symptoms|subjective symptoms
627671|NCT00910702|retinal detachment, vitreous body substitute|retinal detachment, vitreous body substitute
627672|NCT00910689|Migraine Headache|migraine headache
627673|NCT00910689|Preventive Therapy|preventive therapy
627674|NCT00910689|Beta Blocker Medication|beta blocker medication
627675|NCT00910689|Behavior Therapy|behavior therapy
627676|NCT00910689|Clinical Trial|clinical trial
627677|NCT00910676|EGF-R inhibitors|egf-r inhibitors
627678|NCT00910663|Bioequivalence|bioequivalence
627679|NCT00910663|Healthy Subjects|healthy subjects
627680|NCT00910650|Adoptive transfer therapy|adoptive transfer therapy
627681|NCT00910650|Dendritic cell vaccines|dendritic cell vaccines
627682|NCT00910637|Pregnancy prevention|pregnancy prevention
627683|NCT00910637|Female contraception|female contraception
627684|NCT00910637|Patch|patch
627685|NCT00910611|pediatric|pediatric
627686|NCT00910611|immunization|immunization
627687|NCT00910611|pain|pain
627688|NCT00910611|analgesia|analgesia
627689|NCT00910611|Immunization pain|immunization pain
627690|NCT00910598|clinically isolated syndrome|clinically isolated syndrome
627691|NCT00910598|relapsing remitting multiple sclerosis|relapsing remitting multiple sclerosis
627692|NCT00910598|glatiramer acetate|glatiramer acetate
627693|NCT00910598|Optical Coherence Tomography|optical coherence tomography
627694|NCT00910585|childhood|childhood
627695|NCT00910585|asthma|asthma
627696|NCT00910572|Yttrium-90|yttrium-90
627697|NCT00910572|Radiation|radiation
627698|NCT00910572|Radioembolization|radioembolization
627699|NCT00910572|Hepatoma|hepatoma
627700|NCT00910572|BCLC classification|bclc classification
627701|NCT00910572|Hepatic loco-regional treatments|hepatic loco-regional treatments
627702|NCT00910572|Yttrium|yttrium
627703|NCT00910572|Microspheres|microspheres
627704|NCT00910559|Autism Spectrum Disorder|autism spectrum disorder
627705|NCT00910559|Autism|autism
627706|NCT00910559|Asperger Syndrome|asperger syndrome
627802|NCT00910208|Analgesia|analgesia
627707|NCT00910559|Pervasive Developmental Disorders- Not Otherwise Specified|pervasive developmental disorders- not otherwise specified
627708|NCT00910546|Lung Cancer|lung cancer
627709|NCT00910546|Stereotactic radiotherapy|stereotactic radiotherapy
627710|NCT00910546|Image guidance|image guidance
627711|NCT00910546|breathing adaption|breathing adaption
627712|NCT00910546|tumor motion|tumor motion
627713|NCT00910546|implanted marker|implanted marker
627714|NCT00910533|Lyme neuroborreliosis|lyme neuroborreliosis
627715|NCT00910507|Diabetes Mellitus, Type 2|diabetes mellitus, type 2
627716|NCT00910507|Exercise|exercise
627717|NCT00910507|Counseling|counseling
627718|NCT00910507|Behavior|behavior
627719|NCT00910494|Rectal neoplasm C04.588.274.476.411.307.790|rectal neoplasm c04.588.274.476.411.307.790
627720|NCT00910494|Intraoperative Radiotherapy|intraoperative radiotherapy
627721|NCT00910481|Coronary Artery Disease|coronary artery disease
627722|NCT00910481|Percutaneous Transluminal Coronary Angioplasty|percutaneous transluminal coronary angioplasty
627723|NCT00910481|Intraaortic Balloon Pumping|intraaortic balloon pumping
627724|NCT00910481|Left Ventricular Dysfunction|left ventricular dysfunction
627725|NCT00910481|High Risk|high risk
627726|NCT00910455|Phase 1|phase 1
627727|NCT00910455|Safety|safety
627728|NCT00910455|Tolerability|tolerability
627729|NCT00910455|Pharmacokinetics|pharmacokinetics
627730|NCT00910429|Chronic thromboembolic Hypertension|chronic thromboembolic hypertension
627732|NCT00910429|soluble Guanylate Cyclase Stimulator|soluble guanylate cyclase stimulator
627733|NCT00910429|sGC|sgc
627734|NCT00910416|Anesthesia|anesthesia
627735|NCT00910416|Monitoring, Intraoperative|monitoring, intraoperative
627736|NCT00910416|Electroencephalography/*drug effects|electroencephalography/*drug effects
627737|NCT00910403|Presbyopia|presbyopia
627738|NCT00910403|LASIK|lasik
627739|NCT00910403|Hyperopes|hyperopes
627740|NCT00910390|IVF|ivf
627741|NCT00910390|embryo cryopreservation|embryo cryopreservation
627742|NCT00910390|vitrification|vitrification
627743|NCT00910390|Human Embryo|human embryo
627744|NCT00910390|Embryonic development|embryonic development
627745|NCT00910390|Pregnancy rate|pregnancy rate
627746|NCT00910377|breastfeeding|breastfeeding
627747|NCT00910377|exclusive breastfeeding|exclusive breastfeeding
627748|NCT00910377|lactation counseling|lactation counseling
627749|NCT00910377|teenagers|teenagers
627750|NCT00910377|complementary food|complementary food
627751|NCT00910377|adolescent|adolescent
627752|NCT00910377|caregivers|caregivers
627753|NCT00910364|Lower extremity DVT|lower extremity dvt
627754|NCT00910364|Clot|clot
627755|NCT00910364|leg clot|leg clot
627756|NCT00910364|Deep vein thrombosis|deep vein thrombosis
627757|NCT00910364|Thrombosis|thrombosis
627758|NCT00910364|Warfarin|warfarin
627759|NCT00910351|Cystic Fibrosis|cystic fibrosis
627760|NCT00910351|Pharmacokinetics|pharmacokinetics
627761|NCT00910351|Pediatrics|pediatrics
627762|NCT00910351|Inhalation|inhalation
627763|NCT00910351|Sputum|sputum
627764|NCT00910338|Pelvic Floor Muscle Training|pelvic floor muscle training
627765|NCT00910338|Extracorporeal Biofeedback|extracorporeal biofeedback
627766|NCT00910325|Female|female
627767|NCT00910325|Cholelithiasis|cholelithiasis
627768|NCT00910325|Natural Orifice Surgery|natural orifice surgery
627769|NCT00910325|Laparoscopic- Assisted|laparoscopic- assisted
627770|NCT00910325|Transvaginal|transvaginal
627771|NCT00910299|Clopidogrel|clopidogrel
627772|NCT00910299|VerifyNow|verifynow
627773|NCT00910299|PRU Measurements|pru measurements
627774|NCT00910299|Drug Eluting Stents (DES)|drug eluting stents (des)
627775|NCT00910299|Heart Disease|heart disease
627776|NCT00910299|Percutaneous Coronary Intervention (PCI)|percutaneous coronary intervention (pci)
627777|NCT00910299|P2Y12|p2y12
627778|NCT00910299|Platelets|platelets
627779|NCT00910299|Platelet Reactivity|platelet reactivity
627780|NCT00910286|Pressure support ventilation|pressure support ventilation
627781|NCT00910286|cycling off criteria|cycling off criteria
627782|NCT00910286|expiratory trigger|expiratory trigger
627783|NCT00910286|patient-ventilator interaction|patient-ventilator interaction
627784|NCT00910286|patient comfort|patient comfort
627785|NCT00910273|IMT evaluation in AS patients treated with etanercept|imt evaluation in as patients treated with etanercept
627786|NCT00910260|vitamin D level under phototherapy|vitamin d level under phototherapy
627787|NCT00910247|Seizures|seizures
627788|NCT00910247|Epilepsy|epilepsy
627789|NCT00910247|Anticonvulsant|anticonvulsant
627790|NCT00910247|Monotherapy|monotherapy
627791|NCT00910247|Epilepsy with simple or complete partial onset seizures|epilepsy with simple or complete partial onset seizures
627792|NCT00910234|Periventricular leukomalacia (PVL)|periventricular leukomalacia (pvl)
627793|NCT00910234|Erythropoietin (EPO)|erythropoietin (epo)
627794|NCT00910234|Retinopathy of prematurity (ROP)|retinopathy of prematurity (rop)
627795|NCT00910234|Hypoxia-ischemia|hypoxia-ischemia
627796|NCT00910221|Cardiac surgery|cardiac surgery
627797|NCT00910221|Cardiopulmonary bypass|cardiopulmonary bypass
627798|NCT00910221|Oxidative stress|oxidative stress
627799|NCT00910221|Acute renal dysfunction|acute renal dysfunction
627800|NCT00910221|Atorvastatin|atorvastatin
627801|NCT00910208|Pain|pain
627803|NCT00910208|Analgesia, Patient-controlled|analgesia, patient-controlled
627804|NCT00910208|Emergency Medicine|emergency medicine
627805|NCT00910195|Obstructive sleep apnea|obstructive sleep apnea
627806|NCT00910195|CPAP|cpap
627807|NCT00910195|Bi-Level|bi-level
627808|NCT00910182|Splenic rupture|splenic rupture
627809|NCT00910182|abdominal injuries|abdominal injuries
627810|NCT00910182|Surgery|surgery
627811|NCT00910182|Angiography|angiography
627812|NCT00910182|Embolisation|embolisation
627813|NCT00910182|Computed tomography|computed tomography
627814|NCT00910182|Classification|classification
627815|NCT00910169|Anorexia nervosa|anorexia nervosa
627816|NCT00910169|treatment|treatment
627817|NCT00910169|inpatient|inpatient
627818|NCT00910169|efficacy|efficacy
627819|NCT00910169|outcome|outcome
627820|NCT00910143|Rectal cancer|rectal cancer
627821|NCT00910143|Colorectal Surgery|colorectal surgery
627822|NCT00910143|Surgery|surgery
627823|NCT00910143|Local neoplasm recurrence|local neoplasm recurrence
627824|NCT00910143|survival|survival
627825|NCT00910143|Follow-up Study|follow-up study
627826|NCT00910130|Retinol Binding Protein 4|retinol binding protein 4
627827|NCT00910130|Insulin Resistance|insulin resistance
627828|NCT00910130|Diabetes|diabetes
627829|NCT00910130|End Stage Renal Disease|end stage renal disease
627830|NCT00910130|Dialysis|dialysis
627831|NCT00910130|Nutrition|nutrition
627832|NCT00910117|HNSCC|hnscc
627833|NCT00910117|induction chemotherapy|induction chemotherapy
627834|NCT00910117|nimotuzumab|nimotuzumab
627835|NCT00910104|PNALD|pnald
627836|NCT00910104|Omegaven|omegaven
627837|NCT00910104|Parenteral Nutrition Associated Liver Disease|parenteral nutrition associated liver disease
627838|NCT00910104|Cholestasis|cholestasis
712400|NCT00580294|Sciatica|sciatica
627839|NCT00910104|Short Bowel Syndrome|short bowel syndrome
627840|NCT00910091|Endometrial cancer|endometrial cancer
627841|NCT00910091|Antitumour efficacy in women with advanced endometrial cancer|antitumour efficacy in women with advanced endometrial cancer
627842|NCT00910078|Total kappa and lambda ratio|total kappa and lambda ratio
627843|NCT00910078|Stem cell transplantation|stem cell transplantation
627844|NCT00910078|Serum immunofixation|serum immunofixation
627845|NCT00910065|Acute Coronary Syndrome|acute coronary syndrome
627846|NCT00910065|ACS|acs
627847|NCT00910065|Aspirin|aspirin
627848|NCT00910052|randomised|randomised
627849|NCT00910052|controlled|controlled
627850|NCT00910052|double blinded|double blinded
627851|NCT00910039|cognitive/functional effects|cognitive/functional effects
627852|NCT00910039|tumors metastatic to brain|tumors metastatic to brain
627853|NCT00910039|unspecified adult solid tumor, protocol specific|unspecified adult solid tumor, protocol specific
627854|NCT00910026|EBC and mechanical ventilation|ebc and mechanical ventilation
627855|NCT00910026|low tidal volume ventilation|low tidal volume ventilation
627856|NCT00910026|high tidal volume ventilation|high tidal volume ventilation
627857|NCT00910026|inflammatory and oxidative stress EBC biomarkers|inflammatory and oxidative stress ebc biomarkers
627858|NCT00910026|Ventilator induced lung injury|ventilator induced lung injury
627859|NCT00910013|TKR|tkr
627860|NCT00910013|Femoral block|femoral block
627861|NCT00910013|Ropivacaïne|ropivacaïne
627862|NCT00910013|intra-articular ropivacaïne|intra-articular ropivacaïne
627863|NCT00910013|post-operative analgesia|post-operative analgesia
627864|NCT00910000|carboplatin|carboplatin
627865|NCT00910000|gemcitabine|gemcitabine
627866|NCT00910000|vorinostat|vorinostat
627867|NCT00909987|rectum|rectum
627868|NCT00909987|intermediate risk cancer rectum|intermediate risk cancer rectum
627869|NCT00909987|neoadjuvant|neoadjuvant
627870|NCT00909974|multiple micronutrients|multiple micronutrients
627871|NCT00909974|energy deficiency|energy deficiency
627872|NCT00909961|Osteoporosis|osteoporosis
627873|NCT00909961|Bone Mineral Density|bone mineral density
627874|NCT00909961|Biomarkers|biomarkers
627875|NCT00909948|Related stem cell transplant,|related stem cell transplant,
627876|NCT00909948|TBI,|tbi,
627877|NCT00909948|Mismatched stem cell transplant|mismatched stem cell transplant
627878|NCT00909948|Fludarabine|fludarabine
627879|NCT00909948|Non-myeloablative|non-myeloablative
627880|NCT00909948|Lymphoma|lymphoma
627881|NCT00909948|Multiple myeloma|multiple myeloma
627882|NCT00909935|To determine pharmacokinetics of dexmedetomidine in children|to determine pharmacokinetics of dexmedetomidine in children
627883|NCT00909922|Amputation|amputation
627884|NCT00909922|Amputees|amputees
627885|NCT00909922|Artificial Limbs|artificial limbs
627886|NCT00909922|Leg Length Inequality|leg length inequality
627887|NCT00909922|Lower Extremity|lower extremity
627888|NCT00909922|Pelvis|pelvis
627889|NCT00909922|Posture|posture
627890|NCT00909922|Prostheses|prostheses
627891|NCT00909922|Range of Motion|range of motion
627892|NCT00909922|Trunk Muscles|trunk muscles
627893|NCT00909909|ductal breast carcinoma in situ|ductal breast carcinoma in situ
627894|NCT00909909|invasive ductal breast carcinoma|invasive ductal breast carcinoma
627895|NCT00909909|invasive lobular breast carcinoma|invasive lobular breast carcinoma
627896|NCT00909909|medullary ductal breast carcinoma with lymphocytic infiltrate|medullary ductal breast carcinoma with lymphocytic infiltrate
627897|NCT00909909|mucinous ductal breast carcinoma|mucinous ductal breast carcinoma
627898|NCT00909909|papillary ductal breast carcinoma|papillary ductal breast carcinoma
627899|NCT00909909|tubular ductal breast carcinoma|tubular ductal breast carcinoma
627900|NCT00909909|stage I breast cancer|stage i breast cancer
627901|NCT00909909|stage II breast cancer|stage ii breast cancer
627902|NCT00909909|stage IIIA breast cancer|stage iiia breast cancer
627903|NCT00909896|endometrial|endometrial
627904|NCT00909896|pain|pain
627905|NCT00909883|Idiopathic Parkinson's disease|idiopathic parkinson's disease
627906|NCT00909883|Foot (Tiptoe) dystonia|foot (tiptoe) dystonia
627907|NCT00909883|Botulinum Toxin|botulinum toxin
627908|NCT00909883|Muscles : Flexor digitorum longus/ Flexor digitorum brevis/ quadratus plantae|muscles : flexor digitorum longus/ flexor digitorum brevis/ quadratus plantae
627909|NCT00909870|Venous leg ulcer|venous leg ulcer
627910|NCT00909870|randomized trial|randomized trial
627911|NCT00909870|clinical trial|clinical trial
627912|NCT00909870|Dermagraft|dermagraft
627913|NCT00909870|compression therapy|compression therapy
627914|NCT00909870|surgical debridement|surgical debridement
627915|NCT00909870|venous stasis|venous stasis
627916|NCT00909870|chronic ulcer|chronic ulcer
627917|NCT00909870|chronic wound|chronic wound
627918|NCT00909870|fibroblasts|fibroblasts
627919|NCT00909857|Primary Dysmenorrhea|primary dysmenorrhea
627920|NCT00909857|Oral Contraception|oral contraception
627921|NCT00909831|unspecified adult solid tumor, protocol specific|unspecified adult solid tumor, protocol specific
627922|NCT00909805|dermabond glue|dermabond glue
627923|NCT00909805|suture|suture
627924|NCT00909805|children|children
627925|NCT00909779|Chronic obstructive pulmonary disease (COPD)|chronic obstructive pulmonary disease (copd)
627926|NCT00909779|respiratory|respiratory
627927|NCT00909779|long-acting beta agonist (LABA)|long-acting beta agonist (laba)
627928|NCT00909753|Bioequivalence|bioequivalence
627929|NCT00909753|Healthy Subjects|healthy subjects
627930|NCT00909740|Solid Tumor|solid tumor
627931|NCT00909740|Cancer|cancer
627932|NCT00909727|Fibrosis|fibrosis
627933|NCT00909727|Pancreatic Diseases|pancreatic diseases
627934|NCT00909727|Digestive System Diseases|digestive system diseases
627935|NCT00909727|Lung Diseases|lung diseases
627936|NCT00909727|Respiratory Tract Diseases|respiratory tract diseases
627937|NCT00909727|Genetic Diseases, Inborn|genetic diseases, inborn
627938|NCT00909727|Infant, Newborn, Diseases|infant, newborn, diseases
627939|NCT00909727|Pathologic Processes|pathologic processes
627940|NCT00909714|stroke|stroke
627941|NCT00909714|non-invasive cortical stimulation|non-invasive cortical stimulation
627942|NCT00909714|motor recovery|motor recovery
627943|NCT00909714|cortical plasticity|cortical plasticity
627944|NCT00909714|TDCS|tdcs
627945|NCT00909701|Dietary supplement|dietary supplement
627946|NCT00909701|healthy volunteers|healthy volunteers
627947|NCT00909701|Anaesthesia for surgery|anaesthesia for surgery
627948|NCT00909688|Healthy Subjects|healthy subjects
627949|NCT00909662|cognitive/functional effects|cognitive/functional effects
627950|NCT00909662|long-term effects secondary to cancer therapy in adults|long-term effects secondary to cancer therapy in adults
627951|NCT00909662|fatigue|fatigue
627952|NCT00909662|stage I breast cancer|stage i breast cancer
627953|NCT00909662|stage II breast cancer|stage ii breast cancer
627954|NCT00909662|stage IIIA breast cancer|stage iiia breast cancer
627955|NCT00909662|stage IIIB breast cancer|stage iiib breast cancer
627956|NCT00909662|stage IIIC breast cancer|stage iiic breast cancer
627957|NCT00909649|fibrin glue|fibrin glue
627958|NCT00909649|seroma|seroma
627959|NCT00909649|mastectomy|mastectomy
627960|NCT00909636|multiple ascending doses (MAD)|multiple ascending doses (mad)
627961|NCT00909610|Bioequivalence|bioequivalence
627962|NCT00909610|Healthy Subjects|healthy subjects
627963|NCT00909584|Hematology|hematology
627964|NCT00909584|Neutropenia|neutropenia
627965|NCT00909584|SCN|scn
627966|NCT00909584|Severe Chronic Neutropenia|severe chronic neutropenia
627967|NCT00909584|Idiopathic|idiopathic
627968|NCT00909584|Telintra|telintra
627969|NCT00909584|ezatiostat hydrochloride|ezatiostat hydrochloride
627970|NCT00909584|ezatiostat|ezatiostat
627971|NCT00909584|TLK199|tlk199
627972|NCT00909584|Glutathione|glutathione
627973|NCT00909584|Glutathione analog|glutathione analog
627974|NCT00909584|Glutathione Transferase|glutathione transferase
627975|NCT00909584|Glutathione Transferase inhibitor|glutathione transferase inhibitor
627976|NCT00909584|Glutathione Transferase P1-1 inhibitor|glutathione transferase p1-1 inhibitor
627977|NCT00909584|GSTp1-1 inhibitor|gstp1-1 inhibitor
627978|NCT00909584|Apoptosis|apoptosis
627979|NCT00909584|Differentiation|differentiation
627980|NCT00909584|Enzyme inhibitor|enzyme inhibitor
627981|NCT00909571|FK506E|fk506e
627982|NCT00909571|MR4|mr4
627983|NCT00909571|Prograf|prograf
627984|NCT00909571|Tacrolimus|tacrolimus
627985|NCT00909571|Living Liver Transplantation|living liver transplantation
627986|NCT00909558|metastatic malignancies|metastatic malignancies
627987|NCT00909558|tumor markers|tumor markers
627988|NCT00909558|chemotherapy|chemotherapy
627989|NCT00909558|cancer|cancer
627990|NCT00909558|breast cancer|breast cancer
627991|NCT00909558|glioma|glioma
627992|NCT00909558|hepatocellular cancer|hepatocellular cancer
628280|NCT00908232|progression|progression
627993|NCT00909558|squamous cell lung cancer|squamous cell lung cancer
627994|NCT00909558|pancreatic cancer|pancreatic cancer
627995|NCT00909558|colon cancer|colon cancer
627996|NCT00909558|prostate cancer|prostate cancer
627997|NCT00909545|Early Parkinson disease|early parkinson disease
627998|NCT00909532|Fibrosis|fibrosis
627999|NCT00909532|Pancreatic Diseases|pancreatic diseases
628000|NCT00909532|Lung Diseases|lung diseases
628001|NCT00909532|Respiratory Tract Diseases|respiratory tract diseases
628002|NCT00909532|Genetic Diseases, Inborn|genetic diseases, inborn
628003|NCT00909532|Infant, Newborn, Diseases|infant, newborn, diseases
628004|NCT00909532|Pathologic Processes|pathologic processes
628005|NCT00909493|Improvement of patient care as measured by self-rated health and improve physician satisfaction with chronic pain management|improvement of patient care as measured by self-rated health and improve physician satisfaction with chronic pain management
628006|NCT00909454|Vitamin D deficiency|vitamin d deficiency
628007|NCT00909454|Adolescents|adolescents
628008|NCT00909454|African Americans|african americans
628009|NCT00909454|Overweight|overweight
628010|NCT00909454|Obesity|obesity
628011|NCT00909441|Breast Cancer|breast cancer
628012|NCT00909441|Node Positive Breast Cancer|node positive breast cancer
628013|NCT00909441|Sentinel Lymph Node Biopsy|sentinel lymph node biopsy
628014|NCT00909441|Breast Surgery|breast surgery
628015|NCT00909441|Axillary Lymph Node Dissection|axillary lymph node dissection
628016|NCT00909441|Neoadjuvant Chemotherapy|neoadjuvant chemotherapy
628017|NCT00909428|Bladder|bladder
628018|NCT00909428|Urinary Urgency|urinary urgency
628019|NCT00909428|Solifenacin|solifenacin
628020|NCT00909428|Vesicare(R)|vesicare(r)
628021|NCT00909415|patients with anorectal malformation|patients with anorectal malformation
628022|NCT00909376|Pregnancy|pregnancy
628023|NCT00909376|Ultrasonography|ultrasonography
628024|NCT00909376|outcome|outcome
628025|NCT00909376|adverse|adverse
628026|NCT00909350|Barrett's esophagus|barrett's esophagus
628027|NCT00909350|BE|be
628028|NCT00909350|esophageal adenocarcinoma|esophageal adenocarcinoma
628029|NCT00909350|Micro-RNA|micro-rna
628030|NCT00909350|miR expression|mir expression
628031|NCT00909324|Post LASIK dry eye|post lasik dry eye
628032|NCT00909324|Pre LASIK dry eye|pre lasik dry eye
628033|NCT00909324|Hypromellose|hypromellose
628034|NCT00909311|Food effect|food effect
628035|NCT00909298|Left ventricular assist devices|left ventricular assist devices
628036|NCT00909298|Cardiac Disease|cardiac disease
628037|NCT00909298|Heart Failure|heart failure
628038|NCT00909298|Anticoagulant for Left Ventricular Assist Devices|anticoagulant for left ventricular assist devices
628039|NCT00909285|Alzheimer|alzheimer
628041|NCT00909285|cognitive training|cognitive training
628042|NCT00909272|ultrasound|ultrasound
628043|NCT00909272|diagnostic|diagnostic
628044|NCT00909272|lumbar|lumbar
628045|NCT00909272|median branch|median branch
628046|NCT00909272|block|block
628047|NCT00909272|Lumbar facet joint pain|lumbar facet joint pain
628048|NCT00909259|Sleep Disordered Breathing|sleep disordered breathing
628049|NCT00909259|Periodic Breathing|periodic breathing
628050|NCT00909259|Cheyne-Stokes Respiration|cheyne-stokes respiration
628051|NCT00909259|Sleep Apnea|sleep apnea
628052|NCT00909233|Erectile dysfunction,|erectile dysfunction,
628053|NCT00909233|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors
628054|NCT00909220|Major Depressive Disorder, EEG, Negativity bias|major depressive disorder, eeg, negativity bias
628055|NCT00909207|Advanced Cancers|advanced cancers
628056|NCT00909207|Hematologic Disorders|hematologic disorders
628057|NCT00909207|Solid Tumors|solid tumors
628058|NCT00909207|Cognitive Interview|cognitive interview
628059|NCT00909207|Patient-Reported Outcomes|patient-reported outcomes
628060|NCT00909207|PRO|pro
628061|NCT00909207|Common Terminology Criteria for Adverse Events|common terminology criteria for adverse events
628062|NCT00909207|CTCAE|ctcae
628063|NCT00909207|PRO-CTCAE|pro-ctcae
628064|NCT00909207|Cancer Symptoms|cancer symptoms
628065|NCT00909207|Interview|interview
628066|NCT00909194|Juvenile Primary Fibromyalgia|juvenile primary fibromyalgia
628067|NCT00909194|Adolescents|adolescents
628068|NCT00909194|Psychiatry|psychiatry
628069|NCT00909168|Induction chemotherapy|induction chemotherapy
628070|NCT00909168|Fludarabine|fludarabine
628071|NCT00909168|Gemtuzumab Ozogamicin|gemtuzumab ozogamicin
628072|NCT00909155|Major Depressive Disorder|major depressive disorder
628073|NCT00909142|Breast cancer|breast cancer
628074|NCT00909142|Prostate cancer|prostate cancer
628075|NCT00909142|Multiple myeloma|multiple myeloma
628076|NCT00909129|HIV-1|hiv-1
628077|NCT00909129|Chronic hepatitis C|chronic hepatitis c
628078|NCT00909129|Immune activation|immune activation
628079|NCT00909129|HCV kinetics|hcv kinetics
628080|NCT00909129|IP-10|ip-10
628081|NCT00909116|ODS|ods
628082|NCT00909116|chronic constipation|chronic constipation
628083|NCT00909116|internal rectal prolapse|internal rectal prolapse
628084|NCT00909116|rectocele|rectocele
628085|NCT00909116|Stapled Transanal Rectal Resection|stapled transanal rectal resection
628086|NCT00909116|Contour Transtar|contour transtar
628087|NCT00909116|STARR|starr
628088|NCT00909103|Endoscopic Ultrasound Elastography|endoscopic ultrasound elastography
628767|NCT00906126|nulliparous|nulliparous
628089|NCT00909103|Pancreatic adenocarcinoma|pancreatic adenocarcinoma
628090|NCT00909103|Chronic Pancreatitis|chronic pancreatitis
628091|NCT00909090|macular pigment|macular pigment
628092|NCT00909090|glare disability|glare disability
628093|NCT00909090|lutein|lutein
628094|NCT00909090|photostress|photostress
628095|NCT00909077|ITP-Rituximab-dexamethasone|itp-rituximab-dexamethasone
628096|NCT00909051|Diabetes Mellitus|diabetes mellitus
628097|NCT00909012|phenylketonuria|phenylketonuria
628098|NCT00909012|docosahexaenoic acid|docosahexaenoic acid
628099|NCT00909012|visually evoked potential|visually evoked potential
628100|NCT00909012|choice-reaction time|choice-reaction time
628101|NCT00908999|anosognosia fMRI amnestic MCI Alzheimer|anosognosia fmri amnestic mci alzheimer
628102|NCT00908999|anosognosia in AD and MCI|anosognosia in ad and mci
628103|NCT00908986|Lupus Membranous Nephritis|lupus membranous nephritis
628104|NCT00908973|Obesity|obesity
628105|NCT00908973|Gastric bypass|gastric bypass
628106|NCT00908973|Gut hormone|gut hormone
628107|NCT00908973|Intestinal transit time|intestinal transit time
628108|NCT00908960|enoxaparin|enoxaparin
628109|NCT00908947|SFA|sfa
628110|NCT00908947|Stent|stent
628111|NCT00908947|Popliteal|popliteal
628112|NCT00908947|infrainguinal|infrainguinal
628113|NCT00908947|LifeStent|lifestent
628114|NCT00908947|Peripheral|peripheral
628115|NCT00908947|Arterial|arterial
628116|NCT00908934|Relative Bioavailability|relative bioavailability
628117|NCT00908934|AZD9056|azd9056
628118|NCT00908908|Advanced Solid Tumors|advanced solid tumors
628119|NCT00908908|Failure of Multiple Prior Chemotherapy Regimens|failure of multiple prior chemotherapy regimens
628120|NCT00908895|Radius fractures|radius fractures
628121|NCT00908895|Radio-radial fixator|radio-radial fixator
628122|NCT00908895|Percutaneous pinning|percutaneous pinning
628123|NCT00908895|Grip strength|grip strength
628124|NCT00908882|Nursing Care|nursing care
628125|NCT00908882|Veterans|veterans
628126|NCT00908869|advanced neoplasm|advanced neoplasm
628127|NCT00908869|adult advanced neoplasm|adult advanced neoplasm
628128|NCT00908856|stroke cell therapy repair autologous|stroke cell therapy repair autologous
628129|NCT00908843|Contrast nephropathy|contrast nephropathy
628130|NCT00908843|Renal failure|renal failure
628131|NCT00908817|postoperative sore throat|postoperative sore throat
628132|NCT00908817|tracheal intubation|tracheal intubation
628133|NCT00908817|lubrication|lubrication
628134|NCT00908817|triamcinolone|triamcinolone
628135|NCT00908804|acute appendicitis|acute appendicitis
628136|NCT00908791|Conjugated Linoleic Acid|conjugated linoleic acid
628137|NCT00908791|Proof of Principle|proof of principle
628138|NCT00908791|Lipogenic Pathway|lipogenic pathway
628139|NCT00908791|Clarinol|clarinol
628140|NCT00908778|Diabetic Retinopathy|diabetic retinopathy
628141|NCT00908765|Exercise Training COPD|exercise training copd
628142|NCT00908752|HCC|hcc
628143|NCT00908739|stage I renal cell cancer|stage i renal cell cancer
628144|NCT00908739|stage III renal cell cancer|stage iii renal cell cancer
628145|NCT00908739|recurrent renal cell cancer|recurrent renal cell cancer
628146|NCT00908739|clear cell renal cell carcinoma|clear cell renal cell carcinoma
628147|NCT00908739|childhood renal cell carcinoma|childhood renal cell carcinoma
628148|NCT00908713|Severe CAP|severe cap
628149|NCT00908713|Adjuvant therapy|adjuvant therapy
628150|NCT00908713|Glucocorticoids|glucocorticoids
628151|NCT00908713|CAP Fine V with C-reactive protein >= 15 mg/100 mL|cap fine v with c-reactive protein >= 15 mg/100 ml
628152|NCT00908700|Atrial fibrillation|atrial fibrillation
628153|NCT00908700|Stroke|stroke
628154|NCT00908700|left atrial appendage|left atrial appendage
628155|NCT00908700|Re-exploration for bleeding|re-exploration for bleeding
628156|NCT00908661|Parastomal, hernia|parastomal, hernia
628157|NCT00908648|screening colonoscopy|screening colonoscopy
628158|NCT00908648|narrow band imaging|narrow band imaging
628159|NCT00908635|sepsis|sepsis
628160|NCT00908635|organ failure|organ failure
628161|NCT00908622|Percutaneous implantation of autologous myoblasts|percutaneous implantation of autologous myoblasts
628162|NCT00908609|Breast Cancer Diagnosis|breast cancer diagnosis
628163|NCT00908609|Optical Imaging|optical imaging
628164|NCT00908609|Ultrasound Imaging|ultrasound imaging
628165|NCT00908609|Monitoring Neoadjuvant Chemotherapy Response|monitoring neoadjuvant chemotherapy response
628166|NCT00908596|Nephrogenic Systemic Fibrosis (NSF)|nephrogenic systemic fibrosis (nsf)
628167|NCT00908596|Primovist / Eovist|primovist / eovist
628168|NCT00908583|Alloantibody|alloantibody
628169|NCT00908583|Desensitization|desensitization
628170|NCT00908583|Kidney Transplantation|kidney transplantation
628171|NCT00908583|Nephrology|nephrology
628172|NCT00908583|Plasma Cells|plasma cells
628173|NCT00908583|Translational Research/Science|translational research/science
628174|NCT00908570|estrogen|estrogen
628175|NCT00908570|estriol|estriol
628176|NCT00908570|cream|cream
628177|NCT00908570|vagina|vagina
628178|NCT00908570|infection prevention|infection prevention
628179|NCT00908557|Lexicosyntactic readability improvement|lexicosyntactic readability improvement
628180|NCT00908557|phase II/III trials|phase ii/iii trials
628181|NCT00908557|ethic|ethic
628182|NCT00908557|Informed consent|informed consent
628183|NCT00908544|HIV-infection|hiv-infection
628184|NCT00908544|Primary HIV-infection|primary hiv-infection
628185|NCT00908544|Proviral DNA|proviral dna
628186|NCT00908544|Eradication|eradication
628187|NCT00908544|Multi drug class HAART|multi drug class haart
628188|NCT00908531|Breast neoplasms|breast neoplasms
628189|NCT00908531|Randomised trial|randomised trial
628190|NCT00908531|Aromatase Inhibitors|aromatase inhibitors
628191|NCT00908531|Preoperative care|preoperative care
628192|NCT00908531|Age 60 or older|age 60 or older
628193|NCT00908531|Hormone receptor positive tumor|hormone receptor positive tumor
628194|NCT00908531|Tumor lager than 2 cm|tumor lager than 2 cm
628195|NCT00908531|No distant metastasis|no distant metastasis
628196|NCT00908518|Cognitive dysfunction|cognitive dysfunction
628197|NCT00908518|Cardiac morbidity|cardiac morbidity
628198|NCT00908518|anesthesia|anesthesia
628199|NCT00908505|Cystic fibrosis|cystic fibrosis
628200|NCT00908505|physiotherapy|physiotherapy
628201|NCT00908505|pulmonary function test|pulmonary function test
628202|NCT00908492|Randomized control trial|randomized control trial
628203|NCT00908492|Dementia caregivers|dementia caregivers
628204|NCT00908492|Occupational Therapy|occupational therapy
628205|NCT00908492|Caregivers|caregivers
628206|NCT00908479|Exercise|exercise
628207|NCT00908479|Rehabilitation|rehabilitation
628208|NCT00908479|leg function|leg function
628209|NCT00908479|in patient|in patient
628211|NCT00908466|Non-infectious|non-infectious
628213|NCT00908466|Panuveitis|panuveitis
628214|NCT00908453|NPC-06|npc-06
628215|NCT00908453|fosphenytoin|fosphenytoin
628216|NCT00908453|phenytoin|phenytoin
628217|NCT00908453|pharmacokinetics|pharmacokinetics
628218|NCT00908453|safety|safety
628219|NCT00908440|Decision Aid|decision aid
628220|NCT00908440|Posttraumatic Stress Disorder|posttraumatic stress disorder
628221|NCT00908440|evidence-based treatments|evidence-based treatments
628222|NCT00908427|benign prostatic hyperplasia|benign prostatic hyperplasia
628223|NCT00908427|KTP laser|ktp laser
628224|NCT00908427|transurethral resection of prostate|transurethral resection of prostate
628225|NCT00908427|urinary bladder neck obstruction|urinary bladder neck obstruction
628226|NCT00908414|PEPI-TiDP23-C104|pepi-tidp23-c104
628227|NCT00908414|PEPI-C104|pepi-c104
628228|NCT00908414|PEPI|pepi
628229|NCT00908414|TMC589337|tmc589337
628230|NCT00908414|TMC589354|tmc589354
628231|NCT00908414|TMC310911|tmc310911
628232|NCT00908414|Healthy Volunteers|healthy volunteers
628233|NCT00908401|breastmilk|breastmilk
628234|NCT00908401|oral sucrose|oral sucrose
628235|NCT00908401|analgesia|analgesia
628236|NCT00908401|preterm neonates|preterm neonates
628237|NCT00908401|Neonates|neonates
628238|NCT00908388|Acute, Complicated Type B Dissection|acute, complicated type b dissection
628239|NCT00908375|Pregabalin|pregabalin
628240|NCT00908375|Radicular pain|radicular pain
628241|NCT00908375|Failed back surgery|failed back surgery
628242|NCT00908375|Of greater than 3 months duration|of greater than 3 months duration
628243|NCT00908362|Dendritic cells|dendritic cells
628244|NCT00908362|Airway|airway
628245|NCT00908362|Smoker|smoker
628246|NCT00908362|COPD|copd
628247|NCT00908336|Adenocarcinoma|adenocarcinoma
628248|NCT00908336|Carcinoma, Non-Small Cell|carcinoma, non-small cell
628249|NCT00908336|Lung Neoplasms|lung neoplasms
628250|NCT00908336|Docetaxel|docetaxel
628251|NCT00908336|Erlotinib|erlotinib
628252|NCT00908336|Chemotherapy|chemotherapy
628253|NCT00908323|HIV Seronegativity|hiv seronegativity
628254|NCT00908323|HIV Preventive Vaccine|hiv preventive vaccine
628255|NCT00908310|CKD - Chronic Kidney Disease|ckd - chronic kidney disease
628256|NCT00908310|GBCA - Gadolinium-based contrast agent|gbca - gadolinium-based contrast agent
628257|NCT00908310|GFR - Glomerular Filtration Rate|gfr - glomerular filtration rate
628258|NCT00908310|MRI - Magnetic Resonance Imaging|mri - magnetic resonance imaging
628259|NCT00908310|NSF - Nephrogenic Systemic Fibrosis|nsf - nephrogenic systemic fibrosis
628260|NCT00908310|Known or suspected CKD with an eGFR greater than or equal to 30mL & less than 60 mL/min/1.73m2 as measured within 30 days prior to the OMNISCAN.|known or suspected ckd with an egfr greater than or equal to 30ml & less than 60 ml/min/1.73m2 as measured within 30 days prior to the omniscan.
628261|NCT00908297|Cardiovascular disease|cardiovascular disease
628262|NCT00908297|End stage renal disease|end stage renal disease
628263|NCT00908297|Atherosclerosis|atherosclerosis
628264|NCT00908297|Oxidative stress|oxidative stress
628265|NCT00908297|Antioxidants|antioxidants
628266|NCT00908284|AIDS|aids
628267|NCT00908284|Acquired Immune Deficiency Syndrome Virus|acquired immune deficiency syndrome virus
628268|NCT00908284|Human Immunodeficiency Virus|human immunodeficiency virus
628269|NCT00908284|Exercise Physiology|exercise physiology
628270|NCT00908284|Endothelial Dysfunction|endothelial dysfunction
628271|NCT00908245|Preconditioning|preconditioning
628272|NCT00908245|Hepatectomy|hepatectomy
628273|NCT00908245|Clamping|clamping
628274|NCT00908232|multiple myeloma|multiple myeloma
628275|NCT00908232|bortezomib|bortezomib
628276|NCT00908232|hematology|hematology
628277|NCT00908232|bone marrow cancer|bone marrow cancer
628278|NCT00908232|immunoglobulin|immunoglobulin
628279|NCT00908232|refractory|refractory
628281|NCT00908232|dexamethasone|dexamethasone
628282|NCT00908232|lenalidomide|lenalidomide
628283|NCT00908232|cyclophosphamide|cyclophosphamide
628284|NCT00908219|malignant ascites|malignant ascites
628285|NCT00908219|bevacizumab|bevacizumab
628286|NCT00908219|vascular endothelial growth factor (VEGF)|vascular endothelial growth factor (vegf)
628287|NCT00908219|paracentesis|paracentesis
628288|NCT00908206|Alcoholism|alcoholism
628289|NCT00908206|Craving|craving
628290|NCT00908206|Dependence|dependence
628291|NCT00908206|Alcohol|alcohol
628292|NCT00908193|Treatment of abdominal ruptured|treatment of abdominal ruptured
628293|NCT00908193|Digestive system disease|digestive system disease
628294|NCT00908193|Coelioscopy|coelioscopy
628295|NCT00908193|Assistance robotics|assistance robotics
628296|NCT00908193|Medical device|medical device
628297|NCT00908193|DA VINCI Robot|da vinci robot
628298|NCT00908193|Pain patient|pain patient
628299|NCT00908193|Morphine consumption|morphine consumption
628300|NCT00908193|Comparative Randomized study|comparative randomized study
628301|NCT00908193|patient over 18 years|patient over 18 years
628302|NCT00908193|with ruptured abdominal|with ruptured abdominal
628303|NCT00908193|with an indication of treatment of ruptured|with an indication of treatment of ruptured
628304|NCT00908180|recurrent adult Hodgkin lymphoma|recurrent adult hodgkin lymphoma
628305|NCT00908167|sorafenib|sorafenib
628306|NCT00908167|cytarabine|cytarabine
628307|NCT00908167|clofarabine|clofarabine
628308|NCT00908167|acute myeloid leukemia|acute myeloid leukemia
628309|NCT00908167|acute promyelocytic leukemia|acute promyelocytic leukemia
628310|NCT00908167|acute lymphoblastic leukemia|acute lymphoblastic leukemia
628311|NCT00908154|sodium channel blocker|sodium channel blocker
628312|NCT00908154|bipolar disorder|bipolar disorder
628313|NCT00908154|repeat dose|repeat dose
628314|NCT00908141|adenocarcinoma of the prostate|adenocarcinoma of the prostate
628315|NCT00908141|recurrent prostate cancer|recurrent prostate cancer
628316|NCT00908128|Bioequivalence|bioequivalence
628317|NCT00908128|Healthy Subjects|healthy subjects
628318|NCT00908102|low back pain|low back pain
628319|NCT00908102|recurrent|recurrent
628320|NCT00908102|subacute|subacute
628321|NCT00908102|secondary prevention|secondary prevention
628322|NCT00908102|primary care|primary care
628323|NCT00908102|occupational health|occupational health
628324|NCT00908102|back book|back book
628325|NCT00908102|rehabilitation|rehabilitation
628326|NCT00908089|rheumatoid arthritis|rheumatoid arthritis
628327|NCT00908089|methotrexate|methotrexate
628328|NCT00908089|sulfasalazine|sulfasalazine
628329|NCT00908089|hydroxychloroquine|hydroxychloroquine
628330|NCT00908089|infliximab|infliximab
628331|NCT00908076|constipation|constipation
628332|NCT00908076|Parkinson's disease|parkinson's disease
628333|NCT00908063|TBI|tbi
628334|NCT00908063|Traumatic Brain Injury|traumatic brain injury
628335|NCT00908050|bruxism, botulinum toxin, sleep study|bruxism, botulinum toxin, sleep study
628336|NCT00908037|idiopathic thrombocytopenic purpura|idiopathic thrombocytopenic purpura
628337|NCT00908037|thrombocytopenia|thrombocytopenia
628338|NCT00908037|pharmacodynamics|pharmacodynamics
628339|NCT00908037|ITP|itp
628340|NCT00908037|eltrombopag|eltrombopag
628341|NCT00908037|pharmacokinetics|pharmacokinetics
628342|NCT00908037|chronic ITP|chronic itp
628343|NCT00908037|pediatrics|pediatrics
628344|NCT00908011|Hypercholesterolemia|hypercholesterolemia
628345|NCT00908011|HIV|hiv
628346|NCT00908011|Ezetimibe|ezetimibe
628347|NCT00908011|Statin|statin
628348|NCT00908011|Apolipoprotein B100/Apolipoprotein A1 ratio|apolipoprotein b100/apolipoprotein a1 ratio
628349|NCT00907998|Coronary heart disease|coronary heart disease
628350|NCT00907998|APL180|apl180
628351|NCT00907985|Healthy Volunteer|healthy volunteer
628352|NCT00907985|Resting motor threshold (rMT)|resting motor threshold (rmt)
628353|NCT00907985|Transcranial magnetic stimulation (TMS)|transcranial magnetic stimulation (tms)
628354|NCT00907972|Parkinson's Disease|parkinson's disease
628355|NCT00907972|Parkinson Disease|parkinson disease
628356|NCT00907972|PD|pd
628357|NCT00907972|Movement Disorder|movement disorder
628358|NCT00907946|Renal stones|renal stones
628359|NCT00907907|Bioequivalence|bioequivalence
628360|NCT00907907|Subjects|subjects
628361|NCT00907894|Chronic hepatitis B,|chronic hepatitis b,
628362|NCT00907894|telbivudine,|telbivudine,
628363|NCT00907894|pharmacokinetics,|pharmacokinetics,
628364|NCT00907894|safety,|safety,
628365|NCT00907894|tolerability,|tolerability,
628366|NCT00907894|pediatric|pediatric
628367|NCT00907868|ductal breast carcinoma in situ|ductal breast carcinoma in situ
628368|NCT00907855|Ischemic Heart Disease|ischemic heart disease
628369|NCT00907855|Duke Activity Status Index|duke activity status index
628370|NCT00907855|Stress Myocardial Perfusion Imaging|stress myocardial perfusion imaging
628371|NCT00907842|stoma|stoma
628372|NCT00907829|stroke|stroke
628373|NCT00907829|fingertip force|fingertip force
628374|NCT00907829|muscle coordination|muscle coordination
628375|NCT00907816|this study does not look at patient conditions|this study does not look at patient conditions
628376|NCT00907803|Orthopoxvirus|orthopoxvirus
628377|NCT00907803|Smallpox|smallpox
629056|NCT00905021|Metastatic|metastatic
628378|NCT00907803|This is a safety study only|this is a safety study only
628379|NCT00907803|ST-246 is being studied for treatment of Orthopoxviruses|st-246 is being studied for treatment of orthopoxviruses
628380|NCT00907790|Irritable Bowel Syndrome|irritable bowel syndrome
628381|NCT00907790|Cognitive Therapy|cognitive therapy
628382|NCT00907790|Abdominal Pain|abdominal pain
628383|NCT00907790|Quality of Life|quality of life
628384|NCT00907777|Haemophilus influenzae|haemophilus influenzae
628385|NCT00907777|Streptococcus pneumoniae|streptococcus pneumoniae
628387|NCT00907777|Pneumococcal conjugate vaccine|pneumococcal conjugate vaccine
628388|NCT00907777|immunogenicity|immunogenicity
628389|NCT00907725|medical abortion|medical abortion
628390|NCT00907725|serum BhCG follow-up|serum bhcg follow-up
628391|NCT00907725|ultrasonographic follow-up|ultrasonographic follow-up
628392|NCT00907725|follow-up methods|follow-up methods
628393|NCT00907712|amputation|amputation
628394|NCT00907712|vascular|vascular
628395|NCT00907712|below knee|below knee
628396|NCT00907712|above knee|above knee
628397|NCT00907712|cardiovascular|cardiovascular
628398|NCT00907712|echo|echo
628399|NCT00907712|cardiovascular assessment|cardiovascular assessment
628400|NCT00907699|recurrent non-small cell lung cancer|recurrent non-small cell lung cancer
628401|NCT00907699|stage IIIB non-small cell lung cancer|stage iiib non-small cell lung cancer
628524|NCT00907166|Phase I|phase i
628402|NCT00907699|stage IV non-small cell lung cancer|stage iv non-small cell lung cancer
628403|NCT00907686|Transfusion Transmitted Cytomegalovirus (TT-CMV)|transfusion transmitted cytomegalovirus (tt-cmv)
628404|NCT00907686|Low birthweight infants (LBWIs)|low birthweight infants (lbwis)
628405|NCT00907686|Leukoreduction and filter failure|leukoreduction and filter failure
628406|NCT00907686|CMV Seronegative blood products|cmv seronegative blood products
628407|NCT00907660|Obesity|obesity
628408|NCT00907660|Weight loss|weight loss
628409|NCT00907660|Meal replacements|meal replacements
628410|NCT00907660|Health services research|health services research
628411|NCT00907634|cervix|cervix
628412|NCT00907634|cervical|cervical
628413|NCT00907634|radiation|radiation
628414|NCT00907621|Infant Colic|infant colic
628415|NCT00907621|Acupuncture|acupuncture
628416|NCT00907621|General Practice|general practice
628417|NCT00907595|Huntington's chorea|huntington's chorea
628418|NCT00907595|Huntington's Disease|huntington's disease
628419|NCT00907595|Parkinson's Disease|parkinson's disease
628420|NCT00907595|Parkinsonism|parkinsonism
628421|NCT00907595|Dementia|dementia
628422|NCT00907595|Dementia with Lewy Bodies|dementia with lewy bodies
628423|NCT00907595|Actigraphy|actigraphy
628424|NCT00907595|Circadian dysregulation|circadian dysregulation
628425|NCT00907595|Sleep Disorders|sleep disorders
628426|NCT00907595|Circadian rhythm|circadian rhythm
628427|NCT00907582|PCR negative|pcr negative
628428|NCT00907569|Small cell lung cancer|small cell lung cancer
628429|NCT00907569|radiotherapy dose escalation|radiotherapy dose escalation
628430|NCT00907543|esophageal carcinoma|esophageal carcinoma
628431|NCT00907543|chemotherapy|chemotherapy
628432|NCT00907543|radiation|radiation
628433|NCT00907543|surgery|surgery
628434|NCT00907543|randomized clinical trial|randomized clinical trial
628435|NCT00907543|Clinical Trial|clinical trial
628436|NCT00907543|Radiotherapy|radiotherapy
628437|NCT00907491|Cough|cough
628438|NCT00907491|Wheeze Rate|wheeze rate
628439|NCT00907491|Respiratory Function Tests|respiratory function tests
628440|NCT00907478|Idiopathic Thrombocytopenic Purpura|idiopathic thrombocytopenic purpura
628441|NCT00907478|Idiopathic Thrombocytopenia Purpura|idiopathic thrombocytopenia purpura
628442|NCT00907478|Immune Thrombocytopenic Purpura|immune thrombocytopenic purpura
628443|NCT00907478|Immune Thrombocytopenia|immune thrombocytopenia
628444|NCT00907478|ITP|itp
628445|NCT00907452|Pharmacogenomics|pharmacogenomics
628446|NCT00907452|prediction response|prediction response
628447|NCT00907452|prediction adverse event|prediction adverse event
628448|NCT00907439|Diastole, physiopathology|diastole, physiopathology
628449|NCT00907439|coronary artery disease|coronary artery disease
628450|NCT00907439|volatile anesthetic|volatile anesthetic
628451|NCT00907439|sevoflurane|sevoflurane
628452|NCT00907426|eyelashes|eyelashes
628453|NCT00907413|cancer|cancer
628454|NCT00907413|bile duct|bile duct
628455|NCT00907400|Phase 1|phase 1
628456|NCT00907400|Healthy Volunteer|healthy volunteer
628457|NCT00907400|Healthy Volunteer Study|healthy volunteer study
628458|NCT00907387|Lateral Canthal Lines|lateral canthal lines
628459|NCT00907387|Crow's Feet|crow's feet
628460|NCT00907387|Facial Wrinkles|facial wrinkles
628461|NCT00907374|Microalbuminuria|microalbuminuria
628462|NCT00907374|Carotid intima media thickness|carotid intima media thickness
628463|NCT00907374|Endothelial dysfunction|endothelial dysfunction
628464|NCT00907374|Renin angiotensin system|renin angiotensin system
628465|NCT00907374|Diabetic nephropathy|diabetic nephropathy
628466|NCT00907361|pacemaker|pacemaker
628467|NCT00907361|ICD|icd
628468|NCT00907361|Implantable Cardioverter Defibrillator|implantable cardioverter defibrillator
628469|NCT00907361|MRI|mri
628470|NCT00907361|Magnetic Resonance Imaging|magnetic resonance imaging
628471|NCT00907348|NHL|nhl
628472|NCT00907348|Non Hodgkin Lymphoma|non hodgkin lymphoma
628473|NCT00907348|Follicular Lymphoma|follicular lymphoma
628474|NCT00907335|acne|acne
628475|NCT00907335|irritation|irritation
628476|NCT00907335|objective sensory methods|objective sensory methods
628477|NCT00907322|oral, single ascending doses; CYP2D6 metabolizer status; healthy subjects; safety, tolerability, pharmacokinetics|oral, single ascending doses; cyp2d6 metabolizer status; healthy subjects; safety, tolerability, pharmacokinetics
628478|NCT00907309|alcohol abuse|alcohol abuse
628479|NCT00907309|marijuana abuse|marijuana abuse
628480|NCT00907309|drug abuse|drug abuse
628481|NCT00907309|tobacco use|tobacco use
628482|NCT00907309|tobacco dependence|tobacco dependence
628483|NCT00907296|Fracture Healing|fracture healing
628484|NCT00907296|Tibial Diaphyseal Fracture|tibial diaphyseal fracture
628485|NCT00907283|NBIA|nbia
628486|NCT00907283|Iron overload AND brain|iron overload and brain
628487|NCT00907283|Iron chelation AND neurodegeneration|iron chelation and neurodegeneration
628488|NCT00907283|Brain iron Overload|brain iron overload
628489|NCT00907283|Neurodegeneration|neurodegeneration
628490|NCT00907283|Brain iron Accumulation|brain iron accumulation
628491|NCT00907257|acne|acne
628492|NCT00907257|irritation|irritation
628493|NCT00907257|objective sensory methods|objective sensory methods
628494|NCT00907218|ADHD|adhd
628495|NCT00907218|Attention Deficit Hyperactivity Disorder|attention deficit hyperactivity disorder
628496|NCT00907218|ADHD medication|adhd medication
628497|NCT00907218|Chantix|chantix
628498|NCT00907218|varenicline|varenicline
628499|NCT00907218|smoking|smoking
628500|NCT00907218|smoking cessation|smoking cessation
628501|NCT00907218|quit smoking|quit smoking
628502|NCT00907205|Advanced Solid Tumors|advanced solid tumors
628503|NCT00907205|Metastatic Solid Tumors|metastatic solid tumors
628504|NCT00907205|PI3K|pi3k
628505|NCT00907205|PI3K Inhibitors|pi3k inhibitors
628506|NCT00907205|PI3 Kinase Inhibitors|pi3 kinase inhibitors
628507|NCT00907205|mTORC inhibitor|mtorc inhibitor
628508|NCT00907205|mTORC1 inhibitor|mtorc1 inhibitor
628509|NCT00907205|mTORC2 inhibitor|mtorc2 inhibitor
628510|NCT00907205|vascular targeted|vascular targeted
628511|NCT00907205|conjugate|conjugate
628512|NCT00907192|Cancer|cancer
628513|NCT00907192|Opioid analgesic prescriptions|opioid analgesic prescriptions
628514|NCT00907192|Narcotic pain drugs|narcotic pain drugs
628515|NCT00907192|Self-report|self-report
628516|NCT00907192|Questionnaire|questionnaire
628517|NCT00907192|Interview|interview
628518|NCT00907192|Actual use|actual use
628519|NCT00907192|Doctor-prescribed use|doctor-prescribed use
628520|NCT00907192|Frequency of deviation|frequency of deviation
628521|NCT00907166|Cornerstone Pharmaceuticals, Inc.|cornerstone pharmaceuticals, inc.
628522|NCT00907166|CPI-613|cpi-613
628523|NCT00907166|Altered Energy Metabolism Directed Compound|altered energy metabolism directed compound
628525|NCT00907166|Phase II|phase ii
628526|NCT00907166|Cancer|cancer
628527|NCT00907166|Carcinoma of the Pancreas|carcinoma of the pancreas
628528|NCT00907166|Pancreatic Cancer|pancreatic cancer
628529|NCT00907166|Pancreatic Carcinoma|pancreatic carcinoma
628530|NCT00907153|Polycystic Ovary Syndrome|polycystic ovary syndrome
628531|NCT00907153|Vitamin D|vitamin d
628532|NCT00907153|Insulin resistance|insulin resistance
628533|NCT00907153|Inflammation|inflammation
628534|NCT00907140|Cervical Cancer|cervical cancer
628535|NCT00907140|Positron Emission Tomography|positron emission tomography
628536|NCT00907140|Fluorodeoxyglucose|fluorodeoxyglucose
628537|NCT00907127|Metabolic|metabolic
628538|NCT00907127|Syndrome|syndrome
628539|NCT00907127|CAN|can
628540|NCT00907114|proliferative diabetic retinopathy|proliferative diabetic retinopathy
628541|NCT00907114|macular edema|macular edema
628542|NCT00907114|panphotocoagulation|panphotocoagulation
628543|NCT00907114|topic ketorolac|topic ketorolac
628544|NCT00907114|efficacy|efficacy
628545|NCT00907114|treatment|treatment
628546|NCT00907088|Iron depletion|iron depletion
628547|NCT00907088|Children|children
628548|NCT00907088|Educational intervention|educational intervention
628549|NCT00907088|Office-based|office-based
628550|NCT00907075|diabetes|diabetes
628551|NCT00907075|nutrition|nutrition
628552|NCT00907075|diet|diet
628553|NCT00907075|foods|foods
628554|NCT00907062|vitiligo|vitiligo
628555|NCT00907062|leucoderma|leucoderma
628556|NCT00907049|quality of sleep|quality of sleep
628557|NCT00907049|neck pain|neck pain
628558|NCT00907049|disability|disability
628559|NCT00907049|catastrophizing|catastrophizing
628560|NCT00907049|depression|depression
628561|NCT00907036|recurrent adult Hodgkin lymphoma|recurrent adult hodgkin lymphoma
628562|NCT00907023|solid organ transplant|solid organ transplant
628563|NCT00907023|hospital discharge|hospital discharge
628564|NCT00907010|Ageing|ageing
628565|NCT00907010|Sarcopenia|sarcopenia
628566|NCT00907010|Muscular contraction|muscular contraction
628567|NCT00906997|Colorectal cancer|colorectal cancer
628568|NCT00906997|Screening|screening
628569|NCT00906997|Prevention|prevention
628570|NCT00906997|Fecal occult blood test|fecal occult blood test
628571|NCT00906997|Colonoscopy|colonoscopy
629297|NCT00904358|ultrasound|ultrasound
628572|NCT00906997|Colorectal neoplasm|colorectal neoplasm
628573|NCT00906997|Randomized clinical trial|randomized clinical trial
628574|NCT00906984|Hepatocellular carcinoma|hepatocellular carcinoma
628575|NCT00906984|Liver cancer|liver cancer
628576|NCT00906984|Primary liver cancer|primary liver cancer
628577|NCT00906984|Unresectable liver cancer|unresectable liver cancer
628578|NCT00906984|Unresectable hepatocellular carcinoma|unresectable hepatocellular carcinoma
628579|NCT00906984|TheraSphere|therasphere
628580|NCT00906971|Physical Therapy|physical therapy
628581|NCT00906971|Chronic Functional Constipation|chronic functional constipation
628582|NCT00906971|Children|children
628583|NCT00906945|stem cell mobilization|stem cell mobilization
628584|NCT00906945|chemosensitization|chemosensitization
628585|NCT00906945|CXCR4|cxcr4
628586|NCT00906945|SDF-1|sdf-1
628587|NCT00906945|CXCL-12|cxcl-12
628588|NCT00906932|Fiberoptic intubation|fiberoptic intubation
628589|NCT00906932|direct laryngoscopy|direct laryngoscopy
628590|NCT00906932|Trachview|trachview
628591|NCT00906932|Comparison of a fiberoptic intubating videoscope to direct laryngoscopy.|comparison of a fiberoptic intubating videoscope to direct laryngoscopy.
628592|NCT00906919|self-efficacy|self-efficacy
628593|NCT00906919|health behavior|health behavior
628594|NCT00906919|patient education|patient education
628595|NCT00906919|health education|health education
628596|NCT00906893|[18F]-FMISO uptake|[18f]-fmiso uptake
628597|NCT00906893|Glioblastoma|glioblastoma
628598|NCT00906893|Hypoxia|hypoxia
628599|NCT00906893|tumours|tumours
628600|NCT00906880|Human African Trypanosomiasis|human african trypanosomiasis
628601|NCT00906880|HAT|hat
628602|NCT00906880|sleeping sickness|sleeping sickness
628603|NCT00906880|combination treatment|combination treatment
628604|NCT00906880|nifurtimox|nifurtimox
628605|NCT00906880|eflornithine|eflornithine
628606|NCT00906880|Human African Trypanosomiasis in the meningo-encephalitic phase (stage 2 HAT)|human african trypanosomiasis in the meningo-encephalitic phase (stage 2 hat)
628607|NCT00906867|Vocal cord dysfunction|vocal cord dysfunction
628608|NCT00906867|Laryngoscopy|laryngoscopy
628609|NCT00906867|Methacholine challenge|methacholine challenge
628610|NCT00906867|Pulmonary function testing|pulmonary function testing
628611|NCT00906854|urinary incontinence|urinary incontinence
628612|NCT00906854|physical exercise|physical exercise
628613|NCT00906841|Disseminated diffuse large B-cell lymphoma|disseminated diffuse large b-cell lymphoma
628614|NCT00906841|first line treatment|first line treatment
628615|NCT00906841|R CHOP|r chop
628616|NCT00906841|90Y-DOTA-hLL2|90y-dota-hll2
628617|NCT00906841|Patients older than 60 years|patients older than 60 years
628618|NCT00906828|Levodopa/carbidopa infusion|levodopa/carbidopa infusion
628619|NCT00906828|entacapone|entacapone
628620|NCT00906828|tolcapone|tolcapone
628621|NCT00906828|efficacy|efficacy
628622|NCT00906828|pharmacokinetic|pharmacokinetic
628623|NCT00906828|pharmacodynamics|pharmacodynamics
628624|NCT00906802|pancreaticoduodenectomy|pancreaticoduodenectomy
628625|NCT00906802|reconstruction|reconstruction
628626|NCT00906789|Lung Cancer|lung cancer
628627|NCT00906789|Chest Radiograph|chest radiograph
628628|NCT00906789|Computer-aided Detection|computer-aided detection
628629|NCT00906789|Image processing|image processing
628630|NCT00906763|Parkinson's disease|parkinson's disease
628631|NCT00906763|Neurodegenerative Disorders|neurodegenerative disorders
628632|NCT00906763|Biogenic amines|biogenic amines
628633|NCT00906763|Chocolate|chocolate
628634|NCT00906763|Cocoa|cocoa
628635|NCT00906750|FLuMIST|flumist
628636|NCT00906750|Inactivated influenza vaccine|inactivated influenza vaccine
628637|NCT00906750|Study of FluMist versus inactivated influenza vaccine in children with cancer|study of flumist versus inactivated influenza vaccine in children with cancer
628638|NCT00906737|Multiple Sclerosis|multiple sclerosis
628639|NCT00906737|Gait|gait
628640|NCT00906737|foot-drop|foot-drop
628641|NCT00906737|Ankle-Bot|ankle-bot
628642|NCT00906737|Physical Therapy|physical therapy
628643|NCT00906737|Gait Abnormalities|gait abnormalities
628644|NCT00906711|Aging|aging
628645|NCT00906711|Postural Balance|postural balance
628646|NCT00906685|CRVO|crvo
628647|NCT00906685|anti-VEGF|anti-vegf
628648|NCT00906685|Macular edema|macular edema
628649|NCT00906672|Dermal substitute Integra®|dermal substitute integra®
628650|NCT00906672|Flap|flap
628651|NCT00906672|graft|graft
628652|NCT00906672|traumatic wound|traumatic wound
628653|NCT00906672|medico economic costs|medico economic costs
628654|NCT00906672|esthetical and functional scar results|esthetical and functional scar results
628655|NCT00906659|center point thickness|center point thickness
628656|NCT00906659|diabetic retinopathy|diabetic retinopathy
628657|NCT00906659|diabetic macular edema|diabetic macular edema
628658|NCT00906659|macular volume|macular volume
628659|NCT00906659|visual capacity|visual capacity
628660|NCT00906659|visual function|visual function
628661|NCT00906646|cardiac|cardiac
628662|NCT00906646|surgery|surgery
628663|NCT00906646|metabolic|metabolic
628664|NCT00906646|supplements|supplements
628665|NCT00906646|antioxidant|antioxidant
628666|NCT00906633|antifungal therapies|antifungal therapies
628768|NCT00906113|Retinoblastoma|retinoblastoma
628667|NCT00906620|Data on student's healthy and at-risk lifestyles and their relation with health measured by well-being, depression and suicidality|data on student's healthy and at-risk lifestyles and their relation with health measured by well-being, depression and suicidality
628668|NCT00906607|Urinary Incontinence|urinary incontinence
628669|NCT00906581|Depression|depression
628670|NCT00906568|Cystic fibrosis|cystic fibrosis
628671|NCT00906568|Sensitization to Aspergillus|sensitization to aspergillus
628672|NCT00906568|Bronchial allergen challenge|bronchial allergen challenge
628673|NCT00906568|Induced Sputum|induced sputum
628674|NCT00906568|Bronchial inflammation|bronchial inflammation
628675|NCT00906568|Small airways disease (SAD)|small airways disease (sad)
628676|NCT00906542|acute stroke|acute stroke
628677|NCT00906542|ischemic stroke|ischemic stroke
628678|NCT00906542|pneumonia|pneumonia
628679|NCT00906542|chest infection|chest infection
628680|NCT00906542|brain lesion|brain lesion
628681|NCT00906542|lesion topology|lesion topology
628682|NCT00906542|dysphagia|dysphagia
628683|NCT00906542|sympathetic activation|sympathetic activation
628684|NCT00906542|immunosuppression|immunosuppression
628685|NCT00906529|Type 2 Diabetes|type 2 diabetes
628686|NCT00906529|Inpatient|inpatient
628687|NCT00906529|Length of Stay|length of stay
628688|NCT00906529|Blood Glucose Control|blood glucose control
628689|NCT00906516|Recurrent Glioblastoma multiforme (GBM)|recurrent glioblastoma multiforme (gbm)
628690|NCT00906516|Recurrent Brain Tumor|recurrent brain tumor
628691|NCT00906516|Recurrent Brain Disease|recurrent brain disease
628692|NCT00906516|Neuradiab|neuradiab
628693|NCT00906516|Avastin|avastin
628694|NCT00906516|Bevacizumab|bevacizumab
628695|NCT00906503|pulmonary nodule|pulmonary nodule
628696|NCT00906490|Glucose Monitoring|glucose monitoring
628697|NCT00906490|Accurate Blood Glucose Monitoring in critical care setting|accurate blood glucose monitoring in critical care setting
628698|NCT00906451|myocardial infarction|myocardial infarction
628699|NCT00906451|inflammation|inflammation
628700|NCT00906451|endothelial dysfunction|endothelial dysfunction
628701|NCT00906425|Dental Implant|dental implant
628702|NCT00906412|Essential Tremor|essential tremor
628703|NCT00906399|interferon|interferon
628704|NCT00906399|injectable|injectable
628705|NCT00906399|MS|ms
628706|NCT00906399|SC|sc
628707|NCT00906399|PEGylated|pegylated
628708|NCT00906399|Interferon beta-1a|interferon beta-1a
628709|NCT00906399|relapsing|relapsing
628710|NCT00906399|PEG|peg
628711|NCT00906399|multiple sclerosis|multiple sclerosis
628712|NCT00906399|subcutaneous|subcutaneous
628713|NCT00906386|Varenicline|varenicline
628714|NCT00906373|Hepatocellular Carcinoma|hepatocellular carcinoma
628715|NCT00906373|Liver Neoplasms|liver neoplasms
628716|NCT00906373|Antibodies, Monoclonal|antibodies, monoclonal
628717|NCT00906347|Labor augmentation|labor augmentation
628718|NCT00906347|Oral misoprostol|oral misoprostol
628719|NCT00906334|Myelodysplastic Syndrome|myelodysplastic syndrome
628720|NCT00906334|Trisomy 8|trisomy 8
628721|NCT00906334|Intermediate-2 Risk Group|intermediate-2 risk group
628722|NCT00906334|High-Risk Group|high-risk group
628723|NCT00906334|azacitidine|azacitidine
628724|NCT00906334|azacytidine|azacytidine
628725|NCT00906334|Vidaza|vidaza
628726|NCT00906334|decitabine|decitabine
628727|NCT00906334|Dacogen|dacogen
628728|NCT00906321|Web-Based Decision Support|web-based decision support
628729|NCT00906321|Breast Cancer Risk|breast cancer risk
628730|NCT00906295|Hemoglobin|hemoglobin
628731|NCT00906295|Ambulation|ambulation
628732|NCT00906282|neoadjuvant NSCLC|neoadjuvant nsclc
628733|NCT00906282|NSCLC|nsclc
628734|NCT00906282|pemetrexed|pemetrexed
628735|NCT00906269|impotence|impotence
628736|NCT00906269|prostatic neoplasms|prostatic neoplasms
628737|NCT00906269|hyperbaric oxygenation|hyperbaric oxygenation
628738|NCT00906269|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors
628739|NCT00906256|Hepatitis C|hepatitis c
628740|NCT00906256|Pharmacokinetics|pharmacokinetics
628741|NCT00906256|AZD7295|azd7295
628742|NCT00906256|Healthy volunteers|healthy volunteers
628743|NCT00906217|colonoscopy|colonoscopy
628744|NCT00906217|preparation|preparation
628745|NCT00906217|safety|safety
628746|NCT00906217|elderly|elderly
628747|NCT00906204|Renal transplantation|renal transplantation
628748|NCT00906204|Kidney transplantation|kidney transplantation
628749|NCT00906178|HIV prevention|hiv prevention
628750|NCT00906178|technology|technology
628751|NCT00906178|adolescent|adolescent
628752|NCT00906178|developing countries|developing countries
628753|NCT00906152|quality of sleep|quality of sleep
628754|NCT00906152|low back pain|low back pain
628755|NCT00906152|disability|disability
628756|NCT00906152|catastrophizing|catastrophizing
628757|NCT00906152|depression|depression
628758|NCT00906139|Propofol|propofol
628759|NCT00906139|Midazolam|midazolam
628760|NCT00906139|Cirrhosis|cirrhosis
628761|NCT00906139|Gastrointestinal endoscopy|gastrointestinal endoscopy
628762|NCT00906139|Complications|complications
628763|NCT00906139|Sedation|sedation
628764|NCT00906126|oral misoprostol|oral misoprostol
628765|NCT00906126|labor augmentation|labor augmentation
628766|NCT00906126|arrest of dilation|arrest of dilation
628769|NCT00906100|Biventricular ICD|biventricular icd
628770|NCT00906100|AV delay|av delay
628771|NCT00906087|Myocilin gene|myocilin gene
628772|NCT00906087|Glaucoma|glaucoma
628773|NCT00906087|dorzolamide and timolol combination eyedrop|dorzolamide and timolol combination eyedrop
628774|NCT00906074|Surgical Wound Infection|surgical wound infection
628775|NCT00906074|Surgical Site Infection|surgical site infection
628776|NCT00906074|Abdominal Surgery|abdominal surgery
628777|NCT00906061|Carcinoma, Small Cell|carcinoma, small cell
628778|NCT00906061|Lung Neoplasms|lung neoplasms
628779|NCT00906061|Docetaxel|docetaxel
628780|NCT00906061|Gemcitabine|gemcitabine
628782|NCT00906035|Peripheral Arterial Disease|peripheral arterial disease
628783|NCT00906035|PAD|pad
628784|NCT00906035|Claudication|claudication
628785|NCT00906035|Peripheral Vascular Disease|peripheral vascular disease
628786|NCT00906022|Below the Knee|below the knee
628787|NCT00906022|Infrapopliteal arteries|infrapopliteal arteries
628788|NCT00906022|nitinol|nitinol
628789|NCT00906022|limb ischemia|limb ischemia
628790|NCT00906022|claudication|claudication
628791|NCT00906022|self-expanding stent|self-expanding stent
628792|NCT00906022|duplex|duplex
628793|NCT00906022|angiography|angiography
628794|NCT00905983|Carcinoma, Non-Small-Cell|carcinoma, non-small-cell
628795|NCT00905983|Elderly patients|elderly patients
628796|NCT00905983|Docetaxel|docetaxel
628797|NCT00905983|Gemcitabine|gemcitabine
628798|NCT00905957|transversus abdominis plane block|transversus abdominis plane block
628799|NCT00905957|relief|relief
628800|NCT00905944|Left ventricular failure|left ventricular failure
628801|NCT00905944|chronic heart failure|chronic heart failure
628802|NCT00905944|Pacemaker|pacemaker
628803|NCT00905944|Resynchronisation therapy|resynchronisation therapy
628804|NCT00905944|Exercise|exercise
628805|NCT00905944|Endurance exercise|endurance exercise
628806|NCT00905931|Aneurysmal subarachnoid hemorrhage (aSAH)|aneurysmal subarachnoid hemorrhage (asah)
628807|NCT00905931|Cerebral vasospasm|cerebral vasospasm
628808|NCT00905931|impaired cerebral autoregulation|impaired cerebral autoregulation
628809|NCT00905931|transient hyperaemic response test|transient hyperaemic response test
628810|NCT00905931|delayed ischaemic neurological deficits|delayed ischaemic neurological deficits
628811|NCT00905918|colon cancer|colon cancer
628812|NCT00905918|rectal cancer|rectal cancer
628813|NCT00905905|myocardial infarction|myocardial infarction
628814|NCT00905905|systemic inflammatory activity|systemic inflammatory activity
628815|NCT00905905|endothelial function|endothelial function
628816|NCT00905892|overfeeding|overfeeding
628817|NCT00905892|stable isotopes|stable isotopes
628818|NCT00905892|lipoprotein metabolism|lipoprotein metabolism
628819|NCT00905892|lipid oxidation|lipid oxidation
628820|NCT00905892|fat distribution|fat distribution
628821|NCT00905892|gene expression|gene expression
628822|NCT00905892|endotoxemia|endotoxemia
628823|NCT00905892|mass spectrometry/gas chromatography|mass spectrometry/gas chromatography
628824|NCT00905879|Magnetic Resonance Imaging (MRI)|magnetic resonance imaging (mri)
628825|NCT00905879|Observational study|observational study
628826|NCT00905879|Gadobutrol|gadobutrol
628827|NCT00905866|Quality of life|quality of life
628828|NCT00905866|Hyperparathyroidism|hyperparathyroidism
628829|NCT00905853|Ventricular Tachycardia|ventricular tachycardia
628830|NCT00905853|Catheter Ablation|catheter ablation
628831|NCT00905853|ICD therapy|icd therapy
628832|NCT00905853|Antiarrhythmic Drug Therapy|antiarrhythmic drug therapy
628833|NCT00905853|Ischemic Heart Disease|ischemic heart disease
628834|NCT00905827|suicide|suicide
628835|NCT00905827|assessment|assessment
628836|NCT00905827|management|management
628837|NCT00905827|Provider Training|provider training
628838|NCT00905827|health services|health services
628839|NCT00905814|Bioequivalence|bioequivalence
628840|NCT00905801|Non small cell lung cancer|non small cell lung cancer
628841|NCT00905801|NSCLC|nsclc
628842|NCT00905801|CTP|ctp
628843|NCT00905801|Perfusion|perfusion
628844|NCT00905801|Imaging|imaging
628845|NCT00905788|Embryo transfer|embryo transfer
628846|NCT00905788|IVF/ICSI|ivf/icsi
628847|NCT00905788|Embryo expulsion|embryo expulsion
628848|NCT00905775|Isoflurane;|isoflurane;
628849|NCT00905775|Propofol|propofol
628850|NCT00905775|Renal functions tests|renal functions tests
628851|NCT00905775|Cardiovascular tests|cardiovascular tests
628852|NCT00905775|revascularization surgery of the myocardium|revascularization surgery of the myocardium
628853|NCT00905775|extracorporeal circulation|extracorporeal circulation
628854|NCT00905762|pharmacokinetics|pharmacokinetics
628855|NCT00905736|tendon|tendon
628856|NCT00905736|healing|healing
628857|NCT00905736|microcurrent|microcurrent
628858|NCT00905736|chronic tennis elbow|chronic tennis elbow
628859|NCT00905723|climacterium|climacterium
628860|NCT00905723|sexual life|sexual life
628861|NCT00905723|isoflavone|isoflavone
628862|NCT00905723|estrogen|estrogen
628863|NCT00905723|McCoy's sexual questionnaire|mccoy's sexual questionnaire
628864|NCT00905723|Kupperman index|kupperman index
628865|NCT00905710|colorectal adenomas|colorectal adenomas
628866|NCT00905710|colorectal cancer|colorectal cancer
628867|NCT00905710|Lynch syndrome|lynch syndrome
628868|NCT00905710|chromoendoscopy|chromoendoscopy
628869|NCT00905697|Living donor lung transplantation|living donor lung transplantation
628870|NCT00905697|Health-related quality of life|health-related quality of life
628871|NCT00905697|Prognosis|prognosis
628872|NCT00905697|Patient reported outcome|patient reported outcome
628873|NCT00905684|Compliance|compliance
628874|NCT00905684|Hormonal Contraception|hormonal contraception
628875|NCT00905671|Lipid Core Plaque|lipid core plaque
628876|NCT00905671|LCP|lcp
628877|NCT00905671|Bifurcation|bifurcation
628878|NCT00905671|Stenosis|stenosis
628879|NCT00905671|Lesion|lesion
628880|NCT00905671|Angioplasty|angioplasty
628881|NCT00905658|stage IVA cervical cancer|stage iva cervical cancer
628882|NCT00905658|stage IVB cervical cancer|stage ivb cervical cancer
628883|NCT00905658|fallopian tube cancer|fallopian tube cancer
628884|NCT00905658|stage IV ovarian epithelial cancer|stage iv ovarian epithelial cancer
628885|NCT00905658|stage IV ovarian germ cell tumor|stage iv ovarian germ cell tumor
628886|NCT00905658|ovarian sarcoma|ovarian sarcoma
628887|NCT00905658|ovarian stromal cancer|ovarian stromal cancer
628888|NCT00905658|stage IV endometrial carcinoma|stage iv endometrial carcinoma
628889|NCT00905658|stage IV uterine sarcoma|stage iv uterine sarcoma
628890|NCT00905658|stage IVA vaginal cancer|stage iva vaginal cancer
628891|NCT00905658|stage IVB vaginal cancer|stage ivb vaginal cancer
628892|NCT00905658|stage IV vulvar cancer|stage iv vulvar cancer
628893|NCT00905645|Breast Augmentation|breast augmentation
628894|NCT00905645|Breast Reconstruction|breast reconstruction
628895|NCT00905645|Breast Revision|breast revision
628896|NCT00905645|Silicone breast implants|silicone breast implants
628897|NCT00905606|Bioequivalence|bioequivalence
628898|NCT00905606|Healthy Subjects|healthy subjects
628899|NCT00905593|chronic myeloid leukemia,|chronic myeloid leukemia,
628900|NCT00905593|blast crisis,|blast crisis,
628901|NCT00905593|accelerated phase,|accelerated phase,
628902|NCT00905593|nilotinib,|nilotinib,
628903|NCT00905593|imatinib,|imatinib,
628904|NCT00905593|resistant,|resistant,
628905|NCT00905593|intolerant,|intolerant,
628906|NCT00905593|chronic phase|chronic phase
628907|NCT00905580|thyroidectomy|thyroidectomy
628908|NCT00905580|pain, postoperative|pain, postoperative
628909|NCT00905580|pregabalin|pregabalin
628910|NCT00905567|Bioequivalence|bioequivalence
628911|NCT00905567|Healthy Subjects|healthy subjects
628912|NCT00905554|sedation|sedation
628913|NCT00905554|warm water|warm water
628914|NCT00905528|type 2 diabetes mellitus|type 2 diabetes mellitus
628915|NCT00905528|endothelial function|endothelial function
628916|NCT00905528|renal hemodynamics|renal hemodynamics
628917|NCT00905515|Kidney Transplantation|kidney transplantation
628918|NCT00905515|Immunosuppressive Agents|immunosuppressive agents
628919|NCT00905502|Obesity|obesity
628920|NCT00905502|fluid management|fluid management
628921|NCT00905502|postoperative complications|postoperative complications
628922|NCT00905502|bariatric surgery|bariatric surgery
628923|NCT00905502|hemostasis|hemostasis
628924|NCT00905476|NPPV|nppv
628925|NCT00905476|Prognosis|prognosis
628926|NCT00905476|Health-related quality of life|health-related quality of life
628927|NCT00905476|Patient reported outcomes|patient reported outcomes
628928|NCT00905463|Lung transplant candidates|lung transplant candidates
628929|NCT00905463|Health-related quality of life|health-related quality of life
628930|NCT00905463|patient reported outcome|patient reported outcome
628931|NCT00905463|Prognosis|prognosis
628932|NCT00905450|Surgery|surgery
628933|NCT00905437|perioperative|perioperative
628934|NCT00905437|pregabalin|pregabalin
628935|NCT00905437|total hip replacement|total hip replacement
628936|NCT00905437|post-operative pain|post-operative pain
628937|NCT00905411|Overweight|overweight
628938|NCT00905411|blood pressure|blood pressure
628939|NCT00905411|DASH diet|dash diet
628940|NCT00905411|Pacific|pacific
628941|NCT00905411|children|children
628942|NCT00905398|Leukemia|leukemia
628943|NCT00905398|Lymphoblastic|lymphoblastic
628944|NCT00905398|Acute|acute
628945|NCT00905398|Philadelphia|philadelphia
628946|NCT00905398|BCR-ABL|bcr-abl
628947|NCT00905398|Nilotinib|nilotinib
628948|NCT00905398|Treatment|treatment
628949|NCT00905385|nontypeable Haemophilus influenzae, NTHi|nontypeable haemophilus influenzae, nthi
628950|NCT00905346|Bioequivalence|bioequivalence
628951|NCT00905346|Healthy Subjects|healthy subjects
628952|NCT00905333|pharmacokinetics|pharmacokinetics
628953|NCT00905333|candesartan|candesartan
628954|NCT00905333|felodipine|felodipine
628955|NCT00905333|test formulations|test formulations
628956|NCT00905333|Atacand®|atacand®
628957|NCT00905333|Splendil®|splendil®
628958|NCT00905333|healthy volunteers|healthy volunteers
628959|NCT00905333|blood samples|blood samples
628960|NCT00905333|after meal intake interaction|after meal intake interaction
628961|NCT00905333|Kinetic interaction amongst test formulations of Candesartan and Felodipine and the brands Atacand® and Splendil® in healthy volunteers after a fasting period.|kinetic interaction amongst test formulations of candesartan and felodipine and the brands atacand® and splendil® in healthy volunteers after a fasting period.
628962|NCT00905320|Hernia repair|hernia repair
628963|NCT00905307|Schizophrenia|schizophrenia
628964|NCT00905307|Relapsed|relapsed
628965|NCT00905281|Metastatic breast cancer|metastatic breast cancer
628966|NCT00905281|Supportive care|supportive care
628967|NCT00905281|Third or fourth line of chemotherapy|third or fourth line of chemotherapy
628968|NCT00905281|Quality of life|quality of life
628969|NCT00905281|Treatment preferences|treatment preferences
628971|NCT00905268|idebenone|idebenone
628972|NCT00905268|FRDA disease|frda disease
628973|NCT00905255|hyperglycemia|hyperglycemia
628974|NCT00905255|GLP-1|glp-1
628975|NCT00905242|Kidney Transplantation|kidney transplantation
628976|NCT00905242|Gastrointestinal Agents|gastrointestinal agents
628977|NCT00905229|hip fracture|hip fracture
628978|NCT00905229|warfarin|warfarin
628979|NCT00905229|vitamin k|vitamin k
628980|NCT00905229|Phytonadione|phytonadione
628981|NCT00905229|INR level|inr level
628982|NCT00905216|heparin|heparin
628983|NCT00905203|Postmenopausal women|postmenopausal women
628984|NCT00905203|Diabetes|diabetes
628985|NCT00905203|Skin microcirculation|skin microcirculation
628986|NCT00905203|Exercise capacity|exercise capacity
628987|NCT00905203|Skeletal muscle oxygenation|skeletal muscle oxygenation
628988|NCT00905203|Dose-response relationship|dose-response relationship
628989|NCT00905203|postmenopausal diabetic women|postmenopausal diabetic women
628990|NCT00905177|Atrial Fibrillation|atrial fibrillation
628991|NCT00905177|deep vein thrombosis|deep vein thrombosis
628992|NCT00905177|anticoagulation|anticoagulation
628993|NCT00905177|warfarin|warfarin
628994|NCT00905177|coumadin|coumadin
628995|NCT00905164|Bioequivalence|bioequivalence
628996|NCT00905164|Healthy Subjects|healthy subjects
628997|NCT00905151|HIV positive|hiv positive
628998|NCT00905151|AIDS|aids
628999|NCT00905151|antiretroviral|antiretroviral
629000|NCT00905151|Kidney disease|kidney disease
629001|NCT00905151|Antiretroviral Therapy|antiretroviral therapy
629002|NCT00905138|Safety|safety
629003|NCT00905138|Tolerability|tolerability
629004|NCT00905138|Pharmacokinetics|pharmacokinetics
629005|NCT00905125|influenza, trivalent, vaccine, pregnant women|influenza, trivalent, vaccine, pregnant women
629006|NCT00905112|Pregnancy|pregnancy
629007|NCT00905112|Pain|pain
629008|NCT00905112|Musculoskeletal manipulations|musculoskeletal manipulations
629009|NCT00905112|Exercise|exercise
629010|NCT00905086|cognitive/functional effects|cognitive/functional effects
629011|NCT00905086|psychosocial effects of cancer and its treatment|psychosocial effects of cancer and its treatment
629012|NCT00905086|stage I breast cancer|stage i breast cancer
629013|NCT00905086|stage II breast cancer|stage ii breast cancer
629014|NCT00905086|stage IIIA breast cancer|stage iiia breast cancer
629015|NCT00905086|stage IIIB breast cancer|stage iiib breast cancer
629016|NCT00905086|stage IIIC breast cancer|stage iiic breast cancer
629017|NCT00905086|stage I colon cancer|stage i colon cancer
629018|NCT00905086|stage II colon cancer|stage ii colon cancer
629019|NCT00905086|stage III colon cancer|stage iii colon cancer
629020|NCT00905086|stage I rectal cancer|stage i rectal cancer
629021|NCT00905086|stage II rectal cancer|stage ii rectal cancer
629022|NCT00905086|stage III rectal cancer|stage iii rectal cancer
629023|NCT00905086|stage I non-small cell lung cancer|stage i non-small cell lung cancer
629024|NCT00905086|stage II non-small cell lung cancer|stage ii non-small cell lung cancer
629025|NCT00905086|stage IIIA non-small cell lung cancer|stage iiia non-small cell lung cancer
629026|NCT00905086|stage IIIB non-small cell lung cancer|stage iiib non-small cell lung cancer
629027|NCT00905086|stage I prostate cancer|stage i prostate cancer
629028|NCT00905086|stage II prostate cancer|stage ii prostate cancer
629029|NCT00905086|stage III prostate cancer|stage iii prostate cancer
629030|NCT00905086|extensive stage small cell lung cancer|extensive stage small cell lung cancer
629031|NCT00905086|limited stage small cell lung cancer|limited stage small cell lung cancer
629032|NCT00905073|type 1 diabetes mellitus|type 1 diabetes mellitus
629033|NCT00905073|cyclosporin|cyclosporin
629034|NCT00905073|methotrexate|methotrexate
629035|NCT00905073|renal function|renal function
629036|NCT00905060|Newly Diagnosed Glioblastoma Multiforme, vaccine|newly diagnosed glioblastoma multiforme, vaccine
629037|NCT00905047|colo-rectal cancer|colo-rectal cancer
629038|NCT00905047|advanced|advanced
629039|NCT00905047|metastatic|metastatic
629040|NCT00905047|locally advanced or metastatic colo-rectal cancer|locally advanced or metastatic colo-rectal cancer
629041|NCT00905034|Acute lymphoblastic leukemia|acute lymphoblastic leukemia
629042|NCT00905034|ALL|all
629043|NCT00905034|Leukemia|leukemia
629044|NCT00905034|Methotrexate|methotrexate
629045|NCT00905034|Vincristine|vincristine
629046|NCT00905034|PEG-l-asparaginase|peg-l-asparaginase
629047|NCT00905034|PEG asparaginase|peg asparaginase
629048|NCT00905034|Pegaspargase|pegaspargase
629049|NCT00905034|Oncaspar|oncaspar
629050|NCT00905034|Polyethylene Glycol Conjugated Lasparaginase-H|polyethylene glycol conjugated lasparaginase-h
629051|NCT00905034|Dexamethasone|dexamethasone
629052|NCT00905034|Decadron|decadron
629053|NCT00905034|Rituximab|rituximab
629054|NCT00905034|Rituxan|rituxan
629055|NCT00905021|Breast Cancer|breast cancer
629057|NCT00905021|Hormone Receptor Positive|hormone receptor positive
629058|NCT00905008|drug-eluting stent|drug-eluting stent
629059|NCT00905008|bare-metal stent|bare-metal stent
629060|NCT00905008|long-term safety|long-term safety
629061|NCT00905008|mortality|mortality
629062|NCT00905008|stent thrombosis|stent thrombosis
629063|NCT00905008|Angioplasty|angioplasty
629064|NCT00905008|Transluminal|transluminal
629065|NCT00905008|Percutaneous Coronary|percutaneous coronary
629066|NCT00904995|Leukemia|leukemia
629067|NCT00904995|Cancer of the blood|cancer of the blood
629068|NCT00904995|Cancer of the bone marrow|cancer of the bone marrow
629069|NCT00904995|Hematologic malignancy|hematologic malignancy
629070|NCT00904995|Invasive fungal infection|invasive fungal infection
629071|NCT00904995|Voriconazole|voriconazole
629072|NCT00904995|Vfend|vfend
629073|NCT00904995|antifungal prophylaxis|antifungal prophylaxis
629074|NCT00904982|warfarin|warfarin
629075|NCT00904982|coumadin|coumadin
629076|NCT00904982|adherence|adherence
629077|NCT00904982|mechanical heart valves|mechanical heart valves
629078|NCT00904969|Urinary Incontinence, Stress|urinary incontinence, stress
629079|NCT00904969|Intrinsic sphincter deficiency|intrinsic sphincter deficiency
629080|NCT00904969|Secondary|secondary
629081|NCT00904969|Transurethral Resection (TUR)|transurethral resection (tur)
629082|NCT00904969|Transurethral Resection of the Prostate (TURP)|transurethral resection of the prostate (turp)
629083|NCT00904969|Radical prostatectomy|radical prostatectomy
629084|NCT00904969|Open prostatectomy|open prostatectomy
629085|NCT00904969|Post-suprapubic prostatectomy|post-suprapubic prostatectomy
629086|NCT00904956|Latent Tuberculosis Infection|latent tuberculosis infection
629087|NCT00904956|High Resolution Scanners|high resolution scanners
629088|NCT00904956|Dynamic Hypothesis of Latent Tuberculosis Infection|dynamic hypothesis of latent tuberculosis infection
629089|NCT00904943|Bioequivalence|bioequivalence
629090|NCT00904943|Healthy Subjects|healthy subjects
629091|NCT00904930|Tooth mobility assessment|tooth mobility assessment
629092|NCT00904930|Splinting|splinting
629093|NCT00904930|Splint Rigidity|splint rigidity
629094|NCT00904917|African American Mothers|african american mothers
629095|NCT00904917|Children|children
629096|NCT00904917|African American Families|african american families
629097|NCT00904917|Parental Depression|parental depression
629098|NCT00904917|Preventive Intervention|preventive intervention
629099|NCT00904891|Adolescents|adolescents
629100|NCT00904891|Prevention|prevention
629101|NCT00904891|Bibliotherapy|bibliotherapy
629102|NCT00904878|pregnant IBD patients|pregnant ibd patients
629103|NCT00904865|Single port access|single port access
629104|NCT00904865|Laparoscopy|laparoscopy
629105|NCT00904865|cholecystectomy|cholecystectomy
629106|NCT00904865|cholangiography|cholangiography
629107|NCT00904865|cosmesis|cosmesis
629109|NCT00904826|Devic's disease|devic's disease
629110|NCT00904826|Neuromyelitis optica|neuromyelitis optica
629111|NCT00904826|NMO-IgG|nmo-igg
629112|NCT00904826|Aquaporin-4 antibody|aquaporin-4 antibody
629113|NCT00904826|Eculizumab|eculizumab
629114|NCT00904826|Complement|complement
629115|NCT00904813|Rectal cancer|rectal cancer
629116|NCT00904813|Preoperative radiotherapy|preoperative radiotherapy
629117|NCT00904813|Timing of Surgery|timing of surgery
629118|NCT00904813|Prognosis|prognosis
629119|NCT00904800|Phase I|phase i
629120|NCT00904800|Healthy volunteers|healthy volunteers
629121|NCT00904787|Leukemia|leukemia
629122|NCT00904787|Hematologic neoplasms|hematologic neoplasms
629123|NCT00904774|bronchopulmonary dysplasia|bronchopulmonary dysplasia
629124|NCT00904774|neonates|neonates
629125|NCT00904774|lung development|lung development
629126|NCT00904774|prematurity|prematurity
629127|NCT00904761|diabetes mellitus|diabetes mellitus
629128|NCT00904761|autonomic neuropathy|autonomic neuropathy
629129|NCT00904761|exercise training|exercise training
629130|NCT00904761|exercise capacity|exercise capacity
629131|NCT00904761|heart rate variability|heart rate variability
629132|NCT00904748|Sildenafil|sildenafil
629133|NCT00904748|Bio-equivalence|bio-equivalence
629134|NCT00904735|adult grade I meningioma|adult grade i meningioma
629135|NCT00904735|adult grade II meningioma|adult grade ii meningioma
629136|NCT00904735|adult anaplastic meningioma|adult anaplastic meningioma
629137|NCT00904735|adult papillary meningioma|adult papillary meningioma
629138|NCT00904735|recurrent adult brain tumor|recurrent adult brain tumor
629139|NCT00904722|Follicular lymphoma|follicular lymphoma
629140|NCT00904722|Immunotherapy|immunotherapy
629141|NCT00904722|CT-011|ct-011
629142|NCT00904722|Monoclonal Antibody CT-011|monoclonal antibody ct-011
629143|NCT00904722|Rituximab|rituximab
629144|NCT00904722|Rituxan|rituxan
629145|NCT00904696|Irritable bowel syndrome|irritable bowel syndrome
629146|NCT00904696|probiotics|probiotics
629147|NCT00904670|Hyperactivity Attention Deficit Disorder|hyperactivity attention deficit disorder
629148|NCT00904670|ADHD|adhd
629149|NCT00904670|Pediatric Patients|pediatric patients
629150|NCT00904670|Quillivant|quillivant
629151|NCT00904670|methylphenidate|methylphenidate
629152|NCT00904657|pharmacokinetic/pharmacodynamic modeling|pharmacokinetic/pharmacodynamic modeling
629153|NCT00904657|biomarkers (growth factors) as a possible tool of drug effect|biomarkers (growth factors) as a possible tool of drug effect
629154|NCT00904644|HIV|hiv
629155|NCT00904644|antiretroviral treatment|antiretroviral treatment
629156|NCT00904644|Swiss HIV Cohort Study|swiss hiv cohort study
629157|NCT00904644|drug resistance|drug resistance
629158|NCT00904644|integrase inhibitor|integrase inhibitor
629159|NCT00904644|Treatment|treatment
629160|NCT00904618|Suburethral slings|suburethral slings
629161|NCT00904618|Urethra|urethra
629162|NCT00904618|Urinary incontinence|urinary incontinence
629163|NCT00904618|Urinary stress incontinence|urinary stress incontinence
629164|NCT00904592|diabetic retinopathy|diabetic retinopathy
629165|NCT00904592|traditional chinese medicine|traditional chinese medicine
629166|NCT00904579|Organ Transplants|organ transplants
629167|NCT00904579|Immunosuppression|immunosuppression
629168|NCT00904579|Cancer|cancer
629169|NCT00904579|End Stage Renal Disease|end stage renal disease
629170|NCT00904579|ESRD|esrd
629171|NCT00904579|Cancer Risk|cancer risk
629172|NCT00904566|microarray|microarray
629173|NCT00904566|gene expression profiling|gene expression profiling
629174|NCT00904566|MammaPrint|mammaprint
629175|NCT00904566|breast cancer|breast cancer
629176|NCT00904553|Brain|brain
629177|NCT00904553|metastases|metastases
629178|NCT00904527|Relaxation (Schultz)|relaxation (schultz)
629179|NCT00904527|Migraine|migraine
629180|NCT00904527|antipain center|antipain center
629181|NCT00904514|recurrent adult Hodgkin lymphoma|recurrent adult hodgkin lymphoma
629182|NCT00904514|stage IV cutaneous T-cell non-Hodgkin lymphoma|stage iv cutaneous t-cell non-hodgkin lymphoma
629183|NCT00904514|recurrent cutaneous T-cell non-Hodgkin lymphoma|recurrent cutaneous t-cell non-hodgkin lymphoma
629184|NCT00904514|Waldenström macroglobulinemia|waldenström macroglobulinemia
629185|NCT00904514|recurrent adult acute myeloid leukemia|recurrent adult acute myeloid leukemia
629186|NCT00904514|recurrent adult acute lymphoblastic leukemia|recurrent adult acute lymphoblastic leukemia
629187|NCT00904514|relapsing chronic myelogenous leukemia|relapsing chronic myelogenous leukemia
629188|NCT00904514|refractory chronic lymphocytic leukemia|refractory chronic lymphocytic leukemia
629189|NCT00904514|refractory hairy cell leukemia|refractory hairy cell leukemia
629190|NCT00904514|recurrent small lymphocytic lymphoma|recurrent small lymphocytic lymphoma
629191|NCT00904514|recurrent grade 1 follicular lymphoma|recurrent grade 1 follicular lymphoma
629192|NCT00904514|recurrent grade 2 follicular lymphoma|recurrent grade 2 follicular lymphoma
629193|NCT00904514|recurrent grade 3 follicular lymphoma|recurrent grade 3 follicular lymphoma
629194|NCT00904514|recurrent adult diffuse small cleaved cell lymphoma|recurrent adult diffuse small cleaved cell lymphoma
629195|NCT00904514|recurrent adult diffuse mixed cell lymphoma|recurrent adult diffuse mixed cell lymphoma
629196|NCT00904514|recurrent adult diffuse large cell lymphoma|recurrent adult diffuse large cell lymphoma
629197|NCT00904514|recurrent adult immunoblastic large cell lymphoma|recurrent adult immunoblastic large cell lymphoma
629198|NCT00904514|recurrent adult lymphoblastic lymphoma|recurrent adult lymphoblastic lymphoma
629199|NCT00904514|recurrent adult Burkitt lymphoma|recurrent adult burkitt lymphoma
629200|NCT00904514|stage I adult T-cell leukemia/lymphoma|stage i adult t-cell leukemia/lymphoma
629201|NCT00904514|stage II adult T-cell leukemia/lymphoma|stage ii adult t-cell leukemia/lymphoma
629202|NCT00904514|stage III adult T-cell leukemia/lymphoma|stage iii adult t-cell leukemia/lymphoma
629203|NCT00904514|stage IV adult T-cell leukemia/lymphoma|stage iv adult t-cell leukemia/lymphoma
629204|NCT00904514|recurrent adult T-cell leukemia/lymphoma|recurrent adult t-cell leukemia/lymphoma
629205|NCT00904514|prolymphocytic leukemia|prolymphocytic leukemia
629206|NCT00904514|recurrent mantle cell lymphoma|recurrent mantle cell lymphoma
629207|NCT00904514|stage IV mycosis fungoides/Sezary syndrome|stage iv mycosis fungoides/sezary syndrome
629208|NCT00904514|recurrent mycosis fungoides/Sezary syndrome|recurrent mycosis fungoides/sezary syndrome
629209|NCT00904514|recurrent marginal zone lymphoma|recurrent marginal zone lymphoma
629210|NCT00904514|extranodal marginal zone B-cell lymphoma of mucosa-associated lymphoid tissue|extranodal marginal zone b-cell lymphoma of mucosa-associated lymphoid tissue
629211|NCT00904514|nodal marginal zone B-cell lymphoma|nodal marginal zone b-cell lymphoma
629212|NCT00904514|splenic marginal zone lymphoma|splenic marginal zone lymphoma
629213|NCT00904514|stage IV colon cancer|stage iv colon cancer
629214|NCT00904514|stage IV breast cancer|stage iv breast cancer
629215|NCT00904514|recurrent breast cancer|recurrent breast cancer
629216|NCT00904514|stage IV gastric cancer|stage iv gastric cancer
629217|NCT00904514|recurrent gastric cancer|recurrent gastric cancer
629218|NCT00904514|recurrent non-small cell lung cancer|recurrent non-small cell lung cancer
629219|NCT00904514|recurrent pancreatic cancer|recurrent pancreatic cancer
629220|NCT00904514|recurrent colon cancer|recurrent colon cancer
629221|NCT00904514|stage IV esophageal cancer|stage iv esophageal cancer
629222|NCT00904514|recurrent esophageal cancer|recurrent esophageal cancer
629223|NCT00904514|recurrent bladder cancer|recurrent bladder cancer
629224|NCT00904514|stage IV bladder cancer|stage iv bladder cancer
629225|NCT00904514|recurrent ovarian epithelial cancer|recurrent ovarian epithelial cancer
629226|NCT00904514|epithelial mesothelioma|epithelial mesothelioma
629227|NCT00904514|recurrent squamous cell carcinoma of the paranasal sinus and nasal cavity|recurrent squamous cell carcinoma of the paranasal sinus and nasal cavity
629228|NCT00904514|recurrent salivary gland cancer|recurrent salivary gland cancer
629296|NCT00904358|cross sectional area|cross sectional area
629229|NCT00904514|recurrent squamous cell carcinoma of the nasopharynx|recurrent squamous cell carcinoma of the nasopharynx
629230|NCT00904514|stage III cervical cancer|stage iii cervical cancer
629231|NCT00904514|recurrent cervical cancer|recurrent cervical cancer
629232|NCT00904514|stage IVB cervical cancer|stage ivb cervical cancer
629233|NCT00904514|stage IVA cervical cancer|stage iva cervical cancer
629234|NCT00904514|squamous cell lung cancer|squamous cell lung cancer
629235|NCT00904514|stage III ovarian epithelial cancer|stage iii ovarian epithelial cancer
629236|NCT00904514|stage IV ovarian epithelial cancer|stage iv ovarian epithelial cancer
629237|NCT00904514|advanced malignant mesothelioma|advanced malignant mesothelioma
629238|NCT00904514|recurrent malignant mesothelioma|recurrent malignant mesothelioma
629239|NCT00904514|stage IIIA non-small cell lung cancer|stage iiia non-small cell lung cancer
629240|NCT00904514|stage IIIB non-small cell lung cancer|stage iiib non-small cell lung cancer
629241|NCT00904514|stage IV non-small cell lung cancer|stage iv non-small cell lung cancer
712401|NCT00580294|Diabetic Neuropathies|diabetic neuropathies
629242|NCT00904514|recurrent metastatic squamous neck cancer with occult primary|recurrent metastatic squamous neck cancer with occult primary
629243|NCT00904514|ovarian undifferentiated adenocarcinoma|ovarian undifferentiated adenocarcinoma
629244|NCT00904514|ovarian mixed epithelial carcinoma|ovarian mixed epithelial carcinoma
629245|NCT00904514|ovarian serous cystadenocarcinoma|ovarian serous cystadenocarcinoma
629246|NCT00904514|ovarian endometrioid adenocarcinoma|ovarian endometrioid adenocarcinoma
629247|NCT00904514|ovarian clear cell cystadenocarcinoma|ovarian clear cell cystadenocarcinoma
629248|NCT00904514|cervical squamous cell carcinoma|cervical squamous cell carcinoma
629249|NCT00904514|metastatic squamous neck cancer with occult primary squamous cell carcinoma|metastatic squamous neck cancer with occult primary squamous cell carcinoma
629250|NCT00904514|stage III squamous cell carcinoma of the lip and oral cavity|stage iii squamous cell carcinoma of the lip and oral cavity
629251|NCT00904514|stage IV squamous cell carcinoma of the lip and oral cavity|stage iv squamous cell carcinoma of the lip and oral cavity
629252|NCT00904514|recurrent squamous cell carcinoma of the lip and oral cavity|recurrent squamous cell carcinoma of the lip and oral cavity
629253|NCT00904514|stage III squamous cell carcinoma of the oropharynx|stage iii squamous cell carcinoma of the oropharynx
629254|NCT00904514|stage IV squamous cell carcinoma of the oropharynx|stage iv squamous cell carcinoma of the oropharynx
629255|NCT00904514|recurrent squamous cell carcinoma of the oropharynx|recurrent squamous cell carcinoma of the oropharynx
629256|NCT00904514|stage III squamous cell carcinoma of the nasopharynx|stage iii squamous cell carcinoma of the nasopharynx
629257|NCT00904514|stage IV squamous cell carcinoma of the nasopharynx|stage iv squamous cell carcinoma of the nasopharynx
629258|NCT00904514|stage III squamous cell carcinoma of the hypopharynx|stage iii squamous cell carcinoma of the hypopharynx
629259|NCT00904514|stage IV squamous cell carcinoma of the hypopharynx|stage iv squamous cell carcinoma of the hypopharynx
629260|NCT00904514|recurrent squamous cell carcinoma of the hypopharynx|recurrent squamous cell carcinoma of the hypopharynx
629261|NCT00904514|stage III squamous cell carcinoma of the larynx|stage iii squamous cell carcinoma of the larynx
629262|NCT00904514|stage IV squamous cell carcinoma of the larynx|stage iv squamous cell carcinoma of the larynx
629263|NCT00904514|stage III squamous cell carcinoma of the paranasal sinus and nasal cavity|stage iii squamous cell carcinoma of the paranasal sinus and nasal cavity
629264|NCT00904514|stage IV squamous cell carcinoma of the paranasal sinus and nasal cavity|stage iv squamous cell carcinoma of the paranasal sinus and nasal cavity
629265|NCT00904514|fallopian tube cancer|fallopian tube cancer
629266|NCT00904514|primary peritoneal cavity cancer|primary peritoneal cavity cancer
629267|NCT00904514|ovarian carcinosarcoma|ovarian carcinosarcoma
629268|NCT00904514|Brenner tumor|brenner tumor
629269|NCT00904514|untreated metastatic squamous neck cancer with occult primary|untreated metastatic squamous neck cancer with occult primary
629270|NCT00904514|salivary gland squamous cell carcinoma|salivary gland squamous cell carcinoma
629271|NCT00904514|stage III salivary gland cancer|stage iii salivary gland cancer
629272|NCT00904514|stage IV salivary gland cancer|stage iv salivary gland cancer
629273|NCT00904514|stage II pancreatic cancer|stage ii pancreatic cancer
629274|NCT00904514|stage III pancreatic cancer|stage iii pancreatic cancer
629275|NCT00904514|ovarian mucinous cystadenocarcinoma|ovarian mucinous cystadenocarcinoma
629276|NCT00904514|stage IV pancreatic cancer|stage iv pancreatic cancer
629277|NCT00904514|recurrent squamous cell carcinoma of the larynx|recurrent squamous cell carcinoma of the larynx
629278|NCT00904514|adult acute myeloid leukemia with 11q23 (MLL) abnormalities|adult acute myeloid leukemia with 11q23 (mll) abnormalities
629279|NCT00904514|adult acute myeloid leukemia with inv(16)(p13;q22)|adult acute myeloid leukemia with inv(16)(p13;q22)
629280|NCT00904514|adult acute myeloid leukemia with t(15;17)(q22;q12)|adult acute myeloid leukemia with t(15;17)(q22;q12)
629281|NCT00904514|adult acute myeloid leukemia with t(16;16)(p13;q22)|adult acute myeloid leukemia with t(16;16)(p13;q22)
629282|NCT00904514|adult acute myeloid leukemia with t(8;21)(q22;q22)|adult acute myeloid leukemia with t(8;21)(q22;q22)
629283|NCT00904501|Limb ischemia|limb ischemia
629284|NCT00904501|Cell Therapy|cell therapy
629285|NCT00904488|Acute Decompensated Heart Failure|acute decompensated heart failure
629286|NCT00904488|Diuretics|diuretics
629287|NCT00904436|Tetraplegia|tetraplegia
629288|NCT00904436|Breathing Patterns|breathing patterns
629290|NCT00904410|adenocarcinoma|adenocarcinoma
629291|NCT00904410|breast|breast
629292|NCT00904384|HIV+|hiv+
629293|NCT00904384|COPD|copd
629294|NCT00904384|emphysema|emphysema
629295|NCT00904358|internal jugular vein|internal jugular vein
629298|NCT00904358|central venous pressure|central venous pressure
629299|NCT00904345|SCC Head and Neck Cancer|scc head and neck cancer
629300|NCT00904332|Transcranial Magnetic Stimulation (TMS)|transcranial magnetic stimulation (tms)
629301|NCT00904332|Electroencephalogram (EEG)|electroencephalogram (eeg)
629302|NCT00904332|Motor Learning|motor learning
629303|NCT00904332|Health Volunteer|health volunteer
629304|NCT00904332|HV|hv
629305|NCT00904319|osteoarthritis|osteoarthritis
629306|NCT00904319|knee pain|knee pain
629307|NCT00904319|power training|power training
629308|NCT00904319|rehabilitation|rehabilitation
629309|NCT00904306|binge eating|binge eating
629310|NCT00904306|chromium|chromium
629311|NCT00904306|mood|mood
629312|NCT00904306|glucose|glucose
629313|NCT00904306|appetite|appetite
629314|NCT00904293|warfarin|warfarin
629315|NCT00904293|CYP2C9|cyp2c9
629316|NCT00904293|VKOR|vkor
629317|NCT00904293|Coumadin|coumadin
629318|NCT00904293|pharmacogenetics|pharmacogenetics
629319|NCT00904293|pharmacogenomics|pharmacogenomics
629320|NCT00904293|anticoagulation|anticoagulation
629321|NCT00904293|genotype-guided therapy|genotype-guided therapy
629322|NCT00904254|cerebrovascular disorders|cerebrovascular disorders
629323|NCT00904254|symptomatic carotid artery stenosis|symptomatic carotid artery stenosis
629324|NCT00904254|asymptomatic carotid artery stenosis|asymptomatic carotid artery stenosis
629325|NCT00904254|monoclonal antibody|monoclonal antibody
629326|NCT00904254|diagnostics|diagnostics
629327|NCT00904254|molecular target|molecular target
629328|NCT00904254|immunoglobulin Fab fragments|immunoglobulin fab fragments
629329|NCT00904254|physiological effects of drugs|physiological effects of drugs
629330|NCT00904254|Tc99m-pertechnetate|tc99m-pertechnetate
629331|NCT00904254|Fab-fragment of Anti-human CD4|fab-fragment of anti-human cd4
629332|NCT00904254|Antibodies, Monoclonal|antibodies, monoclonal
629333|NCT00904254|Antibodies|antibodies
629334|NCT00904228|hypothermia|hypothermia
629335|NCT00904228|euthermia|euthermia
629336|NCT00904228|hyperthermia|hyperthermia
629337|NCT00904228|mortality|mortality
629338|NCT00904228|morbidity|morbidity
629339|NCT00904228|sepsis|sepsis
629340|NCT00904228|bronchopulmonary dysplasia|bronchopulmonary dysplasia
629341|NCT00904228|intraventricular hemorrhage|intraventricular hemorrhage
629342|NCT00904228|ventilator days|ventilator days
629343|NCT00904150|menstruation|menstruation
629344|NCT00904150|migraine|migraine
629345|NCT00904150|menstrual migraine|menstrual migraine
629346|NCT00904150|genetics|genetics
629347|NCT00904137|Supracondylar fracture|supracondylar fracture
629348|NCT00904137|humerus|humerus
629349|NCT00904137|elbow|elbow
629350|NCT00904124|Dietary fiber|dietary fiber
629351|NCT00904124|guar gum|guar gum
629352|NCT00904124|alginate|alginate
629353|NCT00904124|cellulose|cellulose
629354|NCT00904124|food intake|food intake
629355|NCT00904124|eating behaviour|eating behaviour
629356|NCT00904098|migraine|migraine
629357|NCT00904072|CDSS|cdss
629358|NCT00904072|prescribing error|prescribing error
629359|NCT00904072|prescribing errors influenced by CDSS|prescribing errors influenced by cdss
629360|NCT00904072|CPOE|cpoe
629361|NCT00904046|Uric acid|uric acid
629362|NCT00904046|Nephrolithiasis|nephrolithiasis
629363|NCT00904007|Educational Technology|educational technology
629364|NCT00904007|Hypertension|hypertension
629365|NCT00904007|Education, Professional|education, professional
629366|NCT00903994|Acute Pain|acute pain
629367|NCT00903968|refractory|refractory
629368|NCT00903968|relapsed|relapsed
629369|NCT00903968|bortezomib|bortezomib
629370|NCT00903968|AMD3100|amd3100
629371|NCT00903968|plerixafor|plerixafor
629372|NCT00903955|Mucus|mucus
629373|NCT00903955|COPD|copd
629374|NCT00903955|Chronic Bronchitis|chronic bronchitis
629375|NCT00903916|antipsychotic|antipsychotic
629376|NCT00903916|ghrelin|ghrelin
629377|NCT00903916|PYY|pyy
629378|NCT00903916|appetite|appetite
629379|NCT00903916|weight gain|weight gain
629380|NCT00903903|active synovitis|active synovitis
629381|NCT00903838|Parkinson's disease|parkinson's disease
629382|NCT00903825|femoral artery puncture|femoral artery puncture
629383|NCT00903825|local anesthesia|local anesthesia
629384|NCT00903825|ultrasound guided|ultrasound guided
629385|NCT00903799|Drug-refractory gastroparesis|drug-refractory gastroparesis
629386|NCT00903799|diabetes mellitus induced gastroparesis|diabetes mellitus induced gastroparesis
629387|NCT00903799|Gastric electrical stimulation|gastric electrical stimulation
629388|NCT00903799|Long-term multicenter study|long-term multicenter study
629389|NCT00903786|Seizure|seizure
629390|NCT00903786|epilepsy|epilepsy
629391|NCT00903773|VX-950-TiDP24-C132|vx-950-tidp24-c132
629392|NCT00903773|VX-950-C132|vx-950-c132
629393|NCT00903773|VX-950|vx-950
629394|NCT00903773|HCV|hcv
629395|NCT00903760|Myelodysplastic Syndrome|myelodysplastic syndrome
629396|NCT00903760|MDS|mds
629397|NCT00903760|Leukemia|leukemia
629398|NCT00903760|Decitabine|decitabine
629399|NCT00903760|clofarabine|clofarabine
629400|NCT00903760|Dacogen®|dacogen®
629401|NCT00903760|Clolar®|clolar®
629900|NCT00901836|Sarcoma|sarcoma
629402|NCT00903747|Prucalopride|prucalopride
629403|NCT00903747|safety study|safety study
629404|NCT00903734|Metastatic Cancer|metastatic cancer
629405|NCT00903734|Histology-independent|histology-independent
629406|NCT00903734|EGFR Mutation|egfr mutation
629407|NCT00903734|EGFR inhibitor-sensitive mutation|egfr inhibitor-sensitive mutation
629408|NCT00903734|Erlotinib Hydrochloride|erlotinib hydrochloride
629409|NCT00903734|Tarceva|tarceva
629410|NCT00903734|OSI-774|osi-774
629411|NCT00903734|Cetuximab|cetuximab
629412|NCT00903734|Bortezomib|bortezomib
629413|NCT00903734|Dasatinib|dasatinib
629414|NCT00903708|Advanced Cancers|advanced cancers
629415|NCT00903708|LY2275796|ly2275796
629416|NCT00903708|Eukaryotic initiation factor 4E|eukaryotic initiation factor 4e
629417|NCT00903708|eIF-4E|eif-4e
629418|NCT00903695|Memory XL|memory xl
629419|NCT00903695|Mild Cognitive Impairment|mild cognitive impairment
629420|NCT00903695|cognitive status|cognitive status
629421|NCT00903682|HIV|hiv
629422|NCT00903682|Intelence|intelence
629423|NCT00903682|etravirine|etravirine
629424|NCT00903682|ETR|etr
629425|NCT00903682|TMC125|tmc125
629426|NCT00903682|Sustiva|sustiva
629427|NCT00903682|efavirenz|efavirenz
629428|NCT00903682|EFV|efv
629429|NCT00903682|Non-nucleoside Reverse Transcriptase Inhibitor|non-nucleoside reverse transcriptase inhibitor
629430|NCT00903682|NNRTI|nnrti
629431|NCT00903682|treatment-naive|treatment-naive
629432|NCT00903669|Facial paralysis|facial paralysis
629433|NCT00903669|Muscle tonus|muscle tonus
629434|NCT00903669|Rehabilitation|rehabilitation
629435|NCT00903669|Myofunctional|myofunctional
629436|NCT00903669|Stomatognathic system|stomatognathic system
629437|NCT00903656|metastatic breast cancer|metastatic breast cancer
629438|NCT00903656|Her2|her2
629439|NCT00903656|Lapatinib|lapatinib
629440|NCT00903656|Caelyx|caelyx
629441|NCT00903656|cardiotoxic|cardiotoxic
629442|NCT00903643|Painful Bladder Syndrome|painful bladder syndrome
629443|NCT00903643|Urinary Bladder|urinary bladder
629444|NCT00903630|recurrent ovarian epithelial cancer|recurrent ovarian epithelial cancer
629445|NCT00903630|fallopian tube cancer|fallopian tube cancer
629446|NCT00903630|peritoneal cavity cancer|peritoneal cavity cancer
629447|NCT00903617|lipids|lipids
629448|NCT00903617|HM74A|hm74a
629449|NCT00903604|Cardiac surgery|cardiac surgery
629450|NCT00903604|coronary artery bypass grafting|coronary artery bypass grafting
629451|NCT00903604|valve surgery|valve surgery
629452|NCT00903604|aortic root or ascending aortic aneurysm repair surgery|aortic root or ascending aortic aneurysm repair surgery
629453|NCT00903604|Acute kidney injury|acute kidney injury
629454|NCT00903591|Breast|breast
629455|NCT00903591|cancer|cancer
629456|NCT00903591|09-040|09-040
629457|NCT00903591|blood sample|blood sample
629458|NCT00903591|saliva sample|saliva sample
629459|NCT00903591|WECARE|wecare
629460|NCT00903591|GWA|gwa
629461|NCT00903578|FGF-23|fgf-23
629462|NCT00903578|vitamin D|vitamin d
629463|NCT00903578|phosphate|phosphate
629464|NCT00903578|allograft dysfunction|allograft dysfunction
629465|NCT00903578|mortality|mortality
629466|NCT00903565|genomic profiling|genomic profiling
629467|NCT00903565|gene expression|gene expression
629468|NCT00903565|ColoPrint|coloprint
629469|NCT00903565|adenocarcinoma colon|adenocarcinoma colon
629470|NCT00903565|recurrence risk assessment|recurrence risk assessment
629471|NCT00903565|prospective|prospective
629472|NCT00903539|Peripherally Inserted Central Catheter|peripherally inserted central catheter
629473|NCT00903539|Central Venous Catheter|central venous catheter
629474|NCT00903539|Intravenous Catheter|intravenous catheter
629475|NCT00903539|StatLock|statlock
629476|NCT00903539|Patients indicated to have an intravenous catheter placed|patients indicated to have an intravenous catheter placed
629477|NCT00903526|fungal susceptibility|fungal susceptibility
629478|NCT00903474|anxiety disorder|anxiety disorder
629479|NCT00903474|depression|depression
629480|NCT00903474|cognitive/functional effects|cognitive/functional effects
629481|NCT00903474|psychosocial effects of cancer and its treatment|psychosocial effects of cancer and its treatment
629482|NCT00903474|cancer survivor|cancer survivor
629483|NCT00903474|breast cancer|breast cancer
629484|NCT00903448|Normal Healthy Subject Population|normal healthy subject population
629485|NCT00903435|Cystitis|cystitis
629486|NCT00903435|Urinary|urinary
629487|NCT00903435|Bladder|bladder
629488|NCT00903422|Advanced Myelodysplastic Syndrome|advanced myelodysplastic syndrome
629489|NCT00903422|Thrombocytopenia|thrombocytopenia
629490|NCT00903422|sAML/MDS|saml/mds
629491|NCT00903422|Eltrombopag|eltrombopag
629492|NCT00903422|TPO-R agonist|tpo-r agonist
629493|NCT00903422|de novo AML|de novo aml
629494|NCT00903422|Thrombopoietin|thrombopoietin
629495|NCT00903422|MDS|mds
629496|NCT00903422|Thrombopoietin receptor agonist|thrombopoietin receptor agonist
629497|NCT00903422|secondary Acute Myeloid Leukemia after MDS|secondary acute myeloid leukemia after mds
629498|NCT00903422|Platelets|platelets
629499|NCT00903409|High triglycerides|high triglycerides
629500|NCT00903409|Lovaza|lovaza
629501|NCT00903409|simvastatin|simvastatin
629502|NCT00903409|omega-3-acid ethyl esters|omega-3-acid ethyl esters
629503|NCT00903396|nausea and vomiting|nausea and vomiting
629504|NCT00903396|gastrointestinal carcinoid tumor|gastrointestinal carcinoid tumor
629505|NCT00903396|anal cancer|anal cancer
629506|NCT00903396|carcinoma of the appendix|carcinoma of the appendix
629507|NCT00903396|colon cancer|colon cancer
629508|NCT00903396|rectal cancer|rectal cancer
629509|NCT00903396|extrahepatic bile duct cancer|extrahepatic bile duct cancer
629510|NCT00903396|gallbladder cancer|gallbladder cancer
629511|NCT00903396|gastric cancer|gastric cancer
629512|NCT00903396|liver and intrahepatic biliary tract cancer|liver and intrahepatic biliary tract cancer
629513|NCT00903396|pancreatic cancer|pancreatic cancer
629514|NCT00903396|small intestine cancer|small intestine cancer
629515|NCT00903396|primary peritoneal cavity cancer|primary peritoneal cavity cancer
629516|NCT00903370|Mitral Valve Regurgitation|mitral valve regurgitation
629517|NCT00903370|Mitral Valve Surgery|mitral valve surgery
629518|NCT00903370|Mitral Valve Disease|mitral valve disease
629519|NCT00903370|Ablation, Catheter|ablation, catheter
629520|NCT00903370|Catheter Ablation, Radiofrequency|catheter ablation, radiofrequency
629521|NCT00903357|Atopic dermatitis|atopic dermatitis
629522|NCT00903357|Montelukast|montelukast
629523|NCT00903331|idiopathic pulmonary fibrosis|idiopathic pulmonary fibrosis
629524|NCT00903331|MUSIC|music
629525|NCT00903318|Endocrine|endocrine
629526|NCT00903318|Environmental Chemicals|environmental chemicals
629527|NCT00903318|Male:Female Birth Ratio|male:female birth ratio
629528|NCT00903318|Phthalate Exposure|phthalate exposure
629529|NCT00903318|Generational sex ratio trends|generational sex ratio trends
629530|NCT00903318|Mexican American|mexican american
629531|NCT00903318|Baytown|baytown
629532|NCT00903318|Rio Grande Valley|rio grande valley
629533|NCT00903318|Hidalgo County|hidalgo county
629534|NCT00903318|Texas|texas
629535|NCT00903305|pain|pain
629536|NCT00903305|fatigue|fatigue
629537|NCT00903305|nausea and vomiting|nausea and vomiting
629538|NCT00903305|stage I breast cancer|stage i breast cancer
629539|NCT00903305|stage II breast cancer|stage ii breast cancer
629540|NCT00903305|stage IIIA breast cancer|stage iiia breast cancer
629541|NCT00903305|stage IIIB breast cancer|stage iiib breast cancer
629542|NCT00903305|stage IIIC breast cancer|stage iiic breast cancer
629543|NCT00903292|EGFR|egfr
629544|NCT00903292|NSCLC|nsclc
629545|NCT00903292|EGFR mutation rate|egfr mutation rate
629546|NCT00903279|MRSA colonization|mrsa colonization
629547|NCT00903279|Orthopedic Surgery|orthopedic surgery
629548|NCT00903279|Altabax|altabax
629549|NCT00903279|Placebo|placebo
629550|NCT00903266|Aphasia|aphasia
629551|NCT00903266|Speech Impairment|speech impairment
629552|NCT00903266|Stroke|stroke
629553|NCT00903266|Cerebrovascular Accident|cerebrovascular accident
629554|NCT00903266|Cerebral Infarction|cerebral infarction
629555|NCT00903266|Brain Ischemia|brain ischemia
629556|NCT00903266|Brain Infarction|brain infarction
629557|NCT00903266|Cerebrovascular Disorder|cerebrovascular disorder
629558|NCT00903227|Asthma|asthma
629559|NCT00903227|Allergic rhinitis|allergic rhinitis
629560|NCT00903227|fluticasone|fluticasone
629561|NCT00903227|methacholine|methacholine
629562|NCT00903214|stage I breast cancer|stage i breast cancer
629563|NCT00903214|stage II breast cancer|stage ii breast cancer
629564|NCT00903214|stage IIIA breast cancer|stage iiia breast cancer
629565|NCT00903201|cystic fibrosis|cystic fibrosis
629566|NCT00903188|Renal Transplantation|renal transplantation
629567|NCT00903188|graft function|graft function
629568|NCT00903188|cardiovascular events|cardiovascular events
629569|NCT00903188|malignancy|malignancy
629570|NCT00903188|cyclosporin|cyclosporin
629571|NCT00903188|steroids|steroids
629572|NCT00903188|mycophenolate|mycophenolate
629573|NCT00903188|everolimus|everolimus
629574|NCT00903188|renal biopsies|renal biopsies
629575|NCT00903188|pharmacokinetics|pharmacokinetics
629576|NCT00903175|RAD001|rad001
629577|NCT00903175|everolimus|everolimus
629578|NCT00903175|sunitinib|sunitinib
629579|NCT00903175|renal cell carcinoma|renal cell carcinoma
629580|NCT00903175|kidney cancer|kidney cancer
629581|NCT00903175|metastatic renal cell cancer|metastatic renal cell cancer
629582|NCT00903175|advanced kidney cancer|advanced kidney cancer
629583|NCT00903162|hormone-receptor positive|hormone-receptor positive
629584|NCT00903162|tamoxifen|tamoxifen
629585|NCT00903162|letrozole|letrozole
629586|NCT00903162|zoledronic acid|zoledronic acid
629587|NCT00903162|leuprolide|leuprolide
629588|NCT00903149|Premature babies|premature babies
629589|NCT00903149|Social interaction|social interaction
629590|NCT00903149|Psychoeducative intervention|psychoeducative intervention
629591|NCT00903149|Mother Infant Transaction Program|mother infant transaction program
629592|NCT00903149|Three years follow-up|three years follow-up
629593|NCT00903149|Late preterm|late preterm
629594|NCT00903149|Cognitive development|cognitive development
629595|NCT00903149|Social development|social development
629596|NCT00903149|Emotional development|emotional development
629597|NCT00903149|Motor development|motor development
629598|NCT00903149|Children born preterm and their parents|children born preterm and their parents
629599|NCT00903136|Barrett esophagus|barrett esophagus
629600|NCT00903136|esophageal cancer|esophageal cancer
629601|NCT00903136|adenocarcinoma of the esophagus|adenocarcinoma of the esophagus
629602|NCT00903084|Pharmacokinetics in Hair|pharmacokinetics in hair
629603|NCT00903084|Tenofovir|tenofovir
629604|NCT00903084|Pharmacokinetics|pharmacokinetics
629605|NCT00903084|Concentrations|concentrations
629606|NCT00903084|Hair|hair
629607|NCT00903071|Hypertension|hypertension
629608|NCT00903071|Primary Care|primary care
629609|NCT00903071|Physician Learning|physician learning
629610|NCT00903045|Overactive bladder|overactive bladder
629611|NCT00903045|Propiverin|propiverin
629612|NCT00903032|compliance/adherence|compliance/adherence
629613|NCT00903019|Homebound|homebound
629614|NCT00903019|Older Adults|older adults
629615|NCT00903019|Disability|disability
629616|NCT00903019|Videoconferencing|videoconferencing
629617|NCT00903006|Breast|breast
629618|NCT00903006|Hormone receptor-positive metastatic breast cancer|hormone receptor-positive metastatic breast cancer
629619|NCT00903006|Fulvestrant|fulvestrant
629620|NCT00903006|Faslodex|faslodex
629621|NCT00903006|MK-0646|mk-0646
629622|NCT00903006|Dasatinib|dasatinib
629623|NCT00903006|BMS-354825|bms-354825
629624|NCT00903006|Sprycel|sprycel
629625|NCT00903006|Adjuvant hormonal therapy|adjuvant hormonal therapy
629626|NCT00902993|MAD|mad
629627|NCT00902993|NNR|nnr
629628|NCT00902993|to investigate safety and tolerability in a multiple ascending dose study in Healthy subjects|to investigate safety and tolerability in a multiple ascending dose study in healthy subjects
629629|NCT00902993|AZD1446|azd1446
629630|NCT00902980|Kidney transplantation|kidney transplantation
629631|NCT00902980|Tacrolimus|tacrolimus
629632|NCT00902980|Immunosuppression|immunosuppression
629633|NCT00902967|Postoperative pain|postoperative pain
629634|NCT00902967|atorvastatin|atorvastatin
629635|NCT00902967|analgesic|analgesic
629636|NCT00902967|antiinflammatory|antiinflammatory
629637|NCT00902954|Disease free survival|disease free survival
629638|NCT00902954|Distant disease free survival|distant disease free survival
629639|NCT00902954|Toxicity|toxicity
629640|NCT00902954|Overall survival|overall survival
629641|NCT00902941|Parkinson´s disease|parkinson´s disease
629642|NCT00902941|olfaction|olfaction
629643|NCT00902941|rasagiline|rasagiline
629644|NCT00902941|smell testing|smell testing
629645|NCT00902928|Elective hip replacement surgery|elective hip replacement surgery
629646|NCT00902928|Factor Xa|factor xa
629647|NCT00902928|Venous Thromboembolism|venous thromboembolism
629648|NCT00902928|Thrombosis|thrombosis
629649|NCT00902928|Anticoagulants|anticoagulants
629650|NCT00902928|Prevention|prevention
629651|NCT00902928|YM150|ym150
629652|NCT00902915|multiple myeloma renal insufficiency|multiple myeloma renal insufficiency
629653|NCT00902902|Hepatocellular carcinoma|hepatocellular carcinoma
629654|NCT00902889|Globus pallidus|globus pallidus
629655|NCT00902889|Huntington's Disease|huntington's disease
629656|NCT00902889|Deep Brain Stimulation|deep brain stimulation
629657|NCT00902889|Movement Disorders|movement disorders
629658|NCT00902876|root coverage|root coverage
629659|NCT00902876|gingival recession|gingival recession
629660|NCT00902876|keratinized gingiva|keratinized gingiva
629661|NCT00902863|chronic pain|chronic pain
629662|NCT00902863|mindfulness|mindfulness
629663|NCT00902863|yoga|yoga
629664|NCT00902863|quality of life|quality of life
629665|NCT00902863|stress|stress
629666|NCT00902837|randomised|randomised
629667|NCT00902837|double-blind|double-blind
629668|NCT00902837|double-dummy|double-dummy
629669|NCT00902837|parallel-group|parallel-group
629670|NCT00902837|non-inferiority|non-inferiority
629671|NCT00902837|pain locomotor function|pain locomotor function
629672|NCT00902837|improvement in symptoms of constipation|improvement in symptoms of constipation
629673|NCT00902837|moderate to severe pain due to osteoarthritis (OA)|moderate to severe pain due to osteoarthritis (oa)
629674|NCT00902837|OXN PR|oxn pr
629675|NCT00902837|OxyPR|oxypr
629676|NCT00902837|Moderate to severe chronic nonmalignant OA|moderate to severe chronic nonmalignant oa
629677|NCT00902824|HIV|hiv
629678|NCT00902811|uncomplicated falciparum malaria|uncomplicated falciparum malaria
629679|NCT00902811|artemisinin combination therapy|artemisinin combination therapy
629680|NCT00902798|Autism|autism
629681|NCT00902798|Autism Spectrum Disorders|autism spectrum disorders
629682|NCT00902798|Asperger's Syndrome|asperger's syndrome
629683|NCT00902798|Pervasive Developmental Disorder|pervasive developmental disorder
629684|NCT00902798|Cognition|cognition
629685|NCT00902798|Social Cognition|social cognition
629686|NCT00902798|Psychosocial Treatment|psychosocial treatment
629687|NCT00902798|Cognitive Enhancement Therapy|cognitive enhancement therapy
629688|NCT00902798|Enriched Supportive Therapy|enriched supportive therapy
629689|NCT00902798|Therapy|therapy
629690|NCT00902798|Psychotherapy|psychotherapy
629691|NCT00902785|exploratory|exploratory
629692|NCT00902785|observational|observational
629693|NCT00902785|non-interventional study age-related macular degeneration (AMD) choroidal neovascularization (CNV)|non-interventional study age-related macular degeneration (amd) choroidal neovascularization (cnv)
629694|NCT00902772|Recreational CNS depressant|recreational cns depressant
629695|NCT00902772|Abuse liability|abuse liability
629696|NCT00902772|Abuse potential|abuse potential
629697|NCT00902772|Healthy Recreational CNS Depressant Users|healthy recreational cns depressant users
629698|NCT00902759|Surgery|surgery
629699|NCT00902759|Chemotherapy|chemotherapy
629700|NCT00902759|Radiation Therapy|radiation therapy
629701|NCT00902759|Pancreatic cancer|pancreatic cancer
629702|NCT00902759|Fatigue|fatigue
629703|NCT00902733|pain|pain
629704|NCT00902733|fatigue|fatigue
629705|NCT00902733|nausea and vomiting|nausea and vomiting
629706|NCT00902733|recurrent pancreatic cancer|recurrent pancreatic cancer
629707|NCT00902733|stage I pancreatic cancer|stage i pancreatic cancer
629708|NCT00902733|stage II pancreatic cancer|stage ii pancreatic cancer
629709|NCT00902733|stage III pancreatic cancer|stage iii pancreatic cancer
629710|NCT00902733|stage IV pancreatic cancer|stage iv pancreatic cancer
629711|NCT00902720|Ovarian|ovarian
629712|NCT00902720|Tissue|tissue
629713|NCT00902720|Cryopreservation|cryopreservation
629714|NCT00902707|healthy nonsmokers|healthy nonsmokers
629715|NCT00902694|Serious Mental Illness|serious mental illness
629716|NCT00902694|Weight Loss|weight loss
629717|NCT00902681|Bioequivalence, Pharmacokinetics|bioequivalence, pharmacokinetics
629718|NCT00902668|radiation toxicity|radiation toxicity
629719|NCT00902668|stage IA breast cancer|stage ia breast cancer
629720|NCT00902668|stage IB breast cancer|stage ib breast cancer
629721|NCT00902668|stage II breast cancer|stage ii breast cancer
629722|NCT00902668|breast cancer in situ|breast cancer in situ
629723|NCT00902655|Nocturnal polyuria|nocturnal polyuria
629724|NCT00902655|Nocturnal bladder capacity|nocturnal bladder capacity
629725|NCT00902642|Physical therapy,|physical therapy,
629726|NCT00902642|musculoskeletal pain,|musculoskeletal pain,
629727|NCT00902642|psychosocial factors,|psychosocial factors,
629728|NCT00902642|dissimilation,|dissimilation,
629729|NCT00902642|evidence based,|evidence based,
629730|NCT00902642|education|education
629731|NCT00902629|Epiretinal Fibrosis|epiretinal fibrosis
629732|NCT00902629|Macular Pucker|macular pucker
629733|NCT00902616|Type 2 diabetes|type 2 diabetes
629734|NCT00902616|Peripheral neuropathy|peripheral neuropathy
629735|NCT00902616|Microcirculation|microcirculation
629736|NCT00902603|pulmonary arterial hypertension|pulmonary arterial hypertension
629737|NCT00902603|Ventavis®|ventavis®
629738|NCT00902603|iloprost|iloprost
629739|NCT00902590|renal pelvis|renal pelvis
629740|NCT00902590|ureter|ureter
629741|NCT00902590|bladder|bladder
629742|NCT00902590|09-025|09-025
629743|NCT00902590|Renal Pelvis, Ureter, Bladder Cancer|renal pelvis, ureter, bladder cancer
629744|NCT00902564|Generalized Anxiety Disorder|generalized anxiety disorder
629745|NCT00902564|GAD|gad
629746|NCT00902564|Antidepressant|antidepressant
629747|NCT00902564|Anxiolytic|anxiolytic
629748|NCT00902551|DNA cytometry|dna cytometry
629749|NCT00902551|Cytology|cytology
629750|NCT00902551|Diagnosis accuracy|diagnosis accuracy
629751|NCT00902538|Add on treatment|add on treatment
629752|NCT00902538|essential hypertension|essential hypertension
629753|NCT00902525|two sequential doses of 90Y-Ibritumomab Tiuxetan|two sequential doses of 90y-ibritumomab tiuxetan
629754|NCT00902499|functional magnetic resonance imaging|functional magnetic resonance imaging
629755|NCT00902486|Rheumatoid arthritis|rheumatoid arthritis
629756|NCT00902473|Topiramate fed study|topiramate fed study
629757|NCT00902460|drug interactions CYP3A4 CYP3A5 midazolam anti-rheumatic agents|drug interactions cyp3a4 cyp3a5 midazolam anti-rheumatic agents
629758|NCT00902447|Human Blood Cell Disorders|human blood cell disorders
629759|NCT00902447|lymphoid, myeloid and erythroid proliferative disease|lymphoid, myeloid and erythroid proliferative disease
629760|NCT00902434|Non-Hodgkin's Lymphoma|non-hodgkin's lymphoma
629761|NCT00902421|Overactive bladder|overactive bladder
629762|NCT00902421|SSRI|ssri
629763|NCT00902421|Antimuscarinics|antimuscarinics
629764|NCT00902395|Preschool children|preschool children
629765|NCT00902382|Infertility|infertility
629766|NCT00902382|Ovulation stimulation|ovulation stimulation
629767|NCT00902382|Pregnancy|pregnancy
629768|NCT00902369|AK106-001616|ak106-001616
629769|NCT00902356|Amgen|amgen
629770|NCT00902356|Phase 1|phase 1
629771|NCT00902356|First in Human|first in human
629772|NCT00902356|Postmenopausal|postmenopausal
629773|NCT00902343|Liver|liver
629774|NCT00902343|Cancer|cancer
629775|NCT00902343|Primary|primary
629776|NCT00902343|Metastatic|metastatic
629777|NCT00902343|transfusions|transfusions
629778|NCT00902343|08-158|08-158
629779|NCT00902330|depression|depression
629780|NCT00902330|anxiety disorder|anxiety disorder
629781|NCT00902330|fatigue|fatigue
629782|NCT00902330|pain|pain
629783|NCT00902330|sleep disorders|sleep disorders
629784|NCT00902330|stage IA breast cancer|stage ia breast cancer
629785|NCT00902330|stage IB breast cancer|stage ib breast cancer
629786|NCT00902330|stage II breast cancer|stage ii breast cancer
629787|NCT00902330|stage IIIA breast cancer|stage iiia breast cancer
629788|NCT00902304|Hypertension|hypertension
629789|NCT00902304|valsartan|valsartan
629790|NCT00902291|Clinical Trial, Phase II|clinical trial, phase ii
629791|NCT00902291|Combination Drug Therapy|combination drug therapy
629792|NCT00902291|Gemcitabine|gemcitabine
629793|NCT00902291|AGS-1C4D4|ags-1c4d4
629794|NCT00902291|Pancreatic Cancer|pancreatic cancer
629795|NCT00902278|influenzavirus A|influenzavirus a
629796|NCT00902278|influenzavirus B|influenzavirus b
629797|NCT00902278|human influenza|human influenza
629798|NCT00902278|T lymphocytes|t lymphocytes
629799|NCT00902278|influenza vaccines|influenza vaccines
629800|NCT00902226|Social Anxiety Disorder|social anxiety disorder
629801|NCT00902226|SAD|sad
629802|NCT00902226|Antidepressant|antidepressant
629803|NCT00902226|Anxiolytic|anxiolytic
629804|NCT00902200|Glaucoma|glaucoma
629805|NCT00902200|Intraocular pressure|intraocular pressure
629806|NCT00902187|Bioequivalence|bioequivalence
629807|NCT00902174|Pulmonary arterial hypertension|pulmonary arterial hypertension
629808|NCT00902174|Imatinib|imatinib
629809|NCT00902174|6MWD|6mwd
629810|NCT00902174|Borg scale|borg scale
629811|NCT00902174|Pulmonary hypertension|pulmonary hypertension
629812|NCT00902148|Surgery|surgery
629813|NCT00902148|Colectomy|colectomy
629814|NCT00902148|Proctocolectomy|proctocolectomy
629815|NCT00902148|Adhesions|adhesions
629816|NCT00902135|Multiple Sclerosis|multiple sclerosis
629817|NCT00902135|Interferon beta-1b|interferon beta-1b
629818|NCT00902122|p53 gene|p53 gene
629819|NCT00902122|thyroid|thyroid
629820|NCT00902122|gene therapy|gene therapy
629821|NCT00902122|malignant tumors|malignant tumors
629822|NCT00902109|visual field|visual field
629823|NCT00902109|perimetry|perimetry
629824|NCT00902109|progression|progression
629825|NCT00902109|POAG|poag
629826|NCT00902109|glaucoma|glaucoma
629827|NCT00902096|cord blood|cord blood
629828|NCT00902096|IgE|ige
629829|NCT00902096|prenatal|prenatal
629830|NCT00902096|predictor|predictor
629831|NCT00902083|p53 gene|p53 gene
629832|NCT00902083|Oral and Maxillofacial|oral and maxillofacial
629833|NCT00902083|gene therapy|gene therapy
629834|NCT00902083|malignant tumors|malignant tumors
629835|NCT00902044|Refractory Sarcoma|refractory sarcoma
629836|NCT00902044|Metastatic Sarcoma|metastatic sarcoma
629837|NCT00902044|Sarcoma|sarcoma
629838|NCT00902044|HER2-positive|her2-positive
629839|NCT00902044|Gene Therapy|gene therapy
629840|NCT00902044|HER2-specific T cells|her2-specific t cells
629841|NCT00902031|Docusate|docusate
629842|NCT00902031|Constipation|constipation
629843|NCT00902031|Colace|colace
629844|NCT00902031|Palliative Care|palliative care
629845|NCT00902031|Sennoside|sennoside
629846|NCT00902031|Senokot|senokot
629847|NCT00902031|Terminally Ill|terminally ill
629848|NCT00902031|Stool|stool
629849|NCT00902031|Randomized Trial|randomized trial
629850|NCT00902018|ITP|itp
629851|NCT00902005|Endothelial dysfunction|endothelial dysfunction
629852|NCT00902005|Bone and cartilage markers|bone and cartilage markers
629853|NCT00902005|Inflammatory disease activity|inflammatory disease activity
629854|NCT00902005|Rheumatoid arthritis|rheumatoid arthritis
629855|NCT00902005|Psoriatic arthritis|psoriatic arthritis
629856|NCT00902005|Ankylosing Spondylitis|ankylosing spondylitis
629857|NCT00901992|type 2 diabetes|type 2 diabetes
629858|NCT00901992|education|education
629859|NCT00901992|self-management|self-management
629860|NCT00901992|insulin therapy|insulin therapy
629861|NCT00901979|Type 2 Diabetes|type 2 diabetes
629862|NCT00901966|Melanoma|melanoma
629863|NCT00901966|Sun Exposure History|sun exposure history
629864|NCT00901966|Agricultural Health Study|agricultural health study
629865|NCT00901966|Sun Exposure|sun exposure
629866|NCT00901953|migraine|migraine
629867|NCT00901953|migrainous vertigo|migrainous vertigo
629868|NCT00901953|vestibular evoked myogenic potentials|vestibular evoked myogenic potentials
629869|NCT00901953|vestibular function test|vestibular function test
629870|NCT00901953|vestibular disorders|vestibular disorders
629871|NCT00901927|Lymphoma|lymphoma
629872|NCT00901927|Non-Hodgkin's Lymphoma|non-hodgkin's lymphoma
629873|NCT00901927|Untreated High Risk Follicular Lymphoma|untreated high risk follicular lymphoma
629874|NCT00901927|Bendamustine hydrochloride|bendamustine hydrochloride
629875|NCT00901927|Bendamustine HCI|bendamustine hci
629876|NCT00901927|Bendamustine|bendamustine
629877|NCT00901927|CEP-18083|cep-18083
629878|NCT00901927|SDX-105|sdx-105
629879|NCT00901927|Treanda|treanda
629880|NCT00901927|Mitoxantrone|mitoxantrone
629881|NCT00901927|Novantrone|novantrone
629882|NCT00901927|Rituximab|rituximab
629883|NCT00901927|Rituxan|rituxan
629884|NCT00901914|Hypersensitivity|hypersensitivity
629885|NCT00901914|Allergy|allergy
629886|NCT00901914|Birch, allergy, Sublingual Immunotherapy|birch, allergy, sublingual immunotherapy
629887|NCT00901901|Sorafenib (Nexavar)|sorafenib (nexavar)
629888|NCT00901901|Erlotinib (Tarceva)|erlotinib (tarceva)
629889|NCT00901901|First Line|first line
629891|NCT00901888|Renin Angiotensin System|renin angiotensin system
629892|NCT00901875|Buprenorphine|buprenorphine
629893|NCT00901875|Naloxone|naloxone
629894|NCT00901875|Suboxone|suboxone
629895|NCT00901862|Migraine|migraine
629896|NCT00901862|therapy|therapy
629897|NCT00901862|magnetic therapy|magnetic therapy
629898|NCT00901862|prophylaxis|prophylaxis
629899|NCT00901862|prevention|prevention
629901|NCT00901810|Length Determination|length determination
629902|NCT00901810|Working Length|working length
629903|NCT00901810|Electronic Apex Locator|electronic apex locator
629904|NCT00901810|Root Canal Therapy|root canal therapy
629905|NCT00901810|Endodontics|endodontics
629906|NCT00901797|ABD|abd
629907|NCT00901797|ABDuction|abduction
629908|NCT00901797|ABR|abr
629909|NCT00901797|Arthroscopic Bankart Repair|arthroscopic bankart repair
629910|NCT00901797|ACJ|acj
629911|NCT00901797|AcromioClavicular Joint|acromioclavicular joint
629912|NCT00901797|AD|ad
629913|NCT00901797|Anterior Drawer|anterior drawer
629914|NCT00901797|ARIC|aric
629915|NCT00901797|Arthroscopic Rotator Interval Closure|arthroscopic rotator interval closure
629916|NCT00901797|BL|bl
629917|NCT00901797|Bankart Lesion|bankart lesion
629918|NCT00901797|CHL|chl
629919|NCT00901797|CoracoHumeral Ligament|coracohumeral ligament
629920|NCT00901797|ER|er
629921|NCT00901797|External Rotation|external rotation
629922|NCT00901797|FF|ff
629923|NCT00901797|Forward Flexion|forward flexion
629924|NCT00901797|GHJ|ghj
629925|NCT00901797|GlenoHumeral Joint|glenohumeral joint
629926|NCT00901797|HSL|hsl
629927|NCT00901797|HillSacs Lesion|hillsacs lesion
629928|NCT00901797|IR|ir
629929|NCT00901797|Internal Rotation|internal rotation
629930|NCT00901797|ISP|isp
629931|NCT00901797|InfraSPinatus|infraspinatus
629932|NCT00901797|PD|pd
629933|NCT00901797|Posterior Drawer|posterior drawer
629934|NCT00901797|RI|ri
629935|NCT00901797|Rotator Interval|rotator interval
629936|NCT00901797|ROM|rom
629937|NCT00901797|Range Of Motion|range of motion
629938|NCT00901797|SGHL|sghl
629939|NCT00901797|Superior GlenoHumeral Ligament|superior glenohumeral ligament
629940|NCT00901797|SSC|ssc
629941|NCT00901797|SubSCapularis|subscapularis
629942|NCT00901797|SSP|ssp
629943|NCT00901797|SupraSPinatus|supraspinatus
629944|NCT00901784|Topiramate fasting study|topiramate fasting study
629945|NCT00901771|Sleep|sleep
629946|NCT00901771|Sleep Apnea, Obstructive|sleep apnea, obstructive
629947|NCT00901771|OSA|osa
629948|NCT00901771|OSAH|osah
629949|NCT00901745|Renin angiotensin system|renin angiotensin system
629950|NCT00901745|Apelin|apelin
629951|NCT00901745|Vasodilatation|vasodilatation
629952|NCT00901745|Heart disease|heart disease
629953|NCT00901745|Vascular biology|vascular biology
629954|NCT00901732|Caphosol|caphosol
629955|NCT00901732|Oral Mucositis|oral mucositis
629956|NCT00901732|Eusa Pharma|eusa pharma
629957|NCT00901732|Moffitt Cancer Center|moffitt cancer center
629958|NCT00901719|Renin angiotensin system|renin angiotensin system
629959|NCT00901719|Apelin|apelin
629960|NCT00901719|Cardiac output|cardiac output
629961|NCT00901719|Vasodilatation|vasodilatation
629962|NCT00901706|Self-Neglect|self-neglect
629963|NCT00901706|Comprehensive Geriatric Assessment (CGA)|comprehensive geriatric assessment (cga)
629964|NCT00901706|Geriatric Syndromes|geriatric syndromes
629965|NCT00901706|Quality of Life|quality of life
629966|NCT00901706|Basic Activities of Daily Living|basic activities of daily living
629967|NCT00901706|Instrumental Activities of Daily Living|instrumental activities of daily living
629968|NCT00901693|pink eye|pink eye
629969|NCT00901693|eye infection|eye infection
629970|NCT00901693|conjunctivitis|conjunctivitis
629971|NCT00901680|Tissue Bank|tissue bank
629972|NCT00901654|Vaccination|vaccination
629973|NCT00901654|Diarrhea|diarrhea
629974|NCT00901654|Traveler's Diarrhea|traveler's diarrhea
629975|NCT00901654|ETEC|etec
629976|NCT00901654|Enterotoxigenic E. coli|enterotoxigenic e. coli
629977|NCT00901641|cognitive training|cognitive training
629978|NCT00901641|insomnia|insomnia
629979|NCT00901628|periarticular multimodal drug injection|periarticular multimodal drug injection
629980|NCT00901615|lymphoma|lymphoma
629981|NCT00901615|lenalidomide|lenalidomide
629982|NCT00901615|gela|gela
629983|NCT00901602|streptococcus pneumoniae|streptococcus pneumoniae
629984|NCT00901602|pneumococcus|pneumococcus
629985|NCT00901602|pneumonia|pneumonia
629986|NCT00901602|meningitis|meningitis
629987|NCT00901602|serotypes|serotypes
629988|NCT00901602|bacteremia|bacteremia
629989|NCT00901602|sepsis|sepsis
629990|NCT00901589|n-3 PUFAs|n-3 pufas
629991|NCT00901589|menopause|menopause
629992|NCT00901589|adipose tissue|adipose tissue
629993|NCT00901589|estrogens|estrogens
629994|NCT00901589|Incorporation of fishoil in pre- and postmenopausal women|incorporation of fishoil in pre- and postmenopausal women
629995|NCT00901589|Marine n-3 PUFAs influence on female hormones in blood|marine n-3 pufas influence on female hormones in blood
629996|NCT00901576|Healthy volunteers|healthy volunteers
629997|NCT00901563|Gap Junctions|gap junctions
629998|NCT00901563|Rotigaptide|rotigaptide
629999|NCT00901563|Ischaemia reperfusion|ischaemia reperfusion
630000|NCT00901563|t-PA|t-pa
630001|NCT00901563|Fibrinolysis|fibrinolysis
630002|NCT00901563|Endothelial function|endothelial function
630003|NCT00901563|Venous occlusion plethysmography|venous occlusion plethysmography
630005|NCT00901550|anti-TNF|anti-tnf
630006|NCT00901550|Early RA|early ra
630007|NCT00901537|Non-small Cell Lung Cancer|non-small cell lung cancer
630008|NCT00901537|Head and Neck Cancer|head and neck cancer
630009|NCT00901537|Azacitidine|azacitidine
630010|NCT00901537|Vidaza|vidaza
630011|NCT00901537|Cisplatin|cisplatin
630012|NCT00901524|HCV Genotype 1, 4|hcv genotype 1, 4
630013|NCT00901524|Virological response|virological response
630014|NCT00901524|Ribavirin|ribavirin
630015|NCT00901524|PegPegIFN- alpha 2a|pegpegifn- alpha 2a
630016|NCT00901524|Viral Hepatitis (HCV)|viral hepatitis (hcv)
630017|NCT00901511|Whole lung lavage|whole lung lavage
630018|NCT00901511|Pulmonary surfactant|pulmonary surfactant
630019|NCT00901511|GM-CSF|gm-csf
630020|NCT00901511|Autoantibodies anti GM-CSF|autoantibodies anti gm-csf
630021|NCT00901485|Respiratory insufficiency|respiratory insufficiency
630022|NCT00901485|Hypercapnia|hypercapnia
630023|NCT00901485|Hypoventilation|hypoventilation
630024|NCT00901485|Sleep|sleep
630025|NCT00901485|Polysomnography|polysomnography
630026|NCT00901485|Hypoxia|hypoxia
630027|NCT00901485|Titration|titration
630028|NCT00901485|Non Invasive Ventilation|non invasive ventilation
630029|NCT00901472|Type 2 diabetes,|type 2 diabetes,
630030|NCT00901472|obstructive sleep apnea|obstructive sleep apnea
630031|NCT00901459|Repetitive Transcranial Magnetic Stimulation|repetitive transcranial magnetic stimulation
630032|NCT00901459|Cigarette Smoker|cigarette smoker
630033|NCT00901459|Cigarette Dependence|cigarette dependence
630034|NCT00901459|To block cue-elicited craving in dependent cigarette smokers|to block cue-elicited craving in dependent cigarette smokers
630035|NCT00901433|Asthma|asthma
630036|NCT00901433|Wheeze Rate|wheeze rate
630037|NCT00901433|Respiratory Function Tests|respiratory function tests
630038|NCT00901420|Prostate|prostate
630039|NCT00901420|Urodynamic Evaluation|urodynamic evaluation
630040|NCT00901420|Prostatectomy|prostatectomy
630041|NCT00901420|Salvage prostatectomy|salvage prostatectomy
630042|NCT00901420|Bladder compliance|bladder compliance
630043|NCT00901420|Radiation Therapy|radiation therapy
630044|NCT00901420|External beam radiation therapy|external beam radiation therapy
630045|NCT00901420|Quality-of-life|quality-of-life
630046|NCT00901407|augmentation|augmentation
630047|NCT00901407|depression|depression
630048|NCT00901407|resistance|resistance
630049|NCT00901394|Nitrous oxide|nitrous oxide
630050|NCT00901394|cobalamin|cobalamin
630051|NCT00901394|homocysteine|homocysteine
630052|NCT00901394|vitamin B12|vitamin b12
630053|NCT00901394|folate|folate
630054|NCT00901394|No specific diseases targeted|no specific diseases targeted
630055|NCT00901381|Ischemic stroke|ischemic stroke
630056|NCT00901381|Stem cells|stem cells
630057|NCT00901381|Colony-stimulating factors|colony-stimulating factors
630058|NCT00901381|Filgrastim|filgrastim
630059|NCT00901381|Randomized controlled trial|randomized controlled trial
630060|NCT00901355|Blood pressure|blood pressure
630061|NCT00901355|Arterial stiffness|arterial stiffness
630062|NCT00901355|Morbidity|morbidity
630063|NCT00901355|Mortality|mortality
630064|NCT00901355|Elderly|elderly
630065|NCT00901342|Androgen independent prostate cancer (AIPC)|androgen independent prostate cancer (aipc)
630066|NCT00901342|CRPC|crpc
630067|NCT00901342|prostate cancer|prostate cancer
630068|NCT00901342|prostate|prostate
630069|NCT00901342|immune therapy|immune therapy
630070|NCT00901342|immunotherapy|immunotherapy
630071|NCT00901342|vaccine|vaccine
630072|NCT00901342|dendritic cells|dendritic cells
630073|NCT00901342|antigen-presenting cells|antigen-presenting cells
630074|NCT00901342|antigen presenting cells|antigen presenting cells
630075|NCT00901342|cancer vaccine|cancer vaccine
630076|NCT00901342|prostate specific antigen (PSA)|prostate specific antigen (psa)
630077|NCT00901342|prostatic adenocarcinoma|prostatic adenocarcinoma
630078|NCT00901329|TKA|tka
630079|NCT00901329|functional outcome|functional outcome
630080|NCT00901329|pain|pain
630081|NCT00901329|ROM|rom
630082|NCT00901329|gait|gait
630083|NCT00901316|Skin and Soft Tissue Infections|skin and soft tissue infections
630084|NCT00901316|Abscesses|abscesses
630085|NCT00901316|Boils|boils
630086|NCT00901316|Clorox Baths|clorox baths
630087|NCT00901316|Colonization|colonization
630088|NCT00901316|Staph|staph
630089|NCT00901316|MRSA|mrsa
630090|NCT00901316|MSSA|mssa
630091|NCT00901316|Recurrent Infections|recurrent infections
630092|NCT00901316|Prevention CA-SA Infections|prevention ca-sa infections
630093|NCT00901316|Community-Acquired Staphylococcus in Children|community-acquired staphylococcus in children
630094|NCT00901290|oral contraceptive|oral contraceptive
630095|NCT00901277|Post MI|post mi
630096|NCT00901264|Chemosensitivity, chemotherapy, all cancers, personalized chemotherapy, personalized cancer treatment|chemosensitivity, chemotherapy, all cancers, personalized chemotherapy, personalized cancer treatment
630097|NCT00901264|Cancer Patients for whom chemotherapy is planned.|cancer patients for whom chemotherapy is planned.
630098|NCT00901251|OABSS|oabss
630099|NCT00901238|retinoblastoma|retinoblastoma
630100|NCT00901238|intra-arterial chemotherapy|intra-arterial chemotherapy
630101|NCT00901238|chemosurgery|chemosurgery
630102|NCT00901238|melphalan|melphalan
630103|NCT00901238|topotecan|topotecan
630104|NCT00901225|NHL|nhl
630105|NCT00901212|Heart Failure|heart failure
630965|NCT00900029|Leg Wound|leg wound
630106|NCT00901212|resynchronisation|resynchronisation
630107|NCT00901212|ICD|icd
630108|NCT00901199|Thalassemia|thalassemia
630109|NCT00901199|Chelation|chelation
630110|NCT00901199|Iron Overload|iron overload
630111|NCT00901199|Thalassemia patients with Iron overload|thalassemia patients with iron overload
630112|NCT00901186|Diabetic Macular Edema|diabetic macular edema
630113|NCT00901186|Ranibizumab|ranibizumab
630114|NCT00901186|Laser Treatment|laser treatment
630115|NCT00901186|Visual impairment|visual impairment
630116|NCT00901173|Case-Control Study|case-control study
630117|NCT00901173|Esophageal Squamous Cell Carcinoma|esophageal squamous cell carcinoma
630118|NCT00901173|Risk Factors|risk factors
630119|NCT00901160|thromboelastography|thromboelastography
630120|NCT00901160|post-operative complications|post-operative complications
630121|NCT00901160|anti-platelet agents|anti-platelet agents
630122|NCT00901160|prospective|prospective
630123|NCT00901160|pilot|pilot
630124|NCT00901160|patients taking anti-platelet agents|patients taking anti-platelet agents
630125|NCT00901147|t-cell lymphoma|t-cell lymphoma
630126|NCT00901147|peripheral t-cell lymphoma|peripheral t-cell lymphoma
630127|NCT00901147|nk/t-cell lymphoma, nasal type|nk/t-cell lymphoma, nasal type
630128|NCT00901147|bortezomib|bortezomib
630129|NCT00901147|velcade|velcade
630130|NCT00901147|panobinostat|panobinostat
630131|NCT00901147|LBH589b|lbh589b
630132|NCT00901147|histone deacetylase inhibitor|histone deacetylase inhibitor
630133|NCT00901147|proteasome inhibitor|proteasome inhibitor
630134|NCT00901134|therapeutic hypothermia after cardiac arrest|therapeutic hypothermia after cardiac arrest
630135|NCT00901121|maxillary sinus lift|maxillary sinus lift
630136|NCT00901121|Histomorphometric evaluation|histomorphometric evaluation
630137|NCT00901121|bone graft|bone graft
630138|NCT00901121|bone augmentation|bone augmentation
630139|NCT00901108|open angle glaucoma|open angle glaucoma
630140|NCT00901108|trabectome|trabectome
630141|NCT00901108|trabeculectomy|trabeculectomy
630142|NCT00901108|cataract|cataract
630143|NCT00901082|chronic pain|chronic pain
630144|NCT00901082|anxiety|anxiety
630145|NCT00901082|intervention|intervention
630146|NCT00901082|information|information
630147|NCT00901082|relaxation|relaxation
630148|NCT00901056|ED|ed
630149|NCT00901056|Erectile Dysfunction|erectile dysfunction
630150|NCT00901056|Erectile dysfunction treated with PDE-5 inhibitors|erectile dysfunction treated with pde-5 inhibitors
630151|NCT00901030|platelet function|platelet function
630152|NCT00901030|perioperative complications|perioperative complications
630153|NCT00901030|thromboelastography|thromboelastography
630154|NCT00901030|coronary stents|coronary stents
630155|NCT00901030|non-cardiac surgery|non-cardiac surgery
630156|NCT00901004|Minimal Change|minimal change
630157|NCT00901004|GERD|gerd
630158|NCT00901004|GERDQ|gerdq
630159|NCT00900991|Pandemic Influenza A Vaccine|pandemic influenza a vaccine
630160|NCT00900991|Immunogenictiy|immunogenictiy
630161|NCT00900991|Safety|safety
630162|NCT00900978|Streptococcus pneumoniae|streptococcus pneumoniae
630163|NCT00900978|carriage|carriage
630164|NCT00900978|Resistance|resistance
630165|NCT00900978|Serotype|serotype
630166|NCT00900978|vaccination|vaccination
630167|NCT00900978|Colonization of S. pneumoniae|colonization of s. pneumoniae
630168|NCT00900965|irritable bowel syndrome|irritable bowel syndrome
630169|NCT00900965|IBS|ibs
630170|NCT00900965|fMRI|fmri
630171|NCT00900965|acupuncture|acupuncture
630172|NCT00900965|functional|functional
630173|NCT00900965|brain|brain
630174|NCT00900900|Cigarette Smokers|cigarette smokers
630175|NCT00900900|DHEA|dhea
630176|NCT00900900|dehydroepiandrosterone|dehydroepiandrosterone
630177|NCT00900900|pregnenolone|pregnenolone
630178|NCT00900900|Nicotine withdrawal symptoms|nicotine withdrawal symptoms
630179|NCT00900887|diabetic retinopathy|diabetic retinopathy
630180|NCT00900887|clinically significant macular edema|clinically significant macular edema
630181|NCT00900887|selective photocoagulation|selective photocoagulation
630182|NCT00900887|topic ketorolac|topic ketorolac
630183|NCT00900887|topic nepafenac|topic nepafenac
630184|NCT00900887|efficacy|efficacy
630185|NCT00900887|treatment|treatment
630186|NCT00900874|Formoterol|formoterol
630187|NCT00900874|Rapid bronchodilation|rapid bronchodilation
630188|NCT00900861|asthma control level|asthma control level
630189|NCT00900861|visual analogue scale|visual analogue scale
630190|NCT00900848|Posterior tibial artery bypass|posterior tibial artery bypass
630191|NCT00900848|Iliofemoral artery injury|iliofemoral artery injury
630192|NCT00900848|Shock|shock
630193|NCT00900848|Reconstruction|reconstruction
630194|NCT00900835|fatigue|fatigue
630195|NCT00900835|pain|pain
630196|NCT00900835|recurrent breast cancer|recurrent breast cancer
630197|NCT00900835|stage I breast cancer|stage i breast cancer
630198|NCT00900835|stage II breast cancer|stage ii breast cancer
630199|NCT00900835|stage IIIA breast cancer|stage iiia breast cancer
630200|NCT00900835|stage IIIB breast cancer|stage iiib breast cancer
630201|NCT00900835|stage IIIC breast cancer|stage iiic breast cancer
630202|NCT00900835|stage IV breast cancer|stage iv breast cancer
630203|NCT00900835|recurrent prostate cancer|recurrent prostate cancer
630204|NCT00900835|stage I prostate cancer|stage i prostate cancer
630205|NCT00900835|stage II prostate cancer|stage ii prostate cancer
630206|NCT00900835|stage III prostate cancer|stage iii prostate cancer
630207|NCT00900835|stage IV prostate cancer|stage iv prostate cancer
630208|NCT00900835|recurrent colon cancer|recurrent colon cancer
630209|NCT00900835|stage I colon cancer|stage i colon cancer
630210|NCT00900835|stage II colon cancer|stage ii colon cancer
630211|NCT00900835|stage III colon cancer|stage iii colon cancer
630212|NCT00900835|stage IV colon cancer|stage iv colon cancer
630213|NCT00900835|extensive stage small cell lung cancer|extensive stage small cell lung cancer
630214|NCT00900835|limited stage small cell lung cancer|limited stage small cell lung cancer
630215|NCT00900835|recurrent non-small cell lung cancer|recurrent non-small cell lung cancer
630216|NCT00900835|recurrent small cell lung cancer|recurrent small cell lung cancer
630217|NCT00900835|stage I non-small cell lung cancer|stage i non-small cell lung cancer
630218|NCT00900835|stage II non-small cell lung cancer|stage ii non-small cell lung cancer
630219|NCT00900835|stage IIIA non-small cell lung cancer|stage iiia non-small cell lung cancer
630220|NCT00900835|stage IIIB non-small cell lung cancer|stage iiib non-small cell lung cancer
630221|NCT00900835|stage IV non-small cell lung cancer|stage iv non-small cell lung cancer
630222|NCT00900822|bone grafting|bone grafting
630223|NCT00900822|sinus elevation|sinus elevation
630224|NCT00900822|sinus augmentation|sinus augmentation
630225|NCT00900809|Acute Myeloid Leukemia|acute myeloid leukemia
630226|NCT00900809|Neukoplast™|neukoplast™
630227|NCT00900809|NK-92|nk-92
630228|NCT00900809|Refractory|refractory
630229|NCT00900809|Refractory or Relapsed Acute Myeloid Leukemia|refractory or relapsed acute myeloid leukemia
630230|NCT00900796|Ankylosing spondylitis;predictive factors|ankylosing spondylitis;predictive factors
630231|NCT00900783|herpes zoster|herpes zoster
630232|NCT00900783|shingles|shingles
630233|NCT00900783|Phase II|phase ii
630234|NCT00900783|FV-100|fv-100
630235|NCT00900783|Inhibitex|inhibitex
630236|NCT00900770|dementia|dementia
630237|NCT00900770|mild cognitive impairment|mild cognitive impairment
630238|NCT00900770|beta amyloid|beta amyloid
630239|NCT00900757|Primary Glioma|primary glioma
630240|NCT00900757|Palonosetron|palonosetron
630241|NCT00900757|Standard Radiotherapy|standard radiotherapy
630242|NCT00900757|Temozolomide|temozolomide
630243|NCT00900744|Tamoxifen|tamoxifen
630244|NCT00900744|Breast Cancer|breast cancer
630245|NCT00900731|COPD|copd
630246|NCT00900731|indacaterol|indacaterol
630247|NCT00900731|beta 2 agonist|beta 2 agonist
630248|NCT00900731|tiotropium|tiotropium
630249|NCT00900692|Excessive pronation|excessive pronation
630250|NCT00900692|CVA|cva
630251|NCT00900692|Forearm|forearm
630252|NCT00900692|Excessive pronation following CVA|excessive pronation following cva
630253|NCT00900679|transitional care planning|transitional care planning
630254|NCT00900679|stage I ovarian epithelial cancer|stage i ovarian epithelial cancer
630255|NCT00900679|stage II ovarian epithelial cancer|stage ii ovarian epithelial cancer
630256|NCT00900679|stage III ovarian epithelial cancer|stage iii ovarian epithelial cancer
630257|NCT00900679|stage IV ovarian epithelial cancer|stage iv ovarian epithelial cancer
630258|NCT00900666|Stiff knee gait|stiff knee gait
630259|NCT00900666|Gait analysis|gait analysis
630260|NCT00900666|Traumatic Brain Injury|traumatic brain injury
630261|NCT00900666|Acquired Brain Injury|acquired brain injury
630262|NCT00900653|urinary tract infections|urinary tract infections
630263|NCT00900653|postmenopause|postmenopause
630264|NCT00900653|lactobacillus|lactobacillus
630265|NCT00900653|estriol|estriol
630266|NCT00900627|Cancer|cancer
630267|NCT00900627|Tumour|tumour
630268|NCT00900627|Breast cancer|breast cancer
630269|NCT00900627|Metastatic|metastatic
630270|NCT00900627|Secondary|secondary
630271|NCT00900614|Hematologic malignancy|hematologic malignancy
630272|NCT00900614|Prostate carcinoma|prostate carcinoma
630273|NCT00900614|Hematologic cancer|hematologic cancer
630274|NCT00900614|Prostate cancer|prostate cancer
630275|NCT00900601|Sacroiliac pain|sacroiliac pain
630276|NCT00900601|Sacroiliac instability|sacroiliac instability
630277|NCT00900601|Pelvic girdle pain|pelvic girdle pain
630278|NCT00900601|Sacroiliac arthrodesis|sacroiliac arthrodesis
630279|NCT00900601|Arthrodesis|arthrodesis
630280|NCT00900601|Surgery|surgery
630281|NCT00900588|immunogenictiy|immunogenictiy
630282|NCT00900588|safety|safety
630283|NCT00900588|pandemic influenza A vaccine|pandemic influenza a vaccine
630284|NCT00900575|cervical cancer|cervical cancer
630285|NCT00900575|LEEP|leep
630286|NCT00900575|colposcopy|colposcopy
630287|NCT00900562|Zalypsis|zalypsis
630288|NCT00900562|Cancer|cancer
630289|NCT00900562|Endometrial|endometrial
630290|NCT00900562|Uterine Cervical|uterine cervical
630291|NCT00900562|PharmaMar|pharmamar
630292|NCT00900549|Heart failure|heart failure
630293|NCT00900549|Cardiac resynchronization therapy|cardiac resynchronization therapy
630294|NCT00900549|ICD|icd
630295|NCT00900536|clear cell renal cell carcinoma|clear cell renal cell carcinoma
630296|NCT00900536|stage I renal cell cancer|stage i renal cell cancer
630297|NCT00900536|stage II renal cell cancer|stage ii renal cell cancer
633087|NCT00895869|Retinopathy|retinopathy
630298|NCT00900536|stage III renal cell cancer|stage iii renal cell cancer
630299|NCT00900536|stage IV renal cell cancer|stage iv renal cell cancer
630300|NCT00900536|papillary renal cell carcinoma|papillary renal cell carcinoma
630301|NCT00900523|recurrent ovarian epithelial cancer|recurrent ovarian epithelial cancer
630302|NCT00900523|stage I ovarian epithelial cancer|stage i ovarian epithelial cancer
630303|NCT00900523|stage II ovarian epithelial cancer|stage ii ovarian epithelial cancer
630304|NCT00900523|stage III ovarian epithelial cancer|stage iii ovarian epithelial cancer
630305|NCT00900523|stage IV ovarian epithelial cancer|stage iv ovarian epithelial cancer
630306|NCT00900510|subcutaneous abscess|subcutaneous abscess
630307|NCT00900510|Incision and drainage|incision and drainage
630308|NCT00900510|Methicillin-resistant staphylococcus aureus|methicillin-resistant staphylococcus aureus
630309|NCT00900497|granulocytes|granulocytes
630310|NCT00900497|Graft-vs-Host-Disease|graft-vs-host-disease
630311|NCT00900484|stage I adult diffuse large cell lymphoma|stage i adult diffuse large cell lymphoma
630312|NCT00900484|stage I adult diffuse mixed cell lymphoma|stage i adult diffuse mixed cell lymphoma
630313|NCT00900484|stage I adult diffuse small cleaved cell lymphoma|stage i adult diffuse small cleaved cell lymphoma
630314|NCT00900484|stage II adult diffuse large cell lymphoma|stage ii adult diffuse large cell lymphoma
630315|NCT00900484|stage II adult diffuse mixed cell lymphoma|stage ii adult diffuse mixed cell lymphoma
630316|NCT00900484|stage II adult diffuse small cleaved cell lymphoma|stage ii adult diffuse small cleaved cell lymphoma
630317|NCT00900484|stage III adult diffuse large cell lymphoma|stage iii adult diffuse large cell lymphoma
630318|NCT00900484|stage III adult diffuse mixed cell lymphoma|stage iii adult diffuse mixed cell lymphoma
630319|NCT00900484|stage III adult diffuse small cleaved cell lymphoma|stage iii adult diffuse small cleaved cell lymphoma
630320|NCT00900484|stage IV adult diffuse large cell lymphoma|stage iv adult diffuse large cell lymphoma
630321|NCT00900484|stage IV adult diffuse mixed cell lymphoma|stage iv adult diffuse mixed cell lymphoma
630322|NCT00900484|stage IV adult diffuse small cleaved cell lymphoma|stage iv adult diffuse small cleaved cell lymphoma
630323|NCT00900484|stage I grade 3 follicular lymphoma|stage i grade 3 follicular lymphoma
630324|NCT00900484|stage II grade 3 follicular lymphoma|stage ii grade 3 follicular lymphoma
630325|NCT00900484|stage III grade 3 follicular lymphoma|stage iii grade 3 follicular lymphoma
630326|NCT00900484|stage IV grade 3 follicular lymphoma|stage iv grade 3 follicular lymphoma
630327|NCT00900484|stage I adult immunoblastic large cell lymphoma|stage i adult immunoblastic large cell lymphoma
630328|NCT00900484|stage II adult immunoblastic large cell lymphoma|stage ii adult immunoblastic large cell lymphoma
630329|NCT00900484|stage III adult immunoblastic large cell lymphoma|stage iii adult immunoblastic large cell lymphoma
630330|NCT00900484|stage IV adult immunoblastic large cell lymphoma|stage iv adult immunoblastic large cell lymphoma
630331|NCT00900484|stage I adult lymphoblastic lymphoma|stage i adult lymphoblastic lymphoma
630332|NCT00900484|stage II adult lymphoblastic lymphoma|stage ii adult lymphoblastic lymphoma
630333|NCT00900484|stage III adult lymphoblastic lymphoma|stage iii adult lymphoblastic lymphoma
630334|NCT00900484|stage IV adult lymphoblastic lymphoma|stage iv adult lymphoblastic lymphoma
630335|NCT00900484|stage I adult Burkitt lymphoma|stage i adult burkitt lymphoma
630336|NCT00900484|stage II adult Burkitt lymphoma|stage ii adult burkitt lymphoma
630337|NCT00900484|stage III adult Burkitt lymphoma|stage iii adult burkitt lymphoma
630338|NCT00900484|stage IV adult Burkitt lymphoma|stage iv adult burkitt lymphoma
630339|NCT00900471|unspecified adult solid tumor, protocol specific|unspecified adult solid tumor, protocol specific
630340|NCT00900471|unspecified childhood solid tumor, protocol specific|unspecified childhood solid tumor, protocol specific
630341|NCT00900458|preeclampsia|preeclampsia
630342|NCT00900458|low vs high plasma volume|low vs high plasma volume
630343|NCT00900432|recurrent colon cancer|recurrent colon cancer
630344|NCT00900432|stage I colon cancer|stage i colon cancer
630345|NCT00900432|stage II colon cancer|stage ii colon cancer
630346|NCT00900432|stage III colon cancer|stage iii colon cancer
630347|NCT00900432|stage IV colon cancer|stage iv colon cancer
630348|NCT00900419|non-small cell lung cancer|non-small cell lung cancer
630349|NCT00900419|small cell lung cancer|small cell lung cancer
630350|NCT00900419|squamous lung dysplasia|squamous lung dysplasia
630351|NCT00900419|hypopharyngeal cancer|hypopharyngeal cancer
630352|NCT00900419|laryngeal cancer|laryngeal cancer
630353|NCT00900419|lip and oral cavity cancer|lip and oral cavity cancer
630354|NCT00900419|metastatic squamous neck cancer with occult primary|metastatic squamous neck cancer with occult primary
630355|NCT00900419|nasopharyngeal cancer|nasopharyngeal cancer
630356|NCT00900419|oropharyngeal cancer|oropharyngeal cancer
630357|NCT00900419|paranasal sinus and nasal cavity cancer|paranasal sinus and nasal cavity cancer
630358|NCT00900419|salivary gland cancer|salivary gland cancer
630359|NCT00900419|esophageal cancer|esophageal cancer
630360|NCT00900419|pulmonary carcinoid tumor|pulmonary carcinoid tumor
630361|NCT00900419|tongue cancer|tongue cancer
630362|NCT00900380|adult acute monocytic leukemia (M5b)|adult acute monocytic leukemia (m5b)
630363|NCT00900380|adult acute megakaryoblastic leukemia (M7)|adult acute megakaryoblastic leukemia (m7)
630364|NCT00900380|adult acute myeloblastic leukemia with maturation (M2)|adult acute myeloblastic leukemia with maturation (m2)
630365|NCT00900380|adult acute myeloblastic leukemia without maturation (M1)|adult acute myeloblastic leukemia without maturation (m1)
630366|NCT00900380|adult acute myelomonocytic leukemia (M4)|adult acute myelomonocytic leukemia (m4)
630367|NCT00900380|adult acute monoblastic leukemia (M5a)|adult acute monoblastic leukemia (m5a)
801410|NCT00248781|Aging|aging
630368|NCT00900380|secondary acute myeloid leukemia|secondary acute myeloid leukemia
630369|NCT00900380|untreated adult acute myeloid leukemia|untreated adult acute myeloid leukemia
630370|NCT00900380|adult acute minimally differentiated myeloid leukemia (M0)|adult acute minimally differentiated myeloid leukemia (m0)
630371|NCT00900380|adult acute myeloid leukemia with 11q23 (MLL) abnormalities|adult acute myeloid leukemia with 11q23 (mll) abnormalities
630372|NCT00900380|adult acute myeloid leukemia with inv(16)(p13;q22)|adult acute myeloid leukemia with inv(16)(p13;q22)
630373|NCT00900380|adult acute myeloid leukemia with t(16;16)(p13;q22)|adult acute myeloid leukemia with t(16;16)(p13;q22)
630374|NCT00900380|adult acute myeloid leukemia with t(8;21)(q22;q22)|adult acute myeloid leukemia with t(8;21)(q22;q22)
630375|NCT00900380|adult erythroleukemia (M6a)|adult erythroleukemia (m6a)
630376|NCT00900380|adult pure erythroid leukemia (M6b)|adult pure erythroid leukemia (m6b)
630377|NCT00900367|breast cancer|breast cancer
630378|NCT00900354|unspecified childhood solid tumor, protocol specific|unspecified childhood solid tumor, protocol specific
630379|NCT00900341|adult soft tissue sarcoma|adult soft tissue sarcoma
630380|NCT00900341|childhood soft tissue sarcoma|childhood soft tissue sarcoma
630381|NCT00900328|adenocarcinoma of the lung|adenocarcinoma of the lung
630382|NCT00900328|recurrent non-small cell lung cancer|recurrent non-small cell lung cancer
630383|NCT00900328|stage 0 non-small cell lung cancer|stage 0 non-small cell lung cancer
630384|NCT00900328|stage I non-small cell lung cancer|stage i non-small cell lung cancer
630385|NCT00900328|stage II non-small cell lung cancer|stage ii non-small cell lung cancer
630386|NCT00900328|stage IIIA non-small cell lung cancer|stage iiia non-small cell lung cancer
630387|NCT00900328|stage IIIB non-small cell lung cancer|stage iiib non-small cell lung cancer
630388|NCT00900328|stage IV non-small cell lung cancer|stage iv non-small cell lung cancer
630389|NCT00900302|male breast cancer|male breast cancer
630390|NCT00900302|recurrent breast cancer|recurrent breast cancer
630391|NCT00900302|stage IA breast cancer|stage ia breast cancer
630392|NCT00900302|stage IB breast cancer|stage ib breast cancer
630393|NCT00900302|stage II breast cancer|stage ii breast cancer
630394|NCT00900302|stage IIIA breast cancer|stage iiia breast cancer
630395|NCT00900302|stage IIIB breast cancer|stage iiib breast cancer
630396|NCT00900302|stage IIIC breast cancer|stage iiic breast cancer
630397|NCT00900302|stage IV breast cancer|stage iv breast cancer
630398|NCT00900302|unspecified adult solid tumor, protocol specific|unspecified adult solid tumor, protocol specific
630399|NCT00900302|unspecified childhood solid tumor, protocol specific|unspecified childhood solid tumor, protocol specific
630400|NCT00900302|squamous cell carcinoma of the anus|squamous cell carcinoma of the anus
630401|NCT00900302|squamous cell carcinoma of the bladder|squamous cell carcinoma of the bladder
630402|NCT00900302|squamous cell carcinoma of the esophagus|squamous cell carcinoma of the esophagus
630403|NCT00900302|squamous cell carcinoma of the gallbladder|squamous cell carcinoma of the gallbladder
630404|NCT00900302|squamous cell carcinoma of the skin|squamous cell carcinoma of the skin
630405|NCT00900302|squamous cell carcinoma of the vulva|squamous cell carcinoma of the vulva
630406|NCT00900302|squamous cell lung cancer|squamous cell lung cancer
630407|NCT00900302|vaginal squamous cell carcinoma|vaginal squamous cell carcinoma
630408|NCT00900302|stage I squamous cell carcinoma of the hypopharynx|stage i squamous cell carcinoma of the hypopharynx
630409|NCT00900302|stage II squamous cell carcinoma of the hypopharynx|stage ii squamous cell carcinoma of the hypopharynx
630410|NCT00900302|stage III squamous cell carcinoma of the hypopharynx|stage iii squamous cell carcinoma of the hypopharynx
630411|NCT00900302|stage IV squamous cell carcinoma of the hypopharynx|stage iv squamous cell carcinoma of the hypopharynx
630412|NCT00900302|recurrent squamous cell carcinoma of the hypopharynx|recurrent squamous cell carcinoma of the hypopharynx
630413|NCT00900302|stage I squamous cell carcinoma of the larynx|stage i squamous cell carcinoma of the larynx
630414|NCT00900302|stage I verrucous carcinoma of the larynx|stage i verrucous carcinoma of the larynx
630415|NCT00900302|stage II squamous cell carcinoma of the larynx|stage ii squamous cell carcinoma of the larynx
630416|NCT00900302|stage II verrucous carcinoma of the larynx|stage ii verrucous carcinoma of the larynx
630417|NCT00900302|stage III squamous cell carcinoma of the larynx|stage iii squamous cell carcinoma of the larynx
630418|NCT00900302|stage III verrucous carcinoma of the larynx|stage iii verrucous carcinoma of the larynx
630419|NCT00900302|stage IV squamous cell carcinoma of the larynx|stage iv squamous cell carcinoma of the larynx
630420|NCT00900302|stage IV verrucous carcinoma of the larynx|stage iv verrucous carcinoma of the larynx
630421|NCT00900302|recurrent squamous cell carcinoma of the larynx|recurrent squamous cell carcinoma of the larynx
630422|NCT00900302|recurrent verrucous carcinoma of the larynx|recurrent verrucous carcinoma of the larynx
630423|NCT00900302|stage I squamous cell carcinoma of the lip and oral cavity|stage i squamous cell carcinoma of the lip and oral cavity
630424|NCT00900302|stage II squamous cell carcinoma of the lip and oral cavity|stage ii squamous cell carcinoma of the lip and oral cavity
630425|NCT00900302|stage III squamous cell carcinoma of the lip and oral cavity|stage iii squamous cell carcinoma of the lip and oral cavity
630426|NCT00900302|stage IV squamous cell carcinoma of the lip and oral cavity|stage iv squamous cell carcinoma of the lip and oral cavity
630427|NCT00900302|recurrent squamous cell carcinoma of the lip and oral cavity|recurrent squamous cell carcinoma of the lip and oral cavity
630428|NCT00900302|stage I verrucous carcinoma of the oral cavity|stage i verrucous carcinoma of the oral cavity
712506|NCT00579917|Stem Cell Transplantation|stem cell transplantation
630429|NCT00900302|stage II verrucous carcinoma of the oral cavity|stage ii verrucous carcinoma of the oral cavity
630430|NCT00900302|stage III verrucous carcinoma of the oral cavity|stage iii verrucous carcinoma of the oral cavity
633088|NCT00895869|Prematurity|prematurity
630431|NCT00900302|stage IV verrucous carcinoma of the oral cavity|stage iv verrucous carcinoma of the oral cavity
630432|NCT00900302|recurrent verrucous carcinoma of the oral cavity|recurrent verrucous carcinoma of the oral cavity
630433|NCT00900302|metastatic squamous neck cancer with occult primary squamous cell carcinoma|metastatic squamous neck cancer with occult primary squamous cell carcinoma
630434|NCT00900302|recurrent metastatic squamous neck cancer with occult primary|recurrent metastatic squamous neck cancer with occult primary
630435|NCT00900302|untreated metastatic squamous neck cancer with occult primary|untreated metastatic squamous neck cancer with occult primary
630436|NCT00900302|stage I squamous cell carcinoma of the nasopharynx|stage i squamous cell carcinoma of the nasopharynx
630437|NCT00900302|stage II squamous cell carcinoma of the nasopharynx|stage ii squamous cell carcinoma of the nasopharynx
630438|NCT00900302|stage III squamous cell carcinoma of the nasopharynx|stage iii squamous cell carcinoma of the nasopharynx
630439|NCT00900302|stage IV squamous cell carcinoma of the nasopharynx|stage iv squamous cell carcinoma of the nasopharynx
632317|NCT00897819|stage IV colon cancer|stage iv colon cancer
630440|NCT00900302|recurrent squamous cell carcinoma of the nasopharynx|recurrent squamous cell carcinoma of the nasopharynx
630441|NCT00900302|stage I squamous cell carcinoma of the oropharynx|stage i squamous cell carcinoma of the oropharynx
630442|NCT00900302|stage II squamous cell carcinoma of the oropharynx|stage ii squamous cell carcinoma of the oropharynx
630443|NCT00900302|stage III squamous cell carcinoma of the oropharynx|stage iii squamous cell carcinoma of the oropharynx
630444|NCT00900302|stage IV squamous cell carcinoma of the oropharynx|stage iv squamous cell carcinoma of the oropharynx
630445|NCT00900302|recurrent squamous cell carcinoma of the oropharynx|recurrent squamous cell carcinoma of the oropharynx
630446|NCT00900302|stage I squamous cell carcinoma of the paranasal sinus and nasal cavity|stage i squamous cell carcinoma of the paranasal sinus and nasal cavity
630447|NCT00900302|stage II squamous cell carcinoma of the paranasal sinus and nasal cavity|stage ii squamous cell carcinoma of the paranasal sinus and nasal cavity
630448|NCT00900302|stage III squamous cell carcinoma of the paranasal sinus and nasal cavity|stage iii squamous cell carcinoma of the paranasal sinus and nasal cavity
630449|NCT00900302|stage IV squamous cell carcinoma of the paranasal sinus and nasal cavity|stage iv squamous cell carcinoma of the paranasal sinus and nasal cavity
630450|NCT00900302|recurrent squamous cell carcinoma of the paranasal sinus and nasal cavity|recurrent squamous cell carcinoma of the paranasal sinus and nasal cavity
630451|NCT00900302|salivary gland squamous cell carcinoma|salivary gland squamous cell carcinoma
630452|NCT00900302|stage I salivary gland cancer|stage i salivary gland cancer
630453|NCT00900302|stage II salivary gland cancer|stage ii salivary gland cancer
630454|NCT00900302|stage III salivary gland cancer|stage iii salivary gland cancer
630455|NCT00900302|stage IV salivary gland cancer|stage iv salivary gland cancer
630456|NCT00900302|recurrent salivary gland cancer|recurrent salivary gland cancer
630457|NCT00900302|squamous cell carcinoma of unknown primary|squamous cell carcinoma of unknown primary
630458|NCT00900302|cervical squamous cell carcinoma|cervical squamous cell carcinoma
630459|NCT00900302|penile squamous cell carcinoma|penile squamous cell carcinoma
630460|NCT00900302|recurrent anal cancer|recurrent anal cancer
630461|NCT00900302|stage I anal cancer|stage i anal cancer
630462|NCT00900302|stage II anal cancer|stage ii anal cancer
630463|NCT00900302|stage IIIA anal cancer|stage iiia anal cancer
630464|NCT00900302|stage IIIB anal cancer|stage iiib anal cancer
630465|NCT00900302|stage IV anal cancer|stage iv anal cancer
630466|NCT00900302|recurrent bladder cancer|recurrent bladder cancer
630467|NCT00900302|stage I bladder cancer|stage i bladder cancer
630468|NCT00900302|stage II bladder cancer|stage ii bladder cancer
630469|NCT00900302|stage III bladder cancer|stage iii bladder cancer
630470|NCT00900302|stage IV bladder cancer|stage iv bladder cancer
630471|NCT00900302|recurrent esophageal cancer|recurrent esophageal cancer
630472|NCT00900302|stage I esophageal cancer|stage i esophageal cancer
630473|NCT00900302|stage II esophageal cancer|stage ii esophageal cancer
630474|NCT00900302|stage III esophageal cancer|stage iii esophageal cancer
630475|NCT00900302|stage IV esophageal cancer|stage iv esophageal cancer
630476|NCT00900302|localized gallbladder cancer|localized gallbladder cancer
630477|NCT00900302|recurrent gallbladder cancer|recurrent gallbladder cancer
630478|NCT00900302|unresectable gallbladder cancer|unresectable gallbladder cancer
630479|NCT00900302|recurrent vulvar cancer|recurrent vulvar cancer
630480|NCT00900302|stage I vulvar cancer|stage i vulvar cancer
630481|NCT00900302|stage II vulvar cancer|stage ii vulvar cancer
630482|NCT00900302|stage III vulvar cancer|stage iii vulvar cancer
630483|NCT00900302|stage IV vulvar cancer|stage iv vulvar cancer
630484|NCT00900302|recurrent cervical cancer|recurrent cervical cancer
630485|NCT00900302|stage IA cervical cancer|stage ia cervical cancer
630486|NCT00900302|stage IB cervical cancer|stage ib cervical cancer
630487|NCT00900302|stage IIA cervical cancer|stage iia cervical cancer
630488|NCT00900302|stage IIB cervical cancer|stage iib cervical cancer
630489|NCT00900302|stage III cervical cancer|stage iii cervical cancer
630490|NCT00900302|stage IVA cervical cancer|stage iva cervical cancer
630491|NCT00900302|stage IVB cervical cancer|stage ivb cervical cancer
630492|NCT00900302|recurrent non-small cell lung cancer|recurrent non-small cell lung cancer
801622|NCT00248391|supine|supine
630493|NCT00900302|stage I non-small cell lung cancer|stage i non-small cell lung cancer
630494|NCT00900302|stage II non-small cell lung cancer|stage ii non-small cell lung cancer
630495|NCT00900302|stage IIIA non-small cell lung cancer|stage iiia non-small cell lung cancer
630496|NCT00900302|stage IIIB non-small cell lung cancer|stage iiib non-small cell lung cancer
630497|NCT00900302|stage IV non-small cell lung cancer|stage iv non-small cell lung cancer
630498|NCT00900302|recurrent skin cancer|recurrent skin cancer
630499|NCT00900302|newly diagnosed carcinoma of unknown primary|newly diagnosed carcinoma of unknown primary
630500|NCT00900302|recurrent carcinoma of unknown primary|recurrent carcinoma of unknown primary
630501|NCT00900302|recurrent penile cancer|recurrent penile cancer
630502|NCT00900302|stage I penile cancer|stage i penile cancer
630503|NCT00900302|stage II penile cancer|stage ii penile cancer
630504|NCT00900302|stage III penile cancer|stage iii penile cancer
630505|NCT00900302|stage IV penile cancer|stage iv penile cancer
630506|NCT00900302|recurrent melanoma|recurrent melanoma
630507|NCT00900302|stage IA melanoma|stage ia melanoma
630508|NCT00900302|stage IB melanoma|stage ib melanoma
630509|NCT00900302|stage IIA melanoma|stage iia melanoma
630510|NCT00900302|stage IIB melanoma|stage iib melanoma
630511|NCT00900302|stage IIC melanoma|stage iic melanoma
630512|NCT00900302|stage IIIA melanoma|stage iiia melanoma
630513|NCT00900302|stage IIIB melanoma|stage iiib melanoma
630514|NCT00900302|stage IIIC melanoma|stage iiic melanoma
630515|NCT00900302|stage IV melanoma|stage iv melanoma
630516|NCT00900289|stage IC ovarian epithelial cancer|stage ic ovarian epithelial cancer
630517|NCT00900289|stage IIA ovarian epithelial cancer|stage iia ovarian epithelial cancer
630518|NCT00900289|stage IIB ovarian epithelial cancer|stage iib ovarian epithelial cancer
630519|NCT00900289|stage IIC ovarian epithelial cancer|stage iic ovarian epithelial cancer
630520|NCT00900289|stage IIIA ovarian epithelial cancer|stage iiia ovarian epithelial cancer
630521|NCT00900289|stage IIIB ovarian epithelial cancer|stage iiib ovarian epithelial cancer
630522|NCT00900289|stage IIIC ovarian epithelial cancer|stage iiic ovarian epithelial cancer
630523|NCT00900289|stage IV ovarian epithelial cancer|stage iv ovarian epithelial cancer
630524|NCT00900276|localized transitional cell cancer of the renal pelvis and ureter|localized transitional cell cancer of the renal pelvis and ureter
630525|NCT00900276|metastatic transitional cell cancer of the renal pelvis and ureter|metastatic transitional cell cancer of the renal pelvis and ureter
630526|NCT00900276|recurrent transitional cell cancer of the renal pelvis and ureter|recurrent transitional cell cancer of the renal pelvis and ureter
630527|NCT00900276|regional transitional cell cancer of the renal pelvis and ureter|regional transitional cell cancer of the renal pelvis and ureter
630528|NCT00900276|transitional cell carcinoma of the bladder|transitional cell carcinoma of the bladder
630529|NCT00900276|stage I renal cell cancer|stage i renal cell cancer
630530|NCT00900276|stage II renal cell cancer|stage ii renal cell cancer
630531|NCT00900276|recurrent renal cell cancer|recurrent renal cell cancer
630532|NCT00900276|recurrent bladder cancer|recurrent bladder cancer
630533|NCT00900276|stage I bladder cancer|stage i bladder cancer
630534|NCT00900276|stage II bladder cancer|stage ii bladder cancer
630535|NCT00900276|stage III bladder cancer|stage iii bladder cancer
630536|NCT00900276|stage IV bladder cancer|stage iv bladder cancer
630537|NCT00900276|anterior urethral cancer|anterior urethral cancer
630538|NCT00900276|posterior urethral cancer|posterior urethral cancer
630539|NCT00900276|recurrent urethral cancer|recurrent urethral cancer
630540|NCT00900276|urethral cancer associated with invasive bladder cancer|urethral cancer associated with invasive bladder cancer
630541|NCT00900263|stage I multiple myeloma|stage i multiple myeloma
630542|NCT00900263|isolated plasmacytoma of bone|isolated plasmacytoma of bone
630543|NCT00900263|monoclonal gammopathy of undetermined significance|monoclonal gammopathy of undetermined significance
630544|NCT00900237|Partial|partial
630545|NCT00900237|Epilepsy|epilepsy
630546|NCT00900237|Eslicarbazepine acetate|eslicarbazepine acetate
630547|NCT00900237|Pharmacokinetics|pharmacokinetics
630548|NCT00900237|Tolerability|tolerability
630549|NCT00900224|adult acute myeloid leukemia with 11q23 (MLL) abnormalities|adult acute myeloid leukemia with 11q23 (mll) abnormalities
630550|NCT00900224|adult acute myeloid leukemia with inv(16)(p13;q22)|adult acute myeloid leukemia with inv(16)(p13;q22)
630551|NCT00900224|adult acute myeloid leukemia with t(15;17)(q22;q12)|adult acute myeloid leukemia with t(15;17)(q22;q12)
630552|NCT00900224|adult acute myeloid leukemia with t(16;16)(p13;q22)|adult acute myeloid leukemia with t(16;16)(p13;q22)
630553|NCT00900224|adult acute myeloid leukemia with t(8;21)(q22;q22)|adult acute myeloid leukemia with t(8;21)(q22;q22)
630554|NCT00900224|untreated adult acute myeloid leukemia|untreated adult acute myeloid leukemia
630555|NCT00900224|untreated childhood acute myeloid leukemia and other myeloid malignancies|untreated childhood acute myeloid leukemia and other myeloid malignancies
630556|NCT00900224|secondary acute myeloid leukemia|secondary acute myeloid leukemia
630557|NCT00900211|recurrent adult soft tissue sarcoma|recurrent adult soft tissue sarcoma
630558|NCT00900211|stage I adult soft tissue sarcoma|stage i adult soft tissue sarcoma
630559|NCT00900211|stage II adult soft tissue sarcoma|stage ii adult soft tissue sarcoma
630560|NCT00900211|stage III adult soft tissue sarcoma|stage iii adult soft tissue sarcoma
630561|NCT00900211|adult synovial sarcoma|adult synovial sarcoma
712507|NCT00579904|PCOS|pcos
630562|NCT00900211|adult angiosarcoma|adult angiosarcoma
630563|NCT00900211|adult epithelioid sarcoma|adult epithelioid sarcoma
630564|NCT00900211|adult extraskeletal chondrosarcoma|adult extraskeletal chondrosarcoma
630565|NCT00900211|adult leiomyosarcoma|adult leiomyosarcoma
630566|NCT00900211|adult liposarcoma|adult liposarcoma
630567|NCT00900211|adult malignant fibrous histiocytoma|adult malignant fibrous histiocytoma
630568|NCT00900211|adult malignant hemangiopericytoma|adult malignant hemangiopericytoma
630569|NCT00900211|adult malignant mesenchymoma|adult malignant mesenchymoma
630570|NCT00900211|adult fibrosarcoma|adult fibrosarcoma
630571|NCT00900211|adult neurofibrosarcoma|adult neurofibrosarcoma
630572|NCT00900198|Tissue Collection|tissue collection
630573|NCT00900198|Biospecimen|biospecimen
630574|NCT00900198|Assay Development|assay development
630575|NCT00900198|Tissue Acquisition|tissue acquisition
630576|NCT00900198|Tissue Biopsies|tissue biopsies
630577|NCT00900185|recurrent prostate cancer|recurrent prostate cancer
630578|NCT00900185|stage I prostate cancer|stage i prostate cancer
630579|NCT00900185|stage IIB prostate cancer|stage iib prostate cancer
630580|NCT00900185|stage IIA prostate cancer|stage iia prostate cancer
630581|NCT00900185|stage III prostate cancer|stage iii prostate cancer
630582|NCT00900185|stage IV prostate cancer|stage iv prostate cancer
630583|NCT00900172|stage IIIB non-small cell lung cancer|stage iiib non-small cell lung cancer
630584|NCT00900172|stage IV non-small cell lung cancer|stage iv non-small cell lung cancer
630585|NCT00900172|recurrent non-small cell lung cancer|recurrent non-small cell lung cancer
630586|NCT00900172|adenocarcinoma of the lung|adenocarcinoma of the lung
630587|NCT00900172|bronchoalveolar cell lung cancer|bronchoalveolar cell lung cancer
630588|NCT00900159|Shift-work|shift-work
630589|NCT00900159|SWSD|swsd
630590|NCT00900159|eszopiclone|eszopiclone
630592|NCT00900159|shiftworkers|shiftworkers
630593|NCT00900146|type 2 diabetes|type 2 diabetes
630594|NCT00900146|canakinumab|canakinumab
630595|NCT00900133|stage I breast cancer|stage i breast cancer
630596|NCT00900133|stage II breast cancer|stage ii breast cancer
630597|NCT00900133|stage IIIA breast cancer|stage iiia breast cancer
630598|NCT00900133|stage IIIB breast cancer|stage iiib breast cancer
630599|NCT00900133|stage IIIC breast cancer|stage iiic breast cancer
630600|NCT00900120|aplastic anemia|aplastic anemia
630601|NCT00900120|myelodysplastic/myeloproliferative neoplasm, unclassifiable|myelodysplastic/myeloproliferative neoplasm, unclassifiable
630602|NCT00900120|unspecified adult solid tumor, protocol specific|unspecified adult solid tumor, protocol specific
630603|NCT00900120|unspecified childhood solid tumor, protocol specific|unspecified childhood solid tumor, protocol specific
630604|NCT00900120|secondary myelodysplastic syndromes|secondary myelodysplastic syndromes
630605|NCT00900120|accelerated phase chronic myelogenous leukemia|accelerated phase chronic myelogenous leukemia
630606|NCT00900120|acute undifferentiated leukemia|acute undifferentiated leukemia
630607|NCT00900120|adult acute lymphoblastic leukemia in remission|adult acute lymphoblastic leukemia in remission
630608|NCT00900120|adult acute myeloid leukemia in remission|adult acute myeloid leukemia in remission
630609|NCT00900120|adult acute myeloid leukemia with 11q23 (MLL) abnormalities|adult acute myeloid leukemia with 11q23 (mll) abnormalities
630610|NCT00900120|adult acute myeloid leukemia with inv(16)(p13;q22)|adult acute myeloid leukemia with inv(16)(p13;q22)
630611|NCT00900120|adult acute myeloid leukemia with t(15;17)(q22;q12)|adult acute myeloid leukemia with t(15;17)(q22;q12)
630612|NCT00900120|adult acute myeloid leukemia with t(16;16)(p13;q22)|adult acute myeloid leukemia with t(16;16)(p13;q22)
630613|NCT00900120|adult acute myeloid leukemia with t(8;21)(q22;q22)|adult acute myeloid leukemia with t(8;21)(q22;q22)
630614|NCT00900120|atypical chronic myeloid leukemia, BCR-ABL negative|atypical chronic myeloid leukemia, bcr-abl negative
630615|NCT00900120|blastic phase chronic myelogenous leukemia|blastic phase chronic myelogenous leukemia
630616|NCT00900120|childhood acute lymphoblastic leukemia in remission|childhood acute lymphoblastic leukemia in remission
630617|NCT00900120|childhood acute myeloid leukemia in remission|childhood acute myeloid leukemia in remission
630618|NCT00900120|childhood chronic myelogenous leukemia|childhood chronic myelogenous leukemia
630619|NCT00900120|chronic myelomonocytic leukemia|chronic myelomonocytic leukemia
630620|NCT00900120|chronic phase chronic myelogenous leukemia|chronic phase chronic myelogenous leukemia
630621|NCT00900120|juvenile myelomonocytic leukemia|juvenile myelomonocytic leukemia
630622|NCT00900120|mast cell leukemia|mast cell leukemia
630623|NCT00900120|meningeal chronic myelogenous leukemia|meningeal chronic myelogenous leukemia
630624|NCT00900120|progressive hairy cell leukemia, initial treatment|progressive hairy cell leukemia, initial treatment
630625|NCT00900120|prolymphocytic leukemia|prolymphocytic leukemia
630626|NCT00900120|recurrent adult acute lymphoblastic leukemia|recurrent adult acute lymphoblastic leukemia
630627|NCT00900120|recurrent adult acute myeloid leukemia|recurrent adult acute myeloid leukemia
630628|NCT00900120|recurrent adult T-cell leukemia/lymphoma|recurrent adult t-cell leukemia/lymphoma
630629|NCT00900120|recurrent childhood acute lymphoblastic leukemia|recurrent childhood acute lymphoblastic leukemia
630630|NCT00900120|recurrent childhood acute myeloid leukemia|recurrent childhood acute myeloid leukemia
630631|NCT00900120|refractory chronic lymphocytic leukemia|refractory chronic lymphocytic leukemia
630632|NCT00900120|refractory hairy cell leukemia|refractory hairy cell leukemia
630633|NCT00900120|relapsing chronic myelogenous leukemia|relapsing chronic myelogenous leukemia
630634|NCT00900120|secondary acute myeloid leukemia|secondary acute myeloid leukemia
630635|NCT00900120|stage 0 chronic lymphocytic leukemia|stage 0 chronic lymphocytic leukemia
630636|NCT00900120|stage I adult T-cell leukemia/lymphoma|stage i adult t-cell leukemia/lymphoma
630637|NCT00900120|stage I chronic lymphocytic leukemia|stage i chronic lymphocytic leukemia
630638|NCT00900120|stage II adult T-cell leukemia/lymphoma|stage ii adult t-cell leukemia/lymphoma
630639|NCT00900120|stage II chronic lymphocytic leukemia|stage ii chronic lymphocytic leukemia
630640|NCT00900120|stage III adult T-cell leukemia/lymphoma|stage iii adult t-cell leukemia/lymphoma
630641|NCT00900120|stage III chronic lymphocytic leukemia|stage iii chronic lymphocytic leukemia
633089|NCT00895869|Pain|pain
630642|NCT00900120|stage IV adult T-cell leukemia/lymphoma|stage iv adult t-cell leukemia/lymphoma
630643|NCT00900120|stage IV chronic lymphocytic leukemia|stage iv chronic lymphocytic leukemia
630644|NCT00900120|T-cell large granular lymphocyte leukemia|t-cell large granular lymphocyte leukemia
630645|NCT00900120|untreated adult acute lymphoblastic leukemia|untreated adult acute lymphoblastic leukemia
630646|NCT00900120|untreated adult acute myeloid leukemia|untreated adult acute myeloid leukemia
630647|NCT00900120|untreated childhood acute lymphoblastic leukemia|untreated childhood acute lymphoblastic leukemia
630648|NCT00900120|untreated childhood acute myeloid leukemia and other myeloid malignancies|untreated childhood acute myeloid leukemia and other myeloid malignancies
630649|NCT00900120|untreated hairy cell leukemia|untreated hairy cell leukemia
630650|NCT00900120|AIDS-related diffuse large cell lymphoma|aids-related diffuse large cell lymphoma
630651|NCT00900120|AIDS-related diffuse mixed cell lymphoma|aids-related diffuse mixed cell lymphoma
630652|NCT00900120|AIDS-related diffuse small cleaved cell lymphoma|aids-related diffuse small cleaved cell lymphoma
630653|NCT00900120|AIDS-related immunoblastic large cell lymphoma|aids-related immunoblastic large cell lymphoma
630654|NCT00900120|AIDS-related lymphoblastic lymphoma|aids-related lymphoblastic lymphoma
630655|NCT00900120|AIDS-related peripheral/systemic lymphoma|aids-related peripheral/systemic lymphoma
630656|NCT00900120|AIDS-related primary CNS lymphoma|aids-related primary cns lymphoma
630657|NCT00900120|AIDS-related small noncleaved cell lymphoma|aids-related small noncleaved cell lymphoma
630658|NCT00900120|HIV-associated Hodgkin lymphoma|hiv-associated hodgkin lymphoma
630659|NCT00900120|recurrent adult Hodgkin lymphoma|recurrent adult hodgkin lymphoma
630660|NCT00900120|recurrent/refractory childhood Hodgkin lymphoma|recurrent/refractory childhood hodgkin lymphoma
630661|NCT00900120|stage I adult Hodgkin lymphoma|stage i adult hodgkin lymphoma
630662|NCT00900120|stage I childhood Hodgkin lymphoma|stage i childhood hodgkin lymphoma
630663|NCT00900120|stage II adult Hodgkin lymphoma|stage ii adult hodgkin lymphoma
630664|NCT00900120|stage II childhood Hodgkin lymphoma|stage ii childhood hodgkin lymphoma
630665|NCT00900120|stage III adult Hodgkin lymphoma|stage iii adult hodgkin lymphoma
630666|NCT00900120|stage III childhood Hodgkin lymphoma|stage iii childhood hodgkin lymphoma
630667|NCT00900120|stage IV adult Hodgkin lymphoma|stage iv adult hodgkin lymphoma
630668|NCT00900120|stage IV childhood Hodgkin lymphoma|stage iv childhood hodgkin lymphoma
630669|NCT00900120|anaplastic large cell lymphoma|anaplastic large cell lymphoma
630670|NCT00900120|angioimmunoblastic T-cell lymphoma|angioimmunoblastic t-cell lymphoma
630671|NCT00900120|cutaneous B-cell non-Hodgkin lymphoma|cutaneous b-cell non-hodgkin lymphoma
630672|NCT00900120|recurrent cutaneous T-cell non-Hodgkin lymphoma|recurrent cutaneous t-cell non-hodgkin lymphoma
630673|NCT00900120|stage I cutaneous T-cell non-Hodgkin lymphoma|stage i cutaneous t-cell non-hodgkin lymphoma
630674|NCT00900120|stage II cutaneous T-cell non-Hodgkin lymphoma|stage ii cutaneous t-cell non-hodgkin lymphoma
630675|NCT00900120|stage III cutaneous T-cell non-Hodgkin lymphoma|stage iii cutaneous t-cell non-hodgkin lymphoma
630676|NCT00900120|stage IV cutaneous T-cell non-Hodgkin lymphoma|stage iv cutaneous t-cell non-hodgkin lymphoma
630677|NCT00900120|recurrent mycosis fungoides/Sezary syndrome|recurrent mycosis fungoides/sezary syndrome
630678|NCT00900120|stage I mycosis fungoides/Sezary syndrome|stage i mycosis fungoides/sezary syndrome
630679|NCT00900120|stage II mycosis fungoides/Sezary syndrome|stage ii mycosis fungoides/sezary syndrome
630680|NCT00900120|stage III mycosis fungoides/Sezary syndrome|stage iii mycosis fungoides/sezary syndrome
630681|NCT00900120|stage IV mycosis fungoides/Sezary syndrome|stage iv mycosis fungoides/sezary syndrome
630682|NCT00900120|adult grade III lymphomatoid granulomatosis|adult grade iii lymphomatoid granulomatosis
630683|NCT00900120|adult nasal type extranodal NK/T-cell lymphoma|adult nasal type extranodal nk/t-cell lymphoma
630684|NCT00900120|Waldenstrom macroglobulinemia|waldenstrom macroglobulinemia
630685|NCT00900120|extranodal marginal zone B-cell lymphoma of mucosa-associated lymphoid tissue|extranodal marginal zone b-cell lymphoma of mucosa-associated lymphoid tissue
630686|NCT00900120|nodal marginal zone B-cell lymphoma|nodal marginal zone b-cell lymphoma
630687|NCT00900120|splenic marginal zone lymphoma|splenic marginal zone lymphoma
630688|NCT00900120|contiguous stage II adult Burkitt lymphoma|contiguous stage ii adult burkitt lymphoma
630689|NCT00900120|contiguous stage II adult diffuse large cell lymphoma|contiguous stage ii adult diffuse large cell lymphoma
630690|NCT00900120|contiguous stage II adult diffuse mixed cell lymphoma|contiguous stage ii adult diffuse mixed cell lymphoma
630691|NCT00900120|contiguous stage II adult diffuse small cleaved cell lymphoma|contiguous stage ii adult diffuse small cleaved cell lymphoma
630692|NCT00900120|contiguous stage II adult immunoblastic large cell lymphoma|contiguous stage ii adult immunoblastic large cell lymphoma
710890|NCT00587392|Gastroesophageal Reflux Disease (GERD)|gastroesophageal reflux disease (gerd)
630693|NCT00900120|contiguous stage II adult lymphoblastic lymphoma|contiguous stage ii adult lymphoblastic lymphoma
630694|NCT00900120|contiguous stage II grade 1 follicular lymphoma|contiguous stage ii grade 1 follicular lymphoma
630695|NCT00900120|contiguous stage II grade 2 follicular lymphoma|contiguous stage ii grade 2 follicular lymphoma
630696|NCT00900120|contiguous stage II grade 3 follicular lymphoma|contiguous stage ii grade 3 follicular lymphoma
630697|NCT00900120|contiguous stage II mantle cell lymphoma|contiguous stage ii mantle cell lymphoma
630698|NCT00900120|contiguous stage II marginal zone lymphoma|contiguous stage ii marginal zone lymphoma
630699|NCT00900120|contiguous stage II small lymphocytic lymphoma|contiguous stage ii small lymphocytic lymphoma
630700|NCT00900120|stage I adult Burkitt lymphoma|stage i adult burkitt lymphoma
630701|NCT00900120|stage I adult diffuse large cell lymphoma|stage i adult diffuse large cell lymphoma
630702|NCT00900120|stage I adult diffuse mixed cell lymphoma|stage i adult diffuse mixed cell lymphoma
630967|NCT00900016|recurrent pancreatic cancer|recurrent pancreatic cancer
630703|NCT00900120|stage I adult diffuse small cleaved cell lymphoma|stage i adult diffuse small cleaved cell lymphoma
630704|NCT00900120|stage I adult immunoblastic large cell lymphoma|stage i adult immunoblastic large cell lymphoma
630705|NCT00900120|stage I adult lymphoblastic lymphoma|stage i adult lymphoblastic lymphoma
630706|NCT00900120|stage I grade 1 follicular lymphoma|stage i grade 1 follicular lymphoma
630707|NCT00900120|stage I grade 2 follicular lymphoma|stage i grade 2 follicular lymphoma
630708|NCT00900120|stage I grade 3 follicular lymphoma|stage i grade 3 follicular lymphoma
630709|NCT00900120|stage I mantle cell lymphoma|stage i mantle cell lymphoma
630710|NCT00900120|stage I marginal zone lymphoma|stage i marginal zone lymphoma
630711|NCT00900120|stage I small lymphocytic lymphoma|stage i small lymphocytic lymphoma
630712|NCT00900120|noncontiguous stage II adult Burkitt lymphoma|noncontiguous stage ii adult burkitt lymphoma
630713|NCT00900120|noncontiguous stage II adult diffuse large cell lymphoma|noncontiguous stage ii adult diffuse large cell lymphoma
630714|NCT00900120|noncontiguous stage II adult diffuse mixed cell lymphoma|noncontiguous stage ii adult diffuse mixed cell lymphoma
630715|NCT00900120|noncontiguous stage II adult diffuse small cleaved cell lymphoma|noncontiguous stage ii adult diffuse small cleaved cell lymphoma
630716|NCT00900120|noncontiguous stage II adult immunoblastic large cell lymphoma|noncontiguous stage ii adult immunoblastic large cell lymphoma
630717|NCT00900120|noncontiguous stage II adult lymphoblastic lymphoma|noncontiguous stage ii adult lymphoblastic lymphoma
630718|NCT00900120|noncontiguous stage II grade 1 follicular lymphoma|noncontiguous stage ii grade 1 follicular lymphoma
630719|NCT00900120|noncontiguous stage II grade 2 follicular lymphoma|noncontiguous stage ii grade 2 follicular lymphoma
630720|NCT00900120|noncontiguous stage II grade 3 follicular lymphoma|noncontiguous stage ii grade 3 follicular lymphoma
630721|NCT00900120|noncontiguous stage II mantle cell lymphoma|noncontiguous stage ii mantle cell lymphoma
630722|NCT00900120|noncontiguous stage II marginal zone lymphoma|noncontiguous stage ii marginal zone lymphoma
630723|NCT00900120|noncontiguous stage II small lymphocytic lymphoma|noncontiguous stage ii small lymphocytic lymphoma
630724|NCT00900120|stage I childhood large cell lymphoma|stage i childhood large cell lymphoma
630725|NCT00900120|stage I childhood lymphoblastic lymphoma|stage i childhood lymphoblastic lymphoma
630726|NCT00900120|stage I childhood small noncleaved cell lymphoma|stage i childhood small noncleaved cell lymphoma
630727|NCT00900120|stage II childhood large cell lymphoma|stage ii childhood large cell lymphoma
630728|NCT00900120|stage II childhood lymphoblastic lymphoma|stage ii childhood lymphoblastic lymphoma
630729|NCT00900120|stage II childhood small noncleaved cell lymphoma|stage ii childhood small noncleaved cell lymphoma
630730|NCT00900120|stage III adult Burkitt lymphoma|stage iii adult burkitt lymphoma
630731|NCT00900120|stage III adult diffuse large cell lymphoma|stage iii adult diffuse large cell lymphoma
630732|NCT00900120|stage III adult diffuse mixed cell lymphoma|stage iii adult diffuse mixed cell lymphoma
630733|NCT00900120|stage III adult diffuse small cleaved cell lymphoma|stage iii adult diffuse small cleaved cell lymphoma
630734|NCT00900120|stage III adult immunoblastic large cell lymphoma|stage iii adult immunoblastic large cell lymphoma
630735|NCT00900120|stage III adult lymphoblastic lymphoma|stage iii adult lymphoblastic lymphoma
630736|NCT00900120|stage III childhood large cell lymphoma|stage iii childhood large cell lymphoma
630737|NCT00900120|stage III childhood lymphoblastic lymphoma|stage iii childhood lymphoblastic lymphoma
630738|NCT00900120|stage III childhood small noncleaved cell lymphoma|stage iii childhood small noncleaved cell lymphoma
630739|NCT00900120|stage III grade 1 follicular lymphoma|stage iii grade 1 follicular lymphoma
630740|NCT00900120|stage III grade 2 follicular lymphoma|stage iii grade 2 follicular lymphoma
630741|NCT00900120|stage III grade 3 follicular lymphoma|stage iii grade 3 follicular lymphoma
630742|NCT00900120|stage III mantle cell lymphoma|stage iii mantle cell lymphoma
630743|NCT00900120|stage III marginal zone lymphoma|stage iii marginal zone lymphoma
630744|NCT00900120|stage III small lymphocytic lymphoma|stage iii small lymphocytic lymphoma
630745|NCT00900120|stage IV adult Burkitt lymphoma|stage iv adult burkitt lymphoma
630746|NCT00900120|stage IV adult diffuse large cell lymphoma|stage iv adult diffuse large cell lymphoma
630747|NCT00900120|stage IV adult diffuse mixed cell lymphoma|stage iv adult diffuse mixed cell lymphoma
630748|NCT00900120|stage IV adult diffuse small cleaved cell lymphoma|stage iv adult diffuse small cleaved cell lymphoma
630749|NCT00900120|stage IV adult immunoblastic large cell lymphoma|stage iv adult immunoblastic large cell lymphoma
630750|NCT00900120|stage IV adult lymphoblastic lymphoma|stage iv adult lymphoblastic lymphoma
630751|NCT00900120|stage IV childhood large cell lymphoma|stage iv childhood large cell lymphoma
630752|NCT00900120|stage IV childhood lymphoblastic lymphoma|stage iv childhood lymphoblastic lymphoma
630753|NCT00900120|stage IV childhood small noncleaved cell lymphoma|stage iv childhood small noncleaved cell lymphoma
630754|NCT00900120|stage IV grade 1 follicular lymphoma|stage iv grade 1 follicular lymphoma
630755|NCT00900120|stage IV grade 2 follicular lymphoma|stage iv grade 2 follicular lymphoma
630756|NCT00900120|stage IV grade 3 follicular lymphoma|stage iv grade 3 follicular lymphoma
630757|NCT00900120|stage IV mantle cell lymphoma|stage iv mantle cell lymphoma
630758|NCT00900120|stage IV marginal zone lymphoma|stage iv marginal zone lymphoma
630759|NCT00900120|stage IV small lymphocytic lymphoma|stage iv small lymphocytic lymphoma
630760|NCT00900120|recurrent adult Burkitt lymphoma|recurrent adult burkitt lymphoma
630761|NCT00900120|recurrent adult diffuse large cell lymphoma|recurrent adult diffuse large cell lymphoma
630762|NCT00900120|recurrent adult diffuse mixed cell lymphoma|recurrent adult diffuse mixed cell lymphoma
630763|NCT00900120|recurrent adult diffuse small cleaved cell lymphoma|recurrent adult diffuse small cleaved cell lymphoma
633288|NCT00895193|Flushing|flushing
630764|NCT00900120|recurrent adult grade III lymphomatoid granulomatosis|recurrent adult grade iii lymphomatoid granulomatosis
630765|NCT00900120|recurrent adult immunoblastic large cell lymphoma|recurrent adult immunoblastic large cell lymphoma
630766|NCT00900120|recurrent adult lymphoblastic lymphoma|recurrent adult lymphoblastic lymphoma
630767|NCT00900120|recurrent childhood grade III lymphomatoid granulomatosis|recurrent childhood grade iii lymphomatoid granulomatosis
630768|NCT00900120|recurrent childhood large cell lymphoma|recurrent childhood large cell lymphoma
630769|NCT00900120|recurrent childhood lymphoblastic lymphoma|recurrent childhood lymphoblastic lymphoma
630770|NCT00900120|recurrent childhood small noncleaved cell lymphoma|recurrent childhood small noncleaved cell lymphoma
630771|NCT00900120|recurrent grade 1 follicular lymphoma|recurrent grade 1 follicular lymphoma
630772|NCT00900120|recurrent grade 2 follicular lymphoma|recurrent grade 2 follicular lymphoma
630773|NCT00900120|recurrent grade 3 follicular lymphoma|recurrent grade 3 follicular lymphoma
630774|NCT00900120|recurrent mantle cell lymphoma|recurrent mantle cell lymphoma
630775|NCT00900120|recurrent marginal zone lymphoma|recurrent marginal zone lymphoma
630776|NCT00900120|recurrent small lymphocytic lymphoma|recurrent small lymphocytic lymphoma
630777|NCT00900120|Burkitt lymphoma|burkitt lymphoma
630778|NCT00900120|childhood diffuse large cell lymphoma|childhood diffuse large cell lymphoma
630779|NCT00900120|childhood grade III lymphomatoid granulomatosis|childhood grade iii lymphomatoid granulomatosis
630780|NCT00900120|childhood immunoblastic large cell lymphoma|childhood immunoblastic large cell lymphoma
630781|NCT00900120|childhood nasal type extranodal NK/T-cell lymphoma|childhood nasal type extranodal nk/t-cell lymphoma
630782|NCT00900120|intraocular lymphoma|intraocular lymphoma
630783|NCT00900120|primary central nervous system non-Hodgkin lymphoma|primary central nervous system non-hodgkin lymphoma
630784|NCT00900120|primary central nervous system Hodgkin lymphoma|primary central nervous system hodgkin lymphoma
630785|NCT00900120|post-transplant lymphoproliferative disorder|post-transplant lymphoproliferative disorder
630786|NCT00900120|chronic eosinophilic leukemia|chronic eosinophilic leukemia
630787|NCT00900120|chronic neutrophilic leukemia|chronic neutrophilic leukemia
630788|NCT00900120|primary myelofibrosis|primary myelofibrosis
630789|NCT00900120|essential thrombocythemia|essential thrombocythemia
630790|NCT00900120|polycythemia vera|polycythemia vera
630791|NCT00900120|extramedullary plasmacytoma|extramedullary plasmacytoma
630792|NCT00900120|isolated plasmacytoma of bone|isolated plasmacytoma of bone
630793|NCT00900120|stage I multiple myeloma|stage i multiple myeloma
630794|NCT00900120|stage II multiple myeloma|stage ii multiple myeloma
630795|NCT00900120|stage III multiple myeloma|stage iii multiple myeloma
630796|NCT00900120|primary systemic amyloidosis|primary systemic amyloidosis
630797|NCT00900120|refractory multiple myeloma|refractory multiple myeloma
630798|NCT00900120|de novo myelodysplastic syndromes|de novo myelodysplastic syndromes
630799|NCT00900120|previously treated myelodysplastic syndromes|previously treated myelodysplastic syndromes
630800|NCT00900120|childhood myelodysplastic syndromes|childhood myelodysplastic syndromes
630801|NCT00900120|recurrent childhood anaplastic large cell lymphoma|recurrent childhood anaplastic large cell lymphoma
630802|NCT00900120|stage I childhood anaplastic large cell lymphoma|stage i childhood anaplastic large cell lymphoma
630803|NCT00900120|stage II childhood anaplastic large cell lymphoma|stage ii childhood anaplastic large cell lymphoma
630804|NCT00900120|stage III childhood anaplastic large cell lymphoma|stage iii childhood anaplastic large cell lymphoma
630805|NCT00900120|stage IV childhood anaplastic large cell lymphoma|stage iv childhood anaplastic large cell lymphoma
630806|NCT00900094|stage I breast cancer|stage i breast cancer
630807|NCT00900094|stage II breast cancer|stage ii breast cancer
630808|NCT00900094|stage IIIA breast cancer|stage iiia breast cancer
630809|NCT00900094|stage IIIB breast cancer|stage iiib breast cancer
630810|NCT00900094|stage IV breast cancer|stage iv breast cancer
630811|NCT00900094|adenocarcinoma of the colon|adenocarcinoma of the colon
630812|NCT00900094|stage I colon cancer|stage i colon cancer
630813|NCT00900094|stage II colon cancer|stage ii colon cancer
630814|NCT00900094|stage III colon cancer|stage iii colon cancer
630815|NCT00900094|stage IV colon cancer|stage iv colon cancer
710891|NCT00587392|Long-term follow-up (LTFU)|long-term follow-up (ltfu)
630816|NCT00900094|adenocarcinoma of the esophagus|adenocarcinoma of the esophagus
630817|NCT00900094|squamous cell carcinoma of the esophagus|squamous cell carcinoma of the esophagus
630818|NCT00900094|stage I esophageal cancer|stage i esophageal cancer
630819|NCT00900094|stage II esophageal cancer|stage ii esophageal cancer
630820|NCT00900094|stage III esophageal cancer|stage iii esophageal cancer
630821|NCT00900094|stage IV esophageal cancer|stage iv esophageal cancer
630822|NCT00900094|stage I non-small cell lung cancer|stage i non-small cell lung cancer
630823|NCT00900094|stage II non-small cell lung cancer|stage ii non-small cell lung cancer
630824|NCT00900094|stage IIIA non-small cell lung cancer|stage iiia non-small cell lung cancer
630825|NCT00900094|stage IIIB non-small cell lung cancer|stage iiib non-small cell lung cancer
630826|NCT00900094|stage IV non-small cell lung cancer|stage iv non-small cell lung cancer
630827|NCT00900094|stage I ovarian epithelial cancer|stage i ovarian epithelial cancer
630828|NCT00900094|stage II ovarian epithelial cancer|stage ii ovarian epithelial cancer
630829|NCT00900094|stage III ovarian epithelial cancer|stage iii ovarian epithelial cancer
630830|NCT00900094|stage IV ovarian epithelial cancer|stage iv ovarian epithelial cancer
630831|NCT00900094|localized unresectable adult primary liver cancer|localized unresectable adult primary liver cancer
630832|NCT00900094|advanced adult primary liver cancer|advanced adult primary liver cancer
633393|NCT00894790|NSAID|nsaid
630833|NCT00900094|adenocarcinoma of the pancreas|adenocarcinoma of the pancreas
630834|NCT00900094|stage II pancreatic cancer|stage ii pancreatic cancer
630835|NCT00900094|stage III pancreatic cancer|stage iii pancreatic cancer
630836|NCT00900094|extensive stage small cell lung cancer|extensive stage small cell lung cancer
630837|NCT00900094|stage IIIC breast cancer|stage iiic breast cancer
630838|NCT00900094|stage IV pancreatic cancer|stage iv pancreatic cancer
630839|NCT00900094|recurrent breast cancer|recurrent breast cancer
630840|NCT00900094|recurrent colon cancer|recurrent colon cancer
630841|NCT00900094|recurrent esophageal cancer|recurrent esophageal cancer
630842|NCT00900094|recurrent non-small cell lung cancer|recurrent non-small cell lung cancer
630843|NCT00900094|recurrent ovarian epithelial cancer|recurrent ovarian epithelial cancer
630844|NCT00900094|recurrent adult primary liver cancer|recurrent adult primary liver cancer
630845|NCT00900094|adult primary hepatocellular carcinoma|adult primary hepatocellular carcinoma
630846|NCT00900094|recurrent small cell lung cancer|recurrent small cell lung cancer
630847|NCT00900081|cervical squamous cell carcinoma|cervical squamous cell carcinoma
630848|NCT00900081|stage IA cervical cancer|stage ia cervical cancer
630849|NCT00900081|stage 0 cervical cancer|stage 0 cervical cancer
630850|NCT00900081|cervical intraepithelial neoplasia grade 1|cervical intraepithelial neoplasia grade 1
630851|NCT00900081|cervical intraepithelial neoplasia grade 2|cervical intraepithelial neoplasia grade 2
630852|NCT00900081|cervical intraepithelial neoplasia grade 3|cervical intraepithelial neoplasia grade 3
630853|NCT00900068|nausea and vomiting|nausea and vomiting
630854|NCT00900068|stage III adult Burkitt lymphoma|stage iii adult burkitt lymphoma
630855|NCT00900068|stage III adult diffuse large cell lymphoma|stage iii adult diffuse large cell lymphoma
630856|NCT00900068|stage III adult diffuse mixed cell lymphoma|stage iii adult diffuse mixed cell lymphoma
630857|NCT00900068|stage III adult diffuse small cleaved cell lymphoma|stage iii adult diffuse small cleaved cell lymphoma
630858|NCT00900068|stage III adult Hodgkin lymphoma|stage iii adult hodgkin lymphoma
630859|NCT00900068|stage III adult immunoblastic large cell lymphoma|stage iii adult immunoblastic large cell lymphoma
630860|NCT00900068|stage III adult lymphoblastic lymphoma|stage iii adult lymphoblastic lymphoma
630861|NCT00900068|stage III grade 1 follicular lymphoma|stage iii grade 1 follicular lymphoma
630862|NCT00900068|stage III grade 2 follicular lymphoma|stage iii grade 2 follicular lymphoma
630863|NCT00900068|stage III grade 3 follicular lymphoma|stage iii grade 3 follicular lymphoma
630864|NCT00900068|stage III mantle cell lymphoma|stage iii mantle cell lymphoma
630865|NCT00900068|stage III marginal zone lymphoma|stage iii marginal zone lymphoma
630866|NCT00900068|stage III small lymphocytic lymphoma|stage iii small lymphocytic lymphoma
630867|NCT00900068|stage IV adult Burkitt lymphoma|stage iv adult burkitt lymphoma
630868|NCT00900068|stage IV adult diffuse large cell lymphoma|stage iv adult diffuse large cell lymphoma
630869|NCT00900068|stage IV adult diffuse mixed cell lymphoma|stage iv adult diffuse mixed cell lymphoma
630870|NCT00900068|stage IV adult diffuse small cleaved cell lymphoma|stage iv adult diffuse small cleaved cell lymphoma
630871|NCT00900068|stage IV adult Hodgkin lymphoma|stage iv adult hodgkin lymphoma
630872|NCT00900068|stage IV adult immunoblastic large cell lymphoma|stage iv adult immunoblastic large cell lymphoma
630873|NCT00900068|stage IV adult lymphoblastic lymphoma|stage iv adult lymphoblastic lymphoma
630874|NCT00900068|stage IV grade 1 follicular lymphoma|stage iv grade 1 follicular lymphoma
630875|NCT00900068|stage IV grade 2 follicular lymphoma|stage iv grade 2 follicular lymphoma
630876|NCT00900068|stage IV grade 3 follicular lymphoma|stage iv grade 3 follicular lymphoma
630877|NCT00900068|stage IV mantle cell lymphoma|stage iv mantle cell lymphoma
630878|NCT00900068|stage IV marginal zone lymphoma|stage iv marginal zone lymphoma
630879|NCT00900068|stage IV small lymphocytic lymphoma|stage iv small lymphocytic lymphoma
630880|NCT00900068|recurrent adult Burkitt lymphoma|recurrent adult burkitt lymphoma
630881|NCT00900068|recurrent adult diffuse large cell lymphoma|recurrent adult diffuse large cell lymphoma
712508|NCT00579904|polycystic ovary syndrome|polycystic ovary syndrome
802341|NCT00245518|soy|soy
630882|NCT00900068|recurrent adult diffuse mixed cell lymphoma|recurrent adult diffuse mixed cell lymphoma
630883|NCT00900068|recurrent adult diffuse small cleaved cell lymphoma|recurrent adult diffuse small cleaved cell lymphoma
630884|NCT00900068|recurrent adult Hodgkin lymphoma|recurrent adult hodgkin lymphoma
630885|NCT00900068|recurrent adult immunoblastic large cell lymphoma|recurrent adult immunoblastic large cell lymphoma
630886|NCT00900068|recurrent adult lymphoblastic lymphoma|recurrent adult lymphoblastic lymphoma
630887|NCT00900068|recurrent cutaneous T-cell non-Hodgkin lymphoma|recurrent cutaneous t-cell non-hodgkin lymphoma
630888|NCT00900068|recurrent grade 1 follicular lymphoma|recurrent grade 1 follicular lymphoma
630889|NCT00900068|recurrent grade 2 follicular lymphoma|recurrent grade 2 follicular lymphoma
630890|NCT00900068|recurrent grade 3 follicular lymphoma|recurrent grade 3 follicular lymphoma
630891|NCT00900068|recurrent mantle cell lymphoma|recurrent mantle cell lymphoma
630892|NCT00900068|recurrent marginal zone lymphoma|recurrent marginal zone lymphoma
630893|NCT00900068|recurrent small lymphocytic lymphoma|recurrent small lymphocytic lymphoma
630894|NCT00900068|recurrent mycosis fungoides/Sezary syndrome|recurrent mycosis fungoides/sezary syndrome
630895|NCT00900068|extranodal marginal zone B-cell lymphoma of mucosa-associated lymphoid tissue|extranodal marginal zone b-cell lymphoma of mucosa-associated lymphoid tissue
630896|NCT00900068|nodal marginal zone B-cell lymphoma|nodal marginal zone b-cell lymphoma
630897|NCT00900068|splenic marginal zone lymphoma|splenic marginal zone lymphoma
630898|NCT00900068|noncontiguous stage II adult Burkitt lymphoma|noncontiguous stage ii adult burkitt lymphoma
630966|NCT00900016|adenocarcinoma of the pancreas|adenocarcinoma of the pancreas
630899|NCT00900068|noncontiguous stage II adult diffuse large cell lymphoma|noncontiguous stage ii adult diffuse large cell lymphoma
630900|NCT00900068|noncontiguous stage II adult diffuse mixed cell lymphoma|noncontiguous stage ii adult diffuse mixed cell lymphoma
630901|NCT00900068|noncontiguous stage II adult diffuse small cleaved cell lymphoma|noncontiguous stage ii adult diffuse small cleaved cell lymphoma
630902|NCT00900068|noncontiguous stage II adult immunoblastic large cell lymphoma|noncontiguous stage ii adult immunoblastic large cell lymphoma
630903|NCT00900068|noncontiguous stage II adult lymphoblastic lymphoma|noncontiguous stage ii adult lymphoblastic lymphoma
630904|NCT00900068|noncontiguous stage II grade 1 follicular lymphoma|noncontiguous stage ii grade 1 follicular lymphoma
630905|NCT00900068|noncontiguous stage II grade 2 follicular lymphoma|noncontiguous stage ii grade 2 follicular lymphoma
630906|NCT00900068|noncontiguous stage II grade 3 follicular lymphoma|noncontiguous stage ii grade 3 follicular lymphoma
630907|NCT00900068|noncontiguous stage II mantle cell lymphoma|noncontiguous stage ii mantle cell lymphoma
630908|NCT00900068|noncontiguous stage II marginal zone lymphoma|noncontiguous stage ii marginal zone lymphoma
630909|NCT00900068|noncontiguous stage II small lymphocytic lymphoma|noncontiguous stage ii small lymphocytic lymphoma
630910|NCT00900068|accelerated phase chronic myelogenous leukemia|accelerated phase chronic myelogenous leukemia
630911|NCT00900068|adult acute lymphoblastic leukemia in remission|adult acute lymphoblastic leukemia in remission
630912|NCT00900068|adult acute myeloid leukemia in remission|adult acute myeloid leukemia in remission
630913|NCT00900068|adult acute myeloid leukemia with 11q23 (MLL) abnormalities|adult acute myeloid leukemia with 11q23 (mll) abnormalities
630914|NCT00900068|adult acute myeloid leukemia with inv(16)(p13;q22)|adult acute myeloid leukemia with inv(16)(p13;q22)
630915|NCT00900068|adult acute myeloid leukemia with t(15;17)(q22;q12)|adult acute myeloid leukemia with t(15;17)(q22;q12)
630916|NCT00900068|adult acute myeloid leukemia with t(16;16)(p13;q22)|adult acute myeloid leukemia with t(16;16)(p13;q22)
630917|NCT00900068|adult acute myeloid leukemia with t(8;21)(q22;q22)|adult acute myeloid leukemia with t(8;21)(q22;q22)
630918|NCT00900068|atypical chronic myeloid leukemia, BCR-ABL negative|atypical chronic myeloid leukemia, bcr-abl negative
630919|NCT00900068|blastic phase chronic myelogenous leukemia|blastic phase chronic myelogenous leukemia
630920|NCT00900068|chronic myelomonocytic leukemia|chronic myelomonocytic leukemia
630921|NCT00900068|chronic phase chronic myelogenous leukemia|chronic phase chronic myelogenous leukemia
630922|NCT00900068|recurrent adult acute lymphoblastic leukemia|recurrent adult acute lymphoblastic leukemia
630923|NCT00900068|recurrent adult acute myeloid leukemia|recurrent adult acute myeloid leukemia
630924|NCT00900068|refractory chronic lymphocytic leukemia|refractory chronic lymphocytic leukemia
630925|NCT00900068|refractory hairy cell leukemia|refractory hairy cell leukemia
630926|NCT00900068|relapsing chronic myelogenous leukemia|relapsing chronic myelogenous leukemia
630927|NCT00900068|secondary acute myeloid leukemia|secondary acute myeloid leukemia
630928|NCT00900068|stage III chronic lymphocytic leukemia|stage iii chronic lymphocytic leukemia
630929|NCT00900068|stage IV chronic lymphocytic leukemia|stage iv chronic lymphocytic leukemia
630930|NCT00900068|chronic eosinophilic leukemia|chronic eosinophilic leukemia
630931|NCT00900068|primary myelofibrosis|primary myelofibrosis
630932|NCT00900068|chronic neutrophilic leukemia|chronic neutrophilic leukemia
630933|NCT00900068|de novo myelodysplastic syndromes|de novo myelodysplastic syndromes
630934|NCT00900068|disseminated neuroblastoma|disseminated neuroblastoma
630935|NCT00900068|myelodysplastic/myeloproliferative neoplasm, unclassifiable|myelodysplastic/myeloproliferative neoplasm, unclassifiable
630936|NCT00900068|poor prognosis metastatic gestational trophoblastic tumor|poor prognosis metastatic gestational trophoblastic tumor
630937|NCT00900068|previously treated myelodysplastic syndromes|previously treated myelodysplastic syndromes
630938|NCT00900068|recurrent neuroblastoma|recurrent neuroblastoma
630939|NCT00900068|recurrent ovarian epithelial cancer|recurrent ovarian epithelial cancer
630940|NCT00900068|recurrent ovarian germ cell tumor|recurrent ovarian germ cell tumor
630941|NCT00900068|recurrent malignant testicular germ cell tumor|recurrent malignant testicular germ cell tumor
630942|NCT00900068|secondary myelodysplastic syndromes|secondary myelodysplastic syndromes
630943|NCT00900068|stage I multiple myeloma|stage i multiple myeloma
630944|NCT00900068|stage II multiple myeloma|stage ii multiple myeloma
630945|NCT00900068|stage III multiple myeloma|stage iii multiple myeloma
630946|NCT00900068|stage II ovarian epithelial cancer|stage ii ovarian epithelial cancer
630947|NCT00900068|stage III ovarian epithelial cancer|stage iii ovarian epithelial cancer
630948|NCT00900068|stage IV ovarian epithelial cancer|stage iv ovarian epithelial cancer
630949|NCT00900068|stage III malignant testicular germ cell tumor|stage iii malignant testicular germ cell tumor
630950|NCT00900068|stage IIIA breast cancer|stage iiia breast cancer
630951|NCT00900068|stage IIIB breast cancer|stage iiib breast cancer
630952|NCT00900068|stage IIIC breast cancer|stage iiic breast cancer
630953|NCT00900068|stage IV breast cancer|stage iv breast cancer
630954|NCT00900068|refractory multiple myeloma|refractory multiple myeloma
630955|NCT00900055|Fanconi anemia|fanconi anemia
630956|NCT00900055|multiple myeloma and other plasma cell neoplasms|multiple myeloma and other plasma cell neoplasms
630957|NCT00900055|chronic myeloproliferative disorders|chronic myeloproliferative disorders
630958|NCT00900055|myelodysplastic/myeloproliferative neoplasms|myelodysplastic/myeloproliferative neoplasms
630959|NCT00900042|stage IV renal cell cancer|stage iv renal cell cancer
630960|NCT00900029|Venous Leg Ulcer|venous leg ulcer
630961|NCT00900029|Venous Stasis Ulcer|venous stasis ulcer
630962|NCT00900029|VLU|vlu
630963|NCT00900029|VSU|vsu
630964|NCT00900029|Leg Ulcer|leg ulcer
630968|NCT00900016|stage I pancreatic cancer|stage i pancreatic cancer
630969|NCT00900016|stage II pancreatic cancer|stage ii pancreatic cancer
630970|NCT00900003|stage I pancreatic cancer|stage i pancreatic cancer
630971|NCT00900003|stage II pancreatic cancer|stage ii pancreatic cancer
630972|NCT00900003|stage III pancreatic cancer|stage iii pancreatic cancer
630973|NCT00900003|stage IV pancreatic cancer|stage iv pancreatic cancer
630974|NCT00899977|refractory hypertension|refractory hypertension
630975|NCT00899977|hypertension|hypertension
630976|NCT00899951|unspecified adult solid tumor, protocol specific|unspecified adult solid tumor, protocol specific
630977|NCT00899951|accelerated phase chronic myelogenous leukemia|accelerated phase chronic myelogenous leukemia
630978|NCT00899951|acute undifferentiated leukemia|acute undifferentiated leukemia
630979|NCT00899951|adult acute lymphoblastic leukemia in remission|adult acute lymphoblastic leukemia in remission
630980|NCT00899951|adult acute myeloid leukemia in remission|adult acute myeloid leukemia in remission
630981|NCT00899951|adult acute myeloid leukemia with 11q23 (MLL) abnormalities|adult acute myeloid leukemia with 11q23 (mll) abnormalities
630982|NCT00899951|adult acute myeloid leukemia with inv(16)(p13;q22)|adult acute myeloid leukemia with inv(16)(p13;q22)
630983|NCT00899951|adult acute myeloid leukemia with t(15;17)(q22;q12)|adult acute myeloid leukemia with t(15;17)(q22;q12)
630984|NCT00899951|adult acute myeloid leukemia with t(16;16)(p13;q22)|adult acute myeloid leukemia with t(16;16)(p13;q22)
630985|NCT00899951|adult acute myeloid leukemia with t(8;21)(q22;q22)|adult acute myeloid leukemia with t(8;21)(q22;q22)
630986|NCT00899951|atypical chronic myeloid leukemia, BCR-ABL1 negative|atypical chronic myeloid leukemia, bcr-abl1 negative
630987|NCT00899951|blastic phase chronic myelogenous leukemia|blastic phase chronic myelogenous leukemia
630988|NCT00899951|chronic myelomonocytic leukemia|chronic myelomonocytic leukemia
630989|NCT00899951|chronic phase chronic myelogenous leukemia|chronic phase chronic myelogenous leukemia
630990|NCT00899951|mast cell leukemia|mast cell leukemia
630991|NCT00899951|meningeal chronic myelogenous leukemia|meningeal chronic myelogenous leukemia
630992|NCT00899951|progressive hairy cell leukemia, initial treatment|progressive hairy cell leukemia, initial treatment
630993|NCT00899951|prolymphocytic leukemia|prolymphocytic leukemia
630994|NCT00899951|recurrent adult acute lymphoblastic leukemia|recurrent adult acute lymphoblastic leukemia
630995|NCT00899951|recurrent adult acute myeloid leukemia|recurrent adult acute myeloid leukemia
630996|NCT00899951|recurrent adult T-cell leukemia/lymphoma|recurrent adult t-cell leukemia/lymphoma
630997|NCT00899951|refractory chronic lymphocytic leukemia|refractory chronic lymphocytic leukemia
630998|NCT00899951|refractory hairy cell leukemia|refractory hairy cell leukemia
630999|NCT00899951|relapsing chronic myelogenous leukemia|relapsing chronic myelogenous leukemia
631000|NCT00899951|secondary acute myeloid leukemia|secondary acute myeloid leukemia
631001|NCT00899951|stage 0 chronic lymphocytic leukemia|stage 0 chronic lymphocytic leukemia
631002|NCT00899951|stage I adult T-cell leukemia/lymphoma|stage i adult t-cell leukemia/lymphoma
631003|NCT00899951|stage I chronic lymphocytic leukemia|stage i chronic lymphocytic leukemia
631004|NCT00899951|stage II adult T-cell leukemia/lymphoma|stage ii adult t-cell leukemia/lymphoma
631005|NCT00899951|stage II chronic lymphocytic leukemia|stage ii chronic lymphocytic leukemia
631006|NCT00899951|stage III adult T-cell leukemia/lymphoma|stage iii adult t-cell leukemia/lymphoma
631007|NCT00899951|stage III chronic lymphocytic leukemia|stage iii chronic lymphocytic leukemia
631008|NCT00899951|stage IV adult T-cell leukemia/lymphoma|stage iv adult t-cell leukemia/lymphoma
631009|NCT00899951|stage IV chronic lymphocytic leukemia|stage iv chronic lymphocytic leukemia
631010|NCT00899951|T-cell large granular lymphocyte leukemia|t-cell large granular lymphocyte leukemia
631011|NCT00899951|recurrent adult Hodgkin lymphoma|recurrent adult hodgkin lymphoma
631012|NCT00899951|stage I adult Hodgkin lymphoma|stage i adult hodgkin lymphoma
631013|NCT00899951|stage II adult Hodgkin lymphoma|stage ii adult hodgkin lymphoma
631014|NCT00899951|stage III adult Hodgkin lymphoma|stage iii adult hodgkin lymphoma
631015|NCT00899951|stage IV adult Hodgkin lymphoma|stage iv adult hodgkin lymphoma
631016|NCT00899951|anaplastic large cell lymphoma|anaplastic large cell lymphoma
631017|NCT00899951|angioimmunoblastic T-cell lymphoma|angioimmunoblastic t-cell lymphoma
631018|NCT00899951|cutaneous B-cell non-Hodgkin lymphoma|cutaneous b-cell non-hodgkin lymphoma
631019|NCT00899951|recurrent cutaneous T-cell non-Hodgkin lymphoma|recurrent cutaneous t-cell non-hodgkin lymphoma
631020|NCT00899951|stage I cutaneous T-cell non-Hodgkin lymphoma|stage i cutaneous t-cell non-hodgkin lymphoma
631021|NCT00899951|stage II cutaneous T-cell non-Hodgkin lymphoma|stage ii cutaneous t-cell non-hodgkin lymphoma
631022|NCT00899951|stage III cutaneous T-cell non-Hodgkin lymphoma|stage iii cutaneous t-cell non-hodgkin lymphoma
631023|NCT00899951|stage IV cutaneous T-cell non-Hodgkin lymphoma|stage iv cutaneous t-cell non-hodgkin lymphoma
631024|NCT00899951|recurrent mycosis fungoides/Sezary syndrome|recurrent mycosis fungoides/sezary syndrome
631025|NCT00899951|stage I mycosis fungoides/Sezary syndrome|stage i mycosis fungoides/sezary syndrome
631026|NCT00899951|stage II mycosis fungoides/Sezary syndrome|stage ii mycosis fungoides/sezary syndrome
631027|NCT00899951|stage III mycosis fungoides/Sezary syndrome|stage iii mycosis fungoides/sezary syndrome
631028|NCT00899951|stage IV mycosis fungoides/Sezary syndrome|stage iv mycosis fungoides/sezary syndrome
631029|NCT00899951|adult grade III lymphomatoid granulomatosis|adult grade iii lymphomatoid granulomatosis
631030|NCT00899951|adult nasal type extranodal NK/T-cell lymphoma|adult nasal type extranodal nk/t-cell lymphoma
631031|NCT00899951|Waldenström macroglobulinemia|waldenström macroglobulinemia
631032|NCT00899951|extranodal marginal zone B-cell lymphoma of mucosa-associated lymphoid tissue|extranodal marginal zone b-cell lymphoma of mucosa-associated lymphoid tissue
631033|NCT00899951|nodal marginal zone B-cell lymphoma|nodal marginal zone b-cell lymphoma
631034|NCT00899951|splenic marginal zone lymphoma|splenic marginal zone lymphoma
631035|NCT00899951|contiguous stage II adult Burkitt lymphoma|contiguous stage ii adult burkitt lymphoma
631036|NCT00899951|contiguous stage II adult diffuse large cell lymphoma|contiguous stage ii adult diffuse large cell lymphoma
631037|NCT00899951|contiguous stage II adult diffuse mixed cell lymphoma|contiguous stage ii adult diffuse mixed cell lymphoma
631038|NCT00899951|contiguous stage II adult diffuse small cleaved cell lymphoma|contiguous stage ii adult diffuse small cleaved cell lymphoma
631039|NCT00899951|contiguous stage II adult immunoblastic large cell lymphoma|contiguous stage ii adult immunoblastic large cell lymphoma
631040|NCT00899951|contiguous stage II adult lymphoblastic lymphoma|contiguous stage ii adult lymphoblastic lymphoma
631041|NCT00899951|contiguous stage II grade 1 follicular lymphoma|contiguous stage ii grade 1 follicular lymphoma
631042|NCT00899951|contiguous stage II grade 2 follicular lymphoma|contiguous stage ii grade 2 follicular lymphoma
631043|NCT00899951|contiguous stage II grade 3 follicular lymphoma|contiguous stage ii grade 3 follicular lymphoma
631044|NCT00899951|contiguous stage II mantle cell lymphoma|contiguous stage ii mantle cell lymphoma
631045|NCT00899951|contiguous stage II marginal zone lymphoma|contiguous stage ii marginal zone lymphoma
631046|NCT00899951|contiguous stage II small lymphocytic lymphoma|contiguous stage ii small lymphocytic lymphoma
631047|NCT00899951|stage I adult Burkitt lymphoma|stage i adult burkitt lymphoma
631048|NCT00899951|stage I adult diffuse large cell lymphoma|stage i adult diffuse large cell lymphoma
631049|NCT00899951|stage I adult diffuse mixed cell lymphoma|stage i adult diffuse mixed cell lymphoma
631050|NCT00899951|stage I adult diffuse small cleaved cell lymphoma|stage i adult diffuse small cleaved cell lymphoma
631051|NCT00899951|stage I adult immunoblastic large cell lymphoma|stage i adult immunoblastic large cell lymphoma
631052|NCT00899951|stage I adult lymphoblastic lymphoma|stage i adult lymphoblastic lymphoma
631053|NCT00899951|stage I grade 1 follicular lymphoma|stage i grade 1 follicular lymphoma
631054|NCT00899951|stage I grade 2 follicular lymphoma|stage i grade 2 follicular lymphoma
631055|NCT00899951|stage I grade 3 follicular lymphoma|stage i grade 3 follicular lymphoma
631056|NCT00899951|stage I mantle cell lymphoma|stage i mantle cell lymphoma
631057|NCT00899951|stage I marginal zone lymphoma|stage i marginal zone lymphoma
631058|NCT00899951|stage I small lymphocytic lymphoma|stage i small lymphocytic lymphoma
631059|NCT00899951|noncontiguous stage II adult Burkitt lymphoma|noncontiguous stage ii adult burkitt lymphoma
631060|NCT00899951|noncontiguous stage II adult diffuse large cell lymphoma|noncontiguous stage ii adult diffuse large cell lymphoma
631061|NCT00899951|noncontiguous stage II adult diffuse mixed cell lymphoma|noncontiguous stage ii adult diffuse mixed cell lymphoma
631062|NCT00899951|noncontiguous stage II adult diffuse small cleaved cell lymphoma|noncontiguous stage ii adult diffuse small cleaved cell lymphoma
631063|NCT00899951|noncontiguous stage II adult immunoblastic large cell lymphoma|noncontiguous stage ii adult immunoblastic large cell lymphoma
631064|NCT00899951|noncontiguous stage II adult lymphoblastic lymphoma|noncontiguous stage ii adult lymphoblastic lymphoma
631065|NCT00899951|noncontiguous stage II grade 1 follicular lymphoma|noncontiguous stage ii grade 1 follicular lymphoma
631066|NCT00899951|noncontiguous stage II grade 2 follicular lymphoma|noncontiguous stage ii grade 2 follicular lymphoma
631067|NCT00899951|noncontiguous stage II grade 3 follicular lymphoma|noncontiguous stage ii grade 3 follicular lymphoma
631068|NCT00899951|noncontiguous stage II mantle cell lymphoma|noncontiguous stage ii mantle cell lymphoma
631069|NCT00899951|noncontiguous stage II marginal zone lymphoma|noncontiguous stage ii marginal zone lymphoma
631070|NCT00899951|noncontiguous stage II small lymphocytic lymphoma|noncontiguous stage ii small lymphocytic lymphoma
631071|NCT00899951|stage III adult Burkitt lymphoma|stage iii adult burkitt lymphoma
631072|NCT00899951|stage III adult diffuse large cell lymphoma|stage iii adult diffuse large cell lymphoma
631073|NCT00899951|stage III adult diffuse mixed cell lymphoma|stage iii adult diffuse mixed cell lymphoma
631074|NCT00899951|stage III adult diffuse small cleaved cell lymphoma|stage iii adult diffuse small cleaved cell lymphoma
631075|NCT00899951|stage III adult immunoblastic large cell lymphoma|stage iii adult immunoblastic large cell lymphoma
631076|NCT00899951|stage III adult lymphoblastic lymphoma|stage iii adult lymphoblastic lymphoma
631077|NCT00899951|stage III grade 1 follicular lymphoma|stage iii grade 1 follicular lymphoma
631078|NCT00899951|stage III grade 2 follicular lymphoma|stage iii grade 2 follicular lymphoma
631079|NCT00899951|stage III grade 3 follicular lymphoma|stage iii grade 3 follicular lymphoma
631080|NCT00899951|stage III mantle cell lymphoma|stage iii mantle cell lymphoma
631081|NCT00899951|stage III marginal zone lymphoma|stage iii marginal zone lymphoma
631082|NCT00899951|stage III small lymphocytic lymphoma|stage iii small lymphocytic lymphoma
631083|NCT00899951|stage IV adult Burkitt lymphoma|stage iv adult burkitt lymphoma
631084|NCT00899951|stage IV adult diffuse large cell lymphoma|stage iv adult diffuse large cell lymphoma
631085|NCT00899951|stage IV adult diffuse mixed cell lymphoma|stage iv adult diffuse mixed cell lymphoma
631086|NCT00899951|stage IV adult diffuse small cleaved cell lymphoma|stage iv adult diffuse small cleaved cell lymphoma
631087|NCT00899951|stage IV adult immunoblastic large cell lymphoma|stage iv adult immunoblastic large cell lymphoma
631088|NCT00899951|stage IV adult lymphoblastic lymphoma|stage iv adult lymphoblastic lymphoma
631089|NCT00899951|stage IV grade 1 follicular lymphoma|stage iv grade 1 follicular lymphoma
631090|NCT00899951|stage IV grade 2 follicular lymphoma|stage iv grade 2 follicular lymphoma
631091|NCT00899951|stage IV grade 3 follicular lymphoma|stage iv grade 3 follicular lymphoma
631092|NCT00899951|stage IV mantle cell lymphoma|stage iv mantle cell lymphoma
631277|NCT00899678|Crohn's Disease|crohn's disease
631093|NCT00899951|stage IV marginal zone lymphoma|stage iv marginal zone lymphoma
631094|NCT00899951|stage IV small lymphocytic lymphoma|stage iv small lymphocytic lymphoma
631095|NCT00899951|recurrent adult Burkitt lymphoma|recurrent adult burkitt lymphoma
631096|NCT00899951|recurrent adult diffuse large cell lymphoma|recurrent adult diffuse large cell lymphoma
631097|NCT00899951|recurrent adult diffuse mixed cell lymphoma|recurrent adult diffuse mixed cell lymphoma
631098|NCT00899951|recurrent adult diffuse small cleaved cell lymphoma|recurrent adult diffuse small cleaved cell lymphoma
631099|NCT00899951|recurrent adult grade III lymphomatoid granulomatosis|recurrent adult grade iii lymphomatoid granulomatosis
631100|NCT00899951|recurrent adult immunoblastic large cell lymphoma|recurrent adult immunoblastic large cell lymphoma
631101|NCT00899951|recurrent adult lymphoblastic lymphoma|recurrent adult lymphoblastic lymphoma
631102|NCT00899951|recurrent grade 1 follicular lymphoma|recurrent grade 1 follicular lymphoma
631103|NCT00899951|recurrent grade 2 follicular lymphoma|recurrent grade 2 follicular lymphoma
631104|NCT00899951|recurrent grade 3 follicular lymphoma|recurrent grade 3 follicular lymphoma
631105|NCT00899951|recurrent mantle cell lymphoma|recurrent mantle cell lymphoma
632318|NCT00897819|stage IV rectal cancer|stage iv rectal cancer
631106|NCT00899951|recurrent marginal zone lymphoma|recurrent marginal zone lymphoma
631107|NCT00899951|recurrent small lymphocytic lymphoma|recurrent small lymphocytic lymphoma
631108|NCT00899951|intraocular lymphoma|intraocular lymphoma
631109|NCT00899951|primary central nervous system non-Hodgkin lymphoma|primary central nervous system non-hodgkin lymphoma
631110|NCT00899951|primary central nervous system Hodgkin lymphoma|primary central nervous system hodgkin lymphoma
631111|NCT00899951|post-transplant lymphoproliferative disorder|post-transplant lymphoproliferative disorder
631112|NCT00899951|chronic eosinophilic leukemia|chronic eosinophilic leukemia
631113|NCT00899951|chronic neutrophilic leukemia|chronic neutrophilic leukemia
631114|NCT00899951|primary myelofibrosis|primary myelofibrosis
631115|NCT00899951|essential thrombocythemia|essential thrombocythemia
631116|NCT00899951|polycythemia vera|polycythemia vera
631117|NCT00899951|extramedullary plasmacytoma|extramedullary plasmacytoma
631118|NCT00899951|isolated plasmacytoma of bone|isolated plasmacytoma of bone
631119|NCT00899951|monoclonal gammopathy of undetermined significance|monoclonal gammopathy of undetermined significance
631120|NCT00899951|stage I multiple myeloma|stage i multiple myeloma
631121|NCT00899951|stage II multiple myeloma|stage ii multiple myeloma
631122|NCT00899951|stage III multiple myeloma|stage iii multiple myeloma
631123|NCT00899951|primary systemic amyloidosis|primary systemic amyloidosis
631124|NCT00899951|refractory multiple myeloma|refractory multiple myeloma
631125|NCT00899951|de novo myelodysplastic syndromes|de novo myelodysplastic syndromes
631126|NCT00899951|previously treated myelodysplastic syndromes|previously treated myelodysplastic syndromes
631127|NCT00899951|secondary myelodysplastic syndromes|secondary myelodysplastic syndromes
631128|NCT00899951|myelodysplastic/myeloproliferative neoplasm, unclassifiable|myelodysplastic/myeloproliferative neoplasm, unclassifiable
631129|NCT00899951|pain|pain
631130|NCT00899912|stage IIB prostate cancer|stage iib prostate cancer
631131|NCT00899912|stage IIA prostate cancer|stage iia prostate cancer
631132|NCT00899912|adenocarcinoma of the prostate|adenocarcinoma of the prostate
631133|NCT00899899|adult acute lymphoblastic leukemia in remission|adult acute lymphoblastic leukemia in remission
802776|NCT00244335|PTSD|ptsd
631134|NCT00899899|childhood acute lymphoblastic leukemia in remission|childhood acute lymphoblastic leukemia in remission
631135|NCT00899899|recurrent adult acute lymphoblastic leukemia|recurrent adult acute lymphoblastic leukemia
631136|NCT00899899|recurrent childhood acute lymphoblastic leukemia|recurrent childhood acute lymphoblastic leukemia
631137|NCT00899873|chronic lymphocytic leukemia|chronic lymphocytic leukemia
631138|NCT00899860|recurrent renal cell cancer|recurrent renal cell cancer
631139|NCT00899860|stage I renal cell cancer|stage i renal cell cancer
631140|NCT00899860|stage II renal cell cancer|stage ii renal cell cancer
631141|NCT00899860|stage III renal cell cancer|stage iii renal cell cancer
631142|NCT00899860|stage IV renal cell cancer|stage iv renal cell cancer
631143|NCT00899834|adult brain stem glioma|adult brain stem glioma
631144|NCT00899834|childhood brain stem glioma|childhood brain stem glioma
631145|NCT00899821|recurrent metastatic squamous neck cancer with occult primary|recurrent metastatic squamous neck cancer with occult primary
631146|NCT00899821|untreated metastatic squamous neck cancer with occult primary|untreated metastatic squamous neck cancer with occult primary
631147|NCT00899821|stage I squamous cell carcinoma of the hypopharynx|stage i squamous cell carcinoma of the hypopharynx
631148|NCT00899821|stage I squamous cell carcinoma of the larynx|stage i squamous cell carcinoma of the larynx
631149|NCT00899821|stage I squamous cell carcinoma of the lip and oral cavity|stage i squamous cell carcinoma of the lip and oral cavity
631150|NCT00899821|stage I squamous cell carcinoma of the nasopharynx|stage i squamous cell carcinoma of the nasopharynx
631151|NCT00899821|stage I squamous cell carcinoma of the oropharynx|stage i squamous cell carcinoma of the oropharynx
631152|NCT00899821|stage I squamous cell carcinoma of the paranasal sinus and nasal cavity|stage i squamous cell carcinoma of the paranasal sinus and nasal cavity
631153|NCT00899821|stage II squamous cell carcinoma of the hypopharynx|stage ii squamous cell carcinoma of the hypopharynx
631154|NCT00899821|stage II squamous cell carcinoma of the larynx|stage ii squamous cell carcinoma of the larynx
631155|NCT00899821|stage II squamous cell carcinoma of the lip and oral cavity|stage ii squamous cell carcinoma of the lip and oral cavity
631156|NCT00899821|stage II squamous cell carcinoma of the nasopharynx|stage ii squamous cell carcinoma of the nasopharynx
631278|NCT00899665|stage IV prostate cancer|stage iv prostate cancer
631157|NCT00899821|stage II squamous cell carcinoma of the oropharynx|stage ii squamous cell carcinoma of the oropharynx
631158|NCT00899821|stage II squamous cell carcinoma of the paranasal sinus and nasal cavity|stage ii squamous cell carcinoma of the paranasal sinus and nasal cavity
631159|NCT00899821|stage III squamous cell carcinoma of the hypopharynx|stage iii squamous cell carcinoma of the hypopharynx
631160|NCT00899821|stage III squamous cell carcinoma of the larynx|stage iii squamous cell carcinoma of the larynx
631161|NCT00899821|stage III squamous cell carcinoma of the lip and oral cavity|stage iii squamous cell carcinoma of the lip and oral cavity
631162|NCT00899821|stage III squamous cell carcinoma of the nasopharynx|stage iii squamous cell carcinoma of the nasopharynx
631163|NCT00899821|stage III squamous cell carcinoma of the oropharynx|stage iii squamous cell carcinoma of the oropharynx
631164|NCT00899821|stage III squamous cell carcinoma of the paranasal sinus and nasal cavity|stage iii squamous cell carcinoma of the paranasal sinus and nasal cavity
631165|NCT00899821|stage IV squamous cell carcinoma of the hypopharynx|stage iv squamous cell carcinoma of the hypopharynx
631166|NCT00899821|stage IV squamous cell carcinoma of the larynx|stage iv squamous cell carcinoma of the larynx
631167|NCT00899821|stage IV squamous cell carcinoma of the lip and oral cavity|stage iv squamous cell carcinoma of the lip and oral cavity
631168|NCT00899821|stage IV squamous cell carcinoma of the nasopharynx|stage iv squamous cell carcinoma of the nasopharynx
631169|NCT00899821|stage IV squamous cell carcinoma of the oropharynx|stage iv squamous cell carcinoma of the oropharynx
631170|NCT00899821|stage IV squamous cell carcinoma of the paranasal sinus and nasal cavity|stage iv squamous cell carcinoma of the paranasal sinus and nasal cavity
631171|NCT00899821|recurrent squamous cell carcinoma of the hypopharynx|recurrent squamous cell carcinoma of the hypopharynx
631172|NCT00899821|recurrent squamous cell carcinoma of the larynx|recurrent squamous cell carcinoma of the larynx
631173|NCT00899821|recurrent squamous cell carcinoma of the lip and oral cavity|recurrent squamous cell carcinoma of the lip and oral cavity
631174|NCT00899821|recurrent squamous cell carcinoma of the nasopharynx|recurrent squamous cell carcinoma of the nasopharynx
631175|NCT00899821|recurrent squamous cell carcinoma of the oropharynx|recurrent squamous cell carcinoma of the oropharynx
631176|NCT00899821|recurrent squamous cell carcinoma of the paranasal sinus and nasal cavity|recurrent squamous cell carcinoma of the paranasal sinus and nasal cavity
631177|NCT00899821|recurrent salivary gland cancer|recurrent salivary gland cancer
631178|NCT00899821|salivary gland squamous cell carcinoma|salivary gland squamous cell carcinoma
631179|NCT00899821|stage I salivary gland cancer|stage i salivary gland cancer
631180|NCT00899821|stage II salivary gland cancer|stage ii salivary gland cancer
631181|NCT00899821|stage III salivary gland cancer|stage iii salivary gland cancer
631182|NCT00899821|stage IV salivary gland cancer|stage iv salivary gland cancer
631183|NCT00899808|unspecified adult solid tumor, protocol specific|unspecified adult solid tumor, protocol specific
631184|NCT00899808|unspecified childhood solid tumor, protocol specific|unspecified childhood solid tumor, protocol specific
631185|NCT00899808|hematopoietic/lymphoid cancer|hematopoietic/lymphoid cancer
631186|NCT00899795|adult acute myeloid leukemia with 11q23 (MLL) abnormalities|adult acute myeloid leukemia with 11q23 (mll) abnormalities
631187|NCT00899795|adult acute myeloid leukemia with inv(16)(p13;q22)|adult acute myeloid leukemia with inv(16)(p13;q22)
631188|NCT00899795|adult acute myeloid leukemia with t(15;17)(q22;q12)|adult acute myeloid leukemia with t(15;17)(q22;q12)
631189|NCT00899795|adult acute myeloid leukemia with t(16;16)(p13;q22)|adult acute myeloid leukemia with t(16;16)(p13;q22)
631190|NCT00899795|adult acute myeloid leukemia with t(8;21)(q22;q22)|adult acute myeloid leukemia with t(8;21)(q22;q22)
631191|NCT00899795|de novo myelodysplastic syndromes|de novo myelodysplastic syndromes
631192|NCT00899795|previously treated myelodysplastic syndromes|previously treated myelodysplastic syndromes
631193|NCT00899795|recurrent adult acute myeloid leukemia|recurrent adult acute myeloid leukemia
631194|NCT00899795|secondary acute myeloid leukemia|secondary acute myeloid leukemia
631195|NCT00899795|secondary myelodysplastic syndromes|secondary myelodysplastic syndromes
631196|NCT00899795|untreated adult acute myeloid leukemia|untreated adult acute myeloid leukemia
631197|NCT00899795|childhood myelodysplastic syndromes|childhood myelodysplastic syndromes
631198|NCT00899769|metastatic squamous neck cancer with occult primary squamous cell carcinoma|metastatic squamous neck cancer with occult primary squamous cell carcinoma
631199|NCT00899769|recurrent squamous cell carcinoma of the hypopharynx|recurrent squamous cell carcinoma of the hypopharynx
631200|NCT00899769|recurrent squamous cell carcinoma of the larynx|recurrent squamous cell carcinoma of the larynx
631201|NCT00899769|recurrent squamous cell carcinoma of the lip and oral cavity|recurrent squamous cell carcinoma of the lip and oral cavity
631202|NCT00899769|recurrent squamous cell carcinoma of the nasopharynx|recurrent squamous cell carcinoma of the nasopharynx
631203|NCT00899769|recurrent squamous cell carcinoma of the oropharynx|recurrent squamous cell carcinoma of the oropharynx
631204|NCT00899769|recurrent squamous cell carcinoma of the paranasal sinus and nasal cavity|recurrent squamous cell carcinoma of the paranasal sinus and nasal cavity
631205|NCT00899769|stage I squamous cell carcinoma of the hypopharynx|stage i squamous cell carcinoma of the hypopharynx
631206|NCT00899769|stage I squamous cell carcinoma of the larynx|stage i squamous cell carcinoma of the larynx
631207|NCT00899769|stage I squamous cell carcinoma of the lip and oral cavity|stage i squamous cell carcinoma of the lip and oral cavity
631208|NCT00899769|stage I squamous cell carcinoma of the nasopharynx|stage i squamous cell carcinoma of the nasopharynx
631209|NCT00899769|stage I squamous cell carcinoma of the oropharynx|stage i squamous cell carcinoma of the oropharynx
631210|NCT00899769|stage I squamous cell carcinoma of the paranasal sinus and nasal cavity|stage i squamous cell carcinoma of the paranasal sinus and nasal cavity
631211|NCT00899769|stage II squamous cell carcinoma of the hypopharynx|stage ii squamous cell carcinoma of the hypopharynx
631212|NCT00899769|stage II squamous cell carcinoma of the larynx|stage ii squamous cell carcinoma of the larynx
631213|NCT00899769|stage II squamous cell carcinoma of the lip and oral cavity|stage ii squamous cell carcinoma of the lip and oral cavity
631214|NCT00899769|stage II squamous cell carcinoma of the nasopharynx|stage ii squamous cell carcinoma of the nasopharynx
631215|NCT00899769|stage II squamous cell carcinoma of the oropharynx|stage ii squamous cell carcinoma of the oropharynx
631216|NCT00899769|stage II squamous cell carcinoma of the paranasal sinus and nasal cavity|stage ii squamous cell carcinoma of the paranasal sinus and nasal cavity
631217|NCT00899769|stage III squamous cell carcinoma of the hypopharynx|stage iii squamous cell carcinoma of the hypopharynx
631218|NCT00899769|stage III squamous cell carcinoma of the larynx|stage iii squamous cell carcinoma of the larynx
631219|NCT00899769|stage III squamous cell carcinoma of the lip and oral cavity|stage iii squamous cell carcinoma of the lip and oral cavity
631220|NCT00899769|stage III squamous cell carcinoma of the nasopharynx|stage iii squamous cell carcinoma of the nasopharynx
631221|NCT00899769|stage III squamous cell carcinoma of the oropharynx|stage iii squamous cell carcinoma of the oropharynx
631222|NCT00899769|stage III squamous cell carcinoma of the paranasal sinus and nasal cavity|stage iii squamous cell carcinoma of the paranasal sinus and nasal cavity
631223|NCT00899769|stage IV squamous cell carcinoma of the hypopharynx|stage iv squamous cell carcinoma of the hypopharynx
631224|NCT00899769|stage IV squamous cell carcinoma of the larynx|stage iv squamous cell carcinoma of the larynx
631225|NCT00899769|stage IV squamous cell carcinoma of the lip and oral cavity|stage iv squamous cell carcinoma of the lip and oral cavity
631226|NCT00899769|stage IV squamous cell carcinoma of the nasopharynx|stage iv squamous cell carcinoma of the nasopharynx
631227|NCT00899769|stage IV squamous cell carcinoma of the oropharynx|stage iv squamous cell carcinoma of the oropharynx
631228|NCT00899769|stage IV squamous cell carcinoma of the paranasal sinus and nasal cavity|stage iv squamous cell carcinoma of the paranasal sinus and nasal cavity
631229|NCT00899769|untreated metastatic squamous neck cancer with occult primary|untreated metastatic squamous neck cancer with occult primary
631230|NCT00899769|recurrent metastatic squamous neck cancer with occult primary|recurrent metastatic squamous neck cancer with occult primary
631231|NCT00899769|recurrent salivary gland cancer|recurrent salivary gland cancer
631232|NCT00899769|salivary gland squamous cell carcinoma|salivary gland squamous cell carcinoma
631233|NCT00899769|stage I salivary gland cancer|stage i salivary gland cancer
631234|NCT00899769|stage II salivary gland cancer|stage ii salivary gland cancer
631235|NCT00899769|stage III salivary gland cancer|stage iii salivary gland cancer
631236|NCT00899769|stage IV salivary gland cancer|stage iv salivary gland cancer
631237|NCT00899756|recurrent non-small cell lung cancer|recurrent non-small cell lung cancer
631238|NCT00899756|stage IIIA non-small cell lung cancer|stage iiia non-small cell lung cancer
631239|NCT00899756|stage IIIB non-small cell lung cancer|stage iiib non-small cell lung cancer
712509|NCT00579904|insulin resistance|insulin resistance
631240|NCT00899756|stage IV non-small cell lung cancer|stage iv non-small cell lung cancer
631241|NCT00899743|adult erythroleukemia (M6a)|adult erythroleukemia (m6a)
631242|NCT00899743|adult pure erythroid leukemia (M6b)|adult pure erythroid leukemia (m6b)
631243|NCT00899743|adult acute megakaryoblastic leukemia (M7)|adult acute megakaryoblastic leukemia (m7)
631244|NCT00899743|adult acute minimally differentiated myeloid leukemia (M0)|adult acute minimally differentiated myeloid leukemia (m0)
631245|NCT00899743|adult acute monoblastic leukemia (M5a)|adult acute monoblastic leukemia (m5a)
631246|NCT00899743|adult acute monocytic leukemia (M5b)|adult acute monocytic leukemia (m5b)
631247|NCT00899743|adult acute myeloblastic leukemia with maturation (M2)|adult acute myeloblastic leukemia with maturation (m2)
631248|NCT00899743|adult acute myeloblastic leukemia without maturation (M1)|adult acute myeloblastic leukemia without maturation (m1)
631249|NCT00899743|adult acute myelomonocytic leukemia (M4)|adult acute myelomonocytic leukemia (m4)
631250|NCT00899743|adult acute myeloid leukemia with t(8;21)(q22;q22)|adult acute myeloid leukemia with t(8;21)(q22;q22)
631251|NCT00899743|adult acute myeloid leukemia with t(16;16)(p13;q22)|adult acute myeloid leukemia with t(16;16)(p13;q22)
631252|NCT00899743|adult acute myeloid leukemia with inv(16)(p13;q22)|adult acute myeloid leukemia with inv(16)(p13;q22)
631253|NCT00899743|adult acute myeloid leukemia with 11q23 (MLL) abnormalities|adult acute myeloid leukemia with 11q23 (mll) abnormalities
631254|NCT00899743|untreated adult acute myeloid leukemia|untreated adult acute myeloid leukemia
631255|NCT00899717|Temporomandibular Joint Disorders (TMD)|temporomandibular joint disorders (tmd)
631256|NCT00899717|Orofacial pain|orofacial pain
631257|NCT00899717|Limited mouth opening|limited mouth opening
631258|NCT00899717|Craniomandibular dysfunction syndrome|craniomandibular dysfunction syndrome
631259|NCT00899717|Axiography|axiography
631260|NCT00899717|Gnatography|gnatography
631261|NCT00899717|Preferred chewing side|preferred chewing side
631262|NCT00899717|Occlusal adjustment|occlusal adjustment
631263|NCT00899717|Selective grinding|selective grinding
631264|NCT00899717|Handedness|handedness
631265|NCT00899717|Bruxism|bruxism
631266|NCT00899717|TMD|tmd
631267|NCT00899717|Costen's Syndrome|costen's syndrome
631268|NCT00899717|Myofascial pain|myofascial pain
631269|NCT00899717|TMD treatment|tmd treatment
631270|NCT00899717|Pain|pain
631271|NCT00899704|stage I squamous cell carcinoma of the lip and oral cavity|stage i squamous cell carcinoma of the lip and oral cavity
631272|NCT00899704|stage II squamous cell carcinoma of the lip and oral cavity|stage ii squamous cell carcinoma of the lip and oral cavity
631273|NCT00899704|tongue cancer|tongue cancer
631274|NCT00899691|unspecified adult solid tumor, protocol specific|unspecified adult solid tumor, protocol specific
631275|NCT00899678|Certolizumab Pegol|certolizumab pegol
631276|NCT00899678|Cimzia ®|cimzia ®
631279|NCT00899665|bone metastases|bone metastases
631280|NCT00899665|anemia|anemia
631281|NCT00899665|monoclonal gammopathy of undetermined significance|monoclonal gammopathy of undetermined significance
631282|NCT00899665|de novo myelodysplastic syndromes|de novo myelodysplastic syndromes
631283|NCT00899665|previously treated myelodysplastic syndromes|previously treated myelodysplastic syndromes
631284|NCT00899665|secondary myelodysplastic syndromes|secondary myelodysplastic syndromes
631285|NCT00899652|childhood acute myelomonocytic leukemia (M4)|childhood acute myelomonocytic leukemia (m4)
631286|NCT00899652|childhood acute monocytic leukemia (M5b)|childhood acute monocytic leukemia (m5b)
631287|NCT00899652|childhood acute monoblastic leukemia (M5a)|childhood acute monoblastic leukemia (m5a)
631288|NCT00899652|secondary acute myeloid leukemia|secondary acute myeloid leukemia
631289|NCT00899652|untreated childhood acute lymphoblastic leukemia|untreated childhood acute lymphoblastic leukemia
631290|NCT00899652|untreated childhood acute myeloid leukemia and other myeloid malignancies|untreated childhood acute myeloid leukemia and other myeloid malignancies
631291|NCT00899652|recurrent childhood acute lymphoblastic leukemia|recurrent childhood acute lymphoblastic leukemia
631292|NCT00899652|recurrent childhood acute myeloid leukemia|recurrent childhood acute myeloid leukemia
631293|NCT00899639|stage I breast cancer|stage i breast cancer
631294|NCT00899639|stage II breast cancer|stage ii breast cancer
631295|NCT00899639|stage IIIA breast cancer|stage iiia breast cancer
631296|NCT00899639|estrogen receptor-positive breast cancer|estrogen receptor-positive breast cancer
631297|NCT00899639|male breast cancer|male breast cancer
631298|NCT00899626|colon cancer|colon cancer
631299|NCT00899626|esophageal cancer|esophageal cancer
631300|NCT00899626|gastric cancer|gastric cancer
631301|NCT00899626|pancreatic cancer|pancreatic cancer
631302|NCT00899626|adenomatous polyp|adenomatous polyp
631303|NCT00899613|localized malignant mesothelioma|localized malignant mesothelioma
631304|NCT00899613|lung metastases|lung metastases
631305|NCT00899613|malignant pleural effusion|malignant pleural effusion
631306|NCT00899600|chronic pain|chronic pain
631307|NCT00899600|back surgery|back surgery
631308|NCT00899600|opioid dependent|opioid dependent
631309|NCT00899600|NMDA receptor antagonism|nmda receptor antagonism
631310|NCT00899600|Ketamine|ketamine
631311|NCT00899600|Central sensitization|central sensitization
631312|NCT00899574|toll-like receptor|toll-like receptor
631313|NCT00899574|toll-like receptor agonist|toll-like receptor agonist
631314|NCT00899574|recurrent breast cancer|recurrent breast cancer
631315|NCT00899574|breast cancer metastasized to skin and/or chestwall|breast cancer metastasized to skin and/or chestwall
803189|NCT00242580|AMD|amd
631316|NCT00899574|immunomodulator|immunomodulator
631317|NCT00899561|Chronic rhinosinusitis|chronic rhinosinusitis
631318|NCT00899561|Computed tomography|computed tomography
631319|NCT00899561|Histology|histology
631320|NCT00899561|Middle turbinate|middle turbinate
631321|NCT00899561|Morphometry|morphometry
631322|NCT00899561|osteomyelitis|osteomyelitis
631323|NCT00899561|polyps|polyps
631324|NCT00899548|stage IV breast cancer|stage iv breast cancer
631325|NCT00899548|recurrent breast cancer|recurrent breast cancer
631326|NCT00899535|adenocarcinoma of the lung|adenocarcinoma of the lung
631327|NCT00899535|large cell lung cancer|large cell lung cancer
631328|NCT00899535|squamous cell lung cancer|squamous cell lung cancer
631329|NCT00899535|stage I non-small cell lung cancer|stage i non-small cell lung cancer
631330|NCT00899535|stage II non-small cell lung cancer|stage ii non-small cell lung cancer
631331|NCT00899522|Fanconi anemia|fanconi anemia
631332|NCT00899522|unspecified adult solid tumor, protocol specific|unspecified adult solid tumor, protocol specific
631333|NCT00899522|unspecified childhood solid tumor, protocol specific|unspecified childhood solid tumor, protocol specific
631334|NCT00899509|stage II breast cancer|stage ii breast cancer
631335|NCT00899509|stage IIIA breast cancer|stage iiia breast cancer
631336|NCT00899496|stage IV bladder cancer|stage iv bladder cancer
631337|NCT00899496|stage IV colon cancer|stage iv colon cancer
631338|NCT00899496|stage IV non-small cell lung cancer|stage iv non-small cell lung cancer
631339|NCT00899496|stage IV pancreatic cancer|stage iv pancreatic cancer
631340|NCT00899496|stage IV rectal cancer|stage iv rectal cancer
631341|NCT00899496|stage IV renal cell cancer|stage iv renal cell cancer
631342|NCT00899496|stage IV melanoma|stage iv melanoma
631343|NCT00899496|stage III multiple myeloma|stage iii multiple myeloma
631344|NCT00899496|extensive stage small cell lung cancer|extensive stage small cell lung cancer
631345|NCT00899496|stage IV adult soft tissue sarcoma|stage iv adult soft tissue sarcoma
631346|NCT00899496|stage III malignant testicular germ cell tumor|stage iii malignant testicular germ cell tumor
631347|NCT00899496|stage IV breast cancer|stage iv breast cancer
631348|NCT00899496|stage IV ovarian epithelial cancer|stage iv ovarian epithelial cancer
631349|NCT00899496|stage IV prostate cancer|stage iv prostate cancer
631350|NCT00899496|stage IV endometrial carcinoma|stage iv endometrial carcinoma
631351|NCT00899496|unspecified adult solid tumor, protocol specific|unspecified adult solid tumor, protocol specific
631352|NCT00899496|metastatic osteosarcoma|metastatic osteosarcoma
631353|NCT00899496|stage IV uterine sarcoma|stage iv uterine sarcoma
631354|NCT00899496|stage III ovarian epithelial cancer|stage iii ovarian epithelial cancer
631355|NCT00899496|ovarian sarcoma|ovarian sarcoma
631356|NCT00899496|stage IV adult Burkitt lymphoma|stage iv adult burkitt lymphoma
631357|NCT00899496|stage III adult diffuse large cell lymphoma|stage iii adult diffuse large cell lymphoma
631358|NCT00899496|stage III adult diffuse mixed cell lymphoma|stage iii adult diffuse mixed cell lymphoma
631359|NCT00899496|stage III adult diffuse small cleaved cell lymphoma|stage iii adult diffuse small cleaved cell lymphoma
631360|NCT00899496|stage IV adult diffuse large cell lymphoma|stage iv adult diffuse large cell lymphoma
631361|NCT00899496|stage IV adult diffuse mixed cell lymphoma|stage iv adult diffuse mixed cell lymphoma
631362|NCT00899496|stage IV adult diffuse small cleaved cell lymphoma|stage iv adult diffuse small cleaved cell lymphoma
631363|NCT00899496|stage III adult Burkitt lymphoma|stage iii adult burkitt lymphoma
631364|NCT00899496|stage III adult immunoblastic large cell lymphoma|stage iii adult immunoblastic large cell lymphoma
631365|NCT00899496|stage IV adult immunoblastic large cell lymphoma|stage iv adult immunoblastic large cell lymphoma
631366|NCT00899496|stage III adult lymphoblastic lymphoma|stage iii adult lymphoblastic lymphoma
631367|NCT00899496|stage IV adult lymphoblastic lymphoma|stage iv adult lymphoblastic lymphoma
631368|NCT00899496|stage IV grade 1 follicular lymphoma|stage iv grade 1 follicular lymphoma
631369|NCT00899496|stage IV grade 2 follicular lymphoma|stage iv grade 2 follicular lymphoma
631370|NCT00899496|stage IV grade 3 follicular lymphoma|stage iv grade 3 follicular lymphoma
631371|NCT00899496|stage III mantle cell lymphoma|stage iii mantle cell lymphoma
631372|NCT00899496|stage IV mantle cell lymphoma|stage iv mantle cell lymphoma
631373|NCT00899496|extranodal marginal zone B-cell lymphoma of mucosa-associated lymphoid tissue|extranodal marginal zone b-cell lymphoma of mucosa-associated lymphoid tissue
631374|NCT00899496|nodal marginal zone B-cell lymphoma|nodal marginal zone b-cell lymphoma
631375|NCT00899496|splenic marginal zone lymphoma|splenic marginal zone lymphoma
631376|NCT00899496|stage III marginal zone lymphoma|stage iii marginal zone lymphoma
631377|NCT00899496|stage IV marginal zone lymphoma|stage iv marginal zone lymphoma
631378|NCT00899496|stage III small lymphocytic lymphoma|stage iii small lymphocytic lymphoma
631379|NCT00899496|stage IV small lymphocytic lymphoma|stage iv small lymphocytic lymphoma
631380|NCT00899496|stage III mycosis fungoides/Sezary syndrome|stage iii mycosis fungoides/sezary syndrome
631381|NCT00899496|stage IV mycosis fungoides/Sezary syndrome|stage iv mycosis fungoides/sezary syndrome
631382|NCT00899496|cutaneous B-cell non-Hodgkin lymphoma|cutaneous b-cell non-hodgkin lymphoma
631383|NCT00899496|stage III cutaneous T-cell non-Hodgkin lymphoma|stage iii cutaneous t-cell non-hodgkin lymphoma
631384|NCT00899496|stage IV cutaneous T-cell non-Hodgkin lymphoma|stage iv cutaneous t-cell non-hodgkin lymphoma
712510|NCT00579904|fish oil|fish oil
631385|NCT00899496|stage III adult T-cell leukemia/lymphoma|stage iii adult t-cell leukemia/lymphoma
631386|NCT00899496|stage IV adult T-cell leukemia/lymphoma|stage iv adult t-cell leukemia/lymphoma
631387|NCT00899496|anaplastic large cell lymphoma|anaplastic large cell lymphoma
631388|NCT00899496|angioimmunoblastic T-cell lymphoma|angioimmunoblastic t-cell lymphoma
631389|NCT00899496|adult nasal type extranodal NK/T-cell lymphoma|adult nasal type extranodal nk/t-cell lymphoma
631390|NCT00899496|Waldenstrom macroglobulinemia|waldenstrom macroglobulinemia
631391|NCT00899496|adult grade III lymphomatoid granulomatosis|adult grade iii lymphomatoid granulomatosis
631392|NCT00899496|primary central nervous system non-Hodgkin lymphoma|primary central nervous system non-hodgkin lymphoma
631393|NCT00899496|intraocular lymphoma|intraocular lymphoma
631394|NCT00899457|squamous cell lung cancer|squamous cell lung cancer
631395|NCT00899457|non-small cell lung cancer|non-small cell lung cancer
631396|NCT00899457|small cell lung cancer|small cell lung cancer
631397|NCT00899457|healthy, no evidence of disease|healthy, no evidence of disease
631398|NCT00899431|Nonmyeloablative Stem Cell Transplantation|nonmyeloablative stem cell transplantation
631399|NCT00899431|Chronic Lymphocytic Leukemia|chronic lymphocytic leukemia
631401|NCT00899431|Immunomanipulation|immunomanipulation
631402|NCT00899431|Fludarabine|fludarabine
631403|NCT00899431|Lenalidomide|lenalidomide
631404|NCT00899431|Rituximab|rituximab
631405|NCT00899431|Thymoglobulin|thymoglobulin
631406|NCT00899431|Stem Cell Transplantation|stem cell transplantation
631407|NCT00899418|recurrent breast cancer|recurrent breast cancer
631408|NCT00899418|stage IV breast cancer|stage iv breast cancer
631409|NCT00899405|lung cancer|lung cancer
631410|NCT00899392|consent|consent
631411|NCT00899392|Anxiety|anxiety
631412|NCT00899392|Satisfaction|satisfaction
631413|NCT00899392|Efficiency|efficiency
631414|NCT00899392|Questions|questions
631415|NCT00899392|Attainment of Informed Consent (Consent-20)|attainment of informed consent (consent-20)
631416|NCT00899392|Procedural State Anxiety (STAI)|procedural state anxiety (stai)
631417|NCT00899392|Subject Satisfaction (mGHAA-9)|subject satisfaction (mghaa-9)
631418|NCT00899392|Duration in Endoscopy Suite|duration in endoscopy suite
631419|NCT00899392|Number of questions asked|number of questions asked
631420|NCT00899366|T-cell adult acute lymphoblastic leukemia|t-cell adult acute lymphoblastic leukemia
631421|NCT00899366|T-cell childhood acute lymphoblastic leukemia|t-cell childhood acute lymphoblastic leukemia
631422|NCT00899366|untreated adult acute lymphoblastic leukemia|untreated adult acute lymphoblastic leukemia
631423|NCT00899366|untreated childhood acute lymphoblastic leukemia|untreated childhood acute lymphoblastic leukemia
631424|NCT00899366|recurrent adult acute lymphoblastic leukemia|recurrent adult acute lymphoblastic leukemia
631425|NCT00899366|recurrent childhood acute lymphoblastic leukemia|recurrent childhood acute lymphoblastic leukemia
631426|NCT00899366|adult acute lymphoblastic leukemia in remission|adult acute lymphoblastic leukemia in remission
631427|NCT00899366|childhood acute lymphoblastic leukemia in remission|childhood acute lymphoblastic leukemia in remission
631428|NCT00899353|ES-CLL|es-cll
631429|NCT00899353|MGUS|mgus
631430|NCT00899353|SMM|smm
631431|NCT00899353|Early Stage - Chronic Lymphocytic Leukemia|early stage - chronic lymphocytic leukemia
631432|NCT00899340|recurrent squamous cell carcinoma of the oropharynx|recurrent squamous cell carcinoma of the oropharynx
631433|NCT00899340|stage I squamous cell carcinoma of the oropharynx|stage i squamous cell carcinoma of the oropharynx
631434|NCT00899340|stage II squamous cell carcinoma of the oropharynx|stage ii squamous cell carcinoma of the oropharynx
631435|NCT00899340|stage III squamous cell carcinoma of the oropharynx|stage iii squamous cell carcinoma of the oropharynx
631436|NCT00899340|stage IV squamous cell carcinoma of the oropharynx|stage iv squamous cell carcinoma of the oropharynx
631437|NCT00899327|myelodysplastic syndromes|myelodysplastic syndromes
631438|NCT00899327|acute myeloid leukemia|acute myeloid leukemia
631439|NCT00899301|breast cancer|breast cancer
631440|NCT00899301|stage IA breast cancer|stage ia breast cancer
631441|NCT00899301|stage IB breast cancer|stage ib breast cancer
631442|NCT00899301|stage II breast cancer|stage ii breast cancer
631443|NCT00899301|stage IIIA breast cancer|stage iiia breast cancer
631444|NCT00899301|stage IIIB breast cancer|stage iiib breast cancer
631445|NCT00899301|stage IIIC breast cancer|stage iiic breast cancer
631446|NCT00899301|stage IV breast cancer|stage iv breast cancer
631447|NCT00899288|osteoporosis|osteoporosis
631448|NCT00899288|stage I breast cancer|stage i breast cancer
631449|NCT00899288|stage II breast cancer|stage ii breast cancer
631450|NCT00899288|stage IIIA breast cancer|stage iiia breast cancer
631451|NCT00899262|lung cancer|lung cancer
631452|NCT00899262|tobacco use disorder|tobacco use disorder
631453|NCT00899210|liver metastases|liver metastases
631454|NCT00899210|adenocarcinoma of the colon|adenocarcinoma of the colon
631455|NCT00899210|stage IV colon cancer|stage iv colon cancer
631456|NCT00899210|adenocarcinoma of the rectum|adenocarcinoma of the rectum
631457|NCT00899210|stage IV rectal cancer|stage iv rectal cancer
631458|NCT00899210|recurrent colon cancer|recurrent colon cancer
631459|NCT00899210|recurrent rectal cancer|recurrent rectal cancer
631460|NCT00899197|stage I breast cancer|stage i breast cancer
631461|NCT00899197|stage II breast cancer|stage ii breast cancer
631462|NCT00899197|stage IIIA breast cancer|stage iiia breast cancer
631463|NCT00899197|stage IIIB breast cancer|stage iiib breast cancer
631464|NCT00899184|recurrent prostate cancer|recurrent prostate cancer
631465|NCT00899184|stage IV prostate cancer|stage iv prostate cancer
631466|NCT00899184|stage I prostate cancer|stage i prostate cancer
631467|NCT00899184|stage IIB prostate cancer|stage iib prostate cancer
631468|NCT00899184|stage IIA prostate cancer|stage iia prostate cancer
631469|NCT00899184|stage III prostate cancer|stage iii prostate cancer
631470|NCT00899171|adult acute myeloid leukemia in remission|adult acute myeloid leukemia in remission
631471|NCT00899171|adult acute myeloid leukemia with 11q23 (MLL) abnormalities|adult acute myeloid leukemia with 11q23 (mll) abnormalities
631472|NCT00899171|adult acute myeloid leukemia with inv(16)(p13;q22)|adult acute myeloid leukemia with inv(16)(p13;q22)
631473|NCT00899171|adult acute myeloid leukemia with t(15;17)(q22;q12)|adult acute myeloid leukemia with t(15;17)(q22;q12)
631474|NCT00899171|adult acute myeloid leukemia with t(16;16)(p13;q22)|adult acute myeloid leukemia with t(16;16)(p13;q22)
631475|NCT00899171|adult acute myeloid leukemia with t(8;21)(q22;q22)|adult acute myeloid leukemia with t(8;21)(q22;q22)
631476|NCT00899171|recurrent adult acute myeloid leukemia|recurrent adult acute myeloid leukemia
631477|NCT00899171|untreated adult acute myeloid leukemia|untreated adult acute myeloid leukemia
631478|NCT00899171|adult acute erythroid leukemia (M6)|adult acute erythroid leukemia (m6)
631479|NCT00899171|adult acute megakaryoblastic leukemia (M7)|adult acute megakaryoblastic leukemia (m7)
631480|NCT00899171|adult acute minimally differentiated myeloid leukemia (M0)|adult acute minimally differentiated myeloid leukemia (m0)
631481|NCT00899171|adult acute monoblastic leukemia (M5a)|adult acute monoblastic leukemia (m5a)
631482|NCT00899171|adult acute monocytic leukemia (M5b)|adult acute monocytic leukemia (m5b)
631483|NCT00899171|adult acute myeloblastic leukemia with maturation (M2)|adult acute myeloblastic leukemia with maturation (m2)
631484|NCT00899171|adult acute myeloblastic leukemia without maturation (M1)|adult acute myeloblastic leukemia without maturation (m1)
631485|NCT00899171|adult acute myelomonocytic leukemia (M4)|adult acute myelomonocytic leukemia (m4)
631486|NCT00899171|secondary acute myeloid leukemia|secondary acute myeloid leukemia
631487|NCT00899158|recurrent pancreatic cancer|recurrent pancreatic cancer
631488|NCT00899158|stage I pancreatic cancer|stage i pancreatic cancer
631489|NCT00899158|stage II pancreatic cancer|stage ii pancreatic cancer
631490|NCT00899158|stage III pancreatic cancer|stage iii pancreatic cancer
631491|NCT00899158|stage IV pancreatic cancer|stage iv pancreatic cancer
631492|NCT00899158|cachexia|cachexia
631493|NCT00899132|skin cancer|skin cancer
631494|NCT00899132|small intestine cancer|small intestine cancer
631495|NCT00899132|pancreatic cancer|pancreatic cancer
631496|NCT00899132|malignant testicular germ cell tumor|malignant testicular germ cell tumor
631497|NCT00899132|testicular teratoma|testicular teratoma
631498|NCT00899119|Waldenström macroglobulinemia|waldenström macroglobulinemia
631499|NCT00899080|stage I multiple myeloma|stage i multiple myeloma
631500|NCT00899080|stage II multiple myeloma|stage ii multiple myeloma
631501|NCT00899080|stage III multiple myeloma|stage iii multiple myeloma
631502|NCT00899041|Prosthesis|prosthesis
631503|NCT00899028|stage 0 non-small cell lung cancer|stage 0 non-small cell lung cancer
631504|NCT00899028|stage I non-small cell lung cancer|stage i non-small cell lung cancer
631571|NCT00898898|stage IA breast cancer|stage ia breast cancer
631505|NCT00899028|extensive stage small cell lung cancer|extensive stage small cell lung cancer
631506|NCT00899028|limited stage small cell lung cancer|limited stage small cell lung cancer
631507|NCT00899028|stage II non-small cell lung cancer|stage ii non-small cell lung cancer
631508|NCT00899028|stage IV non-small cell lung cancer|stage iv non-small cell lung cancer
631509|NCT00899028|stage IIIA non-small cell lung cancer|stage iiia non-small cell lung cancer
631510|NCT00899028|stage IIIB non-small cell lung cancer|stage iiib non-small cell lung cancer
631511|NCT00899015|recurrent childhood acute myeloid leukemia|recurrent childhood acute myeloid leukemia
631512|NCT00899015|childhood acute promyelocytic leukemia (M3)|childhood acute promyelocytic leukemia (m3)
631513|NCT00899015|recurrent childhood acute lymphoblastic leukemia|recurrent childhood acute lymphoblastic leukemia
631514|NCT00899015|recurrent childhood large cell lymphoma|recurrent childhood large cell lymphoma
631515|NCT00899015|recurrent childhood lymphoblastic lymphoma|recurrent childhood lymphoblastic lymphoma
631516|NCT00899015|recurrent childhood small noncleaved cell lymphoma|recurrent childhood small noncleaved cell lymphoma
631517|NCT00899015|recurrent/refractory childhood Hodgkin lymphoma|recurrent/refractory childhood hodgkin lymphoma
631518|NCT00899015|childhood chronic myelogenous leukemia|childhood chronic myelogenous leukemia
631519|NCT00899015|atypical chronic myeloid leukemia, BCR-ABL1 negative|atypical chronic myeloid leukemia, bcr-abl1 negative
631520|NCT00899002|childhood hepatocellular carcinoma|childhood hepatocellular carcinoma
631521|NCT00899002|childhood liver cancer|childhood liver cancer
631522|NCT00899002|adult primary liver cancer|adult primary liver cancer
631523|NCT00899002|adult primary hepatocellular carcinoma|adult primary hepatocellular carcinoma
631524|NCT00898976|stage I breast cancer|stage i breast cancer
631525|NCT00898976|stage II breast cancer|stage ii breast cancer
631526|NCT00898976|stage IV breast cancer|stage iv breast cancer
631527|NCT00898976|stage IIIA breast cancer|stage iiia breast cancer
631528|NCT00898976|breast cancer in situ|breast cancer in situ
631529|NCT00898976|recurrent breast cancer|recurrent breast cancer
631530|NCT00898976|stage IIIB breast cancer|stage iiib breast cancer
631531|NCT00898976|inflammatory breast cancer|inflammatory breast cancer
631532|NCT00898976|stage IIIC breast cancer|stage iiic breast cancer
631533|NCT00898963|stage III grade 1 follicular lymphoma|stage iii grade 1 follicular lymphoma
631534|NCT00898963|stage III grade 2 follicular lymphoma|stage iii grade 2 follicular lymphoma
631535|NCT00898963|stage III grade 3 follicular lymphoma|stage iii grade 3 follicular lymphoma
631536|NCT00898963|stage IV grade 1 follicular lymphoma|stage iv grade 1 follicular lymphoma
631537|NCT00898963|stage IV grade 2 follicular lymphoma|stage iv grade 2 follicular lymphoma
631538|NCT00898963|stage IV grade 3 follicular lymphoma|stage iv grade 3 follicular lymphoma
631539|NCT00898950|diabetes|diabetes
631540|NCT00898950|aspirin|aspirin
631541|NCT00898950|oxidative stress|oxidative stress
631542|NCT00898950|insulin resistance|insulin resistance
631543|NCT00898950|endothelial function|endothelial function
631544|NCT00898950|inflammation|inflammation
631545|NCT00898950|photoplethysmography|photoplethysmography
631546|NCT00898950|dysglycaemia|dysglycaemia
631547|NCT00898937|breast cancer|breast cancer
631548|NCT00898924|stage IIIA non-small cell lung cancer|stage iiia non-small cell lung cancer
631549|NCT00898924|stage IIIB non-small cell lung cancer|stage iiib non-small cell lung cancer
631550|NCT00898911|recurrent squamous cell carcinoma of the hypopharynx|recurrent squamous cell carcinoma of the hypopharynx
631551|NCT00898911|stage IV squamous cell carcinoma of the hypopharynx|stage iv squamous cell carcinoma of the hypopharynx
631552|NCT00898911|stage IV squamous cell carcinoma of the larynx|stage iv squamous cell carcinoma of the larynx
631553|NCT00898911|stage IV verrucous carcinoma of the larynx|stage iv verrucous carcinoma of the larynx
631554|NCT00898911|recurrent squamous cell carcinoma of the larynx|recurrent squamous cell carcinoma of the larynx
631555|NCT00898911|recurrent verrucous carcinoma of the larynx|recurrent verrucous carcinoma of the larynx
631556|NCT00898911|recurrent squamous cell carcinoma of the lip and oral cavity|recurrent squamous cell carcinoma of the lip and oral cavity
631557|NCT00898911|stage IV squamous cell carcinoma of the lip and oral cavity|stage iv squamous cell carcinoma of the lip and oral cavity
631558|NCT00898911|recurrent verrucous carcinoma of the oral cavity|recurrent verrucous carcinoma of the oral cavity
631559|NCT00898911|stage IV verrucous carcinoma of the oral cavity|stage iv verrucous carcinoma of the oral cavity
631560|NCT00898911|metastatic squamous neck cancer with occult primary squamous cell carcinoma|metastatic squamous neck cancer with occult primary squamous cell carcinoma
631561|NCT00898911|recurrent metastatic squamous neck cancer with occult primary|recurrent metastatic squamous neck cancer with occult primary
631562|NCT00898911|recurrent squamous cell carcinoma of the nasopharynx|recurrent squamous cell carcinoma of the nasopharynx
631563|NCT00898911|stage IV squamous cell carcinoma of the nasopharynx|stage iv squamous cell carcinoma of the nasopharynx
631564|NCT00898911|recurrent squamous cell carcinoma of the oropharynx|recurrent squamous cell carcinoma of the oropharynx
631565|NCT00898911|stage IV squamous cell carcinoma of the oropharynx|stage iv squamous cell carcinoma of the oropharynx
631566|NCT00898911|recurrent squamous cell carcinoma of the paranasal sinus and nasal cavity|recurrent squamous cell carcinoma of the paranasal sinus and nasal cavity
631567|NCT00898911|stage IV squamous cell carcinoma of the paranasal sinus and nasal cavity|stage iv squamous cell carcinoma of the paranasal sinus and nasal cavity
631568|NCT00898911|recurrent salivary gland cancer|recurrent salivary gland cancer
631569|NCT00898911|salivary gland squamous cell carcinoma|salivary gland squamous cell carcinoma
631570|NCT00898911|stage IV salivary gland cancer|stage iv salivary gland cancer
631572|NCT00898898|stage IB breast cancer|stage ib breast cancer
631573|NCT00898898|stage II breast cancer|stage ii breast cancer
631574|NCT00898898|stage IIIA breast cancer|stage iiia breast cancer
631575|NCT00898898|HER2-positive breast cancer|her2-positive breast cancer
631576|NCT00898885|oral manifestations|oral manifestations
631577|NCT00898885|bone marrow transplantation|bone marrow transplantation
631578|NCT00898885|adverse effects|adverse effects
631579|NCT00898872|recurrent grade 3 follicular lymphoma|recurrent grade 3 follicular lymphoma
631580|NCT00898872|recurrent adult diffuse small cleaved cell lymphoma|recurrent adult diffuse small cleaved cell lymphoma
631581|NCT00898872|recurrent adult diffuse mixed cell lymphoma|recurrent adult diffuse mixed cell lymphoma
631582|NCT00898872|recurrent adult diffuse large cell lymphoma|recurrent adult diffuse large cell lymphoma
631583|NCT00898872|recurrent adult immunoblastic large cell lymphoma|recurrent adult immunoblastic large cell lymphoma
631584|NCT00898872|recurrent adult lymphoblastic lymphoma|recurrent adult lymphoblastic lymphoma
631585|NCT00898872|recurrent adult Burkitt lymphoma|recurrent adult burkitt lymphoma
631586|NCT00898872|recurrent adult grade III lymphomatoid granulomatosis|recurrent adult grade iii lymphomatoid granulomatosis
631587|NCT00898872|recurrent grade 1 follicular lymphoma|recurrent grade 1 follicular lymphoma
631588|NCT00898872|recurrent grade 2 follicular lymphoma|recurrent grade 2 follicular lymphoma
631589|NCT00898872|recurrent mantle cell lymphoma|recurrent mantle cell lymphoma
631590|NCT00898872|recurrent marginal zone lymphoma|recurrent marginal zone lymphoma
631591|NCT00898872|recurrent small lymphocytic lymphoma|recurrent small lymphocytic lymphoma
631592|NCT00898872|extranodal marginal zone B-cell lymphoma of mucosa-associated lymphoid tissue|extranodal marginal zone b-cell lymphoma of mucosa-associated lymphoid tissue
631593|NCT00898872|nodal marginal zone B-cell lymphoma|nodal marginal zone b-cell lymphoma
631594|NCT00898872|splenic marginal zone lymphoma|splenic marginal zone lymphoma
712511|NCT00579904|walnut-oil|walnut-oil
631595|NCT00898872|Waldenström macroglobulinemia|waldenström macroglobulinemia
631596|NCT00898872|adult nasal type extranodal NK/T-cell lymphoma|adult nasal type extranodal nk/t-cell lymphoma
631597|NCT00898872|recurrent childhood grade III lymphomatoid granulomatosis|recurrent childhood grade iii lymphomatoid granulomatosis
631598|NCT00898872|recurrent childhood large cell lymphoma|recurrent childhood large cell lymphoma
631599|NCT00898872|recurrent childhood lymphoblastic lymphoma|recurrent childhood lymphoblastic lymphoma
631600|NCT00898872|recurrent childhood small noncleaved cell lymphoma|recurrent childhood small noncleaved cell lymphoma
631601|NCT00898872|childhood diffuse large cell lymphoma|childhood diffuse large cell lymphoma
631602|NCT00898872|childhood immunoblastic large cell lymphoma|childhood immunoblastic large cell lymphoma
631603|NCT00898872|childhood Burkitt lymphoma|childhood burkitt lymphoma
631604|NCT00898872|childhood nasal type extranodal NK/T-cell lymphoma|childhood nasal type extranodal nk/t-cell lymphoma
631605|NCT00898859|ADAM|adam
631606|NCT00898859|epithelial|epithelial
631607|NCT00898859|COPD|copd
631608|NCT00898846|stage II colon cancer|stage ii colon cancer
631609|NCT00898846|stage II rectal cancer|stage ii rectal cancer
631610|NCT00898846|adenocarcinoma of the colon|adenocarcinoma of the colon
631611|NCT00898846|adenocarcinoma of the rectum|adenocarcinoma of the rectum
631612|NCT00898833|recurrent prostate cancer|recurrent prostate cancer
631613|NCT00898833|stage III prostate cancer|stage iii prostate cancer
631614|NCT00898833|stage IV prostate cancer|stage iv prostate cancer
631615|NCT00898833|adenocarcinoma of the prostate|adenocarcinoma of the prostate
631616|NCT00898820|stage IIIB non-small cell lung cancer|stage iiib non-small cell lung cancer
631617|NCT00898820|stage IV non-small cell lung cancer|stage iv non-small cell lung cancer
631618|NCT00898820|recurrent non-small cell lung cancer|recurrent non-small cell lung cancer
631619|NCT00898807|neuropsychiatric symptoms|neuropsychiatric symptoms
631620|NCT00898807|aggression|aggression
631621|NCT00898807|mood lability|mood lability
631622|NCT00898794|unspecified adult solid tumor, protocol specific|unspecified adult solid tumor, protocol specific
631623|NCT00898794|unspecified childhood solid tumor, protocol specific|unspecified childhood solid tumor, protocol specific
631624|NCT00898781|male breast cancer|male breast cancer
631625|NCT00898781|stage IV breast cancer|stage iv breast cancer
631626|NCT00898781|stage IV ovarian epithelial cancer|stage iv ovarian epithelial cancer
631627|NCT00898781|stage IV ovarian germ cell tumor|stage iv ovarian germ cell tumor
631628|NCT00898781|stage IV pancreatic cancer|stage iv pancreatic cancer
631629|NCT00898781|stage IV colon cancer|stage iv colon cancer
631630|NCT00898781|ovarian sarcoma|ovarian sarcoma
631631|NCT00898768|Lynch syndrome|lynch syndrome
631632|NCT00898768|HNPCC|hnpcc
631633|NCT00898768|Capsule endoscopy|capsule endoscopy
631634|NCT00898768|Small bowel cancer|small bowel cancer
631635|NCT00898768|Double balloon endoscopy|double balloon endoscopy
631636|NCT00898742|recurrent squamous cell carcinoma of the hypopharynx|recurrent squamous cell carcinoma of the hypopharynx
631637|NCT00898742|stage IV squamous cell carcinoma of the hypopharynx|stage iv squamous cell carcinoma of the hypopharynx
631638|NCT00898742|stage IV squamous cell carcinoma of the larynx|stage iv squamous cell carcinoma of the larynx
631639|NCT00898742|stage IV verrucous carcinoma of the larynx|stage iv verrucous carcinoma of the larynx
631640|NCT00898742|recurrent squamous cell carcinoma of the larynx|recurrent squamous cell carcinoma of the larynx
631641|NCT00898742|recurrent verrucous carcinoma of the larynx|recurrent verrucous carcinoma of the larynx
631642|NCT00898742|recurrent squamous cell carcinoma of the lip and oral cavity|recurrent squamous cell carcinoma of the lip and oral cavity
631941|NCT00898482|stage IV pancreatic cancer|stage iv pancreatic cancer
631643|NCT00898742|stage IV squamous cell carcinoma of the lip and oral cavity|stage iv squamous cell carcinoma of the lip and oral cavity
631644|NCT00898742|recurrent verrucous carcinoma of the oral cavity|recurrent verrucous carcinoma of the oral cavity
631645|NCT00898742|stage IV verrucous carcinoma of the oral cavity|stage iv verrucous carcinoma of the oral cavity
631646|NCT00898742|metastatic squamous neck cancer with occult primary squamous cell carcinoma|metastatic squamous neck cancer with occult primary squamous cell carcinoma
631647|NCT00898742|recurrent metastatic squamous neck cancer with occult primary|recurrent metastatic squamous neck cancer with occult primary
631648|NCT00898742|recurrent squamous cell carcinoma of the nasopharynx|recurrent squamous cell carcinoma of the nasopharynx
631649|NCT00898742|stage IV squamous cell carcinoma of the nasopharynx|stage iv squamous cell carcinoma of the nasopharynx
631650|NCT00898742|recurrent squamous cell carcinoma of the oropharynx|recurrent squamous cell carcinoma of the oropharynx
631651|NCT00898742|stage IV squamous cell carcinoma of the oropharynx|stage iv squamous cell carcinoma of the oropharynx
631652|NCT00898742|recurrent squamous cell carcinoma of the paranasal sinus and nasal cavity|recurrent squamous cell carcinoma of the paranasal sinus and nasal cavity
631653|NCT00898742|stage IV squamous cell carcinoma of the paranasal sinus and nasal cavity|stage iv squamous cell carcinoma of the paranasal sinus and nasal cavity
631654|NCT00898742|recurrent salivary gland cancer|recurrent salivary gland cancer
631655|NCT00898742|salivary gland squamous cell carcinoma|salivary gland squamous cell carcinoma
631656|NCT00898742|stage IV salivary gland cancer|stage iv salivary gland cancer
631657|NCT00898703|breast cancer|breast cancer
631658|NCT00898690|stage I breast cancer|stage i breast cancer
631659|NCT00898690|stage II breast cancer|stage ii breast cancer
712512|NCT00579904|walnuts|walnuts
631660|NCT00898690|stage IIIA breast cancer|stage iiia breast cancer
631661|NCT00898690|stage IIIB breast cancer|stage iiib breast cancer
631662|NCT00898690|stage IIIC breast cancer|stage iiic breast cancer
631663|NCT00898690|stage IV breast cancer|stage iv breast cancer
631664|NCT00898690|recurrent breast cancer|recurrent breast cancer
631665|NCT00898664|stage I squamous cell carcinoma of the hypopharynx|stage i squamous cell carcinoma of the hypopharynx
631666|NCT00898664|stage II squamous cell carcinoma of the hypopharynx|stage ii squamous cell carcinoma of the hypopharynx
631667|NCT00898664|stage III squamous cell carcinoma of the hypopharynx|stage iii squamous cell carcinoma of the hypopharynx
631668|NCT00898664|stage IV squamous cell carcinoma of the hypopharynx|stage iv squamous cell carcinoma of the hypopharynx
631669|NCT00898664|recurrent squamous cell carcinoma of the hypopharynx|recurrent squamous cell carcinoma of the hypopharynx
631670|NCT00898664|stage I squamous cell carcinoma of the larynx|stage i squamous cell carcinoma of the larynx
631671|NCT00898664|stage II squamous cell carcinoma of the larynx|stage ii squamous cell carcinoma of the larynx
631672|NCT00898664|stage III squamous cell carcinoma of the larynx|stage iii squamous cell carcinoma of the larynx
631673|NCT00898664|stage IV squamous cell carcinoma of the larynx|stage iv squamous cell carcinoma of the larynx
631674|NCT00898664|recurrent squamous cell carcinoma of the larynx|recurrent squamous cell carcinoma of the larynx
631675|NCT00898664|stage I squamous cell carcinoma of the lip and oral cavity|stage i squamous cell carcinoma of the lip and oral cavity
631676|NCT00898664|stage II squamous cell carcinoma of the lip and oral cavity|stage ii squamous cell carcinoma of the lip and oral cavity
631677|NCT00898664|stage III squamous cell carcinoma of the lip and oral cavity|stage iii squamous cell carcinoma of the lip and oral cavity
631678|NCT00898664|stage IV squamous cell carcinoma of the lip and oral cavity|stage iv squamous cell carcinoma of the lip and oral cavity
631679|NCT00898664|recurrent squamous cell carcinoma of the lip and oral cavity|recurrent squamous cell carcinoma of the lip and oral cavity
631680|NCT00898664|metastatic squamous neck cancer with occult primary squamous cell carcinoma|metastatic squamous neck cancer with occult primary squamous cell carcinoma
631681|NCT00898664|recurrent metastatic squamous neck cancer with occult primary|recurrent metastatic squamous neck cancer with occult primary
631682|NCT00898664|untreated metastatic squamous neck cancer with occult primary|untreated metastatic squamous neck cancer with occult primary
631683|NCT00898664|stage I squamous cell carcinoma of the nasopharynx|stage i squamous cell carcinoma of the nasopharynx
631684|NCT00898664|stage II squamous cell carcinoma of the nasopharynx|stage ii squamous cell carcinoma of the nasopharynx
631685|NCT00898664|stage III squamous cell carcinoma of the nasopharynx|stage iii squamous cell carcinoma of the nasopharynx
632496|NCT00897767|mast cell leukemia|mast cell leukemia
631686|NCT00898664|stage IV squamous cell carcinoma of the nasopharynx|stage iv squamous cell carcinoma of the nasopharynx
631687|NCT00898664|recurrent squamous cell carcinoma of the nasopharynx|recurrent squamous cell carcinoma of the nasopharynx
631688|NCT00898664|stage I squamous cell carcinoma of the oropharynx|stage i squamous cell carcinoma of the oropharynx
631689|NCT00898664|stage II squamous cell carcinoma of the oropharynx|stage ii squamous cell carcinoma of the oropharynx
631690|NCT00898664|stage III squamous cell carcinoma of the oropharynx|stage iii squamous cell carcinoma of the oropharynx
631691|NCT00898664|stage IV squamous cell carcinoma of the oropharynx|stage iv squamous cell carcinoma of the oropharynx
631692|NCT00898664|recurrent squamous cell carcinoma of the oropharynx|recurrent squamous cell carcinoma of the oropharynx
631693|NCT00898664|stage I squamous cell carcinoma of the paranasal sinus and nasal cavity|stage i squamous cell carcinoma of the paranasal sinus and nasal cavity
631694|NCT00898664|stage II squamous cell carcinoma of the paranasal sinus and nasal cavity|stage ii squamous cell carcinoma of the paranasal sinus and nasal cavity
631695|NCT00898664|stage III squamous cell carcinoma of the paranasal sinus and nasal cavity|stage iii squamous cell carcinoma of the paranasal sinus and nasal cavity
631696|NCT00898664|stage IV squamous cell carcinoma of the paranasal sinus and nasal cavity|stage iv squamous cell carcinoma of the paranasal sinus and nasal cavity
633394|NCT00894790|Diclofenac|diclofenac
631697|NCT00898664|recurrent squamous cell carcinoma of the paranasal sinus and nasal cavity|recurrent squamous cell carcinoma of the paranasal sinus and nasal cavity
631698|NCT00898664|salivary gland squamous cell carcinoma|salivary gland squamous cell carcinoma
631699|NCT00898664|stage I salivary gland cancer|stage i salivary gland cancer
631700|NCT00898664|stage II salivary gland cancer|stage ii salivary gland cancer
631701|NCT00898664|stage III salivary gland cancer|stage iii salivary gland cancer
631702|NCT00898664|stage IV salivary gland cancer|stage iv salivary gland cancer
631703|NCT00898664|recurrent salivary gland cancer|recurrent salivary gland cancer
631704|NCT00898638|stage I squamous cell carcinoma of the hypopharynx|stage i squamous cell carcinoma of the hypopharynx
631705|NCT00898638|stage II squamous cell carcinoma of the hypopharynx|stage ii squamous cell carcinoma of the hypopharynx
631706|NCT00898638|stage III squamous cell carcinoma of the hypopharynx|stage iii squamous cell carcinoma of the hypopharynx
631707|NCT00898638|stage IV squamous cell carcinoma of the hypopharynx|stage iv squamous cell carcinoma of the hypopharynx
631708|NCT00898638|recurrent squamous cell carcinoma of the hypopharynx|recurrent squamous cell carcinoma of the hypopharynx
631709|NCT00898638|stage I squamous cell carcinoma of the larynx|stage i squamous cell carcinoma of the larynx
631710|NCT00898638|stage I verrucous carcinoma of the larynx|stage i verrucous carcinoma of the larynx
631711|NCT00898638|stage II squamous cell carcinoma of the larynx|stage ii squamous cell carcinoma of the larynx
631712|NCT00898638|stage II verrucous carcinoma of the larynx|stage ii verrucous carcinoma of the larynx
631713|NCT00898638|stage III squamous cell carcinoma of the larynx|stage iii squamous cell carcinoma of the larynx
631714|NCT00898638|stage III verrucous carcinoma of the larynx|stage iii verrucous carcinoma of the larynx
631715|NCT00898638|stage IV squamous cell carcinoma of the larynx|stage iv squamous cell carcinoma of the larynx
631716|NCT00898638|stage IV verrucous carcinoma of the larynx|stage iv verrucous carcinoma of the larynx
631717|NCT00898638|recurrent squamous cell carcinoma of the larynx|recurrent squamous cell carcinoma of the larynx
631718|NCT00898638|recurrent verrucous carcinoma of the larynx|recurrent verrucous carcinoma of the larynx
631719|NCT00898638|stage I adenoid cystic carcinoma of the oral cavity|stage i adenoid cystic carcinoma of the oral cavity
631720|NCT00898638|stage I basal cell carcinoma of the lip|stage i basal cell carcinoma of the lip
631721|NCT00898638|stage I mucoepidermoid carcinoma of the oral cavity|stage i mucoepidermoid carcinoma of the oral cavity
631722|NCT00898638|stage I squamous cell carcinoma of the lip and oral cavity|stage i squamous cell carcinoma of the lip and oral cavity
631723|NCT00898638|stage I verrucous carcinoma of the oral cavity|stage i verrucous carcinoma of the oral cavity
631724|NCT00898638|stage II adenoid cystic carcinoma of the oral cavity|stage ii adenoid cystic carcinoma of the oral cavity
631725|NCT00898638|stage II basal cell carcinoma of the lip|stage ii basal cell carcinoma of the lip
631726|NCT00898638|stage II mucoepidermoid carcinoma of the oral cavity|stage ii mucoepidermoid carcinoma of the oral cavity
631727|NCT00898638|stage II squamous cell carcinoma of the lip and oral cavity|stage ii squamous cell carcinoma of the lip and oral cavity
631728|NCT00898638|stage II verrucous carcinoma of the oral cavity|stage ii verrucous carcinoma of the oral cavity
631729|NCT00898638|stage III adenoid cystic carcinoma of the oral cavity|stage iii adenoid cystic carcinoma of the oral cavity
631730|NCT00898638|stage III basal cell carcinoma of the lip|stage iii basal cell carcinoma of the lip
631731|NCT00898638|stage III mucoepidermoid carcinoma of the oral cavity|stage iii mucoepidermoid carcinoma of the oral cavity
631732|NCT00898638|stage III squamous cell carcinoma of the lip and oral cavity|stage iii squamous cell carcinoma of the lip and oral cavity
631733|NCT00898638|stage III verrucous carcinoma of the oral cavity|stage iii verrucous carcinoma of the oral cavity
631734|NCT00898638|stage IV adenoid cystic carcinoma of the oral cavity|stage iv adenoid cystic carcinoma of the oral cavity
631735|NCT00898638|stage IV basal cell carcinoma of the lip|stage iv basal cell carcinoma of the lip
631736|NCT00898638|stage IV mucoepidermoid carcinoma of the oral cavity|stage iv mucoepidermoid carcinoma of the oral cavity
631737|NCT00898638|stage IV squamous cell carcinoma of the lip and oral cavity|stage iv squamous cell carcinoma of the lip and oral cavity
631738|NCT00898638|stage IV verrucous carcinoma of the oral cavity|stage iv verrucous carcinoma of the oral cavity
631739|NCT00898638|recurrent adenoid cystic carcinoma of the oral cavity|recurrent adenoid cystic carcinoma of the oral cavity
631740|NCT00898638|recurrent basal cell carcinoma of the lip|recurrent basal cell carcinoma of the lip
631741|NCT00898638|recurrent mucoepidermoid carcinoma of the oral cavity|recurrent mucoepidermoid carcinoma of the oral cavity
631742|NCT00898638|recurrent squamous cell carcinoma of the lip and oral cavity|recurrent squamous cell carcinoma of the lip and oral cavity
631743|NCT00898638|recurrent verrucous carcinoma of the oral cavity|recurrent verrucous carcinoma of the oral cavity
631744|NCT00898638|metastatic squamous neck cancer with occult primary squamous cell carcinoma|metastatic squamous neck cancer with occult primary squamous cell carcinoma
631745|NCT00898638|recurrent metastatic squamous neck cancer with occult primary|recurrent metastatic squamous neck cancer with occult primary
631746|NCT00898638|untreated metastatic squamous neck cancer with occult primary|untreated metastatic squamous neck cancer with occult primary
631747|NCT00898638|stage I lymphoepithelioma of the nasopharynx|stage i lymphoepithelioma of the nasopharynx
631748|NCT00898638|stage I squamous cell carcinoma of the nasopharynx|stage i squamous cell carcinoma of the nasopharynx
631749|NCT00898638|stage II lymphoepithelioma of the nasopharynx|stage ii lymphoepithelioma of the nasopharynx
631750|NCT00898638|stage II squamous cell carcinoma of the nasopharynx|stage ii squamous cell carcinoma of the nasopharynx
631751|NCT00898638|stage III lymphoepithelioma of the nasopharynx|stage iii lymphoepithelioma of the nasopharynx
631752|NCT00898638|stage III squamous cell carcinoma of the nasopharynx|stage iii squamous cell carcinoma of the nasopharynx
631753|NCT00898638|stage IV lymphoepithelioma of the nasopharynx|stage iv lymphoepithelioma of the nasopharynx
631754|NCT00898638|stage IV squamous cell carcinoma of the nasopharynx|stage iv squamous cell carcinoma of the nasopharynx
631755|NCT00898638|recurrent lymphoepithelioma of the nasopharynx|recurrent lymphoepithelioma of the nasopharynx
631756|NCT00898638|recurrent squamous cell carcinoma of the nasopharynx|recurrent squamous cell carcinoma of the nasopharynx
631757|NCT00898638|stage I lymphoepithelioma of the oropharynx|stage i lymphoepithelioma of the oropharynx
631758|NCT00898638|stage I squamous cell carcinoma of the oropharynx|stage i squamous cell carcinoma of the oropharynx
631759|NCT00898638|stage II lymphoepithelioma of the oropharynx|stage ii lymphoepithelioma of the oropharynx
631760|NCT00898638|stage II squamous cell carcinoma of the oropharynx|stage ii squamous cell carcinoma of the oropharynx
631761|NCT00898638|stage III lymphoepithelioma of the oropharynx|stage iii lymphoepithelioma of the oropharynx
631762|NCT00898638|stage III squamous cell carcinoma of the oropharynx|stage iii squamous cell carcinoma of the oropharynx
631763|NCT00898638|stage IV lymphoepithelioma of the oropharynx|stage iv lymphoepithelioma of the oropharynx
631764|NCT00898638|stage IV squamous cell carcinoma of the oropharynx|stage iv squamous cell carcinoma of the oropharynx
631765|NCT00898638|recurrent lymphoepithelioma of the oropharynx|recurrent lymphoepithelioma of the oropharynx
710892|NCT00587392|Endoscopic Full-thickness Plication|endoscopic full-thickness plication
804073|NCT00237796|CBT|cbt
631766|NCT00898638|stage I esthesioneuroblastoma of the paranasal sinus and nasal cavity|stage i esthesioneuroblastoma of the paranasal sinus and nasal cavity
631767|NCT00898638|stage I inverted papilloma of the paranasal sinus and nasal cavity|stage i inverted papilloma of the paranasal sinus and nasal cavity
631853|NCT00898612|adult acute lymphoblastic leukemia in remission|adult acute lymphoblastic leukemia in remission
631768|NCT00898638|stage I midline lethal granuloma of the paranasal sinus and nasal cavity|stage i midline lethal granuloma of the paranasal sinus and nasal cavity
631769|NCT00898638|stage I squamous cell carcinoma of the paranasal sinus and nasal cavity|stage i squamous cell carcinoma of the paranasal sinus and nasal cavity
631770|NCT00898638|stage II esthesioneuroblastoma of the paranasal sinus and nasal cavity|stage ii esthesioneuroblastoma of the paranasal sinus and nasal cavity
631771|NCT00898638|stage II inverted papilloma of the paranasal sinus and nasal cavity|stage ii inverted papilloma of the paranasal sinus and nasal cavity
631772|NCT00898638|stage II midline lethal granuloma of the paranasal sinus and nasal cavity|stage ii midline lethal granuloma of the paranasal sinus and nasal cavity
631773|NCT00898638|stage II squamous cell carcinoma of the paranasal sinus and nasal cavity|stage ii squamous cell carcinoma of the paranasal sinus and nasal cavity
631774|NCT00898638|stage III esthesioneuroblastoma of the paranasal sinus and nasal cavity|stage iii esthesioneuroblastoma of the paranasal sinus and nasal cavity
631775|NCT00898638|stage III inverted papilloma of the paranasal sinus and nasal cavity|stage iii inverted papilloma of the paranasal sinus and nasal cavity
631776|NCT00898638|stage III midline lethal granuloma of the paranasal sinus and nasal cavity|stage iii midline lethal granuloma of the paranasal sinus and nasal cavity
631777|NCT00898638|stage III squamous cell carcinoma of the paranasal sinus and nasal cavity|stage iii squamous cell carcinoma of the paranasal sinus and nasal cavity
631778|NCT00898638|stage IV esthesioneuroblastoma of the paranasal sinus and nasal cavity|stage iv esthesioneuroblastoma of the paranasal sinus and nasal cavity
631779|NCT00898638|stage IV inverted papilloma of the paranasal sinus and nasal cavity|stage iv inverted papilloma of the paranasal sinus and nasal cavity
631780|NCT00898638|stage IV midline lethal granuloma of the paranasal sinus and nasal cavity|stage iv midline lethal granuloma of the paranasal sinus and nasal cavity
631781|NCT00898638|stage IV squamous cell carcinoma of the paranasal sinus and nasal cavity|stage iv squamous cell carcinoma of the paranasal sinus and nasal cavity
631782|NCT00898638|recurrent esthesioneuroblastoma of the paranasal sinus and nasal cavity|recurrent esthesioneuroblastoma of the paranasal sinus and nasal cavity
631783|NCT00898638|recurrent inverted papilloma of the paranasal sinus and nasal cavity|recurrent inverted papilloma of the paranasal sinus and nasal cavity
631784|NCT00898638|recurrent midline lethal granuloma of the paranasal sinus and nasal cavity|recurrent midline lethal granuloma of the paranasal sinus and nasal cavity
631785|NCT00898638|recurrent squamous cell carcinoma of the paranasal sinus and nasal cavity|recurrent squamous cell carcinoma of the paranasal sinus and nasal cavity
631786|NCT00898638|stage I salivary gland cancer|stage i salivary gland cancer
631787|NCT00898638|stage II salivary gland cancer|stage ii salivary gland cancer
631788|NCT00898638|stage III salivary gland cancer|stage iii salivary gland cancer
631789|NCT00898638|stage IV salivary gland cancer|stage iv salivary gland cancer
631790|NCT00898638|recurrent salivary gland cancer|recurrent salivary gland cancer
631791|NCT00898638|recurrent squamous cell carcinoma of the oropharynx|recurrent squamous cell carcinoma of the oropharynx
631792|NCT00898612|stage III adult Burkitt lymphoma|stage iii adult burkitt lymphoma
631793|NCT00898612|stage III adult diffuse large cell lymphoma|stage iii adult diffuse large cell lymphoma
631794|NCT00898612|stage III adult diffuse mixed cell lymphoma|stage iii adult diffuse mixed cell lymphoma
631795|NCT00898612|stage III adult diffuse small cleaved cell lymphoma|stage iii adult diffuse small cleaved cell lymphoma
631796|NCT00898612|stage III adult Hodgkin lymphoma|stage iii adult hodgkin lymphoma
631797|NCT00898612|stage III adult immunoblastic large cell lymphoma|stage iii adult immunoblastic large cell lymphoma
631798|NCT00898612|stage III adult lymphoblastic lymphoma|stage iii adult lymphoblastic lymphoma
631799|NCT00898612|stage III grade 1 follicular lymphoma|stage iii grade 1 follicular lymphoma
631800|NCT00898612|stage III grade 2 follicular lymphoma|stage iii grade 2 follicular lymphoma
631801|NCT00898612|stage III grade 3 follicular lymphoma|stage iii grade 3 follicular lymphoma
631802|NCT00898612|stage III mantle cell lymphoma|stage iii mantle cell lymphoma
631803|NCT00898612|stage III marginal zone lymphoma|stage iii marginal zone lymphoma
631804|NCT00898612|stage III small lymphocytic lymphoma|stage iii small lymphocytic lymphoma
631805|NCT00898612|stage IV adult Burkitt lymphoma|stage iv adult burkitt lymphoma
631806|NCT00898612|stage IV adult diffuse large cell lymphoma|stage iv adult diffuse large cell lymphoma
631807|NCT00898612|stage IV adult diffuse mixed cell lymphoma|stage iv adult diffuse mixed cell lymphoma
631808|NCT00898612|stage IV adult diffuse small cleaved cell lymphoma|stage iv adult diffuse small cleaved cell lymphoma
631809|NCT00898612|stage IV adult Hodgkin lymphoma|stage iv adult hodgkin lymphoma
631810|NCT00898612|stage IV adult immunoblastic large cell lymphoma|stage iv adult immunoblastic large cell lymphoma
631811|NCT00898612|stage IV adult lymphoblastic lymphoma|stage iv adult lymphoblastic lymphoma
631812|NCT00898612|stage IV grade 1 follicular lymphoma|stage iv grade 1 follicular lymphoma
631813|NCT00898612|stage IV grade 2 follicular lymphoma|stage iv grade 2 follicular lymphoma
631814|NCT00898612|stage IV grade 3 follicular lymphoma|stage iv grade 3 follicular lymphoma
631815|NCT00898612|stage IV mantle cell lymphoma|stage iv mantle cell lymphoma
631816|NCT00898612|stage IV marginal zone lymphoma|stage iv marginal zone lymphoma
710893|NCT00587392|Plicator|plicator
631817|NCT00898612|stage IV small lymphocytic lymphoma|stage iv small lymphocytic lymphoma
631818|NCT00898612|recurrent adult Burkitt lymphoma|recurrent adult burkitt lymphoma
631819|NCT00898612|recurrent adult diffuse large cell lymphoma|recurrent adult diffuse large cell lymphoma
631820|NCT00898612|recurrent adult diffuse mixed cell lymphoma|recurrent adult diffuse mixed cell lymphoma
631821|NCT00898612|recurrent adult diffuse small cleaved cell lymphoma|recurrent adult diffuse small cleaved cell lymphoma
631822|NCT00898612|recurrent adult Hodgkin lymphoma|recurrent adult hodgkin lymphoma
631823|NCT00898612|recurrent adult immunoblastic large cell lymphoma|recurrent adult immunoblastic large cell lymphoma
631824|NCT00898612|recurrent adult lymphoblastic lymphoma|recurrent adult lymphoblastic lymphoma
631825|NCT00898612|recurrent childhood large cell lymphoma|recurrent childhood large cell lymphoma
631826|NCT00898612|recurrent childhood lymphoblastic lymphoma|recurrent childhood lymphoblastic lymphoma
631827|NCT00898612|recurrent childhood small noncleaved cell lymphoma|recurrent childhood small noncleaved cell lymphoma
631828|NCT00898612|recurrent cutaneous T-cell non-Hodgkin lymphoma|recurrent cutaneous t-cell non-hodgkin lymphoma
631829|NCT00898612|recurrent grade 1 follicular lymphoma|recurrent grade 1 follicular lymphoma
631830|NCT00898612|recurrent grade 2 follicular lymphoma|recurrent grade 2 follicular lymphoma
631831|NCT00898612|recurrent grade 3 follicular lymphoma|recurrent grade 3 follicular lymphoma
631832|NCT00898612|recurrent mantle cell lymphoma|recurrent mantle cell lymphoma
631833|NCT00898612|recurrent marginal zone lymphoma|recurrent marginal zone lymphoma
631834|NCT00898612|recurrent small lymphocytic lymphoma|recurrent small lymphocytic lymphoma
631835|NCT00898612|recurrent/refractory childhood Hodgkin lymphoma|recurrent/refractory childhood hodgkin lymphoma
631836|NCT00898612|recurrent mycosis fungoides/Sezary syndrome|recurrent mycosis fungoides/sezary syndrome
631837|NCT00898612|extranodal marginal zone B-cell lymphoma of mucosa-associated lymphoid tissue|extranodal marginal zone b-cell lymphoma of mucosa-associated lymphoid tissue
631838|NCT00898612|nodal marginal zone B-cell lymphoma|nodal marginal zone b-cell lymphoma
631839|NCT00898612|splenic marginal zone lymphoma|splenic marginal zone lymphoma
631840|NCT00898612|noncontiguous stage II adult Burkitt lymphoma|noncontiguous stage ii adult burkitt lymphoma
631841|NCT00898612|noncontiguous stage II adult diffuse large cell lymphoma|noncontiguous stage ii adult diffuse large cell lymphoma
631842|NCT00898612|noncontiguous stage II adult diffuse mixed cell lymphoma|noncontiguous stage ii adult diffuse mixed cell lymphoma
631843|NCT00898612|noncontiguous stage II adult diffuse small cleaved cell lymphoma|noncontiguous stage ii adult diffuse small cleaved cell lymphoma
631844|NCT00898612|noncontiguous stage II adult immunoblastic large cell lymphoma|noncontiguous stage ii adult immunoblastic large cell lymphoma
631845|NCT00898612|noncontiguous stage II adult lymphoblastic lymphoma|noncontiguous stage ii adult lymphoblastic lymphoma
631846|NCT00898612|noncontiguous stage II grade 1 follicular lymphoma|noncontiguous stage ii grade 1 follicular lymphoma
631847|NCT00898612|noncontiguous stage II grade 2 follicular lymphoma|noncontiguous stage ii grade 2 follicular lymphoma
631848|NCT00898612|noncontiguous stage II grade 3 follicular lymphoma|noncontiguous stage ii grade 3 follicular lymphoma
631849|NCT00898612|noncontiguous stage II mantle cell lymphoma|noncontiguous stage ii mantle cell lymphoma
631850|NCT00898612|noncontiguous stage II marginal zone lymphoma|noncontiguous stage ii marginal zone lymphoma
631851|NCT00898612|noncontiguous stage II small lymphocytic lymphoma|noncontiguous stage ii small lymphocytic lymphoma
631852|NCT00898612|accelerated phase chronic myelogenous leukemia|accelerated phase chronic myelogenous leukemia
631854|NCT00898612|adult acute myeloid leukemia in remission|adult acute myeloid leukemia in remission
631855|NCT00898612|adult acute myeloid leukemia with 11q23 (MLL) abnormalities|adult acute myeloid leukemia with 11q23 (mll) abnormalities
631856|NCT00898612|adult acute myeloid leukemia with inv(16)(p13;q22)|adult acute myeloid leukemia with inv(16)(p13;q22)
631857|NCT00898612|adult acute myeloid leukemia with t(15;17)(q22;q12)|adult acute myeloid leukemia with t(15;17)(q22;q12)
631858|NCT00898612|adult acute myeloid leukemia with t(16;16)(p13;q22)|adult acute myeloid leukemia with t(16;16)(p13;q22)
631859|NCT00898612|adult acute myeloid leukemia with t(8;21)(q22;q22)|adult acute myeloid leukemia with t(8;21)(q22;q22)
631860|NCT00898612|atypical chronic myeloid leukemia, BCR-ABL negative|atypical chronic myeloid leukemia, bcr-abl negative
631861|NCT00898612|blastic phase chronic myelogenous leukemia|blastic phase chronic myelogenous leukemia
631862|NCT00898612|childhood acute lymphoblastic leukemia in remission|childhood acute lymphoblastic leukemia in remission
631863|NCT00898612|childhood acute myeloid leukemia in remission|childhood acute myeloid leukemia in remission
631864|NCT00898612|childhood chronic myelogenous leukemia|childhood chronic myelogenous leukemia
631865|NCT00898612|chronic myelomonocytic leukemia|chronic myelomonocytic leukemia
631866|NCT00898612|chronic phase chronic myelogenous leukemia|chronic phase chronic myelogenous leukemia
631867|NCT00898612|juvenile myelomonocytic leukemia|juvenile myelomonocytic leukemia
631868|NCT00898612|recurrent adult acute lymphoblastic leukemia|recurrent adult acute lymphoblastic leukemia
631869|NCT00898612|recurrent adult acute myeloid leukemia|recurrent adult acute myeloid leukemia
631870|NCT00898612|recurrent childhood acute lymphoblastic leukemia|recurrent childhood acute lymphoblastic leukemia
631871|NCT00898612|recurrent childhood acute myeloid leukemia|recurrent childhood acute myeloid leukemia
631872|NCT00898612|refractory chronic lymphocytic leukemia|refractory chronic lymphocytic leukemia
631873|NCT00898612|refractory hairy cell leukemia|refractory hairy cell leukemia
631874|NCT00898612|relapsing chronic myelogenous leukemia|relapsing chronic myelogenous leukemia
631875|NCT00898612|secondary acute myeloid leukemia|secondary acute myeloid leukemia
631876|NCT00898612|stage III chronic lymphocytic leukemia|stage iii chronic lymphocytic leukemia
631877|NCT00898612|stage IV chronic lymphocytic leukemia|stage iv chronic lymphocytic leukemia
631878|NCT00898612|childhood myelodysplastic syndromes|childhood myelodysplastic syndromes
631879|NCT00898612|chronic eosinophilic leukemia|chronic eosinophilic leukemia
631880|NCT00898612|primary myelofibrosis|primary myelofibrosis
631881|NCT00898612|chronic neutrophilic leukemia|chronic neutrophilic leukemia
631882|NCT00898612|de novo myelodysplastic syndromes|de novo myelodysplastic syndromes
631883|NCT00898612|disseminated neuroblastoma|disseminated neuroblastoma
631884|NCT00898612|myelodysplastic/myeloproliferative neoplasm, unclassifiable|myelodysplastic/myeloproliferative neoplasm, unclassifiable
631885|NCT00898612|poor prognosis metastatic gestational trophoblastic tumor|poor prognosis metastatic gestational trophoblastic tumor
631886|NCT00898612|previously treated childhood rhabdomyosarcoma|previously treated childhood rhabdomyosarcoma
631887|NCT00898612|previously treated myelodysplastic syndromes|previously treated myelodysplastic syndromes
631888|NCT00898612|recurrent Wilms tumor and other childhood kidney tumors|recurrent wilms tumor and other childhood kidney tumors
631889|NCT00898612|recurrent childhood rhabdomyosarcoma|recurrent childhood rhabdomyosarcoma
631890|NCT00898612|recurrent neuroblastoma|recurrent neuroblastoma
631891|NCT00898612|recurrent ovarian epithelial cancer|recurrent ovarian epithelial cancer
631892|NCT00898612|recurrent ovarian germ cell tumor|recurrent ovarian germ cell tumor
631893|NCT00898612|recurrent malignant testicular germ cell tumor|recurrent malignant testicular germ cell tumor
631894|NCT00898612|secondary myelodysplastic syndromes|secondary myelodysplastic syndromes
631895|NCT00898612|stage I multiple myeloma|stage i multiple myeloma
631896|NCT00898612|stage II multiple myeloma|stage ii multiple myeloma
631897|NCT00898612|stage III multiple myeloma|stage iii multiple myeloma
631898|NCT00898612|stage II ovarian epithelial cancer|stage ii ovarian epithelial cancer
631899|NCT00898612|stage III ovarian epithelial cancer|stage iii ovarian epithelial cancer
631900|NCT00898612|stage IV ovarian epithelial cancer|stage iv ovarian epithelial cancer
631901|NCT00898612|stage III malignant testicular germ cell tumor|stage iii malignant testicular germ cell tumor
631902|NCT00898612|stage IIIA breast cancer|stage iiia breast cancer
631903|NCT00898612|stage IIIB breast cancer|stage iiib breast cancer
631904|NCT00898612|stage IIIC breast cancer|stage iiic breast cancer
631905|NCT00898612|stage IV breast cancer|stage iv breast cancer
631906|NCT00898612|refractory multiple myeloma|refractory multiple myeloma
631907|NCT00898573|breast cancer|breast cancer
631908|NCT00898560|Partial|partial
631909|NCT00898560|Epilepsy|epilepsy
631910|NCT00898560|Eslicarbazepine acetate|eslicarbazepine acetate
631911|NCT00898560|Combined oral contraceptive|combined oral contraceptive
631912|NCT00898560|Pharmacokinetics|pharmacokinetics
631913|NCT00898560|Tolerability|tolerability
631914|NCT00898547|advanced malignant mesothelioma|advanced malignant mesothelioma
631915|NCT00898547|recurrent malignant mesothelioma|recurrent malignant mesothelioma
631916|NCT00898547|epithelial mesothelioma|epithelial mesothelioma
631917|NCT00898547|sarcomatous mesothelioma|sarcomatous mesothelioma
631918|NCT00898534|Pediatrics|pediatrics
631919|NCT00898534|Hemoglobin A1c|hemoglobin a1c
631920|NCT00898534|Point of Care testing|point of care testing
631921|NCT00898508|invasive ductal breast carcinoma|invasive ductal breast carcinoma
631922|NCT00898508|invasive lobular breast carcinoma|invasive lobular breast carcinoma
631923|NCT00898508|ductal breast carcinoma in situ|ductal breast carcinoma in situ
631924|NCT00898508|lobular breast carcinoma in situ|lobular breast carcinoma in situ
631925|NCT00898508|stage I breast cancer|stage i breast cancer
631926|NCT00898508|stage II breast cancer|stage ii breast cancer
631927|NCT00898508|stage IIIA breast cancer|stage iiia breast cancer
631928|NCT00898508|stage IIIB breast cancer|stage iiib breast cancer
631929|NCT00898508|stage IIIC breast cancer|stage iiic breast cancer
631930|NCT00898508|stage IV breast cancer|stage iv breast cancer
631931|NCT00898495|adenocarcinoma of the esophagus|adenocarcinoma of the esophagus
631932|NCT00898495|stage II esophageal cancer|stage ii esophageal cancer
631933|NCT00898495|stage III esophageal cancer|stage iii esophageal cancer
631934|NCT00898495|stage IV esophageal cancer|stage iv esophageal cancer
631935|NCT00898495|stage I esophageal cancer|stage i esophageal cancer
631936|NCT00898482|adenocarcinoma of the pancreas|adenocarcinoma of the pancreas
631937|NCT00898482|recurrent pancreatic cancer|recurrent pancreatic cancer
631938|NCT00898482|stage I pancreatic cancer|stage i pancreatic cancer
631939|NCT00898482|stage II pancreatic cancer|stage ii pancreatic cancer
631940|NCT00898482|stage III pancreatic cancer|stage iii pancreatic cancer
631942|NCT00898469|childhood acute lymphoblastic leukemia|childhood acute lymphoblastic leukemia
631943|NCT00898456|adult acute myeloid leukemia|adult acute myeloid leukemia
631944|NCT00898456|adult acute myeloid leukemia with 11q23 (MLL) abnormalities|adult acute myeloid leukemia with 11q23 (mll) abnormalities
631945|NCT00898456|adult acute myeloid leukemia with inv(16)(p13;q22)|adult acute myeloid leukemia with inv(16)(p13;q22)
631946|NCT00898456|adult acute myeloid leukemia with t(16;16)(p13;q22)|adult acute myeloid leukemia with t(16;16)(p13;q22)
631947|NCT00898456|adult acute myeloid leukemia with t(8;21)(q22;q22)|adult acute myeloid leukemia with t(8;21)(q22;q22)
631948|NCT00898456|adult acute minimally differentiated myeloid leukemia (M0)|adult acute minimally differentiated myeloid leukemia (m0)
710993|NCT00586924|Moxetumomab pasudotox|moxetumomab pasudotox
631949|NCT00898456|adult acute myeloblastic leukemia without maturation (M1)|adult acute myeloblastic leukemia without maturation (m1)
631950|NCT00898456|adult acute myeloblastic leukemia with maturation (M2)|adult acute myeloblastic leukemia with maturation (m2)
631951|NCT00898456|adult acute myelomonocytic leukemia (M4)|adult acute myelomonocytic leukemia (m4)
632315|NCT00897819|stage III colon cancer|stage iii colon cancer
631952|NCT00898456|adult acute monoblastic leukemia (M5a)|adult acute monoblastic leukemia (m5a)
631953|NCT00898456|adult acute monocytic leukemia (M5b)|adult acute monocytic leukemia (m5b)
631954|NCT00898456|adult erythroleukemia (M6a)|adult erythroleukemia (m6a)
631955|NCT00898456|adult pure erythroid leukemia (M6b)|adult pure erythroid leukemia (m6b)
631956|NCT00898456|adult acute megakaryoblastic leukemia (M7)|adult acute megakaryoblastic leukemia (m7)
631957|NCT00898456|adult acute basophilic leukemia|adult acute basophilic leukemia
631958|NCT00898456|adult acute eosinophilic leukemia|adult acute eosinophilic leukemia
631959|NCT00898430|stage III squamous cell carcinoma of the hypopharynx|stage iii squamous cell carcinoma of the hypopharynx
631960|NCT00898430|stage IV squamous cell carcinoma of the hypopharynx|stage iv squamous cell carcinoma of the hypopharynx
631961|NCT00898430|stage III squamous cell carcinoma of the larynx|stage iii squamous cell carcinoma of the larynx
631962|NCT00898430|stage III verrucous carcinoma of the larynx|stage iii verrucous carcinoma of the larynx
631963|NCT00898430|stage IV squamous cell carcinoma of the larynx|stage iv squamous cell carcinoma of the larynx
631964|NCT00898430|stage IV verrucous carcinoma of the larynx|stage iv verrucous carcinoma of the larynx
631965|NCT00898430|stage III squamous cell carcinoma of the lip and oral cavity|stage iii squamous cell carcinoma of the lip and oral cavity
631966|NCT00898430|stage IV squamous cell carcinoma of the lip and oral cavity|stage iv squamous cell carcinoma of the lip and oral cavity
631967|NCT00898430|stage III verrucous carcinoma of the oral cavity|stage iii verrucous carcinoma of the oral cavity
631968|NCT00898430|stage IV verrucous carcinoma of the oral cavity|stage iv verrucous carcinoma of the oral cavity
631969|NCT00898430|metastatic squamous neck cancer with occult primary squamous cell carcinoma|metastatic squamous neck cancer with occult primary squamous cell carcinoma
631970|NCT00898430|untreated metastatic squamous neck cancer with occult primary|untreated metastatic squamous neck cancer with occult primary
631971|NCT00898430|stage III squamous cell carcinoma of the nasopharynx|stage iii squamous cell carcinoma of the nasopharynx
631972|NCT00898430|stage IV squamous cell carcinoma of the nasopharynx|stage iv squamous cell carcinoma of the nasopharynx
631973|NCT00898430|stage III squamous cell carcinoma of the oropharynx|stage iii squamous cell carcinoma of the oropharynx
631974|NCT00898430|stage IV squamous cell carcinoma of the oropharynx|stage iv squamous cell carcinoma of the oropharynx
631975|NCT00898430|stage III squamous cell carcinoma of the paranasal sinus and nasal cavity|stage iii squamous cell carcinoma of the paranasal sinus and nasal cavity
631976|NCT00898430|stage IV squamous cell carcinoma of the paranasal sinus and nasal cavity|stage iv squamous cell carcinoma of the paranasal sinus and nasal cavity
631977|NCT00898430|salivary gland squamous cell carcinoma|salivary gland squamous cell carcinoma
631978|NCT00898430|stage III salivary gland cancer|stage iii salivary gland cancer
631979|NCT00898430|stage IV salivary gland cancer|stage iv salivary gland cancer
631980|NCT00898417|stage IIIB non-small cell lung cancer|stage iiib non-small cell lung cancer
631981|NCT00898417|recurrent non-small cell lung cancer|recurrent non-small cell lung cancer
631982|NCT00898417|stage IV non-small cell lung cancer|stage iv non-small cell lung cancer
631983|NCT00898417|adenocarcinoma of the lung|adenocarcinoma of the lung
631984|NCT00898417|bronchoalveolar cell lung cancer|bronchoalveolar cell lung cancer
631985|NCT00898378|healthy, no evidence of disease|healthy, no evidence of disease
631986|NCT00898378|stage I colon cancer|stage i colon cancer
631987|NCT00898378|stage II colon cancer|stage ii colon cancer
631988|NCT00898378|stage III colon cancer|stage iii colon cancer
631989|NCT00898378|stage IV colon cancer|stage iv colon cancer
631990|NCT00898378|stage I rectal cancer|stage i rectal cancer
631991|NCT00898378|stage II rectal cancer|stage ii rectal cancer
631992|NCT00898378|stage III rectal cancer|stage iii rectal cancer
631993|NCT00898378|stage IV rectal cancer|stage iv rectal cancer
631994|NCT00898378|recurrent rectal cancer|recurrent rectal cancer
631995|NCT00898378|recurrent colon cancer|recurrent colon cancer
631996|NCT00898378|adenomatous polyp|adenomatous polyp
631997|NCT00898352|stage III vulvar cancer|stage iii vulvar cancer
631998|NCT00898352|squamous cell carcinoma of the vulva|squamous cell carcinoma of the vulva
631999|NCT00898326|stage I prostate cancer|stage i prostate cancer
632000|NCT00898326|stage IIB prostate cancer|stage iib prostate cancer
632001|NCT00898326|stage IIA prostate cancer|stage iia prostate cancer
632002|NCT00898313|lung cancer|lung cancer
632003|NCT00898300|stage I squamous cell carcinoma of the hypopharynx|stage i squamous cell carcinoma of the hypopharynx
632004|NCT00898300|stage II squamous cell carcinoma of the hypopharynx|stage ii squamous cell carcinoma of the hypopharynx
632005|NCT00898300|stage III squamous cell carcinoma of the hypopharynx|stage iii squamous cell carcinoma of the hypopharynx
632006|NCT00898300|stage IV squamous cell carcinoma of the hypopharynx|stage iv squamous cell carcinoma of the hypopharynx
632007|NCT00898300|stage I squamous cell carcinoma of the larynx|stage i squamous cell carcinoma of the larynx
632008|NCT00898300|stage II squamous cell carcinoma of the larynx|stage ii squamous cell carcinoma of the larynx
632009|NCT00898300|stage III squamous cell carcinoma of the larynx|stage iii squamous cell carcinoma of the larynx
712513|NCT00579904|almonds|almonds
632010|NCT00898300|stage IV squamous cell carcinoma of the larynx|stage iv squamous cell carcinoma of the larynx
632011|NCT00898300|stage I verrucous carcinoma of the larynx|stage i verrucous carcinoma of the larynx
632012|NCT00898300|stage II verrucous carcinoma of the larynx|stage ii verrucous carcinoma of the larynx
632013|NCT00898300|stage III verrucous carcinoma of the larynx|stage iii verrucous carcinoma of the larynx
632014|NCT00898300|stage IV verrucous carcinoma of the larynx|stage iv verrucous carcinoma of the larynx
632015|NCT00898300|stage I basal cell carcinoma of the lip|stage i basal cell carcinoma of the lip
632016|NCT00898300|stage II basal cell carcinoma of the lip|stage ii basal cell carcinoma of the lip
632017|NCT00898300|stage III basal cell carcinoma of the lip|stage iii basal cell carcinoma of the lip
632018|NCT00898300|stage IV basal cell carcinoma of the lip|stage iv basal cell carcinoma of the lip
632019|NCT00898300|stage I mucoepidermoid carcinoma of the oral cavity|stage i mucoepidermoid carcinoma of the oral cavity
632020|NCT00898300|stage II mucoepidermoid carcinoma of the oral cavity|stage ii mucoepidermoid carcinoma of the oral cavity
632021|NCT00898300|stage III mucoepidermoid carcinoma of the oral cavity|stage iii mucoepidermoid carcinoma of the oral cavity
632022|NCT00898300|stage IV mucoepidermoid carcinoma of the oral cavity|stage iv mucoepidermoid carcinoma of the oral cavity
632023|NCT00898300|stage I verrucous carcinoma of the oral cavity|stage i verrucous carcinoma of the oral cavity
632024|NCT00898300|stage II verrucous carcinoma of the oral cavity|stage ii verrucous carcinoma of the oral cavity
632025|NCT00898300|stage III verrucous carcinoma of the oral cavity|stage iii verrucous carcinoma of the oral cavity
632026|NCT00898300|stage IV verrucous carcinoma of the oral cavity|stage iv verrucous carcinoma of the oral cavity
632027|NCT00898300|stage I adenoid cystic carcinoma of the oral cavity|stage i adenoid cystic carcinoma of the oral cavity
632028|NCT00898300|stage II adenoid cystic carcinoma of the oral cavity|stage ii adenoid cystic carcinoma of the oral cavity
632029|NCT00898300|stage III adenoid cystic carcinoma of the oral cavity|stage iii adenoid cystic carcinoma of the oral cavity
632030|NCT00898300|stage IV adenoid cystic carcinoma of the oral cavity|stage iv adenoid cystic carcinoma of the oral cavity
632031|NCT00898300|stage I squamous cell carcinoma of the lip and oral cavity|stage i squamous cell carcinoma of the lip and oral cavity
632032|NCT00898300|stage II squamous cell carcinoma of the lip and oral cavity|stage ii squamous cell carcinoma of the lip and oral cavity
632033|NCT00898300|stage III squamous cell carcinoma of the lip and oral cavity|stage iii squamous cell carcinoma of the lip and oral cavity
632034|NCT00898300|stage IV squamous cell carcinoma of the lip and oral cavity|stage iv squamous cell carcinoma of the lip and oral cavity
632035|NCT00898300|metastatic squamous neck cancer with occult primary|metastatic squamous neck cancer with occult primary
632036|NCT00898300|stage I lymphoepithelioma of the nasopharynx|stage i lymphoepithelioma of the nasopharynx
632037|NCT00898300|stage II lymphoepithelioma of the nasopharynx|stage ii lymphoepithelioma of the nasopharynx
632038|NCT00898300|stage III lymphoepithelioma of the nasopharynx|stage iii lymphoepithelioma of the nasopharynx
632039|NCT00898300|stage IV lymphoepithelioma of the nasopharynx|stage iv lymphoepithelioma of the nasopharynx
632040|NCT00898300|stage I squamous cell carcinoma of the nasopharynx|stage i squamous cell carcinoma of the nasopharynx
632041|NCT00898300|stage II squamous cell carcinoma of the nasopharynx|stage ii squamous cell carcinoma of the nasopharynx
632042|NCT00898300|stage III squamous cell carcinoma of the nasopharynx|stage iii squamous cell carcinoma of the nasopharynx
632043|NCT00898300|stage IV squamous cell carcinoma of the nasopharynx|stage iv squamous cell carcinoma of the nasopharynx
632044|NCT00898300|stage I lymphoepithelioma of the oropharynx|stage i lymphoepithelioma of the oropharynx
632045|NCT00898300|stage II lymphoepithelioma of the oropharynx|stage ii lymphoepithelioma of the oropharynx
632046|NCT00898300|stage III lymphoepithelioma of the oropharynx|stage iii lymphoepithelioma of the oropharynx
632047|NCT00898300|stage IV lymphoepithelioma of the oropharynx|stage iv lymphoepithelioma of the oropharynx
632048|NCT00898300|stage I squamous cell carcinoma of the oropharynx|stage i squamous cell carcinoma of the oropharynx
632049|NCT00898300|stage II squamous cell carcinoma of the oropharynx|stage ii squamous cell carcinoma of the oropharynx
632050|NCT00898300|stage III squamous cell carcinoma of the oropharynx|stage iii squamous cell carcinoma of the oropharynx
632051|NCT00898300|stage IV squamous cell carcinoma of the oropharynx|stage iv squamous cell carcinoma of the oropharynx
632052|NCT00898300|stage I esthesioneuroblastoma of the paranasal sinus and nasal cavity|stage i esthesioneuroblastoma of the paranasal sinus and nasal cavity
632053|NCT00898300|stage II esthesioneuroblastoma of the paranasal sinus and nasal cavity|stage ii esthesioneuroblastoma of the paranasal sinus and nasal cavity
632054|NCT00898300|stage III esthesioneuroblastoma of the paranasal sinus and nasal cavity|stage iii esthesioneuroblastoma of the paranasal sinus and nasal cavity
632055|NCT00898300|stage IV esthesioneuroblastoma of the paranasal sinus and nasal cavity|stage iv esthesioneuroblastoma of the paranasal sinus and nasal cavity
632056|NCT00898300|stage I inverted papilloma of the paranasal sinus and nasal cavity|stage i inverted papilloma of the paranasal sinus and nasal cavity
632057|NCT00898300|stage II inverted papilloma of the paranasal sinus and nasal cavity|stage ii inverted papilloma of the paranasal sinus and nasal cavity
632058|NCT00898300|stage III inverted papilloma of the paranasal sinus and nasal cavity|stage iii inverted papilloma of the paranasal sinus and nasal cavity
632059|NCT00898300|stage IV inverted papilloma of the paranasal sinus and nasal cavity|stage iv inverted papilloma of the paranasal sinus and nasal cavity
632060|NCT00898300|stage I midline lethal granuloma of the paranasal sinus and nasal cavity|stage i midline lethal granuloma of the paranasal sinus and nasal cavity
632061|NCT00898300|stage II midline lethal granuloma of the paranasal sinus and nasal cavity|stage ii midline lethal granuloma of the paranasal sinus and nasal cavity
632062|NCT00898300|stage III midline lethal granuloma of the paranasal sinus and nasal cavity|stage iii midline lethal granuloma of the paranasal sinus and nasal cavity
632063|NCT00898300|stage IV midline lethal granuloma of the paranasal sinus and nasal cavity|stage iv midline lethal granuloma of the paranasal sinus and nasal cavity
632064|NCT00898300|stage I squamous cell carcinoma of the paranasal sinus and nasal cavity|stage i squamous cell carcinoma of the paranasal sinus and nasal cavity
632065|NCT00898300|stage II squamous cell carcinoma of the paranasal sinus and nasal cavity|stage ii squamous cell carcinoma of the paranasal sinus and nasal cavity
632066|NCT00898300|stage III squamous cell carcinoma of the paranasal sinus and nasal cavity|stage iii squamous cell carcinoma of the paranasal sinus and nasal cavity
632067|NCT00898300|stage IV squamous cell carcinoma of the paranasal sinus and nasal cavity|stage iv squamous cell carcinoma of the paranasal sinus and nasal cavity
632068|NCT00898300|stage I salivary gland cancer|stage i salivary gland cancer
632069|NCT00898300|stage II salivary gland cancer|stage ii salivary gland cancer
632070|NCT00898300|stage III salivary gland cancer|stage iii salivary gland cancer
632071|NCT00898300|stage IV salivary gland cancer|stage iv salivary gland cancer
632072|NCT00898300|recurrent squamous cell carcinoma of the hypopharynx|recurrent squamous cell carcinoma of the hypopharynx
632073|NCT00898300|recurrent squamous cell carcinoma of the larynx|recurrent squamous cell carcinoma of the larynx
632074|NCT00898300|recurrent squamous cell carcinoma of the lip and oral cavity|recurrent squamous cell carcinoma of the lip and oral cavity
632075|NCT00898300|recurrent squamous cell carcinoma of the nasopharynx|recurrent squamous cell carcinoma of the nasopharynx
632076|NCT00898300|recurrent squamous cell carcinoma of the oropharynx|recurrent squamous cell carcinoma of the oropharynx
632077|NCT00898300|recurrent squamous cell carcinoma of the paranasal sinus and nasal cavity|recurrent squamous cell carcinoma of the paranasal sinus and nasal cavity
632078|NCT00898300|recurrent adenoid cystic carcinoma of the oral cavity|recurrent adenoid cystic carcinoma of the oral cavity
632079|NCT00898300|recurrent basal cell carcinoma of the lip|recurrent basal cell carcinoma of the lip
632080|NCT00898300|recurrent esthesioneuroblastoma of the paranasal sinus and nasal cavity|recurrent esthesioneuroblastoma of the paranasal sinus and nasal cavity
632081|NCT00898300|recurrent inverted papilloma of the paranasal sinus and nasal cavity|recurrent inverted papilloma of the paranasal sinus and nasal cavity
632082|NCT00898300|recurrent lymphoepithelioma of the nasopharynx|recurrent lymphoepithelioma of the nasopharynx
632083|NCT00898300|recurrent lymphoepithelioma of the oropharynx|recurrent lymphoepithelioma of the oropharynx
632084|NCT00898300|recurrent midline lethal granuloma of the paranasal sinus and nasal cavity|recurrent midline lethal granuloma of the paranasal sinus and nasal cavity
632085|NCT00898300|recurrent mucoepidermoid carcinoma of the oral cavity|recurrent mucoepidermoid carcinoma of the oral cavity
632086|NCT00898300|recurrent salivary gland cancer|recurrent salivary gland cancer
632087|NCT00898300|recurrent verrucous carcinoma of the larynx|recurrent verrucous carcinoma of the larynx
632088|NCT00898300|recurrent verrucous carcinoma of the oral cavity|recurrent verrucous carcinoma of the oral cavity
632089|NCT00898300|recurrent metastatic squamous neck cancer with occult primary|recurrent metastatic squamous neck cancer with occult primary
632090|NCT00898287|Locally advanced or metastatic adenocarcinoma of pancreas|locally advanced or metastatic adenocarcinoma of pancreas
632091|NCT00898274|prostate cancer|prostate cancer
632092|NCT00898274|high grade prostatic intraepithelial neoplasia|high grade prostatic intraepithelial neoplasia
632093|NCT00898261|adult acute lymphoblastic leukemia in remission|adult acute lymphoblastic leukemia in remission
632094|NCT00898235|primary systemic amyloidosis|primary systemic amyloidosis
632095|NCT00898222|healthy volunteers|healthy volunteers
632096|NCT00898222|aspirin|aspirin
632097|NCT00898222|Normal healthy subjects|normal healthy subjects
632098|NCT00898209|stage I non-small cell lung cancer|stage i non-small cell lung cancer
632099|NCT00898209|stage II non-small cell lung cancer|stage ii non-small cell lung cancer
632100|NCT00898209|stage IIIA non-small cell lung cancer|stage iiia non-small cell lung cancer
632101|NCT00898209|stage IIIB non-small cell lung cancer|stage iiib non-small cell lung cancer
632102|NCT00898209|stage IV non-small cell lung cancer|stage iv non-small cell lung cancer
632103|NCT00898183|stage III melanoma|stage iii melanoma
632104|NCT00898183|stage IV melanoma|stage iv melanoma
632105|NCT00898183|recurrent melanoma|recurrent melanoma
632106|NCT00898170|myoma|myoma
632107|NCT00898170|hypertension|hypertension
632108|NCT00898170|erythropoetin|erythropoetin
632109|NCT00898170|blood pressure|blood pressure
632110|NCT00898170|erythropoetin level|erythropoetin level
632111|NCT00898157|contiguous stage II adult diffuse large cell lymphoma|contiguous stage ii adult diffuse large cell lymphoma
632112|NCT00898157|noncontiguous stage II adult diffuse large cell lymphoma|noncontiguous stage ii adult diffuse large cell lymphoma
632113|NCT00898157|recurrent adult diffuse large cell lymphoma|recurrent adult diffuse large cell lymphoma
632114|NCT00898157|stage I adult diffuse large cell lymphoma|stage i adult diffuse large cell lymphoma
632115|NCT00898157|stage III adult diffuse large cell lymphoma|stage iii adult diffuse large cell lymphoma
632116|NCT00898157|stage IV adult diffuse large cell lymphoma|stage iv adult diffuse large cell lymphoma
632117|NCT00898144|cervical cancer|cervical cancer
632118|NCT00898144|cervical intraepithelial neoplasia grade 2|cervical intraepithelial neoplasia grade 2
632119|NCT00898144|cervical intraepithelial neoplasia grade 3|cervical intraepithelial neoplasia grade 3
632120|NCT00898144|cervical adenocarcinoma|cervical adenocarcinoma
632121|NCT00898144|atypical squamous cells of undetermined significance|atypical squamous cells of undetermined significance
632122|NCT00898131|breast cancer|breast cancer
632123|NCT00898118|refractory cytopenia with multilineage dysplasia|refractory cytopenia with multilineage dysplasia
632124|NCT00898118|childhood myelodysplastic syndromes|childhood myelodysplastic syndromes
632125|NCT00898118|previously treated myelodysplastic syndromes|previously treated myelodysplastic syndromes
632126|NCT00898118|secondary myelodysplastic syndromes|secondary myelodysplastic syndromes
632127|NCT00898092|adult acute minimally differentiated myeloid leukemia (M0)|adult acute minimally differentiated myeloid leukemia (m0)
632316|NCT00897819|stage III rectal cancer|stage iii rectal cancer
632128|NCT00898092|adult acute myeloblastic leukemia without maturation (M1)|adult acute myeloblastic leukemia without maturation (m1)
632129|NCT00898092|adult acute myeloblastic leukemia with maturation (M2)|adult acute myeloblastic leukemia with maturation (m2)
632130|NCT00898092|adult acute myelomonocytic leukemia (M4)|adult acute myelomonocytic leukemia (m4)
632131|NCT00898092|adult acute monoblastic leukemia (M5a)|adult acute monoblastic leukemia (m5a)
632132|NCT00898092|adult acute monocytic leukemia (M5b)|adult acute monocytic leukemia (m5b)
632133|NCT00898092|adult erythroleukemia (M6a)|adult erythroleukemia (m6a)
632134|NCT00898092|adult pure erythroid leukemia (M6b)|adult pure erythroid leukemia (m6b)
632135|NCT00898092|adult acute megakaryoblastic leukemia (M7)|adult acute megakaryoblastic leukemia (m7)
632136|NCT00898092|adult acute eosinophilic leukemia|adult acute eosinophilic leukemia
632137|NCT00898092|adult acute basophilic leukemia|adult acute basophilic leukemia
632138|NCT00898092|untreated adult acute myeloid leukemia|untreated adult acute myeloid leukemia
632139|NCT00898066|Waldenstrom macroglobulinemia|waldenstrom macroglobulinemia
632140|NCT00898066|monoclonal gammopathy of undetermined significance|monoclonal gammopathy of undetermined significance
632141|NCT00898066|primary systemic amyloidosis|primary systemic amyloidosis
632142|NCT00898066|stage I multiple myeloma|stage i multiple myeloma
632143|NCT00898066|stage II multiple myeloma|stage ii multiple myeloma
632144|NCT00898066|stage III multiple myeloma|stage iii multiple myeloma
632145|NCT00898040|stage I multiple myeloma|stage i multiple myeloma
632146|NCT00898040|stage II multiple myeloma|stage ii multiple myeloma
632147|NCT00898040|stage III multiple myeloma|stage iii multiple myeloma
632148|NCT00898040|refractory multiple myeloma|refractory multiple myeloma
632149|NCT00898027|unspecified adult solid tumor, protocol specific|unspecified adult solid tumor, protocol specific
632150|NCT00898014|stage IV breast cancer|stage iv breast cancer
632151|NCT00897988|recurrent squamous cell carcinoma of the oropharynx|recurrent squamous cell carcinoma of the oropharynx
632152|NCT00897988|stage I squamous cell carcinoma of the oropharynx|stage i squamous cell carcinoma of the oropharynx
632153|NCT00897988|stage II squamous cell carcinoma of the oropharynx|stage ii squamous cell carcinoma of the oropharynx
632154|NCT00897988|stage III squamous cell carcinoma of the oropharynx|stage iii squamous cell carcinoma of the oropharynx
632155|NCT00897988|stage IV squamous cell carcinoma of the oropharynx|stage iv squamous cell carcinoma of the oropharynx
632156|NCT00897975|statin associated myalgias|statin associated myalgias
632157|NCT00897975|hyperlipidemia|hyperlipidemia
632158|NCT00897975|red yeast rice|red yeast rice
632159|NCT00897975|phytosterols|phytosterols
632160|NCT00897975|therapeutic lifestyle changes|therapeutic lifestyle changes
632161|NCT00897975|compliance|compliance
632162|NCT00897962|stage IV breast cancer|stage iv breast cancer
632163|NCT00897936|adult acute myeloid leukemia in remission|adult acute myeloid leukemia in remission
632164|NCT00897936|recurrent adult acute myeloid leukemia|recurrent adult acute myeloid leukemia
632165|NCT00897936|untreated adult acute myeloid leukemia|untreated adult acute myeloid leukemia
632166|NCT00897936|adult acute myeloid leukemia with 11q23 (MLL) abnormalities|adult acute myeloid leukemia with 11q23 (mll) abnormalities
632167|NCT00897936|adult acute myeloid leukemia with inv(16)(p13;q22)|adult acute myeloid leukemia with inv(16)(p13;q22)
632168|NCT00897936|adult acute myeloid leukemia with t(15;17)(q22;q12)|adult acute myeloid leukemia with t(15;17)(q22;q12)
632169|NCT00897936|adult acute myeloid leukemia with t(16;16)(p13;q22)|adult acute myeloid leukemia with t(16;16)(p13;q22)
632170|NCT00897936|adult acute myeloid leukemia with t(8;21)(q22;q22)|adult acute myeloid leukemia with t(8;21)(q22;q22)
632171|NCT00897923|AIDS-related peripheral/systemic lymphoma|aids-related peripheral/systemic lymphoma
632172|NCT00897923|AIDS-related primary CNS lymphoma|aids-related primary cns lymphoma
632173|NCT00897923|anaplastic large cell lymphoma|anaplastic large cell lymphoma
632174|NCT00897923|angioimmunoblastic T-cell lymphoma|angioimmunoblastic t-cell lymphoma
632175|NCT00897923|extranodal marginal zone B-cell lymphoma of mucosa-associated lymphoid tissue|extranodal marginal zone b-cell lymphoma of mucosa-associated lymphoid tissue
632176|NCT00897923|intraocular lymphoma|intraocular lymphoma
632177|NCT00897923|nodal marginal zone B-cell lymphoma|nodal marginal zone b-cell lymphoma
632178|NCT00897923|primary central nervous system non-Hodgkin lymphoma|primary central nervous system non-hodgkin lymphoma
632179|NCT00897923|recurrent adult Burkitt lymphoma|recurrent adult burkitt lymphoma
632180|NCT00897923|recurrent adult diffuse large cell lymphoma|recurrent adult diffuse large cell lymphoma
632181|NCT00897923|recurrent adult diffuse mixed cell lymphoma|recurrent adult diffuse mixed cell lymphoma
632182|NCT00897923|recurrent adult diffuse small cleaved cell lymphoma|recurrent adult diffuse small cleaved cell lymphoma
804818|NCT00235521|NO|no
632183|NCT00897923|recurrent adult immunoblastic large cell lymphoma|recurrent adult immunoblastic large cell lymphoma
632184|NCT00897923|recurrent adult lymphoblastic lymphoma|recurrent adult lymphoblastic lymphoma
632185|NCT00897923|recurrent adult T-cell leukemia/lymphoma|recurrent adult t-cell leukemia/lymphoma
632186|NCT00897923|recurrent cutaneous T-cell non-Hodgkin lymphoma|recurrent cutaneous t-cell non-hodgkin lymphoma
632187|NCT00897923|recurrent grade 1 follicular lymphoma|recurrent grade 1 follicular lymphoma
632188|NCT00897923|recurrent grade 2 follicular lymphoma|recurrent grade 2 follicular lymphoma
632189|NCT00897923|recurrent grade 3 follicular lymphoma|recurrent grade 3 follicular lymphoma
632190|NCT00897923|recurrent mantle cell lymphoma|recurrent mantle cell lymphoma
632191|NCT00897923|recurrent marginal zone lymphoma|recurrent marginal zone lymphoma
632192|NCT00897923|recurrent mycosis fungoides/Sezary syndrome|recurrent mycosis fungoides/sezary syndrome
632193|NCT00897923|recurrent small lymphocytic lymphoma|recurrent small lymphocytic lymphoma
632194|NCT00897923|small intestine lymphoma|small intestine lymphoma
632195|NCT00897923|splenic marginal zone lymphoma|splenic marginal zone lymphoma
632196|NCT00897923|stage III adult Burkitt lymphoma|stage iii adult burkitt lymphoma
632197|NCT00897923|stage III adult diffuse large cell lymphoma|stage iii adult diffuse large cell lymphoma
632198|NCT00897923|stage III adult diffuse mixed cell lymphoma|stage iii adult diffuse mixed cell lymphoma
632199|NCT00897923|stage III adult diffuse small cleaved cell lymphoma|stage iii adult diffuse small cleaved cell lymphoma
632200|NCT00897923|stage III adult immunoblastic large cell lymphoma|stage iii adult immunoblastic large cell lymphoma
632201|NCT00897923|stage III adult lymphoblastic lymphoma|stage iii adult lymphoblastic lymphoma
632202|NCT00897923|stage III adult T-cell leukemia/lymphoma|stage iii adult t-cell leukemia/lymphoma
632203|NCT00897923|stage III cutaneous T-cell non-Hodgkin lymphoma|stage iii cutaneous t-cell non-hodgkin lymphoma
632204|NCT00897923|stage III grade 1 follicular lymphoma|stage iii grade 1 follicular lymphoma
632205|NCT00897923|stage III grade 2 follicular lymphoma|stage iii grade 2 follicular lymphoma
632206|NCT00897923|stage III grade 3 follicular lymphoma|stage iii grade 3 follicular lymphoma
632207|NCT00897923|stage III mantle cell lymphoma|stage iii mantle cell lymphoma
632208|NCT00897923|stage III marginal zone lymphoma|stage iii marginal zone lymphoma
632209|NCT00897923|stage III mycosis fungoides/Sezary syndrome|stage iii mycosis fungoides/sezary syndrome
632210|NCT00897923|stage III small lymphocytic lymphoma|stage iii small lymphocytic lymphoma
632211|NCT00897923|stage IV adult Burkitt lymphoma|stage iv adult burkitt lymphoma
632212|NCT00897923|stage IV adult diffuse large cell lymphoma|stage iv adult diffuse large cell lymphoma
632213|NCT00897923|stage IV adult diffuse mixed cell lymphoma|stage iv adult diffuse mixed cell lymphoma
632214|NCT00897923|stage IV adult diffuse small cleaved cell lymphoma|stage iv adult diffuse small cleaved cell lymphoma
632215|NCT00897923|stage IV adult immunoblastic large cell lymphoma|stage iv adult immunoblastic large cell lymphoma
632216|NCT00897923|stage IV adult lymphoblastic lymphoma|stage iv adult lymphoblastic lymphoma
632217|NCT00897923|stage IV adult T-cell leukemia/lymphoma|stage iv adult t-cell leukemia/lymphoma
632218|NCT00897923|stage IV cutaneous T-cell non-Hodgkin lymphoma|stage iv cutaneous t-cell non-hodgkin lymphoma
632219|NCT00897923|stage IV grade 1 follicular lymphoma|stage iv grade 1 follicular lymphoma
632220|NCT00897923|stage IV grade 2 follicular lymphoma|stage iv grade 2 follicular lymphoma
632221|NCT00897923|stage IV grade 3 follicular lymphoma|stage iv grade 3 follicular lymphoma
632222|NCT00897923|stage IV mantle cell lymphoma|stage iv mantle cell lymphoma
632223|NCT00897923|stage IV marginal zone lymphoma|stage iv marginal zone lymphoma
632224|NCT00897923|stage IV mycosis fungoides/Sezary syndrome|stage iv mycosis fungoides/sezary syndrome
632225|NCT00897923|stage IV small lymphocytic lymphoma|stage iv small lymphocytic lymphoma
632226|NCT00897923|Waldenström macroglobulinemia|waldenström macroglobulinemia
632227|NCT00897923|stage I adult Burkitt lymphoma|stage i adult burkitt lymphoma
632228|NCT00897923|stage I adult diffuse large cell lymphoma|stage i adult diffuse large cell lymphoma
632229|NCT00897923|stage I adult diffuse mixed cell lymphoma|stage i adult diffuse mixed cell lymphoma
632230|NCT00897923|stage I adult diffuse small cleaved cell lymphoma|stage i adult diffuse small cleaved cell lymphoma
632231|NCT00897923|stage I adult immunoblastic large cell lymphoma|stage i adult immunoblastic large cell lymphoma
632232|NCT00897923|stage I adult lymphoblastic lymphoma|stage i adult lymphoblastic lymphoma
632233|NCT00897923|stage I adult T-cell leukemia/lymphoma|stage i adult t-cell leukemia/lymphoma
632234|NCT00897923|stage I cutaneous T-cell non-Hodgkin lymphoma|stage i cutaneous t-cell non-hodgkin lymphoma
632235|NCT00897923|stage I grade 1 follicular lymphoma|stage i grade 1 follicular lymphoma
632236|NCT00897923|stage I grade 2 follicular lymphoma|stage i grade 2 follicular lymphoma
632237|NCT00897923|stage I grade 3 follicular lymphoma|stage i grade 3 follicular lymphoma
632238|NCT00897923|stage I mantle cell lymphoma|stage i mantle cell lymphoma
632239|NCT00897923|stage I marginal zone lymphoma|stage i marginal zone lymphoma
632240|NCT00897923|stage I small lymphocytic lymphoma|stage i small lymphocytic lymphoma
632241|NCT00897923|stage II adult T-cell leukemia/lymphoma|stage ii adult t-cell leukemia/lymphoma
632242|NCT00897923|adult grade III lymphomatoid granulomatosis|adult grade iii lymphomatoid granulomatosis
632243|NCT00897923|adult nasal type extranodal NK/T-cell lymphoma|adult nasal type extranodal nk/t-cell lymphoma
632244|NCT00897923|recurrent adult grade III lymphomatoid granulomatosis|recurrent adult grade iii lymphomatoid granulomatosis
632245|NCT00897923|contiguous stage II adult Burkitt lymphoma|contiguous stage ii adult burkitt lymphoma
632246|NCT00897923|contiguous stage II adult diffuse large cell lymphoma|contiguous stage ii adult diffuse large cell lymphoma
632247|NCT00897923|contiguous stage II adult diffuse mixed cell lymphoma|contiguous stage ii adult diffuse mixed cell lymphoma
632248|NCT00897923|contiguous stage II adult diffuse small cleaved cell lymphoma|contiguous stage ii adult diffuse small cleaved cell lymphoma
632249|NCT00897923|contiguous stage II adult immunoblastic large cell lymphoma|contiguous stage ii adult immunoblastic large cell lymphoma
632250|NCT00897923|contiguous stage II adult lymphoblastic lymphoma|contiguous stage ii adult lymphoblastic lymphoma
632251|NCT00897923|contiguous stage II grade 1 follicular lymphoma|contiguous stage ii grade 1 follicular lymphoma
632252|NCT00897923|contiguous stage II grade 2 follicular lymphoma|contiguous stage ii grade 2 follicular lymphoma
632253|NCT00897923|contiguous stage II grade 3 follicular lymphoma|contiguous stage ii grade 3 follicular lymphoma
632254|NCT00897923|contiguous stage II mantle cell lymphoma|contiguous stage ii mantle cell lymphoma
632255|NCT00897923|contiguous stage II marginal zone lymphoma|contiguous stage ii marginal zone lymphoma
632256|NCT00897923|contiguous stage II small lymphocytic lymphoma|contiguous stage ii small lymphocytic lymphoma
632257|NCT00897923|noncontiguous stage II adult Burkitt lymphoma|noncontiguous stage ii adult burkitt lymphoma
632258|NCT00897923|noncontiguous stage II adult diffuse large cell lymphoma|noncontiguous stage ii adult diffuse large cell lymphoma
632259|NCT00897923|noncontiguous stage II adult diffuse mixed cell lymphoma|noncontiguous stage ii adult diffuse mixed cell lymphoma
632260|NCT00897923|noncontiguous stage II adult diffuse small cleaved cell lymphoma|noncontiguous stage ii adult diffuse small cleaved cell lymphoma
632261|NCT00897923|noncontiguous stage II adult immunoblastic large cell lymphoma|noncontiguous stage ii adult immunoblastic large cell lymphoma
632262|NCT00897923|noncontiguous stage II adult lymphoblastic lymphoma|noncontiguous stage ii adult lymphoblastic lymphoma
632263|NCT00897923|noncontiguous stage II grade 1 follicular lymphoma|noncontiguous stage ii grade 1 follicular lymphoma
632264|NCT00897923|noncontiguous stage II grade 2 follicular lymphoma|noncontiguous stage ii grade 2 follicular lymphoma
632265|NCT00897923|noncontiguous stage II grade 3 follicular lymphoma|noncontiguous stage ii grade 3 follicular lymphoma
632266|NCT00897923|noncontiguous stage II mantle cell lymphoma|noncontiguous stage ii mantle cell lymphoma
632267|NCT00897923|noncontiguous stage II marginal zone lymphoma|noncontiguous stage ii marginal zone lymphoma
632268|NCT00897923|noncontiguous stage II small lymphocytic lymphoma|noncontiguous stage ii small lymphocytic lymphoma
632269|NCT00897923|stage I mycosis fungoides/Sezary syndrome|stage i mycosis fungoides/sezary syndrome
632270|NCT00897923|stage II mycosis fungoides/Sezary syndrome|stage ii mycosis fungoides/sezary syndrome
632271|NCT00897923|stage II cutaneous T-cell non-Hodgkin lymphoma|stage ii cutaneous t-cell non-hodgkin lymphoma
632272|NCT00897910|stage I multiple myeloma|stage i multiple myeloma
632273|NCT00897910|stage II multiple myeloma|stage ii multiple myeloma
632274|NCT00897910|stage III multiple myeloma|stage iii multiple myeloma
632275|NCT00897910|refractory multiple myeloma|refractory multiple myeloma
632276|NCT00897897|Uterine Leiomyomas|uterine leiomyomas
632277|NCT00897897|Fibroids|fibroids
632278|NCT00897897|HIFU|hifu
632279|NCT00897897|Ablation|ablation
632280|NCT00897897|High Intensity Focused Ultrasound|high intensity focused ultrasound
632281|NCT00897884|breast cancer|breast cancer
632282|NCT00897884|metformin|metformin
632283|NCT00897884|breast surgery|breast surgery
632284|NCT00897871|unspecified childhood solid tumor, protocol specific|unspecified childhood solid tumor, protocol specific
632285|NCT00897858|childhood central nervous system germ cell tumor|childhood central nervous system germ cell tumor
632286|NCT00897858|childhood choroid plexus tumor|childhood choroid plexus tumor
632287|NCT00897858|childhood grade I meningioma|childhood grade i meningioma
632288|NCT00897858|childhood grade II meningioma|childhood grade ii meningioma
632289|NCT00897858|childhood grade III meningioma|childhood grade iii meningioma
632290|NCT00897858|childhood atypical teratoid/rhabdoid tumor|childhood atypical teratoid/rhabdoid tumor
632291|NCT00897858|untreated childhood visual pathway glioma|untreated childhood visual pathway glioma
632292|NCT00897858|childhood infratentorial ependymoma|childhood infratentorial ependymoma
632293|NCT00897858|childhood supratentorial ependymoma|childhood supratentorial ependymoma
632294|NCT00897858|newly diagnosed childhood ependymoma|newly diagnosed childhood ependymoma
632295|NCT00897858|childhood craniopharyngioma|childhood craniopharyngioma
632296|NCT00897858|untreated childhood medulloblastoma|untreated childhood medulloblastoma
632297|NCT00897858|untreated childhood cerebellar astrocytoma|untreated childhood cerebellar astrocytoma
632298|NCT00897858|untreated childhood supratentorial primitive neuroectodermal tumor|untreated childhood supratentorial primitive neuroectodermal tumor
632299|NCT00897858|untreated childhood brain stem glioma|untreated childhood brain stem glioma
632300|NCT00897858|untreated childhood visual pathway and hypothalamic glioma|untreated childhood visual pathway and hypothalamic glioma
632301|NCT00897858|childhood high-grade cerebral astrocytoma|childhood high-grade cerebral astrocytoma
632302|NCT00897858|childhood low-grade cerebral astrocytoma|childhood low-grade cerebral astrocytoma
632303|NCT00897858|childhood central nervous system choriocarcinoma|childhood central nervous system choriocarcinoma
632304|NCT00897858|childhood central nervous system embryonal tumor|childhood central nervous system embryonal tumor
632305|NCT00897858|childhood central nervous system germinoma|childhood central nervous system germinoma
632306|NCT00897858|childhood central nervous system mixed germ cell tumor|childhood central nervous system mixed germ cell tumor
632307|NCT00897858|childhood central nervous system teratoma|childhood central nervous system teratoma
632308|NCT00897858|childhood central nervous system yolk sac tumor|childhood central nervous system yolk sac tumor
632309|NCT00897845|stage II breast cancer|stage ii breast cancer
632310|NCT00897845|stage IIIA breast cancer|stage iiia breast cancer
632311|NCT00897845|stage IIIB breast cancer|stage iiib breast cancer
632312|NCT00897832|pancreatic cancer|pancreatic cancer
632313|NCT00897819|recurrent colon cancer|recurrent colon cancer
632314|NCT00897819|recurrent rectal cancer|recurrent rectal cancer
632319|NCT00897819|adenocarcinoma of the colon|adenocarcinoma of the colon
632320|NCT00897819|adenocarcinoma of the rectum|adenocarcinoma of the rectum
632321|NCT00897806|stage III ovarian epithelial cancer|stage iii ovarian epithelial cancer
632322|NCT00897806|stage IV ovarian epithelial cancer|stage iv ovarian epithelial cancer
632323|NCT00897806|peritoneal cavity cancer|peritoneal cavity cancer
632324|NCT00897793|recurrent squamous cell carcinoma of the hypopharynx|recurrent squamous cell carcinoma of the hypopharynx
632325|NCT00897793|stage I squamous cell carcinoma of the hypopharynx|stage i squamous cell carcinoma of the hypopharynx
632326|NCT00897793|stage II squamous cell carcinoma of the hypopharynx|stage ii squamous cell carcinoma of the hypopharynx
632327|NCT00897793|stage III squamous cell carcinoma of the hypopharynx|stage iii squamous cell carcinoma of the hypopharynx
632328|NCT00897793|stage IV squamous cell carcinoma of the hypopharynx|stage iv squamous cell carcinoma of the hypopharynx
632329|NCT00897793|recurrent squamous cell carcinoma of the larynx|recurrent squamous cell carcinoma of the larynx
632330|NCT00897793|recurrent verrucous carcinoma of the larynx|recurrent verrucous carcinoma of the larynx
632331|NCT00897793|stage I squamous cell carcinoma of the larynx|stage i squamous cell carcinoma of the larynx
632332|NCT00897793|stage I verrucous carcinoma of the larynx|stage i verrucous carcinoma of the larynx
632333|NCT00897793|stage II squamous cell carcinoma of the larynx|stage ii squamous cell carcinoma of the larynx
632334|NCT00897793|stage II verrucous carcinoma of the larynx|stage ii verrucous carcinoma of the larynx
632335|NCT00897793|stage III squamous cell carcinoma of the larynx|stage iii squamous cell carcinoma of the larynx
632336|NCT00897793|stage III verrucous carcinoma of the larynx|stage iii verrucous carcinoma of the larynx
632337|NCT00897793|stage IV squamous cell carcinoma of the larynx|stage iv squamous cell carcinoma of the larynx
632338|NCT00897793|stage IV verrucous carcinoma of the larynx|stage iv verrucous carcinoma of the larynx
632339|NCT00897793|recurrent adenoid cystic carcinoma of the oral cavity|recurrent adenoid cystic carcinoma of the oral cavity
632340|NCT00897793|recurrent mucoepidermoid carcinoma of the oral cavity|recurrent mucoepidermoid carcinoma of the oral cavity
632341|NCT00897793|recurrent verrucous carcinoma of the oral cavity|recurrent verrucous carcinoma of the oral cavity
632342|NCT00897793|stage I adenoid cystic carcinoma of the oral cavity|stage i adenoid cystic carcinoma of the oral cavity
632343|NCT00897793|stage I mucoepidermoid carcinoma of the oral cavity|stage i mucoepidermoid carcinoma of the oral cavity
632344|NCT00897793|stage I verrucous carcinoma of the oral cavity|stage i verrucous carcinoma of the oral cavity
632345|NCT00897793|stage II adenoid cystic carcinoma of the oral cavity|stage ii adenoid cystic carcinoma of the oral cavity
632346|NCT00897793|stage II mucoepidermoid carcinoma of the oral cavity|stage ii mucoepidermoid carcinoma of the oral cavity
632347|NCT00897793|stage II verrucous carcinoma of the oral cavity|stage ii verrucous carcinoma of the oral cavity
632348|NCT00897793|stage III adenoid cystic carcinoma of the oral cavity|stage iii adenoid cystic carcinoma of the oral cavity
632349|NCT00897793|stage III mucoepidermoid carcinoma of the oral cavity|stage iii mucoepidermoid carcinoma of the oral cavity
632350|NCT00897793|stage III verrucous carcinoma of the oral cavity|stage iii verrucous carcinoma of the oral cavity
632351|NCT00897793|stage IV adenoid cystic carcinoma of the oral cavity|stage iv adenoid cystic carcinoma of the oral cavity
632352|NCT00897793|stage IV mucoepidermoid carcinoma of the oral cavity|stage iv mucoepidermoid carcinoma of the oral cavity
632353|NCT00897793|stage IV verrucous carcinoma of the oral cavity|stage iv verrucous carcinoma of the oral cavity
632354|NCT00897793|stage I squamous cell carcinoma of the lip and oral cavity|stage i squamous cell carcinoma of the lip and oral cavity
632355|NCT00897793|stage II squamous cell carcinoma of the lip and oral cavity|stage ii squamous cell carcinoma of the lip and oral cavity
632356|NCT00897793|stage III squamous cell carcinoma of the lip and oral cavity|stage iii squamous cell carcinoma of the lip and oral cavity
632357|NCT00897793|stage IV squamous cell carcinoma of the lip and oral cavity|stage iv squamous cell carcinoma of the lip and oral cavity
632358|NCT00897793|recurrent basal cell carcinoma of the lip|recurrent basal cell carcinoma of the lip
632359|NCT00897793|recurrent squamous cell carcinoma of the lip and oral cavity|recurrent squamous cell carcinoma of the lip and oral cavity
632360|NCT00897793|stage I basal cell carcinoma of the lip|stage i basal cell carcinoma of the lip
632361|NCT00897793|stage II basal cell carcinoma of the lip|stage ii basal cell carcinoma of the lip
632362|NCT00897793|stage III basal cell carcinoma of the lip|stage iii basal cell carcinoma of the lip
632363|NCT00897793|stage IV basal cell carcinoma of the lip|stage iv basal cell carcinoma of the lip
632364|NCT00897793|metastatic squamous neck cancer with occult primary squamous cell carcinoma|metastatic squamous neck cancer with occult primary squamous cell carcinoma
632365|NCT00897793|recurrent metastatic squamous neck cancer with occult primary|recurrent metastatic squamous neck cancer with occult primary
710994|NCT00586911|Nonalcoholic Steatohepatitis|nonalcoholic steatohepatitis
632366|NCT00897793|untreated metastatic squamous neck cancer with occult primary|untreated metastatic squamous neck cancer with occult primary
632367|NCT00897793|recurrent lymphoepithelioma of the nasopharynx|recurrent lymphoepithelioma of the nasopharynx
632368|NCT00897793|recurrent squamous cell carcinoma of the nasopharynx|recurrent squamous cell carcinoma of the nasopharynx
632369|NCT00897793|stage I lymphoepithelioma of the nasopharynx|stage i lymphoepithelioma of the nasopharynx
632370|NCT00897793|stage I squamous cell carcinoma of the nasopharynx|stage i squamous cell carcinoma of the nasopharynx
632371|NCT00897793|stage II lymphoepithelioma of the nasopharynx|stage ii lymphoepithelioma of the nasopharynx
632372|NCT00897793|stage II squamous cell carcinoma of the nasopharynx|stage ii squamous cell carcinoma of the nasopharynx
633395|NCT00894777|Psoriasis|psoriasis
632373|NCT00897793|stage III lymphoepithelioma of the nasopharynx|stage iii lymphoepithelioma of the nasopharynx
632374|NCT00897793|stage III squamous cell carcinoma of the nasopharynx|stage iii squamous cell carcinoma of the nasopharynx
632375|NCT00897793|stage IV lymphoepithelioma of the nasopharynx|stage iv lymphoepithelioma of the nasopharynx
632376|NCT00897793|stage IV squamous cell carcinoma of the nasopharynx|stage iv squamous cell carcinoma of the nasopharynx
632377|NCT00897793|recurrent lymphoepithelioma of the oropharynx|recurrent lymphoepithelioma of the oropharynx
632378|NCT00897793|recurrent squamous cell carcinoma of the oropharynx|recurrent squamous cell carcinoma of the oropharynx
632379|NCT00897793|stage I lymphoepithelioma of the oropharynx|stage i lymphoepithelioma of the oropharynx
632380|NCT00897793|stage I squamous cell carcinoma of the oropharynx|stage i squamous cell carcinoma of the oropharynx
632381|NCT00897793|stage II lymphoepithelioma of the oropharynx|stage ii lymphoepithelioma of the oropharynx
632382|NCT00897793|stage II squamous cell carcinoma of the oropharynx|stage ii squamous cell carcinoma of the oropharynx
632383|NCT00897793|stage III lymphoepithelioma of the oropharynx|stage iii lymphoepithelioma of the oropharynx
632384|NCT00897793|stage III squamous cell carcinoma of the oropharynx|stage iii squamous cell carcinoma of the oropharynx
632385|NCT00897793|stage IV lymphoepithelioma of the oropharynx|stage iv lymphoepithelioma of the oropharynx
632386|NCT00897793|stage IV squamous cell carcinoma of the oropharynx|stage iv squamous cell carcinoma of the oropharynx
632387|NCT00897793|recurrent esthesioneuroblastoma of the paranasal sinus and nasal cavity|recurrent esthesioneuroblastoma of the paranasal sinus and nasal cavity
632388|NCT00897793|recurrent inverted papilloma of the paranasal sinus and nasal cavity|recurrent inverted papilloma of the paranasal sinus and nasal cavity
632389|NCT00897793|recurrent midline lethal granuloma of the paranasal sinus and nasal cavity|recurrent midline lethal granuloma of the paranasal sinus and nasal cavity
632390|NCT00897793|recurrent squamous cell carcinoma of the paranasal sinus and nasal cavity|recurrent squamous cell carcinoma of the paranasal sinus and nasal cavity
632391|NCT00897793|stage I esthesioneuroblastoma of the paranasal sinus and nasal cavity|stage i esthesioneuroblastoma of the paranasal sinus and nasal cavity
632392|NCT00897793|stage I inverted papilloma of the paranasal sinus and nasal cavity|stage i inverted papilloma of the paranasal sinus and nasal cavity
632393|NCT00897793|stage I midline lethal granuloma of the paranasal sinus and nasal cavity|stage i midline lethal granuloma of the paranasal sinus and nasal cavity
632394|NCT00897793|stage I squamous cell carcinoma of the paranasal sinus and nasal cavity|stage i squamous cell carcinoma of the paranasal sinus and nasal cavity
632395|NCT00897793|stage II esthesioneuroblastoma of the paranasal sinus and nasal cavity|stage ii esthesioneuroblastoma of the paranasal sinus and nasal cavity
632396|NCT00897793|stage II inverted papilloma of the paranasal sinus and nasal cavity|stage ii inverted papilloma of the paranasal sinus and nasal cavity
632397|NCT00897793|stage II midline lethal granuloma of the paranasal sinus and nasal cavity|stage ii midline lethal granuloma of the paranasal sinus and nasal cavity
632398|NCT00897793|stage II squamous cell carcinoma of the paranasal sinus and nasal cavity|stage ii squamous cell carcinoma of the paranasal sinus and nasal cavity
632399|NCT00897793|stage III esthesioneuroblastoma of the paranasal sinus and nasal cavity|stage iii esthesioneuroblastoma of the paranasal sinus and nasal cavity
633119|NCT00895713|liver transplantation|liver transplantation
632400|NCT00897793|stage III inverted papilloma of the paranasal sinus and nasal cavity|stage iii inverted papilloma of the paranasal sinus and nasal cavity
632401|NCT00897793|stage III midline lethal granuloma of the paranasal sinus and nasal cavity|stage iii midline lethal granuloma of the paranasal sinus and nasal cavity
632402|NCT00897793|stage III squamous cell carcinoma of the paranasal sinus and nasal cavity|stage iii squamous cell carcinoma of the paranasal sinus and nasal cavity
632403|NCT00897793|stage IV esthesioneuroblastoma of the paranasal sinus and nasal cavity|stage iv esthesioneuroblastoma of the paranasal sinus and nasal cavity
632404|NCT00897793|stage IV inverted papilloma of the paranasal sinus and nasal cavity|stage iv inverted papilloma of the paranasal sinus and nasal cavity
632405|NCT00897793|stage IV midline lethal granuloma of the paranasal sinus and nasal cavity|stage iv midline lethal granuloma of the paranasal sinus and nasal cavity
632406|NCT00897793|stage IV squamous cell carcinoma of the paranasal sinus and nasal cavity|stage iv squamous cell carcinoma of the paranasal sinus and nasal cavity
632407|NCT00897793|high-grade salivary gland mucoepidermoid carcinoma|high-grade salivary gland mucoepidermoid carcinoma
632408|NCT00897793|low-grade salivary gland mucoepidermoid carcinoma|low-grade salivary gland mucoepidermoid carcinoma
632409|NCT00897793|recurrent salivary gland cancer|recurrent salivary gland cancer
632410|NCT00897793|salivary gland acinic cell tumor|salivary gland acinic cell tumor
632411|NCT00897793|salivary gland adenocarcinoma|salivary gland adenocarcinoma
632412|NCT00897793|salivary gland adenoid cystic carcinoma|salivary gland adenoid cystic carcinoma
710995|NCT00586911|NASH|nash
632413|NCT00897793|salivary gland anaplastic carcinoma|salivary gland anaplastic carcinoma
632414|NCT00897793|salivary gland malignant mixed cell type tumor|salivary gland malignant mixed cell type tumor
632415|NCT00897793|salivary gland poorly differentiated carcinoma|salivary gland poorly differentiated carcinoma
632416|NCT00897793|salivary gland squamous cell carcinoma|salivary gland squamous cell carcinoma
632417|NCT00897793|stage I salivary gland cancer|stage i salivary gland cancer
632418|NCT00897793|stage II salivary gland cancer|stage ii salivary gland cancer
632419|NCT00897793|stage III salivary gland cancer|stage iii salivary gland cancer
632420|NCT00897793|stage IV salivary gland cancer|stage iv salivary gland cancer
632421|NCT00897793|limited stage small cell lung cancer|limited stage small cell lung cancer
632422|NCT00897793|recurrent non-small cell lung cancer|recurrent non-small cell lung cancer
632423|NCT00897793|recurrent small cell lung cancer|recurrent small cell lung cancer
632424|NCT00897793|stage I non-small cell lung cancer|stage i non-small cell lung cancer
633396|NCT00894764|Childhood|childhood
632425|NCT00897793|stage II non-small cell lung cancer|stage ii non-small cell lung cancer
632426|NCT00897793|stage IIIA non-small cell lung cancer|stage iiia non-small cell lung cancer
632427|NCT00897793|stage IIIB non-small cell lung cancer|stage iiib non-small cell lung cancer
632428|NCT00897793|stage IV non-small cell lung cancer|stage iv non-small cell lung cancer
632429|NCT00897793|extensive stage small cell lung cancer|extensive stage small cell lung cancer
632430|NCT00897793|male breast cancer|male breast cancer
632431|NCT00897793|recurrent breast cancer|recurrent breast cancer
632432|NCT00897793|stage I breast cancer|stage i breast cancer
632433|NCT00897793|stage II breast cancer|stage ii breast cancer
632434|NCT00897793|stage IIIA breast cancer|stage iiia breast cancer
632435|NCT00897793|stage IIIB breast cancer|stage iiib breast cancer
632436|NCT00897793|stage IIIC breast cancer|stage iiic breast cancer
632437|NCT00897793|stage IV breast cancer|stage iv breast cancer
632438|NCT00897793|recurrent colon cancer|recurrent colon cancer
632439|NCT00897793|stage I colon cancer|stage i colon cancer
632440|NCT00897793|stage II colon cancer|stage ii colon cancer
632441|NCT00897793|stage III colon cancer|stage iii colon cancer
632442|NCT00897793|stage IV colon cancer|stage iv colon cancer
632443|NCT00897793|recurrent rectal cancer|recurrent rectal cancer
632444|NCT00897793|stage I rectal cancer|stage i rectal cancer
632445|NCT00897793|stage II rectal cancer|stage ii rectal cancer
632446|NCT00897793|stage III rectal cancer|stage iii rectal cancer
632447|NCT00897793|stage IV rectal cancer|stage iv rectal cancer
632448|NCT00897793|recurrent prostate cancer|recurrent prostate cancer
632449|NCT00897793|stage I prostate cancer|stage i prostate cancer
632450|NCT00897793|stage II prostate cancer|stage ii prostate cancer
632451|NCT00897793|stage III prostate cancer|stage iii prostate cancer
632452|NCT00897793|stage IV prostate cancer|stage iv prostate cancer
632453|NCT00897780|Headache|headache
632454|NCT00897780|Pediatric|pediatric
632455|NCT00897780|Virtual Reality|virtual reality
632456|NCT00897780|Biofeedback|biofeedback
632457|NCT00897767|accelerated phase chronic myelogenous leukemia|accelerated phase chronic myelogenous leukemia
632458|NCT00897767|atypical chronic myeloid leukemia, BCR-ABL1 negative|atypical chronic myeloid leukemia, bcr-abl1 negative
632459|NCT00897767|blastic phase chronic myelogenous leukemia|blastic phase chronic myelogenous leukemia
632460|NCT00897767|childhood chronic myelogenous leukemia|childhood chronic myelogenous leukemia
632461|NCT00897767|chronic myelomonocytic leukemia|chronic myelomonocytic leukemia
632462|NCT00897767|chronic phase chronic myelogenous leukemia|chronic phase chronic myelogenous leukemia
632463|NCT00897767|juvenile myelomonocytic leukemia|juvenile myelomonocytic leukemia
632464|NCT00897767|meningeal chronic myelogenous leukemia|meningeal chronic myelogenous leukemia
632465|NCT00897767|progressive hairy cell leukemia, initial treatment|progressive hairy cell leukemia, initial treatment
632466|NCT00897767|recurrent adult acute lymphoblastic leukemia|recurrent adult acute lymphoblastic leukemia
632467|NCT00897767|recurrent adult acute myeloid leukemia|recurrent adult acute myeloid leukemia
632468|NCT00897767|recurrent adult T-cell leukemia/lymphoma|recurrent adult t-cell leukemia/lymphoma
632469|NCT00897767|recurrent childhood acute lymphoblastic leukemia|recurrent childhood acute lymphoblastic leukemia
632470|NCT00897767|recurrent childhood acute myeloid leukemia|recurrent childhood acute myeloid leukemia
632471|NCT00897767|refractory chronic lymphocytic leukemia|refractory chronic lymphocytic leukemia
632472|NCT00897767|refractory hairy cell leukemia|refractory hairy cell leukemia
632473|NCT00897767|relapsing chronic myelogenous leukemia|relapsing chronic myelogenous leukemia
632474|NCT00897767|stage I adult T-cell leukemia/lymphoma|stage i adult t-cell leukemia/lymphoma
632475|NCT00897767|stage I chronic lymphocytic leukemia|stage i chronic lymphocytic leukemia
632476|NCT00897767|stage II adult T-cell leukemia/lymphoma|stage ii adult t-cell leukemia/lymphoma
632477|NCT00897767|stage II chronic lymphocytic leukemia|stage ii chronic lymphocytic leukemia
632478|NCT00897767|stage III adult T-cell leukemia/lymphoma|stage iii adult t-cell leukemia/lymphoma
632479|NCT00897767|stage III chronic lymphocytic leukemia|stage iii chronic lymphocytic leukemia
632480|NCT00897767|stage IV adult T-cell leukemia/lymphoma|stage iv adult t-cell leukemia/lymphoma
632481|NCT00897767|stage IV chronic lymphocytic leukemia|stage iv chronic lymphocytic leukemia
632482|NCT00897767|untreated adult acute lymphoblastic leukemia|untreated adult acute lymphoblastic leukemia
632483|NCT00897767|untreated adult acute myeloid leukemia|untreated adult acute myeloid leukemia
632484|NCT00897767|untreated childhood acute lymphoblastic leukemia|untreated childhood acute lymphoblastic leukemia
632485|NCT00897767|untreated childhood acute myeloid leukemia and other myeloid malignancies|untreated childhood acute myeloid leukemia and other myeloid malignancies
632486|NCT00897767|T-cell large granular lymphocyte leukemia|t-cell large granular lymphocyte leukemia
632487|NCT00897767|adult acute myeloid leukemia in remission|adult acute myeloid leukemia in remission
632488|NCT00897767|adult acute myeloid leukemia with 11q23 (MLL) abnormalities|adult acute myeloid leukemia with 11q23 (mll) abnormalities
632489|NCT00897767|adult acute myeloid leukemia with inv(16)(p13;q22)|adult acute myeloid leukemia with inv(16)(p13;q22)
632490|NCT00897767|adult acute myeloid leukemia with t(15;17)(q22;q12)|adult acute myeloid leukemia with t(15;17)(q22;q12)
632491|NCT00897767|adult acute myeloid leukemia with t(16;16)(p13;q22)|adult acute myeloid leukemia with t(16;16)(p13;q22)
632492|NCT00897767|adult acute myeloid leukemia with t(8;21)(q22;q22)|adult acute myeloid leukemia with t(8;21)(q22;q22)
632493|NCT00897767|secondary acute myeloid leukemia|secondary acute myeloid leukemia
632494|NCT00897767|childhood acute myeloid leukemia in remission|childhood acute myeloid leukemia in remission
632495|NCT00897767|acute undifferentiated leukemia|acute undifferentiated leukemia
632497|NCT00897767|adult acute lymphoblastic leukemia in remission|adult acute lymphoblastic leukemia in remission
632498|NCT00897767|childhood acute lymphoblastic leukemia in remission|childhood acute lymphoblastic leukemia in remission
632499|NCT00897767|prolymphocytic leukemia|prolymphocytic leukemia
632500|NCT00897767|untreated hairy cell leukemia|untreated hairy cell leukemia
632501|NCT00897754|adenocarcinoma of the colon|adenocarcinoma of the colon
632502|NCT00897754|adenocarcinoma of the rectum|adenocarcinoma of the rectum
632503|NCT00897754|recurrent rectal cancer|recurrent rectal cancer
632504|NCT00897754|stage III rectal cancer|stage iii rectal cancer
632505|NCT00897754|stage IV rectal cancer|stage iv rectal cancer
632506|NCT00897754|recurrent colon cancer|recurrent colon cancer
632507|NCT00897754|stage III colon cancer|stage iii colon cancer
632508|NCT00897754|stage IV colon cancer|stage iv colon cancer
632509|NCT00897741|recurrent pancreatic cancer|recurrent pancreatic cancer
632510|NCT00897741|stage IV pancreatic cancer|stage iv pancreatic cancer
632511|NCT00897728|stage IA breast cancer|stage ia breast cancer
632512|NCT00897728|stage IB breast cancer|stage ib breast cancer
632513|NCT00897728|stage II breast cancer|stage ii breast cancer
632514|NCT00897728|stage IIIA breast cancer|stage iiia breast cancer
632515|NCT00897728|stage IIIB breast cancer|stage iiib breast cancer
632516|NCT00897728|stage IIIC breast cancer|stage iiic breast cancer
632517|NCT00897728|HER2-positive breast cancer|her2-positive breast cancer
632518|NCT00897728|triple-negative breast cancer|triple-negative breast cancer
632519|NCT00897728|estrogen receptor-negative breast cancer|estrogen receptor-negative breast cancer
632521|NCT00897715|inflammation|inflammation
632522|NCT00897715|CVD|cvd
632523|NCT00897702|recurrent breast cancer|recurrent breast cancer
632524|NCT00897702|male breast cancer|male breast cancer
632525|NCT00897702|stage IV breast cancer|stage iv breast cancer
632526|NCT00897676|Hyperinsulinism|hyperinsulinism
632527|NCT00897676|Hypoglycemia|hypoglycemia
632528|NCT00897676|KATP channel|katp channel
632529|NCT00897663|adult giant cell glioblastoma|adult giant cell glioblastoma
632530|NCT00897663|adult gliosarcoma|adult gliosarcoma
632531|NCT00897663|adult glioblastoma|adult glioblastoma
632532|NCT00897650|lung cancer|lung cancer
632533|NCT00897624|metastatic intraocular melanoma|metastatic intraocular melanoma
632534|NCT00897624|ciliary body and choroid melanoma, medium/large size|ciliary body and choroid melanoma, medium/large size
632535|NCT00897624|ciliary body and choroid melanoma, small size|ciliary body and choroid melanoma, small size
632536|NCT00897611|adult anaplastic astrocytoma|adult anaplastic astrocytoma
632537|NCT00897611|adult anaplastic oligodendroglioma|adult anaplastic oligodendroglioma
632538|NCT00897611|adult giant cell glioblastoma|adult giant cell glioblastoma
632539|NCT00897611|recurrent adult brain tumor|recurrent adult brain tumor
632540|NCT00897611|adult glioblastoma|adult glioblastoma
632541|NCT00897611|adult gliosarcoma|adult gliosarcoma
632542|NCT00897559|adult acute megakaryoblastic leukemia (M7)|adult acute megakaryoblastic leukemia (m7)
632543|NCT00897546|recurrent melanoma|recurrent melanoma
632544|NCT00897546|stage IV melanoma|stage iv melanoma
632545|NCT00897546|stage IA melanoma|stage ia melanoma
632546|NCT00897546|stage IB melanoma|stage ib melanoma
632547|NCT00897546|stage IIA melanoma|stage iia melanoma
632548|NCT00897546|stage IIB melanoma|stage iib melanoma
632549|NCT00897546|stage IIC melanoma|stage iic melanoma
632550|NCT00897546|stage IIIA melanoma|stage iiia melanoma
632551|NCT00897546|stage IIIB melanoma|stage iiib melanoma
632552|NCT00897546|stage IIIC melanoma|stage iiic melanoma
632553|NCT00897533|recurrent non-small cell lung cancer|recurrent non-small cell lung cancer
632554|NCT00897533|stage IIIB non-small cell lung cancer|stage iiib non-small cell lung cancer
632555|NCT00897533|stage IV non-small cell lung cancer|stage iv non-small cell lung cancer
632556|NCT00897533|adenocarcinoma of the lung|adenocarcinoma of the lung
632557|NCT00897533|squamous cell lung cancer|squamous cell lung cancer
632558|NCT00897533|bronchoalveolar cell lung cancer|bronchoalveolar cell lung cancer
632559|NCT00897520|stage II melanoma|stage ii melanoma
632560|NCT00897520|stage III melanoma|stage iii melanoma
632561|NCT00897520|stage IV melanoma|stage iv melanoma
632562|NCT00897507|childhood acute lymphoblastic leukemia in remission|childhood acute lymphoblastic leukemia in remission
632563|NCT00897507|recurrent childhood acute lymphoblastic leukemia|recurrent childhood acute lymphoblastic leukemia
632564|NCT00897494|stage I pancreatic cancer|stage i pancreatic cancer
632565|NCT00897494|stage II pancreatic cancer|stage ii pancreatic cancer
632566|NCT00897494|stage III pancreatic cancer|stage iii pancreatic cancer
632567|NCT00897494|stage IV pancreatic cancer|stage iv pancreatic cancer
632568|NCT00897481|stage IV melanoma|stage iv melanoma
632569|NCT00897481|recurrent melanoma|recurrent melanoma
632570|NCT00897481|stage IA melanoma|stage ia melanoma
632571|NCT00897481|stage IB melanoma|stage ib melanoma
632572|NCT00897481|stage IIA melanoma|stage iia melanoma
632573|NCT00897481|stage IIB melanoma|stage iib melanoma
632574|NCT00897481|stage IIC melanoma|stage iic melanoma
632575|NCT00897481|stage IIIA melanoma|stage iiia melanoma
632576|NCT00897481|stage IIIB melanoma|stage iiib melanoma
632577|NCT00897481|stage IIIC melanoma|stage iiic melanoma
632578|NCT00897468|breast cancer|breast cancer
632579|NCT00897455|breast cancer|breast cancer
632580|NCT00897455|BRCA1 mutation carrier|brca1 mutation carrier
632581|NCT00897455|BRCA2 mutation carrier|brca2 mutation carrier
632582|NCT00897429|stage IIA colon cancer|stage iia colon cancer
632583|NCT00897429|stage IIB colon cancer|stage iib colon cancer
632584|NCT00897429|stage IIC colon cancer|stage iic colon cancer
632585|NCT00897416|breast cancer|breast cancer
632586|NCT00897416|stage I breast cancer|stage i breast cancer
632587|NCT00897416|stage II breast cancer|stage ii breast cancer
632588|NCT00897416|stage IIIA breast cancer|stage iiia breast cancer
632589|NCT00897416|stage IIIB breast cancer|stage iiib breast cancer
632590|NCT00897416|stage IIIC breast cancer|stage iiic breast cancer
632591|NCT00897416|stage IV breast cancer|stage iv breast cancer
632592|NCT00897403|colon cancer|colon cancer
632593|NCT00897403|health status unknown|health status unknown
632594|NCT00897364|non-small cell lung cancer|non-small cell lung cancer
632595|NCT00897364|small cell lung cancer|small cell lung cancer
632596|NCT00897364|squamous lung dysplasia|squamous lung dysplasia
632597|NCT00897351|recurrent prostate cancer|recurrent prostate cancer
632598|NCT00897338|stage IV breast cancer|stage iv breast cancer
632599|NCT00897312|stage IV melanoma|stage iv melanoma
632600|NCT00897312|hepatitis C infection|hepatitis c infection
632601|NCT00897312|melanoma (skin)|melanoma (skin)
632602|NCT00897312|precancerous/nonmalignant condition|precancerous/nonmalignant condition
632603|NCT00897299|estrogen receptor|estrogen receptor
632605|NCT00897299|PgR|pgr
632606|NCT00897299|stage II breast cancer|stage ii breast cancer
632607|NCT00897299|stage IIIA breast cancer|stage iiia breast cancer
632608|NCT00897299|stage IIIB breast cancer|stage iiib breast cancer
632609|NCT00897286|childhood atypical teratoid/rhabdoid tumor|childhood atypical teratoid/rhabdoid tumor
632610|NCT00897286|childhood choroid plexus tumor|childhood choroid plexus tumor
632611|NCT00897286|childhood medulloblastoma|childhood medulloblastoma
632612|NCT00897286|recurrent childhood medulloblastoma|recurrent childhood medulloblastoma
632613|NCT00897286|childhood infratentorial ependymoma|childhood infratentorial ependymoma
632614|NCT00897286|childhood supratentorial ependymoma|childhood supratentorial ependymoma
632615|NCT00897286|recurrent childhood ependymoma|recurrent childhood ependymoma
632616|NCT00897286|recurrent childhood supratentorial primitive neuroectodermal tumor|recurrent childhood supratentorial primitive neuroectodermal tumor
632617|NCT00897286|untreated childhood supratentorial primitive neuroectodermal tumor|untreated childhood supratentorial primitive neuroectodermal tumor
632618|NCT00897286|gliomas|gliomas
632619|NCT00897273|recurrent squamous cell carcinoma of the oropharynx|recurrent squamous cell carcinoma of the oropharynx
632620|NCT00897273|oropharyngeal cancer|oropharyngeal cancer
632621|NCT00897273|oropharyngeal squamous cell carcinoma|oropharyngeal squamous cell carcinoma
632622|NCT00897273|infection|infection
632623|NCT00897273|precancerous condition|precancerous condition
632624|NCT00897273|human papilloma virus infection|human papilloma virus infection
632625|NCT00897260|Unrelated Umbilical Cord Blood Transplant|unrelated umbilical cord blood transplant
632626|NCT00897260|Multiple cord blood|multiple cord blood
632627|NCT00897247|malignant mesothelioma|malignant mesothelioma
632628|NCT00897247|pulmonary complications|pulmonary complications
632629|NCT00897234|recurrent non-small cell lung cancer|recurrent non-small cell lung cancer
632630|NCT00897234|stage I non-small cell lung cancer|stage i non-small cell lung cancer
632631|NCT00897234|stage II non-small cell lung cancer|stage ii non-small cell lung cancer
632632|NCT00897234|stage IIIA non-small cell lung cancer|stage iiia non-small cell lung cancer
632633|NCT00897234|stage IIIB non-small cell lung cancer|stage iiib non-small cell lung cancer
632634|NCT00897234|stage IV non-small cell lung cancer|stage iv non-small cell lung cancer
632635|NCT00897221|Friedreich's ataxia|friedreich's ataxia
632636|NCT00897208|breast cancer|breast cancer
632637|NCT00897208|ductal breast carcinoma in situ|ductal breast carcinoma in situ
632638|NCT00897208|breast cancer in situ|breast cancer in situ
632639|NCT00897208|stage IA breast cancer|stage ia breast cancer
632640|NCT00897208|stage IB breast cancer|stage ib breast cancer
632641|NCT00897208|stage II breast cancer|stage ii breast cancer
632642|NCT00897182|adult acute myeloid leukemia in remission|adult acute myeloid leukemia in remission
632643|NCT00897182|adult acute myeloid leukemia with inv(16)(p13;q22)|adult acute myeloid leukemia with inv(16)(p13;q22)
632644|NCT00897182|adult acute myeloid leukemia with t(15;17)(q22;q12)|adult acute myeloid leukemia with t(15;17)(q22;q12)
632645|NCT00897182|adult acute myeloid leukemia with t(8;21)(q22;q22)|adult acute myeloid leukemia with t(8;21)(q22;q22)
632646|NCT00897182|childhood acute myeloid leukemia in remission|childhood acute myeloid leukemia in remission
632647|NCT00897182|recurrent adult acute myeloid leukemia|recurrent adult acute myeloid leukemia
632648|NCT00897182|recurrent childhood acute myeloid leukemia|recurrent childhood acute myeloid leukemia
632649|NCT00897182|secondary acute myeloid leukemia|secondary acute myeloid leukemia
632650|NCT00897182|untreated adult acute myeloid leukemia|untreated adult acute myeloid leukemia
632651|NCT00897182|untreated childhood acute myeloid leukemia and other myeloid malignancies|untreated childhood acute myeloid leukemia and other myeloid malignancies
632652|NCT00897143|non-small cell lung cancer|non-small cell lung cancer
632653|NCT00897143|malignant pleural effusion|malignant pleural effusion
632654|NCT00897143|small cell lung cancer|small cell lung cancer
632655|NCT00897130|low-risk (IPSS 0-INT1) MDS according to WHO classification|low-risk (ipss 0-int1) mds according to who classification
632656|NCT00897117|stage I non-small cell lung cancer|stage i non-small cell lung cancer
632657|NCT00897117|stage II non-small cell lung cancer|stage ii non-small cell lung cancer
632658|NCT00897091|stage II breast cancer|stage ii breast cancer
632659|NCT00897091|stage IIIA breast cancer|stage iiia breast cancer
632660|NCT00897078|cancer survivor|cancer survivor
632661|NCT00897078|healthy, no evidence of disease|healthy, no evidence of disease
632662|NCT00897078|long-term effects secondary to cancer therapy in children|long-term effects secondary to cancer therapy in children
632663|NCT00897078|childhood acute lymphoblastic leukemia in remission|childhood acute lymphoblastic leukemia in remission
632664|NCT00897065|stage IA breast cancer|stage ia breast cancer
632665|NCT00897065|stage IB breast cancer|stage ib breast cancer
632666|NCT00897065|stage II breast cancer|stage ii breast cancer
632667|NCT00897065|stage IIIA breast cancer|stage iiia breast cancer
632668|NCT00897065|estrogen receptor-positive breast cancer|estrogen receptor-positive breast cancer
632669|NCT00897065|progesterone receptor-positive breast cancer|progesterone receptor-positive breast cancer
632670|NCT00897052|stage II squamous cell carcinoma of the lip and oral cavity|stage ii squamous cell carcinoma of the lip and oral cavity
632671|NCT00897052|stage III squamous cell carcinoma of the lip and oral cavity|stage iii squamous cell carcinoma of the lip and oral cavity
632672|NCT00897052|stage IV squamous cell carcinoma of the lip and oral cavity|stage iv squamous cell carcinoma of the lip and oral cavity
632673|NCT00897052|stage II squamous cell carcinoma of the oropharynx|stage ii squamous cell carcinoma of the oropharynx
632674|NCT00897052|stage III squamous cell carcinoma of the oropharynx|stage iii squamous cell carcinoma of the oropharynx
632675|NCT00897052|stage IV squamous cell carcinoma of the oropharynx|stage iv squamous cell carcinoma of the oropharynx
632676|NCT00897052|stage II squamous cell carcinoma of the hypopharynx|stage ii squamous cell carcinoma of the hypopharynx
632677|NCT00897052|stage III squamous cell carcinoma of the hypopharynx|stage iii squamous cell carcinoma of the hypopharynx
632678|NCT00897052|stage IV squamous cell carcinoma of the hypopharynx|stage iv squamous cell carcinoma of the hypopharynx
632679|NCT00897052|stage II squamous cell carcinoma of the larynx|stage ii squamous cell carcinoma of the larynx
632680|NCT00897052|stage III squamous cell carcinoma of the larynx|stage iii squamous cell carcinoma of the larynx
632681|NCT00897052|stage IV squamous cell carcinoma of the larynx|stage iv squamous cell carcinoma of the larynx
632682|NCT00897039|ovarian serous cystadenocarcinoma|ovarian serous cystadenocarcinoma
632683|NCT00897039|ovarian undifferentiated adenocarcinoma|ovarian undifferentiated adenocarcinoma
632684|NCT00897039|recurrent ovarian epithelial cancer|recurrent ovarian epithelial cancer
632685|NCT00897039|ovarian clear cell cystadenocarcinoma|ovarian clear cell cystadenocarcinoma
632686|NCT00897039|ovarian endometrioid adenocarcinoma|ovarian endometrioid adenocarcinoma
632687|NCT00897039|ovarian mucinous cystadenocarcinoma|ovarian mucinous cystadenocarcinoma
632688|NCT00897039|stage IA ovarian epithelial cancer|stage ia ovarian epithelial cancer
632689|NCT00897039|stage IB ovarian epithelial cancer|stage ib ovarian epithelial cancer
632690|NCT00897039|stage IC ovarian epithelial cancer|stage ic ovarian epithelial cancer
632691|NCT00897039|stage IIA ovarian epithelial cancer|stage iia ovarian epithelial cancer
632692|NCT00897039|stage IIB ovarian epithelial cancer|stage iib ovarian epithelial cancer
632693|NCT00897039|stage IIC ovarian epithelial cancer|stage iic ovarian epithelial cancer
632694|NCT00897039|stage IIIA ovarian epithelial cancer|stage iiia ovarian epithelial cancer
632695|NCT00897039|stage IIIB ovarian epithelial cancer|stage iiib ovarian epithelial cancer
632696|NCT00897039|stage IIIC ovarian epithelial cancer|stage iiic ovarian epithelial cancer
632697|NCT00897039|recurrent primary peritoneal cavity cancer|recurrent primary peritoneal cavity cancer
632698|NCT00897039|stage IA primary peritoneal cavity cancer|stage ia primary peritoneal cavity cancer
632699|NCT00897039|stage IB primary peritoneal cavity cancer|stage ib primary peritoneal cavity cancer
632700|NCT00897039|stage IC primary peritoneal cavity cancer|stage ic primary peritoneal cavity cancer
632701|NCT00897039|stage IIA primary peritoneal cavity cancer|stage iia primary peritoneal cavity cancer
710996|NCT00586911|Betaine|betaine
632702|NCT00897039|stage IIB primary peritoneal cavity cancer|stage iib primary peritoneal cavity cancer
632703|NCT00897039|stage IIC primary peritoneal cavity cancer|stage iic primary peritoneal cavity cancer
632704|NCT00897039|stage IIIA primary peritoneal cavity cancer|stage iiia primary peritoneal cavity cancer
633120|NCT00895713|Protective levels|protective levels
632705|NCT00897039|stage IIIB primary peritoneal cavity cancer|stage iiib primary peritoneal cavity cancer
632706|NCT00897039|stage IIIC primary peritoneal cavity cancer|stage iiic primary peritoneal cavity cancer
632707|NCT00897039|recurrent fallopian tube cancer|recurrent fallopian tube cancer
632708|NCT00897039|stage IA fallopian tube cancer|stage ia fallopian tube cancer
632709|NCT00897039|stage IB fallopian tube cancer|stage ib fallopian tube cancer
632710|NCT00897039|stage IC fallopian tube cancer|stage ic fallopian tube cancer
632711|NCT00897039|stage IIA fallopian tube cancer|stage iia fallopian tube cancer
632712|NCT00897039|stage IIB fallopian tube cancer|stage iib fallopian tube cancer
632713|NCT00897039|stage IIC fallopian tube cancer|stage iic fallopian tube cancer
632714|NCT00897039|stage IIIA fallopian tube cancer|stage iiia fallopian tube cancer
632715|NCT00897039|stage IIIB fallopian tube cancer|stage iiib fallopian tube cancer
632716|NCT00897039|stage IIIC fallopian tube cancer|stage iiic fallopian tube cancer
632717|NCT00897026|stage II breast cancer|stage ii breast cancer
632718|NCT00897026|stage IIIA breast cancer|stage iiia breast cancer
632719|NCT00896987|Epilepsy|epilepsy
632720|NCT00896987|lamotrigine|lamotrigine
632721|NCT00896987|cognitive function|cognitive function
632722|NCT00896948|head and neck cancer|head and neck cancer
632723|NCT00896935|cancer|cancer
632724|NCT00896922|contiguous stage II grade 1 follicular lymphoma|contiguous stage ii grade 1 follicular lymphoma
632725|NCT00896922|contiguous stage II grade 2 follicular lymphoma|contiguous stage ii grade 2 follicular lymphoma
632726|NCT00896922|contiguous stage II grade 3 follicular lymphoma|contiguous stage ii grade 3 follicular lymphoma
632727|NCT00896922|noncontiguous stage II grade 1 follicular lymphoma|noncontiguous stage ii grade 1 follicular lymphoma
632728|NCT00896922|noncontiguous stage II grade 2 follicular lymphoma|noncontiguous stage ii grade 2 follicular lymphoma
632729|NCT00896922|noncontiguous stage II grade 3 follicular lymphoma|noncontiguous stage ii grade 3 follicular lymphoma
632730|NCT00896922|stage III grade 1 follicular lymphoma|stage iii grade 1 follicular lymphoma
632731|NCT00896922|stage III grade 2 follicular lymphoma|stage iii grade 2 follicular lymphoma
632732|NCT00896922|stage III grade 3 follicular lymphoma|stage iii grade 3 follicular lymphoma
632733|NCT00896922|stage IV grade 1 follicular lymphoma|stage iv grade 1 follicular lymphoma
632734|NCT00896922|stage IV grade 2 follicular lymphoma|stage iv grade 2 follicular lymphoma
632735|NCT00896922|stage IV grade 3 follicular lymphoma|stage iv grade 3 follicular lymphoma
632736|NCT00896909|recurrent non-small cell lung cancer|recurrent non-small cell lung cancer
632737|NCT00896909|stage IIIB non-small cell lung cancer|stage iiib non-small cell lung cancer
632738|NCT00896909|stage IV non-small cell lung cancer|stage iv non-small cell lung cancer
632739|NCT00896896|stage I squamous cell carcinoma of the hypopharynx|stage i squamous cell carcinoma of the hypopharynx
632740|NCT00896896|stage II squamous cell carcinoma of the hypopharynx|stage ii squamous cell carcinoma of the hypopharynx
632741|NCT00896896|stage III squamous cell carcinoma of the hypopharynx|stage iii squamous cell carcinoma of the hypopharynx
632742|NCT00896896|stage IV squamous cell carcinoma of the hypopharynx|stage iv squamous cell carcinoma of the hypopharynx
632743|NCT00896896|recurrent squamous cell carcinoma of the hypopharynx|recurrent squamous cell carcinoma of the hypopharynx
632744|NCT00896896|stage I squamous cell carcinoma of the larynx|stage i squamous cell carcinoma of the larynx
632745|NCT00896896|stage I verrucous carcinoma of the larynx|stage i verrucous carcinoma of the larynx
632746|NCT00896896|stage II squamous cell carcinoma of the larynx|stage ii squamous cell carcinoma of the larynx
632747|NCT00896896|stage II verrucous carcinoma of the larynx|stage ii verrucous carcinoma of the larynx
632748|NCT00896896|stage III squamous cell carcinoma of the larynx|stage iii squamous cell carcinoma of the larynx
632749|NCT00896896|stage III verrucous carcinoma of the larynx|stage iii verrucous carcinoma of the larynx
632750|NCT00896896|stage IV squamous cell carcinoma of the larynx|stage iv squamous cell carcinoma of the larynx
632751|NCT00896896|stage IV verrucous carcinoma of the larynx|stage iv verrucous carcinoma of the larynx
632752|NCT00896896|recurrent squamous cell carcinoma of the larynx|recurrent squamous cell carcinoma of the larynx
632753|NCT00896896|recurrent verrucous carcinoma of the larynx|recurrent verrucous carcinoma of the larynx
632754|NCT00896896|stage I adenoid cystic carcinoma of the oral cavity|stage i adenoid cystic carcinoma of the oral cavity
632755|NCT00896896|stage I basal cell carcinoma of the lip|stage i basal cell carcinoma of the lip
632756|NCT00896896|stage I mucoepidermoid carcinoma of the oral cavity|stage i mucoepidermoid carcinoma of the oral cavity
632757|NCT00896896|stage I squamous cell carcinoma of the lip and oral cavity|stage i squamous cell carcinoma of the lip and oral cavity
632758|NCT00896896|stage I verrucous carcinoma of the oral cavity|stage i verrucous carcinoma of the oral cavity
632759|NCT00896896|stage II adenoid cystic carcinoma of the oral cavity|stage ii adenoid cystic carcinoma of the oral cavity
632760|NCT00896896|stage II basal cell carcinoma of the lip|stage ii basal cell carcinoma of the lip
632761|NCT00896896|stage II mucoepidermoid carcinoma of the oral cavity|stage ii mucoepidermoid carcinoma of the oral cavity
632762|NCT00896896|stage II squamous cell carcinoma of the lip and oral cavity|stage ii squamous cell carcinoma of the lip and oral cavity
710997|NCT00586898|Prostate|prostate
632763|NCT00896896|stage II verrucous carcinoma of the oral cavity|stage ii verrucous carcinoma of the oral cavity
632764|NCT00896896|stage III adenoid cystic carcinoma of the oral cavity|stage iii adenoid cystic carcinoma of the oral cavity
632765|NCT00896896|stage III basal cell carcinoma of the lip|stage iii basal cell carcinoma of the lip
632766|NCT00896896|stage III mucoepidermoid carcinoma of the oral cavity|stage iii mucoepidermoid carcinoma of the oral cavity
632767|NCT00896896|stage III squamous cell carcinoma of the lip and oral cavity|stage iii squamous cell carcinoma of the lip and oral cavity
632768|NCT00896896|stage III verrucous carcinoma of the oral cavity|stage iii verrucous carcinoma of the oral cavity
632769|NCT00896896|stage IV adenoid cystic carcinoma of the oral cavity|stage iv adenoid cystic carcinoma of the oral cavity
632770|NCT00896896|stage IV basal cell carcinoma of the lip|stage iv basal cell carcinoma of the lip
632771|NCT00896896|stage IV mucoepidermoid carcinoma of the oral cavity|stage iv mucoepidermoid carcinoma of the oral cavity
632772|NCT00896896|stage IV squamous cell carcinoma of the lip and oral cavity|stage iv squamous cell carcinoma of the lip and oral cavity
632773|NCT00896896|stage IV verrucous carcinoma of the oral cavity|stage iv verrucous carcinoma of the oral cavity
632774|NCT00896896|recurrent adenoid cystic carcinoma of the oral cavity|recurrent adenoid cystic carcinoma of the oral cavity
632775|NCT00896896|recurrent basal cell carcinoma of the lip|recurrent basal cell carcinoma of the lip
632776|NCT00896896|recurrent mucoepidermoid carcinoma of the oral cavity|recurrent mucoepidermoid carcinoma of the oral cavity
632777|NCT00896896|recurrent squamous cell carcinoma of the lip and oral cavity|recurrent squamous cell carcinoma of the lip and oral cavity
632778|NCT00896896|recurrent verrucous carcinoma of the oral cavity|recurrent verrucous carcinoma of the oral cavity
632779|NCT00896896|metastatic squamous neck cancer with occult primary squamous cell carcinoma|metastatic squamous neck cancer with occult primary squamous cell carcinoma
632835|NCT00896857|breast cancer|breast cancer
632780|NCT00896896|recurrent metastatic squamous neck cancer with occult primary|recurrent metastatic squamous neck cancer with occult primary
632781|NCT00896896|stage I lymphoepithelioma of the nasopharynx|stage i lymphoepithelioma of the nasopharynx
632782|NCT00896896|stage I squamous cell carcinoma of the nasopharynx|stage i squamous cell carcinoma of the nasopharynx
632783|NCT00896896|stage II lymphoepithelioma of the nasopharynx|stage ii lymphoepithelioma of the nasopharynx
632784|NCT00896896|stage II squamous cell carcinoma of the nasopharynx|stage ii squamous cell carcinoma of the nasopharynx
632785|NCT00896896|stage III lymphoepithelioma of the nasopharynx|stage iii lymphoepithelioma of the nasopharynx
632786|NCT00896896|stage III squamous cell carcinoma of the nasopharynx|stage iii squamous cell carcinoma of the nasopharynx
632787|NCT00896896|stage IV lymphoepithelioma of the nasopharynx|stage iv lymphoepithelioma of the nasopharynx
632788|NCT00896896|stage IV squamous cell carcinoma of the nasopharynx|stage iv squamous cell carcinoma of the nasopharynx
632789|NCT00896896|recurrent lymphoepithelioma of the nasopharynx|recurrent lymphoepithelioma of the nasopharynx
632790|NCT00896896|recurrent squamous cell carcinoma of the nasopharynx|recurrent squamous cell carcinoma of the nasopharynx
632791|NCT00896896|stage I lymphoepithelioma of the oropharynx|stage i lymphoepithelioma of the oropharynx
632792|NCT00896896|stage I squamous cell carcinoma of the oropharynx|stage i squamous cell carcinoma of the oropharynx
632793|NCT00896896|stage II lymphoepithelioma of the oropharynx|stage ii lymphoepithelioma of the oropharynx
632794|NCT00896896|stage II squamous cell carcinoma of the oropharynx|stage ii squamous cell carcinoma of the oropharynx
632795|NCT00896896|stage III lymphoepithelioma of the oropharynx|stage iii lymphoepithelioma of the oropharynx
632796|NCT00896896|stage III squamous cell carcinoma of the oropharynx|stage iii squamous cell carcinoma of the oropharynx
632797|NCT00896896|stage IV lymphoepithelioma of the oropharynx|stage iv lymphoepithelioma of the oropharynx
632798|NCT00896896|stage IV squamous cell carcinoma of the oropharynx|stage iv squamous cell carcinoma of the oropharynx
632799|NCT00896896|recurrent lymphoepithelioma of the oropharynx|recurrent lymphoepithelioma of the oropharynx
632800|NCT00896896|stage I esthesioneuroblastoma of the paranasal sinus and nasal cavity|stage i esthesioneuroblastoma of the paranasal sinus and nasal cavity
632801|NCT00896896|stage I inverted papilloma of the paranasal sinus and nasal cavity|stage i inverted papilloma of the paranasal sinus and nasal cavity
632802|NCT00896896|stage I midline lethal granuloma of the paranasal sinus and nasal cavity|stage i midline lethal granuloma of the paranasal sinus and nasal cavity
632803|NCT00896896|stage I squamous cell carcinoma of the paranasal sinus and nasal cavity|stage i squamous cell carcinoma of the paranasal sinus and nasal cavity
632804|NCT00896896|stage II esthesioneuroblastoma of the paranasal sinus and nasal cavity|stage ii esthesioneuroblastoma of the paranasal sinus and nasal cavity
632805|NCT00896896|stage II inverted papilloma of the paranasal sinus and nasal cavity|stage ii inverted papilloma of the paranasal sinus and nasal cavity
632806|NCT00896896|stage II midline lethal granuloma of the paranasal sinus and nasal cavity|stage ii midline lethal granuloma of the paranasal sinus and nasal cavity
632807|NCT00896896|stage II squamous cell carcinoma of the paranasal sinus and nasal cavity|stage ii squamous cell carcinoma of the paranasal sinus and nasal cavity
632808|NCT00896896|stage III esthesioneuroblastoma of the paranasal sinus and nasal cavity|stage iii esthesioneuroblastoma of the paranasal sinus and nasal cavity
632809|NCT00896896|stage III inverted papilloma of the paranasal sinus and nasal cavity|stage iii inverted papilloma of the paranasal sinus and nasal cavity
632810|NCT00896896|stage III midline lethal granuloma of the paranasal sinus and nasal cavity|stage iii midline lethal granuloma of the paranasal sinus and nasal cavity
710282|NCT00589563|contiguous stage II grade 3 follicular lymphoma|contiguous stage ii grade 3 follicular lymphoma
632811|NCT00896896|stage III squamous cell carcinoma of the paranasal sinus and nasal cavity|stage iii squamous cell carcinoma of the paranasal sinus and nasal cavity
632812|NCT00896896|stage IV esthesioneuroblastoma of the paranasal sinus and nasal cavity|stage iv esthesioneuroblastoma of the paranasal sinus and nasal cavity
632813|NCT00896896|stage IV inverted papilloma of the paranasal sinus and nasal cavity|stage iv inverted papilloma of the paranasal sinus and nasal cavity
632814|NCT00896896|stage IV midline lethal granuloma of the paranasal sinus and nasal cavity|stage iv midline lethal granuloma of the paranasal sinus and nasal cavity
632815|NCT00896896|stage IV squamous cell carcinoma of the paranasal sinus and nasal cavity|stage iv squamous cell carcinoma of the paranasal sinus and nasal cavity
632816|NCT00896896|recurrent esthesioneuroblastoma of the paranasal sinus and nasal cavity|recurrent esthesioneuroblastoma of the paranasal sinus and nasal cavity
632817|NCT00896896|recurrent inverted papilloma of the paranasal sinus and nasal cavity|recurrent inverted papilloma of the paranasal sinus and nasal cavity
632818|NCT00896896|recurrent midline lethal granuloma of the paranasal sinus and nasal cavity|recurrent midline lethal granuloma of the paranasal sinus and nasal cavity
632819|NCT00896896|recurrent squamous cell carcinoma of the paranasal sinus and nasal cavity|recurrent squamous cell carcinoma of the paranasal sinus and nasal cavity
632820|NCT00896896|stage I salivary gland cancer|stage i salivary gland cancer
632821|NCT00896896|stage II salivary gland cancer|stage ii salivary gland cancer
632822|NCT00896896|stage III salivary gland cancer|stage iii salivary gland cancer
632823|NCT00896896|stage IV salivary gland cancer|stage iv salivary gland cancer
632824|NCT00896896|recurrent salivary gland cancer|recurrent salivary gland cancer
632825|NCT00896896|recurrent squamous cell carcinoma of the oropharynx|recurrent squamous cell carcinoma of the oropharynx
632826|NCT00896896|recurrent colon cancer|recurrent colon cancer
632827|NCT00896896|stage IV colon cancer|stage iv colon cancer
632828|NCT00896896|recurrent rectal cancer|recurrent rectal cancer
632829|NCT00896896|stage IV rectal cancer|stage iv rectal cancer
632830|NCT00896896|adenocarcinoma of the colon|adenocarcinoma of the colon
632831|NCT00896883|turbinate|turbinate
632832|NCT00896883|implant|implant
632833|NCT00896883|sinus surgery|sinus surgery
632834|NCT00896883|Turbinates|turbinates
632836|NCT00896857|ductal breast carcinoma in situ|ductal breast carcinoma in situ
632837|NCT00896844|emotional disclosure|emotional disclosure
632838|NCT00896844|expressive writing|expressive writing
632839|NCT00896844|students|students
632840|NCT00896831|minimal hepatic encephalopathy|minimal hepatic encephalopathy
632841|NCT00896831|L-ornithine-L-aspartate|l-ornithine-l-aspartate
632842|NCT00896831|psychometric test|psychometric test
632843|NCT00896831|critical flicker frequency|critical flicker frequency
632844|NCT00896831|quality of life|quality of life
632845|NCT00896831|Treatment|treatment
632846|NCT00896831|Health-related quality of life|health-related quality of life
632847|NCT00896818|breast cancer|breast cancer
632848|NCT00896792|unspecified adult solid tumor, protocol specific|unspecified adult solid tumor, protocol specific
632849|NCT00896792|hematopoietic/lymphoid cancer|hematopoietic/lymphoid cancer
632850|NCT00896766|childhood acute lymphoblastic leukemia in remission|childhood acute lymphoblastic leukemia in remission
632851|NCT00896766|B-cell childhood acute lymphoblastic leukemia|b-cell childhood acute lymphoblastic leukemia
632852|NCT00896753|stage IV colon cancer|stage iv colon cancer
632853|NCT00896753|liver metastases|liver metastases
632854|NCT00896753|lung metastases|lung metastases
632855|NCT00896753|recurrent colon cancer|recurrent colon cancer
632856|NCT00896740|Fanconi anemia|fanconi anemia
632857|NCT00896727|stage IA breast cancer|stage ia breast cancer
632858|NCT00896727|stage IB breast cancer|stage ib breast cancer
632859|NCT00896727|stage II breast cancer|stage ii breast cancer
632860|NCT00896727|stage IIIA breast cancer|stage iiia breast cancer
632861|NCT00896701|adult acute myeloid leukemia in remission|adult acute myeloid leukemia in remission
632862|NCT00896701|recurrent adult acute myeloid leukemia|recurrent adult acute myeloid leukemia
632863|NCT00896701|adult acute myeloid leukemia with 11q23 (MLL) abnormalities|adult acute myeloid leukemia with 11q23 (mll) abnormalities
632864|NCT00896701|adult acute myeloid leukemia with inv(16)(p13;q22)|adult acute myeloid leukemia with inv(16)(p13;q22)
632865|NCT00896701|adult acute myeloid leukemia with t(15;17)(q22;q12)|adult acute myeloid leukemia with t(15;17)(q22;q12)
632866|NCT00896701|adult acute myeloid leukemia with t(16;16)(p13;q22)|adult acute myeloid leukemia with t(16;16)(p13;q22)
632867|NCT00896701|adult acute myeloid leukemia with t(8;21)(q22;q22)|adult acute myeloid leukemia with t(8;21)(q22;q22)
632868|NCT00896688|cervical branch block|cervical branch block
632869|NCT00896688|fluoroscopic guidance|fluoroscopic guidance
632870|NCT00896688|ultrasound guidance|ultrasound guidance
632871|NCT00896675|recurrent squamous cell carcinoma of the hypopharynx|recurrent squamous cell carcinoma of the hypopharynx
632872|NCT00896675|stage IV squamous cell carcinoma of the hypopharynx|stage iv squamous cell carcinoma of the hypopharynx
632873|NCT00896675|recurrent squamous cell carcinoma of the larynx|recurrent squamous cell carcinoma of the larynx
632874|NCT00896675|stage IV squamous cell carcinoma of the larynx|stage iv squamous cell carcinoma of the larynx
632875|NCT00896675|stage IV squamous cell carcinoma of the lip and oral cavity|stage iv squamous cell carcinoma of the lip and oral cavity
632876|NCT00896675|recurrent squamous cell carcinoma of the lip and oral cavity|recurrent squamous cell carcinoma of the lip and oral cavity
710283|NCT00589563|contiguous stage II mantle cell lymphoma|contiguous stage ii mantle cell lymphoma
632877|NCT00896675|metastatic squamous neck cancer with occult primary squamous cell carcinoma|metastatic squamous neck cancer with occult primary squamous cell carcinoma
632878|NCT00896675|recurrent metastatic squamous neck cancer with occult primary|recurrent metastatic squamous neck cancer with occult primary
632879|NCT00896675|recurrent squamous cell carcinoma of the nasopharynx|recurrent squamous cell carcinoma of the nasopharynx
632880|NCT00896675|stage IV squamous cell carcinoma of the nasopharynx|stage iv squamous cell carcinoma of the nasopharynx
632881|NCT00896675|recurrent squamous cell carcinoma of the oropharynx|recurrent squamous cell carcinoma of the oropharynx
632882|NCT00896675|stage IV squamous cell carcinoma of the oropharynx|stage iv squamous cell carcinoma of the oropharynx
632883|NCT00896675|recurrent squamous cell carcinoma of the paranasal sinus and nasal cavity|recurrent squamous cell carcinoma of the paranasal sinus and nasal cavity
632884|NCT00896675|stage IV squamous cell carcinoma of the paranasal sinus and nasal cavity|stage iv squamous cell carcinoma of the paranasal sinus and nasal cavity
632885|NCT00896675|salivary gland squamous cell carcinoma|salivary gland squamous cell carcinoma
632886|NCT00896675|stage IV salivary gland cancer|stage iv salivary gland cancer
632887|NCT00896675|recurrent salivary gland cancer|recurrent salivary gland cancer
632888|NCT00896662|unspecified adult solid tumor, protocol specific|unspecified adult solid tumor, protocol specific
632889|NCT00896662|recurrent adult Burkitt lymphoma|recurrent adult burkitt lymphoma
632890|NCT00896662|stage IV adult Burkitt lymphoma|stage iv adult burkitt lymphoma
632891|NCT00896662|recurrent adult diffuse large cell lymphoma|recurrent adult diffuse large cell lymphoma
632892|NCT00896662|recurrent adult diffuse mixed cell lymphoma|recurrent adult diffuse mixed cell lymphoma
632893|NCT00896662|recurrent adult diffuse small cleaved cell lymphoma|recurrent adult diffuse small cleaved cell lymphoma
632894|NCT00896662|stage IV adult diffuse large cell lymphoma|stage iv adult diffuse large cell lymphoma
632895|NCT00896662|stage IV adult diffuse mixed cell lymphoma|stage iv adult diffuse mixed cell lymphoma
632896|NCT00896662|stage IV adult diffuse small cleaved cell lymphoma|stage iv adult diffuse small cleaved cell lymphoma
632897|NCT00896662|recurrent adult immunoblastic large cell lymphoma|recurrent adult immunoblastic large cell lymphoma
632898|NCT00896662|stage IV adult immunoblastic large cell lymphoma|stage iv adult immunoblastic large cell lymphoma
632899|NCT00896662|recurrent adult lymphoblastic lymphoma|recurrent adult lymphoblastic lymphoma
632900|NCT00896662|stage IV adult lymphoblastic lymphoma|stage iv adult lymphoblastic lymphoma
632901|NCT00896662|recurrent grade 1 follicular lymphoma|recurrent grade 1 follicular lymphoma
632902|NCT00896662|recurrent grade 2 follicular lymphoma|recurrent grade 2 follicular lymphoma
632903|NCT00896662|recurrent grade 3 follicular lymphoma|recurrent grade 3 follicular lymphoma
632904|NCT00896662|stage IV grade 1 follicular lymphoma|stage iv grade 1 follicular lymphoma
632905|NCT00896662|stage IV grade 2 follicular lymphoma|stage iv grade 2 follicular lymphoma
632906|NCT00896662|stage IV grade 3 follicular lymphoma|stage iv grade 3 follicular lymphoma
632907|NCT00896662|recurrent mantle cell lymphoma|recurrent mantle cell lymphoma
632908|NCT00896662|stage IV mantle cell lymphoma|stage iv mantle cell lymphoma
632909|NCT00896662|recurrent marginal zone lymphoma|recurrent marginal zone lymphoma
632910|NCT00896662|splenic marginal zone lymphoma|splenic marginal zone lymphoma
632911|NCT00896662|stage IV marginal zone lymphoma|stage iv marginal zone lymphoma
632912|NCT00896662|nodal marginal zone B-cell lymphoma|nodal marginal zone b-cell lymphoma
632913|NCT00896662|extranodal marginal zone B-cell lymphoma of mucosa-associated lymphoid tissue|extranodal marginal zone b-cell lymphoma of mucosa-associated lymphoid tissue
632914|NCT00896662|recurrent small lymphocytic lymphoma|recurrent small lymphocytic lymphoma
632915|NCT00896662|stage IV small lymphocytic lymphoma|stage iv small lymphocytic lymphoma
632916|NCT00896649|breast cancer|breast cancer
632917|NCT00896636|breast cancer|breast cancer
632918|NCT00896636|healthy, no evidence of disease|healthy, no evidence of disease
632919|NCT00896623|stage I breast cancer|stage i breast cancer
632920|NCT00896623|stage II breast cancer|stage ii breast cancer
632921|NCT00896610|Diabetes Type II|diabetes type ii
632922|NCT00896610|Diabetes Type 1|diabetes type 1
632923|NCT00896610|Autoimmunity|autoimmunity
632924|NCT00896610|Type 1 Diabetes|type 1 diabetes
632925|NCT00896610|Type 2 Diabetes|type 2 diabetes
632926|NCT00896610|Autoimmune Diabetes|autoimmune diabetes
632927|NCT00896610|At Risk Diabetes|at risk diabetes
632928|NCT00896584|Chronic obstructive pulmonary disease|chronic obstructive pulmonary disease
632929|NCT00896584|Hypoxemia|hypoxemia
632930|NCT00896584|Pre-flight evaluation|pre-flight evaluation
632931|NCT00896584|Hypobaria|hypobaria
632932|NCT00896584|COPD|copd
632933|NCT00896584|Pulseoximetry|pulseoximetry
632934|NCT00896584|Air travel|air travel
632935|NCT00896584|Exercise desaturation|exercise desaturation
632936|NCT00896571|Fertility control|fertility control
632937|NCT00896571|Contraception|contraception
632938|NCT00896558|GSK1322322, repeat dose, healthy subjects, elderly, drug-drug interaction, probe, midazolam, double-blind|gsk1322322, repeat dose, healthy subjects, elderly, drug-drug interaction, probe, midazolam, double-blind
632939|NCT00896519|stage III grade 1 follicular lymphoma|stage iii grade 1 follicular lymphoma
632940|NCT00896519|stage III grade 2 follicular lymphoma|stage iii grade 2 follicular lymphoma
632941|NCT00896519|stage III grade 3 follicular lymphoma|stage iii grade 3 follicular lymphoma
632942|NCT00896519|stage IV grade 1 follicular lymphoma|stage iv grade 1 follicular lymphoma
710998|NCT00586898|Cancer|cancer
632943|NCT00896519|stage IV grade 2 follicular lymphoma|stage iv grade 2 follicular lymphoma
632944|NCT00896519|stage IV grade 3 follicular lymphoma|stage iv grade 3 follicular lymphoma
632945|NCT00896480|ASCI (Antigen-Specific Cancer Immunotherapeutic)|asci (antigen-specific cancer immunotherapeutic)
632946|NCT00896480|MAGE-A3|mage-a3
632947|NCT00896480|Malignant melanoma|malignant melanoma
632948|NCT00896480|Cancer immunotherapeutic|cancer immunotherapeutic
632949|NCT00896467|anxiety disorder|anxiety disorder
632950|NCT00896467|depression|depression
632951|NCT00896467|stage IV breast cancer|stage iv breast cancer
632952|NCT00896467|stage IV renal cell cancer|stage iv renal cell cancer
632953|NCT00896467|stage IV non-small cell lung cancer|stage iv non-small cell lung cancer
632954|NCT00896467|extensive stage small cell lung cancer|extensive stage small cell lung cancer
632955|NCT00896467|stage IV gastric cancer|stage iv gastric cancer
632956|NCT00896467|stage IV anal cancer|stage iv anal cancer
632957|NCT00896467|stage IV pancreatic cancer|stage iv pancreatic cancer
632958|NCT00896467|stage IV esophageal cancer|stage iv esophageal cancer
632959|NCT00896467|advanced adult primary liver cancer|advanced adult primary liver cancer
632960|NCT00896467|unresectable gallbladder cancer|unresectable gallbladder cancer
632961|NCT00896467|small intestine cancer|small intestine cancer
632962|NCT00896454|hypercalcemia|hypercalcemia
632963|NCT00896454|calcium|calcium
632964|NCT00896454|bisphosphonates|bisphosphonates
632965|NCT00896454|denosumab|denosumab
632966|NCT00896454|amgen|amgen
632967|NCT00896454|malignancy|malignancy
632968|NCT00896454|20070315|20070315
632969|NCT00896454|HMC|hmc
632970|NCT00896454|oncology|oncology
632971|NCT00896454|hematology|hematology
632972|NCT00896428|Asthma|asthma
632973|NCT00896428|gallopamil|gallopamil
632974|NCT00896428|airway remodelling|airway remodelling
632975|NCT00896428|smooth muscle|smooth muscle
632976|NCT00896415|on two models of CT scanner acquire CT images of the abdomen pelvis and midthigh in 20 Postmenopausal female volunteers|on two models of ct scanner acquire ct images of the abdomen pelvis and midthigh in 20 postmenopausal female volunteers
632977|NCT00896402|chloraprep|chloraprep
632978|NCT00896402|betadine|betadine
632979|NCT00896402|colonization|colonization
632980|NCT00896402|femoral catheter|femoral catheter
632981|NCT00896389|hypertension|hypertension
632982|NCT00896389|hydrochlorothiazide|hydrochlorothiazide
632983|NCT00896389|HCTZ|hctz
632984|NCT00896389|Salt sensitivity|salt sensitivity
633086|NCT00895869|Screening|screening
632985|NCT00896389|Hydrochlorothiazide induced hyperglycemia|hydrochlorothiazide induced hyperglycemia
632986|NCT00896376|stage IV breast cancer|stage iv breast cancer
632987|NCT00896376|HER2-positive breast cancer|her2-positive breast cancer
632988|NCT00896363|anti-depressant|anti-depressant
632989|NCT00896363|Severe Depression|severe depression
632990|NCT00896363|Efficacy|efficacy
632991|NCT00896363|Major Depressive Disorder|major depressive disorder
632992|NCT00896363|Major Depressive Episode|major depressive episode
632993|NCT00896337|iliac artery stenosis|iliac artery stenosis
632994|NCT00896337|claudication|claudication
632995|NCT00896337|atherosclerotic iliac disease|atherosclerotic iliac disease
632996|NCT00896337|peripheral vascular disease|peripheral vascular disease
632997|NCT00896324|Quality of life|quality of life
632998|NCT00896298|Lipodystrophy|lipodystrophy
632999|NCT00896298|Insulin secretory response|insulin secretory response
633000|NCT00896285|Pleural malignancy|pleural malignancy
633001|NCT00896285|pleural effusion|pleural effusion
633002|NCT00896285|pleurodesis|pleurodesis
633003|NCT00896285|chest tube|chest tube
633004|NCT00896285|cancer|cancer
633005|NCT00896285|cancer pain management|cancer pain management
633006|NCT00896272|Klinefelter Syndrome|klinefelter syndrome
633007|NCT00896272|47,XXY|47,xxy
633009|NCT00896259|Unilateral total hip arthroplasty|unilateral total hip arthroplasty
633010|NCT00896233|Staging of liver fibrosis prior to clinical trials for treatment of Hepatitis C Virus|staging of liver fibrosis prior to clinical trials for treatment of hepatitis c virus
633011|NCT00896220|chronic critical illness|chronic critical illness
633012|NCT00896220|mechanical ventilation|mechanical ventilation
633013|NCT00896220|outcomes|outcomes
633014|NCT00896220|weakness|weakness
633015|NCT00896220|quality of life|quality of life
633016|NCT00896220|Critically Ill patients and their family caregiver|critically ill patients and their family caregiver
633017|NCT00896194|Overweight|overweight
633018|NCT00896194|Obesity|obesity
633019|NCT00896194|Self-Efficacy|self-efficacy
633020|NCT00896194|Treatment Adherence|treatment adherence
633021|NCT00896168|Arthritis, Rheumatoid|arthritis, rheumatoid
633022|NCT00896168|Infliximab|infliximab
633023|NCT00896168|Methotrexate|methotrexate
633024|NCT00896155|Breast cancer|breast cancer
633025|NCT00896155|Pulmonary fibrosis|pulmonary fibrosis
633026|NCT00896155|tamoxifen|tamoxifen
633027|NCT00896155|radiotherapy|radiotherapy
633028|NCT00896142|ischemic cardiomyopathy|ischemic cardiomyopathy
633029|NCT00896142|cardiac resynchronization therapy|cardiac resynchronization therapy
633030|NCT00896142|LV structure and function|lv structure and function
633031|NCT00896129|Health Outcomes Research|health outcomes research
633032|NCT00896129|CML|cml
633033|NCT00896077|healthy subjects|healthy subjects
633034|NCT00896064|Pneumococcal vaccine|pneumococcal vaccine
633035|NCT00896064|Streptococcus pneumoniae|streptococcus pneumoniae
633036|NCT00896064|Young adults|young adults
633037|NCT00896051|HIV Infections|hiv infections
633038|NCT00896051|Acquired Immunodeficiency Syndrome|acquired immunodeficiency syndrome
633039|NCT00896051|TMC125-TiDP2-C238|tmc125-tidp2-c238
633040|NCT00896051|TMC125-C238|tmc125-c238
633041|NCT00896051|Etravirine|etravirine
633042|NCT00896051|Intelence|intelence
633043|NCT00896051|HIV|hiv
633044|NCT00896051|HIV-1|hiv-1
633045|NCT00896051|Pharmacokinetics|pharmacokinetics
633046|NCT00896038|Alcohol Dependence|alcohol dependence
633047|NCT00896038|Alcohol Treatment|alcohol treatment
633048|NCT00896038|Alcoholics|alcoholics
633049|NCT00896038|Alcoholism|alcoholism
633050|NCT00896038|Posttraumatic Stress Disorder|posttraumatic stress disorder
633051|NCT00896038|PTSD|ptsd
633052|NCT00896025|Liver disease|liver disease
633053|NCT00896012|Kidney Transplant|kidney transplant
633054|NCT00896012|Immunosuppression drugs|immunosuppression drugs
633055|NCT00896012|Rapamune|rapamune
633056|NCT00896012|tacrolimus|tacrolimus
633057|NCT00896012|calcineurin inhibitor|calcineurin inhibitor
633058|NCT00896012|Kidney Biopsy, Needle|kidney biopsy, needle
633059|NCT00895986|Diabetes|diabetes
633060|NCT00895986|Education|education
633061|NCT00895960|Brain|brain
633062|NCT00895960|CNS Disease|cns disease
633063|NCT00895960|CNS|cns
633064|NCT00895960|Intracranial Supratentorial GBM|intracranial supratentorial gbm
633065|NCT00895960|Gliosarcoma|gliosarcoma
633066|NCT00895960|GS|gs
633067|NCT00895960|Glioblastoma|glioblastoma
633068|NCT00895960|GBM|gbm
633069|NCT00895960|Dasatinib|dasatinib
633070|NCT00895960|Sprycel|sprycel
633071|NCT00895960|Temozolomide|temozolomide
633072|NCT00895960|TMZ|tmz
633073|NCT00895960|Temodar|temodar
633074|NCT00895960|Radiation Therapy|radiation therapy
633075|NCT00895960|Radiotherapy|radiotherapy
633076|NCT00895960|RT|rt
633077|NCT00895947|Prophylaxis|prophylaxis
633078|NCT00895947|Treatment|treatment
633079|NCT00895947|Symptoms|symptoms
633080|NCT00895947|Winter Colds and Flu|winter colds and flu
633081|NCT00895921|Insulin Resistance|insulin resistance
633082|NCT00895921|Antipsychotic Medications|antipsychotic medications
633083|NCT00895908|ADHD|adhd
633084|NCT00895908|Psychosocial Intervention|psychosocial intervention
633085|NCT00895908|Social Skills Training|social skills training
633090|NCT00895856|Physiotherapy|physiotherapy
633091|NCT00895856|Aged|aged
633092|NCT00895856|Functionality|functionality
633093|NCT00895856|Physiotherapic assistance|physiotherapic assistance
633094|NCT00895856|Functional capacity|functional capacity
633095|NCT00895843|Third molar|third molar
633096|NCT00895817|Eosinophilic esophagitis|eosinophilic esophagitis
633097|NCT00895817|acid reflux|acid reflux
633098|NCT00895804|MDMA|mdma
633099|NCT00895804|beta adrenergic|beta adrenergic
633100|NCT00895804|Ecstasy|ecstasy
633101|NCT00895791|coronary bifurcation|coronary bifurcation
633102|NCT00895791|stent implantation|stent implantation
633103|NCT00895791|PCI|pci
633104|NCT00895791|Optical Coherence Tomography|optical coherence tomography
633105|NCT00895778|Neuromuscular blockade|neuromuscular blockade
633106|NCT00895778|post-operative pain|post-operative pain
633107|NCT00895778|post-operative pulmonary function|post-operative pulmonary function
633108|NCT00895765|Melamine|melamine
633109|NCT00895765|Calculus|calculus
633110|NCT00895765|Kidney|kidney
633111|NCT00895765|Child|child
633112|NCT00895739|aplastic anemia|aplastic anemia
633113|NCT00895726|cachexia|cachexia
633114|NCT00895726|neoplasms|neoplasms
633115|NCT00895713|Hepatitis B|hepatitis b
633116|NCT00895713|HBV|hbv
633117|NCT00895713|Anti-hepatitis B antibodies|anti-hepatitis b antibodies
633118|NCT00895713|Immunoglobulins|immunoglobulins
633121|NCT00895713|Recurrence|recurrence
633122|NCT00895713|Intramuscular|intramuscular
633123|NCT00895700|Anxiety|anxiety
633124|NCT00895700|ICD concerns|icd concerns
633125|NCT00895700|Quality of life|quality of life
633126|NCT00895687|Metastatic Cancer|metastatic cancer
633127|NCT00895687|Bortezomib|bortezomib
633128|NCT00895687|Velcade|velcade
633129|NCT00895687|Erlotinib|erlotinib
633130|NCT00895687|Erlotinib Hydrochloride|erlotinib hydrochloride
633131|NCT00895687|Tarceva|tarceva
633132|NCT00895687|EGFR|egfr
633133|NCT00895687|EGFR mutations|egfr mutations
633134|NCT00895674|Advanced Renal Cell Carcinoma|advanced renal cell carcinoma
633135|NCT00895661|rituximab|rituximab
633136|NCT00895648|Meso|meso
633137|NCT00895648|mesothelioma|mesothelioma
633138|NCT00895648|pleura|pleura
633139|NCT00895648|pleural|pleural
633140|NCT00895635|Claudication|claudication
633141|NCT00895635|Peripheral Arterial Disease|peripheral arterial disease
633142|NCT00895635|Exercise Rehabilitation|exercise rehabilitation
633143|NCT00895635|Cardiovascular Function|cardiovascular function
633144|NCT00895622|adult grade I meningioma|adult grade i meningioma
633145|NCT00895622|adult grade II meningioma|adult grade ii meningioma
806560|NCT00226889|Therapy|therapy
633146|NCT00895622|adult grade III meningioma|adult grade iii meningioma
633147|NCT00895622|adult anaplastic meningioma|adult anaplastic meningioma
633148|NCT00895622|adult papillary meningioma|adult papillary meningioma
633149|NCT00895622|recurrent adult brain tumor|recurrent adult brain tumor
633150|NCT00895609|Residual neuromuscular block|residual neuromuscular block
633151|NCT00895609|post-operative residual curarization|post-operative residual curarization
633152|NCT00895609|PORC|porc
633153|NCT00895609|sugammadex|sugammadex
633154|NCT00895609|neostigmine|neostigmine
633155|NCT00895609|Shallow neuromuscular block (TOF-ratio of 0.5)|shallow neuromuscular block (tof-ratio of 0.5)
633156|NCT00895596|Chronic hepatitis B|chronic hepatitis b
633157|NCT00895596|Lamivudine resistant|lamivudine resistant
633158|NCT00895596|YMDD mutant type|ymdd mutant type
633159|NCT00895583|renal transplant|renal transplant
633160|NCT00895583|immunosuppression|immunosuppression
633161|NCT00895583|sirolimus/rapamune|sirolimus/rapamune
633162|NCT00895583|planned transition|planned transition
633163|NCT00895570|sleep restriction|sleep restriction
633164|NCT00895570|glucose metabolism|glucose metabolism
633165|NCT00895570|modafinil|modafinil
633166|NCT00895570|euglycemic clamp|euglycemic clamp
633167|NCT00895570|insulin sensitivity|insulin sensitivity
633168|NCT00895570|insulin release|insulin release
633169|NCT00895557|varenicline|varenicline
633170|NCT00895557|cocaine|cocaine
633171|NCT00895557|brain imaging|brain imaging
633172|NCT00895531|Knee Replacement, Total|knee replacement, total
633173|NCT00895531|Morphine|morphine
633174|NCT00895518|PTSD|ptsd
633175|NCT00895505|DVT|dvt
633176|NCT00895505|Venous thromboembolism|venous thromboembolism
633177|NCT00895505|D-Dimer|d-dimer
633178|NCT00895505|thrombophilia|thrombophilia
633179|NCT00895505|secondary prophylaxis|secondary prophylaxis
633180|NCT00895505|secondary prophylaxis using oral anticoagulant treatment (OAT)|secondary prophylaxis using oral anticoagulant treatment (oat)
633181|NCT00895505|higher risk of recurrence in patients showing increased levels|higher risk of recurrence in patients showing increased levels
633182|NCT00895505|of D-Dimer after withdrawal of OAT|of d-dimer after withdrawal of oat
633183|NCT00895505|D-Dimer-based treatment|d-dimer-based treatment
633184|NCT00895492|diarrhea|diarrhea
633185|NCT00895492|rotavirus|rotavirus
633186|NCT00895492|genotype|genotype
633187|NCT00895492|VP4|vp4
633188|NCT00895492|VP7|vp7
633189|NCT00895479|End Stage Renal Disease|end stage renal disease
633190|NCT00895479|ESRD|esrd
633191|NCT00895479|Hemodialysis|hemodialysis
633192|NCT00895479|Access Graft|access graft
633193|NCT00895466|prostatic diseases|prostatic diseases
633194|NCT00895466|neoplasms|neoplasms
633195|NCT00895466|prostatic neoplasms|prostatic neoplasms
633196|NCT00895466|hormones|hormones
633197|NCT00895466|androgen antagonists|androgen antagonists
633198|NCT00895466|vaccines|vaccines
633199|NCT00895466|peptide vaccines|peptide vaccines
633200|NCT00895466|adjuvants, immunological|adjuvants, immunological
633201|NCT00895453|recurrent vulvovaginal candidiasis|recurrent vulvovaginal candidiasis
633202|NCT00895453|itraconazole|itraconazole
633203|NCT00895453|classic homeopathy|classic homeopathy
633204|NCT00895440|Diabetes|diabetes
633205|NCT00895440|Diabetic neuropathy|diabetic neuropathy
633206|NCT00895440|neuropad|neuropad
633207|NCT00895440|Painless peripheral diabetic neuropathy|painless peripheral diabetic neuropathy
633208|NCT00895440|Painful peripheral diabetic neuropathy|painful peripheral diabetic neuropathy
633209|NCT00895440|Autonomic peripheral neuropathy|autonomic peripheral neuropathy
633210|NCT00895440|Charcot neuroarthropathy|charcot neuroarthropathy
633211|NCT00895427|Coronary artery calcification|coronary artery calcification
633212|NCT00895414|stage I breast cancer|stage i breast cancer
633213|NCT00895414|stage II breast cancer|stage ii breast cancer
633214|NCT00895414|stage IIIA breast cancer|stage iiia breast cancer
633215|NCT00895414|stage IIIB breast cancer|stage iiib breast cancer
633216|NCT00895414|stage IIIC breast cancer|stage iiic breast cancer
633217|NCT00895414|stage IV breast cancer|stage iv breast cancer
633218|NCT00895401|Nutritional supplement|nutritional supplement
633219|NCT00895401|Malnutrition|malnutrition
633220|NCT00895401|Hemodialysis|hemodialysis
633221|NCT00895401|Nepro with Carb Steady|nepro with carb steady
633222|NCT00895388|Urinary function|urinary function
633223|NCT00895388|Anal function|anal function
633224|NCT00895375|Dermatology|dermatology
633225|NCT00895375|Skin|skin
633226|NCT00895375|Psoriasis|psoriasis
633227|NCT00895375|Sleep|sleep
633228|NCT00895375|Wake Forest|wake forest
633229|NCT00895375|Insomnia|insomnia
633230|NCT00895362|Advanced Cancer|advanced cancer
633231|NCT00895362|EGFR mutation|egfr mutation
633232|NCT00895362|Erlotinib|erlotinib
633233|NCT00895362|Erlotinib Hydrochloride|erlotinib hydrochloride
633234|NCT00895362|Tarceva|tarceva
633235|NCT00895362|OSI-774|osi-774
633236|NCT00895362|Cetuximab|cetuximab
633237|NCT00895362|C225|c225
633238|NCT00895362|Erbitux|erbitux
633239|NCT00895362|IMC-C225|imc-c225
710999|NCT00586898|Hormones|hormones
806763|NCT00225862|RLS|rls
633240|NCT00895349|Positron Emission Tomography (PET)|positron emission tomography (pet)
633241|NCT00895349|Diagnostic Intervention|diagnostic intervention
633242|NCT00895349|Locally Advanced Cervical Cancer|locally advanced cervical cancer
633243|NCT00895336|Pediatric Ulcerative Colitis|pediatric ulcerative colitis
633244|NCT00895323|stage I colon cancer|stage i colon cancer
633245|NCT00895323|stage II colon cancer|stage ii colon cancer
633246|NCT00895323|stage III colon cancer|stage iii colon cancer
633247|NCT00895323|stage IV colon cancer|stage iv colon cancer
633248|NCT00895323|stage I rectal cancer|stage i rectal cancer
633249|NCT00895323|stage II rectal cancer|stage ii rectal cancer
633250|NCT00895323|stage III rectal cancer|stage iii rectal cancer
633251|NCT00895323|stage IV rectal cancer|stage iv rectal cancer
633252|NCT00895323|recurrent colon cancer|recurrent colon cancer
633253|NCT00895323|recurrent rectal cancer|recurrent rectal cancer
633255|NCT00895310|Ketoconazole|ketoconazole
633256|NCT00895310|Prostate Cancer|prostate cancer
633257|NCT00895310|Hormone Refractory|hormone refractory
633258|NCT00895310|Chemotherapy Regimen|chemotherapy regimen
633259|NCT00895297|Relapsing after allogeneic transplantation|relapsing after allogeneic transplantation
633260|NCT00895297|Dasatinib|dasatinib
633261|NCT00895297|Sprycel|sprycel
633262|NCT00895297|Philadelphia Chromosomes|philadelphia chromosomes
633263|NCT00895284|robotic|robotic
633264|NCT00895284|laparoscopic surgical procedures|laparoscopic surgical procedures
633265|NCT00895271|FIBROBLAST|fibroblast
633266|NCT00895271|Skin Biopsy|skin biopsy
633267|NCT00895271|Primary Immunodeficiency|primary immunodeficiency
633268|NCT00895271|Immunodysregulation|immunodysregulation
633269|NCT00895271|Common Variable Immunodeficiency|common variable immunodeficiency
633270|NCT00895271|Severe Combined Immunodeficiency|severe combined immunodeficiency
633271|NCT00895271|Healthy Volunteer|healthy volunteer
633272|NCT00895271|HV|hv
633273|NCT00895258|Schizoaffective Disorder|schizoaffective disorder
633274|NCT00895258|Major Depressive Disorder|major depressive disorder
633275|NCT00895258|Supported Employment|supported employment
633276|NCT00895258|Work|work
633277|NCT00895258|Rehabilitation|rehabilitation
633278|NCT00895258|Severe Mental Illness|severe mental illness
633279|NCT00895258|Cognitive Training|cognitive training
633280|NCT00895258|Cognitive Rehabilitation|cognitive rehabilitation
633281|NCT00895258|Cognitive Remediation|cognitive remediation
633282|NCT00895219|Hyperventilation|hyperventilation
633283|NCT00895219|Dysfunctional breathing|dysfunctional breathing
633284|NCT00895219|Physiotherapy|physiotherapy
633285|NCT00895219|Musculoskeletal techniques|musculoskeletal techniques
633286|NCT00895193|Niacin|niacin
633287|NCT00895193|Hypercholesterolemia|hypercholesterolemia
633289|NCT00895180|recurrent adult brain tumor|recurrent adult brain tumor
633290|NCT00895180|adult glioblastoma|adult glioblastoma
633291|NCT00895180|adult giant cell glioblastoma|adult giant cell glioblastoma
633292|NCT00895180|adult gliosarcoma|adult gliosarcoma
633293|NCT00895167|Heme Oxygenase|heme oxygenase
633294|NCT00895167|Genetic Polymorphism|genetic polymorphism
633295|NCT00895167|Healthy Subjects|healthy subjects
633296|NCT00895154|Sickle Cell Disease|sickle cell disease
633297|NCT00895154|Sickle Cell|sickle cell
633298|NCT00895154|Memory|memory
633299|NCT00895154|Learning|learning
633300|NCT00895154|Achievement|achievement
633301|NCT00895141|Saturated fat|saturated fat
633302|NCT00895141|LDL size|ldl size
633303|NCT00895141|Large LDL|large ldl
633304|NCT00895141|Large HDL|large hdl
633305|NCT00895128|Advanced Cancer|advanced cancer
633306|NCT00895128|EGFR mutations|egfr mutations
633307|NCT00895128|Dasatinib|dasatinib
633308|NCT00895128|Sprycel|sprycel
633309|NCT00895128|Erlotinib|erlotinib
633310|NCT00895128|Erlotinib Hydrochloride|erlotinib hydrochloride
633311|NCT00895128|Tarceva|tarceva
633312|NCT00895115|prostate cancer|prostate cancer
633313|NCT00895102|Bioavailability (BA)|bioavailability (ba)
633314|NCT00895102|Single Ascending Dose (SAD)|single ascending dose (sad)
633315|NCT00895089|liver abscess|liver abscess
633316|NCT00895089|moxifloxacin|moxifloxacin
633317|NCT00895089|ceftriaxone|ceftriaxone
633318|NCT00895089|treatment|treatment
633319|NCT00895063|Spasmodic Dysphonia|spasmodic dysphonia
633320|NCT00895063|Botulinum Toxin|botulinum toxin
633321|NCT00895063|Vocal Exercise|vocal exercise
633322|NCT00895024|Caregiver|caregiver
633323|NCT00895024|Questionnaire|questionnaire
633324|NCT00895024|Home Hospice Care|home hospice care
633325|NCT00895024|Family Evaluation of Hospice Care|family evaluation of hospice care
633326|NCT00895024|FEHC|fehc
633327|NCT00895024|The Texas Revised Inventory of Grief|the texas revised inventory of grief
633328|NCT00895024|TRIG|trig
633329|NCT00895024|Cross-ethnic differences|cross-ethnic differences
633330|NCT00895024|Parenteral Hydration|parenteral hydration
633331|NCT00895024|Grief|grief
633332|NCT00895011|Erectile Dysfunction|erectile dysfunction
633333|NCT00895011|E.D.|e.d.
633334|NCT00894998|heparin cardiac surgery|heparin cardiac surgery
711000|NCT00586898|01-085|01-085
806804|NCT00225654|stent|stent
633335|NCT00894985|heparin cardiac surgery|heparin cardiac surgery
633336|NCT00894959|heparin cardiac surgery|heparin cardiac surgery
633337|NCT00894946|recurrent IVF implantation failure|recurrent ivf implantation failure
633338|NCT00894933|Prostate Cancer|prostate cancer
633339|NCT00894933|Radical Prostatectomy|radical prostatectomy
633340|NCT00894933|Vesico-Urethral Anastomosis|vesico-urethral anastomosis
633341|NCT00894920|biotin|biotin
633342|NCT00894920|deficiency|deficiency
633343|NCT00894920|pregnancy|pregnancy
633344|NCT00894920|lymphocyte propionyl-CoA carboxylase|lymphocyte propionyl-coa carboxylase
633345|NCT00894907|Severe pancreatitis|severe pancreatitis
633346|NCT00894907|acute pancreatitis|acute pancreatitis
633347|NCT00894907|haemodynamic monitoring|haemodynamic monitoring
633348|NCT00894907|PiCCO|picco
633349|NCT00894894|MP470|mp470
633350|NCT00894894|MP-470|mp-470
633351|NCT00894894|SuperGen|supergen
633352|NCT00894894|Tyrosine|tyrosine
633353|NCT00894894|Kinase|kinase
633354|NCT00894894|Inhibitor|inhibitor
633355|NCT00894894|Solid Malignancies|solid malignancies
633356|NCT00894894|Oncology|oncology
633357|NCT00894881|colonoscopy|colonoscopy
633358|NCT00894881|Healthy individuals before colonoscopy|healthy individuals before colonoscopy
633359|NCT00894868|Congestive Heart Failure|congestive heart failure
633360|NCT00894868|CHF, vildagliptin|chf, vildagliptin
633361|NCT00894868|metabolic disease|metabolic disease
633362|NCT00894868|cardiovascular disease|cardiovascular disease
633363|NCT00894868|T2DM|t2dm
633364|NCT00894855|skin cancer prevention|skin cancer prevention
633365|NCT00894855|SHADE|shade
633366|NCT00894855|Beach|beach
633367|NCT00894842|Schizophrenia|schizophrenia
633368|NCT00894842|Pregnenolone|pregnenolone
633369|NCT00894842|Neurocognition|neurocognition
633370|NCT00894829|heparin cardiac surgery|heparin cardiac surgery
633371|NCT00894816|Prevention|prevention
633372|NCT00894816|Probiotics|probiotics
633373|NCT00894816|Eczema|eczema
633374|NCT00894816|Allergy|allergy
633375|NCT00894816|Asthma|asthma
633376|NCT00894816|Obesity|obesity
633377|NCT00894816|Caries|caries
633378|NCT00894816|Gut microbiota|gut microbiota
633379|NCT00894803|acute ischemic stroke|acute ischemic stroke
633380|NCT00894803|stroke|stroke
633381|NCT00894803|rt-PA, thrombolytic|rt-pa, thrombolytic
633382|NCT00894803|t-PA|t-pa
633383|NCT00894803|recombinant tissue plasminogen activator|recombinant tissue plasminogen activator
633384|NCT00894803|Activase|activase
633385|NCT00894803|eptifibatide|eptifibatide
633386|NCT00894803|Integrilin|integrilin
633387|NCT00894803|fibrinolytic agents|fibrinolytic agents
633388|NCT00894803|clot dissolving|clot dissolving
633389|NCT00894803|blood clot|blood clot
633390|NCT00894790|Treatment of the acute pain due to cervical|treatment of the acute pain due to cervical
633391|NCT00894790|sprain|sprain
633392|NCT00894790|Celecoxib|celecoxib
633397|NCT00894764|Pneumonia|pneumonia
633398|NCT00894764|Pneumococcal|pneumococcal
633399|NCT00894764|pneumococcus|pneumococcus
633400|NCT00894764|Carriage|carriage
633401|NCT00894751|dexmedetomidine and propofol for MRI|dexmedetomidine and propofol for mri
633402|NCT00894751|quality of care between two anesthetic agents for MRI|quality of care between two anesthetic agents for mri
633403|NCT00894738|pediatric|pediatric
633404|NCT00894738|mental illness|mental illness
633405|NCT00894738|antipsychotic|antipsychotic
633406|NCT00894738|cardiometabolic risk|cardiometabolic risk
633407|NCT00894738|Antipsychotic agents|antipsychotic agents
633408|NCT00894738|Mental disorders diagnosed in childhood|mental disorders diagnosed in childhood
633409|NCT00894725|left colon cancer|left colon cancer
633410|NCT00894712|Radiation Therapy|radiation therapy
633411|NCT00894699|procedural sedation|procedural sedation
633412|NCT00894673|heparin cardiac surgery|heparin cardiac surgery
633413|NCT00894660|Bioequivalence, Healthy Volunteers|bioequivalence, healthy volunteers
633414|NCT00894647|actinic keratosis|actinic keratosis
633415|NCT00894647|skin disease|skin disease
633416|NCT00894621|Shock|shock
633417|NCT00894621|Respiration, artificial|respiration, artificial
633418|NCT00894621|Norepinephrine|norepinephrine
633419|NCT00894608|letrozole|letrozole
633420|NCT00894608|ovarian stimulation|ovarian stimulation
633421|NCT00894608|PCOS|pcos
633422|NCT00894608|IVF-ET|ivf-et
633423|NCT00894595|Incidence of ACL injury|incidence of acl injury
633424|NCT00894595|Risk factors for ACL injury|risk factors for acl injury
633425|NCT00894595|Prevention of ACL injury or any acute knee injury|prevention of acl injury or any acute knee injury
633426|NCT00894582|massive ventral hernia|massive ventral hernia
633427|NCT00894582|abdominal volume|abdominal volume
633428|NCT00894582|pulmonary function|pulmonary function
633429|NCT00894582|components separation|components separation
633430|NCT00894582|abdominal compartments syndrome|abdominal compartments syndrome
633431|NCT00894569|carcinoma of unknown primary|carcinoma of unknown primary
633432|NCT00894569|cancer of unknown primary|cancer of unknown primary
633433|NCT00894569|CUP|cup
633434|NCT00894569|carboplatin|carboplatin
633435|NCT00894569|paclitaxel|paclitaxel
633436|NCT00894569|cetuximab|cetuximab
633437|NCT00894556|Treatment of acute migraine with or without aura in adults|treatment of acute migraine with or without aura in adults
633438|NCT00894543|Hot flashes|hot flashes
633439|NCT00894543|Menopause|menopause
633440|NCT00894543|Vasomotor symptoms|vasomotor symptoms
633441|NCT00894504|Metastatic Breast Cancer|metastatic breast cancer
633442|NCT00894504|Triple Negative|triple negative
633443|NCT00894504|Panitumumab|panitumumab
633444|NCT00894504|Vectibix|vectibix
633445|NCT00894504|Gemcitabine|gemcitabine
633446|NCT00894504|Gemzar|gemzar
633447|NCT00894504|Carboplatin|carboplatin
633448|NCT00894491|alternative medicine|alternative medicine
633449|NCT00894491|complementary medicine|complementary medicine
633450|NCT00894491|acupuncture|acupuncture
633451|NCT00894491|Chinese herbals|chinese herbals
633452|NCT00894478|MRI-Negative|mri-negative
633453|NCT00894478|Diffusion tensor imaging|diffusion tensor imaging
633454|NCT00894478|Localization-related epilepsy|localization-related epilepsy
633455|NCT00894478|Partial Epilepsy|partial epilepsy
633456|NCT00894478|Children|children
633457|NCT00894465|Midazolam|midazolam
633458|NCT00894465|VCUG|vcug
633459|NCT00894465|Anxiety|anxiety
633460|NCT00894452|Methadone|methadone
633461|NCT00894452|CYP|cyp
633462|NCT00894452|OPRM1|oprm1
633463|NCT00894452|MDR1|mdr1
633464|NCT00894452|COMT|comt
633465|NCT00894452|Midazolam challenge|midazolam challenge
633466|NCT00894426|COPD|copd
633467|NCT00894426|Symptom|symptom
633468|NCT00894426|Morning activity|morning activity
633469|NCT00894426|Questionnaire|questionnaire
633470|NCT00894400|AF|af
633471|NCT00894400|catheter ablation|catheter ablation
633472|NCT00894400|fractionated electrogram|fractionated electrogram
633473|NCT00894400|complex fractionated atrial electrogram (CFAE)|complex fractionated atrial electrogram (cfae)
633474|NCT00894387|elevated BNP|elevated bnp
633475|NCT00894387|reduced LVEF|reduced lvef
633476|NCT00894387|Acute Heart Failure|acute heart failure
633477|NCT00894387|Cardiovascular death|cardiovascular death
633478|NCT00894387|CHF|chf
633479|NCT00894387|hospitalization|hospitalization
633480|NCT00894387|morbi-mortality trial|morbi-mortality trial
633481|NCT00894387|outcome study|outcome study
633482|NCT00894387|endpoint driven|endpoint driven
633483|NCT00894387|plasma renin activity|plasma renin activity
633484|NCT00894387|renin angiotensin|renin angiotensin
633485|NCT00894387|aldosterone system|aldosterone system
633486|NCT00894387|direct renin inhibitors|direct renin inhibitors
633487|NCT00894387|BNP|bnp
633488|NCT00894387|KCCQ|kccq
633489|NCT00894387|eGFR|egfr
633490|NCT00894374|Bio-equivalence, Healthy Volunteers|bio-equivalence, healthy volunteers
633491|NCT00894361|knee arthritis|knee arthritis
633492|NCT00894361|total knee arthroplasty|total knee arthroplasty
633493|NCT00894361|total knee replacement|total knee replacement
633494|NCT00894361|mobile bearing design|mobile bearing design
633495|NCT00894361|all-polyethylene tibia|all-polyethylene tibia
633496|NCT00894348|ERCP|ercp
633497|NCT00894348|Positive Biliary Brush Cytology|positive biliary brush cytology
633498|NCT00894335|retroperitoneoscopic adrenalectomy|retroperitoneoscopic adrenalectomy
633499|NCT00894335|intraoperative arterial-alveolar Carbon dioxide Difference|intraoperative arterial-alveolar carbon dioxide difference
633500|NCT00894322|diabetes|diabetes
633501|NCT00894322|exenatide once weekly|exenatide once weekly
633502|NCT00894322|Byetta|byetta
633503|NCT00894322|Amylin|amylin
633504|NCT00894322|Lilly|lilly
633505|NCT00894296|MEG|meg
633506|NCT00894296|schizophrenia|schizophrenia
633507|NCT00894296|negative symptoms|negative symptoms
633508|NCT00894283|DVT|dvt
633509|NCT00894283|PE|pe
633510|NCT00894283|MRV|mrv
633511|NCT00894283|bariatric surgery|bariatric surgery
633512|NCT00894270|Diabetes|diabetes
633513|NCT00894270|Injection|injection
633514|NCT00894270|Needle|needle
633515|NCT00894257|HCV infected pregnant women|hcv infected pregnant women
633516|NCT00894244|None- Normal healthy upper arm skin will be used.|none- normal healthy upper arm skin will be used.
633517|NCT00894205|neuropsychological function|neuropsychological function
633518|NCT00894205|cognitive function|cognitive function
633519|NCT00894205|exercise|exercise
633520|NCT00894205|older adult|older adult
633521|NCT00894192|This study tests functional ability of patients with refractive error or normal vision while using different types of eyeglasses.|this study tests functional ability of patients with refractive error or normal vision while using different types of eyeglasses.
633522|NCT00894179|coronary artery disease|coronary artery disease
633523|NCT00894179|stress echocardiography|stress echocardiography
633524|NCT00894179|regadenoson|regadenoson
633525|NCT00894179|atropine|atropine
633526|NCT00894179|coronary angiogram|coronary angiogram
633527|NCT00894166|Smoking Cessation|smoking cessation
633528|NCT00894166|Chantix|chantix
633529|NCT00894166|varenicline|varenicline
633530|NCT00894166|Nicotine Replacement Therapy|nicotine replacement therapy
633531|NCT00894166|Nicotine Patches|nicotine patches
633532|NCT00894166|Zyban|zyban
633533|NCT00894166|bupropion|bupropion
633534|NCT00894166|Quit Smoking|quit smoking
633535|NCT00894153|p53 gene|p53 gene
633536|NCT00894153|head and neck malignent tumors|head and neck malignent tumors
633537|NCT00894153|gene therapy|gene therapy
633538|NCT00894140|Hip|hip
633539|NCT00894140|Cementless|cementless
633540|NCT00894140|Conservative|conservative
633541|NCT00894127|Lung Cancer|lung cancer
633542|NCT00894127|Porphyrin|porphyrin
633543|NCT00894127|Fluorescence|fluorescence
633544|NCT00894127|Diagnostic|diagnostic
633545|NCT00894127|Sputum Cytology|sputum cytology
633546|NCT00894127|Early Detection|early detection
633547|NCT00894075|genetic metabolic disorder|genetic metabolic disorder
633548|NCT00894075|alkaline phosphatase|alkaline phosphatase
633549|NCT00894075|tissue non-specific alkaline phosphatase|tissue non-specific alkaline phosphatase
633550|NCT00894075|rickets|rickets
633551|NCT00894075|osteomalacia|osteomalacia
633552|NCT00894036|esbl children Switzerland|esbl children switzerland
633553|NCT00894036|Colonization|colonization
633554|NCT00894036|ESBL-producing gram-negative bacilli|esbl-producing gram-negative bacilli
633555|NCT00894036|Infection|infection
633556|NCT00894023|Patients with AMI|patients with ami
633557|NCT00894010|Photosensitive epilepsy|photosensitive epilepsy
633558|NCT00894010|Photosensitivity|photosensitivity
633559|NCT00894010|Seizures|seizures
633560|NCT00894010|Epilepsy|epilepsy
633561|NCT00893997|myelodysplastic syndrome|myelodysplastic syndrome
633562|NCT00893997|MDS|mds
633563|NCT00893997|PR1 Peptide Vaccine|pr1 peptide vaccine
633564|NCT00893984|Intolerance|intolerance
633565|NCT00893984|Beta blocker|beta blocker
633566|NCT00893971|Healthy Volunteers|healthy volunteers
633567|NCT00893932|SIRS leptin outcome sepsis|sirs leptin outcome sepsis
633568|NCT00893906|influenza|influenza
633569|NCT00893906|influenza vaccine|influenza vaccine
633570|NCT00893906|vaccine effectiveness|vaccine effectiveness
633571|NCT00893906|cluster randomized|cluster randomized
633572|NCT00893906|Africa|africa
633573|NCT00893893|Obesity|obesity
633574|NCT00893893|Lipid metabolism|lipid metabolism
633575|NCT00893893|VLDL|vldl
633576|NCT00893880|Tinea Pedis|tinea pedis
633577|NCT00893880|Athletes Foot|athletes foot
633578|NCT00893880|Nitric Oxide|nitric oxide
633579|NCT00893867|acute ischemic stroke|acute ischemic stroke
633580|NCT00893867|neuroprotective agent|neuroprotective agent
633581|NCT00893841|bipolar|bipolar
633582|NCT00893841|bipolar depression|bipolar depression
633583|NCT00893841|bipolar disorder|bipolar disorder
633584|NCT00893841|depression|depression
633585|NCT00893841|quetiapine|quetiapine
633586|NCT00893841|pramipexole|pramipexole
633587|NCT00893841|Seroquel XR|seroquel xr
633588|NCT00893841|Mirapex|mirapex
633589|NCT00893815|HIV|hiv
633590|NCT00893815|Neurocognitive function|neurocognitive function
633591|NCT00893802|periodontal disease|periodontal disease
633592|NCT00893802|pregnancy|pregnancy
633593|NCT00893802|periodontal treatment|periodontal treatment
633594|NCT00893763|Nosocomial (Hospital-Acquired) Infections|nosocomial (hospital-acquired) infections
633890|NCT00892593|colon|colon
633595|NCT00893763|Ventilator-Associated Pneumonia|ventilator-associated pneumonia
633596|NCT00893763|Mechanical ventilation|mechanical ventilation
633597|NCT00893763|Endotracheal intubation|endotracheal intubation
633598|NCT00893750|Vulnerable Youths in Northern Uganda|vulnerable youths in northern uganda
633599|NCT00893750|Formerly Abducted Children|formerly abducted children
633600|NCT00893750|Reintegration and Reconciliation|reintegration and reconciliation
633601|NCT00893750|Trauma Treatment|trauma treatment
633602|NCT00893750|Narrative Exposure Therapy|narrative exposure therapy
633603|NCT00893750|Reconciliation|reconciliation
633604|NCT00893750|Revenge Feelings|revenge feelings
633605|NCT00893737|Migraine|migraine
633606|NCT00893737|Headache, Migraine|headache, migraine
633607|NCT00893724|DME|dme
633608|NCT00893724|NAMD|namd
633609|NCT00893724|Oxidative damage|oxidative damage
633610|NCT00893724|Nutritional supplements/vitamins|nutritional supplements/vitamins
633611|NCT00893724|DNA repair|dna repair
633612|NCT00893724|NAMD/wet AMD|namd/wet amd
633613|NCT00893711|infantile colic|infantile colic
633614|NCT00893711|lactobacillus|lactobacillus
633615|NCT00893711|gut microflora|gut microflora
633616|NCT00893711|FISH|fish
633617|NCT00893711|toll like receptor|toll like receptor
633618|NCT00893711|T reg|t reg
633619|NCT00893711|messenger RNA|messenger rna
633620|NCT00893711|CC‑chemokine receptor 7|cc‑chemokine receptor 7
633621|NCT00893711|interleukin 10|interleukin 10
633622|NCT00893685|Telemedicine|telemedicine
633623|NCT00893672|Radiography, Thoracic|radiography, thoracic
633624|NCT00893672|Intensive Care Units|intensive care units
633625|NCT00893672|Ventilation, mechanical|ventilation, mechanical
633626|NCT00893672|Matched-Pair Analysis|matched-pair analysis
633627|NCT00893659|Beta-glucan|beta-glucan
633628|NCT00893659|faecal microflora|faecal microflora
633629|NCT00893659|polypectomized|polypectomized
633630|NCT00893659|Precancerous Nonmalignant Condition|precancerous nonmalignant condition
633631|NCT00893646|abdominal obesity|abdominal obesity
633632|NCT00893646|weight reduction|weight reduction
633633|NCT00893646|diet|diet
633634|NCT00893646|exercise training|exercise training
633635|NCT00893646|lifestyle activity|lifestyle activity
633636|NCT00893646|health-related fitness|health-related fitness
633637|NCT00893646|walking|walking
633638|NCT00893646|actigraphy|actigraphy
633639|NCT00893646|lifestyle modification|lifestyle modification
633640|NCT00893646|sleep|sleep
633641|NCT00893646|sleep hygiene|sleep hygiene
633642|NCT00893646|alertness|alertness
633643|NCT00893646|daytime sleepiness|daytime sleepiness
633644|NCT00893646|metabolic syndrome|metabolic syndrome
633645|NCT00893646|counselling|counselling
633646|NCT00893646|health education|health education
633647|NCT00893646|truck drivers|truck drivers
633648|NCT00893646|bus drivers|bus drivers
633649|NCT00893646|randomized controlled trial|randomized controlled trial
633650|NCT00893633|neuromuscular diseases|neuromuscular diseases
633651|NCT00893633|critical illness|critical illness
633652|NCT00893633|mechanical ventilation|mechanical ventilation
633653|NCT00893633|phrenic nerve|phrenic nerve
633654|NCT00893633|nerve conduction studies|nerve conduction studies
633655|NCT00893620|iliac aneurysm|iliac aneurysm
633656|NCT00893620|endovascular repair|endovascular repair
633657|NCT00893594|migraine|migraine
633658|NCT00893594|migraine with aura|migraine with aura
633659|NCT00893594|headache|headache
633660|NCT00893581|mania|mania
633661|NCT00893581|adolescent|adolescent
633662|NCT00893581|bipolar|bipolar
633663|NCT00893568|Post traumatic stress disorder PTSD|post traumatic stress disorder ptsd
633664|NCT00893555|Invasive fungal infection|invasive fungal infection
633665|NCT00893555|hematological malignancy|hematological malignancy
633666|NCT00893555|voriconazole|voriconazole
633667|NCT00893555|therapeutic drug monitoring|therapeutic drug monitoring
633668|NCT00893529|overweight|overweight
633669|NCT00893529|children|children
633670|NCT00893529|intervention|intervention
633671|NCT00893529|sugar-sweetened beverages|sugar-sweetened beverages
633672|NCT00893516|non cutaneous peripheral t-cell lymphoma with nodal involvement|non cutaneous peripheral t-cell lymphoma with nodal involvement
633673|NCT00893477|stage II grade 1 follicular lymphoma|stage ii grade 1 follicular lymphoma
633674|NCT00893477|stage II grade 2 follicular lymphoma|stage ii grade 2 follicular lymphoma
633675|NCT00893477|stage II grade 3 follicular lymphoma|stage ii grade 3 follicular lymphoma
633676|NCT00893477|stage III grade 1 follicular lymphoma|stage iii grade 1 follicular lymphoma
633677|NCT00893477|stage III grade 2 follicular lymphoma|stage iii grade 2 follicular lymphoma
633678|NCT00893477|stage III grade 3 follicular lymphoma|stage iii grade 3 follicular lymphoma
633679|NCT00893477|stage IV grade 1 follicular lymphoma|stage iv grade 1 follicular lymphoma
633680|NCT00893477|stage IV grade 2 follicular lymphoma|stage iv grade 2 follicular lymphoma
633681|NCT00893477|stage IV grade 3 follicular lymphoma|stage iv grade 3 follicular lymphoma
633682|NCT00893451|renal disease|renal disease
633683|NCT00893451|renal impairment|renal impairment
633684|NCT00893451|chronic kidney disease stage 3-4|chronic kidney disease stage 3-4
633685|NCT00893451|25(OH) vitamin D|25(oh) vitamin d
633686|NCT00893451|cholecalciferol|cholecalciferol
633687|NCT00893451|vitamin D deficiency|vitamin d deficiency
633688|NCT00893451|insulin resistance|insulin resistance
633689|NCT00893451|insulin-glucose clamp|insulin-glucose clamp
633690|NCT00893451|non-diabetic|non-diabetic
633691|NCT00893438|Chronic Fatigue Syndrome (CFS)|chronic fatigue syndrome (cfs)
633692|NCT00893438|Adolescence|adolescence
633693|NCT00893438|Cognitive behaviour therapy (CBT)|cognitive behaviour therapy (cbt)
633694|NCT00893438|Web-based|web-based
633695|NCT00893438|Internet|internet
633696|NCT00893438|Efficacy|efficacy
633698|NCT00893425|ADMA|adma
633699|NCT00893425|proteinuria|proteinuria
633700|NCT00893425|diabetic nephropathy|diabetic nephropathy
633701|NCT00893425|CD95 and ADMA levels|cd95 and adma levels
633702|NCT00893412|HSG|hsg
633703|NCT00893412|analgesia|analgesia
633704|NCT00893412|tramadol|tramadol
633705|NCT00893412|metal cannula|metal cannula
633706|NCT00893412|balloon catheter|balloon catheter
633707|NCT00893399|adult patients|adult patients
633708|NCT00893399|NPM1 mutation|npm1 mutation
633709|NCT00893386|Extraction|extraction
633710|NCT00893386|Removal|removal
633711|NCT00893386|Lead|lead
633712|NCT00893386|Heart Failure|heart failure
633713|NCT00893373|AML|aml
633714|NCT00893373|sorafenib|sorafenib
633715|NCT00893360|Adult Stem cells|adult stem cells
633716|NCT00893360|Cardiosphere derived stem cells|cardiosphere derived stem cells
633717|NCT00893360|Myocardial infarction|myocardial infarction
633718|NCT00893347|Mild traumatic brain injury|mild traumatic brain injury
633719|NCT00893347|Concussion|concussion
633720|NCT00893347|Post-Concussion Syndrome|post-concussion syndrome
633721|NCT00893347|Cognitive-Behavioural Therapy|cognitive-behavioural therapy
633722|NCT00893334|Duchenne and Becker muscular dystrophy|duchenne and becker muscular dystrophy
633723|NCT00893334|muscular dystrophy|muscular dystrophy
633724|NCT00893295|colon cancer|colon cancer
633725|NCT00893295|rectal cancer|rectal cancer
633726|NCT00893282|renal|renal
633727|NCT00893282|calculi|calculi
633728|NCT00893282|kidney|kidney
633729|NCT00893282|stones|stones
633730|NCT00893269|marijuana|marijuana
633731|NCT00893269|cannabis|cannabis
633732|NCT00893269|dependence|dependence
633733|NCT00893269|withdrawal|withdrawal
633734|NCT00893256|schizophrenia|schizophrenia
633735|NCT00893256|risperidone|risperidone
633736|NCT00893256|citalopram|citalopram
633737|NCT00893256|secondary negative symptoms|secondary negative symptoms
633738|NCT00893230|atopic dermatitis|atopic dermatitis
633739|NCT00893230|chemokines|chemokines
633740|NCT00893230|probiotics|probiotics
633741|NCT00893178|eNOS Polymorphism|enos polymorphism
633742|NCT00893178|TNF alpha polymorphism|tnf alpha polymorphism
633743|NCT00893178|pulmonary pressure|pulmonary pressure
633744|NCT00893178|polymorphism of vasoactive substances|polymorphism of vasoactive substances
633745|NCT00893165|inflammation|inflammation
633746|NCT00893165|cardiovascular disease|cardiovascular disease
633747|NCT00893139|Dry Eye|dry eye
633748|NCT00893126|psoriasis|psoriasis
633749|NCT00893126|coronary arteriosclerosis|coronary arteriosclerosis
633750|NCT00893126|coronary events|coronary events
633751|NCT00893126|rheumatoid arthritis|rheumatoid arthritis
633752|NCT00893126|arthritis|arthritis
633753|NCT00893087|Ventilatory care, children, intensive care, asynchrony, triggering|ventilatory care, children, intensive care, asynchrony, triggering
633754|NCT00893087|Children needing ventilatory care|children needing ventilatory care
633755|NCT00893074|withdrawal|withdrawal
633756|NCT00893074|acute effects|acute effects
633757|NCT00893074|cognitive performance|cognitive performance
633758|NCT00893074|Marijuana Use|marijuana use
633759|NCT00893074|Marijuana Abstinence|marijuana abstinence
633760|NCT00893061|stage IA breast cancer|stage ia breast cancer
633761|NCT00893061|stage IB breast cancer|stage ib breast cancer
633762|NCT00893061|stage II breast cancer|stage ii breast cancer
633763|NCT00893061|stage IIIA breast cancer|stage iiia breast cancer
633764|NCT00893061|stage IIIB breast cancer|stage iiib breast cancer
633765|NCT00893061|stage IIIC breast cancer|stage iiic breast cancer
633766|NCT00893061|estrogen receptor-positive breast cancer|estrogen receptor-positive breast cancer
633767|NCT00893061|progesterone receptor-positive breast cancer|progesterone receptor-positive breast cancer
633768|NCT00893048|prednisone|prednisone
633769|NCT00893048|cellulitis|cellulitis
633770|NCT00893048|erysipelas|erysipelas
633771|NCT00893048|steroids|steroids
633772|NCT00893048|oral|oral
633773|NCT00893035|Radiotherapy|radiotherapy
633774|NCT00893035|Late side effects|late side effects
633775|NCT00893035|Predictive assay|predictive assay
633776|NCT00893009|Forced expiratory volume in one second|forced expiratory volume in one second
633777|NCT00893009|Inspiratory capacity|inspiratory capacity
633778|NCT00893009|endurance time|endurance time
633779|NCT00893009|residual volume|residual volume
633780|NCT00892996|Intrathecal morphine|intrathecal morphine
633781|NCT00892996|Cesarean section|cesarean section
633782|NCT00892996|Nausea and vomiting|nausea and vomiting
633783|NCT00892996|Prevention|prevention
633784|NCT00892983|Obesity|obesity
633785|NCT00892983|Sleep|sleep
633786|NCT00892983|Physical activity|physical activity
633787|NCT00892983|Breast feeding|breast feeding
633788|NCT00892983|Depression|depression
633789|NCT00892957|Vascular Surgery|vascular surgery
633790|NCT00892957|Arterio-arterial bypasses|arterio-arterial bypasses
633791|NCT00892957|Arterio-venous (AV) shunts|arterio-venous (av) shunts
633792|NCT00892944|Positron Emission Tomography|positron emission tomography
633793|NCT00892944|Phase 1|phase 1
633794|NCT00892944|Healthy volunteers|healthy volunteers
633795|NCT00892944|AZD2516|azd2516
633796|NCT00892931|Glioblastoma|glioblastoma
633797|NCT00892931|Brain Neoplasms|brain neoplasms
633798|NCT00892931|Recurrence|recurrence
633799|NCT00892918|pterygium|pterygium
633800|NCT00892918|gatifloxacin|gatifloxacin
633801|NCT00892918|moxifloxacin|moxifloxacin
633802|NCT00892918|corneal epithelial defect|corneal epithelial defect
633803|NCT00892905|coagulation|coagulation
633804|NCT00892905|INR|inr
633805|NCT00892905|aPTT|aptt
633806|NCT00892905|point of care|point of care
633807|NCT00892905|laboratory|laboratory
633808|NCT00892905|CABG|cabg
633809|NCT00892905|surgery|surgery
633810|NCT00892892|sympatholytic treatment|sympatholytic treatment
633811|NCT00892892|sympathetic nerve activity|sympathetic nerve activity
633812|NCT00892853|calcification|calcification
633813|NCT00892853|osteoporosis|osteoporosis
633814|NCT00892827|Rituximab|rituximab
633815|NCT00892827|Mabthera|mabthera
633816|NCT00892827|FFP|ffp
633817|NCT00892827|Fresh Frozen Plasma|fresh frozen plasma
633818|NCT00892827|CLL|cll
633819|NCT00892827|Complement|complement
633820|NCT00892827|Response|response
633821|NCT00892827|Overall response rate of FFP+Rituximab combined therapy|overall response rate of ffp+rituximab combined therapy
633822|NCT00892827|Analysis of complement activation pathways prior to, during and|analysis of complement activation pathways prior to, during and
633823|NCT00892827|after the study treatment.|after the study treatment.
633824|NCT00892827|Time to disease progression|time to disease progression
633825|NCT00892827|Time to re-treatment (See Appendix I).|time to re-treatment (see appendix i).
633826|NCT00892827|Safety of the combination treatment of FFP and RTX.|safety of the combination treatment of ffp and rtx.
633827|NCT00892801|tumors metastatic to brain|tumors metastatic to brain
633828|NCT00892801|recurrent non-small cell lung cancer|recurrent non-small cell lung cancer
633829|NCT00892801|stage IV non-small cell lung cancer|stage iv non-small cell lung cancer
633830|NCT00892788|Overweight|overweight
633831|NCT00892788|Obesity|obesity
633832|NCT00892788|Contingency Management|contingency management
633833|NCT00892775|Working seed virus|working seed virus
633834|NCT00892775|Rubella|rubella
633835|NCT00892775|Mumps|mumps
633836|NCT00892775|Varicella|varicella
633837|NCT00892775|Combined measles-mumps-rubella-varicella vaccine|combined measles-mumps-rubella-varicella vaccine
633838|NCT00892775|Pediatric immunization|pediatric immunization
633839|NCT00892775|Measles|measles
633840|NCT00892762|Open Angle Glaucoma|open angle glaucoma
633841|NCT00892762|Ocular hypertension|ocular hypertension
633842|NCT00892762|OAG|oag
633843|NCT00892762|OH|oh
633844|NCT00892749|hyperphosphatemia|hyperphosphatemia
633845|NCT00892749|hemodialysis|hemodialysis
633846|NCT00892749|CKD|ckd
633847|NCT00892749|ASP1585|asp1585
633848|NCT00892723|AZX100|azx100
633849|NCT00892723|Patient and Observer Scar Assessment Scale|patient and observer scar assessment scale
633850|NCT00892723|POSAS|posas
633851|NCT00892723|Visual Analog Scale|visual analog scale
633852|NCT00892723|VAS|vas
633853|NCT00892723|Keloid|keloid
633854|NCT00892723|Scarring|scarring
633855|NCT00892723|Scar reduction|scar reduction
633856|NCT00892723|Scar prevention|scar prevention
633857|NCT00892710|Non small cell lung cancer|non small cell lung cancer
633858|NCT00892710|NSCLC|nsclc
633859|NCT00892710|Pemetrexed|pemetrexed
633860|NCT00892710|Bevacizumab|bevacizumab
633861|NCT00892710|Avastin|avastin
633862|NCT00892710|Carboplatin|carboplatin
633863|NCT00892710|Stage IIIB/IV|stage iiib/iv
633864|NCT00892697|hepatitis C|hepatitis c
633865|NCT00892697|FNA|fna
633866|NCT00892697|intrahepatic|intrahepatic
633867|NCT00892684|Randomized|randomized
633868|NCT00892684|Placebo controlled|placebo controlled
633869|NCT00892684|Double blind|double blind
633870|NCT00892684|Omega-3 fatty acids|omega-3 fatty acids
633871|NCT00892684|Pregnancy|pregnancy
633872|NCT00892684|Childhood allergy|childhood allergy
633873|NCT00892684|Cytokines|cytokines
633874|NCT00892684|Eicosanoids|eicosanoids
633875|NCT00892684|Polyunsaturated fatty acids|polyunsaturated fatty acids
633876|NCT00892671|Perceived effectiveness|perceived effectiveness
633877|NCT00892658|Sorafenib|sorafenib
633878|NCT00892658|Hepatocellular carcinoma|hepatocellular carcinoma
633879|NCT00892632|Biliary Strictures|biliary strictures
633880|NCT00892632|Cholangiocarcinoma|cholangiocarcinoma
633882|NCT00892619|Epiretinal Membrane|epiretinal membrane
633883|NCT00892619|Vitreomacular traction|vitreomacular traction
633884|NCT00892619|MVR blade|mvr blade
633885|NCT00892619|Tano brush|tano brush
633886|NCT00892619|ILM forceps|ilm forceps
633887|NCT00892619|surgical technique|surgical technique
633888|NCT00892606|Surgery, Orthopedic|surgery, orthopedic
633889|NCT00892606|Pain, Postoperative|pain, postoperative
633891|NCT00892593|neoplasia|neoplasia
633892|NCT00892593|polyp|polyp
633893|NCT00892593|adenoma|adenoma
633894|NCT00892593|FIT|fit
633895|NCT00892593|cancer|cancer
633896|NCT00892580|fragile X syndrome|fragile x syndrome
633897|NCT00892580|biomarkers|biomarkers
633898|NCT00892567|breast cancer|breast cancer
633899|NCT00892567|peptide vaccine|peptide vaccine
633900|NCT00892567|immunotherapy|immunotherapy
633901|NCT00892554|Phenylketonurias|phenylketonurias
633902|NCT00892554|Docosahexaenoic Acids|docosahexaenoic acids
633903|NCT00892554|Neuropsychological Tests|neuropsychological tests
633904|NCT00892554|Female|female
633905|NCT00892554|Adolescent|adolescent
633906|NCT00892554|Adult|adult
633907|NCT00892541|Schizophrenia|schizophrenia
633908|NCT00892541|Mood disorders|mood disorders
633909|NCT00892541|Antipsychotic drugs|antipsychotic drugs
633910|NCT00892541|Renal secretion|renal secretion
633911|NCT00892541|ER OROS paliperidone|er oros paliperidone
633912|NCT00892515|breast cancer|breast cancer
633913|NCT00892515|healthy, no evidence of disease|healthy, no evidence of disease
633914|NCT00892502|haematology|haematology
633915|NCT00892502|haematological|haematological
633916|NCT00892502|hematology|hematology
633917|NCT00892502|hematological|hematological
633918|NCT00892502|malignancy|malignancy
633919|NCT00892502|lymphoma|lymphoma
633920|NCT00892502|myeloma|myeloma
633921|NCT00892502|leukemia|leukemia
633922|NCT00892502|blood diseases|blood diseases
633923|NCT00892502|malignant|malignant
633924|NCT00892502|bismuth|bismuth
633925|NCT00892489|Schizophrenia, Mood disorders, Antipsychotics|schizophrenia, mood disorders, antipsychotics
633926|NCT00892489|ER OROS Paliperidone|er oros paliperidone
633927|NCT00892476|myopia|myopia
633928|NCT00892476|calcium supplementation|calcium supplementation
807553|NCT00222456|outcome|outcome
633929|NCT00892476|prematurity|prematurity
633930|NCT00892463|Major Depressive Disorder|major depressive disorder
633931|NCT00892463|Seroquel XR|seroquel xr
633932|NCT00892463|Quetiapine|quetiapine
633933|NCT00892450|Overactive bladder symptoms|overactive bladder symptoms
633934|NCT00892450|Parkinson's disease|parkinson's disease
633935|NCT00892450|darifenacin|darifenacin
633936|NCT00892450|oxybutynin|oxybutynin
633937|NCT00892450|cognition|cognition
633938|NCT00892437|HIV|hiv
633939|NCT00892437|HIV-1|hiv-1
633940|NCT00892437|Antiretroviral Treatment-Naive|antiretroviral treatment-naive
633941|NCT00892424|Liver metastasis|liver metastasis
633942|NCT00892424|sorafenib|sorafenib
633943|NCT00892424|Liver metastasis from cancer|liver metastasis from cancer
633944|NCT00892411|Neuroplasticity|neuroplasticity
633945|NCT00892411|Prognosis|prognosis
633946|NCT00892398|Trabeculectomy|trabeculectomy
633947|NCT00892398|Vascular Endothelial Growth Factor A|vascular endothelial growth factor a
633948|NCT00892398|Wound Healing|wound healing
633949|NCT00892398|Angiogenesis Inhibitors|angiogenesis inhibitors
633950|NCT00892385|unspecified adult solid tumor, protocol specific|unspecified adult solid tumor, protocol specific
633951|NCT00892372|body weight|body weight
633952|NCT00892372|glycohemoglobin|glycohemoglobin
633953|NCT00892359|pharmacokinetics|pharmacokinetics
633954|NCT00892359|renal replacement therapy|renal replacement therapy
633955|NCT00892359|hemofiltration|hemofiltration
633956|NCT00892359|anidulafungin|anidulafungin
633957|NCT00892346|autologous hematopoietic stem cell transplantation|autologous hematopoietic stem cell transplantation
633958|NCT00892346|maintenance|maintenance
633959|NCT00892333|Repair of a large hernia with SurgiMend 3.0, a biologic mesh|repair of a large hernia with surgimend 3.0, a biologic mesh
633960|NCT00892320|Schizophrenia, mood stabilizers, antipsychotics|schizophrenia, mood stabilizers, antipsychotics
633961|NCT00892320|ER OROS paliperidone|er oros paliperidone
633962|NCT00892307|Diagnostic Imaging|diagnostic imaging
633963|NCT00892307|Dual Source Multidetector Computed Tomography|dual source multidetector computed tomography
633964|NCT00892307|Computed Tomography|computed tomography
633965|NCT00892307|CT|ct
633966|NCT00892307|Single Photon Emission Computed Tomography|single photon emission computed tomography
633967|NCT00892307|SPECT|spect
633968|NCT00892307|Myocardial Perfusion|myocardial perfusion
633969|NCT00892307|Atherosclerosis|atherosclerosis
633970|NCT00892268|menopausal symptoms|menopausal symptoms
633971|NCT00892268|estrogen receptor-positive breast cancer|estrogen receptor-positive breast cancer
633972|NCT00892268|progesterone receptor-positive breast cancer|progesterone receptor-positive breast cancer
633973|NCT00892268|breast cancer|breast cancer
633974|NCT00892268|pain|pain
633975|NCT00892255|Liver cancer|liver cancer
633976|NCT00892255|Tumors|tumors
633977|NCT00892242|Neoadjuvant zoledronic acid in resectable pancreas cancer|neoadjuvant zoledronic acid in resectable pancreas cancer
633978|NCT00892229|First trimester missed abortion|first trimester missed abortion
633979|NCT00892229|Misoprostol|misoprostol
633980|NCT00892229|buccal|buccal
633981|NCT00892229|vaginal|vaginal
633982|NCT00892229|cervical ripening|cervical ripening
633983|NCT00892229|first trimester|first trimester
633984|NCT00892229|missed abortion|missed abortion
633985|NCT00892216|PONV|ponv
633986|NCT00892216|NUSS procedure|nuss procedure
633987|NCT00892216|Acupressure|acupressure
633988|NCT00892216|Pectus Excavatum|pectus excavatum
633989|NCT00892203|Migraine|migraine
633990|NCT00892203|Headache|headache
633991|NCT00892190|AML|aml
633992|NCT00892190|Dasatinib|dasatinib
633993|NCT00892190|all trans retinoic acid|all trans retinoic acid
633994|NCT00892190|relapsed AML|relapsed aml
633995|NCT00892190|refractory AML|refractory aml
633996|NCT00892190|Relapsed/Refractory Acute myelogenous leukemia|relapsed/refractory acute myelogenous leukemia
633997|NCT00892190|Elderly subjects (age 65 or older) with acute myelogenous leukemia|elderly subjects (age 65 or older) with acute myelogenous leukemia
633998|NCT00892190|Myelodysplastic Syndrome|myelodysplastic syndrome
633999|NCT00892190|MDS|mds
634000|NCT00892177|adult giant cell glioblastoma|adult giant cell glioblastoma
634001|NCT00892177|adult glioblastoma|adult glioblastoma
634002|NCT00892177|adult gliosarcoma|adult gliosarcoma
634003|NCT00892177|adult mixed glioma|adult mixed glioma
634004|NCT00892177|recurrent adult brain tumor|recurrent adult brain tumor
634005|NCT00892177|adult anaplastic oligodendroglioma|adult anaplastic oligodendroglioma
634006|NCT00892177|adult oligodendroglioma|adult oligodendroglioma
634007|NCT00892177|adult anaplastic astrocytoma|adult anaplastic astrocytoma
634008|NCT00892164|thyroid surgery|thyroid surgery
634009|NCT00892164|total thyroidectomy|total thyroidectomy
634010|NCT00892164|harmonic scalpel|harmonic scalpel
634011|NCT00892164|electrothermal bipolar vessel sealer|electrothermal bipolar vessel sealer
634012|NCT00892164|hemostatic device|hemostatic device
634013|NCT00892138|mindfulness training|mindfulness training
634014|NCT00892138|medical students|medical students
634015|NCT00892138|psychology students|psychology students
634016|NCT00892138|stress management|stress management
634017|NCT00892138|personal development|personal development
634018|NCT00892138|stress|stress
634019|NCT00892125|Schizophrenia|schizophrenia
634020|NCT00892125|Bipolar I disorder|bipolar i disorder
634021|NCT00892125|mood disorders|mood disorders
634022|NCT00892125|antipsychotic drugs|antipsychotic drugs
634023|NCT00892125|enzyme inducer|enzyme inducer
634024|NCT00892125|Paliperidone ER|paliperidone er
634025|NCT00892112|Immunoglobulins, Intravenous|immunoglobulins, intravenous
634026|NCT00892112|Cardiomyopathies|cardiomyopathies
634027|NCT00892112|Parvo B19, Human|parvo b19, human
634028|NCT00892099|end stage renal disease|end stage renal disease
634029|NCT00892099|hemodialysis|hemodialysis
634030|NCT00892086|geriatric syndrome|geriatric syndrome
634031|NCT00892086|immobility|immobility
634032|NCT00892073|Craniopharyngioma surgery|craniopharyngioma surgery
634033|NCT00892073|Hypothalamic Obesity|hypothalamic obesity
634034|NCT00892073|Children|children
634035|NCT00892073|Combined Diazoxide and Metformin|combined diazoxide and metformin
634036|NCT00892047|Depression|depression
634037|NCT00892047|Aripiprazole|aripiprazole
634038|NCT00892047|Venlafaxine|venlafaxine
634039|NCT00892047|Partial Remission|partial remission
634040|NCT00892047|Augmentation strategy|augmentation strategy
634041|NCT00892047|Treatment resistance|treatment resistance
634042|NCT00892047|Elderly|elderly
634043|NCT00892047|Late-life|late-life
634044|NCT00892008|pregabalin|pregabalin
634045|NCT00892008|neuropathic pain|neuropathic pain
634046|NCT00892008|safety|safety
634047|NCT00891995|Type 1 Diabetes|type 1 diabetes
634048|NCT00891995|Closed Loop Therapy|closed loop therapy
634049|NCT00891995|Continuous Glucose Monitor|continuous glucose monitor
634050|NCT00891982|Acne Vulgaris|acne vulgaris
634051|NCT00891969|stage I breast cancer|stage i breast cancer
634052|NCT00891969|stage II breast cancer|stage ii breast cancer
634053|NCT00891969|stage IIIA breast cancer|stage iiia breast cancer
634054|NCT00891956|Rett Syndrome|rett syndrome
634055|NCT00891943|Obesity|obesity
634056|NCT00891943|Overweight|overweight
634057|NCT00891943|Randomised controlled trial|randomised controlled trial
634058|NCT00891943|Primary Care|primary care
634059|NCT00891943|Weight|weight
634060|NCT00891943|Cardiovascular Risk|cardiovascular risk
634061|NCT00891943|Diabetes|diabetes
634062|NCT00891943|Quality of life|quality of life
634063|NCT00891930|wild-type KRAS|wild-type kras
634064|NCT00891930|panitumumab|panitumumab
634065|NCT00891930|biomarker|biomarker
634066|NCT00891930|mechanisms of acquired resistance|mechanisms of acquired resistance
634067|NCT00891930|metastatic colorectal cancer|metastatic colorectal cancer
634068|NCT00891917|Down syndrome|down syndrome
634069|NCT00891917|coenzyme Q10|coenzyme q10
634070|NCT00891917|language function|language function
634071|NCT00891917|behavior|behavior
634072|NCT00891904|recurrent squamous cell carcinoma of the hypopharynx|recurrent squamous cell carcinoma of the hypopharynx
634073|NCT00891904|recurrent squamous cell carcinoma of the larynx|recurrent squamous cell carcinoma of the larynx
634074|NCT00891904|recurrent squamous cell carcinoma of the lip and oral cavity|recurrent squamous cell carcinoma of the lip and oral cavity
634075|NCT00891904|recurrent squamous cell carcinoma of the nasopharynx|recurrent squamous cell carcinoma of the nasopharynx
634076|NCT00891904|recurrent squamous cell carcinoma of the oropharynx|recurrent squamous cell carcinoma of the oropharynx
634077|NCT00891904|recurrent squamous cell carcinoma of the paranasal sinus and nasal cavity|recurrent squamous cell carcinoma of the paranasal sinus and nasal cavity
634078|NCT00891891|spina bifida, psychosocial adjustment, adolescence, emerging adulthood|spina bifida, psychosocial adjustment, adolescence, emerging adulthood
634079|NCT00891878|adenocarcinoma of the esophagus|adenocarcinoma of the esophagus
634080|NCT00891878|adenocarcinoma of the gastroesophageal junction|adenocarcinoma of the gastroesophageal junction
634081|NCT00891878|recurrent esophageal cancer|recurrent esophageal cancer
634082|NCT00891878|stage IV esophageal cancer|stage iv esophageal cancer
634083|NCT00891878|stage III esophageal cancer|stage iii esophageal cancer
634084|NCT00891865|lung transplant|lung transplant
634085|NCT00891865|BOS|bos
634086|NCT00891865|OB|ob
634087|NCT00891865|Respiratory Viral Infection (RVI)|respiratory viral infection (rvi)
634088|NCT00891865|Lung disease|lung disease
634089|NCT00891826|Bipolar disorders|bipolar disorders
634090|NCT00891826|Omega-3 fatty acids|omega-3 fatty acids
634091|NCT00891826|Heart rate|heart rate
634092|NCT00891800|Cancer|cancer
634093|NCT00891800|Breast|breast
634094|NCT00891800|Liver|liver
634095|NCT00891787|Probiotics|probiotics
634096|NCT00891787|Isoagglutinins|isoagglutinins
634097|NCT00891787|Anti-A|anti-a
634098|NCT00891787|Anti-B|anti-b
634099|NCT00891787|Hemolysis|hemolysis
634100|NCT00891787|Healthy Volunteer|healthy volunteer
634101|NCT00891787|HV|hv
634102|NCT00891761|cisplatin|cisplatin
634103|NCT00891761|nausea|nausea
634104|NCT00891761|vomiting|vomiting
634105|NCT00891761|cancer|cancer
634106|NCT00891761|lung cancer|lung cancer
634107|NCT00891735|Lucentis|lucentis
634108|NCT00891735|AMD|amd
634109|NCT00891735|Age-related macular degeneration|age-related macular degeneration
634110|NCT00891735|Subfoveal neovascular age-related macular degeneration|subfoveal neovascular age-related macular degeneration
634111|NCT00891735|Wet AMD|wet amd
634112|NCT00891735|Macular degeneration|macular degeneration
634113|NCT00891735|Ranibizumab|ranibizumab
634114|NCT00891722|recurrent childhood brain stem glioma|recurrent childhood brain stem glioma
634115|NCT00891722|untreated childhood brain stem glioma|untreated childhood brain stem glioma
634116|NCT00891722|recurrent childhood cerebellar astrocytoma|recurrent childhood cerebellar astrocytoma
634117|NCT00891722|untreated childhood cerebellar astrocytoma|untreated childhood cerebellar astrocytoma
634118|NCT00891722|childhood low-grade cerebral astrocytoma|childhood low-grade cerebral astrocytoma
634119|NCT00891722|recurrent childhood cerebral astrocytoma|recurrent childhood cerebral astrocytoma
634120|NCT00891722|childhood oligodendroglioma|childhood oligodendroglioma
634121|NCT00891722|recurrent childhood visual pathway and hypothalamic glioma|recurrent childhood visual pathway and hypothalamic glioma
634122|NCT00891722|untreated childhood visual pathway and hypothalamic glioma|untreated childhood visual pathway and hypothalamic glioma
634123|NCT00891722|childhood mixed glioma|childhood mixed glioma
634124|NCT00891696|Sarcopenia|sarcopenia
634125|NCT00891696|Aging|aging
634126|NCT00891696|Metabolism|metabolism
634127|NCT00891696|Muscle|muscle
634128|NCT00891696|mTOR|mtor
634129|NCT00891696|Essential Amino Acids|essential amino acids
634130|NCT00891696|Exercise|exercise
634131|NCT00891696|Rapamycin|rapamycin
634132|NCT00891683|Diabetic|diabetic
634133|NCT00891683|peripheral|peripheral
634134|NCT00891683|neuropathy|neuropathy
634135|NCT00891683|pain|pain
634136|NCT00891683|hyperalgesia|hyperalgesia
634137|NCT00891683|allodynia|allodynia
634138|NCT00891670|CYP2C19 polymorphism|cyp2c19 polymorphism
634139|NCT00891670|platelet|platelet
634140|NCT00891670|Adjunctive cilostazol|adjunctive cilostazol
634141|NCT00891670|high maintenance dose clopidogrel|high maintenance dose clopidogrel
634142|NCT00891670|P2Y12 Reaction Unit|p2y12 reaction unit
634143|NCT00891657|Adhesion|adhesion
634144|NCT00891657|Fibroid|fibroid
634145|NCT00891657|Myoma|myoma
634146|NCT00891657|Leiomyoma|leiomyoma
634147|NCT00891657|Myomectomy|myomectomy
634148|NCT00891644|HIV|hiv
634149|NCT00891644|Care-seeking|care-seeking
634150|NCT00891631|tobacco|tobacco
634151|NCT00891631|alcohol|alcohol
634152|NCT00891631|marijuana|marijuana
634153|NCT00891631|drug use|drug use
634154|NCT00891631|seat-belt|seat-belt
634155|NCT00891631|weapons|weapons
634156|NCT00891631|depression|depression
634157|NCT00891631|suicidality|suicidality
634158|NCT00891631|sexual risk behaviors|sexual risk behaviors
634159|NCT00891618|Lymphoma|lymphoma
634160|NCT00891618|Myeloma|myeloma
634161|NCT00891618|Multiple Myeloma|multiple myeloma
634162|NCT00891618|MM|mm
634163|NCT00891618|Non-Hodgkin's Lymphoma|non-hodgkin's lymphoma
634164|NCT00891618|NHL|nhl
634165|NCT00891618|Acupuncture|acupuncture
634166|NCT00891618|Treatment-induced Peripheral Neuropathy|treatment-induced peripheral neuropathy
634167|NCT00891618|Thalidomide|thalidomide
634168|NCT00891618|Bortezomib|bortezomib
634169|NCT00891618|Neuropathy|neuropathy
634170|NCT00891618|Peripheral Neuropathy|peripheral neuropathy
634171|NCT00891605|Paclitaxel|paclitaxel
634172|NCT00891605|Solid Tumors|solid tumors
634173|NCT00891592|AML|aml
634174|NCT00891592|MDS|mds
634175|NCT00891592|ALL|all
634176|NCT00891592|NHL|nhl
634177|NCT00891592|Multiple Myeloma|multiple myeloma
634178|NCT00891592|Hodgkin's|hodgkin's
634179|NCT00891579|NSCLC|nsclc
634180|NCT00891579|EGFR|egfr
634181|NCT00891579|Pemetrexed|pemetrexed
634182|NCT00891579|Gefitinib|gefitinib
634183|NCT00891579|without EGFR mutations|without egfr mutations
634184|NCT00891566|medium to large tear|medium to large tear
634185|NCT00891566|rotator cuff tear|rotator cuff tear
634186|NCT00891566|arthroscopic repair|arthroscopic repair
634187|NCT00891566|repair integrity|repair integrity
634188|NCT00891566|immobilization|immobilization
634189|NCT00891553|bone mineral density|bone mineral density
634190|NCT00891553|calcium-sensing receptor antagonist|calcium-sensing receptor antagonist
634191|NCT00891553|ronacaleret|ronacaleret
634192|NCT00891553|postmenopausal osteoporosis|postmenopausal osteoporosis
634193|NCT00891527|Pulmonary Vein Stenosis,|pulmonary vein stenosis,
634194|NCT00891527|Avastin and Gleevec,|avastin and gleevec,
634195|NCT00891527|Targeting VEGF and PDGF|targeting vegf and pdgf
634196|NCT00891514|Exercise|exercise
634197|NCT00891514|Inflammation|inflammation
634198|NCT00891514|Insulin Sensitivity|insulin sensitivity
634199|NCT00891501|autologous bone marrow mesenchymal stem cells|autologous bone marrow mesenchymal stem cells
634200|NCT00891501|cartilage repair|cartilage repair
634201|NCT00891501|osteoarthritis|osteoarthritis
634202|NCT00891501|osteochondral defects|osteochondral defects
634203|NCT00891488|VO2 max|vo2 max
634204|NCT00891488|stress|stress
634205|NCT00891488|cortisol|cortisol
634206|NCT00891488|fitness|fitness
634207|NCT00891475|metastatic renal cell carcinoma|metastatic renal cell carcinoma
634208|NCT00891475|radiofrequency ablation|radiofrequency ablation
634209|NCT00891462|COPD|copd
634210|NCT00891462|Chronic Obstructive Pulmonary Disease|chronic obstructive pulmonary disease
634211|NCT00891462|Chronic Bronchitis|chronic bronchitis
634212|NCT00891462|Emphysema|emphysema
634213|NCT00891462|Airflow Obstruction, Chronic|airflow obstruction, chronic
634214|NCT00891462|Chronic Airflow Obstruction|chronic airflow obstruction
634215|NCT00891462|Chronic Obstructive Airway Disease|chronic obstructive airway disease
634216|NCT00891462|Chronic Obstructive Lung Disease|chronic obstructive lung disease
634217|NCT00891449|space flight simulation study|space flight simulation study
634218|NCT00891449|medical research study|medical research study
634219|NCT00891449|bed rest|bed rest
634220|NCT00891449|microgravity|microgravity
634221|NCT00891449|weightlessness|weightlessness
634222|NCT00891449|The effects of long duration microgravity on humans|the effects of long duration microgravity on humans
634223|NCT00891423|Meropenem|meropenem
634224|NCT00891423|extended infusion|extended infusion
634225|NCT00891423|prolonged infusion|prolonged infusion
634226|NCT00891423|Time above MIC|time above mic
634227|NCT00891397|CPRS|cprs
634228|NCT00891397|stellate ganglion block|stellate ganglion block
634229|NCT00891397|pregabalin|pregabalin
634230|NCT00891397|pain|pain
634231|NCT00891397|Type I|type i
634232|NCT00891384|Multiple Myeloma|multiple myeloma
634233|NCT00891384|maintenance therapy|maintenance therapy
634234|NCT00891384|lenalidomide|lenalidomide
634235|NCT00891371|symptomatic treatment of patients with refractory diarrhea|symptomatic treatment of patients with refractory diarrhea
634236|NCT00891358|Adolescent Medicine Trials Network for HIV/AIDS Interventions|adolescent medicine trials network for hiv/aids interventions
634237|NCT00891358|Human Immunodeficiency Virus|human immunodeficiency virus
634238|NCT00891358|HIV seronegativity|hiv seronegativity
634239|NCT00891345|hormone-refractory prostate cancer|hormone-refractory prostate cancer
634240|NCT00891345|Immunotherapy|immunotherapy
634241|NCT00891319|hand|hand
634242|NCT00891319|stroke|stroke
634243|NCT00891319|hemiplegia|hemiplegia
634244|NCT00891319|electrical stimulation|electrical stimulation
634245|NCT00891319|recovery|recovery
634246|NCT00891306|LPLD, Lipoprotein Lipase Deficiency|lpld, lipoprotein lipase deficiency
634247|NCT00891306|Chylomicronemia|chylomicronemia
634248|NCT00891306|Gene therapy|gene therapy
634249|NCT00891306|AAV|aav
634250|NCT00891306|Lipoprotein Lipase|lipoprotein lipase
634251|NCT00891306|Alipogene tiparvovec|alipogene tiparvovec
634252|NCT00891306|AMT-011|amt-011
634253|NCT00891293|omega-3-acid ethyl esters|omega-3-acid ethyl esters
634254|NCT00891293|Very high triglycerides|very high triglycerides
634255|NCT00891293|Lovaza|lovaza
634256|NCT00891293|fenofibrate|fenofibrate
634257|NCT00891280|Inflammatory breast cancer|inflammatory breast cancer
634258|NCT00891280|Castleman's Disease|castleman's disease
634259|NCT00891280|Multiple Myeloma|multiple myeloma
634260|NCT00891280|Breast cancer|breast cancer
634261|NCT00891280|Solid tumors|solid tumors
634262|NCT00891280|CK2 inhibitor|ck2 inhibitor
634263|NCT00891267|Inflammatory markers|inflammatory markers
634264|NCT00891267|Vascular protection|vascular protection
634265|NCT00891267|OM Effect|om effect
634266|NCT00891267|Metabolic syndrome|metabolic syndrome
634267|NCT00891267|Hypertension|hypertension
634268|NCT00891254|Incisional hernia|incisional hernia
634269|NCT00891254|Intraperitoneal mesh repair|intraperitoneal mesh repair
634270|NCT00891254|On-lay repair|on-lay repair
634271|NCT00891254|Prosthetic mesh|prosthetic mesh
634272|NCT00891254|First repair (no recurrent hernia will be included)|first repair (no recurrent hernia will be included)
634273|NCT00891254|Recurrence|recurrence
634274|NCT00891254|Complications|complications
634275|NCT00891241|Heart Failure, PET Imaging, Implantable Cardioverter-Defibrillator, Dosimetry|heart failure, pet imaging, implantable cardioverter-defibrillator, dosimetry
634276|NCT00891228|Contraception|contraception
634277|NCT00891228|Male Contraception|male contraception
634278|NCT00891228|Suppression of Sperm Production|suppression of sperm production
634279|NCT00891202|Gaucher,|gaucher,
634280|NCT00891202|beta-glucosidase,|beta-glucosidase,
634281|NCT00891202|acid ß-glucosidase,|acid ß-glucosidase,
634282|NCT00891202|glucocerebrosidase,|glucocerebrosidase,
634283|NCT00891202|glucosylceramide,|glucosylceramide,
634284|NCT00891202|D-glucosyl-N-acylsphingosine glucohydrolase,|d-glucosyl-n-acylsphingosine glucohydrolase,
634285|NCT00891202|substrate reduction therapy|substrate reduction therapy
634286|NCT00891189|Circadian Rhythm|circadian rhythm
634287|NCT00891176|Conjugate vaccines|conjugate vaccines
634288|NCT00891176|Meningococcal serogroup C vaccine|meningococcal serogroup c vaccine
634289|NCT00891176|Antibody persistence|antibody persistence
634290|NCT00891176|Pneumococcal vaccine|pneumococcal vaccine
634291|NCT00891176|Haemophilus Influenzae type b vaccine|haemophilus influenzae type b vaccine
634292|NCT00891163|Topical anesthesia|topical anesthesia
634293|NCT00891163|Analgesia|analgesia
634294|NCT00891137|adult acute myeloid leukemia 11q23 (MLL) abnormalities|adult acute myeloid leukemia 11q23 (mll) abnormalities
634295|NCT00891137|adult acute myeloid leukemia inv(16)(p13;q22)|adult acute myeloid leukemia inv(16)(p13;q22)
634296|NCT00891137|adult acute myeloid leukemia t(15;17)(q22;q12)|adult acute myeloid leukemia t(15;17)(q22;q12)
634297|NCT00891137|adult acute myeloid leukemia t(16;16)(p13;q22)|adult acute myeloid leukemia t(16;16)(p13;q22)
808042|NCT00220428|T cell|t cell
634298|NCT00891137|adult acute myeloid leukemia t(8;21)(q22;q22)|adult acute myeloid leukemia t(8;21)(q22;q22)
634299|NCT00891137|accelerated phase chronic myelogenous leukemia|accelerated phase chronic myelogenous leukemia
634300|NCT00891137|adult acute lymphoblastic leukemia in remission|adult acute lymphoblastic leukemia in remission
634301|NCT00891137|adult acute myeloid leukemia in remission|adult acute myeloid leukemia in remission
634302|NCT00891137|childhood acute lymphoblastic leukemia in remission|childhood acute lymphoblastic leukemia in remission
634303|NCT00891137|childhood acute myeloid leukemia in remission|childhood acute myeloid leukemia in remission
634304|NCT00891137|childhood chronic myelogenous leukemia|childhood chronic myelogenous leukemia
634305|NCT00891137|blastic phase chronic myelogenous leukemia|blastic phase chronic myelogenous leukemia
634306|NCT00891137|childhood diffuse large cell lymphoma|childhood diffuse large cell lymphoma
634307|NCT00891137|childhood immunoblastic large cell lymphoma|childhood immunoblastic large cell lymphoma
634308|NCT00891137|chronic phase chronic myelogenous leukemia|chronic phase chronic myelogenous leukemia
634309|NCT00891137|de novo myelodysplastic syndromes|de novo myelodysplastic syndromes
634310|NCT00891137|extranodal marginal zone B-cell lymphoma|extranodal marginal zone b-cell lymphoma
634311|NCT00891137|mucosa-associated lymphoid tissue|mucosa-associated lymphoid tissue
634312|NCT00891137|nodal marginal zone B-cell lymphoma|nodal marginal zone b-cell lymphoma
634313|NCT00891137|stage I adult Burkitt lymphoma|stage i adult burkitt lymphoma
634314|NCT00891137|contiguous stage II adult Burkitt lymphoma|contiguous stage ii adult burkitt lymphoma
634315|NCT00891137|noncontiguous stage II adult Burkitt lymphoma|noncontiguous stage ii adult burkitt lymphoma
634316|NCT00891137|Waldenstrom macroglobulinemia|waldenstrom macroglobulinemia
634317|NCT00891137|noncontiguous stage II adult immunoblastic|noncontiguous stage ii adult immunoblastic
634318|NCT00891137|contiguous stage II adult immunoblastic|contiguous stage ii adult immunoblastic
634319|NCT00891137|large cell lymphoma|large cell lymphoma
634320|NCT00891137|stage I adult immunoblastic large cell lymphoma|stage i adult immunoblastic large cell lymphoma
634321|NCT00891137|previously treated myelodysplastic syndromes|previously treated myelodysplastic syndromes
634322|NCT00891137|recurrent adult Burkitt lymphoma|recurrent adult burkitt lymphoma
634323|NCT00891137|recurrent adult diffuse large cell lymphoma|recurrent adult diffuse large cell lymphoma
634324|NCT00891137|recurrent adult immunoblastic large cell lymphoma|recurrent adult immunoblastic large cell lymphoma
634325|NCT00891137|recurrent adult lymphoblastic lymphoma|recurrent adult lymphoblastic lymphoma
634326|NCT00891137|recurrent grade 1 follicular lymphoma|recurrent grade 1 follicular lymphoma
634327|NCT00891137|recurrent grade 2 follicular lymphoma|recurrent grade 2 follicular lymphoma
634328|NCT00891137|recurrent grade 3 follicular lymphoma|recurrent grade 3 follicular lymphoma
634329|NCT00891137|recurrent marginal zone lymphoma|recurrent marginal zone lymphoma
634330|NCT00891137|recurrent small lymphocytic lymphoma|recurrent small lymphocytic lymphoma
634331|NCT00891137|refractory multiple myeloma|refractory multiple myeloma
634332|NCT00891137|relapsing chronic myelogenous leukemia|relapsing chronic myelogenous leukemia
634333|NCT00891137|secondary acute myeloid leukemia|secondary acute myeloid leukemia
634334|NCT00891137|secondary myelodysplastic syndromes|secondary myelodysplastic syndromes
634335|NCT00891137|splenic marginal zone lymphoma|splenic marginal zone lymphoma
634336|NCT00891137|stage I multiple myeloma|stage i multiple myeloma
634337|NCT00891137|stage II multiple myeloma|stage ii multiple myeloma
634338|NCT00891137|stage III multiple myeloma|stage iii multiple myeloma
634339|NCT00891137|stage III adult Burkitt lymphoma|stage iii adult burkitt lymphoma
634340|NCT00891137|stage III adult diffuse large cell lymphoma|stage iii adult diffuse large cell lymphoma
634341|NCT00891137|stage III adult immunoblastic large cell lymphoma|stage iii adult immunoblastic large cell lymphoma
634342|NCT00891137|stage III adult lymphoblastic lymphoma|stage iii adult lymphoblastic lymphoma
634343|NCT00891137|stage IV adult immunoblastic large cell lymphoma|stage iv adult immunoblastic large cell lymphoma
634458|NCT00890851|Men health|men health
634344|NCT00891137|stage IV adult lymphoblastic lymphoma|stage iv adult lymphoblastic lymphoma
634345|NCT00891137|refractory anemia with excess blasts in transformation|refractory anemia with excess blasts in transformation
634346|NCT00891137|refractory anemia with excess blasts|refractory anemia with excess blasts
634347|NCT00891137|refractory anemia|refractory anemia
634348|NCT00891137|prolymphocytic leukemia|prolymphocytic leukemia
634349|NCT00891137|contiguous stage II adult diffuse large cell lymphoma|contiguous stage ii adult diffuse large cell lymphoma
634350|NCT00891137|noncontiguous stage II adult diffuse large cell lymphoma|noncontiguous stage ii adult diffuse large cell lymphoma
634351|NCT00891137|refractory chronic lymphocytic leukemia|refractory chronic lymphocytic leukemia
634352|NCT00891137|stage IV adult Burkitt lymphoma|stage iv adult burkitt lymphoma
634353|NCT00891137|stage I childhood small noncleaved cell lymphoma|stage i childhood small noncleaved cell lymphoma
634354|NCT00891137|stage II childhood small noncleaved cell lymphoma|stage ii childhood small noncleaved cell lymphoma
634355|NCT00891137|stage III childhood small noncleaved cell lymphoma|stage iii childhood small noncleaved cell lymphoma
634356|NCT00891137|stage IV childhood small noncleaved cell lymphoma|stage iv childhood small noncleaved cell lymphoma
634357|NCT00891137|recurrent childhood small noncleaved cell lymphoma|recurrent childhood small noncleaved cell lymphoma
711001|NCT00586898|ANTIFUNGAL ANTIBIOTICS|antifungal antibiotics
634358|NCT00891137|stage I childhood large cell lymphoma|stage i childhood large cell lymphoma
634359|NCT00891137|stage II childhood large cell lymphoma|stage ii childhood large cell lymphoma
634360|NCT00891137|stage III childhood large cell lymphoma|stage iii childhood large cell lymphoma
634361|NCT00891137|stage IV childhood large cell lymphoma|stage iv childhood large cell lymphoma
634362|NCT00891137|contiguous stage II mantle cell lymphoma|contiguous stage ii mantle cell lymphoma
634363|NCT00891137|contiguous stage II adult lymphoblastic lymphoma|contiguous stage ii adult lymphoblastic lymphoma
634364|NCT00891137|noncontiguous stage II adult lymphoblastic lymphoma|noncontiguous stage ii adult lymphoblastic lymphoma
634365|NCT00891137|noncontiguous stage II mantle cell lymphoma|noncontiguous stage ii mantle cell lymphoma
634366|NCT00891137|stage III mantle cell lymphoma|stage iii mantle cell lymphoma
634367|NCT00891137|stage IV mantle cell lymphoma|stage iv mantle cell lymphoma
634368|NCT00891137|stage I mantle cell lymphoma|stage i mantle cell lymphoma
634369|NCT00891137|stage I adult lymphoblastic lymphoma|stage i adult lymphoblastic lymphoma
634370|NCT00891137|stage I adult diffuse large cell lymphoma|stage i adult diffuse large cell lymphoma
634371|NCT00891137|stage IV adult diffuse large cell lymphoma|stage iv adult diffuse large cell lymphoma
634372|NCT00891137|recurrent childhood large cell lymphoma|recurrent childhood large cell lymphoma
634373|NCT00891137|stage I childhood lymphoblastic lymphoma|stage i childhood lymphoblastic lymphoma
634374|NCT00891137|stage II childhood lymphoblastic lymphoma|stage ii childhood lymphoblastic lymphoma
634375|NCT00891137|stage III childhood lymphoblastic lymphoma|stage iii childhood lymphoblastic lymphoma
634376|NCT00891137|stage IV childhood lymphoblastic lymphoma|stage iv childhood lymphoblastic lymphoma
634377|NCT00891137|recurrent childhood lymphoblastic lymphoma|recurrent childhood lymphoblastic lymphoma
634378|NCT00891137|childhood myelodysplastic syndromes|childhood myelodysplastic syndromes
634379|NCT00891137|Burkitt lymphoma|burkitt lymphoma
634380|NCT00891124|Hypertension|hypertension
634381|NCT00891124|Type II DM|type ii dm
634382|NCT00891124|Hyperlipidemia|hyperlipidemia
634383|NCT00891124|Glycemia|glycemia
634384|NCT00891124|ADA 2008 guideline|ada 2008 guideline
634385|NCT00891124|Patient Consultation|patient consultation
634386|NCT00891111|Health Risk Assessment|health risk assessment
634387|NCT00891111|Incentives|incentives
634388|NCT00891111|Preventative Healthcare|preventative healthcare
634389|NCT00891111|Encouraging Health Risk Assessments|encouraging health risk assessments
634390|NCT00891085|ventilation|ventilation
634391|NCT00891085|ards|ards
634392|NCT00891085|ali|ali
634393|NCT00891085|trauma|trauma
634394|NCT00891085|Trauma Patients with ISS > 25|trauma patients with iss > 25
634395|NCT00891059|Cognitive Impairment|cognitive impairment
634396|NCT00891059|Diskus Inhaler|diskus inhaler
634397|NCT00891059|Nursing Home|nursing home
634398|NCT00891046|Flare|flare
634399|NCT00891046|arthritis|arthritis
634400|NCT00891046|IL-1beta antagonist|il-1beta antagonist
634401|NCT00891046|systemic juvenile idiopathic arthritis|systemic juvenile idiopathic arthritis
634402|NCT00891046|CHAQ|chaq
634403|NCT00891046|steroids|steroids
634404|NCT00891046|ACR pediatric response|acr pediatric response
634405|NCT00891046|Systemic juvenile idiopathic arthritis with active flare|systemic juvenile idiopathic arthritis with active flare
634406|NCT00891033|cancer|cancer
634407|NCT00891007|Measles|measles
634408|NCT00891007|Virus Disease|virus disease
634409|NCT00891007|Paediatric Diseases|paediatric diseases
634410|NCT00891007|Paramyoxyviridae|paramyoxyviridae
634411|NCT00890994|MBI|mbi
634412|NCT00890994|Molecular Breast Imaging|molecular breast imaging
634413|NCT00890994|Breast Cancer|breast cancer
634414|NCT00890994|DCIS|dcis
634415|NCT00890994|Breast|breast
634416|NCT00890994|Calcifications|calcifications
634417|NCT00890994|Microcalcifications|microcalcifications
634418|NCT00890968|hand dermatitis|hand dermatitis
634419|NCT00890968|hand eczema|hand eczema
634420|NCT00890968|triamcinolone acetonide|triamcinolone acetonide
634421|NCT00890955|Solid tumors|solid tumors
634422|NCT00890942|pruritus|pruritus
634423|NCT00890942|intrathecal morphine|intrathecal morphine
634424|NCT00890929|Acute myeloid leukemia|acute myeloid leukemia
634971|NCT00889057|sorafenib|sorafenib
634425|NCT00890929|Acute myeloblastic leukemia|acute myeloblastic leukemia
634426|NCT00890929|AML|aml
634427|NCT00890916|spinal cord injury|spinal cord injury
634428|NCT00890916|neuroprosthesis|neuroprosthesis
634429|NCT00890916|functional electrical stimulation|functional electrical stimulation
634430|NCT00890916|quadriplegia|quadriplegia
634431|NCT00890903|NSCLC|nsclc
634432|NCT00890903|non small cell lung carcinoma|non small cell lung carcinoma
634433|NCT00890903|metastatic breast cancer|metastatic breast cancer
634434|NCT00890903|MBC|mbc
634435|NCT00890903|advanced breast cancer|advanced breast cancer
634436|NCT00890903|Navelbine|navelbine
634437|NCT00890903|Navelbine-ORAL|navelbine-oral
634438|NCT00890903|Vinorelbine|vinorelbine
634439|NCT00890903|Vinorelbine-ORAL|vinorelbine-oral
634440|NCT00890903|daily routine|daily routine
634441|NCT00890903|concomitant antiemetic therapy|concomitant antiemetic therapy
634442|NCT00890903|patient compliance|patient compliance
634443|NCT00890903|germany|germany
634444|NCT00890903|non-interventional study|non-interventional study
634445|NCT00890903|oral anti cancer therapy|oral anti cancer therapy
634446|NCT00890903|quality of life|quality of life
634447|NCT00890877|asthma|asthma
634448|NCT00890877|treatment|treatment
634449|NCT00890877|placebo|placebo
634450|NCT00890877|efficacy|efficacy
634451|NCT00890877|safety|safety
634452|NCT00890864|Breast screening|breast screening
634453|NCT00890864|Mammogram|mammogram
634454|NCT00890864|Routine screening programme|routine screening programme
634455|NCT00890851|Radiofrequency|radiofrequency
634456|NCT00890851|Mini invasin surgery|mini invasin surgery
634457|NCT00890851|Outpatient treatment|outpatient treatment
634459|NCT00890838|IVFO|ivfo
634460|NCT00890838|Inflammation|inflammation
634461|NCT00890838|Valvular surgery|valvular surgery
634462|NCT00890838|Inflammatory status|inflammatory status
634463|NCT00890838|Infectious complications|infectious complications
634464|NCT00890825|Non small cell lung cancer (NSCLC)|non small cell lung cancer (nsclc)
634465|NCT00890825|KRAS mutation|kras mutation
634466|NCT00890812|Acute Ischemic Stroke|acute ischemic stroke
634467|NCT00890799|transcatheter closure|transcatheter closure
634468|NCT00890799|ventricular septal defects|ventricular septal defects
634469|NCT00890760|Malaria|malaria
634470|NCT00890760|Vaccine|vaccine
634471|NCT00890747|HIV Infections|hiv infections
634472|NCT00890747|treatment experienced|treatment experienced
634473|NCT00890721|Hemorrhoid|hemorrhoid
634474|NCT00890721|Hemorrhoidectomy|hemorrhoidectomy
634475|NCT00890721|Postoperative pain|postoperative pain
634476|NCT00890721|Analgesia|analgesia
634477|NCT00890695|supplementary feeding|supplementary feeding
634478|NCT00890695|moderate malnutrition|moderate malnutrition
634479|NCT00890695|acute infection|acute infection
634480|NCT00890695|developing country|developing country
634481|NCT00890695|children|children
634482|NCT00890682|Bunion|bunion
634483|NCT00890682|Bunionectomy|bunionectomy
634484|NCT00890682|Osteotomy|osteotomy
634485|NCT00890669|treadmill training|treadmill training
634486|NCT00890669|body load|body load
634487|NCT00890669|quality of life|quality of life
634488|NCT00890669|Parkinson's disease|parkinson's disease
634489|NCT00890669|Motor Symptoms|motor symptoms
634490|NCT00890656|Acute Lymphoblastic Leukemia|acute lymphoblastic leukemia
634492|NCT00890656|Leukemia|leukemia
634493|NCT00890656|Hyper-CVAD|hyper-cvad
634494|NCT00890643|Stress disorders, post-traumatic|stress disorders, post-traumatic
634495|NCT00890643|Combat Disorders|combat disorders
634496|NCT00890643|prazosin|prazosin
634497|NCT00890643|cognition|cognition
634498|NCT00890643|neurophysiology|neurophysiology
634499|NCT00890617|lung metastases|lung metastases
634500|NCT00890617|stage I non-small cell lung cancer|stage i non-small cell lung cancer
634501|NCT00890591|hypertension|hypertension
634502|NCT00890591|angiotensin II type 1 receptor blocker|angiotensin ii type 1 receptor blocker
634503|NCT00890591|olmesartan|olmesartan
634504|NCT00890578|Histoacryl|histoacryl
634505|NCT00890578|closure of surgical incisions|closure of surgical incisions
634506|NCT00890565|Electrocardiogram|electrocardiogram
634507|NCT00890565|Effect on electrocardiogram|effect on electrocardiogram
634508|NCT00890565|Granisetron|granisetron
634509|NCT00890565|Moxifloxacin|moxifloxacin
634510|NCT00890565|Pharmacokinetic profile|pharmacokinetic profile
634511|NCT00890565|Sancuso® patch|sancuso® patch
634512|NCT00890565|Transdermal|transdermal
634513|NCT00890526|Tinnitus Retraining Therapy (TRT)|tinnitus retraining therapy (trt)
634514|NCT00890474|Breech presentation at 34 to 36 weeks of gestation|breech presentation at 34 to 36 weeks of gestation
634515|NCT00890461|ECG|ecg
634516|NCT00890461|ICD|icd
634517|NCT00890448|Alanine Transaminase elevation|alanine transaminase elevation
634518|NCT00890448|Genetic Markers|genetic markers
634519|NCT00890448|DNA Markers|dna markers
634520|NCT00890435|unspecified adult solid tumor, protocol specific|unspecified adult solid tumor, protocol specific
634521|NCT00890435|unspecified childhood solid tumor, protocol specific|unspecified childhood solid tumor, protocol specific
634522|NCT00890435|recurrent childhood brain stem glioma|recurrent childhood brain stem glioma
634523|NCT00890435|recurrent childhood cerebellar astrocytoma|recurrent childhood cerebellar astrocytoma
634524|NCT00890435|recurrent childhood cerebral astrocytoma|recurrent childhood cerebral astrocytoma
634525|NCT00890435|recurrent childhood medulloblastoma|recurrent childhood medulloblastoma
634526|NCT00890435|recurrent childhood supratentorial primitive neuroectodermal tumor|recurrent childhood supratentorial primitive neuroectodermal tumor
634527|NCT00890435|recurrent childhood ependymoma|recurrent childhood ependymoma
634528|NCT00890435|recurrent childhood pineoblastoma|recurrent childhood pineoblastoma
634529|NCT00890435|recurrent childhood subependymal giant cell astrocytoma|recurrent childhood subependymal giant cell astrocytoma
634530|NCT00890435|recurrent childhood visual pathway and hypothalamic glioma|recurrent childhood visual pathway and hypothalamic glioma
634531|NCT00890435|recurrent childhood acute lymphoblastic leukemia|recurrent childhood acute lymphoblastic leukemia
634532|NCT00890435|recurrent childhood acute myeloid leukemia|recurrent childhood acute myeloid leukemia
634533|NCT00890435|childhood choroid plexus tumor|childhood choroid plexus tumor
634534|NCT00890435|childhood craniopharyngioma|childhood craniopharyngioma
634535|NCT00890435|childhood ependymoblastoma|childhood ependymoblastoma
634536|NCT00890435|childhood medulloepithelioma|childhood medulloepithelioma
634537|NCT00890435|childhood meningioma|childhood meningioma
634538|NCT00890435|childhood mixed glioma|childhood mixed glioma
634539|NCT00890435|childhood oligodendroglioma|childhood oligodendroglioma
634540|NCT00890435|adult astrocytic tumors|adult astrocytic tumors
634541|NCT00890435|adult brain stem glioma|adult brain stem glioma
634542|NCT00890435|adult choroid plexus tumor|adult choroid plexus tumor
634543|NCT00890435|adult craniopharyngioma|adult craniopharyngioma
634544|NCT00890435|adult ependymoblastoma|adult ependymoblastoma
634545|NCT00890435|adult medulloblastoma|adult medulloblastoma
634546|NCT00890435|adult supratentorial primitive neuroectodermal tumor (PNET)|adult supratentorial primitive neuroectodermal tumor (pnet)
634547|NCT00890435|adult ependymal tumors|adult ependymal tumors
634548|NCT00890435|adult meningeal tumor|adult meningeal tumor
634549|NCT00890435|adult mixed glioma|adult mixed glioma
634550|NCT00890435|adult oligodendroglial tumors|adult oligodendroglial tumors
634551|NCT00890435|adult pineal parenchymal tumor|adult pineal parenchymal tumor
634552|NCT00890435|recurrent adult brain tumor|recurrent adult brain tumor
634553|NCT00890435|relapsing chronic myelogenous leukemia|relapsing chronic myelogenous leukemia
634554|NCT00890435|recurrent adult acute lymphoblastic leukemia|recurrent adult acute lymphoblastic leukemia
634555|NCT00890435|recurrent adult acute myeloid leukemia|recurrent adult acute myeloid leukemia
634556|NCT00890435|adult acute myeloid leukemia with 11q23 (MLL) abnormalities|adult acute myeloid leukemia with 11q23 (mll) abnormalities
634557|NCT00890435|adult acute myeloid leukemia with inv(16)(p13;q22)|adult acute myeloid leukemia with inv(16)(p13;q22)
634558|NCT00890435|adult acute myeloid leukemia with t(15;17)(q22;q12)|adult acute myeloid leukemia with t(15;17)(q22;q12)
634559|NCT00890435|adult acute myeloid leukemia with t(16;16)(p13;q22)|adult acute myeloid leukemia with t(16;16)(p13;q22)
634560|NCT00890435|adult acute myeloid leukemia with t(8;21)(q22;q22)|adult acute myeloid leukemia with t(8;21)(q22;q22)
634561|NCT00890435|secondary acute myeloid leukemia|secondary acute myeloid leukemia
634562|NCT00890435|acute undifferentiated leukemia|acute undifferentiated leukemia
634563|NCT00890435|mast cell leukemia|mast cell leukemia
634564|NCT00890435|atypical chronic myeloid leukemia, BCR-ABL1 negative|atypical chronic myeloid leukemia, bcr-abl1 negative
634565|NCT00890435|T-cell large granular lymphocyte leukemia|t-cell large granular lymphocyte leukemia
634566|NCT00890435|refractory chronic lymphocytic leukemia|refractory chronic lymphocytic leukemia
634567|NCT00890435|childhood chronic myelogenous leukemia|childhood chronic myelogenous leukemia
634568|NCT00890435|chronic myelomonocytic leukemia|chronic myelomonocytic leukemia
634569|NCT00890435|juvenile myelomonocytic leukemia|juvenile myelomonocytic leukemia
634570|NCT00890435|refractory hairy cell leukemia|refractory hairy cell leukemia
634571|NCT00890435|prolymphocytic leukemia|prolymphocytic leukemia
634572|NCT00890422|encephalitis|encephalitis
634573|NCT00890422|FSME|fsme
634574|NCT00890422|central european encephalitis|central european encephalitis
634575|NCT00890409|hypothermia|hypothermia
634576|NCT00890409|neonate|neonate
634577|NCT00890409|hypoxic-ischemic encephalopathy|hypoxic-ischemic encephalopathy
634578|NCT00890409|efficacy|efficacy
634579|NCT00890409|safety|safety
634580|NCT00890396|Sickle Cell Anemia|sickle cell anemia
634581|NCT00890396|Hydroxyurea|hydroxyurea
634582|NCT00890383|trauma resuscitation|trauma resuscitation
634583|NCT00890383|abdominal hypertension|abdominal hypertension
634584|NCT00890383|abdominal compartment syndrome|abdominal compartment syndrome
634585|NCT00890370|Cystic fibrosis|cystic fibrosis
634586|NCT00890370|Airway clearance|airway clearance
634587|NCT00890344|PeaPod|peapod
634588|NCT00890344|BIA|bia
634589|NCT00890344|Anthropometry|anthropometry
634590|NCT00890344|Body Composition|body composition
634591|NCT00890344|Fat Mass|fat mass
634592|NCT00890344|Total Body Water|total body water
634593|NCT00890344|Neonatology|neonatology
634594|NCT00890305|Metastatic colorectal cancer|metastatic colorectal cancer
634595|NCT00890305|FOLFOX chemotherapy|folfox chemotherapy
634596|NCT00890292|Attention Deficit Hyperactivity Disorder|attention deficit hyperactivity disorder
634597|NCT00890292|ADHD|adhd
634598|NCT00890292|JNJ-31001074|jnj-31001074
634599|NCT00890279|Autosomal Dominant Polycystic Kidney Disease|autosomal dominant polycystic kidney disease
634600|NCT00890279|Hypertension|hypertension
634601|NCT00890279|Angiotensin-II Receptor Blocker|angiotensin-ii receptor blocker
634602|NCT00890279|Calcium Channel Blocker|calcium channel blocker
634603|NCT00890279|Angiotensin converting enzyme inhibitor|angiotensin converting enzyme inhibitor
634604|NCT00890279|Kidney Volume|kidney volume
634605|NCT00890279|eGFR|egfr
634606|NCT00890266|keratoconus|keratoconus
634607|NCT00890266|collagen cross-linking|collagen cross-linking
634608|NCT00890266|riboflavin|riboflavin
634609|NCT00890266|UV light|uv light
634610|NCT00890253|Renal impairment|renal impairment
634611|NCT00890253|Liver transplantation|liver transplantation
634612|NCT00890253|Chronic Renal Insufficiency|chronic renal insufficiency
634613|NCT00890240|Attention Deficit Hyperactivity Disorder|attention deficit hyperactivity disorder
634614|NCT00890240|ADHD|adhd
634615|NCT00890240|JNJ-31001074|jnj-31001074
634616|NCT00890227|scoliosis|scoliosis
634617|NCT00890227|kyphosis|kyphosis
634618|NCT00890227|Surgical treatment|surgical treatment
634619|NCT00890214|Anticoagulation|anticoagulation
634620|NCT00890214|Prostacyclin|prostacyclin
634621|NCT00890214|Heparin|heparin
634622|NCT00890214|Renal Replacement Therapy|renal replacement therapy
634623|NCT00890214|Kidney failure acute|kidney failure acute
634624|NCT00890214|Platelet aggregation|platelet aggregation
634625|NCT00890201|Pancreaticobiliary reflux|pancreaticobiliary reflux
634626|NCT00890201|Normal pancreaticobiliary junction|normal pancreaticobiliary junction
634627|NCT00890201|Gallstones|gallstones
634628|NCT00890201|Cholelithiasis|cholelithiasis
634629|NCT00890201|Cholecystectomy|cholecystectomy
634630|NCT00890188|THALIDOMIDE|thalidomide
634631|NCT00890188|UFUR|ufur
634632|NCT00890188|Colorectal cancer|colorectal cancer
634633|NCT00890188|Oxaliplatin|oxaliplatin
634634|NCT00890175|Asthma, Staccato loxapine|asthma, staccato loxapine
634635|NCT00890162|Omalizumab|omalizumab
634636|NCT00890162|Idiopathic Anaphylaxis|idiopathic anaphylaxis
634637|NCT00890162|Serum Tryptase|serum tryptase
634638|NCT00890162|Placebo-Controlled|placebo-controlled
634639|NCT00890162|Adult|adult
634640|NCT00890162|Anaphylaxis|anaphylaxis
634641|NCT00890162|Allergic Reaction|allergic reaction
634642|NCT00890149|alcohol abuse|alcohol abuse
634643|NCT00890149|binge drinking|binge drinking
634644|NCT00890149|severe drinking|severe drinking
634645|NCT00890149|alcoholism|alcoholism
634646|NCT00890149|heavy drinking|heavy drinking
634647|NCT00890136|Chronic Obstructive Pulmonary Disease (COPD)|chronic obstructive pulmonary disease (copd)
634648|NCT00890123|Omega 3 Fatty Acids|omega 3 fatty acids
634649|NCT00890123|Inflammation|inflammation
634650|NCT00890123|Hip Surgery|hip surgery
634651|NCT00890123|Inflammatory status|inflammatory status
634652|NCT00890123|Infectious complications|infectious complications
634653|NCT00890110|Renal cell cancer|renal cell cancer
634654|NCT00890110|sunitinib|sunitinib
634655|NCT00890110|autologous vaccine|autologous vaccine
634656|NCT00890110|metastatic RCC|metastatic rcc
634657|NCT00890097|Geographic Atrophy|geographic atrophy
634658|NCT00890097|GA|ga
634659|NCT00890097|Age-Related Macular Degeneration|age-related macular degeneration
634660|NCT00890097|AMD|amd
634661|NCT00890071|Fluid responsiveness|fluid responsiveness
634662|NCT00890071|Ultrasound|ultrasound
634663|NCT00890071|Cardiac output|cardiac output
634664|NCT00890058|Arthritis|arthritis
634665|NCT00890058|Synovitis|synovitis
634666|NCT00890058|Aromatase Inhibitor|aromatase inhibitor
634667|NCT00890058|Arthralgia Syndrome|arthralgia syndrome
634668|NCT00890045|Vascular access hemodialysis|vascular access hemodialysis
634669|NCT00890045|ePTFE graft|eptfe graft
634670|NCT00890045|Graft-eligible|graft-eligible
634671|NCT00890045|Long-term vascular access for hemodialysis|long-term vascular access for hemodialysis
634672|NCT00890032|adult giant cell glioblastoma|adult giant cell glioblastoma
634673|NCT00890032|adult glioblastoma|adult glioblastoma
634674|NCT00890032|adult gliosarcoma|adult gliosarcoma
634675|NCT00890032|adult astrocytoma|adult astrocytoma
634676|NCT00890032|recurrent adult brain tumor|recurrent adult brain tumor
634677|NCT00890006|Prostate cancer|prostate cancer
634678|NCT00890006|Magnetic resonance imaging|magnetic resonance imaging
634679|NCT00889993|Food intake|food intake
634680|NCT00889993|Gut hormones|gut hormones
634681|NCT00889993|Fiber|fiber
634682|NCT00889993|Visual analog scales|visual analog scales
634683|NCT00889967|Pseudomonas aeruginosa|pseudomonas aeruginosa
634684|NCT00889967|antimicrobial|antimicrobial
634685|NCT00889967|inhalation|inhalation
634686|NCT00889967|ciprofloxacin|ciprofloxacin
634687|NCT00889967|Non-Cystic Fibrosis Bronchiectasis|non-cystic fibrosis bronchiectasis
634688|NCT00889954|EBV+|ebv+
634689|NCT00889954|Her2|her2
634690|NCT00889954|TGFBeta|tgfbeta
634691|NCT00889954|EBV positive|ebv positive
634692|NCT00889954|HER 2 positive malignancy|her 2 positive malignancy
634693|NCT00889954|cytotoxic T lymphocytes|cytotoxic t lymphocytes
634694|NCT00889928|gallbladder disease|gallbladder disease
634695|NCT00889928|cholecystectomy|cholecystectomy
634696|NCT00889928|gallbladder disease indicated for cholecystectomy|gallbladder disease indicated for cholecystectomy
634697|NCT00889915|ADHD|adhd
634698|NCT00889915|Methylphenidate|methylphenidate
634699|NCT00889915|Amphetamine|amphetamine
634700|NCT00889902|Molecular Markers|molecular markers
634701|NCT00889902|Cervical Cancer|cervical cancer
634702|NCT00889902|Screening|screening
634703|NCT00889902|Makov|makov
634704|NCT00889889|Influenza|influenza
634705|NCT00889889|Phase II|phase ii
634706|NCT00889889|Placebo-controlled|placebo-controlled
634707|NCT00889876|Obesity|obesity
634708|NCT00889876|Adolescents|adolescents
634709|NCT00889876|Nocturnal blood pressure reduction|nocturnal blood pressure reduction
634710|NCT00889876|Insulin metabolism|insulin metabolism
634711|NCT00889876|Cardiovascular structure and function|cardiovascular structure and function
634712|NCT00889876|Treatment|treatment
634713|NCT00889876|Exercise|exercise
634714|NCT00889876|Metformin|metformin
634715|NCT00889876|Insulin|insulin
634716|NCT00889876|Blood glucose|blood glucose
634717|NCT00889876|Impaired nocturnal blood pressure reduction|impaired nocturnal blood pressure reduction
634718|NCT00889863|Flare|flare
634719|NCT00889863|arthritis|arthritis
634720|NCT00889863|IL-1beta antagonist|il-1beta antagonist
634721|NCT00889863|systemic juvenile idiopathic arthritis|systemic juvenile idiopathic arthritis
634722|NCT00889863|Juvenile rheumatoid|juvenile rheumatoid
634723|NCT00889850|Healthy|healthy
634724|NCT00889850|Bioavailability|bioavailability
634725|NCT00889850|Bioequivalence|bioequivalence
634726|NCT00889850|Esomeprazole|esomeprazole
634727|NCT00889850|Bioavailability, Therapeutical Indication Not Studied|bioavailability, therapeutical indication not studied
634728|NCT00889837|Staccato Loxapine|staccato loxapine
634729|NCT00889837|COPD|copd
634730|NCT00889837|pulmonary safety|pulmonary safety
634731|NCT00889824|Chronic imbalance|chronic imbalance
634732|NCT00889824|vestibular disorders|vestibular disorders
634733|NCT00889824|balance prosthesis|balance prosthesis
634734|NCT00889811|OPCAB|opcab
634735|NCT00889811|RIPC|ripc
634736|NCT00889798|Malignant lymphatic disease|malignant lymphatic disease
634737|NCT00889798|therapy-reality|therapy-reality
634738|NCT00889798|observation|observation
634739|NCT00889798|registry|registry
634740|NCT00889798|therapy sequences|therapy sequences
634741|NCT00889798|NHL|nhl
634742|NCT00889798|CLL|cll
634743|NCT00889798|Germany|germany
634744|NCT00889798|lenalidomide|lenalidomide
634745|NCT00889798|alemtuzumab|alemtuzumab
634746|NCT00889798|rituximab|rituximab
634747|NCT00889798|bendamustin|bendamustin
634748|NCT00889798|thalidomide|thalidomide
634749|NCT00889798|bortezomib|bortezomib
634750|NCT00889798|ibritumomab-tiuxetan|ibritumomab-tiuxetan
634751|NCT00889798|G-CSF (Granulocyte-Colony Stimulating Factor)|g-csf (granulocyte-colony stimulating factor)
634752|NCT00889798|chronic lymphocytic leukaemia|chronic lymphocytic leukaemia
634753|NCT00889798|follicular lymphoma|follicular lymphoma
634754|NCT00889798|gastric MALT lymphoma (Mucosa Associated Lymphoid Tissue)|gastric malt lymphoma (mucosa associated lymphoid tissue)
634755|NCT00889798|nongastric MALT lymphoma (Mucosa Associated Lymphoid Tissue)|nongastric malt lymphoma (mucosa associated lymphoid tissue)
634756|NCT00889798|nodal marginal zone lymphoma|nodal marginal zone lymphoma
634757|NCT00889798|splenic marginal zone lymphoma|splenic marginal zone lymphoma
634758|NCT00889798|mantle cell lymphoma|mantle cell lymphoma
634759|NCT00889798|diffuse large b-cell lymphoma|diffuse large b-cell lymphoma
634760|NCT00889785|Adolescents|adolescents
634761|NCT00889785|Type 2 Diabetes|type 2 diabetes
634762|NCT00889785|Behavioral Research|behavioral research
634763|NCT00889772|Respiratory distress, adult|respiratory distress, adult
634764|NCT00889772|risk|risk
634765|NCT00889772|emergency room|emergency room
634766|NCT00889772|high risk surgery|high risk surgery
634767|NCT00889772|sepsis|sepsis
634768|NCT00889772|trauma|trauma
634769|NCT00889772|aspiration|aspiration
634770|NCT00889772|pneumonia|pneumonia
634771|NCT00889759|Tuberculosis|tuberculosis
634772|NCT00889759|Outbreaks|outbreaks
634773|NCT00889720|smoking cessation|smoking cessation
634774|NCT00889720|varenicline|varenicline
634775|NCT00889720|elective surgery|elective surgery
634776|NCT00889720|wound infections|wound infections
634777|NCT00889720|post-operative complications|post-operative complications
634778|NCT00889707|Benign Prostatic Hyperplasia|benign prostatic hyperplasia
634779|NCT00889707|BPH|bph
634780|NCT00889707|Enlarged Prostate|enlarged prostate
634781|NCT00889668|Glucose monitoring|glucose monitoring
634782|NCT00889668|GlucoTrack|glucotrack
634783|NCT00889668|Self glucose monitoring|self glucose monitoring
634784|NCT00889655|efficacy of bowel cleansing|efficacy of bowel cleansing
634785|NCT00889655|patient tolerability|patient tolerability
634786|NCT00889655|Golytely|golytely
634787|NCT00889655|MiraLax|miralax
634788|NCT00889655|colonoscopy preparation|colonoscopy preparation
634789|NCT00889655|bowel preparation|bowel preparation
634790|NCT00889655|screening colonoscopy|screening colonoscopy
634791|NCT00889629|kidney transplantation|kidney transplantation
634792|NCT00889629|kidney transplant recipients|kidney transplant recipients
634793|NCT00889616|Malaria|malaria
634794|NCT00889616|Asexual Blood Stafe|asexual blood stafe
634795|NCT00889616|Plasmodium Falciparum|plasmodium falciparum
634796|NCT00889616|Immunogenicity|immunogenicity
634797|NCT00889616|Safety|safety
634798|NCT00889616|Vaccine|vaccine
634799|NCT00889603|Aricept® Evess|aricept® evess
634800|NCT00889603|non-interventional study|non-interventional study
634801|NCT00889603|Alzheimer's Disease|alzheimer's disease
634802|NCT00889603|Vascular Dementia|vascular dementia
634803|NCT00889603|efficacy|efficacy
634804|NCT00889603|tolerability|tolerability
634805|NCT00889603|safety.|safety.
634806|NCT00889590|GCT|gct
634807|NCT00889590|Bisfosfonates|bisfosfonates
634808|NCT00889564|Vascular access for hemodialysis|vascular access for hemodialysis
634809|NCT00889564|Catheter dependent patients|catheter dependent patients
634810|NCT00889564|Access challenged patients|access challenged patients
634811|NCT00889564|Bacteremia|bacteremia
634812|NCT00889564|HeRO Vascular Access Device|hero vascular access device
634813|NCT00889538|Autism|autism
634814|NCT00889538|Severe Behavior Disorder|severe behavior disorder
634815|NCT00889538|Glutathione|glutathione
634816|NCT00889538|Antioxidants|antioxidants
634817|NCT00889525|Cabergoline|cabergoline
634818|NCT00889486|gastroparesis|gastroparesis
634819|NCT00889486|diabetes mellitus|diabetes mellitus
634820|NCT00889486|delayed gastric emptying|delayed gastric emptying
634821|NCT00889473|larazotide acetate|larazotide acetate
634822|NCT00889473|gluten|gluten
634823|NCT00889460|rBet v 1|rbet v 1
634824|NCT00889460|Birch pollen allergy|birch pollen allergy
634825|NCT00889460|Sublingual Immunotherapy|sublingual immunotherapy
634826|NCT00889447|Chronic Obstructive Pulmonary disease (COPD)|chronic obstructive pulmonary disease (copd)
634827|NCT00889434|Cystic fibrosis|cystic fibrosis
634828|NCT00889434|splicing mutations|splicing mutations
634829|NCT00889434|molecular therapy|molecular therapy
634830|NCT00889434|EGCG|egcg
634831|NCT00889434|Tocotrienol|tocotrienol
634832|NCT00889434|Splicing-mutation-mediated Cystic Fibrosis|splicing-mutation-mediated cystic fibrosis
634833|NCT00889421|uveitis|uveitis
634834|NCT00889421|apremilast|apremilast
634835|NCT00889408|refractory chronic lymphocytic leukemia|refractory chronic lymphocytic leukemia
634836|NCT00889408|childhood diffuse large cell lymphoma|childhood diffuse large cell lymphoma
634837|NCT00889408|childhood grade III lymphomatoid granulomatosis|childhood grade iii lymphomatoid granulomatosis
634838|NCT00889408|childhood immunoblastic large cell lymphoma|childhood immunoblastic large cell lymphoma
634839|NCT00889408|B-cell adult acute lymphoblastic leukemia|b-cell adult acute lymphoblastic leukemia
634840|NCT00889408|recurrent adult acute lymphoblastic leukemia|recurrent adult acute lymphoblastic leukemia
634841|NCT00889408|B-cell childhood acute lymphoblastic leukemia|b-cell childhood acute lymphoblastic leukemia
634842|NCT00889408|recurrent childhood acute lymphoblastic leukemia|recurrent childhood acute lymphoblastic leukemia
634843|NCT00889408|adult acute myeloid leukemia with 11q23 (MLL) abnormalities|adult acute myeloid leukemia with 11q23 (mll) abnormalities
634844|NCT00889408|adult acute myeloid leukemia with inv(16)(p13;q22)|adult acute myeloid leukemia with inv(16)(p13;q22)
634845|NCT00889408|adult acute myeloid leukemia with t(15;17)(q22;q12)|adult acute myeloid leukemia with t(15;17)(q22;q12)
634846|NCT00889408|adult acute myeloid leukemia with t(16;16)(p13;q22)|adult acute myeloid leukemia with t(16;16)(p13;q22)
634847|NCT00889408|adult acute myeloid leukemia with t(8;21)(q22;q22)|adult acute myeloid leukemia with t(8;21)(q22;q22)
634848|NCT00889408|recurrent adult acute myeloid leukemia|recurrent adult acute myeloid leukemia
634849|NCT00889408|recurrent childhood acute myeloid leukemia|recurrent childhood acute myeloid leukemia
634850|NCT00889408|secondary acute myeloid leukemia|secondary acute myeloid leukemia
634851|NCT00889408|B-cell chronic lymphocytic leukemia|b-cell chronic lymphocytic leukemia
634852|NCT00889408|relapsing chronic myelogenous leukemia|relapsing chronic myelogenous leukemia
634853|NCT00889408|childhood chronic myelogenous leukemia|childhood chronic myelogenous leukemia
634854|NCT00889408|cutaneous B-cell non-Hodgkin lymphoma|cutaneous b-cell non-hodgkin lymphoma
634855|NCT00889408|recurrent adult grade III lymphomatoid granulomatosis|recurrent adult grade iii lymphomatoid granulomatosis
634856|NCT00889408|Waldenström macroglobulinemia|waldenström macroglobulinemia
634857|NCT00889408|recurrent adult Burkitt lymphoma|recurrent adult burkitt lymphoma
634858|NCT00889408|recurrent adult diffuse large cell lymphoma|recurrent adult diffuse large cell lymphoma
634859|NCT00889408|recurrent adult diffuse mixed cell lymphoma|recurrent adult diffuse mixed cell lymphoma
634860|NCT00889408|recurrent adult diffuse small cleaved cell lymphoma|recurrent adult diffuse small cleaved cell lymphoma
634861|NCT00889408|recurrent adult immunoblastic large cell lymphoma|recurrent adult immunoblastic large cell lymphoma
634862|NCT00889408|recurrent adult lymphoblastic lymphoma|recurrent adult lymphoblastic lymphoma
634863|NCT00889408|recurrent grade 1 follicular lymphoma|recurrent grade 1 follicular lymphoma
634864|NCT00889408|recurrent grade 2 follicular lymphoma|recurrent grade 2 follicular lymphoma
634865|NCT00889408|recurrent grade 3 follicular lymphoma|recurrent grade 3 follicular lymphoma
634866|NCT00889408|recurrent mantle cell lymphoma|recurrent mantle cell lymphoma
634867|NCT00889408|recurrent marginal zone lymphoma|recurrent marginal zone lymphoma
634868|NCT00889408|recurrent small lymphocytic lymphoma|recurrent small lymphocytic lymphoma
634869|NCT00889408|extranodal marginal zone B-cell lymphoma of mucosa-associated lymphoid tissue|extranodal marginal zone b-cell lymphoma of mucosa-associated lymphoid tissue
634870|NCT00889408|nodal marginal zone B-cell lymphoma|nodal marginal zone b-cell lymphoma
634871|NCT00889408|splenic marginal zone lymphoma|splenic marginal zone lymphoma
634872|NCT00889408|recurrent childhood grade III lymphomatoid granulomatosis|recurrent childhood grade iii lymphomatoid granulomatosis
634873|NCT00889408|recurrent childhood large cell lymphoma|recurrent childhood large cell lymphoma
635176|NCT00888043|bevacizumab|bevacizumab
634874|NCT00889408|recurrent childhood lymphoblastic lymphoma|recurrent childhood lymphoblastic lymphoma
634875|NCT00889408|recurrent childhood small noncleaved cell lymphoma|recurrent childhood small noncleaved cell lymphoma
634876|NCT00889408|childhood Burkitt lymphoma|childhood burkitt lymphoma
634877|NCT00889408|intraocular lymphoma|intraocular lymphoma
634878|NCT00889408|noncutaneous extranodal lymphoma|noncutaneous extranodal lymphoma
634879|NCT00889408|prolymphocytic leukemia|prolymphocytic leukemia
634880|NCT00889395|MISC|misc
634881|NCT00889395|caregivers|caregivers
808964|NCT00215163|CBT|cbt
634882|NCT00889395|children|children
634883|NCT00889395|psychosocial gains|psychosocial gains
634884|NCT00889395|cognitive benefits|cognitive benefits
634885|NCT00889382|Ovarian|ovarian
634886|NCT00889382|IGF-1R|igf-1r
634887|NCT00889382|Paclitaxel|paclitaxel
634888|NCT00889382|Ovarian Cancer|ovarian cancer
634889|NCT00889382|OSI-906|osi-906
634890|NCT00889382|Solid Tumors|solid tumors
634891|NCT00889369|depression|depression
634892|NCT00889369|duloxetine|duloxetine
634893|NCT00889369|menopause|menopause
634894|NCT00889369|imaging|imaging
634895|NCT00889369|FMRI|fmri
634896|NCT00889369|Menopausal staging|menopausal staging
634897|NCT00889369|vasomotor symptoms|vasomotor symptoms
634898|NCT00889343|Second-line therapy of metastatic colorectal cancer|second-line therapy of metastatic colorectal cancer
634899|NCT00889343|Sorafenib|sorafenib
634900|NCT00889343|Colorectal Neoplasms|colorectal neoplasms
634901|NCT00889343|palliative therapy|palliative therapy
634902|NCT00889343|after progression of firstline therapy with an Oxaliplatin- or Irinotecan based Fluoropyrimidine containing regimen ± bevacizumab|after progression of firstline therapy with an oxaliplatin- or irinotecan based fluoropyrimidine containing regimen ± bevacizumab
634903|NCT00889304|HTO, high tibial osteotomy, open wedge, medial arthritis|hto, high tibial osteotomy, open wedge, medial arthritis
634904|NCT00889291|End stage renal disease|end stage renal disease
634905|NCT00889291|Bacteremia|bacteremia
634906|NCT00889291|HeRO Vascular Access Device|hero vascular access device
634907|NCT00889291|Access challenged|access challenged
634908|NCT00889291|Catheter dependent|catheter dependent
634909|NCT00889291|End stage renal disease requiring vascular access. See HeRO device instructions for use for appropriate patient population|end stage renal disease requiring vascular access. see hero device instructions for use for appropriate patient population
634910|NCT00889278|Lymphoma|lymphoma
634911|NCT00889278|Autologous Peripheral Blood Stem Cell Transplant|autologous peripheral blood stem cell transplant
634912|NCT00889278|APBSCT|apbsct
634913|NCT00889278|Pneumococcal Conjugate Vaccine|pneumococcal conjugate vaccine
634914|NCT00889265|Alveolar Bone Augmentation|alveolar bone augmentation
634915|NCT00889265|Implant Surgery|implant surgery
634916|NCT00889265|Guided Bone Regeneration (GBR)|guided bone regeneration (gbr)
634917|NCT00889265|Guided Tissue Regeneration (GTR)|guided tissue regeneration (gtr)
634918|NCT00889265|Bone Graft|bone graft
634919|NCT00889265|Periodontal Surgery|periodontal surgery
634920|NCT00889239|ceramic|ceramic
634921|NCT00889239|wear rate|wear rate
634922|NCT00889239|opposing enamel|opposing enamel
634923|NCT00889226|pitavastatin|pitavastatin
634925|NCT00889226|ESPRIT|esprit
634926|NCT00889226|Pitavastatin and Atorvastatin|pitavastatin and atorvastatin
634927|NCT00889226|Adiponectin|adiponectin
634928|NCT00889226|fasting insulin|fasting insulin
634929|NCT00889226|hs-CRP|hs-crp
634930|NCT00889226|baPWV|bapwv
634931|NCT00889213|pancreatectomy|pancreatectomy
634932|NCT00889213|fistula|fistula
634933|NCT00889213|fibrin glue|fibrin glue
634934|NCT00889213|falciform patch|falciform patch
634935|NCT00889213|surgery|surgery
634936|NCT00889213|complications|complications
634937|NCT00889187|radiation therapy|radiation therapy
634938|NCT00889187|capecitabine|capecitabine
634939|NCT00889174|Genetic Disorders of the White Matter|genetic disorders of the white matter
634940|NCT00889174|Leukodystrophies|leukodystrophies
634941|NCT00889174|Myelin|myelin
634942|NCT00889174|White Matter Disorder|white matter disorder
634943|NCT00889174|Genetic Disorder|genetic disorder
634944|NCT00889161|Crohn's disease|crohn's disease
634945|NCT00889161|ulcerative colitis|ulcerative colitis
634946|NCT00889161|curcumin|curcumin
634947|NCT00889161|pediatric|pediatric
634948|NCT00889161|inflammatory bowel disease|inflammatory bowel disease
634949|NCT00889148|hip|hip
634950|NCT00889148|arthroplasty|arthroplasty
634951|NCT00889148|postoperative pain|postoperative pain
634952|NCT00889148|gabapentin|gabapentin
634953|NCT00889122|Obesity|obesity
634954|NCT00889122|Exergames|exergames
634955|NCT00889122|Videogames|videogames
634956|NCT00889122|Prevention|prevention
634957|NCT00889122|Family|family
634958|NCT00889122|Dance Dance Revolution|dance dance revolution
634959|NCT00889122|Pedometer|pedometer
634960|NCT00889096|memory|memory
634961|NCT00889096|heart rate|heart rate
634962|NCT00889096|skin conductance|skin conductance
634963|NCT00889096|α-amylase|α-amylase
634964|NCT00889096|propranolol|propranolol
634965|NCT00889096|tolerability|tolerability
634966|NCT00889083|Sepsis|sepsis
634967|NCT00889083|Peritonitis|peritonitis
634968|NCT00889083|Mitochondria|mitochondria
634969|NCT00889083|Liver|liver
634970|NCT00889057|osteosarcoma|osteosarcoma
634972|NCT00889057|target therapy|target therapy
634974|NCT00889018|intraocular retinoblastoma|intraocular retinoblastoma
634975|NCT00889018|chemotherapy|chemotherapy
634976|NCT00889005|Post-traumatic Stress Disorder|post-traumatic stress disorder
634977|NCT00889005|Acute Stress Disorder|acute stress disorder
634978|NCT00889005|Cognitive behavioral therapy|cognitive behavioral therapy
634979|NCT00889005|Secondary Prevention|secondary prevention
634980|NCT00889005|Anxiety disorders|anxiety disorders
634981|NCT00889005|Service Delivery|service delivery
634982|NCT00888992|Smoking|smoking
634983|NCT00888992|Cessation|cessation
634984|NCT00888992|Quitline|quitline
634985|NCT00888992|Counseling|counseling
634986|NCT00888979|Smoking Cessation during Pregnancy|smoking cessation during pregnancy
634987|NCT00888979|Nicotrol Inhaler|nicotrol inhaler
634988|NCT00888966|heart arrest|heart arrest
634989|NCT00888966|oxidative stress|oxidative stress
634990|NCT00888966|lactic acid|lactic acid
634991|NCT00888966|outcome|outcome
634992|NCT00888953|Falls|falls
634993|NCT00888953|Nursing Homes|nursing homes
634994|NCT00888953|Elderly|elderly
634995|NCT00888953|Prevention|prevention
634996|NCT00888953|Spain|spain
634997|NCT00888953|Cluster Randomized Clinical Trial|cluster randomized clinical trial
634998|NCT00888927|T-Cell Lymphoma|t-cell lymphoma
634999|NCT00888927|PTCL|ptcl
635000|NCT00888927|CTCL|ctcl
635001|NCT00888914|Lateral Canthal Lines|lateral canthal lines
635002|NCT00888914|Crow's Feet|crow's feet
635003|NCT00888914|Facial Wrinkles|facial wrinkles
635004|NCT00888901|ITP|itp
635005|NCT00888901|eltrombopag|eltrombopag
635006|NCT00888901|platelet function|platelet function
635007|NCT00888901|thrombocytopenia|thrombocytopenia
635008|NCT00888901|Platelet function in patients with cAITP on eltrombopag|platelet function in patients with caitp on eltrombopag
635009|NCT00888888|Acute appendicitis|acute appendicitis
635010|NCT00888888|Colonic diverticulitis|colonic diverticulitis
635011|NCT00888888|Colonic tumors|colonic tumors
635012|NCT00888888|Colonic resections|colonic resections
635013|NCT00888875|i-gel|i-gel
635014|NCT00888875|Fastrach|fastrach
635015|NCT00888875|intubation|intubation
635016|NCT00888875|fiberoptic|fiberoptic
635017|NCT00888875|difficult airway|difficult airway
635018|NCT00888875|Patients undergoing elective surgery requiring tracheal intubation|patients undergoing elective surgery requiring tracheal intubation
635019|NCT00888875|Presenting at least one sign of difficult intubation|presenting at least one sign of difficult intubation
635020|NCT00888862|depression|depression
635021|NCT00888862|desvenlafaxine|desvenlafaxine
635022|NCT00888862|menopause|menopause
635023|NCT00888862|imaging|imaging
635024|NCT00888862|FMRI|fmri
635025|NCT00888849|Stapling|stapling
635026|NCT00888849|hand sutured anastamosis|hand sutured anastamosis
635027|NCT00888849|colorectal disease|colorectal disease
635028|NCT00888836|bariatric surgery|bariatric surgery
635029|NCT00888836|GBP|gbp
635030|NCT00888836|BPD|bpd
635031|NCT00888836|type 2 diabetes|type 2 diabetes
635032|NCT00888823|Fractionated stereotactic radiotherapy|fractionated stereotactic radiotherapy
635033|NCT00888823|Medically inoperable|medically inoperable
635034|NCT00888823|Image-guided radiotherapy|image-guided radiotherapy
635035|NCT00888810|ovarian - cancer - relapse - topotecan - lapatinib|ovarian - cancer - relapse - topotecan - lapatinib
635036|NCT00888771|Colorectal cancer|colorectal cancer
635037|NCT00888771|polyps|polyps
635038|NCT00888771|colonoscopy|colonoscopy
635039|NCT00888771|advanced imaging|advanced imaging
635040|NCT00888758|Stents|stents
635041|NCT00888745|RA|ra
635042|NCT00888732|Diabetes|diabetes
635043|NCT00888680|Migraine|migraine
635044|NCT00888680|Headaches|headaches
635045|NCT00888680|Migraine headaches|migraine headaches
635046|NCT00888680|Head pain|head pain
635047|NCT00888667|ICD patients with PVCs and EGM recordings|icd patients with pvcs and egm recordings
635048|NCT00888654|adenocarcinoma of the prostate|adenocarcinoma of the prostate
635049|NCT00888654|stage I prostate cancer|stage i prostate cancer
635050|NCT00888654|stage II prostate cancer|stage ii prostate cancer
635051|NCT00888628|Type I diabetes|type i diabetes
635052|NCT00888628|Islet after Kidney Transplant|islet after kidney transplant
635053|NCT00888628|Islet transplantation|islet transplantation
635055|NCT00888589|Molecular Breast Imaging|molecular breast imaging
635056|NCT00888589|Breast|breast
635057|NCT00888589|Breast Cancer|breast cancer
635058|NCT00888589|Molecular Imaging|molecular imaging
635059|NCT00888563|Fatigue|fatigue
635060|NCT00888563|Depression|depression
635061|NCT00888563|Healthy Volunteer|healthy volunteer
635062|NCT00888563|HV|hv
635063|NCT00888537|Decision aid|decision aid
635064|NCT00888537|Heart attack|heart attack
635065|NCT00888537|myocardial infarction|myocardial infarction
635066|NCT00888524|head out water immersion,|head out water immersion,
635067|NCT00888524|high intensity exercise,|high intensity exercise,
635068|NCT00888524|evidence-based physiotherapy;|evidence-based physiotherapy;
635069|NCT00888524|aquatics;|aquatics;
635070|NCT00888524|hydrotherapy|hydrotherapy
635071|NCT00888524|aquatics therapy|aquatics therapy
635072|NCT00888524|exercise therapy|exercise therapy
635073|NCT00888511|Lung cancer|lung cancer
635074|NCT00888511|Non-small cell lung cancer|non-small cell lung cancer
635075|NCT00888511|Tarceva|tarceva
635076|NCT00888511|Radiotherapy|radiotherapy
635077|NCT00888511|Local-regionally advanced non-small cell lung cancer|local-regionally advanced non-small cell lung cancer
809174|NCT00213785|AreET1|areet1
635078|NCT00888498|Sprains and Strains|sprains and strains
635079|NCT00888498|Ankle|ankle
635080|NCT00888498|Manual Therapies|manual therapies
635081|NCT00888498|Outcome Studies|outcome studies
635082|NCT00888472|Extracorporeal leukocytapheresis|extracorporeal leukocytapheresis
635083|NCT00888459|tobacco|tobacco
635084|NCT00888459|chew|chew
635085|NCT00888459|nrt|nrt
635086|NCT00888459|nicotine lozenges|nicotine lozenges
635087|NCT00888459|self-help|self-help
635088|NCT00888446|HIV|hiv
635089|NCT00888446|HIV seronegativity|hiv seronegativity
635090|NCT00888446|preventative vaccine|preventative vaccine
635091|NCT00888433|hypertension|hypertension
635092|NCT00888433|renal denervation|renal denervation
635093|NCT00888433|sympathetic nervous system|sympathetic nervous system
635094|NCT00888433|RDN|rdn
635095|NCT00888420|Chronic Pain|chronic pain
635096|NCT00888407|Asian American Health|asian american health
635097|NCT00888407|Cancer|cancer
635098|NCT00888407|Hepatitis|hepatitis
635099|NCT00888407|Hepatitis B|hepatitis b
635100|NCT00888407|Liver Cancer|liver cancer
635101|NCT00888394|chiropody|chiropody
635102|NCT00888394|podiatry|podiatry
635103|NCT00888394|insoles|insoles
635104|NCT00888394|foot orthesis|foot orthesis
635105|NCT00888342|Pulmonary Disease|pulmonary disease
635106|NCT00888342|Chronic Obstructive|chronic obstructive
635107|NCT00888342|Hypercapnia|hypercapnia
635108|NCT00888342|Hypoxemia|hypoxemia
635109|NCT00888342|Arrhythmias, Cardiac|arrhythmias, cardiac
635110|NCT00888342|Polysomnography|polysomnography
635111|NCT00888342|Capnography|capnography
635112|NCT00888342|Electrocardiography, Holter|electrocardiography, holter
635113|NCT00888329|Elective hysterectomy|elective hysterectomy
635114|NCT00888316|iron overload|iron overload
635115|NCT00888290|metabolic acidosis|metabolic acidosis
635116|NCT00888290|chronic kidney disease|chronic kidney disease
635117|NCT00888290|Estimated GFR 15-45|estimated gfr 15-45
635118|NCT00888264|Antipsychotics|antipsychotics
635119|NCT00888264|Bipolar Disorder|bipolar disorder
635120|NCT00888264|Depressive episodes|depressive episodes
635121|NCT00888264|Bipolar I or II Disorders|bipolar i or ii disorders
635122|NCT00888251|Obesity|obesity
635123|NCT00888251|Meal replacement|meal replacement
635124|NCT00888251|Obesity treatment|obesity treatment
635125|NCT00888251|Weight management|weight management
635126|NCT00888225|Tennis elbow|tennis elbow
635127|NCT00888225|Epicondylitis|epicondylitis
635128|NCT00888225|Pain|pain
635129|NCT00888225|Muscle strength|muscle strength
635130|NCT00888225|Quality of life|quality of life
635131|NCT00888225|RCT|rct
635132|NCT00888225|Tendinitis|tendinitis
635133|NCT00888225|Chronic tennis elbow|chronic tennis elbow
635134|NCT00888199|amputation|amputation
635135|NCT00888199|amputee|amputee
635136|NCT00888199|prosthetic|prosthetic
635137|NCT00888199|foot|foot
635138|NCT00888199|prosthesis|prosthesis
635139|NCT00888199|Tensegrity|tensegrity
635140|NCT00888199|Prosthetics|prosthetics
635141|NCT00888199|K3 Promoter|k3 promoter
635142|NCT00888186|Dyskinesias|dyskinesias
635143|NCT00888186|Duodenal levodopa infusion|duodenal levodopa infusion
635144|NCT00888186|Dose optimization|dose optimization
635145|NCT00888186|Pharmacokinetics|pharmacokinetics
635146|NCT00888186|Pharmacodynamics|pharmacodynamics
635147|NCT00888147|Tube feeding|tube feeding
635148|NCT00888147|Fiber|fiber
635149|NCT00888147|Constipation|constipation
635150|NCT00888095|deep brain stimulation|deep brain stimulation
635151|NCT00888095|caudal Zona incerta|caudal zona incerta
635152|NCT00888095|Nucleus subthalamicus|nucleus subthalamicus
635153|NCT00888095|Parkinson's disease|parkinson's disease
635154|NCT00888095|randomized|randomized
635155|NCT00888095|blinded|blinded
635156|NCT00888095|Movement disorder|movement disorder
635157|NCT00888082|adjuvant chemotherapy|adjuvant chemotherapy
635158|NCT00888082|breast cancer|breast cancer
635159|NCT00888082|goserelin acetate|goserelin acetate
635160|NCT00888082|ovarian function|ovarian function
635161|NCT00888082|Chemotherapy|chemotherapy
635162|NCT00888082|Primary invasive breast cancer|primary invasive breast cancer
635163|NCT00888069|Parathyroid Diseases|parathyroid diseases
635164|NCT00888069|Renal Insufficiency|renal insufficiency
635165|NCT00888069|Kidney Failure, Chronic|kidney failure, chronic
635166|NCT00888069|Hyperparathyroidism, Secondary|hyperparathyroidism, secondary
635167|NCT00888069|Vitamin D|vitamin d
635168|NCT00888069|Hyperparathyroidism|hyperparathyroidism
635169|NCT00888069|Renal Insufficiency, Chronic|renal insufficiency, chronic
635170|NCT00888069|Kidney Diseases|kidney diseases
635171|NCT00888069|Kidney Failure|kidney failure
635172|NCT00888043|solid tumors|solid tumors
635173|NCT00888043|avastin|avastin
635174|NCT00888043|Phase I|phase i
635175|NCT00888043|combination therapy|combination therapy
635177|NCT00888030|p-cresol|p-cresol
635178|NCT00888030|indoxyl sulfate|indoxyl sulfate
635179|NCT00888030|chronic kidney disease|chronic kidney disease
635181|NCT00888017|bone density|bone density
711002|NCT00586898|ESTROGENS|estrogens
635182|NCT00888017|proton pump inhibitors|proton pump inhibitors
635183|NCT00888017|premature infants|premature infants
635184|NCT00888004|Parkinson's|parkinson's
635185|NCT00888004|L-dopa|l-dopa
635186|NCT00888004|dyskinesia|dyskinesia
635187|NCT00887991|Randomised trial|randomised trial
635188|NCT00887991|breast pumps|breast pumps
635189|NCT00887991|efficacy|efficacy
635190|NCT00887991|preterm|preterm
635191|NCT00887991|Mothers of preterm infants who plan to express milk for their infants.|mothers of preterm infants who plan to express milk for their infants.
635192|NCT00887965|Low Bone Mass|low bone mass
635193|NCT00887965|Low Bone Mineral Density|low bone mineral density
635194|NCT00887965|Osteoporosis|osteoporosis
635195|NCT00887965|Postmenopausal Osteoporosis|postmenopausal osteoporosis
635196|NCT00887965|Bone Biopsy|bone biopsy
635197|NCT00887965|Transiliac Crest Bone Histology|transiliac crest bone histology
635198|NCT00887965|Histomorphometry|histomorphometry
635199|NCT00887952|Deep caries lesion|deep caries lesion
635200|NCT00887952|dentine caries removal|dentine caries removal
635201|NCT00887952|dental restoration|dental restoration
635202|NCT00887952|stepwise excavation|stepwise excavation
635203|NCT00887939|Physical Urticaria|physical urticaria
635204|NCT00887939|Pathogenesis|pathogenesis
635205|NCT00887939|Inflammasome|inflammasome
635206|NCT00887939|IL-1|il-1
635207|NCT00887939|Mast Cell|mast cell
635208|NCT00887939|Urticaria|urticaria
635209|NCT00887926|AML|aml
635210|NCT00887926|Leukemia|leukemia
635211|NCT00887926|Acute Myeloid Leukemia|acute myeloid leukemia
635212|NCT00887926|Antibodies, Monoclonal|antibodies, monoclonal
635213|NCT00887900|lamellar keratoplasty|lamellar keratoplasty
635214|NCT00887900|keratoconus|keratoconus
635215|NCT00887900|penetrated keratoplasty|penetrated keratoplasty
635216|NCT00887900|Visual acuity|visual acuity
635217|NCT00887887|liver surgery|liver surgery
635218|NCT00887887|gene polymorphisms|gene polymorphisms
635219|NCT00887887|innate immune response|innate immune response
635220|NCT00887887|infectious complications|infectious complications
635221|NCT00887887|post-resectional liver failure|post-resectional liver failure
635222|NCT00887887|mortality|mortality
635223|NCT00887861|epilepsy|epilepsy
635224|NCT00887861|seizure|seizure
635225|NCT00887861|monotherapy trials|monotherapy trials
635226|NCT00887861|partial seizure|partial seizure
635227|NCT00887861|Partial seizures and undergoing evaluation for epilepsy surgery|partial seizures and undergoing evaluation for epilepsy surgery
635228|NCT00887848|Child|child
635229|NCT00887848|Robotic-assisted treadmill training|robotic-assisted treadmill training
635230|NCT00887848|Rehabilitation|rehabilitation
635231|NCT00887835|PERPOS fusion|perpos fusion
635232|NCT00887809|Bevacizumab (avastin)|bevacizumab (avastin)
635233|NCT00887809|Gemcitabine|gemcitabine
635234|NCT00887809|Taxotere (docetaxel)|taxotere (docetaxel)
635235|NCT00887809|09-015|09-015
635236|NCT00887809|Soft tissue|soft tissue
635237|NCT00887783|Induction chemotherapy|induction chemotherapy
635238|NCT00887783|Non-small cell lung cancer|non-small cell lung cancer
635239|NCT00887783|Randomized phase II study|randomized phase ii study
635240|NCT00887783|Navelbine Oral (R)|navelbine oral (r)
635241|NCT00887783|3D-conformal radiotherapy|3d-conformal radiotherapy
635242|NCT00887783|Chemo-radiotherapy|chemo-radiotherapy
635243|NCT00887783|Local-regionally advanced non-small cell lung cancer|local-regionally advanced non-small cell lung cancer
635244|NCT00887770|QTcF|qtcf
635245|NCT00887770|Crossover|crossover
635246|NCT00887770|ICH E14|ich e14
635247|NCT00887770|QT/QTc prolongation|qt/qtc prolongation
635248|NCT00887770|Moxifloxacin|moxifloxacin
635249|NCT00887770|QT/QTc Interval|qt/qtc interval
635250|NCT00887744|Degenerative Lumbar Spinal Stenosis|degenerative lumbar spinal stenosis
635251|NCT00887744|Neurogenic Intermittent Claudication|neurogenic intermittent claudication
635252|NCT00887744|Interpinous Device|interpinous device
635253|NCT00887744|Percutaneous|percutaneous
635254|NCT00887731|closed loop oxygen controller|closed loop oxygen controller
635255|NCT00887731|premature infants|premature infants
635256|NCT00887731|oxygen exposure|oxygen exposure
635257|NCT00887718|PET scan and Hodgkin's Lymphoma|pet scan and hodgkin's lymphoma
635258|NCT00887718|PET scan and Non Hodgkin's Lymphoma|pet scan and non hodgkin's lymphoma
635259|NCT00887718|PET scan|pet scan
635260|NCT00887705|COPD|copd
635261|NCT00887705|Pulmonary Rehabilitation|pulmonary rehabilitation
635262|NCT00887705|ADL-Training|adl-training
635263|NCT00887705|COPD Rehabilitation|copd rehabilitation
635264|NCT00887679|Escitalopram|escitalopram
635265|NCT00887679|Anxiety Disorder|anxiety disorder
635266|NCT00887679|HIV and AIDS|hiv and aids
635267|NCT00887679|treatment experienced|treatment experienced
635268|NCT00887640|metastatic|metastatic
635269|NCT00887640|Temsirolimus|temsirolimus
635270|NCT00887640|prostate|prostate
635271|NCT00887640|cancer|cancer
635272|NCT00887627|Pharmacokinetics|pharmacokinetics
635273|NCT00887627|Protein Binding|protein binding
635274|NCT00887627|Conivaptan|conivaptan
635275|NCT00887627|Vaprisol|vaprisol
635276|NCT00887627|Kidney Diseases|kidney diseases
635277|NCT00887614|mindfulness|mindfulness
635278|NCT00887614|meditation|meditation
635279|NCT00887614|stress|stress
635280|NCT00887614|rumination|rumination
635281|NCT00887614|emotion regulation|emotion regulation
635282|NCT00887614|sleep quality|sleep quality
635283|NCT00887614|spirituality|spirituality
635284|NCT00887614|quality of life|quality of life
635285|NCT00887588|Chronic heart failure|chronic heart failure
635286|NCT00887588|preserved ejection fraction|preserved ejection fraction
635287|NCT00887588|cardiovascular disease|cardiovascular disease
635288|NCT00887588|NT-proBNP|nt-probnp
635289|NCT00887588|biomarkers|biomarkers
635290|NCT00887588|Heart failure with preserved left-ventricular ejection|heart failure with preserved left-ventricular ejection
635291|NCT00887588|fraction|fraction
635292|NCT00887575|Breast Cancer|breast cancer
635293|NCT00887575|Triple-Negative|triple-negative
635294|NCT00887575|Paclitaxel|paclitaxel
635295|NCT00887575|Carboplatin|carboplatin
635296|NCT00887575|Sunitinib|sunitinib
635297|NCT00887575|Sutent|sutent
635298|NCT00887575|Neoadjuvant|neoadjuvant
635299|NCT00887536|National Surgical Adjuvant Breast and Bowel Project (NSABP)|national surgical adjuvant breast and bowel project (nsabp)
635300|NCT00887536|Taxotere|taxotere
635301|NCT00887536|Docetaxel|docetaxel
635302|NCT00887536|Doxorubicin|doxorubicin
635303|NCT00887536|Cyclophosphamide|cyclophosphamide
635304|NCT00887536|Bevacizumab|bevacizumab
635305|NCT00887536|Breast Neoplasms|breast neoplasms
635306|NCT00887536|Adenocarcinoma|adenocarcinoma
635307|NCT00887536|Breast Diseases|breast diseases
635308|NCT00887536|Carcinoma|carcinoma
635309|NCT00887536|HER2 negative|her2 negative
635310|NCT00887536|Node negative|node negative
635311|NCT00887536|High risk node positive|high risk node positive
635312|NCT00887536|Adjuvant Therapy|adjuvant therapy
635313|NCT00887510|Metabolic Syndrome|metabolic syndrome
635314|NCT00887510|High Blood Pressure|high blood pressure
635315|NCT00887510|Abdominal Obesity|abdominal obesity
635316|NCT00887510|Impaired Glucose Tolerance|impaired glucose tolerance
635317|NCT00887484|Acne|acne
635318|NCT00887484|Acne Vulgaris|acne vulgaris
635319|NCT00887471|Sleep-disordered breathing|sleep-disordered breathing
635320|NCT00887471|Obstructive sleep apnea|obstructive sleep apnea
635321|NCT00887471|Polysomnography|polysomnography
635322|NCT00887471|Tonsillectomy|tonsillectomy
635323|NCT00887471|Microdebrider assisted partial intracapsular tonsillectomy|microdebrider assisted partial intracapsular tonsillectomy
635324|NCT00887458|metastatic prostate cancer|metastatic prostate cancer
635325|NCT00887458|castration resistant prostate cancer|castration resistant prostate cancer
635326|NCT00887458|rising PSA|rising psa
635327|NCT00887445|First in Man|first in man
635328|NCT00887445|SLV341|slv341
635329|NCT00887445|diabetes|diabetes
635330|NCT00887419|chronic back pain|chronic back pain
635331|NCT00887419|spinal cord stimulator implant|spinal cord stimulator implant
635332|NCT00887406|first time in human study|first time in human study
635333|NCT00887406|COPD|copd
635334|NCT00887406|long-acting bronchodilator|long-acting bronchodilator
635335|NCT00887393|morbid obesity|morbid obesity
635336|NCT00887393|non-alcoholic fatty liver disease|non-alcoholic fatty liver disease
635337|NCT00887393|bariatric surgery|bariatric surgery
635338|NCT00887393|low fat diet|low fat diet
635339|NCT00887393|low carbohydrate diet|low carbohydrate diet
635340|NCT00887380|Breast Cancer|breast cancer
635341|NCT00887380|Timing of Radiotherapy|timing of radiotherapy
635342|NCT00887380|Local control|local control
635343|NCT00887367|Healthy volunteers|healthy volunteers
635344|NCT00887367|Substance dependence|substance dependence
635345|NCT00887367|Alcohol dependence|alcohol dependence
635346|NCT00887354|Low bone mass|low bone mass
635347|NCT00887354|Recent pertrochanteric hip fracture|recent pertrochanteric hip fracture
635348|NCT00887328|ischemic stroke|ischemic stroke
635349|NCT00887328|ischemic penumbra|ischemic penumbra
635350|NCT00887328|magnetic resonance imaging|magnetic resonance imaging
635351|NCT00887328|MRI|mri
635352|NCT00887328|diffusion imaging|diffusion imaging
635353|NCT00887328|DWI|dwi
635354|NCT00887328|perfusion imaging|perfusion imaging
635355|NCT00887328|PWI|pwi
635356|NCT00887328|thrombolysis|thrombolysis
635357|NCT00887328|alteplase|alteplase
635358|NCT00887328|tPA|tpa
635359|NCT00887328|EPITHET|epithet
635360|NCT00887315|NSCLC|nsclc
635361|NCT00887315|Metastatic Stage IV NSCLC|metastatic stage iv nsclc
635362|NCT00887315|Limited Volume Stage IV Non-small Cell Lung Cancer|limited volume stage iv non-small cell lung cancer
635363|NCT00887276|Ampicillin|ampicillin
635364|NCT00887276|Amoxicillin|amoxicillin
635365|NCT00887276|Moxifloxacin|moxifloxacin
635366|NCT00887276|Community-Acquired Pneumonia|community-acquired pneumonia
635367|NCT00887237|Heart failure|heart failure
635368|NCT00887237|Cardiac resynchronization|cardiac resynchronization
635369|NCT00887237|Triple site ventricular pacing|triple site ventricular pacing
635370|NCT00887224|Major Depressive Disorder|major depressive disorder
635371|NCT00887211|stent|stent
635372|NCT00887211|coronary artery disease|coronary artery disease
635373|NCT00887198|Prostate cancer|prostate cancer
635374|NCT00887198|Abiraterone acetate|abiraterone acetate
635375|NCT00887198|CB7630|cb7630
635376|NCT00887198|CRPC|crpc
635377|NCT00887198|Metastatic castration-resistant prostate cancer|metastatic castration-resistant prostate cancer
635378|NCT00887198|hormone refractory prostate cancer|hormone refractory prostate cancer
635379|NCT00887185|Surgical Simulation|surgical simulation
635380|NCT00887185|Surgical skills training|surgical skills training
635381|NCT00887185|Temporal bone surgery|temporal bone surgery
635382|NCT00887185|Computer simulation|computer simulation
635383|NCT00887172|Acute upper respiratory tract infections|acute upper respiratory tract infections
635384|NCT00887146|adult anaplastic astrocytoma|adult anaplastic astrocytoma
635385|NCT00887146|adult anaplastic oligodendroglioma|adult anaplastic oligodendroglioma
635386|NCT00887146|adult mixed glioma|adult mixed glioma
635387|NCT00887120|Second line treatment|second line treatment
635388|NCT00887120|therapeutic drug monitoring|therapeutic drug monitoring
635389|NCT00887120|Asia|asia
635390|NCT00887120|LPV|lpv
635391|NCT00887120|children|children
635392|NCT00887120|pharmacokinetic|pharmacokinetic
635393|NCT00887120|To study the pharmacokinetics of low-dose and standard dose, lopinavir/ritonavir in Protease inhibitor (PI)- naive HIV-1 infected Thai patients.|to study the pharmacokinetics of low-dose and standard dose, lopinavir/ritonavir in protease inhibitor (pi)- naive hiv-1 infected thai patients.
635394|NCT00887120|To study clinical and immunological efficacy after 48-weeks of lopinavir/ritonavir-based antiretroviral therapy in PI naive HIV-1 infected Thai patients.|to study clinical and immunological efficacy after 48-weeks of lopinavir/ritonavir-based antiretroviral therapy in pi naive hiv-1 infected thai patients.
635395|NCT00887094|Diabetes mellitus|diabetes mellitus
635396|NCT00887094|Exercise|exercise
635397|NCT00887094|Endurance|endurance
635398|NCT00887094|Resistance|resistance
635399|NCT00887094|Continuous glucose monitoring system|continuous glucose monitoring system
635400|NCT00887081|antiviral treatment in hemoglobinopathies|antiviral treatment in hemoglobinopathies
635401|NCT00887081|management of chronic viral hepatitis C infection|management of chronic viral hepatitis c infection
635402|NCT00887081|antiviral treatment|antiviral treatment
635403|NCT00887068|Leukemia|leukemia
635404|NCT00887068|Acute myelogenous leukemia|acute myelogenous leukemia
635405|NCT00887068|AML|aml
635406|NCT00887068|Myelodysplastic syndrome|myelodysplastic syndrome
635407|NCT00887068|MDS|mds
635408|NCT00887068|Remission|remission
635409|NCT00887068|Allogeneic stem cell transplant|allogeneic stem cell transplant
635410|NCT00887068|Allotx|allotx
635411|NCT00887068|Azacitidine|azacitidine
635412|NCT00887068|5-Azacitidine|5-azacitidine
635413|NCT00887068|5-aza|5-aza
635414|NCT00887068|Vidaza|vidaza
635415|NCT00887068|5-AZC|5-azc
635416|NCT00887068|AZA-CR|aza-cr
635417|NCT00887068|Ladakamycin|ladakamycin
635418|NCT00887068|NSC-102816|nsc-102816
635419|NCT00887042|Acute myeloid leukemia|acute myeloid leukemia
635420|NCT00887042|Cord blood transplantation|cord blood transplantation
635421|NCT00887042|Pediatric|pediatric
635422|NCT00887029|Topical prostaglandin analogue|topical prostaglandin analogue
635423|NCT00887029|glaucoma|glaucoma
635424|NCT00887029|POAG|poag
635425|NCT00887029|OHT|oht
635426|NCT00887029|OAG|oag
635427|NCT00887029|ocular hypertension|ocular hypertension
635428|NCT00887029|fixed combination protaglandin analogue therapy|fixed combination protaglandin analogue therapy
635429|NCT00887029|DuoTrav|duotrav
635430|NCT00887029|timolol|timolol
635431|NCT00887029|travoprost|travoprost
635432|NCT00887029|24 hour post dose|24 hour post dose
635433|NCT00887029|IOP|iop
635434|NCT00887029|dosing preference|dosing preference
635435|NCT00887003|epidural|epidural
635436|NCT00887003|volume|volume
635437|NCT00887003|dose|dose
635438|NCT00887003|pain relief|pain relief
635439|NCT00887003|steroid|steroid
635440|NCT00886990|single- and double-boosted PI|single- and double-boosted pi
635441|NCT00886990|second line regimen|second line regimen
635442|NCT00886990|NNRTI failure|nnrti failure
635443|NCT00886990|HIV-infected children|hiv-infected children
635444|NCT00886990|Compare virological efficacy and safety of single- or double-boosted PI regimens as second line therapy in children with NNRTI-based treatment failure|compare virological efficacy and safety of single- or double-boosted pi regimens as second line therapy in children with nnrti-based treatment failure
635445|NCT00886990|treatment experienced|treatment experienced
635446|NCT00886977|ALS|als
635447|NCT00886964|HBV vaccine|hbv vaccine
635448|NCT00886964|HIV children|hiv children
635449|NCT00886964|immune recovery|immune recovery
635450|NCT00886964|HBV antibody|hbv antibody
635451|NCT00886964|Intradermal|intradermal
635452|NCT00886964|Intramuscular|intramuscular
635453|NCT00886964|antibody response after HBV vaccine|antibody response after hbv vaccine
635454|NCT00886964|treatment experienced|treatment experienced
635455|NCT00886938|tinnitus|tinnitus
635456|NCT00886925|Hepatic encephalopathy|hepatic encephalopathy
635457|NCT00886925|Cirrhosis|cirrhosis
635458|NCT00886925|Albumin|albumin
635459|NCT00886912|mountain sickness|mountain sickness
635460|NCT00886899|CTO|cto
635461|NCT00886899|chronic total occlusion|chronic total occlusion
635462|NCT00886899|CAD|cad
711003|NCT00586898|LUPRON|lupron
635463|NCT00886899|coronary artery disease|coronary artery disease
635464|NCT00886899|interventional cardiology|interventional cardiology
635465|NCT00886899|revascularization|revascularization
635466|NCT00886899|recanalization|recanalization
635467|NCT00886886|MDMA|mdma
635468|NCT00886886|norepinephrine|norepinephrine
635469|NCT00886886|Ecstasy|ecstasy
635470|NCT00886886|stimulant|stimulant
635471|NCT00886873|Uterine fibroids|uterine fibroids
635472|NCT00886873|Mifepristone|mifepristone
635473|NCT00886873|Antiprogestins|antiprogestins
635474|NCT00886860|Efficacy|efficacy
635475|NCT00886860|Cervical ripening/Labor induction|cervical ripening/labor induction
635476|NCT00886860|Titrated oral misoprostol/Conventional oral misoprostol|titrated oral misoprostol/conventional oral misoprostol
635477|NCT00886860|Term pregnancy|term pregnancy
635478|NCT00886847|Lung|lung
635479|NCT00886847|Lymphadenopathy|lymphadenopathy
635480|NCT00886847|Enlarged hilar or/and mediastinal lymph adenopathy|enlarged hilar or/and mediastinal lymph adenopathy
635481|NCT00886847|Benign|benign
635482|NCT00886847|Malignant|malignant
635483|NCT00886847|Mediastinal lymph nodes|mediastinal lymph nodes
635484|NCT00886847|Hilar lymph nodes|hilar lymph nodes
635485|NCT00886847|Fine Needle Aspiration|fine needle aspiration
635487|NCT00886847|Fine Needle Capillary Sampling|fine needle capillary sampling
635488|NCT00886847|FNC|fnc
635489|NCT00886847|Endobronchial Ultrasound-Guided Biopsy|endobronchial ultrasound-guided biopsy
635490|NCT00886847|EBUS|ebus
635491|NCT00886847|Tissue Sample|tissue sample
635492|NCT00886847|Suction|suction
635493|NCT00886834|IUD insertion|iud insertion
635494|NCT00886834|Nulliparous women|nulliparous women
635495|NCT00886834|Contraception|contraception
635496|NCT00886834|Family Planning|family planning
635497|NCT00886834|IUD insertion in nulliparous women|iud insertion in nulliparous women
635498|NCT00886821|Phase 1 Type 2 diabetes CVX-096 diabetes mellitus|phase 1 type 2 diabetes cvx-096 diabetes mellitus
635499|NCT00886821|adult-onset diabetes mellitus|adult-onset diabetes mellitus
635500|NCT00886821|non-insulin dependent|non-insulin dependent
635501|NCT00886808|DME, Diabetic Retinopathy, Diabetic Macular Edema|dme, diabetic retinopathy, diabetic macular edema
635502|NCT00886795|hives|hives
635503|NCT00886795|rash|rash
635504|NCT00886795|pruritis|pruritis
635505|NCT00886782|Advanced and/or Metastatic solid cancers|advanced and/or metastatic solid cancers
635506|NCT00886769|Flare|flare
635507|NCT00886769|arthritis|arthritis
635508|NCT00886769|IL-1beta antagonist|il-1beta antagonist
635509|NCT00886769|systemic juvenile idiopathic arthritis|systemic juvenile idiopathic arthritis
635510|NCT00886769|Juvenile Rheumatoid|juvenile rheumatoid
635511|NCT00886769|Systemic juvenile idiopathic arthritis with active flare|systemic juvenile idiopathic arthritis with active flare
635512|NCT00886756|Phase I|phase i
635513|NCT00886756|Japanese healthy volunteer|japanese healthy volunteer
635514|NCT00886756|AZD8529|azd8529
635515|NCT00886730|Depressive disorder|depressive disorder
635516|NCT00886730|Primary care|primary care
635517|NCT00886730|Internet|internet
635518|NCT00886730|Social support|social support
635519|NCT00886730|Feasibility|feasibility
635520|NCT00886717|stage IIIA ovarian epithelial cancer|stage iiia ovarian epithelial cancer
635521|NCT00886717|stage IIIB ovarian epithelial cancer|stage iiib ovarian epithelial cancer
635522|NCT00886717|stage IIIC ovarian epithelial cancer|stage iiic ovarian epithelial cancer
635523|NCT00886717|stage IV ovarian epithelial cancer|stage iv ovarian epithelial cancer
635524|NCT00886717|stage IIIA ovarian germ cell tumor|stage iiia ovarian germ cell tumor
635525|NCT00886717|stage IIIB ovarian germ cell tumor|stage iiib ovarian germ cell tumor
635526|NCT00886717|stage IIIC ovarian germ cell tumor|stage iiic ovarian germ cell tumor
635527|NCT00886717|stage IV ovarian germ cell tumor|stage iv ovarian germ cell tumor
635528|NCT00886704|Omega-3 fatty acids|omega-3 fatty acids
635529|NCT00886704|dietary supplementation|dietary supplementation
635530|NCT00886704|atherosclerosis|atherosclerosis
635531|NCT00886678|Non-Small Cell Lung Cancer|non-small cell lung cancer
635532|NCT00886678|pemetrexed|pemetrexed
635533|NCT00886678|radiation|radiation
635534|NCT00886665|Diabetic Neuropathy|diabetic neuropathy
635535|NCT00886665|Nerve Conduction Studies|nerve conduction studies
635536|NCT00886665|Clinical Trial|clinical trial
635537|NCT00886652|Scoliosis|scoliosis
635538|NCT00886652|Muscle Strength|muscle strength
635539|NCT00886652|Respiratory function tests|respiratory function tests
635540|NCT00886652|Exercise therapy|exercise therapy
635541|NCT00886639|COPD III/IV|copd iii/iv
635542|NCT00886639|Oxygen Supply|oxygen supply
635543|NCT00886639|Six-Minute-Walking-Test|six-minute-walking-test
635544|NCT00886639|Oxygen Responder|oxygen responder
635545|NCT00886626|Obesity|obesity
635546|NCT00886626|Impaired Glucose Tolerance|impaired glucose tolerance
635547|NCT00886626|Children|children
635548|NCT00886587|eczema|eczema
635549|NCT00886574|Cilostazol versus Aspirin|cilostazol versus aspirin
635550|NCT00886574|Anti-PLT drug|anti-plt drug
635551|NCT00886574|Primary Prevention of Atherosclerotic Events|primary prevention of atherosclerotic events
635552|NCT00886574|Type 2 DM|type 2 dm
635553|NCT00886574|Intima media thickness (IMT)|intima media thickness (imt)
635554|NCT00886561|HIV prevention, female sex workers|hiv prevention, female sex workers
635555|NCT00886561|HIV seronegativity|hiv seronegativity
635556|NCT00886535|breast cancer|breast cancer
635557|NCT00886535|hot flashes|hot flashes
635558|NCT00886535|tamoxifen|tamoxifen
635559|NCT00886522|Anti-thymocyte globulin Fresenius|anti-thymocyte globulin fresenius
635560|NCT00886522|Busulfan|busulfan
635561|NCT00886522|Cord blood|cord blood
635562|NCT00886522|Cyclophosphamide|cyclophosphamide
635563|NCT00886522|Fludarabine|fludarabine
635564|NCT00886522|Human Leucocyte Antigen|human leucocyte antigen
635565|NCT00886522|Hematopoietic Stem Cell|hematopoietic stem cell
635566|NCT00886522|Hematopoietic Stem Cell Transplant|hematopoietic stem cell transplant
635567|NCT00886522|Graft-versus-Host-Disease|graft-versus-host-disease
635568|NCT00886522|Graft-versus-Host-Disease prophylaxis|graft-versus-host-disease prophylaxis
635569|NCT00886522|Intrabone infusion|intrabone infusion
635570|NCT00886522|Thiotepa|thiotepa
635571|NCT00886509|Coronary Artery Disease|coronary artery disease
635573|NCT00886509|Coronary Collaterals|coronary collaterals
635574|NCT00886509|Therapeutic Collateral Promotion (TCP)|therapeutic collateral promotion (tcp)
635575|NCT00886496|unspecified childhood solid tumor, protocol specific|unspecified childhood solid tumor, protocol specific
635576|NCT00886496|fever, sweats, and hot flashes|fever, sweats, and hot flashes
635577|NCT00886496|neutropenia|neutropenia
635578|NCT00886496|infection|infection
635579|NCT00886496|recurrent childhood small noncleaved cell lymphoma|recurrent childhood small noncleaved cell lymphoma
635580|NCT00886496|stage I and II childhood small noncleaved cell lymphoma|stage i and ii childhood small noncleaved cell lymphoma
635581|NCT00886496|stage I childhood small noncleaved cell lymphoma|stage i childhood small noncleaved cell lymphoma
635582|NCT00886496|stage II childhood small noncleaved cell lymphoma|stage ii childhood small noncleaved cell lymphoma
635583|NCT00886496|stage III and IV childhood small noncleaved cell lymphoma|stage iii and iv childhood small noncleaved cell lymphoma
635584|NCT00886496|stage III childhood small noncleaved cell lymphoma|stage iii childhood small noncleaved cell lymphoma
635585|NCT00886496|stage IV childhood small noncleaved cell lymphoma|stage iv childhood small noncleaved cell lymphoma
635586|NCT00886496|recurrent childhood lymphoblastic lymphoma|recurrent childhood lymphoblastic lymphoma
635587|NCT00886496|stage I and II childhood lymphoblastic lymphoma|stage i and ii childhood lymphoblastic lymphoma
635588|NCT00886496|stage I childhood lymphoblastic lymphoma|stage i childhood lymphoblastic lymphoma
635589|NCT00886496|stage II childhood lymphoblastic lymphoma|stage ii childhood lymphoblastic lymphoma
635590|NCT00886496|stage III and IV childhood lymphoblastic lymphoma|stage iii and iv childhood lymphoblastic lymphoma
635591|NCT00886496|stage III childhood lymphoblastic lymphoma|stage iii childhood lymphoblastic lymphoma
635592|NCT00886496|stage IV childhood lymphoblastic lymphoma|stage iv childhood lymphoblastic lymphoma
635593|NCT00886496|childhood Burkitt lymphoma|childhood burkitt lymphoma
635594|NCT00886496|recurrent/refractory childhood Hodgkin lymphoma|recurrent/refractory childhood hodgkin lymphoma
635595|NCT00886496|stage I childhood Hodgkin lymphoma|stage i childhood hodgkin lymphoma
635596|NCT00886496|stage II childhood Hodgkin lymphoma|stage ii childhood hodgkin lymphoma
635597|NCT00886496|stage III childhood Hodgkin lymphoma|stage iii childhood hodgkin lymphoma
635598|NCT00886496|stage IV childhood Hodgkin lymphoma|stage iv childhood hodgkin lymphoma
635599|NCT00886496|childhood acute lymphoblastic leukemia in remission|childhood acute lymphoblastic leukemia in remission
635600|NCT00886496|recurrent childhood acute lymphoblastic leukemia|recurrent childhood acute lymphoblastic leukemia
635601|NCT00886496|untreated childhood acute lymphoblastic leukemia|untreated childhood acute lymphoblastic leukemia
635602|NCT00886496|de novo myelodysplastic syndromes|de novo myelodysplastic syndromes
635603|NCT00886496|previously treated myelodysplastic syndromes|previously treated myelodysplastic syndromes
635604|NCT00886496|secondary myelodysplastic syndromes|secondary myelodysplastic syndromes
635605|NCT00886496|childhood acute myeloid leukemia in remission|childhood acute myeloid leukemia in remission
635606|NCT00886496|recurrent childhood acute myeloid leukemia|recurrent childhood acute myeloid leukemia
635607|NCT00886496|untreated childhood acute myeloid leukemia and other myeloid malignancies|untreated childhood acute myeloid leukemia and other myeloid malignancies
635608|NCT00886496|childhood grade III lymphomatoid granulomatosis|childhood grade iii lymphomatoid granulomatosis
635609|NCT00886496|childhood nasal type extranodal NK/T-cell lymphoma|childhood nasal type extranodal nk/t-cell lymphoma
635610|NCT00886496|recurrent childhood grade III lymphomatoid granulomatosis|recurrent childhood grade iii lymphomatoid granulomatosis
635611|NCT00886496|childhood diffuse large cell lymphoma|childhood diffuse large cell lymphoma
635612|NCT00886496|childhood immunoblastic large cell lymphoma|childhood immunoblastic large cell lymphoma
635613|NCT00886496|recurrent childhood large cell lymphoma|recurrent childhood large cell lymphoma
635614|NCT00886496|stage I childhood large cell lymphoma|stage i childhood large cell lymphoma
635615|NCT00886496|stage II childhood large cell lymphoma|stage ii childhood large cell lymphoma
635616|NCT00886496|stage III and IV childhood large cell lymphoma|stage iii and iv childhood large cell lymphoma
635617|NCT00886496|stage III childhood large cell lymphoma|stage iii childhood large cell lymphoma
635618|NCT00886496|stage IV childhood large cell lymphoma|stage iv childhood large cell lymphoma
635619|NCT00886483|Neurofeedback|neurofeedback
635620|NCT00886470|cytokines|cytokines
635621|NCT00886470|pain|pain
635622|NCT00886470|scarring|scarring
635623|NCT00886470|vascularity|vascularity
635624|NCT00886457|Biopsy proven cancer, which is metastatic or unresectable|biopsy proven cancer, which is metastatic or unresectable
635625|NCT00886431|IVF|ivf
635626|NCT00886431|embryo cryopreservation|embryo cryopreservation
635627|NCT00886431|vitrification|vitrification
635628|NCT00886431|slow cooling|slow cooling
635629|NCT00886431|slow freezing|slow freezing
635630|NCT00886431|surplus embryos|surplus embryos
635631|NCT00886431|Human Reproduction|human reproduction
635632|NCT00886405|Nitroglycerin|nitroglycerin
635633|NCT00886405|Locally advanced non small-cell lung cancer|locally advanced non small-cell lung cancer
635634|NCT00886405|Vascular endothelial growth factor|vascular endothelial growth factor
635635|NCT00886405|Hypoxia Inducible Factor|hypoxia inducible factor
635636|NCT00886405|Clinical stage IIIA and/or IIIB (without pleural effusion)|clinical stage iiia and/or iiib (without pleural effusion)
635637|NCT00886392|Clinically Significant Macular Edema|clinically significant macular edema
635638|NCT00886392|Diabetic Macular Edema|diabetic macular edema
635639|NCT00886392|Optical Coherence Tomography|optical coherence tomography
635640|NCT00886392|Diabetic Retinopathy|diabetic retinopathy
635641|NCT00886392|Severity|severity
635642|NCT00886379|vitamin d|vitamin d
635643|NCT00886379|children|children
635644|NCT00886379|Mongolia|mongolia
635645|NCT00886366|Type II Diabetes|type ii diabetes
635646|NCT00886353|RAS|ras
635647|NCT00886353|ACE2|ace2
635648|NCT00886353|Cardiovascular|cardiovascular
635649|NCT00886353|Pulmonary|pulmonary
635650|NCT00886353|Angiotensin II|angiotensin ii
635651|NCT00886353|Angiotensin 1-7|angiotensin 1-7
635652|NCT00886340|diabetes prevention, primary care|diabetes prevention, primary care
635653|NCT00886327|Colonic capsule endoscopy|colonic capsule endoscopy
635654|NCT00886327|Crohn's disease|crohn's disease
635655|NCT00886327|Capsule endoscopy|capsule endoscopy
635656|NCT00886314|children|children
635657|NCT00886314|surgery|surgery
635658|NCT00886314|anxiety|anxiety
635659|NCT00886301|overweight|overweight
635660|NCT00886301|obesity|obesity
635661|NCT00886301|steatohepatitis|steatohepatitis
635662|NCT00886301|ectopic fat|ectopic fat
635663|NCT00886275|Postoperative sedation in intensive care|postoperative sedation in intensive care
635664|NCT00886262|liver transplantation|liver transplantation
635665|NCT00886262|vasopressin|vasopressin
635666|NCT00886262|renal function|renal function
635667|NCT00886262|hypotension|hypotension
635668|NCT00886262|creatinine|creatinine
635669|NCT00886262|urine output|urine output
635670|NCT00886262|diuretics|diuretics
635671|NCT00886262|vasopressors|vasopressors
635672|NCT00886262|hemodynamic stability|hemodynamic stability
635673|NCT00886249|Vision|vision
635674|NCT00886249|Eye|eye
635675|NCT00886249|Cataract|cataract
635676|NCT00886236|Gastric Bypass|gastric bypass
635677|NCT00886236|Gabapentin|gabapentin
635678|NCT00886236|Postoperative Nausea and Vomiting|postoperative nausea and vomiting
635679|NCT00886236|Analgesics, Opioids|analgesics, opioids
635680|NCT00886236|Sleep Apnea, Obstructive|sleep apnea, obstructive
635681|NCT00886236|Respiratory Depression|respiratory depression
635682|NCT00886236|Oximetry|oximetry
635683|NCT00886223|vaginal vault prolapse repair|vaginal vault prolapse repair
635684|NCT00886223|robot-assisted laparoscopic sacropexy|robot-assisted laparoscopic sacropexy
635685|NCT00886223|robot-assisted laparoscopic sacrocolpopexy|robot-assisted laparoscopic sacrocolpopexy
635686|NCT00886223|robotic laparoscopic sacropexy|robotic laparoscopic sacropexy
635687|NCT00886210|drain|drain
635688|NCT00886210|laparoscopic cholecystectomy|laparoscopic cholecystectomy
635689|NCT00886210|pneumoperitonum|pneumoperitonum
635690|NCT00886197|reflux|reflux
635691|NCT00886197|GERD|gerd
635692|NCT00886184|Hypothermia|hypothermia
635693|NCT00886184|Cardiac arrest|cardiac arrest
635694|NCT00886184|Biomarkers|biomarkers
635695|NCT00886184|Pre hospital cardiac arrest|pre hospital cardiac arrest
635696|NCT00886171|social skills|social skills
635697|NCT00886171|physical activity|physical activity
635698|NCT00886171|peer relationships|peer relationships
635699|NCT00886171|childhood obesity|childhood obesity
635700|NCT00886171|changes in physical activity|changes in physical activity
635701|NCT00886171|changes in social involvement|changes in social involvement
635702|NCT00886158|Organ Transplants|organ transplants
635703|NCT00886145|Spinal Cord Injuries|spinal cord injuries
635704|NCT00886145|Mechanical Stimulation|mechanical stimulation
635705|NCT00886145|Vibration Plate|vibration plate
635706|NCT00886132|Phase 2 Study|phase 2 study
635707|NCT00886132|Sunitinib|sunitinib
635708|NCT00886132|Recurrent|recurrent
635709|NCT00886132|Metastatic|metastatic
635710|NCT00886132|Adenoid Cystic Carcinoma|adenoid cystic carcinoma
635711|NCT00886132|Salivary Glands|salivary glands
635712|NCT00886132|Metastasis|metastasis
635713|NCT00886106|Capsaicin|capsaicin
635714|NCT00886106|Remifentanil|remifentanil
635715|NCT00886106|Hyperalgesia|hyperalgesia
635716|NCT00886093|pharmacokinetics, single dose, crossover, fed vs fasted state|pharmacokinetics, single dose, crossover, fed vs fasted state
635717|NCT00886080|Atrial fibrillation|atrial fibrillation
635718|NCT00886080|Health related Quality of Life|health related quality of life
635719|NCT00886080|Add-on surgery|add-on surgery
635720|NCT00886080|Ablation|ablation
635721|NCT00886080|Randomised controlled trial|randomised controlled trial
635722|NCT00886080|SF-36|sf-36
635723|NCT00886080|EuroQoL|euroqol
635724|NCT00886080|MFI-20|mfi-20
635725|NCT00886067|AZD1446|azd1446
635726|NCT00886067|PET examination|pet examination
635727|NCT00886054|Transcranial Doppler|transcranial doppler
635728|NCT00886054|Transcranial color-coded duplex sonography|transcranial color-coded duplex sonography
635729|NCT00886054|Neurocritical patients|neurocritical patients
635730|NCT00886041|laparoscopy|laparoscopy
635731|NCT00886041|unexplained infertility|unexplained infertility
635732|NCT00886028|Malignant pleural mesothelioma|malignant pleural mesothelioma
635733|NCT00886028|Liposomal doxorubicin|liposomal doxorubicin
635734|NCT00886028|Progression free survival|progression free survival
635735|NCT00886028|Patients who received LD 60mg/m2 plus cisplatin 80 mg/m2 every 4 weeks for 6 cycles|patients who received ld 60mg/m2 plus cisplatin 80 mg/m2 every 4 weeks for 6 cycles
635736|NCT00886028|Patients with epithelial, sarcomatoid or biphasic histological confirmed diagnosis of MPM|patients with epithelial, sarcomatoid or biphasic histological confirmed diagnosis of mpm
635737|NCT00886015|Trachoma|trachoma
635738|NCT00886015|trichiasis|trichiasis
635739|NCT00886015|bilamellar tarsal rotation procedure|bilamellar tarsal rotation procedure
635740|NCT00886002|Healthy volunteers|healthy volunteers
635741|NCT00885989|SLV338|slv338
635742|NCT00885989|phase I|phase i
635743|NCT00885989|healthy volunteers|healthy volunteers
635744|NCT00885950|colorectal liver metastases|colorectal liver metastases
635745|NCT00885950|neoadjuvant chemotherapy|neoadjuvant chemotherapy
635746|NCT00885950|oxaliplatin|oxaliplatin
635747|NCT00885950|sinusoidal obstruction syndrome|sinusoidal obstruction syndrome
635748|NCT00885950|anticoagulants|anticoagulants
635749|NCT00885937|Dexpanthenol|dexpanthenol
635750|NCT00885937|Safety,|safety,
635751|NCT00885937|New formulation|new formulation
635752|NCT00885937|Topical administration|topical administration
635753|NCT00885924|postoperative Hemorrhage|postoperative hemorrhage
635754|NCT00885924|Hemorrhage|hemorrhage
635755|NCT00885924|Vasopressin|vasopressin
635756|NCT00885924|Blood Loss, Surgical|blood loss, surgical
635757|NCT00885911|Intubating laryngeal airway|intubating laryngeal airway
635758|NCT00885911|pediatric|pediatric
635759|NCT00885911|observational study|observational study
635760|NCT00885898|Respiratory Insufficiency|respiratory insufficiency
635761|NCT00885898|Respiratory Failure|respiratory failure
635762|NCT00885885|Colorectal Cancer|colorectal cancer
635763|NCT00885885|Panitumumab|panitumumab
635764|NCT00885885|FOLFOX-4|folfox-4
635765|NCT00885885|FOLFIRI|folfiri
635766|NCT00885846|Qigong|qigong
635767|NCT00885846|Breathing management|breathing management
635768|NCT00885846|Glucose|glucose
635769|NCT00885833|Wiskott-Aldrich syndrome|wiskott-aldrich syndrome
635770|NCT00885833|HSCT|hsct
635771|NCT00885820|Kidney Transplantation|kidney transplantation
635772|NCT00885820|Tacrolimus|tacrolimus
635773|NCT00885820|Immunosuppression|immunosuppression
635774|NCT00885820|Graft Survival|graft survival
635775|NCT00885807|ADHD|adhd
635776|NCT00885807|WFIRS|wfirs
635778|NCT00885794|Clinically Significant Diabetic Macular Edema|clinically significant diabetic macular edema
635779|NCT00885794|Focal Laser|focal laser
635780|NCT00885794|GRID-Laser|grid-laser
635781|NCT00885794|Ranibizumab|ranibizumab
635782|NCT00885794|Lucentis|lucentis
635783|NCT00885794|Microperimetry|microperimetry
635784|NCT00885794|High-Definition OCT|high-definition oct
635785|NCT00885794|Randomized|randomized
635786|NCT00885794|Observer-Blinded|observer-blinded
635787|NCT00885794|Ineffective Treatment with Focal Laser or GRID-Laser|ineffective treatment with focal laser or grid-laser
635788|NCT00885768|RAS(renal Artery Stenosis)|ras(renal artery stenosis)
635789|NCT00885768|Atherosclerosis|atherosclerosis
635790|NCT00885768|angiography|angiography
635791|NCT00885742|Hereditary Factor XIII deficiency|hereditary factor xiii deficiency
635792|NCT00885742|Factor XIII|factor xiii
635793|NCT00885729|Cartilage defect|cartilage defect
635794|NCT00885729|chondrocytes|chondrocytes
635795|NCT00885729|mesenchymal stem cells (MSC)|mesenchymal stem cells (msc)
635796|NCT00885729|femoral condyle|femoral condyle
635797|NCT00885729|knee|knee
635798|NCT00885703|CM|cm
635799|NCT00885703|HIV|hiv
635800|NCT00885703|Meningitis|meningitis
635801|NCT00885690|Schizophrenia|schizophrenia
635802|NCT00885690|Antipsychotic|antipsychotic
635803|NCT00885690|Cognition|cognition
635804|NCT00885664|HIV|hiv
635805|NCT00885664|immune reconstitution|immune reconstitution
635806|NCT00885664|treatment naive|treatment naive
635807|NCT00885651|SNP|snp
635808|NCT00885651|catecholamines|catecholamines
635809|NCT00885651|metoprolole|metoprolole
635810|NCT00885651|healthy subjects|healthy subjects
635811|NCT00885651|physiological stress|physiological stress
635812|NCT00885638|GLP-1|glp-1
635813|NCT00885638|Insulin secretion|insulin secretion
810157|NCT00209729|S-1|s-1
635814|NCT00885638|Macronutrients|macronutrients
635815|NCT00885625|invasive pneumococcal disease|invasive pneumococcal disease
635816|NCT00885625|pneumococcal conjugated vaccine|pneumococcal conjugated vaccine
635817|NCT00885612|CHD-Risk|chd-risk
635818|NCT00885612|Breast Cancer|breast cancer
635819|NCT00885612|Aromatase Inhibitors|aromatase inhibitors
635820|NCT00885612|postmenopausal early breast cancer|postmenopausal early breast cancer
635821|NCT00885599|gingivitis|gingivitis
635822|NCT00885599|natural remedy|natural remedy
635823|NCT00885599|inflammation|inflammation
635824|NCT00885599|C-reactive protein|c-reactive protein
635825|NCT00885599|mouthwash|mouthwash
635826|NCT00885586|herpes zoster|herpes zoster
635827|NCT00885586|neuropathic pain|neuropathic pain
635828|NCT00885586|acupuncture|acupuncture
635829|NCT00885586|randomised controlled trial|randomised controlled trial
635830|NCT00885586|acute herpes zoster|acute herpes zoster
635831|NCT00885573|sleep apnea|sleep apnea
635832|NCT00885573|pharyngeal sensitivity|pharyngeal sensitivity
635833|NCT00885573|pharyngeal dilator reflex|pharyngeal dilator reflex
635834|NCT00885573|diagnosis algorithm|diagnosis algorithm
635835|NCT00885573|patients with suspected sleep apnea syndrome|patients with suspected sleep apnea syndrome
635836|NCT00885560|ADHD|adhd
635837|NCT00885560|SNAP 25|snap 25
635838|NCT00885560|amphetamine|amphetamine
635839|NCT00885560|methylphenidate|methylphenidate
635840|NCT00885534|skin cancer|skin cancer
635841|NCT00885534|CISPLATIN|cisplatin
635842|NCT00885534|TEMOZOLOMIDE|temozolomide
635843|NCT00885534|VINBLASTINE|vinblastine
635844|NCT00885534|09-017|09-017
635845|NCT00885508|MDS|mds
635846|NCT00885508|AML|aml
635847|NCT00885508|deletion 5q|deletion 5q
635848|NCT00885508|Documented diagnosis of MDS, or CMML|documented diagnosis of mds, or cmml
635849|NCT00885508|with WBC < 13,000/mm3 that meets IPSS criteria for intermediate-2|with wbc < 13,000/mm3 that meets ipss criteria for intermediate-2
635850|NCT00885508|or high-risk disease, or AML with an associated del 5q[31]|or high-risk disease, or aml with an associated del 5q[31]
635851|NCT00885508|(the deleted chromosomal region must include 5q[31]),|(the deleted chromosomal region must include 5q[31]),
635852|NCT00885508|with or without additional cytogenetic abnormalities|with or without additional cytogenetic abnormalities
635853|NCT00885495|HIV|hiv
635854|NCT00885495|dyslipidemia|dyslipidemia
635855|NCT00885495|statins|statins
635856|NCT00885495|protease inhibitors|protease inhibitors
635857|NCT00885482|HIV/AIDS|hiv/aids
635858|NCT00885482|HAART|haart
635859|NCT00885482|Simplification|simplification
635860|NCT00885482|Atazanavir|atazanavir
635861|NCT00885482|Lamivudine|lamivudine
635862|NCT00885482|treatment experienced|treatment experienced
635863|NCT00885469|known Barrett's Esophagus|known barrett's esophagus
635864|NCT00885469|Suspected Barrett's Esophagus|suspected barrett's esophagus
635865|NCT00885469|chronic GERD|chronic gerd
635866|NCT00885469|known Barrett's Esophagus or chronic GERD|known barrett's esophagus or chronic gerd
635867|NCT00885456|stroke|stroke
635868|NCT00885456|secondary prevention|secondary prevention
635869|NCT00885456|vascular risk|vascular risk
635870|NCT00885456|behavioral change|behavioral change
635871|NCT00885456|exercise|exercise
635872|NCT00885456|lifestyle modification|lifestyle modification
635873|NCT00885443|propofol|propofol
635874|NCT00885443|sevoflurane|sevoflurane
635875|NCT00885443|pediatric|pediatric
635876|NCT00885443|emergence delirium|emergence delirium
635877|NCT00885443|Induction of sedation|induction of sedation
635878|NCT00885430|colonoscopy|colonoscopy
635879|NCT00885430|preparation|preparation
635880|NCT00885417|Helicobacter pylori|helicobacter pylori
635881|NCT00885417|sequential therapy|sequential therapy
635882|NCT00885417|levofloxacin|levofloxacin
635883|NCT00885417|clarithromycin|clarithromycin
635884|NCT00885417|rescue|rescue
635885|NCT00885417|salvage|salvage
635886|NCT00885417|treatment failure|treatment failure
635887|NCT00885417|For those who fail from one standard eradication therapy for H. pylori infection|for those who fail from one standard eradication therapy for h. pylori infection
635888|NCT00885404|chloride|chloride
635889|NCT00885404|acidosis|acidosis
635890|NCT00885391|Atrial Fibrillation|atrial fibrillation
635891|NCT00885391|Cardioversion|cardioversion
635892|NCT00885391|Direct Current Cardioversion|direct current cardioversion
635893|NCT00885391|QT Interval|qt interval
635894|NCT00885365|cystic fibrosis|cystic fibrosis
635895|NCT00885365|P. aeruginosa|p. aeruginosa
635896|NCT00885365|tobramycin|tobramycin
635897|NCT00885339|Colonic Diseases|colonic diseases
635898|NCT00885326|recurrent neuroblastoma|recurrent neuroblastoma
635899|NCT00885313|NAFLD|nafld
635900|NCT00885313|NASH|nash
635901|NCT00885313|fibrosis|fibrosis
635902|NCT00885287|uncomplicated malaria|uncomplicated malaria
635903|NCT00885287|HIV/AIDS|hiv/aids
635904|NCT00885287|drug interactions|drug interactions
635905|NCT00885287|antimalarial drug efficacy|antimalarial drug efficacy
635906|NCT00885287|antiretrovirals|antiretrovirals
635907|NCT00885287|pharmacovigilance|pharmacovigilance
635908|NCT00885287|Tanzania|tanzania
635909|NCT00885261|chronic pain and metabolic syndrome|chronic pain and metabolic syndrome
635910|NCT00885248|pancreatic cancer|pancreatic cancer
635911|NCT00885248|integrated PET-CT|integrated pet-ct
635912|NCT00885235|Bowel Diseases|bowel diseases
635913|NCT00885222|Parkinson's disease|parkinson's disease
635914|NCT00885222|Major depressive disorder|major depressive disorder
635915|NCT00885222|Deep brain stimulation|deep brain stimulation
635916|NCT00885209|Colonic Diseases|colonic diseases
635917|NCT00885196|Psoriasis|psoriasis
635918|NCT00885196|plaque psoriasis|plaque psoriasis
636025|NCT00884845|Erlotinib|erlotinib
635919|NCT00885196|inflammatory skin disease|inflammatory skin disease
635920|NCT00885196|scaly patches|scaly patches
635921|NCT00885196|AEB071|aeb071
635922|NCT00885183|breast cancer|breast cancer
635923|NCT00885183|chemotherapy|chemotherapy
635924|NCT00885183|adjuvant therapy|adjuvant therapy
635925|NCT00885183|acupuncture|acupuncture
635926|NCT00885183|fatigue|fatigue
635927|NCT00885183|Early stage breast cancer patients|early stage breast cancer patients
635928|NCT00885157|Poliomyelitis|poliomyelitis
635929|NCT00885157|intradermal|intradermal
635930|NCT00885144|Stunting|stunting
635931|NCT00885144|Growth failure|growth failure
635932|NCT00885144|Malnutrition|malnutrition
635933|NCT00885144|Lipid based nutrient supplement|lipid based nutrient supplement
635934|NCT00885144|LNS|lns
635935|NCT00885144|Prevention|prevention
635936|NCT00885144|Malawi|malawi
635937|NCT00885144|Sub-Saharan Africa|sub-saharan africa
635938|NCT00885144|Dietary supplementation|dietary supplementation
635939|NCT00885131|Reward Processing|reward processing
635940|NCT00885131|Motor Cortex|motor cortex
635941|NCT00885131|HV|hv
635942|NCT00885131|Healthy Volunteer|healthy volunteer
635943|NCT00885105|Fluzone® vaccine|fluzone® vaccine
635944|NCT00885105|Influenza|influenza
635945|NCT00885092|Contact lenses|contact lenses
635946|NCT00885092|Disinfecting solutions|disinfecting solutions
635947|NCT00885066|stage III pancreatic cancer|stage iii pancreatic cancer
635948|NCT00885066|stage IV pancreatic cancer|stage iv pancreatic cancer
635949|NCT00885066|adenocarcinoma of the pancreas|adenocarcinoma of the pancreas
635950|NCT00885066|recurrent pancreatic cancer|recurrent pancreatic cancer
635951|NCT00885053|Inflammation|inflammation
635952|NCT00885053|Fatty acids, Omega 3|fatty acids, omega 3
635953|NCT00885053|Leukotrienes|leukotrienes
635954|NCT00885053|Adiponectin|adiponectin
635955|NCT00885053|Adipose tissue|adipose tissue
635956|NCT00885053|RNA, Messenger|rna, messenger
635957|NCT00885040|Neurofeedback|neurofeedback
635958|NCT00885040|Tourette Syndrome|tourette syndrome
635959|NCT00885040|Healthy Volunteer|healthy volunteer
635960|NCT00885040|Movement Disorder|movement disorder
635961|NCT00885040|Brain Activity|brain activity
635962|NCT00885040|fMRI|fmri
635963|NCT00885040|HV|hv
635964|NCT00885014|Depressive disorder|depressive disorder
635965|NCT00885014|Behavior therapy|behavior therapy
635966|NCT00885014|Workplace|workplace
635967|NCT00885014|Subthreshold depression|subthreshold depression
635968|NCT00884988|ankle fracture|ankle fracture
635969|NCT00884988|edema|edema
635970|NCT00884988|surgical repair|surgical repair
635971|NCT00884988|homeopathy|homeopathy
635972|NCT00884988|lymphomyosot|lymphomyosot
635973|NCT00884975|Chronic obstructive pulmonary disease|chronic obstructive pulmonary disease
635974|NCT00884975|exacerbations|exacerbations
635975|NCT00884975|quality of life|quality of life
635976|NCT00884975|emphysema|emphysema
635977|NCT00884962|emphysema|emphysema
635978|NCT00884962|aeris|aeris
635979|NCT00884962|PLVR|plvr
635980|NCT00884962|BLVR|blvr
635981|NCT00884962|germany|germany
635982|NCT00884962|treatment|treatment
635983|NCT00884962|device|device
635984|NCT00884962|breathing|breathing
635985|NCT00884949|Mucopolysaccharidosis IV type A|mucopolysaccharidosis iv type a
635986|NCT00884949|MPS IV Type A|mps iv type a
635987|NCT00884949|Mucopolysaccharidosis IVA|mucopolysaccharidosis iva
635988|NCT00884949|MPS IVA|mps iva
635989|NCT00884949|Morquio A Syndrome|morquio a syndrome
635990|NCT00884949|Lysosomal Storage Disorder|lysosomal storage disorder
635991|NCT00884949|LSD|lsd
635992|NCT00884949|N-acetylgalactosamine-6-sulfatase|n-acetylgalactosamine-6-sulfatase
635993|NCT00884949|N-acetylgalactosamine-6-sulfate sulfatase|n-acetylgalactosamine-6-sulfate sulfatase
635994|NCT00884949|galactose-6-sulfatase|galactose-6-sulfatase
635995|NCT00884949|GALNS|galns
635996|NCT00884949|enzyme replacement therapy|enzyme replacement therapy
635997|NCT00884949|ERT|ert
635998|NCT00884936|Skin|skin
635999|NCT00884936|Aging|aging
636000|NCT00884936|Dermogenomics|dermogenomics
636001|NCT00884936|Genetic|genetic
636002|NCT00884936|Biomarker|biomarker
636003|NCT00884936|Dermatology|dermatology
636004|NCT00884910|laryngectomy|laryngectomy
636005|NCT00884910|Provox Vega|provox vega
636006|NCT00884910|voice prosthesis|voice prosthesis
636007|NCT00884897|Social Cognition|social cognition
636008|NCT00884897|Schizophrenia|schizophrenia
636009|NCT00884897|Oxytocin|oxytocin
636010|NCT00884884|Alcohol dependence|alcohol dependence
636011|NCT00884884|alcohol abuse|alcohol abuse
636012|NCT00884884|topiramate|topiramate
636013|NCT00884884|aripiprazole|aripiprazole
636014|NCT00884871|pelvic floor disorders|pelvic floor disorders
636015|NCT00884871|weight loss|weight loss
636016|NCT00884858|HIV-1|hiv-1
636017|NCT00884858|CD4|cd4
636018|NCT00884858|INR|inr
636019|NCT00884858|HIV-1 infection|hiv-1 infection
636020|NCT00884858|extreme immunological compromission|extreme immunological compromission
636021|NCT00884858|treatment experienced|treatment experienced
636022|NCT00884845|PM2734|pm2734
636023|NCT00884845|Tumors|tumors
636024|NCT00884845|PharmaMar|pharmamar
636026|NCT00884845|Tarceva|tarceva
636027|NCT00884832|fecal incontinence|fecal incontinence
636028|NCT00884832|stool leakage|stool leakage
636029|NCT00884832|incontinence|incontinence
636031|NCT00884832|Urge predominant fecal incontinence|urge predominant fecal incontinence
636032|NCT00884819|polycystic ovary syndrome|polycystic ovary syndrome
636033|NCT00884819|hepatic adiposity|hepatic adiposity
636034|NCT00884819|diabetes|diabetes
636035|NCT00884819|hormones|hormones
636036|NCT00884819|cardiovascular disease|cardiovascular disease
636037|NCT00884806|Contact lenses|contact lenses
636038|NCT00884806|Disinfecting solutions|disinfecting solutions
636039|NCT00884793|HIV|hiv
636040|NCT00884793|persistence|persistence
636041|NCT00884793|reservoirs|reservoirs
636042|NCT00884793|residual replication|residual replication
636043|NCT00884793|gut|gut
636044|NCT00884793|gut-associated lymphoid tissue|gut-associated lymphoid tissue
636045|NCT00884793|treatment experienced|treatment experienced
636046|NCT00884780|Electronic Diary|electronic diary
636047|NCT00884780|Body Map|body map
636048|NCT00884780|Electronic Measure of Pediatric Pain|electronic measure of pediatric pain
636049|NCT00884767|neurotoxicity|neurotoxicity
636050|NCT00884767|chemotherapeutic agent toxicity|chemotherapeutic agent toxicity
636051|NCT00884767|recurrent colon cancer|recurrent colon cancer
636052|NCT00884767|stage I colon cancer|stage i colon cancer
636053|NCT00884767|stage II colon cancer|stage ii colon cancer
636054|NCT00884767|stage III colon cancer|stage iii colon cancer
636055|NCT00884767|stage IV colon cancer|stage iv colon cancer
636056|NCT00884767|recurrent rectal cancer|recurrent rectal cancer
636057|NCT00884767|stage I rectal cancer|stage i rectal cancer
636058|NCT00884767|stage II rectal cancer|stage ii rectal cancer
636059|NCT00884767|stage III rectal cancer|stage iii rectal cancer
636060|NCT00884767|stage IV rectal cancer|stage iv rectal cancer
636061|NCT00884728|Scabies|scabies
636062|NCT00884728|Impetigo|impetigo
636063|NCT00884728|Pyoderma|pyoderma
636064|NCT00884728|Streptococcal infections|streptococcal infections
636065|NCT00884702|Sleep|sleep
636066|NCT00884702|14C-Leucine|14c-leucine
636067|NCT00884702|Cerebral Protein Synthesis|cerebral protein synthesis
636068|NCT00884702|Memory|memory
636069|NCT00884702|Positron Emission Tomography (PET)|positron emission tomography (pet)
636070|NCT00884702|HV|hv
636071|NCT00884702|Healthy Volunteer|healthy volunteer
636072|NCT00884689|Symbicort SMART|symbicort smart
636073|NCT00884689|Free Combination GCS/LABA treatment|free combination gcs/laba treatment
636074|NCT00884676|unspecified adult solid tumor, protocol specific|unspecified adult solid tumor, protocol specific
636075|NCT00884650|Pain|pain
636076|NCT00884650|Pain management|pain management
636077|NCT00884650|Cerebral Palsy|cerebral palsy
636078|NCT00884637|HMP|hmp
636079|NCT00884637|CNV|cnv
636080|NCT00884637|AMD|amd
636081|NCT00884637|PHP|php
636082|NCT00884637|HPHP|hphp
636083|NCT00884637|foresee home|foresee home
636084|NCT00884624|Bowel Diseases|bowel diseases
636085|NCT00884598|adult tumors metastatic to brain|adult tumors metastatic to brain
636086|NCT00884598|extensive stage small cell lung cancer|extensive stage small cell lung cancer
636087|NCT00884598|stage IV non-small cell lung cancer|stage iv non-small cell lung cancer
636088|NCT00884559|Leadership|leadership
636089|NCT00884559|Team building|team building
636090|NCT00884559|Resuscitation|resuscitation
636091|NCT00884533|QTc|qtc
636092|NCT00884533|pharmacokinetics|pharmacokinetics
636093|NCT00884533|rosiglitazone XR|rosiglitazone xr
636094|NCT00884533|cardiac conduction|cardiac conduction
636095|NCT00884533|healthy volunteers|healthy volunteers
636096|NCT00884520|[F-18]VM4-037|[f-18]vm4-037
636097|NCT00884520|VM4-037|vm4-037
636098|NCT00884520|hypoxia|hypoxia
636099|NCT00884520|CA-IX|ca-ix
636100|NCT00884520|CAIX|caix
636101|NCT00884520|carbonic anhydrase IX|carbonic anhydrase ix
636102|NCT00884520|hypoxia marker|hypoxia marker
636103|NCT00884520|lung cancer|lung cancer
636104|NCT00884520|renal carcinoma|renal carcinoma
636105|NCT00884520|squamous cell carcinoma|squamous cell carcinoma
636106|NCT00884520|hepatic carcinoma|hepatic carcinoma
636107|NCT00884520|head and neck cancer|head and neck cancer
636108|NCT00884520|advanced stage lung cancer|advanced stage lung cancer
636109|NCT00884520|exploratory|exploratory
636110|NCT00884494|Obesity|obesity
636111|NCT00884494|Insulin resistance|insulin resistance
636112|NCT00884494|Ghrelin|ghrelin
636113|NCT00884468|Anxiety and depression in patients with psoriatic arthritis|anxiety and depression in patients with psoriatic arthritis
636114|NCT00884455|tissue banking, research|tissue banking, research
636115|NCT00884442|Healthy|healthy
636116|NCT00884442|Bioavailability|bioavailability
636117|NCT00884442|Nifedipine|nifedipine
636118|NCT00884429|Chest physiotherapy|chest physiotherapy
636119|NCT00884416|high grade glioma|high grade glioma
636120|NCT00884416|glioblastoma|glioblastoma
636121|NCT00884416|gliosarcoma|gliosarcoma
636122|NCT00884416|anaplastic astrocytoma|anaplastic astrocytoma
636123|NCT00884416|anaplastic oligoastrocytoma|anaplastic oligoastrocytoma
636124|NCT00884416|anaplastic oligodendroglioma|anaplastic oligodendroglioma
636125|NCT00884416|phase I|phase i
636326|NCT00883584|COPD|copd
636126|NCT00884416|first line treatment|first line treatment
636127|NCT00884416|sorafenib|sorafenib
636128|NCT00884416|temozolomide|temozolomide
636129|NCT00884416|radiation therapy|radiation therapy
636130|NCT00884416|safety|safety
636131|NCT00884416|tolerability|tolerability
636132|NCT00884416|protein kinase inhibitors|protein kinase inhibitors
636133|NCT00884403|abortion|abortion
636134|NCT00884403|pregnancy dating|pregnancy dating
636135|NCT00884403|gestational age|gestational age
636136|NCT00884403|ultrasound|ultrasound
636137|NCT00884390|Hemophilia A|hemophilia a
636138|NCT00884364|Lymphoma|lymphoma
636139|NCT00884364|Leukemia|leukemia
636140|NCT00884364|Multiple myeloma|multiple myeloma
636141|NCT00884364|Hodgkin´s disease|hodgkin´s disease
636142|NCT00884364|Exercise|exercise
636143|NCT00884364|Sport|sport
636144|NCT00884364|Fatigue|fatigue
636145|NCT00884364|Hematological neoplastic diseases|hematological neoplastic diseases
636146|NCT00884351|Epilepsy|epilepsy
636147|NCT00884351|MEG|meg
636148|NCT00884351|Seizures|seizures
636149|NCT00884338|Fatigue|fatigue
636150|NCT00884338|Cancer|cancer
636151|NCT00884338|Cognitive impairment|cognitive impairment
636152|NCT00884338|Exercise|exercise
636153|NCT00884338|Sport|sport
636154|NCT00884338|Peripheral blood stem cell transplantation|peripheral blood stem cell transplantation
636155|NCT00884338|High-dose chemotherapy|high-dose chemotherapy
636156|NCT00884325|Itching|itching
636157|NCT00884325|Atopic Dermatitis|atopic dermatitis
636158|NCT00884312|Multiple myeloma|multiple myeloma
636159|NCT00884312|proteasome|proteasome
636160|NCT00884312|Hematological|hematological
636161|NCT00884312|carfilzomib|carfilzomib
636162|NCT00884312|PR-171|pr-171
636163|NCT00884299|Lung function|lung function
636164|NCT00884299|Chronic obstructive pulmonary disease|chronic obstructive pulmonary disease
636165|NCT00884299|Antioxidants|antioxidants
636166|NCT00884286|Aplidin|aplidin
636167|NCT00884286|Aggressive Non Hodgkin Lymphoma|aggressive non hodgkin lymphoma
636168|NCT00884286|Leukemia-Lymphoma, Adult T-Cell and B-cell|leukemia-lymphoma, adult t-cell and b-cell
636169|NCT00884260|Contraception|contraception
636170|NCT00884260|Intrauterine contraception system|intrauterine contraception system
636171|NCT00884247|GERD|gerd
636172|NCT00884247|Quality of life|quality of life
636173|NCT00884247|Structured treatment|structured treatment
636174|NCT00884234|Lateral Canthal Lines|lateral canthal lines
636175|NCT00884234|Crow's Feet|crow's feet
636176|NCT00884234|Facial Wrinkles|facial wrinkles
636177|NCT00884234|Lateral Canthal Area|lateral canthal area
636178|NCT00884195|Obesity|obesity
636179|NCT00884182|Influenza|influenza
636180|NCT00884182|Orthomyxoviruses|orthomyxoviruses
636181|NCT00884182|Split Virion Pandemic Influenza Vaccine|split virion pandemic influenza vaccine
636182|NCT00884182|A/H5N1|a/h5n1
636183|NCT00884143|tamoxifen|tamoxifen
636184|NCT00884143|arimidex|arimidex
636185|NCT00884143|adjuvant hormonal therapies|adjuvant hormonal therapies
636186|NCT00884143|breast cancer|breast cancer
636187|NCT00884143|post-menopausal|post-menopausal
636188|NCT00884143|Adjuvant hormonal therapy in patients post menopausal with breast cancer|adjuvant hormonal therapy in patients post menopausal with breast cancer
636189|NCT00884130|Laparoscopy|laparoscopy
636190|NCT00884130|Colorectal surgery|colorectal surgery
636191|NCT00884130|Quality of life|quality of life
636192|NCT00884130|economic analysis|economic analysis
636193|NCT00884130|Patients undergoing laparoscopic colorectal surgery|patients undergoing laparoscopic colorectal surgery
636194|NCT00884104|Solifenacin|solifenacin
636195|NCT00884104|Tamsulosin|tamsulosin
636196|NCT00884104|OAB|oab
636197|NCT00884091|Chinese|chinese
636198|NCT00884091|Glucagon-like peptide 1|glucagon-like peptide 1
636199|NCT00884091|Glucagon|glucagon
636200|NCT00884091|Insulin|insulin
636201|NCT00884091|Mixed meals|mixed meals
636202|NCT00884091|Healthy Adults|healthy adults
636203|NCT00884078|Self harm in south asian women|self harm in south asian women
636204|NCT00884078|depression|depression
636205|NCT00884078|suicidal ideations|suicidal ideations
636206|NCT00884078|problem solving training|problem solving training
636207|NCT00884065|Physiotherapy|physiotherapy
636208|NCT00884065|Manual therapy|manual therapy
636209|NCT00884065|Painful Shoulder|painful shoulder
636210|NCT00884065|Diacutaneous Fibrolysis|diacutaneous fibrolysis
636211|NCT00884052|Neonatal seizures|neonatal seizures
636212|NCT00884039|cornea|cornea
636213|NCT00884039|transplant|transplant
636214|NCT00884039|intraocular pressure|intraocular pressure
636215|NCT00884039|steroid response|steroid response
636216|NCT00884026|Cesarean delivery|cesarean delivery
636217|NCT00884026|hypotension|hypotension
636218|NCT00884026|Augmentation Index|augmentation index
636219|NCT00884026|Pulse Wave analysis|pulse wave analysis
636220|NCT00884026|spinal anesthesia|spinal anesthesia
636221|NCT00884026|Hypotension following spinal anesthesia for cesarean delivery|hypotension following spinal anesthesia for cesarean delivery
636222|NCT00884013|Pay for Quality|pay for quality
636223|NCT00884013|Provider|provider
636224|NCT00884013|Clinical Decision Support|clinical decision support
636225|NCT00884013|Quality Reporting|quality reporting
636226|NCT00884013|Quality Measurement|quality measurement
636227|NCT00883974|preterm bith|preterm bith
636228|NCT00883974|neurodevelopment|neurodevelopment
636229|NCT00883974|sensitivity training|sensitivity training
636230|NCT00883974|magnetic resonance imaging (MRI)|magnetic resonance imaging (mri)
636231|NCT00883974|Infant neurodevelopment following preterm birth|infant neurodevelopment following preterm birth
636232|NCT00883961|High-dose chemotherapy|high-dose chemotherapy
636233|NCT00883961|Hematological neoplasties|hematological neoplasties
636234|NCT00883961|Fatigue|fatigue
636235|NCT00883961|Cancer|cancer
636236|NCT00883961|Exercise|exercise
636237|NCT00883961|Sport|sport
636238|NCT00883961|Hematologic neoplastic disorders|hematologic neoplastic disorders
636239|NCT00883948|Acute Lung Injury|acute lung injury
636240|NCT00883948|Acute Respiratory Distress Syndrome|acute respiratory distress syndrome
636241|NCT00883948|Feeding|feeding
636242|NCT00883948|Critical Care|critical care
636243|NCT00883948|Ventilator|ventilator
636244|NCT00883935|GSK1349572|gsk1349572
636245|NCT00883935|Atazanavir|atazanavir
636246|NCT00883935|Ritonavir|ritonavir
636247|NCT00883935|Reyataz|reyataz
636248|NCT00883935|Norvir|norvir
636249|NCT00883935|healthy|healthy
636250|NCT00883935|pharmacokinetic|pharmacokinetic
636251|NCT00883909|Prostate Cancer|prostate cancer
636252|NCT00883909|Benign Prostatic Hyperplasia|benign prostatic hyperplasia
636253|NCT00883896|Rheumatoid Arthritis|rheumatoid arthritis
636255|NCT00883896|Methotrexate|methotrexate
636256|NCT00883896|Interleukin-22|interleukin-22
636257|NCT00883883|Antibiotic|antibiotic
636258|NCT00883870|mesenchymal stem cells|mesenchymal stem cells
636259|NCT00883870|critical limb ischemia|critical limb ischemia
636260|NCT00883844|Hepatitis B|hepatitis b
636261|NCT00883844|sustained response|sustained response
636262|NCT00883844|peginterferon|peginterferon
636263|NCT00883844|nucleos(t)ide analogues|nucleos(t)ide analogues
636264|NCT00883831|Acupuncture|acupuncture
636265|NCT00883831|Hemodialysis|hemodialysis
636266|NCT00883831|Symptom|symptom
636267|NCT00883831|end stage renal disease|end stage renal disease
636268|NCT00883831|chronic kidney disease|chronic kidney disease
636269|NCT00883831|supportive care|supportive care
636270|NCT00883818|Overactive bladder|overactive bladder
636271|NCT00883818|Mycoplasma|mycoplasma
636272|NCT00883805|Metal Ion Concentration|metal ion concentration
636273|NCT00883805|Osteolysis|osteolysis
636274|NCT00883766|Polycystic Ovary Syndrome|polycystic ovary syndrome
636275|NCT00883766|GnRH Antagonist|gnrh antagonist
636276|NCT00883766|Long Agonist Protocol|long agonist protocol
636277|NCT00883766|OHSS|ohss
636278|NCT00883740|Fibromyalgia sleep maintenance disturbance pregabalin|fibromyalgia sleep maintenance disturbance pregabalin
636279|NCT00883727|mesenchymal stem cells|mesenchymal stem cells
636280|NCT00883727|myocardial infarction|myocardial infarction
636281|NCT00883714|Exercise|exercise
636282|NCT00883714|sport|sport
636283|NCT00883714|Allogeneic blood stem cell transplantation|allogeneic blood stem cell transplantation
636284|NCT00883714|Blood stem cell transplantation|blood stem cell transplantation
636285|NCT00883714|Fatigue|fatigue
636286|NCT00883714|Cancer|cancer
636287|NCT00883714|Physical performance|physical performance
636288|NCT00883714|Mood|mood
636289|NCT00883714|Complications|complications
636290|NCT00883701|Chronic Obstructive Pulmonary Disease|chronic obstructive pulmonary disease
636291|NCT00883701|exacerbations|exacerbations
636292|NCT00883701|perforin|perforin
636293|NCT00883701|granzymes|granzymes
636294|NCT00883688|Brain Tumor|brain tumor
636295|NCT00883688|Recurrent Ependymoma|recurrent ependymoma
636296|NCT00883688|Refractory Ependymoma|refractory ependymoma
636297|NCT00883688|Intracranial ependymoma|intracranial ependymoma
636298|NCT00883688|Ependymoblastoma|ependymoblastoma
636299|NCT00883688|Subependymoma|subependymoma
636300|NCT00883688|Myxopapillary|myxopapillary
636301|NCT00883688|Clear cell|clear cell
636302|NCT00883688|Anaplastic|anaplastic
636303|NCT00883688|Bevacizumab|bevacizumab
636304|NCT00883688|Avastin|avastin
636305|NCT00883688|Anti-VEGF Monoclonal Antibody|anti-vegf monoclonal antibody
636306|NCT00883688|rhuMAb-VEGF|rhumab-vegf
636307|NCT00883688|Lapatinib|lapatinib
636308|NCT00883688|Tykerb|tykerb
636309|NCT00883688|GW572016|gw572016
636310|NCT00883675|Lung cancer|lung cancer
636311|NCT00883675|Adjuvant therapy|adjuvant therapy
636312|NCT00883649|Keratoconjunctivitis Sicca|keratoconjunctivitis sicca
636313|NCT00883649|Dry Eyes|dry eyes
636314|NCT00883649|Post-menopausal|post-menopausal
636315|NCT00883636|Podocyte Protein|podocyte protein
636316|NCT00883636|Podocyte Mutation|podocyte mutation
636317|NCT00883623|AL-Amyloidosis|al-amyloidosis
636318|NCT00883623|Lenalidomide|lenalidomide
636319|NCT00883610|QT Interval|qt interval
636320|NCT00883610|Dual Chamber Pacemaker|dual chamber pacemaker
636321|NCT00883610|Atrial Fibrillation|atrial fibrillation
636322|NCT00883584|Proof of Concept|proof of concept
636323|NCT00883584|Inflammatory Markers|inflammatory markers
636324|NCT00883584|Lung Function|lung function
636325|NCT00883584|Chronic Obstructive Pulmonary Disease|chronic obstructive pulmonary disease
636327|NCT00883571|anal stenosis|anal stenosis
636329|NCT00883571|anoplasty|anoplasty
636330|NCT00883558|recombinant human hyaluronidase (rHuPH20)|recombinant human hyaluronidase (rhuph20)
636331|NCT00883558|Insulin lispro|insulin lispro
636332|NCT00883558|regular human insulin|regular human insulin
636333|NCT00883545|Adherence to screening colonoscopy in women|adherence to screening colonoscopy in women
636334|NCT00883532|Preterm infant|preterm infant
636335|NCT00883532|Respiratory distress syndrome|respiratory distress syndrome
636336|NCT00883532|chronic lung disease|chronic lung disease
636337|NCT00883532|budesonide|budesonide
636338|NCT00883532|surfactant|surfactant
636339|NCT00883493|Acute bipolar depression|acute bipolar depression
636340|NCT00883493|Lithium carbonate|lithium carbonate
636341|NCT00883493|quetiapine fumarate|quetiapine fumarate
636342|NCT00883493|MADRS|madrs
636343|NCT00883480|NSCLC|nsclc
636344|NCT00883467|Ischemic Preconditioning|ischemic preconditioning
636345|NCT00883467|functional MRI|functional mri
636346|NCT00883467|BOLD|bold
636347|NCT00883467|Reperfusion|reperfusion
636348|NCT00883454|hepatocellular carcinoma|hepatocellular carcinoma
636349|NCT00883454|liver tumor|liver tumor
636350|NCT00883454|cirrhosis|cirrhosis
636351|NCT00883454|liver resection|liver resection
636352|NCT00883454|tumor staging|tumor staging
636353|NCT00883454|liver disease staging|liver disease staging
636354|NCT00883441|IMPLEMENTATION RESEARCH|implementation research
636355|NCT00883441|AEDES|aedes
636356|NCT00883441|VECTOR CONTROL|vector control
636357|NCT00883428|low back pain|low back pain
636358|NCT00883428|pelvic pain|pelvic pain
636359|NCT00883428|pregnancy|pregnancy
636360|NCT00883415|metabolism|metabolism
636361|NCT00883415|myocardium|myocardium
636362|NCT00883415|chronic kidney disease|chronic kidney disease
636363|NCT00883402|Carotid stenosis|carotid stenosis
636364|NCT00883402|CEA|cea
636365|NCT00883402|CAS|cas
636366|NCT00883402|Stenting|stenting
636367|NCT00883389|patient safety|patient safety
636368|NCT00883389|chronic kidney disease|chronic kidney disease
636369|NCT00883389|med-alert|med-alert
636370|NCT00883376|Classification of Stanford for Snoring|classification of stanford for snoring
636371|NCT00883376|OSAS|osas
636372|NCT00883376|Apnea-Hipopnea Index|apnea-hipopnea index
636373|NCT00883363|precondition|precondition
636374|NCT00883363|ruptured abdominal aortic aneurysm|ruptured abdominal aortic aneurysm
636375|NCT00883363|myocardial infarction|myocardial infarction
636376|NCT00883350|Body weight changes|body weight changes
636377|NCT00883350|Overweight|overweight
636378|NCT00883350|Obesity|obesity
636379|NCT00883337|Relapsing-remitting multiple sclerosis|relapsing-remitting multiple sclerosis
636380|NCT00883324|fFN|ffn
636381|NCT00883324|fetal fibronectin|fetal fibronectin
636382|NCT00883324|non-speculum|non-speculum
636383|NCT00883324|risk of preterm delivery|risk of preterm delivery
636384|NCT00883311|Efficacy|efficacy
636385|NCT00883298|temozolomide|temozolomide
636386|NCT00883298|bevacizumab|bevacizumab
636387|NCT00883298|Temodar|temodar
636388|NCT00883298|Avastin|avastin
636389|NCT00883298|glioblastoma multiforme|glioblastoma multiforme
636390|NCT00883298|gliosarcoma|gliosarcoma
636391|NCT00883298|glioma|glioma
636392|NCT00883298|GBM|gbm
636393|NCT00883298|brain tumor|brain tumor
636394|NCT00883272|Menopause|menopause
636395|NCT00883272|Thrombophilia|thrombophilia
636396|NCT00883272|factor V Leiden|factor v leiden
636397|NCT00883272|Estrogen Replacement Therapy|estrogen replacement therapy
636398|NCT00883272|Hypercoagulability|hypercoagulability
636399|NCT00883272|Venous Thrombosis|venous thrombosis
636400|NCT00883259|High-risk patients|high-risk patients
636401|NCT00883259|Metformin|metformin
636402|NCT00883259|PCOS|pcos
636403|NCT00883259|Pregnancy complications|pregnancy complications
636404|NCT00883259|Previous gestational DM|previous gestational dm
636405|NCT00883246|PAD|pad
636406|NCT00883233|Acne|acne
636407|NCT00883220|self management|self management
636408|NCT00883220|chronic condition|chronic condition
636409|NCT00883220|urinary catheter|urinary catheter
636410|NCT00883207|Depression|depression
636411|NCT00883207|family therapy|family therapy
636412|NCT00883207|dialogical processes|dialogical processes
636413|NCT00883207|Developing couple therapy for depression|developing couple therapy for depression
636414|NCT00883194|Experimental Pain Model|experimental pain model
636415|NCT00883155|Antidepressant|antidepressant
636416|NCT00883142|Lokomat|lokomat
636417|NCT00883142|Suspended walking|suspended walking
636418|NCT00883142|Body Weight Supported|body weight supported
636419|NCT00883142|Treadmill Training|treadmill training
636420|NCT00883129|Systemic Sclerosis|systemic sclerosis
636421|NCT00883129|Mycophenolate Mofetil|mycophenolate mofetil
636422|NCT00883129|Cyclophosphamide|cyclophosphamide
636423|NCT00883129|High Resolution Computerized Tomography|high resolution computerized tomography
636424|NCT00883129|Pulmonary Function|pulmonary function
636425|NCT00883129|Dyspnea|dyspnea
636426|NCT00883129|Health Related Quality of Life|health related quality of life
636427|NCT00883103|female urethral catheterization|female urethral catheterization
636428|NCT00883103|Lidocaine|lidocaine
636429|NCT00883103|lubricant|lubricant
636430|NCT00883103|Q-tip test|q-tip test
636431|NCT00883103|Q tip test|q tip test
636432|NCT00883103|K-Y jelly|k-y jelly
636433|NCT00883103|pain perception|pain perception
636434|NCT00883103|straight catheterization|straight catheterization
636435|NCT00883090|Factor XIII|factor xiii
636436|NCT00883077|permeability|permeability
636437|NCT00883077|inflammatory bowel disease|inflammatory bowel disease
636438|NCT00883077|confocal laser endomicroscopy|confocal laser endomicroscopy
636439|NCT00883077|irritable bowel syndrome|irritable bowel syndrome
636440|NCT00883051|COL-144|col-144
636441|NCT00883051|acute treatment|acute treatment
636442|NCT00883051|migraine|migraine
636443|NCT00883038|insulin resistance|insulin resistance
636444|NCT00883038|vegetarian diet|vegetarian diet
636445|NCT00883025|Friedman Classification|friedman classification
636446|NCT00883025|Apnea-Hypopnea Index|apnea-hypopnea index
636447|NCT00883025|Obstructive Sleep Apnea Syndrome|obstructive sleep apnea syndrome
636448|NCT00883012|Viral-confirmed|viral-confirmed
636449|NCT00882999|Relapsing|relapsing
636450|NCT00882999|Remitting|remitting
636451|NCT00882999|Multiple Sclerosis|multiple sclerosis
636452|NCT00882999|Multiple|multiple
636453|NCT00882999|Sclerosis|sclerosis
636454|NCT00882999|MS|ms
636455|NCT00882999|LY2127399|ly2127399
636456|NCT00882986|insulin resistance|insulin resistance
636457|NCT00882960|pre-hospital|pre-hospital
636458|NCT00882960|intra-nasal fentanyl|intra-nasal fentanyl
636459|NCT00882960|patients requiring analgesia|patients requiring analgesia
636460|NCT00882947|Primary Pulmonary Hypertension (PPH)|primary pulmonary hypertension (pph)
636461|NCT00882934|Placebo|placebo
636462|NCT00882934|Placebo Effect|placebo effect
636463|NCT00882934|Sexual Dysfunction|sexual dysfunction
636464|NCT00882934|Erectile Dysfunction|erectile dysfunction
636465|NCT00882934|Clinical Trial|clinical trial
636466|NCT00882921|MPS 2|mps 2
636467|NCT00882921|MPSII|mpsii
636468|NCT00882921|hunter's disease treatment|hunter's disease treatment
636469|NCT00882921|enzyme replacement therapy|enzyme replacement therapy
636470|NCT00882921|hunter's disease|hunter's disease
636471|NCT00882921|iduronate 2 sulfatase|iduronate 2 sulfatase
636472|NCT00882921|mps diagnosis|mps diagnosis
636473|NCT00882921|mps symptoms|mps symptoms
636474|NCT00882921|iduronate sulfatase|iduronate sulfatase
636475|NCT00882921|MPS II treatment|mps ii treatment
636476|NCT00882921|chronic ear infection|chronic ear infection
636477|NCT00882921|hunters syndrome|hunters syndrome
636478|NCT00882921|mps ii therapy|mps ii therapy
636479|NCT00882921|MPS2|mps2
636480|NCT00882921|hunter's syndrome|hunter's syndrome
636481|NCT00882921|Hunter syndrome|hunter syndrome
636482|NCT00882921|elaprase|elaprase
636483|NCT00882921|lysosomal storage disease|lysosomal storage disease
636484|NCT00882921|hunter syndrome therapy|hunter syndrome therapy
636485|NCT00882921|mps society|mps society
636486|NCT00882921|hunter syndrome treatment|hunter syndrome treatment
636487|NCT00882921|hunter's syndrome treatment|hunter's syndrome treatment
636488|NCT00882921|mucopolysaccharides|mucopolysaccharides
636489|NCT00882921|mps ii|mps ii
636490|NCT00882921|idursulfase|idursulfase
636491|NCT00882921|hunters disease|hunters disease
636492|NCT00882921|enlarged adenoids|enlarged adenoids
636493|NCT00882921|ert treatment|ert treatment
636494|NCT00882921|hunter disease|hunter disease
636495|NCT00882921|lysosomal storage disorder|lysosomal storage disorder
636496|NCT00882908|Hepatitis C|hepatitis c
636497|NCT00882908|TMC435|tmc435
636498|NCT00882908|Peginterferon alpha-2a|peginterferon alpha-2a
636499|NCT00882908|PegIFNalpha-2a|pegifnalpha-2a
636500|NCT00882908|RBV|rbv
636501|NCT00882908|Ribavirin|ribavirin
636502|NCT00882908|Placebo|placebo
636503|NCT00882895|Lymphoma, Non-Hodgkin|lymphoma, non-hodgkin
636504|NCT00882895|Transplantation, Autologous|transplantation, autologous
636505|NCT00882895|Transplantation, Homologous|transplantation, homologous
636506|NCT00882895|Total Lymphoid Irradiation|total lymphoid irradiation
636507|NCT00882895|Anti-thymocyte globulin|anti-thymocyte globulin
636508|NCT00882869|Advanced Hepatocellular carcinoma|advanced hepatocellular carcinoma
636509|NCT00882869|liver|liver
636510|NCT00882869|cancer|cancer
636511|NCT00882869|antisense|antisense
636512|NCT00882869|sorafenib|sorafenib
636513|NCT00882856|Clozapine|clozapine
636514|NCT00882856|Sinustachycardia|sinustachycardia
636515|NCT00882856|Heartrate variability|heartrate variability
636516|NCT00882856|Cardiomyopathy|cardiomyopathy
636517|NCT00882843|Vibrating plate|vibrating plate
636518|NCT00882843|Mechanical Stimulation|mechanical stimulation
636519|NCT00882843|Osteoporosis|osteoporosis
636520|NCT00882830|ICU|icu
636521|NCT00882830|myopathy|myopathy
636522|NCT00882830|neuropathy|neuropathy
636523|NCT00882830|EMS|ems
636524|NCT00882830|critical illness polyneuromyopathy|critical illness polyneuromyopathy
636525|NCT00882830|NIRS|nirs
636526|NCT00882830|muscle biopsy|muscle biopsy
636527|NCT00882830|microdialysis|microdialysis
636528|NCT00882830|CIPNM|cipnm
636529|NCT00882817|ILD|ild
636635|NCT00882219|Stents|stents
636530|NCT00882804|hemin, heme oxygenase, humans, HO-1|hemin, heme oxygenase, humans, ho-1
636531|NCT00882791|Skin Cancer|skin cancer
636532|NCT00882791|Basal Cell|basal cell
636533|NCT00882791|Mohs surgery|mohs surgery
636534|NCT00882765|adenocarcinoma of the pancreas|adenocarcinoma of the pancreas
636535|NCT00882765|stage I pancreatic cancer|stage i pancreatic cancer
636536|NCT00882765|stage II pancreatic cancer|stage ii pancreatic cancer
636537|NCT00882765|stage III pancreatic cancer|stage iii pancreatic cancer
636538|NCT00882752|Ulcerative Colitis (UC)|ulcerative colitis (uc)
636539|NCT00882739|angiography|angiography
636540|NCT00882739|percutaneous coronary intervention|percutaneous coronary intervention
636541|NCT00882739|Platelet Aggregation Inhibitors|platelet aggregation inhibitors
636542|NCT00882739|Platelet Function Tests|platelet function tests
636543|NCT00882726|Diabetes Mellitus, Type 2|diabetes mellitus, type 2
636544|NCT00882726|CNTO 3649|cnto 3649
636545|NCT00882726|safety|safety
636546|NCT00882726|Phase I|phase i
636547|NCT00882726|healthy adults|healthy adults
636548|NCT00882726|Type 2 Diabetes Mellitus|type 2 diabetes mellitus
636549|NCT00882700|Antibiotic|antibiotic
636550|NCT00882661|Neck Pain|neck pain
636551|NCT00882661|Arm Pain|arm pain
636552|NCT00882648|Drug dependence during pregnancy|drug dependence during pregnancy
636553|NCT00882635|STEMI|stemi
636554|NCT00882635|acute coronary syndromes|acute coronary syndromes
636555|NCT00882635|primary percutaneous coronary intervention|primary percutaneous coronary intervention
636556|NCT00882622|Ischemic Preconditioning|ischemic preconditioning
636557|NCT00882622|Cardiac Surgery|cardiac surgery
636558|NCT00882609|bone metastasis|bone metastasis
636559|NCT00882609|bone metastases|bone metastases
636560|NCT00882609|Sodium Fluoride|sodium fluoride
636561|NCT00882609|F18 Fluoride|f18 fluoride
636562|NCT00882609|bone scan|bone scan
636563|NCT00882596|Contura|contura
636564|NCT00882596|Cancer|cancer
636565|NCT00882596|Accelerated|accelerated
636566|NCT00882596|Partial|partial
636567|NCT00882596|Breast|breast
636568|NCT00882596|Irradiation|irradiation
636569|NCT00882583|HNSCC|hnscc
636570|NCT00882583|Dasatinib|dasatinib
636571|NCT00882583|Cetuximab|cetuximab
636572|NCT00882583|Cisplatin|cisplatin
636573|NCT00882570|Antibiotic|antibiotic
636574|NCT00882557|End-stage renal disease|end-stage renal disease
636575|NCT00882557|hemodialysis|hemodialysis
636576|NCT00882557|chronic renal failure|chronic renal failure
636577|NCT00882544|hydronephrosis|hydronephrosis
636578|NCT00882544|robotic pyeloplasty|robotic pyeloplasty
636579|NCT00882544|pediatric pyeloplasty|pediatric pyeloplasty
636580|NCT00882518|Quetiapine Fumarate (SEROQUEL) Extended-Release (XR)|quetiapine fumarate (seroquel) extended-release (xr)
636581|NCT00882518|qualified PANSS assessment|qualified panss assessment
636582|NCT00882492|Cardiac|cardiac
636583|NCT00882492|Surgery|surgery
636584|NCT00882492|Glycemia|glycemia
636585|NCT00882466|erythropoietin|erythropoietin
636586|NCT00882453|Physical Activity|physical activity
636587|NCT00882453|Fatigue|fatigue
636588|NCT00882453|RRMS|rrms
636589|NCT00882453|CIS|cis
636590|NCT00882427|algorithm|algorithm
636591|NCT00882427|tight glycemic control|tight glycemic control
636592|NCT00882427|glucose control|glucose control
636593|NCT00882427|intensive care|intensive care
636594|NCT00882427|insulin|insulin
636595|NCT00882427|ICU|icu
636596|NCT00882414|ferric carboxymaltose|ferric carboxymaltose
636597|NCT00882414|platelet|platelet
636598|NCT00882414|thrombocyte|thrombocyte
636599|NCT00882414|ferritin|ferritin
636600|NCT00882414|hemoglobin|hemoglobin
636601|NCT00882414|transferrin|transferrin
636602|NCT00882388|celecoxib|celecoxib
636603|NCT00882388|platelet|platelet
636604|NCT00882388|thrombosis|thrombosis
636605|NCT00882388|Volunteers|volunteers
636606|NCT00882375|Smoking Cessation|smoking cessation
636607|NCT00882336|Cardiovascular risk management|cardiovascular risk management
636608|NCT00882336|Hyperlipidemia|hyperlipidemia
636609|NCT00882336|Hypertension|hypertension
636610|NCT00882336|Diabetes|diabetes
636611|NCT00882336|Obesity|obesity
636612|NCT00882310|Pancreatic cancer|pancreatic cancer
636613|NCT00882310|Gemzar|gemzar
636614|NCT00882310|Taxotere|taxotere
636615|NCT00882310|Xeloda|xeloda
636616|NCT00882310|GTX|gtx
636617|NCT00882297|Ultrasoundography|ultrasoundography
636618|NCT00882297|catheterization|catheterization
636619|NCT00882297|central venous subclavian vein methods|central venous subclavian vein methods
636620|NCT00882284|NICHD Neonatal Research Network|nichd neonatal research network
636621|NCT00882284|Blood Pressure Management|blood pressure management
636622|NCT00882271|Fibromyalgia|fibromyalgia
636623|NCT00882271|Acupuncture|acupuncture
636624|NCT00882271|Pain|pain
636625|NCT00882258|Uterine fibroids|uterine fibroids
636626|NCT00882232|prostate|prostate
636627|NCT00882232|cancer|cancer
636628|NCT00882232|cross-linked|cross-linked
636629|NCT00882232|hyaluronan|hyaluronan
636630|NCT00882232|gel|gel
636631|NCT00882232|Hylaform|hylaform
636632|NCT00882232|rectal|rectal
636633|NCT00882232|toxicity|toxicity
636634|NCT00882219|Drug eluting stent|drug eluting stent
636636|NCT00882219|Angioplasty|angioplasty
636637|NCT00882219|Chronic coronary occlusion|chronic coronary occlusion
636638|NCT00882219|Stent thrombosis|stent thrombosis
636639|NCT00882219|Vascular disease|vascular disease
636640|NCT00882219|Myocardial ischemia|myocardial ischemia
636641|NCT00882219|Coronary artery stenosis|coronary artery stenosis
636642|NCT00882219|Coronary Disease|coronary disease
636643|NCT00882219|Coronary Artery Disease|coronary artery disease
636644|NCT00882219|Coronary Restenosis|coronary restenosis
636645|NCT00882206|recurrent adult lymphoblastic lymphoma|recurrent adult lymphoblastic lymphoma
636646|NCT00882206|recurrent childhood lymphoblastic lymphoma|recurrent childhood lymphoblastic lymphoma
636647|NCT00882206|recurrent adult acute lymphoblastic leukemia|recurrent adult acute lymphoblastic leukemia
636648|NCT00882206|recurrent childhood acute lymphoblastic leukemia|recurrent childhood acute lymphoblastic leukemia
636649|NCT00882193|Chronic hepatitis C|chronic hepatitis c
636650|NCT00882193|Genotype 1|genotype 1
636651|NCT00882193|Nonresponder|nonresponder
636652|NCT00882193|Relapser|relapser
636653|NCT00882193|Betaine|betaine
636654|NCT00882193|Antiviral therapy|antiviral therapy
636655|NCT00882180|Liver|liver
636656|NCT00882180|Solid Tumors|solid tumors
636657|NCT00882180|Advanced Solid Tumors with Liver Involvement|advanced solid tumors with liver involvement
636658|NCT00882154|Antibiotic|antibiotic
636659|NCT00882141|Exercise|exercise
636660|NCT00882141|Obesity|obesity
636661|NCT00882141|Insulin Sensitivity|insulin sensitivity
636662|NCT00882128|Asthma seasonal respiratory symptoms|asthma seasonal respiratory symptoms
636663|NCT00882128|Asthmatic patients with increase of respiratory symptoms|asthmatic patients with increase of respiratory symptoms
636664|NCT00882115|DEP|dep
636665|NCT00882115|Broccoli Sprout Extract|broccoli sprout extract
636666|NCT00882115|Allergies|allergies
636667|NCT00882102|Acute Myelogenous Leukemia|acute myelogenous leukemia
636668|NCT00882102|High-Risk Myelodysplastic Syndrome|high-risk myelodysplastic syndrome
636669|NCT00882102|AML|aml
636670|NCT00882102|MDS|mds
636671|NCT00882102|Leukemia|leukemia
636672|NCT00882102|Decitabine|decitabine
636673|NCT00882102|Gemtuzumab Ozogamicin|gemtuzumab ozogamicin
636674|NCT00882102|Dacogen|dacogen
636675|NCT00882102|Mylotarg|mylotarg
636676|NCT00882089|Contura|contura
636677|NCT00882089|Cancer|cancer
636678|NCT00882089|Accelerated|accelerated
636679|NCT00882089|Partial|partial
636680|NCT00882089|Breast|breast
636681|NCT00882089|Irradiation|irradiation
636682|NCT00882076|acute lymphoblastic leukemia|acute lymphoblastic leukemia
636683|NCT00882076|chronic lymphocytic leukemia|chronic lymphocytic leukemia
636684|NCT00882063|Multiple Myeloma|multiple myeloma
636685|NCT00882037|Methamphetamine Dependence|methamphetamine dependence
636686|NCT00882037|Substance Abuse Treatment|substance abuse treatment
636687|NCT00882037|Rural and Urban|rural and urban
636688|NCT00882037|Latino and Non-Latino|latino and non-latino
636689|NCT00882024|Rheumatoid arthritis|rheumatoid arthritis
636690|NCT00882011|T-lymphoblastic lymphoma|t-lymphoblastic lymphoma
636691|NCT00882011|Intensive chemo/radiotherapy|intensive chemo/radiotherapy
636692|NCT00882011|Intensive chemotherapy|intensive chemotherapy
636693|NCT00882011|Transplant|transplant
636694|NCT00882011|Adult patients|adult patients
636695|NCT00881998|Evaluate early functional outcomes of two anterior approaches to total hip arthroplasty|evaluate early functional outcomes of two anterior approaches to total hip arthroplasty
636696|NCT00881985|obstructive sleep apnea|obstructive sleep apnea
636697|NCT00881985|resistant hypertension|resistant hypertension
636698|NCT00881985|refractory hypertension|refractory hypertension
636699|NCT00881985|continuous positive airway pressure|continuous positive airway pressure
636700|NCT00881985|blood pressure control|blood pressure control
636701|NCT00881959|exposed Root Surface or Tooth|exposed root surface or tooth
636702|NCT00881959|Tooth Sensitivity Miller Class I|tooth sensitivity miller class i
636703|NCT00881959|Miller Class II|miller class ii
636704|NCT00881959|Gingival Margin|gingival margin
636705|NCT00881946|chronic lymphocytic leukemia|chronic lymphocytic leukemia
636706|NCT00881946|aggressive lymphoma|aggressive lymphoma
636707|NCT00881946|non-Hodgkin's lymphoma|non-hodgkin's lymphoma
636708|NCT00881946|Hodgkin's lymphoma|hodgkin's lymphoma
636709|NCT00881946|chronic myelogenous leukemia|chronic myelogenous leukemia
636710|NCT00881946|multiple myeloma|multiple myeloma
636711|NCT00881946|acute lymphoblastic leukemia|acute lymphoblastic leukemia
636712|NCT00881946|acute myeloid leukemia|acute myeloid leukemia
636713|NCT00881933|Fludarabine, Cyclophosphamide, TBI, severe aplastic anemia,|fludarabine, cyclophosphamide, tbi, severe aplastic anemia,
636714|NCT00881933|cord blood transplantation, pediatric|cord blood transplantation, pediatric
636715|NCT00881920|Lymphocytic|lymphocytic
636716|NCT00881920|Leukemia|leukemia
636717|NCT00881920|B Cell|b cell
636718|NCT00881920|Non-Hodgkin|non-hodgkin
636719|NCT00881920|Multiple Myeloma|multiple myeloma
636720|NCT00881920|Lymphoma|lymphoma
636721|NCT00881907|Regeneration (revascularization) of dental pulp|regeneration (revascularization) of dental pulp
636722|NCT00881907|Immature Permanent Tooth With a Diagnosis of Pulpal Necrosis|immature permanent tooth with a diagnosis of pulpal necrosis
636723|NCT00881894|Rotigotine|rotigotine
636724|NCT00881894|Neupro®|neupro®
636725|NCT00881894|Transdermal Patch|transdermal patch
636726|NCT00881855|Antibiotics|antibiotics
636727|NCT00881842|Influenza|influenza
636728|NCT00881842|Vaccine|vaccine
636729|NCT00881842|CHMP criteria|chmp criteria
636730|NCT00881829|Pulse Oximetry|pulse oximetry
636731|NCT00881829|Temperature|temperature
636732|NCT00881829|Respiratory Rate|respiratory rate
636733|NCT00881829|Respiratory Gases|respiratory gases
636734|NCT00881829|This study determine the measurement accuracy of the physiological parameters|this study determine the measurement accuracy of the physiological parameters
636735|NCT00881816|Liposomal Paclitaxel|liposomal paclitaxel
636736|NCT00881816|Capecitabine|capecitabine
636737|NCT00881816|Maximum tolerated dose|maximum tolerated dose
636738|NCT00881816|Dose limiting toxicity|dose limiting toxicity
636739|NCT00881803|Spinal Cord Injuries|spinal cord injuries
636740|NCT00881803|Ascorbic Acid|ascorbic acid
636741|NCT00881803|Vitamin C|vitamin c
636742|NCT00881803|Iron|iron
636743|NCT00881803|Dietary Supplements|dietary supplements
636744|NCT00881777|Heart Failure|heart failure
636745|NCT00881777|Cardiomyopathy|cardiomyopathy
636746|NCT00881777|Ventricular Dysfunction|ventricular dysfunction
636747|NCT00881777|Heart Disease|heart disease
636748|NCT00881764|Anesthesia|anesthesia
636749|NCT00881764|New York|new york
636750|NCT00881764|Columbia|columbia
636751|NCT00881764|Children|children
636752|NCT00881764|Neurodevelopment|neurodevelopment
636753|NCT00881764|Child development|child development
636754|NCT00881764|Pediatric|pediatric
636755|NCT00881751|adult primary hepatocellular carcinoma|adult primary hepatocellular carcinoma
636756|NCT00881751|advanced adult primary liver cancer|advanced adult primary liver cancer
636757|NCT00881751|recurrent adult primary liver cancer|recurrent adult primary liver cancer
636758|NCT00881738|Antibiotic|antibiotic
636759|NCT00881725|Metformin|metformin
636760|NCT00881725|Prostate Cancer|prostate cancer
636761|NCT00881725|Radical Prostatectomy|radical prostatectomy
636762|NCT00881725|Neoadjuvant Intervention|neoadjuvant intervention
636763|NCT00881725|PTEN/AKT Pathway|pten/akt pathway
636764|NCT00881725|Tumour Expression|tumour expression
636765|NCT00881725|Ki67 Expression|ki67 expression
636766|NCT00881712|Non-small cell lung Cancer|non-small cell lung cancer
636767|NCT00881712|Proton Radiation|proton radiation
636768|NCT00881712|Stage III|stage iii
636769|NCT00881699|HIV Information|hiv information
636770|NCT00881699|HIV Prevention|hiv prevention
636771|NCT00881699|Severe Mental Illness|severe mental illness
636772|NCT00881699|HIV seronegativity|hiv seronegativity
636773|NCT00881686|Ischemic Preconditioning, Myocardial|ischemic preconditioning, myocardial
636774|NCT00881686|Adenosine|adenosine
636775|NCT00881673|Conjunctivitis|conjunctivitis
636776|NCT00881660|Fetal Tracheal Occlusion|fetal tracheal occlusion
636777|NCT00881660|congenital diaphragmatic hernia|congenital diaphragmatic hernia
636778|NCT00881660|FETO plug-unplug|feto plug-unplug
636779|NCT00881660|Goldvalve balloon|goldvalve balloon
636780|NCT00881660|Severe Congenital Diaphragmatic Hernia|severe congenital diaphragmatic hernia
636781|NCT00881660|Extremely Severe Congenital Diaphragmatic Hernia|extremely severe congenital diaphragmatic hernia
636782|NCT00881660|Goldbal balloon|goldbal balloon
636783|NCT00881660|FETO|feto
636784|NCT00881647|PTSD|ptsd
636785|NCT00881647|Insomnia Disorder|insomnia disorder
636786|NCT00881647|Insomnia|insomnia
636787|NCT00881647|CBT|cbt
636788|NCT00881621|Pancreas cancer|pancreas cancer
636789|NCT00881621|lapatinib|lapatinib
636790|NCT00881621|capecitabine|capecitabine
636791|NCT00881608|Menstruation|menstruation
636792|NCT00881595|Sarcomas|sarcomas
636793|NCT00881595|High-Risk Soft Tissue Sarcomas|high-risk soft tissue sarcomas
636794|NCT00881582|Hepatitis c|hepatitis c
636795|NCT00881582|Renal transplantation|renal transplantation
636796|NCT00881582|Pegylated interferon|pegylated interferon
636797|NCT00881556|Allogeneic Stem Cell Transplant|allogeneic stem cell transplant
636798|NCT00881556|AlloSCT|allosct
636799|NCT00881556|RDEB|rdeb
711004|NCT00586898|TESTOSTERONE|testosterone
636800|NCT00881556|recessive dystrophic epidermolysis bullosa|recessive dystrophic epidermolysis bullosa
636801|NCT00881543|Sitagliptin|sitagliptin
636802|NCT00881543|Diets|diets
636803|NCT00881543|Diabetes type 2|diabetes type 2
636804|NCT00881543|Näive patients|näive patients
636805|NCT00881517|human cytomegalovirus|human cytomegalovirus
636806|NCT00881517|immune globulin|immune globulin
636807|NCT00881517|congenital infection|congenital infection
636808|NCT00881517|prevention|prevention
636809|NCT00881517|pregnancy|pregnancy
636810|NCT00881504|Biliary|biliary
636811|NCT00881504|Oxaliplatin|oxaliplatin
636812|NCT00881504|Bevacizumab|bevacizumab
636813|NCT00881491|Regeneration (revascularization) of dental pulp|regeneration (revascularization) of dental pulp
636814|NCT00881491|Immature permanent tooth with a diagnosis of|immature permanent tooth with a diagnosis of
636815|NCT00881478|Obesity|obesity
636816|NCT00881478|Children|children
636817|NCT00881478|Dyslipidemia|dyslipidemia
636818|NCT00881478|Hypertension|hypertension
636819|NCT00881465|Obsessive compulsive disorder|obsessive compulsive disorder
636820|NCT00881452|Autism|autism
636821|NCT00881439|Heart failure|heart failure
636822|NCT00881439|Renal Failure|renal failure
636918|NCT00880919|BPD|bpd
636823|NCT00881439|Cardiorenal Syndrome|cardiorenal syndrome
636824|NCT00881439|Renin inhibition|renin inhibition
636825|NCT00881439|Aliskiren|aliskiren
636826|NCT00881426|Antibiotic|antibiotic
636827|NCT00881413|Peptic ulcer bleeding|peptic ulcer bleeding
636828|NCT00881413|Proton pump inhibitor|proton pump inhibitor
636829|NCT00881413|Esomeprazole|esomeprazole
636830|NCT00881413|Pantoprazole|pantoprazole
636831|NCT00881413|Recurrent bleeding|recurrent bleeding
636832|NCT00881413|bleeding|bleeding
636833|NCT00881400|Antibiotic|antibiotic
636834|NCT00881387|recurrent adult Hodgkin lymphoma|recurrent adult hodgkin lymphoma
636835|NCT00881387|adult lymphocyte depletion Hodgkin lymphoma|adult lymphocyte depletion hodgkin lymphoma
636836|NCT00881387|adult lymphocyte predominant Hodgkin lymphoma|adult lymphocyte predominant hodgkin lymphoma
636837|NCT00881387|adult mixed cellularity Hodgkin lymphoma|adult mixed cellularity hodgkin lymphoma
636838|NCT00881387|adult nodular sclerosis Hodgkin lymphoma|adult nodular sclerosis hodgkin lymphoma
636839|NCT00881361|stage II breast cancer|stage ii breast cancer
636840|NCT00881361|stage IIIA breast cancer|stage iiia breast cancer
636841|NCT00881361|stage IIIB breast cancer|stage iiib breast cancer
636842|NCT00881335|geriatric|geriatric
636843|NCT00881335|pulmonary disease|pulmonary disease
636844|NCT00881335|flutter|flutter
636845|NCT00881335|sputum|sputum
636846|NCT00881335|physical therapy techniques|physical therapy techniques
636847|NCT00881296|Elder Patients|elder patients
636848|NCT00881296|Non-Small Cell Lung Cancer|non-small cell lung cancer
636849|NCT00881296|Previously Untreated|previously untreated
636850|NCT00881296|Advanced|advanced
636851|NCT00881283|Cushing's disease|cushing's disease
636852|NCT00881257|Peripheral Vascular Disease|peripheral vascular disease
636853|NCT00881257|Peripheral Artery Disease|peripheral artery disease
636854|NCT00881257|Radiofrequency|radiofrequency
636855|NCT00881218|myocardial ischemia, perfusion imaging, cardiac MRI|myocardial ischemia, perfusion imaging, cardiac mri
636856|NCT00881205|Multiple Sclerosis|multiple sclerosis
636857|NCT00881205|Cognition|cognition
636858|NCT00881205|Rivastigmine|rivastigmine
636859|NCT00881205|Patch|patch
636860|NCT00881192|CABG|cabg
636861|NCT00881192|coronary surgery|coronary surgery
636862|NCT00881192|intra-aortic balloon pump|intra-aortic balloon pump
636863|NCT00881192|CABG operation|cabg operation
636864|NCT00881179|Antibiotic|antibiotic
636865|NCT00881166|MP-470|mp-470
636866|NCT00881166|Multi-targeted Tyrosine Kinase Inhibitor|multi-targeted tyrosine kinase inhibitor
636867|NCT00881166|Malignant disease|malignant disease
636868|NCT00881153|Antibiotic|antibiotic
636869|NCT00881140|oral mifepristone|oral mifepristone
636870|NCT00881140|vaginal tablets|vaginal tablets
636871|NCT00881114|Head and neck cancer|head and neck cancer
636872|NCT00881114|pharmacogenetics|pharmacogenetics
636873|NCT00881114|chemoradiotherapy|chemoradiotherapy
636874|NCT00881101|Liposomal Paclitaxel|liposomal paclitaxel
636875|NCT00881101|Maximum tolerated dose|maximum tolerated dose
636876|NCT00881101|Dose limiting toxicity|dose limiting toxicity
636877|NCT00881088|Deep vein trombosis|deep vein trombosis
636878|NCT00881088|Profylaxis|profylaxis
636879|NCT00881088|Below knee plaster cast|below knee plaster cast
636880|NCT00881088|Ankle fracture|ankle fracture
636881|NCT00881075|Magnetic resonance imaging|magnetic resonance imaging
636882|NCT00881075|Heart diseases|heart diseases
636883|NCT00881075|myocardial infarction|myocardial infarction
636884|NCT00881075|contrast agents|contrast agents
636885|NCT00881075|manganese|manganese
636886|NCT00881062|ABSORPTION|absorption
636887|NCT00881062|METABOLISM|metabolism
636888|NCT00881062|EXCRETION|excretion
636889|NCT00881049|metastatic acral or mucosal melanoma with c-kit mutation or copy number increase|metastatic acral or mucosal melanoma with c-kit mutation or copy number increase
636890|NCT00881036|Hepatitis B|hepatitis b
636891|NCT00881010|Breast Cancer|breast cancer
711005|NCT00586898|ZOLADEX|zoladex
811548|NCT00202254|MS|ms
636892|NCT00881010|Pain Intervention|pain intervention
636893|NCT00881010|Underserved minority patients|underserved minority patients
636894|NCT00881010|African American|african american
636895|NCT00881010|Hispanic|hispanic
636896|NCT00881010|Automated Telephone System for measuring symptoms|automated telephone system for measuring symptoms
636897|NCT00881010|Interactive voice response|interactive voice response
636898|NCT00881010|IVR|ivr
636899|NCT00880997|Cocaine Dependence|cocaine dependence
636900|NCT00880997|Substance Related Disorders|substance related disorders
636901|NCT00880984|Colon Anastomosis|colon anastomosis
636902|NCT00880984|Rectum Anastomosis|rectum anastomosis
636903|NCT00880984|Intestine|intestine
636904|NCT00880984|Colorectal Surgery|colorectal surgery
636905|NCT00880984|Colorectal Anastomosis|colorectal anastomosis
636906|NCT00880971|Lung|lung
636907|NCT00880971|Carcinoma|carcinoma
636908|NCT00880971|radiotherapy|radiotherapy
636909|NCT00880971|Surgery|surgery
636910|NCT00880945|FBS|fbs
636911|NCT00880945|coin lesions|coin lesions
636912|NCT00880945|ENB|enb
636913|NCT00880945|ROSE|rose
636914|NCT00880932|warfarin|warfarin
636915|NCT00880932|NSAID|nsaid
636916|NCT00880932|The condition is the concomitant prescription of|the condition is the concomitant prescription of
636917|NCT00880919|Borderline Personality Disorder|borderline personality disorder
636919|NCT00880919|Seroquel|seroquel
636920|NCT00880919|Seroquel XR|seroquel xr
636921|NCT00880919|quetiapine|quetiapine
636922|NCT00880919|quetiapine extended-release|quetiapine extended-release
636923|NCT00880906|eosinophilic esophagitis|eosinophilic esophagitis
636924|NCT00880906|esophageal food impaction|esophageal food impaction
636925|NCT00880906|dysphagia|dysphagia
636926|NCT00880893|Dengue virus|dengue virus
636927|NCT00880893|Dengue fever|dengue fever
636928|NCT00880893|Dengue Hemorrhagic fever|dengue hemorrhagic fever
636929|NCT00880893|Dengue diseases|dengue diseases
636930|NCT00880893|Sanofi Pasteur's CYD Dengue Vaccine|sanofi pasteur's cyd dengue vaccine
636931|NCT00880880|urinary incontinence|urinary incontinence
636932|NCT00880880|fecal incontinence|fecal incontinence
636933|NCT00880880|communication|communication
636934|NCT00880867|Low Grade Recurrent B and T Cell Lymphoma|low grade recurrent b and t cell lymphoma
636935|NCT00880854|bladder cancer|bladder cancer
636936|NCT00880854|BCG-resistant localized transitional cell of the bladder|bcg-resistant localized transitional cell of the bladder
636937|NCT00880841|healthy normals, phase 1|healthy normals, phase 1
636938|NCT00880841|phase 1a study for healthy normals|phase 1a study for healthy normals
636939|NCT00880828|Cervical Radiculopathy|cervical radiculopathy
636940|NCT00880828|Radicular Pain|radicular pain
636941|NCT00880828|Acute neck pain|acute neck pain
636942|NCT00880828|Cervicobrachial pain|cervicobrachial pain
636943|NCT00880828|Far-infrared ray|far-infrared ray
636944|NCT00880828|FIR|fir
636945|NCT00880828|Cervical collar|cervical collar
636946|NCT00880828|Cervical device|cervical device
636947|NCT00880828|FIR Device|fir device
636948|NCT00880802|Acute Coronary Syndromes|acute coronary syndromes
636949|NCT00880802|Non ST-Segment Elevation Myocardial Infarction|non st-segment elevation myocardial infarction
636950|NCT00880802|ST-Segment Elevation Myocardial Infarction|st-segment elevation myocardial infarction
636951|NCT00880802|Unstable Angina|unstable angina
636952|NCT00880789|Cord Blood Transplant|cord blood transplant
636953|NCT00880789|cytomegalovirus|cytomegalovirus
636954|NCT00880789|CMV|cmv
636955|NCT00880789|Adenovirus|adenovirus
636956|NCT00880789|ADV|adv
636957|NCT00880750|End stage Renal disease|end stage renal disease
636958|NCT00880724|COPD|copd
636959|NCT00880724|Emphysema|emphysema
636960|NCT00880724|Bronchoscopic Treatment|bronchoscopic treatment
636961|NCT00880724|Interventional Bronchoscopy|interventional bronchoscopy
636962|NCT00880711|Fiona|fiona
636963|NCT00880711|Faslodex|faslodex
636964|NCT00880711|Advanced Breast Cancer|advanced breast cancer
636965|NCT00880711|Real life data|real life data
636966|NCT00880711|Collect real life data in clinical practice across Austria|collect real life data in clinical practice across austria
636967|NCT00880698|Rotavirus|rotavirus
636968|NCT00880698|Rotavirus vaccine|rotavirus vaccine
636969|NCT00880685|Compulsive Stealing|compulsive stealing
636970|NCT00880685|Compulsive Shoplifting|compulsive shoplifting
636971|NCT00880672|prostate, dutasteride|prostate, dutasteride
636972|NCT00880672|vascular endothelial growth factor|vascular endothelial growth factor
636973|NCT00880672|hypoxia inducible factor|hypoxia inducible factor
636974|NCT00880659|Influenza|influenza
636975|NCT00880659|secondary transmission|secondary transmission
636976|NCT00880659|handwashing|handwashing
636977|NCT00880633|EUS|eus
636978|NCT00880633|periampullary neoplasms|periampullary neoplasms
636979|NCT00880620|Parkinson's disease|parkinson's disease
636980|NCT00880607|Pain|pain
636981|NCT00880607|Pediatric|pediatric
636982|NCT00880607|Spinal Fusion|spinal fusion
636983|NCT00880607|pain management|pain management
636984|NCT00880555|Magnetic Resonance Imaging|magnetic resonance imaging
636985|NCT00880555|Alzheimer disease|alzheimer disease
636986|NCT00880555|Mild cognitive impairment|mild cognitive impairment
636987|NCT00880555|Continuous arterial spin labeling|continuous arterial spin labeling
636988|NCT00880555|Semantic memory|semantic memory
636989|NCT00880542|localized osteosarcoma|localized osteosarcoma
636990|NCT00880542|stage II adult soft tissue sarcoma|stage ii adult soft tissue sarcoma
636991|NCT00880542|stage III adult soft tissue sarcoma|stage iii adult soft tissue sarcoma
636992|NCT00880529|rib fractures|rib fractures
636993|NCT00880529|ventilator|ventilator
636994|NCT00880529|ON-Q|on-q
636995|NCT00880529|analgesia|analgesia
636996|NCT00880503|Multidrug Resistance Molecular Target Analysis|multidrug resistance molecular target analysis
636997|NCT00880490|COPD|copd
636998|NCT00880464|autologous vaccination|autologous vaccination
636999|NCT00880464|GM-CSF|gm-csf
637000|NCT00880464|adenoviral mediated gene transfer|adenoviral mediated gene transfer
637001|NCT00880464|Stage IV breast cancer|stage iv breast cancer
637002|NCT00880451|Children and Adolescents|children and adolescents
637003|NCT00880451|Aging|aging
637004|NCT00880451|Brain Imaging|brain imaging
637005|NCT00880451|MRI (Magnetic Resonance Imaging)|mri (magnetic resonance imaging)
637006|NCT00880412|safety|safety
637007|NCT00880412|efficacy|efficacy
637008|NCT00880412|Alzheimer's disease|alzheimer's disease
637009|NCT00880412|treatment|treatment
637010|NCT00880412|phase II|phase ii
637011|NCT00880412|study|study
637012|NCT00880412|cholinesterase inhibitor|cholinesterase inhibitor
637013|NCT00880399|depression|depression
637014|NCT00880399|QIDS-SR|qids-sr
637015|NCT00880399|HAMD-17|hamd-17
637016|NCT00880399|orvepitant|orvepitant
637017|NCT00880399|MDD|mdd
637018|NCT00880399|neurokinin-1 antagonist|neurokinin-1 antagonist
637019|NCT00880399|double-blind|double-blind
637020|NCT00880399|Phase II|phase ii
637021|NCT00880399|randomized|randomized
637022|NCT00880399|efficacy|efficacy
637023|NCT00880399|placebo|placebo
637024|NCT00880399|safety|safety
637025|NCT00880386|dyspnea|dyspnea
637026|NCT00880386|stage I non-small cell lung cancer|stage i non-small cell lung cancer
637027|NCT00880386|stage II non-small cell lung cancer|stage ii non-small cell lung cancer
637028|NCT00880386|stage IIIA non-small cell lung cancer|stage iiia non-small cell lung cancer
637029|NCT00880386|stage IIIB non-small cell lung cancer|stage iiib non-small cell lung cancer
637030|NCT00880386|pulmonary complications|pulmonary complications
637031|NCT00880386|radiation fibrosis|radiation fibrosis
637032|NCT00880373|Sickle Cell Disease|sickle cell disease
637033|NCT00880373|Pain|pain
637034|NCT00880373|Ibuprofen|ibuprofen
637035|NCT00880373|Morphine|morphine
637036|NCT00880373|Diamorphine|diamorphine
637037|NCT00880373|Patient Controlled Analgesia|patient controlled analgesia
637038|NCT00880360|Epithelial Ovarian Cancer|epithelial ovarian cancer
637039|NCT00880360|FIGO (International Fed of Gyn and Ob)Stage III or Stage IV|figo (international fed of gyn and ob)stage iii or stage iv
637040|NCT00880360|Extraovarian Peritoneal Cancer|extraovarian peritoneal cancer
637041|NCT00880360|Fallopian Tube Carcinoma Failing|fallopian tube carcinoma failing
637042|NCT00880347|Alzheimer's disease|alzheimer's disease
637043|NCT00880347|Other dementia|other dementia
637044|NCT00880347|Vascular dementia|vascular dementia
637045|NCT00880347|Mixed dementia|mixed dementia
637046|NCT00880347|Parkinson's Disease dementia|parkinson's disease dementia
637047|NCT00880347|Lewy bodies dementia|lewy bodies dementia
637048|NCT00880347|Frontotemporal dementia|frontotemporal dementia
637049|NCT00880347|Blood signature|blood signature
637050|NCT00880347|Diagnosis|diagnosis
637051|NCT00880347|SpliceArray (tm)|splicearray (tm)
637052|NCT00880347|Alzheimer's Disease and other non-AD dementia|alzheimer's disease and other non-ad dementia
637054|NCT00880334|Zactima|zactima
637055|NCT00880334|docetaxel|docetaxel
637056|NCT00880334|ZD6474|zd6474
637057|NCT00880334|taxotere|taxotere
637058|NCT00880321|first time in human|first time in human
637059|NCT00880321|BRAF inhibitor|braf inhibitor
637060|NCT00880321|dose escalation|dose escalation
637061|NCT00880308|Advanced tumors|advanced tumors
637062|NCT00880308|hedgehog|hedgehog
637063|NCT00880308|smoothened inhibitor|smoothened inhibitor
637064|NCT00880269|Acute myeloid leukemia|acute myeloid leukemia
637065|NCT00880269|AML|aml
637066|NCT00880269|relapsed acute myeloid leukemia|relapsed acute myeloid leukemia
637067|NCT00880269|refractory AML|refractory aml
637068|NCT00880269|refractory de novo AML|refractory de novo aml
637069|NCT00880269|refractory secondary AML|refractory secondary aml
637070|NCT00880269|secondary AML|secondary aml
637071|NCT00880269|AML following myelodysplastic syndrome (MDS)|aml following myelodysplastic syndrome (mds)
637072|NCT00880269|AML following antecedent hematological disorder (AHD)|aml following antecedent hematological disorder (ahd)
637073|NCT00880269|AML resistant to therapy|aml resistant to therapy
637074|NCT00880256|irritable bowel|irritable bowel
637075|NCT00880256|mindfulness|mindfulness
637076|NCT00880256|stress|stress
637077|NCT00880256|meditation|meditation
637078|NCT00880243|Acute myeloid leukemia|acute myeloid leukemia
637079|NCT00880243|Priming|priming
637080|NCT00880243|GM-CSF|gm-csf
811816|NCT00200928|BCG|bcg
637081|NCT00880243|Timed-sequential chemotherapy|timed-sequential chemotherapy
637082|NCT00880243|Prognosis|prognosis
637083|NCT00880230|Iliac Artery Stenting|iliac artery stenting
637084|NCT00880230|Peripheral Artery Disease|peripheral artery disease
637085|NCT00880217|Attention Deficit Hyperactivity Disorder|attention deficit hyperactivity disorder
637086|NCT00880217|Attention Deficit Disorders with Hyperactivity|attention deficit disorders with hyperactivity
637087|NCT00880217|Adult ADHD|adult adhd
637088|NCT00880217|JNJ-31001074|jnj-31001074
637089|NCT00880204|Cluster Randomized Trial|cluster randomized trial
637090|NCT00880204|ESS-EMCH|ess-emch
637091|NCT00880204|Neonatal|neonatal
637092|NCT00880204|Maternal|maternal
637093|NCT00880204|Life threatening emergency event|life threatening emergency event
637094|NCT00880191|nausea and vomiting|nausea and vomiting
637095|NCT00880191|unspecified adult solid tumor, protocol specific|unspecified adult solid tumor, protocol specific
637096|NCT00880178|Simvastatin|simvastatin
637097|NCT00880178|Niacin|niacin
637098|NCT00880178|Vascular Disease|vascular disease
637099|NCT00880178|Magnetic Resonance Imaging|magnetic resonance imaging
637100|NCT00880178|High Density Lipoprotein|high density lipoprotein
637101|NCT00880178|Oxidation|oxidation
637102|NCT00880178|Proteomics|proteomics
637103|NCT00880178|Stroke|stroke
637104|NCT00880178|Cerebrovascular Accident|cerebrovascular accident
637105|NCT00880165|Polysomnogram|polysomnogram
637106|NCT00880165|Continuous positive airway pressure|continuous positive airway pressure
637107|NCT00880152|stress|stress
637108|NCT00880152|mindfulness|mindfulness
637109|NCT00880152|trauma|trauma
637216|NCT00879775|Caffeine|caffeine
637110|NCT00880139|Diabetes mellitus, type 1|diabetes mellitus, type 1
637111|NCT00880139|Inflammation|inflammation
637112|NCT00880139|Cytokines|cytokines
637113|NCT00880139|Vascular reactivity|vascular reactivity
637114|NCT00880126|Individualized Implementation|individualized implementation
637115|NCT00880126|Community Development Teams|community development teams
637116|NCT00880113|CT-perfusion|ct-perfusion
637117|NCT00880113|CT-angiography|ct-angiography
637118|NCT00880100|Steatorrhea|steatorrhea
637119|NCT00880100|Malabsorption of fat|malabsorption of fat
637120|NCT00880100|Pancreatic enzymes|pancreatic enzymes
637121|NCT00880100|Abdominal pain|abdominal pain
637122|NCT00880100|Greasy stools|greasy stools
637123|NCT00880087|Cardiac Arrest|cardiac arrest
637124|NCT00880087|Cardiopulmonary Arrest|cardiopulmonary arrest
637125|NCT00880087|Pediatric Cardiac Arrest|pediatric cardiac arrest
637126|NCT00880087|VABS|vabs
637127|NCT00880087|Vineland Adaptive Behavior Scale|vineland adaptive behavior scale
637128|NCT00880087|POPC/PCPC|popc/pcpc
637129|NCT00880087|hypoxic-ischemic encephalopathy|hypoxic-ischemic encephalopathy
637130|NCT00880074|Advanced Cancers|advanced cancers
637131|NCT00880074|FLT-PET|flt-pet
637132|NCT00880074|Positron Emission Tomography|positron emission tomography
637133|NCT00880074|PET|pet
637134|NCT00880074|[18F] fluorothymidine|[18f] fluorothymidine
637135|NCT00880074|[F-18]-fluoro-L-thymidine|[f-18]-fluoro-l-thymidine
637136|NCT00880074|FLT|flt
637137|NCT00880061|Diffuse Infiltrating Pontine Glioma|diffuse infiltrating pontine glioma
637138|NCT00880061|Supratentorial High Grade Glioma|supratentorial high grade glioma
637139|NCT00880061|Convection-Enhanced Delivery|convection-enhanced delivery
637140|NCT00880061|Pediatric Brain Tumor|pediatric brain tumor
637141|NCT00880061|Brain Tumor|brain tumor
637142|NCT00880061|Glioma|glioma
637143|NCT00880048|depression|depression
637144|NCT00880048|safety|safety
637145|NCT00880048|HAMD|hamd
637146|NCT00880048|QIDS-SR|qids-sr
637147|NCT00880048|NK-1 antagonist|nk-1 antagonist
637148|NCT00880048|efficacy|efficacy
637149|NCT00880048|orvepitant|orvepitant
637151|NCT00880048|MDD|mdd
637152|NCT00880048|video-rating|video-rating
637153|NCT00880035|sedative drug|sedative drug
637154|NCT00880035|stress|stress
637155|NCT00880035|music|music
637156|NCT00880035|mechanical ventilation|mechanical ventilation
637157|NCT00880035|IL-6|il-6
637158|NCT00880035|cortisol|cortisol
637159|NCT00880035|prolactin|prolactin
637160|NCT00880035|CRP|crp
637161|NCT00880035|copeptin|copeptin
637162|NCT00880022|compression|compression
637163|NCT00880022|Flexitouch|flexitouch
637164|NCT00880022|breast cancer|breast cancer
637165|NCT00880022|lymphedema|lymphedema
637166|NCT00879996|Opiate Addiction|opiate addiction
637167|NCT00879996|Narcotic Addiction|narcotic addiction
637168|NCT00879996|Drug Addiction|drug addiction
637169|NCT00879996|Pain|pain
637170|NCT00879983|azithromycin, pharmacokinetics|azithromycin, pharmacokinetics
637171|NCT00879970|Cardiovascular Outcomes|cardiovascular outcomes
637172|NCT00879957|Infant, Premature|infant, premature
637173|NCT00879957|Infant|infant
637174|NCT00879957|Central venous catheterization|central venous catheterization
637175|NCT00879957|Anticoagulants|anticoagulants
637176|NCT00879944|Psoriasis|psoriasis
637177|NCT00879944|Obesity|obesity
637178|NCT00879944|BMI|bmi
637179|NCT00879944|Atopic Dermatitis|atopic dermatitis
637180|NCT00879918|Cigarette Smoking in African Americans|cigarette smoking in african americans
637181|NCT00879905|Phase I|phase i
637182|NCT00879905|Adults|adults
637183|NCT00879905|HSP990|hsp990
637184|NCT00879905|Advanced Solid Tumors|advanced solid tumors
637185|NCT00879905|Hsp90 inhibitor|hsp90 inhibitor
637186|NCT00879905|Cancer|cancer
637187|NCT00879892|xenon|xenon
637188|NCT00879892|hypothermia|hypothermia
637189|NCT00879892|out-of-hospital cardiac arrest|out-of-hospital cardiac arrest
637190|NCT00879879|precancerous condition|precancerous condition
637191|NCT00879866|NSCLC|nsclc
637192|NCT00879866|immunocytokine|immunocytokine
637193|NCT00879866|radiation|radiation
637194|NCT00879866|interleukin-2|interleukin-2
637195|NCT00879866|immunotherapy|immunotherapy
637196|NCT00879866|maintenance therapy|maintenance therapy
637197|NCT00879853|PTSD|ptsd
637198|NCT00879853|Depression|depression
637199|NCT00879853|Anger|anger
637200|NCT00879853|Domestic Violence|domestic violence
637201|NCT00879853|Refugee|refugee
637202|NCT00879853|Asylum Seeker|asylum seeker
637203|NCT00879853|Community Therapist|community therapist
637204|NCT00879853|Paraprofessional Therapists|paraprofessional therapists
637205|NCT00879840|Screening|screening
637206|NCT00879840|Modalities|modalities
637207|NCT00879840|Gynecological Cancers|gynecological cancers
637208|NCT00879801|prevention of diabetes|prevention of diabetes
637209|NCT00879801|susceptibility genes|susceptibility genes
637210|NCT00879801|type 2 diabetes|type 2 diabetes
637211|NCT00879801|insulin resistance|insulin resistance
637212|NCT00879801|beta-cell funtion|beta-cell funtion
637213|NCT00879788|Ramipril fed condition|ramipril fed condition
637214|NCT00879775|Pain|pain
637215|NCT00879775|Cancer patients|cancer patients
637217|NCT00879775|Adjuvant analgesics|adjuvant analgesics
637218|NCT00879775|Sedation|sedation
637219|NCT00879775|Confusion|confusion
637220|NCT00879775|Quality of life|quality of life
637221|NCT00879775|Fatigue|fatigue
637222|NCT00879762|smallpox, vaccine, IMVAMUNE®|smallpox, vaccine, imvamune®
637223|NCT00879736|Doctor-patient communication|doctor-patient communication
637224|NCT00879736|Encounters|encounters
637225|NCT00879736|Patient education training|patient education training
637226|NCT00879723|post-burn recovery|post-burn recovery
637227|NCT00879723|oxidative stress|oxidative stress
637228|NCT00879723|micronutrient protocol|micronutrient protocol
637229|NCT00879710|Diabetes Mellitus|diabetes mellitus
637230|NCT00879710|Hypercholesterolemia|hypercholesterolemia
637231|NCT00879710|Simvastatin|simvastatin
637232|NCT00879710|Ezetimibe.|ezetimibe.
637233|NCT00879697|peripheral arterial disease|peripheral arterial disease
637234|NCT00879697|exercise|exercise
637235|NCT00879697|resistance training|resistance training
637236|NCT00879697|cardiac rehabilitation|cardiac rehabilitation
637237|NCT00879684|Phase 1|phase 1
637238|NCT00879684|Tumors|tumors
637239|NCT00879684|CVX-060|cvx-060
637240|NCT00879671|lutein|lutein
637241|NCT00879671|nonexudative AMD|nonexudative amd
637242|NCT00879671|MPOD|mpod
637243|NCT00879671|Supplementary Concepts|supplementary concepts
637244|NCT00879658|Multiple Sclerosis|multiple sclerosis
637245|NCT00879658|Relapsing-Remitting|relapsing-remitting
637246|NCT00879658|Demyelinating Autoimmune Diseases|demyelinating autoimmune diseases
637247|NCT00879645|Renal Impairment|renal impairment
637248|NCT00879645|Renal Disease|renal disease
637249|NCT00879645|Sodium Sulfide|sodium sulfide
637250|NCT00879606|Sepsis|sepsis
637251|NCT00879606|Acute Lung Injury|acute lung injury
637252|NCT00879606|Acute Respiratory Distress Syndrome|acute respiratory distress syndrome
637253|NCT00879606|ALI/ARDS|ali/ards
637254|NCT00879606|Lung Disease|lung disease
637255|NCT00879580|aneurysm|aneurysm
637256|NCT00879580|stent|stent
637257|NCT00879580|intracranial aneurysm|intracranial aneurysm
637258|NCT00879580|Ruptured Intracranial Aneurysm|ruptured intracranial aneurysm
637259|NCT00879554|Phase 1|phase 1
637260|NCT00879554|Solid Tumors|solid tumors
637261|NCT00879554|CVX-045|cvx-045
637262|NCT00879541|Hemophilia A|hemophilia a
637263|NCT00879528|Hodgkin's Lymphoma|hodgkin's lymphoma
637264|NCT00879528|stem cell reinfusion|stem cell reinfusion
637265|NCT00879515|Fragile X Premutation|fragile x premutation
637266|NCT00879515|Fragile X Syndrome|fragile x syndrome
637267|NCT00879515|Down Syndrome|down syndrome
637268|NCT00879502|Fragile X Premutation|fragile x premutation
637269|NCT00879502|FMR1|fmr1
637270|NCT00879502|Premutation|premutation
637271|NCT00879502|Fragile X|fragile x
637272|NCT00879502|Brain Function|brain function
637273|NCT00879489|Stage IV histologically proven breast cancer|stage iv histologically proven breast cancer
637274|NCT00879476|Bioequivalence ramipril fasting condition|bioequivalence ramipril fasting condition
637275|NCT00879463|Blood transfusion in cardiac operations under CPB|blood transfusion in cardiac operations under cpb
637276|NCT00879463|Infrared spectrophotoscopy|infrared spectrophotoscopy
637277|NCT00879450|Congenital muscular torticollis|congenital muscular torticollis
637278|NCT00879437|brain tumor|brain tumor
637279|NCT00879437|bevacizumab|bevacizumab
637280|NCT00879437|valproic acid|valproic acid
637281|NCT00879437|radiation therapy|radiation therapy
637282|NCT00879424|vitamin D|vitamin d
637283|NCT00879424|atopic dermatitis|atopic dermatitis
637284|NCT00879424|eczema|eczema
637285|NCT00879424|winter|winter
637286|NCT00879385|KRAS wild-type|kras wild-type
637287|NCT00879385|Colon|colon
637288|NCT00879385|Cancer|cancer
637289|NCT00879385|colorectal|colorectal
637290|NCT00879385|metastatic colorectal|metastatic colorectal
637291|NCT00879385|advanced colorectal|advanced colorectal
637292|NCT00879372|Bipolar Disorder|bipolar disorder
637293|NCT00879372|cognitive impairment|cognitive impairment
637294|NCT00879372|depression|depression
637295|NCT00879346|Healthy Volunteers|healthy volunteers
637296|NCT00879346|ADME|adme
637297|NCT00879346|Healthy male volunteers|healthy male volunteers
637298|NCT00879333|Gastric cancer,|gastric cancer,
637299|NCT00879333|advanced gastric cancer,|advanced gastric cancer,
637300|NCT00879333|stomach neoplasm,|stomach neoplasm,
637301|NCT00879333|stomach disease,|stomach disease,
637302|NCT00879333|adenocarcinoma of stomach,|adenocarcinoma of stomach,
637303|NCT00879333|GI neoplasm|gi neoplasm
637304|NCT00879320|ADHD|adhd
637305|NCT00879320|health|health
637306|NCT00879320|healthy lifestyle|healthy lifestyle
637307|NCT00879294|Perforated appendicitis|perforated appendicitis
637308|NCT00879294|Ruptured appendicitis|ruptured appendicitis
637309|NCT00879294|Acute appendicitis with perforation|acute appendicitis with perforation
637310|NCT00879281|COPD|copd
637311|NCT00879281|emphysema|emphysema
637312|NCT00879281|chronic bronchitis|chronic bronchitis
637313|NCT00879268|Liver Transplantation|liver transplantation
637314|NCT00879268|Organ Preservation|organ preservation
637315|NCT00879268|Liver Preservation|liver preservation
637316|NCT00879268|Machine Perfusion|machine perfusion
637317|NCT00879268|Vasosol|vasosol
637318|NCT00879268|Machine Preservation|machine preservation
637319|NCT00879255|cognitive processing therapy|cognitive processing therapy
637320|NCT00879255|combat|combat
637321|NCT00879255|veterans|veterans
637322|NCT00879255|PTSD|ptsd
637323|NCT00879255|Telemental Health|telemental health
637324|NCT00879255|Videoteleconference|videoteleconference
637325|NCT00879255|outcome|outcome
637326|NCT00879255|Rural|rural
637327|NCT00879255|Remote|remote
637328|NCT00879255|CPT|cpt
637329|NCT00879255|VTC|vtc
637330|NCT00879242|Thalassemia|thalassemia
637331|NCT00879242|cardiac MRI T2*|cardiac mri t2*
637332|NCT00879229|Idiopathic Pulmonary Fibrosis|idiopathic pulmonary fibrosis
637333|NCT00879229|Pulmonary Hypertension|pulmonary hypertension
637334|NCT00879229|PH|ph
637335|NCT00879229|IPF|ipf
637336|NCT00879229|Ambrisentan|ambrisentan
637337|NCT00879229|ERA|era
637338|NCT00879229|Endothelin Receptor Antagonist|endothelin receptor antagonist
637339|NCT00879229|Cardiovascular|cardiovascular
637340|NCT00879216|Nocturia|nocturia
637341|NCT00879216|Hyptotension|hyptotension
637342|NCT00879216|Elderly|elderly
637343|NCT00879216|Males|males
637344|NCT00879203|Type 1 Diabetes Mellitis|type 1 diabetes mellitis
637345|NCT00879203|Youth|youth
637346|NCT00879203|Hypoglycemia|hypoglycemia
637347|NCT00879203|Hyperglycemia|hyperglycemia
637348|NCT00879203|Cognition|cognition
637349|NCT00879203|Memory|memory
637350|NCT00879203|Brain Growth & Development|brain growth & development
637351|NCT00879203|Magnetic Resonance Imaging|magnetic resonance imaging
637352|NCT00879177|smoking|smoking
637353|NCT00879177|varenicline|varenicline
637354|NCT00879177|behavioral therapy|behavioral therapy
637355|NCT00879177|ABPM|abpm
637356|NCT00879177|hypertension|hypertension
637357|NCT00879164|hot flashes|hot flashes
637358|NCT00879125|Gastric by-pass on patients with T2DM|gastric by-pass on patients with t2dm
637359|NCT00879112|Hyperlipidemia|hyperlipidemia
637360|NCT00879099|Interaction|interaction
637361|NCT00879099|healthy volunteers|healthy volunteers
637362|NCT00879099|Interaction study for healthy volunteers|interaction study for healthy volunteers
637363|NCT00879086|Breast Cancer|breast cancer
637364|NCT00879086|Oncology|oncology
637365|NCT00879073|Brain and Nervous System|brain and nervous system
637366|NCT00879060|Fibrosis|fibrosis
637367|NCT00879060|Hypertrophic cardiomyopathy|hypertrophic cardiomyopathy
637368|NCT00879060|MRI|mri
637369|NCT00879060|To evaluate the efficacy of spironolactone in decreasing myocardial fibrosis in Hypertrophic cardiomyopathy|to evaluate the efficacy of spironolactone in decreasing myocardial fibrosis in hypertrophic cardiomyopathy
637370|NCT00879047|HIV|hiv
637371|NCT00879047|Hepatitis C|hepatitis c
637372|NCT00879034|Hutchinson-Gilford Progeria Syndrome|hutchinson-gilford progeria syndrome
637373|NCT00879034|HGPS|hgps
637374|NCT00879034|Progeria|progeria
637375|NCT00879034|FTI|fti
637376|NCT00879034|Farnesyltransferase Inhibitor|farnesyltransferase inhibitor
637377|NCT00879034|Lonafarnib|lonafarnib
637378|NCT00879034|Zoledronic Acid|zoledronic acid
637379|NCT00879034|Pravastatin|pravastatin
637380|NCT00879021|The outcome is to prevent Central Neuropathic Pain|the outcome is to prevent central neuropathic pain
637381|NCT00879021|participants will have suffered spinal cord trauma|participants will have suffered spinal cord trauma
637382|NCT00879008|Disease Exacerbation|disease exacerbation
637383|NCT00879008|Acute Exacerbations of Chronic Bronchitis|acute exacerbations of chronic bronchitis
637384|NCT00879008|AECB|aecb
637385|NCT00879008|Avelox|avelox
637386|NCT00879008|Bronchitis|bronchitis
637387|NCT00878995|stage IIB cervical cancer|stage iib cervical cancer
637388|NCT00878995|stage III cervical cancer|stage iii cervical cancer
637389|NCT00878995|recurrent cervical cancer|recurrent cervical cancer
637390|NCT00878995|cachexia|cachexia
637391|NCT00878995|advanced head/neck carcinoma|advanced head/neck carcinoma
637392|NCT00878995|recurrent head/neck carcinoma|recurrent head/neck carcinoma
637393|NCT00878969|Hemodialysis|hemodialysis
637394|NCT00878969|fibrinolysis|fibrinolysis
637395|NCT00878969|oxidative stress|oxidative stress
637396|NCT00878969|systemic inflammatory reaction|systemic inflammatory reaction
637397|NCT00878969|endothelial dysfunction|endothelial dysfunction
637398|NCT00878969|carotid intima media thickness (IMT|carotid intima media thickness (imt
637399|NCT00878969|angiotensin receptor blockade|angiotensin receptor blockade
637400|NCT00878969|angiotensin converting enzyme inhibition|angiotensin converting enzyme inhibition
637401|NCT00878956|Cardiac surgery|cardiac surgery
637402|NCT00878956|Cardiopulmonary bypass|cardiopulmonary bypass
637403|NCT00878956|Oxidative stress|oxidative stress
637404|NCT00878956|Acute renal dysfunction|acute renal dysfunction
637405|NCT00878956|Sodium bicarbonate|sodium bicarbonate
637406|NCT00878943|Open label access|open label access
637407|NCT00878943|sildenafil|sildenafil
637408|NCT00878943|pulmonary arterial hypertension|pulmonary arterial hypertension
637409|NCT00878930|Breast cancer|breast cancer
637410|NCT00878930|Fulvestrant|fulvestrant
637411|NCT00878930|Faslodex|faslodex
637412|NCT00878930|Acceptability|acceptability
637413|NCT00878930|Compliance|compliance
637414|NCT00878930|Efficacy|efficacy
637415|NCT00878917|Equivalence Study|equivalence study
637416|NCT00878917|Eye Drops Solution|eye drops solution
637417|NCT00878917|Dorzolamide|dorzolamide
637418|NCT00878917|Open Angle Glaucoma|open angle glaucoma
637419|NCT00878917|Ocular Hypertension|ocular hypertension
637420|NCT00878904|unspecified adult solid tumor, protocol specific|unspecified adult solid tumor, protocol specific
637421|NCT00878891|Microdialysis|microdialysis
637422|NCT00878891|realtime|realtime
637423|NCT00878891|glucose sensor|glucose sensor
637424|NCT00878891|coronary artery bypass|coronary artery bypass
637425|NCT00878878|Pulmonary artery systolic pressure (PASP)|pulmonary artery systolic pressure (pasp)
637426|NCT00878878|Pulmonary Vascular Resistance (PVR)|pulmonary vascular resistance (pvr)
637427|NCT00878878|Right Heart Catheterization|right heart catheterization
637428|NCT00878878|Pulmonary hemodynamics|pulmonary hemodynamics
637429|NCT00878865|Alprazolam|alprazolam
637430|NCT00878865|bioequivalence|bioequivalence
637431|NCT00878839|Cataract|cataract
637432|NCT00878839|Toric IOL|toric iol
637433|NCT00878839|Corneal Aberration|corneal aberration
637434|NCT00878839|Astigmatism|astigmatism
637435|NCT00878839|AcrySof|acrysof
637436|NCT00878813|Copeptin|copeptin
637437|NCT00878813|Vasopressin|vasopressin
637438|NCT00878813|Stroke|stroke
637439|NCT00878813|Transient ischemic attack|transient ischemic attack
637440|NCT00878813|Thrombolytic therapy|thrombolytic therapy
637441|NCT00878813|Prognosis|prognosis
637442|NCT00878813|Complications|complications
637443|NCT00878800|Phase I/II trial|phase i/ii trial
637444|NCT00878800|Solid tumors|solid tumors
637445|NCT00878800|Soft tissue sarcoma|soft tissue sarcoma
637446|NCT00878800|PXD101|pxd101
637447|NCT00878800|Doxorubicin|doxorubicin
637448|NCT00878774|Ragweed allergy|ragweed allergy
637449|NCT00878774|Immunotherapy|immunotherapy
637450|NCT00878774|Rhinoconjunctivitis|rhinoconjunctivitis
637451|NCT00878774|Toleromune Ragweed|toleromune ragweed
637452|NCT00878761|Renal transplant|renal transplant
637453|NCT00878761|Interstitial fibrosis and tubular atrophy|interstitial fibrosis and tubular atrophy
637454|NCT00878761|Chronic allograft dysfunction|chronic allograft dysfunction
637455|NCT00878761|Chronic allograft nephropathy|chronic allograft nephropathy
637456|NCT00878761|kidney transplant|kidney transplant
637457|NCT00878735|Meditation|meditation
637458|NCT00878735|Mindfulness|mindfulness
637459|NCT00878735|fMRI|fmri
637460|NCT00878735|cancer|cancer
637461|NCT00878735|stress|stress
637462|NCT00878735|anxiety|anxiety
637463|NCT00878735|depression|depression
637464|NCT00878735|attention|attention
637465|NCT00878735|Neuroscience|neuroscience
637466|NCT00878735|Neuroimaging|neuroimaging
637467|NCT00878735|Psychobiology|psychobiology
637468|NCT00878735|Healthy volunteers (regular meditators and non-meditators)|healthy volunteers (regular meditators and non-meditators)
637469|NCT00878722|Acute Myeloid Leukemia|acute myeloid leukemia
637470|NCT00878722|PXD101|pxd101
637471|NCT00878722|Belinostat|belinostat
637472|NCT00878722|Idarubicin|idarubicin
637473|NCT00878709|HER-2/erbB-2 positive breast cancer|her-2/erbb-2 positive breast cancer
637474|NCT00878709|breast cancer|breast cancer
637475|NCT00878709|adjuvant therapy|adjuvant therapy
637476|NCT00878709|neratinib|neratinib
637477|NCT00878709|HKI-272|hki-272
637478|NCT00878709|Nerlynx|nerlynx
637479|NCT00878709|PB-272|pb-272
637480|NCT00878657|adenocarcinoma of the pancreas|adenocarcinoma of the pancreas
637481|NCT00878657|stage III pancreatic cancer|stage iii pancreatic cancer
637482|NCT00878644|Cardiac Arrest|cardiac arrest
637483|NCT00878644|Cardiopulmonary Arrest|cardiopulmonary arrest
637484|NCT00878644|Pediatric Cardiac Arrest|pediatric cardiac arrest
637485|NCT00878644|VABS|vabs
637486|NCT00878644|Vineland Adaptive Behavior Survey|vineland adaptive behavior survey
637487|NCT00878644|POPC/PCPC|popc/pcpc
637488|NCT00878644|hypoxic-ichemic encephalopathy|hypoxic-ichemic encephalopathy
637489|NCT00878631|emergency medical services|emergency medical services
637490|NCT00878631|traumatic brain injury|traumatic brain injury
637491|NCT00878631|hypertonic saline with dextran|hypertonic saline with dextran
637492|NCT00878631|fluid resuscitation|fluid resuscitation
637493|NCT00878618|Healthy volunteers|healthy volunteers
637494|NCT00878605|Diabetes|diabetes
637495|NCT00878605|Cyclo-Z|cyclo-z
637496|NCT00878592|Post liver transplant|post liver transplant
637497|NCT00878592|weight reduction classes|weight reduction classes
637498|NCT00878592|obesity|obesity
637499|NCT00878592|weight management|weight management
637500|NCT00878592|dietary and lifestyle modification|dietary and lifestyle modification
637501|NCT00878579|back pain|back pain
637502|NCT00878579|Spine|spine
637503|NCT00878579|Spinal|spinal
637504|NCT00878579|Lower back pain|lower back pain
637505|NCT00878579|Lumbar|lumbar
637506|NCT00878579|Lumbar Pain|lumbar pain
637508|NCT00878579|Degenerative Disc Disease|degenerative disc disease
637509|NCT00878566|hypertension|hypertension
637510|NCT00878566|pharmacists|pharmacists
637511|NCT00878566|rural health|rural health
637512|NCT00878566|prescribing|prescribing
637513|NCT00878553|insomnia|insomnia
637514|NCT00878553|middle of the night|middle of the night
637515|NCT00878553|sleep maintenance|sleep maintenance
637516|NCT00878540|mirtazapine|mirtazapine
637517|NCT00878540|metabolism|metabolism
637518|NCT00878540|depression|depression
637519|NCT00878540|Healthy males|healthy males
637520|NCT00878527|Heart Failure|heart failure
637521|NCT00878527|Partial Circulatory Assist|partial circulatory assist
637522|NCT00878527|NYHA Class IIIb|nyha class iiib
637523|NCT00878527|NYHA Class IV|nyha class iv
637524|NCT00878527|Ventricular Assist Device|ventricular assist device
637525|NCT00878527|VAD|vad
637526|NCT00878514|Alprazolam|alprazolam
637527|NCT00878514|Bioequivalence|bioequivalence
637528|NCT00878501|Phase II|phase ii
637529|NCT00878501|Pain|pain
637530|NCT00878475|Quantitative Capnometry|quantitative capnometry
637531|NCT00878475|N-Terminal Pro-Brain Natriuretic Peptide|n-terminal pro-brain natriuretic peptide
637532|NCT00878475|Acute Heart Failure|acute heart failure
637533|NCT00878475|Diagnostic Accuracy|diagnostic accuracy
637534|NCT00878436|histone deacetylase inhibitor|histone deacetylase inhibitor
637535|NCT00878436|hormone therapy|hormone therapy
637536|NCT00878436|androgen-independent|androgen-independent
637537|NCT00878436|PSA|psa
637538|NCT00878436|androgen receptor|androgen receptor
637539|NCT00878423|HSP90|hsp90
637540|NCT00878423|Metastatic solid tumor including lymphoma which are|metastatic solid tumor including lymphoma which are
637541|NCT00878423|refractory to standard therapy|refractory to standard therapy
637542|NCT00878397|malaria|malaria
637543|NCT00878397|long lasting insecticide nets|long lasting insecticide nets
637544|NCT00878397|anaemia|anaemia
637545|NCT00878397|schools|schools
637546|NCT00878384|Atrial Fibrillation|atrial fibrillation
637547|NCT00878384|Heart Failure|heart failure
637548|NCT00878384|Heart Rate Control|heart rate control
637549|NCT00878384|Catheter Ablation|catheter ablation
637550|NCT00878371|morphine|morphine
637551|NCT00878371|blood brain barrier|blood brain barrier
637552|NCT00878371|surgery induced peripheral inflammatory response|surgery induced peripheral inflammatory response
637553|NCT00878358|Osteoarthritis|osteoarthritis
637554|NCT00878358|Total knee replacement|total knee replacement
637555|NCT00878345|Pediatric sedation|pediatric sedation
637556|NCT00878345|Pentobarbital|pentobarbital
637557|NCT00878345|Dexmedetomidine|dexmedetomidine
637558|NCT00878345|Procedural sedation in children|procedural sedation in children
637559|NCT00878332|edentulous|edentulous
637560|NCT00878332|fixed dental rehabilitation|fixed dental rehabilitation
637561|NCT00878332|insufficient bone height|insufficient bone height
637562|NCT00878332|Partially edentulous patients|partially edentulous patients
637563|NCT00878332|Patients interested in fixed non removable dental rehabilitation by dental implants.|patients interested in fixed non removable dental rehabilitation by dental implants.
637564|NCT00878332|The recipient bone with insufficient bone height for dental implant insertion.|the recipient bone with insufficient bone height for dental implant insertion.
637565|NCT00878332|Adult patients|adult patients
637566|NCT00878319|Humeral|humeral
637567|NCT00878319|diaphyseal (mid-shaft)|diaphyseal (mid-shaft)
637568|NCT00878319|fracture|fracture
637569|NCT00878319|operative|operative
637570|NCT00878319|non-operative|non-operative
637571|NCT00878306|Treatment of drug dependency with HIV medications|treatment of drug dependency with hiv medications
637572|NCT00878306|HIV|hiv
637573|NCT00878293|analgesic|analgesic
637574|NCT00878293|diabetes mellitus|diabetes mellitus
637575|NCT00878293|chronic neuropathic pain|chronic neuropathic pain
637576|NCT00878293|painful polyneuropathy caused by diabetes mellitus type I or II|painful polyneuropathy caused by diabetes mellitus type i or ii
637577|NCT00878267|Cancer|cancer
637578|NCT00878267|Computer Program|computer program
637579|NCT00878267|Palliative Care|palliative care
637580|NCT00878267|Patient-Reported Outcomes|patient-reported outcomes
637581|NCT00878267|PRO|pro
637582|NCT00878267|Palliative and Hospice Care Practice|palliative and hospice care practice
637583|NCT00878267|Electronic Health Record|electronic health record
637584|NCT00878267|EHR|ehr
637585|NCT00878267|Interview|interview
637586|NCT00878254|Mantle Cell Lymphoma|mantle cell lymphoma
637587|NCT00878254|Non-Hodgkin's Lymphoma|non-hodgkin's lymphoma
637588|NCT00878254|MCL|mcl
637589|NCT00878254|NHL|nhl
637590|NCT00878241|Colon Anastomosis|colon anastomosis
637591|NCT00878241|Rectum Anastomosis|rectum anastomosis
637592|NCT00878241|Intestine|intestine
637593|NCT00878241|Colorectal Surgery|colorectal surgery
637594|NCT00878241|Colorectal Anastomosis|colorectal anastomosis
637595|NCT00878215|Image Guided Liver Surgery|image guided liver surgery
637596|NCT00878189|Phase 1 dose escalation study in advanced solid tumor malignancy and leukemia|phase 1 dose escalation study in advanced solid tumor malignancy and leukemia
637597|NCT00878176|sacral neuromodulation therapy|sacral neuromodulation therapy
637598|NCT00878176|urinary retention|urinary retention
637599|NCT00878176|screening|screening
637600|NCT00878176|non obstructive urinary retention|non obstructive urinary retention
637601|NCT00878150|traumatic brain injury|traumatic brain injury
637602|NCT00878150|TBI|tbi
637603|NCT00878150|head injury|head injury
637604|NCT00878150|brain injury|brain injury
637605|NCT00878150|depression|depression
637606|NCT00878150|major depressive disorder|major depressive disorder
638402|NCT00875004|anemia|anemia
637607|NCT00878150|cognitive behavioral therapy|cognitive behavioral therapy
637609|NCT00878150|counseling|counseling
637610|NCT00878124|Poor ovarian response|poor ovarian response
637611|NCT00878124|Chromosomal aberrations|chromosomal aberrations
637612|NCT00878124|poor pregnancy outcome|poor pregnancy outcome
637613|NCT00878124|Late maternal age|late maternal age
637614|NCT00878111|NGR-hTNF|ngr-htnf
637615|NCT00878111|Solid tumours|solid tumours
637616|NCT00878111|High doses|high doses
637617|NCT00878098|DDT|ddt
637618|NCT00878098|Malaria|malaria
637619|NCT00878098|Pregnancy Outcome|pregnancy outcome
637620|NCT00878098|Spontaneous Abortion|spontaneous abortion
637621|NCT00878098|HIV|hiv
637622|NCT00878098|Pregnancy|pregnancy
637623|NCT00878085|Robot Therapy|robot therapy
637624|NCT00878085|Upper Limb|upper limb
637625|NCT00878085|Stroke|stroke
637626|NCT00878085|Rehabilitation|rehabilitation
637627|NCT00878085|fMRI|fmri
637628|NCT00878085|DTI|dti
637629|NCT00878072|Herpes labialis|herpes labialis
637630|NCT00878072|cold sores|cold sores
637631|NCT00878072|herpes simplex type 1|herpes simplex type 1
637632|NCT00878046|Hip|hip
637633|NCT00878046|Cementless|cementless
637634|NCT00878046|Conservative|conservative
637635|NCT00878007|Anaemia|anaemia
637636|NCT00878007|Malaria|malaria
637637|NCT00878007|Literacy|literacy
637638|NCT00878007|Kenya|kenya
637639|NCT00877994|Disordered Eating|disordered eating
637640|NCT00877994|Parenting|parenting
637641|NCT00877994|Mothers|mothers
637642|NCT00877981|hyperparathyroidism|hyperparathyroidism
637643|NCT00877981|surgery|surgery
637644|NCT00877981|minimal invasive|minimal invasive
637645|NCT00877981|videoassited|videoassited
637646|NCT00877968|Pea flour|pea flour
637647|NCT00877968|Glycemic response|glycemic response
637648|NCT00877968|Diabetes|diabetes
637649|NCT00877968|Sensory|sensory
637650|NCT00877968|Functional food|functional food
637651|NCT00877968|Diabetes control and prevention|diabetes control and prevention
637652|NCT00877955|bioequivalence|bioequivalence
637653|NCT00877955|pharmacokinetic|pharmacokinetic
637654|NCT00877955|alprazolam|alprazolam
637655|NCT00877955|sublingual|sublingual
637656|NCT00877903|Acute myocardial infarction|acute myocardial infarction
637657|NCT00877903|AMI|ami
637658|NCT00877903|Myocardial infarction|myocardial infarction
637659|NCT00877903|Heart attack|heart attack
637660|NCT00877903|Mesenchymal stem cells|mesenchymal stem cells
637661|NCT00877903|MSC|msc
637662|NCT00877903|Adult human stem cells|adult human stem cells
637663|NCT00877903|Osiris|osiris
637664|NCT00877890|diabetes|diabetes
637665|NCT00877890|exenatide once weekly|exenatide once weekly
637666|NCT00877890|Byetta|byetta
637667|NCT00877890|Amylin|amylin
637668|NCT00877890|Lilly|lilly
637669|NCT00877890|Bydureon|bydureon
637670|NCT00877877|HPV vaccine|hpv vaccine
637671|NCT00877877|cervical cancer|cervical cancer
637672|NCT00877864|diabetes|diabetes
637673|NCT00877864|exercise|exercise
812558|NCT00197561|Women|women
637674|NCT00877864|printed materials|printed materials
637675|NCT00877851|Diet|diet
637676|NCT00877851|Physical activity|physical activity
637677|NCT00877851|Self management|self management
637678|NCT00877851|Goal setting|goal setting
637679|NCT00877838|Headache|headache
637680|NCT00877838|Migraine|migraine
637681|NCT00877838|Aura|aura
637682|NCT00877838|Acute|acute
637683|NCT00877838|Attack|attack
637684|NCT00877838|Clinical|clinical
637685|NCT00877838|Trial|trial
637686|NCT00877838|Intervention|intervention
637687|NCT00877838|Nitrogen Oxide|nitrogen oxide
637688|NCT00877838|NOS|nos
637689|NCT00877838|nNOS|nnos
637690|NCT00877838|Triptan|triptan
637691|NCT00877838|5HT|5ht
637692|NCT00877838|Serotonin|serotonin
637693|NCT00877825|Diet Therapy|diet therapy
637694|NCT00877812|Vitamin B6|vitamin b6
637695|NCT00877812|Vitamin B6 deficiency|vitamin b6 deficiency
637696|NCT00877812|Amino acids|amino acids
637697|NCT00877812|pyridoxine|pyridoxine
637698|NCT00877799|pain|pain
637699|NCT00877799|acute pain|acute pain
637700|NCT00877799|visceral pain|visceral pain
637701|NCT00877799|kappa agonist|kappa agonist
637702|NCT00877799|opioid analgesics|opioid analgesics
637703|NCT00877799|peripheral nervous system agents|peripheral nervous system agents
637704|NCT00877799|physiological effects of drugs|physiological effects of drugs
637705|NCT00877799|surgery|surgery
637706|NCT00877799|hysterectomy|hysterectomy
637707|NCT00877799|post-operative|post-operative
637708|NCT00877799|post-operative complications|post-operative complications
637709|NCT00877773|Advanced cancer|advanced cancer
637710|NCT00877773|Advanced Cancer with genetic mutation|advanced cancer with genetic mutation
637711|NCT00877773|Phosphoinositides 3-kinase|phosphoinositides 3-kinase
637712|NCT00877773|PI3K|pi3k
637713|NCT00877773|PIK3 mutations|pik3 mutations
637714|NCT00877773|Temsirolimus|temsirolimus
637715|NCT00877773|CCI-779|cci-779
637716|NCT00877773|Torisel|torisel
637717|NCT00877773|mTOR inhibitor|mtor inhibitor
637718|NCT00877760|Hepatitis B Entecavir pegylated interferon a-2a|hepatitis b entecavir pegylated interferon a-2a
637720|NCT00877734|alcohol dependence|alcohol dependence
637721|NCT00877734|baclofen|baclofen
637722|NCT00877734|pharmacotherapy|pharmacotherapy
637723|NCT00877734|women|women
637724|NCT00877721|Postural Control|postural control
637725|NCT00877721|Gait|gait
637726|NCT00877721|Falls|falls
637727|NCT00877721|Elderly|elderly
637728|NCT00877721|Old adults (65 years old and older) with low risk of falls|old adults (65 years old and older) with low risk of falls
637729|NCT00877708|E. Coli|e. coli
637730|NCT00877708|isolates|isolates
637731|NCT00877695|HIV|hiv
637732|NCT00877695|HIV Seronegativity|hiv seronegativity
637733|NCT00877695|prevention|prevention
637734|NCT00877695|Hispanic|hispanic
637735|NCT00877695|Latino|latino
637736|NCT00877695|MSM|msm
637737|NCT00877695|men|men
637738|NCT00877682|Prostate Cancer|prostate cancer
637739|NCT00877682|Prostate Tumor|prostate tumor
637740|NCT00877682|Adenocarcinoma of the Prostate|adenocarcinoma of the prostate
637741|NCT00877682|PCA|pca
637742|NCT00877682|Regional Prostate Cryoablation|regional prostate cryoablation
637743|NCT00877682|Cryotherapy|cryotherapy
637744|NCT00877682|Cryoablation|cryoablation
637745|NCT00877682|Health Related Quality of Life|health related quality of life
637746|NCT00877682|HRQOL|hrqol
637747|NCT00877617|Quality of Life|quality of life
637748|NCT00877617|QOL|qol
637749|NCT00877617|Questionnaire|questionnaire
637750|NCT00877617|High Risk localized Prostate Cancer|high risk localized prostate cancer
637751|NCT00877617|HRLPC|hrlpc
637752|NCT00877617|Neoadjuvant Investigational Therapy|neoadjuvant investigational therapy
637753|NCT00877617|Radical Prostatectomy|radical prostatectomy
637754|NCT00877604|ALS|als
637755|NCT00877604|Therapy|therapy
637756|NCT00877604|Tauroursodeoxycholic acid|tauroursodeoxycholic acid
637757|NCT00877604|TUDCA|tudca
637758|NCT00877604|antioxidant|antioxidant
637759|NCT00877604|antiapoptotic drug|antiapoptotic drug
637760|NCT00877604|neuroprotective drug|neuroprotective drug
637761|NCT00877591|Interaction of Buprenorphine with HIV and TB Medications|interaction of buprenorphine with hiv and tb medications
637762|NCT00877578|elderly patient|elderly patient
637763|NCT00877578|malnutrition|malnutrition
637764|NCT00877578|new nutritional support|new nutritional support
637765|NCT00877578|micronutrients|micronutrients
637766|NCT00877578|elderly patient malnutrition|elderly patient malnutrition
637767|NCT00877565|LVF|lvf
637768|NCT00877565|Left ventricular systolic function|left ventricular systolic function
637769|NCT00877552|Schizophrenia|schizophrenia
637770|NCT00877552|brain development|brain development
637771|NCT00877552|MRI|mri
637772|NCT00877539|Asthma Allergen Challenge|asthma allergen challenge
637773|NCT00877513|Smoking|smoking
637774|NCT00877513|Insulin resistance|insulin resistance
637775|NCT00877513|Metabolic syndrome|metabolic syndrome
637776|NCT00877513|Body fat distribution|body fat distribution
637777|NCT00877513|Cigarette smoking|cigarette smoking
637778|NCT00877487|ADHD|adhd
637779|NCT00877474|PM01183|pm01183
637780|NCT00877474|Solid tumors|solid tumors
637781|NCT00877474|PharmaMar USA|pharmamar usa
637782|NCT00877448|INFLUENZA|influenza
637783|NCT00877448|VACCINE|vaccine
637784|NCT00877448|UNIVERSAL|universal
637785|NCT00877448|SAFETY|safety
637786|NCT00877422|vitamin deficiency|vitamin deficiency
637787|NCT00877409|Acnase|acnase
637788|NCT00877409|Acne Vulgaris|acne vulgaris
637789|NCT00877409|Safety|safety
637790|NCT00877409|Efficacy|efficacy
637791|NCT00877383|chronic obstructive pulmonary disease|chronic obstructive pulmonary disease
637792|NCT00877383|COPD|copd
637793|NCT00877383|indacaterol|indacaterol
637794|NCT00877383|tiotropium|tiotropium
637795|NCT00877383|bronchodilation|bronchodilation
637796|NCT00877370|ertapenem|ertapenem
637797|NCT00877370|continuous hemodialysis|continuous hemodialysis
637798|NCT00877370|pharmacokinetics|pharmacokinetics
637799|NCT00877357|Vaccine|vaccine
637800|NCT00877357|Prevention|prevention
637801|NCT00877357|Diphtheria|diphtheria
637802|NCT00877357|Tetanus|tetanus
637803|NCT00877357|Pertussis|pertussis
637804|NCT00877357|Hepatitis B|hepatitis b
637805|NCT00877357|Haemophilus influenzae type b|haemophilus influenzae type b
637806|NCT00877357|Lot Consistency|lot consistency
637807|NCT00877357|Long Term Immunogenicity|long term immunogenicity
637808|NCT00877357|Reactogenicity|reactogenicity
637809|NCT00877357|Healthy infants|healthy infants
637810|NCT00877344|Pregnancy|pregnancy
637811|NCT00877344|IUC|iuc
637812|NCT00877344|abortion|abortion
637813|NCT00877344|contraception|contraception
637814|NCT00877331|Drug Abuse|drug abuse
637815|NCT00877331|Drug Addiction|drug addiction
637816|NCT00877331|Drug Dependence|drug dependence
637817|NCT00877331|Drug Usage|drug usage
637818|NCT00877331|Drug Use Disorders|drug use disorders
637819|NCT00877331|Substance Abuse|substance abuse
637820|NCT00877331|Substance Addiction|substance addiction
637821|NCT00877331|Substance Dependence|substance dependence
637822|NCT00877331|Substance Use Disorders|substance use disorders
637823|NCT00877305|Ischemic Preconditioning|ischemic preconditioning
637824|NCT00877305|Cognitive function|cognitive function
637825|NCT00877292|Down Syndrome|down syndrome
637826|NCT00877292|trisomy 21|trisomy 21
637827|NCT00877292|prenatal testing|prenatal testing
637828|NCT00877292|pregnant women|pregnant women
637829|NCT00877279|Facial wrinkles|facial wrinkles
637830|NCT00877279|Nasolabial folds|nasolabial folds
637831|NCT00877266|catheter|catheter
637832|NCT00877266|ultrasound guidance|ultrasound guidance
637833|NCT00877266|nerve stimulation|nerve stimulation
637834|NCT00877266|electrical stimulation|electrical stimulation
637835|NCT00877266|nerve block|nerve block
637836|NCT00877266|UCSD|ucsd
637837|NCT00877266|timed placement|timed placement
637838|NCT00877266|surgery|surgery
637839|NCT00877266|Catheter Placement Time|catheter placement time
637841|NCT00877227|stroke|stroke
637842|NCT00877227|newborns|newborns
637843|NCT00877227|homocysteine|homocysteine
637844|NCT00877227|folinic acid|folinic acid
637845|NCT00877214|Bendamustine|bendamustine
637846|NCT00877214|Rituximab|rituximab
637847|NCT00877214|Significance of maintenance therapy|significance of maintenance therapy
637848|NCT00877214|Efficacy and safety|efficacy and safety
637849|NCT00877201|Accommodation|accommodation
637850|NCT00877201|visual display terminal (VDT)|visual display terminal (vdt)
637851|NCT00877201|antioxidant|antioxidant
637852|NCT00877188|breast cancer|breast cancer
637853|NCT00877188|exercise|exercise
637854|NCT00877188|upper extremity function|upper extremity function
637855|NCT00877188|quality of life|quality of life
637856|NCT00877175|preterm infants|preterm infants
637857|NCT00877175|mydriasis|mydriasis
637858|NCT00877175|pupil dilation|pupil dilation
637859|NCT00877162|Cognitive and behavioural intervention|cognitive and behavioural intervention
637860|NCT00877162|trial|trial
637861|NCT00877162|group|group
637862|NCT00877162|Behavioral sleep problems|behavioral sleep problems
637863|NCT00877149|Chronic HBV|chronic hbv
637864|NCT00877136|Liver tumors|liver tumors
637865|NCT00877136|Liver cancer|liver cancer
637866|NCT00877136|Adult primary hepatocellular carcinoma|adult primary hepatocellular carcinoma
637867|NCT00877136|HCC|hcc
637868|NCT00877136|Hepatoma|hepatoma
637869|NCT00877136|Neoplasms|neoplasms
637870|NCT00877123|fasting glucose|fasting glucose
637871|NCT00877123|obesity|obesity
637872|NCT00877123|arab women|arab women
637873|NCT00877123|interleukin|interleukin
637874|NCT00877123|diabetes|diabetes
637875|NCT00877123|impaired fasting glucose (IFG)|impaired fasting glucose (ifg)
637876|NCT00877110|BETA-D-GLUCAN|beta-d-glucan
637877|NCT00877110|CYCLOPHOSPHAMIDE (CYTOXAN)|cyclophosphamide (cytoxan)
637878|NCT00877110|MAB 131 I - 3F8|mab 131 i - 3f8
637879|NCT00877110|TOPOTECAN|topotecan
637880|NCT00877110|VINCRISTINE|vincristine
637881|NCT00877110|Neuroblastoma|neuroblastoma
637882|NCT00877110|09-011|09-011
637883|NCT00877097|osteoporosis|osteoporosis
637884|NCT00877097|Bone mineral density|bone mineral density
637885|NCT00877097|clodronate|clodronate
637886|NCT00877097|HRT|hrt
637887|NCT00877097|postmenopausal|postmenopausal
637888|NCT00877084|exacerbation|exacerbation
637889|NCT00877084|COPD|copd
637890|NCT00877084|Resistance training|resistance training
637891|NCT00877084|Muscle force|muscle force
637892|NCT00877058|Frailty|frailty
637893|NCT00877058|health promotion|health promotion
637894|NCT00877058|prevention|prevention
637895|NCT00877058|self management|self management
637896|NCT00877058|intervention|intervention
637897|NCT00877045|Gastrointestinal Stromal Tumors|gastrointestinal stromal tumors
637898|NCT00877045|GIST|gist
637899|NCT00877045|tyrosine kinase inhibitors|tyrosine kinase inhibitors
637900|NCT00877045|Imatinib|imatinib
637901|NCT00877045|Gleevec|gleevec
637902|NCT00877045|Suntinib|suntinib
637903|NCT00877045|Sutent|sutent
637904|NCT00877032|Phase 1|phase 1
637905|NCT00877032|Dry Age Related Macular Degeneration|dry age related macular degeneration
637906|NCT00877032|RN6G|rn6g
637907|NCT00877019|sonic brushes|sonic brushes
637908|NCT00877019|time effectiveness|time effectiveness
637909|NCT00877019|brush head design|brush head design
637910|NCT00877019|ADA-toothbrush|ada-toothbrush
637911|NCT00877019|professional brushing|professional brushing
637912|NCT00877019|time dependence|time dependence
637913|NCT00877019|efficacy|efficacy
637914|NCT00877019|toothbrush|toothbrush
637915|NCT00876980|Obstructive sleep apnea|obstructive sleep apnea
637916|NCT00876980|Type II diabetes mellitus|type ii diabetes mellitus
637917|NCT00876980|Randomized controlled trial|randomized controlled trial
637918|NCT00876967|anesthesiology|anesthesiology
637919|NCT00876967|randomized|randomized
637920|NCT00876967|laryngoscope|laryngoscope
637921|NCT00876967|intubation|intubation
637922|NCT00876967|laryngeal exposition|laryngeal exposition
637923|NCT00876967|laryngoscope blades|laryngoscope blades
637924|NCT00876967|plastic single use blade|plastic single use blade
637925|NCT00876967|metallic single use blade|metallic single use blade
637926|NCT00876967|metallic reusable blade|metallic reusable blade
637927|NCT00876967|success to intubation at first attempt|success to intubation at first attempt
637928|NCT00876967|Cormack and lehanne modify grade|cormack and lehanne modify grade
637929|NCT00876941|Drug|drug
637930|NCT00876941|Drug Use|drug use
637931|NCT00876941|Screening|screening
637932|NCT00876941|Brief Intervention|brief intervention
637933|NCT00876941|Primary Care|primary care
637934|NCT00876941|Utilization|utilization
637935|NCT00876928|pre-diabetes|pre-diabetes
637936|NCT00876928|minorities|minorities
637937|NCT00876928|oral glucose tolerance test|oral glucose tolerance test
637938|NCT00876928|disposition index|disposition index
637939|NCT00876928|insulin secretion|insulin secretion
637940|NCT00876928|insulin sensitivity|insulin sensitivity
637941|NCT00876928|diabetes|diabetes
637942|NCT00876915|prevention of VTE and PE in high risk cancer patients|prevention of vte and pe in high risk cancer patients
637943|NCT00876902|liver transplantation|liver transplantation
637944|NCT00876902|cadaveric liver transplantation|cadaveric liver transplantation
637945|NCT00876902|ischemic reperfusion injury|ischemic reperfusion injury
637946|NCT00876902|primary non-function|primary non-function
637947|NCT00876902|delayed non-Function|delayed non-function
637948|NCT00876902|poor early graft function|poor early graft function
637949|NCT00876902|YSPSL|yspsl
637950|NCT00876902|recombinant PSGL-Ig|recombinant psgl-ig
637951|NCT00876889|spinal cord injury|spinal cord injury
637952|NCT00876889|riluzole|riluzole
637953|NCT00876889|pharmacokinetics|pharmacokinetics
637954|NCT00876889|Acute Traumatic Spinal Cord Injury|acute traumatic spinal cord injury
637955|NCT00876876|hypervolemic hyponatremia|hypervolemic hyponatremia
637956|NCT00876876|serum sodium|serum sodium
637957|NCT00876876|fluid overload|fluid overload
637958|NCT00876876|heartfailure|heartfailure
637959|NCT00876876|acute heart failure|acute heart failure
637960|NCT00876876|vasopressin antagonist|vasopressin antagonist
637961|NCT00876863|Alzheimer's disease|alzheimer's disease
637962|NCT00876863|Dementia|dementia
637963|NCT00876863|Memory loss|memory loss
637964|NCT00876863|Cognitive impairment|cognitive impairment
637965|NCT00876863|Nerve growth factor|nerve growth factor
637966|NCT00876863|NGF|ngf
637967|NCT00876863|Neurotrophic factors|neurotrophic factors
637968|NCT00876863|Gene therapy|gene therapy
637969|NCT00876850|cSSI|cssi
637970|NCT00876850|Abscess|abscess
637971|NCT00876850|Would|would
637972|NCT00876850|Cellulitis|cellulitis
637973|NCT00876850|Complicated Skin and Skin Structure Infections (cSSSI)|complicated skin and skin structure infections (csssi)
637974|NCT00876824|Black Fever|black fever
637975|NCT00876824|Kala-Azar|kala-azar
637976|NCT00876824|Amphotericin B lipid emulsion|amphotericin b lipid emulsion
637977|NCT00876824|Liposomal Amphotericin B|liposomal amphotericin b
637978|NCT00876811|raspberry|raspberry
637979|NCT00876811|fruit|fruit
637980|NCT00876811|antioxidants|antioxidants
637981|NCT00876811|polyphenols|polyphenols
637982|NCT00876811|oxidative stress|oxidative stress
637983|NCT00876811|dietary intervention|dietary intervention
637984|NCT00876798|Euvolemic Hyponatremia|euvolemic hyponatremia
637985|NCT00876798|SIADH|siadh
637986|NCT00876798|Serum Sodium|serum sodium
637987|NCT00876785|Rye bread satiety breakfast|rye bread satiety breakfast
637988|NCT00876772|ALS|als
637989|NCT00876772|olanazapine|olanazapine
637990|NCT00876772|Loss of Apptetite|loss of apptetite
637991|NCT00876772|Appetite Loss|appetite loss
637992|NCT00876772|Malnutrition|malnutrition
637993|NCT00876772|Cachexia|cachexia
637994|NCT00876772|Zyprexa|zyprexa
637995|NCT00876759|cerebral metastases|cerebral metastases
637996|NCT00876746|Pain|pain
637997|NCT00876746|surgery|surgery
637998|NCT00876746|catheter|catheter
637999|NCT00876746|nerve block|nerve block
638000|NCT00876746|supraclavicular|supraclavicular
638001|NCT00876746|infraclavicular|infraclavicular
638002|NCT00876746|UCSD|ucsd
638003|NCT00876746|moderate-to-severe pain|moderate-to-severe pain
638004|NCT00876746|Supraclavicular catheter|supraclavicular catheter
638005|NCT00876746|Infraclavicular catheter|infraclavicular catheter
638006|NCT00876720|Tinnitus|tinnitus
638007|NCT00876720|chronic subjective tinnitus|chronic subjective tinnitus
638008|NCT00876720|transcranial magnetic stimulation|transcranial magnetic stimulation
638009|NCT00876720|sensation disorders|sensation disorders
638010|NCT00876720|hearing disorders|hearing disorders
638011|NCT00876707|wavefront|wavefront
638012|NCT00876707|multifocal IOL|multifocal iol
638013|NCT00876707|modulation transfer function|modulation transfer function
638014|NCT00876707|intraocular lenses|intraocular lenses
638015|NCT00876707|wavefront data|wavefront data
638016|NCT00876707|Visual performance|visual performance
638017|NCT00876694|COPD, Chronic Obstructive Pulmonary Disease, Indacaterol, long acting β2-agonist|copd, chronic obstructive pulmonary disease, indacaterol, long acting β2-agonist
638018|NCT00876681|Catheter|catheter
638019|NCT00876681|Ultrasound-guidance|ultrasound-guidance
638020|NCT00876681|Nerve Stimulation|nerve stimulation
638021|NCT00876681|Electrical stimulation|electrical stimulation
638022|NCT00876681|nerve block|nerve block
638023|NCT00876681|UCSD|ucsd
638024|NCT00876681|Orthopedic surgery|orthopedic surgery
638025|NCT00876681|Foot/ankle pain|foot/ankle pain
638026|NCT00876681|Foot/ankle numbness|foot/ankle numbness
638027|NCT00876681|Popliteal-Sciatic Catheters|popliteal-sciatic catheters
638028|NCT00876668|Peripheral Vascular diseases|peripheral vascular diseases
638029|NCT00876668|Microcirculation|microcirculation
638030|NCT00876668|fluorescence angiography|fluorescence angiography
638031|NCT00876642|Radiation dermatitis|radiation dermatitis
638032|NCT00876642|best supportive care|best supportive care
638033|NCT00876642|Aloe vera gel|aloe vera gel
638034|NCT00876642|phase III study was to assess the effectiveness of aloe vera and vitamin E.|phase iii study was to assess the effectiveness of aloe vera and vitamin e.
638035|NCT00876629|MR Elastography|mr elastography
638036|NCT00876629|kidney|kidney
638037|NCT00876629|fibrosis|fibrosis
638038|NCT00876616|lupus nephritis;multi-target therapy; MMF; FK506|lupus nephritis;multi-target therapy; mmf; fk506
638039|NCT00876603|cervical spondylotic myelopathy|cervical spondylotic myelopathy
638040|NCT00876603|anterior decompression and fusion|anterior decompression and fusion
638041|NCT00876603|cervical laminoplasty|cervical laminoplasty
638042|NCT00876577|Acute Exacerbations of Chronic Bronchitis|acute exacerbations of chronic bronchitis
638043|NCT00876577|Avelox|avelox
638044|NCT00876577|Bronchitis|bronchitis
638045|NCT00876564|Triage precision|triage precision
638046|NCT00876551|Negative-Pressure Wound Therapy|negative-pressure wound therapy
638047|NCT00876551|Endoscopic/endoluminal V.A.C. therapy|endoscopic/endoluminal v.a.c. therapy
638048|NCT00876551|Esophagectomy|esophagectomy
638049|NCT00876551|Anastomotic leakage|anastomotic leakage
638050|NCT00876551|Anastomosis, Surgical|anastomosis, surgical
638051|NCT00876538|Chemotherapy Induced Peripheral Neuropathy|chemotherapy induced peripheral neuropathy
638052|NCT00876538|TR019622|tr019622
638053|NCT00876538|Trophos|trophos
638054|NCT00876525|Heart diseases.|heart diseases.
638055|NCT00876525|Aortic valve diseases.|aortic valve diseases.
638056|NCT00876525|Aortic valve insufficiency.|aortic valve insufficiency.
638057|NCT00876525|Aortic valve stenosis.|aortic valve stenosis.
638058|NCT00876512|thienopyridine resistance|thienopyridine resistance
638059|NCT00876512|stable effort angina|stable effort angina
638060|NCT00876512|platelet activation|platelet activation
638061|NCT00876512|ADAMTS13|adamts13
638062|NCT00876512|von Willebrand Factor|von willebrand factor
638063|NCT00876499|Primary Brain Tumor|primary brain tumor
638065|NCT00876499|Brain Cancer|brain cancer
638066|NCT00876499|Primary glioma|primary glioma
638067|NCT00876499|Astrocytoma|astrocytoma
638068|NCT00876499|Oligodendroglioma|oligodendroglioma
638069|NCT00876499|Oligo-astrocytoma|oligo-astrocytoma
638070|NCT00876499|Ependymoma|ependymoma
638071|NCT00876499|Anaplastic astrocytoma|anaplastic astrocytoma
638072|NCT00876499|Anaplastic oligodendroglioma|anaplastic oligodendroglioma
638073|NCT00876499|Anaplastic oligo-astrocytoma|anaplastic oligo-astrocytoma
638074|NCT00876499|Anaplastic ependymoma|anaplastic ependymoma
638075|NCT00876499|Fatigue|fatigue
638076|NCT00876499|Cytokines|cytokines
638077|NCT00876499|Questionnaires|questionnaires
638078|NCT00876499|Actigraphy|actigraphy
638079|NCT00876499|Sleep Disturbance|sleep disturbance
638080|NCT00876499|Radiation Therapy|radiation therapy
638081|NCT00876473|CPAP|cpap
638082|NCT00876473|Acute Respiratory Failure|acute respiratory failure
638083|NCT00876434|Sirolimus|sirolimus
638084|NCT00876434|Anterior Uveitis|anterior uveitis
638085|NCT00876434|Autoimmune Disease|autoimmune disease
638086|NCT00876434|Uveitis|uveitis
638087|NCT00876421|ONO-8539|ono-8539
638088|NCT00876421|Overactive bladder|overactive bladder
638089|NCT00876421|OAB|oab
638090|NCT00876408|RT-PCR molecular profiling assay|rt-pcr molecular profiling assay
638091|NCT00876408|Molecular Profiling-Real Time Polymerase Chain Reaction|molecular profiling-real time polymerase chain reaction
638092|NCT00876408|Unknown Primary|unknown primary
638093|NCT00876408|UPC|upc
638094|NCT00876408|CUP|cup
638095|NCT00876395|Breast Cancer|breast cancer
638096|NCT00876395|HER2+|her2+
638097|NCT00876395|mTOR|mtor
638098|NCT00876395|everolimus|everolimus
638099|NCT00876395|RAD001|rad001
638100|NCT00876395|first line|first line
638101|NCT00876395|metastatic|metastatic
638102|NCT00876395|locally advanced|locally advanced
638103|NCT00876395|Trastuzumab|trastuzumab
638104|NCT00876395|Paclitaxel|paclitaxel
638105|NCT00876395|First Line Therapy|first line therapy
638106|NCT00876395|HER2 Positive|her2 positive
638107|NCT00876395|Metastatic Breast Cancer|metastatic breast cancer
638108|NCT00876382|advanced renal cell carcinoma|advanced renal cell carcinoma
638109|NCT00876382|renal cancer|renal cancer
638110|NCT00876382|renal cell|renal cell
638111|NCT00876382|Sorafenib|sorafenib
638112|NCT00876382|Nexavar|nexavar
638113|NCT00876382|Bevacizumab|bevacizumab
638114|NCT00876382|Avastin|avastin
638115|NCT00876382|Sunitinib|sunitinib
638116|NCT00876382|Sutent|sutent
638117|NCT00876369|urticaria|urticaria
638118|NCT00876369|angioedema|angioedema
638119|NCT00876369|vitamin D|vitamin d
638120|NCT00876369|allergy|allergy
638121|NCT00876356|Asthma|asthma
638122|NCT00876356|Conjugated Linoleic Acid (CLA)|conjugated linoleic acid (cla)
638123|NCT00876356|dietary supplement|dietary supplement
638124|NCT00876330|Clinical Decision Support Systems|clinical decision support systems
638125|NCT00876330|Hyperlipidemia|hyperlipidemia
638126|NCT00876330|Hypertension|hypertension
638127|NCT00876317|Tenosynovitis|tenosynovitis
638128|NCT00876317|Bursitis|bursitis
638129|NCT00876304|PF-04802540 multiple dose safety study|pf-04802540 multiple dose safety study
638130|NCT00876278|Cataract|cataract
638131|NCT00876278|Intraocular Lens (IOL)|intraocular lens (iol)
638132|NCT00876278|Mesotest II|mesotest ii
638133|NCT00876278|Evaluation of usability of Mesotest II for assessment of night driving capacity of pseudo-phakic patients|evaluation of usability of mesotest ii for assessment of night driving capacity of pseudo-phakic patients
638134|NCT00876265|Facial wrinkles|facial wrinkles
638135|NCT00876265|Nasolabial fold|nasolabial fold
638136|NCT00876226|Citalopram|citalopram
638137|NCT00876226|Pharmacokinetics|pharmacokinetics
638138|NCT00876226|Short Bowel Syndrome|short bowel syndrome
638139|NCT00876213|Amylin|amylin
638140|NCT00876213|GLP-1|glp-1
638141|NCT00876213|gastric emptying|gastric emptying
638142|NCT00876213|appetite and food intake|appetite and food intake
638143|NCT00876200|Williams Beuren syndrome|williams beuren syndrome
638144|NCT00876200|Cardiovascular abnormalities|cardiovascular abnormalities
638145|NCT00876200|Cardiovascular structure|cardiovascular structure
638146|NCT00876187|randomized controlled trial|randomized controlled trial
638147|NCT00876187|monoclonal antibody|monoclonal antibody
638148|NCT00876187|nerve growth factor|nerve growth factor
638149|NCT00876187|naproxen|naproxen
638150|NCT00876174|Chronic hepatitis C|chronic hepatitis c
638151|NCT00876174|Genotype 1|genotype 1
638152|NCT00876161|Healthy Adults|healthy adults
638153|NCT00876148|Incidence of hepatitis B after allografting|incidence of hepatitis b after allografting
638154|NCT00876148|Risk of hepatitis B reactivation|risk of hepatitis b reactivation
638155|NCT00876148|Lamivudine prophylaxis|lamivudine prophylaxis
638156|NCT00876122|NHL|nhl
638157|NCT00876122|Metastatic Solid Tumors|metastatic solid tumors
638158|NCT00876122|PI3K Inhibitors|pi3k inhibitors
638159|NCT00876122|PI3K|pi3k
638160|NCT00876109|Metastatic Solid Tumors|metastatic solid tumors
638161|NCT00876109|PI3K|pi3k
638162|NCT00876109|PI3K Inhibitors|pi3k inhibitors
638163|NCT00876096|Diagnosis, Differential|diagnosis, differential
638164|NCT00876083|Drug utilization review|drug utilization review
638165|NCT00876070|Metastatic Breast Cancer|metastatic breast cancer
638166|NCT00876070|Breast Cancer|breast cancer
638167|NCT00876070|MBC|mbc
638168|NCT00876070|Abraxane|abraxane
638169|NCT00876070|Paclitaxel|paclitaxel
638170|NCT00876070|Taxol|taxol
638171|NCT00876070|Docetaxel|docetaxel
638172|NCT00876070|Taxotere|taxotere
638173|NCT00876057|psychological well-being|psychological well-being
638174|NCT00876057|recovery|recovery
638175|NCT00876057|time in hospital|time in hospital
638176|NCT00876057|sick-leave|sick-leave
638177|NCT00876057|complications|complications
638178|NCT00876057|Sexual well-being|sexual well-being
638179|NCT00876031|pediatric soft tissue sarcoma|pediatric soft tissue sarcoma
638180|NCT00876031|rhabdomyosarcoma|rhabdomyosarcoma
638181|NCT00876031|extraosseous Ewing family tumours|extraosseous ewing family tumours
638182|NCT00876031|synovial sarcoma|synovial sarcoma
638183|NCT00876031|undifferentiated sarcoma|undifferentiated sarcoma
638184|NCT00876018|physical performance|physical performance
638185|NCT00876018|micronutrients|micronutrients
638186|NCT00876018|physical fitness|physical fitness
638187|NCT00876018|healthy children|healthy children
638188|NCT00876005|Wound infection|wound infection
638189|NCT00875979|MBC|mbc
638190|NCT00875979|Breast Cancer|breast cancer
638191|NCT00875979|HER2+|her2+
638192|NCT00875979|HER2+ breast cancer|her2+ breast cancer
638193|NCT00875979|HER2 positive breast cancer|her2 positive breast cancer
638194|NCT00875979|herceptin|herceptin
638195|NCT00875979|Trastuzumab emtansine|trastuzumab emtansine
638196|NCT00875953|squamous cell carcinoma|squamous cell carcinoma
638197|NCT00875953|head and neck cancer|head and neck cancer
638198|NCT00875953|neck dissection|neck dissection
638199|NCT00875927|Halitosis|halitosis
638200|NCT00875914|AV-node reentry tachycardia|av-node reentry tachycardia
638201|NCT00875914|radiofrequency ablation|radiofrequency ablation
638202|NCT00875914|magnetic navigation system|magnetic navigation system
638203|NCT00875901|Lung Cancer|lung cancer
638204|NCT00875901|Stage I Non-Small Cell Lung Cancer|stage i non-small cell lung cancer
638205|NCT00875901|Proton Radiation|proton radiation
638206|NCT00875901|HypoIGRT|hypoigrt
638207|NCT00875875|Diarrhea, travelers|diarrhea, travelers
638208|NCT00875875|Acute travelers' diarrhea|acute travelers' diarrhea
638209|NCT00875862|UCSD|ucsd
638210|NCT00875862|pain|pain
638211|NCT00875862|quality-of-life|quality-of-life
638212|NCT00875862|range-of-motion|range-of-motion
638213|NCT00875862|interscalene catheter|interscalene catheter
638214|NCT00875862|nerve block|nerve block
638215|NCT00875862|shoulder|shoulder
638216|NCT00875862|Shoulder Manipulation|shoulder manipulation
638217|NCT00875849|recurrent squamous cell carcinoma of the hypopharynx|recurrent squamous cell carcinoma of the hypopharynx
638218|NCT00875849|stage I squamous cell carcinoma of the hypopharynx|stage i squamous cell carcinoma of the hypopharynx
638219|NCT00875849|stage II squamous cell carcinoma of the hypopharynx|stage ii squamous cell carcinoma of the hypopharynx
638220|NCT00875849|stage III squamous cell carcinoma of the hypopharynx|stage iii squamous cell carcinoma of the hypopharynx
638221|NCT00875849|recurrent squamous cell carcinoma of the larynx|recurrent squamous cell carcinoma of the larynx
638222|NCT00875849|stage I squamous cell carcinoma of the larynx|stage i squamous cell carcinoma of the larynx
638223|NCT00875849|stage II squamous cell carcinoma of the larynx|stage ii squamous cell carcinoma of the larynx
638224|NCT00875849|stage III squamous cell carcinoma of the larynx|stage iii squamous cell carcinoma of the larynx
638225|NCT00875849|stage I squamous cell carcinoma of the lip and oral cavity|stage i squamous cell carcinoma of the lip and oral cavity
638226|NCT00875849|stage II squamous cell carcinoma of the lip and oral cavity|stage ii squamous cell carcinoma of the lip and oral cavity
638227|NCT00875849|stage III squamous cell carcinoma of the lip and oral cavity|stage iii squamous cell carcinoma of the lip and oral cavity
638228|NCT00875849|recurrent squamous cell carcinoma of the lip and oral cavity|recurrent squamous cell carcinoma of the lip and oral cavity
638229|NCT00875849|recurrent squamous cell carcinoma of the oropharynx|recurrent squamous cell carcinoma of the oropharynx
638230|NCT00875849|stage I squamous cell carcinoma of the oropharynx|stage i squamous cell carcinoma of the oropharynx
638231|NCT00875849|stage II squamous cell carcinoma of the oropharynx|stage ii squamous cell carcinoma of the oropharynx
638232|NCT00875849|stage III squamous cell carcinoma of the oropharynx|stage iii squamous cell carcinoma of the oropharynx
638233|NCT00875849|tongue cancer|tongue cancer
638234|NCT00875836|Marijuana|marijuana
638235|NCT00875836|Buspirone|buspirone
638236|NCT00875836|Contingency management|contingency management
638237|NCT00875836|Motivational enhancement therapy|motivational enhancement therapy
638238|NCT00875823|PH|ph
638239|NCT00875823|Primary Hyperoxaluria|primary hyperoxaluria
638240|NCT00875823|Type I|type i
638241|NCT00875823|Type II|type ii
638242|NCT00875823|NonI-NonII|noni-nonii
638243|NCT00875823|Kidney stones|kidney stones
638244|NCT00875823|oxalate|oxalate
638245|NCT00875823|oxalosis|oxalosis
638246|NCT00875797|enteral|enteral
638247|NCT00875797|parenteral|parenteral
638248|NCT00875797|glutamine|glutamine
638249|NCT00875797|intestinal permeability|intestinal permeability
638250|NCT00875797|infection|infection
638251|NCT00875784|Sumatriptan exposure|sumatriptan exposure
638252|NCT00875771|metastatic colorectal cancer|metastatic colorectal cancer
638253|NCT00875771|BEVACIZUMAB|bevacizumab
638254|NCT00875771|CAPECITABINE|capecitabine
638255|NCT00875771|IRINOTECAN|irinotecan
638256|NCT00875758|preterm infants|preterm infants
638257|NCT00875758|IVH|ivh
638258|NCT00875758|germinal matrix|germinal matrix
638259|NCT00875758|intraventricular hemorrhage|intraventricular hemorrhage
813308|NCT00193726|Priming|priming
638260|NCT00875758|hydrocephalus|hydrocephalus
638261|NCT00875732|Resynchronization|resynchronization
638262|NCT00875732|Device|device
638263|NCT00875732|Bradycardia|bradycardia
638264|NCT00875732|atrioventricular block|atrioventricular block
638265|NCT00875732|Cardiac Resynchronization|cardiac resynchronization
638266|NCT00875719|COPD patients with respiratory failure|copd patients with respiratory failure
638267|NCT00875706|Nursing Homes|nursing homes
638268|NCT00875706|Implementation of innovative programs|implementation of innovative programs
638269|NCT00875706|Nursing staff|nursing staff
638270|NCT00875706|Nurses' aides|nurses' aides
638271|NCT00875706|Educational models|educational models
638272|NCT00875693|AML|aml
638273|NCT00875693|leukemia|leukemia
638274|NCT00875693|MDS|mds
638275|NCT00875667|Mantle Cell Lymphoma|mantle cell lymphoma
638276|NCT00875667|Relapsed Mantle Cell Lymphoma|relapsed mantle cell lymphoma
638277|NCT00875667|Refractory Mantle Cell Lymphoma|refractory mantle cell lymphoma
638278|NCT00875667|Lymphoma|lymphoma
638279|NCT00875667|MCL|mcl
638280|NCT00875654|Cell therapy|cell therapy
638281|NCT00875654|Stroke|stroke
638282|NCT00875654|Neuronal Plasticity|neuronal plasticity
638283|NCT00875654|Recovery|recovery
638284|NCT00875654|Mesenchymal Stem Cells|mesenchymal stem cells
638285|NCT00875654|Transplantation|transplantation
638286|NCT00875628|Japanese Healthy volunteers HCV pharmacokinetics PF-00868554 filibuvir|japanese healthy volunteers hcv pharmacokinetics pf-00868554 filibuvir
638287|NCT00875615|adult primary hepatocellular carcinoma|adult primary hepatocellular carcinoma
638288|NCT00875615|localized unresectable adult primary liver cancer|localized unresectable adult primary liver cancer
638289|NCT00875615|advanced adult primary liver cancer|advanced adult primary liver cancer
638290|NCT00875602|All hospitalized patients in a general Med/ Surg unit|all hospitalized patients in a general med/ surg unit
638291|NCT00875589|Traumatic Brain Injury|traumatic brain injury
638292|NCT00875589|Eye movement recording|eye movement recording
638293|NCT00875576|social influences|social influences
638294|NCT00875576|meals|meals
638295|NCT00875576|obesity|obesity
638296|NCT00875576|amount of food consumed|amount of food consumed
638297|NCT00875550|Intubated and mechanically ventilated PICU subjects|intubated and mechanically ventilated picu subjects
638298|NCT00875537|Burning mouth syndrome|burning mouth syndrome
638299|NCT00875537|neuropathy|neuropathy
638300|NCT00875537|inflammation|inflammation
638301|NCT00875537|tongue mucosa|tongue mucosa
638302|NCT00875537|tongue innervation|tongue innervation
638303|NCT00875537|dysgeusia|dysgeusia
638304|NCT00875524|Dengue virus|dengue virus
638305|NCT00875524|Dengue fever|dengue fever
638306|NCT00875524|Dengue hemorrhagic fever|dengue hemorrhagic fever
638307|NCT00875524|Dengue diseases|dengue diseases
638308|NCT00875524|Dengue vaccine|dengue vaccine
638309|NCT00875511|peer rejection|peer rejection
638310|NCT00875511|obesity|obesity
638311|NCT00875511|amount of food chosen|amount of food chosen
638312|NCT00875511|amount of social time chosen|amount of social time chosen
638313|NCT00875498|iTBS|itbs
638314|NCT00875498|Negative Symptoms|negative symptoms
638315|NCT00875485|Monovalent Hepatitis A|monovalent hepatitis a
638316|NCT00875485|hepatitis B vaccine|hepatitis b vaccine
638317|NCT00875485|Belgium and Czech Republic|belgium and czech republic
638318|NCT00875472|social influences|social influences
638319|NCT00875472|food purchases|food purchases
638320|NCT00875472|childhood obesity|childhood obesity
638321|NCT00875472|amount of energy dense food and beverage items purchased|amount of energy dense food and beverage items purchased
638322|NCT00875472|amount of nutrient dense food and beverage items purchased|amount of nutrient dense food and beverage items purchased
638323|NCT00875420|hot flashes|hot flashes
638324|NCT00875420|hot flushes|hot flushes
638325|NCT00875420|vasomotor symptoms|vasomotor symptoms
638326|NCT00875420|postmenopausal|postmenopausal
638327|NCT00875381|Melanocytes|melanocytes
638328|NCT00875368|HIV-1|hiv-1
638329|NCT00875368|HAART|haart
638330|NCT00875368|CD4 cell|cd4 cell
638331|NCT00875368|Immunologic non-responders|immunologic non-responders
638332|NCT00875368|Immunology|immunology
638333|NCT00875368|treatment experienced|treatment experienced
638334|NCT00875355|tumors metastatic to brain|tumors metastatic to brain
638335|NCT00875355|stage IV breast cancer|stage iv breast cancer
638336|NCT00875342|Traumatic Event|traumatic event
638337|NCT00875342|Trauma Survivor|trauma survivor
638338|NCT00875342|Exposure Therapy|exposure therapy
638339|NCT00875342|PTSD DCS|ptsd dcs
638340|NCT00875342|Telemedicine|telemedicine
638341|NCT00875342|Telepsychiatry|telepsychiatry
638342|NCT00875342|Telemental health|telemental health
638343|NCT00875329|Brain Injury|brain injury
638344|NCT00875316|Parkinson's disease|parkinson's disease
638345|NCT00875316|Phase I|phase i
638346|NCT00875303|Parents' plans to discipline their children|parents' plans to discipline their children
638347|NCT00875290|Diabetes Mellitus, Type I|diabetes mellitus, type i
638348|NCT00875290|Children|children
638349|NCT00875290|Insulin pump therapy|insulin pump therapy
638350|NCT00875290|Continuous glucose monitor|continuous glucose monitor
638351|NCT00875264|CEP-11981|cep-11981
638352|NCT00875264|TIE-2|tie-2
638353|NCT00875264|VEGF-R|vegf-r
638354|NCT00875251|body composition|body composition
638355|NCT00875251|preterm infant|preterm infant
638356|NCT00875251|anthropometry|anthropometry
638357|NCT00875238|cardiac toxicity|cardiac toxicity
638358|NCT00875238|cardiovascular complications|cardiovascular complications
638359|NCT00875238|stage I breast cancer|stage i breast cancer
638360|NCT00875238|stage II breast cancer|stage ii breast cancer
638361|NCT00875238|stage IIIA breast cancer|stage iiia breast cancer
638362|NCT00875238|stage IIIB breast cancer|stage iiib breast cancer
638363|NCT00875238|stage IIIC breast cancer|stage iiic breast cancer
638364|NCT00875225|Hypertension|hypertension
638365|NCT00875225|Adherence to medications|adherence to medications
638366|NCT00875212|Calcium glycerophosphate|calcium glycerophosphate
638367|NCT00875212|Fluoride|fluoride
638368|NCT00875212|Dentifrice|dentifrice
638369|NCT00875212|Biofilm|biofilm
638370|NCT00875212|Dental caries|dental caries
638371|NCT00875199|Overweight|overweight
638372|NCT00875199|Obesity|obesity
638373|NCT00875199|Contingency Management|contingency management
638374|NCT00875186|bariatric surgery|bariatric surgery
638375|NCT00875186|co-morbidities|co-morbidities
638376|NCT00875186|aerobic physical exercise|aerobic physical exercise
638377|NCT00875173|Selenium|selenium
638378|NCT00875173|Chagas disease|chagas disease
638379|NCT00875173|Chagasic cardiopathy|chagasic cardiopathy
638380|NCT00875147|neoadjuvant chemotherapy|neoadjuvant chemotherapy
638381|NCT00875147|bevacizumab|bevacizumab
638382|NCT00875121|Food reinforcement|food reinforcement
638383|NCT00875121|social reinforcers|social reinforcers
638384|NCT00875121|overweight|overweight
638385|NCT00875121|children|children
638386|NCT00875095|sperm DNA integrity|sperm dna integrity
638387|NCT00875095|Toluidine blue staining|toluidine blue staining
638388|NCT00875082|Asthma|asthma
638389|NCT00875082|Children|children
638390|NCT00875082|Remodelling|remodelling
638391|NCT00875082|Metalloproteinases|metalloproteinases
638392|NCT00875082|Montelukast|montelukast
638393|NCT00875069|Nosocomial infection|nosocomial infection
638394|NCT00875069|Catheterization|catheterization
638395|NCT00875069|Central Venous Ethanol|central venous ethanol
638396|NCT00875069|lock solution|lock solution
638397|NCT00875069|intensive care units|intensive care units
638398|NCT00875069|Renal replacement therapy in ICU|renal replacement therapy in icu
638399|NCT00875043|ischemic optic neuropathy|ischemic optic neuropathy
638400|NCT00875043|cortical blindness|cortical blindness
638401|NCT00875030|Bioequivalence study-artesunate sachets-arsuamoon tablet|bioequivalence study-artesunate sachets-arsuamoon tablet
638403|NCT00875004|unspecified adult solid tumor, protocol specific|unspecified adult solid tumor, protocol specific
638404|NCT00874991|Cardiac deformation|cardiac deformation
638405|NCT00874991|Cardiopulmonary bypass|cardiopulmonary bypass
638406|NCT00874991|TEE|tee
638407|NCT00874991|Cardiac Surgery|cardiac surgery
638408|NCT00874991|Left ventricular function|left ventricular function
638409|NCT00874991|Pulmonary Artery catheter|pulmonary artery catheter
638410|NCT00874991|Tissue Doppler|tissue doppler
638411|NCT00874991|Left ventricular function in cardiac surgery|left ventricular function in cardiac surgery
638412|NCT00874978|Lenalidomide|lenalidomide
638413|NCT00874978|myelodysplastic syndromes|myelodysplastic syndromes
638414|NCT00874965|Chronic Obstructive Pulmonary Disease (COPD)|chronic obstructive pulmonary disease (copd)
638415|NCT00874965|Electrostimulation|electrostimulation
638416|NCT00874965|Muscle function|muscle function
638417|NCT00874965|Exercise ventilation|exercise ventilation
638418|NCT00874965|Anabolism/catabolism pathway|anabolism/catabolism pathway
638419|NCT00874952|Metabolic syndrome|metabolic syndrome
638420|NCT00874952|Lipids|lipids
638421|NCT00874952|Waist Circumference|waist circumference
638422|NCT00874952|HDL|hdl
638423|NCT00874952|hypertension|hypertension
638424|NCT00874926|Octocog alfa|octocog alfa
638425|NCT00874926|Haemophilia A|haemophilia a
638426|NCT00874913|blood flow|blood flow
638427|NCT00874913|obstructive sleep apnea syndrome|obstructive sleep apnea syndrome
638428|NCT00874913|normal tension glaucoma|normal tension glaucoma
638429|NCT00874874|stage III adult soft tissue sarcoma|stage iii adult soft tissue sarcoma
638430|NCT00874874|stage IV adult soft tissue sarcoma|stage iv adult soft tissue sarcoma
638431|NCT00874874|recurrent adult soft tissue sarcoma|recurrent adult soft tissue sarcoma
638432|NCT00874874|adult angiosarcoma|adult angiosarcoma
638433|NCT00874861|cancer|cancer
638434|NCT00874861|brain|brain
638435|NCT00874861|tumor|tumor
638436|NCT00874861|vaccine|vaccine
638437|NCT00874848|Imprime PGG|imprime pgg
638438|NCT00874848|NSCLC|nsclc
638439|NCT00874848|Cetuximab|cetuximab
638440|NCT00874835|Endothelial Keratoplasty|endothelial keratoplasty
638441|NCT00874835|EK|ek
638442|NCT00874835|Descemet Stripping Endothelial Keratoplasty|descemet stripping endothelial keratoplasty
638443|NCT00874835|Corneal Transplantation|corneal transplantation
638444|NCT00874835|Keratoplasty|keratoplasty
638445|NCT00874835|DSEK|dsek
638446|NCT00874835|DSAEK|dsaek
638447|NCT00874809|insulin pump|insulin pump
638448|NCT00874809|DM Type 2|dm type 2
638449|NCT00874809|CGMS|cgms
638450|NCT00874809|basal rate|basal rate
638451|NCT00874796|apoptosis|apoptosis
638452|NCT00874796|liver inflammation|liver inflammation
638453|NCT00874796|hepatitis C|hepatitis c
638454|NCT00874783|Amyotrophic Lateral Sclerosis|amyotrophic lateral sclerosis
638455|NCT00874783|Familial Dysautonomia|familial dysautonomia
638456|NCT00874783|Parkinson's Disease|parkinson's disease
638457|NCT00874783|Alzheimer's Disease|alzheimer's disease
638458|NCT00874783|Age Related Macular Degeneration|age related macular degeneration
638459|NCT00874783|Retinitis Pigmentosa|retinitis pigmentosa
638460|NCT00874783|Huntington's Disease|huntington's disease
638461|NCT00874783|Machado - Joseph Disease|machado - joseph disease
638462|NCT00874783|SMA - Spinal Muscular Atrophy|sma - spinal muscular atrophy
638463|NCT00874783|Ataxia Telangiectasia|ataxia telangiectasia
638464|NCT00874770|Antivirals|antivirals
638465|NCT00874757|Statins, anti-inflammatory|statins, anti-inflammatory
638466|NCT00874757|Healthy subjects study|healthy subjects study
638467|NCT00874744|Diabetic macular edema|diabetic macular edema
638468|NCT00874744|intravitreal injection|intravitreal injection
638469|NCT00874744|Pharmacological treatment|pharmacological treatment
638470|NCT00874718|repetitive strain injury|repetitive strain injury
638471|NCT00874718|quality of life|quality of life
638472|NCT00874718|functional capacity|functional capacity
638473|NCT00874718|workers|workers
638474|NCT00874692|tap water temperature|tap water temperature
638475|NCT00874692|social housing|social housing
638476|NCT00874692|scald reduction|scald reduction
638477|NCT00874692|Temperature (degrees Celsius) of hot tap water at point of delivery.|temperature (degrees celsius) of hot tap water at point of delivery.
638478|NCT00874666|garlic|garlic
638479|NCT00874666|allicin|allicin
638480|NCT00874666|allyl methyl sulfide|allyl methyl sulfide
638481|NCT00874666|healthy persons|healthy persons
638482|NCT00874640|Drug utilization review|drug utilization review
638483|NCT00874627|children > 5 years old|children > 5 years old
638484|NCT00874627|IgE-mediated|ige-mediated
638485|NCT00874627|cow milk allergy|cow milk allergy
638486|NCT00874627|IgE-mediated cow milk allergy persisting after 5 years|ige-mediated cow milk allergy persisting after 5 years
638487|NCT00874614|radiotherapy|radiotherapy
638488|NCT00874614|MIBG|mibg
638489|NCT00874614|Azedra|azedra
638490|NCT00874614|neuroendocrine tumors|neuroendocrine tumors
638491|NCT00874614|Iobenguane I 131|iobenguane i 131
638492|NCT00874614|progenics|progenics
638493|NCT00874601|acute ischemic stroke|acute ischemic stroke
638494|NCT00874601|blood pressure|blood pressure
638495|NCT00874601|valsartan|valsartan
638496|NCT00874601|death|death
638497|NCT00874601|dependancy|dependancy
638498|NCT00874575|HMB|hmb
638499|NCT00874575|Vitamin D|vitamin d
638500|NCT00874575|Older Adults|older adults
638501|NCT00874562|rapamycin|rapamycin
638502|NCT00874562|corticosteroid|corticosteroid
638504|NCT00874549|Meningococcal Vaccine|meningococcal vaccine
638505|NCT00874549|Menactra®|menactra®
638506|NCT00874549|Menomune®|menomune®
638507|NCT00874536|ADHD|adhd
638508|NCT00874536|methylphenidate|methylphenidate
638509|NCT00874536|omega-3|omega-3
638510|NCT00874523|raltegravir|raltegravir
638511|NCT00874523|atazanavir|atazanavir
638512|NCT00874523|HIV infections|hiv infections
638513|NCT00874523|pharmacokinetics|pharmacokinetics
638514|NCT00874523|antiretroviral agents|antiretroviral agents
638515|NCT00874523|treatment experienced|treatment experienced
638516|NCT00874510|sleep deprivation|sleep deprivation
638517|NCT00874510|fatigue|fatigue
638518|NCT00874458|ductal breast carcinoma in situ|ductal breast carcinoma in situ
638519|NCT00874432|cardiovascular disease|cardiovascular disease
638520|NCT00874432|angiotensin converting enzyme inhibitors|angiotensin converting enzyme inhibitors
638521|NCT00874432|chronic kidney disease|chronic kidney disease
638522|NCT00874432|cardiovascular disease in elderly patients with CKD|cardiovascular disease in elderly patients with ckd
638523|NCT00874419|EGFR mutation|egfr mutation
638524|NCT00874419|EGFR-TKI|egfr-tki
638525|NCT00874419|Chemotherapy|chemotherapy
638526|NCT00874406|colorectal cancer|colorectal cancer
638527|NCT00874406|liver metastasis|liver metastasis
638528|NCT00874406|neoadjuvant chemotherapy|neoadjuvant chemotherapy
638529|NCT00874393|NICHD Neonatal Research Network|nichd neonatal research network
638530|NCT00874393|Very Low Birth Weight (VLBW)|very low birth weight (vlbw)
638531|NCT00874393|Extremely Low Birth Weight (ELBW)|extremely low birth weight (elbw)
638532|NCT00874393|Prematurity|prematurity
638533|NCT00874393|Blood Pressure Management|blood pressure management
638534|NCT00874393|Dopamine|dopamine
638535|NCT00874393|Hydrocortisone|hydrocortisone
638536|NCT00874380|Fiber|fiber
638537|NCT00874380|Dialysis|dialysis
638538|NCT00874380|Renal Replacement Therapy|renal replacement therapy
638539|NCT00874380|Food Frequency Questionnaire|food frequency questionnaire
638540|NCT00874380|FFQ|ffq
638541|NCT00874380|Dietary counseling|dietary counseling
638542|NCT00874367|NICHD Neonatal Research Network|nichd neonatal research network
813687|NCT00189813|Nasea®|nasea®
638543|NCT00874367|Very Low Birth Weight (VLBW)|very low birth weight (vlbw)
638544|NCT00874367|Extremely Low Birth Weight (ELBW)|extremely low birth weight (elbw)
638545|NCT00874367|Prematurity|prematurity
638546|NCT00874367|Early Onset Sepsis|early onset sepsis
638547|NCT00874354|Myocardial Infarction|myocardial infarction
638548|NCT00874354|Heart Attack|heart attack
638549|NCT00874354|Infarct|infarct
638550|NCT00874354|Stem Cells|stem cells
638551|NCT00874354|Bone Marrow Derived Mononuclear Cells|bone marrow derived mononuclear cells
638552|NCT00874354|CHF|chf
638553|NCT00874354|Congestive Heart Failure|congestive heart failure
638554|NCT00874354|Stent|stent
638555|NCT00874354|PCI|pci
638556|NCT00874354|Percutaneous Coronary Intervention|percutaneous coronary intervention
638557|NCT00874341|Fruit|fruit
638558|NCT00874341|Vegetables|vegetables
638559|NCT00874341|Intervention|intervention
638560|NCT00874341|Insulin resistance|insulin resistance
638561|NCT00874341|Cardiovascular disease risk|cardiovascular disease risk
638562|NCT00874341|Dose response|dose response
638563|NCT00874341|High risk of cardiovascular disease|high risk of cardiovascular disease
638564|NCT00874328|Non small cell lung cancer|non small cell lung cancer
638565|NCT00874328|Irinotecan plus Cisplatin plus S-1|irinotecan plus cisplatin plus s-1
638566|NCT00874328|Phase I/II trial|phase i/ii trial
638567|NCT00874315|recurrent or refractory neuroblastoma|recurrent or refractory neuroblastoma
638568|NCT00874302|Uterine fibroids|uterine fibroids
638569|NCT00874289|NGAL|ngal
638570|NCT00874289|Heart failure|heart failure
638571|NCT00874276|DCA|dca
638572|NCT00874276|Dichloroacetate|dichloroacetate
638573|NCT00874276|Trichloroacetate|trichloroacetate
638574|NCT00874263|Probe-based imaging of GI pre-malignant or malignant lesions|probe-based imaging of gi pre-malignant or malignant lesions
638575|NCT00874237|Staccato loxapine|staccato loxapine
638576|NCT00874237|QT/QTc|qt/qtc
638577|NCT00874237|healthy volunteers|healthy volunteers
638578|NCT00874237|Thorough QT/QTc study|thorough qt/qtc study
638579|NCT00874237|ADASUVE|adasuve
638580|NCT00874237|inhaled loxapine|inhaled loxapine
638581|NCT00874224|Colorectal cancer liver metastasis|colorectal cancer liver metastasis
638582|NCT00874224|Benign liver disease|benign liver disease
638583|NCT00874211|bone metastases|bone metastases
638584|NCT00874211|unspecified adult solid tumor, protocol specific|unspecified adult solid tumor, protocol specific
638585|NCT00874211|refractory multiple myeloma|refractory multiple myeloma
638586|NCT00874211|stage I multiple myeloma|stage i multiple myeloma
638587|NCT00874211|stage II multiple myeloma|stage ii multiple myeloma
638588|NCT00874211|stage III multiple myeloma|stage iii multiple myeloma
638589|NCT00874211|male breast cancer|male breast cancer
638590|NCT00874211|recurrent breast cancer|recurrent breast cancer
638591|NCT00874211|stage IA breast cancer|stage ia breast cancer
638592|NCT00874211|stage IB breast cancer|stage ib breast cancer
638593|NCT00874211|stage II breast cancer|stage ii breast cancer
638594|NCT00874211|stage IIIA breast cancer|stage iiia breast cancer
638595|NCT00874211|stage IIIB breast cancer|stage iiib breast cancer
638596|NCT00874211|stage IIIC breast cancer|stage iiic breast cancer
638597|NCT00874211|stage IV breast cancer|stage iv breast cancer
638598|NCT00874211|recurrent prostate cancer|recurrent prostate cancer
638599|NCT00874211|stage I prostate cancer|stage i prostate cancer
638600|NCT00874211|stage IIB prostate cancer|stage iib prostate cancer
638601|NCT00874211|stage IIA prostate cancer|stage iia prostate cancer
638602|NCT00874211|stage III prostate cancer|stage iii prostate cancer
638603|NCT00874211|stage IV prostate cancer|stage iv prostate cancer
638604|NCT00874211|recurrent non-small cell lung cancer|recurrent non-small cell lung cancer
638605|NCT00874211|stage I non-small cell lung cancer|stage i non-small cell lung cancer
638606|NCT00874211|stage II non-small cell lung cancer|stage ii non-small cell lung cancer
638607|NCT00874211|stage IIIA non-small cell lung cancer|stage iiia non-small cell lung cancer
638608|NCT00874211|stage IIIB non-small cell lung cancer|stage iiib non-small cell lung cancer
638609|NCT00874211|stage IV non-small cell lung cancer|stage iv non-small cell lung cancer
638610|NCT00874211|extensive stage small cell lung cancer|extensive stage small cell lung cancer
638611|NCT00874211|limited stage small cell lung cancer|limited stage small cell lung cancer
638612|NCT00874211|recurrent small cell lung cancer|recurrent small cell lung cancer
638613|NCT00874198|normal pressure hydrocephalus|normal pressure hydrocephalus
638614|NCT00874198|cerebrospinal fluid dynamic test|cerebrospinal fluid dynamic test
638615|NCT00874198|cerebrospinal fluid outflow resistance|cerebrospinal fluid outflow resistance
638616|NCT00874198|cerebrospinal compliance|cerebrospinal compliance
638617|NCT00874198|outcome|outcome
638618|NCT00874198|shunt surgery|shunt surgery
638619|NCT00874198|normal pressure hydrocephalus guidelines|normal pressure hydrocephalus guidelines
638620|NCT00874198|biomarkers|biomarkers
638621|NCT00874198|shunt surgery selection|shunt surgery selection
638622|NCT00874198|Outcome measures|outcome measures
638623|NCT00874198|Outcomes assessment|outcomes assessment
638624|NCT00874198|Outcome and process assessment|outcome and process assessment
638625|NCT00874185|satisfaction|satisfaction
638626|NCT00874172|Anemia|anemia
813836|NCT00189150|MPA|mpa
638627|NCT00874172|Sickle Cell|sickle cell
638628|NCT00874172|Analgesic|analgesic
638629|NCT00874172|Pain|pain
638630|NCT00874172|Emergency treatment|emergency treatment
638631|NCT00874172|Quality of life|quality of life
638632|NCT00874107|NSCLC|nsclc
638633|NCT00874107|Phase 2|phase 2
638634|NCT00874107|Randomized|randomized
638635|NCT00874107|Efficacy|efficacy
638636|NCT00874107|Safety|safety
638637|NCT00874107|Imprime PGG|imprime pgg
638638|NCT00874107|Bevacizumab|bevacizumab
638639|NCT00874094|nasolabial folds|nasolabial folds
638640|NCT00874094|platelet rich plasma|platelet rich plasma
638641|NCT00874094|fibrin matrix|fibrin matrix
638642|NCT00874094|facial rhytids|facial rhytids
638643|NCT00874094|dermal filler|dermal filler
638644|NCT00874068|term infants|term infants
638645|NCT00874068|preterm infants|preterm infants
638646|NCT00874068|bone strength|bone strength
638647|NCT00874068|Speed of sound (SOS)|speed of sound (sos)
638648|NCT00874068|Ultrasound|ultrasound
638649|NCT00874055|social influence|social influence
638650|NCT00874055|friends|friends
638651|NCT00874055|eating behavior|eating behavior
638652|NCT00874055|childhood overweight|childhood overweight
638653|NCT00874042|dose escalation|dose escalation
638654|NCT00874042|safety|safety
638655|NCT00874042|tolerability|tolerability
638656|NCT00874042|tumor|tumor
638657|NCT00874042|PK|pk
638658|NCT00874029|Uterine Fibroids|uterine fibroids
638659|NCT00874029|Myomas|myomas
638660|NCT00874016|intubation|intubation
638661|NCT00874016|Airtraq|airtraq
638662|NCT00874016|pediatric|pediatric
638663|NCT00874016|airway|airway
638664|NCT00874003|alcohol dependence|alcohol dependence
638665|NCT00874003|anti-depressant|anti-depressant
638666|NCT00874003|5-HT|5-ht
638667|NCT00874003|NE|ne
638668|NCT00873990|fissure sealant|fissure sealant
638669|NCT00873990|self etch|self etch
638670|NCT00873990|total etch|total etch
638671|NCT00873977|Adherence|adherence
638672|NCT00873977|Continuous Positive Airway Pressure|continuous positive airway pressure
638673|NCT00873964|Metabolic Syndrome|metabolic syndrome
638674|NCT00873964|Obesity|obesity
638675|NCT00873964|Elderly|elderly
638676|NCT00873964|Insulin Resistance|insulin resistance
638677|NCT00873938|Artesunate-Amodiaquine|artesunate-amodiaquine
638678|NCT00873938|Compliance|compliance
638679|NCT00873938|Malaria|malaria
638680|NCT00873925|Type 1 Diabetes|type 1 diabetes
638681|NCT00873912|influenza|influenza
638682|NCT00873912|FluMist|flumist
638683|NCT00873899|Heart Failure|heart failure
638684|NCT00873899|Implantable defibrillator|implantable defibrillator
638685|NCT00873899|Remote Monitoring|remote monitoring
638686|NCT00873873|Asthma Progression|asthma progression
638687|NCT00873873|Airway Wall Thickness|airway wall thickness
638688|NCT00873873|Corticosteroid Resistance|corticosteroid resistance
638689|NCT00873873|Biomarkers|biomarkers
638690|NCT00873873|Pulmonary Physiology|pulmonary physiology
638691|NCT00873860|CAT-354|cat-354
638692|NCT00873860|Tralokinumab|tralokinumab
638693|NCT00873860|Asthma|asthma
638694|NCT00873847|NICHD Neonatal Research Network|nichd neonatal research network
638695|NCT00873847|Very Low Birth Weight (VLBW)|very low birth weight (vlbw)
638696|NCT00873847|Extremely Low Birth Weight (ELBW)|extremely low birth weight (elbw)
638697|NCT00873847|Prematurity|prematurity
638698|NCT00873847|Amplitude-integrated Electroencephalography (aEEG)|amplitude-integrated electroencephalography (aeeg)
638699|NCT00873834|autism|autism
638700|NCT00873834|fluoxetine|fluoxetine
638701|NCT00873834|Comparative|comparative
638702|NCT00873834|double blind|double blind
638703|NCT00873834|placebo|placebo
638704|NCT00873834|controlled trial|controlled trial
638705|NCT00873834|anatomy-functional imaging|anatomy-functional imaging
638706|NCT00873834|children|children
638707|NCT00873834|DSM-IV-R criteria for autism and CARS score (of 30 or above)|dsm-iv-r criteria for autism and cars score (of 30 or above)
638708|NCT00873808|breast cancer|breast cancer
638709|NCT00873795|efficacy|efficacy
638710|NCT00873795|tolerability|tolerability
638711|NCT00873795|combination of aripiprazole and SSRI(sertraline)|combination of aripiprazole and ssri(sertraline)
638712|NCT00873782|Limb Perfusion|limb perfusion
638713|NCT00873782|Gene Therapy|gene therapy
638714|NCT00873769|Staccato Loxapine|staccato loxapine
638715|NCT00873769|pharmacokinetics|pharmacokinetics
638716|NCT00873769|smokers|smokers
638717|NCT00873769|non-smokers|non-smokers
638718|NCT00873756|CRC|crc
638719|NCT00873756|Colon Cancer|colon cancer
638720|NCT00873756|Avastin|avastin
638721|NCT00873756|Apo2L/TRAIL|apo2l/trail
638722|NCT00873743|lower pain intensity with combination drug after cesarian section in first 48h postoperatively|lower pain intensity with combination drug after cesarian section in first 48h postoperatively
638723|NCT00873730|Effect of etanercept in subjects with ankylosing spondylitis|effect of etanercept in subjects with ankylosing spondylitis
638724|NCT00873717|elderly|elderly
638725|NCT00873717|long-term facilities|long-term facilities
638726|NCT00873717|nutritional status|nutritional status
638727|NCT00873691|Patients indicated for an ICD/ CRT-D|patients indicated for an icd/ crt-d
638728|NCT00873678|Molar tooth|molar tooth
638729|NCT00873678|AHI1 gene|ahi1 gene
638730|NCT00873678|CEP290 gene|cep290 gene
638731|NCT00873678|ciliopathies|ciliopathies
638732|NCT00873652|Hepatitis B vaccine|hepatitis b vaccine
638733|NCT00873652|Booster dose|booster dose
638734|NCT00873652|Persistence|persistence
638735|NCT00873652|Immune response|immune response
638736|NCT00873652|Healthy children|healthy children
638737|NCT00873626|Urinary tract infection|urinary tract infection
638738|NCT00873626|treatment duration|treatment duration
638739|NCT00873626|acute pyelonephritis|acute pyelonephritis
638740|NCT00873626|good use of antibiotics|good use of antibiotics
638741|NCT00873600|cognitive/functional effects|cognitive/functional effects
638742|NCT00873600|psychosocial effects of cancer and its treatment|psychosocial effects of cancer and its treatment
638743|NCT00873600|stage I breast cancer|stage i breast cancer
638744|NCT00873600|stage II breast cancer|stage ii breast cancer
638745|NCT00873600|stage IIIA breast cancer|stage iiia breast cancer
638746|NCT00873600|stage IIIB breast cancer|stage iiib breast cancer
638747|NCT00873600|stage IIIC breast cancer|stage iiic breast cancer
638748|NCT00873600|adenocarcinoma of the colon|adenocarcinoma of the colon
638749|NCT00873600|stage I colon cancer|stage i colon cancer
638750|NCT00873600|stage II colon cancer|stage ii colon cancer
638751|NCT00873600|stage III colon cancer|stage iii colon cancer
638752|NCT00873587|Thoracotomy|thoracotomy
638753|NCT00873587|Inspiration|inspiration
638754|NCT00873587|Expiration|expiration
638755|NCT00873587|Chest Tube|chest tube
638756|NCT00873587|pneumothorax|pneumothorax
638757|NCT00873587|Method of chest tube removal|method of chest tube removal
638758|NCT00873574|Familial myeloproliferative disorders|familial myeloproliferative disorders
638759|NCT00873574|JAK-STAT|jak-stat
638760|NCT00873574|V617|v617
638761|NCT00873574|JAK2|jak2
638762|NCT00873561|diabetes|diabetes
638763|NCT00873561|type 1|type 1
638764|NCT00873561|adult|adult
638765|NCT00873561|adolescent|adolescent
638766|NCT00873561|new onset|new onset
638767|NCT00873535|Nicotine|nicotine
638768|NCT00873535|Nicotine dependence|nicotine dependence
638769|NCT00873535|Smoking cessation|smoking cessation
638770|NCT00873535|Alcohol|alcohol
638771|NCT00873535|Alcohol dependence|alcohol dependence
638772|NCT00873535|Alcohol cessation|alcohol cessation
638773|NCT00873535|Treatment|treatment
638774|NCT00873535|Smoking|smoking
638775|NCT00873535|Cigarette|cigarette
638776|NCT00873535|Heavy drinkers|heavy drinkers
638777|NCT00873535|Social drinkers|social drinkers
638778|NCT00873535|Co-morbidity of alcohol and nicotine dependence|co-morbidity of alcohol and nicotine dependence
638779|NCT00873535|Nicotine receptor|nicotine receptor
638780|NCT00873535|Nicotinic receptor|nicotinic receptor
638781|NCT00873535|Nicotinic acetycholine receptor|nicotinic acetycholine receptor
638782|NCT00873535|Alpha-4-beta-2 nicotinic acetycholine receptor|alpha-4-beta-2 nicotinic acetycholine receptor
638783|NCT00873535|Cholinergic receptor|cholinergic receptor
638784|NCT00873535|Dopamine|dopamine
638785|NCT00873535|Craving|craving
638786|NCT00873535|Diary|diary
638787|NCT00873535|Cue induced|cue induced
638788|NCT00873535|Pharmacotherapy|pharmacotherapy
638789|NCT00873535|Varenicline|varenicline
638790|NCT00873535|Chantix|chantix
638791|NCT00873535|Champix|champix
638792|NCT00873522|pneumonia|pneumonia
638793|NCT00873509|Autism|autism
638794|NCT00873496|Sjögren's Syndrome|sjögren's syndrome
638795|NCT00873496|hyposalivation|hyposalivation
638796|NCT00873496|mouth dryness|mouth dryness
638797|NCT00873496|complications|complications
638798|NCT00873483|Pregnancy prevention|pregnancy prevention
638799|NCT00873483|female contraception|female contraception
638800|NCT00873483|patch|patch
638801|NCT00873457|B-Cell Chronic Lymphocytic Leukemia|b-cell chronic lymphocytic leukemia
638802|NCT00873457|Leukemia|leukemia
638804|NCT00873444|Cementless|cementless
638805|NCT00873444|Ceramic-on-Metal|ceramic-on-metal
638806|NCT00873444|Metal-on-Metal|metal-on-metal
638807|NCT00873431|Prevention of pneumococcal infections|prevention of pneumococcal infections
638808|NCT00873418|Heart Failure|heart failure
638809|NCT00873418|Intervention|intervention
638810|NCT00873418|Cognitive Behavior Therapy|cognitive behavior therapy
638811|NCT00873418|Quality of Life|quality of life
638812|NCT00873405|Type 2 diabetes mellitus|type 2 diabetes mellitus
638813|NCT00873405|Metabolic control|metabolic control
638814|NCT00873405|Bariatric Surgery|bariatric surgery
638815|NCT00873405|Weight Loss|weight loss
638816|NCT00873405|Sleeve gastrectomy|sleeve gastrectomy
638817|NCT00873405|BMI reduction|bmi reduction
638818|NCT00873405|Waist circumference reduction|waist circumference reduction
638819|NCT00873405|Percentage of excess BMI loss|percentage of excess bmi loss
638820|NCT00873405|Glucose homeostasis|glucose homeostasis
638821|NCT00873392|Parkinson's disease|parkinson's disease
638822|NCT00873392|Motor fluctuation|motor fluctuation
638823|NCT00873392|Nicotine|nicotine
638824|NCT00873392|Drug treatment|drug treatment
638825|NCT00873392|neuroprotection|neuroprotection
638826|NCT00873366|stage I breast cancer|stage i breast cancer
638827|NCT00873366|stage II breast cancer|stage ii breast cancer
638828|NCT00873366|stage IIIA breast cancer|stage iiia breast cancer
638829|NCT00873366|stage IIIB breast cancer|stage iiib breast cancer
638830|NCT00873366|stage IIIC breast cancer|stage iiic breast cancer
638831|NCT00873353|Metastatic Adenocarcinoma of the Pancreas|metastatic adenocarcinoma of the pancreas
638832|NCT00873340|MS|ms
638833|NCT00873340|Multiple Sclerosis|multiple sclerosis
638834|NCT00873340|Betaferon|betaferon
638835|NCT00873340|Colombia|colombia
638836|NCT00873327|presumed sepsis|presumed sepsis
638837|NCT00873301|vulvodynia|vulvodynia
638838|NCT00873301|vestibulectomy|vestibulectomy
638839|NCT00873301|surgery|surgery
638840|NCT00873301|vestibulitis|vestibulitis
638841|NCT00873288|cervical intraepithelial neoplasia|cervical intraepithelial neoplasia
638842|NCT00873288|atypical squamous cells of undetermined significance|atypical squamous cells of undetermined significance
638843|NCT00873288|high-grade squamous intraepithelial lesion|high-grade squamous intraepithelial lesion
638844|NCT00873288|low-grade squamous intraepithelial lesion|low-grade squamous intraepithelial lesion
638845|NCT00873275|stage IV colon cancer|stage iv colon cancer
638846|NCT00873275|stage IV rectal cancer|stage iv rectal cancer
638847|NCT00873275|recurrent colon cancer|recurrent colon cancer
638848|NCT00873275|recurrent rectal cancer|recurrent rectal cancer
638849|NCT00873275|adenocarcinoma of the colon|adenocarcinoma of the colon
638850|NCT00873275|adenocarcinoma of the rectum|adenocarcinoma of the rectum
638851|NCT00873262|PreMenstrual Syndrome|premenstrual syndrome
638852|NCT00873262|Hormones|hormones
638853|NCT00873262|Skin tests|skin tests
638854|NCT00873262|Desensitization|desensitization
638855|NCT00873262|Allergen Immunotherapy|allergen immunotherapy
638856|NCT00873249|Schizophrenia|schizophrenia
638857|NCT00873249|Therapeutic adherence|therapeutic adherence
638858|NCT00873249|Short message system|short message system
638859|NCT00873249|Mobile phone|mobile phone
638860|NCT00873236|stage III renal cell cancer|stage iii renal cell cancer
638861|NCT00873236|stage IV renal cell cancer|stage iv renal cell cancer
638862|NCT00873210|renal cell carcinoma|renal cell carcinoma
638863|NCT00873210|sunitinib malate|sunitinib malate
638864|NCT00873197|Co-administration of transdermal and intravenous granisetron|co-administration of transdermal and intravenous granisetron
638865|NCT00873197|Granisetron|granisetron
638866|NCT00873197|Healthy subjects|healthy subjects
638867|NCT00873197|Intravenous|intravenous
638868|NCT00873197|Pharmacokinetic profile|pharmacokinetic profile
638869|NCT00873197|Sancuso® patch|sancuso® patch
638870|NCT00873197|Transdermal|transdermal
638871|NCT00873197|Pharmacokinetics|pharmacokinetics
638872|NCT00873184|massage therapy in patients with brain tumors|massage therapy in patients with brain tumors
638873|NCT00873171|Osteopathic Manipulation|osteopathic manipulation
638874|NCT00873158|Adhesive Capsulitis|adhesive capsulitis
638875|NCT00873158|ROM|rom
638876|NCT00873158|Dynasplint|dynasplint
638877|NCT00873145|Survival|survival
638878|NCT00873145|Function|function
638879|NCT00873145|Infection|infection
638880|NCT00873145|Revision|revision
638881|NCT00873145|Loosening|loosening
638882|NCT00873119|Belinostat|belinostat
638883|NCT00873119|PXD101|pxd101
638884|NCT00873119|Carboplatin|carboplatin
638885|NCT00873119|Paclitaxel|paclitaxel
638886|NCT00873119|CUP|cup
638887|NCT00873119|Carcinoma of unknown primary|carcinoma of unknown primary
638888|NCT00873119|Occult primary|occult primary
638889|NCT00873080|reliability|reliability
638890|NCT00873080|photogrammetry|photogrammetry
638891|NCT00873067|Atrial fibrillation|atrial fibrillation
638892|NCT00873067|Complex fractionated electrograms|complex fractionated electrograms
638893|NCT00873067|CFAE|cfae
638894|NCT00873041|Thalassemia|thalassemia
638895|NCT00873041|thalassemia intermedia|thalassemia intermedia
638896|NCT00873041|alpha-thalassemia|alpha-thalassemia
638897|NCT00873041|beta-thalassemia|beta-thalassemia
638898|NCT00873041|deferasirox|deferasirox
638899|NCT00873041|iron overload|iron overload
638900|NCT00873041|non-transfusion dependent|non-transfusion dependent
638901|NCT00873028|Physical therapy|physical therapy
638902|NCT00873028|Inspiratory muscles|inspiratory muscles
638903|NCT00873028|Exercise|exercise
638904|NCT00873015|Cerebral aneurysm|cerebral aneurysm
638905|NCT00873015|Subarachnoid hemorrhage|subarachnoid hemorrhage
638906|NCT00873015|Nitrite|nitrite
638907|NCT00873002|adult primary hepatocellular carcinoma|adult primary hepatocellular carcinoma
638908|NCT00873002|advanced adult primary liver cancer|advanced adult primary liver cancer
638909|NCT00873002|recurrent adult primary liver cancer|recurrent adult primary liver cancer
638910|NCT00873002|localized unresectable adult primary liver cancer|localized unresectable adult primary liver cancer
638911|NCT00872989|recurrent ovarian epithelial cancer|recurrent ovarian epithelial cancer
638912|NCT00872989|recurrent fallopian tube cancer|recurrent fallopian tube cancer
638913|NCT00872989|recurrent primary peritoneal cavity cancer|recurrent primary peritoneal cavity cancer
638914|NCT00872963|malaria vaccine|malaria vaccine
638915|NCT00872963|RTS,S,|rts,s,
638916|NCT00872950|LEMS|lems
638917|NCT00872950|CMS|cms
638918|NCT00872950|3,4 DIAMINOPYRIDINE|3,4 diaminopyridine
638919|NCT00872950|3,4 DAP|3,4 dap
638920|NCT00872924|Bioequivalence|bioequivalence
638921|NCT00872911|Sarcopenia|sarcopenia
638922|NCT00872911|nutrition|nutrition
638923|NCT00872911|aging|aging
638924|NCT00872911|metabolism|metabolism
638925|NCT00872911|exercise|exercise
638926|NCT00872898|autism|autism
638927|NCT00872898|memantine|memantine
638928|NCT00872898|pediatric|pediatric
638929|NCT00872898|Forest Laboratories|forest laboratories
638930|NCT00872898|Autism in pediatric patients|autism in pediatric patients
638931|NCT00872885|analgesic|analgesic
638932|NCT00872885|bunionectomy|bunionectomy
638933|NCT00872885|surgery|surgery
638934|NCT00872885|post operative pain|post operative pain
638935|NCT00872885|single Hallux valgus repair|single hallux valgus repair
638936|NCT00872872|NVP|nvp
638937|NCT00872872|PMTCT|pmtct
638938|NCT00872872|pregnancy|pregnancy
638939|NCT00872872|resistance|resistance
638940|NCT00872859|Breast Cancer|breast cancer
638941|NCT00872859|Cancer of Breast|cancer of breast
638942|NCT00872859|Reconstructive Surgery|reconstructive surgery
638943|NCT00872846|Body weight|body weight
638944|NCT00872846|Signs and symptoms|signs and symptoms
638945|NCT00872846|Obesity|obesity
638946|NCT00872846|Metabolic disease|metabolic disease
638947|NCT00872846|Diabetes mellitus type 2|diabetes mellitus type 2
638948|NCT00872846|Diabetes mellitus|diabetes mellitus
638949|NCT00872846|Nutrition disorder|nutrition disorder
638950|NCT00872846|Endocrine system diseases|endocrine system diseases
638951|NCT00872846|Overweight|overweight
638952|NCT00872846|Overnutrition|overnutrition
638953|NCT00872846|Glucose metabolic disorder|glucose metabolic disorder
638954|NCT00872833|Transfusion-Dependant Thalassemia|transfusion-dependant thalassemia
638955|NCT00872833|Pain|pain
638956|NCT00872833|Mild Pain|mild pain
638957|NCT00872820|Social Anxiety|social anxiety
638958|NCT00872820|Social Anxiety Treatment|social anxiety treatment
638959|NCT00872820|Cognitive Therapy|cognitive therapy
638960|NCT00872820|Mindfulness|mindfulness
638961|NCT00872820|Social Phobia|social phobia
638962|NCT00872820|Social Phobia Treatment|social phobia treatment
638963|NCT00872807|childhood|childhood
638964|NCT00872807|therapy|therapy
638965|NCT00872807|life style|life style
638966|NCT00872807|motor activity|motor activity
638967|NCT00872807|obesity|obesity
638968|NCT00872807|overweight|overweight
638969|NCT00872807|body mass index|body mass index
638970|NCT00872807|treatment|treatment
638971|NCT00872794|Hip|hip
638972|NCT00872794|Conservative|conservative
638973|NCT00872794|Metal on Metal|metal on metal
638974|NCT00872794|Resurfacing|resurfacing
638975|NCT00872781|Bioequivalence fixed dose combination of Quinapril HCl 20 mg and Hydrochlorothiazide 25 mg tablets|bioequivalence fixed dose combination of quinapril hcl 20 mg and hydrochlorothiazide 25 mg tablets
638976|NCT00872742|Impulse Control Disorders|impulse control disorders
638977|NCT00872742|Behavior Therapy|behavior therapy
638978|NCT00872742|Acceptance|acceptance
638979|NCT00872742|Habit Reversal|habit reversal
638980|NCT00872729|cystinosis|cystinosis
638981|NCT00872729|cysteamine|cysteamine
638982|NCT00872729|inheritable disease|inheritable disease
638983|NCT00872729|orphan disease|orphan disease
638984|NCT00872729|CTNS protein, human|ctns protein, human
638985|NCT00872729|nephropathic cystinosis|nephropathic cystinosis
638986|NCT00872716|specific phobia|specific phobia
638987|NCT00872716|simple phobia|simple phobia
638988|NCT00872716|anxiety disorder|anxiety disorder
638990|NCT00872703|Prenatal Diagnosis|prenatal diagnosis
638991|NCT00872703|Ultrasound|ultrasound
638992|NCT00872703|MRI|mri
638993|NCT00872690|Multiple Trauma|multiple trauma
638994|NCT00872690|Blast Injuries|blast injuries
638995|NCT00872690|Brain Injuries|brain injuries
638996|NCT00872690|Rehabilitation, Vocational|rehabilitation, vocational
638997|NCT00872690|Consumer participation|consumer participation
638998|NCT00872677|weight changes|weight changes
638999|NCT00872677|obesity|obesity
639000|NCT00872677|stage I breast cancer|stage i breast cancer
639001|NCT00872677|stage II breast cancer|stage ii breast cancer
639002|NCT00872677|stage IIIA breast cancer|stage iiia breast cancer
639003|NCT00872664|ROP|rop
639004|NCT00872664|anti-oxidants|anti-oxidants
639005|NCT00872664|carotenoids|carotenoids
639006|NCT00872651|Glaucoma|glaucoma
639007|NCT00872651|intraocular pressure|intraocular pressure
639008|NCT00872651|travoprost/timolol|travoprost/timolol
639009|NCT00872651|timolol|timolol
639010|NCT00872638|wound edge eversion|wound edge eversion
639011|NCT00872638|cosmetic outcomes|cosmetic outcomes
639012|NCT00872638|surgical incisions|surgical incisions
639013|NCT00872625|stage IA breast cancer|stage ia breast cancer
639014|NCT00872625|stage IB breast cancer|stage ib breast cancer
639015|NCT00872625|stage II breast cancer|stage ii breast cancer
639016|NCT00872625|stage IIIA breast cancer|stage iiia breast cancer
639017|NCT00872625|stage IIIB breast cancer|stage iiib breast cancer
639018|NCT00872625|stage IIIC breast cancer|stage iiic breast cancer
639019|NCT00872625|recurrent breast cancer|recurrent breast cancer
639020|NCT00872612|Sarcoidosis|sarcoidosis
639021|NCT00872612|Diagnosis|diagnosis
639022|NCT00872612|Non-caseating granulomas|non-caseating granulomas
639024|NCT00872612|EUS-FNA|eus-fna
639025|NCT00872612|EBUS-TBNA|ebus-tbna
639026|NCT00872612|TBLB|tblb
639027|NCT00872599|Hypertension|hypertension
639028|NCT00872599|Phenotyping|phenotyping
639029|NCT00872599|High Salt intake|high salt intake
639030|NCT00872599|frequently sampled IV glucose tolerance test(FSIVGTT)|frequently sampled iv glucose tolerance test(fsivgtt)
639031|NCT00872599|fenofibrate|fenofibrate
639032|NCT00872599|epoxyeicosatrienoic acids|epoxyeicosatrienoic acids
639033|NCT00872599|hydroxyeicosatetraenoic acids|hydroxyeicosatetraenoic acids
639034|NCT00872599|dihydroxyeicosatrienoic acid|dihydroxyeicosatrienoic acid
639035|NCT00872599|PPAR Alpha Agonist|ppar alpha agonist
639036|NCT00872599|CYP Monooxygenase Activity|cyp monooxygenase activity
639037|NCT00872573|Hip|hip
639038|NCT00872573|Cemented|cemented
639039|NCT00872547|Hip|hip
639040|NCT00872547|Resurfacing|resurfacing
639041|NCT00872547|Metal-on-Metal|metal-on-metal
639042|NCT00872547|Large Heads|large heads
639043|NCT00872547|XL Head|xl head
639044|NCT00872547|ASR - osteoarthritis (primary)|asr - osteoarthritis (primary)
639045|NCT00872534|To evaluate the acute gastrointestinal safety of PL-2100.|to evaluate the acute gastrointestinal safety of pl-2100.
639046|NCT00872521|Multiple Myeloma|multiple myeloma
639047|NCT00872521|transplant eligible|transplant eligible
639048|NCT00872521|doxorubicin|doxorubicin
639049|NCT00872521|dexamethasone|dexamethasone
639050|NCT00872521|bortezomib|bortezomib
639051|NCT00872521|bortezomib resistance|bortezomib resistance
639052|NCT00872521|PAD induction|pad induction
639053|NCT00872521|PIMMS Trial|pimms trial
639054|NCT00872495|Urothelial Cancer|urothelial cancer
639055|NCT00872495|Cancer|cancer
639056|NCT00872495|Bladder Neoplasms|bladder neoplasms
639057|NCT00872495|Urinary Bladder Cancer|urinary bladder cancer
639058|NCT00872482|non-small cell lung cancer|non-small cell lung cancer
639059|NCT00872482|NSCLC|nsclc
639060|NCT00872482|Brain metastases|brain metastases
639061|NCT00872482|nimotuzumab|nimotuzumab
639062|NCT00872482|TheraCIM|theracim
639063|NCT00872482|h-R3|h-r3
639064|NCT00872482|Radiation|radiation
639065|NCT00872469|Postpartum haemorrhage|postpartum haemorrhage
639066|NCT00872469|randomised controlled trial|randomised controlled trial
639067|NCT00872469|tranexamic acid|tranexamic acid
639068|NCT00872469|antifibrinolytic|antifibrinolytic
639069|NCT00872456|Diabetes Mellitus|diabetes mellitus
639070|NCT00872456|Cardiovascular Disease|cardiovascular disease
639071|NCT00872456|Haptoglobin|haptoglobin
639072|NCT00872430|constipation|constipation
639073|NCT00872430|RCT|rct
639074|NCT00872430|phytotherapy|phytotherapy
639075|NCT00872417|HIV/AIDS|hiv/aids
639076|NCT00872417|antiretroviral therapy|antiretroviral therapy
639077|NCT00872417|immune reconstitution|immune reconstitution
639078|NCT00872404|CP-751,871|cp-751,871
639079|NCT00872404|squamous cell carcinoma|squamous cell carcinoma
639080|NCT00872404|recurrent or metastatic|recurrent or metastatic
639081|NCT00872404|after 1st line chemotherapy|after 1st line chemotherapy
639082|NCT00872378|Morbid Obesity|morbid obesity
639083|NCT00872378|LAP Band|lap band
639084|NCT00872378|Adjustable Gastric Band|adjustable gastric band
639085|NCT00872378|Exenatide|exenatide
639086|NCT00872378|Byetta|byetta
639087|NCT00872378|Weight Loss|weight loss
639088|NCT00872378|Bariatric Surgery|bariatric surgery
639089|NCT00872365|Pregnancy|pregnancy
639090|NCT00872365|Exercise|exercise
639091|NCT00872365|Nutrition|nutrition
639092|NCT00872365|Micronutrients|micronutrients
639093|NCT00872365|non-transmissible chronic diseases|non-transmissible chronic diseases
639094|NCT00872365|Endothelium|endothelium
639095|NCT00872352|Multiple Myeloma|multiple myeloma
639096|NCT00872352|Bortezomib|bortezomib
639097|NCT00872352|Peripheral Neuropathy|peripheral neuropathy
639098|NCT00872352|evaluation|evaluation
639099|NCT00872352|evaluation of electrophysiological changes related to the dose and time of bortezomib administration|evaluation of electrophysiological changes related to the dose and time of bortezomib administration
639100|NCT00872352|investigation of correlation between the incidence of BIPN and the subtype of myeloma|investigation of correlation between the incidence of bipn and the subtype of myeloma
639101|NCT00872339|Transfusion-Dependent Thalassemia|transfusion-dependent thalassemia
639102|NCT00872339|Non-Transfusion-Dependent Thalassemia|non-transfusion-dependent thalassemia
639103|NCT00872326|Diabetes Complications|diabetes complications
639104|NCT00872326|Lower limb ischemia|lower limb ischemia
639105|NCT00872326|Adult stem cells|adult stem cells
639106|NCT00872313|Labor|labor
639107|NCT00872313|Psychology|psychology
639108|NCT00872313|Postpartum Psychology|postpartum psychology
639109|NCT00872287|minimally invasive surgery|minimally invasive surgery
639110|NCT00872287|scarless cholecystectomy|scarless cholecystectomy
639111|NCT00872287|new techniques in laparoscopy|new techniques in laparoscopy
639112|NCT00872287|invisible scar|invisible scar
639113|NCT00872287|single port access|single port access
639114|NCT00872287|abdominal pain|abdominal pain
639115|NCT00872287|shoulder pain|shoulder pain
639116|NCT00872274|Bioequivalence|bioequivalence
639117|NCT00872261|Clinical Trials as Topic|clinical trials as topic
639118|NCT00872261|Adolescent Psychology|adolescent psychology
639119|NCT00872261|Patient Acceptance of Health Care|patient acceptance of health care
639120|NCT00872261|HIV Risk Behaviors|hiv risk behaviors
639121|NCT00872261|Adolescents|adolescents
639122|NCT00872261|Clinical Trial Recruitment|clinical trial recruitment
639123|NCT00872261|Microbicide Acceptability|microbicide acceptability
639124|NCT00872261|Ethics|ethics
639125|NCT00872261|Mixed Methods|mixed methods
639126|NCT00872261|HIV|hiv
639127|NCT00872248|Restless leg syndrome|restless leg syndrome
639128|NCT00872248|Spinal anesthesia|spinal anesthesia
639129|NCT00872248|Epidural anesthesia|epidural anesthesia
639130|NCT00872248|Neuraxial block|neuraxial block
639131|NCT00872235|Bioequivalence fixed-dose combination of quinapril 20 mg and hydrochlorothiazide 25 mg tablets|bioequivalence fixed-dose combination of quinapril 20 mg and hydrochlorothiazide 25 mg tablets
639132|NCT00872222|Hip|hip
639133|NCT00872222|Cementless|cementless
639134|NCT00872222|Ceramic-on-Ceramic|ceramic-on-ceramic
639135|NCT00872209|swimmer's ear|swimmer's ear
639136|NCT00872209|ear drops|ear drops
639137|NCT00872209|ear foam|ear foam
639138|NCT00872209|otic foam|otic foam
639139|NCT00872209|ear infection|ear infection
639140|NCT00872209|ear pain|ear pain
639141|NCT00872209|ear inflammation|ear inflammation
639142|NCT00872183|Motor Learning|motor learning
639143|NCT00872183|Mirror Neurons|mirror neurons
639144|NCT00872183|Healthy Volunteer|healthy volunteer
639145|NCT00872183|HV|hv
639146|NCT00872170|Pulmonary Hypertension|pulmonary hypertension
639147|NCT00872157|Castrate-Resistant Prostate Cancer|castrate-resistant prostate cancer
639148|NCT00872157|Prostate|prostate
639149|NCT00872157|High-Volume Osseous Metastases|high-volume osseous metastases
639150|NCT00872157|BMTP-11|bmtp-11
639151|NCT00872157|Prostate State Antigen|prostate state antigen
639152|NCT00872157|PSA|psa
639153|NCT00872131|Anxiety|anxiety
639154|NCT00872131|Social Phobia|social phobia
639155|NCT00872131|Generalized Social Anxiety Disorder|generalized social anxiety disorder
639156|NCT00872118|alcohol consumption|alcohol consumption
639157|NCT00872118|social anxiety|social anxiety
639158|NCT00872118|brief intervention|brief intervention
639159|NCT00872118|motivational interviewing|motivational interviewing
639160|NCT00872118|cognitive behavioral|cognitive behavioral
639161|NCT00872105|clavicle|clavicle
639162|NCT00872105|fractures|fractures
639163|NCT00872105|distal|distal
639164|NCT00872092|small bowel|small bowel
639165|NCT00872092|bacterial overgrowth|bacterial overgrowth
639166|NCT00872079|warfarin|warfarin
639167|NCT00872079|pharmacokinetics|pharmacokinetics
639168|NCT00872079|pharmacodynamics|pharmacodynamics
639169|NCT00872066|Hip|hip
639170|NCT00872066|Bone Cement|bone cement
639171|NCT00872053|robot|robot
639172|NCT00872053|treadmill|treadmill
639173|NCT00872053|foot drop|foot drop
639174|NCT00872053|rehabilitation|rehabilitation
639175|NCT00872053|gait|gait
639176|NCT00872040|Sexual function|sexual function
639177|NCT00872040|Pelvic floor disorders|pelvic floor disorders
639178|NCT00872040|Delivery mode|delivery mode
639179|NCT00872027|Critical Illness|critical illness
639180|NCT00872027|Intensive Care Unit|intensive care unit
639973|NCT00869063|patch|patch
639181|NCT00872027|Acute Respiratory Failure|acute respiratory failure
639182|NCT00872027|Prolonged Mechanical Ventilation|prolonged mechanical ventilation
639183|NCT00871975|LUTS|luts
639184|NCT00871975|OAB|oab
639185|NCT00871962|long-term oxygen therapy|long-term oxygen therapy
639186|NCT00871962|COPD patients on necessity of long-term oxygen therapy|copd patients on necessity of long-term oxygen therapy
639187|NCT00871949|Safety tolerability pharmacokinetics PK first in human FIH|safety tolerability pharmacokinetics pk first in human fih
639188|NCT00871923|Non-small cell lung cancer|non-small cell lung cancer
639189|NCT00871923|NSCLC|nsclc
639190|NCT00871923|Brain Metastases|brain metastases
639191|NCT00871923|Brain Cancer|brain cancer
639192|NCT00871923|Lung Cancer|lung cancer
639193|NCT00871923|Tarceva|tarceva
639194|NCT00871923|Erlotinib Hydrochloride|erlotinib hydrochloride
639195|NCT00871923|OSI-774|osi-774
639196|NCT00871923|Radiation Therapy|radiation therapy
639197|NCT00871923|Whole Brain Radiation Therapy|whole brain radiation therapy
639198|NCT00871923|WBRT|wbrt
639199|NCT00871897|Neuropsychology|neuropsychology
639200|NCT00871897|Cardiac Rehabilitation|cardiac rehabilitation
639201|NCT00871884|Post Concussion Syndrome|post concussion syndrome
639202|NCT00871884|Cognitive Behavioral Therapy|cognitive behavioral therapy
639203|NCT00871884|Anxiety Sensitivity|anxiety sensitivity
639204|NCT00871884|Mild Head Injury|mild head injury
639205|NCT00871884|Psychotherapy|psychotherapy
639206|NCT00871884|Chronic Post Concussion Symptoms|chronic post concussion symptoms
639207|NCT00871858|stage II breast cancer|stage ii breast cancer
639208|NCT00871858|stage IIIA breast cancer|stage iiia breast cancer
639209|NCT00871858|stage IIIB breast cancer|stage iiib breast cancer
639210|NCT00871858|estrogen receptor-positive breast cancer|estrogen receptor-positive breast cancer
639211|NCT00871858|progesterone receptor-positive breast cancer|progesterone receptor-positive breast cancer
639212|NCT00871845|obesity|obesity
639213|NCT00871845|hepatitis C|hepatitis c
639214|NCT00871845|insulin resistance|insulin resistance
639215|NCT00871845|metabolic syndrome|metabolic syndrome
639216|NCT00871832|hyperglycemia|hyperglycemia
639217|NCT00871832|HgA1c|hga1c
639218|NCT00871832|mortality|mortality
639219|NCT00871819|Spinal Cord Stimulation|spinal cord stimulation
639220|NCT00871806|Pharmacokinetics|pharmacokinetics
639221|NCT00871806|eletriptan|eletriptan
639222|NCT00871806|bioavailability|bioavailability
639223|NCT00871806|oral disintegrating tablet|oral disintegrating tablet
639224|NCT00871780|TYSABRI naive|tysabri naive
639225|NCT00871780|Relapsing-remitting multiple sclerosis (RRMS)|relapsing-remitting multiple sclerosis (rrms)
639226|NCT00871767|AZD5672|azd5672
639227|NCT00871767|relative bioavailability|relative bioavailability
639228|NCT00871767|rheumatoid arthritis (RA)|rheumatoid arthritis (ra)
639229|NCT00871754|Bladder Cancer|bladder cancer
639230|NCT00871754|Cancer, bladder|cancer, bladder
639231|NCT00871754|Urinary Bladder Cancer|urinary bladder cancer
639232|NCT00871741|Combined vaccine|combined vaccine
639233|NCT00871741|Primary vaccination|primary vaccination
639234|NCT00871728|Onychomycosis, Toe|onychomycosis, toe
639235|NCT00871728|Itraconazole|itraconazole
639236|NCT00871728|Sporanox|sporanox
639237|NCT00871715|stroke|stroke
639238|NCT00871715|hemiparesis|hemiparesis
639239|NCT00871715|physical therapy|physical therapy
639240|NCT00871715|occupational therapy|occupational therapy
639241|NCT00871715|neurorehabilitation|neurorehabilitation
639242|NCT00871715|patient focused|patient focused
639243|NCT00871715|motor learning|motor learning
639244|NCT00871715|motor control|motor control
639245|NCT00871715|skill acquisition|skill acquisition
639246|NCT00871715|skill training|skill training
639247|NCT00871715|motor recovery|motor recovery
639248|NCT00871715|task oriented training|task oriented training
639249|NCT00871715|task specific training|task specific training
639250|NCT00871715|arm function|arm function
639251|NCT00871715|hand function|hand function
639252|NCT00871715|upper extremity|upper extremity
639253|NCT00871715|arm therapy|arm therapy
639254|NCT00871715|physical rehabilitation|physical rehabilitation
639255|NCT00871715|arm rehabilitation|arm rehabilitation
639256|NCT00871715|motor function|motor function
639257|NCT00871702|Leukemia|leukemia
639258|NCT00871702|Lymphoma, Non-Hodgkin|lymphoma, non-hodgkin
639259|NCT00871702|Hodgkin Disease|hodgkin disease
639260|NCT00871702|Myelodysplastic Syndromes|myelodysplastic syndromes
639261|NCT00871702|Multiple Myeloma|multiple myeloma
639262|NCT00871689|recurrent adult acute myeloid leukemia|recurrent adult acute myeloid leukemia
639263|NCT00871689|adult acute myeloid leukemia with 11q23 (MLL) abnormalities|adult acute myeloid leukemia with 11q23 (mll) abnormalities
639264|NCT00871689|adult acute myeloid leukemia with inv(16)(p13;q22)|adult acute myeloid leukemia with inv(16)(p13;q22)
639265|NCT00871689|adult acute myeloid leukemia with t(15;17)(q22;q12)|adult acute myeloid leukemia with t(15;17)(q22;q12)
639266|NCT00871689|adult acute myeloid leukemia with t(16;16)(p13;q22)|adult acute myeloid leukemia with t(16;16)(p13;q22)
639267|NCT00871689|adult acute myeloid leukemia with t(8;21)(q22;q22)|adult acute myeloid leukemia with t(8;21)(q22;q22)
639268|NCT00871689|recurrent childhood acute myeloid leukemia|recurrent childhood acute myeloid leukemia
639269|NCT00871689|secondary acute myeloid leukemia|secondary acute myeloid leukemia
639678|NCT00870246|pulmonary emphysema|pulmonary emphysema
639270|NCT00871689|childhood acute myeloid leukemia with 11q23 (MLL) abnormalities|childhood acute myeloid leukemia with 11q23 (mll) abnormalities
639271|NCT00871689|childhood acute myeloid leukemia with inv(16)(p13;q22)|childhood acute myeloid leukemia with inv(16)(p13;q22)
639272|NCT00871689|childhood acute myeloid leukemia with t(15;17)(q22;q12)|childhood acute myeloid leukemia with t(15;17)(q22;q12)
639273|NCT00871689|childhood acute myeloid leukemia with t(16;16)(p13;q22)|childhood acute myeloid leukemia with t(16;16)(p13;q22)
639274|NCT00871689|childhood acute myeloid leukemia with t(8;21)(q22;q22)|childhood acute myeloid leukemia with t(8;21)(q22;q22)
639275|NCT00871650|Post Traumatic Stress Disorder|post traumatic stress disorder
639276|NCT00871650|PTSD|ptsd
639277|NCT00871650|Brain|brain
639278|NCT00871650|Imaging|imaging
639279|NCT00871650|PET|pet
639280|NCT00871650|Neural|neural
639281|NCT00871650|Sleep|sleep
639282|NCT00871650|REM Sleep|rem sleep
639283|NCT00871637|Pulmonary disease, chronic obstructive|pulmonary disease, chronic obstructive
639284|NCT00871637|Airway macrophages|airway macrophages
639285|NCT00871637|Sputum milieu|sputum milieu
639286|NCT00871637|Airway inflammation|airway inflammation
639287|NCT00871637|Occupational diseases|occupational diseases
639288|NCT00871611|Hereditary|hereditary
639289|NCT00871611|Anderson-Fabry|anderson-fabry
639290|NCT00871611|prevalence|prevalence
639291|NCT00871611|heart|heart
639292|NCT00871611|hypertrophy|hypertrophy
639293|NCT00871611|urine|urine
639294|NCT00871611|globotriaosylceramide|globotriaosylceramide
639295|NCT00871611|isoforms|isoforms
814727|NCT00183547|CBT|cbt
639296|NCT00871611|α - Galactosidase|α - galactosidase
639297|NCT00871598|plaque psoriasis|plaque psoriasis
639298|NCT00871598|BTT1023|btt1023
639299|NCT00871598|safety|safety
639300|NCT00871598|pharmacokinetics|pharmacokinetics
639301|NCT00871585|bicalutamide|bicalutamide
639302|NCT00871585|PSA|psa
639303|NCT00871585|advanced prostate cancer|advanced prostate cancer
639304|NCT00871572|Diabetes Mellitus, Type 2|diabetes mellitus, type 2
639305|NCT00871533|Biochemical Marker|biochemical marker
639306|NCT00871533|Biochemical Markers|biochemical markers
639307|NCT00871533|Biologic Marker|biologic marker
639308|NCT00871533|Biologic Markers|biologic markers
639309|NCT00871533|Biomarkers|biomarkers
639310|NCT00871533|Clinical Marker|clinical marker
639311|NCT00871533|Clinical Markers|clinical markers
639312|NCT00871533|Immune Marker|immune marker
639313|NCT00871533|Immune Markers|immune markers
639314|NCT00871533|Immunologic Marker|immunologic marker
639315|NCT00871533|Immunologic Markers|immunologic markers
639316|NCT00871533|Laboratory Marker|laboratory marker
639317|NCT00871533|Laboratory Markers|laboratory markers
639318|NCT00871533|Marker, Biochemical|marker, biochemical
639319|NCT00871533|Marker, Biological|marker, biological
639320|NCT00871533|Marker, Clinical|marker, clinical
639321|NCT00871533|Marker, Immunologic|marker, immunologic
639322|NCT00871533|Marker, Laboratory|marker, laboratory
639323|NCT00871533|Marker, Serum|marker, serum
639324|NCT00871533|Marker, Surrogate|marker, surrogate
639325|NCT00871533|Markers, Biochemical|markers, biochemical
639326|NCT00871533|Markers, Biological|markers, biological
639327|NCT00871533|Markers, Clinical|markers, clinical
639328|NCT00871533|Markers, Immunologic|markers, immunologic
639329|NCT00871533|Markers, Laboratory|markers, laboratory
639330|NCT00871533|Markers, Serum|markers, serum
639331|NCT00871533|Markers, Surrogate|markers, surrogate
639332|NCT00871533|Markers, Viral|markers, viral
639333|NCT00871533|Serum Marker|serum marker
639334|NCT00871533|Serum Markers|serum markers
639335|NCT00871533|Surrogate End Point|surrogate end point
639336|NCT00871533|Surrogate End Points|surrogate end points
639337|NCT00871533|Surrogate Endpoint|surrogate endpoint
639338|NCT00871533|Surrogate Endpoints|surrogate endpoints
639339|NCT00871533|Surrogate Marker|surrogate marker
639340|NCT00871533|Surrogate Markers|surrogate markers
639341|NCT00871533|Viral Marker|viral marker
639342|NCT00871533|Viral Markers|viral markers
639343|NCT00871520|Palliative Care|palliative care
639344|NCT00871520|Predictive Value of Tests|predictive value of tests
639345|NCT00871520|Prospective Studies|prospective studies
639346|NCT00871520|Survival Analysis|survival analysis
639347|NCT00871520|Survival prediction|survival prediction
639348|NCT00871507|Diabetes Mellitus, Type 2|diabetes mellitus, type 2
639349|NCT00871455|Spinal Cord Injury|spinal cord injury
639350|NCT00871455|Baclofen|baclofen
639351|NCT00871455|Growth Hormone, Pituitary|growth hormone, pituitary
639352|NCT00871455|Insulin-Like Growth Factor I|insulin-like growth factor i
639353|NCT00871442|PCEA|pcea
639354|NCT00871442|labor and delivery|labor and delivery
639355|NCT00871442|pain|pain
639356|NCT00871442|epidural|epidural
639357|NCT00871442|anesthesia|anesthesia
639358|NCT00871442|pregnant women|pregnant women
639359|NCT00871429|skin toxicity|skin toxicity
639360|NCT00871429|cancer patients|cancer patients
639361|NCT00871429|adverse effects|adverse effects
639362|NCT00871403|GW786034|gw786034
639363|NCT00871403|pazopanib|pazopanib
639364|NCT00871403|pemetrexed|pemetrexed
639365|NCT00871403|cisplatin|cisplatin
639366|NCT00871403|non-small cell lung cancer|non-small cell lung cancer
639367|NCT00871403|NSCLC|nsclc
639368|NCT00871390|Paroxysmal Atrial Fibrillation|paroxysmal atrial fibrillation
639369|NCT00871390|Permanent/Persistent Atrial Fibrillation|permanent/persistent atrial fibrillation
639370|NCT00871377|epilepsy|epilepsy
639371|NCT00871377|cardiac risk factors|cardiac risk factors
639372|NCT00871377|memory|memory
639373|NCT00871377|cognition|cognition
639374|NCT00871377|n-3 fatty acids|n-3 fatty acids
639375|NCT00871377|fish oil|fish oil
639376|NCT00871377|EPA|epa
639377|NCT00871377|DHA|dha
639378|NCT00871377|seizures|seizures
639379|NCT00871364|Bioequivalence|bioequivalence
639380|NCT00871364|venlafaxine|venlafaxine
639381|NCT00871364|Healthy subjects|healthy subjects
639382|NCT00871338|combined|combined
639383|NCT00871338|Vaccines|vaccines
639384|NCT00871325|Gastric emptying|gastric emptying
639385|NCT00871325|Small bowel transit|small bowel transit
639386|NCT00871325|Colonic transit|colonic transit
639387|NCT00871325|Whole gut transit|whole gut transit
639388|NCT00871325|Postoperative Ileus|postoperative ileus
639389|NCT00871312|diabetes|diabetes
639390|NCT00871312|diabetic|diabetic
639391|NCT00871312|wound|wound
639392|NCT00871312|ulcer|ulcer
639393|NCT00871312|lower extremity|lower extremity
639394|NCT00871312|foot|foot
639395|NCT00871312|oxygen|oxygen
639396|NCT00871312|hyperbaric|hyperbaric
639397|NCT00871312|topical wound oxygen|topical wound oxygen
639398|NCT00871299|Treatment-resistant depression, meditation, mindfulness|treatment-resistant depression, meditation, mindfulness
639399|NCT00871286|Chronic rhinosinusitis|chronic rhinosinusitis
639400|NCT00871286|Chronic sinusitis|chronic sinusitis
639401|NCT00871286|CRS|crs
639402|NCT00871273|capecitabine|capecitabine
639403|NCT00871273|total gastrectomy|total gastrectomy
639404|NCT00871273|pharmacokinetic|pharmacokinetic
639405|NCT00871260|Coronary Disease|coronary disease
639406|NCT00871260|Stress Testing|stress testing
639407|NCT00871260|Lexiscan (regadenoson)|lexiscan (regadenoson)
639408|NCT00871260|Cardiac Magnetic Resonance Imaging|cardiac magnetic resonance imaging
639409|NCT00871247|Bioequivalence|bioequivalence
639410|NCT00871247|finasteride|finasteride
639411|NCT00871247|Healthy subjects|healthy subjects
639412|NCT00871234|HIV|hiv
639413|NCT00871234|Endothelial function|endothelial function
639414|NCT00871234|Etravirine|etravirine
639415|NCT00871208|Atopic Dermatitis|atopic dermatitis
639416|NCT00871208|pruritus|pruritus
639417|NCT00871208|quality of life|quality of life
639418|NCT00871195|Rhesus D|rhesus d
639419|NCT00871195|RHD|rhd
639420|NCT00871195|genotype|genotype
639421|NCT00871195|phenotype|phenotype
639422|NCT00871195|neonatal|neonatal
639423|NCT00871195|noninvasive|noninvasive
639424|NCT00871195|fetal|fetal
639425|NCT00871195|MassARRAY|massarray
639426|NCT00871195|DNA|dna
639427|NCT00871182|COPD|copd
639428|NCT00871182|obstructive lung diseases|obstructive lung diseases
639429|NCT00871182|Tiotropium|tiotropium
639430|NCT00871169|Irinotecan|irinotecan
639431|NCT00871169|Oxaliplatin|oxaliplatin
639432|NCT00871169|Cetuximab|cetuximab
639433|NCT00871169|Advanced or metastatic pancreatic cancer|advanced or metastatic pancreatic cancer
639434|NCT00871156|Drug-Drug Interaction|drug-drug interaction
639435|NCT00871143|CBT|cbt
639436|NCT00871143|BDD|bdd
639437|NCT00871130|Thyroid gland|thyroid gland
639438|NCT00871130|bariatric surgery|bariatric surgery
639439|NCT00871130|weight loss|weight loss
639440|NCT00871130|thyroid hormones|thyroid hormones
639441|NCT00871130|adult|adult
639442|NCT00871130|morbid obesity|morbid obesity
639443|NCT00871130|cohort|cohort
639444|NCT00871117|Co-administration|co-administration
639445|NCT00871117|Immunization|immunization
639446|NCT00871117|Preschool|preschool
639447|NCT00871117|Booster|booster
639448|NCT00871104|Infective endocarditis|infective endocarditis
639449|NCT00871091|CAD/CAM|cad/cam
639450|NCT00871091|orthodontics|orthodontics
639451|NCT00871091|fixed appliance|fixed appliance
639452|NCT00871091|tooth movement|tooth movement
639453|NCT00871065|Cerebral Vasospasm|cerebral vasospasm
639454|NCT00871065|Vasospasm|vasospasm
639455|NCT00871065|Subarachnoid Hemorrhage|subarachnoid hemorrhage
639456|NCT00871065|Sildenafil citrate|sildenafil citrate
639457|NCT00871065|Aneurysm|aneurysm
639458|NCT00871065|Intracranial aneurysm|intracranial aneurysm
639459|NCT00871052|Polymorphic light eruption|polymorphic light eruption
639460|NCT00871052|UV radiation|uv radiation
639461|NCT00871052|Vitamin D|vitamin d
639462|NCT00871052|Immune suppression|immune suppression
639463|NCT00871052|Prevention|prevention
639464|NCT00871039|Alcoholism|alcoholism
639465|NCT00871039|Mechanical ventilation|mechanical ventilation
639466|NCT00871026|CAD/CAM|cad/cam
639467|NCT00871026|orthodontics|orthodontics
639468|NCT00871026|fixed appliance|fixed appliance
639469|NCT00871026|tooth movement|tooth movement
639470|NCT00871026|Adverse Effects|adverse effects
639471|NCT00871026|Time Factors|time factors
639472|NCT00871026|Treatment Outcome|treatment outcome
639575|NCT00870558|advanced adult primary liver cancer|advanced adult primary liver cancer
639972|NCT00869063|diclofenac|diclofenac
639473|NCT00871013|This study is being done in an attempt to improve the remission rate and the survival time for participants with high-risk myeloma|this study is being done in an attempt to improve the remission rate and the survival time for participants with high-risk myeloma
639474|NCT00871000|Boostrix Polio|boostrix polio
639475|NCT00871000|dTpa-IPV|dtpa-ipv
639476|NCT00870987|Malaria|malaria
639477|NCT00870987|Vaccine|vaccine
639478|NCT00870974|Parkinson|parkinson
639479|NCT00870974|Huntington's|huntington's
639480|NCT00870974|Fragile X|fragile x
639481|NCT00870974|Autistic Spectrum|autistic spectrum
639482|NCT00870974|Alzheimer's|alzheimer's
639483|NCT00870974|MCI|mci
639484|NCT00870961|colon cancer|colon cancer
639485|NCT00870961|rectal cancer|rectal cancer
639486|NCT00870961|adenomatous polyp|adenomatous polyp
639487|NCT00870948|Open Label|open label
639488|NCT00870948|Healthy Volunteers|healthy volunteers
639489|NCT00870935|Balloon catheter|balloon catheter
639490|NCT00870935|Cervical vacuum cup|cervical vacuum cup
639491|NCT00870935|Hysterosalpingography|hysterosalpingography
639492|NCT00870935|Infertility|infertility
639493|NCT00870935|Pain|pain
639494|NCT00870935|Fallopian Tube Patency Tests|fallopian tube patency tests
639495|NCT00870935|Female Infertility|female infertility
639496|NCT00870896|capsaicin|capsaicin
639497|NCT00870896|COPD|copd
639498|NCT00870896|COPD with chronic bronchitis|copd with chronic bronchitis
639499|NCT00870870|Tumors|tumors
639500|NCT00870870|Antibodies, Monoclonal|antibodies, monoclonal
639501|NCT00870870|Stage IIIb Metastatic Non-Small Cell Lung Cancer|stage iiib metastatic non-small cell lung cancer
639502|NCT00870870|Stage IV Metastatic Non-Small Cell Lung Cancer|stage iv metastatic non-small cell lung cancer
639503|NCT00870857|Lungs|lungs
639504|NCT00870857|antiretrovirals|antiretrovirals
639505|NCT00870857|HIV|hiv
639506|NCT00870857|COPD|copd
639507|NCT00870844|Acute ischemic stroke|acute ischemic stroke
639508|NCT00870844|Erythropoietin|erythropoietin
639509|NCT00870844|Carbamylated|carbamylated
639510|NCT00870844|Neuroprotection|neuroprotection
639511|NCT00870831|diabetes|diabetes
639512|NCT00870818|Teplizumab|teplizumab
639513|NCT00870818|Protege|protege
639514|NCT00870818|MGA031|mga031
639515|NCT00870818|Monoclonal antibody|monoclonal antibody
639516|NCT00870818|Type 1 Diabetes Mellitus|type 1 diabetes mellitus
639517|NCT00870818|T1DM|t1dm
639518|NCT00870818|MacroGenics|macrogenics
639519|NCT00870792|HIV|hiv
639520|NCT00870792|antiretroviral therapy|antiretroviral therapy
639521|NCT00870792|medication adherence|medication adherence
639522|NCT00870792|Treatment Experienced|treatment experienced
639523|NCT00870779|Fluorescence|fluorescence
639524|NCT00870779|Brain Tumor|brain tumor
639525|NCT00870779|Malignant Glioma|malignant glioma
639526|NCT00870779|Pituitary Tumor|pituitary tumor
639527|NCT00870779|Skull Base Tumor|skull base tumor
639528|NCT00870779|Brain Lesions|brain lesions
639529|NCT00870779|Brain Metastases|brain metastases
639530|NCT00870779|Meningioma|meningioma
639531|NCT00870753|Eating disorders|eating disorders
639532|NCT00870753|yoga|yoga
639533|NCT00870753|body awareness|body awareness
639534|NCT00870753|depression|depression
639535|NCT00870753|anxiety|anxiety
639536|NCT00870740|MS|ms
639537|NCT00870740|Multiple Sclerosis|multiple sclerosis
639538|NCT00870727|PDD NOS|pdd nos
639539|NCT00870714|Prostate Cancer|prostate cancer
639540|NCT00870714|Neoadjuvant|neoadjuvant
639541|NCT00870701|sarcoma|sarcoma
639542|NCT00870701|soft tissue|soft tissue
639543|NCT00870701|members|members
639544|NCT00870701|radiotherapy|radiotherapy
639545|NCT00870701|absence of radiotherapy|absence of radiotherapy
639546|NCT00870688|valproate|valproate
639547|NCT00870688|epilepsy|epilepsy
639548|NCT00870688|compliance|compliance
639549|NCT00870688|sustained released minitablet|sustained released minitablet
639550|NCT00870688|Orfiril long|orfiril long
639551|NCT00870675|Ventriculomegaly|ventriculomegaly
639552|NCT00870675|ultrasound|ultrasound
639553|NCT00870675|MRI|mri
639554|NCT00870675|fetus|fetus
639555|NCT00870649|Schistosomiasis vaccine|schistosomiasis vaccine
639556|NCT00870649|therapeutic vaccine|therapeutic vaccine
639557|NCT00870649|Bilhvax|bilhvax
639558|NCT00870636|Pan-Vascular Endothelial Growth Factor Blockade|pan-vascular endothelial growth factor blockade
639559|NCT00870636|Safety|safety
639560|NCT00870636|ROP|rop
639561|NCT00870636|Bevacizumab|bevacizumab
639562|NCT00870636|Avastin|avastin
639563|NCT00870610|jugular venous oxygen saturation|jugular venous oxygen saturation
639564|NCT00870610|hypothermia|hypothermia
639565|NCT00870597|Floaters|floaters
639566|NCT00870597|multifocal IOL|multifocal iol
639567|NCT00870597|visual complaints|visual complaints
639568|NCT00870597|vitrectomy|vitrectomy
639569|NCT00870584|Asthma; asthma management; asthma impairment ; Xolair ; omalizumab|asthma; asthma management; asthma impairment ; xolair ; omalizumab
639570|NCT00870571|Bioequivalence|bioequivalence
639571|NCT00870571|amlodipine besylate|amlodipine besylate
639572|NCT00870571|amlodipine|amlodipine
639573|NCT00870571|Healthy subjects|healthy subjects
639574|NCT00870558|adult primary hepatocellular carcinoma|adult primary hepatocellular carcinoma
639576|NCT00870558|localized resectable adult primary liver cancer|localized resectable adult primary liver cancer
639577|NCT00870558|localized unresectable adult primary liver cancer|localized unresectable adult primary liver cancer
639578|NCT00870545|spouses|spouses
639579|NCT00870545|social support|social support
639580|NCT00870545|reintegration|reintegration
639581|NCT00870545|families|families
639582|NCT00870545|military|military
639583|NCT00870545|post deployment|post deployment
639584|NCT00870545|OEF/OIF|oef/oif
639585|NCT00870532|Phase I|phase i
639586|NCT00870532|Combination|combination
639587|NCT00870532|Anti-angiogenic|anti-angiogenic
639588|NCT00870532|Sorafenib|sorafenib
639589|NCT00870532|Metronomic oral vinorelbine|metronomic oral vinorelbine
639590|NCT00870519|Alzheimer disease|alzheimer disease
639591|NCT00870506|Randomized Controlled Trial|randomized controlled trial
639592|NCT00870506|Healthcare Disparities|healthcare disparities
639593|NCT00870493|proteinuria|proteinuria
639594|NCT00870493|renal failure|renal failure
639595|NCT00870493|glomerulonephritis|glomerulonephritis
639596|NCT00870480|Bioequivalence|bioequivalence
639597|NCT00870480|finasteride|finasteride
639598|NCT00870480|Healthy subjects|healthy subjects
639599|NCT00870467|Rheumatoid Arthritis|rheumatoid arthritis
639600|NCT00870454|Diabetic neuropathies|diabetic neuropathies
639601|NCT00870454|Diabetic neuropathy, painful|diabetic neuropathy, painful
639602|NCT00870454|Carisbamate|carisbamate
639603|NCT00870454|Neurotherapeutic agents|neurotherapeutic agents
639604|NCT00870441|ASP2151|asp2151
639605|NCT00870441|Valacyclovir|valacyclovir
639606|NCT00870441|Healthy Volunteers|healthy volunteers
639607|NCT00870428|Preeclampsia|preeclampsia
639608|NCT00870428|proteinuria|proteinuria
639609|NCT00870415|stage IA breast cancer|stage ia breast cancer
639610|NCT00870415|stage IB breast cancer|stage ib breast cancer
639611|NCT00870415|stage II breast cancer|stage ii breast cancer
639612|NCT00870415|stage IIIA breast cancer|stage iiia breast cancer
639613|NCT00870415|stage IIIC breast cancer|stage iiic breast cancer
639614|NCT00870415|ductal breast carcinoma|ductal breast carcinoma
639615|NCT00870415|invasive ductal breast carcinoma|invasive ductal breast carcinoma
639616|NCT00870402|aldosterone|aldosterone
639617|NCT00870402|albuminuria|albuminuria
639618|NCT00870402|diastolic disfunction|diastolic disfunction
639619|NCT00870402|hyperkalemia|hyperkalemia
639620|NCT00870376|lower urinary tract symptoms|lower urinary tract symptoms
639621|NCT00870376|biomarkers|biomarkers
639622|NCT00870376|urodynamic studies|urodynamic studies
639623|NCT00870363|HIV|hiv
639624|NCT00870363|HIV positive|hiv positive
639625|NCT00870363|Gastrointestinal Associated Lymphoid Tissue (GALT)|gastrointestinal associated lymphoid tissue (galt)
639626|NCT00870363|GALT Immune Reconstruction|galt immune reconstruction
639627|NCT00870363|treatment naive|treatment naive
639628|NCT00870350|immunogenicity|immunogenicity
639629|NCT00870350|safety|safety
639630|NCT00870350|tetanus|tetanus
639631|NCT00870350|diphtheria|diphtheria
639632|NCT00870350|acellular|acellular
639633|NCT00870350|pertussis|pertussis
639634|NCT00870350|vaccine|vaccine
639635|NCT00870350|booster|booster
639636|NCT00870350|adverse event|adverse event
639637|NCT00870350|adverse reaction|adverse reaction
639638|NCT00870350|DT1aP|dt1ap
639639|NCT00870350|DT5ap|dt5ap
639641|NCT00870350|fimbriae|fimbriae
639642|NCT00870350|pertactin|pertactin
639643|NCT00870350|SMI|smi
639644|NCT00870350|Smittskyddsinstitutet|smittskyddsinstitutet
639645|NCT00870350|Immune response and safety profile to a Tdap booster|immune response and safety profile to a tdap booster
639646|NCT00870337|recurrent endometrial carcinoma|recurrent endometrial carcinoma
639647|NCT00870337|stage IV endometrial carcinoma|stage iv endometrial carcinoma
639648|NCT00870337|endometrial adenocarcinoma|endometrial adenocarcinoma
639649|NCT00870324|ICD|icd
639650|NCT00870324|Tachyarrhythmias|tachyarrhythmias
639651|NCT00870324|Atrial Fibrillation|atrial fibrillation
639652|NCT00870324|Patients who meets current ICD or CRT-D implant indications|patients who meets current icd or crt-d implant indications
639653|NCT00870311|Lithium|lithium
639654|NCT00870311|Neuroprotection|neuroprotection
639655|NCT00870311|Neurotrophic|neurotrophic
639656|NCT00870311|bcl2|bcl2
639657|NCT00870311|gsk3|gsk3
639658|NCT00870311|pkc|pkc
639659|NCT00870311|MRI|mri
639660|NCT00870311|myoinositol|myoinositol
639661|NCT00870311|MRS|mrs
639662|NCT00870311|Alzheimers Disease|alzheimers disease
639663|NCT00870298|drug orders|drug orders
639664|NCT00870285|Psoriasis|psoriasis
639665|NCT00870285|Biologic|biologic
639666|NCT00870285|Ustekinumab|ustekinumab
639667|NCT00870285|UVB-311nm narrowband|uvb-311nm narrowband
639668|NCT00870285|phototherapy|phototherapy
639669|NCT00870285|half-side comparison|half-side comparison
639670|NCT00870272|Medical Abortion|medical abortion
639671|NCT00870272|Mifepristone|mifepristone
639672|NCT00870272|Misoprostol|misoprostol
639673|NCT00870272|Sublingual administration|sublingual administration
639674|NCT00870272|Buccal administration|buccal administration
639675|NCT00870259|Weight loss|weight loss
639676|NCT00870259|Weight maintenance|weight maintenance
639677|NCT00870246|COPD|copd
639679|NCT00870233|Gynecologic cancers|gynecologic cancers
639680|NCT00870233|Quality of Life|quality of life
639681|NCT00870233|08-155|08-155
639682|NCT00870233|Surgery|surgery
639683|NCT00870220|Turner's Syndrome|turner's syndrome
639684|NCT00870207|Feasibility of implementing TSSC in worksite environment|feasibility of implementing tssc in worksite environment
639685|NCT00870194|diabetes|diabetes
639686|NCT00870194|exenatide|exenatide
639687|NCT00870194|Byetta|byetta
639688|NCT00870194|sitagliptin|sitagliptin
639689|NCT00870194|Januvia|januvia
639690|NCT00870194|Amylin|amylin
639691|NCT00870194|Lilly|lilly
639692|NCT00870168|stage IV breast cancer|stage iv breast cancer
639693|NCT00870168|estrogen receptor-negative breast cancer|estrogen receptor-negative breast cancer
639694|NCT00870168|progesterone receptor-negative breast cancer|progesterone receptor-negative breast cancer
639695|NCT00870142|Bioequivalence|bioequivalence
639696|NCT00870142|amlodipine besylate|amlodipine besylate
639697|NCT00870142|amlodipine|amlodipine
639698|NCT00870142|Healthy subjects|healthy subjects
639699|NCT00870129|brain tumor|brain tumor
639700|NCT00870129|radiation|radiation
639701|NCT00870129|MRI|mri
639702|NCT00870129|09-009|09-009
639703|NCT00870116|SBRT|sbrt
639704|NCT00870116|non-operated|non-operated
639705|NCT00870116|non-metastatic|non-metastatic
639706|NCT00870116|non-small-cell lung cancer|non-small-cell lung cancer
639707|NCT00870116|conformational radiotherapy|conformational radiotherapy
639708|NCT00870116|non-operated non-metastatic non-small-cell lung cancer|non-operated non-metastatic non-small-cell lung cancer
639709|NCT00870103|Cataract|cataract
639710|NCT00870077|Intrahepatic fat|intrahepatic fat
639711|NCT00870077|obesity|obesity
639712|NCT00870077|body fat|body fat
639713|NCT00870077|impaired glucose tolerance|impaired glucose tolerance
639714|NCT00870064|Surgical Procedures, Operative|surgical procedures, operative
639715|NCT00870064|Fractures, Open|fractures, open
639716|NCT00870064|Fracture Fixation|fracture fixation
639717|NCT00870051|Endurant|endurant
639718|NCT00870051|Stent Graft|stent graft
639719|NCT00870051|Abdominal Aortic Aneurysm|abdominal aortic aneurysm
639720|NCT00870038|PCI|pci
639721|NCT00870038|stent|stent
639722|NCT00870038|drug eluting stent|drug eluting stent
639723|NCT00870038|reendothelialization|reendothelialization
639724|NCT00870038|restenosis|restenosis
639725|NCT00870038|Percutaneous Coronary Angioplasty|percutaneous coronary angioplasty
639726|NCT00870025|androgens|androgens
639727|NCT00870025|hCG|hcg
639728|NCT00870025|low response|low response
639729|NCT00870025|IVF|ivf
639730|NCT00870025|Ovarian response in women with previous low response|ovarian response in women with previous low response
639731|NCT00869999|rituximab|rituximab
639732|NCT00869999|everolimus|everolimus
639733|NCT00869999|DLBCL|dlbcl
639734|NCT00869999|mTOR|mtor
639735|NCT00869973|aprepitant|aprepitant
639736|NCT00869973|delayed emesis|delayed emesis
639737|NCT00869973|cyclophosphamide plus anthracyclines|cyclophosphamide plus anthracyclines
639738|NCT00869973|breast cancer|breast cancer
639739|NCT00869973|antiemetic|antiemetic
639740|NCT00869960|Healthy Volunteers|healthy volunteers
639741|NCT00869947|Unilateral below the knee amputation|unilateral below the knee amputation
639742|NCT00869934|Insomnia|insomnia
639743|NCT00869934|Sleep disorders|sleep disorders
639744|NCT00869934|Treatment|treatment
639745|NCT00869934|Sleep disturbances|sleep disturbances
639746|NCT00869895|Advanced solid tumors|advanced solid tumors
639747|NCT00869882|Spondylolisthesis|spondylolisthesis
639748|NCT00869882|degeneration|degeneration
639749|NCT00869882|spinal fusion|spinal fusion
639750|NCT00869869|Heart Failure|heart failure
639751|NCT00869869|Sleep Disorders|sleep disorders
639752|NCT00869869|Melatonin|melatonin
639753|NCT00869869|Antioxidants|antioxidants
639754|NCT00869869|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action
639755|NCT00869869|Nervous System Diseases|nervous system diseases
639756|NCT00869869|Physiological Effects of Drugs|physiological effects of drugs
639757|NCT00869869|Vascular Diseases|vascular diseases
639758|NCT00869869|Central Nervous System Depressants|central nervous system depressants
639759|NCT00869869|Protective Agents|protective agents
639760|NCT00869869|Pharmacologic Actions|pharmacologic actions
639761|NCT00869869|Signs and Symptoms|signs and symptoms
639762|NCT00869869|Mental Disorders|mental disorders
639763|NCT00869869|Therapeutic Uses|therapeutic uses
639764|NCT00869869|Neurologic Manifestations|neurologic manifestations
639765|NCT00869869|Cardiovascular Diseases|cardiovascular diseases
639766|NCT00869869|Central Nervous System Agents|central nervous system agents
639767|NCT00869856|Treatment associated with CRI|treatment associated with cri
639768|NCT00869843|Metastatic colorectal cancer|metastatic colorectal cancer
639769|NCT00869830|Biofeedback|biofeedback
639770|NCT00869830|constipation|constipation
639771|NCT00869830|Parkinson's disease|parkinson's disease
639772|NCT00869817|Alzheimer's disease|alzheimer's disease
639773|NCT00869817|antecedent biomarkers|antecedent biomarkers
639774|NCT00869817|Amyloid Precursor Protein (APP) mutation|amyloid precursor protein (app) mutation
639775|NCT00869817|presenilin I (PS1) mutation|presenilin i (ps1) mutation
639776|NCT00869817|presenilin 2 (PS2) mutation|presenilin 2 (ps2) mutation
639777|NCT00869817|Autosomal Dominant Alzheimer's Disease|autosomal dominant alzheimer's disease
639778|NCT00869804|breast cancer|breast cancer
639779|NCT00869804|chemotherapy-induced peripheral neuropathy|chemotherapy-induced peripheral neuropathy
639780|NCT00869804|exercise|exercise
639781|NCT00869791|Parkinson's|parkinson's
639782|NCT00869778|Chronic Hepatitis B|chronic hepatitis b
639783|NCT00869778|HBeAg positive|hbeag positive
639784|NCT00869778|Therapeutic HBV Vaccine|therapeutic hbv vaccine
639785|NCT00869778|HBV-specific Cytotoxic T Lymphocyte|hbv-specific cytotoxic t lymphocyte
639786|NCT00869765|Depression|depression
639787|NCT00869765|Treatment|treatment
639788|NCT00869765|Transcranial direct current stimulation|transcranial direct current stimulation
639789|NCT00869765|D-cycloserine|d-cycloserine
639790|NCT00869752|combined type small cell lung cancer|combined type small cell lung cancer
639791|NCT00869752|fusiform type small cell lung cancer|fusiform type small cell lung cancer
639792|NCT00869752|polygonal type small cell lung cancer|polygonal type small cell lung cancer
712514|NCT00579904|monounsaturated fats|monounsaturated fats
815338|NCT00181298|SLE|sle
639793|NCT00869752|lymphocyte-like type small cell lung cancer|lymphocyte-like type small cell lung cancer
639794|NCT00869752|extensive stage small cell lung cancer|extensive stage small cell lung cancer
639795|NCT00869739|cancer survivor|cancer survivor
639796|NCT00869739|depression|depression
639797|NCT00869739|psychosocial effects of cancer and its treatment|psychosocial effects of cancer and its treatment
639798|NCT00869739|male erectile disorder|male erectile disorder
639799|NCT00869739|urinary complications|urinary complications
639800|NCT00869739|gastrointestinal complications|gastrointestinal complications
639801|NCT00869739|stage I prostate cancer|stage i prostate cancer
639802|NCT00869739|stage IIB prostate cancer|stage iib prostate cancer
639803|NCT00869739|stage IIA prostate cancer|stage iia prostate cancer
639804|NCT00869739|stage III prostate cancer|stage iii prostate cancer
639805|NCT00869713|Hemorrhagic Fever|hemorrhagic fever
639806|NCT00869713|Viral Infections|viral infections
639807|NCT00869713|Neurologic diseases|neurologic diseases
639808|NCT00869713|Arbovirus Infections|arbovirus infections
639809|NCT00869713|RVF|rvf
639810|NCT00869700|HIV|hiv
639811|NCT00869700|Malaria|malaria
639812|NCT00869700|Pharmacokinetics|pharmacokinetics
639813|NCT00869700|Treatment Experienced|treatment experienced
639814|NCT00869674|GeneSearch|genesearch
639815|NCT00869674|Breast cancer|breast cancer
639816|NCT00869648|Airway|airway
639817|NCT00869648|Anaesthesia|anaesthesia
639818|NCT00869648|Resuscitation|resuscitation
639819|NCT00869648|Ventilation|ventilation
639820|NCT00869635|Cholangiocarcinoma|cholangiocarcinoma
639821|NCT00869635|Photodynamic therapy|photodynamic therapy
639822|NCT00869635|S-1|s-1
639823|NCT00869622|osteoporosis|osteoporosis
639824|NCT00869622|bone mineral density|bone mineral density
639825|NCT00869622|fracture|fracture
639826|NCT00869622|antiepileptic drug|antiepileptic drug
639827|NCT00869622|seizure|seizure
639828|NCT00869622|Prevention of bone loss|prevention of bone loss
639829|NCT00869622|Prevention of osteoporosis|prevention of osteoporosis
639830|NCT00869622|Prevention of Fractures|prevention of fractures
639831|NCT00869609|Diabetes Prevention|diabetes prevention
639832|NCT00869609|CVD Risk Reduction|cvd risk reduction
639833|NCT00869609|Lifestyle Intervention|lifestyle intervention
639834|NCT00869596|Sputum inflammatory biomarkers|sputum inflammatory biomarkers
639835|NCT00869583|Women|women
639836|NCT00869583|Physical Activity|physical activity
639837|NCT00869583|Hispanic|hispanic
639838|NCT00869583|Overweight|overweight
639839|NCT00869570|adenocarcinoma of the rectum|adenocarcinoma of the rectum
639840|NCT00869570|stage II rectal cancer|stage ii rectal cancer
639841|NCT00869570|stage III rectal cancer|stage iii rectal cancer
639842|NCT00869557|HIV|hiv
639843|NCT00869557|HIV-1|hiv-1
639844|NCT00869557|Antiretroviral Treatment-Naive|antiretroviral treatment-naive
639845|NCT00869557|treatment naive|treatment naive
639846|NCT00869544|HIV|hiv
639847|NCT00869544|smoker|smoker
639848|NCT00869544|emphysema|emphysema
639849|NCT00869544|antiretrovirals|antiretrovirals
639850|NCT00869544|COPD|copd
639851|NCT00869531|Obesity|obesity
639852|NCT00869531|wholegrain|wholegrain
639853|NCT00869531|wheat|wheat
639854|NCT00869531|cardiovascular disease|cardiovascular disease
639855|NCT00869518|Staphylococcus aureus|staphylococcus aureus
639856|NCT00869518|colonization|colonization
639857|NCT00869518|eradication|eradication
639858|NCT00869518|HIV|hiv
639859|NCT00869518|rifabutin|rifabutin
639860|NCT00869505|To evaluate the effectiveness of memantine as an augmenting agent for standard intensive residential treatment of severe obsessive-compulsive disorder (OCD)|to evaluate the effectiveness of memantine as an augmenting agent for standard intensive residential treatment of severe obsessive-compulsive disorder (ocd)
639861|NCT00869492|Acne|acne
639862|NCT00869492|Nadifloxacin|nadifloxacin
639863|NCT00869492|benzoyl peroxide|benzoyl peroxide
639864|NCT00869479|Nephrogenic Systemic Fibrosis|nephrogenic systemic fibrosis
639865|NCT00869479|Screening|screening
639866|NCT00869466|weight changes|weight changes
639867|NCT00869466|stage IA breast cancer|stage ia breast cancer
639868|NCT00869466|stage IB breast cancer|stage ib breast cancer
639869|NCT00869466|stage II breast cancer|stage ii breast cancer
639870|NCT00869466|stage IIIA breast cancer|stage iiia breast cancer
639871|NCT00869466|stage IIIB breast cancer|stage iiib breast cancer
639872|NCT00869466|stage IIIC breast cancer|stage iiic breast cancer
639873|NCT00869453|Gut hormone|gut hormone
639874|NCT00869453|hyperglycaemic clamp|hyperglycaemic clamp
639875|NCT00869453|glucose turnver|glucose turnver
639876|NCT00869440|CNS 7056|cns 7056
639877|NCT00869440|Procedural Sedation|procedural sedation
639878|NCT00869440|Sedation|sedation
639879|NCT00869440|Endoscopy|endoscopy
639880|NCT00869427|UVI|uvi
639881|NCT00869427|Spinal cord injury|spinal cord injury
639882|NCT00869427|Prevention|prevention
639883|NCT00869427|Vitamin C|vitamin c
639884|NCT00869414|hypoglycemia|hypoglycemia
639885|NCT00869414|type 1 diabetes|type 1 diabetes
639886|NCT00869414|split dosing insulin glargine|split dosing insulin glargine
639887|NCT00869414|continuous glucose monitoring|continuous glucose monitoring
639888|NCT00869401|adult giant cell glioblastoma|adult giant cell glioblastoma
639889|NCT00869401|adult glioblastoma|adult glioblastoma
639890|NCT00869401|adult gliosarcoma|adult gliosarcoma
639891|NCT00869388|malignant|malignant
639892|NCT00869388|resistant|resistant
639893|NCT00869388|solid tumor|solid tumor
639894|NCT00869375|acute or critical limb ischemia with angiographic thrombus|acute or critical limb ischemia with angiographic thrombus
639895|NCT00869349|Rheumatoid Arthritis|rheumatoid arthritis
639896|NCT00869349|IFS|ifs
639897|NCT00869349|psychosocial|psychosocial
639898|NCT00869349|social support|social support
639899|NCT00869336|Tinea Pedis|tinea pedis
639900|NCT00869336|Athlete's Foot|athlete's foot
639901|NCT00869323|post-transplant lymphoproliferative disorder|post-transplant lymphoproliferative disorder
639902|NCT00869310|aprepitant|aprepitant
639903|NCT00869310|delayed emesis|delayed emesis
639904|NCT00869310|cisplatin|cisplatin
639905|NCT00869310|antiemetic|antiemetic
639906|NCT00869284|High-dose chemotherapy|high-dose chemotherapy
639907|NCT00869284|aggressive NHL|aggressive nhl
639908|NCT00869284|high-risk|high-risk
639909|NCT00869284|PBSC|pbsc
639910|NCT00869271|liver metastasis|liver metastasis
639911|NCT00869271|colorectal cancer|colorectal cancer
639912|NCT00869258|Pancreatic cancer|pancreatic cancer
639913|NCT00869258|Gemcitabine|gemcitabine
639914|NCT00869258|Docetaxel|docetaxel
639915|NCT00869258|Capecitabine|capecitabine
639916|NCT00869245|ACS|acs
639917|NCT00869245|Acute Coronary Syndrome|acute coronary syndrome
639918|NCT00869245|Chest pain|chest pain
639919|NCT00869245|Cardiac MRI|cardiac mri
639920|NCT00869245|CMR|cmr
639921|NCT00869245|Risk Stratification|risk stratification
639922|NCT00869245|Emergency Department|emergency department
639923|NCT00869232|Multiple Myeloma|multiple myeloma
639924|NCT00869219|Pain|pain
639925|NCT00869219|Pain after eyedrops|pain after eyedrops
639926|NCT00869206|pain|pain
639927|NCT00869206|Prostate Adenocarcinoma|prostate adenocarcinoma
639928|NCT00869206|urinary complications|urinary complications
639929|NCT00869206|stage IV breast cancer|stage iv breast cancer
639930|NCT00869206|Recurrent Breast Carcinoma|recurrent breast carcinoma
639931|NCT00869206|stage IV prostate cancer|stage iv prostate cancer
639932|NCT00869206|recurrent prostate cancer|recurrent prostate cancer
639933|NCT00869206|Recurrent Prostate Carcinoma|recurrent prostate carcinoma
639934|NCT00869206|stage I multiple myeloma|stage i multiple myeloma
639935|NCT00869206|stage II multiple myeloma|stage ii multiple myeloma
639936|NCT00869206|Refractory Plasma Cell Myeloma|refractory plasma cell myeloma
639937|NCT00869206|bone metastases|bone metastases
639938|NCT00869193|Blood pressure|blood pressure
639939|NCT00869193|Grape seed|grape seed
639940|NCT00869180|diclofenac|diclofenac
639941|NCT00869180|ankle sprain|ankle sprain
639942|NCT00869180|acute pain|acute pain
639943|NCT00869180|topical|topical
639944|NCT00869180|patch|patch
639945|NCT00869180|Acute Pain due to Mild to Moderate Ankle Sprain|acute pain due to mild to moderate ankle sprain
639946|NCT00869154|Mild TBI|mild tbi
639947|NCT00869154|TBI (Traumatic Brain Injury)|tbi (traumatic brain injury)
639948|NCT00869154|Traumatic Brain Injury|traumatic brain injury
639949|NCT00869154|Injury, Brain, Traumatic|injury, brain, traumatic
639950|NCT00869154|Injuries, Acute Brain|injuries, acute brain
639951|NCT00869154|Brain Injuries, Traumatic|brain injuries, traumatic
639952|NCT00869154|Acute Brain Injuries|acute brain injuries
639953|NCT00869141|Glaucoma tube shunt procedure|glaucoma tube shunt procedure
639954|NCT00869128|melatonin|melatonin
639955|NCT00869128|insomnia|insomnia
639956|NCT00869128|diabetes|diabetes
639957|NCT00869128|sleep|sleep
639958|NCT00869115|Digoxin|digoxin
639959|NCT00869115|Inotropes|inotropes
639960|NCT00869115|Lusitropic agents|lusitropic agents
639961|NCT00869115|Istaroxime|istaroxime
639962|NCT00869115|Debio 0614|debio 0614
639963|NCT00869102|IGT|igt
639964|NCT00869102|IFG|ifg
639965|NCT00869089|PN|pn
639966|NCT00869076|Diabetes Mellitus|diabetes mellitus
639967|NCT00869076|Pharmacist|pharmacist
639968|NCT00869063|wrist|wrist
639969|NCT00869063|sprain|sprain
639970|NCT00869063|strain|strain
639971|NCT00869063|contusion|contusion
639974|NCT00869063|acute pain|acute pain
639975|NCT00869063|acute pain due to mild to moderate wrist sprain, strain or contusion|acute pain due to mild to moderate wrist sprain, strain or contusion
639976|NCT00869050|Pancreatic cancer|pancreatic cancer
639977|NCT00869050|Neuroendocrine tumors|neuroendocrine tumors
639978|NCT00869050|Carcinoid tumors|carcinoid tumors
639979|NCT00869050|Pheochromocytomas|pheochromocytomas
639980|NCT00869050|Gastrinomas|gastrinomas
639981|NCT00869050|Zollinger-Ellison syndrome|zollinger-ellison syndrome
639982|NCT00869050|MEN Type I/II|men type i/ii
639983|NCT00869050|Somatostatinomas|somatostatinomas
639984|NCT00869050|VIPomas|vipomas
639985|NCT00869050|Merkel cell tumors|merkel cell tumors
639986|NCT00869050|medullary thyroid carcinoma|medullary thyroid carcinoma
639987|NCT00869037|Randomized controlled study|randomized controlled study
639988|NCT00869037|Total knee arthroplasty|total knee arthroplasty
639989|NCT00869037|Post operative pain|post operative pain
639990|NCT00869037|Continuous Femoral Nerve Block|continuous femoral nerve block
639991|NCT00869037|Posterior Capsular injection|posterior capsular injection
639992|NCT00869037|Periarticular injection|periarticular injection
639993|NCT00869024|Heart failure|heart failure
639994|NCT00869024|Left ventricular assist device|left ventricular assist device
639995|NCT00869024|Stem cells|stem cells
639996|NCT00869011|Cancer|cancer
639997|NCT00869011|renal cell carcinoma|renal cell carcinoma
639998|NCT00869011|fatigue|fatigue
639999|NCT00869011|exercise|exercise
640000|NCT00868998|Biliary Cancer|biliary cancer
640001|NCT00868972|Renal Artery Obstruction|renal artery obstruction
640002|NCT00868972|renovascular hypertension|renovascular hypertension
640003|NCT00868972|stent|stent
640004|NCT00868972|Kidney Failure|kidney failure
640005|NCT00868972|embolic protection|embolic protection
640006|NCT00868959|Bipolar|bipolar
640007|NCT00868959|Depression|depression
640008|NCT00868959|Lurasidone|lurasidone
640009|NCT00868959|Latuda|latuda
640010|NCT00868946|Ribavirin|ribavirin
640011|NCT00868946|Hemorrhagic Fever with Renal Syndrome|hemorrhagic fever with renal syndrome
640012|NCT00868946|Dobrava Virus|dobrava virus
640013|NCT00868946|Puumala Virus|puumala virus
640014|NCT00868881|Hypertension|hypertension
640015|NCT00868881|Therapeutic diagnostic attitude|therapeutic diagnostic attitude
640016|NCT00868881|Blood pressure|blood pressure
640017|NCT00868868|Pedometer|pedometer
640018|NCT00868868|Prostate|prostate
640019|NCT00868868|Cancer|cancer
640020|NCT00868868|Hormonotherapy|hormonotherapy
640021|NCT00868868|Exercise|exercise
640022|NCT00868855|Coronary Artery Disease|coronary artery disease
640023|NCT00868842|Penicillin|penicillin
640024|NCT00868842|Allergy|allergy
640025|NCT00868842|Prevention|prevention
640026|NCT00868842|Anaphylaxis|anaphylaxis
640027|NCT00868842|Clinically proven history of penicillin allergy|clinically proven history of penicillin allergy
640028|NCT00868842|preventing anaphylaxis|preventing anaphylaxis
640029|NCT00868829|Stent|stent
640030|NCT00868829|FireBird2|firebird2
640031|NCT00868829|Coronary Heart Disease|coronary heart disease
640032|NCT00868816|oxaliplatine|oxaliplatine
640033|NCT00868816|colorectal cancer|colorectal cancer
640034|NCT00868816|chemotherapy|chemotherapy
640035|NCT00868803|prostate cancer|prostate cancer
640036|NCT00868777|Implant site development|implant site development
640037|NCT00868777|Bone grafting|bone grafting
640038|NCT00868777|Dental implants|dental implants
640039|NCT00868764|Effect of age|effect of age
640040|NCT00868764|Effect of body fat|effect of body fat
640041|NCT00868764|Granisetron|granisetron
640042|NCT00868764|Pharmacokinetic profile|pharmacokinetic profile
640043|NCT00868764|Sancuso® patch|sancuso® patch
640044|NCT00868764|Transdermal|transdermal
640045|NCT00868751|Antibodies, Monoclonal|antibodies, monoclonal
640046|NCT00868751|Interleukin 6|interleukin 6
640047|NCT00868738|Calcium|calcium
640048|NCT00868738|Vitamin D|vitamin d
640049|NCT00868738|Magnesium|magnesium
640050|NCT00868738|Zinc|zinc
640051|NCT00868725|oral cavity|oral cavity
640052|NCT00868725|carcinoma|carcinoma
640053|NCT00868725|thermal imaging|thermal imaging
640054|NCT00868712|coronary calcification|coronary calcification
640055|NCT00868712|vitamin K dependent proteins|vitamin k dependent proteins
640056|NCT00868712|warfarin|warfarin
640057|NCT00868699|Bipolar I, Depression|bipolar i, depression
640058|NCT00868673|Role of Fructose in overweight and obesity|role of fructose in overweight and obesity
640059|NCT00868673|Fructose and metabolic syndrome|fructose and metabolic syndrome
640060|NCT00868673|Low fructose diet study|low fructose diet study
640061|NCT00868673|Effects of fructose in blood pressure and hypertension|effects of fructose in blood pressure and hypertension
640062|NCT00868673|Somatometry changes observed in fructose diets|somatometry changes observed in fructose diets
640063|NCT00868673|Fructose induced overweight and obesity|fructose induced overweight and obesity
640064|NCT00868673|Fructose induced metabolic syndrome|fructose induced metabolic syndrome
640065|NCT00868673|Fructose induced hyperuricemia|fructose induced hyperuricemia
640066|NCT00868608|Refractory Indolent NHL|refractory indolent nhl
640067|NCT00868608|lymphoma|lymphoma
640163|NCT00868114|Locally advanced or low volume metatstatic pancreatic cancer|locally advanced or low volume metatstatic pancreatic cancer
640068|NCT00868582|Patients with proven or suspected cancer referred for NaF-18 PET to identify bone metastasis|patients with proven or suspected cancer referred for naf-18 pet to identify bone metastasis
640069|NCT00868569|liver metastasis|liver metastasis
640070|NCT00868569|colorectal cancer|colorectal cancer
640071|NCT00868569|oxaliplatine|oxaliplatine
640072|NCT00868569|transartery chemotherapy|transartery chemotherapy
640073|NCT00868569|embolision|embolision
640074|NCT00868569|Unresectable Liver Metastasis of Colorectal Cancer|unresectable liver metastasis of colorectal cancer
640075|NCT00868556|fMRI scans|fmri scans
640076|NCT00868556|episodic migraine sufferers|episodic migraine sufferers
640077|NCT00868556|chronic migraine sufferers|chronic migraine sufferers
640078|NCT00868556|non migraine sufferers (controls)|non migraine sufferers (controls)
640079|NCT00868543|Gastric bypass|gastric bypass
640081|NCT00868543|superobese|superobese
640082|NCT00868530|On-demand treatment; Hemostatic Efficacy Assessments; Factor VIII recovery; Factor VIII Inhibitor; Chinese|on-demand treatment; hemostatic efficacy assessments; factor viii recovery; factor viii inhibitor; chinese
640083|NCT00868517|Veterans|veterans
640084|NCT00868517|Operation Iraqi Freedom|operation iraqi freedom
640085|NCT00868517|Operation Enduring Freedom|operation enduring freedom
640086|NCT00868517|Combat Disorders|combat disorders
640087|NCT00868517|Acupuncture|acupuncture
640088|NCT00868517|Complementary Therapies|complementary therapies
640089|NCT00868504|GI tract|gi tract
640090|NCT00868504|Tumors|tumors
640091|NCT00868504|Temperatures|temperatures
640092|NCT00868491|head and neck cancer|head and neck cancer
640093|NCT00868491|inoperable|inoperable
640094|NCT00868491|induction chemotherapy|induction chemotherapy
640095|NCT00868491|concomitant radiochemotherapy|concomitant radiochemotherapy
640096|NCT00868491|biological agent|biological agent
640097|NCT00868491|efficacy|efficacy
640098|NCT00868491|toxicity|toxicity
640099|NCT00868478|humanized monoclonal antibody|humanized monoclonal antibody
640100|NCT00868452|Bipolar I|bipolar i
640101|NCT00868452|Latuda|latuda
640102|NCT00868452|Lurasidone|lurasidone
640103|NCT00868439|HF|hf
640104|NCT00868439|Heart failure|heart failure
640105|NCT00868439|hyperkalemia|hyperkalemia
640106|NCT00868439|chronic kidney disease|chronic kidney disease
640107|NCT00868439|prevention of hyperkalemia in heart failure participants|prevention of hyperkalemia in heart failure participants
640108|NCT00868426|Healthy volunteer study|healthy volunteer study
640109|NCT00868400|Preoperative care|preoperative care
640110|NCT00868400|colorectal surgery|colorectal surgery
640111|NCT00868400|carbohydrate|carbohydrate
640112|NCT00868400|fasting|fasting
640113|NCT00868387|weight reduction|weight reduction
640114|NCT00868387|low-carbohydrate|low-carbohydrate
640115|NCT00868387|body fat|body fat
640116|NCT00868387|telemedicine|telemedicine
640117|NCT00868387|cardiovascular risk markers|cardiovascular risk markers
640118|NCT00868361|Mass Balance|mass balance
640119|NCT00868361|Talampanel|talampanel
640120|NCT00868361|Pharmacokinetics|pharmacokinetics
640121|NCT00868361|Metabolism|metabolism
640122|NCT00868361|Metabolites|metabolites
640123|NCT00868361|Healthy Volunteers|healthy volunteers
640124|NCT00868348|Total Knee Arthroplasty|total knee arthroplasty
640125|NCT00868335|Cervical degenerative disc disease|cervical degenerative disc disease
640126|NCT00868335|Anterior cervical discectomy|anterior cervical discectomy
640127|NCT00868335|Cervical disc prosthesis|cervical disc prosthesis
640128|NCT00868335|Activ-C|activ-c
640129|NCT00868335|Mobility|mobility
640130|NCT00868335|Movement|movement
640131|NCT00868309|Snake Bite|snake bite
640132|NCT00868309|Venom and antivenom kinetics|venom and antivenom kinetics
640133|NCT00868296|Safety|safety
640134|NCT00868257|AIDS|aids
640135|NCT00868257|Adherence to Antiretroviral Therapy|adherence to antiretroviral therapy
640136|NCT00868257|Pediatric|pediatric
640137|NCT00868257|Resource Limited Setting|resource limited setting
640138|NCT00868257|Treatment experienced|treatment experienced
640139|NCT00868244|facial patterns|facial patterns
640140|NCT00868244|bruxism|bruxism
640141|NCT00868244|masticatory muscles|masticatory muscles
640142|NCT00868231|COPD|copd
640143|NCT00868231|Antimuscarinic|antimuscarinic
640144|NCT00868218|Influenza A|influenza a
640145|NCT00868218|pandemic|pandemic
640146|NCT00868218|vaccine|vaccine
640147|NCT00868218|immunogenicity|immunogenicity
640148|NCT00868218|Virus|virus
640149|NCT00868218|H5N1|h5n1
640150|NCT00868205|oxidative stress|oxidative stress
640151|NCT00868205|Comet assay|comet assay
640152|NCT00868205|antioxidants|antioxidants
640153|NCT00868179|Thrombosis|thrombosis
640154|NCT00868179|total knee replacement|total knee replacement
640155|NCT00868166|Amyotrophic Lateral Sclerosis|amyotrophic lateral sclerosis
640156|NCT00868166|TRO19622|tro19622
640157|NCT00868166|Trophos|trophos
640158|NCT00868127|Hyperlipidemia|hyperlipidemia
640159|NCT00868127|Drug Therapy|drug therapy
640160|NCT00868127|Dyslipidemia|dyslipidemia
640161|NCT00868114|Inoperable pancreatic cancer|inoperable pancreatic cancer
640162|NCT00868114|Dendritic Cell Vaccine|dendritic cell vaccine
640164|NCT00868101|ischemic|ischemic
640165|NCT00868101|preconditioning|preconditioning
640166|NCT00868101|congenital heart disease|congenital heart disease
640168|NCT00868088|SCC|scc
640169|NCT00868088|SCC-is|scc-is
640170|NCT00868088|PDT|pdt
640171|NCT00868088|Mohs|mohs
640172|NCT00868075|Physiotherapy|physiotherapy
640173|NCT00868075|Rehabilitation|rehabilitation
640174|NCT00868075|Bronchiectasis|bronchiectasis
640175|NCT00868062|The responses of patients to 1L infusions of Gelofusine (succinylated gelatine 40g/L) and Voluven (6% hydroxyethyl starch in 0.9% saline) intraoperatively.|the responses of patients to 1l infusions of gelofusine (succinylated gelatine 40g/l) and voluven (6% hydroxyethyl starch in 0.9% saline) intraoperatively.
640176|NCT00868049|chewing|chewing
640177|NCT00868049|deglutition|deglutition
640178|NCT00868049|orofacial motricity|orofacial motricity
640179|NCT00868049|obesity|obesity
640180|NCT00868036|urticaria|urticaria
640181|NCT00868036|hives|hives
640182|NCT00868036|dermatitis|dermatitis
640183|NCT00868036|rash|rash
640184|NCT00868036|contact dermatitis|contact dermatitis
640185|NCT00868036|contact|contact
640186|NCT00868036|contact sensitization|contact sensitization
640187|NCT00868036|allergy|allergy
640188|NCT00868036|allergen|allergen
640189|NCT00868036|patch testing|patch testing
640190|NCT00868036|IgG|igg
640191|NCT00868036|delayed-hypersensitivity reaction|delayed-hypersensitivity reaction
640192|NCT00868036|hypersensitivity|hypersensitivity
640193|NCT00868010|stroke|stroke
640194|NCT00868010|donepezil|donepezil
640195|NCT00868010|recovery|recovery
640196|NCT00867997|Noncarious Cervical Lesions|noncarious cervical lesions
640197|NCT00867997|Hypersensitivity|hypersensitivity
640198|NCT00867997|Teeth|teeth
640199|NCT00867997|Dentistry|dentistry
640200|NCT00867997|Practice-based research network|practice-based research network
640201|NCT00867984|CRT, resynchronization,|crt, resynchronization,
640202|NCT00867958|Colon Anastomosis|colon anastomosis
640203|NCT00867958|Rectum Anastomosis|rectum anastomosis
640204|NCT00867958|Intestine|intestine
640205|NCT00867958|Colorectal Surgery|colorectal surgery
640206|NCT00867958|Colorectal Anastomosis|colorectal anastomosis
640207|NCT00867932|Alexion|alexion
640208|NCT00867932|Eculizumab|eculizumab
640209|NCT00867932|Paroxysmal Nocturnal Hemoglobinuria|paroxysmal nocturnal hemoglobinuria
640210|NCT00867932|PNH|pnh
640211|NCT00867932|Soliris|soliris
640212|NCT00867906|Cat allergy|cat allergy
640213|NCT00867906|Immunotherapy|immunotherapy
640214|NCT00867906|Cat-PAD|cat-pad
640215|NCT00867880|To evaluate the Pharmacokinetic Profile of IVIb|to evaluate the pharmacokinetic profile of ivib
640216|NCT00867867|Iron deficiency anemia|iron deficiency anemia
640217|NCT00867867|Helicobacter pylori|helicobacter pylori
640218|NCT00867867|Iron absorption|iron absorption
640219|NCT00867867|Iron fortification|iron fortification
640220|NCT00867867|ferrous sulphate|ferrous sulphate
640221|NCT00867867|ferrous fumarate|ferrous fumarate
640222|NCT00867854|de-intensification|de-intensification
640223|NCT00867854|HAART|haart
640224|NCT00867854|monotherapy|monotherapy
640225|NCT00867854|persistent low-level viremia (LLV)|persistent low-level viremia (llv)
640226|NCT00867854|treatment experienced|treatment experienced
640227|NCT00867841|pneumonia, community-acquired|pneumonia, community-acquired
640228|NCT00867841|polymerase chain reaction|polymerase chain reaction
640229|NCT00867841|pneumococcus|pneumococcus
640230|NCT00867841|mycoplasma|mycoplasma
640231|NCT00867841|chlamydophila|chlamydophila
640232|NCT00867841|anti-bacterial agents|anti-bacterial agents
640233|NCT00867828|Decline of global cognitive function|decline of global cognitive function
640234|NCT00867828|Neuropsychological Test Battery (NTB)|neuropsychological test battery (ntb)
640235|NCT00867828|Early stage Alzheimer's disease|early stage alzheimer's disease
640236|NCT00867815|Non-arteritic Anterior Ischemic Optic Neuropathy|non-arteritic anterior ischemic optic neuropathy
640237|NCT00867815|NAION|naion
640238|NCT00867815|PDE5 inhibitors|pde5 inhibitors
640239|NCT00867815|vardenafil|vardenafil
640240|NCT00867815|Levitra|levitra
640241|NCT00867815|sildenafil|sildenafil
640242|NCT00867815|Viagra|viagra
640243|NCT00867815|Tadalafil|tadalafil
640244|NCT00867815|Cialis|cialis
640245|NCT00867815|acute vision loss|acute vision loss
640246|NCT00867815|vision loss|vision loss
640247|NCT00867815|blurred vision|blurred vision
640248|NCT00867815|optic neuropathy|optic neuropathy
640249|NCT00867815|erectile dysfunction.|erectile dysfunction.
640250|NCT00867802|MICAS|micas
640251|NCT00867802|MBSR|mbsr
640252|NCT00867789|abscess|abscess
640253|NCT00867789|outcomes|outcomes
640254|NCT00867789|antibiotics|antibiotics
640255|NCT00867789|incision and drainage|incision and drainage
640256|NCT00867789|skin abscess|skin abscess
640257|NCT00867776|Depression|depression
640258|NCT00867776|African Americans|african americans
640259|NCT00867776|Exercise|exercise
640260|NCT00867776|Culturally tailored intervention|culturally tailored intervention
640261|NCT00867776|Health disparities|health disparities
640262|NCT00867763|Polycystic ovaries,|polycystic ovaries,
640263|NCT00867763|Tubal occlusion|tubal occlusion
640264|NCT00867763|Unexplained infertility|unexplained infertility
640265|NCT00867763|Low ovarian reserve|low ovarian reserve
640266|NCT00867763|Male factor infertility|male factor infertility
640267|NCT00867750|HCC|hcc
640268|NCT00867750|RE|re
640269|NCT00867750|Yttrium-90|yttrium-90
640270|NCT00867750|SIR-Spheres microspheres|sir-spheres microspheres
640271|NCT00867750|TACE|tace
640272|NCT00867750|Radioembolisation|radioembolisation
640273|NCT00867750|Transarterial Chemoembolisation|transarterial chemoembolisation
640274|NCT00867737|Asthma|asthma
640275|NCT00867737|Forced Oscillation|forced oscillation
640276|NCT00867737|Impulse Oscillometry|impulse oscillometry
640277|NCT00867737|Electrical-equivalent respiratory system model|electrical-equivalent respiratory system model
640278|NCT00867724|polyp|polyp
640279|NCT00867698|Hepatic encephalopathy|hepatic encephalopathy
640280|NCT00867698|Mild hepatic encephalopathy|mild hepatic encephalopathy
640281|NCT00867698|HE|he
640282|NCT00867698|MHE|mhe
640283|NCT00867698|Cognitive impairment|cognitive impairment
640284|NCT00867698|Cognitive dysfunction|cognitive dysfunction
640285|NCT00867698|Liver Disease|liver disease
640286|NCT00867698|Cirrhosis|cirrhosis
640287|NCT00867685|Healthy Volunteers|healthy volunteers
640288|NCT00867672|Acute Myeloid Leukemia|acute myeloid leukemia
640289|NCT00867672|Low-dose Decitabine|low-dose decitabine
640290|NCT00867672|Valproic acid|valproic acid
640291|NCT00867672|All-trans retinoic acid|all-trans retinoic acid
640292|NCT00867672|Older Patients|older patients
640293|NCT00867659|ovarian hyperstimulation syndrome|ovarian hyperstimulation syndrome
640294|NCT00867659|cetrotide acetate|cetrotide acetate
640295|NCT00867659|GnRH antagonist|gnrh antagonist
640296|NCT00867659|oocyte donors|oocyte donors
640297|NCT00867646|PT|pt
640298|NCT00867646|DVT|dvt
640299|NCT00867633|urothelial carinoma|urothelial carinoma
640300|NCT00867633|aristolochic acid|aristolochic acid
640301|NCT00867633|DNA|dna
640302|NCT00867633|adduct|adduct
640303|NCT00867607|Contact dermatitis|contact dermatitis
640304|NCT00867607|Eczema|eczema
640305|NCT00867581|middle cerebral artery|middle cerebral artery
640306|NCT00867581|infarction|infarction
640307|NCT00867581|chronic stage|chronic stage
640308|NCT00867581|hippocampal volume|hippocampal volume
640309|NCT00867581|MRI|mri
640310|NCT00867581|MRS|mrs
640311|NCT00867581|neuropsychologic assessment|neuropsychologic assessment
640312|NCT00867568|Relapsed Neuroblastoma|relapsed neuroblastoma
640313|NCT00867568|Refractory Neuroblastoma|refractory neuroblastoma
640314|NCT00867568|Relapsed Medulloblastoma|relapsed medulloblastoma
640315|NCT00867568|Refractory Medulloblastoma|refractory medulloblastoma
640316|NCT00867542|past IUGR|past iugr
640317|NCT00867542|ECC|ecc
640318|NCT00867542|oral findings in children with past IUGR|oral findings in children with past iugr
640319|NCT00867503|ovarian cancer|ovarian cancer
640320|NCT00867503|bendamustine|bendamustine
640321|NCT00867490|Hypertension|hypertension
640322|NCT00867490|aliskiren|aliskiren
640323|NCT00867490|cardiovascular diseases|cardiovascular diseases
640324|NCT00867477|Cancer of esophagus|cancer of esophagus
640325|NCT00867477|Gastrointestine|gastrointestine
640326|NCT00867477|esophagus cancer|esophagus cancer
640327|NCT00867477|Positron emission tomography|positron emission tomography
640328|NCT00867477|PET scan|pet scan
640329|NCT00867477|Nitric oxide|nitric oxide
640330|NCT00867477|NO|no
640331|NCT00867477|NO Breathing Test|no breathing test
640332|NCT00867477|Respiratory symptoms questionnaire|respiratory symptoms questionnaire
640333|NCT00867464|Vaccine Efficacy|vaccine efficacy
640334|NCT00867464|Long-Term Protection|long-term protection
640335|NCT00867464|Immune Response|immune response
640336|NCT00867464|Human Papillomavirus|human papillomavirus
640337|NCT00867464|HPV|hpv
640338|NCT00867464|Vaccine|vaccine
640339|NCT00867451|Attention Deficit Hyperactivity Disorder (ADHD)|attention deficit hyperactivity disorder (adhd)
640340|NCT00867438|ulcerative colitis|ulcerative colitis
640341|NCT00867438|Left-sided, mild to moderate ulcerative colitis|left-sided, mild to moderate ulcerative colitis
640342|NCT00867425|Diabetes|diabetes
640343|NCT00867425|Internet|internet
640344|NCT00867425|Obesity|obesity
640345|NCT00867425|Obesity with high cardiovascular risks|obesity with high cardiovascular risks
640346|NCT00867412|NSCLC|nsclc
640347|NCT00867412|PET/CT|pet/ct
640348|NCT00867412|Surgery|surgery
640349|NCT00867412|FDG|fdg
640350|NCT00867412|staging|staging
640351|NCT00867373|Obesity|obesity
640352|NCT00867373|Weight perceptions|weight perceptions
640353|NCT00867347|transitional cell carcinoma of the bladder|transitional cell carcinoma of the bladder
640354|NCT00867347|stage II bladder cancer|stage ii bladder cancer
640355|NCT00867347|stage III bladder cancer|stage iii bladder cancer
640356|NCT00867334|colorectal neoplasm|colorectal neoplasm
640357|NCT00867334|colorectal cancer|colorectal cancer
640358|NCT00867334|imatinib mesylate|imatinib mesylate
640359|NCT00867334|Gleevec|gleevec
640360|NCT00867334|Physiological Effects of Drugs|physiological effects of drugs
640361|NCT00867334|panitumumab|panitumumab
640362|NCT00867334|Vectibix|vectibix
640363|NCT00867334|c-kit receptor|c-kit receptor
640364|NCT00867334|Receptor|receptor
640455|NCT00866944|Colorectal carcinoma|colorectal carcinoma
640365|NCT00867334|Platelet-Derived Growth Factor alpha|platelet-derived growth factor alpha
640366|NCT00867321|adult primary hepatocellular carcinoma|adult primary hepatocellular carcinoma
640367|NCT00867321|advanced adult primary liver cancer|advanced adult primary liver cancer
640368|NCT00867321|localized unresectable adult primary liver cancer|localized unresectable adult primary liver cancer
640369|NCT00867321|recurrent adult primary liver cancer|recurrent adult primary liver cancer
640370|NCT00867308|IPSS Int-2|ipss int-2
640371|NCT00867308|high risk myelodysplastic syndrome|high risk myelodysplastic syndrome
640372|NCT00867308|MDS)|mds)
640373|NCT00867308|5q31.1 deletions|5q31.1 deletions
640374|NCT00867295|implantable catheters|implantable catheters
640375|NCT00867295|Indwelling Catheters|indwelling catheters
640376|NCT00867295|infection|infection
640377|NCT00867295|cefazolin sodium|cefazolin sodium
640378|NCT00867295|prophylactic|prophylactic
640379|NCT00867295|antibiotic|antibiotic
640380|NCT00867295|totally implantable venous access device|totally implantable venous access device
640381|NCT00867295|cancer patients|cancer patients
640382|NCT00867269|Opportunistic Infection|opportunistic infection
640383|NCT00867269|Immunodeficiency Syndrome|immunodeficiency syndrome
640384|NCT00867269|Autoimmune Disease|autoimmune disease
640385|NCT00867269|CD4+ Lymphocytes|cd4+ lymphocytes
640386|NCT00867269|Idiopathic CD4 Lymphocytopenia|idiopathic cd4 lymphocytopenia
640387|NCT00867256|arthritis|arthritis
640388|NCT00867243|Hepatitis C virus|hepatitis c virus
640389|NCT00867243|HCV|hcv
640390|NCT00867243|Hepatitis C (and cirrhosis)|hepatitis c (and cirrhosis)
640391|NCT00867243|Liver cirrhosis not due to HCV infection|liver cirrhosis not due to hcv infection
640392|NCT00867230|Myelodysplastic Syndrome|myelodysplastic syndrome
640393|NCT00867230|Chronic Myelomonocytic Leukemia|chronic myelomonocytic leukemia
640394|NCT00867230|Acute Myeloid Leukemia|acute myeloid leukemia
640395|NCT00867230|Acute Lymphocytic Leukemia|acute lymphocytic leukemia
640396|NCT00867230|Chronic Lymphocytic Leukemia|chronic lymphocytic leukemia
640397|NCT00867230|Chronic Myelogenous Leukemia|chronic myelogenous leukemia
640398|NCT00867230|Agnogenic Myeloid Metaplasia|agnogenic myeloid metaplasia
640399|NCT00867230|FTS|fts
640400|NCT00867230|S-Trans, Trans-Farnesylthiosalicylic Acid|s-trans, trans-farnesylthiosalicylic acid
640401|NCT00867204|ERCP|ercp
640402|NCT00867204|Study focus was to compare the performance of the ERCP short-wire device versus the Long-wire device.|study focus was to compare the performance of the ercp short-wire device versus the long-wire device.
640403|NCT00867165|heterozygous familial hypercholesterolemia|heterozygous familial hypercholesterolemia
640404|NCT00867165|nonfamilial hypercholesterolemia|nonfamilial hypercholesterolemia
640405|NCT00867152|ritonavir|ritonavir
640406|NCT00867152|GSK1349572|gsk1349572
640407|NCT00867152|integrase|integrase
640408|NCT00867152|lopinavir|lopinavir
640409|NCT00867152|darunavir|darunavir
640410|NCT00867152|etravirine|etravirine
640411|NCT00867139|Influenza|influenza
640412|NCT00867139|Immunocompromised|immunocompromised
640413|NCT00867139|Antiviral|antiviral
640414|NCT00867126|stage IV pancreatic cancer|stage iv pancreatic cancer
640415|NCT00867126|adenocarcinoma of the pancreas|adenocarcinoma of the pancreas
640416|NCT00867126|recurrent pancreatic cancer|recurrent pancreatic cancer
640417|NCT00867113|Imatinib|imatinib
640418|NCT00867113|Protein Kinase Inhibitors|protein kinase inhibitors
640419|NCT00867113|Gastrointestinal Stromal Tumors|gastrointestinal stromal tumors
640420|NCT00867113|Digestive System Diseases|digestive system diseases
640421|NCT00867113|Digestive System Neoplasms|digestive system neoplasms
640422|NCT00867113|Gastrointestinal Diseases|gastrointestinal diseases
640423|NCT00867113|Gastrointestinal Neoplasms|gastrointestinal neoplasms
640424|NCT00867113|Adjuvant|adjuvant
640425|NCT00867113|PERSIST|persist
640426|NCT00867113|PERSIS-5|persis-5
640427|NCT00867087|Diffuse large b-cell lymphoma|diffuse large b-cell lymphoma
640428|NCT00867087|inotuzumab ozogamicin|inotuzumab ozogamicin
640429|NCT00867087|autologous stem cell transplant|autologous stem cell transplant
640430|NCT00867061|Myelodysplastic|myelodysplastic
640431|NCT00867061|IPSS Intermediate 1|ipss intermediate 1
640432|NCT00867061|IPSS Intermediate 2|ipss intermediate 2
640433|NCT00867061|IPSS High risk|ipss high risk
640434|NCT00867048|highly active antiretroviral therapy (HAART)|highly active antiretroviral therapy (haart)
640435|NCT00867048|CD4 Count|cd4 count
640436|NCT00867048|Early Intervention|early intervention
640437|NCT00867048|HIV|hiv
640438|NCT00867048|HIV Infection|hiv infection
640439|NCT00867048|HIV Infections|hiv infections
640440|NCT00867048|treatment naive|treatment naive
640441|NCT00867022|Inflammatory factors|inflammatory factors
640442|NCT00867022|Coagulation factors|coagulation factors
640443|NCT00867022|Sympathetic activity|sympathetic activity
640444|NCT00866996|Attention deficit hyperactivity disorder|attention deficit hyperactivity disorder
640445|NCT00866996|Methylphenidate|methylphenidate
640446|NCT00866996|Atomoxetine|atomoxetine
640447|NCT00866996|Concerta|concerta
640448|NCT00866983|Open label|open label
640449|NCT00866983|sildenafil|sildenafil
640450|NCT00866983|PAH|pah
640451|NCT00866983|Brazil|brazil
640452|NCT00866970|Lung Cancer|lung cancer
640453|NCT00866970|Fatigue|fatigue
640454|NCT00866970|Cachexia|cachexia
640558|NCT00866645|Safety|safety
640456|NCT00866944|Liver metastases (only)|liver metastases (only)
640457|NCT00866944|R0 resection|r0 resection
640458|NCT00866944|R0 resection of liver metastases from colorectal cancer|r0 resection of liver metastases from colorectal cancer
640459|NCT00866905|Breast Cancer|breast cancer
640460|NCT00866905|Ixabepilone|ixabepilone
640461|NCT00866905|Ixempra|ixempra
640462|NCT00866905|Cyclophosphamide|cyclophosphamide
640463|NCT00866905|Cytoxan|cytoxan
640464|NCT00866905|Neoadjuvant Therapy|neoadjuvant therapy
640465|NCT00866879|Sirolimus|sirolimus
640466|NCT00866879|Rapamune|rapamune
640467|NCT00866879|Immunosuppression|immunosuppression
640468|NCT00866879|Renal allograft function|renal allograft function
640469|NCT00866879|Lymphocytes function|lymphocytes function
640470|NCT00866853|TMC435350|tmc435350
640471|NCT00866853|HCV|hcv
640472|NCT00866853|Hepatitis C|hepatitis c
640473|NCT00866853|TMC435|tmc435
640474|NCT00866853|protease inhibitor|protease inhibitor
640475|NCT00866853|CYP|cyp
640476|NCT00866853|Cooperstown 5+1 cocktail|cooperstown 5+1 cocktail
640477|NCT00866840|stage III melanoma|stage iii melanoma
640478|NCT00866840|stage IV melanoma|stage iv melanoma
640479|NCT00866840|recurrent melanoma|recurrent melanoma
640480|NCT00866827|Airway|airway
640481|NCT00866827|Hemangiomas|hemangiomas
640482|NCT00866827|Venous Malformations|venous malformations
640483|NCT00866827|Lymphatic Malformations|lymphatic malformations
640484|NCT00866814|hernia|hernia
640485|NCT00866814|open|open
640486|NCT00866801|coronary blood flow|coronary blood flow
640487|NCT00866801|coronary flow reserve|coronary flow reserve
640488|NCT00866801|cardiac sympathetic innervation|cardiac sympathetic innervation
640489|NCT00866801|general anesthesia|general anesthesia
640490|NCT00866801|thoracic epidural|thoracic epidural
640491|NCT00866801|autonomic dysfunction|autonomic dysfunction
640492|NCT00866801|autonomic neuropathy|autonomic neuropathy
640493|NCT00866788|Xolair|xolair
640494|NCT00866788|CIU|ciu
640495|NCT00866775|Seizure|seizure
640496|NCT00866775|Epilepsy|epilepsy
640497|NCT00866775|Anticonvulsant|anticonvulsant
640498|NCT00866775|Historical Control|historical control
640499|NCT00866775|Monotherapy|monotherapy
640500|NCT00866762|Polycythaemia Vera|polycythaemia vera
640501|NCT00866762|Polycythemia Vera|polycythemia vera
640502|NCT00866762|Essential Thrombocythaemia|essential thrombocythaemia
640503|NCT00866762|Essential Thrombocythemia|essential thrombocythemia
640504|NCT00866762|HDAC-inhibitor|hdac-inhibitor
640505|NCT00866762|Haematology|haematology
640506|NCT00866762|Hematology|hematology
640507|NCT00866762|Haematological disorder|haematological disorder
640508|NCT00866762|Haematological disease|haematological disease
640509|NCT00866762|Hematological disorder|hematological disorder
640510|NCT00866762|Hematological disease|hematological disease
640511|NCT00866749|acute lymphoblastic leukemia|acute lymphoblastic leukemia
640512|NCT00866749|acute lymphoblastic lymphoma|acute lymphoblastic lymphoma
640513|NCT00866749|Leukemia|leukemia
640514|NCT00866749|ALL|all
640515|NCT00866749|6-Thioguanine|6-thioguanine
640516|NCT00866749|Cyclophosphamide|cyclophosphamide
640517|NCT00866749|Cytarabine|cytarabine
640518|NCT00866749|Daunorubicin|daunorubicin
640519|NCT00866749|Doxorubicin|doxorubicin
640520|NCT00866749|Methotrexate|methotrexate
640521|NCT00866749|PEG-L-Asparaginase|peg-l-asparaginase
640522|NCT00866749|Vincristine|vincristine
640523|NCT00866749|Intrathecal Methotrexate|intrathecal methotrexate
640524|NCT00866749|Mercaptopurine|mercaptopurine
640525|NCT00866736|chronic myeloid leukemia|chronic myeloid leukemia
640526|NCT00866736|dasatinib|dasatinib
640527|NCT00866736|chronic phase myeloid leukemia|chronic phase myeloid leukemia
640528|NCT00866723|Avastin|avastin
640529|NCT00866723|bevacizumab|bevacizumab
640530|NCT00866697|fallopian tube cancer|fallopian tube cancer
640531|NCT00866697|pazopanib|pazopanib
640532|NCT00866697|anti-angiogenesis|anti-angiogenesis
640533|NCT00866697|ovarian cancer|ovarian cancer
640534|NCT00866697|primary peritoneal cancer|primary peritoneal cancer
640535|NCT00866697|tyrosine kinase inhibitors|tyrosine kinase inhibitors
640536|NCT00866697|gynecologic cancer|gynecologic cancer
640537|NCT00866684|renal transplant-patients with high-risk for skin cancer|renal transplant-patients with high-risk for skin cancer
640538|NCT00866671|T-ALL|t-all
640539|NCT00866671|Safety|safety
640540|NCT00866671|Post Authorisation Safety Study|post authorisation safety study
640541|NCT00866671|T-LBL|t-lbl
640542|NCT00866671|Lymphoblastic Lymphoma|lymphoblastic lymphoma
640543|NCT00866671|Acute Lymphoblastic Leukemia|acute lymphoblastic leukemia
640544|NCT00866658|hyperglycemia|hyperglycemia
640545|NCT00866658|GLP-1|glp-1
640546|NCT00866658|sulfonylurea|sulfonylurea
640547|NCT00866658|insulin|insulin
640548|NCT00866645|Agitation|agitation
640549|NCT00866645|Schizophrenia|schizophrenia
640550|NCT00866645|Randomized|randomized
640551|NCT00866645|Blind|blind
640552|NCT00866645|Parallel|parallel
640553|NCT00866645|Intramuscular Haloperidol|intramuscular haloperidol
640554|NCT00866645|Controlled|controlled
640555|NCT00866645|Multicenter|multicenter
640556|NCT00866645|Clinical Trial|clinical trial
640557|NCT00866645|Efficacy|efficacy
640559|NCT00866645|Intramuscular Levosulpiride|intramuscular levosulpiride
640560|NCT00866645|Chinese|chinese
640561|NCT00866645|PANSS-EC|panss-ec
640562|NCT00866645|ACES|aces
640563|NCT00866645|CGI|cgi
640564|NCT00866645|BPRS|bprs
640565|NCT00866645|PANSS|panss
640566|NCT00866645|RSESE|rsese
640567|NCT00866645|BAS|bas
640568|NCT00866632|Depression|depression
640569|NCT00866632|Anxiety|anxiety
640570|NCT00866632|Brain Injury|brain injury
640571|NCT00866632|Cognitive Therapy|cognitive therapy
640572|NCT00866632|Coping Skills|coping skills
640573|NCT00866606|On-demand treatment|on-demand treatment
640574|NCT00866606|Hemostatic efficacy|hemostatic efficacy
640575|NCT00866606|Factor IX activity|factor ix activity
640576|NCT00866606|Factor IX recovery|factor ix recovery
640577|NCT00866606|Factor IX inhibitor|factor ix inhibitor
640578|NCT00866606|Chinese|chinese
640579|NCT00866593|major depressive disorder(MDD)|major depressive disorder(mdd)
640580|NCT00866593|depression|depression
640581|NCT00866593|antidepressant|antidepressant
640582|NCT00866593|escitalpram oxalate|escitalpram oxalate
640583|NCT00866593|generic|generic
640584|NCT00866593|innovator|innovator
640585|NCT00866593|Lexapro|lexapro
640586|NCT00866593|efficacy|efficacy
640587|NCT00866593|safety|safety
640588|NCT00866593|multicenter|multicenter
640589|NCT00866593|double-blind|double-blind
640590|NCT00866593|randomized|randomized
640591|NCT00866593|chinese|chinese
640592|NCT00866593|HAMD|hamd
640593|NCT00866593|MADRS|madrs
640594|NCT00866593|HAMA|hama
640595|NCT00866593|VAS-PI|vas-pi
640596|NCT00866593|SDS|sds
640597|NCT00866593|CGI|cgi
640598|NCT00866580|Pandemic influenza|pandemic influenza
640599|NCT00866567|prematurity|prematurity
640600|NCT00866567|VLBW|vlbw
640601|NCT00866567|sepsis|sepsis
640602|NCT00866567|innate immunity|innate immunity
640603|NCT00866554|Prostate|prostate
640604|NCT00866554|Brachytherapy|brachytherapy
640605|NCT00866554|Cytoreduction|cytoreduction
640606|NCT00866554|Sexual function|sexual function
640607|NCT00866554|Toxicity|toxicity
640608|NCT00866541|resistance|resistance
640609|NCT00866541|flow proportional pressure support|flow proportional pressure support
640610|NCT00866541|pressure support ventilation|pressure support ventilation
640611|NCT00866541|volunteers|volunteers
640612|NCT00866541|assistant breathing|assistant breathing
640613|NCT00866541|breathing comfort and objective breathing data|breathing comfort and objective breathing data
640614|NCT00866528|paclitaxel|paclitaxel
640615|NCT00866528|NSCLC|nsclc
640616|NCT00866528|pazopanib|pazopanib
640617|NCT00866528|Advanced Non-Small Cell Lung Cancer|advanced non-small cell lung cancer
640618|NCT00866528|non-small cell lung cancer|non-small cell lung cancer
640619|NCT00866528|Advanced Solid Tumor|advanced solid tumor
640620|NCT00866528|GW786034|gw786034
640621|NCT00866528|Metastatic Non-Small Cell Lung Cancer|metastatic non-small cell lung cancer
640622|NCT00866515|Healthy volunteer|healthy volunteer
640623|NCT00866515|pharmacodynamics|pharmacodynamics
640624|NCT00866515|Ketoconazole|ketoconazole
640625|NCT00866515|Drug Interaction|drug interaction
640626|NCT00866515|pharmacokinetcs|pharmacokinetcs
640627|NCT00866515|GW642444M|gw642444m
640628|NCT00866515|pharmacokinetics|pharmacokinetics
640629|NCT00866502|Parkinson|parkinson
640630|NCT00866502|Safety|safety
640631|NCT00866502|PDGF|pdgf
640632|NCT00866502|Intracerebroventricular|intracerebroventricular
640633|NCT00866502|Infusion|infusion
640634|NCT00866502|Device|device
640635|NCT00866489|Experimental|experimental
640636|NCT00866476|Shigella|shigella
640637|NCT00866476|Vaccine|vaccine
640638|NCT00866476|Mucosal immunity|mucosal immunity
640639|NCT00866463|Sildenafil, Pharmacokinetics, Healthy Volunteer|sildenafil, pharmacokinetics, healthy volunteer
640640|NCT00866437|PMS|pms
640641|NCT00866437|Hormones|hormones
640642|NCT00866437|Skin tests|skin tests
640643|NCT00866437|Allergen Immunotherapy|allergen immunotherapy
640644|NCT00866424|trigeminal neuralgia|trigeminal neuralgia
640645|NCT00866424|pain|pain
640646|NCT00866424|HBO|hbo
640647|NCT00866424|VAS|vas
640648|NCT00866424|MGPQ|mgpq
640649|NCT00866411|cranial electrotherapy stimulation|cranial electrotherapy stimulation
640650|NCT00866411|anxiety|anxiety
640651|NCT00866411|depression|depression
640652|NCT00866411|pain|pain
640653|NCT00866411|sleep disturbance|sleep disturbance
640654|NCT00866411|combat exposure|combat exposure
640655|NCT00866411|post traumatic stress|post traumatic stress
640656|NCT00866411|health status|health status
640657|NCT00866411|medication use|medication use
640658|NCT00866411|soldiers|soldiers
640659|NCT00866398|coronary heart disease|coronary heart disease
640660|NCT00866398|chd|chd
640661|NCT00866398|stent|stent
640662|NCT00866385|Healthy Volunteer|healthy volunteer
640663|NCT00866385|AZD8566|azd8566
640664|NCT00866385|Food Effect|food effect
640665|NCT00866385|Microtracer|microtracer
640666|NCT00866346|Chronic Myelogenous Leukemia|chronic myelogenous leukemia
640667|NCT00866346|CML|cml
641068|NCT00864799|Misoprostol|misoprostol
640668|NCT00866346|Allogeneic Hematopoietic Transplantation|allogeneic hematopoietic transplantation
640669|NCT00866346|Bone Marrow Transplant|bone marrow transplant
640670|NCT00866346|PR1-Specific Cytotoxic T-Lymphocyte Infusion|pr1-specific cytotoxic t-lymphocyte infusion
640671|NCT00866333|Hodgkin's Lymphoma|hodgkin's lymphoma
640672|NCT00866333|Relapsed Hodgkin's Lymphoma|relapsed hodgkin's lymphoma
640673|NCT00866333|Refractory Hodgkin's Lymphoma|refractory hodgkin's lymphoma
640674|NCT00866320|clear cell renal cell carcinoma|clear cell renal cell carcinoma
640675|NCT00866320|recurrent renal cell cancer|recurrent renal cell cancer
640676|NCT00866320|stage IV renal cell cancer|stage iv renal cell cancer
640677|NCT00866294|Immediate-release formulation of paroxetine (paroxetine IR)|immediate-release formulation of paroxetine (paroxetine ir)
640678|NCT00866294|HAM-D (17 items)|ham-d (17 items)
640679|NCT00866294|Controlled-release formulation of paroxetine (paroxetine CR)|controlled-release formulation of paroxetine (paroxetine cr)
640680|NCT00866281|Acute Myeloid Leukemia|acute myeloid leukemia
640681|NCT00866281|AML|aml
640682|NCT00866281|Acute Lymphoblastic Leukemia|acute lymphoblastic leukemia
640683|NCT00866281|ALL|all
640684|NCT00866281|midostaurin|midostaurin
640685|NCT00866281|PKC412|pkc412
640686|NCT00866281|Pediatric relapsed or refractory FLT3 positive Acute Myeloid Leukemia|pediatric relapsed or refractory flt3 positive acute myeloid leukemia
640687|NCT00866281|Pediatric relapsed or refractory Mixed-lineage leukemia gene rearranged Acute Lymphoblastic leukemia|pediatric relapsed or refractory mixed-lineage leukemia gene rearranged acute lymphoblastic leukemia
640688|NCT00866268|Blood loss|blood loss
640689|NCT00866268|Total knee arthroplasty|total knee arthroplasty
640690|NCT00866268|Adults|adults
640691|NCT00866268|Drain|drain
640692|NCT00866268|Drainage system|drainage system
640693|NCT00866255|endotracheal tube|endotracheal tube
640694|NCT00866255|endotracheal pressure|endotracheal pressure
640695|NCT00866255|airway pressure|airway pressure
640696|NCT00866255|pressure drop|pressure drop
640697|NCT00866255|calculation|calculation
640698|NCT00866255|continuous calculation|continuous calculation
640699|NCT00866242|Shigella|shigella
640700|NCT00866242|Vaccine|vaccine
640701|NCT00866242|Mucosal immunity|mucosal immunity
640702|NCT00866190|Mycobacterium tuberculosis, SQ109|mycobacterium tuberculosis, sq109
640703|NCT00866164|back pain|back pain
640704|NCT00866164|intractable pain|intractable pain
640705|NCT00866164|implantable infusion pump|implantable infusion pump
640706|NCT00866164|morphine|morphine
640707|NCT00866151|genetic biomarker|genetic biomarker
640708|NCT00866151|biomarker|biomarker
640709|NCT00866151|molecular diagnostics|molecular diagnostics
640710|NCT00866151|genes|genes
640711|NCT00866151|genetics|genetics
640712|NCT00866151|overweight management|overweight management
640713|NCT00866151|weight management|weight management
640714|NCT00866151|weight reduction|weight reduction
640715|NCT00866151|SNPs|snps
640716|NCT00866151|single nucleotide polymorphisms|single nucleotide polymorphisms
640717|NCT00866138|multiple myeloma|multiple myeloma
640718|NCT00866138|t(4/14)|t(4/14)
640719|NCT00866138|relapsing|relapsing
640720|NCT00866138|refractory|refractory
640721|NCT00866125|Polymyositis|polymyositis
640722|NCT00866125|Dermatomyositis|dermatomyositis
640723|NCT00866125|Grip force|grip force
640724|NCT00866125|Quality of life|quality of life
640725|NCT00866125|Activity performance|activity performance
640726|NCT00866112|Wheelchair use|wheelchair use
640727|NCT00866112|Spinal cord injury|spinal cord injury
640728|NCT00866112|Multiple sclerosis|multiple sclerosis
640729|NCT00866112|Muscular dystrophy|muscular dystrophy
640730|NCT00866112|Cerebral palsy|cerebral palsy
640731|NCT00866112|Spina bifida|spina bifida
640732|NCT00866112|Amputation|amputation
640733|NCT00866112|Arthritis|arthritis
640734|NCT00866112|Stroke|stroke
640735|NCT00866099|Dementia|dementia
640736|NCT00866099|primary care|primary care
640737|NCT00866099|early diagnosis|early diagnosis
640738|NCT00866099|psychosocial interventions|psychosocial interventions
640739|NCT00866099|cholinesterase inhibitors|cholinesterase inhibitors
640740|NCT00866086|stage I non-small cell lung cancer|stage i non-small cell lung cancer
640741|NCT00866086|stage II non-small cell lung cancer|stage ii non-small cell lung cancer
640742|NCT00866086|stage IIIA non-small cell lung cancer|stage iiia non-small cell lung cancer
640743|NCT00866086|stage IIIB non-small cell lung cancer|stage iiib non-small cell lung cancer
640744|NCT00866086|stage IV non-small cell lung cancer|stage iv non-small cell lung cancer
640745|NCT00866086|recurrent non-small cell lung cancer|recurrent non-small cell lung cancer
640746|NCT00866086|pulmonary carcinoid tumor|pulmonary carcinoid tumor
640747|NCT00866086|extensive stage small cell lung cancer|extensive stage small cell lung cancer
640748|NCT00866086|limited stage small cell lung cancer|limited stage small cell lung cancer
640749|NCT00866086|recurrent small cell lung cancer|recurrent small cell lung cancer
640750|NCT00866073|AML|aml
640751|NCT00866073|Acute myeloid leukemia|acute myeloid leukemia
640752|NCT00866073|Decitabine|decitabine
640753|NCT00866060|donepezil|donepezil
640754|NCT00866060|memantine|memantine
640755|NCT00866060|moderately severe Alzheimer's disease|moderately severe alzheimer's disease
640756|NCT00866060|severe Alzheimer's disease|severe alzheimer's disease
640757|NCT00866047|Antigens, CD30|antigens, cd30
640758|NCT00866047|Antibody-Drug Conjugate|antibody-drug conjugate
640759|NCT00866047|Antibodies, Monoclonal|antibodies, monoclonal
640760|NCT00866047|Lymphoma, Non-Hodgkin|lymphoma, non-hodgkin
640761|NCT00866047|Lymphoma, Large-Cell, Anaplastic|lymphoma, large-cell, anaplastic
640762|NCT00866047|monomethyl auristatin E|monomethyl auristatin e
640763|NCT00866047|Drug Therapy|drug therapy
640764|NCT00866047|Immunotherapy|immunotherapy
640765|NCT00866047|Hematologic Diseases|hematologic diseases
640766|NCT00866047|Lymphoma|lymphoma
640767|NCT00866034|Cetrotide|cetrotide
640769|NCT00866034|ICSI|icsi
640770|NCT00866034|Treatment protocol|treatment protocol
640771|NCT00866021|HIV infection|hiv infection
640772|NCT00866021|HCV infection|hcv infection
640773|NCT00866021|treatment experienced|treatment experienced
640774|NCT00866008|IVF|ivf
640775|NCT00866008|In vitro implantation|in vitro implantation
640776|NCT00866008|Preimplantation genetic screening|preimplantation genetic screening
640777|NCT00866008|Aneuploidy|aneuploidy
640778|NCT00865995|pepsin|pepsin
640779|NCT00865995|aspiration|aspiration
640780|NCT00865995|GE reflux|ge reflux
640781|NCT00865982|adenocarcinoma of the stomach, gastro-esophageal junction or distal esophagus|adenocarcinoma of the stomach, gastro-esophageal junction or distal esophagus
640782|NCT00865982|gastric cancer|gastric cancer
640783|NCT00865982|esophageal cancer|esophageal cancer
640784|NCT00865982|gastro-esophageal junction|gastro-esophageal junction
640785|NCT00865982|docetaxel|docetaxel
640786|NCT00865982|capecitabine|capecitabine
640787|NCT00865982|cisplatin|cisplatin
640788|NCT00865982|perioperative chemotherapy|perioperative chemotherapy
640789|NCT00865969|Belinostat|belinostat
640790|NCT00865969|peripheral T-cell lymphoma|peripheral t-cell lymphoma
640791|NCT00865969|PXD101|pxd101
640792|NCT00865969|PTCL|ptcl
640793|NCT00865969|HDAC inhibitor|hdac inhibitor
640794|NCT00865969|histone deacetylase inhibitor|histone deacetylase inhibitor
640795|NCT00865956|disease management|disease management
640796|NCT00865956|substance use disorders|substance use disorders
640797|NCT00865956|behavioral incentives|behavioral incentives
640798|NCT00865943|Bioequivalence|bioequivalence
640799|NCT00865943|Citalopram|citalopram
640800|NCT00865943|Healthy subjects|healthy subjects
640801|NCT00865917|POTS|pots
640802|NCT00865904|∆F508|∆f508
640803|NCT00865904|F508del|f508del
640804|NCT00865904|Cystic Fibrosis Transmembrane Conductance Regulator|cystic fibrosis transmembrane conductance regulator
640805|NCT00865904|CFTR|cftr
640806|NCT00865904|Pancreatic diseases|pancreatic diseases
640807|NCT00865904|Lung diseases|lung diseases
640808|NCT00865904|Genetic disease, inborn|genetic disease, inborn
640809|NCT00865904|Infant, newborn, diseases|infant, newborn, diseases
640810|NCT00865891|Bioequivalence|bioequivalence
640811|NCT00865891|Nifedipine|nifedipine
640812|NCT00865891|Healthy subjects|healthy subjects
640813|NCT00865878|Actinic Keratoses|actinic keratoses
640814|NCT00865878|Skin Neoplasms|skin neoplasms
640815|NCT00865878|Photodynamic Therapy|photodynamic therapy
640816|NCT00865878|Transplants|transplants
640817|NCT00865865|Knee|knee
640818|NCT00865865|Computer|computer
640819|NCT00865865|Gap|gap
640820|NCT00865865|Soft tissue|soft tissue
640821|NCT00865865|Balancing|balancing
640822|NCT00865865|Replacement|replacement
640823|NCT00865865|Arthroplasty|arthroplasty
640824|NCT00865852|Bioequivalence|bioequivalence
640825|NCT00865852|Metformin|metformin
640826|NCT00865852|Healthy subjects|healthy subjects
640827|NCT00865839|Bioequivalence|bioequivalence
640828|NCT00865839|Metformin|metformin
640829|NCT00865839|Healthy subjects|healthy subjects
640830|NCT00865826|Pulmonary Tuberculosis|pulmonary tuberculosis
640831|NCT00865826|Myobacterium Infections|myobacterium infections
640832|NCT00865813|Punch biopsy,|punch biopsy,
640833|NCT00865813|periocular|periocular
640834|NCT00865813|tumors.|tumors.
640835|NCT00865774|Trauma|trauma
640836|NCT00865774|Alcohol|alcohol
640837|NCT00865774|Brief Intervention|brief intervention
640838|NCT00865761|Bioequivalence|bioequivalence
640839|NCT00865761|Alprazolam|alprazolam
640840|NCT00865761|Healthy subjects|healthy subjects
640841|NCT00865748|Bioequivalence|bioequivalence
640842|NCT00865748|Metformin|metformin
640843|NCT00865748|Healthy subjects|healthy subjects
640844|NCT00865722|Remote Postconditioning|remote postconditioning
640845|NCT00865722|Myocardial reperfusion Injury|myocardial reperfusion injury
640846|NCT00865722|Myocardial Infarction|myocardial infarction
640847|NCT00865722|Primary PCI|primary pci
640848|NCT00865709|Colorectal Cancer|colorectal cancer
640849|NCT00865709|Metastasis|metastasis
640850|NCT00865709|Stage IV|stage iv
640851|NCT00865709|Liver Metastasis|liver metastasis
640852|NCT00865696|Bioequivalence|bioequivalence
640853|NCT00865696|Mirtazapine|mirtazapine
640854|NCT00865696|Healthy subjects|healthy subjects
640855|NCT00865683|Gestational Diabetes|gestational diabetes
640856|NCT00865683|Pregnancy|pregnancy
640857|NCT00865683|Docosahexaenoic Acid|docosahexaenoic acid
640858|NCT00865683|DHA|dha
640859|NCT00865683|Maternal-Fetal Exchange|maternal-fetal exchange
640860|NCT00865657|Bioequivalence|bioequivalence
640861|NCT00865657|Alprazolam|alprazolam
640862|NCT00865657|Healthy subjects|healthy subjects
640863|NCT00865644|imiquimod 5% cream|imiquimod 5% cream
640864|NCT00865631|Bioequivalence|bioequivalence
640865|NCT00865631|Gabapentin|gabapentin
640866|NCT00865631|Healthy subjects|healthy subjects
640867|NCT00865605|bioequivalence|bioequivalence
640868|NCT00865605|Vasoconstriction|vasoconstriction
640869|NCT00865605|Halobetasol|halobetasol
640870|NCT00865605|Healthy subjects|healthy subjects
640871|NCT00865592|diabetes|diabetes
640872|NCT00865592|DPP4 inhibitor|dpp4 inhibitor
640873|NCT00865592|dutogliptin|dutogliptin
640874|NCT00865592|PHX1149|phx1149
640875|NCT00865579|MAO inhibitors|mao inhibitors
640876|NCT00865579|motor fluctuations|motor fluctuations
640877|NCT00865579|dyskinesia|dyskinesia
640878|NCT00865579|Parkinson's Disease|parkinson's disease
640879|NCT00865566|HIV Seronegativity|hiv seronegativity
640880|NCT00865566|HIV Preventive Vaccine|hiv preventive vaccine
640881|NCT00865566|HIV Treatment Vaccine|hiv treatment vaccine
640882|NCT00865566|Adenovirus|adenovirus
640883|NCT00865553|tobacco use disorder|tobacco use disorder
640884|NCT00865540|cataract|cataract
640885|NCT00865540|pupillary dilation|pupillary dilation
640886|NCT00865540|anti-inflammatory|anti-inflammatory
640887|NCT00865540|therapeutic use|therapeutic use
640888|NCT00865527|Colorectal cancer|colorectal cancer
640889|NCT00865527|Colon cancer|colon cancer
640890|NCT00865527|Adenomatous polyps|adenomatous polyps
640891|NCT00865527|Screening|screening
640892|NCT00865527|Fecal occult blood test|fecal occult blood test
640893|NCT00865527|Computed tomographic colonography|computed tomographic colonography
640894|NCT00865527|Colonoscopy|colonoscopy
640895|NCT00865514|dichloroacetate|dichloroacetate
640896|NCT00865514|tyrosine|tyrosine
640897|NCT00865514|maleylacetoacetate|maleylacetoacetate
640898|NCT00865514|trichloroethylene|trichloroethylene
640899|NCT00865514|leucine|leucine
640900|NCT00865514|haplotype|haplotype
640901|NCT00865501|primary hypertension|primary hypertension
640902|NCT00865501|aldosterone|aldosterone
640903|NCT00865501|left ventricular hypertrophy|left ventricular hypertrophy
640904|NCT00865475|HIV infection|hiv infection
640905|NCT00865475|Treatment Experienced|treatment experienced
640906|NCT00865462|Bioequivalence|bioequivalence
640907|NCT00865462|Bupropion|bupropion
640908|NCT00865462|Healthy subjects|healthy subjects
640909|NCT00865449|spironolactone|spironolactone
640910|NCT00865449|peritoneal fibrosis|peritoneal fibrosis
640911|NCT00865449|peritoneal dialysis|peritoneal dialysis
640912|NCT00865436|Bioequivalence|bioequivalence
640913|NCT00865436|Metformin|metformin
640914|NCT00865436|Glyburide|glyburide
640915|NCT00865436|Healthy subjects|healthy subjects
640916|NCT00865423|Bioequivalence|bioequivalence
640917|NCT00865423|Gabapentin|gabapentin
640918|NCT00865423|Healthy subjects|healthy subjects
640919|NCT00865410|Bioequivalence|bioequivalence
640920|NCT00865410|Bupropion|bupropion
640921|NCT00865410|Healthy subjects|healthy subjects
640922|NCT00865384|Bioequivalence|bioequivalence
640923|NCT00865384|Mirtazapine|mirtazapine
640924|NCT00865384|Healthy subjects|healthy subjects
640925|NCT00865371|Bioequivalence|bioequivalence
640926|NCT00865371|Bupropion|bupropion
640927|NCT00865371|Healthy subjects|healthy subjects
640928|NCT00865358|yoga|yoga
640929|NCT00865358|complementary alternative medicine|complementary alternative medicine
640930|NCT00865358|low back pain|low back pain
640931|NCT00865358|minority health|minority health
640932|NCT00865358|health care disparities|health care disparities
640933|NCT00865358|community health centers|community health centers
640934|NCT00865345|blood sugar|blood sugar
640935|NCT00865345|glucose|glucose
640936|NCT00865345|sensor|sensor
640938|NCT00865332|fMRI|fmri
640939|NCT00865332|D-Amphetamine|d-amphetamine
640940|NCT00865332|Cocaine Addiction|cocaine addiction
640941|NCT00865332|Methylphenidate|methylphenidate
640942|NCT00865319|Non Small Cell Lung Cancer|non small cell lung cancer
640943|NCT00865319|Spect CT Imaging|spect ct imaging
640944|NCT00865319|PET CT Imaging as Comparator|pet ct imaging as comparator
640945|NCT00865306|Cognitive behavioral therapy|cognitive behavioral therapy
640946|NCT00865306|Anxiety|anxiety
640947|NCT00865306|Preschoolers|preschoolers
640948|NCT00865306|Young Children|young children
640949|NCT00865306|Parents|parents
640950|NCT00865306|At-risk|at-risk
640951|NCT00865306|Behavioral Inhibition|behavioral inhibition
640952|NCT00865293|Obesity|obesity
640953|NCT00865293|expiratory flow limitation|expiratory flow limitation
640954|NCT00865293|EFL|efl
640955|NCT00865293|posture|posture
640956|NCT00865293|small airways obstruction|small airways obstruction
640957|NCT00865293|FOT|fot
640958|NCT00865280|CSSI|cssi
640959|NCT00865280|Abscess|abscess
640960|NCT00865280|Wound|wound
640961|NCT00865280|Cellulitis|cellulitis
640962|NCT00865280|Complicated Skin and Skin Structure Infections (cSSSI)|complicated skin and skin structure infections (csssi)
640963|NCT00865267|Vasoconstriction|vasoconstriction
640964|NCT00865267|Halobetasol|halobetasol
640965|NCT00865267|Healthy adult subjects|healthy adult subjects
640966|NCT00865254|Nicotine Dependence|nicotine dependence
640967|NCT00865254|Smoking|smoking
640968|NCT00865254|Smoking Cessation|smoking cessation
640969|NCT00865254|Contingency Management|contingency management
640970|NCT00865241|Bioequivalence|bioequivalence
640971|NCT00865241|Metformin|metformin
640972|NCT00865241|Glyburide|glyburide
640973|NCT00865241|Healthy subjects|healthy subjects
640974|NCT00865228|Hyperlipidemia|hyperlipidemia
640975|NCT00865228|Dyslipidemia|dyslipidemia
640976|NCT00865228|High Cholesterol|high cholesterol
640977|NCT00865228|Drug Therapy|drug therapy
640978|NCT00865215|Bioequivalence|bioequivalence
640979|NCT00865215|Propranolol|propranolol
640980|NCT00865215|Healthy subjects|healthy subjects
640981|NCT00865202|delirium|delirium
640982|NCT00865202|surgery|surgery
640983|NCT00865202|operation|operation
640984|NCT00865202|geriatric|geriatric
640985|NCT00865202|complication|complication
640986|NCT00865163|Percutaneous Coronary Intervention|percutaneous coronary intervention
640987|NCT00865163|anticoagulation|anticoagulation
640988|NCT00865163|PCI|pci
640989|NCT00865150|Prematurity|prematurity
640990|NCT00865150|Neonatal screening|neonatal screening
640991|NCT00865150|Parenteral nutrition|parenteral nutrition
640992|NCT00865150|Amino acids|amino acids
640993|NCT00865150|Acylcarnitine|acylcarnitine
640994|NCT00865137|Kidney Transplantation|kidney transplantation
640995|NCT00865137|Pharmacokinetics|pharmacokinetics
640996|NCT00865137|Tacrolimus modified release|tacrolimus modified release
640997|NCT00865137|FK506E|fk506e
640998|NCT00865111|Bioequivalence|bioequivalence
640999|NCT00865111|Bupropion|bupropion
641000|NCT00865111|Healthy subjects|healthy subjects
641001|NCT00865098|Newly diagnosed locally advanced squamous cell carcinoma of the head and neck (SCCHN)|newly diagnosed locally advanced squamous cell carcinoma of the head and neck (scchn)
641002|NCT00865085|Bioequivalence|bioequivalence
641003|NCT00865085|Citalopram|citalopram
641004|NCT00865085|Healthy subjects|healthy subjects
641005|NCT00865072|Bioequivalence|bioequivalence
641006|NCT00865072|Metformin|metformin
641007|NCT00865072|Healthy subjects|healthy subjects
641008|NCT00865059|Bioequivalence|bioequivalence
641009|NCT00865059|Gabapentin|gabapentin
641010|NCT00865059|Healthy subjects|healthy subjects
641011|NCT00865046|acupuncture|acupuncture
641012|NCT00865020|Hypertension|hypertension
641013|NCT00865020|ABPM|abpm
641014|NCT00865020|systolic blood pressure|systolic blood pressure
641015|NCT00865020|diastolic blood pressure|diastolic blood pressure
641016|NCT00865020|cardiovascular disease|cardiovascular disease
641017|NCT00865020|aliskiren|aliskiren
641018|NCT00865020|telmisartan|telmisartan
641019|NCT00865007|Lipodystrophy|lipodystrophy
641020|NCT00865007|treatment experienced|treatment experienced
641021|NCT00864994|COPD|copd
641022|NCT00864994|Inflammation|inflammation
641023|NCT00864994|Smoking|smoking
641024|NCT00864994|Multiorgan pathology|multiorgan pathology
641025|NCT00864994|Extra pulmonary manifestations|extra pulmonary manifestations
641026|NCT00864968|Bioequivalence|bioequivalence
641027|NCT00864968|Nabumetone|nabumetone
641028|NCT00864968|Healthy subjects|healthy subjects
641029|NCT00864955|UV-A irradiation|uv-a irradiation
641030|NCT00864955|Cyclobutane-Pyrimidine Dimer|cyclobutane-pyrimidine dimer
641031|NCT00864955|Oxidative lesions|oxidative lesions
641032|NCT00864955|cutaneous phototype|cutaneous phototype
641033|NCT00864955|UV-B irradiation|uv-b irradiation
641034|NCT00864955|DNA damages|dna damages
641035|NCT00864942|CLL|cll
641036|NCT00864942|NHL|nhl
641037|NCT00864942|lymphoma|lymphoma
641038|NCT00864929|Non-interventional study|non-interventional study
641039|NCT00864929|Vietnam|vietnam
641040|NCT00864929|inappropriate treatment|inappropriate treatment
641041|NCT00864929|nosocomial infection|nosocomial infection
641042|NCT00864916|Endothelial Function|endothelial function
641043|NCT00864916|Pentoxifylline|pentoxifylline
641044|NCT00864916|Antiretroviral Therapy|antiretroviral therapy
641045|NCT00864916|Inflammation|inflammation
641046|NCT00864903|enterovirus|enterovirus
641047|NCT00864903|aseptic meningitis|aseptic meningitis
641048|NCT00864903|real time PCR|real time pcr
641049|NCT00864903|diagnostics|diagnostics
641050|NCT00864890|Bioequivalence|bioequivalence
641051|NCT00864890|Citalopram|citalopram
641052|NCT00864890|Healthy subjects|healthy subjects
641053|NCT00864877|retrospective|retrospective
641054|NCT00864877|comparison|comparison
641055|NCT00864877|biodegradable|biodegradable
641056|NCT00864877|implant|implant
641057|NCT00864877|ankle fracture|ankle fracture
641058|NCT00864864|sunitinib|sunitinib
641059|NCT00864838|intraocular pressure|intraocular pressure
641060|NCT00864838|bevacizumab|bevacizumab
641061|NCT00864838|acetazolamide|acetazolamide
641062|NCT00864838|brimonidine|brimonidine
641063|NCT00864838|anterior chamber paracentesis|anterior chamber paracentesis
641064|NCT00864825|Schizophrenia|schizophrenia
641065|NCT00864825|Allopurinol|allopurinol
641066|NCT00864825|Add-on-treatment|add-on-treatment
641067|NCT00864799|Abortion|abortion
641069|NCT00864799|Mifepristone|mifepristone
641070|NCT00864799|Pregnancy|pregnancy
641071|NCT00864799|Fetus|fetus
641072|NCT00864786|Multiple dose safety and pharmacokinetics study|multiple dose safety and pharmacokinetics study
641073|NCT00864760|Bioequivalence|bioequivalence
641074|NCT00864760|Gabapentin|gabapentin
641075|NCT00864760|Healthy subjects|healthy subjects
641076|NCT00864747|Bioequivalence|bioequivalence
641077|NCT00864747|Propranolol|propranolol
641078|NCT00864747|Healthy subjects|healthy subjects
641079|NCT00864734|Bioequivalence|bioequivalence
641080|NCT00864734|Metformin|metformin
641081|NCT00864734|Glyburide|glyburide
641082|NCT00864734|Healthy subjects|healthy subjects
641083|NCT00864721|Untreated NSCLC in patients > 70|untreated nsclc in patients > 70
641084|NCT00864708|Functional Electrical Stimulation|functional electrical stimulation
641085|NCT00864695|Anesthesia|anesthesia
641086|NCT00864695|Ethics|ethics
641087|NCT00864695|Trends|trends
641088|NCT00864695|Manpower|manpower
641089|NCT00864695|Perioperative care|perioperative care
641090|NCT00864682|propofol|propofol
641091|NCT00864682|lidocaine|lidocaine
641092|NCT00864682|injection pain|injection pain
641093|NCT00864669|Bioequivalence|bioequivalence
641094|NCT00864669|Metformin|metformin
641095|NCT00864669|Healthy subjects|healthy subjects
641096|NCT00864656|adrenergic alpha-agonists|adrenergic alpha-agonists
641097|NCT00864656|phenylephrine|phenylephrine
641098|NCT00864656|drug effects|drug effects
641099|NCT00864656|diagnostic use|diagnostic use
641100|NCT00864643|Hyperlipidemia|hyperlipidemia
641101|NCT00864643|Drug Therapy|drug therapy
641102|NCT00864643|Dyslipidemia|dyslipidemia
641103|NCT00864617|Bioequivalence|bioequivalence
641104|NCT00864617|Nifedipine|nifedipine
641105|NCT00864617|Healthy subjects|healthy subjects
641106|NCT00864604|Bioequivalence|bioequivalence
641107|NCT00864604|Nabumetone|nabumetone
641108|NCT00864604|Healthy subjects|healthy subjects
641109|NCT00864591|SPECT Imaging|spect imaging
641110|NCT00864591|Stress adenosine CMR|stress adenosine cmr
641111|NCT00864578|POAG|poag
641113|NCT00864578|Forskolin|forskolin
641114|NCT00864578|Food supplement|food supplement
641115|NCT00864565|Bioequivalence|bioequivalence
641116|NCT00864565|Fentanyl|fentanyl
641117|NCT00864565|Healthy subjects|healthy subjects
641118|NCT00864552|Hemophilia A|hemophilia a
641119|NCT00864552|Recombinant Factor VIII|recombinant factor viii
641120|NCT00864539|vitamin D fortification|vitamin d fortification
641121|NCT00864539|milk|milk
641122|NCT00864539|orange juice|orange juice
641123|NCT00864539|supplement|supplement
641124|NCT00864539|efficacy|efficacy
641125|NCT00864526|Bioequivalence|bioequivalence
641126|NCT00864526|Oxycodone|oxycodone
641127|NCT00864526|Ibuprofen|ibuprofen
641128|NCT00864526|Healthy subjects|healthy subjects
641129|NCT00864513|pancreas|pancreas
641130|NCT00864513|metastatic|metastatic
641131|NCT00864513|recurrent|recurrent
641132|NCT00864500|Bio-Equivalence|bio-equivalence
641133|NCT00864500|Vasoconstriction|vasoconstriction
641134|NCT00864500|Clobetasol|clobetasol
641135|NCT00864500|Healthy adult females|healthy adult females
641136|NCT00864461|Down syndrome|down syndrome
641137|NCT00864461|Metabolic syndrome X|metabolic syndrome x
641138|NCT00864461|Insulin resistance|insulin resistance
641139|NCT00864448|Bioequivalence|bioequivalence
641140|NCT00864448|Ramipril|ramipril
641141|NCT00864448|Healthy subjects|healthy subjects
641142|NCT00864435|Bioequivalence|bioequivalence
641143|NCT00864435|Carvedilol|carvedilol
641144|NCT00864435|Healthy subjects|healthy subjects
641145|NCT00864422|low back pain|low back pain
641146|NCT00864422|motor training|motor training
641147|NCT00864422|motor cortex|motor cortex
641148|NCT00864422|brain plasticity|brain plasticity
641149|NCT00864409|postoperative pain|postoperative pain
641150|NCT00864409|total hip arthroplasty|total hip arthroplasty
641151|NCT00864396|Laryngopharyngeal reflux|laryngopharyngeal reflux
641152|NCT00864396|Gastroesophageal reflux disease|gastroesophageal reflux disease
641153|NCT00864396|GERD|gerd
641154|NCT00864370|Psychiatry|psychiatry
641155|NCT00864370|Pregnancy|pregnancy
641156|NCT00864370|Bipolar Disorder|bipolar disorder
641157|NCT00864357|Bioequivalence|bioequivalence
641158|NCT00864357|Oxycodone|oxycodone
641159|NCT00864357|Ibuprofen|ibuprofen
641160|NCT00864357|Healthy subjects|healthy subjects
641161|NCT00864344|Bioequivalence|bioequivalence
641162|NCT00864344|Sertralin|sertralin
641163|NCT00864344|Healthy subjectse|healthy subjectse
641164|NCT00864331|lung cancer|lung cancer
641165|NCT00864331|nonsmall cell lung cancer|nonsmall cell lung cancer
641166|NCT00864331|radiation therapy|radiation therapy
641167|NCT00864331|chemotherapy|chemotherapy
641168|NCT00864331|Locally advanced and metastatic nonsmall cell lung cancer|locally advanced and metastatic nonsmall cell lung cancer
641169|NCT00864318|refractory|refractory
641170|NCT00864318|germ cell tumors|germ cell tumors
641171|NCT00864318|relapse|relapse
641172|NCT00864318|bad prognosis|bad prognosis
710284|NCT00589563|contiguous stage II marginal zone lymphoma|contiguous stage ii marginal zone lymphoma
641173|NCT00864318|Refractory germ cell tumors with relapse and bad prognosis|refractory germ cell tumors with relapse and bad prognosis
641174|NCT00864305|Bioequivalence|bioequivalence
641175|NCT00864305|Gabapentin|gabapentin
641176|NCT00864305|Healthy subjects|healthy subjects
641177|NCT00864279|Bioequivalence|bioequivalence
641178|NCT00864279|Cetirizine|cetirizine
641179|NCT00864279|Healthy subjects|healthy subjects
641180|NCT00864266|Non small cell lung carcinoma|non small cell lung carcinoma
641181|NCT00864266|Chemotherapy|chemotherapy
641182|NCT00864266|Response prediction|response prediction
641183|NCT00864253|Melanoma|melanoma
641184|NCT00864253|Malignant|malignant
641185|NCT00864253|Abraxane|abraxane
641186|NCT00864253|ABI-007|abi-007
641187|NCT00864253|Dacarbazine|dacarbazine
641188|NCT00864253|Dtic-Dome|dtic-dome
641189|NCT00864240|Vasoconstriction|vasoconstriction
641190|NCT00864240|Clobetasol|clobetasol
641191|NCT00864240|Healthy adult females|healthy adult females
641192|NCT00864227|Acute Lymphoblastic Leukemia/Lymphoma|acute lymphoblastic leukemia/lymphoma
641193|NCT00864227|Acute Myelogenous Leukemia|acute myelogenous leukemia
641194|NCT00864227|Mantel-Cell Lymphoma|mantel-cell lymphoma
641195|NCT00864227|Hematopoietic Transplant|hematopoietic transplant
641196|NCT00864227|Umbilical Cord Blood (UCB)|umbilical cord blood (ucb)
641197|NCT00864227|Non-Myeloablative Transplant|non-myeloablative transplant
641198|NCT00864214|bioidentical hormone|bioidentical hormone
641199|NCT00864214|menopause|menopause
641200|NCT00864214|estrogen|estrogen
641201|NCT00864214|progesterone|progesterone
641202|NCT00864188|skin health|skin health
641203|NCT00864188|probiotics|probiotics
641204|NCT00864188|dairy|dairy
641205|NCT00864188|oral|oral
641206|NCT00864162|Bioequivalence|bioequivalence
641207|NCT00864162|Ramipril|ramipril
641208|NCT00864162|Healthy subjects|healthy subjects
641209|NCT00864149|Bioequivalence|bioequivalence
641210|NCT00864149|Carvedilol|carvedilol
641211|NCT00864149|Healthy subjects|healthy subjects
641212|NCT00864123|Obsessive-compulsive disorder|obsessive-compulsive disorder
641213|NCT00864110|Non small cell lung cancer|non small cell lung cancer
641214|NCT00864110|SPECT CT imaging|spect ct imaging
641215|NCT00864110|Pharmacokinetic|pharmacokinetic
641216|NCT00864110|Radiation Dosimetry|radiation dosimetry
641217|NCT00864110|PET CT comparison|pet ct comparison
641218|NCT00864097|Arthritis monoclonal antibody nerve growth factor (NGF) anti-NGF tanezumab PF-04383119 RN-624 OA|arthritis monoclonal antibody nerve growth factor (ngf) anti-ngf tanezumab pf-04383119 rn-624 oa
641219|NCT00864071|Bioequivalence|bioequivalence
641220|NCT00864071|Griseofulvin|griseofulvin
641221|NCT00864071|Healthy subjects|healthy subjects
641222|NCT00864058|Bioequivalence|bioequivalence
641223|NCT00864058|Gabapentin|gabapentin
641224|NCT00864058|Healthy subjects|healthy subjects
641225|NCT00864032|Soft tissue sarcoma of the extremity and body wall|soft tissue sarcoma of the extremity and body wall
641226|NCT00864019|Bioequivalence|bioequivalence
641227|NCT00864019|Sertraline|sertraline
641228|NCT00864019|Healthy subjects|healthy subjects
641229|NCT00863980|angiotensin|angiotensin
641230|NCT00863980|receptor|receptor
641231|NCT00863980|vulnerable plaque|vulnerable plaque
641232|NCT00863980|coronary artery|coronary artery
641233|NCT00863967|physical examination|physical examination
641234|NCT00863967|diagnostic techniques and procedures|diagnostic techniques and procedures
641235|NCT00863967|diagnosis|diagnosis
641236|NCT00863967|immunologic tests|immunologic tests
641237|NCT00863967|diagnostic tests|diagnostic tests
641238|NCT00863967|causality|causality
641239|NCT00863967|genetic test|genetic test
641240|NCT00863967|biomarker|biomarker
641241|NCT00863941|Bioequivalence|bioequivalence
641242|NCT00863941|Bupropion|bupropion
641243|NCT00863941|Healthy subjects|healthy subjects
641244|NCT00863915|Bioequivalence|bioequivalence
641245|NCT00863915|Ramipril|ramipril
641246|NCT00863915|Healthy subjects|healthy subjects
641247|NCT00863902|Bioequivalence|bioequivalence
641248|NCT00863902|Cetirizine|cetirizine
641249|NCT00863902|Healthy subjects|healthy subjects
641250|NCT00863876|wavefront measurements of the entire eye|wavefront measurements of the entire eye
641251|NCT00863863|Bioequivalence|bioequivalence
641252|NCT00863863|Griseofulvin|griseofulvin
641253|NCT00863863|Healthy subjects|healthy subjects
641254|NCT00863837|Acute variceal bleeding|acute variceal bleeding
641255|NCT00863837|banding ligation|banding ligation
641256|NCT00863837|vasoconstrictor|vasoconstrictor
641257|NCT00863837|proton pump inhibitor|proton pump inhibitor
641258|NCT00863824|NNAL|nnal
641259|NCT00863824|Cotinine|cotinine
641260|NCT00863824|Second hand smoke|second hand smoke
641261|NCT00863824|NNAL is a known lung carcinogen. So, we are studying an agent that can potentially cause lung cancer.|nnal is a known lung carcinogen. so, we are studying an agent that can potentially cause lung cancer.
641262|NCT00863811|POAG|poag
641263|NCT00863811|IOP|iop
641264|NCT00863811|Forskolin|forskolin
641265|NCT00863811|beta-blockers|beta-blockers
641266|NCT00863811|prostaglandins|prostaglandins
641267|NCT00863798|Major Depressive Disorder|major depressive disorder
641268|NCT00863785|Acute Alcoholic Hepatitis|acute alcoholic hepatitis
641269|NCT00863785|Cirrhosis|cirrhosis
641270|NCT00863785|Alcohol|alcohol
641271|NCT00863785|Alcoholic Liver disease|alcoholic liver disease
641272|NCT00863759|intra-ocular lenses|intra-ocular lenses
641273|NCT00863759|comparative study|comparative study
641274|NCT00863759|Ocular aberrations|ocular aberrations
641275|NCT00863759|Contrast Sensitivity|contrast sensitivity
641276|NCT00863746|Non-Small Cell Lung Cancer (NSCLC)|non-small cell lung cancer (nsclc)
641277|NCT00863746|Sorafenib|sorafenib
641278|NCT00863707|regadenoson|regadenoson
641279|NCT00863707|chronic kidney disease stage III|chronic kidney disease stage iii
641280|NCT00863707|chronic kidney disease stage IV|chronic kidney disease stage iv
641281|NCT00863707|renal impairment|renal impairment
641282|NCT00863707|coronary artery disease|coronary artery disease
641283|NCT00863694|cystic fibrosis|cystic fibrosis
641284|NCT00863694|calprotectin|calprotectin
641285|NCT00863694|elastase|elastase
641286|NCT00863681|Pulmonary arterial hypertension|pulmonary arterial hypertension
641287|NCT00863681|PH|ph
641288|NCT00863681|Stimulator|stimulator
641289|NCT00863668|Infection|infection
641290|NCT00863668|HIV 1|hiv 1
641291|NCT00863668|HIV|hiv
641292|NCT00863668|treatment naive|treatment naive
641293|NCT00863655|Breast Cancer|breast cancer
641294|NCT00863655|Estrogen Receptor positive|estrogen receptor positive
641295|NCT00863655|ER+|er+
641296|NCT00863655|exemestane|exemestane
641297|NCT00863655|mTOR|mtor
641298|NCT00863655|everolimus|everolimus
641299|NCT00863655|refractory|refractory
641300|NCT00863655|NSAI|nsai
641301|NCT00863642|Early cholecystectomy|early cholecystectomy
641302|NCT00863642|gallstone pancreatitis|gallstone pancreatitis
641303|NCT00863629|myocardial infarction|myocardial infarction
641304|NCT00863629|oxidative stress|oxidative stress
641305|NCT00863629|stem cells|stem cells
641306|NCT00863629|glycemic control|glycemic control
641307|NCT00863616|COPD|copd
641308|NCT00863616|Mucus hypersecretion|mucus hypersecretion
641309|NCT00863616|HRQL|hrql
641310|NCT00863616|ESWT|eswt
641311|NCT00863616|HFCWO|hfcwo
641312|NCT00863603|Supplemental oxygen|supplemental oxygen
641313|NCT00863603|Intimal hyperplasia|intimal hyperplasia
641314|NCT00863603|Graft patency|graft patency
641315|NCT00863577|Healthy volunteers|healthy volunteers
641316|NCT00863564|Postprandial Period|postprandial period
641317|NCT00863564|Postprandial Lipaemia|postprandial lipaemia
641318|NCT00863564|Incretins|incretins
641319|NCT00863564|Subclinical Inflammation|subclinical inflammation
641320|NCT00863564|Obesity|obesity
641321|NCT00863564|Atherosclerosis|atherosclerosis
641322|NCT00863564|Triglyceride|triglyceride
641323|NCT00863564|Lipoproteins|lipoproteins
641324|NCT00863564|Postprandial inflammation|postprandial inflammation
641325|NCT00863538|Spinocerebellar degeneration|spinocerebellar degeneration
641326|NCT00863538|Thyrotropin-Releasing Hormone (TRH)|thyrotropin-releasing hormone (trh)
641327|NCT00863538|SCD|scd
641328|NCT00863512|stage IA non-small cell lung cancer|stage ia non-small cell lung cancer
641329|NCT00863512|stage IB non-small cell lung cancer|stage ib non-small cell lung cancer
641330|NCT00863512|stage IIA non-small cell lung cancer|stage iia non-small cell lung cancer
641331|NCT00863512|adenocarcinoma of the lung|adenocarcinoma of the lung
641332|NCT00863512|adenosquamous cell lung cancer|adenosquamous cell lung cancer
641333|NCT00863512|bronchoalveolar cell lung cancer|bronchoalveolar cell lung cancer
641334|NCT00863512|large cell lung cancer|large cell lung cancer
641335|NCT00863512|squamous cell lung cancer|squamous cell lung cancer
641336|NCT00863499|Attention Deficit/Hyperactivity Disorder|attention deficit/hyperactivity disorder
641337|NCT00863499|Attention Deficit Disorder|attention deficit disorder
641338|NCT00863499|ADHD|adhd
641339|NCT00863499|ADD|add
641340|NCT00863499|iSPOT|ispot
641341|NCT00863473|Proximal Humerus Fracture in elderly|proximal humerus fracture in elderly
641342|NCT00863421|Sleep disordered breathing|sleep disordered breathing
641343|NCT00863421|Prevalence|prevalence
641344|NCT00863421|Chronic heart failure|chronic heart failure
641345|NCT00863421|Incidence|incidence
641346|NCT00863421|Sleep apnea|sleep apnea
641347|NCT00863421|Cheyne-Stokes-Breathing|cheyne-stokes-breathing
641348|NCT00863408|Mosquito|mosquito
641349|NCT00863408|Human Landing Collection|human landing collection
641350|NCT00863408|Malaria|malaria
641351|NCT00863395|pruritis|pruritis
641352|NCT00863395|itch|itch
641353|NCT00863395|CTCL|ctcl
641354|NCT00863382|atrial fibrillation|atrial fibrillation
641355|NCT00863369|recurrent adult Burkitt lymphoma|recurrent adult burkitt lymphoma
641356|NCT00863369|recurrent adult diffuse large cell lymphoma|recurrent adult diffuse large cell lymphoma
641357|NCT00863369|recurrent adult diffuse mixed cell lymphoma|recurrent adult diffuse mixed cell lymphoma
641358|NCT00863369|recurrent adult diffuse small cleaved cell lymphoma|recurrent adult diffuse small cleaved cell lymphoma
641359|NCT00863369|recurrent adult grade III lymphomatoid granulomatosis|recurrent adult grade iii lymphomatoid granulomatosis
711006|NCT00586885|Nonalcoholic Steatohepatitis|nonalcoholic steatohepatitis
641360|NCT00863369|recurrent adult immunoblastic large cell lymphoma|recurrent adult immunoblastic large cell lymphoma
641361|NCT00863369|recurrent adult lymphoblastic lymphoma|recurrent adult lymphoblastic lymphoma
641362|NCT00863369|recurrent grade 3 follicular lymphoma|recurrent grade 3 follicular lymphoma
641363|NCT00863369|recurrent mantle cell lymphoma|recurrent mantle cell lymphoma
641364|NCT00863369|adult grade III lymphomatoid granulomatosis|adult grade iii lymphomatoid granulomatosis
641365|NCT00863356|Epistaxis|epistaxis
641366|NCT00863356|Chitosan|chitosan
641367|NCT00863356|Hemostatic|hemostatic
641368|NCT00863356|Nose bleed|nose bleed
641369|NCT00863356|Nasal bleeding|nasal bleeding
641370|NCT00863356|Nasal pack|nasal pack
641371|NCT00863356|Sealant|sealant
641372|NCT00863356|ChitoFlex®|chitoflex®
641373|NCT00863356|HemCon|hemcon
641374|NCT00863356|HemCon® ChitoFlex Surgical Dressing|hemcon® chitoflex surgical dressing
641375|NCT00863356|HemCon® Nasal Plugs|hemcon® nasal plugs
641376|NCT00863356|Biocompatible dressing|biocompatible dressing
641377|NCT00863343|Influenza infections|influenza infections
641378|NCT00863343|Orthomyxoviridae infections|orthomyxoviridae infections
641379|NCT00863330|stage IV melanoma|stage iv melanoma
641380|NCT00863330|recurrent melanoma|recurrent melanoma
641381|NCT00863317|Bronchiolitis|bronchiolitis
641382|NCT00863317|montelukast|montelukast
641383|NCT00863317|leukotriene inhibitor|leukotriene inhibitor
641384|NCT00863304|monoclonal antibody RN624 PF-04383119 nerve growth factor anti-nerve growth factor OA pain arthritis|monoclonal antibody rn624 pf-04383119 nerve growth factor anti-nerve growth factor oa pain arthritis
641385|NCT00863291|Depression|depression
641386|NCT00863291|suicidality|suicidality
641387|NCT00863291|buprenorphine|buprenorphine
641388|NCT00863265|Phytosterols|phytosterols
641389|NCT00863265|Ezetimibe|ezetimibe
641390|NCT00863265|Cholesterol Excretion|cholesterol excretion
641391|NCT00863265|Cholesterol Absorption|cholesterol absorption
641393|NCT00863265|Mass Spectrometry|mass spectrometry
641394|NCT00863265|Deuterium|deuterium
641395|NCT00863252|proteinuria|proteinuria
641396|NCT00863252|creatinine|creatinine
641397|NCT00863252|kidney survival|kidney survival
641398|NCT00863252|ESRD|esrd
641399|NCT00863239|treatment naive|treatment naive
641400|NCT00863239|genotype 1|genotype 1
641401|NCT00863226|Quality of Life issues in Parkinson's disease|quality of life issues in parkinson's disease
641402|NCT00863213|Catheter Ablation, Radiofrequency|catheter ablation, radiofrequency
641403|NCT00863213|Atrial fibrillation|atrial fibrillation
641404|NCT00863213|Antiarrhythmic Drugs|antiarrhythmic drugs
641405|NCT00863200|Depression|depression
641406|NCT00863200|Cancer|cancer
641407|NCT00863200|African Americans|african americans
641408|NCT00863200|Latinos|latinos
641409|NCT00863200|Hispanics|hispanics
641410|NCT00863200|Interactive voice response|interactive voice response
641411|NCT00863200|IVR|ivr
641412|NCT00863200|Behavioral Intervention|behavioral intervention
641413|NCT00863174|Multiple myeloma|multiple myeloma
641414|NCT00863174|Bio-equivalence|bio-equivalence
641415|NCT00863161|Safety|safety
641416|NCT00863161|tolerability|tolerability
641417|NCT00863161|exposure|exposure
641418|NCT00863161|healthy|healthy
641419|NCT00863161|renally impaired subjects|renally impaired subjects
641420|NCT00863148|MDS|mds
641421|NCT00863148|AML|aml
641422|NCT00863148|ALL|all
641423|NCT00863148|RIC|ric
641424|NCT00863148|clofarabine|clofarabine
641425|NCT00863148|allo-HSCT|allo-hsct
641426|NCT00863148|high-risk MDS/AML|high-risk mds/aml
641427|NCT00863135|obstructive sleep apnea|obstructive sleep apnea
641428|NCT00863135|refractory arterial hypertension|refractory arterial hypertension
641429|NCT00863135|continuous positive airways pressure|continuous positive airways pressure
641430|NCT00863122|Lapatinib|lapatinib
641431|NCT00863122|Tykerb|tykerb
641432|NCT00863122|EGFR inhibitor|egfr inhibitor
641433|NCT00863122|ErbB2 inhibitor|erbb2 inhibitor
641434|NCT00863122|Pharmacokinetics|pharmacokinetics
641435|NCT00863096|HPV|hpv
641436|NCT00863096|acceptability|acceptability
641437|NCT00863083|pediatric obesity|pediatric obesity
641438|NCT00863083|pediatric overweight|pediatric overweight
641439|NCT00863083|multi-family group weight management intervention|multi-family group weight management intervention
641440|NCT00863083|financial rewards|financial rewards
641441|NCT00863070|Bladder exstrophy|bladder exstrophy
641442|NCT00863070|Abnormal gait|abnormal gait
641443|NCT00863070|anatomy|anatomy
641444|NCT00863070|urinary bladder disease|urinary bladder disease
641445|NCT00863070|urogenital abnormalities|urogenital abnormalities
641446|NCT00863057|HIV Infections|hiv infections
641447|NCT00863057|Neuropathy|neuropathy
641448|NCT00863057|Pain|pain
641449|NCT00863044|off pump coronary bypass|off pump coronary bypass
641450|NCT00863044|high frequency ventilation|high frequency ventilation
641451|NCT00863044|cerebral oxygen saturation|cerebral oxygen saturation
641452|NCT00863044|vasopressors used|vasopressors used
641453|NCT00863044|right and left ventricular function|right and left ventricular function
641454|NCT00863044|arterial blood pressure|arterial blood pressure
641455|NCT00863044|heart rate|heart rate
641456|NCT00863031|mental health|mental health
817428|NCT00170612|Fiji|fiji
641457|NCT00863031|problem-solving therapy|problem-solving therapy
641458|NCT00863031|elderly|elderly
641459|NCT00863031|health-related quality of life|health-related quality of life
641460|NCT00863031|primary care|primary care
641461|NCT00863031|Chinese|chinese
641462|NCT00863018|Corneal endothelial cell|corneal endothelial cell
641463|NCT00863018|Specular microscopy|specular microscopy
641464|NCT00863018|Glaucoma implant surgery|glaucoma implant surgery
641465|NCT00863018|Ahmed glaucoma valve|ahmed glaucoma valve
641466|NCT00863018|Trabeculectomy|trabeculectomy
641467|NCT00862992|schizophrenia|schizophrenia
641468|NCT00862992|antipsychotics|antipsychotics
641469|NCT00862992|dopamine D3/D2 antagonist|dopamine d3/d2 antagonist
641470|NCT00862979|Heart Transplantation|heart transplantation
641471|NCT00862979|Cardiac Transplantation|cardiac transplantation
641472|NCT00862979|CNI-sparing|cni-sparing
641473|NCT00862979|renal function|renal function
641475|NCT00862979|Cyclosporine A|cyclosporine a
641476|NCT00862979|Everolimus|everolimus
641477|NCT00862979|mycophenolic acid|mycophenolic acid
641478|NCT00862953|low carbohydrate|low carbohydrate
641479|NCT00862953|high protein diet|high protein diet
641480|NCT00862940|Memantine|memantine
641481|NCT00862940|Neuroimaging|neuroimaging
641482|NCT00862940|MRI|mri
641483|NCT00862940|Brain atrophy|brain atrophy
641484|NCT00862927|Smoking Cessation|smoking cessation
641485|NCT00862927|Cigarette Smoking|cigarette smoking
641486|NCT00862927|Tobacco Smoking|tobacco smoking
641487|NCT00862927|Cue Reactivity|cue reactivity
641488|NCT00862927|Virtual Reality|virtual reality
641489|NCT00862927|VR|vr
641490|NCT00862927|Contextual Cues|contextual cues
641491|NCT00862927|Explicit Smoking Cues|explicit smoking cues
641492|NCT00862927|Craving|craving
641493|NCT00862927|Physiological Arousal|physiological arousal
641494|NCT00862927|Nicotine Dependence|nicotine dependence
641495|NCT00862927|Breath Sample|breath sample
641496|NCT00862927|Saliva Test|saliva test
641497|NCT00862927|Questionnaire|questionnaire
641498|NCT00862914|Skin|skin
641499|NCT00862914|MicroRNA|microrna
641500|NCT00862914|miRNA|mirna
641501|NCT00862914|Dicer|dicer
641502|NCT00862914|Malignant Melanoma|malignant melanoma
641503|NCT00862901|cancer|cancer
641504|NCT00862901|skin metastases|skin metastases
641505|NCT00862901|chest wall progression of breast cancer|chest wall progression of breast cancer
641506|NCT00862901|malignant melanoma|malignant melanoma
641507|NCT00862901|photodynamic therapy|photodynamic therapy
641508|NCT00862901|photophrin|photophrin
641509|NCT00862901|satellite and in-transit metastases of malignant melanoma|satellite and in-transit metastases of malignant melanoma
641510|NCT00862901|skin cancer|skin cancer
641511|NCT00862875|Insulin initiation|insulin initiation
641512|NCT00862875|oral therapy failure|oral therapy failure
641513|NCT00862862|infection|infection
641514|NCT00862862|staphylococcus aureus|staphylococcus aureus
641515|NCT00862862|vancomycin|vancomycin
641516|NCT00862862|pharmacodynammics|pharmacodynammics
641517|NCT00862849|rHuPH20|rhuph20
641518|NCT00862849|Recombinant Human Hyaluronidase|recombinant human hyaluronidase
641519|NCT00862849|Insulin Lispro|insulin lispro
641520|NCT00862849|Regular Human Insulin|regular human insulin
641521|NCT00862836|ZD6474|zd6474
641522|NCT00862836|Vandetanib|vandetanib
641523|NCT00862836|Zactima|zactima
641524|NCT00862836|Ovarian Cancer|ovarian cancer
641525|NCT00862836|Phase I|phase i
641526|NCT00862836|Phase II|phase ii
641527|NCT00862836|Randomized|randomized
641528|NCT00862836|Safety|safety
641529|NCT00862823|Healthy Volunteers|healthy volunteers
641530|NCT00862810|Human papillomavirus|human papillomavirus
641531|NCT00862810|Cervical cancer|cervical cancer
641532|NCT00862810|Genital warts|genital warts
641533|NCT00862810|Vaccine|vaccine
641534|NCT00862810|Immunogenicity|immunogenicity
641535|NCT00862797|endotracheal tube|endotracheal tube
641536|NCT00862797|swallowing|swallowing
641537|NCT00862797|aspiration|aspiration
641538|NCT00862797|cuff pressure|cuff pressure
641539|NCT00862797|pneumonia|pneumonia
641540|NCT00862784|Colorectal carcinoma|colorectal carcinoma
641541|NCT00862784|CRC|crc
641542|NCT00862784|Colon Cancer|colon cancer
641543|NCT00862758|juvenile idiopathic arthritis|juvenile idiopathic arthritis
641544|NCT00862732|active suicidal ideation|active suicidal ideation
641545|NCT00862732|cognitive behavioural therapy|cognitive behavioural therapy
641546|NCT00862732|Sri Lanka|sri lanka
641547|NCT00862732|RCT|rct
641548|NCT00862706|Chronic HBV|chronic hbv
641549|NCT00862693|Immunoglobulin A|immunoglobulin a
641550|NCT00862693|Antibodies|antibodies
641551|NCT00862693|treatment|treatment
641552|NCT00862667|Pharmacokinetics|pharmacokinetics
641553|NCT00862641|regadenoson|regadenoson
641554|NCT00862641|CVT 3146|cvt 3146
641555|NCT00862641|asthma|asthma
641556|NCT00862641|coronary artery disease|coronary artery disease
641557|NCT00862641|pulmonary disease, chronic obstructive|pulmonary disease, chronic obstructive
641558|NCT00862615|Ageing|ageing
641559|NCT00862615|Inflammation|inflammation
817527|NCT00169897|COPD|copd
641560|NCT00862615|Muscle protein synthesis|muscle protein synthesis
641561|NCT00862615|Osteopenia|osteopenia
641562|NCT00862615|Sarcopenia|sarcopenia
641563|NCT00862602|GDM|gdm
641564|NCT00862602|gestational diabetes|gestational diabetes
641565|NCT00862602|pregnancy|pregnancy
641566|NCT00862602|diabetes|diabetes
641567|NCT00862602|walking|walking
641568|NCT00862602|exercise|exercise
641569|NCT00862602|pedometer|pedometer
641570|NCT00862602|online|online
641571|NCT00862589|glucagon|glucagon
641572|NCT00862589|GLP-1|glp-1
641573|NCT00862589|hyperglycemia|hyperglycemia
641574|NCT00862576|Burning Mouth Syndrome|burning mouth syndrome
641575|NCT00862576|Sleep|sleep
641576|NCT00862576|Neuropathic pain|neuropathic pain
641577|NCT00862576|Glossodynia|glossodynia
641578|NCT00862576|Chronic pain|chronic pain
641579|NCT00862576|Orofacial pain|orofacial pain
641580|NCT00862563|Alcoholism|alcoholism
641581|NCT00862563|Alcohol Dependence|alcohol dependence
641582|NCT00862563|Alcohol Abuse|alcohol abuse
641583|NCT00862563|Substance Abuse|substance abuse
641584|NCT00862563|Alcoholic Intoxication|alcoholic intoxication
641585|NCT00862550|Head and Neck Cancer|head and neck cancer
641586|NCT00862550|HNC|hnc
641587|NCT00862550|Nasopharyngeal carcinoma|nasopharyngeal carcinoma
641588|NCT00862550|Acupuncture|acupuncture
641589|NCT00862550|Radiation-Induced Xerostomia|radiation-induced xerostomia
641590|NCT00862550|Xerostomia|xerostomia
641591|NCT00862550|Dry Mouth|dry mouth
641592|NCT00862550|Radiation|radiation
641593|NCT00862511|metal ion concentration|metal ion concentration
641594|NCT00862511|total knee arthroplasty|total knee arthroplasty
641595|NCT00862511|metal hypersensitivity|metal hypersensitivity
641596|NCT00862498|PTSD|ptsd
641597|NCT00862498|Written Disclosure|written disclosure
641598|NCT00862498|Written Emotional Disclosure|written emotional disclosure
641599|NCT00862498|Narrative Exposure|narrative exposure
641600|NCT00862498|Narrative Writing|narrative writing
641601|NCT00862498|Motor Vehicle Accident|motor vehicle accident
641602|NCT00862472|open-angle glaucoma|open-angle glaucoma
641603|NCT00862472|ocular hypertension|ocular hypertension
641604|NCT00862472|open-angle glaucoma (with or without pseudoexfoliation or pigment dispersion component)|open-angle glaucoma (with or without pseudoexfoliation or pigment dispersion component)
641605|NCT00862459|Contrast Agents|contrast agents
641606|NCT00862446|Parenteral nutrition associate liver disease|parenteral nutrition associate liver disease
641607|NCT00862446|TPN cholestasis|tpn cholestasis
641608|NCT00862446|TPN Associated Liver Disease|tpn associated liver disease
641609|NCT00862433|Non-Insulin Dependent Diabetes|non-insulin dependent diabetes
641610|NCT00862433|Vitamin C|vitamin c
641611|NCT00862433|Antioxidant|antioxidant
641612|NCT00862433|Lipid Peroxidation|lipid peroxidation
641613|NCT00862433|Non-Insulin Requiring Diabetics|non-insulin requiring diabetics
641614|NCT00862433|Alpha-Tocopherol|alpha-tocopherol
641615|NCT00862433|Non-Alcoholic Fatty Liver Disease|non-alcoholic fatty liver disease
641616|NCT00862433|Health Volunteer|health volunteer
641617|NCT00862433|HV|hv
641618|NCT00862433|Normal Weight|normal weight
641619|NCT00862433|Overweight|overweight
641620|NCT00862433|Type 2 Diabetes|type 2 diabetes
641621|NCT00862420|Platelet aggregation inhibitors|platelet aggregation inhibitors
641622|NCT00862420|Peripheral arterial disease (PAD)|peripheral arterial disease (pad)
641623|NCT00862407|Cardiopulmonary bypass|cardiopulmonary bypass
641624|NCT00862407|Non-pulsatile perfusion|non-pulsatile perfusion
641625|NCT00862407|Pulsatile perfusion|pulsatile perfusion
641626|NCT00862407|plasma proteins|plasma proteins
641627|NCT00862381|shock|shock
641628|NCT00862381|Tracheal Intubation|tracheal intubation
641629|NCT00862381|reanimation|reanimation
641630|NCT00862381|suprarenal insufficiency|suprarenal insufficiency
641631|NCT00862381|Etomidate|etomidate
641632|NCT00862381|Adrenocorticotropic Hormone|adrenocorticotropic hormone
641633|NCT00862381|hydrocortisone|hydrocortisone
641634|NCT00862368|Motivational Interviewing|motivational interviewing
641635|NCT00862368|Pediatric Asthma|pediatric asthma
641636|NCT00862368|Smoking Cessation|smoking cessation
641637|NCT00862368|Environmental Tobacco Smoke|environmental tobacco smoke
641638|NCT00862368|Second hand smoke|second hand smoke
641639|NCT00862368|Biomarker|biomarker
641640|NCT00862368|Asthma|asthma
641641|NCT00862368|Asthma Education|asthma education
641642|NCT00862368|Family Intervention|family intervention
641643|NCT00862368|Smoking|smoking
641644|NCT00862368|Nicotine Patch|nicotine patch
641645|NCT00862368|Parents|parents
641646|NCT00862368|Caregivers|caregivers
641647|NCT00862368|Child Wellness|child wellness
641648|NCT00862355|Carcinoma|carcinoma
641649|NCT00862355|Ovary|ovary
641650|NCT00862355|Carcinoma Ovary|carcinoma ovary
641651|NCT00862342|colorectal cancer|colorectal cancer
641652|NCT00862342|Bevacizumab|bevacizumab
641653|NCT00862329|Healthy subjects|healthy subjects
641654|NCT00862316|Eligible for Unicompartmental Knee Arthritis|eligible for unicompartmental knee arthritis
711007|NCT00586885|NASH|nash
641655|NCT00862303|autologous cytokine induced killer cells|autologous cytokine induced killer cells
641656|NCT00862303|dendritic cell|dendritic cell
641657|NCT00862303|vaccine|vaccine
641658|NCT00862303|renal cell carcinoma|renal cell carcinoma
641659|NCT00862290|sepsis|sepsis
641660|NCT00862290|microRNA|microrna
641661|NCT00862277|Menactra®|menactra®
641662|NCT00862277|Menomune®|menomune®
641663|NCT00862277|Meningitis|meningitis
641664|NCT00862277|Meningococcal Infections|meningococcal infections
641665|NCT00862251|cardiovascular disorder|cardiovascular disorder
641666|NCT00862225|rhinomanometry|rhinomanometry
641667|NCT00862225|mode of action|mode of action
641668|NCT00862225|grass pollen|grass pollen
641669|NCT00862212|anxiety|anxiety
641670|NCT00862212|social anxiety|social anxiety
641671|NCT00862212|social anxiety disorder|social anxiety disorder
641672|NCT00862212|coping behaviors|coping behaviors
641673|NCT00862212|alcohol abuse|alcohol abuse
641674|NCT00862186|Neoplasms|neoplasms
641675|NCT00862186|Fatigue|fatigue
641676|NCT00862186|Self Care|self care
641677|NCT00862173|Gene-expression profile|gene-expression profile
641678|NCT00862173|Central nervous system metastasis|central nervous system metastasis
641679|NCT00862173|Non-small-cell lung cancer|non-small-cell lung cancer
641680|NCT00862160|coronary artery bypass surgery|coronary artery bypass surgery
641681|NCT00862160|cardiopulmonary bypass|cardiopulmonary bypass
641682|NCT00862160|heart lung machine|heart lung machine
641683|NCT00862160|acute cerebrovascular event|acute cerebrovascular event
641684|NCT00862160|intracranial embolism|intracranial embolism
641685|NCT00862160|embolism, air|embolism, air
641686|NCT00862160|outcome assessment (health care)|outcome assessment (health care)
641687|NCT00862160|neuropsychological tests|neuropsychological tests
641688|NCT00862160|magnetic resonance imaging|magnetic resonance imaging
641689|NCT00862160|saccadic eye movement test|saccadic eye movement test
641690|NCT00862147|Child psychosocial Functioning|child psychosocial functioning
641691|NCT00862108|Attention Deficit Hyperactivity Disorder|attention deficit hyperactivity disorder
641692|NCT00862108|Polymorphism, Single Nucleotide|polymorphism, single nucleotide
641693|NCT00862108|SLC6A2 protein, human|slc6a2 protein, human
641694|NCT00862108|ADRA2A protein, human|adra2a protein, human
641695|NCT00862056|asymptomatic|asymptomatic
641696|NCT00862056|coronary artery disease|coronary artery disease
641697|NCT00862043|Secondary Pulmonary Hypertension|secondary pulmonary hypertension
641698|NCT00862043|Valvular Heart Disease|valvular heart disease
641699|NCT00862043|Phosphodiesterase-Inhibitors|phosphodiesterase-inhibitors
641700|NCT00862043|Sildenafil|sildenafil
641701|NCT00862043|Outcomes Research|outcomes research
641702|NCT00862030|Palliative radiotherapy|palliative radiotherapy
641703|NCT00862030|Treatment planning|treatment planning
641704|NCT00862030|Non-small cell lung cancer|non-small cell lung cancer
641705|NCT00862017|Physiology|physiology
641706|NCT00862004|video-assisted thoracoscopic surgery (VATS)|video-assisted thoracoscopic surgery (vats)
641707|NCT00862004|systematic node dissection (SND)|systematic node dissection (snd)
641708|NCT00862004|stage IIIA non-small cell lung cancer|stage iiia non-small cell lung cancer
641709|NCT00861991|medical communication|medical communication
641710|NCT00861991|empathy|empathy
641711|NCT00861991|medical education|medical education
641712|NCT00861991|standardized patients|standardized patients
641713|NCT00861991|"enhancing patient satisfaction"|"enhancing patient satisfaction"
641714|NCT00861978|mild to moderate depression with atypical features according to DSM-IV|mild to moderate depression with atypical features according to dsm-iv
641715|NCT00861965|Leukemia|leukemia
641716|NCT00861965|Lymphoma|lymphoma
641717|NCT00861965|Multiple Myeloma|multiple myeloma
641718|NCT00861952|Diabetic peripheral neuropathies|diabetic peripheral neuropathies
641719|NCT00861952|Neuralgia|neuralgia
641720|NCT00861952|Complementary medicine|complementary medicine
641721|NCT00861952|Analgesia|analgesia
641722|NCT00861926|Maintenance and Reliever Treatments|maintenance and reliever treatments
641723|NCT00861887|Clostridium difficile|clostridium difficile
641724|NCT00861887|colitis|colitis
641725|NCT00861887|recurrence|recurrence
641726|NCT00861887|relapse|relapse
641727|NCT00861887|Vancomycin|vancomycin
641728|NCT00861861|Pitavastatin|pitavastatin
641729|NCT00861861|Atorvastatin|atorvastatin
641731|NCT00861861|HDL-C|hdl-c
641732|NCT00861861|Adiponectin|adiponectin
641733|NCT00861822|Anemia|anemia
641734|NCT00861822|Cardiac surgery|cardiac surgery
641735|NCT00861822|RBC transfusion|rbc transfusion
641736|NCT00861822|Acute Kidney Injury|acute kidney injury
641737|NCT00861822|Cardiac surgery with cardiopulmonary bypass|cardiac surgery with cardiopulmonary bypass
641738|NCT00861809|single dose|single dose
641739|NCT00861809|gut motility|gut motility
641740|NCT00861809|Type I Diabetes Mellitus patients|type i diabetes mellitus patients
641741|NCT00861809|tolerability|tolerability
641742|NCT00861809|phase II|phase ii
641743|NCT00861809|13C octanoic acid breath test|13c octanoic acid breath test
641744|NCT00861809|pharmacodynamics|pharmacodynamics
641745|NCT00861809|gastric emtpying|gastric emtpying
641746|NCT00861809|pharmacokinetics|pharmacokinetics
641747|NCT00861783|oxaliplatin|oxaliplatin
641748|NCT00861783|diaminocyclohexane oxalatoplatinum|diaminocyclohexane oxalatoplatinum
641749|NCT00861783|oxalatoplatin|oxalatoplatin
641750|NCT00861783|oxalatoplatinum|oxalatoplatinum
641751|NCT00861783|Eloxatin|eloxatin
641752|NCT00861770|Congestive Heart Failure|congestive heart failure
641753|NCT00861770|Ultrafiltration|ultrafiltration
641754|NCT00861770|Blood Volume Measurement|blood volume measurement
641755|NCT00861744|Measles, Mumps, Rubella, Varicella Vaccine|measles, mumps, rubella, varicella vaccine
641756|NCT00861744|Children|children
641757|NCT00861744|Immunogenicity|immunogenicity
641758|NCT00861744|Safety|safety
641759|NCT00861744|Humans|humans
641760|NCT00861744|Combined Vaccine|combined vaccine
641761|NCT00861744|Vaccines|vaccines
641762|NCT00861731|chronic renal failure|chronic renal failure
641763|NCT00861731|proteinuria|proteinuria
641764|NCT00861731|apolipoprotein|apolipoprotein
641765|NCT00861731|c reactive protein|c reactive protein
641766|NCT00861718|Phase 1|phase 1
641767|NCT00861718|Healthy Volunteer|healthy volunteer
641768|NCT00861692|Argatroban|argatroban
641769|NCT00861692|heparin induced thrombocytopenia (HIT)|heparin induced thrombocytopenia (hit)
641770|NCT00861692|direct thrombin inhibitor (DTI)|direct thrombin inhibitor (dti)
641771|NCT00861679|HSCT|hsct
641772|NCT00861679|ALL|all
641773|NCT00861679|GvHD|gvhd
641774|NCT00861666|Forgiveness|forgiveness
641775|NCT00861666|Writing|writing
641776|NCT00861666|PTSD|ptsd
641777|NCT00861666|OEF|oef
641778|NCT00861666|OIF|oif
641779|NCT00861666|Veterans|veterans
641780|NCT00861653|Atherosclerosis|atherosclerosis
641781|NCT00861653|Subjects diagnosed with atherosclerosis|subjects diagnosed with atherosclerosis
641782|NCT00861640|rabeprazole|rabeprazole
641783|NCT00861640|omeprazole|omeprazole
641784|NCT00861640|upper gastrointestinal bleeding|upper gastrointestinal bleeding
641785|NCT00861627|REOLYSIN|reolysin
641786|NCT00861627|reovirus|reovirus
641787|NCT00861627|non-small cell lung cancer|non-small cell lung cancer
641788|NCT00861627|carcinoma|carcinoma
641789|NCT00861627|oncolytics virus|oncolytics virus
641790|NCT00861627|chemotherapy|chemotherapy
641791|NCT00861627|paclitaxel|paclitaxel
641792|NCT00861627|carboplatin|carboplatin
641793|NCT00861588|complementary & alternative medicine|complementary & alternative medicine
641794|NCT00861588|randomized control trial|randomized control trial
641795|NCT00861588|uroflowmetry|uroflowmetry
641796|NCT00861588|quality of life|quality of life
641797|NCT00861588|benign prostate hyperplasia|benign prostate hyperplasia
641798|NCT00861575|Cardiovascular|cardiovascular
641799|NCT00861562|constipation|constipation
641800|NCT00861562|hemorrhoids|hemorrhoids
641801|NCT00861562|water smartweed|water smartweed
641802|NCT00861562|RCT|rct
641803|NCT00861549|Bioavailability|bioavailability
641804|NCT00861549|Pharmacokinetics|pharmacokinetics
641805|NCT00861549|Safety Evaluation|safety evaluation
641806|NCT00861536|risk factors|risk factors
641807|NCT00861536|immunology|immunology
641808|NCT00861523|nausea|nausea
641809|NCT00861523|vomiting|vomiting
641810|NCT00861523|pregnancy|pregnancy
641811|NCT00861523|thiamine|thiamine
641812|NCT00861523|promethazine|promethazine
641813|NCT00861523|nausea and vomiting in pregnancy|nausea and vomiting in pregnancy
641814|NCT00861510|Small Lymphocytic Lymphoma (SLL)|small lymphocytic lymphoma (sll)
641815|NCT00861510|Prolymphocytic Lymphoma (PLL)|prolymphocytic lymphoma (pll)
641816|NCT00861510|Hairy Cell Leukemia (HCL)|hairy cell leukemia (hcl)
641817|NCT00861510|Mantle Cell Lymphoma|mantle cell lymphoma
641818|NCT00861510|MCL|mcl
641819|NCT00861510|Chronic Lymphocytic Leukemia|chronic lymphocytic leukemia
641820|NCT00861510|CLL|cll
641821|NCT00861510|Multiple Myeloma|multiple myeloma
641822|NCT00861510|MM|mm
641823|NCT00861497|Open-label|open-label
641824|NCT00861497|Flexible-dose|flexible-dose
641825|NCT00861497|Extension|extension
641826|NCT00861497|Safety study|safety study
641827|NCT00861471|hormone refractory prostate cancer|hormone refractory prostate cancer
641828|NCT00861471|tyrosine kinase inhibitor|tyrosine kinase inhibitor
641829|NCT00861471|Gleevec|gleevec
641830|NCT00861471|PSA|psa
641831|NCT00861471|prostate specific antigen|prostate specific antigen
641832|NCT00861471|growth factor receptor inhibitor|growth factor receptor inhibitor
641833|NCT00861471|androgen independent|androgen independent
641834|NCT00861445|Lacosamide, Vimpat®|lacosamide, vimpat®
641835|NCT00861432|Life quality|life quality
641836|NCT00861432|questionnaire|questionnaire
641837|NCT00861432|tumor patients|tumor patients
641838|NCT00861419|AMG 386|amg 386
641839|NCT00861419|AMG 706|amg 706
641840|NCT00861419|Bevacizumab|bevacizumab
641841|NCT00861419|Sorafenib|sorafenib
641842|NCT00861419|Angiogenesis Inhibitors|angiogenesis inhibitors
641843|NCT00861419|Combination Therapy|combination therapy
641844|NCT00861419|Peptibody|peptibody
641845|NCT00861419|Sunitinib|sunitinib
641846|NCT00861406|Melanoma|melanoma
641847|NCT00861406|Stage II melanoma|stage ii melanoma
711008|NCT00586885|L-Alanine|l-alanine
641848|NCT00861406|Pegylated Interferon-alfa 2b|pegylated interferon-alfa 2b
641849|NCT00861406|PEG Interferon alfa-2b|peg interferon alfa-2b
641850|NCT00861406|PEG Intron|peg intron
641851|NCT00861406|Melanoma Peptide Vaccine|melanoma peptide vaccine
641852|NCT00861406|GP100 Vaccine|gp100 vaccine
641853|NCT00861406|gp100|gp100
641854|NCT00861406|peptide vaccine|peptide vaccine
641855|NCT00861406|Leukapheresis|leukapheresis
641856|NCT00861406|Immune-cell response|immune-cell response
641857|NCT00861380|Pneumococcal conjugate vaccine|pneumococcal conjugate vaccine
641858|NCT00861380|Invasive disease|invasive disease
641859|NCT00861380|Respiratory tract infections|respiratory tract infections
641860|NCT00861380|Haemophilus influenzae|haemophilus influenzae
641861|NCT00861380|Streptococcus pneumoniae|streptococcus pneumoniae
641862|NCT00861380|Acute otitis media|acute otitis media
641863|NCT00861380|Pneumonia|pneumonia
641864|NCT00861367|aspirin|aspirin
641865|NCT00861367|blood loss|blood loss
641866|NCT00861367|transurethral surgery|transurethral surgery
641867|NCT00861354|atrial fibrillation|atrial fibrillation
641868|NCT00861354|home blood pressure monitoring|home blood pressure monitoring
641869|NCT00861341|Pioglitazone|pioglitazone
641870|NCT00861341|Thiazolidinediones|thiazolidinediones
641871|NCT00861341|Platelet Function|platelet function
641872|NCT00861341|Platelet aggregation|platelet aggregation
641873|NCT00861341|Diabetic|diabetic
641874|NCT00861341|Aspirin.|aspirin.
641875|NCT00861328|Phase 1|phase 1
641876|NCT00861328|maximum tolerated dose|maximum tolerated dose
641877|NCT00861328|oxaliplatin|oxaliplatin
641878|NCT00861328|irinotecan|irinotecan
641879|NCT00861328|ON 01910.Na|on 01910.na
641880|NCT00861315|Pneumonia|pneumonia
641881|NCT00861315|Nebulization|nebulization
641882|NCT00861315|Amikacin|amikacin
641883|NCT00861276|Smoking Cessation|smoking cessation
641884|NCT00861276|Nicotine|nicotine
641885|NCT00861276|Administration and dosage|administration and dosage
641886|NCT00861276|Randomized Controlled Trial|randomized controlled trial
641887|NCT00861250|Bortezomib plus dexamethasone induction therapy|bortezomib plus dexamethasone induction therapy
642132|NCT00860236|Giardia|giardia
641888|NCT00861250|Autologous stem cell transplantation|autologous stem cell transplantation
641889|NCT00861250|Molecular remission|molecular remission
641890|NCT00861237|Nux vomica|nux vomica
641891|NCT00861237|homeopathy|homeopathy
641892|NCT00861237|heart lung machine|heart lung machine
641893|NCT00861237|heart surgery|heart surgery
641894|NCT00861237|postoperatively studied|postoperatively studied
641895|NCT00861211|asthma|asthma
641896|NCT00861211|inflammation|inflammation
641897|NCT00861211|bronchoconstriction|bronchoconstriction
641898|NCT00861211|allergen challenge|allergen challenge
641899|NCT00861211|KCa3.1|kca3.1
641900|NCT00861185|bronchospasm|bronchospasm
641901|NCT00861185|exercise asthma|exercise asthma
641902|NCT00861185|inflammation|inflammation
641903|NCT00861185|KCa3.1|kca3.1
641904|NCT00861172|Multiple sclerosis|multiple sclerosis
641905|NCT00861172|Active plaque|active plaque
641906|NCT00861172|Multimodal analysis|multimodal analysis
641907|NCT00861172|3T MRI|3t mri
641908|NCT00861172|Weekly follow-up|weekly follow-up
641909|NCT00861172|Physiopathology|physiopathology
641910|NCT00861172|Physiopathology of active lesions formation in Multiple Sclerosis using multimodal MR sequences|physiopathology of active lesions formation in multiple sclerosis using multimodal mr sequences
641911|NCT00861159|RLIP76 Auto Antibodies|rlip76 auto antibodies
641912|NCT00861146|nicotine dependence|nicotine dependence
641913|NCT00861146|tobacco dependence|tobacco dependence
641914|NCT00861146|smoking cessation|smoking cessation
641915|NCT00861146|alcoholism|alcoholism
641916|NCT00861146|self-efficacy|self-efficacy
641917|NCT00861146|relapse|relapse
641918|NCT00861133|cardiac monitor|cardiac monitor
641919|NCT00861133|loop recorder|loop recorder
641920|NCT00861133|stroke|stroke
641922|NCT00861133|Implantable Loop Recorder|implantable loop recorder
641923|NCT00861133|cryptogenic|cryptogenic
641924|NCT00861133|ILR|ilr
641925|NCT00861120|Ovarian cancer|ovarian cancer
641926|NCT00861120|KRAS wildtype|kras wildtype
641927|NCT00861120|Platinum resistant|platinum resistant
641928|NCT00861107|Colorectal cancer|colorectal cancer
641929|NCT00861107|Breast Cancer|breast cancer
641930|NCT00861107|Melanoma|melanoma
641931|NCT00861107|GI cancer|gi cancer
641932|NCT00861107|Prostate cancer|prostate cancer
641933|NCT00861107|Kidney cancer|kidney cancer
641934|NCT00861107|Lung cancer|lung cancer
641935|NCT00861107|all types metastatic cancer where at least one tumor lesion is accessable for percutaneous cryoablation|all types metastatic cancer where at least one tumor lesion is accessable for percutaneous cryoablation
641936|NCT00861094|adenocarcinoma of the esophagus|adenocarcinoma of the esophagus
641937|NCT00861094|squamous cell carcinoma of the esophagus|squamous cell carcinoma of the esophagus
641938|NCT00861094|stage IIA esophageal cancer|stage iia esophageal cancer
641939|NCT00861094|stage IIB esophageal cancer|stage iib esophageal cancer
641940|NCT00861094|stage IIIA esophageal cancer|stage iiia esophageal cancer
641941|NCT00861094|stage IIIB esophageal cancer|stage iiib esophageal cancer
818040|NCT00167778|Amputee|amputee
641942|NCT00861094|stage IIIC esophageal cancer|stage iiic esophageal cancer
641943|NCT00861094|stage IV esophageal cancer|stage iv esophageal cancer
641944|NCT00861081|Group Clinics|group clinics
641945|NCT00861081|Self Management|self management
641946|NCT00861068|Lacosamide, Vimpat®|lacosamide, vimpat®
641947|NCT00861042|Lacosamide, Vimpat®|lacosamide, vimpat®
641948|NCT00861029|GW786034, pazopanib, moxifloxacin, ECG intervals and morphology, QTc, Holter monitor, pharmacokinetics, safety, cancer|gw786034, pazopanib, moxifloxacin, ecg intervals and morphology, qtc, holter monitor, pharmacokinetics, safety, cancer
641949|NCT00861016|Post marketing study|post marketing study
641950|NCT00861003|schizophrenia|schizophrenia
641951|NCT00861003|adherence|adherence
641952|NCT00860977|HIV|hiv
641953|NCT00860977|Herpes simplex virus type II|herpes simplex virus type ii
641954|NCT00860977|Genital herpes|genital herpes
641955|NCT00860977|Treatment Naive|treatment naive
641956|NCT00860964|estradiol valerate|estradiol valerate
641957|NCT00860964|Medroxyprogesterone|medroxyprogesterone
641958|NCT00860964|menopause|menopause
641959|NCT00860964|Lipid|lipid
641960|NCT00860964|Bone mineral density|bone mineral density
641961|NCT00860964|Body Composition|body composition
641962|NCT00860951|Normal|normal
641963|NCT00860938|Inhaled corticosteroids|inhaled corticosteroids
641964|NCT00860938|COPD|copd
641965|NCT00860938|mannitol|mannitol
641966|NCT00860925|Randomized Controlled Trial|randomized controlled trial
641967|NCT00860925|Blinded|blinded
641968|NCT00860925|Clonidine|clonidine
641969|NCT00860925|acetyl-salicylic acid (ASA)|acetyl-salicylic acid (asa)
641970|NCT00860925|Perioperative vascular complications|perioperative vascular complications
641971|NCT00860925|Noncardiac surgery|noncardiac surgery
641972|NCT00860912|Veritas|veritas
641973|NCT00860912|Cystocele|cystocele
641974|NCT00860912|Prolapse|prolapse
641975|NCT00860899|clonidine|clonidine
641976|NCT00860899|levobupivacaine|levobupivacaine
641977|NCT00860899|preoperative analgesia|preoperative analgesia
641978|NCT00860899|postoperative pain|postoperative pain
641979|NCT00860899|systemic inflammatory stress response|systemic inflammatory stress response
641980|NCT00860899|epidural analgesia|epidural analgesia
641981|NCT00860899|Anesthetics, Local|anesthetics, local
641982|NCT00860886|Mongolia|mongolia
641983|NCT00860886|Asia|asia
641984|NCT00860886|GROWTH FACTORS|growth factors
641985|NCT00860886|Hormones|hormones
641986|NCT00860886|Premenopausal|premenopausal
641987|NCT00860886|Breast Cancer|breast cancer
641988|NCT00860860|radioimmunotherapy|radioimmunotherapy
641989|NCT00860860|pretargeting|pretargeting
641990|NCT00860860|bispecific antibody|bispecific antibody
641991|NCT00860860|lutetium 177|lutetium 177
641992|NCT00860860|phase I clinical trial|phase i clinical trial
641993|NCT00860847|Progression of Atherosclerosis|progression of atherosclerosis
641994|NCT00860847|Aged garlic extract|aged garlic extract
641995|NCT00860847|Biomarkers of inflammation|biomarkers of inflammation
641996|NCT00860847|Coronary Plaque Volume and coronary Stenosis|coronary plaque volume and coronary stenosis
641997|NCT00860847|Vascular function|vascular function
641998|NCT00860834|Consumer Participation|consumer participation
641999|NCT00860834|Telephone Coaching Program|telephone coaching program
642000|NCT00860821|Healthy subjects|healthy subjects
642001|NCT00860821|LPS|lps
642002|NCT00860821|Effect|effect
642003|NCT00860821|Intranasally|intranasally
642004|NCT00860808|tinnitus|tinnitus
642005|NCT00860795|Echinacea|echinacea
642006|NCT00860795|prevention|prevention
642007|NCT00860795|immune modulation|immune modulation
642008|NCT00860782|Sickle Cell Disease|sickle cell disease
642009|NCT00860782|Educational Outcomes|educational outcomes
642010|NCT00860782|Neurodevelopmental Functioning|neurodevelopmental functioning
642011|NCT00860756|sleep|sleep
642012|NCT00860756|disturbance|disturbance
642013|NCT00860756|deployment|deployment
642014|NCT00860756|intervention|intervention
642015|NCT00860756|actigraph|actigraph
642016|NCT00860743|intermittent hypoxia|intermittent hypoxia
642017|NCT00860743|ventilatory long-term facilitation|ventilatory long-term facilitation
642018|NCT00860743|autonomic nervous system plasticity|autonomic nervous system plasticity
642019|NCT00860730|Aortic valve replacement|aortic valve replacement
642020|NCT00860730|Aortic stenosis|aortic stenosis
642021|NCT00860730|Biological valve|biological valve
642022|NCT00860730|Sutureless valve|sutureless valve
642023|NCT00860730|Stented valve|stented valve
642024|NCT00860730|Aortic Valve Disease|aortic valve disease
642025|NCT00860717|Leprosy|leprosy
642026|NCT00860717|Ulcers|ulcers
642027|NCT00860717|Laser|laser
642028|NCT00860704|goal directed fluid therapy|goal directed fluid therapy
642029|NCT00860704|lean patients|lean patients
642030|NCT00860704|obese patients|obese patients
642031|NCT00860704|crystalloids|crystalloids
642032|NCT00860704|Esophageal Doppler|esophageal doppler
642033|NCT00860704|tissue oxygenation|tissue oxygenation
642034|NCT00860704|Fluid management during surgery|fluid management during surgery
642035|NCT00860704|Fluid management|fluid management
642036|NCT00860691|Curative surgical resection|curative surgical resection
642037|NCT00860691|Laparoscopic technique|laparoscopic technique
642038|NCT00860665|colorectal cancer|colorectal cancer
642039|NCT00860665|prevention|prevention
642040|NCT00860665|colonoscopy|colonoscopy
642041|NCT00860665|screening|screening
642042|NCT00860665|quality assessment|quality assessment
642043|NCT00860665|colorectal cancer prevention|colorectal cancer prevention
642044|NCT00860652|Oncology|oncology
642045|NCT00860652|Prostate Cancer|prostate cancer
642046|NCT00860652|Radiotherapy|radiotherapy
642047|NCT00860652|Radical Prostatectomy|radical prostatectomy
642048|NCT00860652|Prior Radical Prostatectomy (RP)|prior radical prostatectomy (rp)
642049|NCT00860652|Histological Confirmation of adenocarcinoma of the prostate|histological confirmation of adenocarcinoma of the prostate
642050|NCT00860652|Positive margins and/or extraprostatic extension (EPE)|positive margins and/or extraprostatic extension (epe)
642051|NCT00860639|AML|aml
642052|NCT00860639|gemtuzumab ozogamycin|gemtuzumab ozogamycin
642053|NCT00860613|gestational diabetes|gestational diabetes
642054|NCT00860613|medical nutrition therapy program|medical nutrition therapy program
642055|NCT00860613|glucose monitoring|glucose monitoring
642056|NCT00860613|metabolic control|metabolic control
642057|NCT00860613|nutritional status|nutritional status
642058|NCT00860613|cost effectiveness|cost effectiveness
642059|NCT00860600|Idiopathic Thrombocytopenic Purpura (ITP)|idiopathic thrombocytopenic purpura (itp)
642060|NCT00860600|Platelet Response|platelet response
642061|NCT00860600|PG2 Treatment|pg2 treatment
642062|NCT00860600|Quality of Life|quality of life
642063|NCT00860600|Fatigue|fatigue
642064|NCT00860600|WHO Bleeding score|who bleeding score
642065|NCT00860587|Antibiotic resistance|antibiotic resistance
642066|NCT00860587|Antibiotic treatment|antibiotic treatment
642067|NCT00860561|Efficacy profile|efficacy profile
642068|NCT00860561|Safety profile|safety profile
642069|NCT00860561|Faslodex|faslodex
642070|NCT00860522|relapsed leukemia|relapsed leukemia
642071|NCT00860522|refractory leukemia|refractory leukemia
642072|NCT00860509|phytosterols|phytosterols
642073|NCT00860509|cholesterol excretion|cholesterol excretion
642074|NCT00860509|cholesterol absorption|cholesterol absorption
642075|NCT00860509|diet|diet
642076|NCT00860509|mass spectrometry|mass spectrometry
642077|NCT00860509|deuterium|deuterium
642078|NCT00860496|Immunosuppression, JAK3 inhibitor, calcineurin inhibitors, tacrolimus, cyclosporine, pharmacokinetics, safety, tolerability|immunosuppression, jak3 inhibitor, calcineurin inhibitors, tacrolimus, cyclosporine, pharmacokinetics, safety, tolerability
642079|NCT00860483|Comparison of experienced and novice laparoscopic surgeons|comparison of experienced and novice laparoscopic surgeons
642080|NCT00860470|micronutrients|micronutrients
642081|NCT00860470|deficiency|deficiency
642082|NCT00860470|pregnancy|pregnancy
642083|NCT00860470|birth outcomes|birth outcomes
642084|NCT00860470|infant mortality|infant mortality
642085|NCT00860470|neonatal mortality|neonatal mortality
642086|NCT00860470|malnutrition|malnutrition
642087|NCT00860470|antenatal|antenatal
642088|NCT00860457|Leukemia|leukemia
642089|NCT00860444|Primary Care|primary care
642090|NCT00860444|Diet|diet
642091|NCT00860444|Physical Activity|physical activity
642092|NCT00860418|asthma|asthma
642093|NCT00860418|feedback|feedback
642094|NCT00860418|anti-inflammatory|anti-inflammatory
642095|NCT00860418|ED visits|ed visits
642096|NCT00860366|Acute ischemic stroke|acute ischemic stroke
642097|NCT00860366|thrombolysis|thrombolysis
642098|NCT00860366|alteplase|alteplase
642099|NCT00860366|uric acid|uric acid
642100|NCT00860366|neuroprotection|neuroprotection
642101|NCT00860366|oxidative stress|oxidative stress
642102|NCT00860353|Healthy Volunteer|healthy volunteer
642103|NCT00860353|Single Ascending Dose|single ascending dose
642104|NCT00860353|Safety|safety
642105|NCT00860353|Tolerability|tolerability
642106|NCT00860353|AZD2551|azd2551
642107|NCT00860353|Healthy Volunteer Study|healthy volunteer study
642108|NCT00860340|Congestive Heart Failure|congestive heart failure
642109|NCT00860340|Hemodynamics|hemodynamics
642110|NCT00860340|Echocardiographs|echocardiographs
642111|NCT00860327|Pediatric Heart Disease|pediatric heart disease
642112|NCT00860327|Congenital Heart Disease|congenital heart disease
642113|NCT00860327|Congenital Heart Defects|congenital heart defects
642114|NCT00860327|Developmental Biology|developmental biology
642115|NCT00860327|Contractile Function|contractile function
642116|NCT00860314|external electrical cardioversion|external electrical cardioversion
642117|NCT00860314|typical atrial flutter|typical atrial flutter
642118|NCT00860314|electrode position|electrode position
642119|NCT00860314|antero-lateral|antero-lateral
642120|NCT00860314|antero-posterior|antero-posterior
642121|NCT00860314|biphasic cardioversion|biphasic cardioversion
642122|NCT00860314|step-up protocol|step-up protocol
642123|NCT00860301|infantile colic|infantile colic
642124|NCT00860288|Type 2 Diabetes|type 2 diabetes
642125|NCT00860288|vildagliptin|vildagliptin
642126|NCT00860249|education|education
642127|NCT00860249|preventive service|preventive service
642128|NCT00860249|screening|screening
642129|NCT00860249|Colorectal Cancer Screening|colorectal cancer screening
642130|NCT00860249|Prevention & Control|prevention & control
642131|NCT00860236|CFS|cfs
642133|NCT00860236|Fatigue|fatigue
642134|NCT00860236|Cognitive behavioural therapy|cognitive behavioural therapy
642136|NCT00860236|Chronic fatigue syndrome|chronic fatigue syndrome
642137|NCT00860223|Healthy Subjects|healthy subjects
642138|NCT00860197|Coffee|coffee
642139|NCT00860197|Elderly|elderly
642140|NCT00860197|Immune response|immune response
642141|NCT00860197|Inflammatory status|inflammatory status
642142|NCT00860184|carotid artery|carotid artery
642143|NCT00860184|atherosclerosis|atherosclerosis
642144|NCT00860184|stroke|stroke
642145|NCT00860184|transient ischemic attack|transient ischemic attack
642146|NCT00860184|MRI|mri
642147|NCT00860184|software|software
642148|NCT00860184|risk|risk
642149|NCT00860145|epilepsy|epilepsy
642150|NCT00860145|radiosurgery|radiosurgery
642151|NCT00860145|temporal lobectomy|temporal lobectomy
642345|NCT00859144|HIV Prevention|hiv prevention
642152|NCT00860132|hip fracture elderly orthogeriatric|hip fracture elderly orthogeriatric
642153|NCT00860132|cost effectiveness of hip fracture patients|cost effectiveness of hip fracture patients
642154|NCT00860119|Bioequivalence, Pharmacokinetics, Alprazolam, Sublingual|bioequivalence, pharmacokinetics, alprazolam, sublingual
642155|NCT00860106|VTE|vte
642156|NCT00860106|VKA treatment|vka treatment
642157|NCT00860106|VKA treatment cessation|vka treatment cessation
642158|NCT00860093|Kidney Calculi|kidney calculi
642159|NCT00860093|Urolithiasis|urolithiasis
642160|NCT00860093|Lithotripsy|lithotripsy
642161|NCT00860093|potassium compounds|potassium compounds
642162|NCT00860093|magnesium compounds|magnesium compounds
642163|NCT00860080|post-surgery adhesion formation|post-surgery adhesion formation
642164|NCT00860067|influenza, FluMist, adults, vaccine|influenza, flumist, adults, vaccine
642165|NCT00860054|phytosterols|phytosterols
642166|NCT00860054|cholesterol excretion|cholesterol excretion
642167|NCT00860054|cholesterol absorption|cholesterol absorption
642168|NCT00860054|diet|diet
642169|NCT00860054|mass spectrometry|mass spectrometry
642170|NCT00860054|deuterium|deuterium
642171|NCT00860041|pain|pain
642172|NCT00860041|neurotoxicity|neurotoxicity
642173|NCT00860041|chemotherapeutic agent toxicity|chemotherapeutic agent toxicity
642174|NCT00860041|unspecified adult solid tumor, protocol specific|unspecified adult solid tumor, protocol specific
642175|NCT00860028|Smoking cessation|smoking cessation
642176|NCT00860028|Smoking|smoking
642177|NCT00860028|Tobacco|tobacco
642178|NCT00860028|Varenicline|varenicline
642179|NCT00860028|Alcohol|alcohol
642180|NCT00860002|myomectomy|myomectomy
642181|NCT00860002|uterine artery occlusion|uterine artery occlusion
642182|NCT00860002|uterine vessel occlusion|uterine vessel occlusion
642183|NCT00860002|fibroids|fibroids
642184|NCT00860002|leiomyomas|leiomyomas
642185|NCT00860002|Surgical technique, patient suffering and outcomes|surgical technique, patient suffering and outcomes
642186|NCT00859989|breast cancer|breast cancer
642187|NCT00859989|weight changes|weight changes
642188|NCT00859989|obesity|obesity
642189|NCT00859976|BoneMaster|bonemaster
642190|NCT00859976|Total Hip Replacement|total hip replacement
642191|NCT00859976|Bone Density|bone density
642192|NCT00859976|Patients suitable for Total Hip Replacement|patients suitable for total hip replacement
642193|NCT00859963|Press fit tibial tray|press fit tibial tray
642194|NCT00859950|Sleep Apnea|sleep apnea
642195|NCT00859950|Vascular Occlusion|vascular occlusion
642196|NCT00859950|Nocturnal Polysomnography|nocturnal polysomnography
642197|NCT00859950|Continuous Positive Airway Pressure|continuous positive airway pressure
642198|NCT00859911|micronutrients|micronutrients
642199|NCT00859898|Diabetes Mellitus, Type 2|diabetes mellitus, type 2
642200|NCT00859898|Diabetes Mellitus|diabetes mellitus
642201|NCT00859898|Endocrine System Diseases|endocrine system diseases
642202|NCT00859898|Glucose Metabolism Disorders|glucose metabolism disorders
642203|NCT00859898|Metabolic Diseases|metabolic diseases
642204|NCT00859898|Metformin|metformin
642205|NCT00859898|Dapagliflozin|dapagliflozin
642206|NCT00859898|Hypoglycemic Agents|hypoglycemic agents
642207|NCT00859898|Pharmacologic Actions|pharmacologic actions
642208|NCT00859898|Physiological Effects of Drugs|physiological effects of drugs
642209|NCT00859885|patent foramen ovale|patent foramen ovale
642210|NCT00859885|ischemic stroke|ischemic stroke
642211|NCT00859885|transient ischemic attack|transient ischemic attack
642212|NCT00859885|secondary prevention|secondary prevention
642213|NCT00859885|medical treatment|medical treatment
642214|NCT00859885|percutaneous device closure|percutaneous device closure
642215|NCT00859872|acute psychotic agitation|acute psychotic agitation
642216|NCT00859872|schizophrenia|schizophrenia
642217|NCT00859872|risperidone oral solution|risperidone oral solution
642218|NCT00859872|clonazepam|clonazepam
642219|NCT00859872|haloperidol|haloperidol
642220|NCT00859846|Arterial line|arterial line
642221|NCT00859846|Ultrasound|ultrasound
642222|NCT00859846|Anesthesia|anesthesia
642223|NCT00859846|Pediatric|pediatric
642224|NCT00859833|adenosine|adenosine
642225|NCT00859833|regadenoson|regadenoson
642226|NCT00859833|adenosine receptor subtypes|adenosine receptor subtypes
642227|NCT00859807|Amodiaquine suspension|amodiaquine suspension
642228|NCT00859807|Flavoquine tablets|flavoquine tablets
642229|NCT00859807|Bioequivalence study|bioequivalence study
642230|NCT00859794|Epilepsy|epilepsy
642231|NCT00859794|fMRI|fmri
642232|NCT00859794|Electrophysiology|electrophysiology
642233|NCT00859794|Cortical Mapping|cortical mapping
642234|NCT00859794|Neurosurgery|neurosurgery
642235|NCT00859781|Prostate|prostate
642236|NCT00859768|Cancer|cancer
642237|NCT00859729|DNA|dna
642238|NCT00859729|Vaccine|vaccine
642239|NCT00859729|Electroporation|electroporation
642240|NCT00859729|xenogenic|xenogenic
642241|NCT00859729|PSA|psa
642242|NCT00859716|Vaccination|vaccination
642243|NCT00859716|Diarrhea|diarrhea
642244|NCT00859716|Traveler's Diarrhea|traveler's diarrhea
642245|NCT00859716|Campylobacter jejuni|campylobacter jejuni
642246|NCT00859716|C. jejuni|c. jejuni
642247|NCT00859716|Campylobacter|campylobacter
642248|NCT00859716|Campy|campy
642346|NCT00859144|Youth|youth
642249|NCT00859703|Aromatase inhibitor treatment|aromatase inhibitor treatment
642250|NCT00859703|osteoporosis|osteoporosis
642251|NCT00859703|breast cancer|breast cancer
642252|NCT00859703|bisphosphonates|bisphosphonates
642253|NCT00859690|Obstructive Sleep Apnea|obstructive sleep apnea
642254|NCT00859690|Thrombosis|thrombosis
642255|NCT00859690|Adenosine Deaminase|adenosine deaminase
642256|NCT00859690|Sleep Disorder|sleep disorder
642257|NCT00859677|HIV|hiv
642258|NCT00859677|Methicillin-resistant Staphylococcus aureus (MRSA)|methicillin-resistant staphylococcus aureus (mrsa)
642259|NCT00859677|HIV and Staphylococcus aureus infection|hiv and staphylococcus aureus infection
642260|NCT00859651|breast cancer chemoprevention|breast cancer chemoprevention
642261|NCT00859651|vitamin D|vitamin d
642262|NCT00859651|breast density|breast density
642263|NCT00859625|colonoscopy|colonoscopy
642264|NCT00859625|adenoma detection rate|adenoma detection rate
642265|NCT00859599|Monochromatic Phototherapy|monochromatic phototherapy
642266|NCT00859599|Diabetic Foot Ulcers|diabetic foot ulcers
642267|NCT00859599|Wound healing|wound healing
642268|NCT00859599|Bacterial colonisation|bacterial colonisation
642269|NCT00859586|Acute Myelogenous Leukemia (AML)|acute myelogenous leukemia (aml)
642270|NCT00859586|Acute Lymphoblastic Leukemia (ALL)|acute lymphoblastic leukemia (all)
642271|NCT00859586|Chronic Lymphocytic Leukemia|chronic lymphocytic leukemia
642272|NCT00859586|Myelodysplastic Syndrome (MDS)|myelodysplastic syndrome (mds)
642273|NCT00859586|Acute Myelogenous Leukemia|acute myelogenous leukemia
642274|NCT00859586|AML|aml
642275|NCT00859586|Acute Lymphoblastic Leukemia|acute lymphoblastic leukemia
642276|NCT00859586|ALL|all
642277|NCT00859586|Myelodysplastic Syndrome|myelodysplastic syndrome
642278|NCT00859586|MDS|mds
642279|NCT00859560|Breast cancer|breast cancer
642280|NCT00859560|post-menopausal women|post-menopausal women
642281|NCT00859560|Arimidex|arimidex
642282|NCT00859560|bone fracture|bone fracture
642283|NCT00859534|Solar Urticaria|solar urticaria
642284|NCT00859521|Bioequivalence|bioequivalence
642285|NCT00859521|Healthy Subjects|healthy subjects
642286|NCT00859508|dura repair following cranial surgery|dura repair following cranial surgery
642287|NCT00859482|natalizumab|natalizumab
642288|NCT00859482|multiple sclerosis|multiple sclerosis
642289|NCT00859469|Mesothelioma|mesothelioma
642290|NCT00859430|Bioequivalence|bioequivalence
642291|NCT00859430|Healthy Subjects|healthy subjects
642292|NCT00859417|correction of anterior prolapse|correction of anterior prolapse
642293|NCT00859417|prosthetic trans-obturator way kit|prosthetic trans-obturator way kit
642294|NCT00859417|randomized study|randomized study
642295|NCT00859404|Mild to moderate persistent asthma|mild to moderate persistent asthma
642296|NCT00859391|Celiac Disease|celiac disease
642297|NCT00859378|Hip|hip
642298|NCT00859378|Hip endoprosthesis|hip endoprosthesis
642299|NCT00859378|Hip fracture|hip fracture
642300|NCT00859378|Femoral fracture|femoral fracture
642301|NCT00859378|Bone cement|bone cement
642302|NCT00859378|Non-cemented|non-cemented
642303|NCT00859365|back pain|back pain
642304|NCT00859365|neck pain|neck pain
642305|NCT00859365|anxiety|anxiety
642306|NCT00859365|range of motion|range of motion
642307|NCT00859339|TCC|tcc
642308|NCT00859300|myocardial infarction|myocardial infarction
642309|NCT00859300|ventricular fibrillation|ventricular fibrillation
642310|NCT00859300|sudden death|sudden death
642311|NCT00859300|polymorphism|polymorphism
642312|NCT00859287|Reflux esophagitis|reflux esophagitis
642313|NCT00859287|Omepral®|omepral®
642314|NCT00859287|QOLRAD|qolrad
642315|NCT00859235|Percutaneous endoscopic gastrostomy|percutaneous endoscopic gastrostomy
642316|NCT00859235|peristomal wound infection|peristomal wound infection
642317|NCT00859235|antibiotic mouth wash solution|antibiotic mouth wash solution
642318|NCT00859235|prophylaxis prior Percutaneous endoscopic gastrostomy (PEG)|prophylaxis prior percutaneous endoscopic gastrostomy (peg)
642319|NCT00859222|LBH589|lbh589
642320|NCT00859222|bevacizumab|bevacizumab
642321|NCT00859222|Avastin|avastin
642322|NCT00859222|Panobinostat|panobinostat
642323|NCT00859209|HVF|hvf
642324|NCT00859209|Premature infants|premature infants
642325|NCT00859209|ETCO2|etco2
642326|NCT00859196|Wound healing|wound healing
642327|NCT00859196|Cell proliferation|cell proliferation
642328|NCT00859196|Gene expression|gene expression
642329|NCT00859183|in-stent restenosis|in-stent restenosis
642330|NCT00859183|stents|stents
642331|NCT00859183|sirolimus|sirolimus
642332|NCT00859170|kidney stones|kidney stones
642333|NCT00859170|ureter|ureter
642334|NCT00859170|laser lithotripsy|laser lithotripsy
642335|NCT00859157|perioperative/postoperative complications|perioperative/postoperative complications
642336|NCT00859157|pain|pain
642337|NCT00859157|ductal breast carcinoma in situ|ductal breast carcinoma in situ
642338|NCT00859157|invasive ductal breast carcinoma|invasive ductal breast carcinoma
642339|NCT00859157|invasive lobular breast carcinoma|invasive lobular breast carcinoma
642340|NCT00859157|stage IA breast cancer|stage ia breast cancer
642341|NCT00859157|stage IB breast cancer|stage ib breast cancer
642342|NCT00859157|stage II breast cancer|stage ii breast cancer
642343|NCT00859157|stage IIIA breast cancer|stage iiia breast cancer
642344|NCT00859157|stage IIIB breast cancer|stage iiib breast cancer
642347|NCT00859144|Adolescent|adolescent
642348|NCT00859144|Community Collaboration|community collaboration
642349|NCT00859144|Community Mentorship|community mentorship
642350|NCT00859144|Minority|minority
642351|NCT00859144|Urban|urban
642352|NCT00859144|Sexual Risk Behaviors|sexual risk behaviors
642353|NCT00859144|HIV seronegativity|hiv seronegativity
642354|NCT00859079|diabetes mellitus type 2, GLP-1, insulin infusion|diabetes mellitus type 2, glp-1, insulin infusion
642355|NCT00859040|recurrent intracranial meningioma(s)|recurrent intracranial meningioma(s)
642356|NCT00859040|progressive intracranial meningioma(s)|progressive intracranial meningioma(s)
642357|NCT00859027|Non-metastatic|non-metastatic
642358|NCT00858975|renal tumor|renal tumor
642359|NCT00858975|cryotherapy|cryotherapy
642360|NCT00858975|cytokine|cytokine
642361|NCT00858962|HIV|hiv
642362|NCT00858962|Pharmacokinetics|pharmacokinetics
642363|NCT00858962|Pharmacodynamics|pharmacodynamics
642364|NCT00858962|Buprenorphine|buprenorphine
642365|NCT00858962|Raltegravir|raltegravir
642366|NCT00858962|HIV seronegativity|hiv seronegativity
642367|NCT00858962|Interaction|interaction
642368|NCT00858949|Outpatient surgery|outpatient surgery
642369|NCT00858949|Postoperative nausea and vomiting|postoperative nausea and vomiting
642370|NCT00858949|Costs|costs
642371|NCT00858949|Observational|observational
642372|NCT00858936|CABG(coronary artery bypass graft)|cabg(coronary artery bypass graft)
642373|NCT00858936|Ischemia|ischemia
642374|NCT00858936|Heart surgery|heart surgery
642375|NCT00858936|Heart damage|heart damage
642376|NCT00858923|Extracorporeal Photophoresis|extracorporeal photophoresis
642377|NCT00858923|immuno-therapy|immuno-therapy
642378|NCT00858923|treatment naive|treatment naive
642379|NCT00858910|Motor imagery|motor imagery
642380|NCT00858910|Motor skill|motor skill
642381|NCT00858910|Performance improvement|performance improvement
642382|NCT00858897|Glutathione|glutathione
642383|NCT00858884|Systemic lupus erythematosus|systemic lupus erythematosus
642384|NCT00858884|Libman-Sacks endocarditis|libman-sacks endocarditis
642385|NCT00858884|Stroke|stroke
642386|NCT00858884|Transient ischemic attack|transient ischemic attack
642387|NCT00858884|Neuropsychiatric systemic lupus erythematosus|neuropsychiatric systemic lupus erythematosus
642388|NCT00858884|Transesophageal echocardiography|transesophageal echocardiography
642389|NCT00858884|Magnetic resonance imaging|magnetic resonance imaging
642390|NCT00858845|Leg Weakness|leg weakness
642391|NCT00858845|Skeletal Myopathy|skeletal myopathy
642392|NCT00858845|Sympathetic Nerve Activity|sympathetic nerve activity
642393|NCT00858819|Osteoporosis|osteoporosis
642394|NCT00858819|Fractures|fractures
642395|NCT00858819|Bone Mineral Density|bone mineral density
642396|NCT00858819|Quantitative Computed Tomography|quantitative computed tomography
642397|NCT00858793|AIDS|aids
642398|NCT00858793|HIV|hiv
642399|NCT00858793|Lymphoma|lymphoma
642400|NCT00858793|Stem Cell Transplantation|stem cell transplantation
642401|NCT00858793|gene-modified Stem Cells|gene-modified stem cells
642402|NCT00858793|treatment experienced|treatment experienced
642403|NCT00858767|vitamin K2|vitamin k2
642404|NCT00858767|absorption|absorption
642405|NCT00858767|efficacy|efficacy
642406|NCT00858754|opioid induced constipation|opioid induced constipation
642407|NCT00858754|Cancer patients|cancer patients
642408|NCT00858754|methylnaltrexone|methylnaltrexone
642409|NCT00858741|bone metastases from any histological subtype.|bone metastases from any histological subtype.
642410|NCT00858728|Natural killer cell cytotoxicity|natural killer cell cytotoxicity
642411|NCT00858728|Antibody response|antibody response
642412|NCT00858728|Tetanus toxoid vaccination|tetanus toxoid vaccination
642413|NCT00858728|Pneumovax II vaccination|pneumovax ii vaccination
642414|NCT00858728|Total serum immunoglobulins|total serum immunoglobulins
642415|NCT00858728|IgG subclasses|igg subclasses
642416|NCT00858715|Clopidogrel|clopidogrel
642417|NCT00858715|Aspirin|aspirin
642418|NCT00858715|Antithrombotic therapy|antithrombotic therapy
642419|NCT00858715|Platelet function testing|platelet function testing
642420|NCT00858702|Essential hypertension|essential hypertension
642421|NCT00858702|Combination therapy|combination therapy
642422|NCT00858689|Clinical Drug Trial|clinical drug trial
642423|NCT00858676|acarbose|acarbose
642424|NCT00858676|diabetes mellitus|diabetes mellitus
642425|NCT00858676|impaired glucose tolerance|impaired glucose tolerance
642426|NCT00858676|coronary artery disease|coronary artery disease
642427|NCT00858663|RAD001(Everolimus)|rad001(everolimus)
642428|NCT00858663|Cisplatin|cisplatin
642429|NCT00858663|08-138|08-138
642430|NCT00858650|registry|registry
642431|NCT00858650|natural history|natural history
642432|NCT00858637|Chronic Kidney Disease|chronic kidney disease
642433|NCT00858637|Dialysis|dialysis
642434|NCT00858637|Dyslipidemia|dyslipidemia
642435|NCT00858637|Bile acid sequestrant|bile acid sequestrant
642436|NCT00858624|Cough|cough
642437|NCT00858624|Cough reflex|cough reflex
642438|NCT00858624|NMDA receptor|nmda receptor
642439|NCT00858624|central sensitisation|central sensitisation
642440|NCT00858611|Influenza|influenza
642441|NCT00858611|Healthy|healthy
642442|NCT00858611|Immunity|immunity
642443|NCT00858611|Preventive|preventive
642444|NCT00858611|Flu|flu
642445|NCT00858611|Healthy Volunteer|healthy volunteer
642446|NCT00858611|HV|hv
642447|NCT00858598|Total Knee Arthroplasty|total knee arthroplasty
642448|NCT00858598|Revision|revision
642449|NCT00858598|Tibial|tibial
642450|NCT00858598|Void|void
642451|NCT00858598|Bone Filler|bone filler
642452|NCT00858585|Bone metastasis, SNP concordance|bone metastasis, snp concordance
642453|NCT00858572|Synta|synta
642454|NCT00858572|STA-9090|sta-9090
642455|NCT00858572|AML|aml
642456|NCT00858572|CML|cml
642457|NCT00858572|MDS|mds
642458|NCT00858572|myeloproliferative disorder|myeloproliferative disorder
642459|NCT00858572|hematologic malignancy|hematologic malignancy
642460|NCT00858572|ganetespib|ganetespib
642461|NCT00858559|Implantable cardioverter defibrillator|implantable cardioverter defibrillator
642462|NCT00858559|Remote monitoring|remote monitoring
642463|NCT00858559|Follow-up|follow-up
642464|NCT00858533|early intervention|early intervention
642465|NCT00858533|sickness absence|sickness absence
642466|NCT00858533|return to work|return to work
642467|NCT00858533|primary care|primary care
642468|NCT00858520|COPD|copd
642469|NCT00858520|Lung cancer|lung cancer
642470|NCT00858520|genes|genes
642471|NCT00858520|DNA|dna
642472|NCT00858494|upper respiratory tract infection|upper respiratory tract infection
642473|NCT00858494|children|children
642474|NCT00858494|homeopathic|homeopathic
642475|NCT00858481|Pediculosis capitis|pediculosis capitis
642476|NCT00858481|Head Lice|head lice
642477|NCT00858468|Influenza|influenza
642478|NCT00858468|Influenza vaccine|influenza vaccine
642479|NCT00858455|Healthy Volunteers|healthy volunteers
642480|NCT00858455|Drug interation, Pharmacokinetics|drug interation, pharmacokinetics
642481|NCT00858442|Burn sequelae|burn sequelae
642482|NCT00858442|PRP|prp
642483|NCT00858442|Children|children
642484|NCT00858429|advanced adult primary liver cancer|advanced adult primary liver cancer
642485|NCT00858429|liver metastases|liver metastases
642486|NCT00858429|adult primary cholangiocellular carcinoma|adult primary cholangiocellular carcinoma
642487|NCT00858403|Advanced Non-small Cell Lung Cancer|advanced non-small cell lung cancer
642488|NCT00858377|Amgen|amgen
642489|NCT00858377|Phase 1|phase 1
642490|NCT00858377|First in Human|first in human
642491|NCT00858377|Advanced Solid Tumors|advanced solid tumors
642492|NCT00858377|Clinical Trial|clinical trial
642493|NCT00858377|Aurora kinase inhibitor|aurora kinase inhibitor
642494|NCT00858377|Open-label|open-label
642495|NCT00858377|Oncology|oncology
642496|NCT00858364|darbepoetin alfa|darbepoetin alfa
642497|NCT00858364|non-small cell lung cancer|non-small cell lung cancer
642498|NCT00858364|Aranesp|aranesp
642499|NCT00858364|chemotherapy|chemotherapy
642500|NCT00858364|chemotherapy induce anemia|chemotherapy induce anemia
642501|NCT00858364|advanced lung cancer|advanced lung cancer
642502|NCT00858364|malignant pleural effusion|malignant pleural effusion
642503|NCT00858364|metastatic lung cancer|metastatic lung cancer
642504|NCT00858364|NSCLC|nsclc
642505|NCT00858364|anemia|anemia
642506|NCT00858364|lung cancer|lung cancer
642507|NCT00858364|pleural effusion|pleural effusion
642508|NCT00858364|Stage IIIB lung cancer|stage iiib lung cancer
642509|NCT00858364|Stage IV lung cancer|stage iv lung cancer
642510|NCT00858351|Diabetes|diabetes
642511|NCT00858351|Neuropathy|neuropathy
642512|NCT00858351|Peripheral|peripheral
642513|NCT00858351|Painful|painful
642514|NCT00858351|Thermal|thermal
642515|NCT00858351|Temperature|temperature
642516|NCT00858351|Biofeedback|biofeedback
642517|NCT00858351|Relaxation|relaxation
642518|NCT00858351|Diabetic|diabetic
642519|NCT00858338|stomach cancer|stomach cancer
711009|NCT00586872|Barrett's Esophagus|barrett's esophagus
642520|NCT00858338|gastroesophageal junction cancer|gastroesophageal junction cancer
642521|NCT00858338|GEJ cancer|gej cancer
642522|NCT00858338|intraperitoneal|intraperitoneal
642523|NCT00858338|adjuvant chemoradiation therapy|adjuvant chemoradiation therapy
642524|NCT00858338|resection of advanced stomach cancer|resection of advanced stomach cancer
642525|NCT00858338|locally advanced stomach cancer|locally advanced stomach cancer
642526|NCT00858325|Cubicin|cubicin
642527|NCT00858325|PK|pk
642528|NCT00858325|China Registration|china registration
642529|NCT00858325|Pharmacokinetics|pharmacokinetics
642530|NCT00858312|dairy foods|dairy foods
642531|NCT00858312|weight loss|weight loss
642532|NCT00858312|fat loss|fat loss
642533|NCT00858312|metabolic regulation|metabolic regulation
642534|NCT00858299|proteinuria|proteinuria
642535|NCT00858299|chronic kidney disease|chronic kidney disease
642536|NCT00858299|renin-angiotensin system|renin-angiotensin system
642537|NCT00858299|angiotensinogen|angiotensinogen
642538|NCT00858273|Glutathione|glutathione
642539|NCT00858260|Klotho|klotho
642540|NCT00858260|calcium|calcium
642541|NCT00858260|phosphate|phosphate
642542|NCT00858260|parathormone|parathormone
642543|NCT00858260|survival|survival
642544|NCT00858260|dialysis|dialysis
642545|NCT00858260|Adult patients undergoing maintenance dialysis since at leat three months|adult patients undergoing maintenance dialysis since at leat three months
642546|NCT00858247|vitamin D|vitamin d
642547|NCT00858247|Obesity|obesity
642548|NCT00858247|Insulin sensitivity|insulin sensitivity
642549|NCT00858247|Adolescent Obesity|adolescent obesity
642550|NCT00858221|obesity|obesity
642551|NCT00858221|genes|genes
642552|NCT00858221|polymorphisms|polymorphisms
642553|NCT00858221|weight loss|weight loss
642554|NCT00858221|haplotype|haplotype
642555|NCT00858221|diplotype|diplotype
642556|NCT00858208|efficacy and safety of Macugen in routine clinical practice|efficacy and safety of macugen in routine clinical practice
642557|NCT00858195|Anti-inflammatory|anti-inflammatory
642558|NCT00858182|L-Carnitine|l-carnitine
642559|NCT00858182|Xylitol|xylitol
642560|NCT00858182|Peritoneal Dialysis|peritoneal dialysis
642561|NCT00858169|three-dimensional power Doppler ultrasonography|three-dimensional power doppler ultrasonography
642562|NCT00858169|wrist|wrist
642563|NCT00858169|knee|knee
642564|NCT00858169|rheumatoid arthritis|rheumatoid arthritis
642565|NCT00858156|Pharmacokinetics|pharmacokinetics
642566|NCT00858143|Open-label, national, prospective, observational, non-interventional, multi-center, post marketing surveillance study|open-label, national, prospective, observational, non-interventional, multi-center, post marketing surveillance study
642567|NCT00858130|Veinoplus|veinoplus
642568|NCT00858130|post thrombotic syndrome|post thrombotic syndrome
642569|NCT00858130|deep vein thrombosis|deep vein thrombosis
642570|NCT00858130|electrical muscle stimulator|electrical muscle stimulator
642571|NCT00858130|Venous stasis syndrome|venous stasis syndrome
642572|NCT00858130|venous insufficiency syndrome|venous insufficiency syndrome
642573|NCT00858130|Postphlebitic syndrome|postphlebitic syndrome
642574|NCT00858130|history of deep vein thrombosis|history of deep vein thrombosis
642575|NCT00858117|B-cell chronic lymphocytic leukemia|b-cell chronic lymphocytic leukemia
642576|NCT00858117|stage I chronic lymphocytic leukemia|stage i chronic lymphocytic leukemia
642577|NCT00858117|stage II chronic lymphocytic leukemia|stage ii chronic lymphocytic leukemia
642578|NCT00858117|stage III chronic lymphocytic leukemia|stage iii chronic lymphocytic leukemia
642579|NCT00858117|stage IV chronic lymphocytic leukemia|stage iv chronic lymphocytic leukemia
642580|NCT00858078|Qualitative Research|qualitative research
642581|NCT00858078|Semi-Structured Telephone Interview|semi-structured telephone interview
642582|NCT00858078|BRCA 1/2|brca 1/2
642583|NCT00858078|Psychosocial/Behavioral Research|psychosocial/behavioral research
642584|NCT00858078|Hereditary Cancer Risk|hereditary cancer risk
642585|NCT00858078|BRCA|brca
642586|NCT00858078|BRCA1 Gene|brca1 gene
642587|NCT00858078|BRCA2 Gene|brca2 gene
642588|NCT00858065|Adolescent alcohol and other drug use|adolescent alcohol and other drug use
642589|NCT00858065|Choice|choice
642590|NCT00858065|Family-based|family-based
642591|NCT00858065|Prevention|prevention
642592|NCT00858052|breast implants|breast implants
642593|NCT00858052|saline|saline
642594|NCT00858026|weaning|weaning
642595|NCT00858026|breastfeeding|breastfeeding
642596|NCT00858026|infant formula|infant formula
642597|NCT00858026|fermented formula|fermented formula
642598|NCT00858013|Type 2 Diabetes Mellitus|type 2 diabetes mellitus
642599|NCT00858013|Nateglinide|nateglinide
642600|NCT00858013|Pancreatic beta cell function|pancreatic beta cell function
642601|NCT00858000|markers|markers
642602|NCT00858000|expression analysis|expression analysis
642603|NCT00857987|IRA, Guaifenesin, Etaphedrine, Doxilamine|ira, guaifenesin, etaphedrine, doxilamine
642604|NCT00857974|Physical Activity|physical activity
642605|NCT00857974|Renal Transplant Candidate|renal transplant candidate
642606|NCT00857974|Physical Function|physical function
642607|NCT00857974|Body Composition|body composition
642608|NCT00857948|head lice|head lice
642609|NCT00857948|Pediculus humanus capitis|pediculus humanus capitis
642610|NCT00857948|ivermectin|ivermectin
818921|NCT00163566|libido|libido
642611|NCT00857935|Pediculosis Capitis|pediculosis capitis
642612|NCT00857935|Head Lice|head lice
642613|NCT00857922|Neurological|neurological
642614|NCT00857922|Neurosurgical|neurosurgical
642615|NCT00857896|Study of fesoterodine in pediatric overactive bladder patients|study of fesoterodine in pediatric overactive bladder patients
642616|NCT00857883|Obesity|obesity
642617|NCT00857883|Food Effect|food effect
642618|NCT00857883|Pharmacokinetics|pharmacokinetics
642619|NCT00857883|First-Time-In-Humans|first-time-in-humans
642620|NCT00857883|Pharmacodynamics|pharmacodynamics
642621|NCT00857883|Healthy Volunteers|healthy volunteers
642622|NCT00857857|asthma|asthma
642623|NCT00857857|late phase response|late phase response
642624|NCT00857857|allergen|allergen
642625|NCT00857857|challenge|challenge
642626|NCT00857857|GW870086X|gw870086x
642627|NCT00857844|Chronic Nephrotoxicity|chronic nephrotoxicity
642628|NCT00857844|Kidney dysfunction post liver transplant|kidney dysfunction post liver transplant
642629|NCT00857844|Urinary biomarkers of chronic nephrotoxicity from CI|urinary biomarkers of chronic nephrotoxicity from ci
642630|NCT00857831|spinal cord injury|spinal cord injury
642631|NCT00857831|Vitamin D deficiency|vitamin d deficiency
642632|NCT00857831|Functional Electrical Stimulation|functional electrical stimulation
642633|NCT00857805|Transarterial chemoembolization|transarterial chemoembolization
642634|NCT00857805|Carcinoma, Hepatocellular|carcinoma, hepatocellular
642635|NCT00857805|Proton Beam Radiotherapy|proton beam radiotherapy
642636|NCT00857792|Coronary Disease|coronary disease
642637|NCT00857792|Cardiac CT Imaging|cardiac ct imaging
642638|NCT00857792|Stress Testing|stress testing
642639|NCT00857792|Lexiscan (regadenoson)|lexiscan (regadenoson)
642640|NCT00857779|allergen immunotherapy|allergen immunotherapy
642641|NCT00857779|allergy to grass pollen|allergy to grass pollen
642642|NCT00857766|Chronic Obstructive Pulmonary Disease|chronic obstructive pulmonary disease
642643|NCT00857766|arterial stiffness|arterial stiffness
642644|NCT00857766|Computed Tomography|computed tomography
642645|NCT00857766|pulse wave velocity|pulse wave velocity
642646|NCT00857766|Pulse wave analysis|pulse wave analysis
642647|NCT00857727|Dexmedetomidine|dexmedetomidine
642648|NCT00857727|Emergence Delirium|emergence delirium
642649|NCT00857727|Agitation|agitation
642650|NCT00857727|Pediatric|pediatric
642651|NCT00857727|Anesthesia|anesthesia
642652|NCT00857714|DCIS|dcis
642653|NCT00857714|breast|breast
642654|NCT00857701|total knee arthroplasty|total knee arthroplasty
642655|NCT00857701|Dynamic Splinting|dynamic splinting
642656|NCT00857701|Knee extension|knee extension
642657|NCT00857701|knee|knee
642658|NCT00857701|Reduced knee flexion after total knee arthroscopy|reduced knee flexion after total knee arthroscopy
642659|NCT00857688|aphtous|aphtous
642660|NCT00857688|bismuth|bismuth
642661|NCT00857688|procain|procain
642662|NCT00857688|neomycin|neomycin
642663|NCT00857688|Efficacy of the Association in Treatment of Aphtous|efficacy of the association in treatment of aphtous
642664|NCT00857675|HBV DNA suppression|hbv dna suppression
642665|NCT00857675|ALT normalisation|alt normalisation
642666|NCT00857675|Viral resistance|viral resistance
642667|NCT00857675|HBeAg seroconversion|hbeag seroconversion
642668|NCT00857662|US Multicenter|us multicenter
642669|NCT00857662|Randomized|randomized
642670|NCT00857662|Onyx|onyx
642671|NCT00857662|Brain Arteriovenous Malformation (BAVMs)|brain arteriovenous malformation (bavms)
642672|NCT00857649|Alzheimer's Disease|alzheimer's disease
642673|NCT00857636|Ethnic minority women|ethnic minority women
642674|NCT00857636|Cancer screening|cancer screening
642675|NCT00857636|Health literacy|health literacy
642676|NCT00857636|Behavioral intervention|behavioral intervention
642677|NCT00857636|Breast Cancer screening|breast cancer screening
642678|NCT00857636|Cervical Cancer screening|cervical cancer screening
642679|NCT00857623|Pain|pain
642680|NCT00857623|Diabetic Neuropathy|diabetic neuropathy
642681|NCT00857623|PDN|pdn
642682|NCT00857623|Analgesia|analgesia
642683|NCT00857623|Efficacy|efficacy
642684|NCT00857610|Aged skin|aged skin
642685|NCT00857610|Photoaged skin|photoaged skin
642686|NCT00857610|Retinol|retinol
642687|NCT00857610|Topical retinoids|topical retinoids
642688|NCT00857597|GERD|gerd
642689|NCT00857597|endoscopic|endoscopic
642690|NCT00857597|fundoplication|fundoplication
642691|NCT00857597|Proton Pump Inhibitors|proton pump inhibitors
642692|NCT00857597|heartburn|heartburn
642693|NCT00857597|anti-reflux surgery|anti-reflux surgery
642694|NCT00857584|Bipolar disorder|bipolar disorder
642695|NCT00857584|Bipolar depression|bipolar depression
642696|NCT00857584|quetiapine|quetiapine
642697|NCT00857584|sertraline|sertraline
642698|NCT00857571|Dose Response Bioavailability Study|dose response bioavailability study
642699|NCT00857532|amyloid burden|amyloid burden
642700|NCT00857532|Parkinson's disease|parkinson's disease
642701|NCT00857532|florbetapir PET|florbetapir pet
642702|NCT00857532|amyloid PET imaging|amyloid pet imaging
642703|NCT00857519|retinoblastoma|retinoblastoma
642704|NCT00857519|Intraarterial|intraarterial
642705|NCT00857519|Chemotherapy|chemotherapy
642706|NCT00857519|Melphalan|melphalan
642707|NCT00857519|Carboplatin|carboplatin
642708|NCT00857506|Cognitive outcome|cognitive outcome
642709|NCT00857506|18F-AV-45 PET scan|18f-av-45 pet scan
642710|NCT00857506|Amyloid PET scan|amyloid pet scan
642711|NCT00857506|Florbetapir F 18 amyloid PET scan|florbetapir f 18 amyloid pet scan
642712|NCT00857506|Normal cognition|normal cognition
642713|NCT00857506|Change in cognitive status in relation to brain amyloid on PET|change in cognitive status in relation to brain amyloid on pet
642714|NCT00857415|florbetapir F 18 PET|florbetapir f 18 pet
642715|NCT00857415|amyloid imaging|amyloid imaging
642716|NCT00857415|Amyloid pathology in the brain|amyloid pathology in the brain
642717|NCT00857402|Arginine|arginine
642718|NCT00857402|Nitric oxide|nitric oxide
642719|NCT00857402|Peanuts|peanuts
642720|NCT00857402|Sedimentation rate|sedimentation rate
642721|NCT00857389|Cancer|cancer
642722|NCT00857389|Blood And Marrow Transplantation|blood and marrow transplantation
642723|NCT00857389|Stem Cell|stem cell
642724|NCT00857389|Leukemia|leukemia
642725|NCT00857389|Lymphoma|lymphoma
642726|NCT00857389|Pediatrics|pediatrics
642727|NCT00857389|Bone marrow|bone marrow
642728|NCT00857389|Lymph node system|lymph node system
642729|NCT00857389|Allogeneic Stem Cell Transplant|allogeneic stem cell transplant
642730|NCT00857389|ASCT|asct
642731|NCT00857389|Busulfan|busulfan
642732|NCT00857389|Busulfex|busulfex
642733|NCT00857389|Myleran|myleran
642734|NCT00857389|Clofarabine|clofarabine
642735|NCT00857389|Clofarex|clofarex
642736|NCT00857389|Clolar|clolar
642737|NCT00857389|Thiotepa|thiotepa
642738|NCT00857389|Antithymocyte globulin|antithymocyte globulin
642739|NCT00857389|ATG|atg
642740|NCT00857389|Thymoglobulin|thymoglobulin
642741|NCT00857389|G-CSF|g-csf
642742|NCT00857389|Filgrastim|filgrastim
642743|NCT00857389|Neupogen|neupogen
642744|NCT00857389|Cyclophosphamide|cyclophosphamide
642745|NCT00857389|Cytoxan|cytoxan
642746|NCT00857389|Neosar|neosar
642747|NCT00857389|Mesna|mesna
642748|NCT00857389|Mesnex|mesnex
642749|NCT00857389|Tacrolimus|tacrolimus
642750|NCT00857389|Prograf|prograf
642751|NCT00857389|Methotrexate|methotrexate
642752|NCT00857376|Heart disease risk factors|heart disease risk factors
642753|NCT00857376|Risk factor management|risk factor management
642754|NCT00857376|Pre-Diabetes|pre-diabetes
642755|NCT00857376|Hypertension|hypertension
642757|NCT00857376|glucose intolerance|glucose intolerance
642758|NCT00857376|high cholesterol|high cholesterol
642759|NCT00857376|abdominal obesity|abdominal obesity
642760|NCT00857376|enlarged waist|enlarged waist
642761|NCT00857363|capsule|capsule
642762|NCT00857363|constipation|constipation
642763|NCT00857363|whole gut transit|whole gut transit
642764|NCT00857363|colonic transit|colonic transit
642765|NCT00857363|gastric emptying|gastric emptying
642766|NCT00857363|small bowel transit|small bowel transit
642767|NCT00857350|HIV|hiv
642768|NCT00857350|resistance|resistance
642769|NCT00857350|opioid dependence|opioid dependence
642770|NCT00857324|Refractory or relapsed patients|refractory or relapsed patients
642771|NCT00857324|dose-finding|dose-finding
642772|NCT00857324|Vorinostat|vorinostat
642773|NCT00857298|HIV|hiv
642774|NCT00857298|Metabolic Syndrome|metabolic syndrome
642775|NCT00857298|Obesity|obesity
642776|NCT00857298|Treatment Experienced|treatment experienced
642777|NCT00857272|colonoscopy|colonoscopy
642778|NCT00857272|bowel preparation|bowel preparation
642779|NCT00857259|AMD|amd
642780|NCT00857259|macular degeneration|macular degeneration
642781|NCT00857259|Everolimus|everolimus
642782|NCT00857259|Lucentis|lucentis
642783|NCT00857259|Ranibizumab|ranibizumab
642784|NCT00857259|Choroidal Neo-Vascular (CNV) age-onset macular degeneration|choroidal neo-vascular (cnv) age-onset macular degeneration
642785|NCT00857259|Age-related Macular Degeneration (AMD)|age-related macular degeneration (amd)
642786|NCT00857246|stomach cancer|stomach cancer
642787|NCT00857246|biologics|biologics
642788|NCT00857246|antibody|antibody
642789|NCT00857246|chemotherapy|chemotherapy
642790|NCT00857246|chemoradiation|chemoradiation
642791|NCT00857246|adjuvant therapy|adjuvant therapy
642792|NCT00857246|neoadjuvant therapy|neoadjuvant therapy
642793|NCT00857246|epidermal growth factor receptor|epidermal growth factor receptor
642794|NCT00857246|combination therapy|combination therapy
642795|NCT00857233|Alzheimer's Disease|alzheimer's disease
642796|NCT00857220|Hypnotic|hypnotic
642797|NCT00857220|Eszopiclone|eszopiclone
642798|NCT00857220|Attention Deficit Hyperactivity Disorder|attention deficit hyperactivity disorder
642799|NCT00857220|Insomnia|insomnia
642800|NCT00857220|Children|children
642801|NCT00857220|Adolescent|adolescent
642802|NCT00857207|Cognitive Therapy|cognitive therapy
642803|NCT00857207|Outcomes Assessment|outcomes assessment
642804|NCT00857194|Coronary Heart Disease|coronary heart disease
642805|NCT00857194|spinal cord injury|spinal cord injury
642806|NCT00857194|risk factor|risk factor
642807|NCT00857194|postprandial lipemia|postprandial lipemia
642808|NCT00857181|Liver Cirrhosis|liver cirrhosis
642809|NCT00857181|Infection|infection
642810|NCT00857181|Inflammation|inflammation
642811|NCT00857181|Cytokines|cytokines
642812|NCT00857155|Coronary Artery Disease|coronary artery disease
642813|NCT00857155|CABG|cabg
642814|NCT00857155|Clopidogrel|clopidogrel
642815|NCT00857155|Aspirin|aspirin
642816|NCT00857155|Point of Care devices|point of care devices
642817|NCT00857129|"normal birth"|"normal birth"
642818|NCT00857129|"birth outcome"|"birth outcome"
642819|NCT00857129|"low risk birth"|"low risk birth"
642820|NCT00857129|"low risk units"|"low risk units"
642821|NCT00857129|If type of birth care unit have effect on birth outcome|if type of birth care unit have effect on birth outcome
642822|NCT00857129|Apgar score|apgar score
642823|NCT00857129|breast feeding frequency|breast feeding frequency
642824|NCT00857129|patient satisfaction|patient satisfaction
642825|NCT00857116|Deworming|deworming
642826|NCT00857116|Tuberculosis|tuberculosis
642827|NCT00857116|TB-score|tb-score
642828|NCT00857116|Albendazole|albendazole
642829|NCT00857116|Helminths|helminths
642830|NCT00857103|computer support|computer support
642831|NCT00857103|patient-provider communication|patient-provider communication
642832|NCT00857103|patient-centered care|patient-centered care
642833|NCT00857103|cancer|cancer
642834|NCT00857090|Urinary Calculi|urinary calculi
642835|NCT00857090|Urinary Stones|urinary stones
642836|NCT00857090|Urinary Tract Stones|urinary tract stones
642837|NCT00857090|Renal Calculi|renal calculi
642838|NCT00857090|Kidney Stones|kidney stones
642839|NCT00857090|Calculi|calculi
642840|NCT00857090|Urolithotomy|urolithotomy
642841|NCT00857090|Ureteroscopy|ureteroscopy
642842|NCT00857077|incidence of anaemia|incidence of anaemia
643031|NCT00856297|Adolescents|adolescents
642843|NCT00857064|Schizophrenia|schizophrenia
642844|NCT00857064|antipsychotics|antipsychotics
642845|NCT00857064|social functioning|social functioning
642846|NCT00857064|subjective well being|subjective well being
642847|NCT00857064|Patients suffering from Schizophrenia|patients suffering from schizophrenia
642848|NCT00857051|Stress|stress
642849|NCT00857038|COPD|copd
642850|NCT00857038|Inflammation|inflammation
642851|NCT00857038|Neutrophilic|neutrophilic
642852|NCT00857038|Myeloperoxidase|myeloperoxidase
642853|NCT00857038|Doxycycline|doxycycline
642854|NCT00857025|stage IIIA non-small cell lung cancer|stage iiia non-small cell lung cancer
642855|NCT00857025|stage IIIB non-small cell lung cancer|stage iiib non-small cell lung cancer
642856|NCT00857025|stage IV non-small cell lung cancer|stage iv non-small cell lung cancer
642857|NCT00857025|recurrent non-small cell lung cancer|recurrent non-small cell lung cancer
642858|NCT00857012|Primary early MCa|primary early mca
642859|NCT00857012|Arimidex|arimidex
642860|NCT00856999|Glabellar lines of moderate severity at maximum frown|glabellar lines of moderate severity at maximum frown
642861|NCT00856973|Hypnotic|hypnotic
642862|NCT00856973|Eszopiclone|eszopiclone
642863|NCT00856973|Attention Deficit/Hyperactivity Disorder|attention deficit/hyperactivity disorder
642864|NCT00856973|Insomnia|insomnia
642865|NCT00856973|Children|children
642866|NCT00856973|Adolescent|adolescent
642867|NCT00856973|Polysomnography|polysomnography
642868|NCT00856973|Actigraphy|actigraphy
642869|NCT00856947|wheeze|wheeze
642870|NCT00856947|infections|infections
642871|NCT00856947|allergy|allergy
642872|NCT00856947|eczema|eczema
642873|NCT00856947|vitamin D|vitamin d
642874|NCT00856934|Skin graft donor site healing|skin graft donor site healing
642875|NCT00856934|skin|skin
642876|NCT00856934|wound|wound
642877|NCT00856934|platelet concentrate|platelet concentrate
642878|NCT00856934|keratinocytes|keratinocytes
642879|NCT00856934|burns|burns
642880|NCT00856921|Relationship between achalasia and AAAS gene|relationship between achalasia and aaas gene
642881|NCT00856908|Type II Diabetes|type ii diabetes
642882|NCT00856895|Improved Life Quality|improved life quality
642883|NCT00856856|Bioabsorbable|bioabsorbable
642884|NCT00856856|Coronary Stent|coronary stent
642885|NCT00856856|Everolimus|everolimus
642886|NCT00856856|Drug eluting stents|drug eluting stents
642887|NCT00856856|Stents|stents
642888|NCT00856856|Angioplasty|angioplasty
642889|NCT00856856|Coronary artery disease (CAD)|coronary artery disease (cad)
642890|NCT00856856|Total coronary occlusion|total coronary occlusion
642891|NCT00856856|Coronary artery restenosis|coronary artery restenosis
642892|NCT00856856|Stent thrombosis|stent thrombosis
642893|NCT00856856|Vascular disease|vascular disease
642894|NCT00856856|Myocardial ischemia|myocardial ischemia
642895|NCT00856856|Coronary artery stenosis|coronary artery stenosis
642896|NCT00856843|colonoscopy|colonoscopy
642897|NCT00856843|bowel preparation|bowel preparation
642898|NCT00856830|Small cell lung cancer|small cell lung cancer
642899|NCT00856830|Chemonaive|chemonaive
642900|NCT00856830|Bendamustine|bendamustine
642901|NCT00856830|Irinotecan|irinotecan
642902|NCT00856830|Etoposide|etoposide
642903|NCT00856830|Carboplatin|carboplatin
642904|NCT00856804|Thalidomide|thalidomide
642905|NCT00856804|Hepatitis C|hepatitis c
642906|NCT00856804|Interferon resistance|interferon resistance
642907|NCT00856804|Immunomodulators|immunomodulators
642908|NCT00856791|Ovarian|ovarian
642909|NCT00856791|Cancer|cancer
642910|NCT00856791|Cisplatin|cisplatin
642911|NCT00856791|Carboplatin|carboplatin
642912|NCT00856778|Male sling|male sling
642913|NCT00856778|stress urinary incontinence|stress urinary incontinence
642914|NCT00856778|urinary incontinence|urinary incontinence
642915|NCT00856739|obesity|obesity
642916|NCT00856739|arthritis|arthritis
642917|NCT00856700|GLP-1|glp-1
642918|NCT00856700|Endothelial Function|endothelial function
642919|NCT00856700|Metabolic Syndrome|metabolic syndrome
642920|NCT00856687|Asthma Allergen Challenge|asthma allergen challenge
642921|NCT00856674|IgA nephropathy|iga nephropathy
642922|NCT00856674|chemokine fusion protein|chemokine fusion protein
642923|NCT00856674|leukocyte population modulator|leukocyte population modulator
642924|NCT00856674|phase-1|phase-1
642925|NCT00856661|Acute ischemic stroke|acute ischemic stroke
642926|NCT00856661|Angiography|angiography
642927|NCT00856661|Desmoteplase|desmoteplase
642928|NCT00856661|Thrombolytic|thrombolytic
642929|NCT00856622|open-angle glaucoma ocular hypertension glaucoma|open-angle glaucoma ocular hypertension glaucoma
642930|NCT00856609|Weight Loss|weight loss
642931|NCT00856609|Byetta (Exenatide)|byetta (exenatide)
642932|NCT00856609|Energy Expenditure|energy expenditure
642933|NCT00856609|Food Intake|food intake
642934|NCT00856609|Obesity|obesity
642935|NCT00856596|Tinea pedis|tinea pedis
642936|NCT00856596|Fungus|fungus
642937|NCT00856596|Pruritus|pruritus
642938|NCT00856596|Dermatophyte|dermatophyte
642939|NCT00856596|Athlete's foot|athlete's foot
642940|NCT00856596|Dermatomycosis|dermatomycosis
642941|NCT00856596|Skin manifestation|skin manifestation
642942|NCT00856596|Infectious skin disease|infectious skin disease
642943|NCT00856596|Foot diseases|foot diseases
642944|NCT00856570|YM178|ym178
642945|NCT00856570|Mirabegron|mirabegron
642946|NCT00856570|DDI|ddi
642947|NCT00856570|Phase I|phase i
642948|NCT00856570|Warfarin|warfarin
642949|NCT00856570|Pharmacokinetics|pharmacokinetics
642950|NCT00856557|Patients with complex psychosocial needs|patients with complex psychosocial needs
642951|NCT00856544|Arthritis|arthritis
642952|NCT00856544|Rheumatoid|rheumatoid
642953|NCT00856544|Antirheumatic Agents|antirheumatic agents
642954|NCT00856544|Clinical Trial|clinical trial
642955|NCT00856531|Möbius syndrome|möbius syndrome
642956|NCT00856531|Language|language
642957|NCT00856531|Speech, Language and Hearing Sciences|speech, language and hearing sciences
642958|NCT00856518|Multiple Sclerosis|multiple sclerosis
642959|NCT00856518|Parkinson's disease|parkinson's disease
642960|NCT00856518|Dysphagia|dysphagia
642961|NCT00856505|Hematopoietic Stem Cell Transplantation|hematopoietic stem cell transplantation
642962|NCT00856505|Drug Therapy, Combination|drug therapy, combination
642963|NCT00856505|Immunosuppression|immunosuppression
642964|NCT00856492|inflammatory breast cancer|inflammatory breast cancer
642965|NCT00856492|stage II breast cancer|stage ii breast cancer
642966|NCT00856492|stage IIIA breast cancer|stage iiia breast cancer
642967|NCT00856492|stage IIIB breast cancer|stage iiib breast cancer
642968|NCT00856492|HER2-negative breast cancer|her2-negative breast cancer
642969|NCT00856492|estrogen receptor-negative breast cancer|estrogen receptor-negative breast cancer
642970|NCT00856492|estrogen receptor-positive breast cancer|estrogen receptor-positive breast cancer
642971|NCT00856492|progesterone receptor-negative breast cancer|progesterone receptor-negative breast cancer
642972|NCT00856492|progesterone receptor-positive breast cancer|progesterone receptor-positive breast cancer
642973|NCT00856492|stage IIIC breast cancer|stage iiic breast cancer
642974|NCT00856479|Infuse|infuse
642975|NCT00856479|cost analysis|cost analysis
642976|NCT00856479|Non union diaphyseal fracture|non union diaphyseal fracture
642977|NCT00856479|The efficacy of Infuse BMP 2 in Non union diaphyseal fractures. Also the cost analysis with the amount of time spent in hospital post op.|the efficacy of infuse bmp 2 in non union diaphyseal fractures. also the cost analysis with the amount of time spent in hospital post op.
642978|NCT00856453|fatigue|fatigue
642979|NCT00856453|depression|depression
642980|NCT00856453|recurrent ovarian epithelial cancer|recurrent ovarian epithelial cancer
642981|NCT00856453|recurrent ovarian germ cell tumor|recurrent ovarian germ cell tumor
642982|NCT00856453|stage I ovarian epithelial cancer|stage i ovarian epithelial cancer
642983|NCT00856453|stage I ovarian germ cell tumor|stage i ovarian germ cell tumor
642984|NCT00856453|stage II ovarian epithelial cancer|stage ii ovarian epithelial cancer
642985|NCT00856453|stage II ovarian germ cell tumor|stage ii ovarian germ cell tumor
642986|NCT00856453|stage III ovarian epithelial cancer|stage iii ovarian epithelial cancer
642987|NCT00856453|stage III ovarian germ cell tumor|stage iii ovarian germ cell tumor
642988|NCT00856453|stage IV ovarian epithelial cancer|stage iv ovarian epithelial cancer
642989|NCT00856453|stage IV ovarian germ cell tumor|stage iv ovarian germ cell tumor
642990|NCT00856440|SCI|sci
642991|NCT00856427|stage IIIA non-small cell lung cancer|stage iiia non-small cell lung cancer
642992|NCT00856427|stage IIIB non-small cell lung cancer|stage iiib non-small cell lung cancer
642993|NCT00856427|stage IA non-small cell lung cancer|stage ia non-small cell lung cancer
642994|NCT00856427|stage IB non-small cell lung cancer|stage ib non-small cell lung cancer
642995|NCT00856427|stage IIA non-small cell lung cancer|stage iia non-small cell lung cancer
642996|NCT00856427|stage IIB non-small cell lung cancer|stage iib non-small cell lung cancer
642997|NCT00856401|hypoparathyroidism|hypoparathyroidism
642998|NCT00856401|hypopara|hypopara
642999|NCT00856401|PTH|pth
643000|NCT00856401|parathyroid hormone|parathyroid hormone
643001|NCT00856401|CL-11-040|cl-11-040
643002|NCT00856401|CL1-11 Study|cl1-11 study
643003|NCT00856401|NPSP 558|npsp 558
643004|NCT00856401|RELAY|relay
643005|NCT00856401|RACE|race
643006|NCT00856401|REPLACE|replace
643007|NCT00856401|HEXT|hext
643008|NCT00856401|c10-007|c10-007
643009|NCT00856401|c10-008|c10-008
643010|NCT00856401|NPSP558|npsp558
643011|NCT00856401|Columbia study|columbia study
643012|NCT00856401|Columbia studies|columbia studies
643013|NCT00856401|HPTH|hpth
643014|NCT00856401|PTH1-84|pth1-84
643015|NCT00856375|colorectal cancer|colorectal cancer
643016|NCT00856375|Colorectal cancer, second line|colorectal cancer, second line
643017|NCT00856362|Healthy Subjects|healthy subjects
643018|NCT00856349|Implantable Cardioverter Defibrillator (ICD)|implantable cardioverter defibrillator (icd)
643019|NCT00856349|Cardiac Resynchronization Therapy-Defibrillator (CRT-D)|cardiac resynchronization therapy-defibrillator (crt-d)
643020|NCT00856349|Lead Integrity Alert (LIA)|lead integrity alert (lia)
643021|NCT00856349|Therapy Programming Report (TPR)|therapy programming report (tpr)
643022|NCT00856323|Methamphetamine|methamphetamine
643023|NCT00856323|HIV|hiv
643024|NCT00856323|Post-exposure prophylaxis|post-exposure prophylaxis
643025|NCT00856323|HIV seronegativity|hiv seronegativity
643026|NCT00856310|Healthy volunteers|healthy volunteers
643027|NCT00856297|Meningococcal|meningococcal
643028|NCT00856297|ACWY|acwy
643029|NCT00856297|Conjugate Vaccine|conjugate vaccine
643030|NCT00856297|Meningitis|meningitis
643032|NCT00856297|Persistence|persistence
643033|NCT00856284|Diabetes Mellitus|diabetes mellitus
643034|NCT00856284|Drug Therapy|drug therapy
643035|NCT00856284|Hyperinsulinism|hyperinsulinism
643036|NCT00856284|Hyperglycemia|hyperglycemia
643037|NCT00856284|Glucose Intolerance|glucose intolerance
643038|NCT00856258|Multiple dose in healthy volunteers|multiple dose in healthy volunteers
643039|NCT00856245|non-Hodgkins|non-hodgkins
643040|NCT00856245|lymphoma|lymphoma
643041|NCT00856245|stem cell transplant|stem cell transplant
643042|NCT00856232|Headache|headache
643043|NCT00856232|Cephalgia|cephalgia
643044|NCT00856232|Migraine|migraine
643045|NCT00856219|Immune System|immune system
643046|NCT00856206|Metabolism, Inborn Errors|metabolism, inborn errors
643047|NCT00856206|Allopurinol|allopurinol
643048|NCT00856206|Metabolic Disease|metabolic disease
643049|NCT00856206|Genetic Diseases, Inborn|genetic diseases, inborn
643050|NCT00856206|Musculoskeletal Diseases|musculoskeletal diseases
643051|NCT00856206|Joint Diseases|joint diseases
643052|NCT00856206|Arthritis|arthritis
643053|NCT00856206|Rheumatic Diseases|rheumatic diseases
643054|NCT00856206|Metabolic disorder|metabolic disorder
643055|NCT00856206|Purine Pyrimidine Metabolism, Inborn Errors|purine pyrimidine metabolism, inborn errors
643056|NCT00856206|Gout|gout
643057|NCT00856206|Intercritical Gout|intercritical gout
643058|NCT00856193|COPD|copd
643059|NCT00856193|Bronchodilator|bronchodilator
643060|NCT00856180|avastin|avastin
643061|NCT00856180|bevacizumab|bevacizumab
643062|NCT00856180|cyclophosphamide|cyclophosphamide
643063|NCT00856180|cytoxan|cytoxan
643064|NCT00856180|mullerian malignancies|mullerian malignancies
643065|NCT00856167|temporomandibular dysfunction|temporomandibular dysfunction
643066|NCT00856167|TMD|tmd
643067|NCT00856167|TMJ|tmj
643068|NCT00856167|Traditional Chinese Medicine|traditional chinese medicine
643069|NCT00856167|TCM|tcm
643070|NCT00856154|HIV-1|hiv-1
643071|NCT00856154|HLA-A2|hla-a2
643072|NCT00856154|Therapeutic|therapeutic
643073|NCT00856154|Vaccine|vaccine
643074|NCT00856154|treatment vaccine|treatment vaccine
643075|NCT00856154|treatment naive|treatment naive
643076|NCT00856141|IOP measurement|iop measurement
643077|NCT00856141|IOP fluctuation|iop fluctuation
643078|NCT00856141|in-vivo IOP measuring device|in-vivo iop measuring device
643079|NCT00856141|intraocular pressure measurement|intraocular pressure measurement
643080|NCT00856115|stage I colon cancer|stage i colon cancer
643081|NCT00856115|stage II colon cancer|stage ii colon cancer
643082|NCT00856115|stage III colon cancer|stage iii colon cancer
643083|NCT00856115|stage IV colon cancer|stage iv colon cancer
643084|NCT00856115|stage I rectal cancer|stage i rectal cancer
643085|NCT00856115|stage II rectal cancer|stage ii rectal cancer
643086|NCT00856115|stage III rectal cancer|stage iii rectal cancer
643087|NCT00856115|stage IV rectal cancer|stage iv rectal cancer
643088|NCT00856076|Venous thromboembolism|venous thromboembolism
643089|NCT00856076|Intrauterine fetal death|intrauterine fetal death
643090|NCT00856076|Risk factor|risk factor
643091|NCT00856076|Thrombophilia|thrombophilia
643092|NCT00856076|Venous thromboembolism (in pregnancy)|venous thromboembolism (in pregnancy)
643093|NCT00856063|Attention Deficit Hyperactivity Disorder|attention deficit hyperactivity disorder
643094|NCT00856063|Atomoxetine|atomoxetine
643095|NCT00856063|Electrodermal Response|electrodermal response
643096|NCT00856063|Impulsivity|impulsivity
643097|NCT00856063|Preschool Children|preschool children
643098|NCT00856050|estrogen receptor positive|estrogen receptor positive
643099|NCT00856050|progesterone receptor positive|progesterone receptor positive
643100|NCT00856050|letrozole|letrozole
643101|NCT00855998|Thymidine Kinase 1|thymidine kinase 1
643102|NCT00855998|BRCA1 and BRCA2 mutations|brca1 and brca2 mutations
643103|NCT00855998|hereditary breast/ovarian cancer|hereditary breast/ovarian cancer
643104|NCT00855985|Pancreatic anastomosis|pancreatic anastomosis
643105|NCT00855985|Whipple operation|whipple operation
643106|NCT00855959|Asthma|asthma
643107|NCT00855959|Pulmicort Respules|pulmicort respules
643108|NCT00855946|tumor response|tumor response
643109|NCT00855946|rectal adenocarcinoma|rectal adenocarcinoma
643110|NCT00855946|preoperative radiochemotherapy|preoperative radiochemotherapy
643111|NCT00855946|Proteomic analysis|proteomic analysis
643112|NCT00855946|MALDI-TOF-TOF|maldi-tof-tof
643113|NCT00855946|rectal adenocarcinoma, tumor response after preoperative radiochemotherapy|rectal adenocarcinoma, tumor response after preoperative radiochemotherapy
643114|NCT00855920|Metabolism, Inborn Errors|metabolism, inborn errors
643115|NCT00855920|Allopurinol|allopurinol
643116|NCT00855920|Metabolic Diseases|metabolic diseases
643117|NCT00855920|Genetic Diseases, Inborn|genetic diseases, inborn
643118|NCT00855920|Musculoskeletal Diseases|musculoskeletal diseases
643119|NCT00855920|Joint Diseases|joint diseases
643120|NCT00855920|Arthritis|arthritis
643121|NCT00855920|Rheumatic Diseases|rheumatic diseases
643122|NCT00855920|Metabolic disorder|metabolic disorder
643123|NCT00855920|Purine-Pyrimidine Metabolism, Inborn Errors|purine-pyrimidine metabolism, inborn errors
643124|NCT00855920|Gout|gout
643125|NCT00855920|Flare|flare
643126|NCT00855907|IBD|ibd
643127|NCT00855907|inflammatory bowel disease|inflammatory bowel disease
643128|NCT00855907|fatty liver|fatty liver
643129|NCT00855894|Tarceva|tarceva
643130|NCT00855894|NSCLC|nsclc
643131|NCT00855881|adjuvant chemotherapy for head and neck cancer|adjuvant chemotherapy for head and neck cancer
643132|NCT00855868|Amyloid imaging|amyloid imaging
643133|NCT00855868|Positron Emission Tomography|positron emission tomography
643134|NCT00855868|18F-AV-45|18f-av-45
643135|NCT00855868|florbetapir F 18|florbetapir f 18
643136|NCT00855868|Diagnostic imaging|diagnostic imaging
643137|NCT00855855|Diphtheria|diphtheria
643138|NCT00855855|Tetanus|tetanus
643139|NCT00855855|Pertussis|pertussis
643140|NCT00855855|Poliovirus types 1-3|poliovirus types 1-3
643141|NCT00855855|Haemophilus influenzae type b|haemophilus influenzae type b
643142|NCT00855855|Pentacel®|pentacel®
643143|NCT00855842|second trimester abortion|second trimester abortion
643144|NCT00855842|labor induction abortion|labor induction abortion
643145|NCT00855842|second trimester medical abortion|second trimester medical abortion
643146|NCT00855842|pregnancy|pregnancy
643147|NCT00855803|spinal cord metastases|spinal cord metastases
643148|NCT00855803|unspecified adult solid tumor, protocol specific|unspecified adult solid tumor, protocol specific
643149|NCT00855803|pain|pain
643150|NCT00855790|evaluate the effectiveness of one bite polypectomy with the RJ3 biopsy forcep versus the RJ4 biopsy forcep|evaluate the effectiveness of one bite polypectomy with the rj3 biopsy forcep versus the rj4 biopsy forcep
643151|NCT00855777|third molar extraction|third molar extraction
643152|NCT00855777|etoricoxib|etoricoxib
643153|NCT00855777|ibuprofen|ibuprofen
643154|NCT00855777|analgesic efficacy|analgesic efficacy
643155|NCT00855777|pain|pain
643156|NCT00855738|epilepsy antiepileptic biotherapy|epilepsy antiepileptic biotherapy
643157|NCT00855725|Epilepsy|epilepsy
643158|NCT00855725|Depression|depression
643159|NCT00855725|Neurology|neurology
643160|NCT00855725|fMRI|fmri
643161|NCT00855725|Healthy Controls|healthy controls
643162|NCT00855712|Heart Failure|heart failure
643163|NCT00855712|Transplant|transplant
643164|NCT00855712|Warm Perfusion|warm perfusion
643165|NCT00855712|Organ Care|organ care
643166|NCT00855712|Resting Mode|resting mode
643167|NCT00855699|Alcohol detoxification|alcohol detoxification
643168|NCT00855686|Memantine|memantine
643169|NCT00855686|Cognition|cognition
643170|NCT00855686|Parkinson's Disease Dementia|parkinson's disease dementia
643171|NCT00855686|Dementia With Lewy Bodies|dementia with lewy bodies
643172|NCT00855673|Claudication|claudication
643173|NCT00855673|Peripheral Arterial Disease|peripheral arterial disease
643174|NCT00855673|Intermittent Compression|intermittent compression
643175|NCT00855673|Mechanical Compression|mechanical compression
643176|NCT00855673|Flowmedic|flowmedic
643177|NCT00855660|Bone Metabolism|bone metabolism
643178|NCT00855634|Pancreatic cancer|pancreatic cancer
643179|NCT00855634|metastasis|metastasis
643180|NCT00855634|venous infiltration|venous infiltration
643181|NCT00855634|Pancreatic cancer with minimal metastatic disease or venous infiltration|pancreatic cancer with minimal metastatic disease or venous infiltration
643182|NCT00855621|deep brain stimulation|deep brain stimulation
643183|NCT00855621|subthalamic nucleus|subthalamic nucleus
643184|NCT00855608|choroidal neovascularization|choroidal neovascularization
643185|NCT00855608|diabetic retinopathy|diabetic retinopathy
643186|NCT00855608|uveitis|uveitis
643187|NCT00855608|refractory cases of uveitis|refractory cases of uveitis
643188|NCT00855595|Rosacea|rosacea
643189|NCT00855582|Erectile Dysfunction|erectile dysfunction
643190|NCT00855582|Benign Prostatic Hyperplasia|benign prostatic hyperplasia
643191|NCT00855569|allografting|allografting
643192|NCT00855530|Depression|depression
643193|NCT00855504|preeclampsia|preeclampsia
643194|NCT00855504|periodontitis|periodontitis
643195|NCT00855504|cytokines|cytokines
643196|NCT00855491|PCO|pco
643197|NCT00855491|POCO|poco
643198|NCT00855465|Chronic thromboembolic pulmonary hypertension|chronic thromboembolic pulmonary hypertension
643199|NCT00855465|PH|ph
643200|NCT00855465|soluble Guanylate Cyclase Stimulator|soluble guanylate cyclase stimulator
643201|NCT00855465|sGC|sgc
643202|NCT00855452|GVL|gvl
643203|NCT00855452|rIL-2(LAK)|ril-2(lak)
643204|NCT00855452|GVHD|gvhd
643205|NCT00855452|MST|mst
643206|NCT00855452|alloCT|alloct
643207|NCT00855452|alloBMT|allobmt
643208|NCT00855439|Diabetes|diabetes
643209|NCT00855439|Neuropathy|neuropathy
643210|NCT00855439|Glucose|glucose
643211|NCT00855439|Control|control
643212|NCT00855439|Peripheral|peripheral
643213|NCT00855439|Autonomic|autonomic
643214|NCT00855413|Acute HIV|acute hiv
643215|NCT00855413|HIV|hiv
643216|NCT00855413|Treatment Naive|treatment naive
643217|NCT00855413|Acute Infections|acute infections
643218|NCT00855400|Amyotrophic Lateral Sclerosis|amyotrophic lateral sclerosis
643219|NCT00855400|Bone marrow|bone marrow
643220|NCT00855400|Stem cells|stem cells
643221|NCT00855400|Autologous|autologous
643222|NCT00855400|Safety|safety
643223|NCT00855387|Clinical outcome (complications), in-hospital costs|clinical outcome (complications), in-hospital costs
643224|NCT00855387|The influence and impact of postoperative complications on in-hospital costs|the influence and impact of postoperative complications on in-hospital costs
643225|NCT00855361|Gastroesophageal Reflux|gastroesophageal reflux
643226|NCT00855361|Erosive Gastroesophageal Reflux Disease|erosive gastroesophageal reflux disease
643227|NCT00855361|Ulcerative Gastroesophageal Reflux Disease|ulcerative gastroesophageal reflux disease
643228|NCT00855361|Endoscopy|endoscopy
643229|NCT00855361|Pediatrics|pediatrics
643230|NCT00855361|GERD|gerd
643231|NCT00855361|Rabeprazole, Rabeprazole sodium|rabeprazole, rabeprazole sodium
643232|NCT00855361|AcipHex|aciphex
643233|NCT00855348|colorectal cancer|colorectal cancer
643234|NCT00855348|early detection|early detection
643235|NCT00855348|methylation, biomarker|methylation, biomarker
643236|NCT00855335|HIV-1|hiv-1
643237|NCT00855335|HIV|hiv
643238|NCT00855335|Pregnancy|pregnancy
643239|NCT00855335|Postpartum|postpartum
643240|NCT00855335|Human immunodeficiency virus|human immunodeficiency virus
643241|NCT00855335|PREZISTA|prezista
643242|NCT00855335|INTELENCE|intelence
643243|NCT00855335|NORVIR|norvir
643244|NCT00855335|TMC114|tmc114
643245|NCT00855335|TMC125|tmc125
643246|NCT00855335|darunavir|darunavir
643247|NCT00855335|ritonavir|ritonavir
643248|NCT00855335|etravirine|etravirine
643249|NCT00855335|rilpivirine|rilpivirine
643250|NCT00855335|TMC278|tmc278
643251|NCT00855335|Cobicistat|cobicistat
643252|NCT00855335|treatment experienced|treatment experienced
643253|NCT00855322|Arthritis, Rheumatoid|arthritis, rheumatoid
643254|NCT00855322|Exercise|exercise
643255|NCT00855322|Biological Therapy|biological therapy
643256|NCT00855309|chemotherapeutic agent toxicity|chemotherapeutic agent toxicity
643257|NCT00855309|renal toxicity|renal toxicity
643258|NCT00855309|infection|infection
643259|NCT00855309|neutropenia|neutropenia
643260|NCT00855270|PTSD|ptsd
643261|NCT00855257|Acid nicotinique|acid nicotinique
643262|NCT00855257|FLOW MEDIATED DILATATION (FMD)|flow mediated dilatation (fmd)
643263|NCT00855257|HDL-C< 0.4 G/L|hdl-c< 0.4 g/l
643264|NCT00855244|Bone marrow transplantation|bone marrow transplantation
643265|NCT00855231|Acute coronary syndrome|acute coronary syndrome
643266|NCT00855231|Coronary artery disease|coronary artery disease
643267|NCT00855231|cardiac imaging|cardiac imaging
643268|NCT00855231|computed tomography|computed tomography
643269|NCT00855218|Sorafenib|sorafenib
643270|NCT00855218|TACE|tace
643271|NCT00855218|DC bead|dc bead
643272|NCT00855218|Combination|combination
643273|NCT00855205|pulmonary sarcoidosis|pulmonary sarcoidosis
643274|NCT00855192|anxiety|anxiety
643275|NCT00855192|depression|depression
643276|NCT00855192|pregnancy|pregnancy
643277|NCT00855192|antenatal|antenatal
643278|NCT00855192|prenatal|prenatal
643279|NCT00855192|mindfulness-based therapy|mindfulness-based therapy
643280|NCT00855192|interpersonal therapy|interpersonal therapy
643281|NCT00855192|support groups|support groups
643282|NCT00855166|Dapagliflozin|dapagliflozin
643283|NCT00855166|Metformin|metformin
643284|NCT00855166|Type 2 diabetes|type 2 diabetes
643285|NCT00855166|body weight|body weight
643286|NCT00855153|PTSD|ptsd
643287|NCT00855153|burns|burns
643288|NCT00855153|virtual reality exposure|virtual reality exposure
643289|NCT00855153|D-Cycloserine|d-cycloserine
643290|NCT00855153|Combat related psychological trauma in burned servicemembers|combat related psychological trauma in burned servicemembers
643291|NCT00855140|Insomnia|insomnia
643292|NCT00855140|Primary insomnia|primary insomnia
643293|NCT00855140|Insomnia disorder|insomnia disorder
643294|NCT00855140|Acupuncture|acupuncture
643295|NCT00855127|Biological Markers|biological markers
643296|NCT00855127|Renal Replacement Therapy|renal replacement therapy
643297|NCT00855127|Mortality|mortality
643298|NCT00855114|stage II breast cancer|stage ii breast cancer
643299|NCT00855114|stage III breast cancer|stage iii breast cancer
643300|NCT00855114|stage IIIA breast cancer|stage iiia breast cancer
643301|NCT00855101|Pharmacokinetics and safety of voriconazole intravenous oral adults|pharmacokinetics and safety of voriconazole intravenous oral adults
643302|NCT00855088|HIV seronegativity|hiv seronegativity
643303|NCT00855075|Sedation|sedation
643304|NCT00855075|Analgesia|analgesia
643305|NCT00855075|Mechanical ventilation|mechanical ventilation
643306|NCT00855075|Cerebral State Monitor|cerebral state monitor
643307|NCT00855075|Cerebral State Index|cerebral state index
643308|NCT00855062|Human immunodeficiency virus (HIV)|human immunodeficiency virus (hiv)
643309|NCT00855062|HIV associated cognitive impairment|hiv associated cognitive impairment
643310|NCT00855062|HIV dementia|hiv dementia
643311|NCT00855062|Uganda|uganda
643312|NCT00855062|Acquired immune deficiency syndrome (AIDS)|acquired immune deficiency syndrome (aids)
643313|NCT00855062|Treatment Naive|treatment naive
643314|NCT00855049|Pharmacokinetics|pharmacokinetics
643315|NCT00855049|Acetaminophen|acetaminophen
643316|NCT00855049|Intranasal|intranasal
643317|NCT00855049|Absorption|absorption
643318|NCT00855036|blunt renal injury|blunt renal injury
643319|NCT00855036|kidney laceration|kidney laceration
643320|NCT00855023|anterior cruciate ligament|anterior cruciate ligament
643321|NCT00855023|Knee Joint|knee joint
643322|NCT00855010|Pioglitazone|pioglitazone
643323|NCT00855010|prediabetes|prediabetes
643324|NCT00855010|diabetes|diabetes
643325|NCT00855010|obesity|obesity
643326|NCT00855010|Pancreatic fat|pancreatic fat
643327|NCT00854997|Obstructive sleep apnea; myocardial infarction|obstructive sleep apnea; myocardial infarction
643328|NCT00854984|Depression|depression
643329|NCT00854984|diabetes|diabetes
643330|NCT00854984|Coronary heart disease|coronary heart disease
643331|NCT00854984|CBT|cbt
643332|NCT00854984|Cognitive behavioural therapy|cognitive behavioural therapy
643333|NCT00854971|NKCell|nkcell
643334|NCT00854971|FOLFOX-4|folfox-4
643335|NCT00854971|advanced or unresectable colorectal cancer|advanced or unresectable colorectal cancer
643336|NCT00854958|Oral|oral
643337|NCT00854958|Allergy|allergy
643338|NCT00854958|Syndrome|syndrome
643339|NCT00854958|Food|food
643340|NCT00854958|Pollen|pollen
643341|NCT00854945|Myelodysplastic Syndrome|myelodysplastic syndrome
643342|NCT00854945|Refractory Cytopenia|refractory cytopenia
643343|NCT00854945|Refractory Anemia|refractory anemia
643344|NCT00854945|Dysplasia|dysplasia
643345|NCT00854945|Acute Myeloid Leukemia|acute myeloid leukemia
643346|NCT00854932|procalcitonin|procalcitonin
643347|NCT00854932|sepsis|sepsis
643348|NCT00854932|newborn|newborn
643349|NCT00854932|intervention study|intervention study
643350|NCT00854919|obsessive-compulsive disorder|obsessive-compulsive disorder
643351|NCT00854919|augmentation treatment|augmentation treatment
643352|NCT00854919|SSRI-refractory|ssri-refractory
643353|NCT00854906|dry eye|dry eye
643354|NCT00854906|keratometer|keratometer
643355|NCT00854906|fluorescein|fluorescein
643356|NCT00854893|stroke|stroke
643357|NCT00854893|aphasia|aphasia
643358|NCT00854893|aging|aging
643359|NCT00854893|language learning|language learning
643360|NCT00854880|Erosive Gastritis|erosive gastritis
643361|NCT00854867|Solid tumour neoplastic meningitis|solid tumour neoplastic meningitis
643362|NCT00854867|STNM|stnm
643363|NCT00854867|leptomeningeal metastases|leptomeningeal metastases
643364|NCT00854867|DepoCyte|depocyte
643365|NCT00854867|WBRT|wbrt
643366|NCT00854867|Whole Brain Radiotherapy|whole brain radiotherapy
643367|NCT00854867|Liposomal cytarabine intrathecal|liposomal cytarabine intrathecal
643368|NCT00854867|Solid Tumour Neoplastic Meningitis with or without brain metastasis|solid tumour neoplastic meningitis with or without brain metastasis
643369|NCT00854854|NKCell|nkcell
643370|NCT00854854|FOLFOX-4|folfox-4
643371|NCT00854854|gastric cancer|gastric cancer
643372|NCT00854841|CML|cml
643373|NCT00854841|suboptimal response|suboptimal response
643374|NCT00854841|dasatinib|dasatinib
643375|NCT00854841|imatinib|imatinib
643376|NCT00854828|Symptomatic 40-80 y/o w/lumbar Cobb of 30 degrees|symptomatic 40-80 y/o w/lumbar cobb of 30 degrees
643377|NCT00854828|All Participants must be reasonable surgical candidate at enrollment|all participants must be reasonable surgical candidate at enrollment
643378|NCT00854815|Perforated appendicitis|perforated appendicitis
643379|NCT00854815|laparoscopic appendectomy|laparoscopic appendectomy
643380|NCT00854815|children|children
643381|NCT00854815|irrigation|irrigation
643382|NCT00854802|Hepatitis|hepatitis
643383|NCT00854802|Hepatitis C|hepatitis c
819870|NCT00159224|HIV|hiv
643384|NCT00854789|Breast cancer|breast cancer
643385|NCT00854776|aspirin|aspirin
643386|NCT00854776|clopidogrel|clopidogrel
643387|NCT00854776|proton pump inhibitor|proton pump inhibitor
643388|NCT00854776|peptic ulcer|peptic ulcer
643389|NCT00854776|ulcer complications|ulcer complications
643390|NCT00854750|Multiple Sclerosis, hx of unilateral ON, evidence of thermal sensitivity, and no evidence of an ocular motor syndrome|multiple sclerosis, hx of unilateral on, evidence of thermal sensitivity, and no evidence of an ocular motor syndrome
643391|NCT00854750|Multiple Sclerosis, no evidence of ON, and evidence of thermal sensitivity|multiple sclerosis, no evidence of on, and evidence of thermal sensitivity
643392|NCT00854750|Healthy age/gender matched controls|healthy age/gender matched controls
643393|NCT00854737|bipolar disorder|bipolar disorder
643394|NCT00854737|bipolar depression|bipolar depression
643395|NCT00854737|bipolar mania|bipolar mania
643396|NCT00854737|manic depression|manic depression
643397|NCT00854737|depression|depression
643398|NCT00854737|mania|mania
643399|NCT00854737|hypomania|hypomania
643400|NCT00854711|ST elevated Myocardical infraction|st elevated myocardical infraction
643401|NCT00854698|THE LEFT VENTRICULAR REMODELING AFTER MECHANICAL AORTIC VALVE REPLACEMENT|the left ventricular remodeling after mechanical aortic valve replacement
643402|NCT00854698|exercise training|exercise training
643403|NCT00854672|Sarcoidosis|sarcoidosis
643404|NCT00854672|muscle strength|muscle strength
643405|NCT00854672|exercise intolerance|exercise intolerance
643406|NCT00854672|QOL|qol
643407|NCT00854646|ON 01910.Na|on 01910.na
643408|NCT00854646|refractory|refractory
643409|NCT00854646|leukemia|leukemia
643410|NCT00854646|myelodysplastic|myelodysplastic
643411|NCT00854646|cell cycle|cell cycle
643412|NCT00854633|Pre-term infants|pre-term infants
643413|NCT00854633|Pre-term infants 750 to 1500 grams|pre-term infants 750 to 1500 grams
643414|NCT00854594|Diabetes|diabetes
643415|NCT00854594|Telemedicine|telemedicine
643416|NCT00854594|Shared Medical Appointments|shared medical appointments
643417|NCT00854581|recurrent adult T-cell leukemia/lymphoma|recurrent adult t-cell leukemia/lymphoma
643418|NCT00854581|stage I adult T-cell leukemia/lymphoma|stage i adult t-cell leukemia/lymphoma
643519|NCT00854178|cytokines|cytokines
643419|NCT00854581|stage II adult T-cell leukemia/lymphoma|stage ii adult t-cell leukemia/lymphoma
643420|NCT00854581|stage III adult T-cell leukemia/lymphoma|stage iii adult t-cell leukemia/lymphoma
643421|NCT00854581|stage IV adult T-cell leukemia/lymphoma|stage iv adult t-cell leukemia/lymphoma
643422|NCT00854581|HTLV-1 infection|htlv-1 infection
643423|NCT00854568|B-cell lymphoma|b-cell lymphoma
643424|NCT00854568|CHOP|chop
643425|NCT00854568|CEOP|ceop
643426|NCT00854568|Cardiotoxicity|cardiotoxicity
643427|NCT00854555|incomplete spinal cord injury|incomplete spinal cord injury
643428|NCT00854555|locomotor activity|locomotor activity
643429|NCT00854555|walking function|walking function
643430|NCT00854555|gait|gait
643431|NCT00854542|Telepsychiatry|telepsychiatry
643432|NCT00854542|Culturally Sensitive Collaborative Treatment|culturally sensitive collaborative treatment
643433|NCT00854542|Chinese Americans|chinese americans
643434|NCT00854542|Depression|depression
643435|NCT00854529|bevacizumab|bevacizumab
643436|NCT00854529|subconjunctival injection|subconjunctival injection
643437|NCT00854529|trabeculectomy|trabeculectomy
643438|NCT00854529|bleb|bleb
643439|NCT00854529|mitomycin c|mitomycin c
643440|NCT00854516|compression therapy|compression therapy
643441|NCT00854516|3M|3m
643442|NCT00854503|Statins administration in diabetic dyslipidemia|statins administration in diabetic dyslipidemia
643443|NCT00854477|capecitabine|capecitabine
643444|NCT00854477|Post whipples|post whipples
643445|NCT00854477|pancreatico-duodenectomy|pancreatico-duodenectomy
643446|NCT00854477|pancreatic adenocarcinoma|pancreatic adenocarcinoma
643447|NCT00854477|pharmacokinetic|pharmacokinetic
643448|NCT00854464|Arsenic Methylation Capability|arsenic methylation capability
643449|NCT00854464|Arsenic Methylation Enzymes|arsenic methylation enzymes
643450|NCT00854464|Cigarette Metabolites|cigarette metabolites
643451|NCT00854464|Cigarette Metabolic Enzymes|cigarette metabolic enzymes
643452|NCT00854464|DNA Repair Enzymes|dna repair enzymes
643453|NCT00854464|Inflammatory Factors|inflammatory factors
643454|NCT00854464|Urothelial Carcinoma|urothelial carcinoma
643455|NCT00854451|Helicobacter pylori|helicobacter pylori
643456|NCT00854451|CYP2C19 genotype|cyp2c19 genotype
643457|NCT00854451|intragastric pH|intragastric ph
643458|NCT00854451|dual therapy|dual therapy
643459|NCT00854451|antibiotic resistance|antibiotic resistance
643460|NCT00854438|anticholinergic drugs|anticholinergic drugs
643461|NCT00854438|adverse events|adverse events
643462|NCT00854438|elderly|elderly
643463|NCT00854438|clinical pharmacist|clinical pharmacist
643464|NCT00854438|Evaluate the clinical effects of reducing anticholinergic in elderly|evaluate the clinical effects of reducing anticholinergic in elderly
643465|NCT00854412|Obesity|obesity
643466|NCT00854412|Weight loss|weight loss
643467|NCT00854412|Very low-calorie diet|very low-calorie diet
643468|NCT00854412|Mannose-binding lectin|mannose-binding lectin
643469|NCT00854412|Insulin resistance|insulin resistance
643470|NCT00854386|fluid management|fluid management
643471|NCT00854386|VATS|vats
643472|NCT00854386|ALI|ali
643473|NCT00854386|ARDS|ards
643474|NCT00854373|Infertility|infertility
643475|NCT00854373|Pregnancy|pregnancy
643476|NCT00854373|in vitro fertilization|in vitro fertilization
643477|NCT00854360|Seasonal Allergic Rhinitis|seasonal allergic rhinitis
643478|NCT00854360|Hayfever|hayfever
643479|NCT00854347|hyperglycemia|hyperglycemia
643480|NCT00854347|diabetes|diabetes
643481|NCT00854347|intensive care|intensive care
643482|NCT00854347|prevalence|prevalence
643483|NCT00854334|Sleep|sleep
643484|NCT00854334|Overweight|overweight
643485|NCT00854334|Physical activity|physical activity
643486|NCT00854334|Appetite|appetite
643487|NCT00854334|NEAT|neat
643488|NCT00854321|rheumatoid arthritis|rheumatoid arthritis
643489|NCT00854321|rituximab|rituximab
643490|NCT00854321|therapy|therapy
643491|NCT00854308|Tarceva|tarceva
643492|NCT00854308|Lung Cancer|lung cancer
643493|NCT00854308|NSCLC|nsclc
643494|NCT00854295|arthritis|arthritis
643495|NCT00854295|osteoarthritis|osteoarthritis
643496|NCT00854295|degenerative knee disease|degenerative knee disease
643497|NCT00854295|avascular necrosis|avascular necrosis
643498|NCT00854295|total knee replacement|total knee replacement
643499|NCT00854295|TKA|tka
643500|NCT00854256|glaucoma|glaucoma
643501|NCT00854230|HIV|hiv
643502|NCT00854230|alcohol|alcohol
643503|NCT00854230|naltrexone|naltrexone
643504|NCT00854230|Treatment Experienced|treatment experienced
643505|NCT00854204|Innovation-TiFP4-C101|innovation-tifp4-c101
643506|NCT00854204|Innovation-C101|innovation-c101
643507|NCT00854204|Innovation|innovation
643508|NCT00854204|TMC114/TMC41629|tmc114/tmc41629
643509|NCT00854204|controlled-release coformulations|controlled-release coformulations
643510|NCT00854204|immediate-release coformulation|immediate-release coformulation
643511|NCT00854204|Pharmacokinetics|pharmacokinetics
643512|NCT00854191|mechanical simulator|mechanical simulator
643513|NCT00854191|ERCP|ercp
643514|NCT00854191|training|training
643515|NCT00854178|isoflurane|isoflurane
643516|NCT00854178|propofol|propofol
643517|NCT00854178|genotoxicity|genotoxicity
643518|NCT00854178|gene expression|gene expression
643520|NCT00854178|apoptosis|apoptosis
643521|NCT00854165|lung transplantation|lung transplantation
643522|NCT00854165|respiratory failure|respiratory failure
643524|NCT00854165|Lung transplants in respiratory failure patients|lung transplants in respiratory failure patients
643525|NCT00854152|NHL|nhl
643526|NCT00854152|Tumors|tumors
643527|NCT00854152|Carcinogenic Tumors|carcinogenic tumors
643528|NCT00854139|Multiple myeloma|multiple myeloma
643529|NCT00854139|Renal failure|renal failure
643530|NCT00854139|Kidney transplant|kidney transplant
643531|NCT00854126|NHL|nhl
643532|NCT00854126|Solid Tumors|solid tumors
643533|NCT00854126|Carcinogenic Tumors|carcinogenic tumors
643534|NCT00854113|Diabetes Mellitus Type 2|diabetes mellitus type 2
643535|NCT00854100|Adjunctive|adjunctive
643536|NCT00854100|Depression|depression
643537|NCT00854100|Major Depressive Disorder (MDD)|major depressive disorder (mdd)
643538|NCT00854087|Hepatitis C Virus|hepatitis c virus
643539|NCT00854087|HCV|hcv
643540|NCT00854087|Herbal treatment|herbal treatment
643541|NCT00854087|Herbs|herbs
643542|NCT00854087|San Diego|san diego
643543|NCT00854087|Non responder|non responder
643544|NCT00854087|Relapser|relapser
643545|NCT00854087|Treatment failure|treatment failure
643546|NCT00854087|Antifibrotic|antifibrotic
643547|NCT00854087|Anti-fibrotic|anti-fibrotic
643548|NCT00854087|Fibrosis|fibrosis
643549|NCT00854087|Failure of previous Interferon based therapy|failure of previous interferon based therapy
643550|NCT00854087|Refuse Interferon based therapy|refuse interferon based therapy
643551|NCT00854087|Intolerance to Interferon|intolerance to interferon
643552|NCT00854087|Male or female 18-70 years of age|male or female 18-70 years of age
643553|NCT00854074|Post-operative Paralytic Ileus|post-operative paralytic ileus
643554|NCT00854074|Neuromodulation|neuromodulation
643555|NCT00854074|Neurostimulation|neurostimulation
643556|NCT00854074|Extended loss of functional bowel motility|extended loss of functional bowel motility
643557|NCT00854048|Pediatric|pediatric
643558|NCT00854048|Oxygen Saturation|oxygen saturation
643559|NCT00854048|Cardiopulmonary bypass|cardiopulmonary bypass
643560|NCT00854035|MK-0431/ONO-5435|mk-0431/ono-5435
643561|NCT00854035|Type 2 diabetes mellitus|type 2 diabetes mellitus
643562|NCT00854009|Healthy Subjects|healthy subjects
643563|NCT00853983|Healthy Volunteers|healthy volunteers
643564|NCT00853983|ADME|adme
643565|NCT00853970|Pain and Inflammation as a function of cataract surgery|pain and inflammation as a function of cataract surgery
643566|NCT00853957|Hypertension|hypertension
643567|NCT00853957|African Americans|african americans
643568|NCT00853957|Aliskiren|aliskiren
643569|NCT00853957|Amlodipine|amlodipine
643570|NCT00853957|Systolic blood pressure|systolic blood pressure
643571|NCT00853957|Diastolic blood pressure|diastolic blood pressure
820147|NCT00157976|AMD|amd
643572|NCT00853957|Stage II|stage ii
643573|NCT00853957|Combination|combination
643574|NCT00853944|islet transplantation|islet transplantation
643575|NCT00853944|type 1 diabetes|type 1 diabetes
643576|NCT00853944|incretin|incretin
643577|NCT00853931|KRAS wild type|kras wild type
643578|NCT00853931|metastatic colorectal cancer|metastatic colorectal cancer
643579|NCT00853931|KRAS wild type metastatic colorectal cancer with no prior exposure to EGFR inhibitors|kras wild type metastatic colorectal cancer with no prior exposure to egfr inhibitors
643580|NCT00853918|Physician survey|physician survey
643581|NCT00853918|Mail survey|mail survey
643582|NCT00853918|Response rate|response rate
643583|NCT00853905|open angle glaucoma (POAG)|open angle glaucoma (poag)
643584|NCT00853905|angle closure glaucoma (PACG)|angle closure glaucoma (pacg)
643585|NCT00853905|pigmentary glaucoma|pigmentary glaucoma
643586|NCT00853905|pseudoexfoliation glaucoma|pseudoexfoliation glaucoma
643587|NCT00853905|neovascular glaucoma|neovascular glaucoma
643588|NCT00853905|traumatic glaucoma|traumatic glaucoma
643589|NCT00853892|Healthy Subjects|healthy subjects
643590|NCT00853892|Bioequivalence|bioequivalence
643591|NCT00853866|stroke|stroke
643592|NCT00853866|reboxetine|reboxetine
643593|NCT00853866|noradrenaline|noradrenaline
643594|NCT00853866|motor cortex|motor cortex
643595|NCT00853866|transcranial direct current stimulation|transcranial direct current stimulation
643596|NCT00853866|motor function|motor function
643597|NCT00853866|rehabilitation|rehabilitation
643598|NCT00853866|Jebsen Taylor test|jebsen taylor test
643599|NCT00853853|Hemorrhoidectomy|hemorrhoidectomy
643600|NCT00853853|Hemorrhoids|hemorrhoids
643601|NCT00853840|pharmacodynamics. maraviroc, vardenafil, blood pressure|pharmacodynamics. maraviroc, vardenafil, blood pressure
643602|NCT00853827|CAD|cad
643603|NCT00853827|coronary artery disease|coronary artery disease
643604|NCT00853827|coronary atherosclerosis|coronary atherosclerosis
643605|NCT00853827|coronary angiography|coronary angiography
643606|NCT00853827|IVUS|ivus
643607|NCT00853827|intravascular ultrasound|intravascular ultrasound
643608|NCT00853827|plasma renin activity|plasma renin activity
643609|NCT00853827|renin angiotensin aldosterone system,|renin angiotensin aldosterone system,
643610|NCT00853827|direct renin inhibitors|direct renin inhibitors
643611|NCT00853827|coronary atheroma|coronary atheroma
643612|NCT00853814|adolescence|adolescence
643613|NCT00853814|obesity|obesity
643614|NCT00853814|physical activity|physical activity
643615|NCT00853814|built environment|built environment
643616|NCT00853814|neighborhood environment|neighborhood environment
643617|NCT00853814|children|children
643618|NCT00853814|youth|youth
643619|NCT00853814|increasing physical activity|increasing physical activity
643620|NCT00853814|changing dietary intake|changing dietary intake
643621|NCT00853814|reducing zBMI|reducing zbmi
643622|NCT00853801|Pre-Diabetes|pre-diabetes
643623|NCT00853801|Metabolic Syndrome|metabolic syndrome
643624|NCT00853801|Type 2 Diabetes|type 2 diabetes
643625|NCT00853801|Diabetes Prevention|diabetes prevention
643626|NCT00853801|Lifestyle Modification|lifestyle modification
643627|NCT00853801|Diet Therapy|diet therapy
643628|NCT00853801|Provider Education|provider education
643629|NCT00853788|systemic sclerosis|systemic sclerosis
643630|NCT00853788|biomarkers|biomarkers
643631|NCT00853788|microarray|microarray
643632|NCT00853775|heart disease|heart disease
643633|NCT00853775|cardiovascular disease|cardiovascular disease
643634|NCT00853775|lipoproteins|lipoproteins
643635|NCT00853775|lipoprotein(a)|lipoprotein(a)
643636|NCT00853775|Lp(a)|lp(a)
643637|NCT00853775|apolipoprotein(a)|apolipoprotein(a)
643638|NCT00853775|apo(a)|apo(a)
643639|NCT00853775|fats|fats
643640|NCT00853775|proteins|proteins
643641|NCT00853775|metabolism|metabolism
643642|NCT00853749|Immune response|immune response
643643|NCT00853749|pneumococcal conjugate vaccine|pneumococcal conjugate vaccine
643644|NCT00853749|polysaccharide|polysaccharide
643645|NCT00853736|Healthy Subjects|healthy subjects
643646|NCT00853736|Bioequivalence|bioequivalence
643647|NCT00853723|osteoporosis|osteoporosis
643648|NCT00853723|post-menopausal|post-menopausal
643649|NCT00853723|bone anabolic agents|bone anabolic agents
643650|NCT00853710|Prostate-Specific Antigen|prostate-specific antigen
643651|NCT00853710|Prostate Cancer|prostate cancer
643652|NCT00853710|Cancer|cancer
643653|NCT00853710|Assay|assay
643654|NCT00853697|Prostate|prostate
643655|NCT00853697|DUTASTERIDE|dutasteride
643656|NCT00853697|TESTOSTERONE|testosterone
643657|NCT00853697|09-008|09-008
643658|NCT00853697|Consortium Protocol LOI# c09-028|consortium protocol loi# c09-028
643659|NCT00853684|Advanced Colorectal Cancer|advanced colorectal cancer
643660|NCT00853684|Oxaliplatin|oxaliplatin
643661|NCT00853684|Capecitabine|capecitabine
643662|NCT00853684|Endostar|endostar
643663|NCT00853684|efficacy|efficacy
643664|NCT00853671|Coronary Artery Disease|coronary artery disease
643665|NCT00853671|Multidetector Computed Tomography|multidetector computed tomography
643666|NCT00853671|Myocardial Perfusion Imaging|myocardial perfusion imaging
643667|NCT00853658|Chronic Heart Failure|chronic heart failure
643668|NCT00853658|Cardiovascular death|cardiovascular death
643669|NCT00853658|CHF hospitalization|chf hospitalization
643670|NCT00853658|morbi-mortality trial|morbi-mortality trial
643671|NCT00853658|outcome study|outcome study
643672|NCT00853658|endpoint driven|endpoint driven
643673|NCT00853658|plasma renin activity|plasma renin activity
643674|NCT00853658|renin angiotensin aldosterone system|renin angiotensin aldosterone system
643675|NCT00853658|direct renin inhibitors|direct renin inhibitors
643676|NCT00853658|BNP|bnp
643677|NCT00853658|KCCQ|kccq
643678|NCT00853658|eGFR|egfr
643679|NCT00853658|(NYHA class II to IV) with elevated|(nyha class ii to iv) with elevated
643680|NCT00853658|BNP and reduced LVEF|bnp and reduced lvef
643681|NCT00853632|Mitral valve|mitral valve
643682|NCT00853632|pericardial bioprostheses|pericardial bioprostheses
643683|NCT00853632|PERIMOUNT|perimount
643684|NCT00853632|bovine pericardial leaflets|bovine pericardial leaflets
643685|NCT00853632|mitral valve replacement|mitral valve replacement
643686|NCT00853632|mitral valve regurgitation|mitral valve regurgitation
643687|NCT00853632|Heart valve disease|heart valve disease
643688|NCT00853619|clinical decision support|clinical decision support
643689|NCT00853619|knowledge management|knowledge management
643690|NCT00853619|knowledge representation|knowledge representation
643691|NCT00853619|clinical guidelines|clinical guidelines
643692|NCT00853619|coronary artery disease|coronary artery disease
643693|NCT00853619|myocardial ischemia|myocardial ischemia
643694|NCT00853619|diabetes mellitus|diabetes mellitus
643695|NCT00853619|hypertension|hypertension
643696|NCT00853606|ED|ed
643697|NCT00853606|Erectile Dysfunction|erectile dysfunction
643698|NCT00853606|Dysfunction|dysfunction
643699|NCT00853606|Erectile|erectile
643700|NCT00853593|heart failure|heart failure
643701|NCT00853593|cardiac pacing|cardiac pacing
643702|NCT00853593|cardiac resynchronization therapy|cardiac resynchronization therapy
643703|NCT00853593|left ventricular lead|left ventricular lead
643704|NCT00853580|Neurofibromatosis Type 1, Neurocognitive, Phase II|neurofibromatosis type 1, neurocognitive, phase ii
643705|NCT00853567|Uterine Fibroids|uterine fibroids
643706|NCT00853554|Healthy Subjects|healthy subjects
643707|NCT00853554|Bioequivalence|bioequivalence
643708|NCT00853541|renal impairment|renal impairment
643709|NCT00853541|heart failure|heart failure
643710|NCT00853541|hyperphosphatemia|hyperphosphatemia
643711|NCT00853541|coronary artery calcification|coronary artery calcification
643712|NCT00853528|spinal cord metastases|spinal cord metastases
643713|NCT00853502|anorexia nervosa|anorexia nervosa
643714|NCT00853502|testosterone|testosterone
643715|NCT00853502|disordered eating|disordered eating
643716|NCT00853502|hypogonadism|hypogonadism
643717|NCT00853502|bone|bone
643718|NCT00853489|Open tibia fractures|open tibia fractures
643719|NCT00853489|rhBMP-2|rhbmp-2
643720|NCT00853489|critical size defects|critical size defects
643721|NCT00853489|bone grafting|bone grafting
643722|NCT00853463|Pulmonary Embolism|pulmonary embolism
643723|NCT00853463|Deep Vein Thrombosis|deep vein thrombosis
643724|NCT00853463|Prophylaxis|prophylaxis
643725|NCT00853463|Venous thromboembolism|venous thromboembolism
643726|NCT00853463|Prevention|prevention
643727|NCT00853463|Medical patients|medical patients
643728|NCT00853450|Antiplatelet|antiplatelet
643729|NCT00853437|Comparison of CO by new method to clinician's estimate and implied CO from the measurement of arteriovenous oxygen content difference.|comparison of co by new method to clinician's estimate and implied co from the measurement of arteriovenous oxygen content difference.
643730|NCT00853424|diabetic retinopathy|diabetic retinopathy
643731|NCT00853424|diabetic macular edema|diabetic macular edema
643732|NCT00853424|type 1 diabetes|type 1 diabetes
643733|NCT00853424|intensive medical therapy|intensive medical therapy
643734|NCT00853424|islet cell transplantation|islet cell transplantation
643735|NCT00853424|visual acuity|visual acuity
643736|NCT00853424|diabetic eye disease|diabetic eye disease
643737|NCT00853411|Moderate to severe asthma|moderate to severe asthma
643738|NCT00853398|Primary Osteoarthritis of the knee.|primary osteoarthritis of the knee.
643739|NCT00853385|oral DMARD|oral dmard
643740|NCT00853385|JAK inhibitor|jak inhibitor
643741|NCT00853385|clinical trial|clinical trial
643742|NCT00853346|Depression|depression
643743|NCT00853346|Parkinson's Disease|parkinson's disease
643744|NCT00853346|Major Depression|major depression
643745|NCT00853346|Cognitive Behavioral Therapy|cognitive behavioral therapy
643746|NCT00853333|Pain|pain
643747|NCT00853333|Propofol|propofol
643748|NCT00853333|Dexmedetomidine|dexmedetomidine
643749|NCT00853333|Midazolam|midazolam
643750|NCT00853333|Effects of sedation on pain perception.|effects of sedation on pain perception.
643751|NCT00853320|Healthy Subjects|healthy subjects
643752|NCT00853320|Bioequivalence|bioequivalence
643753|NCT00853307|Drug therapy|drug therapy
643754|NCT00853294|Healthy Subjects|healthy subjects
643755|NCT00853294|Bioequivalence|bioequivalence
643756|NCT00853281|Forest malaria prevention|forest malaria prevention
643757|NCT00853281|Long-lasting insecticidal hammocks|long-lasting insecticidal hammocks
643758|NCT00853281|Cluster randomized trial|cluster randomized trial
643759|NCT00853281|Central Vietnam|central vietnam
643760|NCT00853268|Healthy Subjects|healthy subjects
643761|NCT00853268|Bioequivalence|bioequivalence
643762|NCT00853255|Bird Flu|bird flu
643763|NCT00853242|Chronic Kidney Disease|chronic kidney disease
643764|NCT00853242|Phosphate Binder|phosphate binder
643765|NCT00853242|Phosphate|phosphate
643766|NCT00853242|Hyperphosphatemia|hyperphosphatemia
643767|NCT00853229|vulvodynia|vulvodynia
643768|NCT00853229|vulvar vestibulitis|vulvar vestibulitis
643769|NCT00853229|chronic vulvar pain|chronic vulvar pain
643770|NCT00853229|generalized vulvodynia|generalized vulvodynia
643771|NCT00853229|localized vulvodynia|localized vulvodynia
643772|NCT00853216|Healthy Subjects|healthy subjects
643773|NCT00853216|Bioequivalence|bioequivalence
643774|NCT00853203|Colorectal Cancer|colorectal cancer
643775|NCT00853203|Rectal Cancer|rectal cancer
643776|NCT00853203|Psychosocial|psychosocial
643777|NCT00853203|Expressive Disclosure|expressive disclosure
643778|NCT00853203|Questionnaires|questionnaires
643779|NCT00853203|Quality of life|quality of life
643780|NCT00853203|QOL|qol
643781|NCT00853203|Electronically Activated Recorder|electronically activated recorder
643782|NCT00853203|EAR|ear
643783|NCT00853190|Healthy Subjects|healthy subjects
643784|NCT00853177|Oocyte retrieval|oocyte retrieval
643785|NCT00853177|pain|pain
643786|NCT00853177|surgery|surgery
643787|NCT00853177|anaesthesiology|anaesthesiology
643788|NCT00853177|Assisted Reproductive Technologies|assisted reproductive technologies
643789|NCT00853164|prostate cancer|prostate cancer
643790|NCT00853164|aerobic exercise|aerobic exercise
643791|NCT00853164|resistance training|resistance training
643792|NCT00853138|cognitive-behavioral therapy|cognitive-behavioral therapy
643793|NCT00853138|chronic pain|chronic pain
643794|NCT00853138|randomized controlled trial|randomized controlled trial
643795|NCT00853138|pediatrics|pediatrics
643796|NCT00853125|clear cell renal cell carcinoma|clear cell renal cell carcinoma
643797|NCT00853125|stage IV renal cell cancer|stage iv renal cell cancer
643798|NCT00853112|PAH pulmonary hypertension pulmonary arterial hypertension|pah pulmonary hypertension pulmonary arterial hypertension
643799|NCT00853099|Ulcerative Colitis|ulcerative colitis
643800|NCT00853073|failing blebs|failing blebs
643801|NCT00853073|failing express shunt|failing express shunt
643802|NCT00853073|avastin|avastin
643803|NCT00853073|bevacizumab|bevacizumab
643804|NCT00853073|glaucoma|glaucoma
643805|NCT00853073|prior trabeculectomy|prior trabeculectomy
643990|NCT00852358|Scheie|scheie
643806|NCT00853073|Express shunt placed under a scleral flap|express shunt placed under a scleral flap
643807|NCT00853073|subsequent filtration failure|subsequent filtration failure
643808|NCT00853060|energy expenditure|energy expenditure
643809|NCT00853060|mechanical ventilation|mechanical ventilation
643811|NCT00853060|pressure support ventilation|pressure support ventilation
643812|NCT00853060|T-tube|t-tube
643813|NCT00853034|gastrointestinal effects|gastrointestinal effects
643814|NCT00853034|prebiotic|prebiotic
643815|NCT00853021|clear cell renal cell carcinoma|clear cell renal cell carcinoma
643816|NCT00853021|recurrent renal cell cancer|recurrent renal cell cancer
643817|NCT00853021|stage IV renal cell cancer|stage iv renal cell cancer
643818|NCT00853008|Acute Lymphoblastic Leukemia|acute lymphoblastic leukemia
643819|NCT00853008|High-Risk (HR)|high-risk (hr)
643820|NCT00853008|Philadelphia Chromosome-Negative|philadelphia chromosome-negative
643821|NCT00852995|Venous Leg Ulcer (VLU)|venous leg ulcer (vlu)
643822|NCT00852995|Venous Stasis Ulcer (VSU)|venous stasis ulcer (vsu)
643823|NCT00852995|VLU|vlu
643824|NCT00852995|VSU|vsu
643825|NCT00852995|Leg Ulcer|leg ulcer
643826|NCT00852995|Leg Wound|leg wound
643827|NCT00852982|Exercise|exercise
643828|NCT00852982|Risk factors|risk factors
643829|NCT00852982|Primary health care|primary health care
643830|NCT00852969|Chronic Kidney Disease|chronic kidney disease
643831|NCT00852969|Niacin|niacin
643832|NCT00852969|HDL|hdl
643833|NCT00852969|Endothelial Function|endothelial function
643834|NCT00852956|Betahistine|betahistine
643835|NCT00852956|Olanzapine|olanzapine
643836|NCT00852956|Safety of co-administration of Betahistien and Olanzapine|safety of co-administration of betahistien and olanzapine
643837|NCT00852943|Autoimmune Disease|autoimmune disease
643838|NCT00852943|GENETIC DISEASE|genetic disease
643839|NCT00852943|Inherited Allergic Disease|inherited allergic disease
643840|NCT00852943|Allergy|allergy
643841|NCT00852943|Immunodeficiency Disease|immunodeficiency disease
643842|NCT00852930|lymphedema|lymphedema
643843|NCT00852930|quality of life|quality of life
643844|NCT00852930|breast cancer|breast cancer
643845|NCT00852930|symptoms|symptoms
643846|NCT00852930|lymphedema in breast cancer survivors|lymphedema in breast cancer survivors
643847|NCT00852917|Pain due to Osteoarthritis of the Knee|pain due to osteoarthritis of the knee
643848|NCT00852904|Childhood Growth and Development|childhood growth and development
643849|NCT00852904|Genetics|genetics
643850|NCT00852904|Children|children
643851|NCT00852904|Environment|environment
643852|NCT00852904|Longitudinal Study|longitudinal study
643853|NCT00852904|National Children's Study|national children's study
643854|NCT00852891|weaning|weaning
643855|NCT00852891|echocardiogram|echocardiogram
643856|NCT00852891|diastolic dysfunction|diastolic dysfunction
643857|NCT00852891|Mechanical ventilation|mechanical ventilation
643858|NCT00852878|Recurrent Abdominal Pain|recurrent abdominal pain
643859|NCT00852878|Biofeedback|biofeedback
643860|NCT00852878|Heart Rate Variability|heart rate variability
643861|NCT00852865|Inflammation|inflammation
643862|NCT00852865|Pain|pain
643863|NCT00852852|ESRA-C 2|esra-c 2
643864|NCT00852852|computerized assessment|computerized assessment
643865|NCT00852839|Dry mouth|dry mouth
643866|NCT00852839|Sjogren's syndrome|sjogren's syndrome
643867|NCT00852839|Xerostomia|xerostomia
643868|NCT00852826|axillary seroma|axillary seroma
643869|NCT00852826|axillary lymphadenectomy|axillary lymphadenectomy
643870|NCT00852826|morbidity|morbidity
643871|NCT00852826|morbidity postlymphadenectomy|morbidity postlymphadenectomy
643872|NCT00852826|Lymphadenectomy|lymphadenectomy
643873|NCT00852813|tolerance|tolerance
643874|NCT00852813|prebiotic|prebiotic
643875|NCT00852813|gastrointestinal effects|gastrointestinal effects
643876|NCT00852800|spontaneous bacterial peritonitis|spontaneous bacterial peritonitis
643877|NCT00852800|albumin|albumin
643878|NCT00852800|renal impairment|renal impairment
643879|NCT00852800|mortality|mortality
643880|NCT00852787|Digoxin like substances|digoxin like substances
643881|NCT00852787|digibind|digibind
643882|NCT00852787|digoxin immune fab|digoxin immune fab
643883|NCT00852787|end-stage-renal-disease|end-stage-renal-disease
643884|NCT00852787|marinobufagenin|marinobufagenin
643885|NCT00852761|Psoriasis|psoriasis
643886|NCT00852748|headache|headache
643887|NCT00852735|Cardiovascular diseases|cardiovascular diseases
643888|NCT00852735|Rapeseed oil|rapeseed oil
643889|NCT00852735|Micronutriments|micronutriments
643890|NCT00852735|HDL cholesterol|hdl cholesterol
643891|NCT00852735|Oxidative stress|oxidative stress
643892|NCT00852735|Tocopherols|tocopherols
643893|NCT00852735|Sterols|sterols
643894|NCT00852735|Prevention of cardiovascular diseases|prevention of cardiovascular diseases
643895|NCT00852722|Multiple sclerosis|multiple sclerosis
643896|NCT00852722|Diet|diet
643897|NCT00852709|Myelodysplastic syndrome that has transformed to AML (AML/MDS)|myelodysplastic syndrome that has transformed to aml (aml/mds)
643898|NCT00852709|Treatment-related AML|treatment-related aml
643899|NCT00852709|AML evolving from myeloproliferative disorders (MPD)|aml evolving from myeloproliferative disorders (mpd)
643900|NCT00852709|Acute lymphocytic leukemia (ALL)|acute lymphocytic leukemia (all)
643901|NCT00852709|Acute promyelocytic leukemia (APL) refractory to arsenic therapy or retinoic acid therapy|acute promyelocytic leukemia (apl) refractory to arsenic therapy or retinoic acid therapy
643902|NCT00852709|Relapsed and/or refractory acute leukemia with progressive disease since last therapy|relapsed and/or refractory acute leukemia with progressive disease since last therapy
643903|NCT00852709|Chronic myelogenous leukemia (CML) in accelerated phase or blast crisis refractory to imatinib|chronic myelogenous leukemia (cml) in accelerated phase or blast crisis refractory to imatinib
643904|NCT00852709|High-risk MPD including myelofibrosis, chronic myelomonocytic leukemia (CMML, and relapsed or refractory juvenile myelomonocytic leukemia (JMML).|high-risk mpd including myelofibrosis, chronic myelomonocytic leukemia (cmml, and relapsed or refractory juvenile myelomonocytic leukemia (jmml).
643905|NCT00852696|Overactive Bladder|overactive bladder
643906|NCT00852696|Incontinence|incontinence
643907|NCT00852696|Solifenacin|solifenacin
643908|NCT00852696|Women|women
643909|NCT00852696|Postoperative|postoperative
643910|NCT00852657|Rotator cuff tear|rotator cuff tear
643911|NCT00852657|surgical repair|surgical repair
643912|NCT00852657|Physiotherapy|physiotherapy
643913|NCT00852657|Treatment benefit|treatment benefit
643914|NCT00852657|Surgery|surgery
643915|NCT00852644|stage I non-small cell lung cancer|stage i non-small cell lung cancer
643916|NCT00852644|stage II non-small cell lung cancer|stage ii non-small cell lung cancer
643917|NCT00852631|Quetiapine efficacy in schizophrenia|quetiapine efficacy in schizophrenia
643918|NCT00852618|HIV Integrase Inhibitors|hiv integrase inhibitors
643919|NCT00852618|HIV Nucleoside Reverse Transcriptase Inhibitors|hiv nucleoside reverse transcriptase inhibitors
643920|NCT00852618|Treatment Naive|treatment naive
643921|NCT00852618|Viral Load|viral load
643922|NCT00852605|Acute Lung Injury after allogeneic transplantation|acute lung injury after allogeneic transplantation
643923|NCT00852592|Bipolar Disorder Depression Midday Light Therapy|bipolar disorder depression midday light therapy
643924|NCT00852592|Bipolar Disorder Type I or II|bipolar disorder type i or ii
643925|NCT00852579|Asthma|asthma
643926|NCT00852579|Smoker|smoker
643927|NCT00852579|Macrolide|macrolide
643928|NCT00852566|Chronic myeloid leukemia|chronic myeloid leukemia
643929|NCT00852566|tyrosine kinase inhibitor|tyrosine kinase inhibitor
643930|NCT00852566|stem cell|stem cell
643931|NCT00852566|Philadelphia chromosome|philadelphia chromosome
643932|NCT00852566|dasatinib|dasatinib
643933|NCT00852553|intestinal|intestinal
643934|NCT00852553|smooth|smooth
643935|NCT00852553|muscle|muscle
643936|NCT00852553|GI|gi
643937|NCT00852553|motility|motility
643938|NCT00852540|impetigo|impetigo
643939|NCT00852540|methicillin-resistant Staphylococcus aureus|methicillin-resistant staphylococcus aureus
643940|NCT00852540|linezolid|linezolid
643941|NCT00852540|secondarily-infected traumatic lesion|secondarily-infected traumatic lesion
643942|NCT00852540|uncomplicated skin infection|uncomplicated skin infection
643943|NCT00852540|retapamulin|retapamulin
643944|NCT00852527|Traumatic Brain Injury|traumatic brain injury
643945|NCT00852527|Screening|screening
643946|NCT00852527|Diagnosis|diagnosis
643947|NCT00852527|Rehabilitation Outcome|rehabilitation outcome
643948|NCT00852514|Bioimpedance|bioimpedance
643949|NCT00852514|ultrafiltration|ultrafiltration
643950|NCT00852514|blood pressure|blood pressure
643951|NCT00852514|pulse pressure|pulse pressure
643952|NCT00852501|Non-functioning pituitary adenoma|non-functioning pituitary adenoma
643953|NCT00852501|RTPCR|rtpcr
643954|NCT00852501|Hormonal receptors|hormonal receptors
643955|NCT00852475|MUFA|mufa
643956|NCT00852475|PUFA|pufa
643957|NCT00852475|MOVE! program|move! program
643958|NCT00852462|SAMI|sami
643959|NCT00852462|Symptom Assessment and Management Intervention Program|symptom assessment and management intervention program
643960|NCT00852449|Intraoperative fluid|intraoperative fluid
643961|NCT00852449|Monitoring|monitoring
643962|NCT00852449|Oesophageal Doppler|oesophageal doppler
643963|NCT00852449|Abdominal surgery|abdominal surgery
643964|NCT00852449|major abdominal surgery|major abdominal surgery
643965|NCT00852436|neuropathic pain|neuropathic pain
643966|NCT00852436|orofacial pain|orofacial pain
643967|NCT00852436|clinical trials|clinical trials
643968|NCT00852436|pregabalin|pregabalin
643969|NCT00852436|randomized controlled trial|randomized controlled trial
643970|NCT00852423|Malaria in pregnancy|malaria in pregnancy
643971|NCT00852423|Sub-saharan Africa|sub-saharan africa
643972|NCT00852423|Treatment|treatment
643973|NCT00852423|Artemisinin containing Therapy|artemisinin containing therapy
643974|NCT00852423|Efficacy|efficacy
643975|NCT00852423|Safety|safety
643976|NCT00852410|Endoscopic sinus surgery|endoscopic sinus surgery
643977|NCT00852384|Anesthesia induction|anesthesia induction
643978|NCT00852384|Obese patients|obese patients
643979|NCT00852384|Noninvasive ventilation|noninvasive ventilation
643980|NCT00852384|Alveolar recruitment|alveolar recruitment
643981|NCT00852371|Malaria|malaria
643982|NCT00852371|Intermittent preventive treatment|intermittent preventive treatment
643983|NCT00852371|Efficacy|efficacy
643984|NCT00852371|Safety|safety
643985|NCT00852371|Tolerability|tolerability
643986|NCT00852371|Schoolchildren|schoolchildren
643987|NCT00852371|Uganda|uganda
643988|NCT00852358|mucopolysaccharidosis|mucopolysaccharidosis
643989|NCT00852358|Hurler-Scheie|hurler-scheie
643991|NCT00852358|laronidase|laronidase
643992|NCT00852358|cognitive decline|cognitive decline
643993|NCT00852358|central nervous system|central nervous system
643994|NCT00852358|enzyme replacement therapy|enzyme replacement therapy
643995|NCT00852358|intrathecal|intrathecal
643996|NCT00852358|LA Biomed|la biomed
643997|NCT00852345|multibacillary leprosy|multibacillary leprosy
643998|NCT00852345|leprosy|leprosy
643999|NCT00852345|clofazamine|clofazamine
644000|NCT00852332|male breast cancer|male breast cancer
644001|NCT00852332|stage IIIB breast cancer|stage iiib breast cancer
644002|NCT00852332|stage IIIC breast cancer|stage iiic breast cancer
644003|NCT00852332|stage IV breast cancer|stage iv breast cancer
644004|NCT00852332|recurrent breast cancer|recurrent breast cancer
644005|NCT00852332|stage IIIA breast cancer|stage iiia breast cancer
644006|NCT00852332|HER2-negative breast cancer|her2-negative breast cancer
644007|NCT00852319|Interpregnancy Care|interpregnancy care
644008|NCT00852319|Preconceptual Care|preconceptual care
644009|NCT00852319|Premature Birth|premature birth
644010|NCT00852319|Preterm Delivery|preterm delivery
644011|NCT00852306|oocyte freezing|oocyte freezing
644012|NCT00852306|vitrification|vitrification
644013|NCT00852306|slow freeze|slow freeze
644014|NCT00852306|fertility preservation|fertility preservation
644015|NCT00852293|liver disease|liver disease
644016|NCT00852293|Chitinase 3 like-1 protein|chitinase 3 like-1 protein
644017|NCT00852280|scars|scars
644018|NCT00852280|late effect of burn|late effect of burn
644019|NCT00852280|burn|burn
644020|NCT00852280|pulsed-dye laser|pulsed-dye laser
644021|NCT00852267|cholesterol|cholesterol
644022|NCT00852267|diet|diet
644023|NCT00852267|protein|protein
644024|NCT00852267|carbohydrate|carbohydrate
644025|NCT00852267|saturated fat|saturated fat
644026|NCT00852267|LDL subclass|ldl subclass
644027|NCT00852267|healthy volunteers|healthy volunteers
644028|NCT00852254|Cardiac Index|cardiac index
644029|NCT00852254|Ultrasound Dilution|ultrasound dilution
644030|NCT00852254|Accuracy of ultrasound dilution cardiac index.|accuracy of ultrasound dilution cardiac index.
644031|NCT00852228|colorectal cancer|colorectal cancer
644032|NCT00852228|unresectable metastases|unresectable metastases
644033|NCT00852228|neo-adjuvant chemotherapy|neo-adjuvant chemotherapy
644034|NCT00852228|liver metastases|liver metastases
644035|NCT00852228|chronotherapy|chronotherapy
644036|NCT00852228|cetuximab|cetuximab
644037|NCT00852228|irinotecan|irinotecan
644038|NCT00852228|oxaliplatin|oxaliplatin
644039|NCT00852228|5-fluorouracil|5-fluorouracil
644040|NCT00852228|hepatic artery infusion|hepatic artery infusion
644041|NCT00852228|Unresectable hepatic lesions|unresectable hepatic lesions
644042|NCT00852228|1 to 3 prior chemotherapy regimens|1 to 3 prior chemotherapy regimens
644043|NCT00852215|Angioplasty, Transluminal, Percutaneous Coronary|angioplasty, transluminal, percutaneous coronary
644044|NCT00852215|Paclitaxel-eluting stent|paclitaxel-eluting stent
644045|NCT00852215|Vision stent|vision stent
644046|NCT00852202|bipolar|bipolar
644047|NCT00852202|depression|depression
644048|NCT00852189|Cancer|cancer
644049|NCT00852189|Phase 1|phase 1
644050|NCT00852189|EC0489|ec0489
644051|NCT00852189|EC20|ec20
644052|NCT00852189|Refractory|refractory
644053|NCT00852189|Metastatic|metastatic
644054|NCT00852189|Experimental|experimental
644055|NCT00852176|Coronary brachytherapy|coronary brachytherapy
644056|NCT00852176|Coronary restenosis|coronary restenosis
644057|NCT00852176|Coronary in stent restenosis|coronary in stent restenosis
644058|NCT00852163|conditioning, preparative|conditioning, preparative
644059|NCT00852163|clofarabine; transplant|clofarabine; transplant
644060|NCT00852163|Busulfan|busulfan
644061|NCT00852163|leukemia|leukemia
644062|NCT00852163|myelodysplastic syndrome|myelodysplastic syndrome
644063|NCT00852150|gastritis|gastritis
644064|NCT00852150|duodenitis|duodenitis
644065|NCT00852150|inter-rater reliability|inter-rater reliability
644066|NCT00852150|intra-rater reliablity|intra-rater reliablity
644067|NCT00852150|gastroscopy|gastroscopy
644068|NCT00852150|duodenoscopy|duodenoscopy
644069|NCT00852137|Peplin|peplin
644070|NCT00852137|PEP005|pep005
644071|NCT00852137|Actinic Keratosis|actinic keratosis
644072|NCT00852124|Asthma|asthma
644073|NCT00852124|Probiotic|probiotic
644074|NCT00852124|VSL#3|vsl#3
644075|NCT00852111|Fatigue|fatigue
644076|NCT00852111|Radiotherapy|radiotherapy
644077|NCT00852111|Cancer Therapy|cancer therapy
644078|NCT00852111|Cancer|cancer
644079|NCT00852098|Fundoplication|fundoplication
644080|NCT00852098|gastroesophageal reflux|gastroesophageal reflux
644081|NCT00852098|gastric vessels|gastric vessels
644082|NCT00852098|surgery|surgery
644083|NCT00852085|Counseling|counseling
644084|NCT00852085|Crime|crime
644085|NCT00852085|Adolescent|adolescent
644086|NCT00852072|common bile duct stones|common bile duct stones
644087|NCT00852072|mechanical lithotripsy|mechanical lithotripsy
644088|NCT00852072|balloon sphincteroplasty|balloon sphincteroplasty
644089|NCT00852072|single-operator cholangioscopy-guided laser lithotripy|single-operator cholangioscopy-guided laser lithotripy
644090|NCT00852059|ADHD|adhd
644091|NCT00852059|children|children
644092|NCT00852059|adolescents|adolescents
644093|NCT00852059|methylphenidate|methylphenidate
644094|NCT00852059|adherence|adherence
644095|NCT00852059|immediate release|immediate release
644096|NCT00852059|extended release|extended release
644097|NCT00852059|efficacy|efficacy
644098|NCT00852046|Mechanical ventilation|mechanical ventilation
644099|NCT00852033|alcoholism|alcoholism
644100|NCT00852033|alcohol abuse|alcohol abuse
644101|NCT00852033|prevention|prevention
644102|NCT00852033|behavior modification|behavior modification
644103|NCT00852033|parent offspring interaction|parent offspring interaction
644104|NCT00852033|university student|university student
644105|NCT00852033|substance abuse related behavior|substance abuse related behavior
644106|NCT00852033|adolescence|adolescence
644107|NCT00852007|prostate cancer|prostate cancer
644108|NCT00852007|dendritic cells|dendritic cells
644109|NCT00852007|MUC-1|muc-1
644110|NCT00852007|immune therapy|immune therapy
644111|NCT00851994|Patients having surgery|patients having surgery
644112|NCT00851981|Alcohol Liver Disease|alcohol liver disease
644113|NCT00851968|hepatectomy|hepatectomy
644114|NCT00851968|Selective HepaticVascular Clamping|selective hepaticvascular clamping
644115|NCT00851942|Volunteer|volunteer
644116|NCT00851942|Hypoadrenalism|hypoadrenalism
644117|NCT00851942|Hypopituitarism|hypopituitarism
644118|NCT00851942|Healthy volunteers|healthy volunteers
644119|NCT00851929|sarcoidosis|sarcoidosis
644120|NCT00851929|pulmonary hypertension|pulmonary hypertension
644121|NCT00851929|dyspnea|dyspnea
644122|NCT00851929|sarcoidosis associated pulmonary hypertension|sarcoidosis associated pulmonary hypertension
644123|NCT00851877|stage III squamous cell carcinoma of the oropharynx|stage iii squamous cell carcinoma of the oropharynx
644124|NCT00851877|stage IV squamous cell carcinoma of the oropharynx|stage iv squamous cell carcinoma of the oropharynx
644125|NCT00851877|stage III squamous cell carcinoma of the hypopharynx|stage iii squamous cell carcinoma of the hypopharynx
644126|NCT00851877|stage IV squamous cell carcinoma of the hypopharynx|stage iv squamous cell carcinoma of the hypopharynx
644127|NCT00851877|stage II squamous cell carcinoma of the larynx|stage ii squamous cell carcinoma of the larynx
644128|NCT00851877|stage IV squamous cell carcinoma of the larynx|stage iv squamous cell carcinoma of the larynx
644129|NCT00851877|tongue cancer|tongue cancer
644130|NCT00851864|anticoagulation|anticoagulation
644131|NCT00851864|pregnancy|pregnancy
644132|NCT00851851|Surgical patients|surgical patients
644133|NCT00851838|Peritoneal dialysis|peritoneal dialysis
644134|NCT00851838|L-carnitine|l-carnitine
644135|NCT00851838|ESRD|esrd
644136|NCT00851825|autonomic modulation|autonomic modulation
644137|NCT00851825|heart rate|heart rate
644138|NCT00851825|pressure support ventilation|pressure support ventilation
644139|NCT00851825|T-tube|t-tube
644140|NCT00851825|Mechanical ventilation|mechanical ventilation
644141|NCT00851812|Exercise|exercise
644142|NCT00851812|Breast cancer|breast cancer
644143|NCT00851812|fatigue|fatigue
644144|NCT00851799|ART|art
644145|NCT00851799|Antiretroviral therapy|antiretroviral therapy
644146|NCT00851799|Treatment naive|treatment naive
644147|NCT00851799|Highly active antiretroviral therapy (HAART)|highly active antiretroviral therapy (haart)
644148|NCT00851786|Herpes Zoster Vaccine|herpes zoster vaccine
644149|NCT00851786|Herpes Zoster Virus|herpes zoster virus
644150|NCT00851786|HIV|hiv
644151|NCT00851721|Hemophilia A|hemophilia a
644152|NCT00851721|Factor VIII Inhibitor|factor viii inhibitor
644153|NCT00851721|Factor IX Inhibitor|factor ix inhibitor
644154|NCT00851721|Hemophilia B|hemophilia b
644155|NCT00851708|kidney|kidney
644156|NCT00851708|deceased kidney transplant|deceased kidney transplant
644157|NCT00851708|oxidative stress|oxidative stress
644158|NCT00851708|renal function measurements|renal function measurements
644159|NCT00851695|Lung Function Decline|lung function decline
644160|NCT00851695|Lung Function|lung function
644161|NCT00851695|Allergy|allergy
644162|NCT00851695|COPD|copd
644163|NCT00851695|Vitamin D|vitamin d
644164|NCT00851682|Prostate Cancer|prostate cancer
644165|NCT00851682|Dynamic Contrast Enhanced MRI|dynamic contrast enhanced mri
644166|NCT00851682|Non-invasive Prostate Cancer Detection|non-invasive prostate cancer detection
644167|NCT00851669|depression|depression
644168|NCT00851669|alcohol dependence|alcohol dependence
644169|NCT00851669|women|women
644170|NCT00851669|psychotherapy|psychotherapy
644171|NCT00851669|men|men
644172|NCT00851630|HIV|hiv
644173|NCT00851630|Tuberculosis|tuberculosis
644174|NCT00851630|Treatment Naive|treatment naive
644175|NCT00851617|Mechanical ventilator weaning|mechanical ventilator weaning
644176|NCT00851617|Respiratory Muscle Training|respiratory muscle training
644177|NCT00851617|Ventilator dependent|ventilator dependent
644178|NCT00851604|ProGRP|progrp
644179|NCT00851604|CgA|cga
644180|NCT00851604|NSE|nse
644181|NCT00851604|TUM2-PK|tum2-pk
644182|NCT00851604|Neuroendocrine Tumors|neuroendocrine tumors
644183|NCT00851591|fenugreek|fenugreek
644184|NCT00851591|galactogogue|galactogogue
644185|NCT00851591|breastmilk|breastmilk
644186|NCT00851591|Trigonella foenum-graecum|trigonella foenum-graecum
644187|NCT00851591|Bird's Foot|bird's foot
644188|NCT00851591|Greek Clover|greek clover
644189|NCT00851591|Greek Hay|greek hay
644190|NCT00851591|Hu Lu Ba|hu lu ba
644191|NCT00851591|Trigonella|trigonella
644192|NCT00851578|AF|af
644193|NCT00851578|atrial fibrillation|atrial fibrillation
644194|NCT00851578|LAA occlusion|laa occlusion
644195|NCT00851552|recurrent adult diffuse large cell lymphoma|recurrent adult diffuse large cell lymphoma
644196|NCT00851552|recurrent adult immunoblastic large cell lymphoma|recurrent adult immunoblastic large cell lymphoma
644197|NCT00851552|anaplastic large cell lymphoma|anaplastic large cell lymphoma
644198|NCT00851539|HIV|hiv
644199|NCT00851539|Teenagers|teenagers
644200|NCT00851539|Adolescent|adolescent
644201|NCT00851539|HIV Testing|hiv testing
644202|NCT00851539|HIV Seronegativity|hiv seronegativity
644203|NCT00851526|Coronary bifurcation lesion|coronary bifurcation lesion
644204|NCT00851526|Drug-eluting stent|drug-eluting stent
644205|NCT00851513|Pudendal neuralgia|pudendal neuralgia
644206|NCT00851513|pudendal nerve|pudendal nerve
644207|NCT00851513|Alcock's canal syndrome|alcock's canal syndrome
644208|NCT00851513|Canal syndrome|canal syndrome
644209|NCT00851513|neuropathic pain|neuropathic pain
644210|NCT00851513|infiltration|infiltration
644211|NCT00851513|randomized protocol|randomized protocol
644212|NCT00851513|pain scales|pain scales
644213|NCT00851500|atherosclerosis|atherosclerosis
644214|NCT00851500|carotid artery disease|carotid artery disease
644215|NCT00851487|ARI|ari
644216|NCT00851487|LRTI|lrti
644217|NCT00851474|COstatus(R)|costatus(r)
644218|NCT00851474|Ultrasound Dilution|ultrasound dilution
644219|NCT00851474|Cardiac Output|cardiac output
644220|NCT00851474|Blood Volumes|blood volumes
644221|NCT00851474|Comparison of COstatus(R) cardiac output with other methods|comparison of costatus(r) cardiac output with other methods
644222|NCT00851461|Spinobulbar muscular atrophy|spinobulbar muscular atrophy
644223|NCT00851461|Kennedy's disease|kennedy's disease
644224|NCT00851461|Goserelin|goserelin
644225|NCT00851461|Electrophysiologic study|electrophysiologic study
644226|NCT00851461|Inclusion body|inclusion body
644227|NCT00851435|Pneumonia|pneumonia
644228|NCT00851435|Nosocomial pneumonia|nosocomial pneumonia
644229|NCT00851435|Pseudomonas aeruginosa|pseudomonas aeruginosa
644230|NCT00851435|Monoclonal antibody|monoclonal antibody
644231|NCT00851435|Hospital-Acquired Pneumonia|hospital-acquired pneumonia
644232|NCT00851422|Ultrasound Dilution|ultrasound dilution
644233|NCT00851422|Cardiac Output|cardiac output
644234|NCT00851422|Validation of measured ultrasound dilution cardiac output|validation of measured ultrasound dilution cardiac output
644235|NCT00851396|Vitamin D deficiency|vitamin d deficiency
644236|NCT00851396|Insulin resistance|insulin resistance
644237|NCT00851396|Glucose- Insulin dynamics|glucose- insulin dynamics
644238|NCT00851396|Obese adolescents|obese adolescents
644239|NCT00851383|HIV|hiv
644240|NCT00851383|Human Immunodeficiency Virus|human immunodeficiency virus
644241|NCT00851383|HIV Seronegativity|hiv seronegativity
644242|NCT00851383|Preventive Vaccine|preventive vaccine
644243|NCT00851370|COPD|copd
644244|NCT00851370|Exacerbation|exacerbation
644245|NCT00851357|Nicotine Replacement Therapy|nicotine replacement therapy
644246|NCT00851357|Nicotine Patch|nicotine patch
644247|NCT00851357|Smoking cessation|smoking cessation
644248|NCT00851357|Telephone|telephone
644249|NCT00851357|Tobacco cessation|tobacco cessation
644250|NCT00851357|Counseling|counseling
644251|NCT00851357|Nicotine|nicotine
644252|NCT00851357|Self-Help|self-help
644253|NCT00851357|Smoking abstinence|smoking abstinence
644254|NCT00851357|Tobacco Use Disorder|tobacco use disorder
644255|NCT00851344|Proof-of-Concept|proof-of-concept
644256|NCT00851344|Allergic Rhinitis|allergic rhinitis
644257|NCT00851331|Benign childhood epilepsy|benign childhood epilepsy
644258|NCT00851318|Rheumatoid Arthritis|rheumatoid arthritis
644259|NCT00851318|Certolizumab Pegol|certolizumab pegol
644260|NCT00851318|Cimzia|cimzia
644261|NCT00851305|Stomach|stomach
644262|NCT00851305|endoscopy|endoscopy
644263|NCT00851305|neoplasms|neoplasms
644264|NCT00851292|prostate cancer|prostate cancer
644265|NCT00851292|biopsy|biopsy
644266|NCT00851292|TRUS|trus
644267|NCT00851292|diagnosis|diagnosis
644268|NCT00851279|arrhythmia|arrhythmia
644269|NCT00851279|ventricular tachycardia|ventricular tachycardia
644270|NCT00851279|ablation|ablation
644271|NCT00851279|mapping|mapping
644272|NCT00851279|electrophysiology|electrophysiology
644273|NCT00851253|recurrent adenoid cystic carcinoma of the oral cavity|recurrent adenoid cystic carcinoma of the oral cavity
644274|NCT00851253|recurrent mucoepidermoid carcinoma of the oral cavity|recurrent mucoepidermoid carcinoma of the oral cavity
644275|NCT00851253|recurrent verrucous carcinoma of the oral cavity|recurrent verrucous carcinoma of the oral cavity
644276|NCT00851253|stage II adenoid cystic carcinoma of the oral cavity|stage ii adenoid cystic carcinoma of the oral cavity
644277|NCT00851253|stage II mucoepidermoid carcinoma of the oral cavity|stage ii mucoepidermoid carcinoma of the oral cavity
644278|NCT00851253|stage II verrucous carcinoma of the oral cavity|stage ii verrucous carcinoma of the oral cavity
644279|NCT00851253|stage III adenoid cystic carcinoma of the oral cavity|stage iii adenoid cystic carcinoma of the oral cavity
644280|NCT00851253|stage III mucoepidermoid carcinoma of the oral cavity|stage iii mucoepidermoid carcinoma of the oral cavity
644355|NCT00851136|APM4566g|apm4566g
644356|NCT00851123|Stroke|stroke
644281|NCT00851253|stage III verrucous carcinoma of the oral cavity|stage iii verrucous carcinoma of the oral cavity
644282|NCT00851253|stage II squamous cell carcinoma of the lip and oral cavity|stage ii squamous cell carcinoma of the lip and oral cavity
644283|NCT00851253|stage III squamous cell carcinoma of the lip and oral cavity|stage iii squamous cell carcinoma of the lip and oral cavity
644284|NCT00851253|recurrent basal cell carcinoma of the lip|recurrent basal cell carcinoma of the lip
644285|NCT00851253|recurrent squamous cell carcinoma of the lip and oral cavity|recurrent squamous cell carcinoma of the lip and oral cavity
644286|NCT00851253|stage II basal cell carcinoma of the lip|stage ii basal cell carcinoma of the lip
644287|NCT00851253|stage III basal cell carcinoma of the lip|stage iii basal cell carcinoma of the lip
644288|NCT00851253|recurrent lymphoepithelioma of the nasopharynx|recurrent lymphoepithelioma of the nasopharynx
644289|NCT00851253|recurrent squamous cell carcinoma of the nasopharynx|recurrent squamous cell carcinoma of the nasopharynx
644290|NCT00851253|stage II lymphoepithelioma of the nasopharynx|stage ii lymphoepithelioma of the nasopharynx
644291|NCT00851253|stage II squamous cell carcinoma of the nasopharynx|stage ii squamous cell carcinoma of the nasopharynx
644292|NCT00851253|stage III lymphoepithelioma of the nasopharynx|stage iii lymphoepithelioma of the nasopharynx
644293|NCT00851253|stage III squamous cell carcinoma of the nasopharynx|stage iii squamous cell carcinoma of the nasopharynx
644294|NCT00851253|recurrent lymphoepithelioma of the oropharynx|recurrent lymphoepithelioma of the oropharynx
644295|NCT00851253|recurrent squamous cell carcinoma of the oropharynx|recurrent squamous cell carcinoma of the oropharynx
644296|NCT00851253|stage II lymphoepithelioma of the oropharynx|stage ii lymphoepithelioma of the oropharynx
644297|NCT00851253|stage II squamous cell carcinoma of the oropharynx|stage ii squamous cell carcinoma of the oropharynx
644298|NCT00851253|stage III lymphoepithelioma of the oropharynx|stage iii lymphoepithelioma of the oropharynx
644299|NCT00851253|stage III squamous cell carcinoma of the oropharynx|stage iii squamous cell carcinoma of the oropharynx
644300|NCT00851253|high-grade salivary gland mucoepidermoid carcinoma|high-grade salivary gland mucoepidermoid carcinoma
644301|NCT00851253|low-grade salivary gland mucoepidermoid carcinoma|low-grade salivary gland mucoepidermoid carcinoma
644302|NCT00851253|recurrent salivary gland cancer|recurrent salivary gland cancer
644303|NCT00851253|salivary gland acinic cell tumor|salivary gland acinic cell tumor
644304|NCT00851253|salivary gland adenocarcinoma|salivary gland adenocarcinoma
644305|NCT00851253|salivary gland adenoid cystic carcinoma|salivary gland adenoid cystic carcinoma
644306|NCT00851253|salivary gland anaplastic carcinoma|salivary gland anaplastic carcinoma
644307|NCT00851253|salivary gland malignant mixed cell type tumor|salivary gland malignant mixed cell type tumor
644308|NCT00851253|salivary gland poorly differentiated carcinoma|salivary gland poorly differentiated carcinoma
644309|NCT00851253|salivary gland squamous cell carcinoma|salivary gland squamous cell carcinoma
644310|NCT00851253|stage II salivary gland cancer|stage ii salivary gland cancer
644311|NCT00851253|stage III salivary gland cancer|stage iii salivary gland cancer
644312|NCT00851253|stage IV adenoid cystic carcinoma of the oral cavity|stage iv adenoid cystic carcinoma of the oral cavity
644313|NCT00851253|stage IV mucoepidermoid carcinoma of the oral cavity|stage iv mucoepidermoid carcinoma of the oral cavity
644314|NCT00851253|stage IV squamous cell carcinoma of the lip and oral cavity|stage iv squamous cell carcinoma of the lip and oral cavity
644315|NCT00851253|stage IV verrucous carcinoma of the oral cavity|stage iv verrucous carcinoma of the oral cavity
644316|NCT00851253|stage IV salivary gland cancer|stage iv salivary gland cancer
644317|NCT00851253|stage IV lymphoepithelioma of the nasopharynx|stage iv lymphoepithelioma of the nasopharynx
644318|NCT00851253|stage IV lymphoepithelioma of the oropharynx|stage iv lymphoepithelioma of the oropharynx
644319|NCT00851253|stage IV squamous cell carcinoma of the nasopharynx|stage iv squamous cell carcinoma of the nasopharynx
644320|NCT00851253|stage IV squamous cell carcinoma of the oropharynx|stage iv squamous cell carcinoma of the oropharynx
644321|NCT00851253|stage IV basal cell carcinoma of the lip|stage iv basal cell carcinoma of the lip
644322|NCT00851240|rheumatoid arthritis|rheumatoid arthritis
644323|NCT00851240|safety|safety
644324|NCT00851227|Pharmacokinetics|pharmacokinetics
644325|NCT00851227|Protein Binding|protein binding
644326|NCT00851227|Conivaptan|conivaptan
644327|NCT00851227|Vaprisol|vaprisol
644328|NCT00851227|Liver Disease|liver disease
644329|NCT00851214|Non-invasive hemodynamic monitoring|non-invasive hemodynamic monitoring
644330|NCT00851214|Emergency Department patients|emergency department patients
644331|NCT00851214|trauma with an ISS>15|trauma with an iss>15
644332|NCT00851214|Non-invasive continuous hemodynamic monitoring|non-invasive continuous hemodynamic monitoring
644333|NCT00851201|children|children
644335|NCT00851201|weight loss|weight loss
644336|NCT00851201|prevention|prevention
644337|NCT00851201|diabetes risk|diabetes risk
644338|NCT00851201|cardiometabolic|cardiometabolic
644339|NCT00851162|Bone defect|bone defect
644340|NCT00851162|Benign bone lesions|benign bone lesions
644341|NCT00851162|Stem cells|stem cells
644342|NCT00851149|aorta|aorta
644343|NCT00851149|disease|disease
644344|NCT00851149|abdominal|abdominal
644345|NCT00851149|surgery|surgery
644346|NCT00851149|Osteoarthritis, Hip|osteoarthritis, hip
644347|NCT00851149|replacement|replacement
644348|NCT00851149|blood|blood
644349|NCT00851149|autolog|autolog
644350|NCT00851149|transfusion|transfusion
644351|NCT00851149|cytokines|cytokines
644353|NCT00851136|Colon cancer|colon cancer
644354|NCT00851136|Avastin|avastin
644357|NCT00851123|arm paresis|arm paresis
644358|NCT00851123|mCIMT|mcimt
644359|NCT00851123|bimanual training|bimanual training
644360|NCT00851123|rehabilitation|rehabilitation
644361|NCT00851110|high dose|high dose
644362|NCT00851110|breast cancer|breast cancer
644363|NCT00851110|adjuvant|adjuvant
644364|NCT00851084|Angiogenesis|angiogenesis
644365|NCT00851084|Colon cancer|colon cancer
644366|NCT00851084|Rectal cancer|rectal cancer
644367|NCT00851084|Oxaliplatin|oxaliplatin
644368|NCT00851071|Anxiety|anxiety
644369|NCT00851071|Implantable Cardioverter Defibrillator (ICD)|implantable cardioverter defibrillator (icd)
644370|NCT00851071|Defibrillators, Implantable|defibrillators, implantable
644371|NCT00851058|Behavioral research|behavioral research
644372|NCT00851058|Motivational counseling|motivational counseling
644373|NCT00851058|Group Counseling|group counseling
644374|NCT00851058|Motivational Interviewing|motivational interviewing
644375|NCT00851058|Vicarious Learning|vicarious learning
644376|NCT00851058|Risky alcohol use|risky alcohol use
644377|NCT00851058|Recidivism|recidivism
644378|NCT00851058|Motor Vehicles|motor vehicles
644379|NCT00851058|Crime|crime
644380|NCT00851032|Advanced Cancer|advanced cancer
644381|NCT00851032|Initiative for Molecular Profiling in Advanced Cancer Therapy|initiative for molecular profiling in advanced cancer therapy
644382|NCT00851032|IMPACT|impact
644383|NCT00851032|Molecular Profile-Based Study|molecular profile-based study
644384|NCT00851032|Investigational Cancer Therapeutics Program|investigational cancer therapeutics program
644385|NCT00851032|Molecular profiling|molecular profiling
644386|NCT00851032|Phase I Therapies|phase i therapies
644387|NCT00851032|Tissue Bank|tissue bank
644388|NCT00851019|Exercise|exercise
644389|NCT00851019|Video game|video game
644390|NCT00851019|Type 2 diabetes|type 2 diabetes
644391|NCT00851019|Dance|dance
644392|NCT00851006|Depression|depression
644393|NCT00851006|Females|females
644394|NCT00851006|Adolescents|adolescents
644395|NCT00850993|Hemolysis|hemolysis
644396|NCT00850941|Registry|registry
644397|NCT00850941|Research Database|research database
644398|NCT00850941|Prostate cancer|prostate cancer
644399|NCT00850941|Casodex|casodex
644400|NCT00850941|Flutamide|flutamide
644401|NCT00850941|Goserelin Acetate|goserelin acetate
644402|NCT00850941|Leuprolide Acetate|leuprolide acetate
644403|NCT00850941|Radiation|radiation
644404|NCT00850941|PSA|psa
644405|NCT00850941|Post-prostatectomy|post-prostatectomy
644406|NCT00850941|Radiation Therapy|radiation therapy
644407|NCT00850941|Prostate Specific Antigen|prostate specific antigen
644408|NCT00850941|Adenocarcinoma|adenocarcinoma
644409|NCT00850941|Radical Prostatectomy|radical prostatectomy
644410|NCT00850941|Bicalutamide|bicalutamide
644411|NCT00850941|Zoladex|zoladex
644412|NCT00850941|Lupron Depot|lupron depot
644413|NCT00850941|Tissue banking|tissue banking
644414|NCT00850941|Hormones|hormones
644415|NCT00850928|Postoperative Cognitive Dysfunction|postoperative cognitive dysfunction
644416|NCT00850928|MCI|mci
644417|NCT00850928|Mild Cognitive Impairment|mild cognitive impairment
644418|NCT00850928|Aβ40|aβ40
644419|NCT00850928|Aβ42|aβ42
644420|NCT00850928|Apolipoprotein E|apolipoprotein e
644421|NCT00850928|Inflammatory Markers|inflammatory markers
644422|NCT00850928|Apolipoprotein E Profile|apolipoprotein e profile
644423|NCT00850928|Serum Beta Amyloid Profile|serum beta amyloid profile
644424|NCT00850928|Inflammatory Markers Profile|inflammatory markers profile
644425|NCT00850915|tuberculosis|tuberculosis
644426|NCT00850915|community IPT|community ipt
644427|NCT00850915|isoniazid adverse events|isoniazid adverse events
644428|NCT00850915|tuberculosis incidence|tuberculosis incidence
644429|NCT00850902|ELBW|elbw
644430|NCT00850902|Humidity|humidity
644431|NCT00850902|BPD|bpd
644432|NCT00850889|Aesthetic correction of nasolabial folds|aesthetic correction of nasolabial folds
644433|NCT00850863|COPD|copd
644434|NCT00850863|Inflammation|inflammation
644435|NCT00850863|Smoking|smoking
644436|NCT00850863|Susceptibility|susceptibility
644437|NCT00850850|PACU|pacu
644438|NCT00850850|Physostigmine|physostigmine
644439|NCT00850850|Recovery|recovery
644440|NCT00850850|Postanesthesia Nursing|postanesthesia nursing
644441|NCT00850850|Wakefulness|wakefulness
644442|NCT00850850|General anesthesia|general anesthesia
644443|NCT00850850|General Anesthetics|general anesthetics
644444|NCT00850850|Postoperative Period|postoperative period
644445|NCT00850837|Microbicide|microbicide
644446|NCT00850837|HIV Seronegativity|hiv seronegativity
644447|NCT00850824|T2DM|t2dm
644448|NCT00850811|Peplin|peplin
644449|NCT00850811|PEP005|pep005
644450|NCT00850798|Type 2 diabetes|type 2 diabetes
644451|NCT00850798|Elder patients|elder patients
644452|NCT00850798|Glycemic control|glycemic control
644453|NCT00850798|Men or women aged ≥80 years at time of randomization. There is no upper age limit.|men or women aged ≥80 years at time of randomization. there is no upper age limit.
644454|NCT00850798|Be able to walk by themselves|be able to walk by themselves
644455|NCT00850798|They had their first diagnosis of type 2 diabetes mellitus at age 30 years or older.|they had their first diagnosis of type 2 diabetes mellitus at age 30 years or older.
644456|NCT00850772|Enteral nutrition|enteral nutrition
644457|NCT00850772|Ovarian cancer|ovarian cancer
644458|NCT00850772|Peritoneal cancer|peritoneal cancer
644459|NCT00850772|Fallopian tube cancer|fallopian tube cancer
644460|NCT00850772|Malnutrition|malnutrition
644461|NCT00850772|Surgery|surgery
644462|NCT00850772|Gynecological Cancer|gynecological cancer
644463|NCT00850772|Suspected advanced epithelial ovarian cancer|suspected advanced epithelial ovarian cancer
644464|NCT00850759|pedestrian safety|pedestrian safety
644465|NCT00850759|street-crossing ability|street-crossing ability
644466|NCT00850759|road-crossing|road-crossing
644467|NCT00850759|children|children
644468|NCT00850759|injury prevention|injury prevention
644469|NCT00850746|QT interval|qt interval
644470|NCT00850746|Cardiac Repolarization|cardiac repolarization
644471|NCT00850746|Cardiac Conduction|cardiac conduction
644472|NCT00850746|Healthy Subjects|healthy subjects
644473|NCT00850746|YM443 (Z-338, acotiamide hydrochloride)|ym443 (z-338, acotiamide hydrochloride)
644474|NCT00850746|Evaluation of QT Interval|evaluation of qt interval
644475|NCT00850720|Biological Response Modifiers|biological response modifiers
644476|NCT00850720|Bypass Surgery|bypass surgery
644477|NCT00850720|Cardiology|cardiology
644478|NCT00850720|Congenital Heart Disease|congenital heart disease
644479|NCT00850720|Endocrinology|endocrinology
644480|NCT00850720|Hormone Dysfunction|hormone dysfunction
644481|NCT00850720|Hormones|hormones
644482|NCT00850720|Neuroendocrinology|neuroendocrinology
644483|NCT00850720|Pediatric Surgery|pediatric surgery
644485|NCT00850707|AVG|avg
644486|NCT00850707|TCC|tcc
644487|NCT00850707|inflammation|inflammation
644488|NCT00850707|monocite senescence|monocite senescence
644489|NCT00850694|Vitamin D deficiency|vitamin d deficiency
644490|NCT00850694|Obesity|obesity
644491|NCT00850694|Insulin resistance|insulin resistance
644492|NCT00850694|Glucose tolerance|glucose tolerance
644493|NCT00850681|Peplin|peplin
644494|NCT00850681|PEP005|pep005
644495|NCT00850668|Food Allergy|food allergy
644496|NCT00850668|Peanut Allergy|peanut allergy
644497|NCT00850642|Sputum cell counts|sputum cell counts
644498|NCT00850642|Neutrophils|neutrophils
644499|NCT00850642|Severe Asthma|severe asthma
644500|NCT00850642|ICS|ics
644501|NCT00850642|Inhaled corticosteroids|inhaled corticosteroids
644502|NCT00850629|weight regain|weight regain
644503|NCT00850629|endocrine counterregulation|endocrine counterregulation
644504|NCT00850616|HIV|hiv
644505|NCT00850616|HIV Seronegativity|hiv seronegativity
644506|NCT00850616|Preventive Vaccine|preventive vaccine
644507|NCT00850603|Menomune® - A/C/Y/W-135|menomune® - a/c/y/w-135
644508|NCT00850603|Meningococcal Infections|meningococcal infections
644509|NCT00850603|Meningitis|meningitis
644510|NCT00850564|growth hormone releasing hormone|growth hormone releasing hormone
644511|NCT00850551|Early Intervention|early intervention
644512|NCT00850551|Pulmonary Exacerbation|pulmonary exacerbation
644513|NCT00850551|Cystic Fibrosis|cystic fibrosis
644514|NCT00850551|Lung Function|lung function
644515|NCT00850551|Spirometry|spirometry
644516|NCT00850551|Phillips Telemonitor|phillips telemonitor
644517|NCT00850551|Home Spirometry|home spirometry
644518|NCT00850551|PiKo-6|piko-6
644519|NCT00850551|Home Monitoring|home monitoring
644520|NCT00850538|Bone Marrow Lesion|bone marrow lesion
644521|NCT00850538|BML|bml
644522|NCT00850538|Arthroplasty|arthroplasty
644523|NCT00850538|Replacement|replacement
644524|NCT00850538|Knee|knee
644525|NCT00850538|Discarded tissue|discarded tissue
644526|NCT00850486|women|women
644527|NCT00850486|ischemic heart disease|ischemic heart disease
644528|NCT00850486|high frequency ECG|high frequency ecg
644529|NCT00850486|exercise stress testing|exercise stress testing
644530|NCT00850486|signal processing|signal processing
644531|NCT00850486|ischemic heart disease in women|ischemic heart disease in women
644532|NCT00850473|PET|pet
644533|NCT00850473|CT|ct
644534|NCT00850473|Heart Attack|heart attack
644535|NCT00850473|Coronary Artery disease|coronary artery disease
644536|NCT00850473|Cardiac Catheterization|cardiac catheterization
644537|NCT00850447|Posttraumatic stress disorder|posttraumatic stress disorder
644538|NCT00850447|Cognition|cognition
644539|NCT00850447|Neuropsychological Tests|neuropsychological tests
644540|NCT00850421|migraine headache|migraine headache
644541|NCT00850421|Botulinum Toxin Type A|botulinum toxin type a
644542|NCT00850421|BOTOX|botox
644543|NCT00850421|BTX-A|btx-a
644544|NCT00850408|Stroke|stroke
644545|NCT00850408|rTMS|rtms
644546|NCT00850408|TMS|tms
644547|NCT00850408|Rehabilitation|rehabilitation
644548|NCT00850408|Upper Extremity|upper extremity
644549|NCT00850395|HIV-1|hiv-1
644550|NCT00850395|non-interventional|non-interventional
644551|NCT00850395|CCR-5 tropic virus|ccr-5 tropic virus
644552|NCT00850395|therapy experienced patients|therapy experienced patients
644553|NCT00850382|CBF AML|cbf aml
644554|NCT00850382|Dasatinib|dasatinib
644555|NCT00850382|Core Binding Factor (CBF)|core binding factor (cbf)
644556|NCT00850369|Pulmonary hypertension|pulmonary hypertension
644557|NCT00850369|Sickle cell disease|sickle cell disease
644558|NCT00850356|Bariatric Surgery|bariatric surgery
644559|NCT00850356|Body Weight|body weight
644560|NCT00850356|Health care costs|health care costs
644561|NCT00850356|Obesity|obesity
644562|NCT00850356|Obesity Complications|obesity complications
644563|NCT00850356|Prolonged wait times|prolonged wait times
644564|NCT00850356|Quality of Life|quality of life
644565|NCT00850343|Rheumatoid Arthritis|rheumatoid arthritis
644566|NCT00850343|Certolizumab Pegol|certolizumab pegol
644567|NCT00850343|Cimzia|cimzia
644568|NCT00850330|Drug interactions|drug interactions
644569|NCT00850330|Drug interaction software|drug interaction software
644570|NCT00850330|Older patients|older patients
644571|NCT00850330|Hospitalization|hospitalization
644572|NCT00850304|AML|aml
644573|NCT00850291|Partial duodenopancreatectomy using electrosurgical vessel sealing device|partial duodenopancreatectomy using electrosurgical vessel sealing device
644574|NCT00850278|Brain tumor|brain tumor
644575|NCT00850278|[18F]FLT|[18f]flt
644576|NCT00850278|[11C]MET|[11c]met
644577|NCT00850278|TEP-imaging|tep-imaging
644578|NCT00850278|tumor cell proliferation|tumor cell proliferation
644579|NCT00850265|Asthma|asthma
644580|NCT00850265|Formoterol|formoterol
644581|NCT00850265|Beclomethasone|beclomethasone
644582|NCT00850265|Extrafine formulation|extrafine formulation
644583|NCT00850265|Spacer|spacer
644584|NCT00850265|Moderate|moderate
644585|NCT00850265|Severe|severe
644586|NCT00850265|Stable|stable
644587|NCT00850252|Lifeline|lifeline
644588|NCT00850252|Tissue engineered blood vessel|tissue engineered blood vessel
644589|NCT00850252|A-V shunt|a-v shunt
644590|NCT00850239|diabetes|diabetes
644591|NCT00850239|DPP4 inhibitor|dpp4 inhibitor
644592|NCT00850239|dutogliptin|dutogliptin
644593|NCT00850226|test anxiety|test anxiety
644594|NCT00850200|Hodgkin Lymphoma, Proton Radiation|hodgkin lymphoma, proton radiation
644595|NCT00850187|Knee cartilage diseases|knee cartilage diseases
644596|NCT00850174|Bioequivalence|bioequivalence
644597|NCT00850174|Healthy Subjects|healthy subjects
644598|NCT00850161|Type 1 Diabetes|type 1 diabetes
644599|NCT00850161|Nasal Insulin|nasal insulin
644600|NCT00850161|Insulin Deficiency|insulin deficiency
644601|NCT00850161|Insulin-Dependent|insulin-dependent
644602|NCT00850148|Anwar|anwar
644603|NCT00850148|Melles|melles
644604|NCT00850148|Keratoconus|keratoconus
644605|NCT00850096|Phase 2 Study for novel insulin delivery of type 2 diabetes|phase 2 study for novel insulin delivery of type 2 diabetes
644606|NCT00850083|Fever|fever
644607|NCT00850083|Children|children
644608|NCT00850070|autism|autism
644609|NCT00850044|FIH|fih
644610|NCT00850044|SAD|sad
644611|NCT00850031|Presbyopia|presbyopia
644612|NCT00850031|Accommodation|accommodation
644613|NCT00850031|Near visual acuity|near visual acuity
644614|NCT00850031|LASIK|lasik
644615|NCT00850018|Sickle Cell Disease|sickle cell disease
644616|NCT00850018|Sickle Cell Anemia|sickle cell anemia
644617|NCT00850018|Hemoglobin SS|hemoglobin ss
644618|NCT00850018|Hemoglobin SB0|hemoglobin sb0
644619|NCT00850005|neuropathic pain|neuropathic pain
644620|NCT00850005|resistant|resistant
644621|NCT00850005|neuroinflammation|neuroinflammation
644622|NCT00850005|neuroinflammatory markers|neuroinflammatory markers
644623|NCT00850005|Neuropathic pain that has not responded to standard therapy|neuropathic pain that has not responded to standard therapy
644624|NCT00849992|Actinic cheilitis|actinic cheilitis
644625|NCT00849992|Imiquimod 5%|imiquimod 5%
644626|NCT00849992|Photodynamic therapy|photodynamic therapy
644627|NCT00849979|Colorectal|colorectal
644628|NCT00849979|Gastric|gastric
644629|NCT00849979|Gastrointestinal|gastrointestinal
644630|NCT00849979|GI|gi
644631|NCT00849979|Liver|liver
644632|NCT00849979|Pancreas|pancreas
644633|NCT00849979|Gastrointestinal Cancers|gastrointestinal cancers
644634|NCT00849979|Gastro-Intestinal Chemotherapy|gastro-intestinal chemotherapy
644635|NCT00849979|M.D. Anderson Symptom Inventory|m.d. anderson symptom inventory
644636|NCT00849979|MDASI-GI|mdasi-gi
644637|NCT00849979|Medical Oncology|medical oncology
644638|NCT00849966|Celebrex|celebrex
644639|NCT00849966|celecoxib|celecoxib
644640|NCT00849966|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors
644641|NCT00849966|Anti-Inflammatory Agents Non-Steroidal|anti-inflammatory agents non-steroidal
644642|NCT00849966|Adverse drug events|adverse drug events
644643|NCT00849966|quality of life|quality of life
644644|NCT00849966|Pain Postoperative|pain postoperative
644645|NCT00849966|Tonsillectomy|tonsillectomy
644646|NCT00849966|Adenotonsillectomy|adenotonsillectomy
644647|NCT00849966|Otologic Surgical Procedures|otologic surgical procedures
644648|NCT00849940|Spectroscopy|spectroscopy
644649|NCT00849940|Near infrared|near infrared
644650|NCT00849940|Oximetry|oximetry
644651|NCT00849940|Hypoxemia|hypoxemia
644652|NCT00849940|Tissue oxygenation|tissue oxygenation
644653|NCT00849940|Pediatric|pediatric
644654|NCT00849927|shoulder instability|shoulder instability
644655|NCT00849927|labral lesions|labral lesions
644656|NCT00849927|arthroscopic labral repair|arthroscopic labral repair
644657|NCT00849927|SLAP|slap
644658|NCT00849927|triple labrum|triple labrum
645257|NCT00847392|Pediatric|pediatric
644659|NCT00849927|circumferential labrum|circumferential labrum
644660|NCT00849927|Pan-labral lesion|pan-labral lesion
644661|NCT00849888|Thymus Transplantation|thymus transplantation
644662|NCT00849888|DiGeorge Anomaly|digeorge anomaly
644663|NCT00849888|Athymia|athymia
644664|NCT00849888|Low T cell numbers|low t cell numbers
644665|NCT00849888|Immunoreconstitution|immunoreconstitution
644666|NCT00849888|Immunodeficiency|immunodeficiency
644667|NCT00849875|ASCI|asci
644668|NCT00849875|Dacarbazine|dacarbazine
644669|NCT00849875|Cancer immunotherapeutic|cancer immunotherapeutic
644670|NCT00849875|MAGE-A3|mage-a3
644671|NCT00849875|Malignant melanoma|malignant melanoma
644672|NCT00849862|Bioequivalence|bioequivalence
644673|NCT00849862|Healthy Subjects|healthy subjects
644674|NCT00849849|postgestational diabetes|postgestational diabetes
644675|NCT00849849|diabetes mellitus|diabetes mellitus
644676|NCT00849849|OGTT|ogtt
644677|NCT00849849|insulin sensitivity|insulin sensitivity
644678|NCT00849849|insulin secretion|insulin secretion
644679|NCT00849823|African American|african american
644680|NCT00849823|Men|men
644681|NCT00849823|Condoms|condoms
644682|NCT00849823|Randomization|randomization
644683|NCT00849823|Brief Intervention|brief intervention
644684|NCT00849823|HIV|hiv
644685|NCT00849823|HIV Seronegativity|hiv seronegativity
644686|NCT00849810|Hypertension|hypertension
644687|NCT00849810|Beta-blockers|beta-blockers
644688|NCT00849810|Ambulatory blood pressure|ambulatory blood pressure
644689|NCT00849810|Basal metabolic rate|basal metabolic rate
644690|NCT00849810|Quality of life|quality of life
644691|NCT00849797|Bioequivalence|bioequivalence
644692|NCT00849797|Healthy Subjects|healthy subjects
644693|NCT00849771|Displaced Scapula Fracture|displaced scapula fracture
644694|NCT00849771|Scapula Fracture|scapula fracture
644695|NCT00849771|Extraarticular Scapula Fractures|extraarticular scapula fractures
821567|NCT00150722|HDL|hdl
644696|NCT00849771|Clavicle|clavicle
644697|NCT00849758|breast cancer|breast cancer
644698|NCT00849758|elderly|elderly
644699|NCT00849758|biomarker|biomarker
644700|NCT00849745|severe autoimmune diseases|severe autoimmune diseases
644701|NCT00849745|allogeneic stem cell transplant|allogeneic stem cell transplant
644702|NCT00849732|HIV Seronegativity|hiv seronegativity
644703|NCT00849732|Preventive Vaccine|preventive vaccine
644704|NCT00849719|visual analog scale|visual analog scale
644705|NCT00849719|patient controlled analgesia|patient controlled analgesia
644706|NCT00849719|post operative pain|post operative pain
644707|NCT00849719|rescue drug|rescue drug
644708|NCT00849706|sleep deprivation|sleep deprivation
644709|NCT00849706|workload|workload
644710|NCT00849706|increased workload|increased workload
644711|NCT00849680|HIV Seronegativity|hiv seronegativity
644712|NCT00849680|Preventive Vaccine|preventive vaccine
644713|NCT00849667|ovarian cancer|ovarian cancer
644714|NCT00849667|relapsed ovarian cancer|relapsed ovarian cancer
644715|NCT00849667|Platinum-sensitive Ovarian Cancer|platinum-sensitive ovarian cancer
644716|NCT00849654|PCI-32765|pci-32765
644717|NCT00849654|Lymphoma|lymphoma
644718|NCT00849654|Lymphoma, Non-Hodgkin|lymphoma, non-hodgkin
644719|NCT00849654|Lymphoma, B-Cell|lymphoma, b-cell
644720|NCT00849654|Burkitt Lymphoma|burkitt lymphoma
644721|NCT00849654|Lymphoma, B-Cell, Marginal Zone|lymphoma, b-cell, marginal zone
644722|NCT00849654|Lymphoma, B-Cell, Diffuse|lymphoma, b-cell, diffuse
644723|NCT00849654|Lymphoma, Follicular|lymphoma, follicular
644724|NCT00849654|Lymphoma, Mantle Cell|lymphoma, mantle cell
644725|NCT00849654|Leukemia, Lymphoid|leukemia, lymphoid
644726|NCT00849654|Leukemia, B-Cell|leukemia, b-cell
644727|NCT00849654|Waldenstrom macroglobulinemia|waldenstrom macroglobulinemia
644728|NCT00849654|Bruton's Tyrosine Kinase|bruton's tyrosine kinase
644729|NCT00849641|decompensation|decompensation
644730|NCT00849641|septic shock|septic shock
644731|NCT00849641|tissue oxygenation|tissue oxygenation
644732|NCT00849641|near infrared spectroscopy|near infrared spectroscopy
644733|NCT00849628|Aged|aged
644734|NCT00849628|Polypharmacy|polypharmacy
644735|NCT00849628|Adverse effects|adverse effects
644736|NCT00849628|Nursing homes|nursing homes
644737|NCT00849589|Screening|screening
644738|NCT00849589|Brief intervention|brief intervention
644739|NCT00849589|Underage drinking|underage drinking
644740|NCT00849563|predictive genomics|predictive genomics
644741|NCT00849563|personalized medicine|personalized medicine
644742|NCT00849563|personal genomics|personal genomics
644743|NCT00849563|genetic knowledge|genetic knowledge
644744|NCT00849563|genetic attitudes|genetic attitudes
644745|NCT00849563|prevention|prevention
644746|NCT00849563|health outcomes|health outcomes
644747|NCT00849563|behavioral|behavioral
644748|NCT00849550|Advanced Solid Tumors|advanced solid tumors
644749|NCT00849550|Cancer|cancer
644750|NCT00849550|Capecitabine|capecitabine
644751|NCT00849550|XELOX|xelox
644752|NCT00849550|Neoplasms|neoplasms
644753|NCT00849550|Oxaliplatin|oxaliplatin
644754|NCT00849550|Bevacizumab|bevacizumab
644755|NCT00849550|RAD001|rad001
644756|NCT00849537|Triamcinolon|triamcinolon
644757|NCT00849537|Cataract|cataract
644758|NCT00849537|Diabetic retinopathy|diabetic retinopathy
644759|NCT00849537|non-proliferative retinopathy|non-proliferative retinopathy
644760|NCT00849511|Migraine prevention|migraine prevention
644761|NCT00849511|Crossover|crossover
644762|NCT00849511|Melatonin|melatonin
644763|NCT00849485|Bioequivalence|bioequivalence
644764|NCT00849485|Healthy Subjects|healthy subjects
644765|NCT00849472|Neoadjuvant Breast Cancer|neoadjuvant breast cancer
644766|NCT00849472|Pazopanib (GW786034)|pazopanib (gw786034)
644767|NCT00849472|NSABP Foundation, Inc.|nsabp foundation, inc.
644768|NCT00849472|cyclophosphamide|cyclophosphamide
644769|NCT00849472|Paclitaxel|paclitaxel
644770|NCT00849472|Doxorubicin|doxorubicin
644771|NCT00849459|recurrent breast cancer|recurrent breast cancer
644772|NCT00849459|stage IV breast cancer|stage iv breast cancer
644773|NCT00849433|Inflammation|inflammation
644774|NCT00849433|epithelial|epithelial
644775|NCT00849433|integrity|integrity
644776|NCT00849433|ECIS|ecis
644777|NCT00849394|bevacizumab|bevacizumab
644778|NCT00849394|proteinuria|proteinuria
644779|NCT00849381|HPV|hpv
644780|NCT00849381|HPV vaccine|hpv vaccine
644781|NCT00849381|papillomavirus|papillomavirus
644782|NCT00849381|cervical cancer|cervical cancer
644783|NCT00849381|human papillomavirus|human papillomavirus
644784|NCT00849329|lapatinib (GW572016), subject, pharmacokinetic, esomeprazole, proton-pump inhibitor, drug interaction, Phase 1|lapatinib (gw572016), subject, pharmacokinetic, esomeprazole, proton-pump inhibitor, drug interaction, phase 1
644785|NCT00849303|stroke|stroke
644786|NCT00849303|rehabilitation|rehabilitation
644787|NCT00849303|gait|gait
644788|NCT00849303|timing|timing
644789|NCT00849303|transcranial magnetic stimulation|transcranial magnetic stimulation
644790|NCT00849277|Respiratory Tract Infections|respiratory tract infections
644791|NCT00849277|Influenza, Human|influenza, human
644792|NCT00849277|Probiotics|probiotics
644793|NCT00849264|hepatocellular carcinoma|hepatocellular carcinoma
644794|NCT00849264|portal vein tumor thrombus|portal vein tumor thrombus
644795|NCT00849264|surgical comprehensive treatment|surgical comprehensive treatment
644796|NCT00849212|Seizures|seizures
644797|NCT00849212|epilepsy|epilepsy
644798|NCT00849199|screening|screening
644799|NCT00849199|early detection|early detection
644800|NCT00849199|prevention|prevention
644801|NCT00849199|cancer|cancer
644802|NCT00849199|high risk|high risk
644803|NCT00849199|ovarian cancer|ovarian cancer
644804|NCT00849199|breast cancer|breast cancer
644805|NCT00849186|stage I renal cell cancer|stage i renal cell cancer
644806|NCT00849186|stage II renal cell cancer|stage ii renal cell cancer
644807|NCT00849186|stage III renal cell cancer|stage iii renal cell cancer
644808|NCT00849186|stage IV renal cell cancer|stage iv renal cell cancer
644809|NCT00849173|Endometriosis|endometriosis
644810|NCT00849173|Infertility|infertility
644811|NCT00849173|Tubal Ligation|tubal ligation
644812|NCT00849173|Chronic Pelvic Pain|chronic pelvic pain
644813|NCT00849173|Quality of Life|quality of life
644814|NCT00849160|Treatment Experienced|treatment experienced
644815|NCT00849147|Acute Lymphoblastic Leukemia/Lymphoma|acute lymphoblastic leukemia/lymphoma
644816|NCT00849147|Acute Myelogenous Leukemia|acute myelogenous leukemia
644817|NCT00849147|Mantel-Cell Lymphoma|mantel-cell lymphoma
644818|NCT00849147|Hematopoietic Transplant|hematopoietic transplant
644819|NCT00849147|Haplo-Identical Transplant|haplo-identical transplant
644820|NCT00849147|Non-Myeloablative Transplant|non-myeloablative transplant
644821|NCT00849134|First-Time-in-Human|first-time-in-human
644822|NCT00849134|Tolerability|tolerability
644823|NCT00849134|Pharmacodynamics|pharmacodynamics
644824|NCT00849134|Safety|safety
644825|NCT00849134|Food Effect|food effect
644826|NCT00849134|Pharmacokinetics|pharmacokinetics
644827|NCT00849134|Healthy Volunteers|healthy volunteers
644828|NCT00849121|Vaccine|vaccine
644829|NCT00849121|pTVG-HP|ptvg-hp
644830|NCT00849121|Prostate Cancer|prostate cancer
644831|NCT00849121|Castrate Resistant|castrate resistant
644832|NCT00849108|Myocardial Perfusion|myocardial perfusion
644833|NCT00849108|PET imaging|pet imaging
644834|NCT00849108|SPECT imaging|spect imaging
644835|NCT00849108|Coronary artery disease|coronary artery disease
644836|NCT00849108|Subjects that are male and nonpregnant female patients|subjects that are male and nonpregnant female patients
644837|NCT00849108|presenting with reversible ischemia as characterized by a|presenting with reversible ischemia as characterized by a
644838|NCT00849108|rest/stress SPECT imaging study using|rest/stress spect imaging study using
644839|NCT00849108|Technetium(99mTc)-labeled tracers|technetium(99mtc)-labeled tracers
644840|NCT00849095|Adult|adult
644841|NCT00849095|Asthma|asthma
644842|NCT00849095|Bronchodilator Agents|bronchodilator agents
644843|NCT00849095|Budesonide|budesonide
644844|NCT00849095|Double-Blind Method|double-blind method
644845|NCT00849095|Drug Therapy, Combination|drug therapy, combination
644846|NCT00849095|Ethanolamines|ethanolamines
644847|NCT00849095|Female|female
644848|NCT00849095|Forced Expiratory Volume|forced expiratory volume
644849|NCT00849095|Humans|humans
644850|NCT00849095|Male|male
644851|NCT00849095|Terbutaline|terbutaline
644852|NCT00849082|stage IIB prostate cancer|stage iib prostate cancer
644853|NCT00849082|stage IIA prostate cancer|stage iia prostate cancer
645359|NCT00847028|Pain|pain
644854|NCT00849082|stage III prostate cancer|stage iii prostate cancer
644855|NCT00849082|stage IV prostate cancer|stage iv prostate cancer
644856|NCT00849069|Streptococcus pneumoniae|streptococcus pneumoniae
644857|NCT00849069|Vaccine|vaccine
644858|NCT00849069|Non-typable Haemophilus influenza|non-typable haemophilus influenza
644859|NCT00849069|Adults and Elderly Adults|adults and elderly adults
644860|NCT00849056|diabetes|diabetes
644861|NCT00849043|obstructive sleep apnea hypopnea|obstructive sleep apnea hypopnea
644862|NCT00849043|OSA|osa
644863|NCT00849043|OSAH|osah
644864|NCT00849017|placebo|placebo
644865|NCT00849017|albiglutide|albiglutide
644866|NCT00849017|monotherapy|monotherapy
644867|NCT00849017|diabetes|diabetes
644868|NCT00849004|keloid|keloid
644869|NCT00849004|silicone sheet|silicone sheet
644870|NCT00849004|silicone gel|silicone gel
644871|NCT00849004|paper tape|paper tape
644872|NCT00849004|steri-strip|steri-strip
644873|NCT00848991|precedex|precedex
644874|NCT00848991|propofol|propofol
644875|NCT00848978|Functional capacity|functional capacity
644876|NCT00848978|Quality of life|quality of life
644877|NCT00848978|Depression|depression
644878|NCT00848978|Falls|falls
644879|NCT00848978|Body composition|body composition
644880|NCT00848978|Physical activity|physical activity
644881|NCT00848965|fluticasone propionate|fluticasone propionate
644882|NCT00848965|Vienna Challenge Chamber|vienna challenge chamber
644883|NCT00848965|glucocorticosteroids|glucocorticosteroids
644884|NCT00848965|allergic rhinitis|allergic rhinitis
644885|NCT00848939|systemic sclerosis|systemic sclerosis
644886|NCT00848939|scleroderma|scleroderma
644887|NCT00848939|pharmacokinetics|pharmacokinetics
644888|NCT00848939|treprostinil diethanolamine|treprostinil diethanolamine
644889|NCT00848926|Antigens, CD30|antigens, cd30
644890|NCT00848926|Antibody-Drug Conjugate|antibody-drug conjugate
644891|NCT00848926|Antibodies, Monoclonal|antibodies, monoclonal
644892|NCT00848926|Disease, Hodgkin|disease, hodgkin
644893|NCT00848926|Hematologic Diseases|hematologic diseases
644894|NCT00848926|Lymphoma|lymphoma
644895|NCT00848926|monomethylauristatin E|monomethylauristatin e
644896|NCT00848926|Drug Therapy|drug therapy
644897|NCT00848926|Immunotherapy|immunotherapy
644898|NCT00848913|strength deficit|strength deficit
644899|NCT00848913|physical function|physical function
644900|NCT00848887|Influenza|influenza
644901|NCT00848887|Flu|flu
644902|NCT00848887|Vaccine|vaccine
644903|NCT00848887|Adjuvant|adjuvant
644904|NCT00848861|propofol sedation|propofol sedation
644905|NCT00848861|colonoscopy|colonoscopy
644906|NCT00848861|recovery time|recovery time
644907|NCT00848861|recovery time after sedation for colonoscopy|recovery time after sedation for colonoscopy
644908|NCT00848848|Influenza|influenza
644909|NCT00848848|Flu|flu
644910|NCT00848848|Vaccine|vaccine
644911|NCT00848848|Intradermal|intradermal
644912|NCT00848848|Adjuvant|adjuvant
644913|NCT00848835|defibrillator|defibrillator
644914|NCT00848822|Pediatrics|pediatrics
644915|NCT00848822|Sleep|sleep
644916|NCT00848822|Glucose regulation|glucose regulation
644917|NCT00848822|Type 1 Diabetes Mellitus|type 1 diabetes mellitus
644918|NCT00848809|Acute kidney injury|acute kidney injury
644919|NCT00848809|Vancomycin therapy|vancomycin therapy
644920|NCT00848809|Slow-low efficiency daily dialysis|slow-low efficiency daily dialysis
644921|NCT00848809|Intermittent Hemodialysis|intermittent hemodialysis
644922|NCT00848809|Kidney|kidney
644923|NCT00848809|Vancomycin|vancomycin
644924|NCT00848809|Hemofiltration|hemofiltration
644925|NCT00848796|Heparin Leo|heparin leo
644926|NCT00848796|Hepalean|hepalean
644927|NCT00848796|CPB Cardiopuilmonary Bypass|cpb cardiopuilmonary bypass
644928|NCT00848796|CABG Coronary Artery Bypass Grafting|cabg coronary artery bypass grafting
644929|NCT00848796|Anticoagulation efficacy|anticoagulation efficacy
644930|NCT00848783|gastric cancer|gastric cancer
644931|NCT00848783|gastroesophageal junction|gastroesophageal junction
644932|NCT00848783|stomach cancer|stomach cancer
644933|NCT00848783|intraperitoneal infusion|intraperitoneal infusion
644934|NCT00848783|capecitabine|capecitabine
644935|NCT00848783|irinotecan|irinotecan
644936|NCT00848783|cisplatin|cisplatin
644937|NCT00848783|floxuridine|floxuridine
644938|NCT00848770|Stroke, Acute|stroke, acute
644939|NCT00848770|Systolic Pressure of Blood|systolic pressure of blood
644940|NCT00848757|Diabetes|diabetes
644941|NCT00848757|Lifestyle Intervention|lifestyle intervention
644942|NCT00848744|Acne|acne
644943|NCT00848731|pulmonary hypertension|pulmonary hypertension
644944|NCT00848731|venous thromboembolism|venous thromboembolism
644945|NCT00848718|Tumors, cancer|tumors, cancer
644946|NCT00848705|type 1 diabetes, adolescent, self-management|type 1 diabetes, adolescent, self-management
644947|NCT00848692|Chronic Fatigue Syndrome|chronic fatigue syndrome
644948|NCT00848692|CFS|cfs
644949|NCT00848692|Myalgic Encephalomyelitis|myalgic encephalomyelitis
644950|NCT00848692|Rituximab|rituximab
644951|NCT00848692|B-lymphocyte depletion|b-lymphocyte depletion
644952|NCT00848692|B-cell depletion|b-cell depletion
644953|NCT00848679|Pre-eclampsia|pre-eclampsia
644954|NCT00848679|Pregnancy|pregnancy
644955|NCT00848679|Uteroplacental blood flow|uteroplacental blood flow
644956|NCT00848679|Epidural|epidural
644957|NCT00848679|Anesthesia|anesthesia
644958|NCT00848627|Bladder cancer|bladder cancer
644959|NCT00848627|Smokers|smokers
644960|NCT00848627|Hematuria|hematuria
644961|NCT00848601|SGI-1776|sgi-1776
644962|NCT00848601|PIM|pim
644963|NCT00848601|Hormone & Docetaxel refractory Prostate Cancer|hormone & docetaxel refractory prostate cancer
644964|NCT00848601|Refractory non-Hodgkin's Lymphoma|refractory non-hodgkin's lymphoma
644965|NCT00848588|agonal breathing|agonal breathing
644966|NCT00848588|cardiac arrest|cardiac arrest
644967|NCT00848588|9-1-1 call taker|9-1-1 call taker
644968|NCT00848588|survey|survey
644969|NCT00848562|sudden cardiac death|sudden cardiac death
644970|NCT00848549|Epilepsy|epilepsy
644971|NCT00848549|Monotherapy|monotherapy
644972|NCT00848536|OAG|oag
644973|NCT00848536|OHT|oht
644974|NCT00848523|LBH859|lbh859
644975|NCT00848523|Panobinostat|panobinostat
644976|NCT00848523|GBM|gbm
644977|NCT00848523|Glioma|glioma
644978|NCT00848523|Glioblastoma|glioblastoma
644979|NCT00848523|Astrocytoma|astrocytoma
644980|NCT00848523|oligodendroglioma|oligodendroglioma
644981|NCT00848523|oligoastrocytoma|oligoastrocytoma
644982|NCT00848523|gliosarcoma|gliosarcoma
644983|NCT00848523|anaplastic|anaplastic
644984|NCT00848497|hormone replacement therapy|hormone replacement therapy
644985|NCT00848497|radical prostatectomy|radical prostatectomy
644986|NCT00848497|erectile dysfunctions|erectile dysfunctions
644987|NCT00848497|scheduled for removal of prostate gland|scheduled for removal of prostate gland
822006|NCT00148551|AMD|amd
644988|NCT00848471|Indirect calorimeter|indirect calorimeter
644989|NCT00848471|Validation|validation
644990|NCT00848471|Energy expenditure|energy expenditure
644991|NCT00848471|Healthy volunteers|healthy volunteers
644992|NCT00848458|Azelaic Acid|azelaic acid
644993|NCT00848458|Iontophoresis|iontophoresis
644994|NCT00848432|Schizophrenia|schizophrenia
644995|NCT00848432|Risperidone|risperidone
644996|NCT00848432|Maintenance treatment|maintenance treatment
644997|NCT00848432|Relapse|relapse
644998|NCT00848419|Epidural|epidural
644999|NCT00848419|Analgesia|analgesia
645000|NCT00848419|Methadone|methadone
645001|NCT00848419|Morphine|morphine
645002|NCT00848419|Pharmacokinetic-pharmacodynamic|pharmacokinetic-pharmacodynamic
645003|NCT00848419|Experimental pain - analgesic response|experimental pain - analgesic response
645004|NCT00848406|bronchial|bronchial
645005|NCT00848406|COPD|copd
645006|NCT00848406|Asthma|asthma
645007|NCT00848406|sputum|sputum
645008|NCT00848406|biopsies|biopsies
645009|NCT00848393|pediatric cardiac surgery|pediatric cardiac surgery
645010|NCT00848393|stress response|stress response
645011|NCT00848393|early extubation|early extubation
645012|NCT00848393|Dexmedetomidine|dexmedetomidine
645013|NCT00848393|TOF|tof
645014|NCT00848393|VSD|vsd
645015|NCT00848393|AVSD|avsd
645016|NCT00848380|Hypertension|hypertension
645017|NCT00848380|hyperlipidemia|hyperlipidemia
645018|NCT00848354|enbrel|enbrel
645019|NCT00848354|moderate arthritis|moderate arthritis
645020|NCT00848354|severe arthritis|severe arthritis
645021|NCT00848354|rheumatoid arthritis|rheumatoid arthritis
645022|NCT00848328|recurrent small lymphocytic lymphoma|recurrent small lymphocytic lymphoma
645023|NCT00848328|recurrent grade 1 follicular lymphoma|recurrent grade 1 follicular lymphoma
645024|NCT00848328|recurrent grade 2 follicular lymphoma|recurrent grade 2 follicular lymphoma
645025|NCT00848328|recurrent grade 3 follicular lymphoma|recurrent grade 3 follicular lymphoma
645026|NCT00848315|cognitive behavioral intervention|cognitive behavioral intervention
645027|NCT00848315|low literate/illiterate Hispanic patients|low literate/illiterate hispanic patients
645028|NCT00848302|peripheral vascular disease|peripheral vascular disease
645029|NCT00848302|endothelial dysfunction|endothelial dysfunction
645030|NCT00848302|intravascular ultrasound|intravascular ultrasound
645031|NCT00848302|L-Arginine|l-arginine
645032|NCT00848289|Bladder cancer|bladder cancer
645033|NCT00848289|Genetic susceptibility|genetic susceptibility
645034|NCT00848289|Increased Risk|increased risk
645035|NCT00848276|PCSK9|pcsk9
645036|NCT00848276|Lipoprotein metabolism|lipoprotein metabolism
645037|NCT00848276|testosterone|testosterone
645038|NCT00848276|estradiol|estradiol
645039|NCT00848263|Fracture|fracture
645040|NCT00848263|Radius|radius
645041|NCT00848263|Surgery|surgery
645042|NCT00848263|Osteosynthesis|osteosynthesis
645043|NCT00848250|Cardiopulmonary Bypass|cardiopulmonary bypass
645044|NCT00848250|ACE inhibitor|ace inhibitor
645045|NCT00848250|Pediatrics|pediatrics
645046|NCT00848237|Barrett's Esophagus|barrett's esophagus
645047|NCT00848237|Dysplasia|dysplasia
645048|NCT00848237|Intestinal Metaplasia|intestinal metaplasia
645049|NCT00848224|coronary heart disease|coronary heart disease
645050|NCT00848224|lipid lowering medication|lipid lowering medication
645051|NCT00848224|NCEP guidelines|ncep guidelines
645052|NCT00848211|HIV|hiv
645053|NCT00848211|vaccine|vaccine
645054|NCT00848211|lipopeptide|lipopeptide
645055|NCT00848211|Tat|tat
645056|NCT00848211|TUTI-16|tuti-16
645057|NCT00848211|THYMON|thymon
645058|NCT00848211|Treatment Naive|treatment naive
645059|NCT00848198|Dry Eye Disease|dry eye disease
645060|NCT00848198|Dry Eye Syndrome|dry eye syndrome
645061|NCT00848198|Dry Eye|dry eye
645062|NCT00848185|VEGF|vegf
645063|NCT00848185|Trigger|trigger
645064|NCT00848185|OHSS|ohss
645065|NCT00848172|Essential Tremor|essential tremor
645066|NCT00848172|Octanol|octanol
645067|NCT00848172|Octanoic Acid|octanoic acid
645068|NCT00848172|Ethanol|ethanol
645069|NCT00848172|Accelerometry|accelerometry
645070|NCT00848159|Osteoporosis|osteoporosis
645071|NCT00848159|kyphosis|kyphosis
645072|NCT00848159|photogrammetry|photogrammetry
645073|NCT00848107|systemic sclerosis|systemic sclerosis
645074|NCT00848107|scleroderma|scleroderma
645075|NCT00848107|digital ulcers|digital ulcers
645076|NCT00848107|vasculopathy|vasculopathy
645077|NCT00848094|hepatocellular carcinoma|hepatocellular carcinoma
645078|NCT00848094|radiation therapy|radiation therapy
645079|NCT00848094|3-dimensional conformal radiation therapy (3-DCRT)|3-dimensional conformal radiation therapy (3-dcrt)
645080|NCT00848094|intensity modulated radiation therapy (IMRT)|intensity modulated radiation therapy (imrt)
645081|NCT00848094|active breathing control|active breathing control
645082|NCT00848081|Prostate|prostate
645083|NCT00848081|BPH|bph
645084|NCT00848081|Benign Prostatic Hyperplasia|benign prostatic hyperplasia
645085|NCT00848081|BPH-LUTS|bph-luts
645086|NCT00848081|LUTS|luts
712515|NCT00579904|polyunsaturated fats|polyunsaturated fats
645087|NCT00848081|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors
645088|NCT00848081|tadalafil|tadalafil
645089|NCT00848081|alpha blockers|alpha blockers
645090|NCT00848068|lipid layer thickness|lipid layer thickness
645091|NCT00848042|cancer|cancer
645092|NCT00848042|head and neck|head and neck
645093|NCT00848042|laser|laser
645094|NCT00848042|ablation|ablation
645095|NCT00848029|Influenza vaccine|influenza vaccine
645096|NCT00848003|Probiotics|probiotics
645097|NCT00848003|BB-12|bb-12
645098|NCT00848003|Yogurt|yogurt
645099|NCT00848003|Antibiotics|antibiotics
645100|NCT00847990|Down syndrome|down syndrome
645101|NCT00847990|aneuploidy|aneuploidy
645102|NCT00847990|chromosome abnormality|chromosome abnormality
645103|NCT00847990|amniocentesis|amniocentesis
645104|NCT00847990|chorionic villus sampling|chorionic villus sampling
645105|NCT00847990|Laboratory Developed Test (LDT)|laboratory developed test (ldt)
645106|NCT00847977|Acute head trauma|acute head trauma
645107|NCT00847964|Heart Failure|heart failure
645108|NCT00847951|renal|renal
645109|NCT00847951|neonates|neonates
645110|NCT00847938|neostigmine|neostigmine
645111|NCT00847938|neuromuscular blocking agent|neuromuscular blocking agent
645112|NCT00847938|train of four|train of four
645113|NCT00847938|anesthesia|anesthesia
645114|NCT00847912|NMSC|nmsc
645115|NCT00847912|nonmelanoma skin cancer|nonmelanoma skin cancer
645116|NCT00847912|topical 5-FU 5% cream|topical 5-fu 5% cream
645117|NCT00847912|Neoplasms|neoplasms
645118|NCT00847912|Antineoplastic Agents|antineoplastic agents
645119|NCT00847912|Therapeutic Uses|therapeutic uses
645120|NCT00847912|Dermatologic Agents|dermatologic agents
645121|NCT00847912|Neoplasms by Site|neoplasms by site
645122|NCT00847912|carcinoma, basal cell|carcinoma, basal cell
645123|NCT00847912|carcinoma, squamous cell|carcinoma, squamous cell
645124|NCT00847899|hypertension|hypertension
645125|NCT00847899|impaired glucose tolerance|impaired glucose tolerance
645126|NCT00847899|s-EH enzyme inhibition|s-eh enzyme inhibition
645127|NCT00847899|pre-diabetes|pre-diabetes
645128|NCT00847873|intimate partner violence|intimate partner violence
645129|NCT00847873|domestic violence|domestic violence
645130|NCT00847873|alcohol abuse|alcohol abuse
645131|NCT00847873|alcohol dependence|alcohol dependence
645132|NCT00847873|drug abuse|drug abuse
645133|NCT00847873|drug dependence|drug dependence
645134|NCT00847873|addiction|addiction
645135|NCT00847860|cognition|cognition
645136|NCT00847847|ALS|als
645137|NCT00847847|Motor neuron|motor neuron
645138|NCT00847847|Pathophysiology|pathophysiology
645139|NCT00847847|Neuromuscular junction|neuromuscular junction
645140|NCT00847847|Neuromuscular transmission|neuromuscular transmission
645141|NCT00847847|Microelectrodes|microelectrodes
645142|NCT00847808|Esophageal Reflux|esophageal reflux
645143|NCT00847808|Gastro-Esophageal Reflux|gastro-esophageal reflux
645144|NCT00847808|Gastroesophageal Reflux Disease|gastroesophageal reflux disease
645145|NCT00847808|GERD|gerd
645146|NCT00847808|Regurgitation, Gastric|regurgitation, gastric
645147|NCT00847808|Heartburn|heartburn
645148|NCT00847808|Drug Therapy|drug therapy
645149|NCT00847769|Ankle Sprain|ankle sprain
645150|NCT00847756|Otitis media|otitis media
645151|NCT00847756|demography|demography
645152|NCT00847756|Streptococcus pneumoniae|streptococcus pneumoniae
645153|NCT00847756|Haemophilus influenzae|haemophilus influenzae
645154|NCT00847756|Moraxella catarrhalis|moraxella catarrhalis
645155|NCT00847756|rhinovirus|rhinovirus
645156|NCT00847756|children, 0-5 years of age|children, 0-5 years of age
645157|NCT00847756|diagnosed rAOM, COME or CSOM by an otorhinolaryngologist|diagnosed raom, come or csom by an otorhinolaryngologist
645561|NCT00846235|Dermatitis|dermatitis
645158|NCT00847756|primary and secondary hospital Nijmegen, the Netherlands|primary and secondary hospital nijmegen, the netherlands
645159|NCT00847743|oxidative stress|oxidative stress
645160|NCT00847743|aging|aging
645161|NCT00847743|ischemia-reperfusion|ischemia-reperfusion
645162|NCT00847730|Ease of dressing application, dressing conformability and ease of dressing removal on diabetic foot ulcers using the ActiVAC therapy|ease of dressing application, dressing conformability and ease of dressing removal on diabetic foot ulcers using the activac therapy
645163|NCT00847717|Oral|oral
645164|NCT00847717|cancer|cancer
645165|NCT00847717|surgery|surgery
645166|NCT00847717|neck dissection|neck dissection
645167|NCT00847717|spinal accessory nerve|spinal accessory nerve
645168|NCT00847704|Stroke|stroke
645169|NCT00847704|Rehabilitation|rehabilitation
645170|NCT00847704|Robotics|robotics
645171|NCT00847691|economic evaluation|economic evaluation
645172|NCT00847691|diagnostics|diagnostics
645173|NCT00847691|sarcoma|sarcoma
645174|NCT00847678|Cryptococcal Meningitis|cryptococcal meningitis
645175|NCT00847665|Pressure ulcers|pressure ulcers
645176|NCT00847665|Repositioning|repositioning
645177|NCT00847665|Prevention|prevention
645178|NCT00847665|Mechanical Ventilation|mechanical ventilation
645179|NCT00847665|Critical care|critical care
645180|NCT00847639|Multiple Myeloma|multiple myeloma
645181|NCT00847639|lenalidomide|lenalidomide
822200|NCT00147771|morphea|morphea
645182|NCT00847639|Revlimid|revlimid
645183|NCT00847639|Allogeneic Hematopoietic Cell Transplantation|allogeneic hematopoietic cell transplantation
645184|NCT00847626|Hypertensive|hypertensive
645185|NCT00847626|Blood Pressure, High|blood pressure, high
645186|NCT00847626|Vascular Disease|vascular disease
645187|NCT00847626|Cardiovascular Disease|cardiovascular disease
645188|NCT00847626|Drug Therapy|drug therapy
645189|NCT00847613|double-blind placebo-controlled investigational drug oral therapy safety and efficacy hand and feet x-rays|double-blind placebo-controlled investigational drug oral therapy safety and efficacy hand and feet x-rays
645190|NCT00847600|Schizophrenia|schizophrenia
645191|NCT00847600|Neurosteroids|neurosteroids
645192|NCT00847600|Pregnenolone|pregnenolone
645193|NCT00847600|Augmentation|augmentation
645194|NCT00847587|Contraceptive|contraceptive
645195|NCT00847587|Implant|implant
645196|NCT00847587|Postpartum period|postpartum period
645197|NCT00847587|etonogestrel-releasing|etonogestrel-releasing
645198|NCT00847587|lactogenesis|lactogenesis
645199|NCT00847587|Breastfeeding|breastfeeding
645200|NCT00847574|Weight loss|weight loss
645201|NCT00847574|Weight maintenance|weight maintenance
645202|NCT00847574|Weight management|weight management
645203|NCT00847574|Cardiovascular disease risk|cardiovascular disease risk
645204|NCT00847574|Dietary Guidelines|dietary guidelines
645205|NCT00847574|Diet and exercise|diet and exercise
645206|NCT00847574|Prevention|prevention
645207|NCT00847561|Anxiety|anxiety
645208|NCT00847548|intimate partner violence|intimate partner violence
645209|NCT00847548|domestic violence|domestic violence
645210|NCT00847548|substance abuse|substance abuse
645211|NCT00847548|alcohol abuse|alcohol abuse
645212|NCT00847548|drug abuse|drug abuse
645213|NCT00847548|addiction|addiction
645214|NCT00847522|melanoma|melanoma
645215|NCT00847522|skin cancer|skin cancer
645216|NCT00847522|lymph node|lymph node
645217|NCT00847522|sentinel lymph node|sentinel lymph node
645218|NCT00847522|malignant melanoma|malignant melanoma
645219|NCT00847522|mapping|mapping
645220|NCT00847509|lung cancer|lung cancer
645221|NCT00847509|head and neck cancer|head and neck cancer
645222|NCT00847509|radiotherapy|radiotherapy
645223|NCT00847509|chemoradiotherapy|chemoradiotherapy
645224|NCT00847509|radiation|radiation
645225|NCT00847509|chemoradiation|chemoradiation
645226|NCT00847509|FLT|flt
645227|NCT00847509|[F-18]FLT|[f-18]flt
645228|NCT00847509|FDG|fdg
645229|NCT00847509|[F-18]FDG|[f-18]fdg
645230|NCT00847496|Partial Thickness burn|partial thickness burn
645231|NCT00847496|Biological Dressing|biological dressing
645232|NCT00847483|glaucoma|glaucoma
645233|NCT00847483|ocular hypertension|ocular hypertension
645234|NCT00847483|latanoprost|latanoprost
645235|NCT00847483|travoprost|travoprost
645236|NCT00847483|bimatoprost|bimatoprost
645237|NCT00847470|Dental caries|dental caries
645238|NCT00847470|Assessments|assessments
645239|NCT00847470|dental materials|dental materials
645240|NCT00847457|Exercise|exercise
645241|NCT00847457|Stretching|stretching
645242|NCT00847457|Adolescents|adolescents
645243|NCT00847431|Subthalamic Nucleus|subthalamic nucleus
645244|NCT00847431|Deep Brain Stimulation|deep brain stimulation
645245|NCT00847431|Depression|depression
645246|NCT00847431|Anxiety|anxiety
645247|NCT00847431|Parkinson's Disease|parkinson's disease
645248|NCT00847418|pharmacokinetics|pharmacokinetics
645249|NCT00847418|ketamine|ketamine
645250|NCT00847418|Anesthetics, Dissociative|anesthetics, dissociative
645251|NCT00847405|Bioequivalence|bioequivalence
645252|NCT00847405|Healthy Subjects|healthy subjects
645253|NCT00847392|Urethral catheterization|urethral catheterization
645254|NCT00847392|Emergency Department|emergency department
645255|NCT00847392|Ultrasound|ultrasound
645256|NCT00847392|Urinary tract infection|urinary tract infection
645258|NCT00847379|Duchenne muscular dystrophy|duchenne muscular dystrophy
645259|NCT00847379|Becker muscular dystrophy|becker muscular dystrophy
645260|NCT00847379|Nonsense mutation|nonsense mutation
645261|NCT00847379|Premature stop codon|premature stop codon
645262|NCT00847379|DMD|dmd
645263|NCT00847379|BMD|bmd
645264|NCT00847379|Ataluren|ataluren
645265|NCT00847379|PTC124|ptc124
645266|NCT00847366|Perifosine|perifosine
645267|NCT00847353|high frequency ECG|high frequency ecg
645268|NCT00847353|normal values|normal values
645269|NCT00847353|asymptomatic|asymptomatic
645270|NCT00847353|obese|obese
645271|NCT00847340|Genital warts|genital warts
645272|NCT00847340|HPV typing|hpv typing
645273|NCT00847340|HPV infections|hpv infections
645274|NCT00847340|Condyloma Acuminata|condyloma acuminata
645275|NCT00847327|Type 1 Diabetes|type 1 diabetes
645276|NCT00847327|Parenting|parenting
645277|NCT00847327|Young Children|young children
645278|NCT00847314|Hypogonadism|hypogonadism
645279|NCT00847314|Abdominal obesity|abdominal obesity
645280|NCT00847314|Physical exercise|physical exercise
645281|NCT00847314|Testosterone|testosterone
645282|NCT00847288|Heart Failure|heart failure
645283|NCT00847288|Implantable Cardioverter Defibrillator (ICD)|implantable cardioverter defibrillator (icd)
645284|NCT00847288|Cardiac Resynchronization Therapy with Defibrillator (CRT D)|cardiac resynchronization therapy with defibrillator (crt d)
645285|NCT00847288|OptiVol®|optivol®
645286|NCT00847275|Elderly patients|elderly patients
645287|NCT00847275|renal insufficiency|renal insufficiency
645288|NCT00847275|gerontologic evaluation|gerontologic evaluation
645289|NCT00847262|Hypertension|hypertension
645290|NCT00847262|Abdominal obesity|abdominal obesity
645291|NCT00847262|Diabetes|diabetes
645292|NCT00847262|Treatment|treatment
645293|NCT00847249|safety|safety
645294|NCT00847249|tolerability|tolerability
645295|NCT00847249|healthy|healthy
645296|NCT00847249|inhalation|inhalation
645297|NCT00847249|Healthy males|healthy males
645298|NCT00847236|Polymyalgia Rheumatica|polymyalgia rheumatica
645299|NCT00847236|Rheumatoid Arthritis|rheumatoid arthritis
645300|NCT00847236|Rheumatic Disease|rheumatic disease
645301|NCT00847236|PMR|pmr
645302|NCT00847223|Mantle cell lymphoma|mantle cell lymphoma
645303|NCT00847223|Lymphoma|lymphoma
645304|NCT00847223|relapsed, refractory or progressive MCL|relapsed, refractory or progressive mcl
645305|NCT00847223|Mantle cell lymphoma (relapsed, refractory or progressive)|mantle cell lymphoma (relapsed, refractory or progressive)
645306|NCT00847210|Esophageal Reflux|esophageal reflux
645307|NCT00847210|Gastro-Esophageal Reflux|gastro-esophageal reflux
645308|NCT00847210|Gastroesophageal Reflux Disease|gastroesophageal reflux disease
645309|NCT00847210|GERD|gerd
645310|NCT00847210|Regurgitation, Gastric|regurgitation, gastric
645311|NCT00847210|Heartburn|heartburn
645312|NCT00847210|Drug Therapy|drug therapy
645313|NCT00847210|Adolescent|adolescent
645314|NCT00847184|nasal intubation|nasal intubation
645315|NCT00847184|Aitraq|aitraq
645316|NCT00847184|difficult intubation|difficult intubation
645317|NCT00847171|male breast cancer|male breast cancer
645318|NCT00847171|stage II breast cancer|stage ii breast cancer
645319|NCT00847171|stage IIIA breast cancer|stage iiia breast cancer
645320|NCT00847171|stage IIIB breast cancer|stage iiib breast cancer
645321|NCT00847171|stage IIIC breast cancer|stage iiic breast cancer
645322|NCT00847171|stage IV breast cancer|stage iv breast cancer
645323|NCT00847171|HER2-positive breast cancer|her2-positive breast cancer
645324|NCT00847158|POAG|poag
645325|NCT00847158|Combination glaucoma & cataract procedure|combination glaucoma & cataract procedure
645326|NCT00847158|trabecular micro-bypass stent|trabecular micro-bypass stent
645327|NCT00847158|iStent|istent
645328|NCT00847145|toddler|toddler
645329|NCT00847145|Meningococcal disease|meningococcal disease
645330|NCT00847145|prevention|prevention
645331|NCT00847145|vaccination|vaccination
645332|NCT00847132|Collaborative Care|collaborative care
645333|NCT00847119|rectum|rectum
645334|NCT00847119|adenocarcinoma|adenocarcinoma
645335|NCT00847119|neoadjuvant|neoadjuvant
645336|NCT00847119|bevacizumab|bevacizumab
645337|NCT00847119|capecitabine|capecitabine
645338|NCT00847119|radiotherapy|radiotherapy
645339|NCT00847119|locally|locally
645340|NCT00847119|advanced|advanced
645341|NCT00847119|resectable|resectable
645342|NCT00847119|resectable locally advanced adenocarcinoma of the rectum|resectable locally advanced adenocarcinoma of the rectum
645343|NCT00847119|xeberecto|xeberecto
645344|NCT00847106|Dendritic Cells|dendritic cells
645345|NCT00847106|Regulatory T cells|regulatory t cells
645347|NCT00847106|Melanoma|melanoma
645348|NCT00847106|Immunotherapy|immunotherapy
645349|NCT00847106|Daclizumab|daclizumab
645350|NCT00847106|Stage IV Melanoma|stage iv melanoma
645351|NCT00847080|Reactive hypoglycemia|reactive hypoglycemia
645352|NCT00847080|Sitagliptin|sitagliptin
645353|NCT00847080|Glucagon-Like Peptide 1|glucagon-like peptide 1
645354|NCT00847080|Incretins|incretins
645355|NCT00847080|Prediabetes|prediabetes
645356|NCT00847054|Solid Tumor|solid tumor
645357|NCT00847054|Endosialin|endosialin
645358|NCT00847028|Newborn|newborn
645360|NCT00847028|glucose solution|glucose solution
645361|NCT00847028|venipuncture|venipuncture
645362|NCT00847028|non-pharmacologic pain relief.|non-pharmacologic pain relief.
645363|NCT00847015|Bladder|bladder
645364|NCT00847015|Urinary|urinary
645365|NCT00847015|CISPLATIN|cisplatin
645366|NCT00847015|GEMCITABINE|gemcitabine
645367|NCT00847015|SU011248 (Sunitinib Malate)|su011248 (sunitinib malate)
645368|NCT00847015|08-159|08-159
645369|NCT00847002|Flexitouch system|flexitouch system
645370|NCT00847002|FarrowWrap|farrowwrap
645371|NCT00847002|venous stasis ulcer|venous stasis ulcer
645372|NCT00846989|glaucoma,|glaucoma,
645373|NCT00846989|primary open-angle glaucoma (POAG),|primary open-angle glaucoma (poag),
645374|NCT00846989|ocular hypertension (OH),|ocular hypertension (oh),
645375|NCT00846989|intraocular pressure (IOP)|intraocular pressure (iop)
645376|NCT00846976|Safety|safety
645377|NCT00846963|parenteral nutrition associated cholestasis in neonates|parenteral nutrition associated cholestasis in neonates
645378|NCT00846963|parenteral nutrition induced cholestasis in preterms|parenteral nutrition induced cholestasis in preterms
645379|NCT00846963|Bile duct obstruction|bile duct obstruction
822479|NCT00146536|ALH|alh
645380|NCT00846963|biliary stasis|biliary stasis
645381|NCT00846950|H1-antagonist|h1-antagonist
645382|NCT00846950|Event Related Potentials|event related potentials
645383|NCT00846950|Memory|memory
645384|NCT00846950|Information processing|information processing
645385|NCT00846950|The effects of an H1 antagonist (dexchlorpheniramine) on human cognition|the effects of an h1 antagonist (dexchlorpheniramine) on human cognition
645386|NCT00846937|Cholesterol|cholesterol
645387|NCT00846937|Plant stanolester|plant stanolester
645388|NCT00846937|Beverage|beverage
645389|NCT00846937|Ileostoma|ileostoma
645390|NCT00846937|Serum cholesterol level|serum cholesterol level
645391|NCT00846937|serum LDL-cholesterol level|serum ldl-cholesterol level
645392|NCT00846937|Intestinal cholesterol absorption efficiency|intestinal cholesterol absorption efficiency
645393|NCT00846924|Stroke|stroke
645394|NCT00846924|Transient Ischemic Attack|transient ischemic attack
645395|NCT00846924|Atrial fibrillation|atrial fibrillation
645396|NCT00846924|Atrial flutter|atrial flutter
645397|NCT00846911|Acute Exacerbation of Chronic Bronchitis (AECB) patients|acute exacerbation of chronic bronchitis (aecb) patients
645398|NCT00846898|blood sugar|blood sugar
645399|NCT00846898|cholesterol|cholesterol
645400|NCT00846898|cinnamon|cinnamon
645401|NCT00846898|HbA1c|hba1c
645402|NCT00846885|Bioequivalence|bioequivalence
645403|NCT00846885|Healthy Subjects|healthy subjects
645404|NCT00846872|GHRP-3|ghrp-3
645405|NCT00846872|Insulin Resistance|insulin resistance
645406|NCT00846872|Markers of inflammation|markers of inflammation
645407|NCT00846872|Endothelial Dysfunction|endothelial dysfunction
645408|NCT00846872|Flow Mediated Dilation|flow mediated dilation
645409|NCT00846872|GH/IGF-1 axis|gh/igf-1 axis
645410|NCT00846872|Post menopausal|post menopausal
645411|NCT00846859|alcohol dependence|alcohol dependence
645412|NCT00846859|nicotine dependence|nicotine dependence
645413|NCT00846859|alcohol abuse|alcohol abuse
645414|NCT00846859|varenicline|varenicline
645415|NCT00846859|Champix|champix
645416|NCT00846859|Chantix|chantix
645417|NCT00846859|smoking|smoking
645418|NCT00846859|drinking|drinking
645419|NCT00846859|snuffing|snuffing
645420|NCT00846859|diary|diary
645421|NCT00846859|phosphatidyl ethanol|phosphatidyl ethanol
645422|NCT00846859|PEth|peth
645423|NCT00846833|Melanoma, Experimental|melanoma, experimental
645424|NCT00846755|Thyroid|thyroid
645425|NCT00846755|Pregnancy|pregnancy
645426|NCT00846742|Hodgkin Lymphoma|hodgkin lymphoma
645427|NCT00846716|Type 2 Diabetes Mellitus|type 2 diabetes mellitus
645428|NCT00846716|Diabetic Nephropathy|diabetic nephropathy
645429|NCT00846716|Diabetic Retinopathy|diabetic retinopathy
645430|NCT00846716|pioglitazone|pioglitazone
645431|NCT00846690|topical anesthetics|topical anesthetics
645432|NCT00846690|topical anesthesia|topical anesthesia
645433|NCT00846690|20% benzocaine|20% benzocaine
645434|NCT00846690|TAC alternate gel|tac alternate gel
645435|NCT00846690|combination topical anesthetics|combination topical anesthetics
645436|NCT00846690|dental anesthesia|dental anesthesia
645437|NCT00846677|Healthy|healthy
645438|NCT00846677|Infants|infants
645439|NCT00846677|Vitamin D|vitamin d
645440|NCT00846651|spinal anesthesia|spinal anesthesia
645441|NCT00846651|cesarean section|cesarean section
645442|NCT00846638|Risk drinking|risk drinking
645443|NCT00846638|Women|women
645444|NCT00846638|Medical problems|medical problems
645445|NCT00846625|Biomedical research|biomedical research
645446|NCT00846625|Macular Edema|macular edema
645447|NCT00846625|Uveitis|uveitis
645448|NCT00846625|Ranibizumab|ranibizumab
645449|NCT00846625|Steroids|steroids
645450|NCT00846612|refractory|refractory
645451|NCT00846612|avastin|avastin
645452|NCT00846612|doxil|doxil
645453|NCT00846612|relapsed|relapsed
645454|NCT00846612|ovarian cancer|ovarian cancer
645455|NCT00846612|platinum-resistant|platinum-resistant
645456|NCT00846599|brachial artery ultrasound|brachial artery ultrasound
645457|NCT00846599|brachial artery reactivity|brachial artery reactivity
645458|NCT00846599|HIV|hiv
645562|NCT00846235|Atopic|atopic
645459|NCT00846599|human immunodeficiency virus|human immunodeficiency virus
645460|NCT00846599|cardiovascular risk|cardiovascular risk
645461|NCT00846599|omega three|omega three
645462|NCT00846599|saturated fat|saturated fat
645463|NCT00846599|sustiva|sustiva
645464|NCT00846599|atripla|atripla
645465|NCT00846599|kaletra|kaletra
645466|NCT00846599|treatment naive|treatment naive
645467|NCT00846586|chronic obstructive pulmonary disease|chronic obstructive pulmonary disease
645468|NCT00846586|COPD|copd
645469|NCT00846586|indacaterol|indacaterol
645470|NCT00846586|tiotropium|tiotropium
645471|NCT00846586|bronchodilation|bronchodilation
645472|NCT00846573|Helium|helium
645473|NCT00846573|MRI|mri
645474|NCT00846573|Hyperpolarized Helium|hyperpolarized helium
645475|NCT00846573|Hyperpolarized Noble Gas|hyperpolarized noble gas
645476|NCT00846547|Autism|autism
645477|NCT00846547|Autism Spectrum Disorders|autism spectrum disorders
645478|NCT00846547|irritability|irritability
645479|NCT00846547|aberrant behavior|aberrant behavior
645480|NCT00846534|Oxidative stress markers|oxidative stress markers
645481|NCT00846534|Cardiac surgery|cardiac surgery
645482|NCT00846534|Atrial Fibrillation|atrial fibrillation
645483|NCT00846521|Pediatric Obesity|pediatric obesity
645484|NCT00846521|Insulin Resistance|insulin resistance
645485|NCT00846521|Glucose Tolerance|glucose tolerance
645486|NCT00846521|Adolescents|adolescents
645487|NCT00846521|Acarbose|acarbose
645488|NCT00846521|Continuous Glucose Monitoring (CGMS)|continuous glucose monitoring (cgms)
645489|NCT00846521|Endothelial Dysfunction|endothelial dysfunction
645490|NCT00846508|cervical cancer|cervical cancer
645491|NCT00846508|Cisplatin|cisplatin
645492|NCT00846508|chemoradiation|chemoradiation
645493|NCT00846495|Migraine|migraine
645494|NCT00846495|Migraine prevention|migraine prevention
645495|NCT00846495|Prodrome|prodrome
645496|NCT00846495|Premonitory phase|premonitory phase
645497|NCT00846495|Preemptive therapy|preemptive therapy
645498|NCT00846482|Colorectal cancer|colorectal cancer
645499|NCT00846482|Oxaliplatin|oxaliplatin
645500|NCT00846482|ERCC-1|ercc-1
645501|NCT00846456|Tumor setm cell|tumor setm cell
645502|NCT00846443|non-small cell lung cancer|non-small cell lung cancer
645503|NCT00846430|Neurofibromas|neurofibromas
645504|NCT00846430|Neurofibromatosis 1|neurofibromatosis 1
645505|NCT00846430|Celecoxib|celecoxib
645506|NCT00846430|Celebrex|celebrex
645507|NCT00846430|Peg-Interferon alpha-2b|peg-interferon alpha-2b
645508|NCT00846430|PEG-Intron|peg-intron
645509|NCT00846430|Temozolomide|temozolomide
645510|NCT00846430|Temodar|temodar
645511|NCT00846430|Vincristine Sulfate|vincristine sulfate
645512|NCT00846430|Oncovin|oncovin
645513|NCT00846417|myocardial infarction|myocardial infarction
645514|NCT00846417|heart failure|heart failure
645515|NCT00846417|arrhythmia|arrhythmia
645516|NCT00846404|heart failure|heart failure
645517|NCT00846404|cardiomyopathy|cardiomyopathy
645518|NCT00846404|diastolic dysfunction|diastolic dysfunction
645519|NCT00846378|ST segment elevation myocardial infarction (STEMI)|st segment elevation myocardial infarction (stemi)
645520|NCT00846378|timed balloon inflations|timed balloon inflations
645521|NCT00846378|post conditioning|post conditioning
645522|NCT00846365|Essential Hypertension|essential hypertension
645523|NCT00846365|Hypertensive|hypertensive
645524|NCT00846365|Blood Pressure, High|blood pressure, high
645525|NCT00846365|Vascular Disease|vascular disease
645526|NCT00846365|Cardiovascular Disease|cardiovascular disease
645527|NCT00846365|Drug Therapy|drug therapy
645528|NCT00846352|Bone Marrow Transplantation|bone marrow transplantation
645529|NCT00846352|Hematopoietic Stem Cell Transplantation|hematopoietic stem cell transplantation
645530|NCT00846352|Bronchoscopy|bronchoscopy
645531|NCT00846339|Smoking cessation|smoking cessation
645532|NCT00846339|Bupropion|bupropion
645533|NCT00846326|allergic rhinitis|allergic rhinitis
645534|NCT00846326|rhinitis medicamentosa|rhinitis medicamentosa
645535|NCT00846326|imidazolines|imidazolines
645536|NCT00846326|corticosteroid|corticosteroid
645537|NCT00846313|Dietary intake|dietary intake
645538|NCT00846313|Dietary counseling|dietary counseling
645539|NCT00846313|Weight loss|weight loss
645540|NCT00846313|Body composition|body composition
645541|NCT00846313|Resting energy expenditure|resting energy expenditure
645542|NCT00846313|Quality of life|quality of life
645543|NCT00846300|Patient compliance|patient compliance
645544|NCT00846300|Hispanics|hispanics
645545|NCT00846300|Health Behavior|health behavior
645546|NCT00846300|Family Physicians|family physicians
645547|NCT00846300|Primary Healthcare|primary healthcare
645548|NCT00846287|COPD|copd
645549|NCT00846287|aformoterol|aformoterol
645550|NCT00846287|Helium|helium
645551|NCT00846287|Hyperpolarized helium|hyperpolarized helium
645552|NCT00846287|Hyperpolarized Noble Gas|hyperpolarized noble gas
645553|NCT00846287|MRI|mri
645554|NCT00846274|Healthy Male subjects|healthy male subjects
645555|NCT00846261|infected|infected
645556|NCT00846261|Ilizarov|ilizarov
645557|NCT00846248|diabetes|diabetes
645558|NCT00846248|insulin resistance|insulin resistance
645559|NCT00846248|chromium|chromium
645560|NCT00846248|healthy volunteers|healthy volunteers
645563|NCT00846235|Moisturising cream|moisturising cream
645564|NCT00846235|Skin|skin
645565|NCT00846209|prescription drug|prescription drug
645566|NCT00846209|warnings|warnings
645567|NCT00846209|health literacy|health literacy
645568|NCT00846209|enhanced language|enhanced language
645569|NCT00846183|local injury|local injury
645570|NCT00846183|implantation rate|implantation rate
645571|NCT00846183|endometrial receptivity|endometrial receptivity
645572|NCT00846183|IVF|ivf
645573|NCT00846170|Irritable bowel syndrome probiotics|irritable bowel syndrome probiotics
645574|NCT00846157|natural killer cell|natural killer cell
645575|NCT00846157|DLBCL (Diffuse Large B Cell Lymphoma)|dlbcl (diffuse large b cell lymphoma)
645576|NCT00846144|Glucose stimulated insulin secretion|glucose stimulated insulin secretion
645577|NCT00846144|copper|copper
645578|NCT00846144|cytokines|cytokines
645579|NCT00846144|diabetes|diabetes
645580|NCT00846144|Reduction in insulin secretion|reduction in insulin secretion
645581|NCT00846131|Subjects with primary hepatocellular carcinoma, intended for liver transplantation.|subjects with primary hepatocellular carcinoma, intended for liver transplantation.
645582|NCT00846118|Pitavastatin|pitavastatin
645583|NCT00846118|Hemodialysis|hemodialysis
645584|NCT00846118|Mortality|mortality
645585|NCT00846118|Cardiovascular disease|cardiovascular disease
645586|NCT00846105|methicillin resistant Staphylococcus aureus|methicillin resistant staphylococcus aureus
645587|NCT00846105|MRSA|mrsa
645588|NCT00846105|cross-infection|cross-infection
645589|NCT00846105|staphylococcal infection|staphylococcal infection
645590|NCT00846105|infection control|infection control
645591|NCT00846092|Diabetic Retinopathy|diabetic retinopathy
645592|NCT00846092|Diabetic Macular Edema|diabetic macular edema
645594|NCT00846092|Near-infrared Light Therapy|near-infrared light therapy
645595|NCT00846079|coronary artery disease|coronary artery disease
645596|NCT00846079|stress testing|stress testing
645597|NCT00846066|educational research,|educational research,
645598|NCT00846066|instructional methods,|instructional methods,
645599|NCT00846066|Hands on training,|hands on training,
645600|NCT00846066|Web based training,|web based training,
645601|NCT00846066|pediatric residents|pediatric residents
645602|NCT00846066|preventive oral health,|preventive oral health,
645603|NCT00846066|dental caries,|dental caries,
645604|NCT00846066|Instructional strategies in Preventive Oral health|instructional strategies in preventive oral health
645605|NCT00846066|Web-based training on Preventive Oral Health|web-based training on preventive oral health
645606|NCT00846066|Hands on Training on Preventive Oral Health|hands on training on preventive oral health
645607|NCT00846040|Obesity|obesity
645608|NCT00846040|Weight Loss|weight loss
645609|NCT00846040|Carbohydrate|carbohydrate
645610|NCT00846040|Fat|fat
645611|NCT00846040|Macronutrient Balance|macronutrient balance
645612|NCT00846040|Healthy Volunteer|healthy volunteer
645613|NCT00846014|asthma|asthma
645614|NCT00846014|exacerbation|exacerbation
645615|NCT00846014|Helium|helium
645616|NCT00846014|MRI|mri
645617|NCT00846014|Lung imaging|lung imaging
645618|NCT00846001|Resynchronization Therapy|resynchronization therapy
645619|NCT00845988|Bipolar disorder|bipolar disorder
645620|NCT00845988|metabolic complication|metabolic complication
645621|NCT00845988|Aripiprazole|aripiprazole
645622|NCT00845988|Weight gain|weight gain
645623|NCT00845988|Clinical Trial|clinical trial
645624|NCT00845988|Antipsychotic|antipsychotic
645625|NCT00845988|Metabolic syndrome|metabolic syndrome
645626|NCT00845988|Psychopharmacology|psychopharmacology
645627|NCT00845988|Open Label|open label
645628|NCT00845962|bupivacaine|bupivacaine
645629|NCT00845962|chloroprocaine|chloroprocaine
645630|NCT00845962|spinal|spinal
645631|NCT00845962|anesthesia|anesthesia
645632|NCT00845962|elective surgery|elective surgery
645633|NCT00845962|ambulatory surgery|ambulatory surgery
645634|NCT00845949|chemokines synovium|chemokines synovium
645635|NCT00845936|Atypical antipsychotics|atypical antipsychotics
645636|NCT00845936|Weight|weight
645637|NCT00845936|adolecsents|adolecsents
645638|NCT00845936|pediatric|pediatric
645639|NCT00845936|Metformin|metformin
645640|NCT00845923|Postherpetic neuralgia of at least 6 months|postherpetic neuralgia of at least 6 months
645641|NCT00845897|Diabetes mellitus|diabetes mellitus
645642|NCT00845897|plantar ulcers|plantar ulcers
645643|NCT00845897|peripheral neuropathy|peripheral neuropathy
645644|NCT00845884|Gastric|gastric
645645|NCT00845884|Cancer|cancer
645646|NCT00845884|Advanced|advanced
645647|NCT00845884|Docetaxel|docetaxel
645648|NCT00845884|Cisplatin|cisplatin
645649|NCT00845884|Capecitabine|capecitabine
645650|NCT00845884|Bevacizumab|bevacizumab
645651|NCT00845871|Exjade|exjade
645652|NCT00845871|deferasirox|deferasirox
645653|NCT00845871|palatability|palatability
645654|NCT00845871|tolerability|tolerability
645655|NCT00845871|food|food
645656|NCT00845871|iron overload|iron overload
645657|NCT00845871|Serum Iron overload due to transfusions|serum iron overload due to transfusions
645658|NCT00845858|Gastroparesis|gastroparesis
645659|NCT00845858|Diabetic Gastroparesis|diabetic gastroparesis
645660|NCT00845858|Diabetes|diabetes
645661|NCT00845858|Diabetes Mellitus|diabetes mellitus
645662|NCT00845858|Delayed Gastric Emptying|delayed gastric emptying
645663|NCT00845845|Non-alcoholic steatohepatitis|non-alcoholic steatohepatitis
645664|NCT00845845|Omega-3 fatty acids|omega-3 fatty acids
645665|NCT00845845|MRI|mri
645666|NCT00845845|NASH|nash
645667|NCT00845819|oral mucositis|oral mucositis
645668|NCT00845819|intensive chemotherapy|intensive chemotherapy
645669|NCT00845819|stem cell transplantation|stem cell transplantation
645670|NCT00845819|epidermal growth factor|epidermal growth factor
645671|NCT00845806|Diacritics|diacritics
645672|NCT00845806|Neuronal Processing|neuronal processing
645673|NCT00845806|fMRI|fmri
645674|NCT00845806|Arabic|arabic
645675|NCT00845793|Type 2 diabetes|type 2 diabetes
645676|NCT00845793|Nutrition|nutrition
645677|NCT00845793|Lifestyle modifications|lifestyle modifications
712516|NCT00579904|MUFA|mufa
645678|NCT00845780|persistent atrial fibrillation|persistent atrial fibrillation
645679|NCT00845780|amiodarone|amiodarone
645680|NCT00845780|late recurrence atrial fibrillation|late recurrence atrial fibrillation
645681|NCT00845780|adverse events|adverse events
645682|NCT00845767|Nitric Oxide|nitric oxide
645683|NCT00845767|Nitric Oxide Synthase|nitric oxide synthase
645684|NCT00845767|Air Pollution|air pollution
645685|NCT00845767|Endothelial Dysfunction|endothelial dysfunction
645686|NCT00845767|Diesel Exhaust|diesel exhaust
645687|NCT00845754|Post-operative febrile morbidity|post-operative febrile morbidity
645688|NCT00845754|Post-operative pain management|post-operative pain management
645689|NCT00845728|Indacaterol|indacaterol
645690|NCT00845728|Tiotropium|tiotropium
645691|NCT00845728|COPD|copd
645692|NCT00845715|rotator cuff|rotator cuff
645693|NCT00845715|rehabilitation|rehabilitation
645694|NCT00845715|range of motion|range of motion
645695|NCT00845702|Renal artery stenosis|renal artery stenosis
645696|NCT00845702|Contrast agent|contrast agent
645697|NCT00845702|MRA|mra
645698|NCT00845689|liver surgery|liver surgery
645699|NCT00845676|Hepatitis C virus|hepatitis c virus
645700|NCT00845676|Acute hepatitis C infection|acute hepatitis c infection
645701|NCT00845676|HIV|hiv
645702|NCT00845676|HCV|hcv
645703|NCT00845663|certolizumab pegol|certolizumab pegol
645704|NCT00845663|Cimzia|cimzia
645705|NCT00845663|bioequivalence|bioequivalence
645706|NCT00845663|Comparison Bioequivalence Study|comparison bioequivalence study
645707|NCT00845650|Anthrax|anthrax
645708|NCT00845650|Human Anthrax Immune Globulin Intravenous|human anthrax immune globulin intravenous
645709|NCT00845650|Safety|safety
645710|NCT00845650|Pharmacokinetics|pharmacokinetics
645711|NCT00845637|eggplant|eggplant
645712|NCT00845637|dyslipidemia|dyslipidemia
645713|NCT00845637|postprandial lipemia|postprandial lipemia
645714|NCT00845624|oxygen saturation|oxygen saturation
645715|NCT00845624|retinopathy of prematurity|retinopathy of prematurity
645716|NCT00845624|long term outcomes|long term outcomes
645717|NCT00845624|hypoxia|hypoxia
645718|NCT00845624|hyperoxia|hyperoxia
645719|NCT00845611|peptide vaccine|peptide vaccine
645720|NCT00845611|URLC10|urlc10
645721|NCT00845598|Allergic Rhinitis|allergic rhinitis
645722|NCT00845585|arterial reconstruction|arterial reconstruction
645723|NCT00845585|bypass|bypass
645724|NCT00845585|below knee|below knee
645725|NCT00845585|PZFE|pzfe
645726|NCT00845585|Ovine graft|ovine graft
645727|NCT00845585|Omniflow II|omniflow ii
645728|NCT00845585|graft patency|graft patency
645729|NCT00845572|Schizophrenia|schizophrenia
645730|NCT00845572|Schizoaffective|schizoaffective
645731|NCT00845572|Risperdal Consta|risperdal consta
645732|NCT00845572|Medication Adherence|medication adherence
645733|NCT00845572|Antipsychotic|antipsychotic
645734|NCT00845559|Childhood Obesity|childhood obesity
645735|NCT00845559|Insulin resistance|insulin resistance
645736|NCT00845559|Impaired Glucose Tolerance|impaired glucose tolerance
645737|NCT00845559|Cardiovascular Disease|cardiovascular disease
645738|NCT00845559|Type 2 Diabetes Mellitus|type 2 diabetes mellitus
645739|NCT00845559|Continuous Glucose Monitoring (CGMS)|continuous glucose monitoring (cgms)
645740|NCT00845559|Exenatide|exenatide
645741|NCT00845559|Oral Glucose Tolerance Test|oral glucose tolerance test
645742|NCT00845546|Bioequivalence 10 mg Loratadine 240 mg Pseudoephedrine Sulfate Extended Release Tablets|bioequivalence 10 mg loratadine 240 mg pseudoephedrine sulfate extended release tablets
645743|NCT00845507|weight gain|weight gain
645744|NCT00845494|Medication history|medication history
645745|NCT00845494|medication errors|medication errors
645746|NCT00845494|Reduction of admission medication history errors|reduction of admission medication history errors
645747|NCT00845468|coronary flow reserve|coronary flow reserve
645748|NCT00845468|diabetes mellitus|diabetes mellitus
645749|NCT00845468|acute myocardial infarction|acute myocardial infarction
645750|NCT00845468|transthoracic echocardiography|transthoracic echocardiography
645751|NCT00845442|Bilateral vocal cord paralyses|bilateral vocal cord paralyses
645752|NCT00845442|Implanted laryngeal stimulator|implanted laryngeal stimulator
645753|NCT00845442|vocal cord opening|vocal cord opening
645754|NCT00845442|pulmonary function tests|pulmonary function tests
645755|NCT00845429|Influenza|influenza
645756|NCT00845429|Orthomyxoviruses|orthomyxoviruses
645757|NCT00845429|Split-virion inactivated influenza vaccine|split-virion inactivated influenza vaccine
645758|NCT00845429|cell-based vaccine|cell-based vaccine
645759|NCT00845429|Adults|adults
645760|NCT00845416|TREC|trec
645761|NCT00845416|T cell|t cell
645762|NCT00845416|Primary Immunodeficiency|primary immunodeficiency
645763|NCT00845416|PID|pid
645764|NCT00845416|Navajo|navajo
645765|NCT00845416|SCID|scid
645766|NCT00845403|Hepatitis B carrier|hepatitis b carrier
645767|NCT00845377|Depression|depression
645768|NCT00845377|Aging|aging
645769|NCT00845377|Psychological well-being|psychological well-being
645770|NCT00845377|Psychosocial intervention|psychosocial intervention
645771|NCT00845364|Perhexiline|perhexiline
645772|NCT00845364|Coronary artery bypass|coronary artery bypass
712517|NCT00579904|PUFA|pufa
645773|NCT00845364|Myocardial reperfusion injury|myocardial reperfusion injury
645774|NCT00845364|Cardiac output, low|cardiac output, low
645775|NCT00845364|Troponin|troponin
645776|NCT00845351|Cushing's|cushing's
645777|NCT00845338|Darifenacin|darifenacin
645778|NCT00845338|Multiple Sclerosis|multiple sclerosis
645779|NCT00845338|Open Label Study|open label study
645780|NCT00845325|Carpal tunnel release|carpal tunnel release
645781|NCT00845325|Rehabilitation|rehabilitation
645782|NCT00845325|Early motion|early motion
645783|NCT00845312|Age|age
645784|NCT00845312|Mortality|mortality
645785|NCT00845299|glaucoma|glaucoma
645786|NCT00845299|ocular hypertension|ocular hypertension
645787|NCT00845286|exercise, myocardial dysfunction, endothelial dysfunction,|exercise, myocardial dysfunction, endothelial dysfunction,
645788|NCT00845286|polymorphism|polymorphism
645789|NCT00845273|Subfoveal choroidal neovascularization secondary to age-related macular degeneration|subfoveal choroidal neovascularization secondary to age-related macular degeneration
645790|NCT00845247|Case Management|case management
645791|NCT00845234|behavioral intervention|behavioral intervention
645792|NCT00845234|implantable cardioverter defibrillator|implantable cardioverter defibrillator
645793|NCT00845234|psychosocial education|psychosocial education
645794|NCT00845234|anxiety|anxiety
645795|NCT00845234|depression|depression
645796|NCT00845208|Network Support|network support
645797|NCT00845208|AA|aa
645798|NCT00845208|Contingency Management|contingency management
645799|NCT00845195|Rhinitis|rhinitis
645800|NCT00845195|Allergy|allergy
645801|NCT00845195|Nasal Spray|nasal spray
645802|NCT00845195|Antihistamine|antihistamine
645803|NCT00845195|Intranasal Corticosteroid|intranasal corticosteroid
645804|NCT00845182|Type 2 diabetes pathogenesis, thiazolidinediones|type 2 diabetes pathogenesis, thiazolidinediones
645805|NCT00845182|impaired glucose tolerance|impaired glucose tolerance
645806|NCT00845182|Incretins|incretins
645807|NCT00845182|Insulin secretion|insulin secretion
645808|NCT00845169|Air Pollution|air pollution
645809|NCT00845169|Nitric Oxide|nitric oxide
645810|NCT00845169|Nitric Oxide Synthase|nitric oxide synthase
645811|NCT00845169|Diesel exhaust|diesel exhaust
645812|NCT00845169|endothelial dysfunction|endothelial dysfunction
645813|NCT00845156|Diabetes|diabetes
645814|NCT00845156|Insulin resistance|insulin resistance
645815|NCT00845156|healthy controls|healthy controls
645816|NCT00845156|anti oxidants|anti oxidants
645817|NCT00845143|Non-small cell lung cancer|non-small cell lung cancer
645818|NCT00845143|surgery|surgery
645819|NCT00845143|lung function|lung function
645820|NCT00845130|Diabetes|diabetes
645821|NCT00845130|MR imaging|mr imaging
645822|NCT00845130|Vitamin C|vitamin c
645823|NCT00845117|Aniridia,|aniridia,
645824|NCT00845117|Steven Johnsons Syndrome,|steven johnsons syndrome,
645825|NCT00845117|Ocular burns,|ocular burns,
645826|NCT00845117|Pterygium|pterygium
645827|NCT00845091|Parasympathetic activity|parasympathetic activity
645828|NCT00845091|Exercise|exercise
645829|NCT00845091|Education|education
645830|NCT00845091|Arrhythmias|arrhythmias
645831|NCT00845091|Defibrillators, Implantable|defibrillators, implantable
645832|NCT00845078|Breast|breast
645833|NCT00845078|Radiotherapy|radiotherapy
645834|NCT00845078|Esthetics|esthetics
645835|NCT00845078|Treatment Outcome|treatment outcome
645836|NCT00845078|Reconstructive Surgical Procedures|reconstructive surgical procedures
645837|NCT00845052|Housestaff|housestaff
645838|NCT00845052|Patient Safety|patient safety
645839|NCT00845052|Patient Care|patient care
645840|NCT00845052|Focus of Study: To assess safety climate amongst housestaff|focus of study: to assess safety climate amongst housestaff
645841|NCT00845039|Tumors|tumors
645842|NCT00845039|Antibodies, Monoclonal|antibodies, monoclonal
645843|NCT00845039|Colorectal Neoplasms|colorectal neoplasms
645844|NCT00845039|Metastatic K-RAS Wild-Type Carcinoma of the Colon or Rectum|metastatic k-ras wild-type carcinoma of the colon or rectum
645845|NCT00845013|HIV infection|hiv infection
645846|NCT00845013|pulmonary hypertension|pulmonary hypertension
645847|NCT00845013|endothelial function|endothelial function
645848|NCT00845013|antiretroviral medication|antiretroviral medication
645849|NCT00845013|Treatment Experienced|treatment experienced
645850|NCT00844987|PDGF|pdgf
645851|NCT00844987|HGF|hgf
645852|NCT00844987|VEGF|vegf
645853|NCT00844987|ACS|acs
645854|NCT00844987|markers of myocardial injury|markers of myocardial injury
645855|NCT00844987|Vascular Endothelial Growth Factor|vascular endothelial growth factor
645856|NCT00844987|Hepatocyte Growth Factor|hepatocyte growth factor
645857|NCT00844987|Platelet Derived Growth Factor|platelet derived growth factor
645858|NCT00844987|Strategies in ACS|strategies in acs
645859|NCT00844961|IBS|ibs
645860|NCT00844961|CBT|cbt
645861|NCT00844961|Internet treatment|internet treatment
645862|NCT00844961|Cognitive behavior therapy|cognitive behavior therapy
645863|NCT00844948|Depression|depression
645864|NCT00844935|Heart rate variability, mechanical ventilation, weaning,|heart rate variability, mechanical ventilation, weaning,
645865|NCT00844935|spontaneous breathing trial|spontaneous breathing trial
645866|NCT00844909|CNTO 136|cnto 136
645867|NCT00844909|safety|safety
645868|NCT00844909|pharmacokinetics|pharmacokinetics
645869|NCT00844909|healthy Japanese|healthy japanese
645870|NCT00844909|healthy Caucasian|healthy caucasian
645871|NCT00844909|Phase I|phase i
645872|NCT00844909|antibody|antibody
645873|NCT00844909|male.|male.
645874|NCT00844896|Pathological stress & PTSD in preschool children & parents|pathological stress & ptsd in preschool children & parents
645875|NCT00844896|Child and parent resilience after burn trauma|child and parent resilience after burn trauma
645876|NCT00844883|primary liver cancer|primary liver cancer
645877|NCT00844883|sorafenib|sorafenib
645878|NCT00844883|Nexavar|nexavar
645879|NCT00844883|doxorubicin|doxorubicin
645880|NCT00844883|drug eluting beads|drug eluting beads
645881|NCT00844883|transarterial chemoembolization|transarterial chemoembolization
645882|NCT00844870|rehabilitation, reaching, stroke|rehabilitation, reaching, stroke
645883|NCT00844857|Bipolar I Depression|bipolar i depression
645884|NCT00844844|aHUS|ahus
645885|NCT00844831|Constipation|constipation
645886|NCT00844831|small intestinal bacterial overgrowth|small intestinal bacterial overgrowth
645887|NCT00844831|stool bacteria|stool bacteria
645888|NCT00844818|smoking cessation|smoking cessation
645889|NCT00844818|parents|parents
645890|NCT00844792|Male Urogenital Diseases|male urogenital diseases
645891|NCT00844792|Antioxidants|antioxidants
645892|NCT00844792|Vitamin E|vitamin e
645893|NCT00844792|Vitamin D|vitamin d
645894|NCT00844792|Lycopene|lycopene
645895|NCT00844792|Selenium|selenium
645896|NCT00844779|Metabolic syndrome- hepatic steatosis- steatohepatitis - gene expression|metabolic syndrome- hepatic steatosis- steatohepatitis - gene expression
645897|NCT00844779|Non alcoholic fatty liver disease (NFALD)|non alcoholic fatty liver disease (nfald)
645898|NCT00844766|Lactose intolerance|lactose intolerance
645899|NCT00844766|Lactose|lactose
645900|NCT00844766|Home-screening test|home-screening test
645901|NCT00844766|Validate|validate
645902|NCT00844753|Autism|autism
645903|NCT00844753|PDD NOS|pdd nos
645904|NCT00844753|Attention Deficit Hyperactivity Disorder|attention deficit hyperactivity disorder
645905|NCT00844753|Parent Management Training|parent management training
645906|NCT00844740|Familial hypophosphatemic rickets|familial hypophosphatemic rickets
645907|NCT00844740|Cinacalcet|cinacalcet
645908|NCT00844740|hyperparathyroidism|hyperparathyroidism
645909|NCT00844714|endothelial function|endothelial function
645910|NCT00844714|rheumatoid arthritis|rheumatoid arthritis
645911|NCT00844714|cardiovascular risk|cardiovascular risk
645912|NCT00844714|rituxan therapy|rituxan therapy
645913|NCT00844701|nicotine|nicotine
645914|NCT00844701|addiction|addiction
645915|NCT00844701|fMRI|fmri
645916|NCT00844701|neuroimaging|neuroimaging
645917|NCT00844701|neurobiology|neurobiology
645918|NCT00844701|craving|craving
645919|NCT00844688|Hepatocellular Carcinoma|hepatocellular carcinoma
645920|NCT00844688|Sorafenib|sorafenib
645921|NCT00844688|Gemcitabine|gemcitabine
645922|NCT00844675|endoscopic mucosal resection|endoscopic mucosal resection
645923|NCT00844675|Proton Pump Inhibitor|proton pump inhibitor
645924|NCT00844675|gastrointestinal hemorrhage|gastrointestinal hemorrhage
645925|NCT00844675|rabeprazole|rabeprazole
645926|NCT00844662|Hyperphosphataemia|hyperphosphataemia
645927|NCT00844662|phosphate binder|phosphate binder
645928|NCT00844636|Needlestick injuries|needlestick injuries
645929|NCT00844636|Glove perforations|glove perforations
645930|NCT00844636|Blunt Needles|blunt needles
645931|NCT00844636|Glove perforations of surgeons, assistants|glove perforations of surgeons, assistants
645932|NCT00844636|Needlestick injuries of same|needlestick injuries of same
645933|NCT00844623|primary liver cancer, hepatoma|primary liver cancer, hepatoma
645934|NCT00844584|Atrial fibrillation|atrial fibrillation
645935|NCT00844584|radiofrequency|radiofrequency
645936|NCT00844584|totally thoracoscope|totally thoracoscope
645937|NCT00844584|epicardial|epicardial
645938|NCT00844571|child abuse and neglect|child abuse and neglect
645939|NCT00844571|child maltreatment|child maltreatment
645940|NCT00844571|non accidental injury|non accidental injury
645941|NCT00844571|training|training
645942|NCT00844571|educational program|educational program
645943|NCT00844558|osteoarthritis|osteoarthritis
645944|NCT00844558|knee pain|knee pain
645945|NCT00844558|gait training|gait training
645946|NCT00844558|power training|power training
645947|NCT00844558|rehabilitation|rehabilitation
645948|NCT00844558|physical therapy|physical therapy
645949|NCT00844545|aHUS|ahus
645950|NCT00844532|Atherosclerosis|atherosclerosis
648436|NCT00834145|Pump|pump
645951|NCT00844532|Peripheral artery disease|peripheral artery disease
645952|NCT00844532|Peripheral vascular disease|peripheral vascular disease
645954|NCT00844532|Claudication|claudication
645955|NCT00844532|Peripheral Arterial Occlusive Disease|peripheral arterial occlusive disease
645956|NCT00844532|Stent|stent
645957|NCT00844532|PAOD|paod
645958|NCT00844532|PVD|pvd
645959|NCT00844519|Treatment Experienced|treatment experienced
645960|NCT00844519|CCR5 receptor|ccr5 receptor
645961|NCT00844519|maraviroc|maraviroc
645962|NCT00844506|Ovarian cancer patients with recurrent disease|ovarian cancer patients with recurrent disease
645963|NCT00844493|diarrhea|diarrhea
645964|NCT00844493|vaccine|vaccine
645965|NCT00844493|enterotoxigenic E coli|enterotoxigenic e coli
645966|NCT00844493|colonization factor antigen|colonization factor antigen
645967|NCT00844493|volunteer study|volunteer study
645968|NCT00844480|spinal cord injury|spinal cord injury
645969|NCT00844480|osteoporosis|osteoporosis
645970|NCT00844480|bone loss|bone loss
645971|NCT00844480|zoledronic acid|zoledronic acid
645972|NCT00844480|bisphosphonate|bisphosphonate
645973|NCT00844467|Risk factors|risk factors
645974|NCT00844467|Case fatality|case fatality
645975|NCT00844467|disease burden|disease burden
645976|NCT00844467|Resistance|resistance
645977|NCT00844467|Benefits of pneumococcal vaccination|benefits of pneumococcal vaccination
645978|NCT00844454|hepatocellular carcinoma|hepatocellular carcinoma
645980|NCT00844454|RF ablation|rf ablation
645981|NCT00844454|tumor ablation|tumor ablation
645982|NCT00844441|de novo myelodysplastic syndromes|de novo myelodysplastic syndromes
645983|NCT00844441|previously treated myelodysplastic syndromes|previously treated myelodysplastic syndromes
645984|NCT00844441|secondary myelodysplastic syndromes|secondary myelodysplastic syndromes
645985|NCT00844441|recurrent adult acute myeloid leukemia|recurrent adult acute myeloid leukemia
645986|NCT00844441|untreated adult acute myeloid leukemia|untreated adult acute myeloid leukemia
645987|NCT00844441|adult acute myeloid leukemia with inv(16)(p13;q22)|adult acute myeloid leukemia with inv(16)(p13;q22)
645988|NCT00844441|adult acute myeloid leukemia with t(16;16)(p13;q22)|adult acute myeloid leukemia with t(16;16)(p13;q22)
645989|NCT00844441|adult acute myeloid leukemia with t(8;21)(q22;q22)|adult acute myeloid leukemia with t(8;21)(q22;q22)
645990|NCT00844441|adult acute myeloid leukemia with 11q23 (MLL) abnormalities|adult acute myeloid leukemia with 11q23 (mll) abnormalities
645991|NCT00844441|adult acute minimally differentiated myeloid leukemia (M0)|adult acute minimally differentiated myeloid leukemia (m0)
645992|NCT00844441|adult acute myeloblastic leukemia without maturation (M1)|adult acute myeloblastic leukemia without maturation (m1)
645993|NCT00844441|adult acute myeloblastic leukemia with maturation (M2)|adult acute myeloblastic leukemia with maturation (m2)
645994|NCT00844441|adult acute myelomonocytic leukemia (M4)|adult acute myelomonocytic leukemia (m4)
645995|NCT00844441|adult acute monoblastic leukemia (M5a)|adult acute monoblastic leukemia (m5a)
645996|NCT00844441|adult acute eosinophilic leukemia|adult acute eosinophilic leukemia
645997|NCT00844441|adult acute monocytic leukemia (M5b)|adult acute monocytic leukemia (m5b)
645998|NCT00844441|adult acute megakaryoblastic leukemia (M7)|adult acute megakaryoblastic leukemia (m7)
645999|NCT00844441|adult acute basophilic leukemia|adult acute basophilic leukemia
646000|NCT00844441|acute myeloid leukemia with multilineage dysplasia following myelodysplastic syndrome|acute myeloid leukemia with multilineage dysplasia following myelodysplastic syndrome
646001|NCT00844441|adult erythroleukemia (M6a)|adult erythroleukemia (m6a)
646002|NCT00844441|adult pure erythroid leukemia (M6b)|adult pure erythroid leukemia (m6b)
646003|NCT00844402|Cholestasis|cholestasis
646004|NCT00844402|Atherosclerosis|atherosclerosis
646005|NCT00844402|Statins|statins
646006|NCT00844402|Vascular function|vascular function
646007|NCT00844389|Open Angle Glaucoma|open angle glaucoma
646008|NCT00844389|Biophotomodulation|biophotomodulation
646009|NCT00844389|Near to Infrared light stimulation|near to infrared light stimulation
646010|NCT00844389|Neuroprotection|neuroprotection
646011|NCT00844376|Cardiovascular Diseases|cardiovascular diseases
646012|NCT00844350|Oxytocin|oxytocin
646013|NCT00844350|Letrozole|letrozole
646014|NCT00844350|Induction of ovulation|induction of ovulation
646015|NCT00844337|antibiotic regimens|antibiotic regimens
646016|NCT00844337|sepsis|sepsis
646017|NCT00844337|young infants|young infants
646018|NCT00844337|Bangladeshi|bangladeshi
646019|NCT00844337|outpatient treatment|outpatient treatment
646020|NCT00844337|Suspected sepsis in young infants|suspected sepsis in young infants
646021|NCT00844324|Candesartan|candesartan
646022|NCT00844324|Bioequivalence|bioequivalence
646023|NCT00844311|hCG|hcg
646024|NCT00844311|human chorionic gonadotropin|human chorionic gonadotropin
646025|NCT00844298|Philadelphia chromosome positive adult precursor acute lymphoblastic leukemia|philadelphia chromosome positive adult precursor acute lymphoblastic leukemia
646026|NCT00844298|untreated adult acute lymphoblastic leukemia|untreated adult acute lymphoblastic leukemia
646027|NCT00844285|Certolizumab Pegol, Cimzia ®|certolizumab pegol, cimzia ®
646028|NCT00844285|Crohn's Disease|crohn's disease
646029|NCT00844272|Opiate Dependence|opiate dependence
646030|NCT00844272|Chronic Hepatitis C|chronic hepatitis c
646031|NCT00844259|Down syndrome|down syndrome
646032|NCT00844259|Pragmatics|pragmatics
646033|NCT00844259|Language Development|language development
646034|NCT00844246|Developmental delays|developmental delays
646035|NCT00844246|Early intervention services|early intervention services
646036|NCT00844220|Suspected coronary artery disease|suspected coronary artery disease
646037|NCT00844207|Bioavailability|bioavailability
646038|NCT00844155|Prevention or treatment of influenza in ventilated patients|prevention or treatment of influenza in ventilated patients
646039|NCT00844142|ankylosing spondylitis|ankylosing spondylitis
646040|NCT00844142|axial spondyloarthritis|axial spondyloarthritis
646041|NCT00844142|magnetic resonance imaging|magnetic resonance imaging
646042|NCT00844142|etanercept|etanercept
646043|NCT00844142|sulfasalazine|sulfasalazine
646044|NCT00844129|neurofibromatosis type 1|neurofibromatosis type 1
646045|NCT00844129|spinal abnormalities|spinal abnormalities
646046|NCT00844129|scoliosis|scoliosis
646047|NCT00844116|COPD|copd
646048|NCT00844116|spirometry|spirometry
646049|NCT00844116|Telematic spirometry|telematic spirometry
646050|NCT00844103|Volunteer|volunteer
646051|NCT00844103|Safety|safety
646052|NCT00844103|Tolerability|tolerability
646053|NCT00844103|AZD8566|azd8566
646054|NCT00844090|Apathy|apathy
646055|NCT00844090|Diabetes|diabetes
646056|NCT00844090|Self-care behaviors|self-care behaviors
646057|NCT00844077|Barrett's Intestinal Metaplasia|barrett's intestinal metaplasia
646058|NCT00844064|Pancreatic cancer|pancreatic cancer
646059|NCT00844064|Metastatic melanoma|metastatic melanoma
646060|NCT00844064|Advanced tumor|advanced tumor
646061|NCT00844064|Targeted therapy|targeted therapy
646062|NCT00844064|Antisense|antisense
646063|NCT00844064|Transforming Growth Factor beta 2|transforming growth factor beta 2
646064|NCT00844064|Dose escalation|dose escalation
646065|NCT00844051|Influenza|influenza
646066|NCT00844051|influenza vaccination|influenza vaccination
646067|NCT00844051|school-based vaccination|school-based vaccination
646068|NCT00844038|Steven-Johnson syndrome|steven-johnson syndrome
646069|NCT00844038|erythema multiform|erythema multiform
646070|NCT00844038|autoimmune disease|autoimmune disease
646071|NCT00844025|Adverse drug reaction|adverse drug reaction
646072|NCT00844025|Inappropriate medication|inappropriate medication
646073|NCT00844025|Pharmacist|pharmacist
646074|NCT00844025|Pharmaceutical care|pharmaceutical care
646075|NCT00843986|hyponatremia|hyponatremia
646076|NCT00843986|euvolemic hyponatremia|euvolemic hyponatremia
646077|NCT00843986|hypervolemic hyponatremia|hypervolemic hyponatremia
646078|NCT00843986|acute decompensated heart failure|acute decompensated heart failure
646079|NCT00843986|conivaptan|conivaptan
646080|NCT00843986|Vaprisol|vaprisol
646081|NCT00843973|Iliac Crest Bone Graft|iliac crest bone graft
646082|NCT00843973|Reamer Irrigator Aspirator|reamer irrigator aspirator
646083|NCT00843934|Carcinoma, Hepatocellular|carcinoma, hepatocellular
646084|NCT00843934|Trans arterial chemoembolization|trans arterial chemoembolization
646085|NCT00843934|Epirubicin|epirubicin
646086|NCT00843934|Cisplatin|cisplatin
646087|NCT00843921|Hyperammonemia|hyperammonemia
646088|NCT00843908|Stress incontinence|stress incontinence
646089|NCT00843908|Surgical Treatments|surgical treatments
646090|NCT00843908|Minislings|minislings
646091|NCT00843895|Laboratory based study|laboratory based study
646092|NCT00843895|antibiotic susceptibilty|antibiotic susceptibilty
646093|NCT00843895|invasive strains|invasive strains
646094|NCT00843843|Circadian Rhythms|circadian rhythms
646095|NCT00843817|cystic fibrosis|cystic fibrosis
646096|NCT00843804|nosocomial infection|nosocomial infection
646097|NCT00843804|bloodstream infection|bloodstream infection
646098|NCT00843804|central venous catheter|central venous catheter
646099|NCT00843804|invasive Aspergillosis|invasive aspergillosis
646100|NCT00843804|Clostridium difficile associated disease|clostridium difficile associated disease
646101|NCT00843791|obesity|obesity
646102|NCT00843778|Rheumatoid Arthritis|rheumatoid arthritis
646103|NCT00843778|Moderate to Low Disease Activity|moderate to low disease activity
646104|NCT00843778|Certolizumab Pegol|certolizumab pegol
646105|NCT00843765|Stroke|stroke
646106|NCT00843765|Traditional Chinese Medicine|traditional chinese medicine
646107|NCT00843765|Rehabilitation|rehabilitation
646108|NCT00843739|Breathing|breathing
646109|NCT00843739|Cough|cough
646110|NCT00843739|Speech|speech
646111|NCT00843739|Swallow|swallow
646112|NCT00843739|Parkinson's disease|parkinson's disease
646113|NCT00843726|stage I non-small cell lung cancer|stage i non-small cell lung cancer
646114|NCT00843726|stage II non-small cell lung cancer|stage ii non-small cell lung cancer
646115|NCT00843713|HIV|hiv
646116|NCT00843713|endothelium|endothelium
646117|NCT00843713|inflammation|inflammation
646118|NCT00843713|Treatment Experienced|treatment experienced
646119|NCT00843687|Schizophrenia|schizophrenia
646120|NCT00843687|Risperidone|risperidone
646121|NCT00843687|Long-acting injectable|long-acting injectable
646122|NCT00843687|Intramuscular injection|intramuscular injection
646123|NCT00843687|Pharmacokinetics|pharmacokinetics
646124|NCT00843661|Treatment Experienced|treatment experienced
646125|NCT00843648|antibody immune profile|antibody immune profile
646126|NCT00843648|preterm|preterm
646127|NCT00843648|c-section|c-section
646128|NCT00843648|breastfeeding|breastfeeding
646129|NCT00843635|stage I squamous cell carcinoma of the lip and oral cavity|stage i squamous cell carcinoma of the lip and oral cavity
646130|NCT00843635|stage I squamous cell carcinoma of the oropharynx|stage i squamous cell carcinoma of the oropharynx
646131|NCT00843635|stage II squamous cell carcinoma of the lip and oral cavity|stage ii squamous cell carcinoma of the lip and oral cavity
646132|NCT00843635|stage II squamous cell carcinoma of the oropharynx|stage ii squamous cell carcinoma of the oropharynx
646133|NCT00843635|stage III squamous cell carcinoma of the oropharynx|stage iii squamous cell carcinoma of the oropharynx
646134|NCT00843635|stage III squamous cell carcinoma of the lip and oral cavity|stage iii squamous cell carcinoma of the lip and oral cavity
646135|NCT00843635|stage IV squamous cell carcinoma of the oropharynx|stage iv squamous cell carcinoma of the oropharynx
646136|NCT00843635|stage IV squamous cell carcinoma of the lip and oral cavity|stage iv squamous cell carcinoma of the lip and oral cavity
646137|NCT00843635|stage I verrucous carcinoma of the oral cavity|stage i verrucous carcinoma of the oral cavity
646138|NCT00843635|stage II verrucous carcinoma of the oral cavity|stage ii verrucous carcinoma of the oral cavity
646139|NCT00843635|stage III verrucous carcinoma of the oral cavity|stage iii verrucous carcinoma of the oral cavity
646140|NCT00843635|stage IV verrucous carcinoma of the oral cavity|stage iv verrucous carcinoma of the oral cavity
646141|NCT00843622|Smoking|smoking
646142|NCT00843622|Smoking cessation|smoking cessation
646143|NCT00843622|Smokeless tobacco|smokeless tobacco
646144|NCT00843622|Snus|snus
646145|NCT00843609|diabetes mellitus, type 1|diabetes mellitus, type 1
646146|NCT00843609|hypoglycemia|hypoglycemia
646147|NCT00843609|continuous glucose monitoring|continuous glucose monitoring
646148|NCT00843609|HbA1c|hba1c
646149|NCT00843609|glycemic variability|glycemic variability
646150|NCT00843596|cardiac surgery requiring ECC|cardiac surgery requiring ecc
646151|NCT00843583|prevalence|prevalence
646152|NCT00843583|obstructive sleep apnea|obstructive sleep apnea
646153|NCT00843583|resistant hypertension|resistant hypertension
646154|NCT00843570|IVF|ivf
646155|NCT00843570|Frozen Embryo Replacement|frozen embryo replacement
646156|NCT00843557|critical illness|critical illness
646157|NCT00843557|intensive care|intensive care
646158|NCT00843557|nosocomial infection|nosocomial infection
646159|NCT00843531|neuroendocrine|neuroendocrine
646160|NCT00843531|islet cell|islet cell
646161|NCT00843531|carcinoid|carcinoid
646162|NCT00843531|pancreatic neuroendocrine|pancreatic neuroendocrine
646163|NCT00843531|paraganglioma|paraganglioma
646164|NCT00843531|pheochromocytoma|pheochromocytoma
646165|NCT00843531|RAD001|rad001
646166|NCT00843531|everolimus|everolimus
646167|NCT00843531|erlotinib|erlotinib
646168|NCT00843531|Tarceva|tarceva
646169|NCT00843518|Agitation and Aggression|agitation and aggression
646170|NCT00843505|Smoking Cessation|smoking cessation
646171|NCT00843505|Motivational Interviewing|motivational interviewing
646172|NCT00843505|Quitline|quitline
646173|NCT00843505|Telemedicine|telemedicine
646174|NCT00843505|Stop Smoking Medication|stop smoking medication
646175|NCT00843492|deep vein thrombosis|deep vein thrombosis
646176|NCT00843492|immobilization|immobilization
646177|NCT00843492|nadroparin|nadroparin
646178|NCT00843492|isolated lower-extremity injuries distal to the knee|isolated lower-extremity injuries distal to the knee
646179|NCT00843492|plaster cast|plaster cast
646180|NCT00843492|non-surgical leg injury|non-surgical leg injury
646181|NCT00843492|venous thromboembolism|venous thromboembolism
646182|NCT00843492|bleeding events|bleeding events
646183|NCT00843492|fondaparinux|fondaparinux
646184|NCT00843479|diabetes mellitus, type 2|diabetes mellitus, type 2
646185|NCT00843479|Insulin resistance|insulin resistance
646186|NCT00843479|Aging|aging
646187|NCT00843479|Incretins|incretins
646188|NCT00843479|DPP-IV protein, human|dpp-iv protein, human
646189|NCT00843479|Glucagon-Like Peptide 1|glucagon-like peptide 1
646190|NCT00843479|Gastric Inhibitory Polypeptide|gastric inhibitory polypeptide
646191|NCT00843479|insulin|insulin
646192|NCT00843479|glucagon|glucagon
646193|NCT00843479|ghrelin|ghrelin
646194|NCT00843466|Hand dermatitis|hand dermatitis
646195|NCT00843453|vitamin B12 deficiency|vitamin b12 deficiency
646196|NCT00843453|cyanocobalamin deficiency|cyanocobalamin deficiency
646197|NCT00843453|proton pump inhibitors|proton pump inhibitors
646198|NCT00843453|omeprazole|omeprazole
646199|NCT00843440|Antiangiogenic therapies|antiangiogenic therapies
646200|NCT00843440|Bevacuzimab|bevacuzimab
646201|NCT00843440|Hemorrhagic Hereditary Telangiectasia (HHT) with severe liver involvement|hemorrhagic hereditary telangiectasia (hht) with severe liver involvement
646202|NCT00843427|aphasia|aphasia
646203|NCT00843427|stroke|stroke
646204|NCT00843427|functional magnetic resonance imaging|functional magnetic resonance imaging
646205|NCT00843427|fMRI|fmri
646206|NCT00843427|language recovery after stroke|language recovery after stroke
646207|NCT00843427|constraint-induced aphasia therapy|constraint-induced aphasia therapy
646208|NCT00843427|CIAT|ciat
646209|NCT00843414|Emphysema|emphysema
646210|NCT00843414|Sarcoidosis|sarcoidosis
646211|NCT00843414|Interstitial Pulmonary Fibrosis|interstitial pulmonary fibrosis
646212|NCT00843401|Low oxygen saturation|low oxygen saturation
646213|NCT00843401|Anticipated need for pulse oximetry monitoring|anticipated need for pulse oximetry monitoring
646214|NCT00843401|Arterial line in place as indicated per patient's clinical management needs|arterial line in place as indicated per patient's clinical management needs
646312|NCT00843011|safety and tolerability|safety and tolerability
646215|NCT00843401|Availability to analyze arterial blood saturation by Co-Oximeter or|availability to analyze arterial blood saturation by co-oximeter or
646216|NCT00843401|Blood Gas Analyzer|blood gas analyzer
646217|NCT00843349|Phosphorus|phosphorus
646218|NCT00843349|Fibroblast Growth Factor-23|fibroblast growth factor-23
646219|NCT00843349|Kidney Disease|kidney disease
646220|NCT00843336|fertility monitoring|fertility monitoring
646221|NCT00843336|contraception|contraception
646222|NCT00843310|multiple myeloma|multiple myeloma
646223|NCT00843310|frontline treatment|frontline treatment
646224|NCT00843310|first-line treatment|first-line treatment
646225|NCT00843297|Sudden Cardiac Arrest|sudden cardiac arrest
646226|NCT00843297|Hypothermia|hypothermia
646227|NCT00843297|Outcome, neurological|outcome, neurological
646228|NCT00843297|Coolgard|coolgard
646229|NCT00843297|ArcticSun|arcticsun
646230|NCT00843284|neuropathic, pain, pregabalin, Lyrica|neuropathic, pain, pregabalin, lyrica
646231|NCT00843271|COPD MESA LUNG BIOMARKERS|copd mesa lung biomarkers
646232|NCT00843258|therapy|therapy
646233|NCT00843258|ultrasound|ultrasound
646234|NCT00843258|mild dysplasia|mild dysplasia
646235|NCT00843245|Heart Failure|heart failure
646236|NCT00843245|Electric bioimpedance|electric bioimpedance
646237|NCT00843245|Body composition|body composition
646238|NCT00843245|Diagnosis|diagnosis
646239|NCT00843245|monitoring|monitoring
646240|NCT00843245|Prognosis|prognosis
646241|NCT00843245|Total body water|total body water
646242|NCT00843232|diabetes mellitus, type 2|diabetes mellitus, type 2
646243|NCT00843232|Insulin resistance|insulin resistance
646244|NCT00843232|Aging|aging
646245|NCT00843232|Incretins|incretins
646246|NCT00843232|DPP-IV protein, human|dpp-iv protein, human
646247|NCT00843232|Glucagon-Like Peptide 1|glucagon-like peptide 1
646248|NCT00843232|Gastric Inhibitory Polypeptide|gastric inhibitory polypeptide
646249|NCT00843232|insulin|insulin
646250|NCT00843232|glucagon|glucagon
646251|NCT00843232|ghrelin|ghrelin
646252|NCT00843219|Lung|lung
646253|NCT00843219|Lung Cancer|lung cancer
646254|NCT00843219|Non-small cell Lung Cancer|non-small cell lung cancer
646255|NCT00843219|NSCLC|nsclc
646256|NCT00843219|Motion Correction|motion correction
646257|NCT00843219|PET/CT Scan|pet/ct scan
646259|NCT00843219|Positron Emission Tomography|positron emission tomography
646260|NCT00843219|CT|ct
646261|NCT00843219|Computed Tomography|computed tomography
646262|NCT00843219|Amplitude Gating|amplitude gating
646263|NCT00843193|Asthma|asthma
646264|NCT00843193|Asthma control questionnaire|asthma control questionnaire
646265|NCT00843180|Bone Marrow Transplant|bone marrow transplant
646266|NCT00843180|Massage|massage
646267|NCT00843180|Pediatric Oncology|pediatric oncology
646268|NCT00843180|children undergoing bone marrow transplantation|children undergoing bone marrow transplantation
646269|NCT00843167|mammography|mammography
646270|NCT00843167|biopsy|biopsy
646271|NCT00843167|ductal breast carcinoma in situ|ductal breast carcinoma in situ
646272|NCT00843167|atypical ductal breast hyperplasia|atypical ductal breast hyperplasia
646273|NCT00843154|Natriuretic Peptide, Brain|natriuretic peptide, brain
646274|NCT00843154|Biological Markers|biological markers
646275|NCT00843154|Biomarkers|biomarkers
646276|NCT00843154|Cardiac Failure|cardiac failure
646277|NCT00843154|Congestive Heart Failure|congestive heart failure
646278|NCT00843154|Heart Decompensation|heart decompensation
646279|NCT00843154|Drug Therapy|drug therapy
646280|NCT00843141|ADHD|adhd
646281|NCT00843141|Executive functions|executive functions
646282|NCT00843141|Quality of life|quality of life
646283|NCT00843115|Alzheimer's Disease, naturalistic study|alzheimer's disease, naturalistic study
646284|NCT00843102|atherosclerosis|atherosclerosis
646285|NCT00843102|pulmonary hypertension|pulmonary hypertension
646286|NCT00843089|coronary artery disease|coronary artery disease
646287|NCT00843089|CABG|cabg
646288|NCT00843063|pantoprazole|pantoprazole
646289|NCT00843063|famotidine|famotidine
646290|NCT00843063|aspirin|aspirin
646291|NCT00843063|dyspepsia|dyspepsia
646292|NCT00843063|gastrointestinal bleeding|gastrointestinal bleeding
646293|NCT00843063|peptic ulcer / erosion|peptic ulcer / erosion
646294|NCT00843050|CKD inhibitor|ckd inhibitor
646295|NCT00843050|Mantle Cell Lymphoma|mantle cell lymphoma
646296|NCT00843037|PARAGANGLIOMA|paraganglioma
646297|NCT00843037|PHEOCHROMOCYTOMA|pheochromocytoma
646298|NCT00843037|SUNITINIB|sunitinib
646299|NCT00843037|PHASE II|phase ii
646300|NCT00843037|Metastatic or locally advanced malignant paraganglioma|metastatic or locally advanced malignant paraganglioma
646301|NCT00843037|Metastatic or locally advanced malignant pheochromocytoma|metastatic or locally advanced malignant pheochromocytoma
646302|NCT00843024|Migraine with or without aura|migraine with or without aura
646303|NCT00843024|Migraine efficacy|migraine efficacy
646304|NCT00843024|Migraine|migraine
646305|NCT00843024|Migraine headache|migraine headache
646306|NCT00843024|Adolescent migraine|adolescent migraine
646307|NCT00843024|TREXIMET|treximet
646308|NCT00843024|Sumatriptan succinate|sumatriptan succinate
646309|NCT00843024|Naproxen sodium|naproxen sodium
646310|NCT00843024|Migraine, acute|migraine, acute
646311|NCT00843011|formulation|formulation
646313|NCT00843011|pharmacokinetics|pharmacokinetics
646314|NCT00843011|NK1 antagonist|nk1 antagonist
646315|NCT00843011|effect of food|effect of food
646316|NCT00842998|breast cancer|breast cancer
646317|NCT00842998|HER2|her2
646318|NCT00842998|Trastuzumab|trastuzumab
646319|NCT00842998|Lapatinib|lapatinib
646320|NCT00842998|HER2 gene-amplification|her2 gene-amplification
646321|NCT00842985|Cannabis Abuse|cannabis abuse
646322|NCT00842985|Cannabis Dependence|cannabis dependence
646323|NCT00842985|Cannabis-Related Disorder|cannabis-related disorder
646324|NCT00842985|Marijuana Dependence|marijuana dependence
646325|NCT00842985|Marihuana Abuse|marihuana abuse
646326|NCT00842959|Improvement of adjustment accuracy of intraocular lenses and imaging quality|improvement of adjustment accuracy of intraocular lenses and imaging quality
646327|NCT00842933|Septic shock|septic shock
646328|NCT00842933|Acute adrenal insufficiency|acute adrenal insufficiency
646329|NCT00842920|amnestic MCI|amnestic mci
646330|NCT00842907|Brazil|brazil
646331|NCT00842907|isotretinoin|isotretinoin
646332|NCT00842907|photodamage|photodamage
646333|NCT00842907|photoaging|photoaging
646334|NCT00842881|Healingstone|healingstone
646335|NCT00842868|atherosclerosis|atherosclerosis
646336|NCT00842868|contrast induced nephropathy|contrast induced nephropathy
646337|NCT00842868|renal impairment|renal impairment
646338|NCT00842868|catheterization|catheterization
646339|NCT00842855|GERD|gerd
646340|NCT00842855|PPI|ppi
646341|NCT00842855|partial responders|partial responders
646342|NCT00842842|surgical fixation devices|surgical fixation devices
646343|NCT00842842|postoperative pain|postoperative pain
646344|NCT00842842|ventral hernia|ventral hernia
646345|NCT00842842|fibrin tissue adhesive|fibrin tissue adhesive
646346|NCT00842842|laparoscopy|laparoscopy
646347|NCT00842842|quality of life|quality of life
646348|NCT00842842|fatigue|fatigue
646349|NCT00842829|Breakthrough Cancer Pain|breakthrough cancer pain
646350|NCT00842816|Dementia|dementia
646351|NCT00842816|Alzheimer Type Senile Dementia|alzheimer type senile dementia
646352|NCT00842816|Cognitive impairment|cognitive impairment
646353|NCT00842803|Liver|liver
646354|NCT00842803|transplant|transplant
646355|NCT00842803|albumin|albumin
646356|NCT00842803|outcome|outcome
646357|NCT00842803|Liver transplant recipients canadian transplant status 1 or 2|liver transplant recipients canadian transplant status 1 or 2
646358|NCT00842790|Carcinoma, Renal Cell [C04.557.470.200.025.390]|carcinoma, renal cell [c04.557.470.200.025.390]
646359|NCT00842790|Angiogenesis Inhibitors [D27.505.954.248.025]|angiogenesis inhibitors [d27.505.954.248.025]
646360|NCT00842790|Tomography Scanners, X-Ray Computed [E07.913]|tomography scanners, x-ray computed [e07.913]
646361|NCT00842790|Magnetic Resonance Imaging [E01.370.350.825.500]|magnetic resonance imaging [e01.370.350.825.500]
646362|NCT00842790|Diffusion Magnetic Resonance Imaging [E01.370.350.825.500.150]|diffusion magnetic resonance imaging [e01.370.350.825.500.150]
646363|NCT00842790|Perfusion [E05.680]|perfusion [e05.680]
646364|NCT00842777|Childhood obesity|childhood obesity
646365|NCT00842777|Quality of life|quality of life
646366|NCT00842777|Self-esteem|self-esteem
646367|NCT00842777|BMI|bmi
646368|NCT00842777|parental group treatment|parental group treatment
646369|NCT00842777|Body image|body image
646370|NCT00842764|eyelid fat pads|eyelid fat pads
646371|NCT00842751|5α-reductase|5α-reductase
646372|NCT00842751|androgen|androgen
646373|NCT00842751|dihydrotestosterone (DHT)|dihydrotestosterone (dht)
646374|NCT00842751|drug delivery|drug delivery
646375|NCT00842751|oestradiol|oestradiol
646376|NCT00842738|Screening|screening
646377|NCT00842738|Cervical cancer|cervical cancer
646378|NCT00842738|Cervical dysplasia|cervical dysplasia
646379|NCT00842738|Adverse psychosocial effects|adverse psychosocial effects
646380|NCT00842738|Alternative treatment|alternative treatment
646381|NCT00842712|First-line treatment for subjects with advanced NSCLC,|first-line treatment for subjects with advanced nsclc,
646382|NCT00842712|integrin receptor antagonist, EGFR chimerized monoclonal antibody, chemotherapy|integrin receptor antagonist, egfr chimerized monoclonal antibody, chemotherapy
646383|NCT00842712|safety run-in + randomization part, MTD, PFS, Overall survival time, best overall response|safety run-in + randomization part, mtd, pfs, overall survival time, best overall response
646384|NCT00842686|rectal cancer|rectal cancer
646385|NCT00842686|capecitabine|capecitabine
646386|NCT00842686|bevacizumab|bevacizumab
646387|NCT00842686|radiotherapy|radiotherapy
646388|NCT00842673|Dementia|dementia
646389|NCT00842673|Alzheimer Type Senile Dementia|alzheimer type senile dementia
646390|NCT00842673|Cognitive impairment|cognitive impairment
646391|NCT00842660|Cervical cancer|cervical cancer
646392|NCT00842660|concurrent chemoradiotherapy|concurrent chemoradiotherapy
646393|NCT00842660|gemcitabine|gemcitabine
646394|NCT00842647|Sensitivity|sensitivity
646395|NCT00842647|specificity|specificity
646396|NCT00842647|positive rate|positive rate
646397|NCT00842647|negative rate|negative rate
646398|NCT00842634|HIV|hiv
646399|NCT00842634|Treatment Experienced|treatment experienced
646400|NCT00842621|Sickle Cell Disease, Hemolytic Anemia|sickle cell disease, hemolytic anemia
646401|NCT00842621|Hemolysis|hemolysis
646402|NCT00842608|confusion|confusion
646403|NCT00842608|dementia|dementia
646404|NCT00842595|relapsed aggressive B-cell lymphoma|relapsed aggressive b-cell lymphoma
646405|NCT00842595|Chemotherapy|chemotherapy
823848|NCT00139217|iNO|ino
646406|NCT00842582|Ovarian cancer|ovarian cancer
646407|NCT00842582|chemotherapy|chemotherapy
646408|NCT00842582|azacitidine|azacitidine
646409|NCT00842569|obesity|obesity
646410|NCT00842569|cognitive process|cognitive process
646411|NCT00842569|reward|reward
646412|NCT00842569|P300|p300
646413|NCT00842569|ERP|erp
646414|NCT00842569|Event-related potential during oddball paradigm|event-related potential during oddball paradigm
646415|NCT00842569|brain electrophysiological patterns|brain electrophysiological patterns
646416|NCT00842569|externalizing factor|externalizing factor
646417|NCT00842543|Nutrition|nutrition
646418|NCT00842543|Oxidative Stress|oxidative stress
646419|NCT00842543|Insulin Resistance|insulin resistance
646420|NCT00842543|Whole Food Supplement|whole food supplement
646421|NCT00842543|Pediatric|pediatric
646422|NCT00842543|Retinoids|retinoids
646423|NCT00842543|Antioxidants|antioxidants
646424|NCT00842543|Dietary Supplements|dietary supplements
646425|NCT00842530|Dengue virus|dengue virus
646426|NCT00842530|Dengue fever|dengue fever
646427|NCT00842530|Dengue hemorrhagic fever|dengue hemorrhagic fever
646428|NCT00842530|Dengue diseases|dengue diseases
646429|NCT00842530|Dengue vaccine|dengue vaccine
646430|NCT00842517|Cocaine Dependence|cocaine dependence
646431|NCT00842517|Cocaine Abuse|cocaine abuse
646432|NCT00842517|Substance Abuse|substance abuse
646433|NCT00842517|Contingency Management|contingency management
646434|NCT00842517|Drug Treatment|drug treatment
646435|NCT00842504|Anti-fungal|anti-fungal
646436|NCT00842504|Immunocompromised|immunocompromised
646437|NCT00842504|Pharmacokinetic|pharmacokinetic
646438|NCT00842504|Prophylaxis|prophylaxis
646439|NCT00842504|Pharmacokinetics|pharmacokinetics
646440|NCT00842465|Breast diseases,|breast diseases,
646441|NCT00842465|human mutation,|human mutation,
646442|NCT00842465|prolactin receptor;|prolactin receptor;
646443|NCT00842465|breast cancer|breast cancer
646444|NCT00842452|recurrent ovarian epithelial cancer|recurrent ovarian epithelial cancer
646445|NCT00842452|stage III ovarian epithelial cancer|stage iii ovarian epithelial cancer
646446|NCT00842452|stage IV ovarian epithelial cancer|stage iv ovarian epithelial cancer
646447|NCT00842452|recurrent ovarian germ cell tumor|recurrent ovarian germ cell tumor
646448|NCT00842452|stage III ovarian germ cell tumor|stage iii ovarian germ cell tumor
646449|NCT00842452|stage IV ovarian germ cell tumor|stage iv ovarian germ cell tumor
646450|NCT00842452|recurrent endometrial carcinoma|recurrent endometrial carcinoma
646451|NCT00842452|stage III endometrial carcinoma|stage iii endometrial carcinoma
646452|NCT00842452|stage IV endometrial carcinoma|stage iv endometrial carcinoma
646453|NCT00842452|recurrent uterine sarcoma|recurrent uterine sarcoma
646454|NCT00842452|stage III uterine sarcoma|stage iii uterine sarcoma
646455|NCT00842452|stage IV uterine sarcoma|stage iv uterine sarcoma
646456|NCT00842452|recurrent vaginal cancer|recurrent vaginal cancer
646457|NCT00842452|stage III vaginal cancer|stage iii vaginal cancer
646458|NCT00842452|stage IVA vaginal cancer|stage iva vaginal cancer
646459|NCT00842452|stage IVB vaginal cancer|stage ivb vaginal cancer
646460|NCT00842452|recurrent vulvar cancer|recurrent vulvar cancer
646461|NCT00842452|stage III vulvar cancer|stage iii vulvar cancer
646462|NCT00842452|stage IV vulvar cancer|stage iv vulvar cancer
646463|NCT00842452|recurrent cervical cancer|recurrent cervical cancer
646464|NCT00842452|stage III cervical cancer|stage iii cervical cancer
646465|NCT00842452|stage IVA cervical cancer|stage iva cervical cancer
646466|NCT00842452|stage IVB cervical cancer|stage ivb cervical cancer
646467|NCT00842452|fallopian tube cancer|fallopian tube cancer
646468|NCT00842452|ovarian sarcoma|ovarian sarcoma
646469|NCT00842452|ovarian stromal cancer|ovarian stromal cancer
646470|NCT00842439|aggression|aggression
646471|NCT00842439|Prevention and treatment of youth aggression|prevention and treatment of youth aggression
646472|NCT00842426|Diabetes|diabetes
646473|NCT00842426|Cardiovascular disease|cardiovascular disease
646474|NCT00842426|Metabolic syndrome|metabolic syndrome
646475|NCT00842426|Cardiometabolic|cardiometabolic
646476|NCT00842413|Prefrontal cortex|prefrontal cortex
646477|NCT00842413|visual consciousness|visual consciousness
646478|NCT00842413|focal lesions|focal lesions
646479|NCT00842413|action perception|action perception
646480|NCT00842400|Obesity|obesity
646481|NCT00842387|gastroesophageal reflux disease|gastroesophageal reflux disease
646482|NCT00842387|reflux, heartburn|reflux, heartburn
646483|NCT00842387|regurgitation|regurgitation
646484|NCT00842387|acid control|acid control
646485|NCT00842387|PPI|ppi
646486|NCT00842387|antiacid|antiacid
646487|NCT00842387|primary care|primary care
646488|NCT00842387|esophagitis|esophagitis
646489|NCT00842348|Lanreotide|lanreotide
646490|NCT00842348|Somatuline|somatuline
646491|NCT00842348|Neuroendocrine tumour|neuroendocrine tumour
646492|NCT00842348|NET|net
646493|NCT00842335|solid tumors|solid tumors
646494|NCT00842335|angiogenesis inhibitor|angiogenesis inhibitor
646495|NCT00842335|dose escalation|dose escalation
646496|NCT00842335|maximum tolerated dose|maximum tolerated dose
646497|NCT00842335|JI-101|ji-101
646498|NCT00842322|chronic kidney disease|chronic kidney disease
646499|NCT00842322|transplantation|transplantation
646500|NCT00842322|kidney function|kidney function
646501|NCT00842322|fluid intake|fluid intake
646502|NCT00842322|osmolarity|osmolarity
646504|NCT00842296|RadioFrequency|radiofrequency
646505|NCT00842283|dermatologic diseases|dermatologic diseases
646506|NCT00842270|severe asthma|severe asthma
646507|NCT00842270|corticosteroids dependent|corticosteroids dependent
646508|NCT00842270|asthma exacerbation|asthma exacerbation
646509|NCT00842270|weaning|weaning
646510|NCT00842270|tyrosine kinase inhibitor|tyrosine kinase inhibitor
646511|NCT00842270|severe persistent corticosteroid dependent asthma|severe persistent corticosteroid dependent asthma
646512|NCT00842257|panitumumab|panitumumab
646513|NCT00842257|cetuximab|cetuximab
646514|NCT00842257|KRAS wild-type|kras wild-type
646515|NCT00842231|Corneal astigmatism|corneal astigmatism
646516|NCT00842231|post-cataract surgery|post-cataract surgery
646517|NCT00842231|visual performance|visual performance
646518|NCT00842231|Corneal astigmatism 0.5-0.75 Diopter|corneal astigmatism 0.5-0.75 diopter
646519|NCT00842218|Gait|gait
646520|NCT00842218|scoliosis|scoliosis
646521|NCT00842218|energy|energy
646522|NCT00842218|mechanics|mechanics
646523|NCT00842205|hepatitis C|hepatitis c
646524|NCT00842205|NASH|nash
646525|NCT00842205|Hem Oxygenase|hem oxygenase
646526|NCT00842205|Gene polymorphism|gene polymorphism
646527|NCT00842179|Perclose|perclose
646528|NCT00842153|Psoriasis|psoriasis
646529|NCT00842153|Plaque Type Psoriasis|plaque type psoriasis
646530|NCT00842140|Polycystic ovary syndrome|polycystic ovary syndrome
646531|NCT00842140|Oral Contraceptives, Hormonal|oral contraceptives, hormonal
646532|NCT00842140|Cardiovascular Disease|cardiovascular disease
646533|NCT00842140|Endothelium|endothelium
646534|NCT00842127|Methylphenidate|methylphenidate
646535|NCT00842127|ADHD|adhd
646536|NCT00842127|Multidrug resistance(MDR)polymorphism|multidrug resistance(mdr)polymorphism
646537|NCT00842127|OROS methylphenidate|oros methylphenidate
646538|NCT00842114|Intermediate-high FLIPI score|intermediate-high flipi score
646539|NCT00842114|Follicular Lymphoma|follicular lymphoma
646540|NCT00842114|Progression free survival|progression free survival
646541|NCT00842101|Intramedullary nails|intramedullary nails
646542|NCT00842101|Compartmental syndrome|compartmental syndrome
646543|NCT00842101|Fractures|fractures
646544|NCT00842075|type 1 diabetes|type 1 diabetes
646545|NCT00842075|adolescents|adolescents
646546|NCT00842075|post prandial glucose|post prandial glucose
646547|NCT00842049|Subarachnoid haemorrhage|subarachnoid haemorrhage
646548|NCT00842049|Aneurysm|aneurysm
646549|NCT00842049|Cerebrospinal fluid drainage|cerebrospinal fluid drainage
646550|NCT00842036|Family Therapy|family therapy
646551|NCT00842036|Relationship Dysfunction|relationship dysfunction
646552|NCT00842036|Family Dysfunction|family dysfunction
646553|NCT00842036|Family Relations|family relations
646554|NCT00842036|Stimulant Dependence|stimulant dependence
646555|NCT00842036|Opiate Dependence|opiate dependence
646556|NCT00842036|Alcohol Dependence|alcohol dependence
646557|NCT00842036|Behavior Therapy|behavior therapy
646558|NCT00842036|Drug Treatment|drug treatment
646559|NCT00842036|Substance Abuse|substance abuse
646560|NCT00842036|Drug Addiction|drug addiction
646561|NCT00842023|Natriuretic peptides|natriuretic peptides
646562|NCT00842023|BNP|bnp
646563|NCT00842023|Heart Failure|heart failure
646564|NCT00842023|Nitoglycerin|nitoglycerin
646565|NCT00842023|Biomarkers|biomarkers
646566|NCT00842010|Diabetes|diabetes
646567|NCT00842010|Inpatient|inpatient
646568|NCT00842010|Hospital|hospital
646569|NCT00842010|Hyperglycemia|hyperglycemia
646570|NCT00841984|Magnetic resonance spectroscopy|magnetic resonance spectroscopy
646571|NCT00841984|neurological diseases|neurological diseases
646572|NCT00841984|metabolic|metabolic
646573|NCT00841984|inborn errors of metabolism|inborn errors of metabolism
646574|NCT00841984|Complex neurological diseases of unknown cause|complex neurological diseases of unknown cause
646575|NCT00841945|Diffuse B larg cell lymphoma|diffuse b larg cell lymphoma
646576|NCT00841945|Chemotherapy|chemotherapy
646577|NCT00841945|Radiotherapy|radiotherapy
646578|NCT00841932|Fractional Flow Reserve|fractional flow reserve
646579|NCT00841932|Without anticoagulation|without anticoagulation
646580|NCT00841919|Diabetes|diabetes
646581|NCT00841919|Inpatient|inpatient
646582|NCT00841919|Insulin|insulin
646583|NCT00841919|Insulin pen|insulin pen
646584|NCT00841893|Thermogenesis|thermogenesis
646585|NCT00841893|Meal-induced thermogenesis|meal-induced thermogenesis
646586|NCT00841893|Energy expenditure|energy expenditure
646587|NCT00841893|Fat oxidation|fat oxidation
646588|NCT00841893|Carbohydrate oxidation|carbohydrate oxidation
646589|NCT00841893|Bioactive ingredient|bioactive ingredient
646590|NCT00841893|Spice|spice
646591|NCT00841867|Impaired Glucose Tolerance|impaired glucose tolerance
646592|NCT00841867|Diabetes|diabetes
646593|NCT00841854|Helicobacter pylori|helicobacter pylori
646594|NCT00841854|Bismuth|bismuth
646595|NCT00841854|Salvage treatment|salvage treatment
646596|NCT00841854|Metronidazole|metronidazole
646597|NCT00841841|Analgesia|analgesia
646598|NCT00841841|molar third|molar third
646599|NCT00841841|acetaminophen|acetaminophen
646600|NCT00841841|dipyrone|dipyrone
646601|NCT00841828|HER2-positive breast cancer|her2-positive breast cancer
646602|NCT00841828|Lapatinib|lapatinib
646603|NCT00841828|Neoadjuvant|neoadjuvant
646604|NCT00841828|Trastuzumab|trastuzumab
646605|NCT00841828|Biomarkers|biomarkers
646606|NCT00841815|Bioequivalence|bioequivalence
646607|NCT00841815|Healthy Subjects|healthy subjects
646608|NCT00841802|Chronic sinusitis|chronic sinusitis
646609|NCT00841802|Chronic rhinosinusitis|chronic rhinosinusitis
646610|NCT00841802|Nasal polyps|nasal polyps
646611|NCT00841789|Etanercept|etanercept
646612|NCT00841776|Acne Vulgaris|acne vulgaris
646613|NCT00841776|Acne|acne
646614|NCT00841763|virus|virus
646615|NCT00841763|pandemic influenza|pandemic influenza
646616|NCT00841763|vaccine|vaccine
646617|NCT00841750|Chest Tubes|chest tubes
646618|NCT00841750|Thoracic Surgery, Video-Assisted|thoracic surgery, video-assisted
646619|NCT00841750|Lung Diseases, Interstitial|lung diseases, interstitial
646620|NCT00841750|Pulmonary Nodule, Solitary|pulmonary nodule, solitary
646621|NCT00841737|Depressive Disorders;|depressive disorders;
646622|NCT00841737|Primary Health Care;|primary health care;
646623|NCT00841737|Nurses;|nurses;
646624|NCT00841737|Health education.|health education.
646625|NCT00841724|Allogeneic stem cell transplantation|allogeneic stem cell transplantation
646626|NCT00841724|Reduced-intensity conditioning|reduced-intensity conditioning
646627|NCT00841724|Reduced-toxicity conditioning|reduced-toxicity conditioning
646628|NCT00841724|Hematological malignancies|hematological malignancies
646629|NCT00841724|IV Busulfan|iv busulfan
646630|NCT00841711|HIV|hiv
646631|NCT00841711|AIDS|aids
646632|NCT00841711|Buprenorphine|buprenorphine
646633|NCT00841711|Intensive Case Management|intensive case management
646634|NCT00841711|Money Management|money management
646635|NCT00841711|Rapid Testing|rapid testing
646636|NCT00841711|Substance Abuse|substance abuse
646637|NCT00841711|Opioid Dependance|opioid dependance
646638|NCT00841711|Inmate Population|inmate population
646639|NCT00841698|Bioequivalence|bioequivalence
646640|NCT00841698|Healthy Subjects|healthy subjects
646641|NCT00841672|Hypertension|hypertension
646642|NCT00841672|systolic blood pressure|systolic blood pressure
646643|NCT00841672|cardiovascular disease|cardiovascular disease
646644|NCT00841672|aliskiren|aliskiren
646645|NCT00841672|amlodipine|amlodipine
646646|NCT00841659|Bioequivalence|bioequivalence
646647|NCT00841659|Healthy Subjects|healthy subjects
646648|NCT00841646|Influenza vaccine|influenza vaccine
646649|NCT00841633|subarachnoid hemorrhage|subarachnoid hemorrhage
646650|NCT00841633|ischemia|ischemia
646651|NCT00841633|vasospasm|vasospasm
646652|NCT00841633|CT|ct
646653|NCT00841633|perfusion|perfusion
646654|NCT00841633|induced hypertension|induced hypertension
646655|NCT00841633|delayed cerebral ischemia|delayed cerebral ischemia
646656|NCT00841620|Symptoms|symptoms
646657|NCT00841620|Postoperative pain|postoperative pain
646658|NCT00841620|Postoperative complications|postoperative complications
646659|NCT00841620|Milligan|milligan
646660|NCT00841620|Anopxy|anopxy
646661|NCT00841607|whipple|whipple
646662|NCT00841607|pancreas|pancreas
646663|NCT00841607|reconstruction|reconstruction
646664|NCT00841607|leak|leak
646665|NCT00841607|fistula|fistula
646666|NCT00841594|healthy volunteers|healthy volunteers
646667|NCT00841581|Age Related Macular Degeneration|age related macular degeneration
646668|NCT00841581|Pigment Epithelial Detachment|pigment epithelial detachment
646669|NCT00841581|Intravitreal Detachment|intravitreal detachment
646670|NCT00841581|Anti-VEGF|anti-vegf
646671|NCT00841568|ADPKD|adpkd
646672|NCT00841568|Tolvaptan|tolvaptan
646673|NCT00841555|adult giant cell glioblastoma|adult giant cell glioblastoma
646674|NCT00841555|adult gliosarcoma|adult gliosarcoma
646675|NCT00841555|adult anaplastic astrocytoma|adult anaplastic astrocytoma
646676|NCT00841555|adult glioblastoma|adult glioblastoma
646677|NCT00841555|GBM/AA|gbm/aa
646678|NCT00841542|Bioequivalence|bioequivalence
646679|NCT00841542|Healthy Subjects|healthy subjects
646680|NCT00841529|left atrial appendage|left atrial appendage
646681|NCT00841529|LAA|laa
646682|NCT00841529|atrial fibrillation|atrial fibrillation
646683|NCT00841529|AF|af
646684|NCT00841516|Specific immunotherapy|specific immunotherapy
646685|NCT00841516|SIT|sit
646686|NCT00841516|SCIT|scit
646687|NCT00841516|recombinant|recombinant
646688|NCT00841516|Type 1 - Allergy|type 1 - allergy
646689|NCT00841503|functional food study|functional food study
646690|NCT00841490|Helicobacter pylori|helicobacter pylori
646691|NCT00841490|Oral Health|oral health
646692|NCT00841490|Intellectually & Developmentally Disabled|intellectually & developmentally disabled
646693|NCT00841477|druguser,HB vaccine adherence, HBV, HCV, HIV incidence|druguser,hb vaccine adherence, hbv, hcv, hiv incidence
646694|NCT00841464|Parkinson's disease|parkinson's disease
646695|NCT00841464|Transcranial Magnetic Stimulation|transcranial magnetic stimulation
824160|NCT00137670|HIV|hiv
646696|NCT00841451|Atrial Fibrillation|atrial fibrillation
646697|NCT00841451|Persistent|persistent
646698|NCT00841451|Paroxysmal|paroxysmal
647370|NCT00838682|rabeprazole|rabeprazole
646699|NCT00841451|Pulmonary Vein isolation|pulmonary vein isolation
646700|NCT00841451|Omega three fatty acids|omega three fatty acids
646701|NCT00841451|Fish Oils|fish oils
646702|NCT00841438|Angioplasty|angioplasty
646703|NCT00841438|Transluminal|transluminal
646704|NCT00841438|Percutaneous Coronary|percutaneous coronary
646705|NCT00841412|Usual Care Control Group|usual care control group
646706|NCT00841399|Breast cancer|breast cancer
646707|NCT00841386|Cornea|cornea
646708|NCT00841386|Keratoconus|keratoconus
646709|NCT00841386|Ectasia|ectasia
646710|NCT00841386|Riboflavin|riboflavin
646711|NCT00841386|Collagen cross-linking|collagen cross-linking
646712|NCT00841373|Retinal ischemia: Iris/Angle Neovascularization|retinal ischemia: iris/angle neovascularization
646713|NCT00841360|Social network|social network
646714|NCT00841360|Asymptomatic HIV|asymptomatic hiv
646715|NCT00841347|Obesity|obesity
646716|NCT00841347|Glucose metabolism disorders|glucose metabolism disorders
646717|NCT00841347|Appetite regulation|appetite regulation
646718|NCT00841347|Sleep|sleep
646719|NCT00841347|Adolescent|adolescent
646720|NCT00841347|Randomized controlled trials|randomized controlled trials
646721|NCT00841334|Adolescent|adolescent
646722|NCT00841334|Overweight|overweight
646723|NCT00841334|Obesity|obesity
646724|NCT00841334|Weight loss|weight loss
646725|NCT00841334|Nutrition|nutrition
646726|NCT00841334|Physical activity|physical activity
646727|NCT00841334|Community-based participatory research|community-based participatory research
646728|NCT00841334|School-based|school-based
646729|NCT00841334|Primary Care|primary care
646730|NCT00841334|Motivational interviewing|motivational interviewing
646731|NCT00841321|Ginkgo biloba|ginkgo biloba
646732|NCT00841321|Multiple Sclerosis|multiple sclerosis
646733|NCT00841321|Cognition|cognition
646734|NCT00841321|Neuropsychological Tests|neuropsychological tests
646735|NCT00841321|Neurobehavioral Manifestations|neurobehavioral manifestations
646736|NCT00841321|Quality of life|quality of life
646737|NCT00841321|Randomized Controlled Trials|randomized controlled trials
646738|NCT00841321|Placebos|placebos
646739|NCT00841321|Double-Blind Method|double-blind method
646740|NCT00841282|Colorectal cancer screening|colorectal cancer screening
646741|NCT00841282|Optical colonoscopy|optical colonoscopy
646742|NCT00841282|Water method|water method
646743|NCT00841282|Sedation|sedation
646744|NCT00841269|Bipolar Manic Depression|bipolar manic depression
646745|NCT00841256|specific immunotherapy|specific immunotherapy
646747|NCT00841256|SLIT|slit
646748|NCT00841256|sublingual|sublingual
646749|NCT00841243|Hepatitis C|hepatitis c
646750|NCT00841243|Antiviral therapy|antiviral therapy
646751|NCT00841243|weight loss|weight loss
646752|NCT00841243|dietary support|dietary support
646753|NCT00841243|dietary advise|dietary advise
646754|NCT00841230|Tinnitus|tinnitus
646755|NCT00841217|Drug treatment|drug treatment
646756|NCT00841191|Resistant to anti-EGFR|resistant to anti-egfr
646757|NCT00841191|Interleukin-6|interleukin-6
646758|NCT00841191|Neoplasms by Histologic Type|neoplasms by histologic type
646759|NCT00841191|Immunologic Factors|immunologic factors
646760|NCT00841191|Mol Physiological Effects of Drugs|mol physiological effects of drugs
646761|NCT00841191|KRAS protein, human|kras protein, human
646762|NCT00841191|CNTO 328|cnto 328
646763|NCT00841178|Randomised controlled trial|randomised controlled trial
646764|NCT00841178|Venous insufficiency|venous insufficiency
646765|NCT00841178|Varicose veins|varicose veins
646766|NCT00841178|Quality of Life|quality of life
646767|NCT00841178|Clinical effectiveness|clinical effectiveness
646768|NCT00841178|Cost effectiveness|cost effectiveness
646769|NCT00841165|Carbon Monoxide Toxicity|carbon monoxide toxicity
646770|NCT00841165|Carbon|carbon
646771|NCT00841165|Monoxide|monoxide
646772|NCT00841165|Poisoning|poisoning
646773|NCT00841165|Toxicity|toxicity
646774|NCT00841165|Treatment|treatment
646775|NCT00841165|CPAP|cpap
646776|NCT00841165|Hyperbaric|hyperbaric
646777|NCT00841165|Oxygen|oxygen
646778|NCT00841152|Bone tumors|bone tumors
646779|NCT00841152|Surgery|surgery
646780|NCT00841152|Bone graft substitutes|bone graft substitutes
646781|NCT00841152|Bioactive glass|bioactive glass
646782|NCT00841152|Bioceramics|bioceramics
646783|NCT00841152|Bone autograft|bone autograft
646784|NCT00841152|Bone allograft|bone allograft
646785|NCT00841139|perhexiline|perhexiline
646786|NCT00841139|idiopathic dilated cardiomyopathy|idiopathic dilated cardiomyopathy
646787|NCT00841139|magnetic resonance spectroscopy|magnetic resonance spectroscopy
646788|NCT00841139|cardiac energetics|cardiac energetics
646789|NCT00841126|Hyperphosphatemia|hyperphosphatemia
646790|NCT00841126|Phosphate binder|phosphate binder
646791|NCT00841113|Prostate cancer|prostate cancer
646792|NCT00841113|Advanced|advanced
646793|NCT00841113|Metastatic|metastatic
646794|NCT00841100|PKU|pku
824319|NCT00136929|AMI|ami
646795|NCT00841100|Kuvan|kuvan
646796|NCT00841100|BH4|bh4
646797|NCT00841100|tetrahydrobiopterin|tetrahydrobiopterin
646798|NCT00841074|Pneumonia|pneumonia
646799|NCT00841074|Elderly|elderly
646800|NCT00841074|Chlorhexidine|chlorhexidine
646801|NCT00841074|Respiratory pathogens|respiratory pathogens
646802|NCT00841048|Safety and tolerability|safety and tolerability
646803|NCT00841035|Pancreatic|pancreatic
646804|NCT00841035|Cancer|cancer
646805|NCT00841035|Assay|assay
646806|NCT00841035|Biomarkers|biomarkers
646807|NCT00841022|anxiety|anxiety
646808|NCT00841022|anaesthesia|anaesthesia
646809|NCT00841022|child|child
646810|NCT00841022|RCT|rct
646811|NCT00841022|Elective surgery|elective surgery
646812|NCT00841009|gastric bypass|gastric bypass
646813|NCT00841009|obesity|obesity
646814|NCT00840996|Spine Surgery|spine surgery
646815|NCT00840996|Intraocular pressure|intraocular pressure
646816|NCT00840996|Lidocaine|lidocaine
646817|NCT00840996|Epidural Anesthetic|epidural anesthetic
646818|NCT00840983|delayed cord clamping|delayed cord clamping
646819|NCT00840983|very low birthweight infant|very low birthweight infant
646820|NCT00840983|bronchopulmonary dysplasia|bronchopulmonary dysplasia
646821|NCT00840983|intraventricular hemorrhage|intraventricular hemorrhage
646822|NCT00840983|motor function|motor function
646823|NCT00840944|gonadotropin releasing hormone agonist|gonadotropin releasing hormone agonist
646824|NCT00840944|growth hormone|growth hormone
646825|NCT00840944|final height|final height
646826|NCT00840944|bone density|bone density
646827|NCT00840944|puberty|puberty
646828|NCT00840931|Myeloid|myeloid
646829|NCT00840931|Monocytic|monocytic
646830|NCT00840931|Immunotherapy|immunotherapy
646831|NCT00840931|Vaccine|vaccine
646833|NCT00840931|High Risk Myelodysplastic Syndrome|high risk myelodysplastic syndrome
646834|NCT00840918|Cardiac surgery|cardiac surgery
646835|NCT00840918|Lidocaine|lidocaine
646836|NCT00840918|Quality of life|quality of life
646837|NCT00840905|HPV|hpv
646838|NCT00840879|Bioequivalence|bioequivalence
646839|NCT00840879|Healthy Subjects|healthy subjects
646840|NCT00840866|Bioequivalence|bioequivalence
646841|NCT00840866|Healthy Subjects|healthy subjects
646842|NCT00840853|Stem cell transplant|stem cell transplant
646843|NCT00840853|Acute Lymphoblastic Leukemia (ALL)|acute lymphoblastic leukemia (all)
646844|NCT00840853|Chronic Lymphocytic Leukemia (CLL)|chronic lymphocytic leukemia (cll)
646845|NCT00840853|Non Hodgkin's Lymphoma|non hodgkin's lymphoma
646846|NCT00840853|Cytotoxic T lymphocytes|cytotoxic t lymphocytes
646847|NCT00840853|CTL|ctl
646848|NCT00840853|CD-19|cd-19
646849|NCT00840853|chimeric receptor|chimeric receptor
646850|NCT00840840|Bioequivalence|bioequivalence
646851|NCT00840840|Healthy Subjects|healthy subjects
646852|NCT00840827|stage (IPSS low and INT-1)|stage (ipss low and int-1)
646853|NCT00840827|RBC transfusion-dependent|rbc transfusion-dependent
646854|NCT00840827|non-del 5q MDS|non-del 5q mds
646855|NCT00840814|lymphedema|lymphedema
646856|NCT00840814|stage I squamous cell carcinoma of the hypopharynx|stage i squamous cell carcinoma of the hypopharynx
646857|NCT00840814|stage II squamous cell carcinoma of the hypopharynx|stage ii squamous cell carcinoma of the hypopharynx
646858|NCT00840814|stage III squamous cell carcinoma of the hypopharynx|stage iii squamous cell carcinoma of the hypopharynx
646859|NCT00840814|stage I squamous cell carcinoma of the larynx|stage i squamous cell carcinoma of the larynx
646860|NCT00840814|stage I verrucous carcinoma of the larynx|stage i verrucous carcinoma of the larynx
646861|NCT00840814|stage II squamous cell carcinoma of the larynx|stage ii squamous cell carcinoma of the larynx
646862|NCT00840814|stage II verrucous carcinoma of the larynx|stage ii verrucous carcinoma of the larynx
646863|NCT00840814|stage III squamous cell carcinoma of the larynx|stage iii squamous cell carcinoma of the larynx
646864|NCT00840814|stage III verrucous carcinoma of the larynx|stage iii verrucous carcinoma of the larynx
646865|NCT00840814|stage I squamous cell carcinoma of the lip and oral cavity|stage i squamous cell carcinoma of the lip and oral cavity
646866|NCT00840814|stage II squamous cell carcinoma of the lip and oral cavity|stage ii squamous cell carcinoma of the lip and oral cavity
646867|NCT00840814|stage III squamous cell carcinoma of the lip and oral cavity|stage iii squamous cell carcinoma of the lip and oral cavity
646868|NCT00840814|stage I verrucous carcinoma of the oral cavity|stage i verrucous carcinoma of the oral cavity
646869|NCT00840814|stage II verrucous carcinoma of the oral cavity|stage ii verrucous carcinoma of the oral cavity
646870|NCT00840814|stage III verrucous carcinoma of the oral cavity|stage iii verrucous carcinoma of the oral cavity
646871|NCT00840814|stage I squamous cell carcinoma of the nasopharynx|stage i squamous cell carcinoma of the nasopharynx
646872|NCT00840814|stage II squamous cell carcinoma of the nasopharynx|stage ii squamous cell carcinoma of the nasopharynx
646873|NCT00840814|stage III squamous cell carcinoma of the nasopharynx|stage iii squamous cell carcinoma of the nasopharynx
646874|NCT00840814|stage I squamous cell carcinoma of the oropharynx|stage i squamous cell carcinoma of the oropharynx
646875|NCT00840814|stage II squamous cell carcinoma of the oropharynx|stage ii squamous cell carcinoma of the oropharynx
646876|NCT00840814|stage III squamous cell carcinoma of the oropharynx|stage iii squamous cell carcinoma of the oropharynx
712518|NCT00579891|colorectal cancer|colorectal cancer
646877|NCT00840814|stage I squamous cell carcinoma of the paranasal sinus and nasal cavity|stage i squamous cell carcinoma of the paranasal sinus and nasal cavity
646878|NCT00840814|stage II squamous cell carcinoma of the paranasal sinus and nasal cavity|stage ii squamous cell carcinoma of the paranasal sinus and nasal cavity
646879|NCT00840814|stage III squamous cell carcinoma of the paranasal sinus and nasal cavity|stage iii squamous cell carcinoma of the paranasal sinus and nasal cavity
646880|NCT00840814|salivary gland squamous cell carcinoma|salivary gland squamous cell carcinoma
646881|NCT00840814|stage I salivary gland cancer|stage i salivary gland cancer
647554|NCT00838097|Paediatric|paediatric
646882|NCT00840814|stage II salivary gland cancer|stage ii salivary gland cancer
646883|NCT00840814|stage III salivary gland cancer|stage iii salivary gland cancer
646884|NCT00840788|skin adhesive|skin adhesive
646885|NCT00840788|tissue adhesive|tissue adhesive
646886|NCT00840788|mediolateral episiotomy|mediolateral episiotomy
646887|NCT00840788|perineal repair|perineal repair
646888|NCT00840788|labor and delivery|labor and delivery
646890|NCT00840775|Stent|stent
646891|NCT00840775|interventional cardiology|interventional cardiology
646892|NCT00840775|catheterization|catheterization
646893|NCT00840775|symptomatic ischemic heart disease|symptomatic ischemic heart disease
646894|NCT00840762|HIV-1|hiv-1
646895|NCT00840762|HIV|hiv
646896|NCT00840762|HIV Genotypic testing|hiv genotypic testing
646897|NCT00840762|resistance|resistance
646898|NCT00840749|STARS|stars
646899|NCT00840749|Early Stage Non Small Cell Lung Cancer|early stage non small cell lung cancer
646900|NCT00840749|NSCLC|nsclc
646901|NCT00840749|CyberKnife|cyberknife
646902|NCT00840749|Surgery|surgery
646903|NCT00840749|Accuray|accuray
646904|NCT00840736|VBG|vbg
646905|NCT00840736|LAGB|lagb
646906|NCT00840736|long term results|long term results
646907|NCT00840736|Weight loss|weight loss
646908|NCT00840736|Complications|complications
646909|NCT00840736|Reoperations|reoperations
646910|NCT00840736|Conversion|conversion
646911|NCT00840723|Healthy smokers|healthy smokers
646912|NCT00840723|Current cigarette smokers|current cigarette smokers
646913|NCT00840723|No lung disease|no lung disease
646914|NCT00840710|women in active labor|women in active labor
646915|NCT00840697|low back pain|low back pain
646916|NCT00840697|neck pain|neck pain
646917|NCT00840697|return to work|return to work
646918|NCT00840697|exercises|exercises
646919|NCT00840697|cognitive intervention|cognitive intervention
646920|NCT00840684|adult acute myeloid leukemia with 11q23 (MLL) abnormalities|adult acute myeloid leukemia with 11q23 (mll) abnormalities
646921|NCT00840684|untreated adult acute myeloid leukemia|untreated adult acute myeloid leukemia
646922|NCT00840671|Cerebrolysin|cerebrolysin
646923|NCT00840671|Alteplase|alteplase
646924|NCT00840671|Ischemic Stroke|ischemic stroke
646925|NCT00840671|Modified Rankin Scale|modified rankin scale
646926|NCT00840671|NIH Stroke Scale|nih stroke scale
646927|NCT00840671|Barthel Index|barthel index
646928|NCT00840671|Glasgow Outcome Score|glasgow outcome score
646929|NCT00840658|HIV|hiv
646930|NCT00840658|Injection drug users|injection drug users
646931|NCT00840658|Female sex workers|female sex workers
646932|NCT00840658|STIs|stis
646933|NCT00840658|HIV Seronegativity|hiv seronegativity
646934|NCT00840645|YM178|ym178
646935|NCT00840645|Urinary Bladder, Overactive|urinary bladder, overactive
646936|NCT00840645|Mirabegron|mirabegron
646937|NCT00840632|Bioequivalence|bioequivalence
646938|NCT00840632|Healthy Subjects|healthy subjects
646939|NCT00840606|Bioequivalence|bioequivalence
646940|NCT00840606|Healthy Subjects|healthy subjects
646941|NCT00840593|Acromioclavicular Joint|acromioclavicular joint
646942|NCT00840593|Dislocation|dislocation
646943|NCT00840593|Trials, Randomized Clinical|trials, randomized clinical
646944|NCT00840593|Surgical Procedures, Operative|surgical procedures, operative
646945|NCT00840580|Cataract, Cornea, Vigamox, Cravit|cataract, cornea, vigamox, cravit
646946|NCT00840567|Stem cells|stem cells
646947|NCT00840554|Fatigue|fatigue
646948|NCT00840554|Cancer-related fatigue|cancer-related fatigue
646949|NCT00840554|High grade glioma|high grade glioma
646950|NCT00840554|Quality of life|quality of life
646951|NCT00840554|Exercise|exercise
646952|NCT00840554|Physical Therapy|physical therapy
646953|NCT00840554|HGG|hgg
646954|NCT00840554|QOL|qol
646955|NCT00840528|ozone|ozone
646956|NCT00840502|malaria|malaria
646957|NCT00840502|ultrasound|ultrasound
646958|NCT00840502|pregnancy|pregnancy
646959|NCT00840502|Pregnant women (infected with malaria and without)|pregnant women (infected with malaria and without)
646960|NCT00840476|Bioequivalence|bioequivalence
646961|NCT00840476|Healthy Subjects|healthy subjects
646962|NCT00840463|Pulmonary Hypertension|pulmonary hypertension
646963|NCT00840463|Diastolic Heart Failure|diastolic heart failure
646964|NCT00840450|ovarian cancer|ovarian cancer
646965|NCT00840450|recurrent|recurrent
646966|NCT00840450|Gleevec|gleevec
646967|NCT00840450|Paclitaxel|paclitaxel
646968|NCT00840450|Taxane|taxane
646969|NCT00840450|mullerian|mullerian
646970|NCT00840437|angina|angina
646971|NCT00840437|health related quality of life|health related quality of life
646972|NCT00840411|Bioequivalence|bioequivalence
646973|NCT00840411|Healthy Subjects|healthy subjects
646974|NCT00840398|Bioequivalence|bioequivalence
646975|NCT00840398|Healthy Subjects|healthy subjects
646976|NCT00840385|Peripheral T-cell lymphomas (PTCL)|peripheral t-cell lymphomas (ptcl)
646977|NCT00840385|Fludarabine|fludarabine
646978|NCT00840372|Blunt needles|blunt needles
646979|NCT00840372|Semi-blunt needles|semi-blunt needles
646980|NCT00840372|Buttonhole cannulation method|buttonhole cannulation method
646981|NCT00840359|Cutaneous leishmaniasis|cutaneous leishmaniasis
646982|NCT00840359|Photodynamic therapy|photodynamic therapy
646983|NCT00840346|Acute Myeloblastic Leukaemia (AML)|acute myeloblastic leukaemia (aml)
646984|NCT00840346|Panobinostat|panobinostat
646985|NCT00840320|Safety|safety
646986|NCT00840320|tolerability|tolerability
646987|NCT00840307|Obesity|obesity
646988|NCT00840307|Type 2 Diabetes|type 2 diabetes
646989|NCT00840307|Gastric Banding|gastric banding
646990|NCT00840294|Men with Elevated PSA|men with elevated psa
646991|NCT00840281|Bioequivalence|bioequivalence
646992|NCT00840281|Healthy Subjects|healthy subjects
646993|NCT00840268|OSDI|osdi
646994|NCT00840268|corneal staining|corneal staining
646995|NCT00840268|Dry Eye|dry eye
646996|NCT00840268|Dry Eye Signs and Symptoms in Dry Eye Patients|dry eye signs and symptoms in dry eye patients
646997|NCT00840255|Chronic Insomnia lasting more than 1 month|chronic insomnia lasting more than 1 month
646998|NCT00840229|adhesive capsulitis|adhesive capsulitis
646999|NCT00840229|corticosteroids|corticosteroids
647000|NCT00840229|injection|injection
647001|NCT00840229|pain|pain
647002|NCT00840216|Bioequivalence|bioequivalence
647003|NCT00840216|Healthy Subjects|healthy subjects
647004|NCT00840203|Bioequivalence|bioequivalence
647005|NCT00840203|Healthy Subjects|healthy subjects
647006|NCT00840177|recurrent adult acute myeloid leukemia|recurrent adult acute myeloid leukemia
647007|NCT00840177|adult acute myeloid leukemia with 11q23 (MLL) abnormalities|adult acute myeloid leukemia with 11q23 (mll) abnormalities
647008|NCT00840177|adult acute myeloid leukemia with inv(16)(p13;q22)|adult acute myeloid leukemia with inv(16)(p13;q22)
647009|NCT00840177|adult acute myeloid leukemia with t(15;17)(q22;q12)|adult acute myeloid leukemia with t(15;17)(q22;q12)
647010|NCT00840177|adult acute myeloid leukemia with t(16;16)(p13;q22)|adult acute myeloid leukemia with t(16;16)(p13;q22)
647011|NCT00840177|adult acute myeloid leukemia with t(8;21)(q22;q22)|adult acute myeloid leukemia with t(8;21)(q22;q22)
647012|NCT00840164|small-fiber sensory neuropathy|small-fiber sensory neuropathy
647013|NCT00840164|nerve pathology|nerve pathology
647014|NCT00840164|vasculature pathology|vasculature pathology
647015|NCT00840164|amputation|amputation
647016|NCT00840164|diabetic foot wound|diabetic foot wound
647017|NCT00840164|sensory neuropathy|sensory neuropathy
647018|NCT00840164|below knee amputation|below knee amputation
647019|NCT00840151|Substance Abuse|substance abuse
647020|NCT00840151|Contingency Management|contingency management
647021|NCT00840125|NSCLC|nsclc
647022|NCT00840125|ERLOTINIB|erlotinib
647023|NCT00840125|DOCETAXEL|docetaxel
647024|NCT00840125|first line treatment|first line treatment
647025|NCT00840125|Stage IIIB /IV|stage iiib /iv
647026|NCT00840125|not previously treated|not previously treated
647027|NCT00840125|ECOG PS 2 or age over 65|ecog ps 2 or age over 65
647028|NCT00840112|Long-chain 3-hydroxyacyl CoA dehydrogenase (LCHAD)|long-chain 3-hydroxyacyl coa dehydrogenase (lchad)
647029|NCT00840112|Mitochondrial trifunctional protein (TFP)|mitochondrial trifunctional protein (tfp)
647030|NCT00840112|LCHAD/TFP deficiency with peripheral neuropathy|lchad/tfp deficiency with peripheral neuropathy
647031|NCT00840099|Bioequivalence|bioequivalence
647032|NCT00840099|Healthy Subjects|healthy subjects
647033|NCT00840073|Bioequivalence|bioequivalence
647034|NCT00840073|Healthy Subjects|healthy subjects
647035|NCT00840047|Pediatric brain tumor|pediatric brain tumor
647036|NCT00840047|Pediatric solid tumor|pediatric solid tumor
647037|NCT00840047|Pediatric solid neoplasms|pediatric solid neoplasms
647038|NCT00840008|peptic ulcer bleeding|peptic ulcer bleeding
647039|NCT00840008|upper GI hemorrhage|upper gi hemorrhage
647040|NCT00840008|adherence to guidelines|adherence to guidelines
647041|NCT00840008|knowledge transfer|knowledge transfer
647042|NCT00839995|To determine the efficacy of ROTEM on assessing coagulation profiles.|to determine the efficacy of rotem on assessing coagulation profiles.
647043|NCT00839969|overactive bladder syndrome|overactive bladder syndrome
647044|NCT00839969|voiding|voiding
647045|NCT00839969|pressure flow studies|pressure flow studies
647046|NCT00839969|urethral dilatation|urethral dilatation
647047|NCT00839943|ozone|ozone
647048|NCT00839943|clean air|clean air
647049|NCT00839930|Bioequivalence|bioequivalence
647050|NCT00839930|Healthy Subjects|healthy subjects
647051|NCT00839917|Measles|measles
647052|NCT00839917|Mumps|mumps
647053|NCT00839917|Rubella|rubella
647054|NCT00839917|Varicella|varicella
647055|NCT00839904|children|children
647056|NCT00839904|cancer|cancer
647057|NCT00839904|exercise|exercise
647058|NCT00839904|fitness|fitness
647059|NCT00839904|body composition|body composition
647060|NCT00839891|TQT, QTc|tqt, qtc
647061|NCT00839865|Evidence-based evaluation|evidence-based evaluation
824696|NCT00135512|MDD|mdd
647062|NCT00839865|Multi-center randomized controlled clinical trials|multi-center randomized controlled clinical trials
647063|NCT00839865|Traditional Chinese Medicine|traditional chinese medicine
647064|NCT00839865|therapy|therapy
647065|NCT00839865|diabetic foot ulcer|diabetic foot ulcer
647066|NCT00839865|clinical trails|clinical trails
647067|NCT00839839|infertility|infertility
647068|NCT00839839|egg freezing|egg freezing
647069|NCT00839839|fertility preservation|fertility preservation
647070|NCT00839826|Prevention of Thromboembolism after total hip replacement|prevention of thromboembolism after total hip replacement
647071|NCT00839813|Yoga|yoga
647072|NCT00839813|Posttraumatic Stress Disorder|posttraumatic stress disorder
647073|NCT00839813|PTSD|ptsd
647074|NCT00839813|women's health|women's health
647075|NCT00839800|Asthma|asthma
647076|NCT00839800|Symbicort Turbuhaler|symbicort turbuhaler
647077|NCT00839774|Peas|peas
647078|NCT00839774|Cardiovascular|cardiovascular
647079|NCT00839774|Diabetes|diabetes
647080|NCT00839774|Insulin|insulin
647081|NCT00839774|Insulin resistance|insulin resistance
647082|NCT00839774|Abdominal fat|abdominal fat
647083|NCT00839748|asthma|asthma
647084|NCT00839748|registry for future asthmatic studies|registry for future asthmatic studies
647085|NCT00839748|questionnaires|questionnaires
647086|NCT00839748|lung function tests|lung function tests
647087|NCT00839735|COPD|copd
647088|NCT00839722|Uterine embolization|uterine embolization
647089|NCT00839722|leiomyomas|leiomyomas
647090|NCT00839722|fertility|fertility
647091|NCT00839722|myomectomies|myomectomies
647092|NCT00839709|liver disease|liver disease
647093|NCT00839709|liver transplantation|liver transplantation
647094|NCT00839709|depletion immunosuppression|depletion immunosuppression
647095|NCT00839709|non-depletion immunosuppression|non-depletion immunosuppression
647096|NCT00839696|Breast|breast
647097|NCT00839696|Estrogens|estrogens
647098|NCT00839696|Mammography|mammography
647099|NCT00839670|1- Constraint induced therapy|1- constraint induced therapy
647100|NCT00839670|2- Stroke|2- stroke
647101|NCT00839670|3- Upper limb|3- upper limb
647102|NCT00839670|4- Rehabilitation|4- rehabilitation
647103|NCT00839670|5- Motor training|5- motor training
647104|NCT00839670|1- First time clinical ischemic or hemorrhagic stroke|1- first time clinical ischemic or hemorrhagic stroke
647105|NCT00839670|2- At least 10° of active wrist extension|2- at least 10° of active wrist extension
647106|NCT00839670|3- At least 10° of thumb abduction/ extension|3- at least 10° of thumb abduction/ extension
647107|NCT00839670|4- At least 10° of extension in at least 2 additional digits|4- at least 10° of extension in at least 2 additional digits
647108|NCT00839670|3- Adequate balance while wearing the restraint.|3- adequate balance while wearing the restraint.
647109|NCT00839657|Embolism|embolism
647110|NCT00839657|Thrombosis|thrombosis
647111|NCT00839644|cystic fibrosis|cystic fibrosis
647112|NCT00839644|Chest Wall Oscillation|chest wall oscillation
647113|NCT00839644|drainage, postural|drainage, postural
647114|NCT00839644|Medication Adherence|medication adherence
647115|NCT00839644|patient dropouts|patient dropouts
647116|NCT00839631|subjects with advanced solid tumors refractory to standard therapy or for whom no effective therapy is available.|subjects with advanced solid tumors refractory to standard therapy or for whom no effective therapy is available.
647117|NCT00839605|Thoracic surgery one lung ventilation|thoracic surgery one lung ventilation
647118|NCT00839605|airway reconstruction|airway reconstruction
647119|NCT00839592|Insomnia|insomnia
647120|NCT00839592|Acupuncture|acupuncture
647121|NCT00839592|Electroacupuncture|electroacupuncture
647122|NCT00839592|Randomized Clinical Trial|randomized clinical trial
647123|NCT00839592|Traditional Chinese Medicine|traditional chinese medicine
647124|NCT00839579|slightly overweight|slightly overweight
647125|NCT00839579|males 35-45 years|males 35-45 years
647126|NCT00839566|Atrial Fibrillation|atrial fibrillation
647127|NCT00839566|Heart Failure|heart failure
647128|NCT00839540|candidemia|candidemia
647129|NCT00839540|echinocandin|echinocandin
647130|NCT00839540|micafungin|micafungin
647131|NCT00839540|caspofungin|caspofungin
647132|NCT00839527|diabetes|diabetes
647133|NCT00839514|Parkinson's disease|parkinson's disease
647134|NCT00839514|Trichloroethylene|trichloroethylene
647135|NCT00839488|pantoprazole|pantoprazole
647136|NCT00839488|famotidine|famotidine
647137|NCT00839488|stomach ulcer|stomach ulcer
647138|NCT00839488|digestive system surgical procedure|digestive system surgical procedure
647139|NCT00839475|colposcopy|colposcopy
647140|NCT00839475|Cervical intraepithelial neoplasia|cervical intraepithelial neoplasia
647141|NCT00839475|cervical cancer|cervical cancer
647142|NCT00839475|cervical precancer|cervical precancer
647143|NCT00839462|Thermal Erythema|thermal erythema
647144|NCT00839462|Dexpanthenol|dexpanthenol
647145|NCT00839462|Erythema|erythema
647146|NCT00839462|Efficacy|efficacy
647147|NCT00839449|subarachnoid hemorrhage|subarachnoid hemorrhage
647148|NCT00839449|cerebral vasospasm|cerebral vasospasm
647149|NCT00839449|eicosapentaenoic acid|eicosapentaenoic acid
647150|NCT00839436|Idiopathic CD4+ T-Lymphocytopenia|idiopathic cd4+ t-lymphocytopenia
647151|NCT00839436|Interleukin-7|interleukin-7
647152|NCT00839436|Clinical Trial|clinical trial
647153|NCT00839436|T-Lymphocytes|t-lymphocytes
647154|NCT00839436|Idiopathic CD4 Lymphocytopenia (ICL)|idiopathic cd4 lymphocytopenia (icl)
647155|NCT00839436|ICL|icl
647156|NCT00839423|Major depressive disorder|major depressive disorder
647157|NCT00839423|Placebo-controlled|placebo-controlled
647158|NCT00839423|Active reference|active reference
647159|NCT00839423|Multicenter study|multicenter study
647160|NCT00839423|Randomised study|randomised study
647161|NCT00839423|Acute treatment|acute treatment
647162|NCT00839410|skin cancer|skin cancer
647163|NCT00839410|melanoma|melanoma
647164|NCT00839410|sentinel lymph node biopsy|sentinel lymph node biopsy
647165|NCT00839410|bio bank|bio bank
647166|NCT00839410|genetic polymorphism|genetic polymorphism
647752|NCT00837239|Gemzar|gemzar
647167|NCT00839410|prospective cohort|prospective cohort
647168|NCT00839410|cohort|cohort
647169|NCT00839410|sentinel lymph nodes|sentinel lymph nodes
647170|NCT00839410|tissue samples|tissue samples
647171|NCT00839371|bispectral analysis|bispectral analysis
647172|NCT00839371|bronchoscopy|bronchoscopy
647173|NCT00839371|midazolam|midazolam
647174|NCT00839371|propofol|propofol
647175|NCT00839371|recovery|recovery
647176|NCT00839371|sedation|sedation
647177|NCT00839358|cirrhosis|cirrhosis
647178|NCT00839358|renal failure|renal failure
647179|NCT00839358|midodrine|midodrine
647180|NCT00839358|albumine|albumine
647181|NCT00839345|platelet|platelet
647182|NCT00839345|clopidogrel|clopidogrel
647183|NCT00839345|VerifyNow|verifynow
647184|NCT00839345|ticlopidine|ticlopidine
647185|NCT00839345|thrombosis|thrombosis
647186|NCT00839332|Pancreas|pancreas
647187|NCT00839332|metastatic cancer|metastatic cancer
647188|NCT00839332|advanced cancer|advanced cancer
647189|NCT00839332|Pancreatic cancer|pancreatic cancer
647191|NCT00839319|testosterone|testosterone
647192|NCT00839319|Acyline|acyline
647193|NCT00839319|Intratesticular hormone|intratesticular hormone
647194|NCT00839306|Gastroesophageal|gastroesophageal
647195|NCT00839306|Reflux|reflux
647196|NCT00839306|Disease|disease
647197|NCT00839306|GERD|gerd
647198|NCT00839293|Bioavailability|bioavailability
647199|NCT00839280|Dry skin|dry skin
647200|NCT00839280|Dexpanthenol|dexpanthenol
647201|NCT00839280|Moisturizing effect|moisturizing effect
647202|NCT00839267|platelet|platelet
647203|NCT00839267|VASP|vasp
647204|NCT00839267|clopidogrel|clopidogrel
647205|NCT00839267|cardiogenic shock|cardiogenic shock
647206|NCT00839267|myocardial infarction|myocardial infarction
647207|NCT00839267|percutaneous coronary intervention|percutaneous coronary intervention
647208|NCT00839254|Streptococcus pneumoniae|streptococcus pneumoniae
647209|NCT00839254|acute otitis media|acute otitis media
647210|NCT00839254|Pneumococcal conjugate vaccine|pneumococcal conjugate vaccine
647211|NCT00839254|nasopharyngeal carriage|nasopharyngeal carriage
647212|NCT00839254|Haemophilus influenzae|haemophilus influenzae
647213|NCT00839254|immunogenicity|immunogenicity
647214|NCT00839254|invasive disease|invasive disease
647215|NCT00839228|diastolic dysfunction|diastolic dysfunction
647216|NCT00839228|cardiac energetics|cardiac energetics
647217|NCT00839228|perhexiline|perhexiline
647218|NCT00839228|magnetic resonance spectroscopy|magnetic resonance spectroscopy
647219|NCT00839202|factor VIII|factor viii
647220|NCT00839202|hemophilia A|hemophilia a
647221|NCT00839202|assay|assay
647222|NCT00839189|CCRE|ccre
647223|NCT00839189|endotoxin|endotoxin
647224|NCT00839189|LPS|lps
647225|NCT00839189|asthma|asthma
647226|NCT00839189|allergies|allergies
647227|NCT00839189|allergic rhinitis|allergic rhinitis
647228|NCT00839176|Major Depressive Disorder (MDD)|major depressive disorder (mdd)
647229|NCT00839176|Serdaxin|serdaxin
647230|NCT00839176|Rexahn|rexahn
647231|NCT00839163|Embolism and Thrombosis|embolism and thrombosis
647232|NCT00839163|Pulmonary embolism|pulmonary embolism
647233|NCT00839163|Embolism|embolism
647234|NCT00839163|Thrombosis|thrombosis
647235|NCT00839150|Diabetic retinopathy|diabetic retinopathy
647236|NCT00839150|Color vision|color vision
647237|NCT00839150|Contrast sensitivity|contrast sensitivity
647238|NCT00839150|Electroretinogram|electroretinogram
647239|NCT00839150|Flicker-induced vasodilatation|flicker-induced vasodilatation
647240|NCT00839150|Dynamic Vessel Analyzer|dynamic vessel analyzer
647241|NCT00839137|asthma|asthma
647242|NCT00839137|exercise therapy|exercise therapy
647243|NCT00839124|normal volunteer|normal volunteer
647244|NCT00839124|healthy control volunteer|healthy control volunteer
647245|NCT00839124|healthy subjects|healthy subjects
647246|NCT00839124|asthma|asthma
647247|NCT00839124|allergy|allergy
647248|NCT00839124|allergic asthma|allergic asthma
647249|NCT00839111|Progression free survival|progression free survival
647250|NCT00839111|Toxicity|toxicity
647251|NCT00839111|Response rate|response rate
647252|NCT00839111|overall survival|overall survival
647253|NCT00839098|power wheelchairs|power wheelchairs
647254|NCT00839098|assistive technology|assistive technology
647255|NCT00839098|rehabilitation|rehabilitation
647256|NCT00839085|CABG|cabg
647257|NCT00839085|on pump|on pump
647258|NCT00839085|Grape seed extract|grape seed extract
647259|NCT00839085|Vit C|vit c
647260|NCT00839085|Oxidative stress|oxidative stress
647261|NCT00839072|bioavailability|bioavailability
647262|NCT00839072|pharmacokinetics|pharmacokinetics
647263|NCT00839072|healthy|healthy
647264|NCT00839072|crossover|crossover
647265|NCT00839072|trazodone|trazodone
647266|NCT00839059|AML|aml
647267|NCT00839059|lenalidomide|lenalidomide
647268|NCT00839046|Pediatric Asthma|pediatric asthma
647269|NCT00839046|Air Filters|air filters
647270|NCT00839046|Indoor Particulate Matter|indoor particulate matter
647271|NCT00839033|Cough assisted device|cough assisted device
647272|NCT00839033|Neuromuscular disease|neuromuscular disease
647849|NCT00836940|GRC 8200|grc 8200
647273|NCT00839033|Respiratory exacerbation|respiratory exacerbation
647274|NCT00839033|Invasive ventilation,|invasive ventilation,
647275|NCT00839033|Chest physiotherapy|chest physiotherapy
647276|NCT00839033|Congenital myopathies|congenital myopathies
647277|NCT00839020|Surgical Procedures, Minimally Invasive|surgical procedures, minimally invasive
647278|NCT00839020|Range of Motion|range of motion
647279|NCT00839020|Articular Arthroplasty, Replacement, Knee|articular arthroplasty, replacement, knee
647280|NCT00839007|ADHF|adhf
647281|NCT00839007|AHF|ahf
647282|NCT00839007|HF|hf
647283|NCT00838994|Insomnia|insomnia
647284|NCT00838994|Depression|depression
647285|NCT00838994|Electroacupuncture|electroacupuncture
647286|NCT00838994|Acupuncture|acupuncture
647287|NCT00838994|Randomized Clinical Trial|randomized clinical trial
647288|NCT00838994|Traditional Chinese Medicine|traditional chinese medicine
647289|NCT00838981|Treatment for addiction|treatment for addiction
647290|NCT00838981|Methadone given for opioid dependence|methadone given for opioid dependence
647291|NCT00838981|Cocaine|cocaine
647292|NCT00838981|Opiates|opiates
647293|NCT00838968|hepatocellular carcinoma|hepatocellular carcinoma
647294|NCT00838968|interferon-alpha|interferon-alpha
647295|NCT00838968|p48|p48
647296|NCT00838955|Hodgkin's lymphoma|hodgkin's lymphoma
647297|NCT00838955|relapsed Hodgkin's lymphoma|relapsed hodgkin's lymphoma
647298|NCT00838955|refractory Hodgkin's lymphoma|refractory hodgkin's lymphoma
647299|NCT00838955|Temsirolimus|temsirolimus
647300|NCT00838942|Eyes disease and dementia.|eyes disease and dementia.
647301|NCT00838942|Cataract surgery in the patient with dementia.|cataract surgery in the patient with dementia.
647302|NCT00838942|Visual hallucinations|visual hallucinations
647303|NCT00838942|Visual acuity,|visual acuity,
647304|NCT00838942|Specific eye pathologies in Alzheimer's disease.|specific eye pathologies in alzheimer's disease.
647305|NCT00838942|Improvement of behaviour,|improvement of behaviour,
647306|NCT00838942|Improvement of autonomy|improvement of autonomy
647307|NCT00838942|Improvement of mood|improvement of mood
647308|NCT00838942|Cataract extraction in Alzheimer disease patient|cataract extraction in alzheimer disease patient
647309|NCT00838929|brain metastases|brain metastases
647310|NCT00838929|radiation|radiation
647311|NCT00838929|vorinostat|vorinostat
647312|NCT00838929|lung cancer|lung cancer
647313|NCT00838929|breast cancer|breast cancer
647314|NCT00838916|diabetes|diabetes
647315|NCT00838903|diabetes|diabetes
647316|NCT00838877|Alzheimer's Disease|alzheimer's disease
647317|NCT00838877|PET|pet
647318|NCT00838877|Phase 1|phase 1
647319|NCT00838877|Positron Emission Tomography|positron emission tomography
647320|NCT00838864|variceal bleeding|variceal bleeding
647321|NCT00838864|antibiotic prophylaxis|antibiotic prophylaxis
647322|NCT00838864|ceftrioxone|ceftrioxone
647323|NCT00838851|endotoxin|endotoxin
647324|NCT00838851|CCRE|ccre
647325|NCT00838851|LPS|lps
647326|NCT00838838|Testosterone replacement therapy|testosterone replacement therapy
647327|NCT00838838|Hypogonadism|hypogonadism
647328|NCT00838838|Osteoporosis|osteoporosis
647329|NCT00838838|Immobilisation|immobilisation
647330|NCT00838838|Paraplegia|paraplegia
647331|NCT00838838|Testosterone|testosterone
647332|NCT00838825|diabetes|diabetes
647333|NCT00838825|chronic care management|chronic care management
647334|NCT00838825|resource utilization|resource utilization
647335|NCT00838825|outcome|outcome
647336|NCT00838825|glycohemoglobin|glycohemoglobin
647337|NCT00838825|hospitalization|hospitalization
647338|NCT00838812|clindamycin|clindamycin
647339|NCT00838812|tretinoin|tretinoin
647340|NCT00838812|acne vulgaris|acne vulgaris
647341|NCT00838812|Acne vulgaris mild to moderate|acne vulgaris mild to moderate
647342|NCT00838799|diabetic|diabetic
647343|NCT00838799|peripheral|peripheral
647344|NCT00838799|neuropathic|neuropathic
647345|NCT00838799|pain|pain
647346|NCT00838799|chronic|chronic
647347|NCT00838799|diabetes|diabetes
647348|NCT00838760|PEPI-TiDP23-C103|pepi-tidp23-c103
647349|NCT00838760|PEPI-C103|pepi-c103
647350|NCT00838760|PEPI|pepi
647351|NCT00838760|TMC558445|tmc558445
647352|NCT00838760|TMC310911|tmc310911
647353|NCT00838760|Darunavir, Healthy volunteers|darunavir, healthy volunteers
647354|NCT00838760|Pharmacokinetics|pharmacokinetics
647355|NCT00838760|HIV Infections|hiv infections
647356|NCT00838747|folate receptor|folate receptor
647357|NCT00838747|blood samples|blood samples
647358|NCT00838747|ovarian cancer|ovarian cancer
647359|NCT00838747|development of measure of folate receptor in blood samples|development of measure of folate receptor in blood samples
647360|NCT00838747|possible selection of patients for treatment with FR targeted agents|possible selection of patients for treatment with fr targeted agents
647361|NCT00838734|CORNEAL TOPOGRAPHY|corneal topography
647362|NCT00838734|KERATOPLASTY|keratoplasty
647363|NCT00838721|Open Angle Glaucoma|open angle glaucoma
647364|NCT00838721|Ocular Hypertension|ocular hypertension
647365|NCT00838721|Laser Trabeculoplasty|laser trabeculoplasty
647366|NCT00838695|Hand vein sensitivity|hand vein sensitivity
647367|NCT00838695|phenylephrine|phenylephrine
647368|NCT00838695|nitroglycerin|nitroglycerin
647369|NCT00838682|peptic ulcer bleeding|peptic ulcer bleeding
647371|NCT00838682|proton pump inhibitor|proton pump inhibitor
647372|NCT00838669|Schizophrenia|schizophrenia
647373|NCT00838669|Mood disorders|mood disorders
647374|NCT00838669|Antipsychotic drugs|antipsychotic drugs
647375|NCT00838669|Extended release OROS paliperidone|extended release oros paliperidone
647376|NCT00838656|ovarian carcinosarcoma|ovarian carcinosarcoma
647377|NCT00838656|stage IIIA ovarian epithelial cancer|stage iiia ovarian epithelial cancer
647378|NCT00838656|stage IIIB ovarian epithelial cancer|stage iiib ovarian epithelial cancer
647379|NCT00838656|stage IIIC ovarian epithelial cancer|stage iiic ovarian epithelial cancer
647380|NCT00838656|stage IV ovarian epithelial cancer|stage iv ovarian epithelial cancer
647381|NCT00838656|stage IIIA primary peritoneal cavity cancer|stage iiia primary peritoneal cavity cancer
647382|NCT00838656|stage IIIB primary peritoneal cavity cancer|stage iiib primary peritoneal cavity cancer
647383|NCT00838656|stage IIIC primary peritoneal cavity cancer|stage iiic primary peritoneal cavity cancer
647384|NCT00838656|stage IV primary peritoneal cavity cancer|stage iv primary peritoneal cavity cancer
647385|NCT00838656|stage IIIA fallopian tube cancer|stage iiia fallopian tube cancer
647386|NCT00838656|stage IIIB fallopian tube cancer|stage iiib fallopian tube cancer
647387|NCT00838656|stage IIIC fallopian tube cancer|stage iiic fallopian tube cancer
647388|NCT00838656|stage IV fallopian tube cancer|stage iv fallopian tube cancer
647389|NCT00838643|allogeneic transplantation|allogeneic transplantation
647390|NCT00838643|Invasive aspergillosis|invasive aspergillosis
647391|NCT00838630|Bioequivalence|bioequivalence
647392|NCT00838630|Healthy Subjects|healthy subjects
647393|NCT00838617|Amyotrophic Lateral Sclerosis|amyotrophic lateral sclerosis
647394|NCT00838617|Ultrasonography|ultrasonography
647395|NCT00838617|Atrophy|atrophy
647396|NCT00838591|MN-221|mn-221
647397|NCT00838591|Asthma|asthma
647398|NCT00838591|Acute|acute
647399|NCT00838591|Exacerbation|exacerbation
647400|NCT00838578|KRN330|krn330
647401|NCT00838578|Colorectal Cancer|colorectal cancer
647402|NCT00838578|Antimetabolites|antimetabolites
647403|NCT00838578|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic
647404|NCT00838578|Digestive System Neoplasms|digestive system neoplasms
647405|NCT00838578|Immunologic Factors|immunologic factors
647406|NCT00838578|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action
647407|NCT00838578|Antineoplastic Agents|antineoplastic agents
647408|NCT00838578|Gastrointestinal Diseases|gastrointestinal diseases
647409|NCT00838578|Physiological Effects of Drugs|physiological effects of drugs
647410|NCT00838578|Colonic Diseases|colonic diseases
647411|NCT00838578|Irinotecan|irinotecan
647412|NCT00838578|Enzyme Inhibitors|enzyme inhibitors
647413|NCT00838578|Intestinal Diseases|intestinal diseases
647414|NCT00838578|Immunosuppressive Agents|immunosuppressive agents
647415|NCT00838578|Rectal Diseases|rectal diseases
647416|NCT00838578|Pharmacologic Actions|pharmacologic actions
647417|NCT00838578|Intestinal Neoplasms|intestinal neoplasms
647418|NCT00838578|Neoplasms by Site|neoplasms by site
647419|NCT00838578|Digestive System Diseases|digestive system diseases
647420|NCT00838578|Therapeutic Uses|therapeutic uses
647421|NCT00838578|Fluorouracil|fluorouracil
647422|NCT00838578|Neoplasms|neoplasms
647423|NCT00838578|Gastrointestinal Neoplasms|gastrointestinal neoplasms
647424|NCT00838578|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic
647425|NCT00838578|Colorectal Neoplasms|colorectal neoplasms
647426|NCT00838565|Safety and tolerability Pharmacokinetics Pharmacodynamics PF-04236921|safety and tolerability pharmacokinetics pharmacodynamics pf-04236921
647427|NCT00838552|asthma inflammation bronchoscopy|asthma inflammation bronchoscopy
647428|NCT00838539|Neratinib|neratinib
647429|NCT00838539|solid tumors|solid tumors
647430|NCT00838539|phase 1|phase 1
647431|NCT00838539|dose finding study|dose finding study
647432|NCT00838539|HKI-272|hki-272
647433|NCT00838539|Nerlynx|nerlynx
647434|NCT00838539|Temsirolimus|temsirolimus
647435|NCT00838539|PB-272|pb-272
647436|NCT00838526|Gastroesophageal|gastroesophageal
647437|NCT00838526|Reflux|reflux
647438|NCT00838526|Disease|disease
647439|NCT00838526|GERD|gerd
647440|NCT00838513|aHUS|ahus
647441|NCT00838500|Venous insufficiency|venous insufficiency
647442|NCT00838500|Leg ulcer|leg ulcer
647443|NCT00838500|balneology|balneology
647444|NCT00838500|hydrotherapy|hydrotherapy
647445|NCT00838500|Modified Rutherford score|modified rutherford score
647446|NCT00838500|Euroquol EQ 5d scale|euroquol eq 5d scale
647447|NCT00838500|CIVIQ2 scale|civiq2 scale
647448|NCT00838500|Visual analogic Scale|visual analogic scale
647449|NCT00838500|SPA treatment|spa treatment
647450|NCT00838487|chondroitin|chondroitin
647451|NCT00838487|glucosamine|glucosamine
647452|NCT00838487|osteoarthritis|osteoarthritis
647453|NCT00838474|metabolic rate|metabolic rate
647454|NCT00838474|music|music
647455|NCT00838474|preterm infants|preterm infants
647456|NCT00838474|energy expenditure|energy expenditure
647457|NCT00838474|NIDCA|nidca
647458|NCT00838448|exercise|exercise
647459|NCT00838448|cannabis use|cannabis use
647460|NCT00838448|visual cues|visual cues
647461|NCT00838435|Phenylketonuria|phenylketonuria
647463|NCT00838435|Kuvan|kuvan
647464|NCT00838435|Phenoptin|phenoptin
647465|NCT00838435|Biopten|biopten
647466|NCT00838435|Neurocognitive Function|neurocognitive function
647467|NCT00838435|Phenylalanine|phenylalanine
647468|NCT00838383|multi-center, placebo-controlled, randomized study of sitaxsentan administered to subjects post-cross-clamp release and 12 hours post-CPB|multi-center, placebo-controlled, randomized study of sitaxsentan administered to subjects post-cross-clamp release and 12 hours post-cpb
647469|NCT00838370|Pharmacogenetics|pharmacogenetics
647470|NCT00838370|cost-benefit analysis|cost-benefit analysis
647471|NCT00838370|toxicity|toxicity
647472|NCT00838370|antineoplastic drugs|antineoplastic drugs
647473|NCT00838370|Dihydropyrimidine Dehydrogenase|dihydropyrimidine dehydrogenase
647474|NCT00838357|Mobilisation stem cells|mobilisation stem cells
647475|NCT00838357|G-CSF Mobilisation Regimen|g-csf mobilisation regimen
647476|NCT00838357|Lymphoma|lymphoma
647477|NCT00838357|Multiple Myeloma|multiple myeloma
647478|NCT00838344|medication adherence|medication adherence
647479|NCT00838344|medication persistence|medication persistence
647480|NCT00838344|pharmacist interventions|pharmacist interventions
647481|NCT00838344|diabetes|diabetes
647482|NCT00838344|persistence|persistence
647483|NCT00838344|adherence|adherence
647484|NCT00838331|Blood Transfusions|blood transfusions
647485|NCT00838318|Colorectal CancerScreening|colorectal cancerscreening
647487|NCT00838318|Hispanic|hispanic
647488|NCT00838318|CRC Patients|crc patients
647489|NCT00838318|First-Degree Relatives|first-degree relatives
647490|NCT00838318|FDRs|fdrs
647491|NCT00838318|Interviews|interviews
647492|NCT00838318|Colorectal cancer screening|colorectal cancer screening
647493|NCT00838318|CRCS|crcs
647494|NCT00838318|Key Informants|key informants
647495|NCT00838305|MDMA|mdma
647496|NCT00838305|citalopram|citalopram
647497|NCT00838305|serotonin|serotonin
647498|NCT00838305|psychedelic|psychedelic
647499|NCT00838292|food supplementation|food supplementation
647500|NCT00838292|HIV|hiv
647501|NCT00838292|malnutrition|malnutrition
647502|NCT00838279|Bioequivalence|bioequivalence
647503|NCT00838279|Healthy Subjects|healthy subjects
647504|NCT00838266|mouthrinse|mouthrinse
647505|NCT00838266|grape seed extract|grape seed extract
647506|NCT00838266|fluor|fluor
647507|NCT00838266|plaque index|plaque index
647508|NCT00838253|Acute Heart Failure|acute heart failure
647509|NCT00838253|Inotropes|inotropes
647510|NCT00838253|Lusitropic agents|lusitropic agents
647511|NCT00838253|Istaroxime|istaroxime
647512|NCT00838253|Debio 0614|debio 0614
647513|NCT00838240|adult acute minimally differentiated myeloid leukemia (M0)|adult acute minimally differentiated myeloid leukemia (m0)
647514|NCT00838240|adult acute myeloblastic leukemia without maturation (M1)|adult acute myeloblastic leukemia without maturation (m1)
647515|NCT00838240|adult acute myeloblastic leukemia with maturation (M2)|adult acute myeloblastic leukemia with maturation (m2)
647516|NCT00838240|adult acute myelomonocytic leukemia (M4)|adult acute myelomonocytic leukemia (m4)
647517|NCT00838240|adult acute monoblastic leukemia (M5a)|adult acute monoblastic leukemia (m5a)
647518|NCT00838240|adult acute monocytic leukemia (M5b)|adult acute monocytic leukemia (m5b)
647519|NCT00838240|adult erythroleukemia (M6a)|adult erythroleukemia (m6a)
647520|NCT00838240|adult pure erythroid leukemia (M6b)|adult pure erythroid leukemia (m6b)
647521|NCT00838240|adult acute megakaryoblastic leukemia (M7)|adult acute megakaryoblastic leukemia (m7)
647522|NCT00838240|adult acute myeloid leukemia with 11q23 (MLL) abnormalities|adult acute myeloid leukemia with 11q23 (mll) abnormalities
647523|NCT00838240|adult acute myeloid leukemia with t(16;16)(p13;q22)|adult acute myeloid leukemia with t(16;16)(p13;q22)
647524|NCT00838240|adult acute myeloid leukemia with t(8;21)(q22;q22)|adult acute myeloid leukemia with t(8;21)(q22;q22)
647525|NCT00838240|adult acute myeloid leukemia with inv(16)(p13;q22)|adult acute myeloid leukemia with inv(16)(p13;q22)
647526|NCT00838240|untreated adult acute myeloid leukemia|untreated adult acute myeloid leukemia
647527|NCT00838240|de novo myelodysplastic syndromes|de novo myelodysplastic syndromes
647528|NCT00838240|secondary acute myeloid leukemia|secondary acute myeloid leukemia
647529|NCT00838227|Schizophrenia|schizophrenia
647530|NCT00838227|Cognition|cognition
647531|NCT00838227|Obesity|obesity
647532|NCT00838227|Sedation|sedation
647533|NCT00838201|Androgen deprivation therapy for non-metastatic prostate cancer|androgen deprivation therapy for non-metastatic prostate cancer
647534|NCT00838188|Metabolic rate|metabolic rate
647535|NCT00838188|indirect calorimetry|indirect calorimetry
647536|NCT00838188|oral feeding|oral feeding
647537|NCT00838175|Peripheral Venous Catheterization|peripheral venous catheterization
647538|NCT00838162|Human immunodeficiency virus type 1|human immunodeficiency virus type 1
647539|NCT00838162|HIV-1|hiv-1
647540|NCT00838162|HIV-1 treatment-naive|hiv-1 treatment-naive
647541|NCT00838162|TMC310911|tmc310911
647542|NCT00838162|Protease inhibitor|protease inhibitor
647543|NCT00838162|Ritonavir|ritonavir
647544|NCT00838162|Antiviral Activity|antiviral activity
647545|NCT00838162|HIV Infections|hiv infections
647546|NCT00838162|Treatment Naive|treatment naive
647547|NCT00838136|Bioequivalence|bioequivalence
647548|NCT00838136|Healthy Subjects|healthy subjects
647549|NCT00838110|Alzheimer's Disease|alzheimer's disease
647550|NCT00838110|Dimebon|dimebon
647551|NCT00838110|Safety|safety
647552|NCT00838110|Tolerability|tolerability
647553|NCT00838097|CKD|ckd
647555|NCT00838097|Darbepoetin Alfa|darbepoetin alfa
647556|NCT00838071|Hepatitis B|hepatitis b
647557|NCT00838071|HBV|hbv
647558|NCT00838071|Anti-hepatitis B antibodies|anti-hepatitis b antibodies
647559|NCT00838071|Immunoglobulins|immunoglobulins
647560|NCT00838071|liver transplantation|liver transplantation
647561|NCT00838071|Protective levels|protective levels
647562|NCT00838071|Recurrence|recurrence
647563|NCT00838071|Intravenous|intravenous
647564|NCT00838058|pharmacology formulation normal healthy volunteers food effect|pharmacology formulation normal healthy volunteers food effect
647565|NCT00838032|acute schizophrenic patients|acute schizophrenic patients
647566|NCT00838006|post-traumatic stress disorder|post-traumatic stress disorder
647567|NCT00838006|post-deployment|post-deployment
647568|NCT00838006|prediction|prediction
647569|NCT00838006|prevention|prevention
647570|NCT00837993|Advanced Stage Serous Carcinoma of the Ovary|advanced stage serous carcinoma of the ovary
647571|NCT00837993|serous ovarian carcinoma|serous ovarian carcinoma
647572|NCT00837993|Ovary|ovary
647573|NCT00837993|GOG Protocol 158|gog protocol 158
647574|NCT00837993|Survival Analysis|survival analysis
647575|NCT00837993|Pathology Slides|pathology slides
647576|NCT00837993|Two-tier Grading System|two-tier grading system
647577|NCT00837993|Ancillary Study|ancillary study
647578|NCT00837980|head and neck cancer|head and neck cancer
647579|NCT00837980|DW MRI|dw mri
647580|NCT00837980|PET|pet
647581|NCT00837980|DCE MRI|dce mri
647582|NCT00837980|functional imaging|functional imaging
647583|NCT00837980|IMRT|imrt
647584|NCT00837967|Asthma|asthma
647585|NCT00837967|Symbicort Turbuhaler|symbicort turbuhaler
647586|NCT00837954|PTFE Graft|ptfe graft
647587|NCT00837954|Suture Hole Bleeding|suture hole bleeding
647588|NCT00837954|Hemostasis|hemostasis
647589|NCT00837928|unspecified adult solid tumor, protocol specific|unspecified adult solid tumor, protocol specific
647590|NCT00837928|tumors metastatic to brain|tumors metastatic to brain
647591|NCT00837915|Bioequivaelnce Loratadine 10mg /Pseudoephedrine Sulfate 240 mg Extended Release Tablets|bioequivaelnce loratadine 10mg /pseudoephedrine sulfate 240 mg extended release tablets
647592|NCT00837902|Atenolol|atenolol
647593|NCT00837902|Exercise|exercise
647594|NCT00837902|Genotype|genotype
647595|NCT00837902|Healthy volunteers|healthy volunteers
647596|NCT00837889|cognition|cognition
647597|NCT00837889|decompensation|decompensation
647598|NCT00837889|heart failure|heart failure
647599|NCT00837889|recompensation|recompensation
647600|NCT00837876|recurrent pancreatic cancer|recurrent pancreatic cancer
647601|NCT00837876|stage III pancreatic cancer|stage iii pancreatic cancer
647602|NCT00837876|stage IV pancreatic cancer|stage iv pancreatic cancer
647603|NCT00837876|adenocarcinoma of the pancreas|adenocarcinoma of the pancreas
647604|NCT00837850|total hip arthroplasty|total hip arthroplasty
647605|NCT00837850|Charnley stem|charnley stem
647606|NCT00837850|RSA|rsa
647607|NCT00837850|non-inflammatory arthritis|non-inflammatory arthritis
647608|NCT00837837|pharmacokinetics|pharmacokinetics
647609|NCT00837837|children|children
647610|NCT00837837|adolescents|adolescents
647611|NCT00837837|antihistamine|antihistamine
647612|NCT00837824|Fabry Disease patients with Severe Renal Disease|fabry disease patients with severe renal disease
647613|NCT00837811|Arthritis|arthritis
647614|NCT00837772|Alignment|alignment
647615|NCT00837759|Type I Diabetes|type i diabetes
647616|NCT00837759|Preserve Beta Cell Function|preserve beta cell function
647617|NCT00837759|Sitagliptin|sitagliptin
647618|NCT00837759|Lansoprazole|lansoprazole
647619|NCT00837759|GAD65 (Diamyd)|gad65 (diamyd)
647620|NCT00837759|Diabetes|diabetes
647621|NCT00837759|Type 1 Diabetes|type 1 diabetes
647622|NCT00837759|T1DM|t1dm
647623|NCT00837733|Endometrial biopsy|endometrial biopsy
647624|NCT00837733|IVF/ICSI|ivf/icsi
647625|NCT00837733|Pregnancy outcome|pregnancy outcome
647626|NCT00837733|Recurrent implantation failure|recurrent implantation failure
647627|NCT00837720|hypertension|hypertension
647628|NCT00837720|blood pressure|blood pressure
647629|NCT00837720|Atacand®|atacand®
647630|NCT00837720|candesartan|candesartan
647631|NCT00837707|aripiprazole|aripiprazole
647632|NCT00837707|Tardive Dyskinesia|tardive dyskinesia
647633|NCT00837694|BMI|bmi
647634|NCT00837694|obesity|obesity
647635|NCT00837694|sensitization|sensitization
647636|NCT00837694|food reinforcement|food reinforcement
647637|NCT00837694|snack food|snack food
647638|NCT00837694|Portion size of daily snacks|portion size of daily snacks
647639|NCT00837694|Weight status|weight status
647640|NCT00837681|Bone Marrow Transplant|bone marrow transplant
647641|NCT00837681|hematopoietic stem cell transplantation|hematopoietic stem cell transplantation
647642|NCT00837668|sarcoidosis|sarcoidosis
647643|NCT00837668|stromal gene expression|stromal gene expression
647644|NCT00837668|pulmonary sarcoidosis|pulmonary sarcoidosis
647645|NCT00837668|bronchoscopy|bronchoscopy
647646|NCT00837655|Chronic kidney disease|chronic kidney disease
647647|NCT00837655|End-stage renal disease|end-stage renal disease
647648|NCT00837655|phosphate binder|phosphate binder
647649|NCT00837655|insulin resistance|insulin resistance
647650|NCT00837655|glucose intolerance|glucose intolerance
647651|NCT00837655|sevelamer|sevelamer
647652|NCT00837642|Vascular function in offspring of ART|vascular function in offspring of art
647653|NCT00837629|chronic obstructive pulmonary disease|chronic obstructive pulmonary disease
647654|NCT00837629|COPD|copd
647655|NCT00837629|Symbicort Turbuhaler|symbicort turbuhaler
647656|NCT00837616|Turner Syndrome|turner syndrome
647657|NCT00837616|Hypogonadism|hypogonadism
647658|NCT00837616|GH|gh
647659|NCT00837616|Estrogen|estrogen
647660|NCT00837616|Estrogen Patches|estrogen patches
647661|NCT00837616|IGF-I|igf-i
647662|NCT00837616|Body Composition|body composition
647663|NCT00837616|Protein Metabolism|protein metabolism
647664|NCT00837616|Lipid Oxidation|lipid oxidation
647665|NCT00837616|Estradiol assay by LCMSMS|estradiol assay by lcmsms
647666|NCT00837616|Recombinant Cell Bioassay|recombinant cell bioassay
647667|NCT00837603|tga|tga
647668|NCT00837603|atrial switch|atrial switch
647669|NCT00837603|training|training
647670|NCT00837590|Vascular function|vascular function
647671|NCT00837590|Glucose tolerance|glucose tolerance
647672|NCT00837590|Obesity|obesity
647673|NCT00837590|Pre-diabetes|pre-diabetes
647674|NCT00837564|chronic depression|chronic depression
647675|NCT00837564|CBASP|cbasp
647676|NCT00837564|Escitalopram|escitalopram
647677|NCT00837564|depression|depression
647678|NCT00837564|trauma|trauma
647679|NCT00837551|Non-steroid|non-steroid
647680|NCT00837551|Small molecule|small molecule
647681|NCT00837551|Topical cream|topical cream
647682|NCT00837551|Inflammatory disease|inflammatory disease
647683|NCT00837551|Skin|skin
647684|NCT00837538|Spinal sagittal range of motion|spinal sagittal range of motion
647685|NCT00837538|Intersegmental range of motion|intersegmental range of motion
647686|NCT00837538|Spinal Mouse|spinal mouse
647687|NCT00837512|microneedle continuous subcutaneous insulin infusion|microneedle continuous subcutaneous insulin infusion
647688|NCT00837499|Breast|breast
647689|NCT00837499|Breast Cancer|breast cancer
647690|NCT00837499|Risk Factors|risk factors
647691|NCT00837499|Mexican Women|mexican women
647692|NCT00837499|Mexican-American Women|mexican-american women
647693|NCT00837499|African-American Women|african-american women
647694|NCT00837499|Epidemiological|epidemiological
647695|NCT00837499|Questionnaire|questionnaire
647696|NCT00837499|Survey|survey
647697|NCT00837499|Interview|interview
647698|NCT00837486|Treatment Resistant Depression|treatment resistant depression
647699|NCT00837486|Treatment Refractory Depression|treatment refractory depression
647700|NCT00837486|Deep Brain Stimulation|deep brain stimulation
647701|NCT00837486|Depression|depression
647702|NCT00837473|Bone Void Filler|bone void filler
647703|NCT00837473|Iliac Crest Bone Void Filler|iliac crest bone void filler
647704|NCT00837473|Back Surgery and Autograft Bone|back surgery and autograft bone
647705|NCT00837473|Autograft Bone|autograft bone
647706|NCT00837473|Allograft Bone|allograft bone
647707|NCT00837460|Hand|hand
647708|NCT00837460|Rehabilitation|rehabilitation
647709|NCT00837434|tumor necrosis factor (TNF) blockade|tumor necrosis factor (tnf) blockade
647710|NCT00837434|inflammatory autoimmune disorder|inflammatory autoimmune disorder
647711|NCT00837421|sepsis|sepsis
647712|NCT00837421|registry|registry
647713|NCT00837408|GWAS|gwas
647714|NCT00837395|premenstrual increase in asthma symptoms|premenstrual increase in asthma symptoms
647715|NCT00837369|Stress echocardiography|stress echocardiography
647716|NCT00837369|SPECT|spect
647717|NCT00837369|Myocardial perfusion imaging|myocardial perfusion imaging
647718|NCT00837343|Bipolar disorder|bipolar disorder
647719|NCT00837330|polypoidal choroidal vasculopathy|polypoidal choroidal vasculopathy
647720|NCT00837330|choroidal neovascularization|choroidal neovascularization
647721|NCT00837330|ranibizumab|ranibizumab
647722|NCT00837330|Lucentis|lucentis
647723|NCT00837317|Phenols|phenols
647724|NCT00837317|Laser-Doppler|laser-doppler
647725|NCT00837317|Olive Oil|olive oil
647726|NCT00837317|Sunflower Oil|sunflower oil
647727|NCT00837317|Dimethylpolysiloxane|dimethylpolysiloxane
647728|NCT00837317|Postprandial|postprandial
647729|NCT00837317|Inflammation|inflammation
647730|NCT00837317|Oxidative Stress|oxidative stress
647731|NCT00837291|osteoarthritis|osteoarthritis
647732|NCT00837291|knee|knee
647733|NCT00837291|CF101|cf101
647734|NCT00837278|IVF|ivf
647735|NCT00837278|angiogenic factors|angiogenic factors
647736|NCT00837278|cytokines|cytokines
647737|NCT00837265|Breast Cancer Supportive Care Neutropenia|breast cancer supportive care neutropenia
647738|NCT00837252|Central Serous Chorioretinopathy|central serous chorioretinopathy
647739|NCT00837252|Finasteride|finasteride
647740|NCT00837252|Proscar|proscar
647741|NCT00837252|Retinal Eye Disease|retinal eye disease
647742|NCT00837239|HuaChanSu|huachansu
647743|NCT00837239|HCS|hcs
647744|NCT00837239|Gastrointestinal|gastrointestinal
647745|NCT00837239|Gastrointestinal Disease|gastrointestinal disease
647746|NCT00837239|Metastases|metastases
647747|NCT00837239|Cancer|cancer
647748|NCT00837239|Pancreatic cancer|pancreatic cancer
647749|NCT00837239|Placebo|placebo
647750|NCT00837239|Gemcitabine|gemcitabine
647751|NCT00837239|Gemcitabine Hydrocholoride|gemcitabine hydrocholoride
647753|NCT00837239|Fudan UniversityCancer Hospital|fudan universitycancer hospital
647754|NCT00837213|Acne|acne
647755|NCT00837200|lymphoma|lymphoma
647756|NCT00837200|myeloma|myeloma
647757|NCT00837187|dexmedetomidine|dexmedetomidine
647758|NCT00837187|intranasal|intranasal
647759|NCT00837187|pharmacokinetics|pharmacokinetics
647760|NCT00837187|pharmacodynamics|pharmacodynamics
647761|NCT00837174|non-Hodgkin Lymphoma|non-hodgkin lymphoma
647762|NCT00837174|aggressive lymphoma|aggressive lymphoma
647763|NCT00837174|indolent lymphoma|indolent lymphoma
647764|NCT00837174|B cell lymphoma|b cell lymphoma
647765|NCT00837174|T cell lymphoma|t cell lymphoma
647766|NCT00837174|Diffuse large B cell lymphoma|diffuse large b cell lymphoma
647767|NCT00837174|anaplastic large B cell lymphoma|anaplastic large b cell lymphoma
647768|NCT00837174|lymphoblastic lymphoma|lymphoblastic lymphoma
647769|NCT00837174|Burkitt's lymphoma|burkitt's lymphoma
647770|NCT00837174|transformed follicular center cell lymphoma|transformed follicular center cell lymphoma
647771|NCT00837174|transformed marginal zone lymphoma|transformed marginal zone lymphoma
647772|NCT00837174|transformed small lymphocytic lymphoma|transformed small lymphocytic lymphoma
647773|NCT00837174|grade 3 follicular center cell lymphoma|grade 3 follicular center cell lymphoma
647774|NCT00837174|blastic form marginal zone lymphoma|blastic form marginal zone lymphoma
647775|NCT00837174|transformed cutaneous T cell lymphoma|transformed cutaneous t cell lymphoma
647776|NCT00837174|mycosis fungoides stage IV|mycosis fungoides stage iv
647777|NCT00837174|angioimmunoblastic lymphadenopathy-like T-cell lymphoma|angioimmunoblastic lymphadenopathy-like t-cell lymphoma
647778|NCT00837174|nasal NK/T cell lymphoma|nasal nk/t cell lymphoma
647779|NCT00837174|peripheral T-cell lymphoma|peripheral t-cell lymphoma
647780|NCT00837174|small lymphocytic lymphoma|small lymphocytic lymphoma
647781|NCT00837174|lymphoplasmacytic lymphoma|lymphoplasmacytic lymphoma
647782|NCT00837174|follicular center cell lymphoma grade 1|follicular center cell lymphoma grade 1
647783|NCT00837174|follicular center cell lymphoma grade 2|follicular center cell lymphoma grade 2
647784|NCT00837174|mantle cell lymphoma|mantle cell lymphoma
647785|NCT00837174|marginal zone lymphoma|marginal zone lymphoma
647786|NCT00837174|mycosis fungoides|mycosis fungoides
647787|NCT00837161|High Intensity Focused Ultrasound Ablation|high intensity focused ultrasound ablation
647788|NCT00837161|Uterine Fibroids|uterine fibroids
647789|NCT00837161|Leiomyomata|leiomyomata
647790|NCT00837161|Non-Invasive Treatment of Uterine Fibroids|non-invasive treatment of uterine fibroids
647791|NCT00837161|MRI-Guided|mri-guided
647792|NCT00837161|Fibroids|fibroids
647793|NCT00837161|Uterine Leiomyomata|uterine leiomyomata
647794|NCT00837148|Sarcoma|sarcoma
647795|NCT00837148|Bone|bone
647796|NCT00837148|BAY 43-9006 (SORAFENIB)|bay 43-9006 (sorafenib)
647797|NCT00837148|DACARBAZINE|dacarbazine
647798|NCT00837148|08-068|08-068
647799|NCT00837135|Pancreatic Cancer|pancreatic cancer
647800|NCT00837122|African|african
647801|NCT00837122|Diabetes|diabetes
647802|NCT00837122|Type 2 Diabetes|type 2 diabetes
647803|NCT00837122|Genetics|genetics
647804|NCT00837083|hypercholesterolemia|hypercholesterolemia
647805|NCT00837083|cholesterol|cholesterol
647806|NCT00837083|LDL-cholesterol|ldl-cholesterol
647807|NCT00837083|rosuvastatin|rosuvastatin
647808|NCT00837083|Crestor|crestor
647809|NCT00837070|Zygapophyseal|zygapophyseal
647810|NCT00837070|joint|joint
647811|NCT00837070|cyst|cyst
647812|NCT00837070|Fluoroscopy|fluoroscopy
647813|NCT00837070|guided|guided
647814|NCT00837070|percutaneous|percutaneous
647815|NCT00837070|Lumbar|lumbar
647816|NCT00837031|Pancreatic|pancreatic
647817|NCT00837031|Pancreatic Cancer|pancreatic cancer
647818|NCT00837031|Lenalidomide|lenalidomide
647819|NCT00837031|Revlimid|revlimid
647820|NCT00837031|Gemcitabine|gemcitabine
647821|NCT00837018|OSAS|osas
647822|NCT00837018|exercise|exercise
647823|NCT00837018|metabolic|metabolic
647824|NCT00837018|cardio-vascular|cardio-vascular
647825|NCT00837005|dobutamine stress|dobutamine stress
647826|NCT00837005|inducible ischemia|inducible ischemia
647827|NCT00837005|CAD|cad
647828|NCT00836992|anal cancer|anal cancer
647829|NCT00836992|colon cancer|colon cancer
647830|NCT00836992|rectal cancer|rectal cancer
647831|NCT00836992|esophageal cancer|esophageal cancer
647832|NCT00836992|extrahepatic bile duct cancer|extrahepatic bile duct cancer
647833|NCT00836992|gallbladder cancer|gallbladder cancer
647834|NCT00836992|gastric cancer|gastric cancer
647835|NCT00836992|adult primary liver cancer|adult primary liver cancer
647836|NCT00836992|pancreatic cancer|pancreatic cancer
647837|NCT00836992|small intestine cancer|small intestine cancer
647838|NCT00836992|non-small cell lung cancer|non-small cell lung cancer
647839|NCT00836992|small cell lung cancer|small cell lung cancer
647840|NCT00836992|head and neck cancer|head and neck cancer
647841|NCT00836979|Urinary Incontinence|urinary incontinence
647842|NCT00836979|Incontinence|incontinence
647843|NCT00836979|bladder problems|bladder problems
647844|NCT00836979|bladder dysfunction|bladder dysfunction
647845|NCT00836953|Influenza|influenza
647846|NCT00836953|Fluzone®|fluzone®
647847|NCT00836953|Children|children
647848|NCT00836940|Type 2 diabetes mellitus|type 2 diabetes mellitus
647850|NCT00836914|Allergic Rhinitis|allergic rhinitis
647851|NCT00836914|Allergy|allergy
647852|NCT00836914|Phosphatidylinositol 3-kinase|phosphatidylinositol 3-kinase
647853|NCT00836901|Bioequivalence|bioequivalence
647854|NCT00836901|Healthy Subjects|healthy subjects
647855|NCT00836888|ONO-4538|ono-4538
647856|NCT00836888|MDX-1106|mdx-1106
647857|NCT00836888|solid tumors|solid tumors
647858|NCT00836875|Pediatrics voriconazole invasive fungal infection invasive aspergillosis immunocompromized|pediatrics voriconazole invasive fungal infection invasive aspergillosis immunocompromized
647859|NCT00836862|Hemodialysis|hemodialysis
647860|NCT00836862|Vascular access|vascular access
647861|NCT00836862|Arteriovenous fistula|arteriovenous fistula
647862|NCT00836849|Bioequivalence|bioequivalence
647863|NCT00836849|Healthy Subjects|healthy subjects
647864|NCT00836836|Childhood epilepsy|childhood epilepsy
647865|NCT00836836|ketogenic diet|ketogenic diet
647866|NCT00836823|Patient-reported most bothersome symptom|patient-reported most bothersome symptom
647867|NCT00836823|Patient-reported symptom-specific goal achievement|patient-reported symptom-specific goal achievement
647868|NCT00836823|Medical treatment|medical treatment
647869|NCT00836810|Circadian variations of cytokines in PMR|circadian variations of cytokines in pmr
647870|NCT00836810|effect of TRT Prednisone in cytokines|effect of trt prednisone in cytokines
647871|NCT00836797|Alveolar Bone Loss|alveolar bone loss
647872|NCT00836797|Alveolar ridge|alveolar ridge
647873|NCT00836797|Alveolar Process|alveolar process
647874|NCT00836784|Old tooth brush|old tooth brush
647875|NCT00836784|Plaque removal|plaque removal
647876|NCT00836771|Infant formula|infant formula
647877|NCT00836771|Probiotic microorganisms|probiotic microorganisms
647878|NCT00836771|prebiotic|prebiotic
647879|NCT00836745|Advanced renal cell Cancer|advanced renal cell cancer
647880|NCT00836745|Non interventional study|non interventional study
647881|NCT00836745|Renal Cancer|renal cancer
647882|NCT00836745|Sutent|sutent
647883|NCT00836745|Metastatic|metastatic
647884|NCT00836745|Advanced Renal Cell Carcinoma|advanced renal cell carcinoma
647885|NCT00836732|celle therapy|celle therapy
647886|NCT00836732|cell culture|cell culture
647887|NCT00836732|mesenchymal stem cells|mesenchymal stem cells
647888|NCT00836719|Multiple sclerosis|multiple sclerosis
647889|NCT00836719|safety|safety
647890|NCT00836719|open label|open label
647891|NCT00836719|Polyphenon E|polyphenon e
647892|NCT00836719|EGCG|egcg
647893|NCT00836719|NAA|naa
647894|NCT00836719|N-acetyl-aspartate|n-acetyl-aspartate
647895|NCT00836719|MRI|mri
647896|NCT00836706|Bioequivalence|bioequivalence
647897|NCT00836706|Healthy Subjects|healthy subjects
647898|NCT00836693|Erectile Dysfunction|erectile dysfunction
647899|NCT00836667|Bioequivalence|bioequivalence
647900|NCT00836667|Healthy Subjects|healthy subjects
647901|NCT00836654|EpCAM positive tumor|epcam positive tumor
647902|NCT00836654|malignant ascites|malignant ascites
647903|NCT00836654|intraperitoneal|intraperitoneal
647904|NCT00836641|preschool asthma|preschool asthma
647905|NCT00836641|sequential pneumococcal immunization|sequential pneumococcal immunization
647906|NCT00836641|immunogenicity|immunogenicity
647907|NCT00836641|safety|safety
647908|NCT00836589|Long-term safety and reliability of ICD leads|long-term safety and reliability of icd leads
647909|NCT00836576|Bioequivalence|bioequivalence
647910|NCT00836576|Healthy Subjects|healthy subjects
647911|NCT00836563|Hemodialysis|hemodialysis
647912|NCT00836563|Arteriovenous Graft|arteriovenous graft
647913|NCT00836550|HIV|hiv
647914|NCT00836550|HIV knowledge measure|hiv knowledge measure
647915|NCT00836550|Teen HIV testing|teen hiv testing
647916|NCT00836550|HIV Seronegativity|hiv seronegativity
647917|NCT00836537|Bioequivalence|bioequivalence
647918|NCT00836537|Healthy Subjects|healthy subjects
647919|NCT00836524|IUGR|iugr
647920|NCT00836524|Preeclampsia|preeclampsia
647921|NCT00836524|ultrasound|ultrasound
825788|NCT00131235|STI|sti
647922|NCT00836524|YKL-40|ykl-40
647923|NCT00836472|Bioequivalence|bioequivalence
647924|NCT00836472|Healthy Subjects|healthy subjects
647925|NCT00836459|Humans|humans
647926|NCT00836459|Middle Aged|middle aged
647927|NCT00836459|Behavior Therapy|behavior therapy
647928|NCT00836459|Directive Counseling|directive counseling
647929|NCT00836459|Health Behavior|health behavior
647930|NCT00836459|Interview, Psychological|interview, psychological
647931|NCT00836459|Motivation|motivation
647932|NCT00836459|Exercise|exercise
647933|NCT00836459|Physical Fitness|physical fitness
647934|NCT00836459|Self Efficacy|self efficacy
647935|NCT00836459|Life Style|life style
647936|NCT00836459|Health Promotion|health promotion
647937|NCT00836459|Health Knowledge, Attitudes, Practice|health knowledge, attitudes, practice
647938|NCT00836459|Body Mass Index|body mass index
647939|NCT00836459|Monitoring, Ambulatory|monitoring, ambulatory
647940|NCT00836459|Walking|walking
647941|NCT00836446|school-aged|school-aged
647942|NCT00836446|children|children
647943|NCT00836446|obesity|obesity
647944|NCT00836446|cardiovascular risk|cardiovascular risk
647945|NCT00836446|physical activity|physical activity
647946|NCT00836433|staff education|staff education
647947|NCT00836433|complexity science|complexity science
647948|NCT00836433|social constructivist theory|social constructivist theory
647949|NCT00836420|ammonia|ammonia
647950|NCT00836420|acute liver failure|acute liver failure
647951|NCT00836420|brain edema|brain edema
647952|NCT00836420|oxidative metabolism|oxidative metabolism
647953|NCT00836420|intracranial pressure|intracranial pressure
647954|NCT00836407|pancreatic cancer|pancreatic cancer
647955|NCT00836407|vaccine|vaccine
647956|NCT00836407|immunotherapy|immunotherapy
647957|NCT00836407|antibody|antibody
647958|NCT00836407|CTLA-4|ctla-4
647959|NCT00836394|arthritis|arthritis
647960|NCT00836394|juvenile idiopathic arthritis|juvenile idiopathic arthritis
647961|NCT00836394|pediatric|pediatric
647962|NCT00836394|intervention|intervention
647963|NCT00836394|vibration therapy|vibration therapy
647964|NCT00836394|JIA|jia
647965|NCT00836381|Overactive bladder|overactive bladder
647966|NCT00836381|Antimuscarinics|antimuscarinics
647967|NCT00836381|Patient-reported goal achievement|patient-reported goal achievement
647968|NCT00836368|Asthma|asthma
647969|NCT00836368|Asthmatic|asthmatic
647970|NCT00836368|Allergy|allergy
647971|NCT00836368|Allergic|allergic
647972|NCT00836368|Gamma-tocopherol|gamma-tocopherol
647973|NCT00836368|Vitamin|vitamin
647974|NCT00836368|Vitamin E|vitamin e
647975|NCT00836355|stroke|stroke
647976|NCT00836355|magnetic resonance imaging|magnetic resonance imaging
647977|NCT00836355|enoxaparin|enoxaparin
647978|NCT00836355|minocycline|minocycline
647979|NCT00836355|NIH stroke scale|nih stroke scale
647980|NCT00836355|modified Rankin scale|modified rankin scale
647981|NCT00836355|neuroprotection|neuroprotection
647982|NCT00836342|Non-melanoma skin cancer|non-melanoma skin cancer
647983|NCT00836342|Basal cell carcinoma|basal cell carcinoma
647984|NCT00836342|Squamous cell carcinoma|squamous cell carcinoma
647985|NCT00836329|Neurologic|neurologic
647986|NCT00836329|Diabetes|diabetes
647987|NCT00836329|Cardiac Surgery|cardiac surgery
647988|NCT00836329|Stroke|stroke
647989|NCT00836316|laparoscopic cholecystectomy|laparoscopic cholecystectomy
647990|NCT00836290|risk reduction|risk reduction
647991|NCT00836290|HIV prevention|hiv prevention
647992|NCT00836290|HIV education|hiv education
647993|NCT00836290|HIV Seronegativity|hiv seronegativity
647994|NCT00836277|Panitumumab|panitumumab
647995|NCT00836277|Irinotecan|irinotecan
647996|NCT00836277|Esophageal Adenocarcinoma|esophageal adenocarcinoma
647997|NCT00836277|Phase II|phase ii
647998|NCT00836264|Morphine|morphine
647999|NCT00836264|Phenotype|phenotype
648000|NCT00836264|Genotype|genotype
648001|NCT00836264|Tonsillectomy|tonsillectomy
648002|NCT00836264|Adenoidectomy|adenoidectomy
648003|NCT00836264|Opioid Receptors|opioid receptors
648004|NCT00836264|Genome-Wide Association|genome-wide association
648005|NCT00836264|Pharmacokinetics|pharmacokinetics
648006|NCT00836251|energy expenditure|energy expenditure
648007|NCT00836251|schizophrenia|schizophrenia
648008|NCT00836238|Prostate Cancer|prostate cancer
648009|NCT00836238|Neural Functioning Assessment|neural functioning assessment
648010|NCT00836238|Physical Assessment|physical assessment
648011|NCT00836238|Questionnaire|questionnaire
648012|NCT00836238|Objective Measures of Functional Status|objective measures of functional status
648013|NCT00836238|Physical Function|physical function
648014|NCT00836238|Symptom Assessment Interview|symptom assessment interview
648015|NCT00836238|Elderly|elderly
648016|NCT00836225|diabetes|diabetes
648017|NCT00836225|SGLT2 inhibitor|sglt2 inhibitor
648018|NCT00836212|HIV|hiv
648019|NCT00836212|Adjusting Antiretroviral Therapy|adjusting antiretroviral therapy
648020|NCT00836212|Dosage using Therapeutic Drug Monitoring|dosage using therapeutic drug monitoring
648021|NCT00836212|Swiss HIV Cohort Study|swiss hiv cohort study
825891|NCT00130910|HIV|hiv
648022|NCT00836212|HIV Geneva|hiv geneva
648023|NCT00836212|lopinavir|lopinavir
648024|NCT00836212|efavirenz|efavirenz
648025|NCT00836212|Treatment Experienced|treatment experienced
648026|NCT00836199|smoking cessation|smoking cessation
648027|NCT00836199|NicVAX|nicvax
648028|NCT00836199|smoking vaccine|smoking vaccine
648029|NCT00836199|smoking abstinence|smoking abstinence
648030|NCT00836199|smoking|smoking
648031|NCT00836199|tobacco cessation|tobacco cessation
648032|NCT00836173|CARBOPLATIN|carboplatin
648033|NCT00836173|DEXAMETHASONE|dexamethasone
648034|NCT00836173|DIFFUSE LARGE B-CELL LYMPHOMA|diffuse large b-cell lymphoma
648035|NCT00836173|ETOPOSIDE|etoposide
648036|NCT00836173|GALLIUM NITRATE|gallium nitrate
648037|NCT00836173|IFOSFAMIDE|ifosfamide
648038|NCT00836173|PHASE II|phase ii
648039|NCT00836173|RELAPSED OR REFRACTORY|relapsed or refractory
648040|NCT00836173|RITUXIMAB|rituximab
648041|NCT00836160|EGFR-TKI therapy|egfr-tki therapy
648042|NCT00836160|NSCLC|nsclc
648043|NCT00836160|Efficacy|efficacy
648044|NCT00836134|pain relief after umbilical hernia repair|pain relief after umbilical hernia repair
648045|NCT00836134|morphine consumption|morphine consumption
648046|NCT00836134|plasma bupivacaine levels|plasma bupivacaine levels
648047|NCT00836121|Teratoma|teratoma
648048|NCT00836121|Mediastinum|mediastinum
648049|NCT00836108|Lung Diseases, Obstructive|lung diseases, obstructive
648050|NCT00836108|Breathing Exercises|breathing exercises
648051|NCT00836108|Exercise Tolerance|exercise tolerance
648053|NCT00836108|Arm Exercise|arm exercise
648054|NCT00836095|laryngeal mask, proseal|laryngeal mask, proseal
648055|NCT00836082|Healthy volunteers|healthy volunteers
648056|NCT00836069|Generalized Anxiety Disorder|generalized anxiety disorder
648057|NCT00836056|Bioequivalence|bioequivalence
648058|NCT00836056|Healthy Subjects|healthy subjects
648059|NCT00836043|CLL|cll
648060|NCT00836043|alemtuzumab|alemtuzumab
648061|NCT00836004|Bioequivalence|bioequivalence
648062|NCT00836004|Healthy Subjects|healthy subjects
648063|NCT00835991|Bioequivalence|bioequivalence
648064|NCT00835991|Healthy Subjects|healthy subjects
648065|NCT00835978|axitinib or AG-013736 dose titration (increase) renal cell carcinoma|axitinib or ag-013736 dose titration (increase) renal cell carcinoma
648066|NCT00835978|kidney cancer|kidney cancer
648067|NCT00835965|Laparoscopic|laparoscopic
648068|NCT00835965|Surgery|surgery
648069|NCT00835965|Postoperative|postoperative
648070|NCT00835965|Nausea|nausea
648071|NCT00835965|Vomiting|vomiting
648072|NCT00835965|Aprepitant|aprepitant
648073|NCT00835965|Dexamethasone|dexamethasone
648074|NCT00835965|Postoperative Nausea, Postoperative Vomiting|postoperative nausea, postoperative vomiting
648075|NCT00835939|Achilles|achilles
648076|NCT00835939|Tendinopathy|tendinopathy
648077|NCT00835939|Sclerotherapy|sclerotherapy
648078|NCT00835939|Neovascularisation|neovascularisation
648079|NCT00835939|sports medicine|sports medicine
648080|NCT00835939|interventional radiology|interventional radiology
648081|NCT00835926|Influenza|influenza
648082|NCT00835926|Fluzone®|fluzone®
648083|NCT00835913|Autonomic nervous system|autonomic nervous system
648084|NCT00835913|Sepsis shock|sepsis shock
648085|NCT00835913|severe sepsis|severe sepsis
648086|NCT00835913|sinusal change|sinusal change
648087|NCT00835913|Myocardiac fixing|myocardiac fixing
648088|NCT00835913|NTproBNP|ntprobnp
648089|NCT00835913|Patient in intensive care unit with sepsis shock or severe|patient in intensive care unit with sepsis shock or severe
648090|NCT00835913|Sepsis|sepsis
648091|NCT00835900|smoking cessation|smoking cessation
648092|NCT00835900|varenicline|varenicline
648093|NCT00835900|smoking cessation treatment|smoking cessation treatment
648094|NCT00835874|probiotic|probiotic
648095|NCT00835874|preterm|preterm
648096|NCT00835874|lactation|lactation
648097|NCT00835874|breast feeding|breast feeding
648098|NCT00835874|necrotizing enterocolitis|necrotizing enterocolitis
648099|NCT00835874|sepsis|sepsis
648100|NCT00835874|bacterial cultures|bacterial cultures
648101|NCT00835874|lactating mother|lactating mother
648102|NCT00835874|breast feeding of at least 50% of enteric feeding volume|breast feeding of at least 50% of enteric feeding volume
648103|NCT00835874|Infant, very low birth weight|infant, very low birth weight
648104|NCT00835861|Non Insulin Dependent Diabetes|non insulin dependent diabetes
648105|NCT00835861|Pregnancy|pregnancy
648106|NCT00835848|ST-segment elevation myocardial infarction|st-segment elevation myocardial infarction
648107|NCT00835848|Primary PCI|primary pci
648108|NCT00835848|Postconditioning|postconditioning
648109|NCT00835835|Multiple Sclerosis|multiple sclerosis
648110|NCT00835835|gait|gait
648111|NCT00835835|falls|falls
648112|NCT00835835|lokomat|lokomat
648113|NCT00835835|body-weight support treadmill training|body-weight support treadmill training
648114|NCT00835822|Chronic Venous Insufficiency, Venocur Triplex®|chronic venous insufficiency, venocur triplex®
648115|NCT00835809|Acute respiratory insufficiency respiratory|acute respiratory insufficiency respiratory
648116|NCT00835809|Biomarkers|biomarkers
648117|NCT00835809|Emergency|emergency
648118|NCT00835809|Intensive care unit|intensive care unit
648119|NCT00835809|Prospective|prospective
648120|NCT00835809|Patient hospitalize in emergency or in intensive care unit|patient hospitalize in emergency or in intensive care unit
648121|NCT00835809|for acute respiratory insufficiency|for acute respiratory insufficiency
648122|NCT00835796|Bioequivalence|bioequivalence
648123|NCT00835796|Healthy Subjects|healthy subjects
648124|NCT00835770|relapsing|relapsing
648125|NCT00835770|multiple sclerosis|multiple sclerosis
648126|NCT00835770|remitting|remitting
648127|NCT00835770|oral|oral
648128|NCT00835744|ovulation induction|ovulation induction
648129|NCT00835744|clomiphene citrate|clomiphene citrate
648130|NCT00835744|gonadotropins|gonadotropins
648131|NCT00835731|induced abortion|induced abortion
648132|NCT00835731|misoprostol|misoprostol
648133|NCT00835731|cervical ripening|cervical ripening
648134|NCT00835731|second trimester abortion|second trimester abortion
648135|NCT00835731|Dilapan-S|dilapan-s
648136|NCT00835705|Bioequivalence|bioequivalence
648137|NCT00835705|Healthy Subjects|healthy subjects
648138|NCT00835692|Bioequivalence|bioequivalence
648139|NCT00835692|Healthy Subjects|healthy subjects
648140|NCT00835666|Bioequivalence|bioequivalence
648141|NCT00835666|Healthy Subjects|healthy subjects
648142|NCT00835640|Bioequivalence|bioequivalence
648143|NCT00835640|Healthy Subjects|healthy subjects
648144|NCT00835627|Treatment|treatment
648145|NCT00835627|Cognitive Behavior Therapy|cognitive behavior therapy
648146|NCT00835627|pharmacotherapy|pharmacotherapy
648147|NCT00835627|psychogenic nonepileptic seizures|psychogenic nonepileptic seizures
648148|NCT00835627|pseudoseizures|pseudoseizures
648149|NCT00835627|dissociative seizures|dissociative seizures
648150|NCT00835627|conversion disorder|conversion disorder
648151|NCT00835614|Bioequivalence|bioequivalence
648152|NCT00835614|Healthy Subjects|healthy subjects
648153|NCT00835588|Bioequivalence|bioequivalence
648154|NCT00835588|Healthy Subjects|healthy subjects
648155|NCT00835575|Bioequivalence|bioequivalence
648156|NCT00835575|Healthy Subjects|healthy subjects
648157|NCT00835562|Shoulder fractures|shoulder fractures
648158|NCT00835562|Proximal humeral fractures|proximal humeral fractures
648159|NCT00835562|Randomised clinical trial|randomised clinical trial
648160|NCT00835562|elderly|elderly
648161|NCT00835562|Displaced four-part fractures of the proximal humerus|displaced four-part fractures of the proximal humerus
648162|NCT00835549|Bioequivalence|bioequivalence
648163|NCT00835549|Healthy Subjects|healthy subjects
648164|NCT00835536|Bioequivalence|bioequivalence
648165|NCT00835536|Healthy Subjects|healthy subjects
648166|NCT00835523|frozen-thawed embryo replacement|frozen-thawed embryo replacement
648167|NCT00835523|GnRH agonist|gnrh agonist
648168|NCT00835523|GnRH antagonist|gnrh antagonist
648169|NCT00835523|ovarian hyperstimulation|ovarian hyperstimulation
648170|NCT00835510|Tinea pedis|tinea pedis
648171|NCT00835497|Bioequivalence|bioequivalence
648172|NCT00835497|Healthy Subjects|healthy subjects
648173|NCT00835484|Bioequivalence|bioequivalence
648174|NCT00835484|Healthy Subjects|healthy subjects
648175|NCT00835471|Lung cancer|lung cancer
648176|NCT00835471|non-small-cell|non-small-cell
648177|NCT00835471|erlotinib|erlotinib
648178|NCT00835471|chemotherapy|chemotherapy
648179|NCT00835458|gastric fistula|gastric fistula
648180|NCT00835458|perforation|perforation
648181|NCT00835458|endoscopy|endoscopy
648182|NCT00835458|closure|closure
648183|NCT00835458|endolumenal|endolumenal
648184|NCT00835432|Lateral augmentation|lateral augmentation
648185|NCT00835432|GBR|gbr
648186|NCT00835432|BoneCeramic|boneceramic
648187|NCT00835432|collagen membrane|collagen membrane
648188|NCT00835432|histomorphometry|histomorphometry
648189|NCT00835432|morphometry|morphometry
648190|NCT00835432|reentry|reentry
648191|NCT00835432|biopsy|biopsy
648192|NCT00835419|metastatic malignant melanoma with cyclin D1 positivity|metastatic malignant melanoma with cyclin d1 positivity
648193|NCT00835406|Bioequivalence|bioequivalence
648194|NCT00835406|Healthy Subjects|healthy subjects
648195|NCT00835393|Bioequivalence|bioequivalence
648196|NCT00835393|Healthy Subjects|healthy subjects
648197|NCT00835367|Bioequivalence|bioequivalence
648198|NCT00835367|Healthy Subjects|healthy subjects
648199|NCT00835354|Bioequivalence|bioequivalence
648200|NCT00835354|Healthy Subjects|healthy subjects
648201|NCT00835341|oral epithelial dysplasia|oral epithelial dysplasia
648202|NCT00835341|p16 methylation|p16 methylation
648203|NCT00835341|prognosis|prognosis
648204|NCT00835341|malignant transformation|malignant transformation
648205|NCT00835341|oral squamous cell carcinoma|oral squamous cell carcinoma
648206|NCT00835328|hyperinsulinism|hyperinsulinism
648207|NCT00835328|hypoglycemia|hypoglycemia
648208|NCT00835328|ATP- sensitive potassium channel (KATP)|atp- sensitive potassium channel (katp)
648209|NCT00835315|interdigital psoriasis (psoriasis alba)|interdigital psoriasis (psoriasis alba)
648210|NCT00835302|Cervical|cervical
648211|NCT00835302|Thoracic|thoracic
648212|NCT00835302|Manipulation|manipulation
648213|NCT00835302|Mobilization|mobilization
648214|NCT00835302|Clinical prediction rule|clinical prediction rule
648215|NCT00835302|Shoulder pain.|shoulder pain.
648216|NCT00835289|Clinical Trials, Randomized|clinical trials, randomized
648217|NCT00835276|Bioequivalence|bioequivalence
648218|NCT00835276|Healthy Subjects|healthy subjects
648219|NCT00835263|Bioequivalence|bioequivalence
648220|NCT00835263|Healthy Subjects|healthy subjects
648221|NCT00835250|Transvaginal cholecystectomy|transvaginal cholecystectomy
648222|NCT00835250|NOTES|notes
648223|NCT00835250|Minilaparoscopy|minilaparoscopy
648224|NCT00835250|Endoscopic surgery|endoscopic surgery
648225|NCT00835250|Cholecystectomy|cholecystectomy
648226|NCT00835250|Surgical translumenal endoscopic surgery|surgical translumenal endoscopic surgery
648227|NCT00835250|Transvaginal translumenal endoscopic surgery|transvaginal translumenal endoscopic surgery
648228|NCT00835237|Boostrix®|boostrix®
648229|NCT00835237|adults|adults
648230|NCT00835224|Spinal Cord Injury|spinal cord injury
648231|NCT00835224|Orthostatic Hypotension|orthostatic hypotension
648232|NCT00835224|Blood Pressure|blood pressure
648233|NCT00835224|Midodrine Hydrochloride|midodrine hydrochloride
648234|NCT00835224|L-NAME|l-name
648235|NCT00835211|Bioequivalence|bioequivalence
648236|NCT00835211|Healthy Subjects|healthy subjects
648237|NCT00835185|Antibodies, Monoclonal|antibodies, monoclonal
648238|NCT00835185|Colorectal Neoplasms|colorectal neoplasms
648239|NCT00835172|Bioequivalence|bioequivalence
648240|NCT00835172|Healthy Subjects|healthy subjects
648241|NCT00835159|Postoperative Delirium|postoperative delirium
648242|NCT00835159|Postoperative Cognitive Dysfunction|postoperative cognitive dysfunction
648243|NCT00835159|Rivastigmine|rivastigmine
648244|NCT00835159|Exelon|exelon
648245|NCT00835159|Memory impairment|memory impairment
648246|NCT00835159|Delirium|delirium
648247|NCT00835159|Cognitive function|cognitive function
648248|NCT00835146|Bioequivalence|bioequivalence
648249|NCT00835146|Healthy Subjects|healthy subjects
648250|NCT00835133|family|family
648251|NCT00835133|history|history
648252|NCT00835133|pancreas|pancreas
648253|NCT00835133|cancer|cancer
648254|NCT00835133|melanoma|melanoma
648255|NCT00835133|genetic|genetic
648256|NCT00835107|Bipolar Depression|bipolar depression
648257|NCT00835107|Sleep|sleep
648258|NCT00835107|Polysomnograph|polysomnograph
648259|NCT00835107|Slow Wave Sleep|slow wave sleep
648260|NCT00835107|Ziprasidone|ziprasidone
648261|NCT00835107|Antipsychotic|antipsychotic
648262|NCT00835107|Placebo|placebo
648263|NCT00835081|Bioequivalence|bioequivalence
648264|NCT00835081|Healthy Subjects|healthy subjects
648265|NCT00835068|Hemophilia B|hemophilia b
648266|NCT00835068|observational|observational
648267|NCT00835068|post marketing study|post marketing study
648268|NCT00835055|rectal cancer with neoadjuvant treatment|rectal cancer with neoadjuvant treatment
648269|NCT00835055|standardized clinical tests|standardized clinical tests
648270|NCT00835055|tumor markers on tumor tissue|tumor markers on tumor tissue
648271|NCT00835042|Bioequivalence|bioequivalence
648272|NCT00835042|Healthy Subjects|healthy subjects
648273|NCT00835029|oral|oral
648274|NCT00835029|candida|candida
648275|NCT00835029|denture|denture
648276|NCT00835029|clotrimazole|clotrimazole
648277|NCT00835029|slow releases|slow releases
648278|NCT00835016|Early psychosocial stimulation, RCT, Depressed mother|early psychosocial stimulation, rct, depressed mother
648279|NCT00835003|Neonatal admission|neonatal admission
648280|NCT00835003|Elective Caesarean Section|elective caesarean section
648281|NCT00835003|Timing|timing
648282|NCT00835003|Choice behavior|choice behavior
648283|NCT00835003|Intraoperative complications|intraoperative complications
648284|NCT00835003|Postoperative complications|postoperative complications
648285|NCT00834990|Bioequivalence|bioequivalence
648286|NCT00834990|Healthy Subjects|healthy subjects
648287|NCT00834977|Bioequivalence|bioequivalence
648288|NCT00834977|Healthy Subjects|healthy subjects
648289|NCT00834964|Bioequivalence|bioequivalence
648290|NCT00834964|Healthy Subjects|healthy subjects
648291|NCT00834951|Diffuse large B-cell lymphoma|diffuse large b-cell lymphoma
648292|NCT00834951|Elderly patients|elderly patients
648293|NCT00834951|Low dose total body irradiation|low dose total body irradiation
648294|NCT00834951|RCHOP14|rchop14
648295|NCT00834938|diabetes mellitus, type 2|diabetes mellitus, type 2
648296|NCT00834938|Insulin resistance|insulin resistance
648297|NCT00834938|bariatric surgery|bariatric surgery
648298|NCT00834938|Glucagon-Like Peptide 1|glucagon-like peptide 1
648299|NCT00834938|Gastric Inhibitory Polypeptide|gastric inhibitory polypeptide
648300|NCT00834938|insulin|insulin
648301|NCT00834938|glucagon|glucagon
648302|NCT00834938|ghrelin|ghrelin
648303|NCT00834938|adiponectin|adiponectin
648304|NCT00834938|Cytokines|cytokines
648305|NCT00834938|gastric bypass|gastric bypass
648306|NCT00834938|Obesity|obesity
648307|NCT00834925|atrial fibrillation with rapid ventricular response|atrial fibrillation with rapid ventricular response
648308|NCT00834912|Healthy Subjects|healthy subjects
648309|NCT00834899|Sickle cell disease|sickle cell disease
648310|NCT00834899|Pain crisis|pain crisis
648311|NCT00834899|Acute pain episode|acute pain episode
648312|NCT00834899|Eptifibatide|eptifibatide
648313|NCT00834899|Antiplatelet therapy|antiplatelet therapy
648314|NCT00834899|Safety|safety
648315|NCT00834899|Treatment|treatment
648316|NCT00834873|Bioequivalence|bioequivalence
648317|NCT00834873|Healthy Subjects|healthy subjects
648318|NCT00834860|chronic hepatitis C|chronic hepatitis c
648319|NCT00834860|sustained virological response|sustained virological response
648320|NCT00834860|peginterferon|peginterferon
648321|NCT00834860|ribavirin|ribavirin
648322|NCT00834860|neoplasm|neoplasm
648323|NCT00834847|Bioequivalence|bioequivalence
648324|NCT00834847|Healthy Subjects|healthy subjects
648325|NCT00834834|Suicidal and Self-Injurious Behavior|suicidal and self-injurious behavior
648326|NCT00834821|Attention Deficit Hyperactivity Disorder|attention deficit hyperactivity disorder
648327|NCT00834821|ADHD, Predominantly Inattentive Type|adhd, predominantly inattentive type
648328|NCT00834821|Inattention|inattention
648329|NCT00834821|Psychosocial Intervention|psychosocial intervention
648330|NCT00834821|Behavioral Intervention|behavioral intervention
648331|NCT00834808|Healthy volunteers|healthy volunteers
648332|NCT00834795|Bioequivalence|bioequivalence
648333|NCT00834795|Healthy Subjects|healthy subjects
648335|NCT00834782|IOP|iop
648336|NCT00834756|Bioequivalence|bioequivalence
648337|NCT00834756|Healthy Subjects|healthy subjects
648338|NCT00834743|Bioequivalence|bioequivalence
648339|NCT00834743|Healthy Subjects|healthy subjects
648340|NCT00834717|Bioequivalence|bioequivalence
648341|NCT00834717|Healthy Subjects|healthy subjects
648342|NCT00834704|PEGPH20|pegph20
648343|NCT00834704|PEGylated recombinant human hyaluronidase|pegylated recombinant human hyaluronidase
648344|NCT00834704|Metastatic or locally advanced solid tumor|metastatic or locally advanced solid tumor
648345|NCT00834691|Inflammation|inflammation
648346|NCT00834691|Oxidative stress|oxidative stress
648347|NCT00834691|Estimated glomerular filtration rate|estimated glomerular filtration rate
648348|NCT00834678|male breast cancer|male breast cancer
648349|NCT00834678|recurrent breast cancer|recurrent breast cancer
648350|NCT00834678|stage IIIB breast cancer|stage iiib breast cancer
648351|NCT00834678|stage IIIC breast cancer|stage iiic breast cancer
648352|NCT00834678|stage IV breast cancer|stage iv breast cancer
648353|NCT00834678|estrogen receptor-negative breast cancer|estrogen receptor-negative breast cancer
648354|NCT00834678|HER2-negative breast cancer|her2-negative breast cancer
648355|NCT00834678|progesterone receptor-negative breast cancer|progesterone receptor-negative breast cancer
648356|NCT00834678|triple-negative breast cancer|triple-negative breast cancer
648357|NCT00834652|Metabolic Diseases|metabolic diseases
648358|NCT00834652|Depressive Disorder, Major|depressive disorder, major
648359|NCT00834652|Depressive Disorder|depressive disorder
648360|NCT00834652|Glucose Metabolism Disorders|glucose metabolism disorders
648361|NCT00834652|Depression Recurrence|depression recurrence
648362|NCT00834639|Bioequivalence|bioequivalence
648363|NCT00834639|Healthy Subjects|healthy subjects
648364|NCT00834626|Ileal Interposition|ileal interposition
648365|NCT00834626|Sleeve Gastrectomy|sleeve gastrectomy
648366|NCT00834626|Type-2 Diabetes|type-2 diabetes
648367|NCT00834613|Bioequivalence|bioequivalence
648368|NCT00834613|Healthy Subjects|healthy subjects
648369|NCT00834587|Bioequivalence|bioequivalence
648370|NCT00834587|Healthy Subjects|healthy subjects
648371|NCT00834574|Bioequivalence|bioequivalence
648372|NCT00834574|Healthy Subjects|healthy subjects
648373|NCT00834561|Bioequivalence|bioequivalence
648374|NCT00834561|Healthy Subjects|healthy subjects
648375|NCT00834548|Magnetic resonance|magnetic resonance
648376|NCT00834548|whole body|whole body
648377|NCT00834548|angiography|angiography
648378|NCT00834548|hybrid protocol|hybrid protocol
648380|NCT00834535|Bioequivalence|bioequivalence
648381|NCT00834535|Healthy Subjects|healthy subjects
648382|NCT00834522|Bioequivalence|bioequivalence
648383|NCT00834522|Healthy Subjects|healthy subjects
648384|NCT00834483|Safety|safety
648385|NCT00834483|Efficacy|efficacy
648386|NCT00834483|Cost-savings|cost-savings
648387|NCT00834483|Cosmesis|cosmesis
648388|NCT00834483|Safety and efficacy of wound closure|safety and efficacy of wound closure
648389|NCT00834483|Cost-savings potential|cost-savings potential
648390|NCT00834483|Cosmesis of the wound/scar|cosmesis of the wound/scar
648391|NCT00834457|AIDS-related Kaposi's sarcoma|aids-related kaposi's sarcoma
648392|NCT00834457|antiretroviral therapy|antiretroviral therapy
648393|NCT00834444|Bioequivalence|bioequivalence
648394|NCT00834444|Healthy Subjects|healthy subjects
648395|NCT00834431|Bioequivalence|bioequivalence
648396|NCT00834431|Healthy Subjects|healthy subjects
648397|NCT00834418|Bioequivalence|bioequivalence
648398|NCT00834418|Healthy Subjects|healthy subjects
648399|NCT00834405|Bioequivalence|bioequivalence
648400|NCT00834405|Healthy Subjects|healthy subjects
648401|NCT00834379|Bioequivalence|bioequivalence
648402|NCT00834379|Healthy Subjects|healthy subjects
648403|NCT00834366|Healthy volunteers|healthy volunteers
648404|NCT00834340|Bioequivalence|bioequivalence
648405|NCT00834340|Healthy Subjects|healthy subjects
648406|NCT00834327|Restless Legs Syndrome|restless legs syndrome
648407|NCT00834301|End Stage Renal Disease|end stage renal disease
648408|NCT00834301|Inflammation|inflammation
648409|NCT00834288|Healthy subjects|healthy subjects
648410|NCT00834288|Pharmacokinetics|pharmacokinetics
648411|NCT00834288|Bioavailability|bioavailability
648412|NCT00834275|Bioequivalence|bioequivalence
648413|NCT00834275|Healthy Subjects|healthy subjects
648414|NCT00834249|Bioequivalence|bioequivalence
648415|NCT00834249|Healthy Subjects|healthy subjects
648416|NCT00834236|gastric cancer|gastric cancer
648417|NCT00834236|proteomics|proteomics
648418|NCT00834236|gastric juice|gastric juice
648419|NCT00834223|refractory chronic forms of open angle glaucoma (OAG)|refractory chronic forms of open angle glaucoma (oag)
648420|NCT00834223|OAG|oag
648421|NCT00834223|glaucoma|glaucoma
648422|NCT00834197|Bioequivalence|bioequivalence
648423|NCT00834197|Healthy Subjects|healthy subjects
648424|NCT00834184|nikkomycin Z|nikkomycin z
648425|NCT00834184|evaluate safety, tolerance and pharmacokinetics of nikkomycin Z|evaluate safety, tolerance and pharmacokinetics of nikkomycin z
648426|NCT00834158|Hepatocellular Carcinoma|hepatocellular carcinoma
648427|NCT00834158|Hepatitis B|hepatitis b
648428|NCT00834158|Transarterial chemoembolization (TACE)|transarterial chemoembolization (tace)
648429|NCT00834158|Portal vein embolization (PVE)|portal vein embolization (pve)
648430|NCT00834158|Surgical resection|surgical resection
648431|NCT00834158|Disease-free survival|disease-free survival
648432|NCT00834158|Overall survival|overall survival
648433|NCT00834145|Edema|edema
648434|NCT00834145|Right heart failure|right heart failure
648435|NCT00834145|Cor pulmonale|cor pulmonale
648437|NCT00834145|Leg compression|leg compression
648438|NCT00834132|Bioequivalence|bioequivalence
648439|NCT00834132|Healthy Subjects|healthy subjects
648440|NCT00834106|HPV 6/11/16/18 Infection|hpv 6/11/16/18 infection
648441|NCT00834093|Epstein-Barr Virus|epstein-barr virus
648442|NCT00834093|NPC|npc
648443|NCT00834093|EBV|ebv
648444|NCT00834093|immunotherapy|immunotherapy
648445|NCT00834080|opioid dependence|opioid dependence
648446|NCT00834080|VIVITROL|vivitrol
648447|NCT00834080|opioid-related disorders|opioid-related disorders
648448|NCT00834067|Bioequivalence|bioequivalence
648449|NCT00834067|Healthy Subjects|healthy subjects
648450|NCT00834041|aliskiren|aliskiren
648451|NCT00834041|pediatric|pediatric
648452|NCT00834041|hypertension|hypertension
648453|NCT00834041|pharmacokinetics (PK)|pharmacokinetics (pk)
648454|NCT00834041|pharmacodynamics (PD)|pharmacodynamics (pd)
648455|NCT00834041|plasma renin activity|plasma renin activity
648456|NCT00834041|mini-tablet formulation|mini-tablet formulation
648457|NCT00834028|hepatocellular carcinoma|hepatocellular carcinoma
648458|NCT00834028|vascular endothelial growth factor|vascular endothelial growth factor
648459|NCT00834028|angiopoietin|angiopoietin
648460|NCT00834028|cathepsin|cathepsin
648461|NCT00834015|spinal fusion|spinal fusion
648462|NCT00834015|pain|pain
648463|NCT00834015|disability|disability
648464|NCT00834015|muscle strength|muscle strength
648465|NCT00834015|mobility|mobility
648466|NCT00834015|quality of life|quality of life
648467|NCT00834015|lumbar|lumbar
648468|NCT00834015|isthmic or degenerative spondylolisthesis|isthmic or degenerative spondylolisthesis
648469|NCT00834002|AML in remission|aml in remission
648470|NCT00833950|Tinnitus|tinnitus
648471|NCT00833950|Phase Out|phase out
648472|NCT00833937|Bioequivalence|bioequivalence
648473|NCT00833937|Healthy Subjects|healthy subjects
648474|NCT00833924|Low Profile|low profile
648475|NCT00833924|Abdominal Aortic Aneurysms|abdominal aortic aneurysms
648476|NCT00833924|Endovascular|endovascular
648477|NCT00833911|Moderate to severe symptomatic osteoarthritis of the knee|moderate to severe symptomatic osteoarthritis of the knee
648478|NCT00833898|depression|depression
648479|NCT00833898|stress|stress
648480|NCT00833898|caregiving|caregiving
648481|NCT00833898|anxiety|anxiety
648482|NCT00833898|psychoeducation intervention|psychoeducation intervention
648483|NCT00833898|psycho-oncology|psycho-oncology
648484|NCT00833885|Non pharmaceutical measures|non pharmaceutical measures
648485|NCT00833859|stereotactic radiosurgery|stereotactic radiosurgery
648486|NCT00833859|borderline resectable pancreatic cancer|borderline resectable pancreatic cancer
648487|NCT00833859|gastrointestinal|gastrointestinal
648488|NCT00833859|pancreas|pancreas
648489|NCT00833846|Mitochondria in Platelets|mitochondria in platelets
648490|NCT00833846|Mitochondria in Diabetes|mitochondria in diabetes
648491|NCT00833846|Insulin Resistance and Mitochondria|insulin resistance and mitochondria
648492|NCT00833846|Diabetes|diabetes
648493|NCT00833846|Insulin Resistance|insulin resistance
648494|NCT00833820|ALS|als
648495|NCT00833820|transcranial brain stimulation|transcranial brain stimulation
648496|NCT00833807|Melanoma|melanoma
648497|NCT00833807|Metastatic Melanoma to the Liver|metastatic melanoma to the liver
648498|NCT00833807|Liver metastasis|liver metastasis
648499|NCT00833807|Nab-paclitaxel|nab-paclitaxel
648500|NCT00833807|Abraxane|abraxane
648501|NCT00833807|Paclitaxel (protein-bound)|paclitaxel (protein-bound)
648502|NCT00833807|intraarterial intrahepatic administration|intraarterial intrahepatic administration
648503|NCT00833807|Hepatic Artery|hepatic artery
648504|NCT00833807|Hepatic Arterial Infusion|hepatic arterial infusion
648505|NCT00833807|Hepatic Administration|hepatic administration
648506|NCT00833781|HIV vaccine|hiv vaccine
648507|NCT00833781|Dendritic cells|dendritic cells
648508|NCT00833781|treatment experienced|treatment experienced
648509|NCT00833755|Pain|pain
648510|NCT00833755|Chronic pain|chronic pain
648511|NCT00833755|Opioid induced hyperalgesia|opioid induced hyperalgesia
648512|NCT00833755|Opioid therapy|opioid therapy
648513|NCT00833742|somatization|somatization
648514|NCT00833742|psychosomatic|psychosomatic
648515|NCT00833742|short-term|short-term
648516|NCT00833742|dynamic|dynamic
648517|NCT00833742|psychotherapy|psychotherapy
648518|NCT00833729|psoriasis|psoriasis
648519|NCT00833729|etanercept|etanercept
648520|NCT00833729|adalimumab|adalimumab
648521|NCT00833729|moderate to severe plaque psoriasis|moderate to severe plaque psoriasis
648522|NCT00833703|cyanotic congenital heart disease|cyanotic congenital heart disease
648523|NCT00833703|shunt palliation|shunt palliation
648524|NCT00833703|thrombosis|thrombosis
648525|NCT00833703|clopidogrel|clopidogrel
648526|NCT00833690|Parkinson's disease|parkinson's disease
648527|NCT00833690|Parkinson disease|parkinson disease
648528|NCT00833690|PD|pd
648529|NCT00833690|inosine|inosine
648530|NCT00833690|urate|urate
648531|NCT00833690|uric acid|uric acid
648532|NCT00833690|cerebrospinal fluid|cerebrospinal fluid
648533|NCT00833677|Coping skills|coping skills
648534|NCT00833677|Chinese|chinese
648535|NCT00833677|Immigrant|immigrant
648536|NCT00833677|Type 2 Diabetes Mellitus|type 2 diabetes mellitus
648537|NCT00833677|Family research|family research
648538|NCT00833664|Bioequivalence|bioequivalence
648539|NCT00833664|Healthy Subjects|healthy subjects
648540|NCT00833651|Transplant|transplant
648541|NCT00833651|Immunology|immunology
648542|NCT00833651|Immunosuppression|immunosuppression
648543|NCT00833638|Erectile Dysfunction|erectile dysfunction
648544|NCT00833625|Gastrointestinal|gastrointestinal
648545|NCT00833625|Esophagus|esophagus
648546|NCT00833625|Cancer of the esophagus|cancer of the esophagus
648547|NCT00833625|Biopsy|biopsy
648548|NCT00833625|EGD|egd
648549|NCT00833625|Esophagogastroduodenoscopy|esophagogastroduodenoscopy
648550|NCT00833625|PET/CT|pet/ct
648551|NCT00833625|Positive Emission Tomography/Computerized Tomography|positive emission tomography/computerized tomography
648552|NCT00833625|Esophageal Cancer|esophageal cancer
648553|NCT00833625|Chemoradiation|chemoradiation
648554|NCT00833625|Chemotherapy|chemotherapy
648555|NCT00833625|Radiation Therapy|radiation therapy
648556|NCT00833612|IABC|iabc
648557|NCT00833612|AMI|ami
648558|NCT00833599|Lymphedema|lymphedema
648559|NCT00833599|Genetic|genetic
648560|NCT00833599|Lymphatic Disorder|lymphatic disorder
648561|NCT00833599|Lipedema|lipedema
648562|NCT00833599|Vascular Malformation|vascular malformation
648563|NCT00833599|Vascular Anomaly|vascular anomaly
648564|NCT00833599|Dercum Disease|dercum disease
648565|NCT00833586|Bioequivalence|bioequivalence
648566|NCT00833586|Healthy Subjects|healthy subjects
648567|NCT00833573|GERD digestive expression|gerd digestive expression
648568|NCT00833573|ages|ages
648569|NCT00833560|Multiple Myeloma|multiple myeloma
648570|NCT00833560|Untreated multiple myeloma|untreated multiple myeloma
648571|NCT00833560|Bortezomib|bortezomib
648572|NCT00833560|VELCADE|velcade
648573|NCT00833560|Cyclophosphamide|cyclophosphamide
648574|NCT00833560|Dexamethasone|dexamethasone
648575|NCT00833560|Chemotherapy|chemotherapy
648576|NCT00833560|Remission therapy|remission therapy
648577|NCT00833560|Induction therapy|induction therapy
648578|NCT00833560|Stem Cell Transplantation|stem cell transplantation
648579|NCT00833547|sleep|sleep
648580|NCT00833547|schizophrenia|schizophrenia
648581|NCT00833547|procedural learning|procedural learning
648582|NCT00833547|motor skill|motor skill
648583|NCT00833534|stage I chronic lymphocytic leukemia|stage i chronic lymphocytic leukemia
648584|NCT00833534|stage II chronic lymphocytic leukemia|stage ii chronic lymphocytic leukemia
648585|NCT00833534|stage III chronic lymphocytic leukemia|stage iii chronic lymphocytic leukemia
648586|NCT00833534|stage IV chronic lymphocytic leukemia|stage iv chronic lymphocytic leukemia
648587|NCT00833534|stage I small lymphocytic lymphoma|stage i small lymphocytic lymphoma
648588|NCT00833534|stage III small lymphocytic lymphoma|stage iii small lymphocytic lymphoma
648589|NCT00833534|stage IV small lymphocytic lymphoma|stage iv small lymphocytic lymphoma
648590|NCT00833534|contiguous stage II small lymphocytic lymphoma|contiguous stage ii small lymphocytic lymphoma
648591|NCT00833534|noncontiguous stage II small lymphocytic lymphoma|noncontiguous stage ii small lymphocytic lymphoma
648592|NCT00833521|Bioequivalence|bioequivalence
648593|NCT00833521|Healthy Subjects|healthy subjects
648594|NCT00833508|Exercise capacity|exercise capacity
648595|NCT00833508|Chemoradiotherapy|chemoradiotherapy
648596|NCT00833508|Colorectal cancer|colorectal cancer
648597|NCT00833469|women|women
648598|NCT00833469|postpartum depression|postpartum depression
648599|NCT00833469|anxiety|anxiety
648600|NCT00833456|schizophrenia|schizophrenia
648601|NCT00833456|Seroquel SR|seroquel sr
648602|NCT00833456|atypical antipsychotics|atypical antipsychotics
648603|NCT00833456|assessment of functioning|assessment of functioning
648604|NCT00833456|GAF scale|gaf scale
648605|NCT00833443|Methamphetamine|methamphetamine
648606|NCT00833443|Addiction|addiction
648607|NCT00833443|Pharmacogenomics|pharmacogenomics
648608|NCT00833443|Amphetamine|amphetamine
648609|NCT00833443|Bupropion|bupropion
648610|NCT00833443|Meth|meth
648611|NCT00833443|Crank|crank
648612|NCT00833443|Crystal|crystal
648613|NCT00833430|AVN|avn
648614|NCT00833430|Femoral Head Collapse|femoral head collapse
648615|NCT00833417|BCC|bcc
648616|NCT00833417|Hedgehog Pathway Inhibitor|hedgehog pathway inhibitor
648617|NCT00833417|Hedgehog|hedgehog
648618|NCT00833417|Basal Cell Cancer|basal cell cancer
648619|NCT00833404|Smoking|smoking
648620|NCT00833404|Smoking Cessation|smoking cessation
648621|NCT00833404|Quit Smoking|quit smoking
648622|NCT00833404|Stop Smoking|stop smoking
648623|NCT00833404|Nicotine Patch|nicotine patch
648624|NCT00833404|Nicotine Replacement Therapy|nicotine replacement therapy
648625|NCT00833404|Sexual Functioning|sexual functioning
648626|NCT00833404|Erectile Functioning|erectile functioning
648627|NCT00833404|Sexual Health|sexual health
648628|NCT00833391|healthy volunteer|healthy volunteer
648629|NCT00833391|formulations|formulations
648630|NCT00833391|bioavailability|bioavailability
648631|NCT00833391|pharmacokinetics|pharmacokinetics
648632|NCT00833378|Drug interaction, SB-497115 (eltrombopag), Kaletra (Lopinavir, Ritonavir),thrombocytopenia, pharmacokinetics|drug interaction, sb-497115 (eltrombopag), kaletra (lopinavir, ritonavir),thrombocytopenia, pharmacokinetics
648827|NCT00832533|UV exposure|uv exposure
648633|NCT00833365|premature infants|premature infants
648635|NCT00833365|ibuprofen|ibuprofen
648636|NCT00833313|Atrial fibrillation|atrial fibrillation
648637|NCT00833313|Gene expression|gene expression
648638|NCT00833313|Genetic|genetic
648639|NCT00833300|Delirium|delirium
648640|NCT00833300|Agitation|agitation
648641|NCT00833300|Intensive Care|intensive care
648642|NCT00833300|Critical Care|critical care
648643|NCT00833300|Antipsychotics|antipsychotics
648644|NCT00833300|Olanzapine|olanzapine
648645|NCT00833300|Haloperidol|haloperidol
648646|NCT00833287|immunoregulatory|immunoregulatory
648647|NCT00833287|dysfunction|dysfunction
648648|NCT00833287|obesity|obesity
648649|NCT00833261|recurrent hypopharynx Cancer|recurrent hypopharynx cancer
648650|NCT00833261|recurrent larynx Cancer|recurrent larynx cancer
648651|NCT00833261|recurrent verrucous carcinoma|recurrent verrucous carcinoma
648652|NCT00833261|squamous cell carcinoma|squamous cell carcinoma
648653|NCT00833261|recurrent oral cavity cancer|recurrent oral cavity cancer
648654|NCT00833261|recurrent metastatic occult primary cancer|recurrent metastatic occult primary cancer
648655|NCT00833261|recurrent oropharynx cacner|recurrent oropharynx cacner
648656|NCT00833261|recurrent paranasal sinus and nasal cavity cancer|recurrent paranasal sinus and nasal cavity cancer
648657|NCT00833261|tongue cancer|tongue cancer
648658|NCT00833222|premature birth|premature birth
648659|NCT00833209|Orbitofrontal cortex|orbitofrontal cortex
648660|NCT00833209|Medication Overuse Headache|medication overuse headache
648661|NCT00833209|Chronic headache|chronic headache
648662|NCT00833209|withdrawal|withdrawal
648663|NCT00833170|pediatric inflammatory bowel disease|pediatric inflammatory bowel disease
648664|NCT00833170|multiple site study|multiple site study
648665|NCT00833157|Knee Osteoarthritis|knee osteoarthritis
648666|NCT00833157|exercise|exercise
648667|NCT00833157|strength training|strength training
648668|NCT00833157|Glucosamine|glucosamine
648669|NCT00833157|Dietary supplement|dietary supplement
648670|NCT00833157|Ibuprofen|ibuprofen
648671|NCT00833157|NSAID|nsaid
648672|NCT00833144|heart failure|heart failure
648673|NCT00833144|dyspnea|dyspnea
648674|NCT00833144|ultrasound|ultrasound
648675|NCT00833131|Rectal cancer|rectal cancer
648676|NCT00833131|Preoperative radiotherapy and consolidating chemotherapy|preoperative radiotherapy and consolidating chemotherapy
648677|NCT00833118|Surgery|surgery
648678|NCT00833118|General Anesthesia|general anesthesia
648679|NCT00833118|Intubation|intubation
648680|NCT00833105|Incomplete Spinal Cord Injury|incomplete spinal cord injury
648681|NCT00833105|Rehabilitation|rehabilitation
648682|NCT00833105|Upper Extremity|upper extremity
648683|NCT00833105|AMES device|ames device
648684|NCT00833105|Incomplete SCI|incomplete sci
648685|NCT00833105|Quadriplegia|quadriplegia
648686|NCT00833092|magnesium|magnesium
648687|NCT00833092|Nutritional Requirements|nutritional requirements
648688|NCT00833092|Sleep|sleep
648689|NCT00833079|Atopic Dermatitis|atopic dermatitis
648690|NCT00833066|hay fever|hay fever
648691|NCT00833066|grass pollen allergy|grass pollen allergy
648692|NCT00833040|Cancer breakthrough pain|cancer breakthrough pain
648693|NCT00833001|Anterior vaginal prolapse (medial, lateral,apical cystocele)|anterior vaginal prolapse (medial, lateral,apical cystocele)
711010|NCT00586872|Early Esophageal Adenocarcinoma|early esophageal adenocarcinoma
648694|NCT00833001|Posterior vaginal prolapse (rectocele and/or enterocele)|posterior vaginal prolapse (rectocele and/or enterocele)
648695|NCT00833001|Vault prolapse (enterocele, uterine/vaginal vault prolapse)|vault prolapse (enterocele, uterine/vaginal vault prolapse)
648696|NCT00832988|pacing thresholds|pacing thresholds
648697|NCT00832988|sensing|sensing
648698|NCT00832988|impedance|impedance
648699|NCT00832962|Rhesus D|rhesus d
648700|NCT00832962|Anti-D allo-immunization|anti-d allo-immunization
648701|NCT00832962|Fetal RHD genotyping|fetal rhd genotyping
648702|NCT00832962|anti-D immunoglobulins|anti-d immunoglobulins
648703|NCT00832962|anti-D prophylaxis|anti-d prophylaxis
648704|NCT00832949|Mixed methods research (qualitative and quantitative)|mixed methods research (qualitative and quantitative)
648705|NCT00832949|Peer support|peer support
648706|NCT00832949|Early inflammatory arthritis|early inflammatory arthritis
648707|NCT00832949|Self-management|self-management
648708|NCT00832949|Patient education|patient education
648709|NCT00832923|parental empowerment|parental empowerment
648710|NCT00832923|parent self-efficacy|parent self-efficacy
648711|NCT00832910|Body image|body image
648712|NCT00832910|Rheumatoid Arthritis|rheumatoid arthritis
648713|NCT00832897|Keratoconus|keratoconus
648714|NCT00832897|riboflavin|riboflavin
648715|NCT00832897|cornea|cornea
648716|NCT00832897|crosslinking|crosslinking
648717|NCT00832884|partial|partial
648718|NCT00832884|onset|onset
648719|NCT00832884|epilepsy|epilepsy
648720|NCT00832884|pediatric|pediatric
648721|NCT00832884|lacosamide|lacosamide
648722|NCT00832884|partial onset epilepsy|partial onset epilepsy
648723|NCT00832884|vimpat|vimpat
648724|NCT00832871|Mifepristone|mifepristone
648725|NCT00832871|RU-486|ru-486
648726|NCT00832871|Compassionate Use|compassionate use
648727|NCT00832871|Antiprogesterone|antiprogesterone
648728|NCT00832845|Late-life schizophrenia (LLS)|late-life schizophrenia (lls)
648729|NCT00832845|Cognitive Behavioural Social Skills Training (CBSST)|cognitive behavioural social skills training (cbsst)
648730|NCT00832845|Randomized|randomized
648731|NCT00832832|Glaucoma|glaucoma
648732|NCT00832832|Eye drop|eye drop
648733|NCT00832832|Intraocular pressure|intraocular pressure
648734|NCT00832832|Eyelid closure|eyelid closure
648735|NCT00832819|Cancer|cancer
648736|NCT00832819|Lung Cancer|lung cancer
648737|NCT00832806|smoking|smoking
648738|NCT00832806|Champix|champix
648739|NCT00832806|Integrated Voice Response technology|integrated voice response technology
648740|NCT00832793|Mixed methods research (qualitative and quantitative)|mixed methods research (qualitative and quantitative)
648741|NCT00832793|Peer support|peer support
648742|NCT00832793|Early inflammatory arthritis|early inflammatory arthritis
648743|NCT00832793|Self-management|self-management
648744|NCT00832793|Patient education|patient education
648745|NCT00832780|Lung cancer|lung cancer
648746|NCT00832780|radiation therapy|radiation therapy
648747|NCT00832780|SBRT|sbrt
648748|NCT00832780|Stereotactic Body Radiation Therapy|stereotactic body radiation therapy
648749|NCT00832780|Tomotherapy|tomotherapy
648750|NCT00832780|other solid tumors|other solid tumors
648751|NCT00832767|Laparoscopic Cholecystectomy|laparoscopic cholecystectomy
648752|NCT00832767|Single Incision Laparoscopic Surgery|single incision laparoscopic surgery
648753|NCT00832767|Surgical Procedures, Minimally Invasive|surgical procedures, minimally invasive
648754|NCT00832754|malaria|malaria
648755|NCT00832754|rapid diagnostic test|rapid diagnostic test
648756|NCT00832754|artemisinin|artemisinin
648757|NCT00832754|Ghana|ghana
648758|NCT00832741|GLP-1|glp-1
648759|NCT00832741|Type 1 diabetes|type 1 diabetes
648760|NCT00832741|Glycemic control|glycemic control
648761|NCT00832741|Incretin hormone|incretin hormone
648762|NCT00832715|Lung|lung
648763|NCT00832715|Lung Cancer|lung cancer
648764|NCT00832715|NSCLC|nsclc
648765|NCT00832715|Non Small Cell Lung Cancer|non small cell lung cancer
648766|NCT00832715|Squamous Cell|squamous cell
648767|NCT00832715|Adenocarcinoma|adenocarcinoma
648768|NCT00832715|Large Cell|large cell
648769|NCT00832715|Endobronchial Ultrasound Transbronchial Needle Aspiration|endobronchial ultrasound transbronchial needle aspiration
648770|NCT00832715|Mediastinal lymph node negative disease|mediastinal lymph node negative disease
648771|NCT00832715|Mediastinal Nodal Metastasis|mediastinal nodal metastasis
648772|NCT00832715|EBUS-FNA|ebus-fna
648773|NCT00832715|Endobronchial Ultrasound Fine Needle Aspiration|endobronchial ultrasound fine needle aspiration
648774|NCT00832715|EBUS guided needle mediastinal lymph node biopsy|ebus guided needle mediastinal lymph node biopsy
648775|NCT00832715|Biopsy|biopsy
648776|NCT00832715|PET scan|pet scan
648777|NCT00832715|Positron Emission Tomography|positron emission tomography
648778|NCT00832715|CT Scans|ct scans
648779|NCT00832715|Computed Tomography Scans|computed tomography scans
648780|NCT00832715|Lymph node|lymph node
648781|NCT00832715|Mediastinoscopy|mediastinoscopy
648782|NCT00832715|Bronchoscope|bronchoscope
648783|NCT00832702|Cardiac|cardiac
648784|NCT00832702|MRI|mri
648785|NCT00832702|Coronary Vascular Dysfunction|coronary vascular dysfunction
648786|NCT00832689|toxicity|toxicity
826828|NCT00127452|DHA|dha
648787|NCT00832676|Mixed methods research (qualitative and quantitative)|mixed methods research (qualitative and quantitative)
648788|NCT00832676|Peer support|peer support
648789|NCT00832676|Early inflammatory arthritis|early inflammatory arthritis
648790|NCT00832676|Self-management|self-management
648791|NCT00832676|Patient education|patient education
648792|NCT00832663|Muscle regeneration|muscle regeneration
648793|NCT00832663|Satellite cells|satellite cells
648794|NCT00832663|electrical stimulation|electrical stimulation
648795|NCT00832663|eccentric contractions|eccentric contractions
648796|NCT00832663|myogenic precursor cells|myogenic precursor cells
648797|NCT00832650|Healthy; Fesoterodine; Solifenacin|healthy; fesoterodine; solifenacin
648798|NCT00832637|Liver|liver
648799|NCT00832637|Gallbladder|gallbladder
648800|NCT00832637|Bile duct|bile duct
648801|NCT00832637|Gemzar|gemzar
648802|NCT00832637|Eloxatin|eloxatin
648803|NCT00832637|Tarceva|tarceva
648804|NCT00832637|erlotinib|erlotinib
648805|NCT00832637|Gem-ox|gem-ox
648806|NCT00832611|Lung Disease|lung disease
648807|NCT00832611|Chronic Airflow Obstruction|chronic airflow obstruction
648808|NCT00832611|Chronic Bronchitis|chronic bronchitis
648809|NCT00832611|Chronic Emphysema|chronic emphysema
648810|NCT00832598|18F-FACBC|18f-facbc
648811|NCT00832598|PET scan imaging|pet scan imaging
648812|NCT00832598|08-142|08-142
648813|NCT00832585|Atopic|atopic
648814|NCT00832585|Dermatitis|dermatitis
648815|NCT00832585|chronic|chronic
648816|NCT00832585|skin|skin
648817|NCT00832572|Coronary Artery Disease|coronary artery disease
648818|NCT00832572|Pain|pain
648819|NCT00832572|Peripheral Neuropathy|peripheral neuropathy
648820|NCT00832572|Polyneuropathy|polyneuropathy
648821|NCT00832559|CAVATAK|cavatak
648822|NCT00832559|Coxsackievirus A21|coxsackievirus a21
648823|NCT00832559|CVA21|cva21
648824|NCT00832559|Oncolytic virotherapy|oncolytic virotherapy
648825|NCT00832533|Vitamin D|vitamin d
648826|NCT00832533|Serum 25-Hydroxyvitamin D|serum 25-hydroxyvitamin d
648828|NCT00832533|Ultraviolet Light Exposure|ultraviolet light exposure
648829|NCT00832533|Skin Melanoma Advanced|skin melanoma advanced
648830|NCT00832520|Advanced cancer|advanced cancer
648831|NCT00832520|weight loss|weight loss
648832|NCT00832520|Remeron|remeron
648833|NCT00832520|body weight|body weight
648834|NCT00832507|PAH|pah
648835|NCT00832507|pulmonary hypertension|pulmonary hypertension
648836|NCT00832507|cicletanine|cicletanine
648837|NCT00832507|cicletanine HCL|cicletanine hcl
648838|NCT00832507|cardiovascular|cardiovascular
648839|NCT00832507|endothelin receptor antagonist|endothelin receptor antagonist
648840|NCT00832507|ERA|era
648841|NCT00832507|monotherapy|monotherapy
648842|NCT00832507|combination therapy|combination therapy
648843|NCT00832507|phosphodiesterase type-5 inhibitor|phosphodiesterase type-5 inhibitor
648844|NCT00832507|PDE5i|pde5i
648845|NCT00832507|parenteral prostanoid|parenteral prostanoid
648846|NCT00832507|PH|ph
648847|NCT00832507|pulmonary|pulmonary
648848|NCT00832481|Repaglinide|repaglinide
648849|NCT00832481|Metformin|metformin
648850|NCT00832468|insomnia|insomnia
648851|NCT00832468|ear acupressure|ear acupressure
648852|NCT00832442|Beta blocker|beta blocker
648853|NCT00832442|Heart Failure|heart failure
648854|NCT00832442|Meta analysis|meta analysis
648855|NCT00832442|Individual patient data|individual patient data
648856|NCT00832429|Sebaceous Gland Carcinoma of the Eyelid|sebaceous gland carcinoma of the eyelid
648857|NCT00832429|Eyelid Sebaceous Gland Carcinoma|eyelid sebaceous gland carcinoma
648858|NCT00832429|Cancer of the eyelid|cancer of the eyelid
648859|NCT00832429|Eye Cancer|eye cancer
648860|NCT00832429|Tumors of the Eye|tumors of the eye
648861|NCT00832429|Sentinel Lymph Node Localization and Biopsy|sentinel lymph node localization and biopsy
648862|NCT00832429|SLN|sln
648863|NCT00832429|Metastatic Disease|metastatic disease
648864|NCT00832429|Metastatic Cancer of the Eyelid|metastatic cancer of the eyelid
648865|NCT00832429|Lymphatic Mapping|lymphatic mapping
648866|NCT00832429|SLN Mapping/Biopsy|sln mapping/biopsy
648867|NCT00832429|SLN Biopsy Procedure|sln biopsy procedure
648868|NCT00832429|SLN Biopsy|sln biopsy
648869|NCT00832429|Lymph Nodes|lymph nodes
648870|NCT00832429|Tc99m-Sulfur Colloid|tc99m-sulfur colloid
648871|NCT00832429|Single Photon Emission Computed Tomography|single photon emission computed tomography
648872|NCT00832429|Computed Tomography|computed tomography
648873|NCT00832429|SPECT/CT|spect/ct
648874|NCT00832403|atrophic rhinitis|atrophic rhinitis
648875|NCT00832403|implants|implants
648876|NCT00832403|Polytetrafluoroethylene|polytetrafluoroethylene
648877|NCT00832364|Psoriasis|psoriasis
648878|NCT00832364|Moderate to Severe Plaque Psoriasis|moderate to severe plaque psoriasis
648879|NCT00832351|Stroke|stroke
648880|NCT00832351|Brain infarction|brain infarction
648881|NCT00832351|Intracerebral hemorrhage|intracerebral hemorrhage
648882|NCT00832351|Early Mobilisation|early mobilisation
648883|NCT00832338|Breast cancer|breast cancer
648884|NCT00832338|Tumors, Breast|tumors, breast
648885|NCT00832338|Cancer of the breast|cancer of the breast
648886|NCT00832325|Childhood Survivor|childhood survivor
648887|NCT00832325|survivors|survivors
648888|NCT00832325|Young Adult Cancer Survivors|young adult cancer survivors
648889|NCT00832325|Childhood cancers|childhood cancers
648890|NCT00832325|09-001|09-001
648891|NCT00832312|Osteoarthritis|osteoarthritis
648892|NCT00832312|Knee|knee
648893|NCT00832312|Pain management|pain management
648894|NCT00832312|Ozone therapy|ozone therapy
648895|NCT00832312|Intraarticular injection|intraarticular injection
648896|NCT00832286|genomic techniques,intestinal microbiome|genomic techniques,intestinal microbiome
648897|NCT00832273|Expanded access to ELAD® in patients with liver failure|expanded access to elad® in patients with liver failure
648898|NCT00832247|Hepatitis C|hepatitis c
648899|NCT00832247|Cirrhosis|cirrhosis
648900|NCT00832247|Stem cell|stem cell
648901|NCT00832234|Morbus Waldenstrom|morbus waldenstrom
648902|NCT00832234|Waldenstroms Macroglobulinemia|waldenstroms macroglobulinemia
648903|NCT00832234|Therapy|therapy
648904|NCT00832234|Rituximab|rituximab
648905|NCT00832234|Dexamethasone|dexamethasone
648906|NCT00832234|Bortezomib|bortezomib
648907|NCT00832221|PET|pet
648908|NCT00832221|Phase 1|phase 1
648909|NCT00832221|Depression|depression
648910|NCT00832221|SEROQUEL|seroquel
648911|NCT00832221|Positron Emission Tomography|positron emission tomography
648912|NCT00832221|Drug profile comparison|drug profile comparison
648913|NCT00832195|running|running
648914|NCT00832195|injury|injury
648915|NCT00832195|pronation|pronation
648916|NCT00832195|footwear.|footwear.
648917|NCT00832169|Pain|pain
648918|NCT00832156|Burns|burns
648919|NCT00832156|Cultured autologous keratinocytes|cultured autologous keratinocytes
648920|NCT00832156|Wound healing|wound healing
648921|NCT00832156|Wound closure|wound closure
648922|NCT00832156|Scar quality|scar quality
648923|NCT00832143|neonatal illness|neonatal illness
648924|NCT00832143|qualified care seeking|qualified care seeking
648925|NCT00832143|Behaviour change|behaviour change
648926|NCT00832143|Urban slums|urban slums
648927|NCT00832143|India|india
648928|NCT00832143|Neonatal morbidity|neonatal morbidity
648929|NCT00832143|Care seeking for neonatal illnesses|care seeking for neonatal illnesses
648930|NCT00832143|Qualified medical care seeking|qualified medical care seeking
648931|NCT00832143|Integrated management of neonatal and childhood illnesses (IMNCI)|integrated management of neonatal and childhood illnesses (imnci)
648932|NCT00832117|Lung Cancer (NSCLC)|lung cancer (nsclc)
648933|NCT00832091|Venous Stasis Ulcers|venous stasis ulcers
648934|NCT00832091|venous insufficiency|venous insufficiency
648935|NCT00832091|leg ulcers|leg ulcers
648936|NCT00832091|Thymosin Beta 4|thymosin beta 4
648937|NCT00832091|Laminin-5|laminin-5
648938|NCT00832065|Sleep Apnea Syndrome|sleep apnea syndrome
648939|NCT00832065|Sleep Apnea|sleep apnea
648940|NCT00832065|CPAP|cpap
648941|NCT00832065|Low testosterone|low testosterone
648942|NCT00832065|Sexual Dysfunction|sexual dysfunction
648943|NCT00832052|elderly, multi-dose, safety, efficacy|elderly, multi-dose, safety, efficacy
648944|NCT00832039|sepsis|sepsis
648945|NCT00832039|adjunctive therapy|adjunctive therapy
648946|NCT00832039|sodium-selenite|sodium-selenite
648947|NCT00832039|procalcitonin|procalcitonin
648948|NCT00832026|sleep apnea|sleep apnea
648949|NCT00832026|snoring|snoring
648950|NCT00832026|sleep apnea treatment|sleep apnea treatment
648951|NCT00832026|TNI|tni
648952|NCT00832026|Trans nasal insufflation|trans nasal insufflation
648953|NCT00832026|Open CPAP|open cpap
648954|NCT00832013|Propofol|propofol
648955|NCT00832013|sedation|sedation
648956|NCT00832013|pediatric|pediatric
648957|NCT00832013|Induction of sedation|induction of sedation
648958|NCT00831987|Fluzone®|fluzone®
648959|NCT00831987|Influenza|influenza
648960|NCT00831987|Adults|adults
648961|NCT00831974|mastocytosis|mastocytosis
648962|NCT00831974|indolent|indolent
648963|NCT00831974|handicap|handicap
648964|NCT00831974|wild-type|wild-type
648965|NCT00831974|systemic|systemic
648966|NCT00831974|not D816V mutated|not d816v mutated
648967|NCT00831961|Antibiotic resistance, Conjunctival flora, Intravitreal injections|antibiotic resistance, conjunctival flora, intravitreal injections
648968|NCT00831935|Acoustic properties of voice in depression|acoustic properties of voice in depression
648969|NCT00831922|Rheumatoid Arthritis|rheumatoid arthritis
648970|NCT00831922|DMARD failure|dmard failure
648971|NCT00831922|ACR|acr
648972|NCT00831909|Lung Cancer|lung cancer
648973|NCT00831909|NSCLC management|nsclc management
648974|NCT00831909|NSCLC use of health care resources|nsclc use of health care resources
648975|NCT00831883|Adolescent|adolescent
648976|NCT00831883|Adolescent behavior|adolescent behavior
648977|NCT00831883|Health behavior|health behavior
648978|NCT00831883|Sexual Behavior|sexual behavior
648979|NCT00831883|Incarceration|incarceration
648980|NCT00831883|Behavioral Intervention|behavioral intervention
648981|NCT00831883|Risk Reduction Behavior|risk reduction behavior
648982|NCT00831870|EndoSure Sensor|endosure sensor
648983|NCT00831870|s2 Sensor|s2 sensor
648984|NCT00831870|abdominal aortic aneurysm|abdominal aortic aneurysm
648985|NCT00831831|perinatal|perinatal
648986|NCT00831831|intimate partner violence|intimate partner violence
648987|NCT00831831|randomized controlled trial|randomized controlled trial
648988|NCT00831831|preterm|preterm
648989|NCT00831831|hemorrhage|hemorrhage
648990|NCT00831831|safety|safety
648991|NCT00831818|breastfeeding|breastfeeding
648992|NCT00831818|ghrelin|ghrelin
648993|NCT00831818|PYY|pyy
648994|NCT00831818|appetite-regulation|appetite-regulation
648995|NCT00831805|geriatrics|geriatrics
648996|NCT00831805|psycho-cognitive troubles|psycho-cognitive troubles
648997|NCT00831805|elderly|elderly
648998|NCT00831805|mobile unit|mobile unit
648999|NCT00831805|elderly patients|elderly patients
649000|NCT00831792|Prostate Cancer|prostate cancer
649001|NCT00831792|Advanced Prostate Cancer|advanced prostate cancer
649002|NCT00831792|Castrate Resistant Prostate Cancer|castrate resistant prostate cancer
649003|NCT00831792|Prostate Specific Antigen|prostate specific antigen
649004|NCT00831792|PSA|psa
649005|NCT00831792|Castration-Resistant Prostate Cancer Patients|castration-resistant prostate cancer patients
649006|NCT00831792|TK1258|tk1258
649007|NCT00831792|CHIR-258|chir-258
649008|NCT00831766|Hematopoietic|hematopoietic
649009|NCT00831766|Myeloid and Monocytic Leukemia|myeloid and monocytic leukemia
649010|NCT00831766|AML|aml
649011|NCT00831753|Diphtheria|diphtheria
649012|NCT00831753|Tetanus|tetanus
649013|NCT00831753|Pertussis|pertussis
649014|NCT00831753|whooping cough|whooping cough
649015|NCT00831753|Haemophilus influenzae type b|haemophilus influenzae type b
649016|NCT00831753|Hepatitis B|hepatitis b
649017|NCT00831753|Poliomyelitis|poliomyelitis
649018|NCT00831740|Stroke|stroke
649019|NCT00831740|Communication|communication
649020|NCT00831740|Speech and Language Therapy|speech and language therapy
649021|NCT00831727|expressive writing|expressive writing
649022|NCT00831727|trauma|trauma
649023|NCT00831727|intervention|intervention
649024|NCT00831727|posttraumatic stress|posttraumatic stress
649025|NCT00831714|Prophylaxis of Venous Thromboembolism|prophylaxis of venous thromboembolism
649026|NCT00831701|Adrenergic alpha antagonists|adrenergic alpha antagonists
649027|NCT00831701|drug therapy|drug therapy
649028|NCT00831701|tamsulosin|tamsulosin
649030|NCT00831688|Meniere|meniere
649031|NCT00831688|vertigo|vertigo
649032|NCT00831688|overpressure treatment|overpressure treatment
649033|NCT00831688|caloric irrigation|caloric irrigation
649034|NCT00831688|hearing levels|hearing levels
649035|NCT00831688|vertigo severity|vertigo severity
649036|NCT00831688|functional disability scale|functional disability scale
649037|NCT00831675|Influenza|influenza
649038|NCT00831675|Fluzone® vaccine|fluzone® vaccine
649039|NCT00831675|Infants|infants
649040|NCT00831675|Toddlers|toddlers
649041|NCT00831636|CP-4055|cp-4055
649042|NCT00831636|Cancer|cancer
649043|NCT00831636|Metastatic|metastatic
649044|NCT00831636|Solid tumors|solid tumors
649045|NCT00831636|advanced ovarian cancer|advanced ovarian cancer
649046|NCT00831636|stage III and IV ovarian cancer|stage iii and iv ovarian cancer
649047|NCT00831636|advanced epithelian ovarian cancer|advanced epithelian ovarian cancer
649048|NCT00831623|hypofractionation|hypofractionation
649049|NCT00831623|proton beam radiation|proton beam radiation
649050|NCT00831610|bariatric surgery|bariatric surgery
649051|NCT00831610|plastic surgery|plastic surgery
649052|NCT00831610|abdominal wall|abdominal wall
649053|NCT00831610|skin|skin
649054|NCT00831610|sensation|sensation
649055|NCT00831610|abdominoplasty|abdominoplasty
649056|NCT00831597|Lymphoma|lymphoma
649057|NCT00831597|B-Cell|b-cell
649058|NCT00831571|oxaliplatin|oxaliplatin
649059|NCT00831571|hypersensitivity|hypersensitivity
649060|NCT00831532|Dimebon Hepatic Impairment|dimebon hepatic impairment
649061|NCT00831506|digoxin dimebon drug-drug interaction study|digoxin dimebon drug-drug interaction study
649062|NCT00831493|Pancreas|pancreas
649063|NCT00831493|Pancreatic Cancer|pancreatic cancer
649064|NCT00831493|Locally Advanced Pancreatic Cancer|locally advanced pancreatic cancer
649065|NCT00831493|LAPC|lapc
649066|NCT00831493|Non-Metastatic|non-metastatic
649067|NCT00831493|Unresectable|unresectable
649068|NCT00831493|Vorinostat|vorinostat
649069|NCT00831493|XRT|xrt
649070|NCT00831493|RT|rt
649071|NCT00831493|Radiation Therapy|radiation therapy
649072|NCT00831493|SAHA|saha
649073|NCT00831493|Suberoylanilide Hydroxamic Acid|suberoylanilide hydroxamic acid
649074|NCT00831493|MSK-390|msk-390
649075|NCT00831480|Renal cell carcinoma|renal cell carcinoma
649076|NCT00831480|Everolimus|everolimus
649077|NCT00831480|Neoadjuvant|neoadjuvant
649078|NCT00831480|advanced kidney cancer|advanced kidney cancer
649079|NCT00831467|Hormonal refractory prostate cancer|hormonal refractory prostate cancer
649080|NCT00831467|RNA vaccine|rna vaccine
649081|NCT00831441|NOS|nos
649082|NCT00831428|asthma|asthma
649083|NCT00831428|rhinitis|rhinitis
649084|NCT00831428|swimmers|swimmers
649085|NCT00831428|mannitol|mannitol
649086|NCT00831415|Open-label Long-term extension study|open-label long-term extension study
649087|NCT00831402|woman|woman
649088|NCT00831376|Asthma|asthma
649089|NCT00831376|Genotype|genotype
649090|NCT00831376|Beta2adrenoreceptor|beta2adrenoreceptor
649091|NCT00831376|Levosalbutamol|levosalbutamol
649092|NCT00831363|gait analysis|gait analysis
649093|NCT00831363|minimal invasive approach|minimal invasive approach
649094|NCT00831363|transgluteal approach|transgluteal approach
649095|NCT00831363|THA|tha
649096|NCT00831350|RVO|rvo
649097|NCT00831350|PVD|pvd
649098|NCT00831337|VSL3|vsl3
649099|NCT00831337|Probiotics|probiotics
649100|NCT00831337|Gut microbiota|gut microbiota
649101|NCT00831337|Cytokines|cytokines
649102|NCT00831337|Portal hypertension|portal hypertension
649103|NCT00831337|Chemokines|chemokines
649104|NCT00831337|Liver cirrhosis|liver cirrhosis
649105|NCT00831311|Diphtheria|diphtheria
649106|NCT00831311|Tetanus|tetanus
649107|NCT00831311|Pertussis|pertussis
649108|NCT00831311|Whooping cough|whooping cough
649109|NCT00831311|Hepatitis B|hepatitis b
649110|NCT00831311|Poliomyelitis|poliomyelitis
649111|NCT00831311|Haemophilus influenzae type b|haemophilus influenzae type b
649112|NCT00831298|alzheimer disease|alzheimer disease
649113|NCT00831298|sleep disturbance|sleep disturbance
649114|NCT00831298|apathy|apathy
649115|NCT00831298|memory loss|memory loss
649116|NCT00831285|Healthy volunteers|healthy volunteers
649117|NCT00831259|stroke|stroke
649118|NCT00831259|PFO|pfo
649119|NCT00831259|embolism|embolism
649120|NCT00831246|Ileus,|ileus,
649121|NCT00831246|Gynecologic surgery,|gynecologic surgery,
649122|NCT00831246|Post-operative,|post-operative,
649123|NCT00831246|Flatus|flatus
649124|NCT00831220|COPD|copd
649125|NCT00831220|exacerbations|exacerbations
649126|NCT00831220|EPCs|epcs
649127|NCT00831220|Erythropoietin|erythropoietin
649128|NCT00831220|C-RP|c-rp
649129|NCT00831220|COPD and endothelial dysfunction|copd and endothelial dysfunction
649130|NCT00831207|B-2 microglobulin|b-2 microglobulin
649131|NCT00831207|Serum cytokines|serum cytokines
649132|NCT00831207|HIV-1|hiv-1
649133|NCT00831207|Resistance|resistance
649134|NCT00831207|HAART|haart
649135|NCT00831207|Therapeutic failure|therapeutic failure
649136|NCT00831207|Genotyping.|genotyping.
649137|NCT00831194|Type 2 Diabetes|type 2 diabetes
649138|NCT00831194|Obesity|obesity
649139|NCT00831194|Weight loss|weight loss
649140|NCT00831194|PDA|pda
649141|NCT00831194|Stress|stress
649142|NCT00831194|Dietary lapse|dietary lapse
649143|NCT00831194|salivary alpha amylase|salivary alpha amylase
649144|NCT00831181|stage II rectal cancer|stage ii rectal cancer
649145|NCT00831181|stage III rectal cancer|stage iii rectal cancer
649146|NCT00831181|adenocarcinoma of the rectum|adenocarcinoma of the rectum
649147|NCT00831168|neonatal|neonatal
649148|NCT00831168|premature babies|premature babies
649149|NCT00831168|healthcare research|healthcare research
649150|NCT00831168|Babies born before 27 weeks gestation|babies born before 27 weeks gestation
649151|NCT00831155|smoking|smoking
649152|NCT00831155|nicotine patches|nicotine patches
649153|NCT00831155|extinction based treatment|extinction based treatment
649154|NCT00831142|Prostate Cancer|prostate cancer
649155|NCT00831142|MRI|mri
649156|NCT00831142|Prostatectomy|prostatectomy
649157|NCT00831116|near infrared spectroscopy|near infrared spectroscopy
649158|NCT00831116|LipiScan|lipiscan
649159|NCT00831116|lipid core|lipid core
649160|NCT00831116|percutaneous coronary intervention|percutaneous coronary intervention
649161|NCT00831116|myocardial infarction|myocardial infarction
649162|NCT00831116|NIRS|nirs
649163|NCT00831116|intravascular imaging|intravascular imaging
649164|NCT00831103|EPB348|epb348
649165|NCT00831103|Valomaciclovir Stearate|valomaciclovir stearate
649166|NCT00831103|Valacyclovir|valacyclovir
649167|NCT00831103|Herpes Zoster|herpes zoster
649168|NCT00831103|Shingles|shingles
649169|NCT00831077|Healthy volunteers|healthy volunteers
649170|NCT00831064|bowel preparation quality|bowel preparation quality
649171|NCT00831064|colonoscopy|colonoscopy
649172|NCT00831051|Bunionectomy|bunionectomy
649173|NCT00831038|pulmonary function tests|pulmonary function tests
649174|NCT00831038|infants|infants
649175|NCT00831038|chronic lung disease|chronic lung disease
649176|NCT00831038|dysphagia|dysphagia
649177|NCT00831038|chronic aspiration|chronic aspiration
649178|NCT00831025|Immunotherapy|immunotherapy
649179|NCT00831025|Allergoid|allergoid
649180|NCT00831025|Depigmented|depigmented
649181|NCT00831025|Polymerized|polymerized
649182|NCT00831025|Allergen-extract|allergen-extract
649183|NCT00831025|Rhinoconjunctivitis|rhinoconjunctivitis
649184|NCT00831012|Dengue Vaccine|dengue vaccine
649185|NCT00831012|Dengue Virus|dengue virus
649186|NCT00831012|Dengue Hemorrhagic Fever|dengue hemorrhagic fever
649187|NCT00831012|Dengue Shock Syndrome|dengue shock syndrome
649188|NCT00830999|fat metabolism|fat metabolism
649189|NCT00830999|exercise|exercise
649190|NCT00830999|liver|liver
649191|NCT00830999|lipoproteins|lipoproteins
649192|NCT00830999|triglycerides|triglycerides
649193|NCT00830986|Mental Cognition Change|mental cognition change
649194|NCT00830986|Fat Embolism|fat embolism
649195|NCT00830986|Bone Marrow Debris Emboli|bone marrow debris emboli
649196|NCT00830986|Computer Assisted Total Knee Arthroplasty|computer assisted total knee arthroplasty
649197|NCT00830986|Conventional Instrumented Total Knee Arthroplasty|conventional instrumented total knee arthroplasty
649198|NCT00830973|Estrogen Antagonists|estrogen antagonists
649199|NCT00830973|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal
649200|NCT00830973|Hormone Antagonists|hormone antagonists
649201|NCT00830973|Hormones|hormones
649202|NCT00830973|Hormone Substitutes|hormone substitutes
649203|NCT00830973|Selective Estrogen Receptor Modulators|selective estrogen receptor modulators
649204|NCT00830973|Estrogen Receptor Modulators|estrogen receptor modulators
649205|NCT00830973|Neoplasms|neoplasms
649206|NCT00830973|Neoplasms by Site|neoplasms by site
649207|NCT00830947|Orthodontic|orthodontic
649208|NCT00830947|Extraction|extraction
649209|NCT00830947|Device|device
649210|NCT00830947|Space Closure|space closure
649211|NCT00830947|Orthodontic malocclusion|orthodontic malocclusion
649212|NCT00830934|pelvic girdle pain|pelvic girdle pain
649213|NCT00830934|symphysio pubic dysfunction|symphysio pubic dysfunction
649214|NCT00830934|group care|group care
649215|NCT00830934|individual care|individual care
649216|NCT00830921|Histocytologically proven thoracic malignancy|histocytologically proven thoracic malignancy
649217|NCT00830908|seborrheic dermatitis|seborrheic dermatitis
649218|NCT00830895|Renal cell carcinoma|renal cell carcinoma
649219|NCT00830895|Non-clear cell|non-clear cell
649220|NCT00830895|RAD001|rad001
649221|NCT00830895|Metastatic, non-clear cell, renal cell carcinoma|metastatic, non-clear cell, renal cell carcinoma
649222|NCT00830882|asthma|asthma
649223|NCT00830882|levosalbutamol|levosalbutamol
649224|NCT00830882|genotype|genotype
649225|NCT00830882|bronchoprotection|bronchoprotection
649226|NCT00830869|Drug therapy|drug therapy
649227|NCT00830856|Cryptococcal Meningitis|cryptococcal meningitis
649229|NCT00830856|Fluconazole|fluconazole
649230|NCT00830856|Antiretroviral therapy|antiretroviral therapy
649231|NCT00830856|Africa|africa
649232|NCT00830856|treatment naive|treatment naive
649233|NCT00830843|SAH|sah
649234|NCT00830843|sedation|sedation
649235|NCT00830843|anesthesia|anesthesia
649236|NCT00830817|Topical cream application|topical cream application
649428|NCT00830037|iron|iron
649237|NCT00830817|Mild to moderate psoriasis|mild to moderate psoriasis
649238|NCT00830804|Treatment Naive|treatment naive
649239|NCT00830778|pancreas|pancreas
649240|NCT00830778|surgery|surgery
649241|NCT00830778|cancer|cancer
649242|NCT00830778|pancreaticoduodenectomy (PD)|pancreaticoduodenectomy (pd)
649243|NCT00830778|peri-ampullary tumours (ampulla, duodenum, distal bile duct, and miscellaneous tumours)|peri-ampullary tumours (ampulla, duodenum, distal bile duct, and miscellaneous tumours)
649244|NCT00830778|pancreatic tumors|pancreatic tumors
649245|NCT00830778|peri-ampullary tumors|peri-ampullary tumors
649246|NCT00830752|alexithymia|alexithymia
649247|NCT00830739|Smoking Cessation|smoking cessation
649248|NCT00830739|Dopamine|dopamine
649249|NCT00830739|Cognitive Control|cognitive control
649250|NCT00830739|Reward Processing|reward processing
649251|NCT00830739|Varenicline|varenicline
649252|NCT00830726|Aquaporin|aquaporin
649253|NCT00830726|Epithelial Sodium Channels|epithelial sodium channels
649254|NCT00830726|Heart Failure|heart failure
649255|NCT00830726|Valvular heart disease|valvular heart disease
649256|NCT00830726|Ischemic heart disease|ischemic heart disease
649257|NCT00830713|vitiligo|vitiligo
649258|NCT00830713|skin transplantation|skin transplantation
649259|NCT00830713|non-cultured|non-cultured
649260|NCT00830713|melanocyte|melanocyte
649261|NCT00830713|surgery|surgery
649262|NCT00830700|ADHD|adhd
649263|NCT00830700|telemental health|telemental health
649264|NCT00830700|TMH|tmh
649265|NCT00830700|telepsychiatry|telepsychiatry
649266|NCT00830700|rural mental health services for children|rural mental health services for children
649267|NCT00830687|subcapital femoral fractures|subcapital femoral fractures
649268|NCT00830687|transcervical femoral fractures|transcervical femoral fractures
649269|NCT00830687|TARGON FN|targon fn
649270|NCT00830674|XLH|xlh
649271|NCT00830661|transsphincteric anal fistula|transsphincteric anal fistula
649272|NCT00830661|cryptoglandular origin|cryptoglandular origin
649273|NCT00830661|anal fistula repair|anal fistula repair
649274|NCT00830661|Ligation of Intersphincteric Fistula Track (LIFT) procedure|ligation of intersphincteric fistula track (lift) procedure
649275|NCT00830661|anal fistula plug (Plug)|anal fistula plug (plug)
649276|NCT00830661|surgical repair|surgical repair
649277|NCT00830648|varicella-zoster virus|varicella-zoster virus
649278|NCT00830648|varicella|varicella
649279|NCT00830635|long-term effects of cancer treatment|long-term effects of cancer treatment
649280|NCT00830635|psychosocial effects of cancer and its treatment|psychosocial effects of cancer and its treatment
649281|NCT00830635|depression|depression
649282|NCT00830635|stage IA breast cancer|stage ia breast cancer
649283|NCT00830635|stage IB breast cancer|stage ib breast cancer
649284|NCT00830635|stage II breast cancer|stage ii breast cancer
649285|NCT00830635|stage I prostate cancer|stage i prostate cancer
649286|NCT00830635|stage II prostate cancer|stage ii prostate cancer
649287|NCT00830622|HIV/AIDS|hiv/aids
649288|NCT00830622|Adherence|adherence
649289|NCT00830622|Antiretroviral Therapy, ART, ARV|antiretroviral therapy, art, arv
649290|NCT00830622|Mobile phone, cell phone, telephone|mobile phone, cell phone, telephone
649291|NCT00830622|Text message, SMS|text message, sms
649292|NCT00830622|Telemedicine|telemedicine
649293|NCT00830622|Africa|africa
649294|NCT00830622|Resource-limited setting|resource-limited setting
649295|NCT00830622|Counseling, support|counseling, support
649296|NCT00830622|treatment experienced|treatment experienced
649297|NCT00830609|Chronic Hepatitis C|chronic hepatitis c
649298|NCT00830609|Genotype 3|genotype 3
649299|NCT00830609|High viral load|high viral load
649300|NCT00830570|CYP2C9|cyp2c9
649301|NCT00830570|VKORC1|vkorc1
649302|NCT00830570|polymorphism|polymorphism
649303|NCT00830570|warfarin|warfarin
649304|NCT00830570|Coumadin|coumadin
649305|NCT00830557|recurrent pancreatic cancer|recurrent pancreatic cancer
649306|NCT00830557|stage I pancreatic cancer|stage i pancreatic cancer
649307|NCT00830557|stage II pancreatic cancer|stage ii pancreatic cancer
649308|NCT00830557|stage III pancreatic cancer|stage iii pancreatic cancer
649309|NCT00830557|stage IV pancreatic cancer|stage iv pancreatic cancer
649310|NCT00830557|recurrent islet cell carcinoma|recurrent islet cell carcinoma
649311|NCT00830557|pancreatic alpha cell carcinoma|pancreatic alpha cell carcinoma
649312|NCT00830557|pancreatic beta islet cell carcinoma|pancreatic beta islet cell carcinoma
649313|NCT00830557|pancreatic delta cell carcinoma|pancreatic delta cell carcinoma
649314|NCT00830557|pancreatic G-cell carcinoma|pancreatic g-cell carcinoma
649315|NCT00830544|neoadjuvant chemotherapy breast cancer|neoadjuvant chemotherapy breast cancer
649316|NCT00830544|Breast cancer patients with tumors over one cm|breast cancer patients with tumors over one cm
649317|NCT00830531|Hypoxic-ischemic encephalopathy|hypoxic-ischemic encephalopathy
649318|NCT00830531|Neonatal stroke|neonatal stroke
649319|NCT00830531|Intracranial hemorrhage|intracranial hemorrhage
649320|NCT00830531|Perinatal asphyxia|perinatal asphyxia
649321|NCT00830531|Neonatal Seizures|neonatal seizures
649322|NCT00830518|Drug therapy|drug therapy
649323|NCT00830505|fluticasone|fluticasone
649324|NCT00830505|salmeterol|salmeterol
649325|NCT00830505|bronchoprotection|bronchoprotection
649326|NCT00830492|clomiphene citrate|clomiphene citrate
649327|NCT00830492|GnRH agonist|gnrh agonist
649328|NCT00830492|GnRH antagonist|gnrh antagonist
649329|NCT00830492|in vitro fertilization|in vitro fertilization
649330|NCT00830492|clinical pregnancy|clinical pregnancy
649331|NCT00830492|pregnancy|pregnancy
649332|NCT00830466|port wine stain|port wine stain
649333|NCT00830453|Brain injury with sequelae from stroke, anoxia, or trauma|brain injury with sequelae from stroke, anoxia, or trauma
649334|NCT00830427|asthma bronchial diseases|asthma bronchial diseases
649335|NCT00830414|Bioequivalence|bioequivalence
649336|NCT00830414|Healthy Subjects|healthy subjects
649337|NCT00830401|intra-uterine abnormalities|intra-uterine abnormalities
649338|NCT00830401|intracavitary pathology|intracavitary pathology
649339|NCT00830401|hysteroscopy|hysteroscopy
649340|NCT00830401|IVF|ivf
649341|NCT00830401|ICSI|icsi
649342|NCT00830401|polyp|polyp
649343|NCT00830401|myoma|myoma
649344|NCT00830401|adhesion|adhesion
649345|NCT00830401|septum|septum
649346|NCT00830401|endometritis|endometritis
649347|NCT00830388|tinea versicolor|tinea versicolor
649348|NCT00830388|ketoconazole|ketoconazole
649349|NCT00830375|Buying|buying
649350|NCT00830375|Shopping|shopping
649351|NCT00830375|Impulse Control|impulse control
649352|NCT00830362|cocaine|cocaine
649353|NCT00830362|cocaine-dependent|cocaine-dependent
649354|NCT00830362|propranolol|propranolol
649355|NCT00830362|craving|craving
649356|NCT00830362|beta-blockade|beta-blockade
649357|NCT00830362|cue exposure|cue exposure
649358|NCT00830362|drug|drug
649359|NCT00830362|addiction|addiction
649360|NCT00830362|memory|memory
649361|NCT00830362|addictive behavior|addictive behavior
649362|NCT00830349|Bioequivalence|bioequivalence
649363|NCT00830349|Healthy Subjects|healthy subjects
649364|NCT00830336|Bioequivalence|bioequivalence
649365|NCT00830336|Healthy Subjects|healthy subjects
649366|NCT00830310|Patient Non-Adherence|patient non-adherence
649367|NCT00830310|Patient Non-Compliance|patient non-compliance
649368|NCT00830310|Patient Nonadherence|patient nonadherence
649369|NCT00830310|Patient Noncompliance|patient noncompliance
649370|NCT00830310|Patient Refusal of Treatment|patient refusal of treatment
649371|NCT00830310|Refusal of Treatment|refusal of treatment
649372|NCT00830310|Treatment Refusal|treatment refusal
649373|NCT00830297|TIP|tip
649374|NCT00830297|NODAT|nodat
649375|NCT00830297|hyperglycemia|hyperglycemia
649376|NCT00830297|long-acting insulin|long-acting insulin
649377|NCT00830297|post-transplant hyperglycemia|post-transplant hyperglycemia
649378|NCT00830284|Pediatric Acute Respiratory Distress Syndrome (ARDS)|pediatric acute respiratory distress syndrome (ards)
649379|NCT00830284|Pediatric Acute Lung Injury (ALI)|pediatric acute lung injury (ali)
649380|NCT00830271|surgical site infection|surgical site infection
649381|NCT00830271|wound complications|wound complications
649382|NCT00830271|suture|suture
649383|NCT00830271|antiseptic|antiseptic
649384|NCT00830271|wound closure|wound closure
649385|NCT00830258|Bioequivalence|bioequivalence
649386|NCT00830258|Healthy Subjects|healthy subjects
649387|NCT00830245|EGFR mutation|egfr mutation
649388|NCT00830245|Erlotinib|erlotinib
649389|NCT00830245|Lung cancer|lung cancer
649390|NCT00830245|leptomeningeal carcinomatosis in EGFR mutation positive non-small cell lung cancer|leptomeningeal carcinomatosis in egfr mutation positive non-small cell lung cancer
649391|NCT00830232|Stroke|stroke
649392|NCT00830232|Carotid stenosis|carotid stenosis
649393|NCT00830232|stents|stents
649394|NCT00830219|Bioequivalence|bioequivalence
649395|NCT00830219|Healthy Subjects|healthy subjects
649396|NCT00830206|Bioequivalence|bioequivalence
649397|NCT00830206|Healthy Subjects|healthy subjects
649398|NCT00830193|N-acetylcysteine|n-acetylcysteine
649399|NCT00830193|prevention|prevention
649400|NCT00830193|contrast-induced nephropathy|contrast-induced nephropathy
649401|NCT00830193|critically ill adults|critically ill adults
649402|NCT00830180|Cancer pain|cancer pain
649403|NCT00830180|NGF|ngf
649404|NCT00830180|open-label extension|open-label extension
649405|NCT00830154|stutter|stutter
649406|NCT00830154|stuttering|stuttering
649407|NCT00830154|Adults with a history of stuttering|adults with a history of stuttering
649408|NCT00830141|Ghrelin|ghrelin
649409|NCT00830141|obesity|obesity
649410|NCT00830141|idiopathic short stature (ISS)|idiopathic short stature (iss)
649411|NCT00830115|PPI therapy|ppi therapy
649412|NCT00830115|Pantoprazole|pantoprazole
649413|NCT00830115|eGERD (Erosive Gastroesophageal Reflux Disease)|egerd (erosive gastroesophageal reflux disease)
649414|NCT00830115|NERD (Non-Erosive Reflux Disease)|nerd (non-erosive reflux disease)
649415|NCT00830102|Mild to Moderate Asthma|mild to moderate asthma
649416|NCT00830089|Transversus abdominis plane block|transversus abdominis plane block
649417|NCT00830089|Laparoscopic colorectal surgery|laparoscopic colorectal surgery
649418|NCT00830089|Analgesia|analgesia
649419|NCT00830063|monoclonal antibody|monoclonal antibody
649420|NCT00830063|RN624|rn624
649421|NCT00830063|PF-04383119|pf-04383119
649422|NCT00830063|nerve growth factor|nerve growth factor
649423|NCT00830063|anti-nerve growth factor|anti-nerve growth factor
649424|NCT00830063|OA|oa
649425|NCT00830063|pain|pain
649426|NCT00830050|fMRI functional magnetic resonance imaging Pain|fmri functional magnetic resonance imaging pain
649427|NCT00830037|anemia|anemia
649429|NCT00830037|kidney disease|kidney disease
649430|NCT00830037|progression|progression
649431|NCT00830037|glomerular filtration rate|glomerular filtration rate
649432|NCT00830024|Bioequivalence|bioequivalence
649433|NCT00830024|Healthy Subjects|healthy subjects
649434|NCT00830011|diabetes|diabetes
649435|NCT00830011|neuropathy|neuropathy
649436|NCT00830011|chronic pain|chronic pain
649437|NCT00830011|Cognitive behavioral therapy|cognitive behavioral therapy
649438|NCT00829998|Bioequivalence|bioequivalence
649439|NCT00829998|Healthy Subjects|healthy subjects
649440|NCT00829985|Rhinitis, Allergic, Perennial|rhinitis, allergic, perennial
649441|NCT00829985|Rhinitis, Allergic, Seasonal|rhinitis, allergic, seasonal
649442|NCT00829985|Immunotherapy|immunotherapy
649443|NCT00829985|Asthma|asthma
649444|NCT00829985|Nasal Allergies|nasal allergies
649445|NCT00829985|Hypersensitivity|hypersensitivity
649446|NCT00829959|Ovary, Cancer|ovary, cancer
649447|NCT00829959|Ovarian Cancer|ovarian cancer
649448|NCT00829959|Breast Cancer|breast cancer
649449|NCT00829959|Hereditary Breast and Ovarian Cancer Syndrome|hereditary breast and ovarian cancer syndrome
649450|NCT00829959|HBOC|hboc
649451|NCT00829959|Genetic testing|genetic testing
649452|NCT00829959|Pregnancy|pregnancy
649453|NCT00829959|Fertility|fertility
649454|NCT00829959|Prenatal diagnostic testing|prenatal diagnostic testing
649455|NCT00829946|Strength training|strength training
649456|NCT00829946|Anorexia|anorexia
649457|NCT00829946|Girls|girls
649458|NCT00829946|Quality of life|quality of life
649459|NCT00829946|Functional mobility|functional mobility
649460|NCT00829933|Atrial fibrillation|atrial fibrillation
649461|NCT00829933|Factor Xa inhibition|factor xa inhibition
649462|NCT00829920|Bladder cancer|bladder cancer
649463|NCT00829907|Healthy volunteer study|healthy volunteer study
649464|NCT00829894|Bioequivalence|bioequivalence
649465|NCT00829894|Healthy Subjects|healthy subjects
649466|NCT00829881|Attention|attention
649467|NCT00829868|Bioequivalence|bioequivalence
649468|NCT00829868|Healthy Subjects|healthy subjects
649469|NCT00829855|pulmonary edema|pulmonary edema
649470|NCT00829855|hypertension|hypertension
649471|NCT00829855|echocardiography|echocardiography
649472|NCT00829842|chlorexidine|chlorexidine
649473|NCT00829842|ventilator-associated pneumonia|ventilator-associated pneumonia
649474|NCT00829842|nosocomial pneumonia|nosocomial pneumonia
649475|NCT00829842|heart surgery|heart surgery
649476|NCT00829842|oral hygiene|oral hygiene
649477|NCT00829829|Metabolism, Inborn Errors|metabolism, inborn errors
649478|NCT00829829|Allopurinol|allopurinol
649479|NCT00829829|Metabolic Diseases|metabolic diseases
649480|NCT00829829|Genetic Diseases, Inborn|genetic diseases, inborn
649481|NCT00829829|Musculoskeletal Diseases|musculoskeletal diseases
649482|NCT00829829|Joint Diseases|joint diseases
649483|NCT00829829|Arthritis|arthritis
649484|NCT00829829|Rheumatic Diseases|rheumatic diseases
649485|NCT00829829|Metabolic disorder|metabolic disorder
649486|NCT00829829|Purine-Pyrimidine Metabolism, Inborn Errors|purine-pyrimidine metabolism, inborn errors
649487|NCT00829829|Gout|gout
649488|NCT00829816|Alzheimers disease|alzheimers disease
649489|NCT00829816|donepezil|donepezil
649490|NCT00829816|memantine|memantine
649491|NCT00829803|To acquire developmental data to prospectively support SNAP|to acquire developmental data to prospectively support snap
649492|NCT00829803|II index ranges at the studied anesthetic states.|ii index ranges at the studied anesthetic states.
649493|NCT00829790|Bioequivalence|bioequivalence
649494|NCT00829790|Healthy Subjects|healthy subjects
649495|NCT00829777|Naloxone|naloxone
649496|NCT00829777|6β-Naltrexol|6β-naltrexol
649497|NCT00829777|Opioid-dependent|opioid-dependent
649498|NCT00829777|Pharmacokinetics|pharmacokinetics
649499|NCT00829777|peripheral effects of withdrawal|peripheral effects of withdrawal
649500|NCT00829777|central effects of withdrawal|central effects of withdrawal
649501|NCT00829764|Bioequivalence|bioequivalence
649502|NCT00829764|Healthy Subjects|healthy subjects
649503|NCT00829751|staining|staining
649504|NCT00829751|toxicity|toxicity
649505|NCT00829751|fluorometry|fluorometry
649506|NCT00829751|dye diffusion|dye diffusion
649507|NCT00829751|anterior chamber|anterior chamber
649508|NCT00829738|PPI therapy|ppi therapy
649509|NCT00829738|pantoprazole|pantoprazole
649510|NCT00829738|GERD (Erosive Gastroesophageal Reflux Disease)|gerd (erosive gastroesophageal reflux disease)
649511|NCT00829725|subcapital femoral fractures|subcapital femoral fractures
649512|NCT00829725|transcervical femoral fractures|transcervical femoral fractures
649513|NCT00829725|TARGON FN|targon fn
649514|NCT00829712|Bioequivalence|bioequivalence
649515|NCT00829712|Healthy Subjects|healthy subjects
649516|NCT00829699|endothelial function|endothelial function
649517|NCT00829699|fibrinolytic balance|fibrinolytic balance
649518|NCT00829686|abscess|abscess
649519|NCT00829686|cellulitis|cellulitis
649520|NCT00829686|antibiotics|antibiotics
649521|NCT00829686|MRSA|mrsa
649522|NCT00829673|Bioequivalence|bioequivalence
649523|NCT00829673|Healthy Subjects|healthy subjects
649524|NCT00829660|Acarbose|acarbose
649525|NCT00829647|CLL|cll
649526|NCT00829647|dasatinib|dasatinib
649527|NCT00829647|lenalidomide|lenalidomide
649528|NCT00829647|sprycel|sprycel
649529|NCT00829647|revlimid|revlimid
649530|NCT00829647|CLL relapsed or refractory to fludarabine|cll relapsed or refractory to fludarabine
649531|NCT00829634|methamphetamine|methamphetamine
649532|NCT00829634|inpatient|inpatient
649533|NCT00829634|d-MA|d-ma
649534|NCT00829634|l-MA|l-ma
649535|NCT00829634|APRL|aprl
649536|NCT00829634|San Francisco|san francisco
649537|NCT00829634|metabolism|metabolism
649538|NCT00829634|Metabolism of methamphetamine|metabolism of methamphetamine
649539|NCT00829621|BMP-2|bmp-2
649540|NCT00829621|Incisional Vacuum Assisted Closure (IVAC)|incisional vacuum assisted closure (ivac)
649541|NCT00829608|RRP|rrp
649542|NCT00829608|Recurrent Respiratory Papillomatosis|recurrent respiratory papillomatosis
649543|NCT00829608|HPV vaccine|hpv vaccine
649544|NCT00829608|HPV|hpv
649545|NCT00829595|inflammatory bowel disease|inflammatory bowel disease
649546|NCT00829595|Crohn disease|crohn disease
649547|NCT00829595|ulcerative colitis|ulcerative colitis
649548|NCT00829595|immunosuppression|immunosuppression
649549|NCT00829595|anti tumor necrosis alpha|anti tumor necrosis alpha
649550|NCT00829595|pneumovax|pneumovax
649551|NCT00829595|pneumococcal vaccine|pneumococcal vaccine
649552|NCT00829569|Intralipid|intralipid
649553|NCT00829569|Omegaven|omegaven
649554|NCT00829569|fish oil|fish oil
649555|NCT00829569|hyperinsulinemic isoglycemic clamps|hyperinsulinemic isoglycemic clamps
649556|NCT00829569|C-peptide glucagon test|c-peptide glucagon test
649557|NCT00829569|indirect calorimetry|indirect calorimetry
649558|NCT00829569|F2-isoprostanes|f2-isoprostanes
649559|NCT00829543|Spodyloarthropathy|spodyloarthropathy
649560|NCT00829543|Guide-free sacroiliac injection|guide-free sacroiliac injection
649561|NCT00829530|Bioequivalence|bioequivalence
649562|NCT00829530|Healthy Subjects|healthy subjects
649563|NCT00829517|Contraception|contraception
649564|NCT00829517|sexually transmitted diseases|sexually transmitted diseases
649565|NCT00829504|Bioequivalence|bioequivalence
649566|NCT00829504|Healthy Subjects|healthy subjects
649567|NCT00829491|Cardiovascular Disease Prevention|cardiovascular disease prevention
649568|NCT00829491|Behavior change|behavior change
649569|NCT00829491|Risk Reduction|risk reduction
649570|NCT00829478|Atrial fibrillation|atrial fibrillation
649571|NCT00829478|Cerebrovascular accident|cerebrovascular accident
649572|NCT00829478|Anticoagulation|anticoagulation
649573|NCT00829478|Decision-making|decision-making
649574|NCT00829452|Bioequivalence|bioequivalence
649575|NCT00829452|Healthy Subjects|healthy subjects
649576|NCT00829439|Angelman syndrome|angelman syndrome
649577|NCT00829439|Levodopa|levodopa
649578|NCT00829439|Carbidopa|carbidopa
649579|NCT00829439|L-dopa|l-dopa
649580|NCT00829426|Bioequivalence|bioequivalence
649581|NCT00829426|Healthy Subjects|healthy subjects
649582|NCT00829400|Neuropsychology|neuropsychology
649583|NCT00829400|Cognitive Remediation|cognitive remediation
649584|NCT00829400|Vocational Rehabilitation|vocational rehabilitation
649585|NCT00829400|Schizophrenia|schizophrenia
649586|NCT00829400|Severe and persistent mental illness|severe and persistent mental illness
649587|NCT00829400|Chronic and disabling mental illness|chronic and disabling mental illness
649588|NCT00829387|Diabetes|diabetes
649589|NCT00829387|Pain|pain
649590|NCT00829387|Neuropathic Pain|neuropathic pain
649591|NCT00829374|Alzheimer's disease|alzheimer's disease
649592|NCT00829374|clinical trial|clinical trial
649593|NCT00829374|mitochondria|mitochondria
649594|NCT00829374|memory loss|memory loss
649595|NCT00829374|neurodegenerative disease|neurodegenerative disease
649596|NCT00829374|dementia|dementia
649597|NCT00829374|investigational drug|investigational drug
649598|NCT00829361|Telemedicine|telemedicine
649599|NCT00829361|Acute stroke|acute stroke
649600|NCT00829361|Rural|rural
649601|NCT00829361|thrombosis|thrombosis
649602|NCT00829361|consultation|consultation
649603|NCT00829361|Stroke|stroke
649604|NCT00829361|Cerebral Infarction|cerebral infarction
649605|NCT00829361|Vascular diseases|vascular diseases
649606|NCT00829361|brain ischemia|brain ischemia
649607|NCT00829361|brain infarction|brain infarction
649608|NCT00829361|brain diseases|brain diseases
649609|NCT00829361|cerebrovascular disorders|cerebrovascular disorders
649610|NCT00829348|Compliance|compliance
649611|NCT00829348|Chronic|chronic
649612|NCT00829348|Pharmacotherapy|pharmacotherapy
649613|NCT00829348|Statins|statins
649614|NCT00829335|Intraoperative ultrasound|intraoperative ultrasound
649615|NCT00829335|Segmentectomy|segmentectomy
649616|NCT00829335|HCC|hcc
649617|NCT00829309|Bioequivalence|bioequivalence
649618|NCT00829309|Healthy Subjects|healthy subjects
649619|NCT00829296|diabetes|diabetes
649620|NCT00829296|hypertension|hypertension
649621|NCT00829296|aortic impedance|aortic impedance
649622|NCT00829283|Experimental|experimental
649623|NCT00829283|Comparator|comparator
649624|NCT00829244|Infertility|infertility
649625|NCT00829244|Assisted reproductive technology|assisted reproductive technology
649626|NCT00829231|Liver disease|liver disease
649627|NCT00829218|Irritable Bowel Syndrome|irritable bowel syndrome
649628|NCT00829218|Fibromyalgia|fibromyalgia
649629|NCT00829218|Glutamate|glutamate
649630|NCT00829218|Diet|diet
649631|NCT00829218|Food additives|food additives
649632|NCT00829205|recurrent adult diffuse large cell lymphoma|recurrent adult diffuse large cell lymphoma
649633|NCT00829192|Actinic keratoses (AK)|actinic keratoses (ak)
649634|NCT00829192|Squamous cell carcinomas (SCC)|squamous cell carcinomas (scc)
649635|NCT00829192|CUV1647|cuv1647
649636|NCT00829192|Afamelanotide|afamelanotide
649637|NCT00829192|Clinuvel|clinuvel
649638|NCT00829192|Photoprotection|photoprotection
649639|NCT00829192|Organ transplant|organ transplant
649640|NCT00829179|Asthma|asthma
649641|NCT00829153|Fistula patency|fistula patency
649642|NCT00829127|volunteers|volunteers
649643|NCT00829114|AE|ae
649644|NCT00829114|AIDS|aids
649645|NCT00829114|ALT|alt
649646|NCT00829114|ART|art
649647|NCT00829114|AST|ast
649648|NCT00829114|DCF|dcf
649649|NCT00829114|DMC|dmc
649650|NCT00829114|FDA|fda
649651|NCT00829114|GCP|gcp
649652|NCT00829114|HB sAg|hb sag
649653|NCT00829114|ICH|ich
649654|NCT00829114|IND|ind
649655|NCT00829114|IRB|irb
649656|NCT00829114|IU|iu
649657|NCT00829114|mg|mg
649658|NCT00829114|mm3|mm3
649659|NCT00829114|PCR|pcr
649660|NCT00829114|SAE|sae
649661|NCT00829114|ULN|uln
649662|NCT00829114|WB|wb
649663|NCT00829114|COC|coc
649664|NCT00829114|Combined Oral Contraceptives|combined oral contraceptives
649665|NCT00829101|unilateral cleft lip and palate|unilateral cleft lip and palate
649666|NCT00829101|primary palatal surgery|primary palatal surgery
649667|NCT00829101|articulation|articulation
649668|NCT00829101|phonology|phonology
649669|NCT00829101|one stage palatal repair|one stage palatal repair
649670|NCT00829101|two stage palatal repair|two stage palatal repair
649671|NCT00829088|Mass balance|mass balance
649672|NCT00829088|AZD2066|azd2066
649673|NCT00829088|Pain|pain
649674|NCT00829088|Pain conditions|pain conditions
649675|NCT00829062|Type 1 diabetes|type 1 diabetes
649676|NCT00829062|Insulin pump|insulin pump
649677|NCT00829062|Glycemic variability|glycemic variability
649678|NCT00829036|Rehabilitation|rehabilitation
649679|NCT00829036|Sensory Aid|sensory aid
649680|NCT00829023|Positive aerobic or anaerobic cultures|positive aerobic or anaerobic cultures
649681|NCT00829010|Human Immunodeficiency Virus|human immunodeficiency virus
649682|NCT00829010|Booster vaccination|booster vaccination
649683|NCT00829010|Safety|safety
649684|NCT00829010|Primary vaccination|primary vaccination
649685|NCT00829010|Pneumococcal vaccine|pneumococcal vaccine
649686|NCT00829010|Immunogenicity|immunogenicity
649687|NCT00829010|Pneumococcal disease|pneumococcal disease
649688|NCT00828997|rheumatoid arthritis|rheumatoid arthritis
649689|NCT00828997|spondylarthropathy|spondylarthropathy
649690|NCT00828997|immunological response following vaccination with Prevenar|immunological response following vaccination with prevenar
649691|NCT00828971|Complicated skin and skin structure infections|complicated skin and skin structure infections
649692|NCT00828971|cSSSI|csssi
649693|NCT00828958|schizophrenia|schizophrenia
649694|NCT00828958|Risperidone|risperidone
649695|NCT00828958|Long acting injectable|long acting injectable
649696|NCT00828958|Intradeltoidal injection|intradeltoidal injection
649697|NCT00828919|VEGFR inhibitor|vegfr inhibitor
649698|NCT00828919|angi-angiogenic|angi-angiogenic
649699|NCT00828919|tyrosine kinase inhibitor|tyrosine kinase inhibitor
649700|NCT00828906|Glaucoma|glaucoma
649701|NCT00828906|IOP|iop
649702|NCT00828906|DuoTrav|duotrav
649703|NCT00828893|drain under scanner|drain under scanner
649704|NCT00828867|healthy subjects|healthy subjects
649705|NCT00828867|FTIH, single dose, food effect, healthy subjects, double-blind|ftih, single dose, food effect, healthy subjects, double-blind
649706|NCT00828854|breast cancer|breast cancer
649707|NCT00828854|estrogen receptor postive|estrogen receptor postive
649708|NCT00828828|Influenza Vaccine|influenza vaccine
649709|NCT00828828|Sarcoidosis|sarcoidosis
649710|NCT00828828|Antibody|antibody
649711|NCT00828815|HIV-negative|hiv-negative
649712|NCT00828815|buprenorphine/nalaxone|buprenorphine/nalaxone
649713|NCT00828815|norbuprenorphine|norbuprenorphine
649714|NCT00828815|opioid-dependent|opioid-dependent
649715|NCT00828815|TMC125-TiDP2-C188|tmc125-tidp2-c188
649716|NCT00828815|TMC125-C188|tmc125-c188
649717|NCT00828815|TMC125|tmc125
649718|NCT00828815|HIV Infections|hiv infections
649719|NCT00828802|Myelodysplastic Syndromes|myelodysplastic syndromes
649720|NCT00828802|MDS|mds
649721|NCT00828789|Hepatitis C|hepatitis c
649722|NCT00828789|HCV|hcv
649723|NCT00828789|HIV|hiv
649724|NCT00828789|AIDS|aids
649725|NCT00828789|Telaprevir|telaprevir
649726|NCT00828789|Efavirenz|efavirenz
649727|NCT00828789|Tenofovir disproxil fumarate|tenofovir disproxil fumarate
649728|NCT00828789|Healthy volunteer|healthy volunteer
649729|NCT00828789|VX-950-C134|vx-950-c134
649730|NCT00828789|VX-950-TiDP24-C134|vx-950-tidp24-c134
649731|NCT00828789|HIV Infections|hiv infections
649732|NCT00828776|TTPa|ttpa
649733|NCT00828776|Anti-Xa|anti-xa
649734|NCT00828776|Adverse Reactions|adverse reactions
649735|NCT00828763|healthy volunteer|healthy volunteer
649736|NCT00828763|radiolabelled|radiolabelled
649737|NCT00828750|eltrombopag|eltrombopag
649738|NCT00828750|thrombopoietin receptor agonist|thrombopoietin receptor agonist
649739|NCT00828750|ITP|itp
649740|NCT00828750|blood platelet|blood platelet
649741|NCT00828711|Misoprostol vaginal insert|misoprostol vaginal insert
649742|NCT00828711|Induction of labor|induction of labor
649743|NCT00828711|Cervical ripening|cervical ripening
649744|NCT00828711|Rate of cesarean section|rate of cesarean section
649745|NCT00828698|Death, sudden|death, sudden
649746|NCT00828698|All cause mortality|all cause mortality
649747|NCT00828685|Return to Work|return to work
649748|NCT00828685|CRPP|crpp
649749|NCT00828685|ORIF|orif
649750|NCT00828685|Distal Radius|distal radius
649751|NCT00828672|bevacizumab|bevacizumab
649752|NCT00828672|capecitabine|capecitabine
649753|NCT00828672|radiation therapy|radiation therapy
649754|NCT00828672|oxaliplatin|oxaliplatin
649755|NCT00828672|multimodality treatments|multimodality treatments
649756|NCT00828672|TME (total mesorectal excision)|tme (total mesorectal excision)
649757|NCT00828672|Axe Beam|axe beam
649758|NCT00828672|rectal cancer|rectal cancer
649759|NCT00828672|neoadjuvant|neoadjuvant
649760|NCT00828672|pathological complete response|pathological complete response
649761|NCT00828672|postoperative complications|postoperative complications
649762|NCT00828659|Abuse potential|abuse potential
649763|NCT00828646|Healthy Subjects|healthy subjects
649764|NCT00828633|stage I prostate cancer|stage i prostate cancer
649765|NCT00828633|stage II prostate cancer|stage ii prostate cancer
649766|NCT00828607|Contrast Enhanced Ultrasound (CEUS)|contrast enhanced ultrasound (ceus)
649767|NCT00828607|Liver tumors|liver tumors
649768|NCT00828607|Hepatocellular carcinoma|hepatocellular carcinoma
649769|NCT00828607|Hemangioma|hemangioma
649770|NCT00828607|Focal Nodular Hyperplasia|focal nodular hyperplasia
649771|NCT00828607|Hepatic metastases|hepatic metastases
649772|NCT00828594|Hepatocellular carcinoma|hepatocellular carcinoma
649773|NCT00828594|dose-finding study|dose-finding study
649774|NCT00828594|randomized trial|randomized trial
649775|NCT00828594|medical treatment|medical treatment
649776|NCT00828594|RAD001|rad001
649777|NCT00828594|sorafenib|sorafenib
649778|NCT00828594|Advanced hepatocellular cancer (HCC)|advanced hepatocellular cancer (hcc)
649779|NCT00828568|Actinic Keratosis|actinic keratosis
649780|NCT00828555|HPV vaccine|hpv vaccine
649781|NCT00828555|Tdap vaccine|tdap vaccine
649782|NCT00828542|Adverse Effects|adverse effects
649783|NCT00828542|Etonogestrel|etonogestrel
649784|NCT00828542|Postpartum period|postpartum period
649785|NCT00828542|Contraception|contraception
649786|NCT00828542|Hemostasis|hemostasis
649787|NCT00828542|Metabolism|metabolism
649788|NCT00828529|TMC207-TiDP13-C110|tmc207-tidp13-c110
649789|NCT00828529|TMC207-C110|tmc207-c110
649790|NCT00828529|TMC207|tmc207
649791|NCT00828529|Drug-drug interaction|drug-drug interaction
649792|NCT00828529|Tuberculosis|tuberculosis
649793|NCT00828529|HIV|hiv
649794|NCT00828529|Kaletra|kaletra
649795|NCT00828529|Lopinavir|lopinavir
649796|NCT00828529|Ritonavir|ritonavir
649797|NCT00828529|Open-label|open-label
649798|NCT00828529|HIV Infections|hiv infections
649799|NCT00828516|lymphedema|lymphedema
649800|NCT00828516|male breast cancer|male breast cancer
649801|NCT00828516|stage IA breast cancer|stage ia breast cancer
649802|NCT00828516|stage IB breast cancer|stage ib breast cancer
649803|NCT00828516|stage II breast cancer|stage ii breast cancer
649804|NCT00828516|recurrent breast cancer|recurrent breast cancer
649805|NCT00828516|recurrent squamous cell carcinoma of the hypopharynx|recurrent squamous cell carcinoma of the hypopharynx
649806|NCT00828516|stage I squamous cell carcinoma of the hypopharynx|stage i squamous cell carcinoma of the hypopharynx
649807|NCT00828516|stage II squamous cell carcinoma of the hypopharynx|stage ii squamous cell carcinoma of the hypopharynx
649808|NCT00828516|recurrent squamous cell carcinoma of the larynx|recurrent squamous cell carcinoma of the larynx
649809|NCT00828516|recurrent verrucous carcinoma of the larynx|recurrent verrucous carcinoma of the larynx
649810|NCT00828516|stage I squamous cell carcinoma of the larynx|stage i squamous cell carcinoma of the larynx
649811|NCT00828516|stage I verrucous carcinoma of the larynx|stage i verrucous carcinoma of the larynx
649812|NCT00828516|stage II squamous cell carcinoma of the larynx|stage ii squamous cell carcinoma of the larynx
649813|NCT00828516|stage II verrucous carcinoma of the larynx|stage ii verrucous carcinoma of the larynx
649814|NCT00828516|recurrent adenoid cystic carcinoma of the oral cavity|recurrent adenoid cystic carcinoma of the oral cavity
649815|NCT00828516|recurrent mucoepidermoid carcinoma of the oral cavity|recurrent mucoepidermoid carcinoma of the oral cavity
649816|NCT00828516|recurrent verrucous carcinoma of the oral cavity|recurrent verrucous carcinoma of the oral cavity
649817|NCT00828516|stage I adenoid cystic carcinoma of the oral cavity|stage i adenoid cystic carcinoma of the oral cavity
649818|NCT00828516|stage I mucoepidermoid carcinoma of the oral cavity|stage i mucoepidermoid carcinoma of the oral cavity
649819|NCT00828516|stage I verrucous carcinoma of the oral cavity|stage i verrucous carcinoma of the oral cavity
649820|NCT00828516|stage II adenoid cystic carcinoma of the oral cavity|stage ii adenoid cystic carcinoma of the oral cavity
649821|NCT00828516|stage II mucoepidermoid carcinoma of the oral cavity|stage ii mucoepidermoid carcinoma of the oral cavity
649822|NCT00828516|stage II verrucous carcinoma of the oral cavity|stage ii verrucous carcinoma of the oral cavity
649823|NCT00828516|stage I squamous cell carcinoma of the lip and oral cavity|stage i squamous cell carcinoma of the lip and oral cavity
649824|NCT00828516|stage II squamous cell carcinoma of the lip and oral cavity|stage ii squamous cell carcinoma of the lip and oral cavity
649825|NCT00828516|recurrent basal cell carcinoma of the lip|recurrent basal cell carcinoma of the lip
649826|NCT00828516|recurrent squamous cell carcinoma of the lip and oral cavity|recurrent squamous cell carcinoma of the lip and oral cavity
649827|NCT00828516|stage I basal cell carcinoma of the lip|stage i basal cell carcinoma of the lip
649828|NCT00828516|stage II basal cell carcinoma of the lip|stage ii basal cell carcinoma of the lip
649829|NCT00828516|recurrent metastatic squamous neck cancer with occult primary|recurrent metastatic squamous neck cancer with occult primary
649830|NCT00828516|recurrent lymphoepithelioma of the nasopharynx|recurrent lymphoepithelioma of the nasopharynx
649831|NCT00828516|recurrent squamous cell carcinoma of the nasopharynx|recurrent squamous cell carcinoma of the nasopharynx
649832|NCT00828516|stage I lymphoepithelioma of the nasopharynx|stage i lymphoepithelioma of the nasopharynx
649833|NCT00828516|stage I squamous cell carcinoma of the nasopharynx|stage i squamous cell carcinoma of the nasopharynx
649834|NCT00828516|stage II lymphoepithelioma of the nasopharynx|stage ii lymphoepithelioma of the nasopharynx
649835|NCT00828516|stage II squamous cell carcinoma of the nasopharynx|stage ii squamous cell carcinoma of the nasopharynx
649836|NCT00828516|recurrent lymphoepithelioma of the oropharynx|recurrent lymphoepithelioma of the oropharynx
649837|NCT00828516|recurrent squamous cell carcinoma of the oropharynx|recurrent squamous cell carcinoma of the oropharynx
649838|NCT00828516|stage I lymphoepithelioma of the oropharynx|stage i lymphoepithelioma of the oropharynx
649839|NCT00828516|stage I squamous cell carcinoma of the oropharynx|stage i squamous cell carcinoma of the oropharynx
649840|NCT00828516|stage II lymphoepithelioma of the oropharynx|stage ii lymphoepithelioma of the oropharynx
649841|NCT00828516|stage II squamous cell carcinoma of the oropharynx|stage ii squamous cell carcinoma of the oropharynx
649842|NCT00828516|recurrent esthesioneuroblastoma of the paranasal sinus and nasal cavity|recurrent esthesioneuroblastoma of the paranasal sinus and nasal cavity
649843|NCT00828516|recurrent inverted papilloma of the paranasal sinus and nasal cavity|recurrent inverted papilloma of the paranasal sinus and nasal cavity
649844|NCT00828516|recurrent midline lethal granuloma of the paranasal sinus and nasal cavity|recurrent midline lethal granuloma of the paranasal sinus and nasal cavity
711011|NCT00586872|Endoscopic Mucosal Resection|endoscopic mucosal resection
649845|NCT00828516|recurrent squamous cell carcinoma of the paranasal sinus and nasal cavity|recurrent squamous cell carcinoma of the paranasal sinus and nasal cavity
649846|NCT00828516|stage I esthesioneuroblastoma of the paranasal sinus and nasal cavity|stage i esthesioneuroblastoma of the paranasal sinus and nasal cavity
649847|NCT00828516|stage I inverted papilloma of the paranasal sinus and nasal cavity|stage i inverted papilloma of the paranasal sinus and nasal cavity
649848|NCT00828516|stage I midline lethal granuloma of the paranasal sinus and nasal cavity|stage i midline lethal granuloma of the paranasal sinus and nasal cavity
649849|NCT00828516|stage I squamous cell carcinoma of the paranasal sinus and nasal cavity|stage i squamous cell carcinoma of the paranasal sinus and nasal cavity
649850|NCT00828516|stage II esthesioneuroblastoma of the paranasal sinus and nasal cavity|stage ii esthesioneuroblastoma of the paranasal sinus and nasal cavity
649851|NCT00828516|stage II inverted papilloma of the paranasal sinus and nasal cavity|stage ii inverted papilloma of the paranasal sinus and nasal cavity
649852|NCT00828516|stage II midline lethal granuloma of the paranasal sinus and nasal cavity|stage ii midline lethal granuloma of the paranasal sinus and nasal cavity
649853|NCT00828516|stage II squamous cell carcinoma of the paranasal sinus and nasal cavity|stage ii squamous cell carcinoma of the paranasal sinus and nasal cavity
649854|NCT00828516|low-grade salivary gland mucoepidermoid carcinoma|low-grade salivary gland mucoepidermoid carcinoma
649855|NCT00828516|recurrent salivary gland cancer|recurrent salivary gland cancer
649856|NCT00828516|salivary gland acinic cell tumor|salivary gland acinic cell tumor
649857|NCT00828516|salivary gland adenocarcinoma|salivary gland adenocarcinoma
649858|NCT00828516|salivary gland adenoid cystic carcinoma|salivary gland adenoid cystic carcinoma
649859|NCT00828516|salivary gland anaplastic carcinoma|salivary gland anaplastic carcinoma
649860|NCT00828516|salivary gland malignant mixed cell type tumor|salivary gland malignant mixed cell type tumor
649861|NCT00828516|salivary gland poorly differentiated carcinoma|salivary gland poorly differentiated carcinoma
649862|NCT00828516|salivary gland squamous cell carcinoma|salivary gland squamous cell carcinoma
649863|NCT00828516|stage I salivary gland cancer|stage i salivary gland cancer
649864|NCT00828516|stage II salivary gland cancer|stage ii salivary gland cancer
649865|NCT00828516|tongue cancer|tongue cancer
649866|NCT00828503|Certi-CMV|certi-cmv
649867|NCT00828503|immunosuppressive switch (to Certican)|immunosuppressive switch (to certican)
649868|NCT00828503|renal transplant|renal transplant
649869|NCT00828490|Fraud and Abuse|fraud and abuse
649870|NCT00828490|opioids|opioids
649871|NCT00828464|Dermatosis, Dermatitis, Dry skin, Irritated skin|dermatosis, dermatitis, dry skin, irritated skin
649872|NCT00828451|newborn|newborn
649873|NCT00828451|necrotizing enterocolitis|necrotizing enterocolitis
649874|NCT00828451|genetics|genetics
649875|NCT00828451|growth factors|growth factors
649876|NCT00828451|metabolism|metabolism
649877|NCT00828425|Diabetes Mellitus|diabetes mellitus
649878|NCT00828425|retinopathy|retinopathy
650728|NCT00825240|Questionnaires|questionnaires
649879|NCT00828425|Management of diabetic patients with retinopathy|management of diabetic patients with retinopathy
649880|NCT00828399|Radiotherapy|radiotherapy
649881|NCT00828399|Diarrhoea|diarrhoea
649882|NCT00828399|Glutamine|glutamine
649883|NCT00828399|Oxydative stress|oxydative stress
649884|NCT00828399|Calprotectin|calprotectin
649885|NCT00828399|Citrulline|citrulline
649886|NCT00828386|Nasopharyngeal cancers|nasopharyngeal cancers
649887|NCT00828386|induction chemotherapy|induction chemotherapy
649888|NCT00828386|radiochemotherapy|radiochemotherapy
649889|NCT00828360|Heart Failure|heart failure
649890|NCT00828360|CRT|crt
649891|NCT00828360|Dobutamine echocardiography|dobutamine echocardiography
649892|NCT00828334|transcatheter occlusion of patent ductus arteriosus|transcatheter occlusion of patent ductus arteriosus
649893|NCT00828321|Bioequivalency|bioequivalency
649894|NCT00828321|Healthy Volunteers|healthy volunteers
649895|NCT00828308|localized|localized
649896|NCT00828308|high risk|high risk
649897|NCT00828308|prostate cancer|prostate cancer
649898|NCT00828308|neoadjuvant treatment|neoadjuvant treatment
649899|NCT00828295|Postoperative Nausea and Vomiting|postoperative nausea and vomiting
649900|NCT00828295|palonosetron|palonosetron
649901|NCT00828295|pediatric|pediatric
649902|NCT00828282|Chronic Lymphocytic Leukemia|chronic lymphocytic leukemia
649903|NCT00828282|Simvastatin|simvastatin
649904|NCT00828282|Zocor|zocor
649905|NCT00828269|Patients with Chronic Hepatitis C|patients with chronic hepatitis c
649906|NCT00828256|arthroscopic repair|arthroscopic repair
649907|NCT00828256|rotator cuff|rotator cuff
649908|NCT00828256|tears|tears
649909|NCT00828256|shoulder|shoulder
649910|NCT00828256|chronic tear of rotator cuff|chronic tear of rotator cuff
649911|NCT00828243|Pulmonary surfactants|pulmonary surfactants
649912|NCT00828243|Pulmonary surfactant associated protein B|pulmonary surfactant associated protein b
649913|NCT00828243|Pulmonary surfactant associated protein C|pulmonary surfactant associated protein c
649914|NCT00828243|ATP-binding cassette protein sub member family A3|atp-binding cassette protein sub member family a3
649915|NCT00828230|budesonide|budesonide
649916|NCT00828230|placebo|placebo
649917|NCT00828230|acute radiation proctitis|acute radiation proctitis
649918|NCT00828230|late radiation proctitis|late radiation proctitis
649919|NCT00828230|Prevention of acute radiation proctitis|prevention of acute radiation proctitis
828287|NCT00121823|PCR|pcr
649920|NCT00828230|Prevention of late radiation proctitis|prevention of late radiation proctitis
649921|NCT00828217|adapted physical activity|adapted physical activity
649922|NCT00828217|hospital|hospital
649923|NCT00828217|health-related quality of life|health-related quality of life
649924|NCT00828217|satisfaction with care|satisfaction with care
649925|NCT00828217|child|child
649926|NCT00828217|adolescent|adolescent
649927|NCT00828217|randomized controlled trial|randomized controlled trial
649928|NCT00828217|physical activity|physical activity
649929|NCT00828217|quality of life|quality of life
649930|NCT00828191|Luteal support in IVF|luteal support in ivf
649931|NCT00828178|SLE|sle
649932|NCT00828178|atherosclerosis|atherosclerosis
649933|NCT00828178|omega-3|omega-3
649934|NCT00828126|Metastatic Melanoma|metastatic melanoma
649935|NCT00828126|AJCC Stage III Melanoma|ajcc stage iii melanoma
649936|NCT00828126|AJCC stage IV Melanoma|ajcc stage iv melanoma
649937|NCT00828126|PET-CT|pet-ct
649938|NCT00828126|Positron Emission Tomography-Computed Tomography|positron emission tomography-computed tomography
649939|NCT00828126|Contrast-enhanced Computed Tomography Scan|contrast-enhanced computed tomography scan
649940|NCT00828126|CT|ct
649941|NCT00828126|Conventional Imaging|conventional imaging
649942|NCT00828126|False Positive Rate|false positive rate
649943|NCT00828126|Fluorodeoxyglucose|fluorodeoxyglucose
649944|NCT00828126|FDG|fdg
649945|NCT00828126|Surgery|surgery
649946|NCT00828113|smoking|smoking
649947|NCT00828113|relapse|relapse
649948|NCT00828113|withdrawal|withdrawal
649949|NCT00828087|acute myocardial infarction|acute myocardial infarction
649950|NCT00828087|primary percutaneous coronary intervention|primary percutaneous coronary intervention
649951|NCT00828087|drug-eluting stent|drug-eluting stent
649952|NCT00828074|stage IV breast cancer|stage iv breast cancer
649953|NCT00828074|recurrent breast cancer|recurrent breast cancer
649954|NCT00828035|robotics|robotics
649955|NCT00828035|laparoscopy|laparoscopy
649956|NCT00828035|surgery|surgery
649957|NCT00828035|computer assisted|computer assisted
649958|NCT00828022|measles-positive NSCLC|measles-positive nsclc
649959|NCT00828022|measles vaccine|measles vaccine
649960|NCT00828022|consolidation|consolidation
649961|NCT00828022|Stage 3B with pleural effusion or stage 4 non-small cell lung cancer in remission|stage 3b with pleural effusion or stage 4 non-small cell lung cancer in remission
649962|NCT00828009|stage IIIA non-small cell lung cancer|stage iiia non-small cell lung cancer
649963|NCT00828009|stage IIIB non-small cell lung cancer|stage iiib non-small cell lung cancer
649964|NCT00828009|adenocarcinoma of the lung|adenocarcinoma of the lung
649965|NCT00827996|Apocrine glands|apocrine glands
649966|NCT00827996|abcesses|abcesses
649967|NCT00827983|Luteal Phase Support in IVF patients|luteal phase support in ivf patients
649968|NCT00827970|mass screening|mass screening
649969|NCT00827957|Hypothermia|hypothermia
649970|NCT00827957|Internal cooling|internal cooling
649971|NCT00827957|External cooling|external cooling
649972|NCT00827957|Cardiac arrest|cardiac arrest
649973|NCT00827944|Uncomplicated primary inguinal hernias|uncomplicated primary inguinal hernias
649974|NCT00827931|tranexamic acid|tranexamic acid
649975|NCT00827931|major abdominal surgery|major abdominal surgery
649976|NCT00827931|blood loss|blood loss
649977|NCT00827918|Acute Exacerbation of Schizophrenia|acute exacerbation of schizophrenia
649978|NCT00827905|Non-Contact|non-contact
649979|NCT00827905|Radar|radar
649980|NCT00827905|Respiratory|respiratory
649981|NCT00827905|Respiration|respiration
649982|NCT00827905|Breathing|breathing
649983|NCT00827905|Rate|rate
649984|NCT00827905|Frequency|frequency
649985|NCT00827905|Respiratory Mechanics|respiratory mechanics
649986|NCT00827905|Respiratory Rate Measurement|respiratory rate measurement
649987|NCT00827892|Intracerebral Hemorrhage|intracerebral hemorrhage
649988|NCT00827892|Treatment|treatment
649989|NCT00827892|MRI|mri
649990|NCT00827879|Intimate partner aggression|intimate partner aggression
649991|NCT00827879|Couples intervention|couples intervention
649992|NCT00827879|PTSD|ptsd
649993|NCT00827879|Veterans|veterans
649994|NCT00827879|Prevention|prevention
649995|NCT00827879|Violence Prevention|violence prevention
649996|NCT00827879|Prevention of pertetration of intimate partner aggression.|prevention of pertetration of intimate partner aggression.
649997|NCT00827866|Tobacco quitline|tobacco quitline
649998|NCT00827866|Childhood cancer survivors|childhood cancer survivors
649999|NCT00827866|Adult-onset cancer survivors|adult-onset cancer survivors
650000|NCT00827853|Diabetes|diabetes
650001|NCT00827853|Peripheral Vascular Disease (PVD)|peripheral vascular disease (pvd)
650002|NCT00827853|Superficial Femoral Artery (SFA)|superficial femoral artery (sfa)
650003|NCT00827853|Cryoplasty|cryoplasty
650004|NCT00827853|Restenosis|restenosis
650005|NCT00827827|Stroke|stroke
650006|NCT00827827|Exercise|exercise
650007|NCT00827827|Strength Training|strength training
650008|NCT00827827|Skeletal Muscle|skeletal muscle
650009|NCT00827827|Insulin Sensitivity|insulin sensitivity
650010|NCT00827801|Cancer|cancer
650011|NCT00827801|Heart Failure|heart failure
650012|NCT00827801|HF|hf
650013|NCT00827801|Cancer and Concurrent Heart Failure|cancer and concurrent heart failure
650014|NCT00827801|MDASI-HF Symptom Management Program|mdasi-hf symptom management program
650015|NCT00827801|MDASI-HF|mdasi-hf
650016|NCT00827801|MDASI-HF questionnaire|mdasi-hf questionnaire
650017|NCT00827801|M. D. Anderson Symptom Inventory - Heart Failure|m. d. anderson symptom inventory - heart failure
650018|NCT00827801|Questionnaire|questionnaire
650019|NCT00827801|Symptom Management Gap|symptom management gap
650020|NCT00827788|contrast media|contrast media
650021|NCT00827788|angiography|angiography
650022|NCT00827788|percutaneous coronary intervention|percutaneous coronary intervention
650023|NCT00827775|Hypertension|hypertension
650024|NCT00827775|Hemodialysis|hemodialysis
650025|NCT00827762|phenylketonuria|phenylketonuria
650026|NCT00827762|Kuvan|kuvan
650027|NCT00827762|sapropterin|sapropterin
650028|NCT00827762|behavior|behavior
650029|NCT00827762|cognition|cognition
650030|NCT00827762|executive abilities|executive abilities
650031|NCT00827762|attention|attention
650032|NCT00827749|swallowing disorders|swallowing disorders
650033|NCT00827749|geriatrics|geriatrics
650034|NCT00827736|anal fissure|anal fissure
650035|NCT00827736|fissura ani|fissura ani
650036|NCT00827736|botox|botox
650037|NCT00827736|ISDN|isdn
650038|NCT00827736|Nitric oxide donor|nitric oxide donor
650039|NCT00827723|Hepatic functional reserve|hepatic functional reserve
650040|NCT00827723|Hepatocellular carcinoma (HCC)|hepatocellular carcinoma (hcc)
650041|NCT00827723|Indocyanine Green retention rate at 15 minutes (ICG-R15')|indocyanine green retention rate at 15 minutes (icg-r15')
650042|NCT00827723|Portal Pressure (PP)|portal pressure (pp)
650043|NCT00827723|Hepatic Portal Venous Gradient (HPVG)|hepatic portal venous gradient (hpvg)
650044|NCT00827723|Alcoholic and Viral Cirrhosis|alcoholic and viral cirrhosis
650045|NCT00827723|Makuuchi criteria|makuuchi criteria
650046|NCT00827723|Barcelona Clinic of Liver Cancer (BCLC)|barcelona clinic of liver cancer (bclc)
650047|NCT00827723|Hepatic resection|hepatic resection
650048|NCT00827710|diabetes|diabetes
650049|NCT00827710|registry|registry
650050|NCT00827710|computer|computer
650051|NCT00827710|self management|self management
650052|NCT00827697|Gonorrhea|gonorrhea
650053|NCT00827697|Chlamydia|chlamydia
650054|NCT00827697|Rectal|rectal
650055|NCT00827684|KRAS mutation|kras mutation
650056|NCT00827658|anesthesia, local|anesthesia, local
650057|NCT00827658|ulnar nerve|ulnar nerve
650058|NCT00827658|hand|hand
650059|NCT00827658|surgery, plastic|surgery, plastic
650060|NCT00827658|blinded|blinded
650061|NCT00827658|randomized|randomized
650062|NCT00827658|prospective|prospective
650063|NCT00827658|local anesthesia|local anesthesia
650064|NCT00827658|volar wrist block|volar wrist block
650065|NCT00827658|hypothenar palm block|hypothenar palm block
650066|NCT00827658|hand surgery|hand surgery
650067|NCT00827632|Ovarian Suppression|ovarian suppression
650068|NCT00827632|Oral Contraceptives|oral contraceptives
650069|NCT00827632|Obese and Normal BMI|obese and normal bmi
650070|NCT00827619|Peripheral Arterial Disease|peripheral arterial disease
650071|NCT00827606|pediatric heterozygous familial hypercholesterolemia|pediatric heterozygous familial hypercholesterolemia
650072|NCT00827580|HFS|hfs
650073|NCT00827580|patients with breast or colon cancer receiving capecitabine|patients with breast or colon cancer receiving capecitabine
650074|NCT00827567|Breast cancer|breast cancer
650075|NCT00827567|metastatic breast|metastatic breast
650076|NCT00827567|triple negative|triple negative
650077|NCT00827567|ER/PR negative|er/pr negative
650078|NCT00827567|Her2 Neu negative|her2 neu negative
650079|NCT00827554|Liver Neoplasms|liver neoplasms
650080|NCT00827554|Liver Diseases|liver diseases
650081|NCT00827554|Digestive System Diseases|digestive system diseases
650082|NCT00827554|Digestive System Neoplasms|digestive system neoplasms
650083|NCT00827554|Carcinoma, Hepatocellular|carcinoma, hepatocellular
650084|NCT00827554|Gastrointestinal Neoplasms|gastrointestinal neoplasms
650085|NCT00827554|Adenocarcinoma|adenocarcinoma
650086|NCT00827554|Hepatocellular carcinoma|hepatocellular carcinoma
650087|NCT00827554|Neoplasms|neoplasms
650088|NCT00827554|Transarterial chemoembolization|transarterial chemoembolization
650089|NCT00827554|Nadroparin|nadroparin
650090|NCT00827554|low-molecular-weight heparin|low-molecular-weight heparin
650091|NCT00827554|chemoembolization|chemoembolization
650092|NCT00827541|tigecycline|tigecycline
650093|NCT00827541|complicated intra-abdominal infections (cIAI)|complicated intra-abdominal infections (ciai)
650094|NCT00827541|complicated skin and soft tissue infections (cSSTI).|complicated skin and soft tissue infections (cssti).
650095|NCT00827528|Pelvic Organ Prolapse|pelvic organ prolapse
650096|NCT00827528|Surgical Treatment|surgical treatment
650097|NCT00827515|Relative Bioavailability Effect of food|relative bioavailability effect of food
650098|NCT00827502|TRULIMAX (AZITHROMYCIN ) NON-INTERVENTIONAL STUDY|trulimax (azithromycin ) non-interventional study
650099|NCT00827489|schizophrenia|schizophrenia
650100|NCT00827476|ovary|ovary
650101|NCT00827476|human|human
650102|NCT00827476|transplantaion|transplantaion
650103|NCT00827476|ovarian failure|ovarian failure
650104|NCT00827463|aneamia|aneamia
650105|NCT00827463|aneamia during the maternity|aneamia during the maternity
650106|NCT00827450|hepatic steatosis|hepatic steatosis
650107|NCT00827450|coffee|coffee
650108|NCT00827450|fructose|fructose
650109|NCT00827450|lipids|lipids
650110|NCT00827424|physical activity (PA)|physical activity (pa)
650111|NCT00827424|obesity|obesity
650112|NCT00827424|life style modification|life style modification
650113|NCT00827424|physical activity|physical activity
650114|NCT00827424|diet|diet
650115|NCT00827424|BMI reduction|bmi reduction
650116|NCT00827424|clinical and metabolic measure|clinical and metabolic measure
650117|NCT00827424|health expenditure|health expenditure
650118|NCT00827424|improvement of patient readiness for lifestyle change|improvement of patient readiness for lifestyle change
650119|NCT00827411|Drug Eluting Stent|drug eluting stent
650729|NCT00825240|Survivorship|survivorship
650120|NCT00827411|Percutaneous coronary intervention|percutaneous coronary intervention
650121|NCT00827411|Oral antiplatelet therapy|oral antiplatelet therapy
650122|NCT00827411|Clopidogrel/Aspirin|clopidogrel/aspirin
650123|NCT00827411|Acute Coronary Syndrome|acute coronary syndrome
650125|NCT00827398|GVHD|gvhd
650126|NCT00827398|Adults|adults
650127|NCT00827398|Children|children
650128|NCT00827398|steroid refractory acute GVHD occurring after allogeneic stem cell transplantation|steroid refractory acute gvhd occurring after allogeneic stem cell transplantation
650129|NCT00827359|everolimus|everolimus
650130|NCT00827333|recurrent non-small cell lung cancer|recurrent non-small cell lung cancer
650131|NCT00827333|stage I non-small cell lung cancer|stage i non-small cell lung cancer
650132|NCT00827333|stage II non-small cell lung cancer|stage ii non-small cell lung cancer
650133|NCT00827333|stage IIIA non-small cell lung cancer|stage iiia non-small cell lung cancer
650134|NCT00827333|stage IIIB non-small cell lung cancer|stage iiib non-small cell lung cancer
650135|NCT00827333|stage IV non-small cell lung cancer|stage iv non-small cell lung cancer
650136|NCT00827307|breast carcinoma; goserelin; Mammographic density|breast carcinoma; goserelin; mammographic density
650137|NCT00827294|Phantom limb pain|phantom limb pain
650138|NCT00827294|Mirror therapy|mirror therapy
650139|NCT00827294|amputation|amputation
650140|NCT00827294|Limb loss|limb loss
650141|NCT00827294|treatment|treatment
650142|NCT00827281|DCS|dcs
650143|NCT00827281|CBT|cbt
650144|NCT00827281|smoking|smoking
650145|NCT00827281|tobacco|tobacco
650146|NCT00827268|Dyslexia|dyslexia
650147|NCT00827268|Reading|reading
650148|NCT00827268|Aphasia|aphasia
650149|NCT00827268|Stroke|stroke
650150|NCT00827242|Signs and Symptoms|signs and symptoms
650151|NCT00827242|Prostatic Hyperplasia|prostatic hyperplasia
650152|NCT00827242|Hyperplasia|hyperplasia
650153|NCT00827242|Genital Diseases, Male|genital diseases, male
650154|NCT00827242|Prostatic Diseases|prostatic diseases
650155|NCT00827242|BPH-LUTS|bph-luts
650156|NCT00827229|Active labor|active labor
650157|NCT00827229|Term pregnancy|term pregnancy
650158|NCT00827229|Vertex presentation|vertex presentation
650159|NCT00827229|Single fetus|single fetus
650160|NCT00827216|Gastric emptying|gastric emptying
650161|NCT00827216|emergency anesthesia|emergency anesthesia
650162|NCT00827216|intravenous erythromycin|intravenous erythromycin
650163|NCT00827203|cancer|cancer
650164|NCT00827203|metastatic|metastatic
650165|NCT00827203|Elesclomol Sodium|elesclomol sodium
650166|NCT00827203|tumor|tumor
650167|NCT00827203|Advanced solid tumors that are metastatic and unresectable|advanced solid tumors that are metastatic and unresectable
650168|NCT00827190|Acute Ischemic Stroke|acute ischemic stroke
650169|NCT00827177|dose escalation|dose escalation
650170|NCT00827177|safety|safety
650171|NCT00827177|tolerability|tolerability
650172|NCT00827177|tumor|tumor
650173|NCT00827177|PK|pk
650174|NCT00827177|hepatocellular carcinoma|hepatocellular carcinoma
650175|NCT00827177|renal cell carcinoma|renal cell carcinoma
650176|NCT00827177|melanoma|melanoma
650177|NCT00827177|non-small cell lung cancer|non-small cell lung cancer
650178|NCT00827177|breast cancer|breast cancer
650179|NCT00827164|head and neck cancer|head and neck cancer
650180|NCT00827164|resistance training|resistance training
650181|NCT00827164|nutrition counseling|nutrition counseling
650182|NCT00827164|radiation therapy|radiation therapy
650183|NCT00827164|pharyngeal or laryngeal cancer|pharyngeal or laryngeal cancer
650184|NCT00827151|amenorrhea|amenorrhea
650185|NCT00827151|athletes|athletes
650186|NCT00827151|bone loss|bone loss
650187|NCT00827151|eumenorrhea|eumenorrhea
650188|NCT00827125|active stage|active stage
650189|NCT00827125|labor|labor
650190|NCT00827125|progression|progression
650191|NCT00827125|pregnant woman during active phases of labor|pregnant woman during active phases of labor
650192|NCT00827112|CCR5-tropic HIV-1 virus|ccr5-tropic hiv-1 virus
650193|NCT00827099|accelerated phase cml|accelerated phase cml
650194|NCT00827099|adult ALL in remission|adult all in remission
650195|NCT00827099|adult AML in remission|adult aml in remission
650196|NCT00827099|adult AML with 11q23 (MLL) abnormalities|adult aml with 11q23 (mll) abnormalities
650197|NCT00827099|adult AML with inv(16)(p13;q22)|adult aml with inv(16)(p13;q22)
650198|NCT00827099|adult acute myeloid leukemia with t(15;17)(q22;q12)|adult acute myeloid leukemia with t(15;17)(q22;q12)
650199|NCT00827099|adult acute myeloid leukemia with t(16;16)(p13;q22)|adult acute myeloid leukemia with t(16;16)(p13;q22)
650200|NCT00827099|adult acute myeloid leukemia with t(8;21)(q22;q22)|adult acute myeloid leukemia with t(8;21)(q22;q22)
650201|NCT00827099|blastic phase chronic myelogenous leukemia|blastic phase chronic myelogenous leukemia
650202|NCT00827099|chronic myelomonocytic leukemia|chronic myelomonocytic leukemia
650203|NCT00827099|chronic phase chronic myelogenous leukemia|chronic phase chronic myelogenous leukemia
650204|NCT00827099|prolymphocytic leukemia|prolymphocytic leukemia
650205|NCT00827099|recurrent adult T-cell leukemia/lymphoma|recurrent adult t-cell leukemia/lymphoma
650206|NCT00827099|relapsing chronic myelogenous leukemia|relapsing chronic myelogenous leukemia
650207|NCT00827099|secondary acute myeloid leukemia|secondary acute myeloid leukemia
650208|NCT00827099|refractory chronic lymphocytic leukemia|refractory chronic lymphocytic leukemia
650209|NCT00827099|stage I chronic lymphocytic leukemia|stage i chronic lymphocytic leukemia
650210|NCT00827099|stage II chronic lymphocytic leukemia|stage ii chronic lymphocytic leukemia
650211|NCT00827099|stage III chronic lymphocytic leukemia|stage iii chronic lymphocytic leukemia
650212|NCT00827099|stage IV chronic lymphocytic leukemia|stage iv chronic lymphocytic leukemia
650213|NCT00827099|recurrent adult Hodgkin lymphoma|recurrent adult hodgkin lymphoma
650214|NCT00827099|anaplastic large cell lymphoma|anaplastic large cell lymphoma
650215|NCT00827099|angioimmunoblastic T-cell lymphoma|angioimmunoblastic t-cell lymphoma
650216|NCT00827099|cutaneous B-cell non-Hodgkin lymphoma|cutaneous b-cell non-hodgkin lymphoma
650217|NCT00827099|recurrent cutaneous T-cell non-Hodgkin lymphoma|recurrent cutaneous t-cell non-hodgkin lymphoma
650218|NCT00827099|recurrent mycosis fungoides/Sezary syndrome|recurrent mycosis fungoides/sezary syndrome
650219|NCT00827099|adult grade III lymphomatoid granulomatosis|adult grade iii lymphomatoid granulomatosis
650220|NCT00827099|adult nasal type extranodal NK/T-cell lymphoma|adult nasal type extranodal nk/t-cell lymphoma
650221|NCT00827099|Waldenstrom macroglobulinemia|waldenstrom macroglobulinemia
650222|NCT00827099|extranodal marginal zone B-cell lymphoma of mucosa-associated lymphoid tissue|extranodal marginal zone b-cell lymphoma of mucosa-associated lymphoid tissue
650223|NCT00827099|nodal marginal zone B-cell lymphoma|nodal marginal zone b-cell lymphoma
650224|NCT00827099|splenic marginal zone lymphoma|splenic marginal zone lymphoma
650225|NCT00827099|recurrent adult diffuse large cell lymphoma|recurrent adult diffuse large cell lymphoma
650226|NCT00827099|recurrent adult diffuse mixed cell lymphoma|recurrent adult diffuse mixed cell lymphoma
650227|NCT00827099|recurrent adult diffuse small cleaved cell lymphoma|recurrent adult diffuse small cleaved cell lymphoma
650228|NCT00827099|recurrent adult grade III lymphomatoid granulomatosis|recurrent adult grade iii lymphomatoid granulomatosis
650229|NCT00827099|recurrent grade 1 follicular lymphoma|recurrent grade 1 follicular lymphoma
650230|NCT00827099|recurrent grade 2 follicular lymphoma|recurrent grade 2 follicular lymphoma
650231|NCT00827099|recurrent grade 3 follicular lymphoma|recurrent grade 3 follicular lymphoma
650232|NCT00827099|recurrent mantle cell lymphoma|recurrent mantle cell lymphoma
650233|NCT00827099|recurrent marginal zone lymphoma|recurrent marginal zone lymphoma
650234|NCT00827099|recurrent small lymphocytic lymphoma|recurrent small lymphocytic lymphoma
650235|NCT00827099|chronic idiopathic myelofibrosis|chronic idiopathic myelofibrosis
650236|NCT00827099|stage I multiple myeloma|stage i multiple myeloma
650237|NCT00827099|stage II multiple myeloma|stage ii multiple myeloma
650238|NCT00827099|stage III multiple myeloma|stage iii multiple myeloma
650239|NCT00827099|refractory multiple myeloma|refractory multiple myeloma
650542|NCT00825838|Body weight|body weight
650240|NCT00827099|de novo myelodysplastic syndromes|de novo myelodysplastic syndromes
650241|NCT00827099|previously treated myelodysplastic syndromes|previously treated myelodysplastic syndromes
650242|NCT00827099|secondary myelodysplastic syndromes|secondary myelodysplastic syndromes
650243|NCT00827086|influencing factors (smoking, nutrition, education)|influencing factors (smoking, nutrition, education)
650244|NCT00827060|primary care|primary care
650245|NCT00827060|procalcitonin|procalcitonin
650246|NCT00827060|acute respiratory tract infection|acute respiratory tract infection
650247|NCT00827047|hepatocellular carcinoma|hepatocellular carcinoma
650248|NCT00827047|Surgical resection|surgical resection
650249|NCT00827047|total hemihepatic vascular exclusion|total hemihepatic vascular exclusion
650250|NCT00827047|occlusion|occlusion
650251|NCT00827047|bleeding|bleeding
650252|NCT00827047|overall survival|overall survival
650253|NCT00827034|Dimebon Warfarin Drug-Drug Interaction|dimebon warfarin drug-drug interaction
650254|NCT00826995|patient Education|patient education
650255|NCT00826995|dermatology Patient Education|dermatology patient education
650256|NCT00826995|melanoma|melanoma
650257|NCT00826995|melanoma education|melanoma education
650258|NCT00826995|malignant melanoma|malignant melanoma
650259|NCT00826995|melanoma detection|melanoma detection
650261|NCT00826969|Ciclesonide|ciclesonide
650262|NCT00826943|Allergic Rhinitis|allergic rhinitis
650263|NCT00826930|High Grade Glioma|high grade glioma
650264|NCT00826930|Brain Tumor|brain tumor
650265|NCT00826930|Solid Tumor|solid tumor
650266|NCT00826930|Partial Debulking|partial debulking
650267|NCT00826930|Tumor Resection|tumor resection
650268|NCT00826930|Tumor Tissue Hypoxia|tumor tissue hypoxia
650269|NCT00826930|Radiation Sensitizer|radiation sensitizer
650270|NCT00826930|Cancerous Tumor|cancerous tumor
650271|NCT00826917|3D, 2D, ultrasound, volumetry, multiplanar, VOCALTM, XI VOCALTM, fetal, gestational sac, placenta|3d, 2d, ultrasound, volumetry, multiplanar, vocaltm, xi vocaltm, fetal, gestational sac, placenta
650272|NCT00826904|Fetal programming|fetal programming
650273|NCT00826904|Fetal macrosomia|fetal macrosomia
650274|NCT00826904|Fetal health|fetal health
650275|NCT00826904|Gestational diabetes|gestational diabetes
650276|NCT00826904|Maternal health|maternal health
650277|NCT00826904|Maternal obesity|maternal obesity
650278|NCT00826878|tivozanib|tivozanib
650279|NCT00826878|AV-951|av-951
650280|NCT00826839|In vitro fertilization|in vitro fertilization
650281|NCT00826839|Poor responder patients|poor responder patients
650282|NCT00826839|Randomized clinical trial|randomized clinical trial
650283|NCT00826839|Estrogen patch|estrogen patch
650284|NCT00826839|Gonadotropin-releasing hormone antagonist|gonadotropin-releasing hormone antagonist
650285|NCT00826839|Oral contraceptive pill|oral contraceptive pill
650286|NCT00826839|Microdose lupron|microdose lupron
650287|NCT00826826|Atrial fibrillation|atrial fibrillation
650288|NCT00826826|Amiodarone|amiodarone
650289|NCT00826826|Arrhythmias, Cardiac|arrhythmias, cardiac
650290|NCT00826826|Catheter ablation|catheter ablation
650291|NCT00826813|Dysphagia|dysphagia
650292|NCT00826813|esophageal cancer|esophageal cancer
650293|NCT00826813|stent|stent
650294|NCT00826813|brachytherapy|brachytherapy
650295|NCT00826800|BEVACIZUMAB (AVASTIN)|bevacizumab (avastin)
650296|NCT00826800|FLUOROURACIL|fluorouracil
650297|NCT00826800|LEUCOVORIN|leucovorin
650298|NCT00826800|OXALIPLATIN|oxaliplatin
650299|NCT00826800|Chemotherapy|chemotherapy
650300|NCT00826774|Body Weight|body weight
650301|NCT00826774|Overweight|overweight
650302|NCT00826774|Hypertension|hypertension
650303|NCT00826774|Hyperglycemia|hyperglycemia
650304|NCT00826748|COPD|copd
650305|NCT00826748|inhaled steroids|inhaled steroids
650306|NCT00826748|gene expression|gene expression
650307|NCT00826748|smoker's lungs|smoker's lungs
650308|NCT00826735|third stage of labor|third stage of labor
650309|NCT00826735|bleeding|bleeding
650310|NCT00826735|guided imagery|guided imagery
650311|NCT00826735|childbirth|childbirth
650312|NCT00826696|preeclampsia|preeclampsia
650313|NCT00826683|Non-small cell lung cancer|non-small cell lung cancer
650314|NCT00826683|Endothelial cell progenitor|endothelial cell progenitor
650315|NCT00826683|Angiogenesis|angiogenesis
650316|NCT00826683|Vascular endothelial cell growth factor|vascular endothelial cell growth factor
650317|NCT00826683|Healthy control|healthy control
650318|NCT00826683|COPD patients|copd patients
650319|NCT00826683|NSCLC patients|nsclc patients
650320|NCT00826670|Antibiotic resistance|antibiotic resistance
650321|NCT00826670|ESBL carriage|esbl carriage
650322|NCT00826657|B12 deficiency|b12 deficiency
650323|NCT00826657|methylmalonic acid|methylmalonic acid
650324|NCT00826657|homocystein|homocystein
650325|NCT00826657|vitamin B12 supplementation intervention|vitamin b12 supplementation intervention
650326|NCT00826644|Small cell lung cancer|small cell lung cancer
650327|NCT00826644|Camptothecin|camptothecin
650328|NCT00826644|Response rate|response rate
650329|NCT00826631|weight|weight
650330|NCT00826631|metabolism|metabolism
650331|NCT00826631|cholesterol|cholesterol
650332|NCT00826631|insulin|insulin
650333|NCT00826618|Uveitis|uveitis
650334|NCT00826618|Cystoid Macular Edema|cystoid macular edema
650335|NCT00826605|Weight loss, urobilinogen|weight loss, urobilinogen
650336|NCT00826592|patient education|patient education
650337|NCT00826592|dermatology patient education|dermatology patient education
650338|NCT00826592|atopic dermatitis|atopic dermatitis
650339|NCT00826592|atopic dermatitis education|atopic dermatitis education
650340|NCT00826592|atopic eczema|atopic eczema
650341|NCT00826592|infantile eczema|infantile eczema
650342|NCT00826592|hand eczema|hand eczema
650343|NCT00826579|Sentinel lymph node|sentinel lymph node
650344|NCT00826579|Lymph node analysis|lymph node analysis
650345|NCT00826579|Bone marrow analysis|bone marrow analysis
650346|NCT00826566|COPD|copd
650347|NCT00826566|caffeine|caffeine
650348|NCT00826566|chronic systemic inflammation|chronic systemic inflammation
650349|NCT00826566|oxidative stress|oxidative stress
650350|NCT00826566|supplementation|supplementation
650351|NCT00826566|stable COPD GOLD stage II with CRP levels ≥ 3 mg/l|stable copd gold stage ii with crp levels ≥ 3 mg/l
650352|NCT00826553|sedative|sedative
650354|NCT00826553|alpha 2 agonist|alpha 2 agonist
650355|NCT00826553|propofol|propofol
650356|NCT00826553|midazolam|midazolam
650357|NCT00826553|lorazepam|lorazepam
650358|NCT00826553|dexmedetomidine|dexmedetomidine
650359|NCT00826553|sleep|sleep
650360|NCT00826553|electroencephalogram|electroencephalogram
650361|NCT00826553|polysomnogram|polysomnogram
650362|NCT00826553|ICU|icu
650363|NCT00826514|Chronic Prostatis|chronic prostatis
650364|NCT00826488|Breast Cancer|breast cancer
650365|NCT00826488|Mammography|mammography
650366|NCT00826488|Benign masses|benign masses
828916|NCT00119483|Men|men
650367|NCT00826488|Breast Lump|breast lump
650368|NCT00826488|Breast Biopsy|breast biopsy
650369|NCT00826488|Breast Mass|breast mass
650370|NCT00826475|Migraine|migraine
650371|NCT00826475|Headache|headache
650372|NCT00826462|Randomised|randomised
650373|NCT00826462|Placebo-controlled|placebo-controlled
650374|NCT00826462|double blind|double blind
650375|NCT00826462|Intervention study|intervention study
650376|NCT00826462|Primary health care|primary health care
650377|NCT00826449|Advanced Solid Tumors|advanced solid tumors
650378|NCT00826449|Advanced Cancer|advanced cancer
650379|NCT00826449|Non-Small Cell Lung Cancer|non-small cell lung cancer
650380|NCT00826449|NSCLC|nsclc
650381|NCT00826449|Solid Tumor Malignancy|solid tumor malignancy
650382|NCT00826449|Dasatinib|dasatinib
650383|NCT00826449|BMS-354825|bms-354825
650384|NCT00826449|Sprycel®|sprycel®
650385|NCT00826449|Erlotinib|erlotinib
650386|NCT00826449|Erlotinib hydrochloride|erlotinib hydrochloride
650387|NCT00826449|Tarceva|tarceva
650388|NCT00826449|OSI-774|osi-774
650389|NCT00826423|treatment with Triple antibiotic therapy|treatment with triple antibiotic therapy
650390|NCT00826410|Laparotomy|laparotomy
650391|NCT00826410|Surgical site infection|surgical site infection
650392|NCT00826410|Drainage|drainage
650393|NCT00826397|Aromatase Inhibitors|aromatase inhibitors
650394|NCT00826397|Joint Pain|joint pain
650395|NCT00826397|Symptoms Control|symptoms control
650396|NCT00826397|Acupuncture|acupuncture
650397|NCT00826384|hepatocellular carcinoma|hepatocellular carcinoma
650398|NCT00826384|transcatheter arterial chemoembolization|transcatheter arterial chemoembolization
650399|NCT00826384|overall survival|overall survival
650400|NCT00826371|AMD|amd
650401|NCT00826371|Ranibizumab|ranibizumab
650402|NCT00826358|Adverse events|adverse events
650403|NCT00826358|Pharmacokinetic|pharmacokinetic
650404|NCT00826345|Peripheral Neuropathy|peripheral neuropathy
650405|NCT00826345|Neuropathy|neuropathy
650406|NCT00826345|HIV|hiv
650407|NCT00826345|AIDS|aids
650408|NCT00826345|DSP|dsp
650409|NCT00826345|alternative therapies|alternative therapies
650410|NCT00826332|ultrasound|ultrasound
650411|NCT00826332|IVF|ivf
650412|NCT00826332|Embryo transfer|embryo transfer
650413|NCT00826332|Pregnancy rate|pregnancy rate
650414|NCT00826332|female patient undergoing IVF|female patient undergoing ivf
650415|NCT00826319|Chronic Kidney Disease|chronic kidney disease
650416|NCT00826319|Renal Insufficiency|renal insufficiency
650417|NCT00826319|Biomarkers|biomarkers
650418|NCT00826319|Observational|observational
650419|NCT00826306|patient education|patient education
650420|NCT00826306|dermatology patient education|dermatology patient education
650421|NCT00826306|sunscreen|sunscreen
650422|NCT00826306|sunscreen education|sunscreen education
650423|NCT00826306|skin cancer|skin cancer
650424|NCT00826280|pharmacologic stress|pharmacologic stress
650425|NCT00826280|ischemia|ischemia
650426|NCT00826280|coronary artery disease (CAD)|coronary artery disease (cad)
650427|NCT00826254|vitamin K|vitamin k
650428|NCT00826254|Bone Mineral Density|bone mineral density
650429|NCT00826254|undercarboxylated osteocalcin|undercarboxylated osteocalcin
650430|NCT00826241|Brain Tumor|brain tumor
650431|NCT00826241|Central Nervous System|central nervous system
650432|NCT00826241|CNS|cns
650433|NCT00826241|Spinal Cord Tumor|spinal cord tumor
650434|NCT00826241|Anaplastic Ependymoma|anaplastic ependymoma
650435|NCT00826241|Supratentorial Ependymoma|supratentorial ependymoma
650436|NCT00826241|Infratentorial Ependymoma|infratentorial ependymoma
651130|NCT00823654|Breast|breast
650437|NCT00826241|Spinal Cord Ependymoma|spinal cord ependymoma
650438|NCT00826241|Lapatinib|lapatinib
650439|NCT00826241|GW572016|gw572016
650440|NCT00826241|Temozolomide|temozolomide
650441|NCT00826241|Temodar|temodar
650442|NCT00826215|mechanical|mechanical
650443|NCT00826215|neck pain|neck pain
650444|NCT00826215|chronic|chronic
650445|NCT00826215|acupuncture|acupuncture
650446|NCT00826215|chronic mechanical neck pain|chronic mechanical neck pain
650447|NCT00826202|schizophrenia|schizophrenia
650448|NCT00826202|d-serine|d-serine
650449|NCT00826202|prodrome|prodrome
650450|NCT00826189|Probiotics|probiotics
650451|NCT00826189|Asthma|asthma
650452|NCT00826189|Allergic Rhinitis|allergic rhinitis
650453|NCT00826150|ovarian cancer|ovarian cancer
650454|NCT00826150|H19 gene|h19 gene
650455|NCT00826150|plasmid|plasmid
650456|NCT00826150|inodiftagene vixteplasmid|inodiftagene vixteplasmid
650457|NCT00826137|prebiotics|prebiotics
650458|NCT00826137|Antibiotic-associated diarrhea|antibiotic-associated diarrhea
650459|NCT00826124|low back pain|low back pain
650460|NCT00826124|radiculopathy|radiculopathy
650461|NCT00826124|sciatica|sciatica
650462|NCT00826111|Magnetic Resonance Spectroscopy|magnetic resonance spectroscopy
650463|NCT00826111|Glutamate|glutamate
650464|NCT00826111|Glutamine|glutamine
650465|NCT00826111|GABA|gaba
650466|NCT00826111|Lexapro|lexapro
650467|NCT00826111|Lunesta|lunesta
650468|NCT00826111|Escitalopram|escitalopram
650469|NCT00826111|Eszopiclone|eszopiclone
650470|NCT00826098|Total knee replacement|total knee replacement
650471|NCT00826098|Platelet Rich Plasma|platelet rich plasma
650472|NCT00826098|PRP|prp
650473|NCT00826098|Biologic|biologic
650474|NCT00826098|Randomized|randomized
650475|NCT00826085|Breast Cancer|breast cancer
650476|NCT00826085|Recurrent Chest Wall Cancer|recurrent chest wall cancer
650477|NCT00826085|Loco-regional Recurrent Breast Cancer|loco-regional recurrent breast cancer
650478|NCT00826085|Breast Cancer Recurrence at the Chest Wall|breast cancer recurrence at the chest wall
650479|NCT00826072|Single Nucleotide Polymorphism|single nucleotide polymorphism
650480|NCT00826072|cardiopulmonary bypass|cardiopulmonary bypass
650481|NCT00826072|cardiac surgery|cardiac surgery
650482|NCT00826059|acute ischemic stroke|acute ischemic stroke
650483|NCT00826059|randomized clinical trial|randomized clinical trial
650484|NCT00826059|effectiveness|effectiveness
650485|NCT00826059|safety|safety
650486|NCT00826046|GVHD|gvhd
650487|NCT00826046|Prochymal|prochymal
650488|NCT00826046|Graft vs Host Disease|graft vs host disease
650489|NCT00826033|Fluorine-18-α-methyltyrosine|fluorine-18-α-methyltyrosine
650490|NCT00826033|Positron emission tomography|positron emission tomography
650491|NCT00826033|Lung cancer|lung cancer
650492|NCT00826033|chemotherapy|chemotherapy
650493|NCT00826033|monitoring|monitoring
650494|NCT00826020|PN|pn
650495|NCT00826020|parenteral nutrition|parenteral nutrition
650496|NCT00826020|fat emulsions|fat emulsions
650497|NCT00826020|omega-6 fatty acid|omega-6 fatty acid
650498|NCT00826020|liver disease|liver disease
650499|NCT00826020|fatty acid deficiency|fatty acid deficiency
650500|NCT00826007|perioperative hypoglycemia diabetes surgery|perioperative hypoglycemia diabetes surgery
650501|NCT00826007|surgery|surgery
650502|NCT00825994|menopause|menopause
650503|NCT00825994|perimenopause|perimenopause
650504|NCT00825994|postmenopause|postmenopause
650505|NCT00825994|depression|depression
650506|NCT00825994|mood|mood
650507|NCT00825994|sleep|sleep
650508|NCT00825994|hot flashes|hot flashes
650509|NCT00825968|Electrophysiological|electrophysiological
650510|NCT00825968|Heart Disease|heart disease
650511|NCT00825968|Cardiology|cardiology
650512|NCT00825968|Atrial Fibrillation|atrial fibrillation
650513|NCT00825968|Risk Factors|risk factors
650514|NCT00825968|Follow-up|follow-up
650515|NCT00825968|Outcomes|outcomes
650516|NCT00825942|Asteroid hyalosis|asteroid hyalosis
650517|NCT00825942|Opthalmic Study|opthalmic study
650518|NCT00825929|pharmacokinetics|pharmacokinetics
650519|NCT00825929|pregnancy|pregnancy
650520|NCT00825929|antiretrovirals|antiretrovirals
650521|NCT00825929|neonates|neonates
650522|NCT00825929|HIV|hiv
650523|NCT00825929|treatment experienced|treatment experienced
650524|NCT00825916|AZX100|azx100
650525|NCT00825916|Patient and Observer Scar Assessment Scale|patient and observer scar assessment scale
650526|NCT00825916|POSAS|posas
650527|NCT00825916|Visual Analog Scale|visual analog scale
650528|NCT00825916|VAS|vas
650529|NCT00825916|Keloid|keloid
650530|NCT00825916|Scarring|scarring
650531|NCT00825916|Scar reduction|scar reduction
650532|NCT00825916|Scar prevention|scar prevention
650533|NCT00825903|aquatic exercise|aquatic exercise
650534|NCT00825903|asthma|asthma
650535|NCT00825890|high cup disc ratio|high cup disc ratio
650536|NCT00825890|glaucoma suspect|glaucoma suspect
650537|NCT00825877|Hepatitis C|hepatitis c
650538|NCT00825877|Sustained Virological Response|sustained virological response
650539|NCT00825877|HALT-C|halt-c
650540|NCT00825877|Peginterferon and Ribavirin|peginterferon and ribavirin
650541|NCT00825877|HCV RNA|hcv rna
650543|NCT00825838|Body composition|body composition
650544|NCT00825838|Resting metabolic rate and fat oxidation in men|resting metabolic rate and fat oxidation in men
650545|NCT00825838|class I obese|class i obese
650546|NCT00825825|Citalopram|citalopram
650547|NCT00825825|Escitalopram|escitalopram
650549|NCT00825825|Lexapro|lexapro
650550|NCT00825825|fMRI|fmri
650551|NCT00825825|antidepressant|antidepressant
650552|NCT00825825|healthy volunteers|healthy volunteers
650553|NCT00825799|biomarker|biomarker
650554|NCT00825799|depression|depression
650555|NCT00825799|blood test|blood test
650556|NCT00825786|surgery for arm hand or elbow|surgery for arm hand or elbow
650557|NCT00825786|mepivacaine|mepivacaine
650558|NCT00825786|ropivacaine|ropivacaine
650559|NCT00825786|hand surgery|hand surgery
650560|NCT00825786|elbow surgery|elbow surgery
650561|NCT00825786|forearm surgery|forearm surgery
650562|NCT00825773|TVF|tvf
650563|NCT00825773|TLF|tlf
650564|NCT00825773|MACE|mace
650565|NCT00825773|Ischemia-driven Target Vessel Failure (TVF) at 12 months.|ischemia-driven target vessel failure (tvf) at 12 months.
650566|NCT00825773|Ischemia-driven Target Lesion Failure (TLF) at 12 months defined as a|ischemia-driven target lesion failure (tlf) at 12 months defined as a
650567|NCT00825773|composite of cardiac death that can not be clearly attributed to a vessel|composite of cardiac death that can not be clearly attributed to a vessel
650568|NCT00825773|other than the target vessel, target vessel MI (Q and Non-Q wave) and|other than the target vessel, target vessel mi (q and non-q wave) and
650569|NCT00825773|ischemia-driven TLR.|ischemia-driven tlr.
650570|NCT00825773|Rates of stent thrombosis, defined (per ARC definition) as definite or probable|rates of stent thrombosis, defined (per arc definition) as definite or probable
650571|NCT00825773|and categorized as early, late or very late.|and categorized as early, late or very late.
650572|NCT00825773|Major Adverse Cardiac Events (MACE) defined as cardiac death, target|major adverse cardiac events (mace) defined as cardiac death, target
650573|NCT00825773|vessel MI (Q and Non-Q wave), or target lesion revascularization (TLR) at 30|vessel mi (q and non-q wave), or target lesion revascularization (tlr) at 30
650574|NCT00825773|days, 6 months, 12 months and 2 to 5 years annually.|days, 6 months, 12 months and 2 to 5 years annually.
650575|NCT00825760|Antimicrobial Photodynamic Therapy|antimicrobial photodynamic therapy
650576|NCT00825760|Photodynamic Therapy|photodynamic therapy
650577|NCT00825760|PDT|pdt
650578|NCT00825760|Red light|red light
650579|NCT00825760|Visible light|visible light
650580|NCT00825760|Antimicrobial|antimicrobial
650581|NCT00825760|Antibacterial|antibacterial
650582|NCT00825760|Wound healing|wound healing
650583|NCT00825760|Wound management|wound management
650584|NCT00825760|Leg ulcer|leg ulcer
650585|NCT00825760|Chronic venous leg ulcer|chronic venous leg ulcer
650586|NCT00825760|Chronic wound|chronic wound
650587|NCT00825760|Wound therapy|wound therapy
650588|NCT00825760|Antimicrobial therapy|antimicrobial therapy
650589|NCT00825747|Cataract|cataract
650590|NCT00825747|Cataract surgery|cataract surgery
650591|NCT00825747|intraocular lens|intraocular lens
650592|NCT00825747|Aspheric lens|aspheric lens
650593|NCT00825734|Metastatic Breast Cancer|metastatic breast cancer
650594|NCT00825734|Sorafenib|sorafenib
650595|NCT00825734|Nexavar|nexavar
650596|NCT00825734|Ixabepilone|ixabepilone
650597|NCT00825734|Ixempra|ixempra
650598|NCT00825721|Cataract Study|cataract study
650599|NCT00825721|Ophthalmic Study|ophthalmic study
650600|NCT00825721|Agerelated cataract|agerelated cataract
650601|NCT00825721|Nuclear Cataract|nuclear cataract
650602|NCT00825721|Low grade nuclear cataracts|low grade nuclear cataracts
650603|NCT00825708|ADHD|adhd
650604|NCT00825682|Breast cancer|breast cancer
650605|NCT00825682|Radiation therapy|radiation therapy
650606|NCT00825682|Reflexology|reflexology
650607|NCT00825682|Fatigue|fatigue
650608|NCT00825682|Quality of life|quality of life
650609|NCT00825682|Sleep disturbance|sleep disturbance
650610|NCT00825669|hepatocellular carcinoma|hepatocellular carcinoma
650611|NCT00825669|Portal vein tumor thrombus|portal vein tumor thrombus
650612|NCT00825669|laser ablation|laser ablation
650613|NCT00825656|Allergic Rhinitis|allergic rhinitis
650614|NCT00825656|Capsaicin|capsaicin
650615|NCT00825656|Homeopathic|homeopathic
650616|NCT00825656|Sinol|sinol
650617|NCT00825656|Sinol-M|sinol-m
650618|NCT00825630|HP|hp
650619|NCT00825630|UBT|ubt
650620|NCT00825630|PPI|ppi
650621|NCT00825617|TS|ts
650622|NCT00825617|HRT|hrt
650623|NCT00825617|Liver function tests|liver function tests
650624|NCT00825604|stable coronary artery disease|stable coronary artery disease
650625|NCT00825604|quality of life|quality of life
650626|NCT00825604|target achievement|target achievement
650627|NCT00825604|physical training|physical training
650628|NCT00825604|percutaneous coronary intervention|percutaneous coronary intervention
650629|NCT00825591|optic nerve hypoplasia|optic nerve hypoplasia
650630|NCT00825591|septo-optic dysplasia|septo-optic dysplasia
650631|NCT00825591|melatonin|melatonin
650632|NCT00825591|circadian rhythm|circadian rhythm
650633|NCT00825578|intrabronchial valve|intrabronchial valve
650634|NCT00825578|heterogeneous emphysema|heterogeneous emphysema
650635|NCT00825578|non-upper lobe|non-upper lobe
650636|NCT00825565|Epidermolysis bullosa|epidermolysis bullosa
650637|NCT00825552|Risperidone|risperidone
650638|NCT00825552|Severe mood dysregulation|severe mood dysregulation
650639|NCT00825552|bipolar|bipolar
650640|NCT00825552|children|children
650641|NCT00825539|Schizophrenia|schizophrenia
650642|NCT00825539|Manic depression|manic depression
650643|NCT00825539|anxiety|anxiety
650644|NCT00825526|Mindfulness Based Stress Reduction (MBSR)|mindfulness based stress reduction (mbsr)
650645|NCT00825526|Stress Reduction|stress reduction
650646|NCT00825526|hypertension|hypertension
650647|NCT00825526|high blood pressure|high blood pressure
650648|NCT00825526|ambulatory blood pressure monitoring|ambulatory blood pressure monitoring
650649|NCT00825500|Migraine headache|migraine headache
650650|NCT00825500|Loxapine|loxapine
650651|NCT00825500|Staccato|staccato
650652|NCT00825487|metastatic|metastatic
650653|NCT00825487|hematologic|hematologic
650654|NCT00825487|malignancy|malignancy
650655|NCT00825487|multiple|multiple
650656|NCT00825487|myeloma|myeloma
650657|NCT00825487|malignant|malignant
650658|NCT00825487|lymphoma|lymphoma
650659|NCT00825487|chronic|chronic
650660|NCT00825487|lymphocytic|lymphocytic
650661|NCT00825487|leukemia|leukemia
650662|NCT00825487|acute|acute
650663|NCT00825487|myelogenous|myelogenous
650664|NCT00825487|promyelocytic|promyelocytic
650665|NCT00825487|dose escalation|dose escalation
650666|NCT00825487|safety|safety
650667|NCT00825487|tolerability|tolerability
650668|NCT00825487|pharmacodynamics|pharmacodynamics
650669|NCT00825487|tumor|tumor
650670|NCT00825487|PK|pk
650671|NCT00825474|small hepatocellular carcinoma|small hepatocellular carcinoma
650672|NCT00825474|partial hepatectomy|partial hepatectomy
650673|NCT00825474|TACE plus PEI|tace plus pei
650674|NCT00825461|Anorexia Nervosa|anorexia nervosa
650675|NCT00825448|alcohol addiction|alcohol addiction
650676|NCT00825435|Coronary CT angiogram|coronary ct angiogram
650677|NCT00825435|Cardiac imaging|cardiac imaging
650678|NCT00825435|Cost analysis|cost analysis
650679|NCT00825435|acute chest pain|acute chest pain
650680|NCT00825435|risk stratification|risk stratification
650681|NCT00825435|cumulative costs over 90-days of providing treatment services|cumulative costs over 90-days of providing treatment services
650682|NCT00825422|Posterior lumbar arthrodesis|posterior lumbar arthrodesis
650683|NCT00825422|Degenerative spine|degenerative spine
650684|NCT00825422|Postoperative analgesia|postoperative analgesia
650685|NCT00825422|Local anesthesic|local anesthesic
650686|NCT00825422|Continuous wound infusion catheter|continuous wound infusion catheter
650687|NCT00825422|Pain|pain
650688|NCT00825422|lumbar vertebrae|lumbar vertebrae
650689|NCT00825422|Spinal fusion|spinal fusion
650690|NCT00825383|Diabetes|diabetes
650691|NCT00825383|lipids|lipids
650692|NCT00825383|fiber|fiber
650693|NCT00825370|Hydromorphone|hydromorphone
650694|NCT00825370|acute pain|acute pain
650695|NCT00825370|Protocolized|protocolized
650696|NCT00825370|Efficacy|efficacy
650697|NCT00825370|Safety|safety
650698|NCT00825357|biological markers|biological markers
650699|NCT00825357|sepsis|sepsis
650700|NCT00825357|acute lung injury|acute lung injury
650701|NCT00825344|postoperative pain|postoperative pain
650702|NCT00825344|inguinal hernia|inguinal hernia
650703|NCT00825344|chronic postsurgical pain|chronic postsurgical pain
650704|NCT00825344|cytokine|cytokine
650705|NCT00825344|preemptive analgesia|preemptive analgesia
650706|NCT00825344|patients with inguinal hernia scheduled for surgery|patients with inguinal hernia scheduled for surgery
650707|NCT00825331|guide wire|guide wire
650708|NCT00825331|cardiac catheterization|cardiac catheterization
650709|NCT00825331|ultrasound-guided examination of the access site|ultrasound-guided examination of the access site
650710|NCT00825331|graduated scheme|graduated scheme
650711|NCT00825331|elective and non elective cardiac catheterization|elective and non elective cardiac catheterization
650712|NCT00825318|End-stage renal disease|end-stage renal disease
650713|NCT00825318|Chronic kidney disease|chronic kidney disease
650714|NCT00825318|Hemodialysis|hemodialysis
650715|NCT00825305|vaccine|vaccine
650716|NCT00825305|prevention|prevention
650717|NCT00825305|rabies|rabies
650718|NCT00825305|Rabies disease|rabies disease
650719|NCT00825292|colon polyps, colon adenomas|colon polyps, colon adenomas
650720|NCT00825279|Biodegradable polymer|biodegradable polymer
650721|NCT00825279|Drug Eluting Stent|drug eluting stent
650722|NCT00825279|In stent restenosis|in stent restenosis
650723|NCT00825279|stent thrombosis|stent thrombosis
650724|NCT00825279|Bare Metal Stent|bare metal stent
650725|NCT00825266|pulmonary hypertension & insulin resistance|pulmonary hypertension & insulin resistance
650726|NCT00825240|Colorectal Cancer|colorectal cancer
650727|NCT00825240|Cancer Survivorship Study|cancer survivorship study
650730|NCT00825240|Survivor Health|survivor health
650731|NCT00825240|Health Promotion|health promotion
650732|NCT00825240|Behavior Changes|behavior changes
650733|NCT00825240|Computer-assisted intervention program|computer-assisted intervention program
650734|NCT00825227|Cancer|cancer
650735|NCT00825227|Fatigue|fatigue
650736|NCT00825227|Taxanes|taxanes
650737|NCT00825201|peritoneal carcinomatosis|peritoneal carcinomatosis
650738|NCT00825201|peritoneal cavity cancer|peritoneal cavity cancer
650739|NCT00825201|stage IV ovarian epithelial cancer|stage iv ovarian epithelial cancer
650740|NCT00825201|recurrent ovarian epithelial cancer|recurrent ovarian epithelial cancer
650741|NCT00825201|unspecified adult solid tumor, protocol specific|unspecified adult solid tumor, protocol specific
650742|NCT00825175|Down syndrome|down syndrome
650743|NCT00825175|Gait|gait
650744|NCT00825175|Motor Development|motor development
650745|NCT00825175|Orthoses|orthoses
650746|NCT00825136|Panic Disorder|panic disorder
650747|NCT00825136|Temperature Biofeedback|temperature biofeedback
650748|NCT00825136|Internet|internet
650749|NCT00825123|healthy individuals|healthy individuals
650750|NCT00825110|colorectal|colorectal
650751|NCT00825110|cancer|cancer
650752|NCT00825110|gene expression|gene expression
650753|NCT00825110|biomarker|biomarker
650754|NCT00825110|genomic mismatch repair|genomic mismatch repair
650755|NCT00825097|Spastic equinovarus foot|spastic equinovarus foot
650756|NCT00825097|Stroke|stroke
650757|NCT00825097|Tibial neurotomy|tibial neurotomy
650758|NCT00825097|Botulinum toxin type A|botulinum toxin type a
650759|NCT00825097|Selective tibial neurotomy|selective tibial neurotomy
650760|NCT00825084|Dimebon, Japanese and Western population, pharmacokinetics|dimebon, japanese and western population, pharmacokinetics
650761|NCT00825071|Postoperative Nausea and Vomiting|postoperative nausea and vomiting
650762|NCT00825071|Ondansetron|ondansetron
650763|NCT00825071|Dexamethasone|dexamethasone
650764|NCT00825058|Depression|depression
650765|NCT00825045|dopamine|dopamine
650766|NCT00825045|D2|d2
650767|NCT00825045|D3|d3
650768|NCT00825045|caudate|caudate
650769|NCT00825045|putamen|putamen
650770|NCT00825045|globus pallidus|globus pallidus
650771|NCT00825045|antipsychotic|antipsychotic
650772|NCT00825045|risperidone|risperidone
650773|NCT00825045|geriatric|geriatric
650774|NCT00825045|Brief Psychiatric Rating Scale|brief psychiatric rating scale
650775|NCT00825045|PET|pet
650776|NCT00825045|radiotracer|radiotracer
650777|NCT00825045|[11C]-(+)-PHNO|[11c]-(+)-phno
650778|NCT00825045|[11C]-raclopride|[11c]-raclopride
650779|NCT00825032|Pulmonary disease, chronic obstructive|pulmonary disease, chronic obstructive
650780|NCT00825032|Upper extremity|upper extremity
650781|NCT00825032|Exercise therapy|exercise therapy
650782|NCT00825019|Depression|depression
650783|NCT00825006|Cardiac resynchronization therapy|cardiac resynchronization therapy
650784|NCT00825006|Anodal stimulation|anodal stimulation
650785|NCT00824993|Blood Cancer|blood cancer
650786|NCT00824993|Calcium|calcium
650787|NCT00824993|Vitamin D|vitamin d
650788|NCT00824993|Ibandronate|ibandronate
650789|NCT00824993|Boniva|boniva
650790|NCT00824993|Hematological Malignancies|hematological malignancies
650791|NCT00824993|Bone Marrow Transplantation|bone marrow transplantation
650792|NCT00824993|BMT|bmt
650793|NCT00824993|Osteoporosis|osteoporosis
650794|NCT00824993|Bone Loss|bone loss
650795|NCT00824993|Allogeneic Bone Marrow Transplantation|allogeneic bone marrow transplantation
650796|NCT00824954|0 to 30 years|0 to 30 years
650797|NCT00824954|Refractory Acute GVHD|refractory acute gvhd
650798|NCT00824941|Abdominal Pain|abdominal pain
650799|NCT00824941|Women's Health and Disease|women's health and disease
650800|NCT00824941|Inflammation|inflammation
650801|NCT00824941|Symptoms|symptoms
650802|NCT00824941|Brain|brain
650803|NCT00824941|Chronic Abdominal Pain|chronic abdominal pain
650804|NCT00824928|Prostate Cancer|prostate cancer
650805|NCT00824928|Recurrent Prostate Cancer|recurrent prostate cancer
650806|NCT00824928|Prostate Cancer Recurrence|prostate cancer recurrence
650807|NCT00824928|Radiation Failure|radiation failure
650808|NCT00824928|Salvage Cryotherapy|salvage cryotherapy
650809|NCT00824915|Lead Integrity Algorithm|lead integrity algorithm
650810|NCT00824902|Prostate Cancer|prostate cancer
650811|NCT00824902|Prostate|prostate
650812|NCT00824902|Radical Prostatectomy|radical prostatectomy
650813|NCT00824902|Tissue Elastography|tissue elastography
650814|NCT00824902|Tissue Elastography Imaging|tissue elastography imaging
650815|NCT00824902|Software Program Measuring Prostate Elasticity|software program measuring prostate elasticity
650816|NCT00824902|Elasticity/Tissue Strain-Hardening Imaging|elasticity/tissue strain-hardening imaging
650817|NCT00824902|Ultrasound|ultrasound
650818|NCT00824876|Mammae cancer patients|mammae cancer patients
650819|NCT00824863|pityrosporum folliculitis|pityrosporum folliculitis
650820|NCT00824863|ketoconazole 2% foam|ketoconazole 2% foam
650821|NCT00824850|Single site|single site
650822|NCT00824850|single dose|single dose
650823|NCT00824850|Participated in Wyeth D118-P8|participated in wyeth d118-p8
650824|NCT00824837|beta 2 microglobulin|beta 2 microglobulin
650825|NCT00824837|haemodialysis|haemodialysis
650826|NCT00824837|albumin|albumin
650827|NCT00824824|Retinal Vascular Autoregulation|retinal vascular autoregulation
650828|NCT00824811|Epiphora|epiphora
650829|NCT00824811|Breast Cancer|breast cancer
650830|NCT00824811|Lung Cancer|lung cancer
650831|NCT00824811|Prostate Cancer|prostate cancer
650832|NCT00824811|Non-small cell lung cancer|non-small cell lung cancer
650833|NCT00824811|Bladder Cancer|bladder cancer
650834|NCT00824811|Esophageal Cancer|esophageal cancer
650835|NCT00824811|Head and Neck Cancer|head and neck cancer
650836|NCT00824811|HNC|hnc
650837|NCT00824811|Small Cell Lung Cancer|small cell lung cancer
650838|NCT00824811|SCLC|sclc
650839|NCT00824811|Ovarian Cancer|ovarian cancer
650840|NCT00824811|Stomach Cancer|stomach cancer
650841|NCT00824811|Canalicular Stenosis|canalicular stenosis
650842|NCT00824811|Excessive tearing|excessive tearing
650843|NCT00824811|Eye inflammation|eye inflammation
650844|NCT00824811|Cyclosporine Ophthalmic Emulsion 0.05%|cyclosporine ophthalmic emulsion 0.05%
650845|NCT00824811|Docetaxel|docetaxel
650846|NCT00824811|Taxotere|taxotere
650847|NCT00824811|Restasis®|restasis®
650848|NCT00824811|Cyclosporine|cyclosporine
650849|NCT00824811|Cyclosporine eye drops|cyclosporine eye drops
650850|NCT00824811|FML Forte®|fml forte®
650851|NCT00824811|Fluorometholone 0.25% ophthalmic suspension|fluorometholone 0.25% ophthalmic suspension
650852|NCT00824811|Fluorometholone eye drops|fluorometholone eye drops
650853|NCT00824811|Fluorometholone|fluorometholone
650854|NCT00824811|Refresh Endura™|refresh endura™
650855|NCT00824811|Lubricant eye drops|lubricant eye drops
650856|NCT00824811|Eye drops|eye drops
829512|NCT00117299|KDR|kdr
650857|NCT00824798|gait|gait
650858|NCT00824798|haemophilia|haemophilia
650859|NCT00824798|arthropathy|arthropathy
650860|NCT00824785|epirubicin|epirubicin
650861|NCT00824785|oxaliplatin|oxaliplatin
650862|NCT00824785|capecitabine|capecitabine
650863|NCT00824785|panitumumab|panitumumab
650864|NCT00824772|pharmacogenetics|pharmacogenetics
650865|NCT00824759|Healthy subjects|healthy subjects
650866|NCT00824759|CABG|cabg
650867|NCT00824759|Patients undergoing coronary artery bypass graft under cardiopulmonary bypass|patients undergoing coronary artery bypass graft under cardiopulmonary bypass
650868|NCT00824746|Gefitinib|gefitinib
650869|NCT00824746|Recurrence|recurrence
650870|NCT00824746|Carcinoma, Non-Small-Cell Lung|carcinoma, non-small-cell lung
650871|NCT00824733|recurrent breast cancer|recurrent breast cancer
650872|NCT00824733|stage IV breast cancer|stage iv breast cancer
650873|NCT00824733|stage IIIA breast cancer|stage iiia breast cancer
650874|NCT00824733|stage IIIB breast cancer|stage iiib breast cancer
650875|NCT00824733|stage IIIC breast cancer|stage iiic breast cancer
650876|NCT00824733|HER2-positive breast cancer|her2-positive breast cancer
650877|NCT00824733|male breast cancer|male breast cancer
650878|NCT00824707|primary liver cancer|primary liver cancer
650879|NCT00824707|hepatitis B virus|hepatitis b virus
650880|NCT00824707|anti-virus therapy|anti-virus therapy
650881|NCT00824694|Glucose|glucose
650882|NCT00824694|Diabetes Mellitus, Type 2|diabetes mellitus, type 2
650883|NCT00824694|HbA1c|hba1c
650884|NCT00824681|Psychological adjustment of family|psychological adjustment of family
650885|NCT00824681|family of patients|family of patients
650886|NCT00824681|children of patients|children of patients
650887|NCT00824681|intensive care unit|intensive care unit
650888|NCT00824681|burn|burn
650889|NCT00824681|music therapy|music therapy
650890|NCT00824681|music|music
650891|NCT00824681|music program|music program
650892|NCT00824681|anxiety|anxiety
650893|NCT00824681|coping|coping
650894|NCT00824681|adjustment|adjustment
650895|NCT00824681|psychological stressor|psychological stressor
650896|NCT00824681|emotional stressor|emotional stressor
650897|NCT00824655|Healthy Subjects|healthy subjects
650898|NCT00824655|Vaccines|vaccines
650899|NCT00824655|Pneumococcal|pneumococcal
650900|NCT00824642|Asthma|asthma
650901|NCT00824642|Exercise training|exercise training
650902|NCT00824642|TENS|tens
650903|NCT00824642|Acupuncture|acupuncture
650904|NCT00824642|FEV1|fev1
650905|NCT00824629|Embryo transfer|embryo transfer
650906|NCT00824629|IVF|ivf
650907|NCT00824629|Ultrasound embryo transfer|ultrasound embryo transfer
650908|NCT00824590|Dimebon|dimebon
650909|NCT00824590|renal impairment|renal impairment
650910|NCT00824590|pharmacokinetics|pharmacokinetics
650911|NCT00824577|heart rate variability|heart rate variability
650912|NCT00824577|autonomic function|autonomic function
650913|NCT00824577|heart function|heart function
650914|NCT00824564|Tranexamic Acid|tranexamic acid
650915|NCT00824564|Blood Loss|blood loss
650916|NCT00824564|Long Bone Fracture Surgery|long bone fracture surgery
650917|NCT00824551|Acute Thermal Burns|acute thermal burns
650918|NCT00824551|Hyperbaric Oxygen Therapy|hyperbaric oxygen therapy
650919|NCT00824551|Burns conversion|burns conversion
650920|NCT00824538|stage IA breast cancer|stage ia breast cancer
650921|NCT00824538|stage IB breast cancer|stage ib breast cancer
650922|NCT00824538|stage II breast cancer|stage ii breast cancer
650923|NCT00824538|stage IIIA breast cancer|stage iiia breast cancer
650924|NCT00824538|stage IIIB breast cancer|stage iiib breast cancer
650925|NCT00824538|stage IIIC breast cancer|stage iiic breast cancer
650926|NCT00824486|child|child
650927|NCT00824486|injury prevention|injury prevention
650928|NCT00824460|Hemodialysis|hemodialysis
650929|NCT00824447|randomised|randomised
650930|NCT00824447|double-blind|double-blind
650931|NCT00824447|placebo-controlled|placebo-controlled
650932|NCT00824447|long-term efficacy and safety|long-term efficacy and safety
650933|NCT00824447|Oralgen® Grass Pollen|oralgen® grass pollen
650934|NCT00824447|allergic rhinoconjunctivitis|allergic rhinoconjunctivitis
650935|NCT00824447|Allergy|allergy
650936|NCT00824447|Rhinoconjunctivitis|rhinoconjunctivitis
650937|NCT00824447|Immunotherapy|immunotherapy
650938|NCT00824447|Grass pollen extract|grass pollen extract
650939|NCT00824434|Atherosclerosis|atherosclerosis
650940|NCT00824434|Coronary Artery Disease|coronary artery disease
650941|NCT00824421|HIV-1. Treatment Naive|hiv-1. treatment naive
650942|NCT00824421|HIV Infections|hiv infections
650943|NCT00824421|treatment naive|treatment naive
650944|NCT00824395|diabetes|diabetes
650945|NCT00824395|type 1|type 1
650946|NCT00824395|type 2|type 2
650947|NCT00824395|metabolic syndrome|metabolic syndrome
650948|NCT00824395|mitochondria|mitochondria
650949|NCT00824369|HIV-1|hiv-1
650950|NCT00824369|Rollover|rollover
650951|NCT00824369|Safety.|safety.
650952|NCT00824369|HIV Infections|hiv infections
650953|NCT00824369|treatment experienced|treatment experienced
650954|NCT00824356|Allergic Rhinitis|allergic rhinitis
650955|NCT00824356|Proof-of-Concept|proof-of-concept
650956|NCT00824330|Aging|aging
650957|NCT00824330|Type 2 diabetes|type 2 diabetes
650958|NCT00824330|exercise|exercise
650959|NCT00824330|walking|walking
650960|NCT00824330|glucose metabolism|glucose metabolism
650961|NCT00824330|arterial baroreceptors|arterial baroreceptors
650962|NCT00824330|heart rate variability|heart rate variability
650963|NCT00824330|cerebral autoregulation|cerebral autoregulation
650964|NCT00824330|tilt table study|tilt table study
650965|NCT00824330|transcranial Doppler|transcranial doppler
650966|NCT00824330|autonomic nervous system|autonomic nervous system
650967|NCT00824304|cognitive performance|cognitive performance
650968|NCT00824304|growth|growth
650969|NCT00824304|iron|iron
650970|NCT00824304|zinc|zinc
650971|NCT00824291|Major Depressive Disorder|major depressive disorder
650972|NCT00824278|Pediatrics|pediatrics
650973|NCT00824278|Distresss Screening|distresss screening
650974|NCT00824278|Cancer|cancer
650975|NCT00824278|Neurofibromatosis|neurofibromatosis
650976|NCT00824278|HIV|hiv
650977|NCT00824278|Pediatric Cancer|pediatric cancer
650978|NCT00824278|Distress Screening|distress screening
650979|NCT00824265|Relapsed|relapsed
650980|NCT00824265|Oncology|oncology
650982|NCT00824265|Chronic Lymphocytic Leukemia|chronic lymphocytic leukemia
650983|NCT00824265|Ofatumumab|ofatumumab
650984|NCT00824265|Efficacy|efficacy
650985|NCT00824252|Head And Neck Cancer|head and neck cancer
650986|NCT00824252|HNC|hnc
650987|NCT00824252|Radiation Therapy|radiation therapy
650988|NCT00824252|Spousal Support|spousal support
650989|NCT00824252|Emotional Disclosure|emotional disclosure
650990|NCT00824252|Observational|observational
650991|NCT00824252|Social Constraints|social constraints
650992|NCT00824252|Questionnaires|questionnaires
650993|NCT00824252|Videotaped Interview|videotaped interview
650994|NCT00824252|Quality of Life|quality of life
650995|NCT00824239|critical care|critical care
650996|NCT00824239|sedation|sedation
650997|NCT00824239|Mechanically ventilated patients|mechanically ventilated patients
650998|NCT00824226|primary hypoparathyroidism|primary hypoparathyroidism
650999|NCT00824226|secondary hypoparathyroidism|secondary hypoparathyroidism
651000|NCT00824226|magnesium|magnesium
651001|NCT00824213|Whole Body SPECT imaging|whole body spect imaging
651002|NCT00824200|Sleep|sleep
651003|NCT00824200|Quality of life|quality of life
651004|NCT00824200|nocturia|nocturia
651005|NCT00824187|Premenstrual Dysphoric Disorder ( PMDD)|premenstrual dysphoric disorder ( pmdd)
651006|NCT00824187|Oral contraceptive|oral contraceptive
651007|NCT00824174|Questionnaire|questionnaire
651008|NCT00824174|Head and Neck Cancer|head and neck cancer
651009|NCT00824174|Skin Cancer|skin cancer
651010|NCT00824174|Body Image|body image
651011|NCT00824174|Surgical Treatment|surgical treatment
651012|NCT00824174|Oral Cavity Cancer|oral cavity cancer
651013|NCT00824174|Cutaneous Cancer|cutaneous cancer
651014|NCT00824148|Real-time glucose monitoring system|real-time glucose monitoring system
651015|NCT00824148|HbA1c|hba1c
651016|NCT00824148|Quality of life|quality of life
651017|NCT00824148|Hypoglycemia|hypoglycemia
651018|NCT00824135|Stem Cell Transplantation, Hematopoietic|stem cell transplantation, hematopoietic
651019|NCT00824135|Peripheral Blood Stem Cell Transplantation|peripheral blood stem cell transplantation
651020|NCT00824135|Maximal Tolerated Dose|maximal tolerated dose
651021|NCT00824135|Clofarabine|clofarabine
651022|NCT00824135|Hematological Malignancies|hematological malignancies
651023|NCT00824135|Apheresis|apheresis
651024|NCT00824109|Aneurysmal disease of the abdominal aorta|aneurysmal disease of the abdominal aorta
651025|NCT00824109|Occlusive disease of the abdominal aorta|occlusive disease of the abdominal aorta
651026|NCT00824096|endotracheal intubation|endotracheal intubation
651027|NCT00824096|cuff-leak test|cuff-leak test
651028|NCT00824096|post-extubation stridor|post-extubation stridor
651029|NCT00824096|bronchoscopy|bronchoscopy
651030|NCT00824096|corticosteroids|corticosteroids
651031|NCT00824096|Cuff-leak volume less than 24%|cuff-leak volume less than 24%
651032|NCT00824083|bone tumors|bone tumors
651033|NCT00824083|long-term function|long-term function
651034|NCT00824083|daily activity|daily activity
651035|NCT00824083|late sequelae|late sequelae
651036|NCT00824070|Bioavailability|bioavailability
651037|NCT00824057|Phase I|phase i
651038|NCT00824044|Major Depressive Disorder (MDD)|major depressive disorder (mdd)
651039|NCT00824044|Cognitive Behavioral Therapy (CBT)|cognitive behavioral therapy (cbt)
651040|NCT00824044|Escitalopram|escitalopram
651041|NCT00824044|Quantitative EEG (QEEG)|quantitative eeg (qeeg)
651042|NCT00824031|schizophrenia|schizophrenia
651043|NCT00824031|medical mental care|medical mental care
651044|NCT00824031|caregiver|caregiver
651045|NCT00824031|Sapin|sapin
651046|NCT00824005|Congestive Heart Failure|congestive heart failure
651047|NCT00824005|Regional Wall Motion|regional wall motion
651048|NCT00824005|Perfusion Defects|perfusion defects
651049|NCT00823979|HIV-1 NNRTI Treatment Experienced|hiv-1 nnrti treatment experienced
651050|NCT00823979|may have Protease inhibitor experience|may have protease inhibitor experience
651051|NCT00823953|diabetes type 2|diabetes type 2
651052|NCT00823940|FTIH|ftih
651053|NCT00823940|Glucagon|glucagon
651054|NCT00823940|Safety|safety
651055|NCT00823940|GSK1362885|gsk1362885
651056|NCT00823940|Pharmacokinetics|pharmacokinetics
651057|NCT00823940|Tolerability|tolerability
651058|NCT00823940|Pharmacodynamics|pharmacodynamics
651059|NCT00823927|lung damage|lung damage
651060|NCT00823927|cigarette smoking|cigarette smoking
651061|NCT00823927|HIV-seropositive|hiv-seropositive
651062|NCT00823927|emphysema|emphysema
651063|NCT00823914|Psoriasis|psoriasis
651064|NCT00823914|Quality of Life|quality of life
651065|NCT00823901|rosacea|rosacea
651066|NCT00823901|clindamycin|clindamycin
651067|NCT00823901|tretinoin|tretinoin
651068|NCT00823901|clinical study|clinical study
651069|NCT00823901|treatment|treatment
651070|NCT00823888|Knee Osteoarthritis|knee osteoarthritis
651071|NCT00823888|pneumatic bracing|pneumatic bracing
651072|NCT00823862|HCV|hcv
651073|NCT00823862|Immunostimulatory sequence (ISS)|immunostimulatory sequence (iss)
651074|NCT00823862|TLR9 (toll-like receptor 9)|tlr9 (toll-like receptor 9)
651075|NCT00823862|interferon (IFN)|interferon (ifn)
651076|NCT00823862|ribavirin|ribavirin
651077|NCT00823849|type 2 diabetes mellitus, with Arteriosclerosis obliterans|type 2 diabetes mellitus, with arteriosclerosis obliterans
651078|NCT00823836|Ropinirole, advanced Parkinson's disease, L-dopa adjunctive therapy|ropinirole, advanced parkinson's disease, l-dopa adjunctive therapy
651079|NCT00823823|Casting techniques|casting techniques
651080|NCT00823823|Bivalved cast|bivalved cast
651081|NCT00823823|Circumferential cast|circumferential cast
651082|NCT00823823|Displaced distal radius fracture|displaced distal radius fracture
651083|NCT00823823|Children|children
651084|NCT00823810|Colorectal cancer|colorectal cancer
651085|NCT00823810|Response to treatment|response to treatment
651086|NCT00823810|FDG PET/CT|fdg pet/ct
651087|NCT00823784|hemorrhoids|hemorrhoids
651088|NCT00823784|stapler|stapler
651089|NCT00823784|Doppler|doppler
651090|NCT00823784|artery ligation|artery ligation
651091|NCT00823784|outcome|outcome
651092|NCT00823784|recurrence|recurrence
651093|NCT00823758|Acetaminophen|acetaminophen
651094|NCT00823758|Liver|liver
651095|NCT00823758|Centers for Education and Research on Therapeutics|centers for education and research on therapeutics
651096|NCT00823758|CERTS|certs
651097|NCT00823758|Over-the-counter Acetaminophen|over-the-counter acetaminophen
651098|NCT00823758|OTC|otc
651099|NCT00823758|Self-administration|self-administration
651100|NCT00823758|Parental administration|parental administration
651101|NCT00823758|Houston|houston
651102|NCT00823758|Texas|texas
651103|NCT00823758|Liver toxicity|liver toxicity
651104|NCT00823758|Qualitative study|qualitative study
651105|NCT00823758|Pharmacists|pharmacists
651106|NCT00823758|Adolescents|adolescents
651107|NCT00823758|Primary care physicians|primary care physicians
651108|NCT00823758|Family Practitioners|family practitioners
651109|NCT00823758|General Internist|general internist
651110|NCT00823732|stage IIIB non-small cell lung cancer|stage iiib non-small cell lung cancer
651111|NCT00823732|stage IV non-small cell lung cancer|stage iv non-small cell lung cancer
651112|NCT00823732|recurrent non-small cell lung cancer|recurrent non-small cell lung cancer
651113|NCT00823719|Salvage chemotherapy|salvage chemotherapy
651114|NCT00823719|relapsed|relapsed
651115|NCT00823719|grade 3B follicular lymphoma|grade 3b follicular lymphoma
651116|NCT00823719|efficacy|efficacy
651117|NCT00823719|safety|safety
651118|NCT00823719|DHAP|dhap
651119|NCT00823719|ofatumumab|ofatumumab
651120|NCT00823719|refractory|refractory
651121|NCT00823719|Non-Hodgkin's Lymphoma|non-hodgkin's lymphoma
651122|NCT00823719|Diffuse Large B Cell Lymphoma (DLBCL)|diffuse large b cell lymphoma (dlbcl)
651123|NCT00823719|Oncology|oncology
651124|NCT00823719|ICE|ice
651125|NCT00823719|Transformed follicular lymphoma|transformed follicular lymphoma
651126|NCT00823706|chronic angle closure hyperopia|chronic angle closure hyperopia
651127|NCT00823667|stage I non-small cell lung cancer|stage i non-small cell lung cancer
651128|NCT00823667|stage II non-small cell lung cancer|stage ii non-small cell lung cancer
651129|NCT00823667|stage IIIA non-small cell lung cancer|stage iiia non-small cell lung cancer
651131|NCT00823654|Questionaires|questionaires
651132|NCT00823654|Blood draw|blood draw
651133|NCT00823654|BRCA1|brca1
651134|NCT00823654|BRCA2|brca2
651135|NCT00823654|08-156|08-156
651136|NCT00823641|HAM/TSP|ham/tsp
651137|NCT00823641|HTLV-I|htlv-i
651138|NCT00823602|GnRH antagonist|gnrh antagonist
651139|NCT00823602|GnRH agonist|gnrh agonist
651140|NCT00823602|pregnancy rate|pregnancy rate
651141|NCT00823602|Ovarian stimulation|ovarian stimulation
651142|NCT00823589|ELDERLY POPULATION|elderly population
651143|NCT00823576|Arthodeses rachis lombar|arthodeses rachis lombar
651144|NCT00823576|Spinal Surgery|spinal surgery
651145|NCT00823550|Chronic hepatitis B|chronic hepatitis b
651146|NCT00823550|Advanced fibrosis|advanced fibrosis
651147|NCT00823550|Lamivudine|lamivudine
651148|NCT00823550|Entecavir|entecavir
711012|NCT00586859|Gastroesophageal Reflux Disease (GERD)|gastroesophageal reflux disease (gerd)
651149|NCT00823524|accelerated phase chronic myelogenous leukemia|accelerated phase chronic myelogenous leukemia
651150|NCT00823524|acute undifferentiated leukemia|acute undifferentiated leukemia
651151|NCT00823524|adult acute myeloid leukemia with 11q23 (MLL) abnormalities|adult acute myeloid leukemia with 11q23 (mll) abnormalities
651152|NCT00823524|adult acute myeloid leukemia with inv(16)(p13;q22)|adult acute myeloid leukemia with inv(16)(p13;q22)
651153|NCT00823524|adult acute myeloid leukemia with t(15;17)(q22;q12)|adult acute myeloid leukemia with t(15;17)(q22;q12)
651154|NCT00823524|adult acute myeloid leukemia with t(16;16)(p13;q22)|adult acute myeloid leukemia with t(16;16)(p13;q22)
651155|NCT00823524|adult acute myeloid leukemia with t(8;21)(q22;q22)|adult acute myeloid leukemia with t(8;21)(q22;q22)
651156|NCT00823524|atypical chronic myeloid leukemia, BCR-ABL1 negative|atypical chronic myeloid leukemia, bcr-abl1 negative
651157|NCT00823524|blastic phase chronic myelogenous leukemia|blastic phase chronic myelogenous leukemia
651158|NCT00823524|chronic myelomonocytic leukemia|chronic myelomonocytic leukemia
651159|NCT00823524|chronic phase chronic myelogenous leukemia|chronic phase chronic myelogenous leukemia
651160|NCT00823524|mast cell leukemia|mast cell leukemia
651161|NCT00823524|meningeal chronic myelogenous leukemia|meningeal chronic myelogenous leukemia
651162|NCT00823524|progressive hairy cell leukemia, initial treatment|progressive hairy cell leukemia, initial treatment
651163|NCT00823524|prolymphocytic leukemia|prolymphocytic leukemia
651164|NCT00823524|recurrent adult acute lymphoblastic leukemia|recurrent adult acute lymphoblastic leukemia
651165|NCT00823524|recurrent adult acute myeloid leukemia|recurrent adult acute myeloid leukemia
651166|NCT00823524|recurrent adult T-cell leukemia/lymphoma|recurrent adult t-cell leukemia/lymphoma
651167|NCT00823524|refractory chronic lymphocytic leukemia|refractory chronic lymphocytic leukemia
651168|NCT00823524|refractory hairy cell leukemia|refractory hairy cell leukemia
651169|NCT00823524|relapsing chronic myelogenous leukemia|relapsing chronic myelogenous leukemia
651170|NCT00823524|secondary acute myeloid leukemia|secondary acute myeloid leukemia
651171|NCT00823524|stage III adult T-cell leukemia/lymphoma|stage iii adult t-cell leukemia/lymphoma
651172|NCT00823524|stage III chronic lymphocytic leukemia|stage iii chronic lymphocytic leukemia
651173|NCT00823524|stage IV adult T-cell leukemia/lymphoma|stage iv adult t-cell leukemia/lymphoma
651174|NCT00823524|stage IV chronic lymphocytic leukemia|stage iv chronic lymphocytic leukemia
651175|NCT00823524|T-cell large granular lymphocyte leukemia|t-cell large granular lymphocyte leukemia
651176|NCT00823524|adult grade III lymphomatoid granulomatosis|adult grade iii lymphomatoid granulomatosis
651177|NCT00823524|adult nasal type extranodal NK/T-cell lymphoma|adult nasal type extranodal nk/t-cell lymphoma
651178|NCT00823524|anaplastic large cell lymphoma|anaplastic large cell lymphoma
651179|NCT00823524|angioimmunoblastic T-cell lymphoma|angioimmunoblastic t-cell lymphoma
651180|NCT00823524|splenic marginal zone lymphoma|splenic marginal zone lymphoma
651181|NCT00823524|extranodal marginal zone B-cell lymphoma of mucosa-associated lymphoid tissue|extranodal marginal zone b-cell lymphoma of mucosa-associated lymphoid tissue
651182|NCT00823524|nodal marginal zone B-cell lymphoma|nodal marginal zone b-cell lymphoma
651183|NCT00823524|stage III adult Burkitt lymphoma|stage iii adult burkitt lymphoma
651184|NCT00823524|stage III adult diffuse large cell lymphoma|stage iii adult diffuse large cell lymphoma
651185|NCT00823524|stage III adult diffuse mixed cell lymphoma|stage iii adult diffuse mixed cell lymphoma
651186|NCT00823524|stage III adult diffuse small cleaved cell lymphoma|stage iii adult diffuse small cleaved cell lymphoma
651187|NCT00823524|stage III adult Hodgkin lymphoma|stage iii adult hodgkin lymphoma
651188|NCT00823524|stage III adult immunoblastic large cell lymphoma|stage iii adult immunoblastic large cell lymphoma
651189|NCT00823524|stage III adult lymphoblastic lymphoma|stage iii adult lymphoblastic lymphoma
651190|NCT00823524|stage III cutaneous T-cell non-Hodgkin lymphoma|stage iii cutaneous t-cell non-hodgkin lymphoma
651191|NCT00823524|stage III mycosis fungoides/Sezary syndrome|stage iii mycosis fungoides/sezary syndrome
651192|NCT00823524|stage III grade 1 follicular lymphoma|stage iii grade 1 follicular lymphoma
651193|NCT00823524|stage III grade 2 follicular lymphoma|stage iii grade 2 follicular lymphoma
651194|NCT00823524|stage III grade 3 follicular lymphoma|stage iii grade 3 follicular lymphoma
651195|NCT00823524|stage III mantle cell lymphoma|stage iii mantle cell lymphoma
651196|NCT00823524|stage III marginal zone lymphoma|stage iii marginal zone lymphoma
651197|NCT00823524|stage III small lymphocytic lymphoma|stage iii small lymphocytic lymphoma
651198|NCT00823524|stage IV adult Burkitt lymphoma|stage iv adult burkitt lymphoma
651199|NCT00823524|stage IV adult diffuse large cell lymphoma|stage iv adult diffuse large cell lymphoma
651200|NCT00823524|stage IV adult diffuse mixed cell lymphoma|stage iv adult diffuse mixed cell lymphoma
651201|NCT00823524|stage IV adult diffuse small cleaved cell lymphoma|stage iv adult diffuse small cleaved cell lymphoma
651202|NCT00823524|stage IV adult Hodgkin lymphoma|stage iv adult hodgkin lymphoma
651203|NCT00823524|stage IV adult immunoblastic large cell lymphoma|stage iv adult immunoblastic large cell lymphoma
651204|NCT00823524|stage IV adult lymphoblastic lymphoma|stage iv adult lymphoblastic lymphoma
651205|NCT00823524|stage IV cutaneous T-cell non-Hodgkin lymphoma|stage iv cutaneous t-cell non-hodgkin lymphoma
651206|NCT00823524|stage IV mycosis fungoides/Sezary syndrome|stage iv mycosis fungoides/sezary syndrome
651207|NCT00823524|stage IV grade 1 follicular lymphoma|stage iv grade 1 follicular lymphoma
651208|NCT00823524|stage IV grade 2 follicular lymphoma|stage iv grade 2 follicular lymphoma
651209|NCT00823524|stage IV grade 3 follicular lymphoma|stage iv grade 3 follicular lymphoma
651210|NCT00823524|stage IV mantle cell lymphoma|stage iv mantle cell lymphoma
651211|NCT00823524|stage IV marginal zone lymphoma|stage iv marginal zone lymphoma
651212|NCT00823524|stage IV small lymphocytic lymphoma|stage iv small lymphocytic lymphoma
651213|NCT00823524|recurrent adult Hodgkin lymphoma|recurrent adult hodgkin lymphoma
651214|NCT00823524|recurrent adult Burkitt lymphoma|recurrent adult burkitt lymphoma
651215|NCT00823524|recurrent adult diffuse large cell lymphoma|recurrent adult diffuse large cell lymphoma
651216|NCT00823524|recurrent adult diffuse mixed cell lymphoma|recurrent adult diffuse mixed cell lymphoma
651217|NCT00823524|recurrent adult diffuse small cleaved cell lymphoma|recurrent adult diffuse small cleaved cell lymphoma
651218|NCT00823524|recurrent adult grade III lymphomatoid granulomatosis|recurrent adult grade iii lymphomatoid granulomatosis
651219|NCT00823524|recurrent adult immunoblastic large cell lymphoma|recurrent adult immunoblastic large cell lymphoma
651220|NCT00823524|recurrent adult lymphoblastic lymphoma|recurrent adult lymphoblastic lymphoma
651221|NCT00823524|recurrent cutaneous T-cell non-Hodgkin lymphoma|recurrent cutaneous t-cell non-hodgkin lymphoma
651222|NCT00823524|recurrent mycosis fungoides/Sezary syndrome|recurrent mycosis fungoides/sezary syndrome
651223|NCT00823524|recurrent grade 1 follicular lymphoma|recurrent grade 1 follicular lymphoma
651224|NCT00823524|recurrent grade 2 follicular lymphoma|recurrent grade 2 follicular lymphoma
651225|NCT00823524|recurrent grade 3 follicular lymphoma|recurrent grade 3 follicular lymphoma
651226|NCT00823524|recurrent mantle cell lymphoma|recurrent mantle cell lymphoma
651227|NCT00823524|recurrent marginal zone lymphoma|recurrent marginal zone lymphoma
651228|NCT00823524|recurrent small lymphocytic lymphoma|recurrent small lymphocytic lymphoma
651229|NCT00823524|intraocular lymphoma|intraocular lymphoma
651230|NCT00823524|primary central nervous system non-Hodgkin lymphoma|primary central nervous system non-hodgkin lymphoma
651231|NCT00823524|primary central nervous system Hodgkin lymphoma|primary central nervous system hodgkin lymphoma
651232|NCT00823524|post-transplant lymphoproliferative disorder|post-transplant lymphoproliferative disorder
651233|NCT00823524|chronic eosinophilic leukemia|chronic eosinophilic leukemia
651234|NCT00823524|chronic neutrophilic leukemia|chronic neutrophilic leukemia
651235|NCT00823524|primary myelofibrosis|primary myelofibrosis
651236|NCT00823524|essential thrombocythemia|essential thrombocythemia
651237|NCT00823524|polycythemia vera|polycythemia vera
651238|NCT00823524|extramedullary plasmacytoma|extramedullary plasmacytoma
651239|NCT00823524|isolated plasmacytoma of bone|isolated plasmacytoma of bone
651240|NCT00823524|stage II multiple myeloma|stage ii multiple myeloma
651241|NCT00823524|stage III multiple myeloma|stage iii multiple myeloma
651242|NCT00823524|primary systemic amyloidosis|primary systemic amyloidosis
651243|NCT00823524|refractory multiple myeloma|refractory multiple myeloma
651244|NCT00823524|de novo myelodysplastic syndromes|de novo myelodysplastic syndromes
651245|NCT00823524|previously treated myelodysplastic syndromes|previously treated myelodysplastic syndromes
651246|NCT00823524|secondary myelodysplastic syndromes|secondary myelodysplastic syndromes
651247|NCT00823524|myelodysplastic/myeloproliferative neoplasm, unclassifiable|myelodysplastic/myeloproliferative neoplasm, unclassifiable
651248|NCT00823524|cutaneous B-cell non-Hodgkin lymphoma|cutaneous b-cell non-hodgkin lymphoma
651249|NCT00823524|Waldenström macroglobulinemia|waldenström macroglobulinemia
651250|NCT00823524|unspecified adult solid tumor, protocol specific|unspecified adult solid tumor, protocol specific
651251|NCT00823511|HPV|hpv
651252|NCT00823511|Human Papillomavirus Infection|human papillomavirus infection
651253|NCT00823511|Cervix Uteri|cervix uteri
651254|NCT00823511|Cancer Control|cancer control
651255|NCT00823511|Risk Assessment, Detection & Intervention|risk assessment, detection & intervention
651256|NCT00823511|Sexually Transmitted|sexually transmitted
651257|NCT00823511|Neoplasia|neoplasia
651258|NCT00823511|Carcinogenesis|carcinogenesis
651259|NCT00823511|Cervix|cervix
651260|NCT00823498|Cancer Prevention|cancer prevention
651261|NCT00823498|African American|african american
651262|NCT00823498|African American Parents|african american parents
651263|NCT00823498|African American Youth|african american youth
651264|NCT00823498|Public Housing|public housing
651265|NCT00823498|Physical Activity|physical activity
651266|NCT00823498|Focus Groups|focus groups
651267|NCT00823498|Housing Developments|housing developments
651268|NCT00823498|Houston Public Housing|houston public housing
651269|NCT00823498|Photovoice Project|photovoice project
651270|NCT00823498|Prevention|prevention
651271|NCT00823472|embryonic structures|embryonic structures
651272|NCT00823472|sperm injections, intracytoplasmic|sperm injections, intracytoplasmic
651273|NCT00823472|IVF|ivf
651274|NCT00823472|GnRH antagonist|gnrh antagonist
651275|NCT00823472|ovarian stimulation|ovarian stimulation
651276|NCT00823472|cycle day 2 versus cycle day 5|cycle day 2 versus cycle day 5
651277|NCT00823433|Penicillin|penicillin
651278|NCT00823433|Group B Streptococcus|group b streptococcus
651279|NCT00823433|Pregnancy|pregnancy
651280|NCT00823433|Labor|labor
651281|NCT00823420|PCOS and normal ovulatory patients|pcos and normal ovulatory patients
651282|NCT00823420|aneuploidy|aneuploidy
651283|NCT00823420|in-vitro maturation of oocytes|in-vitro maturation of oocytes
651284|NCT00823407|MDA|mda
651285|NCT00823407|MDMA|mdma
651286|NCT00823407|Ecstasy|ecstasy
651287|NCT00823407|entactogen|entactogen
651288|NCT00823407|pharmacokinetics|pharmacokinetics
651289|NCT00823407|pharmacodynamics|pharmacodynamics
651290|NCT00823407|Pharmacokinetics and pharmacodynamics of MDA studies in healthy volunteers|pharmacokinetics and pharmacodynamics of mda studies in healthy volunteers
651291|NCT00823394|African American|african american
651292|NCT00823394|Adults|adults
651293|NCT00823394|African American Cancer Prevention Project|african american cancer prevention project
651294|NCT00823394|Health Disparities|health disparities
651295|NCT00823394|Questionnaire|questionnaire
651296|NCT00823394|Body Measurements|body measurements
651297|NCT00823394|Self-help|self-help
651298|NCT00823394|Cancer Rates|cancer rates
651299|NCT00823394|Prevention|prevention
651300|NCT00823381|obesity|obesity
651301|NCT00823381|metabolic syndrome|metabolic syndrome
651302|NCT00823381|diabetes|diabetes
651303|NCT00823381|aging|aging
651304|NCT00823381|calorie restriction|calorie restriction
651305|NCT00823381|resveratrol|resveratrol
651306|NCT00823381|antioxidant|antioxidant
651307|NCT00823368|fragile X syndrome|fragile x syndrome
651308|NCT00823368|biomarkers|biomarkers
651309|NCT00823342|HBe, Hepatitis, Vireda (TENOFOVIR, CLEVUDINE), HBV, HBe Ag negative|hbe, hepatitis, vireda (tenofovir, clevudine), hbv, hbe ag negative
651310|NCT00823329|measurement of energy expenditure of physical activity|measurement of energy expenditure of physical activity
651311|NCT00823329|analysis of body composition and hydration status|analysis of body composition and hydration status
651312|NCT00823316|Mesenchymal Stem Cells|mesenchymal stem cells
651313|NCT00823316|Allogeneic Transplantation|allogeneic transplantation
651314|NCT00823316|Engraftment|engraftment
651315|NCT00823316|GvHD|gvhd
651316|NCT00823316|Childhood|childhood
651317|NCT00823316|unrelated HSCT|unrelated hsct
651318|NCT00823303|PTH|pth
651319|NCT00823303|Active Vitamin D|active vitamin d
651320|NCT00823303|hypercalcemia|hypercalcemia
651321|NCT00823303|Chronic Kidney Disease|chronic kidney disease
651323|NCT00823290|sorafenib|sorafenib
651324|NCT00823290|HDAC|hdac
651325|NCT00823290|LBH589|lbh589
651326|NCT00823290|Panobinostat|panobinostat
651327|NCT00823264|Anticonvulsants|anticonvulsants
651328|NCT00823264|Toxicology|toxicology
651329|NCT00823264|multidose charcoal|multidose charcoal
651330|NCT00823264|phenytoin|phenytoin
651331|NCT00823225|Diabetes|diabetes
651332|NCT00823225|urokinase|urokinase
651333|NCT00823225|ulcer healing|ulcer healing
651334|NCT00823225|major amputation|major amputation
651335|NCT00823225|survival|survival
651336|NCT00823212|drug-eluting stents|drug-eluting stents
651337|NCT00823212|DES|des
651338|NCT00823212|atherosclerotic|atherosclerotic
651339|NCT00823186|cervical carcinoma|cervical carcinoma
651340|NCT00823186|neoadjuvant chemotherapy|neoadjuvant chemotherapy
651341|NCT00823173|Uveitis|uveitis
651342|NCT00823173|TNF-alpha|tnf-alpha
651343|NCT00823173|Topical|topical
651344|NCT00823173|ESBA105|esba105
651345|NCT00823173|scFv antibody fragment|scfv antibody fragment
651346|NCT00823173|ocular inflammation|ocular inflammation
651347|NCT00823160|Pericardial window|pericardial window
651348|NCT00823160|Sternotomy|sternotomy
651349|NCT00823160|Haemopericardium|haemopericardium
651350|NCT00823147|Pain|pain
651351|NCT00823147|Systemic Inflammation|systemic inflammation
651352|NCT00823147|Pain Catastrophizing|pain catastrophizing
651353|NCT00823121|Fresh embryo transfer|fresh embryo transfer
651354|NCT00823121|frozen- thawed embryo transfer|frozen- thawed embryo transfer
651355|NCT00823121|vitrification|vitrification
651356|NCT00823121|endometrial receptivity|endometrial receptivity
651357|NCT00823121|implantation rate|implantation rate
651358|NCT00823121|pregnancy|pregnancy
651359|NCT00823121|ART|art
651360|NCT00823108|GIK, septic shock, sepsis|gik, septic shock, sepsis
651361|NCT00823095|chronic cutaneous ulcers|chronic cutaneous ulcers
651362|NCT00823095|Nitric Oxide|nitric oxide
651363|NCT00823095|topically applied|topically applied
651364|NCT00823095|Biofilm|biofilm
651365|NCT00823095|Colonized chronic non-healing ulcers|colonized chronic non-healing ulcers
651366|NCT00823082|antithrombin|antithrombin
651367|NCT00823082|ATIII|atiii
651368|NCT00823082|acquired deficiency|acquired deficiency
651369|NCT00823082|anticoagulants|anticoagulants
651370|NCT00823082|cardiopulmonary bypass|cardiopulmonary bypass
651371|NCT00823082|surgery|surgery
651372|NCT00823082|complications|complications
651373|NCT00823082|postoperative outcomes|postoperative outcomes
651374|NCT00823069|Correction of Nasolabial Folds|correction of nasolabial folds
651375|NCT00823056|Probiotics|probiotics
651376|NCT00823056|Infections|infections
651377|NCT00823056|Children|children
651479|NCT00822731|Lymphoma|lymphoma
651378|NCT00823030|Interstitial Cystitis|interstitial cystitis
651379|NCT00823030|Intravesical Lidocaine|intravesical lidocaine
651380|NCT00823017|ICU environment|icu environment
651381|NCT00823017|Auditory stimulation|auditory stimulation
651382|NCT00823017|Properties of relaxation music|properties of relaxation music
651383|NCT00823017|music|music
651384|NCT00823017|music therapy|music therapy
651385|NCT00823017|pain|pain
651386|NCT00823017|anxiety|anxiety
651387|NCT00823017|cortisol|cortisol
651389|NCT00823017|biomarkers|biomarkers
651390|NCT00823017|relaxation music|relaxation music
651391|NCT00823004|controlled ovarian hyperstimulation|controlled ovarian hyperstimulation
651392|NCT00823004|pregnancy rate|pregnancy rate
651393|NCT00823004|Poor responders|poor responders
651394|NCT00823004|GnRH antagonist|gnrh antagonist
651395|NCT00823004|GnRH agonist|gnrh agonist
651396|NCT00823004|letrozole|letrozole
651397|NCT00823004|in vitro fertilization|in vitro fertilization
651398|NCT00822991|Sonazoid|sonazoid
651399|NCT00822991|Early detection|early detection
651400|NCT00822991|Hepatocellular carcinoma|hepatocellular carcinoma
651401|NCT00822991|Liver cirrhosis|liver cirrhosis
651402|NCT00822978|healthy|healthy
651403|NCT00822978|volunteers|volunteers
651404|NCT00822978|subjects|subjects
651405|NCT00822965|Pacemakers|pacemakers
651406|NCT00822965|PM|pm
651407|NCT00822965|Implantable cardioverter-defibrillators|implantable cardioverter-defibrillators
651408|NCT00822965|ICD|icd
651409|NCT00822965|Implantable pulse generators|implantable pulse generators
651410|NCT00822965|Educational Interventions|educational interventions
651411|NCT00822913|Botulinum A toxin|botulinum a toxin
651412|NCT00822913|Parkinson's disease|parkinson's disease
651413|NCT00822900|Trauma|trauma
651414|NCT00822900|Brain Injury|brain injury
651415|NCT00822887|malignant|malignant
651416|NCT00822887|gliomas|gliomas
651417|NCT00822874|PCOS and normal ovulatory patients|pcos and normal ovulatory patients
651418|NCT00822874|aneuploidy|aneuploidy
651419|NCT00822874|in-vitro maturation of oocytes|in-vitro maturation of oocytes
651420|NCT00822848|stage II adult soft tissue sarcoma|stage ii adult soft tissue sarcoma
651421|NCT00822848|stage III adult soft tissue sarcoma|stage iii adult soft tissue sarcoma
651422|NCT00822822|Questionnaire|questionnaire
651423|NCT00822822|Electronic Health History|electronic health history
651424|NCT00822809|Cancer|cancer
651425|NCT00822809|Neoplasms|neoplasms
651426|NCT00822809|Carcinoma|carcinoma
651427|NCT00822809|Malignant Ascites|malignant ascites
651428|NCT00822809|Drug therapy|drug therapy
651429|NCT00822809|Antineoplastic Protocols|antineoplastic protocols
651430|NCT00822809|Immunotherapy|immunotherapy
651431|NCT00822809|Phase III|phase iii
651432|NCT00822809|trifunctional antibody|trifunctional antibody
651433|NCT00822809|monoclonal antibody|monoclonal antibody
651434|NCT00822809|EpCAM|epcam
651435|NCT00822796|Hypothermia|hypothermia
651436|NCT00822796|Severe burns|severe burns
651437|NCT00822796|Warming catheter|warming catheter
651438|NCT00822796|Thermogard™|thermogard™
651439|NCT00822796|Coagulopathy|coagulopathy
651440|NCT00822783|Serum IgE levels|serum ige levels
651441|NCT00822783|inflammatory cells in the skin|inflammatory cells in the skin
651442|NCT00822783|inflammatory cells in the blood|inflammatory cells in the blood
651443|NCT00822783|IgE|ige
651444|NCT00822783|IgE depletion|ige depletion
651445|NCT00822783|atopic dermatitis|atopic dermatitis
651446|NCT00822783|atopic eczema|atopic eczema
651447|NCT00822783|Omalizumab|omalizumab
651448|NCT00822770|Blood Stem Cell Transplantation|blood stem cell transplantation
651449|NCT00822770|Bone Marrow Transplantation|bone marrow transplantation
651450|NCT00822770|Bone Marrow Cell Transplantation|bone marrow cell transplantation
651451|NCT00822770|Stem Cell Transplantation|stem cell transplantation
651452|NCT00822770|Allogeneic Hematopoietic Transplantation|allogeneic hematopoietic transplantation
651453|NCT00822770|Advanced Myeloid Leukemia|advanced myeloid leukemia
651454|NCT00822770|Acute Myeloid Leukemia|acute myeloid leukemia
651455|NCT00822770|AML|aml
651456|NCT00822770|Myelodysplastic syndrome|myelodysplastic syndrome
651457|NCT00822770|MDS|mds
651458|NCT00822770|Chronic Myeloid Leukemia|chronic myeloid leukemia
651459|NCT00822770|CML|cml
651460|NCT00822770|Graft Versus Host Disease|graft versus host disease
651461|NCT00822770|GVHD|gvhd
651462|NCT00822770|ATG|atg
651463|NCT00822770|Busulfan|busulfan
651464|NCT00822770|Busulfex™|busulfex™
651465|NCT00822770|Myleran®|myleran®
651466|NCT00822770|Filgrastim|filgrastim
651467|NCT00822770|Neupogen|neupogen
651468|NCT00822770|Fludarabine|fludarabine
651469|NCT00822770|Fludarabine Phosphate|fludarabine phosphate
651470|NCT00822770|Fludara™|fludara™
651471|NCT00822770|G-CSF|g-csf
651472|NCT00822770|Plerixafor|plerixafor
651473|NCT00822770|Antithymocyte globulin|antithymocyte globulin
651474|NCT00822770|Thymoglobulin|thymoglobulin
651475|NCT00822757|study in healthy subjects|study in healthy subjects
651476|NCT00822744|Depression|depression
651477|NCT00822744|Major Depressive Episode|major depressive episode
651478|NCT00822744|Antidepressant|antidepressant
651480|NCT00822731|prognosis|prognosis
651481|NCT00822731|morbidity|morbidity
651482|NCT00822718|obestatin|obestatin
651483|NCT00822718|ghrelin|ghrelin
651484|NCT00822718|stomach cancer|stomach cancer
651485|NCT00822718|distal gastrectomy|distal gastrectomy
651486|NCT00822705|Appetite, energy consumption, gastrointestinal hormones|appetite, energy consumption, gastrointestinal hormones
651487|NCT00822692|Abscess|abscess
651488|NCT00822692|Cellulitis|cellulitis
830380|NCT00114504|PET|pet
651489|NCT00822692|Antibiotics|antibiotics
651490|NCT00822692|MRSA|mrsa
651491|NCT00822679|Acute Coronary Syndrome|acute coronary syndrome
651492|NCT00822679|cytokines|cytokines
651493|NCT00822679|pro-coagulant mediators|pro-coagulant mediators
651494|NCT00822679|sleep disorders|sleep disorders
651495|NCT00822666|Platelet aggregation|platelet aggregation
651496|NCT00822666|Platelet|platelet
651497|NCT00822666|Thrombosis|thrombosis
651498|NCT00822666|Clopidogrel|clopidogrel
651499|NCT00822653|hemodialysis treatment|hemodialysis treatment
651500|NCT00822653|pump stimulation|pump stimulation
651501|NCT00822653|reduce hypotensive episodes|reduce hypotensive episodes
651502|NCT00822640|Prosthesis Design|prosthesis design
651503|NCT00822640|Range of Motion, Articular|range of motion, articular
651504|NCT00822640|Arthroplasty, Replacement, Knee|arthroplasty, replacement, knee
651505|NCT00822627|Influenza|influenza
651506|NCT00822627|vaccination|vaccination
651507|NCT00822627|Emergency Department|emergency department
651508|NCT00822614|Pain|pain
651509|NCT00822601|Repetitive Transcranial Magnetic Stimulation|repetitive transcranial magnetic stimulation
651510|NCT00822601|Supplementary Motor Area|supplementary motor area
651511|NCT00822601|Obsessive-Compulsive Disorder|obsessive-compulsive disorder
651512|NCT00822601|Sham rTMS|sham rtms
651513|NCT00822601|Placebo-controlled|placebo-controlled
651514|NCT00822601|Randomized|randomized
651515|NCT00822601|Double-blind|double-blind
651516|NCT00822601|fMRI|fmri
651517|NCT00822601|DSM-IV Obsessive-Compulsive Disorder|dsm-iv obsessive-compulsive disorder
651518|NCT00822575|mosquito bites|mosquito bites
651519|NCT00822575|itching|itching
651520|NCT00822562|hepatocellular carcinoma|hepatocellular carcinoma
651521|NCT00822562|surgery|surgery
651522|NCT00822549|Morphine titration|morphine titration
651523|NCT00822549|Sub acute pain|sub acute pain
651524|NCT00822549|Major orthopaedic surgery|major orthopaedic surgery
651525|NCT00822549|Pharmacokinetics|pharmacokinetics
651526|NCT00822549|Pharmacodynamics|pharmacodynamics
651527|NCT00822549|Genetic polymorphism|genetic polymorphism
651528|NCT00822549|PACU|pacu
651529|NCT00822549|Patients undergoing major scheduled orthopaedic surgery|patients undergoing major scheduled orthopaedic surgery
651530|NCT00822536|Drug-eluting stent|drug-eluting stent
651531|NCT00822536|Clopidogrel|clopidogrel
651532|NCT00822536|Stent thrombosis|stent thrombosis
651533|NCT00822536|Myocardial infarction|myocardial infarction
651534|NCT00822510|Psychosocial Intervention|psychosocial intervention
651535|NCT00822510|Men with Prostate Cancer & Partners|men with prostate cancer & partners
651536|NCT00822497|music therapy|music therapy
651537|NCT00822497|pain|pain
651538|NCT00822497|anxiety|anxiety
651539|NCT00822497|muscle tension|muscle tension
651540|NCT00822471|Diabetes|diabetes
651541|NCT00822471|Self-Management Education|self-management education
651542|NCT00822471|Library|library
651543|NCT00822471|Emergency Department Visits|emergency department visits
651544|NCT00822471|African American|african american
651545|NCT00822471|CVD prevention|cvd prevention
651546|NCT00822471|Prevention|prevention
651547|NCT00822471|Uncontrolled diabetes|uncontrolled diabetes
651548|NCT00822445|Biomarker|biomarker
651549|NCT00822445|S100 protein|s100 protein
651550|NCT00822445|Traumatic brain injury|traumatic brain injury
651551|NCT00822445|Craniocerebral tomodensitometry|craniocerebral tomodensitometry
651552|NCT00822445|Neurological sequelae|neurological sequelae
651553|NCT00822432|biomarkers|biomarkers
651554|NCT00822432|ABC transporters|abc transporters
651555|NCT00822432|MRP2|mrp2
651556|NCT00822432|MTX pharmacokinetics|mtx pharmacokinetics
651557|NCT00822419|sternotomy pain|sternotomy pain
651558|NCT00822406|allergy|allergy
651559|NCT00822406|rhinitis|rhinitis
651560|NCT00822406|homeopathy|homeopathy
651561|NCT00822406|double-blind|double-blind
651562|NCT00822393|Treosulfan|treosulfan
651563|NCT00822393|Busulfan|busulfan
651564|NCT00822393|Conditioning|conditioning
651565|NCT00822393|Allogeneic|allogeneic
651566|NCT00822393|Transplantation|transplantation
651567|NCT00822380|Anemia|anemia
651568|NCT00822380|Iron|iron
651569|NCT00822380|Children|children
651570|NCT00822380|Micronutrients|micronutrients
651571|NCT00822354|Secondary Raynaud's Phenomenon|secondary raynaud's phenomenon
651572|NCT00822328|Probiotics|probiotics
651573|NCT00822328|Lactobacillus|lactobacillus
651574|NCT00822328|Intestine|intestine
651575|NCT00822328|Flora|flora
651576|NCT00822315|HIV|hiv
651577|NCT00822315|Tuberculosis|tuberculosis
651578|NCT00822315|Pharmacokinetics|pharmacokinetics
651579|NCT00822315|Raltegravir|raltegravir
651580|NCT00822315|France|france
651581|NCT00822315|Brazil|brazil
651582|NCT00822315|treatment naive|treatment naive
651583|NCT00822302|atherosclerosis|atherosclerosis
651585|NCT00822302|ischaemia|ischaemia
651586|NCT00822289|radioactive iodine|radioactive iodine
651587|NCT00822289|Helicobacter pylori|helicobacter pylori
651588|NCT00822289|Thyroid diseases|thyroid diseases
651589|NCT00822289|CagA|caga
651590|NCT00822276|Methicillin-resistant Staphylococcus aureus|methicillin-resistant staphylococcus aureus
651591|NCT00822276|MRSA|mrsa
651592|NCT00822276|Methicillin-sensitive Staphylococcus aureus|methicillin-sensitive staphylococcus aureus
651593|NCT00822276|MSSA|mssa
651594|NCT00822276|Atopic Dermatitis|atopic dermatitis
651595|NCT00822276|Eczema Herpeticum|eczema herpeticum
651596|NCT00822263|mild traumatic brain injury|mild traumatic brain injury
651597|NCT00822263|anti-oxidant|anti-oxidant
651598|NCT00822263|early treatment|early treatment
651599|NCT00822224|acute pain|acute pain
651600|NCT00822224|MEOPA|meopa
651601|NCT00822224|Dementia|dementia
651602|NCT00822211|Diabetes Mellitus|diabetes mellitus
651603|NCT00822211|HbA1c reduction|hba1c reduction
651604|NCT00822211|vildagliptin|vildagliptin
651605|NCT00822211|add-on to metformin|add-on to metformin
651606|NCT00822211|Chinese patients|chinese patients
651607|NCT00822198|peripheral neuropathy|peripheral neuropathy
651608|NCT00822198|diabetes|diabetes
651609|NCT00822198|plantar vibration|plantar vibration
651610|NCT00822172|Peripheral Vascular Disease|peripheral vascular disease
651611|NCT00822172|Peripheral Arterial Disease|peripheral arterial disease
651612|NCT00822172|Intermittent Claudication|intermittent claudication
651613|NCT00822172|Peak Walking Time|peak walking time
651614|NCT00822172|Claudication Onset Time|claudication onset time
651615|NCT00822172|Cilostazol|cilostazol
651616|NCT00822172|Carnitine|carnitine
651617|NCT00822159|Fixation failure|fixation failure
651618|NCT00822159|Bone strength|bone strength
651619|NCT00822159|DensiProbe|densiprobe
651620|NCT00822146|CRT|crt
651621|NCT00822133|ketamine|ketamine
651622|NCT00822133|preemption|preemption
651623|NCT00822133|postoperative|postoperative
651624|NCT00822133|pain|pain
651625|NCT00822133|safety|safety
651626|NCT00822120|stage III adult Hodgkin lymphoma|stage iii adult hodgkin lymphoma
651627|NCT00822120|stage IV adult Hodgkin lymphoma|stage iv adult hodgkin lymphoma
651628|NCT00822120|adult lymphocyte depletion Hodgkin lymphoma|adult lymphocyte depletion hodgkin lymphoma
651629|NCT00822120|adult lymphocyte predominant Hodgkin lymphoma|adult lymphocyte predominant hodgkin lymphoma
651630|NCT00822120|adult mixed cellularity Hodgkin lymphoma|adult mixed cellularity hodgkin lymphoma
651631|NCT00822120|adult nodular sclerosis Hodgkin lymphoma|adult nodular sclerosis hodgkin lymphoma
651632|NCT00822120|HIV infection|hiv infection
651633|NCT00822107|Hypokalemia|hypokalemia
651634|NCT00822107|Bartter Syndrome|bartter syndrome
651635|NCT00822107|Salt Wasting|salt wasting
651636|NCT00822094|Acute|acute
651637|NCT00822094|Myeloid|myeloid
651638|NCT00822094|Leukemia|leukemia
651639|NCT00822094|Adult|adult
651640|NCT00822094|First|first
651641|NCT00822094|Relapse|relapse
651642|NCT00822094|AML|aml
651643|NCT00822094|Acute Myelogenous leukemia|acute myelogenous leukemia
651644|NCT00822094|Leukemia, Myeloid|leukemia, myeloid
651645|NCT00822094|Leukemia, Myeloid, Acute|leukemia, myeloid, acute
651646|NCT00822094|Acute myelocytic leukemia|acute myelocytic leukemia
651647|NCT00822068|stroke|stroke
651648|NCT00822068|aphasia|aphasia
651649|NCT00822068|rehabilitation|rehabilitation
651650|NCT00822068|transcranial direct current stimulation|transcranial direct current stimulation
651651|NCT00822068|intensive training|intensive training
651652|NCT00822068|chronic aphasia after stroke|chronic aphasia after stroke
651653|NCT00822042|Lipodystrophy|lipodystrophy
651654|NCT00822042|Adipokines|adipokines
651655|NCT00822042|Glucocorticoids|glucocorticoids
651656|NCT00822042|Patients with glucocorticoids|patients with glucocorticoids
651657|NCT00822016|Best Supportive Care|best supportive care
651658|NCT00822016|Protocol of Standard Practice|protocol of standard practice
651659|NCT00822016|Carcinoma of the Lung|carcinoma of the lung
651660|NCT00822003|GLP-1|glp-1
651661|NCT00822003|insulin|insulin
651662|NCT00822003|glucose|glucose
651663|NCT00821990|Failed after previous chemotherapy|failed after previous chemotherapy
651664|NCT00821977|Type 2 Diabetes|type 2 diabetes
651665|NCT00821977|Vildagliptin|vildagliptin
651666|NCT00821964|Breast Cancer|breast cancer
651667|NCT00821964|Stage IV|stage iv
651668|NCT00821964|cream|cream
651669|NCT00821964|topical|topical
651670|NCT00821938|Narrow QRS|narrow qrs
651671|NCT00821938|CRT|crt
651672|NCT00821925|osteoporosis|osteoporosis
651673|NCT00821899|diabetes type 1|diabetes type 1
651674|NCT00821899|bone marrow transplantation|bone marrow transplantation
651675|NCT00821886|Breast Cancer|breast cancer
651676|NCT00821886|Neoadjuvant|neoadjuvant
651677|NCT00821886|Ixabepilone|ixabepilone
651678|NCT00821886|Carboplatin|carboplatin
651679|NCT00821886|Trastuzumab|trastuzumab
651680|NCT00821873|Cartilage injury|cartilage injury
651681|NCT00821873|OATS|oats
651682|NCT00821873|Knee injury|knee injury
651683|NCT00821873|allograft|allograft
651684|NCT00821873|autograft|autograft
651685|NCT00821860|epithelial mesothelioma|epithelial mesothelioma
651686|NCT00821860|recurrent malignant mesothelioma|recurrent malignant mesothelioma
651687|NCT00821860|sarcomatous mesothelioma|sarcomatous mesothelioma
651688|NCT00821860|malignant pleural effusion|malignant pleural effusion
651689|NCT00821860|stage IA malignant mesothelioma|stage ia malignant mesothelioma
651690|NCT00821860|stage IB malignant mesothelioma|stage ib malignant mesothelioma
651691|NCT00821860|stage II malignant mesothelioma|stage ii malignant mesothelioma
651692|NCT00821860|stage III malignant mesothelioma|stage iii malignant mesothelioma
651693|NCT00821860|stage IV malignant mesothelioma|stage iv malignant mesothelioma
651694|NCT00821847|HIV|hiv
651695|NCT00821847|glomerular filtration rate|glomerular filtration rate
651696|NCT00821847|cockcroft|cockcroft
651697|NCT00821847|MDRD formula|mdrd formula
651698|NCT00821847|creatinine|creatinine
651699|NCT00821847|cystatin C|cystatin c
651700|NCT00821847|isotopic clearance|isotopic clearance
651701|NCT00821847|EDTA-51Cr|edta-51cr
651702|NCT00821847|DEXA scan|dexa scan
651703|NCT00821834|Old Myocardial infarction|old myocardial infarction
651704|NCT00821834|Platelet Aggregation Inhibitors|platelet aggregation inhibitors
651705|NCT00821834|Angioplasty|angioplasty
651706|NCT00821834|Transluminal|transluminal
651707|NCT00821834|Percutaneous Coronary|percutaneous coronary
651708|NCT00821834|Stents|stents
651709|NCT00821795|Diabetes Mellitus, Type 2|diabetes mellitus, type 2
651710|NCT00821795|insulin|insulin
651711|NCT00821795|therapy|therapy
651712|NCT00821782|Bacteria|bacteria
651713|NCT00821782|Oral flora bacteria|oral flora bacteria
651714|NCT00821782|Resistance|resistance
651715|NCT00821756|Suicidal behaviour|suicidal behaviour
651716|NCT00821756|Attempted suicide|attempted suicide
651717|NCT00821756|Self harm|self harm
651718|NCT00821756|Suicide|suicide
651719|NCT00821756|Health system contacts|health system contacts
651720|NCT00821756|Contacts with health system|contacts with health system
651721|NCT00821730|Mixed methods research (qualitative and quantitative)|mixed methods research (qualitative and quantitative)
651722|NCT00821730|Peer support|peer support
651723|NCT00821730|Early inflammatory arthritis|early inflammatory arthritis
651724|NCT00821730|Self-management|self-management
651725|NCT00821730|Patient education|patient education
651726|NCT00821717|Chronic Heart Failure|chronic heart failure
651727|NCT00821717|Iron deficiency|iron deficiency
651728|NCT00821717|Iron deficiency anaemia|iron deficiency anaemia
651729|NCT00821717|Anaemia|anaemia
651730|NCT00821717|Heart disease|heart disease
651731|NCT00821691|cerebral infarction|cerebral infarction
651732|NCT00821678|telemedicine|telemedicine
651733|NCT00821678|rural|rural
651734|NCT00821678|veterans|veterans
651735|NCT00821678|care management|care management
651736|NCT00821678|psychotherapy|psychotherapy
651737|NCT00821665|Type 2 diabetes|type 2 diabetes
651738|NCT00821665|Glycemic control|glycemic control
651739|NCT00821665|(postprandial) Hyperglycemia|(postprandial) hyperglycemia
651740|NCT00821665|Sucrose|sucrose
651741|NCT00821652|Tumor|tumor
651742|NCT00821652|NY-ESO-1 expression|ny-eso-1 expression
651743|NCT00821652|Tumors that often express NY-ESO-1.|tumors that often express ny-eso-1.
651744|NCT00821626|Influenza|influenza
651745|NCT00821626|Rapid flu test|rapid flu test
651746|NCT00821626|Returning travelers with fever|returning travelers with fever
651747|NCT00821600|Risperidone|risperidone
651748|NCT00821600|Antipsychotic|antipsychotic
651749|NCT00821600|Pharmacokinetic|pharmacokinetic
651750|NCT00821600|Long-acting Injectable|long-acting injectable
651751|NCT00821587|Hepatitis C Post Liver Transplant|hepatitis c post liver transplant
651752|NCT00821574|Hypertension, dyslipidemia|hypertension, dyslipidemia
651753|NCT00821561|Persistent|persistent
651754|NCT00821561|cornea|cornea
651755|NCT00821561|defect|defect
651756|NCT00821561|Nexagon|nexagon
651757|NCT00821561|Coda|coda
651758|NCT00821548|facioscapulohumeral muscular dystrophy|facioscapulohumeral muscular dystrophy
651759|NCT00821548|electrostimulation|electrostimulation
651760|NCT00821548|training|training
651761|NCT00821535|pharmacokinetics, Japanese, healthy volunteer, maraviroc|pharmacokinetics, japanese, healthy volunteer, maraviroc
651762|NCT00821522|Acute Kidney Insufficiency|acute kidney insufficiency
651763|NCT00821522|Acute Renal Insufficiency|acute renal insufficiency
651764|NCT00821522|Acute Kidney Injury|acute kidney injury
651765|NCT00821522|Cardiac Surgical Procedures|cardiac surgical procedures
651766|NCT00821522|Ischemic Preconditioning|ischemic preconditioning
651767|NCT00821509|virus infection|virus infection
651768|NCT00821509|hygiene|hygiene
651769|NCT00821509|transmission|transmission
651770|NCT00821509|intervention|intervention
651771|NCT00821496|Multiple dose administration|multiple dose administration
651772|NCT00821496|Oral Contraceptives|oral contraceptives
651773|NCT00821470|osteonecrosis|osteonecrosis
651774|NCT00821470|bone marrow|bone marrow
651775|NCT00821470|core decompression|core decompression
651776|NCT00821470|femoral head|femoral head
651777|NCT00821457|existing scars the are two to six months old|existing scars the are two to six months old
651875|NCT00019539|recurrent renal cell cancer|recurrent renal cell cancer
651778|NCT00821444|schizophrenia, pharmacokinetics, bioavailability, food effect|schizophrenia, pharmacokinetics, bioavailability, food effect
651779|NCT00821405|Number : 250~300 patients|number : 250~300 patients
710285|NCT00589563|contiguous stage II small lymphocytic lymphoma|contiguous stage ii small lymphocytic lymphoma
651780|NCT00821405|Correlation between PET, glucose loading and peritoneal thickness/calcification|correlation between pet, glucose loading and peritoneal thickness/calcification
651781|NCT00821379|PCOS|pcos
651782|NCT00821379|Polycystic Ovary Syndrome|polycystic ovary syndrome
651783|NCT00821379|Pregnancy Complications|pregnancy complications
651784|NCT00821379|Gestational Diabetes|gestational diabetes
651785|NCT00821379|Pre eclampsia|pre eclampsia
651786|NCT00821379|Prediction Model|prediction model
651787|NCT00821379|Pre conceptional|pre conceptional
651788|NCT00821366|HIV/AIDS|hiv/aids
651789|NCT00821366|Food security|food security
651790|NCT00821366|treatment experienced|treatment experienced
651791|NCT00821353|Atrial fibrillation|atrial fibrillation
651792|NCT00821353|Hypertrophic cardiomyopathy|hypertrophic cardiomyopathy
651793|NCT00821353|RF ablation|rf ablation
651794|NCT00821353|Antiarrhythmic drugs|antiarrhythmic drugs
651795|NCT00821340|Leber congenital amaurosis|leber congenital amaurosis
651796|NCT00821340|LCA|lca
651797|NCT00821340|RPE65|rpe65
651798|NCT00821340|RPE65-associated Leber congenital amaurosis|rpe65-associated leber congenital amaurosis
651799|NCT00821340|Retinal disease due to RPE65 mutations|retinal disease due to rpe65 mutations
651800|NCT00821301|Multiple myeloma|multiple myeloma
651801|NCT00821288|cancer survivorship|cancer survivorship
651802|NCT00821288|survivorship prescription|survivorship prescription
651803|NCT00821288|cancer related anxiety|cancer related anxiety
651804|NCT00821275|Uterine Artery Embolization|uterine artery embolization
651805|NCT00821275|Leiomyoma|leiomyoma
651806|NCT00821275|myomectomy|myomectomy
651807|NCT00821275|hysterectomy|hysterectomy
651808|NCT00821275|pregnancy|pregnancy
651809|NCT00821275|complication|complication
651810|NCT00821275|ovarian function|ovarian function
651811|NCT00821275|quality of life|quality of life
651812|NCT00821262|Sevoflurane|sevoflurane
651813|NCT00821262|Anesthesia|anesthesia
651814|NCT00821262|Troponin|troponin
651815|NCT00821262|Myocardial Preconditioning|myocardial preconditioning
651816|NCT00821262|Surgery, Cardiac|surgery, cardiac
651817|NCT00821262|Stents|stents
651818|NCT00821262|Non-cardiac Surgery|non-cardiac surgery
651819|NCT00821262|Surgery|surgery
651820|NCT00821249|plasma cell dyscrasia|plasma cell dyscrasia
651821|NCT00821249|plasmacytoma|plasmacytoma
651822|NCT00821249|kinesin spindle protein|kinesin spindle protein
651823|NCT00821249|anti-mitotic|anti-mitotic
651824|NCT00821236|Myopia|myopia
651825|NCT00821236|LASIK|lasik
651826|NCT00821236|Astigmatism|astigmatism
651827|NCT00821236|Laser Vision Correction|laser vision correction
651828|NCT00821236|Excimer Laser|excimer laser
651829|NCT00821223|phacoemulsification|phacoemulsification
651830|NCT00821223|manual small incision cataract surgery|manual small incision cataract surgery
651831|NCT00821223|visual acuity|visual acuity
651832|NCT00821223|contrast sensitivity|contrast sensitivity
651833|NCT00821223|quality of vision|quality of vision
651834|NCT00821210|Obstructive sleep apnea|obstructive sleep apnea
651835|NCT00821210|myocardial infarction|myocardial infarction
651836|NCT00821197|obesity|obesity
651837|NCT00821197|laparoscopy|laparoscopy
651838|NCT00821197|bariatric|bariatric
651839|NCT00821197|super obesity|super obesity
651840|NCT00821184|urinary incontinence|urinary incontinence
651841|NCT00821184|overactive bladder|overactive bladder
651842|NCT00821184|urinary frequency|urinary frequency
651843|NCT00821145|abdominal aortic aneurysms|abdominal aortic aneurysms
651844|NCT00821132|FALS|fals
651845|NCT00821132|ALS|als
651846|NCT00821132|ALS/FTD|als/ftd
651847|NCT00821132|SALS|sals
651848|NCT00821132|MND|mnd
651849|NCT00821132|PLS|pls
651850|NCT00821119|non invasive ventilation|non invasive ventilation
651851|NCT00821119|mechanical ventilation|mechanical ventilation
651852|NCT00821119|pulmonary morbidity|pulmonary morbidity
651853|NCT00821119|preterm infant|preterm infant
651854|NCT00821119|Respiratory distress syndrome|respiratory distress syndrome
651855|NCT00821119|nasal intermittent positive pressure|nasal intermittent positive pressure
651856|NCT00821119|nasal continuous positive pressure|nasal continuous positive pressure
651857|NCT00821119|bronchopulmonary dysplasia|bronchopulmonary dysplasia
651858|NCT00821106|Coronary angiography|coronary angiography
651859|NCT00821106|percutaneous coronary intervention|percutaneous coronary intervention
651860|NCT00821106|Transradial approach|transradial approach
651861|NCT00821093|respiratory|respiratory
651862|NCT00821093|dyspnea|dyspnea
651863|NCT00821093|breathlessness|breathlessness
651864|NCT00821093|COPD|copd
651865|NCT00821093|indacaterol|indacaterol
651866|NCT00821093|long-acting β2-agonist|long-acting β2-agonist
651867|NCT00821080|vandetanib|vandetanib
651868|NCT00821080|sirolimus|sirolimus
651869|NCT00821080|recurrent glioblastoma|recurrent glioblastoma
651870|NCT00019539|adult solid tumor|adult solid tumor
651871|NCT00019539|body system/site cancer|body system/site cancer
651872|NCT00019539|cancer|cancer
651873|NCT00019539|kidney tumor|kidney tumor
651874|NCT00019539|kidney/urinary cancer|kidney/urinary cancer
651876|NCT00019539|renal cell cancer|renal cell cancer
651877|NCT00019539|solid tumor|solid tumor
651878|NCT00019539|stage IV renal cell cancer|stage iv renal cell cancer
651879|NCT00019539|stage, renal cell cancer|stage, renal cell cancer
651880|NCT00821054|Phase I Food Effect|phase i food effect
651881|NCT00821041|insomnia|insomnia
651882|NCT00821041|online systems|online systems
651883|NCT00821028|atherosclerosis|atherosclerosis
651884|NCT00821028|angioplasty|angioplasty
651885|NCT00821028|peripheral arterial disease|peripheral arterial disease
651886|NCT00821015|cryoablation|cryoablation
651887|NCT00821015|recurring arrhythmia|recurring arrhythmia
651888|NCT00821015|stroke|stroke
651889|NCT00821015|RF ablation|rf ablation
651890|NCT00821015|LA ablation|la ablation
651891|NCT00821015|nodal ablation|nodal ablation
651892|NCT00821015|catheter ablation|catheter ablation
651893|NCT00821002|Glaucoma|glaucoma
651894|NCT00820989|Healthy Immune System|healthy immune system
651895|NCT00820976|G-CSF|g-csf
651896|NCT00820976|AML|aml
651897|NCT00820976|survival|survival
651898|NCT00820963|adult giant cell glioblastoma|adult giant cell glioblastoma
651899|NCT00820963|adult glioblastoma|adult glioblastoma
651900|NCT00820963|adult gliosarcoma|adult gliosarcoma
651901|NCT00820924|HER-2|her-2
651902|NCT00820924|Circulating Tumour Cell (CTC)|circulating tumour cell (ctc)
651903|NCT00820924|EGFR|egfr
651904|NCT00820924|Lapatinib (GW572016)|lapatinib (gw572016)
651905|NCT00820924|Breast Cancer|breast cancer
651906|NCT00820911|Kidney transplant|kidney transplant
651907|NCT00820911|AEB071|aeb071
651908|NCT00820872|male breast cancer|male breast cancer
651909|NCT00820872|stage I breast cancer|stage i breast cancer
651910|NCT00820872|stage II breast cancer|stage ii breast cancer
651911|NCT00820872|stage IIIA breast cancer|stage iiia breast cancer
651912|NCT00820872|stage IIIB breast cancer|stage iiib breast cancer
651913|NCT00820859|Cognition disorder|cognition disorder
651914|NCT00820859|nursing home residents|nursing home residents
651915|NCT00820859|agitation|agitation
651916|NCT00820859|behavior disorder|behavior disorder
651917|NCT00820846|HIV Seronegativity|hiv seronegativity
651918|NCT00820846|HIV Preventive Vaccine|hiv preventive vaccine
651919|NCT00820833|infant formula|infant formula
651920|NCT00820833|obesity|obesity
651921|NCT00820833|growth|growth
651922|NCT00820820|Atopic Dermatitis|atopic dermatitis
651923|NCT00820820|immunosuppression|immunosuppression
651924|NCT00820820|Measles vaccine|measles vaccine
651925|NCT00820820|T lymphocytes|t lymphocytes
651926|NCT00820820|Atopic Dermatitis in adults|atopic dermatitis in adults
651927|NCT00820807|dietary fiber|dietary fiber
651928|NCT00820807|fiber|fiber
651929|NCT00820807|insulin sensitivity|insulin sensitivity
651930|NCT00820807|insulin resistance|insulin resistance
651931|NCT00820807|glucose metabolism|glucose metabolism
651932|NCT00820794|Drug-drug interaction, lithium, PD 0332334, pharmacokinetics|drug-drug interaction, lithium, pd 0332334, pharmacokinetics
651933|NCT00820781|bleeding gastric varices|bleeding gastric varices
651934|NCT00820781|cirrhosis of the liver|cirrhosis of the liver
651935|NCT00820781|portacaval shunt|portacaval shunt
651936|NCT00820781|endoscopic variceal sclerotherapy|endoscopic variceal sclerotherapy
651937|NCT00820781|endoscopic variceal ligation|endoscopic variceal ligation
651938|NCT00820781|Bleeding gastric varices due to cirrhosis of the liver|bleeding gastric varices due to cirrhosis of the liver
651939|NCT00820742|A5751025|a5751025
651940|NCT00820729|interstitial lung disease|interstitial lung disease
651941|NCT00820729|pulmonary hypertension|pulmonary hypertension
651942|NCT00820729|biomarkers|biomarkers
651943|NCT00820729|NT-pro-BNP|nt-pro-bnp
651944|NCT00820729|von Willebrand factor|von willebrand factor
651945|NCT00820729|D-dimer|d-dimer
651946|NCT00820729|Exhaled NO|exhaled no
651947|NCT00820729|Troponin-t|troponin-t
651948|NCT00820716|Asthma|asthma
651949|NCT00820716|Asthmatic subjects|asthmatic subjects
651950|NCT00820716|Exercise training|exercise training
651951|NCT00820716|Constant load|constant load
651952|NCT00820716|Alternate load|alternate load
651953|NCT00820703|Nexagon|nexagon
651954|NCT00820703|CoDa|coda
651955|NCT00820703|ulcer|ulcer
651956|NCT00820703|diabetic|diabetic
651957|NCT00820703|foot|foot
651958|NCT00820690|neoadjuvant chemotherapy|neoadjuvant chemotherapy
651959|NCT00820690|advanced breast cancer|advanced breast cancer
651960|NCT00820690|microarray|microarray
651961|NCT00820690|correlation analysis|correlation analysis
651962|NCT00820690|oncoplastic surgery|oncoplastic surgery
651963|NCT00820651|Nonalcoholic steatohepatitis|nonalcoholic steatohepatitis
651964|NCT00820651|Insulinresistance|insulinresistance
651965|NCT00820651|Diet and exercise|diet and exercise
651966|NCT00820651|Nutritional supplement|nutritional supplement
651967|NCT00820651|Nonalcoholic fatty liver disease|nonalcoholic fatty liver disease
651968|NCT00820651|Lifestyle modifications|lifestyle modifications
651969|NCT00820638|neurorobotics|neurorobotics
651970|NCT00820638|occupational therapy|occupational therapy
651971|NCT00820599|Sapien Valve|sapien valve
651972|NCT00820599|Cardiovascular Diseases|cardiovascular diseases
651973|NCT00820599|Valvular Heart Disease|valvular heart disease
651974|NCT00820599|Aortic Stenosis|aortic stenosis
651975|NCT00820599|Heart Valve Therapy|heart valve therapy
831018|NCT00112307|MRI|mri
651976|NCT00820599|Transfemoral|transfemoral
651977|NCT00820599|Transcatheter|transcatheter
651978|NCT00820586|Intramyocardial|intramyocardial
651979|NCT00820586|Autologous|autologous
651980|NCT00820586|Bone|bone
651981|NCT00820586|Marrow|marrow
651982|NCT00820586|Randomized|randomized
651983|NCT00820586|Percutaneous|percutaneous
651984|NCT00820586|CD34+|cd34+
651985|NCT00820586|Refractory|refractory
651986|NCT00820586|Angina|angina
651987|NCT00820586|Pectoris.|pectoris.
651988|NCT00820573|Diabetes|diabetes
651989|NCT00820547|inflammatory breast cancer|inflammatory breast cancer
651990|NCT00820547|stage IIIA breast cancer|stage iiia breast cancer
651991|NCT00820547|stage IIIB breast cancer|stage iiib breast cancer
651992|NCT00820547|stage IIIC breast cancer|stage iiic breast cancer
651993|NCT00820547|male breast cancer|male breast cancer
651994|NCT00820547|HER2-negative breast cancer|her2-negative breast cancer
651995|NCT00820534|cold sore|cold sore
651996|NCT00820508|Haematological disease|haematological disease
651997|NCT00820508|Lymphoid malignancy|lymphoid malignancy
651998|NCT00820508|Histone deacetylase inhibitor|histone deacetylase inhibitor
651999|NCT00820508|dose escalation|dose escalation
652000|NCT00820495|Smokeless tobacco|smokeless tobacco
652001|NCT00820495|Chewing Tobacco|chewing tobacco
652002|NCT00820495|Internet|internet
652003|NCT00820495|Adolescent|adolescent
652004|NCT00820469|Rituximab|rituximab
652005|NCT00820469|Plasma exchange|plasma exchange
652006|NCT00820469|Autoimmune diseases|autoimmune diseases
652007|NCT00820456|colorectal cancer|colorectal cancer
652008|NCT00820456|colorectal neoplasm|colorectal neoplasm
652009|NCT00820456|colorectal neoplasms|colorectal neoplasms
652010|NCT00820456|metastasis|metastasis
652011|NCT00820456|metastases|metastases
652012|NCT00820456|liver|liver
652013|NCT00820456|hepatic metastasis|hepatic metastasis
652014|NCT00820456|liver metastasis|liver metastasis
652015|NCT00820456|perfusion imaging|perfusion imaging
652016|NCT00820456|MRI|mri
652017|NCT00820456|magnetic resonance imaging|magnetic resonance imaging
652018|NCT00820456|dynamic contrast enhanced MRI|dynamic contrast enhanced mri
652019|NCT00820456|dynamic contrast enhanced magnetic resonance imaging|dynamic contrast enhanced magnetic resonance imaging
652020|NCT00820430|osteoarthritis|osteoarthritis
652021|NCT00820430|knee|knee
652022|NCT00820430|magnetic resonance imaging|magnetic resonance imaging
652023|NCT00820430|knee cartilage|knee cartilage
652024|NCT00820430|reproducibility|reproducibility
652025|NCT00820417|cetuximab|cetuximab
652026|NCT00820417|monoclonal|monoclonal
652027|NCT00820417|antibody|antibody
652028|NCT00820417|epidermal|epidermal
652029|NCT00820417|growth|growth
652030|NCT00820417|factor|factor
652031|NCT00820417|receptor|receptor
652032|NCT00820417|EGFR|egfr
652033|NCT00820417|Gefitinib|gefitinib
652034|NCT00820417|tyrosine|tyrosine
652035|NCT00820417|kinase|kinase
652036|NCT00820417|inhibitor|inhibitor
652037|NCT00820417|advanced|advanced
652038|NCT00820417|cancer|cancer
652039|NCT00820391|Post-traumatic Stress disorder (PTSD)|post-traumatic stress disorder (ptsd)
652040|NCT00820378|Aortic dimension|aortic dimension
652041|NCT00820378|Atherosclerosis|atherosclerosis
652042|NCT00820378|Vascular disease|vascular disease
652043|NCT00820378|Risk factors|risk factors
652044|NCT00820365|Inflammatory Bowel Disease (IBD)|inflammatory bowel disease (ibd)
652045|NCT00820365|Crohn's Disease|crohn's disease
652046|NCT00820365|Ulcerative Colitis|ulcerative colitis
652047|NCT00820365|SC12267|sc12267
652048|NCT00820365|4SC-101|4sc-101
652049|NCT00820365|Phase II|phase ii
652050|NCT00820352|HFNEF|hfnef
652051|NCT00820352|HFPEF|hfpef
652052|NCT00820352|Secondary Pulmonary Hypertension|secondary pulmonary hypertension
652053|NCT00820352|Endothelin Receptor Blockade|endothelin receptor blockade
652054|NCT00820339|hepatocellular carcinoma|hepatocellular carcinoma
652055|NCT00820339|hepatic vein|hepatic vein
652056|NCT00820339|Surgical resection|surgical resection
652057|NCT00820339|occlusion|occlusion
652058|NCT00820339|time to recurrence|time to recurrence
652059|NCT00820339|overall survival|overall survival
652060|NCT00820313|Coronary Heart Disease|coronary heart disease
652061|NCT00820313|Biomarkers of Cardiovascular Disease|biomarkers of cardiovascular disease
652062|NCT00820313|Health Related Quality of Life|health related quality of life
652063|NCT00820313|Diabetes|diabetes
652064|NCT00820313|Diet|diet
652065|NCT00820287|Testicular cancer|testicular cancer
652066|NCT00820287|incidence|incidence
652067|NCT00820287|young men|young men
652068|NCT00820261|Genotypes|genotypes
652069|NCT00820261|Epidemiology|epidemiology
652070|NCT00820261|Diarrhea|diarrhea
652071|NCT00820248|stage III squamous cell carcinoma of the hypopharynx|stage iii squamous cell carcinoma of the hypopharynx
652072|NCT00820248|stage III squamous cell carcinoma of the larynx|stage iii squamous cell carcinoma of the larynx
652323|NCT00819325|stents|stents
652073|NCT00820248|stage III verrucous carcinoma of the larynx|stage iii verrucous carcinoma of the larynx
831081|NCT00112151|PRT|prt
652074|NCT00820248|stage III squamous cell carcinoma of the oropharynx|stage iii squamous cell carcinoma of the oropharynx
652075|NCT00820248|stage IV squamous cell carcinoma of the hypopharynx|stage iv squamous cell carcinoma of the hypopharynx
652076|NCT00820248|stage IV squamous cell carcinoma of the larynx|stage iv squamous cell carcinoma of the larynx
652077|NCT00820248|stage IV verrucous carcinoma of the larynx|stage iv verrucous carcinoma of the larynx
652078|NCT00820248|stage IV squamous cell carcinoma of the oropharynx|stage iv squamous cell carcinoma of the oropharynx
652079|NCT00820248|stage III verrucous carcinoma of the oral cavity|stage iii verrucous carcinoma of the oral cavity
652080|NCT00820248|stage III squamous cell carcinoma of the lip and oral cavity|stage iii squamous cell carcinoma of the lip and oral cavity
652081|NCT00820248|stage IV verrucous carcinoma of the oral cavity|stage iv verrucous carcinoma of the oral cavity
652082|NCT00820248|stage IV squamous cell carcinoma of the lip and oral cavity|stage iv squamous cell carcinoma of the lip and oral cavity
652084|NCT00820222|HERCEPTIN|herceptin
652085|NCT00820222|XELODA|xeloda
652086|NCT00820222|ErbB1|erbb1
652087|NCT00820222|TYKERB|tykerb
652088|NCT00820222|metastatic breast cancer|metastatic breast cancer
652089|NCT00820222|trastuzumab|trastuzumab
652090|NCT00820222|breast cancer|breast cancer
652091|NCT00820222|capecitabine|capecitabine
652092|NCT00820222|lapatinib|lapatinib
652093|NCT00820222|brain metastases|brain metastases
652094|NCT00820222|HER2 positive|her2 positive
652095|NCT00820222|TYVERB|tyverb
652096|NCT00820196|Venous ulcer|venous ulcer
652097|NCT00820196|Nexagon|nexagon
652098|NCT00820196|CoDa|coda
652099|NCT00820183|Hypertension|hypertension
652100|NCT00820183|Intervention|intervention
652101|NCT00820183|Primary Care|primary care
652102|NCT00820183|Quality improvement|quality improvement
652103|NCT00820170|Breast|breast
652104|NCT00820170|Cancer|cancer
652105|NCT00820170|DASATINIB|dasatinib
652106|NCT00820170|TAXOL (PACLITAXEL)|taxol (paclitaxel)
652107|NCT00820170|08-122|08-122
652108|NCT00820157|Carcinoma, Hepatocellular|carcinoma, hepatocellular
652109|NCT00820157|Chemoembolization, Therapeutic|chemoembolization, therapeutic
652110|NCT00820157|Cytoreductive|cytoreductive
652111|NCT00820144|immune response|immune response
652112|NCT00820144|b-subunit of cholera toxin|b-subunit of cholera toxin
652113|NCT00820144|mucosal way|mucosal way
652114|NCT00820144|healthy volonteers|healthy volonteers
652115|NCT00820144|vaccine|vaccine
652116|NCT00820118|ANTIRETROVIRAL THERAPY|antiretroviral therapy
652117|NCT00820118|STRUCTURED TREATMENT INTERRUPTIONS|structured treatment interruptions
652118|NCT00820118|treatment naive|treatment naive
652119|NCT00820105|Migraine|migraine
652120|NCT00820105|Aura|aura
652121|NCT00820105|Migraine headache|migraine headache
652122|NCT00820092|Xerecept|xerecept
652123|NCT00820092|Pharmacokinetics|pharmacokinetics
652124|NCT00820092|Japanese versus Caucasians|japanese versus caucasians
652125|NCT00820079|Gastroesophageal reflux|gastroesophageal reflux
652126|NCT00820079|Heartburn|heartburn
652127|NCT00820079|Regurgitation|regurgitation
652128|NCT00820053|hepatocellular carcinoma|hepatocellular carcinoma
652129|NCT00820053|adjuvant therapy|adjuvant therapy
652130|NCT00820053|TACE|tace
652131|NCT00820053|time to recurrence|time to recurrence
652132|NCT00820053|overall survival|overall survival
652133|NCT00820014|ESBA105|esba105
652134|NCT00820014|scFv antibody fragment|scfv antibody fragment
652135|NCT00820014|cataract surgery|cataract surgery
652136|NCT00820014|pharmacokinetics|pharmacokinetics
652137|NCT00820014|biodistribution|biodistribution
652138|NCT00820014|Irvine-Gass syndrome|irvine-gass syndrome
652139|NCT00820001|Cognitive Behavioral Therapy|cognitive behavioral therapy
652140|NCT00820001|Multimodal Treatment|multimodal treatment
652141|NCT00820001|Physiological Parameters|physiological parameters
652142|NCT00820001|Hormone Concentration in pubertal development|hormone concentration in pubertal development
652143|NCT00820001|Treatment as usual comparison|treatment as usual comparison
652144|NCT00819988|Postoperative|postoperative
652145|NCT00819988|Perioperative|perioperative
652146|NCT00819988|Orthopedic surgery|orthopedic surgery
652147|NCT00819988|Vascular surgery|vascular surgery
652148|NCT00819988|Gabapentinoid|gabapentinoid
652149|NCT00819975|Casein|casein
652150|NCT00819975|Whey|whey
652151|NCT00819975|postprandial|postprandial
652152|NCT00819975|Triglyceride|triglyceride
652153|NCT00819975|Free fatty acids|free fatty acids
652154|NCT00819975|Retinyl palmitate|retinyl palmitate
652155|NCT00819975|Incretins|incretins
652156|NCT00819975|Type 2 Diabetes|type 2 diabetes
652157|NCT00819949|Robot|robot
652158|NCT00819949|Treadmill|treadmill
652159|NCT00819949|Rehabilitation|rehabilitation
652160|NCT00819949|Freezing of gait|freezing of gait
652161|NCT00819936|abdominal aorta surgery|abdominal aorta surgery
652162|NCT00819936|Physical Training|physical training
652163|NCT00819936|backward walking|backward walking
652164|NCT00819936|physiotherapy|physiotherapy
652165|NCT00819923|Titanium|titanium
652166|NCT00819923|everolimus|everolimus
652167|NCT00819923|drug eluting stent|drug eluting stent
652168|NCT00819923|stent thrombosis|stent thrombosis
652169|NCT00819923|restenosis|restenosis
652170|NCT00819923|percutaneous coronary intervention|percutaneous coronary intervention
652171|NCT00819923|acute coronary syndrome|acute coronary syndrome
652172|NCT00819910|Type 4 hyperlipidemia|type 4 hyperlipidemia
652173|NCT00819910|Rosiglitazone|rosiglitazone
652174|NCT00819910|Fenofibrate|fenofibrate
652176|NCT00819897|CIS|cis
652177|NCT00819897|IFN|ifn
652178|NCT00819897|MRI|mri
652179|NCT00819897|OCT|oct
652180|NCT00819897|QOL|qol
652181|NCT00819884|Type II Diabetes|type ii diabetes
652182|NCT00819884|24 hour glucose profile|24 hour glucose profile
652183|NCT00819858|weight loss|weight loss
652184|NCT00819858|weight gain|weight gain
652185|NCT00819858|malnutrition|malnutrition
652186|NCT00819858|convalescence|convalescence
652187|NCT00819858|malaria|malaria
652188|NCT00819858|RUTF|rutf
652189|NCT00819858|RUF|ruf
652190|NCT00819858|supplementation|supplementation
652191|NCT00819858|nutrition|nutrition
652192|NCT00819845|Duchenne|duchenne
652193|NCT00819845|Becker muscular dystrophy|becker muscular dystrophy
652194|NCT00819845|cardioprotective therapy|cardioprotective therapy
652195|NCT00819845|cardiac magnetic resonance|cardiac magnetic resonance
652196|NCT00819845|ultrasound tissue characterization|ultrasound tissue characterization
652197|NCT00819832|vertebral compression fractures|vertebral compression fractures
652198|NCT00819832|VCF|vcf
652199|NCT00819832|Spinal|spinal
652200|NCT00819832|Broken spinal bones|broken spinal bones
652201|NCT00819832|Kyphoplasty|kyphoplasty
652202|NCT00819832|vertebroplasty|vertebroplasty
652203|NCT00819832|Cavity SpineWand|cavity spinewand
652204|NCT00819832|Circulating Tumor Cell Burden|circulating tumor cell burden
652205|NCT00819832|CTCB|ctcb
652206|NCT00819832|Spine pain|spine pain
652207|NCT00819832|Coblation|coblation
652208|NCT00819832|plasma radiofrequency ablation|plasma radiofrequency ablation
652209|NCT00819832|Plasma-mediated ablation technology|plasma-mediated ablation technology
652210|NCT00819832|precise molecular dissociation (ablation) process|precise molecular dissociation (ablation) process
652211|NCT00819832|medical cement|medical cement
652212|NCT00819793|Cardiac Dysfunction|cardiac dysfunction
652213|NCT00819793|Failure-to-wean from CPB|failure-to-wean from cpb
652214|NCT00819793|CentriMag|centrimag
652215|NCT00819793|Levitronix|levitronix
652216|NCT00819793|Thoratec Corporation|thoratec corporation
652217|NCT00819780|Colon Cancer|colon cancer
652218|NCT00819780|Colorectal Cancer|colorectal cancer
652219|NCT00819780|Rectal Cancer|rectal cancer
652220|NCT00819780|Panitumumab|panitumumab
652221|NCT00819780|Vectibix|vectibix
652222|NCT00819780|modified FOLFOX 6|modified folfox 6
652223|NCT00819780|mFOLFOX 6|mfolfox 6
652224|NCT00819780|FOLFOX|folfox
652225|NCT00819780|Bevacizumab|bevacizumab
652226|NCT00819780|Avastin|avastin
652227|NCT00819780|First-Line|first-line
652228|NCT00819780|metastatic|metastatic
652229|NCT00819767|hypertension|hypertension
652230|NCT00819767|systolic blood pressure|systolic blood pressure
652231|NCT00819767|exercise test|exercise test
652232|NCT00819767|cardiovascular disease|cardiovascular disease
652233|NCT00819767|aliskiren|aliskiren
652234|NCT00819767|valsartan|valsartan
652235|NCT00819715|Preterm infants|preterm infants
652236|NCT00819715|small for gestational age|small for gestational age
652237|NCT00819715|electrogastrography|electrogastrography
652238|NCT00819702|child abuse prevention|child abuse prevention
652239|NCT00819702|primary care|primary care
652240|NCT00819702|professional education in primary care|professional education in primary care
652241|NCT00819650|hepatocellular carcinoma|hepatocellular carcinoma
652242|NCT00819650|adjuvant therapy|adjuvant therapy
652243|NCT00819650|Licartin|licartin
652244|NCT00819650|time to recurrence|time to recurrence
652245|NCT00819650|overall survival|overall survival
652246|NCT00819637|Acute asthma|acute asthma
652247|NCT00819637|Arformoterol|arformoterol
652248|NCT00819637|Long acting beta agonists|long acting beta agonists
652249|NCT00819624|fibromyalgia methodology pain sleep fatigue|fibromyalgia methodology pain sleep fatigue
652250|NCT00819611|Attention deficit disorder with hyperactivity|attention deficit disorder with hyperactivity
652251|NCT00819611|Working memory training|working memory training
652252|NCT00819611|Placebo|placebo
652253|NCT00819611|Behavioral symptoms|behavioral symptoms
652254|NCT00819611|Neuropsychology|neuropsychology
652255|NCT00819611|Electropsychophysiology|electropsychophysiology
652256|NCT00819585|Gout|gout
652257|NCT00819585|Chronic gout|chronic gout
652258|NCT00819585|Gouty arthritis|gouty arthritis
652259|NCT00819585|Gout flares|gout flares
652260|NCT00819572|Osteoarthritis|osteoarthritis
652261|NCT00819572|TNF-alpha|tnf-alpha
652262|NCT00819572|DLX105|dlx105
652263|NCT00819572|scFv antibody fragment|scfv antibody fragment
652264|NCT00819572|pain|pain
652265|NCT00819572|fragment|fragment
652266|NCT00819572|antibody fragment|antibody fragment
652267|NCT00819559|Rectal neoplasm|rectal neoplasm
652268|NCT00819559|Clinical stage|clinical stage
652269|NCT00819559|T3N0|t3n0
652270|NCT00819559|Preoperative chemoradiotherapy|preoperative chemoradiotherapy
652271|NCT00819559|Laparoscopic|laparoscopic
652272|NCT00819559|Open resection|open resection
652273|NCT00819546|AML|aml
652274|NCT00819546|MDS|mds
652275|NCT00819520|pediculosis capitis|pediculosis capitis
652276|NCT00819520|pediculus|pediculus
652277|NCT00819507|Skin barrier|skin barrier
652278|NCT00819507|Atopic Dermatitis|atopic dermatitis
652279|NCT00819507|Corticosteroid|corticosteroid
652280|NCT00819507|Effects on skin severity and barrier function|effects on skin severity and barrier function
652281|NCT00819494|Contrast media skin test|contrast media skin test
652282|NCT00819494|Skin test|skin test
652283|NCT00819494|hypersensitivity|hypersensitivity
652284|NCT00819494|contrast media|contrast media
652285|NCT00819481|Total knee replacement|total knee replacement
652286|NCT00819455|Diabetes|diabetes
652287|NCT00819455|Prevention of Diabetes|prevention of diabetes
652288|NCT00819455|Lifestyle Modification|lifestyle modification
652289|NCT00819455|Text messages|text messages
652290|NCT00819442|heart failure|heart failure
652291|NCT00819442|desmin|desmin
652292|NCT00819442|ubiquitin|ubiquitin
652293|NCT00819429|Attention Deficit Hyperactivity Disorder|attention deficit hyperactivity disorder
652294|NCT00819429|Conduct Disorder|conduct disorder
652295|NCT00819429|Oppositional Defiant Disorder|oppositional defiant disorder
652296|NCT00819429|Omega 3 Supplements|omega 3 supplements
652297|NCT00819429|Social Skills Training|social skills training
652298|NCT00819429|Dietary Intake|dietary intake
652299|NCT00819429|Aggression|aggression
652300|NCT00819429|Nutrition|nutrition
652301|NCT00819429|Disruptive Behaviors Disorder|disruptive behaviors disorder
652302|NCT00819416|randomized controlled trial|randomized controlled trial
652303|NCT00819416|clinical trial|clinical trial
652304|NCT00819403|triglycerides|triglycerides
652305|NCT00819403|hypertension|hypertension
652306|NCT00819403|low hdl|low hdl
652307|NCT00819403|obesity|obesity
652308|NCT00819377|Valvular surgery|valvular surgery
652309|NCT00819377|pulmonary artery pressure|pulmonary artery pressure
652310|NCT00819364|Autism|autism
652311|NCT00819364|early intervention|early intervention
652312|NCT00819364|BCRI model|bcri model
652313|NCT00819351|acute lymphoblastic leukemia|acute lymphoblastic leukemia
652314|NCT00819351|child|child
652315|NCT00819351|PEG-Asparaginase|peg-asparaginase
652316|NCT00819351|EFS|efs
652317|NCT00819351|efficacy|efficacy
652318|NCT00819351|childhood acute lymphoblastic leukemia|childhood acute lymphoblastic leukemia
652319|NCT00819338|Non-alcoholic fatty liver disease|non-alcoholic fatty liver disease
652320|NCT00819338|Polyunsaturated fatty acids|polyunsaturated fatty acids
652321|NCT00819338|Omega-3|omega-3
652322|NCT00819325|diabetes|diabetes
652324|NCT00819325|restenosis|restenosis
652325|NCT00819325|thiazolidinediones|thiazolidinediones
652326|NCT00819325|coronary atherosclerosis|coronary atherosclerosis
652327|NCT00819312|Contraceptives,|contraceptives,
652328|NCT00819312|Oral Hormonal;|oral hormonal;
652329|NCT00819312|Contraceptive Methods;|contraceptive methods;
652330|NCT00819312|Female|female
652331|NCT00819299|Presbyopia|presbyopia
652332|NCT00819299|accommodation|accommodation
652333|NCT00819299|near visual acuity|near visual acuity
652334|NCT00819299|LASIK|lasik
652335|NCT00819286|open heart surgery|open heart surgery
652336|NCT00819273|hsCRP|hscrp
652337|NCT00819260|Mammaplasty|mammaplasty
652338|NCT00819260|Electrocoagulation|electrocoagulation
652339|NCT00819260|Breast|breast
652340|NCT00819234|Leptin|leptin
652341|NCT00819234|Pramlintide|pramlintide
652342|NCT00819234|Obese|obese
652343|NCT00819234|Symlin|symlin
652344|NCT00819234|Amylin|amylin
652345|NCT00819221|advanced tumors|advanced tumors
652346|NCT00819221|solid tumors|solid tumors
652347|NCT00819221|dose escalation|dose escalation
652348|NCT00819221|combination|combination
652349|NCT00819221|AZD2281|azd2281
652350|NCT00819221|liposomal doxorubicin|liposomal doxorubicin
652351|NCT00819221|pharmacology|pharmacology
652352|NCT00819221|phase I|phase i
652353|NCT00819221|multicenter|multicenter
652354|NCT00819208|fatigue|fatigue
652355|NCT00819208|sleep disorders|sleep disorders
652356|NCT00819208|depression|depression
652357|NCT00819208|anxiety disorder|anxiety disorder
652358|NCT00819208|psychosocial effects of cancer and its treatment|psychosocial effects of cancer and its treatment
652359|NCT00819208|cognitive/functional effects|cognitive/functional effects
652360|NCT00819208|stage II colon cancer|stage ii colon cancer
652361|NCT00819208|stage III colon cancer|stage iii colon cancer
652362|NCT00819208|adenocarcinoma of the colon|adenocarcinoma of the colon
652363|NCT00819195|relapsing-remitting|relapsing-remitting
652364|NCT00819195|multiple sclerosis|multiple sclerosis
652365|NCT00819195|Copaxone|copaxone
652366|NCT00819195|glatiramer acetate|glatiramer acetate
652367|NCT00819195|MS|ms
652368|NCT00819182|Menopause|menopause
652369|NCT00819182|Breast Cancer|breast cancer
652370|NCT00819182|Hot Flash|hot flash
652371|NCT00819182|Night Sweats|night sweats
652372|NCT00819169|AMG 655|amg 655
652373|NCT00819169|AMG 479|amg 479
652374|NCT00819169|Apoptosis|apoptosis
652375|NCT00819169|Monoclonal Antibody|monoclonal antibody
652376|NCT00819169|Tumor Necrosis Factor|tumor necrosis factor
652377|NCT00819169|Insulin-like Growth Factor|insulin-like growth factor
652378|NCT00819143|Tissue Procurement|tissue procurement
652379|NCT00819143|Sample Collection|sample collection
652380|NCT00819143|Chronic Myelogenous Leukemia|chronic myelogenous leukemia
652381|NCT00819143|Laboratory Research|laboratory research
652382|NCT00819117|Epicardial leads|epicardial leads
652383|NCT00819117|Cardiac Resynchronization Therapy|cardiac resynchronization therapy
652384|NCT00819104|Primary hypertension|primary hypertension
652385|NCT00819104|Metoprolol XL|metoprolol xl
652386|NCT00819104|Amlodipine|amlodipine
652387|NCT00819078|adolescent|adolescent
652388|NCT00819078|bupropion|bupropion
652389|NCT00819078|smoking|smoking
652390|NCT00819078|cessation|cessation
652391|NCT00819078|depression|depression
652392|NCT00819065|Botulinum toxin A|botulinum toxin a
652393|NCT00819065|Spasticity|spasticity
652394|NCT00819065|Randomized Clinical Trial|randomized clinical trial
652395|NCT00819000|Specialty Pharmacy|specialty pharmacy
652396|NCT00819000|Therapy Management|therapy management
652397|NCT00819000|Medication Compliance|medication compliance
652398|NCT00819000|Medication Adherence|medication adherence
652399|NCT00819000|Medication Persistence|medication persistence
652400|NCT00819000|Health Outcomes|health outcomes
652401|NCT00818987|Operative|operative
652402|NCT00818987|Non operative|non operative
652403|NCT00818961|accelerated phase chronic myelogenous leukemia|accelerated phase chronic myelogenous leukemia
652404|NCT00818961|adult acute lymphoblastic leukemia in remission|adult acute lymphoblastic leukemia in remission
652405|NCT00818961|adult acute myeloid leukemia in remission|adult acute myeloid leukemia in remission
652406|NCT00818961|adult AML with 11q23 (MLL) abnormalities|adult aml with 11q23 (mll) abnormalities
652407|NCT00818961|blastic phase chronic myelogenous leukemia|blastic phase chronic myelogenous leukemia
652408|NCT00818961|chronic myelomonocytic leukemia|chronic myelomonocytic leukemia
652409|NCT00818961|chronic phase chronic myelogenous leukemia|chronic phase chronic myelogenous leukemia
652410|NCT00818961|prolymphocytic leukemia|prolymphocytic leukemia
652411|NCT00818961|recurrent adult T-cell leukemia/lymphoma|recurrent adult t-cell leukemia/lymphoma
652412|NCT00818961|refractory chronic lymphocytic leukemia|refractory chronic lymphocytic leukemia
652413|NCT00818961|relapsing chronic myelogenous leukemia|relapsing chronic myelogenous leukemia
652414|NCT00818961|secondary acute myeloid leukemia|secondary acute myeloid leukemia
652415|NCT00818961|stage I adult T-cell leukemia/lymphoma|stage i adult t-cell leukemia/lymphoma
652416|NCT00818961|stage I chronic lymphocytic leukemia|stage i chronic lymphocytic leukemia
652417|NCT00818961|stage II adult T-cell leukemia/lymphoma|stage ii adult t-cell leukemia/lymphoma
652418|NCT00818961|stage II chronic lymphocytic leukemia|stage ii chronic lymphocytic leukemia
652419|NCT00818961|stage III adult T-cell leukemia/lymphoma|stage iii adult t-cell leukemia/lymphoma
652420|NCT00818961|stage III chronic lymphocytic leukemia|stage iii chronic lymphocytic leukemia
652421|NCT00818961|stage IV adult T-cell leukemia/lymphoma|stage iv adult t-cell leukemia/lymphoma
652422|NCT00818961|stage IV chronic lymphocytic leukemia|stage iv chronic lymphocytic leukemia
652423|NCT00818961|recurrent adult Hodgkin lymphoma|recurrent adult hodgkin lymphoma
652424|NCT00818961|anaplastic large cell lymphoma|anaplastic large cell lymphoma
652425|NCT00818961|angioimmunoblastic T-cell lymphoma|angioimmunoblastic t-cell lymphoma
652426|NCT00818961|cutaneous B-cell non-Hodgkin lymphoma|cutaneous b-cell non-hodgkin lymphoma
652427|NCT00818961|recurrent cutaneous T-cell NHL|recurrent cutaneous t-cell nhl
652428|NCT00818961|stage I cutaneous T-cell NHL|stage i cutaneous t-cell nhl
652429|NCT00818961|stage II cutaneous T-cell NHL|stage ii cutaneous t-cell nhl
652430|NCT00818961|stage III cutaneous T-cell NHL|stage iii cutaneous t-cell nhl
652431|NCT00818961|stage IV cutaneous T-cell NHL|stage iv cutaneous t-cell nhl
652432|NCT00818961|extranodal marginal zone B-cell lymphoma of mucosal tissue|extranodal marginal zone b-cell lymphoma of mucosal tissue
652433|NCT00818961|nodal marginal zone B-cell lymphoma|nodal marginal zone b-cell lymphoma
652434|NCT00818961|splenic marginal zone lymphoma|splenic marginal zone lymphoma
652435|NCT00818961|contiguous st II adult diffuse large cell lymphoma|contiguous st ii adult diffuse large cell lymphoma
652436|NCT00818961|contiguous st II adult diffuse mixed cell lymphoma|contiguous st ii adult diffuse mixed cell lymphoma
652437|NCT00818961|contiguous st II adult diffuse sm cleaved cell lymphoma|contiguous st ii adult diffuse sm cleaved cell lymphoma
652438|NCT00818961|contiguous st II grade 1 follicular lymphoma|contiguous st ii grade 1 follicular lymphoma
652439|NCT00818961|contiguous st II grade 2 follicular lymphoma|contiguous st ii grade 2 follicular lymphoma
652440|NCT00818961|contiguous st II grade 3 follicular lymphoma|contiguous st ii grade 3 follicular lymphoma
652441|NCT00818961|contiguous st II mantle cell lymphoma|contiguous st ii mantle cell lymphoma
652442|NCT00818961|contiguous st II marginal zone lymphoma|contiguous st ii marginal zone lymphoma
652443|NCT00818961|contiguous st II small lymphocytic lymphoma|contiguous st ii small lymphocytic lymphoma
652444|NCT00818961|stage I adult diffuse large cell lymphoma|stage i adult diffuse large cell lymphoma
652445|NCT00818961|stage I adult diffuse mixed cell lymphoma|stage i adult diffuse mixed cell lymphoma
652446|NCT00818961|stage I adult diffuse small cleaved cell lymphoma|stage i adult diffuse small cleaved cell lymphoma
652447|NCT00818961|stage I grade 1 follicular lymphoma|stage i grade 1 follicular lymphoma
652448|NCT00818961|stage I grade 2 follicular lymphoma|stage i grade 2 follicular lymphoma
652449|NCT00818961|stage I grade 3 follicular lymphoma|stage i grade 3 follicular lymphoma
652450|NCT00818961|stage I mantle cell lymphoma|stage i mantle cell lymphoma
652451|NCT00818961|stage I marginal zone lymphoma|stage i marginal zone lymphoma
652452|NCT00818961|stage I small lymphocytic lymphoma|stage i small lymphocytic lymphoma
652453|NCT00818961|noncontiguous st II adult diffuse large cell lymphoma|noncontiguous st ii adult diffuse large cell lymphoma
652454|NCT00818961|noncontiguous st II adult diffuse mixed cell lymphoma|noncontiguous st ii adult diffuse mixed cell lymphoma
652455|NCT00818961|noncontiguous st II adult diffuse sm cleaved cell lymphoma|noncontiguous st ii adult diffuse sm cleaved cell lymphoma
652456|NCT00818961|noncontiguous st II grade 1 follicular lymphoma|noncontiguous st ii grade 1 follicular lymphoma
652457|NCT00818961|noncontiguous st II grade 2 follicular lymphoma|noncontiguous st ii grade 2 follicular lymphoma
652458|NCT00818961|noncontiguous st II grade 3 follicular lymphoma|noncontiguous st ii grade 3 follicular lymphoma
652459|NCT00818961|noncontiguous st II mantle cell lymphoma|noncontiguous st ii mantle cell lymphoma
652460|NCT00818961|noncontiguous st II marginal zone lymphoma|noncontiguous st ii marginal zone lymphoma
652461|NCT00818961|noncontiguous st II small lymphocytic lymphoma|noncontiguous st ii small lymphocytic lymphoma
652462|NCT00818961|stage III adult diffuse large cell lymphoma|stage iii adult diffuse large cell lymphoma
652463|NCT00818961|stage III adult diffuse mixed cell lymphoma|stage iii adult diffuse mixed cell lymphoma
652464|NCT00818961|stage III adult diffuse small cleaved cell lymphoma|stage iii adult diffuse small cleaved cell lymphoma
652465|NCT00818961|stage III grade 1 follicular lymphoma|stage iii grade 1 follicular lymphoma
652466|NCT00818961|stage III grade 2 follicular lymphoma|stage iii grade 2 follicular lymphoma
652467|NCT00818961|stage III grade 3 follicular lymphoma|stage iii grade 3 follicular lymphoma
652468|NCT00818961|stage III mantle cell lymphoma|stage iii mantle cell lymphoma
652469|NCT00818961|stage III marginal zone lymphoma|stage iii marginal zone lymphoma
652470|NCT00818961|stage III small lymphocytic lymphoma|stage iii small lymphocytic lymphoma
652471|NCT00818961|stage IV adult diffuse large cell lymphoma|stage iv adult diffuse large cell lymphoma
652472|NCT00818961|stage IV adult diffuse mixed cell lymphoma|stage iv adult diffuse mixed cell lymphoma
652473|NCT00818961|stage IV adult diffuse small cleaved cell lymphoma|stage iv adult diffuse small cleaved cell lymphoma
652474|NCT00818961|stage IV grade 1 follicular lymphoma|stage iv grade 1 follicular lymphoma
652475|NCT00818961|stage IV grade 2 follicular lymphoma|stage iv grade 2 follicular lymphoma
652476|NCT00818961|stage IV grade 3 follicular lymphoma|stage iv grade 3 follicular lymphoma
652477|NCT00818961|stage IV mantle cell lymphoma|stage iv mantle cell lymphoma
652478|NCT00818961|stage IV marginal zone lymphoma|stage iv marginal zone lymphoma
652479|NCT00818961|stage IV small lymphocytic lymphoma|stage iv small lymphocytic lymphoma
652480|NCT00818961|recurrent adult diffuse large cell lymphoma|recurrent adult diffuse large cell lymphoma
652481|NCT00818961|recurrent adult diffuse mixed cell lymphoma|recurrent adult diffuse mixed cell lymphoma
652482|NCT00818961|recurrent adult diffuse small cleaved cell lymphoma|recurrent adult diffuse small cleaved cell lymphoma
652483|NCT00818961|recurrent adult gr III lymphomatoid granulomatosis|recurrent adult gr iii lymphomatoid granulomatosis
652484|NCT00818961|recurrent grade 1 follicular lymphoma|recurrent grade 1 follicular lymphoma
652485|NCT00818961|recurrent grade 2 follicular lymphoma|recurrent grade 2 follicular lymphoma
652486|NCT00818961|recurrent grade 3 follicular lymphoma|recurrent grade 3 follicular lymphoma
652487|NCT00818961|recurrent mantle cell lymphoma|recurrent mantle cell lymphoma
652488|NCT00818961|recurrent marginal zone lymphoma|recurrent marginal zone lymphoma
652489|NCT00818961|recurrent small lymphocytic lymphoma|recurrent small lymphocytic lymphoma
652490|NCT00818961|de novo MDS|de novo mds
652491|NCT00818961|previously treated MDS|previously treated mds
652492|NCT00818961|secondary myelodysplastic syndromes|secondary myelodysplastic syndromes
652493|NCT00818961|Waldenstrom macroglobulinemia|waldenstrom macroglobulinemia
652494|NCT00818961|myelodysplastic/myeloproliferative disease|myelodysplastic/myeloproliferative disease
652495|NCT00818948|Lupus|lupus
652496|NCT00818948|Nephritis|nephritis
652497|NCT00818909|Dry eye|dry eye
652498|NCT00818909|Systane|systane
652499|NCT00818909|Moderate to severe dry eye|moderate to severe dry eye
652500|NCT00818896|thyroid deficiency|thyroid deficiency
652501|NCT00818896|pregnancy|pregnancy
652502|NCT00818896|post-partum thyroid dysfunction|post-partum thyroid dysfunction
652503|NCT00818896|permanent hypothyroidism|permanent hypothyroidism
652504|NCT00818883|Essential Hypertension|essential hypertension
652505|NCT00818883|Hypertensive|hypertensive
652506|NCT00818883|Blood Pressure, High|blood pressure, high
652507|NCT00818883|Vascular Disease|vascular disease
652508|NCT00818883|Cardiovascular Disease|cardiovascular disease
652509|NCT00818883|Drug Therapy|drug therapy
652510|NCT00818870|Gastroesophageal Reflux|gastroesophageal reflux
652511|NCT00818870|GERD|gerd
652512|NCT00818870|Nocturnal GERD|nocturnal gerd
652513|NCT00818870|Heartburn|heartburn
652514|NCT00818870|Nighttime Heartburn|nighttime heartburn
652515|NCT00818870|Nocturnal Heartburn|nocturnal heartburn
652516|NCT00818857|cancer screening|cancer screening
652517|NCT00818857|screening disparities|screening disparities
652518|NCT00818857|underserved populations|underserved populations
652519|NCT00818844|Nepafenac|nepafenac
652520|NCT00818844|vitrectomy surgery|vitrectomy surgery
652521|NCT00818844|Epiretinal membrane surgery|epiretinal membrane surgery
652522|NCT00818831|Advanced, refractory solid tumors|advanced, refractory solid tumors
652523|NCT00818818|Leishmaniasis|leishmaniasis
652524|NCT00818818|Cutaneous leishmaniasis|cutaneous leishmaniasis
652525|NCT00818818|Leishmania braziliensis|leishmania braziliensis
652526|NCT00818818|Pentavalent antimonial|pentavalent antimonial
652527|NCT00818818|Glucantime|glucantime
652528|NCT00818805|conjunctivitis|conjunctivitis
652529|NCT00818792|Percutaneous coronary intervention|percutaneous coronary intervention
652530|NCT00818792|Drug-eluting stent|drug-eluting stent
652531|NCT00818792|Chronic kidney disease|chronic kidney disease
652532|NCT00818792|Restenosis|restenosis
652533|NCT00818779|diabetes|diabetes
652534|NCT00818779|heart disease|heart disease
652535|NCT00818779|atherosclerosis|atherosclerosis
652536|NCT00818766|Thoracic Surgery|thoracic surgery
652537|NCT00818766|Antibiotic Prophylaxis|antibiotic prophylaxis
652538|NCT00818766|Chest Tube|chest tube
652539|NCT00818727|Bone density|bone density
652540|NCT00818727|SSRI|ssri
652541|NCT00818727|newborn infants|newborn infants
652542|NCT00818714|IIIA, selected IIIB|iiia, selected iiib
652543|NCT00818714|(T1N2-3M0, T2N2-3M0, T3N1-3M0)|(t1n2-3m0, t2n2-3m0, t3n1-3m0)
652544|NCT00818701|Congestive Heart Failure|congestive heart failure
652545|NCT00818701|Congestive Heart Failure with a NYHF Class 2-3|congestive heart failure with a nyhf class 2-3
652546|NCT00818701|Ejection Fraction of 35 or less|ejection fraction of 35 or less
652547|NCT00818688|Superficial thrombophlebitis (ST)|superficial thrombophlebitis (st)
652548|NCT00818688|Deep-vein thrombosis|deep-vein thrombosis
652549|NCT00818688|Symptomatic pulmonary embolism|symptomatic pulmonary embolism
652550|NCT00818688|Symptomatic Superficial Thrombophlebitis of the lower limbs|symptomatic superficial thrombophlebitis of the lower limbs
652551|NCT00818662|Alzheimer´s|alzheimer´s
652552|NCT00818662|Dementia|dementia
652553|NCT00818662|Dementia of Alzheimer Type|dementia of alzheimer type
652554|NCT00818662|Immunoglobulins|immunoglobulins
652555|NCT00818662|Gammaglobulins|gammaglobulins
652556|NCT00818662|Immune Globulin Intravenous (IGIV)|immune globulin intravenous (igiv)
652557|NCT00818662|Intravenous Immune Globulin (IVIG)|intravenous immune globulin (ivig)
652558|NCT00818662|Antibodies|antibodies
652559|NCT00818662|Amyloid|amyloid
652560|NCT00818662|Immunotherapy|immunotherapy
652561|NCT00818649|de novo myelodysplastic syndromes|de novo myelodysplastic syndromes
652562|NCT00818649|previously treated myelodysplastic syndromes|previously treated myelodysplastic syndromes
652563|NCT00818649|secondary myelodysplastic syndromes|secondary myelodysplastic syndromes
652564|NCT00818649|refractory anemia with excess blasts|refractory anemia with excess blasts
652565|NCT00818649|adult acute myeloblastic leukemia with maturation (M2)|adult acute myeloblastic leukemia with maturation (m2)
652566|NCT00818649|adult acute myeloblastic leukemia without maturation (M1)|adult acute myeloblastic leukemia without maturation (m1)
652567|NCT00818649|adult acute minimally differentiated myeloid leukemia (M0)|adult acute minimally differentiated myeloid leukemia (m0)
652568|NCT00818649|adult acute myelomonocytic leukemia (M4)|adult acute myelomonocytic leukemia (m4)
652569|NCT00818649|adult acute monoblastic leukemia (M5a)|adult acute monoblastic leukemia (m5a)
652570|NCT00818649|adult acute monocytic leukemia (M5b)|adult acute monocytic leukemia (m5b)
652571|NCT00818649|adult erythroleukemia (M6a)|adult erythroleukemia (m6a)
652572|NCT00818649|adult pure erythroid leukemia (M6b)|adult pure erythroid leukemia (m6b)
652573|NCT00818649|adult acute megakaryoblastic leukemia (M7)|adult acute megakaryoblastic leukemia (m7)
652574|NCT00818649|recurrent adult acute myeloid leukemia|recurrent adult acute myeloid leukemia
652575|NCT00818649|untreated adult acute myeloid leukemia|untreated adult acute myeloid leukemia
652576|NCT00818649|adult acute myeloid leukemia with 11q23 (MLL) abnormalities|adult acute myeloid leukemia with 11q23 (mll) abnormalities
652577|NCT00818649|adult acute myeloid leukemia with inv(16)(p13;q22)|adult acute myeloid leukemia with inv(16)(p13;q22)
652578|NCT00818649|adult acute myeloid leukemia with t(16;16)(p13;q22)|adult acute myeloid leukemia with t(16;16)(p13;q22)
652579|NCT00818649|adult acute myeloid leukemia with t(8;21)(q22;q22)|adult acute myeloid leukemia with t(8;21)(q22;q22)
652580|NCT00818636|expressive writing|expressive writing
652581|NCT00818636|ruminating|ruminating
652582|NCT00818636|ruminative thinking|ruminative thinking
652583|NCT00818636|experiential avoidance|experiential avoidance
652584|NCT00818636|depression|depression
652585|NCT00818636|alcohol|alcohol
652586|NCT00818636|drinking|drinking
652587|NCT00818636|emotional processing|emotional processing
652588|NCT00818610|Community-acquired infections|community-acquired infections
652589|NCT00818610|Pneumonia|pneumonia
652590|NCT00818610|Clinical Stability|clinical stability
652591|NCT00818610|Antibiotics|antibiotics
652592|NCT00818610|Combination therapy|combination therapy
652593|NCT00818610|Atypical bacteria|atypical bacteria
652594|NCT00818597|septic shock|septic shock
652595|NCT00818597|immunoparalysis|immunoparalysis
652596|NCT00818597|extracorporeal|extracorporeal
652597|NCT00818597|granulocyte bioreactor|granulocyte bioreactor
652598|NCT00818597|plasmapheresis|plasmapheresis
652599|NCT00818584|Micafungin|micafungin
652600|NCT00818584|Candida|candida
652601|NCT00818584|Neonates|neonates
652602|NCT00818584|Mycamine|mycamine
652603|NCT00818584|FK463|fk463
652604|NCT00818571|Renal impairment|renal impairment
652605|NCT00818571|Diabetes|diabetes
652606|NCT00818571|vildagliptin|vildagliptin
652607|NCT00818571|Galvus|galvus
652608|NCT00818571|Eucreas|eucreas
652609|NCT00818558|non small cell lung cancer|non small cell lung cancer
652610|NCT00818545|aging|aging
652611|NCT00818545|barrier function|barrier function
652612|NCT00818545|transcriptomic|transcriptomic
652613|NCT00818532|Corneal astigmatism|corneal astigmatism
652614|NCT00818532|Low diopter|low diopter
652615|NCT00818532|Corneal measurement|corneal measurement
652616|NCT00818532|Corneal astigmatism < 1 Diopter|corneal astigmatism < 1 diopter
652617|NCT00818519|Moderate Acne Vulgaris|moderate acne vulgaris
652618|NCT00818519|Oral contraceptive|oral contraceptive
652619|NCT00818519|Female|female
652620|NCT00818506|Depression|depression
652621|NCT00818506|Major depressive disorder|major depressive disorder
652622|NCT00818506|Coronary artery disease|coronary artery disease
652623|NCT00818506|White Matter Hyperintensities|white matter hyperintensities
652624|NCT00818506|White Matter Lesions|white matter lesions
652625|NCT00818506|Coronary artery calcification|coronary artery calcification
652626|NCT00818493|total knee arthroplasty|total knee arthroplasty
652627|NCT00818493|total hip arthroplasty|total hip arthroplasty
652628|NCT00818480|prostate cancer|prostate cancer
652629|NCT00818480|melanoma|melanoma
652630|NCT00818480|lymphoma|lymphoma
652631|NCT00818480|YM155|ym155
652632|NCT00818467|Skin tone|skin tone
652633|NCT00818467|Vitamin D|vitamin d
652634|NCT00818441|lung cancer adenocarcinoma HER2|lung cancer adenocarcinoma her2
652635|NCT00818428|Phonological Awareness|phonological awareness
652636|NCT00818428|Speech Articulation Disorder|speech articulation disorder
652637|NCT00818428|Development Articulation Disorder|development articulation disorder
652638|NCT00818428|Phonological Impairment|phonological impairment
652639|NCT00818428|Dyslexia|dyslexia
652640|NCT00818428|Speech Therapy|speech therapy
652641|NCT00818428|School Transition|school transition
652642|NCT00818402|Quality of life|quality of life
652643|NCT00818402|symptoms|symptoms
652644|NCT00818389|Amyotrophic lateral sclerosis|amyotrophic lateral sclerosis
652645|NCT00818389|ALS|als
652646|NCT00818389|Lou Gehrig's disease|lou gehrig's disease
652647|NCT00818389|riluzole|riluzole
652648|NCT00818389|lithium|lithium
652649|NCT00818389|neurodegeneration|neurodegeneration
652650|NCT00818376|Chlorhexidine|chlorhexidine
652651|NCT00818376|adverse effects|adverse effects
652652|NCT00818376|staining|staining
652653|NCT00818376|dental calculus|dental calculus
652654|NCT00818376|dental plaque|dental plaque
652655|NCT00818363|Postoperative pain|postoperative pain
652656|NCT00818363|shoulder surgery|shoulder surgery
652657|NCT00818363|opioid|opioid
652658|NCT00818311|Light emitting diode|light emitting diode
652659|NCT00818311|tolerance|tolerance
652660|NCT00818311|photomodulation|photomodulation
652661|NCT00818298|schizophrenia|schizophrenia
652662|NCT00818298|schizoaffective disorder|schizoaffective disorder
652663|NCT00818298|PET Scan|pet scan
652664|NCT00818298|ziprasidone|ziprasidone
652665|NCT00818298|dopamine|dopamine
652666|NCT00818298|D2|d2
652667|NCT00818298|receptor|receptor
652668|NCT00818298|antagonist|antagonist
652669|NCT00818298|occupancy|occupancy
652670|NCT00818298|dissociation|dissociation
652671|NCT00818298|affinity|affinity
652672|NCT00818298|constant|constant
652673|NCT00818298|Ki|ki
652674|NCT00818298|ligand|ligand
652675|NCT00818298|raclopride|raclopride
652676|NCT00818298|half-life|half-life
652677|NCT00818298|striatal|striatal
652678|NCT00818298|plasma dynamics|plasma dynamics
652679|NCT00818298|central dynamics|central dynamics
652680|NCT00818298|plasma drug level|plasma drug level
652681|NCT00818298|compliance|compliance
652682|NCT00818298|antipsychotic|antipsychotic
652683|NCT00818298|pharmacotherapy|pharmacotherapy
652684|NCT00818298|twice daily dosing|twice daily dosing
652685|NCT00818298|BID dosing|bid dosing
652686|NCT00818298|once daily dosing|once daily dosing
652687|NCT00818298|od dosing|od dosing
652688|NCT00818298|qd dosing|qd dosing
652689|NCT00818298|dosing schedule|dosing schedule
652690|NCT00818233|dynamic contour tonometry|dynamic contour tonometry
652691|NCT00818233|variability|variability
652692|NCT00818233|pulse amplitude|pulse amplitude
652693|NCT00818233|Ocular pulse amplitude|ocular pulse amplitude
652694|NCT00818220|intraventricular hemorrhage|intraventricular hemorrhage
652695|NCT00818220|sepsis|sepsis
652696|NCT00818220|motor function|motor function
652697|NCT00818220|motor functioning at 7 months corrected age|motor functioning at 7 months corrected age
652698|NCT00818220|cytokines in cord blood and at 6 and 20 hours of age|cytokines in cord blood and at 6 and 20 hours of age
652699|NCT00818220|stem cells in cord blood and at 20 hours of age|stem cells in cord blood and at 20 hours of age
652700|NCT00818207|Smoking cessation|smoking cessation
652701|NCT00818207|quit rates|quit rates
652702|NCT00818207|reimbursement|reimbursement
652703|NCT00818207|drug coverage|drug coverage
652704|NCT00818207|effectiveness|effectiveness
652705|NCT00818207|cost-effectiveness|cost-effectiveness
652706|NCT00818207|health policy|health policy
652707|NCT00818207|drug utilization|drug utilization
652708|NCT00818207|adherence|adherence
652709|NCT00818207|urine cotinine.|urine cotinine.
652710|NCT00818194|Tacrolimus|tacrolimus
652711|NCT00818194|cyclosporine A|cyclosporine a
652712|NCT00818194|renal plasma flow|renal plasma flow
652713|NCT00818194|glomerular filtration rate|glomerular filtration rate
652714|NCT00818194|human|human
652715|NCT00818194|pharmacodynamics|pharmacodynamics
652716|NCT00818194|pharmacokinetics|pharmacokinetics
652717|NCT00818194|Pharmacodynamics of tacrolimus|pharmacodynamics of tacrolimus
652718|NCT00818181|Type I - Allergy, rhinoconjunctivitis|type i - allergy, rhinoconjunctivitis
652719|NCT00818129|Phase I|phase i
652720|NCT00818129|Japan|japan
652721|NCT00818129|Japanese|japanese
652722|NCT00818129|oral solution|oral solution
652723|NCT00818116|Cataract|cataract
652724|NCT00818116|visual acuity|visual acuity
652725|NCT00818116|AcrySof ReSTOR Aspheric Intraoculare Lens|acrysof restor aspheric intraoculare lens
652726|NCT00818116|Bilateral cataract|bilateral cataract
652727|NCT00818103|Multiple Sclerosis,Genetics,Pathogenesis,Pathology,Therapy|multiple sclerosis,genetics,pathogenesis,pathology,therapy
652728|NCT00818090|thymic epithelial tumor|thymic epithelial tumor
652729|NCT00818090|paclitaxel|paclitaxel
652730|NCT00818090|cisplatin|cisplatin
652731|NCT00818090|thymic carcinoma|thymic carcinoma
652732|NCT00818090|invasive thymoma|invasive thymoma
652733|NCT00818051|stage IA breast cancer|stage ia breast cancer
652734|NCT00818051|stage IB breast cancer|stage ib breast cancer
652735|NCT00818051|stage II breast cancer|stage ii breast cancer
652736|NCT00818051|stage IIIA breast cancer|stage iiia breast cancer
652737|NCT00818038|RRMS|rrms
652738|NCT00818038|Relapsing Remitting|relapsing remitting
652739|NCT00818038|MS|ms
652740|NCT00818025|Transplantation|transplantation
652741|NCT00818025|Self-care agency|self-care agency
652742|NCT00818025|Self-care behaviors|self-care behaviors
652743|NCT00818025|Hand-held device|hand-held device
652744|NCT00818012|atrial fibrillation|atrial fibrillation
652745|NCT00818012|atrial electromechanical interval|atrial electromechanical interval
652746|NCT00818012|direct current cardioversion|direct current cardioversion
652747|NCT00818012|pulse wave velocity|pulse wave velocity
652748|NCT00817999|Platelet Aggregation Inhibition|platelet aggregation inhibition
652749|NCT00817986|Acute back pain in the lumbar region|acute back pain in the lumbar region
652750|NCT00817973|Whey protein|whey protein
652751|NCT00817973|gluten|gluten
652752|NCT00817973|casein|casein
652753|NCT00817973|cod protein|cod protein
652754|NCT00817973|GLP-1|glp-1
652755|NCT00817973|postprandial|postprandial
652756|NCT00817973|triglyceride|triglyceride
652757|NCT00817973|free fatty acids|free fatty acids
652758|NCT00817973|chylomicrons|chylomicrons
652759|NCT00817973|retinyl palmitate|retinyl palmitate
652760|NCT00817973|type 2 diabetes|type 2 diabetes
652761|NCT00817973|GIP|gip
652762|NCT00817973|Postprandial incretins|postprandial incretins
652763|NCT00817960|Dual tasking|dual tasking
652764|NCT00817960|Postural Control|postural control
652765|NCT00817960|Methylphenidate (Ritalin)|methylphenidate (ritalin)
652766|NCT00817960|old adults|old adults
652767|NCT00817947|Airway clearance|airway clearance
652768|NCT00817947|Cystic fibrosis|cystic fibrosis
652769|NCT00817947|High frequency chest wall oscillation|high frequency chest wall oscillation
652770|NCT00817934|Efficacy|efficacy
652771|NCT00817934|patient's tolerance|patient's tolerance
652772|NCT00817934|patient's safety|patient's safety
652773|NCT00817921|premature renal function|premature renal function
652774|NCT00817921|ibuprofen|ibuprofen
652775|NCT00817921|blood pressure|blood pressure
652776|NCT00817921|Renal function|renal function
652777|NCT00817908|liver transplant|liver transplant
652778|NCT00817908|lung transplant|lung transplant
652779|NCT00817908|kidney transplant|kidney transplant
652780|NCT00817908|heart transplant|heart transplant
652781|NCT00817908|CMV CMI|cmv cmi
652782|NCT00817908|Transplant|transplant
652783|NCT00817895|hepatocellular carcinoma|hepatocellular carcinoma
652784|NCT00817895|liver resection|liver resection
652785|NCT00817895|intraoperative chemotherapy|intraoperative chemotherapy
652786|NCT00817882|vocational|vocational
652787|NCT00817882|rehabilitation|rehabilitation
652788|NCT00817882|work|work
652789|NCT00817882|ability|ability
652790|NCT00817882|low back pain|low back pain
652791|NCT00817869|Floors and Floorcoverings|floors and floorcoverings
652792|NCT00817869|Health Services for the Aged|health services for the aged
652793|NCT00817869|Fractures, bone|fractures, bone
652794|NCT00817869|Delirium, Dementia, Amnestic, Cognitive Disorders|delirium, dementia, amnestic, cognitive disorders
652795|NCT00817869|Frail Elderly|frail elderly
652796|NCT00817869|Aged, 80 and over|aged, 80 and over
652797|NCT00817843|Postprandial hypertriglyceridemia|postprandial hypertriglyceridemia
652798|NCT00817843|Metabolic syndrome|metabolic syndrome
652799|NCT00817843|Endothelial function|endothelial function
652800|NCT00817843|Flow mediated dilatation|flow mediated dilatation
652801|NCT00817843|EndoPAT|endopat
652802|NCT00817843|Simvastatin|simvastatin
652803|NCT00817843|Ezetimibe|ezetimibe
652804|NCT00817830|Coronaropathy|coronaropathy
652805|NCT00817830|lodenafil carbonate|lodenafil carbonate
652806|NCT00817830|Erectile dysfunction|erectile dysfunction
652807|NCT00817830|Treatment|treatment
652808|NCT00817830|QT interval|qt interval
652809|NCT00817830|Phosphodiesterase inhibitors|phosphodiesterase inhibitors
652810|NCT00817830|Cardiac arrhythmia|cardiac arrhythmia
652811|NCT00817830|Effort testPhosphodiesterase 5 inhibitors|effort testphosphodiesterase 5 inhibitors
652812|NCT00817830|Cardiovascular test|cardiovascular test
652813|NCT00817804|noninvasive ventilation|noninvasive ventilation
652815|NCT00817791|hyperbaric oxygen|hyperbaric oxygen
652816|NCT00817791|preconditioning|preconditioning
652817|NCT00817791|S100B|s100b
652818|NCT00817791|NSE|nse
652819|NCT00817791|Troponin I|troponin i
652820|NCT00817791|CABG surgery|cabg surgery
652821|NCT00817791|neuroprotection|neuroprotection
652822|NCT00817778|Type II Diabetes|type ii diabetes
652823|NCT00817765|interaction|interaction
652824|NCT00817765|pharmacokinetics|pharmacokinetics
652825|NCT00817765|boosting|boosting
652826|NCT00817765|drug-drug interaction|drug-drug interaction
652827|NCT00817765|safety|safety
652828|NCT00817752|stress|stress
652829|NCT00817752|inflammation|inflammation
652830|NCT00817752|natural remedy|natural remedy
652831|NCT00817752|cytokines|cytokines
652832|NCT00817752|interleukin|interleukin
652833|NCT00817752|inflammatory conditions|inflammatory conditions
652834|NCT00817752|auto-immune disorders|auto-immune disorders
652835|NCT00817739|Drug therapy|drug therapy
652836|NCT00817726|Rapid Eye Movement Sleep Behavior Disorder|rapid eye movement sleep behavior disorder
652837|NCT00817726|Parkinson's Disease|parkinson's disease
652838|NCT00817726|Parkinsonian Syndromes|parkinsonian syndromes
652839|NCT00817726|Atypical Parkinson's|atypical parkinson's
652840|NCT00817726|RBD|rbd
652841|NCT00817726|PD|pd
652842|NCT00817726|fMRI|fmri
652843|NCT00817726|PSP|psp
652844|NCT00817726|MSA|msa
652845|NCT00817713|Human Immunodeficiency Virus|human immunodeficiency virus
652846|NCT00817713|Helminthiasis|helminthiasis
652847|NCT00817713|treatment naive|treatment naive
652848|NCT00817713|co-infection|co-infection
652849|NCT00817713|immune modulation|immune modulation
652850|NCT00817700|Sleep|sleep
652851|NCT00817700|young adults|young adults
652852|NCT00817700|middle-age adults|middle-age adults
652853|NCT00817700|older adults|older adults
652854|NCT00817674|CKD|ckd
652855|NCT00817674|Kidney Disease|kidney disease
652856|NCT00817674|poor sleep|poor sleep
652857|NCT00817674|CKD progression|ckd progression
652858|NCT00817661|vitamin A|vitamin a
652859|NCT00817661|influenza vaccine|influenza vaccine
652860|NCT00817661|passive immunity|passive immunity
652861|NCT00817661|pregnant mothers|pregnant mothers
652862|NCT00817661|vitamin A suplementation|vitamin a suplementation
652863|NCT00817661|Influenza vaccination|influenza vaccination
652864|NCT00817661|Infant immune responses|infant immune responses
652865|NCT00817648|schizophrenia|schizophrenia
652866|NCT00817648|antipsychotics|antipsychotics
652867|NCT00817648|quetiapine|quetiapine
652868|NCT00817648|risperidone|risperidone
652869|NCT00817648|efficacy|efficacy
652870|NCT00817648|safety|safety
652871|NCT00817648|multicenter|multicenter
652872|NCT00817648|rater-blind|rater-blind
652873|NCT00817648|randomized|randomized
652874|NCT00817648|chinese|chinese
652875|NCT00817648|han|han
652876|NCT00817635|Blood Pressure|blood pressure
652877|NCT00817635|Hypertension|hypertension
652878|NCT00817635|Resistant Hypertension|resistant hypertension
652879|NCT00817622|diabetes mellitus type 2|diabetes mellitus type 2
652880|NCT00817622|EPA|epa
652881|NCT00817622|leptin|leptin
652882|NCT00817622|adiponectin|adiponectin
652883|NCT00817609|Angongniuhuang Pill|angongniuhuang pill
652884|NCT00817609|consciousness level of patients who suffered from a stroke|consciousness level of patients who suffered from a stroke
652885|NCT00817583|Phase 2 Clinical Trial|phase 2 clinical trial
652886|NCT00817583|NPC|npc
652887|NCT00817583|neoadjuvant chemotherapy|neoadjuvant chemotherapy
652888|NCT00817583|concurrent chemoradiation|concurrent chemoradiation
652889|NCT00817570|Trans Femoral Amputees Balance Reactions|trans femoral amputees balance reactions
652890|NCT00817557|Contact lenses|contact lenses
652891|NCT00817557|Loteprednol|loteprednol
652892|NCT00817557|Effect on CL dryness|effect on cl dryness
652893|NCT00817544|3098004|3098004
652894|NCT00817544|Healthy volunteers|healthy volunteers
652895|NCT00817531|Breast Cancer|breast cancer
652896|NCT00817505|Type I diabetes|type i diabetes
652897|NCT00817505|bioavailability|bioavailability
652898|NCT00817492|Sleep|sleep
652899|NCT00817492|CKD|ckd
652900|NCT00817492|kidney|kidney
652901|NCT00817492|PSG|psg
652902|NCT00817492|polysomnography|polysomnography
652903|NCT00817492|Decreased sleep time|decreased sleep time
652904|NCT00817492|Decreased sleep quality|decreased sleep quality
711013|NCT00586859|NDO Full-thickness Plicator|ndo full-thickness plicator
652905|NCT00817479|Subject has intraabdominal disease either proven or strongly|subject has intraabdominal disease either proven or strongly
652906|NCT00817479|suspected to be ovarian or primary peritoneal cancer|suspected to be ovarian or primary peritoneal cancer
652907|NCT00817466|bronchiolitis|bronchiolitis
652908|NCT00817466|infants|infants
652909|NCT00817466|racemic adrenaline|racemic adrenaline
652910|NCT00817466|inhalations|inhalations
652911|NCT00817466|treatment|treatment
652912|NCT00817453|Parkinson's Disease|parkinson's disease
652913|NCT00817440|growth hormone insulin signaltransduction signalpathways|growth hormone insulin signaltransduction signalpathways
652914|NCT00817440|growth hormone and insulin signalpathways|growth hormone and insulin signalpathways
652915|NCT00817427|Chronic Kidney Disease|chronic kidney disease
652916|NCT00817427|Poor sleep|poor sleep
652917|NCT00817427|CKD|ckd
652918|NCT00817427|Kidney Failure|kidney failure
652919|NCT00817414|Blood Pressure|blood pressure
652920|NCT00817414|Hypertension|hypertension
652921|NCT00817414|Cortisol|cortisol
652922|NCT00817401|asphyxia|asphyxia
652923|NCT00817401|hypothermia|hypothermia
652924|NCT00817401|hypoxic-ischemic encephalopathy|hypoxic-ischemic encephalopathy
652925|NCT00817401|neonates|neonates
652926|NCT00817388|Interstitial cystitis|interstitial cystitis
652927|NCT00817388|pelvic pain|pelvic pain
652928|NCT00817375|Pharmacogenomics|pharmacogenomics
652929|NCT00817375|Prediction of Antidepressant Response|prediction of antidepressant response
652930|NCT00817375|Depressed Patients|depressed patients
652931|NCT00817362|Breast Cancer|breast cancer
652932|NCT00817362|Advanced Breast Cancer|advanced breast cancer
652933|NCT00817362|Metastatic Breast Cancer|metastatic breast cancer
652934|NCT00817362|HER2 Positive Breast Cancer|her2 positive breast cancer
652935|NCT00817362|Cancer of the breast|cancer of the breast
652936|NCT00817362|Trastuzumab|trastuzumab
652937|NCT00817362|Herceptin|herceptin
652938|NCT00817349|Angio-Seal|angio-seal
652939|NCT00817349|Peripheral vascular disease|peripheral vascular disease
652940|NCT00817349|Vascular closure device|vascular closure device
652941|NCT00817349|Arterial closure|arterial closure
652942|NCT00817349|Coronary artery disease|coronary artery disease
652943|NCT00817349|Arterial hemostasis|arterial hemostasis
652944|NCT00817349|Coronary cardiac catheterization|coronary cardiac catheterization
652945|NCT00817349|Percutaneous coronary intervention|percutaneous coronary intervention
652946|NCT00817349|Interventional catheterization|interventional catheterization
652947|NCT00817349|Diagnostic catheterization|diagnostic catheterization
652948|NCT00817349|Common femoral artery|common femoral artery
652949|NCT00817349|Manual compression|manual compression
652950|NCT00817349|Vascular intervention|vascular intervention
652951|NCT00817349|Angiogram|angiogram
652952|NCT00817349|Coronary intervention|coronary intervention
652953|NCT00817349|Coronary angioplasty|coronary angioplasty
652954|NCT00817349|Angiography|angiography
652955|NCT00817349|Arteriotomy|arteriotomy
652956|NCT00817349|Vascular access|vascular access
652957|NCT00817336|biomarker|biomarker
652958|NCT00817336|EEG|eeg
652959|NCT00817336|schizophrenia|schizophrenia
652960|NCT00817336|NMDA|nmda
652961|NCT00817336|D-serine|d-serine
652962|NCT00817323|bipolar depression|bipolar depression
652963|NCT00817323|atypical antipsychotic|atypical antipsychotic
652964|NCT00817323|remission|remission
652965|NCT00817323|depletion|depletion
652966|NCT00817323|mood|mood
652967|NCT00817297|noninvasive ventilation|noninvasive ventilation
652968|NCT00817284|Newly diagnosed patients with glioblastoma multiforme.|newly diagnosed patients with glioblastoma multiforme.
652969|NCT00817284|Performance status 0-2.|performance status 0-2.
652970|NCT00817271|Type II Diabetes|type ii diabetes
652971|NCT00817271|Counter-regulatory response|counter-regulatory response
652972|NCT00817271|Hypoglycemia|hypoglycemia
652973|NCT00817258|Phase 2 Clinical Trial|phase 2 clinical trial
652974|NCT00817258|NPC|npc
652975|NCT00817258|radiation therapy|radiation therapy
652976|NCT00817258|chemotherapy|chemotherapy
652977|NCT00817245|CSR|csr
652978|NCT00817245|Helicobacter pylori|helicobacter pylori
652979|NCT00817232|tennis elbow|tennis elbow
652980|NCT00817232|microcurrent|microcurrent
652981|NCT00817232|tissue healing|tissue healing
652982|NCT00817206|kidney transplantation|kidney transplantation
652983|NCT00817206|renal transplantation|renal transplantation
652984|NCT00817206|maintenance immunosuppression|maintenance immunosuppression
652985|NCT00817206|tacrolimus|tacrolimus
652986|NCT00817206|Prevention of acute allograft rejection|prevention of acute allograft rejection
652987|NCT00817193|Clinical trial|clinical trial
652988|NCT00817193|Short Physical Performance Battery|short physical performance battery
652989|NCT00817193|Disability|disability
652990|NCT00817193|Senior Housing|senior housing
652991|NCT00817193|Aging|aging
652992|NCT00817180|physiotherapy|physiotherapy
652993|NCT00817180|airway clearance techniques|airway clearance techniques
652994|NCT00817180|Positive Expiratory Pressure Technique|positive expiratory pressure technique
652995|NCT00817180|high frequency Chest Wall Oscillation|high frequency chest wall oscillation
652996|NCT00817180|vest|vest
711014|NCT00586859|Plicator|plicator
652997|NCT00817167|Known or suspected lung disease|known or suspected lung disease
652998|NCT00817167|Candidates for non-emergency bronchoscopy|candidates for non-emergency bronchoscopy
652999|NCT00817154|Older persons with SMI|older persons with smi
653000|NCT00817128|Complex Regional Pain Syndrome Type I|complex regional pain syndrome type i
653001|NCT00817128|Sympathetic Reflex Dystrophy|sympathetic reflex dystrophy
653002|NCT00817128|Pain Exposure Physical Therapy|pain exposure physical therapy
653003|NCT00817128|Pharmacological treatment|pharmacological treatment
653004|NCT00817128|Functional recovery|functional recovery
653005|NCT00817115|Region-of-Interest Imaging|region-of-interest imaging
653006|NCT00817115|X-ray Fovea Imaging|x-ray fovea imaging
653007|NCT00817115|Cardiovascular Diseases|cardiovascular diseases
653008|NCT00817115|Radiation Dosage|radiation dosage
653009|NCT00817115|Radiographic Image Enhancement|radiographic image enhancement
653010|NCT00817115|Radiography, Interventional|radiography, interventional
653011|NCT00817102|coronary artery stenoses|coronary artery stenoses
653012|NCT00817063|retinoid treatment|retinoid treatment
653013|NCT00817063|fingertip dermatitis|fingertip dermatitis
653014|NCT00817063|hyperkeratotic hand eczema|hyperkeratotic hand eczema
653015|NCT00817063|vesicular hand eczema|vesicular hand eczema
653016|NCT00817063|pompholyx|pompholyx
653017|NCT00817037|Chronic kidney disease|chronic kidney disease
653018|NCT00817037|Proteinuria|proteinuria
653019|NCT00817037|Blood pressure|blood pressure
653020|NCT00817037|Arterial stiffness|arterial stiffness
653021|NCT00817037|Endothelin antagonist|endothelin antagonist
653022|NCT00817037|Sitaxsentan|sitaxsentan
653023|NCT00817024|Coronary Heart Disease|coronary heart disease
653024|NCT00817024|PCI|pci
653025|NCT00817024|Traditional Chinese Medicine|traditional chinese medicine
653026|NCT00817024|Quality of Life|quality of life
653027|NCT00817011|depression|depression
653028|NCT00817011|pharmacogenomics|pharmacogenomics
653029|NCT00817011|antidepressant response|antidepressant response
653030|NCT00817011|biological markers|biological markers
653031|NCT00817011|clinical variables|clinical variables
653032|NCT00816998|Radius fractures|radius fractures
653033|NCT00816985|Female|female
653034|NCT00816985|Lymphedema|lymphedema
653035|NCT00816959|Lymphocytic Predominant Hodgkin's Lymphoma|lymphocytic predominant hodgkin's lymphoma
653036|NCT00816959|Late, widespread and recurrent LPHD|late, widespread and recurrent lphd
653037|NCT00816946|malnutrition|malnutrition
653038|NCT00816946|growth|growth
653039|NCT00816933|pain|pain
653040|NCT00816933|operative times|operative times
653041|NCT00816933|complication|complication
653042|NCT00816933|time to return for normal life|time to return for normal life
653043|NCT00816933|pain using VAS score|pain using vas score
653044|NCT00816920|distal DVT|distal dvt
653045|NCT00816920|calf DVT|calf dvt
653046|NCT00816920|DVT diagnosis|dvt diagnosis
653047|NCT00816920|management of patients with suspected leg DVT|management of patients with suspected leg dvt
653048|NCT00816907|Schizoaffective Disorder|schizoaffective disorder
653049|NCT00816894|schizophrenia|schizophrenia
653050|NCT00816894|treatment resistance|treatment resistance
653051|NCT00816894|D-serine|d-serine
653052|NCT00816894|Olanzapine|olanzapine
653053|NCT00816894|treatment refractory schizophrenia|treatment refractory schizophrenia
653054|NCT00816881|Pulmonary Disease, Chronic Obstructive|pulmonary disease, chronic obstructive
653055|NCT00816881|flutter|flutter
653056|NCT00816881|airway clearance|airway clearance
653057|NCT00816881|sputum|sputum
653058|NCT00816881|Physical Therapy Techniques|physical therapy techniques
653059|NCT00816868|stage IIIB/IV adenocarcinoma non-small cell lung cancer|stage iiib/iv adenocarcinoma non-small cell lung cancer
653060|NCT00816855|Phase 2 Clinical Trial|phase 2 clinical trial
653062|NCT00816855|neoadjuvant chemotherapy|neoadjuvant chemotherapy
653063|NCT00816855|concurrent chemoradiation|concurrent chemoradiation
653064|NCT00816842|citrulline|citrulline
653065|NCT00816842|malabsorption|malabsorption
653066|NCT00816842|Villous atrophy|villous atrophy
653067|NCT00816842|enteropathy|enteropathy
653068|NCT00816829|Dyslipidemia|dyslipidemia
653069|NCT00816829|Sleep Apnea Syndromes|sleep apnea syndromes
653070|NCT00816829|Fenofibrate|fenofibrate
653071|NCT00816829|Obese|obese
653072|NCT00816829|Overweight or obese patients|overweight or obese patients
653073|NCT00816816|Phase 2 Clinical Trial|phase 2 clinical trial
653074|NCT00816816|NPC|npc
653075|NCT00816816|neoadjuvant chemotherapy|neoadjuvant chemotherapy
653076|NCT00816816|concurrent chemoradiation|concurrent chemoradiation
653077|NCT00816803|Spinal cord injury|spinal cord injury
653078|NCT00816790|Septic shock|septic shock
653079|NCT00816790|Acute Renal Failure|acute renal failure
653080|NCT00816790|Antimicrobial|antimicrobial
653081|NCT00816790|Drug Dosing|drug dosing
653082|NCT00816790|Feasibility Study|feasibility study
653083|NCT00816777|Cancer|cancer
653084|NCT00816777|Carcinoma|carcinoma
653085|NCT00816777|Colon Cancer|colon cancer
653086|NCT00816777|Colorectal Cancer|colorectal cancer
653087|NCT00816777|Gastric Cancer|gastric cancer
653088|NCT00816777|Gastrointestinal Cancer|gastrointestinal cancer
653089|NCT00816777|Metastases|metastases
653090|NCT00816777|Metastatic Cancer|metastatic cancer
653091|NCT00816777|Metastatic Colorectal Cancer|metastatic colorectal cancer
653092|NCT00816777|Oncology|oncology
653093|NCT00816777|Rectal Cancer|rectal cancer
653094|NCT00816764|clinical trial, phase 1|clinical trial, phase 1
653095|NCT00816764|carcinoma|carcinoma
653096|NCT00816764|pharmacokinetics|pharmacokinetics
653097|NCT00816764|safety|safety
653098|NCT00816764|ovarian|ovarian
653099|NCT00816751|Local anesthesia|local anesthesia
653100|NCT00816751|Paracervical|paracervical
653101|NCT00816751|Intracervical|intracervical
653102|NCT00816751|Abortion|abortion
653103|NCT00816751|Pain|pain
653194|NCT00816465|NASH|nash
653104|NCT00816751|Local anesthesia for elective first trimester abortion|local anesthesia for elective first trimester abortion
653105|NCT00816738|Nd: YAG laser|nd: yag laser
653106|NCT00816738|recurrent corneal erosions|recurrent corneal erosions
653107|NCT00816738|trauma|trauma
653108|NCT00816738|anterior stromal puncture|anterior stromal puncture
653109|NCT00816725|Postnatal Depression|postnatal depression
653110|NCT00816725|Cognitive Behavioral Therapy|cognitive behavioral therapy
653111|NCT00816725|Mood Management|mood management
653112|NCT00816725|Self-help|self-help
653113|NCT00816725|Internet|internet
653114|NCT00816712|Males with low-normal serum total testosterone levels.|males with low-normal serum total testosterone levels.
653115|NCT00816699|Anxiety|anxiety
653116|NCT00816699|preprint anesthetic risk information|preprint anesthetic risk information
653117|NCT00816686|clinical trial, phase 1|clinical trial, phase 1
653118|NCT00816686|carcinoma, advanced renal cell|carcinoma, advanced renal cell
653119|NCT00816686|kidney|kidney
653120|NCT00816686|pharmacokinetics|pharmacokinetics
653121|NCT00816686|safety|safety
653122|NCT00816686|AGS-16M18|ags-16m18
653123|NCT00816673|Insomnia|insomnia
653124|NCT00816673|Primary insomnia|primary insomnia
653125|NCT00816673|sleep latency|sleep latency
653126|NCT00816673|non restorative sleep|non restorative sleep
653127|NCT00816673|sleep quality|sleep quality
653128|NCT00816673|Double-Blind|double-blind
653129|NCT00816673|Placebo Controlled|placebo controlled
653130|NCT00816673|Parallel-Group|parallel-group
653131|NCT00816673|Sleep Laboratory Study|sleep laboratory study
653132|NCT00816647|Patella|patella
653133|NCT00816647|Dislocation|dislocation
653134|NCT00816647|Knee|knee
653135|NCT00816647|Medial Patellofemoral Ligament|medial patellofemoral ligament
653136|NCT00816634|First line chemotherapy|first line chemotherapy
653137|NCT00816634|Advanced or recurrent esophageal squamous cell carcinoma|advanced or recurrent esophageal squamous cell carcinoma
653138|NCT00816621|Internationally Adopted Children|internationally adopted children
653139|NCT00816621|Adoption|adoption
653140|NCT00816621|Attachment|attachment
653141|NCT00816621|Inattention|inattention
653142|NCT00816621|Prevention|prevention
653143|NCT00816608|diabetes|diabetes
653144|NCT00816608|prediabetes|prediabetes
653145|NCT00816608|impaired fasting glucose (IFG)|impaired fasting glucose (ifg)
653146|NCT00816608|impaired glucose tolerance (IGT)|impaired glucose tolerance (igt)
653147|NCT00816608|body weight|body weight
653148|NCT00816595|B-cell chronic lymphocytic leukemia|b-cell chronic lymphocytic leukemia
653149|NCT00816595|stage 0 chronic lymphocytic leukemia|stage 0 chronic lymphocytic leukemia
653150|NCT00816595|stage I chronic lymphocytic leukemia|stage i chronic lymphocytic leukemia
653151|NCT00816595|stage II chronic lymphocytic leukemia|stage ii chronic lymphocytic leukemia
653152|NCT00816595|stage III chronic lymphocytic leukemia|stage iii chronic lymphocytic leukemia
653153|NCT00816595|stage IV chronic lymphocytic leukemia|stage iv chronic lymphocytic leukemia
653154|NCT00816595|stage I small lymphocytic lymphoma|stage i small lymphocytic lymphoma
653155|NCT00816595|stage III small lymphocytic lymphoma|stage iii small lymphocytic lymphoma
653156|NCT00816595|stage IV small lymphocytic lymphoma|stage iv small lymphocytic lymphoma
653157|NCT00816595|contiguous stage II small lymphocytic lymphoma|contiguous stage ii small lymphocytic lymphoma
653158|NCT00816595|noncontiguous stage II small lymphocytic lymphoma|noncontiguous stage ii small lymphocytic lymphoma
653159|NCT00816582|Post-menopausal hormone receptor positive recurrent/metastatic breast cancer.|post-menopausal hormone receptor positive recurrent/metastatic breast cancer.
653161|NCT00816582|Recurrent or metastatic|recurrent or metastatic
653162|NCT00816569|Orthokeratology|orthokeratology
653163|NCT00816569|Keratoconus|keratoconus
653164|NCT00816530|breast|breast
653165|NCT00816530|breast cancer|breast cancer
653166|NCT00816530|breast screening|breast screening
653167|NCT00816530|breast cancer screening|breast cancer screening
653168|NCT00816530|ultrasound|ultrasound
653169|NCT00816530|ultrasonography|ultrasonography
653170|NCT00816530|mammogram|mammogram
653171|NCT00816530|mammography|mammography
653172|NCT00816530|breast density|breast density
653173|NCT00816530|dense breasts|dense breasts
653174|NCT00816530|early detection|early detection
653175|NCT00816530|somo v|somo v
653176|NCT00816530|somo•v|somo•v
653177|NCT00816530|U-Systems|u-systems
653178|NCT00816530|Automated Breast Ultrasound|automated breast ultrasound
653179|NCT00816530|Ultrasonography, Mammary|ultrasonography, mammary
653180|NCT00816530|Breast Neoplasms|breast neoplasms
653181|NCT00816530|Breast Density > 50% (BI-RADS III & IV)|breast density > 50% (bi-rads iii & iv)
653182|NCT00816517|Psoriasis|psoriasis
653183|NCT00816517|Botulinum toxin|botulinum toxin
653184|NCT00816504|FSGS|fsgs
653185|NCT00816504|Permeability factor|permeability factor
653186|NCT00816504|Galactose|galactose
653187|NCT00816504|Primary FSGS, resistant to immunosuppressive medication|primary fsgs, resistant to immunosuppressive medication
653188|NCT00816491|patient with long-standing UC|patient with long-standing uc
653189|NCT00816478|FSGS|fsgs
653190|NCT00816478|Permeability factor|permeability factor
653191|NCT00816478|Galactose|galactose
653192|NCT00816478|Primary FSGS, resistant to immunosuppressive medication|primary fsgs, resistant to immunosuppressive medication
653193|NCT00816465|Hoodia gordoni|hoodia gordoni
653195|NCT00816465|NAFLD|nafld
653196|NCT00816452|Osteoporosis|osteoporosis
653197|NCT00816452|Prostate Cancer|prostate cancer
653198|NCT00816452|Osteoporosis in male with Prostate Cancer|osteoporosis in male with prostate cancer
653199|NCT00816439|Positron Emission Tomography|positron emission tomography
653200|NCT00816439|Brain Imaging|brain imaging
653201|NCT00816439|Alcoholism|alcoholism
653202|NCT00816426|Tuberculosis|tuberculosis
653203|NCT00816426|Lesions|lesions
653204|NCT00816426|Pharmacokinetics|pharmacokinetics
653205|NCT00816426|Maldistribution|maldistribution
653206|NCT00816426|Histopathology|histopathology
653207|NCT00816413|adult acute myeloid leukemia with 11q23 (MLL) abnormalities|adult acute myeloid leukemia with 11q23 (mll) abnormalities
653208|NCT00816413|adult acute myeloid leukemia with inv(16)(p13;q22)|adult acute myeloid leukemia with inv(16)(p13;q22)
653209|NCT00816413|adult acute myeloid leukemia with t(15;17)(q22;q12)|adult acute myeloid leukemia with t(15;17)(q22;q12)
653210|NCT00816413|adult acute myeloid leukemia with t(16;16)(p13;q22)|adult acute myeloid leukemia with t(16;16)(p13;q22)
653211|NCT00816413|adult acute myeloid leukemia with t(8;21)(q22;q22)|adult acute myeloid leukemia with t(8;21)(q22;q22)
653212|NCT00816413|adult acute myeloid leukemia in remission|adult acute myeloid leukemia in remission
653213|NCT00816413|recurrent adult acute myeloid leukemia|recurrent adult acute myeloid leukemia
653214|NCT00816413|secondary acute myeloid leukemia|secondary acute myeloid leukemia
653215|NCT00816413|adult acute lymphoblastic leukemia in remission|adult acute lymphoblastic leukemia in remission
653216|NCT00816413|recurrent adult acute lymphoblastic leukemia|recurrent adult acute lymphoblastic leukemia
653217|NCT00816413|accelerated phase chronic myelogenous leukemia|accelerated phase chronic myelogenous leukemia
653218|NCT00816413|blastic phase chronic myelogenous leukemia|blastic phase chronic myelogenous leukemia
653219|NCT00816413|chronic phase chronic myelogenous leukemia|chronic phase chronic myelogenous leukemia
653220|NCT00816413|relapsing chronic myelogenous leukemia|relapsing chronic myelogenous leukemia
653221|NCT00816413|chronic myelomonocytic leukemia|chronic myelomonocytic leukemia
653222|NCT00816413|de novo myelodysplastic syndromes|de novo myelodysplastic syndromes
653223|NCT00816413|previously treated myelodysplastic syndromes|previously treated myelodysplastic syndromes
653224|NCT00816413|secondary myelodysplastic syndromes|secondary myelodysplastic syndromes
653225|NCT00816413|essential thrombocythemia|essential thrombocythemia
653226|NCT00816413|polycythemia vera|polycythemia vera
653227|NCT00816413|primary myelofibrosis|primary myelofibrosis
653228|NCT00816413|stage III mantle cell lymphoma|stage iii mantle cell lymphoma
653229|NCT00816413|stage IV mantle cell lymphoma|stage iv mantle cell lymphoma
653230|NCT00816413|extranodal marginal zone B-cell lymphoma of mucosa-associated lymphoid tissue|extranodal marginal zone b-cell lymphoma of mucosa-associated lymphoid tissue
653231|NCT00816413|nodal marginal zone B-cell lymphoma|nodal marginal zone b-cell lymphoma
653232|NCT00816413|splenic marginal zone lymphoma|splenic marginal zone lymphoma
653233|NCT00816413|stage III adult lymphoblastic lymphoma|stage iii adult lymphoblastic lymphoma
653234|NCT00816413|stage IV adult lymphoblastic lymphoma|stage iv adult lymphoblastic lymphoma
653235|NCT00816413|aplastic anemia|aplastic anemia
653236|NCT00816413|chronic eosinophilic leukemia|chronic eosinophilic leukemia
653237|NCT00816413|chronic neutrophilic leukemia|chronic neutrophilic leukemia
653238|NCT00816413|contiguous stage II adult diffuse small cleaved cell lymphoma|contiguous stage ii adult diffuse small cleaved cell lymphoma
653239|NCT00816413|noncontiguous stage II adult diffuse small cleaved cell lymphoma|noncontiguous stage ii adult diffuse small cleaved cell lymphoma
653240|NCT00816413|stage I adult diffuse small cleaved cell lymphoma|stage i adult diffuse small cleaved cell lymphoma
653241|NCT00816413|stage III adult diffuse small cleaved cell lymphoma|stage iii adult diffuse small cleaved cell lymphoma
653242|NCT00816413|stage IV adult diffuse small cleaved cell lymphoma|stage iv adult diffuse small cleaved cell lymphoma
653243|NCT00816413|contiguous stage II grade 1 follicular lymphoma|contiguous stage ii grade 1 follicular lymphoma
653244|NCT00816413|contiguous stage II grade 2 follicular lymphoma|contiguous stage ii grade 2 follicular lymphoma
653245|NCT00816413|noncontiguous stage II grade 1 follicular lymphoma|noncontiguous stage ii grade 1 follicular lymphoma
653246|NCT00816413|noncontiguous stage II grade 2 follicular lymphoma|noncontiguous stage ii grade 2 follicular lymphoma
653247|NCT00816413|stage I grade 1 follicular lymphoma|stage i grade 1 follicular lymphoma
653248|NCT00816413|stage I grade 2 follicular lymphoma|stage i grade 2 follicular lymphoma
653249|NCT00816413|stage III grade 1 follicular lymphoma|stage iii grade 1 follicular lymphoma
653250|NCT00816413|stage III grade 2 follicular lymphoma|stage iii grade 2 follicular lymphoma
653251|NCT00816413|stage IV grade 1 follicular lymphoma|stage iv grade 1 follicular lymphoma
653252|NCT00816413|stage IV grade 2 follicular lymphoma|stage iv grade 2 follicular lymphoma
653253|NCT00816413|contiguous stage II marginal zone lymphoma|contiguous stage ii marginal zone lymphoma
653254|NCT00816413|noncontiguous stage II marginal zone lymphoma|noncontiguous stage ii marginal zone lymphoma
653255|NCT00816413|stage I marginal zone lymphoma|stage i marginal zone lymphoma
653256|NCT00816413|stage III marginal zone lymphoma|stage iii marginal zone lymphoma
653257|NCT00816413|stage IV marginal zone lymphoma|stage iv marginal zone lymphoma
653258|NCT00816413|contiguous stage II small lymphocytic lymphoma|contiguous stage ii small lymphocytic lymphoma
653259|NCT00816413|noncontiguous stage II small lymphocytic lymphoma|noncontiguous stage ii small lymphocytic lymphoma
653260|NCT00816413|stage I small lymphocytic lymphoma|stage i small lymphocytic lymphoma
653261|NCT00816413|stage III small lymphocytic lymphoma|stage iii small lymphocytic lymphoma
655040|NCT00809835|Methadone|methadone
653262|NCT00816413|stage IV small lymphocytic lymphoma|stage iv small lymphocytic lymphoma
653263|NCT00816413|contiguous stage II mantle cell lymphoma|contiguous stage ii mantle cell lymphoma
653264|NCT00816413|noncontiguous stage II mantle cell lymphoma|noncontiguous stage ii mantle cell lymphoma
653265|NCT00816413|stage I mantle cell lymphoma|stage i mantle cell lymphoma
653266|NCT00816413|contiguous stage II adult lymphoblastic lymphoma|contiguous stage ii adult lymphoblastic lymphoma
653267|NCT00816413|noncontiguous stage II adult lymphoblastic lymphoma|noncontiguous stage ii adult lymphoblastic lymphoma
653268|NCT00816413|stage I adult lymphoblastic lymphoma|stage i adult lymphoblastic lymphoma
653269|NCT00816413|stage I chronic lymphocytic leukemia|stage i chronic lymphocytic leukemia
653270|NCT00816413|stage II chronic lymphocytic leukemia|stage ii chronic lymphocytic leukemia
653271|NCT00816413|stage III chronic lymphocytic leukemia|stage iii chronic lymphocytic leukemia
653272|NCT00816413|stage IV chronic lymphocytic leukemia|stage iv chronic lymphocytic leukemia
653273|NCT00816374|cutaneous malignant melanoma|cutaneous malignant melanoma
653274|NCT00816374|CMM|cmm
653275|NCT00816374|total cutaneous examination|total cutaneous examination
653276|NCT00816374|TCE|tce
653277|NCT00816374|skin self-examination|skin self-examination
653278|NCT00816374|SSE|sse
653279|NCT00816374|first degree relatives|first degree relatives
653280|NCT00816374|FDR|fdr
653281|NCT00816374|skin cancer protection|skin cancer protection
653282|NCT00816374|skin cancer screening|skin cancer screening
653283|NCT00816348|Cholestasis|cholestasis
653284|NCT00816348|Parenteral Nutrition Associated Liver Disease|parenteral nutrition associated liver disease
653285|NCT00816335|unspecified adult solid tumor, protocol specific|unspecified adult solid tumor, protocol specific
653286|NCT00816309|physiotherapy|physiotherapy
653287|NCT00816309|bronchiectasis|bronchiectasis
653288|NCT00816296|NAFLD|nafld
653289|NCT00816296|Obesity|obesity
653290|NCT00816296|Microbiome|microbiome
653291|NCT00816283|accelerated phase chronic myelogenous leukemia|accelerated phase chronic myelogenous leukemia
653292|NCT00816283|blastic phase chronic myelogenous leukemia|blastic phase chronic myelogenous leukemia
653293|NCT00816283|relapsing chronic myelogenous leukemia|relapsing chronic myelogenous leukemia
653294|NCT00816283|Philadelphia chromosome positive adult precursor acute lymphoblastic leukemia|philadelphia chromosome positive adult precursor acute lymphoblastic leukemia
653295|NCT00816283|recurrent adult acute lymphoblastic leukemia|recurrent adult acute lymphoblastic leukemia
653296|NCT00816283|untreated adult acute lymphoblastic leukemia|untreated adult acute lymphoblastic leukemia
653297|NCT00816270|Blepharoptosis|blepharoptosis
653298|NCT00816270|Dermatochalasis|dermatochalasis
653299|NCT00816270|octyl 2-cyanoacrylate|octyl 2-cyanoacrylate
653300|NCT00816270|Suture Techniques|suture techniques
653301|NCT00816270|Tissue Adhesive|tissue adhesive
653302|NCT00816257|lung tissue repository|lung tissue repository
653303|NCT00816244|Breast cancer|breast cancer
653304|NCT00816244|Postmenopausal|postmenopausal
653305|NCT00816244|Neo-adjuvant|neo-adjuvant
653306|NCT00816244|Tumor proliferation|tumor proliferation
653307|NCT00816244|Statin|statin
653308|NCT00816244|Atorvastatin|atorvastatin
653309|NCT00816244|Ki67|ki67
653310|NCT00816244|Translational research|translational research
653311|NCT00816244|Cell cycle regulators|cell cycle regulators
653312|NCT00816244|Gene expression|gene expression
653313|NCT00816244|Genomic profiling|genomic profiling
653314|NCT00816244|Apoptosis|apoptosis
653315|NCT00816244|Window-of-opportunity|window-of-opportunity
653316|NCT00816231|Prevention Intervention|prevention intervention
653317|NCT00816231|Alcohol|alcohol
653318|NCT00816231|Tobacco|tobacco
653319|NCT00816231|Nicotine|nicotine
653320|NCT00816231|Craving|craving
653321|NCT00816231|Cue Reactivity|cue reactivity
653322|NCT00816231|Cross Cue Reactions|cross cue reactions
653323|NCT00816192|FA|fa
653324|NCT00816192|Atrial fibrillation|atrial fibrillation
653325|NCT00816192|Catheter|catheter
653326|NCT00816192|Ablation|ablation
653327|NCT00816192|RF|rf
653328|NCT00816179|Pancreatic head mass|pancreatic head mass
653329|NCT00816179|Pancreatic cancer|pancreatic cancer
653330|NCT00816179|NOTES|notes
653331|NCT00816179|Endoscopic peritoneoscopy|endoscopic peritoneoscopy
653332|NCT00816179|Whipple|whipple
653333|NCT00816179|palliative gastrojejunostomy|palliative gastrojejunostomy
653334|NCT00816166|Ischemic stroke|ischemic stroke
653335|NCT00816166|Transient Ischemic Attack|transient ischemic attack
653336|NCT00816166|Intracranial Stenting|intracranial stenting
653337|NCT00816153|Pleth variability Index|pleth variability index
653338|NCT00816153|Fluid management|fluid management
653339|NCT00816153|Fluid management during surgery|fluid management during surgery
653340|NCT00816140|Helicobacter pylori|helicobacter pylori
653341|NCT00816140|levofloxacin|levofloxacin
653342|NCT00816140|clarithromycin|clarithromycin
653343|NCT00816140|ERADICATION RATE|eradication rate
653344|NCT00816127|liver cirrhosis|liver cirrhosis
653345|NCT00816127|coagulopathy|coagulopathy
653346|NCT00816127|desmopressin|desmopressin
653347|NCT00816127|blood transfusion|blood transfusion
653348|NCT00816114|Imatinib|imatinib
653349|NCT00816114|Gleevec|gleevec
653350|NCT00816114|Chronic Myelogenous Leukemia|chronic myelogenous leukemia
653351|NCT00816114|CML|cml
655041|NCT00809835|CBT|cbt
653352|NCT00816101|Curettage and electrodesiccation|curettage and electrodesiccation
653353|NCT00816101|acute wounds|acute wounds
653354|NCT00816101|partial thickness wounds|partial thickness wounds
653355|NCT00816088|chemotherapy|chemotherapy
653356|NCT00816088|Stem cell transplantation|stem cell transplantation
653357|NCT00816075|distilled water|distilled water
653358|NCT00816075|recurrent|recurrent
653359|NCT00816075|bladder|bladder
653360|NCT00816075|mitomycin|mitomycin
653361|NCT00816062|Aortic Aneurysm|aortic aneurysm
653362|NCT00816062|Aneurysm|aneurysm
653363|NCT00816062|Abdominal Aortic Aneurysm|abdominal aortic aneurysm
653364|NCT00816062|Talent|talent
653365|NCT00816062|Medtronic|medtronic
653366|NCT00816049|acute lymphoblastic leukemia|acute lymphoblastic leukemia
653367|NCT00816049|child|child
653368|NCT00816049|6-mercaptopurine|6-mercaptopurine
653369|NCT00816049|minimal residual disease|minimal residual disease
653370|NCT00816049|efficacy|efficacy
653371|NCT00816049|childhood acute lymphoblastic leukemia|childhood acute lymphoblastic leukemia
653372|NCT00816036|Smoking Cessation|smoking cessation
653373|NCT00816036|Practice Guidelines|practice guidelines
653374|NCT00816036|Inpatient|inpatient
653375|NCT00816036|Effectiveness Trial|effectiveness trial
653376|NCT00816036|Veterans Administration|veterans administration
653377|NCT00816036|Relapse prevention|relapse prevention
653378|NCT00816010|drug compliance|drug compliance
653379|NCT00816010|lifestyle modification|lifestyle modification
653380|NCT00815997|radial artery|radial artery
653381|NCT00815997|transradial intervention|transradial intervention
653382|NCT00815997|stent|stent
653383|NCT00815984|Asthma|asthma
653384|NCT00815984|Allergic Rhinitis|allergic rhinitis
653385|NCT00815984|Atopic Dermatitis|atopic dermatitis
653386|NCT00815984|Children|children
653387|NCT00815984|lung function|lung function
653388|NCT00815984|skin prick tests|skin prick tests
653389|NCT00815984|FeNO|feno
653390|NCT00815971|EGFR mutations|egfr mutations
653391|NCT00815971|EGFR inhibitor|egfr inhibitor
653392|NCT00815971|erlotinib|erlotinib
653393|NCT00815958|knee replacement surgery|knee replacement surgery
653394|NCT00815958|Reamer-Irrigator-Aspirator|reamer-irrigator-aspirator
653395|NCT00815958|femoral reaming|femoral reaming
653396|NCT00815958|fat embolism|fat embolism
653397|NCT00815945|leiomyosarcoma|leiomyosarcoma
653398|NCT00815945|carcinosarcoma|carcinosarcoma
653399|NCT00815945|mixed epithelial mesenchymal tumor|mixed epithelial mesenchymal tumor
653400|NCT00815945|endometrial stroma sarcomas|endometrial stroma sarcomas
653401|NCT00815945|Müllerian mixed tumors|müllerian mixed tumors
653402|NCT00815945|carcinosarcoma of the uterus|carcinosarcoma of the uterus
653403|NCT00815945|mesenchymal tumors of the ovary or uterus|mesenchymal tumors of the ovary or uterus
653404|NCT00815945|mixed epithelial mesenchymal tumors of the ovary or uterus|mixed epithelial mesenchymal tumors of the ovary or uterus
653405|NCT00815919|cGVHD|cgvhd
653406|NCT00815919|Velcade|velcade
653407|NCT00815919|bortezomib|bortezomib
653408|NCT00815893|Dexmedetomidine|dexmedetomidine
653409|NCT00815893|Fiberoptic nasal intubation|fiberoptic nasal intubation
653410|NCT00815893|satisfaction|satisfaction
653411|NCT00815880|Heart Failure|heart failure
653412|NCT00815880|Device|device
653413|NCT00815880|Implantable|implantable
653414|NCT00815880|Active|active
653415|NCT00815880|Class III and Class IV|class iii and class iv
653416|NCT00815880|Counterpulsation|counterpulsation
653417|NCT00815867|kidney failure|kidney failure
653418|NCT00815867|kidney transplant|kidney transplant
653419|NCT00815867|graft function|graft function
653420|NCT00815867|haemoglobin|haemoglobin
653421|NCT00815867|epoetin|epoetin
653422|NCT00815854|Antipsychotic|antipsychotic
653423|NCT00815854|Metabolic Syndrome|metabolic syndrome
653424|NCT00815854|Insulin Resistance|insulin resistance
653425|NCT00815854|Endothelial Function|endothelial function
653426|NCT00815841|Determine the effect of MPH on a diagnostic continuous performance task that assesses attention and on a decision making test in young healthy adults|determine the effect of mph on a diagnostic continuous performance task that assesses attention and on a decision making test in young healthy adults
653427|NCT00815828|Gestational Diabetes|gestational diabetes
653428|NCT00815828|Resistance Exercise|resistance exercise
653429|NCT00815828|Pregnancy|pregnancy
653430|NCT00815828|Insulin|insulin
653431|NCT00815815|Anorexia Nervosa|anorexia nervosa
653432|NCT00815802|Children in day care centers|children in day care centers
653433|NCT00815802|cytomegalovirus excretion|cytomegalovirus excretion
653434|NCT00815776|Temporomandibular disorders|temporomandibular disorders
653435|NCT00815763|randomized trial|randomized trial
653436|NCT00815763|ischemic stroke|ischemic stroke
653437|NCT00815763|Ginsenoside-Rd|ginsenoside-rd
653438|NCT00815750|Prostate Cancer|prostate cancer
653439|NCT00815737|Lung Infection After Cerebral Hemorrhage|lung infection after cerebral hemorrhage
653440|NCT00815737|Prevention of Pneumonia|prevention of pneumonia
653441|NCT00815737|Rhubarb|rhubarb
653442|NCT00815724|Daily Inhaled Corticosteroids|daily inhaled corticosteroids
653443|NCT00815724|Distributed Learning|distributed learning
653444|NCT00815724|E-learning|e-learning
653446|NCT00815698|pain|pain
653447|NCT00815685|n-3 fatty acids|n-3 fatty acids
653448|NCT00815685|nutritional treatment|nutritional treatment
653449|NCT00815685|molecular pathogenesis|molecular pathogenesis
653450|NCT00815672|Exercise|exercise
653451|NCT00815672|Prostate cancer|prostate cancer
653452|NCT00815672|Fatigue|fatigue
653453|NCT00815659|plasma lipid profile|plasma lipid profile
653454|NCT00815659|metabolic syndrome|metabolic syndrome
653455|NCT00815646|Immersion pulmonary edema|immersion pulmonary edema
653456|NCT00815646|Diving|diving
653457|NCT00815646|Swimming|swimming
653458|NCT00815646|Pulmonary edema|pulmonary edema
653459|NCT00815646|Cold water immersion|cold water immersion
653460|NCT00815633|PRP|prp
653461|NCT00815633|Pityriasis Rubra Pilaris|pityriasis rubra pilaris
653462|NCT00815633|Amevive|amevive
653463|NCT00815633|Alefacept|alefacept
653464|NCT00815633|Biologic|biologic
653465|NCT00815633|Immunosuppressant|immunosuppressant
653466|NCT00815633|Severe skin disease|severe skin disease
653467|NCT00815620|neuroendocrine tumors|neuroendocrine tumors
653468|NCT00815620|transcatheter arterial chemoembolization|transcatheter arterial chemoembolization
653469|NCT00815620|selective internal radiotherapy|selective internal radiotherapy
653470|NCT00815620|surgery|surgery
653471|NCT00815620|radio-frequency ablation|radio-frequency ablation
653472|NCT00815620|peptide-receptor radiotherapy|peptide-receptor radiotherapy
653473|NCT00815620|progression-free survival|progression-free survival
653474|NCT00815620|quality of life|quality of life
653475|NCT00815620|overall survival|overall survival
653476|NCT00815620|weight|weight
653477|NCT00815620|time of hospitalization|time of hospitalization
653478|NCT00815607|melanoma|melanoma
653479|NCT00815607|biologic|biologic
653480|NCT00815607|immunotherapy|immunotherapy
653481|NCT00815607|cancer|cancer
653482|NCT00815594|bleb|bleb
653483|NCT00815594|vascular change|vascular change
653484|NCT00815594|bevacizumab|bevacizumab
653485|NCT00815594|trabeculectomy|trabeculectomy
653486|NCT00815594|Bleb vascularity associated with increased scarring activity|bleb vascularity associated with increased scarring activity
653487|NCT00815594|Conjunctival scarring finally leads to the obstruction of the fistula tract created by the filtering surgery|conjunctival scarring finally leads to the obstruction of the fistula tract created by the filtering surgery
653488|NCT00815594|the recombinant human anti-VEGF antibody could inhibit angiogenesis of conjunctiva.|the recombinant human anti-vegf antibody could inhibit angiogenesis of conjunctiva.
653489|NCT00815581|children between 1 to 10 years old|children between 1 to 10 years old
653490|NCT00815581|amblyopy|amblyopy
653491|NCT00815568|fludarabine|fludarabine
653492|NCT00815568|busulfan|busulfan
653493|NCT00815568|total body irradiation|total body irradiation
653494|NCT00815568|conditioning regimen|conditioning regimen
653495|NCT00815555|receptor positive breast cancer|receptor positive breast cancer
653496|NCT00815555|Tamoxifen treatment|tamoxifen treatment
653497|NCT00815555|CYP2D6 status|cyp2d6 status
653498|NCT00815555|relapse|relapse
653499|NCT00815529|Acupuncture|acupuncture
653500|NCT00815529|Chronic low back pain|chronic low back pain
653501|NCT00815529|Qualitative study|qualitative study
653502|NCT00815516|candidiasis|candidiasis
653503|NCT00815516|candida|candida
653504|NCT00815516|Neonate|neonate
653505|NCT00815516|candidemia|candidemia
653506|NCT00815516|Micafungin|micafungin
653507|NCT00815516|Mycamine|mycamine
653508|NCT00815516|amphotericin B deoxycholate|amphotericin b deoxycholate
653509|NCT00815503|Anesthetics|anesthetics
653510|NCT00815503|Local infiltration|local infiltration
653511|NCT00815503|Periacetabular osteotomy|periacetabular osteotomy
653512|NCT00815490|Spectroscopy, near infrared|spectroscopy, near infrared
653513|NCT00815490|Oximetry|oximetry
653514|NCT00815490|Hypoxemia|hypoxemia
653515|NCT00815490|Tissue oxygenation|tissue oxygenation
653516|NCT00815464|Chronic Hepatitis B|chronic hepatitis b
653517|NCT00815464|Liquid Acupuncture(Herb Acupoint Injection)|liquid acupuncture(herb acupoint injection)
653518|NCT00815464|Therapeutics|therapeutics
653519|NCT00815464|Herbalist|herbalist
653520|NCT00815464|Acupoint|acupoint
653521|NCT00815438|Transvaginal|transvaginal
653522|NCT00815438|Cholecystectomy|cholecystectomy
653523|NCT00815438|NOTES|notes
653524|NCT00815438|Endoscopic|endoscopic
653525|NCT00815425|African American|african american
653526|NCT00815386|mitral valve|mitral valve
653527|NCT00815386|heart failure|heart failure
653528|NCT00815386|mitral regurgitation|mitral regurgitation
653529|NCT00815386|annuloplasty|annuloplasty
653530|NCT00815386|coronary sinus|coronary sinus
653531|NCT00815373|Ocular Blood flow|ocular blood flow
653532|NCT00815373|Ocular hypertension|ocular hypertension
653533|NCT00815373|POAG|poag
653534|NCT00815373|Ocular hemodynamics|ocular hemodynamics
653535|NCT00815373|Xalacom|xalacom
653536|NCT00815373|Cosopt|cosopt
653537|NCT00815360|diabetic macular edema|diabetic macular edema
653538|NCT00815347|Asthma|asthma
653539|NCT00815334|vesicoureteral reflux|vesicoureteral reflux
653540|NCT00815334|low compliant bladder|low compliant bladder
653541|NCT00815321|chronic myeloid leukemia|chronic myeloid leukemia
653542|NCT00815321|autologous cytokine induced killer cells|autologous cytokine induced killer cells
655143|NCT00809367|AML|aml
653543|NCT00815321|Chronic myeloid leukemia in blast crisis treated with chemotherapy or kinase inhibitors|chronic myeloid leukemia in blast crisis treated with chemotherapy or kinase inhibitors
653544|NCT00815321|Chronic myeloid leukemia with mutation resistant to kinase inhibitors|chronic myeloid leukemia with mutation resistant to kinase inhibitors
653545|NCT00815321|chronic myeloid leukemia with good response to kinase inhibitor and stable persistence of residual disease|chronic myeloid leukemia with good response to kinase inhibitor and stable persistence of residual disease
653546|NCT00815308|Therapeutic|therapeutic
653547|NCT00815308|Drug Therapy, combination|drug therapy, combination
653548|NCT00815308|Radiotherapy|radiotherapy
653549|NCT00815295|squamous cell cancer, head and neck|squamous cell cancer, head and neck
653550|NCT00815269|Inhalant anesthetic|inhalant anesthetic
653551|NCT00815269|Vasodilation|vasodilation
653552|NCT00815269|General anesthesia|general anesthesia
653553|NCT00815269|Ultrasonography|ultrasonography
653554|NCT00815256|Cornea degeneration|cornea degeneration
653555|NCT00815256|keratoconus|keratoconus
653556|NCT00815256|collagen cross linking|collagen cross linking
653558|NCT00815256|Riboflavin|riboflavin
653559|NCT00815243|fracture|fracture
653560|NCT00815243|coxarthrosis|coxarthrosis
653561|NCT00815243|complication|complication
653562|NCT00815243|congenital abnormalities|congenital abnormalities
653563|NCT00815243|bone|bone
653564|NCT00815243|joint|joint
653565|NCT00815243|telemedicine|telemedicine
653566|NCT00815243|transportation|transportation
653567|NCT00815243|decision making|decision making
653568|NCT00815243|outcomes|outcomes
653569|NCT00815230|radiation injury|radiation injury
653570|NCT00815230|computed tomography|computed tomography
653571|NCT00815230|reactive oxygen species|reactive oxygen species
653572|NCT00815230|free radicals|free radicals
653573|NCT00815217|Lipoaspirate|lipoaspirate
653574|NCT00815217|Diabetes Mellitus|diabetes mellitus
653575|NCT00815217|Mesenchymal Stem cells|mesenchymal stem cells
653576|NCT00815217|Fat grafts|fat grafts
653577|NCT00815217|venous stasis|venous stasis
653578|NCT00815204|PTSD|ptsd
653579|NCT00815204|HPA axis|hpa axis
653580|NCT00815204|Pituitary volume|pituitary volume
653581|NCT00815191|temperature|temperature
653582|NCT00815191|surgery|surgery
653583|NCT00815191|heating device|heating device
653584|NCT00815178|inspiratory muscle weakness|inspiratory muscle weakness
653585|NCT00815178|autonomic modulation|autonomic modulation
653586|NCT00815178|diabetes mellitus|diabetes mellitus
653587|NCT00815178|heart rate variability|heart rate variability
653588|NCT00815178|functional capacity|functional capacity
653589|NCT00815165|cytomegalovirus, CMV, cell-mediated immunity, children, sub-study|cytomegalovirus, cmv, cell-mediated immunity, children, sub-study
653590|NCT00815152|high grade glioma|high grade glioma
653591|NCT00815152|Coping skills intervention|coping skills intervention
653592|NCT00815152|caregivers|caregivers
653593|NCT00815139|Coronary artery disease, stent|coronary artery disease, stent
653594|NCT00815113|Gastric cancer|gastric cancer
653595|NCT00815113|screening|screening
653596|NCT00815113|high-risk|high-risk
653597|NCT00815113|relatives|relatives
653598|NCT00815113|gastroscopy|gastroscopy
653599|NCT00815100|Ivabradine|ivabradine
653600|NCT00815100|Acute coronary syndrome.|acute coronary syndrome.
653601|NCT00815100|Inflammation|inflammation
653602|NCT00815100|C-reactive protein|c-reactive protein
653603|NCT00815100|Atherosclerosis|atherosclerosis
653604|NCT00815087|Nasopharyngeal carcinoma|nasopharyngeal carcinoma
653605|NCT00815087|functional electrical stimulation|functional electrical stimulation
653606|NCT00815074|Military Women|military women
653607|NCT00815074|Women's Health|women's health
653608|NCT00815074|Genitourinary Symptoms|genitourinary symptoms
653609|NCT00815074|Illness Behaviors|illness behaviors
653610|NCT00815074|To determine how women manage genitourinary symptoms while deployed.|to determine how women manage genitourinary symptoms while deployed.
653611|NCT00815061|prevalence|prevalence
653612|NCT00815061|Incidence|incidence
653613|NCT00815061|crohn's disease|crohn's disease
653614|NCT00815061|ulcerative colitis|ulcerative colitis
653615|NCT00815061|Epidemiology|epidemiology
653616|NCT00815048|Remifentanil|remifentanil
653617|NCT00815048|Endotracheal intubation|endotracheal intubation
653618|NCT00815048|Premedication|premedication
653619|NCT00815048|Sedation|sedation
653620|NCT00815048|Endotracheal Intubation in Neonates|endotracheal intubation in neonates
653621|NCT00815035|Peanut Allergy|peanut allergy
653622|NCT00815022|Temperature|temperature
653623|NCT00815022|Spinal anesthesia|spinal anesthesia
653624|NCT00815022|Cesarean section|cesarean section
653625|NCT00815022|Cephalad sensory blockade|cephalad sensory blockade
653626|NCT00815022|Regional anesthesia|regional anesthesia
653627|NCT00815009|NAFLD|nafld
653628|NCT00815009|NASH|nash
653629|NCT00814983|myeloablative|myeloablative
653630|NCT00814983|stem cell|stem cell
653631|NCT00814983|naive T-cell depleted|naive t-cell depleted
653632|NCT00814983|allogeneic|allogeneic
653633|NCT00814970|PAD|pad
653634|NCT00814970|peripheral arterial disease|peripheral arterial disease
653635|NCT00814970|stent|stent
653636|NCT00814970|SFA|sfa
653637|NCT00814970|PPA|ppa
653638|NCT00814957|positron emission tomography|positron emission tomography
653639|NCT00814957|addiction|addiction
653640|NCT00814944|dry eye|dry eye
653641|NCT00814944|sirolimus|sirolimus
653642|NCT00814944|rapamycin|rapamycin
653643|NCT00814918|acne vulgaris|acne vulgaris
653644|NCT00814918|acne|acne
653645|NCT00814918|dermatalogy|dermatalogy
653646|NCT00814905|chorioamnionitis|chorioamnionitis
653647|NCT00814905|antibiotics|antibiotics
653648|NCT00814905|cesarean|cesarean
653649|NCT00814905|vaginal delivery|vaginal delivery
653650|NCT00814892|adenocarcinoma of the prostate|adenocarcinoma of the prostate
653651|NCT00814892|recurrent prostate cancer|recurrent prostate cancer
653652|NCT00814892|stage I prostate cancer|stage i prostate cancer
653653|NCT00814892|stage IIB prostate cancer|stage iib prostate cancer
653654|NCT00814892|stage IIA prostate cancer|stage iia prostate cancer
653655|NCT00814892|stage III prostate cancer|stage iii prostate cancer
653656|NCT00814892|stage IV prostate cancer|stage iv prostate cancer
653657|NCT00814879|Acquired Immune Deficiency Syndrome|acquired immune deficiency syndrome
653658|NCT00814879|AIDS|aids
653659|NCT00814879|Anti-Infective Agents|anti-infective agents
653660|NCT00814879|Antiretroviral|antiretroviral
653661|NCT00814879|Antiviral Agents|antiviral agents
653662|NCT00814879|Atazanavir|atazanavir
653663|NCT00814879|Human Immunodeficiency Virus|human immunodeficiency virus
653664|NCT00814879|HIV|hiv
653665|NCT00814879|HIV Protease Inhibitors|hiv protease inhibitors
653666|NCT00814879|NRTI|nrti
653667|NCT00814879|Nucleoside Reverse Transcriptase Inhibitors|nucleoside reverse transcriptase inhibitors
653668|NCT00814879|Raltegravir|raltegravir
653669|NCT00814879|Resistance|resistance
653670|NCT00814879|treatment experienced|treatment experienced
653671|NCT00814866|Rheumatoid arthritis|rheumatoid arthritis
653672|NCT00814866|arthritis|arthritis
653673|NCT00814866|osteoclasts|osteoclasts
653674|NCT00814866|bone|bone
653675|NCT00814853|Extubation|extubation
653676|NCT00814853|testing|testing
653677|NCT00814853|ventilator weaning|ventilator weaning
653678|NCT00814853|Pediatric extubation|pediatric extubation
653679|NCT00814840|Heart failure|heart failure
653680|NCT00814840|Dyssynchrony|dyssynchrony
653681|NCT00814840|Cardiac resynchronization|cardiac resynchronization
653682|NCT00814840|Triple-site pacing|triple-site pacing
653683|NCT00814827|Interferon-Gamma|interferon-gamma
653684|NCT00814827|Autoantibodies|autoantibodies
653685|NCT00814827|Disseminated Infection|disseminated infection
653686|NCT00814827|Pulmonary Infection|pulmonary infection
653687|NCT00814827|Blood Donor|blood donor
653688|NCT00814801|Alzheimer's Disease|alzheimer's disease
653689|NCT00814801|Cognitive dysfunction|cognitive dysfunction
653690|NCT00814801|Dementia|dementia
653691|NCT00814801|Galantamine|galantamine
653692|NCT00814801|R113675|r113675
653693|NCT00814788|stage IV prostate cancer|stage iv prostate cancer
653694|NCT00814788|adenocarcinoma of the prostate|adenocarcinoma of the prostate
653695|NCT00814788|recurrent prostate cancer|recurrent prostate cancer
653696|NCT00814775|Laryngeal mask|laryngeal mask
653697|NCT00814775|Difficult intubation|difficult intubation
653698|NCT00814762|immunogenicity|immunogenicity
653699|NCT00814762|HIV|hiv
653700|NCT00814762|reactogenicity|reactogenicity
653701|NCT00814762|safety|safety
653702|NCT00814762|vaccine|vaccine
653703|NCT00814762|HIV Infections|hiv infections
653704|NCT00814749|stress urinary incontinence|stress urinary incontinence
653705|NCT00814749|urodynamics|urodynamics
653706|NCT00814749|randomized clinical trial|randomized clinical trial
653707|NCT00814749|surgery|surgery
653708|NCT00814710|Pneumococcal disease|pneumococcal disease
653709|NCT00814710|Pneumococcal vaccine|pneumococcal vaccine
653710|NCT00814710|Safety|safety
653711|NCT00814710|Primary vaccination|primary vaccination
653712|NCT00814710|Immunogenicity|immunogenicity
653713|NCT00814697|Alzheimer|alzheimer
653714|NCT00814697|Language|language
653715|NCT00814697|Treatment|treatment
653716|NCT00814697|TMS|tms
653717|NCT00814697|rTMS|rtms
653718|NCT00814671|Tuberculosis|tuberculosis
653719|NCT00814671|Pharmacokinetics|pharmacokinetics
653720|NCT00814658|Dementia|dementia
653721|NCT00814658|Mixed Dementia|mixed dementia
653722|NCT00814658|Galantamine|galantamine
653723|NCT00814658|Reminyl ER|reminyl er
653724|NCT00814658|Nimodipine|nimodipine
653725|NCT00814632|vulvodynia|vulvodynia
653726|NCT00814632|pelvic pain|pelvic pain
653727|NCT00814632|vulvar pain|vulvar pain
653728|NCT00814619|adenocarcinoma of the rectum|adenocarcinoma of the rectum
653729|NCT00814619|stage III rectal cancer|stage iii rectal cancer
653730|NCT00814619|stage II rectal cancer|stage ii rectal cancer
653731|NCT00814606|genotype 1 hepatitis C|genotype 1 hepatitis c
653732|NCT00814606|hepatitis C|hepatitis c
653733|NCT00814606|HCV|hcv
653734|NCT00814606|liver|liver
653735|NCT00814593|adult giant cell glioblastoma|adult giant cell glioblastoma
653736|NCT00814593|adult gliosarcoma|adult gliosarcoma
653737|NCT00814593|adult glioblastoma|adult glioblastoma
653738|NCT00814580|analgesia|analgesia
653739|NCT00814580|postoperative pain|postoperative pain
653740|NCT00814580|opioid|opioid
653741|NCT00814580|rotator cuff repair|rotator cuff repair
653742|NCT00814580|labral tear repair|labral tear repair
653743|NCT00814580|Bankart procedure|bankart procedure
653744|NCT00814580|oxycodone|oxycodone
653745|NCT00814580|tapentadol|tapentadol
653746|NCT00814580|arthroscopic shoulder surgery|arthroscopic shoulder surgery
653747|NCT00814567|recurrent breast cancer|recurrent breast cancer
653748|NCT00814567|stage IA breast cancer|stage ia breast cancer
653749|NCT00814567|stage II breast cancer|stage ii breast cancer
653750|NCT00814567|invasive ductal breast carcinoma|invasive ductal breast carcinoma
653751|NCT00814567|invasive ductal breast carcinoma with predominant intraductal component|invasive ductal breast carcinoma with predominant intraductal component
653753|NCT00814554|nutrition|nutrition
653754|NCT00814554|cluster randomized trial|cluster randomized trial
653755|NCT00814554|high school|high school
653756|NCT00814554|primary prevention|primary prevention
653757|NCT00814541|refractory multiple myeloma|refractory multiple myeloma
653758|NCT00814541|stage I multiple myeloma|stage i multiple myeloma
653759|NCT00814541|stage II multiple myeloma|stage ii multiple myeloma
653760|NCT00814541|stage III multiple myeloma|stage iii multiple myeloma
653761|NCT00814528|actinic keratosis|actinic keratosis
653762|NCT00814528|skin lesions|skin lesions
653763|NCT00814528|5-ALA|5-ala
653765|NCT00814528|Blu-Light|blu-light
653766|NCT00814515|Moderate|moderate
653767|NCT00814515|Severe|severe
653768|NCT00814515|Dry|dry
653769|NCT00814515|Eye|eye
653770|NCT00814515|Ciclosporin|ciclosporin
653771|NCT00814515|Cyclosporine|cyclosporine
653772|NCT00814502|Alzheimer disease|alzheimer disease
653773|NCT00814502|Dementia, vascular|dementia, vascular
653774|NCT00814502|Actigraphy|actigraphy
653775|NCT00814502|Circadian dysregulation|circadian dysregulation
653776|NCT00814502|Sleep Disorders|sleep disorders
653777|NCT00814502|Circadian rhythm|circadian rhythm
653778|NCT00814489|Non-typable Haemophilus influenzae|non-typable haemophilus influenzae
653779|NCT00814489|protein vaccine|protein vaccine
653780|NCT00814489|Streptococcus pneumoniae|streptococcus pneumoniae
653781|NCT00814489|young adults|young adults
653782|NCT00814476|Medtronic CareLink|medtronic carelink
653783|NCT00814476|therapy management|therapy management
653784|NCT00814476|diabetes|diabetes
653785|NCT00814476|insulin pump|insulin pump
653786|NCT00814476|Blood glucose monitor|blood glucose monitor
653787|NCT00814463|tumors metastatic to brain|tumors metastatic to brain
653788|NCT00814463|unspecified adult solid tumor, protocol specific|unspecified adult solid tumor, protocol specific
653789|NCT00814450|Biopsy|biopsy
653790|NCT00814450|Fine needle aspiration|fine needle aspiration
653791|NCT00814424|EtCO2|etco2
653792|NCT00814424|supplemental oxygen delivery|supplemental oxygen delivery
653793|NCT00814424|ERCP|ercp
653794|NCT00814411|contraception|contraception
653795|NCT00814411|noninferiority|noninferiority
653796|NCT00814411|intention|intention
653797|NCT00814411|family planning counseling|family planning counseling
653798|NCT00814411|post abortion care|post abortion care
653799|NCT00814411|Family planning intention among women with unmet need|family planning intention among women with unmet need
653800|NCT00814398|Infertility|infertility
653801|NCT00814398|IVF|ivf
653802|NCT00814398|SET|set
653803|NCT00814398|DET|det
653804|NCT00814398|Blastocyst|blastocyst
653805|NCT00814359|mucositis|mucositis
653806|NCT00814359|radiation|radiation
653807|NCT00814359|magic mouthwash|magic mouthwash
653808|NCT00814359|sucralfate|sucralfate
653809|NCT00814359|benzydamine|benzydamine
653810|NCT00814359|diphenhydramine|diphenhydramine
653811|NCT00814359|dexamethasone|dexamethasone
653812|NCT00814359|nystatin|nystatin
653813|NCT00814346|Mild Alzheimer's disease (AD) patients|mild alzheimer's disease (ad) patients
653814|NCT00814346|Memory complaint patients with cognitive impairment (MC)|memory complaint patients with cognitive impairment (mc)
653815|NCT00814346|Memory complaint patients cognitively normal (CNE)|memory complaint patients cognitively normal (cne)
653816|NCT00814333|epistaxis|epistaxis
653817|NCT00814307|Antirheumatic Agents Clinical Trial|antirheumatic agents clinical trial
653818|NCT00814294|Type 2|type 2
653819|NCT00814281|particulate air pollution|particulate air pollution
653820|NCT00814281|leukotriene|leukotriene
653821|NCT00814281|asthma|asthma
653822|NCT00814281|montelukast|montelukast
653823|NCT00814281|vascular endothelial dysfunction|vascular endothelial dysfunction
653824|NCT00814281|nitric oxide(NO)endothelin (ET) system|nitric oxide(no)endothelin (et) system
653825|NCT00814255|Primary FSGS|primary fsgs
653826|NCT00814255|Steroid Resistant|steroid resistant
653827|NCT00814255|Rosiglitazone|rosiglitazone
653828|NCT00814255|Adalimumab|adalimumab
653829|NCT00814255|Resistant primary FSGS|resistant primary fsgs
653830|NCT00814255|GALACTOSE|galactose
653831|NCT00814242|Hepatocellular Carcinoma|hepatocellular carcinoma
653832|NCT00814242|Adjacent to Major Blood Vessels|adjacent to major blood vessels
653833|NCT00814242|Surgical resection|surgical resection
653834|NCT00814242|Ppercutaneous radiationfrequency ablation|ppercutaneous radiationfrequency ablation
653835|NCT00814242|Time to recurrence|time to recurrence
653836|NCT00814242|Disease-free survival|disease-free survival
653837|NCT00814242|Overall survival|overall survival
653838|NCT00814229|influenza|influenza
653839|NCT00814229|H9N2|h9n2
653840|NCT00814229|vaccine|vaccine
653841|NCT00814216|Efficacy|efficacy
653842|NCT00814216|safety|safety
653843|NCT00814216|QAV680|qav680
653844|NCT00814216|pharmacokinetics|pharmacokinetics
653845|NCT00814216|corticosteroid|corticosteroid
653846|NCT00814216|asthma|asthma
653847|NCT00814203|COPD|copd
653848|NCT00814190|Type 2 Diabetes|type 2 diabetes
653849|NCT00814190|Internet Therapeutic Intervention|internet therapeutic intervention
653850|NCT00814177|warfarin|warfarin
653851|NCT00814177|dosing|dosing
653852|NCT00814177|prothrombin time|prothrombin time
653853|NCT00814177|Heart valve prosthesis|heart valve prosthesis
653854|NCT00814164|adult erythroleukemia (M6a)|adult erythroleukemia (m6a)
653855|NCT00814164|adult pure erythroid leukemia (M6b)|adult pure erythroid leukemia (m6b)
653856|NCT00814164|adult acute megakaryoblastic leukemia (M7)|adult acute megakaryoblastic leukemia (m7)
653857|NCT00814164|adult acute minimally differentiated myeloid leukemia (M0)|adult acute minimally differentiated myeloid leukemia (m0)
653858|NCT00814164|adult acute monoblastic leukemia (M5a)|adult acute monoblastic leukemia (m5a)
653859|NCT00814164|adult acute monocytic leukemia (M5b)|adult acute monocytic leukemia (m5b)
653860|NCT00814164|adult acute myeloblastic leukemia with maturation (M2)|adult acute myeloblastic leukemia with maturation (m2)
653861|NCT00814164|adult acute myeloblastic leukemia without maturation (M1)|adult acute myeloblastic leukemia without maturation (m1)
653862|NCT00814164|adult acute myelomonocytic leukemia (M4)|adult acute myelomonocytic leukemia (m4)
653863|NCT00814164|untreated adult acute myeloid leukemia|untreated adult acute myeloid leukemia
653864|NCT00814164|adult acute myeloid leukemia with 11q23 (MLL) abnormalities|adult acute myeloid leukemia with 11q23 (mll) abnormalities
653865|NCT00814164|adult acute myeloid leukemia with inv(16)(p13;q22)|adult acute myeloid leukemia with inv(16)(p13;q22)
653866|NCT00814164|adult acute myeloid leukemia with t(16;16)(p13;q22)|adult acute myeloid leukemia with t(16;16)(p13;q22)
653867|NCT00814164|adult acute myeloid leukemia with t(8;21)(q22;q22)|adult acute myeloid leukemia with t(8;21)(q22;q22)
653868|NCT00814164|secondary acute myeloid leukemia|secondary acute myeloid leukemia
653869|NCT00814151|Blood culture|blood culture
653870|NCT00814151|Staphylococcus aureus|staphylococcus aureus
653871|NCT00814151|Bacteremia|bacteremia
653872|NCT00814151|MRSA|mrsa
653873|NCT00814151|MSSA|mssa
653874|NCT00814151|MicroPhage|microphage
653875|NCT00814138|myasthenia gravis|myasthenia gravis
653876|NCT00814125|Endometrial|endometrial
653877|NCT00814125|Endometrial histological findings|endometrial histological findings
653878|NCT00814099|Acute Respiratory Failure|acute respiratory failure
653879|NCT00814099|Acute Lung Injury|acute lung injury
653880|NCT00814073|Mastocytosis with handicap|mastocytosis with handicap
653881|NCT00814073|Mastocytosis|mastocytosis
653882|NCT00814073|Mast cell|mast cell
653883|NCT00814073|Mast cell infiltration|mast cell infiltration
653884|NCT00814073|Skin|skin
653885|NCT00814073|Bone marrow|bone marrow
653886|NCT00814073|Pruritus|pruritus
653887|NCT00814073|Flushes|flushes
653888|NCT00814073|c-kit|c-kit
653889|NCT00814073|c-kit mutation|c-kit mutation
653890|NCT00814073|Wild Type|wild type
653891|NCT00814073|Mutation Asp-816-Val(D816V)|mutation asp-816-val(d816v)
653892|NCT00814073|Indolent systemic mastocytosis|indolent systemic mastocytosis
653893|NCT00814073|smoldering systemic mastocytosis|smoldering systemic mastocytosis
653894|NCT00814047|ultrasonography|ultrasonography
653895|NCT00814034|Aromatase Inhibitors|aromatase inhibitors
653896|NCT00814034|Coagulation parameters|coagulation parameters
653897|NCT00814034|Tamoxifen|tamoxifen
653898|NCT00814021|recurrent renal cell cancer|recurrent renal cell cancer
653899|NCT00814021|stage IV renal cell cancer|stage iv renal cell cancer
653900|NCT00814021|tumors metastatic to brain|tumors metastatic to brain
653901|NCT00813969|Mesenchymal Stem Cell|mesenchymal stem cell
653902|NCT00813969|MSC|msc
653903|NCT00813969|Autologous|autologous
653904|NCT00813969|Multiple Sclerosis|multiple sclerosis
653905|NCT00813956|triple negative breast cancer|triple negative breast cancer
653906|NCT00813943|Newly diagnosed Glioblastoma (WHO Grade IV)|newly diagnosed glioblastoma (who grade iv)
653907|NCT00813943|Cilengitide|cilengitide
653908|NCT00813943|Temozolomide|temozolomide
653909|NCT00813943|Radiotherapy|radiotherapy
653910|NCT00813930|Diabetes|diabetes
653911|NCT00813930|Lifestyle Intervention|lifestyle intervention
653912|NCT00813930|Cardiovascular risk reduction|cardiovascular risk reduction
653913|NCT00813891|ranibizumab|ranibizumab
653914|NCT00813891|verteporfin|verteporfin
653915|NCT00813878|breast cancer|breast cancer
653916|NCT00813878|breast cancer in situ|breast cancer in situ
653917|NCT00813865|Amicus Therapeutics|amicus therapeutics
653918|NCT00813865|AT2101|at2101
653919|NCT00813865|afegostat tartrate|afegostat tartrate
653920|NCT00813865|isofagomine tartrate|isofagomine tartrate
653921|NCT00813852|obstructive sleep apnea|obstructive sleep apnea
653922|NCT00813852|skeletal muscle|skeletal muscle
653923|NCT00813852|magnetic stimulation|magnetic stimulation
653924|NCT00813852|magnetic resonance spectroscopy|magnetic resonance spectroscopy
653925|NCT00813852|inflammatory markers|inflammatory markers
653926|NCT00813852|exercise|exercise
653927|NCT00813839|SmartCare|smartcare
653928|NCT00813839|Spontaneous Breathing Trials|spontaneous breathing trials
653929|NCT00813839|Mechanical Ventilation|mechanical ventilation
653930|NCT00813839|Weaning|weaning
653931|NCT00813839|Patients requiring prolonged mechanical ventilation (>72 hours)|patients requiring prolonged mechanical ventilation (>72 hours)
653933|NCT00813826|Pain after Shingles|pain after shingles
653934|NCT00813800|Smoking|smoking
653935|NCT00813800|Bipolar Disorder|bipolar disorder
653936|NCT00813800|Depression|depression
653937|NCT00813787|Magnetic Resonance Imaging|magnetic resonance imaging
653938|NCT00813787|Glioma|glioma
653939|NCT00813774|Cimzia|cimzia
653940|NCT00813774|certolizumab pegol|certolizumab pegol
653941|NCT00813774|Bioavailability|bioavailability
653942|NCT00813774|Healthy volunteers|healthy volunteers
653943|NCT00813748|Asthma|asthma
653944|NCT00813748|Anaphylaxis|anaphylaxis
653945|NCT00813735|Insomnia|insomnia
653946|NCT00813735|Major Depression|major depression
653947|NCT00813735|Geriatric|geriatric
653948|NCT00813722|adherence|adherence
653949|NCT00813722|blood pressure|blood pressure
653950|NCT00813722|hypertension|hypertension
653951|NCT00813722|compliance|compliance
653952|NCT00813722|atenolol|atenolol
653953|NCT00813722|hydrochlorothiazide|hydrochlorothiazide
653954|NCT00813722|amlodipine|amlodipine
653955|NCT00813722|losartan|losartan
653956|NCT00813709|Interferon 1-beta|interferon 1-beta
653957|NCT00813709|Clinical Definite Multiple Sclerosis|clinical definite multiple sclerosis
653958|NCT00813696|chemotherapy|chemotherapy
653959|NCT00813696|advanced cancer|advanced cancer
653960|NCT00813696|inoperable|inoperable
653961|NCT00813696|Stage II, III, IV|stage ii, iii, iv
653962|NCT00813683|Acupuncture, moxybustion,|acupuncture, moxybustion,
653963|NCT00813683|Cephalic version,|cephalic version,
653964|NCT00813683|Breech presentation|breech presentation
653965|NCT00813631|Malignant fungating wound|malignant fungating wound
653966|NCT00813631|Head and neck|head and neck
653967|NCT00813631|Ionic silver-releasing dressing|ionic silver-releasing dressing
653968|NCT00813631|Wound care|wound care
653969|NCT00813631|RCT|rct
653970|NCT00813618|Acute GvHD of at least Grade II severity|acute gvhd of at least grade ii severity
653971|NCT00813605|AMG 655|amg 655
653972|NCT00813605|AMG 479|amg 479
653973|NCT00813605|Colon Cancer|colon cancer
653974|NCT00813605|Rectal Cancer|rectal cancer
653975|NCT00813605|Monoclonal Antibody|monoclonal antibody
653976|NCT00813605|Clinical Trial|clinical trial
653977|NCT00813605|Colorectal Cancer|colorectal cancer
653978|NCT00813605|metastatic colorectal cancer|metastatic colorectal cancer
653979|NCT00813605|metastatic cancer|metastatic cancer
653980|NCT00813605|antibody-2nd line|antibody-2nd line
653981|NCT00813605|KRAS|kras
653982|NCT00813605|adenocarcinoma|adenocarcinoma
653983|NCT00813592|meningioma|meningioma
653984|NCT00813592|brain|brain
653985|NCT00813579|assess the safety of living kidney donation|assess the safety of living kidney donation
653986|NCT00813566|cancer|cancer
653987|NCT00813566|imaging|imaging
653988|NCT00813566|PET scanning|pet scanning
653989|NCT00813553|physical fitness|physical fitness
653990|NCT00813553|exercise|exercise
653991|NCT00813553|amino acid|amino acid
653992|NCT00813540|Colonic Neoplasms|colonic neoplasms
653993|NCT00813540|Aerobic Exercise|aerobic exercise
653994|NCT00813540|Weight Lifting|weight lifting
653995|NCT00813540|Body Composition|body composition
653996|NCT00813527|Drug Therapy|drug therapy
653997|NCT00813527|Lipid Metabolism Disorders|lipid metabolism disorders
653998|NCT00813527|Hyperlipidemias|hyperlipidemias
653999|NCT00813527|Hypercholesterolemia|hypercholesterolemia
654000|NCT00813527|Hypertriglyceridemia|hypertriglyceridemia
654001|NCT00813514|AMD|amd
654002|NCT00813514|VEGF genotyping|vegf genotyping
654003|NCT00813514|complement H gene polymorphism|complement h gene polymorphism
654004|NCT00813514|Vascular Endothelial Growth Factor A|vascular endothelial growth factor a
654005|NCT00813501|graft versus host disease|graft versus host disease
654006|NCT00813501|infection|infection
654007|NCT00813501|therapy-related toxicity|therapy-related toxicity
654008|NCT00813501|stage III adult Burkitt lymphoma|stage iii adult burkitt lymphoma
654009|NCT00813501|stage III adult diffuse large cell lymphoma|stage iii adult diffuse large cell lymphoma
654010|NCT00813501|stage III adult diffuse mixed cell lymphoma|stage iii adult diffuse mixed cell lymphoma
654011|NCT00813501|stage III adult diffuse small cleaved cell lymphoma|stage iii adult diffuse small cleaved cell lymphoma
654012|NCT00813501|stage III adult Hodgkin lymphoma|stage iii adult hodgkin lymphoma
654013|NCT00813501|stage III adult immunoblastic large cell lymphoma|stage iii adult immunoblastic large cell lymphoma
654014|NCT00813501|stage III adult lymphoblastic lymphoma|stage iii adult lymphoblastic lymphoma
654015|NCT00813501|stage III grade 1 follicular lymphoma|stage iii grade 1 follicular lymphoma
654016|NCT00813501|stage III grade 2 follicular lymphoma|stage iii grade 2 follicular lymphoma
654017|NCT00813501|stage III grade 3 follicular lymphoma|stage iii grade 3 follicular lymphoma
654018|NCT00813501|stage III mantle cell lymphoma|stage iii mantle cell lymphoma
654019|NCT00813501|stage III marginal zone lymphoma|stage iii marginal zone lymphoma
654020|NCT00813501|stage III small lymphocytic lymphoma|stage iii small lymphocytic lymphoma
654021|NCT00813501|stage IV adult Burkitt lymphoma|stage iv adult burkitt lymphoma
654022|NCT00813501|stage IV adult diffuse large cell lymphoma|stage iv adult diffuse large cell lymphoma
654023|NCT00813501|stage IV adult diffuse mixed cell lymphoma|stage iv adult diffuse mixed cell lymphoma
654024|NCT00813501|stage IV adult diffuse small cleaved cell lymphoma|stage iv adult diffuse small cleaved cell lymphoma
654025|NCT00813501|stage IV adult Hodgkin lymphoma|stage iv adult hodgkin lymphoma
654026|NCT00813501|stage IV adult immunoblastic large cell lymphoma|stage iv adult immunoblastic large cell lymphoma
654027|NCT00813501|stage IV adult lymphoblastic lymphoma|stage iv adult lymphoblastic lymphoma
654028|NCT00813501|stage IV grade 1 follicular lymphoma|stage iv grade 1 follicular lymphoma
654029|NCT00813501|stage IV grade 2 follicular lymphoma|stage iv grade 2 follicular lymphoma
654030|NCT00813501|stage IV grade 3 follicular lymphoma|stage iv grade 3 follicular lymphoma
654031|NCT00813501|stage IV mantle cell lymphoma|stage iv mantle cell lymphoma
654032|NCT00813501|stage IV marginal zone lymphoma|stage iv marginal zone lymphoma
654033|NCT00813501|stage IV small lymphocytic lymphoma|stage iv small lymphocytic lymphoma
654034|NCT00813501|recurrent adult Burkitt lymphoma|recurrent adult burkitt lymphoma
654035|NCT00813501|recurrent adult diffuse large cell lymphoma|recurrent adult diffuse large cell lymphoma
654036|NCT00813501|recurrent adult diffuse mixed cell lymphoma|recurrent adult diffuse mixed cell lymphoma
654037|NCT00813501|recurrent adult diffuse small cleaved cell lymphoma|recurrent adult diffuse small cleaved cell lymphoma
654038|NCT00813501|recurrent adult Hodgkin lymphoma|recurrent adult hodgkin lymphoma
654039|NCT00813501|recurrent adult immunoblastic large cell lymphoma|recurrent adult immunoblastic large cell lymphoma
654040|NCT00813501|recurrent adult lymphoblastic lymphoma|recurrent adult lymphoblastic lymphoma
654041|NCT00813501|recurrent cutaneous T-cell non-Hodgkin lymphoma|recurrent cutaneous t-cell non-hodgkin lymphoma
654042|NCT00813501|recurrent grade 1 follicular lymphoma|recurrent grade 1 follicular lymphoma
654043|NCT00813501|recurrent grade 2 follicular lymphoma|recurrent grade 2 follicular lymphoma
654044|NCT00813501|recurrent grade 3 follicular lymphoma|recurrent grade 3 follicular lymphoma
654045|NCT00813501|recurrent mantle cell lymphoma|recurrent mantle cell lymphoma
654046|NCT00813501|recurrent marginal zone lymphoma|recurrent marginal zone lymphoma
654047|NCT00813501|recurrent small lymphocytic lymphoma|recurrent small lymphocytic lymphoma
654048|NCT00813501|recurrent mycosis fungoides/Sezary syndrome|recurrent mycosis fungoides/sezary syndrome
654049|NCT00813501|extranodal marginal zone B-cell lymphoma of mucosa-associated lymphoid tissue|extranodal marginal zone b-cell lymphoma of mucosa-associated lymphoid tissue
654050|NCT00813501|nodal marginal zone B-cell lymphoma|nodal marginal zone b-cell lymphoma
654051|NCT00813501|splenic marginal zone lymphoma|splenic marginal zone lymphoma
654052|NCT00813501|noncontiguous stage II adult Burkitt lymphoma|noncontiguous stage ii adult burkitt lymphoma
654053|NCT00813501|noncontiguous stage II adult diffuse large cell lymphoma|noncontiguous stage ii adult diffuse large cell lymphoma
654054|NCT00813501|noncontiguous stage II adult diffuse mixed cell lymphoma|noncontiguous stage ii adult diffuse mixed cell lymphoma
654055|NCT00813501|noncontiguous stage II adult diffuse small cleaved cell lymphoma|noncontiguous stage ii adult diffuse small cleaved cell lymphoma
654056|NCT00813501|noncontiguous stage II adult immunoblastic large cell lymphoma|noncontiguous stage ii adult immunoblastic large cell lymphoma
654057|NCT00813501|noncontiguous stage II adult lymphoblastic lymphoma|noncontiguous stage ii adult lymphoblastic lymphoma
654058|NCT00813501|noncontiguous stage II grade 1 follicular lymphoma|noncontiguous stage ii grade 1 follicular lymphoma
654059|NCT00813501|noncontiguous stage II grade 2 follicular lymphoma|noncontiguous stage ii grade 2 follicular lymphoma
654060|NCT00813501|noncontiguous stage II grade 3 follicular lymphoma|noncontiguous stage ii grade 3 follicular lymphoma
654061|NCT00813501|noncontiguous stage II mantle cell lymphoma|noncontiguous stage ii mantle cell lymphoma
654062|NCT00813501|noncontiguous stage II marginal zone lymphoma|noncontiguous stage ii marginal zone lymphoma
654063|NCT00813501|noncontiguous stage II small lymphocytic lymphoma|noncontiguous stage ii small lymphocytic lymphoma
654064|NCT00813501|accelerated phase chronic myelogenous leukemia|accelerated phase chronic myelogenous leukemia
654065|NCT00813501|adult acute lymphoblastic leukemia in remission|adult acute lymphoblastic leukemia in remission
654066|NCT00813501|adult acute myeloid leukemia in remission|adult acute myeloid leukemia in remission
654067|NCT00813501|adult acute myeloid leukemia with 11q23 (MLL) abnormalities|adult acute myeloid leukemia with 11q23 (mll) abnormalities
654068|NCT00813501|adult acute myeloid leukemia with inv(16)(p13;q22)|adult acute myeloid leukemia with inv(16)(p13;q22)
654069|NCT00813501|adult acute myeloid leukemia with t(15;17)(q22;q12)|adult acute myeloid leukemia with t(15;17)(q22;q12)
654070|NCT00813501|adult acute myeloid leukemia with t(16;16)(p13;q22)|adult acute myeloid leukemia with t(16;16)(p13;q22)
654071|NCT00813501|adult acute myeloid leukemia with t(8;21)(q22;q22)|adult acute myeloid leukemia with t(8;21)(q22;q22)
654072|NCT00813501|atypical chronic myeloid leukemia, BCR-ABL negative|atypical chronic myeloid leukemia, bcr-abl negative
654073|NCT00813501|blastic phase chronic myelogenous leukemia|blastic phase chronic myelogenous leukemia
654074|NCT00813501|chronic myelomonocytic leukemia|chronic myelomonocytic leukemia
654075|NCT00813501|chronic phase chronic myelogenous leukemia|chronic phase chronic myelogenous leukemia
654076|NCT00813501|recurrent adult acute lymphoblastic leukemia|recurrent adult acute lymphoblastic leukemia
654077|NCT00813501|recurrent adult acute myeloid leukemia|recurrent adult acute myeloid leukemia
654078|NCT00813501|refractory chronic lymphocytic leukemia|refractory chronic lymphocytic leukemia
654079|NCT00813501|refractory hairy cell leukemia|refractory hairy cell leukemia
654080|NCT00813501|relapsing chronic myelogenous leukemia|relapsing chronic myelogenous leukemia
655239|NCT00809029|GIP|gip
654081|NCT00813501|secondary acute myeloid leukemia|secondary acute myeloid leukemia
654082|NCT00813501|stage III chronic lymphocytic leukemia|stage iii chronic lymphocytic leukemia
654083|NCT00813501|stage IV chronic lymphocytic leukemia|stage iv chronic lymphocytic leukemia
654084|NCT00813501|chronic eosinophilic leukemia|chronic eosinophilic leukemia
654085|NCT00813501|primary myelofibrosis|primary myelofibrosis
654086|NCT00813501|chronic neutrophilic leukemia|chronic neutrophilic leukemia
654087|NCT00813501|de novo myelodysplastic syndromes|de novo myelodysplastic syndromes
654088|NCT00813501|disseminated neuroblastoma|disseminated neuroblastoma
654214|NCT00813124|Methotrexate|methotrexate
654089|NCT00813501|myelodysplastic/myeloproliferative neoplasm, unclassifiable|myelodysplastic/myeloproliferative neoplasm, unclassifiable
654090|NCT00813501|previously treated myelodysplastic syndromes|previously treated myelodysplastic syndromes
654091|NCT00813501|secondary myelodysplastic syndromes|secondary myelodysplastic syndromes
654092|NCT00813501|stage I multiple myeloma|stage i multiple myeloma
654093|NCT00813501|stage II multiple myeloma|stage ii multiple myeloma
654094|NCT00813501|stage III multiple myeloma|stage iii multiple myeloma
654095|NCT00813501|refractory multiple myeloma|refractory multiple myeloma
654096|NCT00813488|Breakthrough Pain|breakthrough pain
654097|NCT00813488|Opioid-tolerant|opioid-tolerant
654098|NCT00813488|Chronic Pain|chronic pain
654099|NCT00813475|cardio vascular outcome|cardio vascular outcome
654100|NCT00813449|Endostar|endostar
654101|NCT00813449|advanced melanoma|advanced melanoma
654102|NCT00813449|combined chemotherapy|combined chemotherapy
654103|NCT00813436|ToM|tom
654104|NCT00813436|Theory of Mind|theory of mind
654105|NCT00813436|Simulation|simulation
654106|NCT00813436|Empathy|empathy
654107|NCT00813436|Oxytocin|oxytocin
654108|NCT00813436|Schizophrenia|schizophrenia
654109|NCT00813384|Cancer|cancer
654110|NCT00813384|Solid Tumors|solid tumors
654111|NCT00813384|Phase 1|phase 1
654112|NCT00813384|C-met inhibitor|c-met inhibitor
654113|NCT00813384|Clinical Trial|clinical trial
654114|NCT00813371|Acute Respiratory Distress Syndrome|acute respiratory distress syndrome
654115|NCT00813371|acute lung injury|acute lung injury
654116|NCT00813371|Airway Pressure Release Ventilation|airway pressure release ventilation
654117|NCT00813371|ARDSnet|ardsnet
654118|NCT00813371|Bi-level|bi-level
654119|NCT00813371|respiratory failure|respiratory failure
654120|NCT00813371|trauma|trauma
654121|NCT00813371|APRV|aprv
654122|NCT00813358|Endovascular Aneurysm Repair|endovascular aneurysm repair
654123|NCT00813358|Aortic Aneurysm|aortic aneurysm
654124|NCT00813358|Thoracic|thoracic
654125|NCT00813345|anesthesia propofol ambulatory rhythm|anesthesia propofol ambulatory rhythm
654126|NCT00813332|Endostar|endostar
654127|NCT00813332|NSCLC|nsclc
654128|NCT00813332|Docetaxel|docetaxel
654129|NCT00813332|Combined therapy|combined therapy
654130|NCT00813332|second-line chemotherapy|second-line chemotherapy
654131|NCT00813319|GARDASIL|gardasil
654132|NCT00813319|HPV|hpv
654133|NCT00813319|Vaccination|vaccination
654134|NCT00813306|GERD|gerd
654135|NCT00813306|TLESR|tlesr
654136|NCT00813306|reflux|reflux
654137|NCT00813293|Hepatocellular Cancer|hepatocellular cancer
654138|NCT00813293|HCC|hcc
654139|NCT00813293|Liver Cancer|liver cancer
654140|NCT00813293|radiofrequency ablation|radiofrequency ablation
654141|NCT00813293|RFA|rfa
654142|NCT00813293|sorafenib|sorafenib
654143|NCT00813293|nexavaar|nexavaar
654144|NCT00813293|liver directed therapy|liver directed therapy
654145|NCT00813293|interventional radiology|interventional radiology
654146|NCT00813267|Mesenchymal Stem Cells|mesenchymal stem cells
654147|NCT00813267|Osteonecrosis of the Femoral Head|osteonecrosis of the femoral head
654148|NCT00813254|Platinum-Resistant Ovarian Cancer|platinum-resistant ovarian cancer
654149|NCT00813254|Platinum-based chemotherapy|platinum-based chemotherapy
654150|NCT00813254|Ovarian Cancer|ovarian cancer
654151|NCT00813254|Ovary|ovary
654152|NCT00813254|Epithelial ovarian cancer|epithelial ovarian cancer
654153|NCT00813254|Quality of Life|quality of life
654154|NCT00813254|Cost Utility Analysis|cost utility analysis
654155|NCT00813254|Sexual functioning|sexual functioning
654156|NCT00813254|Questionnaire|questionnaire
654157|NCT00813254|Caregiver|caregiver
654158|NCT00813241|Ankylosing spondylitis,Rheumatoid Arthritis,Adenomatous Polyposis Coli,Osteoarthritis,Dysmenorrhoea,pharmacokinetic study|ankylosing spondylitis,rheumatoid arthritis,adenomatous polyposis coli,osteoarthritis,dysmenorrhoea,pharmacokinetic study
654159|NCT00813228|Immune Function|immune function
654160|NCT00813228|DDP-4|ddp-4
654161|NCT00813228|Sitagliptin|sitagliptin
654162|NCT00813228|GLP-1|glp-1
654163|NCT00813228|TGF Beta|tgf beta
654164|NCT00813215|Type 2 diabetes mellitus|type 2 diabetes mellitus
654165|NCT00813215|Postprandial dysmetabolism|postprandial dysmetabolism
654166|NCT00813215|Postprandial inflammation|postprandial inflammation
654167|NCT00813215|Relatives|relatives
654168|NCT00813215|Meal challenge|meal challenge
654169|NCT00813202|Nesiritide|nesiritide
654170|NCT00813202|Natrecor|natrecor
654171|NCT00813202|Quanke|quanke
654172|NCT00813202|Acute Decompensated Heart Failure|acute decompensated heart failure
654173|NCT00813189|glucocorticoid therapy|glucocorticoid therapy
655240|NCT00809029|OBESITY|obesity
654174|NCT00813189|muscle function|muscle function
654175|NCT00813189|growth hormone treatment|growth hormone treatment
654176|NCT00813176|Obesity|obesity
654177|NCT00813176|One-Lung Ventilation|one-lung ventilation
654178|NCT00813176|Anesthesia|anesthesia
654179|NCT00813176|Thoracic|thoracic
654180|NCT00813176|One-lung ventilation in the morbidly obese patient|one-lung ventilation in the morbidly obese patient
654181|NCT00813163|Phase II study|phase ii study
654182|NCT00813163|Second line|second line
654183|NCT00813163|Pancreatic cancer|pancreatic cancer
654184|NCT00813163|Metastatic|metastatic
654185|NCT00813150|Multiple myeloma|multiple myeloma
654186|NCT00813150|Bortezomib|bortezomib
654187|NCT00813150|Dexamethasone|dexamethasone
654188|NCT00813150|Cyclophosphamide|cyclophosphamide
654189|NCT00813150|Oncology|oncology
654190|NCT00813137|Colorectal Cancer|colorectal cancer
654191|NCT00813137|chemotherapy|chemotherapy
654192|NCT00813137|recombinant human endostatin|recombinant human endostatin
654193|NCT00813124|Chronic Myelogenous Leukemia|chronic myelogenous leukemia
654194|NCT00813124|CML|cml
654195|NCT00813124|Donor stem cell transplant|donor stem cell transplant
654196|NCT00813124|Allogeneic stem cell transplantation|allogeneic stem cell transplantation
654197|NCT00813124|Stem cell transplant|stem cell transplant
654198|NCT00813124|ATG|atg
654199|NCT00813124|Antithymocyte globulin|antithymocyte globulin
654200|NCT00813124|Vidaza|vidaza
654201|NCT00813124|Azacitidine|azacitidine
654202|NCT00813124|5-Azacitidine|5-azacitidine
654203|NCT00813124|5-Aza|5-aza
654204|NCT00813124|5-AZC|5-azc
654205|NCT00813124|Ladakamycin|ladakamycin
654206|NCT00813124|NSC-102816|nsc-102816
654207|NCT00813124|allotx|allotx
654208|NCT00813124|Busulfan|busulfan
654209|NCT00813124|Busulfex|busulfex
654210|NCT00813124|Myleran|myleran
654211|NCT00813124|Fludarabine|fludarabine
654212|NCT00813124|Fludarabine Phosphate|fludarabine phosphate
654213|NCT00813124|Tacrolimus|tacrolimus
654215|NCT00813124|Azacitidine maintenance therapy|azacitidine maintenance therapy
654216|NCT00813124|molecular remission|molecular remission
654217|NCT00813124|HLA compatible donor|hla compatible donor
654218|NCT00813124|Engraftment|engraftment
654219|NCT00813124|Chimerism|chimerism
654220|NCT00813124|Graft vs host disease|graft vs host disease
654221|NCT00813124|GVHD|gvhd
654222|NCT00813111|Postsurgical pain|postsurgical pain
654223|NCT00813111|Analgesia|analgesia
654224|NCT00813111|Breast augmentation|breast augmentation
654225|NCT00813085|Diabetes|diabetes
654226|NCT00813085|Computerized clinical decision support|computerized clinical decision support
654227|NCT00813085|shared care|shared care
654228|NCT00813085|patient self-monitoring|patient self-monitoring
654229|NCT00813085|quality of care|quality of care
654230|NCT00813085|complex interventions|complex interventions
654231|NCT00813085|composite outcomes|composite outcomes
654232|NCT00813072|Gastric Cancer|gastric cancer
654233|NCT00813072|Stomach Cancer|stomach cancer
654234|NCT00813072|Gastroesophageal|gastroesophageal
654235|NCT00813072|Gastroesophageal Junction|gastroesophageal junction
654236|NCT00813072|Esophageal Cancer|esophageal cancer
654237|NCT00813072|phase II|phase ii
654238|NCT00813072|PEP02|pep02
654239|NCT00813072|randomization|randomization
654240|NCT00813072|randomisation|randomisation
654241|NCT00813072|adenocarcinoma|adenocarcinoma
654242|NCT00813072|locally advanced|locally advanced
654243|NCT00813072|metastatic|metastatic
654244|NCT00813072|simon's two|simon's two
654245|NCT00813059|NAION|naion
654246|NCT00813059|bevacizumab|bevacizumab
654247|NCT00813033|create a patient decision aid for endoscopy|create a patient decision aid for endoscopy
654248|NCT00813033|evaluate efficacy of a patient decision aid for endoscopy|evaluate efficacy of a patient decision aid for endoscopy
654249|NCT00813007|Cervical Cancer|cervical cancer
654250|NCT00813007|Cervix|cervix
654251|NCT00813007|Questionnaire|questionnaire
654252|NCT00813007|Adenocarcinoma of uterine cervix|adenocarcinoma of uterine cervix
654253|NCT00813007|Squamous cell carcinoma of uterine cervix|squamous cell carcinoma of uterine cervix
654254|NCT00813007|Adenosquamous carcinoma of uterine cervix|adenosquamous carcinoma of uterine cervix
654255|NCT00813007|Abdominal radical trachelectomy|abdominal radical trachelectomy
654256|NCT00813007|Trachelectomy|trachelectomy
654257|NCT00813007|Quality of life|quality of life
654258|NCT00813007|Sexual functioning|sexual functioning
654259|NCT00812994|Depression|depression
654260|NCT00812994|BDNF|bdnf
654261|NCT00812994|neurotrophic factor|neurotrophic factor
654262|NCT00812994|neurosetroid|neurosetroid
654263|NCT00812994|allopregnanolone|allopregnanolone
654264|NCT00812981|Pandemic influenza|pandemic influenza
654265|NCT00812968|Myelodysplastic Syndromes|myelodysplastic syndromes
654266|NCT00812968|Lenalidomide|lenalidomide
654267|NCT00812955|Dyslipidemia|dyslipidemia
654268|NCT00812955|Hypercholesterolemia|hypercholesterolemia
654269|NCT00812955|Hypertriglyceridemia|hypertriglyceridemia
654270|NCT00812942|average-risk subjects for|average-risk subjects for
654271|NCT00812929|Asthma, Exercise Induced Asthma, Exercise Induced Bronchospasm|asthma, exercise induced asthma, exercise induced bronchospasm
654464|NCT00812058|Bipolar Depression|bipolar depression
654272|NCT00812916|Persistent or longstanding persistent atrial fibrillation|persistent or longstanding persistent atrial fibrillation
654273|NCT00812903|Neck|neck
654274|NCT00812903|Pain|pain
654275|NCT00812903|Exercise|exercise
654276|NCT00812903|Pilots|pilots
654277|NCT00812903|Crew|crew
654278|NCT00812877|pulp capping|pulp capping
654279|NCT00812877|MTA|mta
654280|NCT00812877|CaOH|caoh
654281|NCT00812877|Mineral Trioxide Aggregate|mineral trioxide aggregate
654282|NCT00812877|Calcium Hydroxide|calcium hydroxide
654283|NCT00812864|Capecitabine|capecitabine
654284|NCT00812864|pharmacocinetics|pharmacocinetics
654285|NCT00812864|Breast metastatic cancer|breast metastatic cancer
654286|NCT00812864|colorectal metastatic cancer|colorectal metastatic cancer
654287|NCT00812864|Elderly patients|elderly patients
654288|NCT00812851|ALS|als
654289|NCT00812851|cramps|cramps
654290|NCT00812851|THC|thc
654291|NCT00812851|Dronabinol|dronabinol
654292|NCT00812825|Safety Tolerability Pharmacokinetics/pharmacodynamics|safety tolerability pharmacokinetics/pharmacodynamics
654293|NCT00812812|paroxetine|paroxetine
654294|NCT00812812|selective serotonin reuptake inhibitor|selective serotonin reuptake inhibitor
654295|NCT00812812|CDRS-R|cdrs-r
654296|NCT00812812|children and adolescents|children and adolescents
654297|NCT00812799|randomised|randomised
654298|NCT00812799|double-blind|double-blind
654299|NCT00812799|placebo-controlled|placebo-controlled
654300|NCT00812799|efficacy and safety|efficacy and safety
654301|NCT00812799|Oralgen® Grass Pollen|oralgen® grass pollen
654302|NCT00812799|allergic rhinoconjunctivitis|allergic rhinoconjunctivitis
654303|NCT00812799|allergy|allergy
654304|NCT00812799|rhinoconjunctivitis|rhinoconjunctivitis
654305|NCT00812799|immunotherapy|immunotherapy
654306|NCT00812799|grass pollen extract|grass pollen extract
654307|NCT00812786|heart transplantation|heart transplantation
654308|NCT00812786|immunosuppressive drugs|immunosuppressive drugs
654309|NCT00812786|individual dose adjustment|individual dose adjustment
654310|NCT00812786|harmacokinetics|harmacokinetics
654311|NCT00812786|modelling|modelling
654312|NCT00812773|GSK2190915|gsk2190915
654313|NCT00812773|Repeat|repeat
654314|NCT00812773|Oral|oral
654315|NCT00812773|Dose|dose
654316|NCT00812773|Challenge|challenge
654317|NCT00812773|Asthma|asthma
654318|NCT00812773|Allergen|allergen
654319|NCT00812760|Electroretinography|electroretinography
654320|NCT00812760|levodopa|levodopa
654321|NCT00812747|surgical wound infection|surgical wound infection
654322|NCT00812747|risk factor|risk factor
654323|NCT00812734|Neuropathic pain|neuropathic pain
654324|NCT00812734|chronic pain|chronic pain
654325|NCT00812734|postoperative|postoperative
654326|NCT00812734|surgery|surgery
654327|NCT00812734|anesthesiology|anesthesiology
654328|NCT00812734|Scheduled surgery|scheduled surgery
654329|NCT00812721|higher order aberrations|higher order aberrations
654330|NCT00812721|tear blur|tear blur
654331|NCT00812708|aniridia|aniridia
654332|NCT00812708|Morcher iris diaphragms|morcher iris diaphragms
654333|NCT00812708|modified capsule tension ring|modified capsule tension ring
654334|NCT00812708|artificial iris|artificial iris
654335|NCT00812708|iris reconstruction lens|iris reconstruction lens
654336|NCT00812708|glare sensitivity|glare sensitivity
654337|NCT00812708|photophobia|photophobia
654338|NCT00812695|Obstructive sleep apnea|obstructive sleep apnea
654339|NCT00812695|Refractory hypertension|refractory hypertension
654340|NCT00812695|Heart remodeling|heart remodeling
654341|NCT00812695|Arterial stiffness|arterial stiffness
654342|NCT00812695|CPAP|cpap
654343|NCT00812682|SYMBICORT AMD|symbicort amd
654344|NCT00812669|B-cell chronic lymphocytic leukemia|b-cell chronic lymphocytic leukemia
654345|NCT00812669|refractory chronic lymphocytic leukemia|refractory chronic lymphocytic leukemia
654346|NCT00812669|stage I chronic lymphocytic leukemia|stage i chronic lymphocytic leukemia
654347|NCT00812669|stage II chronic lymphocytic leukemia|stage ii chronic lymphocytic leukemia
654348|NCT00812669|stage III chronic lymphocytic leukemia|stage iii chronic lymphocytic leukemia
654349|NCT00812669|stage IV chronic lymphocytic leukemia|stage iv chronic lymphocytic leukemia
654350|NCT00812643|pharmacokinetics|pharmacokinetics
654351|NCT00812630|male hormonal contraception|male hormonal contraception
654352|NCT00812630|Blood pressure, sperm concentration|blood pressure, sperm concentration
654353|NCT00812578|Type 2 diabetes|type 2 diabetes
654354|NCT00812578|Vitamin D insufficiency|vitamin d insufficiency
654355|NCT00812578|Insulin secretion|insulin secretion
654356|NCT00812578|Insulin sensitivity|insulin sensitivity
654357|NCT00812578|Pulsatility|pulsatility
654358|NCT00812539|Diabetes|diabetes
654359|NCT00812539|Blood glucose monitoring|blood glucose monitoring
654360|NCT00812539|Internet|internet
654361|NCT00812526|Choroid|choroid
654362|NCT00812526|Regional blood flow|regional blood flow
654363|NCT00812526|Autoregulation|autoregulation
654364|NCT00812526|Laser Doppler flowmetry|laser doppler flowmetry
654365|NCT00812513|rhPDGF-BB|rhpdgf-bb
654366|NCT00812513|Platelet derived growth factor|platelet derived growth factor
654367|NCT00812513|Burns|burns
654368|NCT00812513|Thermal burns|thermal burns
654369|NCT00812513|Electric burns|electric burns
654370|NCT00812500|assess the effect of age on the EAR and RDA for protein|assess the effect of age on the ear and rda for protein
654371|NCT00812487|congestive heart failure|congestive heart failure
654372|NCT00812487|diabetes mellitus|diabetes mellitus
654373|NCT00812487|hyperglycemia|hyperglycemia
654374|NCT00812474|cerebral blood flow|cerebral blood flow
654375|NCT00812461|Pharmacologic Actions|pharmacologic actions
654376|NCT00812461|Alcohol-Related Disorders|alcohol-related disorders
654377|NCT00812461|Alcoholism|alcoholism
654378|NCT00812461|Mental Disorders|mental disorders
654379|NCT00812461|Central Nervous System Agents|central nervous system agents
654380|NCT00812448|prophylaxis|prophylaxis
654381|NCT00812448|influenza infection|influenza infection
654382|NCT00812448|catechins|catechins
654383|NCT00812448|prophylaxis of influenza infection|prophylaxis of influenza infection
654384|NCT00812435|STEMI|stemi
654385|NCT00812435|Patients|patients
654386|NCT00812435|male or female|male or female
654387|NCT00812435|greater than 18 years of age|greater than 18 years of age
654388|NCT00812435|presenting with ST elevation myocardial infarction|presenting with st elevation myocardial infarction
654389|NCT00812422|Fever due to acute upper respiratory tract infection|fever due to acute upper respiratory tract infection
654390|NCT00812409|Measuring markers of metabolic syndrome in overweight and obese adults.|measuring markers of metabolic syndrome in overweight and obese adults.
654391|NCT00812396|Biomarkers of muscle anabolism|biomarkers of muscle anabolism
654392|NCT00812370|DVT|dvt
654393|NCT00812370|Deep Venous Thrombosis|deep venous thrombosis
654394|NCT00812370|UNBLOCK|unblock
654395|NCT00812370|Bivalirudin|bivalirudin
654396|NCT00812370|Angiomax|angiomax
654397|NCT00812357|Symbicort Turbuhaler|symbicort turbuhaler
654398|NCT00812357|asthma|asthma
654399|NCT00812357|cohort study|cohort study
654400|NCT00812357|France|france
654401|NCT00812344|pharmacokinetics|pharmacokinetics
654402|NCT00812331|Hepatitis C|hepatitis c
654403|NCT00812331|TMC435|tmc435
654404|NCT00812318|HIV infected subjects|hiv infected subjects
654405|NCT00812318|Healthy volunteer|healthy volunteer
654406|NCT00812318|GSK1265744.|gsk1265744.
654407|NCT00812292|TMC278|tmc278
654408|NCT00812292|TMC278-C145|tmc278-c145
654409|NCT00812292|TMC278-TiDP38-C145|tmc278-tidp38-c145
654410|NCT00812292|concept pediatric formulations of TMC278|concept pediatric formulations of tmc278
654411|NCT00812292|HIV Infections|hiv infections
654412|NCT00812279|Smokers with acceptable health conditions|smokers with acceptable health conditions
654413|NCT00812266|SCLC|sclc
654414|NCT00812266|Extensive disease|extensive disease
654415|NCT00812266|topotecan|topotecan
654416|NCT00812253|Heart failure|heart failure
654417|NCT00812253|Hyperglycemia|hyperglycemia
654418|NCT00812253|Hospital|hospital
654419|NCT00812253|Diabetes Mellitus|diabetes mellitus
654420|NCT00812240|Gastro-Intestinal Stromal Tumor|gastro-intestinal stromal tumor
654421|NCT00812240|GIST|gist
654422|NCT00812240|metastatic|metastatic
654423|NCT00812240|non resectable locally advanced|non resectable locally advanced
654424|NCT00812227|Depression|depression
654425|NCT00812227|Psychotherapy|psychotherapy
654426|NCT00812227|Neuroimaging|neuroimaging
654427|NCT00812227|Subjects with Major Depressive Disorder (MDD)|subjects with major depressive disorder (mdd)
654428|NCT00812214|insomnia|insomnia
654429|NCT00812214|migraine|migraine
654430|NCT00812214|eszopiclone|eszopiclone
654431|NCT00812214|insomnia in migraineurs|insomnia in migraineurs
654432|NCT00812201|Heart failure|heart failure
654433|NCT00812201|auto threshold|auto threshold
654434|NCT00812201|pacing|pacing
654435|NCT00812201|CRT-P or CRT-D recipients, threshold measurements|crt-p or crt-d recipients, threshold measurements
654436|NCT00812188|Morphea|morphea
654437|NCT00812188|Plaque morphea|plaque morphea
654438|NCT00812188|Localized Scleroderma|localized scleroderma
654439|NCT00812175|Hepatocellular Carcinoma|hepatocellular carcinoma
654440|NCT00812175|HCC|hcc
654441|NCT00812175|Sorafenib|sorafenib
654442|NCT00812149|Type-2 Deiodinase|type-2 deiodinase
654443|NCT00812149|Genetic Polymorphism|genetic polymorphism
654444|NCT00812149|Triiodothyronine (T3)|triiodothyronine (t3)
654445|NCT00812149|Thyrotropin Releasing Hormone (TRH) Test|thyrotropin releasing hormone (trh) test
654446|NCT00812136|Using Parent Mentors to Improve Asthma Care for Urban Minority Children|using parent mentors to improve asthma care for urban minority children
654447|NCT00812123|kidney transplantation|kidney transplantation
654448|NCT00812123|calcineurin inhibitor free|calcineurin inhibitor free
654449|NCT00812123|protocol biopsy|protocol biopsy
654450|NCT00812123|Cyclosporin A|cyclosporin a
654451|NCT00812123|Sirolimus|sirolimus
654452|NCT00812110|Influenza prevention|influenza prevention
654453|NCT00812097|Breast Augmentation|breast augmentation
654454|NCT00812097|Breast Reconstruction|breast reconstruction
654455|NCT00812097|Breast Revision|breast revision
654456|NCT00812097|Silicone gel|silicone gel
654457|NCT00812097|Contour Profile Gel|contour profile gel
654458|NCT00812097|Siltex®|siltex®
654459|NCT00812084|Quality of life|quality of life
654460|NCT00812084|health resources|health resources
654461|NCT00812084|costs|costs
654462|NCT00812084|community-acquired pneumonia|community-acquired pneumonia
654463|NCT00812071|volunteers|volunteers
654465|NCT00812058|Bipolar Disease|bipolar disease
654466|NCT00812058|Bipolar Disorder|bipolar disorder
654467|NCT00812058|Bipolar|bipolar
654468|NCT00812058|Manic Depression|manic depression
654469|NCT00812058|Manic Depressive Disorder|manic depressive disorder
654470|NCT00812045|Induced sputum|induced sputum
654471|NCT00812045|cystic fibrosis|cystic fibrosis
654472|NCT00812045|biomarker|biomarker
654473|NCT00812045|CYBER|cyber
654474|NCT00812032|NIDDM|niddm
654475|NCT00812032|Aspirin|aspirin
654476|NCT00812032|platelet inhibition|platelet inhibition
654477|NCT00812032|Aspirin treatment|aspirin treatment
654478|NCT00812019|H5N1 Influenza|h5n1 influenza
654479|NCT00812019|Pandemic Flu|pandemic flu
654480|NCT00812019|MF59 Adjuvant|mf59 adjuvant
654481|NCT00812019|Cell Culture-Derived|cell culture-derived
654482|NCT00812019|Safety|safety
654483|NCT00812019|Immunogenicity|immunogenicity
654484|NCT00812019|Vaccination|vaccination
654485|NCT00812019|H5N1 influenza pandemic|h5n1 influenza pandemic
654486|NCT00811954|Treatment naive|treatment naive
654487|NCT00811954|Treatment inexperienced|treatment inexperienced
654488|NCT00811941|Pharmacologic Actions|pharmacologic actions
654489|NCT00811941|Alcohol-Related Disorders|alcohol-related disorders
654490|NCT00811941|Alcoholism|alcoholism
654491|NCT00811941|Mental Disorders|mental disorders
654492|NCT00811941|Central Nervous System Agents|central nervous system agents
654493|NCT00811928|high-risk leukopenic patients|high-risk leukopenic patients
654494|NCT00811915|Sirolimus|sirolimus
654495|NCT00811915|Tacrolimus|tacrolimus
654496|NCT00811915|Kidney transplantation|kidney transplantation
654497|NCT00811915|Kidney Transplant Recipients|kidney transplant recipients
654498|NCT00811902|Multiple sclerosis|multiple sclerosis
654499|NCT00811876|Prostate cancer|prostate cancer
654500|NCT00811863|Nephrogenic Systemic Fibrosis|nephrogenic systemic fibrosis
654501|NCT00811863|Renal Insufficiency|renal insufficiency
654502|NCT00811863|Gadoversetamide|gadoversetamide
654503|NCT00811863|OptiMARK|optimark
654504|NCT00811863|Magnetic Resonance Imaging|magnetic resonance imaging
654505|NCT00811837|Sunburn|sunburn
654506|NCT00811837|Remifentanil|remifentanil
654507|NCT00811837|Hyperalgesia|hyperalgesia
654508|NCT00811824|Weight loss|weight loss
654509|NCT00811824|Physical activity|physical activity
654510|NCT00811824|Dietary change|dietary change
654511|NCT00811811|Hypertension|hypertension
654512|NCT00811811|Biofeedback|biofeedback
654513|NCT00811811|Relaxation training|relaxation training
654514|NCT00811798|Hong Kong|hong kong
654515|NCT00811798|Human papillomavirus|human papillomavirus
654516|NCT00811798|Safety|safety
654517|NCT00811785|Copper Deficiency|copper deficiency
654518|NCT00811785|Menkes Disease|menkes disease
654519|NCT00811785|Neurodegeneration|neurodegeneration
654520|NCT00811785|Occipital Horn Syndrome|occipital horn syndrome
654521|NCT00811785|Copper|copper
654522|NCT00811772|Randomized controlled trial|randomized controlled trial
654523|NCT00811772|Bare metal stent|bare metal stent
654524|NCT00811772|Drug eluting stent|drug eluting stent
654525|NCT00811759|stage IV melanoma|stage iv melanoma
654526|NCT00811759|stage III melanoma|stage iii melanoma
654527|NCT00811759|recurrent melanoma|recurrent melanoma
654528|NCT00811746|obstructive sleep apnea|obstructive sleep apnea
654529|NCT00811746|eszopiclone|eszopiclone
654530|NCT00811746|ramelteon|ramelteon
654531|NCT00811746|polysomnography|polysomnography
654532|NCT00811733|Waldenstrom's Macroglobulinemia|waldenstrom's macroglobulinemia
654533|NCT00811733|Ofatumumab|ofatumumab
654534|NCT00811720|Alcohol-Related Disorders|alcohol-related disorders
654535|NCT00811720|Alcoholism|alcoholism
654536|NCT00811720|Mental Disorders|mental disorders
654537|NCT00811720|Central Nervous System Agents|central nervous system agents
654538|NCT00811707|ultrasound image|ultrasound image
654539|NCT00811707|epidural space|epidural space
654540|NCT00811694|glaucoma|glaucoma
654541|NCT00811694|ficker stimulation|ficker stimulation
654542|NCT00811694|ocular blood flow|ocular blood flow
654543|NCT00811681|Friedreich's ataxia|friedreich's ataxia
654544|NCT00811681|Pioglitazone|pioglitazone
654545|NCT00811668|Sleep Apnea Syndromes|sleep apnea syndromes
654546|NCT00811668|heart diseases|heart diseases
654547|NCT00811655|tumors metastatic to brain|tumors metastatic to brain
654548|NCT00811655|unspecified adult solid tumor, protocol specific|unspecified adult solid tumor, protocol specific
654549|NCT00811642|refractory or first line medication intolerable invasive fungal infection|refractory or first line medication intolerable invasive fungal infection
654550|NCT00811629|Receptor for advanced glycation end products (RAGE)|receptor for advanced glycation end products (rage)
654551|NCT00811629|Soluble RAGE (sRAGE)|soluble rage (srage)
654552|NCT00811629|Acute Lung Injury (ALI)|acute lung injury (ali)
654553|NCT00811629|Acute respiratory distress syndrome (ARDS)|acute respiratory distress syndrome (ards)
654554|NCT00811629|Severe sepsis|severe sepsis
654555|NCT00811629|Septic shock|septic shock
654556|NCT00811629|Alveolar epithelium|alveolar epithelium
654557|NCT00811629|Mechanical ventilation|mechanical ventilation
654558|NCT00811629|Intensive Care Unit (ICU)|intensive care unit (icu)
654559|NCT00811616|Coronary artery disease|coronary artery disease
654560|NCT00811616|Supralimus-Core™|supralimus-core™
654561|NCT00811616|de novo native coronary artery lesion|de novo native coronary artery lesion
654562|NCT00811603|Antibiotic|antibiotic
654563|NCT00811603|Prophylaxis|prophylaxis
654564|NCT00811603|Cesarean|cesarean
654565|NCT00811603|Infection|infection
654566|NCT00811603|Antibiotic prophylaxis|antibiotic prophylaxis
654568|NCT00811590|Polyps|polyps
654569|NCT00811577|AZX100|azx100
654570|NCT00811577|Patient and Observer Scar Assessment Scale|patient and observer scar assessment scale
654571|NCT00811577|POSAS|posas
654572|NCT00811577|Visual Analog Scale|visual analog scale
654574|NCT00811577|Trocar|trocar
654575|NCT00811577|Scarring|scarring
654576|NCT00811577|Scar reduction|scar reduction
654577|NCT00811577|Scar prevention|scar prevention
654578|NCT00811551|Heart Failure|heart failure
654579|NCT00811551|Impedance Monitoring|impedance monitoring
654580|NCT00811551|Wedge Pressure|wedge pressure
654581|NCT00811538|ischemic stroke|ischemic stroke
654582|NCT00811538|endovascular treatment|endovascular treatment
654583|NCT00811538|Thrombolysis|thrombolysis
654584|NCT00811538|outcome|outcome
654585|NCT00811525|Breast Augmentation|breast augmentation
654586|NCT00811525|Breast Reconstruction|breast reconstruction
654587|NCT00811525|Breast Revision|breast revision
654588|NCT00811525|Silicone gel|silicone gel
654589|NCT00811525|Contour Profile Gel|contour profile gel
654590|NCT00811525|Siltex|siltex
654591|NCT00811512|retina|retina
654592|NCT00811512|fold|fold
654593|NCT00811512|fovea|fovea
654594|NCT00811473|Bipolar Depression|bipolar depression
654595|NCT00811473|Depression|depression
654596|NCT00811473|Children|children
654597|NCT00811473|Adolescents|adolescents
654598|NCT00811473|Seroquel|seroquel
654599|NCT00811473|Bipolar Depression in Children and Adolescents|bipolar depression in children and adolescents
654600|NCT00811434|encephalopathy|encephalopathy
654601|NCT00811434|pediatric liver disease|pediatric liver disease
654602|NCT00811434|pediatric cirrhosis|pediatric cirrhosis
654603|NCT00811434|serum ammonia levels|serum ammonia levels
654604|NCT00811421|Malaria|malaria
654605|NCT00811421|Pregnancy|pregnancy
654607|NCT00811421|Prevention|prevention
654608|NCT00811421|Malaria prevention|malaria prevention
654609|NCT00811408|human papilloma virus infection|human papilloma virus infection
654610|NCT00811408|cervical squamous cell carcinoma|cervical squamous cell carcinoma
654611|NCT00811408|cervical adenocarcinoma|cervical adenocarcinoma
654612|NCT00811408|stage IB cervical cancer|stage ib cervical cancer
654613|NCT00811408|stage II cervical cancer|stage ii cervical cancer
654614|NCT00811408|stage III cervical cancer|stage iii cervical cancer
654615|NCT00811408|stage IVA cervical cancer|stage iva cervical cancer
654616|NCT00811382|CRT|crt
654617|NCT00811382|therapy of AF|therapy of af
654618|NCT00811382|telecardiology|telecardiology
654619|NCT00811382|home monitoring|home monitoring
654620|NCT00811382|cardiovascular hospitalization|cardiovascular hospitalization
654621|NCT00811382|cardiovascular mortality|cardiovascular mortality
654622|NCT00811369|Breast Cancer|breast cancer
654623|NCT00811369|Bone Metastases|bone metastases
654624|NCT00811369|Telopeptide|telopeptide
654625|NCT00811369|Zactima|zactima
654626|NCT00811369|Fulvestrant|fulvestrant
654627|NCT00811356|Food Effect|food effect
654628|NCT00811356|Drug-Drug Interaction|drug-drug interaction
654629|NCT00811356|Antimalarial|antimalarial
654630|NCT00811356|First Time In Human|first time in human
654631|NCT00811356|Single Dose|single dose
654632|NCT00811356|Repeat Dose|repeat dose
654633|NCT00811343|anti TNF Therapy|anti tnf therapy
654634|NCT00811343|Tuberculosis|tuberculosis
654635|NCT00811343|Tuberculin test|tuberculin test
654636|NCT00811343|QFTB-G|qftb-g
654637|NCT00811343|T-SPOT.TB|t-spot.tb
654638|NCT00811343|Need anti TNF Therapy|need anti tnf therapy
654639|NCT00811330|Left ventricular hypertrophy|left ventricular hypertrophy
654640|NCT00811330|Aortic valve stenosis|aortic valve stenosis
654641|NCT00811330|Aortic valve replacement|aortic valve replacement
654642|NCT00811330|Cardiopulmonary bypass|cardiopulmonary bypass
654643|NCT00811330|Statins|statins
654644|NCT00811330|Myocardial preconditioning|myocardial preconditioning
654645|NCT00811330|Left ventricular reverse remodeling|left ventricular reverse remodeling
654646|NCT00811317|diabetes|diabetes
654647|NCT00811317|glucose|glucose
654648|NCT00811317|hyperglycemia|hyperglycemia
654649|NCT00811317|hypoglycemia|hypoglycemia
654650|NCT00811317|insulin|insulin
654651|NCT00811317|glucagon|glucagon
654652|NCT00811317|counter-regulation|counter-regulation
654653|NCT00811317|closed-loop|closed-loop
654654|NCT00811317|feedback|feedback
654655|NCT00811317|control|control
654656|NCT00811317|dual-infusion|dual-infusion
654657|NCT00811317|subcutaneous|subcutaneous
654658|NCT00811317|automated|automated
654659|NCT00811317|artificial pancreas|artificial pancreas
654660|NCT00811317|intensive insulin therapy|intensive insulin therapy
654661|NCT00811304|ultrasound|ultrasound
654662|NCT00811304|labor epidural|labor epidural
654663|NCT00811304|failed epidural|failed epidural
654664|NCT00811304|outcome|outcome
654848|NCT00810615|oxygen|oxygen
654665|NCT00811304|Epidural insertion under realtime ultrasound guidance|epidural insertion under realtime ultrasound guidance
654666|NCT00811291|B-vitamins|b-vitamins
654667|NCT00811291|Folic-Acid|folic-acid
654668|NCT00811291|kindergarten kids|kindergarten kids
654669|NCT00811291|cognitive tests|cognitive tests
654670|NCT00811291|Healthy kids|healthy kids
654671|NCT00811291|second part low urine vitamine-B-metabolites|second part low urine vitamine-b-metabolites
654672|NCT00811278|inhaled corticosteroids|inhaled corticosteroids
654673|NCT00811265|ExAblate MRgFUS|exablate mrgfus
654674|NCT00811265|Focused ultrasound|focused ultrasound
654675|NCT00811265|Magnetic resonance imaging|magnetic resonance imaging
654676|NCT00811265|Prostate cancer|prostate cancer
654677|NCT00811265|Radical prostatectomy candidate|radical prostatectomy candidate
654678|NCT00811252|Depression|depression
654679|NCT00811252|Elderly|elderly
654680|NCT00811252|Acute treatment|acute treatment
654681|NCT00811239|antivenom|antivenom
654682|NCT00811239|snake bite|snake bite
654683|NCT00811239|Bungarus multicinctus|bungarus multicinctus
654684|NCT00811239|Vietnam|vietnam
654685|NCT00811226|Hypertension Stage I|hypertension stage i
654686|NCT00811226|Hypertension Stage II|hypertension stage ii
654687|NCT00811200|radiation|radiation
654688|NCT00811200|retinopathy|retinopathy
654689|NCT00811200|maculopathy|maculopathy
654690|NCT00811200|choroidopathy|choroidopathy
654691|NCT00811200|uveal|uveal
654692|NCT00811200|melanoma|melanoma
654693|NCT00811200|lucentis|lucentis
654694|NCT00811200|ranibizumab|ranibizumab
654695|NCT00811200|kenalog|kenalog
654696|NCT00811200|triamcinolone acetonide|triamcinolone acetonide
654697|NCT00811200|radiation retinopathy after irradiation of uveal melanoma|radiation retinopathy after irradiation of uveal melanoma
654698|NCT00811200|radiation maculopathy after irradiation of uveal melanoma|radiation maculopathy after irradiation of uveal melanoma
654699|NCT00811200|radiation choroidopathy after irradiation of uveal melanoma|radiation choroidopathy after irradiation of uveal melanoma
654700|NCT00811187|Hysteroscopy|hysteroscopy
654701|NCT00811187|Pain medication|pain medication
654702|NCT00811187|Lidocaine|lidocaine
654703|NCT00811187|Office Procedures|office procedures
654704|NCT00811161|Remodeling|remodeling
654705|NCT00811161|Airgent|airgent
654706|NCT00811161|Hyaluronic acid|hyaluronic acid
654707|NCT00811161|Collagen formation|collagen formation
654708|NCT00811148|Brain Neoplasms|brain neoplasms
654709|NCT00811148|Central Nervous System Diseases|central nervous system diseases
654710|NCT00811148|Central Nervous System Neoplasms|central nervous system neoplasms
654711|NCT00811148|Brain Diseases|brain diseases
654712|NCT00811148|Nervous System Neoplasms|nervous system neoplasms
654713|NCT00811122|Alzheimer's disease|alzheimer's disease
654714|NCT00811122|AD|ad
654715|NCT00811122|Frontotemporal dementia|frontotemporal dementia
654716|NCT00811122|FTD|ftd
654717|NCT00811109|Acute Kidney Injury|acute kidney injury
654718|NCT00811109|Critical care|critical care
654719|NCT00811109|Hypotension|hypotension
654720|NCT00811109|Renal replacement therapy|renal replacement therapy
654721|NCT00811109|Efficacy|efficacy
654722|NCT00811109|Tolerance|tolerance
654723|NCT00811109|Outcome|outcome
654724|NCT00811096|Malaria, Vivax/*drug therapy|malaria, vivax/*drug therapy
711015|NCT00586859|Endoluminal GERD Therapy|endoluminal gerd therapy
654725|NCT00811096|Tinidazole/pharmacology/*therapeutic use|tinidazole/pharmacology/*therapeutic use
654726|NCT00811096|Recurrence|recurrence
654727|NCT00811096|Plasmodium vivax/*drug effects|plasmodium vivax/*drug effects
654728|NCT00811083|autism|autism
654729|NCT00811083|toxic metals|toxic metals
654730|NCT00811083|DMSA|dmsa
654731|NCT00811083|dimercaptosuccinic acid|dimercaptosuccinic acid
654732|NCT00811083|chelation|chelation
654733|NCT00811070|CML. Chronic myelocytic leukemia. Philadelphia Chromosome. Japanese. SKI-606. Bosutinib. Imatinib resistant. Imatinib intolerant|cml. chronic myelocytic leukemia. philadelphia chromosome. japanese. ski-606. bosutinib. imatinib resistant. imatinib intolerant
654734|NCT00811057|Preterm Labor in Pregnancy|preterm labor in pregnancy
654735|NCT00811044|diabetes|diabetes
654736|NCT00811044|genetics|genetics
654737|NCT00811044|oral glucose tolerance testing|oral glucose tolerance testing
654738|NCT00811044|family history of diabetes|family history of diabetes
654739|NCT00811044|gestational diabetes|gestational diabetes
654740|NCT00811031|Prostate|prostate
654741|NCT00811031|prostate gland|prostate gland
654742|NCT00811031|prostate cancer markers|prostate cancer markers
654743|NCT00811031|Taxotere®|taxotere®
654744|NCT00811031|Docetaxel|docetaxel
654745|NCT00811031|Prednisone|prednisone
654746|NCT00811031|Castration Resistant Prostate Cancer|castration resistant prostate cancer
654747|NCT00811031|adenocarcinoma of the prostate|adenocarcinoma of the prostate
654748|NCT00811018|Open-label study|open-label study
654749|NCT00811005|acitretin|acitretin
654750|NCT00811005|fumaric acid ester|fumaric acid ester
654751|NCT00811005|pustular palmoplantar psoriasis|pustular palmoplantar psoriasis
654752|NCT00811005|PUVA|puva
654753|NCT00810992|dietary, behavior|dietary, behavior
654754|NCT00810992|IDF criteria|idf criteria
654755|NCT00810992|coronary artery disease|coronary artery disease
654756|NCT00810992|Traditional Tibetan Medicine|traditional tibetan medicine
654849|NCT00810615|chronic brain injury|chronic brain injury
655241|NCT00809029|HSL|hsl
654757|NCT00810992|coronary artery disease in patients, who have an increased cardiovascular risk profile according to the criteria by the International Diabetes Federation (IDF)|coronary artery disease in patients, who have an increased cardiovascular risk profile according to the criteria by the international diabetes federation (idf)
654758|NCT00810940|TBI|tbi
654759|NCT00810940|closed head injury|closed head injury
654760|NCT00810940|severe head trauma|severe head trauma
654761|NCT00810940|traumatic brain injury|traumatic brain injury
654762|NCT00810914|Patient controlled epidural anesthesia|patient controlled epidural anesthesia
654763|NCT00810914|Pain control in labor|pain control in labor
654764|NCT00810901|ethnic minority adolescents|ethnic minority adolescents
654765|NCT00810901|designated organ donor|designated organ donor
654766|NCT00810888|intracerebral hemorrhage|intracerebral hemorrhage
654767|NCT00810888|ICH|ich
654768|NCT00810888|computed tomography angiography|computed tomography angiography
654769|NCT00810888|CTA|cta
654770|NCT00810888|recombinant activated factor seven|recombinant activated factor seven
654771|NCT00810888|rFVIIa|rfviia
654772|NCT00810888|NovoSeven|novoseven
654773|NCT00810888|recombinant activated factor VII|recombinant activated factor vii
654774|NCT00810875|pregnancy|pregnancy
654775|NCT00810875|immunity|immunity
654776|NCT00810875|cord blood|cord blood
654777|NCT00810875|influenza vaccines|influenza vaccines
654778|NCT00810875|disease transmission, vertical|disease transmission, vertical
654779|NCT00810862|African American children|african american children
654780|NCT00810849|Tuberculosis, pericardium|tuberculosis, pericardium
654781|NCT00810823|Diabetes|diabetes
654782|NCT00810823|gastric bypass|gastric bypass
654783|NCT00810823|type 2 diabetes and gastric bypass|type 2 diabetes and gastric bypass
654784|NCT00810810|Blood Component Transfusion|blood component transfusion
654785|NCT00810810|Leukoreduction|leukoreduction
654786|NCT00810810|HLA antibody|hla antibody
654787|NCT00810810|Immunosuppression|immunosuppression
654788|NCT00810797|recurrent breast cancer|recurrent breast cancer
654789|NCT00810797|stage IV breast cancer|stage iv breast cancer
654790|NCT00810784|Venous Thromboembolism|venous thromboembolism
654791|NCT00810784|Prevention|prevention
654792|NCT00810784|Quality Improvement|quality improvement
654793|NCT00810784|Education|education
654794|NCT00810784|Compliance with VTE prophylaxis|compliance with vte prophylaxis
654795|NCT00810771|Hospitals, Veterans|hospitals, veterans
654796|NCT00810771|Mass Screening/utilization|mass screening/utilization
654797|NCT00810771|Patient Preference|patient preference
654798|NCT00810771|Prevention & Control|prevention & control
654799|NCT00810771|Epidemiology|epidemiology
654800|NCT00810758|HCV|hcv
654801|NCT00810758|Toll-like receptor 7|toll-like receptor 7
654802|NCT00810758|Multiple oral dose escalation study of PF-04878691|multiple oral dose escalation study of pf-04878691
654803|NCT00810745|ODS|ods
654804|NCT00810745|stapled transanal rectal resection|stapled transanal rectal resection
654805|NCT00810732|This study is being conducted to evaluate sitaxsentan dosing in subjects with chronic kidney disease.|this study is being conducted to evaluate sitaxsentan dosing in subjects with chronic kidney disease.
654806|NCT00810732|B1321005|b1321005
654807|NCT00810719|recurrent pancreatic cancer|recurrent pancreatic cancer
654808|NCT00810719|stage IV pancreatic cancer|stage iv pancreatic cancer
654809|NCT00810706|Breast Cancer|breast cancer
654810|NCT00810706|Aromatase inhibitors|aromatase inhibitors
654811|NCT00810706|Exemestane|exemestane
654812|NCT00810706|Tamoxifen|tamoxifen
654813|NCT00810706|Lipids|lipids
654814|NCT00810693|Pulmonary arterial hypertension|pulmonary arterial hypertension
654815|NCT00810693|PH|ph
654816|NCT00810693|Stimulator|stimulator
654817|NCT00810680|chronic lymphocytic leukemia|chronic lymphocytic leukemia
654818|NCT00810680|relapsed|relapsed
654819|NCT00810680|refractory|refractory
654820|NCT00810680|valproic acid|valproic acid
654821|NCT00810680|valproate|valproate
654822|NCT00810667|Schizophrenia|schizophrenia
654823|NCT00810667|Cognition|cognition
654824|NCT00810667|BACS|bacs
654825|NCT00810667|Risperidone|risperidone
654826|NCT00810667|Augmentation therapy|augmentation therapy
654827|NCT00810667|Add-on therapy|add-on therapy
654828|NCT00810667|Lu AE58054|lu ae58054
654829|NCT00810654|Celiac disease|celiac disease
654830|NCT00810654|Coeliac disease|coeliac disease
654831|NCT00810654|treatment|treatment
654832|NCT00810654|AN-PEP|an-pep
654833|NCT00810654|prolyl endoprotease|prolyl endoprotease
654834|NCT00810654|gluten|gluten
654835|NCT00810641|BPPV(benign paroxysmal positional vertigo)|bppv(benign paroxysmal positional vertigo)
654836|NCT00810641|HC-BPPV(BPPV involving the horizontal semicircular canal)|hc-bppv(bppv involving the horizontal semicircular canal)
654837|NCT00810641|Nystagmus|nystagmus
654838|NCT00810641|Treatment outcome|treatment outcome
654839|NCT00810641|Horizontal Canal Benign Paroxysmal Positional Vertigo|horizontal canal benign paroxysmal positional vertigo
654840|NCT00810628|Parkinson's disease|parkinson's disease
654841|NCT00810628|depression|depression
654842|NCT00810628|Parkinson's disease with mild to moderate depression.|parkinson's disease with mild to moderate depression.
654843|NCT00810615|chronic TBI|chronic tbi
654844|NCT00810615|cognitive function|cognitive function
654845|NCT00810615|PTSD|ptsd
654846|NCT00810615|HBO|hbo
654847|NCT00810615|hyperbaric|hyperbaric
654850|NCT00810576|Relapsed T-Cell Non-Hodgkin's Lymphoma|relapsed t-cell non-hodgkin's lymphoma
654851|NCT00810576|Refractory T-Cell Non-Hodgkin's Lymphoma|refractory t-cell non-hodgkin's lymphoma
654852|NCT00810576|NHL|nhl
654853|NCT00810576|T-cell NHL|t-cell nhl
654854|NCT00810576|vorinostat|vorinostat
654855|NCT00810576|SAHA|saha
654856|NCT00810576|Suberoylanilide Hydroxamic Acid|suberoylanilide hydroxamic acid
654857|NCT00810576|MSK-390|msk-390
654858|NCT00810576|Zolinza|zolinza
654859|NCT00810576|Bortezomib|bortezomib
654860|NCT00810576|Velcade|velcade
654861|NCT00810576|LDP-341|ldp-341
654862|NCT00810576|MLN341|mln341
654863|NCT00810576|PS-341|ps-341
654864|NCT00810576|Peripheral T-cell lymphoma|peripheral t-cell lymphoma
654865|NCT00810576|CD 30 + anaplastic large cell lymphoma|cd 30 + anaplastic large cell lymphoma
654866|NCT00810576|Angioimmunoblastic T-cell lymphoma|angioimmunoblastic t-cell lymphoma
654867|NCT00810576|Angiocentric/nasal type T/NK-cell lymphoma|angiocentric/nasal type t/nk-cell lymphoma
654868|NCT00810576|Intestinal T-cell lymphoma|intestinal t-cell lymphoma
654869|NCT00810576|Hepatosplenic gamma delta T-cell lymphoma|hepatosplenic gamma delta t-cell lymphoma
654870|NCT00810576|Subcutaneous panniculitic T-cell lymphoma|subcutaneous panniculitic t-cell lymphoma
654871|NCT00810576|Transformed Mycosis fungoides|transformed mycosis fungoides
654872|NCT00810563|pain|pain
654873|NCT00810563|tubal ligation|tubal ligation
654874|NCT00810563|bupivacaine|bupivacaine
654875|NCT00810563|laparoscopy|laparoscopy
654876|NCT00810524|Chronic hepatitis B|chronic hepatitis b
654877|NCT00810524|antiviral treatment|antiviral treatment
654878|NCT00810524|long term prognosis|long term prognosis
654879|NCT00810485|Gastroesophageal reflux|gastroesophageal reflux
654880|NCT00810485|Proton pump inhibitor|proton pump inhibitor
654881|NCT00810485|Heartburn|heartburn
654882|NCT00810485|Regurgitation|regurgitation
654883|NCT00810472|Penetrating keratoplasty|penetrating keratoplasty
654884|NCT00810472|HLA matching|hla matching
654885|NCT00810472|Corneal diseases that require penetrating keratoplasty|corneal diseases that require penetrating keratoplasty
654886|NCT00810420|Hypoglycemia|hypoglycemia
654887|NCT00810420|EEG|eeg
654888|NCT00810420|type 1 diabetes|type 1 diabetes
654889|NCT00810420|neuroglycopenia|neuroglycopenia
654890|NCT00810420|Hypoglycemia is a potential dangerous condition|hypoglycemia is a potential dangerous condition
654891|NCT00810420|EEG is changed during hypoglycemia|eeg is changed during hypoglycemia
654892|NCT00810420|A hypoglycemia alarm based on EEG-measures may prevent development of severe hypoglycemia|a hypoglycemia alarm based on eeg-measures may prevent development of severe hypoglycemia
654893|NCT00810394|unspecified adult solid tumor, protocol specific|unspecified adult solid tumor, protocol specific
654894|NCT00810381|Nitrovasodilators|nitrovasodilators
654895|NCT00810381|ONH blood flow|onh blood flow
654896|NCT00810381|Choroidal blood flow|choroidal blood flow
654897|NCT00810381|Nitroglycerin|nitroglycerin
654898|NCT00810381|Isosorbide Dinitrate|isosorbide dinitrate
654899|NCT00810381|Sodium nitroprusside|sodium nitroprusside
654900|NCT00810381|Laser-Doppler Flowmetry|laser-doppler flowmetry
654901|NCT00810381|Regional Blood Flow|regional blood flow
834740|NCT00099762|FGF-23|fgf-23
654902|NCT00810368|Carnosine|carnosine
654903|NCT00810368|antioxidant|antioxidant
654904|NCT00810368|Persian Gulf War|persian gulf war
654905|NCT00810368|Gulf War Syndrome|gulf war syndrome
654906|NCT00810368|GWI|gwi
654907|NCT00810368|Gulf War Illness|gulf war illness
654908|NCT00810368|Exercise|exercise
654909|NCT00810368|Chronic Fatigue|chronic fatigue
654910|NCT00810368|Fibromyalgia|fibromyalgia
654911|NCT00810368|Veterans|veterans
654912|NCT00810368|Irritable Bowel Syndrome|irritable bowel syndrome
654913|NCT00810368|Migraine headaches|migraine headaches
654914|NCT00810368|Neuropathy|neuropathy
654915|NCT00810368|Multiple Chemical Sensitivity|multiple chemical sensitivity
654916|NCT00810355|Schizophrenia Spectrum Disorders|schizophrenia spectrum disorders
654917|NCT00810355|Cognitive Behavior Therapy|cognitive behavior therapy
654918|NCT00810355|work|work
654919|NCT00810342|physical activity standard|physical activity standard
654920|NCT00810342|exercise|exercise
654921|NCT00810329|CFS,FM,CSF,Proteomics,Pain,Fatigue,GWI,IBS,IC,MCS.|cfs,fm,csf,proteomics,pain,fatigue,gwi,ibs,ic,mcs.
654922|NCT00810316|Alprazolam|alprazolam
654923|NCT00810316|Alprazolam extended release|alprazolam extended release
654924|NCT00810316|Clonazepam|clonazepam
654925|NCT00810316|Pharmacokinetics|pharmacokinetics
654926|NCT00810316|Mexican population|mexican population
654927|NCT00810316|Healthy|healthy
654928|NCT00810290|Metabolic syndrome|metabolic syndrome
654929|NCT00810290|Latino health|latino health
654930|NCT00810290|Community participatory research|community participatory research
654931|NCT00810290|Translational Research|translational research
654932|NCT00810264|Long-term safety and reliability of a bipolar left ventricular lead on congestive heart failure patients|long-term safety and reliability of a bipolar left ventricular lead on congestive heart failure patients
654933|NCT00810251|rib fracture|rib fracture
654934|NCT00810251|flail chest|flail chest
654935|NCT00810251|plate|plate
654936|NCT00810251|chest trauma|chest trauma
654937|NCT00810251|osteosynthesis|osteosynthesis
654938|NCT00810251|mechanical ventilation|mechanical ventilation
654939|NCT00810251|respirator|respirator
654940|NCT00810238|Heart failure|heart failure
654941|NCT00810238|Cell therapy|cell therapy
654942|NCT00810225|CNDP1|cndp1
654943|NCT00810225|carnosine dipeptidase 1|carnosine dipeptidase 1
654944|NCT00810225|Persian Gulf War|persian gulf war
654945|NCT00810225|Gulf War Syndrome|gulf war syndrome
654946|NCT00810225|GWI|gwi
654947|NCT00810225|Gulf War Illness|gulf war illness
654948|NCT00810225|Exercise|exercise
654949|NCT00810225|Chronic Fatigue|chronic fatigue
654950|NCT00810225|Fibromyalgia|fibromyalgia
654951|NCT00810225|Veterans|veterans
654952|NCT00810225|Irritable Bowel Syndrome|irritable bowel syndrome
654953|NCT00810225|Migraine headaches|migraine headaches
654954|NCT00810225|Neuropathy|neuropathy
654955|NCT00810225|Multiple Chemical Sensitivity|multiple chemical sensitivity
654956|NCT00810212|Degenerative disc disease|degenerative disc disease
654957|NCT00810212|Spondylolisthesis|spondylolisthesis
654958|NCT00810212|Spinal stenosis|spinal stenosis
654959|NCT00810212|Stem cell|stem cell
654960|NCT00810212|Spinal Fusion|spinal fusion
654961|NCT00810173|type 2 diabetes|type 2 diabetes
654962|NCT00810173|physical activity|physical activity
654963|NCT00810173|behavior change|behavior change
654964|NCT00810173|profile personality|profile personality
654965|NCT00810173|phone call support|phone call support
654966|NCT00810160|probiotic|probiotic
654967|NCT00810160|prebiotic|prebiotic
654968|NCT00810160|oligosaccharides|oligosaccharides
654969|NCT00810160|GOS|gos
654970|NCT00810160|galacto oligosaccharides|galacto oligosaccharides
654971|NCT00810160|Bifidobacterium infantis|bifidobacterium infantis
654972|NCT00810160|Bifidobacterium animalis|bifidobacterium animalis
654973|NCT00810134|Superficial femoral artery occlusion (TASC II B or C)|superficial femoral artery occlusion (tasc ii b or c)
654974|NCT00810108|HIV/AIDS|hiv/aids
654975|NCT00810108|pediatrics|pediatrics
654976|NCT00810108|resource-limited settings|resource-limited settings
654977|NCT00810108|lopinavir|lopinavir
654978|NCT00810108|ritonavir|ritonavir
654979|NCT00810108|Kaletra®|kaletra®
654980|NCT00810108|antiretroviral treatment|antiretroviral treatment
654981|NCT00810108|crushed tablets|crushed tablets
654982|NCT00810108|treatment experienced|treatment experienced
654983|NCT00810095|Cerebral Infarction|cerebral infarction
654984|NCT00810095|Stroke|stroke
654985|NCT00810095|Vascular Diseases|vascular diseases
654986|NCT00810095|Central Nervous System Diseases|central nervous system diseases
654987|NCT00810095|Penumbra|penumbra
654988|NCT00810095|Functional Outcome|functional outcome
654989|NCT00810095|Aphasia|aphasia
654990|NCT00810095|Hemiplegia|hemiplegia
654991|NCT00810095|Left sided weakness|left sided weakness
654992|NCT00810095|Right Sided weakness|right sided weakness
654993|NCT00810069|Major Depressive Disorder|major depressive disorder
654994|NCT00810069|MDD|mdd
654995|NCT00810069|Depression|depression
654996|NCT00810056|Child abuse and neglect|child abuse and neglect
654997|NCT00810056|Out-of-home care|out-of-home care
654998|NCT00810056|Mentoring|mentoring
654999|NCT00810056|Skills groups|skills groups
655000|NCT00810056|Assessment|assessment
655001|NCT00810030|ferric carboxymaltose|ferric carboxymaltose
655002|NCT00810030|iron sucrose|iron sucrose
655003|NCT00810030|Iron-Deficiency Anemia|iron-deficiency anemia
655004|NCT00810030|Crohn's Disease|crohn's disease
655005|NCT00810030|Ulcerative Colitis|ulcerative colitis
655006|NCT00810030|Ferritin|ferritin
655007|NCT00810030|Transferrin|transferrin
655008|NCT00810017|Her2 Positive|her2 positive
655009|NCT00810017|Breast Cancer|breast cancer
655010|NCT00810017|Metastatic|metastatic
655011|NCT00809991|Prostate Cancer|prostate cancer
655012|NCT00809965|Rivaroxaban|rivaroxaban
655013|NCT00809965|Acute Coronary Syndrome|acute coronary syndrome
655014|NCT00809965|ACS|acs
655015|NCT00809965|Aspirin|aspirin
655016|NCT00809965|Thienopyridine|thienopyridine
655017|NCT00809965|Unstable Angina|unstable angina
655018|NCT00809965|Myocardial Infarction|myocardial infarction
655019|NCT00809965|Anticoagulation|anticoagulation
655020|NCT00809965|Clopidogrel (Plavix)|clopidogrel (plavix)
655021|NCT00809939|preterm delivery|preterm delivery
655022|NCT00809939|short cervical length|short cervical length
655023|NCT00809939|progesterone|progesterone
655024|NCT00809926|Hypertension, aliskiren and valsartan|hypertension, aliskiren and valsartan
655025|NCT00809913|Urinary Tract Infection|urinary tract infection
655026|NCT00809913|Fever|fever
655027|NCT00809913|Acute Pyelonephritis|acute pyelonephritis
655028|NCT00809913|Treatment duration|treatment duration
655029|NCT00809913|Febrile Urinary Tract Infection Treatment Duration|febrile urinary tract infection treatment duration
655030|NCT00809887|catheter fungal infections, antimicrobial lock therapy, micafungin, central venous catheter|catheter fungal infections, antimicrobial lock therapy, micafungin, central venous catheter
655031|NCT00809874|Postprandial Period|postprandial period
655032|NCT00809874|Postprandial Lipaemia|postprandial lipaemia
655033|NCT00809874|Incretins|incretins
655034|NCT00809874|Subclinical Inflammation|subclinical inflammation
655035|NCT00809874|Obesity|obesity
655036|NCT00809874|Atherosclerosis|atherosclerosis
655037|NCT00809874|Triglyceride|triglyceride
655038|NCT00809874|Lipoproteins|lipoproteins
655039|NCT00809835|Cocaine|cocaine
655042|NCT00809822|IVIG in pemphigoid|ivig in pemphigoid
655043|NCT00809822|Patients with bullous pemphigoid unresponsive to corticosteroids|patients with bullous pemphigoid unresponsive to corticosteroids
655044|NCT00809809|Cold sores|cold sores
655045|NCT00809809|Zinc|zinc
655046|NCT00809809|HSL|hsl
655047|NCT00809809|Herpes simple labialis|herpes simple labialis
655048|NCT00809783|Tanezumab OA arthritis|tanezumab oa arthritis
655049|NCT00809770|stimulant abuse|stimulant abuse
655050|NCT00809770|drug abuse|drug abuse
655051|NCT00809770|schizophrenia|schizophrenia
655052|NCT00809770|bipolar disorder|bipolar disorder
655053|NCT00809770|major depressive disorder|major depressive disorder
655054|NCT00809770|contingency management|contingency management
655055|NCT00809770|psychosocial treatment|psychosocial treatment
655056|NCT00809757|Asthma|asthma
655057|NCT00809731|Schizophrenia remission status by 8-item PANSS|schizophrenia remission status by 8-item panss
655058|NCT00809718|Raltegravir|raltegravir
655059|NCT00809718|Pharmacokinetics|pharmacokinetics
655060|NCT00809718|Rifapentine|rifapentine
655061|NCT00809718|Drug Kinetics|drug kinetics
655062|NCT00809692|histamine biotransformation|histamine biotransformation
655063|NCT00809692|laser Doppler flowimetry|laser doppler flowimetry
655064|NCT00809692|pediatric pharmacology|pediatric pharmacology
655065|NCT00809679|Postherpetic neuralgia|postherpetic neuralgia
655066|NCT00809679|Varicella Zoster|varicella zoster
655067|NCT00809679|Shingles|shingles
655068|NCT00809679|Neuropathic pain|neuropathic pain
655069|NCT00809679|Analgesia|analgesia
655071|NCT00809666|pregnancy|pregnancy
655072|NCT00809666|hypertension|hypertension
655073|NCT00809666|mercury sphygmomanometry|mercury sphygmomanometry
655074|NCT00809666|blood pressure|blood pressure
655075|NCT00809666|automated blood pressure|automated blood pressure
655076|NCT00809666|pre eclampsia|pre eclampsia
655077|NCT00809666|Hypertension in pregnancy|hypertension in pregnancy
655078|NCT00809653|Air pollution|air pollution
655079|NCT00809653|Face mask|face mask
655080|NCT00809653|Myocardial ischaemia|myocardial ischaemia
655081|NCT00809653|Heart rate variability|heart rate variability
655082|NCT00809653|Angina pectoris|angina pectoris
655083|NCT00809653|Coronary heart disease|coronary heart disease
655084|NCT00809640|low back pain|low back pain
655085|NCT00809640|prevention|prevention
655086|NCT00809640|schoolchildren|schoolchildren
655087|NCT00809640|education campaign|education campaign
655088|NCT00809627|headache|headache
655089|NCT00809627|caffeine|caffeine
655090|NCT00809627|pain|pain
655091|NCT00809614|Psoriatic arthritis|psoriatic arthritis
655092|NCT00809614|IgG1K monoclonal antibody|igg1k monoclonal antibody
655093|NCT00809614|Interleukin -17A neutralizing|interleukin -17a neutralizing
655094|NCT00809588|vaccination|vaccination
655095|NCT00809588|GM-CSF|gm-csf
655096|NCT00809588|autologous|autologous
655097|NCT00809588|irradiated|irradiated
655098|NCT00809575|adult|adult
655099|NCT00809575|de novo myelodysplastic syndromes|de novo myelodysplastic syndromes
655100|NCT00809575|Quality of life|quality of life
655101|NCT00809575|Patient reported outcomes|patient reported outcomes
655102|NCT00809549|Stroke|stroke
655103|NCT00809549|GCSF|gcsf
655104|NCT00809549|Hematopoeitic|hematopoeitic
655105|NCT00809549|Neupogen|neupogen
655106|NCT00809549|Filgrastim|filgrastim
655107|NCT00809536|metformin, PD 0332334, organic cation transporter, OCT2, pharmacokinetics|metformin, pd 0332334, organic cation transporter, oct2, pharmacokinetics
655108|NCT00809523|SAD|sad
655109|NCT00809523|winter depression|winter depression
655110|NCT00809497|PLC for treatment of peripheral arterial diseases|plc for treatment of peripheral arterial diseases
655111|NCT00809484|Arimidex|arimidex
655112|NCT00809484|Bone Mineral density|bone mineral density
655113|NCT00809484|Bisphosphonates|bisphosphonates
655114|NCT00809484|Aromatase Inhibitors|aromatase inhibitors
655115|NCT00809471|ED|ed
655116|NCT00809471|Erectile Dysfunction|erectile dysfunction
655117|NCT00809471|Dysfunction|dysfunction
655118|NCT00809471|Diabetic|diabetic
655119|NCT00809471|Erectile|erectile
655120|NCT00809458|Vitamin E|vitamin e
655121|NCT00809458|Prostate Cancer|prostate cancer
655122|NCT00809458|Alpha-tocopherol (α-tocopherol)|alpha-tocopherol (α-tocopherol)
655123|NCT00809432|Air pollution|air pollution
655124|NCT00809432|Heart rate|heart rate
655125|NCT00809432|Heart rate variability|heart rate variability
655126|NCT00809432|Blood pressure|blood pressure
655127|NCT00809432|Face mask|face mask
655128|NCT00809419|Brachytherapy|brachytherapy
655129|NCT00809419|EpiRad|epirad
655130|NCT00809419|Macular Degeneration|macular degeneration
655131|NCT00809419|Ranibizumab|ranibizumab
655132|NCT00809393|Antifibrinolytic|antifibrinolytic
655133|NCT00809393|Tranexamic acid|tranexamic acid
655134|NCT00809393|Cardiopulmonary bypass|cardiopulmonary bypass
655135|NCT00809393|Transfusion|transfusion
655136|NCT00809393|Hemorrhage|hemorrhage
655137|NCT00809380|Conscious sedation|conscious sedation
655138|NCT00809380|Parental presence|parental presence
655139|NCT00809380|Invasive procedure|invasive procedure
655140|NCT00809380|Children|children
655141|NCT00809380|Anxiety|anxiety
655142|NCT00809367|MDS|mds
655144|NCT00809367|banking study|banking study
655145|NCT00809354|monoclonal antibody|monoclonal antibody
655146|NCT00809354|nerve growth factor (NGF)|nerve growth factor (ngf)
655147|NCT00809354|anti-NGF|anti-ngf
655148|NCT00809354|tanezumab|tanezumab
655149|NCT00809354|PF-04383119|pf-04383119
655150|NCT00809354|RN624|rn624
655151|NCT00809354|osteoarthritis (OA)|osteoarthritis (oa)
655152|NCT00809341|B-Cell|b-cell
655153|NCT00809341|non-Hodgkin's|non-hodgkin's
655154|NCT00809341|Lymphoma|lymphoma
655155|NCT00809315|Child abuse and neglect|child abuse and neglect
655156|NCT00809315|Out-of-home care|out-of-home care
655157|NCT00809315|Mentoring|mentoring
655158|NCT00809315|Skills groups|skills groups
655159|NCT00809315|Assessment|assessment
655160|NCT00809315|Functioning as a result of maltreatment and placement in out-of-home care|functioning as a result of maltreatment and placement in out-of-home care
655161|NCT00809289|Thorough QT/QTc study|thorough qt/qtc study
655162|NCT00809276|Acute lymphocytic leukemia (ALL)|acute lymphocytic leukemia (all)
655163|NCT00809276|Acute myeloid leukemia (AML)|acute myeloid leukemia (aml)
655164|NCT00809276|Acute Leukemia|acute leukemia
655165|NCT00809276|Refractory or Relapsed AML|refractory or relapsed aml
655166|NCT00809276|Myelodysplastic syndrome (MDS)|myelodysplastic syndrome (mds)
655167|NCT00809276|Chronic myeloid leukemia (CML)|chronic myeloid leukemia (cml)
655168|NCT00809276|Chronic myelomonocytic leukemia|chronic myelomonocytic leukemia
655169|NCT00809276|Hodgkin's Lymphoma|hodgkin's lymphoma
655170|NCT00809276|Non-Hodgkin's lymphoma|non-hodgkin's lymphoma
655171|NCT00809276|Philadelphia-negative myeloproliferative disorder|philadelphia-negative myeloproliferative disorder
655172|NCT00809276|Hematologic Malignancies|hematologic malignancies
655173|NCT00809276|Transplantation|transplantation
655174|NCT00809276|Busulfan|busulfan
655175|NCT00809276|Fludarabine|fludarabine
655176|NCT00809276|Cytoxan|cytoxan
655177|NCT00809276|Bone Marrow|bone marrow
655178|NCT00809276|Allogeneic|allogeneic
655179|NCT00809276|Related donor|related donor
655180|NCT00809276|unrelated donor|unrelated donor
655181|NCT00809263|homeopathy|homeopathy
655182|NCT00809263|homeopathic drug proving|homeopathic drug proving
655183|NCT00809263|Document symptoms associated with administration of a homeopathic remedy.|document symptoms associated with administration of a homeopathic remedy.
655184|NCT00809250|vaccination|vaccination
655185|NCT00809250|AML|aml
655186|NCT00809250|CMML|cmml
655187|NCT00809250|MDS-RAEB|mds-raeb
655188|NCT00809237|Non-small cell lung cancer|non-small cell lung cancer
655189|NCT00809237|Gefitinib|gefitinib
655190|NCT00809237|Hydroxychloroquine|hydroxychloroquine
655191|NCT00809224|ALS|als
655192|NCT00809224|amyotrophic lateral sclerosis|amyotrophic lateral sclerosis
655193|NCT00809224|brain-computer interface|brain-computer interface
655194|NCT00809224|functional magnetic resonance imaging|functional magnetic resonance imaging
655195|NCT00809224|radiology|radiology
655196|NCT00809224|fMRI|fmri
655197|NCT00809211|chronic myelogenous leukemia, BCR-ABL1 positive|chronic myelogenous leukemia, bcr-abl1 positive
655198|NCT00809211|chronic phase chronic myelogenous leukemia|chronic phase chronic myelogenous leukemia
655199|NCT00809198|Sodium Hyaluronate, Kynex, Carboxymethylcellulose sodium|sodium hyaluronate, kynex, carboxymethylcellulose sodium
655200|NCT00809198|Refresh Plus|refresh plus
655201|NCT00809198|Dry Eye|dry eye
655202|NCT00809198|Cornea Staining|cornea staining
655203|NCT00809198|TBUT|tbut
655204|NCT00809185|de novo myelodysplastic syndromes|de novo myelodysplastic syndromes
655205|NCT00809185|secondary myelodysplastic syndromes|secondary myelodysplastic syndromes
655206|NCT00809185|previously treated myelodysplastic syndromes|previously treated myelodysplastic syndromes
655207|NCT00809172|Atopic-dermatitis|atopic-dermatitis
655208|NCT00809172|scorad|scorad
655209|NCT00809172|methotrexate|methotrexate
655210|NCT00809172|ciclosporin|ciclosporin
655211|NCT00809159|ankylosing spondylitis|ankylosing spondylitis
655212|NCT00809146|Status Epilepticus|status epilepticus
655213|NCT00809146|Emergency Medical Services|emergency medical services
655214|NCT00809146|Anticonvulsants|anticonvulsants
655215|NCT00809146|Drug Administration Routes|drug administration routes
655216|NCT00809146|Seizures|seizures
655217|NCT00809120|Electrostimulation|electrostimulation
655218|NCT00809120|COPD|copd
655219|NCT00809120|Tolerance|tolerance
655220|NCT00809120|Muscle fatigue|muscle fatigue
655221|NCT00809120|Cardio-respiratory response|cardio-respiratory response
655222|NCT00809107|natural cycle|natural cycle
655223|NCT00809107|FET|fet
655224|NCT00809107|spontaneous LH pic|spontaneous lh pic
655225|NCT00809107|HCG|hcg
655226|NCT00809081|periampullar carcinoma|periampullar carcinoma
655227|NCT00809081|Pancreaticoduodenectomy|pancreaticoduodenectomy
655228|NCT00809081|Enteral feeding|enteral feeding
655229|NCT00809081|Total Parenteral Support|total parenteral support
655230|NCT00809068|Menopause|menopause
655231|NCT00809068|menopausal symptoms|menopausal symptoms
655232|NCT00809068|tibolone|tibolone
655233|NCT00809068|HDL-C|hdl-c
655234|NCT00809068|fenofibrate|fenofibrate
655235|NCT00809042|Hydroxyurea|hydroxyurea
655236|NCT00809042|magnesium chloride|magnesium chloride
655237|NCT00809042|L-carnitine|l-carnitine
655238|NCT00809042|β-thalassemia intermedia|β-thalassemia intermedia
655243|NCT00809029|ADIPOCYTOKINES|adipocytokines
655244|NCT00809029|BARIATRIC SURGERY|bariatric surgery
655245|NCT00809016|recurrent squamous cell carcinoma of the hypopharynx|recurrent squamous cell carcinoma of the hypopharynx
655246|NCT00809016|stage III squamous cell carcinoma of the hypopharynx|stage iii squamous cell carcinoma of the hypopharynx
655247|NCT00809016|stage IV squamous cell carcinoma of the hypopharynx|stage iv squamous cell carcinoma of the hypopharynx
655248|NCT00809016|recurrent squamous cell carcinoma of the larynx|recurrent squamous cell carcinoma of the larynx
655249|NCT00809016|stage III squamous cell carcinoma of the larynx|stage iii squamous cell carcinoma of the larynx
655250|NCT00809016|stage IV squamous cell carcinoma of the larynx|stage iv squamous cell carcinoma of the larynx
655251|NCT00809016|recurrent verrucous carcinoma of the larynx|recurrent verrucous carcinoma of the larynx
655252|NCT00809016|stage III verrucous carcinoma of the larynx|stage iii verrucous carcinoma of the larynx
655253|NCT00809016|stage IV verrucous carcinoma of the larynx|stage iv verrucous carcinoma of the larynx
655254|NCT00809016|recurrent adenoid cystic carcinoma of the oral cavity|recurrent adenoid cystic carcinoma of the oral cavity
655255|NCT00809016|recurrent mucoepidermoid carcinoma of the oral cavity|recurrent mucoepidermoid carcinoma of the oral cavity
655256|NCT00809016|recurrent verrucous carcinoma of the oral cavity|recurrent verrucous carcinoma of the oral cavity
655257|NCT00809016|stage III adenoid cystic carcinoma of the oral cavity|stage iii adenoid cystic carcinoma of the oral cavity
655258|NCT00809016|stage III mucoepidermoid carcinoma of the oral cavity|stage iii mucoepidermoid carcinoma of the oral cavity
655259|NCT00809016|stage III verrucous carcinoma of the oral cavity|stage iii verrucous carcinoma of the oral cavity
655260|NCT00809016|stage IV adenoid cystic carcinoma of the oral cavity|stage iv adenoid cystic carcinoma of the oral cavity
655261|NCT00809016|stage IV mucoepidermoid carcinoma of the oral cavity|stage iv mucoepidermoid carcinoma of the oral cavity
655262|NCT00809016|stage IV verrucous carcinoma of the oral cavity|stage iv verrucous carcinoma of the oral cavity
655263|NCT00809016|recurrent basal cell carcinoma of the lip|recurrent basal cell carcinoma of the lip
655264|NCT00809016|recurrent squamous cell carcinoma of the lip and oral cavity|recurrent squamous cell carcinoma of the lip and oral cavity
655265|NCT00809016|stage III basal cell carcinoma of the lip|stage iii basal cell carcinoma of the lip
655266|NCT00809016|stage III squamous cell carcinoma of the lip and oral cavity|stage iii squamous cell carcinoma of the lip and oral cavity
655267|NCT00809016|stage IV basal cell carcinoma of the lip|stage iv basal cell carcinoma of the lip
655268|NCT00809016|stage IV squamous cell carcinoma of the lip and oral cavity|stage iv squamous cell carcinoma of the lip and oral cavity
655269|NCT00809016|metastatic squamous neck cancer with occult primary squamous cell carcinoma|metastatic squamous neck cancer with occult primary squamous cell carcinoma
655270|NCT00809016|recurrent metastatic squamous neck cancer with occult primary|recurrent metastatic squamous neck cancer with occult primary
655271|NCT00809016|untreated metastatic squamous neck cancer with occult primary|untreated metastatic squamous neck cancer with occult primary
655272|NCT00809016|recurrent lymphoepithelioma of the oropharynx|recurrent lymphoepithelioma of the oropharynx
655273|NCT00809016|recurrent squamous cell carcinoma of the oropharynx|recurrent squamous cell carcinoma of the oropharynx
655274|NCT00809016|stage III lymphoepithelioma of the oropharynx|stage iii lymphoepithelioma of the oropharynx
655275|NCT00809016|stage III squamous cell carcinoma of the oropharynx|stage iii squamous cell carcinoma of the oropharynx
655276|NCT00809016|stage IV lymphoepithelioma of the oropharynx|stage iv lymphoepithelioma of the oropharynx
655277|NCT00809016|stage IV squamous cell carcinoma of the oropharynx|stage iv squamous cell carcinoma of the oropharynx
655278|NCT00809016|high-grade salivary gland mucoepidermoid carcinoma|high-grade salivary gland mucoepidermoid carcinoma
655279|NCT00809016|low-grade salivary gland mucoepidermoid carcinoma|low-grade salivary gland mucoepidermoid carcinoma
655280|NCT00809016|recurrent salivary gland cancer|recurrent salivary gland cancer
655281|NCT00809016|salivary gland acinic cell tumor|salivary gland acinic cell tumor
655282|NCT00809016|salivary gland adenocarcinoma|salivary gland adenocarcinoma
655283|NCT00809016|salivary gland adenoid cystic carcinoma|salivary gland adenoid cystic carcinoma
655284|NCT00809016|salivary gland anaplastic carcinoma|salivary gland anaplastic carcinoma
655285|NCT00809016|salivary gland malignant mixed cell type tumor|salivary gland malignant mixed cell type tumor
655286|NCT00809016|salivary gland poorly differentiated carcinoma|salivary gland poorly differentiated carcinoma
655287|NCT00809016|salivary gland squamous cell carcinoma|salivary gland squamous cell carcinoma
655288|NCT00809016|stage III salivary gland cancer|stage iii salivary gland cancer
655289|NCT00809016|stage IV salivary gland cancer|stage iv salivary gland cancer
655290|NCT00809003|Non dry eyed(normals)|non dry eyed(normals)
655291|NCT00808990|Non Alcoholic Fatty Liver Disease|non alcoholic fatty liver disease
655292|NCT00808990|Non Alcoholic SteatoHepatitis|non alcoholic steatohepatitis
655293|NCT00808990|Small bowel bacterial overgrowth|small bowel bacterial overgrowth
655294|NCT00808990|Probiotics|probiotics
655295|NCT00808990|Patients with Non Alcoholic Fatty Liver Disease|patients with non alcoholic fatty liver disease
655296|NCT00808964|CABG|cabg
655297|NCT00808964|anticoagulant|anticoagulant
655298|NCT00808964|Off-Pump CABG|off-pump cabg
655299|NCT00808951|Uncomplicated malaria|uncomplicated malaria
655300|NCT00808951|P falciparum|p falciparum
655301|NCT00808951|Children|children
655302|NCT00808951|National treatment protocol|national treatment protocol
655303|NCT00808951|Burkina Faso|burkina faso
655304|NCT00808951|Artemether-lumefantrine|artemether-lumefantrine
655305|NCT00808951|Artesunate-amodiaquine|artesunate-amodiaquine
655306|NCT00808951|In vivo efficacy|in vivo efficacy
655307|NCT00808951|In vitro efficacy|in vitro efficacy
655308|NCT00808925|acclimation|acclimation
655309|NCT00808925|heat|heat
655310|NCT00808925|cytokines|cytokines
655311|NCT00808925|stress|stress
655312|NCT00808925|inflammation|inflammation
655313|NCT00808912|phosphodiesterase|phosphodiesterase
655314|NCT00808912|sildenafil|sildenafil
655315|NCT00808912|pulmonary hypertension|pulmonary hypertension
655316|NCT00808912|exercise performance|exercise performance
655317|NCT00808912|air pollution|air pollution
655318|NCT00808899|Neuroblastoma|neuroblastoma
655319|NCT00808886|cataract|cataract
655320|NCT00808886|locs3|locs3
655321|NCT00808886|pentacam|pentacam
655322|NCT00808873|attempted suicide|attempted suicide
655323|NCT00808873|socio-educational intervention|socio-educational intervention
655324|NCT00808873|follow up study|follow up study
655325|NCT00808860|Herbal medicine|herbal medicine
655326|NCT00808860|Type 2 diabetes|type 2 diabetes
655327|NCT00808860|Gynostemma pentaphyllum Tea|gynostemma pentaphyllum tea
655328|NCT00808860|Insulin sensitivity|insulin sensitivity
655329|NCT00808860|add-on|add-on
655330|NCT00808808|FluMist, TIV, vaccination rates|flumist, tiv, vaccination rates
655331|NCT00808795|Acute kidney injury|acute kidney injury
655332|NCT00808795|contrast-induced nephropathy|contrast-induced nephropathy
655333|NCT00808795|Chronic kidney disease|chronic kidney disease
655334|NCT00808795|Diabetes mellitus|diabetes mellitus
655335|NCT00808795|N-acetylcysteine|n-acetylcysteine
655336|NCT00808782|Pervasive Developmental Disorders|pervasive developmental disorders
655337|NCT00808782|Asperger Syndrome|asperger syndrome
655338|NCT00808782|Autism|autism
655339|NCT00808756|Carbohydrates|carbohydrates
655340|NCT00808756|Infant|infant
655341|NCT00808756|Intestine|intestine
655342|NCT00808756|Faeces|faeces
655343|NCT00808756|Growth|growth
655344|NCT00808756|Diet|diet
655345|NCT00808743|Familial adenomatous polyposis|familial adenomatous polyposis
655346|NCT00808743|Adenomatous Polyposis Coli|adenomatous polyposis coli
655347|NCT00808743|Digestive System Neoplasms|digestive system neoplasms
655348|NCT00808743|Gastrointestinal Disease|gastrointestinal disease
655349|NCT00808743|Intestinal disease|intestinal disease
655350|NCT00808743|Intestinal neoplasms|intestinal neoplasms
655351|NCT00808743|Gastrointestinal neoplasms|gastrointestinal neoplasms
655352|NCT00808743|Polyps|polyps
655353|NCT00808743|Adenoma|adenoma
655354|NCT00808743|Adenomatous Polyps|adenomatous polyps
655355|NCT00808743|Neoplastic Syndromes, Hereditary|neoplastic syndromes, hereditary
655356|NCT00808743|Digestive System Diseases|digestive system diseases
655357|NCT00808743|Genetic Diseases, Inborn|genetic diseases, inborn
655358|NCT00808743|Chemoprevention|chemoprevention
655359|NCT00808743|Celecoxib|celecoxib
655360|NCT00808743|Ursodeoxycholic acid|ursodeoxycholic acid
655361|NCT00808743|Anti-Inflammatory agents, Non-Steroidal|anti-inflammatory agents, non-steroidal
655362|NCT00808743|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors
655363|NCT00808730|Asthma, airway remodelling, smooth muscle, mitochondria|asthma, airway remodelling, smooth muscle, mitochondria
655364|NCT00808717|Myocardial Infarction|myocardial infarction
655365|NCT00808717|Coronary Angioplasty|coronary angioplasty
655366|NCT00808717|Myocardial infarction, Angioplasty, Transluminal, Percutaneous Coronary|myocardial infarction, angioplasty, transluminal, percutaneous coronary
655367|NCT00808704|asphyxia|asphyxia
655368|NCT00808704|erythropoietin|erythropoietin
655369|NCT00808704|neonates|neonates
655370|NCT00808678|Adverse Events|adverse events
655371|NCT00808665|Lumbar Fusion|lumbar fusion
655372|NCT00808665|Inflammation|inflammation
655373|NCT00808665|Dexmedetomidine|dexmedetomidine
655374|NCT00808665|Length of Hospital Stay|length of hospital stay
655375|NCT00808665|General Anesthesia|general anesthesia
655376|NCT00808665|Anti-inflammatory|anti-inflammatory
655377|NCT00808665|GPCR|gpcr
655378|NCT00808665|Cytokine|cytokine
655379|NCT00808665|Immune Response|immune response
655380|NCT00808639|pegfilgrastim|pegfilgrastim
655381|NCT00808639|MVAC|mvac
655382|NCT00808600|lung transplantation|lung transplantation
655383|NCT00808600|heart-lung transplantation|heart-lung transplantation
655384|NCT00808600|rehabilitation|rehabilitation
655385|NCT00808600|resource-activating training|resource-activating training
655386|NCT00808600|anaerobic exercise training|anaerobic exercise training
655387|NCT00808587|Genomic Scan|genomic scan
655388|NCT00808587|Personalized Medicine|personalized medicine
655389|NCT00808587|Gene testing|gene testing
655390|NCT00808574|Obstructive sleep apnea|obstructive sleep apnea
655391|NCT00808574|Internet|internet
655392|NCT00808574|Screening|screening
655393|NCT00808574|Health belief model|health belief model
655394|NCT00808548|stress|stress
655395|NCT00808548|carer's experiences|carer's experiences
655396|NCT00808548|Prader-willi syndrome|prader-willi syndrome
655397|NCT00808548|personal experiences|personal experiences
655398|NCT00808535|Endothelial dysfunction|endothelial dysfunction
655399|NCT00808535|Cardiac Perfusion MRI|cardiac perfusion mri
655400|NCT00808535|Vasomotor Stress|vasomotor stress
655401|NCT00808535|Cold Pressor Test|cold pressor test
655402|NCT00808535|Adenosine Stress|adenosine stress
655403|NCT00808522|Breast Cancer|breast cancer
655404|NCT00808522|Chemoprevention|chemoprevention
655405|NCT00808522|Tamoxifen|tamoxifen
655406|NCT00808522|Breast density|breast density
655407|NCT00808522|Hcg|hcg
655408|NCT00808509|adalimumab,Remission,drug discontinuation|adalimumab,remission,drug discontinuation
655409|NCT00808496|Magnetic resonance imaging|magnetic resonance imaging
655410|NCT00808496|Radiography|radiography
655411|NCT00808496|Randomized controlled trial|randomized controlled trial
655412|NCT00808496|Antirheumatic agents|antirheumatic agents
655413|NCT00808483|total hip arthroplasty|total hip arthroplasty
655414|NCT00808483|physical functioning|physical functioning
655415|NCT00808483|training program|training program
655416|NCT00808483|self-efficacy|self-efficacy
655417|NCT00808483|exercise therapy|exercise therapy
655418|NCT00808483|walking|walking
655419|NCT00808470|Noise|noise
655420|NCT00808470|Hearing Loss|hearing loss
655421|NCT00808470|Tinnitus|tinnitus
655422|NCT00808470|Antioxidant|antioxidant
655423|NCT00808470|Vasodilator|vasodilator
655424|NCT00808470|Beta-Carotene|beta-carotene
655425|NCT00808470|Vitamin C|vitamin c
655426|NCT00808470|Vitamin E|vitamin e
655427|NCT00808470|Magnesium|magnesium
655428|NCT00808457|chest ultrasound|chest ultrasound
655429|NCT00808457|pneumonia|pneumonia
655430|NCT00808457|X-ray|x-ray
655431|NCT00808457|CT|ct
655432|NCT00808457|Sensitivity and specificity of chest ultrasound in diagnosing pneumonia|sensitivity and specificity of chest ultrasound in diagnosing pneumonia
655433|NCT00808444|Pneumococcal vaccine|pneumococcal vaccine
655434|NCT00808444|Immunogenicity|immunogenicity
655435|NCT00808444|Primary vaccination|primary vaccination
655436|NCT00808444|Safety|safety
655437|NCT00808444|Pneumococcal disease|pneumococcal disease
655438|NCT00808431|Obesity|obesity
655439|NCT00808431|Diabetes|diabetes
655440|NCT00808431|Physical Activity|physical activity
655441|NCT00808431|Child Feeding|child feeding
655442|NCT00808431|Growth Trajectories|growth trajectories
655443|NCT00808431|Family based|family based
655444|NCT00808418|prostate|prostate
655445|NCT00808418|cancer|cancer
655446|NCT00808418|metastatic|metastatic
655447|NCT00808418|castration|castration
655448|NCT00808418|refractory|refractory
655449|NCT00808418|elesclomol|elesclomol
655450|NCT00808418|sodium|sodium
655451|NCT00808418|docetaxel|docetaxel
655452|NCT00808418|prednisone|prednisone
655453|NCT00808405|herpes simplex virus|herpes simplex virus
655454|NCT00808405|acyclovir|acyclovir
655455|NCT00808405|HSV shedding|hsv shedding
655456|NCT00808405|women|women
655457|NCT00808405|Africa|africa
655458|NCT00808392|vaccine|vaccine
655459|NCT00808392|prevention|prevention
655460|NCT00808392|haemophilus influenzae type b|haemophilus influenzae type b
655461|NCT00808392|children|children
655462|NCT00808379|Unresectable rectal cancers|unresectable rectal cancers
655463|NCT00808353|CVD|cvd
655464|NCT00808327|Cesarean section|cesarean section
655465|NCT00808327|Spinal|spinal
655466|NCT00808314|Lexiscan(TM)|lexiscan(tm)
655467|NCT00808314|Dipyridamole|dipyridamole
655468|NCT00808314|Myocardial Perfusion|myocardial perfusion
655469|NCT00808314|Positron Emission Computed Tomography|positron emission computed tomography
655470|NCT00808301|Coeliac disease|coeliac disease
655471|NCT00808301|Oat|oat
655472|NCT00808288|COPD Respiratory Long acting beta agonist|copd respiratory long acting beta agonist
655473|NCT00808275|dietary calcium|dietary calcium
655474|NCT00808275|weight loss|weight loss
655475|NCT00808262|anti-TNFa|anti-tnfa
655476|NCT00808262|immunization|immunization
655477|NCT00808262|kinoid|kinoid
655478|NCT00808262|crohn's disease|crohn's disease
655479|NCT00808249|Generalized Anxiety Disorder|generalized anxiety disorder
655480|NCT00808249|GAD|gad
655481|NCT00808249|Anxiety|anxiety
655482|NCT00808236|Cardiac Arrest|cardiac arrest
655483|NCT00808236|Pre-hospital|pre-hospital
655484|NCT00808236|Mild hypothermia|mild hypothermia
655485|NCT00808236|Resuscitation|resuscitation
655486|NCT00808223|alefacept|alefacept
655487|NCT00808223|adolescent|adolescent
655488|NCT00808223|psoriasis|psoriasis
655489|NCT00808210|RA|ra
655490|NCT00808210|Arthritis|arthritis
655491|NCT00808197|AMD|amd
655492|NCT00808197|choroidal blood flow|choroidal blood flow
655493|NCT00808197|fellow eye in patients with unilateral choroidal neovascularisation|fellow eye in patients with unilateral choroidal neovascularisation
655494|NCT00808184|Histologically or cytologically proven solid tumour for which CPT-11 given by the Folfiri regimen|histologically or cytologically proven solid tumour for which cpt-11 given by the folfiri regimen
655495|NCT00808171|lumbar punction|lumbar punction
655496|NCT00808171|myelogram|myelogram
655497|NCT00808171|pain assessment|pain assessment
655498|NCT00808171|nitrous oxide and EMLA|nitrous oxide and emla
655499|NCT00808171|Leukemia and non Hodgkin lymphoma|leukemia and non hodgkin lymphoma
655500|NCT00808145|Treatment of advanced liver cancer|treatment of advanced liver cancer
655501|NCT00808132|Postmenopausal Women|postmenopausal women
655502|NCT00808132|Bazedoxifene/Conjugated Estrogens|bazedoxifene/conjugated estrogens
655503|NCT00808106|Oculocutaneous Albinism|oculocutaneous albinism
655504|NCT00808093|Food Effect|food effect
655505|NCT00808093|GSK256073F|gsk256073f
655506|NCT00808093|TRIS Salt|tris salt
655507|NCT00808080|AML|aml
655508|NCT00808054|Pain|pain
655509|NCT00808054|preterm neonate|preterm neonate
655510|NCT00808054|pain assessment|pain assessment
655511|NCT00808054|EMLA|emla
655512|NCT00808054|oral glucose|oral glucose
655513|NCT00808041|Neoadjuvant Treatment|neoadjuvant treatment
655514|NCT00808041|Therapy Response|therapy response
655515|NCT00808041|Breast Computed Tomography|breast computed tomography
655516|NCT00808015|Observational non-interventional trial|observational non-interventional trial
655517|NCT00808002|Maraviroc|maraviroc
655518|NCT00808002|CCR5 antagonists|ccr5 antagonists
655519|NCT00808002|Primary HIV Infection|primary hiv infection
655520|NCT00808002|HIV-1 reservoir|hiv-1 reservoir
655521|NCT00808002|eradication|eradication
655522|NCT00808002|treatment naive|treatment naive
655523|NCT00807976|Diabetes mellitus|diabetes mellitus
655524|NCT00807976|Elderly|elderly
655525|NCT00807976|Orthostatic hypotension|orthostatic hypotension
655526|NCT00807963|Pharmacokinetics|pharmacokinetics
655527|NCT00807963|rHuPH20|rhuph20
655528|NCT00807937|Generalized Anxiety Disorder|generalized anxiety disorder
655529|NCT00807937|GAD|gad
655530|NCT00807937|Anxiety|anxiety
655531|NCT00807924|Fibroadenomas|fibroadenomas
655532|NCT00807924|Papillomas|papillomas
655533|NCT00807924|Breast|breast
655534|NCT00807924|Minimally invasive|minimally invasive
655535|NCT00807924|Interstitial laser therapy|interstitial laser therapy
655536|NCT00807924|Laser ablation|laser ablation
655537|NCT00807924|Benign|benign
655538|NCT00807924|Non-cancerous|non-cancerous
655539|NCT00807924|Breast lesion|breast lesion
655540|NCT00807924|Breast tumor|breast tumor
655541|NCT00807911|rectal cancer|rectal cancer
655542|NCT00807911|adjuvant chemotherapy|adjuvant chemotherapy
655543|NCT00807911|FOLFOX|folfox
655544|NCT00807898|Gardasil|gardasil
655545|NCT00807898|HPV vaccine|hpv vaccine
655546|NCT00807898|decision making|decision making
655547|NCT00807898|mother|mother
655548|NCT00807898|daughter|daughter
655549|NCT00807885|dehydration|dehydration
655550|NCT00807885|fluid therapy|fluid therapy
655551|NCT00807885|hyaluronoglucosaminidase|hyaluronoglucosaminidase
655552|NCT00807885|hyaluronidase|hyaluronidase
655553|NCT00807885|hypodermoclysis|hypodermoclysis
655554|NCT00807885|clysis|clysis
655555|NCT00807885|subcutaneous hydration|subcutaneous hydration
655556|NCT00807885|subcutaneous rehydration|subcutaneous rehydration
655557|NCT00807885|hyaluronan|hyaluronan
655558|NCT00807885|rHuPH20|rhuph20
655559|NCT00807872|Radioimmunoimaging|radioimmunoimaging
655560|NCT00807872|AL Amyloidosis|al amyloidosis
655561|NCT00807872|PET/CT|pet/ct
655562|NCT00807859|AMG 386|amg 386
655563|NCT00807859|Paclitaxel|paclitaxel
655564|NCT00807859|Trastuzumab|trastuzumab
655565|NCT00807859|Capecitabine|capecitabine
655566|NCT00807859|Lapatinib|lapatinib
655567|NCT00807859|HER2-positive|her2-positive
655568|NCT00807859|metastatic breast cancer|metastatic breast cancer
655569|NCT00807859|locally recurrent breast cancer|locally recurrent breast cancer
655570|NCT00807859|Taxol|taxol
655571|NCT00807859|Herceptin|herceptin
655572|NCT00807859|Xeloda|xeloda
655573|NCT00807859|Tykerb|tykerb
655574|NCT00807859|anti-angiogenic therapy|anti-angiogenic therapy
655575|NCT00807846|Juvenile Arthritis; Juvenile Rheumatoid Arthritis;Blood Pressure;Juvenile Idiopathic Arthritis|juvenile arthritis; juvenile rheumatoid arthritis;blood pressure;juvenile idiopathic arthritis
655576|NCT00807833|SAH|sah
655577|NCT00807833|TBI|tbi
655578|NCT00807820|Prostate Cancer|prostate cancer
655579|NCT00807807|Plasma Homocysteine Concentration|plasma homocysteine concentration
655580|NCT00807807|Folate|folate
655581|NCT00807807|Homocysteine|homocysteine
655582|NCT00807807|Supplements|supplements
655583|NCT00807807|Folic Acid|folic acid
655584|NCT00807755|unspecified adult solid tumor, protocol specific|unspecified adult solid tumor, protocol specific
655585|NCT00807755|extensive stage small cell lung cancer|extensive stage small cell lung cancer
655586|NCT00807755|recurrent small cell lung cancer|recurrent small cell lung cancer
655587|NCT00807742|Contingency management for smoking for substance abusers|contingency management for smoking for substance abusers
655588|NCT00807742|Contingency reinforcement for smoking abstinence|contingency reinforcement for smoking abstinence
655589|NCT00807742|Contingency Management|contingency management
655590|NCT00807742|Noncontingent Reinforcement|noncontingent reinforcement
655591|NCT00807729|Laparoscopy|laparoscopy
655592|NCT00807729|Endoscopic retrograde cholangiopancreatography|endoscopic retrograde cholangiopancreatography
655593|NCT00807729|Sphincterotomy|sphincterotomy
655594|NCT00807729|Common bile duct stones|common bile duct stones
655595|NCT00807729|Laparoscoopic common bile duct exploration|laparoscoopic common bile duct exploration
655596|NCT00807729|Cost efficiency|cost efficiency
655597|NCT00807729|Examination of efficacy, safety, cost of intervention for patients with choleclithiasis and likely common bile duct stones|examination of efficacy, safety, cost of intervention for patients with choleclithiasis and likely common bile duct stones
655598|NCT00807716|physiotherapy|physiotherapy
655599|NCT00807716|functional outcome|functional outcome
655600|NCT00807716|activity level|activity level
655601|NCT00807716|self efficacy|self efficacy
655602|NCT00807716|task oriented exercises|task oriented exercises
655603|NCT00807703|Parkinson|parkinson
655604|NCT00807703|deep brain stimulation (DBS)|deep brain stimulation (dbs)
655605|NCT00807703|subthalamic nucleus (STN)|subthalamic nucleus (stn)
655606|NCT00807703|Parkinson patients|parkinson patients
655607|NCT00807690|vitiligo|vitiligo
655608|NCT00807690|tacrolimus ointment 0.1%|tacrolimus ointment 0.1%
655609|NCT00807690|narrowband UVB (TL01)|narrowband uvb (tl01)
655610|NCT00807677|Chronic myelogenous leukemia (CML) in chronic phase, accelerated phase, or blast crisis|chronic myelogenous leukemia (cml) in chronic phase, accelerated phase, or blast crisis
655611|NCT00807677|Intermediate or high risk myelodysplastic syndrome|intermediate or high risk myelodysplastic syndrome
655612|NCT00807677|Philadelphia chromosome-negative CML (including blast phase)|philadelphia chromosome-negative cml (including blast phase)
655613|NCT00807677|All subtypes of myeloid metaplasia with myelofibrosis; advanced polycythemia|all subtypes of myeloid metaplasia with myelofibrosis; advanced polycythemia
655614|NCT00807651|Diabetes Mellitus|diabetes mellitus
655615|NCT00807651|Stem cells|stem cells
655616|NCT00807651|Autologous stem cell transplantation|autologous stem cell transplantation
655617|NCT00807651|Autoimmune diseases|autoimmune diseases
655618|NCT00807625|HIV/AIDS|hiv/aids
655619|NCT00807625|Contraception|contraception
655620|NCT00807625|Birth control|birth control
655622|NCT00807625|Viral Load|viral load
655623|NCT00807625|T-cell activation|t-cell activation
655624|NCT00807625|B-cell activation|b-cell activation
655625|NCT00807625|Hormonal|hormonal
655626|NCT00807625|Intrauterine device|intrauterine device
655627|NCT00807625|Depo Provera|depo provera
655628|NCT00807625|Women|women
655629|NCT00807625|IUCD|iucd
655630|NCT00807625|treatment naive|treatment naive
655631|NCT00807612|AMG 479|amg 479
655632|NCT00807612|IGF-1R|igf-1r
655633|NCT00807612|Apoptosis|apoptosis
655634|NCT00807612|Monoclonal Antibody|monoclonal antibody
655635|NCT00807612|Advanced Squamous Non-Small Cell Lung Cancer|advanced squamous non-small cell lung cancer
655636|NCT00807612|antibody 1st-line|antibody 1st-line
655637|NCT00807599|CYCLOPHOSPHAMIDE (CYTOXAN)|cyclophosphamide (cytoxan)
655638|NCT00807599|DEXAMETHASONE|dexamethasone
655639|NCT00807599|G-CSF|g-csf
655640|NCT00807599|Lenalidomide|lenalidomide
655641|NCT00807599|MELPHALAN|melphalan
655642|NCT00807599|PEG-FILGRASTIM (NEULASTA)|peg-filgrastim (neulasta)
655643|NCT00807599|08-121|08-121
655644|NCT00807586|Atrial Fibrillation|atrial fibrillation
655645|NCT00807586|Corticosteroid|corticosteroid
655646|NCT00807586|Radiofrequency catheter ablation for atrial fibrillation|radiofrequency catheter ablation for atrial fibrillation
655647|NCT00807573|BEVACIZUMAB (AVASTIN)|bevacizumab (avastin)
655648|NCT00807573|PEMETREXED (ALTIMA)|pemetrexed (altima)
655649|NCT00807573|TAXOL (PACLITAXEL)|taxol (paclitaxel)
655650|NCT00807573|08-109|08-109
655651|NCT00807560|Overweight|overweight
655652|NCT00807560|Obesity|obesity
655653|NCT00807560|Adolescents|adolescents
655654|NCT00807560|Family Therapy|family therapy
655655|NCT00807534|Chronic Obstructive Pulmonary Disease (COPD)|chronic obstructive pulmonary disease (copd)
655656|NCT00807534|Exercise|exercise
655657|NCT00807534|3-min constant rate stepping test|3-min constant rate stepping test
655658|NCT00807534|3-min constant rate walking test|3-min constant rate walking test
655659|NCT00807534|Bronchodilation|bronchodilation
655660|NCT00807534|Ipratropium bromide|ipratropium bromide
655661|NCT00807495|MLN8237|mln8237
655662|NCT00807495|Alisertib|alisertib
655663|NCT00807495|Drug therapy|drug therapy
655664|NCT00807482|Primary Ciliary Dyskinesia|primary ciliary dyskinesia
655665|NCT00807482|Mucociliary Clearance|mucociliary clearance
655666|NCT00807482|Genetic Mutation|genetic mutation
655667|NCT00807469|COPD|copd
655668|NCT00807469|smoking|smoking
655669|NCT00807469|susceptibility|susceptibility
655670|NCT00807469|inflammation|inflammation
655671|NCT00807469|genetic|genetic
655672|NCT00807443|HIV-1|hiv-1
655673|NCT00807443|integrase inhibitor (raltegravir)|integrase inhibitor (raltegravir)
655674|NCT00807443|the cell reservoir of HIV-1|the cell reservoir of hiv-1
655675|NCT00807443|treatment experienced|treatment experienced
655676|NCT00807430|Bruxism|bruxism
655677|NCT00807430|EMG|emg
655678|NCT00807430|Biofeedback|biofeedback
655679|NCT00807404|ductal intraepithelial neoplasia|ductal intraepithelial neoplasia
655680|NCT00807391|lung cancer|lung cancer
655681|NCT00807391|transbronchial biopsy|transbronchial biopsy
655682|NCT00807391|transbronchial catheter aspiration|transbronchial catheter aspiration
655683|NCT00807391|transbronchial needle aspiration|transbronchial needle aspiration
655684|NCT00807391|peripheral pulmonary lesion|peripheral pulmonary lesion
655685|NCT00807391|bronchoscopy|bronchoscopy
655686|NCT00807378|CNS viral infection|cns viral infection
655687|NCT00807378|PCR|pcr
655688|NCT00807378|HYBRIDIZATION|hybridization
655689|NCT00807365|Growth Hormone-Releasing Hormone|growth hormone-releasing hormone
655690|NCT00807365|Growth Hormone Insufficiency|growth hormone insufficiency
655691|NCT00807365|Aging|aging
655692|NCT00807365|Growth Hormone|growth hormone
655693|NCT00807365|Physiological Effects of Drugs|physiological effects of drugs
655694|NCT00807365|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists
655695|NCT00807365|Hormones|hormones
655696|NCT00807352|Triage|triage
655697|NCT00807352|Pediatrics|pediatrics
655698|NCT00807352|Emergency Department|emergency department
655699|NCT00807339|CyberKnife|cyberknife
655700|NCT00807326|Antidiarrheals|antidiarrheals
655701|NCT00807313|Oligometastatic disease|oligometastatic disease
655702|NCT00807313|Colorectal cancer|colorectal cancer
655703|NCT00807313|Stereotactic body radiotherapy|stereotactic body radiotherapy
655704|NCT00807313|Tomotherapy|tomotherapy
655705|NCT00807313|Metabolic response|metabolic response
655706|NCT00807313|Stage IV|stage iv
655707|NCT00807300|percutaneous treatment|percutaneous treatment
655708|NCT00807287|jejunal tube placement|jejunal tube placement
655709|NCT00807274|Adult congenital heart disease|adult congenital heart disease
655710|NCT00807274|Heart failure|heart failure
655711|NCT00807274|Renal failure|renal failure
655712|NCT00807274|Proteinuria|proteinuria
655713|NCT00807235|Lucinactant|lucinactant
655714|NCT00807235|Nasal continuous positive airway pressure (nCPAP)|nasal continuous positive airway pressure (ncpap)
655715|NCT00807235|Respiratory distress syndrome (RDS)|respiratory distress syndrome (rds)
655716|NCT00807235|Pediatric|pediatric
655717|NCT00807235|Premature|premature
655718|NCT00807222|ADHD|adhd
655719|NCT00807222|Vyvanse|vyvanse
655720|NCT00807222|lisdexamfetamine dimesylate|lisdexamfetamine dimesylate
655721|NCT00807222|LDX|ldx
655722|NCT00807222|sleep|sleep
655723|NCT00807209|Pain|pain
655724|NCT00807209|postoperative|postoperative
655725|NCT00807209|thoracotomy|thoracotomy
655726|NCT00807196|Allogeneic Stem Cell Transplantation|allogeneic stem cell transplantation
655727|NCT00807196|Zevalin|zevalin
655728|NCT00807196|Non-Hodgkins Lymphoma|non-hodgkins lymphoma
655729|NCT00807170|Non-small Cell Lung Cancer (NSCLC)|non-small cell lung cancer (nsclc)
655730|NCT00807170|Whole Brain Radiotherapy|whole brain radiotherapy
655731|NCT00807170|metastasis|metastasis
655732|NCT00807157|PROBIOSTICK®|probiostick®
655733|NCT00807157|Probiotic|probiotic
655734|NCT00807157|Anxiety|anxiety
655735|NCT00807157|Daily stress|daily stress
655736|NCT00807144|Kidney transplant|kidney transplant
655737|NCT00807144|Rejection|rejection
655738|NCT00807144|Adherence|adherence
655739|NCT00807144|Quality of life|quality of life
655740|NCT00807131|pharmacy care|pharmacy care
655741|NCT00807131|hypertension|hypertension
655742|NCT00807131|primary care|primary care
655743|NCT00807131|adherence|adherence
655744|NCT00807118|bioequivalence, food effect|bioequivalence, food effect
655745|NCT00807105|MOOD EVALUATION|mood evaluation
655746|NCT00807079|recurrent cervical cancer|recurrent cervical cancer
655747|NCT00807079|stage IVB cervical cancer|stage ivb cervical cancer
655748|NCT00807079|stage IVA cervical cancer|stage iva cervical cancer
655749|NCT00807079|cervical adenocarcinoma|cervical adenocarcinoma
655750|NCT00807079|cervical adenosquamous cell carcinoma|cervical adenosquamous cell carcinoma
655751|NCT00807079|cervical squamous cell carcinoma|cervical squamous cell carcinoma
655752|NCT00807066|QUALITY OF LIFE|quality of life
655753|NCT00807053|Seasonal Allergic Rhinitis|seasonal allergic rhinitis
655754|NCT00807053|Ciclesonide|ciclesonide
655755|NCT00807053|SAR|sar
655756|NCT00807040|Ischemic Mitral Regurgitation|ischemic mitral regurgitation
655757|NCT00807040|Mitral Valve Disease|mitral valve disease
655758|NCT00807040|Severe Mitral Regurgitation|severe mitral regurgitation
655759|NCT00807027|Glioblastoma|glioblastoma
655760|NCT00807027|Newly diagnosed Glioblastoma|newly diagnosed glioblastoma
655761|NCT00807014|Differin|differin
655762|NCT00807014|quality of life|quality of life
655763|NCT00807014|Acne|acne
655764|NCT00807014|Duac|duac
655765|NCT00807014|Acne Vulgaris|acne vulgaris
655766|NCT00807001|Hepatitis C, HCV, treatment-naive|hepatitis c, hcv, treatment-naive
655767|NCT00806988|Ischemic Mitral Regurgitation|ischemic mitral regurgitation
655768|NCT00806988|Mitral Valve Regurgitation|mitral valve regurgitation
655769|NCT00806910|Heart Failure|heart failure
655770|NCT00806910|conivaptan|conivaptan
655771|NCT00806910|Diuresis|diuresis
655772|NCT00806884|Cystic Fibrosis|cystic fibrosis
655773|NCT00806884|Musculoskeletal Physiotherapy|musculoskeletal physiotherapy
655774|NCT00806884|Manual therapy|manual therapy
655775|NCT00806884|Posture|posture
655776|NCT00806884|Pain|pain
655777|NCT00806845|HIV|hiv
655778|NCT00806845|B-lymphocyte|b-lymphocyte
655779|NCT00806832|Medical clowns|medical clowns
655780|NCT00806832|Cataract surgery|cataract surgery
655781|NCT00806832|Blood pressure|blood pressure
655782|NCT00806832|Heart rate|heart rate
655783|NCT00806806|pain management|pain management
655784|NCT00806806|postoperative|postoperative
655785|NCT00806780|gallstones|gallstones
655786|NCT00806780|cholangiography|cholangiography
655787|NCT00806767|stage III adult Burkitt lymphoma|stage iii adult burkitt lymphoma
655788|NCT00806767|stage III adult diffuse large cell lymphoma|stage iii adult diffuse large cell lymphoma
655789|NCT00806767|stage III adult diffuse mixed cell lymphoma|stage iii adult diffuse mixed cell lymphoma
655790|NCT00806767|stage III adult diffuse small cleaved cell lymphoma|stage iii adult diffuse small cleaved cell lymphoma
655884|NCT00806741|Optic Disk|optic disk
655791|NCT00806767|stage III adult Hodgkin lymphoma|stage iii adult hodgkin lymphoma
655792|NCT00806767|stage III adult immunoblastic large cell lymphoma|stage iii adult immunoblastic large cell lymphoma
655793|NCT00806767|stage III adult lymphoblastic lymphoma|stage iii adult lymphoblastic lymphoma
655794|NCT00806767|stage III grade 1 follicular lymphoma|stage iii grade 1 follicular lymphoma
655795|NCT00806767|stage III grade 2 follicular lymphoma|stage iii grade 2 follicular lymphoma
655796|NCT00806767|stage III grade 3 follicular lymphoma|stage iii grade 3 follicular lymphoma
655797|NCT00806767|stage III mantle cell lymphoma|stage iii mantle cell lymphoma
655798|NCT00806767|stage III marginal zone lymphoma|stage iii marginal zone lymphoma
655799|NCT00806767|stage III small lymphocytic lymphoma|stage iii small lymphocytic lymphoma
655800|NCT00806767|stage IV adult Burkitt lymphoma|stage iv adult burkitt lymphoma
655801|NCT00806767|stage IV adult diffuse large cell lymphoma|stage iv adult diffuse large cell lymphoma
655802|NCT00806767|stage IV adult diffuse mixed cell lymphoma|stage iv adult diffuse mixed cell lymphoma
655803|NCT00806767|stage IV adult diffuse small cleaved cell lymphoma|stage iv adult diffuse small cleaved cell lymphoma
655804|NCT00806767|stage IV adult Hodgkin lymphoma|stage iv adult hodgkin lymphoma
655805|NCT00806767|stage IV adult immunoblastic large cell lymphoma|stage iv adult immunoblastic large cell lymphoma
655806|NCT00806767|stage IV adult lymphoblastic lymphoma|stage iv adult lymphoblastic lymphoma
655807|NCT00806767|stage IV grade 1 follicular lymphoma|stage iv grade 1 follicular lymphoma
655808|NCT00806767|stage IV grade 2 follicular lymphoma|stage iv grade 2 follicular lymphoma
655809|NCT00806767|stage IV grade 3 follicular lymphoma|stage iv grade 3 follicular lymphoma
655810|NCT00806767|stage IV mantle cell lymphoma|stage iv mantle cell lymphoma
655811|NCT00806767|stage IV marginal zone lymphoma|stage iv marginal zone lymphoma
655812|NCT00806767|stage IV small lymphocytic lymphoma|stage iv small lymphocytic lymphoma
655813|NCT00806767|recurrent adult Burkitt lymphoma|recurrent adult burkitt lymphoma
655814|NCT00806767|recurrent adult diffuse large cell lymphoma|recurrent adult diffuse large cell lymphoma
655815|NCT00806767|recurrent adult diffuse mixed cell lymphoma|recurrent adult diffuse mixed cell lymphoma
655816|NCT00806767|recurrent adult diffuse small cleaved cell lymphoma|recurrent adult diffuse small cleaved cell lymphoma
655817|NCT00806767|recurrent adult Hodgkin lymphoma|recurrent adult hodgkin lymphoma
655818|NCT00806767|recurrent adult immunoblastic large cell lymphoma|recurrent adult immunoblastic large cell lymphoma
655819|NCT00806767|recurrent adult lymphoblastic lymphoma|recurrent adult lymphoblastic lymphoma
655820|NCT00806767|recurrent cutaneous T-cell non-Hodgkin lymphoma|recurrent cutaneous t-cell non-hodgkin lymphoma
655821|NCT00806767|recurrent grade 1 follicular lymphoma|recurrent grade 1 follicular lymphoma
655822|NCT00806767|recurrent grade 2 follicular lymphoma|recurrent grade 2 follicular lymphoma
655823|NCT00806767|recurrent grade 3 follicular lymphoma|recurrent grade 3 follicular lymphoma
655824|NCT00806767|recurrent mantle cell lymphoma|recurrent mantle cell lymphoma
655825|NCT00806767|recurrent marginal zone lymphoma|recurrent marginal zone lymphoma
655826|NCT00806767|recurrent small lymphocytic lymphoma|recurrent small lymphocytic lymphoma
655827|NCT00806767|recurrent mycosis fungoides/Sezary syndrome|recurrent mycosis fungoides/sezary syndrome
655828|NCT00806767|extranodal marginal zone B-cell lymphoma of mucosa-associated lymphoid tissue|extranodal marginal zone b-cell lymphoma of mucosa-associated lymphoid tissue
655829|NCT00806767|nodal marginal zone B-cell lymphoma|nodal marginal zone b-cell lymphoma
655830|NCT00806767|splenic marginal zone lymphoma|splenic marginal zone lymphoma
655831|NCT00806767|noncontiguous stage II adult Burkitt lymphoma|noncontiguous stage ii adult burkitt lymphoma
655832|NCT00806767|noncontiguous stage II adult diffuse large cell lymphoma|noncontiguous stage ii adult diffuse large cell lymphoma
655833|NCT00806767|noncontiguous stage II adult diffuse mixed cell lymphoma|noncontiguous stage ii adult diffuse mixed cell lymphoma
655834|NCT00806767|noncontiguous stage II adult diffuse small cleaved cell lymphoma|noncontiguous stage ii adult diffuse small cleaved cell lymphoma
655835|NCT00806767|noncontiguous stage II adult immunoblastic large cell lymphoma|noncontiguous stage ii adult immunoblastic large cell lymphoma
655836|NCT00806767|noncontiguous stage II adult lymphoblastic lymphoma|noncontiguous stage ii adult lymphoblastic lymphoma
655837|NCT00806767|noncontiguous stage II grade 1 follicular lymphoma|noncontiguous stage ii grade 1 follicular lymphoma
655838|NCT00806767|noncontiguous stage II grade 2 follicular lymphoma|noncontiguous stage ii grade 2 follicular lymphoma
655839|NCT00806767|noncontiguous stage II grade 3 follicular lymphoma|noncontiguous stage ii grade 3 follicular lymphoma
655840|NCT00806767|noncontiguous stage II mantle cell lymphoma|noncontiguous stage ii mantle cell lymphoma
655841|NCT00806767|noncontiguous stage II marginal zone lymphoma|noncontiguous stage ii marginal zone lymphoma
655842|NCT00806767|noncontiguous stage II small lymphocytic lymphoma|noncontiguous stage ii small lymphocytic lymphoma
655843|NCT00806767|accelerated phase chronic myelogenous leukemia|accelerated phase chronic myelogenous leukemia
655844|NCT00806767|adult acute lymphoblastic leukemia in remission|adult acute lymphoblastic leukemia in remission
655845|NCT00806767|adult acute myeloid leukemia in remission|adult acute myeloid leukemia in remission
655846|NCT00806767|adult acute myeloid leukemia with 11q23 (MLL) abnormalities|adult acute myeloid leukemia with 11q23 (mll) abnormalities
655847|NCT00806767|adult acute myeloid leukemia with inv(16)(p13;q22)|adult acute myeloid leukemia with inv(16)(p13;q22)
655848|NCT00806767|adult acute myeloid leukemia with t(15;17)(q22;q12)|adult acute myeloid leukemia with t(15;17)(q22;q12)
655849|NCT00806767|adult acute myeloid leukemia with t(16;16)(p13;q22)|adult acute myeloid leukemia with t(16;16)(p13;q22)
655850|NCT00806767|adult acute myeloid leukemia with t(8;21)(q22;q22)|adult acute myeloid leukemia with t(8;21)(q22;q22)
655851|NCT00806767|atypical chronic myeloid leukemia, BCR-ABL1 negative|atypical chronic myeloid leukemia, bcr-abl1 negative
655852|NCT00806767|blastic phase chronic myelogenous leukemia|blastic phase chronic myelogenous leukemia
655853|NCT00806767|chronic myelomonocytic leukemia|chronic myelomonocytic leukemia
655854|NCT00806767|chronic phase chronic myelogenous leukemia|chronic phase chronic myelogenous leukemia
655855|NCT00806767|recurrent adult acute lymphoblastic leukemia|recurrent adult acute lymphoblastic leukemia
655856|NCT00806767|recurrent adult acute myeloid leukemia|recurrent adult acute myeloid leukemia
655857|NCT00806767|recurrent childhood acute lymphoblastic leukemia|recurrent childhood acute lymphoblastic leukemia
655858|NCT00806767|recurrent childhood acute myeloid leukemia|recurrent childhood acute myeloid leukemia
655859|NCT00806767|refractory chronic lymphocytic leukemia|refractory chronic lymphocytic leukemia
655860|NCT00806767|refractory hairy cell leukemia|refractory hairy cell leukemia
655861|NCT00806767|relapsing chronic myelogenous leukemia|relapsing chronic myelogenous leukemia
655862|NCT00806767|secondary acute myeloid leukemia|secondary acute myeloid leukemia
655863|NCT00806767|stage III chronic lymphocytic leukemia|stage iii chronic lymphocytic leukemia
655864|NCT00806767|stage IV chronic lymphocytic leukemia|stage iv chronic lymphocytic leukemia
655865|NCT00806767|chronic eosinophilic leukemia|chronic eosinophilic leukemia
655866|NCT00806767|primary myelofibrosis|primary myelofibrosis
655867|NCT00806767|chronic neutrophilic leukemia|chronic neutrophilic leukemia
655868|NCT00806767|de novo myelodysplastic syndromes|de novo myelodysplastic syndromes
655869|NCT00806767|myelodysplastic/myeloproliferative neoplasm, unclassifiable|myelodysplastic/myeloproliferative neoplasm, unclassifiable
655870|NCT00806767|previously treated myelodysplastic syndromes|previously treated myelodysplastic syndromes
655871|NCT00806767|secondary myelodysplastic syndromes|secondary myelodysplastic syndromes
655872|NCT00806767|stage I multiple myeloma|stage i multiple myeloma
655873|NCT00806767|stage II multiple myeloma|stage ii multiple myeloma
655874|NCT00806767|stage III multiple myeloma|stage iii multiple myeloma
655875|NCT00806767|refractory multiple myeloma|refractory multiple myeloma
655876|NCT00806754|Perennial Allergic Rhinitis|perennial allergic rhinitis
655877|NCT00806754|Ciclesonide|ciclesonide
655878|NCT00806754|PAR|par
655879|NCT00806741|L-NG-Monomethyl Arginine|l-ng-monomethyl arginine
655880|NCT00806741|Optic Nerve Head blood flow|optic nerve head blood flow
655881|NCT00806741|Intraocular Pressure|intraocular pressure
655882|NCT00806741|Regional blood flow|regional blood flow
655883|NCT00806741|Ocular Physiology|ocular physiology
655885|NCT00806715|hemochromatosis|hemochromatosis
655886|NCT00806715|Iron overload|iron overload
655887|NCT00806715|Stem cell transplant|stem cell transplant
655888|NCT00806715|Pediatrics|pediatrics
655889|NCT00806715|Pediatric Stem cell transplant|pediatric stem cell transplant
655890|NCT00806689|heart rhythm surveillance|heart rhythm surveillance
655891|NCT00806689|follow-up|follow-up
655892|NCT00806689|atrial fibrillation success|atrial fibrillation success
655893|NCT00806676|chronic kidney disease|chronic kidney disease
655894|NCT00806676|children|children
655895|NCT00806676|dialysis|dialysis
655896|NCT00806676|kidney transplant|kidney transplant
655897|NCT00806676|human papilloma virus|human papilloma virus
655898|NCT00806676|Gardasil|gardasil
655899|NCT00806676|Chronic kidney disease (non-dialysis, dialysis, and kidney transplant) secondary to any cause.|chronic kidney disease (non-dialysis, dialysis, and kidney transplant) secondary to any cause.
655900|NCT00806663|mCRC|mcrc
655901|NCT00806663|colorectal cancer|colorectal cancer
655902|NCT00806663|FOLFIRI|folfiri
655903|NCT00806663|sunitinib|sunitinib
655904|NCT00806663|DCE-MRI|dce-mri
655905|NCT00806663|DCE-USI|dce-usi
655906|NCT00806650|stage I renal cell cancer|stage i renal cell cancer
655907|NCT00806650|stage II renal cell cancer|stage ii renal cell cancer
655908|NCT00806650|stage III renal cell cancer|stage iii renal cell cancer
655909|NCT00806650|stage IV renal cell cancer|stage iv renal cell cancer
655910|NCT00806637|Vessel sealing system|vessel sealing system
655911|NCT00806637|uvulopalatoplasty|uvulopalatoplasty
655912|NCT00806637|UPPP|uppp
655913|NCT00806637|uvulopalatal flap|uvulopalatal flap
655914|NCT00806637|bleeding|bleeding
655915|NCT00806637|operative time|operative time
655916|NCT00806637|adverse effects|adverse effects
655917|NCT00806611|pancreatic cancer|pancreatic cancer
655918|NCT00806611|periampullary cancer|periampullary cancer
655919|NCT00806611|resectable|resectable
655920|NCT00806611|unresectable|unresectable
655921|NCT00806611|celiac plexus neurolysis|celiac plexus neurolysis
655922|NCT00806611|surgery|surgery
655923|NCT00806598|Myelodysplastic Syndrome|myelodysplastic syndrome
655924|NCT00806598|Aplastic Anemia|aplastic anemia
655925|NCT00806598|Thymoglobulin|thymoglobulin
655926|NCT00806598|Cyclosporine|cyclosporine
655927|NCT00806598|Methylprednisolone|methylprednisolone
655928|NCT00806598|G-CSF|g-csf
655929|NCT00806572|Diabetes, juvenile diabetes, teplizumab|diabetes, juvenile diabetes, teplizumab
655930|NCT00806559|effects clinical space|effects clinical space
655931|NCT00806559|follow-up appointments|follow-up appointments
655932|NCT00806520|Continuous Glucose Monitoring|continuous glucose monitoring
655933|NCT00806520|Exenatide Once Weekly or|exenatide once weekly or
655934|NCT00806520|Januvia or|januvia or
655935|NCT00806520|Actos|actos
655936|NCT00806507|Tissue Doppler Imaging|tissue doppler imaging
655937|NCT00806507|B-type natriuretic peptide|b-type natriuretic peptide
655938|NCT00806507|Advia Centaur immunoassay system|advia centaur immunoassay system
655939|NCT00806507|GE Vivid ultrasound machine|ge vivid ultrasound machine
655940|NCT00806507|Roche 2010 system|roche 2010 system
655941|NCT00806507|Echocardiography|echocardiography
655942|NCT00806507|Herceptin|herceptin
655943|NCT00806494|Fesoterodine|fesoterodine
655944|NCT00806494|Open Label|open label
655945|NCT00806494|Flexible Dose|flexible dose
655946|NCT00806494|OAB|oab
655947|NCT00806481|Phosphate|phosphate
655948|NCT00806468|nycturia|nycturia
655949|NCT00806468|Parkinson syndrome|parkinson syndrome
655950|NCT00806468|desmopressin|desmopressin
655951|NCT00806468|Nocturnal polyuria in patients with Parkinson syndrome|nocturnal polyuria in patients with parkinson syndrome
655952|NCT00806455|to determine how often exercise-induced bronchospasm|to determine how often exercise-induced bronchospasm
655953|NCT00806455|occurs in cystic fibrosis|occurs in cystic fibrosis
655954|NCT00806455|Exercise-induced bronchospasm in cystic fibrosis|exercise-induced bronchospasm in cystic fibrosis
655955|NCT00806442|Asthma|asthma
655956|NCT00806442|Fatty acids|fatty acids
655957|NCT00806442|Leukotrienes|leukotrienes
655958|NCT00806442|Diet|diet
655959|NCT00806429|appendicitis|appendicitis
655960|NCT00806429|surgery|surgery
655961|NCT00806429|laparoscopy|laparoscopy
655962|NCT00806429|natural orifice transluminal surgery|natural orifice transluminal surgery
655963|NCT00806403|thrombolysis|thrombolysis
655964|NCT00806403|primary PCI|primary pci
655965|NCT00806403|abciximab|abciximab
655966|NCT00806403|ST-segment resolution|st-segment resolution
655967|NCT00806403|TIMI flow|timi flow
655968|NCT00806390|ejection fraction|ejection fraction
655969|NCT00806390|anthracyclines|anthracyclines
655970|NCT00806390|beta-adrenergic blockade|beta-adrenergic blockade
655971|NCT00806390|Patients receiving anthracyclines|patients receiving anthracyclines
655972|NCT00806377|Electromagnetic field|electromagnetic field
655973|NCT00806377|Oversensing|oversensing
655974|NCT00806377|Non-thoracic surgery|non-thoracic surgery
655975|NCT00806364|Skin|skin
655976|NCT00806364|HV|hv
655977|NCT00806364|Allergy|allergy
655978|NCT00806364|Healthy Volunteer|healthy volunteer
655979|NCT00806364|Non-atopic|non-atopic
655980|NCT00806351|Candidiasis; Invasive Candidiasis; Candida; Candidemia; Fungal Infection; Neutropenia|candidiasis; invasive candidiasis; candida; candidemia; fungal infection; neutropenia
655981|NCT00806325|Severe Sepsis|severe sepsis
655982|NCT00806325|Acute Myeloid Leukemia|acute myeloid leukemia
655983|NCT00806325|Sepsis in patients being treated for Acute Myeloid Leukemia|sepsis in patients being treated for acute myeloid leukemia
655984|NCT00806312|MiRNA|mirna
655985|NCT00806312|pulmonary arterial hypertension|pulmonary arterial hypertension
655986|NCT00806273|debridement|debridement
655987|NCT00806273|root canal|root canal
655988|NCT00806260|Overweight|overweight
655989|NCT00806260|Obesity|obesity
655990|NCT00806260|coordination|coordination
655991|NCT00806260|psychomotor|psychomotor
655992|NCT00806247|Tapentadol|tapentadol
655993|NCT00806247|Bunionectomy|bunionectomy
655994|NCT00806247|Analgesia|analgesia
655995|NCT00806247|Acute pain|acute pain
655996|NCT00806247|Postsurgical pain|postsurgical pain
655997|NCT00806234|Weight Gain|weight gain
655998|NCT00806234|Obesity|obesity
655999|NCT00806234|IMPACT|impact
656000|NCT00806234|Antipsychotic Treatment|antipsychotic treatment
656001|NCT00806234|Excessive Weight Gain Associated With Antipsychotic Treatment|excessive weight gain associated with antipsychotic treatment
656002|NCT00806234|Hybrid Efficacy/Effectiveness Design|hybrid efficacy/effectiveness design
656003|NCT00806234|Reducing Weight Gain|reducing weight gain
656004|NCT00806234|Improving Metabolic Parameters|improving metabolic parameters
656005|NCT00806234|Aripiprazole|aripiprazole
656006|NCT00806234|Metformin|metformin
656007|NCT00806234|Risperdal|risperdal
656008|NCT00806234|Seroquel|seroquel
656009|NCT00806234|Quetiapine|quetiapine
656010|NCT00806234|Olanzapine|olanzapine
656011|NCT00806234|Zyprexa|zyprexa
656012|NCT00806234|Geodon|geodon
656013|NCT00806234|Risperidone|risperidone
656014|NCT00806234|Abilify|abilify
656015|NCT00806234|Trilafon|trilafon
656016|NCT00806234|Perphenazine|perphenazine
656017|NCT00806234|Glucophage|glucophage
656018|NCT00806234|Paliperidone|paliperidone
656019|NCT00806234|Olanzapine/fluoxetine|olanzapine/fluoxetine
656020|NCT00806221|Atopic Dermatitis|atopic dermatitis
656021|NCT00806221|Prevention|prevention
656022|NCT00806221|Skin Barrier|skin barrier
656023|NCT00806195|vaccine|vaccine
656024|NCT00806195|infants|infants
656025|NCT00806195|healthy|healthy
656026|NCT00806195|meningitis|meningitis
656027|NCT00806195|meningococcal|meningococcal
656028|NCT00806182|paraneoplastic|paraneoplastic
656029|NCT00806182|neuroblastoma|neuroblastoma
656030|NCT00806182|Kinsbourne syndrome|kinsbourne syndrome
656031|NCT00806182|autoimmune disease|autoimmune disease
656032|NCT00806182|immunotherapy|immunotherapy
656033|NCT00806182|ataxia|ataxia
656034|NCT00806169|combined therapy|combined therapy
656035|NCT00806169|DRP|drp
656036|NCT00806169|efficacy|efficacy
656037|NCT00806169|safety|safety
656038|NCT00806169|sustainability|sustainability
656039|NCT00806169|macular edema due to DRP|macular edema due to drp
656040|NCT00806143|Depression|depression
656041|NCT00806143|TMS|tms
656042|NCT00806117|Cervical cancer|cervical cancer
656043|NCT00806117|Concurrent chemoradiation|concurrent chemoradiation
656044|NCT00806117|Randomized controlled clinical trials|randomized controlled clinical trials
656045|NCT00806091|AM proteomes will be compared between smokers with and without COPD|am proteomes will be compared between smokers with and without copd
656046|NCT00806078|Healthy|healthy
656047|NCT00806078|Bioequivalence|bioequivalence
656048|NCT00806078|Pharmacokinetics|pharmacokinetics
656049|NCT00806039|Kidney Failure, Acute|kidney failure, acute
656050|NCT00806039|Renal Insufficiency, Acute|renal insufficiency, acute
656051|NCT00806039|Kidney Failure|kidney failure
656052|NCT00806039|Renal Insufficiency|renal insufficiency
656053|NCT00806026|RLS|rls
656054|NCT00806013|genotype|genotype
656055|NCT00806000|Prevalence of Exercised induced asthma in athletes|prevalence of exercised induced asthma in athletes
656056|NCT00805974|diapasom|diapasom
656057|NCT00805974|sleep quality|sleep quality
656058|NCT00805974|type I diabete|type i diabete
656059|NCT00805974|blood pressure|blood pressure
656060|NCT00805974|plasma glucose|plasma glucose
656061|NCT00805974|daytime and nighttime variations|daytime and nighttime variations
656062|NCT00805961|Glioblastoma Multiforme|glioblastoma multiforme
656063|NCT00805961|Radiation Therapy|radiation therapy
656064|NCT00805961|Temozolomide|temozolomide
656065|NCT00805961|Bevacizumab|bevacizumab
656066|NCT00805961|Everolimus|everolimus
656067|NCT00805948|thoracic aneurysm|thoracic aneurysm
656068|NCT00805948|thoracic aortic aneurysms|thoracic aortic aneurysms
656069|NCT00805948|Thoracic Endovascular Aneurysm Repair (TEVAR)|thoracic endovascular aneurysm repair (tevar)
656070|NCT00805948|Talent Thoracic Stent Graft|talent thoracic stent graft
656071|NCT00805935|pre-menopausal women|pre-menopausal women
656072|NCT00805935|PCOS|pcos
656073|NCT00805935|polycystic ovarian syndrome|polycystic ovarian syndrome
656074|NCT00805935|infertility|infertility
656075|NCT00805935|IVF|ivf
656076|NCT00805935|in vitro fertilization|in vitro fertilization
836249|NCT00094172|MS|ms
656077|NCT00805883|Prostate Neoplasm|prostate neoplasm
656078|NCT00805883|Localized|localized
656079|NCT00805883|Photothermal|photothermal
656080|NCT00805883|Radical Prostatectomy|radical prostatectomy
656081|NCT00805844|Spine|spine
656082|NCT00805844|Motor Evoked Potentials|motor evoked potentials
656083|NCT00805831|sutureless vascular bypass|sutureless vascular bypass
656084|NCT00805805|Copper|copper
656085|NCT00805805|ceruloplasmin|ceruloplasmin
656086|NCT00805805|tetrathiomolybdate|tetrathiomolybdate
656087|NCT00805792|Ischemic stroke|ischemic stroke
656088|NCT00805792|treatment|treatment
656089|NCT00805792|recovery|recovery
656090|NCT00805792|donepezil|donepezil
656091|NCT00805792|Aricept|aricept
656092|NCT00805779|Overactive Bladder|overactive bladder
656093|NCT00805779|Overactive Urinary Bladder|overactive urinary bladder
656094|NCT00805779|Bladder, Overactive|bladder, overactive
656095|NCT00805779|Overactive Detrusor|overactive detrusor
656096|NCT00805779|Detrusor, Overactive|detrusor, overactive
656097|NCT00805779|Overactive Detrusor Function|overactive detrusor function
656098|NCT00805779|Detrusor Function, Overactive|detrusor function, overactive
656099|NCT00805766|Infliximab|infliximab
656100|NCT00805766|REMICADE|remicade
656101|NCT00805766|Crohn's disease|crohn's disease
656102|NCT00805740|Candidiasis; Invasive Candidiasis; Deep Tissue Candidiasis; Candida; Candidemia; Fungal Infection|candidiasis; invasive candidiasis; deep tissue candidiasis; candida; candidemia; fungal infection
656103|NCT00805714|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors
656104|NCT00805701|prostate|prostate
656105|NCT00805701|cancer|cancer
656106|NCT00805701|avodart|avodart
656107|NCT00805701|dutasteride|dutasteride
656108|NCT00805701|mitcheson|mitcheson
656109|NCT00805688|Questionnaire|questionnaire
656110|NCT00805688|Pancreas|pancreas
656111|NCT00805688|Pancreatic Cancer|pancreatic cancer
656112|NCT00805688|Metastatic Disease|metastatic disease
656113|NCT00805688|symptom outcomes|symptom outcomes
656114|NCT00805688|Biomarkers|biomarkers
656115|NCT00805688|Pedometer|pedometer
656116|NCT00805688|MDASI-GI symptom assessment|mdasi-gi symptom assessment
656117|NCT00805688|interactive voice response telephone system|interactive voice response telephone system
656118|NCT00805688|IVRS|ivrs
656119|NCT00805675|Chronic HBV|chronic hbv
656120|NCT00805675|Asian adult subjects with chronic HBV, in immune tolerant phase, and positive for hepatitis B e antigen (HBeAg)|asian adult subjects with chronic hbv, in immune tolerant phase, and positive for hepatitis b e antigen (hbeag)
656121|NCT00805662|IUI|iui
656122|NCT00805662|oxytocin|oxytocin
656123|NCT00805649|ARMD|armd
656124|NCT00805649|combined therapy|combined therapy
656125|NCT00805649|efficacy|efficacy
656126|NCT00805649|safety|safety
656127|NCT00805636|cell death|cell death
656128|NCT00805636|PET imaging|pet imaging
656129|NCT00805636|brain metastases|brain metastases
656130|NCT00805636|stereotactic radiosurgery|stereotactic radiosurgery
656131|NCT00805623|sucrose|sucrose
656132|NCT00805623|sucking|sucking
656133|NCT00805623|pain relief|pain relief
656134|NCT00805623|infant|infant
656135|NCT00805623|require venous puncture|require venous puncture
656136|NCT00805610|Liver Failure|liver failure
656137|NCT00805610|Hepatocyte Transplantation|hepatocyte transplantation
656138|NCT00805610|Liver Transplantation|liver transplantation
656139|NCT00805597|breast cancer|breast cancer
656140|NCT00805597|mastectomy|mastectomy
656141|NCT00805597|one to three positive nodes|one to three positive nodes
656142|NCT00805597|radiotherapy|radiotherapy
656143|NCT00805571|Rejection|rejection
656144|NCT00805571|Infection|infection
656145|NCT00805571|Side effect of immunosuppressive drug (nephrotoxicity)|side effect of immunosuppressive drug (nephrotoxicity)
656146|NCT00805558|Chronic Periodontitis|chronic periodontitis
656147|NCT00805558|antibiotics|antibiotics
656148|NCT00805532|PTSD|ptsd
656149|NCT00805532|depression|depression
656150|NCT00805532|behavior therapy|behavior therapy
656151|NCT00805532|veterans|veterans
656152|NCT00805532|behavioral activation|behavioral activation
656153|NCT00805532|usual care|usual care
656154|NCT00805519|Osteoarthritis of the Knee|osteoarthritis of the knee
656155|NCT00805519|Glucosamine Chondroitin sulfate|glucosamine chondroitin sulfate
656156|NCT00805519|Prednisolone|prednisolone
656157|NCT00805519|Chloroquine|chloroquine
656158|NCT00805506|continuous glucose monitoring accuracy|continuous glucose monitoring accuracy
656159|NCT00805493|Mania|mania
656160|NCT00805493|Bipolar|bipolar
656161|NCT00805493|Bipolar Disorder|bipolar disorder
656162|NCT00805493|Bipolar Manic-Depressive Illness|bipolar manic-depressive illness
656163|NCT00805493|Bipolar Mood Disorder|bipolar mood disorder
656164|NCT00805480|Plaque|plaque
656165|NCT00805480|psoriasis|psoriasis
656166|NCT00805480|inflammatory skin disease|inflammatory skin disease
656167|NCT00805480|skin condition, thickening|skin condition, thickening
656168|NCT00805480|flaking|flaking
656169|NCT00805480|scaly patches|scaly patches
656170|NCT00805480|skin disease|skin disease
656171|NCT00805467|RA|ra
656172|NCT00805454|Healthy Volunteers|healthy volunteers
656173|NCT00805454|Phase I|phase i
656174|NCT00805454|Pet Scan|pet scan
656175|NCT00805441|Alcoholic|alcoholic
656176|NCT00805415|Oral Contraceptive|oral contraceptive
656177|NCT00805415|Ovulation Inhibition|ovulation inhibition
656178|NCT00805389|Adjuvant Systems|adjuvant systems
656179|NCT00805389|Hepatitis B|hepatitis b
656180|NCT00805376|Brain|brain
656181|NCT00805376|Brain Cancer|brain cancer
656182|NCT00805376|Central Nervous System Diseases|central nervous system diseases
656183|NCT00805376|CNS|cns
656184|NCT00805376|Conditionally Replication-Competent Adenovirus|conditionally replication-competent adenovirus
656185|NCT00805376|Delta-24-RGD|delta-24-rgd
656186|NCT00805376|DNX-2401|dnx-2401
656187|NCT00805376|Recurrent Malignant Gliomas|recurrent malignant gliomas
656188|NCT00805376|malignant brain tumor|malignant brain tumor
656189|NCT00805350|Insomnia|insomnia
656190|NCT00805350|Sleep Maintenance|sleep maintenance
656191|NCT00805350|Polysomnography|polysomnography
656192|NCT00805337|Cancer amplitude-modulated electromagnetic fields|cancer amplitude-modulated electromagnetic fields
656193|NCT00805311|Internal Carotid Artery Stenosis|internal carotid artery stenosis
656194|NCT00805311|Carotid Endarterectomy|carotid endarterectomy
656195|NCT00805311|Stroke|stroke
656196|NCT00805311|Cerebrovascular|cerebrovascular
656197|NCT00805311|Atherosclerosis|atherosclerosis
656198|NCT00805298|third molar|third molar
656199|NCT00805298|postoperative pain|postoperative pain
656200|NCT00805298|thermography|thermography
656201|NCT00805298|postoperative inflammation|postoperative inflammation
656202|NCT00805298|methylprednisolone|methylprednisolone
656203|NCT00805298|local anaesthetic|local anaesthetic
656204|NCT00805298|postoperative pain after removal of lower third molars|postoperative pain after removal of lower third molars
656205|NCT00805298|inflammation after removal of lower third molars|inflammation after removal of lower third molars
656206|NCT00805285|Inflammatory Bowel Disease|inflammatory bowel disease
656207|NCT00805285|Ulcerative Colitis|ulcerative colitis
656208|NCT00805285|Budesonide|budesonide
656209|NCT00805285|Corticosteroids|corticosteroids
656210|NCT00805272|HIV|hiv
656211|NCT00805272|tuberculosis|tuberculosis
656212|NCT00805272|IGRA|igra
656213|NCT00805272|diagnosis|diagnosis
656214|NCT00805272|treatment naive|treatment naive
656215|NCT00805259|cognitive function|cognitive function
656216|NCT00805259|elderly|elderly
656217|NCT00805259|technology|technology
656218|NCT00805259|financial incentives|financial incentives
656219|NCT00805259|General maintenance of cognitive function|general maintenance of cognitive function
656220|NCT00805246|Pulmonary embolism|pulmonary embolism
656221|NCT00805246|PE|pe
656222|NCT00805246|CT|ct
656223|NCT00805246|Biomarker|biomarker
656224|NCT00805246|Prognosis|prognosis
656225|NCT00805246|Risk Prediction|risk prediction
656226|NCT00805233|Neovascular|neovascular
656227|NCT00805233|AMD|amd
656228|NCT00805233|Treatment|treatment
656229|NCT00805233|Lucentis|lucentis
656230|NCT00805233|Bromfenac|bromfenac
656231|NCT00805220|frail elderly walking capacity walk training Nordic Walking|frail elderly walking capacity walk training nordic walking
656232|NCT00805207|sleep apnea|sleep apnea
656233|NCT00805207|obese|obese
656234|NCT00805207|Very-low density lipoprotein (VLDL) metabolism|very-low density lipoprotein (vldl) metabolism
656235|NCT00805207|isotope tracer|isotope tracer
656236|NCT00805207|women|women
656237|NCT00805155|Bioequivalence|bioequivalence
656238|NCT00805155|Mometasone Furoate|mometasone furoate
656239|NCT00805142|Pain|pain
656240|NCT00805142|Cancer|cancer
656241|NCT00805142|Tapentadol|tapentadol
656242|NCT00805129|URETER|ureter
656243|NCT00805129|URINARY BLADDER|urinary bladder
656244|NCT00805129|RAD001|rad001
656245|NCT00805129|Everolimus|everolimus
656246|NCT00805129|Urothelium|urothelium
656247|NCT00805129|08-123|08-123
656248|NCT00805103|Brain Metastases|brain metastases
656249|NCT00805103|Stereotactic radiosurgery (SRS)|stereotactic radiosurgery (srs)
656250|NCT00805103|Hypofractionated stereotactic radiotherapy (HSRT)|hypofractionated stereotactic radiotherapy (hsrt)
656251|NCT00805103|Recurrent Brain Metastases|recurrent brain metastases
656252|NCT00805090|Renal|renal
656253|NCT00805090|Hepatic|hepatic
656254|NCT00805090|Healthy|healthy
656255|NCT00805077|interoperative care|interoperative care
656256|NCT00805077|Tidal volume|tidal volume
656257|NCT00805077|Postoperative complications|postoperative complications
656258|NCT00805077|Pneumonectomy|pneumonectomy
656259|NCT00805077|Lobectomy|lobectomy
656260|NCT00805077|Mechanical ventilation|mechanical ventilation
656261|NCT00805051|Aortic stenosis|aortic stenosis
656262|NCT00805051|aortic valve replacement|aortic valve replacement
656263|NCT00805051|von Willebrand disease|von willebrand disease
656264|NCT00805051|blood loss|blood loss
656265|NCT00805012|S-1|s-1
656266|NCT00805012|docetaxel|docetaxel
656267|NCT00805012|head and neck cancer|head and neck cancer
656268|NCT00805012|Recurrent or metastatic head and neck squamous cell carcinoma|recurrent or metastatic head and neck squamous cell carcinoma
656269|NCT00804999|confocal microscopy|confocal microscopy
656270|NCT00804999|contact lens wear|contact lens wear
656271|NCT00804999|contact lens solutions|contact lens solutions
656272|NCT00804999|sodium fluorescein|sodium fluorescein
656273|NCT00804973|Migraine|migraine
656274|NCT00804973|Headache|headache
656275|NCT00804960|Cost of Infertility Treatment|cost of infertility treatment
656276|NCT00804960|Ovulation Induction|ovulation induction
656277|NCT00804960|Letrozole|letrozole
656278|NCT00804960|In Vitro Fertilization|in vitro fertilization
656279|NCT00804947|Autologous transplantation|autologous transplantation
656280|NCT00804947|Multiple Myeloma|multiple myeloma
656281|NCT00804947|Intravenous Busulfan|intravenous busulfan
656282|NCT00804921|bevacizumab|bevacizumab
656283|NCT00804921|intra-ocular pressure|intra-ocular pressure
656284|NCT00804921|acetazolamide|acetazolamide
656285|NCT00804921|anterior chamber paracentesis|anterior chamber paracentesis
656286|NCT00804921|brimonidine|brimonidine
656287|NCT00804921|macular edema secondary to diabetic retinopathy or macular degeneration|macular edema secondary to diabetic retinopathy or macular degeneration
656288|NCT00804908|Temozolomide|temozolomide
656289|NCT00804908|Skin cancer|skin cancer
656290|NCT00804908|Melanoma|melanoma
656291|NCT00804908|Metastatic Melanoma|metastatic melanoma
656292|NCT00804908|ABT-888|abt-888
656293|NCT00804908|MM|mm
656294|NCT00804895|cluster headache|cluster headache
656295|NCT00804895|greater occipital nerve block|greater occipital nerve block
656296|NCT00804895|cortivazol|cortivazol
656297|NCT00804882|Metabolic syndrome|metabolic syndrome
656298|NCT00804882|Heart failure|heart failure
656299|NCT00804882|Mexican Americans|mexican americans
656300|NCT00804882|Ethnic differences|ethnic differences
656301|NCT00804882|Echocardiography|echocardiography
656302|NCT00804830|adjuvant|adjuvant
656303|NCT00804830|Anaplastic thyroid cancer|anaplastic thyroid cancer
656304|NCT00804817|self management|self management
656305|NCT00804817|adherence|adherence
656306|NCT00804817|activity enhancement|activity enhancement
656307|NCT00804817|oral mucositis prevention|oral mucositis prevention
656308|NCT00804817|and mal nutrition prevention|and mal nutrition prevention
656309|NCT00804817|cancer|cancer
656310|NCT00804817|hematopoietic stem cell transplantation (HSCT)|hematopoietic stem cell transplantation (hsct)
656311|NCT00804817|loss of activity|loss of activity
656312|NCT00804804|Sleep|sleep
656313|NCT00804804|aging|aging
656314|NCT00804804|cognitives processes|cognitives processes
656315|NCT00804804|constant routine|constant routine
656316|NCT00804791|dry eye|dry eye
656317|NCT00804791|autofluorescence|autofluorescence
656318|NCT00804791|residence time|residence time
656319|NCT00804778|CAD|cad
656320|NCT00804778|CABG|cabg
656321|NCT00804778|CO|co
656322|NCT00804778|CI|ci
656323|NCT00804778|thermodilution|thermodilution
656324|NCT00804778|USCOM|uscom
656325|NCT00804765|Prevention|prevention
656326|NCT00804765|child obesity|child obesity
656327|NCT00804765|pregnancy|pregnancy
656328|NCT00804765|overweight women|overweight women
656329|NCT00804765|obese women|obese women
656330|NCT00804752|Patients with Chronic Hepatitis C|patients with chronic hepatitis c
656331|NCT00804739|Major Depression|major depression
657271|NCT00800839|Myeloma|myeloma
656332|NCT00804739|Postpartum Depression|postpartum depression
656333|NCT00804739|Perinatal Depression|perinatal depression
656334|NCT00804739|Treatment Feasibility|treatment feasibility
656335|NCT00804739|Treatment Engagement|treatment engagement
656336|NCT00804739|Treatment Adherence|treatment adherence
656337|NCT00804739|Postpartum|postpartum
656338|NCT00804739|Interpersonal Psychotherapy|interpersonal psychotherapy
656339|NCT00804739|IPT|ipt
656340|NCT00804739|Sertraline|sertraline
656341|NCT00804739|Zoloft|zoloft
656342|NCT00804726|Cataract extraction|cataract extraction
656343|NCT00804726|Phacoemulsification|phacoemulsification
656344|NCT00804713|TB|tb
656345|NCT00804713|tuberculosis diagnosis|tuberculosis diagnosis
656346|NCT00804713|TB screening|tb screening
656347|NCT00804700|synchronous|synchronous
656348|NCT00804700|exercise|exercise
656349|NCT00804700|music|music
656350|NCT00804700|heartbeat|heartbeat
656351|NCT00804700|tunes|tunes
656352|NCT00804687|Allergy|allergy
656353|NCT00804687|Rhinitis|rhinitis
656354|NCT00804687|Allergic Rhinitis|allergic rhinitis
656355|NCT00804687|JNJ-39220675|jnj-39220675
656356|NCT00804687|Pseudoephedrine|pseudoephedrine
656357|NCT00804674|bupivacain|bupivacain
656358|NCT00804674|breast|breast
656359|NCT00804674|reconstruction|reconstruction
656360|NCT00804674|diep|diep
656361|NCT00804674|pain|pain
656362|NCT00804674|postoperative|postoperative
656363|NCT00804674|catheter|catheter
656364|NCT00804674|anesthesia|anesthesia
656365|NCT00804661|sleep|sleep
656366|NCT00804661|nocturnal hypoventilation|nocturnal hypoventilation
656367|NCT00804661|sleep quality|sleep quality
656368|NCT00804661|lung function|lung function
656369|NCT00804622|HBeAg positive compensated chronic hepatitis B|hbeag positive compensated chronic hepatitis b
656370|NCT00804583|Cystic Fibrosis|cystic fibrosis
656371|NCT00804583|Liver Disease|liver disease
656372|NCT00804583|Genetic Modifiers|genetic modifiers
656373|NCT00804557|Male Urinary Disorders|male urinary disorders
656374|NCT00804557|Urinary catheterization|urinary catheterization
656375|NCT00804557|Urinary retention|urinary retention
656376|NCT00804544|Integrated SPECT/CT|integrated spect/ct
656377|NCT00804544|99mTc-sestMIBI|99mtc-sestmibi
656378|NCT00804544|Chemosensitivity|chemosensitivity
656379|NCT00804531|Low back pain|low back pain
656380|NCT00804531|steroid injection|steroid injection
656381|NCT00804531|inter-vertebral disc|inter-vertebral disc
656382|NCT00804531|randomized trial|randomized trial
656383|NCT00804531|Lack of efficacy of usual recommended treatments|lack of efficacy of usual recommended treatments
656384|NCT00804531|More than 40 on the pain numeric scale (0-100)|more than 40 on the pain numeric scale (0-100)
656385|NCT00804531|Inflammatory discopathy (MODIC I) on MRI|inflammatory discopathy (modic i) on mri
656386|NCT00804518|Aging|aging
656387|NCT00804518|Diastolic dysfunction|diastolic dysfunction
656388|NCT00804518|Systolic function|systolic function
656389|NCT00804518|Exercise|exercise
656390|NCT00804518|Echocardiography|echocardiography
656391|NCT00804518|tissue Doppler imaging|tissue doppler imaging
656392|NCT00804518|Cardiac function|cardiac function
656393|NCT00804505|Substantial equivalence to control device|substantial equivalence to control device
656394|NCT00804492|To organize a multidisciplinary team for integrated falls prevention|to organize a multidisciplinary team for integrated falls prevention
656395|NCT00804492|To draft a guideline for falls prevention in the elderly|to draft a guideline for falls prevention in the elderly
656396|NCT00804492|To set up a multidisciplinary fall clinic|to set up a multidisciplinary fall clinic
656397|NCT00804492|To set up a falls prevention classroom|to set up a falls prevention classroom
656398|NCT00804492|To enhance cooperate between hospitals and primary care units for falls prevention|to enhance cooperate between hospitals and primary care units for falls prevention
656399|NCT00804466|Human Papillomavirus|human papillomavirus
656400|NCT00804466|Cervical Cancer|cervical cancer
656401|NCT00804466|Screening|screening
656402|NCT00804453|Chronic Kidney Failure|chronic kidney failure
656403|NCT00804453|Hemodialysis|hemodialysis
656404|NCT00804453|Biocompatibility|biocompatibility
656405|NCT00804440|bioequivalency|bioequivalency
656406|NCT00804440|ibuprofen|ibuprofen
656407|NCT00804427|Fish oil|fish oil
656408|NCT00804427|Triglycerides|triglycerides
656409|NCT00804427|Low-density Lipoprotein (LDL) cholesterol|low-density lipoprotein (ldl) cholesterol
656410|NCT00804427|Low-density Lipoprotein (LDL) subclass|low-density lipoprotein (ldl) subclass
656411|NCT00804427|Low-density Lipoprotein (LDL) particle size|low-density lipoprotein (ldl) particle size
656412|NCT00804427|Low-density Lipoprotein (LDL) phenotype|low-density lipoprotein (ldl) phenotype
656413|NCT00804414|Diabetes|diabetes
656414|NCT00804414|Diabetic ulcer|diabetic ulcer
656415|NCT00804414|Chronic ulcer|chronic ulcer
656416|NCT00804414|SBG|sbg
656417|NCT00804401|bioequivalency|bioequivalency
656418|NCT00804401|Naproxen|naproxen
656419|NCT00804388|Vitamine E|vitamine e
656420|NCT00804388|E-poly|e-poly
656421|NCT00804388|Hip|hip
656422|NCT00804388|Degenerative joint disease|degenerative joint disease
656423|NCT00804375|stump pain|stump pain
656424|NCT00804349|Heart Decompensation|heart decompensation
656425|NCT00804349|Heart Failure, Congestive|heart failure, congestive
656426|NCT00804349|Heart Failure, Left-Sided|heart failure, left-sided
656427|NCT00804349|Heart Failure, Right-Sided|heart failure, right-sided
656428|NCT00804349|Apnea, Sleep|apnea, sleep
656429|NCT00804349|Sleep Apnea, Mixed Central and Obstructive|sleep apnea, mixed central and obstructive
656430|NCT00804349|Sleep Hypopnea|sleep hypopnea
656431|NCT00804349|Sleep-Disordered Breathing|sleep-disordered breathing
656432|NCT00804336|pasireotide|pasireotide
656434|NCT00804336|RAD001|rad001
656435|NCT00804310|unspecified adult solid tumor, protocol specific|unspecified adult solid tumor, protocol specific
656436|NCT00804297|Hypoglycemia|hypoglycemia
656437|NCT00804297|Diabetes Mellitus|diabetes mellitus
656438|NCT00804297|Octreotide|octreotide
656439|NCT00804284|DAPTACEL®|daptacel®
656440|NCT00804284|PENTACEL®|pentacel®
656441|NCT00804284|Diphtheria|diphtheria
656442|NCT00804284|Tetanus|tetanus
656443|NCT00804284|Pertussis|pertussis
656444|NCT00804284|Haemophilus influenzae type b|haemophilus influenzae type b
656445|NCT00804258|recurrent ovarian epithelial cancer|recurrent ovarian epithelial cancer
656446|NCT00804258|recurrent ovarian germ cell tumor|recurrent ovarian germ cell tumor
656447|NCT00804258|stage I ovarian epithelial cancer|stage i ovarian epithelial cancer
656448|NCT00804258|stage I ovarian germ cell tumor|stage i ovarian germ cell tumor
656449|NCT00804258|stage II ovarian epithelial cancer|stage ii ovarian epithelial cancer
656450|NCT00804258|stage II ovarian germ cell tumor|stage ii ovarian germ cell tumor
656451|NCT00804258|stage III ovarian epithelial cancer|stage iii ovarian epithelial cancer
656452|NCT00804258|stage III ovarian germ cell tumor|stage iii ovarian germ cell tumor
656453|NCT00804258|stage IV ovarian epithelial cancer|stage iv ovarian epithelial cancer
656454|NCT00804258|stage IV ovarian germ cell tumor|stage iv ovarian germ cell tumor
656455|NCT00804245|adenocarcinoma of the prostate|adenocarcinoma of the prostate
656456|NCT00804245|stage I prostate cancer|stage i prostate cancer
656457|NCT00804245|stage II prostate cancer|stage ii prostate cancer
711016|NCT00586846|Cisplatin|cisplatin
836692|NCT00091936|DOT|dot
656458|NCT00804245|stage III prostate cancer|stage iii prostate cancer
656459|NCT00804245|stage IV prostate cancer|stage iv prostate cancer
656460|NCT00804232|Diabetes type1; children|diabetes type1; children
656461|NCT00804219|low responsiveness after vaccination|low responsiveness after vaccination
656462|NCT00804206|Intravitreal injection of Bevacizumab|intravitreal injection of bevacizumab
656463|NCT00804206|Visual acuity|visual acuity
656464|NCT00804206|central retinal thickness|central retinal thickness
656465|NCT00804206|color studies, Farnsworth-Munsell|color studies, farnsworth-munsell
656466|NCT00804206|electroretinogram studies|electroretinogram studies
656467|NCT00804193|Tinea Pedis|tinea pedis
656468|NCT00804193|Ciclopirox Olamine|ciclopirox olamine
656469|NCT00804180|anxiety|anxiety
656470|NCT00804180|injection|injection
656471|NCT00804180|needle|needle
656472|NCT00804180|pediatric|pediatric
656473|NCT00804180|youth|youth
656474|NCT00804180|children|children
656475|NCT00804180|adolescents|adolescents
656476|NCT00804180|cognitive behavioral|cognitive behavioral
656477|NCT00804180|behavioral|behavioral
656478|NCT00804180|exposure|exposure
656479|NCT00804180|group|group
656480|NCT00804180|treatment|treatment
656481|NCT00804180|chronic illness|chronic illness
656482|NCT00804180|adherence|adherence
656483|NCT00804167|Hypertensive patients aged of 75 years and older|hypertensive patients aged of 75 years and older
656484|NCT00804167|renal damage|renal damage
656485|NCT00804167|Clinical characteristics of hypertensive patients aged of 75 years and older seen in general practitioner consultation according to their renal damage|clinical characteristics of hypertensive patients aged of 75 years and older seen in general practitioner consultation according to their renal damage
656486|NCT00804154|Vanilloid|vanilloid
656487|NCT00804154|Capsaicin|capsaicin
656488|NCT00804154|Cancer Pain|cancer pain
656489|NCT00804154|Nerve Block|nerve block
656490|NCT00804141|treatment for opioid-induced constipation|treatment for opioid-induced constipation
656491|NCT00804128|ductal breast carcinoma in situ|ductal breast carcinoma in situ
656492|NCT00804115|Exfoliation Syndrome|exfoliation syndrome
656493|NCT00804115|Latanoprost|latanoprost
656494|NCT00804115|Timolol|timolol
656495|NCT00804115|Pilocarpine|pilocarpine
656496|NCT00804102|Retinitis pigmentosa|retinitis pigmentosa
656497|NCT00804102|Macula off|macula off
656498|NCT00804102|Primary open angle Glaucoma|primary open angle glaucoma
656499|NCT00804102|Hereditary Macular Degeneration|hereditary macular degeneration
656500|NCT00804102|Treated Retina detachment|treated retina detachment
656501|NCT00804102|Retinal Artery Occlusion|retinal artery occlusion
656502|NCT00804102|Retinal Vein Occlusion,|retinal vein occlusion,
656503|NCT00804102|Non-Arthritic-Anterior-Ischemic Optic-Neuropathy|non-arthritic-anterior-ischemic optic-neuropathy
656504|NCT00804102|Hereditary autosomal dominant Optic atrophy|hereditary autosomal dominant optic atrophy
656505|NCT00804102|dry Age-related Macular Degeneration|dry age-related macular degeneration
656506|NCT00804102|Ischemic Macula edema|ischemic macula edema
656507|NCT00804089|Low Back Pain, Chronic|low back pain, chronic
656508|NCT00804089|Acupuncture|acupuncture
656509|NCT00804089|Dry Needling|dry needling
656510|NCT00804089|Acupressure|acupressure
656511|NCT00804089|Acupuncture Points|acupuncture points
656512|NCT00804089|Trigger Points, Myofascial|trigger points, myofascial
656513|NCT00804076|gene therapy|gene therapy
656514|NCT00804076|replication defective HSV vector|replication defective hsv vector
656515|NCT00804076|pain|pain
656516|NCT00804076|enkephalin|enkephalin
656517|NCT00804076|intradermal|intradermal
656518|NCT00804063|glaucoma|glaucoma
656519|NCT00804063|citrate|citrate
656520|NCT00804050|Myelodysplastic Syndromes|myelodysplastic syndromes
656521|NCT00804050|Erythropoietin|erythropoietin
656522|NCT00804050|Acid 13-Cis-Retinoic|acid 13-cis-retinoic
656523|NCT00804050|Dihydroxyvitamin D3|dihydroxyvitamin d3
656524|NCT00804050|low or intermediate-1 IPSS|low or intermediate-1 ipss
656525|NCT00804050|MDS low risk|mds low risk
656526|NCT00804037|Snoring and Mild Apnea|snoring and mild apnea
656527|NCT00804024|Heart Diseases. Vascular Diseases.|heart diseases. vascular diseases.
656528|NCT00804011|Snakebite|snakebite
656529|NCT00804011|Weaning|weaning
656530|NCT00804011|Mechanical ventilation|mechanical ventilation
656531|NCT00803985|Inguinal hernia|inguinal hernia
656532|NCT00803985|TEP|tep
656533|NCT00803985|Lichtenstein|lichtenstein
656534|NCT00803985|Mesh|mesh
656535|NCT00803985|Randomized|randomized
656536|NCT00803985|Chronic pain|chronic pain
656537|NCT00803985|Sexual dysfunction|sexual dysfunction
656538|NCT00803972|Humalog|humalog
656539|NCT00803972|Humulin R|humulin r
656540|NCT00803972|rHuPH20|rhuph20
656541|NCT00803972|Hylenex|hylenex
656542|NCT00803959|Stress urinary incontinence, Mixed, Urge|stress urinary incontinence, mixed, urge
656543|NCT00803946|bioequivalency|bioequivalency
656544|NCT00803946|ibuprofen|ibuprofen
656545|NCT00803933|first stage|first stage
656546|NCT00803933|Trypanosoma brucei gambiense|trypanosoma brucei gambiense
656547|NCT00803933|T. b. gambiense|t. b. gambiense
656548|NCT00803933|sleeping sickness|sleeping sickness
656549|NCT00803933|First stage T. b. gambiense sleeping sickness|first stage t. b. gambiense sleeping sickness
656550|NCT00803920|exenatide twice daily or once weekly|exenatide twice daily or once weekly
656551|NCT00803920|continuous glucose monitoring|continuous glucose monitoring
656552|NCT00803907|immunomodulator|immunomodulator
656553|NCT00803907|Carcinoma, Basal Cell|carcinoma, basal cell
656554|NCT00803894|Biomarkers of Notch inhibition|biomarkers of notch inhibition
656555|NCT00803855|single dose|single dose
656556|NCT00803855|pharmacokinetics|pharmacokinetics
656557|NCT00803855|safety|safety
656558|NCT00803855|healthy volunteers|healthy volunteers
656559|NCT00803855|food interaction|food interaction
656560|NCT00803855|AZD1446|azd1446
656561|NCT00803842|erlotinib|erlotinib
656562|NCT00803842|rash|rash
656563|NCT00803842|supportive care|supportive care
656564|NCT00803816|endogoneous|endogoneous
656565|NCT00803816|posterior|posterior
656566|NCT00803816|intermediate|intermediate
656567|NCT00803803|Pilocarpine|pilocarpine
656568|NCT00803803|POAG|poag
656569|NCT00803803|IOP|iop
656570|NCT00803803|Concentration|concentration
656571|NCT00803803|Frequency|frequency
656572|NCT00803803|Primary open-angle glaucoma|primary open-angle glaucoma
656573|NCT00803803|Primary open-angle glaucoma suspect|primary open-angle glaucoma suspect
656574|NCT00803764|bioequivalency|bioequivalency
656575|NCT00803764|naproxen|naproxen
656576|NCT00803751|Laryngoscopy [E04.580.373]|laryngoscopy [e04.580.373]
656577|NCT00803738|Vulvovaginal Candidiasis|vulvovaginal candidiasis
656578|NCT00803738|Terconazole|terconazole
656579|NCT00803725|spinal anesthesia|spinal anesthesia
656580|NCT00803725|mepivacaine|mepivacaine
656581|NCT00803725|fentanyl|fentanyl
656582|NCT00803725|duration of anesthesia|duration of anesthesia
656583|NCT00803725|knee arthroscopy|knee arthroscopy
656584|NCT00803725|regional anesthesia|regional anesthesia
656585|NCT00803725|Spinal anesthesia for knee arthroscopy|spinal anesthesia for knee arthroscopy
656586|NCT00803699|selenium|selenium
656587|NCT00803673|Healthy volunteers|healthy volunteers
656588|NCT00803673|New formulation|new formulation
656589|NCT00803660|hypertension|hypertension
656590|NCT00803660|BP|bp
656591|NCT00803660|diabetes|diabetes
656592|NCT00803660|anti-hypertensive treatment|anti-hypertensive treatment
656593|NCT00803660|ACE-I|ace-i
656594|NCT00803660|ARB|arb
656595|NCT00803647|NSABP|nsabp
656596|NCT00803647|Cetuximab|cetuximab
656597|NCT00803647|FOLFOX7|folfox7
656598|NCT00803647|Oxaliplatin|oxaliplatin
656599|NCT00803647|Leucovorin|leucovorin
656600|NCT00803647|5-FU|5-fu
656601|NCT00803647|colorectal cancer|colorectal cancer
656602|NCT00803647|KRAS wild type|kras wild type
656603|NCT00803647|metastatic colorectal cancer|metastatic colorectal cancer
656604|NCT00803647|Erbitux|erbitux
656605|NCT00803647|Eloxatin|eloxatin
656606|NCT00803647|Liver resection|liver resection
656607|NCT00803647|Liver ablation|liver ablation
656608|NCT00803647|Metastasectomy|metastasectomy
656609|NCT00803634|Hypertension|hypertension
656610|NCT00803634|Antihypertensive Agent|antihypertensive agent
656611|NCT00803634|Calcium Channel Blocker|calcium channel blocker
656612|NCT00803608|Plantar|plantar
656613|NCT00803608|Ulcer|ulcer
656614|NCT00803608|Diabetes|diabetes
656615|NCT00803595|Influenza|influenza
656616|NCT00803595|Neuraminidase inhibitor|neuraminidase inhibitor
656617|NCT00803569|recurrent ovarian epithelial cancer|recurrent ovarian epithelial cancer
656618|NCT00803569|stage II ovarian epithelial cancer|stage ii ovarian epithelial cancer
656619|NCT00803569|stage III ovarian epithelial cancer|stage iii ovarian epithelial cancer
656620|NCT00803569|stage IV ovarian epithelial cancer|stage iv ovarian epithelial cancer
656621|NCT00803569|fallopian tube cancer|fallopian tube cancer
656622|NCT00803569|peritoneal cavity cancer|peritoneal cavity cancer
656623|NCT00803543|HSV-2|hsv-2
656624|NCT00803543|Herpes Simplex|herpes simplex
656625|NCT00803543|HSV Type 2|hsv type 2
656626|NCT00803543|HIV|hiv
656627|NCT00803543|HIV/HSV|hiv/hsv
656628|NCT00803543|treatment experienced|treatment experienced
656629|NCT00803530|myelodysplastic syndromes|myelodysplastic syndromes
656630|NCT00803530|arsenic trioxide|arsenic trioxide
656631|NCT00803530|ascorbic acid|ascorbic acid
656632|NCT00803517|chronic central serous chorioretinopathy|chronic central serous chorioretinopathy
656633|NCT00803517|multifocal electroretinogram|multifocal electroretinogram
656634|NCT00803517|central retinal function after treatment in chronic serous chorioretinopathy|central retinal function after treatment in chronic serous chorioretinopathy
656635|NCT00803504|optic disc morphology|optic disc morphology
656636|NCT00803504|ocular blood flow|ocular blood flow
656637|NCT00803504|retina|retina
656638|NCT00803504|ocular physiology|ocular physiology
656639|NCT00803491|Rheumatic diseases|rheumatic diseases
656640|NCT00803491|Problem based learning|problem based learning
656641|NCT00803491|Health-related quality of life|health-related quality of life
656642|NCT00803491|Empowerment|empowerment
656643|NCT00803491|Self-care|self-care
656644|NCT00803478|IntraLase LASIK for primary myopia|intralase lasik for primary myopia
656645|NCT00803465|Bioequivalence|bioequivalence
656646|NCT00803465|Fluticasone Propionate|fluticasone propionate
656647|NCT00803452|Meibomian gland dysfunction|meibomian gland dysfunction
656648|NCT00803452|Lid margin disease|lid margin disease
656649|NCT00803452|doxycycline|doxycycline
656650|NCT00803452|azithromycin|azithromycin
656651|NCT00803452|essential fatty acid|essential fatty acid
656652|NCT00803439|Bioequivalence|bioequivalence
656653|NCT00803439|Clobetasol Propionate|clobetasol propionate
656654|NCT00803426|ultrasound-guided regional anesthesia|ultrasound-guided regional anesthesia
656655|NCT00803426|nerve block|nerve block
656656|NCT00803426|popliteal fossa|popliteal fossa
656657|NCT00803426|sciatic nerve|sciatic nerve
656658|NCT00803426|common peroneal nerve|common peroneal nerve
656659|NCT00803426|tibial nerve|tibial nerve
656660|NCT00803426|onset time|onset time
656661|NCT00803426|ankle surgery|ankle surgery
656662|NCT00803426|foot surgery|foot surgery
656663|NCT00803413|Chronic low back pain|chronic low back pain
656664|NCT00803413|Back School|back school
656665|NCT00803413|Walking|walking
656666|NCT00803413|Physical activity|physical activity
656667|NCT00803400|Panic disorder|panic disorder
656668|NCT00803400|Exercise|exercise
656669|NCT00803400|Alprazolam|alprazolam
656670|NCT00803400|Aerobic|aerobic
656671|NCT00803387|ocular dryness|ocular dryness
656672|NCT00803387|ocular irritation|ocular irritation
656673|NCT00803387|open-angle glaucoma|open-angle glaucoma
656674|NCT00803387|ocular hypertension|ocular hypertension
656675|NCT00803387|TravatanZ|travatanz
656676|NCT00803387|Xalatan|xalatan
656677|NCT00803361|anxiety|anxiety
656678|NCT00803348|continuous femoral nerve blockade|continuous femoral nerve blockade
656679|NCT00803348|knee arthroplasty|knee arthroplasty
656680|NCT00803348|knee replacement|knee replacement
656681|NCT00803348|regional anesthesia|regional anesthesia
656682|NCT00803348|readiness to discharge|readiness to discharge
656683|NCT00803348|Femoral nerve blockade for total knee arthroplasty|femoral nerve blockade for total knee arthroplasty
656684|NCT00803335|pelvic organ prolapse|pelvic organ prolapse
656685|NCT00803335|vaginal atrophy|vaginal atrophy
656686|NCT00803335|atrophic vaginitis|atrophic vaginitis
656687|NCT00803335|postmenopausal|postmenopausal
656688|NCT00803335|posthysterectomy|posthysterectomy
656689|NCT00803335|vaginal health|vaginal health
656690|NCT00803335|vaginal cytology|vaginal cytology
656691|NCT00803335|vaginal maturity index|vaginal maturity index
656692|NCT00803335|vaginal histology|vaginal histology
656693|NCT00803335|quality of life questionnaires|quality of life questionnaires
656694|NCT00803322|TB|tb
656695|NCT00803322|community|community
656696|NCT00803322|community health workers|community health workers
656697|NCT00803322|Ethiopia|ethiopia
656698|NCT00803322|identify suspects of pulmonary tuberculosis|identify suspects of pulmonary tuberculosis
656699|NCT00803322|collect sputum specimen for examination|collect sputum specimen for examination
656700|NCT00803322|treat smear positive cases in the community|treat smear positive cases in the community
656701|NCT00803309|Chronic HCV-genotype 2/3|chronic hcv-genotype 2/3
656702|NCT00803309|Efficacy of treatment extension|efficacy of treatment extension
656703|NCT00803309|PegIntron|pegintron
656704|NCT00803309|pegylated interferon alpha-2b|pegylated interferon alpha-2b
656705|NCT00803309|Rebetol|rebetol
656706|NCT00803309|ribavirin|ribavirin
656707|NCT00803283|Pain|pain
656708|NCT00803283|Hydromorphone hydrochloride OROS|hydromorphone hydrochloride oros
656709|NCT00803283|Morphine|morphine
657373|NCT00800423|timolol|timolol
656710|NCT00803270|Stress urinary incontinence, Mixed, Urge|stress urinary incontinence, mixed, urge
656711|NCT00803257|Carpal Tunnel Syndrome|carpal tunnel syndrome
656712|NCT00803257|Splint|splint
656713|NCT00803257|Hand exercises|hand exercises
656714|NCT00803244|allergic rhinoconjunctivitis|allergic rhinoconjunctivitis
656715|NCT00803218|Bioequivalence|bioequivalence
656716|NCT00803218|Fluticasone Propionate|fluticasone propionate
656717|NCT00803205|Cystic fibrosis|cystic fibrosis
656718|NCT00803205|Nonsense mutation|nonsense mutation
656719|NCT00803205|Premature stop codon|premature stop codon
656720|NCT00803205|PTC124|ptc124
656721|NCT00803205|Ataluren|ataluren
656722|NCT00803192|bioavailability|bioavailability
656723|NCT00803192|famotidine|famotidine
656724|NCT00803179|CF|cf
656725|NCT00803166|Bioequivalence|bioequivalence
656726|NCT00803166|Halobetasol Propionate|halobetasol propionate
656727|NCT00803153|Panretinal photocoagulation|panretinal photocoagulation
656728|NCT00803153|Bruch rupture|bruch rupture
656729|NCT00803153|Choroidal detachment|choroidal detachment
656730|NCT00803153|complication rates|complication rates
656731|NCT00803140|scarring|scarring
656732|NCT00803127|vaginal infection, color appearance|vaginal infection, color appearance
656733|NCT00803114|Postpartum perineal pain|postpartum perineal pain
656734|NCT00803114|Epidural morphine|epidural morphine
656735|NCT00803114|Randomised clinical trial|randomised clinical trial
656736|NCT00803101|Anticoagulant reversal|anticoagulant reversal
656737|NCT00803101|Prothrombin Complex Concentrate|prothrombin complex concentrate
656738|NCT00803101|Coagulopathy|coagulopathy
656739|NCT00803101|Coumarin derivatives|coumarin derivatives
656740|NCT00803101|Emergency surgery|emergency surgery
656741|NCT00803101|Invasive procedures|invasive procedures
656742|NCT00803101|Vitamin K|vitamin k
656743|NCT00803101|Reversal of coagulopathy induced by coumarin derivatives|reversal of coagulopathy induced by coumarin derivatives
656744|NCT00803101|Kcentra|kcentra
656745|NCT00803049|Multiple Sclerosis|multiple sclerosis
656746|NCT00803049|Oral treatment|oral treatment
656747|NCT00803036|spreading cortical depression|spreading cortical depression
656748|NCT00803036|electroencephalography|electroencephalography
656749|NCT00803036|traumatic brain injury|traumatic brain injury
656750|NCT00803036|intensive care|intensive care
656751|NCT00803036|vascular hypotension|vascular hypotension
656752|NCT00803036|intracranial hypertension|intracranial hypertension
656753|NCT00803010|Acute Graft Versus Host Disease (aGVHD)|acute graft versus host disease (agvhd)
656754|NCT00803010|GVHD|gvhd
656755|NCT00803010|graft-versus-host disease|graft-versus-host disease
656756|NCT00803010|tacrolimus|tacrolimus
656757|NCT00803010|sirolimus|sirolimus
656758|NCT00803010|methotrexate|methotrexate
656759|NCT00803010|combination therapy|combination therapy
656760|NCT00803010|GVHD prophylaxis|gvhd prophylaxis
656761|NCT00802971|Reactive hypoglycaemia|reactive hypoglycaemia
656762|NCT00802971|Fiber|fiber
656763|NCT00802971|Prevalence|prevalence
656764|NCT00802971|Randomised controlled trial|randomised controlled trial
656765|NCT00802971|Idiopathic reactive hypoglycemia|idiopathic reactive hypoglycemia
656766|NCT00802958|Bioequivalence|bioequivalence
656767|NCT00802958|Halobetasol Propionate|halobetasol propionate
656768|NCT00802932|breast cancer|breast cancer
656769|NCT00802932|female|female
656770|NCT00802932|metallic markers|metallic markers
656771|NCT00802932|image guided radiation therapy|image guided radiation therapy
656772|NCT00802932|IGRT|igrt
656773|NCT00802919|schizophrenia|schizophrenia
656774|NCT00802919|smoking|smoking
656775|NCT00802919|nicotine|nicotine
656776|NCT00802919|cognitive deficits|cognitive deficits
656777|NCT00802919|nicotinic receptors|nicotinic receptors
656778|NCT00802919|Cognitive Deficits in Schizophrenia|cognitive deficits in schizophrenia
656779|NCT00802906|micropulselaserphotocoagulation|micropulselaserphotocoagulation
656780|NCT00802906|bevacizumab|bevacizumab
656781|NCT00802906|CSC|csc
656782|NCT00802893|Isolated Systolic Hypertension with Endothelial Dysfunction|isolated systolic hypertension with endothelial dysfunction
656783|NCT00802867|DAPTACEL®|daptacel®
656784|NCT00802867|PENTACEL™|pentacel™
656785|NCT00802867|Diphtheria|diphtheria
656786|NCT00802867|Tetanus|tetanus
656787|NCT00802867|Pertussis|pertussis
656788|NCT00802867|Haemophilus influenzae type b|haemophilus influenzae type b
656789|NCT00802854|anidulafungin|anidulafungin
656790|NCT00802854|safety|safety
656791|NCT00802854|efficacy|efficacy
656792|NCT00802841|Chronic|chronic
656793|NCT00802841|Myelogenous|myelogenous
656794|NCT00802841|Leukemia|leukemia
656795|NCT00802841|CML|cml
656796|NCT00802841|Chronic Phase|chronic phase
656797|NCT00802841|Suboptimal Response|suboptimal response
656798|NCT00802828|bioavailability|bioavailability
656799|NCT00802828|famotidine|famotidine
656800|NCT00802763|VAGINAL INFECTION|vaginal infection
656801|NCT00802763|COLOR APPEARANCE|color appearance
656802|NCT00802763|ELEVATED Ph|elevated ph
656803|NCT00802737|Maintenance|maintenance
656804|NCT00802737|Retreatment|retreatment
656805|NCT00802737|Chronic lymphocytic leukemia|chronic lymphocytic leukemia
656806|NCT00802737|B-Cell Chronic Lymphocytic Leukemia|b-cell chronic lymphocytic leukemia
656807|NCT00802737|Ofatumumab|ofatumumab
656808|NCT00802724|low back pain|low back pain
656809|NCT00802724|classification|classification
656810|NCT00802724|spine|spine
656811|NCT00802711|stage IA breast cancer|stage ia breast cancer
656812|NCT00802711|stage IB breast cancer|stage ib breast cancer
656813|NCT00802711|stage II breast cancer|stage ii breast cancer
656814|NCT00802711|invasive ductal breast carcinoma|invasive ductal breast carcinoma
656815|NCT00802698|Biphasic waveform|biphasic waveform
656816|NCT00802698|Central retinal artery occlusion|central retinal artery occlusion
656817|NCT00802698|To describe the effect of Transcorneal Electrical Stimulation (TES) with a non conventional biphasic bipolar waveform|to describe the effect of transcorneal electrical stimulation (tes) with a non conventional biphasic bipolar waveform
656818|NCT00802698|in central retinal artery occlusion|in central retinal artery occlusion
656819|NCT00802685|Patent ductus arteriosus|patent ductus arteriosus
656820|NCT00802685|Respiratory outcome|respiratory outcome
656821|NCT00802672|Tinea Pedis|tinea pedis
656822|NCT00802672|Ciclopirox Olamine|ciclopirox olamine
656823|NCT00802646|first-time mother|first-time mother
656824|NCT00802646|epidural request|epidural request
656825|NCT00802646|vaginal childbirth|vaginal childbirth
656826|NCT00802633|Tissue sealing device|tissue sealing device
656827|NCT00802633|Articulating stapling device|articulating stapling device
656828|NCT00802633|Radical cystectomy|radical cystectomy
656829|NCT00802620|Amniotic membrane|amniotic membrane
656830|NCT00802620|Conjunctival autograft|conjunctival autograft
656831|NCT00802620|Recurrent pterygia|recurrent pterygia
656832|NCT00802620|compare amniotic membrane associated with conjunctival autograft versus conjunctival autograft alone in the treatment of recurrent pterygia|compare amniotic membrane associated with conjunctival autograft versus conjunctival autograft alone in the treatment of recurrent pterygia
656833|NCT00802607|Bone Diseases|bone diseases
656834|NCT00802607|Connective Tissue Diseases|connective tissue diseases
656835|NCT00802594|first stage|first stage
656836|NCT00802594|T.b. gambiense|t.b. gambiense
656837|NCT00802594|sleeping sickness|sleeping sickness
656838|NCT00802594|Patients with first stage T.b. gambiense sleeping sickness|patients with first stage t.b. gambiense sleeping sickness
656839|NCT00802581|sciatic nerve block|sciatic nerve block
656840|NCT00802581|local anesthetic|local anesthetic
656841|NCT00802581|lidocaine|lidocaine
656842|NCT00802581|ankle surgery|ankle surgery
656843|NCT00802581|foot surgery|foot surgery
656844|NCT00802581|ultrasound-guided regional anesthesia|ultrasound-guided regional anesthesia
656845|NCT00802581|circumferential spread|circumferential spread
656846|NCT00802581|anesthetic infiltration|anesthetic infiltration
656847|NCT00802568|stage I multiple myeloma|stage i multiple myeloma
656848|NCT00802568|stage II multiple myeloma|stage ii multiple myeloma
656849|NCT00802568|stage III multiple myeloma|stage iii multiple myeloma
656850|NCT00802568|refractory multiple myeloma|refractory multiple myeloma
656851|NCT00802568|osteolytic lesions of multiple myeloma|osteolytic lesions of multiple myeloma
656853|NCT00802555|Cirrhotic Patients with Hepatocellular Carcinoma|cirrhotic patients with hepatocellular carcinoma
656854|NCT00802542|Hypertension|hypertension
656855|NCT00802542|blood pressure|blood pressure
656856|NCT00802542|Atacand|atacand
656857|NCT00802529|Meniere's disease|meniere's disease
656858|NCT00802529|transtympanic steroids|transtympanic steroids
656859|NCT00802529|Randomised controlled trial|randomised controlled trial
656860|NCT00802503|Critically ill|critically ill
656861|NCT00802503|nutrition|nutrition
656862|NCT00802503|randomised controlled clinical trial|randomised controlled clinical trial
656864|NCT00802503|adult|adult
656865|NCT00802503|Supplemental parenteral nutrition|supplemental parenteral nutrition
656866|NCT00802490|Attention Deficit Hyperactivity Disorder|attention deficit hyperactivity disorder
656867|NCT00802490|Electroencephalogram biofeedback|electroencephalogram biofeedback
656868|NCT00802490|Inattention|inattention
656869|NCT00802490|Brain-Computer Interface System|brain-computer interface system
656870|NCT00802477|mastectomy|mastectomy
656871|NCT00802477|seroma|seroma
656872|NCT00802477|lymph node dissection|lymph node dissection
656873|NCT00802464|Cytokine|cytokine
656874|NCT00802464|Vaccine|vaccine
656875|NCT00802464|Herpes Zoster (HZ)|herpes zoster (hz)
656876|NCT00802464|Cell mediated immunity (CMI)|cell mediated immunity (cmi)
656877|NCT00802464|Antibody response|antibody response
656878|NCT00802464|Varicella Zoster Virus (VZV)|varicella zoster virus (vzv)
656879|NCT00802464|Shingles|shingles
656880|NCT00802451|Bioavailability|bioavailability
656881|NCT00802451|Mesalamine|mesalamine
656882|NCT00802438|asthma|asthma
656883|NCT00802438|allergic inflammation|allergic inflammation
656884|NCT00802438|interleukin-5|interleukin-5
656885|NCT00802425|Sudden hearing loss|sudden hearing loss
656886|NCT00802425|Sudden deafness|sudden deafness
656887|NCT00802425|Acoustic trauma|acoustic trauma
656888|NCT00802425|Noise trauma|noise trauma
656889|NCT00802412|tobacco use disorders|tobacco use disorders
656890|NCT00802412|alcoholism|alcoholism
656891|NCT00802399|Cornea|cornea
656892|NCT00802399|Dry eye|dry eye
656893|NCT00802399|lacrimal punctual occlusion|lacrimal punctual occlusion
656894|NCT00802399|lacrimal film|lacrimal film
656895|NCT00802399|ocular surface|ocular surface
656896|NCT00802386|BACTERIAL VAGINOSIS|bacterial vaginosis
656897|NCT00802386|IUD INSERTION|iud insertion
656898|NCT00802373|Overactive Bladder|overactive bladder
656899|NCT00802360|Healthy, pre-menopausal women, age 18-42 with a history of infertility and requiring IVF|healthy, pre-menopausal women, age 18-42 with a history of infertility and requiring ivf
656900|NCT00802347|Delayed Graft Function|delayed graft function
656901|NCT00802347|Kidney Transplant|kidney transplant
656902|NCT00802347|Renal Transplant|renal transplant
656903|NCT00802347|small interfering ribonucleic acid (siRNA)|small interfering ribonucleic acid (sirna)
656904|NCT00802334|generic lopinavir/ritonavir|generic lopinavir/ritonavir
656905|NCT00802334|therapeutic drug monitoring|therapeutic drug monitoring
656906|NCT00802334|safety and efficacy|safety and efficacy
656907|NCT00802321|steroid 5AReductase|steroid 5areductase
656908|NCT00802321|genetic polymorphism|genetic polymorphism
656909|NCT00802321|GABA receptor|gaba receptor
656910|NCT00802295|Ovarian|ovarian
656911|NCT00802295|hyperstimulation|hyperstimulation
656912|NCT00802295|Embryo|embryo
656913|NCT00802295|Aneuploidy|aneuploidy
656914|NCT00802295|Ovarian hyperstimulation and Embryo Aneuploidy Rates|ovarian hyperstimulation and embryo aneuploidy rates
656915|NCT00802282|healthy volunteers|healthy volunteers
656916|NCT00802282|spirituality|spirituality
656917|NCT00802282|psilocybin|psilocybin
656918|NCT00802282|meditation|meditation
656919|NCT00802269|Proliferative diabetic retinopathy|proliferative diabetic retinopathy
656920|NCT00802269|Laser photocoagulation|laser photocoagulation
656921|NCT00802269|Pain|pain
656922|NCT00802256|pulpotomy|pulpotomy
656923|NCT00802256|primary molar teeth|primary molar teeth
656924|NCT00802256|MTA|mta
656925|NCT00802256|NEC|nec
656926|NCT00802256|CEM|cem
710344|NCT00589563|stage III small lymphocytic lymphoma|stage iii small lymphocytic lymphoma
656927|NCT00802256|Primary Molar Teeth Which Require Pulpotomy Treatment|primary molar teeth which require pulpotomy treatment
656928|NCT00802243|Bullous pemphigoid|bullous pemphigoid
656929|NCT00802243|leflunomide|leflunomide
656930|NCT00802243|corticosteroid treatment reduction|corticosteroid treatment reduction
656931|NCT00802243|Patients are screened by: the physicians in different departments of the hospital, the liberal dermatologists and the general practicioners.|patients are screened by: the physicians in different departments of the hospital, the liberal dermatologists and the general practicioners.
656932|NCT00802243|Phase I: Patients will be referred to the investigators of Dupuytren Hospital Dermatology Department.|phase i: patients will be referred to the investigators of dupuytren hospital dermatology department.
656933|NCT00802243|Phase II: Patients will be referred to the investigators of Purpan (Toulouse), Haut Leveque (Pessac) and Dupuytren (Limoges) Hospitals.|phase ii: patients will be referred to the investigators of purpan (toulouse), haut leveque (pessac) and dupuytren (limoges) hospitals.
656934|NCT00802217|Pharmacokinetics|pharmacokinetics
656935|NCT00802217|Safety|safety
656936|NCT00802217|Tolerability|tolerability
656937|NCT00802217|Healthy Volunteers|healthy volunteers
656938|NCT00802204|Obesity|obesity
656939|NCT00802204|Insulin Resistance|insulin resistance
656940|NCT00802204|Neuroendocrine regulation|neuroendocrine regulation
656941|NCT00802204|Eating behaviors|eating behaviors
656942|NCT00802204|Dopamine signaling|dopamine signaling
656943|NCT00802165|Asymptomatic normals|asymptomatic normals
656944|NCT00802152|Diabetes|diabetes
656945|NCT00802152|Hypertension|hypertension
656946|NCT00802139|iron deficiency anemia|iron deficiency anemia
656947|NCT00802139|pregnant women with iron deficiency anemia|pregnant women with iron deficiency anemia
656948|NCT00802113|Autologous Stem Cell Transplant|autologous stem cell transplant
656949|NCT00802113|Cord Blood Transplant|cord blood transplant
656950|NCT00802113|Allogeneic Stem Cell Transplant|allogeneic stem cell transplant
656951|NCT00802113|Relapsed Lymphoma|relapsed lymphoma
656952|NCT00802100|Schizoaffective Disorder|schizoaffective disorder
656953|NCT00802087|Hydrocodone|hydrocodone
656954|NCT00802087|Pharmacokinetics|pharmacokinetics
656955|NCT00802087|Safety & Tolerability|safety & tolerability
656956|NCT00802074|Healthy Subjects|healthy subjects
656957|NCT00802074|Pharmacokinetics study|pharmacokinetics study
656958|NCT00802074|Pharmacokinetics of medications|pharmacokinetics of medications
656959|NCT00802061|progressive glaucoma despite controlled IOP|progressive glaucoma despite controlled iop
656960|NCT00802048|Sternotomy|sternotomy
656961|NCT00802048|Postoperative hyperalgesia|postoperative hyperalgesia
656962|NCT00802048|Intralesional anesthetic infusion|intralesional anesthetic infusion
656963|NCT00802048|Ropivacaïne|ropivacaïne
656964|NCT00802048|Chronic|chronic
656965|NCT00802048|Postoperative pain|postoperative pain
656966|NCT00802048|Cardiac surgery|cardiac surgery
656967|NCT00802048|Sternum|sternum
656968|NCT00802048|Cardiac surgical procedures|cardiac surgical procedures
656969|NCT00802035|ALK29|alk29
656970|NCT00802035|Alcohol Dependence|alcohol dependence
656971|NCT00802035|Pharmacokinetics|pharmacokinetics
656972|NCT00802022|diabetic neuropathies|diabetic neuropathies
656973|NCT00802022|electric stimulation therapy|electric stimulation therapy
656974|NCT00802009|ultrasound-guided regional anesthesia|ultrasound-guided regional anesthesia
656975|NCT00802009|nerve block|nerve block
656976|NCT00802009|brachial plexus|brachial plexus
656977|NCT00802009|mepivicaine|mepivicaine
656978|NCT00802009|dexamethasone|dexamethasone
656979|NCT00802009|hand wrist surgery|hand wrist surgery
656980|NCT00802009|duration|duration
657082|NCT00801580|refractory ALL|refractory all
657529|NCT00799955|ultrasound|ultrasound
656981|NCT00802009|anesthetic duration following brachial plexus/nerve block for hand/wrist surgery|anesthetic duration following brachial plexus/nerve block for hand/wrist surgery
656982|NCT00801996|prostate cancer|prostate cancer
656983|NCT00801996|genetics|genetics
656984|NCT00801970|Fear of childbirth|fear of childbirth
656985|NCT00801970|Tokophobia|tokophobia
656986|NCT00801970|Anxiety|anxiety
656987|NCT00801970|Labor|labor
656988|NCT00801970|Pregnancy|pregnancy
656989|NCT00801970|Cognitive-behavioral|cognitive-behavioral
656990|NCT00801970|Psychoanalysis|psychoanalysis
656991|NCT00801970|Group Therapy|group therapy
656992|NCT00801970|etiology|etiology
656993|NCT00801957|atopic dermatitis|atopic dermatitis
656994|NCT00801957|meningitis|meningitis
656995|NCT00801957|vaccination|vaccination
656996|NCT00801957|tacrolimus|tacrolimus
656997|NCT00801957|steroids|steroids
656998|NCT00801957|equivalence response|equivalence response
656999|NCT00801957|meningococcal vaccine|meningococcal vaccine
657000|NCT00801944|Overactive Bladder|overactive bladder
657001|NCT00801931|Cord Blood Transplant|cord blood transplant
657002|NCT00801931|Allogeneic Stem Cell Transplant|allogeneic stem cell transplant
657003|NCT00801918|lymphoma|lymphoma
657004|NCT00801918|pediatric|pediatric
657005|NCT00801918|adolescent|adolescent
657006|NCT00801918|relapsed|relapsed
657007|NCT00801918|refractory|refractory
657008|NCT00801918|denileukin diftitox|denileukin diftitox
657009|NCT00801918|Ontak|ontak
657010|NCT00801905|Macular thickening|macular thickening
657011|NCT00801905|Macular edema|macular edema
711017|NCT00586846|Doxorubicin|doxorubicin
657012|NCT00801905|Pan-retinal photocoagulation|pan-retinal photocoagulation
657013|NCT00801905|Nepafenac|nepafenac
657014|NCT00801905|Topical non-steroidal anti inflammatory agents|topical non-steroidal anti inflammatory agents
657015|NCT00801892|daytime sleepiness|daytime sleepiness
657016|NCT00801892|obstructive sleep apnea|obstructive sleep apnea
657017|NCT00801892|type 2 diabetes mellitus|type 2 diabetes mellitus
657018|NCT00801892|diabetes management|diabetes management
657019|NCT00801879|mupirocin|mupirocin
657020|NCT00801879|Staphylococcus aureus|staphylococcus aureus
657021|NCT00801879|colonization|colonization
657022|NCT00801879|infection|infection
657023|NCT00801879|HIV|hiv
657024|NCT00801866|Panretinal Photocoagulation|panretinal photocoagulation
657025|NCT00801866|Macular Edema|macular edema
657026|NCT00801866|Intravitreal Bevacizumab|intravitreal bevacizumab
657027|NCT00801853|asthma|asthma
657028|NCT00801853|allergy|allergy
657029|NCT00801853|atopy|atopy
657030|NCT00801853|atopic|atopic
657031|NCT00801853|wheeze|wheeze
657032|NCT00801827|Obesity|obesity
657033|NCT00801827|Addiction|addiction
657034|NCT00801827|PET imaging|pet imaging
657035|NCT00801814|viscous|viscous
657036|NCT00801814|fibre|fibre
657037|NCT00801814|polysaccharide|polysaccharide
657038|NCT00801814|blood glucose|blood glucose
657039|NCT00801814|post prandial|post prandial
657040|NCT00801801|Docetaxel|docetaxel
657041|NCT00801801|Sorafenib|sorafenib
657042|NCT00801775|calorimetry|calorimetry
657043|NCT00801736|Recurrent non-small cell lung cancer|recurrent non-small cell lung cancer
657044|NCT00801736|Stage IIIB non-small cell lung cancer|stage iiib non-small cell lung cancer
657045|NCT00801736|Stage IV non-small cell lung cancer|stage iv non-small cell lung cancer
657046|NCT00801723|Ulcerative Colitis|ulcerative colitis
657047|NCT00801697|HIV Seronegativity|hiv seronegativity
657048|NCT00801697|HIV Preventive Vaccine|hiv preventive vaccine
657049|NCT00801697|Adenovirus|adenovirus
657050|NCT00801684|COPD|copd
657051|NCT00801684|pulmonary|pulmonary
657052|NCT00801684|inhalation|inhalation
657053|NCT00801671|obstructive sleep apnea|obstructive sleep apnea
657054|NCT00801671|obstructive sleep apnea syndrome|obstructive sleep apnea syndrome
657055|NCT00801671|hypertension|hypertension
657056|NCT00801671|systemic hypertension|systemic hypertension
657057|NCT00801671|ambulatory blood pressure monitoring|ambulatory blood pressure monitoring
657058|NCT00801658|glaucoma|glaucoma
657059|NCT00801658|SLT|slt
657060|NCT00801658|Laser treatment|laser treatment
657061|NCT00801658|IOP|iop
657062|NCT00801658|glaucoma treated with eye drops but IOP not controlled|glaucoma treated with eye drops but iop not controlled
657063|NCT00801645|Obesity|obesity
657064|NCT00801645|Cardiovascular disease|cardiovascular disease
657065|NCT00801645|Endothelial function|endothelial function
657066|NCT00801645|Blood pressure|blood pressure
657067|NCT00801645|Exercise|exercise
657068|NCT00801645|Physical activity|physical activity
657069|NCT00801645|Metabolic syndrome|metabolic syndrome
657070|NCT00801645|Children|children
657071|NCT00801645|Pediatric|pediatric
657072|NCT00801632|renal allograft tolerance|renal allograft tolerance
657073|NCT00801632|mixed chimerism|mixed chimerism
657074|NCT00801632|kidney transplant|kidney transplant
657075|NCT00801632|bone marrow transplant|bone marrow transplant
657076|NCT00801632|antirejection|antirejection
657077|NCT00801632|immunosuppression|immunosuppression
657078|NCT00801606|Micronutrient|micronutrient
657079|NCT00801606|Childhood Tuberculosis|childhood tuberculosis
657080|NCT00801593|JIA|jia
657081|NCT00801580|relapsed ALL|relapsed all
657083|NCT00801580|relapsed adult acute lymphoid leukemia|relapsed adult acute lymphoid leukemia
657084|NCT00801567|Bipolar disorder|bipolar disorder
657085|NCT00801567|Schizophrenia|schizophrenia
657086|NCT00801567|Healthy volunteer|healthy volunteer
657087|NCT00801567|Brain imaging|brain imaging
657088|NCT00801567|Photic stimulation|photic stimulation
657089|NCT00801554|Autism Spectrum Disorder|autism spectrum disorder
657090|NCT00801554|ASD|asd
657091|NCT00801554|Autism|autism
657092|NCT00801554|Asperger's Syndrome|asperger's syndrome
657093|NCT00801554|PDD-NOS|pdd-nos
657094|NCT00801554|Pervasive Developmental Disorders- Not Otherwise Specified|pervasive developmental disorders- not otherwise specified
657095|NCT00801554|Adults|adults
657096|NCT00801554|Children|children
657097|NCT00801541|AMD|amd
657098|NCT00801528|ropivacaine|ropivacaine
657099|NCT00801528|diclofenac|diclofenac
657100|NCT00801528|local anesthetic instillation|local anesthetic instillation
657101|NCT00801515|Compassionate|compassionate
657102|NCT00801515|HIV|hiv
657103|NCT00801515|CCR5|ccr5
657104|NCT00801502|Omega-3|omega-3
657105|NCT00801502|Oily fish|oily fish
657106|NCT00801502|Antioxidant|antioxidant
657107|NCT00801502|Selenium|selenium
657108|NCT00801502|Atopic disease|atopic disease
657109|NCT00801502|Pregnancy|pregnancy
657110|NCT00801502|Nutrient status|nutrient status
657111|NCT00801476|Breast Cancer|breast cancer
657112|NCT00801476|Magnetic Resonance Imaging|magnetic resonance imaging
657113|NCT00801476|Preoperative MRI|preoperative mri
657114|NCT00801463|Focal Segmental Glomerulosclerosis|focal segmental glomerulosclerosis
657115|NCT00801463|Prednisone|prednisone
657116|NCT00801463|Tripterygium Wilfordii|tripterygium wilfordii
657117|NCT00801450|diabetes|diabetes
657118|NCT00801450|macular edema|macular edema
657119|NCT00801450|triamcinolone|triamcinolone
657120|NCT00801450|cataract|cataract
657121|NCT00801450|refractory diabetic macular edema|refractory diabetic macular edema
657122|NCT00801437|glaucoma, open-angle, non-interventional study, safety, tolerability|glaucoma, open-angle, non-interventional study, safety, tolerability
657123|NCT00801424|abdominal surgery|abdominal surgery
657124|NCT00801424|hypothermia|hypothermia
657125|NCT00801424|wound dessication|wound dessication
657126|NCT00801424|warming|warming
657127|NCT00801411|stage II breast cancer|stage ii breast cancer
657128|NCT00801398|Opioid tolerant|opioid tolerant
657129|NCT00801398|Pediatric|pediatric
657130|NCT00801398|Pain|pain
657131|NCT00801398|Non malignant|non malignant
657132|NCT00801398|Malignant|malignant
657133|NCT00801385|recurrent non-small cell lung cancer|recurrent non-small cell lung cancer
657134|NCT00801385|stage IIIB non-small cell lung cancer|stage iiib non-small cell lung cancer
657135|NCT00801385|stage IV non-small cell lung cancer|stage iv non-small cell lung cancer
657136|NCT00801372|pregnant, healthy females older than 18 who signed an informed consent for the termination of the pregnancy.|pregnant, healthy females older than 18 who signed an informed consent for the termination of the pregnancy.
657137|NCT00801372|pregnant healthy couples older than 18 who signed an informed consent for a c-section.|pregnant healthy couples older than 18 who signed an informed consent for a c-section.
657138|NCT00801372|healthy male newborns, undergoing surgical circumcision who's parents older than 18 signed an informed consent.|healthy male newborns, undergoing surgical circumcision who's parents older than 18 signed an informed consent.
657139|NCT00801359|cataract|cataract
657140|NCT00801359|phacoemulsification|phacoemulsification
657141|NCT00801359|irrigation solution|irrigation solution
657142|NCT00801359|endothelial cell density|endothelial cell density
657143|NCT00801359|corneal thickness|corneal thickness
657144|NCT00801346|fatigue|fatigue
657145|NCT00801346|long-term effects secondary to cancer therapy in children|long-term effects secondary to cancer therapy in children
657146|NCT00801346|childhood acute lymphoblastic leukemia in remission|childhood acute lymphoblastic leukemia in remission
657147|NCT00801346|B-cell childhood acute lymphoblastic leukemia|b-cell childhood acute lymphoblastic leukemia
657148|NCT00801346|T-cell childhood acute lymphoblastic leukemia|t-cell childhood acute lymphoblastic leukemia
657149|NCT00801333|ALS|als
657150|NCT00801320|tumor harvest|tumor harvest
657151|NCT00801320|tumor collection|tumor collection
657152|NCT00801320|tumor storage|tumor storage
657153|NCT00801307|evaluate Inspiratory Capacity (IC) measured by spirometry|evaluate inspiratory capacity (ic) measured by spirometry
657154|NCT00801281|Lymphoma|lymphoma
657155|NCT00801281|Immunochemotherapy|immunochemotherapy
657156|NCT00801281|Induction therapy|induction therapy
657157|NCT00801281|Maintenance therapy|maintenance therapy
657158|NCT00801281|Follicular lymphoma grade 1,2,3a|follicular lymphoma grade 1,2,3a
657159|NCT00801281|Marginal zone lymphoma, including MALT type|marginal zone lymphoma, including malt type
657160|NCT00801281|Small lymphocytic lymphoma (BM inv. <30%)|small lymphocytic lymphoma (bm inv. <30%)
657161|NCT00801268|polycystic kidney disease|polycystic kidney disease
657162|NCT00801268|tripterygium wilfordii|tripterygium wilfordii
657163|NCT00801229|ADHD|adhd
657164|NCT00801229|young adults|young adults
657165|NCT00801229|driving|driving
657166|NCT00801229|Vyvanse|vyvanse
657167|NCT00801229|lisdexamfetamine|lisdexamfetamine
657168|NCT00801216|B-cell lymphomas|b-cell lymphomas
657169|NCT00801216|lymphomatous meningitis|lymphomatous meningitis
657170|NCT00801216|liposomal cytarabine|liposomal cytarabine
657171|NCT00801216|autologous transplant|autologous transplant
657172|NCT00801216|CNS involvement|cns involvement
657173|NCT00801216|Secondary CNS lymphomas|secondary cns lymphomas
657174|NCT00801203|Stress Urinary Incontinence|stress urinary incontinence
657175|NCT00801190|colloid|colloid
657176|NCT00801190|CABG|cabg
657177|NCT00801190|cardiopulmonary bypass|cardiopulmonary bypass
657178|NCT00801190|bleeding|bleeding
657179|NCT00801177|Tumors|tumors
657180|NCT00801177|Antibodies, Monoclonal|antibodies, monoclonal
657181|NCT00801164|Diabetes Type 2|diabetes type 2
657182|NCT00801164|Periodontitis|periodontitis
657183|NCT00801138|ropivacaine|ropivacaine
657184|NCT00801138|bupivacaine|bupivacaine
657185|NCT00801138|glucocorticoid|glucocorticoid
657186|NCT00801112|Bioimpedance|bioimpedance
657187|NCT00801112|Fluid status|fluid status
657188|NCT00801112|Peritoneal Dialysis|peritoneal dialysis
657189|NCT00801112|Extra-cellular fluid volume|extra-cellular fluid volume
657190|NCT00801099|Postoperative wound infection|postoperative wound infection
657191|NCT00801099|surgical site infection|surgical site infection
657192|NCT00801099|antimicrobial prophylaxis|antimicrobial prophylaxis
657193|NCT00801099|developing countries|developing countries
657194|NCT00801099|Sub-Saharan Africa|sub-saharan africa
657195|NCT00801099|reduction of SSI using preoperative antibiotics|reduction of ssi using preoperative antibiotics
657196|NCT00801086|Alopecia|alopecia
657197|NCT00801086|Hair loss|hair loss
657198|NCT00801086|Radiation|radiation
657199|NCT00801086|Whole brain radiotherapy|whole brain radiotherapy
657200|NCT00801086|Radiation-induced alopecia|radiation-induced alopecia
657201|NCT00801073|Amniotic membrane|amniotic membrane
657202|NCT00801073|Cornea|cornea
657203|NCT00801073|Scleral thinning|scleral thinning
657204|NCT00801060|Fludara|fludara
657205|NCT00801060|CD23|cd23
657206|NCT00801060|Cyclophosphamide|cyclophosphamide
657207|NCT00801060|Antibody|antibody
657208|NCT00801060|Fludarabine|fludarabine
657209|NCT00801060|CLL|cll
657210|NCT00801060|Rituximab|rituximab
657211|NCT00801060|Mabthera|mabthera
657212|NCT00801060|Biogen Idec|biogen idec
657213|NCT00801060|Lumiliximab|lumiliximab
657214|NCT00801060|Rituxan|rituxan
657215|NCT00801060|Cytoxan|cytoxan
657216|NCT00801060|Chronic Lymphocytic Leukemia|chronic lymphocytic leukemia
657217|NCT00801047|Epidural|epidural
657218|NCT00801047|Labor|labor
657219|NCT00801047|Remifentanil|remifentanil
657220|NCT00801034|hypertension|hypertension
657221|NCT00801034|potassium|potassium
657222|NCT00801034|blood pressure|blood pressure
657223|NCT00801021|Cystitis|cystitis
657224|NCT00801021|Urinary Tract Infections|urinary tract infections
657225|NCT00801008|young adult|young adult
657226|NCT00801008|cancer|cancer
657227|NCT00801008|exercise|exercise
657228|NCT00801008|relaxation|relaxation
657229|NCT00800995|ARMD|armd
657230|NCT00800995|SOD|sod
657231|NCT00800982|Obese patients (BMI>30)|obese patients (bmi>30)
657232|NCT00800982|Patients with moderate to severe psoriasis|patients with moderate to severe psoriasis
657233|NCT00800969|Adenocarcinoma of the stomach and esophagogastric junction|adenocarcinoma of the stomach and esophagogastric junction
657234|NCT00800956|Radiolabel ADME study Healthy volunteers|radiolabel adme study healthy volunteers
657235|NCT00800943|Leukemia|leukemia
657236|NCT00800943|Chronic|chronic
657237|NCT00800943|Chronic Lymphocytic Leukemia|chronic lymphocytic leukemia
657238|NCT00800943|CAMPATH|campath
657239|NCT00800943|Alemtuzumab|alemtuzumab
657240|NCT00800943|MabCampath|mabcampath
657241|NCT00800943|Subcutaneous|subcutaneous
657242|NCT00800943|CLL|cll
657243|NCT00800943|C-CLL|c-cll
657244|NCT00800943|Residual|residual
657245|NCT00800930|Shigellosis|shigellosis
657246|NCT00800930|sodium butyrate|sodium butyrate
657247|NCT00800930|antimicrobial peptides|antimicrobial peptides
657248|NCT00800930|LL-37|ll-37
657249|NCT00800930|innate immunity|innate immunity
657250|NCT00800930|The aims are to assess efficacy of sodium butyrate enema in|the aims are to assess efficacy of sodium butyrate enema in
657251|NCT00800930|marked improvement in clinical features|marked improvement in clinical features
657252|NCT00800930|endoscopic findings|endoscopic findings
657253|NCT00800930|histological features|histological features
657254|NCT00800930|Induction of LL-37 in the rectum.|induction of ll-37 in the rectum.
657255|NCT00800904|Asthma|asthma
657256|NCT00800904|Inhaled corticosteroid|inhaled corticosteroid
657257|NCT00800904|Thai patient eligibility|thai patient eligibility
657258|NCT00800904|Persistent asthma|persistent asthma
657259|NCT00800878|Chronic Kidney Disease|chronic kidney disease
657260|NCT00800878|Renal insufficiency|renal insufficiency
657261|NCT00800852|adiponectin|adiponectin
657262|NCT00800852|adiponectin receptor|adiponectin receptor
657263|NCT00800852|Prader-Willi syndrome|prader-willi syndrome
657264|NCT00800839|Post-allogeneic transplantation|post-allogeneic transplantation
657265|NCT00800839|Graft-versus-Host Disease Prophylaxis|graft-versus-host disease prophylaxis
657266|NCT00800839|Graft-versus-Host Disease|graft-versus-host disease
657267|NCT00800839|GVHD|gvhd
657268|NCT00800839|Hematologic malignancies|hematologic malignancies
657269|NCT00800839|Leukemia|leukemia
657270|NCT00800839|Lymphoma|lymphoma
657272|NCT00800839|Human Leukocyte Antigen|human leukocyte antigen
657273|NCT00800839|HLA|hla
657274|NCT00800839|Busulfan|busulfan
657275|NCT00800839|Cyclophosphamide|cyclophosphamide
657276|NCT00800839|Fludarabine|fludarabine
657277|NCT00800839|Mesna|mesna
657278|NCT00800839|Cytoxan®|cytoxan®
657279|NCT00800839|Neosar®|neosar®
657280|NCT00800839|Busulfex|busulfex
657281|NCT00800839|Myleran®|myleran®
657282|NCT00800839|Fludarabine Phosphate|fludarabine phosphate
657283|NCT00800813|Prostate|prostate
657284|NCT00800813|Erectile function|erectile function
657285|NCT00800813|Peyronie's Plaque|peyronie's plaque
657286|NCT00800813|08-135|08-135
657287|NCT00800800|progression of aortic stenosis|progression of aortic stenosis
657288|NCT00800787|Chronic hepatitis B liver disease|chronic hepatitis b liver disease
657289|NCT00800774|LASIK|lasik
657290|NCT00800774|safety|safety
657291|NCT00800774|efficacy|efficacy
657292|NCT00800774|stability|stability
657293|NCT00800774|high anisometropia|high anisometropia
657294|NCT00800774|patients 8 to 15 years old|patients 8 to 15 years old
657295|NCT00800774|conventional treatments have failed|conventional treatments have failed
657296|NCT00800722|hypervascular anomalies|hypervascular anomalies
657297|NCT00800709|Alzheimer's Disease|alzheimer's disease
657298|NCT00800709|tau protein|tau protein
657299|NCT00800709|PET|pet
657300|NCT00800709|Memantine|memantine
657301|NCT00800696|antibiotics|antibiotics
657302|NCT00800696|Hospitalization|hospitalization
657303|NCT00800696|oral care|oral care
657304|NCT00800670|tuberculosis|tuberculosis
657305|NCT00800670|vaccine|vaccine
657306|NCT00800670|adenovirus|adenovirus
657307|NCT00800657|Cardiac Resynchronization|cardiac resynchronization
657308|NCT00800657|Dilated Cardiomyopathy|dilated cardiomyopathy
657309|NCT00800657|Stem Cells Therapy|stem cells therapy
657310|NCT00800657|Heart Failure|heart failure
657311|NCT00800657|Stem Cells/Cardiac Pacing, Artificial|stem cells/cardiac pacing, artificial
657312|NCT00800644|Cervical Cancer|cervical cancer
657313|NCT00800644|Endometrial Cancer|endometrial cancer
657314|NCT00800644|Vaginal Cancer|vaginal cancer
657315|NCT00800644|Cervix|cervix
657316|NCT00800644|Endometrial|endometrial
657317|NCT00800644|X-ray|x-ray
657318|NCT00800644|Computed tomography|computed tomography
657319|NCT00800644|Magnetic resonance imaging|magnetic resonance imaging
657320|NCT00800644|Vagina|vagina
657321|NCT00800644|Pelvic radiation therapy|pelvic radiation therapy
657322|NCT00800644|Bone density|bone density
657323|NCT00800644|Bone mineral density test|bone mineral density test
657324|NCT00800644|Pelvic fractures|pelvic fractures
657325|NCT00800644|Gynecologic Oncology|gynecologic oncology
657326|NCT00800644|Bone turnover|bone turnover
657327|NCT00800592|Sildenafil, Revatio, PAH, IV, Bolus|sildenafil, revatio, pah, iv, bolus
657328|NCT00800579|cystic fibrosis|cystic fibrosis
657329|NCT00800579|CF|cf
657330|NCT00800579|mucociliary clearance|mucociliary clearance
657331|NCT00800579|amiloride|amiloride
657332|NCT00800579|ENaC|enac
657333|NCT00800579|ENaC Inhibitor|enac inhibitor
657334|NCT00800579|airway hydration|airway hydration
657335|NCT00800579|epithelial sodium channel inhibitor|epithelial sodium channel inhibitor
657336|NCT00800566|Clofarabine|clofarabine
657337|NCT00800566|Leukemia|leukemia
657338|NCT00800566|Chronic Lymphocytic Leukemia|chronic lymphocytic leukemia
657339|NCT00800553|sleep deprivation|sleep deprivation
657340|NCT00800553|fMRI|fmri
657341|NCT00800553|double blind crossover study|double blind crossover study
657342|NCT00800540|glaucoma|glaucoma
657343|NCT00800540|ocular perfusion pressure|ocular perfusion pressure
657344|NCT00800540|ocular blood flow|ocular blood flow
657345|NCT00800540|open angle glaucoma requiring more than one IOP-lowering medication|open angle glaucoma requiring more than one iop-lowering medication
657346|NCT00800527|sternotomy|sternotomy
657347|NCT00800527|pain|pain
657348|NCT00800527|paresthesia|paresthesia
657573|NCT00799825|HPV|hpv
657349|NCT00800527|Poststernotomy chest pain|poststernotomy chest pain
657350|NCT00800527|Poststernotomy chest paresthesia|poststernotomy chest paresthesia
657351|NCT00800514|perception of time, traumatic brain injury, amantadine|perception of time, traumatic brain injury, amantadine
657352|NCT00800501|ALS|als
657353|NCT00800501|VEGF165|vegf165
657354|NCT00800501|Safety|safety
657355|NCT00800501|Intracerebroventricular|intracerebroventricular
657356|NCT00800501|Infusion|infusion
657357|NCT00800501|Implantable|implantable
657358|NCT00800488|Fever|fever
657359|NCT00800488|Infant|infant
657360|NCT00800488|Procalcitonin|procalcitonin
657361|NCT00800488|Serious Bacterial Infection|serious bacterial infection
657362|NCT00800475|bioavailability|bioavailability
657363|NCT00800475|Gemfibrozil|gemfibrozil
657364|NCT00800449|Haptoglobin|haptoglobin
657365|NCT00800449|sepsis|sepsis
657366|NCT00800449|premature babies|premature babies
657367|NCT00800423|corneal edema|corneal edema
657368|NCT00800423|postoperative corneal edema|postoperative corneal edema
657369|NCT00800423|central corneal thickness|central corneal thickness
657370|NCT00800423|visual acuity|visual acuity
657371|NCT00800423|postoperative|postoperative
657372|NCT00800423|brimonidine|brimonidine
657374|NCT00800423|cataract surgery|cataract surgery
657375|NCT00800410|Randomized Controlled Trial|randomized controlled trial
657376|NCT00800371|JIA|jia
657377|NCT00800358|Secondary hyperparathyroidism|secondary hyperparathyroidism
657378|NCT00800358|End stage renal disease|end stage renal disease
657379|NCT00800358|Haemodialysis|haemodialysis
657380|NCT00800358|Peritoneal dialysis|peritoneal dialysis
657381|NCT00800358|Paricalcitol (Zemplar)|paricalcitol (zemplar)
657382|NCT00800358|Calcitriol|calcitriol
657383|NCT00800345|Gynecologic tumors|gynecologic tumors
657384|NCT00800332|Rhinoconjunctivitis due to house dust mite allergy|rhinoconjunctivitis due to house dust mite allergy
657385|NCT00800319|Alcohol dependence|alcohol dependence
657386|NCT00800319|Opioid antagonist|opioid antagonist
657387|NCT00800319|RDC-0313|rdc-0313
657388|NCT00800306|sepsis|sepsis
657389|NCT00800306|septic shock|septic shock
657390|NCT00800306|microcirculation|microcirculation
657391|NCT00800306|levosimendan|levosimendan
657392|NCT00800306|dobutamine|dobutamine
657393|NCT00800306|inotropes|inotropes
657394|NCT00800306|inhaled nitric oxide|inhaled nitric oxide
657395|NCT00800293|bioequivalence|bioequivalence
657396|NCT00800293|betamethasone dipropionate|betamethasone dipropionate
657397|NCT00800293|Bioequivalency|bioequivalency
657398|NCT00800280|cimetidine, PD 0332334, organic cation transporter, OCT2, pharmacokinetics|cimetidine, pd 0332334, organic cation transporter, oct2, pharmacokinetics
657399|NCT00800267|glaucoma|glaucoma
837799|NCT00090558|CAD|cad
657400|NCT00800267|ocular hypertension|ocular hypertension
657401|NCT00800267|Fixed combination latanoprost-timolol|fixed combination latanoprost-timolol
657402|NCT00800267|latanoprost|latanoprost
657403|NCT00800267|timolol|timolol
657404|NCT00800254|electrical stimulation|electrical stimulation
657405|NCT00800254|total knee arthroplasty|total knee arthroplasty
657406|NCT00800254|quadriceps|quadriceps
657407|NCT00800254|muscle|muscle
657408|NCT00800254|arthroscopy|arthroscopy
657409|NCT00800241|Asthma|asthma
657410|NCT00800241|Symbicort SMART|symbicort smart
657411|NCT00800241|Thai patient eligibility|thai patient eligibility
657412|NCT00800241|Persistent asthma|persistent asthma
657413|NCT00800228|salt|salt
657414|NCT00800228|blood pressure|blood pressure
657415|NCT00800228|breathing|breathing
657416|NCT00800215|Epilepsy|epilepsy
657417|NCT00800150|adult acute myeloid leukemia with 11q23 (MLL) abnormalities|adult acute myeloid leukemia with 11q23 (mll) abnormalities
657418|NCT00800150|adult acute myeloid leukemia with inv(16)(p13;q22)|adult acute myeloid leukemia with inv(16)(p13;q22)
657419|NCT00800150|adult acute myeloid leukemia with t(15;17)(q22;q12)|adult acute myeloid leukemia with t(15;17)(q22;q12)
657420|NCT00800150|adult acute myeloid leukemia with t(16;16)(p13;q22)|adult acute myeloid leukemia with t(16;16)(p13;q22)
657421|NCT00800150|adult acute myeloid leukemia with t(8;21)(q22;q22)|adult acute myeloid leukemia with t(8;21)(q22;q22)
657422|NCT00800150|recurrent adult acute lymphoblastic leukemia|recurrent adult acute lymphoblastic leukemia
657423|NCT00800150|recurrent adult acute myeloid leukemia|recurrent adult acute myeloid leukemia
657424|NCT00800150|recurrent adult T-cell leukemia/lymphoma|recurrent adult t-cell leukemia/lymphoma
657425|NCT00800150|secondary acute myeloid leukemia|secondary acute myeloid leukemia
657426|NCT00800150|stage III adult T-cell leukemia/lymphoma|stage iii adult t-cell leukemia/lymphoma
657427|NCT00800150|stage IV adult T-cell leukemia/lymphoma|stage iv adult t-cell leukemia/lymphoma
657428|NCT00800150|adult grade III lymphomatoid granulomatosis|adult grade iii lymphomatoid granulomatosis
657429|NCT00800150|adult nasal type extranodal NK/T-cell lymphoma|adult nasal type extranodal nk/t-cell lymphoma
657430|NCT00800150|anaplastic large cell lymphoma|anaplastic large cell lymphoma
657431|NCT00800150|angioimmunoblastic T-cell lymphoma|angioimmunoblastic t-cell lymphoma
657432|NCT00800150|splenic marginal zone lymphoma|splenic marginal zone lymphoma
657433|NCT00800150|extranodal marginal zone B-cell lymphoma of mucosa-associated lymphoid tissue|extranodal marginal zone b-cell lymphoma of mucosa-associated lymphoid tissue
657434|NCT00800150|nodal marginal zone B-cell lymphoma|nodal marginal zone b-cell lymphoma
657435|NCT00800150|stage III adult Burkitt lymphoma|stage iii adult burkitt lymphoma
657436|NCT00800150|stage III adult diffuse large cell lymphoma|stage iii adult diffuse large cell lymphoma
657437|NCT00800150|stage III adult diffuse mixed cell lymphoma|stage iii adult diffuse mixed cell lymphoma
657438|NCT00800150|stage III adult diffuse small cleaved cell lymphoma|stage iii adult diffuse small cleaved cell lymphoma
657439|NCT00800150|stage III adult immunoblastic large cell lymphoma|stage iii adult immunoblastic large cell lymphoma
657440|NCT00800150|stage III adult lymphoblastic lymphoma|stage iii adult lymphoblastic lymphoma
657441|NCT00800150|stage III cutaneous T-cell non-Hodgkin lymphoma|stage iii cutaneous t-cell non-hodgkin lymphoma
657442|NCT00800150|stage III mycosis fungoides/Sezary syndrome|stage iii mycosis fungoides/sezary syndrome
657443|NCT00800150|stage III grade 1 follicular lymphoma|stage iii grade 1 follicular lymphoma
657444|NCT00800150|stage III grade 2 follicular lymphoma|stage iii grade 2 follicular lymphoma
657445|NCT00800150|stage III grade 3 follicular lymphoma|stage iii grade 3 follicular lymphoma
657446|NCT00800150|stage III mantle cell lymphoma|stage iii mantle cell lymphoma
657447|NCT00800150|stage III marginal zone lymphoma|stage iii marginal zone lymphoma
657448|NCT00800150|stage III small lymphocytic lymphoma|stage iii small lymphocytic lymphoma
657449|NCT00800150|stage IV adult Burkitt lymphoma|stage iv adult burkitt lymphoma
657450|NCT00800150|stage IV adult diffuse large cell lymphoma|stage iv adult diffuse large cell lymphoma
657631|NCT00799669|laryngeal cancer|laryngeal cancer
657451|NCT00800150|stage IV adult diffuse mixed cell lymphoma|stage iv adult diffuse mixed cell lymphoma
657452|NCT00800150|stage IV adult diffuse small cleaved cell lymphoma|stage iv adult diffuse small cleaved cell lymphoma
657453|NCT00800150|stage IV adult immunoblastic large cell lymphoma|stage iv adult immunoblastic large cell lymphoma
657454|NCT00800150|stage IV adult lymphoblastic lymphoma|stage iv adult lymphoblastic lymphoma
657455|NCT00800150|stage IV cutaneous T-cell non-Hodgkin lymphoma|stage iv cutaneous t-cell non-hodgkin lymphoma
657456|NCT00800150|stage IV mycosis fungoides/Sezary syndrome|stage iv mycosis fungoides/sezary syndrome
657457|NCT00800150|stage IV grade 1 follicular lymphoma|stage iv grade 1 follicular lymphoma
657458|NCT00800150|stage IV grade 2 follicular lymphoma|stage iv grade 2 follicular lymphoma
657459|NCT00800150|stage IV grade 3 follicular lymphoma|stage iv grade 3 follicular lymphoma
657460|NCT00800150|stage IV mantle cell lymphoma|stage iv mantle cell lymphoma
657461|NCT00800150|stage IV marginal zone lymphoma|stage iv marginal zone lymphoma
657462|NCT00800150|stage IV small lymphocytic lymphoma|stage iv small lymphocytic lymphoma
657463|NCT00800150|recurrent adult Burkitt lymphoma|recurrent adult burkitt lymphoma
657464|NCT00800150|recurrent adult diffuse large cell lymphoma|recurrent adult diffuse large cell lymphoma
657465|NCT00800150|recurrent adult diffuse mixed cell lymphoma|recurrent adult diffuse mixed cell lymphoma
710345|NCT00589563|stage IV adult Burkitt lymphoma|stage iv adult burkitt lymphoma
657466|NCT00800150|recurrent adult diffuse small cleaved cell lymphoma|recurrent adult diffuse small cleaved cell lymphoma
657467|NCT00800150|recurrent adult grade III lymphomatoid granulomatosis|recurrent adult grade iii lymphomatoid granulomatosis
657468|NCT00800150|recurrent adult immunoblastic large cell lymphoma|recurrent adult immunoblastic large cell lymphoma
657469|NCT00800150|recurrent adult lymphoblastic lymphoma|recurrent adult lymphoblastic lymphoma
657470|NCT00800150|recurrent cutaneous T-cell non-Hodgkin lymphoma|recurrent cutaneous t-cell non-hodgkin lymphoma
657471|NCT00800150|recurrent mycosis fungoides/Sezary syndrome|recurrent mycosis fungoides/sezary syndrome
657472|NCT00800150|recurrent grade 1 follicular lymphoma|recurrent grade 1 follicular lymphoma
657473|NCT00800150|recurrent grade 2 follicular lymphoma|recurrent grade 2 follicular lymphoma
657474|NCT00800150|recurrent grade 3 follicular lymphoma|recurrent grade 3 follicular lymphoma
657475|NCT00800150|recurrent mantle cell lymphoma|recurrent mantle cell lymphoma
657476|NCT00800150|recurrent marginal zone lymphoma|recurrent marginal zone lymphoma
657477|NCT00800150|recurrent small lymphocytic lymphoma|recurrent small lymphocytic lymphoma
657478|NCT00800150|intraocular lymphoma|intraocular lymphoma
657479|NCT00800150|primary central nervous system non-Hodgkin lymphoma|primary central nervous system non-hodgkin lymphoma
657480|NCT00800150|primary myelofibrosis|primary myelofibrosis
657481|NCT00800150|stage II multiple myeloma|stage ii multiple myeloma
657482|NCT00800150|stage III multiple myeloma|stage iii multiple myeloma
657483|NCT00800150|refractory multiple myeloma|refractory multiple myeloma
657484|NCT00800150|de novo myelodysplastic syndromes|de novo myelodysplastic syndromes
657485|NCT00800150|previously treated myelodysplastic syndromes|previously treated myelodysplastic syndromes
657486|NCT00800150|secondary myelodysplastic syndromes|secondary myelodysplastic syndromes
657487|NCT00800150|myelodysplastic/myeloproliferative neoplasm, unclassifiable|myelodysplastic/myeloproliferative neoplasm, unclassifiable
657488|NCT00800150|cutaneous B-cell non-Hodgkin lymphoma|cutaneous b-cell non-hodgkin lymphoma
657489|NCT00800150|Waldenstrom macroglobulinemia|waldenstrom macroglobulinemia
657490|NCT00800137|coumadin|coumadin
657491|NCT00800137|device surgery|device surgery
657492|NCT00800137|pocket hematoma|pocket hematoma
657493|NCT00800137|Pocket hematoma and device surgery|pocket hematoma and device surgery
657494|NCT00800124|hip fracture|hip fracture
657495|NCT00800124|hemiprosthesis|hemiprosthesis
657496|NCT00800124|bone cement|bone cement
657497|NCT00800124|clinical outcome|clinical outcome
657498|NCT00800111|failed penetrating keratoplasty|failed penetrating keratoplasty
657499|NCT00800085|first degree relatives of type 1 diabetes patients|first degree relatives of type 1 diabetes patients
657500|NCT00800085|hyperglycemic clamp test|hyperglycemic clamp test
657501|NCT00800072|to verify accurrancy of data collected by the NOWOX|to verify accurrancy of data collected by the nowox
657502|NCT00800059|Relapse|relapse
657503|NCT00800059|Refractory|refractory
657504|NCT00800046|Mitral valve|mitral valve
657505|NCT00800046|Mitral regurgitation|mitral regurgitation
657506|NCT00800046|Functional mitral regurgitation|functional mitral regurgitation
657507|NCT00800046|MR|mr
657508|NCT00800046|FMR|fmr
657509|NCT00800046|Heart valve|heart valve
657510|NCT00800046|Mitral valve insufficiency|mitral valve insufficiency
657511|NCT00800046|Valve repair|valve repair
657512|NCT00800046|Valve disorder|valve disorder
657513|NCT00800046|Cardiac surgery|cardiac surgery
657514|NCT00800033|metabolic syndrome|metabolic syndrome
657515|NCT00800033|lipids|lipids
657516|NCT00800033|blood pressure|blood pressure
657517|NCT00800033|body composition|body composition
657518|NCT00800007|Hepatitis C, HCV, ANZ-521, Listeria|hepatitis c, hcv, anz-521, listeria
657519|NCT00799994|glaucoma|glaucoma
657520|NCT00799994|intraocular pressure|intraocular pressure
657521|NCT00799994|multifocal visually evoked potentials|multifocal visually evoked potentials
657522|NCT00799968|Thrombolytic therapy|thrombolytic therapy
657523|NCT00799968|Urokinase|urokinase
657524|NCT00799968|Efficacy|efficacy
657525|NCT00799968|Safety|safety
657526|NCT00799955|Cesarean delivery|cesarean delivery
657527|NCT00799955|post-operative analgesia|post-operative analgesia
657528|NCT00799955|TAP block|tap block
657530|NCT00799942|Nystagmus, congenital idiopathic|nystagmus, congenital idiopathic
657531|NCT00799929|IVF Research Study|ivf research study
657532|NCT00799929|Infertility Sudy|infertility sudy
657533|NCT00799929|in vitro fertilization|in vitro fertilization
657534|NCT00799929|Mini IVF|mini ivf
657535|NCT00799929|Conventional IVF|conventional ivf
657536|NCT00799916|Sepsis|sepsis
657537|NCT00799916|Fluid resuscitation|fluid resuscitation
657538|NCT00799916|Voluven|voluven
657539|NCT00799916|Colloids|colloids
657540|NCT00799916|Saline solution|saline solution
657541|NCT00799916|Crystalloids|crystalloids
657542|NCT00799916|Sublingual microcirculation|sublingual microcirculation
657543|NCT00799903|heart disease|heart disease
657544|NCT00799903|Lp-PLA2 inhibitor|lp-pla2 inhibitor
657545|NCT00799903|cardiovascular disease|cardiovascular disease
657546|NCT00799903|coronary heart disease|coronary heart disease
657547|NCT00799903|CV risk|cv risk
657548|NCT00799903|Atherosclerosis|atherosclerosis
657549|NCT00799890|primary or secondary chronic-progressive|primary or secondary chronic-progressive
657550|NCT00799890|sunphenon egcg|sunphenon egcg
657551|NCT00799890|brain atrophy|brain atrophy
657552|NCT00799890|T2 lesions|t2 lesions
657553|NCT00799877|Psoriasis|psoriasis
657554|NCT00799877|Moderate Psoriasis|moderate psoriasis
657555|NCT00799877|Severe Psoriasis|severe psoriasis
657556|NCT00799877|Chronic Plaque Psoriasis|chronic plaque psoriasis
657557|NCT00799877|Severe Chronic Plaque Psoriasis|severe chronic plaque psoriasis
657558|NCT00799877|Registry|registry
657559|NCT00799864|HIV Infection|hiv infection
657560|NCT00799864|Antiretroviral|antiretroviral
657561|NCT00799864|HIV-1|hiv-1
657562|NCT00799864|AIDS|aids
657563|NCT00799864|Children|children
657564|NCT00799864|Rilpivirine (TMC278)|rilpivirine (tmc278)
657565|NCT00799864|Pediatric|pediatric
657566|NCT00799851|advanced liver disease|advanced liver disease
657567|NCT00799851|esophageal varices|esophageal varices
657568|NCT00799851|band ligation|band ligation
657569|NCT00799851|cyanoacrylate injection|cyanoacrylate injection
657570|NCT00799825|papillomavirus|papillomavirus
657571|NCT00799825|HPV vaccine|hpv vaccine
657572|NCT00799825|cervical cancer|cervical cancer
657574|NCT00799825|human papillomavirus|human papillomavirus
657575|NCT00799812|antimicrobial|antimicrobial
657576|NCT00799812|antisepsis|antisepsis
657577|NCT00799799|Nk cells infusion|nk cells infusion
657578|NCT00799799|minimal residual disease in AML patients|minimal residual disease in aml patients
657579|NCT00799799|trafficking of NK cells after infusion|trafficking of nk cells after infusion
657580|NCT00799799|cytolytic effects on leukemic cells|cytolytic effects on leukemic cells
657582|NCT00799773|Rituximab|rituximab
657583|NCT00799773|Plasma Exchange|plasma exchange
657584|NCT00799760|influenza A|influenza a
657585|NCT00799760|neuraminidase inhibitor|neuraminidase inhibitor
657586|NCT00799760|oseltamivir|oseltamivir
657587|NCT00799760|zanamivir|zanamivir
657588|NCT00799760|treatment outcome|treatment outcome
657589|NCT00799760|resistance|resistance
657590|NCT00799760|mutation|mutation
657591|NCT00799760|combination therapy|combination therapy
657592|NCT00799760|monotherapy|monotherapy
657593|NCT00799760|pandemic|pandemic
657594|NCT00799760|primary care|primary care
657595|NCT00799760|randomized controlled trials|randomized controlled trials
657596|NCT00799760|antiviral agent|antiviral agent
657597|NCT00799747|safety|safety
657598|NCT00799747|tolerability|tolerability
657599|NCT00799747|pharmacokinetics|pharmacokinetics
657600|NCT00799747|AZD4017Japanese|azd4017japanese
657601|NCT00799734|hot flushes|hot flushes
657602|NCT00799734|night sweats|night sweats
657603|NCT00799734|menopausal symptoms|menopausal symptoms
657604|NCT00799734|osteoporosis|osteoporosis
657605|NCT00799734|complementary and alternative medicine|complementary and alternative medicine
657606|NCT00799721|ROP|rop
657607|NCT00799721|VLBW|vlbw
657608|NCT00799721|Epo|epo
657609|NCT00799721|IUGR|iugr
657610|NCT00799721|VEGF|vegf
657611|NCT00799721|sFLT-1|sflt-1
657612|NCT00799721|very low birth weight infants|very low birth weight infants
657613|NCT00799721|retinopathy of prematurity|retinopathy of prematurity
657614|NCT00799721|erythropoietin therapy and risk of ROP|erythropoietin therapy and risk of rop
657615|NCT00799708|Biomarkers of estrogen receptor beta activation|biomarkers of estrogen receptor beta activation
657616|NCT00799695|diabetic retinopathy|diabetic retinopathy
657617|NCT00799695|screening|screening
657618|NCT00799695|annual|annual
657619|NCT00799682|Dry Eye|dry eye
657620|NCT00799682|Monotherapy for Ocular Hypertension, Glaucoma|monotherapy for ocular hypertension, glaucoma
657621|NCT00799682|Ocular Hypertension|ocular hypertension
657622|NCT00799682|Chronic Open-Angle Glaucoma|chronic open-angle glaucoma
657623|NCT00799682|Chronic Angle-Closure Glaucoma|chronic angle-closure glaucoma
657624|NCT00799682|Iridotomy|iridotomy
657625|NCT00799682|Iridectomy|iridectomy
657626|NCT00799682|Pseudo Exfoliate|pseudo exfoliate
657627|NCT00799682|Pigmentary Glaucoma|pigmentary glaucoma
657628|NCT00799682|Systemic Non-Glaucoma Medications|systemic non-glaucoma medications
657629|NCT00799682|Hyperemia|hyperemia
657630|NCT00799669|hypopharyngeal cancer|hypopharyngeal cancer
657632|NCT00799669|lip and oral cavity cancer|lip and oral cavity cancer
657633|NCT00799669|nasopharyngeal cancer|nasopharyngeal cancer
657634|NCT00799669|oropharyngeal cancer|oropharyngeal cancer
657635|NCT00799669|paranasal sinus and nasal cavity cancer|paranasal sinus and nasal cavity cancer
657636|NCT00799669|tobacco use disorder|tobacco use disorder
657637|NCT00799656|Diabetic neuropathy|diabetic neuropathy
657638|NCT00799656|painful pain|painful pain
657639|NCT00799656|postoperative|postoperative
657640|NCT00799643|Type 2 Diabetes Mellitus (T2D)|type 2 diabetes mellitus (t2d)
657641|NCT00799643|Inflammation|inflammation
657642|NCT00799643|Obesity|obesity
657643|NCT00799643|Metabolic Syndrome|metabolic syndrome
657644|NCT00799643|Salicylates|salicylates
657645|NCT00799630|energy drink|energy drink
657646|NCT00799630|exercise|exercise
657647|NCT00799630|BCAA|bcaa
657648|NCT00799630|peripheral and central fatigue|peripheral and central fatigue
657649|NCT00799617|Testosterone|testosterone
657650|NCT00799617|Mobility disability|mobility disability
657651|NCT00799617|Decreased libido|decreased libido
657652|NCT00799617|Age associated memory impairment|age associated memory impairment
657653|NCT00799617|Low vitality|low vitality
657654|NCT00799617|Anemia|anemia
657655|NCT00799604|Hypertension|hypertension
657656|NCT00799604|Antihypertensive Agent|antihypertensive agent
657657|NCT00799604|Calcium Channel Blocker|calcium channel blocker
657658|NCT00799591|Registre MONTRAVERS|registre montravers
657659|NCT00799578|NASH, NAFLD,nonalcoholic steatohepatitis|nash, nafld,nonalcoholic steatohepatitis
657660|NCT00799565|Mitral Valve prolapse|mitral valve prolapse
657661|NCT00799565|echography|echography
657662|NCT00799565|genetic study|genetic study
657663|NCT00799565|study case-witness|study case-witness
657664|NCT00799565|Patients with a Mitral Valve Prolapse|patients with a mitral valve prolapse
657665|NCT00799552|Keratoconjunctivitis Sicca|keratoconjunctivitis sicca
657666|NCT00799552|Dry eye|dry eye
657667|NCT00799552|Resolvin|resolvin
657668|NCT00799539|Prednisone|prednisone
657669|NCT00799539|Bortezomib|bortezomib
657670|NCT00799539|Melphalan|melphalan
657671|NCT00799526|Ex Vivo Conjunctival Epithelial Cell|ex vivo conjunctival epithelial cell
657672|NCT00799526|Transplantation|transplantation
657673|NCT00799513|Lenalidomide|lenalidomide
657674|NCT00799513|revlimid|revlimid
657675|NCT00799513|large B-cell lymphoma|large b-cell lymphoma
657676|NCT00799513|relapse|relapse
657677|NCT00799487|ADHD|adhd
657678|NCT00799487|Attention Deficit Hyperactivity Disorder|attention deficit hyperactivity disorder
657679|NCT00799435|Diabetes|diabetes
657680|NCT00799435|Diastolic Heart Failure|diastolic heart failure
657681|NCT00799435|Aortic Stiffness|aortic stiffness
657682|NCT00799435|Exenatide|exenatide
657683|NCT00799422|Conjunctival Staining|conjunctival staining
657684|NCT00799422|lens parameters|lens parameters
657685|NCT00799422|lens fit|lens fit
657686|NCT00799409|ADHD|adhd
657687|NCT00799409|Attention Deficit Hyperactivity Disorder|attention deficit hyperactivity disorder
657688|NCT00799383|Risperidone|risperidone
657689|NCT00799383|hyperprolactinemia|hyperprolactinemia
657690|NCT00799383|children|children
657691|NCT00799383|adolescents|adolescents
657692|NCT00799383|antipsychotics|antipsychotics
657693|NCT00799383|prevention|prevention
657694|NCT00799383|calcium|calcium
657695|NCT00799383|vitamin D|vitamin d
657696|NCT00799383|Risperidone-induced hyperprolactinemia|risperidone-induced hyperprolactinemia
657697|NCT00799370|Osteotomy|osteotomy
657698|NCT00799370|Weight bearing|weight bearing
657699|NCT00799370|Opening wedge|opening wedge
657700|NCT00799357|ultrasound|ultrasound
657701|NCT00799344|Coronary Stent|coronary stent
657702|NCT00799331|Healthy volunteers|healthy volunteers
657703|NCT00799279|smoking|smoking
657704|NCT00799279|cessation|cessation
657705|NCT00799279|family medicine|family medicine
657706|NCT00799279|evidence-based|evidence-based
657707|NCT00799279|knowledge translation|knowledge translation
657708|NCT00799279|smoking cessation, primary care|smoking cessation, primary care
657709|NCT00799266|Osteoporosis, children and adolescents, zoledronic acid, chronic inflammation, Duchenne muscular dystrophy, glucocorticoids, chronic inflammatory conditions|osteoporosis, children and adolescents, zoledronic acid, chronic inflammation, duchenne muscular dystrophy, glucocorticoids, chronic inflammatory conditions
657710|NCT00799240|lung cancer|lung cancer
657711|NCT00799240|stage IIIb|stage iiib
657712|NCT00799240|pleural effusion|pleural effusion
657713|NCT00799240|stage IV|stage iv
657714|NCT00799240|metastatic lung cancer|metastatic lung cancer
657715|NCT00799240|non squamous lung cancer|non squamous lung cancer
657716|NCT00799240|IGF-1R|igf-1r
657717|NCT00799240|Pemetrexed|pemetrexed
657718|NCT00799240|Cisplatin|cisplatin
657719|NCT00799214|bacterial vaginosis|bacterial vaginosis
657720|NCT00799214|intravaginal|intravaginal
657721|NCT00799214|boric acid|boric acid
657722|NCT00799214|metronidazole|metronidazole
657723|NCT00799214|placebo controlled|placebo controlled
657724|NCT00799214|double-blind|double-blind
657725|NCT00799214|randomized|randomized
657726|NCT00799214|multicenter|multicenter
657727|NCT00799214|non-inferiority|non-inferiority
657728|NCT00799201|Enteral nutrition|enteral nutrition
657729|NCT00799201|Constipation|constipation
657730|NCT00799201|Gastrointestinal motility|gastrointestinal motility
657731|NCT00799201|Naloxone|naloxone
657732|NCT00799201|Docusate|docusate
657733|NCT00799201|Bowel stimulant|bowel stimulant
657734|NCT00799201|Stool softener|stool softener
657735|NCT00799188|Cardiac Transplantation|cardiac transplantation
657736|NCT00799188|Skin cancer|skin cancer
657737|NCT00799188|Everolimus|everolimus
657738|NCT00799175|Postoperative pain|postoperative pain
657739|NCT00799175|Local infiltration analgesia|local infiltration analgesia
657740|NCT00799175|Knee arthroplasty|knee arthroplasty
657741|NCT00799149|Post-operative pain|post-operative pain
657742|NCT00799149|Knee arthroscopy|knee arthroscopy
657743|NCT00799149|Gabapentin|gabapentin
657744|NCT00799149|Etoricoxib|etoricoxib
657745|NCT00799149|Elective ambulatory knee arthroscopy|elective ambulatory knee arthroscopy
657746|NCT00799136|Lymphoma Large B Cell Diffuse|lymphoma large b cell diffuse
657747|NCT00799136|Acquired Immunodeficiency|acquired immunodeficiency
657748|NCT00799123|NT-proBNP|nt-probnp
657749|NCT00799110|dendritic cells|dendritic cells
657750|NCT00799110|fusion vaccines|fusion vaccines
657751|NCT00799110|GM-CSF|gm-csf
657752|NCT00799110|imiquimod|imiquimod
657753|NCT00799084|symptom management|symptom management
657754|NCT00799084|cancer|cancer
657755|NCT00799084|chemotherapy treatment|chemotherapy treatment
657756|NCT00799084|Behavioral Research|behavioral research
657757|NCT00799084|Physiological Effects of Drugs|physiological effects of drugs
657758|NCT00799084|Clinical Trial, Phase II|clinical trial, phase ii
657759|NCT00799071|prophylaxis|prophylaxis
657761|NCT00799071|pharmacokinetics|pharmacokinetics
657762|NCT00799058|HIV-1 infections|hiv-1 infections
657763|NCT00799045|Migraine|migraine
657764|NCT00799045|atrial septal defects|atrial septal defects
657765|NCT00799045|transcatheter|transcatheter
657766|NCT00799045|clopidogrel|clopidogrel
657767|NCT00799032|Coronary Stent|coronary stent
657768|NCT00799019|EPO antibody mediated PRCA|epo antibody mediated prca
657769|NCT00799019|Erythropoiesis stimulating agents|erythropoiesis stimulating agents
657770|NCT00799006|Single Ascending Dose Study in Overweight subjects|single ascending dose study in overweight subjects
657771|NCT00798993|Chronic kidney failure|chronic kidney failure
657772|NCT00798993|25 hydroxyvitamin D|25 hydroxyvitamin d
657773|NCT00798993|falls|falls
657774|NCT00798993|exercise|exercise
657775|NCT00798993|quadriceps strength|quadriceps strength
657776|NCT00798980|Mirena|mirena
657777|NCT00798980|Nulliparous|nulliparous
657778|NCT00798980|Intrauterine Devices|intrauterine devices
657779|NCT00798967|SBS|sbs
657780|NCT00798967|short bowel syndrome|short bowel syndrome
657781|NCT00798967|TPN|tpn
657782|NCT00798967|parenteral nutrition|parenteral nutrition
657783|NCT00798967|PN|pn
657784|NCT00798915|Diabetes|diabetes
657785|NCT00798915|Blood Sugar|blood sugar
657786|NCT00798915|Xenin-25|xenin-25
657787|NCT00798915|GIP|gip
657788|NCT00798915|Insulin|insulin
657789|NCT00798902|DDD|ddd
657790|NCT00798902|Spondylolisthesis|spondylolisthesis
657791|NCT00798902|Spine Fusion|spine fusion
657792|NCT00798902|Lumbar Spine|lumbar spine
657793|NCT00798902|Bone Graft|bone graft
657794|NCT00798889|Solid tumors|solid tumors
657795|NCT00798863|submandibular gland|submandibular gland
657796|NCT00798863|video assisted neck surgery|video assisted neck surgery
657797|NCT00798850|Claudication|claudication
657798|NCT00798850|Vascular claudication|vascular claudication
657799|NCT00798850|Peripheral Vascular Disease|peripheral vascular disease
657800|NCT00798850|Peripheral arterial disease|peripheral arterial disease
657801|NCT00798850|Peripheral arterial occlusive disease|peripheral arterial occlusive disease
657802|NCT00798850|Angioplasty|angioplasty
657803|NCT00798850|Femoral angioplasty|femoral angioplasty
657804|NCT00798850|Superficial femoral artery|superficial femoral artery
657805|NCT00798850|Femoral arterial disease|femoral arterial disease
657806|NCT00798850|Exercise|exercise
657807|NCT00798850|Supervised exercise|supervised exercise
657808|NCT00798850|Exercise therapy|exercise therapy
657809|NCT00798850|Exercise programme|exercise programme
657810|NCT00798850|Infrainuginal|infrainuginal
657811|NCT00798850|Quality of life|quality of life
657812|NCT00798850|SF36|sf36
657813|NCT00798850|Questionnaire|questionnaire
657814|NCT00798850|VascuQol|vascuqol
657815|NCT00798850|Randomised|randomised
657816|NCT00798850|Randomised trial|randomised trial
657817|NCT00798850|Combination therapy|combination therapy
657818|NCT00798850|Intermittent Claudication due to Femoropopliteal Disease|intermittent claudication due to femoropopliteal disease
657819|NCT00798837|prostate|prostate
657820|NCT00798837|cancer|cancer
657821|NCT00798837|IMRT|imrt
657822|NCT00798837|radiation|radiation
657823|NCT00798824|tube feeding|tube feeding
657824|NCT00798824|premature infant|premature infant
657825|NCT00798811|brain tumor|brain tumor
657826|NCT00798811|high-dose chemotherapy|high-dose chemotherapy
657827|NCT00798811|autologous stem cell transplantation|autologous stem cell transplantation
657829|NCT00798785|diabetes mellitus type 1|diabetes mellitus type 1
657830|NCT00798785|pancreatic beta cell|pancreatic beta cell
657831|NCT00798785|transplantation|transplantation
657832|NCT00798772|HIV infection|hiv infection
657833|NCT00798772|Micronutrients|micronutrients
657834|NCT00798772|Antioxidants|antioxidants
657835|NCT00798759|Open-angle glaucoma|open-angle glaucoma
657836|NCT00798759|Ocular hypertension|ocular hypertension
657837|NCT00798746|Esophageal cancer|esophageal cancer
657838|NCT00798746|pyloric drainage|pyloric drainage
657839|NCT00798746|pyloric drainage procedure|pyloric drainage procedure
657840|NCT00798746|reflux|reflux
657841|NCT00798746|reflux symptoms|reflux symptoms
657842|NCT00798746|esophagectomy|esophagectomy
657843|NCT00798746|Quality of Life|quality of life
657844|NCT00798746|Health-related quality of life|health-related quality of life
657845|NCT00798746|HRQL|hrql
657846|NCT00798720|non small cell lung cancer|non small cell lung cancer
657847|NCT00798720|HDAC|hdac
657848|NCT00798720|proteasome inhibitor|proteasome inhibitor
657849|NCT00798707|Major Depressive Disorder|major depressive disorder
657850|NCT00798694|glaucoma|glaucoma
657851|NCT00798694|impression cytology|impression cytology
657852|NCT00798694|ocular surface changes|ocular surface changes
657853|NCT00798694|prostaglandins|prostaglandins
657854|NCT00798681|parenteral nutrition|parenteral nutrition
657855|NCT00798681|ready-to-use|ready-to-use
657856|NCT00798681|customized nutrition formulation|customized nutrition formulation
657857|NCT00798681|olive oil|olive oil
657858|NCT00798681|soybean oil|soybean oil
657859|NCT00798681|LCT/MCT|lct/mct
657860|NCT00798681|Clinoleic|clinoleic
657861|NCT00798681|oliclinomel|oliclinomel
657862|NCT00798681|number of infections associated with TPN delivery system|number of infections associated with tpn delivery system
657863|NCT00798681|BSI|bsi
657864|NCT00798681|Infection rates|infection rates
657865|NCT00798668|Endocrine and Gastrointestinal Response to Food|endocrine and gastrointestinal response to food
657866|NCT00798655|panitumumab|panitumumab
657867|NCT00798655|cisplatin|cisplatin
657868|NCT00798655|radiation|radiation
657869|NCT00798642|Hypnotherapy|hypnotherapy
657870|NCT00798642|Ulcerative Colitis|ulcerative colitis
657871|NCT00798642|Inflammatory Bowel Disease|inflammatory bowel disease
657872|NCT00798642|Gastrointestinal Diseases|gastrointestinal diseases
657873|NCT00798642|Digestive System Diseases|digestive system diseases
657874|NCT00798642|Intestinal Diseases|intestinal diseases
657875|NCT00798642|Colonic Diseases|colonic diseases
657876|NCT00798629|stage III melanoma|stage iii melanoma
657877|NCT00798629|stage IV melanoma|stage iv melanoma
657878|NCT00798629|recurrent melanoma|recurrent melanoma
657879|NCT00798629|mucosal melanoma|mucosal melanoma
657880|NCT00798616|bronchiolitis|bronchiolitis
657881|NCT00798616|steroids|steroids
657882|NCT00798616|corticosteroids|corticosteroids
657883|NCT00798616|albuterol|albuterol
657884|NCT00798616|child|child
657885|NCT00798616|infant|infant
657886|NCT00798616|pediatric|pediatric
657887|NCT00798603|stage IIIB non-small cell lung cancer|stage iiib non-small cell lung cancer
657888|NCT00798603|stage IV non-small cell lung cancer|stage iv non-small cell lung cancer
657889|NCT00798603|recurrent non-small cell lung cancer|recurrent non-small cell lung cancer
657890|NCT00798603|adenocarcinoma of the lung|adenocarcinoma of the lung
657891|NCT00798603|adenosquamous cell lung cancer|adenosquamous cell lung cancer
657892|NCT00798590|Intensive insulin therapy (IIT)|intensive insulin therapy (iit)
657893|NCT00798590|Insulin infusion|insulin infusion
657894|NCT00798590|Tight glycemic control|tight glycemic control
657895|NCT00798590|Intensive Care Units|intensive care units
657896|NCT00798577|Bacterial Conjunctivitis|bacterial conjunctivitis
657897|NCT00798564|Exercise|exercise
657898|NCT00798564|Mannitol|mannitol
657899|NCT00798538|Buprenorphine|buprenorphine
657900|NCT00798538|HIV|hiv
657901|NCT00798538|Drug Abuse|drug abuse
657902|NCT00798538|Drug Addiction|drug addiction
657903|NCT00798538|Drug Dependence|drug dependence
657904|NCT00798538|Drug Use Disorders|drug use disorders
657905|NCT00798538|Drug Use Disorder|drug use disorder
657906|NCT00798538|Substance Abuse|substance abuse
657907|NCT00798538|Opiate Addiction|opiate addiction
657908|NCT00798538|Substance-related disorders|substance-related disorders
657909|NCT00798525|thrombocytopenia|thrombocytopenia
657910|NCT00798525|Heparin|heparin
657911|NCT00798525|Lepirudin|lepirudin
657912|NCT00798525|Argatroban|argatroban
657913|NCT00798525|critically ill patients|critically ill patients
657914|NCT00798512|carotid artery stenting|carotid artery stenting
657915|NCT00798512|cerebral protection|cerebral protection
657916|NCT00798512|stroke|stroke
657917|NCT00798512|ischemic lesion|ischemic lesion
657918|NCT00798512|DW-MRI|dw-mri
657919|NCT00798499|haemophilia|haemophilia
657920|NCT00798499|patients with haemophilia|patients with haemophilia
657921|NCT00798473|Crohn's disease|crohn's disease
657922|NCT00798473|Osteopenia|osteopenia
657923|NCT00798473|Osteoporosis|osteoporosis
657924|NCT00798473|Bisphosphonates|bisphosphonates
657925|NCT00798473|Zoledronate|zoledronate
657926|NCT00798460|Chronic hepatitis B|chronic hepatitis b
657927|NCT00798460|lamivudine resistance|lamivudine resistance
657928|NCT00798460|clevudine|clevudine
657929|NCT00798447|post OP|post op
657930|NCT00798434|Overactive bladder syndrome|overactive bladder syndrome
657931|NCT00798434|fesoterodine|fesoterodine
657932|NCT00798434|elderly|elderly
657933|NCT00798434|flexible dose regimen|flexible dose regimen
657934|NCT00798434|urgency|urgency
657935|NCT00798434|frequency|frequency
657936|NCT00798434|urge urinary incontinence|urge urinary incontinence
657937|NCT00798434|anticholinergic|anticholinergic
657938|NCT00798434|antimuscarinic|antimuscarinic
657939|NCT00798421|Influenza, transmission|influenza, transmission
657940|NCT00798408|Evaluate the effects of energy-yielding fluids and solids endocrine and metabolic response to food in the elderly|evaluate the effects of energy-yielding fluids and solids endocrine and metabolic response to food in the elderly
657941|NCT00798369|Acute flares|acute flares
657942|NCT00798369|Gout|gout
657943|NCT00798369|Anti-interleukin-1β monoclonal antibody|anti-interleukin-1β monoclonal antibody
657944|NCT00798369|Colchicine|colchicine
657945|NCT00798369|Triamcinolone acetonide|triamcinolone acetonide
657946|NCT00798356|atrial fibrillation, yoga|atrial fibrillation, yoga
657947|NCT00798343|Influenza, heterosubtypic immune responses|influenza, heterosubtypic immune responses
657948|NCT00798330|Cancer|cancer
657949|NCT00798330|Blood stream infections|blood stream infections
657950|NCT00798330|Bacteremia|bacteremia
657951|NCT00798330|Dental procedure|dental procedure
657952|NCT00798330|Central venous catheters|central venous catheters
657953|NCT00798330|Mediport|mediport
657954|NCT00798330|PICC line|picc line
657955|NCT00798304|Meningococcal B vaccine|meningococcal b vaccine
657956|NCT00798304|infants|infants
657957|NCT00798304|safety|safety
657958|NCT00798304|immunogenicity|immunogenicity
657959|NCT00798278|Empyema|empyema
657960|NCT00798278|Urokinase|urokinase
657961|NCT00798278|Thoracoscopic|thoracoscopic
657962|NCT00798278|Childhood|childhood
657963|NCT00798265|HPV Vaccination|hpv vaccination
657964|NCT00798265|HPV Immunogenicity|hpv immunogenicity
657965|NCT00798265|HIV Infection|hiv infection
657966|NCT00798265|HIV Negative|hiv negative
657967|NCT00798265|Adolescents and Young Adults|adolescents and young adults
657968|NCT00798265|Healthy Volunteer|healthy volunteer
657970|NCT00798265|Adolescent|adolescent
657971|NCT00798252|metastatic, chemotherapy combination|metastatic, chemotherapy combination
657972|NCT00798239|DDD|ddd
657973|NCT00798239|Spondylolisthesis|spondylolisthesis
657974|NCT00798239|Spine Fusion|spine fusion
657975|NCT00798239|Lumbar Spine|lumbar spine
657976|NCT00798239|Bone Graft|bone graft
657977|NCT00798226|Asthma|asthma
657978|NCT00798226|Eczema|eczema
657979|NCT00798226|Sensitization|sensitization
657980|NCT00798226|Allergy|allergy
657981|NCT00798200|Cancer|cancer
657982|NCT00798200|Oncology|oncology
657983|NCT00798200|Rehabilitation|rehabilitation
657984|NCT00798200|Endurance|endurance
657985|NCT00798200|Strength|strength
657986|NCT00798187|Prostate Cancer|prostate cancer
657987|NCT00798187|Breast Cancer|breast cancer
657988|NCT00798187|Behavioral Intervention|behavioral intervention
657989|NCT00798187|Cancer Support Programs|cancer support programs
657990|NCT00798187|Social Comparison|social comparison
657991|NCT00798187|Heterogeneous support group|heterogeneous support group
657992|NCT00798187|Homogeneous support group|homogeneous support group
657993|NCT00798174|DFT|dft
657994|NCT00798174|Congestive Heart failure (CHF)|congestive heart failure (chf)
657995|NCT00798174|ICD|icd
657996|NCT00798148|Neuroblastoma|neuroblastoma
657997|NCT00798148|MIBG|mibg
657998|NCT00798148|Autologous Peripheral Stem Cell Transplantation|autologous peripheral stem cell transplantation
657999|NCT00798122|sex|sex
658000|NCT00798122|acute coronary syndromes|acute coronary syndromes
658001|NCT00798122|normal angiogram|normal angiogram
658002|NCT00798122|no obstruction at angiography|no obstruction at angiography
658003|NCT00798122|women|women
658004|NCT00798109|Schizophrenia|schizophrenia
658005|NCT00798109|Cannabis misuse comorbidity|cannabis misuse comorbidity
658006|NCT00798109|Motivational interview|motivational interview
658007|NCT00798109|Randomised open trial|randomised open trial
658008|NCT00798096|T Cell Lymphoma|t cell lymphoma
658009|NCT00798096|Lymphoma|lymphoma
658010|NCT00798070|Lymph node positive or high risk lymph node negative breast|lymph node positive or high risk lymph node negative breast
658011|NCT00798070|cancer|cancer
658012|NCT00798057|Pituitary tumor|pituitary tumor
658013|NCT00798057|Outcomes|outcomes
658014|NCT00798057|Proton radiation|proton radiation
658015|NCT00798044|quality improvement|quality improvement
658016|NCT00798044|feedback|feedback
658017|NCT00798044|substance use disorders|substance use disorders
658018|NCT00798031|dental implant|dental implant
658019|NCT00798031|upper jaw|upper jaw
658020|NCT00798031|posterior tooth loss|posterior tooth loss
658021|NCT00798031|short dental implant|short dental implant
658022|NCT00798031|Adults, 18 years of age and older|adults, 18 years of age and older
658023|NCT00798031|Missing a minimum of two posterior teeth in their upper jaw|missing a minimum of two posterior teeth in their upper jaw
658024|NCT00798031|Subjects in need of dental implants|subjects in need of dental implants
658025|NCT00798031|the research study is survival and function of the implants|the research study is survival and function of the implants
658026|NCT00798018|lidocaine|lidocaine
658027|NCT00798018|tetracaine|tetracaine
658028|NCT00798018|tracheal intubation|tracheal intubation
658029|NCT00798018|pharyngitis|pharyngitis
658030|NCT00798005|NV1FGF|nv1fgf
658031|NCT00798005|PAOD|paod
658032|NCT00798005|CLI|cli
658033|NCT00797992|Bevacizumab|bevacizumab
658034|NCT00797992|Myopia|myopia
658035|NCT00797992|Complications|complications
658036|NCT00797992|Neovascularization|neovascularization
658037|NCT00797992|OCT|oct
658038|NCT00797979|Craniotomy|craniotomy
658039|NCT00797979|Skull fixation|skull fixation
658040|NCT00797979|Skull Grip|skull grip
658041|NCT00797979|Reconstructive cranial surgery|reconstructive cranial surgery
658042|NCT00797966|OPC-34712, Major Depressive Disorder, Adjunctive Treatment|opc-34712, major depressive disorder, adjunctive treatment
658043|NCT00797953|Angina Pectoris Treatment|angina pectoris treatment
658044|NCT00797940|GBM|gbm
658045|NCT00797940|Glioblastoma|glioblastoma
658046|NCT00797940|Glioblastoma Multiforme|glioblastoma multiforme
658047|NCT00797940|Brain Tumor|brain tumor
658048|NCT00797940|Brain Cancer|brain cancer
658049|NCT00797940|Glioma|glioma
658050|NCT00797927|schizophrenia|schizophrenia
658051|NCT00797927|quetiapine|quetiapine
658052|NCT00797927|conventional antipsychotics|conventional antipsychotics
658053|NCT00797927|magnetic resonance spectroscopy|magnetic resonance spectroscopy
658054|NCT00797914|Colonoscopy|colonoscopy
658055|NCT00797914|Instrumentation|instrumentation
658056|NCT00797914|Force Monitoring|force monitoring
658057|NCT00797914|Quality Control|quality control
658058|NCT00797914|Training|training
658059|NCT00797888|diabetes|diabetes
658060|NCT00797888|behavioral intervention|behavioral intervention
658061|NCT00797888|HbA1c|hba1c
658062|NCT00797888|health disparities|health disparities
658063|NCT00797875|proprioceptive neuromuscular facilitation stretching technique, total knee arthroplasty, range of motion|proprioceptive neuromuscular facilitation stretching technique, total knee arthroplasty, range of motion
658064|NCT00797862|Aliskiren|aliskiren
658065|NCT00797862|Amlodipine|amlodipine
658066|NCT00797862|Hypertension|hypertension
658067|NCT00797862|SPA1000|spa1000
658068|NCT00797862|Norvasc|norvasc
658069|NCT00797849|phantom limb pain|phantom limb pain
658070|NCT00797849|amputees|amputees
658071|NCT00797849|Farabloc|farabloc
658072|NCT00797849|Phantom limb pain in the missing limb of Veteran amputees|phantom limb pain in the missing limb of veteran amputees
658073|NCT00797836|Occupational Diseases|occupational diseases
658074|NCT00797836|Tuberculosis|tuberculosis
658075|NCT00797836|Tuberculin Test|tuberculin test
658076|NCT00797836|Immunoassay|immunoassay
658077|NCT00797823|diabetes|diabetes
658078|NCT00797823|pancreas|pancreas
658079|NCT00797823|beta cell|beta cell
658080|NCT00797823|glucagon|glucagon
658081|NCT00797823|insulin|insulin
658082|NCT00797823|hypoglycemia|hypoglycemia
658083|NCT00797810|Acute lymphoblastic leukemia of the mature B-cell type|acute lymphoblastic leukemia of the mature b-cell type
658084|NCT00797810|High-grade non-Hodgkin's lymphoma|high-grade non-hodgkin's lymphoma
658085|NCT00797797|fibromyalgia|fibromyalgia
658086|NCT00797797|milnacipran|milnacipran
658087|NCT00797797|pregabalin|pregabalin
658088|NCT00797797|treatment|treatment
658089|NCT00797797|Forest Research Institute|forest research institute
658090|NCT00797771|Insulin delivery|insulin delivery
658091|NCT00797758|Cord blood transplantation|cord blood transplantation
658092|NCT00797758|Conditioning regimen|conditioning regimen
658093|NCT00797758|Acute myeloid leukaemia|acute myeloid leukaemia
658094|NCT00797758|SORROR comorbidity index|sorror comorbidity index
658095|NCT00797758|Quality of life|quality of life
658096|NCT00797758|Innate immunity|innate immunity
658097|NCT00797758|Immune reconstitution post transplant|immune reconstitution post transplant
658098|NCT00797758|Umbilical Cord Blood Stem Cell Transplantation|umbilical cord blood stem cell transplantation
658099|NCT00797758|Hematopoietic Stem Cell Transplantation|hematopoietic stem cell transplantation
658100|NCT00797745|genotype 1 infection|genotype 1 infection
658101|NCT00797732|acupuncture|acupuncture
658102|NCT00797732|dysphagia|dysphagia
658103|NCT00797732|chemoradiation related effects|chemoradiation related effects
658104|NCT00797732|squamous cell carcinoma of the head and neck|squamous cell carcinoma of the head and neck
658105|NCT00797732|nasopharyngeal cancer|nasopharyngeal cancer
658106|NCT00797732|oropharynx cancer|oropharynx cancer
658107|NCT00797732|hypopharynx cancer|hypopharynx cancer
658108|NCT00797732|larynx cancer|larynx cancer
658109|NCT00797719|MPM|mpm
658110|NCT00797719|Short hemithoracic IMRT|short hemithoracic imrt
658111|NCT00797693|First trimester|first trimester
658112|NCT00797693|missed abortion|missed abortion
658113|NCT00797693|misoprostol|misoprostol
658114|NCT00797693|cervical ripening|cervical ripening
658115|NCT00797693|oral|oral
658116|NCT00797693|vaginal|vaginal
658117|NCT00797693|first trimester missed abortion|first trimester missed abortion
658118|NCT00797680|Pediatric cardiac arrest|pediatric cardiac arrest
658119|NCT00797654|Sexual Risks for HIV|sexual risks for hiv
658120|NCT00797654|Psychosocial Sequelae Relating to Childhood Sexual Abuse|psychosocial sequelae relating to childhood sexual abuse
658121|NCT00797641|bleeding|bleeding
658122|NCT00797641|ulcer|ulcer
658123|NCT00797641|hemorrhage|hemorrhage
658124|NCT00797641|gastrointestinal diseases|gastrointestinal diseases
658125|NCT00797641|digestive system disease|digestive system disease
658126|NCT00797641|peptic ulcer|peptic ulcer
658127|NCT00797641|proton pump inhibitor|proton pump inhibitor
658128|NCT00797602|Chordomas|chordomas
658129|NCT00797602|Chondrosarcomas|chondrosarcomas
658130|NCT00797602|Cancer|cancer
658131|NCT00797602|Outcomes|outcomes
658132|NCT00797602|Proton radiation|proton radiation
658133|NCT00797589|aorta valve|aorta valve
658134|NCT00797589|mitral valve|mitral valve
658135|NCT00797589|coronary artery bypass grafting surgery|coronary artery bypass grafting surgery
658136|NCT00797589|perfusion|perfusion
658137|NCT00797589|priming|priming
658138|NCT00797576|left atrial appendage thrombi|left atrial appendage thrombi
658139|NCT00797576|transesophageal echocardiogram|transesophageal echocardiogram
658140|NCT00797576|cardiac magnetic resonance imaging|cardiac magnetic resonance imaging
658141|NCT00797576|atrial fibrillation|atrial fibrillation
658142|NCT00797576|cardioversion|cardioversion
658143|NCT00797550|posterolateral spine fusion|posterolateral spine fusion
658144|NCT00797550|bone graft|bone graft
658145|NCT00797537|Inflammation of bone and cartilage|inflammation of bone and cartilage
658146|NCT00797511|Diphtheria|diphtheria
658147|NCT00797511|Tetanus|tetanus
658148|NCT00797511|Pertussis|pertussis
658149|NCT00797511|Poliomyelitis|poliomyelitis
658150|NCT00797498|Nasal Cavity|nasal cavity
658151|NCT00797498|Paranasal Sinuses|paranasal sinuses
658152|NCT00797498|Proton Radiation|proton radiation
658153|NCT00797498|Outcomes|outcomes
658154|NCT00797485|stage IV colon cancer|stage iv colon cancer
658155|NCT00797485|stage IV rectal cancer|stage iv rectal cancer
658156|NCT00797472|Hodgkin's Lymphoma|hodgkin's lymphoma
658157|NCT00797472|R-mabHD|r-mabhd
658158|NCT00797472|ABVD treatment|abvd treatment
658159|NCT00797472|Hodgkin's Disease|hodgkin's disease
658160|NCT00797459|Correction of Nasolabial Folds|correction of nasolabial folds
658161|NCT00797446|Oropharyngeal|oropharyngeal
658162|NCT00797446|cancer|cancer
658163|NCT00797446|proton|proton
658164|NCT00797446|radiation|radiation
658165|NCT00797446|outcomes|outcomes
658166|NCT00797433|testosterone|testosterone
658167|NCT00797433|mechanical ventilation|mechanical ventilation
658168|NCT00797420|fluconazole|fluconazole
658169|NCT00797420|pharmacokinetic|pharmacokinetic
658170|NCT00797420|candidiasis|candidiasis
658171|NCT00797420|sepsis|sepsis
658172|NCT00797420|pediatric|pediatric
658173|NCT00797420|infants|infants
658174|NCT00797420|antifungal|antifungal
658175|NCT00797420|candidemia|candidemia
658176|NCT00797420|fungemia|fungemia
658177|NCT00797420|loading dose|loading dose
658178|NCT00797407|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors
658179|NCT00797407|Creatine|creatine
658180|NCT00797407|Adverse Effects|adverse effects
658181|NCT00797407|Muscle Toxicity|muscle toxicity
658182|NCT00797394|prostate|prostate
658183|NCT00797394|dietary supplements|dietary supplements
658184|NCT00797394|saw palmetto|saw palmetto
658185|NCT00797394|canada|canada
658186|NCT00797381|MK-0518|mk-0518
658187|NCT00797381|HIV|hiv
658188|NCT00797381|AIDS|aids
658189|NCT00797381|hemophilia|hemophilia
658190|NCT00797381|treatment experienced|treatment experienced
658191|NCT00797368|ankle sprain|ankle sprain
658192|NCT00797368|manual therapy|manual therapy
658193|NCT00797368|exercise|exercise
658194|NCT00797368|physical therapy|physical therapy
658195|NCT00797368|Patients who have sustained an inversion ankle sprain|patients who have sustained an inversion ankle sprain
658196|NCT00797342|rheumatoid arthritis First in human safety pharmacokinetics pharmacodynamics|rheumatoid arthritis first in human safety pharmacokinetics pharmacodynamics
658197|NCT00797329|psychiatric patients with violent behavior|psychiatric patients with violent behavior
658198|NCT00797316|Hypertension|hypertension
658199|NCT00797316|Metabolic Syndrome|metabolic syndrome
658200|NCT00797316|aliskiren|aliskiren
658201|NCT00797316|hydrochlorothiazide|hydrochlorothiazide
658202|NCT00797316|systolic blood pressure|systolic blood pressure
658203|NCT00797316|diastolic blood pressure|diastolic blood pressure
658204|NCT00797316|stage 2|stage 2
658205|NCT00797303|bevacizumab|bevacizumab
658206|NCT00797303|cornea|cornea
658207|NCT00797303|neovascularization|neovascularization
658208|NCT00797290|Nasopharynx Cancer, Proton Radiation, Outcomes|nasopharynx cancer, proton radiation, outcomes
658209|NCT00797277|schizophrenia|schizophrenia
658210|NCT00797277|schizoaffective disorder|schizoaffective disorder
658211|NCT00797277|olanzapine|olanzapine
658212|NCT00797277|haloperidol|haloperidol
658213|NCT00797277|lorazepam|lorazepam
658214|NCT00797277|agitation|agitation
658215|NCT00797264|Ketamine|ketamine
658216|NCT00797264|Morphine|morphine
658217|NCT00797264|PCA|pca
658218|NCT00797264|Hyperalgesia|hyperalgesia
658219|NCT00797264|Nor-ketamine|nor-ketamine
658220|NCT00797251|Colorectal liver metastasis|colorectal liver metastasis
658221|NCT00797251|hepatocellular carcinoma|hepatocellular carcinoma
658222|NCT00797251|liver surgery|liver surgery
658521|NCT00795964|surgery|surgery
658223|NCT00797251|intraoperative ultrasound|intraoperative ultrasound
658224|NCT00797251|finger-compression|finger-compression
658225|NCT00797238|Gene Expression|gene expression
658226|NCT00797238|Carcinoma, Non-Small-Cell Lung|carcinoma, non-small-cell lung
658227|NCT00797238|Chemotherapy|chemotherapy
658228|NCT00797225|bone mineral density,endometriosis,pelvic pain|bone mineral density,endometriosis,pelvic pain
658229|NCT00797199|Breast Cancer Risk|breast cancer risk
658230|NCT00797199|Hormone Replacement Therapy|hormone replacement therapy
658231|NCT00797199|Optical Transillumination Spectroscopy|optical transillumination spectroscopy
658232|NCT00797199|Optical Breast Spectroscopy|optical breast spectroscopy
658233|NCT00797199|Transillumination Breast Spectroscopy|transillumination breast spectroscopy
658234|NCT00797186|diabetes|diabetes
658235|NCT00797186|dyslipidemia|dyslipidemia
658236|NCT00797186|microvascular dysfunction|microvascular dysfunction
658237|NCT00797186|imaging|imaging
658238|NCT00797160|propofol|propofol
658239|NCT00797160|midazolam|midazolam
658240|NCT00797160|neonate|neonate
658241|NCT00797160|tracheal intubation|tracheal intubation
838608|NCT00089700|HIV|hiv
658242|NCT00797121|Cholangiocarcinoma|cholangiocarcinoma
658243|NCT00797121|Drainage|drainage
658244|NCT00797095|Adolescence|adolescence
658245|NCT00797095|Obesity|obesity
658246|NCT00797095|Substance use|substance use
658247|NCT00797095|Prevalence|prevalence
658248|NCT00797095|Social and Environmental Contexts|social and environmental contexts
658249|NCT00797095|Survey|survey
658250|NCT00797082|Diabetic|diabetic
658251|NCT00797082|Coronary disease|coronary disease
658252|NCT00797082|Atherosclerosis|atherosclerosis
658253|NCT00797082|Magnetic resonance imaging|magnetic resonance imaging
658254|NCT00797082|Myocardial Perfusion Scintigraphy|myocardial perfusion scintigraphy
658255|NCT00797082|Coronary angiography|coronary angiography
658256|NCT00797056|G-CSF|g-csf
658257|NCT00797056|angiogenesis|angiogenesis
658258|NCT00797056|endothelial progenitor cell|endothelial progenitor cell
658259|NCT00797056|limb ischemia|limb ischemia
658260|NCT00797056|revascularization|revascularization
658261|NCT00797043|Carcinoma of the skin of the head and neck|carcinoma of the skin of the head and neck
658262|NCT00797043|Proton radiation|proton radiation
658263|NCT00797043|Outcomes|outcomes
658264|NCT00797030|dry eye syndromes|dry eye syndromes
658265|NCT00797030|keratoconjuntivitis sicca / drug therapy|keratoconjuntivitis sicca / drug therapy
658266|NCT00797030|cyclosporine|cyclosporine
658267|NCT00797030|ophthalmic solutions|ophthalmic solutions
658268|NCT00797030|HIV seropositivity|hiv seropositivity
658269|NCT00797017|Chronic Pain|chronic pain
658270|NCT00797017|Fentanyl Matrix|fentanyl matrix
658271|NCT00797017|Spinal disorder-related pain|spinal disorder-related pain
658272|NCT00797004|olfactory dysfunction|olfactory dysfunction
658273|NCT00796991|Untreated Advanced Melanoma|untreated advanced melanoma
658274|NCT00796978|stage I breast cancer|stage i breast cancer
658275|NCT00796978|stage II breast cancer|stage ii breast cancer
658276|NCT00796978|stage IIIA breast cancer|stage iiia breast cancer
658277|NCT00796978|stage IIIB breast cancer|stage iiib breast cancer
658278|NCT00796978|stage IIIC breast cancer|stage iiic breast cancer
658279|NCT00796978|HER2-positive breast cancer|her2-positive breast cancer
658280|NCT00796965|Phase 1|phase 1
658281|NCT00796952|Head/ neck cancer|head/ neck cancer
658282|NCT00796952|Swallowing|swallowing
658283|NCT00796952|behavioral treatment|behavioral treatment
658284|NCT00796939|Delayed Sleep Phase Syndrome|delayed sleep phase syndrome
658285|NCT00796939|Sleep|sleep
658286|NCT00796900|Hyperthermia|hyperthermia
658287|NCT00796900|subarachnoidal hemorrhage|subarachnoidal hemorrhage
658288|NCT00796900|placebo controlled|placebo controlled
658289|NCT00796900|double blinded|double blinded
658290|NCT00796900|Dantrolene|dantrolene
658291|NCT00796887|Ischemic Stroke|ischemic stroke
658292|NCT00796887|Recovery of Function|recovery of function
658293|NCT00796887|Extended-release niacin|extended-release niacin
658294|NCT00796874|stage I prostate cancer|stage i prostate cancer
658295|NCT00796874|stage II prostate cancer|stage ii prostate cancer
658296|NCT00796861|malignant ascites|malignant ascites
658297|NCT00796835|Schizophrenia|schizophrenia
658298|NCT00796835|Mood disorders|mood disorders
658299|NCT00796835|Antipsychotic drugs|antipsychotic drugs
658300|NCT00796835|ER OROS Paliperidone|er oros paliperidone
658301|NCT00796822|Endothelial Function|endothelial function
658302|NCT00796822|Inflammation|inflammation
658303|NCT00796809|TNF inhibitors|tnf inhibitors
658304|NCT00796809|Biologic agents|biologic agents
658305|NCT00796809|coccidioidomycosis|coccidioidomycosis
658306|NCT00796809|Rheumatoid arthritis|rheumatoid arthritis
658307|NCT00796796|Non-small cell lung cancer|non-small cell lung cancer
658308|NCT00796796|temsirolimus|temsirolimus
658309|NCT00796796|radiation therapy|radiation therapy
658310|NCT00796783|Cushing's Disease|cushing's disease
658311|NCT00796783|Cushing's Syndrome|cushing's syndrome
658312|NCT00796783|Cushings|cushings
658313|NCT00796783|Pituitary|pituitary
658314|NCT00796783|ACTH|acth
658315|NCT00796783|Adrenocorticotropic hormone|adrenocorticotropic hormone
658316|NCT00796783|Ectopic|ectopic
658317|NCT00796783|Adrenal adenoma|adrenal adenoma
658318|NCT00796783|Adrenal carcinoma|adrenal carcinoma
658319|NCT00796783|Adrenal autonomy|adrenal autonomy
658320|NCT00796783|Cortisol|cortisol
658321|NCT00796783|Hypercortisolemia|hypercortisolemia
658322|NCT00796783|Cushinoid|cushinoid
658323|NCT00796783|Moon facies|moon facies
658324|NCT00796783|Dorsalcervical fat|dorsalcervical fat
658325|NCT00796783|Plethora|plethora
658326|NCT00796783|Hirsutism|hirsutism
658327|NCT00796783|Violaceous striae|violaceous striae
658329|NCT00796783|Contraceptive|contraceptive
658330|NCT00796783|Endocrine|endocrine
658331|NCT00796783|Cushing Syndrome|cushing syndrome
658332|NCT00796783|Ectopic ACTH Secretion|ectopic acth secretion
658333|NCT00796770|HIV|hiv
658334|NCT00796770|Vaccine|vaccine
658335|NCT00796770|HAART|haart
658336|NCT00796770|HIV-1|hiv-1
658337|NCT00796770|AIDS|aids
658338|NCT00796770|Dendritic Cells|dendritic cells
658339|NCT00796770|DALIA|dalia
658340|NCT00796744|Diabetes mellitus|diabetes mellitus
658341|NCT00796744|Diabetic neuropathy|diabetic neuropathy
658342|NCT00796744|Peripheral vascular disease|peripheral vascular disease
658343|NCT00796744|Infection|infection
658344|NCT00796744|Topical application|topical application
658345|NCT00796744|plantar foot ulcers|plantar foot ulcers
658346|NCT00796731|B-cell lymphoma|b-cell lymphoma
658347|NCT00796731|NHL|nhl
658348|NCT00796692|Heparin|heparin
658349|NCT00796692|Low molecular weight heparin|low molecular weight heparin
658350|NCT00796692|Safety|safety
658351|NCT00796692|Efficacy|efficacy
658352|NCT00796692|Cost effective|cost effective
658353|NCT00796679|paricalcitol|paricalcitol
658354|NCT00796679|chronic kidney disease|chronic kidney disease
658355|NCT00796679|cardiac hypertrophy|cardiac hypertrophy
658356|NCT00796666|endothelin receptor antagonist (ETRA)|endothelin receptor antagonist (etra)
658357|NCT00796666|Sitaxsentan|sitaxsentan
658358|NCT00796640|Schizophrenia|schizophrenia
658359|NCT00796640|Mood disorders|mood disorders
658360|NCT00796640|Antipsychotic drugs|antipsychotic drugs
658361|NCT00796640|ER Paliperidone|er paliperidone
658362|NCT00796627|Wound Healing|wound healing
658363|NCT00796627|Burns|burns
658364|NCT00796627|HIF-1|hif-1
658365|NCT00796627|CAC|cac
658366|NCT00796614|tamsulosin|tamsulosin
658367|NCT00796614|pediatric|pediatric
658368|NCT00796614|neurogenic bladder|neurogenic bladder
658369|NCT00796601|double-blind placebo-controlled maintenance of efficacy|double-blind placebo-controlled maintenance of efficacy
658370|NCT00796588|preconditioning|preconditioning
658371|NCT00796588|remote|remote
658372|NCT00796575|multiple ascending dose healthy volunteers|multiple ascending dose healthy volunteers
658373|NCT00796575|pharmacokinetics|pharmacokinetics
658374|NCT00796575|pharmacodynamics|pharmacodynamics
658375|NCT00796562|Leukemia|leukemia
658376|NCT00796562|Lymphoma|lymphoma
658377|NCT00796562|Hematologic malignancies|hematologic malignancies
658378|NCT00796562|ALL|all
658379|NCT00796562|AML|aml
658380|NCT00796562|MDS|mds
658381|NCT00796562|Transplantation|transplantation
658382|NCT00796562|Mismatched|mismatched
658383|NCT00796562|Haploidentical|haploidentical
658384|NCT00796562|Busulfan|busulfan
658385|NCT00796562|Cyclophosphamide|cyclophosphamide
658386|NCT00796562|Cellcept|cellcept
658387|NCT00796562|Tacrolimus|tacrolimus
658388|NCT00796562|TBI|tbi
658389|NCT00796562|CMMOL|cmmol
658390|NCT00796562|CML|cml
658391|NCT00796562|JMML|jmml
658392|NCT00796536|Acute Pain|acute pain
658393|NCT00796536|Low Back Pain|low back pain
658394|NCT00796536|Back Pain|back pain
658395|NCT00796536|Functional Magnetic Resonance Imaging (fMRI)|functional magnetic resonance imaging (fmri)
658396|NCT00796536|Cognitive Behavioral Therapy|cognitive behavioral therapy
658397|NCT00796536|Pain Education|pain education
658398|NCT00796523|colic|colic
658399|NCT00796523|crying|crying
658400|NCT00796523|clinical trial|clinical trial
658401|NCT00796510|endothelin receptor antagonist (ETRA)|endothelin receptor antagonist (etra)
658402|NCT00796510|sitaxsentan|sitaxsentan
658403|NCT00796497|Obsessive Compulsive Disorder|obsessive compulsive disorder
658404|NCT00796497|5-ht3|5-ht3
658405|NCT00796497|ondansetron|ondansetron
658406|NCT00796484|Cancer|cancer
658407|NCT00796484|Solid Tumors|solid tumors
658408|NCT00796471|Schizophrenia|schizophrenia
658409|NCT00796471|Mood Disorders|mood disorders
658410|NCT00796471|Antipsychotic drugs|antipsychotic drugs
658411|NCT00796471|Paliperidone ER|paliperidone er
658412|NCT00796458|pain|pain
658413|NCT00796458|adenocarcinoma of the prostate|adenocarcinoma of the prostate
658414|NCT00796458|recurrent prostate cancer|recurrent prostate cancer
658415|NCT00796458|stage IV prostate cancer|stage iv prostate cancer
658416|NCT00796458|stage III prostate cancer|stage iii prostate cancer
658417|NCT00796445|DERMA|derma
658418|NCT00796445|Tumor antigen|tumor antigen
658419|NCT00796445|Immunotherapeutic|immunotherapeutic
658420|NCT00796445|Adjuvant cancer therapy|adjuvant cancer therapy
658421|NCT00796445|Melanoma|melanoma
658422|NCT00796445|ASCI|asci
658423|NCT00796432|Schizophrenia|schizophrenia
658424|NCT00796432|mood disorders|mood disorders
658425|NCT00796432|antipsychotic drugs|antipsychotic drugs
658426|NCT00796432|dopamine|dopamine
658427|NCT00796432|receptor occupancy|receptor occupancy
658428|NCT00796432|OROS paliperidone|oros paliperidone
658429|NCT00796419|Acute lung injury (ALI)|acute lung injury (ali)
658430|NCT00796419|Acute respiratory distress syndrome (ARDS)|acute respiratory distress syndrome (ards)
658431|NCT00796419|Respiratory failure|respiratory failure
658432|NCT00796367|Obesity|obesity
658433|NCT00796354|Constipation|constipation
658434|NCT00796354|Irritable Bowel Syndrome|irritable bowel syndrome
658435|NCT00796341|invitro-fertilization ,embryo transfer,endometrial injury|invitro-fertilization ,embryo transfer,endometrial injury
658436|NCT00796315|Pharmacokinetic study|pharmacokinetic study
658437|NCT00796302|Conduct Disorder|conduct disorder
658438|NCT00796302|Attention Deficit and Disruptive Behavior Disorders|attention deficit and disruptive behavior disorders
658439|NCT00796289|anovulatory/oligoovulatory infertility|anovulatory/oligoovulatory infertility
658440|NCT00796276|Schizophrenia|schizophrenia
658441|NCT00796276|Mood disorders|mood disorders
658442|NCT00796276|Antipsychotics|antipsychotics
658443|NCT00796276|Pharmacokinetics|pharmacokinetics
658444|NCT00796276|Enantiomer|enantiomer
658445|NCT00796276|IR OROS Paliperidone|ir oros paliperidone
658446|NCT00796276|ER OROS Paliperidone|er oros paliperidone
658447|NCT00796263|Acute HIV infection|acute hiv infection
658448|NCT00796263|Chronic HIV infection|chronic hiv infection
658449|NCT00796237|stroke|stroke
658450|NCT00796237|bone|bone
658451|NCT00796237|gait|gait
658452|NCT00796237|muscle|muscle
658453|NCT00796237|vibration|vibration
658454|NCT00796237|motor balance|motor balance
658455|NCT00796224|azithromycin, pharmacokinetics, pediatrics|azithromycin, pharmacokinetics, pediatrics
658456|NCT00796211|Psoriasis|psoriasis
658457|NCT00796211|CRx-197|crx-197
658458|NCT00796211|nortriptyline|nortriptyline
658459|NCT00796211|loratadine|loratadine
658460|NCT00796211|CombinatoRx|combinatorx
658461|NCT00796211|Dermatology|dermatology
658462|NCT00796211|Erythema|erythema
658463|NCT00796211|Pruritus|pruritus
658464|NCT00796198|Glaucoma|glaucoma
658465|NCT00796198|Intraocular pressure|intraocular pressure
658466|NCT00796198|Ocular diastolic perfusion pressure|ocular diastolic perfusion pressure
658467|NCT00796198|Dorzolamide/timolol Fixed combination|dorzolamide/timolol fixed combination
658468|NCT00796198|Heidelberg Retina Flowmeter|heidelberg retina flowmeter
658469|NCT00796185|Schizophrenia|schizophrenia
658470|NCT00796185|Schizoaffective Disorder|schizoaffective disorder
658471|NCT00796185|Mood Disorders|mood disorders
658472|NCT00796185|Antipsychotic drugs|antipsychotic drugs
658473|NCT00796185|Paliperidone ER|paliperidone er
658474|NCT00796172|Hypertension|hypertension
658475|NCT00796172|High Blood Pressure|high blood pressure
658476|NCT00796172|Blood Lipid Management|blood lipid management
658477|NCT00796159|Efficacy; Tolerability; Safety; Essential Hypertension|efficacy; tolerability; safety; essential hypertension
658478|NCT00796133|NES/E2|nes/e2
658479|NCT00796133|transdermal gel delivery|transdermal gel delivery
658480|NCT00796133|contraception|contraception
658481|NCT00796133|ovulation|ovulation
658482|NCT00796133|bleeding patterns|bleeding patterns
658483|NCT00796120|Sarcomas|sarcomas
658484|NCT00796120|Trabectedin|trabectedin
658485|NCT00796120|Doxorubicin|doxorubicin
658486|NCT00796120|Ifosfamide|ifosfamide
658487|NCT00796120|YONDELIS|yondelis
658488|NCT00796081|Schizophrenia|schizophrenia
658489|NCT00796081|Schizoaffective disorder|schizoaffective disorder
658490|NCT00796081|Schizophreniform disorders|schizophreniform disorders
658491|NCT00796081|Mood disorders|mood disorders
658492|NCT00796081|Antipshychotic drugs|antipshychotic drugs
658493|NCT00796081|Pediatrics|pediatrics
658494|NCT00796081|ER OROS Paliperidone, Paliperidone ER|er oros paliperidone, paliperidone er
658495|NCT00796042|Pressure Ulcer|pressure ulcer
658496|NCT00796042|Bed Sores|bed sores
658497|NCT00796042|Bedsore|bedsore
658498|NCT00796042|Decubitus Ulcer|decubitus ulcer
658499|NCT00796042|Pressure Sore|pressure sore
658500|NCT00796042|Best rest|best rest
658501|NCT00796042|mobility|mobility
658502|NCT00796042|pressure management|pressure management
658503|NCT00796029|Schizophrenia|schizophrenia
658504|NCT00796029|Mood disorders|mood disorders
658505|NCT00796029|Antipsychotic drugs: 14C-paliperidone|antipsychotic drugs: 14c-paliperidone
658506|NCT00796003|Myelodysplastic syndrome|myelodysplastic syndrome
658507|NCT00796003|MDS|mds
658508|NCT00796003|Decitabine|decitabine
658509|NCT00796003|JNJ-30979754|jnj-30979754
658510|NCT00795990|Efficacy of early vs late use of ibuprofen for PDA closure|efficacy of early vs late use of ibuprofen for pda closure
658511|NCT00795977|preoperative|preoperative
658512|NCT00795977|intratumor|intratumor
658513|NCT00795977|dendritic cells|dendritic cells
658514|NCT00795977|pancreatic cancer|pancreatic cancer
658515|NCT00795977|OK-432|ok-432
658516|NCT00795964|tidal volume|tidal volume
658517|NCT00795964|predicted body weight|predicted body weight
658518|NCT00795964|lung function|lung function
658519|NCT00795964|respiratory outcome|respiratory outcome
658520|NCT00795964|Respiratory Function Tests|respiratory function tests
658522|NCT00795951|allergic|allergic
658523|NCT00795951|contact dermatitis|contact dermatitis
658524|NCT00795951|contact allergy|contact allergy
658525|NCT00795951|Type IV|type iv
658526|NCT00795951|Children|children
658527|NCT00795951|TRUE TEST|true test
658528|NCT00795925|propiverine|propiverine
658529|NCT00795925|anticholinergics|anticholinergics
658530|NCT00795925|urinary incontinence|urinary incontinence
658531|NCT00795925|overactive bladder|overactive bladder
658532|NCT00795925|children|children
658533|NCT00795925|dose-finding in children aged 5-10 years|dose-finding in children aged 5-10 years
658534|NCT00795912|Systolic heart failure|systolic heart failure
658535|NCT00795912|HMG CoA reductase inhibitors|hmg coa reductase inhibitors
658536|NCT00795912|B-type natriuretic peptide|b-type natriuretic peptide
658537|NCT00795912|Inflammation|inflammation
658538|NCT00795912|Myocardial collagen turnover|myocardial collagen turnover
658539|NCT00795899|Safety and efficacy of experimental treatment|safety and efficacy of experimental treatment
658540|NCT00795886|ALL|all
658541|NCT00795886|Cancer|cancer
658542|NCT00795886|Stem Cell Transplant|stem cell transplant
658543|NCT00795873|Heart failure|heart failure
658544|NCT00795873|cardiac resynchronization therapy|cardiac resynchronization therapy
658545|NCT00795860|Insulin sensitivity|insulin sensitivity
658546|NCT00795860|fat metabolism|fat metabolism
658547|NCT00795860|inflammation|inflammation
658548|NCT00795847|Hypertensive patients with morning hypertension|hypertensive patients with morning hypertension
658549|NCT00795834|polyphenolics|polyphenolics
658550|NCT00795834|flavonols|flavonols
658551|NCT00795834|lipids|lipids
658552|NCT00795834|endothelial function|endothelial function
658553|NCT00795834|vascular risk factors|vascular risk factors
658554|NCT00795808|Polycystic ovary syndrome|polycystic ovary syndrome
658555|NCT00795808|PCOS|pcos
658556|NCT00795808|Anovulation|anovulation
658557|NCT00795808|Infertility|infertility
658558|NCT00795808|Anovulatory polycystic ovary syndrome (PCOS)|anovulatory polycystic ovary syndrome (pcos)
658559|NCT00795795|Chromosomal abnormalities in preimplantation embryos|chromosomal abnormalities in preimplantation embryos
658560|NCT00795782|Papillary thyroid carcinoma|papillary thyroid carcinoma
658561|NCT00795782|Lymph node dissection|lymph node dissection
658562|NCT00795782|Lymph node metastasis|lymph node metastasis
658563|NCT00795782|Prophylactic node dissection|prophylactic node dissection
658564|NCT00795782|Central lymph node metastasis|central lymph node metastasis
658565|NCT00795756|Adults|adults
658566|NCT00795756|Central nervous system prophylaxis|central nervous system prophylaxis
658567|NCT00795756|Minimal residual disease|minimal residual disease
658568|NCT00795743|Central Venous Catheterization|central venous catheterization
658569|NCT00795743|coagulopathy|coagulopathy
658570|NCT00795743|thromboelastography|thromboelastography
658571|NCT00795730|Alzheimer's Disease|alzheimer's disease
658572|NCT00795730|schizophrenia|schizophrenia
658573|NCT00795717|HIV|hiv
658574|NCT00795717|cardiovascular risk|cardiovascular risk
658575|NCT00795717|atherogenic lipid profile|atherogenic lipid profile
658576|NCT00795717|brachial artery reactivity|brachial artery reactivity
658577|NCT00795717|omega three fatty acids|omega three fatty acids
658578|NCT00795704|Herbal Supplement|herbal supplement
658579|NCT00795704|Type 2 Diabetes|type 2 diabetes
658580|NCT00795704|Mulberry|mulberry
658581|NCT00795704|Hemoglobin A1C|hemoglobin a1c
658582|NCT00795691|diabetes|diabetes
658583|NCT00795691|low-carbohydrate diet|low-carbohydrate diet
658584|NCT00795691|weight loss|weight loss
658585|NCT00795691|obesity|obesity
658586|NCT00795691|dietary intervention|dietary intervention
658587|NCT00795678|tumors metastatic to brain|tumors metastatic to brain
658588|NCT00795678|stage IV breast cancer|stage iv breast cancer
658589|NCT00795665|adult anaplastic astrocytoma|adult anaplastic astrocytoma
658590|NCT00795665|adult glioblastoma|adult glioblastoma
658591|NCT00795665|adult gliosarcoma|adult gliosarcoma
658592|NCT00795665|adult giant cell glioblastoma|adult giant cell glioblastoma
658593|NCT00795665|adult anaplastic oligodendroglioma|adult anaplastic oligodendroglioma
658594|NCT00795665|adult mixed glioma|adult mixed glioma
658595|NCT00795665|recurrent adult brain tumor|recurrent adult brain tumor
658596|NCT00795652|Postpartum depression|postpartum depression
658597|NCT00795652|Distance therapy|distance therapy
658598|NCT00795652|depression|depression
658599|NCT00795652|Distance Treatment|distance treatment
658600|NCT00795652|Barriers to care|barriers to care
658601|NCT00795639|Sitaxsentan|sitaxsentan
658602|NCT00795639|endothelin receptor antagonist|endothelin receptor antagonist
658603|NCT00795626|nursing education|nursing education
658604|NCT00795626|cardiovascular risk factors|cardiovascular risk factors
658605|NCT00795626|coronary heart disease|coronary heart disease
658606|NCT00795613|PET|pet
658607|NCT00795574|Hidradenitis Suppurativa|hidradenitis suppurativa
658608|NCT00795561|Hyperemesis gravidarum|hyperemesis gravidarum
658609|NCT00795561|nausea|nausea
658610|NCT00795561|vomiting|vomiting
658611|NCT00795561|pregnancy|pregnancy
658612|NCT00795561|day care|day care
658613|NCT00795561|inpatient management|inpatient management
658614|NCT00795561|Nausea and vomiting of pregnancy|nausea and vomiting of pregnancy
658710|NCT00795093|PPI|ppi
658615|NCT00795548|Myelodysplastic syndrome (MDS)|myelodysplastic syndrome (mds)
658616|NCT00795548|Acute myeloid leukemia (AML)|acute myeloid leukemia (aml)
658617|NCT00795548|Stem cell transplantation|stem cell transplantation
658618|NCT00795548|5-Azacitidine|5-azacitidine
658619|NCT00795548|Donor lymphocyte infusion|donor lymphocyte infusion
658620|NCT00795548|MDS or AML relapsed after stem cell transplantation|mds or aml relapsed after stem cell transplantation
658621|NCT00795535|Injury|injury
658622|NCT00795496|Atopic dermatitis|atopic dermatitis
658623|NCT00795496|Bronchial hyperreactivity|bronchial hyperreactivity
658624|NCT00795496|Skin prick tests|skin prick tests
658625|NCT00795496|Serum IgE|serum ige
658626|NCT00795496|Mantoux test|mantoux test
658627|NCT00795483|Osteoporosis|osteoporosis
658628|NCT00795483|HIV infection|hiv infection
658629|NCT00795483|Bisphosphonates|bisphosphonates
658630|NCT00795483|Zoledronic acid|zoledronic acid
658631|NCT00795470|urinary tract infection|urinary tract infection
658632|NCT00795470|critically ill|critically ill
658633|NCT00795470|ICU|icu
658634|NCT00795470|antimicrobial|antimicrobial
658635|NCT00795470|Catheter associated urinary tract infections|catheter associated urinary tract infections
658636|NCT00795457|vaccine|vaccine
658637|NCT00795457|WHO Grade II Astrocytoma|who grade ii astrocytoma
658638|NCT00795457|WHO Grade II Oligo-Astrocytoma|who grade ii oligo-astrocytoma
658639|NCT00795444|HIV-1|hiv-1
658640|NCT00795444|CCR5 coreceptor antagonist (Maraviroc)|ccr5 coreceptor antagonist (maraviroc)
658641|NCT00795444|the cell reservoir of HIV-1|the cell reservoir of hiv-1
658642|NCT00795418|Active immunization|active immunization
658643|NCT00795418|Alzheimer's disease|alzheimer's disease
658644|NCT00795418|Antibody|antibody
658645|NCT00795418|Vaccine|vaccine
658646|NCT00795418|Central Nervous System Diseases|central nervous system diseases
658647|NCT00795418|Neurodegenerative diseases|neurodegenerative diseases
658648|NCT00795405|sporting events|sporting events
658649|NCT00795405|stress|stress
658650|NCT00795405|myocardial ischemia|myocardial ischemia
658651|NCT00795405|ST-segment depression|st-segment depression
658652|NCT00795405|blood pressure|blood pressure
658653|NCT00795392|Psychology|psychology
658654|NCT00795392|Postoperative outcome|postoperative outcome
658655|NCT00795392|Surgical Operation|surgical operation
658656|NCT00795379|Psychotherapy|psychotherapy
658657|NCT00795366|TBI, trauma, brain|tbi, trauma, brain
658658|NCT00795353|plaque psoriasis|plaque psoriasis
658659|NCT00795353|psoriasis|psoriasis
658660|NCT00795353|alefacept|alefacept
658661|NCT00795353|Amevive|amevive
658662|NCT00795340|stage IIIB non-small cell lung cancer|stage iiib non-small cell lung cancer
658663|NCT00795340|stage IV non-small cell lung cancer|stage iv non-small cell lung cancer
658664|NCT00795340|recurrent non-small cell lung cancer|recurrent non-small cell lung cancer
658665|NCT00795314|Opioids|opioids
658666|NCT00795314|General anesthesia|general anesthesia
658667|NCT00795301|tumor|tumor
658668|NCT00795288|subarachnoid hemorrhage|subarachnoid hemorrhage
658669|NCT00795288|vasospasm|vasospasm
658670|NCT00795288|cerebral blood flow|cerebral blood flow
658671|NCT00795288|cerebral metabolism|cerebral metabolism
658672|NCT00795288|autoregulation|autoregulation
658673|NCT00795288|statin|statin
658674|NCT00795288|Vasospasm associated with Subarachnoid hemorrhage|vasospasm associated with subarachnoid hemorrhage
658675|NCT00795275|pre-diabetes|pre-diabetes
658676|NCT00795275|isotopes|isotopes
658677|NCT00795275|insulin secretion|insulin secretion
658678|NCT00795275|insulin action|insulin action
658679|NCT00795275|GLP-1|glp-1
658680|NCT00795275|simple obesity|simple obesity
658681|NCT00795275|impaired fasting glucose|impaired fasting glucose
658682|NCT00795262|brachial artery reactivity|brachial artery reactivity
658683|NCT00795236|melatonin|melatonin
658684|NCT00795210|HIV lipodystrophy|hiv lipodystrophy
658685|NCT00795210|growth hormone|growth hormone
658686|NCT00795210|growth hormone releasing hormone|growth hormone releasing hormone
658687|NCT00795197|Gaucher Disease,|gaucher disease,
658688|NCT00795197|acid B-glucosidase,|acid b-glucosidase,
658689|NCT00795197|gluco cerebrosidase,|gluco cerebrosidase,
658690|NCT00795197|glucosylceramide,|glucosylceramide,
658691|NCT00795184|Barrett's Esophagus|barrett's esophagus
658692|NCT00795184|EsoGastroDuodenoscopy|esogastroduodenoscopy
658693|NCT00795184|Barrett's Carcinoma|barrett's carcinoma
658694|NCT00795184|adenocarcinoma|adenocarcinoma
658695|NCT00795184|Cellvizio|cellvizio
658696|NCT00795184|endomicroscopy|endomicroscopy
658697|NCT00795184|random biopsy|random biopsy
658698|NCT00795145|Linezolid, QTc interval, pharmacokinetics, therapeutic dose, supra-therapeutic dose|linezolid, qtc interval, pharmacokinetics, therapeutic dose, supra-therapeutic dose
658699|NCT00795132|cancer|cancer
658700|NCT00795132|Hematologic Malignancies|hematologic malignancies
658701|NCT00795132|Hematopoietic Cell Transplantation|hematopoietic cell transplantation
658702|NCT00795119|Near Infrared Spectroscopy|near infrared spectroscopy
658703|NCT00795119|Diagnosis|diagnosis
658704|NCT00795119|Children|children
658705|NCT00795106|Capsaicin|capsaicin
658706|NCT00795106|hydrogel|hydrogel
658707|NCT00795106|myofascial pain syndrome|myofascial pain syndrome
658708|NCT00795106|neck pain|neck pain
658709|NCT00795093|GERD|gerd
658711|NCT00795093|partial responders|partial responders
658712|NCT00795080|CVJ malformations|cvj malformations
658713|NCT00795054|Stem cell transplantation|stem cell transplantation
658714|NCT00795054|Financial impact|financial impact
658715|NCT00795041|vitrification|vitrification
658716|NCT00795041|ovarian stimulation|ovarian stimulation
658717|NCT00795041|reproductive medicine|reproductive medicine
658718|NCT00795028|older women|older women
658719|NCT00795028|hip fracture|hip fracture
658720|NCT00795028|exercise intervention|exercise intervention
658721|NCT00795015|postoperative blood glucose control|postoperative blood glucose control
658722|NCT00795015|IV insulin infusion|iv insulin infusion
658723|NCT00794989|breast cancer|breast cancer
658724|NCT00794989|atypical ductal breast hyperplasia|atypical ductal breast hyperplasia
658725|NCT00794989|lobular breast carcinoma in situ|lobular breast carcinoma in situ
658726|NCT00794989|ductal breast carcinoma in situ|ductal breast carcinoma in situ
658727|NCT00794989|breast cancer prevention|breast cancer prevention
658728|NCT00794989|high risk breast cancer|high risk breast cancer
658729|NCT00794950|Bladder Cancer|bladder cancer
658730|NCT00794950|High Risk Non-muscle Invasive Lower Urinary Tract Urothelial Carcinoma|high risk non-muscle invasive lower urinary tract urothelial carcinoma
658731|NCT00794924|probiotics|probiotics
658732|NCT00794924|elderly|elderly
658733|NCT00794924|motility|motility
658734|NCT00794924|diarrhea|diarrhea
658735|NCT00794911|Liver Transplantation|liver transplantation
658736|NCT00794911|Quality of Life|quality of life
658737|NCT00794911|Chronic HCV|chronic hcv
658738|NCT00794911|Hepatitis C Virus|hepatitis c virus
658739|NCT00794911|Cirrhosis|cirrhosis
658740|NCT00794911|Liver disease|liver disease
658741|NCT00794885|hypertension|hypertension
658742|NCT00794885|stroke|stroke
658743|NCT00794885|cardiovascular events|cardiovascular events
658744|NCT00794885|enalapril|enalapril
658745|NCT00794885|folic acid|folic acid
658746|NCT00794885|randomized controlled trial|randomized controlled trial
658747|NCT00794885|MTHFR C677T genotype|mthfr c677t genotype
658748|NCT00794872|Cardiovascular autonomic neuropathy|cardiovascular autonomic neuropathy
658749|NCT00794872|Chemoreflex sensitivity|chemoreflex sensitivity
658750|NCT00794872|Chronic kidney disease|chronic kidney disease
658751|NCT00794872|Sudden cardiac arrest|sudden cardiac arrest
658752|NCT00794820|Chronic Lymphocytic Leukemia|chronic lymphocytic leukemia
658753|NCT00794820|CLL|cll
658754|NCT00794820|Leukemia|leukemia
658755|NCT00794820|Fludarabine phosphate|fludarabine phosphate
658756|NCT00794820|Cyclophosphamide|cyclophosphamide
658757|NCT00794820|Rituximab|rituximab
658758|NCT00794820|FCR|fcr
658759|NCT00794820|Cytoxan®|cytoxan®
658760|NCT00794820|Neosar®|neosar®
658761|NCT00794820|Rituxan®|rituxan®
658762|NCT00794807|Alefacept|alefacept
658763|NCT00794807|Skin Diseases|skin diseases
658764|NCT00794807|Psoriasis|psoriasis
658765|NCT00794807|Skin Diseases, Papulosquamos|skin diseases, papulosquamos
658766|NCT00794807|Therapeutic Uses|therapeutic uses
658767|NCT00794807|Dermatologic Agents|dermatologic agents
658768|NCT00794781|Cancer|cancer
658769|NCT00794781|solid tumors|solid tumors
658770|NCT00794755|Vitamin K|vitamin k
658771|NCT00794755|Vitamin K1 (Phytonadione)|vitamin k1 (phytonadione)
658772|NCT00794755|Unstable INR|unstable inr
658773|NCT00794755|VTE or Thrombosis|vte or thrombosis
658774|NCT00794755|Warfarin|warfarin
658775|NCT00794755|Anticoagulation Control|anticoagulation control
658776|NCT00794755|Patients on warfarin with unstable anticoagulation control|patients on warfarin with unstable anticoagulation control
658777|NCT00794742|Burn|burn
658778|NCT00794742|Antimicrobial|antimicrobial
658779|NCT00794742|Bacteria|bacteria
658780|NCT00794742|Resistance|resistance
658781|NCT00794742|Biofilm|biofilm
658782|NCT00794742|Pathogen|pathogen
658783|NCT00794729|Healthy Volunteers|healthy volunteers
658784|NCT00794729|Consents|consents
658785|NCT00794703|Antifungal|antifungal
658786|NCT00794703|micafungin|micafungin
658787|NCT00794703|itraconazole|itraconazole
658788|NCT00794690|cimicifuga racemosa|cimicifuga racemosa
658789|NCT00794690|liver blood flow and functions|liver blood flow and functions
658790|NCT00794677|Hypercholesterolemia|hypercholesterolemia
658791|NCT00794677|Oxysterol|oxysterol
658792|NCT00794677|Ezetimibe|ezetimibe
658793|NCT00794677|Zetia|zetia
658794|NCT00794651|osteoarthritis|osteoarthritis
658795|NCT00794651|testing kit|testing kit
658796|NCT00794651|knee|knee
658797|NCT00794638|Non-Hodgkin's Lymphoma|non-hodgkin's lymphoma
658798|NCT00794638|Diffuse Large B-Cell Lymphoma|diffuse large b-cell lymphoma
658799|NCT00794638|Mantle cell Lymphoma|mantle cell lymphoma
658800|NCT00794638|Transformed lymphoma, transformed to diffuse large B-cell lymphoma|transformed lymphoma, transformed to diffuse large b-cell lymphoma
658801|NCT00794638|Follicular Lymphoma|follicular lymphoma
658802|NCT00794625|Attention-Deficit/Hyperactivity Disorder|attention-deficit/hyperactivity disorder
658803|NCT00794625|Aggressive Behavior|aggressive behavior
658804|NCT00794625|Oppositional Defiant Disorder|oppositional defiant disorder
658805|NCT00794625|Conduct Disorder|conduct disorder
658806|NCT00794586|cystic fibrosis|cystic fibrosis
658807|NCT00794586|CF|cf
658808|NCT00794586|inhaled antibiotic|inhaled antibiotic
658809|NCT00794586|antipseudomonal antibiotic|antipseudomonal antibiotic
658810|NCT00794586|tobramycin|tobramycin
658811|NCT00794586|fosfomycin|fosfomycin
658812|NCT00794586|lung infection|lung infection
658813|NCT00794586|pseudomonal infection|pseudomonal infection
658814|NCT00794586|FTI|fti
658815|NCT00794573|Smoking Cessation|smoking cessation
658816|NCT00794573|Cardiac Population|cardiac population
658817|NCT00794573|Acute Coronary Syndrome|acute coronary syndrome
658818|NCT00794573|Varenicline|varenicline
658819|NCT00794573|Champix|champix
658820|NCT00794560|Heparin, Low-Molecular-Weight|heparin, low-molecular-weight
658821|NCT00794560|compliance|compliance
658822|NCT00794560|drug safety|drug safety
658823|NCT00794560|self-administration|self-administration
658824|NCT00794560|ambulatory Care|ambulatory care
658825|NCT00794560|Pharmaceutical Services|pharmaceutical services
658826|NCT00794547|lung cancer; nsclc|lung cancer; nsclc
658827|NCT00794508|Severe Combined Immune Deficiency|severe combined immune deficiency
658828|NCT00794508|Adenosine Deaminase Deficiency|adenosine deaminase deficiency
658829|NCT00794508|Gene Therapy|gene therapy
658830|NCT00794508|Hematopoietic Stem Cells|hematopoietic stem cells
658831|NCT00794508|Retroviral Vector|retroviral vector
658832|NCT00794508|ADA-deficient SCID|ada-deficient scid
658833|NCT00794469|Resting metabolic rate|resting metabolic rate
658834|NCT00794456|Passiflora|passiflora
658835|NCT00794456|Crataegus|crataegus
658836|NCT00794456|Herbal|herbal
658837|NCT00794456|Valeriana|valeriana
658838|NCT00794456|anxiety|anxiety
658839|NCT00794443|ONO-5920|ono-5920
658840|NCT00794443|YM529|ym529
658841|NCT00794443|Bone mineral density|bone mineral density
658842|NCT00794443|Minodronic acid|minodronic acid
658843|NCT00794430|Safety|safety
658844|NCT00794430|Tolerability|tolerability
658845|NCT00794430|Efficacy|efficacy
658846|NCT00794430|Patients|patients
658847|NCT00794430|Diabetic peripheral neuropathic pain.|diabetic peripheral neuropathic pain.
658848|NCT00794417|advanced cancer|advanced cancer
658849|NCT00794417|lung cancer|lung cancer
658850|NCT00794417|NSCLC|nsclc
658851|NCT00794417|Non-small Cell Lung Cancer|non-small cell lung cancer
658852|NCT00794417|aflibercept|aflibercept
658853|NCT00794417|chemotherapy|chemotherapy
658854|NCT00794391|Vulnerable Populations|vulnerable populations
658855|NCT00794391|Injecting drug users|injecting drug users
658856|NCT00794391|IDU|idu
658857|NCT00794391|Risky injecting practices|risky injecting practices
658858|NCT00794391|Psychotherapy, brief|psychotherapy, brief
658859|NCT00794391|Motivational interviewing|motivational interviewing
658860|NCT00794391|Educational activities|educational activities
658861|NCT00794391|Clinical trial|clinical trial
658862|NCT00794391|Risk behavior|risk behavior
658863|NCT00794391|risk reduction behavior|risk reduction behavior
658864|NCT00794365|Smoking; smoking cessation; Philippines; Varenicline|smoking; smoking cessation; philippines; varenicline
658865|NCT00794352|Inflammation|inflammation
658866|NCT00794352|Multiple Sclerosis|multiple sclerosis
658867|NCT00794352|Neuroimmunology|neuroimmunology
658868|NCT00794352|Immune Disorder|immune disorder
658869|NCT00794352|Neuroimaging|neuroimaging
658870|NCT00794352|Central Nervous System Disease|central nervous system disease
658871|NCT00794352|Healthy Volunteers|healthy volunteers
658872|NCT00794352|HV|hv
658873|NCT00794339|cervical squamous cell carcinoma|cervical squamous cell carcinoma
658874|NCT00794339|stage IIB cervical cancer|stage iib cervical cancer
658875|NCT00794339|stage III cervical cancer|stage iii cervical cancer
658876|NCT00794339|stage IV cervical cancer|stage iv cervical cancer
658877|NCT00794339|stage IVA cervical cancer|stage iva cervical cancer
658878|NCT00794339|stage IB cervical cancer|stage ib cervical cancer
658879|NCT00794339|stage IIA cervical cancer|stage iia cervical cancer
658880|NCT00794326|Chronic Kidney Failure|chronic kidney failure
658881|NCT00794326|Peritoneal Dialysis|peritoneal dialysis
658882|NCT00794326|Low sodium solution|low sodium solution
658883|NCT00794326|Hypertension|hypertension
658884|NCT00794326|Total Body Water|total body water
658885|NCT00794313|Parkinsons disease|parkinsons disease
658886|NCT00794313|dyskinesia|dyskinesia
658887|NCT00794313|amantadine|amantadine
658888|NCT00794313|efficacy|efficacy
658889|NCT00794300|reproducibility|reproducibility
658890|NCT00794300|contrast agent|contrast agent
658891|NCT00794300|magnetic resonance imaging|magnetic resonance imaging
658892|NCT00794300|infarct size|infarct size
658893|NCT00794300|myocardial salvage index|myocardial salvage index
658894|NCT00794300|myocardial salvage assessment|myocardial salvage assessment
658895|NCT00794274|Sarcodiosis|sarcodiosis
658896|NCT00794274|tumor necrosis factor|tumor necrosis factor
658897|NCT00794261|Myeloma|myeloma
658898|NCT00794261|lymphoma|lymphoma
658899|NCT00794261|high-dose chemotherapy|high-dose chemotherapy
658900|NCT00794261|PSC infusion, autologous|psc infusion, autologous
658901|NCT00794261|neutropenia|neutropenia
658902|NCT00794261|thrombocytopenia|thrombocytopenia
658903|NCT00794261|hospital stay|hospital stay
658904|NCT00794261|infection|infection
659003|NCT00793767|Erythropoietin|erythropoietin
659880|NCT00790192|SM-13496|sm-13496
658905|NCT00794261|Autologous PSC transplantation for patients with lymphoma or myeloma treated with high-dose chemotherapy|autologous psc transplantation for patients with lymphoma or myeloma treated with high-dose chemotherapy
658906|NCT00794222|Cellular phones|cellular phones
658907|NCT00794222|mental health|mental health
658908|NCT00794222|Early intervention|early intervention
658909|NCT00794222|prevention|prevention
658910|NCT00794222|momentary sampling|momentary sampling
658911|NCT00794222|Adolescent|adolescent
658912|NCT00794209|AeroLEF, fentanyl, liposome encapsulated, opioid|aerolef, fentanyl, liposome encapsulated, opioid
658913|NCT00794196|Medication adherence|medication adherence
658914|NCT00794196|Antidepressive agents|antidepressive agents
658915|NCT00794196|Primary care|primary care
658916|NCT00794196|Pharmaceutical care|pharmaceutical care
658917|NCT00794183|heart failure|heart failure
658918|NCT00794183|CRT|crt
658919|NCT00794183|CHF|chf
658920|NCT00794170|Treatment Compliance|treatment compliance
658921|NCT00794157|COPD|copd
658922|NCT00794157|chronic obstructive pulmonary disease|chronic obstructive pulmonary disease
658923|NCT00794157|indacaterol|indacaterol
658924|NCT00794157|long acting β2-agonist|long acting β2-agonist
658925|NCT00794144|Allergic Rhinitis|allergic rhinitis
658926|NCT00794144|Pediatric|pediatric
658927|NCT00794144|PATANASE|patanase
658928|NCT00794131|cancer|cancer
658929|NCT00794131|vaccinia virus|vaccinia virus
658930|NCT00794131|vaccinia|vaccinia
658931|NCT00794131|oncolytic|oncolytic
658932|NCT00794131|oncolytic virus|oncolytic virus
658933|NCT00794131|biological|biological
658934|NCT00794131|imaging|imaging
658935|NCT00794105|Gas|gas
658936|NCT00794105|Middle ear|middle ear
658937|NCT00794079|Healthy volunteers|healthy volunteers
658938|NCT00794079|young adults|young adults
658939|NCT00794079|Aged|aged
658940|NCT00794066|PAD|pad
658941|NCT00794066|Stroke|stroke
658942|NCT00794066|ICH|ich
658943|NCT00794066|prevalence|prevalence
658944|NCT00794053|Sentinel lymph node|sentinel lymph node
658945|NCT00794053|thyroid cancer|thyroid cancer
658946|NCT00794053|neck dissection|neck dissection
658947|NCT00794040|Irritability|irritability
658948|NCT00794040|Attention Deficit Hyperactivity Disorder|attention deficit hyperactivity disorder
658949|NCT00794040|Explosive|explosive
658950|NCT00794040|Tantrums|tantrums
658951|NCT00794040|Bipolar Mood Disorder|bipolar mood disorder
658952|NCT00794040|Mood Disorder|mood disorder
658953|NCT00794040|Childhood Mood Disorder|childhood mood disorder
658954|NCT00794040|ADHD|adhd
658955|NCT00794027|heart failure|heart failure
658956|NCT00794027|yoga|yoga
658957|NCT00794027|quality of life|quality of life
658958|NCT00794014|Angioplasty, Transluminal, Percutaneous Coronary|angioplasty, transluminal, percutaneous coronary
658959|NCT00794001|myocardial infarction|myocardial infarction
658960|NCT00794001|angioplasty|angioplasty
658961|NCT00794001|data feedback|data feedback
658962|NCT00794001|continuous quality improvement|continuous quality improvement
658963|NCT00794001|STEMI|stemi
658964|NCT00794001|Feedback|feedback
658965|NCT00794001|Quality Assurance, Health Care|quality assurance, health care
658966|NCT00794001|Emergency service hospital|emergency service hospital
658967|NCT00793988|vibration|vibration
658968|NCT00793988|local anaesthesia|local anaesthesia
658969|NCT00793988|ptosis surgery|ptosis surgery
658970|NCT00793988|blepharoplasty|blepharoplasty
658971|NCT00793988|Upper eyelid surgery|upper eyelid surgery
658972|NCT00793988|dermatochalasis +/- blepharoptosis|dermatochalasis +/- blepharoptosis
658973|NCT00793975|Tumors|tumors
658974|NCT00793975|Antibodies, Monoclonal|antibodies, monoclonal
658975|NCT00793962|breast cancer|breast cancer
658976|NCT00793962|mastectomy|mastectomy
658977|NCT00793962|radiotherapy|radiotherapy
658978|NCT00793962|fractionation|fractionation
658979|NCT00793936|Right Double Lumen Tube|right double lumen tube
658980|NCT00793923|Exudative Age Related Macular Degeneration|exudative age related macular degeneration
658981|NCT00793910|Gabapentin|gabapentin
658982|NCT00793910|PRK|prk
658983|NCT00793910|pain|pain
658984|NCT00793897|Subjects with Advanced or Metastatic Solid Tumors or Neoplasms|subjects with advanced or metastatic solid tumors or neoplasms
658985|NCT00793884|Diabetes|diabetes
658986|NCT00793884|Latino population|latino population
658987|NCT00793871|sunitinib|sunitinib
658988|NCT00793871|Phase IV|phase iv
658989|NCT00793871|gastrointestinal stomal tumor|gastrointestinal stomal tumor
658990|NCT00793871|imatinib resistant or intolerant|imatinib resistant or intolerant
658991|NCT00793871|Chinese|chinese
658992|NCT00793845|tandem high-dose chemotherapy for high-risk neuroblastoma|tandem high-dose chemotherapy for high-risk neuroblastoma
658993|NCT00793832|weight loss|weight loss
658994|NCT00793819|nocturia|nocturia
658995|NCT00793819|BPH|bph
658996|NCT00793819|benign prostate hyperplasia|benign prostate hyperplasia
658997|NCT00793819|nocturia in men with benign prostate hyperplasia|nocturia in men with benign prostate hyperplasia
658998|NCT00793806|chronic kidney disease|chronic kidney disease
658999|NCT00793780|obesity|obesity
659000|NCT00793780|schizophrenia|schizophrenia
659001|NCT00793780|schizoaffective disorder|schizoaffective disorder
659002|NCT00793780|weight loss|weight loss
659004|NCT00793767|human muscle tissue|human muscle tissue
659005|NCT00793767|insulin sensitivity|insulin sensitivity
659006|NCT00793767|substrate metabolism|substrate metabolism
659007|NCT00793741|Type 1 diabetes|type 1 diabetes
659008|NCT00793741|Hypoglycemia unawareness|hypoglycemia unawareness
659009|NCT00793741|Islet transplant|islet transplant
659010|NCT00793728|Morbid obesity|morbid obesity
659011|NCT00793728|High risk|high risk
659012|NCT00793715|acute pancreatitis|acute pancreatitis
659013|NCT00793715|abdominal compartment syndrome|abdominal compartment syndrome
659014|NCT00793715|decompressive laparotomy|decompressive laparotomy
659015|NCT00793715|percutaneous abdominal puncture|percutaneous abdominal puncture
659016|NCT00793715|Mortality of patients treated in both arms|mortality of patients treated in both arms
659017|NCT00793702|tuberculosis|tuberculosis
659018|NCT00793702|diagnosis|diagnosis
659019|NCT00793702|ESAT-6|esat-6
659020|NCT00793702|CFP-10|cfp-10
659021|NCT00793702|skin test|skin test
659022|NCT00793702|Skin test for the diagnosis of tuberculosis infection|skin test for the diagnosis of tuberculosis infection
659023|NCT00793689|parathyroid|parathyroid
659024|NCT00793689|thyroidectomy|thyroidectomy
659025|NCT00793689|hypoparathyroidism|hypoparathyroidism
659026|NCT00793689|Parathyroid function after total thyroidectomy|parathyroid function after total thyroidectomy
659027|NCT00793676|GPCR expression|gpcr expression
659028|NCT00793676|transcriptomic|transcriptomic
659029|NCT00793676|white blood cells|white blood cells
659030|NCT00793676|diagnostic|diagnostic
659031|NCT00793676|Control|control
659032|NCT00793663|Xenon|xenon
659033|NCT00793663|Sevoflurane|sevoflurane
659034|NCT00793663|Postoperative Nausea and vomiting|postoperative nausea and vomiting
659035|NCT00793663|Depth of anaesthesia|depth of anaesthesia
659036|NCT00793650|Cancer|cancer
659037|NCT00793650|Multiple Myeloma|multiple myeloma
659038|NCT00793650|Peripheral Blood Stem Cell Transplant|peripheral blood stem cell transplant
659039|NCT00793637|Angular stable locking system|angular stable locking system
659040|NCT00793637|Handling test|handling test
659041|NCT00793637|Complications|complications
659042|NCT00793611|Overactive Bladder|overactive bladder
659043|NCT00793611|Hypnotherapy|hypnotherapy
659044|NCT00793598|CMX001|cmx001
659045|NCT00793598|Kidney transplant|kidney transplant
659046|NCT00793598|HSCT transplant|hsct transplant
659047|NCT00793598|BK Virus|bk virus
659048|NCT00793598|Post kidney transplant patients with BK virus viruria > 10^4|post kidney transplant patients with bk virus viruria > 10^4
659049|NCT00793598|Post HSCT transplant patients with BK virus viruria > 10^4|post hsct transplant patients with bk virus viruria > 10^4
659050|NCT00793585|IgA nephropathy|iga nephropathy
659051|NCT00793559|septic shock refractory to catecholamines|septic shock refractory to catecholamines
659052|NCT00793546|Bosutinib|bosutinib
659053|NCT00793546|Exemestane|exemestane
659054|NCT00793546|postmenopausal|postmenopausal
659055|NCT00793546|breast cancer|breast cancer
659056|NCT00793520|fibromyalgia|fibromyalgia
659057|NCT00793520|milnacipran|milnacipran
659058|NCT00793520|Forest Laboratories|forest laboratories
659059|NCT00793507|childhood caries|childhood caries
659185|NCT00792883|Resistance|resistance
659060|NCT00793494|Irritable bowel syndrome|irritable bowel syndrome
659061|NCT00793494|Children|children
659062|NCT00793494|Pediatrics|pediatrics
659063|NCT00793494|Probiotics|probiotics
659064|NCT00793481|Metabolic Syndrome|metabolic syndrome
659065|NCT00793468|nicotine dependence|nicotine dependence
659066|NCT00793468|smoking|smoking
659067|NCT00793468|pharmacological treatment|pharmacological treatment
659068|NCT00793468|relapse prevention|relapse prevention
659069|NCT00793455|education|education
659070|NCT00793455|preventive service|preventive service
659071|NCT00793455|screening|screening
659072|NCT00793442|sepsis|sepsis
659073|NCT00793442|severe sepsis|severe sepsis
659074|NCT00793442|septic shock|septic shock
659075|NCT00793442|endothelium|endothelium
659076|NCT00793442|microcirculation|microcirculation
659077|NCT00793442|biomarkers|biomarkers
659078|NCT00793429|electrocardiographic safety|electrocardiographic safety
659079|NCT00793429|pharmacokinetics|pharmacokinetics
659080|NCT00793416|Normal Pressure Hydrocephalus|normal pressure hydrocephalus
659081|NCT00793416|Valve Adjustment|valve adjustment
659082|NCT00793416|Blocked Shunt in NPH patients|blocked shunt in nph patients
659083|NCT00793416|Diagnosis of blockage|diagnosis of blockage
659084|NCT00793403|Observational cohort|observational cohort
659085|NCT00793403|prospectives|prospectives
659086|NCT00793403|multicentre|multicentre
659087|NCT00793403|the Italian study RA patient CLARA and PRO-CLARA|the italian study ra patient clara and pro-clara
659088|NCT00793390|Aggressive Breat Cancer|aggressive breat cancer
659089|NCT00793364|Cholesterol, stanol-ester, mediterranean diet, cardiac risk|cholesterol, stanol-ester, mediterranean diet, cardiac risk
659090|NCT00793351|reduced intensity stem cell transplantation for neuroblastoma|reduced intensity stem cell transplantation for neuroblastoma
659091|NCT00793351|relapsed neuroblastoma after high-dose chemotherapy and autologous stem cell rescue|relapsed neuroblastoma after high-dose chemotherapy and autologous stem cell rescue
659092|NCT00793338|Heart failure|heart failure
659093|NCT00793338|Sildenafil|sildenafil
659094|NCT00793338|Cardiopulmonary exercise test|cardiopulmonary exercise test
659095|NCT00793338|quality of life|quality of life
659096|NCT00793338|6 minute walk test|6 minute walk test
659097|NCT00793286|inguinal hernia|inguinal hernia
659098|NCT00793286|laparoscopy|laparoscopy
659099|NCT00793286|mesh|mesh
659100|NCT00793234|TKR|tkr
659101|NCT00793234|VTE|vte
659102|NCT00793234|DVT|dvt
659103|NCT00793221|Coronary stent.|coronary stent.
659104|NCT00793221|Restenosis.|restenosis.
659105|NCT00793221|Coronary artery disease.|coronary artery disease.
659106|NCT00793221|Chronic total occlusion.|chronic total occlusion.
659107|NCT00793208|Lung cancer|lung cancer
659108|NCT00793208|non small cell|non small cell
659109|NCT00793208|vaccine|vaccine
659110|NCT00793208|carcinoma|carcinoma
659111|NCT00793208|immunization|immunization
659112|NCT00793208|autologous Tumor|autologous tumor
659113|NCT00793208|vaccination|vaccination
659114|NCT00793195|Neonates|neonates
839573|NCT00088751|FTD|ftd
659115|NCT00793195|Short Bowel Syndrome|short bowel syndrome
659116|NCT00793195|Intestinal Failure|intestinal failure
659117|NCT00793195|Liver Failure|liver failure
659118|NCT00793195|Parenteral Nutrition|parenteral nutrition
659119|NCT00793195|Intralipid|intralipid
659120|NCT00793195|SMOF|smof
659121|NCT00793182|Renal|renal
659122|NCT00793182|Kidney|kidney
659123|NCT00793182|Contrast Induced Nephropathy|contrast induced nephropathy
659124|NCT00793169|squamous cell carcinoma of the head or neck|squamous cell carcinoma of the head or neck
659125|NCT00793156|uremic pruritus|uremic pruritus
659126|NCT00793143|morbid obesity|morbid obesity
659127|NCT00793143|laparoscopic sleeve gastrectomy|laparoscopic sleeve gastrectomy
659128|NCT00793143|LSG|lsg
659129|NCT00793143|laparoscopic gastric bypass|laparoscopic gastric bypass
659130|NCT00793143|LGB|lgb
659131|NCT00793143|comorbidities|comorbidities
659132|NCT00793143|diabetes|diabetes
659133|NCT00793143|excessive weight loss|excessive weight loss
659134|NCT00793143|weight loss|weight loss
659135|NCT00793130|Ulcerative|ulcerative
659136|NCT00793130|Colitis|colitis
659137|NCT00793130|Coltect|coltect
659138|NCT00793130|Curcumin|curcumin
659139|NCT00793130|Green tea|green tea
659140|NCT00793130|Selenium|selenium
659141|NCT00793130|inflammation|inflammation
659142|NCT00793130|bowel|bowel
659143|NCT00793117|chronic sinusitis|chronic sinusitis
659144|NCT00793117|FESS|fess
659145|NCT00793117|packing|packing
659146|NCT00793104|allograft|allograft
659147|NCT00793104|knee injury|knee injury
659148|NCT00793104|cartilage injury|cartilage injury
659149|NCT00793104|Osteochondral defects in the articular femoral cartilage|osteochondral defects in the articular femoral cartilage
659150|NCT00793078|sepsis|sepsis
659151|NCT00793078|arterial blood pressure|arterial blood pressure
659152|NCT00793078|complexity|complexity
659153|NCT00793078|variability|variability
659154|NCT00793065|electronic health records|electronic health records
659155|NCT00793065|health information technology|health information technology
659156|NCT00793065|physician incentives|physician incentives
659157|NCT00793065|quality of health care|quality of health care
659158|NCT00793052|trismus|trismus
659159|NCT00793052|Edema|edema
659160|NCT00793052|pain|pain
659161|NCT00793013|Acute Lung Injury|acute lung injury
659162|NCT00793013|Adult Respiratory Distress Syndrome|adult respiratory distress syndrome
659163|NCT00793013|Airway Pressure Release Ventilation|airway pressure release ventilation
659164|NCT00793013|Acute Kidney Injury|acute kidney injury
659165|NCT00793013|Pressure Trial|pressure trial
659166|NCT00793000|Safety tolerability pharmacokinetics PK first in human FIH|safety tolerability pharmacokinetics pk first in human fih
659167|NCT00792974|Cognitive behavioral education|cognitive behavioral education
659168|NCT00792974|COPD (Chronic Obstructive Pulmonary Disease), GOLD II-IV|copd (chronic obstructive pulmonary disease), gold ii-iv
659169|NCT00792961|Prostate cancer|prostate cancer
659170|NCT00792961|Robotic surgery|robotic surgery
659171|NCT00792961|Endomicroscopy|endomicroscopy
659172|NCT00792922|Trachoma|trachoma
659173|NCT00792922|Azithromycin|azithromycin
659174|NCT00792922|Mass treatment|mass treatment
659175|NCT00792909|Pneumococcal vaccine|pneumococcal vaccine
659176|NCT00792909|Pneumococcal disease|pneumococcal disease
659177|NCT00792909|Safety|safety
659178|NCT00792909|Immunogenicity|immunogenicity
659179|NCT00792883|PICU|picu
659180|NCT00792883|BIA|bia
659181|NCT00792883|Phase angle|phase angle
659182|NCT00792883|RQ|rq
659183|NCT00792883|EEM|eem
659184|NCT00792883|Compliance|compliance
659186|NCT00792883|Curves|curves
659187|NCT00792883|Polymorphisms|polymorphisms
659188|NCT00792883|NF-kappa B|nf-kappa b
659189|NCT00792883|Scores|scores
659190|NCT00792883|PIM 2|pim 2
659191|NCT00792883|PRISM I|prism i
659192|NCT00792870|Obesity|obesity
659193|NCT00792870|Weight loss|weight loss
659194|NCT00792870|Internet|internet
659195|NCT00792857|Parathyroid Diseases|parathyroid diseases
659196|NCT00792857|Renal Insufficiency|renal insufficiency
659197|NCT00792857|Kidney Failure, Chronic|kidney failure, chronic
659198|NCT00792857|Hyperparathyroidism, Secondary|hyperparathyroidism, secondary
659199|NCT00792857|Vitamin D|vitamin d
659200|NCT00792857|Hyperparathyroidism|hyperparathyroidism
659201|NCT00792857|Renal Insufficiency, Chronic|renal insufficiency, chronic
659202|NCT00792857|Kidney Diseases|kidney diseases
659203|NCT00792857|Kidney Failure|kidney failure
659204|NCT00792818|Osteoarthritis, Knee, Curcumin, Multicenter, RCT|osteoarthritis, knee, curcumin, multicenter, rct
659206|NCT00792805|indacaterol|indacaterol
659207|NCT00792805|long-acting β2-agonist|long-acting β2-agonist
659208|NCT00792805|adults|adults
659209|NCT00792792|tissue transfer|tissue transfer
659210|NCT00792779|Morbid obesity|morbid obesity
659211|NCT00792779|General anaesthesia|general anaesthesia
659212|NCT00792779|Propofol|propofol
659213|NCT00792779|Sevoflurane|sevoflurane
659214|NCT00792766|Tuberous Sclerosis Complex (TSC)|tuberous sclerosis complex (tsc)
659215|NCT00792766|Angiolipoma|angiolipoma
659216|NCT00792766|mTOR|mtor
659217|NCT00792766|Everolimus|everolimus
659218|NCT00792753|Coronary Artery Disease|coronary artery disease
659219|NCT00792727|Pain|pain
659220|NCT00792727|Knee|knee
659221|NCT00792727|Arthritis|arthritis
659222|NCT00792727|Knee pain|knee pain
659223|NCT00792701|stage I non-small cell lung cancer|stage i non-small cell lung cancer
659224|NCT00792688|burn wounds|burn wounds
659225|NCT00792688|wound healing|wound healing
659226|NCT00792675|exercise|exercise
659227|NCT00792675|disease activity|disease activity
659228|NCT00792675|inflammation|inflammation
659229|NCT00792675|resistance training|resistance training
659230|NCT00792675|rehabilitation|rehabilitation
659231|NCT00792662|Diabetes Mellitus|diabetes mellitus
659232|NCT00792662|Alzheimer's Disease|alzheimer's disease
659233|NCT00792662|Apathy|apathy
659234|NCT00792662|Methylphenidate|methylphenidate
659235|NCT00792662|Dementia|dementia
659236|NCT00792636|sumatriptan and naproxen sodium|sumatriptan and naproxen sodium
659237|NCT00792636|migraine with or without aura|migraine with or without aura
659238|NCT00792636|naproxen sodium|naproxen sodium
659239|NCT00792636|sumatriptan|sumatriptan
659240|NCT00792636|blood pressure|blood pressure
659241|NCT00792636|migraine headaches|migraine headaches
659242|NCT00792623|Varicella|varicella
659243|NCT00792623|VarilrixTM|varilrixtm
659244|NCT00792610|youth|youth
659245|NCT00792610|hepatitis B|hepatitis b
659246|NCT00792610|vaccination|vaccination
659247|NCT00792610|booster|booster
659248|NCT00792610|immunity response|immunity response
659249|NCT00792584|etravirine|etravirine
659250|NCT00792584|efavirenz|efavirenz
659251|NCT00792584|anxiety|anxiety
659252|NCT00792584|depression|depression
659253|NCT00792584|sleep quality|sleep quality
659254|NCT00792584|HIV|hiv
659255|NCT00792584|NNRTI|nnrti
659256|NCT00792584|Tritherapy|tritherapy
659257|NCT00792584|compliance|compliance
659258|NCT00792584|stocrin|stocrin
659259|NCT00792584|To replace efavirenz in long-term users with etravirine|to replace efavirenz in long-term users with etravirine
659260|NCT00792584|To investigate effect of such replacement on patient preference, sleep quality, daytime sleepiness, and anxiety|to investigate effect of such replacement on patient preference, sleep quality, daytime sleepiness, and anxiety
659261|NCT00792519|alcohol use|alcohol use
659262|NCT00792519|HIV|hiv
659263|NCT00792519|cognitive behavioral treatment|cognitive behavioral treatment
659264|NCT00792519|Kenya|kenya
659265|NCT00792519|hazardous/binge drinking|hazardous/binge drinking
659266|NCT00792519|alcohol abuse/dependence|alcohol abuse/dependence
659267|NCT00792493|Healthy volunteer study|healthy volunteer study
659268|NCT00792480|Obesity|obesity
659269|NCT00792480|Pregnancy|pregnancy
659270|NCT00792480|Exercise|exercise
659271|NCT00792480|Nutrition|nutrition
659272|NCT00792480|obesity in pregnancy|obesity in pregnancy
659273|NCT00792454|Chronic kidney disease|chronic kidney disease
659274|NCT00792454|End stage renal disease|end stage renal disease
659275|NCT00792454|Exercise|exercise
659276|NCT00792454|Cardiovascular disease|cardiovascular disease
659277|NCT00792441|Specific inspiratory muscle training(SIMT)|specific inspiratory muscle training(simt)
659278|NCT00792441|Loaded deep breathing|loaded deep breathing
659279|NCT00792441|Weaning|weaning
659280|NCT00792441|Mechanical ventilation|mechanical ventilation
659281|NCT00792441|Respiratory muscle|respiratory muscle
659282|NCT00792428|Stroke|stroke
659283|NCT00792428|Ischemia|ischemia
659284|NCT00792428|Infarction|infarction
659285|NCT00792428|Cerebrovascular Disorder|cerebrovascular disorder
659286|NCT00792428|Central Nervous System Diseases|central nervous system diseases
659287|NCT00792428|Brain Infarction|brain infarction
659288|NCT00792428|Brain Ischemia|brain ischemia
659289|NCT00792428|Rehabilitation|rehabilitation
659290|NCT00792428|Recovery|recovery
659291|NCT00792428|Neurorehabilitation|neurorehabilitation
659292|NCT00792428|Plasticity|plasticity
659293|NCT00792415|Abstinence syndrome symptoms|abstinence syndrome symptoms
659294|NCT00792415|Withdrawal symptoms|withdrawal symptoms
659295|NCT00792415|Opioid dependence|opioid dependence
659296|NCT00792402|chronic heart failure|chronic heart failure
659297|NCT00792402|Computerized clinical guidelines|computerized clinical guidelines
659298|NCT00792402|Primary care|primary care
659299|NCT00792389|Gallstones|gallstones
659300|NCT00792389|Gallbladder|gallbladder
659301|NCT00792389|Cholecystectomy|cholecystectomy
659302|NCT00792389|Gallstone disease|gallstone disease
659303|NCT00792376|NSAID|nsaid
659304|NCT00792376|tendon|tendon
659305|NCT00792376|pain|pain
659306|NCT00792376|stiffness|stiffness
659307|NCT00792376|Achilles|achilles
659308|NCT00792363|KRAS|kras
659309|NCT00792350|Carcinoma, Hepatocellular|carcinoma, hepatocellular
659310|NCT00792350|Sorafenib|sorafenib
659311|NCT00792311|Tsui test|tsui test
659312|NCT00792311|Epidural Analgesia|epidural analgesia
659313|NCT00792285|Colon cancer|colon cancer
659314|NCT00792285|Prevention|prevention
659315|NCT00792285|Screening|screening
659316|NCT00792285|Telephone|telephone
659317|NCT00792272|aspirin resistance|aspirin resistance
659318|NCT00792272|aspirin resistance in hemodialysis patients|aspirin resistance in hemodialysis patients
659319|NCT00792246|pharmacokinetics|pharmacokinetics
659320|NCT00792246|pediatric|pediatric
659321|NCT00792246|bioavailability|bioavailability
659322|NCT00792233|Poly JIA|poly jia
659323|NCT00792233|TNF|tnf
659324|NCT00792233|Remission|remission
659325|NCT00792220|stroke|stroke
659326|NCT00792220|mobile stroke unit|mobile stroke unit
659327|NCT00792220|thrombolysis|thrombolysis
659328|NCT00792220|stroke management|stroke management
659329|NCT00792220|computerized tomography|computerized tomography
659330|NCT00792194|Cystic fibrosis|cystic fibrosis
659331|NCT00792194|Exercise training|exercise training
659332|NCT00792194|Home training|home training
659333|NCT00792194|Aerobic capacity|aerobic capacity
659334|NCT00792181|The focus is the pain reduce in the first 15 minutes for patients suffering an acute myocardial infarction, treated by caregivers in Ambulance service.|the focus is the pain reduce in the first 15 minutes for patients suffering an acute myocardial infarction, treated by caregivers in ambulance service.
659335|NCT00792155|PKD|pkd
659336|NCT00792142|neurotoxicity|neurotoxicity
659337|NCT00792142|stage I multiple myeloma|stage i multiple myeloma
659338|NCT00792142|stage II multiple myeloma|stage ii multiple myeloma
659339|NCT00792142|stage III multiple myeloma|stage iii multiple myeloma
659340|NCT00792129|MIS|mis
659341|NCT00792129|Minimally invasive|minimally invasive
659342|NCT00792129|Atavi|atavi
659343|NCT00792129|Flex Posure|flex posure
659344|NCT00792129|retractor|retractor
659345|NCT00792129|Patients with chronic low back and/or leg pain who are candidates for elective lumbar interbody fusion through a posterior unilateral approach,|patients with chronic low back and/or leg pain who are candidates for elective lumbar interbody fusion through a posterior unilateral approach,
659346|NCT00792129|for inclusion in the study.|for inclusion in the study.
659347|NCT00792129|If the patient meets all of the eligibility criteria,|if the patient meets all of the eligibility criteria,
659348|NCT00792129|they will be enrolled into the study and have either the MiLIF or open procedure depending on the surgeon they present to|they will be enrolled into the study and have either the milif or open procedure depending on the surgeon they present to
659349|NCT00792129|(i.e., what group their surgeon agreed to participate in.)|(i.e., what group their surgeon agreed to participate in.)
659350|NCT00792090|allergy|allergy
659351|NCT00792090|cow's milk|cow's milk
659352|NCT00792090|sensibilisation|sensibilisation
659353|NCT00792090|fermented milk|fermented milk
659354|NCT00792090|infant formula|infant formula
659355|NCT00792077|Leukemia|leukemia
659356|NCT00792077|Lenalidomide|lenalidomide
659357|NCT00792077|Actigraph|actigraph
659358|NCT00792077|Sleep Test Study|sleep test study
659359|NCT00792077|Chronic Lymphocytic Leukemia|chronic lymphocytic leukemia
659360|NCT00792077|CC-5013|cc-5013
659361|NCT00792077|Revlimid|revlimid
659362|NCT00792064|quality of life|quality of life
659363|NCT00792064|adverse effects|adverse effects
659364|NCT00792051|influenza|influenza
659365|NCT00792051|vaccination|vaccination
659366|NCT00792051|children|children
659367|NCT00792051|Influenza-like illness|influenza-like illness
659368|NCT00792038|Psychological tests|psychological tests
659369|NCT00792038|Magnetic Resonance Imaging|magnetic resonance imaging
659370|NCT00792038|Cognitive therapy|cognitive therapy
659371|NCT00792025|metastatic transitional cell cancer of the renal pelvis and ureter|metastatic transitional cell cancer of the renal pelvis and ureter
659372|NCT00792025|recurrent transitional cell cancer of the renal pelvis and ureter|recurrent transitional cell cancer of the renal pelvis and ureter
659373|NCT00792025|regional transitional cell cancer of the renal pelvis and ureter|regional transitional cell cancer of the renal pelvis and ureter
659374|NCT00792025|stage III bladder cancer|stage iii bladder cancer
659375|NCT00792025|stage IV bladder cancer|stage iv bladder cancer
659376|NCT00792025|transitional cell carcinoma of the bladder|transitional cell carcinoma of the bladder
659377|NCT00792025|recurrent bladder cancer|recurrent bladder cancer
659378|NCT00792012|Glioblastoma Multiforme|glioblastoma multiforme
659379|NCT00791999|Rheumatoid Arthritis|rheumatoid arthritis
659380|NCT00791999|Certolizumab Pegol|certolizumab pegol
659381|NCT00791999|Cimzia|cimzia
659382|NCT00791986|Breathing exercise|breathing exercise
659383|NCT00791986|blood pressure|blood pressure
659384|NCT00791986|hypertension|hypertension
659385|NCT00791960|Cesarean Section|cesarean section
659386|NCT00791960|Dimenhydrinate|dimenhydrinate
659387|NCT00791960|Gravol|gravol
659388|NCT00791960|Antiemetics|antiemetics
659389|NCT00791921|Rheumatoid Arthritis|rheumatoid arthritis
659390|NCT00791921|Certolizumab Pegol|certolizumab pegol
659391|NCT00791921|Cimzia|cimzia
659392|NCT00791869|bupropion|bupropion
659393|NCT00791869|smoking|smoking
659394|NCT00791869|pharmacokinetics|pharmacokinetics
659395|NCT00791869|Pharmacokinetics of bupropion|pharmacokinetics of bupropion
659396|NCT00791843|CHF|chf
659397|NCT00791830|Residual renal function|residual renal function
659398|NCT00791830|Haemodialysis|haemodialysis
659399|NCT00791830|Applanation tonometry|applanation tonometry
659400|NCT00791830|Cardiac output|cardiac output
659401|NCT00791830|Quality of life|quality of life
659402|NCT00791830|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers
659403|NCT00791817|pharmacokinetics study|pharmacokinetics study
659404|NCT00791804|Pain|pain
659405|NCT00791804|Post Op pain|post op pain
659406|NCT00791804|Fentanyl|fentanyl
659407|NCT00791804|Pain Control|pain control
659408|NCT00791804|Surgery|surgery
659409|NCT00791791|Anesthesia General|anesthesia general
659410|NCT00791791|Anesthetics Inhalation|anesthetics inhalation
659411|NCT00791791|Stress measurement|stress measurement
659412|NCT00791791|Surgical Stress|surgical stress
659413|NCT00791791|Diagnostic Techniques and Procedures|diagnostic techniques and procedures
659414|NCT00791778|Peritoneal Neoplasma|peritoneal neoplasma
659415|NCT00791765|Scalp|scalp
659416|NCT00791765|Psoriasis|psoriasis
659417|NCT00791765|Plaque Psoriasis|plaque psoriasis
659418|NCT00791765|Skin Diseases|skin diseases
659419|NCT00791765|Moderate to severe plaque psoriasis|moderate to severe plaque psoriasis
659420|NCT00791765|etanercept|etanercept
659421|NCT00791752|Safety and Tolerability|safety and tolerability
659422|NCT00791739|fibromyalgia|fibromyalgia
659423|NCT00791739|trazodone|trazodone
659424|NCT00791739|pregabalin|pregabalin
659425|NCT00791739|Fibromyalgia Impact Questionnaire (FIQ)|fibromyalgia impact questionnaire (fiq)
659426|NCT00791739|Pittsburgh Sleep Quality Inventory (PSQI)|pittsburgh sleep quality inventory (psqi)
659427|NCT00791739|Brief Pain Inventory (BPI)|brief pain inventory (bpi)
659428|NCT00791726|microperimetry|microperimetry
659429|NCT00791726|macular edema|macular edema
659430|NCT00791726|uveitis|uveitis
659431|NCT00791726|Retinal sensitivity as measured with fundus related microperimetry|retinal sensitivity as measured with fundus related microperimetry
659432|NCT00791713|Paliperidone ER|paliperidone er
659433|NCT00791713|Antipsychotic drugs|antipsychotic drugs
659434|NCT00791713|Selective serotonin reuptake inhibitors|selective serotonin reuptake inhibitors
659435|NCT00791713|Mood disorders|mood disorders
659436|NCT00791713|Schizophrenia|schizophrenia
659437|NCT00791700|Open label pharmacokinetic safety and efficacy in HIV-1 infected pediatrics|open label pharmacokinetic safety and efficacy in hiv-1 infected pediatrics
659438|NCT00791687|Antioxidant enzymes|antioxidant enzymes
659439|NCT00791687|Glutathione|glutathione
659440|NCT00791687|Oxidative stress|oxidative stress
659441|NCT00791687|Prematurity|prematurity
659442|NCT00791687|Respiratory distress|respiratory distress
659443|NCT00791687|Non enzymatic antioxidant defense system|non enzymatic antioxidant defense system
659444|NCT00791687|Enzymatic antioxidant defense system|enzymatic antioxidant defense system
659445|NCT00791674|Opiates|opiates
659446|NCT00791674|sleep apnea|sleep apnea
659447|NCT00791674|ventilatory failure|ventilatory failure
659448|NCT00791648|aki|aki
659449|NCT00791648|delirium|delirium
659450|NCT00791648|statin|statin
659451|NCT00791648|short-term|short-term
659452|NCT00791648|cardiac|cardiac
659453|NCT00791635|Cervical Cancer|cervical cancer
659454|NCT00791635|Vaginal Cancer|vaginal cancer
659455|NCT00791635|Endometrial Cancer|endometrial cancer
659456|NCT00791635|Cervix|cervix
659457|NCT00791635|Endometrial|endometrial
659458|NCT00791635|Pelvic Exenteration|pelvic exenteration
659459|NCT00791635|Pelvic Exenteration Surgery|pelvic exenteration surgery
659460|NCT00791635|Questionnaire|questionnaire
659461|NCT00791635|Gynecologic Cancer|gynecologic cancer
659462|NCT00791635|Vagina|vagina
659463|NCT00791635|Vulva|vulva
659464|NCT00791635|Gynecologic Malignancy|gynecologic malignancy
659465|NCT00791622|Paliperidone ER|paliperidone er
659466|NCT00791622|Schizophernia|schizophernia
659467|NCT00791622|Mood Disorders, Antipsychotic drugs|mood disorders, antipsychotic drugs
659468|NCT00791622|Cardiovascular|cardiovascular
659469|NCT00791622|Schizoaffective Disorder|schizoaffective disorder
659470|NCT00791609|cancer|cancer
659471|NCT00791596|Ergonomic intervention|ergonomic intervention
659472|NCT00791596|Musculoskeletal disorders|musculoskeletal disorders
659473|NCT00791596|Low back pain|low back pain
659474|NCT00791596|Posture|posture
659475|NCT00791596|Video display terminal|video display terminal
659476|NCT00791583|Emergency Medicine (EM)|emergency medicine (em)
659477|NCT00791583|Central Venous Catheter (CVC)|central venous catheter (cvc)
659478|NCT00791583|Maximal Barrier Precaution (MBP)|maximal barrier precaution (mbp)
659479|NCT00791583|Precaution Technique during Central Venous Cathether Placement|precaution technique during central venous cathether placement
659480|NCT00791544|monoclonal antibody, anti IGF1R|monoclonal antibody, anti igf1r
659481|NCT00791531|Methotrexate|methotrexate
659482|NCT00791531|Malaria|malaria
659483|NCT00791518|Chronic Obstructive Pulmonary Disease (COPD)|chronic obstructive pulmonary disease (copd)
659484|NCT00791518|Spirometry|spirometry
659485|NCT00791505|chronic obstructive pulmonary disease|chronic obstructive pulmonary disease
659486|NCT00791505|pulmonary infection|pulmonary infection
659487|NCT00791505|antibiotic|antibiotic
659488|NCT00791492|FAP|fap
659489|NCT00791492|Familial Amyloid Polyneuropathy|familial amyloid polyneuropathy
659490|NCT00791492|ATTR-PN|attr-pn
659491|NCT00791492|transthyretin|transthyretin
659492|NCT00791492|TTR|ttr
659493|NCT00791492|amyloid|amyloid
659494|NCT00791492|polyneuropathy|polyneuropathy
659495|NCT00791492|familial|familial
659496|NCT00791492|hereditary|hereditary
659497|NCT00791492|amyloidosis|amyloidosis
659498|NCT00791492|FoldRx|foldrx
659499|NCT00791479|Diabetes, type 2 diabetes|diabetes, type 2 diabetes
659500|NCT00791466|Iodine deficiency|iodine deficiency
659501|NCT00791466|Pregnancy|pregnancy
659502|NCT00791466|Thyroid function|thyroid function
659503|NCT00791466|Infant development|infant development
659504|NCT00791466|Growth|growth
659505|NCT00791453|Diabetic patients at the Clarksdale Diabetes|diabetic patients at the clarksdale diabetes
659506|NCT00791453|and Metabolism Clinic and must be between the|and metabolism clinic and must be between the
659507|NCT00791453|ages of 18 and 64 years of age.|ages of 18 and 64 years of age.
659508|NCT00791440|Schizophrenia|schizophrenia
659509|NCT00791440|Schizoaffective|schizoaffective
659510|NCT00791440|Schizophreniform|schizophreniform
659511|NCT00791440|Psychosis|psychosis
659512|NCT00791440|Psychotic|psychotic
659513|NCT00791440|Hallucinations|hallucinations
659514|NCT00791440|Delusions|delusions
659515|NCT00791440|Paranoia|paranoia
659516|NCT00791440|Paranoid|paranoid
659517|NCT00791440|Voices|voices
659518|NCT00791440|CBT|cbt
659519|NCT00791440|Cognitive Behavior Therapy|cognitive behavior therapy
659520|NCT00791440|Cognitive Therapy|cognitive therapy
659521|NCT00791401|Schizophrenia|schizophrenia
659522|NCT00791401|Mood disorders|mood disorders
659523|NCT00791401|Antipsychotic drugs|antipsychotic drugs
659524|NCT00791401|ER OROS Paliperidone|er oros paliperidone
659525|NCT00791388|Pharmacokinetics|pharmacokinetics
659526|NCT00791375|young adult|young adult
659527|NCT00791375|cancer|cancer
659528|NCT00791375|exercise|exercise
659529|NCT00791375|physical activity|physical activity
659530|NCT00791362|accreditation|accreditation
659531|NCT00791362|cardiovascular disease|cardiovascular disease
659532|NCT00791362|primary care|primary care
659533|NCT00791349|Schizophrenia|schizophrenia
659534|NCT00791349|Schizoaffective Disorder|schizoaffective disorder
659535|NCT00791349|Mood Disorders|mood disorders
659536|NCT00791349|Antipsychotic drugs|antipsychotic drugs
659537|NCT00791349|Cardiovascular|cardiovascular
659538|NCT00791349|Immediate release (IR) Paliperidone|immediate release (ir) paliperidone
659539|NCT00791336|NSCLC|nsclc
659540|NCT00791336|chemotherapy|chemotherapy
659541|NCT00791336|radiation therapy|radiation therapy
659542|NCT00791336|nelfinavir|nelfinavir
659543|NCT00791336|NFV|nfv
659544|NCT00791310|Medical ICU|medical icu
659545|NCT00791310|Severe sepsis|severe sepsis
659546|NCT00791297|CDB-2914|cdb-2914
659547|NCT00791297|Contraceptive Vaginal Rings|contraceptive vaginal rings
659548|NCT00791297|ovulation|ovulation
659549|NCT00791297|endometrial changes|endometrial changes
659550|NCT00791297|bleeding patterns|bleeding patterns
659551|NCT00791297|normal cycling women|normal cycling women
659552|NCT00791297|Inhibition of ovulation, endometrial changes and bleeding patterns in normal cycling women|inhibition of ovulation, endometrial changes and bleeding patterns in normal cycling women
659553|NCT00791284|Schizophrenia|schizophrenia
659554|NCT00791284|Mood disorders|mood disorders
659555|NCT00791284|Antipsychotic drugs|antipsychotic drugs
659556|NCT00791284|intermediate release (IR) Paliperidone|intermediate release (ir) paliperidone
659557|NCT00791271|Melanoma|melanoma
659558|NCT00791271|Malignant melanoma|malignant melanoma
659559|NCT00791271|Unresectable|unresectable
659560|NCT00791271|Decitabine|decitabine
659561|NCT00791271|PEG Interferon Alpha-2b|peg interferon alpha-2b
659562|NCT00791271|PEG Intron|peg intron
659563|NCT00791271|5-Aza-Deoxycytidine|5-aza-deoxycytidine
659564|NCT00791271|Dacogen|dacogen
659565|NCT00791245|ISTO Technologies, Inc|isto technologies, inc
659566|NCT00791245|cartilage repair|cartilage repair
659567|NCT00791245|arthroscopy|arthroscopy
659568|NCT00791245|361 HCT/P|361 hct/p
659569|NCT00791245|human tissue|human tissue
659570|NCT00791245|biologic|biologic
659571|NCT00791245|knee|knee
659572|NCT00791232|Extended-release paliperidone|extended-release paliperidone
659573|NCT00791232|Schizophrenia, Mood disorders, Antipsychotic drugs|schizophrenia, mood disorders, antipsychotic drugs
659574|NCT00791232|ER OROS paliperidone|er oros paliperidone
659575|NCT00791219|Onychomycosis|onychomycosis
659576|NCT00791206|exercise|exercise
659577|NCT00791206|ischemia|ischemia
659578|NCT00791206|MRI|mri
659579|NCT00791206|MRI spectroscopy|mri spectroscopy
659580|NCT00791206|Ischemia preconditioning|ischemia preconditioning
659581|NCT00791193|Paliperidone ER|paliperidone er
659582|NCT00791193|Antipsychotic drugs|antipsychotic drugs
659583|NCT00791193|Schizophrenia|schizophrenia
659584|NCT00791193|Mood disorders|mood disorders
659779|NCT00790452|Brain|brain
659585|NCT00791180|dynamic stabilization|dynamic stabilization
659586|NCT00791180|Dynesys|dynesys
659587|NCT00791180|fusion success|fusion success
659588|NCT00791180|Immobilization of spinal segments as an adjunct to fusion in the treatment of the following:|immobilization of spinal segments as an adjunct to fusion in the treatment of the following:
659589|NCT00791180|acute and chronic instabilities or deformities of the thoracic, lumbar, and sacral spine|acute and chronic instabilities or deformities of the thoracic, lumbar, and sacral spine
659590|NCT00791180|degenerative spondylolisthesis with objective evidence of neurologic impairment|degenerative spondylolisthesis with objective evidence of neurologic impairment
659591|NCT00791180|failed previous fusion (pseudarthrosis).|failed previous fusion (pseudarthrosis).
659592|NCT00791167|Mood Disorders, Antipsychotic drugs|mood disorders, antipsychotic drugs
659593|NCT00791167|Schizophrenia|schizophrenia
659594|NCT00791167|Paliperidone ER|paliperidone er
659595|NCT00791154|Extensive disease|extensive disease
659596|NCT00791154|Extrathoracic metasasis|extrathoracic metasasis
659597|NCT00791154|Malignant pericardial effusion|malignant pericardial effusion
659598|NCT00791154|Malignant pleural effusion|malignant pleural effusion
659599|NCT00791154|Contralateral hilar adenopathy|contralateral hilar adenopathy
659600|NCT00791141|Head and Neck Cancer|head and neck cancer
659601|NCT00791141|Radiation therapy|radiation therapy
659602|NCT00791141|Chemotherapy|chemotherapy
659603|NCT00791141|Chemoradiotherapy|chemoradiotherapy
659604|NCT00791141|adjuvant cetuximab administration|adjuvant cetuximab administration
659605|NCT00791128|Type 2 Diabetes|type 2 diabetes
659606|NCT00791115|Prostate cancer|prostate cancer
659607|NCT00791115|prostatectomy|prostatectomy
659608|NCT00791115|radiotherapy|radiotherapy
659609|NCT00791115|prostatectomy after radiotherapy|prostatectomy after radiotherapy
659610|NCT00791089|Radiofrequency Ablation|radiofrequency ablation
659611|NCT00791089|atrial fibrillation|atrial fibrillation
659612|NCT00791076|Insulin pump therapy|insulin pump therapy
659613|NCT00791076|Type 1 diabetic|type 1 diabetic
659614|NCT00791076|Chronic pancreatitis|chronic pancreatitis
659615|NCT00791076|Pancreatic resection|pancreatic resection
659616|NCT00791076|Pancreatic polypeptide|pancreatic polypeptide
659617|NCT00791063|cell death|cell death
659618|NCT00791063|Apoptosis|apoptosis
659619|NCT00791063|PET imaging|pet imaging
659620|NCT00791063|brain metastases|brain metastases
659621|NCT00791063|whole brain radiation therapy|whole brain radiation therapy
659622|NCT00791050|Hypothermia/complications/etiology|hypothermia/complications/etiology
659623|NCT00791050|coronary artery bypass/adverse effects|coronary artery bypass/adverse effects
659624|NCT00791024|Analgesia Tests|analgesia tests
659625|NCT00791024|Analog Pain Scale|analog pain scale
659626|NCT00791024|Pain Measurement|pain measurement
659627|NCT00791011|Lymphoma|lymphoma
659628|NCT00791011|AMG 655|amg 655
659629|NCT00791011|Trail receptor|trail receptor
659630|NCT00791011|Apoptosis|apoptosis
659631|NCT00791011|Vorinostat|vorinostat
659632|NCT00791011|Bortezomib|bortezomib
659633|NCT00791011|SAHA|saha
659634|NCT00791011|Velcade|velcade
659635|NCT00790998|onchocerciasis|onchocerciasis
659636|NCT00790998|river blindness|river blindness
659637|NCT00790998|onchocerca volvulus|onchocerca volvulus
659638|NCT00790998|moxidectin|moxidectin
659639|NCT00790998|ivermectin|ivermectin
659640|NCT00790972|MRSA|mrsa
659641|NCT00790972|sinofresh|sinofresh
659642|NCT00790972|nasal spray|nasal spray
659643|NCT00790959|Intimate Partner Violence|intimate partner violence
659644|NCT00790959|HIV/AIDS|hiv/aids
659645|NCT00790959|Gender|gender
659646|NCT00790959|Prevention|prevention
659647|NCT00790959|Community mobilisation|community mobilisation
659648|NCT00790959|Uganda|uganda
659649|NCT00790946|valsartan|valsartan
659650|NCT00790946|Metabolic syndrome|metabolic syndrome
659651|NCT00790933|Drug therapy|drug therapy
659652|NCT00790920|Acute ischemic stroke|acute ischemic stroke
659653|NCT00790920|Angiography|angiography
659654|NCT00790920|Desmoteplase|desmoteplase
659655|NCT00790920|Thrombolytic|thrombolytic
659656|NCT00790907|Unstable angina|unstable angina
659657|NCT00790907|Non ST elevation myocardial infarction|non st elevation myocardial infarction
659658|NCT00790907|PCI|pci
659659|NCT00790907|unfractionated heparin|unfractionated heparin
659660|NCT00790907|fondaparinux|fondaparinux
659661|NCT00790907|acute coronary syndrome|acute coronary syndrome
659662|NCT00790881|malaria|malaria
659663|NCT00790881|HIV|hiv
659664|NCT00790881|AIDS|aids
659665|NCT00790881|nevirapine|nevirapine
659666|NCT00790881|lumefantrine|lumefantrine
659667|NCT00790881|artemether|artemether
659668|NCT00790881|drug interaction|drug interaction
659669|NCT00790881|pharmacokinetics|pharmacokinetics
659670|NCT00790868|Panic Disorder|panic disorder
659671|NCT00790868|Anxiety|anxiety
659672|NCT00790868|D-cycloserine|d-cycloserine
659673|NCT00790868|DCS|dcs
659674|NCT00790868|Cognitive Behavioral Therapy|cognitive behavioral therapy
659675|NCT00790868|CBT|cbt
659676|NCT00790855|Bendamustine|bendamustine
659677|NCT00790855|Acute Leukemia|acute leukemia
659678|NCT00790855|Leukemia|leukemia
659679|NCT00790855|Acute myeloid leukemia|acute myeloid leukemia
659680|NCT00790855|Myelodysplastic Syndrome|myelodysplastic syndrome
659681|NCT00790855|Acute lymphoblastic leukemia|acute lymphoblastic leukemia
659682|NCT00790855|Chronic myeloid leukemia|chronic myeloid leukemia
659683|NCT00790855|MDS|mds
659684|NCT00790855|ALL|all
659685|NCT00790855|AML|aml
659686|NCT00790855|CML|cml
659687|NCT00790842|Refractory Multiple Myeloma|refractory multiple myeloma
659688|NCT00790842|Relapsed Multiple Myeloma|relapsed multiple myeloma
659689|NCT00790842|Multiple Myeloma with Renal Dysfunction|multiple myeloma with renal dysfunction
659690|NCT00790842|Stage I Multiple Myeloma|stage i multiple myeloma
659691|NCT00790842|Stage II Multiple Myeloma|stage ii multiple myeloma
659692|NCT00790842|Stage III Multiple Myeloma|stage iii multiple myeloma
659693|NCT00790829|preemptive|preemptive
659694|NCT00790829|Nicotine Patch|nicotine patch
659695|NCT00790829|Open Abdominal Surgery|open abdominal surgery
659696|NCT00790816|Cancer|cancer
659697|NCT00790816|lapatinib|lapatinib
659698|NCT00790816|Combination therapy|combination therapy
659699|NCT00790816|Chronic administration|chronic administration
659700|NCT00790803|uveitis|uveitis
659701|NCT00790803|cystoid macular edema|cystoid macular edema
659702|NCT00790777|Paliperidone ER|paliperidone er
659703|NCT00790777|Schizophrenia, Mood disorders, Antipsychotic drugs|schizophrenia, mood disorders, antipsychotic drugs
659704|NCT00790751|ED|ed
659705|NCT00790751|Erectile Dysfunction|erectile dysfunction
659706|NCT00790751|Dysfunction|dysfunction
659707|NCT00790751|Erectile|erectile
659708|NCT00790738|bipolar disorder|bipolar disorder
659709|NCT00790738|depression|depression
659710|NCT00790738|treatment|treatment
659711|NCT00790738|randomized controlled trial|randomized controlled trial
659712|NCT00790699|diabetes|diabetes
659713|NCT00790699|Symlin|symlin
659714|NCT00790699|pramlintide acetate|pramlintide acetate
659715|NCT00790699|insulin|insulin
659716|NCT00790699|multiple injection port|multiple injection port
659717|NCT00790699|I-PORT|i-port
659718|NCT00790686|Ureteral obstruction|ureteral obstruction
659719|NCT00790686|Urologic surgical procedure|urologic surgical procedure
659720|NCT00790686|Stents|stents
659721|NCT00790686|Endoscopy|endoscopy
659722|NCT00790686|Urology|urology
659723|NCT00790673|Hepatitis C|hepatitis c
659724|NCT00790673|Viral hepatitis|viral hepatitis
659725|NCT00790660|ASP1941|asp1941
659726|NCT00790660|Type 2 Diabetes Mellitus|type 2 diabetes mellitus
659727|NCT00790647|primary systemic amyloidosis|primary systemic amyloidosis
659728|NCT00790595|Prostatectomy|prostatectomy
659729|NCT00790582|ALS|als
659730|NCT00790582|Amyotrophic Lateral Sclerosis|amyotrophic lateral sclerosis
659731|NCT00790582|Lou Gehrig's Disease|lou gehrig's disease
659732|NCT00790582|Lithium|lithium
659733|NCT00790582|Lithium Carbonate|lithium carbonate
659734|NCT00790569|bladder cancer|bladder cancer
659735|NCT00790569|cervical cancer|cervical cancer
659736|NCT00790569|esophageal cancer|esophageal cancer
659737|NCT00790569|gastric cancer|gastric cancer
659738|NCT00790569|renal cell carcinoma|renal cell carcinoma
659739|NCT00790569|adult primary liver cancer|adult primary liver cancer
659740|NCT00790569|non-small cell lung cancer|non-small cell lung cancer
659741|NCT00790569|small cell lung cancer|small cell lung cancer
659742|NCT00790569|pancreatic cancer|pancreatic cancer
659743|NCT00790569|hypopharyngeal cancer|hypopharyngeal cancer
659744|NCT00790569|laryngeal cancer|laryngeal cancer
659745|NCT00790569|lip and oral cavity cancer|lip and oral cavity cancer
659746|NCT00790569|nasopharyngeal cancer|nasopharyngeal cancer
659747|NCT00790569|oropharyngeal cancer|oropharyngeal cancer
659748|NCT00790569|paranasal sinus and nasal cavity cancer|paranasal sinus and nasal cavity cancer
659749|NCT00790569|adult acute myeloid leukemia|adult acute myeloid leukemia
659750|NCT00790569|tobacco use disorder|tobacco use disorder
659751|NCT00790543|Crohn's Disease|crohn's disease
659752|NCT00790543|Inflammatory Bowel Disease|inflammatory bowel disease
659753|NCT00790530|Diabetes|diabetes
659754|NCT00790530|Information Technology|information technology
659755|NCT00790530|Health Plans|health plans
659756|NCT00790517|Weight loss|weight loss
659757|NCT00790517|Diabetes prevention|diabetes prevention
659758|NCT00790517|Serious mental illness|serious mental illness
659759|NCT00790517|Antipsychotic medications|antipsychotic medications
659760|NCT00790517|Lifestyle intervention|lifestyle intervention
659761|NCT00790517|Antipsychotic Agents|antipsychotic agents
659762|NCT00790504|Pelvic floor|pelvic floor
659763|NCT00790504|Transperineal ultrasound|transperineal ultrasound
659764|NCT00790504|Multiple pregnancy|multiple pregnancy
659765|NCT00790504|Singleton pregnancy|singleton pregnancy
659766|NCT00790504|Female pelvic floor|female pelvic floor
659767|NCT00790491|reduction in risk of heart disease and diabetes|reduction in risk of heart disease and diabetes
659768|NCT00790478|Ulcerative Colitis|ulcerative colitis
659769|NCT00790478|Melatonin|melatonin
659770|NCT00790478|Gastrointestinal|gastrointestinal
659771|NCT00790478|Irritable Bowel syndrome|irritable bowel syndrome
659772|NCT00790478|Sleep|sleep
659773|NCT00790478|Pilot Study|pilot study
659774|NCT00790465|achalasia|achalasia
659775|NCT00790465|lower esophageal sphincter|lower esophageal sphincter
659776|NCT00790465|nitric oxide|nitric oxide
659777|NCT00790465|dark chocolate|dark chocolate
659778|NCT00790465|flavanols|flavanols
659780|NCT00790452|Hematologic Disorder|hematologic disorder
659781|NCT00790452|Venous Thromboembolism|venous thromboembolism
659782|NCT00790452|Glioblastoma|glioblastoma
659783|NCT00790452|Aspirin|aspirin
659784|NCT00790452|Placebo|placebo
659785|NCT00790452|VTE|vte
659786|NCT00790452|ASA|asa
659787|NCT00790452|DVT|dvt
659788|NCT00790439|Insulin dependence|insulin dependence
659789|NCT00790426|Advanced urothelial cancer|advanced urothelial cancer
659790|NCT00790413|Radiotherapy|radiotherapy
659791|NCT00790413|Immunotherapy|immunotherapy
659792|NCT00790413|Hematopoietic Stem Cell Transplantation|hematopoietic stem cell transplantation
659793|NCT00790400|Angiomyolipoma|angiomyolipoma
659794|NCT00790400|AML|aml
659795|NCT00790400|Tuberous Sclerosis Complex|tuberous sclerosis complex
659796|NCT00790400|TSC|tsc
659797|NCT00790400|mTOR|mtor
659798|NCT00790400|RAD001|rad001
659799|NCT00790400|Mammalian Target of Rapamycin|mammalian target of rapamycin
659800|NCT00790400|Everolimus|everolimus
659801|NCT00790400|Afinitor|afinitor
659802|NCT00790400|SEGA|sega
660050|NCT00789503|osteoporosis|osteoporosis
659803|NCT00790400|Subependymal Giant Cell Astrocytoma|subependymal giant cell astrocytoma
659804|NCT00790400|Seizures|seizures
659805|NCT00790400|Tuberous sclerosis complex (TSC)|tuberous sclerosis complex (tsc)
659806|NCT00790400|Tuberous sclerosis|tuberous sclerosis
659807|NCT00790400|benign tumors of brain|benign tumors of brain
659808|NCT00790400|kidney|kidney
659809|NCT00790400|heart|heart
659810|NCT00790400|eyes|eyes
659811|NCT00790400|lungs|lungs
659812|NCT00790400|skinTSC1|skintsc1
659813|NCT00790400|TSC2|tsc2
659814|NCT00790400|hamaratin|hamaratin
659815|NCT00790400|tuberin, tumor growth suppressors|tuberin, tumor growth suppressors
659816|NCT00790400|gyri|gyri
659817|NCT00790400|tubers|tubers
659818|NCT00790400|Sporadic Lymphangioleiomyomatosis.|sporadic lymphangioleiomyomatosis.
659819|NCT00790400|Lymphangioleiomyomatosis (LAM)|lymphangioleiomyomatosis (lam)
659820|NCT00790400|rare lung disease|rare lung disease
659821|NCT00790387|enoxaparin|enoxaparin
659822|NCT00790387|tirofiban|tirofiban
659823|NCT00790387|percutaneous intervention|percutaneous intervention
659824|NCT00790387|platelet inhibition|platelet inhibition
659825|NCT00790387|CD40L|cd40l
659826|NCT00790387|Mac-1|mac-1
659827|NCT00790387|prothrombin fragment 1+2.|prothrombin fragment 1+2.
659828|NCT00790374|Pharmacodynamic profile and safety of BN83495|pharmacodynamic profile and safety of bn83495
659829|NCT00790361|cervical spondylotic myelopathy|cervical spondylotic myelopathy
659830|NCT00790361|spinal cord compression|spinal cord compression
659831|NCT00790361|magnetic resonance spectroscopy|magnetic resonance spectroscopy
659832|NCT00790361|functional magnetic resonance imaging|functional magnetic resonance imaging
659833|NCT00790361|brain plasticity|brain plasticity
659834|NCT00790335|deep vein thrombosis|deep vein thrombosis
659835|NCT00790335|deep venous thrombosis|deep venous thrombosis
659836|NCT00790335|post thrombotic syndrome|post thrombotic syndrome
659837|NCT00790335|blood clot|blood clot
659838|NCT00790335|thrombolysis|thrombolysis
659839|NCT00790335|tissue plasminogen activator|tissue plasminogen activator
659840|NCT00790335|rt-PA|rt-pa
659841|NCT00790335|Activase|activase
659842|NCT00790335|mechanical thrombectomy|mechanical thrombectomy
659843|NCT00790335|pharmacomechanical|pharmacomechanical
659844|NCT00790335|ATTRACT|attract
659845|NCT00790322|Cancer|cancer
659846|NCT00790322|Radiation therapy|radiation therapy
659847|NCT00790322|Radiotherapy|radiotherapy
659848|NCT00790322|Oral Mucositis|oral mucositis
659849|NCT00790322|SBG|sbg
659850|NCT00790309|Obesity|obesity
659851|NCT00790309|Diabetes|diabetes
659852|NCT00790309|Bariatric surgery|bariatric surgery
659853|NCT00790296|cancer fatigue|cancer fatigue
659854|NCT00790283|Treatment of de novo lesions in native coronary arteries|treatment of de novo lesions in native coronary arteries
659855|NCT00790270|Cervical strain|cervical strain
659856|NCT00790270|whiplash|whiplash
659857|NCT00790270|ibuprofen|ibuprofen
659858|NCT00790270|cyclobenzaprine|cyclobenzaprine
659859|NCT00790257|Diabetes|diabetes
659860|NCT00790257|Islets transplantation|islets transplantation
659861|NCT00790257|Encapsulation|encapsulation
659862|NCT00790244|Soft-tissue sarcomas|soft-tissue sarcomas
659863|NCT00790244|prognostic factors|prognostic factors
659864|NCT00790244|adjuvant|adjuvant
659865|NCT00790244|chemotherapy|chemotherapy
659866|NCT00790244|radiotherapy|radiotherapy
659867|NCT00790244|metastases-free survival|metastases-free survival
659868|NCT00790244|toxicity|toxicity
659869|NCT00790244|High malignancy grade|high malignancy grade
659870|NCT00790244|High-risk for metastases|high-risk for metastases
659871|NCT00790244|Adult|adult
659872|NCT00790231|urinary bladder|urinary bladder
659873|NCT00790231|thoracic epidural analgesia|thoracic epidural analgesia
659874|NCT00790231|urodynamics|urodynamics
659875|NCT00790231|open kidney surgery with lumbotomy|open kidney surgery with lumbotomy
659876|NCT00790218|Hepatocellular carcinoma|hepatocellular carcinoma
659877|NCT00790218|Hepatoma|hepatoma
659878|NCT00790218|HCC|hcc
659879|NCT00790192|Schizophrenia|schizophrenia
659881|NCT00790192|Latuda|latuda
659882|NCT00790192|Lurasidone|lurasidone
659883|NCT00790179|Continuous lumbar plexus,Femoral,hydromorphone|continuous lumbar plexus,femoral,hydromorphone
659884|NCT00790153|Type 2 diabetes, hormonal response|type 2 diabetes, hormonal response
659885|NCT00790140|Esophageal Cancer|esophageal cancer
659886|NCT00790140|esophagectomy|esophagectomy
659887|NCT00790140|enteral feeding|enteral feeding
659888|NCT00790140|body composition|body composition
659889|NCT00790140|immunology|immunology
659890|NCT00790114|Phase I|phase i
659891|NCT00790088|Diabetes Mellitus, Type 1|diabetes mellitus, type 1
659892|NCT00790088|continuous glucose monitoring|continuous glucose monitoring
659893|NCT00790088|sensor-augmented pump therapy|sensor-augmented pump therapy
659894|NCT00790075|agitation|agitation
659895|NCT00790075|Episodes of agitation regardless of diagnosis|episodes of agitation regardless of diagnosis
659896|NCT00790062|Uterine atony|uterine atony
659897|NCT00790062|Postpartum hemorrhage|postpartum hemorrhage
659898|NCT00790062|clinical trial|clinical trial
659899|NCT00790062|Prophylactic oxytocin|prophylactic oxytocin
659900|NCT00790036|Diffuse large B cell lymphoma|diffuse large b cell lymphoma
659901|NCT00790036|DLBCL|dlbcl
659902|NCT00790036|poor risk|poor risk
659903|NCT00790036|R-IPI 3-5|r-ipi 3-5
659904|NCT00790036|adjuvant therapy|adjuvant therapy
659905|NCT00790036|after R-CHOP or R-EPOCH|after r-chop or r-epoch
659906|NCT00790036|after R-CHOP|after r-chop
659907|NCT00790036|B-cell lymphoma|b-cell lymphoma
659908|NCT00790036|lymphoma|lymphoma
659909|NCT00790036|b cells|b cells
659910|NCT00790036|blood cancer|blood cancer
659911|NCT00790036|lymph nodes|lymph nodes
659912|NCT00790036|Hodgkin's|hodgkin's
659913|NCT00790036|non-Hodgkin|non-hodgkin
659914|NCT00790023|SAR|sar
659915|NCT00790010|bevacizumab|bevacizumab
659916|NCT00790010|ipilimumab|ipilimumab
659917|NCT00790010|unresectable stage III melanoma|unresectable stage iii melanoma
659918|NCT00790010|unresectable stage IV melanoma|unresectable stage iv melanoma
659919|NCT00789997|COPD Exacerbation|copd exacerbation
659920|NCT00789997|Etanercept|etanercept
659921|NCT00789997|TNF alpha|tnf alpha
659922|NCT00789997|Randomized|randomized
659923|NCT00789984|Keratic precipitates|keratic precipitates
659924|NCT00789971|orbital floor triamcinolone|orbital floor triamcinolone
659925|NCT00789971|phacoemulsification|phacoemulsification
659926|NCT00789971|post op inflammation|post op inflammation
659927|NCT00789971|cmo|cmo
659928|NCT00789958|cholangiocarcinoma of the extrahepatic bile duct|cholangiocarcinoma of the extrahepatic bile duct
659929|NCT00789958|cholangiocarcinoma of the gallbladder|cholangiocarcinoma of the gallbladder
659930|NCT00789958|localized extrahepatic bile duct cancer|localized extrahepatic bile duct cancer
659931|NCT00789958|localized gallbladder cancer|localized gallbladder cancer
659932|NCT00789958|unresectable extrahepatic bile duct cancer|unresectable extrahepatic bile duct cancer
659933|NCT00789958|unresectable gallbladder cancer|unresectable gallbladder cancer
659934|NCT00789958|metastatic extrahepatic bile duct cancer|metastatic extrahepatic bile duct cancer
659935|NCT00789958|metastatic gallbladder cancer|metastatic gallbladder cancer
659936|NCT00789945|type 1 diabetes|type 1 diabetes
659937|NCT00789945|continuous glucose monitoring|continuous glucose monitoring
659938|NCT00789945|Intensive Insulin therapy|intensive insulin therapy
659939|NCT00789919|Mild Preeclampsia|mild preeclampsia
659940|NCT00789906|Computerized Neuropsychological Assessment|computerized neuropsychological assessment
659941|NCT00789906|Development of Population Norms of the Computerized Neuropsychological Assessment|development of population norms of the computerized neuropsychological assessment
659942|NCT00789893|external beam pelvic radiation|external beam pelvic radiation
659943|NCT00789893|brachytherapy|brachytherapy
659944|NCT00789880|Vitamin D3|vitamin d3
659945|NCT00789880|Atopic Dermatitis|atopic dermatitis
659946|NCT00789880|Antimicrobial Peptide Expression|antimicrobial peptide expression
659947|NCT00789867|Single dose|single dose
659948|NCT00789867|Pilot|pilot
659949|NCT00789867|Safety|safety
659950|NCT00789867|Gene expression|gene expression
659951|NCT00789867|Tolerability|tolerability
659952|NCT00789867|CFTR gene|cftr gene
659953|NCT00789867|Cystic fibrosis|cystic fibrosis
659954|NCT00789867|Non-viral|non-viral
659955|NCT00789854|Depression|depression
659956|NCT00789854|MDD|mdd
659957|NCT00789854|TRD|trd
659958|NCT00789841|Neuroendocrine tumor|neuroendocrine tumor
659959|NCT00789841|Carcinoid syndrome|carcinoid syndrome
659960|NCT00789841|Motility|motility
659961|NCT00789841|Transit time|transit time
659962|NCT00789828|SEGA|sega
659963|NCT00789828|Tuberous Sclerosis|tuberous sclerosis
659964|NCT00789828|Subependymal Giant Cell Astrocytoma|subependymal giant cell astrocytoma
659965|NCT00789828|mTOR|mtor
659966|NCT00789828|RAD001|rad001
659967|NCT00789828|Mamalian Target Rapamycin|mamalian target rapamycin
659968|NCT00789828|Everolimus|everolimus
659969|NCT00789828|TSC|tsc
659970|NCT00789815|flexible bronchoscopy|flexible bronchoscopy
659971|NCT00789815|sedation|sedation
659972|NCT00789815|bispectral index|bispectral index
659973|NCT00789802|contraception|contraception
659974|NCT00789802|progestin contraception|progestin contraception
659975|NCT00789802|intrauterine contraception|intrauterine contraception
659976|NCT00789802|unscheduled bleeding|unscheduled bleeding
659977|NCT00789802|placebo|placebo
659978|NCT00789789|Cohort|cohort
659979|NCT00789789|HIV uninfected volunteers|hiv uninfected volunteers
659980|NCT00789789|HIV preventive vaccine|hiv preventive vaccine
659981|NCT00789789|Long term safety|long term safety
659982|NCT00789763|pancreatic cancer|pancreatic cancer
659983|NCT00789763|Pancreatic cancer locally advanced|pancreatic cancer locally advanced
659984|NCT00789724|acute myocardial infarction|acute myocardial infarction
659985|NCT00789698|Schizophrenia|schizophrenia
659986|NCT00789698|SM-13496|sm-13496
659987|NCT00789698|Latuda|latuda
659988|NCT00789698|Lurasidone|lurasidone
659989|NCT00789685|Open label|open label
659990|NCT00789672|Amblyopia|amblyopia
659991|NCT00789672|Patching|patching
659992|NCT00789672|Levodopa|levodopa
659993|NCT00789659|Fracture fixation, internal|fracture fixation, internal
659994|NCT00789659|Obesity|obesity
659995|NCT00789659|Pelvis|pelvis
659996|NCT00789659|Negative pressure wound therapy|negative pressure wound therapy
659997|NCT00789659|Vacuum-assisted closure|vacuum-assisted closure
659998|NCT00789646|corneal ulcer|corneal ulcer
659999|NCT00789646|painless|painless
660000|NCT00789646|subconjunctival injection|subconjunctival injection
660001|NCT00789646|antibiotics|antibiotics
660002|NCT00789646|antifungal|antifungal
660003|NCT00789646|lidocaine|lidocaine
660004|NCT00789633|Pancreatic cancer|pancreatic cancer
660005|NCT00789633|Advanced pancreatic cancer|advanced pancreatic cancer
660006|NCT00789633|Metastatic pancreatic cancer|metastatic pancreatic cancer
660007|NCT00789633|Gemcitabine|gemcitabine
660008|NCT00789633|Chemo-naive|chemo-naive
660009|NCT00789620|intravenous lidocaine|intravenous lidocaine
660010|NCT00789620|laparoscopic urological surgery|laparoscopic urological surgery
660011|NCT00789620|hospital stay|hospital stay
660012|NCT00789620|pain|pain
660013|NCT00789620|fatigue|fatigue
660014|NCT00789620|length of stay|length of stay
660015|NCT00789607|prostate cancer|prostate cancer
660016|NCT00789607|individualized radiotherapy|individualized radiotherapy
660017|NCT00789607|fiducial markers|fiducial markers
660018|NCT00789607|MRI|mri
660019|NCT00789607|ultrasound|ultrasound
660020|NCT00789607|High-Risk Localized Prostate Cancer|high-risk localized prostate cancer
660021|NCT00789594|Monitoring|monitoring
660022|NCT00789594|Testing|testing
660023|NCT00789594|Medications|medications
660024|NCT00789594|Patients receiving medications and having laboratory tests|patients receiving medications and having laboratory tests
660025|NCT00789581|Breast Cancer|breast cancer
660026|NCT00789581|Adjuvant|adjuvant
660027|NCT00789581|Doxorubicin|doxorubicin
660028|NCT00789581|Cyclophosphamide|cyclophosphamide
660029|NCT00789581|Paclitaxel|paclitaxel
660030|NCT00789581|Ixabepilone|ixabepilone
660031|NCT00789581|TITAN|titan
660032|NCT00789568|Hyperphenylalanemia due to Phenylketonuria|hyperphenylalanemia due to phenylketonuria
660033|NCT00789555|nasal allergy|nasal allergy
660034|NCT00789555|nasal spray|nasal spray
660035|NCT00789555|seasonal allergy|seasonal allergy
660036|NCT00789555|perennial allergy|perennial allergy
660037|NCT00789542|stroke|stroke
660038|NCT00789542|deep vein thrombosis|deep vein thrombosis
660039|NCT00789542|doppler|doppler
660040|NCT00789529|Contact lenses, wettability, Contact Lens Disinfectant Solutions, pre-lens tear film|contact lenses, wettability, contact lens disinfectant solutions, pre-lens tear film
660041|NCT00789516|Coagulation markers, thalassemia disease post SCT|coagulation markers, thalassemia disease post sct
660042|NCT00789503|dietary fortification|dietary fortification
660043|NCT00789503|Vitamin D3|vitamin d3
660044|NCT00789503|Osteomalacia|osteomalacia
660045|NCT00789503|bread|bread
660046|NCT00789503|bone mineral density|bone mineral density
660047|NCT00789503|geriatrics|geriatrics
660048|NCT00789503|cholecalciferol|cholecalciferol
660049|NCT00789503|calcidiol|calcidiol
660051|NCT00789503|dual-energy photon absorptiometry|dual-energy photon absorptiometry
660052|NCT00789503|bread fortification|bread fortification
660053|NCT00789490|pregnancy|pregnancy
660054|NCT00789490|relative bioavailability|relative bioavailability
660055|NCT00789490|iron|iron
660056|NCT00789490|folic acid|folic acid
660057|NCT00789490|ferric pyrophosphate|ferric pyrophosphate
660058|NCT00789490|Study focus is to compare the relative bioavailability of SuppleFem Sprinkles to the current tradtional tablet Materna in pregnant women|study focus is to compare the relative bioavailability of supplefem sprinkles to the current tradtional tablet materna in pregnant women
660059|NCT00789464|Urinary Tract Infection|urinary tract infection
660060|NCT00789464|Probiotics|probiotics
660061|NCT00789464|Dietary Supplements|dietary supplements
660062|NCT00789464|Bacteriuria|bacteriuria
660063|NCT00789451|Ischaemia reperfusion|ischaemia reperfusion
660064|NCT00789451|t-PA|t-pa
660065|NCT00789451|Fibrinolysis|fibrinolysis
660066|NCT00789451|Endothelial function|endothelial function
660067|NCT00789438|Analgesia|analgesia
660068|NCT00789438|Sedation|sedation
660069|NCT00789438|Spinal|spinal
660070|NCT00789438|Stress|stress
660071|NCT00789438|Surgical|surgical
660072|NCT00789438|Surgical Stress|surgical stress
660073|NCT00789438|Pain|pain
660074|NCT00789425|osteoporosis|osteoporosis
660075|NCT00789425|osteopenia|osteopenia
660076|NCT00789425|olive extract|olive extract
660077|NCT00789425|oleuropein|oleuropein
660078|NCT00789412|Analgesia|analgesia
660079|NCT00789412|Sedation|sedation
660080|NCT00789412|Critical Illness|critical illness
660081|NCT00789412|Intensive Care|intensive care
660082|NCT00789399|deep vein thrombosis|deep vein thrombosis
660083|NCT00789399|coronary artery bypass surgery|coronary artery bypass surgery
660084|NCT00789399|Venous thromboembolism|venous thromboembolism
660085|NCT00789386|Capsaicin|capsaicin
660086|NCT00789386|Remifentanil|remifentanil
660087|NCT00789386|Hyperalgesia|hyperalgesia
660088|NCT00789360|Healthy volunteers|healthy volunteers
660089|NCT00789347|Neuropathic pain|neuropathic pain
660090|NCT00789347|Cortical excitability|cortical excitability
660091|NCT00789347|Transcranial magnetic stimulation|transcranial magnetic stimulation
660092|NCT00789347|Contact Heat evoked potential|contact heat evoked potential
660093|NCT00789347|peripheral nerve stimulation|peripheral nerve stimulation
660094|NCT00789347|neurotrophic factors|neurotrophic factors
660095|NCT00789308|Insulin dependence|insulin dependence
660096|NCT00789295|Mediterranean diet|mediterranean diet
660097|NCT00789295|Postprandial lipids|postprandial lipids
660098|NCT00789295|Postprandial glucose|postprandial glucose
660099|NCT00789295|High fibre diet|high fibre diet
660100|NCT00789295|Low- CHO diet|low- cho diet
660101|NCT00789295|High MUFA diet|high mufa diet
660102|NCT00789295|Dietary approach|dietary approach
660103|NCT00789282|chronic disease|chronic disease
660104|NCT00789282|Family Physician|family physician
660105|NCT00789282|primary care network|primary care network
660106|NCT00789282|practice-based model|practice-based model
660107|NCT00789282|type 2 diabetes|type 2 diabetes
660108|NCT00789282|complications|complications
660109|NCT00789282|sequelae|sequelae
660110|NCT00789269|lung infection after ischemic Stroke|lung infection after ischemic stroke
660111|NCT00789269|prevention of pneumonia|prevention of pneumonia
660112|NCT00789269|rhubarb|rhubarb
660113|NCT00789256|Acute Myelogenous Leukemia|acute myelogenous leukemia
660114|NCT00789256|AML|aml
660115|NCT00789256|Myelodysplastic Syndromes|myelodysplastic syndromes
660116|NCT00789256|MDS|mds
660117|NCT00789256|Melphalan|melphalan
660118|NCT00789256|Bortezomib|bortezomib
660119|NCT00789256|Velcade|velcade
660120|NCT00789243|Ischaemia reperfusion|ischaemia reperfusion
660121|NCT00789243|t-PA|t-pa
660122|NCT00789243|Fibrinolysis|fibrinolysis
660123|NCT00789243|Endothelial function|endothelial function
660124|NCT00789243|Local and remote ischaemic preconditioning|local and remote ischaemic preconditioning
660125|NCT00789230|umbilical|umbilical
660126|NCT00789230|hernia|hernia
660127|NCT00789230|mesh|mesh
660128|NCT00789217|Penicillin|penicillin
660129|NCT00789217|Beta-Lactams|beta-lactams
660130|NCT00789217|Allergy|allergy
660131|NCT00789217|Hypersensitivity|hypersensitivity
660132|NCT00789204|exercise|exercise
660133|NCT00789204|low back pain|low back pain
660134|NCT00789204|posture|posture
660135|NCT00789204|rehabilitation|rehabilitation
660136|NCT00789178|memory disturbances|memory disturbances
660137|NCT00789165|Brugada syndrome|brugada syndrome
660138|NCT00789165|quinidine|quinidine
660139|NCT00789165|Asymptomatic Brugada Syndrome|asymptomatic brugada syndrome
660140|NCT00789113|lamotrigine|lamotrigine
660141|NCT00789113|epilepsy|epilepsy
660142|NCT00789113|metabolism|metabolism
660143|NCT00789113|bipolar disorder|bipolar disorder
660144|NCT00789113|bipolar depression|bipolar depression
660145|NCT00789113|glucuronidation|glucuronidation
660146|NCT00789100|telehealth|telehealth
660147|NCT00789100|telemonitor|telemonitor
660148|NCT00789100|telemedicine|telemedicine
660149|NCT00789100|Co-morbidities|co-morbidities
660150|NCT00789087|Pleural Effusion.|pleural effusion.
660151|NCT00789087|Talc.|talc.
660152|NCT00789087|Pleurodesis.|pleurodesis.
660153|NCT00789087|Quality of Life.|quality of life.
660154|NCT00789087|Thoracoscopy.|thoracoscopy.
660155|NCT00789074|Smoking cessation|smoking cessation
660156|NCT00789074|Tobacco dependence|tobacco dependence
660157|NCT00789074|Varenicline|varenicline
660158|NCT00789074|Preloading|preloading
660159|NCT00789061|Acute hearing loss in patients with SLC26A4 mutations|acute hearing loss in patients with slc26a4 mutations
660160|NCT00789048|hip|hip
660161|NCT00789048|arthroplasty|arthroplasty
660162|NCT00789048|radiograph|radiograph
660163|NCT00789022|First-Psychotic-Episode (FPE)|first-psychotic-episode (fpe)
660164|NCT00789022|Glutamatergic system|glutamatergic system
660165|NCT00789022|Glycine|glycine
660166|NCT00789022|D-Serine|d-serine
660167|NCT00789022|Oxytocin|oxytocin
660168|NCT00789022|Estrogen|estrogen
660169|NCT00789009|Opportunistic Infections|opportunistic infections
660170|NCT00789009|AIDS|aids
660171|NCT00789009|HIV|hiv
660172|NCT00788996|Tobacco Smoke Pollution/prevention and control|tobacco smoke pollution/prevention and control
660173|NCT00788996|Parent-Child Relations|parent-child relations
660174|NCT00788996|Environmental Tobacco Smoke (ETS)|environmental tobacco smoke (ets)
660175|NCT00788983|Induced hypoxia|induced hypoxia
660176|NCT00788983|Pulse oximeter|pulse oximeter
660177|NCT00788983|Nonin Medical|nonin medical
660178|NCT00788983|Verification of SpO2 accuracy|verification of spo2 accuracy
660179|NCT00788970|Acupressure|acupressure
660180|NCT00788970|Shiatsu|shiatsu
660181|NCT00788970|Schizophrenia|schizophrenia
660182|NCT00788957|panitumumab|panitumumab
660183|NCT00788957|vectibix|vectibix
660184|NCT00788957|AMG 102|amg 102
660185|NCT00788957|AMG 479|amg 479
660186|NCT00788957|colon cancer|colon cancer
660187|NCT00788957|rectal cancer|rectal cancer
660188|NCT00788957|colorectal cancer|colorectal cancer
660189|NCT00788957|metastatic colorectal cancer|metastatic colorectal cancer
660190|NCT00788957|EGFR inhibitor|egfr inhibitor
660191|NCT00788957|IGF inhibitor|igf inhibitor
660192|NCT00788957|c-MET inhibitor|c-met inhibitor
660193|NCT00788931|Breast Cancer|breast cancer
660194|NCT00788931|HER2 positive|her2 positive
660195|NCT00788931|adult-female|adult-female
660196|NCT00788931|LBH589|lbh589
660197|NCT00788931|HDAC inhibitor|hdac inhibitor
660198|NCT00788931|panobinostat|panobinostat
660199|NCT00788931|metastatic breast|metastatic breast
660200|NCT00788931|adult female patients|adult female patients
660201|NCT00788918|Chronic Hepatitis C|chronic hepatitis c
660202|NCT00788918|cognitive dysfunction|cognitive dysfunction
660203|NCT00788918|MRI|mri
660204|NCT00788918|MR spectroscopy|mr spectroscopy
660205|NCT00788918|interferon|interferon
660206|NCT00788918|ribavirin|ribavirin
660207|NCT00788918|sustained virologic response, major depressive disorder|sustained virologic response, major depressive disorder
660208|NCT00788905|Hemodialysis|hemodialysis
660209|NCT00788892|Acute|acute
660210|NCT00788892|Myeloid|myeloid
660211|NCT00788892|Leukemia|leukemia
660212|NCT00788892|elderly|elderly
660213|NCT00788892|Newly|newly
660214|NCT00788892|Diagnosed|diagnosed
660215|NCT00788879|Behavioral Journalism|behavioral journalism
660216|NCT00788879|Mexican-Americans|mexican-americans
660217|NCT00788879|Obesity|obesity
660218|NCT00788879|Nutrition|nutrition
660219|NCT00788879|Physical Activity|physical activity
660220|NCT00788879|Border Health|border health
660221|NCT00788866|Neuroprotection|neuroprotection
660222|NCT00788866|Antioxidants|antioxidants
660223|NCT00788866|Neonatal brain injury|neonatal brain injury
660224|NCT00788866|Pomegranate juice|pomegranate juice
660225|NCT00788853|DiabCare Asia 2008, Cross-sectional survey, Glycemic control, Psychosocial well-being, Diabetic complications, Quality of life.|diabcare asia 2008, cross-sectional survey, glycemic control, psychosocial well-being, diabetic complications, quality of life.
660226|NCT00788827|diabetes type I|diabetes type i
660227|NCT00788827|diabetes type 2|diabetes type 2
660228|NCT00788827|renal transplant|renal transplant
660229|NCT00788827|stem cells|stem cells
660230|NCT00788827|successful renal transplant|successful renal transplant
660231|NCT00788788|Airway obstruction|airway obstruction
660232|NCT00788788|Heliox|heliox
660233|NCT00788788|Different Helium content|different helium content
660234|NCT00788775|nilotinib|nilotinib
660235|NCT00788762|glaucoma|glaucoma
660236|NCT00788762|myocilin|myocilin
660237|NCT00788749|chronic rhinosinusitis|chronic rhinosinusitis
660238|NCT00788749|nasal polyps|nasal polyps
660239|NCT00788749|oral steroid|oral steroid
660240|NCT00788749|intranasal steroid|intranasal steroid
660241|NCT00788749|medical polypectomy|medical polypectomy
660242|NCT00788736|venous thromboembolism|venous thromboembolism
660243|NCT00788736|long-term oral anticoagulant therapy|long-term oral anticoagulant therapy
660244|NCT00788736|warfarin|warfarin
660245|NCT00788736|bleeding risk|bleeding risk
660246|NCT00788736|clinical prediction rule|clinical prediction rule
660247|NCT00788736|predictors|predictors
660248|NCT00788736|deep vein thrombosis|deep vein thrombosis
660249|NCT00788736|pulmonary embolism|pulmonary embolism
660250|NCT00788736|vitamin k antagonist|vitamin k antagonist
660251|NCT00788736|side effect|side effect
660252|NCT00788723|Severe Brain Injury|severe brain injury
660253|NCT00788723|Excitability|excitability
660254|NCT00788723|Transcranial Magnetic Stimulation|transcranial magnetic stimulation
660255|NCT00788684|Non-Hodgkin's Lymphoma|non-hodgkin's lymphoma
660256|NCT00788684|Rituximab|rituximab
660257|NCT00788684|Chronic Lymphoid Leukemia|chronic lymphoid leukemia
660258|NCT00788684|Hematological Malignancies|hematological malignancies
660259|NCT00788684|ABT-263|abt-263
660260|NCT00788684|Navitoclax|navitoclax
660261|NCT00788684|CD20-Positive Lymphoid Malignancies|cd20-positive lymphoid malignancies
660262|NCT00788658|Obstructed constipation|obstructed constipation
660263|NCT00788658|Quality of life|quality of life
660264|NCT00788645|Smoking|smoking
660265|NCT00788645|COPD|copd
660266|NCT00788645|Chronic Obstructive Lung Disease|chronic obstructive lung disease
660267|NCT00788645|COPD Exacerbations|copd exacerbations
660268|NCT00788645|Viruses and Bacteria associated with COPD exacerbations|viruses and bacteria associated with copd exacerbations
660269|NCT00788632|Osteoporosis|osteoporosis
660270|NCT00788632|BMD|bmd
660271|NCT00788632|Bisphosphonates|bisphosphonates
660272|NCT00788632|Educational materials|educational materials
660273|NCT00788632|Patient Stories|patient stories
660274|NCT00788619|Infertility|infertility
660275|NCT00788619|Assisted reproductive technology|assisted reproductive technology
660276|NCT00788619|Nitric oxide|nitric oxide
660277|NCT00788606|diffused large B cell lymphoma, DLBCL, R-Chop, bevacizumab|diffused large b cell lymphoma, dlbcl, r-chop, bevacizumab
660278|NCT00788606|Diffuse large B-cell non-Hodgkin's lymphoma.|diffuse large b-cell non-hodgkin's lymphoma.
660279|NCT00788593|Chronic Pancreatitis|chronic pancreatitis
660280|NCT00788593|Exocrine Pancreatic Insufficiency|exocrine pancreatic insufficiency
660281|NCT00788580|unspecified adult solid tumor, protocol specific|unspecified adult solid tumor, protocol specific
660282|NCT00788554|groin|groin
660283|NCT00788554|inguinal|inguinal
660284|NCT00788554|hernia|hernia
660285|NCT00788554|lichtenstein|lichtenstein
660286|NCT00788554|TEP|tep
660287|NCT00788541|Open-Angle Glaucoma|open-angle glaucoma
660288|NCT00788541|Intraocular Pressure|intraocular pressure
660289|NCT00788541|Anecortave Acetate|anecortave acetate
660290|NCT00788528|Obesity|obesity
660291|NCT00788515|insomnia|insomnia
660292|NCT00788515|sleep maintenance|sleep maintenance
660293|NCT00788489|breast cancer|breast cancer
660294|NCT00788489|FDG-PET|fdg-pet
660295|NCT00788489|MRI|mri
660296|NCT00788489|chemotherapy|chemotherapy
660297|NCT00788489|ultrasonography|ultrasonography
660298|NCT00788476|Needs Assessment Survey|needs assessment survey
660299|NCT00788476|Childhood Cancer Survivors|childhood cancer survivors
660300|NCT00788476|Parents|parents
660301|NCT00788476|Primary Caregiver|primary caregiver
660302|NCT00788476|Survey|survey
660303|NCT00788463|administration, intranasal|administration, intranasal
660304|NCT00788463|aerosol|aerosol
660305|NCT00788463|beclomethasone|beclomethasone
660306|NCT00788463|QVAR|qvar
660307|NCT00788463|corticosteroids|corticosteroids
660308|NCT00788463|nasal polyps|nasal polyps
660309|NCT00788463|rhinomanometry|rhinomanometry
660310|NCT00788463|Rhinitis Quality of Life Questionnaire|rhinitis quality of life questionnaire
660311|NCT00788463|Quality of Life|quality of life
660312|NCT00788424|AS101 Psoriasis|as101 psoriasis
660313|NCT00788385|Hydrocephalus|hydrocephalus
660314|NCT00788385|High Pressure|high pressure
660315|NCT00788385|Shunt Blockage|shunt blockage
660316|NCT00788372|Chronic pain|chronic pain
660317|NCT00788372|Fentanyl Patch|fentanyl patch
660318|NCT00788359|cystic fibrosis|cystic fibrosis
660319|NCT00788359|pulmonary exacerbation|pulmonary exacerbation
660320|NCT00788359|biomarkers|biomarkers
660321|NCT00788346|Heavily marketed medications|heavily marketed medications
660322|NCT00788346|Prescribing|prescribing
660323|NCT00788346|Health information technology|health information technology
660324|NCT00788346|Education|education
660325|NCT00788333|Advanced or Metastatic Her-2-positive Breast Cancer|advanced or metastatic her-2-positive breast cancer
660326|NCT00788320|Tuberculosis|tuberculosis
660327|NCT00788320|vitamin D|vitamin d
660328|NCT00788320|immune system|immune system
660329|NCT00788307|adenocarcinoma of the prostate|adenocarcinoma of the prostate
660330|NCT00788307|recurrent prostate cancer|recurrent prostate cancer
660331|NCT00788307|stage I prostate cancer|stage i prostate cancer
660332|NCT00788307|stage II prostate cancer|stage ii prostate cancer
660333|NCT00788294|Pharmacokinetics tanezumab subcutaneous bioavailability intravenous Japanese subjects|pharmacokinetics tanezumab subcutaneous bioavailability intravenous japanese subjects
660334|NCT00788242|Cardiac surgery|cardiac surgery
660335|NCT00788242|Cardioprotection|cardioprotection
660336|NCT00788242|Aortocoronary bypass graft|aortocoronary bypass graft
660337|NCT00788242|Aortic stenosis|aortic stenosis
660338|NCT00788229|Dry Eye Syndromes|dry eye syndromes
660339|NCT00788229|Keratoconjunctivitis Sicca|keratoconjunctivitis sicca
660340|NCT00788229|artificial tears|artificial tears
660341|NCT00788229|carboxymethylcellulose sodium|carboxymethylcellulose sodium
660342|NCT00788229|sodium hyaluronate|sodium hyaluronate
660343|NCT00788216|Radical hysterectomy|radical hysterectomy
660344|NCT00788216|Whole pelvic radiation|whole pelvic radiation
660345|NCT00788216|Brachytherapy|brachytherapy
660346|NCT00788216|Chemoradiation|chemoradiation
660347|NCT00788216|Complications|complications
660348|NCT00788216|Quality of Life|quality of life
660349|NCT00788190|Distal Radius Fracture|distal radius fracture
660350|NCT00788190|Elderly|elderly
660351|NCT00788190|Prospective randomized trial|prospective randomized trial
660352|NCT00788190|Outcomes|outcomes
660353|NCT00788190|Pain and Function|pain and function
660354|NCT00788190|Surgical Vs. conservative management|surgical vs. conservative management
660355|NCT00788190|Fractures with borderline alignment|fractures with borderline alignment
660356|NCT00788177|age-related macular degeneration|age-related macular degeneration
660357|NCT00788177|subretinal injection|subretinal injection
660358|NCT00788177|Pegaptanib|pegaptanib
660359|NCT00788177|Macugen|macugen
660360|NCT00788164|cervical cancer|cervical cancer
660361|NCT00788164|cervical intraepithelial neoplasia grade 3|cervical intraepithelial neoplasia grade 3
660362|NCT00788164|therapeutic vaccine|therapeutic vaccine
660363|NCT00788164|treatment|treatment
660364|NCT00788164|CIN|cin
660365|NCT00788164|HPV|hpv
660366|NCT00788164|vaccine|vaccine
660367|NCT00788164|Hopkins|hopkins
660368|NCT00788164|Trimble|trimble
660369|NCT00788151|Dengue virus|dengue virus
660370|NCT00788151|Dengue fever|dengue fever
660371|NCT00788151|Dengue Hemorrhagic fever|dengue hemorrhagic fever
660372|NCT00788151|Dengue diseases|dengue diseases
660373|NCT00788151|Dengue vaccine|dengue vaccine
660374|NCT00788138|Cystic Fibrosis|cystic fibrosis
660375|NCT00788138|Vitamin D|vitamin d
660376|NCT00788138|Anti-microbial peptides|anti-microbial peptides
660377|NCT00788125|previously treated childhood rhabdomyosarcoma|previously treated childhood rhabdomyosarcoma
660378|NCT00788125|metastatic childhood soft tissue sarcoma|metastatic childhood soft tissue sarcoma
660379|NCT00788125|metastatic Ewing sarcoma/peripheral primitive neuroectodermal tumor|metastatic ewing sarcoma/peripheral primitive neuroectodermal tumor
660380|NCT00788125|metastatic osteosarcoma|metastatic osteosarcoma
660381|NCT00788125|recurrent childhood rhabdomyosarcoma|recurrent childhood rhabdomyosarcoma
660382|NCT00788125|recurrent childhood soft tissue sarcoma|recurrent childhood soft tissue sarcoma
660383|NCT00788125|recurrent Ewing sarcoma/peripheral primitive neuroectodermal tumor|recurrent ewing sarcoma/peripheral primitive neuroectodermal tumor
660384|NCT00788125|recurrent osteosarcoma|recurrent osteosarcoma
660385|NCT00788125|unspecified childhood solid tumor, protocol specific|unspecified childhood solid tumor, protocol specific
660386|NCT00788125|recurrent Wilms tumor and other childhood kidney tumors|recurrent wilms tumor and other childhood kidney tumors
660387|NCT00788125|recurrent neuroblastoma|recurrent neuroblastoma
660388|NCT00788125|stage 4S neuroblastoma|stage 4s neuroblastoma
660389|NCT00788125|childhood extracranial germ cell tumor|childhood extracranial germ cell tumor
660390|NCT00788125|childhood malignant ovarian germ cell tumor|childhood malignant ovarian germ cell tumor
660391|NCT00788125|childhood malignant testicular germ cell tumor|childhood malignant testicular germ cell tumor
660392|NCT00788125|childhood teratoma|childhood teratoma
660393|NCT00788125|clear cell sarcoma of the kidney|clear cell sarcoma of the kidney
660394|NCT00788125|childhood renal cell carcinoma|childhood renal cell carcinoma
660395|NCT00788125|recurrent renal cell cancer|recurrent renal cell cancer
660396|NCT00788125|congenital mesoblastic nephroma|congenital mesoblastic nephroma
660397|NCT00788125|cystic nephroma|cystic nephroma
660398|NCT00788125|peripheral primitive neuroectodermal tumor of the kidney|peripheral primitive neuroectodermal tumor of the kidney
660399|NCT00788125|rhabdoid tumor of the kidney|rhabdoid tumor of the kidney
660400|NCT00788125|disseminated neuroblastoma|disseminated neuroblastoma
660401|NCT00788125|recurrent malignant testicular germ cell tumor|recurrent malignant testicular germ cell tumor
660402|NCT00788125|recurrent ovarian germ cell tumor|recurrent ovarian germ cell tumor
660403|NCT00788125|recurrent childhood liver cancer|recurrent childhood liver cancer
660404|NCT00788125|stage IV childhood liver cancer|stage iv childhood liver cancer
660405|NCT00788125|angioimmunoblastic T-cell lymphoma|angioimmunoblastic t-cell lymphoma
660406|NCT00788125|stage IV childhood Hodgkin lymphoma|stage iv childhood hodgkin lymphoma
660407|NCT00788125|stage IV childhood large cell lymphoma|stage iv childhood large cell lymphoma
660408|NCT00788125|stage IV childhood lymphoblastic lymphoma|stage iv childhood lymphoblastic lymphoma
660409|NCT00788125|stage IV childhood small noncleaved cell lymphoma|stage iv childhood small noncleaved cell lymphoma
660410|NCT00788125|recurrent childhood grade III lymphomatoid granulomatosis|recurrent childhood grade iii lymphomatoid granulomatosis
660411|NCT00788125|recurrent childhood large cell lymphoma|recurrent childhood large cell lymphoma
660412|NCT00788125|recurrent childhood lymphoblastic lymphoma|recurrent childhood lymphoblastic lymphoma
660413|NCT00788125|recurrent childhood small noncleaved cell lymphoma|recurrent childhood small noncleaved cell lymphoma
660414|NCT00788125|recurrent/refractory childhood Hodgkin lymphoma|recurrent/refractory childhood hodgkin lymphoma
660415|NCT00788125|childhood diffuse large cell lymphoma|childhood diffuse large cell lymphoma
660416|NCT00788125|childhood grade III lymphomatoid granulomatosis|childhood grade iii lymphomatoid granulomatosis
660417|NCT00788125|childhood immunoblastic large cell lymphoma|childhood immunoblastic large cell lymphoma
660418|NCT00788125|childhood nasal type extranodal NK/T-cell lymphoma|childhood nasal type extranodal nk/t-cell lymphoma
660419|NCT00788125|Burkitt lymphoma|burkitt lymphoma
660420|NCT00788125|primary central nervous system non-Hodgkin lymphoma|primary central nervous system non-hodgkin lymphoma
660421|NCT00788125|recurrent childhood anaplastic large cell lymphoma|recurrent childhood anaplastic large cell lymphoma
660422|NCT00788125|stage IV childhood anaplastic large cell lymphoma|stage iv childhood anaplastic large cell lymphoma
660423|NCT00788125|childhood central nervous system choriocarcinoma|childhood central nervous system choriocarcinoma
660424|NCT00788125|childhood central nervous system embryonal tumor|childhood central nervous system embryonal tumor
660425|NCT00788125|childhood central nervous system germ cell tumor|childhood central nervous system germ cell tumor
660426|NCT00788125|childhood central nervous system germinoma|childhood central nervous system germinoma
660427|NCT00788125|childhood central nervous system mixed germ cell tumor|childhood central nervous system mixed germ cell tumor
660428|NCT00788125|childhood central nervous system teratoma|childhood central nervous system teratoma
660429|NCT00788125|childhood central nervous system yolk sac tumor|childhood central nervous system yolk sac tumor
660430|NCT00788125|recurrent childhood central nervous system embryonal tumor|recurrent childhood central nervous system embryonal tumor
660431|NCT00788125|childhood choroid plexus tumor|childhood choroid plexus tumor
660432|NCT00788125|childhood craniopharyngioma|childhood craniopharyngioma
660433|NCT00788125|childhood ependymoblastoma|childhood ependymoblastoma
660434|NCT00788125|childhood medulloepithelioma|childhood medulloepithelioma
660435|NCT00788125|childhood infratentorial ependymoma|childhood infratentorial ependymoma
660768|NCT00787384|Imatinib|imatinib
660436|NCT00788125|childhood supratentorial ependymoma|childhood supratentorial ependymoma
660437|NCT00788125|childhood oligodendroglioma|childhood oligodendroglioma
660438|NCT00788125|childhood pineal parenchymal tumor|childhood pineal parenchymal tumor
660439|NCT00788125|childhood grade I meningioma|childhood grade i meningioma
660440|NCT00788125|childhood grade II meningioma|childhood grade ii meningioma
660441|NCT00788125|childhood grade III meningioma|childhood grade iii meningioma
660442|NCT00788125|recurrent childhood cerebellar astrocytoma|recurrent childhood cerebellar astrocytoma
711018|NCT00586846|Methotrexate|methotrexate
660443|NCT00788125|recurrent childhood cerebral astrocytoma|recurrent childhood cerebral astrocytoma
660444|NCT00788125|recurrent childhood ependymoma|recurrent childhood ependymoma
660445|NCT00788125|recurrent childhood medulloblastoma|recurrent childhood medulloblastoma
660446|NCT00788125|recurrent childhood pineoblastoma|recurrent childhood pineoblastoma
660447|NCT00788125|recurrent childhood supratentorial primitive neuroectodermal tumor|recurrent childhood supratentorial primitive neuroectodermal tumor
660448|NCT00788125|recurrent childhood visual pathway and hypothalamic glioma|recurrent childhood visual pathway and hypothalamic glioma
660449|NCT00788125|recurrent uterine sarcoma|recurrent uterine sarcoma
660450|NCT00788125|childhood high-grade cerebellar astrocytoma|childhood high-grade cerebellar astrocytoma
660451|NCT00788125|childhood high-grade cerebral astrocytoma|childhood high-grade cerebral astrocytoma
660452|NCT00788125|childhood low-grade cerebellar astrocytoma|childhood low-grade cerebellar astrocytoma
660453|NCT00788125|childhood low-grade cerebral astrocytoma|childhood low-grade cerebral astrocytoma
660454|NCT00788125|childhood atypical teratoid/rhabdoid tumor|childhood atypical teratoid/rhabdoid tumor
660455|NCT00788125|primary central nervous system Hodgkin lymphoma|primary central nervous system hodgkin lymphoma
660456|NCT00788125|childhood extragonadal germ cell tumor|childhood extragonadal germ cell tumor
660457|NCT00788125|recurrent childhood malignant germ cell tumor|recurrent childhood malignant germ cell tumor
660458|NCT00788125|recurrent childhood brain stem glioma|recurrent childhood brain stem glioma
660459|NCT00788125|recurrent childhood subependymal giant cell astrocytoma|recurrent childhood subependymal giant cell astrocytoma
660460|NCT00788125|recurrent childhood brain tumor|recurrent childhood brain tumor
660461|NCT00788125|recurrent childhood spinal cord neoplasm|recurrent childhood spinal cord neoplasm
660462|NCT00788112|ductal breast carcinoma in situ|ductal breast carcinoma in situ
660464|NCT00788099|Plitidepsin|plitidepsin
660465|NCT00788099|Tumors|tumors
660466|NCT00788099|Lymphomas|lymphomas
660467|NCT00788073|fragile X syndrome|fragile x syndrome
660468|NCT00788073|irritability|irritability
660469|NCT00788073|behavior problems|behavior problems
660470|NCT00788060|Renal Cell Carcinoma|renal cell carcinoma
660471|NCT00788060|Rad001|rad001
660472|NCT00788060|Sutent|sutent
660473|NCT00788034|Relapse prevention|relapse prevention
660474|NCT00788034|GAD|gad
660475|NCT00788034|Maintenance|maintenance
660476|NCT00788034|Double-blind|double-blind
660477|NCT00788034|Multicentre|multicentre
660478|NCT00788021|Transplant|transplant
660479|NCT00788021|Immunity|immunity
660480|NCT00788021|Immunosuppression|immunosuppression
660481|NCT00788008|spinal, joint|spinal, joint
660482|NCT00787995|Mucopolysaccharidosis IV type A|mucopolysaccharidosis iv type a
660483|NCT00787995|MPS IV Type A|mps iv type a
660484|NCT00787995|Mucopolysaccharidosis IVA|mucopolysaccharidosis iva
660485|NCT00787995|MPS IVA|mps iva
660486|NCT00787995|Morquio A Syndrome|morquio a syndrome
660487|NCT00787995|Lysosomal Storage Disorder|lysosomal storage disorder
660488|NCT00787995|LSD|lsd
660489|NCT00787995|N-acetylgalactosamine-6-sulfatase|n-acetylgalactosamine-6-sulfatase
660490|NCT00787995|galactose-6-sulfatase|galactose-6-sulfatase
660491|NCT00787995|GALNS|galns
660492|NCT00787995|enzyme replacement therapy|enzyme replacement therapy
660493|NCT00787995|ERT|ert
660494|NCT00787982|brain|brain
660495|NCT00787982|metastasis|metastasis
660496|NCT00787982|neoplasm|neoplasm
660497|NCT00787982|tumor|tumor
660498|NCT00787982|Patients with secondary brain neoplasms|patients with secondary brain neoplasms
660499|NCT00787982|laser therapy|laser therapy
660500|NCT00787982|laser interstitial thermal therapy|laser interstitial thermal therapy
660501|NCT00787969|stage I mantle cell lymphoma|stage i mantle cell lymphoma
660502|NCT00787969|Stage II Contiguous Mantle Cell Lymphoma|stage ii contiguous mantle cell lymphoma
660503|NCT00787969|Stage II Non-Contiguous Mantle Cell Lymphoma|stage ii non-contiguous mantle cell lymphoma
660504|NCT00787969|Stage III Mantle Cell Lymphoma|stage iii mantle cell lymphoma
660505|NCT00787969|Stage IV Mantle Cell Lymphoma|stage iv mantle cell lymphoma
660506|NCT00787943|Acne|acne
660507|NCT00787930|BPD|bpd
660508|NCT00787917|Cystic Fibrosis|cystic fibrosis
660509|NCT00787917|Allergic Bronchopulmonary Aspergillosis|allergic bronchopulmonary aspergillosis
660510|NCT00787917|omalizumab|omalizumab
660511|NCT00787917|oral corticosteroid use|oral corticosteroid use
660512|NCT00787917|anti-immunoglobulin E|anti-immunoglobulin e
660513|NCT00787904|Osteoporosis, T-cells|osteoporosis, t-cells
660514|NCT00787891|Gastroesophageal Reflux Disease (GERD)|gastroesophageal reflux disease (gerd)
660515|NCT00787891|Erosive Gastroesophageal Reflux Disease|erosive gastroesophageal reflux disease
660516|NCT00787891|Ulcerative Gastroesophageal Reflux Disease|ulcerative gastroesophageal reflux disease
660517|NCT00787891|Endoscopy|endoscopy
660518|NCT00787891|Pediatrics|pediatrics
660519|NCT00787891|Rabeprazole|rabeprazole
660769|NCT00787384|Response|response
660520|NCT00787865|Diffusion Tensor Imaging|diffusion tensor imaging
660521|NCT00787865|DTI|dti
660522|NCT00787865|Newborn|newborn
660523|NCT00787865|Krabbe Disease|krabbe disease
660524|NCT00787865|Motor Development|motor development
660525|NCT00787865|Motor Disability|motor disability
660526|NCT00787852|dasatinib|dasatinib
660527|NCT00787852|radiation|radiation
660528|NCT00787852|paclitaxel|paclitaxel
660529|NCT00787852|carboplatin|carboplatin
841033|NCT00087763|AMD|amd
660530|NCT00787852|NSCLC|nsclc
660531|NCT00787852|safety addition of dasatinib to chemo RT stage III NSCLC|safety addition of dasatinib to chemo rt stage iii nsclc
660532|NCT00787839|type 2 diabetes mellitus|type 2 diabetes mellitus
660533|NCT00787839|prediabetic state|prediabetic state
660534|NCT00787839|mass screening|mass screening
660535|NCT00787839|glucose tolerance test|glucose tolerance test
660536|NCT00787826|Live Vaccine Strain (LVS)|live vaccine strain (lvs)
660537|NCT00787813|N-acetyl cysteine (NAC)|n-acetyl cysteine (nac)
660538|NCT00787813|Cervical cerclage|cervical cerclage
660539|NCT00787813|cervical cerclage for cervical insufficiency|cervical cerclage for cervical insufficiency
660540|NCT00787800|Shock prevention|shock prevention
660541|NCT00787800|Single vs. Dual Chamber|single vs. dual chamber
660542|NCT00787800|Reduce ventricular pacing|reduce ventricular pacing
660543|NCT00787800|Atrial Fibrillation|atrial fibrillation
660544|NCT00787800|Remote Monitoring|remote monitoring
660545|NCT00787800|ICD|icd
660546|NCT00787800|Implantable Cardioverter Defibrillator|implantable cardioverter defibrillator
660547|NCT00787774|HIV|hiv
660548|NCT00787774|resistance|resistance
660549|NCT00787774|integrase|integrase
660550|NCT00787761|accelerated phase CML|accelerated phase cml
660551|NCT00787761|blastic phase CML|blastic phase cml
660552|NCT00787761|Philadelphia chromosome positive CML|philadelphia chromosome positive cml
660553|NCT00787761|stage I CLL|stage i cll
660554|NCT00787761|stage II CLL|stage ii cll
660555|NCT00787761|stage III CLL|stage iii cll
660556|NCT00787761|stage IV CLL|stage iv cll
660557|NCT00787761|stage I multiple myeloma|stage i multiple myeloma
660558|NCT00787761|stage II multiple myeloma|stage ii multiple myeloma
660559|NCT00787761|stage III multiple myeloma|stage iii multiple myeloma
660560|NCT00787761|adult AML with 11q23 (MLL) abnormalities|adult aml with 11q23 (mll) abnormalities
660561|NCT00787761|adult CML in remission|adult cml in remission
660562|NCT00787761|adult ALL in remission|adult all in remission
660563|NCT00787761|stage IV renal cell cancer|stage iv renal cell cancer
660564|NCT00787761|de novo MDS|de novo mds
660565|NCT00787761|previously treated MDS|previously treated mds
660566|NCT00787761|secondary MDS|secondary mds
660567|NCT00787761|atypical CML, BCR-ABL negative|atypical cml, bcr-abl negative
660568|NCT00787761|chronic myelomonocytic leukemia|chronic myelomonocytic leukemia
660569|NCT00787761|MDS/myeloproliferative neoplasm, unclassifiable|mds/myeloproliferative neoplasm, unclassifiable
660570|NCT00787761|primary myelofibrosis|primary myelofibrosis
660571|NCT00787761|chronic neutrophilic leukemia|chronic neutrophilic leukemia
660572|NCT00787761|recurrent adult Hodgkin lymphoma|recurrent adult hodgkin lymphoma
660573|NCT00787761|clear cell renal cell carcinoma|clear cell renal cell carcinoma
660574|NCT00787761|adult AML with inv(16)(p13;q22)|adult aml with inv(16)(p13;q22)
660575|NCT00787761|adult AML with t(15;17)(q22;q12)|adult aml with t(15;17)(q22;q12)
660576|NCT00787761|adult AML with t(16;16)(p13;q22)|adult aml with t(16;16)(p13;q22)
660577|NCT00787761|adult AML with t(8;21)(q22;q22)|adult aml with t(8;21)(q22;q22)
660578|NCT00787761|adult nasal type extranodal NK/T-cell lymphoma|adult nasal type extranodal nk/t-cell lymphoma
660579|NCT00787761|AML/transient myeloproliferative disorder|aml/transient myeloproliferative disorder
660580|NCT00787761|Burkitt lymphoma|burkitt lymphoma
660581|NCT00787761|chronic phase CML|chronic phase cml
660582|NCT00787761|extranodal marginal zone B-cell lymphoma of mucosa tissue|extranodal marginal zone b-cell lymphoma of mucosa tissue
660583|NCT00787761|nodal marginal zone B-cell lymphoma|nodal marginal zone b-cell lymphoma
660584|NCT00787761|stage III adult Burkitt lymphoma|stage iii adult burkitt lymphoma
660585|NCT00787761|stage IV adult Burkitt lymphoma|stage iv adult burkitt lymphoma
660586|NCT00787761|recurrent adult Burkitt lymphoma|recurrent adult burkitt lymphoma
660587|NCT00787761|stage III adult diffuse large cell lymphoma|stage iii adult diffuse large cell lymphoma
660588|NCT00787761|stage III adult diffuse mixed cell lymphoma|stage iii adult diffuse mixed cell lymphoma
660589|NCT00787761|recurrent adult diffuse large cell lymphoma|recurrent adult diffuse large cell lymphoma
660590|NCT00787761|stage IV adult diffuse large cell lymphoma|stage iv adult diffuse large cell lymphoma
660591|NCT00787761|stage IV adult diffuse mixed cell lymphoma|stage iv adult diffuse mixed cell lymphoma
660592|NCT00787761|recurrent adult diffuse mixed cell lymphoma|recurrent adult diffuse mixed cell lymphoma
660593|NCT00787761|stage III adult immunoblastic large cell lymphoma|stage iii adult immunoblastic large cell lymphoma
660594|NCT00787761|stage IV adult immunoblastic large cell lymphoma|stage iv adult immunoblastic large cell lymphoma
660595|NCT00787761|stage III adult lymphoblastic lymphoma|stage iii adult lymphoblastic lymphoma
660596|NCT00787761|stage IV adult lymphoblastic lymphoma|stage iv adult lymphoblastic lymphoma
660597|NCT00787761|recurrent adult immunoblastic large cell lymphoma|recurrent adult immunoblastic large cell lymphoma
660598|NCT00787761|recurrent adult lymphoblastic lymphoma|recurrent adult lymphoblastic lymphoma
660599|NCT00787761|recurrent grade 3 follicular lymphoma|recurrent grade 3 follicular lymphoma
660966|NCT00786513|biofilm|biofilm
660600|NCT00787761|stage III grade 3 follicular lymphoma|stage iii grade 3 follicular lymphoma
660601|NCT00787761|stage IV grade 3 follicular lymphoma|stage iv grade 3 follicular lymphoma
660602|NCT00787761|recurrent mantle cell lymphoma|recurrent mantle cell lymphoma
660603|NCT00787761|stage III mantle cell lymphoma|stage iii mantle cell lymphoma
660604|NCT00787761|stage IV mantle cell lymphoma|stage iv mantle cell lymphoma
660605|NCT00787761|contiguous st II adult diffuse small cleaved cell lymphoma|contiguous st ii adult diffuse small cleaved cell lymphoma
660606|NCT00787761|noncontiguous st II diffuse small cleaved cell lymphoma|noncontiguous st ii diffuse small cleaved cell lymphoma
660607|NCT00787761|recurrent adult diffuse small cleaved cell lymphoma|recurrent adult diffuse small cleaved cell lymphoma
660608|NCT00787761|stage III adult diffuse small cleaved cell lymphoma|stage iii adult diffuse small cleaved cell lymphoma
660609|NCT00787761|stage IV adult diffuse small cleaved cell lymphoma|stage iv adult diffuse small cleaved cell lymphoma
660610|NCT00787761|contiguous stage II grade 1 follicular lymphoma|contiguous stage ii grade 1 follicular lymphoma
660611|NCT00787761|contiguous stage II grade 2 follicular lymphoma|contiguous stage ii grade 2 follicular lymphoma
660612|NCT00787761|noncontiguous stage II grade 1 follicular lymphoma|noncontiguous stage ii grade 1 follicular lymphoma
660613|NCT00787761|noncontiguous stage II grade 2 follicular lymphoma|noncontiguous stage ii grade 2 follicular lymphoma
660614|NCT00787761|recurrent grade 1 follicular lymphoma|recurrent grade 1 follicular lymphoma
660615|NCT00787761|recurrent grade 2 follicular lymphoma|recurrent grade 2 follicular lymphoma
660616|NCT00787761|stage III grade 1 follicular lymphoma|stage iii grade 1 follicular lymphoma
660617|NCT00787761|stage III grade 2 follicular lymphoma|stage iii grade 2 follicular lymphoma
660618|NCT00787761|stage IV grade 1 follicular lymphoma|stage iv grade 1 follicular lymphoma
660619|NCT00787761|stage IV grade 2 follicular lymphoma|stage iv grade 2 follicular lymphoma
660620|NCT00787761|contiguous stage II marginal zone lymphoma|contiguous stage ii marginal zone lymphoma
660621|NCT00787761|noncontiguous stage II marginal zone lymphoma|noncontiguous stage ii marginal zone lymphoma
660622|NCT00787761|recurrent marginal zone lymphoma|recurrent marginal zone lymphoma
660623|NCT00787761|stage III marginal zone lymphoma|stage iii marginal zone lymphoma
660624|NCT00787761|stage IV marginal zone lymphoma|stage iv marginal zone lymphoma
660625|NCT00787761|contiguous stage II small lymphocytic lymphoma|contiguous stage ii small lymphocytic lymphoma
660626|NCT00787761|noncontiguous stage II small lymphocytic lymphoma|noncontiguous stage ii small lymphocytic lymphoma
660627|NCT00787761|recurrent small lymphocytic lymphoma|recurrent small lymphocytic lymphoma
660628|NCT00787761|stage III small lymphocytic lymphoma|stage iii small lymphocytic lymphoma
660629|NCT00787761|stage IV small lymphocytic lymphoma|stage iv small lymphocytic lymphoma
660630|NCT00787761|recurrent adult grade III lymphomatoid granulomatosis|recurrent adult grade iii lymphomatoid granulomatosis
660631|NCT00787761|relapsing chronic myelogenous leukemia|relapsing chronic myelogenous leukemia
660632|NCT00787761|refractory chronic lymphocytic leukemia|refractory chronic lymphocytic leukemia
660633|NCT00787761|splenic marginal zone lymphoma|splenic marginal zone lymphoma
660634|NCT00787761|Waldenstrom macroglobulinemia|waldenstrom macroglobulinemia
660635|NCT00787761|recurrent adult T-cell leukemia/lymphoma|recurrent adult t-cell leukemia/lymphoma
660636|NCT00787761|stage III adult T-cell leukemia/lymphoma|stage iii adult t-cell leukemia/lymphoma
660637|NCT00787761|stage IV adult T-cell leukemia/lymphoma|stage iv adult t-cell leukemia/lymphoma
660638|NCT00787761|anaplastic large cell lymphoma|anaplastic large cell lymphoma
660639|NCT00787761|angioimmunoblastic T-cell lymphoma|angioimmunoblastic t-cell lymphoma
660640|NCT00787748|Cardiovascular|cardiovascular
660641|NCT00787748|COPD|copd
660642|NCT00787748|Population|population
660643|NCT00787748|Prevalence|prevalence
660644|NCT00787748|Underdiagnosis|underdiagnosis
660645|NCT00787722|High dose immunosuppressive therapy|high dose immunosuppressive therapy
660646|NCT00787722|Hematopoietic stem cell support|hematopoietic stem cell support
660647|NCT00787709|Obesity prevention|obesity prevention
660648|NCT00787709|Health promotion|health promotion
660649|NCT00787709|School based curriculum|school based curriculum
660650|NCT00787696|HIV prevention|hiv prevention
660651|NCT00787696|female adolescent offenders|female adolescent offenders
660652|NCT00787696|sexual risk reduction|sexual risk reduction
660653|NCT00787696|alcohol and other drug abuse|alcohol and other drug abuse
660654|NCT00787683|Patients with ventricular arrhythmias and the prevention of sudden cardiac death|patients with ventricular arrhythmias and the prevention of sudden cardiac death
660655|NCT00787670|Obese|obese
660656|NCT00787670|Type 2 Diabetes Mellitus|type 2 diabetes mellitus
660657|NCT00787670|Gastric Bypass surgery|gastric bypass surgery
660658|NCT00787670|Risk of cardiovascular diseases|risk of cardiovascular diseases
660659|NCT00787657|Clinically Isolated Syndrome (CIS)|clinically isolated syndrome (cis)
660660|NCT00787644|Asthma|asthma
660661|NCT00787644|Adipose Tissue|adipose tissue
660662|NCT00787644|Asthmatics|asthmatics
660663|NCT00787644|Pioglitazone|pioglitazone
660664|NCT00787644|Actos|actos
660665|NCT00787644|Obesity|obesity
660666|NCT00787644|Exacerbation|exacerbation
660667|NCT00787644|Fat|fat
660668|NCT00787644|Overweight|overweight
660669|NCT00787644|Leptin|leptin
660670|NCT00787644|Adiponectin|adiponectin
660671|NCT00787644|Wheezing|wheezing
660672|NCT00787644|Vermont|vermont
660673|NCT00787644|Pulmonary|pulmonary
660674|NCT00787644|Lung|lung
660675|NCT00787631|birch pollen pollen allergy|birch pollen pollen allergy
660676|NCT00787631|oral allergy syndrome to apple|oral allergy syndrome to apple
660677|NCT00787631|cross reactivity|cross reactivity
660678|NCT00787631|bet v 1|bet v 1
660679|NCT00787631|mal d 1|mal d 1
660680|NCT00787618|Renal impairment|renal impairment
660681|NCT00787605|Hypertension, diabetes mellitus, aliskiren, hydrochlorothiazide, systolic blood pressure, diastolic blood pressure, amlodipine, stage 2|hypertension, diabetes mellitus, aliskiren, hydrochlorothiazide, systolic blood pressure, diastolic blood pressure, amlodipine, stage 2
660682|NCT00787592|Burns|burns
660683|NCT00787592|children|children
660684|NCT00787592|collagenase|collagenase
660685|NCT00787592|silver sulfadiazine|silver sulfadiazine
660686|NCT00787592|Childhood burns|childhood burns
660687|NCT00787579|Myopia, bifocal, children|myopia, bifocal, children
660688|NCT00787566|Highly emetogenic chemotherapy induced nausea and vomiting|highly emetogenic chemotherapy induced nausea and vomiting
660689|NCT00787553|hysterectomy|hysterectomy
660690|NCT00787553|antibiotic prophylaxis|antibiotic prophylaxis
660691|NCT00787553|bacterial vaginosis|bacterial vaginosis
660692|NCT00787553|tinidazole|tinidazole
660693|NCT00787553|cefazolin|cefazolin
660694|NCT00787540|Coronary disease|coronary disease
660695|NCT00787540|Psychosocial|psychosocial
660696|NCT00787540|Nursing|nursing
660697|NCT00787527|Lymphoma|lymphoma
660698|NCT00787527|Non-Hodgkin's Lymphoma|non-hodgkin's lymphoma
660699|NCT00787527|SAHA|saha
660700|NCT00787527|Vorinostat|vorinostat
660701|NCT00787527|Suberoylanilide Hydroxamic Acid|suberoylanilide hydroxamic acid
660702|NCT00787527|MSK-390|msk-390
660703|NCT00787527|CHOP|chop
660704|NCT00787527|Cyclophosphamide|cyclophosphamide
660705|NCT00787527|Doxorubicin|doxorubicin
660707|NCT00787527|Hydroxydaunomycin hydrochloride|hydroxydaunomycin hydrochloride
660708|NCT00787527|Cytoxan|cytoxan
660709|NCT00787527|Neosar|neosar
660710|NCT00787527|Vincristine|vincristine
660711|NCT00787527|Prednisone|prednisone
660712|NCT00787527|Untreated T-cell|untreated t-cell
660713|NCT00787527|T-cell NHL|t-cell nhl
660714|NCT00787527|Peripheral T-cell lymphoma|peripheral t-cell lymphoma
660715|NCT00787527|PTCL|ptcl
660716|NCT00787527|CD 30|cd 30
660717|NCT00787527|Anaplastic large cell lymphoma|anaplastic large cell lymphoma
660718|NCT00787527|Angioimmunoblastic T-cell lymphoma|angioimmunoblastic t-cell lymphoma
660719|NCT00787527|Intestinal T-cell lymphoma|intestinal t-cell lymphoma
660720|NCT00787527|Subcutaneous panniculitic T-cell lymphoma|subcutaneous panniculitic t-cell lymphoma
660721|NCT00787514|ovarian cancer, folate receptor, plasma|ovarian cancer, folate receptor, plasma
660722|NCT00787501|Major Depressive Disorder|major depressive disorder
660723|NCT00787501|Depression|depression
660724|NCT00787501|Selective Serotonin Reuptake Inhibitors|selective serotonin reuptake inhibitors
660725|NCT00787501|Cognitive Behavior Therapy|cognitive behavior therapy
660726|NCT00787501|Cognitive Therapy|cognitive therapy
660727|NCT00787501|antidepressant medications|antidepressant medications
660728|NCT00787488|Ovarian|ovarian
660729|NCT00787488|debulked|debulked
660730|NCT00787488|recurrent|recurrent
660731|NCT00787488|Stage III|stage iii
660732|NCT00787488|Stage IV|stage iv
660733|NCT00787475|Diabetes|diabetes
660734|NCT00787475|Community health worker|community health worker
660735|NCT00787475|Community outreach|community outreach
660736|NCT00787462|Neuropathic|neuropathic
660737|NCT00787462|Neuropathic pain|neuropathic pain
660738|NCT00787462|Nerve pain|nerve pain
660739|NCT00787462|Pain|pain
660740|NCT00787462|Chronic pain|chronic pain
660741|NCT00787462|Pregabalin|pregabalin
660742|NCT00787462|Lyrica|lyrica
660743|NCT00787462|Small fiber neuropathy|small fiber neuropathy
660744|NCT00787462|Neuropathy|neuropathy
660745|NCT00787436|portal hypertension|portal hypertension
660746|NCT00787436|Gastroesophageal|gastroesophageal
660747|NCT00787436|Varices|varices
660748|NCT00787436|Liver disease|liver disease
660749|NCT00787436|cirrhosis|cirrhosis
660750|NCT00787423|Field Tools|field tools
660751|NCT00787423|Stress|stress
660752|NCT00787423|Psychological Stress|psychological stress
660753|NCT00787423|Ecological Monetary Assessment (EMA)|ecological monetary assessment (ema)
660754|NCT00787423|Global Positioning Units|global positioning units
660755|NCT00787423|Drug Use|drug use
660756|NCT00787410|malignant mesothelioma|malignant mesothelioma
660757|NCT00787410|IRESSA|iressa
660758|NCT00787410|ZD1839|zd1839
660759|NCT00787397|Sleep difficulties in pediatric anxiety disorder|sleep difficulties in pediatric anxiety disorder
660760|NCT00787397|Neural correlates of pediatric anxiety disorder|neural correlates of pediatric anxiety disorder
660761|NCT00787397|Social correlates of pediatric anxiety disorder|social correlates of pediatric anxiety disorder
660762|NCT00787397|Generalized Anxiety Disorder in pediatric populations|generalized anxiety disorder in pediatric populations
660763|NCT00787397|Separation Anxiety Disorder in pediatric populations|separation anxiety disorder in pediatric populations
660764|NCT00787397|Social Phobia in pediatric populations|social phobia in pediatric populations
660765|NCT00787384|Hypereosinophilic syndrome (HES)|hypereosinophilic syndrome (hes)
660766|NCT00787384|chronic eosinophilic leukaemia (CEL)|chronic eosinophilic leukaemia (cel)
660767|NCT00787384|chronic idiopathic hypereosinophilia (CIH)|chronic idiopathic hypereosinophilia (cih)
660770|NCT00787384|Timing to response|timing to response
660771|NCT00787371|alanine transaminase|alanine transaminase
660772|NCT00787358|osteoporosis|osteoporosis
660773|NCT00787358|intertrochanteric|intertrochanteric
660774|NCT00787358|hip fracture|hip fracture
841280|NCT00086645|PDD|pdd
660775|NCT00787358|compression hip screw|compression hip screw
660776|NCT00787358|surgical fixation|surgical fixation
660777|NCT00787345|precaution technique during central venous catheter placement.|precaution technique during central venous catheter placement.
660778|NCT00787332|Suspected Heparin Induced Thrombocytopenia (HIT)|suspected heparin induced thrombocytopenia (hit)
660779|NCT00787319|Ophthalmology|ophthalmology
660780|NCT00787319|Age-related macular degeneration|age-related macular degeneration
660781|NCT00787319|outpatients|outpatients
660782|NCT00787306|chronic disease management|chronic disease management
660783|NCT00787306|decision aids|decision aids
660784|NCT00787306|cardiovascular risk factors|cardiovascular risk factors
660785|NCT00787293|Heart Failure|heart failure
660786|NCT00787293|Mitral Regurgitation|mitral regurgitation
660787|NCT00787293|Percutaneous|percutaneous
660788|NCT00787293|Coronary sinus|coronary sinus
660789|NCT00787280|obese|obese
660790|NCT00787280|overweight|overweight
660791|NCT00787280|fMRI|fmri
660792|NCT00787280|Diet|diet
660793|NCT00787267|NSCLC|nsclc
660794|NCT00787267|Lung Cancer|lung cancer
660795|NCT00787267|Dasatinib|dasatinib
660796|NCT00787267|Genomics|genomics
660797|NCT00787267|Genomics analysis|genomics analysis
660798|NCT00787267|Genomic signature|genomic signature
660799|NCT00787254|Curling Ulcer|curling ulcer
660800|NCT00787254|Gastric Ulcer|gastric ulcer
660801|NCT00787254|Nonsteroid anti-inflammatory drug|nonsteroid anti-inflammatory drug
660802|NCT00787254|Drug Therapy|drug therapy
660803|NCT00787241|Platelets|platelets
660804|NCT00787241|Labor|labor
660805|NCT00787241|Preeclampsia|preeclampsia
660806|NCT00787215|oral glucose tolerance test|oral glucose tolerance test
660807|NCT00787215|Hong Kong Chinese|hong kong chinese
660808|NCT00787202|treatment of ulcerative colitis; CP 690 550|treatment of ulcerative colitis; cp 690 550
660809|NCT00787189|sensorineural hearing loss|sensorineural hearing loss
660810|NCT00787189|tinnitus|tinnitus
660811|NCT00787189|word recognition|word recognition
660812|NCT00787176|Oxytocin|oxytocin
660813|NCT00787176|Labor, Obstetric|labor, obstetric
660814|NCT00787176|Non-reassuring fetal heart rate|non-reassuring fetal heart rate
660815|NCT00787176|epidural|epidural
660816|NCT00787163|pPROM|pprom
660817|NCT00787163|oligohydramnios|oligohydramnios
660818|NCT00787163|amnioinfusion|amnioinfusion
660819|NCT00787163|prematurity|prematurity
660820|NCT00787163|Early premature rupture of membranes in pregnancy|early premature rupture of membranes in pregnancy
660821|NCT00787111|Drug: Fluoxetine|drug: fluoxetine
660822|NCT00787098|therapeutic mobility|therapeutic mobility
660823|NCT00787098|acute care|acute care
660824|NCT00787098|nursing|nursing
660825|NCT00787098|inflammatory markers|inflammatory markers
660826|NCT00787085|Funguria|funguria
660827|NCT00787085|Epidemiology|epidemiology
660828|NCT00787085|Urinary Tract Infections|urinary tract infections
660829|NCT00787059|Adenylyl Cyclase|adenylyl cyclase
660830|NCT00787059|AC6|ac6
660831|NCT00787059|adenovirus|adenovirus
660832|NCT00787059|gene therapy|gene therapy
660833|NCT00787059|congestive heart failure|congestive heart failure
660834|NCT00787059|intracoronary|intracoronary
660835|NCT00787059|nitroprusside|nitroprusside
660836|NCT00787033|Focal Adhesion Kinase; Advanced Non-Hematologic Malignancies|focal adhesion kinase; advanced non-hematologic malignancies
660837|NCT00787020|Cerebrospinal Fluid|cerebrospinal fluid
660838|NCT00787020|Ventriculostomy|ventriculostomy
660839|NCT00787020|Subarachnoid hemorrhage|subarachnoid hemorrhage
660840|NCT00787020|vasospasm|vasospasm
660841|NCT00787020|Human Subjects|human subjects
660842|NCT00787007|healthy volunteers|healthy volunteers
660843|NCT00787007|pharmacokinetics|pharmacokinetics
660844|NCT00786994|Actinic Keratoses|actinic keratoses
660845|NCT00786968|mucopolysaccharidosis|mucopolysaccharidosis
660846|NCT00786968|Hurler-Scheie|hurler-scheie
660847|NCT00786968|Scheie|scheie
660848|NCT00786968|laronidase|laronidase
660849|NCT00786968|spinal cord compression|spinal cord compression
660850|NCT00786968|central nervous system|central nervous system
660851|NCT00786968|enzyme replacement therapy|enzyme replacement therapy
660852|NCT00786968|intrathecal|intrathecal
660853|NCT00786942|osteotomy|osteotomy
660854|NCT00786942|knee|knee
660855|NCT00786942|varus deformity|varus deformity
660856|NCT00786942|bone graft|bone graft
660857|NCT00786929|Conversion to more aggressive treatment of recurrent fluid collection|conversion to more aggressive treatment of recurrent fluid collection
660858|NCT00786916|pain|pain
660859|NCT00786916|propofol|propofol
660860|NCT00786916|lidocaine|lidocaine
660861|NCT00786916|sedation|sedation
660862|NCT00786916|pediatric|pediatric
660863|NCT00786890|Prediabetes (IFG, IGT)|prediabetes (ifg, igt)
660864|NCT00786890|Hong Kong Chinese|hong kong chinese
660865|NCT00786890|Cardiovascular risk factors|cardiovascular risk factors
660866|NCT00786877|pneumonia|pneumonia
661658|NCT00783835|CONQoL|conqol
660867|NCT00786864|Randomised controlled trial|randomised controlled trial
660868|NCT00786864|low back pain|low back pain
660869|NCT00786864|exercise|exercise
660870|NCT00786864|children|children
660871|NCT00786864|school-based|school-based
660872|NCT00786864|prevalence|prevalence
660873|NCT00786864|intensity|intensity
660874|NCT00786851|MANTLE CELL LYMPHOMA (MCL)|mantle cell lymphoma (mcl)
660875|NCT00786851|Lenalidomide (Len)|lenalidomide (len)
660876|NCT00786851|Dexamethasone (Dex)|dexamethasone (dex)
660877|NCT00786838|Solid tumor|solid tumor
660878|NCT00786838|Advanced solid tumor|advanced solid tumor
660879|NCT00786838|Malignant tumors|malignant tumors
660880|NCT00786838|Sarcoma|sarcoma
660881|NCT00786838|Breast tumor|breast tumor
660882|NCT00786838|Ovarian tumor|ovarian tumor
660883|NCT00786838|QT interval|qt interval
660884|NCT00786838|Trabectedin|trabectedin
660885|NCT00786838|Yondelis|yondelis
660886|NCT00786838|Ecteinascidin 743|ecteinascidin 743
660887|NCT00786838|ET743|et743
660888|NCT00786825|Type 1 diabetes|type 1 diabetes
660889|NCT00786825|Hypoglycemia unawareness|hypoglycemia unawareness
660890|NCT00786812|Leukemia|leukemia
660891|NCT00786812|adult chronic myeloid leukemia|adult chronic myeloid leukemia
660892|NCT00786812|imatinib|imatinib
660893|NCT00786812|nilotinib|nilotinib
660894|NCT00786786|Any person with a spinal cord injury|any person with a spinal cord injury
660895|NCT00786786|at least 18 years of age|at least 18 years of age
660896|NCT00786773|GERD|gerd
660897|NCT00786773|reflux symptom|reflux symptom
660898|NCT00786773|heartburn|heartburn
660899|NCT00786773|acid regurgitation|acid regurgitation
660901|NCT00786773|H2RA|h2ra
660902|NCT00786773|antacid|antacid
660903|NCT00786760|HPV|hpv
660904|NCT00786760|Papillomavirus|papillomavirus
660905|NCT00786760|Infection|infection
660906|NCT00786760|Sexually transmitted disease|sexually transmitted disease
660907|NCT00786760|STD|std
660908|NCT00786747|Computer-assisted instruction|computer-assisted instruction
660909|NCT00786747|Health knowledge, attitudes, practice|health knowledge, attitudes, practice
660910|NCT00786747|Mass screening|mass screening
660911|NCT00786747|Patient acceptance of health care|patient acceptance of health care
660912|NCT00786747|Patient education as topic|patient education as topic
660913|NCT00786747|Primary health care|primary health care
660914|NCT00786747|Self-efficacy|self-efficacy
660915|NCT00786734|pitavastatin|pitavastatin
660916|NCT00786734|PCI|pci
660917|NCT00786734|stable angina|stable angina
660918|NCT00786721|Mitochondria and Metabolic Syndrome|mitochondria and metabolic syndrome
660919|NCT00786708|renal|renal
660920|NCT00786708|kidney|kidney
660921|NCT00786708|lipocalin|lipocalin
660922|NCT00786708|urine|urine
660923|NCT00786708|biomarker|biomarker
660924|NCT00786708|Azotemia|azotemia
660925|NCT00786708|Renal insufficiency, chronic|renal insufficiency, chronic
660926|NCT00786708|Renal failure, acute|renal failure, acute
660927|NCT00786708|Hydronephrosis|hydronephrosis
660928|NCT00786695|noncardiac chest pain|noncardiac chest pain
660929|NCT00786695|gastroesophageal reflux disease|gastroesophageal reflux disease
660930|NCT00786695|diagnostic test|diagnostic test
660931|NCT00786695|proton pump inhibitor|proton pump inhibitor
660932|NCT00786695|esomeprazole|esomeprazole
660933|NCT00786682|stage IV prostate cancer|stage iv prostate cancer
660934|NCT00786682|recurrent prostate cancer|recurrent prostate cancer
660935|NCT00786656|Navigation|navigation
660936|NCT00786656|Coordination|coordination
660937|NCT00786656|Cancer Care|cancer care
660938|NCT00786656|Patient Experience|patient experience
660939|NCT00786656|Cancer|cancer
660940|NCT00786656|Patient Survey|patient survey
660941|NCT00786643|Gamma Interferon|gamma interferon
660942|NCT00786643|5-FU|5-fu
660943|NCT00786643|LV|lv
660944|NCT00786630|Drug treatment entry and retention|drug treatment entry and retention
660945|NCT00786630|Drug injection frequency|drug injection frequency
660946|NCT00786630|HIV risk behaviors|hiv risk behaviors
660947|NCT00786630|Hepatitis C risk behaviors|hepatitis c risk behaviors
660948|NCT00786591|Acute pancreatitis|acute pancreatitis
660949|NCT00786591|biological markers|biological markers
660950|NCT00786591|substance P|substance p
660951|NCT00786591|hydrogen sulfide|hydrogen sulfide
660952|NCT00786591|disease severity index|disease severity index
660953|NCT00786578|training|training
660954|NCT00786578|intramyocellular lipid|intramyocellular lipid
660955|NCT00786578|insulin resistance|insulin resistance
660956|NCT00786552|recurrent/advanced thyroid cancer|recurrent/advanced thyroid cancer
660957|NCT00786552|papillary or anaplastic thyroid cancer|papillary or anaplastic thyroid cancer
660958|NCT00786539|mitochondrial|mitochondrial
660959|NCT00786526|Mechanical ventilation|mechanical ventilation
660960|NCT00786526|Ventilator induced diaphragmatic dysfunction|ventilator induced diaphragmatic dysfunction
660961|NCT00786526|Weaning|weaning
660962|NCT00786526|Neuromuscular diseases- Respiratory function tests|neuromuscular diseases- respiratory function tests
660963|NCT00786526|Intubated patients in intensive care unit|intubated patients in intensive care unit
660964|NCT00786513|Cystic fibrosis|cystic fibrosis
660965|NCT00786513|Pseudomonas aeruginosa|pseudomonas aeruginosa
660967|NCT00786513|antibiotic susceptibility testing|antibiotic susceptibility testing
660968|NCT00786513|pediatrics|pediatrics
841491|NCT00086541|HCV|hcv
660969|NCT00786500|Herbal medicine|herbal medicine
660970|NCT00786500|Type 2 diabetes|type 2 diabetes
660971|NCT00786500|Insulin sensitivity|insulin sensitivity
660972|NCT00786500|Insulin secretion|insulin secretion
660973|NCT00786487|insulin resistance|insulin resistance
660974|NCT00786487|lipid metabolism|lipid metabolism
660975|NCT00786487|lipid infusion|lipid infusion
660976|NCT00786487|glycerol infusion|glycerol infusion
660977|NCT00786487|skeletal muscle|skeletal muscle
660978|NCT00786487|diabetes|diabetes
660979|NCT00786474|Bridging Anticoagulation|bridging anticoagulation
660980|NCT00786461|silver nitrate|silver nitrate
660981|NCT00786461|marsupialisation|marsupialisation
660982|NCT00786448|Overactive Bladder|overactive bladder
660983|NCT00786422|Embolism and Thrombosis|embolism and thrombosis
660984|NCT00786422|Pulmonary Embolism|pulmonary embolism
660985|NCT00786422|Embolism|embolism
660986|NCT00786422|Venous Thrombosis|venous thrombosis
660987|NCT00786422|Thrombosis|thrombosis
660988|NCT00786422|Enzyme Inducers|enzyme inducers
660989|NCT00786422|CYP Inducers|cyp inducers
660990|NCT00786422|Cohort Study|cohort study
660991|NCT00786422|Pharmacologic Actions|pharmacologic actions
660992|NCT00786422|Respiratory Tract Diseases|respiratory tract diseases
660993|NCT00786422|Lung Diseases|lung diseases
660994|NCT00786422|Vascular Diseases|vascular diseases
660995|NCT00786422|Human Immunodeficiency Virus (HIV)|human immunodeficiency virus (hiv)
660996|NCT00786422|Neurologic disease|neurologic disease
660997|NCT00786422|Additional relevant MeSH terms:|additional relevant mesh terms:
660998|NCT00786422|Fibrin Modulating Agents|fibrin modulating agents
660999|NCT00786422|Anticoagulants|anticoagulants
661000|NCT00786422|Therapeutic Uses|therapeutic uses
661001|NCT00786422|Hematologic Agents|hematologic agents
661002|NCT00786422|Enzyme Inhibitors|enzyme inhibitors
661003|NCT00786422|Cardiovascular Diseases|cardiovascular diseases
661004|NCT00786422|Cardiovascular Agents|cardiovascular agents
661005|NCT00786409|Lupus|lupus
661006|NCT00786396|HIV|hiv
661007|NCT00786396|AIDS|aids
661008|NCT00786396|substance abuse|substance abuse
661009|NCT00786396|directly administered antiretroviral therapy|directly administered antiretroviral therapy
661010|NCT00786396|adherence|adherence
661011|NCT00786396|Substance Abuse and Dependency|substance abuse and dependency
661012|NCT00786383|Phase I|phase i
661013|NCT00786383|cancer|cancer
661014|NCT00786383|solid tumors|solid tumors
661015|NCT00786383|1121B|1121b
661016|NCT00786383|VEGFR-2|vegfr-2
661017|NCT00786383|Anti-Vascular Endothelial Growth Factor Receptor 2|anti-vascular endothelial growth factor receptor 2
661018|NCT00786370|propofol|propofol
661019|NCT00786370|dexmedetomidine|dexmedetomidine
661020|NCT00786370|cataract|cataract
661021|NCT00786370|respiratory|respiratory
661022|NCT00786370|blood pressure|blood pressure
661023|NCT00786370|Cataract surgery|cataract surgery
661024|NCT00786357|shift-work|shift-work
661025|NCT00786357|sleep|sleep
661026|NCT00786357|nurse|nurse
661027|NCT00786357|relaxation|relaxation
661028|NCT00786344|Health Promotion: Wellness Programs|health promotion: wellness programs
661029|NCT00786344|Occupational Therapy|occupational therapy
661030|NCT00786344|Quality of Life|quality of life
661031|NCT00786344|Health|health
661032|NCT00786344|Biomarkers|biomarkers
661033|NCT00786331|second line treatment|second line treatment
661034|NCT00786331|pemetrexed|pemetrexed
661035|NCT00786331|carboplatin|carboplatin
661036|NCT00786318|Psychosis|psychosis
661037|NCT00786318|Agitation|agitation
661038|NCT00786318|Delirium|delirium
661039|NCT00786305|Nebulization|nebulization
661040|NCT00786305|ceftazidime|ceftazidime
661041|NCT00786305|amikacin|amikacin
661042|NCT00786305|pneumonia|pneumonia
661043|NCT00786305|Pseudomonas aeruginosa|pseudomonas aeruginosa
661044|NCT00786305|mechanical ventilation|mechanical ventilation
661045|NCT00786305|Ventilator-associated pneumonia|ventilator-associated pneumonia
661046|NCT00786305|treatment|treatment
661047|NCT00786279|atherosclerosis|atherosclerosis
661048|NCT00786266|shift-work|shift-work
661049|NCT00786266|sleep|sleep
661050|NCT00786266|nurse|nurse
661051|NCT00786266|relaxation|relaxation
661052|NCT00786253|Erectile dysfunction|erectile dysfunction
661053|NCT00786253|Vardenafil|vardenafil
661054|NCT00786240|Bioequivalence|bioequivalence
661055|NCT00786240|Therapeutic Equivalency|therapeutic equivalency
661056|NCT00786214|Functional Dyspepsia|functional dyspepsia
661057|NCT00786214|Acupuncture|acupuncture
661058|NCT00786214|Traditional Chinese Medicine|traditional chinese medicine
661059|NCT00786201|CNTO 888|cnto 888
661060|NCT00786201|Idiopathic Pulmonary Fibrosis|idiopathic pulmonary fibrosis
661061|NCT00786201|IPF|ipf
661062|NCT00786188|Menopause|menopause
661063|NCT00786188|Vasomotor Symptoms|vasomotor symptoms
661064|NCT00786188|Hot flash|hot flash
661065|NCT00786188|Perimenopause|perimenopause
661066|NCT00786188|Nonhormonal therapies|nonhormonal therapies
661067|NCT00786188|Climacteric symptoms|climacteric symptoms
661068|NCT00786188|Mesafem|mesafem
661069|NCT00786188|Low-Dose Mesylate salt of Paroxetine (LDMP)|low-dose mesylate salt of paroxetine (ldmp)
661070|NCT00786149|Underserved populations|underserved populations
661071|NCT00786149|Homelessness|homelessness
661072|NCT00786149|Nicotine replacement therapy|nicotine replacement therapy
661073|NCT00786149|Counseling|counseling
661074|NCT00786149|Cancer Prevention and control|cancer prevention and control
661075|NCT00786136|diabetes mellitus|diabetes mellitus
661076|NCT00786136|chronic kidney disease|chronic kidney disease
661077|NCT00786136|contrast induced acute kidney injury|contrast induced acute kidney injury
661078|NCT00786136|angiography|angiography
661079|NCT00786123|irritable bowel syndrome|irritable bowel syndrome
661080|NCT00786123|rectal hypersensitivity|rectal hypersensitivity
661081|NCT00786123|probiotics|probiotics
661082|NCT00786123|melatonin|melatonin
661083|NCT00786123|brain-gut axis|brain-gut axis
661084|NCT00786110|Sorafenib|sorafenib
661085|NCT00786110|Paclitaxel|paclitaxel
661086|NCT00786110|Disease free survival|disease free survival
661087|NCT00786084|Hiatal hernia|hiatal hernia
661088|NCT00786084|PEH|peh
661089|NCT00786084|paraesophageal hernia|paraesophageal hernia
661090|NCT00786084|synthetic mesh|synthetic mesh
661091|NCT00786084|small intestine submucosa|small intestine submucosa
661092|NCT00786071|Rett syndrome.|rett syndrome.
661093|NCT00786071|Nutritional status.|nutritional status.
661094|NCT00786071|Metabolic alterations.|metabolic alterations.
661095|NCT00786058|refractory pancreatic cancer|refractory pancreatic cancer
661096|NCT00786058|gemcitabine|gemcitabine
661097|NCT00786058|phase III|phase iii
661098|NCT00786058|second line|second line
661099|NCT00786045|stroke|stroke
661100|NCT00786045|rehabilitation|rehabilitation
661101|NCT00786045|walking|walking
661102|NCT00786032|Amyotrophic Lateral Sclerosis|amyotrophic lateral sclerosis
661103|NCT00786032|Brain Computer Interface (BCI)|brain computer interface (bci)
661104|NCT00786032|Lou Gehrig's disease|lou gehrig's disease
661105|NCT00786019|Type|type
661106|NCT00786019|2|2
661107|NCT00786019|Diabetes|diabetes
661108|NCT00786019|Blood|blood
661109|NCT00786019|Vessel|vessel
661110|NCT00786019|Function|function
661111|NCT00786019|Exercise|exercise
661112|NCT00786019|Program|program
661113|NCT00786019|Intervention|intervention
661114|NCT00786019|Vitamin|vitamin
661115|NCT00786019|C|c
661116|NCT00786019|Men|men
661118|NCT00786019|Blood vessel function|blood vessel function
661119|NCT00786006|pancreatic cancer|pancreatic cancer
661120|NCT00786006|gemcitabine|gemcitabine
661121|NCT00786006|oxaliplatin|oxaliplatin
661122|NCT00786006|irinotecan|irinotecan
661123|NCT00786006|fluorouracil|fluorouracil
661124|NCT00786006|Failure to gemcitabine chemotherapy|failure to gemcitabine chemotherapy
661125|NCT00785993|Egg banking, clinical outcome|egg banking, clinical outcome
661126|NCT00785980|quinine sulfate|quinine sulfate
661127|NCT00785980|ciprofloxacin|ciprofloxacin
661128|NCT00785980|drug interactions|drug interactions
661129|NCT00785980|cytochrome p450|cytochrome p450
661130|NCT00785980|male|male
661131|NCT00785980|female|female
661132|NCT00785980|adult|adult
661133|NCT00785980|pharmacokinetics|pharmacokinetics
661134|NCT00785967|V(D)J recombination; RAG-1/2 recombinase function|v(d)j recombination; rag-1/2 recombinase function
661135|NCT00785954|Heart Diseases|heart diseases
661136|NCT00785954|Myocardial Ischemia|myocardial ischemia
661137|NCT00785954|Infarction|infarction
661138|NCT00785954|Myocardial Infarction|myocardial infarction
661139|NCT00785941|Tumors|tumors
661140|NCT00785941|Antibodies, Monoclonal|antibodies, monoclonal
661141|NCT00785928|Arthritis|arthritis
661142|NCT00785915|AZD6765|azd6765
661143|NCT00785915|Japanese and Caucasian Healthy Volunteers|japanese and caucasian healthy volunteers
661144|NCT00785915|Phase I study|phase i study
661145|NCT00785915|Single and multiple Ascending Dose|single and multiple ascending dose
661146|NCT00785915|Japanese volunteers|japanese volunteers
661147|NCT00785889|Colorectal cancer screening|colorectal cancer screening
661148|NCT00785889|optical colonoscopy|optical colonoscopy
661149|NCT00785889|water method|water method
661150|NCT00785889|sedation|sedation
661151|NCT00785876|Paediatric|paediatric
661152|NCT00785876|Emergency Department|emergency department
661153|NCT00785876|Ankle|ankle
661154|NCT00785876|Injury|injury
661155|NCT00785876|Low risk ankle rule|low risk ankle rule
661156|NCT00785863|hyperalgesia|hyperalgesia
661157|NCT00785863|remifentanil|remifentanil
661158|NCT00785863|ketorolac|ketorolac
661159|NCT00785863|parecoxib|parecoxib
661160|NCT00785863|COX-1 inhibitor|cox-1 inhibitor
661161|NCT00785863|COX-2 inhibitor|cox-2 inhibitor
661162|NCT00785837|Hydrotherapy|hydrotherapy
661163|NCT00785837|Perinatal Care|perinatal care
661164|NCT00785837|Neonatology|neonatology
661165|NCT00785824|Lactation|lactation
661166|NCT00785824|Endocrine System Diseases|endocrine system diseases
661167|NCT00785824|Musculoskeletal System Disease|musculoskeletal system disease
661168|NCT00785824|Hormone|hormone
661169|NCT00785824|Physiological Properties|physiological properties
661170|NCT00785798|Relapsed Lymphomas|relapsed lymphomas
661171|NCT00785798|Refractory Lymphomas|refractory lymphomas
661172|NCT00785785|Unresectable GIST|unresectable gist
661173|NCT00785785|metastatic GIST|metastatic gist
661174|NCT00785785|nilotinib|nilotinib
661175|NCT00785785|AMN107|amn107
661176|NCT00785785|imatinib|imatinib
661177|NCT00785785|STI571|sti571
661178|NCT00785772|Gabapentin Pharmacokinetics|gabapentin pharmacokinetics
661179|NCT00785759|Alzheimer's Disease|alzheimer's disease
661180|NCT00785746|elderly, balance, core, strength|elderly, balance, core, strength
661181|NCT00785733|asthma|asthma
661182|NCT00785707|sensorineural hearing loss|sensorineural hearing loss
661183|NCT00785707|cochlear implant|cochlear implant
661184|NCT00785668|Asthma|asthma
661185|NCT00785668|Allergy|allergy
661186|NCT00785668|Interleukin-4|interleukin-4
661187|NCT00785668|Interleukin-13|interleukin-13
661188|NCT00785668|IL-4|il-4
661189|NCT00785668|IL-13|il-13
661190|NCT00785668|Pharmacokinetics|pharmacokinetics
661191|NCT00785668|Safety|safety
661192|NCT00785668|Tolerability|tolerability
661193|NCT00785668|Aerovance|aerovance
661194|NCT00785668|dry powder|dry powder
661195|NCT00785629|phosphorus|phosphorus
661196|NCT00785629|secondary hyperparathyroidism|secondary hyperparathyroidism
661197|NCT00785629|vascular calcification|vascular calcification
661198|NCT00785616|HIV|hiv
661199|NCT00785616|Adherence|adherence
661200|NCT00785616|MEMS|mems
661201|NCT00785603|Depression|depression
661202|NCT00785603|pain|pain
661203|NCT00785603|CYP2D6|cyp2d6
661204|NCT00785603|interactions|interactions
661205|NCT00785603|Pupillometry|pupillometry
661206|NCT00785603|Tramadol|tramadol
661207|NCT00785603|Paroxetine|paroxetine
661208|NCT00785603|MR-ratio|mr-ratio
661209|NCT00785564|T-wave memory|t-wave memory
661210|NCT00785564|Sick Sinus Syndrome|sick sinus syndrome
661211|NCT00785551|male|male
661212|NCT00785551|female|female
661213|NCT00785551|pharmacokinetics|pharmacokinetics
661214|NCT00785551|normal and impaired renal function|normal and impaired renal function
661215|NCT00785538|Tumors|tumors
661216|NCT00785538|Antibodies, Monoclonal|antibodies, monoclonal
661217|NCT00785525|Healthy Unrelated Stem Cell Donors|healthy unrelated stem cell donors
661218|NCT00785512|nebivolol|nebivolol
661219|NCT00785512|Bystolic®|bystolic®
661220|NCT00785512|Hypertension|hypertension
661221|NCT00785512|blood pressure|blood pressure
661222|NCT00785512|withdrawal|withdrawal
661223|NCT00785499|obesity|obesity
661224|NCT00785499|metabolic syndrome|metabolic syndrome
661225|NCT00785499|milk components|milk components
661226|NCT00785499|casein|casein
661227|NCT00785499|whey|whey
661228|NCT00785499|children|children
661229|NCT00785499|adolescent|adolescent
661230|NCT00785486|midazolam|midazolam
661231|NCT00785486|drug interactions|drug interactions
661232|NCT00785486|cytochrome p450|cytochrome p450
661233|NCT00785447|Cardiopulmonary Resuscitation|cardiopulmonary resuscitation
661234|NCT00785447|Respiratory Physiology|respiratory physiology
661235|NCT00785447|Mouth to mouth ventilation|mouth to mouth ventilation
661236|NCT00785447|Mouth to nose ventilation|mouth to nose ventilation
661237|NCT00785434|MDD|mdd
661238|NCT00785434|escitalopram|escitalopram
661239|NCT00785421|heparin|heparin
661240|NCT00785421|LMWH|lmwh
661241|NCT00785421|pancreatic cancer|pancreatic cancer
661242|NCT00785408|obesity|obesity
661243|NCT00785408|overweight|overweight
661244|NCT00785408|weight loss|weight loss
661245|NCT00785408|Amylin|amylin
661246|NCT00785408|AC2307|ac2307
661247|NCT00785382|Pain, Pregabalin, Lyrica, Breast surgery|pain, pregabalin, lyrica, breast surgery
661248|NCT00785369|skin disorders|skin disorders
661249|NCT00785369|skin cancer|skin cancer
661250|NCT00785369|melanoma|melanoma
661251|NCT00785369|lentigo maligna|lentigo maligna
661252|NCT00785356|Uterine fibroids|uterine fibroids
661253|NCT00785356|Anemia|anemia
661254|NCT00785343|stroke|stroke
661255|NCT00785343|acute|acute
661256|NCT00785343|arm|arm
661257|NCT00785343|robot|robot
661258|NCT00785343|therapy|therapy
661259|NCT00785343|arm paresis|arm paresis
661260|NCT00785330|rituximab|rituximab
661261|NCT00785330|Non-Hodgkin's lymphoma|non-hodgkin's lymphoma
661262|NCT00785330|diffuse large B cell lymphoma|diffuse large b cell lymphoma
661263|NCT00785330|peripheral t cell lymphoma|peripheral t cell lymphoma
661264|NCT00785330|graft-versus-host disease|graft-versus-host disease
661265|NCT00785330|graft-versus-lymphoma effect|graft-versus-lymphoma effect
661266|NCT00785330|allogeneic haematopoietic stem cell transplantation|allogeneic haematopoietic stem cell transplantation
661267|NCT00785330|relapsed or primary progressive aggressive Non-Hodgkin's lymphoma|relapsed or primary progressive aggressive non-hodgkin's lymphoma
661268|NCT00785317|Postmenopausal Hormone Replacement Therapy|postmenopausal hormone replacement therapy
661269|NCT00785278|Wheelchair Set-Up|wheelchair set-up
661270|NCT00785278|Shoulder Joint Forces|shoulder joint forces
661271|NCT00785278|Manual Wheelchair Users|manual wheelchair users
661272|NCT00785278|Paraplegia|paraplegia
661273|NCT00785278|Upper Limb Pain|upper limb pain
661274|NCT00785278|Secondary Injury to Spinal Cord Injury|secondary injury to spinal cord injury
661275|NCT00785278|Biomechanics|biomechanics
661276|NCT00785265|Live Donor Kidney Transplantation|live donor kidney transplantation
661277|NCT00785265|LDKT|ldkt
661278|NCT00785265|African Americans|african americans
661279|NCT00785265|Disparity|disparity
661280|NCT00785265|Education|education
661281|NCT00785252|Catheters, Indwelling|catheters, indwelling
661282|NCT00785239|Malignant Airway Disease|malignant airway disease
661283|NCT00785239|Benign Airway Disease|benign airway disease
661284|NCT00785239|Lung Cancer|lung cancer
661285|NCT00785239|Emphysema|emphysema
661286|NCT00785239|Chronic Bronchitis|chronic bronchitis
661287|NCT00785239|COPD|copd
661288|NCT00785239|Asthma|asthma
661289|NCT00785239|Sarcoidosis|sarcoidosis
661290|NCT00785239|Mesothelioma|mesothelioma
661291|NCT00785239|CryoSpray Ablation|cryospray ablation
661292|NCT00785239|Cryotherapy|cryotherapy
661293|NCT00785239|Cryospray|cryospray
661294|NCT00785239|Cryo|cryo
661295|NCT00785213|rosiglitazone|rosiglitazone
661296|NCT00785213|quinine sulfate|quinine sulfate
661297|NCT00785213|drug interactions|drug interactions
661298|NCT00785213|cytochrome p450|cytochrome p450
661299|NCT00785200|MRSA|mrsa
661300|NCT00785200|Methicillin-resistant Staphylococcus aureus|methicillin-resistant staphylococcus aureus
661301|NCT00785200|Chlorhexidine|chlorhexidine
661302|NCT00785200|Asymptomatic colonization|asymptomatic colonization
661303|NCT00785200|Asymptomatic colonization, MRSA|asymptomatic colonization, mrsa
661304|NCT00785200|Skin and soft tissue infections|skin and soft tissue infections
661305|NCT00785187|UVB induced skin erythema|uvb induced skin erythema
661306|NCT00785174|noninvasive ventilation, continuous posi|noninvasive ventilation, continuous posi
661307|NCT00785161|Penumbra System|penumbra system
661308|NCT00785161|Mechanical Thrombectomy|mechanical thrombectomy
661309|NCT00785161|Ischemic Stroke|ischemic stroke
661310|NCT00785161|Intervention|intervention
661311|NCT00785161|Neurovascular|neurovascular
661312|NCT00785161|Thrombus|thrombus
661313|NCT00785161|Imaging|imaging
661314|NCT00785161|Ischemic Penumbra|ischemic penumbra
661315|NCT00785161|Functional Outcome|functional outcome
661316|NCT00785135|vision, binocular|vision, binocular
661317|NCT00785135|vision disparity|vision disparity
661318|NCT00785135|headache|headache
661319|NCT00785135|dizziness|dizziness
661320|NCT00785135|anxiety|anxiety
661321|NCT00785135|neck pain|neck pain
661322|NCT00785135|learning disorders|learning disorders
661323|NCT00785135|asthenopia|asthenopia
661324|NCT00785135|motion sickness|motion sickness
661325|NCT00785135|depth perception|depth perception
661326|NCT00785135|gait disorder|gait disorder
661327|NCT00785135|diplopia|diplopia
661328|NCT00785135|photophobia|photophobia
661329|NCT00785135|agoraphobia|agoraphobia
661330|NCT00785135|panic disorder|panic disorder
661331|NCT00785122|cancer vaccine|cancer vaccine
661332|NCT00785109|aortic valve calcification|aortic valve calcification
661333|NCT00785109|vitamin K supplementation|vitamin k supplementation
661334|NCT00785096|Perception, surgical complications, patients, nurses and physicians|perception, surgical complications, patients, nurses and physicians
661335|NCT00785083|Asthma, adrenergic beta agonists, multiple sclerosis, pulmonary function tests, forced expiratory volume|asthma, adrenergic beta agonists, multiple sclerosis, pulmonary function tests, forced expiratory volume
661336|NCT00785070|Perioperative|perioperative
661337|NCT00785070|Obstructive Sleep Apnea|obstructive sleep apnea
661338|NCT00785070|Screening|screening
661339|NCT00785070|Home Sleep Testing|home sleep testing
661340|NCT00785057|Hypertension|hypertension
661341|NCT00785057|Stroke|stroke
661342|NCT00785057|Neurology|neurology
661343|NCT00785057|JNC7|jnc7
661344|NCT00785057|2007 ESH-ESC guidelines|2007 esh-esc guidelines
661345|NCT00785057|survey|survey
661346|NCT00785044|Heart Failure|heart failure
661347|NCT00785044|MIBG|mibg
661348|NCT00785044|123I-mIBG|123i-mibg
661349|NCT00785031|risk management|risk management
661350|NCT00785031|Self Management|self management
661351|NCT00785031|Self-Efficacy|self-efficacy
661352|NCT00785031|Disease management|disease management
661353|NCT00785031|nurse practitioner|nurse practitioner
661354|NCT00785031|internet|internet
661355|NCT00785031|risk factors|risk factors
661356|NCT00785031|vascular diseases|vascular diseases
661357|NCT00785031|economic evaluation|economic evaluation
661358|NCT00785018|Endotoxin|endotoxin
661359|NCT00785018|C1-inhibitor|c1-inhibitor
661360|NCT00785018|Inflammation|inflammation
661361|NCT00785018|Sepsis|sepsis
661362|NCT00785018|Multi organ dysfunction syndrome|multi organ dysfunction syndrome
661363|NCT00785018|Complement activation|complement activation
661364|NCT00785005|Diabetes|diabetes
661365|NCT00785005|Exercise|exercise
661366|NCT00785005|Women|women
661367|NCT00785005|Research|research
661368|NCT00785005|Bike|bike
661369|NCT00785005|Type|type
661370|NCT00785005|Control|control
661371|NCT00785005|Healthy|healthy
661372|NCT00784992|NLDO|nldo
661373|NCT00784992|DCR|dcr
661374|NCT00784992|silicone tubes|silicone tubes
661375|NCT00784992|stent|stent
661376|NCT00784979|Renal|renal
661377|NCT00784979|Transplant|transplant
661378|NCT00784979|PRA|pra
661379|NCT00784966|Islet transplantation|islet transplantation
661380|NCT00784966|Type 1 Diabetes Mellitus|type 1 diabetes mellitus
661381|NCT00784966|Kidney Transplantation|kidney transplantation
661382|NCT00784953|Symbicort SMART|symbicort smart
661383|NCT00784953|budesonide|budesonide
661384|NCT00784953|formoterol|formoterol
661385|NCT00784953|ICS/LABA|ics/laba
661386|NCT00784953|Asthma Control Questionnaire|asthma control questionnaire
661387|NCT00784953|Not optimally controlled asthma|not optimally controlled asthma
661388|NCT00784927|stage I grade 1 follicular lymphoma|stage i grade 1 follicular lymphoma
661389|NCT00784927|contiguous stage II grade 1 follicular lymphoma|contiguous stage ii grade 1 follicular lymphoma
661390|NCT00784927|noncontiguous stage II grade 1 follicular lymphoma|noncontiguous stage ii grade 1 follicular lymphoma
661391|NCT00784927|stage III grade 1 follicular lymphoma|stage iii grade 1 follicular lymphoma
661392|NCT00784927|stage IV grade 1 follicular lymphoma|stage iv grade 1 follicular lymphoma
661393|NCT00784927|stage I grade 2 follicular lymphoma|stage i grade 2 follicular lymphoma
661394|NCT00784927|contiguous stage II grade 2 follicular lymphoma|contiguous stage ii grade 2 follicular lymphoma
661395|NCT00784927|noncontiguous stage II grade 2 follicular lymphoma|noncontiguous stage ii grade 2 follicular lymphoma
661396|NCT00784927|stage III grade 2 follicular lymphoma|stage iii grade 2 follicular lymphoma
661397|NCT00784927|stage IV grade 2 follicular lymphoma|stage iv grade 2 follicular lymphoma
661398|NCT00784927|stage I small lymphocytic lymphoma|stage i small lymphocytic lymphoma
661399|NCT00784927|contiguous stage II small lymphocytic lymphoma|contiguous stage ii small lymphocytic lymphoma
661400|NCT00784927|noncontiguous stage II small lymphocytic lymphoma|noncontiguous stage ii small lymphocytic lymphoma
661401|NCT00784927|stage III small lymphocytic lymphoma|stage iii small lymphocytic lymphoma
661402|NCT00784927|stage IV small lymphocytic lymphoma|stage iv small lymphocytic lymphoma
661403|NCT00784927|Waldenstrom macroglobulinemia|waldenstrom macroglobulinemia
661404|NCT00784927|extranodal marginal zone B-cell lymphoma of mucosa-associated lymphoid tissue|extranodal marginal zone b-cell lymphoma of mucosa-associated lymphoid tissue
661405|NCT00784927|nodal marginal zone B-cell lymphoma|nodal marginal zone b-cell lymphoma
661406|NCT00784927|splenic marginal zone lymphoma|splenic marginal zone lymphoma
661407|NCT00784927|stage I marginal zone lymphoma|stage i marginal zone lymphoma
661408|NCT00784927|contiguous stage II marginal zone lymphoma|contiguous stage ii marginal zone lymphoma
661409|NCT00784927|noncontiguous stage II marginal zone lymphoma|noncontiguous stage ii marginal zone lymphoma
661410|NCT00784927|stage III marginal zone lymphoma|stage iii marginal zone lymphoma
661411|NCT00784927|stage IV marginal zone lymphoma|stage iv marginal zone lymphoma
661412|NCT00784914|adult anaplastic astrocytoma|adult anaplastic astrocytoma
661413|NCT00784914|adult diffuse astrocytoma|adult diffuse astrocytoma
661414|NCT00784914|adult craniopharyngioma|adult craniopharyngioma
661415|NCT00784914|adult choroid plexus tumor|adult choroid plexus tumor
661416|NCT00784914|adult brain stem glioma|adult brain stem glioma
661417|NCT00784914|tumors metastatic to brain|tumors metastatic to brain
661418|NCT00784914|recurrent adult brain tumor|recurrent adult brain tumor
661419|NCT00784914|adult gliosarcoma|adult gliosarcoma
661420|NCT00784914|adult giant cell glioblastoma|adult giant cell glioblastoma
661421|NCT00784914|adult ependymoblastoma|adult ependymoblastoma
661422|NCT00784914|adult medulloblastoma|adult medulloblastoma
661423|NCT00784914|adult supratentorial primitive neuroectodermal tumor (PNET)|adult supratentorial primitive neuroectodermal tumor (pnet)
661424|NCT00784914|adult anaplastic ependymoma|adult anaplastic ependymoma
661425|NCT00784914|adult ependymoma|adult ependymoma
661426|NCT00784914|adult myxopapillary ependymoma|adult myxopapillary ependymoma
661427|NCT00784914|adult subependymoma|adult subependymoma
661428|NCT00784914|adult mixed glioma|adult mixed glioma
661429|NCT00784914|meningeal melanocytoma|meningeal melanocytoma
661430|NCT00784914|adult meningeal hemangiopericytoma|adult meningeal hemangiopericytoma
661431|NCT00784914|adult grade I meningioma|adult grade i meningioma
661432|NCT00784914|adult grade II meningioma|adult grade ii meningioma
661433|NCT00784914|adult grade III meningioma|adult grade iii meningioma
661434|NCT00784914|adult anaplastic oligodendroglioma|adult anaplastic oligodendroglioma
661435|NCT00784914|adult oligodendroglioma|adult oligodendroglioma
661436|NCT00784914|adult pineoblastoma|adult pineoblastoma
661437|NCT00784914|adult pineocytoma|adult pineocytoma
661438|NCT00784901|Macular Thickness Analyzed by Optical Coherence Tomography in Retinitis Pigmemtosa|macular thickness analyzed by optical coherence tomography in retinitis pigmemtosa
661439|NCT00784888|aromatase inhibitor|aromatase inhibitor
661440|NCT00784888|quality of life|quality of life
661441|NCT00784888|safety|safety
661442|NCT00784888|postmenopausal breast cancer|postmenopausal breast cancer
661443|NCT00784849|Breast cancer|breast cancer
661444|NCT00784849|diagnostic|diagnostic
661445|NCT00784849|lymph nodes|lymph nodes
661446|NCT00784836|Multiple Sclerosis - Relapsing|multiple sclerosis - relapsing
661447|NCT00784810|Efficacy, tolerability, moderate/severe, oxycodone/naloxone|efficacy, tolerability, moderate/severe, oxycodone/naloxone
661448|NCT00784810|codeine/paracetamol, chronic low back pain, osteoarthritis|codeine/paracetamol, chronic low back pain, osteoarthritis
661449|NCT00784784|antiviral drugs|antiviral drugs
661450|NCT00784784|influenza vaccines|influenza vaccines
661451|NCT00784771|Hypnotherapy|hypnotherapy
661452|NCT00784771|Hypnosis|hypnosis
661453|NCT00784771|PTSD|ptsd
661454|NCT00784758|Asthma|asthma
842026|NCT00085995|AS|as
661455|NCT00784758|Lung Diseases|lung diseases
661456|NCT00784758|Respiratory Tract Diseases|respiratory tract diseases
661457|NCT00784745|incretin effect|incretin effect
661458|NCT00784745|type 2 diabetes|type 2 diabetes
661459|NCT00784745|GLP-1|glp-1
661460|NCT00784745|GIP|gip
661461|NCT00784745|dexamethasone|dexamethasone
661462|NCT00784732|Seasonal Allergic Rhinitis|seasonal allergic rhinitis
661463|NCT00784732|Environmental Exposure Chamber|environmental exposure chamber
661464|NCT00784732|nasal lavage|nasal lavage
661465|NCT00784719|Dry eye|dry eye
661466|NCT00784706|stroke rehabilitation|stroke rehabilitation
661467|NCT00784706|perceptual deficits|perceptual deficits
661468|NCT00784706|kinematic analysis|kinematic analysis
661469|NCT00784693|Endometriosis|endometriosis
661470|NCT00784693|pain|pain
661471|NCT00784693|tanezumab|tanezumab
661472|NCT00784693|nerve growth factor|nerve growth factor
661473|NCT00784693|questionnaires|questionnaires
661474|NCT00784667|Colorectal neoplasm|colorectal neoplasm
661475|NCT00784667|Metastasis|metastasis
661476|NCT00784615|Phenotypes of Polycystic Ovary Syndrome|phenotypes of polycystic ovary syndrome
661477|NCT00784615|Cardiovascular risk factors|cardiovascular risk factors
661478|NCT00784615|Adiponectin|adiponectin
661479|NCT00784615|C Reactive Protein|c reactive protein
661480|NCT00784602|prolapse|prolapse
661481|NCT00784602|pelvic organ prolapse|pelvic organ prolapse
661482|NCT00784589|Corticothérapy|corticothérapy
661483|NCT00784589|Rituximab|rituximab
661484|NCT00784589|therapeutic efficacity|therapeutic efficacity
661485|NCT00784589|therapeutic tolerance|therapeutic tolerance
661486|NCT00784576|Delirium|delirium
661487|NCT00784576|Cardiac Surgery|cardiac surgery
661488|NCT00784576|Depression|depression
661489|NCT00784576|Cognitive Impairment|cognitive impairment
661490|NCT00784576|Diagnostic Criteria for Delirium|diagnostic criteria for delirium
661491|NCT00784576|Memorial Delirium Assessment Scale|memorial delirium assessment scale
661492|NCT00784576|Delirium Index|delirium index
661493|NCT00784563|Parkinson Disease|parkinson disease
661494|NCT00784563|Exercise/*physiology|exercise/*physiology
661495|NCT00784563|*Physical Fitness|*physical fitness
661496|NCT00784563|Rehabilitation|rehabilitation
661497|NCT00784563|Cognition|cognition
661498|NCT00784550|Spirometry|spirometry
661499|NCT00784550|COPD|copd
661500|NCT00784537|Hodgkin's lymphoma|hodgkin's lymphoma
661501|NCT00784537|ABVD|abvd
661502|NCT00784537|FDG-PET (18-Fluoro-deoxy-D-glucose Positron Emission Tomography)|fdg-pet (18-fluoro-deoxy-d-glucose positron emission tomography)
661503|NCT00784537|Radiotherapy|radiotherapy
661504|NCT00784524|stage IV breast cancer|stage iv breast cancer
661505|NCT00784524|recurrent breast cancer|recurrent breast cancer
661506|NCT00784524|metastatic breast cancer|metastatic breast cancer
661507|NCT00784511|diabetes|diabetes
661508|NCT00784511|vitamin D|vitamin d
661509|NCT00784511|African Americans|african americans
661510|NCT00784511|overweight|overweight
661511|NCT00784511|insulin sensitivity|insulin sensitivity
661512|NCT00784511|glucose control|glucose control
661513|NCT00784498|Procedural sedation and analgesia|procedural sedation and analgesia
661514|NCT00784498|Emergency Department|emergency department
661515|NCT00784498|propofol versus ketamine and midazolam|propofol versus ketamine and midazolam
661516|NCT00784498|painful orthopedic manipulations|painful orthopedic manipulations
661517|NCT00784485|Asthma|asthma
661518|NCT00784485|Respiratory Tract Diseases|respiratory tract diseases
661519|NCT00784485|Lung Diseases|lung diseases
661520|NCT00784485|Dyspnea|dyspnea
661521|NCT00784472|PCNL|pcnl
661522|NCT00784472|oxycodone|oxycodone
661523|NCT00784472|morphine|morphine
661524|NCT00784472|visceral pain|visceral pain
661525|NCT00784459|Asthma|asthma
661526|NCT00784459|Allergy|allergy
661527|NCT00784446|AIO|aio
661528|NCT00784446|colorectal cancer|colorectal cancer
661529|NCT00784446|0205|0205
661530|NCT00784446|Capecitabine|capecitabine
661531|NCT00784446|Oxaliplatin|oxaliplatin
661532|NCT00784446|Bevacizumab|bevacizumab
661533|NCT00784446|Imatinib|imatinib
661534|NCT00784433|alcohol diabetes CVD|alcohol diabetes cvd
661535|NCT00784420|Drug Interaction, Pharmacokinetics|drug interaction, pharmacokinetics
661536|NCT00784407|thyroid surgery|thyroid surgery
661537|NCT00784407|total thyroidectomy|total thyroidectomy
661538|NCT00784407|harmonic scalpel|harmonic scalpel
661539|NCT00784381|Renal failure|renal failure
661540|NCT00784381|Elderly|elderly
661541|NCT00784381|Drug Therapy Computer-Assisted|drug therapy computer-assisted
661542|NCT00784381|Quality of care|quality of care
661543|NCT00784381|Patients With Impaired Renal Function|patients with impaired renal function
661544|NCT00784381|Inappropriateness of target drug prescribed|inappropriateness of target drug prescribed
661545|NCT00784368|Mycoses|mycoses
661546|NCT00784368|Candidiasis|candidiasis
661547|NCT00784368|Aspergillosis|aspergillosis
661548|NCT00784368|Cryptococcosis|cryptococcosis
661549|NCT00784368|Blastomycosis|blastomycosis
661550|NCT00784368|Histoplasmosis|histoplasmosis
661551|NCT00784368|Neutropenia|neutropenia
661552|NCT00784368|Itraconazole|itraconazole
661553|NCT00784368|JK1211|jk1211
661554|NCT00784355|recurrence of idiopathic pancreatitis|recurrence of idiopathic pancreatitis
661851|NCT00782873|safety|safety
661555|NCT00784355|laparoscopic cholecystectomy|laparoscopic cholecystectomy
661556|NCT00784355|etiology of pancreatitis|etiology of pancreatitis
661557|NCT00784342|COPD|copd
661558|NCT00784329|Lung Cancer|lung cancer
661559|NCT00784329|Squamous Cell Lung Cancer|squamous cell lung cancer
661560|NCT00784329|Bronchial carcinoma in situ|bronchial carcinoma in situ
661561|NCT00784329|Central Airway Diseases|central airway diseases
661562|NCT00784316|Prevention|prevention
661563|NCT00784303|Thyroid Cancer|thyroid cancer
661564|NCT00784277|Pain medication|pain medication
661565|NCT00784277|Arthritis|arthritis
661566|NCT00784277|Joint pain|joint pain
661567|NCT00784277|Analgesia|analgesia
661568|NCT00784277|Analgesics|analgesics
661569|NCT00784277|tapentadol|tapentadol
661570|NCT00784277|CG5503|cg5503
661571|NCT00784277|Nucynta|nucynta
661572|NCT00784264|Asymptomatic atherosclerosis|asymptomatic atherosclerosis
661573|NCT00784264|Intima media thickness (IMT)|intima media thickness (imt)
661574|NCT00784264|central obesity|central obesity
661575|NCT00784264|cardiovascular disease|cardiovascular disease
661576|NCT00784251|Pain|pain
661577|NCT00784251|Leg pain|leg pain
661578|NCT00784251|Back pain|back pain
661579|NCT00784251|PROMIS|promis
661580|NCT00784238|Schizophrenia|schizophrenia
661581|NCT00784238|Paliperidone Extended-release|paliperidone extended-release
661582|NCT00784238|Paliperidone|paliperidone
661583|NCT00784238|R076477|r076477
661584|NCT00784225|cataract|cataract
661585|NCT00784225|advanced macular degeneration|advanced macular degeneration
661586|NCT00784212|Photosensitive Epilepsy, photic stimulation, electroencephalogram|photosensitive epilepsy, photic stimulation, electroencephalogram
661587|NCT00784199|MDD|mdd
661588|NCT00784199|Depression|depression
661589|NCT00784186|Pregnancy termination|pregnancy termination
661590|NCT00784186|abortion|abortion
661591|NCT00784186|medical abortion|medical abortion
661592|NCT00784186|2nd trimester|2nd trimester
661593|NCT00784186|mifepristone|mifepristone
661594|NCT00784186|misoprostol|misoprostol
661595|NCT00784173|Syndrome|syndrome
661596|NCT00784173|Velocardiofacial|velocardiofacial
661597|NCT00784173|Middle ear|middle ear
661598|NCT00784173|Inner ear|inner ear
661599|NCT00784173|Malformation|malformation
661600|NCT00784147|HIV|hiv
661601|NCT00784147|CD4|cd4
661602|NCT00784147|experienced|experienced
661603|NCT00784147|resistant|resistant
661604|NCT00784147|resistance|resistance
661605|NCT00784147|monoclonal|monoclonal
661606|NCT00784147|antibody|antibody
661607|NCT00784147|infusion|infusion
661608|NCT00784147|ibalizumab|ibalizumab
661609|NCT00784147|TNX355|tnx355
661610|NCT00784147|TNX-355|tnx-355
661611|NCT00784147|TMB355|tmb355
661612|NCT00784147|TMB-355|tmb-355
661613|NCT00784134|intraventricular hemorrhage thrombolysis|intraventricular hemorrhage thrombolysis
661614|NCT00784095|quality of life|quality of life
661615|NCT00784082|Sickle cell disease, hydroxyurea, inflammation|sickle cell disease, hydroxyurea, inflammation
661616|NCT00784043|Cochlear implant|cochlear implant
661617|NCT00784043|hearing loss|hearing loss
661618|NCT00784030|Autosomal Dominant Polycystic Kidney Disease|autosomal dominant polycystic kidney disease
661619|NCT00784030|Polycystic Kidney Disease|polycystic kidney disease
661620|NCT00784030|Water Loading|water loading
661621|NCT00784030|Biomarkers|biomarkers
661622|NCT00784017|Children with previously untreated acute lymphoblastic leukemia|children with previously untreated acute lymphoblastic leukemia
661623|NCT00784004|breathing patterns,|breathing patterns,
661624|NCT00784004|unidirectional breathing,|unidirectional breathing,
661625|NCT00784004|mask ventilation,|mask ventilation,
661626|NCT00784004|respiratory physiology|respiratory physiology
661627|NCT00783991|IVF|ivf
661628|NCT00783991|PDA|pda
661629|NCT00783991|PC|pc
661630|NCT00783991|CAT|cat
661631|NCT00783991|COPD|copd
661632|NCT00783991|MDD|mdd
661633|NCT00783991|RA|ra
661634|NCT00783978|Surfactant protein C|surfactant protein c
661635|NCT00783978|Interstitial|interstitial
661636|NCT00783978|lung|lung
661637|NCT00783978|Children|children
661638|NCT00783965|nevoid basal cell carcinoma syndrome|nevoid basal cell carcinoma syndrome
661639|NCT00783965|basal cell carcinoma of the skin|basal cell carcinoma of the skin
661640|NCT00783952|Mixed venous oxygen saturation|mixed venous oxygen saturation
661641|NCT00783952|Tissue oxygenation|tissue oxygenation
661642|NCT00783952|Near infrared spectroscopy|near infrared spectroscopy
661643|NCT00783913|Direct Current Stimulation|direct current stimulation
661644|NCT00783913|Rehabilitation|rehabilitation
661645|NCT00783913|Motor Learning|motor learning
661646|NCT00783913|Stroke|stroke
661647|NCT00783900|Prevention|prevention
661648|NCT00783887|Cilia|cilia
661649|NCT00783887|Axoneme|axoneme
661650|NCT00783887|Dynein|dynein
661651|NCT00783887|Gene|gene
661652|NCT00783887|Ultrastructure|ultrastructure
661653|NCT00783887|Linkage analysis|linkage analysis
661654|NCT00783848|CHF|chf
661655|NCT00783835|Attention Deficit Hyperactivity Disorder|attention deficit hyperactivity disorder
661656|NCT00783835|Methylphenidate|methylphenidate
661657|NCT00783835|Concerta|concerta
661659|NCT00783822|breast neoplasms|breast neoplasms
661660|NCT00783822|genetic counseling|genetic counseling
661661|NCT00783809|intracranial pressure|intracranial pressure
661662|NCT00783809|intracranial hypertension|intracranial hypertension
661663|NCT00783809|ultrasound|ultrasound
661664|NCT00783809|emergency|emergency
661665|NCT00783809|traumatic brain injury|traumatic brain injury
661666|NCT00783809|ocular ultrasound|ocular ultrasound
661667|NCT00783796|Coronary artery disease|coronary artery disease
661668|NCT00783796|Atherosclerosis|atherosclerosis
661669|NCT00783796|Myocardial ischemia|myocardial ischemia
661670|NCT00783783|Psychiatric disorders|psychiatric disorders
661671|NCT00783783|Neurodevelopmental disorders|neurodevelopmental disorders
661672|NCT00783783|Autism|autism
661673|NCT00783783|Risperidone|risperidone
661674|NCT00783783|Pharmacogenetics|pharmacogenetics
661675|NCT00783783|Pharmacokinetics|pharmacokinetics
661676|NCT00783770|Breastfeeding|breastfeeding
661677|NCT00783770|Infant|infant
661678|NCT00783770|Preterm|preterm
661679|NCT00783770|Nutrition|nutrition
661680|NCT00783757|neo-adjuvant chemotherapy|neo-adjuvant chemotherapy
661681|NCT00783757|TOBI|tobi
661682|NCT00783757|breast imaging|breast imaging
661683|NCT00783757|optical imaging|optical imaging
661684|NCT00783731|intubation|intubation
661685|NCT00783679|Cardiac output|cardiac output
661686|NCT00783679|Noninvasive cardiac output measurement|noninvasive cardiac output measurement
661687|NCT00783679|Thermodilution|thermodilution
661688|NCT00783653|AML|aml
661689|NCT00783653|FLT3|flt3
661690|NCT00783653|acute myeloid leukemia|acute myeloid leukemia
661691|NCT00783653|FLT 3 inhibitor|flt 3 inhibitor
661692|NCT00783653|FLT3 mutated AML|flt3 mutated aml
661693|NCT00783627|Endothelium|endothelium
661694|NCT00783627|progenitors|progenitors
661695|NCT00783627|stem cells|stem cells
661696|NCT00783627|sickle cell|sickle cell
661697|NCT00783614|HIV|hiv
661698|NCT00783614|Cardiovascular Disease|cardiovascular disease
661699|NCT00783614|Endothelial Dysfunction|endothelial dysfunction
661700|NCT00783601|Chronic Asthma|chronic asthma
661701|NCT00783588|Chronic lymphocytic leukemia|chronic lymphocytic leukemia
661702|NCT00783588|CLL|cll
661703|NCT00783588|Leukemia|leukemia
661704|NCT00783588|Leukemia, Lymphocytic, Chronic, B-Cell|leukemia, lymphocytic, chronic, b-cell
661705|NCT00783588|Leukemia, B-Cell|leukemia, b-cell
661706|NCT00783588|Immune System Diseases|immune system diseases
661707|NCT00783588|ISF35|isf35
661708|NCT00783588|Ad-ISF35|ad-isf35
661709|NCT00783588|Immunotherapy|immunotherapy
661710|NCT00783588|Immune therapy|immune therapy
661711|NCT00783588|Active immune therapy|active immune therapy
661712|NCT00783575|Crohn's disease|crohn's disease
661713|NCT00783575|Ulcerative colitis|ulcerative colitis
661714|NCT00783575|Inflammatory bowel disease|inflammatory bowel disease
661715|NCT00783575|NOD2,CARD 15 mutations|nod2,card 15 mutations
661716|NCT00783562|Low back pain|low back pain
661717|NCT00783562|Neck pain|neck pain
661718|NCT00783562|Functional disability|functional disability
661719|NCT00783562|Nursery school teachers|nursery school teachers
661720|NCT00783562|Exercise program|exercise program
661721|NCT00783562|Prevention|prevention
661722|NCT00783549|tolerability|tolerability
661723|NCT00783549|pharmacodynamics|pharmacodynamics
661724|NCT00783549|pharmacokinetics|pharmacokinetics
661725|NCT00783549|safety|safety
661726|NCT00783536|An randomized, open label, multicenter study to compare the ef|an randomized, open label, multicenter study to compare the ef
661727|NCT00783510|JIA|jia
661728|NCT00783510|Juvenile Idiopathic Arthritis|juvenile idiopathic arthritis
661729|NCT00783510|Juvenile Arthritis|juvenile arthritis
661730|NCT00783510|Polyarticular JIA|polyarticular jia
661731|NCT00783510|Polyarticular-course JIA|polyarticular-course jia
661732|NCT00783497|High Blood Pressure|high blood pressure
661733|NCT00783497|Stress|stress
661734|NCT00783484|First in Human (FIH), PF-03716539, PK enhancer|first in human (fih), pf-03716539, pk enhancer
661735|NCT00783445|Metabolic Cardiovascular Syndrome|metabolic cardiovascular syndrome
661736|NCT00783445|Metabolic Syndrome|metabolic syndrome
661737|NCT00783445|Obesity|obesity
661738|NCT00783445|Hyperglycemia|hyperglycemia
661739|NCT00783419|tubo-ovarian abscess, pelvic-inflammatory disease|tubo-ovarian abscess, pelvic-inflammatory disease
661740|NCT00783406|COPD|copd
661741|NCT00783380|Influenza vaccination|influenza vaccination
661742|NCT00783380|Subunit|subunit
661743|NCT00783380|Virosomal|virosomal
661744|NCT00783380|HIV/AIDS|hiv/aids
661745|NCT00783380|Renal Dialysis|renal dialysis
661746|NCT00783380|Kidney transplantation|kidney transplantation
661747|NCT00783380|Rheumatologic diseases|rheumatologic diseases
661748|NCT00783380|Immunogenicity|immunogenicity
661749|NCT00783380|Reactogenicity|reactogenicity
661750|NCT00783367|Revlimid|revlimid
661751|NCT00783367|Celgene brand of lenalidomide|celgene brand of lenalidomide
661752|NCT00783367|lenalidomide|lenalidomide
661753|NCT00783367|Rituxan|rituxan
661754|NCT00783367|CD20 antibody, rituximab|cd20 antibody, rituximab
661755|NCT00783367|rituximab|rituximab
661756|NCT00783367|Follicular Lymphoma|follicular lymphoma
661757|NCT00783367|Marginal Zone B-Cell Lymphoma|marginal zone b-cell lymphoma
661758|NCT00783367|Lymphoma, Small Lymphocytic|lymphoma, small lymphocytic
661759|NCT00783367|Waldenstrom Macroglobulinemia|waldenstrom macroglobulinemia
661760|NCT00783367|Mantle-Cell Lymphoma|mantle-cell lymphoma
661761|NCT00783367|Antigens, CD20|antigens, cd20
661762|NCT00783367|refractory|refractory
661763|NCT00783367|resistantRefractory/progressive lymphoma less than 6 months from first rituximab dose of previous rituximab-containing regimen|resistantrefractory/progressive lymphoma less than 6 months from first rituximab dose of previous rituximab-containing regimen
661764|NCT00783367|Previously treated|previously treated
661765|NCT00783367|Treated with rituximab|treated with rituximab
661766|NCT00783328|solid tumor|solid tumor
661767|NCT00783315|Hypertension|hypertension
661768|NCT00783315|Diabetes|diabetes
661769|NCT00783315|Hypercholesterolemia|hypercholesterolemia
661770|NCT00783302|CAD|cad
661771|NCT00783302|Visipaque|visipaque
661772|NCT00783302|CCTA|ccta
661773|NCT00783250|COPD|copd
661774|NCT00783250|Respiratory Mechanics|respiratory mechanics
661775|NCT00783250|Bronchodilators|bronchodilators
661776|NCT00783250|COPD patients with poor reversibility|copd patients with poor reversibility
661777|NCT00783185|psychotic disorders|psychotic disorders
661778|NCT00783185|cannabis|cannabis
661779|NCT00783185|intervention|intervention
661780|NCT00783172|pancreas|pancreas
661781|NCT00783172|pancreatic cancer|pancreatic cancer
661782|NCT00783172|cancer|cancer
661783|NCT00783172|Opioid Growth Factor|opioid growth factor
661784|NCT00783172|OGF|ogf
661785|NCT00783172|gemcitabine|gemcitabine
661786|NCT00783172|chemotherapy|chemotherapy
661787|NCT00783159|Muscle power|muscle power
661788|NCT00783159|Frailty|frailty
661789|NCT00783159|Exercise|exercise
661790|NCT00783159|Vitamin D|vitamin d
661791|NCT00783120|schizophrenia, negative symptoms, TMS, magnetic stimulation|schizophrenia, negative symptoms, tms, magnetic stimulation
661792|NCT00783107|Gold Stage III COPD|gold stage iii copd
661793|NCT00783081|Intermittent Claudication|intermittent claudication
661794|NCT00783081|Peripheral Arterial Disease|peripheral arterial disease
661795|NCT00783068|Endotoxin|endotoxin
661796|NCT00783068|GTS-21|gts-21
661797|NCT00783068|Vagal activity|vagal activity
661798|NCT00783068|Autonomic balance|autonomic balance
661799|NCT00783055|Autonomy|autonomy
661800|NCT00783055|Older people|older people
661801|NCT00783055|Physically frail|physically frail
661802|NCT00783055|Nursing home|nursing home
661803|NCT00783055|Intervention study|intervention study
661804|NCT00783042|TTDE-CFR|ttde-cfr
661805|NCT00783042|coronary artery function|coronary artery function
661806|NCT00783042|cardiovascular biomarkers|cardiovascular biomarkers
661807|NCT00783042|rosuvastatin|rosuvastatin
661808|NCT00783042|Crestor|crestor
661809|NCT00783029|Vasodilation|vasodilation
661810|NCT00783029|Vessel Reactivity|vessel reactivity
661811|NCT00783029|Dynamic Vessel Analyzer|dynamic vessel analyzer
661812|NCT00783029|Retina|retina
661813|NCT00783016|appendicitis|appendicitis
661814|NCT00783016|diagnosis|diagnosis
661815|NCT00783003|Tolerability|tolerability
661816|NCT00783003|Muscarinic Receptor Antagonist, Anticholinergic|muscarinic receptor antagonist, anticholinergic
661817|NCT00783003|Safety|safety
661818|NCT00783003|Anticholinergic|anticholinergic
661819|NCT00783003|ß2 agonist|ß2 agonist
661820|NCT00783003|Pharmacokinetics|pharmacokinetics
661821|NCT00782990|stress urinary incontinence|stress urinary incontinence
661822|NCT00782990|female incontinence|female incontinence
661823|NCT00782990|surgical treatment|surgical treatment
661824|NCT00782990|Female stress urinary incontinence|female stress urinary incontinence
661825|NCT00782977|Apneic oxygenation|apneic oxygenation
661826|NCT00782977|Apneic diffusion oxygenation|apneic diffusion oxygenation
661827|NCT00782964|Depression|depression
661828|NCT00782964|Major Depressive Disorder|major depressive disorder
661829|NCT00782964|SSRI resistant depression|ssri resistant depression
661830|NCT00782964|strategies in depression|strategies in depression
661831|NCT00782925|Low back pain|low back pain
661832|NCT00782925|recurrence|recurrence
661833|NCT00782925|chronic low back pain|chronic low back pain
661834|NCT00782925|educational program|educational program
661835|NCT00782925|physical therapy|physical therapy
661836|NCT00782925|home exercise|home exercise
661837|NCT00782925|compliance|compliance
661838|NCT00782912|postpartum anemia, postpartum depression|postpartum anemia, postpartum depression
661839|NCT00782899|Schizophrenia|schizophrenia
661840|NCT00782899|subjective well-being|subjective well-being
661841|NCT00782899|depressive symptoms|depressive symptoms
661842|NCT00782899|schizophrenia course|schizophrenia course
661843|NCT00782886|Pathfinder|pathfinder
661844|NCT00782886|Liver|liver
661845|NCT00782886|Resection|resection
661846|NCT00782886|Surgery|surgery
661847|NCT00782886|To evaluate the effectiveness of image-guided liver surgery by measuring variables before, during and following surgery.|to evaluate the effectiveness of image-guided liver surgery by measuring variables before, during and following surgery.
661848|NCT00782886|Completeness of resection and the accuracy of the resection, as determined by preoperative predicted RLV|completeness of resection and the accuracy of the resection, as determined by preoperative predicted rlv
661849|NCT00782873|propofol|propofol
661850|NCT00782873|sedation|sedation
661852|NCT00782873|obesity|obesity
661853|NCT00782860|Early pregnancy failure|early pregnancy failure
661854|NCT00782860|Misoprostol|misoprostol
661855|NCT00782860|Gestational sac volume|gestational sac volume
661856|NCT00782847|diabetes mellitus|diabetes mellitus
661857|NCT00782847|diabetic nephropathy|diabetic nephropathy
661858|NCT00782847|hypertension|hypertension
661859|NCT00782834|GIST|gist
661860|NCT00782834|Nilotinib|nilotinib
661861|NCT00782821|Kidney|kidney
661862|NCT00782821|Renal|renal
661863|NCT00782821|Rejection|rejection
661864|NCT00782821|High risk|high risk
661865|NCT00782821|Induction|induction
661866|NCT00782821|Immunology|immunology
661867|NCT00782821|Transplantation|transplantation
661868|NCT00782821|B Cell|b cell
661869|NCT00782821|Allograft|allograft
661870|NCT00782821|Desensitization|desensitization
661871|NCT00782808|HIV DNA in Monocytes|hiv dna in monocytes
661872|NCT00782795|Chronic pancreatitis|chronic pancreatitis
661873|NCT00782795|Insulin resistance|insulin resistance
661874|NCT00782756|Radiation|radiation
661875|NCT00782756|BEVACIZUMAB|bevacizumab
661876|NCT00782756|AVASTIN|avastin
661877|NCT00782756|TEMOZOLOMIDE|temozolomide
661878|NCT00782756|newly diagnosed|newly diagnosed
661879|NCT00782756|Glioblastoma|glioblastoma
661880|NCT00782756|GBM|gbm
661881|NCT00782756|malignant glioma|malignant glioma
661882|NCT00782756|Radiotherapy|radiotherapy
661883|NCT00782756|08-126|08-126
661884|NCT00782743|phenprocoumon|phenprocoumon
661885|NCT00782743|anticoagulation|anticoagulation
661886|NCT00782743|acetylic salicylic acid|acetylic salicylic acid
661887|NCT00782743|Need for new anticoagulation treatment|need for new anticoagulation treatment
661888|NCT00782730|bladder volume measurement|bladder volume measurement
661889|NCT00782730|pregnancy|pregnancy
661890|NCT00782730|bladder function|bladder function
661891|NCT00782730|Postvoid residual volume assessment|postvoid residual volume assessment
661892|NCT00782730|Bladder volumes|bladder volumes
661893|NCT00782717|diabetic retinopathy|diabetic retinopathy
661894|NCT00782717|cystoid macular edema;|cystoid macular edema;
661895|NCT00782704|A self-administered questionnaire to collect data from patients, physicians and nurses about the severity of postoperative surgical complications.|a self-administered questionnaire to collect data from patients, physicians and nurses about the severity of postoperative surgical complications.
661896|NCT00782704|Based on this questionnaire we will develop the morbidity index|based on this questionnaire we will develop the morbidity index
661897|NCT00782691|FDG-PET segmentation tools|fdg-pet segmentation tools
661898|NCT00782691|Head-and-neck cancer|head-and-neck cancer
661899|NCT00782691|Histological validation|histological validation
661900|NCT00782665|postoperative|postoperative
661901|NCT00782665|infection|infection
661902|NCT00782665|c-section|c-section
661903|NCT00782652|myocaridal infarction|myocaridal infarction
661904|NCT00782652|right ventricular infarction|right ventricular infarction
661905|NCT00782652|cardiogenic shock|cardiogenic shock
661906|NCT00782652|RVAD|rvad
661907|NCT00782652|Right ventricular assist device|right ventricular assist device
661908|NCT00782652|cardiac disease|cardiac disease
661909|NCT00782652|right ventricle|right ventricle
661910|NCT00782652|cardiac shock|cardiac shock
661911|NCT00782652|heart dysfunction|heart dysfunction
661912|NCT00782626|RAD001|rad001
661913|NCT00782613|Psoriasis|psoriasis
661914|NCT00782613|The primary objective of this study will be to evaluate the|the primary objective of this study will be to evaluate the
661915|NCT00782613|efficacy of topical ALT-2074 applied twice daily for 28|efficacy of topical alt-2074 applied twice daily for 28
661916|NCT00782613|days for treatment of chronic plaque psoriasis in adult|days for treatment of chronic plaque psoriasis in adult
661917|NCT00782613|subjects.|subjects.
661918|NCT00782613|The secondary objective will be to evaluate the safety|the secondary objective will be to evaluate the safety
661919|NCT00782613|of topical ALT-2074 applied twice daily for 28 days for|of topical alt-2074 applied twice daily for 28 days for
661920|NCT00782613|treatment of chronic plaque psoriasis in adult subjects.|treatment of chronic plaque psoriasis in adult subjects.
661921|NCT00782613|Tertiary objectives will be to provide visual documentation|tertiary objectives will be to provide visual documentation
661922|NCT00782613|of the improvement of psoriatic plaques treated with|of the improvement of psoriatic plaques treated with
661923|NCT00782613|ALT-2074 using digital photography, and to determine the|alt-2074 using digital photography, and to determine the
661924|NCT00782613|extent of systemic absorption of topically applied ALT-2074|extent of systemic absorption of topically applied alt-2074
661925|NCT00782613|based on a pharmacokinetic measurement of blood|based on a pharmacokinetic measurement of blood
661926|NCT00782613|concentration.|concentration.
661927|NCT00782600|Pharmacokinetics Immediate Release Oral Suspension Controlled Release Formulation|pharmacokinetics immediate release oral suspension controlled release formulation
661928|NCT00782587|Non-Muscle-Invasive Bladder Cancer|non-muscle-invasive bladder cancer
661929|NCT00782587|Superficial Bladder Cancer|superficial bladder cancer
661930|NCT00782587|recombinant human hyaluronidase|recombinant human hyaluronidase
661931|NCT00782587|rHuPH20|rhuph20
661932|NCT00782587|Chemophase®|chemophase®
661933|NCT00782587|Mitomycin|mitomycin
661934|NCT00782574|Advanced solid tumours|advanced solid tumours
661935|NCT00782574|Poly(ADP ribose) polymerases|poly(adp ribose) polymerases
661936|NCT00782574|homologous deficiency|homologous deficiency
661937|NCT00782574|BRCA1|brca1
661938|NCT00782561|steroid resistant focal segmental glomerulosclerosis|steroid resistant focal segmental glomerulosclerosis
661939|NCT00782561|FSGS|fsgs
661940|NCT00782561|adolescent focal segmental glomerulosclerosis|adolescent focal segmental glomerulosclerosis
661941|NCT00782561|focal segmental glomerulosclerosis|focal segmental glomerulosclerosis
661942|NCT00782548|KADIAN|kadian
661943|NCT00782548|morphine|morphine
661944|NCT00782548|Avinza|avinza
661945|NCT00782548|30 mg|30 mg
661946|NCT00782548|bioequivalence|bioequivalence
661947|NCT00782548|fed|fed
661948|NCT00782483|Diagnosis|diagnosis
661949|NCT00782483|Port Wine Stain|port wine stain
661950|NCT00782483|PWS|pws
661951|NCT00782405|antidepressant action|antidepressant action
661952|NCT00782405|clinical psychopharmacology|clinical psychopharmacology
661953|NCT00782392|Nutrition|nutrition
661954|NCT00782392|Infant Formula|infant formula
661955|NCT00782379|stage III adult diffuse large cell lymphoma|stage iii adult diffuse large cell lymphoma
661956|NCT00782379|stage III adult diffuse mixed cell lymphoma|stage iii adult diffuse mixed cell lymphoma
661957|NCT00782379|stage III adult diffuse small cleaved cell lymphoma|stage iii adult diffuse small cleaved cell lymphoma
661958|NCT00782379|stage III adult Hodgkin lymphoma|stage iii adult hodgkin lymphoma
661959|NCT00782379|stage III adult lymphoblastic lymphoma|stage iii adult lymphoblastic lymphoma
661960|NCT00782379|stage III grade 1 follicular lymphoma|stage iii grade 1 follicular lymphoma
661961|NCT00782379|stage III grade 2 follicular lymphoma|stage iii grade 2 follicular lymphoma
661962|NCT00782379|stage III grade 3 follicular lymphoma|stage iii grade 3 follicular lymphoma
661963|NCT00782379|stage III mantle cell lymphoma|stage iii mantle cell lymphoma
661964|NCT00782379|stage IV adult diffuse large cell lymphoma|stage iv adult diffuse large cell lymphoma
661965|NCT00782379|stage IV adult diffuse mixed cell lymphoma|stage iv adult diffuse mixed cell lymphoma
661966|NCT00782379|stage IV adult diffuse small cleaved cell lymphoma|stage iv adult diffuse small cleaved cell lymphoma
661967|NCT00782379|stage IV adult Hodgkin lymphoma|stage iv adult hodgkin lymphoma
661968|NCT00782379|stage IV adult lymphoblastic lymphoma|stage iv adult lymphoblastic lymphoma
661969|NCT00782379|stage IV grade 1 follicular lymphoma|stage iv grade 1 follicular lymphoma
661970|NCT00782379|stage IV grade 2 follicular lymphoma|stage iv grade 2 follicular lymphoma
661971|NCT00782379|stage IV grade 3 follicular lymphoma|stage iv grade 3 follicular lymphoma
661972|NCT00782379|stage IV mantle cell lymphoma|stage iv mantle cell lymphoma
661973|NCT00782379|recurrent adult diffuse large cell lymphoma|recurrent adult diffuse large cell lymphoma
661974|NCT00782379|recurrent adult diffuse mixed cell lymphoma|recurrent adult diffuse mixed cell lymphoma
661975|NCT00782379|recurrent adult diffuse small cleaved cell lymphoma|recurrent adult diffuse small cleaved cell lymphoma
661976|NCT00782379|recurrent adult Hodgkin lymphoma|recurrent adult hodgkin lymphoma
661977|NCT00782379|recurrent grade 1 follicular lymphoma|recurrent grade 1 follicular lymphoma
661978|NCT00782379|recurrent grade 2 follicular lymphoma|recurrent grade 2 follicular lymphoma
661979|NCT00782379|recurrent grade 3 follicular lymphoma|recurrent grade 3 follicular lymphoma
661980|NCT00782379|recurrent mantle cell lymphoma|recurrent mantle cell lymphoma
661981|NCT00782379|noncontiguous stage II adult diffuse large cell lymphoma|noncontiguous stage ii adult diffuse large cell lymphoma
661982|NCT00782379|noncontiguous stage II adult diffuse mixed cell lymphoma|noncontiguous stage ii adult diffuse mixed cell lymphoma
661983|NCT00782379|noncontiguous stage II adult diffuse small cleaved cell lymphoma|noncontiguous stage ii adult diffuse small cleaved cell lymphoma
661984|NCT00782379|noncontiguous stage II adult lymphoblastic lymphoma|noncontiguous stage ii adult lymphoblastic lymphoma
661985|NCT00782379|noncontiguous stage II grade 1 follicular lymphoma|noncontiguous stage ii grade 1 follicular lymphoma
661986|NCT00782379|noncontiguous stage II grade 2 follicular lymphoma|noncontiguous stage ii grade 2 follicular lymphoma
661987|NCT00782379|noncontiguous stage II grade 3 follicular lymphoma|noncontiguous stage ii grade 3 follicular lymphoma
661988|NCT00782379|noncontiguous stage II mantle cell lymphoma|noncontiguous stage ii mantle cell lymphoma
661989|NCT00782379|accelerated phase chronic myelogenous leukemia|accelerated phase chronic myelogenous leukemia
661990|NCT00782379|adult acute lymphoblastic leukemia in remission|adult acute lymphoblastic leukemia in remission
661991|NCT00782379|adult acute myeloid leukemia in remission|adult acute myeloid leukemia in remission
661992|NCT00782379|adult acute myeloid leukemia with 11q23 (MLL) abnormalities|adult acute myeloid leukemia with 11q23 (mll) abnormalities
661993|NCT00782379|adult acute myeloid leukemia with inv(16)(p13;q22)|adult acute myeloid leukemia with inv(16)(p13;q22)
661994|NCT00782379|adult acute myeloid leukemia with t(15;17)(q22;q12)|adult acute myeloid leukemia with t(15;17)(q22;q12)
661995|NCT00782379|adult acute myeloid leukemia with t(16;16)(p13;q22)|adult acute myeloid leukemia with t(16;16)(p13;q22)
661996|NCT00782379|adult acute myeloid leukemia with t(8;21)(q22;q22)|adult acute myeloid leukemia with t(8;21)(q22;q22)
661997|NCT00782379|chronic myelomonocytic leukemia|chronic myelomonocytic leukemia
661998|NCT00782379|chronic phase chronic myelogenous leukemia|chronic phase chronic myelogenous leukemia
661999|NCT00782379|recurrent adult acute myeloid leukemia|recurrent adult acute myeloid leukemia
662000|NCT00782379|refractory chronic lymphocytic leukemia|refractory chronic lymphocytic leukemia
662001|NCT00782379|relapsing chronic myelogenous leukemia|relapsing chronic myelogenous leukemia
662002|NCT00782379|secondary acute myeloid leukemia|secondary acute myeloid leukemia
662003|NCT00782379|stage III chronic lymphocytic leukemia|stage iii chronic lymphocytic leukemia
662004|NCT00782379|stage IV chronic lymphocytic leukemia|stage iv chronic lymphocytic leukemia
662087|NCT00782080|children|children
662005|NCT00782379|de novo myelodysplastic syndromes|de novo myelodysplastic syndromes
662006|NCT00782379|previously treated myelodysplastic syndromes|previously treated myelodysplastic syndromes
662007|NCT00782379|secondary myelodysplastic syndromes|secondary myelodysplastic syndromes
662008|NCT00782379|prolymphocytic leukemia|prolymphocytic leukemia
662009|NCT00782366|predictive genomics|predictive genomics
662010|NCT00782366|personalized medicine|personalized medicine
662011|NCT00782366|personal genomics|personal genomics
662012|NCT00782366|direct-to-consumer genetic testing|direct-to-consumer genetic testing
662013|NCT00782366|genetic knowledge|genetic knowledge
662014|NCT00782366|genetic attitudes|genetic attitudes
662016|NCT00782340|NOH|noh
662017|NCT00782340|Neurogenic Orthostatic Hypotension|neurogenic orthostatic hypotension
662018|NCT00782340|Orthostatic hypotension|orthostatic hypotension
662019|NCT00782340|PAF|paf
662020|NCT00782340|Pure Autonomic Failure|pure autonomic failure
662021|NCT00782340|MSA|msa
662022|NCT00782340|Multiple System Atrophy|multiple system atrophy
662023|NCT00782340|Neuropathy|neuropathy
662024|NCT00782340|Autonomic Failure|autonomic failure
662025|NCT00782340|Parkinson|parkinson
662026|NCT00782340|Dopamine Deficiency|dopamine deficiency
662027|NCT00782340|Dopamine|dopamine
662028|NCT00782340|Droxidopa|droxidopa
662029|NCT00782314|asthma|asthma
662030|NCT00782314|SMART|smart
662031|NCT00782314|Symbicort Turbuhaler|symbicort turbuhaler
662032|NCT00782314|asthma control|asthma control
662033|NCT00782301|HIV and Hepatitis co-infection|hiv and hepatitis co-infection
662034|NCT00782288|digitoxin|digitoxin
662035|NCT00782288|inflammatory markers|inflammatory markers
662036|NCT00782288|cytokines|cytokines
662037|NCT00782288|gene expression|gene expression
662038|NCT00782275|RCC|rcc
662039|NCT00782275|avastin|avastin
662040|NCT00782275|temsirolimus|temsirolimus
662041|NCT00782223|hips, spine, lower limb, digital radiograph measurements, TraumaCad, digital software|hips, spine, lower limb, digital radiograph measurements, traumacad, digital software
662042|NCT00782223|Measurements of orthopaedic parameters on digital X-rays using particular software|measurements of orthopaedic parameters on digital x-rays using particular software
662043|NCT00782197|osteoarthritis|osteoarthritis
662044|NCT00782197|knee|knee
662045|NCT00782197|PRGF|prgf
662046|NCT00782197|autologous plasma|autologous plasma
662047|NCT00782197|plasma preparations|plasma preparations
662048|NCT00782197|treatment|treatment
662049|NCT00782171|Dental implants|dental implants
662050|NCT00782158|HIV|hiv
662051|NCT00782158|Hepatitis B|hepatitis b
662052|NCT00782158|Coinfection|coinfection
662053|NCT00782158|Liver Fibrosis|liver fibrosis
662054|NCT00782158|Transient Elastography|transient elastography
662055|NCT00782145|psychosocial effects of cancer and its treatment|psychosocial effects of cancer and its treatment
662056|NCT00782145|recurrent childhood large cell lymphoma|recurrent childhood large cell lymphoma
662057|NCT00782145|recurrent childhood lymphoblastic lymphoma|recurrent childhood lymphoblastic lymphoma
662058|NCT00782145|recurrent childhood small noncleaved cell lymphoma|recurrent childhood small noncleaved cell lymphoma
662059|NCT00782145|recurrent/refractory childhood Hodgkin lymphoma|recurrent/refractory childhood hodgkin lymphoma
662060|NCT00782145|accelerated phase chronic myelogenous leukemia|accelerated phase chronic myelogenous leukemia
662061|NCT00782145|atypical chronic myeloid leukemia, BCR-ABL negative|atypical chronic myeloid leukemia, bcr-abl negative
662062|NCT00782145|blastic phase chronic myelogenous leukemia|blastic phase chronic myelogenous leukemia
662063|NCT00782145|childhood acute lymphoblastic leukemia in remission|childhood acute lymphoblastic leukemia in remission
662064|NCT00782145|childhood acute myeloid leukemia in remission|childhood acute myeloid leukemia in remission
662065|NCT00782145|childhood chronic myelogenous leukemia|childhood chronic myelogenous leukemia
662066|NCT00782145|chronic myelomonocytic leukemia|chronic myelomonocytic leukemia
662067|NCT00782145|chronic phase chronic myelogenous leukemia|chronic phase chronic myelogenous leukemia
662068|NCT00782145|juvenile myelomonocytic leukemia|juvenile myelomonocytic leukemia
662069|NCT00782145|recurrent childhood acute lymphoblastic leukemia|recurrent childhood acute lymphoblastic leukemia
662070|NCT00782145|recurrent childhood acute myeloid leukemia|recurrent childhood acute myeloid leukemia
662071|NCT00782145|relapsing chronic myelogenous leukemia|relapsing chronic myelogenous leukemia
662072|NCT00782145|secondary acute myeloid leukemia|secondary acute myeloid leukemia
662073|NCT00782145|childhood myelodysplastic syndromes|childhood myelodysplastic syndromes
662074|NCT00782145|primary myelofibrosis|primary myelofibrosis
662075|NCT00782145|de novo myelodysplastic syndromes|de novo myelodysplastic syndromes
662076|NCT00782145|disseminated neuroblastoma|disseminated neuroblastoma
662077|NCT00782145|myelodysplastic/myeloproliferative neoplasm, unclassifiable|myelodysplastic/myeloproliferative neoplasm, unclassifiable
662078|NCT00782145|previously treated childhood rhabdomyosarcoma|previously treated childhood rhabdomyosarcoma
662079|NCT00782145|previously treated myelodysplastic syndromes|previously treated myelodysplastic syndromes
662080|NCT00782145|recurrent childhood rhabdomyosarcoma|recurrent childhood rhabdomyosarcoma
662081|NCT00782145|recurrent neuroblastoma|recurrent neuroblastoma
662082|NCT00782145|recurrent ovarian germ cell tumor|recurrent ovarian germ cell tumor
662083|NCT00782145|secondary myelodysplastic syndromes|secondary myelodysplastic syndromes
662084|NCT00782132|Infertility Services, HIV, pregnancy planning|infertility services, hiv, pregnancy planning
662085|NCT00782093|AMD|amd
662086|NCT00782080|ADHD|adhd
662088|NCT00782080|adolescents|adolescents
662089|NCT00782080|St. John`s Wort|st. john`s wort
662090|NCT00782080|Valerian extract|valerian extract
662091|NCT00782080|Safety|safety
662092|NCT00782080|Efficacy|efficacy
662093|NCT00782067|Aggressive systemic mastocytosis|aggressive systemic mastocytosis
662094|NCT00782067|mast cell leukemia|mast cell leukemia
662095|NCT00782067|C-Findings|c-findings
662096|NCT00782067|tyrosine kinase inhibitor|tyrosine kinase inhibitor
662097|NCT00782067|KIT mutation|kit mutation
662098|NCT00782067|AHNMD|ahnmd
662099|NCT00782067|Systemic|systemic
662100|NCT00782067|Aggressive|aggressive
662101|NCT00782054|pruritus|pruritus
662102|NCT00782054|itch|itch
662103|NCT00782054|burn|burn
662104|NCT00782054|endopeptidase|endopeptidase
662105|NCT00782054|moisturizer|moisturizer
662106|NCT00782054|randomized controlled|randomized controlled
662107|NCT00782028|primary care, high-risk families, maternal depression|primary care, high-risk families, maternal depression
662108|NCT00782015|almonds|almonds
662109|NCT00782015|heart disease|heart disease
662110|NCT00782015|vascular reactivity|vascular reactivity
662111|NCT00782015|inflammation|inflammation
662112|NCT00782015|dyslipidemia|dyslipidemia
662113|NCT00782015|oxidative stress|oxidative stress
662114|NCT00782002|Solid Tumors|solid tumors
662115|NCT00782002|VEGF-A|vegf-a
662116|NCT00782002|stromal cells|stromal cells
662117|NCT00782002|endothelial cells|endothelial cells
662118|NCT00782002|malignant cells|malignant cells
662119|NCT00781989|early rheumatoid arthritis|early rheumatoid arthritis
662120|NCT00781989|biomarkers|biomarkers
662121|NCT00781989|ultrasound|ultrasound
662122|NCT00781963|cognitive behavior therapy|cognitive behavior therapy
662123|NCT00781963|insomnia|insomnia
662124|NCT00781950|PAD|pad
662125|NCT00781950|Peripheral Arterial Disease|peripheral arterial disease
662126|NCT00781950|Diabetes|diabetes
662127|NCT00781950|Atherosclerosis|atherosclerosis
662128|NCT00781950|Flax|flax
662129|NCT00781950|Flaxseeds|flaxseeds
662130|NCT00781950|Functional Foods|functional foods
662131|NCT00781950|Essential Fatty Acids|essential fatty acids
662132|NCT00781950|Winnipeg|winnipeg
662133|NCT00781911|Islet Cell|islet cell
662134|NCT00781911|CARCINOMA, ISLET CELL|carcinoma, islet cell
662135|NCT00781911|Octreotide|octreotide
662136|NCT00781911|depot octreotide acetate|depot octreotide acetate
662137|NCT00781911|Insulin-Like Growth Factor (IGF) 1|insulin-like growth factor (igf) 1
662138|NCT00781911|Metastatic, Carcinoid or Islet Cell|metastatic, carcinoid or islet cell
662139|NCT00781911|Neuroendocrine Tumors|neuroendocrine tumors
662140|NCT00781898|Depot naltrexone|depot naltrexone
662141|NCT00781898|Parolees|parolees
662142|NCT00781898|Opioid addiction prevention|opioid addiction prevention
662143|NCT00781898|Medication Treatment Alternatives|medication treatment alternatives
662144|NCT00781898|Prevention of Relapse to Opioid Addiction|prevention of relapse to opioid addiction
662145|NCT00781872|multiple sclerosis (MS)|multiple sclerosis (ms)
662146|NCT00781872|bone marrow stromal cells|bone marrow stromal cells
662147|NCT00781872|stem cells|stem cells
662148|NCT00781833|Therapeutic Electric Stimulation|therapeutic electric stimulation
662149|NCT00781833|Functional Electric Stimulation|functional electric stimulation
662150|NCT00781833|Implantable Stimulator|implantable stimulator
662151|NCT00781833|Muscle Strength|muscle strength
662152|NCT00781833|Muscle Spasticity|muscle spasticity
662153|NCT00781820|Bifonazole|bifonazole
662154|NCT00781820|Placebo|placebo
662155|NCT00781820|Urea|urea
662156|NCT00781820|Nail fungus|nail fungus
662157|NCT00781807|Heart-Assist-Devices|heart-assist-devices
662158|NCT00781807|Rehabilitation|rehabilitation
662159|NCT00781807|Outcome Assessment (Health Care)|outcome assessment (health care)
662160|NCT00781807|Exercise Capacity|exercise capacity
662161|NCT00781807|Ergometry|ergometry
662162|NCT00781807|Social Support|social support
662163|NCT00781807|Quality of Life|quality of life
662164|NCT00781807|Nutrition Assessment|nutrition assessment
662165|NCT00781807|Nutrition Therapy|nutrition therapy
662166|NCT00781807|Neuropsychological Tests|neuropsychological tests
662167|NCT00781781|Myeloid and Lymphoid malignances|myeloid and lymphoid malignances
662168|NCT00781768|Bone Marrow Transplant|bone marrow transplant
662169|NCT00781768|Nausea|nausea
662170|NCT00781768|Vomiting|vomiting
662171|NCT00781768|NK-1 antagonist|nk-1 antagonist
662172|NCT00781755|smoking cessation|smoking cessation
662173|NCT00781755|varenicline|varenicline
662174|NCT00781755|schizophrenia|schizophrenia
662175|NCT00781755|serious mental illness|serious mental illness
662176|NCT00781755|Nicotine addiction|nicotine addiction
662177|NCT00781755|Smoking Behavior|smoking behavior
662178|NCT00781742|Depression|depression
662179|NCT00781742|Depressive Disorder|depressive disorder
662180|NCT00781742|MDD|mdd
662181|NCT00781729|Kyphosis|kyphosis
662182|NCT00781729|Yoga|yoga
662183|NCT00781729|Aging|aging
662184|NCT00781729|Physical performance|physical performance
662185|NCT00781729|Quality of Life|quality of life
662186|NCT00781716|ST elevation myocardial infarction|st elevation myocardial infarction
662187|NCT00781716|Drug eluting stents|drug eluting stents
662188|NCT00781690|Chronic kidney failure|chronic kidney failure
662190|NCT00781690|Hemodialysis|hemodialysis
662191|NCT00781690|Biocompatibility|biocompatibility
662192|NCT00781677|Major Depressive Disorder|major depressive disorder
662193|NCT00781677|Depression|depression
662194|NCT00781677|Anxiety|anxiety
662195|NCT00781638|Pediatric UC, Adacolumn apheresis|pediatric uc, adacolumn apheresis
662196|NCT00781625|probiotics|probiotics
662197|NCT00781625|QoL|qol
662198|NCT00781625|inflammation|inflammation
662199|NCT00781625|nutritional factors|nutritional factors
662200|NCT00781625|prophylactic aid|prophylactic aid
662201|NCT00781625|Lactobacillus rhamnosus GR-1|lactobacillus rhamnosus gr-1
662202|NCT00781625|Lactobacillus reuteri RC-14|lactobacillus reuteri rc-14
662203|NCT00781625|Recurrent lower UTI in women|recurrent lower uti in women
662204|NCT00781599|African american|african american
662205|NCT00781599|smokers|smokers
662206|NCT00781599|smoking cessation|smoking cessation
662207|NCT00781599|African American smokers|african american smokers
662208|NCT00781586|Energy expenditure|energy expenditure
662209|NCT00781586|Nutritional|nutritional
662210|NCT00781586|Weight control|weight control
662211|NCT00781573|Drug Eluting Stent|drug eluting stent
662212|NCT00781573|Clopidogrel|clopidogrel
662213|NCT00781573|Optimal duration of clopidogrel post DES stent implantation|optimal duration of clopidogrel post des stent implantation
662214|NCT00781560|Hyperlipidemia|hyperlipidemia
662215|NCT00781560|Chinese National Adult Lipid Treatment Guideline (2007)|chinese national adult lipid treatment guideline (2007)
662216|NCT00781560|Crestor®|crestor®
662217|NCT00781547|growth hormone|growth hormone
662218|NCT00781547|obesity|obesity
662219|NCT00781547|abdominal obesity|abdominal obesity
662220|NCT00781534|Health Supplements|health supplements
662221|NCT00781534|Ginseng|ginseng
662222|NCT00781534|Diabetes|diabetes
662223|NCT00781508|heart failure, left sided|heart failure, left sided
662224|NCT00781508|ventricular dysfunction|ventricular dysfunction
662225|NCT00781508|diastolic dysfunction|diastolic dysfunction
662226|NCT00781508|sildenafil|sildenafil
662227|NCT00781495|insulin|insulin
662228|NCT00781482|Positron Emission Tomography|positron emission tomography
662229|NCT00781482|GABA receptor binding|gaba receptor binding
662230|NCT00781482|Hypnotic Drugs|hypnotic drugs
662231|NCT00781482|Eszopiclone|eszopiclone
662232|NCT00781482|Zolpidem|zolpidem
662233|NCT00781482|[11-C] Flumazenil|[11-c] flumazenil
662234|NCT00781482|Molecular imaging of the brain|molecular imaging of the brain
662235|NCT00781469|Rheumatoid arthritis|rheumatoid arthritis
662236|NCT00781469|RNA|rna
662237|NCT00781469|Synovium|synovium
662238|NCT00781469|Peripheral blood mononuclear cells|peripheral blood mononuclear cells
662239|NCT00781456|Migraine headache|migraine headache
662240|NCT00781456|menstrual|menstrual
662241|NCT00781456|oral contraceptive|oral contraceptive
662242|NCT00781456|Menstrually-Related Migraine Headache|menstrually-related migraine headache
662243|NCT00781443|Asthma|asthma
662244|NCT00781417|vitamin D|vitamin d
662245|NCT00781417|Chronic Kidney Disease|chronic kidney disease
662246|NCT00781417|parathyroid hormone|parathyroid hormone
662247|NCT00781417|Chronic kidney disease Stage II and III|chronic kidney disease stage ii and iii
662248|NCT00781404|adenosine|adenosine
662249|NCT00781404|angioplasty|angioplasty
662250|NCT00781404|acute myocardial infarction|acute myocardial infarction
662251|NCT00781404|acute coronary syndrome with ST segment elevation|acute coronary syndrome with st segment elevation
662252|NCT00781404|infarct size|infarct size
662253|NCT00781404|rescued myocardium|rescued myocardium
662254|NCT00781391|Systemic embolic events|systemic embolic events
662255|NCT00781378|Thrombolytic therapy|thrombolytic therapy
662256|NCT00781378|Recombinant tissue plasminogen activator|recombinant tissue plasminogen activator
662257|NCT00781378|Efficacy|efficacy
662258|NCT00781378|Safety|safety
662259|NCT00781365|Hypertension|hypertension
662260|NCT00781365|Telemonitoring|telemonitoring
662261|NCT00781365|Pharmacy management|pharmacy management
662262|NCT00781352|nitrous oxide|nitrous oxide
662263|NCT00781352|cancer recurrence|cancer recurrence
662264|NCT00781352|colorectal surgery|colorectal surgery
662265|NCT00781339|Bacteriuria|bacteriuria
662266|NCT00781339|Catheterized|catheterized
662267|NCT00781339|Chronically Catheterized|chronically catheterized
662268|NCT00781326|Depressive Disorder, Major|depressive disorder, major
662269|NCT00781326|Cerebrovascular Disorders|cerebrovascular disorders
662270|NCT00781326|Risk Factors|risk factors
662271|NCT00781326|Nimodipine|nimodipine
662272|NCT00781300|Intraocular pressure|intraocular pressure
662273|NCT00781300|Pterygium|pterygium
662274|NCT00781300|Surgery|surgery
662275|NCT00781300|Steroids|steroids
662276|NCT00781300|Glaucoma|glaucoma
662277|NCT00781287|human immunodeficiency virus|human immunodeficiency virus
662278|NCT00781287|raltegravir|raltegravir
662279|NCT00781287|primary HIV infection|primary hiv infection
662280|NCT00781287|HIV-1|hiv-1
662281|NCT00781261|hip|hip
662282|NCT00781261|collapse femoral head|collapse femoral head
662283|NCT00781261|bisphosphonates|bisphosphonates
662284|NCT00781261|osteonecrosis|osteonecrosis
662285|NCT00781248|enteral feeding|enteral feeding
662286|NCT00781248|Subject who requires nasogastric tube|subject who requires nasogastric tube
662287|NCT00781209|irradiation|irradiation
662288|NCT00781209|stereotactic radiosurgery|stereotactic radiosurgery
662289|NCT00781209|posterior fossa|posterior fossa
662290|NCT00781209|cerebellar metastases|cerebellar metastases
662291|NCT00781196|phenytoin|phenytoin
662292|NCT00781196|gum hyperplasia|gum hyperplasia
662293|NCT00781196|phenytoin induced gingival overgrowth|phenytoin induced gingival overgrowth
662294|NCT00781196|plaque index|plaque index
662295|NCT00781196|gingival overgrowth grade|gingival overgrowth grade
662296|NCT00781183|COPD|copd
662297|NCT00781183|rehabilitation|rehabilitation
662298|NCT00781183|walking|walking
662299|NCT00781170|Multiple Myeloma|multiple myeloma
662300|NCT00781170|Plasmocytoma|plasmocytoma
662301|NCT00781170|Stem Cell Transplantation|stem cell transplantation
662302|NCT00781157|Spinal induced hypotension in cesarean delivery|spinal induced hypotension in cesarean delivery
662303|NCT00781118|Acute Myocardial Infarction (MI)|acute myocardial infarction (mi)
662304|NCT00781118|ST Shift|st shift
662305|NCT00781118|Coronary Occlusion|coronary occlusion
662306|NCT00781118|Acute Coronary Syndrome|acute coronary syndrome
662307|NCT00781105|Chronic hepatitis B|chronic hepatitis b
662308|NCT00781105|Adult|adult
662309|NCT00781105|HBV DNA suppression|hbv dna suppression
662310|NCT00781105|Telbivudine|telbivudine
662311|NCT00781092|Dry Eyes|dry eyes
662312|NCT00781092|LASIK|lasik
662313|NCT00781092|Laser Vision Correction|laser vision correction
662314|NCT00781079|Organization Innovation|organization innovation
662315|NCT00781079|Opinion Leaders|opinion leaders
662316|NCT00781079|Schizophrenia|schizophrenia
662317|NCT00781066|POSTPARTUM HEMORRHAGE|postpartum hemorrhage
662318|NCT00781066|PREVENTION|prevention
662319|NCT00781066|CORD TRACTION|cord traction
662320|NCT00781066|THIRD STAGE LABOR|third stage labor
662321|NCT00781053|skin fibrosis|skin fibrosis
662322|NCT00781053|systemic scleroderma|systemic scleroderma
662323|NCT00781053|systemic sclerosis|systemic sclerosis
662324|NCT00781053|p144|p144
662325|NCT00781053|orphan drug|orphan drug
662326|NCT00781040|Severe sepsis in neutropenic haematological patients|severe sepsis in neutropenic haematological patients
662327|NCT00781001|neuropathic pain|neuropathic pain
662328|NCT00781001|diabetic neuropathy|diabetic neuropathy
662329|NCT00781001|cannabis|cannabis
662330|NCT00781001|marijuana|marijuana
662331|NCT00780975|Aplidin|aplidin
662332|NCT00780975|Plitidepsin|plitidepsin
662333|NCT00780975|Prostate|prostate
662334|NCT00780975|Cancer|cancer
662336|NCT00780962|Radiocontrast Nephropathy|radiocontrast nephropathy
662337|NCT00780962|N-Acetylcysteine|n-acetylcysteine
662338|NCT00780962|RCN|rcn
662339|NCT00780962|RCIN|rcin
662340|NCT00780962|Creatinine|creatinine
662341|NCT00780962|Computerized Tomography|computerized tomography
662342|NCT00780962|CT|ct
662343|NCT00780962|Emergency Department|emergency department
662344|NCT00780962|ED|ed
662345|NCT00780949|Crohn's Disease, inflammatory bowel disease, Peyer's patches|crohn's disease, inflammatory bowel disease, peyer's patches
662346|NCT00780897|PREMATURE OVARIAN FAILURE (POF)|premature ovarian failure (pof)
662347|NCT00780897|GENETIC ANALYSIS|genetic analysis
662348|NCT00780897|PHYSIOPATHOLOGIC ANALYSIS|physiopathologic analysis
662349|NCT00780884|acupuncture|acupuncture
662350|NCT00780884|schizophrenia|schizophrenia
662351|NCT00780884|insomnia|insomnia
662352|NCT00780858|GnRH antagonist|gnrh antagonist
662353|NCT00780858|IUI|iui
662354|NCT00780845|Acute Kidney failure|acute kidney failure
662355|NCT00780845|Clinical outcomes|clinical outcomes
662356|NCT00780845|On-pump|on-pump
662357|NCT00780845|Coronary artery bypass grafting|coronary artery bypass grafting
662358|NCT00780845|Morbidity|morbidity
662359|NCT00780845|Mortality|mortality
662360|NCT00780832|overactive bladder|overactive bladder
662361|NCT00780832|dietary caffeine|dietary caffeine
662362|NCT00780832|anticholinergic medication|anticholinergic medication
662363|NCT00780832|lifestyle modification|lifestyle modification
662364|NCT00780832|incontinence|incontinence
662365|NCT00780832|urinary frequency|urinary frequency
662366|NCT00780806|MnB|mnb
662367|NCT00780806|rLP2086|rlp2086
662368|NCT00780806|blood collection|blood collection
662369|NCT00780806|vaccination|vaccination
662370|NCT00780793|Rheumatoid arthritis|rheumatoid arthritis
662371|NCT00780793|Remission|remission
662372|NCT00780793|Therapeutic strategy|therapeutic strategy
662373|NCT00780793|DMARDs|dmards
662374|NCT00780793|Biological agents|biological agents
662375|NCT00780780|triamcinolone|triamcinolone
662376|NCT00780780|nepafenac|nepafenac
662377|NCT00780780|DME|dme
662378|NCT00780780|edema macular|edema macular
662379|NCT00780767|angiojet|angiojet
662380|NCT00780767|massive pulmonary embolism|massive pulmonary embolism
662381|NCT00780767|RHEOLYTIC THROMBECTOMY|rheolytic thrombectomy
662382|NCT00780767|patients presenting with massive pulmonary embolism|patients presenting with massive pulmonary embolism
662383|NCT00780754|prostate cancer|prostate cancer
662384|NCT00780754|chemoprevention|chemoprevention
662385|NCT00780754|dutasteride|dutasteride
662386|NCT00780741|Nasolacrimal duct obstruction|nasolacrimal duct obstruction
662387|NCT00780741|Simple probing|simple probing
662388|NCT00780715|Diabetes therapies|diabetes therapies
662389|NCT00780715|Pharmacogenetics|pharmacogenetics
662390|NCT00780702|Cocaine|cocaine
662391|NCT00780702|Treatment|treatment
662392|NCT00780702|Airpiprazole|airpiprazole
662393|NCT00780702|Methadone|methadone
662394|NCT00780702|Relapse|relapse
662395|NCT00780702|HIV|hiv
662396|NCT00780702|Ecological Momentary Assessment (EMA)|ecological momentary assessment (ema)
662397|NCT00780702|Contingency Management|contingency management
662398|NCT00780676|Dasatinib|dasatinib
662399|NCT00780676|Metastatic Breast Cancer|metastatic breast cancer
662400|NCT00780676|Sprycel|sprycel
662401|NCT00780676|BMS-354825|bms-354825
662402|NCT00780676|Genetic testing|genetic testing
662403|NCT00780676|AZD6244|azd6244
662404|NCT00780676|Selumetinib|selumetinib
662405|NCT00780663|Neuroendocrine|neuroendocrine
662406|NCT00780663|Carcinoid|carcinoid
662407|NCT00780663|NET|net
662408|NCT00780663|MEN-1|men-1
662409|NCT00780663|Islet cell|islet cell
662410|NCT00780637|Heart Transplant|heart transplant
662411|NCT00780637|Endothelial Function|endothelial function
662412|NCT00780637|Fibrinolysis|fibrinolysis
662413|NCT00780637|Transplant recipients at baseline|transplant recipients at baseline
662414|NCT00780624|RDS|rds
662415|NCT00780624|Infant, newborn|infant, newborn
662416|NCT00780624|NIPPV|nippv
662417|NCT00780624|CPAP|cpap
662418|NCT00780598|Acute Myeloid Leukemia|acute myeloid leukemia
662419|NCT00780598|AML|aml
662420|NCT00780598|Cancer|cancer
662421|NCT00780598|Hematological malignancies|hematological malignancies
662422|NCT00780598|Elderly|elderly
662423|NCT00780598|Refractory|refractory
662424|NCT00780598|Relapsed|relapsed
662425|NCT00780598|Blood disorder|blood disorder
662426|NCT00780572|Safety Management|safety management
662427|NCT00780572|Risk Management|risk management
662428|NCT00780572|surveillance|surveillance
662429|NCT00780572|triggers|triggers
662430|NCT00780559|Neuropathy|neuropathy
662431|NCT00780559|diabetes|diabetes
662432|NCT00780546|tuberculosis|tuberculosis
662433|NCT00780546|spatial epidemiology|spatial epidemiology
662434|NCT00780546|geographic information system|geographic information system
662435|NCT00780520|glutamine inflammation HSP70 sepsis|glutamine inflammation hsp70 sepsis
662436|NCT00780481|Obesity|obesity
662437|NCT00780481|Endothelial Function|endothelial function
662438|NCT00780481|Fibrinolytic Balance|fibrinolytic balance
662439|NCT00780481|Baseline|baseline
662440|NCT00780468|Weight loss|weight loss
662441|NCT00780468|Diet|diet
662442|NCT00780468|Obesity|obesity
662443|NCT00780455|KineSEP|kinesep
662444|NCT00780455|Rehabilitation|rehabilitation
662445|NCT00780455|Betaferon|betaferon
662446|NCT00780442|substance related disorders|substance related disorders
662447|NCT00780429|kidney|kidney
662448|NCT00780429|transplant|transplant
662449|NCT00780429|Mycophenolic acid|mycophenolic acid
662450|NCT00780429|Inosine monophosphate dehydrogenase|inosine monophosphate dehydrogenase
662451|NCT00780416|Chronic Hepatitis C|chronic hepatitis c
662452|NCT00780416|Protease Inhibitor|protease inhibitor
662453|NCT00780416|Telaprevir|telaprevir
662454|NCT00780416|Peginterferon Alfa-2b|peginterferon alfa-2b
662455|NCT00780416|Ribavirin|ribavirin
662456|NCT00780390|RSD|rsd
662457|NCT00780390|SCS|scs
662458|NCT00780390|CRPS|crps
662459|NCT00780390|Complex regional pain syndrome patients before undergoing spinal cord stimulator implant and under other treatments|complex regional pain syndrome patients before undergoing spinal cord stimulator implant and under other treatments
662460|NCT00780377|Heart Transplant|heart transplant
662461|NCT00780377|Fibrinolysis|fibrinolysis
662462|NCT00780377|Resting conditions|resting conditions
662463|NCT00780364|stroke; sour taste; cold temperature; pharyngeal swallowing|stroke; sour taste; cold temperature; pharyngeal swallowing
662464|NCT00780351|vancomycin, SLEDD-f|vancomycin, sledd-f
662465|NCT00780325|Cyclooxygenase-2|cyclooxygenase-2
662466|NCT00780325|Carbonic anhydrase|carbonic anhydrase
662467|NCT00780325|Eicosanoids|eicosanoids
662468|NCT00780325|Healthy volunteers|healthy volunteers
662469|NCT00780312|radiotherapy|radiotherapy
662470|NCT00780312|trismus|trismus
662471|NCT00780312|physiotherapy|physiotherapy
662472|NCT00780312|lymphoedema|lymphoedema
662473|NCT00780312|late side effects|late side effects
662474|NCT00780312|fibrosis|fibrosis
662475|NCT00780312|decreased cervical range of motion|decreased cervical range of motion
662476|NCT00780312|quality of life|quality of life
662477|NCT00780299|Plasma epuration|plasma epuration
662478|NCT00780299|Hemofiltration|hemofiltration
662479|NCT00780299|Cardiac arrest|cardiac arrest
662480|NCT00780299|Shock|shock
662481|NCT00780299|Inflammatory mediators|inflammatory mediators
662482|NCT00780273|subjects with edentulous mandible|subjects with edentulous mandible
662483|NCT00780260|HIV/AIDS|hiv/aids
662484|NCT00780260|African Americans|african americans
662485|NCT00780260|Women|women
662486|NCT00780260|Case Management|case management
662487|NCT00780247|Vitamin D|vitamin d
662488|NCT00780247|Sun|sun
662489|NCT00780247|Latitude|latitude
662490|NCT00780247|Vitamin D status|vitamin d status
662491|NCT00780234|chemoprevention|chemoprevention
662492|NCT00780234|lung cancer|lung cancer
662493|NCT00780234|pioglitazone|pioglitazone
662494|NCT00780221|CRP|crp
662495|NCT00780221|coronary artery disease|coronary artery disease
662496|NCT00780221|polymorphisms|polymorphisms
662497|NCT00780208|Attention Deficit Hyperactivity ADHD|attention deficit hyperactivity adhd
662498|NCT00780195|hypoglycemia|hypoglycemia
662499|NCT00780195|African Americans|african americans
662500|NCT00780182|Bioavailability|bioavailability
662501|NCT00780156|Drug eluting stent|drug eluting stent
662502|NCT00780156|Dual antiplatelet therapy|dual antiplatelet therapy
662503|NCT00780156|bleeding|bleeding
662504|NCT00780156|stent thrombosis|stent thrombosis
662505|NCT00780156|follow-up of the drug eluting stent|follow-up of the drug eluting stent
662506|NCT00780143|Tumor|tumor
662507|NCT00780143|Leukemia|leukemia
662508|NCT00780143|Plitidepsin|plitidepsin
662509|NCT00780143|Aplidin|aplidin
662510|NCT00780117|CURRARINO syndrome|currarino syndrome
662511|NCT00780117|Sacrococcygeal teratoma|sacrococcygeal teratoma
662512|NCT00780117|HLXB9 (MNX1) gene|hlxb9 (mnx1) gene
662513|NCT00780117|Alpha foeto protein|alpha foeto protein
662514|NCT00780117|Prognosis factors|prognosis factors
662515|NCT00780104|Advanced myeloid leukemias|advanced myeloid leukemias
662516|NCT00780104|AML|aml
662517|NCT00780104|Leukemia|leukemia
662518|NCT00780104|Relapsed myeloid leukemias|relapsed myeloid leukemias
662519|NCT00780104|Refractory myeloid leukemias|refractory myeloid leukemias
662520|NCT00780104|MEC|mec
662521|NCT00780104|Rapamycin|rapamycin
662522|NCT00780104|Sirolimus|sirolimus
662523|NCT00780091|optimization|optimization
662524|NCT00780091|risk scale|risk scale
662525|NCT00780091|non inferiority|non inferiority
662526|NCT00780091|cluster randomization|cluster randomization
662527|NCT00780091|monitoring strategies|monitoring strategies
662528|NCT00780078|Intensive care unit|intensive care unit
662529|NCT00780078|Extubation failure|extubation failure
662530|NCT00780078|Physiotherapist|physiotherapist
662531|NCT00780078|Pre-extubation bedside tests|pre-extubation bedside tests
662532|NCT00780078|Swallowing disorders|swallowing disorders
662533|NCT00780052|Hematologic Malignancies|hematologic malignancies
662534|NCT00780052|c-myb|c-myb
662535|NCT00780052|c-myb AS ODN|c-myb as odn
662536|NCT00780026|liver|liver
662537|NCT00780026|transplant|transplant
662538|NCT00780026|blood sugar|blood sugar
662539|NCT00780013|Bioequivalence metformin hydrochloride|bioequivalence metformin hydrochloride
662540|NCT00779987|Dry eye|dry eye
662541|NCT00779987|Autologous serum|autologous serum
662542|NCT00779987|Ocular Surface Disease Index|ocular surface disease index
662543|NCT00779974|Total Shoulder Arthroplasty|total shoulder arthroplasty
662544|NCT00779974|Osteoarthritis|osteoarthritis
662545|NCT00779961|pediatric|pediatric
662546|NCT00779961|cleft palate|cleft palate
662547|NCT00779961|plastic surgery|plastic surgery
662548|NCT00779961|palatoplasty|palatoplasty
662549|NCT00779961|pharyngoplasty|pharyngoplasty
662550|NCT00779948|Femoral Neck Fracture|femoral neck fracture
662551|NCT00779948|Internal Fixation|internal fixation
662552|NCT00779948|Dynamic Hip Screw|dynamic hip screw
662553|NCT00779922|Multiple Myeloma|multiple myeloma
662554|NCT00779922|impaired renal function|impaired renal function
662555|NCT00779909|vitamin D|vitamin d
662556|NCT00779909|gingivitis|gingivitis
662557|NCT00779909|periodontal disease|periodontal disease
662558|NCT00779909|inflammation|inflammation
662559|NCT00779896|To evaluate therapeutic potential of tazarotene 0.1% cream for the treatment of Stage I-IIA CTCL. Patients with Stage I-IIA disease are enrolled into the study|to evaluate therapeutic potential of tazarotene 0.1% cream for the treatment of stage i-iia ctcl. patients with stage i-iia disease are enrolled into the study
662560|NCT00779896|Stage I-IIA disease CTCL|stage i-iia disease ctcl
662561|NCT00779883|Chronic lymphocytic leukemia|chronic lymphocytic leukemia
662562|NCT00779883|CLL|cll
662563|NCT00779883|Leukemia|leukemia
662564|NCT00779883|Leukemia, Lymphocytic, Chronic, B-Cell|leukemia, lymphocytic, chronic, b-cell
662565|NCT00779883|Leukemia, B-Cell|leukemia, b-cell
662566|NCT00779883|Immune System Diseases|immune system diseases
662567|NCT00779883|ISF35|isf35
662568|NCT00779883|Ad-ISF35|ad-isf35
662569|NCT00779883|Immunotherapy|immunotherapy
662570|NCT00779883|Immune therapy|immune therapy
662571|NCT00779883|Active immune therapy|active immune therapy
662572|NCT00779870|asthma severity|asthma severity
662573|NCT00779870|airway smooth muscle|airway smooth muscle
662574|NCT00779870|oxidative stress|oxidative stress
662575|NCT00779857|left atrial appendage|left atrial appendage
662576|NCT00779857|laa|laa
662577|NCT00779857|atrial fibrillation|atrial fibrillation
662578|NCT00779857|afib|afib
662579|NCT00779857|af|af
662580|NCT00779857|stroke|stroke
662581|NCT00779857|tia|tia
662582|NCT00779844|Anesthesia|anesthesia
662583|NCT00779844|Obesity|obesity
662584|NCT00779831|Bioequivalence Pseudoephedrine hydrochloride 120 mg extended release tablets|bioequivalence pseudoephedrine hydrochloride 120 mg extended release tablets
662779|NCT00778921|Aliskiren|aliskiren
662585|NCT00779805|Bioequivalence Pseudoephedrine hydrochloride 120 mg ER tablets|bioequivalence pseudoephedrine hydrochloride 120 mg er tablets
662586|NCT00779792|Irritant contact dermatitis|irritant contact dermatitis
662587|NCT00779792|experimental contact dermatitis|experimental contact dermatitis
662588|NCT00779792|treatment|treatment
662589|NCT00779792|efficacy|efficacy
662590|NCT00779792|topical steroids|topical steroids
662591|NCT00779792|topical immune modulators|topical immune modulators
662592|NCT00779792|glycerol|glycerol
662593|NCT00779779|Gastroenteritis|gastroenteritis
662594|NCT00779766|Human papillomavirus|human papillomavirus
662595|NCT00779766|vaccine|vaccine
662596|NCT00779766|cervical cancer|cervical cancer
662597|NCT00779766|cervical infection|cervical infection
662598|NCT00779753|Parenteral Feeding|parenteral feeding
662599|NCT00779753|Neonate|neonate
662600|NCT00779753|Lysine|lysine
662601|NCT00779727|women|women
662602|NCT00779727|increased|increased
662603|NCT00779727|risk|risk
662604|NCT00779714|metastatic (AJCC stage IV)|metastatic (ajcc stage iv)
662605|NCT00779714|first-line chemotherapy|first-line chemotherapy
662606|NCT00779714|ex-vivo chemosensitivity profiling|ex-vivo chemosensitivity profiling
662607|NCT00779714|evaluation of biomarkers|evaluation of biomarkers
662608|NCT00779701|Hyperglycemia|hyperglycemia
662609|NCT00779701|Glycemic control|glycemic control
662610|NCT00779688|Endoscopic Retrograde Cholangiopancreatography|endoscopic retrograde cholangiopancreatography
662611|NCT00779688|ERCP|ercp
662612|NCT00779688|bile duct cancer|bile duct cancer
662613|NCT00779688|pancreatic duct cancer|pancreatic duct cancer
662614|NCT00779688|gall bladder|gall bladder
662615|NCT00779688|pancreas|pancreas
662616|NCT00779688|duodenoscope|duodenoscope
662617|NCT00779688|Cellvizio|cellvizio
662618|NCT00779688|endomicroscopy|endomicroscopy
662619|NCT00779688|cholangiopancreatoscopy|cholangiopancreatoscopy
662620|NCT00779688|Biliary Tract Neoplasms (suspected)|biliary tract neoplasms (suspected)
662621|NCT00779688|Biliary Tract Mass (suspected)|biliary tract mass (suspected)
662622|NCT00779688|Biliary Tract Stricture (suspected)|biliary tract stricture (suspected)
662623|NCT00779688|Pancreatic Duct Neoplasms (suspected)|pancreatic duct neoplasms (suspected)
662624|NCT00779688|Pancreatic Duct Mass (suspected)|pancreatic duct mass (suspected)
662625|NCT00779688|Pancreatic Duct Stricture (suspected)|pancreatic duct stricture (suspected)
662626|NCT00779662|Rheumatic Heart Disease|rheumatic heart disease
662627|NCT00779662|Streptococcus|streptococcus
662628|NCT00779662|Fiji|fiji
662629|NCT00779649|Colonoscopy,|colonoscopy,
662630|NCT00779649|Prep|prep
662631|NCT00779649|MoviPrep|moviprep
662632|NCT00779649|HalfLytely|halflytely
662633|NCT00779649|The effectiveness of colonoscopy preps|the effectiveness of colonoscopy preps
662634|NCT00779597|self care|self care
662635|NCT00779597|symptom management|symptom management
662636|NCT00779597|pain|pain
662637|NCT00779597|cancer|cancer
662638|NCT00779597|nurse coaching|nurse coaching
662639|NCT00779597|patient education|patient education
662640|NCT00779571|Polycystic Ovary Syndrome|polycystic ovary syndrome
662641|NCT00779571|Morbid Obesity|morbid obesity
662642|NCT00779571|Type 2 DM|type 2 dm
662643|NCT00779571|Coronary heart disease|coronary heart disease
662644|NCT00779532|Electrocardiography|electrocardiography
662645|NCT00779532|Pharmacokinetics|pharmacokinetics
662646|NCT00779519|Obesity|obesity
662647|NCT00779519|Class 1|class 1
662648|NCT00779519|Class 2|class 2
662649|NCT00779519|Weight Loss|weight loss
662650|NCT00779519|AgRP|agrp
662651|NCT00779519|TTP435|ttp435
662652|NCT00779519|alphaMSH|alphamsh
662653|NCT00779519|Agouti-Related Protein|agouti-related protein
662654|NCT00779519|alpha-melanocyte stimulating hormone|alpha-melanocyte stimulating hormone
662655|NCT00779506|Acute schizophrenia|acute schizophrenia
662656|NCT00779506|PANSS|panss
662657|NCT00779493|irritable bowel syndrome|irritable bowel syndrome
662658|NCT00779493|constipation|constipation
662659|NCT00779493|diarrhea|diarrhea
662660|NCT00779493|gas|gas
662661|NCT00779493|bloating|bloating
662662|NCT00779493|abdominal pain|abdominal pain
662663|NCT00779493|disturbance of defecation|disturbance of defecation
662664|NCT00779493|irritable colon|irritable colon
662665|NCT00779480|Acute Myelogenous Leukemia|acute myelogenous leukemia
662666|NCT00779480|Safety|safety
662667|NCT00779480|Dose Tolerance|dose tolerance
662668|NCT00779480|Pharmacokinetics/Pharmacodynamics|pharmacokinetics/pharmacodynamics
662669|NCT00779480|FLT-3|flt-3
662670|NCT00779467|non narcotic|non narcotic
662671|NCT00779467|epidural|epidural
662672|NCT00779467|labor pain|labor pain
662673|NCT00779467|Non narcotic treatment of labor pain|non narcotic treatment of labor pain
662674|NCT00779454|KRAS wild-type|kras wild-type
662675|NCT00779454|Cholangiocarcinoma|cholangiocarcinoma
662676|NCT00779454|Inoperable|inoperable
662677|NCT00779441|Bioequivalence zolpidem 10mg tablets|bioequivalence zolpidem 10mg tablets
662678|NCT00779428|This is an open-label continuing treatment protocol in patients with advanced malignancies who will receive Tanespimycin|this is an open-label continuing treatment protocol in patients with advanced malignancies who will receive tanespimycin
662679|NCT00779415|Partial Thickness|partial thickness
662780|NCT00778921|Amlodipine|amlodipine
662680|NCT00779415|Rotator Cuff|rotator cuff
662681|NCT00779402|cancer|cancer
662682|NCT00779402|prostate cancer|prostate cancer
662683|NCT00779402|prostatectomy|prostatectomy
662684|NCT00779402|PSA|psa
662685|NCT00779402|sipuleucel-T|sipuleucel-t
662686|NCT00779402|PROVENGE|provenge
662687|NCT00779402|APC8015|apc8015
662688|NCT00779402|non-metastatic|non-metastatic
662689|NCT00779402|nonmetastatic|nonmetastatic
662690|NCT00779402|androgen-sensitive|androgen-sensitive
662691|NCT00779402|androgen sensitive|androgen sensitive
662692|NCT00779402|biochemical recurrence|biochemical recurrence
662693|NCT00779402|biochemically recurrent|biochemically recurrent
662694|NCT00779402|immune therapy|immune therapy
662695|NCT00779402|immunotherapy|immunotherapy
662697|NCT00779402|dendritic cells|dendritic cells
662698|NCT00779402|antigen-presenting cells|antigen-presenting cells
662699|NCT00779402|antigen presenting cells|antigen presenting cells
662700|NCT00779402|cancer vaccine|cancer vaccine
662701|NCT00779402|therapeutic vaccine|therapeutic vaccine
662702|NCT00779402|therapeutic cancer vaccine|therapeutic cancer vaccine
662703|NCT00779402|biologic|biologic
662704|NCT00779402|booster|booster
662705|NCT00779389|Head and Neck cancer|head and neck cancer
662706|NCT00779376|Bioequivalence|bioequivalence
662707|NCT00779363|obese,|obese,
662708|NCT00779363|Diabetes|diabetes
662709|NCT00779350|Bioequivalence sertraline 100 mg tablets fasting conditions|bioequivalence sertraline 100 mg tablets fasting conditions
662710|NCT00779337|Epstein-Barr virus|epstein-barr virus
662711|NCT00779337|lymphoma|lymphoma
662712|NCT00779337|immunotherapy|immunotherapy
662713|NCT00779324|traumatic brain injury|traumatic brain injury
662714|NCT00779324|irritability|irritability
662715|NCT00779324|aggression|aggression
662716|NCT00779324|amantadine|amantadine
662717|NCT00779324|behavior|behavior
662718|NCT00779311|Metastatic Colorectal Cancer|metastatic colorectal cancer
662719|NCT00779298|rye whole-meal bread|rye whole-meal bread
662720|NCT00779298|white-wheat bread|white-wheat bread
662721|NCT00779298|gastric emptying rate|gastric emptying rate
662722|NCT00779298|postprandial glucose response|postprandial glucose response
662723|NCT00779298|healthy subjects|healthy subjects
662724|NCT00779272|neoadjuvant chemotherapy|neoadjuvant chemotherapy
662725|NCT00779272|clinically postoperative outcome|clinically postoperative outcome
662726|NCT00779272|liver regeneration after liver resection|liver regeneration after liver resection
662727|NCT00779259|quinine sulfate|quinine sulfate
662728|NCT00779259|theophylline|theophylline
662729|NCT00779259|drug interactions|drug interactions
662730|NCT00779259|cytochrome p450|cytochrome p450
662731|NCT00779259|humans|humans
662732|NCT00779259|male|male
662733|NCT00779259|adult|adult
662734|NCT00779246|Methicillin resistance|methicillin resistance
662735|NCT00779246|Infection control|infection control
662736|NCT00779246|Staphylococcus aureus|staphylococcus aureus
662737|NCT00779246|Cross infection|cross infection
662738|NCT00779246|Epidemiology|epidemiology
662739|NCT00779246|Chlorhexidine|chlorhexidine
662740|NCT00779233|Bioequivalence|bioequivalence
662741|NCT00779207|obesity|obesity
662742|NCT00779207|aging|aging
662743|NCT00779207|exercise|exercise
662744|NCT00779207|diet|diet
662745|NCT00779207|weight loss|weight loss
662746|NCT00779207|physical function|physical function
662747|NCT00779207|Obesity in the Elderly|obesity in the elderly
662748|NCT00779181|Hypertension|hypertension
662749|NCT00779181|High blood pressure|high blood pressure
662750|NCT00779181|Htn|htn
662751|NCT00779181|Addrenex|addrenex
662752|NCT00779168|recurrent prostate cancer|recurrent prostate cancer
662753|NCT00779168|adenocarcinoma of the prostate|adenocarcinoma of the prostate
662754|NCT00779142|resistant diabetic macular edema|resistant diabetic macular edema
662755|NCT00779103|puberty|puberty
662756|NCT00779103|precocious puberty|precocious puberty
662757|NCT00779103|early puberty|early puberty
662758|NCT00779103|early onset puberty|early onset puberty
662759|NCT00779103|histrelin|histrelin
662760|NCT00779103|histrelin subcutaneous implant|histrelin subcutaneous implant
662761|NCT00779103|implant therapy|implant therapy
662762|NCT00779077|device characteristics|device characteristics
662763|NCT00779064|Atrial Fibrillation|atrial fibrillation
662764|NCT00779051|Bioequivalence Zolpidem 10mg tablets|bioequivalence zolpidem 10mg tablets
662765|NCT00779038|IONSYS|ionsys
662766|NCT00779038|Fentanyl Iontophoretic Transdermal System|fentanyl iontophoretic transdermal system
662767|NCT00779038|Postoperative pain|postoperative pain
662768|NCT00778986|heart failure|heart failure
662769|NCT00778986|remote patient monitoring|remote patient monitoring
662770|NCT00778986|telemonitoring|telemonitoring
662771|NCT00778986|home monitoring|home monitoring
662772|NCT00778986|randomized controlled trial|randomized controlled trial
662773|NCT00778986|self care|self care
662774|NCT00778973|Bioequivalence sertraline 100 mg tablets under fed conditions|bioequivalence sertraline 100 mg tablets under fed conditions
662775|NCT00778947|Breast Reconstruction|breast reconstruction
662776|NCT00778947|Halmonic Scalpel|halmonic scalpel
662777|NCT00778947|diathermy|diathermy
662778|NCT00778947|Free Tissue Transfer|free tissue transfer
662781|NCT00778921|Non-responder to Amlodipine|non-responder to amlodipine
662782|NCT00778908|Nasopharyngeal carcinoma|nasopharyngeal carcinoma
662783|NCT00778908|Locally advanced disease|locally advanced disease
662784|NCT00778908|Intensity-modulated radiation therapy|intensity-modulated radiation therapy
662785|NCT00778908|Accelerated hyperfractionation|accelerated hyperfractionation
662786|NCT00778908|Concomitant boost radiation therapy|concomitant boost radiation therapy
662787|NCT00778908|Concurrent chemotherapy|concurrent chemotherapy
662789|NCT00778895|Safety|safety
662790|NCT00778895|Immunogenicity|immunogenicity
662791|NCT00778895|Flu vaccine|flu vaccine
662792|NCT00778895|Influenza|influenza
662793|NCT00778895|Virus|virus
662794|NCT00778882|Chronic Granulomatous Disease|chronic granulomatous disease
662795|NCT00778882|Retroviral Vector|retroviral vector
662796|NCT00778882|Gene Therapy|gene therapy
662797|NCT00778843|Chronic hepatitis C|chronic hepatitis c
662798|NCT00778843|Oxidative stress|oxidative stress
662799|NCT00778843|Antioxidant|antioxidant
662800|NCT00778843|Cytokines|cytokines
662801|NCT00778843|Nutritional supplement|nutritional supplement
662802|NCT00778830|mCRC|mcrc
662803|NCT00778804|CVD risk|cvd risk
662804|NCT00778804|self monitoring|self monitoring
662805|NCT00778804|Internet|internet
662806|NCT00778804|telemedicine|telemedicine
662807|NCT00778791|Bioequivalence metformin HC1 750 mg extended-release tablets|bioequivalence metformin hc1 750 mg extended-release tablets
662808|NCT00778778|Bioequivalence cefprozil 500mg tablets fasting conditions|bioequivalence cefprozil 500mg tablets fasting conditions
662809|NCT00778765|Bioequivalence gabapentin fed conditions|bioequivalence gabapentin fed conditions
662810|NCT00778752|Multiple Myeloma|multiple myeloma
662811|NCT00778752|Stem Cell Transplantation|stem cell transplantation
662812|NCT00778752|Revlimid|revlimid
662813|NCT00778752|Lenalidomide|lenalidomide
662814|NCT00778739|bioequivalence 1) CEFPROZIL FOR ORAL SUSPENSION USP 250 mg/ 5 mL fed conditions|bioequivalence 1) cefprozil for oral suspension usp 250 mg/ 5 ml fed conditions
662815|NCT00778726|Bioequivalence benazepril and hydrochlorothiazide tablets|bioequivalence benazepril and hydrochlorothiazide tablets
662816|NCT00778713|Bioequivalence|bioequivalence
662817|NCT00778674|Bioequivalence Benazepril HCl Hydrochlorothiazide Tablets|bioequivalence benazepril hcl hydrochlorothiazide tablets
662818|NCT00778661|Bioequivalence|bioequivalence
662819|NCT00778648|Common cold|common cold
662820|NCT00778648|prevention|prevention
662821|NCT00778648|dietary supplement|dietary supplement
662822|NCT00778609|Combined Oral Contraceptives|combined oral contraceptives
662823|NCT00778609|Pelvic Pain|pelvic pain
662824|NCT00778609|Headache|headache
662825|NCT00778596|Hepatitis B|hepatitis b
662826|NCT00778596|Telbivudine|telbivudine
662827|NCT00778596|Prednisolone|prednisolone
662828|NCT00778583|Bioequivalence Nitrofurantoin capsules|bioequivalence nitrofurantoin capsules
662829|NCT00778557|CEFPROZIL FOR ORAL SUSPENSION USP 250 mg/ 5 mL, Bioequivalence fasting conditions|cefprozil for oral suspension usp 250 mg/ 5 ml, bioequivalence fasting conditions
662830|NCT00778544|Bioequivalence amoxicillin-clavulanic acid 600 mg 42.9 mg per 5 mL oral suspension|bioequivalence amoxicillin-clavulanic acid 600 mg 42.9 mg per 5 ml oral suspension
662831|NCT00778518|growth hormone|growth hormone
662832|NCT00778518|growth hormone deficiency|growth hormone deficiency
662833|NCT00778518|GHD|ghd
662834|NCT00778518|PEG|peg
662835|NCT00778518|pegylated|pegylated
662836|NCT00778518|IGF-1|igf-1
662837|NCT00778505|Anesthesia|anesthesia
662838|NCT00778492|Thrombelastogram|thrombelastogram
662839|NCT00778492|Microvascular bleeding|microvascular bleeding
662840|NCT00778492|antiplatelet medication|antiplatelet medication
662841|NCT00778492|cardiac surgery|cardiac surgery
662842|NCT00778492|consumption of blood products|consumption of blood products
662843|NCT00778492|preoperative platelet mapping derived from modified TEG|preoperative platelet mapping derived from modified teg
662844|NCT00778492|postoperative bleeding|postoperative bleeding
662845|NCT00778466|Bioequivalence metformin hydrochloride 1000 mg tablets fed conditions|bioequivalence metformin hydrochloride 1000 mg tablets fed conditions
662846|NCT00778453|stroke rehabilitation|stroke rehabilitation
662847|NCT00778453|kinematic analysis|kinematic analysis
662848|NCT00778453|upper extremity training|upper extremity training
662849|NCT00778453|predictors|predictors
662850|NCT00778440|Injuries|injuries
662851|NCT00778440|Traffic Injuries|traffic injuries
662852|NCT00778440|Preventive medicine|preventive medicine
662853|NCT00778440|Observational studies|observational studies
662854|NCT00778440|Primary care|primary care
662855|NCT00778427|Bioequivalence metformin hydrochloride 1000 mg tablets fasting conditions|bioequivalence metformin hydrochloride 1000 mg tablets fasting conditions
710277|NCT00589563|contiguous stage II adult diffuse small cleaved cell lymphoma|contiguous stage ii adult diffuse small cleaved cell lymphoma
662856|NCT00778414|Bioequivalence Amoxicillin Clavulanic acid 600mg 42.9 mg per 5 mL oral suspension|bioequivalence amoxicillin clavulanic acid 600mg 42.9 mg per 5 ml oral suspension
662857|NCT00778401|Bioequivalence Gabapentin tablets 800 mg fasting conditions|bioequivalence gabapentin tablets 800 mg fasting conditions
662858|NCT00778388|Pseudomonas Aeruginosa|pseudomonas aeruginosa
662859|NCT00778375|Leukemia|leukemia
662860|NCT00778375|Acute Myeloid Leukemia|acute myeloid leukemia
662861|NCT00778375|Myelodysplastic Syndrome|myelodysplastic syndrome
662862|NCT00778375|AML|aml
662863|NCT00778375|MDS|mds
662864|NCT00778375|Clofarabine|clofarabine
662865|NCT00778375|Ara-C|ara-c
662866|NCT00778375|Cytarabine|cytarabine
662867|NCT00778375|Decitabine|decitabine
662868|NCT00778362|OPSI|opsi
662869|NCT00778362|Splenectomy|splenectomy
662870|NCT00778349|Bioavailability Metformin solution 100 mg/mL|bioavailability metformin solution 100 mg/ml
662871|NCT00778336|Peripheral Thrombosis|peripheral thrombosis
662872|NCT00778336|DVT|dvt
662873|NCT00778336|Limb Ischemia|limb ischemia
662874|NCT00778336|AV Access|av access
662875|NCT00778336|AngioJet|angiojet
662876|NCT00778336|Thrombectomy|thrombectomy
662877|NCT00778323|remote ischemic preconditioning|remote ischemic preconditioning
662878|NCT00778323|cervical compression myelopathy|cervical compression myelopathy
662879|NCT00778323|spinal cord|spinal cord
662880|NCT00778323|neuron-specific enolase|neuron-specific enolase
662881|NCT00778323|s-100B|s-100b
662882|NCT00778310|Attention Deficit Disorder with Hyperactivity|attention deficit disorder with hyperactivity
662883|NCT00778310|Attention Deficit Hyperactivity Disorder|attention deficit hyperactivity disorder
662884|NCT00778310|ADHD|adhd
662885|NCT00778297|prevention|prevention
662886|NCT00778297|influenza|influenza
662887|NCT00778297|infection|infection
662888|NCT00778297|vaccine|vaccine
662889|NCT00778297|Influenza vaccine|influenza vaccine
662890|NCT00778297|Influenza in humans|influenza in humans
662891|NCT00778284|Bioequivalence|bioequivalence
662892|NCT00778271|Bioequivalence gabapentin 400mg capsules fasting conditions|bioequivalence gabapentin 400mg capsules fasting conditions
662893|NCT00778258|Food Allergy|food allergy
662894|NCT00778258|Milk Allergy|milk allergy
662895|NCT00778245|Bioequivalence cefprozil 500mg tablets fed conditions|bioequivalence cefprozil 500mg tablets fed conditions
662896|NCT00778232|Bioequivalence Gabapentin tablets 800 mg fed conditions|bioequivalence gabapentin tablets 800 mg fed conditions
662897|NCT00778219|heart rate variability, tracheal intubation|heart rate variability, tracheal intubation
662898|NCT00778206|Phenylketonuria|phenylketonuria
662899|NCT00778206|Hyperphenylalaninemia|hyperphenylalaninemia
662900|NCT00778206|PKU|pku
662901|NCT00778206|Phenylalanine|phenylalanine
662902|NCT00778193|NSAID|nsaid
662903|NCT00778193|ulcer|ulcer
662904|NCT00778193|gastroduodenal ulcer|gastroduodenal ulcer
662905|NCT00778193|naproxen|naproxen
662906|NCT00778193|aspirin|aspirin
662907|NCT00778193|ASA|asa
662908|NCT00778193|celecoxib|celecoxib
662909|NCT00778193|clopidogrel|clopidogrel
662910|NCT00778193|healing|healing
662911|NCT00778193|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors
662912|NCT00778193|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal
662913|NCT00778193|Platelet Aggregation Inhibitors|platelet aggregation inhibitors
662914|NCT00778193|Wound Healing|wound healing
662915|NCT00778180|Bioequivalence furosemide 80 mg tablets|bioequivalence furosemide 80 mg tablets
662916|NCT00778141|Bioequivalecne metformin HC1 750 mg extended-release tablets|bioequivalecne metformin hc1 750 mg extended-release tablets
662917|NCT00778128|CP-4126|cp-4126
662918|NCT00778128|Cancer|cancer
662919|NCT00778128|Metastatic|metastatic
662920|NCT00778128|Solid tumours|solid tumours
662921|NCT00778128|Gemzitabine|gemzitabine
662922|NCT00778128|Gemzar|gemzar
662923|NCT00778115|Bioequivalence Loperamide HCl 2 mg and simethicone 125 mg tablets|bioequivalence loperamide hcl 2 mg and simethicone 125 mg tablets
662924|NCT00778089|skin test|skin test
662925|NCT00778089|ArteFill|artefill
662926|NCT00778089|Skin test prior to administration of ArteFill® implant|skin test prior to administration of artefill® implant
662927|NCT00778076|Knee OA, Hyaluronic acid, Gait, Pain, Synovial fluid|knee oa, hyaluronic acid, gait, pain, synovial fluid
662928|NCT00778063|dexmedetomidine|dexmedetomidine
662929|NCT00778063|pressure equalization tubes in the ear|pressure equalization tubes in the ear
662930|NCT00778063|myringotomy|myringotomy
662931|NCT00778063|sevoflurane|sevoflurane
662932|NCT00778050|Bioequivalence, amoxicillin 600mg fasting conditions|bioequivalence, amoxicillin 600mg fasting conditions
662933|NCT00778037|Bioequivalence Cyclobenzaprine hydrochloride 10 mg tablet fasting conditions|bioequivalence cyclobenzaprine hydrochloride 10 mg tablet fasting conditions
662934|NCT00778024|Bioequivalence fluoxetine HCL 40 mg capsules fasting conditions|bioequivalence fluoxetine hcl 40 mg capsules fasting conditions
662935|NCT00778011|Nausea|nausea
662936|NCT00778011|Vomiting|vomiting
662937|NCT00778011|Ondansetron|ondansetron
662938|NCT00778011|Metoclopramide|metoclopramide
662939|NCT00778011|Randomized|randomized
662940|NCT00778011|Double-Blind|double-blind
662941|NCT00778011|nausea and vomiting in the emergency department|nausea and vomiting in the emergency department
662942|NCT00777998|Multiple Myeloma|multiple myeloma
662943|NCT00777998|Stem Cell Transplantation|stem cell transplantation
662944|NCT00777998|Thalidomide|thalidomide
662945|NCT00777998|DLI|dli
662946|NCT00777985|Cardiovascular system|cardiovascular system
662947|NCT00777985|Sleep|sleep
662948|NCT00777985|Endothelial function|endothelial function
662949|NCT00777985|Endothelin system|endothelin system
662950|NCT00777972|Bioequivalence Fosinopril sodium and hydrochlorothiazide 20-12.5 mg tablets fasting conditions|bioequivalence fosinopril sodium and hydrochlorothiazide 20-12.5 mg tablets fasting conditions
662951|NCT00777946|Aliskiren, Amlodipine, Non-responder to aliskiren|aliskiren, amlodipine, non-responder to aliskiren
662952|NCT00777907|neurovascular embolization|neurovascular embolization
662953|NCT00777907|therapeutic embolization|therapeutic embolization
662954|NCT00777894|advanced adult primary liver cancer|advanced adult primary liver cancer
662955|NCT00777894|localized unresectable adult primary liver cancer|localized unresectable adult primary liver cancer
662956|NCT00777894|adult primary hepatocellular carcinoma|adult primary hepatocellular carcinoma
662957|NCT00777855|warfarin|warfarin
662958|NCT00777855|pharmacokinetics|pharmacokinetics
662959|NCT00777855|drug transporter|drug transporter
662960|NCT00777855|healthy volunteer|healthy volunteer
662961|NCT00777855|drug interaction|drug interaction
662962|NCT00777855|rifampin|rifampin
662963|NCT00777829|Nap|nap
662964|NCT00777829|Pharmacology|pharmacology
662965|NCT00777829|Memory|memory
662966|NCT00777829|Visual Learning|visual learning
662967|NCT00777829|Verbal Memory|verbal memory
662968|NCT00777829|Motor Learning|motor learning
662969|NCT00777816|Rheumatoid|rheumatoid
662970|NCT00777816|Arthritis|arthritis
662971|NCT00777790|Meningitis|meningitis
662972|NCT00777790|Meningococcemia|meningococcemia
662973|NCT00777790|Neisseria meningitidis|neisseria meningitidis
662974|NCT00777777|multi-vessel, therapy, surgery, CABG|multi-vessel, therapy, surgery, cabg
662975|NCT00777764|Xolair|xolair
662976|NCT00777764|Asthma|asthma
662977|NCT00777764|Skin Tests|skin tests
662978|NCT00777751|Chest Tumor|chest tumor
662979|NCT00777751|Heart|heart
662980|NCT00777751|Lung Cancer|lung cancer
662981|NCT00777751|Esophageal Cancer|esophageal cancer
662982|NCT00777751|Thymoma|thymoma
662983|NCT00777751|Radiation dose to the heart|radiation dose to the heart
662984|NCT00777751|Cardiac Enzymes|cardiac enzymes
662985|NCT00777751|Cardiac Biomarkers|cardiac biomarkers
662986|NCT00777751|Radiation Therapy|radiation therapy
662987|NCT00777751|RT|rt
662988|NCT00777751|Electrocardiograms|electrocardiograms
662989|NCT00777751|ECG|ecg
662990|NCT00777738|Advanced Waldenström's macroglobulinemia|advanced waldenström's macroglobulinemia
662991|NCT00777738|Bortezomib|bortezomib
662992|NCT00777738|Dexamethasone|dexamethasone
662993|NCT00777738|Safety|safety
662994|NCT00777738|Efficacy|efficacy
662995|NCT00777712|Wound healing|wound healing
662996|NCT00777712|diabetes|diabetes
662997|NCT00777712|inflammatory cell|inflammatory cell
662998|NCT00777712|monocyte|monocyte
662999|NCT00777712|leukocyte|leukocyte
663000|NCT00777712|macrophage|macrophage
663001|NCT00777699|Cancer|cancer
663002|NCT00777699|Solid Tumors|solid tumors
663003|NCT00777699|NSCLC|nsclc
663004|NCT00777686|Intracranial Glioblastoma|intracranial glioblastoma
663005|NCT00777686|Intracranial Gliosarcoma|intracranial gliosarcoma
663006|NCT00777686|glioblastoma|glioblastoma
663007|NCT00777686|recurrent glioblastoma|recurrent glioblastoma
663008|NCT00777686|gliosarcoma|gliosarcoma
663009|NCT00777686|brain cancer|brain cancer
663010|NCT00777686|magnetic resonance spectroscopy|magnetic resonance spectroscopy
663011|NCT00777686|MRS|mrs
663012|NCT00777686|magnetic resonance imaging|magnetic resonance imaging
663013|NCT00777686|MRI|mri
663014|NCT00777686|MRI/MRS|mri/mrs
663015|NCT00777686|Recurrent Glioblastoma Treated with Antiangiogenic agents|recurrent glioblastoma treated with antiangiogenic agents
663016|NCT00777686|contrast enhanced MRI|contrast enhanced mri
663017|NCT00777686|DCE-MRI|dce-mri
663018|NCT00777686|diffusion-weighted MRI|diffusion-weighted mri
663019|NCT00777686|DSC|dsc
663020|NCT00777686|DW-MRI|dw-mri
663021|NCT00777673|Breast Cancer|breast cancer
663022|NCT00777673|Triple Negative|triple negative
663023|NCT00777673|Neoadjuvant|neoadjuvant
663024|NCT00777673|Neoadjuvant therapy|neoadjuvant therapy
663025|NCT00777673|ER, PR and HER2 Negative|er, pr and her2 negative
663026|NCT00777634|Binge Eating Disorder|binge eating disorder
663027|NCT00777634|Eating Disorder|eating disorder
663028|NCT00777595|QTc|qtc
663029|NCT00777595|CHF 4226 HFA|chf 4226 hfa
663030|NCT00777595|pMDI|pmdi
663031|NCT00777595|Carmoterol|carmoterol
663032|NCT00777582|Poly (ADP ribose) polymerases|poly (adp ribose) polymerases
663033|NCT00777582|Homologous Recombination Deficiency (HRD)|homologous recombination deficiency (hrd)
663034|NCT00777582|Advanced solid tumours|advanced solid tumours
663035|NCT00777569|Smoking|smoking
663036|NCT00777569|PREPS|preps
663037|NCT00777569|Harm reduction|harm reduction
663038|NCT00777569|Biomarkers of tobacco exposure|biomarkers of tobacco exposure
663039|NCT00777569|Compensatory smoking|compensatory smoking
663040|NCT00777543|Bioavailability|bioavailability
663041|NCT00777543|Ferulic acid|ferulic acid
663042|NCT00777543|Phenolic compounds|phenolic compounds
663043|NCT00777543|Colonic metabolites|colonic metabolites
663044|NCT00777543|Immunomodulatory effects|immunomodulatory effects
663045|NCT00777543|No disease|no disease
663046|NCT00777517|Cardiovascular Diseases|cardiovascular diseases
663047|NCT00777504|angiogenesis|angiogenesis
663048|NCT00777504|inhibitor|inhibitor
663049|NCT00777504|duration of therapy|duration of therapy
663050|NCT00777504|GIST|gist
663051|NCT00777491|stage II bladder cancer|stage ii bladder cancer
663052|NCT00777491|stage III bladder cancer|stage iii bladder cancer
663053|NCT00777491|transitional cell carcinoma of the bladder|transitional cell carcinoma of the bladder
663054|NCT00777478|Sunitinib|sunitinib
663055|NCT00777478|Capecitabine|capecitabine
663056|NCT00777478|Irinotecan|irinotecan
663057|NCT00777478|colorectal cancer|colorectal cancer
663058|NCT00777465|Acute kidney injury|acute kidney injury
663059|NCT00777465|Kidney failure|kidney failure
663060|NCT00777465|Risk factors|risk factors
663061|NCT00777465|Clinical outcomes|clinical outcomes
663062|NCT00777465|Cardiac valve surgery|cardiac valve surgery
663063|NCT00777465|Coronary artery bypass grafting|coronary artery bypass grafting
663064|NCT00777465|Morbidity|morbidity
663065|NCT00777465|Mortality|mortality
663066|NCT00777452|quality of life|quality of life
663067|NCT00777452|localized prostate cancer|localized prostate cancer
663068|NCT00777452|FACT-P|fact-p
663069|NCT00777439|Dopamine|dopamine
663070|NCT00777439|Domperidone|domperidone
663071|NCT00777439|Gastroparesis|gastroparesis
663072|NCT00777439|Gastrointestinal Diseases|gastrointestinal diseases
663073|NCT00777439|Neurologic Manifestations|neurologic manifestations
663074|NCT00777439|Stomach Diseases|stomach diseases
663075|NCT00777439|Digestive System Diseases|digestive system diseases
663076|NCT00777439|Esophagitis|esophagitis
663077|NCT00777439|Esophageal Disorders|esophageal disorders
663078|NCT00777439|Paralysis|paralysis
663079|NCT00777426|HIV positive with HAD|hiv positive with had
663080|NCT00777413|Bioequiavlence Minocycline Tablets|bioequiavlence minocycline tablets
663081|NCT00777400|Kidney transplant|kidney transplant
663082|NCT00777400|T regulatory cells|t regulatory cells
663083|NCT00777400|Efalizumab|efalizumab
663084|NCT00777400|Rejection|rejection
663085|NCT00777400|Safely convert renal transplant from mycophenolate mofetil and Calcineurin inhibitor to efalizumab and sirolimus|safely convert renal transplant from mycophenolate mofetil and calcineurin inhibitor to efalizumab and sirolimus
663086|NCT00777387|human oocyte cryopreservation|human oocyte cryopreservation
663087|NCT00777387|slow-freeze|slow-freeze
663088|NCT00777387|vitrification|vitrification
663089|NCT00777361|Mass balance|mass balance
663090|NCT00777361|AZD3480, Pharmacokinetics, Healthy volunteers|azd3480, pharmacokinetics, healthy volunteers
663091|NCT00777322|keratoconus|keratoconus
663092|NCT00777322|pellucid marginal degeneration|pellucid marginal degeneration
663093|NCT00777322|corneal ectasia|corneal ectasia
663094|NCT00777322|collagen cross-linking|collagen cross-linking
663095|NCT00777322|riboflavin|riboflavin
663096|NCT00777322|UV light|uv light
663097|NCT00777322|excimer laser|excimer laser
663098|NCT00777322|Topography-Computer Assisted Treatment (T-Cat)|topography-computer assisted treatment (t-cat)
663099|NCT00777322|Wavelight Allegretto laser|wavelight allegretto laser
663100|NCT00777309|NSCLC|nsclc
663101|NCT00777296|Cystic Fibrosis|cystic fibrosis
663102|NCT00777296|Respiratory Infections|respiratory infections
663103|NCT00777296|Pulmonary Cystic Fibrosis|pulmonary cystic fibrosis
663104|NCT00777296|CFTR|cftr
663105|NCT00777270|episiotomy|episiotomy
663106|NCT00777270|perineal lesion|perineal lesion
663107|NCT00777270|vaginal trauma|vaginal trauma
663108|NCT00777257|Meningitis|meningitis
663109|NCT00777257|Meningococcemia|meningococcemia
663110|NCT00777257|Pertussis|pertussis
663111|NCT00777257|Neisseria meningitidis|neisseria meningitidis
663112|NCT00777257|Tetanus|tetanus
663113|NCT00777257|Diphtheria|diphtheria
663114|NCT00777244|mitotane|mitotane
663115|NCT00777244|adjuvant therapy|adjuvant therapy
663116|NCT00777244|disease free survival|disease free survival
663117|NCT00777231|Sickle Cell|sickle cell
663118|NCT00777231|Stem Cell|stem cell
663119|NCT00777231|Tolerance|tolerance
663120|NCT00777231|Bone Marrow Transplant|bone marrow transplant
663121|NCT00777231|Total Body Irradiation (TBI)|total body irradiation (tbi)
663122|NCT00777231|Apheresis|apheresis
663123|NCT00777231|Aplastic Anemia|aplastic anemia
663124|NCT00777231|Hemoglobinopathies|hemoglobinopathies
663125|NCT00777231|Non Malignant|non malignant
663126|NCT00777218|migraine|migraine
663127|NCT00777205|Peer Support|peer support
663128|NCT00777205|Quality of Life|quality of life
663129|NCT00777205|Telephone|telephone
663130|NCT00777192|colon cancer|colon cancer
663131|NCT00777192|Cancers of the colon and rectum|cancers of the colon and rectum
663132|NCT00777192|Oxaliplatin|oxaliplatin
663133|NCT00777192|oxaliplatin chemotherapy|oxaliplatin chemotherapy
663134|NCT00777192|inflammatory cytokines|inflammatory cytokines
663135|NCT00777192|neurocognitive symptoms|neurocognitive symptoms
663136|NCT00777192|neuropsychiatric symptoms|neuropsychiatric symptoms
663137|NCT00777179|Vandetanib, NSCLC, Maintenance, Phase II|vandetanib, nsclc, maintenance, phase ii
663138|NCT00777166|oxytocin|oxytocin
663139|NCT00777166|ST depression|st depression
663140|NCT00777166|cesarean section|cesarean section
663141|NCT00777166|blood loss|blood loss
663142|NCT00777153|Cancer|cancer
663143|NCT00777153|Tumour|tumour
663144|NCT00777153|Advanced Solid Tumour|advanced solid tumour
663145|NCT00777153|GBM|gbm
663146|NCT00777153|Glioblastoma|glioblastoma
663147|NCT00777140|Stroke|stroke
663148|NCT00777140|Ischemic Stroke|ischemic stroke
663149|NCT00777140|Thrombolytic treatment|thrombolytic treatment
663150|NCT00777140|Middle cerebral artery occlusion|middle cerebral artery occlusion
663151|NCT00777140|Deferoxamine|deferoxamine
663152|NCT00777140|Iron chelator|iron chelator
663440|NCT00775684|Sitagliptin|sitagliptin
663153|NCT00777140|Acute Ischemic Stroke treated with Intravenous Thrombolytic|acute ischemic stroke treated with intravenous thrombolytic
663154|NCT00777127|actinic keratosis|actinic keratosis
663155|NCT00777127|invasive SCC|invasive scc
663156|NCT00777127|in situ SCC|in situ scc
663157|NCT00777127|histological classification|histological classification
663158|NCT00777127|histological progression|histological progression
663159|NCT00777127|clinical clearance|clinical clearance
663160|NCT00777127|cryotherapy|cryotherapy
663161|NCT00777114|relapsed non-Hodgkin's lymphoma|relapsed non-hodgkin's lymphoma
663162|NCT00777101|HER2|her2
663163|NCT00777101|ErbB2|erbb2
663164|NCT00777101|metastatic|metastatic
663165|NCT00777101|neratinib|neratinib
663166|NCT00777101|lapatinib|lapatinib
663167|NCT00777101|capecitabine|capecitabine
663168|NCT00777101|HKI-272|hki-272
663169|NCT00777101|Nerlynx|nerlynx
663170|NCT00777101|PB-272|pb-272
663171|NCT00777088|neurovascular embolization|neurovascular embolization
663172|NCT00777088|therapeutic embolization|therapeutic embolization
663173|NCT00777075|nitrate|nitrate
663174|NCT00777075|nitric oxide|nitric oxide
663175|NCT00777075|asymmetric dimethylarginine|asymmetric dimethylarginine
663176|NCT00777075|blood pressure|blood pressure
663177|NCT00777075|NOS|nos
663178|NCT00777075|IIEF|iief
663179|NCT00777062|alcohol|alcohol
663180|NCT00777062|cocaine|cocaine
663181|NCT00777062|addiction|addiction
663182|NCT00777062|alcoholism|alcoholism
663183|NCT00777062|substance dependence|substance dependence
663184|NCT00777062|substance abuse|substance abuse
663185|NCT00777036|Leukemia, Pediatric|leukemia, pediatric
663186|NCT00777023|Hot Flashes|hot flashes
663187|NCT00777023|Hot Flushes|hot flushes
663188|NCT00777023|Postmenopausal symptoms|postmenopausal symptoms
663189|NCT00777023|Vasomotor symptoms|vasomotor symptoms
663190|NCT00777010|memory loss|memory loss
663191|NCT00777010|mild cognitive impairment|mild cognitive impairment
663192|NCT00777010|forgetfulness|forgetfulness
663193|NCT00776997|Gastroesophageal Reflux|gastroesophageal reflux
663194|NCT00776958|A Lynne Cohen Consortium Project|a lynne cohen consortium project
663195|NCT00776958|Multi-Center Database Registry|multi-center database registry
663196|NCT00776958|High Risk|high risk
663197|NCT00776958|Cancer|cancer
663198|NCT00776958|Breast|breast
663199|NCT00776958|BRCA1 or BRCA2 gene|brca1 or brca2 gene
663200|NCT00776958|Ovary|ovary
663201|NCT00776958|Questionnaire|questionnaire
663202|NCT00776919|Acne Vulgaris|acne vulgaris
663203|NCT00776919|Acne|acne
663204|NCT00776880|Surgical operation|surgical operation
663205|NCT00776867|Pediatric|pediatric
663206|NCT00776867|solid tumors|solid tumors
663207|NCT00776867|Pediatric solid tumors|pediatric solid tumors
663208|NCT00776867|08-091|08-091
663209|NCT00776841|Phase-I|phase-i
663210|NCT00776841|Hypercholesterolemia|hypercholesterolemia
663211|NCT00776841|Obesity|obesity
663212|NCT00776841|fatty liver|fatty liver
663213|NCT00776841|Part A: Healthy male volunteers Part B: Mildly overweight, otherwise healthy hypercholesterolemic male volunteers|part a: healthy male volunteers part b: mildly overweight, otherwise healthy hypercholesterolemic male volunteers
663214|NCT00776828|cilostazol|cilostazol
663215|NCT00776828|clopidogrel|clopidogrel
663216|NCT00776828|statin|statin
663217|NCT00776828|drug-eluting stent|drug-eluting stent
663218|NCT00776802|GCS-100|gcs-100
663219|NCT00776802|Diffuse Large B-cell Lymphoma|diffuse large b-cell lymphoma
663220|NCT00776802|DLBCL|dlbcl
663221|NCT00776802|Relapsed or refractory DLBCL|relapsed or refractory dlbcl
663222|NCT00776802|Etoposide; Dexamethasone|etoposide; dexamethasone
663223|NCT00776789|Skin to skin contact|skin to skin contact
663224|NCT00776789|Salivary cortisol|salivary cortisol
663225|NCT00776789|Breast feeding Behavior|breast feeding behavior
663226|NCT00776776|BMI > 40|bmi > 40
663227|NCT00776776|Obesity|obesity
663228|NCT00776776|Adolescents|adolescents
663229|NCT00776776|Weight Loss Surgery|weight loss surgery
663230|NCT00776737|Attention Deficit Disorder|attention deficit disorder
663231|NCT00776737|Attention Deficit Hyperactivity Disorder|attention deficit hyperactivity disorder
663232|NCT00776737|Computer Aided Learning|computer aided learning
663233|NCT00776737|Attention Deficits|attention deficits
663234|NCT00776737|Healthy Volunteer|healthy volunteer
663236|NCT00776724|breast ca|breast ca
663237|NCT00776724|phase III|phase iii
663238|NCT00776724|Tailored neoadjuvant chemotherapy|tailored neoadjuvant chemotherapy
663239|NCT00776724|stage II/III|stage ii/iii
663240|NCT00776711|Healthy|healthy
663241|NCT00776711|Avian Influenza|avian influenza
663242|NCT00776711|Immunity|immunity
663243|NCT00776711|Preventive|preventive
663244|NCT00776711|Bird Flu|bird flu
663245|NCT00776711|Healthy Volunteer|healthy volunteer
663246|NCT00776711|HV|hv
663247|NCT00776711|Influenza|influenza
663248|NCT00776672|Bioequivalence Fosinopril Tablets|bioequivalence fosinopril tablets
663249|NCT00776659|An Observational Study of Indian Breast Cancer Patients Receiving Adjuvant Therapy with Aromasin|an observational study of indian breast cancer patients receiving adjuvant therapy with aromasin
663250|NCT00776659|Antineoplastic Hormonal Drugs|antineoplastic hormonal drugs
663251|NCT00776659|Aromasin|aromasin
663441|NCT00775684|Glimepiride|glimepiride
663252|NCT00776646|bioequivalence hydrochlorothiazide 50 mg tablet fasting conditions|bioequivalence hydrochlorothiazide 50 mg tablet fasting conditions
663253|NCT00776633|aspirin|aspirin
663254|NCT00776633|clopidogrel|clopidogrel
663255|NCT00776633|oral anticoagulation|oral anticoagulation
663256|NCT00776633|warfarin|warfarin
663257|NCT00776633|drug eluting stent|drug eluting stent
663258|NCT00776633|phenprocoumon|phenprocoumon
663259|NCT00776620|Bioequivalence Glimepiride Tablets|bioequivalence glimepiride tablets
663260|NCT00776607|LADA|lada
663261|NCT00776607|Latent autoimmune diabetes in adults|latent autoimmune diabetes in adults
663262|NCT00776607|Type 1.5|type 1.5
663263|NCT00776607|Slowly progressive type 1 diabetes|slowly progressive type 1 diabetes
663264|NCT00776594|Androgen deprivation therapy|androgen deprivation therapy
663265|NCT00776594|ADT|adt
663266|NCT00776594|bevacizumab|bevacizumab
663267|NCT00776581|Combined spinal-epidural analgesia|combined spinal-epidural analgesia
663268|NCT00776581|Patient-controlled analgesia|patient-controlled analgesia
663269|NCT00776581|Epidural analgesia|epidural analgesia
663270|NCT00776555|Not required|not required
663271|NCT00776542|bioequivalence Minocycline Tablets|bioequivalence minocycline tablets
663272|NCT00776529|sensorimotor training|sensorimotor training
663273|NCT00776529|Strengthening|strengthening
663274|NCT00776529|Balance|balance
663275|NCT00776516|Healthy volunteer subjects|healthy volunteer subjects
663276|NCT00776516|CYP3A4 inducer|cyp3a4 inducer
663277|NCT00776516|rifampin|rifampin
663278|NCT00776516|drug interaction|drug interaction
663279|NCT00776516|pharmacokinetics|pharmacokinetics
663280|NCT00776516|YM178|ym178
663281|NCT00776516|mirabegron|mirabegron
663282|NCT00776503|Epigenetic|epigenetic
663283|NCT00776503|Myelodysplasia|myelodysplasia
663284|NCT00776503|Cytarabine|cytarabine
663285|NCT00776490|Bioequivalence Glimepiride Tablets|bioequivalence glimepiride tablets
663286|NCT00776451|AMD|amd
663287|NCT00776438|Influenza|influenza
663288|NCT00776438|Orthomyxoviruses|orthomyxoviruses
663289|NCT00776438|Myxovirus Infection|myxovirus infection
663290|NCT00776438|Inactivated Split-virion influenza vaccine|inactivated split-virion influenza vaccine
663291|NCT00776438|Adults|adults
663292|NCT00776438|Elderly|elderly
663293|NCT00776412|Immunologic Non-Responder|immunologic non-responder
663294|NCT00776412|Cardiovascular Disease|cardiovascular disease
663295|NCT00776412|Antiretroviral|antiretroviral
663296|NCT00776412|Mortality|mortality
663297|NCT00776412|HIV Positive|hiv positive
663298|NCT00776412|HIV Negative|hiv negative
663299|NCT00776412|Healthy Volunteer|healthy volunteer
663300|NCT00776412|HV|hv
663301|NCT00776399|Colorectal cancer|colorectal cancer
663302|NCT00776399|lung metastasis|lung metastasis
663303|NCT00776399|radiofrequency ablation|radiofrequency ablation
663304|NCT00776399|metastasectomy|metastasectomy
663305|NCT00776399|Lung metastasis from colorectal cancer|lung metastasis from colorectal cancer
663307|NCT00776373|Burkitt's Lymphoma|burkitt's lymphoma
663308|NCT00776373|Adult T-Cell leukemia/lymphoma|adult t-cell leukemia/lymphoma
663309|NCT00776373|Lymphoblastic leukemia|lymphoblastic leukemia
663310|NCT00776373|CML in lymphoid blast crisis patients|cml in lymphoid blast crisis patients
663311|NCT00776373|HiVAC|hivac
663312|NCT00776373|Rapamycin|rapamycin
663313|NCT00776360|oxytocin|oxytocin
663314|NCT00776360|gastroparesis|gastroparesis
663315|NCT00776360|diabetics|diabetics
663316|NCT00776360|The effect of oxytocin on gastric emptying|the effect of oxytocin on gastric emptying
663317|NCT00776347|Dementia with Lewy bodies (DLB)|dementia with lewy bodies (dlb)
663318|NCT00776347|FDG-PET|fdg-pet
663319|NCT00776334|bioequivalence Fosinopril Tablets|bioequivalence fosinopril tablets
663320|NCT00776321|hypercholesterolemia|hypercholesterolemia
663321|NCT00776321|dyslipidemia|dyslipidemia
663322|NCT00776321|thyroid|thyroid
663323|NCT00776321|safety|safety
663324|NCT00776308|molecular breast imaging|molecular breast imaging
663325|NCT00776308|breast cancer|breast cancer
663326|NCT00776308|mammography|mammography
663327|NCT00776295|Small Cell Lung Cancer|small cell lung cancer
663328|NCT00776295|SCLC|sclc
663329|NCT00776295|Limited Stage Small Cell Lung Cancer|limited stage small cell lung cancer
663330|NCT00776282|bioequivalence loratadine 10 mg orally disintegrating|bioequivalence loratadine 10 mg orally disintegrating
663331|NCT00776282|tablets fed conditions|tablets fed conditions
663332|NCT00776269|Argon laser|argon laser
663333|NCT00776269|Trichiasis|trichiasis
663334|NCT00776269|Radiofrequency|radiofrequency
663335|NCT00776269|Patients with trichiasis|patients with trichiasis
663336|NCT00776256|satiety|satiety
663337|NCT00776256|food intake|food intake
663338|NCT00776243|incretin|incretin
663339|NCT00776243|GLP-1|glp-1
663340|NCT00776243|GIP|gip
663341|NCT00776243|intensive insulin therapy|intensive insulin therapy
663342|NCT00776217|bioequivalence loratadine 10 mg orally disintegrating tablets fasting|bioequivalence loratadine 10 mg orally disintegrating tablets fasting
663343|NCT00776204|Coronary Artery Disease|coronary artery disease
663344|NCT00776204|Drug eluting stent|drug eluting stent
663345|NCT00776204|Percutaneous Coronary Interventions|percutaneous coronary interventions
663346|NCT00776204|Optical Coherence Tomography|optical coherence tomography
663347|NCT00776191|Physioneal 35|physioneal 35
663348|NCT00776191|Physioneal 40|physioneal 40
663349|NCT00776191|children|children
663350|NCT00776191|chronic peritoneal dialysis|chronic peritoneal dialysis
663351|NCT00776178|Survival Study|survival study
663352|NCT00776178|Bladder Cancer|bladder cancer
663353|NCT00776178|Cancer Recurrence|cancer recurrence
663354|NCT00776178|Tumor Markers/Heterogeneity|tumor markers/heterogeneity
663355|NCT00776139|Cetirizine Hydrochloride 10 mg tablet fasting conditions|cetirizine hydrochloride 10 mg tablet fasting conditions
663356|NCT00776126|Breast|breast
663357|NCT00776126|3D Digital Mammography|3d digital mammography
663358|NCT00776126|Digital Breast Tomosynthesis|digital breast tomosynthesis
663359|NCT00776113|Bioequivalence Carvedilol fasting|bioequivalence carvedilol fasting
663360|NCT00776100|stage IV non-small cell lung cancer|stage iv non-small cell lung cancer
663361|NCT00776100|adenosquamous cell lung cancer|adenosquamous cell lung cancer
663362|NCT00776100|squamous cell lung cancer|squamous cell lung cancer
663363|NCT00776100|large cell lung cancer|large cell lung cancer
663364|NCT00776100|adenocarcinoma of the lung|adenocarcinoma of the lung
663365|NCT00776100|bronchoalveolar cell lung cancer|bronchoalveolar cell lung cancer
663366|NCT00776087|Medical costs|medical costs
663367|NCT00776087|Telemonitoring|telemonitoring
663368|NCT00776087|Implantable cardioverter-defibrillator|implantable cardioverter-defibrillator
663369|NCT00776074|Leiomyoma|leiomyoma
663370|NCT00776074|Uterine Fibroids|uterine fibroids
663371|NCT00776074|Drug Therapy|drug therapy
663372|NCT00776074|Uterine Neoplasms|uterine neoplasms
663373|NCT00776074|Fibroid Tumor|fibroid tumor
663374|NCT00776035|Obesity|obesity
663375|NCT00776035|Heart|heart
663376|NCT00776035|Failure|failure
663378|NCT00776035|radiation|radiation
663379|NCT00776035|metabolism|metabolism
663380|NCT00776022|Bioequivalence Cetirizine Hydrochloride 10 mg tablet fed conditions|bioequivalence cetirizine hydrochloride 10 mg tablet fed conditions
663381|NCT00776009|ADHD, children, subjects, laboratory classroom|adhd, children, subjects, laboratory classroom
663382|NCT00775996|bioequivalence Clorazepate Tablets|bioequivalence clorazepate tablets
663383|NCT00775970|Obesity|obesity
663384|NCT00775970|Weight loss maintenance|weight loss maintenance
663385|NCT00775970|Spontaneous physical activity|spontaneous physical activity
663386|NCT00775970|Lipid oxydation|lipid oxydation
663387|NCT00775970|Walking|walking
663388|NCT00775944|Tobacco|tobacco
663389|NCT00775944|Cigarette|cigarette
663390|NCT00775944|Smoking|smoking
663391|NCT00775944|Counselling|counselling
663392|NCT00775944|Nicotine Replacement Therapy|nicotine replacement therapy
663393|NCT00775944|Telephone|telephone
663394|NCT00775944|Quitline|quitline
663395|NCT00775944|Helpline|helpline
663396|NCT00775931|osteopetrosis|osteopetrosis
663397|NCT00775918|Bioequivalence Doxycycline monohydrate 100mg tablets fed conditions|bioequivalence doxycycline monohydrate 100mg tablets fed conditions
663398|NCT00775905|Bioequivalence amlodipine tablets fasting|bioequivalence amlodipine tablets fasting
663399|NCT00775892|ACL|acl
663400|NCT00775892|Ligament|ligament
663401|NCT00775879|Général anesthesia|général anesthesia
663402|NCT00775879|Gynecology|gynecology
663403|NCT00775866|prostate cancer, magnetic resonance imaging, guided imagery|prostate cancer, magnetic resonance imaging, guided imagery
663404|NCT00775853|Biomarkers|biomarkers
663405|NCT00775853|Catecholamines|catecholamines
663406|NCT00775853|18F-Fluoro-L-dopa|18f-fluoro-l-dopa
663407|NCT00775853|Fluorodopamine|fluorodopamine
663408|NCT00775853|Parkinson's Disease|parkinson's disease
663409|NCT00775853|Parkinson Disease|parkinson disease
663410|NCT00775853|PD|pd
663411|NCT00775840|Cardiac Failure|cardiac failure
663412|NCT00775840|Congestive Heart Failure|congestive heart failure
663413|NCT00775840|Drug Therapy|drug therapy
663414|NCT00775840|Hypertension|hypertension
663415|NCT00775840|Diabetes Mellitus|diabetes mellitus
663416|NCT00775827|bioequivalence fenofibrate tablets|bioequivalence fenofibrate tablets
663417|NCT00775814|Hypertension|hypertension
663418|NCT00775814|Drug Therapy|drug therapy
663419|NCT00775814|Blood Pressure|blood pressure
663420|NCT00775814|Insulin, Resistant|insulin, resistant
663421|NCT00775788|Fat Injection to Breast|fat injection to breast
663422|NCT00775788|Fat Grafting to Breast|fat grafting to breast
663423|NCT00775762|Symptomatic Polyvascular disease|symptomatic polyvascular disease
663424|NCT00775762|Multiple recurrent cardiovascular events|multiple recurrent cardiovascular events
663425|NCT00775749|post operative nausea and vomiting|post operative nausea and vomiting
663426|NCT00775749|gynecological surgery|gynecological surgery
663427|NCT00775749|outpatient surgery|outpatient surgery
663428|NCT00775749|nicotine patch|nicotine patch
663429|NCT00775749|laparoscopic surgery|laparoscopic surgery
663430|NCT00775723|6sulphatoxymelatonin|6sulphatoxymelatonin
663431|NCT00775723|preterm infants|preterm infants
663432|NCT00775723|melatonin is low in preterm infants at least until the age of 6 months|melatonin is low in preterm infants at least until the age of 6 months
663433|NCT00775697|wheezing|wheezing
663434|NCT00775697|children|children
663435|NCT00775697|montelukast|montelukast
663436|NCT00775697|bronchodilators|bronchodilators
663437|NCT00775697|lung function|lung function
663438|NCT00775697|Rint|rint
663439|NCT00775684|Exenatide|exenatide
663442|NCT00775684|Glucagon-Like Peptide-1|glucagon-like peptide-1
663443|NCT00775684|Impaired Fasting Glucose|impaired fasting glucose
663444|NCT00775684|Type 2 Diabetes|type 2 diabetes
663445|NCT00775684|Beta-cell Function|beta-cell function
663446|NCT00775684|Beta-cell Secretory Capacity|beta-cell secretory capacity
663447|NCT00775684|Glucose-potentiated arginine|glucose-potentiated arginine
663449|NCT00775658|skin testing|skin testing
663450|NCT00775658|eye drops|eye drops
663451|NCT00775658|antihistamines|antihistamines
663452|NCT00775645|neurotoxicity|neurotoxicity
663453|NCT00775645|chemotherapeutic agent toxicity|chemotherapeutic agent toxicity
663454|NCT00775645|fatigue|fatigue
663455|NCT00775645|neuropathy|neuropathy
663456|NCT00775645|stage IA breast cancer|stage ia breast cancer
663457|NCT00775645|stage IB breast cancer|stage ib breast cancer
663458|NCT00775645|stage II breast cancer|stage ii breast cancer
663459|NCT00775645|stage IIIA breast cancer|stage iiia breast cancer
663460|NCT00775645|stage IIIB breast cancer|stage iiib breast cancer
663461|NCT00775645|stage IIIC breast cancer|stage iiic breast cancer
663462|NCT00775632|Graft Versus Host Disease|graft versus host disease
663463|NCT00775632|Alemtuzumab|alemtuzumab
663464|NCT00775632|Campath|campath
663465|NCT00775632|Bone Marrow Transplants|bone marrow transplants
663466|NCT00775619|bioequivalence Carvedilol 12.5 mg tablets fed conditions|bioequivalence carvedilol 12.5 mg tablets fed conditions
663467|NCT00775606|AIDS, HIV|aids, hiv
663468|NCT00775593|recurrent adult acute myeloid leukemia|recurrent adult acute myeloid leukemia
663469|NCT00775593|adult acute basophilic leukemia|adult acute basophilic leukemia
663470|NCT00775593|adult acute eosinophilic leukemia|adult acute eosinophilic leukemia
663471|NCT00775593|adult erythroleukemia (M6a)|adult erythroleukemia (m6a)
663472|NCT00775593|adult pure erythroid leukemia (M6b)|adult pure erythroid leukemia (m6b)
663473|NCT00775593|adult acute megakaryoblastic leukemia (M7)|adult acute megakaryoblastic leukemia (m7)
663474|NCT00775593|adult acute minimally differentiated myeloid leukemia (M0)|adult acute minimally differentiated myeloid leukemia (m0)
663475|NCT00775593|adult acute monoblastic leukemia (M5a)|adult acute monoblastic leukemia (m5a)
663476|NCT00775593|adult acute monocytic leukemia (M5b)|adult acute monocytic leukemia (m5b)
663477|NCT00775593|adult acute myeloblastic leukemia with maturation (M2)|adult acute myeloblastic leukemia with maturation (m2)
663478|NCT00775593|adult acute myeloblastic leukemia without maturation (M1)|adult acute myeloblastic leukemia without maturation (m1)
663479|NCT00775593|adult acute myelomonocytic leukemia (M4)|adult acute myelomonocytic leukemia (m4)
663480|NCT00775593|adult acute myeloid leukemia with 11q23 (MLL) abnormalities|adult acute myeloid leukemia with 11q23 (mll) abnormalities
663481|NCT00775593|adult acute myeloid leukemia with t(16;16)(p13;q22)|adult acute myeloid leukemia with t(16;16)(p13;q22)
663482|NCT00775593|adult acute myeloid leukemia with t(8;21)(q22;q22)|adult acute myeloid leukemia with t(8;21)(q22;q22)
663483|NCT00775593|adult acute myeloid leukemia with inv(16)(p13;q22)|adult acute myeloid leukemia with inv(16)(p13;q22)
663484|NCT00775580|bioequivalence Atenolol Tablets|bioequivalence atenolol tablets
663485|NCT00775567|Fructose|fructose
663486|NCT00775567|Intolerance|intolerance
663487|NCT00775567|Adaptation|adaptation
663488|NCT00775567|Prebiotic|prebiotic
663489|NCT00775567|Healthy men or women 18-40|healthy men or women 18-40
663490|NCT00775541|Diabetes|diabetes
663491|NCT00775541|Type 2 Diabetes|type 2 diabetes
663492|NCT00775528|Cystic Fibrosis|cystic fibrosis
663493|NCT00775528|Pancreatic Exocrine Insufficiency|pancreatic exocrine insufficiency
663494|NCT00775515|chronic|chronic
663495|NCT00775515|prostatitis|prostatitis
663496|NCT00775515|prostate|prostate
663497|NCT00775515|pain|pain
663498|NCT00775515|pelvic|pelvic
663499|NCT00775515|pelvis|pelvis
663500|NCT00775515|inflamation|inflamation
663501|NCT00775502|Multiple myeloma|multiple myeloma
663502|NCT00775502|GM-2 ganglioside|gm-2 ganglioside
663503|NCT00775502|monoclonal antibody|monoclonal antibody
663504|NCT00775502|Potelligent design|potelligent design
663505|NCT00775502|Treatment of subjects who have failed previous treatment|treatment of subjects who have failed previous treatment
663506|NCT00775489|glaucoma, steroid, nasal|glaucoma, steroid, nasal
663507|NCT00775476|Systemic lupus erythematosus (SLE), an autoimmune disease|systemic lupus erythematosus (sle), an autoimmune disease
663508|NCT00775463|Scleroderma, Diffuse|scleroderma, diffuse
663509|NCT00775463|Scleroderma, Limited|scleroderma, limited
663510|NCT00775463|Scleroderma, Systemic|scleroderma, systemic
663511|NCT00775463|Ulcer|ulcer
663512|NCT00775463|prostacyclin|prostacyclin
663513|NCT00775450|Influenza|influenza
663514|NCT00775450|Orthomyxovirus Infection|orthomyxovirus infection
663515|NCT00775450|Inactivated Split-virion influenza vaccine|inactivated split-virion influenza vaccine
663516|NCT00775450|Elderly|elderly
663517|NCT00775437|juvenile idiopathic arthritis|juvenile idiopathic arthritis
663518|NCT00775437|compassionate use|compassionate use
663519|NCT00775437|open label|open label
663520|NCT00775424|HIV infection|hiv infection
663521|NCT00775424|DNA vaccine|dna vaccine
663522|NCT00775424|IL-12 adjuvant|il-12 adjuvant
663523|NCT00775424|IL-15 adjuvant|il-15 adjuvant
663524|NCT00775398|Hemostasis|hemostasis
663525|NCT00775398|Thrombin-JMI|thrombin-jmi
663526|NCT00775398|Thrombin|thrombin
663527|NCT00775398|Blood Coagulation|blood coagulation
663528|NCT00775385|Chemotherapy, Adjuvant|chemotherapy, adjuvant
663529|NCT00775372|Bioequivalence study of clarithromycin 250mg/5mL powdder|bioequivalence study of clarithromycin 250mg/5ml powdder
663530|NCT00775359|bioequivalence fenofibrate tablets|bioequivalence fenofibrate tablets
663531|NCT00775333|Carpal Tunnel Syndrome|carpal tunnel syndrome
663532|NCT00775333|Diabetes|diabetes
663533|NCT00775333|APB strength|apb strength
663534|NCT00775333|Sensory Function|sensory function
663535|NCT00775333|Pillar Pain|pillar pain
663536|NCT00775333|Cold Intolerance|cold intolerance
663537|NCT00775333|Patient Satisfaction|patient satisfaction
663538|NCT00775320|Brain scan|brain scan
663539|NCT00775307|Non-small cell lung cancer|non-small cell lung cancer
663540|NCT00775307|Stage I|stage i
663541|NCT00775307|adjuvant therapy|adjuvant therapy
663542|NCT00775307|Adjuvant Drug Therapy|adjuvant drug therapy
663543|NCT00775281|Tachykinin receptors|tachykinin receptors
663544|NCT00775281|Protein expression|protein expression
663545|NCT00775281|Contractile proteins|contractile proteins
663546|NCT00775281|Inflammatory proteins|inflammatory proteins
663547|NCT00775268|18F Fluorothymidine|18f fluorothymidine
663548|NCT00775268|PET/CT|pet/ct
663549|NCT00775268|FLT|flt
663550|NCT00775268|Lymphoma|lymphoma
663551|NCT00775268|FDG|fdg
663552|NCT00775255|Bioequiavelnce clarithromycin|bioequiavelnce clarithromycin
663553|NCT00775242|Menopause|menopause
663554|NCT00775242|Hormone Replacement Therapy|hormone replacement therapy
663555|NCT00775242|Microspheres|microspheres
663556|NCT00775242|Progesterone|progesterone
663557|NCT00775242|Estradiol|estradiol
663558|NCT00775242|Hot flashes|hot flashes
663559|NCT00775229|hair pulling|hair pulling
663560|NCT00775203|Unipolar|unipolar
663561|NCT00775190|birth control pills|birth control pills
663562|NCT00775190|oral contraceptives|oral contraceptives
663563|NCT00775190|brand name|brand name
663564|NCT00775190|generic|generic
663565|NCT00775190|side effects|side effects
663566|NCT00775190|oral contraceptive side effects|oral contraceptive side effects
663567|NCT00775190|dysfunctional uterine bleeding|dysfunctional uterine bleeding
663568|NCT00775190|pre-menstrual symptoms|pre-menstrual symptoms
663569|NCT00775177|Bioequivalence Doxycycline monohydrate 100mg tablets fed conditions|bioequivalence doxycycline monohydrate 100mg tablets fed conditions
663570|NCT00775164|Obese children with insulin resistance|obese children with insulin resistance
663571|NCT00775151|Bioequivalence amlodipine 10 mg tablet under fed conditions|bioequivalence amlodipine 10 mg tablet under fed conditions
663572|NCT00775138|Bronchiectasis|bronchiectasis
663573|NCT00775138|Respiratory Infections|respiratory infections
663574|NCT00775138|Amikacin|amikacin
663575|NCT00775138|Respiratory Tract Diseases|respiratory tract diseases
663576|NCT00775138|Respiratory Tract Infections|respiratory tract infections
663577|NCT00775138|Lung Diseases|lung diseases
663578|NCT00775138|Pseudomonas aeruginosa|pseudomonas aeruginosa
663579|NCT00775138|Amikacin liposome inhalation suspension (ALIS)|amikacin liposome inhalation suspension (alis)
663580|NCT00775125|VX-950-TiDP24-C124|vx-950-tidp24-c124
663581|NCT00775125|VX-950-C124|vx-950-c124
663582|NCT00775125|HCV|hcv
663583|NCT00775125|DDI|ddi
663584|NCT00775125|telaprevir|telaprevir
663585|NCT00775125|darunavir|darunavir
663586|NCT00775125|ritonavir|ritonavir
663587|NCT00775125|fosamprenavir|fosamprenavir
663588|NCT00775125|interaction|interaction
663589|NCT00775125|pharmacokinetics|pharmacokinetics
663590|NCT00775125|steady-state|steady-state
663591|NCT00775112|supportive care|supportive care
663592|NCT00775112|lumbar puncture|lumbar puncture
663593|NCT00775112|childhood disease|childhood disease
663594|NCT00775112|pediatric hemato-oncology|pediatric hemato-oncology
663595|NCT00775099|Air Pollution|air pollution
663596|NCT00775099|Particles|particles
663597|NCT00775099|Particulate Matter|particulate matter
663598|NCT00775099|Vascular function|vascular function
663599|NCT00775099|Endothelial function|endothelial function
663600|NCT00775099|Thrombosis|thrombosis
663601|NCT00775086|ORTHO EVRA|ortho evra
663602|NCT00775086|contraception|contraception
663603|NCT00775086|NGMN|ngmn
663604|NCT00775086|contraceptive patch|contraceptive patch
663605|NCT00775086|bioequivalence|bioequivalence
663606|NCT00775086|EE|ee
663607|NCT00775086|norelgestromin|norelgestromin
663608|NCT00775086|ethinyl estradiol|ethinyl estradiol
663609|NCT00775073|Liver cancer|liver cancer
663610|NCT00775073|HCC|hcc
663611|NCT00775047|depo medroxyprogesterone acetate|depo medroxyprogesterone acetate
663612|NCT00775047|Depo Provera|depo provera
663613|NCT00775047|contraceptive compliance|contraceptive compliance
663614|NCT00775047|pharmacists|pharmacists
663615|NCT00775047|Compliance in receiving additional Depo Provera injections|compliance in receiving additional depo provera injections
663616|NCT00775047|Satisfaction in receiving Depo Provera injections at a pharmacy compared with usual clinic|satisfaction in receiving depo provera injections at a pharmacy compared with usual clinic
663617|NCT00775008|weight loss, health information, e-health|weight loss, health information, e-health
663618|NCT00774995|Engerix-B|engerix-b
663619|NCT00774995|Hepatitis B|hepatitis b
663620|NCT00774982|Crohns Disease|crohns disease
663621|NCT00774982|Pharmacokinetics|pharmacokinetics
665403|NCT00768248|catheter|catheter
663622|NCT00774982|Local Targeted Delivery to the Ileum|local targeted delivery to the ileum
663623|NCT00774982|Delayed Release|delayed release
663624|NCT00774982|Immunology Measurements|immunology measurements
663625|NCT00774982|Pharmacokinetics in Crohns Disease Patients|pharmacokinetics in crohns disease patients
663626|NCT00774943|Systemic lupus erythematosus|systemic lupus erythematosus
663627|NCT00774943|ICOSL|icosl
663628|NCT00774943|B7RP-1|b7rp-1
663629|NCT00774943|Costimulation|costimulation
663630|NCT00774930|Carcinoid tumor|carcinoid tumor
663631|NCT00774930|Somatuline Depot|somatuline depot
663632|NCT00774930|Lanreotide Autogel|lanreotide autogel
663633|NCT00774930|Neuroendocrine tumor|neuroendocrine tumor
663634|NCT00774930|NET|net
663635|NCT00774930|Diarrhea|diarrhea
663636|NCT00774930|Flushing|flushing
663637|NCT00774930|Carcinoid tumour|carcinoid tumour
663638|NCT00774930|Neuroendocrine tumour|neuroendocrine tumour
663639|NCT00774930|Diarrhoea|diarrhoea
663640|NCT00774917|numen|numen
663641|NCT00774917|hyperplasia|hyperplasia
663642|NCT00774904|Type 2 Diabetes|type 2 diabetes
663643|NCT00774904|Diabetic Nephropathy|diabetic nephropathy
663644|NCT00774904|Glucose Metabolism|glucose metabolism
663645|NCT00774904|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers
663646|NCT00774891|Echocardiography- exercise|echocardiography- exercise
663647|NCT00774891|Echocardiography- dobutamine|echocardiography- dobutamine
663648|NCT00774891|Wall stress|wall stress
663649|NCT00774891|Ventricular volume-left|ventricular volume-left
663650|NCT00774891|Ischemia|ischemia
663651|NCT00774891|Angina|angina
663652|NCT00774891|Heart diseases|heart diseases
663653|NCT00774891|Stress echocardiography|stress echocardiography
663654|NCT00774891|Ventricular volume|ventricular volume
663655|NCT00774891|Vascular diseases|vascular diseases
663656|NCT00774878|Breast cancer|breast cancer
663657|NCT00774878|Breast Tumors|breast tumors
663658|NCT00774878|Anti IGF-1R|anti igf-1r
663659|NCT00774878|Hormonosensitivity|hormonosensitivity
663660|NCT00774865|Robotic|robotic
663661|NCT00774865|CABG|cabg
663662|NCT00774865|LITA|lita
663663|NCT00774865|Patency|patency
663664|NCT00774865|Long|long
663665|NCT00774865|Term|term
663666|NCT00774852|lupus|lupus
663667|NCT00774852|systemic lupus erythematosus|systemic lupus erythematosus
663668|NCT00774852|lupus nephritis|lupus nephritis
663669|NCT00774852|SLE|sle
663670|NCT00774852|abatacept|abatacept
663671|NCT00774852|CTLA4|ctla4
663672|NCT00774852|CTLA4Ig|ctla4ig
663673|NCT00774852|glomerulonephritis|glomerulonephritis
663674|NCT00774839|Newly Diagnosed|newly diagnosed
663675|NCT00774839|Colon|colon
663676|NCT00774839|Stage II|stage ii
663677|NCT00774839|Stage III|stage iii
663678|NCT00774826|Follicular lymphoma|follicular lymphoma
663679|NCT00774826|Rituximab|rituximab
663680|NCT00774813|Depression|depression
663681|NCT00774813|Mild|mild
663682|NCT00774813|Moderate|moderate
663683|NCT00774813|Anxiety|anxiety
663684|NCT00774813|Kalaco Scientific, Inc.|kalaco scientific, inc.
663685|NCT00774800|Recombinant Hyaluronidase|recombinant hyaluronidase
663686|NCT00774800|Type 1 Diabetes Mellitus|type 1 diabetes mellitus
663687|NCT00774800|Humalog|humalog
663688|NCT00774800|Humulin R|humulin r
663689|NCT00774800|rHuPH20|rhuph20
663690|NCT00774800|Hylenex|hylenex
663691|NCT00774787|Combination treatment|combination treatment
663692|NCT00774787|Imiquimod|imiquimod
663693|NCT00774787|Cryotherapy|cryotherapy
663694|NCT00774774|Influenza, human|influenza, human
663695|NCT00774774|Masks|masks
663696|NCT00774774|Disease Transmission, Horizontal|disease transmission, horizontal
663697|NCT00774761|Chronic|chronic
663698|NCT00774761|Obstructive|obstructive
663699|NCT00774761|Pulmonary|pulmonary
663700|NCT00774761|Disease|disease
663701|NCT00774761|COPD|copd
663702|NCT00774761|Pharmacodynamic|pharmacodynamic
663703|NCT00774761|Pharmacokinetic|pharmacokinetic
663704|NCT00774748|low molecular weight heparin|low molecular weight heparin
663705|NCT00774748|enoxaparin|enoxaparin
663706|NCT00774748|Lovenox|lovenox
663707|NCT00774748|Insuflon|insuflon
663708|NCT00774748|subcutaneous catheter|subcutaneous catheter
663709|NCT00774748|once or twice daily dosing of subcutaneous enoxaparin|once or twice daily dosing of subcutaneous enoxaparin
663710|NCT00774735|healthy volunteer|healthy volunteer
663711|NCT00774735|darunavir|darunavir
663712|NCT00774735|lopinavir|lopinavir
663713|NCT00774735|ritonavir|ritonavir
663714|NCT00774735|GSK1349572|gsk1349572
663715|NCT00774735|integrase|integrase
663716|NCT00774735|pharmacokinetics|pharmacokinetics
663717|NCT00774709|Heart failure|heart failure
663718|NCT00774709|Preserved ejection fraction|preserved ejection fraction
663719|NCT00774709|Diastolic dysfunction|diastolic dysfunction
663720|NCT00774709|Dyssynchrony|dyssynchrony
663721|NCT00774709|Echocardiography|echocardiography
663722|NCT00774709|Patients with acute heart failure clinically|patients with acute heart failure clinically
663723|NCT00774709|diagnosed|diagnosed
663724|NCT00774709|BNP level > 100 ng / l or NT-proBNP > 300 ng /l|bnp level > 100 ng / l or nt-probnp > 300 ng /l
665404|NCT00768248|nerve block|nerve block
663725|NCT00774709|Preserved left ventricular ejection fraction(LVEF|preserved left ventricular ejection fraction(lvef
663726|NCT00774709|≥ 45%)|≥ 45%)
663727|NCT00774696|Bioequivalence study of clarithromycin|bioequivalence study of clarithromycin
663728|NCT00774683|Pilot|pilot
663729|NCT00774683|Pharmacokinetics|pharmacokinetics
663730|NCT00774683|Raltegravir|raltegravir
663731|NCT00774683|Cervicovaginal|cervicovaginal
663732|NCT00774683|HIV|hiv
663733|NCT00774683|Women|women
663734|NCT00774657|Aortic Stenosis|aortic stenosis
663735|NCT00774657|Valvular heart disease|valvular heart disease
663736|NCT00774657|Heart disease|heart disease
663737|NCT00774657|Cardiovascular disease|cardiovascular disease
663738|NCT00774657|Two dimensional echocardiography|two dimensional echocardiography
663739|NCT00774657|Three dimensional echocardiography|three dimensional echocardiography
663740|NCT00774631|Meningitis|meningitis
663741|NCT00774631|Hypothermia|hypothermia
663742|NCT00774631|Intensive care|intensive care
663743|NCT00774618|Rib Fracture|rib fracture
663744|NCT00774618|Thoracic Injuries|thoracic injuries
663745|NCT00774618|Flail Chest|flail chest
663746|NCT00774618|Rib Fracture Repair|rib fracture repair
663747|NCT00774618|Rib Fracture ORIF|rib fracture orif
663748|NCT00774618|Chronic rib fractures|chronic rib fractures
663749|NCT00774618|Non-healing rib fractures|non-healing rib fractures
663750|NCT00774618|Rib Fracture Non-union|rib fracture non-union
663751|NCT00774605|percutaneous, transcutaneous, topical, varenicline, transdermal, transdermal delivery system, patch|percutaneous, transcutaneous, topical, varenicline, transdermal, transdermal delivery system, patch
663752|NCT00774592|Adolescent Risk Reduction|adolescent risk reduction
663753|NCT00774592|HIV/AIDS Prevention|hiv/aids prevention
663754|NCT00774592|Behavioral Change|behavioral change
663755|NCT00774592|HIV|hiv
663756|NCT00774579|growth hormone|growth hormone
663757|NCT00774579|growth hormone deficiency|growth hormone deficiency
663758|NCT00774579|liver fat|liver fat
663759|NCT00774579|liver steatosis|liver steatosis
663760|NCT00774579|growth hormone replacement|growth hormone replacement
663761|NCT00774566|catheter ablation|catheter ablation
663762|NCT00774566|randomized|randomized
663763|NCT00774566|cryo|cryo
663764|NCT00774566|radiofrequency|radiofrequency
663765|NCT00774566|atrial fibrillation|atrial fibrillation
663766|NCT00774566|cryo-balloon|cryo-balloon
663767|NCT00774566|PV-Isolation|pv-isolation
663768|NCT00774553|Type 2 diabetes|type 2 diabetes
663769|NCT00774540|Acute pain|acute pain
663770|NCT00774540|Inflammatory pain|inflammatory pain
663771|NCT00774540|Inflammatory mediators|inflammatory mediators
663772|NCT00774540|Pain relief|pain relief
663773|NCT00774540|Microdialysis|microdialysis
663774|NCT00774514|Air Pollution|air pollution
663775|NCT00774514|Nitrogen Dioxide|nitrogen dioxide
663776|NCT00774514|NO2|no2
663777|NCT00774514|Endothelial dysfunction|endothelial dysfunction
663778|NCT00774501|Anesthesia|anesthesia
663779|NCT00774501|suspended ventilation|suspended ventilation
663780|NCT00774488|Euglycemic-hyperinsulinemic clamp|euglycemic-hyperinsulinemic clamp
663781|NCT00774488|fat biopsies|fat biopsies
663782|NCT00774488|microarray analysis|microarray analysis
663783|NCT00774488|quantitative real time PCR|quantitative real time pcr
663784|NCT00774488|overnutrition|overnutrition
663785|NCT00774488|low grade-inflammation|low grade-inflammation
663786|NCT00774475|Clopidogrel therapy|clopidogrel therapy
663787|NCT00774475|platelet function inhibition|platelet function inhibition
663788|NCT00774462|Myositis|myositis
663789|NCT00774462|Anti-synthetase|anti-synthetase
663790|NCT00774462|Anti-SRP|anti-srp
663791|NCT00774462|Myasthenia gravis|myasthenia gravis
663792|NCT00774462|Rituximab|rituximab
663793|NCT00774449|lung transplantation|lung transplantation
663794|NCT00774449|bronchiolitis obliterans syndrome|bronchiolitis obliterans syndrome
663795|NCT00774449|broncholaveolar lavage|broncholaveolar lavage
663796|NCT00774449|high-resolution computertomography|high-resolution computertomography
663797|NCT00774449|quality of life|quality of life
663798|NCT00774436|focal cryotherapy|focal cryotherapy
663799|NCT00774436|low-risk prostate cancer|low-risk prostate cancer
663800|NCT00774423|Spinal muscular atrophies (SMA)|spinal muscular atrophies (sma)
663801|NCT00774423|Degeneration of the motor neurons|degeneration of the motor neurons
663802|NCT00774423|Anterior horn of the spinal cord|anterior horn of the spinal cord
663803|NCT00774423|Riluzole|riluzole
663804|NCT00774384|Neisseria meningitidis|neisseria meningitidis
663805|NCT00774384|Mucosal|mucosal
663806|NCT00774384|Vaccination|vaccination
663807|NCT00774384|Immunity|immunity
663808|NCT00774384|T cells|t cells
663809|NCT00774384|T regulatory cells|t regulatory cells
663810|NCT00774371|Overweight|overweight
663811|NCT00774371|Obese|obese
663812|NCT00774371|Breast cancer survivors|breast cancer survivors
663813|NCT00774371|Weight loss|weight loss
663814|NCT00774371|Physical activity|physical activity
663815|NCT00774371|Exercise|exercise
663816|NCT00774371|Cognitive behavioral therapy|cognitive behavioral therapy
663817|NCT00774358|Primary Immunodeficiency|primary immunodeficiency
663818|NCT00774319|HNSCC|hnscc
663819|NCT00774319|neo Adjuvant|neo adjuvant
663820|NCT00774319|Chemoradiation therapy|chemoradiation therapy
663822|NCT00774306|vascular risk|vascular risk
663823|NCT00774306|lipid fractions|lipid fractions
663824|NCT00774306|lipoprotein(a)|lipoprotein(a)
663825|NCT00774306|C-reactive protein|c-reactive protein
663826|NCT00774306|subarachnoid hemorrhage|subarachnoid hemorrhage
663827|NCT00774306|antiepileptic drug|antiepileptic drug
663828|NCT00774306|randomized|randomized
663829|NCT00774306|seizure|seizure
663830|NCT00774306|cholesterol|cholesterol
663831|NCT00774293|Homoeopathic treatment,|homoeopathic treatment,
663832|NCT00774293|heart surgery,|heart surgery,
663833|NCT00774293|randomized clinical trial|randomized clinical trial
663834|NCT00774254|Virtual Reality Technology|virtual reality technology
663835|NCT00774254|Communication|communication
663836|NCT00774254|Doctor-Patient Communication|doctor-patient communication
663837|NCT00774228|Cataract or intraocular lens placement surgery|cataract or intraocular lens placement surgery
663838|NCT00774215|Pelvic Organ Prolapse|pelvic organ prolapse
663839|NCT00774215|Cystocele|cystocele
663840|NCT00774215|Rectocele|rectocele
663841|NCT00774215|Enterocele|enterocele
663842|NCT00774215|Synthetic Mesh|synthetic mesh
663843|NCT00774215|Vaginal Mesh|vaginal mesh
663844|NCT00774215|Transobturator|transobturator
663845|NCT00774202|Pts w/ Chronic ITP who have fail/relap after Rituxan rx|pts w/ chronic itp who have fail/relap after rituxan rx
663846|NCT00774189|Bioequivalence clarithromycin 250mg tablets fasting|bioequivalence clarithromycin 250mg tablets fasting
663847|NCT00774176|Chronic Obstructive Pulmonary Disease|chronic obstructive pulmonary disease
663848|NCT00774176|COPD|copd
663849|NCT00774176|COPD Exacerbation|copd exacerbation
663850|NCT00774176|Genetic markers COPD|genetic markers copd
663851|NCT00774176|Gene expression in COPD exacerbations|gene expression in copd exacerbations
663852|NCT00774176|COPD Exacerbation Symptom Reporting|copd exacerbation symptom reporting
663853|NCT00774176|COPD Exacerbation Disease Management|copd exacerbation disease management
663854|NCT00774176|COPD Treatment|copd treatment
663855|NCT00774176|Breathing disorders|breathing disorders
663856|NCT00774176|Emphysema|emphysema
663857|NCT00774176|COPD with Healthy Control comparators for genetic association studies.|copd with healthy control comparators for genetic association studies.
663858|NCT00774163|probiotics|probiotics
663859|NCT00774163|lactobacillus|lactobacillus
663860|NCT00774163|reuteri|reuteri
663861|NCT00774163|none (safety only)|none (safety only)
663862|NCT00774150|Neural correlates of pediatric anxiety disorder|neural correlates of pediatric anxiety disorder
663863|NCT00774150|Social correlates of pediatric anxiety disorder|social correlates of pediatric anxiety disorder
663864|NCT00774150|Generalized Anxiety Disorder in pediatric populations|generalized anxiety disorder in pediatric populations
663865|NCT00774150|Separation Anxiety Disorder in pediatric populations|separation anxiety disorder in pediatric populations
663866|NCT00774150|Social Phobia in pediatric populations|social phobia in pediatric populations
663867|NCT00774137|Acute Kidney Injury|acute kidney injury
663868|NCT00774137|IL-18|il-18
663869|NCT00774137|NGAL|ngal
663870|NCT00774137|Cystatin C|cystatin c
663871|NCT00774137|Biomarkers|biomarkers
663872|NCT00774137|Dialysis|dialysis
663873|NCT00774124|GDM, pregnancy, macrosomia|gdm, pregnancy, macrosomia
663874|NCT00774111|healthy volunteer|healthy volunteer
663875|NCT00774111|pharmacokinetics|pharmacokinetics
663876|NCT00774111|GSK1349572|gsk1349572
663877|NCT00774111|integrase|integrase
663878|NCT00774111|etravirine|etravirine
663879|NCT00774098|all adult patients (>18 years) planned to undergo a major liver resection|all adult patients (>18 years) planned to undergo a major liver resection
663880|NCT00774085|Schizophrenia|schizophrenia
663881|NCT00774085|Risperidone|risperidone
663882|NCT00774085|Risperdal Consta|risperdal consta
663883|NCT00774085|Propective|propective
663884|NCT00774085|Retrospective|retrospective
663885|NCT00774085|Mental disorders|mental disorders
663886|NCT00774085|Observational|observational
663887|NCT00774072|subjects with cystic fibrosis and pseudomonas aeruginosa colonization in the upper airways|subjects with cystic fibrosis and pseudomonas aeruginosa colonization in the upper airways
663888|NCT00774059|Breast ptosis, Breast lift|breast ptosis, breast lift
663889|NCT00774046|Therapy-related myelodysplastic syndrome/ Therapy -related Acute myeloid leukemia|therapy-related myelodysplastic syndrome/ therapy -related acute myeloid leukemia
663890|NCT00774046|Myelodysplastic syndrome|myelodysplastic syndrome
663891|NCT00774046|Acute myeloid leukemia|acute myeloid leukemia
663892|NCT00774033|Keratinocytes|keratinocytes
663893|NCT00774033|Cell spray|cell spray
663894|NCT00774033|Deep partial thickness burns|deep partial thickness burns
663895|NCT00774033|Full thickness burns|full thickness burns
663896|NCT00774020|Paget's Disease of Bone|paget's disease of bone
663897|NCT00774020|Serum Alkaline Phosphatase|serum alkaline phosphatase
663898|NCT00774007|Irritable bowel syndrome, abdominal pain, abdominal bloating, immune cells, mast cells|irritable bowel syndrome, abdominal pain, abdominal bloating, immune cells, mast cells
663899|NCT00773994|anterior palatal eminence|anterior palatal eminence
663900|NCT00773994|palatal elevation above the maxillary plane|palatal elevation above the maxillary plane
663901|NCT00773994|anterior uvular prolapse|anterior uvular prolapse
663902|NCT00773994|"inverted-V present in base view."|"inverted-v present in base view."
663903|NCT00773981|anastomotic leakage|anastomotic leakage
663904|NCT00773942|Medication therapy management|medication therapy management
663905|NCT00773942|Pharmacist|pharmacist
663906|NCT00773942|Chronic care|chronic care
663907|NCT00773942|Medicare|medicare
663908|NCT00773942|Medicaid|medicaid
663909|NCT00773942|Medication reconciliation|medication reconciliation
663910|NCT00773942|Adverse drug events|adverse drug events
663911|NCT00773942|Drug related problems|drug related problems
663912|NCT00773916|Attention Deficit Disorder|attention deficit disorder
663913|NCT00773916|Attention Deficit Disorders with Hyperactivity|attention deficit disorders with hyperactivity
663914|NCT00773916|Hyperkinetic Syndrome|hyperkinetic syndrome
663915|NCT00773916|Family Function|family function
663916|NCT00773916|Adverse Factors|adverse factors
663917|NCT00773916|Parental Psychopathology|parental psychopathology
663918|NCT00773877|RNFL thickness|rnfl thickness
663919|NCT00773864|Healthcare employees who work in the rehabilitation center|healthcare employees who work in the rehabilitation center
663920|NCT00773851|ventral hernia|ventral hernia
663921|NCT00773851|laparoscopy|laparoscopy
663922|NCT00773851|mesh|mesh
663923|NCT00773851|recurrence|recurrence
663924|NCT00773825|Genomic imprinting|genomic imprinting
663925|NCT00773825|Reproductive techniques, assisted|reproductive techniques, assisted
663926|NCT00773825|Beckwith-Wiedemann syndrome|beckwith-wiedemann syndrome
663927|NCT00773825|Angelman syndrome|angelman syndrome
663928|NCT00773812|Autistic Disorder|autistic disorder
663929|NCT00773812|Autism|autism
663930|NCT00773812|Mecamylamine|mecamylamine
663931|NCT00773812|Pervasive Developmental Disorder-Not Otherwise Specified|pervasive developmental disorder-not otherwise specified
663932|NCT00773799|To define activities and patient characteristics likely to lead to dissemination of resistant bacteria in rehabilitation centers and|to define activities and patient characteristics likely to lead to dissemination of resistant bacteria in rehabilitation centers and
663933|NCT00773799|To define specific risk factors for acquisition of resistant bacteria (ESBL producers and MRSA) in rehabilitation centers.|to define specific risk factors for acquisition of resistant bacteria (esbl producers and mrsa) in rehabilitation centers.
663934|NCT00773799|ESBL producers|esbl producers
663935|NCT00773799|MRSA|mrsa
663936|NCT00773786|COPD|copd
663937|NCT00773786|Bronchodilator|bronchodilator
663938|NCT00773786|arformoterol|arformoterol
663939|NCT00773786|tiotropium|tiotropium
663940|NCT00773773|Biomarkers - PSA, hK2 and solubilized|biomarkers - psa, hk2 and solubilized
663941|NCT00773773|urokinase-receptor forms (su-PAR)|urokinase-receptor forms (su-par)
663942|NCT00773773|08-114|08-114
663943|NCT00773760|opioids|opioids
663944|NCT00773760|COMT|comt
663945|NCT00773760|SNP|snp
663946|NCT00773760|analgesia|analgesia
663947|NCT00773760|postoperative pain|postoperative pain
663948|NCT00773747|Neoplasms, Plasma Cell|neoplasms, plasma cell
663949|NCT00773747|Neoplasms by Histologic Type|neoplasms by histologic type
663950|NCT00773747|Neoplasms|neoplasms
663951|NCT00773747|Hemostatic Disorders|hemostatic disorders
663952|NCT00773747|Vascular Diseases|vascular diseases
663953|NCT00773747|Cardiovascular Diseases|cardiovascular diseases
663954|NCT00773747|Paraproteinemias|paraproteinemias
663955|NCT00773747|Blood Protein Disorders|blood protein disorders
663956|NCT00773747|Hematologic Diseases|hematologic diseases
663957|NCT00773747|Hemorrhagic Disorders|hemorrhagic disorders
663958|NCT00773747|Lymphoproliferative Disorders|lymphoproliferative disorders
663959|NCT00773747|Immunoproliferative Disorders|immunoproliferative disorders
663960|NCT00773747|Immune System Diseases|immune system diseases
663961|NCT00773747|Vorinostat|vorinostat
663962|NCT00773747|Bortezomib|bortezomib
663963|NCT00773747|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal
663964|NCT00773747|Analgesics, Non-Narcotic|analgesics, non-narcotic
663965|NCT00773747|Analgesics|analgesics
663966|NCT00773747|Sensory System Agents|sensory system agents
663967|NCT00773747|Peripheral Nervous System Agents|peripheral nervous system agents
663968|NCT00773747|Physiological Effects of Drugs|physiological effects of drugs
663969|NCT00773747|Pharmacologic Actions|pharmacologic actions
663970|NCT00773747|Anti-Inflammatory Agents|anti-inflammatory agents
663971|NCT00773747|Therapeutic Uses|therapeutic uses
663972|NCT00773747|Antirheumatic Agents|antirheumatic agents
663973|NCT00773747|Antineoplastic Agents|antineoplastic agents
663974|NCT00773747|Enzyme Inhibitors|enzyme inhibitors
663975|NCT00773747|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action
663976|NCT00773747|Anticarcinogenic Agents|anticarcinogenic agents
663977|NCT00773734|moderate-to-severe plaque-type psoriasis|moderate-to-severe plaque-type psoriasis
663978|NCT00773708|HIV infection|hiv infection
663979|NCT00773708|Discordant patient|discordant patient
663980|NCT00773708|CD4 recovery|cd4 recovery
663981|NCT00773708|intensification antiretroviral therapy|intensification antiretroviral therapy
663982|NCT00773708|raltegravir|raltegravir
663983|NCT00773708|"HIV-1 infected patient classified as discordant who showed high level of CD8+HLADR+CD38+ and cell death values at the screening"|"hiv-1 infected patient classified as discordant who showed high level of cd8+hladr+cd38+ and cell death values at the screening"
663984|NCT00773682|osteoarthritis|osteoarthritis
663985|NCT00773682|hands|hands
663986|NCT00773682|mud-packs therapy|mud-packs therapy
663987|NCT00773682|balneotherapy|balneotherapy
663988|NCT00773682|Osteoarthritis of the hands|osteoarthritis of the hands
663989|NCT00773669|male breast cancer|male breast cancer
665596|NCT00767117|HIV|hiv
663990|NCT00773669|Male breast cancer patients diagnosed and/or|male breast cancer patients diagnosed and/or
663991|NCT00773669|treated at Summa Health System/Akron City Hospital|treated at summa health system/akron city hospital
663992|NCT00773669|from the reference year of 1995 through 2007.|from the reference year of 1995 through 2007.
663993|NCT00773656|Radiotherapy|radiotherapy
663994|NCT00773656|Biologically effective dose|biologically effective dose
663995|NCT00773656|Radiation injury|radiation injury
663996|NCT00773643|to procure human temporalis muscle, subcutaneous adipose (fat), and bone tissue samples from children with craniosynostosis,|to procure human temporalis muscle, subcutaneous adipose (fat), and bone tissue samples from children with craniosynostosis,
663997|NCT00773643|to grow cells from these tissues in vitro|to grow cells from these tissues in vitro
663998|NCT00773643|to evaluate the osteogenic potentials of these cell types.|to evaluate the osteogenic potentials of these cell types.
663999|NCT00773617|Bulimia Nervosa|bulimia nervosa
664000|NCT00773617|Treatment Efficacy|treatment efficacy
664001|NCT00773617|Integrative Cognitive Affective Therapy|integrative cognitive affective therapy
664002|NCT00773617|Cognitive Behavior Therapy|cognitive behavior therapy
664003|NCT00773604|blepharospasm|blepharospasm
664004|NCT00773604|Deep brain Stimulation|deep brain stimulation
664005|NCT00773604|cervical dystonia|cervical dystonia
664006|NCT00773604|cranial dystonia|cranial dystonia
664007|NCT00773604|generalized dystonia|generalized dystonia
664008|NCT00773604|subthalamic nucleus|subthalamic nucleus
664009|NCT00773604|DBS|dbs
664010|NCT00773591|Sleep-related breathing disorders|sleep-related breathing disorders
664011|NCT00773591|Snoring|snoring
664012|NCT00773578|Children|children
664013|NCT00773578|Tobacco smoke exposure|tobacco smoke exposure
664014|NCT00773578|Exhaled nitric oxide|exhaled nitric oxide
664015|NCT00773578|Nasal lavage|nasal lavage
664016|NCT00773578|Cytokines|cytokines
664017|NCT00773565|patients with obesity (BMI > 30 kg/m2)|patients with obesity (bmi > 30 kg/m2)
664019|NCT00773552|overactive bladder|overactive bladder
664020|NCT00773552|urinary urge|urinary urge
664021|NCT00773552|urge incontinence|urge incontinence
664022|NCT00773552|urge|urge
664023|NCT00773539|atrial fibrillation|atrial fibrillation
664024|NCT00773539|pulmonary veins|pulmonary veins
664025|NCT00773539|ablation|ablation
664026|NCT00773500|Medication Errors|medication errors
664027|NCT00773487|Asthma GINA 1|asthma gina 1
664028|NCT00773487|Mild intermittant asthma|mild intermittant asthma
664029|NCT00773448|Cancer|cancer
664030|NCT00773448|Screening|screening
664031|NCT00773435|Upper respiratory tract infections|upper respiratory tract infections
664032|NCT00773435|Children|children
664033|NCT00773435|Echinacea|echinacea
664034|NCT00773435|Prevention|prevention
664035|NCT00773435|Immune modulation|immune modulation
664036|NCT00773422|smoking lapse behavior|smoking lapse behavior
664037|NCT00773422|smoking cessation|smoking cessation
664038|NCT00773422|varenicline|varenicline
664039|NCT00773422|naltrexone|naltrexone
664040|NCT00773422|medication effect on smoking lapse behavior|medication effect on smoking lapse behavior
664041|NCT00773370|stroke|stroke
664042|NCT00773370|exercise|exercise
664043|NCT00773357|smoking lapse behavior|smoking lapse behavior
664044|NCT00773357|smoking cessation|smoking cessation
664045|NCT00773357|guanfacine|guanfacine
664046|NCT00773357|carvedilol|carvedilol
664047|NCT00773357|medication effect on smoking lapse behavior|medication effect on smoking lapse behavior
664048|NCT00773357|medication effect on smoking cessation|medication effect on smoking cessation
664049|NCT00773357|stress|stress
664050|NCT00773357|gender differences|gender differences
664051|NCT00773344|Solid Tumors (dose escalation/Phase 1)|solid tumors (dose escalation/phase 1)
664052|NCT00773344|Breast Cancer (recommended dose phase/Phase 2)|breast cancer (recommended dose phase/phase 2)
664053|NCT00773318|LM/SL|lm/sl
664054|NCT00773318|SPECT/low-dose multislice CT|spect/low-dose multislice ct
664055|NCT00773305|seed implantation|seed implantation
664056|NCT00773292|HAM/TSP|ham/tsp
664057|NCT00773266|Aphakia|aphakia
664058|NCT00773266|Secondary IOL-Implantation|secondary iol-implantation
664059|NCT00773266|Iris-Fixated IOL|iris-fixated iol
664060|NCT00773266|Artisan|artisan
664061|NCT00773266|Anterior Segment OCT|anterior segment oct
664062|NCT00773266|Aphakia - secondary iris-fixated IOL position|aphakia - secondary iris-fixated iol position
664063|NCT00773253|dystonia|dystonia
664064|NCT00773253|cervical dystonia|cervical dystonia
664065|NCT00773253|Botox|botox
664066|NCT00773253|idiopathic primary cervical dystonia|idiopathic primary cervical dystonia
664067|NCT00773227|Oculopharyngeal muscular dystrophy|oculopharyngeal muscular dystrophy
664068|NCT00773227|Swallowing disorders, dysphagia|swallowing disorders, dysphagia
664069|NCT00773227|Pharyngeal propulsion|pharyngeal propulsion
664070|NCT00773227|Upper oesophageal sphincter|upper oesophageal sphincter
664071|NCT00773227|Cricopharyngeal muscle|cricopharyngeal muscle
664072|NCT00773227|Autologous myoblasts|autologous myoblasts
664073|NCT00773227|Autograft|autograft
664074|NCT00773227|Myotomy of the upper oesophageal sphincter|myotomy of the upper oesophageal sphincter
664075|NCT00773227|Fibroscopy of swallowing|fibroscopy of swallowing
664076|NCT00773227|Videofluoroscopy of swallowing|videofluoroscopy of swallowing
664077|NCT00773214|Obesity|obesity
664078|NCT00773214|Appetite|appetite
664079|NCT00773214|Body composition|body composition
664080|NCT00773214|Energy compensation|energy compensation
664081|NCT00773201|Long QT syndrome|long qt syndrome
664082|NCT00773201|Cardiac repolarisation|cardiac repolarisation
664083|NCT00773201|Genome-wide association|genome-wide association
664084|NCT00773201|Electrophysiology|electrophysiology
664085|NCT00773201|Drugs/adverse effects|drugs/adverse effects
664086|NCT00773175|pediatric|pediatric
664087|NCT00773175|hylenex|hylenex
664088|NCT00773175|subcutaneous infusion|subcutaneous infusion
664089|NCT00773175|hyaluronidase|hyaluronidase
664090|NCT00773175|rHuPH20|rhuph20
664091|NCT00773175|recombinant human hyaluronidase|recombinant human hyaluronidase
664092|NCT00773149|Adult Acute Lymphocytic Leukemia|adult acute lymphocytic leukemia
664093|NCT00773149|Alemtuzumab|alemtuzumab
664094|NCT00773136|Bimatoprost|bimatoprost
664095|NCT00773136|Eyelash lengthening|eyelash lengthening
664096|NCT00773136|Prostaglandin Analogs|prostaglandin analogs
664097|NCT00773136|Cosmetics|cosmetics
664098|NCT00773123|RT-View|rt-view
664099|NCT00773123|Spectral domain OCT|spectral domain oct
664100|NCT00773123|Ganglion cell layer|ganglion cell layer
664101|NCT00773123|RNFL|rnfl
664102|NCT00773123|Visual field defect|visual field defect
664103|NCT00773110|hemolysis|hemolysis
664104|NCT00773110|systemic inflammatory response syndrome|systemic inflammatory response syndrome
664105|NCT00773110|cardiopulmonary bypass|cardiopulmonary bypass
664106|NCT00773110|albumin|albumin
664107|NCT00773097|Prevention|prevention
664108|NCT00773097|Colorectal Cancer|colorectal cancer
664109|NCT00773084|Diastolic Heart Failure|diastolic heart failure
664110|NCT00773084|Hispanic Americans|hispanic americans
664111|NCT00773084|Aliskiren|aliskiren
664112|NCT00773084|Spironolactone|spironolactone
664113|NCT00773084|Lisinopril|lisinopril
664114|NCT00773084|Diastolic Heart Failure in Hispanic Americans|diastolic heart failure in hispanic americans
664115|NCT00773071|Cervical cancer, vulvar cancer, LM/SL, SPECT/CT|cervical cancer, vulvar cancer, lm/sl, spect/ct
664116|NCT00773058|acute respiratory distress syndrome|acute respiratory distress syndrome
664117|NCT00773058|glucocorticoid|glucocorticoid
664118|NCT00773058|adrenal insufficiency|adrenal insufficiency
664119|NCT00773045|pain scores|pain scores
664120|NCT00773045|critically ill patients|critically ill patients
664121|NCT00773045|ICU|icu
664122|NCT00773045|pain management|pain management
664123|NCT00773045|pain measurement|pain measurement
664124|NCT00773019|infusion pump|infusion pump
664125|NCT00773019|implantable|implantable
664126|NCT00773019|performance|performance
664127|NCT00773006|coronary artery disease|coronary artery disease
664128|NCT00773006|percutaneous coronary intervention|percutaneous coronary intervention
664129|NCT00773006|anticoagulation|anticoagulation
664130|NCT00772993|glaucoma|glaucoma
664131|NCT00772993|myopia|myopia
664132|NCT00772993|myopia with glaucoma|myopia with glaucoma
664133|NCT00772993|normal control|normal control
664134|NCT00772954|Clostridium difficile diarrhea|clostridium difficile diarrhea
664135|NCT00772954|Clostridium difficile toxoid vaccine|clostridium difficile toxoid vaccine
664136|NCT00772928|Pertussis|pertussis
664137|NCT00772928|Whooping cough|whooping cough
664138|NCT00772928|Diphtheria|diphtheria
664139|NCT00772928|Tetanus|tetanus
664140|NCT00772928|Haemophilus influenzae|haemophilus influenzae
664141|NCT00772928|Poliovirus Types 1, 2, and 3.|poliovirus types 1, 2, and 3.
664142|NCT00772915|stage I multiple myeloma|stage i multiple myeloma
664143|NCT00772915|stage II multiple myeloma|stage ii multiple myeloma
664144|NCT00772915|stage III multiple myeloma|stage iii multiple myeloma
664145|NCT00772902|HIV-1|hiv-1
664146|NCT00772902|LDL|ldl
664147|NCT00772902|HDL|hdl
664148|NCT00772902|non-HDL cholesterol|non-hdl cholesterol
664149|NCT00772902|triglycerides|triglycerides
664150|NCT00772902|cholesterol|cholesterol
664151|NCT00772889|Elderly|elderly
664152|NCT00772889|Vaccine|vaccine
664153|NCT00772889|Influenza|influenza
664154|NCT00772876|P1446A-05|p1446a-05
664155|NCT00772876|Advanced refractory malignancies|advanced refractory malignancies
664156|NCT00772876|Phase I|phase i
664157|NCT00772850|Humeral fracture; Antegrade nailing; Rotator cuff|humeral fracture; antegrade nailing; rotator cuff
664158|NCT00772837|Functional Dyspepsia|functional dyspepsia
664159|NCT00772837|Helicobacter Pylori eradication|helicobacter pylori eradication
664160|NCT00772837|Quality of Life|quality of life
664161|NCT00772837|Dyspeptic Symptoms|dyspeptic symptoms
664162|NCT00772824|Breast cancer|breast cancer
664163|NCT00772824|Chemotherapy|chemotherapy
664164|NCT00772824|Epirubicin|epirubicin
664165|NCT00772824|Glutamine|glutamine
664166|NCT00772824|FEC chemotherapy|fec chemotherapy
664167|NCT00772798|ovarian cancer|ovarian cancer
664168|NCT00772798|HDAC inhibitor|hdac inhibitor
664169|NCT00772798|vorinostat|vorinostat
664170|NCT00772785|opioid dependence|opioid dependence
664171|NCT00772785|opioid addiction|opioid addiction
664172|NCT00772785|buprenorphine|buprenorphine
664173|NCT00772785|methadone|methadone
664174|NCT00772785|heroin|heroin
664175|NCT00772785|implant|implant
664176|NCT00772785|opioid withdrawal|opioid withdrawal
664177|NCT00772785|opioid pain medication|opioid pain medication
664178|NCT00772785|suboxone|suboxone
664179|NCT00772772|Vitamin D3 repletion|vitamin d3 repletion
664180|NCT00772772|levels of endotoxin|levels of endotoxin
664181|NCT00772772|intestinal permeability|intestinal permeability
664182|NCT00772772|accelerated atherosclerosis|accelerated atherosclerosis
664183|NCT00772759|AZD3199|azd3199
664184|NCT00772759|Japanese Healthy Volunteers|japanese healthy volunteers
664185|NCT00772759|Phase I study|phase i study
664186|NCT00772759|Single and Multiple Ascending Dose|single and multiple ascending dose
664187|NCT00772759|safety|safety
664188|NCT00772759|tolerability|tolerability
664190|NCT00772746|panic|panic
664191|NCT00772746|respiration|respiration
664192|NCT00772746|anxiety|anxiety
664193|NCT00772746|exercise|exercise
664194|NCT00772746|cognition|cognition
664195|NCT00772733|Quality assurance|quality assurance
664196|NCT00772733|rehabilitation|rehabilitation
664197|NCT00772733|chronic care model|chronic care model
664198|NCT00772733|COPD|copd
664199|NCT00772707|contact lens solution|contact lens solution
664200|NCT00772707|OPTI-FREE RepleniSH|opti-free replenish
664201|NCT00772707|contact lenses|contact lenses
664202|NCT00772694|testicular cancer|testicular cancer
664203|NCT00772694|germ cell cancer|germ cell cancer
664204|NCT00772694|sorafenib|sorafenib
664205|NCT00772668|stage III grade 1 follicular lymphoma|stage iii grade 1 follicular lymphoma
664206|NCT00772668|stage IV grade 1 follicular lymphoma|stage iv grade 1 follicular lymphoma
664207|NCT00772668|stage III grade 2 follicular lymphoma|stage iii grade 2 follicular lymphoma
664208|NCT00772668|stage IV grade 2 follicular lymphoma|stage iv grade 2 follicular lymphoma
664209|NCT00772668|stage III marginal zone lymphoma|stage iii marginal zone lymphoma
664210|NCT00772668|stage IV marginal zone lymphoma|stage iv marginal zone lymphoma
664211|NCT00772655|Follicular Lymphoma|follicular lymphoma
664212|NCT00772655|First line therapy|first line therapy
664213|NCT00772655|Zevalin|zevalin
664214|NCT00772655|90Yttrium-Ibritumomab Tiuxetan|90yttrium-ibritumomab tiuxetan
664215|NCT00772655|Yttrium|yttrium
664216|NCT00772655|Rituximab|rituximab
664217|NCT00772655|Radio-immuno therapy|radio-immuno therapy
664218|NCT00772642|Cross-Sectional|cross-sectional
664219|NCT00772642|Plasmodium Falciparum Malaria|plasmodium falciparum malaria
664220|NCT00772642|Cord Blood|cord blood
664221|NCT00772642|Immunology|immunology
664222|NCT00772642|Mali|mali
664223|NCT00772642|Malaria|malaria
664224|NCT00772629|Menactra®|menactra®
664225|NCT00772629|Meningitis|meningitis
664226|NCT00772629|Meningococcemia|meningococcemia
664227|NCT00772629|Neisseria meningitidis|neisseria meningitidis
664228|NCT00772616|Anesthesia|anesthesia
664229|NCT00772616|Analgesia|analgesia
664230|NCT00772616|Patient-Controlled Analgesia|patient-controlled analgesia
664231|NCT00772616|Hyperalgesia|hyperalgesia
664232|NCT00772603|Partial onset epilepsy|partial onset epilepsy
664233|NCT00772603|Partial onset seizures|partial onset seizures
664234|NCT00772590|HIV|hiv
664235|NCT00772590|antiretroviral therapy intensification|antiretroviral therapy intensification
664236|NCT00772590|suboptimal CD4+ T cell response|suboptimal cd4+ t cell response
664237|NCT00772590|virological suppression|virological suppression
664238|NCT00772590|bovine colostrum|bovine colostrum
664239|NCT00772590|raltegravir|raltegravir
664240|NCT00772577|Hypertension, Obese, aliskiren, hydrochlorothiazide, systolic blood pressure, diastolic blood pressure, ramipril, stage 2|hypertension, obese, aliskiren, hydrochlorothiazide, systolic blood pressure, diastolic blood pressure, ramipril, stage 2
664241|NCT00772564|Acute ST Elevation Myocardial Infarction|acute st elevation myocardial infarction
664242|NCT00772525|Visual acuity|visual acuity
664243|NCT00772525|Contrast sensitivity|contrast sensitivity
664244|NCT00772525|Visual Evoked Potentials|visual evoked potentials
664245|NCT00772525|Optical Coherence Tomography|optical coherence tomography
664246|NCT00772512|PF-04802540, polysomnography, REM, cross over|pf-04802540, polysomnography, rem, cross over
664247|NCT00772486|Chronic lymphocytic leukemia|chronic lymphocytic leukemia
664248|NCT00772486|Leukemia|leukemia
664249|NCT00772486|Leukemia, Lymphocytic, Chronic, B-Cell|leukemia, lymphocytic, chronic, b-cell
664250|NCT00772486|Leukemia, B-Cell|leukemia, b-cell
664251|NCT00772486|Immune System Diseases|immune system diseases
664252|NCT00772486|Rituximab|rituximab
664253|NCT00772486|Fludarabine|fludarabine
664254|NCT00772486|Cyclophosphamide|cyclophosphamide
664255|NCT00772486|ISF35|isf35
664256|NCT00772486|Ad-ISF35|ad-isf35
664257|NCT00772486|Refractory|refractory
845008|NCT00082927|pain|pain
664258|NCT00772486|Resistant|resistant
664259|NCT00772486|17p-|17p-
664260|NCT00772486|del 17p|del 17p
664261|NCT00772486|17p|17p
664262|NCT00772486|Resistant CLL|resistant cll
664263|NCT00772486|Refractory CLL|refractory cll
664264|NCT00772486|17p- CLL|17p- cll
664265|NCT00772486|CLL|cll
664266|NCT00772460|patient warming|patient warming
664267|NCT00772460|convective warming|convective warming
664268|NCT00772460|conductive warming|conductive warming
664269|NCT00772460|intraoperative normothermia|intraoperative normothermia
664270|NCT00772460|accidental hypothermia|accidental hypothermia
664271|NCT00772460|intraoperative hypothermia|intraoperative hypothermia
664272|NCT00772447|Skin Infections|skin infections
664367|NCT00772109|Orthomyxoviruses|orthomyxoviruses
664273|NCT00772447|Complicated Bacterial Skin and Skin Structure Infection due to Gram-positive Pathogens|complicated bacterial skin and skin structure infection due to gram-positive pathogens
664274|NCT00772421|Epilepsy|epilepsy
664275|NCT00772421|Recruitment rhythm|recruitment rhythm
664276|NCT00772421|DBS|dbs
664277|NCT00772408|pulmonary tuberculosis|pulmonary tuberculosis
664278|NCT00772408|Toll-like receptor 2 gene polymorphisms|toll-like receptor 2 gene polymorphisms
664279|NCT00772408|blood lymphocyte subsets|blood lymphocyte subsets
664280|NCT00772408|systemic symptoms|systemic symptoms
664281|NCT00772408|pleural effusion|pleural effusion
664282|NCT00772395|Periprosthetic bone loss risedronate bisphosphonates|periprosthetic bone loss risedronate bisphosphonates
664283|NCT00772382|Chronic Kidney Disease|chronic kidney disease
664284|NCT00772382|Dialysis|dialysis
664285|NCT00772382|Hyperphosphatemia|hyperphosphatemia
664286|NCT00772382|Phosphate binder|phosphate binder
664287|NCT00772369|Pertussis|pertussis
664288|NCT00772369|Whooping cough|whooping cough
664289|NCT00772369|Diphtheria|diphtheria
664290|NCT00772369|Tetanus|tetanus
664291|NCT00772369|Haemophilus influenzae|haemophilus influenzae
664292|NCT00772369|Poliovirus Types 1, 2, and 3.|poliovirus types 1, 2, and 3.
664293|NCT00772343|Diarrhea|diarrhea
664294|NCT00772343|Clostridium difficile infection|clostridium difficile infection
664295|NCT00772343|Clostridium difficile toxoid|clostridium difficile toxoid
664296|NCT00772330|MIDI Arrow|midi arrow
664297|NCT00772330|Glaucoma Drainage Device|glaucoma drainage device
664298|NCT00772330|GDD|gdd
664299|NCT00772330|InnFocus|innfocus
664300|NCT00772330|Glaucoma treatment|glaucoma treatment
664301|NCT00772317|Recurrent|recurrent
664302|NCT00772317|prostate cancer|prostate cancer
664303|NCT00772317|ebrt|ebrt
664304|NCT00772317|hifu|hifu
664305|NCT00772304|rhinitis|rhinitis
664306|NCT00772291|inguinal|inguinal
664307|NCT00772291|hernia|hernia
664308|NCT00772291|chronic|chronic
664309|NCT00772291|pain|pain
664310|NCT00772291|pregabalin|pregabalin
664311|NCT00772291|chronic pain after inguinal herniorraphy|chronic pain after inguinal herniorraphy
664312|NCT00772278|carotid stenosis|carotid stenosis
664313|NCT00772278|asymptomatic|asymptomatic
664314|NCT00772278|carotid stenting|carotid stenting
664315|NCT00772278|carotid endarterectomy|carotid endarterectomy
664316|NCT00772265|Bioequivalence|bioequivalence
664317|NCT00772265|pharmacokinetic|pharmacokinetic
664318|NCT00772265|Pharmacodynamic|pharmacodynamic
664319|NCT00772265|Isophane insulin|isophane insulin
664320|NCT00772252|Liver support treatment|liver support treatment
664321|NCT00772239|Coagulation Management|coagulation management
664322|NCT00772239|Cardiac surgery|cardiac surgery
664323|NCT00772239|Bleeding|bleeding
664324|NCT00772239|Rotem|rotem
664325|NCT00772226|laparoscopic cholecystectomy|laparoscopic cholecystectomy
664326|NCT00772226|pain|pain
664327|NCT00772226|PONV|ponv
664328|NCT00772226|music|music
664329|NCT00772226|therapy|therapy
664330|NCT00772226|fatigue after elective laparoscopic cholecystectomy|fatigue after elective laparoscopic cholecystectomy
664331|NCT00772213|multiple trauma|multiple trauma
664332|NCT00772213|outcome and process assessment|outcome and process assessment
664333|NCT00772187|Laparoscopic surgery (general surgery).|laparoscopic surgery (general surgery).
664334|NCT00772174|Glucose Metabolism Disorder|glucose metabolism disorder
664335|NCT00772174|Dysmetabolic Syndrome|dysmetabolic syndrome
664336|NCT00772174|Type II Diabetes|type ii diabetes
664337|NCT00772174|Diabetes Mellitus, Lipoatrophic|diabetes mellitus, lipoatrophic
664338|NCT00772174|Dyslipidemia|dyslipidemia
664339|NCT00772174|Drug Therapy|drug therapy
664340|NCT00772161|ADHD|adhd
664341|NCT00772161|Attention Deficit Disorder|attention deficit disorder
664342|NCT00772161|Attention Deficit an Disruptive Behavior Disorders|attention deficit an disruptive behavior disorders
664343|NCT00772161|Children|children
664344|NCT00772161|Central Nervous System Stimulants|central nervous system stimulants
664345|NCT00772161|Methylphenidate|methylphenidate
664346|NCT00772161|Pharmacokinetics|pharmacokinetics
664347|NCT00772161|Area Under Curve|area under curve
664348|NCT00772161|Therapeutic Equivalency|therapeutic equivalency
664349|NCT00772161|Psychopharmacology|psychopharmacology
664350|NCT00772148|Liver|liver
664351|NCT00772148|Hepatic|hepatic
664352|NCT00772148|Transplantation|transplantation
664353|NCT00772148|Immunosuppression|immunosuppression
664354|NCT00772148|Tacrolimus|tacrolimus
664355|NCT00772148|Prograf|prograf
664356|NCT00772135|pulmonary hypertension|pulmonary hypertension
664357|NCT00772135|congenital heart defects|congenital heart defects
664358|NCT00772135|exercise|exercise
664359|NCT00772135|phosphodiesterase inhibitors|phosphodiesterase inhibitors
664360|NCT00772135|Exercise induced pulmonary arterial hypertensive response in congenital heart disease|exercise induced pulmonary arterial hypertensive response in congenital heart disease
664361|NCT00772122|Recurrent Miscarriage|recurrent miscarriage
664362|NCT00772122|G-CSF|g-csf
664363|NCT00772122|pregnancy outcome|pregnancy outcome
664364|NCT00772122|pregnancy outcome of pregnancies treated with G-CSF|pregnancy outcome of pregnancies treated with g-csf
664365|NCT00772122|treatment of recurrent miscarriage|treatment of recurrent miscarriage
664366|NCT00772109|Influenza|influenza
664368|NCT00772109|Inactivated Split-virion influenza vaccine|inactivated split-virion influenza vaccine
664369|NCT00772109|Fluzone®|fluzone®
664370|NCT00772109|Adults|adults
664371|NCT00772070|Menactra®|menactra®
664372|NCT00772070|Menomune®|menomune®
664373|NCT00772070|Meningitis|meningitis
664374|NCT00772070|Meningococcemia|meningococcemia
664375|NCT00772070|Neisseria meningitidis|neisseria meningitidis
664376|NCT00772044|OSA|osa
664377|NCT00772044|sleep apnea|sleep apnea
664378|NCT00772044|apnea|apnea
664379|NCT00772044|AHI|ahi
664380|NCT00772031|chronic migraine, migraine prevention, chronic headache|chronic migraine, migraine prevention, chronic headache
664381|NCT00772018|stage 0 bladder cancer|stage 0 bladder cancer
664382|NCT00771992|Asthma GINA 1|asthma gina 1
664383|NCT00771979|Healthy Volunteers|healthy volunteers
664384|NCT00771979|Relative Bioavailability|relative bioavailability
664385|NCT00771966|patients with cancer in the prostate|patients with cancer in the prostate
664386|NCT00771953|apricoxib|apricoxib
664387|NCT00771953|docetaxel|docetaxel
664388|NCT00771953|pemetrexed|pemetrexed
664389|NCT00771953|Stage IIIb or Stage IV|stage iiib or stage iv
664390|NCT00771927|Vimpat®|vimpat®
664391|NCT00771927|Lacosamide|lacosamide
664392|NCT00771927|LCM|lcm
664393|NCT00771927|epilepsy|epilepsy
664394|NCT00771927|epilepsies|epilepsies
664395|NCT00771927|seizure|seizure
664396|NCT00771927|partial seizure|partial seizure
664397|NCT00771927|partial onset|partial onset
664398|NCT00771927|seizure disorder|seizure disorder
664399|NCT00771927|single seizure|single seizure
664400|NCT00771927|motor seizure|motor seizure
664401|NCT00771927|convulsions|convulsions
664402|NCT00771927|add-on|add-on
664403|NCT00771927|AED|aed
664404|NCT00771927|anti-epileptic|anti-epileptic
664405|NCT00771927|anti-epileptic drug|anti-epileptic drug
664406|NCT00771927|seizure control|seizure control
664407|NCT00771927|open-label|open-label
664408|NCT00771927|post authorization|post authorization
664409|NCT00771927|PASS|pass
664410|NCT00771927|late stage|late stage
664411|NCT00771927|trial|trial
664412|NCT00771927|study|study
664413|NCT00771927|phase 4|phase 4
664414|NCT00771927|phase IV|phase iv
664415|NCT00771914|aspirin|aspirin
664416|NCT00771914|omega 3 fatty acids|omega 3 fatty acids
664417|NCT00771914|Lovaza|lovaza
664418|NCT00771914|myocardial infarction|myocardial infarction
664419|NCT00771914|aspirin resistance|aspirin resistance
664420|NCT00771914|cardiovascular disease|cardiovascular disease
664421|NCT00771901|obesity|obesity
664422|NCT00771901|insulin resistance|insulin resistance
664423|NCT00771901|type II diabetes|type ii diabetes
664424|NCT00771862|pain|pain
664425|NCT00771862|amputation|amputation
664426|NCT00771862|phantom limb|phantom limb
664427|NCT00771862|stump pain|stump pain
664428|NCT00771862|catheter|catheter
664429|NCT00771862|nerve block|nerve block
664430|NCT00771862|peripheral nerve block|peripheral nerve block
664431|NCT00771862|ucsd|ucsd
664432|NCT00771862|post-amputation phantom limb or stump pain|post-amputation phantom limb or stump pain
664433|NCT00771849|Meningitis|meningitis
664434|NCT00771849|Meningococcemia|meningococcemia
664435|NCT00771849|Neisseria meningitidis|neisseria meningitidis
664436|NCT00771836|Stem cell transplantation|stem cell transplantation
664437|NCT00771836|Airway hyper-reactivity|airway hyper-reactivity
664438|NCT00771836|methacholine|methacholine
664439|NCT00771836|pediatric|pediatric
664440|NCT00771810|Ovarian Cancer|ovarian cancer
664441|NCT00771810|Thrombocytopenia|thrombocytopenia
664442|NCT00771810|Cytopenia|cytopenia
664443|NCT00771810|Chemotherapy|chemotherapy
664444|NCT00771797|PAOD|paod
664445|NCT00771797|diabetis|diabetis
664446|NCT00771797|vascular function|vascular function
664447|NCT00771797|in diabetics with PAOD|in diabetics with paod
664448|NCT00771784|Endotracheal intubation|endotracheal intubation
664449|NCT00771784|tracheostomy|tracheostomy
664450|NCT00771784|laryngeal mask|laryngeal mask
664451|NCT00771771|Stroke|stroke
664452|NCT00771771|Rehabilitation|rehabilitation
664453|NCT00771771|Early Supported Discharge|early supported discharge
664454|NCT00771771|ESD|esd
664455|NCT00771771|RCT|rct
664456|NCT00771758|Vertebral compression fracture|vertebral compression fracture
664457|NCT00771758|Osteoporosis|osteoporosis
664458|NCT00771758|Acute pain|acute pain
664459|NCT00771758|Analgesic|analgesic
664460|NCT00771758|Oxycodone|oxycodone
664461|NCT00771758|Tapentadol|tapentadol
664462|NCT00771732|toe nail fungus|toe nail fungus
664463|NCT00771719|VAP|vap
664464|NCT00771706|Pediatric Cough, Quality of Life|pediatric cough, quality of life
664465|NCT00771706|Drug (including placebo)|drug (including placebo)
664466|NCT00771693|NIDDM|niddm
664467|NCT00771693|Platelet Activation|platelet activation
664468|NCT00771693|Postprandial hyperglycemia|postprandial hyperglycemia
664469|NCT00771693|insulin|insulin
664470|NCT00771667|Interleukin-12|interleukin-12
664471|NCT00771667|Inflammation|inflammation
664472|NCT00771667|Research study|research study
664473|NCT00771667|Ustekinumab|ustekinumab
664474|NCT00771667|CNTO1275|cnto1275
664475|NCT00771667|Interleukin-23|interleukin-23
664476|NCT00771641|stage III squamous cell carcinoma of the lip and oral cavity|stage iii squamous cell carcinoma of the lip and oral cavity
664477|NCT00771641|stage IV squamous cell carcinoma of the lip and oral cavity|stage iv squamous cell carcinoma of the lip and oral cavity
664478|NCT00771641|stage II squamous cell carcinoma of the oropharynx|stage ii squamous cell carcinoma of the oropharynx
664479|NCT00771641|stage II lymphoepithelioma of the oropharynx|stage ii lymphoepithelioma of the oropharynx
664480|NCT00771641|stage III squamous cell carcinoma of the oropharynx|stage iii squamous cell carcinoma of the oropharynx
664481|NCT00771641|stage III lymphoepithelioma of the oropharynx|stage iii lymphoepithelioma of the oropharynx
664482|NCT00771641|stage IV squamous cell carcinoma of the oropharynx|stage iv squamous cell carcinoma of the oropharynx
664483|NCT00771641|stage IV lymphoepithelioma of the oropharynx|stage iv lymphoepithelioma of the oropharynx
664484|NCT00771641|stage II squamous cell carcinoma of the hypopharynx|stage ii squamous cell carcinoma of the hypopharynx
664485|NCT00771641|stage III squamous cell carcinoma of the hypopharynx|stage iii squamous cell carcinoma of the hypopharynx
664486|NCT00771641|stage IV squamous cell carcinoma of the hypopharynx|stage iv squamous cell carcinoma of the hypopharynx
664487|NCT00771641|stage III squamous cell carcinoma of the larynx|stage iii squamous cell carcinoma of the larynx
664488|NCT00771641|stage IV squamous cell carcinoma of the larynx|stage iv squamous cell carcinoma of the larynx
664489|NCT00771628|Intubation, Flex-It, stylet, GlideScope|intubation, flex-it, stylet, glidescope
664490|NCT00771615|human|human
664491|NCT00771615|Avian|avian
664492|NCT00771615|safety|safety
664493|NCT00771615|vaccines|vaccines
664494|NCT00771615|influenza|influenza
664495|NCT00771615|pandemic|pandemic
664496|NCT00771615|immunogenicity|immunogenicity
664497|NCT00771615|H5N1|h5n1
664498|NCT00771602|Chronic Lymphocytic Leukemia|chronic lymphocytic leukemia
664499|NCT00771602|Leukemia|leukemia
664500|NCT00771602|CLL|cll
664501|NCT00771602|PLL|pll
664502|NCT00771602|SLL|sll
664503|NCT00771602|Rituximab|rituximab
664504|NCT00771602|Rituxan|rituxan
664505|NCT00771602|Alemtuzumab|alemtuzumab
664506|NCT00771602|Campath|campath
664507|NCT00771576|Diabetes Mellitus|diabetes mellitus
664508|NCT00771576|T1DM|t1dm
664509|NCT00771563|Non-Small Cell Lung Cancer|non-small cell lung cancer
664510|NCT00771563|chemotherapy|chemotherapy
664511|NCT00771563|Low Molecular Weight Heparin|low molecular weight heparin
664512|NCT00771537|HIV Testing|hiv testing
664513|NCT00771537|Persuasion|persuasion
664514|NCT00771537|Health Communication|health communication
664515|NCT00771537|Clinical Trials Participation|clinical trials participation
664516|NCT00771537|Attitudes toward Health|attitudes toward health
664517|NCT00771537|Diagnostic Tests|diagnostic tests
664518|NCT00771537|Behavioral Research|behavioral research
664519|NCT00771537|Intervention Studies|intervention studies
664520|NCT00771524|Pharmacokinetics|pharmacokinetics
664521|NCT00771524|Hip replacement|hip replacement
664522|NCT00771524|Ceftobiprole|ceftobiprole
664523|NCT00771498|rifampin|rifampin
664524|NCT00771498|lopinavir|lopinavir
664525|NCT00771498|drug interaction|drug interaction
664526|NCT00771498|pharmacokinetic|pharmacokinetic
664527|NCT00771459|Local infiltration analgesia|local infiltration analgesia
664528|NCT00771459|postoperative pain|postoperative pain
664529|NCT00771459|ropivacaine|ropivacaine
664530|NCT00771446|Hepatitis, acute|hepatitis, acute
664531|NCT00771446|Acute Hepatitis OR Chronic Hepatitis|acute hepatitis or chronic hepatitis
664532|NCT00771433|neutropenia|neutropenia
664533|NCT00771433|chemotherapeutic agent toxicity|chemotherapeutic agent toxicity
664534|NCT00771433|recurrent breast cancer|recurrent breast cancer
664535|NCT00771433|stage I breast cancer|stage i breast cancer
664536|NCT00771433|stage II breast cancer|stage ii breast cancer
664537|NCT00771433|stage IIIA breast cancer|stage iiia breast cancer
664538|NCT00771433|stage IIIB breast cancer|stage iiib breast cancer
664539|NCT00771433|stage IIIC breast cancer|stage iiic breast cancer
664540|NCT00771433|stage IV breast cancer|stage iv breast cancer
664541|NCT00771407|Ostomy creation|ostomy creation
664542|NCT00771407|Parastomal hernia|parastomal hernia
664543|NCT00771394|Vesicare|vesicare
664544|NCT00771394|Solifenacin succinate|solifenacin succinate
664545|NCT00771394|Tamsulosin|tamsulosin
664546|NCT00771394|Overactive Bladder|overactive bladder
664548|NCT00771381|18F-FAZA|18f-faza
664549|NCT00771381|18F-FDG|18f-fdg
664550|NCT00771381|Positron Emission Tomography|positron emission tomography
664551|NCT00771381|Cell Hypoxia|cell hypoxia
664552|NCT00771303|Pregnancy|pregnancy
664553|NCT00771303|Pulmonary embolism|pulmonary embolism
664554|NCT00771303|MSCT|msct
664555|NCT00771290|Rectal sparing|rectal sparing
664556|NCT00771290|Colon cancer|colon cancer
664557|NCT00771277|Brain Injuries|brain injuries
664558|NCT00771277|Caregivers|caregivers
664559|NCT00771277|Volunteer Workers|volunteer workers
664560|NCT00771277|Social Networks|social networks
664561|NCT00771264|Overactive Bladder|overactive bladder
664562|NCT00771251|Rheumatoid arthritis|rheumatoid arthritis
664563|NCT00771251|Fully Human anti-TNFa monoclonal antibody|fully human anti-tnfa monoclonal antibody
664564|NCT00771251|CNTO148|cnto148
664565|NCT00771251|Golimumab|golimumab
664566|NCT00771238|pressure ulcers|pressure ulcers
664567|NCT00771238|Therapy mattresses|therapy mattresses
664568|NCT00771238|Incidence of pressure ulcers|incidence of pressure ulcers
664569|NCT00771225|genital prolapse|genital prolapse
664570|NCT00771225|surgery|surgery
664571|NCT00771225|fascial repair|fascial repair
664572|NCT00771225|mesh|mesh
664573|NCT00771225|prolift|prolift
664574|NCT00771212|Pain|pain
664575|NCT00771212|Observational|observational
664576|NCT00771212|Taiwan|taiwan
664577|NCT00771199|Cancer pain|cancer pain
664578|NCT00771199|Pain|pain
664579|NCT00771199|Fentanyl|fentanyl
664580|NCT00771199|Durogesic|durogesic
664581|NCT00771199|Cancer|cancer
664582|NCT00771199|Transdermal|transdermal
664583|NCT00771186|pediatric|pediatric
664584|NCT00771186|Laryngeal EMG|laryngeal emg
664585|NCT00771173|Phenazopyrdine|phenazopyrdine
664586|NCT00771173|post operative bladder catheritization|post operative bladder catheritization
664587|NCT00771173|VAS scores|vas scores
664588|NCT00771173|Bladder pain related to indwelling foley catheters.|bladder pain related to indwelling foley catheters.
664589|NCT00771173|Bladder irritaion related to indwelling foley catheters.|bladder irritaion related to indwelling foley catheters.
664590|NCT00771147|Advanced Renal Cell Carcinoma ( RCC)|advanced renal cell carcinoma ( rcc)
664591|NCT00771134|Depression|depression
664592|NCT00771134|Bipolar I Disorder|bipolar i disorder
664593|NCT00771134|Bipolar II Disorder|bipolar ii disorder
664594|NCT00771134|Placebo-controlled|placebo-controlled
664595|NCT00771134|Double-blind|double-blind
664596|NCT00771134|Randomised controlled|randomised controlled
664597|NCT00771134|Multicenter|multicenter
664598|NCT00771134|Clinical study|clinical study
664599|NCT00771134|Mania|mania
664600|NCT00771108|NAFLD|nafld
664601|NCT00771108|Obesity|obesity
664602|NCT00771108|Metabolic Syndrome|metabolic syndrome
664603|NCT00771108|Nonalcoholic Fatty Liver Disease|nonalcoholic fatty liver disease
664604|NCT00771095|weight loss|weight loss
664605|NCT00771095|elaboration|elaboration
664606|NCT00771095|self efficacy|self efficacy
664607|NCT00771082|inflammatory markers|inflammatory markers
664608|NCT00771082|bone markers|bone markers
664609|NCT00771082|OA|oa
664610|NCT00771069|Hypertension|hypertension
664611|NCT00771069|Type II DM|type ii dm
664612|NCT00771069|DM related complication|dm related complication
664613|NCT00771069|JNC7|jnc7
664614|NCT00771069|2007 ESH-ESC guidelines|2007 esh-esc guidelines
664615|NCT00771069|survey|survey
664616|NCT00771056|untreated|untreated
664617|NCT00771017|adenocarcinoma of the prostate|adenocarcinoma of the prostate
664618|NCT00771017|recurrent prostate cancer|recurrent prostate cancer
664619|NCT00771017|stage II prostate cancer|stage ii prostate cancer
664620|NCT00771017|stage III prostate cancer|stage iii prostate cancer
664621|NCT00771017|stage I prostate cancer|stage i prostate cancer
664622|NCT00771004|drug effects|drug effects
664623|NCT00771004|Type II Diabetes|type ii diabetes
664624|NCT00771004|Angioplasty, Transluminal, Percutaneous Coronary|angioplasty, transluminal, percutaneous coronary
664625|NCT00771004|Drug Therapy|drug therapy
664626|NCT00771004|Heart|heart
664627|NCT00771004|physiology|physiology
664628|NCT00771004|function|function
664629|NCT00770991|Polyp, Familial Adenomatous Polyposis, Prevention|polyp, familial adenomatous polyposis, prevention
664630|NCT00770978|ICU|icu
664631|NCT00770965|Plaque psoriasis, skin condition, thickening, flaking, skin disease, autoimmune disease|plaque psoriasis, skin condition, thickening, flaking, skin disease, autoimmune disease
664632|NCT00770952|Glucose Metabolism Disorder|glucose metabolism disorder
664633|NCT00770952|Dysmetabolic Syndrome|dysmetabolic syndrome
664634|NCT00770952|Type II Diabetes|type ii diabetes
664635|NCT00770952|Diabetes Mellitus, Lipoatrophic|diabetes mellitus, lipoatrophic
664636|NCT00770952|Dyslipidemia|dyslipidemia
664637|NCT00770952|Drug Therapy|drug therapy
664638|NCT00770939|Complete healing of chronic diabetic foot ulcers|complete healing of chronic diabetic foot ulcers
664639|NCT00770939|Platelet Rich Fibrin|platelet rich fibrin
664640|NCT00770939|Vivostat|vivostat
664641|NCT00770939|Growth factor treatment|growth factor treatment
664642|NCT00770939|Treatment of chronic diabetic foot ulcers|treatment of chronic diabetic foot ulcers
664643|NCT00770926|risk reduction|risk reduction
664644|NCT00770926|minority|minority
664645|NCT00770926|diabetes prevention|diabetes prevention
664646|NCT00770926|lifestyle program|lifestyle program
664647|NCT00770926|behavior change|behavior change
664648|NCT00770913|reflux esophagitis|reflux esophagitis
664649|NCT00770913|rabeprazole|rabeprazole
664650|NCT00770913|GERD|gerd
664651|NCT00770913|Japan|japan
664652|NCT00770887|Undesired fertility|undesired fertility
664653|NCT00770861|nebivolol|nebivolol
664654|NCT00770861|Bystolic ™|bystolic ™
664655|NCT00770861|Hypertension|hypertension
664656|NCT00770861|Hispanic|hispanic
664657|NCT00770861|Hypertension in Hispanic patients|hypertension in hispanic patients
664658|NCT00770848|CRPC|crpc
664659|NCT00770835|Glucose Metabolism Disorder|glucose metabolism disorder
664660|NCT00770835|Dysmetabolic Syndrome|dysmetabolic syndrome
664661|NCT00770835|Type II Diabetes|type ii diabetes
664662|NCT00770835|Diabetes Mellitus, Lipoatrophic|diabetes mellitus, lipoatrophic
664663|NCT00770835|Dyslipidemia|dyslipidemia
664664|NCT00770835|Drug Therapy|drug therapy
664666|NCT00770822|Prostate|prostate
664667|NCT00770822|Cancer|cancer
664668|NCT00770822|Primary T1c/T2a organ confined prostate cancer|primary t1c/t2a organ confined prostate cancer
664669|NCT00770822|organ-confined|organ-confined
664670|NCT00770796|Contrast induced nephropathy|contrast induced nephropathy
664671|NCT00770770|Macular edema secondary to RVO|macular edema secondary to rvo
664672|NCT00770744|Schizophrenia|schizophrenia
664673|NCT00770744|Antipsychotic|antipsychotic
664674|NCT00770744|Olanzapine|olanzapine
664675|NCT00770744|Lu 31-130|lu 31-130
664676|NCT00770731|Torisel|torisel
664677|NCT00770731|Temsirolimus|temsirolimus
664678|NCT00770731|Hycamtin|hycamtin
664679|NCT00770731|Topotecan hydrochloride|topotecan hydrochloride
664680|NCT00770731|Velcade|velcade
664681|NCT00770731|Bortezomib|bortezomib
664682|NCT00770731|FDG-PET Scans|fdg-pet scans
664683|NCT00770731|18F-Fluoro-2-Deoxyglucose Positron Emission Tomography|18f-fluoro-2-deoxyglucose positron emission tomography
664684|NCT00770718|intracranial hemorrhage|intracranial hemorrhage
664685|NCT00770718|warfarin|warfarin
664686|NCT00770718|anticoagulant|anticoagulant
664687|NCT00770718|Factor VII|factor vii
664688|NCT00770718|Prothrombin|prothrombin
664689|NCT00770692|insomnia|insomnia
664690|NCT00770692|primary insomnia|primary insomnia
664691|NCT00770692|insomnia associated with psychiatric or physical disorder(s)|insomnia associated with psychiatric or physical disorder(s)
664692|NCT00770666|Tobacco dependence treatment|tobacco dependence treatment
664693|NCT00770653|Glucose Metabolism Disorder|glucose metabolism disorder
664694|NCT00770653|Dysmetabolic Syndrome|dysmetabolic syndrome
664695|NCT00770653|Type II Diabetes|type ii diabetes
664696|NCT00770653|Diabetes Mellitus, Lipoatrophic|diabetes mellitus, lipoatrophic
664697|NCT00770653|Dyslipidemia|dyslipidemia
664698|NCT00770653|Hyperlipidemias|hyperlipidemias
664699|NCT00770653|Drug Therapy|drug therapy
664700|NCT00770640|Glucose Metabolism Disorder|glucose metabolism disorder
664701|NCT00770640|Dysmetabolic Syndrome|dysmetabolic syndrome
664702|NCT00770640|Type II Diabetes|type ii diabetes
664703|NCT00770640|Diabetes Mellitus, Lipoatrophic|diabetes mellitus, lipoatrophic
664704|NCT00770640|Dyslipidemia|dyslipidemia
664705|NCT00770640|Drug Therapy|drug therapy
664706|NCT00770627|160 children|160 children
664707|NCT00770627|parallel group|parallel group
664708|NCT00770614|Contrast Induced Nephropathy|contrast induced nephropathy
664709|NCT00770601|NOMID|nomid
664710|NCT00770601|CINCA Syndrome|cinca syndrome
664711|NCT00770601|Canakinumab|canakinumab
664712|NCT00770588|non-small cell lung cancer (NSCLC)|non-small cell lung cancer (nsclc)
664713|NCT00770588|Gefitinib|gefitinib
664714|NCT00770575|Biological Markers|biological markers
664715|NCT00770575|Biochemical Markers|biochemical markers
664716|NCT00770575|Carotid Artery, Internal|carotid artery, internal
664717|NCT00770575|Carotid Artery, Common|carotid artery, common
664718|NCT00770575|Marker, Surrogate|marker, surrogate
664719|NCT00770575|Vascular Diseases|vascular diseases
664720|NCT00770575|Diabetes Mellitus|diabetes mellitus
664721|NCT00770575|Drug Therapy|drug therapy
664722|NCT00770536|fallopian tube cancer|fallopian tube cancer
664723|NCT00770536|Gynecological Malignancy|gynecological malignancy
664724|NCT00770536|primary peritoneal cancer of predominantly epithelial origin|primary peritoneal cancer of predominantly epithelial origin
664725|NCT00770536|Stage II to IV ovarian cancer|stage ii to iv ovarian cancer
664726|NCT00770523|patients without comorbidity|patients without comorbidity
664727|NCT00770510|Primary insomnia|primary insomnia
664728|NCT00770497|drug effects|drug effects
664729|NCT00770497|Hypertension|hypertension
664730|NCT00770497|Vascular Resistance|vascular resistance
664731|NCT00770497|Drug Therapy|drug therapy
664732|NCT00770497|physiopathology, vascular|physiopathology, vascular
664733|NCT00770484|Exercise|exercise
664734|NCT00770484|Propanolol|propanolol
664735|NCT00770484|Beta blockers|beta blockers
664736|NCT00770471|adult glioblastoma|adult glioblastoma
664737|NCT00770471|adult gliosarcoma|adult gliosarcoma
664738|NCT00770471|adult giant cell glioblastoma|adult giant cell glioblastoma
664739|NCT00770458|Down Syndrome|down syndrome
845487|NCT00082303|Anxiety|anxiety
664740|NCT00770445|Glucose Metabolism Disorder|glucose metabolism disorder
664741|NCT00770445|Dysmetabolic Syndrome|dysmetabolic syndrome
664742|NCT00770445|Type II Diabetes|type ii diabetes
664743|NCT00770445|Diabetes Mellitus, Lipoatrophic|diabetes mellitus, lipoatrophic
664744|NCT00770445|Dyslipidemia|dyslipidemia
664745|NCT00770445|Drug Therapy|drug therapy
664746|NCT00770432|Human Experimentation|human experimentation
664747|NCT00770419|depression|depression
664748|NCT00770419|psychosocial effects of cancer and its treatment|psychosocial effects of cancer and its treatment
664749|NCT00770419|unspecified adult solid tumor, protocol specific|unspecified adult solid tumor, protocol specific
664750|NCT00770419|acute undifferentiated leukemia|acute undifferentiated leukemia
664751|NCT00770419|adult acute lymphoblastic leukemia in remission|adult acute lymphoblastic leukemia in remission
664752|NCT00770419|adult acute myeloid leukemia in remission|adult acute myeloid leukemia in remission
664753|NCT00770419|adult acute myeloid leukemia with 11q23 (MLL) abnormalities|adult acute myeloid leukemia with 11q23 (mll) abnormalities
664754|NCT00770419|adult acute myeloid leukemia with inv(16)(p13;q22)|adult acute myeloid leukemia with inv(16)(p13;q22)
664755|NCT00770419|adult acute myeloid leukemia with t(15;17)(q22;q12)|adult acute myeloid leukemia with t(15;17)(q22;q12)
664756|NCT00770419|adult acute myeloid leukemia with t(16;16)(p13;q22)|adult acute myeloid leukemia with t(16;16)(p13;q22)
664757|NCT00770419|adult acute myeloid leukemia with t(8;21)(q22;q22)|adult acute myeloid leukemia with t(8;21)(q22;q22)
664758|NCT00770419|atypical chronic myeloid leukemia, BCR-ABL negative|atypical chronic myeloid leukemia, bcr-abl negative
664759|NCT00770419|chronic myelomonocytic leukemia|chronic myelomonocytic leukemia
664760|NCT00770419|mast cell leukemia|mast cell leukemia
664761|NCT00770419|meningeal chronic myelogenous leukemia|meningeal chronic myelogenous leukemia
664762|NCT00770419|prolymphocytic leukemia|prolymphocytic leukemia
664763|NCT00770419|recurrent adult acute lymphoblastic leukemia|recurrent adult acute lymphoblastic leukemia
664764|NCT00770419|recurrent adult acute myeloid leukemia|recurrent adult acute myeloid leukemia
664765|NCT00770419|recurrent adult T-cell leukemia/lymphoma|recurrent adult t-cell leukemia/lymphoma
664766|NCT00770419|refractory chronic lymphocytic leukemia|refractory chronic lymphocytic leukemia
664767|NCT00770419|refractory hairy cell leukemia|refractory hairy cell leukemia
664768|NCT00770419|relapsing chronic myelogenous leukemia|relapsing chronic myelogenous leukemia
664769|NCT00770419|secondary acute myeloid leukemia|secondary acute myeloid leukemia
664770|NCT00770419|T-cell large granular lymphocyte leukemia|t-cell large granular lymphocyte leukemia
664771|NCT00770419|AIDS-related diffuse large cell lymphoma|aids-related diffuse large cell lymphoma
664772|NCT00770419|AIDS-related diffuse mixed cell lymphoma|aids-related diffuse mixed cell lymphoma
664773|NCT00770419|AIDS-related diffuse small cleaved cell lymphoma|aids-related diffuse small cleaved cell lymphoma
664774|NCT00770419|AIDS-related immunoblastic large cell lymphoma|aids-related immunoblastic large cell lymphoma
664775|NCT00770419|AIDS-related lymphoblastic lymphoma|aids-related lymphoblastic lymphoma
664776|NCT00770419|AIDS-related peripheral/systemic lymphoma|aids-related peripheral/systemic lymphoma
664777|NCT00770419|AIDS-related primary CNS lymphoma|aids-related primary cns lymphoma
664778|NCT00770419|AIDS-related small noncleaved cell lymphoma|aids-related small noncleaved cell lymphoma
664779|NCT00770419|HIV-associated Hodgkin lymphoma|hiv-associated hodgkin lymphoma
664780|NCT00770419|recurrent adult Hodgkin lymphoma|recurrent adult hodgkin lymphoma
664781|NCT00770419|anaplastic large cell lymphoma|anaplastic large cell lymphoma
664782|NCT00770419|angioimmunoblastic T-cell lymphoma|angioimmunoblastic t-cell lymphoma
664783|NCT00770419|cutaneous B-cell non-Hodgkin lymphoma|cutaneous b-cell non-hodgkin lymphoma
664784|NCT00770419|recurrent cutaneous T-cell non-Hodgkin lymphoma|recurrent cutaneous t-cell non-hodgkin lymphoma
664785|NCT00770419|recurrent mycosis fungoides/Sezary syndrome|recurrent mycosis fungoides/sezary syndrome
664786|NCT00770419|adult grade III lymphomatoid granulomatosis|adult grade iii lymphomatoid granulomatosis
664787|NCT00770419|adult nasal type extranodal NK/T-cell lymphoma|adult nasal type extranodal nk/t-cell lymphoma
664788|NCT00770419|Waldenstrom macroglobulinemia|waldenstrom macroglobulinemia
664789|NCT00770419|extranodal marginal zone B-cell lymphoma of mucosa-associated lymphoid tissue|extranodal marginal zone b-cell lymphoma of mucosa-associated lymphoid tissue
664790|NCT00770419|nodal marginal zone B-cell lymphoma|nodal marginal zone b-cell lymphoma
664791|NCT00770419|splenic marginal zone lymphoma|splenic marginal zone lymphoma
664792|NCT00770419|recurrent adult Burkitt lymphoma|recurrent adult burkitt lymphoma
664793|NCT00770419|recurrent adult diffuse large cell lymphoma|recurrent adult diffuse large cell lymphoma
664794|NCT00770419|recurrent adult diffuse mixed cell lymphoma|recurrent adult diffuse mixed cell lymphoma
664795|NCT00770419|recurrent adult diffuse small cleaved cell lymphoma|recurrent adult diffuse small cleaved cell lymphoma
664796|NCT00770419|recurrent adult grade III lymphomatoid granulomatosis|recurrent adult grade iii lymphomatoid granulomatosis
664797|NCT00770419|recurrent adult immunoblastic large cell lymphoma|recurrent adult immunoblastic large cell lymphoma
664798|NCT00770419|recurrent adult lymphoblastic lymphoma|recurrent adult lymphoblastic lymphoma
664799|NCT00770419|recurrent grade 1 follicular lymphoma|recurrent grade 1 follicular lymphoma
664800|NCT00770419|recurrent grade 2 follicular lymphoma|recurrent grade 2 follicular lymphoma
664801|NCT00770419|recurrent grade 3 follicular lymphoma|recurrent grade 3 follicular lymphoma
664802|NCT00770419|recurrent mantle cell lymphoma|recurrent mantle cell lymphoma
664803|NCT00770419|recurrent marginal zone lymphoma|recurrent marginal zone lymphoma
664804|NCT00770419|recurrent small lymphocytic lymphoma|recurrent small lymphocytic lymphoma
664805|NCT00770419|intraocular lymphoma|intraocular lymphoma
664806|NCT00770419|primary central nervous system non-Hodgkin lymphoma|primary central nervous system non-hodgkin lymphoma
664807|NCT00770419|primary central nervous system Hodgkin lymphoma|primary central nervous system hodgkin lymphoma
664808|NCT00770419|chronic eosinophilic leukemia|chronic eosinophilic leukemia
664809|NCT00770419|chronic neutrophilic leukemia|chronic neutrophilic leukemia
664810|NCT00770419|primary myelofibrosis|primary myelofibrosis
664811|NCT00770419|primary systemic amyloidosis|primary systemic amyloidosis
664812|NCT00770419|refractory multiple myeloma|refractory multiple myeloma
664813|NCT00770419|previously treated myelodysplastic syndromes|previously treated myelodysplastic syndromes
664814|NCT00770419|secondary myelodysplastic syndromes|secondary myelodysplastic syndromes
664815|NCT00770419|myelodysplastic/myeloproliferative neoplasm, unclassifiable|myelodysplastic/myeloproliferative neoplasm, unclassifiable
664816|NCT00770393|squamous cell carcinoma of the pyriform sinus|squamous cell carcinoma of the pyriform sinus
664817|NCT00770393|laryngeal preservation|laryngeal preservation
665209|NCT00769197|optic disc|optic disc
664818|NCT00770393|patients with biopsy-proven previously untreated resectable T3 with fixed cord involvement squamous cell carcinoma of the pyriform sinus|patients with biopsy-proven previously untreated resectable t3 with fixed cord involvement squamous cell carcinoma of the pyriform sinus
664820|NCT00770367|Cardiovascular risk|cardiovascular risk
664821|NCT00770367|biological markers|biological markers
664822|NCT00770354|Breast cancer|breast cancer
664823|NCT00770328|Plasma PAI-1 level at 0, 4, 8 weeks|plasma pai-1 level at 0, 4, 8 weeks
664824|NCT00770328|Plasma hsCRP level at 0, 4, 8 weeks|plasma hscrp level at 0, 4, 8 weeks
664825|NCT00770328|Plasma TNF-a level at 0, 4, 8 weeks|plasma tnf-a level at 0, 4, 8 weeks
664826|NCT00770302|DPP-4 inhibitors|dpp-4 inhibitors
664827|NCT00770302|HBA1c|hba1c
664828|NCT00770302|Incretins|incretins
664829|NCT00770302|Pharmacokinetics|pharmacokinetics
664830|NCT00770276|obesity WHO I-III|obesity who i-iii
664831|NCT00770276|metabolic syndrome|metabolic syndrome
664832|NCT00770276|Framingham risk score|framingham risk score
664833|NCT00770276|subclinical atherosclerosis|subclinical atherosclerosis
664834|NCT00770276|endothelial dysfunction|endothelial dysfunction
664835|NCT00770263|any solid tumors|any solid tumors
664836|NCT00770250|asthma symptoms|asthma symptoms
664837|NCT00770250|words used by patients and physicians|words used by patients and physicians
664838|NCT00770250|express asthma symptoms|express asthma symptoms
664839|NCT00770237|Smoking|smoking
664840|NCT00770237|Nicotine|nicotine
664841|NCT00770237|Schizophrenia|schizophrenia
664842|NCT00770224|contiguous stage II grade 1 follicular lymphoma|contiguous stage ii grade 1 follicular lymphoma
664843|NCT00770224|contiguous stage II grade 2 follicular lymphoma|contiguous stage ii grade 2 follicular lymphoma
664844|NCT00770224|contiguous stage II grade 3 follicular lymphoma|contiguous stage ii grade 3 follicular lymphoma
664845|NCT00770224|noncontiguous stage II grade 1 follicular lymphoma|noncontiguous stage ii grade 1 follicular lymphoma
664846|NCT00770224|noncontiguous stage II grade 2 follicular lymphoma|noncontiguous stage ii grade 2 follicular lymphoma
665281|NCT00768859|carboplatin|carboplatin
664847|NCT00770224|noncontiguous stage II grade 3 follicular lymphoma|noncontiguous stage ii grade 3 follicular lymphoma
664848|NCT00770224|stage III grade 1 follicular lymphoma|stage iii grade 1 follicular lymphoma
664849|NCT00770224|stage III grade 2 follicular lymphoma|stage iii grade 2 follicular lymphoma
664850|NCT00770224|stage III grade 3 follicular lymphoma|stage iii grade 3 follicular lymphoma
664851|NCT00770224|stage IV grade 1 follicular lymphoma|stage iv grade 1 follicular lymphoma
664852|NCT00770224|stage IV grade 2 follicular lymphoma|stage iv grade 2 follicular lymphoma
664853|NCT00770224|stage IV grade 3 follicular lymphoma|stage iv grade 3 follicular lymphoma
664854|NCT00770198|liver|liver
664855|NCT00770198|alcohol|alcohol
664856|NCT00770198|HCV|hcv
664857|NCT00770185|endometrial adenocarcinoma|endometrial adenocarcinoma
664858|NCT00770185|endometrial adenosquamous cell carcinoma|endometrial adenosquamous cell carcinoma
664859|NCT00770185|endometrial clear cell carcinoma|endometrial clear cell carcinoma
664860|NCT00770185|endometrial papillary carcinoma|endometrial papillary carcinoma
664861|NCT00770185|recurrent endometrial carcinoma|recurrent endometrial carcinoma
664862|NCT00770185|stage III endometrial carcinoma|stage iii endometrial carcinoma
664863|NCT00770185|stage IV endometrial carcinoma|stage iv endometrial carcinoma
664864|NCT00770172|chemotherapeutic agent toxicity|chemotherapeutic agent toxicity
664865|NCT00770172|neutropenia|neutropenia
664866|NCT00770172|unspecified adult solid tumor, protocol specific|unspecified adult solid tumor, protocol specific
664867|NCT00770120|recurrent malignant mesothelioma|recurrent malignant mesothelioma
664868|NCT00770120|stage II malignant mesothelioma|stage ii malignant mesothelioma
664869|NCT00770120|stage III malignant mesothelioma|stage iii malignant mesothelioma
664870|NCT00770120|stage IV malignant mesothelioma|stage iv malignant mesothelioma
664871|NCT00770094|LASIK|lasik
664872|NCT00770094|Laser Vision correction|laser vision correction
664873|NCT00770094|Myopia|myopia
664874|NCT00770094|Myopia with astigmatism|myopia with astigmatism
664875|NCT00770094|Nearsighted|nearsighted
664876|NCT00770081|Type 2 diabetes|type 2 diabetes
664877|NCT00770081|vildagliptin|vildagliptin
664878|NCT00770068|Mood Disorders|mood disorders
664879|NCT00770068|Major Depressive Disorder|major depressive disorder
664880|NCT00770068|Bipolar Disorder|bipolar disorder
664881|NCT00770068|Tree Pollen|tree pollen
664882|NCT00770068|Ragweed Pollen|ragweed pollen
664883|NCT00770068|Rhinitis|rhinitis
664884|NCT00770068|Allergic|allergic
664885|NCT00770068|Seasonal|seasonal
664886|NCT00770068|Allergens|allergens
664887|NCT00770055|stage IV breast cancer|stage iv breast cancer
664888|NCT00770055|recurrent breast cancer|recurrent breast cancer
664889|NCT00770016|insulin sensitivity|insulin sensitivity
664890|NCT00770016|Substrate metabolism|substrate metabolism
664891|NCT00770016|Fatty liver|fatty liver
664892|NCT00770016|intramyocellular lipid|intramyocellular lipid
664893|NCT00770016|intracellular signaling|intracellular signaling
664894|NCT00770003|patients|patients
664895|NCT00770003|allergic rhinitis|allergic rhinitis
664896|NCT00770003|tolerability|tolerability
664897|NCT00770003|safety|safety
664898|NCT00770003|nasal symptoms|nasal symptoms
664899|NCT00769990|bone metastases|bone metastases
664900|NCT00769990|pain|pain
664901|NCT00769990|recurrent breast cancer|recurrent breast cancer
664902|NCT00769990|stage IV breast cancer|stage iv breast cancer
664903|NCT00769990|recurrent prostate cancer|recurrent prostate cancer
664904|NCT00769990|stage IV prostate cancer|stage iv prostate cancer
664905|NCT00769990|recurrent melanoma|recurrent melanoma
664906|NCT00769990|stage IV melanoma|stage iv melanoma
664907|NCT00769990|recurrent renal cell cancer|recurrent renal cell cancer
664908|NCT00769990|stage IV renal cell cancer|stage iv renal cell cancer
664909|NCT00769990|recurrent non-small cell lung cancer|recurrent non-small cell lung cancer
664910|NCT00769990|stage IV non-small cell lung cancer|stage iv non-small cell lung cancer
664911|NCT00769990|extensive stage small cell lung cancer|extensive stage small cell lung cancer
664912|NCT00769990|recurrent small cell lung cancer|recurrent small cell lung cancer
664913|NCT00769964|Healthy (Dysmenorrhea)|healthy (dysmenorrhea)
664914|NCT00769951|pain|pain
664915|NCT00769951|depression|depression
664916|NCT00769951|weight changes|weight changes
664917|NCT00769951|cognitive/functional effects|cognitive/functional effects
664918|NCT00769951|malnutrition|malnutrition
664919|NCT00769951|psychosocial effects of cancer and its treatment|psychosocial effects of cancer and its treatment
664920|NCT00769951|unspecified adult solid tumor, protocol specific|unspecified adult solid tumor, protocol specific
664921|NCT00769951|hematopoietic/lymphoid cancer|hematopoietic/lymphoid cancer
664922|NCT00769938|Atrial fibrillation|atrial fibrillation
664923|NCT00769938|Percutaneous coronary stenting|percutaneous coronary stenting
664924|NCT00769938|Bleeding complications|bleeding complications
664925|NCT00769938|Triple therapy|triple therapy
664926|NCT00769925|Generalized Anxiety|generalized anxiety
664927|NCT00769925|Social Phobia|social phobia
664928|NCT00769925|Separation Anxiety|separation anxiety
664929|NCT00769925|Phobia|phobia
664930|NCT00769899|AZD7325|azd7325
664931|NCT00769899|Japanese Healthy Volunteers|japanese healthy volunteers
664932|NCT00769899|Phase I study|phase i study
664933|NCT00769899|Single Ascending Dose|single ascending dose
664934|NCT00769873|anticoagulation|anticoagulation
664935|NCT00769873|thrombosis|thrombosis
664936|NCT00769873|portal vein thrombosis|portal vein thrombosis
664937|NCT00769873|splenic vein thrombosis|splenic vein thrombosis
664938|NCT00769873|splenectomy|splenectomy
664939|NCT00769873|randomized|randomized
664940|NCT00769873|laparoscopic splenectomy|laparoscopic splenectomy
664941|NCT00769873|lovenox|lovenox
664942|NCT00769860|myositis|myositis
664944|NCT00769860|inclusion body myositis|inclusion body myositis
664945|NCT00769847|Endoscopic, craniosynostosis, sagittal, synostosis|endoscopic, craniosynostosis, sagittal, synostosis
664946|NCT00769834|chronic kidney disease|chronic kidney disease
664947|NCT00769834|chronic renal insufficiency|chronic renal insufficiency
664948|NCT00769834|uremia|uremia
664949|NCT00769834|disc edema|disc edema
664950|NCT00769834|papilledema|papilledema
664951|NCT00769834|idiopathic intracranial hypertension|idiopathic intracranial hypertension
664952|NCT00769834|pseudotumor cerebri|pseudotumor cerebri
664953|NCT00769821|lymphedema|lymphedema
664954|NCT00769821|perioperative/postoperative complications|perioperative/postoperative complications
664955|NCT00769821|cancer survivor|cancer survivor
664956|NCT00769821|stage I breast cancer|stage i breast cancer
664957|NCT00769821|stage II breast cancer|stage ii breast cancer
664958|NCT00769821|stage IIIA breast cancer|stage iiia breast cancer
664959|NCT00769821|stage IIIB breast cancer|stage iiib breast cancer
664960|NCT00769821|stage IIIC breast cancer|stage iiic breast cancer
664961|NCT00769821|stage IV breast cancer|stage iv breast cancer
664962|NCT00769795|prostate cancer|prostate cancer
664963|NCT00769795|prostatic neoplasm|prostatic neoplasm
665282|NCT00768846|PCI|pci
664964|NCT00769795|androgen deprivation therapy|androgen deprivation therapy
664965|NCT00769795|insulin-like growth factor receptor I|insulin-like growth factor receptor i
664966|NCT00769795|neoadjuvant|neoadjuvant
664967|NCT00769795|prostatectomy|prostatectomy
664968|NCT00769782|gastrointestinal stromal tumor|gastrointestinal stromal tumor
664969|NCT00769782|liver metastases|liver metastases
664970|NCT00769769|Health Status|health status
711019|NCT00586846|Osteosarcoma|osteosarcoma
845807|NCT00004246|RT|rt
664971|NCT00769756|Different Strategies to Fight Obesity in Families|different strategies to fight obesity in families
664972|NCT00769730|hepatocellular carcinoma|hepatocellular carcinoma
664973|NCT00769730|hepatitis B virus|hepatitis b virus
664974|NCT00769730|transcatheter arterial chemoembolization|transcatheter arterial chemoembolization
664975|NCT00769717|obesity|obesity
664976|NCT00769717|wellness|wellness
664977|NCT00769717|cardiovascular disease prevention|cardiovascular disease prevention
664978|NCT00769717|health at every size|health at every size
664979|NCT00769717|weight loss|weight loss
664980|NCT00769704|Melanoma|melanoma
664981|NCT00769704|OncoVEX^GM-CSF|oncovex^gm-csf
664982|NCT00769704|GM-CSF|gm-csf
664983|NCT00769704|Stage IIIb, IIIc and IV Disease|stage iiib, iiic and iv disease
664984|NCT00769704|oncolytic|oncolytic
664985|NCT00769704|OncoVex|oncovex
664986|NCT00769704|T-Vec|t-vec
664987|NCT00769704|talimogene laherparepvec|talimogene laherparepvec
664988|NCT00769691|Cardiac surgery|cardiac surgery
664989|NCT00769691|Cerebral blood flow autoregulation|cerebral blood flow autoregulation
664990|NCT00769678|Biventricular Pacing|biventricular pacing
664991|NCT00769665|Dry Eye|dry eye
664992|NCT00769665|re-wetting drops|re-wetting drops
664993|NCT00769652|malnutrition|malnutrition
664994|NCT00769652|non-small cell lung cancer|non-small cell lung cancer
664995|NCT00769652|small cell lung cancer|small cell lung cancer
664996|NCT00769652|stage III prostate cancer|stage iii prostate cancer
664997|NCT00769652|stage IV prostate cancer|stage iv prostate cancer
664998|NCT00769652|pancreatic cancer|pancreatic cancer
664999|NCT00769652|weight changes|weight changes
665000|NCT00769626|Low Back Pain|low back pain
665001|NCT00769626|Clinical Practice Guidelines|clinical practice guidelines
665002|NCT00769626|Spinal Manipulation|spinal manipulation
665003|NCT00769626|Physical Therapy Techniques|physical therapy techniques
665004|NCT00769613|stage III adult Burkitt lymphoma|stage iii adult burkitt lymphoma
665005|NCT00769613|stage III adult diffuse large cell lymphoma|stage iii adult diffuse large cell lymphoma
665006|NCT00769613|stage III adult diffuse mixed cell lymphoma|stage iii adult diffuse mixed cell lymphoma
665007|NCT00769613|stage III adult diffuse small cleaved cell lymphoma|stage iii adult diffuse small cleaved cell lymphoma
665008|NCT00769613|stage III adult Hodgkin lymphoma|stage iii adult hodgkin lymphoma
665009|NCT00769613|stage III adult immunoblastic large cell lymphoma|stage iii adult immunoblastic large cell lymphoma
665010|NCT00769613|stage III adult lymphoblastic lymphoma|stage iii adult lymphoblastic lymphoma
665011|NCT00769613|stage III grade 1 follicular lymphoma|stage iii grade 1 follicular lymphoma
665012|NCT00769613|stage III grade 2 follicular lymphoma|stage iii grade 2 follicular lymphoma
665013|NCT00769613|stage III grade 3 follicular lymphoma|stage iii grade 3 follicular lymphoma
665014|NCT00769613|stage III mantle cell lymphoma|stage iii mantle cell lymphoma
665015|NCT00769613|stage III marginal zone lymphoma|stage iii marginal zone lymphoma
665016|NCT00769613|stage III small lymphocytic lymphoma|stage iii small lymphocytic lymphoma
665017|NCT00769613|stage IV adult Burkitt lymphoma|stage iv adult burkitt lymphoma
665018|NCT00769613|stage IV adult diffuse large cell lymphoma|stage iv adult diffuse large cell lymphoma
665019|NCT00769613|stage IV adult diffuse mixed cell lymphoma|stage iv adult diffuse mixed cell lymphoma
665020|NCT00769613|stage IV adult diffuse small cleaved cell lymphoma|stage iv adult diffuse small cleaved cell lymphoma
665021|NCT00769613|stage IV adult Hodgkin lymphoma|stage iv adult hodgkin lymphoma
665022|NCT00769613|stage IV adult immunoblastic large cell lymphoma|stage iv adult immunoblastic large cell lymphoma
665023|NCT00769613|stage IV adult lymphoblastic lymphoma|stage iv adult lymphoblastic lymphoma
665024|NCT00769613|stage IV grade 1 follicular lymphoma|stage iv grade 1 follicular lymphoma
665025|NCT00769613|stage IV grade 2 follicular lymphoma|stage iv grade 2 follicular lymphoma
665026|NCT00769613|stage IV grade 3 follicular lymphoma|stage iv grade 3 follicular lymphoma
665027|NCT00769613|stage IV mantle cell lymphoma|stage iv mantle cell lymphoma
665028|NCT00769613|stage IV marginal zone lymphoma|stage iv marginal zone lymphoma
665029|NCT00769613|stage IV small lymphocytic lymphoma|stage iv small lymphocytic lymphoma
665030|NCT00769613|recurrent adult Burkitt lymphoma|recurrent adult burkitt lymphoma
665031|NCT00769613|recurrent adult diffuse large cell lymphoma|recurrent adult diffuse large cell lymphoma
665032|NCT00769613|recurrent adult diffuse mixed cell lymphoma|recurrent adult diffuse mixed cell lymphoma
665033|NCT00769613|recurrent adult diffuse small cleaved cell lymphoma|recurrent adult diffuse small cleaved cell lymphoma
665034|NCT00769613|recurrent adult Hodgkin lymphoma|recurrent adult hodgkin lymphoma
665035|NCT00769613|recurrent adult immunoblastic large cell lymphoma|recurrent adult immunoblastic large cell lymphoma
665036|NCT00769613|recurrent adult lymphoblastic lymphoma|recurrent adult lymphoblastic lymphoma
665037|NCT00769613|recurrent childhood large cell lymphoma|recurrent childhood large cell lymphoma
665038|NCT00769613|recurrent childhood lymphoblastic lymphoma|recurrent childhood lymphoblastic lymphoma
665039|NCT00769613|recurrent childhood small noncleaved cell lymphoma|recurrent childhood small noncleaved cell lymphoma
665040|NCT00769613|recurrent cutaneous T-cell non-Hodgkin lymphoma|recurrent cutaneous t-cell non-hodgkin lymphoma
665041|NCT00769613|recurrent grade 1 follicular lymphoma|recurrent grade 1 follicular lymphoma
665042|NCT00769613|recurrent grade 2 follicular lymphoma|recurrent grade 2 follicular lymphoma
665043|NCT00769613|recurrent grade 3 follicular lymphoma|recurrent grade 3 follicular lymphoma
665044|NCT00769613|recurrent mantle cell lymphoma|recurrent mantle cell lymphoma
665045|NCT00769613|recurrent marginal zone lymphoma|recurrent marginal zone lymphoma
665046|NCT00769613|recurrent small lymphocytic lymphoma|recurrent small lymphocytic lymphoma
665047|NCT00769613|recurrent/refractory childhood Hodgkin lymphoma|recurrent/refractory childhood hodgkin lymphoma
665048|NCT00769613|recurrent mycosis fungoides/Sezary syndrome|recurrent mycosis fungoides/sezary syndrome
665049|NCT00769613|extranodal marginal zone B-cell lymphoma of mucosa-associated lymphoid tissue|extranodal marginal zone b-cell lymphoma of mucosa-associated lymphoid tissue
665050|NCT00769613|nodal marginal zone B-cell lymphoma|nodal marginal zone b-cell lymphoma
665051|NCT00769613|splenic marginal zone lymphoma|splenic marginal zone lymphoma
665052|NCT00769613|noncontiguous stage II adult Burkitt lymphoma|noncontiguous stage ii adult burkitt lymphoma
665053|NCT00769613|noncontiguous stage II adult diffuse large cell lymphoma|noncontiguous stage ii adult diffuse large cell lymphoma
665054|NCT00769613|noncontiguous stage II adult diffuse mixed cell lymphoma|noncontiguous stage ii adult diffuse mixed cell lymphoma
665055|NCT00769613|noncontiguous stage II adult diffuse small cleaved cell lymphoma|noncontiguous stage ii adult diffuse small cleaved cell lymphoma
665056|NCT00769613|noncontiguous stage II adult immunoblastic large cell lymphoma|noncontiguous stage ii adult immunoblastic large cell lymphoma
665057|NCT00769613|noncontiguous stage II adult lymphoblastic lymphoma|noncontiguous stage ii adult lymphoblastic lymphoma
665058|NCT00769613|noncontiguous stage II grade 1 follicular lymphoma|noncontiguous stage ii grade 1 follicular lymphoma
665059|NCT00769613|noncontiguous stage II grade 2 follicular lymphoma|noncontiguous stage ii grade 2 follicular lymphoma
665060|NCT00769613|noncontiguous stage II grade 3 follicular lymphoma|noncontiguous stage ii grade 3 follicular lymphoma
665061|NCT00769613|noncontiguous stage II mantle cell lymphoma|noncontiguous stage ii mantle cell lymphoma
665062|NCT00769613|noncontiguous stage II marginal zone lymphoma|noncontiguous stage ii marginal zone lymphoma
665063|NCT00769613|noncontiguous stage II small lymphocytic lymphoma|noncontiguous stage ii small lymphocytic lymphoma
665064|NCT00769613|accelerated phase chronic myelogenous leukemia|accelerated phase chronic myelogenous leukemia
665065|NCT00769613|adult acute lymphoblastic leukemia in remission|adult acute lymphoblastic leukemia in remission
665066|NCT00769613|adult acute myeloid leukemia in remission|adult acute myeloid leukemia in remission
665067|NCT00769613|adult acute myeloid leukemia with 11q23 (MLL) abnormalities|adult acute myeloid leukemia with 11q23 (mll) abnormalities
665068|NCT00769613|adult acute myeloid leukemia with inv(16)(p13;q22)|adult acute myeloid leukemia with inv(16)(p13;q22)
665069|NCT00769613|adult acute myeloid leukemia with t(15;17)(q22;q12)|adult acute myeloid leukemia with t(15;17)(q22;q12)
665070|NCT00769613|adult acute myeloid leukemia with t(16;16)(p13;q22)|adult acute myeloid leukemia with t(16;16)(p13;q22)
665071|NCT00769613|adult acute myeloid leukemia with t(8;21)(q22;q22)|adult acute myeloid leukemia with t(8;21)(q22;q22)
665072|NCT00769613|atypical chronic myeloid leukemia, BCR-ABL1 negative|atypical chronic myeloid leukemia, bcr-abl1 negative
665073|NCT00769613|blastic phase chronic myelogenous leukemia|blastic phase chronic myelogenous leukemia
665074|NCT00769613|childhood acute lymphoblastic leukemia in remission|childhood acute lymphoblastic leukemia in remission
665075|NCT00769613|childhood acute myeloid leukemia in remission|childhood acute myeloid leukemia in remission
665076|NCT00769613|childhood chronic myelogenous leukemia|childhood chronic myelogenous leukemia
665077|NCT00769613|chronic myelomonocytic leukemia|chronic myelomonocytic leukemia
665078|NCT00769613|chronic phase chronic myelogenous leukemia|chronic phase chronic myelogenous leukemia
665079|NCT00769613|juvenile myelomonocytic leukemia|juvenile myelomonocytic leukemia
665080|NCT00769613|recurrent adult acute lymphoblastic leukemia|recurrent adult acute lymphoblastic leukemia
665081|NCT00769613|recurrent adult acute myeloid leukemia|recurrent adult acute myeloid leukemia
665082|NCT00769613|recurrent childhood acute lymphoblastic leukemia|recurrent childhood acute lymphoblastic leukemia
665083|NCT00769613|recurrent childhood acute myeloid leukemia|recurrent childhood acute myeloid leukemia
665084|NCT00769613|refractory chronic lymphocytic leukemia|refractory chronic lymphocytic leukemia
665085|NCT00769613|refractory hairy cell leukemia|refractory hairy cell leukemia
665086|NCT00769613|relapsing chronic myelogenous leukemia|relapsing chronic myelogenous leukemia
665087|NCT00769613|secondary acute myeloid leukemia|secondary acute myeloid leukemia
665088|NCT00769613|stage III chronic lymphocytic leukemia|stage iii chronic lymphocytic leukemia
665089|NCT00769613|stage IV chronic lymphocytic leukemia|stage iv chronic lymphocytic leukemia
665090|NCT00769613|childhood myelodysplastic syndromes|childhood myelodysplastic syndromes
665091|NCT00769613|chronic eosinophilic leukemia|chronic eosinophilic leukemia
665092|NCT00769613|primary myelofibrosis|primary myelofibrosis
665093|NCT00769613|chronic neutrophilic leukemia|chronic neutrophilic leukemia
665094|NCT00769613|de novo myelodysplastic syndromes|de novo myelodysplastic syndromes
665095|NCT00769613|disseminated neuroblastoma|disseminated neuroblastoma
665096|NCT00769613|myelodysplastic/myeloproliferative neoplasm, unclassifiable|myelodysplastic/myeloproliferative neoplasm, unclassifiable
665097|NCT00769613|high risk metastatic gestational trophoblastic tumor|high risk metastatic gestational trophoblastic tumor
665098|NCT00769613|previously treated childhood rhabdomyosarcoma|previously treated childhood rhabdomyosarcoma
665099|NCT00769613|previously treated myelodysplastic syndromes|previously treated myelodysplastic syndromes
665100|NCT00769613|recurrent Wilms tumor and other childhood kidney tumors|recurrent wilms tumor and other childhood kidney tumors
665101|NCT00769613|recurrent childhood rhabdomyosarcoma|recurrent childhood rhabdomyosarcoma
665102|NCT00769613|recurrent neuroblastoma|recurrent neuroblastoma
665103|NCT00769613|recurrent ovarian epithelial cancer|recurrent ovarian epithelial cancer
665104|NCT00769613|recurrent ovarian germ cell tumor|recurrent ovarian germ cell tumor
665105|NCT00769613|recurrent malignant testicular germ cell tumor|recurrent malignant testicular germ cell tumor
665106|NCT00769613|secondary myelodysplastic syndromes|secondary myelodysplastic syndromes
665107|NCT00769613|stage I multiple myeloma|stage i multiple myeloma
665108|NCT00769613|stage II multiple myeloma|stage ii multiple myeloma
665109|NCT00769613|stage III multiple myeloma|stage iii multiple myeloma
665110|NCT00769613|stage II ovarian epithelial cancer|stage ii ovarian epithelial cancer
665111|NCT00769613|stage III ovarian epithelial cancer|stage iii ovarian epithelial cancer
665112|NCT00769613|stage IV ovarian epithelial cancer|stage iv ovarian epithelial cancer
665113|NCT00769613|stage III malignant testicular germ cell tumor|stage iii malignant testicular germ cell tumor
665114|NCT00769613|stage IIIA breast cancer|stage iiia breast cancer
665115|NCT00769613|stage IIIB breast cancer|stage iiib breast cancer
665116|NCT00769613|stage IIIC breast cancer|stage iiic breast cancer
665117|NCT00769613|stage IV breast cancer|stage iv breast cancer
665118|NCT00769613|refractory multiple myeloma|refractory multiple myeloma
665119|NCT00769613|cytomegalovirus infection|cytomegalovirus infection
665120|NCT00769600|Recurrent Non-Small Cell Lung Cancer|recurrent non-small cell lung cancer
665121|NCT00769587|aggressive systemic mastocytosis|aggressive systemic mastocytosis
665210|NCT00769197|optic nerve|optic nerve
665122|NCT00769587|smoldering systemic mastocytosis|smoldering systemic mastocytosis
665123|NCT00769561|Temporomandibular disorders|temporomandibular disorders
665124|NCT00769561|Biofeedback|biofeedback
665125|NCT00769561|Cognitive behavioral therapy|cognitive behavioral therapy
665127|NCT00769548|adenocarcinoma of the prostate|adenocarcinoma of the prostate
665128|NCT00769548|stage I prostate cancer|stage i prostate cancer
665129|NCT00769548|stage IIB prostate cancer|stage iib prostate cancer
665130|NCT00769548|stage IIA prostate cancer|stage iia prostate cancer
665131|NCT00769548|stage III prostate cancer|stage iii prostate cancer
665132|NCT00769548|stage IV prostate cancer|stage iv prostate cancer
665133|NCT00769535|heat shock protein70|heat shock protein70
665134|NCT00769535|tumor necrosis factor-alpha promoter|tumor necrosis factor-alpha promoter
665135|NCT00769535|polymorphism|polymorphism
665136|NCT00769522|B-cell chronic lymphocytic leukemia|b-cell chronic lymphocytic leukemia
665137|NCT00769522|stage 0 chronic lymphocytic leukemia|stage 0 chronic lymphocytic leukemia
665138|NCT00769522|stage I chronic lymphocytic leukemia|stage i chronic lymphocytic leukemia
665139|NCT00769522|stage II chronic lymphocytic leukemia|stage ii chronic lymphocytic leukemia
665140|NCT00769522|stage III chronic lymphocytic leukemia|stage iii chronic lymphocytic leukemia
665141|NCT00769522|stage IV chronic lymphocytic leukemia|stage iv chronic lymphocytic leukemia
665142|NCT00769509|energy expenditure|energy expenditure
665143|NCT00769509|indirect calorimetry|indirect calorimetry
665144|NCT00769509|human milk|human milk
665145|NCT00769509|preterm formula|preterm formula
665146|NCT00769509|premature infant|premature infant
665147|NCT00769483|Pancreas|pancreas
665148|NCT00769483|Pancreatic Cancer|pancreatic cancer
665149|NCT00769483|Advanced cancer of the pancreas|advanced cancer of the pancreas
665150|NCT00769483|Pancreatic Adenocarcinoma|pancreatic adenocarcinoma
665151|NCT00769483|MK-0646|mk-0646
665152|NCT00769483|Gemcitabine|gemcitabine
665153|NCT00769483|Gemzar|gemzar
665154|NCT00769483|Erlotinib hydrochloride|erlotinib hydrochloride
665155|NCT00769483|Erlotinib|erlotinib
665156|NCT00769483|OSI-774|osi-774
665157|NCT00769483|Tarceva|tarceva
665158|NCT00769470|stage I breast cancer|stage i breast cancer
665159|NCT00769470|stage II breast cancer|stage ii breast cancer
665160|NCT00769470|stage IIIA breast cancer|stage iiia breast cancer
665161|NCT00769470|stage IIIB breast cancer|stage iiib breast cancer
665162|NCT00769470|stage IIIC breast cancer|stage iiic breast cancer
665163|NCT00769470|HER2-positive breast cancer|her2-positive breast cancer
665164|NCT00769431|stage I prostate cancer|stage i prostate cancer
665165|NCT00769431|stage IIB prostate cancer|stage iib prostate cancer
665166|NCT00769431|stage IIA prostate cancer|stage iia prostate cancer
665167|NCT00769405|recurrent colon cancer|recurrent colon cancer
665168|NCT00769405|stage IV colon cancer|stage iv colon cancer
665169|NCT00769405|recurrent rectal cancer|recurrent rectal cancer
665170|NCT00769405|stage IV rectal cancer|stage iv rectal cancer
665171|NCT00769405|peritoneal carcinomatosis|peritoneal carcinomatosis
665172|NCT00769392|Macular Degeneration|macular degeneration
665173|NCT00769392|Intravitreal injections|intravitreal injections
665174|NCT00769392|Eye anesthesia-Topical/subconjunctival|eye anesthesia-topical/subconjunctival
665175|NCT00769392|Eye-surgical procedures|eye-surgical procedures
665176|NCT00769392|Ophthalmologic anesthesia methods|ophthalmologic anesthesia methods
665177|NCT00769327|chronic myelogenous leukemia, BCR-ABL1 positive|chronic myelogenous leukemia, bcr-abl1 positive
665178|NCT00769327|chronic phase chronic myelogenous leukemia|chronic phase chronic myelogenous leukemia
665179|NCT00769301|Symptoms|symptoms
665180|NCT00769301|pain|pain
665181|NCT00769301|fatigue|fatigue
665182|NCT00769301|depression|depression
665183|NCT00769301|sleeplessness|sleeplessness
665184|NCT00769301|genetic markers|genetic markers
665185|NCT00769301|caregiver burden.|caregiver burden.
665186|NCT00769275|silent ischemia|silent ischemia
665187|NCT00769275|type 2 diabetes mellitus|type 2 diabetes mellitus
665188|NCT00769275|screening|screening
665189|NCT00769275|cardiac outcome|cardiac outcome
665190|NCT00769275|Prevalence silent myocardial ischemia|prevalence silent myocardial ischemia
665191|NCT00769275|Cardiac outcome in screened and not-screened subjects|cardiac outcome in screened and not-screened subjects
665192|NCT00769262|Premature neonates|premature neonates
665193|NCT00769262|Thermoregulation|thermoregulation
665194|NCT00769262|Isolette|isolette
665195|NCT00769262|Feeding status|feeding status
665196|NCT00769249|psychosocial effects of cancer and its treatment|psychosocial effects of cancer and its treatment
665197|NCT00769249|unspecified adult solid tumor, protocol specific|unspecified adult solid tumor, protocol specific
665198|NCT00769223|radiation toxicity|radiation toxicity
665199|NCT00769223|recurrent prostate cancer|recurrent prostate cancer
665200|NCT00769223|stage IIB prostate cancer|stage iib prostate cancer
665201|NCT00769223|stage IIA prostate cancer|stage iia prostate cancer
665202|NCT00769223|stage III prostate cancer|stage iii prostate cancer
665203|NCT00769223|stage I prostate cancer|stage i prostate cancer
665204|NCT00769223|stage IV prostate cancer|stage iv prostate cancer
665205|NCT00769223|adenocarcinoma of the prostate|adenocarcinoma of the prostate
665206|NCT00769197|optic disc cupping|optic disc cupping
665207|NCT00769197|cerebral palsy|cerebral palsy
665208|NCT00769197|static encephalopathy|static encephalopathy
665211|NCT00769197|periventricular Leukomalacia|periventricular leukomalacia
665212|NCT00769184|chronic plaque psoriasis|chronic plaque psoriasis
665213|NCT00769171|Complicated Intra-Abdominal Infections|complicated intra-abdominal infections
665214|NCT00769158|Alcohol|alcohol
665215|NCT00769158|Alcoholism|alcoholism
665216|NCT00769158|Alcohol Dependence|alcohol dependence
665217|NCT00769145|Corneal neovascularization|corneal neovascularization
665218|NCT00769145|Ranibizumab|ranibizumab
665219|NCT00769145|Corneal transplantation|corneal transplantation
665220|NCT00769119|bronchiectasis|bronchiectasis
665221|NCT00769119|Phase II|phase ii
665222|NCT00769106|hepatocellular carcinoma|hepatocellular carcinoma
665223|NCT00769106|recurrent|recurrent
665224|NCT00769106|cytokine-induced killer cell|cytokine-induced killer cell
665225|NCT00769093|ferumoxytol|ferumoxytol
665226|NCT00769093|diagnostic imaging|diagnostic imaging
665227|NCT00769080|PSP|psp
665228|NCT00769080|Standard Treatment|standard treatment
665229|NCT00769080|Standard Treatment plus PSP|standard treatment plus psp
665230|NCT00769067|Lung cancer|lung cancer
665231|NCT00769067|advanced|advanced
665232|NCT00769067|second or third line|second or third line
665233|NCT00769054|Postoperative pain|postoperative pain
665234|NCT00769054|PONV|ponv
665235|NCT00769028|Systemic sclerosis|systemic sclerosis
665236|NCT00769028|Diffuse cutaneous systemic sclerosis|diffuse cutaneous systemic sclerosis
665237|NCT00769028|Scleroderma|scleroderma
665238|NCT00769028|Biological|biological
665239|NCT00769028|Hyperimmune caprine serum|hyperimmune caprine serum
665240|NCT00769028|Goat Serum|goat serum
665241|NCT00769015|age-related macular degeneration|age-related macular degeneration
665242|NCT00769015|depression|depression
665243|NCT00769015|vision loss|vision loss
665244|NCT00769002|influenza|influenza
665245|NCT00769002|flu|flu
665246|NCT00769002|vaccine|vaccine
665247|NCT00769002|vaccination|vaccination
665248|NCT00769002|immune response|immune response
665249|NCT00769002|FluShield|flushield
665250|NCT00769002|FluMist|flumist
665251|NCT00769002|PET-CT|pet-ct
665252|NCT00769002|Healthy Volunteers|healthy volunteers
665253|NCT00768989|Combination Therapy|combination therapy
665254|NCT00768976|Participant must have participated in a clinical trial conducted by the Summa Health System Hospitals Cancer Research Program.|participant must have participated in a clinical trial conducted by the summa health system hospitals cancer research program.
665255|NCT00768976|Participant should have been registered for clinical trial participation three months prior to receiving the satisfaction survey.|participant should have been registered for clinical trial participation three months prior to receiving the satisfaction survey.
665256|NCT00768963|ranibizumab|ranibizumab
665257|NCT00768963|pterygium|pterygium
665258|NCT00768950|Seronegative spondyloarthropathies|seronegative spondyloarthropathies
665259|NCT00768950|Endoscopic capsule examination|endoscopic capsule examination
665260|NCT00768950|Small bowel and colon lesions|small bowel and colon lesions
665261|NCT00768950|Nonsteroidal anti-inflammatory drugs|nonsteroidal anti-inflammatory drugs
665262|NCT00768950|Anti TNF Alpha Drugs|anti tnf alpha drugs
665263|NCT00768937|hepatocellular carcinoma|hepatocellular carcinoma
665264|NCT00768937|sorafenib|sorafenib
665265|NCT00768937|transarterial chemoembolization|transarterial chemoembolization
665266|NCT00768937|tumor angiogenesis|tumor angiogenesis
665267|NCT00768937|angiogenic factors|angiogenic factors
665268|NCT00768924|Bone Void Filler|bone void filler
665269|NCT00768924|Post-Harvest Iliac Crest|post-harvest iliac crest
665270|NCT00768924|Ability of CopiOs to fill the post-harvest iliac crest bone void created by a surgeon during spinal fusion.|ability of copios to fill the post-harvest iliac crest bone void created by a surgeon during spinal fusion.
665271|NCT00768911|glioblastoma|glioblastoma
665272|NCT00768911|Glioblastoma multiforme (newly diagnosed)|glioblastoma multiforme (newly diagnosed)
665273|NCT00768898|conjunctival|conjunctival
665274|NCT00768898|staining|staining
665275|NCT00768872|activity, spinal cord stimulation, pain|activity, spinal cord stimulation, pain
665276|NCT00768859|breast cancer|breast cancer
665277|NCT00768859|HER2 positive|her2 positive
665278|NCT00768859|neo-adjuvant|neo-adjuvant
665279|NCT00768859|trastuzumab|trastuzumab
665280|NCT00768859|paclitaxel|paclitaxel
665283|NCT00768846|Stent|stent
665284|NCT00768846|DES|des
665285|NCT00768846|CAD|cad
665286|NCT00768833|S.pneumoniae healthy subjects|s.pneumoniae healthy subjects
665287|NCT00768833|Healthy subjects|healthy subjects
665288|NCT00768820|Velocardiofacial syndrome|velocardiofacial syndrome
665289|NCT00768820|Williams syndrome|williams syndrome
665290|NCT00768820|fragile X syndrome|fragile x syndrome
665291|NCT00768820|cognitive phenotype|cognitive phenotype
665292|NCT00768820|psychiatric phenotype|psychiatric phenotype
665293|NCT00768794|thrush|thrush
665294|NCT00768781|insomnia|insomnia
665295|NCT00768781|hyperarousal|hyperarousal
665296|NCT00768781|mindfulness meditation|mindfulness meditation
665297|NCT00768781|complementary and alternative medicine|complementary and alternative medicine
665298|NCT00768781|cognitive-behavioral therapy|cognitive-behavioral therapy
665299|NCT00768768|iontophoresis|iontophoresis
665300|NCT00768768|terbinafine|terbinafine
665301|NCT00768768|onychomycosis|onychomycosis
665302|NCT00768755|non-squamous NSCLC|non-squamous nsclc
665303|NCT00768755|axitinib|axitinib
665304|NCT00768755|pemetrexed/cisplatin|pemetrexed/cisplatin
665305|NCT00768742|Uterine Fibroid RF Ablation|uterine fibroid rf ablation
665306|NCT00768742|Intrauterine Ultrasound|intrauterine ultrasound
665307|NCT00768742|VizAblate|vizablate
665308|NCT00768729|End stage renal disease|end stage renal disease
665309|NCT00768729|Kidney transplantation|kidney transplantation
665310|NCT00768729|Renal transplantation|renal transplantation
665311|NCT00768729|Kidney failure|kidney failure
665312|NCT00768729|Children|children
665313|NCT00768729|Adolescents|adolescents
665314|NCT00768729|Sirolimus|sirolimus
665315|NCT00768729|Rapamycin|rapamycin
665316|NCT00768729|CellCept|cellcept
665317|NCT00768729|Mycophenolate mofetil (MMF)|mycophenolate mofetil (mmf)
665318|NCT00768729|Azathioprine|azathioprine
665319|NCT00768703|Congenital diaphragmatic hernia|congenital diaphragmatic hernia
665320|NCT00768703|lung-head ratio|lung-head ratio
665321|NCT00768703|percutaneous tracheal occlusion|percutaneous tracheal occlusion
665322|NCT00768703|fetal intervention|fetal intervention
665323|NCT00768677|binge eating behavior|binge eating behavior
665324|NCT00768677|adolescents|adolescents
665325|NCT00768664|recurrent or metastatic squamous cell cancer of the Head and Neck; no prior systemic therapy for recurrence|recurrent or metastatic squamous cell cancer of the head and neck; no prior systemic therapy for recurrence
665326|NCT00768638|Chronic kidney disease|chronic kidney disease
665327|NCT00768612|Acute, Schizophrenia, Phase2a, Vabicaserin|acute, schizophrenia, phase2a, vabicaserin
665328|NCT00768599|Econazole|econazole
665329|NCT00768599|Foam|foam
665330|NCT00768599|Quinnova|quinnova
665331|NCT00768573|taste test|taste test
665332|NCT00768534|Acute Otitis Media|acute otitis media
665333|NCT00768534|Serotype distribution|serotype distribution
665334|NCT00768508|Alcohol|alcohol
665335|NCT00768508|Alcohol Dependence|alcohol dependence
665336|NCT00768508|Alcoholism|alcoholism
665337|NCT00768495|revascularization|revascularization
665338|NCT00768495|claudication|claudication
665339|NCT00768495|hyperspectral|hyperspectral
665340|NCT00768495|oxygenation|oxygenation
665341|NCT00768495|limb ischemia|limb ischemia
665342|NCT00768482|opioid dependence|opioid dependence
665343|NCT00768482|opioid addiction|opioid addiction
665344|NCT00768482|buprenorphine|buprenorphine
665345|NCT00768482|methadone|methadone
665346|NCT00768482|heroin|heroin
665347|NCT00768482|implant|implant
665348|NCT00768482|opioid withdrawal|opioid withdrawal
665349|NCT00768482|opioid pain medication|opioid pain medication
665350|NCT00768482|suboxone|suboxone
665351|NCT00768469|HKI-272|hki-272
665352|NCT00768469|Paclitaxel|paclitaxel
665353|NCT00768469|Combination|combination
665354|NCT00768469|Solid Tumor|solid tumor
665355|NCT00768443|GERD|gerd
665356|NCT00768443|PPI|ppi
665357|NCT00768417|Nuts|nuts
665358|NCT00768417|Lipids|lipids
665359|NCT00768417|Mastication|mastication
665360|NCT00768417|Bioaccessibility|bioaccessibility
665361|NCT00768417|Satiety|satiety
665362|NCT00768417|Hormones|hormones
665363|NCT00768417|Human|human
665364|NCT00768391|Tumors|tumors
665365|NCT00768391|Lymphoma|lymphoma
665366|NCT00768391|Antibodies, Monoclonal|antibodies, monoclonal
665367|NCT00768378|Physical Therapy (Specialty)|physical therapy (specialty)
665368|NCT00768378|Balance dysfunction or disorder|balance dysfunction or disorder
665369|NCT00768378|Vestibular|vestibular
665370|NCT00768378|Rehabilitation|rehabilitation
665371|NCT00768365|adrenal incidentaloma|adrenal incidentaloma
665372|NCT00768365|cardiovascular risk|cardiovascular risk
665373|NCT00768352|Pediatric|pediatric
665374|NCT00768352|Resident|resident
665375|NCT00768352|Depression|depression
665376|NCT00768352|Screening|screening
665377|NCT00768352|Substance Abuse|substance abuse
665378|NCT00768352|Pediatric Resident knowledge of mental health topics|pediatric resident knowledge of mental health topics
665379|NCT00768352|Pediatric Resident current practices for screening and treating mental health disorders|pediatric resident current practices for screening and treating mental health disorders
665380|NCT00768352|Pediatric Resident mental health care competency|pediatric resident mental health care competency
665381|NCT00768339|antisense|antisense
665382|NCT00768339|AEG35156|aeg35156
665383|NCT00768339|lymphocytic|lymphocytic
665384|NCT00768339|lymphoma|lymphoma
665385|NCT00768339|leukemia|leukemia
665386|NCT00768339|B-cell|b-cell
665387|NCT00768326|Schizophrenia|schizophrenia
665388|NCT00768326|Antipsychotic|antipsychotic
665389|NCT00768326|Lu 31-130|lu 31-130
665390|NCT00768313|scoliosis correction rod strength adolescent|scoliosis correction rod strength adolescent
665391|NCT00768300|idiopathic pulmonary fibrosis|idiopathic pulmonary fibrosis
665392|NCT00768300|interstitial lung disease|interstitial lung disease
665393|NCT00768300|ambrisentan|ambrisentan
665394|NCT00768274|Cholesterol|cholesterol
665395|NCT00768274|High density lipoprotein|high density lipoprotein
665396|NCT00768274|Dyslipidemia|dyslipidemia
665397|NCT00768274|Atherosclerosis|atherosclerosis
665398|NCT00768274|Apolipoprotein A-I|apolipoprotein a-i
665399|NCT00768261|Dementia of the Alzheimer type|dementia of the alzheimer type
665400|NCT00768248|pain|pain
665401|NCT00768248|phantom limb|phantom limb
665402|NCT00768248|stump pain|stump pain
665405|NCT00768248|peripheral nerve block|peripheral nerve block
665406|NCT00768248|NMCSD|nmcsd
665407|NCT00768248|Post-Amputation Phantom Limb or Stump Pain|post-amputation phantom limb or stump pain
665408|NCT00768235|Sedentary elderly women that had medical assignment|sedentary elderly women that had medical assignment
665409|NCT00768222|wound healing|wound healing
665410|NCT00768209|Pharmacokinetics|pharmacokinetics
665411|NCT00768196|GERD|gerd
665412|NCT00768196|Korea|korea
665413|NCT00768196|typical symptom|typical symptom
665414|NCT00768196|quality of life|quality of life
665415|NCT00768196|Naturalistic|naturalistic
665416|NCT00768196|epidemiological|epidemiological
665417|NCT00768183|KADIAN|kadian
665418|NCT00768183|morphine|morphine
665419|NCT00768183|alcohol|alcohol
665420|NCT00768183|water|water
665421|NCT00768183|Ethanol|ethanol
665422|NCT00768183|solution|solution
665423|NCT00768183|fed|fed
665424|NCT00768183|fasting|fasting
665425|NCT00768157|hepatocellular carcinoma|hepatocellular carcinoma
665426|NCT00768157|hepatitis B virus|hepatitis b virus
665427|NCT00768157|surgery|surgery
665428|NCT00768157|anti-virus|anti-virus
665429|NCT00768157|recurrence|recurrence
665430|NCT00768144|Sutent|sutent
665431|NCT00768144|sunitinib|sunitinib
665432|NCT00768118|healthy, no evidence of disease|healthy, no evidence of disease
665433|NCT00768105|Type 2 diabetes|type 2 diabetes
665434|NCT00768079|Benralizumab|benralizumab
665435|NCT00768079|MEDI-563|medi-563
665436|NCT00768079|Asthma|asthma
665437|NCT00768066|Chronic Ischemic Left Ventricular Dysfunction|chronic ischemic left ventricular dysfunction
665438|NCT00768053|EULAR-RAID|eular-raid
665439|NCT00768053|active rheumatoid arthritis|active rheumatoid arthritis
665440|NCT00768053|etanercept|etanercept
665441|NCT00768040|Diabetes|diabetes
665442|NCT00768040|Macular edema|macular edema
665443|NCT00768040|Aliskiren|aliskiren
665444|NCT00768040|Diabetic retinopathy|diabetic retinopathy
665445|NCT00768040|Diabetes mellitus type 1|diabetes mellitus type 1
665446|NCT00768040|Diabetes mellitus type 2|diabetes mellitus type 2
665447|NCT00768027|hyperspectral imaging|hyperspectral imaging
665448|NCT00768027|tissue oxygenation|tissue oxygenation
665449|NCT00768027|wounds|wounds
665450|NCT00768027|wound healing|wound healing
665451|NCT00768027|prevention|prevention
665452|NCT00768027|hyperbaric|hyperbaric
665453|NCT00767988|Probiotics|probiotics
665454|NCT00767988|Spina Bifida|spina bifida
665455|NCT00767988|Dietary Supplements|dietary supplements
665456|NCT00767988|Bacteriuria|bacteriuria
665457|NCT00767988|Urinary Tract Infection (UTI)|urinary tract infection (uti)
665458|NCT00767962|recurrent primary spontaneous pneumothorax|recurrent primary spontaneous pneumothorax
665459|NCT00767949|wet|wet
665460|NCT00767949|AMD|amd
665461|NCT00767923|hyperspectral imaging|hyperspectral imaging
665462|NCT00767923|tissue oxygenation|tissue oxygenation
665463|NCT00767923|foot amputation|foot amputation
665464|NCT00767923|critical limb ischemia|critical limb ischemia
665465|NCT00767923|tissue necrosis|tissue necrosis
665466|NCT00767897|Dose response relationship|dose response relationship
665467|NCT00767897|immunity|immunity
665468|NCT00767884|panretinal photocoagulation|panretinal photocoagulation
665469|NCT00767884|diabetic retinopathy|diabetic retinopathy
665470|NCT00767884|optic nerve head changes|optic nerve head changes
665471|NCT00767871|Panic disorder|panic disorder
665472|NCT00767871|PET|pet
665473|NCT00767871|Escitaopram|escitaopram
665474|NCT00767858|Genetic|genetic
665475|NCT00767858|Genetic Literacy|genetic literacy
665476|NCT00767858|Human Genetic Research|human genetic research
665477|NCT00767858|Cultural Congruence|cultural congruence
846422|NCT00081887|CLL|cll
665478|NCT00767858|Interview|interview
665479|NCT00767845|psychosocial effects of cancer and its treatment|psychosocial effects of cancer and its treatment
665480|NCT00767845|stage I prostate cancer|stage i prostate cancer
665481|NCT00767845|stage II prostate cancer|stage ii prostate cancer
665482|NCT00767845|stage III prostate cancer|stage iii prostate cancer
665483|NCT00767819|progressive GIST|progressive gist
665484|NCT00767819|progressive sarcoma|progressive sarcoma
665485|NCT00767767|anesthetic drugs, associative memory, fear|anesthetic drugs, associative memory, fear
665486|NCT00767754|panic disorder|panic disorder
665487|NCT00767754|paroxetine|paroxetine
665488|NCT00767754|PET|pet
665489|NCT00767741|diabetes|diabetes
665490|NCT00767741|post prandial glucose level|post prandial glucose level
665491|NCT00767741|insulin|insulin
665492|NCT00767741|pharmacokinetics|pharmacokinetics
665493|NCT00767741|pharmacodynamics|pharmacodynamics
665494|NCT00767728|UC|uc
665495|NCT00767728|ulcerative colitis|ulcerative colitis
665496|NCT00767728|IBD|ibd
665497|NCT00767728|Inflammatory Bowel Disease|inflammatory bowel disease
665498|NCT00767702|Genetic/Genomic Researchers|genetic/genomic researchers
665499|NCT00767702|Human Genetic Variation|human genetic variation
665500|NCT00767702|Interviews|interviews
665501|NCT00767702|Research Design|research design
665502|NCT00767702|Race/Ethnicity|race/ethnicity
665503|NCT00767702|Interview|interview
665504|NCT00767676|Contact sensitization|contact sensitization
665505|NCT00767676|Healthy Adult Volunteers|healthy adult volunteers
665506|NCT00767650|Aplastic Anemia|aplastic anemia
665507|NCT00767650|Cyclosporine|cyclosporine
665508|NCT00767650|Campath|campath
665509|NCT00767650|Neurophyschological Side Effect|neurophyschological side effect
665510|NCT00767611|Infertility|infertility
665511|NCT00767611|Sperm|sperm
665512|NCT00767611|Embryo Development|embryo development
665513|NCT00767611|In Vitro Fertilization|in vitro fertilization
665514|NCT00767598|CYP3A5|cyp3a5
665515|NCT00767598|sildenafil|sildenafil
665516|NCT00767598|udenafil|udenafil
665517|NCT00767598|vardenafil|vardenafil
665518|NCT00767585|breast cancer|breast cancer
665519|NCT00767585|aromatase inhibitors|aromatase inhibitors
665520|NCT00767585|bone mineral density|bone mineral density
665521|NCT00767585|osteoporosis|osteoporosis
665522|NCT00767572|Coarctation of the aorta|coarctation of the aorta
665523|NCT00767572|cross over design|cross over design
665524|NCT00767572|atorvastatin|atorvastatin
665525|NCT00767572|endothelial function|endothelial function
665526|NCT00767559|Deep Vein Thrombosis, anticoagulants, surgery, pulmonary embolus, warfarin, fondaparinox|deep vein thrombosis, anticoagulants, surgery, pulmonary embolus, warfarin, fondaparinox
665527|NCT00767546|seborrhic dermatitis|seborrhic dermatitis
665528|NCT00767546|parkinson's disease|parkinson's disease
665529|NCT00767546|Parkinson disease parkinsonism and seborrhic dermatitis|parkinson disease parkinsonism and seborrhic dermatitis
665530|NCT00767520|Advanced Estrogen Receptor Positive Breast Cancer|advanced estrogen receptor positive breast cancer
665531|NCT00767494|OAG|oag
665532|NCT00767494|OH|oh
665533|NCT00767494|Open-angle glaucoma or ocular hypertension|open-angle glaucoma or ocular hypertension
665534|NCT00767481|glaucoma|glaucoma
665535|NCT00767481|Patients with open-angle glaucoma or ocular hypertension|patients with open-angle glaucoma or ocular hypertension
665536|NCT00767468|adult primary hepatocellular carcinoma|adult primary hepatocellular carcinoma
665537|NCT00767468|advanced adult primary liver cancer|advanced adult primary liver cancer
665538|NCT00767468|localized unresectable adult primary liver cancer|localized unresectable adult primary liver cancer
665539|NCT00767468|recurrent adult primary liver cancer|recurrent adult primary liver cancer
665540|NCT00767455|cumulative irritation|cumulative irritation
665541|NCT00767455|healthy adult volunteers|healthy adult volunteers
665542|NCT00767429|accelerometer|accelerometer
665543|NCT00767429|fall risk|fall risk
665544|NCT00767429|target group|target group
665545|NCT00767429|field measurements|field measurements
665546|NCT00767416|MEDI-559|medi-559
665547|NCT00767416|Respiratory Syncytial Virus|respiratory syncytial virus
665548|NCT00767416|RSV|rsv
665549|NCT00767416|Pediatric|pediatric
665550|NCT00767416|Vaccine|vaccine
665551|NCT00767416|respiratory syncytial virus, RSV, pediatric, vaccine|respiratory syncytial virus, rsv, pediatric, vaccine
665552|NCT00767390|ACL Patch Placement|acl patch placement
665553|NCT00767377|Time to Progression|time to progression
665554|NCT00767377|Overall survival|overall survival
665555|NCT00767377|Response rate|response rate
665556|NCT00767377|Quality of Live|quality of live
665557|NCT00767377|Toxicities|toxicities
665558|NCT00767364|Infant|infant
665559|NCT00767338|Infertility|infertility
665560|NCT00767338|Pregnancy|pregnancy
665561|NCT00767338|Men|men
665562|NCT00767338|Palpable varicocele|palpable varicocele
665563|NCT00767338|Abnormal semen analysis|abnormal semen analysis
665564|NCT00767338|Intrauterine insemination|intrauterine insemination
665565|NCT00767338|Microsurgical varicocelectomy|microsurgical varicocelectomy
665566|NCT00767312|HIV|hiv
665567|NCT00767312|Antiretrovial Therapy|antiretrovial therapy
665568|NCT00767312|Viremia|viremia
711020|NCT00586846|03-074|03-074
665569|NCT00767312|Genetic Analysis|genetic analysis
665570|NCT00767312|Single Copy Assay|single copy assay
665571|NCT00767286|stage IIB prostate cancer|stage iib prostate cancer
665572|NCT00767286|stage IIA prostate cancer|stage iia prostate cancer
665573|NCT00767286|stage III prostate cancer|stage iii prostate cancer
665574|NCT00767286|stage IV prostate cancer|stage iv prostate cancer
665575|NCT00767260|type 2 diabetes mellitus|type 2 diabetes mellitus
665576|NCT00767260|bone marrow mononuclear cell|bone marrow mononuclear cell
665577|NCT00767260|hyperbaric oxygen therapy|hyperbaric oxygen therapy
665578|NCT00767247|Arterial Hypertension|arterial hypertension
665579|NCT00767208|type 2 diabetic subjects|type 2 diabetic subjects
665580|NCT00767195|pulmonary edema|pulmonary edema
665581|NCT00767195|cardiogenic|cardiogenic
665582|NCT00767195|non-cardiogenic|non-cardiogenic
665583|NCT00767195|mortality|mortality
665584|NCT00767195|length of stay|length of stay
665585|NCT00767182|preeclampsia|preeclampsia
665586|NCT00767182|eclampsia|eclampsia
665587|NCT00767182|retroplacental hematoma|retroplacental hematoma
665588|NCT00767182|vascular IUGR|vascular iugr
665589|NCT00767182|IUFD|iufd
665590|NCT00767182|placental volume|placental volume
665591|NCT00767169|Edentatio (Toothlessness)|edentatio (toothlessness)
665592|NCT00767156|Sea buckthorn oil, Oral and topical treatment, Skin aging|sea buckthorn oil, oral and topical treatment, skin aging
665593|NCT00767130|single nucleotide polymorphisms, SNP, LDL cholesterol, statin myopathy, atorvastatin, simvastatin, rosuvastatin|single nucleotide polymorphisms, snp, ldl cholesterol, statin myopathy, atorvastatin, simvastatin, rosuvastatin
665594|NCT00767117|TMC125-C197|tmc125-c197
665595|NCT00767117|TMC125-TiDP2-C197|tmc125-tidp2-c197
665597|NCT00767117|DDI|ddi
665598|NCT00767117|Lopinavir|lopinavir
665599|NCT00767117|Intelence|intelence
665600|NCT00767117|Kaletra|kaletra
665601|NCT00767117|Ritonavir|ritonavir
665602|NCT00767117|Etravirine|etravirine
665603|NCT00767117|Interaction|interaction
665604|NCT00767117|Pharmacokinetics|pharmacokinetics
665605|NCT00767117|Steady-state|steady-state
665606|NCT00767091|Parkinson's disease|parkinson's disease
665607|NCT00767091|Apathy|apathy
665608|NCT00767091|Rivastigmine|rivastigmine
665609|NCT00767091|transdermal patch|transdermal patch
665610|NCT00767091|anticholinesterasic|anticholinesterasic
665611|NCT00767091|acetylcholine|acetylcholine
665612|NCT00767052|Healthy Volunteer|healthy volunteer
665613|NCT00767052|Safety|safety
665614|NCT00767052|Tolerability|tolerability
665615|NCT00767052|Pharmacokinetics|pharmacokinetics
665616|NCT00767052|AZD1236|azd1236
665617|NCT00767039|Very Premature|very premature
665618|NCT00767039|RDS|rds
665619|NCT00767039|Surfactant|surfactant
665620|NCT00767026|Epilepsy|epilepsy
665621|NCT00767026|Caregiver Burden|caregiver burden
665622|NCT00767026|Parenting a Child with a Chronic Illness|parenting a child with a chronic illness
665623|NCT00767013|DSCT, coronary artery disease, aortic valve stenosis|dsct, coronary artery disease, aortic valve stenosis
665624|NCT00766987|coronary artery disease|coronary artery disease
665625|NCT00766987|FDG PET viability imaging|fdg pet viability imaging
665626|NCT00766987|morbidity and mortality|morbidity and mortality
665627|NCT00766987|revascularization|revascularization
665628|NCT00766987|resource utilization|resource utilization
665629|NCT00766974|Chronic Venous Disease|chronic venous disease
665630|NCT00766974|C3|c3
665631|NCT00766974|Edema|edema
665632|NCT00766974|Compression Garments|compression garments
665633|NCT00766974|Compression Stockings|compression stockings
665634|NCT00766974|Bioimpedance|bioimpedance
665635|NCT00766961|Peptic ulcer bleeding uncontrolled by endoscopic therapy.|peptic ulcer bleeding uncontrolled by endoscopic therapy.
665636|NCT00766935|Lymphedema|lymphedema
665637|NCT00766935|Bioimpedance|bioimpedance
665638|NCT00766909|Insulin pulsatility|insulin pulsatility
665639|NCT00766909|Insulin secretion|insulin secretion
665640|NCT00766909|Insulin sensitivity|insulin sensitivity
665641|NCT00766909|Calcineurin inhibitor|calcineurin inhibitor
665642|NCT00766909|Cyclosporine|cyclosporine
665643|NCT00766909|Tacrolimus|tacrolimus
665644|NCT00766896|Stroke|stroke
665645|NCT00766896|Cerebral Infarction|cerebral infarction
665646|NCT00766896|Acute Coronary Syndrome|acute coronary syndrome
665647|NCT00766896|Cardiovascular Diseases|cardiovascular diseases
665648|NCT00766896|Vascular Diseases|vascular diseases
665649|NCT00766896|Platelet Activation|platelet activation
665650|NCT00766896|Platelets|platelets
665651|NCT00766896|Platelet Function Tests|platelet function tests
665652|NCT00766896|Aspirin|aspirin
665653|NCT00766896|Atherosclerosis|atherosclerosis
665654|NCT00766896|Ischemia|ischemia
665655|NCT00766896|Thrombosis|thrombosis
665656|NCT00766883|Allogeneic HSCT|allogeneic hsct
665657|NCT00766883|Psychosocial Distress|psychosocial distress
665658|NCT00766883|Coping|coping
665659|NCT00766883|Cognitive Behavior Therapy|cognitive behavior therapy
665660|NCT00766883|Self Efficacy|self efficacy
665661|NCT00766883|Allogeneic Stem Cell Transplant|allogeneic stem cell transplant
665662|NCT00766870|Efficacy|efficacy
665663|NCT00766870|Safety|safety
665664|NCT00766870|Depression|depression
665665|NCT00766870|Interventional|interventional
665666|NCT00766870|Placebo|placebo
665667|NCT00766870|Short-term|short-term
665668|NCT00766870|Major Depressive Disorder|major depressive disorder
665669|NCT00766870|Major Depressive Episode|major depressive episode
665670|NCT00766857|Exenatide|exenatide
665671|NCT00766857|Type 2 diabetes mellitus|type 2 diabetes mellitus
665672|NCT00766857|Congestive heart failure|congestive heart failure
665673|NCT00766857|Incretin hormones|incretin hormones
665674|NCT00766857|GLP-1 agonist|glp-1 agonist
665675|NCT00766857|Cardiac metabolism|cardiac metabolism
665676|NCT00766857|Insulin resistance|insulin resistance
665677|NCT00766857|Cardiac MRI|cardiac mri
665678|NCT00766844|vasospasm|vasospasm
665679|NCT00766844|spinal cord stimulation|spinal cord stimulation
665680|NCT00766844|aneurysm|aneurysm
665681|NCT00766844|subarachnoid hemorrhage|subarachnoid hemorrhage
665682|NCT00766831|Cancer pain|cancer pain
665683|NCT00766831|Hydromorphone OROS|hydromorphone oros
665684|NCT00766831|Jurnista|jurnista
665685|NCT00766779|hematopoietic cell transplantation|hematopoietic cell transplantation
665686|NCT00766779|Acute Myeloid Leukemia|acute myeloid leukemia
665687|NCT00766779|first Complete Remission|first complete remission
665688|NCT00766766|Environmental Tobacco Exposure|environmental tobacco exposure
665689|NCT00766753|HLA-A2 positive|hla-a2 positive
665690|NCT00766753|Malignant Gliomas|malignant gliomas
665691|NCT00766753|Vaccine|vaccine
665692|NCT00766740|ST elevation myocardial infarction|st elevation myocardial infarction
665693|NCT00766740|thrombectomy|thrombectomy
665694|NCT00766740|primary PCI|primary pci
665695|NCT00766675|Pain|pain
665696|NCT00766675|Fibromyalgia|fibromyalgia
665697|NCT00766675|Ultracet|ultracet
665698|NCT00766675|Tramadol Hydrochloride|tramadol hydrochloride
665699|NCT00766675|Acetaminophen|acetaminophen
665700|NCT00766662|Malaria|malaria
665701|NCT00766662|Intermittent Preventive Treatment|intermittent preventive treatment
665702|NCT00766662|EPI vaccine coverage|epi vaccine coverage
665703|NCT00766662|Resistance of P. falciparum to Sulfadoxine- Pyrimethamine|resistance of p. falciparum to sulfadoxine- pyrimethamine
665704|NCT00766649|Age Related Macular Degeneration (AMD)|age related macular degeneration (amd)
665705|NCT00766649|Geographic Atrophy|geographic atrophy
665706|NCT00766649|Sirolimus|sirolimus
665707|NCT00766649|Age-Related Macular Degeneration|age-related macular degeneration
665708|NCT00766649|AMD|amd
665709|NCT00766636|Adenocarcinoma of the pancreatic head|adenocarcinoma of the pancreatic head
665710|NCT00766636|Pancreaticoduodenectomy|pancreaticoduodenectomy
665711|NCT00766636|Preoperative chemotherapy|preoperative chemotherapy
665712|NCT00766636|Chemoradiation|chemoradiation
665713|NCT00766636|Resectable pancreatic cancer|resectable pancreatic cancer
665714|NCT00766636|Surgical removal of the pancreas and duodenum|surgical removal of the pancreas and duodenum
665715|NCT00766636|External-beam radiation therapy|external-beam radiation therapy
665716|NCT00766636|EBRT|ebrt
665717|NCT00766636|Gemcitabine|gemcitabine
665718|NCT00766636|Erlotinib|erlotinib
665719|NCT00766623|endothelium,|endothelium,
665720|NCT00766623|postprandial|postprandial
665721|NCT00766623|microvascular|microvascular
665722|NCT00766623|macrovascular|macrovascular
665723|NCT00766597|Treatment Experienced|treatment experienced
665724|NCT00766584|Aging|aging
665725|NCT00766584|Autonomic nervous system|autonomic nervous system
665726|NCT00766584|stroke|stroke
665727|NCT00766584|Myocardiac infarction|myocardiac infarction
665728|NCT00766584|Prospective cohort|prospective cohort
665729|NCT00766584|Sleep apnea/hypopnea|sleep apnea/hypopnea
665730|NCT00766571|VACTERL Association|vacterl association
665731|NCT00766571|VATER Association|vater association
665732|NCT00766571|Multiple Congenital Anomalies|multiple congenital anomalies
665733|NCT00766571|VACTERL|vacterl
665734|NCT00766571|Congenital Defects|congenital defects
665735|NCT00766571|Birth Defects|birth defects
665736|NCT00766571|Congenital Abnormalities|congenital abnormalities
665737|NCT00766558|anorexia|anorexia
665738|NCT00766558|bulimia|bulimia
665739|NCT00766558|eating disorder not otherwise specified|eating disorder not otherwise specified
665740|NCT00766519|fluid responsiveness|fluid responsiveness
665741|NCT00766519|monitoring|monitoring
665742|NCT00766519|arterial pulse pressure|arterial pulse pressure
665743|NCT00766506|IONSYS|ionsys
665744|NCT00766506|Fentanyl|fentanyl
665745|NCT00766506|Morphine|morphine
665746|NCT00766506|PCA|pca
665747|NCT00766506|Postoperative pain|postoperative pain
665748|NCT00766506|Mobilization|mobilization
665749|NCT00766493|carotid artery stenosis|carotid artery stenosis
665750|NCT00766493|embolic protection device|embolic protection device
665751|NCT00766493|distal embolic filter|distal embolic filter
665752|NCT00766493|minimizing risks of carotid artery stenting|minimizing risks of carotid artery stenting
665753|NCT00766480|squamous cell carcinoma of the esophagus|squamous cell carcinoma of the esophagus
665754|NCT00766480|stage IIA esophageal cancer|stage iia esophageal cancer
665755|NCT00766480|stage IIB esophageal cancer|stage iib esophageal cancer
665756|NCT00766480|stage IIIA esophageal cancer|stage iiia esophageal cancer
665757|NCT00766480|stage IIIB esophageal cancer|stage iiib esophageal cancer
665758|NCT00766480|stage IIIC esophageal cancer|stage iiic esophageal cancer
665759|NCT00766467|armodafinil|armodafinil
665760|NCT00766467|Nuvigil|nuvigil
665761|NCT00766467|fatigue|fatigue
665762|NCT00766454|breast cancer|breast cancer
665763|NCT00766441|diabetes|diabetes
665764|NCT00766441|hypoglycemia|hypoglycemia
665765|NCT00766441|ramadan|ramadan
665766|NCT00766441|fasting|fasting
665767|NCT00766415|COPD|copd
665768|NCT00766415|Moderate to severe COPD|moderate to severe copd
665769|NCT00766402|Spondylitis, ankylosing|spondylitis, ankylosing
665770|NCT00766402|Pain|pain
665771|NCT00766402|Ultracet|ultracet
665772|NCT00766402|Diclofenac|diclofenac
665773|NCT00766402|Voltaren|voltaren
665774|NCT00766402|Tramadol/acetaminophen|tramadol/acetaminophen
665775|NCT00766389|Glaucoma|glaucoma
665776|NCT00766389|Retinal nerve fiber layer|retinal nerve fiber layer
665777|NCT00766389|Cirrus OCT|cirrus oct
665778|NCT00766389|Stratus OCT|stratus oct
665779|NCT00766363|Alzheimer's Disease|alzheimer's disease
665780|NCT00766363|Central Nervous System Diseases|central nervous system diseases
665781|NCT00766363|Pharmacokinetics|pharmacokinetics
665782|NCT00766363|Cognition|cognition
665783|NCT00766350|fibromyalgia|fibromyalgia
665784|NCT00766350|quetiapine|quetiapine
665785|NCT00766350|amitriptyline|amitriptyline
665786|NCT00766337|wet AMD|wet amd
665787|NCT00766298|Exercise|exercise
665788|NCT00766298|Weight Loss|weight loss
665789|NCT00766298|Physical Activity|physical activity
665790|NCT00766298|Type 2 Diabetes Mellitus|type 2 diabetes mellitus
665791|NCT00766285|Baculovirus, influenza, stem cell transplant|baculovirus, influenza, stem cell transplant
665792|NCT00766272|Rehabilitation|rehabilitation
665793|NCT00766272|Treadmill|treadmill
665794|NCT00766272|MS|ms
665795|NCT00766272|Gait|gait
665796|NCT00766272|Robot|robot
665797|NCT00766259|methicillin-resistant Staphylococcus|methicillin-resistant staphylococcus
665798|NCT00766259|colonization|colonization
665799|NCT00766246|Non-Small Cell Lung Cancer|non-small cell lung cancer
665800|NCT00766246|Advanced Non-Small Cell Lung Cancer|advanced non-small cell lung cancer
665801|NCT00766246|Lung Cancer|lung cancer
665802|NCT00766233|Hyperthermia|hyperthermia
665803|NCT00766233|superficial tumor treatment|superficial tumor treatment
665804|NCT00766233|superficial tumors|superficial tumors
665805|NCT00766220|Colon|colon
665806|NCT00766220|Liver|liver
665807|NCT00766220|Colorectal cancer|colorectal cancer
665808|NCT00766220|Colorectal cancer metastases to the liver|colorectal cancer metastases to the liver
665809|NCT00766220|Metastases to the liver|metastases to the liver
665810|NCT00766220|Colorectal cancer mets to liver|colorectal cancer mets to liver
665811|NCT00766220|Colon cancer metastasized to liver|colon cancer metastasized to liver
665812|NCT00766220|Yttrium microspheres|yttrium microspheres
665813|NCT00766220|SIR-Spheres|sir-spheres
665814|NCT00766220|Yttrium-90|yttrium-90
665815|NCT00766220|Cetuximab|cetuximab
665816|NCT00766220|C225|c225
665817|NCT00766220|Erbitux|erbitux
665818|NCT00766220|IMC-C225|imc-c225
665819|NCT00766220|Irinotecan|irinotecan
665820|NCT00766220|CPT-11|cpt-11
665821|NCT00766220|Liver directed therapy|liver directed therapy
665822|NCT00766207|Teratogens|teratogens
665823|NCT00766207|Abnormalities, Drug-Induced|abnormalities, drug-induced
665824|NCT00766207|Contraception|contraception
665825|NCT00766181|IV placement; Parent satisfaction level|iv placement; parent satisfaction level
665826|NCT00766168|contact lens|contact lens
665827|NCT00766168|rigid gas permeable|rigid gas permeable
665828|NCT00766168|refractive index|refractive index
665829|NCT00766155|stage II rectal cancer|stage ii rectal cancer
665830|NCT00766155|stage III rectal cancer|stage iii rectal cancer
665831|NCT00766155|adenocarcinoma of the rectum|adenocarcinoma of the rectum
665832|NCT00766142|adenocarcinoma of the colon|adenocarcinoma of the colon
665833|NCT00766142|recurrent colon cancer|recurrent colon cancer
665834|NCT00766142|stage IV colon cancer|stage iv colon cancer
665835|NCT00766142|adenocarcinoma of the rectum|adenocarcinoma of the rectum
665836|NCT00766142|recurrent rectal cancer|recurrent rectal cancer
665837|NCT00766142|stage IV rectal cancer|stage iv rectal cancer
665838|NCT00766142|peritoneal carcinomatosis|peritoneal carcinomatosis
665839|NCT00766129|saphenous vein graft, TAXUS stent, Chopin stent|saphenous vein graft, taxus stent, chopin stent
665840|NCT00766116|AML|aml
665841|NCT00766103|Cerebral metabolism, perfusion, induced hypothermia|cerebral metabolism, perfusion, induced hypothermia
665842|NCT00766064|posttraumatic stress disorder|posttraumatic stress disorder
665843|NCT00766051|Neurophysiologically Based Occupational Therapy Intervention (NBOTI)|neurophysiologically based occupational therapy intervention (nboti)
665844|NCT00766051|NBOTI|nboti
665845|NCT00766051|NICU|nicu
665846|NCT00766051|NCCU|nccu
665847|NCT00766051|Developmental Biology|developmental biology
665848|NCT00766051|Critical Period|critical period
665849|NCT00766051|Brain Development|brain development
665850|NCT00766051|Sensory Integration|sensory integration
665851|NCT00766051|Neurodevelopment|neurodevelopment
665852|NCT00766051|Sensitive Period|sensitive period
665853|NCT00766038|Mood disorders|mood disorders
665854|NCT00766038|Cognitive disorders|cognitive disorders
665855|NCT00766038|Fatigue|fatigue
665856|NCT00766038|Metabolic disorders|metabolic disorders
665857|NCT00766025|Taiwanese Subjects|taiwanese subjects
665858|NCT00766025|CYP2C19|cyp2c19
665859|NCT00766025|Poor Metabolizers|poor metabolizers
665860|NCT00766025|Extensive Metabolizers|extensive metabolizers
665861|NCT00766025|Taiwanese Subjects identified as CYP2C19 Poor or Extensive Metabolizers|taiwanese subjects identified as cyp2c19 poor or extensive metabolizers
665862|NCT00766012|safety|safety
665863|NCT00766012|tolerability|tolerability
665864|NCT00766012|pharmacokinetics|pharmacokinetics
665865|NCT00766012|AZD2066|azd2066
665866|NCT00766012|Japanese|japanese
665867|NCT00765999|Constipation|constipation
665868|NCT00765999|Chronic Constipation|chronic constipation
665869|NCT00765999|Irritable Bowel Syndrome With Constipation|irritable bowel syndrome with constipation
665870|NCT00765999|Linaclotide|linaclotide
665871|NCT00765986|18F-FAZA|18f-faza
665872|NCT00765986|18F-FDG|18f-fdg
665873|NCT00765986|Positron Emission Tomography|positron emission tomography
665874|NCT00765973|Other Advanced Solid Tumors|other advanced solid tumors
665875|NCT00765960|Vision|vision
665876|NCT00765947|Essential Hypertension ( mild to moderate)|essential hypertension ( mild to moderate)
665877|NCT00765934|Healthy|healthy
665878|NCT00765921|glaucoma, neovascular|glaucoma, neovascular
665879|NCT00765921|macular edema|macular edema
665880|NCT00765921|eye enucleation|eye enucleation
665881|NCT00765921|antibodies, monoclonal|antibodies, monoclonal
665882|NCT00765921|radiation oncology|radiation oncology
665883|NCT00765895|idiopathic gastroparesis|idiopathic gastroparesis
665884|NCT00765882|Constipation|constipation
665885|NCT00765882|Chronic Constipation|chronic constipation
665886|NCT00765882|Linaclotide|linaclotide
665887|NCT00765869|Decision support techniques|decision support techniques
665888|NCT00765856|Opioid tolerant|opioid tolerant
665889|NCT00765856|Pediatric|pediatric
665890|NCT00765856|Male 6-17 years of age|male 6-17 years of age
665891|NCT00765856|Female 6-17 years of age|female 6-17 years of age
665892|NCT00765856|Pain|pain
665893|NCT00765856|Non malignant|non malignant
665894|NCT00765856|Malignant|malignant
665895|NCT00765843|heel pain|heel pain
665896|NCT00765830|Type 2 diabetes, vildagliptin|type 2 diabetes, vildagliptin
665897|NCT00765817|diabetes|diabetes
665898|NCT00765817|exenatide|exenatide
665899|NCT00765817|Amylin|amylin
665900|NCT00765817|Lilly|lilly
665901|NCT00765817|metformin|metformin
665902|NCT00765817|pioglitazone|pioglitazone
665903|NCT00765817|insulin glargine|insulin glargine
665904|NCT00765804|Dry Eye|dry eye
665905|NCT00765804|Iontophoresis|iontophoresis
665906|NCT00765804|Ophthalmic Delivery|ophthalmic delivery
665907|NCT00765791|head and neck cancer|head and neck cancer
665908|NCT00765791|oral cancer|oral cancer
665909|NCT00765791|oropharyngeal cancer|oropharyngeal cancer
665910|NCT00765791|laryngeal cancer|laryngeal cancer
665911|NCT00765791|selective neck dissection|selective neck dissection
665912|NCT00765791|submuscular recess|submuscular recess
665913|NCT00765791|level 2b|level 2b
665914|NCT00765778|resistant bacteria rehabilitation centers|resistant bacteria rehabilitation centers
665915|NCT00765765|stage IV breast cancer|stage iv breast cancer
665916|NCT00765765|recurrent breast cancer|recurrent breast cancer
665917|NCT00765765|male breast cancer|male breast cancer
665918|NCT00765752|Insomnia|insomnia
665919|NCT00765752|depression|depression
665920|NCT00765752|GABA|gaba
665921|NCT00765752|magnetic resonance spectroscopy|magnetic resonance spectroscopy
665922|NCT00765752|MRS|mrs
665923|NCT00765752|Sleep|sleep
665924|NCT00765752|antidepressant medication use|antidepressant medication use
665925|NCT00765739|muscle fibers|muscle fibers
665926|NCT00765739|aging|aging
665927|NCT00765726|hemophilia|hemophilia
665928|NCT00765726|hemophilia A|hemophilia a
665929|NCT00765726|ReFacto|refacto
665930|NCT00765726|Xyntha|xyntha
665931|NCT00765726|moroctocog alfa|moroctocog alfa
665932|NCT00765726|bleeding disorder|bleeding disorder
665933|NCT00765713|Sleep apnea|sleep apnea
665934|NCT00765713|CPAP|cpap
665935|NCT00765713|Ventricular arrhythmias|ventricular arrhythmias
665936|NCT00765713|Defibrillator therapies|defibrillator therapies
665937|NCT00765700|Sprain|sprain
665938|NCT00765700|Strain|strain
665939|NCT00765700|Pain|pain
665940|NCT00765700|Ankle Pain|ankle pain
665941|NCT00765700|Shoulder Pain|shoulder pain
665942|NCT00765700|Elbow Pain|elbow pain
665943|NCT00765700|Tennis Elbow|tennis elbow
665944|NCT00765700|Knee pain|knee pain
665945|NCT00765700|Wrist Pain|wrist pain
665946|NCT00765700|Hand Pain|hand pain
665947|NCT00765700|Muscle, Bone and Cartilage Disorders|muscle, bone and cartilage disorders
665948|NCT00765674|aliskiren|aliskiren
665949|NCT00765674|antihypertensive|antihypertensive
665950|NCT00765674|hypertension|hypertension
665951|NCT00765674|renin inhibitor|renin inhibitor
665952|NCT00765674|moderate-severe hypertension|moderate-severe hypertension
665953|NCT00765661|Kidney|kidney
665954|NCT00765661|Transplantation|transplantation
665955|NCT00765661|Immunosuppression|immunosuppression
665956|NCT00765661|Tacrolimus|tacrolimus
665957|NCT00765661|Prograf|prograf
665958|NCT00765648|hypertension|hypertension
665959|NCT00765648|emergency department|emergency department
665960|NCT00765648|Nicardipine|nicardipine
665961|NCT00765648|Labetalol|labetalol
665962|NCT00765648|hypertensive emergency|hypertensive emergency
665963|NCT00765648|hypertensive urgency|hypertensive urgency
665964|NCT00765635|complete occlusion of the ear canal due to cerumen|complete occlusion of the ear canal due to cerumen
665965|NCT00765622|Urinary incontinence|urinary incontinence
665966|NCT00765622|pelvic floor|pelvic floor
665967|NCT00765622|functional evaluation|functional evaluation
665968|NCT00765609|Paediatric|paediatric
665969|NCT00765609|Analgesic|analgesic
665970|NCT00765609|Prescribing|prescribing
665971|NCT00765609|Parents|parents
665972|NCT00765596|Obesity|obesity
665973|NCT00765596|Insulin resistance|insulin resistance
665974|NCT00765596|Gastric tube|gastric tube
665975|NCT00765596|Ghrelin|ghrelin
665976|NCT00765583|Wrinkles (Nasolabial Folds)|wrinkles (nasolabial folds)
665977|NCT00765570|large tumors in the head & neck, lung, abdomen or pelvis|large tumors in the head & neck, lung, abdomen or pelvis
665978|NCT00765557|Laxative therapy|laxative therapy
665979|NCT00765557|URGE Syndrome|urge syndrome
665980|NCT00765557|Pediatric constipation|pediatric constipation
665981|NCT00765544|MS|ms
665982|NCT00765544|Rehabilitation|rehabilitation
665983|NCT00765544|Treadmill|treadmill
665984|NCT00765544|Robot|robot
665985|NCT00765544|Foot-drop|foot-drop
665986|NCT00765531|Determine prevalence of genetic mutations in a population.|determine prevalence of genetic mutations in a population.
665987|NCT00765531|Identify stone formers w/significant family history.|identify stone formers w/significant family history.
665988|NCT00765531|follow a cohort of pediatric stone formers & their families.|follow a cohort of pediatric stone formers & their families.
666061|NCT00765310|overweight|overweight
665989|NCT00765531|Report long-term recurrence rates & therapeutic outcomes.|report long-term recurrence rates & therapeutic outcomes.
665990|NCT00765518|Ischemic Dilated Cardiomyopathy|ischemic dilated cardiomyopathy
665991|NCT00765518|Non-Ischemic Dilated Cardiomyopathy|non-ischemic dilated cardiomyopathy
665992|NCT00765518|ixmyelocel-T|ixmyelocel-t
665993|NCT00765505|Insulin Resistance|insulin resistance
665994|NCT00765505|Obesity|obesity
665995|NCT00765505|Exercise Training|exercise training
665996|NCT00765505|Physical Activity|physical activity
665997|NCT00765492|Phase I|phase i
665998|NCT00765479|stage IIB prostate cancer|stage iib prostate cancer
665999|NCT00765479|stage IIA prostate cancer|stage iia prostate cancer
666000|NCT00765466|Explore the effect of AVR118 4.0 mL, given subcutaneously on appetite|explore the effect of avr118 4.0 ml, given subcutaneously on appetite
666001|NCT00765453|Heart attack|heart attack
666002|NCT00765453|Anterior Myocardial infarction (MI)|anterior myocardial infarction (mi)
666003|NCT00765453|adult stem cells|adult stem cells
666004|NCT00765453|bone marrow progenitor cells|bone marrow progenitor cells
666005|NCT00765453|bone marrow stem cells|bone marrow stem cells
666006|NCT00765453|autologous|autologous
666007|NCT00765453|left ventricular function|left ventricular function
666008|NCT00765453|intracoronary injection|intracoronary injection
666009|NCT00765440|infection|infection
666010|NCT00765440|malnutrition|malnutrition
666011|NCT00765440|stage I adenoid cystic carcinoma of the oral cavity|stage i adenoid cystic carcinoma of the oral cavity
666012|NCT00765440|stage I mucoepidermoid carcinoma of the oral cavity|stage i mucoepidermoid carcinoma of the oral cavity
666013|NCT00765440|stage I verrucous carcinoma of the oral cavity|stage i verrucous carcinoma of the oral cavity
666014|NCT00765440|stage II adenoid cystic carcinoma of the oral cavity|stage ii adenoid cystic carcinoma of the oral cavity
666015|NCT00765440|stage II mucoepidermoid carcinoma of the oral cavity|stage ii mucoepidermoid carcinoma of the oral cavity
666016|NCT00765440|stage II verrucous carcinoma of the oral cavity|stage ii verrucous carcinoma of the oral cavity
666017|NCT00765440|stage III adenoid cystic carcinoma of the oral cavity|stage iii adenoid cystic carcinoma of the oral cavity
666018|NCT00765440|stage III mucoepidermoid carcinoma of the oral cavity|stage iii mucoepidermoid carcinoma of the oral cavity
666019|NCT00765440|stage III verrucous carcinoma of the oral cavity|stage iii verrucous carcinoma of the oral cavity
666020|NCT00765440|stage IV adenoid cystic carcinoma of the oral cavity|stage iv adenoid cystic carcinoma of the oral cavity
666021|NCT00765440|stage IV mucoepidermoid carcinoma of the oral cavity|stage iv mucoepidermoid carcinoma of the oral cavity
666022|NCT00765440|stage IV verrucous carcinoma of the oral cavity|stage iv verrucous carcinoma of the oral cavity
666023|NCT00765440|stage I squamous cell carcinoma of the larynx|stage i squamous cell carcinoma of the larynx
666024|NCT00765440|stage I verrucous carcinoma of the larynx|stage i verrucous carcinoma of the larynx
666025|NCT00765440|stage II squamous cell carcinoma of the larynx|stage ii squamous cell carcinoma of the larynx
666026|NCT00765440|stage II verrucous carcinoma of the larynx|stage ii verrucous carcinoma of the larynx
666027|NCT00765440|stage III squamous cell carcinoma of the larynx|stage iii squamous cell carcinoma of the larynx
666028|NCT00765440|stage III verrucous carcinoma of the larynx|stage iii verrucous carcinoma of the larynx
666029|NCT00765440|stage IV squamous cell carcinoma of the larynx|stage iv squamous cell carcinoma of the larynx
666030|NCT00765440|stage IV verrucous carcinoma of the larynx|stage iv verrucous carcinoma of the larynx
666031|NCT00765440|stage I lymphoepithelioma of the oropharynx|stage i lymphoepithelioma of the oropharynx
666032|NCT00765440|stage I squamous cell carcinoma of the oropharynx|stage i squamous cell carcinoma of the oropharynx
666033|NCT00765440|stage II lymphoepithelioma of the oropharynx|stage ii lymphoepithelioma of the oropharynx
666034|NCT00765440|stage II squamous cell carcinoma of the oropharynx|stage ii squamous cell carcinoma of the oropharynx
666035|NCT00765440|stage III lymphoepithelioma of the oropharynx|stage iii lymphoepithelioma of the oropharynx
666036|NCT00765440|stage III squamous cell carcinoma of the oropharynx|stage iii squamous cell carcinoma of the oropharynx
666037|NCT00765440|stage IV lymphoepithelioma of the oropharynx|stage iv lymphoepithelioma of the oropharynx
666038|NCT00765440|stage IV squamous cell carcinoma of the oropharynx|stage iv squamous cell carcinoma of the oropharynx
666039|NCT00765440|stage I squamous cell carcinoma of the hypopharynx|stage i squamous cell carcinoma of the hypopharynx
666040|NCT00765440|stage II squamous cell carcinoma of the hypopharynx|stage ii squamous cell carcinoma of the hypopharynx
666041|NCT00765440|stage III squamous cell carcinoma of the hypopharynx|stage iii squamous cell carcinoma of the hypopharynx
666042|NCT00765440|stage IV squamous cell carcinoma of the hypopharynx|stage iv squamous cell carcinoma of the hypopharynx
666043|NCT00765440|tongue cancer|tongue cancer
666044|NCT00765401|Abdominal Pain|abdominal pain
666045|NCT00765401|Cystic Fibrosis|cystic fibrosis
666046|NCT00765401|H. pylori|h. pylori
666047|NCT00765401|Children|children
666048|NCT00765388|urostomy, 1-piece, cross-over, randomised, preference|urostomy, 1-piece, cross-over, randomised, preference
666049|NCT00765375|acne|acne
666050|NCT00765375|Botox|botox
666051|NCT00765375|cosmetic treatments|cosmetic treatments
666052|NCT00765336|Spermatogenesis in Healthy Males|spermatogenesis in healthy males
666053|NCT00765323|Octreotide|octreotide
666054|NCT00765323|Sandostatin LAR|sandostatin lar
666055|NCT00765323|Growth hormone|growth hormone
666056|NCT00765323|IGF-1|igf-1
666057|NCT00765310|atherosclerosis|atherosclerosis
666058|NCT00765310|lipoic acid|lipoic acid
666059|NCT00765310|thioctic acid|thioctic acid
666060|NCT00765310|triglycerides|triglycerides
666062|NCT00765310|obesity|obesity
666063|NCT00765310|oxidative stress|oxidative stress
666064|NCT00765310|inflammation|inflammation
666065|NCT00765297|fall risk|fall risk
666066|NCT00765297|movement characteristics|movement characteristics
666067|NCT00765297|stumble detection|stumble detection
666068|NCT00765297|accelerometry|accelerometry
666070|NCT00765284|RCT|rct
666071|NCT00765284|Cholesterol|cholesterol
666072|NCT00765245|stage I adult diffuse large cell lymphoma|stage i adult diffuse large cell lymphoma
666073|NCT00765245|contiguous stage II adult diffuse large cell lymphoma|contiguous stage ii adult diffuse large cell lymphoma
666074|NCT00765245|noncontiguous stage II adult diffuse large cell lymphoma|noncontiguous stage ii adult diffuse large cell lymphoma
666075|NCT00765245|stage III adult diffuse large cell lymphoma|stage iii adult diffuse large cell lymphoma
666076|NCT00765245|stage IV adult diffuse large cell lymphoma|stage iv adult diffuse large cell lymphoma
666077|NCT00765232|laparoscopic|laparoscopic
666078|NCT00765232|donor|donor
666079|NCT00765232|nephrectomy|nephrectomy
666080|NCT00765219|Generalized Anxiety Disorder|generalized anxiety disorder
666081|NCT00765219|Geriatric|geriatric
666082|NCT00765180|colonoscopy|colonoscopy
666083|NCT00765180|hood|hood
666084|NCT00765180|NBI|nbi
666085|NCT00765141|wound debridement|wound debridement
666086|NCT00765141|removed orthopedic implants|removed orthopedic implants
666087|NCT00765141|removed catheters or shunts|removed catheters or shunts
666088|NCT00765141|excised tonsils|excised tonsils
666089|NCT00765141|amputated tissue|amputated tissue
666090|NCT00765141|sputum, stool|sputum, stool
666091|NCT00765141|or other excretions.|or other excretions.
666092|NCT00765128|Percutaneous|percutaneous
666093|NCT00765128|Nephrolithotomy|nephrolithotomy
666094|NCT00765128|Kidney stones|kidney stones
666095|NCT00765102|Multiple Myelonoma|multiple myelonoma
666096|NCT00765102|Romidepsin|romidepsin
666097|NCT00765102|Bortezomib|bortezomib
666098|NCT00765076|Vaccine|vaccine
666099|NCT00765076|Elderly|elderly
666100|NCT00765076|Influenza|influenza
666101|NCT00765063|Diabetic Foot Ulcers Neuroischaemic|diabetic foot ulcers neuroischaemic
666102|NCT00765050|Cellular therapy|cellular therapy
666103|NCT00765050|CD133+|cd133+
666104|NCT00765024|strongyloidiasis, ivermectin, albendazole|strongyloidiasis, ivermectin, albendazole
666105|NCT00765011|Head and Neck Cancer|head and neck cancer
666106|NCT00764998|Influenza|influenza
666107|NCT00764998|HIV|hiv
666108|NCT00764998|Influenza Vaccine|influenza vaccine
666109|NCT00764998|Efficacy|efficacy
666110|NCT00764985|Syncope|syncope
666111|NCT00764985|Pre-Syncope|pre-syncope
666112|NCT00764985|Fainting|fainting
666113|NCT00764972|To evaluate the use of sorafenib added to vinorelbine chemotherapy, to find out which are the doses of two drugs can be safely combined|to evaluate the use of sorafenib added to vinorelbine chemotherapy, to find out which are the doses of two drugs can be safely combined
666114|NCT00764933|information programme|information programme
666115|NCT00764933|anxiety reduction|anxiety reduction
666116|NCT00764933|multicenter trial|multicenter trial
666117|NCT00764933|intensive care|intensive care
666118|NCT00764933|critical care|critical care
666119|NCT00764920|human skin|human skin
666120|NCT00764907|T-cell childhood acute lymphoblastic leukemia|t-cell childhood acute lymphoblastic leukemia
666121|NCT00764907|B-cell childhood acute lymphoblastic leukemia|b-cell childhood acute lymphoblastic leukemia
666122|NCT00764907|untreated childhood acute lymphoblastic leukemia|untreated childhood acute lymphoblastic leukemia
666123|NCT00764881|Oral contraceptive|oral contraceptive
666124|NCT00764881|Sexual dysfunction|sexual dysfunction
666125|NCT00764881|Libido|libido
666126|NCT00764829|hematopoietic stem cell transplantation|hematopoietic stem cell transplantation
666127|NCT00764829|fludarabine|fludarabine
666128|NCT00764829|mycophenolate mofetil|mycophenolate mofetil
666129|NCT00764829|mycophenolic acid|mycophenolic acid
666130|NCT00764829|biomarkers|biomarkers
666131|NCT00764816|Chronic kidney disease, stages 3 and 4|chronic kidney disease, stages 3 and 4
666132|NCT00764816|phosphaturia|phosphaturia
666133|NCT00764816|phosphorus|phosphorus
666134|NCT00764816|PTH|pth
666135|NCT00764816|FGF23|fgf23
666136|NCT00764816|Dietary protein source|dietary protein source
666137|NCT00764777|Peripheral Vascular Disease|peripheral vascular disease
666138|NCT00764777|Intermittent Claudication|intermittent claudication
666139|NCT00764777|Critical limb Ischemia|critical limb ischemia
666140|NCT00764777|TASC A|tasc a
666141|NCT00764777|TASC B|tasc b
666142|NCT00764777|TASC C|tasc c
666143|NCT00764777|TASC D|tasc d
666144|NCT00764777|balloon-expandable stent|balloon-expandable stent
666145|NCT00764777|Self-expanding stent|self-expanding stent
666146|NCT00764777|TASC|tasc
666147|NCT00764764|shoulder pain|shoulder pain
666148|NCT00764764|rotator cuff|rotator cuff
666149|NCT00764764|impingement|impingement
666150|NCT00764764|cervical referred pain|cervical referred pain
666151|NCT00764764|neural tension|neural tension
666152|NCT00764738|ARMD|armd
666153|NCT00764738|AMD|amd
666154|NCT00764738|exudative AMD|exudative amd
666155|NCT00764712|Tight glycemia control|tight glycemia control
666156|NCT00764712|cardiac surgery patients|cardiac surgery patients
666157|NCT00764699|poor growth|poor growth
666158|NCT00764699|inflammatory bowel disease|inflammatory bowel disease
666159|NCT00764686|Exercise|exercise
666160|NCT00764686|Education|education
666161|NCT00764686|Hydrotherapy|hydrotherapy
666162|NCT00764686|Physical Therapy Modalities|physical therapy modalities
666163|NCT00764647|family caregivers|family caregivers
666164|NCT00764647|caregiver education|caregiver education
666165|NCT00764647|caregiver burden|caregiver burden
666166|NCT00764647|caregiver hardiness|caregiver hardiness
666167|NCT00764647|caregiver depressive symptoms|caregiver depressive symptoms
666168|NCT00764621|Gadolinium ethoxybenzyl DTPA|gadolinium ethoxybenzyl dtpa
666169|NCT00764621|Contrast media|contrast media
666170|NCT00764621|Outcome Assessment (Health Care)|outcome assessment (health care)
666171|NCT00764621|Magnetic Resonance Imaging|magnetic resonance imaging
666172|NCT00764621|Tomography, X-Ray Computed|tomography, x-ray computed
666173|NCT00764621|Liver|liver
666174|NCT00764595|gastrointestinal stromal tumor|gastrointestinal stromal tumor
666175|NCT00764595|liver metastases|liver metastases
666176|NCT00764582|Corneal penetration of levofloxacin and moxifloxacin|corneal penetration of levofloxacin and moxifloxacin
666177|NCT00764569|oral tissue|oral tissue
666178|NCT00764556|Glucose|glucose
666179|NCT00764556|Insulin|insulin
666180|NCT00764556|COPD|copd
666181|NCT00764556|Exacerbations|exacerbations
666182|NCT00764556|Tight glycaemic control|tight glycaemic control
666183|NCT00764556|Acute hospital ward|acute hospital ward
666184|NCT00764543|Unilateral hydronephrosis|unilateral hydronephrosis
666185|NCT00764543|Multicystic-dysplastic Kidney|multicystic-dysplastic kidney
666186|NCT00764465|Healthy Subjects|healthy subjects
666187|NCT00764465|Pharmacokinetics study|pharmacokinetics study
666188|NCT00764465|Pharmacokinetics of medications|pharmacokinetics of medications
666189|NCT00764426|alcoholic beverages|alcoholic beverages
666190|NCT00764426|non-alcoholic beverages|non-alcoholic beverages
666191|NCT00764426|inflammation|inflammation
666192|NCT00764426|Serum concentration of inflammatory markers before and after intervention|serum concentration of inflammatory markers before and after intervention
666193|NCT00764413|EDSS|edss
666194|NCT00764413|methylprednisolone|methylprednisolone
666195|NCT00764413|circadian rhythms|circadian rhythms
666196|NCT00764413|MSFC|msfc
666197|NCT00764400|aphasia|aphasia
666198|NCT00764400|anomia|anomia
666199|NCT00764400|speech therapy|speech therapy
666200|NCT00764400|rehabilitation|rehabilitation
666201|NCT00764387|Neoplastic CNS lesions|neoplastic cns lesions
666202|NCT00764387|Contrast enhanced MRI|contrast enhanced mri
666203|NCT00764387|Comparison|comparison
666204|NCT00764374|YM443|ym443
666205|NCT00764374|Z-338|z-338
666206|NCT00764374|Acotiamide|acotiamide
666207|NCT00764374|Rome III|rome iii
666208|NCT00764374|Signs and symptoms, digestive|signs and symptoms, digestive
666209|NCT00764361|Diabetic|diabetic
666210|NCT00764361|Ulcer|ulcer
666211|NCT00764361|Wound|wound
666212|NCT00764348|Acute and Chronic Wounds|acute and chronic wounds
666213|NCT00764322|menopausal symptoms|menopausal symptoms
666214|NCT00764322|recurrent breast cancer|recurrent breast cancer
666215|NCT00764322|stage I breast cancer|stage i breast cancer
666216|NCT00764322|stage II breast cancer|stage ii breast cancer
666217|NCT00764322|stage IIIA breast cancer|stage iiia breast cancer
666218|NCT00764322|stage IIIB breast cancer|stage iiib breast cancer
666219|NCT00764322|stage IIIC breast cancer|stage iiic breast cancer
666220|NCT00764322|stage IV breast cancer|stage iv breast cancer
666221|NCT00764322|ductal breast carcinoma in situ|ductal breast carcinoma in situ
666222|NCT00764322|breast cancer in situ|breast cancer in situ
666223|NCT00764296|acute wounds and chronic wounds|acute wounds and chronic wounds
666224|NCT00764270|atherosclerosis|atherosclerosis
666225|NCT00764270|lipoic acid|lipoic acid
666226|NCT00764270|thioctic acid|thioctic acid
666227|NCT00764270|triglycerides|triglycerides
666228|NCT00764270|overweight|overweight
666229|NCT00764270|obesity|obesity
666230|NCT00764270|oxidative stress|oxidative stress
666231|NCT00764270|inflammation|inflammation
666232|NCT00764244|Diabetes|diabetes
666233|NCT00764244|Macular edema|macular edema
666234|NCT00764244|Optical Coherence tomography|optical coherence tomography
666235|NCT00764244|VitrectomyLaser therapy|vitrectomylaser therapy
666236|NCT00764244|Intravitreal triamcinolone injection|intravitreal triamcinolone injection
666237|NCT00764231|acute myeloid leukemia|acute myeloid leukemia
666238|NCT00764231|exercise|exercise
666239|NCT00764231|fatigue|fatigue
666240|NCT00764231|quality of life|quality of life
666241|NCT00764231|home-based|home-based
666242|NCT00764231|AML|aml
666243|NCT00764218|Obstructive sleep apnea syndrome|obstructive sleep apnea syndrome
666244|NCT00764218|Hypertension|hypertension
666245|NCT00764218|Cardiovascular phenotype|cardiovascular phenotype
666246|NCT00764205|ACS|acs
666247|NCT00764205|non STEMI|non stemi
666248|NCT00764205|ECG troponin|ecg troponin
666249|NCT00764205|iSTAT|istat
666250|NCT00764205|Acute coronary syndrome without ST-segment elevation|acute coronary syndrome without st-segment elevation
666251|NCT00764192|hemodialysis|hemodialysis
666252|NCT00764192|Flow-mediated dilation|flow-mediated dilation
666253|NCT00764192|nictric oxide|nictric oxide
666254|NCT00764192|endothelial function|endothelial function
666619|NCT00762723|Spinal Stenosis|spinal stenosis
666255|NCT00764179|Neonates with intra-uterine growth delay|neonates with intra-uterine growth delay
666256|NCT00764166|PSA (biochemical)|psa (biochemical)
666257|NCT00764166|Progression- free Survival|progression- free survival
666258|NCT00764166|Clinical progress|clinical progress
666259|NCT00764166|Overall survival|overall survival
666260|NCT00764166|Tolerance to the treatment|tolerance to the treatment
666261|NCT00764166|Quality of Live|quality of live
666262|NCT00764153|Displaced Femoral Neck Fractures|displaced femoral neck fractures
666263|NCT00764153|Treatment|treatment
666264|NCT00764153|Function|function
666265|NCT00764153|Pain|pain
666266|NCT00764153|Quality of life|quality of life
666267|NCT00764153|Complications|complications
666268|NCT00764153|Reoperations|reoperations
666269|NCT00764153|Internal Fixation|internal fixation
666270|NCT00764153|Hemiarthroplasty|hemiarthroplasty
666271|NCT00764153|Activities of Daily Living|activities of daily living
666272|NCT00764140|tumor growth factor|tumor growth factor
666273|NCT00764127|adolescent|adolescent
666274|NCT00764127|obesity|obesity
666275|NCT00764127|bariatric surgery|bariatric surgery
666276|NCT00764127|eating|eating
666277|NCT00764114|Spondylodiscitis|spondylodiscitis
666278|NCT00764114|Duration treatment|duration treatment
666279|NCT00764114|Antibiotic|antibiotic
666280|NCT00764114|men or women more than 18 years|men or women more than 18 years
666281|NCT00764114|proved bacterial spondylodiscitis|proved bacterial spondylodiscitis
666282|NCT00764114|patient for which is decided a treatment antibiotic|patient for which is decided a treatment antibiotic
666283|NCT00764114|the diagnosis on clinical|the diagnosis on clinical
666284|NCT00764114|Radiological|radiological
666285|NCT00764114|microbiological criteria|microbiological criteria
666286|NCT00764088|full Thickness wounds|full thickness wounds
666287|NCT00764075|heart failure; EF<35%; NYHA II, III or IV|heart failure; ef<35%; nyha ii, iii or iv
666288|NCT00764062|Amoxicillin|amoxicillin
666289|NCT00764062|Drug resistance, microbial|drug resistance, microbial
666290|NCT00764062|Streptococcus|streptococcus
666291|NCT00764062|Surgery, oral|surgery, oral
666292|NCT00764049|Albumin dialysis|albumin dialysis
666293|NCT00764049|Artificial liver support|artificial liver support
666294|NCT00764049|Acute on chronic liver failure|acute on chronic liver failure
666295|NCT00764036|phase I|phase i
666296|NCT00764036|safety|safety
666297|NCT00764023|wound debridement|wound debridement
666298|NCT00764023|removed orthopedic implants|removed orthopedic implants
666299|NCT00764023|removed catheters or shunts|removed catheters or shunts
666300|NCT00764023|excised tonsils, amputated tissue|excised tonsils, amputated tissue
666301|NCT00764023|sputum|sputum
666302|NCT00764023|stool|stool
666303|NCT00764023|other excretions.|other excretions.
666304|NCT00763997|dipyrone|dipyrone
666305|NCT00763997|platelet aggregation|platelet aggregation
666306|NCT00763997|neuraxial blockage|neuraxial blockage
666307|NCT00763997|ibuprofen|ibuprofen
666308|NCT00763997|platelet aggregation under dipyrone compared to ibuprofen, acetaminophen and parecoxib/valdecoxib|platelet aggregation under dipyrone compared to ibuprofen, acetaminophen and parecoxib/valdecoxib
710278|NCT00589563|contiguous stage II adult immunoblastic large cell lymphoma|contiguous stage ii adult immunoblastic large cell lymphoma
666309|NCT00763997|neuraxial blockage in patients receiving ibuprofen is critical in special circumstances, but traditionally not fpr dipyrone|neuraxial blockage in patients receiving ibuprofen is critical in special circumstances, but traditionally not fpr dipyrone
666310|NCT00763984|Bladder Control for Women|bladder control for women
666311|NCT00763984|Exercising Your Pelvic Muscles|exercising your pelvic muscles
666312|NCT00763984|Kegel Exercises: How to Strengthen Pelvic Floor Muscles|kegel exercises: how to strengthen pelvic floor muscles
666313|NCT00763984|Kegel Exercises for Your Pelvic Muscles|kegel exercises for your pelvic muscles
666314|NCT00763984|Pelvic Floor Disorders|pelvic floor disorders
666315|NCT00763984|Pelvic Support Problems|pelvic support problems
666316|NCT00763984|Pregnancy|pregnancy
666317|NCT00763984|Pregnancy Childbirth and Bladder Control|pregnancy childbirth and bladder control
666318|NCT00763984|Urinary Incontinence|urinary incontinence
666319|NCT00763984|Urinary Incontinence: Embarrassing but Treatable|urinary incontinence: embarrassing but treatable
666320|NCT00763958|opiates|opiates
666321|NCT00763958|HIV|hiv
666322|NCT00763945|Acute coronary Syndrome|acute coronary syndrome
666323|NCT00763945|STEMI|stemi
666324|NCT00763945|NSTEMI|nstemi
666325|NCT00763945|Registry|registry
666326|NCT00763919|Patient Non-Adherence|patient non-adherence
666327|NCT00763919|Patient Non-Compliance|patient non-compliance
666328|NCT00763919|Patient Nonadherence|patient nonadherence
666329|NCT00763919|Patient Noncompliance|patient noncompliance
666330|NCT00763919|Patient Refusal of Treatment|patient refusal of treatment
666331|NCT00763919|Refusal of Treatment|refusal of treatment
666332|NCT00763919|Treatment Refusal|treatment refusal
666333|NCT00763906|septic shock|septic shock
666334|NCT00763906|fuzzy logic|fuzzy logic
666335|NCT00763906|norepinephrine weaning|norepinephrine weaning
666336|NCT00763893|Marfan syndrome|marfan syndrome
666337|NCT00763893|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers
666338|NCT00763893|Aortic Aneurysm, Thoracic|aortic aneurysm, thoracic
666339|NCT00763880|Hematoma block|hematoma block
666340|NCT00763880|Lidocaine|lidocaine
666341|NCT00763880|Forearm fracture|forearm fracture
666342|NCT00763880|Radius fracture|radius fracture
666343|NCT00763880|Ulna fracture|ulna fracture
666344|NCT00763880|Ketamine|ketamine
666345|NCT00763880|Midazolam|midazolam
666346|NCT00763880|Procedural sedation|procedural sedation
666347|NCT00763867|Heart Failure, Diastolic|heart failure, diastolic
666348|NCT00763867|Decompensated Heart Failure|decompensated heart failure
666349|NCT00763867|Sildenafil|sildenafil
666350|NCT00763867|Exercise Capacity|exercise capacity
666351|NCT00763841|Auditory hallucinations|auditory hallucinations
666352|NCT00763828|Myocardial Infarction|myocardial infarction
666353|NCT00763828|Hypothermia, Induced|hypothermia, induced
666354|NCT00763815|hyperglycemia GLP-1 pioglitazone|hyperglycemia glp-1 pioglitazone
666355|NCT00763789|conscious sedation|conscious sedation
666356|NCT00763789|remifentanil|remifentanil
666357|NCT00763789|hysteroscopic surgery|hysteroscopic surgery
666358|NCT00763789|anesthesia recovery period|anesthesia recovery period
666359|NCT00763789|ambulatory surgery|ambulatory surgery
666360|NCT00763789|patient satisfaction|patient satisfaction
666361|NCT00763789|length of stay|length of stay
666362|NCT00763776|Liver cirrhosis|liver cirrhosis
666363|NCT00763776|Hepatectomy|hepatectomy
666364|NCT00763776|Liver parenchyma transection|liver parenchyma transection
666365|NCT00763776|Randomized controlled trial|randomized controlled trial
666366|NCT00763763|Imatinib mesylate|imatinib mesylate
666367|NCT00763763|Combination therapy|combination therapy
666368|NCT00763763|Leukemia, Lymphocytic, Acute|leukemia, lymphocytic, acute
666369|NCT00763763|Philadelphia Chromosome|philadelphia chromosome
666370|NCT00763763|Blast Crisis|blast crisis
666371|NCT00763763|Leukemia, Myeloid, Chronic|leukemia, myeloid, chronic
666372|NCT00763750|glioblastoma multiforme or anaplastic glioma|glioblastoma multiforme or anaplastic glioma
666373|NCT00763737|congenital diaphragmatic hernia|congenital diaphragmatic hernia
666374|NCT00763737|fetal surgery|fetal surgery
666375|NCT00763737|pulmonary hypoplasia|pulmonary hypoplasia
666376|NCT00763737|observed/expected lung to head ratio|observed/expected lung to head ratio
666377|NCT00763737|liver position|liver position
666378|NCT00763737|feto|feto
666379|NCT00763737|fetoscopic endoluminal tracheal occlusion|fetoscopic endoluminal tracheal occlusion
666380|NCT00763737|standardized neonatal care|standardized neonatal care
666381|NCT00763711|Urinary Incontinence|urinary incontinence
666382|NCT00763711|ISD|isd
666383|NCT00763698|Left heart pacing lead|left heart pacing lead
666384|NCT00763698|Cardiac resynchronization therapy (CRT)|cardiac resynchronization therapy (crt)
666385|NCT00763698|Heart failure|heart failure
666386|NCT00763698|ICD|icd
666387|NCT00763685|preoperative pain prophylaxis|preoperative pain prophylaxis
666388|NCT00763685|postoperative pain|postoperative pain
666389|NCT00763672|Preeclampsia|preeclampsia
666390|NCT00763672|Hypertension|hypertension
666391|NCT00763672|Intra uterine growth retardation|intra uterine growth retardation
666392|NCT00763672|Antiangiogenic factor|antiangiogenic factor
666393|NCT00763672|Prevention|prevention
666394|NCT00763646|Gastric or Gastroesophageal Junction Adenocarcinoma|gastric or gastroesophageal junction adenocarcinoma
666395|NCT00763633|nausea|nausea
666396|NCT00763633|vomiting|vomiting
666397|NCT00763633|pregnancy|pregnancy
666398|NCT00763633|B6|b6
666399|NCT00763620|Community acquired pneumonia|community acquired pneumonia
666400|NCT00763620|Nosocomial pneumonia|nosocomial pneumonia
666401|NCT00763620|Mini bronchoalveolar lavage|mini bronchoalveolar lavage
666402|NCT00763620|Endotracheal aspirates|endotracheal aspirates
666403|NCT00763620|Expectorated sputum|expectorated sputum
666404|NCT00763607|non small cell lung cancer patients|non small cell lung cancer patients
666405|NCT00763594|Major Depression|major depression
666406|NCT00763594|Interpersonal Psychotherapy|interpersonal psychotherapy
666407|NCT00763594|Brief Relational Therapy|brief relational therapy
666408|NCT00763594|Outcome research|outcome research
666409|NCT00763581|Patient Non-Adherence|patient non-adherence
666410|NCT00763581|Patient Non-Compliance|patient non-compliance
666411|NCT00763581|Patient Nonadherence|patient nonadherence
666412|NCT00763581|Patient Noncompliance|patient noncompliance
666413|NCT00763581|Patient Refusal of Treatment|patient refusal of treatment
666414|NCT00763581|Treatment Refusal|treatment refusal
666415|NCT00763581|Refusal of Treatment|refusal of treatment
666416|NCT00763568|Chronic hepatitis C|chronic hepatitis c
666417|NCT00763568|Viral hepatitis|viral hepatitis
666418|NCT00763555|psoriasis|psoriasis
666419|NCT00763555|spray|spray
666420|NCT00763555|calcitriol|calcitriol
666421|NCT00763516|Pancreatic Cancer|pancreatic cancer
666422|NCT00763516|Proton radiation|proton radiation
666423|NCT00763516|Chemotherapy|chemotherapy
666424|NCT00763516|Xeloda|xeloda
666425|NCT00763516|Gemzar|gemzar
666426|NCT00763516|Resectable|resectable
666427|NCT00763516|Surgery|surgery
666428|NCT00763503|psoriasis|psoriasis
666429|NCT00763503|PK|pk
666430|NCT00763503|calcitriol|calcitriol
666431|NCT00763490|umbilical cord blood|umbilical cord blood
666432|NCT00763490|stem cell transplant|stem cell transplant
666433|NCT00763490|leukemia|leukemia
666434|NCT00763490|multiple myeloma|multiple myeloma
666435|NCT00763490|lymphoma|lymphoma
666436|NCT00763477|Cystic fibrosis|cystic fibrosis
666437|NCT00763477|Weight|weight
666438|NCT00763477|Appetite|appetite
666439|NCT00763477|Ghrelin|ghrelin
666440|NCT00763477|Cystic fibrosis with low BMI|cystic fibrosis with low bmi
666441|NCT00763464|Coronary Artery Disease|coronary artery disease
666442|NCT00763464|ischemia diagnostic|ischemia diagnostic
666443|NCT00763451|hyperglycemia, GLP-1|hyperglycemia, glp-1
666444|NCT00763438|Schizophrenia|schizophrenia
666445|NCT00763438|Sertindole|sertindole
666446|NCT00763438|Safety study|safety study
666447|NCT00763425|polypectomy|polypectomy
666448|NCT00763425|colonic polyp|colonic polyp
666449|NCT00763425|colorectal polyp|colorectal polyp
666450|NCT00763425|colorectal cancer prevention|colorectal cancer prevention
666451|NCT00763412|Cystic Fibrosis|cystic fibrosis
666452|NCT00763412|Diabetes|diabetes
666453|NCT00763412|Cystic Fibrosis Related Diabetes|cystic fibrosis related diabetes
666454|NCT00763412|Pre-diabetes|pre-diabetes
666455|NCT00763412|oral hypoglycemic agents|oral hypoglycemic agents
666456|NCT00763412|Repaglinide|repaglinide
666457|NCT00763412|treatment|treatment
666458|NCT00763412|inflammatory markers|inflammatory markers
666459|NCT00763412|Lung function|lung function
666460|NCT00763412|nutrition|nutrition
666461|NCT00763399|probiotics|probiotics
666462|NCT00763386|Total Knee Arthroplasty|total knee arthroplasty
666463|NCT00763386|Osteoarthritis|osteoarthritis
666464|NCT00763386|Knee|knee
666465|NCT00763373|Lower respiratory infection|lower respiratory infection
666466|NCT00763373|Upper respiratory infection|upper respiratory infection
666467|NCT00763373|Urinary tract infection|urinary tract infection
666468|NCT00763373|Soft tissue infection|soft tissue infection
666469|NCT00763373|Hepatobiliary infection|hepatobiliary infection
666470|NCT00763360|Cataract|cataract
666471|NCT00763347|Glucose Metabolism Disorder|glucose metabolism disorder
666472|NCT00763347|Dysmetabolic Syndrome|dysmetabolic syndrome
666473|NCT00763347|Type II Diabetes|type ii diabetes
666474|NCT00763347|Diabetes Mellitus, Lipoatrophic|diabetes mellitus, lipoatrophic
666475|NCT00763347|Dyslipidemia|dyslipidemia
666476|NCT00763347|Drug Therapy|drug therapy
666477|NCT00763321|Effect on sleep interference by pain|effect on sleep interference by pain
666478|NCT00763308|Weight|weight
666479|NCT00763308|Blood Pressure|blood pressure
666480|NCT00763308|Smoking Status|smoking status
666481|NCT00763308|Cardiovascular Risk Profile|cardiovascular risk profile
666482|NCT00763295|latent tuberculosis|latent tuberculosis
666483|NCT00763295|HIV|hiv
666484|NCT00763295|IFN-γ based assay|ifn-γ based assay
666485|NCT00763282|Spinal cord injuries|spinal cord injuries
666486|NCT00763282|Pressure ulcers|pressure ulcers
666487|NCT00763282|Health behavior|health behavior
666488|NCT00763282|self management|self management
666489|NCT00763282|Rehabilitation|rehabilitation
666490|NCT00763282|Outcome assessment|outcome assessment
666491|NCT00763282|QUERI|queri
666492|NCT00763282|Veterans|veterans
666493|NCT00763243|profound bilateral hearing loss with cochlear implants|profound bilateral hearing loss with cochlear implants
666494|NCT00763230|Depression|depression
666495|NCT00763230|Treatment|treatment
666496|NCT00763230|Transcranial direct current stimulation|transcranial direct current stimulation
666497|NCT00763217|inflammation|inflammation
666498|NCT00763217|coagulation|coagulation
666499|NCT00763217|neuroprotection|neuroprotection
666500|NCT00763217|drugs|drugs
666501|NCT00763217|clinical neurology|clinical neurology
666502|NCT00763217|pharmacology|pharmacology
666503|NCT00763217|biological factors|biological factors
666504|NCT00763204|Plaque Type Psoriasis|plaque type psoriasis
666505|NCT00763204|Topical|topical
666506|NCT00763178|PTSD|ptsd
666507|NCT00763152|prostate|prostate
666508|NCT00763152|prostate bed|prostate bed
666509|NCT00763152|periprostatic|periprostatic
666511|NCT00763139|Rheumatoid Arthritis|rheumatoid arthritis
666512|NCT00763126|parturient|parturient
666513|NCT00763126|epidural analgesia|epidural analgesia
666514|NCT00763126|labor|labor
666515|NCT00763126|spouse|spouse
666516|NCT00763126|Stress levels|stress levels
666517|NCT00763126|Salivary amylase|salivary amylase
666518|NCT00763100|Breast cancer|breast cancer
666519|NCT00763100|Three dimensional versus two dimensional|three dimensional versus two dimensional
666520|NCT00763100|Breast cancer surveillance|breast cancer surveillance
666521|NCT00763100|Tomosynthesis|tomosynthesis
666522|NCT00763087|diabetes mellitus|diabetes mellitus
666523|NCT00763087|peripheral neuropathy|peripheral neuropathy
666524|NCT00763087|exercise|exercise
666525|NCT00763074|Intra-Abdominal Fat|intra-abdominal fat
666526|NCT00763074|Adipokines|adipokines
666527|NCT00763074|Exercise|exercise
666528|NCT00763074|Diet therapy|diet therapy
666529|NCT00763061|Glaucoma|glaucoma
666530|NCT00763035|Coronary Artery Disease|coronary artery disease
666531|NCT00763035|Coronary Vessels|coronary vessels
666532|NCT00763035|Myocardial Ischemia|myocardial ischemia
666533|NCT00763035|Coronary Disease|coronary disease
666534|NCT00763035|Ischemic heart disease|ischemic heart disease
666535|NCT00763035|asthma|asthma
666536|NCT00763035|copd|copd
666632|NCT00762710|Alcoholic|alcoholic
666537|NCT00763022|Glucose Metabolism Disorder|glucose metabolism disorder
666538|NCT00763022|Dysmetabolic Syndrome|dysmetabolic syndrome
666539|NCT00763022|Type II Diabetes|type ii diabetes
666540|NCT00763022|Diabetes Mellitus, Lipoatrophic|diabetes mellitus, lipoatrophic
666541|NCT00763022|Dyslipidemia|dyslipidemia
666542|NCT00763022|Drug Therapy|drug therapy
666543|NCT00762957|Glucose Metabolism Disorder|glucose metabolism disorder
666544|NCT00762957|Dysmetabolic Syndrome|dysmetabolic syndrome
666545|NCT00762957|Type II Diabetes|type ii diabetes
666546|NCT00762957|Diabetes Mellitus, Lipoatrophic|diabetes mellitus, lipoatrophic
666547|NCT00762957|Dyslipidemia|dyslipidemia
666548|NCT00762957|Drug Therapy|drug therapy
666549|NCT00762944|Patients requiring total joint reconstruction due to:|patients requiring total joint reconstruction due to:
666550|NCT00762944|Arthritis (osteo-, rheumatoid, traumatic) malignancy|arthritis (osteo-, rheumatoid, traumatic) malignancy
666551|NCT00762944|Ankylosis functional deformity|ankylosis functional deformity
666552|NCT00762944|Avascular necrosis revisions|avascular necrosis revisions
666553|NCT00762944|Benign neoplasms fracture|benign neoplasms fracture
666554|NCT00762944|Multiple operated joints|multiple operated joints
666555|NCT00762931|bronchoconstriction|bronchoconstriction
666556|NCT00762931|neuromodulation|neuromodulation
666557|NCT00762931|neurostimulation|neurostimulation
666558|NCT00762931|vagus nerve stimulation|vagus nerve stimulation
666559|NCT00762931|vagal nerve stimulation|vagal nerve stimulation
666560|NCT00762931|nVNS|nvns
666561|NCT00762931|VNS|vns
666562|NCT00762931|non invasive|non invasive
666563|NCT00762931|gammacore|gammacore
666564|NCT00762918|cystic fibrosis|cystic fibrosis
666565|NCT00762918|vitamin d|vitamin d
666566|NCT00762918|inflammation|inflammation
666567|NCT00762905|cyanoacrylate|cyanoacrylate
666568|NCT00762905|LiquiBand Laparoscopic|liquiband laparoscopic
666569|NCT00762905|Dermabond|dermabond
666570|NCT00762905|The rate of complete dermal apposition|the rate of complete dermal apposition
666571|NCT00762905|The rate of wound infections and wound dehiscence|the rate of wound infections and wound dehiscence
666572|NCT00762905|The rate of optimal cosmesis|the rate of optimal cosmesis
666573|NCT00762892|Raltegravir|raltegravir
666574|NCT00762892|Integrase inhibitor|integrase inhibitor
666575|NCT00762892|Protease inhibitor|protease inhibitor
666576|NCT00762892|Naive patients|naive patients
666577|NCT00762892|HIV disease|hiv disease
666578|NCT00762892|Lipids|lipids
666579|NCT00762892|Treatment Naïve|treatment naïve
666580|NCT00762879|Juvenile Idiopathic Arthritis|juvenile idiopathic arthritis
666581|NCT00762879|JIA|jia
666582|NCT00762879|Arthritis|arthritis
666583|NCT00762879|Osteoporosis|osteoporosis
666584|NCT00762879|Osteoporosis in Children|osteoporosis in children
666585|NCT00762866|Major Depressive Disorder|major depressive disorder
666586|NCT00762866|Depression|depression
666587|NCT00762866|Bipolar I Disorder|bipolar i disorder
666588|NCT00762866|Bipolar II Disorder|bipolar ii disorder
666589|NCT00762866|Bipolar Disorder NOS|bipolar disorder nos
666590|NCT00762866|Psychotic Disorder|psychotic disorder
666591|NCT00762866|Schizophrenia|schizophrenia
666592|NCT00762866|Schizoaffective Disorder|schizoaffective disorder
666593|NCT00762840|Periapical lesions|periapical lesions
666594|NCT00762840|Apical Periodontitis|apical periodontitis
666595|NCT00762840|endodontic procedure|endodontic procedure
666596|NCT00762840|root canal treatment|root canal treatment
666597|NCT00762814|Parkinson disease|parkinson disease
666598|NCT00762814|Individuals|individuals
666599|NCT00762814|frequent|frequent
666600|NCT00762814|freezing|freezing
666601|NCT00762814|during|during
666602|NCT00762814|gait|gait
666603|NCT00762801|RLIP76|rlip76
666604|NCT00762801|Cancer|cancer
666605|NCT00762801|apoptosis|apoptosis
666606|NCT00762775|Bone resorption|bone resorption
666607|NCT00762775|Calcium homeostasis|calcium homeostasis
666608|NCT00762775|Bone markers|bone markers
666609|NCT00762775|Calcium and Vitamin D supplementation|calcium and vitamin d supplementation
666610|NCT00762775|Parathyroid hormone levels|parathyroid hormone levels
666611|NCT00762775|Interaction between calcium and vitamin D supplementation|interaction between calcium and vitamin d supplementation
666612|NCT00762736|Glucose Metabolism Disorder|glucose metabolism disorder
666613|NCT00762736|Dysmetabolic Syndrome|dysmetabolic syndrome
666614|NCT00762736|Type II Diabetes|type ii diabetes
666615|NCT00762736|Diabetes Mellitus, Lipoatrophic|diabetes mellitus, lipoatrophic
666616|NCT00762736|Dyslipidemia|dyslipidemia
666617|NCT00762736|Drug Therapy|drug therapy
666618|NCT00762723|Degenerative Disc Disease|degenerative disc disease
666620|NCT00762723|Spondylolisthesis|spondylolisthesis
666621|NCT00762723|ALIF|alif
666622|NCT00762723|fusion success|fusion success
666623|NCT00762723|Anterior Lumbar Plate|anterior lumbar plate
666624|NCT00762723|fixed versus variable screw configurations|fixed versus variable screw configurations
666625|NCT00762723|Anterior Lumbar Interbody Fusion to treat spinal instability|anterior lumbar interbody fusion to treat spinal instability
666626|NCT00762710|Alcohol|alcohol
666627|NCT00762710|Abuse|abuse
666628|NCT00762710|Use|use
666629|NCT00762710|Disorder|disorder
666630|NCT00762710|Dependence|dependence
666631|NCT00762710|Symptoms|symptoms
666633|NCT00762710|Alcoholism|alcoholism
666634|NCT00762710|Prazosin|prazosin
666635|NCT00762710|Drug|drug
666636|NCT00762710|Medicine|medicine
666637|NCT00762710|Medication|medication
666638|NCT00762710|Treatment|treatment
666639|NCT00762710|Study|study
666640|NCT00762710|Placebo|placebo
666641|NCT00762710|Medical|medical
666642|NCT00762710|Management|management
666643|NCT00762710|Craving|craving
666644|NCT00762710|Consumption|consumption
666645|NCT00762710|Binge|binge
666646|NCT00762710|Drinking|drinking
666647|NCT00762710|Drink|drink
666648|NCT00762710|Heavy|heavy
666649|NCT00762697|diabetic, venous insufficiency|diabetic, venous insufficiency
666650|NCT00762684|Glucose Metabolism Disorder|glucose metabolism disorder
666651|NCT00762684|Dysmetabolic Syndrome|dysmetabolic syndrome
666652|NCT00762684|Type II Diabetes|type ii diabetes
666653|NCT00762684|Diabetes Mellitus, Lipoatrophic|diabetes mellitus, lipoatrophic
666654|NCT00762684|Dyslipidemia|dyslipidemia
666655|NCT00762658|Plaque Type Psoriasis|plaque type psoriasis
666656|NCT00762658|Topical|topical
666657|NCT00762645|IOP lowering efficacy|iop lowering efficacy
666658|NCT00762645|CACG|cacg
666659|NCT00762632|patients with c-kit+ AML|patients with c-kit+ aml
666660|NCT00762606|Cataract|cataract
666661|NCT00762593|urinary stress incontinence|urinary stress incontinence
666662|NCT00762593|urinary stress incontinence in women|urinary stress incontinence in women
666663|NCT00762580|rotator cuff|rotator cuff
666664|NCT00762580|rehabilitation|rehabilitation
666665|NCT00762554|analgesia|analgesia
666666|NCT00762554|cesarean section|cesarean section
666667|NCT00762554|fentanyl|fentanyl
666668|NCT00762554|Depodur|depodur
666669|NCT00762554|Post-cesarean section analgesia|post-cesarean section analgesia
666670|NCT00762541|Myopia|myopia
666671|NCT00762541|Laser In Situ Keratomileusis|laser in situ keratomileusis
666672|NCT00762541|Laser Therapy|laser therapy
666673|NCT00762541|Laser Corneal Surgery|laser corneal surgery
666674|NCT00762541|Refractive Surgical Procedures|refractive surgical procedures
666675|NCT00762541|Ophthalmologic Surgical Procedure|ophthalmologic surgical procedure
666676|NCT00762541|Operative Surgical Procedures|operative surgical procedures
666677|NCT00762541|Therapeutics|therapeutics
666678|NCT00762489|Temporal artery thermometry|temporal artery thermometry
666679|NCT00762489|Rectal temperature|rectal temperature
666680|NCT00762489|Axillary temperature|axillary temperature
666681|NCT00762489|Newborns|newborns
666682|NCT00762489|Temperature measurement|temperature measurement
666683|NCT00762476|cold, common|cold, common
666684|NCT00762476|rhinovirus|rhinovirus
666685|NCT00762424|Kidney stone|kidney stone
666686|NCT00762424|Ureterolithiasis|ureterolithiasis
666687|NCT00762424|Tamsulosin|tamsulosin
666688|NCT00762424|Flowmax|flowmax
666689|NCT00762424|Emergency Department|emergency department
666690|NCT00762411|Alzheimer's Disease|alzheimer's disease
666691|NCT00762398|Major surgery, excpected blood loss, arterial line|major surgery, excpected blood loss, arterial line
666692|NCT00762372|anesthesia|anesthesia
666693|NCT00762372|desflurane|desflurane
847741|NCT00081497|a-GAL|a-gal
666694|NCT00762359|Curling Ulcer|curling ulcer
666695|NCT00762359|Gastric Ulcer|gastric ulcer
666696|NCT00762359|Aspirin|aspirin
666697|NCT00762359|Acetylsalicylic Acid|acetylsalicylic acid
666698|NCT00762359|Drug Therapy|drug therapy
666699|NCT00762346|non small cell lung cancer|non small cell lung cancer
666701|NCT00762346|zometa|zometa
666702|NCT00762320|HIV|hiv
666703|NCT00762320|Kaletra|kaletra
666704|NCT00762320|treatment Experienced|treatment experienced
666705|NCT00762294|breast cancer|breast cancer
666706|NCT00762294|arimidex|arimidex
666707|NCT00762294|femara|femara
666708|NCT00762294|bone health|bone health
666709|NCT00762281|Hyperopia|hyperopia
666710|NCT00762281|Laser In Situ Keratomileusis|laser in situ keratomileusis
666711|NCT00762281|Laser Therapy|laser therapy
666712|NCT00762281|Laser Corneal Surgery|laser corneal surgery
666713|NCT00762281|Refractive Surgical Procedures|refractive surgical procedures
666714|NCT00762281|Ophthalmologic Surgical Procedure|ophthalmologic surgical procedure
666715|NCT00762281|Operative Surgical Procedures|operative surgical procedures
666716|NCT00762281|Therapeutics|therapeutics
666717|NCT00762268|SAMe|same
666718|NCT00762268|alternative treatments|alternative treatments
666719|NCT00762268|bipolar disorder|bipolar disorder
666720|NCT00762268|depression|depression
666721|NCT00762268|bipolar depression|bipolar depression
666722|NCT00762268|treatment-resistant depression|treatment-resistant depression
666723|NCT00762255|recurrent glioblastoma|recurrent glioblastoma
666724|NCT00762255|multiple agents|multiple agents
666725|NCT00762255|immunotherapy|immunotherapy
666726|NCT00762255|chemotherapy|chemotherapy
666727|NCT00762255|brain and nervous system|brain and nervous system
666728|NCT00762242|metabolomics|metabolomics
666729|NCT00762242|flow-mediated vasodilation|flow-mediated vasodilation
666730|NCT00762229|Cholesterol|cholesterol
666731|NCT00762229|Ezetimibe|ezetimibe
666732|NCT00762216|Cataract|cataract
666733|NCT00762190|Glucose Metabolism Disorder|glucose metabolism disorder
666734|NCT00762190|Dysmetabolic Syndrome|dysmetabolic syndrome
666735|NCT00762190|Type II Diabetes|type ii diabetes
666736|NCT00762190|Diabetes Mellitus, Lipoatrophic|diabetes mellitus, lipoatrophic
666737|NCT00762190|Dyslipidemia|dyslipidemia
666738|NCT00762190|Drug Therapy|drug therapy
666739|NCT00762164|Hypercholesterolemia|hypercholesterolemia
666740|NCT00762164|Statins|statins
666741|NCT00762164|Ezetimibe|ezetimibe
666742|NCT00762151|Dental Plaque|dental plaque
666743|NCT00762138|Platelet rich plasma|platelet rich plasma
666744|NCT00762138|wounds|wounds
666745|NCT00762138|leg ulcers|leg ulcers
666746|NCT00762138|pressure ulcers|pressure ulcers
666747|NCT00762138|diabetic ulcers|diabetic ulcers
666748|NCT00762138|management of mechanically or surgically-debrided wounds|management of mechanically or surgically-debrided wounds
666749|NCT00762125|Fibromyalgia Syndrome|fibromyalgia syndrome
666751|NCT00762125|Physical Therapy|physical therapy
666752|NCT00762125|Psychotherapy|psychotherapy
666753|NCT00762125|Group Counseling|group counseling
666754|NCT00762125|Individual Counseling|individual counseling
666755|NCT00762125|Chronic Pain|chronic pain
666756|NCT00762112|Glucose Metabolism Disorder|glucose metabolism disorder
666757|NCT00762112|Dysmetabolic Syndrome|dysmetabolic syndrome
666758|NCT00762112|Type II Diabetes|type ii diabetes
666759|NCT00762112|Diabetes Mellitus, Lipoatrophic|diabetes mellitus, lipoatrophic
666760|NCT00762112|Dyslipidemia|dyslipidemia
666761|NCT00762112|Drug Therapy.|drug therapy.
666762|NCT00762099|Arthroplasty, Hip|arthroplasty, hip
666763|NCT00762099|Hip replacement|hip replacement
666764|NCT00762099|Pain Management|pain management
666765|NCT00762099|Functional Rehabilitation|functional rehabilitation
666766|NCT00762099|Anxiety|anxiety
666767|NCT00762099|Perioperative|perioperative
666768|NCT00762099|Pregabalin|pregabalin
666769|NCT00762099|Arthroplasty|arthroplasty
666770|NCT00762086|Peripheral Arterial Disease|peripheral arterial disease
666771|NCT00762086|intermittent pneumatic compression treatment|intermittent pneumatic compression treatment
666772|NCT00762086|Initial claudication|initial claudication
666773|NCT00762073|eosinophilic esophagitis|eosinophilic esophagitis
666774|NCT00762060|colorectal surgery|colorectal surgery
666775|NCT00762047|Fecal Incontinence|fecal incontinence
666776|NCT00762021|cataract|cataract
666777|NCT00762008|biomarkers|biomarkers
666778|NCT00761995|Raised IOP|raised iop
666779|NCT00761969|peripheral arterial disease|peripheral arterial disease
666780|NCT00761969|secondary prevention|secondary prevention
666781|NCT00761969|cardiovascular /atherothrombotic events|cardiovascular /atherothrombotic events
666782|NCT00761969|European guidelines|european guidelines
666783|NCT00761969|Cardiovascular disease prevention|cardiovascular disease prevention
666784|NCT00761956|Total Knee Arthroplasty|total knee arthroplasty
666785|NCT00761956|Osteoarthritis|osteoarthritis
666786|NCT00761956|Knee|knee
666787|NCT00761943|Adhesive Capsulitis|adhesive capsulitis
666788|NCT00761943|Bursitis|bursitis
666789|NCT00761943|Frozen Shoulder|frozen shoulder
666790|NCT00761904|hypertension|hypertension
666791|NCT00761904|hyperlipidemia|hyperlipidemia
666792|NCT00761904|free generic samples|free generic samples
666793|NCT00761891|aspirin|aspirin
666794|NCT00761891|cyclooxygenase-1|cyclooxygenase-1
666795|NCT00761891|aspirin resistance|aspirin resistance
666796|NCT00761891|aspirin nonresponse|aspirin nonresponse
666797|NCT00761891|platelet|platelet
666798|NCT00761891|Normal volunteers|normal volunteers
666799|NCT00761878|Skin aging|skin aging
666800|NCT00761878|Skin wrinkling|skin wrinkling
666801|NCT00761865|Lateral Ankle Sprin|lateral ankle sprin
666802|NCT00761865|Air Cast Stirrup Brace|air cast stirrup brace
666803|NCT00761865|High Tide Fracture Boot|high tide fracture boot
666804|NCT00761839|wound healing|wound healing
666805|NCT00761839|self-management|self-management
666806|NCT00761839|patient education|patient education
666807|NCT00761826|Mixed Astigmatism|mixed astigmatism
666808|NCT00761826|Laser In Situ Keratomileusis|laser in situ keratomileusis
666809|NCT00761826|Laser Therapy|laser therapy
666810|NCT00761826|Laser Corneal Surgery|laser corneal surgery
666811|NCT00761826|Refractive Surgical Procedures|refractive surgical procedures
666812|NCT00761826|Ophthalmologic Surgical Procedure|ophthalmologic surgical procedure
666813|NCT00761826|Operative Surgical Procedures|operative surgical procedures
666814|NCT00761826|Therapeutics|therapeutics
666815|NCT00761813|Sliding Hip Screw Fixation|sliding hip screw fixation
666816|NCT00761813|Cannulated Screw Fixation|cannulated screw fixation
666817|NCT00761787|allograft|allograft
666818|NCT00761787|rejection|rejection
666819|NCT00761787|biopsy|biopsy
666820|NCT00761787|gene|gene
666821|NCT00761787|expression|expression
666822|NCT00761787|cardiology|cardiology
666823|NCT00761787|heart|heart
666824|NCT00761787|transplant|transplant
666825|NCT00761774|Epilepsy|epilepsy
666826|NCT00761774|Monotherapy|monotherapy
666827|NCT00761774|Partial Onset Seizures|partial onset seizures
666828|NCT00761761|Sensoril|sensoril
666829|NCT00761761|Bipolar Illness|bipolar illness
666830|NCT00761761|Cognitive enhancement|cognitive enhancement
666831|NCT00761748|Urostomy,|urostomy,
666832|NCT00761748|2-piece,|2-piece,
666833|NCT00761748|preference,|preference,
666834|NCT00761722|Acute Myeloid Leukemia|acute myeloid leukemia
666835|NCT00761722|Myelodysplastic Syndromes|myelodysplastic syndromes
666836|NCT00761722|Lymphoma|lymphoma
666837|NCT00761722|Multiple Myeloma|multiple myeloma
666838|NCT00761722|Chronic Myelomonocytic Leukemia (CMML)|chronic myelomonocytic leukemia (cmml)
666839|NCT00761709|Open Angle Glaucoma|open angle glaucoma
666840|NCT00761709|Ocular Hypertension|ocular hypertension
666841|NCT00761696|solid tumor malignancies|solid tumor malignancies
666842|NCT00761683|Endometriosis|endometriosis
666843|NCT00761657|Kidney|kidney
666844|NCT00761657|Chronic Kidney Disease|chronic kidney disease
666845|NCT00761657|CKD|ckd
666846|NCT00761657|Stage 3 or 4 Chronic Kidney Disease|stage 3 or 4 chronic kidney disease
666847|NCT00761657|Renal|renal
666848|NCT00761657|Anemia|anemia
666849|NCT00761657|Oral anemia treatment|oral anemia treatment
666850|NCT00761657|Hemoglobin levels|hemoglobin levels
666851|NCT00761657|Blood count|blood count
666852|NCT00761657|Erythropoietin|erythropoietin
666853|NCT00761644|Metastatic cancer|metastatic cancer
666854|NCT00761644|Doxil|doxil
666855|NCT00761644|Liposomal doxorubicin|liposomal doxorubicin
666856|NCT00761644|Doxorubicin hydrochloride (liposomal)|doxorubicin hydrochloride (liposomal)
666857|NCT00761644|Avastin|avastin
666858|NCT00761644|Bevacizumab|bevacizumab
666859|NCT00761644|Anti-VEGF monoclonal antibody|anti-vegf monoclonal antibody
666860|NCT00761644|rhuMAb-VEGF|rhumab-vegf
666861|NCT00761644|Torisel|torisel
666862|NCT00761644|Temsirolimus|temsirolimus
666863|NCT00761644|CCI-779|cci-779
666864|NCT00761644|Dynamic contrast-enhanced magnetic resonance imaging|dynamic contrast-enhanced magnetic resonance imaging
666865|NCT00761644|DCE-MRI scan|dce-mri scan
666866|NCT00761618|Intrapleural catheter|intrapleural catheter
666867|NCT00761618|IPC|ipc
666868|NCT00761618|Pleurodesis|pleurodesis
666869|NCT00761618|PD|pd
666870|NCT00761618|Pleural effusion|pleural effusion
666871|NCT00761618|Fluid in the chest cavity|fluid in the chest cavity
666872|NCT00761618|Recurrent malignant pleural effusion|recurrent malignant pleural effusion
666873|NCT00761618|MPE|mpe
666874|NCT00761618|Pleural inflammatory response|pleural inflammatory response
666875|NCT00761605|Schizophrenia|schizophrenia
666876|NCT00761605|Paliperidone|paliperidone
666877|NCT00761605|Paliperidone extended-release|paliperidone extended-release
666878|NCT00761605|Antipsychotics Agents|antipsychotics agents
666879|NCT00761579|Schizophrenia|schizophrenia
666880|NCT00761579|Paliperidone|paliperidone
666881|NCT00761579|Antipsychotics Agents|antipsychotics agents
666882|NCT00761566|Elite swimmers|elite swimmers
666883|NCT00761566|Exercise|exercise
666884|NCT00761566|Preconditioning|preconditioning
666885|NCT00761553|The study is designed to determine the effects of food supplements and strength training.|the study is designed to determine the effects of food supplements and strength training.
666886|NCT00761501|Phase I|phase i
666887|NCT00761501|Healthy Volunteer|healthy volunteer
666888|NCT00761488|Visual acuity,|visual acuity,
666889|NCT00761488|corneal and|corneal and
666890|NCT00761488|refractive|refractive
666891|NCT00761488|cylinder|cylinder
666892|NCT00761488|following|following
666893|NCT00761488|implantation of the|implantation of the
666894|NCT00761488|AcrySof® Toric|acrysof® toric
666895|NCT00761475|incisional hernia|incisional hernia
666896|NCT00761462|Pediatrics|pediatrics
666897|NCT00761462|Safety|safety
666898|NCT00761462|Musculoskeletal System|musculoskeletal system
666899|NCT00761462|Neurologic Manifestations|neurologic manifestations
666900|NCT00761462|Joint Diseases|joint diseases
666901|NCT00761462|Joint Deformities, Acquired|joint deformities, acquired
666902|NCT00761449|MDS|mds
666903|NCT00761449|AML|aml
666904|NCT00761449|Lenalidomide|lenalidomide
666905|NCT00761449|monosomy 5|monosomy 5
666906|NCT00761449|del5q|del5q
666907|NCT00761410|Arthroplasty|arthroplasty
666908|NCT00761410|Knee|knee
666909|NCT00761410|Replacement|replacement
666910|NCT00761410|High Flexion|high flexion
666911|NCT00761410|PFC Sigma RP-F|pfc sigma rp-f
666912|NCT00761397|Oropharyngeal cancer|oropharyngeal cancer
666913|NCT00761397|Dysphagic|dysphagic
666914|NCT00761397|Swallowing exercises|swallowing exercises
666915|NCT00761397|Swallowing rehabilitative regimens|swallowing rehabilitative regimens
666916|NCT00761397|PREPARE|prepare
666917|NCT00761397|Patients' Radiation Expectations|patients' radiation expectations
666918|NCT00761397|Prevention, Adherence, Rehabilitative Exercises|prevention, adherence, rehabilitative exercises
666919|NCT00761384|B-cell lymphoma|b-cell lymphoma
666920|NCT00761384|Refractory|refractory
666921|NCT00761384|Recurrent|recurrent
666922|NCT00761384|90Y-ibritumomab|90y-ibritumomab
666923|NCT00761384|Stem cells support|stem cells support
666924|NCT00761384|Dosimetry study|dosimetry study
666925|NCT00761371|external genital and perianal warts|external genital and perianal warts
666926|NCT00761358|Acotiamide|acotiamide
666927|NCT00761345|pancreatic cancer|pancreatic cancer
666928|NCT00761345|locally advanced|locally advanced
666929|NCT00761345|unresectable|unresectable
666930|NCT00761345|metastatic pancreatic cancer|metastatic pancreatic cancer
666931|NCT00761319|Open-angle glaucoma|open-angle glaucoma
666932|NCT00761319|ocular hypertension|ocular hypertension
666933|NCT00761306|Major Depressive Disorder|major depressive disorder
666934|NCT00761306|Long-term|long-term
666935|NCT00761306|Safety|safety
666936|NCT00761306|Open-label|open-label
666937|NCT00761280|Anaplastic astrocytoma|anaplastic astrocytoma
666938|NCT00761280|Glioblastoma|glioblastoma
666939|NCT00761280|Antisense|antisense
666940|NCT00761280|Cancer|cancer
666941|NCT00761280|Transforming Growth Factor beta 2|transforming growth factor beta 2
666942|NCT00761280|Targeted therapy|targeted therapy
666943|NCT00761280|Brain tumor|brain tumor
666944|NCT00761280|Glioma|glioma
666945|NCT00761280|Central Nervous System (CNS)|central nervous system (cns)
666946|NCT00761280|Convection Enhanced Delivery (CED)|convection enhanced delivery (ced)
666947|NCT00761280|Intratumoral administration|intratumoral administration
666948|NCT00761267|Anidulafungin|anidulafungin
666949|NCT00761267|pediatrics|pediatrics
666950|NCT00761267|candidemia|candidemia
666951|NCT00761267|invasive candidiasis|invasive candidiasis
666952|NCT00761267|safety|safety
666953|NCT00761254|Domperidone|domperidone
666954|NCT00761254|Gastroparesis|gastroparesis
666955|NCT00761241|pancreas cancer|pancreas cancer
666956|NCT00761241|combined modality therapy|combined modality therapy
666957|NCT00761228|Vegetative State|vegetative state
666958|NCT00761228|Minimally Conscious State|minimally conscious state
666959|NCT00761228|Coma|coma
666960|NCT00761228|Traumatic Brain Injury|traumatic brain injury
666961|NCT00761215|Skin|skin
666962|NCT00761215|Infection|infection
666963|NCT00761215|Complicated Skin and Skin Structure Infection|complicated skin and skin structure infection
666964|NCT00761189|Paliperidone|paliperidone
666965|NCT00761189|R076477|r076477
666966|NCT00761189|Schizophrenia|schizophrenia
666967|NCT00761176|Diabetes|diabetes
666968|NCT00761176|Ulcers|ulcers
666969|NCT00761176|Wounds|wounds
666970|NCT00761163|The purpose of this study is to identify the body's response to aerobic vs. resistance exercise|the purpose of this study is to identify the body's response to aerobic vs. resistance exercise
666971|NCT00761150|Effect on sleep interference by pain|effect on sleep interference by pain
666972|NCT00761137|sialorrhea|sialorrhea
666973|NCT00761137|drooling|drooling
666974|NCT00761137|excessive salivation|excessive salivation
666975|NCT00761137|parkinson's disease|parkinson's disease
666976|NCT00761124|PSA screening|psa screening
666977|NCT00761124|Prostate cancer and Latino men|prostate cancer and latino men
666978|NCT00761111|information booklet|information booklet
666979|NCT00761111|low back beliefs|low back beliefs
666980|NCT00761111|education|education
666981|NCT00761111|disc hernia|disc hernia
666982|NCT00761111|discectomy|discectomy
666983|NCT00761111|A common monoradicular sciatica|a common monoradicular sciatica
666984|NCT00761111|on a slipped disc|on a slipped disc
666985|NCT00761111|with a clinical radio|with a clinical radio
666986|NCT00761111|agreement requiring a surgical treatment|agreement requiring a surgical treatment
666987|NCT00761111|carried out|carried out
666988|NCT00761111|one duration|one duration
666989|NCT00761111|of evolution higher|of evolution higher
666990|NCT00761111|than four weeks|than four weeks
666991|NCT00761111|at naive subjects|at naive subjects
666992|NCT00761111|of any rachidian interventional treatment|of any rachidian interventional treatment
666993|NCT00761111|after failure of an good ambulatory|after failure of an good ambulatory
666994|NCT00761098|Cirrhosis|cirrhosis
666995|NCT00761098|SBP|sbp
666996|NCT00761072|Propofol|propofol
666997|NCT00761072|Remifentanil|remifentanil
666998|NCT00761072|Total Intravenous Anesthesia|total intravenous anesthesia
666999|NCT00761059|analgesia|analgesia
667000|NCT00761059|infant, premature|infant, premature
667001|NCT00761059|glucose|glucose
667002|NCT00761059|nasopharyngeal suctioning|nasopharyngeal suctioning
667003|NCT00761033|children undergoing intravenous placement in the pediatric emergency department|children undergoing intravenous placement in the pediatric emergency department
667004|NCT00761020|Malaria|malaria
667005|NCT00761020|Diagnosis|diagnosis
667006|NCT00761020|Biomarker|biomarker
667007|NCT00761007|Irritable Bowel Syndrome|irritable bowel syndrome
667008|NCT00761007|Bowel disease|bowel disease
667009|NCT00760994|Alcohol|alcohol
667010|NCT00760994|Alcoholic|alcoholic
667011|NCT00760994|Alcoholism|alcoholism
667012|NCT00760994|Post-traumatic stress disorder|post-traumatic stress disorder
667013|NCT00760994|PTSD|ptsd
667014|NCT00760994|Experiential acceptance|experiential acceptance
667015|NCT00760994|Mindfulness|mindfulness
667016|NCT00760994|Meditation|meditation
667017|NCT00760994|Meditate|meditate
667018|NCT00760994|Cognitive restructuring|cognitive restructuring
667019|NCT00760994|Cognitive|cognitive
667020|NCT00760994|Behavioral|behavioral
667021|NCT00760994|Therapy|therapy
667022|NCT00760994|Treatment|treatment
667023|NCT00760994|Study|study
667024|NCT00760994|Intervention|intervention
667025|NCT00760968|Rheumatoid Arthritis|rheumatoid arthritis
667026|NCT00760968|Drug Therapy|drug therapy
667027|NCT00760955|Asymmetric Diabetic Proximal Motor Neuropathy|asymmetric diabetic proximal motor neuropathy
667028|NCT00760955|Diabetic Amyotrophy|diabetic amyotrophy
667127|NCT00760513|RCT|rct
667029|NCT00760955|Diabetic Autonomic Neuropathy|diabetic autonomic neuropathy
667030|NCT00760955|Diabetic Polyneuropathy|diabetic polyneuropathy
667031|NCT00760955|Neuralgia, Diabetic|neuralgia, diabetic
667032|NCT00760955|Symmetric Diabetic Proximal Motor Neuropathy|symmetric diabetic proximal motor neuropathy
667033|NCT00760955|Drug Therapy|drug therapy
667034|NCT00760942|Low birth weight|low birth weight
667035|NCT00760942|neonates|neonates
667036|NCT00760942|premature infants|premature infants
667037|NCT00760942|nutrition|nutrition
667038|NCT00760942|human milk fortification|human milk fortification
667039|NCT00760942|Infant|infant
667040|NCT00760916|Pulmonary Arterial Hypertension|pulmonary arterial hypertension
667041|NCT00760903|Moderate brain trauma|moderate brain trauma
667042|NCT00760890|Iron, breastfed infant|iron, breastfed infant
667043|NCT00760877|MYELOGENOUS|myelogenous
667044|NCT00760877|LEUKEMIA|leukemia
667045|NCT00760877|Chronic Phase|chronic phase
667046|NCT00760877|CML|cml
667047|NCT00760864|Rheumatoid Arthritis|rheumatoid arthritis
667048|NCT00760864|Drug Therapy|drug therapy
667049|NCT00760851|Probiotics|probiotics
667050|NCT00760851|Child, preschool|child, preschool
667051|NCT00760851|Child Day Care Centers|child day care centers
667052|NCT00760851|Health|health
667053|NCT00760851|Immune system|immune system
667054|NCT00760838|Inadequately controlled severe asthma|inadequately controlled severe asthma
667055|NCT00760825|cholera|cholera
667056|NCT00760825|vibrios|vibrios
667057|NCT00760825|oral cholera vaccine|oral cholera vaccine
667058|NCT00760812|Autism|autism
667059|NCT00760812|Autism Spectrum Disorders|autism spectrum disorders
667060|NCT00760812|Pervasive Developmental Disorders|pervasive developmental disorders
667061|NCT00760812|Toddlers|toddlers
667062|NCT00760812|Intervention|intervention
667063|NCT00760799|Lumbar Disc Herniation|lumbar disc herniation
667064|NCT00760786|IVUS-VH|ivus-vh
667065|NCT00760786|Plaque characterization|plaque characterization
667066|NCT00760786|Omega3-fatty acid|omega3-fatty acid
667067|NCT00760786|Atorvastatin|atorvastatin
667068|NCT00760773|Probiotic treatment|probiotic treatment
667069|NCT00760773|Daycare attendance|daycare attendance
667070|NCT00760773|Pediatric|pediatric
667071|NCT00760773|Emergency department|emergency department
667072|NCT00760747|ADHD|adhd
667073|NCT00760747|Children|children
667074|NCT00760747|Stimulant|stimulant
667075|NCT00760747|Atomoxetine|atomoxetine
667076|NCT00760747|Adolescents|adolescents
667077|NCT00760734|Chronic traumatic brain injury|chronic traumatic brain injury
667078|NCT00760734|Post concussion syndrome|post concussion syndrome
667079|NCT00760734|Post traumatic stress disorder|post traumatic stress disorder
667080|NCT00760734|Chronic post traumatic stress disorder|chronic post traumatic stress disorder
667081|NCT00760721|Hepatitis B Screening|hepatitis b screening
667082|NCT00760721|Korean Americans|korean americans
667083|NCT00760708|nucleosides|nucleosides
667084|NCT00760708|neurotransmitter|neurotransmitter
667085|NCT00760708|myocardial ischemia|myocardial ischemia
667086|NCT00760708|Adenosine|adenosine
667087|NCT00760695|anorexia nervosa|anorexia nervosa
667088|NCT00760695|chronic|chronic
667089|NCT00760695|dronabinol|dronabinol
667090|NCT00760695|weight gain|weight gain
667091|NCT00760695|EDI|edi
667092|NCT00760682|osteoradionecrosis|osteoradionecrosis
667093|NCT00760682|hyperbaric oxygen|hyperbaric oxygen
667094|NCT00760682|sequestrectomy|sequestrectomy
667095|NCT00760669|Spondylitis, Ankylosing|spondylitis, ankylosing
667096|NCT00760669|Arthritis, Rheumatoid|arthritis, rheumatoid
667097|NCT00760669|Psoriasis|psoriasis
667098|NCT00760669|Arthritis, Psoriatic|arthritis, psoriatic
667099|NCT00760669|Infliximab|infliximab
667100|NCT00760669|Remicade|remicade
667101|NCT00760656|Health outcomes in adults who survived pediatric cancer|health outcomes in adults who survived pediatric cancer
667102|NCT00760656|Survivors of Pediatric Cancer|survivors of pediatric cancer
667103|NCT00760630|abnormal stress test|abnormal stress test
667104|NCT00760630|fractional flow reserve|fractional flow reserve
667105|NCT00760630|pressure drop coefficient|pressure drop coefficient
667106|NCT00760630|lesion flow coefficient|lesion flow coefficient
667107|NCT00760617|Influenza|influenza
667108|NCT00760617|Elderly|elderly
667109|NCT00760604|Esophageal neoplasms|esophageal neoplasms
667110|NCT00760604|Esophagectomy|esophagectomy
667111|NCT00760591|Acute kidney failure|acute kidney failure
667112|NCT00760591|Colonoscopy|colonoscopy
667113|NCT00760591|Neutrophil gelatinase-associated lipocalin|neutrophil gelatinase-associated lipocalin
667114|NCT00760552|Hypertension|hypertension
667115|NCT00760552|Adherence|adherence
667116|NCT00760552|Pharmacist|pharmacist
667117|NCT00760552|Interdisciplinary|interdisciplinary
667118|NCT00760552|Randomized Controlled|randomized controlled
667119|NCT00760552|Primary Care|primary care
667120|NCT00760539|Glaucoma|glaucoma
667121|NCT00760539|Hypertension|hypertension
667122|NCT00760526|Continuous Glucose Monitor|continuous glucose monitor
667123|NCT00760513|non alcoholic fatty liver disease|non alcoholic fatty liver disease
667124|NCT00760513|NAFLD|nafld
667125|NCT00760513|fish oil|fish oil
667126|NCT00760513|intervention|intervention
667128|NCT00760513|biomarkers|biomarkers
667129|NCT00760487|Cataract AcrySof Toric IOL|cataract acrysof toric iol
667130|NCT00760487|Bilateral cataract|bilateral cataract
667131|NCT00760474|Fibromyalgia; fMRI; pain; pregabalin; Lyrica; imaging|fibromyalgia; fmri; pain; pregabalin; lyrica; imaging
667132|NCT00760435|Kawasaki disease|kawasaki disease
667133|NCT00760435|Infliximab|infliximab
667134|NCT00760435|Remicade|remicade
667135|NCT00760435|Pediatrics|pediatrics
667136|NCT00760409|recurrent tumor|recurrent tumor
667137|NCT00760396|healthy volunteers|healthy volunteers
667138|NCT00760383|Total Knee Arthroplasty|total knee arthroplasty
667139|NCT00760383|Osteoarthritis|osteoarthritis
667140|NCT00760383|Muscle Metabolism|muscle metabolism
667141|NCT00760383|Rehabilitation|rehabilitation
667142|NCT00760383|Physical Therapy|physical therapy
667143|NCT00760370|bone marker|bone marker
667144|NCT00760370|bisphosphonate|bisphosphonate
667145|NCT00760370|Zometa|zometa
667146|NCT00760370|retention|retention
667147|NCT00760370|breast cancer|breast cancer
667148|NCT00760370|multiple myeloma|multiple myeloma
667149|NCT00760370|CTX|ctx
667150|NCT00760370|bone specific ALP|bone specific alp
667151|NCT00760357|Critical Ischemia|critical ischemia
667152|NCT00760344|Glucose Metabolism Disorder|glucose metabolism disorder
667153|NCT00760344|Dysmetabolic Syndrome|dysmetabolic syndrome
667154|NCT00760344|Type II Diabetes|type ii diabetes
667155|NCT00760344|Diabetes Mellitus, Lipoatrophic|diabetes mellitus, lipoatrophic
667156|NCT00760344|Dyslipidemia|dyslipidemia
667157|NCT00760344|Drug Therapy|drug therapy
667158|NCT00760331|HNF1B|hnf1b
667159|NCT00760331|TCF2|tcf2
667160|NCT00760331|MODY-5|mody-5
667161|NCT00760331|CAKUT|cakut
667162|NCT00760331|Anomaly of renal development|anomaly of renal development
667163|NCT00760318|cervical dystonia, keppra, botox, spasmodic torticollis|cervical dystonia, keppra, botox, spasmodic torticollis
667164|NCT00760305|cancer pain|cancer pain
667165|NCT00760305|bone metastasis|bone metastasis
667166|NCT00760305|patient education|patient education
667167|NCT00760305|psychoeducational education|psychoeducational education
667168|NCT00760305|side effects|side effects
667169|NCT00760305|analgesics|analgesics
667170|NCT00760292|Type 2 Diabetes Mellitus|type 2 diabetes mellitus
667171|NCT00760292|Genetic Variants|genetic variants
667172|NCT00760292|SNP|snp
667173|NCT00760292|DNA microarray|dna microarray
667174|NCT00760279|Bacterial infection|bacterial infection
667175|NCT00760279|Azithromycin|azithromycin
667176|NCT00760266|Hypertension|hypertension
667177|NCT00760266|older population|older population
667178|NCT00760266|aliskiren|aliskiren
667179|NCT00760266|hydrochlorothiazide|hydrochlorothiazide
667180|NCT00760266|systolic blood pressure|systolic blood pressure
667181|NCT00760266|diastolic blood pressure|diastolic blood pressure
667182|NCT00760266|amlodipine, stage 2|amlodipine, stage 2
667183|NCT00760253|target control infusion|target control infusion
667184|NCT00760253|alfentanyl|alfentanyl
667185|NCT00760253|propofol|propofol
667186|NCT00760253|BIS|bis
667187|NCT00760240|compliance|compliance
667188|NCT00760240|eyedrop instillation|eyedrop instillation
667189|NCT00760240|How patients with low vision due to glaucoma or retinal pathology instill eyedrops into their own eyes.|how patients with low vision due to glaucoma or retinal pathology instill eyedrops into their own eyes.
667190|NCT00760214|Essential Hypertension|essential hypertension
667191|NCT00760214|Hypertension|hypertension
667192|NCT00760214|Drug Therapy|drug therapy
667193|NCT00760214|Blood Pressure, High|blood pressure, high
667194|NCT00760214|Vascular Disease|vascular disease
667195|NCT00760214|Cardiovascular Disease|cardiovascular disease
667196|NCT00760201|executive|executive
667197|NCT00760201|administrator|administrator
667198|NCT00760201|perceptions|perceptions
667199|NCT00760201|legal counsel|legal counsel
667200|NCT00760201|end of life|end of life
667201|NCT00760188|knee replacement|knee replacement
667202|NCT00760175|Lung transplant Recipients|lung transplant recipients
667203|NCT00760175|Vaxigrip|vaxigrip
667204|NCT00760162|Chronic Kidney failure stage three and four|chronic kidney failure stage three and four
667205|NCT00760162|Probiotics|probiotics
667206|NCT00760162|Kibow Biotics|kibow biotics
667207|NCT00760162|Enteric Dialysis|enteric dialysis
667208|NCT00760162|Gut based removal uremic toxin removal|gut based removal uremic toxin removal
667209|NCT00760149|tuberculosis|tuberculosis
667210|NCT00760149|rifampicin|rifampicin
667211|NCT00760149|pharmacokinetics|pharmacokinetics
667212|NCT00760149|pharmacodynamics|pharmacodynamics
667213|NCT00760136|patellofemoral pain|patellofemoral pain
667214|NCT00760136|quadriceps contraction|quadriceps contraction
667215|NCT00760123|Lymphedema|lymphedema
667216|NCT00760123|Prevention|prevention
667217|NCT00760123|Breast cancer|breast cancer
667218|NCT00760123|Physical therapy|physical therapy
667219|NCT00760110|Morning BP|morning bp
667220|NCT00760110|Clinic BP|clinic bp
667221|NCT00760110|micro- and macrovascular complications|micro- and macrovascular complications
667222|NCT00760084|Acute Myelogenous Leukemia|acute myelogenous leukemia
667223|NCT00760084|Myelodysplastic Syndrome|myelodysplastic syndrome
667224|NCT00760084|Dacogen|dacogen
667225|NCT00760084|Decitabine|decitabine
667226|NCT00760071|cystic fibrosis,|cystic fibrosis,
667227|NCT00760071|lung disease,|lung disease,
667229|NCT00760071|morphology,|morphology,
667230|NCT00760071|function|function
667231|NCT00760071|morphological MRI|morphological mri
667232|NCT00760071|functional MRI|functional mri
667233|NCT00760071|correlation to clinical data|correlation to clinical data
667234|NCT00760058|cataract, intraocular lens|cataract, intraocular lens
667235|NCT00760032|Cirrhosis|cirrhosis
667236|NCT00760032|Ascites|ascites
667237|NCT00760032|Lipopolysaccharide binding protein|lipopolysaccharide binding protein
667238|NCT00760032|Infections|infections
667239|NCT00760032|Cytokines|cytokines
667240|NCT00760032|Ciprofloxacin|ciprofloxacin
667241|NCT00760019|vascular inflammation|vascular inflammation
667242|NCT00760019|endothelium-dependent flow-mediated blood vessel function|endothelium-dependent flow-mediated blood vessel function
667243|NCT00760006|cleft secondary palate|cleft secondary palate
667244|NCT00760006|primary closure of secondary cleft palate|primary closure of secondary cleft palate
667245|NCT00760006|Prophylactic Antibiotics|prophylactic antibiotics
667246|NCT00760006|Unasyn|unasyn
667247|NCT00760006|Cleft Palate|cleft palate
667248|NCT00759993|weight gain|weight gain
667249|NCT00759993|Obesity|obesity
667250|NCT00759993|Psychiatry|psychiatry
667251|NCT00759993|Medication|medication
667252|NCT00759993|Induced|induced
667253|NCT00759980|Thrombocytopenia|thrombocytopenia
667254|NCT00759980|Platelet transfusion|platelet transfusion
667255|NCT00759967|Randomized|randomized
667256|NCT00759967|Cross-Over|cross-over
667257|NCT00759967|Conventional|conventional
667258|NCT00759967|Daily|daily
667259|NCT00759967|Hemodialysis|hemodialysis
667260|NCT00759954|bioequivalence|bioequivalence
667261|NCT00759954|morphine sulfate sustained release capsules|morphine sulfate sustained release capsules
667262|NCT00759954|KADIAN capsules|kadian capsules
667263|NCT00759954|200 mg|200 mg
667264|NCT00759954|applesauce|applesauce
667265|NCT00759941|Glaucoma|glaucoma
667266|NCT00759928|Refractory Solid Tumors|refractory solid tumors
667267|NCT00759928|Unresectable Stage III/IV|unresectable stage iii/iv
667268|NCT00759928|Sorafenib|sorafenib
667269|NCT00759928|Erlotinib|erlotinib
667270|NCT00759928|Pharmacokinetics|pharmacokinetics
667271|NCT00759915|10 mg|10 mg
667272|NCT00759915|KADIAN capsules|kadian capsules
667273|NCT00759915|20 mg|20 mg
667274|NCT00759915|fed conditions|fed conditions
667275|NCT00759915|bioequivalence|bioequivalence
667276|NCT00759902|bioequivalence|bioequivalence
667277|NCT00759902|10 mg|10 mg
667278|NCT00759902|KADIAN capsules|kadian capsules
667279|NCT00759902|20 mg|20 mg
667280|NCT00759902|under fasted conditions|under fasted conditions
667281|NCT00759889|venous leg ulcer|venous leg ulcer
667282|NCT00759876|Duchenne muscular dystrophy|duchenne muscular dystrophy
667283|NCT00759876|Nonsense mutation|nonsense mutation
667284|NCT00759876|Premature stop codon|premature stop codon
667285|NCT00759876|DMD|dmd
667286|NCT00759876|PTC124|ptc124
667287|NCT00759876|Ataluren|ataluren
667288|NCT00759850|Acute Myocardial Infarction|acute myocardial infarction
667289|NCT00759850|Drug Eluting Stent|drug eluting stent
667290|NCT00759850|Primary PCI|primary pci
667291|NCT00759824|Small cell lung carcinoma|small cell lung carcinoma
667292|NCT00759824|Valproic acid|valproic acid
667293|NCT00759824|Adriamycin|adriamycin
667294|NCT00759824|Cyclophosphamide|cyclophosphamide
667295|NCT00759824|Vindesine|vindesine
667296|NCT00759824|Second-line chemotherapy|second-line chemotherapy
667297|NCT00759811|Heart Failure|heart failure
667298|NCT00759811|Myocardial Ischemia|myocardial ischemia
667299|NCT00759811|Methotrexate|methotrexate
667300|NCT00759811|Inflammation|inflammation
667301|NCT00759811|Anti-Inflammatory Agents|anti-inflammatory agents
667302|NCT00759811|Inflammation Mediators|inflammation mediators
667303|NCT00759798|Chronic Lymphocytic Leukemia|chronic lymphocytic leukemia
667304|NCT00759798|Leukemia|leukemia
667305|NCT00759798|FCR|fcr
667306|NCT00759798|Fludarabine|fludarabine
667307|NCT00759798|Cyclophosphamide|cyclophosphamide
667308|NCT00759798|Rituximab|rituximab
667309|NCT00759772|Anorexia Nervosa|anorexia nervosa
667310|NCT00759772|Disordered Eating|disordered eating
667311|NCT00759772|Osteoporosis|osteoporosis
667312|NCT00759772|Parathyroid Hormone|parathyroid hormone
667313|NCT00759772|Bone|bone
667314|NCT00759759|bioequivalence|bioequivalence
667315|NCT00759759|morphine sulfate sustained release capsules|morphine sulfate sustained release capsules
667316|NCT00759759|KADIAN capsules|kadian capsules
667317|NCT00759759|200 mg|200 mg
667318|NCT00759746|Weight loss maintenance|weight loss maintenance
667319|NCT00759733|pregnancy|pregnancy
667320|NCT00759733|heart disease|heart disease
667321|NCT00759733|heart function testing|heart function testing
667322|NCT00759733|echocardiography|echocardiography
667323|NCT00759733|B-type natriuretic peptide|b-type natriuretic peptide
667324|NCT00759733|obstetrical care|obstetrical care
667325|NCT00759720|Glucose Metabolism Disorder|glucose metabolism disorder
667326|NCT00759720|Dysmetabolic Syndrome|dysmetabolic syndrome
667327|NCT00759720|Type II Diabetes|type ii diabetes
667328|NCT00759720|Diabetes Mellitus, Lipoatrophic|diabetes mellitus, lipoatrophic
667329|NCT00759720|Dyslipidemia|dyslipidemia
667330|NCT00759720|Drug Therapy|drug therapy
667331|NCT00759707|saphenous vein bypass grafts|saphenous vein bypass grafts
667332|NCT00759707|flow-mediated vasodilation|flow-mediated vasodilation
667333|NCT00759681|Arterial Surgery|arterial surgery
667334|NCT00759681|Open vascular Surgery|open vascular surgery
667335|NCT00759681|Sealant|sealant
667336|NCT00759655|hemophilia A|hemophilia a
667337|NCT00759655|Xyntha|xyntha
667338|NCT00759655|ReFacto|refacto
667339|NCT00759655|moroctocog alfa|moroctocog alfa
667340|NCT00759655|bleeding disorder|bleeding disorder
667341|NCT00759642|breast cancer|breast cancer
667342|NCT00759642|hormone receptor positive|hormone receptor positive
667343|NCT00759642|HER-2 negative|her-2 negative
667344|NCT00759616|Knee Replacement|knee replacement
667345|NCT00759603|Leukemia|leukemia
667346|NCT00759603|CLL|cll
667347|NCT00759603|Chronic Lymphocytic Leukemia|chronic lymphocytic leukemia
667348|NCT00759603|SLL|sll
667349|NCT00759603|Small Lymphocytic Lymphoma|small lymphocytic lymphoma
667350|NCT00759603|Lenalidomide|lenalidomide
667351|NCT00759603|Revlimid|revlimid
667352|NCT00759603|Rituximab|rituximab
667353|NCT00759603|Rituxan|rituxan
667354|NCT00759551|Blood Pressure|blood pressure
667355|NCT00759551|Drug Therapy|drug therapy
667356|NCT00759551|Systolic Pressure|systolic pressure
667357|NCT00759551|Diastolic Pressure|diastolic pressure
667358|NCT00759551|Vascular Diseases|vascular diseases
667359|NCT00759538|Lung Transplantation|lung transplantation
667360|NCT00759538|Pulmonary Rehabilitation|pulmonary rehabilitation
667361|NCT00759538|Exercise tolerance|exercise tolerance
667362|NCT00759538|Quality of Life|quality of life
667363|NCT00759499|study of debridement tissue for research purposes.|study of debridement tissue for research purposes.
667364|NCT00759499|open wound|open wound
667365|NCT00759486|craniofacial fracture|craniofacial fracture
667366|NCT00759486|Subjects who are in the active phase of craniofacial skeletal growth, and have sustained a craniofacial fracture|subjects who are in the active phase of craniofacial skeletal growth, and have sustained a craniofacial fracture
667367|NCT00759473|substance-related disorders|substance-related disorders
667368|NCT00759460|Schizophrenia|schizophrenia
667369|NCT00759447|Breast cancer|breast cancer
667370|NCT00759447|tomosynthesis|tomosynthesis
667371|NCT00759434|Varicose veins|varicose veins
667372|NCT00759434|Chronic venous insufficiency|chronic venous insufficiency
667373|NCT00759434|Venous ulceration|venous ulceration
667374|NCT00759434|Surgery|surgery
667375|NCT00759434|Endovenous Laser|endovenous laser
667376|NCT00759421|Schizophrenia|schizophrenia
667377|NCT00759408|primary pulmonary hypertension|primary pulmonary hypertension
667378|NCT00759408|secondary pulmonary hypertension due to left heart failure|secondary pulmonary hypertension due to left heart failure
667379|NCT00759408|secondary pulmonary hypertension due to other causes|secondary pulmonary hypertension due to other causes
710279|NCT00589563|contiguous stage II adult lymphoblastic lymphoma|contiguous stage ii adult lymphoblastic lymphoma
667380|NCT00759408|patients without pulmonary disease or pulmonary hypertension|patients without pulmonary disease or pulmonary hypertension
667381|NCT00759395|Anxious Major Depressive Disorder|anxious major depressive disorder
667382|NCT00759382|Non small cell lung carcinoma|non small cell lung carcinoma
667383|NCT00759382|PET scan|pet scan
667384|NCT00759382|Observational study|observational study
667385|NCT00759382|Non metastatic|non metastatic
667386|NCT00759382|treated|treated
667387|NCT00759382|curative intent|curative intent
667388|NCT00759369|ADPKD|adpkd
667389|NCT00759356|bioavailability|bioavailability
667390|NCT00759356|KADIAN|kadian
667391|NCT00759356|200 mg|200 mg
667392|NCT00759356|morphine sulfate sustained release capsules|morphine sulfate sustained release capsules
667393|NCT00759356|100 mg|100 mg
667394|NCT00759356|fed conditions|fed conditions
667395|NCT00759343|Kidney stones|kidney stones
667396|NCT00759343|urinary stone disease|urinary stone disease
667397|NCT00759343|urinary stones|urinary stones
667398|NCT00759343|urine|urine
667399|NCT00759343|serum|serum
667400|NCT00759330|Flurbiprofen, low back pain, chronic low back pain|flurbiprofen, low back pain, chronic low back pain
667401|NCT00759317|normal controls|normal controls
667402|NCT00759304|Aging|aging
667403|NCT00759304|cardiovascular risk factors|cardiovascular risk factors
667404|NCT00759304|Autonomic nervous system|autonomic nervous system
667405|NCT00759304|stroke|stroke
667406|NCT00759304|Myocardiac infarction|myocardiac infarction
667407|NCT00759304|Neuropsychological evaluation|neuropsychological evaluation
667408|NCT00759304|Prospective cohort|prospective cohort
667409|NCT00759291|free fatty acids|free fatty acids
667410|NCT00759291|insulin-mediated|insulin-mediated
667411|NCT00759291|endothelium-dependent vasodilation|endothelium-dependent vasodilation
667412|NCT00759291|metabolic syndrome|metabolic syndrome
667413|NCT00759278|pregnancy|pregnancy
667414|NCT00759278|umbilical artery systolic to diastolic flow ratio|umbilical artery systolic to diastolic flow ratio
667415|NCT00759278|middle cerebral artery peak systolic flow|middle cerebral artery peak systolic flow
667416|NCT00759278|antihypertensive medication|antihypertensive medication
667417|NCT00759265|Muscle strength|muscle strength
667418|NCT00759265|Physical activity|physical activity
667419|NCT00759265|Mobility|mobility
667420|NCT00759265|Gait analysis|gait analysis
667421|NCT00759252|diagnosis of dementia|diagnosis of dementia
667422|NCT00759252|perceptions of risk|perceptions of risk
667423|NCT00759252|dementia screening|dementia screening
667424|NCT00759239|Open-angle glaucoma (with or without pseudoexfoliation or pigment dispersion component), or ocular hypertension|open-angle glaucoma (with or without pseudoexfoliation or pigment dispersion component), or ocular hypertension
667425|NCT00759226|esophageal cancer|esophageal cancer
667426|NCT00759226|Gemcitabine|gemcitabine
667427|NCT00759226|Cisplatin|cisplatin
667428|NCT00759226|5-FU|5-fu
667429|NCT00759226|Folinic Acid|folinic acid
667430|NCT00759226|inoperable esophageal cancer|inoperable esophageal cancer
667431|NCT00759213|Discharge planning|discharge planning
667432|NCT00759213|Family needs|family needs
667433|NCT00759213|Family concerns|family concerns
667434|NCT00759213|NICU|nicu
667435|NCT00759213|Infants|infants
667436|NCT00759200|Chronic hepatitis C|chronic hepatitis c
667437|NCT00759200|genotype 2|genotype 2
667438|NCT00759200|genotype 3|genotype 3
667439|NCT00759200|albumin interferon alfa-2b|albumin interferon alfa-2b
667440|NCT00759200|alb-interferon|alb-interferon
667441|NCT00759174|Optic Neuropathy Acute NAION PDE5 Inhibitor|optic neuropathy acute naion pde5 inhibitor
667442|NCT00759161|Plaque Type Psoriasis|plaque type psoriasis
667443|NCT00759161|Topical|topical
667444|NCT00759148|pink eye|pink eye
667445|NCT00759148|conjunctivitis|conjunctivitis
667446|NCT00759148|moxifloxacin|moxifloxacin
667447|NCT00759148|fluoroquinolone|fluoroquinolone
667448|NCT00759135|Benign Prostatic Hyperplasia|benign prostatic hyperplasia
667449|NCT00759135|BPH|bph
667450|NCT00759135|Enlarged Prostate|enlarged prostate
667451|NCT00759122|mdd|mdd
667452|NCT00759122|major depressive disorder|major depressive disorder
667453|NCT00759122|depression|depression
667454|NCT00759096|bilateral implantation|bilateral implantation
667455|NCT00759096|ReSTOR Aspheric IOL|restor aspheric iol
667456|NCT00759096|uniocular unaided distance|uniocular unaided distance
667457|NCT00759096|binocular unaided distance|binocular unaided distance
667458|NCT00759096|intermediate visual acuity|intermediate visual acuity
667459|NCT00759096|near visual acuity|near visual acuity
667460|NCT00759083|HIT|hit
667461|NCT00759083|HITTS|hitts
667462|NCT00759070|Treatment Naïve|treatment naïve
667463|NCT00759057|Spinal Stenosis|spinal stenosis
667464|NCT00759057|Spinal Instability|spinal instability
667465|NCT00759057|Leg Pain|leg pain
667466|NCT00759018|GVHD|gvhd
667467|NCT00759018|Prochymal|prochymal
667468|NCT00759018|Graft vs Host Disease|graft vs host disease
667469|NCT00758992|gene transfer|gene transfer
667470|NCT00758966|OCD,|ocd,
667471|NCT00758966|naltrexone,|naltrexone,
667472|NCT00758966|fluoxetine,|fluoxetine,
667473|NCT00758966|obsessive-compulsive disorder|obsessive-compulsive disorder
667474|NCT00758940|Clinical|clinical
667475|NCT00758940|assessment|assessment
667476|NCT00758940|of visual|of visual
667477|NCT00758940|function|function
667478|NCT00758940|with the Acrysof ReSTOR|with the acrysof restor
667479|NCT00758940|multifocal IOL|multifocal iol
667480|NCT00758927|diabetes mellitus|diabetes mellitus
667481|NCT00758927|combined hyperlipidemia|combined hyperlipidemia
667482|NCT00758927|OMACOR|omacor
667483|NCT00758927|small dense LDL|small dense ldl
667484|NCT00758927|HDL subfraction|hdl subfraction
667485|NCT00758914|Vitamin E|vitamin e
667486|NCT00758849|NOH|noh
667487|NCT00758849|Orthostatic hypotension|orthostatic hypotension
667488|NCT00758849|PAF|paf
667489|NCT00758849|MSA|msa
667490|NCT00758849|Shy-Drager syndrome|shy-drager syndrome
667491|NCT00758849|Olivopontocerebellar atrophy|olivopontocerebellar atrophy
667492|NCT00758849|Striatonigral degeneration|striatonigral degeneration
667493|NCT00758849|Autonomic Failure|autonomic failure
667494|NCT00758849|Parkinson|parkinson
667495|NCT00758849|Fipamezole|fipamezole
667497|NCT00758823|head lice|head lice
667498|NCT00758810|Health Education|health education
667499|NCT00758810|Myocardial Infarction|myocardial infarction
667500|NCT00758810|Acute Coronary Syndrome|acute coronary syndrome
667501|NCT00758810|Quality of Life|quality of life
667502|NCT00758797|metastatic melanoma|metastatic melanoma
667503|NCT00758758|Anterior Cervical Discectomy and Fusion,|anterior cervical discectomy and fusion,
667504|NCT00758758|Degenerative Disc Disease,|degenerative disc disease,
667505|NCT00758758|Cervical Spine,|cervical spine,
667506|NCT00758758|Herniated Disc|herniated disc
667507|NCT00758745|Cataract|cataract
667508|NCT00758745|Patients|patients
667509|NCT00758745|bilateral|bilateral
667510|NCT00758745|age related|age related
667511|NCT00758745|undergoing|undergoing
667512|NCT00758745|phacoemulsification|phacoemulsification
667513|NCT00758732|Cancer|cancer
667514|NCT00758732|Ovarian cancer|ovarian cancer
667515|NCT00758732|Chemotherapy|chemotherapy
667516|NCT00758732|Docetaxel|docetaxel
667517|NCT00758732|Carboplatin|carboplatin
667518|NCT00758732|Pegylated doxorubicin|pegylated doxorubicin
667519|NCT00758732|Platinum sensitive|platinum sensitive
667520|NCT00758719|Spinal Fusion|spinal fusion
667521|NCT00758719|DDD|ddd
667522|NCT00758706|COPD|copd
667523|NCT00758693|Chronic Lymphocytic Leukemia|chronic lymphocytic leukemia
667524|NCT00758693|Bendamustine|bendamustine
667525|NCT00758693|Treanda|treanda
667526|NCT00758693|Rituximab|rituximab
667527|NCT00758693|Rituxan|rituxan
667528|NCT00758667|capsular contracture|capsular contracture
667529|NCT00758667|capsulectomy|capsulectomy
667530|NCT00758667|mesna|mesna
667531|NCT00758667|Capsular contracture after breast implant placement|capsular contracture after breast implant placement
667532|NCT00758654|myocardial strain|myocardial strain
667533|NCT00758654|Strain-Encoded MRI|strain-encoded mri
667534|NCT00758654|dobutamine stress MRI|dobutamine stress mri
667535|NCT00758654|ischemia|ischemia
667536|NCT00758654|strain rate reserve|strain rate reserve
667537|NCT00758641|plantar fasciitis|plantar fasciitis
667538|NCT00758641|platelet rich plasma|platelet rich plasma
667539|NCT00758641|GPS|gps
667540|NCT00758615|Obesity|obesity
667541|NCT00758615|Physical activity|physical activity
667542|NCT00758615|Injury Prevention|injury prevention
667543|NCT00758615|Pedestrian safety|pedestrian safety
667544|NCT00758615|Self efficacy|self efficacy
667545|NCT00758615|School|school
667546|NCT00758615|Walking School Bus|walking school bus
667547|NCT00758615|Safe Routes to School|safe routes to school
667548|NCT00758589|Asthma|asthma
667549|NCT00758576|Cataract|cataract
667550|NCT00758550|Visual function;|visual function;
667551|NCT00758550|Refractive cylinder;|refractive cylinder;
667552|NCT00758550|AcrySof® Toric;|acrysof® toric;
667553|NCT00758550|AcrySof® Natural|acrysof® natural
667554|NCT00758537|Assessment of tryptophan and tryptophan catabolites and IDO-activity in patients with chronic kidney disease|assessment of tryptophan and tryptophan catabolites and ido-activity in patients with chronic kidney disease
667555|NCT00758524|Essential hypertension|essential hypertension
667556|NCT00758524|phase 2 study|phase 2 study
667557|NCT00758524|antihypertensive agent|antihypertensive agent
667558|NCT00758511|cortisol|cortisol
667559|NCT00758511|pain|pain
667560|NCT00758511|pain management|pain management
667561|NCT00758511|preterm infants|preterm infants
667562|NCT00758511|sucrose|sucrose
667563|NCT00758511|facilitated tucking|facilitated tucking
667564|NCT00758459|COPD|copd
667565|NCT00758433|Adverse Events|adverse events
667566|NCT00758433|Erythema Rating|erythema rating
667567|NCT00758433|Pharmacokinetics|pharmacokinetics
667568|NCT00758433|Civamide|civamide
667569|NCT00758433|Phase 1|phase 1
667570|NCT00758433|Pain|pain
667571|NCT00758433|Patch|patch
667572|NCT00758420|Varicose Veins|varicose veins
667573|NCT00758407|Fatigue, Cancer, Methylphenidate,|fatigue, cancer, methylphenidate,
667574|NCT00758381|pancreatic cancer|pancreatic cancer
667575|NCT00758381|advanced or metastatic|advanced or metastatic
667576|NCT00758381|sorafenib|sorafenib
667577|NCT00758368|Parkinson's disease|parkinson's disease
667578|NCT00758368|PD|pd
848541|NCT00003232|pain|pain
667579|NCT00758368|pulsatile apomorphine|pulsatile apomorphine
667580|NCT00758368|dyskinesia|dyskinesia
667581|NCT00758368|apomorphine|apomorphine
667582|NCT00758368|continuous dopaminergic stimulation|continuous dopaminergic stimulation
667583|NCT00758342|IOP lowering efficacy and safety of Azopt plus Travatan|iop lowering efficacy and safety of azopt plus travatan
667584|NCT00758316|Malignant|malignant
667585|NCT00758316|Pleural|pleural
667586|NCT00758316|Effusions|effusions
667587|NCT00758316|Thoracoscopy|thoracoscopy
667588|NCT00758316|Catheter|catheter
667589|NCT00758303|Triglycerides|triglycerides
667590|NCT00758303|Cholesterol|cholesterol
667591|NCT00758277|prevention of alcohol relapse|prevention of alcohol relapse
667592|NCT00758264|Safety|safety
667593|NCT00758264|Routine infancy vaccination|routine infancy vaccination
667594|NCT00758264|Meningococcal vaccine|meningococcal vaccine
667595|NCT00758264|Immunogenicity|immunogenicity
667596|NCT00758264|Pneumococcal vaccine|pneumococcal vaccine
667597|NCT00758251|Schizophrenia|schizophrenia
667598|NCT00758251|Seroquel XR|seroquel xr
667599|NCT00758251|CGI|cgi
667600|NCT00758238|hypertension|hypertension
667601|NCT00758238|self-management|self-management
667602|NCT00758238|e-health|e-health
667603|NCT00758225|Duchenne Muscular Dystrophy|duchenne muscular dystrophy
667604|NCT00758225|DMD|dmd
667605|NCT00758225|Duchenne|duchenne
667606|NCT00758225|Idebenone|idebenone
667607|NCT00758212|Influenza in Humans|influenza in humans
667608|NCT00758212|Acquired Immune Deficiency Syndrome|acquired immune deficiency syndrome
667609|NCT00758212|Immunization, Active|immunization, active
667610|NCT00758186|Colorectal cancer|colorectal cancer
667611|NCT00758186|Endoscopic stent|endoscopic stent
667612|NCT00758186|Intestinal obstruction|intestinal obstruction
667613|NCT00758186|Laparoscopy|laparoscopy
667614|NCT00758173|prostate cancer|prostate cancer
667615|NCT00758160|Attention Deficit Disorder With Hyperactivity|attention deficit disorder with hyperactivity
667616|NCT00758160|Methylphenidate|methylphenidate
667617|NCT00758160|Concerta|concerta
667618|NCT00758147|force feedback joystick|force feedback joystick
667619|NCT00758147|stroke|stroke
667620|NCT00758147|haptics|haptics
667621|NCT00758147|kinematics|kinematics
667622|NCT00758147|rehabilitation|rehabilitation
667623|NCT00758147|robotics|robotics
667624|NCT00758147|Force feedback joystick in stroke rehabilitation|force feedback joystick in stroke rehabilitation
667625|NCT00758108|Genotype/Phenotype Correlation|genotype/phenotype correlation
667626|NCT00758108|Energy Homeostasis|energy homeostasis
667627|NCT00758108|Nociception|nociception
667628|NCT00758108|Obesity|obesity
667629|NCT00758108|Behavior and Neurocognition|behavior and neurocognition
667630|NCT00758108|WAGR Syndrome|wagr syndrome
667631|NCT00758108|Wilm's Tumor|wilm's tumor
667632|NCT00758108|Aniridia|aniridia
667633|NCT00758108|Mental Retardation|mental retardation
667634|NCT00758108|Urogenital Abnormalities|urogenital abnormalities
667635|NCT00758108|Healthy Volunteer|healthy volunteer
667636|NCT00758082|type 1 diabetes|type 1 diabetes
667637|NCT00758082|PDA phone (Personal Digital Assistant)|pda phone (personal digital assistant)
667638|NCT00758082|HbA1c|hba1c
667639|NCT00758056|endometrial cancer|endometrial cancer
667640|NCT00758043|Genotype 1|genotype 1
667641|NCT00758030|Schizophrenia|schizophrenia
667642|NCT00758030|Paliperidone|paliperidone
667643|NCT00758017|low back pain|low back pain
667644|NCT00758017|acupuncture|acupuncture
667645|NCT00758004|Cardiovascular Diseases|cardiovascular diseases
667646|NCT00757991|healthy, no evidence of disease|healthy, no evidence of disease
667647|NCT00757978|Schizophrenia|schizophrenia
667648|NCT00757978|negative symptoms|negative symptoms
667649|NCT00757978|clozapine|clozapine
667650|NCT00757965|colon cancer|colon cancer
667651|NCT00757965|rectal cancer|rectal cancer
667652|NCT00757952|ovarian epithelial cancer|ovarian epithelial cancer
667653|NCT00757939|Alzheimer's Disease, MRI, PET|alzheimer's disease, mri, pet
667654|NCT00757900|influenza, human|influenza, human
667655|NCT00757887|malaria|malaria
667656|NCT00757887|plasmodium|plasmodium
667657|NCT00757887|falciparum|falciparum
667658|NCT00757887|human|human
667659|NCT00757887|experimental infection|experimental infection
667660|NCT00757874|Female urogenital disease|female urogenital disease
667661|NCT00757874|skin disease|skin disease
667662|NCT00757848|cystic fibrosis|cystic fibrosis
667663|NCT00757835|24-hour IOP|24-hour iop
667664|NCT00757835|exfoliative glaucoma|exfoliative glaucoma
667665|NCT00757835|travoprost/timolol|travoprost/timolol
667666|NCT00757835|latanoprost/timolol|latanoprost/timolol
667667|NCT00757835|fixed combinations|fixed combinations
667668|NCT00757783|HIV|hiv
667669|NCT00757783|AIDS|aids
667670|NCT00757783|Immunodeficiency Virus, Human|immunodeficiency virus, human
667671|NCT00757783|PREZISTA|prezista
667672|NCT00757783|darunavir|darunavir
667673|NCT00757783|TMC114|tmc114
667674|NCT00757783|Protease Inhibitor|protease inhibitor
667675|NCT00757783|Truvada|truvada
667676|NCT00757783|Atazanavir|atazanavir
667677|NCT00757783|REYATAZ|reyataz
667678|NCT00757783|HIV Infections|hiv infections
667679|NCT00757783|Treatment Naïve|treatment naïve
667680|NCT00757770|Gastroenteritis|gastroenteritis
667681|NCT00757757|Prostate cancer|prostate cancer
667682|NCT00757757|bone metastases|bone metastases
667683|NCT00757757|anti-M-CSF|anti-m-csf
667684|NCT00757757|M-CSF antibody|m-csf antibody
667685|NCT00757757|M-CSF|m-csf
667686|NCT00757757|Prostate Cancer with bone metastases|prostate cancer with bone metastases
667687|NCT00757744|drug counseling|drug counseling
667688|NCT00757744|HIV risks|hiv risks
667689|NCT00757744|methadone maintenance|methadone maintenance
667690|NCT00757744|HIV Seronegativity|hiv seronegativity
667691|NCT00757718|Sleep Disordered Breathing|sleep disordered breathing
667692|NCT00757718|Obstructive Sleep Apnea|obstructive sleep apnea
667693|NCT00757718|Gestational Hypertension|gestational hypertension
667694|NCT00757718|Preeclampsia|preeclampsia
667695|NCT00757705|Schizophrenia|schizophrenia
667696|NCT00757705|Paliperidone Extended-Release|paliperidone extended-release
667697|NCT00757692|Vandetanib (ZD6474)|vandetanib (zd6474)
667698|NCT00757692|Hormone|hormone
667699|NCT00757692|Refractory|refractory
667700|NCT00757692|Prostate Cancer|prostate cancer
667701|NCT00757692|Chemotherapy|chemotherapy
667702|NCT00757692|Naïve|naïve
667703|NCT00757666|Pacemaker|pacemaker
667704|NCT00757640|gastric cancer, surgery, prophylactic cholecystectomy|gastric cancer, surgery, prophylactic cholecystectomy
667705|NCT00757614|AIDS-related lymphoma|aids-related lymphoma
667706|NCT00757614|cutaneous lymphoma|cutaneous lymphoma
667707|NCT00757614|adult Hodgkin lymphoma|adult hodgkin lymphoma
667708|NCT00757614|adult non-Hodgkin lymphoma|adult non-hodgkin lymphoma
667709|NCT00757614|intraocular lymphoma|intraocular lymphoma
667710|NCT00757614|adult T-cell leukemia/lymphoma|adult t-cell leukemia/lymphoma
667711|NCT00757614|primary central nervous system non-Hodgkin lymphoma|primary central nervous system non-hodgkin lymphoma
667712|NCT00757614|primary central nervous system Hodgkin lymphoma|primary central nervous system hodgkin lymphoma
667713|NCT00757614|noncutaneous extranodal lymphoma|noncutaneous extranodal lymphoma
667714|NCT00757614|adult astrocytic tumors|adult astrocytic tumors
667715|NCT00757614|adult brain stem glioma|adult brain stem glioma
667716|NCT00757614|adult choroid plexus tumor|adult choroid plexus tumor
667717|NCT00757614|adult craniopharyngioma|adult craniopharyngioma
667718|NCT00757614|adult embryonal tumor|adult embryonal tumor
668535|NCT00754481|Paediatrics|paediatrics
667719|NCT00757614|adult ependymal tumors|adult ependymal tumors
667720|NCT00757614|adult meningeal tumor|adult meningeal tumor
667721|NCT00757614|adult oligodendroglial tumors|adult oligodendroglial tumors
667722|NCT00757614|adult pineal parenchymal tumor|adult pineal parenchymal tumor
667723|NCT00757614|adult brain tumor|adult brain tumor
667724|NCT00757614|intraocular melanoma|intraocular melanoma
667725|NCT00757614|bladder cancer|bladder cancer
667726|NCT00757614|clear cell sarcoma of the kidney|clear cell sarcoma of the kidney
667727|NCT00757614|congenital mesoblastic nephroma|congenital mesoblastic nephroma
667728|NCT00757614|esophageal cancer|esophageal cancer
667729|NCT00757614|melanoma|melanoma
667730|NCT00757614|pancreatic cancer|pancreatic cancer
667731|NCT00757614|peripheral primitive neuroectodermal tumor of the kidney|peripheral primitive neuroectodermal tumor of the kidney
667732|NCT00757614|renal cell carcinoma|renal cell carcinoma
667733|NCT00757614|rhabdoid tumor of the kidney|rhabdoid tumor of the kidney
667734|NCT00757614|transitional cell cancer of the renal pelvis and ureter|transitional cell cancer of the renal pelvis and ureter
667735|NCT00757575|PNEUMONET JAPAN STUDY|pneumonet japan study
667736|NCT00757549|recurrent squamous cell carcinoma of the hypopharynx|recurrent squamous cell carcinoma of the hypopharynx
667737|NCT00757549|recurrent squamous cell carcinoma of the larynx|recurrent squamous cell carcinoma of the larynx
667738|NCT00757549|recurrent squamous cell carcinoma of the oropharynx|recurrent squamous cell carcinoma of the oropharynx
667739|NCT00757549|stage III squamous cell carcinoma of the hypopharynx|stage iii squamous cell carcinoma of the hypopharynx
667740|NCT00757549|stage III squamous cell carcinoma of the larynx|stage iii squamous cell carcinoma of the larynx
667741|NCT00757549|stage III squamous cell carcinoma of the oropharynx|stage iii squamous cell carcinoma of the oropharynx
667742|NCT00757549|stage IV squamous cell carcinoma of the hypopharynx|stage iv squamous cell carcinoma of the hypopharynx
667743|NCT00757549|stage IV squamous cell carcinoma of the larynx|stage iv squamous cell carcinoma of the larynx
667744|NCT00757549|stage IV squamous cell carcinoma of the oropharynx|stage iv squamous cell carcinoma of the oropharynx
667745|NCT00757536|Rhegmatogenous retinal detachment|rhegmatogenous retinal detachment
667746|NCT00757536|primary vitrectomy|primary vitrectomy
667747|NCT00757536|encircling band|encircling band
667748|NCT00757536|endolaser treatment|endolaser treatment
667749|NCT00757523|Acne Vulgaris|acne vulgaris
667751|NCT00757523|Acne|acne
667752|NCT00757523|Akne Vulgaris|akne vulgaris
667753|NCT00757510|Congenital Heart Disease|congenital heart disease
667754|NCT00757497|Treatment Study|treatment study
667755|NCT00757497|Psychosis|psychosis
667756|NCT00757497|Electrical Stimulation|electrical stimulation
667757|NCT00757497|Refractory|refractory
667758|NCT00757497|Novel|novel
667759|NCT00757497|Childhood Onset Psychotic Disorders|childhood onset psychotic disorders
667760|NCT00757497|Schizophrenia|schizophrenia
667761|NCT00757471|Macular hole surgery|macular hole surgery
667762|NCT00757471|membranepeeling|membranepeeling
667763|NCT00757471|closure rate|closure rate
667764|NCT00757471|vitreoretinal dyes|vitreoretinal dyes
667765|NCT00757458|Propofol|propofol
667766|NCT00757458|Bacterial growth|bacterial growth
667767|NCT00757458|Fungal growth|fungal growth
667768|NCT00757458|EDTA|edta
667769|NCT00757458|Target controlled infusion|target controlled infusion
667770|NCT00757445|Antibiotic therapy|antibiotic therapy
667771|NCT00757445|Microbiological diagnosis|microbiological diagnosis
667772|NCT00757419|Safety|safety
667773|NCT00757419|tolerability|tolerability
667774|NCT00757419|healthy subjects|healthy subjects
667775|NCT00757406|Lymphedema|lymphedema
667776|NCT00757406|Bioimpedance|bioimpedance
667777|NCT00757393|Growth hormone|growth hormone
667778|NCT00757393|Pediatrics|pediatrics
667779|NCT00757393|Vitamin D|vitamin d
667780|NCT00757393|Calcium|calcium
667781|NCT00757393|Exercise|exercise
667782|NCT00757380|epiretinal membranes|epiretinal membranes
667783|NCT00757380|vitreoretinal dyes|vitreoretinal dyes
667784|NCT00757380|membranepeeling|membranepeeling
667785|NCT00757367|Healthy subjects|healthy subjects
667786|NCT00757367|insulin|insulin
667787|NCT00757367|bronchoscope|bronchoscope
667788|NCT00757367|serum insulin|serum insulin
667789|NCT00757367|serum C-Peptide|serum c-peptide
667790|NCT00757367|BAL fluid|bal fluid
667791|NCT00757367|FDKP|fdkp
667792|NCT00757328|Bipolar depression Treatment|bipolar depression treatment
667793|NCT00757315|acne keloidalis nuchae|acne keloidalis nuchae
667794|NCT00757315|NdYag laser|ndyag laser
667795|NCT00757315|AKN|akn
667796|NCT00757315|acne keloidalis|acne keloidalis
667797|NCT00757315|AK|ak
667798|NCT00757315|dermatitis papillaris capillitii|dermatitis papillaris capillitii
667799|NCT00757315|folliculitis keloidalis nuchae|folliculitis keloidalis nuchae
667800|NCT00757315|sycosis nuchae|sycosis nuchae
667801|NCT00757315|acne keloid|acne keloid
667802|NCT00757315|keloidal folliculitis|keloidal folliculitis
667803|NCT00757315|lichen keloidalis nuchae|lichen keloidalis nuchae
667804|NCT00757315|folliculitis nuchae scleroticans|folliculitis nuchae scleroticans
667805|NCT00757315|sycosis framboesiformis|sycosis framboesiformis
667806|NCT00757302|breast cancer|breast cancer
667807|NCT00757302|CarolIReS|carolires
667808|NCT00757302|intraoperative gamma camera|intraoperative gamma camera
669040|NCT00752466|Flunarizine|flunarizine
667809|NCT00757302|lymphoscintigraphy|lymphoscintigraphy
667810|NCT00757302|sentinel lymph node|sentinel lymph node
667811|NCT00757302|Hundred and ten patients with infiltrative breast cancer or ductal carcinoma in situ (DCIS), diagnosed preoperatively by core biopsy or cytology.|hundred and ten patients with infiltrative breast cancer or ductal carcinoma in situ (dcis), diagnosed preoperatively by core biopsy or cytology.
667812|NCT00757289|Tennis Elbow|tennis elbow
667813|NCT00757276|Copeptin|copeptin
667814|NCT00757276|Diabetes insipidus|diabetes insipidus
667815|NCT00757276|diagnostic marker|diagnostic marker
667816|NCT00757276|Vasopressin|vasopressin
667817|NCT00757276|antidiuretic hormone (ADH)|antidiuretic hormone (adh)
667818|NCT00757263|ovarian epithelial cancer|ovarian epithelial cancer
667819|NCT00757263|ovarian germ cell tumor|ovarian germ cell tumor
667820|NCT00757263|ovarian sarcoma|ovarian sarcoma
667821|NCT00757263|ovarian stromal cancer|ovarian stromal cancer
667822|NCT00757250|HIV|hiv
667823|NCT00757250|AIDS|aids
667824|NCT00757250|Human Immunodeficiency Virus|human immunodeficiency virus
667825|NCT00757250|CD4+ T-lymphocytes|cd4+ t-lymphocytes
667826|NCT00757250|treatment Experienced|treatment experienced
667827|NCT00757237|aztreonam lysine|aztreonam lysine
667828|NCT00757237|tobramycin inhalation solution|tobramycin inhalation solution
667829|NCT00757237|tobramycin nebuliser solution|tobramycin nebuliser solution
667830|NCT00757237|cystic fibrosis|cystic fibrosis
667831|NCT00757237|pseudomonas aeruginosa|pseudomonas aeruginosa
667832|NCT00757237|lung infection|lung infection
667833|NCT00757237|CFQ-R|cfq-r
667834|NCT00757237|inhaled antibiotic|inhaled antibiotic
667835|NCT00757211|breast cancer|breast cancer
667836|NCT00757211|male breast cancer|male breast cancer
667837|NCT00757198|pain, postoperative, opioid, PCA, cardiac surgery|pain, postoperative, opioid, pca, cardiac surgery
667838|NCT00757185|skin blood flow|skin blood flow
667839|NCT00757185|microcirculation|microcirculation
667840|NCT00757172|adenocarcinoma of the esophagus|adenocarcinoma of the esophagus
667841|NCT00757172|adenocarcinoma of the gastroesophageal junction|adenocarcinoma of the gastroesophageal junction
667842|NCT00757172|stage II esophageal cancer|stage ii esophageal cancer
667843|NCT00757172|stage III esophageal cancer|stage iii esophageal cancer
667844|NCT00757172|stage IV esophageal cancer|stage iv esophageal cancer
667845|NCT00757159|Periodontal disease|periodontal disease
667846|NCT00757159|Hydroxyapatite|hydroxyapatite
667847|NCT00757159|Enamel matrix protein|enamel matrix protein
667848|NCT00757159|Regeneration|regeneration
667849|NCT00757159|Human|human
667850|NCT00757146|chronic lung disease|chronic lung disease
667851|NCT00757146|bronchopulmonary dysplasia|bronchopulmonary dysplasia
667852|NCT00757146|inhaled nitric oxide|inhaled nitric oxide
667853|NCT00757146|premature infants|premature infants
667854|NCT00757120|COPD|copd
667855|NCT00757120|Cigarette Smoke-Induced Inflammation|cigarette smoke-induced inflammation
667856|NCT00757120|EMMPRIN|emmprin
667857|NCT00757120|Matrix Metalloproteinase|matrix metalloproteinase
667858|NCT00757107|Short femoral stem|short femoral stem
667859|NCT00757107|Stress shielding|stress shielding
667860|NCT00757107|Stem migration|stem migration
667861|NCT00757107|Implant Survival|implant survival
667862|NCT00757107|DEXA|dexa
667863|NCT00757107|Radiostereometric analysis|radiostereometric analysis
667864|NCT00757094|Fasting|fasting
667865|NCT00757094|Chemotherapy|chemotherapy
667866|NCT00757094|Cancer|cancer
667867|NCT00757068|Non-smoking|non-smoking
667868|NCT00757068|Women|women
667869|NCT00757068|Pregnancy|pregnancy
667870|NCT00757068|Treatment|treatment
667871|NCT00757068|Mood|mood
667872|NCT00757068|Weight|weight
667873|NCT00757068|Supportive|supportive
667874|NCT00757068|Adjustment|adjustment
667875|NCT00757055|Heart failure|heart failure
667876|NCT00757055|Diastolic heart failure|diastolic heart failure
667877|NCT00757055|Heart failure with preserved systolic function|heart failure with preserved systolic function
667878|NCT00757055|Heart failure with normal ejection fraction|heart failure with normal ejection fraction
667879|NCT00757055|Ivabradine|ivabradine
667880|NCT00757055|Diastolic dysfunction|diastolic dysfunction
667881|NCT00757042|atopic dermatitis|atopic dermatitis
667882|NCT00757042|skin diseases|skin diseases
667883|NCT00757042|healthy volunteer|healthy volunteer
667884|NCT00757029|ADHD,|adhd,
667885|NCT00757029|norepinephrine transporter|norepinephrine transporter
667886|NCT00757029|pharmacogenetics|pharmacogenetics
667887|NCT00757016|low back pain|low back pain
667888|NCT00757016|randomised controlled trial|randomised controlled trial
667889|NCT00757016|slow release corticosteroid|slow release corticosteroid
667890|NCT00757016|injection treatment|injection treatment
667891|NCT00756977|Colonoscopy|colonoscopy
667892|NCT00756977|screening|screening
667893|NCT00756964|cardiac surgery|cardiac surgery
667894|NCT00756964|hyperuricemia|hyperuricemia
667895|NCT00756951|SCV-07|scv-07
667896|NCT00756951|Oral Mucositis|oral mucositis
667897|NCT00756925|CRH|crh
667898|NCT00756925|cocaine|cocaine
667899|NCT00756925|functional magnetic resonance imaging|functional magnetic resonance imaging
667900|NCT00756925|gender differences|gender differences
667901|NCT00756912|ANC|anc
667902|NCT00756912|BMT|bmt
667903|NCT00756912|graft versus leukemia|graft versus leukemia
667904|NCT00756912|graft vs. host disease|graft vs. host disease
667905|NCT00756912|MD2 (endotoxin binding-protein)|md2 (endotoxin binding-protein)
667906|NCT00756912|undergo allogeneic BMT|undergo allogeneic bmt
667907|NCT00756912|myeloablative|myeloablative
667908|NCT00756912|conditioning|conditioning
667909|NCT00756912|therapy|therapy
667910|NCT00756899|Vitamin D deficiency, insulin resistance, obesity, bone|vitamin d deficiency, insulin resistance, obesity, bone
667911|NCT00756873|Elective tonsillectomy|elective tonsillectomy
667912|NCT00756847|Solid Tumors|solid tumors
667913|NCT00756847|NSCLC|nsclc
667914|NCT00756847|Ovarian Cancer|ovarian cancer
667915|NCT00756847|Endometrial Cancer|endometrial cancer
667916|NCT00756821|Spinal Muscular Atrophy|spinal muscular atrophy
667917|NCT00756821|Blood Biomarkers|blood biomarkers
667918|NCT00756821|Urine Biomarkers|urine biomarkers
667919|NCT00756821|Type I Spinal Muscular Atrophy|type i spinal muscular atrophy
667920|NCT00756821|Type II Spinal Muscular Atrophy|type ii spinal muscular atrophy
667921|NCT00756821|Type III Spinal Muscular Atrophy|type iii spinal muscular atrophy
667922|NCT00756821|Modified Hammersmith Functional Motor Scale|modified hammersmith functional motor scale
667923|NCT00756821|Disease severity|disease severity
667924|NCT00756821|Biomarkers|biomarkers
667925|NCT00756808|latent tuberculosis in elderly|latent tuberculosis in elderly
667926|NCT00756782|hepatocellular carcinoma|hepatocellular carcinoma
667927|NCT00756756|G-CSF|g-csf
667928|NCT00756756|Myocardial infarction|myocardial infarction
667929|NCT00756743|PF-04802540 multiple dose safety study|pf-04802540 multiple dose safety study
667930|NCT00756730|lopinavir|lopinavir
667931|NCT00756730|ritonavir|ritonavir
667932|NCT00756730|atazanavir|atazanavir
667933|NCT00756730|fosamprenavir|fosamprenavir
667934|NCT00756730|darunavir|darunavir
667935|NCT00756730|anti-retroviral|anti-retroviral
667936|NCT00756730|AIDS|aids
667937|NCT00756730|HIV|hiv
667938|NCT00756730|LARD|lard
667939|NCT00756730|triglyceride|triglyceride
667940|NCT00756730|protease inhibitors|protease inhibitors
667941|NCT00756730|treatment Experienced|treatment experienced
667942|NCT00756717|MK-0752|mk-0752
667943|NCT00756717|Tamoxifen|tamoxifen
667944|NCT00756717|Letroxole|letroxole
667945|NCT00756704|Smoking Cessation|smoking cessation
667946|NCT00756704|Emergency Medicine|emergency medicine
667947|NCT00756704|Emergency Nursing|emergency nursing
667948|NCT00756704|Effectiveness Trial|effectiveness trial
667949|NCT00756704|Implementation|implementation
667950|NCT00756704|Relapse prevention|relapse prevention
667951|NCT00756691|18F-FAZA|18f-faza
667952|NCT00756691|Positron Emission Tomography|positron emission tomography
667953|NCT00756691|Radiation dosimetry|radiation dosimetry
667954|NCT00756691|Pharmacokinetics|pharmacokinetics
667955|NCT00756665|prostate|prostate
667956|NCT00756665|cancer|cancer
667957|NCT00756639|small cell carcinoma of the bladder|small cell carcinoma of the bladder
667958|NCT00756639|urothelial carcinoma|urothelial carcinoma
667959|NCT00756639|genitourinary bladder|genitourinary bladder
667960|NCT00756639|urothelium|urothelium
667961|NCT00756639|bladder|bladder
667962|NCT00756639|bladder cancer|bladder cancer
667963|NCT00756639|prophylactic cranial irradiation|prophylactic cranial irradiation
667964|NCT00756639|PCI|pci
667965|NCT00756639|brain metastasis|brain metastasis
667966|NCT00756639|genitourinary|genitourinary
667967|NCT00756639|radiation|radiation
667968|NCT00756639|TCC|tcc
667969|NCT00756639|adenocarcinoma|adenocarcinoma
667970|NCT00756626|Bottle Weaning|bottle weaning
667971|NCT00756626|Bottle Feeding|bottle feeding
667972|NCT00756626|Overweight in toddlers|overweight in toddlers
667973|NCT00756626|Bottle use|bottle use
667974|NCT00756626|excess weight for length|excess weight for length
667975|NCT00756600|Infants|infants
667976|NCT00756600|scheduled|scheduled
667977|NCT00756600|unilateral|unilateral
667978|NCT00756600|bilateral|bilateral
667979|NCT00756600|repair|repair
667980|NCT00756587|Cup Feeding|cup feeding
667981|NCT00756587|late Preterm|late preterm
667982|NCT00756574|N95|n95
667983|NCT00756574|Respirator|respirator
667984|NCT00756574|mask|mask
667985|NCT00756574|influenza|influenza
667986|NCT00756574|efficacy|efficacy
667987|NCT00756561|Fine Needle Aspiration|fine needle aspiration
667988|NCT00756561|Male Health|male health
667989|NCT00756561|Male Contraception|male contraception
667990|NCT00756548|colonoscopy|colonoscopy
667991|NCT00756548|screening|screening
667992|NCT00756535|Exercise Therapy|exercise therapy
667993|NCT00756535|Length of Stay|length of stay
667994|NCT00756535|Disability Evaluation|disability evaluation
667995|NCT00756522|COPD|copd
667996|NCT00756509|unresectable or metastatic GIST|unresectable or metastatic gist
667997|NCT00756509|1st. line treatment|1st. line treatment
667998|NCT00756483|Resistance|resistance
667999|NCT00756483|Exercise|exercise
668000|NCT00756470|Breast Cancer|breast cancer
668001|NCT00756470|Inflammatory Breast Cancer|inflammatory breast cancer
668002|NCT00756470|IBC|ibc
668003|NCT00756470|ErbB2 overexpression|erbb2 overexpression
668004|NCT00756470|Lapatinib|lapatinib
668005|NCT00756470|Paclitaxel|paclitaxel
668006|NCT00756470|5-Fluorouracil|5-fluorouracil
668007|NCT00756470|Epirubicin|epirubicin
668008|NCT00756470|Cyclophosphamide|cyclophosphamide
668009|NCT00756470|Neoadjuvant Chemotherapy|neoadjuvant chemotherapy
668010|NCT00756457|PTTD|pttd
668011|NCT00756457|Tendinopathy|tendinopathy
668012|NCT00756457|Tendon Injuries|tendon injuries
668013|NCT00756457|Muscular Diseases|muscular diseases
668014|NCT00756457|Foot Diseases|foot diseases
668015|NCT00756444|PK Study, Metastatic Recurrent|pk study, metastatic recurrent
668016|NCT00756405|Adults|adults
668017|NCT00756405|Antioxidants|antioxidants
668018|NCT00756405|Inflammatory markers|inflammatory markers
668019|NCT00756405|Diet|diet
668020|NCT00756405|Supplements|supplements
668021|NCT00756392|3T MR Spectroscopy|3t mr spectroscopy
668022|NCT00756392|Prostate Imaging|prostate imaging
668023|NCT00756379|Cardiovascular disease|cardiovascular disease
668024|NCT00756379|Atherosclerosis|atherosclerosis
668025|NCT00756379|Coronary artery disease|coronary artery disease
668026|NCT00756379|Coronary perfusion defect|coronary perfusion defect
668027|NCT00756379|Absolute coronary flow|absolute coronary flow
668028|NCT00756379|Lifestyle management|lifestyle management
668029|NCT00756379|Cardiovascular rehabilitation|cardiovascular rehabilitation
668030|NCT00756379|Cardiovascular dietary guidelines|cardiovascular dietary guidelines
668031|NCT00756366|positron emission tomography|positron emission tomography
668032|NCT00756366|myocardial energetics|myocardial energetics
668033|NCT00756366|sympathetic nerve function|sympathetic nerve function
668034|NCT00756353|Heroin|heroin
668035|NCT00756353|Buprenorphine use|buprenorphine use
668036|NCT00756327|pediatric eyes|pediatric eyes
668037|NCT00756327|bilateral cataract|bilateral cataract
668038|NCT00756327|IOL implantation|iol implantation
668039|NCT00756327|Aqualase capsule wash|aqualase capsule wash
668040|NCT00756327|posterior capsule opacification|posterior capsule opacification
668041|NCT00756314|Ambulatory Care Facilities|ambulatory care facilities
668042|NCT00756314|abortion care|abortion care
668043|NCT00756314|contraception|contraception
668044|NCT00756314|counseling|counseling
668045|NCT00756314|outpatient clinic|outpatient clinic
668046|NCT00756288|Actinic Keratoses|actinic keratoses
668047|NCT00756288|Blue light therapy|blue light therapy
668048|NCT00756288|photosensitizer|photosensitizer
668049|NCT00756288|Retinoid|retinoid
668050|NCT00756275|Tobacco Smoking|tobacco smoking
668051|NCT00756275|Smoking Cessation|smoking cessation
668052|NCT00756275|Nicotine Dependence|nicotine dependence
668053|NCT00756275|Tobacco Use Disorder|tobacco use disorder
668054|NCT00756262|Vancomycin Resistant enterococcal colonization|vancomycin resistant enterococcal colonization
668055|NCT00756262|Probiotics|probiotics
668056|NCT00756262|LGG|lgg
668057|NCT00756262|Lactobacillus rhamnosus|lactobacillus rhamnosus
668058|NCT00756249|Acute ischemic stroke|acute ischemic stroke
668059|NCT00756249|Erythropoietin|erythropoietin
668060|NCT00756249|Carbamylated|carbamylated
668061|NCT00756249|Neuroprotection|neuroprotection
668062|NCT00756197|Radiation Proctitis|radiation proctitis
668063|NCT00756197|Radiation Induced Proctitis|radiation induced proctitis
668064|NCT00756184|Glaucoma|glaucoma
668065|NCT00756184|Adherence|adherence
668066|NCT00756184|Teaching|teaching
668067|NCT00756171|Cholestatic|cholestatic
668068|NCT00756171|pruritus|pruritus
668069|NCT00756171|of any cause|of any cause
668070|NCT00756158|Attention Deficit Hyperactivity Disorder|attention deficit hyperactivity disorder
668071|NCT00756158|dopaminergic|dopaminergic
668072|NCT00756158|noradrenergic|noradrenergic
668073|NCT00756158|endophenotype|endophenotype
668074|NCT00756158|molecular genetics|molecular genetics
668075|NCT00756158|candidate gene|candidate gene
668076|NCT00756158|Family-based Association study|family-based association study
668077|NCT00756145|stage V|stage v
668078|NCT00756145|treated|treated
668079|NCT00756145|hemodiafiltration|hemodiafiltration
668080|NCT00756132|Breast|breast
668081|NCT00756132|Neoplasm|neoplasm
668082|NCT00756132|Locally Advanced|locally advanced
668083|NCT00756132|Stage IV|stage iv
668084|NCT00756132|Stage III|stage iii
668085|NCT00756132|Cognitive Function|cognitive function
668086|NCT00756132|Cytokines|cytokines
668087|NCT00756132|Inflammatory|inflammatory
668088|NCT00756132|Node positive|node positive
668089|NCT00756106|adult glioblastoma|adult glioblastoma
668090|NCT00756106|adult giant cell glioblastoma|adult giant cell glioblastoma
668091|NCT00756106|adult gliosarcoma|adult gliosarcoma
668092|NCT00756106|adult anaplastic astrocytoma|adult anaplastic astrocytoma
668093|NCT00756106|adult anaplastic ependymoma|adult anaplastic ependymoma
668094|NCT00756106|adult anaplastic oligodendroglioma|adult anaplastic oligodendroglioma
668095|NCT00756106|adult mixed glioma|adult mixed glioma
668096|NCT00756093|Dry Eye, Artificial Tears,|dry eye, artificial tears,
668097|NCT00756067|Streptococcus pneumoniae|streptococcus pneumoniae
668098|NCT00756067|pneumococcal vaccine|pneumococcal vaccine
668099|NCT00756041|Diabetic Mononeuropathy|diabetic mononeuropathy
668100|NCT00756041|Diabetic Neuralgia|diabetic neuralgia
668101|NCT00756041|Mononeuropathy, Diabetic|mononeuropathy, diabetic
668102|NCT00756041|Neuralgia, Diabetic|neuralgia, diabetic
668103|NCT00756041|Diabetic Polyneuropathy|diabetic polyneuropathy
668104|NCT00756041|Drug Therapy|drug therapy
668106|NCT00756028|quality of life|quality of life
668107|NCT00756028|IVF|ivf
668108|NCT00756028|ICSI|icsi
668109|NCT00756028|GnRH-agonist|gnrh-agonist
668110|NCT00756028|GnRH-antagonist|gnrh-antagonist
668111|NCT00756015|rotator cuff|rotator cuff
668112|NCT00756015|post-operative immobilization protocol|post-operative immobilization protocol
668113|NCT00756015|post-operative early motion protocol|post-operative early motion protocol
668114|NCT00756015|physical therapy|physical therapy
668115|NCT00756015|cuff repair integrity|cuff repair integrity
668116|NCT00756015|ultrasound|ultrasound
668117|NCT00756002|Chronic Insomnia|chronic insomnia
668118|NCT00756002|DIMS (Disorders of Initiating and Maintaining Sleep)|dims (disorders of initiating and maintaining sleep)
668119|NCT00756002|Disorders of Initiating and Maintaining Sleep|disorders of initiating and maintaining sleep
668120|NCT00756002|Insomnia Disorder Sleep Initiation Dysfunction|insomnia disorder sleep initiation dysfunction
668121|NCT00756002|Transient Insomnia|transient insomnia
668122|NCT00756002|Drug Therapy|drug therapy
668123|NCT00756002|Sleep Disorders, Intrinsic|sleep disorders, intrinsic
668124|NCT00755976|stage IV melanoma|stage iv melanoma
668125|NCT00755950|Acute|acute
668126|NCT00755950|Hepatitis|hepatitis
668127|NCT00755950|Silymarin|silymarin
668128|NCT00755950|Global Health|global health
668129|NCT00755911|dental|dental
668130|NCT00755911|tooth|tooth
668131|NCT00755911|implant|implant
668132|NCT00755911|extraction|extraction
668133|NCT00755911|Oral|oral
668134|NCT00755911|Surgical|surgical
668135|NCT00755911|Procedures|procedures
668136|NCT00755898|cancer|cancer
668137|NCT00755898|diagnostic test|diagnostic test
668138|NCT00755898|urine|urine
668139|NCT00755898|amantadine acetylation|amantadine acetylation
668140|NCT00755885|stage IIIA breast cancer|stage iiia breast cancer
668141|NCT00755885|stage IIIB breast cancer|stage iiib breast cancer
668142|NCT00755885|stage IIIC breast cancer|stage iiic breast cancer
668143|NCT00755885|stage IV breast cancer|stage iv breast cancer
668144|NCT00755885|recurrent breast cancer|recurrent breast cancer
668145|NCT00755885|estrogen receptor-positive breast cancer|estrogen receptor-positive breast cancer
668146|NCT00755885|progesterone receptor-positive breast cancer|progesterone receptor-positive breast cancer
668147|NCT00755859|IgA nephropathy|iga nephropathy
668148|NCT00755859|steroids|steroids
668149|NCT00755859|azathioprine|azathioprine
668150|NCT00755859|chronic kidney disease progression|chronic kidney disease progression
668151|NCT00755859|proteinuria|proteinuria
668152|NCT00755846|Diabetes Mellitus|diabetes mellitus
668153|NCT00755846|Drug Therapy|drug therapy
668154|NCT00755846|Diabetes Mellitus, Type II|diabetes mellitus, type ii
668155|NCT00755846|Type 2 Diabetes Mellitus|type 2 diabetes mellitus
668156|NCT00755846|Hyperinsulinism|hyperinsulinism
668157|NCT00755846|Insulin Resistance|insulin resistance
668158|NCT00755807|Central Neuropathic Pain|central neuropathic pain
668159|NCT00755807|Multiple Sclerosis|multiple sclerosis
668160|NCT00755781|lung transplant|lung transplant
668161|NCT00755781|lung transplant recipient|lung transplant recipient
668162|NCT00755781|bronchiolitis obliterans syndrome|bronchiolitis obliterans syndrome
668163|NCT00755781|bronchiolitis obliterans|bronchiolitis obliterans
668164|NCT00755781|single lung transplant|single lung transplant
668165|NCT00755781|double lung transplant|double lung transplant
668166|NCT00755781|heart-lung transplant|heart-lung transplant
668167|NCT00755781|Aerosol|aerosol
668168|NCT00755768|hemodialysis|hemodialysis
668169|NCT00755768|phosphate|phosphate
668170|NCT00755768|calcium phosphate product|calcium phosphate product
668171|NCT00755768|dietician|dietician
668172|NCT00755768|dietetic advice|dietetic advice
668173|NCT00755742|obesity|obesity
668174|NCT00755742|insulin resistance|insulin resistance
668175|NCT00755742|metabolic syndrome|metabolic syndrome
668176|NCT00755742|hepatitis C|hepatitis c
668177|NCT00755742|adipokine|adipokine
668178|NCT00755742|TNF|tnf
668179|NCT00755742|leptin|leptin
668180|NCT00755742|adiponectin|adiponectin
668181|NCT00755742|fatigue|fatigue
668182|NCT00755742|mood|mood
668183|NCT00755742|depression|depression
668184|NCT00755742|exercise|exercise
668185|NCT00755742|diet|diet
668186|NCT00755742|counseling|counseling
668187|NCT00755742|behavior modification|behavior modification
668188|NCT00755729|Preoperative oral carbohydrate|preoperative oral carbohydrate
668189|NCT00755729|Insulin resistance|insulin resistance
668190|NCT00755729|phosphatidylinositol-3-kinase|phosphatidylinositol-3-kinase
668191|NCT00755716|nicotine patch|nicotine patch
668192|NCT00755716|smoking|smoking
668193|NCT00755716|topiramate|topiramate
668194|NCT00755703|Influenza|influenza
668195|NCT00755703|Vaccine|vaccine
668196|NCT00755703|Pandemic|pandemic
668197|NCT00755703|Avian influenza|avian influenza
668198|NCT00755703|Adenovirus strain 5|adenovirus strain 5
668199|NCT00755703|Vectored vaccine|vectored vaccine
668200|NCT00755703|Intranasal|intranasal
668201|NCT00755703|Tissue-culture derived|tissue-culture derived
668202|NCT00755703|Non-replicating|non-replicating
668203|NCT00755690|Chronic Kidney Disease|chronic kidney disease
668204|NCT00755690|CKD|ckd
668205|NCT00755690|Diet|diet
668206|NCT00755690|Dietary Phosphate|dietary phosphate
668207|NCT00755690|Mineral Metabolism|mineral metabolism
668208|NCT00755690|FGF-23|fgf-23
668209|NCT00755664|homocysteine|homocysteine
668210|NCT00755664|folate acid,|folate acid,
668211|NCT00755664|vitamin B|vitamin b
668212|NCT00755664|random controlled trail|random controlled trail
668213|NCT00755651|Menorrhagia|menorrhagia
668214|NCT00755651|Uterine fibroids|uterine fibroids
668215|NCT00755651|Endometrial polyps|endometrial polyps
668216|NCT00755651|Endometrial cancer|endometrial cancer
668217|NCT00755599|Papanicolaou Smear|papanicolaou smear
668218|NCT00755599|Vaginitis|vaginitis
668219|NCT00755599|Patient Satisfaction|patient satisfaction
668220|NCT00755586|Brachial plexus|brachial plexus
668221|NCT00755586|Muscle denervation|muscle denervation
668222|NCT00755586|Stem cell transplantation|stem cell transplantation
668223|NCT00755586|Bone marrow cells|bone marrow cells
668224|NCT00755586|Satellite cells|satellite cells
668225|NCT00755586|Fibrosis|fibrosis
668226|NCT00755573|Pain|pain
668227|NCT00755573|Neuropathic pain|neuropathic pain
668228|NCT00755560|Toxocara|toxocara
668229|NCT00755560|Pediatrics|pediatrics
668230|NCT00755560|Albendazole|albendazole
668231|NCT00755560|eosinophilia|eosinophilia
668232|NCT00755560|parasitology|parasitology
668233|NCT00755560|pediatric clinical pharmacology|pediatric clinical pharmacology
668234|NCT00755547|Childhood|childhood
668235|NCT00755547|insulin sensitivity|insulin sensitivity
668236|NCT00755547|steatosis, spectroscopy|steatosis, spectroscopy
668237|NCT00755534|Metastatic colorectal cancer|metastatic colorectal cancer
668238|NCT00755534|Second line|second line
668239|NCT00755534|Irinotecan|irinotecan
668240|NCT00755534|Cetuximab (Erbitux)|cetuximab (erbitux)
668241|NCT00755534|Capecitabine (Xeloda)|capecitabine (xeloda)
668242|NCT00755521|Fibromyalgia|fibromyalgia
668243|NCT00755521|tenderness|tenderness
668244|NCT00755521|widespread pain|widespread pain
668245|NCT00755521|comrbidity|comrbidity
668246|NCT00755508|Chronic Insomnia|chronic insomnia
668247|NCT00755508|DIMS (Disorders of Initiating and Maintaining Sleep)|dims (disorders of initiating and maintaining sleep)
668248|NCT00755508|Disorders of Initiating and Maintaining Sleep|disorders of initiating and maintaining sleep
668249|NCT00755508|Insomnia Disorder Sleep Initiation Dysfunction|insomnia disorder sleep initiation dysfunction
668250|NCT00755508|Transient Insomnia|transient insomnia
668251|NCT00755508|Drug Therapy|drug therapy
668252|NCT00755508|Sleep Disorders, Intrinsic|sleep disorders, intrinsic
668253|NCT00755495|Chronic Insomnia|chronic insomnia
668254|NCT00755495|DIMS (Disorders of Initiating and Maintaining Sleep)|dims (disorders of initiating and maintaining sleep)
668255|NCT00755495|Disorders of Initiating and Maintaining Sleep|disorders of initiating and maintaining sleep
668256|NCT00755495|Insomnia Disorder Sleep Initiation Dysfunction|insomnia disorder sleep initiation dysfunction
668257|NCT00755495|Transient Insomnia|transient insomnia
668258|NCT00755495|Drug Therapy|drug therapy
668259|NCT00755495|Sleep Disorders, Intrinsic|sleep disorders, intrinsic
668260|NCT00755482|Osteoarthritis|osteoarthritis
668261|NCT00755482|Clinical trial|clinical trial
668262|NCT00755482|Aquamin F|aquamin f
668263|NCT00755482|NSAID|nsaid
668264|NCT00755469|Reperfusion injury|reperfusion injury
668265|NCT00755469|Post-Conditioning|post-conditioning
668266|NCT00755469|Infarct size|infarct size
668267|NCT00755456|Peritoneal dialysis|peritoneal dialysis
668268|NCT00755456|L-carnitine|l-carnitine
668269|NCT00755456|Insulin resistance|insulin resistance
668270|NCT00755456|Glucose homeostasis|glucose homeostasis
668271|NCT00755456|Dyslipidemia|dyslipidemia
668272|NCT00755430|autism spectrum disorders (ASD)|autism spectrum disorders (asd)
668273|NCT00755430|structural and functional connectivity|structural and functional connectivity
668274|NCT00755430|diffusion spectrum imaging (DSI)|diffusion spectrum imaging (dsi)
668275|NCT00755430|functional magnetic resonance imaging (fMRI)|functional magnetic resonance imaging (fmri)
668276|NCT00755430|siblings|siblings
668277|NCT00755430|repeated follow-up measurement|repeated follow-up measurement
668278|NCT00755417|Hot flashes|hot flashes
668279|NCT00755417|Hot flushes|hot flushes
668280|NCT00755417|Postmenopausal symptoms|postmenopausal symptoms
668281|NCT00755417|Vasomotor symptoms|vasomotor symptoms
668282|NCT00755404|Peritoneal dialysis|peritoneal dialysis
668283|NCT00755404|L-carnitine|l-carnitine
668284|NCT00755404|Diabetes|diabetes
668285|NCT00755404|Glucose homeostasis|glucose homeostasis
668286|NCT00755404|Dyslipidemia|dyslipidemia
668287|NCT00755391|BN and subthreshold BN|bn and subthreshold bn
668288|NCT00755378|Phase I|phase i
668289|NCT00755365|pelvic fractures|pelvic fractures
668290|NCT00755365|angioembolism|angioembolism
668291|NCT00755365|Treatment at Hershey Medical Center|treatment at hershey medical center
668292|NCT00755365|Angioembolization in Operating Room|angioembolization in operating room
668293|NCT00755339|Repetitive TMS (rTMS)|repetitive tms (rtms)
668294|NCT00755339|Magnetoencephalogram|magnetoencephalogram
668295|NCT00755339|Transcranial Magnetic Stimulation (TMS)|transcranial magnetic stimulation (tms)
668296|NCT00755339|Tourette Syndrome|tourette syndrome
668297|NCT00755339|Tic Disorder|tic disorder
668298|NCT00755339|Tourete Syndrome|tourete syndrome
668299|NCT00755326|OA|oa
668300|NCT00755313|cognitive/functional effects|cognitive/functional effects
668301|NCT00755313|fatigue|fatigue
668302|NCT00755313|long-term effects secondary to cancer therapy in adults|long-term effects secondary to cancer therapy in adults
668303|NCT00755313|psychosocial effects of cancer and its treatment|psychosocial effects of cancer and its treatment
668304|NCT00755313|chemotherapeutic agent toxicity|chemotherapeutic agent toxicity
668305|NCT00755313|neurotoxicity|neurotoxicity
668306|NCT00755313|stage IA breast cancer|stage ia breast cancer
668307|NCT00755313|stage IB breast cancer|stage ib breast cancer
668308|NCT00755313|stage II breast cancer|stage ii breast cancer
668309|NCT00755313|stage IIIA breast cancer|stage iiia breast cancer
668310|NCT00755313|stage IIIB breast cancer|stage iiib breast cancer
668311|NCT00755313|stage IIIC breast cancer|stage iiic breast cancer
668312|NCT00755313|estrogen receptor-negative breast cancer|estrogen receptor-negative breast cancer
668313|NCT00755313|estrogen receptor-positive breast cancer|estrogen receptor-positive breast cancer
668314|NCT00755313|progesterone receptor-negative breast cancer|progesterone receptor-negative breast cancer
668315|NCT00755313|progesterone receptor-positive breast cancer|progesterone receptor-positive breast cancer
668316|NCT00755300|Total knee replacement|total knee replacement
668317|NCT00755300|esophageal echocardiography|esophageal echocardiography
668318|NCT00755274|Influenza|influenza
668319|NCT00755274|Orthomyxoviruses|orthomyxoviruses
668320|NCT00755274|Orthomyxoviridae Infections|orthomyxoviridae infections
668321|NCT00755274|Influenza vaccine|influenza vaccine
668322|NCT00755261|STS|sts
668323|NCT00755248|Coronary Artery Bypass Grafting (CABG)|coronary artery bypass grafting (cabg)
668324|NCT00755248|outcome|outcome
668325|NCT00755248|saphenous graft patency|saphenous graft patency
668326|NCT00755248|biochemical factors|biochemical factors
668327|NCT00755248|genomics|genomics
668328|NCT00755235|Depression|depression
668329|NCT00755235|Primary care|primary care
668330|NCT00755235|Effectiveness|effectiveness
668331|NCT00755235|Care management|care management
668332|NCT00755222|Peyronie's disease|peyronie's disease
668333|NCT00755222|penile plaque|penile plaque
668334|NCT00755222|penile curvature|penile curvature
668335|NCT00755209|Traumatic brain injury (TBI)|traumatic brain injury (tbi)
668336|NCT00755209|Adults|adults
668337|NCT00755209|Moderately severe TBI|moderately severe tbi
668338|NCT00755209|Delayed traumatic intracranial haemorrhage|delayed traumatic intracranial haemorrhage
668339|NCT00755209|Expanding traumatic intracranial haemorrhage|expanding traumatic intracranial haemorrhage
668340|NCT00755209|Progressive intracranial haemorrhage (PIH)|progressive intracranial haemorrhage (pih)
668341|NCT00755209|Antifibrinolytic agent|antifibrinolytic agent
668342|NCT00755209|Tranexamic acid (TXA)|tranexamic acid (txa)
668343|NCT00755209|Randomised, placebo-controlled trial|randomised, placebo-controlled trial
668344|NCT00755209|Human|human
668345|NCT00755196|Plaque Type Psoriasis|plaque type psoriasis
668346|NCT00755196|Topical|topical
668347|NCT00755183|Meibomian Gland Dysfunction|meibomian gland dysfunction
668348|NCT00755183|Dry Eye Syndrome|dry eye syndrome
668349|NCT00755170|Vinorelbine|vinorelbine
668350|NCT00755170|Bevacizumab|bevacizumab
668351|NCT00755170|Chemotherapy|chemotherapy
668352|NCT00755157|Cancer|cancer
668353|NCT00755157|SCLC|sclc
668354|NCT00755157|Docetaxel|docetaxel
668355|NCT00755157|Bevacizumab|bevacizumab
668356|NCT00755157|Chemotherapy|chemotherapy
668357|NCT00755131|Cardiac Rehabilitation|cardiac rehabilitation
668358|NCT00755131|High Mobility Group Box proteins|high mobility group box proteins
668359|NCT00755131|Inflammatory markers|inflammatory markers
668360|NCT00755131|Cardiopulmonary Functional Capacity|cardiopulmonary functional capacity
668361|NCT00755131|Maximal Oxygen Consumption|maximal oxygen consumption
668362|NCT00755131|Echocardiography|echocardiography
668363|NCT00755131|Left Ventricular Ejection Fraction|left ventricular ejection fraction
668364|NCT00755131|Left Ventricular Chambers Dilation|left ventricular chambers dilation
668365|NCT00755131|Left Ventricular Remodeling|left ventricular remodeling
668366|NCT00755131|Left Atrium Remodeling|left atrium remodeling
668367|NCT00755131|Cardiac Remodeling|cardiac remodeling
668368|NCT00755131|Exercise Training|exercise training
668369|NCT00755118|Metastatic colorectal cancer|metastatic colorectal cancer
668370|NCT00755118|Second line|second line
668371|NCT00755118|Irinotecan|irinotecan
668372|NCT00755118|Cetuximab|cetuximab
668373|NCT00755118|Bevacizumab|bevacizumab
668374|NCT00755105|body iron excretion|body iron excretion
668375|NCT00755105|Iron isotopes|iron isotopes
668376|NCT00755092|Doula|doula
668377|NCT00755092|Psychological care|psychological care
668378|NCT00755092|Labor analgesia|labor analgesia
668379|NCT00755079|spinal cord injury|spinal cord injury
668380|NCT00755079|beta-2 agonist|beta-2 agonist
668381|NCT00755079|respiratory muscle strength|respiratory muscle strength
668382|NCT00755079|pulmonary function test|pulmonary function test
668383|NCT00755053|Clotrimazole|clotrimazole
668384|NCT00755053|Ovule|ovule
668385|NCT00755053|Tablet|tablet
668386|NCT00755053|Vulvovaginal candidiasis|vulvovaginal candidiasis
668387|NCT00755053|Non-inferiority|non-inferiority
668388|NCT00755040|graft versus host disease|graft versus host disease
668389|NCT00755040|stage III adult Burkitt lymphoma|stage iii adult burkitt lymphoma
668390|NCT00755040|stage III adult diffuse large cell lymphoma|stage iii adult diffuse large cell lymphoma
668391|NCT00755040|stage III adult diffuse mixed cell lymphoma|stage iii adult diffuse mixed cell lymphoma
668392|NCT00755040|stage III adult diffuse small cleaved cell lymphoma|stage iii adult diffuse small cleaved cell lymphoma
668393|NCT00755040|stage III adult Hodgkin lymphoma|stage iii adult hodgkin lymphoma
668394|NCT00755040|stage III adult immunoblastic large cell lymphoma|stage iii adult immunoblastic large cell lymphoma
668395|NCT00755040|stage III adult lymphoblastic lymphoma|stage iii adult lymphoblastic lymphoma
668396|NCT00755040|stage III grade 1 follicular lymphoma|stage iii grade 1 follicular lymphoma
668397|NCT00755040|stage III grade 2 follicular lymphoma|stage iii grade 2 follicular lymphoma
668398|NCT00755040|stage III grade 3 follicular lymphoma|stage iii grade 3 follicular lymphoma
668399|NCT00755040|stage III mantle cell lymphoma|stage iii mantle cell lymphoma
668400|NCT00755040|stage III marginal zone lymphoma|stage iii marginal zone lymphoma
668401|NCT00755040|stage III small lymphocytic lymphoma|stage iii small lymphocytic lymphoma
668402|NCT00755040|stage IV adult Burkitt lymphoma|stage iv adult burkitt lymphoma
668403|NCT00755040|stage IV adult diffuse large cell lymphoma|stage iv adult diffuse large cell lymphoma
668404|NCT00755040|stage IV adult diffuse mixed cell lymphoma|stage iv adult diffuse mixed cell lymphoma
668405|NCT00755040|stage IV adult diffuse small cleaved cell lymphoma|stage iv adult diffuse small cleaved cell lymphoma
668406|NCT00755040|stage IV adult Hodgkin lymphoma|stage iv adult hodgkin lymphoma
668407|NCT00755040|stage IV adult immunoblastic large cell lymphoma|stage iv adult immunoblastic large cell lymphoma
668408|NCT00755040|stage IV adult lymphoblastic lymphoma|stage iv adult lymphoblastic lymphoma
668409|NCT00755040|stage IV grade 1 follicular lymphoma|stage iv grade 1 follicular lymphoma
668410|NCT00755040|stage IV grade 2 follicular lymphoma|stage iv grade 2 follicular lymphoma
668411|NCT00755040|stage IV grade 3 follicular lymphoma|stage iv grade 3 follicular lymphoma
668412|NCT00755040|stage IV mantle cell lymphoma|stage iv mantle cell lymphoma
668413|NCT00755040|stage IV marginal zone lymphoma|stage iv marginal zone lymphoma
668414|NCT00755040|stage IV small lymphocytic lymphoma|stage iv small lymphocytic lymphoma
668415|NCT00755040|extranodal marginal zone B-cell lymphoma of mucosa-associated lymphoid tissue|extranodal marginal zone b-cell lymphoma of mucosa-associated lymphoid tissue
668416|NCT00755040|nodal marginal zone B-cell lymphoma|nodal marginal zone b-cell lymphoma
668417|NCT00755040|splenic marginal zone lymphoma|splenic marginal zone lymphoma
668418|NCT00755040|noncontiguous stage II adult Burkitt lymphoma|noncontiguous stage ii adult burkitt lymphoma
668419|NCT00755040|noncontiguous stage II adult diffuse large cell lymphoma|noncontiguous stage ii adult diffuse large cell lymphoma
668420|NCT00755040|noncontiguous stage II adult diffuse mixed cell lymphoma|noncontiguous stage ii adult diffuse mixed cell lymphoma
668421|NCT00755040|noncontiguous stage II adult diffuse small cleaved cell lymphoma|noncontiguous stage ii adult diffuse small cleaved cell lymphoma
668422|NCT00755040|noncontiguous stage II adult immunoblastic large cell lymphoma|noncontiguous stage ii adult immunoblastic large cell lymphoma
668423|NCT00755040|noncontiguous stage II adult lymphoblastic lymphoma|noncontiguous stage ii adult lymphoblastic lymphoma
668424|NCT00755040|noncontiguous stage II grade 1 follicular lymphoma|noncontiguous stage ii grade 1 follicular lymphoma
668425|NCT00755040|noncontiguous stage II grade 2 follicular lymphoma|noncontiguous stage ii grade 2 follicular lymphoma
668426|NCT00755040|noncontiguous stage II grade 3 follicular lymphoma|noncontiguous stage ii grade 3 follicular lymphoma
668427|NCT00755040|noncontiguous stage II mantle cell lymphoma|noncontiguous stage ii mantle cell lymphoma
668428|NCT00755040|noncontiguous stage II marginal zone lymphoma|noncontiguous stage ii marginal zone lymphoma
668429|NCT00755040|noncontiguous stage II small lymphocytic lymphoma|noncontiguous stage ii small lymphocytic lymphoma
668430|NCT00755040|accelerated phase chronic myelogenous leukemia|accelerated phase chronic myelogenous leukemia
668431|NCT00755040|adult acute lymphoblastic leukemia in remission|adult acute lymphoblastic leukemia in remission
668432|NCT00755040|adult acute myeloid leukemia in remission|adult acute myeloid leukemia in remission
668433|NCT00755040|adult acute myeloid leukemia with 11q23 (MLL) abnormalities|adult acute myeloid leukemia with 11q23 (mll) abnormalities
668434|NCT00755040|adult acute myeloid leukemia with inv(16)(p13;q22)|adult acute myeloid leukemia with inv(16)(p13;q22)
668435|NCT00755040|adult acute myeloid leukemia with t(15;17)(q22;q12)|adult acute myeloid leukemia with t(15;17)(q22;q12)
668436|NCT00755040|adult acute myeloid leukemia with t(16;16)(p13;q22)|adult acute myeloid leukemia with t(16;16)(p13;q22)
668437|NCT00755040|adult acute myeloid leukemia with t(8;21)(q22;q22)|adult acute myeloid leukemia with t(8;21)(q22;q22)
668438|NCT00755040|atypical chronic myeloid leukemia, BCR-ABL negative|atypical chronic myeloid leukemia, bcr-abl negative
668439|NCT00755040|blastic phase chronic myelogenous leukemia|blastic phase chronic myelogenous leukemia
668440|NCT00755040|chronic myelomonocytic leukemia|chronic myelomonocytic leukemia
668441|NCT00755040|chronic phase chronic myelogenous leukemia|chronic phase chronic myelogenous leukemia
668442|NCT00755040|secondary acute myeloid leukemia|secondary acute myeloid leukemia
668443|NCT00755040|stage III chronic lymphocytic leukemia|stage iii chronic lymphocytic leukemia
668444|NCT00755040|stage IV chronic lymphocytic leukemia|stage iv chronic lymphocytic leukemia
668445|NCT00755040|chronic eosinophilic leukemia|chronic eosinophilic leukemia
668446|NCT00755040|primary myelofibrosis|primary myelofibrosis
668447|NCT00755040|chronic neutrophilic leukemia|chronic neutrophilic leukemia
668448|NCT00755040|de novo myelodysplastic syndromes|de novo myelodysplastic syndromes
668449|NCT00755040|myelodysplastic/myeloproliferative neoplasm, unclassifiable|myelodysplastic/myeloproliferative neoplasm, unclassifiable
668450|NCT00755040|previously treated myelodysplastic syndromes|previously treated myelodysplastic syndromes
668451|NCT00755040|secondary myelodysplastic syndromes|secondary myelodysplastic syndromes
668452|NCT00755040|stage I multiple myeloma|stage i multiple myeloma
668453|NCT00755040|stage II multiple myeloma|stage ii multiple myeloma
668454|NCT00755040|stage III multiple myeloma|stage iii multiple myeloma
668455|NCT00755027|Parkinson's disease|parkinson's disease
668456|NCT00755027|Apathy|apathy
668457|NCT00755027|Rasagiline|rasagiline
668458|NCT00755001|Total Hip Replacement|total hip replacement
668459|NCT00754949|Blepharoconjunctivitis,|blepharoconjunctivitis,
668460|NCT00754949|Ophthalmology|ophthalmology
668461|NCT00754936|Depression|depression
668462|NCT00754923|recurrent non-small cell lung cancer|recurrent non-small cell lung cancer
668463|NCT00754923|stage IIIB non-small cell lung cancer|stage iiib non-small cell lung cancer
668464|NCT00754923|stage IV non-small cell lung cancer|stage iv non-small cell lung cancer
668465|NCT00754923|adenocarcinoma of the lung|adenocarcinoma of the lung
668466|NCT00754923|bronchoalveolar cell lung cancer|bronchoalveolar cell lung cancer
668467|NCT00754923|large cell lung cancer|large cell lung cancer
668468|NCT00754910|stage I non-small cell lung cancer|stage i non-small cell lung cancer
668469|NCT00754910|stage II non-small cell lung cancer|stage ii non-small cell lung cancer
668470|NCT00754910|stage IIIA non-small cell lung cancer|stage iiia non-small cell lung cancer
668471|NCT00754910|stage IIIB non-small cell lung cancer|stage iiib non-small cell lung cancer
668472|NCT00754910|stage IV non-small cell lung cancer|stage iv non-small cell lung cancer
668473|NCT00754910|recurrent non-small cell lung cancer|recurrent non-small cell lung cancer
668474|NCT00754897|Phone Interview|phone interview
668475|NCT00754897|Anesthesia|anesthesia
668476|NCT00754897|Siblings|siblings
668477|NCT00754897|Inguinal Hernia|inguinal hernia
668478|NCT00754897|Neurologic Examination|neurologic examination
668479|NCT00754897|Developmental Delay Disorders|developmental delay disorders
668480|NCT00754884|salmon calcitonin|salmon calcitonin
668481|NCT00754884|endorphins|endorphins
668482|NCT00754884|treatment|treatment
668483|NCT00754884|fibromyalgia|fibromyalgia
668484|NCT00754858|extensive stage small cell lung cancer|extensive stage small cell lung cancer
668485|NCT00754845|stage I breast cancer|stage i breast cancer
668486|NCT00754845|stage II breast cancer|stage ii breast cancer
668487|NCT00754845|stage IIIA breast cancer|stage iiia breast cancer
668488|NCT00754845|stage IIIB breast cancer|stage iiib breast cancer
668489|NCT00754845|stage IIIC breast cancer|stage iiic breast cancer
668490|NCT00754832|Multiple sclerosis|multiple sclerosis
668491|NCT00754832|fatigue|fatigue
668492|NCT00754832|ginseng|ginseng
668493|NCT00754806|HALS|hals
668494|NCT00754806|open splenectomy|open splenectomy
668495|NCT00754806|splenomegaly|splenomegaly
668496|NCT00754806|HALS as a hybrid approach of pure laparoscopy and open surgery has some definite advantages over open surgery|hals as a hybrid approach of pure laparoscopy and open surgery has some definite advantages over open surgery
668497|NCT00754806|In the HALS group, incision length is significantly shorter|in the hals group, incision length is significantly shorter
668498|NCT00754806|In the HALS group, postoperative pain is less than with open surgery|in the hals group, postoperative pain is less than with open surgery
668499|NCT00754806|In the HALS group, postoperative hospital stay is shorter than with open surgery|in the hals group, postoperative hospital stay is shorter than with open surgery
668500|NCT00754780|NF1|nf1
668501|NCT00754780|plexiform neurofibroma|plexiform neurofibroma
668502|NCT00754767|neurotoxicity|neurotoxicity
668503|NCT00754767|chemotherapeutic agent toxicity|chemotherapeutic agent toxicity
668504|NCT00754767|stage IV breast cancer|stage iv breast cancer
668505|NCT00754767|recurrent breast cancer|recurrent breast cancer
668506|NCT00754754|brain|brain
668507|NCT00754754|surgery|surgery
668508|NCT00754754|retraction|retraction
668509|NCT00754754|injury|injury
668510|NCT00754754|monitoring|monitoring
668511|NCT00754741|medication adherence|medication adherence
668512|NCT00754741|motivational interviewing|motivational interviewing
668513|NCT00754715|Multiple dosing study,|multiple dosing study,
668514|NCT00754715|safety|safety
668515|NCT00754702|Vinorelbine metronomic-lapatinib|vinorelbine metronomic-lapatinib
668516|NCT00754702|Chemotherapy|chemotherapy
668517|NCT00754702|Targeted therapy|targeted therapy
668518|NCT00754689|Rimonabant/metformin combination|rimonabant/metformin combination
668519|NCT00754663|exercise|exercise
668520|NCT00754663|implantable cardioverter-defibrillator|implantable cardioverter-defibrillator
668521|NCT00754663|arrhythmia|arrhythmia
668522|NCT00754637|Joint|joint
668523|NCT00754637|Osteoarthritis|osteoarthritis
668524|NCT00754637|Avascular Necrosis|avascular necrosis
668525|NCT00754546|exercise;|exercise;
668526|NCT00754546|treadmill;|treadmill;
668527|NCT00754546|cycle ergometer;|cycle ergometer;
668528|NCT00754546|breathlessness;|breathlessness;
668529|NCT00754546|leg discomfort|leg discomfort
668530|NCT00754533|cardiac rehabilitation|cardiac rehabilitation
668531|NCT00754533|coronary heart disease|coronary heart disease
668532|NCT00754533|interval training|interval training
668533|NCT00754533|continuous training|continuous training
668534|NCT00754533|ventilatory threshold|ventilatory threshold
668536|NCT00754468|Barrett's Esophagus|barrett's esophagus
668537|NCT00754468|Esophageal Cancer|esophageal cancer
668538|NCT00754468|Esophageal Dysplasia|esophageal dysplasia
668539|NCT00754468|Low Grade Dysplasia|low grade dysplasia
668540|NCT00754468|High Grade Dysplasia|high grade dysplasia
668541|NCT00754442|hyperparathyroidism|hyperparathyroidism
668542|NCT00754442|parathyroid|parathyroid
668543|NCT00754442|vitamin D|vitamin d
668544|NCT00754442|vitamin D deficiency|vitamin d deficiency
668545|NCT00754416|Shoulder Replacement|shoulder replacement
668546|NCT00754403|Glucose Metabolism Disorder|glucose metabolism disorder
668547|NCT00754403|Dysmetabolic Syndrome|dysmetabolic syndrome
668548|NCT00754403|Type II Diabetes|type ii diabetes
668549|NCT00754403|Diabetes Mellitus, Lipoatrophic|diabetes mellitus, lipoatrophic
668550|NCT00754403|Dyslipidemia|dyslipidemia
668551|NCT00754403|Drug Therapy|drug therapy
668552|NCT00754390|dietary zinc absorption|dietary zinc absorption
668553|NCT00754390|dietary phytic acid|dietary phytic acid
668554|NCT00754390|dietary calcium|dietary calcium
668555|NCT00754377|Education|education
668556|NCT00754377|Program Evaluation|program evaluation
668557|NCT00754377|Quality of Health Care|quality of health care
668558|NCT00754377|Medical Residents|medical residents
668559|NCT00754351|docetaxel|docetaxel
668560|NCT00754351|gemcitabine|gemcitabine
668561|NCT00754351|bevacizumab|bevacizumab
668562|NCT00754351|chemotherapy|chemotherapy
668563|NCT00754338|comfort|comfort
668564|NCT00754338|wetability|wetability
668565|NCT00754338|protein deposit|protein deposit
668566|NCT00754338|lipid deposit|lipid deposit
668567|NCT00754312|breast cancer|breast cancer
668568|NCT00754299|nonunion/malunion osseous fractures|nonunion/malunion osseous fractures
668569|NCT00754299|nicotine dependent|nicotine dependent
668570|NCT00754299|chronic osseous infection|chronic osseous infection
668571|NCT00754299|infected osseous nonunions|infected osseous nonunions
668572|NCT00754299|Fracture nonunion or infection|fracture nonunion or infection
668573|NCT00754286|Aromatherapy|aromatherapy
668574|NCT00754247|Keloid|keloid
668575|NCT00754247|Hypertrophic scar|hypertrophic scar
668576|NCT00754247|Hydrocortisone, silicone, vitamin E lotion|hydrocortisone, silicone, vitamin e lotion
668578|NCT00754247|Onion extract gel|onion extract gel
668579|NCT00754247|OE|oe
668580|NCT00754247|Cetearyl alcohol lotion|cetearyl alcohol lotion
668581|NCT00754247|CEA|cea
668582|NCT00754234|iron absorption|iron absorption
668583|NCT00754234|iron requirements|iron requirements
668584|NCT00754234|dietary guidelines|dietary guidelines
668585|NCT00754234|MyPyramid|mypyramid
668586|NCT00754221|Phase 3, safety study, [S,S]-Reboxetine, Fibromyalgia|phase 3, safety study, [s,s]-reboxetine, fibromyalgia
668587|NCT00754208|Attention Deficit Hyperactivity Disorder|attention deficit hyperactivity disorder
668588|NCT00754208|Stimulant Treatment|stimulant treatment
668589|NCT00754208|Young Children|young children
668590|NCT00754195|Thoracotomy|thoracotomy
668591|NCT00754182|thyroidectomy|thyroidectomy
668592|NCT00754182|surgery|surgery
668593|NCT00754182|synthetic glue|synthetic glue
668594|NCT00754182|subcuticular suture|subcuticular suture
668595|NCT00754169|Traumatic Brain Injury|traumatic brain injury
668596|NCT00754169|Brain Imaging|brain imaging
668597|NCT00754169|Brain Plasticity|brain plasticity
668598|NCT00754169|Neuroplasticity|neuroplasticity
668599|NCT00754169|Neuropsychological Testing|neuropsychological testing
668600|NCT00754169|Head Injury|head injury
668601|NCT00754169|Healthy Volunteer|healthy volunteer
668602|NCT00754156|Closure, Wounds|closure, wounds
668603|NCT00754143|Type 1 or Type 2 diabetes|type 1 or type 2 diabetes
668604|NCT00754143|proteinuria|proteinuria
668605|NCT00754117|diffuse large b cell lymphoma|diffuse large b cell lymphoma
668606|NCT00754117|newly diagnosed|newly diagnosed
668607|NCT00754078|tomotherapy|tomotherapy
668608|NCT00754065|Oral contraceptive|oral contraceptive
668609|NCT00754065|Estradiol valerate and dienogest|estradiol valerate and dienogest
668610|NCT00754065|EV/DNG|ev/dng
668611|NCT00754065|comparative tolerability|comparative tolerability
668612|NCT00754052|Pediatric|pediatric
668613|NCT00754052|Down syndrome|down syndrome
668614|NCT00754052|Downs|downs
668615|NCT00754052|Cognitive Dysfunction of Down syndrome|cognitive dysfunction of down syndrome
668616|NCT00754039|Mixed hyperlipidemia|mixed hyperlipidemia
668617|NCT00754026|Shoulder surgery|shoulder surgery
668618|NCT00754013|pediatric|pediatric
668619|NCT00754013|Down syndrome|down syndrome
668620|NCT00754013|cognitive dysfunction|cognitive dysfunction
668621|NCT00754013|Downs|downs
668622|NCT00754013|Aricept|aricept
668623|NCT00754013|children with Down syndrome|children with down syndrome
668624|NCT00753987|Cystic Fibrosis|cystic fibrosis
668625|NCT00753987|Hypertonic Saline|hypertonic saline
668626|NCT00753987|Infants|infants
668627|NCT00753961|Shiftworkers|shiftworkers
668628|NCT00753961|volunteers|volunteers
668629|NCT00753948|Tetraplegia|tetraplegia
668630|NCT00753948|Mild asthma|mild asthma
668631|NCT00753948|Exhaled Nitric Oxide|exhaled nitric oxide
668632|NCT00753948|NOS inhibitor|nos inhibitor
668633|NCT00753948|Spinal cord injury|spinal cord injury
668634|NCT00753948|Pulmonary Function|pulmonary function
668635|NCT00753935|aspirin|aspirin
668636|NCT00753935|aspirin resistance|aspirin resistance
668637|NCT00753935|aspirin nonresponse|aspirin nonresponse
668638|NCT00753935|cyclooxygenase|cyclooxygenase
668639|NCT00753935|thromboxane|thromboxane
668640|NCT00753935|oxidative stress|oxidative stress
668641|NCT00753922|Breast Reconstruction|breast reconstruction
668642|NCT00753922|Breast Augmentation|breast augmentation
668643|NCT00753922|Revision|revision
668644|NCT00753922|Silicone breast implants|silicone breast implants
668645|NCT00753922|Round low-bleed|round low-bleed
668646|NCT00753909|Non Small Cell Lung Cancer|non small cell lung cancer
668647|NCT00753909|Paclitaxel|paclitaxel
668648|NCT00753909|Carboplatin|carboplatin
668649|NCT00753909|Bevacizumab|bevacizumab
668650|NCT00753896|Amylin|amylin
668651|NCT00753896|Lilly|lilly
668652|NCT00753896|exenatide once weekly|exenatide once weekly
668653|NCT00753896|thiazolidinedione|thiazolidinedione
668654|NCT00753896|metformin|metformin
668655|NCT00753870|current|current
668656|NCT00753870|no health problems|no health problems
668657|NCT00753870|no daily cough from smoking|no daily cough from smoking
668658|NCT00753857|risk communication|risk communication
668659|NCT00753857|probability sample by random digit dialing|probability sample by random digit dialing
668660|NCT00753844|peptide vaccine|peptide vaccine
668661|NCT00753844|URLC10|urlc10
668662|NCT00753831|Blepharoptosis|blepharoptosis
668663|NCT00753831|Ophthalmoplegia|ophthalmoplegia
668664|NCT00753831|Blepharospasm|blepharospasm
668665|NCT00753818|infant formula|infant formula
668666|NCT00753818|visual development|visual development
668667|NCT00753805|mare's milk|mare's milk
668668|NCT00753805|atopic dermatitis|atopic dermatitis
668669|NCT00753805|endogenous eczema|endogenous eczema
668670|NCT00753805|SCORAD|scorad
668671|NCT00753805|Bifidobacteria|bifidobacteria
668672|NCT00753792|multiple sclerosis|multiple sclerosis
668673|NCT00753792|relapse|relapse
668674|NCT00753792|methylprednisolone|methylprednisolone
668676|NCT00753766|Blood Glucose Management|blood glucose management
668677|NCT00753766|Blood Pressure|blood pressure
668678|NCT00753766|Case Management|case management
668679|NCT00753766|Diabetes Mellitus|diabetes mellitus
668680|NCT00753766|Intervention study|intervention study
668681|NCT00753766|Multifactorial|multifactorial
668682|NCT00753766|Peri-operative complications|peri-operative complications
668683|NCT00753766|Pre-operative|pre-operative
668684|NCT00753753|stent thrombosis|stent thrombosis
668685|NCT00753753|clopidogrel|clopidogrel
668686|NCT00753753|aspirin|aspirin
668687|NCT00753753|bleeding|bleeding
668688|NCT00753753|coronary|coronary
668689|NCT00753753|angioplasty|angioplasty
668690|NCT00753740|Cancer|cancer
668691|NCT00753740|Neoplasms|neoplasms
668692|NCT00753740|Solid Tumor|solid tumor
668693|NCT00753740|Ovarian Cancer|ovarian cancer
668694|NCT00753740|Solid Malignancies|solid malignancies
668695|NCT00753727|soft tissue|soft tissue
668696|NCT00753727|Sarcoma|sarcoma
668697|NCT00753727|Sunitinib|sunitinib
668698|NCT00753727|neoadjuvant|neoadjuvant
668699|NCT00753727|radiotherapy|radiotherapy
668700|NCT00753714|ZD6474|zd6474
668701|NCT00753714|VANDETANIB|vandetanib
668702|NCT00753714|ZACTIMA|zactima
668703|NCT00753714|ADVANCED|advanced
668704|NCT00753714|NSCLC|nsclc
668705|NCT00753714|LUNG CANCER|lung cancer
668706|NCT00753714|ELDERLY PATIENTS|elderly patients
668707|NCT00753714|GEMCITABINE|gemcitabine
668708|NCT00753714|PHASE II|phase ii
668709|NCT00753714|RANDOMIZED|randomized
668710|NCT00753714|DOUBLE-BLIND|double-blind
668711|NCT00753714|histologically or cytologically-confirmed advanced (stage IIIB with supraclavicular lymph node metastases or pleural effusion or stage IV) NSCLC|histologically or cytologically-confirmed advanced (stage iiib with supraclavicular lymph node metastases or pleural effusion or stage iv) nsclc
668712|NCT00753688|metastatic soft-tissue sarcoma|metastatic soft-tissue sarcoma
668713|NCT00753688|pazopanib|pazopanib
668714|NCT00753688|Soft Tissue Sarcoma|soft tissue sarcoma
668715|NCT00753688|placebo|placebo
668716|NCT00753675|Intrahepatic|intrahepatic
668717|NCT00753675|Cholangiocarcinoma|cholangiocarcinoma
668718|NCT00753675|Vandetanib|vandetanib
668719|NCT00753675|Zactima|zactima
668720|NCT00753675|Advanced|advanced
668721|NCT00753675|Biliary|biliary
668722|NCT00753675|Tract|tract
668723|NCT00753675|Gallbladder|gallbladder
668724|NCT00753675|Extrahepatic Bile Duct|extrahepatic bile duct
668725|NCT00753675|Intrahepatic Cholangiocarcinoma|intrahepatic cholangiocarcinoma
668726|NCT00753675|Ampullary Carcinoma|ampullary carcinoma
668727|NCT00753662|TMS AD H2 coil|tms ad h2 coil
668728|NCT00753649|Infant|infant
668729|NCT00753649|First nation|first nation
668730|NCT00753649|Aboriginal|aboriginal
668731|NCT00753649|Canada|canada
668732|NCT00753636|Parkinson's disease|parkinson's disease
668733|NCT00753636|Isradipine|isradipine
668734|NCT00753636|Neuroprotection|neuroprotection
668735|NCT00753623|Pain|pain
668736|NCT00753623|Neuropathic pain|neuropathic pain
668737|NCT00753623|Pain scores|pain scores
668738|NCT00753610|EPC|epc
668739|NCT00753610|CCRT|ccrt
668740|NCT00753610|Cervical cancer|cervical cancer
668741|NCT00753597|B cell depletion|b cell depletion
668742|NCT00753597|steroidogenesis|steroidogenesis
668743|NCT00753571|Amyotrophic Lateral Sclerosis|amyotrophic lateral sclerosis
668744|NCT00753571|Cistanche Total Glycosides|cistanche total glycosides
668745|NCT00753571|Randomized Control Trial Study|randomized control trial study
668746|NCT00753545|Serous,|serous,
668747|NCT00753545|Ovarian cancer,|ovarian cancer,
668748|NCT00753545|PARP,|parp,
668749|NCT00753545|BRCA1,|brca1,
668750|NCT00753545|BRCA2,|brca2,
668751|NCT00753545|Poly(ADP ribose) polymerases,|poly(adp ribose) polymerases,
668752|NCT00753545|Platinum sensitive,|platinum sensitive,
668753|NCT00753545|Homologous Recombination Deficiency (HRD)|homologous recombination deficiency (hrd)
668754|NCT00753532|Carotid artery stenoses|carotid artery stenoses
668755|NCT00753532|Brain ischaemia|brain ischaemia
668756|NCT00753532|stroke|stroke
668757|NCT00753532|Lipid abnormalities|lipid abnormalities
668758|NCT00753532|Fatty Liver|fatty liver
668759|NCT00753519|Parkinson's Disease|parkinson's disease
668760|NCT00753519|Brain Stimulation|brain stimulation
668761|NCT00753519|Motor Cortex|motor cortex
668762|NCT00753519|Bradykinesia|bradykinesia
668763|NCT00753519|Parkinson Disease|parkinson disease
668764|NCT00753519|PD|pd
668765|NCT00753480|EOC|eoc
668766|NCT00753480|PPC|ppc
668767|NCT00753480|FTC|ftc
668768|NCT00753467|HBV|hbv
668769|NCT00753467|Treatment|treatment
668770|NCT00753467|Interferon-gamma|interferon-gamma
668771|NCT00753467|combination|combination
668772|NCT00753467|Hepsera|hepsera
668773|NCT00753467|Actimmune|actimmune
668774|NCT00753467|HBV DNA|hbv dna
668775|NCT00753454|Rheumatoid Arthritis|rheumatoid arthritis
668776|NCT00753454|Joint Disease|joint disease
668777|NCT00753454|Arthritis|arthritis
668778|NCT00753454|Certolizumab pegol|certolizumab pegol
668779|NCT00753454|Cimzia|cimzia
668780|NCT00753441|Pancreatic cancer|pancreatic cancer
668781|NCT00753441|Bile duct obstruction|bile duct obstruction
668782|NCT00753441|Stent|stent
668783|NCT00753441|Bypass|bypass
668784|NCT00753428|HIV-free survival|hiv-free survival
668785|NCT00753428|Community based evaluation|community based evaluation
668786|NCT00753428|Pregnancy|pregnancy
668787|NCT00753428|Under 2 child survival|under 2 child survival
668788|NCT00753428|PMTCT|pmtct
668789|NCT00753428|Pediatric HIV infection|pediatric hiv infection
668790|NCT00753428|HAART|haart
668791|NCT00753428|Routine ART|routine art
668792|NCT00753428|HIV Seronegativity|hiv seronegativity
668793|NCT00753415|Urinary Bladder Neoplasms|urinary bladder neoplasms
668794|NCT00753415|Breast Neoplasms|breast neoplasms
668795|NCT00753415|Renal Cell carcinoma|renal cell carcinoma
668796|NCT00753415|Melanoma|melanoma
668797|NCT00753415|Prostatic Neoplasms|prostatic neoplasms
668798|NCT00753415|Colonic Neoplasms|colonic neoplasms
668799|NCT00753415|Urologic Neoplasms|urologic neoplasms
668800|NCT00753415|Urogenital Neoplasms|urogenital neoplasms
668801|NCT00753415|Urinary Bladder Diseases|urinary bladder diseases
668802|NCT00753415|Urologic Diseases|urologic diseases
668803|NCT00753415|Breast Diseases|breast diseases
668804|NCT00753415|Skin Diseases|skin diseases
668805|NCT00753415|Neoplasms|neoplasms
668806|NCT00753415|Glandular and Epithelial Neoplasms by Histologic Type|glandular and epithelial neoplasms by histologic type
668807|NCT00753415|Adenocarcinoma|adenocarcinoma
668808|NCT00753415|Kidney Neoplasms|kidney neoplasms
668809|NCT00753415|Kidney Diseases|kidney diseases
668810|NCT00753415|Neuroendocrine Tumors|neuroendocrine tumors
668811|NCT00753415|Neuroectodermal Tumors|neuroectodermal tumors
668812|NCT00753415|Neoplasms, Germ Cell and Embryonal|neoplasms, germ cell and embryonal
668813|NCT00753415|Neoplasms, Nerve Tissue|neoplasms, nerve tissue
668814|NCT00753415|Nevi and Melanomas|nevi and melanomas
668815|NCT00753415|Genital Neoplasms|genital neoplasms
668816|NCT00753415|Male Genital Diseases|male genital diseases
668817|NCT00753415|Male, Prostatic Diseases|male, prostatic diseases
668818|NCT00753415|Colorectal Neoplasms|colorectal neoplasms
668819|NCT00753415|Intestinal Neoplasms|intestinal neoplasms
668820|NCT00753389|Postoperative residual curarization,|postoperative residual curarization,
668821|NCT00753389|muscle relaxants,|muscle relaxants,
668822|NCT00753389|morbidity mortality|morbidity mortality
668823|NCT00753363|Glucose Metabolism|glucose metabolism
668824|NCT00753350|obesity|obesity
668825|NCT00753324|PMTCT|pmtct
668826|NCT00753324|HAART|haart
668827|NCT00753324|Pregnancy|pregnancy
668828|NCT00753324|HIV Infection|hiv infection
668829|NCT00753324|HIV Transmission|hiv transmission
668830|NCT00753324|HIV Seronegativity|hiv seronegativity
668831|NCT00753311|migraine|migraine
668832|NCT00753311|rizatriptan|rizatriptan
668833|NCT00753311|unilateral trigeminal autonomic symptoms|unilateral trigeminal autonomic symptoms
668834|NCT00753311|Migraine with or without aura|migraine with or without aura
668835|NCT00753272|Efficacy|efficacy
668836|NCT00753272|Influenza Vaccines|influenza vaccines
668837|NCT00753272|Influenza|influenza
668838|NCT00753272|Vaccine|vaccine
668839|NCT00753272|Elderly|elderly
668840|NCT00753259|atrial fibrillation|atrial fibrillation
668841|NCT00753259|disease management program|disease management program
668842|NCT00753259|integrated chronic care program|integrated chronic care program
668843|NCT00753259|guideline|guideline
668844|NCT00753259|stroke|stroke
668845|NCT00753259|heart failure|heart failure
668846|NCT00753259|quality of life|quality of life
668847|NCT00753259|costs|costs
668848|NCT00753246|glioblastoma multiforma|glioblastoma multiforma
668849|NCT00753233|Hypertrophic Cardiomyopathy|hypertrophic cardiomyopathy
668850|NCT00753233|Children|children
668851|NCT00753233|Sudden Death|sudden death
668852|NCT00753233|Arrhythmias|arrhythmias
668853|NCT00753233|Electrophysiology Study|electrophysiology study
668854|NCT00753220|Metastatic|metastatic
668855|NCT00753220|Androgen|androgen
668856|NCT00753220|Independent|independent
668857|NCT00753220|Prostate Cancer|prostate cancer
668858|NCT00753220|(AIPC),|(aipc),
668859|NCT00753220|Hormone-refractory|hormone-refractory
668860|NCT00753220|(HRPC),|(hrpc),
668861|NCT00753220|cryotherapy,|cryotherapy,
668862|NCT00753220|dendritic cell,|dendritic cell,
668863|NCT00753220|immunotherapy|immunotherapy
668864|NCT00753220|Chemo-naïve|chemo-naïve
668865|NCT00753220|lymph nodes|lymph nodes
668866|NCT00753220|bone|bone
668867|NCT00753207|stage IV breast cancer|stage iv breast cancer
668868|NCT00753207|recurrent breast cancer|recurrent breast cancer
668869|NCT00753194|hearing|hearing
668870|NCT00753194|newborn|newborn
668871|NCT00753194|otoacoustic emissions|otoacoustic emissions
668872|NCT00753168|glaucoma, open angle, ocular hypertension, beta blocker, beta adrenergic, intraocular pressure|glaucoma, open angle, ocular hypertension, beta blocker, beta adrenergic, intraocular pressure
668873|NCT00753155|HRQoL;|hrqol;
668874|NCT00753155|exercise|exercise
668875|NCT00753155|capacity|capacity
668876|NCT00753142|Hyperglycemia|hyperglycemia
668877|NCT00753129|Prone position|prone position
668878|NCT00753129|ALI/ARDS|ali/ards
668879|NCT00753129|Head elevation|head elevation
668880|NCT00753103|Infliximab|infliximab
668881|NCT00753103|Vasculitis|vasculitis
668882|NCT00753103|antitnf monoclonal antibody|antitnf monoclonal antibody
668883|NCT00753064|Red Scorpion envenomation|red scorpion envenomation
668884|NCT00753064|Composite clinical scoring system|composite clinical scoring system
668885|NCT00753064|AScVS|ascvs
668886|NCT00753064|Prazosin|prazosin
668887|NCT00753064|Superiority|superiority
668888|NCT00753051|clozapine-resistant schizophrenics|clozapine-resistant schizophrenics
668889|NCT00753051|haloperidol augmenting clozapine|haloperidol augmenting clozapine
711021|NCT00586833|Heart Failure|heart failure
668890|NCT00753051|electroconvulsive therapy augmenting clozapine|electroconvulsive therapy augmenting clozapine
668891|NCT00753038|carcinoma|carcinoma
668892|NCT00753038|squamous cell|squamous cell
668893|NCT00753038|head|head
668894|NCT00753038|neck|neck
668895|NCT00753038|REOLYSIN|reolysin
668896|NCT00753038|chemotherapy|chemotherapy
668897|NCT00753038|Carboplatin|carboplatin
668898|NCT00753038|Paclitaxel|paclitaxel
668899|NCT00753025|lower extremity ischemia|lower extremity ischemia
668900|NCT00753025|Bone marrow|bone marrow
668901|NCT00753025|Progenitor cells|progenitor cells
668902|NCT00753025|Neoangiogenesis|neoangiogenesis
668903|NCT00753012|cardiovascular testing|cardiovascular testing
668904|NCT00753012|home blood pressure monitoring|home blood pressure monitoring
668905|NCT00753012|office home blood pressure monitoring|office home blood pressure monitoring
668906|NCT00753012|cardiopulmonary exercise testing|cardiopulmonary exercise testing
668907|NCT00753012|transthoracic echocardiography|transthoracic echocardiography
668908|NCT00753012|Lisdexamfetamine|lisdexamfetamine
668909|NCT00753012|Vyvanse|vyvanse
668910|NCT00753012|normotensive and hypertensive adults with ADHD|normotensive and hypertensive adults with adhd
668911|NCT00753012|ADHD medication.|adhd medication.
668912|NCT00752999|SLE|sle
668913|NCT00752999|Lupus|lupus
668914|NCT00752986|ZD6474|zd6474
668915|NCT00752986|Vandetanib|vandetanib
668916|NCT00752986|Zactima|zactima
668917|NCT00752986|Fulvestrant|fulvestrant
668918|NCT00752986|Faslodex|faslodex
668919|NCT00752986|Breast Cancer|breast cancer
668920|NCT00752986|Advanced, Metastatic|advanced, metastatic
668921|NCT00752986|Hormone Receptor Positive|hormone receptor positive
668922|NCT00752986|Post-Menopausal Patients|post-menopausal patients
668923|NCT00752986|post-menopausal women with hormone receptor positive advanced breast cancer|post-menopausal women with hormone receptor positive advanced breast cancer
668924|NCT00752973|Head Lice|head lice
668925|NCT00752960|single nucleotide polymorphism, SNP, aripiprazole, olanzapine, quetiapine, risperidone, ziprasidone, metabolic syndrome|single nucleotide polymorphism, snp, aripiprazole, olanzapine, quetiapine, risperidone, ziprasidone, metabolic syndrome
668926|NCT00752934|nursing homes|nursing homes
668927|NCT00752934|children|children
668928|NCT00752934|ages 1-18 years|ages 1-18 years
668929|NCT00752934|spastic quadriplegia|spastic quadriplegia
668930|NCT00752921|Etoricoxib, Fasting Headache, Headache, Yom Kippur|etoricoxib, fasting headache, headache, yom kippur
668931|NCT00752895|stage I chronic lymphocytic leukemia|stage i chronic lymphocytic leukemia
668932|NCT00752895|stage II chronic lymphocytic leukemia|stage ii chronic lymphocytic leukemia
668933|NCT00752895|stage III chronic lymphocytic leukemia|stage iii chronic lymphocytic leukemia
668934|NCT00752895|stage IV chronic lymphocytic leukemia|stage iv chronic lymphocytic leukemia
668935|NCT00752882|Ceftazidime|ceftazidime
668936|NCT00752882|Pharmacokinetics|pharmacokinetics
668937|NCT00752882|Pseudomonas|pseudomonas
668938|NCT00752882|aeruginosa|aeruginosa
668939|NCT00752882|Meningitis|meningitis
668940|NCT00752882|Patients|patients
668941|NCT00752882|hospitalised|hospitalised
668942|NCT00752882|cerebrolesion|cerebrolesion
668943|NCT00752882|acquired|acquired
668944|NCT00752882|pneumopathy|pneumopathy
668945|NCT00752882|mechanic|mechanic
668946|NCT00752882|ventilation|ventilation
668947|NCT00752869|low testosterone|low testosterone
668948|NCT00752856|HIV treatment|hiv treatment
668949|NCT00752856|Treatment-naive|treatment-naive
668950|NCT00752856|Adult|adult
668951|NCT00752843|mifepristone|mifepristone
668952|NCT00752843|CORLUX|corlux
668953|NCT00752843|fluvastatin|fluvastatin
668954|NCT00752843|Lescol|lescol
668955|NCT00752843|drug-drug interaction|drug-drug interaction
668956|NCT00752843|DDI|ddi
668957|NCT00752843|pharmacokinetics|pharmacokinetics
668958|NCT00752830|AZD0328|azd0328
668959|NCT00752830|Food Effect|food effect
668960|NCT00752817|Virtual Reality|virtual reality
668961|NCT00752817|Simulator|simulator
668962|NCT00752817|Proficiency|proficiency
668963|NCT00752817|Laparoscopic|laparoscopic
668964|NCT00752817|Colectomy|colectomy
668965|NCT00752817|Education|education
668966|NCT00752817|Surgical Training|surgical training
668967|NCT00752804|ICU patients with acute renal failure after cardiac surgery|icu patients with acute renal failure after cardiac surgery
668968|NCT00752791|Anemia|anemia
668969|NCT00752791|Drug Therapy|drug therapy
668970|NCT00752791|Peritoneal Dialysis.|peritoneal dialysis.
668971|NCT00752778|MRI, PET scan|mri, pet scan
668972|NCT00752765|knee osteoarthritis|knee osteoarthritis
668973|NCT00752765|bariatric surgery|bariatric surgery
668974|NCT00752765|weight loss|weight loss
668975|NCT00752765|knee pain|knee pain
668976|NCT00752752|Marathon Running|marathon running
668977|NCT00752752|Cardiac Ischemia|cardiac ischemia
668978|NCT00752752|Magnetic Resonance Imaging|magnetic resonance imaging
668979|NCT00752739|adenocarcinoma of the prostate|adenocarcinoma of the prostate
668980|NCT00752739|stage I prostate cancer|stage i prostate cancer
668981|NCT00752739|stage II prostate cancer|stage ii prostate cancer
668982|NCT00752739|stage III prostate cancer|stage iii prostate cancer
668983|NCT00752739|stage IV prostate cancer|stage iv prostate cancer
668984|NCT00752726|overweight, orlistat, body composition|overweight, orlistat, body composition
668985|NCT00752713|AMI,|ami,
668986|NCT00752713|Reperfusion|reperfusion
668987|NCT00752713|successful|successful
668988|NCT00752700|Patients|patients
668989|NCT00752700|radically|radically
668990|NCT00752700|treated|treated
668991|NCT00752687|Phase 1|phase 1
668992|NCT00752674|Low back pain|low back pain
668993|NCT00752674|physical therapy|physical therapy
668994|NCT00752674|pain|pain
668995|NCT00752661|osteoarthritis|osteoarthritis
668996|NCT00752661|low back pain|low back pain
668997|NCT00752661|oral drug|oral drug
668998|NCT00752661|tramadol|tramadol
668999|NCT00752648|TMC435350-TiDP16-C106|tmc435350-tidp16-c106
669000|NCT00752648|TMC435350-C106|tmc435350-c106
669001|NCT00752648|Bioavailability|bioavailability
669002|NCT00752648|Pharmacokinetics|pharmacokinetics
669003|NCT00752635|TriCilest|tricilest
669004|NCT00752635|acne vulgaris|acne vulgaris
669005|NCT00752609|Anemia|anemia
669006|NCT00752609|Drug Therapy|drug therapy
669007|NCT00752609|Hemodialysis|hemodialysis
669008|NCT00752609|Kidney Failure|kidney failure
669009|NCT00752596|patients|patients
669010|NCT00752596|with ICD|with icd
669011|NCT00752583|Chronic renal insufficiency (patients under dialysis)|chronic renal insufficiency (patients under dialysis)
669012|NCT00752570|Metastatic Colorectal Cancer|metastatic colorectal cancer
669013|NCT00752570|colorectal cancer|colorectal cancer
669014|NCT00752570|colon cancer|colon cancer
669015|NCT00752557|Bone mineral density|bone mineral density
669016|NCT00752557|bone morphogenetic protein|bone morphogenetic protein
669017|NCT00752557|osteoporosis|osteoporosis
669018|NCT00752544|TMC435350|tmc435350
669019|NCT00752544|HCV|hcv
669020|NCT00752544|Hepatitis C|hepatitis c
669021|NCT00752544|TMC435350-TiDP16-C109|tmc435350-tidp16-c109
669022|NCT00752544|TMC435350-C109|tmc435350-c109
669023|NCT00752531|Chronic Obstructive Pulmonary Disease|chronic obstructive pulmonary disease
669024|NCT00752531|COPD|copd
669025|NCT00752518|bolus|bolus
669026|NCT00752518|intravenous|intravenous
669027|NCT00752518|proteasome inhibitor|proteasome inhibitor
669028|NCT00752518|multiple myeloma|multiple myeloma
669029|NCT00752518|refractory|refractory
669030|NCT00752518|relapse|relapse
669031|NCT00752505|Fibromyalgia|fibromyalgia
669032|NCT00752492|Isocapnic hyperpnoea|isocapnic hyperpnoea
669033|NCT00752492|obesity|obesity
669034|NCT00752492|isoflurane|isoflurane
669035|NCT00752492|Recovery of obese patient from isoflurane anesthesia|recovery of obese patient from isoflurane anesthesia
669036|NCT00752479|living|living
669037|NCT00752479|related|related
669038|NCT00752466|Healthy volunteers|healthy volunteers
669039|NCT00752466|drug interaction|drug interaction
669041|NCT00752466|Topiramate|topiramate
669042|NCT00752466|Migraine|migraine
669043|NCT00752453|ICU|icu
669044|NCT00752453|patients|patients
669045|NCT00752453|lactate|lactate
669046|NCT00752453|acidosis|acidosis
669047|NCT00752440|Diabetes Mellitus|diabetes mellitus
669048|NCT00752440|Autonomic Neuropathy|autonomic neuropathy
669049|NCT00752440|Inspiratory Muscle training|inspiratory muscle training
669050|NCT00752427|Schizophrenia: paliperidone|schizophrenia: paliperidone
669051|NCT00752414|COPD|copd
669052|NCT00752414|Patients|patients
669053|NCT00752401|Vitamin D|vitamin d
669054|NCT00752401|Cholecalciferol|cholecalciferol
669055|NCT00752401|Vitamin D3|vitamin d3
669056|NCT00752401|25-hydroxyvitamin D3|25-hydroxyvitamin d3
669057|NCT00752401|Immunomodulation|immunomodulation
669058|NCT00752401|Vitamin D deficiency|vitamin d deficiency
669059|NCT00752401|Kidney transplantation|kidney transplantation
669060|NCT00752401|Renal transplantation|renal transplantation
669061|NCT00752401|Graft function|graft function
669062|NCT00752401|Acute rejection|acute rejection
669063|NCT00752401|Renal osteodystrophy|renal osteodystrophy
669064|NCT00752401|Posttransplant bone loss|posttransplant bone loss
669065|NCT00752375|pyelonephritis|pyelonephritis
669066|NCT00752375|pediatric pyelonephritis|pediatric pyelonephritis
669067|NCT00752375|vesicoureteral reflux|vesicoureteral reflux
669068|NCT00752375|DMSA scan|dmsa scan
669069|NCT00752362|Supralimus®,|supralimus®,
669070|NCT00752362|Infinnium®,|infinnium®,
669071|NCT00752362|Matrix®,|matrix®,
669072|NCT00752362|Restenosis|restenosis
669073|NCT00752362|Percutaneous|percutaneous
669074|NCT00752362|Revascularization|revascularization
669075|NCT00752362|Techniques|techniques
669076|NCT00752362|Metallic|metallic
669077|NCT00752362|Platform|platform
669078|NCT00752362|Agents|agents
669079|NCT00752362|Antiproliferative|antiproliferative
669080|NCT00752362|Properties|properties
669081|NCT00752349|Videofluoroscopic|videofluoroscopic
669082|NCT00752349|swallowing|swallowing
669083|NCT00752349|study|study
669084|NCT00752349|(VFSS)|(vfss)
669085|NCT00752349|ultrasound|ultrasound
669086|NCT00752336|HRQoL|hrqol
669087|NCT00752336|exercise capacity|exercise capacity
669088|NCT00752323|adult giant cell glioblastoma|adult giant cell glioblastoma
669089|NCT00752323|adult glioblastoma|adult glioblastoma
850155|NCT00080093|Condom|condom
669090|NCT00752323|adult gliosarcoma|adult gliosarcoma
669091|NCT00752323|recurrent adult brain tumor|recurrent adult brain tumor
669092|NCT00752310|TMC114-TiDP29-C169|tmc114-tidp29-c169
669093|NCT00752310|TMC114-C169|tmc114-c169
669094|NCT00752310|Darunavir (suspension formulation)|darunavir (suspension formulation)
669095|NCT00752297|Botulinum Toxin Type A|botulinum toxin type a
669096|NCT00752297|Botulinum Toxin|botulinum toxin
669097|NCT00752297|Glabellar Rhytides|glabellar rhytides
669098|NCT00752297|Rhytides|rhytides
669099|NCT00752297|Frown Lines|frown lines
669100|NCT00752297|Neuromuscular Agents|neuromuscular agents
669101|NCT00752297|Neurotoxin|neurotoxin
669102|NCT00752297|Forehead|forehead
669103|NCT00752297|Eyebrow|eyebrow
669104|NCT00752297|Wrinkle|wrinkle
669105|NCT00752284|coronectomy|coronectomy
669106|NCT00752284|neurosensory deficit|neurosensory deficit
669107|NCT00752284|third molar surgery|third molar surgery
669108|NCT00752271|Arthroscopic|arthroscopic
669109|NCT00752258|Botulinum Toxin Type A|botulinum toxin type a
669110|NCT00752258|Botulinum Toxin|botulinum toxin
669111|NCT00752258|Glabellar Rhytides|glabellar rhytides
669112|NCT00752258|Rhytides|rhytides
669113|NCT00752258|Frown Lines|frown lines
669114|NCT00752258|Neuromuscular Agents|neuromuscular agents
669115|NCT00752258|Neurotoxin|neurotoxin
669116|NCT00752258|Forehead|forehead
669117|NCT00752258|Eyebrow|eyebrow
669118|NCT00752258|Wrinkle|wrinkle
669119|NCT00752258|Frown Lines Between the Eyebrows|frown lines between the eyebrows
669120|NCT00752245|ICU patients with acute renal failure with sepsis/multi-organ failure|icu patients with acute renal failure with sepsis/multi-organ failure
669121|NCT00752232|Phase IIa|phase iia
669122|NCT00752232|multiple ascending dose study of ACC-001|multiple ascending dose study of acc-001
669123|NCT00752206|AZD0530|azd0530
669124|NCT00752206|Saracatinib|saracatinib
669125|NCT00752206|Osteosarcoma|osteosarcoma
669126|NCT00752206|Recurrent|recurrent
669127|NCT00752206|Localized|localized
669128|NCT00752206|to the Lung|to the lung
669129|NCT00752180|pharmacokinetics|pharmacokinetics
669130|NCT00752180|pharmacodynamics|pharmacodynamics
669131|NCT00752180|type 1 diabetics|type 1 diabetics
669132|NCT00752180|recombinant human insulin|recombinant human insulin
669133|NCT00752167|exercise induced bronchospasm|exercise induced bronchospasm
669134|NCT00752167|asthma|asthma
669135|NCT00752167|athlete|athlete
669136|NCT00752167|sports|sports
669137|NCT00752167|eucapnic voluntary hyperventilation|eucapnic voluntary hyperventilation
669138|NCT00752167|albuterol|albuterol
669139|NCT00752154|Subjects|subjects
669140|NCT00752154|active|active
669141|NCT00752154|Rheumatoid|rheumatoid
669142|NCT00752154|Arthritis|arthritis
669143|NCT00752154|revised|revised
669144|NCT00752154|American|american
669145|NCT00752154|College|college
669146|NCT00752154|Rheumatology|rheumatology
669147|NCT00752154|Criteria|criteria
669148|NCT00752128|Drug Eluting Stent|drug eluting stent
669149|NCT00752128|Interventional Cardiology|interventional cardiology
669150|NCT00752128|Percutaneous Coronary Intervention|percutaneous coronary intervention
669151|NCT00752115|non-small cell lung cancer|non-small cell lung cancer
669152|NCT00752115|previously untreated|previously untreated
669153|NCT00752102|Secondary Hyperparathryoidism|secondary hyperparathryoidism
669154|NCT00752102|Chronic Kidney Disease|chronic kidney disease
669155|NCT00752102|Vitamin D|vitamin d
669156|NCT00752102|Coronary Calcification|coronary calcification
669157|NCT00752102|Bone metabolism|bone metabolism
669158|NCT00752089|enamel fluoride uptake|enamel fluoride uptake
669159|NCT00752089|erosion|erosion
669160|NCT00752089|enamel remineralization|enamel remineralization
669161|NCT00752076|EGFR mutation|egfr mutation
669162|NCT00752076|NSCLC cell line|nsclc cell line
669163|NCT00752076|Malignant pleural effusion|malignant pleural effusion
669164|NCT00752063|Sorafenib|sorafenib
669165|NCT00752063|Capecitabine|capecitabine
669166|NCT00752063|Oxaliplatin|oxaliplatin
669167|NCT00752063|Advanced Hepatocellular Carcinoma|advanced hepatocellular carcinoma
669168|NCT00752063|Metastatic Hepatocellular Carcinoma|metastatic hepatocellular carcinoma
669169|NCT00752050|Botulinum Toxin Type A|botulinum toxin type a
669170|NCT00752050|Botulinum Toxin|botulinum toxin
669171|NCT00752050|Glabellar Rhytides|glabellar rhytides
669172|NCT00752050|Rhytides|rhytides
669173|NCT00752050|Frown Lines|frown lines
669174|NCT00752050|Neuromuscular Agents|neuromuscular agents
669175|NCT00752050|Neurotoxin|neurotoxin
669176|NCT00752050|Forehead|forehead
669177|NCT00752050|Eyebrow|eyebrow
669178|NCT00752050|Wrinkle|wrinkle
669179|NCT00752037|HIV|hiv
669180|NCT00752037|Protease Inhibitor|protease inhibitor
669181|NCT00752037|Integrase Inhibitor|integrase inhibitor
669182|NCT00752037|Treatment Experienced|treatment experienced
669183|NCT00752037|Naive|naive
669184|NCT00752024|HICH|hich
669185|NCT00752024|Suction drainages|suction drainages
669186|NCT00752024|TTAC|ttac
669187|NCT00752011|Cancer|cancer
669188|NCT00752011|Solid Tumors|solid tumors
669189|NCT00752011|Advanced Cancer|advanced cancer
669190|NCT00752011|Carboplatin|carboplatin
669191|NCT00752011|Paraplatin|paraplatin
669192|NCT00752011|TAS-106|tas-106
669193|NCT00752011|Antitumor Activity|antitumor activity
669194|NCT00752011|Biomarkers|biomarkers
669195|NCT00751998|biliary|biliary
669196|NCT00751998|ERCP|ercp
669197|NCT00751998|cholangioscopy|cholangioscopy
669198|NCT00751998|pancreatic|pancreatic
669199|NCT00751985|Heavy drinking|heavy drinking
669200|NCT00751985|Ultra-brief intervention|ultra-brief intervention
669201|NCT00751985|Brief intervention|brief intervention
669202|NCT00751985|Alcohol prevention|alcohol prevention
669203|NCT00751985|Randomized trial|randomized trial
669204|NCT00751985|Personal normative feedback|personal normative feedback
669205|NCT00751985|Self-help material|self-help material
669206|NCT00751985|Web-based|web-based
669207|NCT00751985|Intervention Studies|intervention studies
669208|NCT00751985|prevention & control|prevention & control
669209|NCT00751959|Continuous positive airway pressure (CPAP)|continuous positive airway pressure (cpap)
669210|NCT00751959|extremely preterm infant|extremely preterm infant
669211|NCT00751959|Idiopathic respiratory distress syndrome (IRDS)|idiopathic respiratory distress syndrome (irds)
669212|NCT00751959|Surfactant|surfactant
669213|NCT00751946|Posttraumatic Stress Disorder|posttraumatic stress disorder
669214|NCT00751946|PTSD|ptsd
669215|NCT00751946|psychotherapy|psychotherapy
669216|NCT00751946|adolescents|adolescents
669217|NCT00751946|clinical trial|clinical trial
669218|NCT00751933|Ulcerative colitis|ulcerative colitis
669219|NCT00751933|Vaccines|vaccines
669220|NCT00751933|Oats|oats
669221|NCT00751920|Magnetic Resonance Imaging|magnetic resonance imaging
669222|NCT00751920|Pediatrics|pediatrics
669223|NCT00751920|Multi-Detector Computed Tomography|multi-detector computed tomography
669224|NCT00751920|Computed Tomography|computed tomography
669225|NCT00751920|Detection|detection
669226|NCT00751907|Cerebral blood flow|cerebral blood flow
669227|NCT00751894|Children|children
669228|NCT00751894|cancer|cancer
669229|NCT00751894|Bone marrow transplantation|bone marrow transplantation
669230|NCT00751894|Stem cell mobilization|stem cell mobilization
669231|NCT00751894|G-CSF|g-csf
669232|NCT00751894|Children with solid malignancies|children with solid malignancies
669233|NCT00751881|relapsing multiple sclerosis|relapsing multiple sclerosis
669234|NCT00751868|breast cancer|breast cancer
669235|NCT00751842|Diabetes|diabetes
669236|NCT00751842|Juvenile Diabetes|juvenile diabetes
669237|NCT00751842|Diabetes type 1|diabetes type 1
669238|NCT00751842|Autoimmune Diabetes|autoimmune diabetes
669239|NCT00751842|Insulin dependent Diabetes|insulin dependent diabetes
669240|NCT00751842|Type 1 diabetes|type 1 diabetes
669241|NCT00751842|Type 1 diabetes mellitus|type 1 diabetes mellitus
669242|NCT00751842|Diamyd|diamyd
669243|NCT00751842|rhGAD65|rhgad65
669244|NCT00751842|GAD|gad
669245|NCT00751842|GAD-alum|gad-alum
669246|NCT00751816|musculoskeletal complications|musculoskeletal complications
669247|NCT00751816|stage I squamous cell carcinoma of the hypopharynx|stage i squamous cell carcinoma of the hypopharynx
669248|NCT00751816|stage II squamous cell carcinoma of the hypopharynx|stage ii squamous cell carcinoma of the hypopharynx
669249|NCT00751816|stage III squamous cell carcinoma of the hypopharynx|stage iii squamous cell carcinoma of the hypopharynx
669250|NCT00751816|stage IV squamous cell carcinoma of the hypopharynx|stage iv squamous cell carcinoma of the hypopharynx
669251|NCT00751816|stage I squamous cell carcinoma of the larynx|stage i squamous cell carcinoma of the larynx
669252|NCT00751816|stage I verrucous carcinoma of the larynx|stage i verrucous carcinoma of the larynx
669253|NCT00751816|stage II squamous cell carcinoma of the larynx|stage ii squamous cell carcinoma of the larynx
669254|NCT00751816|stage II verrucous carcinoma of the larynx|stage ii verrucous carcinoma of the larynx
669255|NCT00751816|stage III squamous cell carcinoma of the larynx|stage iii squamous cell carcinoma of the larynx
669256|NCT00751816|stage III verrucous carcinoma of the larynx|stage iii verrucous carcinoma of the larynx
669257|NCT00751816|stage IV squamous cell carcinoma of the larynx|stage iv squamous cell carcinoma of the larynx
669258|NCT00751816|stage IV verrucous carcinoma of the larynx|stage iv verrucous carcinoma of the larynx
669259|NCT00751816|stage I adenoid cystic carcinoma of the oral cavity|stage i adenoid cystic carcinoma of the oral cavity
669260|NCT00751816|stage I mucoepidermoid carcinoma of the oral cavity|stage i mucoepidermoid carcinoma of the oral cavity
669261|NCT00751816|stage I verrucous carcinoma of the oral cavity|stage i verrucous carcinoma of the oral cavity
669262|NCT00751816|stage II adenoid cystic carcinoma of the oral cavity|stage ii adenoid cystic carcinoma of the oral cavity
669263|NCT00751816|stage II mucoepidermoid carcinoma of the oral cavity|stage ii mucoepidermoid carcinoma of the oral cavity
669264|NCT00751816|stage II verrucous carcinoma of the oral cavity|stage ii verrucous carcinoma of the oral cavity
669265|NCT00751816|stage III adenoid cystic carcinoma of the oral cavity|stage iii adenoid cystic carcinoma of the oral cavity
669266|NCT00751816|stage III mucoepidermoid carcinoma of the oral cavity|stage iii mucoepidermoid carcinoma of the oral cavity
669267|NCT00751816|stage III verrucous carcinoma of the oral cavity|stage iii verrucous carcinoma of the oral cavity
669268|NCT00751816|stage IV adenoid cystic carcinoma of the oral cavity|stage iv adenoid cystic carcinoma of the oral cavity
669269|NCT00751816|stage IV mucoepidermoid carcinoma of the oral cavity|stage iv mucoepidermoid carcinoma of the oral cavity
710346|NCT00589563|stage IV adult diffuse large cell lymphoma|stage iv adult diffuse large cell lymphoma
669270|NCT00751816|stage IV verrucous carcinoma of the oral cavity|stage iv verrucous carcinoma of the oral cavity
669271|NCT00751816|stage I squamous cell carcinoma of the lip and oral cavity|stage i squamous cell carcinoma of the lip and oral cavity
669272|NCT00751816|stage II squamous cell carcinoma of the lip and oral cavity|stage ii squamous cell carcinoma of the lip and oral cavity
669273|NCT00751816|stage III squamous cell carcinoma of the lip and oral cavity|stage iii squamous cell carcinoma of the lip and oral cavity
669274|NCT00751816|stage IV squamous cell carcinoma of the lip and oral cavity|stage iv squamous cell carcinoma of the lip and oral cavity
669275|NCT00751816|stage I basal cell carcinoma of the lip|stage i basal cell carcinoma of the lip
669276|NCT00751816|stage II basal cell carcinoma of the lip|stage ii basal cell carcinoma of the lip
669277|NCT00751816|stage III basal cell carcinoma of the lip|stage iii basal cell carcinoma of the lip
669278|NCT00751816|stage IV basal cell carcinoma of the lip|stage iv basal cell carcinoma of the lip
669279|NCT00751816|stage I lymphoepithelioma of the nasopharynx|stage i lymphoepithelioma of the nasopharynx
669280|NCT00751816|stage I squamous cell carcinoma of the nasopharynx|stage i squamous cell carcinoma of the nasopharynx
669281|NCT00751816|stage II lymphoepithelioma of the nasopharynx|stage ii lymphoepithelioma of the nasopharynx
669282|NCT00751816|stage II squamous cell carcinoma of the nasopharynx|stage ii squamous cell carcinoma of the nasopharynx
669283|NCT00751816|stage III lymphoepithelioma of the nasopharynx|stage iii lymphoepithelioma of the nasopharynx
669284|NCT00751816|stage III squamous cell carcinoma of the nasopharynx|stage iii squamous cell carcinoma of the nasopharynx
669285|NCT00751816|stage IV lymphoepithelioma of the nasopharynx|stage iv lymphoepithelioma of the nasopharynx
669286|NCT00751816|stage IV squamous cell carcinoma of the nasopharynx|stage iv squamous cell carcinoma of the nasopharynx
669287|NCT00751816|stage I lymphoepithelioma of the oropharynx|stage i lymphoepithelioma of the oropharynx
669288|NCT00751816|stage I squamous cell carcinoma of the oropharynx|stage i squamous cell carcinoma of the oropharynx
669289|NCT00751816|stage II lymphoepithelioma of the oropharynx|stage ii lymphoepithelioma of the oropharynx
669290|NCT00751816|stage II squamous cell carcinoma of the oropharynx|stage ii squamous cell carcinoma of the oropharynx
669291|NCT00751816|stage III lymphoepithelioma of the oropharynx|stage iii lymphoepithelioma of the oropharynx
669292|NCT00751816|stage III squamous cell carcinoma of the oropharynx|stage iii squamous cell carcinoma of the oropharynx
669293|NCT00751816|stage IV lymphoepithelioma of the oropharynx|stage iv lymphoepithelioma of the oropharynx
669294|NCT00751816|stage IV squamous cell carcinoma of the oropharynx|stage iv squamous cell carcinoma of the oropharynx
669295|NCT00751816|stage I esthesioneuroblastoma of the paranasal sinus and nasal cavity|stage i esthesioneuroblastoma of the paranasal sinus and nasal cavity
669296|NCT00751816|stage I inverted papilloma of the paranasal sinus and nasal cavity|stage i inverted papilloma of the paranasal sinus and nasal cavity
669297|NCT00751816|stage I midline lethal granuloma of the paranasal sinus and nasal cavity|stage i midline lethal granuloma of the paranasal sinus and nasal cavity
669298|NCT00751816|stage I squamous cell carcinoma of the paranasal sinus and nasal cavity|stage i squamous cell carcinoma of the paranasal sinus and nasal cavity
669299|NCT00751816|stage II esthesioneuroblastoma of the paranasal sinus and nasal cavity|stage ii esthesioneuroblastoma of the paranasal sinus and nasal cavity
669370|NCT00751504|Psychotic depression|psychotic depression
669300|NCT00751816|stage II inverted papilloma of the paranasal sinus and nasal cavity|stage ii inverted papilloma of the paranasal sinus and nasal cavity
669301|NCT00751816|stage II midline lethal granuloma of the paranasal sinus and nasal cavity|stage ii midline lethal granuloma of the paranasal sinus and nasal cavity
669302|NCT00751816|stage II squamous cell carcinoma of the paranasal sinus and nasal cavity|stage ii squamous cell carcinoma of the paranasal sinus and nasal cavity
669303|NCT00751816|stage III esthesioneuroblastoma of the paranasal sinus and nasal cavity|stage iii esthesioneuroblastoma of the paranasal sinus and nasal cavity
669304|NCT00751816|stage III inverted papilloma of the paranasal sinus and nasal cavity|stage iii inverted papilloma of the paranasal sinus and nasal cavity
669305|NCT00751816|stage III midline lethal granuloma of the paranasal sinus and nasal cavity|stage iii midline lethal granuloma of the paranasal sinus and nasal cavity
669306|NCT00751816|stage III squamous cell carcinoma of the paranasal sinus and nasal cavity|stage iii squamous cell carcinoma of the paranasal sinus and nasal cavity
669307|NCT00751816|stage IV esthesioneuroblastoma of the paranasal sinus and nasal cavity|stage iv esthesioneuroblastoma of the paranasal sinus and nasal cavity
669308|NCT00751816|stage IV inverted papilloma of the paranasal sinus and nasal cavity|stage iv inverted papilloma of the paranasal sinus and nasal cavity
669309|NCT00751816|stage IV midline lethal granuloma of the paranasal sinus and nasal cavity|stage iv midline lethal granuloma of the paranasal sinus and nasal cavity
669310|NCT00751816|stage IV squamous cell carcinoma of the paranasal sinus and nasal cavity|stage iv squamous cell carcinoma of the paranasal sinus and nasal cavity
669311|NCT00751816|high-grade salivary gland mucoepidermoid carcinoma|high-grade salivary gland mucoepidermoid carcinoma
669312|NCT00751816|low-grade salivary gland mucoepidermoid carcinoma|low-grade salivary gland mucoepidermoid carcinoma
669313|NCT00751816|salivary gland acinic cell tumor|salivary gland acinic cell tumor
669314|NCT00751816|salivary gland adenocarcinoma|salivary gland adenocarcinoma
669315|NCT00751816|salivary gland adenoid cystic carcinoma|salivary gland adenoid cystic carcinoma
669316|NCT00751816|salivary gland anaplastic carcinoma|salivary gland anaplastic carcinoma
669317|NCT00751816|salivary gland malignant mixed cell type tumor|salivary gland malignant mixed cell type tumor
669318|NCT00751816|salivary gland poorly differentiated carcinoma|salivary gland poorly differentiated carcinoma
669319|NCT00751816|salivary gland squamous cell carcinoma|salivary gland squamous cell carcinoma
669320|NCT00751816|stage I salivary gland cancer|stage i salivary gland cancer
669321|NCT00751816|stage II salivary gland cancer|stage ii salivary gland cancer
669322|NCT00751816|stage III salivary gland cancer|stage iii salivary gland cancer
669323|NCT00751816|stage IV salivary gland cancer|stage iv salivary gland cancer
669324|NCT00751790|triptorelin, 6-month formulation, advanced prostate cancer|triptorelin, 6-month formulation, advanced prostate cancer
669325|NCT00751712|Aortic Arch|aortic arch
669326|NCT00751699|Pharmacokinetics|pharmacokinetics
669327|NCT00751686|Gastroenteritis|gastroenteritis
669328|NCT00751686|Burden|burden
669329|NCT00751686|Rotavirus|rotavirus
669330|NCT00751686|< 5 years|< 5 years
669331|NCT00751686|Greece|greece
669332|NCT00751686|Children|children
669333|NCT00751660|small cell lung cancer|small cell lung cancer
669334|NCT00751660|non-small cell lung cancer|non-small cell lung cancer
669335|NCT00751660|tobacco use disorder|tobacco use disorder
669336|NCT00751647|CF|cf
669337|NCT00751634|subarachnoid hemorrhage|subarachnoid hemorrhage
669338|NCT00751634|intracerebral hemorrhage|intracerebral hemorrhage
669339|NCT00751634|fever|fever
669340|NCT00751621|Immune globulin subcutaneous|immune globulin subcutaneous
669341|NCT00751621|SCIG|scig
669342|NCT00751621|primary immunodeficiency|primary immunodeficiency
669343|NCT00751621|PID|pid
669344|NCT00751608|Familial hypercholesterolemia, endothelial function, venous occlusion plethysmography, forearm blood flow, ApoAI-mimetic, endothelial dependent vasodilation|familial hypercholesterolemia, endothelial function, venous occlusion plethysmography, forearm blood flow, apoai-mimetic, endothelial dependent vasodilation
669345|NCT00751595|HIV|hiv
669346|NCT00751595|Tat protein|tat protein
669347|NCT00751595|Therapeutic vaccine|therapeutic vaccine
669348|NCT00751595|HAART|haart
669349|NCT00751595|HIV Therapeutic Vaccine|hiv therapeutic vaccine
669350|NCT00751595|Treatment Experienced|treatment experienced
669351|NCT00751582|nutrition|nutrition
669352|NCT00751582|education|education
669353|NCT00751582|supplementation|supplementation
669354|NCT00751569|umbilical cord blood|umbilical cord blood
669355|NCT00751556|Naproxen Sodium|naproxen sodium
669356|NCT00751556|Bioavailability|bioavailability
669357|NCT00751543|To evaluate the longitudinal change of tumor perfusion in the course of radiation therapy in adenocarcinoma and squamous cell carcinoma using perfusion MDCT|to evaluate the longitudinal change of tumor perfusion in the course of radiation therapy in adenocarcinoma and squamous cell carcinoma using perfusion mdct
669358|NCT00751543|Comparison between adenocarcinoma and squamous cell carcinoma will be evaluated according to the derived perfusion parameter obtained from perfusion MDCT|comparison between adenocarcinoma and squamous cell carcinoma will be evaluated according to the derived perfusion parameter obtained from perfusion mdct
669359|NCT00751530|HIV|hiv
669360|NCT00751530|AIDS|aids
669361|NCT00751530|raltegravir|raltegravir
669362|NCT00751530|BRAVO|bravo
669363|NCT00751530|protease inhibitor|protease inhibitor
669364|NCT00751530|treatment Experienced|treatment experienced
669365|NCT00751517|Vasculitis|vasculitis
669366|NCT00751517|Cyclophosphamide|cyclophosphamide
669367|NCT00751517|Methotrexate|methotrexate
669368|NCT00751517|Systemic Necrotizing Vasculitides|systemic necrotizing vasculitides
669369|NCT00751504|Quetiapine|quetiapine
669371|NCT00751491|Stable angina|stable angina
669372|NCT00751491|Percutaneous Coronary Intervention|percutaneous coronary intervention
669373|NCT00751491|Myonecrosis|myonecrosis
669374|NCT00751478|ALO-01|alo-01
669375|NCT00751478|morphine|morphine
669376|NCT00751478|Determination of the relative pharmacodynamic effects|determination of the relative pharmacodynamic effects
669377|NCT00751478|(including drug-liking), pharmacokinetics, and safety of|(including drug-liking), pharmacokinetics, and safety of
669378|NCT00751478|ALO-01 when administered whole or crushed and compared to|alo-01 when administered whole or crushed and compared to
669379|NCT00751478|equivalent doses of immediate release morphine and placebo|equivalent doses of immediate release morphine and placebo
669380|NCT00751465|Social Anxiety Disorder|social anxiety disorder
669381|NCT00751465|Social Phobia|social phobia
669382|NCT00751465|Fear of blushing|fear of blushing
669383|NCT00751465|attention|attention
669384|NCT00751465|attention training|attention training
669385|NCT00751465|cognitive behavior therapy|cognitive behavior therapy
669386|NCT00751452|Children|children
669387|NCT00751452|Allogeneic bone marrow transplantation|allogeneic bone marrow transplantation
669388|NCT00751452|Intestinal damage|intestinal damage
669389|NCT00751452|Citrulline|citrulline
669390|NCT00751452|Graft versus Host Disease|graft versus host disease
669391|NCT00751452|0 to 18 years old|0 to 18 years old
669392|NCT00751439|Oximeter|oximeter
669393|NCT00751439|Arterial blood gas|arterial blood gas
669394|NCT00751439|comparison|comparison
669395|NCT00751426|Interferon-alpha|interferon-alpha
669396|NCT00751426|hepatitis c|hepatitis c
669397|NCT00751426|Drug addiction|drug addiction
669398|NCT00751426|methadone|methadone
669399|NCT00751426|psychiatric disorder|psychiatric disorder
669400|NCT00751426|Safety and efficacy of Interferon-alpha i patients with a psychiatric disorder.|safety and efficacy of interferon-alpha i patients with a psychiatric disorder.
669401|NCT00751400|Non-prescription|non-prescription
669402|NCT00751361|Rheopheresis|rheopheresis
669403|NCT00751361|Dry Age Related Macular Degeneration|dry age related macular degeneration
669404|NCT00751361|AMD|amd
669405|NCT00751361|apheresis|apheresis
669406|NCT00751361|microcirculation|microcirculation
669407|NCT00751348|second year of life|second year of life
669408|NCT00751348|one-dose schedule|one-dose schedule
669409|NCT00751348|varicella|varicella
669410|NCT00751348|rubella|rubella
669411|NCT00751348|measles|measles
669412|NCT00751348|mumps|mumps
669413|NCT00751335|Obstructive Sleep Apnea|obstructive sleep apnea
669414|NCT00751335|Humidification|humidification
669415|NCT00751335|Continuous Positive Airway Pressure|continuous positive airway pressure
669416|NCT00751322|Pulmonary|pulmonary
669417|NCT00751322|Protein|protein
669418|NCT00751309|allograft|allograft
669419|NCT00751309|rejection|rejection
669420|NCT00751309|biopsy|biopsy
669421|NCT00751309|gene|gene
669422|NCT00751309|expression|expression
669423|NCT00751309|pulmonary|pulmonary
669424|NCT00751309|lung|lung
669425|NCT00751309|transplant|transplant
669426|NCT00751296|Lenalidomide|lenalidomide
669427|NCT00751296|immunomodulatory drug (IMiD®)|immunomodulatory drug (imid®)
669428|NCT00751296|Thalidomide analogues|thalidomide analogues
669429|NCT00751270|Immunotherapy|immunotherapy
669430|NCT00751270|Gene therapy|gene therapy
669431|NCT00751270|Tumor Vaccine|tumor vaccine
669432|NCT00751270|Cytotoxicity|cytotoxicity
669433|NCT00751270|Radiation|radiation
669434|NCT00751257|Nicotine|nicotine
669435|NCT00751257|N-acetylcysteine|n-acetylcysteine
669436|NCT00751257|smoking reduction|smoking reduction
669437|NCT00751244|women|women
669438|NCT00751244|posttraumatic stress disorder|posttraumatic stress disorder
669439|NCT00751244|PTSD|ptsd
669440|NCT00751244|psychotherapy|psychotherapy
669441|NCT00751244|clinical trial|clinical trial
669442|NCT00751244|emotion regulation|emotion regulation
669443|NCT00751231|PCI|pci
669444|NCT00751231|percutaneous coronary intervention|percutaneous coronary intervention
669445|NCT00751205|Peripheral Neuropathy|peripheral neuropathy
669446|NCT00751205|Prostate Carcinoma|prostate carcinoma
669447|NCT00751205|Ovarian Carcinoma|ovarian carcinoma
669448|NCT00751192|Men who have sex with men|men who have sex with men
669449|NCT00751192|Peru|peru
669450|NCT00751192|HIV testing|hiv testing
669451|NCT00751192|video|video
669452|NCT00751192|online|online
669453|NCT00751192|Internet|internet
669454|NCT00751192|HIV Seronegativity|hiv seronegativity
669455|NCT00751153|drug substitution|drug substitution
669456|NCT00751153|Raltegravir|raltegravir
669457|NCT00751153|Atazanavir|atazanavir
669458|NCT00751153|treatment Experienced|treatment experienced
669459|NCT00751140|surgical candidates|surgical candidates
669460|NCT00751140|upper urinary tract|upper urinary tract
669461|NCT00751140|urothelial carcinoma|urothelial carcinoma
669462|NCT00751140|lymph node dissection|lymph node dissection
669463|NCT00751127|open angle glaucoma|open angle glaucoma
669464|NCT00751127|ocular hypertension|ocular hypertension
669465|NCT00751101|palmar-plantar erythrodysesthesia|palmar-plantar erythrodysesthesia
669466|NCT00751101|chemotherapeutic agent toxicity|chemotherapeutic agent toxicity
669467|NCT00751101|stage IV breast cancer|stage iv breast cancer
669468|NCT00751101|recurrent breast cancer|recurrent breast cancer
669469|NCT00751088|single-incision|single-incision
669470|NCT00751088|sling|sling
669471|NCT00751088|stress incontinence|stress incontinence
669472|NCT00751088|surgery|surgery
669473|NCT00751088|treatment|treatment
669474|NCT00751088|Female urinary stress incontinence|female urinary stress incontinence
669475|NCT00751062|open angle glaucoma ocular hypertension|open angle glaucoma ocular hypertension
669476|NCT00751049|open angle glaucoma ocular hypertension|open angle glaucoma ocular hypertension
669477|NCT00751036|GIST|gist
669478|NCT00751023|Methamphetamine|methamphetamine
669479|NCT00751023|Modafinil|modafinil
669480|NCT00751023|Addiction|addiction
669481|NCT00751023|Craving|craving
669482|NCT00751023|Cognitive|cognitive
669483|NCT00751010|Vulvar pain|vulvar pain
669484|NCT00751010|Vulvodynia|vulvodynia
669485|NCT00751010|Interstitial cystitis|interstitial cystitis
669486|NCT00750971|ASSIST|assist
669487|NCT00750971|SLE|sle
669488|NCT00750971|Stem Cell Transplantation|stem cell transplantation
669489|NCT00750971|Tolerance|tolerance
669490|NCT00750958|cardiac rhythm changes|cardiac rhythm changes
669491|NCT00750945|Parkinson's disease|parkinson's disease
669492|NCT00750945|Cueing training|cueing training
669493|NCT00750945|Treadmill training|treadmill training
669494|NCT00750945|Music|music
669495|NCT00750893|Gastroenteritis|gastroenteritis
669496|NCT00750867|multiple system atrophy, MSA,|multiple system atrophy, msa,
669497|NCT00750867|intravenous immunoglobulin, IVIg|intravenous immunoglobulin, ivig
669498|NCT00750854|arthritis|arthritis
669499|NCT00750854|osteoarthritis|osteoarthritis
669500|NCT00750854|fibromyalgia|fibromyalgia
669501|NCT00750854|connective tissue disorder|connective tissue disorder
669502|NCT00750841|advanced cancer|advanced cancer
669503|NCT00750841|metastatic|metastatic
669504|NCT00750841|rifampicin|rifampicin
669505|NCT00750841|pharmacokinetics|pharmacokinetics
669506|NCT00750841|Phase I|phase i
669507|NCT00750841|Advanced solid tumours|advanced solid tumours
669508|NCT00750828|Saliva|saliva
669509|NCT00750828|Sjögren's Syndrome|sjögren's syndrome
669510|NCT00750828|GCF|gcf
669511|NCT00750828|Oral Mucosal Wetness|oral mucosal wetness
669512|NCT00750815|B Cell|b cell
669513|NCT00750815|hematologic malignancy|hematologic malignancy
669514|NCT00750815|plasma|plasma
669515|NCT00750815|bone marrow|bone marrow
669516|NCT00750802|Phase I|phase i
669517|NCT00750776|Quality assurance|quality assurance
669518|NCT00750776|medical treatment|medical treatment
669519|NCT00750776|Patient satisfaction|patient satisfaction
669520|NCT00750763|Mucosal inflammation|mucosal inflammation
669521|NCT00750763|Fleet|fleet
669522|NCT00750763|Picoprep|picoprep
669523|NCT00750763|Colonlytely|colonlytely
669524|NCT00750763|Colonoscopy|colonoscopy
669525|NCT00750763|tolerability|tolerability
669526|NCT00750763|efficacy|efficacy
669527|NCT00750737|Hematologic Malignancies|hematologic malignancies
669528|NCT00750737|Blood Cancer|blood cancer
669529|NCT00750737|Lymphatic Cancer|lymphatic cancer
669530|NCT00750737|Amphotericin B Lipid Complex|amphotericin b lipid complex
669531|NCT00750737|Amphotericin B|amphotericin b
669532|NCT00750737|ABLC|ablc
669533|NCT00750737|Fungizone|fungizone
669534|NCT00750737|Noxafil|noxafil
669535|NCT00750737|SCH56592|sch56592
669536|NCT00750737|Posaconazole|posaconazole
669537|NCT00750737|Invasive fungal infections|invasive fungal infections
669538|NCT00750737|IFI|ifi
669539|NCT00750737|Hematopoietic Stem Cell Transplant|hematopoietic stem cell transplant
669540|NCT00750737|HSCT|hsct
669541|NCT00750737|Bone Marrow Transplant|bone marrow transplant
669542|NCT00750737|Allogeneic hematopoietic stem cell transplant|allogeneic hematopoietic stem cell transplant
669543|NCT00750724|Hyaluronic acid,|hyaluronic acid,
669544|NCT00750724|OA knee,|oa knee,
669545|NCT00750724|MRI|mri
669546|NCT00750698|lung cancer|lung cancer
669547|NCT00750698|non small cell lung cancer|non small cell lung cancer
669548|NCT00750685|Primary Breast Reconstruction|primary breast reconstruction
669549|NCT00750672|Endometrial neoplasia|endometrial neoplasia
669550|NCT00750672|Follow-up care|follow-up care
669551|NCT00750672|survivorship|survivorship
669552|NCT00750672|Primary care provider|primary care provider
669553|NCT00750659|Chronic myeloid leukemia|chronic myeloid leukemia
669554|NCT00750659|Ph+ acute lymphoblastic leukemia|ph+ acute lymphoblastic leukemia
669555|NCT00750659|stem cell transplantation|stem cell transplantation
669556|NCT00750659|nilotinib|nilotinib
669557|NCT00750646|compliance|compliance
669558|NCT00750646|eye drop administration|eye drop administration
669559|NCT00750646|MEMS|mems
669560|NCT00750646|adherence|adherence
669561|NCT00750633|swimmer's ear|swimmer's ear
669562|NCT00750633|ear drops|ear drops
669563|NCT00750633|ear infection|ear infection
669564|NCT00750633|ear pain|ear pain
669565|NCT00750633|ear inflammation|ear inflammation
669566|NCT00750620|mild, moderate, and severe renal impaired subjects|mild, moderate, and severe renal impaired subjects
669567|NCT00750620|normal renal function subjects|normal renal function subjects
669568|NCT00750620|Glomerular filtration rate (GFR)|glomerular filtration rate (gfr)
669569|NCT00750620|Modification of Diet in Renal Disease (MDRD) formula|modification of diet in renal disease (mdrd) formula
669570|NCT00750620|YM178|ym178
669571|NCT00750620|pharmacokinetics|pharmacokinetics
669572|NCT00750594|Children|children
669573|NCT00750594|Migraine headaches|migraine headaches
669574|NCT00750581|Patent Ductus Arteriosus|patent ductus arteriosus
669575|NCT00750568|Bronchial asthma|bronchial asthma
669576|NCT00750568|Asthma, bronchial|asthma, bronchial
669577|NCT00750568|Status Asthmaticus|status asthmaticus
669578|NCT00750568|Terbutaline sulfate|terbutaline sulfate
669579|NCT00750555|squamous cell cancer of head and neck|squamous cell cancer of head and neck
669580|NCT00750555|SCCHN|scchn
669581|NCT00750529|sleep|sleep
669582|NCT00750529|Alzheimer|alzheimer
669583|NCT00750529|old patients|old patients
669584|NCT00750516|Lactic acid|lactic acid
669585|NCT00750516|hypotension|hypotension
669586|NCT00750516|sepsis|sepsis
669587|NCT00750503|tobacco cessation|tobacco cessation
669588|NCT00750503|behavioral therapy|behavioral therapy
669589|NCT00750503|pharmacotherapy|pharmacotherapy
669590|NCT00750503|workplace|workplace
669591|NCT00750503|oral cancer screening|oral cancer screening
669592|NCT00750503|Tobacco Quit rates|tobacco quit rates
669593|NCT00750477|osteoarthritis|osteoarthritis
669594|NCT00750477|arthritis|arthritis
669595|NCT00750477|knee|knee
669596|NCT00750477|eggshell|eggshell
669597|NCT00750477|membrane|membrane
669598|NCT00750477|OPTION|option
669599|NCT00750451|fertilization in vitro|fertilization in vitro
669600|NCT00750451|assisted reproduction|assisted reproduction
669601|NCT00750451|recurrent implantation failure|recurrent implantation failure
669602|NCT00750451|low molecular weight heparin|low molecular weight heparin
669603|NCT00750451|heparin|heparin
669604|NCT00750451|luteal phase|luteal phase
669605|NCT00750438|Obesity|obesity
669606|NCT00750438|Short chain fatty acids|short chain fatty acids
669607|NCT00750438|Appetite|appetite
669608|NCT00750438|Body weight|body weight
669609|NCT00750438|Insulin sensitivity|insulin sensitivity
669610|NCT00750438|Propionate|propionate
669611|NCT00750438|Propionate ester|propionate ester
669612|NCT00750425|advanced cancer,|advanced cancer,
669613|NCT00750425|metastatic|metastatic
669614|NCT00750425|ketoconazole|ketoconazole
669615|NCT00750425|pharmacokinetics|pharmacokinetics
669616|NCT00750425|Phase I|phase i
669617|NCT00750412|TeenScreen|teenscreen
669618|NCT00750412|Mental Health|mental health
669619|NCT00750412|Adolescent Mental Health|adolescent mental health
669620|NCT00750412|Social Work|social work
669621|NCT00750399|radiation|radiation
669622|NCT00750399|retinopathy|retinopathy
669623|NCT00750399|ranibizumab|ranibizumab
669624|NCT00750399|melanoma|melanoma
669625|NCT00750399|choroid|choroid
669626|NCT00750386|Cancer|cancer
669627|NCT00750386|Ovarian cancer|ovarian cancer
669628|NCT00750386|Dose-dense chemotherapy|dose-dense chemotherapy
669629|NCT00750373|Endocarditis|endocarditis
669630|NCT00750360|Influenza|influenza
669631|NCT00750360|Korea|korea
669632|NCT00750360|FluarixTM|fluarixtm
669633|NCT00750347|pain,|pain,
669634|NCT00750347|analgesia|analgesia
669635|NCT00750347|Healthy volunteers|healthy volunteers
669636|NCT00750334|Oral Clofarabine,|oral clofarabine,
669637|NCT00750334|relapsed/refractory MDS,|relapsed/refractory mds,
669638|NCT00750334|Myelodysplastic|myelodysplastic
669639|NCT00750295|Chronic kidney disease,|chronic kidney disease,
669640|NCT00750295|hemodialysis,|hemodialysis,
669641|NCT00750295|serum phosphorus,|serum phosphorus,
669642|NCT00750295|phosphate binders|phosphate binders
669643|NCT00750282|Alzheimer Disease|alzheimer disease
669644|NCT00750282|Amyloid beta-Protein|amyloid beta-protein
669645|NCT00750269|stage I non-small cell lung cancer|stage i non-small cell lung cancer
669646|NCT00750256|tolerability|tolerability
669647|NCT00750256|Safety|safety
669648|NCT00750256|pharmacokinetics|pharmacokinetics
669649|NCT00750230|arthritis|arthritis
669650|NCT00750230|osteoarthritis|osteoarthritis
669651|NCT00750230|fibromyalgia|fibromyalgia
669652|NCT00750230|connective tissue disorder|connective tissue disorder
669653|NCT00750217|transfer methadone buprenorphine patch heroin addiction|transfer methadone buprenorphine patch heroin addiction
669654|NCT00750204|Acute Lung Injury|acute lung injury
669655|NCT00750204|ALI|ali
669656|NCT00750204|Acute Respiratory Distress Syndrome|acute respiratory distress syndrome
669657|NCT00750204|Mechanical Ventilation|mechanical ventilation
669658|NCT00750204|Sedation|sedation
669659|NCT00750204|Critical Illness|critical illness
669660|NCT00750204|Ventilator Induced Lung Injury|ventilator induced lung injury
669661|NCT00750204|VILI|vili
669662|NCT00750204|Cytokines|cytokines
669663|NCT00750204|Protective Ventilation|protective ventilation
669664|NCT00750204|Airway Pressure Release Ventilation|airway pressure release ventilation
669665|NCT00750204|APRV|aprv
669666|NCT00750204|Breathing Comfort|breathing comfort
669667|NCT00750204|Dyssynchrony|dyssynchrony
669668|NCT00750204|Asynchrony|asynchrony
669669|NCT00750191|Lower Back Pain|lower back pain
669670|NCT00750165|Obstructive Sleep Apnea|obstructive sleep apnea
669671|NCT00750165|Humidification|humidification
669672|NCT00750165|Continuous Positive Airway Pressure|continuous positive airway pressure
669673|NCT00750152|tinea cruris|tinea cruris
669674|NCT00750152|jock itch|jock itch
669675|NCT00750139|Tinea Pedis|tinea pedis
669676|NCT00750139|Athlete's foot|athlete's foot
669677|NCT00750126|Allograft|allograft
669678|NCT00750126|Children|children
669679|NCT00750126|malignancy|malignancy
669680|NCT00750126|Reduced Intensity Conditioning|reduced intensity conditioning
669681|NCT00750126|Fludarabin|fludarabin
669682|NCT00750126|Busulfex|busulfex
669683|NCT00750126|Thymoglobulin|thymoglobulin
669684|NCT00750100|infertility|infertility
669686|NCT00750100|hCG|hcg
669687|NCT00750100|primary infertility|primary infertility
669688|NCT00750100|secondary infertility|secondary infertility
669689|NCT00750100|patients requiring in-vitro fertilisation|patients requiring in-vitro fertilisation
669690|NCT00750087|Schizophrenia|schizophrenia
669691|NCT00750074|mechanical ventilation|mechanical ventilation
669692|NCT00750061|Spinal Cord Injury|spinal cord injury
669693|NCT00750048|pain,|pain,
669694|NCT00750048|sensitization,|sensitization,
669695|NCT00750048|analgesia|analgesia
669696|NCT00750035|Total hysterectomy|total hysterectomy
669697|NCT00750035|subtotal hysterectomy|subtotal hysterectomy
669698|NCT00750035|urinary function|urinary function
669699|NCT00750035|bowel function|bowel function
669700|NCT00750035|sexual function|sexual function
669701|NCT00750035|Quality of life|quality of life
669702|NCT00750035|Psychological function|psychological function
669703|NCT00750009|unspecified adult solid tumor, protocol specific|unspecified adult solid tumor, protocol specific
669704|NCT00750009|accelerated phase chronic myelogenous leukemia|accelerated phase chronic myelogenous leukemia
669705|NCT00750009|acute undifferentiated leukemia|acute undifferentiated leukemia
669706|NCT00750009|adult acute lymphoblastic leukemia in remission|adult acute lymphoblastic leukemia in remission
669707|NCT00750009|adult acute myeloid leukemia in remission|adult acute myeloid leukemia in remission
669708|NCT00750009|adult acute myeloid leukemia with 11q23 (MLL) abnormalities|adult acute myeloid leukemia with 11q23 (mll) abnormalities
669709|NCT00750009|adult acute myeloid leukemia with inv(16)(p13;q22)|adult acute myeloid leukemia with inv(16)(p13;q22)
669710|NCT00750009|adult acute myeloid leukemia with t(15;17)(q22;q12)|adult acute myeloid leukemia with t(15;17)(q22;q12)
669711|NCT00750009|adult acute myeloid leukemia with t(16;16)(p13;q22)|adult acute myeloid leukemia with t(16;16)(p13;q22)
669712|NCT00750009|adult acute myeloid leukemia with t(8;21)(q22;q22)|adult acute myeloid leukemia with t(8;21)(q22;q22)
669713|NCT00750009|atypical chronic myeloid leukemia, BCR-ABL1 negative|atypical chronic myeloid leukemia, bcr-abl1 negative
669714|NCT00750009|blastic phase chronic myelogenous leukemia|blastic phase chronic myelogenous leukemia
669715|NCT00750009|childhood acute lymphoblastic leukemia in remission|childhood acute lymphoblastic leukemia in remission
669716|NCT00750009|childhood acute myeloid leukemia in remission|childhood acute myeloid leukemia in remission
669717|NCT00750009|childhood chronic myelogenous leukemia|childhood chronic myelogenous leukemia
669718|NCT00750009|chronic myelomonocytic leukemia|chronic myelomonocytic leukemia
669719|NCT00750009|chronic phase chronic myelogenous leukemia|chronic phase chronic myelogenous leukemia
669720|NCT00750009|juvenile myelomonocytic leukemia|juvenile myelomonocytic leukemia
669721|NCT00750009|mast cell leukemia|mast cell leukemia
669722|NCT00750009|meningeal chronic myelogenous leukemia|meningeal chronic myelogenous leukemia
669723|NCT00750009|progressive hairy cell leukemia, initial treatment|progressive hairy cell leukemia, initial treatment
669724|NCT00750009|prolymphocytic leukemia|prolymphocytic leukemia
669725|NCT00750009|recurrent adult acute lymphoblastic leukemia|recurrent adult acute lymphoblastic leukemia
669726|NCT00750009|recurrent adult acute myeloid leukemia|recurrent adult acute myeloid leukemia
669727|NCT00750009|recurrent adult T-cell leukemia/lymphoma|recurrent adult t-cell leukemia/lymphoma
669728|NCT00750009|recurrent childhood acute lymphoblastic leukemia|recurrent childhood acute lymphoblastic leukemia
669729|NCT00750009|recurrent childhood acute myeloid leukemia|recurrent childhood acute myeloid leukemia
669730|NCT00750009|refractory chronic lymphocytic leukemia|refractory chronic lymphocytic leukemia
669731|NCT00750009|refractory hairy cell leukemia|refractory hairy cell leukemia
669732|NCT00750009|relapsing chronic myelogenous leukemia|relapsing chronic myelogenous leukemia
669733|NCT00750009|secondary acute myeloid leukemia|secondary acute myeloid leukemia
669734|NCT00750009|stage 0 chronic lymphocytic leukemia|stage 0 chronic lymphocytic leukemia
669735|NCT00750009|stage I adult T-cell leukemia/lymphoma|stage i adult t-cell leukemia/lymphoma
669736|NCT00750009|stage I chronic lymphocytic leukemia|stage i chronic lymphocytic leukemia
669737|NCT00750009|stage II adult T-cell leukemia/lymphoma|stage ii adult t-cell leukemia/lymphoma
669738|NCT00750009|stage II chronic lymphocytic leukemia|stage ii chronic lymphocytic leukemia
669739|NCT00750009|stage III adult T-cell leukemia/lymphoma|stage iii adult t-cell leukemia/lymphoma
669740|NCT00750009|stage III chronic lymphocytic leukemia|stage iii chronic lymphocytic leukemia
669741|NCT00750009|stage IV adult T-cell leukemia/lymphoma|stage iv adult t-cell leukemia/lymphoma
669742|NCT00750009|stage IV chronic lymphocytic leukemia|stage iv chronic lymphocytic leukemia
669743|NCT00750009|T-cell large granular lymphocyte leukemia|t-cell large granular lymphocyte leukemia
669744|NCT00750009|untreated adult acute lymphoblastic leukemia|untreated adult acute lymphoblastic leukemia
669745|NCT00750009|untreated adult acute myeloid leukemia|untreated adult acute myeloid leukemia
669746|NCT00750009|untreated childhood acute lymphoblastic leukemia|untreated childhood acute lymphoblastic leukemia
669747|NCT00750009|untreated childhood acute myeloid leukemia and other myeloid malignancies|untreated childhood acute myeloid leukemia and other myeloid malignancies
669748|NCT00750009|untreated hairy cell leukemia|untreated hairy cell leukemia
669749|NCT00750009|AIDS-related diffuse large cell lymphoma|aids-related diffuse large cell lymphoma
669750|NCT00750009|AIDS-related diffuse mixed cell lymphoma|aids-related diffuse mixed cell lymphoma
669751|NCT00750009|AIDS-related diffuse small cleaved cell lymphoma|aids-related diffuse small cleaved cell lymphoma
669752|NCT00750009|AIDS-related immunoblastic large cell lymphoma|aids-related immunoblastic large cell lymphoma
669753|NCT00750009|AIDS-related lymphoblastic lymphoma|aids-related lymphoblastic lymphoma
669754|NCT00750009|AIDS-related peripheral/systemic lymphoma|aids-related peripheral/systemic lymphoma
669755|NCT00750009|AIDS-related primary CNS lymphoma|aids-related primary cns lymphoma
669756|NCT00750009|AIDS-related small noncleaved cell lymphoma|aids-related small noncleaved cell lymphoma
669757|NCT00750009|HIV-associated Hodgkin lymphoma|hiv-associated hodgkin lymphoma
669758|NCT00750009|recurrent adult Hodgkin lymphoma|recurrent adult hodgkin lymphoma
669759|NCT00750009|recurrent/refractory childhood Hodgkin lymphoma|recurrent/refractory childhood hodgkin lymphoma
669760|NCT00750009|stage I adult Hodgkin lymphoma|stage i adult hodgkin lymphoma
669761|NCT00750009|stage I childhood Hodgkin lymphoma|stage i childhood hodgkin lymphoma
669762|NCT00750009|stage II adult Hodgkin lymphoma|stage ii adult hodgkin lymphoma
669763|NCT00750009|stage II childhood Hodgkin lymphoma|stage ii childhood hodgkin lymphoma
669764|NCT00750009|stage III adult Hodgkin lymphoma|stage iii adult hodgkin lymphoma
669765|NCT00750009|stage III childhood Hodgkin lymphoma|stage iii childhood hodgkin lymphoma
669766|NCT00750009|stage IV adult Hodgkin lymphoma|stage iv adult hodgkin lymphoma
669767|NCT00750009|stage IV childhood Hodgkin lymphoma|stage iv childhood hodgkin lymphoma
669768|NCT00750009|anaplastic large cell lymphoma|anaplastic large cell lymphoma
669769|NCT00750009|angioimmunoblastic T-cell lymphoma|angioimmunoblastic t-cell lymphoma
669770|NCT00750009|cutaneous B-cell non-Hodgkin lymphoma|cutaneous b-cell non-hodgkin lymphoma
669771|NCT00750009|recurrent cutaneous T-cell non-Hodgkin lymphoma|recurrent cutaneous t-cell non-hodgkin lymphoma
669772|NCT00750009|stage I cutaneous T-cell non-Hodgkin lymphoma|stage i cutaneous t-cell non-hodgkin lymphoma
669773|NCT00750009|stage II cutaneous T-cell non-Hodgkin lymphoma|stage ii cutaneous t-cell non-hodgkin lymphoma
669774|NCT00750009|stage III cutaneous T-cell non-Hodgkin lymphoma|stage iii cutaneous t-cell non-hodgkin lymphoma
669775|NCT00750009|stage IV cutaneous T-cell non-Hodgkin lymphoma|stage iv cutaneous t-cell non-hodgkin lymphoma
669776|NCT00750009|recurrent mycosis fungoides/Sezary syndrome|recurrent mycosis fungoides/sezary syndrome
669777|NCT00750009|stage I mycosis fungoides/Sezary syndrome|stage i mycosis fungoides/sezary syndrome
669778|NCT00750009|stage II mycosis fungoides/Sezary syndrome|stage ii mycosis fungoides/sezary syndrome
669779|NCT00750009|stage III mycosis fungoides/Sezary syndrome|stage iii mycosis fungoides/sezary syndrome
669780|NCT00750009|stage IV mycosis fungoides/Sezary syndrome|stage iv mycosis fungoides/sezary syndrome
669781|NCT00750009|adult grade III lymphomatoid granulomatosis|adult grade iii lymphomatoid granulomatosis
669782|NCT00750009|adult nasal type extranodal NK/T-cell lymphoma|adult nasal type extranodal nk/t-cell lymphoma
669783|NCT00750009|Waldenstrom macroglobulinemia|waldenstrom macroglobulinemia
669784|NCT00750009|extranodal marginal zone B-cell lymphoma of mucosa-associated lymphoid tissue|extranodal marginal zone b-cell lymphoma of mucosa-associated lymphoid tissue
669785|NCT00750009|nodal marginal zone B-cell lymphoma|nodal marginal zone b-cell lymphoma
669786|NCT00750009|splenic marginal zone lymphoma|splenic marginal zone lymphoma
669787|NCT00750009|contiguous stage II adult Burkitt lymphoma|contiguous stage ii adult burkitt lymphoma
669788|NCT00750009|contiguous stage II adult diffuse large cell lymphoma|contiguous stage ii adult diffuse large cell lymphoma
669789|NCT00750009|contiguous stage II adult diffuse mixed cell lymphoma|contiguous stage ii adult diffuse mixed cell lymphoma
669790|NCT00750009|contiguous stage II adult diffuse small cleaved cell lymphoma|contiguous stage ii adult diffuse small cleaved cell lymphoma
669791|NCT00750009|contiguous stage II adult immunoblastic large cell lymphoma|contiguous stage ii adult immunoblastic large cell lymphoma
669792|NCT00750009|contiguous stage II adult lymphoblastic lymphoma|contiguous stage ii adult lymphoblastic lymphoma
669793|NCT00750009|contiguous stage II grade 1 follicular lymphoma|contiguous stage ii grade 1 follicular lymphoma
669794|NCT00750009|contiguous stage II grade 2 follicular lymphoma|contiguous stage ii grade 2 follicular lymphoma
669795|NCT00750009|contiguous stage II grade 3 follicular lymphoma|contiguous stage ii grade 3 follicular lymphoma
669796|NCT00750009|contiguous stage II mantle cell lymphoma|contiguous stage ii mantle cell lymphoma
669797|NCT00750009|contiguous stage II marginal zone lymphoma|contiguous stage ii marginal zone lymphoma
669798|NCT00750009|contiguous stage II small lymphocytic lymphoma|contiguous stage ii small lymphocytic lymphoma
669799|NCT00750009|stage I adult Burkitt lymphoma|stage i adult burkitt lymphoma
669800|NCT00750009|stage I adult diffuse large cell lymphoma|stage i adult diffuse large cell lymphoma
669801|NCT00750009|stage I adult diffuse mixed cell lymphoma|stage i adult diffuse mixed cell lymphoma
669802|NCT00750009|stage I adult diffuse small cleaved cell lymphoma|stage i adult diffuse small cleaved cell lymphoma
669803|NCT00750009|stage I adult immunoblastic large cell lymphoma|stage i adult immunoblastic large cell lymphoma
669804|NCT00750009|stage I adult lymphoblastic lymphoma|stage i adult lymphoblastic lymphoma
669805|NCT00750009|stage I grade 1 follicular lymphoma|stage i grade 1 follicular lymphoma
669806|NCT00750009|stage I grade 2 follicular lymphoma|stage i grade 2 follicular lymphoma
670046|NCT00749502|Prostatic diseases|prostatic diseases
669807|NCT00750009|stage I grade 3 follicular lymphoma|stage i grade 3 follicular lymphoma
669808|NCT00750009|stage I mantle cell lymphoma|stage i mantle cell lymphoma
669809|NCT00750009|stage I marginal zone lymphoma|stage i marginal zone lymphoma
669810|NCT00750009|stage I small lymphocytic lymphoma|stage i small lymphocytic lymphoma
669811|NCT00750009|noncontiguous stage II adult Burkitt lymphoma|noncontiguous stage ii adult burkitt lymphoma
669812|NCT00750009|noncontiguous stage II adult diffuse large cell lymphoma|noncontiguous stage ii adult diffuse large cell lymphoma
669813|NCT00750009|noncontiguous stage II adult diffuse mixed cell lymphoma|noncontiguous stage ii adult diffuse mixed cell lymphoma
669814|NCT00750009|noncontiguous stage II adult diffuse small cleaved cell lymphoma|noncontiguous stage ii adult diffuse small cleaved cell lymphoma
669815|NCT00750009|noncontiguous stage II adult immunoblastic large cell lymphoma|noncontiguous stage ii adult immunoblastic large cell lymphoma
669816|NCT00750009|noncontiguous stage II adult lymphoblastic lymphoma|noncontiguous stage ii adult lymphoblastic lymphoma
669817|NCT00750009|noncontiguous stage II grade 1 follicular lymphoma|noncontiguous stage ii grade 1 follicular lymphoma
669818|NCT00750009|noncontiguous stage II grade 2 follicular lymphoma|noncontiguous stage ii grade 2 follicular lymphoma
669819|NCT00750009|noncontiguous stage II grade 3 follicular lymphoma|noncontiguous stage ii grade 3 follicular lymphoma
669820|NCT00750009|noncontiguous stage II mantle cell lymphoma|noncontiguous stage ii mantle cell lymphoma
669821|NCT00750009|noncontiguous stage II marginal zone lymphoma|noncontiguous stage ii marginal zone lymphoma
669822|NCT00750009|noncontiguous stage II small lymphocytic lymphoma|noncontiguous stage ii small lymphocytic lymphoma
669823|NCT00750009|stage I childhood large cell lymphoma|stage i childhood large cell lymphoma
669824|NCT00750009|stage I childhood lymphoblastic lymphoma|stage i childhood lymphoblastic lymphoma
669825|NCT00750009|stage I childhood small noncleaved cell lymphoma|stage i childhood small noncleaved cell lymphoma
669826|NCT00750009|stage II childhood large cell lymphoma|stage ii childhood large cell lymphoma
669827|NCT00750009|stage II childhood lymphoblastic lymphoma|stage ii childhood lymphoblastic lymphoma
851056|NCT00079612|RCC|rcc
669828|NCT00750009|stage II childhood small noncleaved cell lymphoma|stage ii childhood small noncleaved cell lymphoma
669829|NCT00750009|stage III adult Burkitt lymphoma|stage iii adult burkitt lymphoma
669830|NCT00750009|stage III adult diffuse large cell lymphoma|stage iii adult diffuse large cell lymphoma
669831|NCT00750009|stage III adult diffuse mixed cell lymphoma|stage iii adult diffuse mixed cell lymphoma
669832|NCT00750009|stage III adult diffuse small cleaved cell lymphoma|stage iii adult diffuse small cleaved cell lymphoma
669833|NCT00750009|stage III adult immunoblastic large cell lymphoma|stage iii adult immunoblastic large cell lymphoma
669834|NCT00750009|stage III adult lymphoblastic lymphoma|stage iii adult lymphoblastic lymphoma
669835|NCT00750009|stage III childhood large cell lymphoma|stage iii childhood large cell lymphoma
669836|NCT00750009|stage III childhood lymphoblastic lymphoma|stage iii childhood lymphoblastic lymphoma
669837|NCT00750009|stage III childhood small noncleaved cell lymphoma|stage iii childhood small noncleaved cell lymphoma
669838|NCT00750009|stage III grade 1 follicular lymphoma|stage iii grade 1 follicular lymphoma
669839|NCT00750009|stage III grade 2 follicular lymphoma|stage iii grade 2 follicular lymphoma
669840|NCT00750009|stage III grade 3 follicular lymphoma|stage iii grade 3 follicular lymphoma
669841|NCT00750009|stage III mantle cell lymphoma|stage iii mantle cell lymphoma
669842|NCT00750009|stage III marginal zone lymphoma|stage iii marginal zone lymphoma
669843|NCT00750009|stage III small lymphocytic lymphoma|stage iii small lymphocytic lymphoma
669844|NCT00750009|stage IV adult Burkitt lymphoma|stage iv adult burkitt lymphoma
669845|NCT00750009|stage IV adult diffuse large cell lymphoma|stage iv adult diffuse large cell lymphoma
669846|NCT00750009|stage IV adult diffuse mixed cell lymphoma|stage iv adult diffuse mixed cell lymphoma
669847|NCT00750009|stage IV adult diffuse small cleaved cell lymphoma|stage iv adult diffuse small cleaved cell lymphoma
669848|NCT00750009|stage IV adult immunoblastic large cell lymphoma|stage iv adult immunoblastic large cell lymphoma
669849|NCT00750009|stage IV adult lymphoblastic lymphoma|stage iv adult lymphoblastic lymphoma
669850|NCT00750009|stage IV childhood large cell lymphoma|stage iv childhood large cell lymphoma
669851|NCT00750009|stage IV childhood lymphoblastic lymphoma|stage iv childhood lymphoblastic lymphoma
669852|NCT00750009|stage IV childhood small noncleaved cell lymphoma|stage iv childhood small noncleaved cell lymphoma
669853|NCT00750009|stage IV grade 1 follicular lymphoma|stage iv grade 1 follicular lymphoma
669854|NCT00750009|stage IV grade 2 follicular lymphoma|stage iv grade 2 follicular lymphoma
669855|NCT00750009|stage IV grade 3 follicular lymphoma|stage iv grade 3 follicular lymphoma
669856|NCT00750009|stage IV mantle cell lymphoma|stage iv mantle cell lymphoma
669857|NCT00750009|stage IV marginal zone lymphoma|stage iv marginal zone lymphoma
669858|NCT00750009|stage IV small lymphocytic lymphoma|stage iv small lymphocytic lymphoma
669859|NCT00750009|recurrent adult Burkitt lymphoma|recurrent adult burkitt lymphoma
669860|NCT00750009|recurrent adult diffuse large cell lymphoma|recurrent adult diffuse large cell lymphoma
669861|NCT00750009|recurrent adult diffuse mixed cell lymphoma|recurrent adult diffuse mixed cell lymphoma
669862|NCT00750009|recurrent adult diffuse small cleaved cell lymphoma|recurrent adult diffuse small cleaved cell lymphoma
669863|NCT00750009|recurrent adult grade III lymphomatoid granulomatosis|recurrent adult grade iii lymphomatoid granulomatosis
669864|NCT00750009|recurrent adult immunoblastic large cell lymphoma|recurrent adult immunoblastic large cell lymphoma
669865|NCT00750009|recurrent adult lymphoblastic lymphoma|recurrent adult lymphoblastic lymphoma
669866|NCT00750009|recurrent childhood grade III lymphomatoid granulomatosis|recurrent childhood grade iii lymphomatoid granulomatosis
669867|NCT00750009|recurrent childhood large cell lymphoma|recurrent childhood large cell lymphoma
669868|NCT00750009|recurrent childhood lymphoblastic lymphoma|recurrent childhood lymphoblastic lymphoma
669869|NCT00750009|recurrent childhood small noncleaved cell lymphoma|recurrent childhood small noncleaved cell lymphoma
669870|NCT00750009|recurrent grade 1 follicular lymphoma|recurrent grade 1 follicular lymphoma
669871|NCT00750009|recurrent grade 2 follicular lymphoma|recurrent grade 2 follicular lymphoma
669872|NCT00750009|recurrent grade 3 follicular lymphoma|recurrent grade 3 follicular lymphoma
669873|NCT00750009|recurrent mantle cell lymphoma|recurrent mantle cell lymphoma
669874|NCT00750009|recurrent marginal zone lymphoma|recurrent marginal zone lymphoma
669875|NCT00750009|recurrent small lymphocytic lymphoma|recurrent small lymphocytic lymphoma
669876|NCT00750009|Burkitt lymphoma|burkitt lymphoma
669877|NCT00750009|childhood diffuse large cell lymphoma|childhood diffuse large cell lymphoma
669878|NCT00750009|childhood grade III lymphomatoid granulomatosis|childhood grade iii lymphomatoid granulomatosis
669879|NCT00750009|childhood immunoblastic large cell lymphoma|childhood immunoblastic large cell lymphoma
669880|NCT00750009|childhood nasal type extranodal NK/T-cell lymphoma|childhood nasal type extranodal nk/t-cell lymphoma
669881|NCT00750009|intraocular lymphoma|intraocular lymphoma
669882|NCT00750009|primary central nervous system non-Hodgkin lymphoma|primary central nervous system non-hodgkin lymphoma
669883|NCT00750009|primary central nervous system Hodgkin lymphoma|primary central nervous system hodgkin lymphoma
669884|NCT00750009|post-transplant lymphoproliferative disorder|post-transplant lymphoproliferative disorder
669885|NCT00750009|chronic eosinophilic leukemia|chronic eosinophilic leukemia
669886|NCT00750009|chronic neutrophilic leukemia|chronic neutrophilic leukemia
669887|NCT00750009|primary myelofibrosis|primary myelofibrosis
669888|NCT00750009|essential thrombocythemia|essential thrombocythemia
669889|NCT00750009|polycythemia vera|polycythemia vera
669890|NCT00750009|extramedullary plasmacytoma|extramedullary plasmacytoma
669891|NCT00750009|isolated plasmacytoma of bone|isolated plasmacytoma of bone
669892|NCT00750009|stage I multiple myeloma|stage i multiple myeloma
669893|NCT00750009|stage II multiple myeloma|stage ii multiple myeloma
669894|NCT00750009|stage III multiple myeloma|stage iii multiple myeloma
669895|NCT00750009|primary systemic amyloidosis|primary systemic amyloidosis
669896|NCT00750009|refractory multiple myeloma|refractory multiple myeloma
669897|NCT00750009|de novo myelodysplastic syndromes|de novo myelodysplastic syndromes
669898|NCT00750009|previously treated myelodysplastic syndromes|previously treated myelodysplastic syndromes
669899|NCT00750009|secondary myelodysplastic syndromes|secondary myelodysplastic syndromes
669900|NCT00750009|myelodysplastic/myeloproliferative neoplasm, unclassifiable|myelodysplastic/myeloproliferative neoplasm, unclassifiable
669901|NCT00750009|childhood myelodysplastic syndromes|childhood myelodysplastic syndromes
669902|NCT00750009|recurrent childhood anaplastic large cell lymphoma|recurrent childhood anaplastic large cell lymphoma
669903|NCT00750009|stage I childhood anaplastic large cell lymphoma|stage i childhood anaplastic large cell lymphoma
669904|NCT00750009|stage II childhood anaplastic large cell lymphoma|stage ii childhood anaplastic large cell lymphoma
669905|NCT00750009|stage III childhood anaplastic large cell lymphoma|stage iii childhood anaplastic large cell lymphoma
669906|NCT00750009|stage IV childhood anaplastic large cell lymphoma|stage iv childhood anaplastic large cell lymphoma
669907|NCT00749970|schizophrenia|schizophrenia
669908|NCT00749970|subjective well-being|subjective well-being
669909|NCT00749970|psychometric validation|psychometric validation
669910|NCT00749957|AAV|aav
669911|NCT00749957|adeno-associated virus|adeno-associated virus
669912|NCT00749957|RPE65|rpe65
669913|NCT00749957|Leber congenital amaurosis|leber congenital amaurosis
669914|NCT00749957|LCA|lca
669915|NCT00749957|gene therapy|gene therapy
669916|NCT00749957|human gene transfer|human gene transfer
669917|NCT00749944|nicotine withdrawal, smoking cessation, varenicline|nicotine withdrawal, smoking cessation, varenicline
669918|NCT00749931|IDC, DCIS, ILC|idc, dcis, ilc
669919|NCT00749918|vitamin D|vitamin d
669920|NCT00749918|Cholecalciferol|cholecalciferol
669921|NCT00749918|Insulin sensitivity|insulin sensitivity
669922|NCT00749918|MinMod Millennium|minmod millennium
669923|NCT00749918|FSIGT|fsigt
669924|NCT00749918|modified frequently sampled IV glucose tolerance test|modified frequently sampled iv glucose tolerance test
669925|NCT00749879|PK|pk
669926|NCT00749879|Pharmacokinetics|pharmacokinetics
669927|NCT00749866|Nebulised antibiotics|nebulised antibiotics
669928|NCT00749866|Non cystic fibrosis bronchiectasis|non cystic fibrosis bronchiectasis
669929|NCT00749866|Bacterial Load|bacterial load
669930|NCT00749866|Inflammation|inflammation
669931|NCT00749866|Quality of Life|quality of life
669932|NCT00749866|Side Effects|side effects
669933|NCT00749853|ovarian stimulation|ovarian stimulation
669934|NCT00749853|FSH|fsh
669935|NCT00749853|genotyping|genotyping
669936|NCT00749853|polymorphism|polymorphism
669937|NCT00749840|Acquired Immune Deficiency Syndrome|acquired immune deficiency syndrome
669938|NCT00749840|Human Immunodeficiency Virus|human immunodeficiency virus
669939|NCT00749840|Questionnaire|questionnaire
669940|NCT00749840|AIDS|aids
669941|NCT00749840|HIV|hiv
669942|NCT00749840|Highly Active Antiretroviral Therapy|highly active antiretroviral therapy
669943|NCT00749840|HAART|haart
669944|NCT00749840|Steps of HIV Care|steps of hiv care
669945|NCT00749840|CDC|cdc
669946|NCT00749827|Contrast Induced Nephropathy, fluid prophylaxis|contrast induced nephropathy, fluid prophylaxis
670047|NCT00749489|Pain|pain
669947|NCT00749814|sleep patterns in children in the night prior to surgery and post surgery.|sleep patterns in children in the night prior to surgery and post surgery.
669948|NCT00749814|the influence of melatonin on sleep patterns|the influence of melatonin on sleep patterns
669949|NCT00749801|drug naive|drug naive
669950|NCT00749801|Dyslipidemic|dyslipidemic
669951|NCT00749801|nattokinase|nattokinase
669952|NCT00749801|fibrinolytic|fibrinolytic
669953|NCT00749775|Eplerenone|eplerenone
669954|NCT00749775|Selara|selara
669955|NCT00749775|Hypertension|hypertension
669956|NCT00749775|Good post-marketing study Practice|good post-marketing study practice
669957|NCT00749775|Drug use Investigation|drug use investigation
669958|NCT00749775|Regulatory Post Marketing Commitment Plan|regulatory post marketing commitment plan
669959|NCT00749775|ESSENCE|essence
669960|NCT00749762|DURING|during
669961|NCT00749762|PRONE|prone
669962|NCT00749762|SUPINE|supine
669963|NCT00749762|POSITIONING|positioning
669964|NCT00749749|Abdominal Hysterectomy|abdominal hysterectomy
669965|NCT00749749|Postoperative pain|postoperative pain
669966|NCT00749736|vitamin D|vitamin d
669967|NCT00749736|determine|determine
669968|NCT00749736|normal|normal
669969|NCT00749736|intrapatient|intrapatient
669970|NCT00749736|interpatient|interpatient
669971|NCT00749736|variability|variability
669972|NCT00749736|measures|measures
669973|NCT00749736|immune system|immune system
669974|NCT00749723|brain tumor|brain tumor
669975|NCT00749723|relapse|relapse
669976|NCT00749723|children|children
669977|NCT00749723|etoposide|etoposide
669978|NCT00749723|intraventricular|intraventricular
669979|NCT00749723|temozolomide|temozolomide
669980|NCT00749710|femoral neck fractures|femoral neck fractures
669981|NCT00749710|pertrochanteric fractures|pertrochanteric fractures
669982|NCT00749710|antiaggregant therapy|antiaggregant therapy
669983|NCT00749710|clopidogrel|clopidogrel
669984|NCT00749710|plavix|plavix
669985|NCT00749697|radioiodine|radioiodine
669986|NCT00749697|differentiated thyroid cancers|differentiated thyroid cancers
669987|NCT00749697|dosimetry|dosimetry
669988|NCT00749697|metastases|metastases
669989|NCT00749684|interferon-alpha|interferon-alpha
669990|NCT00749658|Tobacco|tobacco
669991|NCT00749658|Nicotine|nicotine
669992|NCT00749658|Smoking|smoking
669993|NCT00749658|Varenicline|varenicline
669994|NCT00749658|Bupropion|bupropion
669995|NCT00749658|Human laboratory study|human laboratory study
669996|NCT00749658|Stress tolerance|stress tolerance
669997|NCT00749658|Startle response|startle response
669998|NCT00749658|Cognitive assessment|cognitive assessment
669999|NCT00749658|Progressive ratio|progressive ratio
670000|NCT00749658|Motivation|motivation
670001|NCT00749645|Arthritis, Rheumatoid, Andrographolides treatment, Efficacy.|arthritis, rheumatoid, andrographolides treatment, efficacy.
670002|NCT00749632|urinary incontinence, urge|urinary incontinence, urge
670003|NCT00749632|urinary urge incontinence|urinary urge incontinence
670004|NCT00749632|urge incontinence|urge incontinence
670005|NCT00749632|over active bladder|over active bladder
670006|NCT00749619|Tunneled Cuffed Catheter|tunneled cuffed catheter
670007|NCT00749619|Catheter Lock Solution|catheter lock solution
670008|NCT00749619|Catheter Related Bacteremia|catheter related bacteremia
670009|NCT00749606|Obesity|obesity
670010|NCT00749606|Metabolic syndrome|metabolic syndrome
670011|NCT00749606|Weight loss|weight loss
670012|NCT00749606|Diabetes prevention|diabetes prevention
670013|NCT00749593|Congenital Adrenal Hyperplasia|congenital adrenal hyperplasia
670014|NCT00749593|Quality of Life|quality of life
670015|NCT00749593|Genotype|genotype
670016|NCT00749593|Metabolic outcomes|metabolic outcomes
670017|NCT00749580|Safety|safety
670018|NCT00749567|NSCLC|nsclc
670019|NCT00749567|TKI's|tki's
670020|NCT00749567|Anti-VEGF|anti-vegf
670021|NCT00749554|Cooled Radiofrequency|cooled radiofrequency
670022|NCT00749554|Disc biacuplasty|disc biacuplasty
670023|NCT00749554|TransDiscal system|transdiscal system
670024|NCT00749554|Discogenic pain|discogenic pain
670025|NCT00749541|vitamin d coronary catheterization|vitamin d coronary catheterization
670026|NCT00749528|Wheezing|wheezing
670027|NCT00749528|Hair trace elements|hair trace elements
670028|NCT00749528|Hair toxic metals|hair toxic metals
670029|NCT00749528|Oxidative stress|oxidative stress
670030|NCT00749515|Thalassemia|thalassemia
670031|NCT00749515|Iron|iron
670032|NCT00749515|Chelation|chelation
670033|NCT00749502|Neoplasms|neoplasms
670034|NCT00749502|Ovarian neoplasms|ovarian neoplasms
670035|NCT00749502|Prostatic neoplasms|prostatic neoplasms
670036|NCT00749502|Endocrine gland neoplasms|endocrine gland neoplasms
670037|NCT00749502|Ovarian diseases|ovarian diseases
670038|NCT00749502|Adnexal diseases|adnexal diseases
670039|NCT00749502|Genital diseases, female|genital diseases, female
670040|NCT00749502|Genital diseases, male|genital diseases, male
670041|NCT00749502|Genital neoplasms, female|genital neoplasms, female
670042|NCT00749502|Urogenital neoplasms|urogenital neoplasms
670043|NCT00749502|Endocrine system diseases|endocrine system diseases
670044|NCT00749502|Gonadal disorders|gonadal disorders
670045|NCT00749502|Genital neoplasms, male|genital neoplasms, male
670048|NCT00749489|Hip Fractures|hip fractures
670049|NCT00749489|Femoral Fractures|femoral fractures
670050|NCT00749489|Analgesics|analgesics
670051|NCT00749489|Opioid|opioid
670052|NCT00749489|Nerve Block|nerve block
670053|NCT00749489|Geriatric|geriatric
670054|NCT00749489|Nerve Stimulation|nerve stimulation
670055|NCT00749463|nicotine dependence, smoking cessation, NRT|nicotine dependence, smoking cessation, nrt
670056|NCT00749450|stage II colon cancer|stage ii colon cancer
670057|NCT00749450|stage III colon cancer|stage iii colon cancer
670058|NCT00749450|stage II rectal cancer|stage ii rectal cancer
670059|NCT00749450|stage III rectal cancer|stage iii rectal cancer
670060|NCT00749437|stage I breast cancer|stage i breast cancer
670061|NCT00749437|stage II breast cancer|stage ii breast cancer
670062|NCT00749437|ductal breast carcinoma in situ|ductal breast carcinoma in situ
670063|NCT00749437|invasive ductal breast carcinoma|invasive ductal breast carcinoma
670064|NCT00749437|medullary ductal breast carcinoma with lymphocytic infiltrate|medullary ductal breast carcinoma with lymphocytic infiltrate
670065|NCT00749437|papillary ductal breast carcinoma|papillary ductal breast carcinoma
670066|NCT00749437|tubular ductal breast carcinoma|tubular ductal breast carcinoma
670067|NCT00749437|mucinous ductal breast carcinoma|mucinous ductal breast carcinoma
670068|NCT00749437|breast cancer in situ|breast cancer in situ
670069|NCT00749411|COPD|copd
670070|NCT00749411|long-acting beta agonist|long-acting beta agonist
670071|NCT00749411|Emphysema|emphysema
670072|NCT00749411|Chronic Bronchitis|chronic bronchitis
670073|NCT00749411|Chronic Obstructive Pulmonary Disease (COPD)|chronic obstructive pulmonary disease (copd)
670074|NCT00749411|bronchodilator|bronchodilator
670075|NCT00749411|long acting muscarinic antagonist|long acting muscarinic antagonist
670076|NCT00749359|healthy volunteers|healthy volunteers
670077|NCT00749359|paroxetine|paroxetine
670078|NCT00749346|TTFields|ttfields
670079|NCT00749346|NSCLC|nsclc
670080|NCT00749346|Alimta|alimta
670081|NCT00749346|Pemetrexed|pemetrexed
670082|NCT00749333|Healthy Volunteer|healthy volunteer
670083|NCT00749333|Safety|safety
670084|NCT00749333|Tolerability|tolerability
670085|NCT00749333|AZD8566|azd8566
670086|NCT00749333|study|study
670087|NCT00749320|MRI|mri
670088|NCT00749320|Sunitinib|sunitinib
670089|NCT00749320|Pazopanib|pazopanib
670090|NCT00749307|Heart rate variability|heart rate variability
670091|NCT00749307|Docosahexaenoic acid|docosahexaenoic acid
670092|NCT00749307|DHA|dha
670093|NCT00749307|Long chain fatty acids|long chain fatty acids
670094|NCT00749307|Long chain polyunsaturated fatty acids|long chain polyunsaturated fatty acids
670095|NCT00749307|Algal fatty acids|algal fatty acids
670096|NCT00749307|Schizochytrium|schizochytrium
670097|NCT00749307|Omega 3|omega 3
670098|NCT00749307|Death, Sudden, Cardiac|death, sudden, cardiac
670099|NCT00749307|Arrhythmias, Cardiac|arrhythmias, cardiac
670100|NCT00749281|atherosclerosis|atherosclerosis
670101|NCT00749281|ngal|ngal
670102|NCT00749281|coronary artery disease|coronary artery disease
670103|NCT00749268|hernia|hernia
670104|NCT00749255|Breast Cancer|breast cancer
670105|NCT00749255|Digital archiver software|digital archiver software
670106|NCT00749242|Traumatic vertebral fracture|traumatic vertebral fracture
670107|NCT00749242|Vertebroplasty|vertebroplasty
670108|NCT00749242|Balloon kyphoplasty|balloon kyphoplasty
670109|NCT00749242|Bohler bracing|bohler bracing
670110|NCT00749229|Traumatic vertebral fracture|traumatic vertebral fracture
670111|NCT00749229|Balloon Kyphoplasty|balloon kyphoplasty
670112|NCT00749229|type A3.2, or A3.3 or B1 or C1 in the MAGERL CLASSIFICATION|type a3.2, or a3.3 or b1 or c1 in the magerl classification
670113|NCT00749203|Stress Disorders, Post-Traumatic|stress disorders, post-traumatic
670114|NCT00749203|PTSD|ptsd
670115|NCT00749203|anxiety disorder|anxiety disorder
670116|NCT00749203|ketamine|ketamine
670117|NCT00749203|depression|depression
670118|NCT00749203|depressed mood|depressed mood
670119|NCT00749177|traditional healing|traditional healing
670120|NCT00749177|anxiety|anxiety
670121|NCT00749177|depression|depression
670122|NCT00749177|aboriginal|aboriginal
670123|NCT00749177|children|children
670124|NCT00749177|youth|youth
670125|NCT00749164|Mesenchymal stem cells|mesenchymal stem cells
670126|NCT00749164|Umbilical cord|umbilical cord
670127|NCT00749164|graft-vs-host disease|graft-vs-host disease
670128|NCT00749164|Steroid resistant|steroid resistant
670129|NCT00749151|smoking cessation|smoking cessation
670130|NCT00749151|telephone help line|telephone help line
670131|NCT00749138|hepatitis C, tamoxifen|hepatitis c, tamoxifen
670132|NCT00749125|Emotional Circuitry|emotional circuitry
670133|NCT00749125|fMRI|fmri
670134|NCT00749112|Idiopathic Thrombocytopenic Purpura|idiopathic thrombocytopenic purpura
670135|NCT00749112|Anemia|anemia
670136|NCT00749112|Hemolytic|hemolytic
670137|NCT00749112|Autoimmune|autoimmune
670138|NCT00749112|Alemtuzumab|alemtuzumab
670139|NCT00749112|Rituximab|rituximab
670140|NCT00749086|Osteoporosis|osteoporosis
670141|NCT00749086|Non-traumatic vertebral fracture|non-traumatic vertebral fracture
670142|NCT00749086|Vertebral compression|vertebral compression
670143|NCT00749086|Balloon kyphoplasty|balloon kyphoplasty
670144|NCT00749086|Vertebroplasty|vertebroplasty
670145|NCT00749073|Spinal Stenosis|spinal stenosis
670146|NCT00749073|Lumbar Spinal Stenosis|lumbar spinal stenosis
670147|NCT00749073|Laminotomy|laminotomy
670148|NCT00749073|Laminectomy|laminectomy
670149|NCT00749073|Spine Surgery|spine surgery
670150|NCT00749060|osteoporosis|osteoporosis
670151|NCT00749060|non-traumatic vertebral fracture|non-traumatic vertebral fracture
670152|NCT00749060|vertebral compression|vertebral compression
670153|NCT00749060|Balloon kyphoplasty|balloon kyphoplasty
670154|NCT00749060|vertebroplasty|vertebroplasty
670155|NCT00749047|Pioglitazone|pioglitazone
670156|NCT00749047|Open study|open study
670157|NCT00749047|Proteinuria|proteinuria
670158|NCT00749047|Glomerular selectivity indices|glomerular selectivity indices
670159|NCT00749034|Safety|safety
670160|NCT00749034|Immunogenicity|immunogenicity
670161|NCT00749034|Tuberculosis|tuberculosis
670162|NCT00749034|Vaccination|vaccination
670163|NCT00749034|Vaccination against tuberculosis|vaccination against tuberculosis
670164|NCT00749034|Safety and immunogenicity of VPM1002 in comparison with BCG|safety and immunogenicity of vpm1002 in comparison with bcg
670165|NCT00749021|choroidal neovascularization|choroidal neovascularization
670166|NCT00749021|vascularized|vascularized
670167|NCT00749008|Cerebral palsy|cerebral palsy
670168|NCT00749008|Generalized movements|generalized movements
670169|NCT00749008|Fidgety movements|fidgety movements
670170|NCT00749008|Prechtl|prechtl
670171|NCT00748982|AZD1305|azd1305
670172|NCT00748982|anti-arrhythmics|anti-arrhythmics
670173|NCT00748982|safety|safety
670174|NCT00748969|MPS I|mps i
670175|NCT00748969|MPS II|mps ii
670176|NCT00748969|MPS VI|mps vi
670177|NCT00748969|growth hormone|growth hormone
670178|NCT00748969|short stature|short stature
670179|NCT00748956|Mood Disorder|mood disorder
670180|NCT00748956|Anxiety Disorders|anxiety disorders
670181|NCT00748943|chlorine|chlorine
670182|NCT00748943|dioxide|dioxide
670183|NCT00748943|mouthwash|mouthwash
670184|NCT00748943|halitosis|halitosis
670185|NCT00748943|bacteria|bacteria
670186|NCT00748943|saliva|saliva
670187|NCT00748904|cirrhosis of liver and progressive renal failure|cirrhosis of liver and progressive renal failure
670188|NCT00748891|Cancer|cancer
670189|NCT00748891|tumour|tumour
670190|NCT00748891|advanced sold tumour|advanced sold tumour
670191|NCT00748891|imaging|imaging
670192|NCT00748891|DCE-CT Scan|dce-ct scan
670193|NCT00748891|DCE-MRI scan|dce-mri scan
670194|NCT00748891|Cediranib|cediranib
670195|NCT00748891|Recentin|recentin
670196|NCT00748878|To better understand platelet function during ECMO|to better understand platelet function during ecmo
670197|NCT00748865|Dry Eye|dry eye
670198|NCT00748865|Artificial Tears|artificial tears
670199|NCT00748839|HIT|hit
670200|NCT00748839|Heparin-induced thrombocytopenia|heparin-induced thrombocytopenia
670201|NCT00748839|heparin treatment|heparin treatment
670202|NCT00748839|venous thrombosis|venous thrombosis
670203|NCT00748839|arterial thrombosis|arterial thrombosis
670204|NCT00748839|predictive clinical score|predictive clinical score
670205|NCT00748839|biological test|biological test
670206|NCT00748839|anti-H-PF4 antibodies|anti-h-pf4 antibodies
670207|NCT00748813|Influenza vaccine|influenza vaccine
670208|NCT00748800|HIV prevention|hiv prevention
670209|NCT00748800|HIV seronegativity|hiv seronegativity
670210|NCT00748774|Primary Brain Tumor|primary brain tumor
670211|NCT00748774|Caregivers|caregivers
670212|NCT00748774|Symptom Severity|symptom severity
670213|NCT00748774|Questionnaire|questionnaire
670214|NCT00748774|M.D. Anderson Symptom Inventory-Brain Tumor|m.d. anderson symptom inventory-brain tumor
670215|NCT00748774|MDASI-BT|mdasi-bt
670216|NCT00748761|Obsessive-Compulsive Disorder|obsessive-compulsive disorder
670217|NCT00748761|OCD|ocd
670218|NCT00748761|Cognitive-Behavioral Therapy|cognitive-behavioral therapy
670219|NCT00748761|CBT|cbt
670220|NCT00748761|MRSI|mrsi
670221|NCT00748761|Glutamate|glutamate
670222|NCT00748735|cardiac resynchronization therapy|cardiac resynchronization therapy
670223|NCT00748735|echocardiography|echocardiography
670224|NCT00748735|heart failure|heart failure
670225|NCT00748735|left ventricular function|left ventricular function
670226|NCT00748735|pacing|pacing
670227|NCT00748735|myocardial deformation imaging|myocardial deformation imaging
670228|NCT00748735|Optimal Definition of Left Ventricular Lead Position in Cardiac Resynchronization Therapy|optimal definition of left ventricular lead position in cardiac resynchronization therapy
670229|NCT00748722|Breast reconstruction|breast reconstruction
670230|NCT00748722|Perforator flaps|perforator flaps
670231|NCT00748722|CT Angiography|ct angiography
670232|NCT00748696|sarcopenia|sarcopenia
670233|NCT00748696|elderly|elderly
670234|NCT00748696|resistance training|resistance training
670235|NCT00748696|oral nutritional supplement|oral nutritional supplement
670236|NCT00748683|elderly|elderly
670237|NCT00748683|longterm care|longterm care
670238|NCT00748644|Wegener's granulomatosis,|wegener's granulomatosis,
670239|NCT00748644|microscopic polyangiitis,|microscopic polyangiitis,
670240|NCT00748644|ANCA-associated vasculitis,|anca-associated vasculitis,
670241|NCT00748644|rituximab,|rituximab,
670242|NCT00748644|azathioprine|azathioprine
670333|NCT00748280|Permanent|permanent
670243|NCT00748631|Vertebral fracture|vertebral fracture
670244|NCT00748631|Vertebral compression fracture|vertebral compression fracture
670245|NCT00748631|Multiple Myeloma Bone marrow diseases|multiple myeloma bone marrow diseases
670246|NCT00748631|Vertebral metastases|vertebral metastases
670247|NCT00748631|Balloon Kyphoplasty|balloon kyphoplasty
670248|NCT00748618|Kidney transplantation (KTX)|kidney transplantation (ktx)
670249|NCT00748618|Vitamin D deficiency|vitamin d deficiency
670250|NCT00748618|Cardiovascular Disease (CVD)|cardiovascular disease (cvd)
670251|NCT00748618|Vascular risk|vascular risk
670252|NCT00748618|Parathyroid hormone (PTH)|parathyroid hormone (pth)
670253|NCT00748618|Carotid intima media thickness (CIMT)|carotid intima media thickness (cimt)
670254|NCT00748618|Insulin resistance (IR)|insulin resistance (ir)
670255|NCT00748605|Obesity|obesity
670256|NCT00748592|Insomnia, Primary Insomnia, Chronic Insomnia, DIMS (Disorders of Initiating and Maintaining Sleep), Disorders of Initiating and Maintaining Sleep|insomnia, primary insomnia, chronic insomnia, dims (disorders of initiating and maintaining sleep), disorders of initiating and maintaining sleep
670257|NCT00748566|Ziprasidone|ziprasidone
670258|NCT00748566|metabolic syndrome|metabolic syndrome
670259|NCT00748566|risk factors|risk factors
670260|NCT00748566|schizophrenia|schizophrenia
670261|NCT00748566|psychotic disorders.|psychotic disorders.
670262|NCT00748540|sensorineural hearing loss|sensorineural hearing loss
670263|NCT00748540|conductive hearing loss|conductive hearing loss
670264|NCT00748540|mixed hearing loss|mixed hearing loss
670265|NCT00748527|fallopian tube cancer|fallopian tube cancer
670266|NCT00748527|stage III ovarian epithelial cancer|stage iii ovarian epithelial cancer
670267|NCT00748527|stage IV ovarian epithelial cancer|stage iv ovarian epithelial cancer
670268|NCT00748527|recurrent ovarian epithelial cancer|recurrent ovarian epithelial cancer
670269|NCT00748527|peritoneal cavity cancer|peritoneal cavity cancer
670270|NCT00748514|capsular incision|capsular incision
670271|NCT00748514|biochemical recurrence|biochemical recurrence
670272|NCT00748514|radical perineal prostatectomy|radical perineal prostatectomy
670273|NCT00748501|Amyotrophic Lateral Sclerosis,|amyotrophic lateral sclerosis,
670274|NCT00748501|ALS,|als,
670275|NCT00748501|Lou Gehrig's Disease|lou gehrig's disease
670276|NCT00748488|Parkinson|parkinson
670277|NCT00748488|Physical Therapy|physical therapy
670278|NCT00748488|Physical Activity|physical activity
670279|NCT00748462|Acne scar, Wrinkle, Pigmentation, Fractional CO2 laser|acne scar, wrinkle, pigmentation, fractional co2 laser
670280|NCT00748449|Colorectal advanced adenoma|colorectal advanced adenoma
670281|NCT00748449|Colorectal cancer polypectomy (endoscopic)|colorectal cancer polypectomy (endoscopic)
670282|NCT00748449|Colectomy|colectomy
670283|NCT00748449|Colonoscopy with anaesthesia|colonoscopy with anaesthesia
670284|NCT00748449|CT-colonography|ct-colonography
670285|NCT00748436|Obese females|obese females
670286|NCT00748436|Weight loss|weight loss
670287|NCT00748436|Betahistine|betahistine
670288|NCT00748423|Inhaled drug|inhaled drug
670289|NCT00748423|Acute lung injury|acute lung injury
670290|NCT00748423|Nitric oxide|nitric oxide
670291|NCT00748423|Sickle cell|sickle cell
670292|NCT00748410|CD11b|cd11b
670293|NCT00748410|Ulcerative colitis|ulcerative colitis
670294|NCT00748410|99mTc-HMPAO-labelled leukocyte scintigraphy|99mtc-hmpao-labelled leukocyte scintigraphy
670295|NCT00748384|HMP, CNV, AMD, PHP, HPHP, foresee|hmp, cnv, amd, php, hphp, foresee
670296|NCT00748371|platelet aggregation|platelet aggregation
670297|NCT00748371|granule secretion|granule secretion
670298|NCT00748371|thromboxane production|thromboxane production
670299|NCT00748371|prostacyclin production|prostacyclin production
670300|NCT00748358|metastatic prostate carcinoma|metastatic prostate carcinoma
670301|NCT00748358|sunitinib [Substance Name]|sunitinib [substance name]
670302|NCT00748358|Clinical Trial, Phase II [Publication Type]|clinical trial, phase ii [publication type]
670303|NCT00748345|Caspofungin,|caspofungin,
670304|NCT00748345|burn patients,|burn patients,
670305|NCT00748345|pharmacokinetics,|pharmacokinetics,
670306|NCT00748345|optimal dose,|optimal dose,
670307|NCT00748345|antifungal treatment|antifungal treatment
670308|NCT00748319|Receptors KIR|receptors kir
670309|NCT00748319|Polymerase chain reaction|polymerase chain reaction
670310|NCT00748319|Diagnosis|diagnosis
670311|NCT00748319|Lymphoma T-cell cutaneous|lymphoma t-cell cutaneous
670312|NCT00748319|Mycosis fungicides|mycosis fungicides
670313|NCT00748319|Sezary syndrome|sezary syndrome
670314|NCT00748319|Differential diagnosis from dermatitis|differential diagnosis from dermatitis
670315|NCT00748306|challenge|challenge
670316|NCT00748306|early asthmatic response|early asthmatic response
670317|NCT00748306|mild asthmatics|mild asthmatics
670318|NCT00748306|Allergen|allergen
670319|NCT00748306|methacholine|methacholine
670320|NCT00748293|Colonoscopy|colonoscopy
670321|NCT00748293|Colon cleansing|colon cleansing
670322|NCT00748293|Low-reside diet|low-reside diet
670323|NCT00748293|Compliance|compliance
670324|NCT00748293|PEG-ELS|peg-els
670325|NCT00748280|Endodontics|endodontics
670326|NCT00748280|CEM cement|cem cement
670327|NCT00748280|Calcium enriched mixture|calcium enriched mixture
670328|NCT00748280|MTA|mta
670329|NCT00748280|Root Canal Therapy|root canal therapy
670330|NCT00748280|Pain|pain
670331|NCT00748280|Pulpotomy|pulpotomy
670332|NCT00748280|Human|human
670334|NCT00748280|Molar teeth|molar teeth
670335|NCT00748267|anxiety disorder|anxiety disorder
670337|NCT00748267|nausea and vomiting|nausea and vomiting
670338|NCT00748267|breast cancer|breast cancer
670339|NCT00748254|Rheumatoid arthritis|rheumatoid arthritis
670340|NCT00748215|diarrhea|diarrhea
670341|NCT00748215|chemotherapeutic agent toxicity|chemotherapeutic agent toxicity
670342|NCT00748215|recurrent colon cancer|recurrent colon cancer
670343|NCT00748215|recurrent rectal cancer|recurrent rectal cancer
670344|NCT00748215|stage IV colon cancer|stage iv colon cancer
670345|NCT00748215|stage IV rectal cancer|stage iv rectal cancer
670346|NCT00748202|Hereditary angioedema|hereditary angioedema
670347|NCT00748202|C1-Esterase inhibitor|c1-esterase inhibitor
670348|NCT00748202|intravenous|intravenous
670349|NCT00748202|subcutaneous|subcutaneous
670350|NCT00748202|pharmacokinetic|pharmacokinetic
670351|NCT00748189|Safety|safety
670352|NCT00748189|Untreated|untreated
670353|NCT00748189|Efficacy|efficacy
670354|NCT00748189|Chronic Lymphocytic Leukemia|chronic lymphocytic leukemia
670355|NCT00748189|Chronic Lymphocytic Leukemia (CLL), untreated|chronic lymphocytic leukemia (cll), untreated
670356|NCT00748189|Ofatumumab|ofatumumab
670357|NCT00748189|Oncology|oncology
670358|NCT00748163|stage IV non-small cell lung cancer|stage iv non-small cell lung cancer
670359|NCT00748150|flu|flu
670360|NCT00748150|influenza|influenza
670361|NCT00748150|influenza vaccine antigen|influenza vaccine antigen
670362|NCT00748150|immunogenicity|immunogenicity
670363|NCT00748150|antibody response|antibody response
670364|NCT00748150|intra muscular|intra muscular
670365|NCT00748150|elderly|elderly
670366|NCT00748150|non-elderly|non-elderly
670367|NCT00748137|Type 1 Diabetes|type 1 diabetes
670368|NCT00748137|Youth|youth
670369|NCT00748137|Insulin dose|insulin dose
670370|NCT00748111|Sudden death|sudden death
670371|NCT00748111|Out of hospital cardiac arrest|out of hospital cardiac arrest
670372|NCT00748111|Acute myocardial infarction|acute myocardial infarction
670373|NCT00748111|Acute coronary syndrome|acute coronary syndrome
670374|NCT00748098|PSG|psg
670375|NCT00748098|Restless Legs Syndrome|restless legs syndrome
670376|NCT00748098|gabapentin enacarbil|gabapentin enacarbil
670377|NCT00748098|XP13512|xp13512
670378|NCT00748098|GSK1838262|gsk1838262
670379|NCT00748098|sleep disturbance|sleep disturbance
670380|NCT00748098|RLS|rls
670381|NCT00748098|polysomnography|polysomnography
670382|NCT00748085|Malignant Airway Disease|malignant airway disease
670383|NCT00748085|Lung Cancer|lung cancer
670384|NCT00748085|Inoperable Lung Cancer|inoperable lung cancer
670385|NCT00748085|Mesothelioma|mesothelioma
670386|NCT00748085|Endoluminal Tumor|endoluminal tumor
670387|NCT00748072|Vasopressin|vasopressin
670388|NCT00748072|bleeding|bleeding
670389|NCT00748072|biopsy|biopsy
670390|NCT00748072|ultrasonography|ultrasonography
670391|NCT00748059|autonomic nervous system diseases|autonomic nervous system diseases
670392|NCT00748059|blood pressure|blood pressure
670393|NCT00748059|congenital|congenital
670394|NCT00748059|orthostasis|orthostasis
670395|NCT00748059|catecholamines|catecholamines
670396|NCT00748046|Biodistribution|biodistribution
670397|NCT00748046|Radiation dosimetry|radiation dosimetry
670398|NCT00748046|Pharmacokinetics|pharmacokinetics
670399|NCT00748046|Safety|safety
670400|NCT00748007|Down syndrome, cholinesterase inhibitor, Rivastigmine|down syndrome, cholinesterase inhibitor, rivastigmine
670401|NCT00747994|Paget's disease of bone|paget's disease of bone
670402|NCT00747994|Relatives|relatives
670403|NCT00747994|Mutations screening|mutations screening
670404|NCT00747994|Haplotypes analysis|haplotypes analysis
670405|NCT00747994|Linkage analysis|linkage analysis
670406|NCT00747994|< 55 years|< 55 years
670407|NCT00747994|4 > or = WAFFECTED Bones|4 > or = waffected bones
670408|NCT00747994|bone deformity|bone deformity
670409|NCT00747981|CT Scan|ct scan
670410|NCT00747981|Endoscopy|endoscopy
670411|NCT00747981|Aspiration|aspiration
670412|NCT00747981|Foreign Bodies|foreign bodies
670413|NCT00747955|Human Performance|human performance
670414|NCT00747955|Physical Disability|physical disability
670415|NCT00747955|Functional Outcome Measures|functional outcome measures
670416|NCT00747955|Health Volunteer|health volunteer
670417|NCT00747955|HV|hv
670418|NCT00747942|overweight|overweight
670419|NCT00747942|physical inactivity|physical inactivity
670420|NCT00747942|physical fitness|physical fitness
670421|NCT00747942|lifestyle change|lifestyle change
670422|NCT00747929|Obesity|obesity
670423|NCT00747916|Parietal pleura|parietal pleura
670424|NCT00747916|Neoplasms|neoplasms
670425|NCT00747916|Pleural Surface|pleural surface
670426|NCT00747916|Pleural Neoplasms|pleural neoplasms
670427|NCT00747916|Lung Cancer|lung cancer
670428|NCT00747903|basal cell carcinoma of the skin|basal cell carcinoma of the skin
670429|NCT00747903|recurrent skin cancer|recurrent skin cancer
670430|NCT00747877|stage II multiple myeloma|stage ii multiple myeloma
670431|NCT00747877|stage III multiple myeloma|stage iii multiple myeloma
670432|NCT00747877|refractory multiple myeloma|refractory multiple myeloma
670433|NCT00747877|stage I multiple myeloma|stage i multiple myeloma
670434|NCT00747864|Gestational Age|gestational age
670435|NCT00747864|Urine|urine
670436|NCT00747864|Concentration|concentration
670437|NCT00747864|of S100B|of s100b
670438|NCT00747851|protein|protein
670439|NCT00747851|synthesis|synthesis
670440|NCT00747851|response|response
670441|NCT00747851|PAF-stimulated|paf-stimulated
670442|NCT00747851|PMNs|pmns
670443|NCT00747851|collected|collected
670444|NCT00747838|Afib|afib
670445|NCT00747838|Atrial Fibrillation|atrial fibrillation
670446|NCT00747838|Maze|maze
670447|NCT00747838|Mini-Maze|mini-maze
670448|NCT00747825|cancer|cancer
670449|NCT00747825|oncology|oncology
670450|NCT00747825|melanoma|melanoma
670451|NCT00747825|tumor|tumor
670452|NCT00747812|Headache|headache
670453|NCT00747812|Migraine|migraine
670454|NCT00747812|Refractory|refractory
670455|NCT00747812|Chronic|chronic
670456|NCT00747812|Pain|pain
670457|NCT00747799|recurrent or metastatic Nasopharyngeal Neoplasms|recurrent or metastatic nasopharyngeal neoplasms
670458|NCT00747773|Lung Cancer|lung cancer
670459|NCT00747773|CryoPsray Ablation|cryopsray ablation
670460|NCT00747773|CSA therapy|csa therapy
670461|NCT00747773|CSA treatment|csa treatment
670462|NCT00747773|Lobectomy|lobectomy
670463|NCT00747773|lung resection|lung resection
670464|NCT00747760|TSH Receptor, resistance TSH, Hyperthyrortropinemia|tsh receptor, resistance tsh, hyperthyrortropinemia
670465|NCT00747747|Sinusitis|sinusitis
670466|NCT00747734|Neuropilin-1|neuropilin-1
670467|NCT00747734|NRP1|nrp1
670468|NCT00747734|anti-NRP1|anti-nrp1
670469|NCT00747734|anti-angiogenic|anti-angiogenic
851708|NCT00078507|Adult|adult
670470|NCT00747708|heart failure|heart failure
670471|NCT00747708|coronary heart disease|coronary heart disease
670472|NCT00747708|adult stem cells|adult stem cells
670473|NCT00747708|bone marrow progenitor cells|bone marrow progenitor cells
670474|NCT00747708|bone marrow stem cells|bone marrow stem cells
670475|NCT00747708|autologous|autologous
670476|NCT00747708|granulocyte-colony stimulating factor|granulocyte-colony stimulating factor
670477|NCT00747708|left ventricular function|left ventricular function
670478|NCT00747708|intracoronary injection|intracoronary injection
670479|NCT00747708|intramyocardial injection|intramyocardial injection
670480|NCT00747695|Pediatric Pharmacokinetics|pediatric pharmacokinetics
670481|NCT00747695|Pediatric Pharmacodynamics|pediatric pharmacodynamics
670482|NCT00747695|Rabeprazole|rabeprazole
670483|NCT00747695|Pediatric GERD|pediatric gerd
670484|NCT00747695|Aciphex|aciphex
670485|NCT00747682|Cerebral Perfusion,|cerebral perfusion,
670486|NCT00747682|Oxygenation,|oxygenation,
670487|NCT00747682|Electrical|electrical
670488|NCT00747682|Activity|activity
670489|NCT00747656|Electrocardiography|electrocardiography
670490|NCT00747656|Emergency medical services|emergency medical services
670491|NCT00747656|Emergency medicine|emergency medicine
670492|NCT00747656|Health services|health services
670493|NCT00747656|Cost effectiveness|cost effectiveness
670494|NCT00747643|tobacco|tobacco
670495|NCT00747643|nicotine|nicotine
670496|NCT00747643|smoking|smoking
670497|NCT00747643|reward|reward
670498|NCT00747643|reinforcement|reinforcement
670499|NCT00747643|craving|craving
670500|NCT00747643|cues|cues
670501|NCT00747643|conditioned stimuli|conditioned stimuli
670502|NCT00747643|cue reactivity|cue reactivity
670503|NCT00747630|Fetal Alcohol Syndrome|fetal alcohol syndrome
670504|NCT00747630|Teen pregnancy|teen pregnancy
670505|NCT00747617|polycystic ovary syndrome|polycystic ovary syndrome
670506|NCT00747617|androgens|androgens
670507|NCT00747617|ovary|ovary
670508|NCT00747617|LH|lh
670509|NCT00747604|Growth Hormone (GH) Insensitivity Syndrome|growth hormone (gh) insensitivity syndrome
670510|NCT00747604|Insulin-like Growth Factor Deficiency (IGFD)|insulin-like growth factor deficiency (igfd)
670511|NCT00747604|Short Stature|short stature
670512|NCT00747604|Insulin-like Growth Factor (IGF-1)|insulin-like growth factor (igf-1)
670513|NCT00747604|Growth|growth
670514|NCT00747591|urine|urine
670515|NCT00747591|concentration|concentration
670516|NCT00747591|of S100B|of s100b
670517|NCT00747578|ankylosing spondylitis (AS), costs,|ankylosing spondylitis (as), costs,
670518|NCT00747578|rheumatoid arthritis (RA),|rheumatoid arthritis (ra),
670519|NCT00747578|systemic lupus erythematosus (SLE),|systemic lupus erythematosus (sle),
670520|NCT00747578|health-related|health-related
670521|NCT00747578|quality of life (HRQOL)|quality of life (hrqol)
670522|NCT00747578|compare|compare
670523|NCT00747578|utility|utility
670524|NCT00747578|patients|patients
670525|NCT00747565|cataract, tecnis, multifocal, intraocular lens|cataract, tecnis, multifocal, intraocular lens
670526|NCT00747552|IAP measurements|iap measurements
670527|NCT00747552|Abdominal compartment syndrome|abdominal compartment syndrome
670528|NCT00747552|NICU patients|nicu patients
670529|NCT00747552|Intra-abdominal Hypertension|intra-abdominal hypertension
670530|NCT00747539|Hepatitis C Virus|hepatitis c virus
670531|NCT00747539|HCV|hcv
670532|NCT00747539|Human Immunodeficiency Virus|human immunodeficiency virus
670533|NCT00747539|Coinfection|coinfection
670534|NCT00747526|Gastroesophageal Reflux Disease (GERD)|gastroesophageal reflux disease (gerd)
670535|NCT00747526|Pediatrics|pediatrics
670536|NCT00747526|Pharmacokinetics|pharmacokinetics
670537|NCT00747526|Pharmacodynamics|pharmacodynamics
670538|NCT00747526|Rabeprazole|rabeprazole
670539|NCT00747526|GERD|gerd
670540|NCT00747526|Aciphex|aciphex
670541|NCT00747513|school|school
670542|NCT00747513|prevention|prevention
670543|NCT00747513|overweight|overweight
670544|NCT00747513|children|children
670545|NCT00747513|diet|diet
670546|NCT00747513|physical activity|physical activity
670547|NCT00747513|fitness|fitness
670548|NCT00747487|Leber|leber
670549|NCT00747487|LHON|lhon
670550|NCT00747487|Leber's Hereditary Optic Neuropathy|leber's hereditary optic neuropathy
670551|NCT00747487|Idebenone|idebenone
670552|NCT00747461|Benign Airway Disease|benign airway disease
670553|NCT00747461|Airway Injury|airway injury
670554|NCT00747461|Sarcoidosis|sarcoidosis
670555|NCT00747461|Wegener's Granulomatosis|wegener's granulomatosis
670556|NCT00747461|Rhinoscleroma|rhinoscleroma
670557|NCT00747461|Recurrent Respiratory Papillomatosis(RRP)|recurrent respiratory papillomatosis(rrp)
670558|NCT00747448|Barrett's Esophagus|barrett's esophagus
670559|NCT00747448|High Grade Dysplasia|high grade dysplasia
670560|NCT00747448|Low Grade Dysplasia|low grade dysplasia
670561|NCT00747448|Squamous Dysplasia|squamous dysplasia
670562|NCT00747448|Esophageal Cancer|esophageal cancer
670563|NCT00747448|CryoSpray Ablation|cryospray ablation
670564|NCT00747448|Cryotherapy|cryotherapy
670565|NCT00747448|Cryospray|cryospray
670566|NCT00747435|sensorineural hearing loss|sensorineural hearing loss
670567|NCT00747435|ski slope audiogram|ski slope audiogram
670568|NCT00747435|electric acoustic stimulation|electric acoustic stimulation
670569|NCT00747409|postprandial glucose, diastolic function, analogue insulins|postprandial glucose, diastolic function, analogue insulins
670570|NCT00747396|Romania,|romania,
670571|NCT00747396|children,|children,
670572|NCT00747396|foster care,|foster care,
670573|NCT00747396|institutionalization,|institutionalization,
670574|NCT00747396|brain function,|brain function,
670575|NCT00747396|MRI,|mri,
670576|NCT00747396|attachment,|attachment,
670577|NCT00747396|language,|language,
670578|NCT00747396|growth,|growth,
670579|NCT00747396|IQ,|iq,
670580|NCT00747396|psychiatric symptomatology|psychiatric symptomatology
670581|NCT00747396|early intervention|early intervention
670582|NCT00747383|Diabetes Mellitus|diabetes mellitus
670583|NCT00747383|GLP1|glp1
670584|NCT00747383|DPP4|dpp4
670585|NCT00747370|stress urinary incontinence|stress urinary incontinence
670586|NCT00747370|Tension free vaginal tape|tension free vaginal tape
670587|NCT00747370|tension free vaginal tape obturator|tension free vaginal tape obturator
670588|NCT00747370|genital prolapse|genital prolapse
670589|NCT00747344|Psoriasis|psoriasis
670590|NCT00747344|Psoriatic Arthritis|psoriatic arthritis
670591|NCT00747344|Ustekinumab|ustekinumab
670592|NCT00747344|CNTO 1275|cnto 1275
670593|NCT00747331|Cardiopulmonary bypass|cardiopulmonary bypass
670594|NCT00747331|Lactic acidosis|lactic acidosis
670595|NCT00747331|Oxygen delivery|oxygen delivery
670596|NCT00747331|Acute renal failure|acute renal failure
670597|NCT00747331|outcome|outcome
670598|NCT00747331|cardiac|cardiac
670599|NCT00747331|surgery|surgery
670600|NCT00747318|Moderate to Severe|moderate to severe
670601|NCT00747305|stage IV renal cell cancer|stage iv renal cell cancer
670602|NCT00747305|clear cell renal cell carcinoma|clear cell renal cell carcinoma
670603|NCT00747305|recurrent renal cell cancer|recurrent renal cell cancer
670604|NCT00747292|laparoscopic|laparoscopic
670605|NCT00747292|colon|colon
670606|NCT00747292|analgesia|analgesia
670607|NCT00747292|fluid optimised|fluid optimised
670608|NCT00747253|laser interstitial thermal therapy|laser interstitial thermal therapy
670609|NCT00747253|laser therapy|laser therapy
670610|NCT00747253|thermal therapy|thermal therapy
670611|NCT00747253|brain tumors|brain tumors
670612|NCT00747253|recurrent brain tumor|recurrent brain tumor
670613|NCT00747253|progressive brain tumor|progressive brain tumor
670614|NCT00747253|glioblastoma multiforme tumor|glioblastoma multiforme tumor
670615|NCT00747240|Ile198Thr|ile198thr
670616|NCT00747240|Ala379Val|ala379val
670617|NCT00747240|variants|variants
670618|NCT00747240|PAF-AH|paf-ah
670619|NCT00747227|cataract|cataract
670620|NCT00747227|monofocal|monofocal
670621|NCT00747227|intraocular lens|intraocular lens
670622|NCT00747227|acrylic|acrylic
670623|NCT00747214|Rheumatoid Arthritis|rheumatoid arthritis
670624|NCT00747214|RA|ra
670625|NCT00747214|DMARD|dmard
670626|NCT00747214|CRP|crp
670627|NCT00747201|Replicating Effective Programs|replicating effective programs
670628|NCT00747201|Care Management|care management
670629|NCT00747201|Implementation|implementation
670630|NCT00747201|Intervention|intervention
670631|NCT00747188|Problem-based learning (PBL)|problem-based learning (pbl)
670632|NCT00747188|lecture|lecture
670633|NCT00747188|nursing|nursing
670634|NCT00747188|education|education
670635|NCT00747188|none of students had any prior exposure to PBL|none of students had any prior exposure to pbl
670636|NCT00747175|Type 2 diabetes|type 2 diabetes
670637|NCT00747162|Compartment Syndrome|compartment syndrome
670743|NCT00746668|Reading|reading
670638|NCT00747162|Muscle Oxygenation|muscle oxygenation
670639|NCT00747162|Skin Pigmentation|skin pigmentation
670640|NCT00747149|diabetes|diabetes
670641|NCT00747149|type 2|type 2
670642|NCT00747136|Barrett's|barrett's
670643|NCT00747136|Dysplasia|dysplasia
670644|NCT00747136|esophageal cancer|esophageal cancer
670645|NCT00747136|Patients|patients
670646|NCT00747110|5-ASA|5-asa
670647|NCT00747110|mesalamine|mesalamine
670648|NCT00747110|mesalazine|mesalazine
670649|NCT00747110|budesonide|budesonide
670650|NCT00747110|ulcerative colitis|ulcerative colitis
670651|NCT00747084|unsedated colonoscopy|unsedated colonoscopy
670652|NCT00747071|Clostridium difficile|clostridium difficile
670653|NCT00747071|diarrhea|diarrhea
670654|NCT00747071|colostrum|colostrum
670655|NCT00747058|phase 1, human study, healthy volunteers|phase 1, human study, healthy volunteers
670656|NCT00747045|Chronic Thromboembolic Pulmonary Hypertension|chronic thromboembolic pulmonary hypertension
670657|NCT00747045|Lung Injury|lung injury
670658|NCT00747045|Ventilation Strategies|ventilation strategies
670659|NCT00746993|Contraception|contraception
670660|NCT00746993|Counseling|counseling
670661|NCT00746980|alopecia|alopecia
670662|NCT00746980|areata|areata
670663|NCT00746980|universalis|universalis
670664|NCT00746980|severe|severe
670665|NCT00746980|ophiasis|ophiasis
670666|NCT00746980|variants|variants
670667|NCT00746954|buspirone|buspirone
670668|NCT00746954|acetazolamide|acetazolamide
670669|NCT00746941|PML|pml
670670|NCT00746941|Human Polyomavirus JC|human polyomavirus jc
670671|NCT00746941|HIV|hiv
670672|NCT00746941|Central Nervous System Disease|central nervous system disease
670673|NCT00746941|Mefloquine|mefloquine
670674|NCT00746941|JC Virus|jc virus
670675|NCT00746928|Blood pressure|blood pressure
670676|NCT00746928|Hypertension|hypertension
670677|NCT00746928|sympathetic control|sympathetic control
670678|NCT00746928|chemosensitivity|chemosensitivity
670679|NCT00746928|baroreflex|baroreflex
670680|NCT00746915|Patients undergoing elective pain relief treatment of lumbar epidural steroid injection under fluoroscopy|patients undergoing elective pain relief treatment of lumbar epidural steroid injection under fluoroscopy
670681|NCT00746902|Refractory hypertension|refractory hypertension
670682|NCT00746902|Obstructive sleep apnea syndrome|obstructive sleep apnea syndrome
670683|NCT00746902|Obesity|obesity
670684|NCT00746902|Leptinemia|leptinemia
670685|NCT00746902|RHOOSAS study|rhoosas study
670686|NCT00746889|osteoarthritis|osteoarthritis
670687|NCT00746889|knee|knee
670688|NCT00746889|corticosteroids|corticosteroids
670689|NCT00746889|ultrasound|ultrasound
670690|NCT00746876|Hip|hip
670691|NCT00746876|Fracture|fracture
670692|NCT00746876|Femoral neck|femoral neck
670693|NCT00746876|Hemiarthroplasty|hemiarthroplasty
670694|NCT00746876|Bipolar|bipolar
670695|NCT00746876|Unipolar|unipolar
670696|NCT00746876|Displaced femoral neck fractures|displaced femoral neck fractures
670697|NCT00746863|mid-urethral sling|mid-urethral sling
670698|NCT00746863|pubovaginal sling|pubovaginal sling
670699|NCT00746863|postoperative pain|postoperative pain
670700|NCT00746863|visual analog scale|visual analog scale
670701|NCT00746863|suprapubic approach|suprapubic approach
670702|NCT00746863|SPARC sling|sparc sling
670703|NCT00746850|acute cholecystitis|acute cholecystitis
670704|NCT00746850|laparoscopic cholecystectomy|laparoscopic cholecystectomy
670705|NCT00746850|conversion rate|conversion rate
670706|NCT00746850|morbidity|morbidity
670707|NCT00746850|mortality|mortality
670708|NCT00746850|postoperative pain|postoperative pain
670709|NCT00746850|hospital stay|hospital stay
670710|NCT00746837|AZD5672|azd5672
670711|NCT00746824|Obesity|obesity
670712|NCT00746824|weight loss|weight loss
670713|NCT00746824|7TM Pharma|7tm pharma
670714|NCT00746824|TM30339|tm30339
670715|NCT00746824|Y4 receptor antagonist|y4 receptor antagonist
670716|NCT00746811|cholesterol|cholesterol
670717|NCT00746811|hypercholesterolemia|hypercholesterolemia
670718|NCT00746811|omega 3|omega 3
670719|NCT00746798|West Nile Fever|west nile fever
670720|NCT00746798|ChimeriVax|chimerivax
670721|NCT00746798|West Nile Virus Vaccine|west nile virus vaccine
670722|NCT00746785|Olanzapine|olanzapine
670723|NCT00746772|antioxidant|antioxidant
670724|NCT00746772|oral lichen planus|oral lichen planus
670725|NCT00746772|treatment|treatment
670726|NCT00746772|purslane|purslane
670727|NCT00746759|Lung Cancer|lung cancer
670728|NCT00746759|Smoker|smoker
670729|NCT00746759|Former Smoker|former smoker
670730|NCT00746759|Gene Expression|gene expression
670731|NCT00746759|Bronchoscopy|bronchoscopy
670732|NCT00746746|Advanced Melanoma|advanced melanoma
670733|NCT00746733|Drug|drug
670734|NCT00746733|Interaction|interaction
670735|NCT00746733|Study|study
670736|NCT00746720|hip replacement|hip replacement
670737|NCT00746720|osteoarthritis|osteoarthritis
670738|NCT00746720|etoricoxib|etoricoxib
670739|NCT00746720|pain|pain
670740|NCT00746720|cerebrospinal fluid|cerebrospinal fluid
670741|NCT00746720|pharmacokinetics|pharmacokinetics
670742|NCT00746707|adhesive glue, perineal tear, suture|adhesive glue, perineal tear, suture
670744|NCT00746668|Macular Degeneration|macular degeneration
670745|NCT00746668|Rehabilitation|rehabilitation
670746|NCT00746668|Vision, Low|vision, low
670747|NCT00746655|Hepatocellular|hepatocellular
670748|NCT00746642|glucose measurements|glucose measurements
670749|NCT00746616|Total Hip Arthroplasty,|total hip arthroplasty,
670750|NCT00746616|Acetabular Cup,|acetabular cup,
670751|NCT00746616|Hip Resurfacing|hip resurfacing
670753|NCT00746616|active|active
670754|NCT00746616|patients|patients
670755|NCT00746590|hepatocellular carcinoma|hepatocellular carcinoma
670756|NCT00746590|liver cancer|liver cancer
670757|NCT00746590|Prolarix|prolarix
670758|NCT00746590|tretazicar|tretazicar
670759|NCT00746590|caricotamide|caricotamide
670760|NCT00746590|Phase 2|phase 2
670761|NCT00746590|tumor|tumor
670762|NCT00746590|chemotherapy|chemotherapy
670763|NCT00746564|Implantable Cardiac Monitor|implantable cardiac monitor
670764|NCT00746564|Arrhythmias|arrhythmias
670765|NCT00746564|Atrial Fibrillation|atrial fibrillation
670766|NCT00746551|iron deficiency anemia|iron deficiency anemia
670767|NCT00746551|pregnancy|pregnancy
670768|NCT00746551|third trimester|third trimester
670769|NCT00746551|intravenous iron|intravenous iron
670770|NCT00746551|efficacy|efficacy
670771|NCT00746551|a randomized trial|a randomized trial
670772|NCT00746551|Female|female
670773|NCT00746551|Ferric Compounds/therapeutic use*|ferric compounds/therapeutic use*
670774|NCT00746551|Infusions, Intravenous|infusions, intravenous
670775|NCT00746551|Hematologic/therapy*|hematologic/therapy*
670776|NCT00746538|Hilar cholangiocarcinoma|hilar cholangiocarcinoma
670777|NCT00746538|biliary stent|biliary stent
670778|NCT00746538|plastic stent|plastic stent
670779|NCT00746538|metallic stent|metallic stent
670780|NCT00746538|quality of life|quality of life
670781|NCT00746525|stroke|stroke
670782|NCT00746525|motor learning|motor learning
670783|NCT00746525|rehabilitation of upper extremity|rehabilitation of upper extremity
670784|NCT00746525|functional electrical stimulation|functional electrical stimulation
670785|NCT00746525|FES|fes
670786|NCT00746525|brain computer interface|brain computer interface
670787|NCT00746525|BCI|bci
670788|NCT00746525|coordination|coordination
670789|NCT00746525|motor control|motor control
670790|NCT00746460|primary prevention|primary prevention
670791|NCT00746460|patient knowledge|patient knowledge
670792|NCT00746460|nurse|nurse
670793|NCT00746460|exercise|exercise
670794|NCT00746460|smoking cessation|smoking cessation
670795|NCT00746460|weight loss|weight loss
670796|NCT00746447|maintenance|maintenance
670797|NCT00746447|5-ASA|5-asa
670798|NCT00746447|mesalamine|mesalamine
670799|NCT00746447|mesalazine|mesalazine
670800|NCT00746447|ulcerative colitis|ulcerative colitis
670801|NCT00746434|Mild plaque psoriasis,|mild plaque psoriasis,
670802|NCT00746434|Moderate plaque psoriasis,|moderate plaque psoriasis,
670803|NCT00746434|0.5% Roflumilast cream|0.5% roflumilast cream
670804|NCT00746421|Cognition|cognition
670805|NCT00746421|attention|attention
670806|NCT00746421|bipolar|bipolar
670807|NCT00746421|disability|disability
670808|NCT00746408|Internet|internet
670809|NCT00746408|Information supply|information supply
670810|NCT00746408|Tailoring|tailoring
670811|NCT00746408|Patient empowerment|patient empowerment
670812|NCT00746408|Headaches|headaches
670813|NCT00746408|Consumer Health Information|consumer health information
670814|NCT00746408|Information Services|information services
670815|NCT00746408|Information Storage and Retrieval|information storage and retrieval
670816|NCT00746408|Information Systems|information systems
670817|NCT00746395|capsule|capsule
670818|NCT00746395|endoscopy|endoscopy
670819|NCT00746395|prokinetic|prokinetic
670820|NCT00746395|lubiprostone|lubiprostone
670821|NCT00746395|Normal|normal
670822|NCT00746395|volunteers|volunteers
670823|NCT00746382|Mild atopic dermatitis, Roflumilast cream 0.5%|mild atopic dermatitis, roflumilast cream 0.5%
670824|NCT00746369|HIV|hiv
670825|NCT00746369|Prevention|prevention
670826|NCT00746369|Adolescents|adolescents
670827|NCT00746369|HIV Seronegativity|hiv seronegativity
670828|NCT00746356|heart failure|heart failure
670829|NCT00746356|cardiac resynchronization therapy|cardiac resynchronization therapy
670830|NCT00746356|autocapture|autocapture
670831|NCT00746356|Current RF|current rf
670832|NCT00746356|Promote RF|promote rf
670833|NCT00746343|Bipolar I Disorder|bipolar i disorder
670834|NCT00746343|Medical Risks|medical risks
670835|NCT00746343|Integrated Risk Reduction Intervention|integrated risk reduction intervention
670836|NCT00746343|Currently in Remission|currently in remission
670837|NCT00746343|BMI|bmi
670838|NCT00746330|Asthma|asthma
670839|NCT00746330|Children|children
670840|NCT00746330|Persistent asthma|persistent asthma
670841|NCT00746304|botulinum|botulinum
670842|NCT00746304|esotropia|esotropia
670843|NCT00746278|Ovarian Cysts|ovarian cysts
670844|NCT00746278|Electrocoagulation|electrocoagulation
670845|NCT00746278|Ovarian Function Tests|ovarian function tests
670846|NCT00746278|Laparoscopy|laparoscopy
670947|NCT00745875|NSCLC|nsclc
670847|NCT00746265|behavioral interventions for weight loss|behavioral interventions for weight loss
670848|NCT00746252|bipolar|bipolar
670849|NCT00746252|children|children
670850|NCT00746252|antipsychotic|antipsychotic
670851|NCT00746252|side effect|side effect
670852|NCT00746239|insomnia|insomnia
670853|NCT00746239|sleep difficulty|sleep difficulty
670854|NCT00746239|panic disorder|panic disorder
670855|NCT00746239|nocturnal panic attacks|nocturnal panic attacks
670856|NCT00746239|anxiety|anxiety
670857|NCT00746226|birch pollen|birch pollen
670858|NCT00746213|Thoracotomy|thoracotomy
670859|NCT00746213|Chronic Pain|chronic pain
670860|NCT00746200|chronic constipation|chronic constipation
670861|NCT00746200|electroacupuncture|electroacupuncture
670862|NCT00746200|randomized controlled trial|randomized controlled trial
670863|NCT00746174|insulin sensitivity|insulin sensitivity
670864|NCT00746174|magnetic resonance spectroscopy (MRS)|magnetic resonance spectroscopy (mrs)
670865|NCT00746174|lipotoxicity|lipotoxicity
670866|NCT00746174|lipid oxidation|lipid oxidation
670867|NCT00746174|thiazolidinediones|thiazolidinediones
670868|NCT00746174|intracellular|intracellular
670869|NCT00746174|triglyceride|triglyceride
670870|NCT00746174|content|content
670871|NCT00746161|total gastrectomy|total gastrectomy
670872|NCT00746161|double tract reconstruction|double tract reconstruction
670873|NCT00746161|gastric cancer|gastric cancer
670874|NCT00746161|Total gastrectomy in patients with gastric cancer|total gastrectomy in patients with gastric cancer
670875|NCT00746148|Polycystic Ovary Syndrome|polycystic ovary syndrome
670876|NCT00746148|Reflexology|reflexology
670877|NCT00746148|Complementary and Alternative Medicine|complementary and alternative medicine
670878|NCT00746148|Endocrinopathy|endocrinopathy
670879|NCT00746148|Oligo|oligo
670880|NCT00746148|Amenorrhoea|amenorrhoea
670881|NCT00746135|Heart failure (NYHA class III and IV)|heart failure (nyha class iii and iv)
670882|NCT00746135|Ventricular Dyssynchrony|ventricular dyssynchrony
670883|NCT00746109|randomized|randomized
670884|NCT00746109|clinical trial|clinical trial
670885|NCT00746109|ultrasound|ultrasound
670886|NCT00746109|prospective|prospective
670887|NCT00746109|abscess|abscess
670888|NCT00746109|packing|packing
670889|NCT00746109|incision and drainage|incision and drainage
670890|NCT00746109|superficial soft tissue infection|superficial soft tissue infection
670891|NCT00746083|pediatric|pediatric
670892|NCT00746083|obesity|obesity
670893|NCT00746083|African American|african american
670894|NCT00746083|adolescents|adolescents
670895|NCT00746083|intervention|intervention
670896|NCT00746083|home-based|home-based
670897|NCT00746083|community-based|community-based
670898|NCT00746070|cardiovascular disease, endothelium function, aldosterone|cardiovascular disease, endothelium function, aldosterone
670899|NCT00746057|Renal graft|renal graft
670900|NCT00746057|chronic rejection|chronic rejection
670901|NCT00746057|tolerance|tolerance
670902|NCT00746057|DNA chip|dna chip
670903|NCT00746057|biopsy|biopsy
670904|NCT00746044|Healthy|healthy
670905|NCT00746031|MTI|mti
670906|NCT00746031|Fibroids|fibroids
670907|NCT00746031|Novel|novel
670908|NCT00746031|MR imaging|mr imaging
670909|NCT00746031|techniques|techniques
670910|NCT00746018|ovary|ovary
670911|NCT00746018|uterus|uterus
670912|NCT00746018|cervix|cervix
670913|NCT00746018|08-092|08-092
670914|NCT00746005|mild cognitive impairment|mild cognitive impairment
670915|NCT00745992|Voriconazole|voriconazole
670916|NCT00745992|Antifungal Agents|antifungal agents
670917|NCT00745992|Invasive fungal infections|invasive fungal infections
670918|NCT00745992|Therapeutic drug monitoring|therapeutic drug monitoring
670919|NCT00745992|CYP Genetic polymorphism|cyp genetic polymorphism
670920|NCT00745966|Bipolar|bipolar
670921|NCT00745966|atypical antipsychotics|atypical antipsychotics
670922|NCT00745966|quality of life|quality of life
670923|NCT00745966|observational|observational
670924|NCT00745953|Metabolic syndrome|metabolic syndrome
670925|NCT00745953|Lipotoxicity|lipotoxicity
670926|NCT00745953|Insulin sensitivity|insulin sensitivity
670927|NCT00745953|Myocardial triglyceride levels|myocardial triglyceride levels
670928|NCT00745953|Hepatic triglyceride levels|hepatic triglyceride levels
670929|NCT00745953|Magnetic resonance spectroscopy|magnetic resonance spectroscopy
670930|NCT00745940|Mindfulness-Based Cognitive Therapy|mindfulness-based cognitive therapy
670931|NCT00745940|MBCT|mbct
670932|NCT00745940|Depression|depression
670933|NCT00745940|Traumatic Brain Injury|traumatic brain injury
670934|NCT00745940|TBI|tbi
670935|NCT00745927|Colorectal neoplasm|colorectal neoplasm
670936|NCT00745927|Colorectal cancer|colorectal cancer
670937|NCT00745927|Screening colonoscopy|screening colonoscopy
670938|NCT00745927|CO2 insufflations|co2 insufflations
670939|NCT00745927|Colonoscopy|colonoscopy
670940|NCT00745914|PPAR-gamma, diabetic, kidney disease, atherosclerosis|ppar-gamma, diabetic, kidney disease, atherosclerosis
670941|NCT00745901|contraception|contraception
670942|NCT00745901|bleeding|bleeding
670943|NCT00745901|cycle control|cycle control
670944|NCT00745888|oxidative stress|oxidative stress
670945|NCT00745888|intensive care|intensive care
670946|NCT00745888|Postoperative intensive care|postoperative intensive care
670948|NCT00745875|Phase II|phase ii
670949|NCT00745875|ZD4054|zd4054
670950|NCT00745875|Pemetrexed|pemetrexed
670951|NCT00745875|Lung Cancer|lung cancer
670952|NCT00745862|Skin|skin
670953|NCT00745849|non-allergic rhinitis, laryngopharyngeal reflux|non-allergic rhinitis, laryngopharyngeal reflux
670954|NCT00745836|insulin sensitivity|insulin sensitivity
670955|NCT00745823|HIV Infections|hiv infections
670956|NCT00745823|Treatment Naïve|treatment naïve
670957|NCT00745810|cardiopulmonary bypass|cardiopulmonary bypass
670958|NCT00745810|oxidative injuries|oxidative injuries
670959|NCT00745797|nonsmall cell lung cancer|nonsmall cell lung cancer
670960|NCT00745797|brain metastasis|brain metastasis
670961|NCT00745797|prophylactic cranial irradiation|prophylactic cranial irradiation
670962|NCT00745784|Young Bereaved Spouses|young bereaved spouses
670963|NCT00745771|pharmacokinetics|pharmacokinetics
670964|NCT00745771|of Diractin®|of diractin®
670965|NCT00745771|safety|safety
670966|NCT00745771|efficacy|efficacy
670967|NCT00745771|exercise|exercise
670968|NCT00745758|SAH, vasospasm, ADMA|sah, vasospasm, adma
670969|NCT00745732|Non-Small Cell Lung Cancer|non-small cell lung cancer
670970|NCT00745732|Lung Cancer|lung cancer
670971|NCT00745732|NSCLC|nsclc
670972|NCT00745732|ZD6474|zd6474
670973|NCT00745732|ZACTIMA|zactima
670974|NCT00745732|Vandetanib|vandetanib
670975|NCT00745732|Inoperable NSCLC|inoperable nsclc
670976|NCT00745732|Unresectable NSCLC|unresectable nsclc
670977|NCT00745732|Radiation Therapy|radiation therapy
670978|NCT00745732|Palliative radiation therapy|palliative radiation therapy
670979|NCT00745732|Angiogenesis|angiogenesis
670980|NCT00745719|parathyroidectomy|parathyroidectomy
670981|NCT00745719|cardiovascular|cardiovascular
670982|NCT00745719|bone|bone
670983|NCT00745719|endstage renal disease|endstage renal disease
670984|NCT00745693|Endothelin|endothelin
670985|NCT00745693|Air pollution|air pollution
670986|NCT00745693|Diesel exhaust|diesel exhaust
670987|NCT00745693|Vascular function|vascular function
670988|NCT00745693|exposure|exposure
670989|NCT00745680|Left ventricular remodeling, acute myocardial infarction|left ventricular remodeling, acute myocardial infarction
670990|NCT00745667|laparoscopic|laparoscopic
670991|NCT00745667|peptic ulcer|peptic ulcer
670992|NCT00745654|Lung Transplantation|lung transplantation
670993|NCT00745654|Chronic pain|chronic pain
670994|NCT00745654|Thoracotomy|thoracotomy
670995|NCT00745641|radiation injury|radiation injury
670996|NCT00745641|computed tomography|computed tomography
670997|NCT00745641|reactive oxygen species|reactive oxygen species
670998|NCT00745641|free radicals|free radicals
670999|NCT00745628|coronary heart disease|coronary heart disease
671000|NCT00745628|secondary prevention|secondary prevention
671001|NCT00745602|direct current cardioversion, cerebral blood flow|direct current cardioversion, cerebral blood flow
671002|NCT00745589|vascular,|vascular,
671003|NCT00745589|valvular calcification,|valvular calcification,
671004|NCT00745589|phosphate binder,|phosphate binder,
671005|NCT00745589|sevelamer,|sevelamer,
671006|NCT00745589|endstage renal disease|endstage renal disease
671007|NCT00745589|peritoneal dialysis|peritoneal dialysis
671008|NCT00745563|infertility|infertility
671009|NCT00745563|insemination|insemination
671010|NCT00745563|slow release|slow release
671011|NCT00745550|SB1518|sb1518
671012|NCT00745550|Chronic Idiopathic Myelofibrosis|chronic idiopathic myelofibrosis
671013|NCT00745550|Myeloproliferative disorders|myeloproliferative disorders
671014|NCT00745550|Polycythemia Vera|polycythemia vera
671015|NCT00745550|Essential Thrombocythemia|essential thrombocythemia
671016|NCT00745550|JAK2 inhibitor|jak2 inhibitor
671017|NCT00745537|postpartum major depression|postpartum major depression
671018|NCT00745537|adolescent mothers|adolescent mothers
671019|NCT00745537|telephone depression care management|telephone depression care management
671020|NCT00745537|barriers to depression care|barriers to depression care
671021|NCT00745524|Attention-deficit hyperactivity disorder|attention-deficit hyperactivity disorder
671022|NCT00745524|adolescent|adolescent
671023|NCT00745524|adult|adult
671024|NCT00745524|high risk population|high risk population
671025|NCT00745524|functional impairment|functional impairment
671026|NCT00745524|quality of life|quality of life
671028|NCT00745511|Avastin|avastin
671029|NCT00745511|ORA102|ora102
671030|NCT00745511|macular degeneration|macular degeneration
671031|NCT00745511|neo-vascular age related macular degeneration (AMD)|neo-vascular age related macular degeneration (amd)
671032|NCT00745498|Proliferative diabetic retinopathy|proliferative diabetic retinopathy
671033|NCT00745498|vitrectomy|vitrectomy
671034|NCT00745498|bevacizumab|bevacizumab
671035|NCT00745498|vitreous hemorrhage|vitreous hemorrhage
671036|NCT00745485|Osteoporosis|osteoporosis
671037|NCT00745485|zoledronic acid|zoledronic acid
671038|NCT00745485|postmenopausal women|postmenopausal women
671039|NCT00745472|AEP|aep
671040|NCT00745472|experimental pain|experimental pain
671041|NCT00745472|healthy volunteers|healthy volunteers
671042|NCT00745459|Patients|patients
671043|NCT00745459|undergoing|undergoing
671044|NCT00745459|gastric|gastric
671045|NCT00745459|endoscopy|endoscopy
671046|NCT00745446|Air pollution|air pollution
671047|NCT00745446|Diesel exhaust|diesel exhaust
671048|NCT00745446|Endothelial function|endothelial function
671049|NCT00745446|Vascular function|vascular function
671050|NCT00745446|Particle trap|particle trap
671051|NCT00745446|Thrombosis|thrombosis
671053|NCT00745446|inhalation|inhalation
671054|NCT00745420|Sickle Cell Disease|sickle cell disease
671055|NCT00745420|Sickle Cell Anemia|sickle cell anemia
671056|NCT00745407|adipocytokines|adipocytokines
671057|NCT00745407|insulin sensitivity|insulin sensitivity
671058|NCT00745407|hypertriglyceridemic patients|hypertriglyceridemic patients
671059|NCT00745394|NIRS|nirs
671060|NCT00745394|bypass|bypass
671061|NCT00745394|cardiopulmonary|cardiopulmonary
671062|NCT00745394|CPB|cpb
671063|NCT00745394|monitoring|monitoring
671064|NCT00745394|system|system
671065|NCT00745381|PANCREAS|pancreas
671066|NCT00745381|STOMACH|stomach
671067|NCT00745381|Questionnaire|questionnaire
671068|NCT00745381|08-105|08-105
671069|NCT00745368|HIV|hiv
671070|NCT00745368|Raltegravir|raltegravir
671071|NCT00745368|pharmacokinetics|pharmacokinetics
671072|NCT00745368|Treatment Experienced|treatment experienced
671073|NCT00745355|Quality of Life|quality of life
671074|NCT00745355|Questionnaires|questionnaires
671075|NCT00745355|08-076|08-076
671076|NCT00745342|type 1 diabetes|type 1 diabetes
671077|NCT00745342|glycemic control|glycemic control
671078|NCT00745342|family conflict|family conflict
671079|NCT00745342|quality of life|quality of life
671080|NCT00745342|parental involvement|parental involvement
671081|NCT00745316|Heart Failure|heart failure
671082|NCT00745316|Renal Insufficiency|renal insufficiency
671083|NCT00745316|Congestive Heart Failure|congestive heart failure
671084|NCT00745303|Tai Chi Chuan; Lipid; Cytokine|tai chi chuan; lipid; cytokine
671085|NCT00745290|Total knee arthroplasty|total knee arthroplasty
671086|NCT00745290|Pain|pain
671087|NCT00745290|Analgesia|analgesia
671088|NCT00745264|heat|heat
671089|NCT00745264|exercise|exercise
671090|NCT00745251|Sleep apnea; obesity|sleep apnea; obesity
671091|NCT00745238|endothelial function|endothelial function
671092|NCT00745238|peripheral arterial tone|peripheral arterial tone
671093|NCT00745238|systemic inflammation|systemic inflammation
671094|NCT00745238|oxidative stress|oxidative stress
671095|NCT00745238|respiratory and peripheral muscular function|respiratory and peripheral muscular function
671096|NCT00745225|peritoneal dialysis, cardiovascular, PPAR-gamma|peritoneal dialysis, cardiovascular, ppar-gamma
671097|NCT00745212|venous thromboembolism diseases|venous thromboembolism diseases
671098|NCT00745212|placental vascular pathologies|placental vascular pathologies
671099|NCT00745212|antithrombotic treatment|antithrombotic treatment
671100|NCT00745212|symptomatic thromboembolic events|symptomatic thromboembolic events
671101|NCT00745212|pregnant women|pregnant women
671102|NCT00745212|score|score
671103|NCT00745212|therapeutic strategies|therapeutic strategies
671104|NCT00745212|heparin|heparin
671105|NCT00745212|aspirin|aspirin
671106|NCT00745212|pregnancy pathology|pregnancy pathology
671107|NCT00745199|End Stage Renal Disease|end stage renal disease
671108|NCT00745199|Cromolyn Sodium|cromolyn sodium
671109|NCT00745199|Pruritus|pruritus
671110|NCT00745199|Tryptase|tryptase
671111|NCT00745160|Questionaires|questionaires
671112|NCT00745147|constipation|constipation
671113|NCT00745147|traditional Chinese medicine|traditional chinese medicine
671114|NCT00745147|Chinese herbal formula|chinese herbal formula
671115|NCT00745147|lactulose|lactulose
671116|NCT00745147|cost-effective|cost-effective
671117|NCT00745147|long-term care|long-term care
671118|NCT00745095|Safety|safety
671119|NCT00745095|Efficacy|efficacy
671120|NCT00745095|Colonoscopy|colonoscopy
671121|NCT00745095|PIEE|piee
671122|NCT00745095|MoviPrep|moviprep
671123|NCT00745095|Neostigmine|neostigmine
671124|NCT00745095|Glycopyrrolate|glycopyrrolate
671125|NCT00745069|Tapentadol|tapentadol
671126|NCT00745069|Osteoarthritis|osteoarthritis
671127|NCT00745069|Analgesia|analgesia
671128|NCT00745069|Chronic pain|chronic pain
671129|NCT00745056|Cognition|cognition
671130|NCT00745056|Memory|memory
671131|NCT00745056|Hormone Therapy|hormone therapy
671132|NCT00745056|HT|ht
671133|NCT00745043|COPD|copd
671134|NCT00745043|Betablockers|betablockers
671135|NCT00745043|bronchodilator|bronchodilator
671136|NCT00745043|exercise capacity|exercise capacity
671137|NCT00745043|methacholine challenge|methacholine challenge
671138|NCT00745030|Parkinson's disease|parkinson's disease
671139|NCT00745030|Multiple Systems Atrophy|multiple systems atrophy
671140|NCT00745030|Lewy Body Dementia|lewy body dementia
671141|NCT00745017|recurrent depression|recurrent depression
671142|NCT00745017|major depressive disorder|major depressive disorder
671143|NCT00745017|interpersonal therapy|interpersonal therapy
671144|NCT00745017|cognitive behavioral therapy|cognitive behavioral therapy
671145|NCT00745017|antidepressant therapies|antidepressant therapies
671146|NCT00745017|outome predictors|outome predictors
671147|NCT00745017|personality dimensions|personality dimensions
671148|NCT00745004|IBS D|ibs d
671149|NCT00744978|Efficacy|efficacy
671150|NCT00744978|Safety|safety
671151|NCT00744978|Pharmacokinetics|pharmacokinetics
671152|NCT00744978|Alzheimer's disease|alzheimer's disease
671153|NCT00744952|Large-vessel vasculitis|large-vessel vasculitis
671154|NCT00744939|Gadolinium|gadolinium
671155|NCT00744939|NSF|nsf
671156|NCT00744939|Renal Impairment|renal impairment
671157|NCT00744939|chemically induced|chemically induced
671158|NCT00744939|adverse effects|adverse effects
671159|NCT00744939|Contrast Media|contrast media
671160|NCT00744939|complications|complications
671161|NCT00744913|Pregnancy|pregnancy
671162|NCT00744913|Women|women
671163|NCT00744913|Nicotine replacement therapy|nicotine replacement therapy
671164|NCT00744913|Smoking cessation|smoking cessation
671165|NCT00744900|Pemetrexed, Non-Small Cell Lung Cancer, brain metastasis|pemetrexed, non-small cell lung cancer, brain metastasis
671166|NCT00744887|TMC114-TiDP3-C181|tmc114-tidp3-c181
671167|NCT00744887|TMC114-C181, health volunteers, Darunavir, ritonavir oral solution|tmc114-c181, health volunteers, darunavir, ritonavir oral solution
671168|NCT00744874|atrial fibrillation|atrial fibrillation
671169|NCT00744861|Lumbar Fusion|lumbar fusion
671170|NCT00744861|exospine|exospine
671171|NCT00744861|Exo-Spine|exo-spine
671172|NCT00744848|hemorrhoids|hemorrhoids
671173|NCT00744835|atrial fibrillation|atrial fibrillation
671174|NCT00744822|Lung Transplantation|lung transplantation
671175|NCT00744822|Infections|infections
671176|NCT00744822|Graft Rejection|graft rejection
671177|NCT00744809|TMC278-C152|tmc278-c152
671178|NCT00744809|TMC278-TiDP6-C152|tmc278-tidp6-c152
671179|NCT00744809|Healthy Volunteers|healthy volunteers
671180|NCT00744809|QT/QTc interval|qt/qtc interval
671181|NCT00744796|Endothelial Dystrophy|endothelial dystrophy
671182|NCT00744796|Fuchs' Endothelial Corneal Dystrophy|fuchs' endothelial corneal dystrophy
671183|NCT00744770|TMC278-TiDP6-C121|tmc278-tidp6-c121
671184|NCT00744770|TMC278-C121|tmc278-c121
671185|NCT00744770|open-label|open-label
671186|NCT00744770|drug-drug interaction|drug-drug interaction
671187|NCT00744770|methadone|methadone
671188|NCT00744770|TMC278|tmc278
671189|NCT00744757|5-aza-2'-deoxycytidine|5-aza-2'-deoxycytidine
671190|NCT00744757|decitabine|decitabine
671191|NCT00744757|dacogen|dacogen
671192|NCT00744757|Myelodysplastic Syndrome|myelodysplastic syndrome
671193|NCT00744744|stage 0 bladder cancer|stage 0 bladder cancer
671194|NCT00744731|Partial-onset Seizures|partial-onset seizures
671195|NCT00744731|Simple Partial Seizures|simple partial seizures
671196|NCT00744731|Complex Partial Seizures|complex partial seizures
671197|NCT00744705|Retinal nerve fiber layer|retinal nerve fiber layer
671198|NCT00744705|Glaucoma|glaucoma
671199|NCT00744705|Myopia|myopia
671200|NCT00744692|Immunodeficiencies|immunodeficiencies
671201|NCT00744692|Congenital Marrow Failures|congenital marrow failures
671202|NCT00744692|Hemoglobinopathies|hemoglobinopathies
671203|NCT00744692|Inborn Errors of Metabolism|inborn errors of metabolism
671204|NCT00744692|SCIDS|scids
671205|NCT00744692|Wiskott Aldrich|wiskott aldrich
671206|NCT00744692|FEL|fel
671207|NCT00744692|HLH|hlh
671208|NCT00744692|IPEX|ipex
671209|NCT00744692|LAD|lad
671210|NCT00744692|Sickle Cell|sickle cell
671211|NCT00744692|Thalassemia|thalassemia
671212|NCT00744692|Omenn's Syndrome|omenn's syndrome
671213|NCT00744692|Hurler's Syndrome|hurler's syndrome
671214|NCT00744692|MLD|mld
671215|NCT00744692|ALD|ald
671216|NCT00744692|Sanfilippo|sanfilippo
671217|NCT00744692|Krabbe|krabbe
671218|NCT00744692|Hunter's syndrome|hunter's syndrome
671219|NCT00744692|TaySachs|taysachs
671220|NCT00744692|Diamond Blackfan Anemia|diamond blackfan anemia
671221|NCT00744692|transplant|transplant
671223|NCT00744692|Gaucher|gaucher
671224|NCT00744679|MS|ms
671225|NCT00744679|Multiple Sclerosis|multiple sclerosis
671226|NCT00744666|Intravitreal triamcinolone acetonide|intravitreal triamcinolone acetonide
671227|NCT00744666|Side-effects|side-effects
671228|NCT00744666|Ocular hypertension|ocular hypertension
671229|NCT00744666|Glaucoma|glaucoma
671230|NCT00744666|Prevention|prevention
671231|NCT00744666|Vitreoretinal diseases requiring IVTA for treatment|vitreoretinal diseases requiring ivta for treatment
671232|NCT00744653|Breast Cancer|breast cancer
671233|NCT00744653|Recurrence|recurrence
671234|NCT00744640|advanced pancreatic cancer|advanced pancreatic cancer
671235|NCT00744640|palliative chemotherapy|palliative chemotherapy
671236|NCT00744640|first-line therapy|first-line therapy
671237|NCT00744640|capecitabine|capecitabine
671238|NCT00744640|oxaliplatin|oxaliplatin
671239|NCT00744640|gemcitabine|gemcitabine
671240|NCT00744640|dose-finding study|dose-finding study
671241|NCT00744640|Phase II|phase ii
671242|NCT00744627|Generalized Anxiety Disorder|generalized anxiety disorder
671243|NCT00744627|Anxiety Disorders|anxiety disorders
671244|NCT00744627|Drug Therapy|drug therapy
671245|NCT00744614|PC02|pc02
671246|NCT00744614|Respiratory Rate|respiratory rate
671247|NCT00744614|Arterial blood gas|arterial blood gas
671248|NCT00744614|Intubation|intubation
671249|NCT00744614|Capnography|capnography
671250|NCT00744601|impulsivity|impulsivity
671251|NCT00744601|cocaine dependence|cocaine dependence
671252|NCT00744601|relapse|relapse
671253|NCT00744601|neuroimaging|neuroimaging
671254|NCT00744601|functional magnetic resonance imaging (fMRI)|functional magnetic resonance imaging (fmri)
671255|NCT00744601|single photon emission computed tomography (SPECT)|single photon emission computed tomography (spect)
671256|NCT00744588|substance abuse|substance abuse
671257|NCT00744588|alcohol dependence|alcohol dependence
671258|NCT00744588|hypothalamic-pituitary-adrenal (HPA) system|hypothalamic-pituitary-adrenal (hpa) system
671259|NCT00744588|cosyntropin|cosyntropin
671260|NCT00744588|corticotropin-releasing Hormone (CRH)|corticotropin-releasing hormone (crh)
671261|NCT00744588|pituitary-adrenal system|pituitary-adrenal system
671262|NCT00744588|stress|stress
671263|NCT00744588|trauma|trauma
671264|NCT00744588|neurosteroids|neurosteroids
671265|NCT00744588|cortisol|cortisol
671266|NCT00744588|relapse|relapse
671267|NCT00744575|back pain|back pain
671268|NCT00744575|eeg|eeg
671269|NCT00744575|chronic pain|chronic pain
671270|NCT00744562|Phase 1,|phase 1,
671271|NCT00744562|dose escalation,|dose escalation,
671272|NCT00744562|histologically|histologically
671273|NCT00744562|confirmed|confirmed
671274|NCT00744562|malignancy|malignancy
671275|NCT00744562|metastatic|metastatic
671276|NCT00744549|Male Urogenital Diseases|male urogenital diseases
671277|NCT00744549|Antioxidants|antioxidants
671278|NCT00744549|Vitamin E|vitamin e
671279|NCT00744549|Vitamin D|vitamin d
671280|NCT00744549|Lycopene|lycopene
671281|NCT00744549|Selenium|selenium
671282|NCT00744536|Myelodysplastic syndrome|myelodysplastic syndrome
671283|NCT00744536|Chronic myelomonocytic leukemia|chronic myelomonocytic leukemia
671284|NCT00744536|High intermediate risk and high risk IPSS score|high intermediate risk and high risk ipss score
671285|NCT00744536|Angiogenesis|angiogenesis
671286|NCT00744536|Metronomic chemotherapy|metronomic chemotherapy
671287|NCT00744536|Myelodysplastic Myeloproliferative Diseases|myelodysplastic myeloproliferative diseases
671288|NCT00744523|carotid artery stenting|carotid artery stenting
671289|NCT00744523|stroke|stroke
671290|NCT00744523|cerebral protection|cerebral protection
671291|NCT00744523|high surgical risk|high surgical risk
671292|NCT00744510|Polycystic Ovary Syndrome|polycystic ovary syndrome
671293|NCT00744510|Reflexology|reflexology
671294|NCT00744510|Complementary and Alternative Medicine|complementary and alternative medicine
671295|NCT00744510|Endocrinopathy|endocrinopathy
671296|NCT00744510|Oligo|oligo
671297|NCT00744510|Amenorrhoea|amenorrhoea
671298|NCT00744484|Chronic Obstructive Pulmonary Disease|chronic obstructive pulmonary disease
671299|NCT00744484|COPD|copd
671300|NCT00744484|Physical group training|physical group training
671301|NCT00744484|Water exercise|water exercise
671302|NCT00744484|Cardiorespiratory fitness|cardiorespiratory fitness
671303|NCT00744484|Functional exercise capacity|functional exercise capacity
671304|NCT00744484|Health related quality of life|health related quality of life
671305|NCT00744471|monoclonal antibody RN624 PF-04383119 nerve growth factor anti-nerve growth OA|monoclonal antibody rn624 pf-04383119 nerve growth factor anti-nerve growth oa
671306|NCT00744458|Primary Health care in rural Africa|primary health care in rural africa
671307|NCT00744458|Chronic non-communicable diseases|chronic non-communicable diseases
671308|NCT00744458|Patient Compliance|patient compliance
671309|NCT00744458|Treatment adherence|treatment adherence
671310|NCT00744445|hemodialysis|hemodialysis
671311|NCT00744445|erythropoietin|erythropoietin
671312|NCT00744419|GERD|gerd
671313|NCT00744419|pharmacokinetics|pharmacokinetics
671314|NCT00744419|pantoprazole|pantoprazole
671315|NCT00744419|neonates|neonates
671316|NCT00744419|infants|infants
671317|NCT00744406|recurrent depression|recurrent depression
671318|NCT00744406|major depressive disorder|major depressive disorder
671319|NCT00744406|interpersonal therapy|interpersonal therapy
671320|NCT00744406|cognitive behavioral therapy|cognitive behavioral therapy
671321|NCT00744406|antidepressant treatment|antidepressant treatment
671322|NCT00744406|outcome predictors|outcome predictors
671323|NCT00744406|personality dimensions|personality dimensions
671324|NCT00744393|sleep|sleep
671325|NCT00744393|critically ill|critically ill
671326|NCT00744393|mechanical ventilation|mechanical ventilation
671327|NCT00744380|Analgesia|analgesia
671328|NCT00744380|Mechanical ventilation|mechanical ventilation
671329|NCT00744354|refractory multiple myeloma|refractory multiple myeloma
671330|NCT00744354|stage I multiple myeloma|stage i multiple myeloma
671331|NCT00744354|stage II multiple myeloma|stage ii multiple myeloma
671332|NCT00744354|stage III multiple myeloma|stage iii multiple myeloma
671333|NCT00744341|SLV320; Acute Decompensated Heart Failure (ADHF); chronic heart failure; renal failure; I.V. doses; hospitalization|slv320; acute decompensated heart failure (adhf); chronic heart failure; renal failure; i.v. doses; hospitalization
671334|NCT00744328|Postpartum depression|postpartum depression
671335|NCT00744328|estradiol|estradiol
671336|NCT00744328|Postpartum major depressive disorder|postpartum major depressive disorder
671337|NCT00744315|myocardial revascularization|myocardial revascularization
671338|NCT00744315|myocardial ischemia|myocardial ischemia
671339|NCT00744315|genetics, medical|genetics, medical
671340|NCT00744315|Angiogenesis Inducing Agents|angiogenesis inducing agents
671341|NCT00744302|Dialysate calcium|dialysate calcium
671342|NCT00744302|Mineral metabolism|mineral metabolism
671343|NCT00744302|Parathyroid hormone|parathyroid hormone
671344|NCT00744302|Calcification|calcification
671345|NCT00744302|Cardiovascular disease|cardiovascular disease
671346|NCT00744302|Haemodialysis|haemodialysis
671347|NCT00744289|Hepatitis B|hepatitis b
671348|NCT00744289|People who inject drugs|people who inject drugs
671349|NCT00744289|Financial incentive|financial incentive
671350|NCT00744289|Vaccine completion|vaccine completion
671351|NCT00744276|fibrocystic breast disease|fibrocystic breast disease
671352|NCT00744276|fibrocystic disease of breast|fibrocystic disease of breast
671353|NCT00744276|breast pain|breast pain
671354|NCT00744276|mastalgia|mastalgia
671355|NCT00744276|cyclic mastalgia|cyclic mastalgia
671356|NCT00744276|cystic breast disease|cystic breast disease
671357|NCT00744250|Exocrine Pancreatic Insufficiency|exocrine pancreatic insufficiency
671358|NCT00744250|Chronic Pancreatitis|chronic pancreatitis
671359|NCT00744250|Cystic fibrosis|cystic fibrosis
671360|NCT00744250|Pancrelipase|pancrelipase
671361|NCT00744250|Pancrecarb|pancrecarb
671362|NCT00744250|Intraduodenal aspiration|intraduodenal aspiration
671363|NCT00744250|Bioavailability|bioavailability
671364|NCT00744237|nebivolol|nebivolol
671365|NCT00744237|Bystolic ™|bystolic ™
671366|NCT00744237|Hypertension|hypertension
671367|NCT00744237|Diabetes|diabetes
671368|NCT00744198|Autologous|autologous
671369|NCT00744198|Biological|biological
671370|NCT00744198|Mesh|mesh
671371|NCT00744198|Polypropylene|polypropylene
671372|NCT00744198|Sling|sling
671373|NCT00744198|Synthetic|synthetic
671374|NCT00744198|Stress incontinence|stress incontinence
671375|NCT00744198|Surgery|surgery
671377|NCT00744198|Treatment|treatment
671378|NCT00744185|infantile capillary hemangiomas|infantile capillary hemangiomas
671379|NCT00744185|propranolol|propranolol
671380|NCT00744185|ultrasonography|ultrasonography
671381|NCT00744172|hysterectomy|hysterectomy
671382|NCT00744172|vaginal|vaginal
671383|NCT00744172|laparoscopy|laparoscopy
671384|NCT00744172|abdominal|abdominal
671385|NCT00744172|complication|complication
671386|NCT00744172|quality of life|quality of life
671387|NCT00744172|cost-effectiveness|cost-effectiveness
671388|NCT00744172|Morbidity of three types of hysterectomy|morbidity of three types of hysterectomy
671389|NCT00744159|colon cancer|colon cancer
671390|NCT00744159|laparoscopic colorectal surgery|laparoscopic colorectal surgery
671391|NCT00744159|cellular immunity|cellular immunity
671392|NCT00744159|HLA-DR expression on monocyte|hla-dr expression on monocyte
671393|NCT00744133|Plasmodium falciparum, NF54, Anopheles stephensi, mosquito, malaria|plasmodium falciparum, nf54, anopheles stephensi, mosquito, malaria
671394|NCT00744120|cancer|cancer
671395|NCT00744107|Ischemic coronary artery disease in native coronary arteries|ischemic coronary artery disease in native coronary arteries
671396|NCT00744107|Single stent|single stent
671397|NCT00744107|RVD 2.5- 4.0mm|rvd 2.5- 4.0mm
671398|NCT00744107|Lesion length up to 26mm|lesion length up to 26mm
671399|NCT00744107|de novo or previously unstented lesions|de novo or previously unstented lesions
671400|NCT00744094|resistance training|resistance training
671401|NCT00744094|protein supplementation|protein supplementation
671402|NCT00744094|hypertrophy|hypertrophy
671403|NCT00744068|Stimulant|stimulant
671404|NCT00744068|Drug treatment|drug treatment
671405|NCT00744068|Continuing care|continuing care
671406|NCT00744068|Telephone support|telephone support
671407|NCT00744068|Aftercare|aftercare
671408|NCT00744055|alcohol dependence|alcohol dependence
671409|NCT00744055|post traumatic stress disorder|post traumatic stress disorder
671410|NCT00744055|treatment|treatment
671411|NCT00744055|prazosin|prazosin
671412|NCT00744042|Hypophosphatasia|hypophosphatasia
671413|NCT00744042|HPP|hpp
671414|NCT00744042|Bone Disease|bone disease
671415|NCT00744042|Soft Bones|soft bones
671416|NCT00744042|Low Alkaline Phosphatase|low alkaline phosphatase
671417|NCT00744042|genetic metabolic disorder|genetic metabolic disorder
671418|NCT00744042|alkaline phosphatase|alkaline phosphatase
671419|NCT00744042|tissue non-specific alkaline phosphatase|tissue non-specific alkaline phosphatase
671420|NCT00744042|rickets|rickets
671421|NCT00744042|osteomalacia|osteomalacia
671422|NCT00744029|prehospital delays|prehospital delays
671423|NCT00744029|intervention|intervention
671424|NCT00744029|population-based|population-based
671425|NCT00744029|stroke|stroke
671426|NCT00744016|UC|uc
671427|NCT00744016|Ulcerative colitis|ulcerative colitis
671428|NCT00744016|IBD|ibd
671429|NCT00744016|Inflammatory bowel disease|inflammatory bowel disease
671430|NCT00743990|Cough symptoms|cough symptoms
671431|NCT00743990|Cold symptoms|cold symptoms
671432|NCT00743990|Congestion|congestion
671433|NCT00743990|Children|children
671434|NCT00743990|URI|uri
671435|NCT00743990|Alternative cough symptom treatment|alternative cough symptom treatment
671436|NCT00743951|patient decision aids|patient decision aids
671437|NCT00743951|patient preferences|patient preferences
671438|NCT00743951|osteoarthritis|osteoarthritis
671439|NCT00743951|joint replacement|joint replacement
671440|NCT00743951|waiting times|waiting times
671441|NCT00743925|Unstable Angina|unstable angina
671442|NCT00743925|STEMI|stemi
671443|NCT00743925|NSTEMI|nstemi
671445|NCT00743925|Acute Coronary Syndrome|acute coronary syndrome
671446|NCT00743925|C14.280.647.124|c14.280.647.124
671447|NCT00743925|C14.280.647.500|c14.280.647.500
671448|NCT00743912|rifaximin|rifaximin
671449|NCT00743912|midazolam|midazolam
671450|NCT00743912|pharmacokinetics|pharmacokinetics
671451|NCT00743899|Angioplasty, Transluminal, Percutaneous Coronary|angioplasty, transluminal, percutaneous coronary
671452|NCT00743899|Everolimus-eluting stent|everolimus-eluting stent
671453|NCT00743873|medial retinaculum tear s/p patella dislocation|medial retinaculum tear s/p patella dislocation
671454|NCT00743860|darapladib|darapladib
671455|NCT00743860|pharmacokinetics|pharmacokinetics
671456|NCT00743860|metabolite|metabolite
671457|NCT00743860|SB-480848|sb-480848
671458|NCT00743847|schizophrenia, treatment, cognition|schizophrenia, treatment, cognition
671459|NCT00743808|hypertension|hypertension
671460|NCT00743808|diabetes|diabetes
671461|NCT00743808|quality improvement|quality improvement
671462|NCT00743808|blood pressure|blood pressure
671463|NCT00743795|Hepatitis C|hepatitis c
671464|NCT00743795|HCV|hcv
671465|NCT00743795|Rapid Virologic Response|rapid virologic response
671466|NCT00743795|Sustained Virologic Response|sustained virologic response
671467|NCT00743795|HCV RNA|hcv rna
671468|NCT00743795|Polymerase inhibitor|polymerase inhibitor
671469|NCT00743795|GS-9190|gs-9190
671470|NCT00743782|Hypoparathyroidism|hypoparathyroidism
671471|NCT00743782|Parathyroid Hormone 1-34|parathyroid hormone 1-34
671472|NCT00743769|Myocardial Infarction|myocardial infarction
671473|NCT00743769|Myocardial Ischemia|myocardial ischemia
671474|NCT00743769|Myocardial Diseases|myocardial diseases
671475|NCT00743769|Infarction|infarction
671476|NCT00743756|obesity|obesity
671477|NCT00743756|diabetes|diabetes
671478|NCT00743756|endothelial function|endothelial function
671479|NCT00743756|insulin sensitivity|insulin sensitivity
671480|NCT00743743|dementia|dementia
671481|NCT00743743|Alzheimer disease|alzheimer disease
671482|NCT00743743|cognition|cognition
671483|NCT00743743|function|function
671484|NCT00743743|behavior|behavior
671485|NCT00743743|treatment|treatment
671486|NCT00743730|developmental delay|developmental delay
671487|NCT00743730|cognitive impairment|cognitive impairment
671488|NCT00743730|pain control|pain control
671489|NCT00743730|post operative pain|post operative pain
671490|NCT00743730|opioid|opioid
671491|NCT00743730|pain assessment|pain assessment
671492|NCT00743730|Parent Nurse controlled Analgesic|parent nurse controlled analgesic
671493|NCT00743730|patient controlled analgesic|patient controlled analgesic
671494|NCT00743730|children|children
671495|NCT00743730|pain|pain
671496|NCT00743730|analgesic|analgesic
671497|NCT00743730|safety|safety
671498|NCT00743730|parent satisfaction|parent satisfaction
671499|NCT00743730|nurse satisfaction|nurse satisfaction
671500|NCT00743730|Pediatric|pediatric
671501|NCT00743717|total knee arthroplasty|total knee arthroplasty
671502|NCT00743717|osteoarthritis|osteoarthritis
671503|NCT00743717|ceramic bearing|ceramic bearing
671504|NCT00743717|zirconia|zirconia
671505|NCT00743691|Ethiopia|ethiopia
671506|NCT00743691|Community|community
671507|NCT00743691|Community based|community based
671508|NCT00743691|Health extension Worker|health extension worker
671509|NCT00743691|Health Extension Program|health extension program
671510|NCT00743678|Colorectal Cancer|colorectal cancer
671511|NCT00743678|Unresectable liver metastasis|unresectable liver metastasis
671512|NCT00743678|FOLFOX6|folfox6
671513|NCT00743678|Cetuximab|cetuximab
671514|NCT00743678|Neoadjuvant therapy|neoadjuvant therapy
671515|NCT00743665|Youth|youth
671516|NCT00743665|consensus|consensus
671517|NCT00743665|criteria|criteria
671518|NCT00743665|CVS|cvs
671519|NCT00743652|13 valent Pneumococcal Conjugate Vaccine|13 valent pneumococcal conjugate vaccine
671520|NCT00743652|Antibody Response|antibody response
671521|NCT00743652|safety|safety
671522|NCT00743652|Alaskan Native Children|alaskan native children
671523|NCT00743639|Cardiomyopathy|cardiomyopathy
671524|NCT00743639|stem cell|stem cell
671525|NCT00743639|cardiac failure|cardiac failure
671526|NCT00743626|Pap test|pap test
671527|NCT00743626|HPV|hpv
671528|NCT00743626|Healthy patients screened for cervical cancer tests.|healthy patients screened for cervical cancer tests.
671529|NCT00743613|Erectile Dysfunction|erectile dysfunction
671530|NCT00743613|ED|ed
671531|NCT00743613|Peripheral Arterial Disease|peripheral arterial disease
671532|NCT00743613|PAD|pad
671533|NCT00743613|Ankle-Brachial Index|ankle-brachial index
671534|NCT00743613|ABI|abi
671535|NCT00743600|ultrasound|ultrasound
671536|NCT00743600|rotator cuff|rotator cuff
671537|NCT00743561|MSA|msa
671538|NCT00743561|sleep apnea|sleep apnea
671539|NCT00743561|ambulatory polygraphy|ambulatory polygraphy
671540|NCT00743561|polysomnography|polysomnography
671541|NCT00743548|interdental self-care aids|interdental self-care aids
671542|NCT00743548|plaque|plaque
671543|NCT00743548|bleeding gums|bleeding gums
671544|NCT00743535|Cystocele|cystocele
671545|NCT00743535|Mesh|mesh
671546|NCT00743535|Prolapse|prolapse
671547|NCT00743535|Sling|sling
671548|NCT00743535|Stress incontinence|stress incontinence
671549|NCT00743535|Surgery|surgery
671550|NCT00743535|TOT|tot
671551|NCT00743535|TVT|tvt
671552|NCT00743535|Treatment|treatment
671553|NCT00743522|Reducing shocks|reducing shocks
671554|NCT00743509|sarcoma|sarcoma
671555|NCT00743509|Cyclophosphamide|cyclophosphamide
671556|NCT00743509|Sirolimus|sirolimus
671557|NCT00743509|Progressive or recurrent, advanced (unresectable or metastatic) high-grade osteosarcoma, Ewing's or soft tissue sarcoma previously treated with chemotherapy.|progressive or recurrent, advanced (unresectable or metastatic) high-grade osteosarcoma, ewing's or soft tissue sarcoma previously treated with chemotherapy.
671558|NCT00743483|cystic fibrosis|cystic fibrosis
671559|NCT00743483|pancreatic insufficiency|pancreatic insufficiency
671560|NCT00743483|bucelipase alfa|bucelipase alfa
671561|NCT00743483|bile salt stimulating lipase|bile salt stimulating lipase
671562|NCT00743483|BSSL|bssl
671563|NCT00743483|coefficient of fat absorption|coefficient of fat absorption
671564|NCT00743470|HIV co-infected with tuberculosis|hiv co-infected with tuberculosis
671565|NCT00743457|Possible VPS failure with symptom such as headache|possible vps failure with symptom such as headache
671566|NCT00743457|vomiting|vomiting
671567|NCT00743457|lethargy|lethargy
671568|NCT00743457|VPS failure|vps failure
671569|NCT00743444|GERD|gerd
671570|NCT00743444|transient lower esophageal sphincter relaxations (TLESRs)|transient lower esophageal sphincter relaxations (tlesrs)
671571|NCT00743444|reflux|reflux
671572|NCT00743405|schizophrenia|schizophrenia
671573|NCT00743405|M1 receptor agonist|m1 receptor agonist
671574|NCT00743405|safety|safety
671575|NCT00743405|pharmacokinetics|pharmacokinetics
671576|NCT00743405|GSK1034702|gsk1034702
671577|NCT00743379|Phase 1/2|phase 1/2
671578|NCT00743379|Advanced Solid Tumors|advanced solid tumors
671579|NCT00743379|Hypoxia|hypoxia
671580|NCT00743379|Prodrug|prodrug
671581|NCT00743379|Dose-Escalation|dose-escalation
671582|NCT00743379|Evofosfamide|evofosfamide
671583|NCT00743366|quetiapine|quetiapine
671584|NCT00743366|smoked marijuana|smoked marijuana
671585|NCT00743366|marijuana use|marijuana use
671586|NCT00743353|laryngeal|laryngeal
671587|NCT00743353|squamous cell|squamous cell
671588|NCT00743353|anaplastic astrocytoma|anaplastic astrocytoma
671589|NCT00743353|oligodendroglioma|oligodendroglioma
671590|NCT00743353|glioblastoma multiforme|glioblastoma multiforme
671591|NCT00743340|HIV-1 infection|hiv-1 infection
671592|NCT00743340|emtricitabine|emtricitabine
671593|NCT00743340|pediatrics|pediatrics
671594|NCT00743340|pediatric patients|pediatric patients
671595|NCT00743327|hormone therapy|hormone therapy
671596|NCT00743314|lymphedema|lymphedema
671597|NCT00743314|stage I breast cancer|stage i breast cancer
671598|NCT00743314|stage II breast cancer|stage ii breast cancer
671599|NCT00743301|CVD|cvd
671600|NCT00743301|Palm olein|palm olein
671601|NCT00743301|Olive oil|olive oil
671602|NCT00743301|Lard|lard
671603|NCT00743301|healthy men|healthy men
671604|NCT00743301|metabolic syndrome|metabolic syndrome
671605|NCT00743301|Risk of cardiovascular disease and metabolic syndrome|risk of cardiovascular disease and metabolic syndrome
671606|NCT00743288|stage I multiple myeloma|stage i multiple myeloma
671607|NCT00743288|stage II multiple myeloma|stage ii multiple myeloma
671608|NCT00743288|stage III multiple myeloma|stage iii multiple myeloma
671609|NCT00743288|refractory multiple myeloma|refractory multiple myeloma
671610|NCT00743275|Influenza|influenza
671611|NCT00743262|laryngectomy|laryngectomy
671612|NCT00743262|larynx cancer|larynx cancer
671613|NCT00743249|Dry eye|dry eye
671614|NCT00743249|Tear duct|tear duct
671615|NCT00743249|Punctal plug|punctal plug
671616|NCT00743236|perioperative/postoperative complications|perioperative/postoperative complications
671617|NCT00743236|urinary complications|urinary complications
671618|NCT00743236|long-term effects secondary to cancer therapy in adults|long-term effects secondary to cancer therapy in adults
671619|NCT00743236|stage I renal cell cancer|stage i renal cell cancer
671620|NCT00743223|temporomandibular disorder|temporomandibular disorder
671621|NCT00743223|orofacial pain|orofacial pain
671622|NCT00743223|posture of the head|posture of the head
671623|NCT00743210|pregnancy|pregnancy
671624|NCT00743210|obesity|obesity
671625|NCT00743210|asymmetric dimethylarginine|asymmetric dimethylarginine
671626|NCT00743210|L-arginine|l-arginine
671627|NCT00743210|L-citrulline|l-citrulline
671628|NCT00743197|coronary artery disease (CAD)|coronary artery disease (cad)
671629|NCT00743197|chest pain|chest pain
671630|NCT00743197|myocardial ischemia|myocardial ischemia
671631|NCT00743197|endothelial function|endothelial function
671632|NCT00743184|BPH|bph
671633|NCT00743184|LUTS|luts
671634|NCT00743184|Lower urinary tract symptoms (LUTS)|lower urinary tract symptoms (luts)
671635|NCT00743171|Lung transplantation|lung transplantation
671636|NCT00743171|Home spirometry|home spirometry
671637|NCT00743171|non-adherence|non-adherence
671638|NCT00743171|outcomes|outcomes
671639|NCT00743171|bronchiolitis obliterans|bronchiolitis obliterans
671640|NCT00743158|ztr|ztr
671641|NCT00743158|transfer impedance|transfer impedance
671642|NCT00743158|cystic fibrosis|cystic fibrosis
671643|NCT00743158|pulmonary function test|pulmonary function test
671645|NCT00743145|naltrexone|naltrexone
671646|NCT00743145|smoked marijuana|smoked marijuana
671647|NCT00743145|marijuana use|marijuana use
671648|NCT00743132|evaluation|evaluation
671649|NCT00743132|incidence|incidence
671650|NCT00743132|liver surgery|liver surgery
671651|NCT00743132|resection|resection
671652|NCT00743132|impact|impact
671653|NCT00743132|postoperative|postoperative
671654|NCT00743132|mortality|mortality
671655|NCT00743119|oral thc|oral thc
671656|NCT00743119|cannabis|cannabis
671657|NCT00743119|pain|pain
671658|NCT00743119|analgesic effects|analgesic effects
671659|NCT00743119|dronabinol|dronabinol
671660|NCT00743106|nephrectomy|nephrectomy
671661|NCT00743106|fenoldopam|fenoldopam
671662|NCT00743106|atrophic minimally functioning kidney|atrophic minimally functioning kidney
671663|NCT00743093|acetaminophen|acetaminophen
671664|NCT00743093|protein adducts|protein adducts
671665|NCT00743093|drug safety|drug safety
671666|NCT00743093|alanine aminotransferase|alanine aminotransferase
671667|NCT00743093|Alanine Amino Transferase|alanine amino transferase
671668|NCT00743080|laparoscopy|laparoscopy
671669|NCT00743080|myomectomy|myomectomy
671670|NCT00743080|myomas|myomas
671671|NCT00743080|morcellator|morcellator
671672|NCT00743080|supracervical hysterectomy|supracervical hysterectomy
671673|NCT00743080|surgery|surgery
671674|NCT00743080|symptomatic uterine myomas|symptomatic uterine myomas
671675|NCT00743067|XL880|xl880
671676|NCT00743067|MET inhibitor|met inhibitor
671677|NCT00743067|GSK1363089|gsk1363089
671678|NCT00743067|Solid Tumors|solid tumors
671679|NCT00743067|c-Met|c-met
671680|NCT00743054|Carcinoma, Renal Cell|carcinoma, renal cell
671681|NCT00743054|MicroRNAs|micrornas
671682|NCT00743041|PTSD, EFT, depression, anxiety, telephone|ptsd, eft, depression, anxiety, telephone
671683|NCT00743028|Other hematological and non-hematological malignancies|other hematological and non-hematological malignancies
671684|NCT00743002|TT223|tt223
671685|NCT00742989|osteopathic|osteopathic
671686|NCT00742989|lymphatic|lymphatic
671687|NCT00742989|treatment|treatment
671688|NCT00742989|OLT|olt
671689|NCT00742989|normal|normal
671690|NCT00742976|Weight gain in insulin treated type 2 diabetes|weight gain in insulin treated type 2 diabetes
671691|NCT00742976|extracellular volume|extracellular volume
671692|NCT00742976|insulin treatment|insulin treatment
671693|NCT00742976|sodium retention|sodium retention
671694|NCT00742963|TH-302|th-302
671695|NCT00742963|Advanced Soft Tissue Sarcoma|advanced soft tissue sarcoma
671696|NCT00742963|Doxorubicin|doxorubicin
671697|NCT00742963|Phase 1/2|phase 1/2
671698|NCT00742950|Corneal incision|corneal incision
671699|NCT00742950|Cataract surgery|cataract surgery
671700|NCT00742950|Phacoemulsification|phacoemulsification
671701|NCT00742950|Surgically induced astigmatism|surgically induced astigmatism
671702|NCT00742950|Corneal Topography|corneal topography
671703|NCT00742937|Hypovitaminosis A|hypovitaminosis a
671704|NCT00742924|metastatic osteosarcoma|metastatic osteosarcoma
671705|NCT00742911|Solid Tumors, Liver|solid tumors, liver
671706|NCT00742898|Quasi-experimental design|quasi-experimental design
671707|NCT00742898|Non-targeted opt-out rapid HIV screening|non-targeted opt-out rapid hiv screening
671708|NCT00742898|Diagnostic rapid HIV testing|diagnostic rapid hiv testing
671709|NCT00742898|Emergency department|emergency department
671710|NCT00742898|Effectiveness|effectiveness
671711|NCT00742898|Efficiency|efficiency
671712|NCT00742898|Health services research|health services research
671713|NCT00742898|Program evaluation|program evaluation
671714|NCT00742898|Effectiveness and efficiency of non-targeted rapid HIV screening in the ED|effectiveness and efficiency of non-targeted rapid hiv screening in the ed
671715|NCT00742885|Immunogenicity|immunogenicity
671716|NCT00742885|Safety|safety
671717|NCT00742885|Pandemic Influenza|pandemic influenza
671718|NCT00742872|Mosapride|mosapride
671719|NCT00742872|Irritable Bowel Syndrome|irritable bowel syndrome
671720|NCT00742872|Constipation|constipation
671721|NCT00742859|Atrial Fibrillation|atrial fibrillation
671722|NCT00742859|Betrixaban|betrixaban
671723|NCT00742859|Factor Xa inhibitor|factor xa inhibitor
671724|NCT00742859|Warfarin|warfarin
671725|NCT00742846|Adhesive Capsulitis|adhesive capsulitis
671726|NCT00742846|Subacromial injection|subacromial injection
671727|NCT00742846|Intraarticular injection|intraarticular injection
671728|NCT00742833|Overactive bladder|overactive bladder
671729|NCT00742833|Frequency|frequency
671730|NCT00742833|Micturition|micturition
671731|NCT00742833|Urgency|urgency
671732|NCT00742833|Urge urinary incontinence|urge urinary incontinence
671733|NCT00742833|β3-agonist|β3-agonist
671734|NCT00742820|bioequivalence|bioequivalence
671735|NCT00742807|sensation|sensation
671736|NCT00742807|relief|relief
671737|NCT00742807|during|during
671738|NCT00742807|surgery|surgery
671739|NCT00742781|Crohn's|crohn's
671740|NCT00742781|vitamin D|vitamin d
671741|NCT00742768|absorption|absorption
671742|NCT00742768|encapsulation|encapsulation
671743|NCT00742768|menaquinone|menaquinone
671744|NCT00742768|Bio-availability|bio-availability
671745|NCT00742755|Follow-up of breast abnormalities|follow-up of breast abnormalities
671746|NCT00742755|Korean American immigrants|korean american immigrants
671747|NCT00742742|Walnut|walnut
671748|NCT00742742|Lipids|lipids
671749|NCT00742742|Blood Glucose|blood glucose
671750|NCT00742729|Colorectal cancer screening|colorectal cancer screening
671751|NCT00742729|Fecal occult blood test|fecal occult blood test
671752|NCT00742729|Endoscopies|endoscopies
671753|NCT00742729|Filipino American immigrants|filipino american immigrants
671754|NCT00742729|Community based organizations and churches|community based organizations and churches
671755|NCT00742716|Parathyroid Diseases|parathyroid diseases
671756|NCT00742716|Renal Insufficiency|renal insufficiency
671757|NCT00742716|Kidney Failure, Chronic|kidney failure, chronic
671758|NCT00742716|Hyperparathyroidism, Secondary|hyperparathyroidism, secondary
671759|NCT00742716|Vitamin D|vitamin d
671760|NCT00742716|Hyperparathyroidism|hyperparathyroidism
671761|NCT00742716|Renal Insufficiency, Chronic|renal insufficiency, chronic
671762|NCT00742716|Kidney Diseases|kidney diseases
671763|NCT00742716|Kidney Failure|kidney failure
671764|NCT00742690|cirrhosis|cirrhosis
671765|NCT00742690|type 1 hepatorenal syndrome|type 1 hepatorenal syndrome
671766|NCT00742690|terlipressin|terlipressin
671767|NCT00742690|albumin|albumin
671768|NCT00742690|effective circulating volume|effective circulating volume
671769|NCT00742690|Patients|patients
671770|NCT00742690|with|with
671771|NCT00742677|female reproductive cancer|female reproductive cancer
671772|NCT00742664|Prader-Willi Syndrome|prader-willi syndrome
671773|NCT00742664|Compulsive behavior|compulsive behavior
671774|NCT00742664|Hoarding|hoarding
671775|NCT00742664|Obsessive-compulsive disorder|obsessive-compulsive disorder
671776|NCT00742664|Children|children
671777|NCT00742664|Treatment|treatment
671778|NCT00742664|genetically|genetically
671779|NCT00742664|confirmed|confirmed
671780|NCT00742664|diagnosis|diagnosis
671781|NCT00742638|CCMD-3,|ccmd-3,
671782|NCT00742638|CRF,|crf,
671783|NCT00742638|EPS,|eps,
671784|NCT00742638|GCP,|gcp,
671785|NCT00742638|ICH,|ich,
671786|NCT00742638|ITT,|itt,
671787|NCT00742638|LOCF,|locf,
671788|NCT00742638|MADRS,|madrs,
671789|NCT00742638|PANSS,|panss,
671790|NCT00742638|YMRS.|ymrs.
671791|NCT00742638|Acute|acute
671792|NCT00742638|manic|manic
671793|NCT00742638|patients|patients
671794|NCT00742638|with|with
671795|NCT00742638|bipolar|bipolar
671796|NCT00742638|disorder|disorder
671797|NCT00742612|Carotid Endarterectomy|carotid endarterectomy
671798|NCT00742612|von Willebrand Factor|von willebrand factor
671799|NCT00742612|Microembolic Signal|microembolic signal
671800|NCT00742599|Stomach Diseases|stomach diseases
671801|NCT00742586|Gene Expression Changes in Blood Cells|gene expression changes in blood cells
671802|NCT00742586|RNA|rna
671803|NCT00742586|Pure Autonomic Failure|pure autonomic failure
671804|NCT00742586|Multiply System Atrophy|multiply system atrophy
671805|NCT00742586|Parkinson's Plus|parkinson's plus
671806|NCT00742573|Major Depressive Disorder|major depressive disorder
671807|NCT00742573|Mood Disorders|mood disorders
671808|NCT00742573|Hispanic|hispanic
671809|NCT00742560|Multiple Myeloma|multiple myeloma
671810|NCT00742547|prevention|prevention
671811|NCT00742547|health services research|health services research
671812|NCT00742534|Bronchopulmonary Dysplasia|bronchopulmonary dysplasia
671813|NCT00742534|Prematurity|prematurity
671814|NCT00742534|Lung Disease|lung disease
671815|NCT00742534|preterm infants|preterm infants
671816|NCT00742521|cortisol|cortisol
671817|NCT00742521|catecholamines|catecholamines
671818|NCT00742521|Type 1 DM|type 1 dm
671819|NCT00742508|carvedilol phosphate|carvedilol phosphate
671820|NCT00742508|ß-blocker|ß-blocker
671821|NCT00742508|SK&F-105517-D|sk&f-105517-d
671822|NCT00742508|Chronic heart failure(CHF)|chronic heart failure(chf)
671823|NCT00742469|TD|td
671824|NCT00742469|traveller's diarrhea|traveller's diarrhea
671825|NCT00742469|campylobacter|campylobacter
671826|NCT00742469|shigella|shigella
671827|NCT00742469|salmonella|salmonella
671828|NCT00742469|E. coli|e. coli
671829|NCT00742469|diarrhea|diarrhea
671830|NCT00742456|Microcirculation|microcirculation
671831|NCT00742456|Insulin|insulin
671832|NCT00742456|Hypertension|hypertension
671833|NCT00742456|Obesity|obesity
671834|NCT00742443|Scar Revision|scar revision
671835|NCT00742430|aspirin resistance|aspirin resistance
671836|NCT00742430|coronary artery disease|coronary artery disease
671837|NCT00742430|clopidogrel resistance|clopidogrel resistance
671838|NCT00742430|major adverse cardiac events|major adverse cardiac events
671839|NCT00742430|multiplate platelet function analyser|multiplate platelet function analyser
671840|NCT00742430|percutaneous coronary intervention|percutaneous coronary intervention
671841|NCT00742417|Alzheimer's|alzheimer's
671842|NCT00742417|Dementia|dementia
671843|NCT00742417|Senile|senile
671844|NCT00742417|Loss of cognitive abilities|loss of cognitive abilities
671845|NCT00742417|Old age|old age
671846|NCT00742417|Elderly|elderly
671847|NCT00742417|Aging|aging
671848|NCT00742417|Albumin|albumin
671849|NCT00742417|Caregiver|caregiver
671850|NCT00742417|amyloid|amyloid
671851|NCT00742417|beta amyloid|beta amyloid
671852|NCT00742417|Central Nervous System Diseases|central nervous system diseases
671853|NCT00742417|Brain Disease|brain disease
671854|NCT00742417|Mental Disorders|mental disorders
671855|NCT00742417|Plasma Exchange|plasma exchange
671856|NCT00742404|stage I multiple myeloma|stage i multiple myeloma
671857|NCT00742404|stage II multiple myeloma|stage ii multiple myeloma
671858|NCT00742404|stage III multiple myeloma|stage iii multiple myeloma
671859|NCT00742391|Peplin|peplin
671860|NCT00742391|Actinic keratosis|actinic keratosis
671861|NCT00742391|PEP005|pep005
671862|NCT00742378|Glaucoma|glaucoma
671863|NCT00742378|Retinal nerve fiber layer|retinal nerve fiber layer
671864|NCT00742378|Cirrus OCT|cirrus oct
671865|NCT00742365|Seasonal Affective Disorder|seasonal affective disorder
671866|NCT00742365|Light Therapy|light therapy
671867|NCT00742365|Seasonal Depression|seasonal depression
671868|NCT00742365|Psychiatric Disorder|psychiatric disorder
671869|NCT00742365|Bright Light|bright light
671870|NCT00742365|Major Depressive Disorder|major depressive disorder
671871|NCT00742365|Bipolar Disorder|bipolar disorder
671872|NCT00742339|cirrhosis|cirrhosis
671873|NCT00742339|hepatorenal syndrome|hepatorenal syndrome
671874|NCT00742339|terlipressin|terlipressin
671875|NCT00742339|midodrine|midodrine
671876|NCT00742339|octreotide|octreotide
671877|NCT00742339|human albumin|human albumin
671878|NCT00742339|effective circulating volume|effective circulating volume
671879|NCT00742339|The criteria which will be used for the diagnosis of HRS will be the criteria which were recently published by the International Ascites Club|the criteria which will be used for the diagnosis of hrs will be the criteria which were recently published by the international ascites club
671880|NCT00742339|Patients with cirrhosis and type 2 HRS only with serum creatinine value > 2.5 mg/dl|patients with cirrhosis and type 2 hrs only with serum creatinine value > 2.5 mg/dl
671881|NCT00742339|All patients with cirrhosis and type 1 HRS|all patients with cirrhosis and type 1 hrs
671882|NCT00742326|HIV|hiv
671883|NCT00742326|Hepatitis C|hepatitis c
671884|NCT00742326|Liver Disease|liver disease
671885|NCT00742326|Fatty Liver|fatty liver
671886|NCT00742326|Steatosis|steatosis
671887|NCT00742313|Endoscopic|endoscopic
671888|NCT00742313|saphenous|saphenous
671889|NCT00742313|vein|vein
671890|NCT00742313|harvest|harvest
671891|NCT00742300|ASCT|asct
671892|NCT00742300|Tolerance induction|tolerance induction
671893|NCT00742300|SLE|sle
671894|NCT00742300|Transplantation|transplantation
671895|NCT00742300|Autoimmune diseases|autoimmune diseases
671896|NCT00742287|smoking|smoking
671897|NCT00742287|oligomeric proanthocyanidins|oligomeric proanthocyanidins
671898|NCT00742287|polyphenols|polyphenols
671899|NCT00742287|supplementation|supplementation
671900|NCT00742287|vascular function|vascular function
671901|NCT00742287|oxidative stress|oxidative stress
671902|NCT00742287|inflammation|inflammation
671903|NCT00742261|Pharmacokinetics|pharmacokinetics
671904|NCT00742261|Safety|safety
671905|NCT00742261|MET|met
671906|NCT00742261|Bioavailability|bioavailability
671907|NCT00742261|Patients|patients
671908|NCT00742261|GSK1363089A|gsk1363089a
671909|NCT00742261|GSK1363089G|gsk1363089g
671910|NCT00742261|GSK1363089|gsk1363089
671911|NCT00742261|Relative|relative
671912|NCT00742248|COPD|copd
671913|NCT00742222|Electronic brachytherapy registry|electronic brachytherapy registry
671914|NCT00742222|Multi-society registry|multi-society registry
671915|NCT00742222|Breast cancer registry|breast cancer registry
671916|NCT00742209|migraine|migraine
671917|NCT00742209|prophylaxis|prophylaxis
671918|NCT00742209|prevention|prevention
671919|NCT00742196|Parapapillary atrophy|parapapillary atrophy
671920|NCT00742196|Retinal nerve fiber layer thickness|retinal nerve fiber layer thickness
671921|NCT00742196|Glaucoma|glaucoma
671922|NCT00742196|Cirrus OCT|cirrus oct
671923|NCT00742170|opioid dependence|opioid dependence
671924|NCT00742170|opioid detoxification|opioid detoxification
671925|NCT00742170|electroacupuncture|electroacupuncture
671926|NCT00742170|adjunctive treatment|adjunctive treatment
671927|NCT00742170|alternative/complementary medicine|alternative/complementary medicine
671928|NCT00742157|Growth Hormone|growth hormone
671929|NCT00742157|TPN|tpn
671930|NCT00742157|Total Parenteral Nutrition|total parenteral nutrition
671931|NCT00742157|Glutamine|glutamine
671932|NCT00742157|Short Bowel Syndrome|short bowel syndrome
671933|NCT00742157|Increase in absorption of small bowel.|increase in absorption of small bowel.
671934|NCT00742144|CD20 positive|cd20 positive
671935|NCT00742144|Chronic lymphocytic leukemia|chronic lymphocytic leukemia
671936|NCT00742144|Follicular lymphoma|follicular lymphoma
671937|NCT00742144|GSK1841157|gsk1841157
671938|NCT00742144|Japanese patient|japanese patient
671939|NCT00742144|Ofatumumab|ofatumumab
671940|NCT00742131|MET inhibitor|met inhibitor
671941|NCT00742131|c-Met|c-met
671942|NCT00742131|XL880|xl880
671943|NCT00742131|GSK1363089|gsk1363089
671944|NCT00742131|Solid Tumors|solid tumors
671945|NCT00742105|PI3K|pi3k
671946|NCT00742105|mTOR|mtor
671947|NCT00742105|Advanced solid tumor|advanced solid tumor
671948|NCT00742105|Adult|adult
671949|NCT00742079|Paranoid Schizophrenia|paranoid schizophrenia
671950|NCT00742079|Paranoid Delusions|paranoid delusions
671951|NCT00742079|CBT|cbt
671952|NCT00742079|D-Cycloserine|d-cycloserine
671953|NCT00742066|Hypertension|hypertension
671954|NCT00742066|Insulin resistance|insulin resistance
671955|NCT00742066|Microcirculation|microcirculation
671956|NCT00742066|Angiotensin II receptor blocker|angiotensin ii receptor blocker
671957|NCT00742053|ECG PICC|ecg picc
671958|NCT00742053|Patients undergoing PICC placement|patients undergoing picc placement
671959|NCT00742040|up-titration|up-titration
671960|NCT00742040|captopril|captopril
671961|NCT00742040|pediatric|pediatric
671962|NCT00742040|cardiac patients|cardiac patients
671963|NCT00742027|Classical Hodgkin Lymphoma|classical hodgkin lymphoma
671964|NCT00742027|Classical Hodgkin's Lymphoma|classical hodgkin's lymphoma
671965|NCT00742027|Hodgkin Lymphoma|hodgkin lymphoma
671966|NCT00742027|Hodgkin's Lymphoma|hodgkin's lymphoma
671967|NCT00742027|Nodular sclerosing|nodular sclerosing
671968|NCT00742027|Mixed-cellularity|mixed-cellularity
671969|NCT00742027|Lymphocyte-rich|lymphocyte-rich
671970|NCT00742027|Lymphocyte depleted|lymphocyte depleted
671971|NCT00742027|HL|hl
671972|NCT00742027|Classical HL|classical hl
671973|NCT00742027|Refractory Hodgkin's Lymphoma|refractory hodgkin's lymphoma
671974|NCT00742027|Refractory Hodgkin Lymphoma|refractory hodgkin lymphoma
671975|NCT00742027|Refractory HL|refractory hl
671976|NCT00742014|Pulmonary arterial hypertension|pulmonary arterial hypertension
671977|NCT00742014|Pediatrics|pediatrics
671978|NCT00742014|Sildenafil|sildenafil
671979|NCT00742014|Catheterization|catheterization
671980|NCT00742014|Right ventricular contractility|right ventricular contractility
671981|NCT00742001|red blood cells|red blood cells
671982|NCT00742001|transfusion|transfusion
671983|NCT00742001|recovery|recovery
671984|NCT00742001|feasibility|feasibility
671985|NCT00742001|white blood cell inactivation|white blood cell inactivation
671986|NCT00741988|Non-Small Cell Lung Cancer|non-small cell lung cancer
671987|NCT00741988|Advanced Disease|advanced disease
671988|NCT00741988|Untreated|untreated
671989|NCT00741988|Ixabepilone|ixabepilone
671990|NCT00741988|Carboplatin|carboplatin
671991|NCT00741988|Bevacizumab|bevacizumab
671992|NCT00741975|HIV prevention|hiv prevention
671993|NCT00741949|Respiratory failure|respiratory failure
671994|NCT00741949|Target Controlled Infusion|target controlled infusion
671995|NCT00741949|TCI|tci
671996|NCT00741949|Propofol|propofol
671997|NCT00741949|Noninvasive ventilation|noninvasive ventilation
671998|NCT00741949|Broncho-alveolar lavage|broncho-alveolar lavage
671999|NCT00741936|Functional Constipation|functional constipation
672000|NCT00741936|Chinese Herbal Medicine|chinese herbal medicine
672001|NCT00741936|MaZiRenWan|mazirenwan
672002|NCT00741936|Hemp Seed Pill|hemp seed pill
672003|NCT00741936|Traditional Chinese Medicine|traditional chinese medicine
672004|NCT00741936|Herbal Medicine|herbal medicine
672005|NCT00741923|beans|beans
672006|NCT00741923|pulses|pulses
672007|NCT00741923|satiety|satiety
672008|NCT00741923|appetite|appetite
672009|NCT00741923|obesity|obesity
672010|NCT00741923|overweight|overweight
672011|NCT00741923|diabetes|diabetes
672012|NCT00741923|metabolic syndrome|metabolic syndrome
672013|NCT00741923|hypertension|hypertension
672014|NCT00741923|blood glucose|blood glucose
672015|NCT00741923|insulin|insulin
672016|NCT00741923|cholesterol|cholesterol
672017|NCT00741923|HDL|hdl
672018|NCT00741923|LDL|ldl
672019|NCT00741923|leptin|leptin
672020|NCT00741923|GLP-1|glp-1
672021|NCT00741923|adiponectin|adiponectin
672022|NCT00741923|Peptide YY|peptide yy
672023|NCT00741923|diet|diet
672024|NCT00741910|Crohn's Disease|crohn's disease
672025|NCT00741910|TNF-alpha inhibitor|tnf-alpha inhibitor
672026|NCT00741910|MAP Kinase inhibitor|map kinase inhibitor
672027|NCT00741910|CNI-1493|cni-1493
672028|NCT00741871|Lymphoid malignancies|lymphoid malignancies
672029|NCT00741871|Hodgkin's Lymphoma|hodgkin's lymphoma
672030|NCT00741871|Diffuse large B cell lymphoma|diffuse large b cell lymphoma
672031|NCT00741858|Chiari malformation;|chiari malformation;
672032|NCT00741858|Duraplasty;|duraplasty;
672033|NCT00741858|Posterior fossa decompression;|posterior fossa decompression;
672034|NCT00741858|Duragen;|duragen;
672035|NCT00741858|Duraguard|duraguard
672036|NCT00741832|chronic obstructive pulmonary disease|chronic obstructive pulmonary disease
672037|NCT00741832|dynamic hyperinflation|dynamic hyperinflation
672038|NCT00741832|dyspnea|dyspnea
672039|NCT00741832|recovery|recovery
672040|NCT00741832|positive expiratory pressure|positive expiratory pressure
672041|NCT00741832|exercise|exercise
672042|NCT00741819|pulmonary arterial hypertension|pulmonary arterial hypertension
672043|NCT00741819|PAH|pah
672044|NCT00741819|treprostinil sodium|treprostinil sodium
672045|NCT00741819|inhalation|inhalation
672046|NCT00741819|ventavis|ventavis
672047|NCT00741819|iloprost|iloprost
672048|NCT00741806|vaccination|vaccination
672049|NCT00741806|avian|avian
672050|NCT00741793|Rheumatoid arthritis; psoriatic arthritis; axial spondyloarthritis|rheumatoid arthritis; psoriatic arthritis; axial spondyloarthritis
672051|NCT00741793|Remicade®|remicade®
672052|NCT00741793|Simponi®|simponi®
672053|NCT00741793|Simponi® I.V|simponi® i.v
672054|NCT00741793|Stelara®|stelara®
672055|NCT00741793|Registry|registry
672056|NCT00741793|BioTRAC|biotrac
672057|NCT00741767|Chronic Obstructive Pulmonary Disease|chronic obstructive pulmonary disease
672058|NCT00741767|COPD|copd
672059|NCT00741767|Sleep|sleep
672060|NCT00741767|Sleep quality|sleep quality
672061|NCT00741767|Lung hyperinflation|lung hyperinflation
672062|NCT00741754|salivary flow|salivary flow
672063|NCT00741754|oral neoplasm|oral neoplasm
672064|NCT00741754|calcium hydroxide|calcium hydroxide
672065|NCT00741754|sodium dodecylsulphate|sodium dodecylsulphate
672066|NCT00741754|radiotherapy.|radiotherapy.
672067|NCT00741741|TMC278-C150|tmc278-c150
672068|NCT00741741|TMC278-TiDP15-C150|tmc278-tidp15-c150
672069|NCT00741741|HIV-1 infected patients|hiv-1 infected patients
672070|NCT00741741|Intramuscular or subcutaneous injection|intramuscular or subcutaneous injection
672071|NCT00741741|Nanosuspension|nanosuspension
672072|NCT00741741|Therapy|therapy
672073|NCT00741741|Prevention|prevention
672074|NCT00741741|Healthy volunteers|healthy volunteers
672075|NCT00741741|HIV Infections|hiv infections
672076|NCT00741728|epidemiology|epidemiology
672077|NCT00741728|risk factors|risk factors
672078|NCT00741728|heart rate|heart rate
672079|NCT00741728|baroreflex sensitivity|baroreflex sensitivity
672080|NCT00741728|sudden death|sudden death
672081|NCT00741715|primary hypercholesterolemia|primary hypercholesterolemia
672082|NCT00741702|Hypertension|hypertension
672083|NCT00741702|Type 2 diabetes|type 2 diabetes
672084|NCT00741702|First Nations populations|first nations populations
672085|NCT00741689|Japanese|japanese
672086|NCT00741689|healthy|healthy
672087|NCT00741689|volunteers|volunteers
672088|NCT00741663|cirrhosis|cirrhosis
672089|NCT00741663|ascites|ascites
672090|NCT00741663|diuretic therapy|diuretic therapy
672091|NCT00741663|potassium canrenoate|potassium canrenoate
672092|NCT00741663|furosemide|furosemide
672093|NCT00741663|hyperkalemia|hyperkalemia
672094|NCT00741663|plasma renin activity|plasma renin activity
672095|NCT00741663|nitric oxide|nitric oxide
672096|NCT00741663|serum sodium concentration|serum sodium concentration
672097|NCT00741663|refractory ascites|refractory ascites
672098|NCT00741663|Nonazotemic patients with cirrhosis and moderate ascites|nonazotemic patients with cirrhosis and moderate ascites
672099|NCT00741650|Musculoskeletal pain|musculoskeletal pain
672100|NCT00741650|Brief cognitive intervention|brief cognitive intervention
672101|NCT00741650|Cognitive behavior therapy|cognitive behavior therapy
672102|NCT00741650|Intervention Study|intervention study
672103|NCT00741650|Health prevention|health prevention
672104|NCT00741650|workplace intervention|workplace intervention
672105|NCT00741637|Vibrio Cholerae|vibrio cholerae
672106|NCT00741637|Diarrhea|diarrhea
672107|NCT00741637|Live oral Vaccines|live oral vaccines
672108|NCT00741637|Immunogenicity|immunogenicity
672109|NCT00741637|Safety|safety
672110|NCT00741637|HIV|hiv
672111|NCT00741624|refractive surgery|refractive surgery
672112|NCT00741585|Ambulatory blood pressure monitoring|ambulatory blood pressure monitoring
672113|NCT00741585|Chronotherapy|chronotherapy
672114|NCT00741585|Circadian|circadian
672115|NCT00741585|Non-dipper|non-dipper
672116|NCT00741585|Type 2 diabetes|type 2 diabetes
672117|NCT00741585|Resistant hypertension|resistant hypertension
672118|NCT00741585|Total mortality|total mortality
672119|NCT00741572|sarcoidosis|sarcoidosis
672120|NCT00741572|fibrosis|fibrosis
672121|NCT00741572|oxidative stress|oxidative stress
672122|NCT00741572|inflammation|inflammation
672123|NCT00741572|triggers|triggers
672124|NCT00741572|individual sensitivity|individual sensitivity
672125|NCT00741559|epilepsy|epilepsy
672126|NCT00741559|pediatrics|pediatrics
672127|NCT00741559|magnetoencephalography|magnetoencephalography
672128|NCT00741559|electroencephalography|electroencephalography
672129|NCT00741559|positron emission tomography|positron emission tomography
672130|NCT00741546|Vitamin D|vitamin d
672131|NCT00741546|malnutrition|malnutrition
672132|NCT00741546|cardiac surgery|cardiac surgery
672133|NCT00741546|study|study
672134|NCT00741546|emphasize|emphasize
672135|NCT00741546|importance|importance
672136|NCT00741546|significant|significant
672137|NCT00741546|high risk patient|high risk patient
672138|NCT00741520|Obstructive Sleep Apnea|obstructive sleep apnea
672139|NCT00741520|Blood Pressure|blood pressure
672140|NCT00741520|PreHypertension|prehypertension
672141|NCT00741520|Masked Hypertension|masked hypertension
672142|NCT00741507|Anesthetics|anesthetics
672143|NCT00741507|Sedatives|sedatives
672144|NCT00741507|Analgesics|analgesics
672145|NCT00741494|infertility|infertility
672146|NCT00741494|ICSI|icsi
672147|NCT00741494|hyaluronan binding|hyaluronan binding
672148|NCT00741494|sperm|sperm
672149|NCT00741494|sperm selection|sperm selection
672150|NCT00741494|male factor|male factor
672151|NCT00741494|hyaluronan|hyaluronan
672152|NCT00741494|sperm maturity|sperm maturity
672153|NCT00741494|clinical pregnancy rates|clinical pregnancy rates
672154|NCT00741494|hyaluronan binding assay|hyaluronan binding assay
672155|NCT00741494|HBA|hba
672156|NCT00741494|PICSI|picsi
672157|NCT00741481|metastatic colorectal cancer|metastatic colorectal cancer
672158|NCT00741481|fdg pet|fdg pet
672159|NCT00741481|response evaluation|response evaluation
672160|NCT00741468|Drug-drug interactions|drug-drug interactions
672161|NCT00741468|DDI|ddi
672162|NCT00741455|Non-myeloablative transplant|non-myeloablative transplant
672163|NCT00741455|Chronic Myelogenous Leukemia|chronic myelogenous leukemia
672164|NCT00741455|Acute Myelogenous Leukemia|acute myelogenous leukemia
672165|NCT00741455|Acute Lymphoblastic Leukemia|acute lymphoblastic leukemia
672166|NCT00741455|Multiple Myeloma|multiple myeloma
672167|NCT00741455|Non-Hodgkin's Lymphoma|non-hodgkin's lymphoma
672168|NCT00741455|Myelodysplastic syndrome|myelodysplastic syndrome
672169|NCT00741455|Chronic Lymphocytic Leukemia|chronic lymphocytic leukemia
672170|NCT00741455|Hodgkin's Disease|hodgkin's disease
672171|NCT00741416|Heart Disease|heart disease
672172|NCT00741416|Biorepository|biorepository
672173|NCT00741416|Biobank|biobank
672174|NCT00741403|Phase I|phase i
672175|NCT00741403|malignancies|malignancies
672176|NCT00741403|refractory|refractory
672177|NCT00741403|relapsed|relapsed
672178|NCT00741390|Diabetes|diabetes
672179|NCT00741390|Lancets|lancets
672180|NCT00741390|Pain|pain
672181|NCT00741377|Multiple myeloma|multiple myeloma
672182|NCT00741377|bone disease|bone disease
672183|NCT00741377|antibody|antibody
672184|NCT00741364|vitamin D|vitamin d
672185|NCT00741364|prostate cancer|prostate cancer
672186|NCT00741364|prostatectomy|prostatectomy
672187|NCT00741364|pathology|pathology
672188|NCT00741364|immunohistochemistry|immunohistochemistry
672189|NCT00741351|Anesthesia|anesthesia
672190|NCT00741351|Craniotomy|craniotomy
672191|NCT00741351|Neurosurgery|neurosurgery
672192|NCT00741338|MPS I, Mucopolysaccharidosis, Hurler syndrome|mps i, mucopolysaccharidosis, hurler syndrome
672193|NCT00741312|pregnancy|pregnancy
672194|NCT00741312|preeclampsia|preeclampsia
672195|NCT00741312|exercise|exercise
672196|NCT00741299|bipolar affective disorder, Smoking|bipolar affective disorder, smoking
672197|NCT00741286|Cerebral infarction|cerebral infarction
672198|NCT00741286|Cilostazol|cilostazol
672199|NCT00741286|Aspirin|aspirin
672200|NCT00741286|Transcranial Doppler|transcranial doppler
672201|NCT00741286|Pulsatile Index|pulsatile index
672202|NCT00741260|Solid Tumor|solid tumor
672203|NCT00741260|erbB2+ Breast Cancer|erbb2+ breast cancer
672204|NCT00741260|Prior trastuzumab|prior trastuzumab
672205|NCT00741260|Metastatic|metastatic
672206|NCT00741260|Neratinib|neratinib
672207|NCT00741260|HKI-272|hki-272
672208|NCT00741260|Nerlynx|nerlynx
672209|NCT00741260|HER2|her2
672210|NCT00741260|PB-272|pb-272
672211|NCT00741247|staging|staging
672212|NCT00741247|Endobronchial ultrasound|endobronchial ultrasound
672213|NCT00741247|Endoscopic ultrasound|endoscopic ultrasound
672214|NCT00741234|SB939|sb939
672215|NCT00741234|Myelodysplastic Syndrome|myelodysplastic syndrome
672216|NCT00741234|Combination with azacitidine|combination with azacitidine
672217|NCT00741234|Solid malignancies|solid malignancies
672218|NCT00741234|Hematologic malignancies|hematologic malignancies
672219|NCT00741234|HDAC inhibitor|hdac inhibitor
672220|NCT00741234|Refractory to standard therapy|refractory to standard therapy
672221|NCT00741221|Cancer|cancer
672222|NCT00741221|NSCLC|nsclc
672223|NCT00741221|Docetaxel|docetaxel
672224|NCT00741221|Bevacizumab|bevacizumab
672226|NCT00741208|soy isoflavone|soy isoflavone
672227|NCT00741208|genistein|genistein
672228|NCT00741208|soy|soy
672229|NCT00741195|Cancer|cancer
672230|NCT00741195|NSCLC|nsclc
672231|NCT00741195|Docetaxel|docetaxel
672232|NCT00741195|Bevacizumab|bevacizumab
672233|NCT00741182|Fracture|fracture
672234|NCT00741182|Osteoporosis|osteoporosis
672235|NCT00741182|Forsteo|forsteo
672236|NCT00741182|Teriparatide|teriparatide
672237|NCT00741182|Fracture healing|fracture healing
672238|NCT00741169|TMC435350-TiDP16-C105|tmc435350-tidp16-c105
672239|NCT00741169|TMC435350-C105|tmc435350-c105
672240|NCT00741169|Hepatitis C|hepatitis c
672241|NCT00741169|HCV|hcv
672242|NCT00741169|Rifampin|rifampin
672243|NCT00741156|pediatric|pediatric
672244|NCT00741156|hypertension|hypertension
672245|NCT00741156|congestive cardiomyopathy|congestive cardiomyopathy
672246|NCT00741156|angiotensin-converting enzyme inhibitor|angiotensin-converting enzyme inhibitor
672247|NCT00741156|cardiac catheterization|cardiac catheterization
672248|NCT00741143|Food Fortification|food fortification
672249|NCT00741143|Iron deficiency|iron deficiency
672250|NCT00741143|NaFeEdta|nafeedta
672251|NCT00741143|Iron deficiency anemia|iron deficiency anemia
672252|NCT00741143|Cognition|cognition
672253|NCT00741130|retinal nerve fiber layer|retinal nerve fiber layer
672254|NCT00741130|optic nerve head|optic nerve head
672255|NCT00741130|Cirrus OCT|cirrus oct
672256|NCT00741117|Pulse Oximetry|pulse oximetry
672257|NCT00741117|Blood Gas Analysis|blood gas analysis
672258|NCT00741117|Liver Disease|liver disease
672259|NCT00741117|Hyperbilirubinemia|hyperbilirubinemia
672260|NCT00741091|Cerebrovascular Disease|cerebrovascular disease
672261|NCT00741091|Carotid Stent|carotid stent
672262|NCT00741091|Stent|stent
672263|NCT00741091|Carotid Endarterectomy (CEA)|carotid endarterectomy (cea)
672264|NCT00741078|endothelial|endothelial
672265|NCT00741078|function|function
672266|NCT00741078|insulin|insulin
672267|NCT00741078|sensitivity|sensitivity
672268|NCT00741065|Coronary Artery Bypass Grafting|coronary artery bypass grafting
672269|NCT00741065|Myocardial Regeneration|myocardial regeneration
672270|NCT00741052|V. cholerae,|v. cholerae,
672271|NCT00741052|ciprofloxacin,|ciprofloxacin,
672272|NCT00741052|azithromycin,|azithromycin,
672273|NCT00741052|randomized|randomized
672274|NCT00741039|Breast|breast
672275|NCT00741039|Lung|lung
672276|NCT00741039|Prostate|prostate
672277|NCT00741039|Vaccine|vaccine
672278|NCT00741026|Insulin Resistance|insulin resistance
672279|NCT00741026|Diabetes mellitus|diabetes mellitus
672280|NCT00741026|Antipsychotic|antipsychotic
672281|NCT00741013|randomized|randomized
672282|NCT00741013|positron emission tomography|positron emission tomography
672283|NCT00741013|lung inflammation|lung inflammation
672284|NCT00741013|lovastatin|lovastatin
853562|NCT00076752|SLE|sle
672285|NCT00741013|recombinant human activated protein C|recombinant human activated protein c
672286|NCT00741013|endotoxin|endotoxin
672287|NCT00741013|fluorodeoxyglucose|fluorodeoxyglucose
672288|NCT00740987|Mechanical device|mechanical device
672289|NCT00740987|Intermittent pneumatic compression|intermittent pneumatic compression
672290|NCT00740987|Venous thromboembolism prophylaxis|venous thromboembolism prophylaxis
672291|NCT00740987|Intensive care unit|intensive care unit
672292|NCT00740987|Hospitalization|hospitalization
672293|NCT00740987|Intensive|intensive
672294|NCT00740987|Care|care
672295|NCT00740987|Unit|unit
672296|NCT00740961|psychosocial effects of cancer and its treatment|psychosocial effects of cancer and its treatment
672297|NCT00740961|cognitive/functional effects|cognitive/functional effects
672298|NCT00740961|breast cancer|breast cancer
672299|NCT00740961|colon cancer|colon cancer
672300|NCT00740948|Sjogren's disease|sjogren's disease
672301|NCT00740948|Rituximab|rituximab
672302|NCT00740948|Treatment|treatment
672303|NCT00740948|anti CD20|anti cd20
672304|NCT00740935|prevention|prevention
672305|NCT00740935|rotavirus vaccine|rotavirus vaccine
672306|NCT00740935|gastroenteritis|gastroenteritis
672307|NCT00740935|systematic vaccination|systematic vaccination
672308|NCT00740935|infants|infants
672309|NCT00740935|aged 6 to 12 weeks|aged 6 to 12 weeks
672310|NCT00740922|Becaplermin gel|becaplermin gel
672311|NCT00740922|Target Ulcer|target ulcer
672312|NCT00740922|Retrospective Studies|retrospective studies
672313|NCT00740922|Diabetic Foot|diabetic foot
672314|NCT00740922|Neoplasms|neoplasms
672315|NCT00740922|Long-Term Safety|long-term safety
672316|NCT00740922|Topical Administration|topical administration
672317|NCT00740909|Trich|trich
672318|NCT00740909|Hair Pulling|hair pulling
672319|NCT00740909|Cognitive Behavioral Therapy|cognitive behavioral therapy
672320|NCT00740909|Behavioral Therapy|behavioral therapy
672321|NCT00740896|Cigarette Smoking|cigarette smoking
672322|NCT00740896|Airway dendritic cells|airway dendritic cells
672323|NCT00740883|venous thromboembolism|venous thromboembolism
672324|NCT00740883|warfarin|warfarin
672325|NCT00740883|duration of anticoagulation|duration of anticoagulation
672326|NCT00740883|recurrent venous thromboembolism|recurrent venous thromboembolism
672327|NCT00740883|anticoagulant-related bleeding|anticoagulant-related bleeding
672328|NCT00740857|Dental pain analgesia|dental pain analgesia
672329|NCT00740844|Intermittent pneumatic compression|intermittent pneumatic compression
672330|NCT00740844|Hospitalization|hospitalization
672331|NCT00740844|Intensive care unit|intensive care unit
672332|NCT00740844|High bleeding risk|high bleeding risk
672333|NCT00740844|Venous thromboembolism prophylaxis|venous thromboembolism prophylaxis
672334|NCT00740831|Uterine Myomas|uterine myomas
672335|NCT00740779|prostatitis, chronic pelvic pain|prostatitis, chronic pelvic pain
672336|NCT00740766|Perinatal Outcomes|perinatal outcomes
672337|NCT00740766|Obesity|obesity
672338|NCT00740766|Pregnant women|pregnant women
672339|NCT00740753|liver tumor|liver tumor
672340|NCT00740753|cancer|cancer
672341|NCT00740753|hepatoma|hepatoma
672342|NCT00740753|yttrium|yttrium
672343|NCT00740740|Aneurysm|aneurysm
672344|NCT00740740|Rupture|rupture
672345|NCT00740727|Disaster|disaster
672346|NCT00740727|Mass casualty incident|mass casualty incident
672347|NCT00740727|Prehospital|prehospital
672348|NCT00740727|Rehydration|rehydration
672349|NCT00740727|Intravascular access|intravascular access
672350|NCT00740714|Parkinson disease|parkinson disease
672352|NCT00740714|Coenzyme Q10|coenzyme q10
672353|NCT00740714|CoQ|coq
672354|NCT00740701|TMS|tms
672355|NCT00740701|fMRI|fmri
672356|NCT00740701|verbal working memory|verbal working memory
672357|NCT00740701|classical conditioning|classical conditioning
672358|NCT00740701|eyeblink|eyeblink
672359|NCT00740701|classical eyeblink conditioning|classical eyeblink conditioning
672360|NCT00740701|Healthy subjects|healthy subjects
672361|NCT00740701|Memory|memory
672362|NCT00740675|adverse drug events|adverse drug events
672363|NCT00740675|outpatient|outpatient
672364|NCT00740662|morbid obesity|morbid obesity
672365|NCT00740662|small bowel|small bowel
672366|NCT00740662|gastric bypass|gastric bypass
672367|NCT00740662|weight loss|weight loss
672368|NCT00740636|TEMOZOLOMIDE|temozolomide
672369|NCT00740636|Lung|lung
672370|NCT00740623|Partial Onset Seizures|partial onset seizures
672371|NCT00740623|Simple Partial Seizures|simple partial seizures
672372|NCT00740623|Complex Partial Seizures|complex partial seizures
672373|NCT00740597|recurrent adult soft tissue sarcoma|recurrent adult soft tissue sarcoma
672374|NCT00740597|stage I adult soft tissue sarcoma|stage i adult soft tissue sarcoma
672375|NCT00740597|stage II adult soft tissue sarcoma|stage ii adult soft tissue sarcoma
672376|NCT00740597|stage III adult soft tissue sarcoma|stage iii adult soft tissue sarcoma
672377|NCT00740597|adult alveolar soft-part sarcoma|adult alveolar soft-part sarcoma
672378|NCT00740597|adult epithelioid sarcoma|adult epithelioid sarcoma
672379|NCT00740597|adult extraskeletal chondrosarcoma|adult extraskeletal chondrosarcoma
672380|NCT00740597|adult extraskeletal osteosarcoma|adult extraskeletal osteosarcoma
672381|NCT00740597|adult fibrosarcoma|adult fibrosarcoma
672382|NCT00740597|adult malignant fibrous histiocytoma|adult malignant fibrous histiocytoma
672383|NCT00740597|adult malignant hemangiopericytoma|adult malignant hemangiopericytoma
672384|NCT00740597|adult malignant mesenchymoma|adult malignant mesenchymoma
672385|NCT00740597|adult neurofibrosarcoma|adult neurofibrosarcoma
672386|NCT00740597|adult rhabdomyosarcoma|adult rhabdomyosarcoma
672387|NCT00740597|dermatofibrosarcoma protuberans|dermatofibrosarcoma protuberans
672388|NCT00740584|Prevention|prevention
672389|NCT00740571|neuralgia|neuralgia
672390|NCT00740571|off-label|off-label
672391|NCT00740571|cancer|cancer
672393|NCT00740558|Activator|activator
672394|NCT00740558|Chiropractic|chiropractic
672395|NCT00740558|VLF|vlf
672396|NCT00740558|HF|hf
672397|NCT00740558|LF|lf
672398|NCT00740558|LF/HF|lf/hf
672399|NCT00740532|EGFR, HER-2, HER-3, MET, KRAS|egfr, her-2, her-3, met, kras
672400|NCT00740506|Behavioral|behavioral
672401|NCT00740506|Environmental|environmental
672402|NCT00740506|Delivery|delivery
672403|NCT00740506|Pregnancy|pregnancy
672404|NCT00740493|recurrent venous thromboembolism|recurrent venous thromboembolism
672405|NCT00740493|idiopathic deep vein thrombosis|idiopathic deep vein thrombosis
672406|NCT00740493|optimal duration of anticoagulation|optimal duration of anticoagulation
672407|NCT00740480|Evaluation|evaluation
672408|NCT00740480|ENTact™|entact™
672409|NCT00740480|Septal|septal
672410|NCT00740480|Staple|staple
672411|NCT00740480|System|system
672412|NCT00740480|tissue|tissue
672413|NCT00740480|approximation|approximation
672414|NCT00740480|during|during
672415|NCT00740480|septoplasties|septoplasties
672416|NCT00740467|graft versus host disease|graft versus host disease
672417|NCT00740467|adult acute myeloid leukemia in remission|adult acute myeloid leukemia in remission
672418|NCT00740467|adult acute myeloid leukemia with 11q23 (MLL) abnormalities|adult acute myeloid leukemia with 11q23 (mll) abnormalities
672419|NCT00740467|adult acute myeloid leukemia with inv(16)(p13;q22)|adult acute myeloid leukemia with inv(16)(p13;q22)
672420|NCT00740467|adult acute myeloid leukemia with t(15;17)(q22;q12)|adult acute myeloid leukemia with t(15;17)(q22;q12)
672421|NCT00740467|adult acute myeloid leukemia with t(16;16)(p13;q22)|adult acute myeloid leukemia with t(16;16)(p13;q22)
672422|NCT00740467|adult acute myeloid leukemia with t(8;21)(q22;q22)|adult acute myeloid leukemia with t(8;21)(q22;q22)
672423|NCT00740467|recurrent adult acute myeloid leukemia|recurrent adult acute myeloid leukemia
672424|NCT00740467|adult acute lymphoblastic leukemia in remission|adult acute lymphoblastic leukemia in remission
672425|NCT00740467|recurrent adult acute lymphoblastic leukemia|recurrent adult acute lymphoblastic leukemia
672426|NCT00740467|accelerated phase chronic myelogenous leukemia|accelerated phase chronic myelogenous leukemia
672427|NCT00740467|chronic phase chronic myelogenous leukemia|chronic phase chronic myelogenous leukemia
672428|NCT00740467|refractory multiple myeloma|refractory multiple myeloma
672429|NCT00740467|relapsing chronic myelogenous leukemia|relapsing chronic myelogenous leukemia
672430|NCT00740467|recurrent adult Hodgkin lymphoma|recurrent adult hodgkin lymphoma
672431|NCT00740467|adult nasal type extranodal NK/T-cell lymphoma|adult nasal type extranodal nk/t-cell lymphoma
672432|NCT00740467|anaplastic large cell lymphoma|anaplastic large cell lymphoma
672433|NCT00740467|angioimmunoblastic T-cell lymphoma|angioimmunoblastic t-cell lymphoma
672434|NCT00740467|extranodal marginal zone B-cell lymphoma of mucosa-associated lymphoid tissue|extranodal marginal zone b-cell lymphoma of mucosa-associated lymphoid tissue
672435|NCT00740467|nodal marginal zone B-cell lymphoma|nodal marginal zone b-cell lymphoma
672436|NCT00740467|recurrent adult Burkitt lymphoma|recurrent adult burkitt lymphoma
672437|NCT00740467|recurrent adult diffuse large cell lymphoma|recurrent adult diffuse large cell lymphoma
672438|NCT00740467|recurrent adult diffuse mixed cell lymphoma|recurrent adult diffuse mixed cell lymphoma
672439|NCT00740467|recurrent adult diffuse small cleaved cell lymphoma|recurrent adult diffuse small cleaved cell lymphoma
672440|NCT00740467|recurrent adult grade III lymphomatoid granulomatosis|recurrent adult grade iii lymphomatoid granulomatosis
672441|NCT00740467|recurrent adult immunoblastic large cell lymphoma|recurrent adult immunoblastic large cell lymphoma
672442|NCT00740467|recurrent adult lymphoblastic lymphoma|recurrent adult lymphoblastic lymphoma
672443|NCT00740467|recurrent adult T-cell leukemia/lymphoma|recurrent adult t-cell leukemia/lymphoma
672444|NCT00740467|recurrent cutaneous T-cell non-Hodgkin lymphoma|recurrent cutaneous t-cell non-hodgkin lymphoma
672445|NCT00740467|recurrent grade 1 follicular lymphoma|recurrent grade 1 follicular lymphoma
672446|NCT00740467|recurrent grade 2 follicular lymphoma|recurrent grade 2 follicular lymphoma
672447|NCT00740467|recurrent grade 3 follicular lymphoma|recurrent grade 3 follicular lymphoma
672448|NCT00740467|recurrent grade I lymphomatoid granulomatosis|recurrent grade i lymphomatoid granulomatosis
672449|NCT00740467|recurrent grade II lymphomatoid granulomatosis|recurrent grade ii lymphomatoid granulomatosis
672450|NCT00740467|recurrent mantle cell lymphoma|recurrent mantle cell lymphoma
672451|NCT00740467|recurrent marginal zone lymphoma|recurrent marginal zone lymphoma
672452|NCT00740467|recurrent small lymphocytic lymphoma|recurrent small lymphocytic lymphoma
672453|NCT00740467|splenic marginal zone lymphoma|splenic marginal zone lymphoma
672454|NCT00740467|refractory chronic lymphocytic leukemia|refractory chronic lymphocytic leukemia
672455|NCT00740454|pregnancy|pregnancy
672456|NCT00740454|postpartum|postpartum
672457|NCT00740454|deep vein thrombosis|deep vein thrombosis
672458|NCT00740454|venous thromboembolism|venous thromboembolism
672459|NCT00740454|diagnosis|diagnosis
672460|NCT00740454|compression ultrasonography|compression ultrasonography
672461|NCT00740441|renal cell carcinoma|renal cell carcinoma
672462|NCT00740441|rcc|rcc
672463|NCT00740441|kidney cancer|kidney cancer
672464|NCT00740428|Pelvic floor,|pelvic floor,
672465|NCT00740428|muscular dysfunction,|muscular dysfunction,
672466|NCT00740428|urinary incontinence|urinary incontinence
672467|NCT00740415|contiguous stage II mantle cell lymphoma|contiguous stage ii mantle cell lymphoma
672468|NCT00740415|noncontiguous stage II mantle cell lymphoma|noncontiguous stage ii mantle cell lymphoma
672469|NCT00740415|stage III mantle cell lymphoma|stage iii mantle cell lymphoma
672470|NCT00740415|stage IV mantle cell lymphoma|stage iv mantle cell lymphoma
672471|NCT00740389|TMC125-C187|tmc125-c187
672472|NCT00740389|TMC125-TiDP2-C187|tmc125-tidp2-c187
672473|NCT00740389|HIV|hiv
672474|NCT00740389|AIDS|aids
672475|NCT00740389|Fungal Infection|fungal infection
672476|NCT00740389|Pharmacokinetics|pharmacokinetics
672477|NCT00740376|osteoarthritis|osteoarthritis
672478|NCT00740363|renal transplantation|renal transplantation
672479|NCT00740363|diabetes|diabetes
672480|NCT00740363|glucose intolerance|glucose intolerance
672481|NCT00740363|impaired glucose tolerance|impaired glucose tolerance
672482|NCT00740337|Chronic Obstructive Pulmonary Disease|chronic obstructive pulmonary disease
672483|NCT00740337|COPD|copd
672484|NCT00740337|Emphysema|emphysema
672485|NCT00740337|Natural Killer T-cell|natural killer t-cell
672486|NCT00740337|Interleukin-13|interleukin-13
672487|NCT00740337|Innate Immune Signaling|innate immune signaling
672488|NCT00740324|During|during
672489|NCT00740324|Endoscopy|endoscopy
672490|NCT00740324|Gastric|gastric
672491|NCT00740324|Peristalsis|peristalsis
672492|NCT00740311|Prevention of the reduction of the alveolar crest|prevention of the reduction of the alveolar crest
672493|NCT00740298|infants|infants
672494|NCT00740298|undergoing|undergoing
672495|NCT00740298|vaccinations|vaccinations
672496|NCT00740285|scleroderma|scleroderma
672497|NCT00740285|scleroderma - limited or diffuse types|scleroderma - limited or diffuse types
672498|NCT00740285|lidocaine|lidocaine
672499|NCT00740285|effectiveness|effectiveness
672500|NCT00740272|brady-tachy syndrome|brady-tachy syndrome
672501|NCT00740272|AF ablation|af ablation
672502|NCT00740259|flunarizine|flunarizine
672503|NCT00740259|schizophrenia|schizophrenia
672504|NCT00740259|antipsychotic|antipsychotic
672505|NCT00740233|fibromyalgia|fibromyalgia
672506|NCT00740233|irritable bowel syndrome|irritable bowel syndrome
672507|NCT00740233|interstitial cystitis|interstitial cystitis
672508|NCT00740233|chronic fatigue syndrome|chronic fatigue syndrome
672509|NCT00740233|vulvodynia|vulvodynia
672510|NCT00740233|chronic stress|chronic stress
672511|NCT00740233|chronic pain|chronic pain
672512|NCT00740233|stress-related conditions|stress-related conditions
672513|NCT00740233|functional GI disorders|functional gi disorders
672514|NCT00740220|hypoxemia|hypoxemia
672515|NCT00740220|anoxia|anoxia
672516|NCT00740220|oxygen|oxygen
672517|NCT00740220|dyspnea|dyspnea
672518|NCT00740220|pulmonary disease|pulmonary disease
672519|NCT00740220|chronic obstructive|chronic obstructive
672520|NCT00740194|Physiology|physiology
672521|NCT00740194|males|males
672522|NCT00740181|myelodysplasia|myelodysplasia
672523|NCT00740181|refractory leukemia|refractory leukemia
672524|NCT00740181|acute leukemia|acute leukemia
672525|NCT00740168|bevacizumab|bevacizumab
672526|NCT00740168|cancer|cancer
672527|NCT00740155|Dengue virus|dengue virus
672528|NCT00740155|Dengue fever|dengue fever
672529|NCT00740155|Dengue hemorrhagic fever|dengue hemorrhagic fever
672530|NCT00740155|Dengue diseases|dengue diseases
672828|NCT00739089|shock|shock
672531|NCT00740142|L ornithine L aspartate|l ornithine l aspartate
672532|NCT00740142|Lactulose|lactulose
672533|NCT00740142|Hepatic encephalopathy|hepatic encephalopathy
672534|NCT00740142|LOLA|lola
672535|NCT00740129|Paget's Disease|paget's disease
672536|NCT00740129|Zoledronic acid|zoledronic acid
672537|NCT00740129|Reclast®/Aclasta®|reclast®/aclasta®
672538|NCT00740129|infusion|infusion
672539|NCT00740129|re-treatment|re-treatment
672540|NCT00740129|re-lapse|re-lapse
672541|NCT00740116|Tumor of ovary|tumor of ovary
672542|NCT00740116|Surgical blood loss|surgical blood loss
672543|NCT00740116|Postoperative blood loss|postoperative blood loss
672544|NCT00740116|Preventive therapy|preventive therapy
672545|NCT00740116|Thromboembolism|thromboembolism
672546|NCT00740103|Semapimod|semapimod
672547|NCT00740103|Crohn's Disease|crohn's disease
672548|NCT00740103|TNF-alpha inhibitor|tnf-alpha inhibitor
672549|NCT00740103|MAP Kinase inhibitor|map kinase inhibitor
672550|NCT00740103|CNI-1493|cni-1493
672551|NCT00740090|Malaria|malaria
672552|NCT00740090|Reactogenicity, Safety, Immunogenicity|reactogenicity, safety, immunogenicity
672553|NCT00740090|Maleria Endemic|maleria endemic
672554|NCT00740090|Plasmodium Falciparum|plasmodium falciparum
672555|NCT00740090|Dose Escalating|dose escalating
672556|NCT00740077|cranberry|cranberry
672557|NCT00740077|flavonoid|flavonoid
672558|NCT00740077|phenolic acid|phenolic acid
672559|NCT00740077|phytochemical|phytochemical
672560|NCT00740077|bioavailability|bioavailability
672561|NCT00740064|HIV infections|hiv infections
672562|NCT00740038|Stress Management|stress management
672563|NCT00740038|Quality of Life|quality of life
672564|NCT00740038|Exercise|exercise
672565|NCT00740038|Cancer|cancer
672566|NCT00740038|Chemotherapy|chemotherapy
672567|NCT00740025|QD dose|qd dose
672568|NCT00740025|BID dosing|bid dosing
672569|NCT00740025|peak estradiol|peak estradiol
672570|NCT00740025|oocytes|oocytes
672571|NCT00740025|implantation rate|implantation rate
672572|NCT00740025|pregnancy rate|pregnancy rate
672573|NCT00740012|Nocturnal glucose profiles|nocturnal glucose profiles
672574|NCT00740012|continuous glucose profiles|continuous glucose profiles
672575|NCT00739999|heterozygous familial hypercholesterolemia (HeFH); atorvastatin; pediatric|heterozygous familial hypercholesterolemia (hefh); atorvastatin; pediatric
672576|NCT00739986|Crohn's Disease|crohn's disease
672577|NCT00739986|TNF-alpha|tnf-alpha
672578|NCT00739986|IL-6|il-6
672579|NCT00739986|MAP Kinase|map kinase
672580|NCT00739986|CNI-1493|cni-1493
672581|NCT00739973|Hypertension, Aliskiren, Amlodipine|hypertension, aliskiren, amlodipine
672582|NCT00739947|Observational|observational
672583|NCT00739947|rotator cuff tear|rotator cuff tear
672584|NCT00739947|arthroscopic|arthroscopic
672585|NCT00739947|surgical|surgical
672586|NCT00739947|outcome study|outcome study
672587|NCT00739934|Open-Label|open-label
672588|NCT00739934|Pharmacokinetics|pharmacokinetics
672589|NCT00739934|Intravenous to oral switch|intravenous to oral switch
672590|NCT00739934|Safety|safety
672591|NCT00739934|Voriconazole|voriconazole
672592|NCT00739934|Immunocompromise|immunocompromise
672593|NCT00739934|Children|children
672594|NCT00739934|High Risk For Systemic Fungal Infection.|high risk for systemic fungal infection.
672595|NCT00739921|PCR Analysis|pcr analysis
672596|NCT00739921|Allergic fungal sinusitis|allergic fungal sinusitis
672597|NCT00739921|Chronic rhinosinusitis|chronic rhinosinusitis
672598|NCT00739921|Nasal Polyps|nasal polyps
672599|NCT00739908|MDD|mdd
672600|NCT00739895|athletes|athletes
672601|NCT00739882|Efalizumab,|efalizumab,
672602|NCT00739882|Chronic plaque psoriasis|chronic plaque psoriasis
672603|NCT00739882|moderate to severe|moderate to severe
672604|NCT00739882|involving|involving
672605|NCT00739882|hands|hands
672606|NCT00739882|feet|feet
672607|NCT00739869|Silent Infarcts|silent infarcts
672608|NCT00739869|Magnetic Resonance Imaging|magnetic resonance imaging
672609|NCT00739869|MRI|mri
672610|NCT00739869|Subclinical Cerebrovascular Disease|subclinical cerebrovascular disease
672611|NCT00739869|White Matter Grade Abnormalities|white matter grade abnormalities
672612|NCT00739869|Total Brain Volume|total brain volume
672613|NCT00739869|Ventricular and Hippocampal Volume|ventricular and hippocampal volume
672614|NCT00739869|Subclinical Vascular Abnormalities|subclinical vascular abnormalities
672615|NCT00739869|Cerebrovascular Disease|cerebrovascular disease
672616|NCT00739869|CVD|cvd
672617|NCT00739869|Subclinical CVD|subclinical cvd
672618|NCT00739856|posttraumatic stress disorder|posttraumatic stress disorder
672619|NCT00739856|electroconvulsive therapy|electroconvulsive therapy
672620|NCT00739856|medication refractoriness|medication refractoriness
672621|NCT00739843|Dementia,|dementia,
672622|NCT00739843|Cognitive Disorders,|cognitive disorders,
672623|NCT00739843|Hemodialysis|hemodialysis
672624|NCT00739791|adenocarcinoma of the prostate|adenocarcinoma of the prostate
672625|NCT00739791|stage I prostate cancer|stage i prostate cancer
672626|NCT00739791|stage IIB prostate cancer|stage iib prostate cancer
672627|NCT00739791|stage IIA prostate cancer|stage iia prostate cancer
672628|NCT00739765|Trauma|trauma
672629|NCT00739765|Psychotherapy|psychotherapy
672630|NCT00739765|Anxiety|anxiety
672631|NCT00739752|Attitude to Health|attitude to health
672632|NCT00739752|Communication|communication
672633|NCT00739752|Intervention Studies|intervention studies
672634|NCT00739752|Health Promotion|health promotion
672635|NCT00739752|Psychology, Medical|psychology, medical
672636|NCT00739752|Sexual Behavior|sexual behavior
672637|NCT00739752|Behavioral Research|behavioral research
672638|NCT00739752|Vaccination|vaccination
672639|NCT00739713|dry eye|dry eye
672640|NCT00739713|sea buckthorn|sea buckthorn
672641|NCT00739713|Hippophaë|hippophaë
672642|NCT00739700|hemodynamics|hemodynamics
672643|NCT00739700|blood pressure|blood pressure
672644|NCT00739700|blood pressure monitors|blood pressure monitors
672645|NCT00739687|Chronic Heart Failure|chronic heart failure
672646|NCT00739661|Systemic Hedgehog|systemic hedgehog
672647|NCT00739661|Hedgehog Pathway Inhibitor|hedgehog pathway inhibitor
672648|NCT00739648|COPD|copd
672649|NCT00739648|Patients|patients
672650|NCT00739622|TMC278-TiDP6-C136|tmc278-tidp6-c136
672651|NCT00739622|TMC278-C136|tmc278-c136
672652|NCT00739622|Healthy Volunteer|healthy volunteer
672653|NCT00739596|Hypertension|hypertension
672654|NCT00739596|African American|african american
672655|NCT00739596|aliskiren|aliskiren
672656|NCT00739596|hydrochlorothiazide|hydrochlorothiazide
672657|NCT00739596|systolic blood pressure|systolic blood pressure
672658|NCT00739596|diastolic blood pressure|diastolic blood pressure
672659|NCT00739596|amlodipine|amlodipine
672660|NCT00739596|stage 2|stage 2
672661|NCT00739583|Skin preparation|skin preparation
672662|NCT00739583|Skin marking|skin marking
672663|NCT00739583|site marking|site marking
672664|NCT00739583|Site identification|site identification
672665|NCT00739570|Activator|activator
672666|NCT00739570|EMG|emg
672667|NCT00739570|Thermography|thermography
672668|NCT00739570|Diagnostic|diagnostic
672669|NCT00739570|X-Rays|x-rays
672670|NCT00739557|elective TAAA repair|elective taaa repair
672671|NCT00739544|Reference Values|reference values
672672|NCT00739544|Sensory Thresholds|sensory thresholds
672673|NCT00739544|Pain Threshold|pain threshold
672674|NCT00739544|Breast Neoplasms|breast neoplasms
672675|NCT00739531|Asthma|asthma
672676|NCT00739531|nitric oxide|nitric oxide
672677|NCT00739531|eNO|eno
672678|NCT00739531|FENO|feno
672679|NCT00739531|Apieron INSIGHT|apieron insight
672680|NCT00739531|Aerocrine NIOX|aerocrine niox
672681|NCT00739518|Neurological|neurological
672682|NCT00739518|MRI|mri
672683|NCT00739505|Hypophosphatasia|hypophosphatasia
672684|NCT00739505|Bone Disease|bone disease
672685|NCT00739505|Soft Bones|soft bones
672686|NCT00739505|Low Alkaline Phosphatase|low alkaline phosphatase
672687|NCT00739505|genetic metabolic disorder|genetic metabolic disorder
672688|NCT00739505|alkaline phosphatase|alkaline phosphatase
672689|NCT00739505|tissue non-specific alkaline phosphatase|tissue non-specific alkaline phosphatase
672690|NCT00739505|rickets|rickets
672691|NCT00739505|osteomalacia|osteomalacia
672692|NCT00739492|weight loss, obesity, financial incentives|weight loss, obesity, financial incentives
672693|NCT00739479|Metabolic Syndrome|metabolic syndrome
672694|NCT00739479|METS|mets
672695|NCT00739479|Obesity|obesity
672696|NCT00739479|Partially Hydrolyzed Whey Protein|partially hydrolyzed whey protein
672697|NCT00739479|Partially Hydrolyzed Gelatin|partially hydrolyzed gelatin
672698|NCT00739479|PHWP|phwp
672699|NCT00739479|PHG|phg
672700|NCT00739479|Weight Loss|weight loss
672701|NCT00739466|Liposomal Alendronate|liposomal alendronate
672702|NCT00739466|Percutaneous coronary intervention|percutaneous coronary intervention
672703|NCT00739466|Coronary stenting|coronary stenting
672704|NCT00739466|de novo stenotic lesions|de novo stenotic lesions
672705|NCT00739466|Native coronary arteries|native coronary arteries
672706|NCT00739466|Restenosis|restenosis
672707|NCT00739466|Bare metal stent|bare metal stent
672708|NCT00739466|Presillion CoCr coronary stent|presillion cocr coronary stent
672709|NCT00739453|Pancreatic cancer|pancreatic cancer
672710|NCT00739453|Advanced cancer|advanced cancer
672711|NCT00739453|Prostate cancer|prostate cancer
672712|NCT00739453|Non-small cell lung cancer|non-small cell lung cancer
672713|NCT00739453|Colorectal cancer|colorectal cancer
672714|NCT00739414|Histone Deacetylases|histone deacetylases
672715|NCT00739414|HDAC inhibitor|hdac inhibitor
672716|NCT00739414|LBH589|lbh589
672717|NCT00739414|Advanced solid tumor|advanced solid tumor
672718|NCT00739414|Adult|adult
672719|NCT00739401|AAA|aaa
672720|NCT00739401|Aneurysm|aneurysm
672721|NCT00739401|Suprarenal|suprarenal
672722|NCT00739401|Proximal|proximal
672723|NCT00739401|Cuff|cuff
672724|NCT00739401|Extension|extension
672725|NCT00739401|Endograft|endograft
672726|NCT00739401|Endovascular repair|endovascular repair
672727|NCT00739401|EVAR|evar
672728|NCT00739401|Endoleak|endoleak
672729|NCT00739401|Type I|type i
672730|NCT00739388|adult acute myeloid leukemia with 11q23 (MLL) abnormalities|adult acute myeloid leukemia with 11q23 (mll) abnormalities
672731|NCT00739388|adult acute myeloid leukemia with inv(16)(p13;q22)|adult acute myeloid leukemia with inv(16)(p13;q22)
672829|NCT00739089|sepsis|sepsis
672732|NCT00739388|adult acute myeloid leukemia with t(16;16)(p13;q22)|adult acute myeloid leukemia with t(16;16)(p13;q22)
672733|NCT00739388|adult acute myeloid leukemia with t(8;21)(q22;q22)|adult acute myeloid leukemia with t(8;21)(q22;q22)
672734|NCT00739388|secondary acute myeloid leukemia|secondary acute myeloid leukemia
672735|NCT00739388|untreated adult acute myeloid leukemia|untreated adult acute myeloid leukemia
672736|NCT00739388|adult acute myeloblastic leukemia without maturation (M1)|adult acute myeloblastic leukemia without maturation (m1)
672737|NCT00739388|adult acute myeloblastic leukemia with maturation (M2)|adult acute myeloblastic leukemia with maturation (m2)
672738|NCT00739388|adult acute myelomonocytic leukemia (M4)|adult acute myelomonocytic leukemia (m4)
672739|NCT00739388|adult acute monoblastic leukemia (M5a)|adult acute monoblastic leukemia (m5a)
672740|NCT00739388|adult acute monocytic leukemia (M5b)|adult acute monocytic leukemia (m5b)
672741|NCT00739388|adult erythroleukemia (M6a)|adult erythroleukemia (m6a)
672742|NCT00739388|adult pure erythroid leukemia (M6b)|adult pure erythroid leukemia (m6b)
672743|NCT00739388|adult acute megakaryoblastic leukemia (M7)|adult acute megakaryoblastic leukemia (m7)
672744|NCT00739375|Influence|influence
672745|NCT00739375|of av access|of av access
672746|NCT00739375|flow|flow
672747|NCT00739375|development|development
672748|NCT00739362|Behavioral Weight Loss Treatment|behavioral weight loss treatment
672749|NCT00739362|Obesity|obesity
672750|NCT00739362|Appetite Control|appetite control
672751|NCT00739362|Weight Loss|weight loss
672752|NCT00739362|Transcranial Direct Current Stimulation (TDCS)|transcranial direct current stimulation (tdcs)
672753|NCT00739349|Dry Eye|dry eye
672754|NCT00739349|Cyclosporine|cyclosporine
672755|NCT00739336|diabetes mellitus|diabetes mellitus
672756|NCT00739336|obesity|obesity
672757|NCT00739336|prevention|prevention
672758|NCT00739310|High Frequency Chest Wall Oscillation|high frequency chest wall oscillation
672759|NCT00739310|Cerebral Palsy|cerebral palsy
672760|NCT00739310|Restrictive lung disease|restrictive lung disease
672761|NCT00739297|Chronic asthma|chronic asthma
672762|NCT00739284|preferred|preferred
672763|NCT00739284|procedure|procedure
672764|NCT00739284|drainage|drainage
672765|NCT00739284|obstructed|obstructed
672766|NCT00739284|kidney|kidney
672767|NCT00739284|stone|stone
672768|NCT00739258|HIV-infected person|hiv-infected person
672769|NCT00739258|Entamoeba|entamoeba
672770|NCT00739258|Cryptosporidium|cryptosporidium
672771|NCT00739258|Giardia|giardia
672772|NCT00739258|ELISA|elisa
672773|NCT00739258|PCR|pcr
672774|NCT00739258|IDU|idu
672775|NCT00739258|Gonorrhea|gonorrhea
672776|NCT00739258|Chlamydial trachomatis|chlamydial trachomatis
672777|NCT00739258|Syphilis|syphilis
672778|NCT00739258|Genital warts|genital warts
672779|NCT00739258|Herpes simplex virus|herpes simplex virus
672780|NCT00739232|Safety and tolerability of HSD-016|safety and tolerability of hsd-016
672781|NCT00739219|Asthma|asthma
672782|NCT00739219|inflammation|inflammation
672783|NCT00739219|nitric oxide|nitric oxide
672784|NCT00739219|eNO|eno
672785|NCT00739219|FENO|feno
672786|NCT00739206|uncomplicated|uncomplicated
672787|NCT00739206|severe|severe
672788|NCT00739206|treatment|treatment
672789|NCT00739206|Plasmodium Falciparum|plasmodium falciparum
672790|NCT00739193|Blood Pressure|blood pressure
672791|NCT00739180|Childhood obesity|childhood obesity
672792|NCT00739180|Abdominal obesity|abdominal obesity
672793|NCT00739180|Visceral fat|visceral fat
672794|NCT00739180|Insulin resistance|insulin resistance
672795|NCT00739180|Liver fat|liver fat
672796|NCT00739180|Skeletal muscle lipid|skeletal muscle lipid
672797|NCT00739180|Fitness|fitness
672798|NCT00739167|adult primary hepatocellular carcinoma|adult primary hepatocellular carcinoma
672799|NCT00739167|advanced adult primary liver cancer|advanced adult primary liver cancer
672800|NCT00739167|liver metastases|liver metastases
672801|NCT00739167|recurrent adult primary liver cancer|recurrent adult primary liver cancer
672802|NCT00739154|glaucoma|glaucoma
672803|NCT00739154|Phenytoin|phenytoin
672804|NCT00739154|retinal nerve fiber layer|retinal nerve fiber layer
672805|NCT00739154|corrected pattern standard deviation|corrected pattern standard deviation
672806|NCT00739154|visual acuity|visual acuity
672807|NCT00739154|optic disc cupping|optic disc cupping
672808|NCT00739141|CYCLOPHOSPHAMIDE (CYTOXAN)|cyclophosphamide (cytoxan)
672809|NCT00739141|CYCLOSPORINE A|cyclosporine a
672810|NCT00739141|FLUDARABINE|fludarabine
672811|NCT00739141|G-CSF|g-csf
672812|NCT00739141|MYCOPHENOLATE MOFETIL (MMF)|mycophenolate mofetil (mmf)
672813|NCT00739141|THI0TEPA|thi0tepa
672814|NCT00739141|UMBILICAL CORD BLOOD (UCB)|umbilical cord blood (ucb)
672815|NCT00739141|08-087|08-087
672816|NCT00739128|celiac disease|celiac disease
672817|NCT00739128|hepatitis B vaccine|hepatitis b vaccine
672818|NCT00739115|Respiratory|respiratory
672819|NCT00739115|Distress|distress
672820|NCT00739115|Prematurity|prematurity
672821|NCT00739115|Heliox|heliox
672822|NCT00739115|CPAP|cpap
672823|NCT00739102|Superficial Femoral Artery|superficial femoral artery
672824|NCT00739102|Nitinol Self-Expandable Stent System|nitinol self-expandable stent system
672825|NCT00739089|hemodynamics|hemodynamics
672826|NCT00739089|oxygen|oxygen
672827|NCT00739089|renal dialysis|renal dialysis
672830|NCT00739089|hypotension|hypotension
672831|NCT00739089|lactic acidosis|lactic acidosis
672832|NCT00739063|Breast cancer|breast cancer
672833|NCT00739063|Carcinoma of the breast|carcinoma of the breast
672834|NCT00739063|Stage IV|stage iv
672835|NCT00739063|Triple receptor-negative|triple receptor-negative
672836|NCT00739063|Triple receptor-negative breast cancer|triple receptor-negative breast cancer
672837|NCT00739063|Metastatic triple receptor-negative breast cancer|metastatic triple receptor-negative breast cancer
672838|NCT00739063|Epidermal growth factor receptor|epidermal growth factor receptor
672839|NCT00739063|EGFR|egfr
672840|NCT00739063|EGFR-overexpressing|egfr-overexpressing
672841|NCT00739063|GFR inhibitor erlotinib|gfr inhibitor erlotinib
672842|NCT00739063|Erlotinib hydrochloride|erlotinib hydrochloride
672843|NCT00739063|Erlotinib|erlotinib
672844|NCT00739063|Tarceva|tarceva
672845|NCT00739063|OSI-774|osi-774
672846|NCT00739024|Migraine|migraine
672847|NCT00739024|Headache|headache
672848|NCT00738998|Breast Cancer|breast cancer
672849|NCT00738998|Aromatase Inhibitors|aromatase inhibitors
672850|NCT00738998|Symptom Assessment|symptom assessment
672851|NCT00738998|Questionnaire|questionnaire
672852|NCT00738998|Survey|survey
672853|NCT00738998|Phone Call|phone call
672854|NCT00738998|Arimidex|arimidex
672855|NCT00738998|Anastrozole|anastrozole
672856|NCT00738959|AZD0328|azd0328
672857|NCT00738959|Japanese|japanese
672858|NCT00738959|Caucasian|caucasian
672859|NCT00738959|pharmacokinetics|pharmacokinetics
672860|NCT00738959|safety|safety
672861|NCT00738959|tolerability|tolerability
672862|NCT00738946|Intermittent Preventive treatment|intermittent preventive treatment
672863|NCT00738946|insecticide treated bednets|insecticide treated bednets
672864|NCT00738946|malaria|malaria
672865|NCT00738933|Atherosclerosis|atherosclerosis
672866|NCT00738933|Plant sterols|plant sterols
672867|NCT00738933|Plant stanols|plant stanols
672868|NCT00738933|Aortic valve|aortic valve
672869|NCT00738907|Type 1 diabetes|type 1 diabetes
672870|NCT00738894|cryptogenic|cryptogenic
672871|NCT00738894|stroke|stroke
672872|NCT00738894|transient ischemic attack|transient ischemic attack
672874|NCT00738894|PFO|pfo
672875|NCT00738894|Patent foramen ovale|patent foramen ovale
672876|NCT00738894|HELEX|helex
672877|NCT00738894|Septal Occluder|septal occluder
672878|NCT00738894|PFO Occluder|pfo occluder
672879|NCT00738868|recurrent squamous cell carcinoma of the hypopharynx|recurrent squamous cell carcinoma of the hypopharynx
672880|NCT00738868|stage III squamous cell carcinoma of the hypopharynx|stage iii squamous cell carcinoma of the hypopharynx
672881|NCT00738868|stage III squamous cell carcinoma of the larynx|stage iii squamous cell carcinoma of the larynx
672882|NCT00738868|stage III verrucous carcinoma of the larynx|stage iii verrucous carcinoma of the larynx
672883|NCT00738868|recurrent squamous cell carcinoma of the larynx|recurrent squamous cell carcinoma of the larynx
672884|NCT00738868|recurrent verrucous carcinoma of the larynx|recurrent verrucous carcinoma of the larynx
672885|NCT00738868|recurrent squamous cell carcinoma of the lip and oral cavity|recurrent squamous cell carcinoma of the lip and oral cavity
672886|NCT00738868|stage III squamous cell carcinoma of the lip and oral cavity|stage iii squamous cell carcinoma of the lip and oral cavity
672887|NCT00738868|recurrent verrucous carcinoma of the oral cavity|recurrent verrucous carcinoma of the oral cavity
672888|NCT00738868|stage III verrucous carcinoma of the oral cavity|stage iii verrucous carcinoma of the oral cavity
672889|NCT00738868|recurrent squamous cell carcinoma of the nasopharynx|recurrent squamous cell carcinoma of the nasopharynx
672890|NCT00738868|stage III squamous cell carcinoma of the nasopharynx|stage iii squamous cell carcinoma of the nasopharynx
672891|NCT00738868|recurrent squamous cell carcinoma of the oropharynx|recurrent squamous cell carcinoma of the oropharynx
672892|NCT00738868|stage III squamous cell carcinoma of the oropharynx|stage iii squamous cell carcinoma of the oropharynx
672893|NCT00738868|recurrent squamous cell carcinoma of the paranasal sinus and nasal cavity|recurrent squamous cell carcinoma of the paranasal sinus and nasal cavity
672894|NCT00738868|stage III squamous cell carcinoma of the paranasal sinus and nasal cavity|stage iii squamous cell carcinoma of the paranasal sinus and nasal cavity
672895|NCT00738868|recurrent salivary gland cancer|recurrent salivary gland cancer
672896|NCT00738868|salivary gland squamous cell carcinoma|salivary gland squamous cell carcinoma
672897|NCT00738868|stage III salivary gland cancer|stage iii salivary gland cancer
672898|NCT00738855|Adhesions|adhesions
672899|NCT00738855|Oral contrast|oral contrast
672900|NCT00738855|Exploration|exploration
672901|NCT00738842|Uric|uric
672902|NCT00738842|Acid|acid
672903|NCT00738842|Level|level
672904|NCT00738829|CLL|cll
672905|NCT00738829|untreated|untreated
672906|NCT00738829|immune therapy|immune therapy
672907|NCT00738829|dose escalation|dose escalation
672908|NCT00738829|maximum tolerated dose|maximum tolerated dose
672909|NCT00738829|maintenance therapy|maintenance therapy
672910|NCT00738829|Lenalidomide|lenalidomide
672911|NCT00738829|Rituximab|rituximab
672912|NCT00738829|Fludarabine|fludarabine
672913|NCT00738816|Medication review|medication review
672914|NCT00738816|Patient|patient
672915|NCT00738816|Safety|safety
672916|NCT00738816|Drug|drug
672917|NCT00738816|Prescriptions|prescriptions
672918|NCT00738816|Drug-use|drug-use
672919|NCT00738803|leg length|leg length
672920|NCT00738803|hip arthroplasty|hip arthroplasty
672921|NCT00738803|offset|offset
672922|NCT00738790|rectal cancer|rectal cancer
672923|NCT00738790|preoperative radiotherapy and local excision|preoperative radiotherapy and local excision
672924|NCT00738777|pre-operative|pre-operative
672925|NCT00738777|endocrine treatment|endocrine treatment
672926|NCT00738777|drug resistance|drug resistance
672927|NCT00738764|cancer|cancer
672928|NCT00738764|antibody|antibody
672929|NCT00738764|Phase 1 Clinical Trial|phase 1 clinical trial
672930|NCT00738751|NSCLC|nsclc
672931|NCT00738751|Metastatic|metastatic
672932|NCT00738751|erlotinib|erlotinib
672933|NCT00738751|aerodigestive tract cancers|aerodigestive tract cancers
672934|NCT00738751|non-small cell lung cancer|non-small cell lung cancer
672935|NCT00738751|H&N cancer|h&n cancer
672936|NCT00738738|Generalized Anxiety Disorder Elderly|generalized anxiety disorder elderly
672937|NCT00738725|High risk plaque|high risk plaque
672938|NCT00738725|High-risk plaque|high-risk plaque
672939|NCT00738725|Vulnerable plaque|vulnerable plaque
672940|NCT00738725|Atherosclerotic Disease|atherosclerotic disease
672941|NCT00738725|Heart Disease|heart disease
672942|NCT00738725|Stroke|stroke
672943|NCT00738712|Vascular MRI|vascular mri
672944|NCT00738712|Abdominal MRI|abdominal mri
672945|NCT00738712|Pelvic MRI|pelvic mri
672946|NCT00738712|Breast MRI|breast mri
672947|NCT00738712|Magnetic Resonance Imaging (MRI)|magnetic resonance imaging (mri)
672948|NCT00738699|ovarian cancer|ovarian cancer
672949|NCT00738699|relapsed ovarian cancer|relapsed ovarian cancer
672950|NCT00738699|refractory ovarian cancer|refractory ovarian cancer
672951|NCT00738686|coronary artery disease|coronary artery disease
672952|NCT00738686|drug-eluting stent|drug-eluting stent
672953|NCT00738686|percutaneous coronary intervention|percutaneous coronary intervention
672954|NCT00738686|major adverse cardiac event|major adverse cardiac event
672955|NCT00738686|in-stent restenosis|in-stent restenosis
672956|NCT00738686|stent thrombosis|stent thrombosis
672957|NCT00738673|Hormone refractory prostate cancer|hormone refractory prostate cancer
672958|NCT00738673|Agonist treatment failure|agonist treatment failure
672959|NCT00738660|type1 DM|type1 dm
672960|NCT00738660|microalbuminuria|microalbuminuria
672961|NCT00738660|nephropathy|nephropathy
672962|NCT00738660|albumin excretion rate|albumin excretion rate
672963|NCT00738660|dual blockade|dual blockade
672964|NCT00738660|ACEI|acei
672965|NCT00738660|ARB|arb
672966|NCT00738647|Filling materials|filling materials
672967|NCT00738647|Restorative materials|restorative materials
672968|NCT00738647|clinical trial|clinical trial
672969|NCT00738647|Resin based composite|resin based composite
672970|NCT00738634|Depression|depression
672971|NCT00738634|Motor Activity|motor activity
672972|NCT00738634|Adolescent|adolescent
672973|NCT00738621|PONV|ponv
672974|NCT00738621|breast surgery|breast surgery
672975|NCT00738621|prevention|prevention
672976|NCT00738621|antiemetics|antiemetics
672977|NCT00738608|morphine|morphine
672978|NCT00738608|consumption|consumption
672979|NCT00738608|postoperative|postoperative
672980|NCT00738608|pain|pain
672981|NCT00738608|Pain during 24h postoperative|pain during 24h postoperative
672982|NCT00738608|Morphine consumption in 24h postoperative|morphine consumption in 24h postoperative
672983|NCT00738595|Smoking Cessation|smoking cessation
672984|NCT00738569|Chronic inflammation|chronic inflammation
672985|NCT00738569|memory cells|memory cells
672986|NCT00738569|activated t-lymphocytes|activated t-lymphocytes
672987|NCT00738543|Antiseptics|antiseptics
672988|NCT00738543|Administration, cutaneous|administration, cutaneous
672989|NCT00738543|Iodophors|iodophors
672990|NCT00738543|Chlorine compounds|chlorine compounds
672991|NCT00738543|Anti-infecting agents, local|anti-infecting agents, local
672992|NCT00738517|heart failure|heart failure
672993|NCT00738517|coronary heart disease|coronary heart disease
672994|NCT00738517|autoantibodies|autoantibodies
672995|NCT00738517|immunoadsorption|immunoadsorption
672996|NCT00738517|immunoglobulin substitution|immunoglobulin substitution
672997|NCT00738504|Intensive insulin therapy|intensive insulin therapy
672998|NCT00738504|Carbohydrate restrictive strategy|carbohydrate restrictive strategy
672999|NCT00738504|RIFLE Criteria|rifle criteria
673000|NCT00738504|Acute Kidney Injury|acute kidney injury
673001|NCT00738504|Critically ill patients|critically ill patients
673002|NCT00738504|Acute|acute
673003|NCT00738491|Angina pectoris|angina pectoris
673004|NCT00738491|Exercise capacity|exercise capacity
673005|NCT00738491|Myocardial ischaemia|myocardial ischaemia
673006|NCT00738491|Air pollution|air pollution
673007|NCT00738478|distal gastrectomy|distal gastrectomy
673008|NCT00738478|quality of life|quality of life
673009|NCT00738452|recurrent non-small cell lung cancer|recurrent non-small cell lung cancer
673010|NCT00738452|stage II non-small cell lung cancer|stage ii non-small cell lung cancer
673011|NCT00738452|stage IIIA non-small cell lung cancer|stage iiia non-small cell lung cancer
673012|NCT00738452|stage IIIB non-small cell lung cancer|stage iiib non-small cell lung cancer
673013|NCT00738439|scoliosis|scoliosis
673014|NCT00738439|kyphosis|kyphosis
673015|NCT00738439|treatment outcomes|treatment outcomes
673016|NCT00738439|spinal deformity|spinal deformity
673017|NCT00738426|non-invasive body contouring of waists hips and thighs|non-invasive body contouring of waists hips and thighs
673018|NCT00738413|Iron chelation|iron chelation
673019|NCT00738413|Iron balance|iron balance
673020|NCT00738413|Secondary iron overload|secondary iron overload
673021|NCT00738413|deferoxamine|deferoxamine
673022|NCT00738413|deferasirox|deferasirox
673023|NCT00738400|Vardenafil|vardenafil
673024|NCT00738400|Erectile Dysfunction|erectile dysfunction
673025|NCT00738400|Double-blind study|double-blind study
673026|NCT00738387|Tumor vascular disrupting agent|tumor vascular disrupting agent
673027|NCT00738387|VDA|vda
673028|NCT00738387|ASA404|asa404
673029|NCT00738387|non-small cell lung cancer|non-small cell lung cancer
673030|NCT00738387|NSCLC|nsclc
673031|NCT00738361|ciliary body and choroid melanoma, medium/large size|ciliary body and choroid melanoma, medium/large size
673032|NCT00738361|iris melanoma|iris melanoma
673033|NCT00738361|metastatic intraocular melanoma|metastatic intraocular melanoma
673034|NCT00738361|recurrent intraocular melanoma|recurrent intraocular melanoma
673035|NCT00738361|extraocular extension melanoma|extraocular extension melanoma
673036|NCT00738348|surgery|surgery
673037|NCT00738335|stage IV non-small cell lung cancer|stage iv non-small cell lung cancer
673038|NCT00738335|tumors metastatic to brain|tumors metastatic to brain
673039|NCT00738335|recurrent non-small cell lung cancer|recurrent non-small cell lung cancer
673040|NCT00738322|AZD1305|azd1305
673041|NCT00738322|safety|safety
673042|NCT00738322|pharmacokinetics|pharmacokinetics
673043|NCT00738322|single ascending doses|single ascending doses
673044|NCT00738322|Japanese|japanese
673045|NCT00738322|male|male
673046|NCT00738309|Treatment Outcomes|treatment outcomes
673047|NCT00738309|Spinal Deformity|spinal deformity
673048|NCT00738309|Scheuermann's Kyphosis|scheuermann's kyphosis
673049|NCT00738283|Zinc|zinc
673050|NCT00738283|Copper|copper
673051|NCT00738283|Neonate|neonate
673052|NCT00738257|Renal|renal
673053|NCT00738257|transplant,|transplant,
673054|NCT00738257|pamidronate,|pamidronate,
673055|NCT00738257|ciclosporin,|ciclosporin,
673056|NCT00738257|Ciclosporin A,|ciclosporin a,
673057|NCT00738257|steroids,|steroids,
673058|NCT00738257|bone mineral density,|bone mineral density,
673059|NCT00738257|fracture rates|fracture rates
673060|NCT00738257|immunosuppressive|immunosuppressive
673061|NCT00738257|regimen|regimen
673062|NCT00738244|hearing aid algorithm|hearing aid algorithm
673063|NCT00738244|wind-noise suppression|wind-noise suppression
673064|NCT00738231|risk factors; coronary arterial hearth disease|risk factors; coronary arterial hearth disease
673065|NCT00738218|Coronary Artery Disease|coronary artery disease
673066|NCT00738218|Computed Tomography|computed tomography
673067|NCT00738218|Angiography|angiography
673068|NCT00738205|Electronic device|electronic device
673069|NCT00738205|Growth hormone treatment|growth hormone treatment
673070|NCT00738192|Postoperative analgesia|postoperative analgesia
673071|NCT00738192|Opioids|opioids
673072|NCT00738192|Laparoscopic surgery|laparoscopic surgery
673073|NCT00738179|Continuous Positive Airway Pressure (CPAP)|continuous positive airway pressure (cpap)
673074|NCT00738179|Obstructive Sleep Apnea (OSA)|obstructive sleep apnea (osa)
673075|NCT00738179|Cardiovascular (CV)|cardiovascular (cv)
673076|NCT00738179|Cardiovascular Disease|cardiovascular disease
673077|NCT00738179|Clinical Trial|clinical trial
673078|NCT00738166|diet, organic, health|diet, organic, health
673079|NCT00738166|healthy people|healthy people
673080|NCT00738140|insulin sensitivity|insulin sensitivity
673081|NCT00738140|Diabetes Prevention Program|diabetes prevention program
673082|NCT00738140|lifestyle intervention|lifestyle intervention
673083|NCT00738127|Acute trans-scaphoid perilunate dislocations|acute trans-scaphoid perilunate dislocations
673084|NCT00738127|Open reduction and internal fixation|open reduction and internal fixation
673085|NCT00738127|Kirschner-wire|kirschner-wire
673086|NCT00738127|Range of motion|range of motion
673087|NCT00738114|non-cardiac|non-cardiac
673088|NCT00738114|surgery|surgery
673089|NCT00738114|mortality|mortality
673090|NCT00738114|morbidity|morbidity
673091|NCT00738114|perioperative|perioperative
673092|NCT00738114|period|period
673093|NCT00738101|Omega-3|omega-3
673094|NCT00738101|Omegaven|omegaven
673095|NCT00738101|Cholestasis|cholestasis
673096|NCT00738101|Liver damage|liver damage
673097|NCT00738088|Sulphonylurea|sulphonylurea
673098|NCT00738088|Pharmacogenetics|pharmacogenetics
673100|NCT00738062|Neurogenic Orthostatic Hypotension|neurogenic orthostatic hypotension
673101|NCT00738062|Orthostatic hypotension|orthostatic hypotension
673102|NCT00738062|PAF|paf
673103|NCT00738062|Pure Autonomic Failure|pure autonomic failure
673104|NCT00738062|MSA|msa
673105|NCT00738062|Multiple System Atrophy|multiple system atrophy
673106|NCT00738062|Neuropathy|neuropathy
673107|NCT00738062|Autonomic Failure|autonomic failure
673108|NCT00738062|Parkinson|parkinson
673109|NCT00738062|Dopamine Deficiency|dopamine deficiency
673110|NCT00738062|Dopamine|dopamine
673111|NCT00738062|Droxidopa|droxidopa
673112|NCT00738049|atherosclerosis|atherosclerosis
673113|NCT00738049|coronary artery disease|coronary artery disease
673614|NCT00736463|statin|statin
673114|NCT00738049|myocardial perfusion defect|myocardial perfusion defect
673115|NCT00738049|endothelial dysfunction|endothelial dysfunction
673116|NCT00738049|endothelin receptor blockade|endothelin receptor blockade
673117|NCT00738036|Analgesics|analgesics
673118|NCT00738036|Opioid|opioid
673119|NCT00738036|Opioid maintenance therapy|opioid maintenance therapy
673120|NCT00738036|Acute pain|acute pain
673121|NCT00738023|diabetes,|diabetes,
673122|NCT00738023|hypertension,|hypertension,
673123|NCT00738023|free-fatty acids|free-fatty acids
673124|NCT00738010|NMES|nmes
673125|NCT00738010|ACL|acl
673126|NCT00738010|Atrophy Prevention|atrophy prevention
673127|NCT00738010|Accelerated Recovery|accelerated recovery
673128|NCT00738010|Knee Surgery|knee surgery
673129|NCT00737997|Pediatrics|pediatrics
673130|NCT00737997|Scoliosis|scoliosis
673131|NCT00737997|Morphine|morphine
673132|NCT00737997|Surgery|surgery
673133|NCT00737997|Analgesia|analgesia
673134|NCT00737984|Infertility|infertility
673135|NCT00737984|Clinical pregnancy rate|clinical pregnancy rate
673136|NCT00737971|avastin|avastin
673137|NCT00737971|bevacizumab|bevacizumab
673138|NCT00737971|triamcinolone|triamcinolone
673139|NCT00737971|diabetic macular edema|diabetic macular edema
673140|NCT00737971|macular edema|macular edema
673141|NCT00737971|intravitreal injection|intravitreal injection
673142|NCT00737958|Angina pectoris|angina pectoris
673143|NCT00737958|Air pollution|air pollution
673144|NCT00737958|Diesel exhaust|diesel exhaust
673145|NCT00737958|Myocardial ischaemia|myocardial ischaemia
673146|NCT00737958|Exercise capacity|exercise capacity
673147|NCT00737919|Cholesterol|cholesterol
673148|NCT00737919|Plant sterols|plant sterols
673149|NCT00737919|Atherosclerotic carotid plaques|atherosclerotic carotid plaques
673150|NCT00737906|Chronic rhinitis|chronic rhinitis
673151|NCT00737906|Nasal Obstruction|nasal obstruction
673152|NCT00737906|Nasal Obstruction Symptoms|nasal obstruction symptoms
673153|NCT00737906|Failed Medical Management for Nasal Obstruction|failed medical management for nasal obstruction
673154|NCT00737906|Inflammation of the nasal mucosa|inflammation of the nasal mucosa
673155|NCT00737906|Pediatric Turbinate reduction|pediatric turbinate reduction
673156|NCT00737906|Coblation|coblation
673157|NCT00737906|Arthrocare|arthrocare
673158|NCT00737906|ENT|ent
673159|NCT00737906|Failed Medical Management for Chronic Sinusitis|failed medical management for chronic sinusitis
673160|NCT00737906|Turbinate|turbinate
673161|NCT00737906|Inferior Turbinate Hypertrophy|inferior turbinate hypertrophy
673162|NCT00737906|Bilateral Inferior Turbinate Hypertrophy|bilateral inferior turbinate hypertrophy
673163|NCT00737906|Turbinate Hypertrophy|turbinate hypertrophy
673164|NCT00737906|Inferior Turbinate|inferior turbinate
673165|NCT00737906|Bilateral Inferior Turbinate|bilateral inferior turbinate
673166|NCT00737893|Erythropoietin|erythropoietin
673167|NCT00737893|Radical Prostatectomy|radical prostatectomy
673168|NCT00737893|Erectile Dysfunction|erectile dysfunction
673169|NCT00737893|Prostate Cancer|prostate cancer
673170|NCT00737880|Pancreas Clinical, Donor|pancreas clinical, donor
673171|NCT00737880|Pancreas Clinical, Preservation Solutions|pancreas clinical, preservation solutions
673172|NCT00737880|Organ Preservation and Procurement, Surgery|organ preservation and procurement, surgery
673173|NCT00737880|Organ Procurement, Ischemia reperfusion Injury|organ procurement, ischemia reperfusion injury
673174|NCT00737880|Organ Preservation and Procurement|organ preservation and procurement
673175|NCT00737867|lung cancer|lung cancer
673176|NCT00737867|chemotherapy|chemotherapy
673177|NCT00737867|vinorelbine|vinorelbine
673178|NCT00737867|gemcitabine|gemcitabine
673179|NCT00737867|carboplatin|carboplatin
673180|NCT00737867|advanced lung cancer|advanced lung cancer
673181|NCT00737867|non-small cell lung cancer|non-small cell lung cancer
673182|NCT00737854|OLP|olp
673183|NCT00737854|Free Soft Tissue Graft|free soft tissue graft
673184|NCT00737854|Treatment|treatment
673185|NCT00737841|stress|stress
673186|NCT00737841|brain-gut interactions|brain-gut interactions
673187|NCT00737841|visceral perception|visceral perception
673188|NCT00737841|gastrointestinal motility|gastrointestinal motility
673189|NCT00737841|emotion|emotion
673190|NCT00737828|Cardiopulmonary exercise test|cardiopulmonary exercise test
673191|NCT00737828|CPX|cpx
673192|NCT00737828|CPEX|cpex
673193|NCT00737828|surgical outcome|surgical outcome
673194|NCT00737828|colorectal surgery|colorectal surgery
673195|NCT00737828|risk stratification|risk stratification
673196|NCT00737815|Randomized Controlled Trial|randomized controlled trial
673197|NCT00737815|Magnesium|magnesium
673198|NCT00737815|Diabetes Mellitus, Type 2|diabetes mellitus, type 2
673199|NCT00737815|Inflammation|inflammation
673200|NCT00737802|GERD|gerd
673201|NCT00737802|Heartburn|heartburn
673202|NCT00737802|Esophageal reflux|esophageal reflux
673203|NCT00737802|Barretts esophagus|barretts esophagus
673204|NCT00737802|Normal subjects|normal subjects
673205|NCT00737763|efalizumab|efalizumab
673206|NCT00737763|Raptiva|raptiva
673207|NCT00737763|Diabetes|diabetes
673208|NCT00737763|Type 1 Diabetes Mellitus|type 1 diabetes mellitus
673209|NCT00737750|Neuromuscular electrical stimulation (NMES)|neuromuscular electrical stimulation (nmes)
673210|NCT00737750|Knee Surgery|knee surgery
673211|NCT00737750|Anterior cruciate ligament|anterior cruciate ligament
673212|NCT00737750|Atrophy Prevention|atrophy prevention
673213|NCT00737750|Accelerated Recovery|accelerated recovery
673214|NCT00737737|Analgesia|analgesia
673215|NCT00737737|Chronic Pain|chronic pain
673216|NCT00737737|Neuroendocrine Axis|neuroendocrine axis
673217|NCT00737737|Degenerative Diseases|degenerative diseases
673218|NCT00737724|Enzyme-Linked ImmunoSpot|enzyme-linked immunospot
673219|NCT00737724|Deferred treatment|deferred treatment
673220|NCT00737724|Immune Recovery Inflammatory Syndrome|immune recovery inflammatory syndrome
673221|NCT00737698|COPD|copd
673222|NCT00737698|exercise|exercise
673223|NCT00737698|repetitive magnetic stimulation|repetitive magnetic stimulation
673224|NCT00737698|quadriceps strength|quadriceps strength
673225|NCT00737685|Pediatric|pediatric
673226|NCT00737685|UBMT|ubmt
673227|NCT00737685|Severe|severe
673228|NCT00737672|Hemodialysis|hemodialysis
673229|NCT00737672|Stent Graft|stent graft
673230|NCT00737672|Venous Anastomosis|venous anastomosis
673231|NCT00737672|Arteriovenous Grafts|arteriovenous grafts
673232|NCT00737659|Renal Transplant|renal transplant
673233|NCT00737659|Renal|renal
673234|NCT00737659|Transplant|transplant
673235|NCT00737659|MMF|mmf
673236|NCT00737659|MPA|mpa
673237|NCT00737659|Recipients|recipients
673238|NCT00737646|Cancer|cancer
673239|NCT00737646|Colorectal cancer|colorectal cancer
673240|NCT00737646|Patient education|patient education
673241|NCT00737646|Physician education|physician education
673242|NCT00737633|Diabetes|diabetes
673243|NCT00737633|Type 2 Diabetes|type 2 diabetes
673244|NCT00737633|Diabetes Mellitus|diabetes mellitus
673245|NCT00737633|Metabolic Diseases|metabolic diseases
673246|NCT00737633|Glucose Metabolism Disorders|glucose metabolism disorders
673247|NCT00737633|Glycemic Control|glycemic control
673248|NCT00737620|Renal Failure, End Stage|renal failure, end stage
673249|NCT00737620|Blood Vessel Grafting|blood vessel grafting
673250|NCT00737620|Hemodialysis|hemodialysis
673251|NCT00737620|Surgical Arteriovenous Shunt|surgical arteriovenous shunt
673252|NCT00737607|outcome|outcome
673253|NCT00737607|surgery|surgery
673254|NCT00737607|lumbar spinal stenosis|lumbar spinal stenosis
673255|NCT00737607|minimally invasive|minimally invasive
673256|NCT00737581|Subject's|subject's
673257|NCT00737581|response|response
673258|NCT00737581|changes|changes
673259|NCT00737581|in spinal|in spinal
673260|NCT00737581|cord|cord
673261|NCT00737581|stimulation|stimulation
673262|NCT00737581|during|during
673263|NCT00737581|postural|postural
673264|NCT00737568|Tenofovir DF|tenofovir df
673265|NCT00737568|Emtricitabine|emtricitabine
673266|NCT00737568|Chronic hepatitis B|chronic hepatitis b
673267|NCT00737568|Combination therapy|combination therapy
673268|NCT00737555|Solid tumour|solid tumour
673269|NCT00737555|Solid tumor|solid tumor
673270|NCT00737555|Pharmacokinetic|pharmacokinetic
673271|NCT00737555|Interaction|interaction
673272|NCT00737555|dose escalation|dose escalation
673273|NCT00737555|cancer|cancer
673274|NCT00737555|paclitaxel|paclitaxel
673275|NCT00737542|management|management
673276|NCT00737542|post|post
673277|NCT00737529|Mantle Cell Lymphoma|mantle cell lymphoma
673278|NCT00737529|Non-Hodgkin's Lymphoma|non-hodgkin's lymphoma
673279|NCT00737529|CC-5013|cc-5013
673280|NCT00737529|Revlimid|revlimid
673281|NCT00737529|Lenalidomide|lenalidomide
673282|NCT00737516|Registry|registry
673283|NCT00737516|Unrelated Umbilical Cord Blood donor|unrelated umbilical cord blood donor
673284|NCT00737516|Hematopoietic Reconstitution|hematopoietic reconstitution
673285|NCT00737516|Center for Cord Blood|center for cord blood
673286|NCT00737516|Bone Marrow Transplantation|bone marrow transplantation
673287|NCT00737503|vaccine effectiveness, rotavirus, diarrhoea, Bangladesh|vaccine effectiveness, rotavirus, diarrhoea, bangladesh
673288|NCT00737451|urticaria|urticaria
673289|NCT00737451|goiter|goiter
673290|NCT00737438|BEVACIZUMAB (AVASTIN)|bevacizumab (avastin)
673291|NCT00737438|CAPECITABINE (ORAL)|capecitabine (oral)
673292|NCT00737438|CISPLATIN|cisplatin
673293|NCT00737438|EPIRUBICIN|epirubicin
673294|NCT00737438|IRINOTECAN (CPT-11) CAMPTOSAR|irinotecan (cpt-11) camptosar
673295|NCT00737438|TAXOTERE (DOCETAXEL)|taxotere (docetaxel)
673296|NCT00737438|ESOPHAGUS|esophagus
673297|NCT00737438|STOMACH|stomach
673298|NCT00737438|08-081|08-081
673299|NCT00737425|laparoscopic-assisted surgery|laparoscopic-assisted surgery
673300|NCT00737425|abdominal|abdominal
673301|NCT00737425|pain relief|pain relief
673302|NCT00737425|wound healing|wound healing
673303|NCT00737425|low intensity ultrasound|low intensity ultrasound
673304|NCT00737412|Bio-K+CL1285|bio-k+cl1285
673305|NCT00737412|Probiotics|probiotics
673306|NCT00737412|Traveler's Diarrhea|traveler's diarrhea
673307|NCT00737412|Lactobacillus Acidophilus|lactobacillus acidophilus
673308|NCT00737412|Lactobacillus Casei|lactobacillus casei
673309|NCT00737399|depression|depression
673310|NCT00737399|anxiety|anxiety
673311|NCT00737399|pain|pain
673312|NCT00737399|insomnia|insomnia
673313|NCT00737399|cancer|cancer
673314|NCT00737399|cholangiocarcinoma|cholangiocarcinoma
673315|NCT00737399|EFT (Emotional Freedom Techniques)|eft (emotional freedom techniques)
673316|NCT00737386|Leishmania tropica|leishmania tropica
673317|NCT00737386|Hyrax|hyrax
673318|NCT00737386|Sandfly|sandfly
673319|NCT00737347|type 2 diabetes|type 2 diabetes
673320|NCT00737347|obesity|obesity
673321|NCT00737347|weight gain|weight gain
673322|NCT00737347|thiazolidinediones|thiazolidinediones
673323|NCT00737334|Carotid stenosis|carotid stenosis
673324|NCT00737334|EEGo|eego
673325|NCT00737334|nonlinear EEG|nonlinear eeg
673326|NCT00737334|BIS|bis
673327|NCT00737334|cerebral oximetry|cerebral oximetry
673328|NCT00737334|FORE-SIGHT cerebral oximeter|fore-sight cerebral oximeter
673329|NCT00737334|cerebral monitoring|cerebral monitoring
673330|NCT00737334|arterial jugular venous lactate difference|arterial jugular venous lactate difference
673331|NCT00737334|cerebral ischemia|cerebral ischemia
673332|NCT00737334|carotid endarterectomy|carotid endarterectomy
673333|NCT00737321|Impact of ischemia|impact of ischemia
673334|NCT00737321|Impact of stress and|impact of stress and
673335|NCT00737321|Identify patterns of gene expression|identify patterns of gene expression
673336|NCT00737308|crowns|crowns
673337|NCT00737308|ceramics|ceramics
673338|NCT00737295|Biliary|biliary
673339|NCT00737295|Dyskinesia|dyskinesia
673340|NCT00737295|Gallbladder|gallbladder
673341|NCT00737295|Cholecystitis|cholecystitis
673342|NCT00737282|Uterine Fibroids|uterine fibroids
673343|NCT00737269|Complicated Skin and Soft-Tissue Infection|complicated skin and soft-tissue infection
673344|NCT00737269|Skin Infection|skin infection
673345|NCT00737269|Skin Infection Registry|skin infection registry
673346|NCT00737269|cSSTI Registry|cssti registry
673347|NCT00737243|Carcinoma of Unknown Primary Site|carcinoma of unknown primary site
673348|NCT00737243|Molecular profiling assay|molecular profiling assay
673349|NCT00737243|Bevacizumab|bevacizumab
673350|NCT00737243|Erlotinib|erlotinib
673351|NCT00737243|Paclitaxel|paclitaxel
673352|NCT00737243|Carboplatin|carboplatin
673353|NCT00737230|long-term effects secondary to cancer therapy in adults|long-term effects secondary to cancer therapy in adults
673354|NCT00737230|long-term effects secondary to cancer therapy in children|long-term effects secondary to cancer therapy in children
673355|NCT00737230|gastrointestinal complications|gastrointestinal complications
673356|NCT00737230|radiation toxicity|radiation toxicity
673357|NCT00737230|prostate cancer|prostate cancer
673358|NCT00737230|bladder cancer|bladder cancer
673359|NCT00737230|vulvar cancer|vulvar cancer
673360|NCT00737230|vaginal cancer|vaginal cancer
673361|NCT00737230|cervical cancer|cervical cancer
673362|NCT00737230|endometrial cancer|endometrial cancer
673363|NCT00737230|anal cancer|anal cancer
673364|NCT00737230|rectal cancer|rectal cancer
673365|NCT00737230|malignant testicular germ cell tumor|malignant testicular germ cell tumor
673366|NCT00737204|HIV|hiv
673367|NCT00737204|AIDS|aids
673368|NCT00737204|Armodafinil|armodafinil
673369|NCT00737204|Depression|depression
673370|NCT00737191|unspecified adult solid tumor, protocol specific|unspecified adult solid tumor, protocol specific
673371|NCT00737191|hematopoietic/lymphoid cancer|hematopoietic/lymphoid cancer
673372|NCT00737191|pain|pain
673373|NCT00737178|IUD|iud
673374|NCT00737178|Intrauterine device|intrauterine device
673375|NCT00737178|Intrauterine contraception|intrauterine contraception
673376|NCT00737178|Medication abortion|medication abortion
673377|NCT00737178|Medical abortion|medical abortion
673378|NCT00737165|Suicide, Prevention|suicide, prevention
673379|NCT00737165|Community|community
673380|NCT00737152|RAS 130|ras 130
673381|NCT00737152|Exercise|exercise
673382|NCT00737152|Diabetes Mellitus|diabetes mellitus
673383|NCT00737152|Type II Diabetes|type ii diabetes
673384|NCT00737152|Diabetes|diabetes
673385|NCT00737152|Aerobic|aerobic
673386|NCT00737139|Hip|hip
673387|NCT00737139|Knee|knee
673388|NCT00737139|Arthroplasty|arthroplasty
673389|NCT00737139|Epinephrine|epinephrine
673390|NCT00737139|Hemostasis|hemostasis
673391|NCT00737126|Diabetic nephropathies|diabetic nephropathies
673392|NCT00737126|Hyperhomocysteinemia|hyperhomocysteinemia
673393|NCT00737126|Folic acid|folic acid
673394|NCT00737126|Endothelial dysfunction|endothelial dysfunction
673395|NCT00737113|allogeneic stem cell transplantation|allogeneic stem cell transplantation
673396|NCT00737113|Engrafted|engrafted
673397|NCT00737113|subjects|subjects
673398|NCT00737087|total shoulder replacement|total shoulder replacement
673399|NCT00737087|rotator cuff|rotator cuff
673400|NCT00737087|osteoarthritis|osteoarthritis
673401|NCT00737087|rheumatoid arthritis|rheumatoid arthritis
673402|NCT00737087|Delta Extend|delta extend
673403|NCT00737074|Fibrovascular proliferation|fibrovascular proliferation
673404|NCT00737074|Internal limiting membrane peeling|internal limiting membrane peeling
673405|NCT00737074|Macular detachment|macular detachment
673406|NCT00737074|Macular hole|macular hole
673407|NCT00737074|Proliferative diabetic retinopathy.|proliferative diabetic retinopathy.
673408|NCT00737061|Female|female
673409|NCT00737061|Sterilization|sterilization
673410|NCT00737048|Pain|pain
673411|NCT00737048|Tooth extraction|tooth extraction
673412|NCT00737048|Oral surgery|oral surgery
673710|NCT00735969|Relapser|relapser
673413|NCT00737048|Postoperative pain|postoperative pain
673414|NCT00737048|JNS013|jns013
673415|NCT00737048|Tramadol hydrochloride|tramadol hydrochloride
673416|NCT00737048|Acetaminophen|acetaminophen
673417|NCT00737035|Intimate Partner Homicide|intimate partner homicide
673418|NCT00737035|Parental Homicide|parental homicide
673419|NCT00737035|Guardians of Child Survivors of Parental Homicide|guardians of child survivors of parental homicide
673420|NCT00737035|Post-Traumatic Stress Disorder|post-traumatic stress disorder
673421|NCT00737035|Uxoricide Project|uxoricide project
673422|NCT00737022|Diabetic vitrectomy|diabetic vitrectomy
673423|NCT00737022|Epiretinal membrane (ERM)|epiretinal membrane (erm)
673424|NCT00737022|Macular appearance|macular appearance
673425|NCT00737022|Optical coherence tomography (OCT)|optical coherence tomography (oct)
673426|NCT00737022|Visual function|visual function
673427|NCT00737009|Breast cancer|breast cancer
673428|NCT00737009|adherence|adherence
673429|NCT00737009|anastrozole|anastrozole
673430|NCT00737009|post-menopausal women|post-menopausal women
673431|NCT00736996|Metabolic Syndrome|metabolic syndrome
673432|NCT00736996|Mild Cognitive Impairment|mild cognitive impairment
673433|NCT00736996|Insulin Resistance|insulin resistance
673434|NCT00736996|Endurance Exercise|endurance exercise
673435|NCT00736983|Perianal fistulas|perianal fistulas
673436|NCT00736983|Crohn's disease|crohn's disease
673437|NCT00736970|ridaforolimus|ridaforolimus
673438|NCT00736970|deforolimus|deforolimus
673439|NCT00736970|AP23573|ap23573
673440|NCT00736970|breast cancer|breast cancer
673441|NCT00736957|Chronic Pain|chronic pain
673442|NCT00736957|Acetaminophen|acetaminophen
673443|NCT00736957|Tramadol|tramadol
673444|NCT00736957|JNS013|jns013
673445|NCT00736931|Brivaracetam|brivaracetam
673446|NCT00736931|Cognitive neurophysiological tests (CNT)|cognitive neurophysiological tests (cnt)
673447|NCT00736931|Neuropsychological assessments|neuropsychological assessments
673448|NCT00736918|Suicide Attempt|suicide attempt
673449|NCT00736905|TMC278-TiDP6-C130|tmc278-tidp6-c130
673450|NCT00736905|TMC278-C130|tmc278-c130
673451|NCT00736905|healthy volunteer|healthy volunteer
673452|NCT00736905|hepatic impairment|hepatic impairment
673453|NCT00736905|HIV Infections|hiv infections
673454|NCT00736892|Acute lung injury|acute lung injury
673455|NCT00736892|Acute respiratory distress syndrome|acute respiratory distress syndrome
673456|NCT00736892|Mechanical ventilation|mechanical ventilation
673457|NCT00736892|Prognosis|prognosis
673458|NCT00736892|Definitions|definitions
673459|NCT00736879|Diabetes Mellitus, Type 2|diabetes mellitus, type 2
673460|NCT00736879|Diabetes Mellitus|diabetes mellitus
673461|NCT00736879|Endocrine System Diseases|endocrine system diseases
673462|NCT00736879|Glucose Metabolism Disorders|glucose metabolism disorders
673463|NCT00736879|Metabolic Diseases|metabolic diseases
673464|NCT00736866|acetylcysteine|acetylcysteine
673465|NCT00736866|contrast-induced nephropathy|contrast-induced nephropathy
673466|NCT00736866|angiography|angiography
673467|NCT00736866|angioplasty with or without Stent|angioplasty with or without stent
673468|NCT00736853|Chronic pain|chronic pain
673469|NCT00736853|Acetoaminophen|acetoaminophen
673470|NCT00736853|Tramadol|tramadol
673471|NCT00736853|Osteoarthritis of the knee|osteoarthritis of the knee
673472|NCT00736853|Low back pain|low back pain
673473|NCT00736840|Methacetin|methacetin
673474|NCT00736840|Breath|breath
673475|NCT00736840|Test|test
673476|NCT00736840|Cirrhosis|cirrhosis
673477|NCT00736827|BK virus|bk virus
673478|NCT00736827|acute renal failure|acute renal failure
673479|NCT00736827|hemodiafiltration|hemodiafiltration
673480|NCT00736827|humans|humans
673481|NCT00736827|patients|patients
673482|NCT00736827|polytrauma|polytrauma
673483|NCT00736827|surgery|surgery
673484|NCT00736827|complement|complement
673485|NCT00736827|inflammation|inflammation
673486|NCT00736827|inflammatory response|inflammatory response
673487|NCT00736827|biomarkers|biomarkers
673488|NCT00736827|cytokines|cytokines
673489|NCT00736827|cell surface markers|cell surface markers
673490|NCT00736827|functional polymorphisms|functional polymorphisms
673491|NCT00736827|infections|infections
673492|NCT00736827|systemic inflammatory response syndrome|systemic inflammatory response syndrome
673493|NCT00736827|SIRS|sirs
673494|NCT00736827|sepsis|sepsis
673495|NCT00736827|severe sepsis|severe sepsis
673496|NCT00736827|shock|shock
673497|NCT00736827|organ dysfunctions|organ dysfunctions
673498|NCT00736827|SOFA|sofa
673499|NCT00736827|severity of disease|severity of disease
673500|NCT00736827|APACHEII|apacheii
673501|NCT00736827|SAPSII|sapsii
673502|NCT00736827|SPAPS3|spaps3
673503|NCT00736827|length of stay|length of stay
673504|NCT00736827|outcome|outcome
673505|NCT00736827|mortality|mortality
673506|NCT00736814|stage IIIB non-small cell lung cancer|stage iiib non-small cell lung cancer
673507|NCT00736814|stage IV non-small cell lung cancer|stage iv non-small cell lung cancer
673508|NCT00736801|Airway hyperresponsiveness|airway hyperresponsiveness
673509|NCT00736788|AZD1704,|azd1704,
673510|NCT00736788|Japanese|japanese
673511|NCT00736788|Healthy|healthy
673512|NCT00736788|Volunteers,|volunteers,
673513|NCT00736788|Phase I study,|phase i study,
673514|NCT00736788|Single Ascending Dose|single ascending dose
673515|NCT00736788|Safety,|safety,
673516|NCT00736788|Tolerability|tolerability
673517|NCT00736788|Pharmacokinetics|pharmacokinetics
673519|NCT00736775|Alzheimer's|alzheimer's
673520|NCT00736775|Alzheimers|alzheimers
673521|NCT00736762|Global postural re-education|global postural re-education
673522|NCT00736762|Balance|balance
673523|NCT00736762|Physical therapy|physical therapy
673524|NCT00736762|older people|older people
673525|NCT00736723|NT-proBNP|nt-probnp
673526|NCT00736723|myocardial dysfunction|myocardial dysfunction
673527|NCT00736723|humans|humans
673528|NCT00736723|patients|patients
673529|NCT00736723|polytrauma|polytrauma
673530|NCT00736723|complement|complement
673531|NCT00736723|inflammation|inflammation
673532|NCT00736723|inflammatory response|inflammatory response
673533|NCT00736723|biomarkers|biomarkers
673534|NCT00736723|cytokines|cytokines
673535|NCT00736723|cell surface markers|cell surface markers
673536|NCT00736723|functional polymorphisms|functional polymorphisms
673537|NCT00736723|infections|infections
673538|NCT00736723|systemic inflammatory response syndrome|systemic inflammatory response syndrome
673539|NCT00736723|SIRS|sirs
673540|NCT00736723|sepsis|sepsis
673541|NCT00736723|severe sepsis|severe sepsis
673542|NCT00736723|shock|shock
673543|NCT00736723|organ dysfunctions|organ dysfunctions
673544|NCT00736723|SOFA|sofa
673545|NCT00736723|severity of disease|severity of disease
673546|NCT00736723|APACHEII|apacheii
673547|NCT00736723|SAPSII|sapsii
673548|NCT00736723|SPAPS3|spaps3
673549|NCT00736723|length of stay|length of stay
673550|NCT00736723|outcome|outcome
673551|NCT00736723|mortality|mortality
673552|NCT00736710|Repetitive Transcranial Magnetic Stimulation|repetitive transcranial magnetic stimulation
673553|NCT00736710|Cigarette smoking|cigarette smoking
673554|NCT00736710|Schizophrenia|schizophrenia
673555|NCT00736710|Randomized|randomized
673556|NCT00736710|Double-blind|double-blind
673557|NCT00736710|Placebo-controlled|placebo-controlled
673558|NCT00736710|longitudinal|longitudinal
673559|NCT00736710|nicotine patch|nicotine patch
673560|NCT00736684|Femoral fractures [MeSH]|femoral fractures [mesh]
673561|NCT00736684|hip fractures [MeSH]|hip fractures [mesh]
673562|NCT00736684|trochanteric fractures (femoral neck fractures [MeSH])|trochanteric fractures (femoral neck fractures [mesh])
673563|NCT00736684|intramedullary nailing (fracture fixation, intramedullary [MeSH])|intramedullary nailing (fracture fixation, intramedullary [mesh])
673564|NCT00736684|complex femoral fractures|complex femoral fractures
673565|NCT00736684|femoral nail|femoral nail
673566|NCT00736684|surgical treatment (surgical procedures, operative [MeSH])|surgical treatment (surgical procedures, operative [mesh])
673567|NCT00736684|complications|complications
673568|NCT00736658|Japanese|japanese
673569|NCT00736658|MAD|mad
673570|NCT00736658|Multiple ascending dose|multiple ascending dose
673571|NCT00736658|Chronic pain|chronic pain
673572|NCT00736645|adenocarcinoma of the prostate|adenocarcinoma of the prostate
673573|NCT00736645|stage I prostate cancer|stage i prostate cancer
673574|NCT00736645|stage II prostate cancer|stage ii prostate cancer
673575|NCT00736632|Vitamin D|vitamin d
673576|NCT00736632|Insulin Resistance|insulin resistance
673577|NCT00736632|Type 2 Diabetes Mellitus|type 2 diabetes mellitus
673578|NCT00736632|Cardiovascular Disease|cardiovascular disease
673579|NCT00736619|MAB C225(CETUXIMAB)(ANTI-EGFR)|mab c225(cetuximab)(anti-egfr)
673580|NCT00736619|TAXOL (PACLITAXEL)|taxol (paclitaxel)
673581|NCT00736619|Radiation Therapy|radiation therapy
673582|NCT00736619|08-084|08-084
673583|NCT00736606|simvastatin|simvastatin
673584|NCT00736606|AZD5672|azd5672
673585|NCT00736593|Wound|wound
673586|NCT00736593|Healing|healing
673587|NCT00736580|Cesarean delivery|cesarean delivery
673588|NCT00736580|Surgical Needles|surgical needles
673589|NCT00736580|blunt-tip needles|blunt-tip needles
673590|NCT00736580|surgical glove perforation|surgical glove perforation
673591|NCT00736567|Diarrhea|diarrhea
673592|NCT00736567|Diagnostic|diagnostic
673593|NCT00736567|Pediatric|pediatric
673594|NCT00736554|Staphylococcus aureus|staphylococcus aureus
673595|NCT00736554|CA-MRSA|ca-mrsa
673596|NCT00736554|skin and soft tissue infections|skin and soft tissue infections
673597|NCT00736554|resistance|resistance
673598|NCT00736554|emergency department|emergency department
673599|NCT00736541|ARF|arf
673600|NCT00736541|OLT|olt
673601|NCT00736541|NAC|nac
673602|NCT00736541|I/R injury|i/r injury
673603|NCT00736528|safety, tolerability, pharmacokinetics, cognition|safety, tolerability, pharmacokinetics, cognition
673604|NCT00736515|combination therapy,monotherapy,gliclazide MR,insulin,CGMS|combination therapy,monotherapy,gliclazide mr,insulin,cgms
673605|NCT00736489|Asthma|asthma
673606|NCT00736489|airway obstruction|airway obstruction
673607|NCT00736489|beta2-agonist|beta2-agonist
673608|NCT00736489|efficacy|efficacy
673609|NCT00736489|inhalation|inhalation
673610|NCT00736476|helicobacter pylori infection|helicobacter pylori infection
673611|NCT00736476|vaccination|vaccination
673612|NCT00736476|adults|adults
673613|NCT00736463|HDL cholesterol|hdl cholesterol
673615|NCT00736463|inflammation|inflammation
673616|NCT00736463|atherosclerosis|atherosclerosis
673617|NCT00736463|prevention|prevention
673618|NCT00736463|patients with low baseline HDL cholesterol|patients with low baseline hdl cholesterol
673619|NCT00736437|UV-induced|uv-induced
673620|NCT00736437|Herpes labialis|herpes labialis
673621|NCT00736437|time to healing|time to healing
673622|NCT00736424|Epilepsy|epilepsy
673623|NCT00736424|SUDEP|sudep
673624|NCT00736424|DBS|dbs
673625|NCT00736411|infertility|infertility
673626|NCT00736411|IVF|ivf
673627|NCT00736411|acupuncture|acupuncture
673628|NCT00736385|nonalcoholic fatty liver disease|nonalcoholic fatty liver disease
673629|NCT00736372|cancer|cancer
673630|NCT00736372|metastatic cancer|metastatic cancer
673631|NCT00736372|advanced or metastatic cancer|advanced or metastatic cancer
673632|NCT00736346|Panic Disorder|panic disorder
673633|NCT00736346|anxiety|anxiety
673634|NCT00736346|chest pain|chest pain
673635|NCT00736346|emergency department|emergency department
673636|NCT00736346|cognitive-behavioral treatment|cognitive-behavioral treatment
673637|NCT00736320|Hodgkin Lymphoma|hodgkin lymphoma
673638|NCT00736320|early stage|early stage
673639|NCT00736320|PET|pet
673640|NCT00736307|limbal stem cell deficiency|limbal stem cell deficiency
673641|NCT00736294|Catheter Ablation, Radiofrequency|catheter ablation, radiofrequency
673642|NCT00736294|Angiotensin-Converting Enzyme Inhibitors|angiotensin-converting enzyme inhibitors
673643|NCT00736281|Sublingual Immunotherapy for Food Allergy|sublingual immunotherapy for food allergy
673644|NCT00736281|Food Drops for Food Allergy|food drops for food allergy
673645|NCT00736268|Lung Disease|lung disease
673646|NCT00736268|Chronic Bronchitis|chronic bronchitis
673647|NCT00736268|Emphysema|emphysema
673648|NCT00736268|Caregiver stress|caregiver stress
673649|NCT00736268|COPD|copd
673650|NCT00736268|Chronic Obstructive Pulmonary Disease|chronic obstructive pulmonary disease
673651|NCT00736255|ADHD|adhd
673652|NCT00736255|Smoking|smoking
673653|NCT00736242|HIV|hiv
673654|NCT00736229|hyperglycemia|hyperglycemia
673655|NCT00736229|acute coronary syndromes|acute coronary syndromes
673656|NCT00736229|myocardial infarction|myocardial infarction
673657|NCT00736216|cervical cancer|cervical cancer
673658|NCT00736216|human papilloma virus infection|human papilloma virus infection
673659|NCT00736203|fMRI|fmri
673660|NCT00736203|non-smokers|non-smokers
673661|NCT00736190|Hepatitis B|hepatitis b
673662|NCT00736190|Hepatitis|hepatitis
673663|NCT00736190|Tenofovir disoproxil fumarate|tenofovir disoproxil fumarate
673664|NCT00736190|Tenofovir DF|tenofovir df
673665|NCT00736190|Asian-American|asian-american
673666|NCT00736177|IVF|ivf
673667|NCT00736177|blastocyst transfer|blastocyst transfer
673668|NCT00736177|endometrium|endometrium
673669|NCT00736177|embryo cryopreservation|embryo cryopreservation
673670|NCT00736164|stage I prostate cancer|stage i prostate cancer
673671|NCT00736164|stage II prostate cancer|stage ii prostate cancer
673672|NCT00736164|adenocarcinoma of the prostate|adenocarcinoma of the prostate
673673|NCT00736125|postoperative cognitive dysfunction|postoperative cognitive dysfunction
673674|NCT00736125|total knee arthroplasty|total knee arthroplasty
673675|NCT00736125|cerebral emboli|cerebral emboli
673676|NCT00736125|carbon dioxide lavage|carbon dioxide lavage
673677|NCT00736125|pulsatile saline lavage|pulsatile saline lavage
673678|NCT00736112|Food Allergy in Children|food allergy in children
673679|NCT00736112|Otitis Media with Effusion (OME)|otitis media with effusion (ome)
673680|NCT00736112|Recurrent Middle Ear Infections|recurrent middle ear infections
673681|NCT00736112|Middle Ear Fluid|middle ear fluid
673682|NCT00736112|Food Allergy and Otitis Media with Effusion|food allergy and otitis media with effusion
673683|NCT00736112|Recurrent middle ear fluid in children <4 years old|recurrent middle ear fluid in children <4 years old
673684|NCT00736112|Chronic ear infections in children <4 years old|chronic ear infections in children <4 years old
673685|NCT00736086|femoral artery|femoral artery
673686|NCT00736086|post-percutaneous cardiac catheterization|post-percutaneous cardiac catheterization
673687|NCT00736086|post-percutaneous peripheral vascular catheterization|post-percutaneous peripheral vascular catheterization
673688|NCT00736086|post-percutaneous diagnostic catheterization|post-percutaneous diagnostic catheterization
673689|NCT00736086|early ambulation|early ambulation
673690|NCT00736086|vascular closure|vascular closure
673691|NCT00736073|pancreatitis|pancreatitis
673692|NCT00736060|Fever|fever
673693|NCT00736060|Blood cultures|blood cultures
673694|NCT00736047|Smokers|smokers
673695|NCT00736047|smoking cessation|smoking cessation
673696|NCT00736047|vaccine|vaccine
673697|NCT00736047|antibodies|antibodies
673698|NCT00736047|anti-nicotine|anti-nicotine
673699|NCT00736034|Age Associated Memory Impairment|age associated memory impairment
673700|NCT00736021|PTSD|ptsd
673701|NCT00736021|Pharmacological Treatment|pharmacological treatment
673702|NCT00736021|SSRI|ssri
673703|NCT00736021|Escitalopram|escitalopram
673704|NCT00736021|Anxiety Disorders|anxiety disorders
673705|NCT00736008|Factor V Leiden|factor v leiden
673706|NCT00736008|Prothrombin Mutation|prothrombin mutation
673707|NCT00736008|Hypercoagulability|hypercoagulability
673708|NCT00736008|Pediatrics|pediatrics
673709|NCT00735969|Non-Responder|non-responder
673711|NCT00735969|High Dose Ribavirin|high dose ribavirin
673712|NCT00735969|Peginterferon|peginterferon
673713|NCT00735969|Chronic Hepatitis C|chronic hepatitis c
673714|NCT00735956|Screening|screening
673715|NCT00735956|Brief Intervention|brief intervention
673716|NCT00735943|Pegaptanib|pegaptanib
673717|NCT00735943|macular degeneration|macular degeneration
673718|NCT00735943|vascular endothelial growth factor|vascular endothelial growth factor
673719|NCT00735904|AG-013736|ag-013736
673720|NCT00735904|axitinib|axitinib
673721|NCT00735904|cisplatin|cisplatin
673722|NCT00735904|gemcitabine|gemcitabine
673723|NCT00735904|NSCLC|nsclc
673724|NCT00735904|squamous cell|squamous cell
673725|NCT00735904|lung cancer|lung cancer
673726|NCT00735878|Lung Cancer|lung cancer
673727|NCT00735878|Advanced Lung Cancer|advanced lung cancer
673728|NCT00735878|NSCLC|nsclc
673729|NCT00735865|Dry Eye Syndrome|dry eye syndrome
673730|NCT00735865|Punctal Occlusion|punctal occlusion
673731|NCT00735865|Punctal Plugs|punctal plugs
673732|NCT00735865|Tear Drainage duct blockage|tear drainage duct blockage
673733|NCT00735852|endometriosis|endometriosis
673734|NCT00735852|chronic cyclical pelvic pain|chronic cyclical pelvic pain
673735|NCT00735826|resectable|resectable
673736|NCT00735826|stage I-III|stage i-iii
673737|NCT00735826|NSCLC|nsclc
673738|NCT00735826|vorinostat|vorinostat
673739|NCT00735826|esophagus|esophagus
673740|NCT00735826|head and neck|head and neck
673741|NCT00735826|proof of principle|proof of principle
673742|NCT00735813|Catheterization, Central|catheterization, central
673743|NCT00735813|Catheterization, Peripheral|catheterization, peripheral
673744|NCT00735813|Infection|infection
673745|NCT00735813|Methods|methods
673746|NCT00735813|Sepsis|sepsis
673747|NCT00735813|Microscopy, Electron, Scanning|microscopy, electron, scanning
673748|NCT00735813|Sonication|sonication
673749|NCT00735813|Taurolidine|taurolidine
673750|NCT00735813|Catheters, Indwelling|catheters, indwelling
673751|NCT00735813|Pediatrics|pediatrics
673752|NCT00735800|Dementia|dementia
673753|NCT00735800|Caregivers|caregivers
673754|NCT00735800|Alzheimer's disease|alzheimer's disease
673755|NCT00735774|Healthy volunteer study|healthy volunteer study
673756|NCT00735748|Patients who will undergo a general anesthesia for a procedure in short stay|patients who will undergo a general anesthesia for a procedure in short stay
673757|NCT00735735|low back pain|low back pain
673758|NCT00735735|chronic|chronic
673759|NCT00735735|Substance P|substance p
673760|NCT00735722|AF|af
673761|NCT00735722|CAD|cad
673762|NCT00735709|Depression|depression
673763|NCT00735709|Depressive Disorder|depressive disorder
673764|NCT00735709|Mood Disorder|mood disorder
673765|NCT00735709|Mental Disorder|mental disorder
673766|NCT00735709|Melancholia, Involutional|melancholia, involutional
673767|NCT00735709|Paraphrenia, Involutional|paraphrenia, involutional
673768|NCT00735709|Drug Therapy|drug therapy
673769|NCT00735696|Non Small Cell Lung Cancer|non small cell lung cancer
673770|NCT00735696|Lung|lung
673771|NCT00735696|NSCLC|nsclc
673772|NCT00735683|Weight loss|weight loss
673773|NCT00735683|Weight-loss drugs|weight-loss drugs
673774|NCT00735683|Obesity|obesity
673775|NCT00735683|Overweight|overweight
673776|NCT00735683|Body weight|body weight
673777|NCT00735683|Diet|diet
673778|NCT00735683|Metabolic Disorder|metabolic disorder
673779|NCT00735683|Nutrition Disorder|nutrition disorder
673780|NCT00735670|SCI|sci
673781|NCT00735657|Efficiency|efficiency
673782|NCT00735657|Pars|pars
673783|NCT00735657|Plana|plana
673784|NCT00735657|Vitrectomy|vitrectomy
673785|NCT00735644|Japanese encephalitis, Hepatitis A, Inactivated Mouse-Brain|japanese encephalitis, hepatitis a, inactivated mouse-brain
673786|NCT00735631|Patients entering the post-operative cardiac intensive care unit following coronary artery reconstruction surgery.|patients entering the post-operative cardiac intensive care unit following coronary artery reconstruction surgery.
673787|NCT00735618|Advanced Cancer|advanced cancer
673788|NCT00735618|Cancer Patients|cancer patients
673789|NCT00735618|Relaxation Therapy|relaxation therapy
673790|NCT00735618|Relaxation and Heart Rate Variability|relaxation and heart rate variability
673791|NCT00735618|Guided Relaxation|guided relaxation
673792|NCT00735618|HRV|hrv
673793|NCT00735618|Stress, Anxiety, and Panic Disorder|stress, anxiety, and panic disorder
673794|NCT00735605|obstructed defecation|obstructed defecation
673795|NCT00735605|constipation|constipation
673796|NCT00735605|puborectalis|puborectalis
673797|NCT00735592|X rays findings|x rays findings
673798|NCT00735579|major abdominal surgery|major abdominal surgery
673799|NCT00735579|coagulation|coagulation
673800|NCT00735579|extracellular matrix proteins|extracellular matrix proteins
673801|NCT00735579|wound healing after major abdominal surgery|wound healing after major abdominal surgery
673802|NCT00735566|gastric cancer|gastric cancer
673803|NCT00735566|antiangiogenic factors|antiangiogenic factors
673804|NCT00735566|TNM stage|tnm stage
673805|NCT00735553|Uterine Fibroids|uterine fibroids
673806|NCT00735527|seizures|seizures
673807|NCT00735527|status epilepticus|status epilepticus
673808|NCT00735527|lorazepam|lorazepam
673809|NCT00735527|intra-nasal|intra-nasal
673810|NCT00735514|radiation toxicity|radiation toxicity
673811|NCT00735514|sexuality and reproductive issues|sexuality and reproductive issues
673812|NCT00735514|stage I endometrial carcinoma|stage i endometrial carcinoma
673813|NCT00735514|stage II endometrial carcinoma|stage ii endometrial carcinoma
673814|NCT00735514|stage IB cervical cancer|stage ib cervical cancer
673815|NCT00735514|stage IIA cervical cancer|stage iia cervical cancer
673816|NCT00735514|stage IIB cervical cancer|stage iib cervical cancer
673817|NCT00735514|stage III cervical cancer|stage iii cervical cancer
673818|NCT00735488|Thalassemia|thalassemia
673819|NCT00735488|Sickle cell anemia|sickle cell anemia
673820|NCT00735488|Carrier detection|carrier detection
673821|NCT00735488|Prenatal Diagnosis|prenatal diagnosis
673822|NCT00735488|Genetic counseling|genetic counseling
673823|NCT00735462|external genital warts|external genital warts
673824|NCT00735462|perianal warts|perianal warts
673825|NCT00735462|condylomata acuminata|condylomata acuminata
673826|NCT00735462|human papilloma virus|human papilloma virus
673827|NCT00735462|HPV types 6 and 11|hpv types 6 and 11
673828|NCT00735436|Malignant glioma|malignant glioma
673829|NCT00735436|Glioblastoma multiforme|glioblastoma multiforme
673831|NCT00735436|Gliosarcoma|gliosarcoma
673832|NCT00735436|Gliadel|gliadel
673833|NCT00735436|Carmustine|carmustine
673834|NCT00735436|Irinotecan|irinotecan
673835|NCT00735436|CPT-11|cpt-11
673836|NCT00735436|Camptosar|camptosar
673837|NCT00735436|Avastin|avastin
673838|NCT00735436|Bevacizumab|bevacizumab
673839|NCT00735423|Healthy children|healthy children
673840|NCT00735423|Brain Function|brain function
673841|NCT00735423|Diet|diet
673842|NCT00735423|Nutrition|nutrition
673843|NCT00735423|Language|language
673844|NCT00735423|fMRI|fmri
673845|NCT00735423|ERP|erp
673846|NCT00735423|Behavior|behavior
673847|NCT00735410|Influenza vaccine|influenza vaccine
673848|NCT00735410|Seasonal|seasonal
673849|NCT00735410|Split|split
673850|NCT00735397|Partial onset seizures|partial onset seizures
673851|NCT00735384|sepsis|sepsis
673852|NCT00735384|critical illness|critical illness
673853|NCT00735384|muscle, skeletal|muscle, skeletal
673854|NCT00735384|myopathy|myopathy
673855|NCT00735384|isometric contraction|isometric contraction
673856|NCT00735384|intensive care units|intensive care units
673857|NCT00735384|torque|torque
673858|NCT00735384|muscular atrophy|muscular atrophy
673859|NCT00735384|malignant hyperthermia|malignant hyperthermia
673860|NCT00735384|skin resistance|skin resistance
673861|NCT00735358|gastric variceal bleeding|gastric variceal bleeding
673862|NCT00735358|cyanoacrylate|cyanoacrylate
673863|NCT00735358|rebleeding|rebleeding
673864|NCT00735358|complication|complication
673865|NCT00735358|survival|survival
673866|NCT00735358|acute gastric variceal bleeding|acute gastric variceal bleeding
673867|NCT00735345|Esophageal cancer|esophageal cancer
673868|NCT00735345|Pre-operative|pre-operative
673869|NCT00735345|Chemo-immunotherapy|chemo-immunotherapy
673870|NCT00735345|Radiochemo-immunotherapy|radiochemo-immunotherapy
673871|NCT00735345|EGFR|egfr
673872|NCT00735345|Radiosensitivity|radiosensitivity
673873|NCT00735345|Resection|resection
673874|NCT00735332|Melanoma|melanoma
673875|NCT00735332|Metastatic Melanoma|metastatic melanoma
673876|NCT00735332|Phase II|phase ii
673877|NCT00735332|Skin Cancer|skin cancer
673878|NCT00735319|Neonatal Jaundice|neonatal jaundice
673879|NCT00735319|Physiological Neonatal Jaundice|physiological neonatal jaundice
673880|NCT00735319|Neonatal Hyperbilirubinemia|neonatal hyperbilirubinemia
673881|NCT00735319|Transcutaneous Bilirubinometer|transcutaneous bilirubinometer
673882|NCT00735306|Locally advanced|locally advanced
673883|NCT00735306|Unresectable|unresectable
673884|NCT00735293|hyperhidrosis|hyperhidrosis
673885|NCT00735293|bromidrosis|bromidrosis
673886|NCT00735293|bromhidrosis|bromhidrosis
673887|NCT00735293|osmidrosis|osmidrosis
673888|NCT00735293|hircismus|hircismus
673889|NCT00735293|excessive|excessive
673890|NCT00735293|underarm|underarm
673891|NCT00735293|sweat|sweat
673892|NCT00735293|perspiration|perspiration
673893|NCT00735293|Body Odor|body odor
673894|NCT00735280|Coronary artery disease, stent, heparin|coronary artery disease, stent, heparin
673895|NCT00735267|Generalized Anxiety Disorder|generalized anxiety disorder
673896|NCT00735254|post|post
673897|NCT00735254|surgical|surgical
673898|NCT00735241|colon cancer|colon cancer
673899|NCT00735241|colorectal cancer|colorectal cancer
673900|NCT00735241|liver metastases|liver metastases
673901|NCT00735241|SIR-Spheres Microspheres|sir-spheres microspheres
673902|NCT00735241|yttrium-90|yttrium-90
673903|NCT00735241|FOLFOX|folfox
673904|NCT00735241|Bevacizumab|bevacizumab
673905|NCT00735241|chemo-radiation|chemo-radiation
673906|NCT00735228|surgery|surgery
673907|NCT00735228|artificial pancreas|artificial pancreas
673908|NCT00735228|tight glycemic control|tight glycemic control
673909|NCT00735228|Liver|liver
673910|NCT00735215|Breast cancer,|breast cancer,
673911|NCT00735215|fulvestrant,|fulvestrant,
673912|NCT00735215|postmenopausal,|postmenopausal,
673913|NCT00735215|women|women
673914|NCT00735215|locally advanced,|locally advanced,
673915|NCT00735215|hormone receptor-positive.|hormone receptor-positive.
673916|NCT00735189|warfarin|warfarin
673917|NCT00735189|anticoagulation|anticoagulation
673918|NCT00735189|anticoagulation clinics|anticoagulation clinics
673919|NCT00735176|Radiculopathy, cervical|radiculopathy, cervical
673920|NCT00735176|Nerve Root Compression|nerve root compression
673921|NCT00735176|Disc, intervertebral|disc, intervertebral
673922|NCT00735176|Intervertebral Disk Displacement|intervertebral disk displacement
673923|NCT00735176|Spondylosis|spondylosis
673924|NCT00735176|Spinal Osteophytosis|spinal osteophytosis
673925|NCT00735176|Arthroplasty, replacement|arthroplasty, replacement
673926|NCT00735176|Diskectomy|diskectomy
673927|NCT00735176|Spinal Fusion|spinal fusion
673928|NCT00735163|algorithm|algorithm
673929|NCT00735163|tight glycemic control|tight glycemic control
673930|NCT00735163|glucose control|glucose control
673931|NCT00735163|intensive care|intensive care
673932|NCT00735163|insulin|insulin
673933|NCT00735163|ICU|icu
673934|NCT00735150|Breast|breast
673935|NCT00735150|Ovary|ovary
673936|NCT00735150|Mutation carrier|mutation carrier
673937|NCT00735137|Twins|twins
673938|NCT00735137|Short cervix|short cervix
673939|NCT00735137|Preterm birth|preterm birth
673940|NCT00735137|Vaginal pessary|vaginal pessary
673941|NCT00735124|analgesia requirement and post operative pain|analgesia requirement and post operative pain
673942|NCT00735111|QOL|qol
673943|NCT00735111|Quality of Life|quality of life
673944|NCT00735111|KPS|kps
673945|NCT00735111|Karnofsky Performance Status|karnofsky performance status
673946|NCT00735111|Cancer|cancer
673947|NCT00735098|Knee Osteoarthritis|knee osteoarthritis
673948|NCT00735098|arthritis|arthritis
673949|NCT00735085|Brain Injury|brain injury
673950|NCT00735072|HIV infection|hiv infection
673951|NCT00735072|T cell activation|t cell activation
673952|NCT00735072|Antiretroviral Therapy|antiretroviral therapy
673953|NCT00735072|CCR5|ccr5
673954|NCT00735072|Maraviroc|maraviroc
673955|NCT00735059|dialysis membrane|dialysis membrane
673956|NCT00735059|Polynephron|polynephron
673957|NCT00735059|Elisio H|elisio h
673958|NCT00735059|Polyethersulfone|polyethersulfone
673960|NCT00735059|PES-DS|pes-ds
673961|NCT00735059|online post-dilution hemodiafiltration|online post-dilution hemodiafiltration
673962|NCT00735059|hemodialysis|hemodialysis
673963|NCT00735059|protein-bound toxins|protein-bound toxins
673964|NCT00735059|beta-2-microglobulin|beta-2-microglobulin
673965|NCT00735059|hemodialysis patients|hemodialysis patients
673966|NCT00735046|Early dementia in Alzheimer's disease (MMSE ≥ 21)|early dementia in alzheimer's disease (mmse ≥ 21)
673967|NCT00735033|Physical therapy|physical therapy
673968|NCT00735033|Physical therapy modalities|physical therapy modalities
673969|NCT00735033|Cerebral Vascular Accident (CVA)|cerebral vascular accident (cva)
673970|NCT00735020|influenza|influenza
673971|NCT00735020|vaccine|vaccine
673972|NCT00735020|adjuvants|adjuvants
673973|NCT00735020|flu|flu
673974|NCT00735007|Multiple Sclerosis|multiple sclerosis
673975|NCT00734968|Urinary tract infection (UTI)|urinary tract infection (uti)
673976|NCT00734968|suburethral sling|suburethral sling
673977|NCT00734968|Prevention|prevention
673978|NCT00734968|Nitrofurantoin|nitrofurantoin
673979|NCT00734968|Prophylaxis|prophylaxis
673980|NCT00734955|Partial Mastectomy|partial mastectomy
673981|NCT00734955|Lumpectomy|lumpectomy
673982|NCT00734955|Mastectomy|mastectomy
673983|NCT00734942|young carers|young carers
673984|NCT00734942|family support|family support
673985|NCT00734942|children (up to the age of 18) of chronically ill parents|children (up to the age of 18) of chronically ill parents
673986|NCT00734929|PONV|ponv
673987|NCT00734929|nausea|nausea
673988|NCT00734929|emesis|emesis
673989|NCT00734929|antiemetics|antiemetics
673990|NCT00734929|aprepitant|aprepitant
673991|NCT00734929|ondansetron|ondansetron
673992|NCT00734929|dexamethasone|dexamethasone
673993|NCT00734916|total parenteral nutrition|total parenteral nutrition
673994|NCT00734916|infections|infections
673995|NCT00734916|Infectious complications related to parenteral nutrition|infectious complications related to parenteral nutrition
673996|NCT00734903|Women|women
673997|NCT00734903|Substance Use Disorders|substance use disorders
673998|NCT00734903|Treatment Efficacy|treatment efficacy
673999|NCT00734903|Women's Health|women's health
674000|NCT00734903|Outcome Assessment (Health Care)|outcome assessment (health care)
674001|NCT00734890|unspecified adult solid tumor, protocol specific|unspecified adult solid tumor, protocol specific
674002|NCT00734890|AIDS-related diffuse large cell lymphoma|aids-related diffuse large cell lymphoma
674003|NCT00734890|AIDS-related diffuse mixed cell lymphoma|aids-related diffuse mixed cell lymphoma
674004|NCT00734890|AIDS-related diffuse small cleaved cell lymphoma|aids-related diffuse small cleaved cell lymphoma
674005|NCT00734890|AIDS-related immunoblastic large cell lymphoma|aids-related immunoblastic large cell lymphoma
674006|NCT00734890|AIDS-related lymphoblastic lymphoma|aids-related lymphoblastic lymphoma
674007|NCT00734890|AIDS-related peripheral/systemic lymphoma|aids-related peripheral/systemic lymphoma
674008|NCT00734890|AIDS-related small noncleaved cell lymphoma|aids-related small noncleaved cell lymphoma
674577|NCT00733018|Life Style|life style
674009|NCT00734890|HIV-associated Hodgkin lymphoma|hiv-associated hodgkin lymphoma
674010|NCT00734890|recurrent adult Burkitt lymphoma|recurrent adult burkitt lymphoma
674011|NCT00734890|recurrent adult diffuse large cell lymphoma|recurrent adult diffuse large cell lymphoma
674012|NCT00734890|recurrent adult diffuse mixed cell lymphoma|recurrent adult diffuse mixed cell lymphoma
674013|NCT00734890|recurrent adult diffuse small cleaved cell lymphoma|recurrent adult diffuse small cleaved cell lymphoma
674014|NCT00734890|recurrent adult grade III lymphomatoid granulomatosis|recurrent adult grade iii lymphomatoid granulomatosis
674015|NCT00734890|recurrent adult Hodgkin lymphoma|recurrent adult hodgkin lymphoma
710347|NCT00589563|stage IV adult diffuse mixed cell lymphoma|stage iv adult diffuse mixed cell lymphoma
674016|NCT00734890|recurrent adult immunoblastic large cell lymphoma|recurrent adult immunoblastic large cell lymphoma
674017|NCT00734890|recurrent adult lymphoblastic lymphoma|recurrent adult lymphoblastic lymphoma
674018|NCT00734890|recurrent adult T-cell leukemia/lymphoma|recurrent adult t-cell leukemia/lymphoma
674019|NCT00734890|recurrent cutaneous T-cell non-Hodgkin lymphoma|recurrent cutaneous t-cell non-hodgkin lymphoma
674020|NCT00734890|recurrent grade 1 follicular lymphoma|recurrent grade 1 follicular lymphoma
674021|NCT00734890|recurrent grade 2 follicular lymphoma|recurrent grade 2 follicular lymphoma
674022|NCT00734890|recurrent grade 3 follicular lymphoma|recurrent grade 3 follicular lymphoma
674023|NCT00734890|recurrent mantle cell lymphoma|recurrent mantle cell lymphoma
674024|NCT00734890|recurrent marginal zone lymphoma|recurrent marginal zone lymphoma
674025|NCT00734890|recurrent small lymphocytic lymphoma|recurrent small lymphocytic lymphoma
674026|NCT00734890|anaplastic large cell lymphoma|anaplastic large cell lymphoma
674027|NCT00734890|angioimmunoblastic T-cell lymphoma|angioimmunoblastic t-cell lymphoma
674028|NCT00734890|recurrent mycosis fungoides/Sezary syndrome|recurrent mycosis fungoides/sezary syndrome
674029|NCT00734890|adult nasal type extranodal NK/T-cell lymphoma|adult nasal type extranodal nk/t-cell lymphoma
674030|NCT00734890|Waldenström macroglobulinemia|waldenström macroglobulinemia
674031|NCT00734890|extranodal marginal zone B-cell lymphoma of mucosa-associated lymphoid tissue|extranodal marginal zone b-cell lymphoma of mucosa-associated lymphoid tissue
674032|NCT00734890|nodal marginal zone B-cell lymphoma|nodal marginal zone b-cell lymphoma
674033|NCT00734890|splenic marginal zone lymphoma|splenic marginal zone lymphoma
674034|NCT00734890|intraocular lymphoma|intraocular lymphoma
674035|NCT00734890|post-transplant lymphoproliferative disorder|post-transplant lymphoproliferative disorder
674036|NCT00734890|cutaneous B-cell non-Hodgkin lymphoma|cutaneous b-cell non-hodgkin lymphoma
674037|NCT00734890|small intestine lymphoma|small intestine lymphoma
674038|NCT00734890|adenocarcinoma of the lung|adenocarcinoma of the lung
674039|NCT00734890|bronchoalveolar cell lung cancer|bronchoalveolar cell lung cancer
674040|NCT00734890|large cell lung cancer|large cell lung cancer
674041|NCT00734890|adenosquamous cell lung cancer|adenosquamous cell lung cancer
674042|NCT00734890|recurrent non-small cell lung cancer|recurrent non-small cell lung cancer
674043|NCT00734890|stage IIIA non-small cell lung cancer|stage iiia non-small cell lung cancer
674044|NCT00734890|stage IIIB non-small cell lung cancer|stage iiib non-small cell lung cancer
674045|NCT00734890|stage IV non-small cell lung cancer|stage iv non-small cell lung cancer
674046|NCT00734890|stage III adult Burkitt lymphoma|stage iii adult burkitt lymphoma
674047|NCT00734890|stage III adult diffuse large cell lymphoma|stage iii adult diffuse large cell lymphoma
674048|NCT00734890|stage III adult diffuse mixed cell lymphoma|stage iii adult diffuse mixed cell lymphoma
674049|NCT00734890|stage III adult diffuse small cleaved cell lymphoma|stage iii adult diffuse small cleaved cell lymphoma
674050|NCT00734890|stage III adult Hodgkin lymphoma|stage iii adult hodgkin lymphoma
674051|NCT00734890|stage III adult immunoblastic large cell lymphoma|stage iii adult immunoblastic large cell lymphoma
674052|NCT00734890|stage III adult lymphoblastic lymphoma|stage iii adult lymphoblastic lymphoma
674053|NCT00734890|stage III adult T-cell leukemia/lymphoma|stage iii adult t-cell leukemia/lymphoma
674054|NCT00734890|stage III cutaneous T-cell non-Hodgkin lymphoma|stage iii cutaneous t-cell non-hodgkin lymphoma
674055|NCT00734890|stage III grade 1 follicular lymphoma|stage iii grade 1 follicular lymphoma
674056|NCT00734890|stage III grade 2 follicular lymphoma|stage iii grade 2 follicular lymphoma
674057|NCT00734890|stage III grade 3 follicular lymphoma|stage iii grade 3 follicular lymphoma
674058|NCT00734890|stage III mantle cell lymphoma|stage iii mantle cell lymphoma
674059|NCT00734890|stage III marginal zone lymphoma|stage iii marginal zone lymphoma
674060|NCT00734890|stage III mycosis fungoides/Sezary syndrome|stage iii mycosis fungoides/sezary syndrome
674061|NCT00734890|stage III small lymphocytic lymphoma|stage iii small lymphocytic lymphoma
674062|NCT00734890|stage IV adult Burkitt lymphoma|stage iv adult burkitt lymphoma
674063|NCT00734890|stage IV adult diffuse large cell lymphoma|stage iv adult diffuse large cell lymphoma
674064|NCT00734890|stage IV adult diffuse mixed cell lymphoma|stage iv adult diffuse mixed cell lymphoma
674065|NCT00734890|stage IV adult diffuse small cleaved cell lymphoma|stage iv adult diffuse small cleaved cell lymphoma
674066|NCT00734890|stage IV adult Hodgkin lymphoma|stage iv adult hodgkin lymphoma
674067|NCT00734890|stage IV adult immunoblastic large cell lymphoma|stage iv adult immunoblastic large cell lymphoma
674068|NCT00734890|stage IV adult lymphoblastic lymphoma|stage iv adult lymphoblastic lymphoma
674069|NCT00734890|stage IV adult T-cell leukemia/lymphoma|stage iv adult t-cell leukemia/lymphoma
674070|NCT00734890|stage IV cutaneous T-cell non-Hodgkin lymphoma|stage iv cutaneous t-cell non-hodgkin lymphoma
674071|NCT00734890|stage IV grade 1 follicular lymphoma|stage iv grade 1 follicular lymphoma
674072|NCT00734890|stage IV grade 2 follicular lymphoma|stage iv grade 2 follicular lymphoma
674073|NCT00734890|stage IV grade 3 follicular lymphoma|stage iv grade 3 follicular lymphoma
674074|NCT00734890|stage IV mantle cell lymphoma|stage iv mantle cell lymphoma
674075|NCT00734890|stage IV marginal zone lymphoma|stage iv marginal zone lymphoma
674076|NCT00734890|stage IV mycosis fungoides/Sezary syndrome|stage iv mycosis fungoides/sezary syndrome
674077|NCT00734890|stage IV small lymphocytic lymphoma|stage iv small lymphocytic lymphoma
674078|NCT00734864|Dasatinib|dasatinib
674079|NCT00734864|Sprycel|sprycel
674080|NCT00734864|Temozolomide|temozolomide
674081|NCT00734864|Temodar|temodar
674082|NCT00734864|Recurrent Malignant Glioma|recurrent malignant glioma
674083|NCT00734864|Malignant Glioma|malignant glioma
674084|NCT00734864|glioblastoma multiforme|glioblastoma multiforme
674085|NCT00734864|gliosarcoma|gliosarcoma
674086|NCT00734864|anaplastic astrocytoma|anaplastic astrocytoma
674087|NCT00734864|anaplastic oligodendroglioma|anaplastic oligodendroglioma
674088|NCT00734864|anaplastic mixed glioma|anaplastic mixed glioma
674089|NCT00734864|glioma|glioma
674090|NCT00734851|prostate cancer|prostate cancer
674091|NCT00734851|sunitinib|sunitinib
674092|NCT00734851|docetaxel|docetaxel
674093|NCT00734851|PSA|psa
674094|NCT00734851|radiation|radiation
674095|NCT00734851|PSA recurrence|psa recurrence
674096|NCT00734851|No metastatic disease|no metastatic disease
674097|NCT00734838|Breast Cancer|breast cancer
674098|NCT00734838|Breast Biopsy|breast biopsy
674099|NCT00734838|Reduction mammoplasty|reduction mammoplasty
674100|NCT00734825|Appendicitis|appendicitis
674101|NCT00734825|IV Contrast|iv contrast
674102|NCT00734825|Oral Contrast|oral contrast
674103|NCT00734825|CT scan|ct scan
674104|NCT00734812|Hysterectomy|hysterectomy
674105|NCT00734812|Laparoscopic|laparoscopic
674106|NCT00734799|Posttraumatic Stress Disorder|posttraumatic stress disorder
674107|NCT00734799|Insomnia,|insomnia,
674108|NCT00734799|Imagery Rehearsal Therapy,|imagery rehearsal therapy,
674109|NCT00734799|IRT,|irt,
674110|NCT00734799|Cognitive Behavioral Therapy for Insomnia,|cognitive behavioral therapy for insomnia,
674111|NCT00734799|CBTI.|cbti.
674112|NCT00734786|gonyautoxin|gonyautoxin
674113|NCT00734773|neurotoxicity|neurotoxicity
674114|NCT00734773|primary central nervous system non-Hodgkin lymphoma|primary central nervous system non-hodgkin lymphoma
674115|NCT00734773|primary central nervous system Hodgkin lymphoma|primary central nervous system hodgkin lymphoma
674116|NCT00734760|patient education|patient education
674117|NCT00734760|acute coronary syndrome|acute coronary syndrome
674118|NCT00734760|prehospital delay to treatment|prehospital delay to treatment
674119|NCT00734747|GERD|gerd
674120|NCT00734747|Gastroesophageal Reflux|gastroesophageal reflux
674121|NCT00734747|Fundoplication|fundoplication
674122|NCT00734747|Endoluminal|endoluminal
674123|NCT00734747|Gastroesophageal Flap Valve|gastroesophageal flap valve
674124|NCT00734734|Prophylaxis of Influenza|prophylaxis of influenza
674125|NCT00734734|Influenza Vaccines|influenza vaccines
674126|NCT00734734|MF59C.1|mf59c.1
674127|NCT00734721|intravitreal injection|intravitreal injection
674128|NCT00734695|BURN|burn
674129|NCT00734695|EYE|eye
674130|NCT00734695|VITAMIN C|vitamin c
674131|NCT00734695|ASCORBIC ACID|ascorbic acid
674132|NCT00734682|Glioblastoma|glioblastoma
674133|NCT00734682|Gliosarcoma|gliosarcoma
674134|NCT00734682|Anaplastic Astrocytoma|anaplastic astrocytoma
674135|NCT00734682|Anaplastic Oligodendroglioma|anaplastic oligodendroglioma
674136|NCT00734682|Anaplastic Mixed Oligoastrocytoma|anaplastic mixed oligoastrocytoma
674137|NCT00734682|Malignant Astrocytoma NOS|malignant astrocytoma nos
674138|NCT00734682|Nanoliposomal CPT-11|nanoliposomal cpt-11
674139|NCT00734682|liposomal irinotecan|liposomal irinotecan
674140|NCT00734669|Diabetes|diabetes
674141|NCT00734669|Hypoglycemia|hypoglycemia
674142|NCT00734656|steroid 5Alpha Reductase|steroid 5alpha reductase
674143|NCT00734656|dutasteride|dutasteride
674144|NCT00734656|neuroactive steroid|neuroactive steroid
674145|NCT00734643|Hypoplastic Left Heart Syndrome|hypoplastic left heart syndrome
674146|NCT00734643|Family coping|family coping
674147|NCT00734643|Complex Congenital Heart Disease|complex congenital heart disease
674148|NCT00734630|nebivolol|nebivolol
674149|NCT00734630|Bystolic ™|bystolic ™
674150|NCT00734630|lisinopril|lisinopril
674151|NCT00734630|losartan|losartan
674152|NCT00734630|Hypertension|hypertension
674153|NCT00734617|Cigarette|cigarette
674154|NCT00734617|Nicotine|nicotine
674155|NCT00734591|Observational Study Exubera|observational study exubera
674156|NCT00734565|vaccine|vaccine
674157|NCT00734565|prevention|prevention
674158|NCT00734565|haemophilus influenzae type b|haemophilus influenzae type b
674159|NCT00734565|children|children
674160|NCT00734552|Continuous Ambulatory Peritoneal Dialysis|continuous ambulatory peritoneal dialysis
674161|NCT00734552|α-Keto Acid|α-keto acid
674162|NCT00734552|Low Protein Diet|low protein diet
674163|NCT00734552|Residual Renal Function|residual renal function
674164|NCT00734539|Candida|candida
674165|NCT00734539|Neonate|neonate
674166|NCT00734539|Fluconazole|fluconazole
674167|NCT00734539|Prophylaxis|prophylaxis
674168|NCT00734539|Colonization|colonization
674169|NCT00734539|Resistance|resistance
674170|NCT00734526|Glioblastoma|glioblastoma
674171|NCT00734526|Gliosarcoma|gliosarcoma
675440|NCT00729417|of age 18|of age 18
674172|NCT00734526|Brain Cancer|brain cancer
674173|NCT00734526|Sorafenib|sorafenib
674174|NCT00734526|Temozolomide|temozolomide
674175|NCT00734526|Radiation|radiation
674176|NCT00734526|Radiotherapy|radiotherapy
674177|NCT00734526|XRT|xrt
674178|NCT00734513|GI Cancer|gi cancer
674179|NCT00734513|Emotional Disclosure|emotional disclosure
674180|NCT00734513|Behavioral Intervention|behavioral intervention
674181|NCT00734513|Partner|partner
674182|NCT00734513|Couples|couples
674183|NCT00734487|Spectral Domain Optical Coherence Tomography|spectral domain optical coherence tomography
674184|NCT00734487|Optical Coherence Tomography|optical coherence tomography
674185|NCT00734487|AREDS2|areds2
674186|NCT00734487|AMD|amd
674187|NCT00734487|Age-related macular degeneration|age-related macular degeneration
674188|NCT00734487|Drusen|drusen
674189|NCT00734474|Diabetes, type 2 diabetes|diabetes, type 2 diabetes
674190|NCT00734461|Non-physically dependent subjects|non-physically dependent subjects
674191|NCT00734461|history of opioid abuse|history of opioid abuse
674192|NCT00734448|gestational diabetes mellitus|gestational diabetes mellitus
674193|NCT00734448|carbohydrate intolerance|carbohydrate intolerance
674194|NCT00734448|myo-inositol|myo-inositol
674195|NCT00734448|insulin resistance|insulin resistance
674196|NCT00734435|schizophrenia|schizophrenia
674197|NCT00734435|schizophreniform|schizophreniform
674198|NCT00734435|schizoaffective disorder|schizoaffective disorder
674199|NCT00734435|Zyprexa|zyprexa
674200|NCT00734435|olanzapine|olanzapine
674201|NCT00734422|Phobic Disorders (Fear of Flying)|phobic disorders (fear of flying)
674202|NCT00734422|Virtual Reality Exposure Therapy|virtual reality exposure therapy
674203|NCT00734422|Fear extinction|fear extinction
674204|NCT00734422|Yohimbine|yohimbine
674205|NCT00734409|Mechanical ventilation|mechanical ventilation
674206|NCT00734409|Human|human
674207|NCT00734409|conscious sedation|conscious sedation
674208|NCT00734409|bispectral index|bispectral index
674209|NCT00734409|monitoring|monitoring
674210|NCT00734409|critical care|critical care
674211|NCT00734409|propofol|propofol
674212|NCT00734396|Mesenchymal stem cells|mesenchymal stem cells
674213|NCT00734396|Allograft rejection|allograft rejection
674214|NCT00734396|Subclinical rejection|subclinical rejection
674215|NCT00734383|coronary artery bypass surgery|coronary artery bypass surgery
674216|NCT00734383|coronary artery bypass grafting|coronary artery bypass grafting
674217|NCT00734383|cardiopulmonary bypass|cardiopulmonary bypass
674218|NCT00734383|diabetes|diabetes
674219|NCT00734383|myocardial injury markers,|myocardial injury markers,
674220|NCT00734383|sex differences|sex differences
674221|NCT00734383|cardiac anesthesia|cardiac anesthesia
674222|NCT00734383|inhalational anesthetics|inhalational anesthetics
674223|NCT00734370|Panic Disorder and Agoraphobia|panic disorder and agoraphobia
674224|NCT00734370|Virtual Reality Exposure Therapy|virtual reality exposure therapy
674225|NCT00734357|contrast|contrast
674226|NCT00734357|ct|ct
674227|NCT00734357|cat scan|cat scan
674228|NCT00734357|kidney|kidney
674229|NCT00734357|nephrotoxicity|nephrotoxicity
674230|NCT00734357|Computerized Emission Tomography|computerized emission tomography
674231|NCT00734331|inflammatory bowel disease|inflammatory bowel disease
674232|NCT00734331|micro RNA|micro rna
674233|NCT00734331|cholinergic tone|cholinergic tone
674234|NCT00734331|inflammation|inflammation
674235|NCT00734318|Severe asthma|severe asthma
674236|NCT00734318|Fluticasone|fluticasone
674237|NCT00734318|Formoterol|formoterol
674238|NCT00734305|cancer, solid tumors, oncology, Phase I, ErbB3, HER3|cancer, solid tumors, oncology, phase i, erbb3, her3
674239|NCT00734305|(erbB-3, HER-3)|(erbb-3, her-3)
674240|NCT00734292|Asthma|asthma
674241|NCT00734292|Asthma Mild to Moderate|asthma mild to moderate
674242|NCT00734279|Puberty|puberty
674243|NCT00734279|Delayed|delayed
674244|NCT00734279|Early|early
674245|NCT00734279|Precocious|precocious
674246|NCT00734279|Peripubertal|peripubertal
674247|NCT00734279|Gonadotropin|gonadotropin
674248|NCT00734279|FSH|fsh
674249|NCT00734279|LH|lh
674250|NCT00734266|COPD|copd
674251|NCT00734266|CPB|cpb
674252|NCT00734266|Leukotrienes|leukotrienes
674253|NCT00734253|Nephropathy|nephropathy
674254|NCT00734253|Kidney Disease|kidney disease
674255|NCT00734253|Diabetes|diabetes
674256|NCT00734253|Pyridoxamine|pyridoxamine
674257|NCT00734253|Pyridorin|pyridorin
674258|NCT00734253|NephroGenex|nephrogenex
674259|NCT00734253|PYR-210|pyr-210
674260|NCT00734227|Survival and control of hemorrhage|survival and control of hemorrhage
674261|NCT00734214|Parenteral Fluids|parenteral fluids
674262|NCT00734214|Isotonic|isotonic
674263|NCT00734214|Hypotonic|hypotonic
674264|NCT00734214|Pediatric|pediatric
674265|NCT00734214|Fluid overload|fluid overload
674266|NCT00734201|Study effects on blood pressure and weight in obese subjects|study effects on blood pressure and weight in obese subjects
674267|NCT00734175|Vaccine|vaccine
674268|NCT00734175|Influenza|influenza
674269|NCT00734162|tenofovir|tenofovir
674270|NCT00734162|adolescents|adolescents
674271|NCT00734162|chronic hepatitis B|chronic hepatitis b
674272|NCT00734149|Multiple myeloma|multiple myeloma
674273|NCT00734136|Angiogenic Factors|angiogenic factors
674274|NCT00734136|Hepatorenal Syndrome|hepatorenal syndrome
674275|NCT00734136|Liver Disease|liver disease
674276|NCT00734136|Renal Failure|renal failure
674277|NCT00734136|Liver Cirrhosis|liver cirrhosis
674279|NCT00734123|Atherosclerosis|atherosclerosis
674280|NCT00734123|Cardiovascular Prevention|cardiovascular prevention
674281|NCT00734123|Carotid Intima-Media Thickness|carotid intima-media thickness
674282|NCT00734123|Ankle-Brachial Index|ankle-brachial index
674283|NCT00734110|Arthroplasty, Replacement, Knee, P.F.C. Sigma RPF, Sigma RP|arthroplasty, replacement, knee, p.f.c. sigma rpf, sigma rp
674284|NCT00734097|heartburn|heartburn
674285|NCT00734097|reflux|reflux
674286|NCT00734097|proton|proton
674287|NCT00734097|pump|pump
674288|NCT00734097|inhibitor|inhibitor
674289|NCT00734084|Arthroplasty|arthroplasty
674290|NCT00734084|Knee|knee
674291|NCT00734084|UKA|uka
674292|NCT00734084|Partial|partial
674293|NCT00734084|Preservation|preservation
674294|NCT00734071|Generalized Anxiety Disorder|generalized anxiety disorder
674295|NCT00734071|Mood Disorder|mood disorder
674296|NCT00734071|Affective Disorder|affective disorder
674297|NCT00734071|Anxiety Disorder|anxiety disorder
674298|NCT00734071|Drug Therapy|drug therapy
674299|NCT00734058|Ablation|ablation
674300|NCT00734058|AF|af
674301|NCT00734058|Atrial Fibrillation|atrial fibrillation
674302|NCT00734058|Cardiac|cardiac
674303|NCT00734058|Endocardial|endocardial
674304|NCT00734058|Endocardium|endocardium
674305|NCT00734058|EP|ep
674306|NCT00734058|Electrophysiology|electrophysiology
674307|NCT00734058|Epicardial|epicardial
674308|NCT00734058|Epicardium|epicardium
674309|NCT00734058|Heart|heart
674310|NCT00734058|Interventional|interventional
674311|NCT00734058|Lesion|lesion
674312|NCT00734058|PVI|pvi
674313|NCT00734058|Pulmonary Vein|pulmonary vein
674314|NCT00734058|MAZE|maze
674315|NCT00734058|Surgery|surgery
674316|NCT00734058|Surgical|surgical
674317|NCT00734058|Treatment|treatment
674318|NCT00734058|Patients with persistent AF with 3 months duration|patients with persistent af with 3 months duration
674319|NCT00734058|Requiring concomitant open heart surgery|requiring concomitant open heart surgery
674320|NCT00734045|Congestive Heart Failure (CHF)|congestive heart failure (chf)
674321|NCT00734045|NT-proBNP|nt-probnp
674322|NCT00734032|SB-480848|sb-480848
674323|NCT00734032|Dyslipidaemia|dyslipidaemia
674324|NCT00734019|Arthroplasty, Replacement, Knee, TKR, PFC Sigma|arthroplasty, replacement, knee, tkr, pfc sigma
674325|NCT00734006|Cortico-cortical|cortico-cortical
674326|NCT00734006|connectivity|connectivity
674327|NCT00734006|Transcranial|transcranial
674328|NCT00734006|Magnetic|magnetic
674329|NCT00734006|Stimulation|stimulation
674330|NCT00733993|substance abuse|substance abuse
674331|NCT00733993|cocaine|cocaine
674332|NCT00733993|caffeine|caffeine
674333|NCT00733993|impulsivity|impulsivity
674334|NCT00733980|Depressive Disorder, Major|depressive disorder, major
674335|NCT00733967|Methamphetamine|methamphetamine
674336|NCT00733967|Chantix|chantix
674337|NCT00733967|Varenicline|varenicline
674338|NCT00733941|Exercise test|exercise test
674339|NCT00733941|Running|running
674340|NCT00733941|Arterial diameter|arterial diameter
674341|NCT00733941|Monitoring, physiologic|monitoring, physiologic
674342|NCT00733941|Oxygen Consumption|oxygen consumption
674343|NCT00733928|Arthroplasty,|arthroplasty,
674344|NCT00733928|Replacement,|replacement,
674345|NCT00733928|Knee,|knee,
674346|NCT00733928|P.F.C.|p.f.c.
674347|NCT00733928|Sigma|sigma
674348|NCT00733928|all-polyethylene|all-polyethylene
674349|NCT00733915|Arthroplasty, knee, TKA, TKR, Duofix, Porocoat, LCS|arthroplasty, knee, tka, tkr, duofix, porocoat, lcs
674350|NCT00733902|monoclonal antibody|monoclonal antibody
674351|NCT00733902|RN624|rn624
674352|NCT00733902|PF-04383119|pf-04383119
674353|NCT00733902|nerve growth factor|nerve growth factor
674354|NCT00733902|anti-nerve growth factor|anti-nerve growth factor
674355|NCT00733902|OA|oa
674356|NCT00733902|pain|pain
674357|NCT00733889|esophageal carcinoma|esophageal carcinoma
674358|NCT00733889|cetuximab|cetuximab
674359|NCT00733889|docetaxel|docetaxel
674360|NCT00733889|cisplatin|cisplatin
674361|NCT00733889|5-fluorouracil|5-fluorouracil
674362|NCT00733876|Acute Renal Failure Cardiac Surgery Stem Cell|acute renal failure cardiac surgery stem cell
674363|NCT00733863|Active immunization|active immunization
674364|NCT00733863|Alzheimer disease|alzheimer disease
674365|NCT00733863|Antibody|antibody
674366|NCT00733863|Central Nervous System Diseases|central nervous system diseases
674367|NCT00733863|Neurodegenerative diseases|neurodegenerative diseases
674368|NCT00733863|Vaccine|vaccine
674369|NCT00733824|Plerixafor|plerixafor
674370|NCT00733824|Lymphoma|lymphoma
674371|NCT00733824|Hematopoietic Stem Cell Mobilization|hematopoietic stem cell mobilization
674372|NCT00733824|Transplantation, Autologous|transplantation, autologous
674373|NCT00733824|Receptors, CXCR4|receptors, cxcr4
674374|NCT00733811|thalassemia major|thalassemia major
674375|NCT00733811|chelation treatment|chelation treatment
674376|NCT00733811|secondary hemochromatosis|secondary hemochromatosis
674377|NCT00733798|Melanoma|melanoma
674378|NCT00733798|Malignant melanoma|malignant melanoma
674379|NCT00733798|metastatic melanoma|metastatic melanoma
674380|NCT00733798|Phase 1|phase 1
674381|NCT00733798|Phase 2|phase 2
674382|NCT00733785|Rosiglitazone XR|rosiglitazone xr
674383|NCT00733785|Pharmacokinetics|pharmacokinetics
674384|NCT00733785|Strength Equivalence.|strength equivalence.
674385|NCT00733785|Alzheimers Disease|alzheimers disease
674386|NCT00733785|Repeat dose|repeat dose
674387|NCT00733785|Dose proportionality|dose proportionality
674388|NCT00733772|flaxseed|flaxseed
674389|NCT00733772|lignans|lignans
674390|NCT00733772|alpha-Linolenic Acid|alpha-linolenic acid
674391|NCT00733772|LDL Cholesterol|ldl cholesterol
674392|NCT00733746|adenocarcinoma of the pancreas|adenocarcinoma of the pancreas
674393|NCT00733746|stage I pancreatic cancer|stage i pancreatic cancer
674394|NCT00733746|stage II pancreatic cancer|stage ii pancreatic cancer
674395|NCT00733733|kidney|kidney
674396|NCT00733733|transplantation|transplantation
674397|NCT00733733|non-heart-beating donor|non-heart-beating donor
674398|NCT00733733|delayed graft function|delayed graft function
674399|NCT00733733|Antithymocyte globulin|antithymocyte globulin
674400|NCT00733733|ischemia-reperfusion damage|ischemia-reperfusion damage
674401|NCT00733707|adherence|adherence
674402|NCT00733707|oral contraceptive pills|oral contraceptive pills
674403|NCT00733707|contraception|contraception
674404|NCT00733707|text messaging|text messaging
674405|NCT00733694|Arthroplasty, Replacement, Knee,LCS|arthroplasty, replacement, knee,lcs
674406|NCT00733681|Arthroplasty, Replacement, Knee|arthroplasty, replacement, knee
674407|NCT00733681|Prosthesis Failure|prosthesis failure
674408|NCT00733681|Revision surgery|revision surgery
674409|NCT00733668|considered|considered
674410|NCT00733668|entry|entry
674411|NCT00733668|into|into
674412|NCT00733668|the study|the study
674413|NCT00733668|SSRI|ssri
674414|NCT00733668|Seroquel|seroquel
674415|NCT00733668|Quetiapine|quetiapine
674416|NCT00733668|fumarate|fumarate
674417|NCT00733668|antipsychotic|antipsychotic
674418|NCT00733642|antibody amyloid Alzheimer's Disease AD|antibody amyloid alzheimer's disease ad
674419|NCT00733616|advanced gastric adenocarcinoma|advanced gastric adenocarcinoma
674420|NCT00733616|docetaxel|docetaxel
674421|NCT00733616|oxaliplatin|oxaliplatin
674422|NCT00733616|capecitabine|capecitabine
674423|NCT00733616|intermediate general status|intermediate general status
674424|NCT00733603|Interstitial Cystitis|interstitial cystitis
674425|NCT00733603|IC|ic
674426|NCT00733603|Painful Bladder Syndrome|painful bladder syndrome
674427|NCT00733603|PBS|pbs
674428|NCT00733603|Bladder Pain|bladder pain
674429|NCT00733603|Pelvic Pain|pelvic pain
674430|NCT00733590|defibrillator, implanted|defibrillator, implanted
674431|NCT00733590|genomics|genomics
674432|NCT00733590|electrocardiography|electrocardiography
674433|NCT00733590|electrophysiological study|electrophysiological study
674434|NCT00733590|proteomics|proteomics
674435|NCT00733577|diabetes|diabetes
674436|NCT00733577|pharmacodynamics|pharmacodynamics
674437|NCT00733577|safety|safety
674438|NCT00733577|pharmacokinetics|pharmacokinetics
674439|NCT00733564|Local anesthetic|local anesthetic
674440|NCT00733564|Propofol|propofol
674441|NCT00733564|Sevoflurane|sevoflurane
674442|NCT00733551|motilin|motilin
674443|NCT00733551|gastric emptying|gastric emptying
674444|NCT00733551|GSK962040|gsk962040
674445|NCT00733551|oral dose|oral dose
674446|NCT00733538|stage I multiple myeloma|stage i multiple myeloma
674447|NCT00733525|Bulimia Nervosa|bulimia nervosa
674448|NCT00733512|ReSTOR Aspheric +4 IOL|restor aspheric +4 iol
674449|NCT00733499|Arthroplasty, replacement, Knee, LCS Duofix, Porocoat|arthroplasty, replacement, knee, lcs duofix, porocoat
674450|NCT00733486|Arthroplasty, Replacement, Knee, LCS Complete APG (MeSH);|arthroplasty, replacement, knee, lcs complete apg (mesh);
674451|NCT00733473|Wheezing|wheezing
674452|NCT00733473|Acute asthma|acute asthma
674453|NCT00733473|Children|children
674454|NCT00733460|BFPET|bfpet
674455|NCT00733460|Coronary Artery Disease|coronary artery disease
674456|NCT00733460|Myocardial Perfusion Imaging|myocardial perfusion imaging
674457|NCT00733460|Radiation Dosimetry|radiation dosimetry
674458|NCT00733447|Biventricular failure|biventricular failure
674459|NCT00733434|Microsurgery|microsurgery
674460|NCT00733434|Head and neck|head and neck
674461|NCT00733434|Prostaglandin E1|prostaglandin e1
674462|NCT00733434|Thrombosis|thrombosis
674463|NCT00733434|Complication|complication
674464|NCT00733421|Day surgery|day surgery
674465|NCT00733421|Hallux Valgus|hallux valgus
674466|NCT00733421|Pain|pain
674467|NCT00733421|Analgesics|analgesics
674468|NCT00733395|Muscle pain|muscle pain
674469|NCT00733382|migraine|migraine
674470|NCT00733382|dexamethasone|dexamethasone
674471|NCT00733382|dihydroergotamine|dihydroergotamine
674472|NCT00733369|Arthroplasty|arthroplasty
674473|NCT00733369|Replacement|replacement
674474|NCT00733369|Knee|knee
674475|NCT00733369|PFC Sigma RPF|pfc sigma rpf
674476|NCT00733369|PFC Sigma RP|pfc sigma rp
674477|NCT00733356|Attention Deficit Hyperactivity Disorder|attention deficit hyperactivity disorder
674478|NCT00733356|ADHD|adhd
674479|NCT00733356|ADD|add
674480|NCT00733356|reading|reading
674481|NCT00733356|brain hemodynamics|brain hemodynamics
674482|NCT00733356|brain imaging|brain imaging
674483|NCT00733356|attention|attention
856069|NCT00070720|Uruguay|uruguay
674484|NCT00733356|Near-Infrared Spectroscopy|near-infrared spectroscopy
674485|NCT00733356|NIRS|nirs
674486|NCT00733356|MSIT|msit
674487|NCT00733343|heart failure|heart failure
674488|NCT00733343|sleep disordered breathing|sleep disordered breathing
674489|NCT00733343|sleep apnea|sleep apnea
674490|NCT00733343|left ventricular systolic dysfunction|left ventricular systolic dysfunction
674491|NCT00733343|SBAS|sbas
674492|NCT00733343|HF|hf
674493|NCT00733330|Arthroplasty, Knee, TKA, TKR, CAS, minimally invasive|arthroplasty, knee, tka, tkr, cas, minimally invasive
674494|NCT00733317|Wheezing|wheezing
674495|NCT00733317|Acute asthma|acute asthma
674496|NCT00733317|Children|children
674497|NCT00733317|Budesonide|budesonide
674498|NCT00733317|Emergency room|emergency room
674499|NCT00733304|age-related macular degeneration (AMD)|age-related macular degeneration (amd)
674500|NCT00733304|choroidal neovascularization (CNV)|choroidal neovascularization (cnv)
674501|NCT00733304|vascular endothelial growth factor (VEGF)|vascular endothelial growth factor (vegf)
674502|NCT00733304|pazopanib|pazopanib
674503|NCT00733304|angiogenesis|angiogenesis
674504|NCT00733291|Daily disposable contact lenses|daily disposable contact lenses
674505|NCT00733291|Multi-purpose disinfecting solutions|multi-purpose disinfecting solutions
674506|NCT00733278|Postpartum contraception|postpartum contraception
674507|NCT00733278|Copper IUD|copper iud
674508|NCT00733265|Renal Impairment|renal impairment
674509|NCT00733252|non-small cell lung cancer|non-small cell lung cancer
674510|NCT00733252|small cell lung cancer|small cell lung cancer
674511|NCT00733252|benign respiratory tract neoplasm|benign respiratory tract neoplasm
674512|NCT00733252|lung papilloma|lung papilloma
674513|NCT00733252|recurrent respiratory papillomatosis|recurrent respiratory papillomatosis
674514|NCT00733252|squamous lung dysplasia|squamous lung dysplasia
674515|NCT00733252|malignant mesothelioma|malignant mesothelioma
674516|NCT00733252|pulmonary carcinoid tumor|pulmonary carcinoid tumor
674517|NCT00733252|lung metastases|lung metastases
674518|NCT00733239|methadone|methadone
674519|NCT00733239|opioid dependence|opioid dependence
674520|NCT00733239|opioid|opioid
674521|NCT00733226|wheezing|wheezing
674522|NCT00733226|asthma|asthma
674523|NCT00733226|childhood|childhood
674524|NCT00733226|OM-85 BV|om-85 bv
674525|NCT00733226|Broncho-Vaxom|broncho-vaxom
674526|NCT00733213|Prostate Cancer, Treatment alternatives, Metastasis|prostate cancer, treatment alternatives, metastasis
674527|NCT00733200|Minor Liver Resection|minor liver resection
674528|NCT00733200|Major Liver Resection|major liver resection
674529|NCT00733200|Hilar|hilar
674530|NCT00733174|IGT|igt
674531|NCT00733161|passive leg exercise|passive leg exercise
674532|NCT00733161|congestive heart failure|congestive heart failure
674533|NCT00733161|endothelium-derived factors|endothelium-derived factors
674534|NCT00733161|elderly|elderly
674535|NCT00733148|glucose, interstitial, intensive care|glucose, interstitial, intensive care
674536|NCT00733135|peripheral vascular disease|peripheral vascular disease
674537|NCT00733135|atherectomy|atherectomy
674538|NCT00733135|atherosclerosis|atherosclerosis
674539|NCT00733135|calcified lesions|calcified lesions
674540|NCT00733109|CIN2|cin2
674541|NCT00733109|management|management
674542|NCT00733096|radiculopathy|radiculopathy
674543|NCT00733096|sciatica|sciatica
674544|NCT00733096|low back pain|low back pain
674545|NCT00733083|tonsillectomy|tonsillectomy
674546|NCT00733083|paediatric|paediatric
674547|NCT00733083|pain|pain
674548|NCT00733083|child|child
674549|NCT00733083|opiates|opiates
674550|NCT00733083|pre-emptive|pre-emptive
674551|NCT00733083|oxycodone|oxycodone
674552|NCT00733083|morphine|morphine
674553|NCT00733083|dexamethasone|dexamethasone
674554|NCT00733070|CTO|cto
674555|NCT00733070|Chronic Total Occlusion|chronic total occlusion
674556|NCT00733070|Revascularization|revascularization
674557|NCT00733057|Minocycline|minocycline
674558|NCT00733057|Schizophrenia|schizophrenia
674559|NCT00733057|Negative symptoms|negative symptoms
674560|NCT00733057|Cognitive|cognitive
674561|NCT00733044|Objective tinnitus|objective tinnitus
674562|NCT00733044|Tinnitus|tinnitus
674563|NCT00733044|RCT|rct
674564|NCT00733044|Specialised treatment|specialised treatment
674565|NCT00733044|Usual care|usual care
674566|NCT00733044|Cost-effectiveness|cost-effectiveness
674567|NCT00733031|Phase I,|phase i,
674568|NCT00733031|cancer,|cancer,
674569|NCT00733031|solid tumors,|solid tumors,
674570|NCT00733031|advanced solid malignancies,|advanced solid malignancies,
674571|NCT00733031|dose escalation,|dose escalation,
674572|NCT00733031|combination treatment,|combination treatment,
674573|NCT00733031|TRK inhibitor|trk inhibitor
674574|NCT00733018|Nutrigenomics|nutrigenomics
674575|NCT00733018|Gene Expression|gene expression
674576|NCT00733018|Diet, Carbohydrate-Restricted|diet, carbohydrate-restricted
674578|NCT00733018|Health Behavior|health behavior
674579|NCT00732992|Solid tumor|solid tumor
674580|NCT00732992|malignancy|malignancy
674581|NCT00732992|sunitinib|sunitinib
674582|NCT00732992|pemetrexed|pemetrexed
674583|NCT00732992|phase 1|phase 1
674584|NCT00732992|neoplasms|neoplasms
674585|NCT00732979|Elective|elective
674586|NCT00732979|hepatic|hepatic
674587|NCT00732979|resection|resection
674588|NCT00732979|due to any|due to any
674589|NCT00732979|reason.|reason.
674590|NCT00732966|cyp2c9|cyp2c9
674591|NCT00732966|losartan|losartan
674592|NCT00732966|pharmacogenetics|pharmacogenetics
674593|NCT00732966|pharmacokinetics|pharmacokinetics
674594|NCT00732966|pharmacodynamics|pharmacodynamics
674595|NCT00732953|patients with coronary artery disease|patients with coronary artery disease
674596|NCT00732953|percutaneous coronary intervention|percutaneous coronary intervention
674597|NCT00732953|stent implantation|stent implantation
674598|NCT00732953|paclitaxel eluting balloon|paclitaxel eluting balloon
674599|NCT00732953|angiographic follow-up|angiographic follow-up
674600|NCT00732953|clinical follow-up|clinical follow-up
674601|NCT00732940|SLE|sle
674602|NCT00732940|Lupus|lupus
674603|NCT00732940|Systemic Lupus Erythematosus|systemic lupus erythematosus
674604|NCT00732940|Antibodies|antibodies
674605|NCT00732940|Autoimmune Diseases|autoimmune diseases
674606|NCT00732940|Belimumab|belimumab
674607|NCT00732927|thrombosis, vein, retina|thrombosis, vein, retina
674608|NCT00732914|Renal Cell Carcinoma|renal cell carcinoma
674609|NCT00732914|Sunitinib|sunitinib
674610|NCT00732914|Sorafenib|sorafenib
674611|NCT00732914|Sequential|sequential
674612|NCT00732901|substance abuse|substance abuse
674613|NCT00732901|cocaine|cocaine
674614|NCT00732901|impulsivity|impulsivity
674615|NCT00732901|serotonin|serotonin
674616|NCT00732901|Remeron|remeron
674617|NCT00732901|Mirtzapine|mirtzapine
674618|NCT00732901|Lexapro|lexapro
674619|NCT00732901|Escatilopram|escatilopram
674620|NCT00732888|Pharmacokinetics|pharmacokinetics
674621|NCT00732888|Healthy volunteers|healthy volunteers
674622|NCT00732888|No condition|no condition
674623|NCT00732888|Pharmacokinetics study|pharmacokinetics study
674624|NCT00732862|Type 2 diabetes|type 2 diabetes
674625|NCT00732862|intensive therapy|intensive therapy
674626|NCT00732849|immunonutrition|immunonutrition
674627|NCT00732849|surgical patients|surgical patients
674628|NCT00732849|postoperative period|postoperative period
674629|NCT00732836|Liver Cancer|liver cancer
674630|NCT00732836|Solid Cancer|solid cancer
674631|NCT00732836|Abraxane|abraxane
674632|NCT00732836|nab paclitaxel|nab paclitaxel
674633|NCT00732836|HAI abraxane|hai abraxane
674634|NCT00732836|HAI|hai
674635|NCT00732836|hepatic arterial infusion|hepatic arterial infusion
674636|NCT00732836|hepatic metastases|hepatic metastases
674637|NCT00732797|Dizziness|dizziness
674638|NCT00732797|Self-management|self-management
674639|NCT00732797|booklet-based|booklet-based
674640|NCT00732797|vestibular rehabilitation|vestibular rehabilitation
674641|NCT00732784|Pharmacokinetics|pharmacokinetics
674642|NCT00732784|Healthy volunteers|healthy volunteers
674643|NCT00732784|No condition|no condition
674644|NCT00732784|Pharmacokinetics study|pharmacokinetics study
674645|NCT00732771|primary hyperaldosteronism|primary hyperaldosteronism
674646|NCT00732771|hypokalemia|hypokalemia
674647|NCT00732771|hypertension|hypertension
674648|NCT00732771|aldosterone synthase inhibitor|aldosterone synthase inhibitor
674649|NCT00732758|Vitamin D Deficiency|vitamin d deficiency
674650|NCT00732758|Vitamin D Insufficiency|vitamin d insufficiency
674651|NCT00732758|Child|child
674652|NCT00732758|Adolescent|adolescent
674653|NCT00732758|African American|african american
674654|NCT00732758|Caucasian|caucasian
674655|NCT00732758|Definition|definition
674656|NCT00732758|Preadolescent|preadolescent
674657|NCT00732745|adenocarcinoma of the esophagus|adenocarcinoma of the esophagus
674658|NCT00732745|adenocarcinoma of the gastroesophageal junction|adenocarcinoma of the gastroesophageal junction
674659|NCT00732745|squamous cell carcinoma of the esophagus|squamous cell carcinoma of the esophagus
674660|NCT00732745|stage III esophageal cancer|stage iii esophageal cancer
674661|NCT00732745|stage IV esophageal cancer|stage iv esophageal cancer
674662|NCT00732745|recurrent esophageal cancer|recurrent esophageal cancer
674663|NCT00732732|diarrhea|diarrhea
674664|NCT00732732|Plantain|plantain
674665|NCT00732732|Green banana|green banana
674666|NCT00732732|Infants|infants
674667|NCT00732732|Children|children
674668|NCT00732706|FNB|fnb
674669|NCT00732706|Femoral Nerve|femoral nerve
674670|NCT00732706|Sartorius Twitch|sartorius twitch
674671|NCT00732706|Quadriceps Twitch|quadriceps twitch
674672|NCT00732706|Analgesia|analgesia
674673|NCT00732706|Anesthesia|anesthesia
674674|NCT00732693|Premature ovarian failure|premature ovarian failure
674675|NCT00732693|Sex hormone replacement|sex hormone replacement
674676|NCT00732693|HRT|hrt
674677|NCT00732693|Blood pressure|blood pressure
674678|NCT00732693|Bone mineral density|bone mineral density
674679|NCT00732693|Bone metabolism|bone metabolism
674680|NCT00732693|Uterine function|uterine function
674681|NCT00732680|Empty nose syndrome|empty nose syndrome
674682|NCT00732680|Over resection of turbinate|over resection of turbinate
674683|NCT00732680|Atrophic rhinitis|atrophic rhinitis
674684|NCT00732654|Food Allergy|food allergy
674685|NCT00732654|Oral Immunotherapy|oral immunotherapy
674686|NCT00732654|Immunoglobulin E|immunoglobulin e
674687|NCT00732615|Hypoparathyroidism|hypoparathyroidism
674688|NCT00732602|Glucagon|glucagon
674689|NCT00732602|Glucose-dependent Insulinotropic Polypeptide|glucose-dependent insulinotropic polypeptide
674690|NCT00732602|Glucagon-Like peptide 2|glucagon-like peptide 2
674691|NCT00732589|suprascapular nerve block|suprascapular nerve block
674692|NCT00732589|shoulder pain|shoulder pain
674693|NCT00732589|hemiplegia|hemiplegia
674694|NCT00732576|Cardiovascular|cardiovascular
674695|NCT00732576|Calcification|calcification
674696|NCT00732563|stage I non-small cell lung cancer|stage i non-small cell lung cancer
674697|NCT00732563|stage II non-small cell lung cancer|stage ii non-small cell lung cancer
674698|NCT00732550|cholelithiasis|cholelithiasis
674699|NCT00732550|cholecystitis|cholecystitis
674700|NCT00732537|Hypoxia|hypoxia
674701|NCT00732537|Respiratory failure|respiratory failure
674702|NCT00732537|Infant, term|infant, term
674703|NCT00732537|Nitric oxide|nitric oxide
674704|NCT00732524|Hyperglycemia|hyperglycemia
674705|NCT00732524|Glucose toxicity|glucose toxicity
674706|NCT00732524|Glargine|glargine
674707|NCT00732524|Glipizide|glipizide
674708|NCT00732511|Endothelial dysfunction|endothelial dysfunction
674709|NCT00732511|Blood vessel stiffness|blood vessel stiffness
674710|NCT00732511|Nitric oxide|nitric oxide
674711|NCT00732511|Oxidative stress|oxidative stress
674712|NCT00732498|contiguous stage II grade 1 follicular lymphoma|contiguous stage ii grade 1 follicular lymphoma
674713|NCT00732498|contiguous stage II grade 2 follicular lymphoma|contiguous stage ii grade 2 follicular lymphoma
674714|NCT00732498|contiguous stage II grade 3 follicular lymphoma|contiguous stage ii grade 3 follicular lymphoma
674715|NCT00732498|noncontiguous stage II grade 1 follicular lymphoma|noncontiguous stage ii grade 1 follicular lymphoma
674716|NCT00732498|noncontiguous stage II grade 2 follicular lymphoma|noncontiguous stage ii grade 2 follicular lymphoma
674717|NCT00732498|noncontiguous stage II grade 3 follicular lymphoma|noncontiguous stage ii grade 3 follicular lymphoma
674718|NCT00732498|recurrent grade 1 follicular lymphoma|recurrent grade 1 follicular lymphoma
674719|NCT00732498|recurrent grade 2 follicular lymphoma|recurrent grade 2 follicular lymphoma
674720|NCT00732498|recurrent grade 3 follicular lymphoma|recurrent grade 3 follicular lymphoma
674721|NCT00732498|stage III grade 1 follicular lymphoma|stage iii grade 1 follicular lymphoma
674722|NCT00732498|stage III grade 2 follicular lymphoma|stage iii grade 2 follicular lymphoma
674723|NCT00732498|stage III grade 3 follicular lymphoma|stage iii grade 3 follicular lymphoma
674724|NCT00732498|stage IV grade 1 follicular lymphoma|stage iv grade 1 follicular lymphoma
674725|NCT00732498|stage IV grade 2 follicular lymphoma|stage iv grade 2 follicular lymphoma
674726|NCT00732498|stage IV grade 3 follicular lymphoma|stage iv grade 3 follicular lymphoma
674727|NCT00732485|Burn injury|burn injury
674728|NCT00732485|Fenofibrate|fenofibrate
674729|NCT00732485|Insulin resistance|insulin resistance
674730|NCT00732485|Mitochondrial function|mitochondrial function
674731|NCT00732485|Fat oxidation|fat oxidation
674732|NCT00732485|PPAR|ppar
674733|NCT00732485|Protein|protein
674734|NCT00732485|Glucose|glucose
674735|NCT00732485|Wound|wound
674736|NCT00732472|Chronic Obstructive Pulmonary Disease (COPD)|chronic obstructive pulmonary disease (copd)
674737|NCT00732472|Magnesium stearate|magnesium stearate
674738|NCT00732472|GSK573719|gsk573719
674739|NCT00732459|myocardial protection|myocardial protection
674740|NCT00732459|cardiac surgery|cardiac surgery
674741|NCT00732459|heart valve replacement|heart valve replacement
674742|NCT00732446|moxifloxacin|moxifloxacin
674743|NCT00732446|dexamethasone|dexamethasone
674744|NCT00732446|ocular inflammation|ocular inflammation
674745|NCT00732446|ocular infection|ocular infection
674746|NCT00732420|pazopanib|pazopanib
674747|NCT00732420|Phase I|phase i
674748|NCT00732420|topotecan|topotecan
674749|NCT00732420|Advanced Solid Tumors|advanced solid tumors
674750|NCT00732407|aliskiren|aliskiren
674751|NCT00732407|arteial stiffness|arteial stiffness
674752|NCT00732407|platelet function|platelet function
674753|NCT00732407|diabetes mellitus|diabetes mellitus
674754|NCT00732355|syphilis|syphilis
674755|NCT00732342|Alcohol Abuse|alcohol abuse
674756|NCT00732342|Contingency Management|contingency management
674757|NCT00732342|Treatment Duration|treatment duration
674758|NCT00732316|accelerated phase chronic myelogenous leukemia|accelerated phase chronic myelogenous leukemia
674759|NCT00732316|adult acute lymphoblastic leukemia in remission|adult acute lymphoblastic leukemia in remission
674760|NCT00732316|adult acute myeloid leukemia in remission|adult acute myeloid leukemia in remission
674761|NCT00732316|acute undifferentiated leukemia|acute undifferentiated leukemia
674762|NCT00732316|blastic phase chronic myelogenous leukemia|blastic phase chronic myelogenous leukemia
674763|NCT00732316|childhood acute lymphoblastic leukemia in remission|childhood acute lymphoblastic leukemia in remission
674764|NCT00732316|childhood acute myeloid leukemia in remission|childhood acute myeloid leukemia in remission
674765|NCT00732316|childhood chronic myelogenous leukemia|childhood chronic myelogenous leukemia
675441|NCT00729417|above|above
674766|NCT00732316|childhood myelodysplastic syndromes|childhood myelodysplastic syndromes
674767|NCT00732316|chronic phase chronic myelogenous leukemia|chronic phase chronic myelogenous leukemia
674768|NCT00732316|chronic myelomonocytic leukemia|chronic myelomonocytic leukemia
674769|NCT00732316|de novo myelodysplastic syndromes|de novo myelodysplastic syndromes
674770|NCT00732316|previously treated myelodysplastic syndromes|previously treated myelodysplastic syndromes
674771|NCT00732316|recurrent childhood acute lymphoblastic leukemia|recurrent childhood acute lymphoblastic leukemia
674772|NCT00732316|recurrent childhood acute myeloid leukemia|recurrent childhood acute myeloid leukemia
674773|NCT00732316|recurrent adult acute lymphoblastic leukemia|recurrent adult acute lymphoblastic leukemia
674774|NCT00732316|recurrent adult acute myeloid leukemia|recurrent adult acute myeloid leukemia
674775|NCT00732316|refractory anemia with excess blasts|refractory anemia with excess blasts
674776|NCT00732316|refractory anemia with excess blasts in transformation|refractory anemia with excess blasts in transformation
674777|NCT00732316|relapsing chronic myelogenous leukemia|relapsing chronic myelogenous leukemia
674778|NCT00732316|secondary myelodysplastic syndromes|secondary myelodysplastic syndromes
674779|NCT00732290|Healthy volunteer|healthy volunteer
674780|NCT00732290|Pharmacokinetic|pharmacokinetic
674781|NCT00732290|pharmacodynamic|pharmacodynamic
674782|NCT00732290|Polymorphism, Genetic|polymorphism, genetic
674783|NCT00732277|sepsis|sepsis
674784|NCT00732277|septicaemia|septicaemia
674785|NCT00732277|septicemia|septicemia
674786|NCT00732277|paediatric|paediatric
674787|NCT00732277|pediatric|pediatric
674788|NCT00732277|children|children
674789|NCT00732251|Bipolar Disorder|bipolar disorder
674790|NCT00732251|Stable Bipolar Disorder|stable bipolar disorder
674791|NCT00732251|Mania|mania
674792|NCT00732251|Mixed mania|mixed mania
674793|NCT00732251|Allopurinol|allopurinol
674794|NCT00732238|Spinal Cord Injury|spinal cord injury
674795|NCT00732238|Urinary Tract Infection|urinary tract infection
674796|NCT00732238|Catheter Dependent|catheter dependent
674797|NCT00732225|DisCoVisc OVD|discovisc ovd
674798|NCT00732225|Ophthalmic Viscosurgical Device|ophthalmic viscosurgical device
674799|NCT00732212|UGI Bleeding|ugi bleeding
674800|NCT00732212|Ulcer or variceal hemorrhage|ulcer or variceal hemorrhage
674801|NCT00732212|Stigmata of recent hemorrhage|stigmata of recent hemorrhage
674802|NCT00732212|Endoscopy|endoscopy
674803|NCT00732212|Randomized Controlled Trial|randomized controlled trial
674804|NCT00732212|Non-variceal UGI hemorrhage|non-variceal ugi hemorrhage
674805|NCT00732212|Variceal hemorrhage|variceal hemorrhage
674806|NCT00732199|apneic threshold|apneic threshold
674807|NCT00732199|central apnea|central apnea
674808|NCT00732199|intermittent hypoxia|intermittent hypoxia
674809|NCT00732199|aging|aging
674810|NCT00732199|ventilation|ventilation
674811|NCT00732199|chemoresponsiveness|chemoresponsiveness
674812|NCT00732199|carbon-dioxide reserve|carbon-dioxide reserve
674813|NCT00732173|stage I endometrial carcinoma|stage i endometrial carcinoma
674814|NCT00732173|stage II endometrial carcinoma|stage ii endometrial carcinoma
674815|NCT00732160|Glucose|glucose
674816|NCT00732160|Insulin|insulin
674817|NCT00732147|triglycerides|triglycerides
674818|NCT00732147|endogenous|endogenous
674819|NCT00732147|glucose|glucose
674820|NCT00732147|production|production
674821|NCT00732121|Type 2 Diabetes|type 2 diabetes
674822|NCT00732108|migraine|migraine
674823|NCT00732108|headache|headache
674824|NCT00732108|dizziness|dizziness
674825|NCT00732108|vertigo|vertigo
674826|NCT00732108|topiramate|topiramate
674827|NCT00732108|Topamax|topamax
674828|NCT00732095|Self-change|self-change
674829|NCT00732095|Natural recovery|natural recovery
674830|NCT00732095|Alcohol Drinking|alcohol drinking
674831|NCT00732095|Mechanisms of Change|mechanisms of change
674832|NCT00732095|Advertisements|advertisements
674833|NCT00732082|LAG-3 and gemcitabine treatment for advanced pancreas cancer|lag-3 and gemcitabine treatment for advanced pancreas cancer
674834|NCT00732069|hemodialysis|hemodialysis
674835|NCT00732069|oxidative stress|oxidative stress
674836|NCT00732069|inflammation|inflammation
674837|NCT00732069|kallikrein-kinin|kallikrein-kinin
674838|NCT00732069|angiotensin receptor blockade|angiotensin receptor blockade
674839|NCT00732069|angiotensin converting enzyme inhibition|angiotensin converting enzyme inhibition
674840|NCT00732069|RAAS|raas
674841|NCT00732069|fibrinolysis|fibrinolysis
674842|NCT00732069|endothelial dysfunction|endothelial dysfunction
674843|NCT00732056|Metastatic Breast Cancer|metastatic breast cancer
674844|NCT00732056|Recurrent Breast Cancer|recurrent breast cancer
674845|NCT00732043|prostate cancer|prostate cancer
674846|NCT00732043|prostate-specific antigen|prostate-specific antigen
674847|NCT00732043|PSA|psa
674848|NCT00732043|pomegranate|pomegranate
674849|NCT00732030|Toric IOL|toric iol
674850|NCT00732017|Sprain|sprain
674851|NCT00732017|Electric stimulation|electric stimulation
674852|NCT00732017|Physical trauma|physical trauma
674853|NCT00732017|Inflammation|inflammation
674854|NCT00731991|Muscle|muscle
674855|NCT00731978|Near-Infrared Spectroscopy|near-infrared spectroscopy
674856|NCT00731978|Intraoperative Care|intraoperative care
674857|NCT00731965|Arthritis, Juvenile Rheumatoid|arthritis, juvenile rheumatoid
676357|NCT00726388|diclofenac|diclofenac
674858|NCT00731965|Measles-Mumps-Rubella Vaccine|measles-mumps-rubella vaccine
674859|NCT00731965|Serology|serology
674860|NCT00731965|Lymphocytes|lymphocytes
674861|NCT00731952|surgically resectable|surgically resectable
674862|NCT00731939|Erectile Dysfunction|erectile dysfunction
674863|NCT00731939|Penile implant|penile implant
674864|NCT00731939|Titan|titan
674865|NCT00731913|Surgical wounds|surgical wounds
674866|NCT00731913|Sutures|sutures
674867|NCT00731900|pharmacogenetic|pharmacogenetic
674868|NCT00731900|study|study
674869|NCT00731900|Topirmate|topirmate
674870|NCT00731900|induced|induced
674871|NCT00731887|Burn injury|burn injury
674872|NCT00731887|Burn recovery|burn recovery
674873|NCT00731874|Kidney transplantation|kidney transplantation
674874|NCT00731874|Immunosuppression|immunosuppression
674875|NCT00731874|Minimization|minimization
674876|NCT00731874|Tacrolimus|tacrolimus
674877|NCT00731874|Prograf|prograf
674878|NCT00731874|Thymoglobulin|thymoglobulin
674879|NCT00731848|prostate cancer|prostate cancer
674880|NCT00731848|prostate-specific antigens|prostate-specific antigens
674881|NCT00731848|PSA|psa
674882|NCT00731835|Vascular|vascular
674883|NCT00731822|Chronic Obstructive Pulmonary Disease|chronic obstructive pulmonary disease
674884|NCT00731822|Novel Dry Powder Inhaler|novel dry powder inhaler
674885|NCT00731822|Chronic Obstructive Pulmonary Disease (COPD)|chronic obstructive pulmonary disease (copd)
674886|NCT00731822|GW685698/GW642444|gw685698/gw642444
674887|NCT00731809|Crohn's disease|crohn's disease
674888|NCT00731796|Stroke|stroke
674889|NCT00731796|Retrochiasmatic|retrochiasmatic
674890|NCT00731796|Vision|vision
674891|NCT00731796|VFD|vfd
674892|NCT00731783|Abscesses|abscesses
674893|NCT00731783|Furunculosis|furunculosis
674894|NCT00731783|Staphylococcus aureus colonization|staphylococcus aureus colonization
674895|NCT00731783|Staphylococcal Skin Infections|staphylococcal skin infections
674896|NCT00731783|MRSA|mrsa
674897|NCT00731770|COPD|copd
674898|NCT00731770|sleep|sleep
674899|NCT00731770|daytime somnolence|daytime somnolence
674900|NCT00731718|Head Lice|head lice
674901|NCT00731692|FTY720, primary progressive multiple sclerosis,PPMS|fty720, primary progressive multiple sclerosis,ppms
674902|NCT00731679|IBS|ibs
674903|NCT00731679|Abdominal pain|abdominal pain
674904|NCT00731679|Bloating|bloating
674905|NCT00731679|Diarrhea|diarrhea
674906|NCT00731679|Rifaximin|rifaximin
674907|NCT00731666|penile length|penile length
674908|NCT00731666|IPP|ipp
674909|NCT00731666|Erectile dysfunction|erectile dysfunction
674910|NCT00731653|depression|depression
674911|NCT00731653|combination|combination
674912|NCT00731640|AcrySof|acrysof
674913|NCT00731640|ReSTOR|restor
674914|NCT00731640|Multifocal|multifocal
674915|NCT00731640|Intraocular Lens|intraocular lens
674916|NCT00731627|intracranial aneurysm|intracranial aneurysm
674917|NCT00731614|cognitive therapy|cognitive therapy
674918|NCT00731614|mirror training|mirror training
674919|NCT00731614|nondirective therapy|nondirective therapy
674920|NCT00731614|veterans|veterans
674921|NCT00731614|amputees|amputees
674922|NCT00731601|shock|shock
674923|NCT00731601|peptic ulcer bleeding|peptic ulcer bleeding
674924|NCT00731601|rebleeding|rebleeding
674925|NCT00731575|asthma|asthma
674926|NCT00731575|child|child
674927|NCT00731575|pathogenesis|pathogenesis
674928|NCT00731575|rhinovirus|rhinovirus
674929|NCT00731575|prednisolone|prednisolone
674930|NCT00731575|Prevention|prevention
674931|NCT00731575|pediatric|pediatric
674932|NCT00731562|food, varenicline, pharmacokinetics, bioavailability|food, varenicline, pharmacokinetics, bioavailability
674933|NCT00731549|Aripiprazole|aripiprazole
674934|NCT00731549|IM Depot|im depot
674935|NCT00731549|Schizophrenia|schizophrenia
674936|NCT00731549|Intramuscular|intramuscular
674937|NCT00731536|Hepatosplenic T-cell Lymphoma|hepatosplenic t-cell lymphoma
674938|NCT00731536|Remicade|remicade
674939|NCT00731536|Infliximab|infliximab
674940|NCT00731536|Dutch national database of pathology|dutch national database of pathology
674941|NCT00731536|PALGA|palga
674942|NCT00731536|Autoimmune disease|autoimmune disease
674943|NCT00731536|Non-Hodgkin lymphoma|non-hodgkin lymphoma
674944|NCT00731523|FTY720, Pharmacokinetics, Renal insufficiency|fty720, pharmacokinetics, renal insufficiency
674945|NCT00731510|Acute mountain sickness|acute mountain sickness
674946|NCT00731510|Body composition,Hypoxia|body composition,hypoxia
674947|NCT00731510|Carbohydrate supplementation|carbohydrate supplementation
674948|NCT00731510|Expedition,|expedition,
674949|NCT00731510|Hydration,|hydration,
674950|NCT00731510|Hypoxia|hypoxia
674951|NCT00731510|Performance|performance
674952|NCT00731497|SODIS|sodis
674953|NCT00731497|Drinking Water|drinking water
674954|NCT00731497|Disinfection|disinfection
674955|NCT00731497|Intervention Trial|intervention trial
674956|NCT00731484|Dry Eye Disease|dry eye disease
674957|NCT00731484|Tear Osmolarity|tear osmolarity
674958|NCT00731484|Tear Osmolality|tear osmolality
674959|NCT00731458|OCT;|oct;
674960|NCT00731458|Cirrus;|cirrus;
674961|NCT00731458|Stratus;|stratus;
676361|NCT00726362|LDL-C|ldl-c
674962|NCT00731458|macular thickness|macular thickness
674963|NCT00731445|Z-208|z-208
710418|NCT00589394|pneumococcal vaccine|pneumococcal vaccine
674964|NCT00731432|gingivitis, diabetes mellitus, herbal, oral inflammation|gingivitis, diabetes mellitus, herbal, oral inflammation
674965|NCT00731419|biliary|biliary
674966|NCT00731419|obstruction|obstruction
674967|NCT00731419|malignant|malignant
674968|NCT00731419|stent|stent
674969|NCT00731419|palliation|palliation
674970|NCT00731393|Thiomersal-free influenza split vaccine 2003/2004|thiomersal-free influenza split vaccine 2003/2004
674971|NCT00731393|Influsplit SSW®/Fluarix™ 2003/2004|influsplit ssw®/fluarix™ 2003/2004
674972|NCT00731393|Influenza|influenza
674973|NCT00731380|Abraxane|abraxane
674974|NCT00731380|Head and Neck Cancer|head and neck cancer
674975|NCT00731380|Determine|determine
674976|NCT00731380|Maximum|maximum
674977|NCT00731380|Tolerated dose|tolerated dose
674978|NCT00731380|ABI-007|abi-007
674979|NCT00731380|Combination|combination
674980|NCT00731380|Cisplatin|cisplatin
674981|NCT00731380|5-Fluorouracil|5-fluorouracil
674982|NCT00731380|Patients|patients
674983|NCT00731354|lipoplasty|lipoplasty
674984|NCT00731354|liposuction|liposuction
674985|NCT00731354|VASER|vaser
674986|NCT00731354|body contouring|body contouring
674987|NCT00731354|body sculpting|body sculpting
674988|NCT00731354|Any patient|any patient
674989|NCT00731354|expressing|expressing
674990|NCT00731354|interest|interest
674991|NCT00731354|in elective surgery|in elective surgery
674992|NCT00731341|Uterine fibroids|uterine fibroids
674993|NCT00731341|Leiomyoma|leiomyoma
674994|NCT00731341|Menorrhagia|menorrhagia
674995|NCT00731341|Hysteroscopic cryoablation|hysteroscopic cryoablation
674996|NCT00731341|Minimally invasive|minimally invasive
674997|NCT00731328|refractory anemia|refractory anemia
674998|NCT00731328|refractory anemia with ringed sideroblasts|refractory anemia with ringed sideroblasts
674999|NCT00731328|refractory cytopenia with multilineage dysplasia|refractory cytopenia with multilineage dysplasia
675000|NCT00731328|childhood myelodysplastic syndromes|childhood myelodysplastic syndromes
675001|NCT00731328|de novo myelodysplastic syndromes|de novo myelodysplastic syndromes
675002|NCT00731328|previously treated myelodysplastic syndromes|previously treated myelodysplastic syndromes
675003|NCT00731328|secondary myelodysplastic syndromes|secondary myelodysplastic syndromes
675004|NCT00731328|aplastic anemia|aplastic anemia
675005|NCT00731328|paroxysmal nocturnal hemoglobinuria|paroxysmal nocturnal hemoglobinuria
675006|NCT00731315|UTI|uti
675007|NCT00731315|Kiosk|kiosk
675008|NCT00731315|Computer Assisted Care|computer assisted care
675009|NCT00731315|cystitis|cystitis
675010|NCT00731289|Osteoarthritis|osteoarthritis
675011|NCT00731289|Knee|knee
675012|NCT00731289|Hyaluronan|hyaluronan
675013|NCT00731289|Gait Analysis|gait analysis
675014|NCT00731276|unspecified adult solid tumor, protocol specific|unspecified adult solid tumor, protocol specific
675015|NCT00731263|Cancer|cancer
675016|NCT00731263|Advance solid tumours|advance solid tumours
675017|NCT00731263|Dose Escalation|dose escalation
675018|NCT00731263|Preliminary efficacy|preliminary efficacy
675019|NCT00731263|AZD8055|azd8055
675020|NCT00731263|Tor kinase inhibitor|tor kinase inhibitor
675021|NCT00731263|Oral administration|oral administration
675022|NCT00731250|Capsaicin challenge|capsaicin challenge
675023|NCT00731237|Drug Eluting Stent|drug eluting stent
675024|NCT00731237|Percutaneous Coronary Intervention|percutaneous coronary intervention
675025|NCT00731237|Everolimus|everolimus
675026|NCT00731224|Alzheimer's disease, rivastigmine, patch|alzheimer's disease, rivastigmine, patch
675027|NCT00731211|Renal Cell Carcinoma|renal cell carcinoma
675028|NCT00731211|Metastatic|metastatic
675029|NCT00731211|Pazopanib|pazopanib
675030|NCT00731211|Previously-treated|previously-treated
675031|NCT00731198|ERCP|ercp
675032|NCT00731198|Drotaverine hydrochloride|drotaverine hydrochloride
675033|NCT00731198|Hyoscine-N-butylbromide|hyoscine-n-butylbromide
675034|NCT00731185|functional|functional
675035|NCT00731185|endoscopic|endoscopic
675036|NCT00731185|sinus|sinus
675037|NCT00731185|surgery|surgery
675038|NCT00731172|crohns disease|crohns disease
675039|NCT00731146|Interscalene Brachial Plexus Block|interscalene brachial plexus block
675040|NCT00731146|Regional Anesthesia|regional anesthesia
675041|NCT00731146|Ultrasound guided peripheral nerve block|ultrasound guided peripheral nerve block
675042|NCT00731146|Minimum Effective Anesthetic Volume|minimum effective anesthetic volume
675043|NCT00731146|Nerve Stimulator guided peripheral nerve block|nerve stimulator guided peripheral nerve block
675044|NCT00731133|disulfiram|disulfiram
675045|NCT00731133|methamphetamine dependence|methamphetamine dependence
675046|NCT00731133|open label|open label
675047|NCT00731120|Generalized Anxiety Disorder|generalized anxiety disorder
675048|NCT00731120|Mood Disorder|mood disorder
675049|NCT00731120|Affective Disorder|affective disorder
675050|NCT00731120|Anxiety Disorder|anxiety disorder
675051|NCT00731120|Drug Therapy|drug therapy
675052|NCT00731107|Veress Needle|veress needle
675053|NCT00731107|XCEL bladeless trocar|xcel bladeless trocar
675054|NCT00731107|Laparoscopic entry techniques|laparoscopic entry techniques
675055|NCT00731094|overweight|overweight
675056|NCT00731094|sedentary lifestyle|sedentary lifestyle
675057|NCT00731094|exercise|exercise
675058|NCT00731094|primary health care|primary health care
675059|NCT00731094|controlled clinical trials, randomized|controlled clinical trials, randomized
675060|NCT00731068|Achilles tendon|achilles tendon
675061|NCT00731042|Skin health|skin health
675062|NCT00731029|Influenza|influenza
675063|NCT00731029|Thiomersal-free influenza split vaccine 2002/2003|thiomersal-free influenza split vaccine 2002/2003
675064|NCT00731029|Influsplit SSW®/Fluarix™ 2002/2003|influsplit ssw®/fluarix™ 2002/2003
675065|NCT00731003|serotonin|serotonin
675066|NCT00731003|gut permeability|gut permeability
675067|NCT00731003|visceral sensitivity|visceral sensitivity
675068|NCT00731003|irritable bowel syndrome|irritable bowel syndrome
675069|NCT00730990|Positron Emission Tomography study in healthy volunteers for ligand qualification and receptor occupancy determination.|positron emission tomography study in healthy volunteers for ligand qualification and receptor occupancy determination.
675070|NCT00730964|Surveillance|surveillance
675071|NCT00730964|Optison|optison
675072|NCT00730964|Perflutren|perflutren
675073|NCT00730964|Echocardiography|echocardiography
675074|NCT00730964|Subjects receive Optison during enhanced echocardiography|subjects receive optison during enhanced echocardiography
675075|NCT00730938|fibrin|fibrin
675076|NCT00730938|endophthalmitis|endophthalmitis
675077|NCT00730938|cataract extraction|cataract extraction
675078|NCT00730938|Lens|lens
675079|NCT00730938|implantation,|implantation,
675080|NCT00730938|intraocular|intraocular
675081|NCT00730886|Uterine Fibroids|uterine fibroids
675082|NCT00730886|Unexplained Infertility|unexplained infertility
675083|NCT00730886|MRgFUS|mrgfus
675084|NCT00730886|ExAblate|exablate
675085|NCT00730886|Focused Ultrasound|focused ultrasound
675086|NCT00730886|Myomectomy|myomectomy
675087|NCT00730860|radiofrequency ablation|radiofrequency ablation
675088|NCT00730860|Cancer of Liver|cancer of liver
675089|NCT00730860|postoperative|postoperative
675090|NCT00730860|transhepatic arterial chemoembolization|transhepatic arterial chemoembolization
675091|NCT00730860|prospective|prospective
675092|NCT00730847|Cervarix|cervarix
675093|NCT00730847|Filipinos|filipinos
675094|NCT00730847|Safety and reactogenicity|safety and reactogenicity
675095|NCT00730847|Human papillomavirus|human papillomavirus
675096|NCT00730834|tinnitus|tinnitus
675097|NCT00730834|ringing in the ears|ringing in the ears
675098|NCT00730834|buzzing|buzzing
675099|NCT00730834|static|static
675100|NCT00730834|hyperacusis|hyperacusis
675101|NCT00730834|loudness discomfort|loudness discomfort
675102|NCT00730834|Clinically|clinically
675103|NCT00730834|significant|significant
675104|NCT00730834|discomfort|discomfort
675105|NCT00730808|Enteral nutritional regimen prior to surgery|enteral nutritional regimen prior to surgery
675106|NCT00730795|Tuberculosis vaccine|tuberculosis vaccine
675107|NCT00730769|Valganciclovir|valganciclovir
675108|NCT00730769|Ganciclovir|ganciclovir
675109|NCT00730769|Pharmacokinetics|pharmacokinetics
675110|NCT00730769|Solid organ transplantation|solid organ transplantation
675111|NCT00730769|Transplant|transplant
675112|NCT00730756|Adolescents|adolescents
675113|NCT00730756|Irritant(non-allergic)rhinitis|irritant(non-allergic)rhinitis
675114|NCT00730756|Adults|adults
675115|NCT00730756|GW685698|gw685698
675116|NCT00730756|Air Pollution|air pollution
675117|NCT00730730|Iliac Artery, Peripheral Vascular Disease (PVD)|iliac artery, peripheral vascular disease (pvd)
675118|NCT00730704|Human Papilloma Virus vaccines|human papilloma virus vaccines
675119|NCT00730704|HPV|hpv
675120|NCT00730704|Gardasil|gardasil
675121|NCT00730704|Post partum|post partum
675122|NCT00730691|Generalized Anxiety Disorder|generalized anxiety disorder
675123|NCT00730691|Mood Disorder|mood disorder
675124|NCT00730691|Affective Disorder|affective disorder
675125|NCT00730691|Anxiety Disorder|anxiety disorder
675126|NCT00730691|Drug Therapy|drug therapy
675127|NCT00730678|Metabolism|metabolism
675128|NCT00730678|Pharmacogenetic testing|pharmacogenetic testing
675129|NCT00730665|PPI partial responders with non-erosive GERD.|ppi partial responders with non-erosive gerd.
675130|NCT00730652|Medarex Inc.|medarex inc.
675131|NCT00730626|Probiotics|probiotics
675132|NCT00730626|Immunity|immunity
675133|NCT00730626|Immune response|immune response
675134|NCT00730626|Intestinal microflora|intestinal microflora
675135|NCT00730626|Blood lipids|blood lipids
675136|NCT00730626|Phagocytosis activity|phagocytosis activity
675137|NCT00730613|adult anaplastic astrocytoma|adult anaplastic astrocytoma
675138|NCT00730613|adult diffuse astrocytoma|adult diffuse astrocytoma
675139|NCT00730613|adult pilocytic astrocytoma|adult pilocytic astrocytoma
675140|NCT00730613|adult subependymal giant cell astrocytoma|adult subependymal giant cell astrocytoma
675141|NCT00730613|adult anaplastic ependymoma|adult anaplastic ependymoma
675142|NCT00730613|adult ependymoma|adult ependymoma
675143|NCT00730613|adult myxopapillary ependymoma|adult myxopapillary ependymoma
675144|NCT00730613|adult subependymoma|adult subependymoma
675145|NCT00730613|adult anaplastic oligodendroglioma|adult anaplastic oligodendroglioma
675146|NCT00730613|adult oligodendroglioma|adult oligodendroglioma
675147|NCT00730613|adult brain stem glioma|adult brain stem glioma
675148|NCT00730613|adult giant cell glioblastoma|adult giant cell glioblastoma
675149|NCT00730613|adult glioblastoma|adult glioblastoma
676935|NCT00724035|Ultrasound|ultrasound
675150|NCT00730613|recurrent adult brain tumor|recurrent adult brain tumor
675151|NCT00730613|adult gliosarcoma|adult gliosarcoma
675152|NCT00730613|adult mixed glioma|adult mixed glioma
675153|NCT00730613|adult pineal gland astrocytoma|adult pineal gland astrocytoma
675154|NCT00730600|Thai Traditional massage|thai traditional massage
675155|NCT00730600|Bone Formation|bone formation
675156|NCT00730600|Bone Resorption|bone resorption
675157|NCT00730587|Nutrition|nutrition
675158|NCT00730587|Body Fat|body fat
675159|NCT00730587|Infant|infant
675160|NCT00730587|Healthy Babies|healthy babies
675161|NCT00730561|nerve conduction velocity|nerve conduction velocity
675162|NCT00730561|hematopoietic stem cell transplantation|hematopoietic stem cell transplantation
675163|NCT00730535|Overactive bladder, Tolterodine,Symptoms Relapse, Predictor|overactive bladder, tolterodine,symptoms relapse, predictor
675164|NCT00730522|Methamphetamine|methamphetamine
675165|NCT00730522|Dependency|dependency
675166|NCT00730522|Addiction|addiction
675167|NCT00730522|vigabatrin|vigabatrin
675168|NCT00730509|cystic fibrosis|cystic fibrosis
675169|NCT00730509|folate|folate
675170|NCT00730509|vitamin B12|vitamin b12
675171|NCT00730496|Embryo culture supernatant|embryo culture supernatant
675172|NCT00730496|injection|injection
675173|NCT00730496|embryo transfer|embryo transfer
675174|NCT00730496|embryo implantation rate|embryo implantation rate
675175|NCT00730483|liver metastases|liver metastases
675176|NCT00730483|metastatic gastrointestinal carcinoid tumor|metastatic gastrointestinal carcinoid tumor
675177|NCT00730483|regional gastrointestinal carcinoid tumor|regional gastrointestinal carcinoid tumor
675178|NCT00730483|islet cell carcinoma|islet cell carcinoma
675179|NCT00730483|gastrinoma|gastrinoma
675180|NCT00730483|insulinoma|insulinoma
675181|NCT00730483|glucagonoma|glucagonoma
675182|NCT00730483|pancreatic polypeptide tumor|pancreatic polypeptide tumor
675183|NCT00730483|somatostatinoma|somatostatinoma
675184|NCT00730470|Human Epidermal Growth Factor Receptor 3|human epidermal growth factor receptor 3
675185|NCT00730470|HER3|her3
675186|NCT00730470|Heregulin|heregulin
675187|NCT00730470|erb B3|erb b3
675188|NCT00730470|Solid Tumors|solid tumors
675189|NCT00730470|Phase I Clinical Study|phase i clinical study
675190|NCT00730457|influenza|influenza
675191|NCT00730457|recombinant|recombinant
675192|NCT00730457|hemagglutinin|hemagglutinin
675193|NCT00730457|vaccine|vaccine
675194|NCT00730444|Neuroblastoma|neuroblastoma
675195|NCT00730444|Nuclear medicine|nuclear medicine
675196|NCT00730444|Diagnostic scintigraphy|diagnostic scintigraphy
675197|NCT00730444|Known and suspected neuroblastoma|known and suspected neuroblastoma
675198|NCT00730431|Hepatitis C, healthy volunteers|hepatitis c, healthy volunteers
675199|NCT00730418|Benign Prostatic Hyperplasia|benign prostatic hyperplasia
675200|NCT00730418|alpha Adrenergic Blockers|alpha adrenergic blockers
675201|NCT00730418|alpha-1 Adrenergic Receptor|alpha-1 adrenergic receptor
675202|NCT00730405|Distal, Subungual onychomycosis|distal, subungual onychomycosis
675203|NCT00730405|onychomycosis|onychomycosis
675204|NCT00730405|nail fungus|nail fungus
675205|NCT00730405|Toenail fungus|toenail fungus
675206|NCT00730392|Type 1 diabetes, Etanercept, honeymoon period|type 1 diabetes, etanercept, honeymoon period
675207|NCT00730366|Malaria|malaria
675208|NCT00730366|Pregnancy|pregnancy
675209|NCT00730366|Intermittent Preventive Treatment|intermittent preventive treatment
675210|NCT00730340|Tonsillectomy, tonsillar fossa, wound closure|tonsillectomy, tonsillar fossa, wound closure
675211|NCT00730314|unrelated|unrelated
675213|NCT00730314|HSCT|hsct
675214|NCT00730314|bone marrow transplantation|bone marrow transplantation
675215|NCT00730314|sickle cell disease|sickle cell disease
675216|NCT00730314|thalassemia|thalassemia
675217|NCT00730314|CGD|cgd
675218|NCT00730314|HLH|hlh
675219|NCT00730314|Blackfan-Diamond anemia|blackfan-diamond anemia
675220|NCT00730314|Hurler|hurler
675221|NCT00730314|leukodystrophy|leukodystrophy
675222|NCT00730314|LAD I|lad i
675223|NCT00730314|Genetic diseases|genetic diseases
675224|NCT00730314|Red blood cell defects|red blood cell defects
675225|NCT00730314|Leukocyte defects and immune deficiencies|leukocyte defects and immune deficiencies
675226|NCT00730314|Hereditary Lymphohistiocytosis|hereditary lymphohistiocytosis
675227|NCT00730314|chronic granulomatous disease|chronic granulomatous disease
675228|NCT00730314|Wiskott-Aldrich syndrome|wiskott-aldrich syndrome
675229|NCT00730314|Chediak Higashi syndrome|chediak higashi syndrome
675230|NCT00730314|CD40 ligand deficiency|cd40 ligand deficiency
675231|NCT00730314|Hyper IgM syndrome|hyper igm syndrome
675232|NCT00730314|leucocytes adhesion defect type 1|leucocytes adhesion defect type 1
675233|NCT00730314|Osteopetrosis|osteopetrosis
675234|NCT00730314|congenital neutropenia|congenital neutropenia
675235|NCT00730314|X-linked lymphoproliferative disease|x-linked lymphoproliferative disease
675236|NCT00730314|Platelets defects|platelets defects
675237|NCT00730314|Congenital amegakaryocytic thrombocytopenia|congenital amegakaryocytic thrombocytopenia
675238|NCT00730314|Metabolic and storage disorders|metabolic and storage disorders
675239|NCT00730314|Hurler disease|hurler disease
675240|NCT00730314|leukodystrophies|leukodystrophies
675241|NCT00730314|Niemann-Pick disease|niemann-pick disease
675242|NCT00730314|Fucosidosis|fucosidosis
675243|NCT00730314|Stem cell defects|stem cell defects
675244|NCT00730314|reticular agenesis|reticular agenesis
675245|NCT00730301|Emphysema|emphysema
675246|NCT00730301|Chronic obstructive pulmonary disease|chronic obstructive pulmonary disease
675247|NCT00730301|Lung volume reduction|lung volume reduction
675248|NCT00730301|Lung function|lung function
675250|NCT00730288|Dengue fever|dengue fever
675251|NCT00730288|Dengue hemorrhagic fever|dengue hemorrhagic fever
675252|NCT00730288|Dengue virus|dengue virus
675253|NCT00730262|Glioblastoma Multiforme (GBM)|glioblastoma multiforme (gbm)
675254|NCT00730262|Phase II|phase ii
675255|NCT00730262|Brain Cancer|brain cancer
675256|NCT00730249|ADHD|adhd
675257|NCT00730249|Attention Deficit Hyperactivity Disorder|attention deficit hyperactivity disorder
675258|NCT00730249|adult|adult
675259|NCT00730249|methylphenidate hydrochloride|methylphenidate hydrochloride
675260|NCT00730249|Medikinet retard|medikinet retard
675261|NCT00730249|controlled clinical trial|controlled clinical trial
675262|NCT00730249|safety|safety
675263|NCT00730249|randomized, double-blind, placebo-controlled trial|randomized, double-blind, placebo-controlled trial
675264|NCT00730249|treatment|treatment
675265|NCT00730249|central nervous system stimulants|central nervous system stimulants
675266|NCT00730249|therapeutic uses|therapeutic uses
675267|NCT00730223|Nevirapine|nevirapine
675268|NCT00730223|Efavirenz|efavirenz
675269|NCT00730223|pharmacokinetics|pharmacokinetics
675270|NCT00730223|healthy|healthy
675271|NCT00730223|CYP2B6|cyp2b6
675272|NCT00730223|HIV/AIDS|hiv/aids
675273|NCT00730210|Hypoparathyroidism|hypoparathyroidism
675274|NCT00730210|HypoPTH|hypopth
675275|NCT00730210|PTH|pth
675276|NCT00730184|acid-base|acid-base
675277|NCT00730184|potassium|potassium
675278|NCT00730184|acidosis|acidosis
675279|NCT00730184|osteoporosis|osteoporosis
675280|NCT00730184|sarcopenia|sarcopenia
675281|NCT00730184|calcium absorption|calcium absorption
675282|NCT00730184|dietary protein|dietary protein
675283|NCT00730145|pharmacokinetics, PD-0332334, hemodialysis, renal dialysis|pharmacokinetics, pd-0332334, hemodialysis, renal dialysis
675284|NCT00730119|Non-invasive Blood Pressure (NIBP)|non-invasive blood pressure (nibp)
675285|NCT00730119|GE Monitor|ge monitor
675286|NCT00730119|Temperature|temperature
675287|NCT00730119|SpO2|spo2
675288|NCT00730119|Respiration, ECG|respiration, ecg
675289|NCT00730106|Gastroesophageal reflux disease|gastroesophageal reflux disease
675290|NCT00730106|Alarm symptoms|alarm symptoms
675291|NCT00730106|Gastrointestinal endoscopy|gastrointestinal endoscopy
675292|NCT00730093|Vitamin B12 absorption|vitamin b12 absorption
675293|NCT00730093|Pregnancy|pregnancy
675294|NCT00730080|phenylketonuria|phenylketonuria
675295|NCT00730080|sapropterin|sapropterin
675296|NCT00730080|Kuvan|kuvan
675297|NCT00730080|cognition|cognition
675298|NCT00730080|executive abilities|executive abilities
675299|NCT00730080|brain|brain
675300|NCT00730067|COPD|copd
675301|NCT00730067|Pulmonary hypertension|pulmonary hypertension
675302|NCT00730067|Sildenafil|sildenafil
675303|NCT00730067|NT-pro BNP|nt-pro bnp
675304|NCT00730067|apelin|apelin
675305|NCT00730054|Remifentanil|remifentanil
675306|NCT00730054|clonidine|clonidine
675307|NCT00730054|acute pain|acute pain
675308|NCT00730054|respiration|respiration
675309|NCT00730054|sedation|sedation
675310|NCT00730054|cognitive function|cognitive function
675311|NCT00730041|obstructive sleep apnea|obstructive sleep apnea
675312|NCT00730041|continuous positive air pressure|continuous positive air pressure
675313|NCT00730028|Methicillin-resistant Staphylococcus aureus (MRSA), cellulitis, abscess, children, elderly|methicillin-resistant staphylococcus aureus (mrsa), cellulitis, abscess, children, elderly
675314|NCT00730002|Lupus|lupus
675315|NCT00729989|Meconium Aspiration|meconium aspiration
675316|NCT00729989|Respiratory Distress|respiratory distress
675317|NCT00729989|Meconium Stained Amniotic Fluid|meconium stained amniotic fluid
675318|NCT00729976|Ibuprofen|ibuprofen
675319|NCT00729976|Suppository|suppository
675320|NCT00729976|febrile children|febrile children
675321|NCT00729937|Methicillin, Staphylococcus aureus, MRSA|methicillin, staphylococcus aureus, mrsa
675322|NCT00729924|Raltegravir|raltegravir
675323|NCT00729924|CSF|csf
675324|NCT00729924|ABCB1 SNP|abcb1 snp
675325|NCT00729924|HIV/AIDS|hiv/aids
675326|NCT00729911|Atrial fibrillation Ablation|atrial fibrillation ablation
675327|NCT00729885|Vertigo|vertigo
675328|NCT00729885|Benign Paroxysmal Positional Vertigo|benign paroxysmal positional vertigo
675329|NCT00729885|BPPV|bppv
675330|NCT00729885|Positional Vertigo|positional vertigo
675331|NCT00729872|AG011|ag011
675332|NCT00729872|Ulcerative Colitis|ulcerative colitis
675333|NCT00729872|human Interleukin-10|human interleukin-10
675334|NCT00729859|HDL|hdl
675335|NCT00729859|Insulin sensitivity|insulin sensitivity
675336|NCT00729859|testosterone|testosterone
675337|NCT00729859|estradiol|estradiol
675338|NCT00729859|cholesterol|cholesterol
675339|NCT00729846|choroidal neovascularization|choroidal neovascularization
675340|NCT00729846|macular degeneration|macular degeneration
675341|NCT00729846|macular edema|macular edema
675342|NCT00729846|intravitreal bevacizumab|intravitreal bevacizumab
857018|NCT00069082|EC|ec
675343|NCT00729846|vegf|vegf
675344|NCT00729846|verteporfin PDT|verteporfin pdt
675345|NCT00729820|PERSONALITY|personality
675346|NCT00729820|COGNITIVE PERFORMANCE|cognitive performance
675347|NCT00729820|the practical usefulness (validity) of processing speed, accuracy of performance and personality measures in predicting impulsive behavior|the practical usefulness (validity) of processing speed, accuracy of performance and personality measures in predicting impulsive behavior
675348|NCT00729807|recurrent melanoma|recurrent melanoma
675349|NCT00729794|Vasopressin|vasopressin
675350|NCT00729794|Epinephrine|epinephrine
675351|NCT00729794|Adrenal Cortex Hormones|adrenal cortex hormones
675352|NCT00729794|Heart Arrest|heart arrest
675353|NCT00729781|nasal obstruction|nasal obstruction
675354|NCT00729781|airway resistance|airway resistance
675355|NCT00729781|soft tissue collapse|soft tissue collapse
675356|NCT00729781|cosmetic contour deformity|cosmetic contour deformity
675357|NCT00729768|Renal transplant|renal transplant
675358|NCT00729768|Raptiva|raptiva
675359|NCT00729755|Creatine|creatine
675360|NCT00729755|Augmentation|augmentation
675361|NCT00729755|Major Depressive Disorder|major depressive disorder
675362|NCT00729755|Efficacy|efficacy
675363|NCT00729755|Brain Energy Metabolism|brain energy metabolism
675364|NCT00729729|Comparative|comparative
675365|NCT00729729|bioavailability|bioavailability
675366|NCT00729729|of PCA|of pca
675367|NCT00729729|formulations|formulations
675368|NCT00729716|Microfracture|microfracture
675369|NCT00729716|Cartilage repair|cartilage repair
675370|NCT00729716|Autologous chondrocyte implantation|autologous chondrocyte implantation
675371|NCT00729703|ICD|icd
675372|NCT00729703|Minimized|minimized
675373|NCT00729703|ventricular|ventricular
675374|NCT00729703|pacing|pacing
675375|NCT00729703|indication|indication
675376|NCT00729703|Clinical outcome|clinical outcome
675377|NCT00729703|Inappropriate shock|inappropriate shock
675378|NCT00729690|Pregabalin|pregabalin
675379|NCT00729690|CSF|csf
675380|NCT00729690|Neurotransmitter|neurotransmitter
675381|NCT00729677|nausea and vomiting|nausea and vomiting
675382|NCT00729677|colon cancer|colon cancer
675383|NCT00729677|rectal cancer|rectal cancer
675384|NCT00729638|relapsed multiple myeloma|relapsed multiple myeloma
675385|NCT00729638|refractory multiple myeloma|refractory multiple myeloma
675386|NCT00729638|RAD001|rad001
675387|NCT00729638|lenalidomide|lenalidomide
675388|NCT00729625|stroke, rehabilitation, robotics|stroke, rehabilitation, robotics
675389|NCT00729612|stage IIIB non-small cell lung cancer|stage iiib non-small cell lung cancer
675390|NCT00729612|stage IV non-small cell lung cancer|stage iv non-small cell lung cancer
675391|NCT00729612|recurrent non-small cell lung cancer|recurrent non-small cell lung cancer
675392|NCT00729612|squamous cell lung cancer|squamous cell lung cancer
675393|NCT00729573|Microbicide|microbicide
675394|NCT00729573|HIV Seronegativity|hiv seronegativity
675395|NCT00729573|Bone Mineral Density|bone mineral density
675396|NCT00729560|PCOS|pcos
675397|NCT00729547|Depression|depression
675398|NCT00729547|Biofeedback|biofeedback
675399|NCT00729547|Psychophysiology|psychophysiology
675400|NCT00729534|Perception|perception
675401|NCT00729534|Focus Group|focus group
675402|NCT00729534|Perception of Clinical Research Participation|perception of clinical research participation
675403|NCT00729521|Fall injury hospitalization|fall injury hospitalization
675404|NCT00729521|Fall injury emergency department visit|fall injury emergency department visit
675405|NCT00729521|Fall injury death|fall injury death
675406|NCT00729508|Cat allergy|cat allergy
675407|NCT00729508|Immunotherapy|immunotherapy
675408|NCT00729508|Cat-PAD|cat-pad
675409|NCT00729508|Environmental Exposure Chamber|environmental exposure chamber
675410|NCT00729495|Phase I,|phase i,
675411|NCT00729495|Healthy|healthy
675412|NCT00729495|Volunteer|volunteer
675413|NCT00729495|Study|study
675414|NCT00729482|RAD001 (everolimus)|rad001 (everolimus)
675415|NCT00729482|second-line treatment|second-line treatment
675416|NCT00729482|advanced gastric cancer|advanced gastric cancer
675417|NCT00729469|Vulvar and vaginal atrophy in postmenopausal women|vulvar and vaginal atrophy in postmenopausal women
675418|NCT00729469|Menopausal symptoms|menopausal symptoms
675419|NCT00729469|Vaginal atrophy|vaginal atrophy
675420|NCT00729469|Urogenital atrophy|urogenital atrophy
675421|NCT00729456|Diabetes|diabetes
675422|NCT00729456|Education|education
675424|NCT00729456|Foot|foot
675425|NCT00729456|Behaviour|behaviour
675426|NCT00729443|Single dose|single dose
675427|NCT00729443|Phase 1|phase 1
675428|NCT00729443|Safety of AZD3241|safety of azd3241
675429|NCT00729443|tolerability of AZD3241|tolerability of azd3241
675430|NCT00729430|Heart Attack|heart attack
675431|NCT00729430|Sudden Cardiac Death|sudden cardiac death
675432|NCT00729430|Peri-infarct Zone|peri-infarct zone
675433|NCT00729430|Omega-3 Fatty Acids|omega-3 fatty acids
675434|NCT00729430|Biological Markers|biological markers
675435|NCT00729430|Cytogenetic Analysis|cytogenetic analysis
675436|NCT00729430|Cardiac Arrest|cardiac arrest
675437|NCT00729417|incontinence|incontinence
675438|NCT00729417|obstetric risk factors|obstetric risk factors
675439|NCT00729417|women|women
675442|NCT00729404|Female Contraception|female contraception
675443|NCT00729404|Ovulation Inhibition|ovulation inhibition
675444|NCT00729391|HIV|hiv
675445|NCT00729391|Sexual Risk|sexual risk
675446|NCT00729391|Substance Abuse|substance abuse
675447|NCT00729391|Victimization|victimization
675448|NCT00729391|Violence|violence
675449|NCT00729391|Voluntary Counseling and Testing (VCT)|voluntary counseling and testing (vct)
675450|NCT00729365|Urine albumin excretion rates|urine albumin excretion rates
675451|NCT00729365|Nighttime and daytime blood pressure|nighttime and daytime blood pressure
675452|NCT00729365|Endothelial Dysfunction|endothelial dysfunction
675453|NCT00729352|NQO1, ozone, airway mucociliary clearance.|nqo1, ozone, airway mucociliary clearance.
675454|NCT00729339|Gastroesophageal reflux disease|gastroesophageal reflux disease
675455|NCT00729339|Mosapride|mosapride
675456|NCT00729339|Lansoprazole|lansoprazole
675457|NCT00729326|diabetes|diabetes
675458|NCT00729326|exenatide|exenatide
675459|NCT00729326|sitagliptin|sitagliptin
675460|NCT00729326|Amylin|amylin
675461|NCT00729326|Lilly|lilly
675462|NCT00729326|metformin|metformin
675463|NCT00729326|thiazolidinedione|thiazolidinedione
675464|NCT00729313|Treatment|treatment
675465|NCT00729300|cocaine|cocaine
675466|NCT00729300|disulfiram|disulfiram
675467|NCT00729300|antabuse|antabuse
675468|NCT00729300|addiction|addiction
675469|NCT00729300|stimulant|stimulant
675470|NCT00729287|stage 0 bladder cancer|stage 0 bladder cancer
675471|NCT00729287|stage I bladder cancer|stage i bladder cancer
675472|NCT00729287|transitional cell carcinoma of the bladder|transitional cell carcinoma of the bladder
675473|NCT00729261|mechanical ventilation|mechanical ventilation
675474|NCT00729261|extubation|extubation
675475|NCT00729261|outcomes|outcomes
675476|NCT00729261|brain injury|brain injury
675477|NCT00729248|Transplants|transplants
675478|NCT00729248|Kidney Transplantation|kidney transplantation
675479|NCT00729248|Immunosuppression|immunosuppression
675480|NCT00729248|Assay|assay
675481|NCT00729248|Graft Rejection|graft rejection
675482|NCT00729235|Slow VT, CRT-D, ATP therapy|slow vt, crt-d, atp therapy
675483|NCT00729235|Incidence|incidence
675484|NCT00729235|of slow VTs|of slow vts
675485|NCT00729235|in CRT-D patients|in crt-d patients
675486|NCT00729235|Clinical|clinical
675487|NCT00729235|relevance|relevance
675488|NCT00729235|treatment|treatment
675489|NCT00729235|VTs|vts
675490|NCT00729235|during|during
675491|NCT00729235|2-years|2-years
675492|NCT00729235|follow-up|follow-up
675493|NCT00729196|Obesity|obesity
675494|NCT00729196|Type 2 Diabetes|type 2 diabetes
675495|NCT00729196|Glycemic Load|glycemic load
675496|NCT00729196|Weight Loss|weight loss
675497|NCT00729196|Glycated Hemoglobin|glycated hemoglobin
675498|NCT00729170|Milk|milk
675499|NCT00729170|Calcium|calcium
675500|NCT00729170|Weight loss|weight loss
675501|NCT00729170|Bone density|bone density
675502|NCT00729170|Appetite|appetite
675503|NCT00729144|fecal incontinence|fecal incontinence
675504|NCT00729144|bowel incontinence|bowel incontinence
675505|NCT00729144|pelvic floor disorder|pelvic floor disorder
675506|NCT00729131|Ozone, TNF, TNF promoter polymorphism, airway hyperresponsiveness.|ozone, tnf, tnf promoter polymorphism, airway hyperresponsiveness.
675507|NCT00729118|stage I multiple myeloma|stage i multiple myeloma
675508|NCT00729118|stage II multiple myeloma|stage ii multiple myeloma
675509|NCT00729118|stage III multiple myeloma|stage iii multiple myeloma
675510|NCT00729118|refractory multiple myeloma|refractory multiple myeloma
675511|NCT00729092|PET SCAN|pet scan
675512|NCT00729092|PAIN LEVELS|pain levels
675513|NCT00729079|Diabetes Prevention|diabetes prevention
675514|NCT00729079|Pre-Diabetes|pre-diabetes
675515|NCT00729079|Exercise|exercise
675516|NCT00729079|Fat Intake|fat intake
675517|NCT00729079|Fasting blood sugar|fasting blood sugar
675518|NCT00729079|tobacco cessation|tobacco cessation
675519|NCT00729053|renal|renal
675520|NCT00729053|cell|cell
675521|NCT00729053|renal carcinoma|renal carcinoma
675522|NCT00729053|metastatic|metastatic
675523|NCT00729053|recurrent|recurrent
675524|NCT00729053|treatment naive|treatment naive
675525|NCT00729040|heart|heart
675526|NCT00729040|weight|weight
675527|NCT00729040|Overweight|overweight
675528|NCT00729040|bmi|bmi
675529|NCT00729040|diabetes|diabetes
675530|NCT00729040|type 2|type 2
675531|NCT00729040|diabetic|diabetic
675532|NCT00729040|walk|walk
675533|NCT00729040|walk*|walk*
675534|NCT00729040|diab*|diab*
675535|NCT00729040|obese|obese
675536|NCT00729040|exercise|exercise
675537|NCT00729040|activity|activity
675538|NCT00729040|coronary|coronary
675539|NCT00729040|pedometer|pedometer
675540|NCT00729027|hypercholesterolemia|hypercholesterolemia
675541|NCT00729014|herbal nephropathy|herbal nephropathy
675542|NCT00729014|Chinese herbal nephropathy|chinese herbal nephropathy
675543|NCT00729014|nephrotoxicity|nephrotoxicity
675544|NCT00729014|renal disease|renal disease
675545|NCT00729014|adverse drug reaction|adverse drug reaction
675546|NCT00729014|Chinese herbal medicine|chinese herbal medicine
677037|NCT00723502|Dyspepsia|dyspepsia
675547|NCT00729001|Rotavirus Gastroenteritis|rotavirus gastroenteritis
675548|NCT00729001|Human rotavirus vaccine|human rotavirus vaccine
675549|NCT00728988|Asia Lipitor Pre-treatment in Acute Coronary Syndrome|asia lipitor pre-treatment in acute coronary syndrome
675550|NCT00728975|constipation|constipation
675551|NCT00728975|cancer|cancer
675552|NCT00728975|palliative care|palliative care
675553|NCT00728975|terminal|terminal
675554|NCT00728975|bowel|bowel
675555|NCT00728962|dental implants|dental implants
675556|NCT00728962|Osseotite Certain Prevail|osseotite certain prevail
675557|NCT00728962|multicenter|multicenter
675558|NCT00728962|observational|observational
675559|NCT00728962|clinical study|clinical study
675560|NCT00728962|partial edentulism|partial edentulism
675561|NCT00728962|single stage|single stage
675562|NCT00728962|immediate occlusal loading|immediate occlusal loading
675563|NCT00728962|crestal bone level|crestal bone level
675564|NCT00728962|short fixed bridge|short fixed bridge
675565|NCT00728949|breast cancer|breast cancer
675566|NCT00728949|Postmenopausal|postmenopausal
675567|NCT00728949|Hormones|hormones
675568|NCT00728949|Antiestrogen|antiestrogen
675569|NCT00728936|Hepatitis C|hepatitis c
675570|NCT00728936|unresponsive to pegylated interferon and ribavirin therapy|unresponsive to pegylated interferon and ribavirin therapy
675571|NCT00728936|hepatitis C virus|hepatitis c virus
675573|NCT00728910|Low HDL cholesterol|low hdl cholesterol
675574|NCT00728910|High triglycerides|high triglycerides
675575|NCT00728910|niacin|niacin
675576|NCT00728910|fibrate|fibrate
675577|NCT00728897|Healthy volunteer|healthy volunteer
675578|NCT00728897|relative bioavailability.|relative bioavailability.
675579|NCT00728884|dental implants|dental implants
675580|NCT00728884|Certain Prevail|certain prevail
675581|NCT00728884|multicenter|multicenter
675582|NCT00728884|clinical study|clinical study
675583|NCT00728884|partial edentulism|partial edentulism
675584|NCT00728884|total edentulism|total edentulism
675585|NCT00728884|platform switching|platform switching
675586|NCT00728884|single stage|single stage
675587|NCT00728884|early loading|early loading
675588|NCT00728884|crestal bone level|crestal bone level
675589|NCT00728884|single tooth replacements|single tooth replacements
675590|NCT00728884|short or long fixed bridges|short or long fixed bridges
675591|NCT00728884|overdenture|overdenture
675592|NCT00728884|fixed denture|fixed denture
675593|NCT00728871|cervical cancer, HPV, immunity|cervical cancer, hpv, immunity
675594|NCT00728858|Hypertension|hypertension
675595|NCT00728858|SNP|snp
675596|NCT00728858|Nifedipine|nifedipine
675597|NCT00728858|Barnidipine|barnidipine
675598|NCT00728845|adenocarcinoma of the lung|adenocarcinoma of the lung
675599|NCT00728845|large cell lung cancer|large cell lung cancer
675600|NCT00728845|recurrent non-small cell lung cancer|recurrent non-small cell lung cancer
675601|NCT00728845|stage IIIB non-small cell lung cancer|stage iiib non-small cell lung cancer
675602|NCT00728845|stage IV non-small cell lung cancer|stage iv non-small cell lung cancer
675603|NCT00728832|extended release epidural morphine|extended release epidural morphine
675604|NCT00728832|morphine|morphine
675605|NCT00728832|thoracic epidural|thoracic epidural
675606|NCT00728832|pharmacokinetics|pharmacokinetics
675607|NCT00728832|pharmacodynamics|pharmacodynamics
675608|NCT00728832|postoperative pain|postoperative pain
675609|NCT00728832|upper abdominal surgery|upper abdominal surgery
675610|NCT00728819|Inpatients|inpatients
675611|NCT00728819|Requiring|requiring
675612|NCT00728819|DL PICC|dl picc
675613|NCT00728819|Access|access
675614|NCT00728819|Medications|medications
675615|NCT00728819|Blood|blood
675616|NCT00728806|Continuous Ambulatory Peritoneal Dialysis|continuous ambulatory peritoneal dialysis
675617|NCT00728806|Ultrafiltration failure|ultrafiltration failure
675618|NCT00728806|Biomarker|biomarker
675619|NCT00728806|Proteomics|proteomics
675620|NCT00728793|Advanced Solid Tumors|advanced solid tumors
675621|NCT00728793|EGFR|egfr
675622|NCT00728793|HDAC|hdac
675623|NCT00728793|Her2|her2
675624|NCT00728793|Open-Label|open-label
675625|NCT00728793|Dose-Escalation|dose-escalation
675626|NCT00728780|Adverse events|adverse events
675627|NCT00728780|Pharmacokinetic variables|pharmacokinetic variables
675628|NCT00728767|Heavy drinking|heavy drinking
675629|NCT00728767|Brief intervention|brief intervention
675630|NCT00728767|Alcohol prevention|alcohol prevention
675631|NCT00728767|Randomized trial|randomized trial
675632|NCT00728767|Motivational interviewing|motivational interviewing
675633|NCT00728767|Intervention Studies|intervention studies
675634|NCT00728767|prevention & control|prevention & control
675635|NCT00728754|dental implants|dental implants
675636|NCT00728754|Osseotite Certain Prevail|osseotite certain prevail
675637|NCT00728754|Lateralized|lateralized
675638|NCT00728754|non-lateralized|non-lateralized
675639|NCT00728754|Osseotite Certain|osseotite certain
675640|NCT00728754|multicenter|multicenter
675641|NCT00728754|randomized|randomized
675642|NCT00728754|clinical study|clinical study
675643|NCT00728754|partial edentulism|partial edentulism
675644|NCT00728754|single stage|single stage
675645|NCT00728754|early loading|early loading
675646|NCT00728754|crestal bone level|crestal bone level
675647|NCT00728754|short fixed bridge|short fixed bridge
675648|NCT00728741|Neural Networks|neural networks
675649|NCT00728741|Cortical Activation|cortical activation
675650|NCT00728741|Strategy|strategy
675651|NCT00728741|fMRI|fmri
675652|NCT00728741|Healthy Volunteer|healthy volunteer
675653|NCT00728741|HV|hv
675654|NCT00728728|pregnenolone|pregnenolone
675655|NCT00728728|schizophrenia|schizophrenia
675656|NCT00728728|cognitive|cognitive
675657|NCT00728728|positive symptom|positive symptom
675658|NCT00728728|negative symptom|negative symptom
675659|NCT00728728|placebo control|placebo control
675660|NCT00728715|Budesonide|budesonide
675661|NCT00728715|Formoterol|formoterol
675662|NCT00728715|Non cystic fibrosis bronchiectasis|non cystic fibrosis bronchiectasis
675663|NCT00728689|Orthopoxviral|orthopoxviral
675664|NCT00728689|Smallpox|smallpox
675665|NCT00728689|Monkey pox|monkey pox
675666|NCT00728676|PKU,|pku,
675667|NCT00728676|Phe,|phe,
675668|NCT00728676|PAH,|pah,
675669|NCT00728676|Kuvan,|kuvan,
675670|NCT00728676|Trp,|trp,
675671|NCT00728676|Tyr|tyr
675672|NCT00728663|adenocarcinoma of the prostate|adenocarcinoma of the prostate
675673|NCT00728663|recurrent prostate cancer|recurrent prostate cancer
675674|NCT00728663|stage IV prostate cancer|stage iv prostate cancer
675675|NCT00728650|hepatocellular carcinoma|hepatocellular carcinoma
675676|NCT00728650|colorectal carcinoma metastatic to liver|colorectal carcinoma metastatic to liver
675677|NCT00728650|primary liver cancer|primary liver cancer
675678|NCT00728637|Prevention|prevention
675679|NCT00728624|Antibiotic susceptibility; beta lactamase; ESBLs|antibiotic susceptibility; beta lactamase; esbls
675680|NCT00728598|Proliferative diabetic retinopathy|proliferative diabetic retinopathy
675681|NCT00728598|Angiogenesis|angiogenesis
675682|NCT00728598|Vitreous levels|vitreous levels
675683|NCT00728598|Vascular endothelial growth factor|vascular endothelial growth factor
675684|NCT00728598|Fractalkine|fractalkine
675685|NCT00728598|Growth factor|growth factor
675686|NCT00728559|laparoscopy|laparoscopy
675687|NCT00728559|preemptive|preemptive
675688|NCT00728559|postoperative|postoperative
675689|NCT00728559|pain|pain
675690|NCT00728559|trocar|trocar
675691|NCT00728559|site|site
675692|NCT00728546|tuberculosis|tuberculosis
675693|NCT00728546|isoniazid|isoniazid
675694|NCT00728546|Arylamine N-acetyl transferase|arylamine n-acetyl transferase
675695|NCT00728546|genotyping|genotyping
675696|NCT00728546|hepatotoxicity|hepatotoxicity
675697|NCT00728546|pharmacogenetics|pharmacogenetics
675698|NCT00728533|Prostate Cancer requiring Androgen Ablation Therapy|prostate cancer requiring androgen ablation therapy
675699|NCT00728520|Leukemia|leukemia
675700|NCT00728520|Azacitidine|azacitidine
675701|NCT00728520|Untreated|untreated
675702|NCT00728520|Elderly|elderly
675703|NCT00728507|Tuberculosis|tuberculosis
675704|NCT00728507|Moxifloxacin|moxifloxacin
675705|NCT00728507|Rifapentine|rifapentine
675706|NCT00728468|Phase 1|phase 1
675707|NCT00728468|PF-00299804|pf-00299804
675708|NCT00728468|Dextromethorphan|dextromethorphan
675709|NCT00728468|CYP2D6 Inhibition|cyp2d6 inhibition
675710|NCT00728468|Cancer Patients|cancer patients
675711|NCT00728442|Clinical practice guidelines|clinical practice guidelines
675712|NCT00728442|Guideline adherence|guideline adherence
675713|NCT00728442|Clinical decision support systems|clinical decision support systems
675714|NCT00728442|Randomized controlled trial|randomized controlled trial
675715|NCT00728442|Intervention study|intervention study
675716|NCT00728429|cardiac toxicity|cardiac toxicity
675717|NCT00728429|chemotherapeutic agent toxicity|chemotherapeutic agent toxicity
675718|NCT00728429|unspecified adult solid tumor, protocol specific|unspecified adult solid tumor, protocol specific
675719|NCT00728390|advanced cancer refractory advanced non-small cell lung cancer|advanced cancer refractory advanced non-small cell lung cancer
675720|NCT00728377|gestational diabetes|gestational diabetes
675721|NCT00728377|physical activity|physical activity
675722|NCT00728377|behavior change|behavior change
675723|NCT00728377|glucose tolerance|glucose tolerance
675724|NCT00728377|pregnancy|pregnancy
675725|NCT00728364|Anderson Fabry disease|anderson fabry disease
675726|NCT00728364|chronic kidney disease|chronic kidney disease
675727|NCT00728364|prevalence|prevalence
675728|NCT00728351|Type 2 diabetes, vildagliptin|type 2 diabetes, vildagliptin
675729|NCT00728338|docosahexenoic acid (DHA)|docosahexenoic acid (dha)
675730|NCT00728338|dietary supplement|dietary supplement
675731|NCT00728338|n-3 polyunsaturated fatty acid|n-3 polyunsaturated fatty acid
675732|NCT00728338|cardiovascular disease|cardiovascular disease
675733|NCT00728325|PTSD|ptsd
675734|NCT00728325|Vocational Rehabilitation|vocational rehabilitation
675735|NCT00728325|Supported Employment|supported employment
675736|NCT00728312|Methamphetamine|methamphetamine
675737|NCT00728312|Therapeutics|therapeutics
675738|NCT00728312|Psychopharmacology|psychopharmacology
675739|NCT00728312|Amphetamine|amphetamine
710419|NCT00589394|normal response|normal response
675740|NCT00728299|Coronary artery disease, carotid intima-media thickness|coronary artery disease, carotid intima-media thickness
675741|NCT00728286|Type 2 Diabetes Mellitus|type 2 diabetes mellitus
677236|NCT00722644|HIV|hiv
675742|NCT00728286|Acute Coronary Syndrome|acute coronary syndrome
675743|NCT00728286|Platelet dependent thrombogenicity|platelet dependent thrombogenicity
675744|NCT00728273|Efficacy|efficacy
675745|NCT00728273|Vietnam|vietnam
675746|NCT00728273|school children|school children
675747|NCT00728273|anemia|anemia
675748|NCT00728273|fortification|fortification
675749|NCT00728273|micronutrient|micronutrient
675750|NCT00728260|Meningitis|meningitis
675751|NCT00728260|Meningococcal disease|meningococcal disease
675752|NCT00728260|Menactra vaccine|menactra vaccine
675753|NCT00728247|Cervical Spine|cervical spine
675754|NCT00728247|Kinematics|kinematics
675755|NCT00728247|Manipulation|manipulation
675756|NCT00728247|Biomechanics|biomechanics
675757|NCT00728234|aEEG|aeeg
675758|NCT00728234|preterm infants|preterm infants
675759|NCT00728234|predictive value|predictive value
675760|NCT00728234|outcome|outcome
675761|NCT00728221|Ginseng|ginseng
675762|NCT00728221|Korean Red Ginseng|korean red ginseng
675763|NCT00728221|Ginsenoside|ginsenoside
675764|NCT00728221|Flow Mediated Dilation|flow mediated dilation
675765|NCT00728221|Endothelial Function|endothelial function
675766|NCT00728221|Hypertension|hypertension
675767|NCT00728208|Young|young
675768|NCT00728208|Elderly|elderly
675769|NCT00728208|Randomised|randomised
675770|NCT00728208|GSK372475|gsk372475
675771|NCT00728195|Schizophrenia|schizophrenia
675772|NCT00728195|Central Nervous System|central nervous system
675773|NCT00728195|JNJ-37822681|jnj-37822681
675774|NCT00728182|Stroke|stroke
675775|NCT00728182|Vascular cognitive impairment|vascular cognitive impairment
675776|NCT00728182|Coiling|coiling
675777|NCT00728182|Endovascular repair|endovascular repair
675778|NCT00728182|Brain aneurysm|brain aneurysm
675779|NCT00728182|NA-1|na-1
675780|NCT00728169|Asthma|asthma
675781|NCT00728169|Focus Group|focus group
675782|NCT00728169|Community Based Participatory Research|community based participatory research
675783|NCT00728156|Type 2 Diabetes mellitus|type 2 diabetes mellitus
675784|NCT00728156|Coronary artery disease|coronary artery disease
675785|NCT00728156|Platelet dependent thrombogenicity|platelet dependent thrombogenicity
675786|NCT00728156|Aspirin|aspirin
675787|NCT00728156|Clopidogrel|clopidogrel
675788|NCT00728156|Badimon Chamber|badimon chamber
675789|NCT00728130|carcinoma|carcinoma
675790|NCT00728130|upper|upper
675791|NCT00728130|aerodigestive|aerodigestive
675792|NCT00728130|tract|tract
675793|NCT00728130|submandibular|submandibular
675794|NCT00728130|gland|gland
675795|NCT00728117|indomethacin|indomethacin
675796|NCT00728117|ibuprofen|ibuprofen
675797|NCT00728117|preterm infant|preterm infant
675798|NCT00728104|Learn|learn
675799|NCT00728104|L-Carnitine|l-carnitine
675800|NCT00728104|Co-enzyme Q10|co-enzyme q10
675801|NCT00728104|Effective|effective
675802|NCT00728104|These supplements|these supplements
675803|NCT00728104|Compared|compared
675804|NCT00728104|Standard|standard
675805|NCT00728091|aquaretic|aquaretic
675806|NCT00728091|SIADH|siadh
675807|NCT00728078|hepatocellular carcinoma|hepatocellular carcinoma
675808|NCT00728078|liver cancer|liver cancer
675809|NCT00728078|radiofrequency ablation|radiofrequency ablation
675810|NCT00728078|thalidomide|thalidomide
675811|NCT00728052|Tolerability|tolerability
675812|NCT00728052|dose escalation|dose escalation
675813|NCT00728052|GSK598809|gsk598809
675814|NCT00728052|Pharmacodynamics|pharmacodynamics
675815|NCT00728052|Safety|safety
675816|NCT00728052|single|single
675817|NCT00728052|placebo|placebo
675818|NCT00728052|Smokers|smokers
675819|NCT00728052|Pharmacokinetics|pharmacokinetics
675820|NCT00728039|Youth|youth
675821|NCT00728039|Consensus|consensus
675822|NCT00728039|Criteria|criteria
675823|NCT00728039|CVS|cvs
675824|NCT00728026|Chart must reveal the following procedures:|chart must reveal the following procedures:
675825|NCT00728026|Heart rate variability,|heart rate variability,
675826|NCT00728026|Deep Breathing Test,|deep breathing test,
675827|NCT00728026|Valsalva maneuver,|valsalva maneuver,
675828|NCT00728026|Table test,|table test,
675829|NCT00728026|Thermoregulatory Sweat Testing,|thermoregulatory sweat testing,
675830|NCT00728026|Quantitative Sudomotor Axon Reflex Test (QSART),|quantitative sudomotor axon reflex test (qsart),
675831|NCT00728026|Vital signs,|vital signs,
675832|NCT00728026|postural changes in heart rate and blood pressure,|postural changes in heart rate and blood pressure,
675833|NCT00728026|composite autonomic score|composite autonomic score
675834|NCT00728013|Acute coronary syndrome|acute coronary syndrome
675835|NCT00728013|intensive lipid-lowering|intensive lipid-lowering
675836|NCT00728013|statins|statins
675837|NCT00728000|Pancreatic Cancer|pancreatic cancer
675838|NCT00727987|Rheumatoid arthritis|rheumatoid arthritis
675839|NCT00727987|Fully Human anti-TNFa monoclonal antibody|fully human anti-tnfa monoclonal antibody
675840|NCT00727987|CNTO148|cnto148
675841|NCT00727987|Golimumab|golimumab
675842|NCT00727974|Genome Wide Scan (GWS)|genome wide scan (gws)
675843|NCT00727974|Mitochondrial scan|mitochondrial scan
675844|NCT00727974|Family trios|family trios
675845|NCT00727948|Breast cancer|breast cancer
675846|NCT00727948|Angiogenesis|angiogenesis
675848|NCT00727948|Tamoxifen|tamoxifen
675849|NCT00727935|Women|women
675850|NCT00727935|parturients|parturients
675851|NCT00727935|with|with
675852|NCT00727935|realization|realization
675853|NCT00727935|episiotomy|episiotomy
675854|NCT00727922|Neuropathy|neuropathy
675855|NCT00727922|Oxaliplatin|oxaliplatin
675856|NCT00727922|Mangafodipir|mangafodipir
675857|NCT00727909|Hearing loss|hearing loss
675858|NCT00727909|Hearing Aids|hearing aids
675859|NCT00727909|Speech Perception|speech perception
675860|NCT00727909|Persons with Hearing Impairment|persons with hearing impairment
675861|NCT00727896|Life style modification,|life style modification,
675862|NCT00727896|Type 2 diabetes,|type 2 diabetes,
675863|NCT00727896|SMS,|sms,
675864|NCT00727896|Patient adherence|patient adherence
675865|NCT00727883|Breast Cancer|breast cancer
675866|NCT00727883|Adjuvant TAM|adjuvant tam
675867|NCT00727883|post-menopausal|post-menopausal
675868|NCT00727883|women|women
675869|NCT00727870|Shave Biopsy management|shave biopsy management
675870|NCT00727870|"Biopsy/adverse effects[Mesh]"|"biopsy/adverse effects[mesh]"
675871|NCT00727870|"Biopsy/complications[Mesh])"|"biopsy/complications[mesh])"
675872|NCT00727857|Glucose Metabolism Disorder|glucose metabolism disorder
675873|NCT00727857|Dysmetabolic Syndrome|dysmetabolic syndrome
675874|NCT00727857|Type II Diabetes|type ii diabetes
675875|NCT00727857|Diabetes Mellitus, Lipoatrophic|diabetes mellitus, lipoatrophic
675876|NCT00727857|Dyslipidemia|dyslipidemia
675877|NCT00727857|Drug Therapy|drug therapy
675878|NCT00727844|XDR-TB|xdr-tb
675879|NCT00727844|Linezolid|linezolid
675880|NCT00727844|Drug Resistance|drug resistance
675881|NCT00727844|Computed Tomography|computed tomography
675882|NCT00727844|Pharmacokinetics|pharmacokinetics
675883|NCT00727844|Tuberculosis|tuberculosis
675884|NCT00727844|Drug Resistance Tuberculosis|drug resistance tuberculosis
675885|NCT00727844|MDR-TB|mdr-tb
675886|NCT00727831|neurotoxicity|neurotoxicity
675887|NCT00727831|chemotherapeutic agent toxicity|chemotherapeutic agent toxicity
675888|NCT00727831|mucositis|mucositis
675889|NCT00727831|primary central nervous system non-Hodgkin lymphoma|primary central nervous system non-hodgkin lymphoma
675890|NCT00727831|contiguous stage II adult diffuse large cell lymphoma|contiguous stage ii adult diffuse large cell lymphoma
675891|NCT00727831|noncontiguous stage II adult diffuse large cell lymphoma|noncontiguous stage ii adult diffuse large cell lymphoma
675892|NCT00727831|stage I adult diffuse large cell lymphoma|stage i adult diffuse large cell lymphoma
675893|NCT00727831|stage III adult diffuse large cell lymphoma|stage iii adult diffuse large cell lymphoma
675894|NCT00727831|stage IV adult diffuse large cell lymphoma|stage iv adult diffuse large cell lymphoma
675895|NCT00727792|participants|participants
675896|NCT00727792|scheduled|scheduled
675897|NCT00727792|clinically|clinically
675898|NCT00727792|ordered|ordered
675899|NCT00727792|MRI|mri
675900|NCT00727779|diabetes, metabolic syndrome, type 2 diabetes|diabetes, metabolic syndrome, type 2 diabetes
675901|NCT00727766|Clofarabine|clofarabine
675902|NCT00727766|Clolar|clolar
675903|NCT00727766|AML|aml
675904|NCT00727766|Consolidation|consolidation
675905|NCT00727753|Macular Degeneration|macular degeneration
675906|NCT00727753|Age-Related Maculopathies|age-related maculopathies
675907|NCT00727740|Cholangiopancreatography, Endoscopic Retrograde|cholangiopancreatography, endoscopic retrograde
675908|NCT00727740|Pancreatitis|pancreatitis
675909|NCT00727740|Indomethacin|indomethacin
675910|NCT00727727|Piribedil (trade name: Clarium)|piribedil (trade name: clarium)
675911|NCT00727727|non-ergot dopamine agonist|non-ergot dopamine agonist
675912|NCT00727727|Morbus Parkinson|morbus parkinson
675913|NCT00727727|Tolerability|tolerability
675914|NCT00727727|Efficacy|efficacy
675915|NCT00727727|Post Marketing Surveillance|post marketing surveillance
675916|NCT00727714|Cement dust exposure|cement dust exposure
675917|NCT00727714|Cross-shift study|cross-shift study
675918|NCT00727714|Lung function indices|lung function indices
675919|NCT00727714|Exhaled nitric oxide|exhaled nitric oxide
675920|NCT00727714|Serum inflammatory markers|serum inflammatory markers
675921|NCT00727701|varicose ulcer|varicose ulcer
675923|NCT00727701|recurrence|recurrence
675924|NCT00727701|aftercare|aftercare
675925|NCT00727675|chronic pain|chronic pain
675926|NCT00727675|opioid dependence|opioid dependence
675927|NCT00727675|Cognitive Behavioral Therapy (CBT)|cognitive behavioral therapy (cbt)
675928|NCT00727662|Breast Cancer|breast cancer
675929|NCT00727662|Fatigue|fatigue
675930|NCT00727662|Proinflammatory Cytokines|proinflammatory cytokines
675931|NCT00727662|Physical functioning|physical functioning
675932|NCT00727662|Quality of life|quality of life
675933|NCT00727649|fecal incontinence|fecal incontinence
675934|NCT00727649|adults|adults
675935|NCT00727649|diarrhea|diarrhea
675936|NCT00727636|inflammatory bowel disease (IBD)|inflammatory bowel disease (ibd)
675937|NCT00727636|immunogenicity|immunogenicity
675938|NCT00727636|safety|safety
675939|NCT00727636|HPV|hpv
675940|NCT00727636|Gardasil|gardasil
675941|NCT00727636|vaccine|vaccine
675942|NCT00727623|acute coronary syndrome|acute coronary syndrome
675943|NCT00727623|myocardial infarction|myocardial infarction
675944|NCT00727623|predictors of mortality|predictors of mortality
675945|NCT00727623|reperfusion therapy|reperfusion therapy
675946|NCT00727610|Adverse drug event|adverse drug event
675947|NCT00727610|harm|harm
675948|NCT00727610|patient safety|patient safety
675949|NCT00727610|clinical decision support|clinical decision support
675950|NCT00727610|Adverse drug related event|adverse drug related event
675951|NCT00727584|spinal cord compression|spinal cord compression
675952|NCT00727584|unspecified adult solid tumor, protocol specific|unspecified adult solid tumor, protocol specific
675953|NCT00727571|Anemia|anemia
675954|NCT00727571|Chronic Kidney Disease|chronic kidney disease
675955|NCT00727571|Quality of Life|quality of life
675956|NCT00727571|CKD|ckd
675957|NCT00727571|Chronic Renal Insufficiency|chronic renal insufficiency
675958|NCT00727558|refractive error|refractive error
675959|NCT00727532|clear cell renal cell carcinoma|clear cell renal cell carcinoma
675960|NCT00727532|hereditary clear cell renal cell carcinoma|hereditary clear cell renal cell carcinoma
675961|NCT00727532|recurrent renal cell cancer|recurrent renal cell cancer
675962|NCT00727532|stage I renal cell cancer|stage i renal cell cancer
675963|NCT00727532|stage II renal cell cancer|stage ii renal cell cancer
675964|NCT00727532|stage III renal cell cancer|stage iii renal cell cancer
675965|NCT00727532|stage IV renal cell cancer|stage iv renal cell cancer
675966|NCT00727519|Hemodialysis|hemodialysis
675967|NCT00727519|Nephrology|nephrology
675968|NCT00727519|Pomegranate Juice|pomegranate juice
675969|NCT00727519|Israel|israel
675970|NCT00727493|osteoporosis,|osteoporosis,
675971|NCT00727493|bisphosphonate|bisphosphonate
675972|NCT00727493|therapy|therapy
675973|NCT00727493|dental implant|dental implant
675974|NCT00727480|vascularity|vascularity
675975|NCT00727480|fingertips|fingertips
675976|NCT00727467|auditory cueing device|auditory cueing device
675977|NCT00727467|Parkinson's disease|parkinson's disease
675978|NCT00727467|freezing|freezing
675979|NCT00727467|gait|gait
675980|NCT00727467|mobility|mobility
675981|NCT00727454|Obstructive sleep apnea|obstructive sleep apnea
675982|NCT00727454|CPAP|cpap
675983|NCT00727454|Heart remodeling|heart remodeling
675984|NCT00727454|Cardiovascular disease|cardiovascular disease
675985|NCT00727454|MRI|mri
675986|NCT00727441|adenocarcinoma of the pancreas|adenocarcinoma of the pancreas
675987|NCT00727441|stage I pancreatic cancer|stage i pancreatic cancer
675988|NCT00727441|stage II pancreatic cancer|stage ii pancreatic cancer
675989|NCT00727428|FluLaval® TF|flulaval® tf
675990|NCT00727428|Safety|safety
675991|NCT00727428|Immunogenicity|immunogenicity
675992|NCT00727428|Influenza|influenza
675993|NCT00727415|advanced or progressive chronic lymphocytic leukemia|advanced or progressive chronic lymphocytic leukemia
675994|NCT00727415|Lenalidomide|lenalidomide
675995|NCT00727415|Fludarabine|fludarabine
675996|NCT00727389|Prevention|prevention
675997|NCT00727389|Quality of Health Care|quality of health care
675998|NCT00727389|Health Care Evaluation Mechanisms|health care evaluation mechanisms
675999|NCT00727376|esophageal|esophageal
676000|NCT00727376|stenting|stenting
676001|NCT00727363|probiotics|probiotics
676002|NCT00727363|lactobacillus reuteri|lactobacillus reuteri
676003|NCT00727363|preterm infants|preterm infants
676004|NCT00727363|nosocomial infection|nosocomial infection
676005|NCT00727363|necrotizing enterocolitis|necrotizing enterocolitis
676006|NCT00727350|NSCLC|nsclc
676007|NCT00727350|Novalis|novalis
676008|NCT00727350|Stereotactic|stereotactic
676009|NCT00727350|SBRT|sbrt
676010|NCT00727350|T1, T2 or T3NO NSCLC|t1, t2 or t3no nsclc
676011|NCT00727337|auditory perception|auditory perception
676012|NCT00727337|rehabilitation of hearing impaired|rehabilitation of hearing impaired
676013|NCT00727324|Ulcerative Colitis|ulcerative colitis
676014|NCT00727324|UC|uc
676015|NCT00727324|moderate|moderate
676016|NCT00727324|severe|severe
676017|NCT00727324|LPS|lps
676018|NCT00727324|Alkaline Phosphatase|alkaline phosphatase
676019|NCT00727324|AP|ap
676020|NCT00727324|BIAP|biap
676021|NCT00727324|Mucositis|mucositis
676022|NCT00727285|Cystic Fibrosis|cystic fibrosis
676023|NCT00727285|pulmonary exacerbation|pulmonary exacerbation
676024|NCT00727285|gene expression|gene expression
676025|NCT00727285|biomarker|biomarker
676026|NCT00727285|inflammation|inflammation
676027|NCT00727285|CF pulmonary exacerbation|cf pulmonary exacerbation
676028|NCT00727272|Bioavailability|bioavailability
676029|NCT00727246|Traumatic Brain Injury|traumatic brain injury
676030|NCT00727246|FMRI|fmri
676031|NCT00727246|Memory|memory
676032|NCT00727246|Cognition|cognition
676033|NCT00727246|Neuropsychology|neuropsychology
676034|NCT00727233|Neuroblastosis Type I|neuroblastosis type i
676035|NCT00727233|Plexiform Neurofibromas|plexiform neurofibromas
676036|NCT00727233|Angiogenesis Inhibitor|angiogenesis inhibitor
676037|NCT00727233|Kinase Inhibitor|kinase inhibitor
676038|NCT00727233|Neurofibromatosis Type 1|neurofibromatosis type 1
676039|NCT00727233|NF1|nf1
676040|NCT00727233|Plexiform Neurofibroma|plexiform neurofibroma
676041|NCT00727220|type 1 diabetes|type 1 diabetes
676358|NCT00726388|pain, postoperative|pain, postoperative
676042|NCT00727220|continuous glucose sensor monitoring|continuous glucose sensor monitoring
676043|NCT00727207|recurrent mantle cell lymphoma|recurrent mantle cell lymphoma
676044|NCT00727207|contiguous stage II mantle cell lymphoma|contiguous stage ii mantle cell lymphoma
676045|NCT00727207|noncontiguous stage II mantle cell lymphoma|noncontiguous stage ii mantle cell lymphoma
676046|NCT00727207|stage I mantle cell lymphoma|stage i mantle cell lymphoma
676047|NCT00727207|stage III mantle cell lymphoma|stage iii mantle cell lymphoma
676048|NCT00727207|stage IV mantle cell lymphoma|stage iv mantle cell lymphoma
676049|NCT00727181|aortic valve|aortic valve
676050|NCT00727181|heart valve|heart valve
676051|NCT00727181|tissue valve|tissue valve
676052|NCT00727181|bioprosthesis|bioprosthesis
676053|NCT00727181|valve disorder|valve disorder
676054|NCT00727181|valve disease|valve disease
676055|NCT00727181|cardiac surgery|cardiac surgery
676056|NCT00727181|aortic valve stenosis|aortic valve stenosis
676057|NCT00727181|aortic valve regurgitation|aortic valve regurgitation
676058|NCT00727168|prevalence study|prevalence study
676059|NCT00727168|glaucoma|glaucoma
676061|NCT00727142|Hydrocephalus|hydrocephalus
676062|NCT00727142|Shunt|shunt
676063|NCT00727129|vasomotor symptoms|vasomotor symptoms
676064|NCT00727129|estrogen|estrogen
676065|NCT00727129|estradiol|estradiol
676066|NCT00727129|hot flashes|hot flashes
676067|NCT00727103|Varenicline|varenicline
676068|NCT00727103|Smoking cessation|smoking cessation
676069|NCT00727103|Schizophrenia|schizophrenia
676070|NCT00727103|Schizoaffective disorder|schizoaffective disorder
676071|NCT00727103|Alcohol dependence|alcohol dependence
676072|NCT00727103|Nicotine dependence|nicotine dependence
676073|NCT00727064|Healthy Subjects|healthy subjects
676074|NCT00727051|invasive coronary angiography|invasive coronary angiography
676075|NCT00727051|multidetector coronary CTA|multidetector coronary cta
676076|NCT00727051|coronary artery disease|coronary artery disease
676077|NCT00727051|detecting coronary artery disease|detecting coronary artery disease
676078|NCT00727038|glaucoma|glaucoma
676079|NCT00727038|neovascular glaucoma|neovascular glaucoma
676080|NCT00727038|new onset glaucoma|new onset glaucoma
676081|NCT00727038|retinal ischemia|retinal ischemia
676082|NCT00727038|central retinal vein occlusion|central retinal vein occlusion
676083|NCT00727038|proliferative diabetic retinopathy|proliferative diabetic retinopathy
676084|NCT00727038|ocular ischemic syndrome|ocular ischemic syndrome
676085|NCT00727038|carotid stenosis|carotid stenosis
676086|NCT00727038|vascular endothelial growth factor|vascular endothelial growth factor
676087|NCT00727038|neovascular|neovascular
676088|NCT00727025|skin closure devices|skin closure devices
676089|NCT00727025|linear scars|linear scars
676090|NCT00727012|mitral valve|mitral valve
676091|NCT00727012|heart valve|heart valve
676092|NCT00727012|valve repair|valve repair
676093|NCT00727012|valve disorder|valve disorder
676094|NCT00727012|valve disease|valve disease
676095|NCT00727012|cardiac surgery|cardiac surgery
676096|NCT00726999|Gabapentin|gabapentin
676097|NCT00726999|Pediatric Spinal Fusion|pediatric spinal fusion
676098|NCT00726999|Narcotic Use|narcotic use
676099|NCT00726986|extensive stage small cell lung cancer|extensive stage small cell lung cancer
676100|NCT00726973|Macular edema|macular edema
676101|NCT00726960|Heroin abuse|heroin abuse
676102|NCT00726960|Opioids|opioids
676103|NCT00726960|Opiates|opiates
676104|NCT00726960|Substance abuse|substance abuse
676105|NCT00726960|Addiction|addiction
676106|NCT00726934|Neutropenic Diet|neutropenic diet
676107|NCT00726934|Food Safety Guidelines|food safety guidelines
676108|NCT00726934|child|child
676109|NCT00726934|cancer|cancer
676110|NCT00726908|Obesity|obesity
676111|NCT00726908|diet|diet
676112|NCT00726908|carbohydrate|carbohydrate
676113|NCT00726908|insulin|insulin
676114|NCT00726895|Bioavailability|bioavailability
676115|NCT00726882|HCV Infection|hcv infection
676116|NCT00726869|Patients After One to three Prior Therapies|patients after one to three prior therapies
676117|NCT00726843|Headache|headache
676118|NCT00726843|Complementary and Alternative Medicine|complementary and alternative medicine
676119|NCT00726843|Pediatric|pediatric
676120|NCT00726843|Yoga|yoga
676121|NCT00726830|pain|pain
676122|NCT00726830|unspecified adult solid tumor, protocol specific|unspecified adult solid tumor, protocol specific
676123|NCT00726830|accelerated phase chronic myelogenous leukemia|accelerated phase chronic myelogenous leukemia
676124|NCT00726830|acute undifferentiated leukemia|acute undifferentiated leukemia
676125|NCT00726830|adult acute myeloid leukemia with 11q23 (MLL) abnormalities|adult acute myeloid leukemia with 11q23 (mll) abnormalities
676126|NCT00726830|adult acute myeloid leukemia with inv(16)(p13;q22)|adult acute myeloid leukemia with inv(16)(p13;q22)
676127|NCT00726830|adult acute myeloid leukemia with t(15;17)(q22;q12)|adult acute myeloid leukemia with t(15;17)(q22;q12)
676128|NCT00726830|adult acute myeloid leukemia with t(16;16)(p13;q22)|adult acute myeloid leukemia with t(16;16)(p13;q22)
676129|NCT00726830|adult acute myeloid leukemia with t(8;21)(q22;q22)|adult acute myeloid leukemia with t(8;21)(q22;q22)
676130|NCT00726830|atypical chronic myeloid leukemia, BCR-ABL1 negative|atypical chronic myeloid leukemia, bcr-abl1 negative
676131|NCT00726830|blastic phase chronic myelogenous leukemia|blastic phase chronic myelogenous leukemia
676359|NCT00726375|(GVHD)|(gvhd)
676132|NCT00726830|chronic myelomonocytic leukemia|chronic myelomonocytic leukemia
676133|NCT00726830|chronic phase chronic myelogenous leukemia|chronic phase chronic myelogenous leukemia
676134|NCT00726830|mast cell leukemia|mast cell leukemia
676135|NCT00726830|meningeal chronic myelogenous leukemia|meningeal chronic myelogenous leukemia
676136|NCT00726830|progressive hairy cell leukemia, initial treatment|progressive hairy cell leukemia, initial treatment
676137|NCT00726830|prolymphocytic leukemia|prolymphocytic leukemia
676138|NCT00726830|recurrent adult acute lymphoblastic leukemia|recurrent adult acute lymphoblastic leukemia
676139|NCT00726830|recurrent adult acute myeloid leukemia|recurrent adult acute myeloid leukemia
676140|NCT00726830|recurrent adult T-cell leukemia/lymphoma|recurrent adult t-cell leukemia/lymphoma
676141|NCT00726830|refractory chronic lymphocytic leukemia|refractory chronic lymphocytic leukemia
676142|NCT00726830|refractory hairy cell leukemia|refractory hairy cell leukemia
676143|NCT00726830|relapsing chronic myelogenous leukemia|relapsing chronic myelogenous leukemia
676144|NCT00726830|secondary acute myeloid leukemia|secondary acute myeloid leukemia
676145|NCT00726830|stage III adult T-cell leukemia/lymphoma|stage iii adult t-cell leukemia/lymphoma
676146|NCT00726830|stage III chronic lymphocytic leukemia|stage iii chronic lymphocytic leukemia
676147|NCT00726830|stage IV adult T-cell leukemia/lymphoma|stage iv adult t-cell leukemia/lymphoma
676148|NCT00726830|stage IV chronic lymphocytic leukemia|stage iv chronic lymphocytic leukemia
676149|NCT00726830|T-cell large granular lymphocyte leukemia|t-cell large granular lymphocyte leukemia
676150|NCT00726830|untreated adult acute lymphoblastic leukemia|untreated adult acute lymphoblastic leukemia
676151|NCT00726830|untreated adult acute myeloid leukemia|untreated adult acute myeloid leukemia
676152|NCT00726830|untreated hairy cell leukemia|untreated hairy cell leukemia
676153|NCT00726830|adult grade III lymphomatoid granulomatosis|adult grade iii lymphomatoid granulomatosis
676154|NCT00726830|adult nasal type extranodal NK/T-cell lymphoma|adult nasal type extranodal nk/t-cell lymphoma
676155|NCT00726830|AIDS-related diffuse large cell lymphoma|aids-related diffuse large cell lymphoma
676156|NCT00726830|AIDS-related diffuse mixed cell lymphoma|aids-related diffuse mixed cell lymphoma
676157|NCT00726830|AIDS-related diffuse small cleaved cell lymphoma|aids-related diffuse small cleaved cell lymphoma
676158|NCT00726830|AIDS-related immunoblastic large cell lymphoma|aids-related immunoblastic large cell lymphoma
676159|NCT00726830|AIDS-related peripheral/systemic lymphoma|aids-related peripheral/systemic lymphoma
676160|NCT00726830|AIDS-related primary CNS lymphoma|aids-related primary cns lymphoma
676161|NCT00726830|AIDS-related small noncleaved cell lymphoma|aids-related small noncleaved cell lymphoma
676162|NCT00726830|AIDS-related lymphoblastic lymphoma|aids-related lymphoblastic lymphoma
676163|NCT00726830|anaplastic large cell lymphoma|anaplastic large cell lymphoma
676164|NCT00726830|angioimmunoblastic T-cell lymphoma|angioimmunoblastic t-cell lymphoma
676165|NCT00726830|splenic marginal zone lymphoma|splenic marginal zone lymphoma
676166|NCT00726830|extranodal marginal zone B-cell lymphoma of mucosa-associated lymphoid tissue|extranodal marginal zone b-cell lymphoma of mucosa-associated lymphoid tissue
676167|NCT00726830|nodal marginal zone B-cell lymphoma|nodal marginal zone b-cell lymphoma
676168|NCT00726830|stage III adult Burkitt lymphoma|stage iii adult burkitt lymphoma
676169|NCT00726830|stage III adult diffuse large cell lymphoma|stage iii adult diffuse large cell lymphoma
676170|NCT00726830|stage III adult diffuse mixed cell lymphoma|stage iii adult diffuse mixed cell lymphoma
676171|NCT00726830|stage III adult diffuse small cleaved cell lymphoma|stage iii adult diffuse small cleaved cell lymphoma
676172|NCT00726830|stage III adult Hodgkin lymphoma|stage iii adult hodgkin lymphoma
676173|NCT00726830|stage III adult immunoblastic large cell lymphoma|stage iii adult immunoblastic large cell lymphoma
676174|NCT00726830|stage III adult lymphoblastic lymphoma|stage iii adult lymphoblastic lymphoma
676175|NCT00726830|stage III cutaneous T-cell non-Hodgkin lymphoma|stage iii cutaneous t-cell non-hodgkin lymphoma
676176|NCT00726830|stage III mycosis fungoides/Sezary syndrome|stage iii mycosis fungoides/sezary syndrome
676177|NCT00726830|stage III grade 1 follicular lymphoma|stage iii grade 1 follicular lymphoma
676178|NCT00726830|stage III grade 2 follicular lymphoma|stage iii grade 2 follicular lymphoma
676179|NCT00726830|stage III grade 3 follicular lymphoma|stage iii grade 3 follicular lymphoma
676180|NCT00726830|stage III mantle cell lymphoma|stage iii mantle cell lymphoma
676181|NCT00726830|stage III marginal zone lymphoma|stage iii marginal zone lymphoma
676182|NCT00726830|stage III small lymphocytic lymphoma|stage iii small lymphocytic lymphoma
676183|NCT00726830|stage IV adult Burkitt lymphoma|stage iv adult burkitt lymphoma
676184|NCT00726830|stage IV adult diffuse large cell lymphoma|stage iv adult diffuse large cell lymphoma
676185|NCT00726830|stage IV adult diffuse mixed cell lymphoma|stage iv adult diffuse mixed cell lymphoma
676186|NCT00726830|stage IV adult diffuse small cleaved cell lymphoma|stage iv adult diffuse small cleaved cell lymphoma
676187|NCT00726830|stage IV adult Hodgkin lymphoma|stage iv adult hodgkin lymphoma
676188|NCT00726830|stage IV adult immunoblastic large cell lymphoma|stage iv adult immunoblastic large cell lymphoma
676189|NCT00726830|stage IV adult lymphoblastic lymphoma|stage iv adult lymphoblastic lymphoma
676190|NCT00726830|stage IV cutaneous T-cell non-Hodgkin lymphoma|stage iv cutaneous t-cell non-hodgkin lymphoma
857955|NCT00067067|Glioma|glioma
676191|NCT00726830|stage IV mycosis fungoides/Sezary syndrome|stage iv mycosis fungoides/sezary syndrome
676192|NCT00726830|stage IV grade 1 follicular lymphoma|stage iv grade 1 follicular lymphoma
676193|NCT00726830|stage IV grade 2 follicular lymphoma|stage iv grade 2 follicular lymphoma
676194|NCT00726830|stage IV grade 3 follicular lymphoma|stage iv grade 3 follicular lymphoma
676195|NCT00726830|stage IV mantle cell lymphoma|stage iv mantle cell lymphoma
676360|NCT00726362|Statin|statin
676196|NCT00726830|stage IV marginal zone lymphoma|stage iv marginal zone lymphoma
676197|NCT00726830|stage IV small lymphocytic lymphoma|stage iv small lymphocytic lymphoma
676198|NCT00726830|HIV-associated Hodgkin lymphoma|hiv-associated hodgkin lymphoma
676199|NCT00726830|recurrent adult Hodgkin lymphoma|recurrent adult hodgkin lymphoma
676200|NCT00726830|recurrent adult Burkitt lymphoma|recurrent adult burkitt lymphoma
676201|NCT00726830|recurrent adult diffuse large cell lymphoma|recurrent adult diffuse large cell lymphoma
676202|NCT00726830|recurrent adult diffuse mixed cell lymphoma|recurrent adult diffuse mixed cell lymphoma
676203|NCT00726830|recurrent adult diffuse small cleaved cell lymphoma|recurrent adult diffuse small cleaved cell lymphoma
676204|NCT00726830|recurrent adult grade III lymphomatoid granulomatosis|recurrent adult grade iii lymphomatoid granulomatosis
676205|NCT00726830|recurrent adult immunoblastic large cell lymphoma|recurrent adult immunoblastic large cell lymphoma
676206|NCT00726830|recurrent adult lymphoblastic lymphoma|recurrent adult lymphoblastic lymphoma
676207|NCT00726830|recurrent cutaneous T-cell non-Hodgkin lymphoma|recurrent cutaneous t-cell non-hodgkin lymphoma
676208|NCT00726830|recurrent mycosis fungoides/Sezary syndrome|recurrent mycosis fungoides/sezary syndrome
676209|NCT00726830|recurrent grade 1 follicular lymphoma|recurrent grade 1 follicular lymphoma
676210|NCT00726830|recurrent grade 2 follicular lymphoma|recurrent grade 2 follicular lymphoma
676211|NCT00726830|recurrent grade 3 follicular lymphoma|recurrent grade 3 follicular lymphoma
676212|NCT00726830|recurrent mantle cell lymphoma|recurrent mantle cell lymphoma
676213|NCT00726830|recurrent marginal zone lymphoma|recurrent marginal zone lymphoma
676214|NCT00726830|recurrent small lymphocytic lymphoma|recurrent small lymphocytic lymphoma
676215|NCT00726830|intraocular lymphoma|intraocular lymphoma
676216|NCT00726830|primary central nervous system non-Hodgkin lymphoma|primary central nervous system non-hodgkin lymphoma
676217|NCT00726830|primary central nervous system Hodgkin lymphoma|primary central nervous system hodgkin lymphoma
676218|NCT00726830|post-transplant lymphoproliferative disorder|post-transplant lymphoproliferative disorder
676219|NCT00726830|chronic eosinophilic leukemia|chronic eosinophilic leukemia
676220|NCT00726830|chronic neutrophilic leukemia|chronic neutrophilic leukemia
676221|NCT00726830|primary myelofibrosis|primary myelofibrosis
676222|NCT00726830|essential thrombocythemia|essential thrombocythemia
676223|NCT00726830|polycythemia vera|polycythemia vera
676224|NCT00726830|extramedullary plasmacytoma|extramedullary plasmacytoma
676225|NCT00726830|isolated plasmacytoma of bone|isolated plasmacytoma of bone
676226|NCT00726830|monoclonal gammopathy of undetermined significance|monoclonal gammopathy of undetermined significance
676227|NCT00726830|stage II multiple myeloma|stage ii multiple myeloma
676228|NCT00726830|stage III multiple myeloma|stage iii multiple myeloma
676229|NCT00726830|primary systemic amyloidosis|primary systemic amyloidosis
676230|NCT00726830|refractory multiple myeloma|refractory multiple myeloma
676231|NCT00726830|de novo myelodysplastic syndromes|de novo myelodysplastic syndromes
676232|NCT00726830|previously treated myelodysplastic syndromes|previously treated myelodysplastic syndromes
676233|NCT00726830|secondary myelodysplastic syndromes|secondary myelodysplastic syndromes
676234|NCT00726830|myelodysplastic/myeloproliferative neoplasm, unclassifiable|myelodysplastic/myeloproliferative neoplasm, unclassifiable
676235|NCT00726830|cutaneous B-cell non-Hodgkin lymphoma|cutaneous b-cell non-hodgkin lymphoma
676236|NCT00726830|Waldenström macroglobulinemia|waldenström macroglobulinemia
676237|NCT00726817|butyrate, visceral perception, compliance|butyrate, visceral perception, compliance
676238|NCT00726791|chronic pain|chronic pain
676239|NCT00726791|pain disorder|pain disorder
676240|NCT00726778|race/ethnicity|race/ethnicity
676241|NCT00726778|insulin senistivity|insulin senistivity
676242|NCT00726778|genetic admixture|genetic admixture
676243|NCT00726778|type 2 diabetes|type 2 diabetes
676245|NCT00726778|body composition|body composition
676246|NCT00726778|Insulin dynamics|insulin dynamics
676247|NCT00726778|Racial/ethnic differences|racial/ethnic differences
676248|NCT00726752|solid tumor|solid tumor
676249|NCT00726752|Axitinib|axitinib
676250|NCT00726752|Pharmacokinetics|pharmacokinetics
676251|NCT00726752|Phase 1|phase 1
676252|NCT00726739|recurrent melanoma|recurrent melanoma
676253|NCT00726713|Metanx|metanx
676254|NCT00726713|diabetes|diabetes
676255|NCT00726713|neuropathy|neuropathy
676256|NCT00726713|folic acid|folic acid
676257|NCT00726713|folate|folate
676258|NCT00726713|L-methylfolate|l-methylfolate
676259|NCT00726713|vitamin B6|vitamin b6
676260|NCT00726713|Pyridoxal 5'-phosphate|pyridoxal 5'-phosphate
676261|NCT00726713|vitamin B12|vitamin b12
676262|NCT00726713|methylcobalamin|methylcobalamin
676263|NCT00726700|stage III grade 3 follicular lymphoma|stage iii grade 3 follicular lymphoma
676264|NCT00726700|stage I adult lymphoblastic lymphoma|stage i adult lymphoblastic lymphoma
676265|NCT00726700|stage III adult lymphoblastic lymphoma|stage iii adult lymphoblastic lymphoma
676266|NCT00726700|stage IV adult lymphoblastic lymphoma|stage iv adult lymphoblastic lymphoma
676267|NCT00726700|contiguous stage II adult lymphoblastic lymphoma|contiguous stage ii adult lymphoblastic lymphoma
676268|NCT00726700|noncontiguous stage II adult lymphoblastic lymphoma|noncontiguous stage ii adult lymphoblastic lymphoma
676269|NCT00726700|anaplastic large cell lymphoma|anaplastic large cell lymphoma
676270|NCT00726700|stage III adult diffuse large cell lymphoma|stage iii adult diffuse large cell lymphoma
676271|NCT00726700|stage I adult diffuse large cell lymphoma|stage i adult diffuse large cell lymphoma
676272|NCT00726700|stage IV adult diffuse large cell lymphoma|stage iv adult diffuse large cell lymphoma
676273|NCT00726700|contiguous stage II adult diffuse large cell lymphoma|contiguous stage ii adult diffuse large cell lymphoma
676274|NCT00726700|contiguous stage II adult immunoblastic large cell lymphoma|contiguous stage ii adult immunoblastic large cell lymphoma
676275|NCT00726700|noncontiguous stage II adult diffuse large cell lymphoma|noncontiguous stage ii adult diffuse large cell lymphoma
676276|NCT00726700|noncontiguous stage II adult immunoblastic large cell lymphoma|noncontiguous stage ii adult immunoblastic large cell lymphoma
676277|NCT00726700|stage III adult immunoblastic large cell lymphoma|stage iii adult immunoblastic large cell lymphoma
676278|NCT00726700|stage I adult immunoblastic large cell lymphoma|stage i adult immunoblastic large cell lymphoma
676279|NCT00726700|stage IV adult immunoblastic large cell lymphoma|stage iv adult immunoblastic large cell lymphoma
676280|NCT00726700|stage III adult Burkitt lymphoma|stage iii adult burkitt lymphoma
676281|NCT00726700|stage IV adult Burkitt lymphoma|stage iv adult burkitt lymphoma
676282|NCT00726700|stage III mantle cell lymphoma|stage iii mantle cell lymphoma
676283|NCT00726700|stage I mantle cell lymphoma|stage i mantle cell lymphoma
676284|NCT00726700|contiguous stage II mantle cell lymphoma|contiguous stage ii mantle cell lymphoma
676285|NCT00726700|noncontiguous stage II mantle cell lymphoma|noncontiguous stage ii mantle cell lymphoma
676286|NCT00726700|stage I adult Burkitt lymphoma|stage i adult burkitt lymphoma
676287|NCT00726700|contiguous stage II adult Burkitt lymphoma|contiguous stage ii adult burkitt lymphoma
676288|NCT00726700|noncontiguous stage II adult Burkitt lymphoma|noncontiguous stage ii adult burkitt lymphoma
676289|NCT00726700|stage III marginal zone lymphoma|stage iii marginal zone lymphoma
676290|NCT00726700|stage IV marginal zone lymphoma|stage iv marginal zone lymphoma
676291|NCT00726700|stage I marginal zone lymphoma|stage i marginal zone lymphoma
676292|NCT00726700|contiguous stage II marginal zone lymphoma|contiguous stage ii marginal zone lymphoma
676293|NCT00726700|noncontiguous stage II marginal zone lymphoma|noncontiguous stage ii marginal zone lymphoma
676295|NCT00726687|Indibulin|indibulin
676296|NCT00726687|Capecitabine|capecitabine
676297|NCT00726687|Xeloda|xeloda
676298|NCT00726674|Diabetes HbA1C|diabetes hba1c
676299|NCT00726661|Metastatic Breast Cancer|metastatic breast cancer
676300|NCT00726661|Locally Recurrent Breast Cancer|locally recurrent breast cancer
676301|NCT00726661|Avastin|avastin
676302|NCT00726648|CDP323|cdp323
676303|NCT00726648|Relapsing multiple sclerosis|relapsing multiple sclerosis
676304|NCT00726648|Blood biomarkers|blood biomarkers
676305|NCT00726622|rectal cancer|rectal cancer
676306|NCT00726622|adenocarcinoma of the rectum|adenocarcinoma of the rectum
676307|NCT00726596|recurrent prostate cancer|recurrent prostate cancer
676308|NCT00726596|stage IV prostate cancer|stage iv prostate cancer
676309|NCT00726596|Prostate-Specific Antigen|prostate-specific antigen
676310|NCT00726583|Cancer|cancer
676311|NCT00726583|Solid Tumors|solid tumors
676312|NCT00726583|Carcinoma|carcinoma
676313|NCT00726583|PI-3K|pi-3k
676314|NCT00726583|PI3 kinase|pi3 kinase
676315|NCT00726583|PI3K|pi3k
676316|NCT00726570|Disorders, Blood coagulation|disorders, blood coagulation
676317|NCT00726570|Deep Vein Thrombosis|deep vein thrombosis
676318|NCT00726570|Perioperative Care|perioperative care
676319|NCT00726570|Digestive System Surgical Procedures|digestive system surgical procedures
676320|NCT00726544|thrombocytopenia|thrombocytopenia
676321|NCT00726544|microangiopathic hemolytic anemia|microangiopathic hemolytic anemia
676322|NCT00726544|von Willebrand Factor|von willebrand factor
676323|NCT00726544|ADAMTS13|adamts13
676324|NCT00726531|Falls prevention|falls prevention
676325|NCT00726531|Exercise promotion|exercise promotion
676326|NCT00726531|Older people|older people
676327|NCT00726466|Age Related Macular Degeneration|age related macular degeneration
676328|NCT00726466|AMD|amd
676329|NCT00726466|CNV|cnv
676330|NCT00726453|TARGET VESSEL REVASCULARIZATION (TVR)|target vessel revascularization (tvr)
676331|NCT00726453|MYOCARDIAL INFARCTION (MI)|myocardial infarction (mi)
676332|NCT00726453|TARGET VESSEL FAILURE (TVF)|target vessel failure (tvf)
676333|NCT00726453|TARGET LESION REVASCULARIZATION (TLR)|target lesion revascularization (tlr)
676334|NCT00726453|TARGET LESION FAILURE (TLF)|target lesion failure (tlf)
676335|NCT00726453|STENT THROMBOSIS|stent thrombosis
676336|NCT00726453|RESTENOTIC LESION|restenotic lesion
676337|NCT00726453|PERCUTANEOUS CORONARY INTERVENTION (PCI)|percutaneous coronary intervention (pci)
676338|NCT00726440|Type 1 Diabetes|type 1 diabetes
676339|NCT00726440|Real Time Continuous Glucose Monitoring System|real time continuous glucose monitoring system
676340|NCT00726440|HbA1c|hba1c
676341|NCT00726440|Navigator®|navigator®
676342|NCT00726427|pharmacokinetics|pharmacokinetics
676343|NCT00726427|pharmacodynamics|pharmacodynamics
676344|NCT00726427|AZD1656|azd1656
676345|NCT00726427|safety|safety
676346|NCT00726427|tolerability|tolerability
676347|NCT00726427|Healthy Volunteers|healthy volunteers
676348|NCT00726414|Bioavailability|bioavailability
676349|NCT00726401|Allergies|allergies
676350|NCT00726401|Nasal|nasal
676351|NCT00726401|Congestion|congestion
676352|NCT00726401|Sneezing|sneezing
676353|NCT00726401|Pruritus|pruritus
676354|NCT00726401|Teary|teary
676355|NCT00726401|Eyes|eyes
676356|NCT00726388|safety|safety
676362|NCT00726336|healthy volunteer|healthy volunteer
676363|NCT00726336|pharmacokinetics|pharmacokinetics
676364|NCT00726336|GSK1349572|gsk1349572
676365|NCT00726336|integrase|integrase
676366|NCT00726323|c-Met|c-met
676367|NCT00726323|Papillary Renal Cell Carcinoma(PRC)|papillary renal cell carcinoma(prc)
676368|NCT00726323|Sporadic papillary renal cell carcinoma,|sporadic papillary renal cell carcinoma,
676369|NCT00726323|Clear cell renal carcinoma|clear cell renal carcinoma
676370|NCT00726323|Hereditary papillary renal cell carcinoma,|hereditary papillary renal cell carcinoma,
676371|NCT00726310|Spondylolisthesis|spondylolisthesis
676372|NCT00726310|Instability|instability
676373|NCT00726284|HNP|hnp
676374|NCT00726271|obesity|obesity
676375|NCT00726271|appetite set point|appetite set point
676376|NCT00726219|Major|major
676377|NCT00726219|knee|knee
676378|NCT00726219|surgery|surgery
676379|NCT00726180|Breast cancer|breast cancer
676380|NCT00726180|Women|women
676381|NCT00726180|w/Her2|w/her2
676382|NCT00726180|positive|positive
676383|NCT00726180|ERnegative|ernegative
676384|NCT00726180|not metastasized|not metastasized
676385|NCT00726167|Ventilator associated Pneumonia|ventilator associated pneumonia
676386|NCT00726167|mechanically ventilated|mechanically ventilated
676387|NCT00726167|procalcitonin|procalcitonin
676388|NCT00726167|pneumonia scores|pneumonia scores
676389|NCT00726154|Bipolar Disorder|bipolar disorder
676390|NCT00726154|Circadian Rhythm|circadian rhythm
676391|NCT00726154|Moderators|moderators
676392|NCT00726154|Lithium|lithium
676393|NCT00726154|Quetiapine|quetiapine
676394|NCT00726141|Brief Intervention|brief intervention
676395|NCT00726141|Smoking Cessation|smoking cessation
676396|NCT00726141|Motivational Interviewing|motivational interviewing
676397|NCT00726141|Expert System|expert system
676398|NCT00726141|Readiness to Change|readiness to change
676399|NCT00726141|Hormonal Contraceptive|hormonal contraceptive
676400|NCT00726141|Adolescents|adolescents
676401|NCT00726128|DDD|ddd
676402|NCT00726102|Zinc nutrition|zinc nutrition
676403|NCT00726102|Growth|growth
676404|NCT00726102|Development|development
676405|NCT00726102|China|china
676406|NCT00726102|Infants|infants
676407|NCT00726102|Toddlers|toddlers
676408|NCT00726076|Epilepsy|epilepsy
676409|NCT00726076|Medication|medication
676410|NCT00726076|Stress|stress
676411|NCT00726076|Sleep|sleep
676412|NCT00726076|Lifestyle Management|lifestyle management
676413|NCT00726063|dental implants|dental implants
676414|NCT00726063|Nanotite implant|nanotite implant
676415|NCT00726063|Osseotite implants|osseotite implants
676416|NCT00726063|multicenter|multicenter
676417|NCT00726063|randomized|randomized
676418|NCT00726063|clinical study|clinical study
676419|NCT00726063|partial edentulism|partial edentulism
676420|NCT00726063|prosthesis|prosthesis
676421|NCT00726050|Theta Burst Stimulation|theta burst stimulation
676422|NCT00726050|Somatosensory Stimulation|somatosensory stimulation
676423|NCT00726050|Somatosensory Cortex|somatosensory cortex
676424|NCT00726050|Tactile Discrimination|tactile discrimination
676425|NCT00726050|Healthy Volunteer|healthy volunteer
676426|NCT00726050|HV|hv
676427|NCT00726037|Denileukin diftitox|denileukin diftitox
676428|NCT00726037|Metastatic Pancreatic Cancer|metastatic pancreatic cancer
676429|NCT00726037|Ontak|ontak
676430|NCT00726037|Regulatory T-cell|regulatory t-cell
676431|NCT00726011|due|due
676432|NCT00726011|cancer treatment|cancer treatment
676433|NCT00725998|Cochlear Implantation.|cochlear implantation.
676434|NCT00725998|Cochlear nerve.|cochlear nerve.
676435|NCT00725998|Child.|child.
676436|NCT00725998|study|study
676437|NCT00725998|ECAP|ecap
676438|NCT00725998|During|during
676439|NCT00725998|First year|first year
676440|NCT00725985|Clinically Isolated Syndrome (CIS)|clinically isolated syndrome (cis)
676441|NCT00725985|Early MS|early ms
676442|NCT00725985|Multiple Sclerosis|multiple sclerosis
676443|NCT00725972|Improve|improve
676444|NCT00725972|Patient care|patient care
676445|NCT00725972|Applying|applying
676446|NCT00725972|Systematic|systematic
676447|NCT00725972|Fashion|fashion
676448|NCT00725972|Proven|proven
676449|NCT00725972|Resuscitation|resuscitation
676450|NCT00725972|Algorithms|algorithms
676451|NCT00725972|High risk|high risk
676452|NCT00725972|Surgical|surgical
676453|NCT00725959|HIV Prevention|hiv prevention
676454|NCT00725959|Social Networking|social networking
676455|NCT00725959|Technology Based Intervention|technology based intervention
676456|NCT00725920|PTSD,|ptsd,
676457|NCT00725920|posttraumatic|posttraumatic
676458|NCT00725920|stress|stress
676459|NCT00725920|disorder,|disorder,
676460|NCT00725920|randomization,|randomization,
676461|NCT00725920|placebo,|placebo,
676462|NCT00725920|controlled|controlled
676463|NCT00725907|PRP|prp
676464|NCT00725907|ATFL|atfl
676465|NCT00725881|PAD|pad
676466|NCT00725881|Peripheral arterial disease|peripheral arterial disease
676467|NCT00725881|Peripheral artery disease|peripheral artery disease
676468|NCT00725881|Intermittent claudication|intermittent claudication
676469|NCT00725881|IC|ic
676470|NCT00725881|atherosclerosis|atherosclerosis
676471|NCT00725881|leg pain|leg pain
676472|NCT00725881|walking pain|walking pain
676473|NCT00725868|Major adverse|major adverse
676474|NCT00725855|Schizophrenia|schizophrenia
676475|NCT00725855|P50 Sensory Gating|p50 sensory gating
676476|NCT00725855|Mismatched Negativity|mismatched negativity
676477|NCT00725829|coagulation|coagulation
676478|NCT00725829|cholesterol|cholesterol
676479|NCT00725829|acute ischemia|acute ischemia
676480|NCT00725829|fibrin clot|fibrin clot
676481|NCT00725803|Hepatitis C|hepatitis c
676482|NCT00725803|HCV|hcv
676483|NCT00725803|Fibrosis|fibrosis
676484|NCT00725803|Apoptosis|apoptosis
676485|NCT00725803|GS-9450|gs-9450
676486|NCT00725790|Erectile Dysfunction|erectile dysfunction
676487|NCT00725790|Spinal Cord Injury|spinal cord injury
676488|NCT00725764|VEGFR2|vegfr2
676489|NCT00725764|XL880|xl880
676490|NCT00725764|foretinib|foretinib
676491|NCT00725764|Squamous Cell Cancer of the Head and Neck|squamous cell cancer of the head and neck
676492|NCT00725764|MET|met
676493|NCT00725764|GSK1363089|gsk1363089
676494|NCT00725738|Myocardial|myocardial
676495|NCT00725738|Infarction,|infarction,
676496|NCT00725738|Stem|stem
676497|NCT00725738|Cell|cell
676498|NCT00725738|Therapy|therapy
676499|NCT00725712|c-Met|c-met
676500|NCT00725712|Metastatic Gastric Carcinoma|metastatic gastric carcinoma
676501|NCT00725712|adenocarcinoma|adenocarcinoma
676502|NCT00725712|Gastric cancer|gastric cancer
676503|NCT00725712|GSK1363089|gsk1363089
676504|NCT00725712|XL880|xl880
676505|NCT00725712|MET inhibitor|met inhibitor
676506|NCT00725686|"Choroidal Neovascularization (CNV) WET AMD"|"choroidal neovascularization (cnv) wet amd"
676507|NCT00725673|COPD|copd
676508|NCT00725673|Osteoporosis|osteoporosis
676509|NCT00725673|BMD|bmd
676510|NCT00725673|DEXA-scan|dexa-scan
676511|NCT00725660|pre eclampsia|pre eclampsia
676512|NCT00725660|doppler|doppler
676513|NCT00725660|uterine|uterine
676514|NCT00725660|arteries|arteries
676515|NCT00725660|angiogenic|angiogenic
676516|NCT00725660|factors|factors
676517|NCT00725647|N terminal B type natriuretic peptide|n terminal b type natriuretic peptide
676518|NCT00725647|echocardiography|echocardiography
676519|NCT00725647|diagnosis|diagnosis
676520|NCT00725647|atrial natriuretic peptides|atrial natriuretic peptides
676521|NCT00725647|preterm infant|preterm infant
676522|NCT00725634|Neoplasms,|neoplasms,
676523|NCT00725634|Lymphoma,|lymphoma,
676524|NCT00725634|Multiple Myeloma,|multiple myeloma,
676525|NCT00725634|Neoplasms, Plasma Cell,|neoplasms, plasma cell,
676526|NCT00725634|Neoplasms by Histologic Type,|neoplasms by histologic type,
676527|NCT00725634|Lymphoproliferative Disorders,|lymphoproliferative disorders,
676528|NCT00725634|Lymphatic Diseases, Immunoproliferative Disorders|lymphatic diseases, immunoproliferative disorders
676529|NCT00725634|Immune System Diseases Hemostatic Disorders|immune system diseases hemostatic disorders
676530|NCT00725634|Vascular Diseases|vascular diseases
676531|NCT00725634|Cardiovascular Diseases|cardiovascular diseases
676532|NCT00725634|Paraproteinemias|paraproteinemias
676533|NCT00725634|Blood Protein Disorders|blood protein disorders
676534|NCT00725634|Hematologic Diseases|hematologic diseases
676535|NCT00725634|Hemorrhagic Disorders|hemorrhagic disorders
676536|NCT00725634|Erlotinib|erlotinib
676537|NCT00725634|Protein Kinase Inhibitors|protein kinase inhibitors
676538|NCT00725634|Enzyme Inhibitors,|enzyme inhibitors,
676539|NCT00725634|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action
676540|NCT00725634|Pharmacologic Actions|pharmacologic actions
676541|NCT00725608|Suboxone|suboxone
676542|NCT00725608|Subutex|subutex
676543|NCT00725608|Buprenorphine|buprenorphine
676544|NCT00725608|Naloxone|naloxone
676545|NCT00725595|Cheyne Stocks respiration|cheyne stocks respiration
676546|NCT00725595|heart failure|heart failure
676547|NCT00725595|sleep apnea|sleep apnea
676548|NCT00725595|ventilator|ventilator
676549|NCT00725569|Caesarian Section|caesarian section
676550|NCT00725569|Homeopathy|homeopathy
676551|NCT00725569|Pain|pain
676552|NCT00725569|Analgesia|analgesia
676553|NCT00725556|Autism|autism
676554|NCT00725556|Asperger Syndrome|asperger syndrome
676555|NCT00725530|Lens deposits|lens deposits
676556|NCT00725530|Soft contact lens wearers|soft contact lens wearers
676557|NCT00725517|Icodextrin|icodextrin
676558|NCT00725517|ultrafiltration|ultrafiltration
676559|NCT00725517|creatinine clearance|creatinine clearance
676560|NCT00725517|urea nitrogen clearance|urea nitrogen clearance
676561|NCT00725491|Reproductive|reproductive
676562|NCT00725491|techniques|techniques
676563|NCT00725491|assisted|assisted
676564|NCT00725478|Piribedil (trade name: CLARIUM)|piribedil (trade name: clarium)
676565|NCT00725478|non-ergot dopamine agonist|non-ergot dopamine agonist
676566|NCT00725478|Morbus Parkinson|morbus parkinson
676567|NCT00725478|Tolerability|tolerability
676568|NCT00725478|Efficacy|efficacy
676569|NCT00725478|Post Marketing Surveillance|post marketing surveillance
676570|NCT00725465|laparoscopy|laparoscopy
676571|NCT00725465|CO2 colonoscopy|co2 colonoscopy
677534|NCT00721396|Prevention,|prevention,
676572|NCT00725465|intraoperative CO2 colonoscopy|intraoperative co2 colonoscopy
676573|NCT00725465|combined Lap-CO2 procedure|combined lap-co2 procedure
676574|NCT00725426|healthy subjects|healthy subjects
676575|NCT00725400|Colorectal Cancer|colorectal cancer
676576|NCT00725400|Erbitux|erbitux
676577|NCT00725400|Cetuximab|cetuximab
676578|NCT00725400|Surgery|surgery
676579|NCT00725400|Radiation|radiation
676580|NCT00725348|Psoriasis|psoriasis
676581|NCT00725335|ischemia|ischemia
676582|NCT00725335|liver cancer|liver cancer
676583|NCT00725335|radical excision|radical excision
676584|NCT00725335|prognosis|prognosis
676585|NCT00725309|Chronic Obstructive Pulmonary Disease|chronic obstructive pulmonary disease
676586|NCT00725309|COPD|copd
676587|NCT00725309|Elastin|elastin
676588|NCT00725309|ELN|eln
676589|NCT00725283|Leukemia|leukemia
676590|NCT00725283|ASCI|asci
676591|NCT00725283|Complete remission|complete remission
676592|NCT00725283|Immunotherapy|immunotherapy
676593|NCT00725283|adult|adult
676594|NCT00725283|Acute Myeloid Leukemia|acute myeloid leukemia
676595|NCT00725283|Tumor antigen|tumor antigen
676596|NCT00725283|WT1|wt1
676597|NCT00725244|Radiation Injuries|radiation injuries
676598|NCT00725244|Telangiectasis|telangiectasis
676599|NCT00725244|Bipolar Eletrocoagulation|bipolar eletrocoagulation
676600|NCT00725244|Argon Plasma Coagulation|argon plasma coagulation
676601|NCT00725231|T cell lymphoma|t cell lymphoma
676602|NCT00725218|NSAIDs|nsaids
676603|NCT00725218|Postoperative pain|postoperative pain
676604|NCT00725218|Analgesia|analgesia
676605|NCT00725218|Abortion|abortion
676606|NCT00725192|PTSD|ptsd
676607|NCT00725192|Posttraumatic Stress Disorder|posttraumatic stress disorder
676608|NCT00725192|Physical Assault|physical assault
676609|NCT00725192|Physical Abuse|physical abuse
676610|NCT00725192|Sexual Assault|sexual assault
676611|NCT00725192|Sexual Abuse|sexual abuse
676612|NCT00725192|Interpersonal Assault|interpersonal assault
676613|NCT00725192|Cognitive Processing Therapy|cognitive processing therapy
676614|NCT00725192|Sleep Impairment|sleep impairment
676615|NCT00725192|Insomnia|insomnia
676616|NCT00725192|Hypnosis|hypnosis
676617|NCT00725179|acetaminophen toxicity|acetaminophen toxicity
676618|NCT00725179|n-acetylcysteine|n-acetylcysteine
676619|NCT00725179|liver toxicity|liver toxicity
676620|NCT00725166|Aging|aging
676621|NCT00725166|Biopsy|biopsy
676622|NCT00725166|Skeletal muscle|skeletal muscle
676623|NCT00725166|Molecular biology|molecular biology
676624|NCT00725166|Genetic markers|genetic markers
676625|NCT00725166|Gene expression regulation|gene expression regulation
676626|NCT00725166|Young and old men|young and old men
676627|NCT00725166|Healthy volunteers|healthy volunteers
676628|NCT00725153|Contact lens deposits|contact lens deposits
676629|NCT00725153|Soft contact lenses|soft contact lenses
676630|NCT00725153|Myopia|myopia
676631|NCT00725140|Migraine|migraine
676632|NCT00725140|Early intervention|early intervention
676633|NCT00725140|Primary Care|primary care
676634|NCT00725140|Almotriptan|almotriptan
676636|NCT00725127|Chronotherapy|chronotherapy
676637|NCT00725127|Primary prevention|primary prevention
676638|NCT00725127|Impaired fasting glucose|impaired fasting glucose
676639|NCT00725127|Type 2 diabetes|type 2 diabetes
676640|NCT00725127|Total mortality|total mortality
676641|NCT00725127|Myocardial infarction|myocardial infarction
676642|NCT00725127|Stroke|stroke
676643|NCT00725127|Angina pectoris|angina pectoris
676644|NCT00725127|Chronic kidney disease|chronic kidney disease
676645|NCT00725114|due|due
676646|NCT00725114|cancer|cancer
676647|NCT00725114|treatment|treatment
676648|NCT00725088|ST-Elevated Myocardial Infarction|st-elevated myocardial infarction
676649|NCT00725088|Exercise Training|exercise training
676650|NCT00725088|Rehabilitation|rehabilitation
676651|NCT00725075|Negative symptoms|negative symptoms
676652|NCT00725075|Glycine Uptake inhibitor|glycine uptake inhibitor
676653|NCT00725075|Add-on treatment|add-on treatment
676654|NCT00725075|Second Generation Antipsychotic|second generation antipsychotic
676655|NCT00725062|graft versus host disease|graft versus host disease
676656|NCT00725062|adult acute lymphoblastic leukemia in remission|adult acute lymphoblastic leukemia in remission
676657|NCT00725062|adult acute myeloid leukemia in remission|adult acute myeloid leukemia in remission
676658|NCT00725062|adult acute myeloid leukemia with 11q23 (MLL) abnormalities|adult acute myeloid leukemia with 11q23 (mll) abnormalities
676659|NCT00725062|adult acute myeloid leukemia with inv(16)(p13;q22)|adult acute myeloid leukemia with inv(16)(p13;q22)
676660|NCT00725062|adult acute myeloid leukemia with t(15;17)(q22;q12)|adult acute myeloid leukemia with t(15;17)(q22;q12)
676661|NCT00725062|adult acute myeloid leukemia with t(16;16)(p13;q22)|adult acute myeloid leukemia with t(16;16)(p13;q22)
676662|NCT00725062|adult acute myeloid leukemia with t(8;21)(q22;q22)|adult acute myeloid leukemia with t(8;21)(q22;q22)
676663|NCT00725062|chronic phase chronic myelogenous leukemia|chronic phase chronic myelogenous leukemia
676664|NCT00725062|accelerated phase chronic myelogenous leukemia|accelerated phase chronic myelogenous leukemia
676665|NCT00725062|relapsing chronic myelogenous leukemia|relapsing chronic myelogenous leukemia
676666|NCT00725062|de novo myelodysplastic syndromes|de novo myelodysplastic syndromes
677631|NCT00720993|RTPCR|rtpcr
676667|NCT00725062|previously treated myelodysplastic syndromes|previously treated myelodysplastic syndromes
676668|NCT00725062|secondary myelodysplastic syndromes|secondary myelodysplastic syndromes
676669|NCT00725062|stage I multiple myeloma|stage i multiple myeloma
676670|NCT00725062|stage II multiple myeloma|stage ii multiple myeloma
676671|NCT00725062|stage III multiple myeloma|stage iii multiple myeloma
676672|NCT00725062|refractory multiple myeloma|refractory multiple myeloma
676673|NCT00725062|stage III adult Burkitt lymphoma|stage iii adult burkitt lymphoma
676674|NCT00725062|stage III adult diffuse large cell lymphoma|stage iii adult diffuse large cell lymphoma
676675|NCT00725062|stage III adult diffuse mixed cell lymphoma|stage iii adult diffuse mixed cell lymphoma
676676|NCT00725062|stage III adult diffuse small cleaved cell lymphoma|stage iii adult diffuse small cleaved cell lymphoma
676677|NCT00725062|stage III adult immunoblastic large cell lymphoma|stage iii adult immunoblastic large cell lymphoma
676678|NCT00725062|stage III adult lymphoblastic lymphoma|stage iii adult lymphoblastic lymphoma
676679|NCT00725062|stage III grade 1 follicular lymphoma|stage iii grade 1 follicular lymphoma
676680|NCT00725062|stage III grade 2 follicular lymphoma|stage iii grade 2 follicular lymphoma
676681|NCT00725062|stage III grade 3 follicular lymphoma|stage iii grade 3 follicular lymphoma
676682|NCT00725062|stage III mantle cell lymphoma|stage iii mantle cell lymphoma
676683|NCT00725062|stage III marginal zone lymphoma|stage iii marginal zone lymphoma
676684|NCT00725062|stage III small lymphocytic lymphoma|stage iii small lymphocytic lymphoma
676685|NCT00725062|stage IV adult Burkitt lymphoma|stage iv adult burkitt lymphoma
676686|NCT00725062|stage IV adult diffuse large cell lymphoma|stage iv adult diffuse large cell lymphoma
676687|NCT00725062|stage IV adult diffuse mixed cell lymphoma|stage iv adult diffuse mixed cell lymphoma
676688|NCT00725062|stage IV adult diffuse small cleaved cell lymphoma|stage iv adult diffuse small cleaved cell lymphoma
676689|NCT00725062|stage IV adult immunoblastic large cell lymphoma|stage iv adult immunoblastic large cell lymphoma
676690|NCT00725062|stage IV adult lymphoblastic lymphoma|stage iv adult lymphoblastic lymphoma
676691|NCT00725062|stage IV grade 1 follicular lymphoma|stage iv grade 1 follicular lymphoma
676692|NCT00725062|stage IV grade 2 follicular lymphoma|stage iv grade 2 follicular lymphoma
676693|NCT00725062|stage IV grade 3 follicular lymphoma|stage iv grade 3 follicular lymphoma
676694|NCT00725062|stage IV mantle cell lymphoma|stage iv mantle cell lymphoma
676695|NCT00725062|stage IV marginal zone lymphoma|stage iv marginal zone lymphoma
676696|NCT00725062|stage IV small lymphocytic lymphoma|stage iv small lymphocytic lymphoma
676697|NCT00725062|extranodal marginal zone B-cell lymphoma of mucosa-associated lymphoid tissue|extranodal marginal zone b-cell lymphoma of mucosa-associated lymphoid tissue
676698|NCT00725062|nodal marginal zone B-cell lymphoma|nodal marginal zone b-cell lymphoma
676699|NCT00725062|splenic marginal zone lymphoma|splenic marginal zone lymphoma
676700|NCT00725062|recurrent adult acute lymphoblastic leukemia|recurrent adult acute lymphoblastic leukemia
676701|NCT00725062|recurrent childhood acute myeloid leukemia|recurrent childhood acute myeloid leukemia
676702|NCT00725062|recurrent adult Burkitt lymphoma|recurrent adult burkitt lymphoma
676703|NCT00725062|recurrent adult diffuse large cell lymphoma|recurrent adult diffuse large cell lymphoma
676704|NCT00725062|recurrent adult diffuse mixed cell lymphoma|recurrent adult diffuse mixed cell lymphoma
676705|NCT00725062|recurrent adult diffuse small cleaved cell lymphoma|recurrent adult diffuse small cleaved cell lymphoma
676706|NCT00725062|recurrent adult immunoblastic large cell lymphoma|recurrent adult immunoblastic large cell lymphoma
676707|NCT00725062|recurrent adult lymphoblastic lymphoma|recurrent adult lymphoblastic lymphoma
676708|NCT00725062|recurrent grade 1 follicular lymphoma|recurrent grade 1 follicular lymphoma
676709|NCT00725062|recurrent grade 2 follicular lymphoma|recurrent grade 2 follicular lymphoma
676710|NCT00725062|recurrent grade 3 follicular lymphoma|recurrent grade 3 follicular lymphoma
676711|NCT00725062|recurrent mantle cell lymphoma|recurrent mantle cell lymphoma
676712|NCT00725062|recurrent marginal zone lymphoma|recurrent marginal zone lymphoma
676713|NCT00725062|recurrent small lymphocytic lymphoma|recurrent small lymphocytic lymphoma
676714|NCT00725049|dental implants|dental implants
676715|NCT00725049|Nanotite Certain implant|nanotite certain implant
676716|NCT00725049|Osseotite|osseotite
676717|NCT00725049|multicenter|multicenter
676718|NCT00725049|randomized|randomized
676719|NCT00725049|clinical study|clinical study
676720|NCT00725049|partial edentulism|partial edentulism
676721|NCT00725049|crestal bone level|crestal bone level
676722|NCT00725049|short fixed bridge|short fixed bridge
676723|NCT00725049|cost analysis|cost analysis
676724|NCT00725023|Pain, chronic pain, tennis elbow, lateral epicondylitis|pain, chronic pain, tennis elbow, lateral epicondylitis
676725|NCT00724997|live attenuated flu vaccines|live attenuated flu vaccines
676726|NCT00724997|Influenza A (H1N1)|influenza a (h1n1)
676727|NCT00724997|intranasally application|intranasally application
858566|NCT00066209|SARS|sars
676728|NCT00724997|replication-deficient influenza virus|replication-deficient influenza virus
676729|NCT00724984|PCI-24781|pci-24781
676730|NCT00724984|Lymphoma|lymphoma
676731|NCT00724984|Hodgkin Disease|hodgkin disease
676732|NCT00724984|Lymphoma, Non-Hodgkin|lymphoma, non-hodgkin
676733|NCT00724984|Lymphoma, Large B-Cell, Diffuse|lymphoma, large b-cell, diffuse
676734|NCT00724984|Lymphoma, Follicular|lymphoma, follicular
676735|NCT00724984|Lymphoma, B-Cell, Marginal Zone|lymphoma, b-cell, marginal zone
676736|NCT00724984|Leukemia, Lymphocytic, Chronic, B-Cell|leukemia, lymphocytic, chronic, b-cell
676737|NCT00724984|Lymphoma, Mantle Cell|lymphoma, mantle cell
677709|NCT00720837|LITT|litt
676738|NCT00724984|Lymphoma, T-Cell, Cutaneous|lymphoma, t-cell, cutaneous
676739|NCT00724984|Lymphoma, T-Cell, Peripheral|lymphoma, t-cell, peripheral
676740|NCT00724971|B-cell Non-Hodgkin's Lymphoma|b-cell non-hodgkin's lymphoma
676741|NCT00724971|NHL|nhl
676742|NCT00724919|ESBL|esbl
676743|NCT00724906|Essential Tremor|essential tremor
676744|NCT00724906|Parkinsonian Tremor|parkinsonian tremor
676745|NCT00724906|Parkinson Disease|parkinson disease
676746|NCT00724906|Upper Extremity Tremor with duration of less than 2 years|upper extremity tremor with duration of less than 2 years
676747|NCT00724906|Diagnosis|diagnosis
676748|NCT00724906|Subjects|subjects
676749|NCT00724906|Upper|upper
676750|NCT00724906|Extremity|extremity
676751|NCT00724906|Tremor|tremor
676752|NCT00724906|Less|less
676753|NCT00724906|Than 2 years|than 2 years
676754|NCT00724880|coronary artery bypass grafting|coronary artery bypass grafting
676755|NCT00724880|clopidogrel|clopidogrel
676756|NCT00724880|post-operative bleeding|post-operative bleeding
676757|NCT00724867|Systemic Lupus Erythematosus|systemic lupus erythematosus
676758|NCT00724867|Belimumab|belimumab
676759|NCT00724867|SLE|sle
676760|NCT00724867|Antibodies|antibodies
676761|NCT00724867|Lupus|lupus
676762|NCT00724867|Autoimmune Diseases|autoimmune diseases
676763|NCT00724828|Bacterial otitis media|bacterial otitis media
676764|NCT00724828|pneumoniae|pneumoniae
676765|NCT00724828|sepsis|sepsis
676766|NCT00724828|bacteremia|bacteremia
676767|NCT00724828|meningitis|meningitis
676768|NCT00724828|Streptococcus pneumoniae carriage rate|streptococcus pneumoniae carriage rate
676769|NCT00724802|babies with canavan disease|babies with canavan disease
676770|NCT00724789|Neonatal outcome|neonatal outcome
676771|NCT00724789|Congenital malformations|congenital malformations
676772|NCT00724789|In-Vitro fertilization|in-vitro fertilization
676773|NCT00724789|Controlled ovarian stimulation|controlled ovarian stimulation
676774|NCT00724789|Follow-up|follow-up
676775|NCT00724776|Chronic hepatitis C, Albinterferon alfa 2b, phase I, Japan|chronic hepatitis c, albinterferon alfa 2b, phase i, japan
676776|NCT00724763|acupuncture, high blood pressure, HRV|acupuncture, high blood pressure, hrv
676777|NCT00724724|Stroke|stroke
676778|NCT00724724|Transient Ischemic Attack|transient ischemic attack
676779|NCT00724711|HIV|hiv
676780|NCT00724711|HIV 1|hiv 1
676781|NCT00724685|Ropivacaine|ropivacaine
676782|NCT00724685|elastomeric pump|elastomeric pump
676783|NCT00724685|patient controlled analgesia|patient controlled analgesia
676784|NCT00724685|morphine consumption|morphine consumption
676785|NCT00724659|Arthrogram|arthrogram
676786|NCT00724659|Contrast|contrast
676787|NCT00724659|Joint|joint
676788|NCT00724659|Ultrasound|ultrasound
676789|NCT00724646|parents|parents
676790|NCT00724646|medically fragile|medically fragile
676791|NCT00724646|death|death
676792|NCT00724646|end-of-life care|end-of-life care
676793|NCT00724646|surveys|surveys
676794|NCT00724633|dialysate|dialysate
676795|NCT00724633|sodium|sodium
676796|NCT00724633|hemodialysis|hemodialysis
676797|NCT00724633|blood pressure|blood pressure
676798|NCT00724633|thirst|thirst
676799|NCT00724633|intradialytic symptoms|intradialytic symptoms
676800|NCT00724633|interdialytic weight gain|interdialytic weight gain
676801|NCT00724633|extracellular fluid balance|extracellular fluid balance
676802|NCT00724633|mechanisms|mechanisms
676803|NCT00724607|Concussion, traumatic brain injury|concussion, traumatic brain injury
676804|NCT00724607|Screening|screening
676805|NCT00724607|neuroimaging|neuroimaging
676806|NCT00724607|Posttraumatic stress disorder|posttraumatic stress disorder
676807|NCT00724594|chorioamnionitis|chorioamnionitis
676808|NCT00724594|maternal chorioamnionitis|maternal chorioamnionitis
676809|NCT00724594|neonatal white matter injury|neonatal white matter injury
676810|NCT00724594|N-acetylcysteine|n-acetylcysteine
676811|NCT00724594|NAC|nac
676812|NCT00724594|anti-oxidant treatment|anti-oxidant treatment
676813|NCT00724581|Atrial fibrillation, amiodarone|atrial fibrillation, amiodarone
676814|NCT00724568|Newly Diagnosed Multiple Myeloma|newly diagnosed multiple myeloma
676815|NCT00724555|stroke|stroke
676816|NCT00724555|tissue plasminogen activator|tissue plasminogen activator
676817|NCT00724555|tPA|tpa
676818|NCT00724529|Crohn's Disease|crohn's disease
676819|NCT00724529|Ankylosing Spondylitis|ankylosing spondylitis
676820|NCT00724516|Mammogram|mammogram
676821|NCT00724516|Biopsy|biopsy
676822|NCT00724516|Needle|needle
676823|NCT00724516|Wire|wire
676824|NCT00724516|Localization|localization
676825|NCT00724516|Compression|compression
676826|NCT00724516|Paddle|paddle
676827|NCT00724503|colon cancer|colon cancer
676828|NCT00724503|Colorectal carcinoma|colorectal carcinoma
676829|NCT00724503|liver metastases|liver metastases
676830|NCT00724503|SIR-Spheres microspheres|sir-spheres microspheres
676831|NCT00724503|yttrium-90|yttrium-90
676832|NCT00724503|FOLFOX|folfox
676833|NCT00724503|bevacizumab|bevacizumab
676834|NCT00724503|metastatic colorectal cancer|metastatic colorectal cancer
676835|NCT00724490|Deep Brain Stimulation|deep brain stimulation
676836|NCT00724490|Obsessive Compulsive Disorder|obsessive compulsive disorder
676837|NCT00724490|Nucleus Accumbens|nucleus accumbens
676838|NCT00724438|Contraception|contraception
676839|NCT00724438|Implanon|implanon
676840|NCT00724438|Obesity|obesity
676841|NCT00724438|Blood spots|blood spots
676842|NCT00724438|Implant|implant
676843|NCT00724438|Pharmacokinetics|pharmacokinetics
676844|NCT00724412|Dry Eye|dry eye
676845|NCT00724412|Corneal Staining|corneal staining
676846|NCT00724360|relapsed/refractory|relapsed/refractory
676847|NCT00724360|HER2|her2
676848|NCT00724360|positive|positive
676849|NCT00724360|B-ALL|b-all
676850|NCT00724360|trastuzumab|trastuzumab
676851|NCT00724347|Auditory Perception|auditory perception
676852|NCT00724347|Hearing Loss|hearing loss
676853|NCT00724347|Presbycusis|presbycusis
676854|NCT00724347|Perceptual Learning|perceptual learning
676855|NCT00724347|Hearing Prosthesis|hearing prosthesis
676856|NCT00724347|Speech Discrimination|speech discrimination
676857|NCT00724347|Delayed Treatment|delayed treatment
676858|NCT00724334|myelofibrosis|myelofibrosis
676859|NCT00724321|iloprost|iloprost
676860|NCT00724321|hypoxic|hypoxic
676861|NCT00724321|pulmonary|pulmonary
676862|NCT00724321|vasoconstriction|vasoconstriction
676863|NCT00724321|altitude|altitude
676864|NCT00724308|Smoking|smoking
676865|NCT00724308|Smoking Cessation|smoking cessation
676866|NCT00724308|Tobacco|tobacco
676867|NCT00724308|Mental Health|mental health
676868|NCT00724282|sleep|sleep
676869|NCT00724282|eszopiclone|eszopiclone
676870|NCT00724282|insulin secretion|insulin secretion
676871|NCT00724282|insulin action|insulin action
676872|NCT00724282|glucose tolerance|glucose tolerance
676873|NCT00724269|Contact lens wear|contact lens wear
676874|NCT00724269|multi-purpose solution|multi-purpose solution
676875|NCT00724269|corneal staining|corneal staining
676876|NCT00724256|Pyelonephritis.|pyelonephritis.
676877|NCT00724256|Urinary Tract Infections.|urinary tract infections.
676878|NCT00724256|Children.|children.
676879|NCT00724256|Randomised controlled trial.|randomised controlled trial.
676880|NCT00724256|Therapy.|therapy.
676881|NCT00724256|Ceftibuten.|ceftibuten.
676882|NCT00724204|probiotics|probiotics
676883|NCT00724204|safety|safety
676884|NCT00724204|fecal microbiota|fecal microbiota
676885|NCT00724204|infections|infections
676886|NCT00724178|Pediatric HIV infection, bone mineral content, bone mineral density, Vitamin D, calcium Dual x-ray absorptiometry|pediatric hiv infection, bone mineral content, bone mineral density, vitamin d, calcium dual x-ray absorptiometry
676887|NCT00724165|physical activity|physical activity
676888|NCT00724165|Latinas|latinas
676889|NCT00724152|coping skills|coping skills
676890|NCT00724152|psychology|psychology
676891|NCT00724152|audiology|audiology
676892|NCT00724152|veterans|veterans
676893|NCT00724152|tinnitus|tinnitus
676894|NCT00724152|adult|adult
676895|NCT00724152|intervention studies|intervention studies
676896|NCT00724152|tinnitus, noise induced|tinnitus, noise induced
676897|NCT00724152|noise|noise
676898|NCT00724152|auditory perception|auditory perception
676899|NCT00724126|Diarrhea|diarrhea
676900|NCT00724126|Rifaximin|rifaximin
676901|NCT00724126|IBS|ibs
676902|NCT00724126|Abdominal pain|abdominal pain
676903|NCT00724126|Bloating|bloating
676904|NCT00724113|Shoulder capsulitis|shoulder capsulitis
676905|NCT00724113|ARTHRO distension|arthro distension
676906|NCT00724113|Mobilisation|mobilisation
676907|NCT00724113|Randomised clinical trial|randomised clinical trial
676908|NCT00724100|Malignancy|malignancy
676909|NCT00724100|Solid tumor|solid tumor
676910|NCT00724100|Tubulin inhibitor|tubulin inhibitor
676911|NCT00724087|short sleep duration|short sleep duration
676912|NCT00724087|energy expenditure|energy expenditure
676913|NCT00724087|insulin secretion|insulin secretion
676914|NCT00724087|insulin action|insulin action
676915|NCT00724087|lipid turnover|lipid turnover
676916|NCT00724087|free fatty acids|free fatty acids
676917|NCT00724074|Arthritis of the knee|arthritis of the knee
676918|NCT00724074|Knee replacement|knee replacement
676919|NCT00724074|Osteoarthritis, knee|osteoarthritis, knee
676920|NCT00724074|Arthroplasty, knee|arthroplasty, knee
676921|NCT00724061|recurrent mycosis fungoides/Sezary syndrome|recurrent mycosis fungoides/sezary syndrome
676922|NCT00724061|stage I mycosis fungoides/Sezary syndrome|stage i mycosis fungoides/sezary syndrome
710420|NCT00589394|immunodeficiency|immunodeficiency
676923|NCT00724061|stage II mycosis fungoides/Sezary syndrome|stage ii mycosis fungoides/sezary syndrome
676924|NCT00724061|stage III mycosis fungoides/Sezary syndrome|stage iii mycosis fungoides/sezary syndrome
676925|NCT00724061|stage IV mycosis fungoides/Sezary syndrome|stage iv mycosis fungoides/sezary syndrome
676926|NCT00724061|recurrent cutaneous T-cell non-Hodgkin lymphoma|recurrent cutaneous t-cell non-hodgkin lymphoma
676927|NCT00724061|stage I cutaneous T-cell non-Hodgkin lymphoma|stage i cutaneous t-cell non-hodgkin lymphoma
676928|NCT00724061|stage II cutaneous T-cell non-Hodgkin lymphoma|stage ii cutaneous t-cell non-hodgkin lymphoma
676929|NCT00724061|stage III cutaneous T-cell non-Hodgkin lymphoma|stage iii cutaneous t-cell non-hodgkin lymphoma
676930|NCT00724061|stage IV cutaneous T-cell non-Hodgkin lymphoma|stage iv cutaneous t-cell non-hodgkin lymphoma
676931|NCT00724048|Huntington Disease|huntington disease
676932|NCT00724035|Anesthesia|anesthesia
676933|NCT00724035|Upper extremity|upper extremity
676934|NCT00724035|Nerve block|nerve block
676936|NCT00724035|Brachial plexus|brachial plexus
676937|NCT00724022|Kidney transplant status|kidney transplant status
676938|NCT00724022|Steroid free|steroid free
676939|NCT00724022|Reduced|reduced
676940|NCT00724022|Calcineurin|calcineurin
676941|NCT00724022|Inhibitor|inhibitor
676942|NCT00724022|Immunosuppression|immunosuppression
676943|NCT00723970|Major Depressive Disorder|major depressive disorder
676944|NCT00723970|Insomnia|insomnia
676945|NCT00723970|Hot Flashes|hot flashes
676946|NCT00723970|Menopause|menopause
676947|NCT00723970|Quetiapine|quetiapine
676948|NCT00723944|dental implants|dental implants
676949|NCT00723944|Osseotite Certain Prevail|osseotite certain prevail
676950|NCT00723944|Lateralized|lateralized
676951|NCT00723944|non-lateralized|non-lateralized
676952|NCT00723944|Osseotite Certain|osseotite certain
676953|NCT00723944|multicenter|multicenter
676954|NCT00723944|randomized|randomized
676955|NCT00723944|clinical study|clinical study
676956|NCT00723944|partial edentulism|partial edentulism
676957|NCT00723944|single stage|single stage
676958|NCT00723944|early loading|early loading
676959|NCT00723944|crestal bone level|crestal bone level
676960|NCT00723944|short fixed bridge|short fixed bridge
676961|NCT00723918|HIV-associated neuropathy|hiv-associated neuropathy
676962|NCT00723918|HIV|hiv
676963|NCT00723918|AIDS|aids
676964|NCT00723918|cannabinoid|cannabinoid
676965|NCT00723918|Cannabis|cannabis
676966|NCT00723918|methadone|methadone
676967|NCT00723918|distal sensory polyneuropathy|distal sensory polyneuropathy
676968|NCT00723918|polyneuropathy|polyneuropathy
676969|NCT00723905|Crohn's Disease, Rheumatoid Arthritis|crohn's disease, rheumatoid arthritis
676970|NCT00723866|Botulinum toxin, Spasticity, Stroke, Rehabilitation.|botulinum toxin, spasticity, stroke, rehabilitation.
676971|NCT00723853|Obesity|obesity
676972|NCT00723853|Type 2 diabetes|type 2 diabetes
676973|NCT00723853|African American children|african american children
676974|NCT00723853|African American youth|african american youth
676975|NCT00723853|Community based|community based
676976|NCT00723853|Family oriented|family oriented
676977|NCT00723853|Obesity & Risk of type 2 diabetes|obesity & risk of type 2 diabetes
676978|NCT00723840|EuroQOL (EQ-5D)|euroqol (eq-5d)
676979|NCT00723814|normal|normal
676980|NCT00723801|Marfan syndrome|marfan syndrome
676981|NCT00723801|Losartan|losartan
676982|NCT00723801|Atenolol|atenolol
676983|NCT00723801|Diastolic Function|diastolic function
676984|NCT00723801|Aortic Stiffness|aortic stiffness
676985|NCT00723788|Appendicitis|appendicitis
676986|NCT00723788|Children|children
676987|NCT00723788|Magnetic Resonance Imaging|magnetic resonance imaging
676988|NCT00723775|KALETRA|kaletra
676989|NCT00723775|GSK706769|gsk706769
676990|NCT00723775|HIV|hiv
676991|NCT00723775|healthy volunteers|healthy volunteers
676992|NCT00723762|Valproic acid|valproic acid
676993|NCT00723762|Urea cycle|urea cycle
676994|NCT00723762|Ornithine|ornithine
676995|NCT00723762|Valproate|valproate
676996|NCT00723762|Side effect|side effect
676997|NCT00723749|Suboxone|suboxone
676998|NCT00723749|Subutex|subutex
676999|NCT00723749|Buprenorphine|buprenorphine
677000|NCT00723749|Naloxone|naloxone
677001|NCT00723697|Subutex|subutex
677002|NCT00723684|ADHD|adhd
677003|NCT00723684|Children|children
677004|NCT00723684|EEG-Neurofeedback|eeg-neurofeedback
677005|NCT00723658|Waldenström macroglobulinemia|waldenström macroglobulinemia
677006|NCT00723619|asthma|asthma
677007|NCT00723619|spirometry|spirometry
677008|NCT00723619|FENO|feno
677009|NCT00723619|normal values for spirometry in childhood|normal values for spirometry in childhood
677010|NCT00723619|normal values for FENO in childhood|normal values for feno in childhood
677011|NCT00723606|Intramuscular ziprasidone, agitation, efficacy and safety|intramuscular ziprasidone, agitation, efficacy and safety
677012|NCT00723593|Graft-Versus-Host Disease|graft-versus-host disease
677013|NCT00723593|Gastrointestinal|gastrointestinal
677014|NCT00723593|Apoptotic Assay|apoptotic assay
677015|NCT00723593|Serum Proteomic Pattern Analysis|serum proteomic pattern analysis
677016|NCT00723593|Mucosal Biopsy|mucosal biopsy
677017|NCT00723593|Graft Versus Host Disease|graft versus host disease
677018|NCT00723593|GVHD|gvhd
677019|NCT00723580|Kabuki Syndrome|kabuki syndrome
677020|NCT00723580|Actigraphy|actigraphy
677021|NCT00723580|Treatment Response Measurement|treatment response measurement
677022|NCT00723567|Spectrin Gene|spectrin gene
677023|NCT00723567|Hereditary Elliptocytosis (HE)|hereditary elliptocytosis (he)
677024|NCT00723567|Hereditary Pyropoikilocytosis (HPP)|hereditary pyropoikilocytosis (hpp)
677025|NCT00723567|Genetics|genetics
677026|NCT00723554|pulmonary arterial hypertension|pulmonary arterial hypertension
677027|NCT00723554|inhaled therapy|inhaled therapy
677028|NCT00723554|power disc-15|power disc-15
677029|NCT00723528|Psoriasis|psoriasis
677030|NCT00723528|Ustekinumab|ustekinumab
677031|NCT00723528|CNTO 1275|cnto 1275
677032|NCT00723515|White spot lesion|white spot lesion
677033|NCT00723515|Tooth remineralization|tooth remineralization
677034|NCT00723515|Fluoride varnishes|fluoride varnishes
677035|NCT00723502|Helicobacter pylori|helicobacter pylori
677036|NCT00723502|Eradication|eradication
677038|NCT00723489|Yellow Fever Vaccine|yellow fever vaccine
677039|NCT00723489|Scarification Method|scarification method
677040|NCT00723489|Atopic Dermatitis|atopic dermatitis
677041|NCT00723489|IgG antibodies|igg antibodies
677042|NCT00723476|Quality of Life|quality of life
677043|NCT00723476|Adolescent|adolescent
677044|NCT00723476|Advance Care Planning|advance care planning
677045|NCT00723476|Palliative Care|palliative care
677046|NCT00723476|End-of-Life Care|end-of-life care
677047|NCT00723476|HIV/AIDS|hiv/aids
677048|NCT00723476|Psychological Adjustment|psychological adjustment
677049|NCT00723450|Bipolar I pediatric lamictal adolescent|bipolar i pediatric lamictal adolescent
677050|NCT00723437|nail, psoriasis, NAPSI,acitretin|nail, psoriasis, napsi,acitretin
677051|NCT00723424|AZD5672|azd5672
677052|NCT00723424|digoxin|digoxin
677053|NCT00723411|Diabetes|diabetes
677054|NCT00723411|Juvenile Diabetes|juvenile diabetes
677055|NCT00723411|Diabetes type 1|diabetes type 1
677056|NCT00723411|Autoimmune Diabetes|autoimmune diabetes
677057|NCT00723411|Insulin dependent Diabetes|insulin dependent diabetes
677058|NCT00723411|Type 1 diabetes|type 1 diabetes
677059|NCT00723411|Type 1 diabetes mellitus|type 1 diabetes mellitus
677060|NCT00723411|Diamyd|diamyd
677061|NCT00723411|rhGAD65|rhgad65
677062|NCT00723411|GAD|gad
677063|NCT00723411|GAD-alum|gad-alum
677064|NCT00723398|omega-3 fatty acids|omega-3 fatty acids
677065|NCT00723398|antiestrogens|antiestrogens
677066|NCT00723398|breast cancer prevention|breast cancer prevention
677067|NCT00723398|breast density|breast density
677068|NCT00723398|biomarkers of mammary carcinogenesis|biomarkers of mammary carcinogenesis
677069|NCT00723385|cholesterol|cholesterol
677070|NCT00723385|LDL-cholesterol|ldl-cholesterol
677071|NCT00723385|cholecalciferol|cholecalciferol
677072|NCT00723385|lipids|lipids
677073|NCT00723385|C-reactive protein|c-reactive protein
677074|NCT00723359|Multiple Myeloma|multiple myeloma
677075|NCT00723359|Refractory|refractory
677076|NCT00723359|Relapsed|relapsed
677077|NCT00723346|Relapse|relapse
677078|NCT00723346|Lymphoma lymphoblastic|lymphoma lymphoblastic
677079|NCT00723333|Bone Marrow Transplant|bone marrow transplant
677080|NCT00723333|Myelofibrosis|myelofibrosis
677081|NCT00723333|Stem Cell Transplant|stem cell transplant
677082|NCT00723333|Allogenic Transplant|allogenic transplant
677083|NCT00723320|Atherosclerosis|atherosclerosis
677084|NCT00723320|Atorvastatin|atorvastatin
677085|NCT00723320|Therapeutic lifestyle change|therapeutic lifestyle change
677086|NCT00723320|CIMT|cimt
677087|NCT00723320|ABI|abi
677088|NCT00723320|PWV|pwv
677089|NCT00723307|No diabetes mellitus|no diabetes mellitus
677090|NCT00723307|Elevated waist circumference|elevated waist circumference
677091|NCT00723294|invasive ductal breast carcinoma|invasive ductal breast carcinoma
677092|NCT00723294|male breast cancer|male breast cancer
677093|NCT00723294|stage IA breast cancer|stage ia breast cancer
677094|NCT00723294|stage IB breast cancer|stage ib breast cancer
677095|NCT00723294|stage II breast cancer|stage ii breast cancer
677096|NCT00723281|transplant coronary artery disease|transplant coronary artery disease
677097|NCT00723281|CT angiography|ct angiography
677098|NCT00723281|conventional angiography|conventional angiography
677099|NCT00723281|intravascular ultrasound|intravascular ultrasound
677100|NCT00723281|Heart transplant patients with known transplant coronary artery disease|heart transplant patients with known transplant coronary artery disease
677101|NCT00723268|Oral ulcers|oral ulcers
677102|NCT00723216|Prevention|prevention
677103|NCT00723216|venous thromboembolism|venous thromboembolism
677104|NCT00723216|curative surgery|curative surgery
677105|NCT00723203|Philadelphia chromosome positive adult precursor acute lymphoblastic leukemia|philadelphia chromosome positive adult precursor acute lymphoblastic leukemia
677106|NCT00723203|recurrent adult acute lymphoblastic leukemia|recurrent adult acute lymphoblastic leukemia
677107|NCT00723203|recurrent adult acute myeloid leukemia|recurrent adult acute myeloid leukemia
677108|NCT00723190|CLONICEL|clonicel
677109|NCT00723190|Attention Deficit Hyperactivity Disorder|attention deficit hyperactivity disorder
677110|NCT00723190|clonidine HCl sustained release|clonidine hcl sustained release
677111|NCT00723177|opioid withdrawal, analgesia|opioid withdrawal, analgesia
677112|NCT00723164|Sevoflurane induction|sevoflurane induction
858981|NCT00065299|PKU|pku
677113|NCT00723164|Premedication|premedication
677114|NCT00723164|laryngeal mask airway|laryngeal mask airway
677115|NCT00723164|Anesthesia, inhalation [E03.155.197.197]|anesthesia, inhalation [e03.155.197.197]
677116|NCT00723125|Breast Cancer|breast cancer
677117|NCT00723112|Myelodysplastic Syndrome|myelodysplastic syndrome
677118|NCT00723112|Erythropoiesis|erythropoiesis
677119|NCT00723112|Ineffective Hematopoiesis|ineffective hematopoiesis
677120|NCT00723112|Erythroid Progenitors|erythroid progenitors
677121|NCT00723112|Dyserythropoiesis|dyserythropoiesis
677122|NCT00723086|docetaxel, prednisolone, drug combination|docetaxel, prednisolone, drug combination
677123|NCT00723073|micafungin, caspofungin, febrile neutropenia|micafungin, caspofungin, febrile neutropenia
677124|NCT00723047|Patients|patients
677125|NCT00723047|CD complicated|cd complicated
677126|NCT00723047|least|least
677127|NCT00723047|One perianal fistula|one perianal fistula
677128|NCT00723047|Draining|draining
677129|NCT00723047|2 months duration|2 months duration
677130|NCT00723021|Bronchodilator|bronchodilator
677131|NCT00723008|anxiety|anxiety
677132|NCT00723008|insomnia|insomnia
677133|NCT00723008|pain|pain
677134|NCT00723008|Alpha Stim|alpha stim
677135|NCT00723008|Cranial electrotherapy stimulation|cranial electrotherapy stimulation
677136|NCT00722995|Morbid obesity|morbid obesity
677137|NCT00722995|Sleeve gastrectomy|sleeve gastrectomy
677138|NCT00722995|Gastric bypass|gastric bypass
677139|NCT00722995|Complications|complications
677140|NCT00722995|Efficacity|efficacity
677141|NCT00722995|Safety|safety
677142|NCT00722995|Compare|compare
677143|NCT00722982|coxarthrosis|coxarthrosis
677145|NCT00722982|RSA|rsa
677146|NCT00722982|DXA|dxa
677147|NCT00722982|C-stem AMT|c-stem amt
677148|NCT00722982|Marathon|marathon
677149|NCT00722969|non-small cell lung cancer|non-small cell lung cancer
677150|NCT00722969|erlotinib|erlotinib
677151|NCT00722969|sorafenib|sorafenib
677152|NCT00722956|atorvastatin|atorvastatin
677153|NCT00722956|AZD5672|azd5672
677154|NCT00722943|infant|infant
677155|NCT00722943|premature|premature
677156|NCT00722943|message|message
677157|NCT00722943|therapy|therapy
677158|NCT00722943|NICU|nicu
677159|NCT00722943|neonatal intensive care unit|neonatal intensive care unit
677160|NCT00722943|cortisol level|cortisol level
677161|NCT00722943|stress|stress
677162|NCT00722943|postnatal|postnatal
677163|NCT00722943|weight gain|weight gain
677164|NCT00722943|DMT|dmt
677165|NCT00722943|Development Message Therapy|development message therapy
677166|NCT00722943|growth|growth
677167|NCT00722930|Follicular Lymphoma|follicular lymphoma
677168|NCT00722930|High-risk FLIPI|high-risk flipi
677169|NCT00722930|R-CHOP|r-chop
677170|NCT00722930|GOTEL|gotel
677171|NCT00722930|Partial|partial
677172|NCT00722930|Complete|complete
677173|NCT00722930|Response|response
677174|NCT00722930|Induction|induction
677175|NCT00722930|Chemotherapy|chemotherapy
677176|NCT00722917|Glucose Metabolism Disorder|glucose metabolism disorder
677177|NCT00722917|Dysmetabolic Syndrome|dysmetabolic syndrome
677178|NCT00722917|Type II Diabetes|type ii diabetes
677179|NCT00722917|Diabetes Mellitus, Lipoatrophic|diabetes mellitus, lipoatrophic
677180|NCT00722917|Dyslipidemia|dyslipidemia
677181|NCT00722917|Drug Therapy|drug therapy
677182|NCT00722904|post-intervention surveillance of aortic coarctation|post-intervention surveillance of aortic coarctation
677183|NCT00722904|MRA and 2D phase contrast imaging|mra and 2d phase contrast imaging
677184|NCT00722904|4D Flow velocity mapping|4d flow velocity mapping
677185|NCT00722904|Patients undergoing routine post-intervention surveillance of aortic coarctation|patients undergoing routine post-intervention surveillance of aortic coarctation
677186|NCT00722904|Healthy volunteers|healthy volunteers
677187|NCT00722891|Eye Diseases|eye diseases
677188|NCT00722878|Primary Ciliary Dyskinesia|primary ciliary dyskinesia
677189|NCT00722865|Avastin|avastin
677190|NCT00722865|bevacizumab|bevacizumab
677191|NCT00722865|ABVD|abvd
677192|NCT00722865|angiogenesis|angiogenesis
677193|NCT00722865|antiangiogenic|antiangiogenic
677194|NCT00722865|Hodgkin|hodgkin
677195|NCT00722839|cytomegalovirus infection|cytomegalovirus infection
677196|NCT00722826|Pulmonary Regurgitation|pulmonary regurgitation
677197|NCT00722826|Tetralogy of Fallot|tetralogy of fallot
677198|NCT00722800|YAZ|yaz
677199|NCT00722800|oral contraceptive|oral contraceptive
677200|NCT00722800|hidradenitis suppurativa|hidradenitis suppurativa
677201|NCT00722774|Vaccine|vaccine
677202|NCT00722774|Influenza|influenza
677203|NCT00722761|YAZ|yaz
677204|NCT00722761|oral contraceptive|oral contraceptive
677205|NCT00722761|Acne vulgaris|acne vulgaris
677206|NCT00722748|Genebank|genebank
677207|NCT00722748|Gene registry|gene registry
677208|NCT00722748|Cardiac Arrythmia Disease|cardiac arrythmia disease
677209|NCT00722735|uncomplicated Urinary Tract Infection in Women|uncomplicated urinary tract infection in women
677210|NCT00722735|Antibacterial Chemotherapy|antibacterial chemotherapy
677211|NCT00722735|Proof-of-Concept|proof-of-concept
677212|NCT00722709|Pain|pain
677213|NCT00722709|Fatigue|fatigue
677214|NCT00722709|Colon|colon
677215|NCT00722709|Surgery|surgery
677216|NCT00722709|ERAS|eras
677217|NCT00722709|Fastrack|fastrack
677218|NCT00722709|Local anaesthetic|local anaesthetic
677219|NCT00722709|Peritoneum|peritoneum
677220|NCT00722709|Metabolic|metabolic
677221|NCT00722709|Endocrine|endocrine
677222|NCT00722709|Post surgical metabolic response|post surgical metabolic response
677223|NCT00722709|Complications|complications
677224|NCT00722709|Time to passage of flatus|time to passage of flatus
677225|NCT00722709|Time to passage of stool|time to passage of stool
677226|NCT00722709|Time to discharge from facility|time to discharge from facility
677227|NCT00722709|Re-admission rate|re-admission rate
677228|NCT00722696|Metabolism|metabolism
677229|NCT00722696|Muscles|muscles
677230|NCT00722696|Exercise|exercise
677231|NCT00722670|risk reduction|risk reduction
677232|NCT00722670|prevention|prevention
677233|NCT00722670|HIV prevention|hiv prevention
677234|NCT00722657|asthma|asthma
677235|NCT00722657|epidemiology|epidemiology
677237|NCT00722644|Medication Adherence|medication adherence
677238|NCT00722644|Stress Management|stress management
677239|NCT00722644|CD4/Viral Loads|cd4/viral loads
677240|NCT00722644|Cognitive Behavioral Treatment|cognitive behavioral treatment
677241|NCT00722618|Infertility|infertility
677242|NCT00722605|lung|lung
677243|NCT00722605|esophageal|esophageal
677244|NCT00722605|cone beam ct scan|cone beam ct scan
677245|NCT00722592|cancer|cancer
677246|NCT00722592|ovarian|ovarian
677247|NCT00722592|platinum-resistant|platinum-resistant
677248|NCT00722592|Phase II|phase ii
677249|NCT00722592|EC145|ec145
677250|NCT00722592|EC20|ec20
677251|NCT00722579|Coronary Artery Disease|coronary artery disease
677252|NCT00722553|Transitional Cell Carcinoma of the Urinary Bladder|transitional cell carcinoma of the urinary bladder
677253|NCT00722553|Transitional Cell Carcinoma|transitional cell carcinoma
677254|NCT00722553|Bladder Cancer|bladder cancer
677255|NCT00722553|Urinary Bladder Cancer|urinary bladder cancer
677256|NCT00722553|Bladder|bladder
677257|NCT00722553|Carcinoma|carcinoma
677258|NCT00722553|Urinary|urinary
677259|NCT00722553|Metastatic|metastatic
677260|NCT00722553|Relapsed|relapsed
677261|NCT00722527|Primary Familial and Congenital Polycythemia|primary familial and congenital polycythemia
677262|NCT00722527|Polycythemia|polycythemia
677263|NCT00722527|Molecular Biology|molecular biology
677264|NCT00722527|Genetics|genetics
677265|NCT00722527|Erythropoiesis|erythropoiesis
677266|NCT00722527|EPOR mutation|epor mutation
677267|NCT00722527|Thrombocytosis|thrombocytosis
677268|NCT00722527|Hypoxia|hypoxia
677269|NCT00722475|recurrent miscarriage|recurrent miscarriage
677270|NCT00722475|immunology|immunology
677271|NCT00722475|intravenous immunoglobulin|intravenous immunoglobulin
677272|NCT00722475|miscarriage|miscarriage
677273|NCT00722462|Infertility|infertility
677274|NCT00722462|IVF|ivf
677275|NCT00722462|Acupuncture|acupuncture
677276|NCT00722436|antifibrinolytic, tranexamic acid|antifibrinolytic, tranexamic acid
677277|NCT00722423|Hepatitis C|hepatitis c
677278|NCT00722423|integrated care|integrated care
677279|NCT00722423|alpha interferon|alpha interferon
677280|NCT00722423|mental health|mental health
677281|NCT00722410|Carbapenem|carbapenem
677282|NCT00722410|resistant|resistant
677283|NCT00722410|Klebsiella pneumoniae|klebsiella pneumoniae
677284|NCT00722410|Carpapenemases|carpapenemases
677285|NCT00722410|Probiotics|probiotics
677286|NCT00722410|VSL3|vsl3
677287|NCT00722397|genetics, pediatrics|genetics, pediatrics
677288|NCT00722384|AMD|amd
677289|NCT00722384|Macular Degeneration|macular degeneration
677290|NCT00722384|Opko Health|opko health
677291|NCT00722384|Acuity Pharmaceuticals|acuity pharmaceuticals
677292|NCT00722384|bevasiranib|bevasiranib
677293|NCT00722384|Cand5|cand5
677294|NCT00722384|Age-Related|age-related
677295|NCT00722345|Obesity|obesity
677296|NCT00722345|Physical activity|physical activity
677297|NCT00722345|Adolescents|adolescents
677298|NCT00722345|Exercise counseling intervention|exercise counseling intervention
677299|NCT00722332|HBIG (Hepatitis B Immune Globulin)|hbig (hepatitis b immune globulin)
677300|NCT00722332|Chronic Hepatitis B Recurrence|chronic hepatitis b recurrence
677301|NCT00722332|Liver Transplant|liver transplant
677302|NCT00722319|oral anticoagulation|oral anticoagulation
677303|NCT00722319|warfarin|warfarin
677304|NCT00722319|percutaneous coronary intervention|percutaneous coronary intervention
677305|NCT00722319|stent|stent
677306|NCT00722319|antiplatelet agents|antiplatelet agents
677307|NCT00722306|non-restorative|non-restorative
677308|NCT00722306|sleep|sleep
677309|NCT00722293|Solid tumors|solid tumors
677310|NCT00722293|Cancer|cancer
677311|NCT00722293|Neoplasms, Ovarian|neoplasms, ovarian
677312|NCT00722293|doxorubicin|doxorubicin
677313|NCT00722293|epirubicin|epirubicin
677314|NCT00722293|anti-angiogenesis|anti-angiogenesis
677315|NCT00722293|pharmacodynamics|pharmacodynamics
677316|NCT00722293|pazopanib (GW786034)|pazopanib (gw786034)
677317|NCT00722293|pharmacokinetics|pharmacokinetics
677318|NCT00722293|Soft Tissue|soft tissue
677319|NCT00722293|Sarcoma|sarcoma
677320|NCT00722280|Amputation, upper limb, composite tissue, immunosuppression|amputation, upper limb, composite tissue, immunosuppression
677321|NCT00722267|severe COPD|severe copd
677322|NCT00722267|COPD symptoms|copd symptoms
677323|NCT00722267|variability of symptoms|variability of symptoms
677324|NCT00722267|patient's perception|patient's perception
677325|NCT00722254|Myeloproliferative Disorder|myeloproliferative disorder
677326|NCT00722254|Primary Myelofibrosis|primary myelofibrosis
677327|NCT00722254|Primary Pulmonary Hypertension|primary pulmonary hypertension
677328|NCT00722254|Secondary Myelofibrosis|secondary myelofibrosis
677329|NCT00722254|Pulmonary Arterial Hypertension|pulmonary arterial hypertension
677330|NCT00722254|Flolan|flolan
677331|NCT00722254|Clonality|clonality
677332|NCT00722254|CD34+ cells|cd34+ cells
677333|NCT00722254|Hematologic abnormalities|hematologic abnormalities
677334|NCT00722241|Continuous Glucose Monitoring|continuous glucose monitoring
677335|NCT00722241|Interstitial Fluid|interstitial fluid
677336|NCT00722241|Diabetes Mellitus|diabetes mellitus
677337|NCT00722215|Endothelin antagonist|endothelin antagonist
677338|NCT00722215|Chronic kidney disease|chronic kidney disease
677339|NCT00722215|Proteinuria|proteinuria
677340|NCT00722215|Cardiovascular disease|cardiovascular disease
677341|NCT00722215|Blood pressure|blood pressure
677342|NCT00722215|Arterial stiffness|arterial stiffness
677343|NCT00722215|Endothelial function|endothelial function
677344|NCT00722189|Mycoses|mycoses
677345|NCT00722176|Schizophrenia|schizophrenia
677346|NCT00722163|Cognitive Behavioural therapy|cognitive behavioural therapy
677347|NCT00722163|Psychosis|psychosis
677348|NCT00722150|Artesunate|artesunate
677349|NCT00722150|Plasmodium Falciparum|plasmodium falciparum
677350|NCT00722150|Cambodia|cambodia
677351|NCT00722124|tobacco use|tobacco use
677352|NCT00722124|cigarettes|cigarettes
677353|NCT00722124|smokers|smokers
677354|NCT00722111|tongue|tongue
677355|NCT00722111|pressure|pressure
677356|NCT00722098|Melanoma|melanoma
677357|NCT00722098|Dendritic Cell|dendritic cell
677358|NCT00722098|Vaccine|vaccine
677359|NCT00722098|Immunotherapy|immunotherapy
677360|NCT00722098|Cyclophosphamide|cyclophosphamide
677361|NCT00722085|Amniotic Fluid Sludge|amniotic fluid sludge
677362|NCT00722085|Cerclage|cerclage
677363|NCT00722085|Ultrasound|ultrasound
677364|NCT00722085|Preterm Delivery|preterm delivery
677365|NCT00722085|Neonatal|neonatal
677366|NCT00722072|male breast cancer|male breast cancer
677367|NCT00722072|stage IIIA breast cancer|stage iiia breast cancer
677368|NCT00722072|stage IIIB breast cancer|stage iiib breast cancer
677369|NCT00722072|stage IIIC breast cancer|stage iiic breast cancer
677370|NCT00722072|stage IV breast cancer|stage iv breast cancer
677371|NCT00722072|recurrent breast cancer|recurrent breast cancer
677372|NCT00722046|Alzheimer's disease|alzheimer's disease
677373|NCT00722046|antibody|antibody
677374|NCT00722046|amyloid|amyloid
677375|NCT00722033|preterm|preterm
677376|NCT00722033|aEEG|aeeg
677377|NCT00722033|apneas|apneas
677378|NCT00722033|surfactant|surfactant
677379|NCT00722033|indomethacin|indomethacin
677380|NCT00722033|aminophyline|aminophyline
677381|NCT00722020|Asthma|asthma
677382|NCT00722020|Bronchial Disease|bronchial disease
677383|NCT00722020|Status Asthmaticus|status asthmaticus
677384|NCT00722020|High Frequency Chest Wall Oscillation|high frequency chest wall oscillation
677385|NCT00722020|the Vest|the vest
677386|NCT00722020|HFCWO|hfcwo
677387|NCT00722007|hip resurfacing|hip resurfacing
677388|NCT00722007|osteoarthritis|osteoarthritis
677389|NCT00722007|avascular necrosis|avascular necrosis
677390|NCT00722007|rheumatoid arthritis|rheumatoid arthritis
677391|NCT00721994|hip resurfacing|hip resurfacing
677392|NCT00721994|osteoarthritis|osteoarthritis
677393|NCT00721994|avascular necrosis|avascular necrosis
677394|NCT00721994|rheumatoid arthritis|rheumatoid arthritis
677395|NCT00721981|patient preference|patient preference
677396|NCT00721981|oncology|oncology
677397|NCT00721981|chemotherapy|chemotherapy
677398|NCT00721981|NSCLC|nsclc
677399|NCT00721968|Open angle|open angle
677400|NCT00721968|Glaucoma|glaucoma
677401|NCT00721968|Cataract|cataract
677402|NCT00721968|Surgery|surgery
677403|NCT00721955|Bipolar 1 disorder,|bipolar 1 disorder,
677404|NCT00721955|agitation,|agitation,
677405|NCT00721955|acute,|acute,
677406|NCT00721955|treatment|treatment
677407|NCT00721929|adrenal glands, adrenal masses|adrenal glands, adrenal masses
677408|NCT00721890|chemoprevention|chemoprevention
677409|NCT00721890|green tea|green tea
677410|NCT00721890|relapse free-survival|relapse free-survival
677411|NCT00721890|proteases|proteases
677412|NCT00721864|Paroxysmal Nocturnal Hemoglobinuria|paroxysmal nocturnal hemoglobinuria
677413|NCT00721864|PIG-A Mutation|pig-a mutation
677414|NCT00721864|Prion Protein|prion protein
677415|NCT00721864|Hematopoietic stem cells|hematopoietic stem cells
677416|NCT00721864|Clonal disorder|clonal disorder
677417|NCT00721838|adolescent obesity|adolescent obesity
677418|NCT00721838|eating behavior|eating behavior
677419|NCT00721838|dietary intake|dietary intake
677420|NCT00721825|Stroke|stroke
677421|NCT00721825|Cerebral infarct|cerebral infarct
677422|NCT00721825|Rehabilitation|rehabilitation
677423|NCT00721825|Double blind Randomized|double blind randomized
677424|NCT00721825|Placebo controlled|placebo controlled
677425|NCT00721825|Traditional Chinese Medicine|traditional chinese medicine
677426|NCT00721825|Neuroaid|neuroaid
677427|NCT00721812|pharmacokinetics|pharmacokinetics
677428|NCT00721812|Phase 1|phase 1
677429|NCT00721812|first time in humans|first time in humans
677430|NCT00721812|IBD|ibd
677431|NCT00721812|safety|safety
677432|NCT00721812|human volunteers|human volunteers
677433|NCT00721799|Positron-Emission Tomography|positron-emission tomography
677434|NCT00721799|radiation therapy|radiation therapy
677435|NCT00721799|cisplatin|cisplatin
677436|NCT00721799|chemotherapy|chemotherapy
677437|NCT00721799|FLT|flt
677438|NCT00721786|Smoking cessation|smoking cessation
677439|NCT00721786|Cigarette smoking|cigarette smoking
677440|NCT00721786|Tobacco smoking|tobacco smoking
677441|NCT00721786|Internet interventions|internet interventions
677442|NCT00721786|Spanish-speaking|spanish-speaking
677443|NCT00721773|Continuous Ambulatory Peritoneal Dialysis|continuous ambulatory peritoneal dialysis
677444|NCT00721773|Angiotensin-converting Enzyme Inhibitor|angiotensin-converting enzyme inhibitor
677445|NCT00721773|Angiotensin II Receptor Blocker|angiotensin ii receptor blocker
677446|NCT00721773|Renin angiotensin system inhibitor|renin angiotensin system inhibitor
677447|NCT00721773|Residual Renal Function|residual renal function
677448|NCT00721760|Hip fractures|hip fractures
677449|NCT00721760|Heparin Low-Molecular-Weight|heparin low-molecular-weight
677450|NCT00721760|Randomized Controlled Trial|randomized controlled trial
677451|NCT00721747|breast cancer patients her2 negative pathological responses|breast cancer patients her2 negative pathological responses
677452|NCT00721734|Myeloma|myeloma
677453|NCT00721734|Renal Insufficiency|renal insufficiency
677454|NCT00721734|Proteasome|proteasome
677455|NCT00721734|Hematological|hematological
677456|NCT00721734|carfilzomib|carfilzomib
677457|NCT00721734|PR-171|pr-171
677458|NCT00721721|Dietary Sodium|dietary sodium
677459|NCT00721721|Dietary Potassium|dietary potassium
677460|NCT00721721|Genes|genes
677461|NCT00721721|Genomics|genomics
677462|NCT00721708|histidine dipeptides|histidine dipeptides
677463|NCT00721708|carnosine|carnosine
677464|NCT00721708|anserine|anserine
677465|NCT00721695|Cataract|cataract
677466|NCT00721695|Cataract Extraction|cataract extraction
677467|NCT00721695|Lens Implantation|lens implantation
677468|NCT00721695|Phacoemulsification|phacoemulsification
677469|NCT00721682|Pediatry|pediatry
677470|NCT00721682|Ill-treatment|ill-treatment
677471|NCT00721682|Pain|pain
677472|NCT00721682|maltreated children|maltreated children
677473|NCT00721669|solid tumor|solid tumor
677474|NCT00721656|Dry eye syndromes|dry eye syndromes
677475|NCT00721656|Corneal diseases|corneal diseases
677476|NCT00721656|Conjunctival Diseases|conjunctival diseases
677477|NCT00721643|Angelica keiskei|angelica keiskei
677478|NCT00721643|absorption kinetics|absorption kinetics
677479|NCT00721643|quercetin|quercetin
677480|NCT00721630|CAPECITABINE|capecitabine
677481|NCT00721630|LAPATINIB|lapatinib
677482|NCT00721604|shock|shock
677483|NCT00721604|fluid responsiveness|fluid responsiveness
677484|NCT00721604|volume expansion|volume expansion
677485|NCT00721591|Recurrent Pregnancy Loss|recurrent pregnancy loss
677486|NCT00721591|Habitual abortion|habitual abortion
677487|NCT00721591|Fetal demise|fetal demise
677488|NCT00721591|Antiphospholipid antibodies|antiphospholipid antibodies
677489|NCT00721591|Inherited thrombophilia|inherited thrombophilia
677490|NCT00721578|Observational study|observational study
677491|NCT00721578|Effectiveness|effectiveness
677492|NCT00721578|Safety|safety
677493|NCT00721578|Tolerability|tolerability
677494|NCT00721578|Systemic Fungal Infection|systemic fungal infection
677495|NCT00721565|Breast Cancer|breast cancer
677496|NCT00721565|Exercise|exercise
677497|NCT00721565|Social Cognitive Theory|social cognitive theory
677498|NCT00721565|Adherence|adherence
677499|NCT00721565|Symptoms|symptoms
677500|NCT00721565|Body Composition|body composition
677501|NCT00721552|beta-cell function|beta-cell function
677502|NCT00721552|glucocorticoid-induced diabetes|glucocorticoid-induced diabetes
677503|NCT00721552|glucocorticoid|glucocorticoid
677504|NCT00721552|DPP-4 inhibitors|dpp-4 inhibitors
677505|NCT00721552|sitagliptin|sitagliptin
677506|NCT00721552|diabetes mellitus|diabetes mellitus
677507|NCT00721552|steroid diabetes|steroid diabetes
677508|NCT00721552|insulin resistance|insulin resistance
677509|NCT00721552|insulin sensitivity|insulin sensitivity
677510|NCT00721526|alcohol dependence|alcohol dependence
677511|NCT00721526|alcoholism|alcoholism
677512|NCT00721526|anxiety disorder|anxiety disorder
677513|NCT00721526|pharmacotherapy|pharmacotherapy
677514|NCT00721526|disulfiram|disulfiram
677515|NCT00721526|lorazepam|lorazepam
677516|NCT00721513|stage III squamous cell carcinoma of the oropharynx|stage iii squamous cell carcinoma of the oropharynx
710421|NCT00589394|Healthy patients|healthy patients
677517|NCT00721513|stage IV squamous cell carcinoma of the oropharynx|stage iv squamous cell carcinoma of the oropharynx
677518|NCT00721513|stage III squamous cell carcinoma of the hypopharynx|stage iii squamous cell carcinoma of the hypopharynx
677519|NCT00721513|stage IV squamous cell carcinoma of the hypopharynx|stage iv squamous cell carcinoma of the hypopharynx
677520|NCT00721513|stage III squamous cell carcinoma of the larynx|stage iii squamous cell carcinoma of the larynx
677521|NCT00721513|stage III verrucous carcinoma of the larynx|stage iii verrucous carcinoma of the larynx
677522|NCT00721513|stage IV squamous cell carcinoma of the larynx|stage iv squamous cell carcinoma of the larynx
677523|NCT00721513|stage IV verrucous carcinoma of the larynx|stage iv verrucous carcinoma of the larynx
677524|NCT00721487|C. albicans|c. albicans
677525|NCT00721487|fluconazole|fluconazole
677526|NCT00721461|Assess|assess
677527|NCT00721461|Tolerability|tolerability
677528|NCT00721461|MedPulser DDS device|medpulser dds device
677529|NCT00721448|Pharmacokinetics|pharmacokinetics
677530|NCT00721422|Pharmacokinetics of PD 0332334 in subjects with renal insufficiency|pharmacokinetics of pd 0332334 in subjects with renal insufficiency
677531|NCT00721409|hormone-receptor positive advanced breast cancer|hormone-receptor positive advanced breast cancer
677532|NCT00721396|Meningococcal disease,|meningococcal disease,
677533|NCT00721396|Neisseria meningitidis serogroup B,|neisseria meningitidis serogroup b,
677535|NCT00721396|Vaccination,|vaccination,
677536|NCT00721396|Infants|infants
677537|NCT00721383|caregiving, Alzheimer's disease, physical activity|caregiving, alzheimer's disease, physical activity
677538|NCT00721370|sentinel lymph node mapping|sentinel lymph node mapping
677539|NCT00721370|breast cancer|breast cancer
677540|NCT00721370|near infrared imaging|near infrared imaging
677541|NCT00721357|muscles|muscles
677542|NCT00721357|work|work
677543|NCT00721357|Magnetic Resonance Imaging|magnetic resonance imaging
677544|NCT00721357|control groups|control groups
677545|NCT00721344|Healthy males and females|healthy males and females
677546|NCT00721331|CombinatoRx|combinatorx
677547|NCT00721331|Atopic|atopic
677548|NCT00721331|Dermatitis|dermatitis
677549|NCT00721331|Topical|topical
677550|NCT00721331|CRx-197|crx-197
677551|NCT00721331|Normal Healthy Volunteers|normal healthy volunteers
677552|NCT00721318|chronic widespread pain|chronic widespread pain
677553|NCT00721318|fibromyalgia|fibromyalgia
677554|NCT00721318|rheumatoid arthritis|rheumatoid arthritis
677555|NCT00721318|Estonia|estonia
677556|NCT00721305|Type 1 human immunodeficiency virus infection|type 1 human immunodeficiency virus infection
677557|NCT00721305|Lovastatin|lovastatin
677558|NCT00721305|Adaptive Immunity|adaptive immunity
677559|NCT00721305|Cellular cholesterol|cellular cholesterol
677560|NCT00721305|Rho GTPases|rho gtpases
677561|NCT00721305|Lymphocyte function-associated antigen-1|lymphocyte function-associated antigen-1
677562|NCT00721253|ReSTOR|restor
677563|NCT00721240|responder|responder
677564|NCT00721240|leucotriene antagonist|leucotriene antagonist
677565|NCT00721214|Myelodysplastic Syndrome|myelodysplastic syndrome
677566|NCT00721214|5-azacytidine|5-azacytidine
677567|NCT00721214|allogeneic stem cell transplantation|allogeneic stem cell transplantation
677568|NCT00721201|subclinical Cushing's|subclinical cushing's
677569|NCT00721175|biliary stent|biliary stent
677570|NCT00721175|plastic stent|plastic stent
677571|NCT00721175|metallic stent|metallic stent
677572|NCT00721175|Complex hilar cholangiocarcinoma (Bismuth type II,III,IV)|complex hilar cholangiocarcinoma (bismuth type ii,iii,iv)
677573|NCT00721162|Ovarian Cancer,|ovarian cancer,
677574|NCT00721162|Fallopian Tube Cancer|fallopian tube cancer
677575|NCT00721162|Primary Peritoneal Carcinoma|primary peritoneal carcinoma
677576|NCT00721149|Atrial Fibrillation|atrial fibrillation
677577|NCT00721149|Paroxysmal Atrial Fibrillation|paroxysmal atrial fibrillation
677578|NCT00721149|Ablation|ablation
677579|NCT00721149|Non-randomized|non-randomized
677580|NCT00721136|bleeding|bleeding
677581|NCT00721136|anticoagulation|anticoagulation
677582|NCT00721136|pacemaker|pacemaker
677583|NCT00721136|implantable cardioverter-defibrillator|implantable cardioverter-defibrillator
677584|NCT00721136|"patients undergoing implantation of a pacemaker or defibrillator (ICD)"|"patients undergoing implantation of a pacemaker or defibrillator (icd)"
677585|NCT00721110|pain control|pain control
677586|NCT00721110|nausea|nausea
677587|NCT00721110|surgery recovery|surgery recovery
677588|NCT00721097|Severe asthma|severe asthma
677589|NCT00721097|exacerbation|exacerbation
677590|NCT00721097|predictive factors|predictive factors
677591|NCT00721097|Severe|severe
677592|NCT00721084|short sleep duration|short sleep duration
677593|NCT00721084|maximal aerobic capacity|maximal aerobic capacity
677594|NCT00721084|body fat|body fat
677595|NCT00721084|visceral adiposity|visceral adiposity
677596|NCT00721084|activity-related energy expenditure|activity-related energy expenditure
677597|NCT00721084|energy metabolism|energy metabolism
677598|NCT00721071|Pediatrics|pediatrics
677599|NCT00721071|Cystic Fibrosis|cystic fibrosis
677600|NCT00721071|Hypertonic Saline|hypertonic saline
677601|NCT00721071|Induced Sputum|induced sputum
677602|NCT00721071|Expectorated Sputum|expectorated sputum
677603|NCT00721058|Eligible|eligible
677604|NCT00721058|Operable|operable
677605|NCT00721058|Disease|disease
677606|NCT00721058|Conserving|conserving
677607|NCT00721058|Therapy|therapy
677608|NCT00721058|Visible mass on mammography|visible mass on mammography
677609|NCT00721058|Ultrasound > 0.5 cm|ultrasound > 0.5 cm
677610|NCT00721058|Histologically|histologically
677611|NCT00721058|Proven|proven
677612|NCT00721045|Heart Failure|heart failure
677613|NCT00721045|Congestive Heart Failure|congestive heart failure
677614|NCT00721032|Ventricular tachycardia (VT)|ventricular tachycardia (vt)
677615|NCT00721032|Implantable cardioverter-defibrillator (ICD)|implantable cardioverter-defibrillator (icd)
677616|NCT00721032|Ablation|ablation
677617|NCT00721032|Cardiomyopathy|cardiomyopathy
677618|NCT00721032|Electrophysiology study|electrophysiology study
677619|NCT00721019|short sleep duration|short sleep duration
677620|NCT00721019|glucose clamp technique|glucose clamp technique
677621|NCT00721019|insulin secretion|insulin secretion
677622|NCT00721019|insulin action|insulin action
677623|NCT00721019|lipid turnover|lipid turnover
677624|NCT00721019|free fatty acids|free fatty acids
677625|NCT00721006|peripheral artery disease|peripheral artery disease
677626|NCT00721006|peripheral vascular disease|peripheral vascular disease
677627|NCT00721006|PAD|pad
677628|NCT00721006|PVD|pvd
677629|NCT00720993|Colorectal cancer screening|colorectal cancer screening
677630|NCT00720993|Gene expression|gene expression
677632|NCT00720980|granuloma annulare, ROM|granuloma annulare, rom
677633|NCT00720967|Renal dysfunction|renal dysfunction
677634|NCT00720967|Hemodialysis|hemodialysis
677635|NCT00720967|Modified ultrafiltration|modified ultrafiltration
677636|NCT00720967|Open heart surgery|open heart surgery
677637|NCT00720954|Thoracoscopy|thoracoscopy
677638|NCT00720954|Pleural needle biopsy|pleural needle biopsy
677639|NCT00720954|Malignant pleural diseases|malignant pleural diseases
677640|NCT00720954|Mesothelioma|mesothelioma
677641|NCT00720954|Diagnosis|diagnosis
677642|NCT00720954|Pleurisy tuberculosis|pleurisy tuberculosis
677643|NCT00720954|Patients with pleural diseases and pleural effusion should have been included in the study.|patients with pleural diseases and pleural effusion should have been included in the study.
677644|NCT00720941|SUTENT|sutent
677645|NCT00720941|Locally advanced and/or metastatic renal cell carcinoma|locally advanced and/or metastatic renal cell carcinoma
677646|NCT00720941|Pazopanib|pazopanib
677647|NCT00720941|Sunitinib|sunitinib
677648|NCT00720941|GW786034|gw786034
677649|NCT00720941|Renal cell carcinoma|renal cell carcinoma
677650|NCT00720928|Behcet's disease|behcet's disease
677651|NCT00720928|posterior uveitis|posterior uveitis
677652|NCT00720928|flucinolone acetonide|flucinolone acetonide
677653|NCT00720928|RETISERT|retisert
677654|NCT00720915|unprovoked deep vein thrombosis|unprovoked deep vein thrombosis
677655|NCT00720915|unprovoked pulmonary embolism|unprovoked pulmonary embolism
677656|NCT00720915|anticoagulant therapy|anticoagulant therapy
677657|NCT00720889|short sleep duration|short sleep duration
677658|NCT00720889|glucose clamp technique|glucose clamp technique
677659|NCT00720889|insulin secretion|insulin secretion
677660|NCT00720889|insulin action|insulin action
677661|NCT00720889|lipid turnover|lipid turnover
677662|NCT00720889|free fatty acids|free fatty acids
677663|NCT00720876|contiguous stage II grade 1 follicular lymphoma|contiguous stage ii grade 1 follicular lymphoma
677664|NCT00720876|contiguous stage II grade 2 follicular lymphoma|contiguous stage ii grade 2 follicular lymphoma
677665|NCT00720876|contiguous stage II grade 3 follicular lymphoma|contiguous stage ii grade 3 follicular lymphoma
677666|NCT00720876|noncontiguous stage II grade 1 follicular lymphoma|noncontiguous stage ii grade 1 follicular lymphoma
677667|NCT00720876|noncontiguous stage II grade 2 follicular lymphoma|noncontiguous stage ii grade 2 follicular lymphoma
677668|NCT00720876|noncontiguous stage II grade 3 follicular lymphoma|noncontiguous stage ii grade 3 follicular lymphoma
677669|NCT00720876|recurrent grade 1 follicular lymphoma|recurrent grade 1 follicular lymphoma
677670|NCT00720876|recurrent grade 2 follicular lymphoma|recurrent grade 2 follicular lymphoma
677671|NCT00720876|recurrent grade 3 follicular lymphoma|recurrent grade 3 follicular lymphoma
677672|NCT00720876|stage I grade 1 follicular lymphoma|stage i grade 1 follicular lymphoma
677673|NCT00720876|stage I grade 2 follicular lymphoma|stage i grade 2 follicular lymphoma
677674|NCT00720876|stage I grade 3 follicular lymphoma|stage i grade 3 follicular lymphoma
677675|NCT00720876|stage III grade 1 follicular lymphoma|stage iii grade 1 follicular lymphoma
677676|NCT00720876|stage III grade 2 follicular lymphoma|stage iii grade 2 follicular lymphoma
677677|NCT00720876|stage III grade 3 follicular lymphoma|stage iii grade 3 follicular lymphoma
677678|NCT00720876|stage IV grade 1 follicular lymphoma|stage iv grade 1 follicular lymphoma
677679|NCT00720876|stage IV grade 2 follicular lymphoma|stage iv grade 2 follicular lymphoma
677680|NCT00720876|stage IV grade 3 follicular lymphoma|stage iv grade 3 follicular lymphoma
677681|NCT00720876|contiguous stage II marginal zone lymphoma|contiguous stage ii marginal zone lymphoma
677682|NCT00720876|extranodal marginal zone B-cell lymphoma of mucosa-associated lymphoid tissue|extranodal marginal zone b-cell lymphoma of mucosa-associated lymphoid tissue
677683|NCT00720876|nodal marginal zone B-cell lymphoma|nodal marginal zone b-cell lymphoma
677684|NCT00720876|noncontiguous stage II marginal zone lymphoma|noncontiguous stage ii marginal zone lymphoma
677685|NCT00720876|recurrent marginal zone lymphoma|recurrent marginal zone lymphoma
677686|NCT00720876|splenic marginal zone lymphoma|splenic marginal zone lymphoma
710422|NCT00589394|Healthy Volunteers|healthy volunteers
677687|NCT00720876|stage I marginal zone lymphoma|stage i marginal zone lymphoma
677688|NCT00720876|stage III marginal zone lymphoma|stage iii marginal zone lymphoma
677689|NCT00720876|stage IV marginal zone lymphoma|stage iv marginal zone lymphoma
677690|NCT00720876|contiguous stage II mantle cell lymphoma|contiguous stage ii mantle cell lymphoma
677691|NCT00720876|noncontiguous stage II mantle cell lymphoma|noncontiguous stage ii mantle cell lymphoma
677692|NCT00720876|recurrent mantle cell lymphoma|recurrent mantle cell lymphoma
677693|NCT00720876|stage I mantle cell lymphoma|stage i mantle cell lymphoma
677694|NCT00720876|stage III mantle cell lymphoma|stage iii mantle cell lymphoma
677695|NCT00720876|stage IV mantle cell lymphoma|stage iv mantle cell lymphoma
677696|NCT00720850|MDS|mds
677697|NCT00720850|AML|aml
677698|NCT00720850|Lenalidomide|lenalidomide
677699|NCT00720850|monosomy 5|monosomy 5
677700|NCT00720850|monosomy del5q|monosomy del5q
677701|NCT00720837|Brain Tumor|brain tumor
677702|NCT00720837|Brain Cancer|brain cancer
677703|NCT00720837|MR-guided laser thermal ablation of brain tumors|mr-guided laser thermal ablation of brain tumors
677704|NCT00720837|Visualase® Thermal Therapy System|visualase® thermal therapy system
677705|NCT00720837|Magnetic Resonance Thermal Imaging|magnetic resonance thermal imaging
677706|NCT00720837|MRTI|mrti
677707|NCT00720837|Visualase Cooled Laser Application System|visualase cooled laser application system
677708|NCT00720837|Laser Interstitial Thermal Therapy|laser interstitial thermal therapy
677710|NCT00720824|Immunizations|immunizations
677711|NCT00720824|Children|children
677712|NCT00720824|Injections|injections
677713|NCT00720824|aged 4-6 Years|aged 4-6 years
677714|NCT00720824|Hypnosis|hypnosis
677715|NCT00720811|Malaria ACT|malaria act
677716|NCT00720811|Rapid|rapid
677717|NCT00720811|Diagnosis|diagnosis
677718|NCT00720811|Community|community
677719|NCT00720811|health|health
677720|NCT00720811|worker|worker
677721|NCT00720811|Artemesinin|artemesinin
677722|NCT00720811|based|based
677723|NCT00720811|Combination|combination
677724|NCT00720811|Therapy|therapy
677725|NCT00720811|Anti Malarial|anti malarial
677726|NCT00720811|Treatment|treatment
677727|NCT00720811|antibiotics|antibiotics
677728|NCT00720785|Metastatic Solid Tumor|metastatic solid tumor
677729|NCT00720785|Chronic Myelogenous Leukemia (CML)|chronic myelogenous leukemia (cml)
677730|NCT00720785|Small Lymphocytic Lymphoma (SLL)|small lymphocytic lymphoma (sll)
677731|NCT00720785|Chronic Lymphocytic Leukemia (CLL)|chronic lymphocytic leukemia (cll)
677732|NCT00720785|Multiple Myeloma|multiple myeloma
677733|NCT00720785|Lung Cancer|lung cancer
677734|NCT00720785|Prostate Cancer|prostate cancer
677735|NCT00720785|Colon Cancer|colon cancer
677736|NCT00720785|Kidney Cancer|kidney cancer
677737|NCT00720785|Pancreatic Cancer|pancreatic cancer
677738|NCT00720785|Leukemia|leukemia
677739|NCT00720785|Chronic Myelogenous Leukemia|chronic myelogenous leukemia
677740|NCT00720785|CML|cml
677741|NCT00720785|Small Lymphocytic Lymphoma|small lymphocytic lymphoma
677742|NCT00720785|SLL|sll
677743|NCT00720785|Chronic Lymphocytic Leukemia|chronic lymphocytic leukemia
677744|NCT00720785|CLL|cll
677745|NCT00720772|coronary calcification|coronary calcification
677746|NCT00720772|vascular calcification|vascular calcification
677747|NCT00720772|sodium thiosulfate|sodium thiosulfate
677748|NCT00720759|stroke|stroke
677749|NCT00720759|hemiparesis|hemiparesis
677750|NCT00720759|randomized controlled trial|randomized controlled trial
677751|NCT00720759|d-cycloserine|d-cycloserine
677752|NCT00720759|distributed practice|distributed practice
677753|NCT00720759|constraint induced movement therapy|constraint induced movement therapy
677754|NCT00720733|HIV|hiv
677755|NCT00720733|Mood|mood
677756|NCT00720733|Emotion|emotion
677757|NCT00720733|Coping|coping
677758|NCT00720733|Aids|aids
677759|NCT00720733|Affect|affect
677760|NCT00720733|Adults|adults
677761|NCT00720733|Diagnosed|diagnosed
677762|NCT00720707|Coronally advanced flap|coronally advanced flap
677763|NCT00720707|gingival recession|gingival recession
677764|NCT00720707|enamel matrix protein|enamel matrix protein
677765|NCT00720707|acellular dermal matrix|acellular dermal matrix
677766|NCT00720707|root coverage|root coverage
677767|NCT00720668|hepatitis B|hepatitis b
677768|NCT00720668|hepatocellular carcinoma|hepatocellular carcinoma
677769|NCT00720668|radiofrequency ablation|radiofrequency ablation
677770|NCT00720668|reactivation|reactivation
677771|NCT00720655|coronary heart disease|coronary heart disease
677772|NCT00720629|graft versus host disease|graft versus host disease
677773|NCT00720629|GVHD|gvhd
677774|NCT00720629|allogeneic transplant|allogeneic transplant
677775|NCT00720629|GVHD prevention|gvhd prevention
677776|NCT00720629|unrelated donors|unrelated donors
677777|NCT00720629|mismatched unrelated donors|mismatched unrelated donors
677778|NCT00720629|hematological malignancies|hematological malignancies
677779|NCT00720629|Leukemia|leukemia
677780|NCT00720629|Lymphoma|lymphoma
677781|NCT00720629|Myelodysplastic Syndrome|myelodysplastic syndrome
677782|NCT00720629|Myelofibrosis|myelofibrosis
677783|NCT00720629|Aplastic Anemia|aplastic anemia
677784|NCT00720629|Multiple Myeloma|multiple myeloma
677785|NCT00720616|Growth hormone|growth hormone
677786|NCT00720616|Metabolic syndrome|metabolic syndrome
677787|NCT00720616|Insulin sensitivity|insulin sensitivity
677788|NCT00720603|Autologous Stem Cell Transplant|autologous stem cell transplant
677789|NCT00720577|Peripheral Arterial Disease|peripheral arterial disease
677790|NCT00720577|PAD|pad
677791|NCT00720577|Lower extremity peripheral arterial atherosclerotic plaque|lower extremity peripheral arterial atherosclerotic plaque
677792|NCT00720577|RNA Expression|rna expression
677793|NCT00720577|Lipid Biomarkers|lipid biomarkers
677794|NCT00720564|adult glioblastoma|adult glioblastoma
677795|NCT00720564|adult anaplastic astrocytoma|adult anaplastic astrocytoma
677796|NCT00720564|adult anaplastic oligodendroglioma|adult anaplastic oligodendroglioma
677797|NCT00720564|adult gliosarcoma|adult gliosarcoma
677798|NCT00720564|adult mixed glioma|adult mixed glioma
677799|NCT00720551|STISIM|stisim
677800|NCT00720551|Alcohol|alcohol
677801|NCT00720538|Inflammatory bowel diseases.|inflammatory bowel diseases.
677802|NCT00720538|Crohn disease.|crohn disease.
677803|NCT00720538|Ulcerative, colitis.|ulcerative, colitis.
677804|NCT00720538|Randomised controlled trial.|randomised controlled trial.
677805|NCT00720538|Therapy.|therapy.
677806|NCT00720538|Thalidomide.|thalidomide.
677807|NCT00720538|Children.|children.
677808|NCT00720525|arterial stiffness|arterial stiffness
677809|NCT00720525|arterial wave reflections|arterial wave reflections
677810|NCT00720525|diastolic heart failure|diastolic heart failure
677811|NCT00720512|adenocarcinoma of the colon|adenocarcinoma of the colon
677812|NCT00720512|adenocarcinoma of the rectum|adenocarcinoma of the rectum
677813|NCT00720512|recurrent colon cancer|recurrent colon cancer
677814|NCT00720512|recurrent rectal cancer|recurrent rectal cancer
677815|NCT00720512|stage IV colon cancer|stage iv colon cancer
677816|NCT00720512|stage IV rectal cancer|stage iv rectal cancer
677817|NCT00720512|stage III rectal cancer|stage iii rectal cancer
677818|NCT00720512|stage III colon cancer|stage iii colon cancer
677819|NCT00720473|Bipolar depression|bipolar depression
677820|NCT00720473|Elderly|elderly
677821|NCT00720473|Lamotrigine|lamotrigine
677822|NCT00720473|Brain energy metabolism|brain energy metabolism
677823|NCT00720460|Magnetic Resonance Imaging|magnetic resonance imaging
677824|NCT00720460|Minimally Invasive Therapy|minimally invasive therapy
677825|NCT00720460|Transcatheter Therapeutics|transcatheter therapeutics
677826|NCT00720460|Healthy Volunteers|healthy volunteers
677827|NCT00720460|Gadolinium Contrast|gadolinium contrast
677828|NCT00720460|Healthy Volunteer|healthy volunteer
677829|NCT00720460|HV|hv
677830|NCT00720447|stage III mantle cell lymphoma|stage iii mantle cell lymphoma
677831|NCT00720447|stage IV mantle cell lymphoma|stage iv mantle cell lymphoma
677832|NCT00720421|Phase I|phase i
677833|NCT00720421|pharmacodynamic study|pharmacodynamic study
677834|NCT00720408|Immunosuppressant|immunosuppressant
677835|NCT00720408|Graft loss|graft loss
677836|NCT00720408|Combination drug therapy|combination drug therapy
677837|NCT00720408|Randomized controlled trial|randomized controlled trial
677838|NCT00720408|Open level method|open level method
677839|NCT00720395|Psychiatry|psychiatry
677840|NCT00720395|Pregnancy|pregnancy
677841|NCT00720369|Bipolar depression|bipolar depression
677842|NCT00720369|elderly|elderly
677843|NCT00720369|Coenzyme Q10|coenzyme q10
677844|NCT00720369|Magnetic resonance spectroscopy|magnetic resonance spectroscopy
677845|NCT00720356|adult glioblastoma|adult glioblastoma
677846|NCT00720356|adult gliosarcoma|adult gliosarcoma
677847|NCT00720330|Inguinal Herniorrhaphy|inguinal herniorrhaphy
677848|NCT00720330|Pain assessment|pain assessment
677849|NCT00720330|Outcomes|outcomes
677850|NCT00720317|Diabetic Retinopathy|diabetic retinopathy
677851|NCT00720317|Sickle Cell Trait|sickle cell trait
677852|NCT00720317|Vision Loss|vision loss
677853|NCT00720317|Eye disease|eye disease
677854|NCT00720304|stage III squamous cell carcinoma of the hypopharynx|stage iii squamous cell carcinoma of the hypopharynx
677855|NCT00720304|stage IV squamous cell carcinoma of the hypopharynx|stage iv squamous cell carcinoma of the hypopharynx
677856|NCT00720304|stage III squamous cell carcinoma of the larynx|stage iii squamous cell carcinoma of the larynx
677857|NCT00720304|stage III verrucous carcinoma of the larynx|stage iii verrucous carcinoma of the larynx
677858|NCT00720304|stage IV squamous cell carcinoma of the larynx|stage iv squamous cell carcinoma of the larynx
677859|NCT00720304|stage IV verrucous carcinoma of the larynx|stage iv verrucous carcinoma of the larynx
677860|NCT00720304|stage III squamous cell carcinoma of the lip and oral cavity|stage iii squamous cell carcinoma of the lip and oral cavity
677861|NCT00720304|stage IV squamous cell carcinoma of the lip and oral cavity|stage iv squamous cell carcinoma of the lip and oral cavity
677862|NCT00720304|stage III verrucous carcinoma of the oral cavity|stage iii verrucous carcinoma of the oral cavity
677863|NCT00720304|stage IV verrucous carcinoma of the oral cavity|stage iv verrucous carcinoma of the oral cavity
677864|NCT00720304|metastatic squamous neck cancer with occult primary squamous cell carcinoma|metastatic squamous neck cancer with occult primary squamous cell carcinoma
677865|NCT00720304|stage III squamous cell carcinoma of the nasopharynx|stage iii squamous cell carcinoma of the nasopharynx
677866|NCT00720304|stage IV squamous cell carcinoma of the nasopharynx|stage iv squamous cell carcinoma of the nasopharynx
710600|NCT00588653|capsule endoscopy|capsule endoscopy
859855|NCT00063245|HV|hv
677867|NCT00720304|stage III squamous cell carcinoma of the oropharynx|stage iii squamous cell carcinoma of the oropharynx
677868|NCT00720304|stage IV squamous cell carcinoma of the oropharynx|stage iv squamous cell carcinoma of the oropharynx
677869|NCT00720291|Metronidazole|metronidazole
677870|NCT00720291|BV|bv
677871|NCT00720291|Pregnancy|pregnancy
677872|NCT00720265|Organ Transplantation|organ transplantation
677873|NCT00720265|Tacrolimus|tacrolimus
677874|NCT00720265|Prograf|prograf
677875|NCT00720265|FK506MR|fk506mr
677876|NCT00720226|COPD|copd
677877|NCT00720226|emphysema|emphysema
677878|NCT00720226|angiotensin receptor blocker|angiotensin receptor blocker
677879|NCT00720200|Communication|communication
677880|NCT00720200|Intensive Care Units|intensive care units
677881|NCT00720200|Palliative Care|palliative care
677882|NCT00720200|End-of-Life Issues|end-of-life issues
677883|NCT00720200|Talking with Your Doctor|talking with your doctor
677884|NCT00720200|Coping with Chronic Illness|coping with chronic illness
677885|NCT00720161|metformin, spina bifida, duchenne, insulin resistance|metformin, spina bifida, duchenne, insulin resistance
677886|NCT00720148|Solid tumors|solid tumors
677887|NCT00720122|Bone density|bone density
677888|NCT00720122|Bone turnover markers|bone turnover markers
677889|NCT00720122|rhIGF-1|rhigf-1
677890|NCT00720122|Bone structure|bone structure
677891|NCT00720122|Anorexia nervosa|anorexia nervosa
677892|NCT00720096|Persistent Ovarian Cancer|persistent ovarian cancer
677893|NCT00720096|Genomic directed salvage chemotherapy|genomic directed salvage chemotherapy
677894|NCT00720096|Genomic Microarray|genomic microarray
678035|NCT00719810|complicated|complicated
677895|NCT00720083|stage III squamous cell carcinoma of the hypopharynx|stage iii squamous cell carcinoma of the hypopharynx
677896|NCT00720083|stage IV squamous cell carcinoma of the hypopharynx|stage iv squamous cell carcinoma of the hypopharynx
677897|NCT00720083|stage III squamous cell carcinoma of the larynx|stage iii squamous cell carcinoma of the larynx
677898|NCT00720083|stage IV squamous cell carcinoma of the larynx|stage iv squamous cell carcinoma of the larynx
677899|NCT00720083|stage III verrucous carcinoma of the oral cavity|stage iii verrucous carcinoma of the oral cavity
677900|NCT00720083|stage IV verrucous carcinoma of the oral cavity|stage iv verrucous carcinoma of the oral cavity
677901|NCT00720083|stage III squamous cell carcinoma of the oropharynx|stage iii squamous cell carcinoma of the oropharynx
677902|NCT00720083|stage IV squamous cell carcinoma of the oropharynx|stage iv squamous cell carcinoma of the oropharynx
677903|NCT00720070|stage I squamous cell carcinoma of the oropharynx|stage i squamous cell carcinoma of the oropharynx
677904|NCT00720070|stage II squamous cell carcinoma of the oropharynx|stage ii squamous cell carcinoma of the oropharynx
677905|NCT00720070|stage III squamous cell carcinoma of the oropharynx|stage iii squamous cell carcinoma of the oropharynx
677906|NCT00720070|stage I squamous cell carcinoma of the larynx|stage i squamous cell carcinoma of the larynx
677907|NCT00720070|stage I verrucous carcinoma of the larynx|stage i verrucous carcinoma of the larynx
677908|NCT00720070|stage II squamous cell carcinoma of the larynx|stage ii squamous cell carcinoma of the larynx
677909|NCT00720070|stage II verrucous carcinoma of the larynx|stage ii verrucous carcinoma of the larynx
677910|NCT00720070|stage III squamous cell carcinoma of the larynx|stage iii squamous cell carcinoma of the larynx
677911|NCT00720070|stage III verrucous carcinoma of the larynx|stage iii verrucous carcinoma of the larynx
677912|NCT00720070|stage I squamous cell carcinoma of the lip and oral cavity|stage i squamous cell carcinoma of the lip and oral cavity
677913|NCT00720070|stage I verrucous carcinoma of the oral cavity|stage i verrucous carcinoma of the oral cavity
677914|NCT00720070|stage II squamous cell carcinoma of the lip and oral cavity|stage ii squamous cell carcinoma of the lip and oral cavity
677915|NCT00720070|stage II verrucous carcinoma of the oral cavity|stage ii verrucous carcinoma of the oral cavity
677916|NCT00720070|stage III squamous cell carcinoma of the lip and oral cavity|stage iii squamous cell carcinoma of the lip and oral cavity
677917|NCT00720070|stage III verrucous carcinoma of the oral cavity|stage iii verrucous carcinoma of the oral cavity
677918|NCT00720070|stage I squamous cell carcinoma of the hypopharynx|stage i squamous cell carcinoma of the hypopharynx
677919|NCT00720070|stage II squamous cell carcinoma of the hypopharynx|stage ii squamous cell carcinoma of the hypopharynx
677920|NCT00720070|stage III squamous cell carcinoma of the hypopharynx|stage iii squamous cell carcinoma of the hypopharynx
677921|NCT00720070|tongue cancer|tongue cancer
677922|NCT00720057|Dental Pain|dental pain
677923|NCT00720057|Analgesia|analgesia
677924|NCT00720031|Melanoma,|melanoma,
677925|NCT00720031|Melan-A tumor reactive T cell clones,|melan-a tumor reactive t cell clones,
677926|NCT00720031|immunotherapy|immunotherapy
677927|NCT00720031|HLA-A2 melanoma patients with|hla-a2 melanoma patients with
677928|NCT00720031|either loco-regional or lymphnode metastasis|either loco-regional or lymphnode metastasis
677929|NCT00720031|transit nodules not surgically resectable|transit nodules not surgically resectable
677930|NCT00720031|-measurable cutaneous or visceral metastasis .|-measurable cutaneous or visceral metastasis .
677931|NCT00720031|Patients' tumor express Melan-A/MART-1 antigen.|patients' tumor express melan-a/mart-1 antigen.
677932|NCT00720005|Cataract|cataract
677933|NCT00720005|cataract extraction|cataract extraction
677934|NCT00720005|intraocular lens|intraocular lens
677935|NCT00720005|age related|age related
677936|NCT00719992|Exercise tolerance test|exercise tolerance test
677937|NCT00719992|HS-CRP|hs-crp
677938|NCT00719992|Coronary angiography|coronary angiography
677939|NCT00719992|Patients|patients
677940|NCT00719979|Major Depressive Disorder|major depressive disorder
677941|NCT00719979|Cognitive Behavior Therapy|cognitive behavior therapy
677942|NCT00719979|Technology Assisted|technology assisted
677943|NCT00719979|Internet|internet
677944|NCT00719979|Primary Care|primary care
677945|NCT00719966|stage IA breast cancer|stage ia breast cancer
677946|NCT00719966|stage IB breast cancer|stage ib breast cancer
677947|NCT00719966|stage II breast cancer|stage ii breast cancer
677948|NCT00719966|stage IIIA breast cancer|stage iiia breast cancer
677949|NCT00719966|stage IIIB breast cancer|stage iiib breast cancer
677950|NCT00719966|stage IIIC breast cancer|stage iiic breast cancer
677951|NCT00719966|stage IV breast cancer|stage iv breast cancer
677952|NCT00719966|ductal breast carcinoma in situ|ductal breast carcinoma in situ
677953|NCT00719953|Cognitex|cognitex
677954|NCT00719953|subjects|subjects
677955|NCT00719940|tinnitus, cognitive behavioral therapy, CBT|tinnitus, cognitive behavioral therapy, cbt
677956|NCT00719927|Social Support|social support
677957|NCT00719914|eptifibatide|eptifibatide
677958|NCT00719914|Integrilin|integrilin
677959|NCT00719914|ST-Elevation Myocardial Infarction|st-elevation myocardial infarction
677960|NCT00719914|Acute Myocardial Infarction|acute myocardial infarction
677961|NCT00719849|chronic myelogenous leukemia|chronic myelogenous leukemia
677962|NCT00719849|acute lymphoblastic leukemia|acute lymphoblastic leukemia
677963|NCT00719849|acute myeloid leukemia|acute myeloid leukemia
677964|NCT00719849|atypical chronic myeloid leukemia|atypical chronic myeloid leukemia
677965|NCT00719849|chronic myelomonocytic leukemia|chronic myelomonocytic leukemia
677966|NCT00719849|anaplastic large cell lymphoma|anaplastic large cell lymphoma
677967|NCT00719849|splenic marginal zone lymphoma|splenic marginal zone lymphoma
677968|NCT00719849|nodal marginal zone B-cell lymphoma|nodal marginal zone b-cell lymphoma
677969|NCT00719849|recurrent adult Hodgkin lymphoma|recurrent adult hodgkin lymphoma
677970|NCT00719849|recurrent adult diffuse large cell lymphoma|recurrent adult diffuse large cell lymphoma
677971|NCT00719849|recurrent adult immunoblastic large cell lymphoma|recurrent adult immunoblastic large cell lymphoma
677972|NCT00719849|recurrent childhood large cell lymphoma|recurrent childhood large cell lymphoma
677973|NCT00719849|recurrent mycosis fungoides/Sezary syndrome|recurrent mycosis fungoides/sezary syndrome
677974|NCT00719849|recurrent grade 1 follicular lymphoma|recurrent grade 1 follicular lymphoma
677975|NCT00719849|recurrent grade 2 follicular lymphoma|recurrent grade 2 follicular lymphoma
677976|NCT00719849|recurrent grade 3 follicular lymphoma|recurrent grade 3 follicular lymphoma
677977|NCT00719849|recurrent mantle cell lymphoma|recurrent mantle cell lymphoma
677978|NCT00719849|recurrent marginal zone lymphoma|recurrent marginal zone lymphoma
677979|NCT00719849|recurrent small lymphocytic lymphoma|recurrent small lymphocytic lymphoma
677980|NCT00719849|recurrent/refractory childhood Hodgkin lymphoma|recurrent/refractory childhood hodgkin lymphoma
677981|NCT00719849|childhood diffuse large cell lymphoma|childhood diffuse large cell lymphoma
677982|NCT00719849|childhood immunoblastic large cell lymphoma|childhood immunoblastic large cell lymphoma
677983|NCT00719849|refractory multiple myeloma|refractory multiple myeloma
677984|NCT00719849|de novo myelodysplastic syndromes|de novo myelodysplastic syndromes
677985|NCT00719849|previously treated myelodysplastic syndromes|previously treated myelodysplastic syndromes
677986|NCT00719849|secondary myelodysplastic syndromes|secondary myelodysplastic syndromes
677987|NCT00719849|myelodysplastic/myeloproliferative disease|myelodysplastic/myeloproliferative disease
677988|NCT00719849|childhood myelodysplastic syndromes|childhood myelodysplastic syndromes
677989|NCT00719849|recurrent childhood anaplastic large cell lymphoma|recurrent childhood anaplastic large cell lymphoma
677990|NCT00719849|refractory anemia|refractory anemia
677991|NCT00719849|refractory anemia with excess blasts|refractory anemia with excess blasts
677992|NCT00719849|refractory anemia with ringed sideroblasts|refractory anemia with ringed sideroblasts
677993|NCT00719849|refractory cytopenia with multilineage dysplasia|refractory cytopenia with multilineage dysplasia
677994|NCT00719849|stage III adult diffuse large cell lymphoma|stage iii adult diffuse large cell lymphoma
677995|NCT00719849|stage IV adult diffuse large cell lymphoma|stage iv adult diffuse large cell lymphoma
677996|NCT00719849|stage III adult immunoblastic large cell lymphoma|stage iii adult immunoblastic large cell lymphoma
677997|NCT00719849|stage IV adult immunoblastic large cell lymphoma|stage iv adult immunoblastic large cell lymphoma
677998|NCT00719849|stage III childhood anaplastic large cell lymphoma|stage iii childhood anaplastic large cell lymphoma
677999|NCT00719849|stage III childhood large cell lymphoma|stage iii childhood large cell lymphoma
678000|NCT00719849|stage IV childhood anaplastic large cell lymphoma|stage iv childhood anaplastic large cell lymphoma
678001|NCT00719849|stage IV childhood large cell lymphoma|stage iv childhood large cell lymphoma
678002|NCT00719849|stage III adult Hodgkin lymphoma|stage iii adult hodgkin lymphoma
678003|NCT00719849|stage III childhood Hodgkin lymphoma|stage iii childhood hodgkin lymphoma
678004|NCT00719849|stage IV adult Hodgkin lymphoma|stage iv adult hodgkin lymphoma
678005|NCT00719849|stage IV childhood Hodgkin lymphoma|stage iv childhood hodgkin lymphoma
678006|NCT00719849|stage II multiple myeloma|stage ii multiple myeloma
678007|NCT00719849|stage III multiple myeloma|stage iii multiple myeloma
678008|NCT00719849|stage III chronic lymphocytic leukemia|stage iii chronic lymphocytic leukemia
678009|NCT00719849|stage IV chronic lymphocytic leukemia|stage iv chronic lymphocytic leukemia
678010|NCT00719849|stage III small lymphocytic lymphoma|stage iii small lymphocytic lymphoma
678011|NCT00719849|stage IV small lymphocytic lymphoma|stage iv small lymphocytic lymphoma
678012|NCT00719849|stage III marginal zone lymphoma|stage iii marginal zone lymphoma
678013|NCT00719849|stage IV marginal zone lymphoma|stage iv marginal zone lymphoma
678014|NCT00719849|stage III grade 1 follicular lymphoma|stage iii grade 1 follicular lymphoma
678015|NCT00719849|stage III grade 2 follicular lymphoma|stage iii grade 2 follicular lymphoma
678016|NCT00719849|stage III grade 3 follicular lymphoma|stage iii grade 3 follicular lymphoma
678017|NCT00719849|stage IV grade 1 follicular lymphoma|stage iv grade 1 follicular lymphoma
678018|NCT00719849|stage IV grade 2 follicular lymphoma|stage iv grade 2 follicular lymphoma
678019|NCT00719849|stage IV grade 3 follicular lymphoma|stage iv grade 3 follicular lymphoma
678020|NCT00719849|Waldenstrom macroglobulinemia|waldenstrom macroglobulinemia
678021|NCT00719849|stage III mantle cell lymphoma|stage iii mantle cell lymphoma
678022|NCT00719849|stage IV mantle cell lymphoma|stage iv mantle cell lymphoma
678023|NCT00719849|stage III mycosis fungoides/Sezary syndrome|stage iii mycosis fungoides/sezary syndrome
678024|NCT00719849|stage IV mycosis fungoides/Sezary syndrome|stage iv mycosis fungoides/sezary syndrome
678025|NCT00719849|juvenile myelomonocytic leukemia|juvenile myelomonocytic leukemia
678026|NCT00719849|chronic eosinophilic leukemia|chronic eosinophilic leukemia
678027|NCT00719849|chronic idiopathic myelofibrosis|chronic idiopathic myelofibrosis
678028|NCT00719849|chronic neutrophilic leukemia|chronic neutrophilic leukemia
678029|NCT00719849|essential thrombocythemia|essential thrombocythemia
678030|NCT00719849|polycythemia vera|polycythemia vera
678031|NCT00719836|SB1518|sb1518
678032|NCT00719836|Chronic Idiopathic Myelofibrosis|chronic idiopathic myelofibrosis
678033|NCT00719836|JAK2 Inhibitor|jak2 inhibitor
678034|NCT00719823|Maraviroc Compassionate Use|maraviroc compassionate use
678036|NCT00719810|skin|skin
678037|NCT00719797|stage IV rectal cancer|stage iv rectal cancer
678038|NCT00719797|stage IV colon cancer|stage iv colon cancer
678039|NCT00719797|stage III rectal cancer|stage iii rectal cancer
678040|NCT00719797|stage III colon cancer|stage iii colon cancer
678041|NCT00719784|Respiratory|respiratory
678042|NCT00719784|Pulmonary|pulmonary
678043|NCT00719784|Thoracic|thoracic
678044|NCT00719784|Chest|chest
678045|NCT00719784|Lung|lung
678046|NCT00719771|Osteoarthritis|osteoarthritis
678047|NCT00719771|Glenohumeral joint|glenohumeral joint
678048|NCT00719771|Glenoid|glenoid
678049|NCT00719771|Shoulder arthroplasty|shoulder arthroplasty
678050|NCT00719758|TRK-100STP,|trk-100stp,
678051|NCT00719758|beraprost sodium,|beraprost sodium,
678052|NCT00719758|Careload LA|careload la
678053|NCT00719758|AST-120|ast-120
678054|NCT00719758|Spherical carbon adsorbent|spherical carbon adsorbent
678055|NCT00719758|Drug-drug interaction|drug-drug interaction
678056|NCT00719745|Organ transplantation|organ transplantation
678057|NCT00719745|Tacrolimus|tacrolimus
678058|NCT00719745|Prograf|prograf
678059|NCT00719745|MR4|mr4
678060|NCT00719732|ReSTOR Aspheric +3 IOL|restor aspheric +3 iol
678061|NCT00719719|Antigen Specific|antigen specific
678062|NCT00719719|Mast Cell|mast cell
678063|NCT00719719|Tryptase|tryptase
678064|NCT00719719|Bone Marrow|bone marrow
678065|NCT00719719|Hives|hives
678066|NCT00719719|Adult|adult
678067|NCT00719719|Anaphylaxis|anaphylaxis
678068|NCT00719706|Bipolar disorder|bipolar disorder
678069|NCT00719706|Bipolar depression|bipolar depression
678070|NCT00719706|Natural substances|natural substances
678071|NCT00719706|Depression|depression
678072|NCT00719693|Food effect, phase I|food effect, phase i
678073|NCT00719693|adverse events|adverse events
678074|NCT00719680|CVID|cvid
678075|NCT00719680|XLA|xla
678076|NCT00719667|OPCAB|opcab
678077|NCT00719667|coronary|coronary
678078|NCT00719667|bypass|bypass
678079|NCT00719667|grafting|grafting
678080|NCT00719667|off pump|off pump
678081|NCT00719654|Preeclampsia|preeclampsia
678082|NCT00719654|Proteome|proteome
678083|NCT00719654|Pregnancy|pregnancy
678084|NCT00719641|Colonoscopy|colonoscopy
678085|NCT00719641|Looping|looping
678086|NCT00719641|Prevent Looping|prevent looping
678087|NCT00719641|Colon Cancer Screening|colon cancer screening
678088|NCT00719641|Segmental Stiffening Wire|segmental stiffening wire
678089|NCT00719628|Postoperative|postoperative
678090|NCT00719628|Cognitive|cognitive
678091|NCT00719628|Dysfunction|dysfunction
678092|NCT00719615|Thyroid Cancer|thyroid cancer
678093|NCT00719615|Thyroid Nodules|thyroid nodules
678094|NCT00719615|Vitamin D|vitamin d
678095|NCT00719602|Coinfection|coinfection
678096|NCT00719589|Voiding Dysfunction|voiding dysfunction
678097|NCT00719589|Interstim|interstim
678098|NCT00719576|Cartilage legions|cartilage legions
678099|NCT00719576|symptomatic focal cartilage defects|symptomatic focal cartilage defects
678100|NCT00719576|microfracture|microfracture
678101|NCT00719576|MACI|maci
678102|NCT00719576|autologous chondrocyte|autologous chondrocyte
678103|NCT00719563|fatigue|fatigue
860179|NCT00062517|GAD|gad
678104|NCT00719563|unspecified adult solid tumor, protocol specific|unspecified adult solid tumor, protocol specific
678105|NCT00719563|accelerated phase chronic myelogenous leukemia|accelerated phase chronic myelogenous leukemia
678106|NCT00719563|acute undifferentiated leukemia|acute undifferentiated leukemia
678107|NCT00719563|adult acute lymphoblastic leukemia in remission|adult acute lymphoblastic leukemia in remission
678108|NCT00719563|adult acute myeloid leukemia in remission|adult acute myeloid leukemia in remission
678109|NCT00719563|adult acute myeloid leukemia with 11q23 (MLL) abnormalities|adult acute myeloid leukemia with 11q23 (mll) abnormalities
678110|NCT00719563|adult acute myeloid leukemia with inv(16)(p13;q22)|adult acute myeloid leukemia with inv(16)(p13;q22)
678111|NCT00719563|adult acute myeloid leukemia with t(15;17)(q22;q12)|adult acute myeloid leukemia with t(15;17)(q22;q12)
678112|NCT00719563|adult acute myeloid leukemia with t(16;16)(p13;q22)|adult acute myeloid leukemia with t(16;16)(p13;q22)
678113|NCT00719563|adult acute myeloid leukemia with t(8;21)(q22;q22)|adult acute myeloid leukemia with t(8;21)(q22;q22)
678114|NCT00719563|atypical chronic myeloid leukemia, BCR-ABL1 negative|atypical chronic myeloid leukemia, bcr-abl1 negative
678115|NCT00719563|blastic phase chronic myelogenous leukemia|blastic phase chronic myelogenous leukemia
678116|NCT00719563|chronic myelomonocytic leukemia|chronic myelomonocytic leukemia
678117|NCT00719563|chronic phase chronic myelogenous leukemia|chronic phase chronic myelogenous leukemia
678118|NCT00719563|mast cell leukemia|mast cell leukemia
678119|NCT00719563|progressive hairy cell leukemia, initial treatment|progressive hairy cell leukemia, initial treatment
678120|NCT00719563|prolymphocytic leukemia|prolymphocytic leukemia
678121|NCT00719563|recurrent adult acute lymphoblastic leukemia|recurrent adult acute lymphoblastic leukemia
678122|NCT00719563|recurrent adult acute myeloid leukemia|recurrent adult acute myeloid leukemia
678123|NCT00719563|recurrent adult T-cell leukemia/lymphoma|recurrent adult t-cell leukemia/lymphoma
678124|NCT00719563|refractory chronic lymphocytic leukemia|refractory chronic lymphocytic leukemia
678125|NCT00719563|refractory hairy cell leukemia|refractory hairy cell leukemia
678126|NCT00719563|relapsing chronic myelogenous leukemia|relapsing chronic myelogenous leukemia
679328|NCT00715455|PCI|pci
678127|NCT00719563|secondary acute myeloid leukemia|secondary acute myeloid leukemia
678128|NCT00719563|stage 0 chronic lymphocytic leukemia|stage 0 chronic lymphocytic leukemia
678129|NCT00719563|stage I adult T-cell leukemia/lymphoma|stage i adult t-cell leukemia/lymphoma
678130|NCT00719563|stage I chronic lymphocytic leukemia|stage i chronic lymphocytic leukemia
678131|NCT00719563|stage II adult T-cell leukemia/lymphoma|stage ii adult t-cell leukemia/lymphoma
678132|NCT00719563|stage II chronic lymphocytic leukemia|stage ii chronic lymphocytic leukemia
678133|NCT00719563|stage III adult T-cell leukemia/lymphoma|stage iii adult t-cell leukemia/lymphoma
678134|NCT00719563|stage III chronic lymphocytic leukemia|stage iii chronic lymphocytic leukemia
678135|NCT00719563|stage IV adult T-cell leukemia/lymphoma|stage iv adult t-cell leukemia/lymphoma
678136|NCT00719563|stage IV chronic lymphocytic leukemia|stage iv chronic lymphocytic leukemia
678137|NCT00719563|T-cell large granular lymphocyte leukemia|t-cell large granular lymphocyte leukemia
678138|NCT00719563|untreated adult acute lymphoblastic leukemia|untreated adult acute lymphoblastic leukemia
678139|NCT00719563|recurrent adult Hodgkin lymphoma|recurrent adult hodgkin lymphoma
678140|NCT00719563|stage I adult Hodgkin lymphoma|stage i adult hodgkin lymphoma
678141|NCT00719563|stage II adult Hodgkin lymphoma|stage ii adult hodgkin lymphoma
678142|NCT00719563|stage III adult Hodgkin lymphoma|stage iii adult hodgkin lymphoma
678143|NCT00719563|stage IV adult Hodgkin lymphoma|stage iv adult hodgkin lymphoma
678144|NCT00719563|anaplastic large cell lymphoma|anaplastic large cell lymphoma
678145|NCT00719563|angioimmunoblastic T-cell lymphoma|angioimmunoblastic t-cell lymphoma
678146|NCT00719563|cutaneous B-cell non-Hodgkin lymphoma|cutaneous b-cell non-hodgkin lymphoma
678147|NCT00719563|recurrent cutaneous T-cell non-Hodgkin lymphoma|recurrent cutaneous t-cell non-hodgkin lymphoma
678148|NCT00719563|stage I cutaneous T-cell non-Hodgkin lymphoma|stage i cutaneous t-cell non-hodgkin lymphoma
678149|NCT00719563|stage II cutaneous T-cell non-Hodgkin lymphoma|stage ii cutaneous t-cell non-hodgkin lymphoma
678150|NCT00719563|stage III cutaneous T-cell non-Hodgkin lymphoma|stage iii cutaneous t-cell non-hodgkin lymphoma
678151|NCT00719563|stage IV cutaneous T-cell non-Hodgkin lymphoma|stage iv cutaneous t-cell non-hodgkin lymphoma
678152|NCT00719563|recurrent mycosis fungoides/Sezary syndrome|recurrent mycosis fungoides/sezary syndrome
678153|NCT00719563|stage I mycosis fungoides/Sezary syndrome|stage i mycosis fungoides/sezary syndrome
678154|NCT00719563|stage II mycosis fungoides/Sezary syndrome|stage ii mycosis fungoides/sezary syndrome
678155|NCT00719563|stage III mycosis fungoides/Sezary syndrome|stage iii mycosis fungoides/sezary syndrome
678156|NCT00719563|stage IV mycosis fungoides/Sezary syndrome|stage iv mycosis fungoides/sezary syndrome
678157|NCT00719563|adult grade III lymphomatoid granulomatosis|adult grade iii lymphomatoid granulomatosis
678158|NCT00719563|adult nasal type extranodal NK/T-cell lymphoma|adult nasal type extranodal nk/t-cell lymphoma
678159|NCT00719563|Waldenström macroglobulinemia|waldenström macroglobulinemia
678160|NCT00719563|extranodal marginal zone B-cell lymphoma of mucosa-associated lymphoid tissue|extranodal marginal zone b-cell lymphoma of mucosa-associated lymphoid tissue
678161|NCT00719563|nodal marginal zone B-cell lymphoma|nodal marginal zone b-cell lymphoma
678162|NCT00719563|splenic marginal zone lymphoma|splenic marginal zone lymphoma
678163|NCT00719563|contiguous stage II adult Burkitt lymphoma|contiguous stage ii adult burkitt lymphoma
710601|NCT00588653|computed tomography enterography|computed tomography enterography
678164|NCT00719563|contiguous stage II adult diffuse large cell lymphoma|contiguous stage ii adult diffuse large cell lymphoma
678165|NCT00719563|contiguous stage II adult diffuse mixed cell lymphoma|contiguous stage ii adult diffuse mixed cell lymphoma
678166|NCT00719563|contiguous stage II adult diffuse small cleaved cell lymphoma|contiguous stage ii adult diffuse small cleaved cell lymphoma
678167|NCT00719563|contiguous stage II adult immunoblastic large cell lymphoma|contiguous stage ii adult immunoblastic large cell lymphoma
678168|NCT00719563|contiguous stage II adult lymphoblastic lymphoma|contiguous stage ii adult lymphoblastic lymphoma
678169|NCT00719563|contiguous stage II grade 1 follicular lymphoma|contiguous stage ii grade 1 follicular lymphoma
678170|NCT00719563|contiguous stage II grade 2 follicular lymphoma|contiguous stage ii grade 2 follicular lymphoma
678171|NCT00719563|contiguous stage II grade 3 follicular lymphoma|contiguous stage ii grade 3 follicular lymphoma
678172|NCT00719563|contiguous stage II mantle cell lymphoma|contiguous stage ii mantle cell lymphoma
678173|NCT00719563|contiguous stage II marginal zone lymphoma|contiguous stage ii marginal zone lymphoma
678174|NCT00719563|contiguous stage II small lymphocytic lymphoma|contiguous stage ii small lymphocytic lymphoma
678175|NCT00719563|stage I adult Burkitt lymphoma|stage i adult burkitt lymphoma
678176|NCT00719563|stage I adult diffuse large cell lymphoma|stage i adult diffuse large cell lymphoma
678177|NCT00719563|stage I adult diffuse mixed cell lymphoma|stage i adult diffuse mixed cell lymphoma
678178|NCT00719563|stage I adult diffuse small cleaved cell lymphoma|stage i adult diffuse small cleaved cell lymphoma
678179|NCT00719563|stage I adult immunoblastic large cell lymphoma|stage i adult immunoblastic large cell lymphoma
678180|NCT00719563|stage I adult lymphoblastic lymphoma|stage i adult lymphoblastic lymphoma
678181|NCT00719563|stage I grade 1 follicular lymphoma|stage i grade 1 follicular lymphoma
678182|NCT00719563|stage I grade 2 follicular lymphoma|stage i grade 2 follicular lymphoma
678183|NCT00719563|stage I grade 3 follicular lymphoma|stage i grade 3 follicular lymphoma
678184|NCT00719563|stage I mantle cell lymphoma|stage i mantle cell lymphoma
678185|NCT00719563|stage I marginal zone lymphoma|stage i marginal zone lymphoma
678186|NCT00719563|stage I small lymphocytic lymphoma|stage i small lymphocytic lymphoma
678187|NCT00719563|noncontiguous stage II adult Burkitt lymphoma|noncontiguous stage ii adult burkitt lymphoma
678188|NCT00719563|noncontiguous stage II adult diffuse large cell lymphoma|noncontiguous stage ii adult diffuse large cell lymphoma
678189|NCT00719563|noncontiguous stage II adult diffuse mixed cell lymphoma|noncontiguous stage ii adult diffuse mixed cell lymphoma
678190|NCT00719563|noncontiguous stage II adult diffuse small cleaved cell lymphoma|noncontiguous stage ii adult diffuse small cleaved cell lymphoma
678191|NCT00719563|noncontiguous stage II adult immunoblastic large cell lymphoma|noncontiguous stage ii adult immunoblastic large cell lymphoma
678192|NCT00719563|noncontiguous stage II adult lymphoblastic lymphoma|noncontiguous stage ii adult lymphoblastic lymphoma
678193|NCT00719563|noncontiguous stage II grade 1 follicular lymphoma|noncontiguous stage ii grade 1 follicular lymphoma
678194|NCT00719563|noncontiguous stage II grade 2 follicular lymphoma|noncontiguous stage ii grade 2 follicular lymphoma
678195|NCT00719563|noncontiguous stage II grade 3 follicular lymphoma|noncontiguous stage ii grade 3 follicular lymphoma
678196|NCT00719563|noncontiguous stage II mantle cell lymphoma|noncontiguous stage ii mantle cell lymphoma
678197|NCT00719563|noncontiguous stage II marginal zone lymphoma|noncontiguous stage ii marginal zone lymphoma
678198|NCT00719563|noncontiguous stage II small lymphocytic lymphoma|noncontiguous stage ii small lymphocytic lymphoma
678199|NCT00719563|stage III adult Burkitt lymphoma|stage iii adult burkitt lymphoma
678200|NCT00719563|stage III adult diffuse large cell lymphoma|stage iii adult diffuse large cell lymphoma
678201|NCT00719563|stage III adult diffuse mixed cell lymphoma|stage iii adult diffuse mixed cell lymphoma
678202|NCT00719563|stage III adult diffuse small cleaved cell lymphoma|stage iii adult diffuse small cleaved cell lymphoma
678203|NCT00719563|stage III adult immunoblastic large cell lymphoma|stage iii adult immunoblastic large cell lymphoma
678204|NCT00719563|stage III adult lymphoblastic lymphoma|stage iii adult lymphoblastic lymphoma
678205|NCT00719563|stage III grade 1 follicular lymphoma|stage iii grade 1 follicular lymphoma
678206|NCT00719563|stage III grade 2 follicular lymphoma|stage iii grade 2 follicular lymphoma
678207|NCT00719563|stage III grade 3 follicular lymphoma|stage iii grade 3 follicular lymphoma
678208|NCT00719563|stage III mantle cell lymphoma|stage iii mantle cell lymphoma
678209|NCT00719563|stage III marginal zone lymphoma|stage iii marginal zone lymphoma
678210|NCT00719563|stage III small lymphocytic lymphoma|stage iii small lymphocytic lymphoma
678211|NCT00719563|stage IV adult Burkitt lymphoma|stage iv adult burkitt lymphoma
678212|NCT00719563|stage IV adult diffuse large cell lymphoma|stage iv adult diffuse large cell lymphoma
678213|NCT00719563|stage IV adult diffuse mixed cell lymphoma|stage iv adult diffuse mixed cell lymphoma
678214|NCT00719563|stage IV adult diffuse small cleaved cell lymphoma|stage iv adult diffuse small cleaved cell lymphoma
678215|NCT00719563|stage IV adult immunoblastic large cell lymphoma|stage iv adult immunoblastic large cell lymphoma
678216|NCT00719563|stage IV adult lymphoblastic lymphoma|stage iv adult lymphoblastic lymphoma
678217|NCT00719563|stage IV grade 1 follicular lymphoma|stage iv grade 1 follicular lymphoma
678218|NCT00719563|stage IV grade 2 follicular lymphoma|stage iv grade 2 follicular lymphoma
678219|NCT00719563|stage IV grade 3 follicular lymphoma|stage iv grade 3 follicular lymphoma
678220|NCT00719563|stage IV mantle cell lymphoma|stage iv mantle cell lymphoma
678221|NCT00719563|stage IV marginal zone lymphoma|stage iv marginal zone lymphoma
678222|NCT00719563|stage IV small lymphocytic lymphoma|stage iv small lymphocytic lymphoma
710602|NCT00588653|colonoscopy|colonoscopy
678223|NCT00719563|recurrent adult Burkitt lymphoma|recurrent adult burkitt lymphoma
678224|NCT00719563|recurrent adult diffuse large cell lymphoma|recurrent adult diffuse large cell lymphoma
678225|NCT00719563|recurrent adult diffuse mixed cell lymphoma|recurrent adult diffuse mixed cell lymphoma
678226|NCT00719563|recurrent adult diffuse small cleaved cell lymphoma|recurrent adult diffuse small cleaved cell lymphoma
678227|NCT00719563|recurrent adult grade III lymphomatoid granulomatosis|recurrent adult grade iii lymphomatoid granulomatosis
678228|NCT00719563|recurrent adult immunoblastic large cell lymphoma|recurrent adult immunoblastic large cell lymphoma
678229|NCT00719563|recurrent adult lymphoblastic lymphoma|recurrent adult lymphoblastic lymphoma
678230|NCT00719563|recurrent grade 1 follicular lymphoma|recurrent grade 1 follicular lymphoma
678231|NCT00719563|recurrent grade 2 follicular lymphoma|recurrent grade 2 follicular lymphoma
678232|NCT00719563|recurrent grade 3 follicular lymphoma|recurrent grade 3 follicular lymphoma
678233|NCT00719563|recurrent mantle cell lymphoma|recurrent mantle cell lymphoma
678234|NCT00719563|recurrent marginal zone lymphoma|recurrent marginal zone lymphoma
678235|NCT00719563|recurrent small lymphocytic lymphoma|recurrent small lymphocytic lymphoma
678236|NCT00719563|intraocular lymphoma|intraocular lymphoma
678237|NCT00719563|post-transplant lymphoproliferative disorder|post-transplant lymphoproliferative disorder
678238|NCT00719563|chronic eosinophilic leukemia|chronic eosinophilic leukemia
678239|NCT00719563|chronic neutrophilic leukemia|chronic neutrophilic leukemia
678240|NCT00719563|primary myelofibrosis|primary myelofibrosis
678241|NCT00719563|essential thrombocythemia|essential thrombocythemia
678242|NCT00719563|polycythemia vera|polycythemia vera
678243|NCT00719563|extramedullary plasmacytoma|extramedullary plasmacytoma
678244|NCT00719563|isolated plasmacytoma of bone|isolated plasmacytoma of bone
678245|NCT00719563|monoclonal gammopathy of undetermined significance|monoclonal gammopathy of undetermined significance
678246|NCT00719563|stage I multiple myeloma|stage i multiple myeloma
678247|NCT00719563|stage II multiple myeloma|stage ii multiple myeloma
678248|NCT00719563|stage III multiple myeloma|stage iii multiple myeloma
678249|NCT00719563|primary systemic amyloidosis|primary systemic amyloidosis
678250|NCT00719563|refractory multiple myeloma|refractory multiple myeloma
678251|NCT00719563|de novo myelodysplastic syndromes|de novo myelodysplastic syndromes
678252|NCT00719563|previously treated myelodysplastic syndromes|previously treated myelodysplastic syndromes
678458|NCT00718666|Vaccines, conjugate|vaccines, conjugate
678253|NCT00719563|secondary myelodysplastic syndromes|secondary myelodysplastic syndromes
678254|NCT00719563|myelodysplastic/myeloproliferative neoplasm, unclassifiable|myelodysplastic/myeloproliferative neoplasm, unclassifiable
678255|NCT00719550|Locally Advanced|locally advanced
678256|NCT00719550|Metastatic|metastatic
678257|NCT00719537|preeclampsia|preeclampsia
678258|NCT00719537|progesterone|progesterone
678259|NCT00719537|aspirin|aspirin
678260|NCT00719537|prevent|prevent
678261|NCT00719537|soluble fms-like tyrosine kinase (sFlt-1)|soluble fms-like tyrosine kinase (sflt-1)
678262|NCT00719537|Placental Growth Factor (PlGF)|placental growth factor (plgf)
678263|NCT00719537|risk|risk
678264|NCT00719524|Neoplasms|neoplasms
678265|NCT00719524|Antineoplastic Combined Chemotherapy Protocol|antineoplastic combined chemotherapy protocol
678266|NCT00719511|Rhinoconjunctivitis|rhinoconjunctivitis
678267|NCT00719511|Allergic|allergic
678268|NCT00719498|Epo-alpha|epo-alpha
678269|NCT00719498|Cardiac arrest|cardiac arrest
678270|NCT00719498|Mild hypothermia|mild hypothermia
678271|NCT00719485|lumbar decompression|lumbar decompression
678272|NCT00719472|Follicular NHL|follicular nhl
678273|NCT00719472|NHL|nhl
678274|NCT00719472|Large B-Cell NHL|large b-cell nhl
678275|NCT00719446|Acute Lung Injury|acute lung injury
678276|NCT00719433|stroke|stroke
678277|NCT00719433|chronic|chronic
678278|NCT00719433|rehabilitation|rehabilitation
678279|NCT00719433|robot therapy|robot therapy
678280|NCT00719433|arm therapy|arm therapy
678281|NCT00719420|Randomized clinical trial|randomized clinical trial
678282|NCT00719420|Helicobacter pylori|helicobacter pylori
678283|NCT00719420|clarithromycin|clarithromycin
678284|NCT00719420|metronidazole|metronidazole
678285|NCT00719420|amoxicillin|amoxicillin
678286|NCT00719420|proton pump inhibitor|proton pump inhibitor
678287|NCT00719420|Colombia|colombia
678288|NCT00719407|birth asphyxia|birth asphyxia
678289|NCT00719407|neonatal encephalopathy|neonatal encephalopathy
678290|NCT00719407|hypoxic-ischemic encephalopathy|hypoxic-ischemic encephalopathy
678291|NCT00719407|neuroprotection|neuroprotection
678292|NCT00719407|neonate|neonate
678293|NCT00719394|alzheimer Disease|alzheimer disease
678294|NCT00719368|Groin hernia|groin hernia
678295|NCT00719368|pain|pain
678296|NCT00719368|chronic|chronic
678297|NCT00719368|quantitative sensory testing|quantitative sensory testing
678298|NCT00719368|Persistent postoperative pain|persistent postoperative pain
678299|NCT00719342|Retinal vessel diameter|retinal vessel diameter
678300|NCT00719342|Flicker-induced vasodilatation|flicker-induced vasodilatation
678301|NCT00719342|Optic nerve head blood flow|optic nerve head blood flow
678302|NCT00719342|Ocular Physiology|ocular physiology
678303|NCT00719342|Regional Blood Flow|regional blood flow
678304|NCT00719329|chlorhexidine|chlorhexidine
678305|NCT00719329|umbilical cord|umbilical cord
678306|NCT00719316|Renin inhibitor|renin inhibitor
678307|NCT00719316|Patients|patients
678308|NCT00719316|ACE inhibitor or ARB|ace inhibitor or arb
678309|NCT00719316|Chronic Kidney Disease|chronic kidney disease
678310|NCT00719316|Hypertension|hypertension
678311|NCT00719290|Primary Angle Closure Glaucoma|primary angle closure glaucoma
678312|NCT00719290|Phacoemulsification|phacoemulsification
678313|NCT00719290|Goniosynechialysis|goniosynechialysis
678314|NCT00719290|Outflow facility|outflow facility
678315|NCT00719277|cardiac arrhythmia|cardiac arrhythmia
678316|NCT00719277|syncope|syncope
678317|NCT00719277|ECG|ecg
678318|NCT00719277|implantable ECG monitor|implantable ecg monitor
678319|NCT00719277|ILR|ilr
678320|NCT00719264|Renal cell carcinoma|renal cell carcinoma
678321|NCT00719264|Adults|adults
678322|NCT00719264|Bevacizumab|bevacizumab
678323|NCT00719264|RAD001|rad001
678324|NCT00719264|Everolimus|everolimus
678325|NCT00719264|Interferon|interferon
678326|NCT00719264|Clear|clear
678327|NCT00719264|Roferon|roferon
678328|NCT00719264|Avastin|avastin
678329|NCT00719264|Nephrectomy|nephrectomy
678330|NCT00719264|newly diagnosed|newly diagnosed
678331|NCT00719251|Complications of Diabetes Mellitus|complications of diabetes mellitus
678332|NCT00719251|Electric stimulation|electric stimulation
678333|NCT00719251|Low-Level Laser Therapy|low-level laser therapy
678334|NCT00719199|Colorectal cancer|colorectal cancer
678335|NCT00719199|metastatic cancer|metastatic cancer
678336|NCT00719199|prior therapy|prior therapy
678337|NCT00719199|1b|1b
678338|NCT00719186|Polycystic Ovary Syndrome|polycystic ovary syndrome
678339|NCT00719186|Infertility|infertility
678340|NCT00719186|Pregnancy|pregnancy
678341|NCT00719186|Women|women
678342|NCT00719173|nausea and vomiting|nausea and vomiting
678343|NCT00719173|breast cancer|breast cancer
678344|NCT00719160|Gastric acid|gastric acid
678345|NCT00719160|Dietary protein|dietary protein
678346|NCT00719160|Calcium|calcium
678347|NCT00719160|Intestinal absorption|intestinal absorption
678348|NCT00719160|Calcium sensing receptor|calcium sensing receptor
678349|NCT00719108|Diabetes, Healthy Volunteers|diabetes, healthy volunteers
678350|NCT00719095|prescription opioid|prescription opioid
678351|NCT00719095|opioid detoxification|opioid detoxification
678352|NCT00719095|buprenorphine|buprenorphine
678353|NCT00719095|naltrexone|naltrexone
678354|NCT00719095|community reinforcement approach|community reinforcement approach
678355|NCT00719095|prescription opioid abuse|prescription opioid abuse
678356|NCT00719082|Human Stability|human stability
678357|NCT00719082|Geriatric|geriatric
678358|NCT00719082|Posturography|posturography
678359|NCT00719056|teicoplanin|teicoplanin
678360|NCT00719056|prophylaxis|prophylaxis
678361|NCT00719056|arthroplasty|arthroplasty
678362|NCT00719056|surgical site infections|surgical site infections
678363|NCT00719043|Influenza|influenza
678364|NCT00719043|H5N1|h5n1
678365|NCT00719043|Avian|avian
678366|NCT00719043|Vaccines|vaccines
678367|NCT00719043|Safety|safety
678368|NCT00719043|Immunogenicity|immunogenicity
678369|NCT00719043|Pandemic|pandemic
678370|NCT00719043|Human|human
678371|NCT00719017|Brachytherapy|brachytherapy
678372|NCT00719017|Early stage edometrial cancer|early stage edometrial cancer
678373|NCT00719017|Quality of life|quality of life
678374|NCT00719017|Recurrence|recurrence
678375|NCT00719017|Treatment|treatment
678376|NCT00719017|Vaginectomy|vaginectomy
678377|NCT00719004|Anatomy|anatomy
678378|NCT00719004|Foot|foot
678379|NCT00719004|Sonography|sonography
678380|NCT00719004|Medical|medical
678381|NCT00718991|CLI|cli
678382|NCT00718991|excimer laser|excimer laser
678383|NCT00718991|debulking|debulking
678384|NCT00718978|bioengineered|bioengineered
678385|NCT00718978|ski|ski
678386|NCT00718978|keratinocytes|keratinocytes
678387|NCT00718978|fibroblasts|fibroblasts
678388|NCT00718978|skin|skin
678389|NCT00718978|culture|culture
678390|NCT00718978|autologous|autologous
678391|NCT00718978|CSS|css
678392|NCT00718978|full-thickness loss of substance from:|full-thickness loss of substance from:
678393|NCT00718978|burns|burns
678394|NCT00718978|ulcers|ulcers
678395|NCT00718978|giant nevi|giant nevi
678396|NCT00718978|cicatricial outcomes|cicatricial outcomes
678397|NCT00718965|Primary hypercholesterolemia|primary hypercholesterolemia
678398|NCT00718952|Pulmonary Hypertension|pulmonary hypertension
678399|NCT00718939|Diastolic Heart Failure|diastolic heart failure
678400|NCT00718939|Cardiac dysfunction|cardiac dysfunction
678401|NCT00718939|Heart Failure|heart failure
678402|NCT00718926|dry eye|dry eye
678403|NCT00718926|Thiol redox|thiol redox
678404|NCT00718926|Oxidative stress|oxidative stress
678405|NCT00718913|Adjuvant Gastric Cancer|adjuvant gastric cancer
678406|NCT00718913|Adjuvant chemotherapy|adjuvant chemotherapy
678407|NCT00718913|Adjuvant chemo-radiation|adjuvant chemo-radiation
678408|NCT00718913|Capecitabine|capecitabine
678409|NCT00718874|obesity, puberty, diabetes,insulin dynamics|obesity, puberty, diabetes,insulin dynamics
678410|NCT00718861|Osteoporosis|osteoporosis
678411|NCT00718861|zoledronic acid|zoledronic acid
678412|NCT00718861|post-menopausal|post-menopausal
678413|NCT00718848|hemodialysis|hemodialysis
678414|NCT00718848|left ventricular hypertrophy|left ventricular hypertrophy
678415|NCT00718848|left ventricular systolic function|left ventricular systolic function
678416|NCT00718835|smoking cessation|smoking cessation
678417|NCT00718835|behavioral treatment|behavioral treatment
678418|NCT00718835|contingency management|contingency management
678419|NCT00718835|opioid maintenance|opioid maintenance
678420|NCT00718835|methadone|methadone
678421|NCT00718835|buprenorphine|buprenorphine
678422|NCT00718822|clinical outcome|clinical outcome
678423|NCT00718822|ICSI cycles|icsi cycles
678424|NCT00718822|low oxygen|low oxygen
678425|NCT00718822|poor responders|poor responders
678426|NCT00718822|pregnancy rate|pregnancy rate
678427|NCT00718822|prospective randomized study|prospective randomized study
678428|NCT00718796|cardiovascular disease|cardiovascular disease
678429|NCT00718796|naturopathic medicine|naturopathic medicine
678430|NCT00718796|natural health products|natural health products
678431|NCT00718796|lifestyle intervention|lifestyle intervention
678432|NCT00718796|dietary advice|dietary advice
678433|NCT00718796|coronary heart disease|coronary heart disease
678434|NCT00718770|Not respond|not respond
678435|NCT00718770|Radioactive iodine|radioactive iodine
678436|NCT00718770|Therapy|therapy
678437|NCT00718770|Shows signs|shows signs
678438|NCT00718770|Aggressive behavior|aggressive behavior
678439|NCT00718744|Allergen-extract|allergen-extract
678440|NCT00718744|Standardization|standardization
678441|NCT00718731|Alzheimer Disease|alzheimer disease
678442|NCT00718718|Arthritis, Rheumatoid|arthritis, rheumatoid
678443|NCT00718718|Rheumatoid Arthritis|rheumatoid arthritis
678444|NCT00718718|Active Rheumatoid Arthritis|active rheumatoid arthritis
678445|NCT00718718|CNTO 136|cnto 136
678446|NCT00718718|Interleukin-6|interleukin-6
678447|NCT00718718|Anti-interleukin-6 monoclonal antibody|anti-interleukin-6 monoclonal antibody
678448|NCT00718718|Methotrexate|methotrexate
678449|NCT00718718|Placebo|placebo
678450|NCT00718705|Prematurity|prematurity
678451|NCT00718705|Ureaplasma spp|ureaplasma spp
678452|NCT00718705|Mycoplasma Hominis|mycoplasma hominis
678453|NCT00718705|Amniotic fluid|amniotic fluid
678454|NCT00718705|Josamycine|josamycine
678455|NCT00718692|Idiopathic|idiopathic
678456|NCT00718692|ITP|itp
678457|NCT00718666|Safety|safety
678459|NCT00718666|Immunogenicity|immunogenicity
678460|NCT00718666|Meningococcal vaccine|meningococcal vaccine
678461|NCT00718666|Booster vaccination|booster vaccination
678462|NCT00718666|Primary vaccination|primary vaccination
678463|NCT00718666|Neisseria meningitides|neisseria meningitides
678464|NCT00718666|Toddlers|toddlers
678466|NCT00718666|Meningococcal disease|meningococcal disease
678467|NCT00718653|Macular pigment, lutein, green tea extract, antioxidant|macular pigment, lutein, green tea extract, antioxidant
678468|NCT00718640|Multiple Myeloma|multiple myeloma
678469|NCT00718640|Velcade|velcade
678470|NCT00718640|Bortezomib|bortezomib
678471|NCT00718640|Dexamethasone|dexamethasone
678472|NCT00718627|Urea cycle Disorders|urea cycle disorders
678473|NCT00718627|Carbamoylphosphate synthetase I deficiency|carbamoylphosphate synthetase i deficiency
678474|NCT00718627|Ornithine transcarbamoylase deficiency|ornithine transcarbamoylase deficiency
678475|NCT00718627|Argininosuccinate synthase deficiency|argininosuccinate synthase deficiency
678476|NCT00718627|Citrullinemia|citrullinemia
678477|NCT00718627|newborns|newborns
678478|NCT00718627|infants|infants
678479|NCT00718627|liver cell transplantation|liver cell transplantation
678480|NCT00718627|liver cell infusion|liver cell infusion
678481|NCT00718614|Choroidal blood flow|choroidal blood flow
678482|NCT00718614|Laser Doppler flowmetry|laser doppler flowmetry
678483|NCT00718614|Diabetic Retinopathy|diabetic retinopathy
678484|NCT00718614|Diabetic Neuropathy|diabetic neuropathy
678485|NCT00718601|Myeloma|myeloma
678486|NCT00718601|Multiple Myeloma|multiple myeloma
678487|NCT00718601|Relapsed Multiple Myeloma|relapsed multiple myeloma
678488|NCT00718601|Refractory Multiple Myeloma|refractory multiple myeloma
678489|NCT00718601|Relapsed or Refractory Multiple Myeloma|relapsed or refractory multiple myeloma
678490|NCT00718588|RA|ra
678491|NCT00718575|Liver Disease|liver disease
678492|NCT00718575|Transplantation|transplantation
678493|NCT00718562|nilotinib|nilotinib
678494|NCT00718562|AMN107|amn107
678495|NCT00718562|Sunitinib|sunitinib
678496|NCT00718562|Sunitinib malate|sunitinib malate
678497|NCT00718562|Imatinib|imatinib
678498|NCT00718562|Imatinib mesylate|imatinib mesylate
678499|NCT00718562|Tyrosine|tyrosine
678500|NCT00718536|Atazanavir|atazanavir
678501|NCT00718536|Raltegravir|raltegravir
678502|NCT00718536|once-daily|once-daily
678503|NCT00718536|pharmacokinetics|pharmacokinetics
678504|NCT00718536|HIV|hiv
678505|NCT00718497|Amyotrophic Lateral Sclerosis|amyotrophic lateral sclerosis
678506|NCT00718497|Cerebrospinal Fluid|cerebrospinal fluid
678507|NCT00718497|Neurodegenerative Disease|neurodegenerative disease
678508|NCT00718497|Motor Neuron Disease|motor neuron disease
678509|NCT00718497|Autonomic Nervous System|autonomic nervous system
678510|NCT00718497|Neurodegenerative Diseases|neurodegenerative diseases
678511|NCT00718497|Movement Disorders|movement disorders
678512|NCT00718484|Sarcoma|sarcoma
678513|NCT00718484|Soft Tissue Sarcoma|soft tissue sarcoma
678514|NCT00718484|Doxorubicin|doxorubicin
678515|NCT00718484|anthracyclin|anthracyclin
678516|NCT00718484|Palifosfamide|palifosfamide
678517|NCT00718484|IFOS|ifos
678518|NCT00718471|STEMI|stemi
678519|NCT00718471|Primary PCI|primary pci
678520|NCT00718471|Anticoagulation|anticoagulation
678521|NCT00718458|Amyotrophic Lateral Sclerosis|amyotrophic lateral sclerosis
678522|NCT00718458|Cerebrospinal Fluid|cerebrospinal fluid
678523|NCT00718458|Neurodegenerative Disease|neurodegenerative disease
678524|NCT00718458|Motor Neuron Disease|motor neuron disease
678525|NCT00718458|Autonomic Nervous System|autonomic nervous system
678526|NCT00718458|Neurodegenerative Diseases|neurodegenerative diseases
678527|NCT00718458|Movement Disorders|movement disorders
678528|NCT00718445|Amyotrophic Lateral Sclerosis|amyotrophic lateral sclerosis
678529|NCT00718445|Cerebrospinal Fluid|cerebrospinal fluid
678530|NCT00718445|Neurodegenerative Disease|neurodegenerative disease
678531|NCT00718445|Motor Neuron Disease|motor neuron disease
678532|NCT00718445|Autonomic Nervous System|autonomic nervous system
678533|NCT00718445|Neurodegenerative Diseases|neurodegenerative diseases
678534|NCT00718445|Movement Disorders|movement disorders
678535|NCT00718432|Frailty|frailty
678536|NCT00718432|Osteoporosis|osteoporosis
678537|NCT00718432|Depression|depression
678538|NCT00718419|Waldenstrom's Macroglobulinemia|waldenstrom's macroglobulinemia
678539|NCT00718419|Multiple Myeloma|multiple myeloma
678540|NCT00718406|Acute coronary syndrome|acute coronary syndrome
678541|NCT00718406|Chest pain|chest pain
678542|NCT00718406|Betablockers|betablockers
678543|NCT00718406|Morphine|morphine
678544|NCT00718406|Prehospital phase|prehospital phase
678545|NCT00718393|Amyotrophic Lateral Sclerosis|amyotrophic lateral sclerosis
678546|NCT00718393|Cerebrospinal Fluid|cerebrospinal fluid
678547|NCT00718393|Neurodegenerative Disease|neurodegenerative disease
678548|NCT00718393|Motor Neuron Disease|motor neuron disease
678549|NCT00718393|Autonomic Nervous System|autonomic nervous system
678550|NCT00718393|Neurodegenerative Diseases|neurodegenerative diseases
678551|NCT00718393|Movement Disorders|movement disorders
678552|NCT00718354|Bleeding events|bleeding events
678553|NCT00718341|Fragile X Syndrome, adults, efficacy|fragile x syndrome, adults, efficacy
678554|NCT00718328|Intracerebral|intracerebral
678555|NCT00718328|Hemorrhage|hemorrhage
678556|NCT00718328|Edema|edema
678557|NCT00718328|Statins|statins
678558|NCT00718302|Ankle Fractures|ankle fractures
678559|NCT00718302|Displaced Lateral Malleolus Fractures|displaced lateral malleolus fractures
678560|NCT00718302|Antiglide Plating|antiglide plating
678561|NCT00718302|Lateral Plating|lateral plating
678562|NCT00718289|Citric acid|citric acid
678563|NCT00718289|citrate|citrate
678564|NCT00718289|acetic acid|acetic acid
678565|NCT00718289|acetate|acetate
678566|NCT00718289|haemodialysis|haemodialysis
678567|NCT00718289|calcium|calcium
678568|NCT00718289|hypotension|hypotension
678569|NCT00718289|haemodynamics|haemodynamics
678570|NCT00718289|Dialysate for Haemodialysis|dialysate for haemodialysis
678571|NCT00718276|Healthy postmenopausal women|healthy postmenopausal women
678572|NCT00718250|Acute myeloid leukaemia|acute myeloid leukaemia
678573|NCT00718250|Cancer vaccines|cancer vaccines
678574|NCT00718250|Immunotherapy|immunotherapy
678575|NCT00718237|Gastroenteritis|gastroenteritis
678576|NCT00718237|Rotavirus|rotavirus
678577|NCT00718224|Knee surgery|knee surgery
678578|NCT00718224|VTE prevention|vte prevention
678579|NCT00718198|Inpatient|inpatient
678580|NCT00718198|Computer Physician Order Entry|computer physician order entry
678581|NCT00718198|Diabetes Mellitus|diabetes mellitus
678582|NCT00718185|Sildenafil|sildenafil
678583|NCT00718185|Pediatrics|pediatrics
678584|NCT00718172|Ribavirin Pretreatment|ribavirin pretreatment
678585|NCT00718172|Gene Expression|gene expression
678586|NCT00718172|Peginterferon|peginterferon
678587|NCT00718172|Hepatitis C|hepatitis c
678588|NCT00718172|Liver Biopsy|liver biopsy
678589|NCT00718172|HCV|hcv
678590|NCT00718159|Acute Myeloid Leukemia|acute myeloid leukemia
678591|NCT00718159|Myeloid Leukemia|myeloid leukemia
678592|NCT00718159|Relapsed|relapsed
678593|NCT00718159|Refractory|refractory
678594|NCT00718146|Influenza|influenza
678595|NCT00718146|Orthomyxoviridae Infections|orthomyxoviridae infections
678596|NCT00718146|Orthomyxoviruses|orthomyxoviruses
678597|NCT00718146|Split-virion influenza vaccine|split-virion influenza vaccine
678598|NCT00718133|Asthma|asthma
678599|NCT00718133|Allergy|allergy
678600|NCT00718133|Respiratory|respiratory
678601|NCT00718133|Pollution|pollution
678602|NCT00718133|Children|children
678603|NCT00718133|Air pollution|air pollution
678604|NCT00718120|Fluviral|fluviral
678605|NCT00718120|Influenza|influenza
678606|NCT00718107|Amyotrophic Lateral Sclerosis|amyotrophic lateral sclerosis
678607|NCT00718107|Cerebrospinal Fluid|cerebrospinal fluid
678608|NCT00718107|Neurodegenerative Disease|neurodegenerative disease
678609|NCT00718107|Motor Neuron Disease|motor neuron disease
678610|NCT00718107|Autonomic Nervous System|autonomic nervous system
678611|NCT00718107|Neurodegenerative Diseases|neurodegenerative diseases
678612|NCT00718107|Movement Disorders|movement disorders
678613|NCT00718107|Quality of Life|quality of life
678614|NCT00718094|Ulcerative colitis|ulcerative colitis
678615|NCT00718094|EGCG|egcg
678616|NCT00718094|Green tea polyphenols|green tea polyphenols
678617|NCT00718094|Inflammatory bowel disease|inflammatory bowel disease
678618|NCT00718094|Colitis|colitis
678619|NCT00718094|IBD|ibd
678620|NCT00718094|Green tea|green tea
678621|NCT00718068|Potassium chloride|potassium chloride
678622|NCT00718068|Preparations, Pharmaceutical|preparations, pharmaceutical
678623|NCT00718068|Hypokalemia|hypokalemia
678624|NCT00718068|Critical Care|critical care
678625|NCT00718068|Adult|adult
678626|NCT00718068|Randomized Controlled Trial|randomized controlled trial
678627|NCT00718055|MRI|mri
678628|NCT00718055|liverspecific|liverspecific
678629|NCT00718055|contrast|contrast
678630|NCT00718055|colorectal|colorectal
678631|NCT00718055|metastases|metastases
678632|NCT00718042|healthy donors|healthy donors
678633|NCT00718029|Human Immunodeficiency Virus|human immunodeficiency virus
678634|NCT00718029|Cerebrospinal Fluid|cerebrospinal fluid
678635|NCT00718029|Raltegravir|raltegravir
678636|NCT00718029|Drug Concentrations|drug concentrations
678637|NCT00718016|Amyotrophic Lateral Sclerosis|amyotrophic lateral sclerosis
678638|NCT00718016|Cerebrospinal Fluid|cerebrospinal fluid
678639|NCT00718016|Neurodegenerative Disease|neurodegenerative disease
678640|NCT00718016|Motor Neuron Disease|motor neuron disease
678641|NCT00718016|Autonomic Nervous System|autonomic nervous system
678642|NCT00718016|Neurodegenerative Diseases|neurodegenerative diseases
678643|NCT00718016|Movement Disorders|movement disorders
678644|NCT00718003|Amyotrophic Lateral Sclerosis|amyotrophic lateral sclerosis
678645|NCT00718003|Cerebrospinal Fluid|cerebrospinal fluid
678646|NCT00718003|Neurodegenerative Disease|neurodegenerative disease
678647|NCT00718003|Motor Neuron Disease|motor neuron disease
678648|NCT00718003|Autonomic Nervous System|autonomic nervous system
678649|NCT00718003|Neurodegenerative Diseases|neurodegenerative diseases
678650|NCT00718003|Movement Disorders|movement disorders
678651|NCT00717990|Colorectal cancer|colorectal cancer
678652|NCT00717990|Bevacizumab|bevacizumab
678653|NCT00717990|XELIRI|xeliri
678654|NCT00717951|advanced breast cancer|advanced breast cancer
678655|NCT00717951|docetaxol|docetaxol
678656|NCT00717951|capecitabine|capecitabine
678657|NCT00717951|cisplatin|cisplatin
678658|NCT00717925|B-cell Non-Hodgkin's Lymphoma|b-cell non-hodgkin's lymphoma
678660|NCT00717912|BLOOD GLUCOSE|blood glucose
678661|NCT00717912|glycemic index|glycemic index
678662|NCT00717912|rates of digestion and absorption of food|rates of digestion and absorption of food
678663|NCT00717899|Asthma|asthma
678664|NCT00717899|Allergy|allergy
678665|NCT00717899|Respiratory|respiratory
678666|NCT00717899|Pollution|pollution
678667|NCT00717899|Children|children
678668|NCT00717899|Air pollution|air pollution
678669|NCT00717886|Breast|breast
678670|NCT00717886|Lymph Nodes|lymph nodes
678671|NCT00717873|Mucus Clearance|mucus clearance
678672|NCT00717873|Secretion Clearance|secretion clearance
678673|NCT00717873|HFCWO|hfcwo
678674|NCT00717808|Tranilast|tranilast
678675|NCT00717808|Rheumatoid Arthritis|rheumatoid arthritis
678676|NCT00717808|Pharmacokinetics|pharmacokinetics
678677|NCT00717808|Methotrexate|methotrexate
678678|NCT00717795|Survivor|survivor
678679|NCT00717795|Physical Activity|physical activity
678680|NCT00717795|NED|ned
678681|NCT00717795|08-067|08-067
678682|NCT00717782|botulinum toxin|botulinum toxin
678683|NCT00717782|thrombosed external haemorrhoids|thrombosed external haemorrhoids
678684|NCT00717782|pain|pain
678685|NCT00717769|Atopic Dermatitis|atopic dermatitis
678686|NCT00717756|liver cancer, second line|liver cancer, second line
678687|NCT00717743|RCC|rcc
678688|NCT00717743|patients|patients
678689|NCT00717743|scheduled|scheduled
678690|NCT00717743|nephrectomy|nephrectomy
678691|NCT00717730|Nutrition|nutrition
678692|NCT00717730|Children|children
678693|NCT00717730|Folate|folate
678694|NCT00717730|Vitamin B12|vitamin b12
678695|NCT00717730|India|india
678696|NCT00717730|Homocysteine|homocysteine
678697|NCT00717730|Methyl Malonic Acid|methyl malonic acid
678698|NCT00717717|Cancer Survivor|cancer survivor
678699|NCT00717717|Physical Activity|physical activity
678700|NCT00717717|Health Behavior|health behavior
678701|NCT00717717|Psychosocial Well-being|psychosocial well-being
678702|NCT00717717|Coaching|coaching
678703|NCT00717717|Long Term|long term
678704|NCT00717717|Consequences|consequences
678705|NCT00717717|Chemotherapy|chemotherapy
678706|NCT00717717|Motivation|motivation
678707|NCT00717704|Malignant solid tumor|malignant solid tumor
678708|NCT00717704|Phase 1|phase 1
678709|NCT00717704|Dose escalation|dose escalation
678710|NCT00717704|Metastatic or locally advanced/unresectable|metastatic or locally advanced/unresectable
678711|NCT00717704|Disease progression through standard therapy|disease progression through standard therapy
678712|NCT00717691|Hallux Limitus|hallux limitus
678713|NCT00717691|Dynamic Splinting|dynamic splinting
678714|NCT00717691|Dynasplint|dynasplint
860870|NCT00061334|Memory|memory
678715|NCT00717678|Immunosuppressant|immunosuppressant
678716|NCT00717678|Combination drug therapy|combination drug therapy
678717|NCT00717678|Graft loss|graft loss
678718|NCT00717678|Randomized controlled trial|randomized controlled trial
678719|NCT00717678|Open level method|open level method
678720|NCT00717665|Hypertension|hypertension
678721|NCT00717665|Telemanagement|telemanagement
678722|NCT00717665|Home blood pressure monitoring|home blood pressure monitoring
678723|NCT00717665|Self care|self care
678724|NCT00717639|diagnostic accuracy|diagnostic accuracy
678725|NCT00717639|magnetic resonance angiography|magnetic resonance angiography
678726|NCT00717639|steady state|steady state
678727|NCT00717639|digital subtraction angiography|digital subtraction angiography
678728|NCT00717639|peripheral arteries|peripheral arteries
678729|NCT00717626|Hemophilia|hemophilia
678730|NCT00717626|Prophylaxis|prophylaxis
678731|NCT00717626|Youth|youth
678732|NCT00717626|Young Adults|young adults
678733|NCT00717626|Feasibility|feasibility
678734|NCT00717600|bacteriuria|bacteriuria
678735|NCT00717600|urinary tract infection|urinary tract infection
678736|NCT00717600|probiotics|probiotics
678737|NCT00717600|lactobacillus|lactobacillus
678738|NCT00717600|vagina|vagina
678739|NCT00717600|bladder|bladder
678740|NCT00717600|neurogenic bladder|neurogenic bladder
678741|NCT00717600|spina bifida|spina bifida
678742|NCT00717600|myelomeningocele|myelomeningocele
678743|NCT00717600|neuropathic bladder|neuropathic bladder
678744|NCT00717587|stage IV renal cell cancer|stage iv renal cell cancer
678745|NCT00717587|recurrent renal cell cancer|recurrent renal cell cancer
678746|NCT00717574|depth of sedation|depth of sedation
678747|NCT00717574|nitrous oxide|nitrous oxide
678748|NCT00717574|general anesthesia|general anesthesia
678749|NCT00717574|anesthesia indices|anesthesia indices
678750|NCT00717561|CAP|cap
678751|NCT00717561|Community-acquired pneumonia|community-acquired pneumonia
678752|NCT00717548|Somatic Complaints|somatic complaints
678753|NCT00717535|health status unknown|health status unknown
678754|NCT00717522|Soft Tissue Sarcoma|soft tissue sarcoma
678755|NCT00717522|CC-4047|cc-4047
678756|NCT00717522|Pomalidomide|pomalidomide
678757|NCT00717509|schizophrenia|schizophrenia
678758|NCT00717509|metabolic side effect|metabolic side effect
678759|NCT00717509|clozapine|clozapine
679326|NCT00715481|Albuminuria|albuminuria
678760|NCT00717509|genetic polymorphism|genetic polymorphism
678761|NCT00717496|Breastfeeding|breastfeeding
678762|NCT00717496|Telephone Support|telephone support
678763|NCT00717496|Latino|latino
678764|NCT00717470|Kidney|kidney
678765|NCT00717470|Prograf|prograf
678766|NCT00717470|Transplant|transplant
678767|NCT00717470|Advagraf|advagraf
678768|NCT00717470|Immunosuppression|immunosuppression
678769|NCT00717470|FK506|fk506
678770|NCT00717444|Substance Abuse|substance abuse
678771|NCT00717444|HIV|hiv
678772|NCT00717444|Contingency Management|contingency management
678773|NCT00717444|Physical Activity|physical activity
678774|NCT00717431|Deep Brain Stimulation|deep brain stimulation
678775|NCT00717431|Seizures|seizures
678776|NCT00717431|Epilepsy|epilepsy
678777|NCT00717392|ADHD|adhd
678778|NCT00717392|ASD|asd
678779|NCT00717379|Organ Transplantation|organ transplantation
678780|NCT00717379|Tacrolimus|tacrolimus
678781|NCT00717379|Prograf|prograf
678782|NCT00717379|Kidney|kidney
678783|NCT00717379|Immunosuppression|immunosuppression
678784|NCT00717340|tivozanib|tivozanib
678785|NCT00717340|AV-951|av-951
678786|NCT00717327|MRL|mrl
678787|NCT00717327|Adolescents|adolescents
678788|NCT00717327|Health Literacy|health literacy
678789|NCT00717301|TBI, traumatic brain injury, S100B, head CT scan|tbi, traumatic brain injury, s100b, head ct scan
678790|NCT00717288|diabetes|diabetes
678791|NCT00717288|hyperglycemia|hyperglycemia
678792|NCT00717288|open heart surgery|open heart surgery
678793|NCT00717288|cardiothoracic surgery|cardiothoracic surgery
678794|NCT00717288|detemir|detemir
678795|NCT00717288|insulin infusion|insulin infusion
678796|NCT00717288|intravenous insulin|intravenous insulin
678797|NCT00717275|Brain Metastases|brain metastases
678798|NCT00717275|Temozolomide|temozolomide
678799|NCT00717275|Temodar|temodar
678800|NCT00717275|TMZ|tmz
678801|NCT00717275|Stereotactic Radiosurgery|stereotactic radiosurgery
678802|NCT00717275|SRS|srs
678803|NCT00717236|Certolizumab pegol|certolizumab pegol
678804|NCT00717236|Cimzia|cimzia
678805|NCT00717236|Rheumatoid Arthritis|rheumatoid arthritis
678806|NCT00717236|Joint Disease|joint disease
678807|NCT00717236|Chronic Arthritis|chronic arthritis
678808|NCT00717223|Diabetes|diabetes
678809|NCT00717223|Type 1 diabetes mellitus|type 1 diabetes mellitus
678810|NCT00717223|Type 2 diabetes mellitus|type 2 diabetes mellitus
678811|NCT00717223|Literacy|literacy
678812|NCT00717223|Glycemic control|glycemic control
678813|NCT00717210|1p/19q loss|1p/19q loss
678814|NCT00717210|MGMT|mgmt
678815|NCT00717210|prognostic factors|prognostic factors
678816|NCT00717210|PCV|pcv
678817|NCT00717210|temozolomide|temozolomide
861058|NCT00061204|HV|hv
678818|NCT00717197|HGG|hgg
678819|NCT00717197|anaplastic astrocytoma|anaplastic astrocytoma
678820|NCT00717197|anaplastic oligodendroglioma|anaplastic oligodendroglioma
678821|NCT00717197|anaplastic mixed glioma|anaplastic mixed glioma
678822|NCT00717197|glioblastoma multiforme|glioblastoma multiforme
678823|NCT00717197|GBM|gbm
678824|NCT00717197|Xeloda|xeloda
678825|NCT00717197|capecitabine|capecitabine
678826|NCT00717171|electrical stimulation|electrical stimulation
678827|NCT00717171|pain|pain
678828|NCT00717171|medication|medication
678829|NCT00717171|edema|edema
678830|NCT00717171|interferential|interferential
678831|NCT00717171|neuromuscular|neuromuscular
678832|NCT00717171|high voltage pulsed current|high voltage pulsed current
678833|NCT00717171|knee|knee
678834|NCT00717158|Health Behavior|health behavior
678835|NCT00717158|Lifestyle|lifestyle
678836|NCT00717158|health care costs|health care costs
678837|NCT00717158|quality of life|quality of life
678838|NCT00717145|bioequivalence|bioequivalence
678839|NCT00717132|weight|weight
678840|NCT00717132|cost effectiveness|cost effectiveness
678841|NCT00717132|obesity|obesity
678842|NCT00717132|family based behavioral treatment|family based behavioral treatment
678843|NCT00717119|GI|gi
678844|NCT00717119|NSAID|nsaid
678845|NCT00717119|Complications|complications
678846|NCT00717119|Treated|treated
678847|NCT00717119|Patients|patients
678848|NCT00717106|ILR|ilr
678849|NCT00717106|ECG monitoring|ecg monitoring
678850|NCT00717106|cardiac arrhythmia|cardiac arrhythmia
678851|NCT00717106|syncope|syncope
678852|NCT00717106|presyncope|presyncope
678853|NCT00717106|fainting|fainting
678854|NCT00717080|Retinitis Pigmentosa|retinitis pigmentosa
678855|NCT00717080|Cataract|cataract
678856|NCT00717067|maraviroc, pharmacokinetics, renal impairment|maraviroc, pharmacokinetics, renal impairment
678857|NCT00717054|postoperative nausea and vomiting|postoperative nausea and vomiting
678858|NCT00717041|Depression|depression
678859|NCT00717041|Anxiety|anxiety
678860|NCT00717041|Cognitive Impairment|cognitive impairment
678861|NCT00717041|Emergency medicine|emergency medicine
678862|NCT00717041|prehospital care|prehospital care
678863|NCT00717028|Cerebral palsy|cerebral palsy
678864|NCT00717028|Dysphagia|dysphagia
678865|NCT00717028|Deglutition|deglutition
678866|NCT00717028|Endoscopy|endoscopy
678867|NCT00717015|Hormone Receptor Positive Breast Cancer|hormone receptor positive breast cancer
678868|NCT00716989|Cutaneous immune system|cutaneous immune system
678869|NCT00716989|innate immunity|innate immunity
678870|NCT00716989|tuberculin skin tests|tuberculin skin tests
678871|NCT00716989|intradermal vaccination|intradermal vaccination
678872|NCT00716989|pathophysiology|pathophysiology
678873|NCT00716989|Healthy subjects|healthy subjects
678874|NCT00716989|Immunosuppressed patients|immunosuppressed patients
678875|NCT00716976|ototoxicity|ototoxicity
678876|NCT00716976|childhood central nervous system germ cell tumor|childhood central nervous system germ cell tumor
678877|NCT00716976|childhood extracranial germ cell tumor|childhood extracranial germ cell tumor
678878|NCT00716976|childhood extragonadal germ cell tumor|childhood extragonadal germ cell tumor
678879|NCT00716976|childhood malignant testicular germ cell tumor|childhood malignant testicular germ cell tumor
678880|NCT00716976|childhood malignant ovarian germ cell tumor|childhood malignant ovarian germ cell tumor
678881|NCT00716976|childhood teratoma|childhood teratoma
678882|NCT00716976|childhood medulloblastoma|childhood medulloblastoma
678883|NCT00716976|disseminated neuroblastoma|disseminated neuroblastoma
678884|NCT00716976|regional neuroblastoma|regional neuroblastoma
678885|NCT00716976|localized resectable neuroblastoma|localized resectable neuroblastoma
678886|NCT00716976|localized unresectable neuroblastoma|localized unresectable neuroblastoma
678887|NCT00716976|stage 4S neuroblastoma|stage 4s neuroblastoma
678888|NCT00716976|localized osteosarcoma|localized osteosarcoma
678889|NCT00716976|metastatic osteosarcoma|metastatic osteosarcoma
678890|NCT00716976|childhood hepatoblastoma|childhood hepatoblastoma
678891|NCT00716976|stage I childhood liver cancer|stage i childhood liver cancer
678892|NCT00716976|stage II childhood liver cancer|stage ii childhood liver cancer
678893|NCT00716976|stage III childhood liver cancer|stage iii childhood liver cancer
678894|NCT00716976|stage IV childhood liver cancer|stage iv childhood liver cancer
678895|NCT00716963|late allergic response|late allergic response
678896|NCT00716963|fluticasone propionate|fluticasone propionate
678897|NCT00716937|pilonidal sinus|pilonidal sinus
678898|NCT00716937|karydakis|karydakis
678899|NCT00716937|laying open|laying open
678900|NCT00716911|cytomegalovirus infection|cytomegalovirus infection
678901|NCT00716911|accelerated phase chronic myelogenous leukemia|accelerated phase chronic myelogenous leukemia
678902|NCT00716911|atypical chronic myeloid leukemia, BCR-ABL negative|atypical chronic myeloid leukemia, bcr-abl negative
678903|NCT00716911|blastic phase chronic myelogenous leukemia|blastic phase chronic myelogenous leukemia
678904|NCT00716911|chronic myelomonocytic leukemia|chronic myelomonocytic leukemia
678905|NCT00716911|chronic phase chronic myelogenous leukemia|chronic phase chronic myelogenous leukemia
678906|NCT00716911|recurrent adult acute lymphoblastic leukemia|recurrent adult acute lymphoblastic leukemia
710603|NCT00588653|small bowel follow-through|small bowel follow-through
678907|NCT00716911|recurrent adult acute myeloid leukemia|recurrent adult acute myeloid leukemia
678908|NCT00716911|refractory chronic lymphocytic leukemia|refractory chronic lymphocytic leukemia
678909|NCT00716911|refractory hairy cell leukemia|refractory hairy cell leukemia
678910|NCT00716911|relapsing chronic myelogenous leukemia|relapsing chronic myelogenous leukemia
678911|NCT00716911|secondary acute myeloid leukemia|secondary acute myeloid leukemia
678912|NCT00716911|stage III chronic lymphocytic leukemia|stage iii chronic lymphocytic leukemia
678913|NCT00716911|stage IV chronic lymphocytic leukemia|stage iv chronic lymphocytic leukemia
678914|NCT00716911|splenic marginal zone lymphoma|splenic marginal zone lymphoma
678915|NCT00716911|extranodal marginal zone B-cell lymphoma of mucosa-associated lymphoid tissue|extranodal marginal zone b-cell lymphoma of mucosa-associated lymphoid tissue
678916|NCT00716911|nodal marginal zone B-cell lymphoma|nodal marginal zone b-cell lymphoma
678917|NCT00716911|stage III adult Burkitt lymphoma|stage iii adult burkitt lymphoma
678918|NCT00716911|stage III adult diffuse large cell lymphoma|stage iii adult diffuse large cell lymphoma
678919|NCT00716911|stage III adult diffuse mixed cell lymphoma|stage iii adult diffuse mixed cell lymphoma
678920|NCT00716911|stage III adult diffuse small cleaved cell lymphoma|stage iii adult diffuse small cleaved cell lymphoma
678921|NCT00716911|stage III adult immunoblastic large cell lymphoma|stage iii adult immunoblastic large cell lymphoma
678922|NCT00716911|stage III adult lymphoblastic lymphoma|stage iii adult lymphoblastic lymphoma
678923|NCT00716911|stage III grade 1 follicular lymphoma|stage iii grade 1 follicular lymphoma
678924|NCT00716911|stage III grade 2 follicular lymphoma|stage iii grade 2 follicular lymphoma
678925|NCT00716911|stage III grade 3 follicular lymphoma|stage iii grade 3 follicular lymphoma
678926|NCT00716911|stage III mantle cell lymphoma|stage iii mantle cell lymphoma
678927|NCT00716911|stage III marginal zone lymphoma|stage iii marginal zone lymphoma
678928|NCT00716911|stage III small lymphocytic lymphoma|stage iii small lymphocytic lymphoma
678929|NCT00716911|stage IV adult Burkitt lymphoma|stage iv adult burkitt lymphoma
678930|NCT00716911|stage IV adult diffuse large cell lymphoma|stage iv adult diffuse large cell lymphoma
678931|NCT00716911|stage IV adult diffuse mixed cell lymphoma|stage iv adult diffuse mixed cell lymphoma
678932|NCT00716911|stage IV adult diffuse small cleaved cell lymphoma|stage iv adult diffuse small cleaved cell lymphoma
678933|NCT00716911|stage IV adult immunoblastic large cell lymphoma|stage iv adult immunoblastic large cell lymphoma
678934|NCT00716911|stage IV adult lymphoblastic lymphoma|stage iv adult lymphoblastic lymphoma
678935|NCT00716911|stage IV grade 1 follicular lymphoma|stage iv grade 1 follicular lymphoma
678936|NCT00716911|stage IV grade 2 follicular lymphoma|stage iv grade 2 follicular lymphoma
678937|NCT00716911|stage IV grade 3 follicular lymphoma|stage iv grade 3 follicular lymphoma
678938|NCT00716911|stage IV mantle cell lymphoma|stage iv mantle cell lymphoma
678939|NCT00716911|stage IV marginal zone lymphoma|stage iv marginal zone lymphoma
678940|NCT00716911|stage IV small lymphocytic lymphoma|stage iv small lymphocytic lymphoma
678941|NCT00716911|recurrent adult Hodgkin lymphoma|recurrent adult hodgkin lymphoma
678942|NCT00716911|recurrent adult Burkitt lymphoma|recurrent adult burkitt lymphoma
678943|NCT00716911|recurrent adult diffuse large cell lymphoma|recurrent adult diffuse large cell lymphoma
678944|NCT00716911|recurrent adult diffuse mixed cell lymphoma|recurrent adult diffuse mixed cell lymphoma
678945|NCT00716911|recurrent adult diffuse small cleaved cell lymphoma|recurrent adult diffuse small cleaved cell lymphoma
678946|NCT00716911|recurrent adult immunoblastic large cell lymphoma|recurrent adult immunoblastic large cell lymphoma
678947|NCT00716911|recurrent adult lymphoblastic lymphoma|recurrent adult lymphoblastic lymphoma
678948|NCT00716911|recurrent cutaneous T-cell non-Hodgkin lymphoma|recurrent cutaneous t-cell non-hodgkin lymphoma
678949|NCT00716911|recurrent mycosis fungoides/Sezary syndrome|recurrent mycosis fungoides/sezary syndrome
678950|NCT00716911|recurrent grade 1 follicular lymphoma|recurrent grade 1 follicular lymphoma
678951|NCT00716911|recurrent grade 2 follicular lymphoma|recurrent grade 2 follicular lymphoma
678952|NCT00716911|recurrent grade 3 follicular lymphoma|recurrent grade 3 follicular lymphoma
678953|NCT00716911|recurrent mantle cell lymphoma|recurrent mantle cell lymphoma
678954|NCT00716911|recurrent marginal zone lymphoma|recurrent marginal zone lymphoma
678955|NCT00716911|recurrent small lymphocytic lymphoma|recurrent small lymphocytic lymphoma
678956|NCT00716911|chronic eosinophilic leukemia|chronic eosinophilic leukemia
678957|NCT00716911|chronic neutrophilic leukemia|chronic neutrophilic leukemia
678958|NCT00716911|primary myelofibrosis|primary myelofibrosis
678959|NCT00716911|stage II multiple myeloma|stage ii multiple myeloma
678960|NCT00716911|stage III multiple myeloma|stage iii multiple myeloma
678961|NCT00716911|refractory multiple myeloma|refractory multiple myeloma
678962|NCT00716911|de novo myelodysplastic syndromes|de novo myelodysplastic syndromes
678963|NCT00716911|previously treated myelodysplastic syndromes|previously treated myelodysplastic syndromes
678964|NCT00716911|secondary myelodysplastic syndromes|secondary myelodysplastic syndromes
678965|NCT00716911|myelodysplastic/myeloproliferative neoplasm, unclassifiable|myelodysplastic/myeloproliferative neoplasm, unclassifiable
678966|NCT00716911|stage I multiple myeloma|stage i multiple myeloma
678967|NCT00716898|Condition|condition
678968|NCT00716898|Cancer|cancer
678969|NCT00716898|Patients|patients
678970|NCT00716898|Thrombosis|thrombosis
678971|NCT00716898|Unstable|unstable
678972|NCT00716898|Angina|angina
678973|NCT00716898|Pectoris|pectoris
861220|NCT00060866|NCS|ncs
678974|NCT00716885|Heart failure|heart failure
678975|NCT00716885|Oxidative stress|oxidative stress
678976|NCT00716885|Endothelial Progenitor Cells|endothelial progenitor cells
678977|NCT00716885|White blood cells|white blood cells
678978|NCT00716872|cancer|cancer
678979|NCT00716872|sleep|sleep
678980|NCT00716872|insomnia|insomnia
678981|NCT00716872|Internet|internet
678982|NCT00716872|SHUTi|shuti
678983|NCT00716833|pain|pain
678984|NCT00716833|coxibe|coxibe
678985|NCT00716833|preemptive|preemptive
678986|NCT00716833|abdominothoracic|abdominothoracic
678987|NCT00716833|sensibilisation|sensibilisation
678988|NCT00716833|Analgesia|analgesia
678989|NCT00716807|BMS|bms
678990|NCT00716807|TMD|tmd
678991|NCT00716794|Prostate cancer|prostate cancer
678992|NCT00716794|HE3235|he3235
678993|NCT00716794|Apoptone|apoptone
678994|NCT00716781|Group B streptococcus|group b streptococcus
678995|NCT00716781|Sepsis|sepsis
678996|NCT00716781|Infants|infants
678997|NCT00716781|Diagnosis|diagnosis
678998|NCT00716781|Physical examination|physical examination
678999|NCT00716781|Laboratory tests|laboratory tests
679000|NCT00716768|Laparoscopic|laparoscopic
679001|NCT00716768|Inguinal Hernia|inguinal hernia
679002|NCT00716768|Infants|infants
679003|NCT00716755|Positron emission tomography|positron emission tomography
679004|NCT00716755|antipsychotics|antipsychotics
679005|NCT00716755|risperidone|risperidone
679006|NCT00716755|olanzapine|olanzapine
679007|NCT00716755|Dopamine|dopamine
679008|NCT00716755|D2 receptor|d2 receptor
679009|NCT00716755|elderly|elderly
679010|NCT00716755|schizophrenia|schizophrenia
679011|NCT00716755|schizoaffective disorder|schizoaffective disorder
679012|NCT00716755|schizophreniform disorder|schizophreniform disorder
679013|NCT00716755|delusional disorder|delusional disorder
679014|NCT00716755|psychotic disorder NOS|psychotic disorder nos
679015|NCT00716729|Questionnaire|questionnaire
679016|NCT00716729|Hip|hip
679017|NCT00716729|Groin|groin
679018|NCT00716729|Disability|disability
679019|NCT00716729|Strength|strength
679020|NCT00716729|To develop two new outcome measures for patients with hip and groin disability|to develop two new outcome measures for patients with hip and groin disability
679021|NCT00716716|Hemophilia B severe, previously treated patients|hemophilia b severe, previously treated patients
679022|NCT00716703|Appendicitis|appendicitis
679023|NCT00716703|Computed tomography|computed tomography
679024|NCT00716703|pediatric|pediatric
679025|NCT00716703|child|child
679026|NCT00716703|sensitivity|sensitivity
679027|NCT00716703|specificity|specificity
679028|NCT00716703|contrast administration route|contrast administration route
679029|NCT00716703|time factors|time factors
679030|NCT00716690|Stem cell transplantation|stem cell transplantation
679031|NCT00716690|GVHD|gvhd
679032|NCT00716677|difficult asthma|difficult asthma
679033|NCT00716677|respiratory inductance plethysmography|respiratory inductance plethysmography
679034|NCT00716664|cystic fibrosis|cystic fibrosis
679035|NCT00716664|musculoskeletal|musculoskeletal
679036|NCT00716664|exercise capacity|exercise capacity
679037|NCT00716664|posture|posture
679038|NCT00716664|lung function|lung function
679039|NCT00716664|physical functioning|physical functioning
679040|NCT00716612|Coenzyme Q 10|coenzyme q 10
679041|NCT00716612|Statin|statin
679042|NCT00716612|Myalgia|myalgia
679043|NCT00716599|malaria|malaria
679044|NCT00716599|diagnosis|diagnosis
679045|NCT00716599|rapid diagnostic test|rapid diagnostic test
679046|NCT00716599|rapid diagnostic tests|rapid diagnostic tests
679047|NCT00716599|fever case management|fever case management
679048|NCT00716599|training|training
679049|NCT00716599|fever case management in malaria-endemic areas|fever case management in malaria-endemic areas
679050|NCT00716573|Cardiac transplantation|cardiac transplantation
679051|NCT00716573|Chronic renal insufficiency|chronic renal insufficiency
679052|NCT00716573|Everolimus|everolimus
679053|NCT00716521|mobile actigraphy inpatient polysomnography actigraphy ambien|mobile actigraphy inpatient polysomnography actigraphy ambien
679054|NCT00716508|Patella tendon rupute, suture anchors, repair patella tendon|patella tendon rupute, suture anchors, repair patella tendon
679055|NCT00716482|breast|breast
679056|NCT00716482|lesion|lesion
679057|NCT00716482|ultrasound|ultrasound
679058|NCT00716482|BI-RADS|bi-rads
679059|NCT00716482|malignancy|malignancy
679060|NCT00716482|women|women
679061|NCT00716469|Neurofibroma|neurofibroma
679062|NCT00716469|Plexiform|plexiform
679063|NCT00716469|NF1|nf1
679064|NCT00716469|Photo dynamic therapy|photo dynamic therapy
679065|NCT00716456|MAB C225(CETUXIMAB)(ANTI-EGFR)|mab c225(cetuximab)(anti-egfr)
679066|NCT00716456|OSI-774, TARCEVA (ERLOTINIB)|osi-774, tarceva (erlotinib)
679067|NCT00716456|Lung|lung
679068|NCT00716456|Adenocarcinoma|adenocarcinoma
679069|NCT00716456|Lung cancer|lung cancer
679070|NCT00716443|Nasolabial folds|nasolabial folds
679071|NCT00716443|wrinkles|wrinkles
679072|NCT00716443|topical anesthetic|topical anesthetic
679073|NCT00716430|acute coronary syndromes|acute coronary syndromes
679074|NCT00716430|quality improvement|quality improvement
679075|NCT00716404|FlowMedica|flowmedica
679076|NCT00716404|Benephit|benephit
679077|NCT00716404|TRT|trt
679078|NCT00716404|Patients|patients
679079|NCT00716404|Components|components
679080|NCT00716404|Benephit Infusion System|benephit infusion system
679081|NCT00716404|Planned|planned
679082|NCT00716404|To be used|to be used
679083|NCT00716391|Head and Neck Cancer|head and neck cancer
679084|NCT00716378|Simulated Driving|simulated driving
679085|NCT00716378|Risky Driving Behavior|risky driving behavior
679086|NCT00716378|Social Influences|social influences
679087|NCT00716365|angiography|angiography
679088|NCT00716365|hemostasis|hemostasis
679089|NCT00716365|femoral artery|femoral artery
679090|NCT00716365|duplex|duplex
679091|NCT00716352|non-ST elevation acute coronary syndrome|non-st elevation acute coronary syndrome
679092|NCT00716352|educational intervention|educational intervention
679093|NCT00716352|evidence based practice|evidence based practice
679094|NCT00716352|guidelines|guidelines
679095|NCT00716339|pseudophakic accommodation|pseudophakic accommodation
679096|NCT00716326|Transcutaneous Electrical Nerve Stimulation|transcutaneous electrical nerve stimulation
679097|NCT00716326|Chronic pain|chronic pain
679098|NCT00716326|Neuropathic pain|neuropathic pain
679099|NCT00716326|Short-term efficacy|short-term efficacy
679100|NCT00716326|Long-term efficacy|long-term efficacy
679101|NCT00716300|obesity|obesity
679102|NCT00716300|CVD|cvd
679103|NCT00716300|HDL kinetics|hdl kinetics
679104|NCT00716300|Anti-inflammatory and anti-oxidation studies|anti-inflammatory and anti-oxidation studies
679105|NCT00716300|30 subjects recruited (15 MetS and 15 lean controls)|30 subjects recruited (15 mets and 15 lean controls)
679106|NCT00716261|Parkinson's disease|parkinson's disease
679107|NCT00716261|Audio feedback|audio feedback
679108|NCT00716261|postural control|postural control
679109|NCT00716235|ADHD|adhd
679110|NCT00716235|ASD|asd
679111|NCT00716235|PDD|pdd
679112|NCT00716235|DCD|dcd
679113|NCT00716235|Executive Functions|executive functions
679114|NCT00716196|thin prep|thin prep
679115|NCT00716196|EUS|eus
679116|NCT00716183|mastitis|mastitis
679117|NCT00716183|Staphylococcus|staphylococcus
679118|NCT00716183|Streptococcus|streptococcus
679119|NCT00716183|lactation|lactation
679120|NCT00716183|breastfeeding|breastfeeding
679121|NCT00716170|Diabetes Mellitus|diabetes mellitus
679122|NCT00716170|Glucagon|glucagon
679123|NCT00716170|Insulin|insulin
679124|NCT00716170|Incretin hormones|incretin hormones
679125|NCT00716170|Glucose-dependent insulinotropic polypeptide|glucose-dependent insulinotropic polypeptide
679126|NCT00716170|Glucagon-like peptide-1|glucagon-like peptide-1
679127|NCT00716170|Glucagon-like peptide-2|glucagon-like peptide-2
679128|NCT00716144|Psoriasis|psoriasis
679327|NCT00715455|CAD|cad
679129|NCT00716131|Amyotrophic Lateral Sclerosis|amyotrophic lateral sclerosis
679130|NCT00716131|Cerebrospinal Fluid|cerebrospinal fluid
679131|NCT00716131|Neurodegenerative Disease|neurodegenerative disease
679132|NCT00716131|Motor Neuron Disease|motor neuron disease
679133|NCT00716131|Autonomic Nervous System|autonomic nervous system
679134|NCT00716131|Neurodegenerative Diseases|neurodegenerative diseases
679135|NCT00716131|Movement Disorders|movement disorders
679136|NCT00716118|Oocyte Cryopreservation|oocyte cryopreservation
679137|NCT00716118|Slow-Freeze|slow-freeze
679138|NCT00716118|Egg Freezing|egg freezing
679139|NCT00716118|Meiotic Spindle|meiotic spindle
679140|NCT00716118|Mitochondria|mitochondria
679141|NCT00716118|Human Oocytes Freezing.|human oocytes freezing.
679142|NCT00716105|Infant formula|infant formula
679143|NCT00716105|Protein metabolism|protein metabolism
679144|NCT00716079|Cerebral Hemorrhage|cerebral hemorrhage
679145|NCT00716079|Stroke|stroke
679146|NCT00716079|antihypertensive drugs|antihypertensive drugs
679147|NCT00716079|blood pressure|blood pressure
679148|NCT00716079|disability|disability
679149|NCT00716079|clinical trial|clinical trial
679150|NCT00716079|outcomes|outcomes
679151|NCT00716066|neurologic autoimmune disease|neurologic autoimmune disease
679152|NCT00716066|autologous transplant autoimmune|autologous transplant autoimmune
679153|NCT00716066|multiple sclerosis transplant|multiple sclerosis transplant
679154|NCT00716066|MS stem cell transplant|ms stem cell transplant
679155|NCT00716066|multiple sclerosis stem cell transplant|multiple sclerosis stem cell transplant
679156|NCT00716066|Stiff Person Syndrome|stiff person syndrome
679157|NCT00716066|HCT for neurologic autoimmune disorders|hct for neurologic autoimmune disorders
679158|NCT00716066|CIDP transplant|cidp transplant
679159|NCT00716066|myasthenia gravis transplant|myasthenia gravis transplant
679160|NCT00716053|emphysema|emphysema
679161|NCT00716053|chronic obstructive pulmonary disease|chronic obstructive pulmonary disease
679162|NCT00716053|COPD|copd
679163|NCT00716053|lung volume reduction|lung volume reduction
679164|NCT00716053|LVRS|lvrs
679165|NCT00716053|BLVR|blvr
679166|NCT00716053|Aeris|aeris
679167|NCT00716040|AIDS treatment|aids treatment
679168|NCT00716040|HAART adherence|haart adherence
679169|NCT00716040|intervention|intervention
710604|NCT00588640|Pain|pain
679170|NCT00716014|Pachyonychia Congenita|pachyonychia congenita
679171|NCT00716014|siRNA|sirna
679172|NCT00716001|patients with chronic renal failure undergoing elective percutaneous coronary intervention|patients with chronic renal failure undergoing elective percutaneous coronary intervention
679173|NCT00715988|Methadone|methadone
679174|NCT00715988|analgesia|analgesia
679175|NCT00715988|newborns|newborns
679176|NCT00715988|QT prolongation|qt prolongation
679177|NCT00715988|Young Infants|young infants
679178|NCT00715975|clobetasol|clobetasol
679179|NCT00715975|halobetasol|halobetasol
679180|NCT00715975|psoriasis|psoriasis
679181|NCT00715975|evaluating the efficacy and tolerability of the drug Halobetasol propionate|evaluating the efficacy and tolerability of the drug halobetasol propionate
679182|NCT00715962|Hospitalization|hospitalization
679183|NCT00715962|Aged|aged
679184|NCT00715949|traumatic brain injury|traumatic brain injury
679185|NCT00715949|pediatric|pediatric
679186|NCT00715949|neurocognitive|neurocognitive
679187|NCT00715949|concussion|concussion
679188|NCT00715936|Integrated early child development, growth and health|integrated early child development, growth and health
679189|NCT00715936|Psychosocial stimulation|psychosocial stimulation
679190|NCT00715936|Care for child development|care for child development
679191|NCT00715923|informed consent document|informed consent document
679192|NCT00715923|ethics|ethics
679193|NCT00715910|Meningococcal vaccine|meningococcal vaccine
679194|NCT00715910|Booster vaccination|booster vaccination
679195|NCT00715910|Immunogenicity|immunogenicity
679196|NCT00715910|Meningococcal disease|meningococcal disease
679197|NCT00715910|Safety|safety
679198|NCT00715897|chronic neurological deficient due to stroke|chronic neurological deficient due to stroke
679199|NCT00715884|Atherosclerosis|atherosclerosis
679200|NCT00715884|de novo native coronary lesion|de novo native coronary lesion
679201|NCT00715871|smoking|smoking
679202|NCT00715871|smoke cessation|smoke cessation
679203|NCT00715871|stop smoking|stop smoking
679204|NCT00715871|quit smoking|quit smoking
679205|NCT00715871|nicotine replacement therapy|nicotine replacement therapy
679206|NCT00715871|Smoke Break|smoke break
679207|NCT00715871|liquid cigarette|liquid cigarette
679208|NCT00715871|liquid nicotine cigarette|liquid nicotine cigarette
679209|NCT00715858|Alzheimer's disease|alzheimer's disease
679210|NCT00715858|dementia|dementia
679211|NCT00715858|inflammation|inflammation
679212|NCT00715858|cytokine|cytokine
679213|NCT00715858|biomarker|biomarker
679214|NCT00715858|cerebrospinal fluid|cerebrospinal fluid
679215|NCT00715858|serum|serum
679216|NCT00715858|doxycycline|doxycycline
679217|NCT00715858|rifampin|rifampin
679218|NCT00715845|cardiovascular disease|cardiovascular disease
679219|NCT00715845|embolism|embolism
679220|NCT00715845|microemboli|microemboli
679221|NCT00715845|cognitive decline|cognitive decline
679222|NCT00715845|mitral valve repair|mitral valve repair
679223|NCT00715845|cerebral microemboli|cerebral microemboli
679224|NCT00715845|coronary artery bypass graft|coronary artery bypass graft
679225|NCT00715845|CABG|cabg
679226|NCT00715845|transcranial doppler|transcranial doppler
679227|NCT00715845|transesophageal echocardiogram|transesophageal echocardiogram
679228|NCT00715845|magnetic resonance imaging|magnetic resonance imaging
679229|NCT00715845|carbon dioxide|carbon dioxide
679230|NCT00715832|Breast cancer|breast cancer
679231|NCT00715832|Dendritic cell vaccine|dendritic cell vaccine
679232|NCT00715832|OFA/iLRP|ofa/ilrp
679233|NCT00715832|Patients|patients
679234|NCT00715832|Line|line
679235|NCT00715832|Chemotherapy|chemotherapy
679236|NCT00715832|Setting|setting
679237|NCT00715832|Four different lines|four different lines
679238|NCT00715806|claustrophobia|claustrophobia
679239|NCT00715806|magnetic resonance imaging|magnetic resonance imaging
679240|NCT00715806|MRI|mri
679241|NCT00715806|anxiety|anxiety
679242|NCT00715806|open design|open design
679243|NCT00715806|severely anxious patients|severely anxious patients
679244|NCT00715793|Decitabine|decitabine
679245|NCT00715793|Temozolomide|temozolomide
679246|NCT00715793|Metastatic|metastatic
679247|NCT00715793|Melanoma|melanoma
679248|NCT00715793|Non-resectable|non-resectable
679249|NCT00715793|Stage IIIB melanoma|stage iiib melanoma
679250|NCT00715793|stage IV melanoma|stage iv melanoma
679251|NCT00715793|TMZ|tmz
679252|NCT00715793|DTIC|dtic
679253|NCT00715793|promoter methylation|promoter methylation
679254|NCT00715793|skin cancer|skin cancer
679255|NCT00715793|chemotherapy|chemotherapy
679256|NCT00715767|BLS training|bls training
679257|NCT00715767|CPR|cpr
679258|NCT00715767|post graduate education|post graduate education
679259|NCT00715767|resource-limited settings|resource-limited settings
679260|NCT00715767|medical education|medical education
679261|NCT00715767|CPR retention|cpr retention
679262|NCT00715767|cultural barriers|cultural barriers
679263|NCT00715741|atelectasis|atelectasis
679264|NCT00715741|oxygen|oxygen
679265|NCT00715741|saturation|saturation
679266|NCT00715728|Plastic surgery|plastic surgery
679267|NCT00715728|Warming|warming
679268|NCT00715728|Core temperature|core temperature
679269|NCT00715728|Bair Hugger|bair hugger
679270|NCT00715728|Hot Dog heating system|hot dog heating system
679271|NCT00715715|Hepatitis B e Antigen|hepatitis b e antigen
679272|NCT00715715|HBeAg-positive chronic hepatitis B|hbeag-positive chronic hepatitis b
679273|NCT00715702|AZD5672|azd5672
679274|NCT00715676|Osteoporosis|osteoporosis
679275|NCT00715676|2-methylene-19-nor-(20S)-1a, 25-dihydroxyvitamin D3|2-methylene-19-nor-(20s)-1a, 25-dihydroxyvitamin d3
679276|NCT00715676|Vitamin D|vitamin d
679277|NCT00715676|Bone Density Conservation Agents|bone density conservation agents
679278|NCT00715676|Bone Regeneration|bone regeneration
679279|NCT00715650|Rehabilitation, Vocational|rehabilitation, vocational
679280|NCT00715650|Compensation and Redress|compensation and redress
679281|NCT00715650|disability evaluation|disability evaluation
679282|NCT00715637|AML|aml
679283|NCT00715637|Leukemia|leukemia
679284|NCT00715637|MDS|mds
679285|NCT00715637|Amonafide|amonafide
679286|NCT00715637|Cytarabine|cytarabine
679287|NCT00715637|Daunorubicin|daunorubicin
679288|NCT00715637|Lymphatic disorders|lymphatic disorders
679289|NCT00715624|hyperglycemia, GLP-1, metformin, insulin|hyperglycemia, glp-1, metformin, insulin
679290|NCT00715611|pemetrexed|pemetrexed
679291|NCT00715611|cisplatin|cisplatin
679292|NCT00715611|IMRT|imrt
679293|NCT00715611|PLEURA|pleura
679294|NCT00715611|Malignant|malignant
679295|NCT00715611|08-053|08-053
679296|NCT00715598|Pain Assessment|pain assessment
679297|NCT00715598|Measurement|measurement
679298|NCT00715585|diabetes|diabetes
679299|NCT00715585|education|education
679300|NCT00715585|health literacy|health literacy
679301|NCT00715572|hypothyroidism, treatment, thyroxine, triiodothyronine|hypothyroidism, treatment, thyroxine, triiodothyronine
679302|NCT00715559|Major depressive disorder, depression|major depressive disorder, depression
679303|NCT00715559|neurotrophic|neurotrophic
679304|NCT00715559|brain-derived neurotrophic factor|brain-derived neurotrophic factor
679305|NCT00715559|antidepressant|antidepressant
679306|NCT00715559|cysteamine|cysteamine
679307|NCT00715546|Adipose-derived stem cell|adipose-derived stem cell
679308|NCT00715546|Lipodystrophy|lipodystrophy
679309|NCT00715533|acute (< 24 hours) stroke|acute (< 24 hours) stroke
679310|NCT00715533|stroke|stroke
679311|NCT00715533|TIA|tia
679312|NCT00715533|MRI|mri
679313|NCT00715533|imaging|imaging
679314|NCT00715533|acute|acute
679315|NCT00715520|Transcranial Magnetic Stimulation|transcranial magnetic stimulation
679316|NCT00715520|Rehabilitation|rehabilitation
679317|NCT00715520|Stroke|stroke
679318|NCT00715520|Plasticity|plasticity
679319|NCT00715507|decision making|decision making
679320|NCT00715507|graphic display|graphic display
679321|NCT00715494|brain injuries, dementia, myopathies, muscle disorders|brain injuries, dementia, myopathies, muscle disorders
679322|NCT00715481|Type 2 diabetes|type 2 diabetes
679323|NCT00715481|Cardiovascular disease|cardiovascular disease
679324|NCT00715481|Diabetic Nephropathy|diabetic nephropathy
679325|NCT00715481|Glomerular filtration rate|glomerular filtration rate
679329|NCT00715455|ANTICOAGULANT|anticoagulant
679330|NCT00715442|Kidney|kidney
679331|NCT00715442|Renal Cell Carcinoma|renal cell carcinoma
679332|NCT00715442|RCC|rcc
679333|NCT00715442|Sutent|sutent
679334|NCT00715442|Sunitinib malate|sunitinib malate
679335|NCT00715442|Clear cell|clear cell
679336|NCT00715442|SU011248|su011248
679337|NCT00715442|Nephrectomy|nephrectomy
679338|NCT00715442|Surgical removal of kidney|surgical removal of kidney
679339|NCT00715442|Cytoreductive nephrectomy|cytoreductive nephrectomy
679340|NCT00715429|Leg cramps|leg cramps
679341|NCT00715429|vitamin D deficiency|vitamin d deficiency
679342|NCT00715416|peripheral vascular diseases|peripheral vascular diseases
679343|NCT00715416|Intermittent Claudication|intermittent claudication
679344|NCT00715416|Angioplasty|angioplasty
679345|NCT00715390|Children|children
679346|NCT00715390|Cardiac Arrhythmia|cardiac arrhythmia
679347|NCT00715390|General Anesthesia|general anesthesia
679348|NCT00715377|benztropine|benztropine
679349|NCT00715377|Anticholinergic antiparkinsonian agents|anticholinergic antiparkinsonian agents
679350|NCT00715377|antipsychotics|antipsychotics
679351|NCT00715377|elderly population|elderly population
679352|NCT00715377|side-effects|side-effects
679353|NCT00715338|Exhaled Breath Condensate|exhaled breath condensate
679354|NCT00715338|elective surgery|elective surgery
679355|NCT00715338|mechanical ventilation|mechanical ventilation
679356|NCT00715338|Isofurans|isofurans
679357|NCT00715338|thrombomodulin|thrombomodulin
679358|NCT00715338|requiring|requiring
679359|NCT00715338|mechanical|mechanical
679360|NCT00715338|ventilation|ventilation
679361|NCT00715325|colonoscopy|colonoscopy
679362|NCT00715325|disposable|disposable
679363|NCT00715325|single use|single use
679364|NCT00715312|Inflammation|inflammation
679365|NCT00715312|LDL|ldl
679366|NCT00715312|Oleic acid|oleic acid
679367|NCT00715312|Palmitic acid|palmitic acid
679368|NCT00715312|trans fatty acid|trans fatty acid
679369|NCT00715312|C-reactive protein|c-reactive protein
679370|NCT00715286|epithelial ovarian cancer|epithelial ovarian cancer
679371|NCT00715286|neoadjuvant chemotherapy|neoadjuvant chemotherapy
679372|NCT00715286|randomized study|randomized study
679373|NCT00715273|Magnetic Resonance Imaging|magnetic resonance imaging
679374|NCT00715273|Atherosclerotic Plaque|atherosclerotic plaque
679375|NCT00715273|Lipid Lowering Therapy|lipid lowering therapy
679376|NCT00715247|Myeloproliferative Disorders|myeloproliferative disorders
679377|NCT00715247|Hematological Malignancies|hematological malignancies
679378|NCT00715247|Polycythemia Vera|polycythemia vera
679379|NCT00715247|Essential Thrombocythemia|essential thrombocythemia
679380|NCT00715247|Myelofibrosis|myelofibrosis
679381|NCT00715247|Genetics|genetics
679382|NCT00715247|Chronic Leukemia|chronic leukemia
679383|NCT00715234|adolescent reminder/recall|adolescent reminder/recall
679384|NCT00715234|adolescent vaccines|adolescent vaccines
679385|NCT00715234|Tdap|tdap
679386|NCT00715234|Meningococcal|meningococcal
679387|NCT00715234|HPV|hpv
679388|NCT00715234|Reminder cards|reminder cards
679389|NCT00715234|Recall messages|recall messages
679390|NCT00715234|vaccine|vaccine
679391|NCT00715234|conjugate|conjugate
679392|NCT00715221|Diabetes|diabetes
679393|NCT00715195|Cognitive behavioral|cognitive behavioral
679394|NCT00715195|Long-term study|long-term study
679395|NCT00715195|Education|education
679396|NCT00715182|Renal Cell Cancer|renal cell cancer
679397|NCT00715156|allergy, peach, birch|allergy, peach, birch
679398|NCT00715156|recombinants allergens diagnosis|recombinants allergens diagnosis
679399|NCT00715156|OAS|oas
679400|NCT00715156|LTP|ltp
679401|NCT00715156|systemic reactions|systemic reactions
679402|NCT00715156|subjects with severe reaction to other fruits|subjects with severe reaction to other fruits
679403|NCT00715143|hip|hip
679404|NCT00715143|replacement|replacement
679405|NCT00715143|ceramic|ceramic
679406|NCT00715143|orthopaedic|orthopaedic
679407|NCT00715143|joint|joint
679408|NCT00715143|degenerative|degenerative
679409|NCT00715143|non-inflammatory|non-inflammatory
679410|NCT00715143|osteoarthritis|osteoarthritis
679411|NCT00715143|avascular necrosis|avascular necrosis
679412|NCT00715143|congenital hip dysplasia|congenital hip dysplasia
679413|NCT00715143|traumatic arthritis|traumatic arthritis
679414|NCT00715130|Energy|energy
679415|NCT00715130|Obesity|obesity
679416|NCT00715130|Energy Balance|energy balance
679417|NCT00715130|Physical Activity|physical activity
679418|NCT00715130|Dietary Intake|dietary intake
679419|NCT00715130|Overweight|overweight
679420|NCT00715130|Sedentary|sedentary
679421|NCT00715130|Worksite|worksite
679422|NCT00715130|Body Mass Index|body mass index
679423|NCT00715130|Weight Maintenance|weight maintenance
679424|NCT00715117|children|children
679425|NCT00715117|pediatric|pediatric
679426|NCT00715117|Crohn's Disease|crohn's disease
679427|NCT00715117|naltrexone|naltrexone
679428|NCT00715117|LDN|ldn
679429|NCT00715117|IBD|ibd
679430|NCT00715117|Inflammatory bowel disease|inflammatory bowel disease
679431|NCT00715091|NSAIDS|nsaids
679432|NCT00715091|ankylosing spondylitis|ankylosing spondylitis
679433|NCT00715091|SpA|spa
679434|NCT00715091|Spondyloarthritis|spondyloarthritis
679435|NCT00715091|radiographic changes|radiographic changes
679436|NCT00715078|prostate cancer|prostate cancer
679437|NCT00715078|prostate|prostate
679438|NCT00715078|immune therapy|immune therapy
679439|NCT00715078|immunotherapy|immunotherapy
679440|NCT00715078|vaccine|vaccine
679441|NCT00715078|dendritic cells|dendritic cells
679442|NCT00715078|antigen-presenting cells|antigen-presenting cells
679443|NCT00715078|antigen presenting cells|antigen presenting cells
679444|NCT00715078|cancer vaccine|cancer vaccine
679445|NCT00715078|prostate specific antigen (PSA)|prostate specific antigen (psa)
679446|NCT00715078|prostatic adenocarcinoma|prostatic adenocarcinoma
679447|NCT00715065|syncope|syncope
679448|NCT00715065|faint|faint
679449|NCT00715065|blood|blood
679450|NCT00715065|blood injury phobia|blood injury phobia
679451|NCT00715065|phobia|phobia
679452|NCT00715052|neurologic deficiency due traumatic brain injury|neurologic deficiency due traumatic brain injury
679453|NCT00715039|generalized anxiety disorder|generalized anxiety disorder
679454|NCT00715039|onset of efficacy|onset of efficacy
679455|NCT00715039|Daily Assessment of Symptoms-Anxiety (DAS-A)|daily assessment of symptoms-anxiety (das-a)
679456|NCT00715039|Methods|methods
679457|NCT00715026|Arthritis|arthritis
679458|NCT00715026|Total Hip|total hip
679459|NCT00715026|Ceramic|ceramic
679460|NCT00715026|Hip Replacement|hip replacement
679461|NCT00715026|Total Hip Arthroplasty (THA)|total hip arthroplasty (tha)
679462|NCT00715026|Joint Disease|joint disease
679463|NCT00715013|recurrent Glioblastoma|recurrent glioblastoma
679464|NCT00715000|Preterm babies hydration|preterm babies hydration
679465|NCT00715000|Oral rehydration solution|oral rehydration solution
679466|NCT00715000|Continuous gastric drip|continuous gastric drip
679467|NCT00715000|Fluid therapy|fluid therapy
679468|NCT00715000|Premature babies comfort|premature babies comfort
679469|NCT00715000|Infant care|infant care
679470|NCT00715000|Technical challenge for the nurses/doctors in charge|technical challenge for the nurses/doctors in charge
679471|NCT00714987|ARDS|ards
679472|NCT00714987|Mechanical ventilation|mechanical ventilation
679473|NCT00714987|PEEP with low level|peep with low level
679474|NCT00714987|PEEP with high level|peep with high level
679475|NCT00714987|EVLW|evlw
679476|NCT00714987|Picco® system|picco® system
679477|NCT00714987|PaO2/FiO2 ratio|pao2/fio2 ratio
679478|NCT00714974|Neuromuscular blocking agents|neuromuscular blocking agents
679479|NCT00714974|Bispectral analysis|bispectral analysis
679480|NCT00714948|Bladder|bladder
679481|NCT00714948|Urinary|urinary
679482|NCT00714948|SORAFENIB|sorafenib
679483|NCT00714948|CISPLATIN|cisplatin
679484|NCT00714948|GEMCITABINE|gemcitabine
679485|NCT00714935|Risk Factors|risk factors
679486|NCT00714935|Risk Reduction Behavior|risk reduction behavior
679487|NCT00714935|Counseling|counseling
679488|NCT00714909|Breast cancer|breast cancer
679489|NCT00714909|Catheter related thrombosis|catheter related thrombosis
679490|NCT00714909|Diagnosis|diagnosis
679491|NCT00714909|Echography doppler|echography doppler
679492|NCT00714909|Risk factors|risk factors
679493|NCT00714896|smoking cessation|smoking cessation
679494|NCT00714896|nicotine dependence|nicotine dependence
679495|NCT00714896|stage-based intervention|stage-based intervention
679496|NCT00714896|nicotine replacement medications|nicotine replacement medications
679497|NCT00714896|counseling|counseling
679498|NCT00714896|substance abuse treatment|substance abuse treatment
679499|NCT00714883|drug-eluting stents|drug-eluting stents
679500|NCT00714883|Percutaneous coronary intervention (PCI)|percutaneous coronary intervention (pci)
679501|NCT00714870|BMI|bmi
679502|NCT00714870|Quality of life|quality of life
679503|NCT00714857|ICU patients|icu patients
679504|NCT00714857|Dexmedetomidine|dexmedetomidine
679505|NCT00714857|Sedation|sedation
679506|NCT00714857|Judged|judged
679507|NCT00714857|Attending|attending
679508|NCT00714857|Physician|physician
679509|NCT00714844|insulin therapy|insulin therapy
679510|NCT00714844|insulin detemir|insulin detemir
679511|NCT00714844|waist circumference|waist circumference
679512|NCT00714831|Physical activity promotion|physical activity promotion
679513|NCT00714831|Primary health care|primary health care
679514|NCT00714831|Adherence|adherence
679515|NCT00714818|Schizophrenia|schizophrenia
679516|NCT00714818|Bipolar Disorder|bipolar disorder
679517|NCT00714818|Schizoaffective disorder|schizoaffective disorder
679518|NCT00714818|Genetic Counseling|genetic counseling
679519|NCT00714818|Risk perception|risk perception
679520|NCT00714818|Stigma|stigma
679521|NCT00714818|Control|control
679522|NCT00714818|Knowledge|knowledge
679523|NCT00714818|family members|family members
679524|NCT00714818|Sibling parent or child with schizophrenia|sibling parent or child with schizophrenia
679525|NCT00714818|Sibling parent or child with bipolar disorder|sibling parent or child with bipolar disorder
679526|NCT00714818|Sibling parent or child with schizoaffective disorder|sibling parent or child with schizoaffective disorder
679527|NCT00714805|Amyotrophic Lateral Sclerosis|amyotrophic lateral sclerosis
679528|NCT00714805|Gastric Motility|gastric motility
679529|NCT00714805|Autonomic Nervous System|autonomic nervous system
679530|NCT00714805|Neurodegenerative Diseases|neurodegenerative diseases
679531|NCT00714805|Movement Disorders|movement disorders
679532|NCT00714805|Gastrointestinal Motility|gastrointestinal motility
679533|NCT00714779|Major depressive Disorder|major depressive disorder
679534|NCT00714779|fluoxetine|fluoxetine
679535|NCT00714779|short-term psychodynamic psychotherapy|short-term psychodynamic psychotherapy
679536|NCT00714779|PET|pet
679537|NCT00714753|stage I prostate cancer|stage i prostate cancer
679538|NCT00714753|stage II prostate cancer|stage ii prostate cancer
679539|NCT00714753|adenocarcinoma of the prostate|adenocarcinoma of the prostate
679540|NCT00714740|apnea, sleep, altitude, hypoxia|apnea, sleep, altitude, hypoxia
679541|NCT00714727|migraine|migraine
679542|NCT00714727|headache|headache
679543|NCT00714727|acupuncture|acupuncture
679544|NCT00714714|acne|acne
679545|NCT00714714|irritation|irritation
679546|NCT00714714|objective sensory methods|objective sensory methods
679547|NCT00714688|Adult|adult
679548|NCT00714688|ADHD|adhd
679549|NCT00714688|Concerta|concerta
679550|NCT00714675|citrulline|citrulline
679551|NCT00714675|protein-energy malnutrition|protein-energy malnutrition
679552|NCT00714675|aged|aged
679553|NCT00714675|protein biosynthesis|protein biosynthesis
679554|NCT00714675|amino acid|amino acid
679555|NCT00714662|high flux hemodialysis|high flux hemodialysis
679556|NCT00714649|Head and Neck Squamous Cell Carcinoma treated with surgery|head and neck squamous cell carcinoma treated with surgery
679557|NCT00714649|and/or radiotherapy|and/or radiotherapy
679558|NCT00714636|Amyotrophic Lateral Sclerosis|amyotrophic lateral sclerosis
679559|NCT00714636|Cerebrospinal Fluid|cerebrospinal fluid
679560|NCT00714636|Neurodegenerative Disease|neurodegenerative disease
679561|NCT00714636|Motor Neuron Disease|motor neuron disease
679562|NCT00714636|Autonomic Nervous System|autonomic nervous system
679563|NCT00714636|Neurodegenerative Diseases|neurodegenerative diseases
679564|NCT00714636|Movement Disorders|movement disorders
679565|NCT00714623|Coronary Artery Disease|coronary artery disease
679566|NCT00714623|Coronary Restenosis|coronary restenosis
679567|NCT00714623|Coronary Thrombosis|coronary thrombosis
679568|NCT00714623|Drug-Eluting Stents|drug-eluting stents
679569|NCT00714623|Angioplasty, Transluminal, Percutaneous Coronary|angioplasty, transluminal, percutaneous coronary
679570|NCT00714610|Serum metal ion concentration|serum metal ion concentration
679571|NCT00714597|Venous thrombosis|venous thrombosis
679572|NCT00714597|Primary prevention|primary prevention
679573|NCT00714584|Infusions, Intravenous|infusions, intravenous
679574|NCT00714584|Safety|safety
679575|NCT00714584|Pharmacokinetics|pharmacokinetics
679576|NCT00714584|Naltrexone|naltrexone
679577|NCT00714584|Administration, Oral|administration, oral
679578|NCT00714571|cognitive rehabilitation|cognitive rehabilitation
679579|NCT00714571|explicit memory training|explicit memory training
679580|NCT00714571|mild cognitive impairment|mild cognitive impairment
679581|NCT00714571|Alzheimer's disease|alzheimer's disease
679582|NCT00714571|traumatic brain injury|traumatic brain injury
679583|NCT00714571|veterans|veterans
679584|NCT00714558|Pharmacokinetics|pharmacokinetics
679585|NCT00714558|Administration, Oral|administration, oral
679586|NCT00714558|Naltrexone|naltrexone
679587|NCT00714558|Biological Availability|biological availability
679588|NCT00714558|Infusions, Intravenous|infusions, intravenous
679589|NCT00714558|Fentanyl|fentanyl
679590|NCT00714558|Safety|safety
679591|NCT00714558|Naloxone|naloxone
679592|NCT00714545|Coronary Artery Disease|coronary artery disease
679593|NCT00714545|Coronary Restenosis|coronary restenosis
679594|NCT00714545|Brachytherapy|brachytherapy
679595|NCT00714532|smoking cessation|smoking cessation
679596|NCT00714532|Asian American|asian american
679597|NCT00714532|Chinese American|chinese american
679598|NCT00714532|smoking reduction|smoking reduction
679599|NCT00714532|stage-based intervention|stage-based intervention
679600|NCT00714532|expert system|expert system
679601|NCT00714532|nicotine replacement|nicotine replacement
679602|NCT00714532|counseling|counseling
679603|NCT00714519|Xenaderm|xenaderm
679604|NCT00714519|partial|partial
679605|NCT00714519|thickness|thickness
679606|NCT00714519|wounds|wounds
679607|NCT00714519|Nursing Homes|nursing homes
679608|NCT00714506|obesity|obesity
679609|NCT00714506|physical activity|physical activity
679610|NCT00714506|older adults|older adults
679611|NCT00714506|functional disability|functional disability
679612|NCT00714493|rheumatoid arthritis|rheumatoid arthritis
679613|NCT00714493|remicade|remicade
679614|NCT00714493|infliximab|infliximab
679615|NCT00714493|Centocor|centocor
679616|NCT00714493|etanercept|etanercept
679617|NCT00714493|enbrel|enbrel
679618|NCT00714493|adalimumab|adalimumab
679619|NCT00714493|humira|humira
679620|NCT00714493|restart|restart
679621|NCT00714493|swollen joints|swollen joints
679622|NCT00714493|tender joints.|tender joints.
679623|NCT00714480|Thymoglobulin|thymoglobulin
679624|NCT00714480|Renal Transplant|renal transplant
679625|NCT00714480|Kidney Transplant|kidney transplant
679626|NCT00714480|Immunosuppression|immunosuppression
679627|NCT00714480|Induction therapy|induction therapy
679628|NCT00714467|smoking cessation|smoking cessation
679629|NCT00714467|Asian|asian
679630|NCT00714467|Chinese American|chinese american
679631|NCT00714467|family support|family support
679632|NCT00714467|social support|social support
679633|NCT00714467|stage-based intervention|stage-based intervention
679634|NCT00714441|Diabetes Type 2|diabetes type 2
679635|NCT00714441|Distress|distress
679636|NCT00714441|Problem Solving Therapy|problem solving therapy
679637|NCT00714441|Computer Automated Self-Management (CASM)|computer automated self-management (casm)
679638|NCT00714428|Traumatic Brain Injury|traumatic brain injury
679639|NCT00714428|Quality of Life|quality of life
679640|NCT00714402|UTI|uti
679641|NCT00714389|Urogynecology|urogynecology
679642|NCT00714376|Prostate cancer|prostate cancer
679643|NCT00714376|High-risk prostate cancer|high-risk prostate cancer
679644|NCT00714376|Radical prostatectomy|radical prostatectomy
679645|NCT00714376|Early rising PSA|early rising psa
679646|NCT00714376|Taxotere|taxotere
679647|NCT00714376|Docetaxel|docetaxel
679648|NCT00714350|Information Display|information display
679649|NCT00714350|situational awareness|situational awareness
679650|NCT00714350|Create intuitive visualization|create intuitive visualization
679651|NCT00714337|Formulation|formulation
679652|NCT00714337|pharmacokinetics|pharmacokinetics
679653|NCT00714324|Nutrition|nutrition
679654|NCT00714324|Screening|screening
679655|NCT00714311|borderline personality disorder|borderline personality disorder
679656|NCT00714311|randomized controlled trial|randomized controlled trial
679657|NCT00714311|Transference-Focused Psychotherapy|transference-focused psychotherapy
679658|NCT00714311|treatment by experienced community psychotherapists|treatment by experienced community psychotherapists
679659|NCT00714298|biological markers|biological markers
679660|NCT00714298|emergency service hospital|emergency service hospital
679661|NCT00714298|heart fatty acid binding protein|heart fatty acid binding protein
679662|NCT00714298|ischemia modified albumin|ischemia modified albumin
679663|NCT00714285|Primary study|primary study
679664|NCT00714285|immunogenicity|immunogenicity
679665|NCT00714285|safety|safety
679666|NCT00714259|Low Grade B Cell Malignancies|low grade b cell malignancies
679667|NCT00714259|nonmyeloablative transplant|nonmyeloablative transplant
679668|NCT00714259|allogeneic|allogeneic
679669|NCT00714246|advanced non small cell lung cancer|advanced non small cell lung cancer
679670|NCT00714233|Polycystic Ovary Syndrome|polycystic ovary syndrome
679671|NCT00714233|Overweight Adolescent Girls|overweight adolescent girls
679672|NCT00714233|Irregular Menstrual Cycles|irregular menstrual cycles
679673|NCT00714220|Amyotrophic Lateral Sclerosis|amyotrophic lateral sclerosis
679674|NCT00714220|Gastric Motility|gastric motility
679675|NCT00714220|Autonomic Nervous System|autonomic nervous system
679676|NCT00714220|Neurodegenerative Diseases|neurodegenerative diseases
679677|NCT00714220|Movement Disorders|movement disorders
679678|NCT00714220|Substrate Utilization|substrate utilization
679679|NCT00714207|adolescents|adolescents
679680|NCT00714207|smoking|smoking
679681|NCT00714207|smoking cessation|smoking cessation
679682|NCT00714207|tobacco use|tobacco use
679683|NCT00714194|sedation|sedation
679684|NCT00714194|delirium|delirium
679685|NCT00714194|sleep|sleep
679686|NCT00714194|sedation withdrawal|sedation withdrawal
679687|NCT00714194|ICU patients|icu patients
679688|NCT00714181|unspecified adult solid tumor, protocol specific|unspecified adult solid tumor, protocol specific
679689|NCT00714168|Weight Loss|weight loss
679690|NCT00714168|Weight Control|weight control
679691|NCT00714155|Colpocleisis|colpocleisis
679692|NCT00714142|Renal blood flow|renal blood flow
679693|NCT00714142|PET imaging|pet imaging
679694|NCT00714129|Steatosis|steatosis
679695|NCT00714129|Diabetes|diabetes
679696|NCT00714116|safety|safety
679697|NCT00714116|pharmacokinetics|pharmacokinetics
679698|NCT00714103|Leukemia|leukemia
679699|NCT00714103|Chronic Lymphocytic Leukemia|chronic lymphocytic leukemia
679700|NCT00714103|CLL|cll
679701|NCT00714103|8-Chloro-Adenosine|8-chloro-adenosine
679702|NCT00714103|purine analogues|purine analogues
679703|NCT00714103|Cancer|cancer
679704|NCT00714090|repetitive Transcranial Magnetic Stimulation (rTMS)|repetitive transcranial magnetic stimulation (rtms)
679705|NCT00714090|Major depressive disorders|major depressive disorders
679706|NCT00714090|Depression|depression
679707|NCT00714090|Venlafaxine|venlafaxine
679708|NCT00714077|rectal cancer|rectal cancer
679709|NCT00714077|concurrent chemoradiotherapy|concurrent chemoradiotherapy
679710|NCT00714077|adjuvant therapy|adjuvant therapy
679711|NCT00714077|phase III study|phase iii study
679712|NCT00714038|Quality development project|quality development project
679713|NCT00714038|primary care nurses|primary care nurses
679714|NCT00714038|asthma|asthma
679715|NCT00714038|patient compliance|patient compliance
679716|NCT00714038|follow-up|follow-up
679717|NCT00714025|RAD001|rad001
679718|NCT00714025|TCC|tcc
679719|NCT00714025|Palliative treatment|palliative treatment
679720|NCT00714025|advance or metastatic TCC|advance or metastatic tcc
679721|NCT00714025|Failure after Platinum-based chemotherapy|failure after platinum-based chemotherapy
679722|NCT00714012|Display development|display development
679824|NCT00713570|COMT|comt
679723|NCT00714012|Intuitive display use|intuitive display use
679724|NCT00714012|visualizations are intuitive|visualizations are intuitive
679725|NCT00713999|Sexually transmitted infections|sexually transmitted infections
679726|NCT00713999|Urogenital schistosomiasis|urogenital schistosomiasis
679727|NCT00713999|Schistosoma haematobium|schistosoma haematobium
679728|NCT00713999|Reproductive health|reproductive health
679729|NCT00713999|Pelvic examination|pelvic examination
679730|NCT00713999|Ultrasonography|ultrasonography
679731|NCT00713999|Questionnaire|questionnaire
679732|NCT00713999|Madagascar|madagascar
679733|NCT00713986|Pain|pain
679734|NCT00713986|Newborn Infant|newborn infant
679735|NCT00713986|Analgesia|analgesia
679736|NCT00713960|Quality development project|quality development project
679737|NCT00713960|primary care nurses|primary care nurses
679738|NCT00713960|cardiovascular disease|cardiovascular disease
679739|NCT00713960|secondary prevention|secondary prevention
679740|NCT00713960|follow-up|follow-up
679741|NCT00713947|Gastric lesions induced by low dose of aspirin|gastric lesions induced by low dose of aspirin
679742|NCT00713947|Helicobacter pylori|helicobacter pylori
679743|NCT00713934|Autologous Bone marrow stem cells|autologous bone marrow stem cells
679744|NCT00713934|Cirrhosis|cirrhosis
679745|NCT00713921|Female|female
679746|NCT00713921|Diabetics|diabetics
679747|NCT00713921|Stroke|stroke
679748|NCT00713908|Voiding dysfunction following TVT placement|voiding dysfunction following tvt placement
679749|NCT00713895|smoking cessation|smoking cessation
679750|NCT00713895|randomized trial|randomized trial
679751|NCT00713895|Asian|asian
679752|NCT00713895|Chinese American|chinese american
679753|NCT00713895|stages of change|stages of change
679754|NCT00713882|Survivors|survivors
679755|NCT00713882|Quality of Life|quality of life
679756|NCT00713869|Oocyte cryopreservation|oocyte cryopreservation
679757|NCT00713869|Slow freeze|slow freeze
679758|NCT00713843|Neck Pain|neck pain
679759|NCT00713843|Manuel Therapy Utrecht|manuel therapy utrecht
679760|NCT00713843|Physiotherapy|physiotherapy
679761|NCT00713830|hyperglycemia, GLP-1|hyperglycemia, glp-1
679762|NCT00713817|Pain|pain
679763|NCT00713817|Peripheral Neuropathy|peripheral neuropathy
679764|NCT00713804|Schizophrenia|schizophrenia
679765|NCT00713804|Bipolar Disorder|bipolar disorder
679766|NCT00713804|Schizoaffective disorder|schizoaffective disorder
679767|NCT00713804|Genetic Counseling|genetic counseling
679768|NCT00713804|Risk perception|risk perception
679769|NCT00713804|Stigma|stigma
679770|NCT00713804|Control|control
679771|NCT00713804|Knowledge|knowledge
679772|NCT00713791|Healthy Volunteers|healthy volunteers
679773|NCT00713791|ZD4054|zd4054
679774|NCT00713778|Ovarian Cysts|ovarian cysts
679775|NCT00713778|Electrocoagulation|electrocoagulation
679776|NCT00713778|Ovarian Function Tests|ovarian function tests
679777|NCT00713778|Laparoscopy|laparoscopy
679778|NCT00713765|Healthy volunteers|healthy volunteers
679779|NCT00713752|HIV-negative|hiv-negative
679780|NCT00713739|kidney stones|kidney stones
679781|NCT00713739|ureteral stones|ureteral stones
679782|NCT00713739|medical expulsion therapy|medical expulsion therapy
679783|NCT00713726|Pain|pain
679784|NCT00713726|Analgesia|analgesia
679785|NCT00713726|Newborn Infant|newborn infant
679786|NCT00713726|Opioids|opioids
679787|NCT00713726|Side-effects|side-effects
679788|NCT00713726|Intensive care|intensive care
679789|NCT00713726|Postoperative|postoperative
679790|NCT00713713|Respiratory Distress Syndrome, Adult|respiratory distress syndrome, adult
679791|NCT00713713|Tidal volume|tidal volume
679792|NCT00713713|cardiac output|cardiac output
679793|NCT00713713|Respiration, Artificial|respiration, artificial
679794|NCT00713713|Protective ventilation|protective ventilation
679795|NCT00713700|patent ductus arteriosus|patent ductus arteriosus
679796|NCT00713700|PDA|pda
679797|NCT00713687|photodynamic therapy|photodynamic therapy
679798|NCT00713687|PDT|pdt
679799|NCT00713687|gemcitabine|gemcitabine
679800|NCT00713687|oxaliplatin|oxaliplatin
679801|NCT00713687|cholangiocarcinoma|cholangiocarcinoma
679802|NCT00713674|Methicillin resistance|methicillin resistance
679803|NCT00713661|Colorectal Anastomosis|colorectal anastomosis
679804|NCT00713661|Colorectal Resection|colorectal resection
679805|NCT00713661|Tachosil|tachosil
679806|NCT00713635|Congenital Heart Disease|congenital heart disease
679807|NCT00713622|Partial|partial
679808|NCT00713622|onset|onset
679809|NCT00713622|seizures|seizures
679810|NCT00713609|Acne|acne
679811|NCT00713609|Acne Vulgaris|acne vulgaris
679812|NCT00713609|Pimples|pimples
679813|NCT00713596|Nasal Surgery|nasal surgery
679814|NCT00713596|Septorhinoplasty|septorhinoplasty
679815|NCT00713596|fibrin glue|fibrin glue
679816|NCT00713596|fibrinogen|fibrinogen
679817|NCT00713596|Swelling|swelling
679818|NCT00713596|fibrin|fibrin
679819|NCT00713596|tisseel|tisseel
679820|NCT00713583|Cocaine, levodopa, contingency management|cocaine, levodopa, contingency management
679821|NCT00713570|intellectual functioning|intellectual functioning
679822|NCT00713570|memory,visual-spatial and perceptual functions|memory,visual-spatial and perceptual functions
679823|NCT00713570|cognitive abilities|cognitive abilities
679825|NCT00713570|BDNF|bdnf
679826|NCT00713570|neuron biological systemic pathway candidate genes|neuron biological systemic pathway candidate genes
679827|NCT00713570|Chinese|chinese
679828|NCT00713570|Taiwan|taiwan
679829|NCT00713570|Healthy subjects|healthy subjects
679830|NCT00713557|coronary angioplasty|coronary angioplasty
679831|NCT00713544|Rheumatoid Arthritis|rheumatoid arthritis
679833|NCT00713544|AZD5672|azd5672
679834|NCT00713531|HIV-negative|hiv-negative
679835|NCT00713531|male and female clients|male and female clients
679836|NCT00713531|ages 18-50 years|ages 18-50 years
679837|NCT00713531|seeking HIV counseling|seeking hiv counseling
679838|NCT00713531|testing at TRCARC|testing at trcarc
679839|NCT00713518|AMD Age Related Macular Degeneration Choroidal Neovascularization Monet|amd age related macular degeneration choroidal neovascularization monet
679840|NCT00713505|psychosocial effects of cancer and its treatment|psychosocial effects of cancer and its treatment
679841|NCT00713505|long-term effects secondary to cancer therapy in children|long-term effects secondary to cancer therapy in children
679842|NCT00713505|cancer survivor|cancer survivor
679843|NCT00713505|cognitive/functional effects|cognitive/functional effects
679844|NCT00713505|childhood acute lymphoblastic leukemia|childhood acute lymphoblastic leukemia
679845|NCT00713505|childhood acute myeloid leukemia in remission|childhood acute myeloid leukemia in remission
679846|NCT00713505|childhood anaplastic large cell lymphoma|childhood anaplastic large cell lymphoma
679847|NCT00713505|childhood large cell lymphoma|childhood large cell lymphoma
679848|NCT00713505|childhood lymphoblastic lymphoma|childhood lymphoblastic lymphoma
679849|NCT00713505|childhood small noncleaved cell lymphoma|childhood small noncleaved cell lymphoma
679850|NCT00713505|childhood nasal type extranodal NK/T-cell lymphoma|childhood nasal type extranodal nk/t-cell lymphoma
679851|NCT00713505|childhood grade III lymphomatoid granulomatosis|childhood grade iii lymphomatoid granulomatosis
679852|NCT00713505|childhood chronic myelogenous leukemia|childhood chronic myelogenous leukemia
679853|NCT00713492|Alcohol|alcohol
679854|NCT00713492|Self -Administration|self -administration
679855|NCT00713492|Intoxication|intoxication
679856|NCT00713492|Healthy Volunteer|healthy volunteer
679857|NCT00713492|HV|hv
679858|NCT00713479|methamphetamine|methamphetamine
679859|NCT00713479|varenicline|varenicline
679860|NCT00713479|Chantix|chantix
679861|NCT00713479|stimulant|stimulant
679862|NCT00713479|crystal meth|crystal meth
679863|NCT00713466|CLIPP cases|clipp cases
679864|NCT00713466|Pediatric clerkship|pediatric clerkship
679865|NCT00713466|Standardizing|standardizing
679866|NCT00713466|Students' exposure|students' exposure
679867|NCT00713466|Essential|essential
679868|NCT00713466|Enhancing|enhancing
679869|NCT00713466|Experience|experience
679870|NCT00713453|Pompe disease|pompe disease
679871|NCT00713453|muscle|muscle
679872|NCT00713453|enzyme replacement therapy|enzyme replacement therapy
679873|NCT00713440|Incretin Effect|incretin effect
679874|NCT00713440|Steroids|steroids
679875|NCT00713440|Glucagon-Like Peptide 1|glucagon-like peptide 1
679876|NCT00713440|Gastric Inhibitory Peptide|gastric inhibitory peptide
679877|NCT00713440|Glucose-dependent Insulinotropic Polypeptide|glucose-dependent insulinotropic polypeptide
679878|NCT00713440|Insulin|insulin
679879|NCT00713440|C-peptide|c-peptide
679880|NCT00713440|Glucagon|glucagon
679881|NCT00713427|Biliary|biliary
679882|NCT00713427|Strictures|strictures
679883|NCT00713427|Malignant|malignant
679884|NCT00713427|Neoplasm|neoplasm
679885|NCT00713427|Palliation|palliation
679886|NCT00713414|Spasmodic Dysphonia|spasmodic dysphonia
679887|NCT00713414|Dystonia|dystonia
679888|NCT00713414|Basal Ganglia|basal ganglia
679889|NCT00713414|PET Imaging|pet imaging
679890|NCT00713414|fMRI|fmri
679891|NCT00713414|Voice Disorder|voice disorder
679892|NCT00713414|Healthy Volunteer|healthy volunteer
679893|NCT00713414|HV|hv
679894|NCT00713375|Autonomic Nervous System|autonomic nervous system
679895|NCT00713375|Subarachnoid Hemorrhage|subarachnoid hemorrhage
679896|NCT00713375|Intracranial Hemorrhages|intracranial hemorrhages
679897|NCT00713375|Cerebral Hemorrhage|cerebral hemorrhage
679898|NCT00713362|Aspiration, chest tube, pneumothorax, thoracoscopic surgery|aspiration, chest tube, pneumothorax, thoracoscopic surgery
679899|NCT00713349|White|white
679900|NCT00713349|Petrolatum|petrolatum
679901|NCT00713349|Xenaderm|xenaderm
679902|NCT00713349|Vehicle|vehicle
679903|NCT00713349|Partial thickness wounds|partial thickness wounds
679904|NCT00713349|Healing|healing
679905|NCT00713349|Cryo-surgery|cryo-surgery
679906|NCT00713336|ZD4054|zd4054
679907|NCT00713336|Healthy Volunteers|healthy volunteers
679908|NCT00713336|QT interval|qt interval
679909|NCT00713323|Pain|pain
679910|NCT00713323|Peripheral Neuropathy|peripheral neuropathy
679911|NCT00713297|medication errors|medication errors
679912|NCT00713297|computerized physician order entry|computerized physician order entry
679913|NCT00713297|pharmaceutical care|pharmaceutical care
679914|NCT00713297|chemotherapeutic agents|chemotherapeutic agents
679915|NCT00713297|reengineering|reengineering
679916|NCT00713284|Kidney transplantation|kidney transplantation
679917|NCT00713284|Sirolimus|sirolimus
679918|NCT00713284|Immunosuppression|immunosuppression
679919|NCT00713284|Tacrolimus|tacrolimus
679920|NCT00713271|Healthy male|healthy male
679921|NCT00713271|tolerability|tolerability
679922|NCT00713271|safety|safety
679923|NCT00713271|inhalation|inhalation
679924|NCT00713258|Postmenopausal women|postmenopausal women
679925|NCT00713258|Back pain|back pain
679926|NCT00713258|Osteoporosis related fracture|osteoporosis related fracture
679927|NCT00713245|Pompe disease|pompe disease
679928|NCT00713245|late onset|late onset
679929|NCT00713232|naming test|naming test
679930|NCT00713219|IMRT|imrt
679931|NCT00713219|cetuximab|cetuximab
679932|NCT00713219|docetaxel|docetaxel
679933|NCT00713206|Dental implants, maxilla, sinus lift, augmentation|dental implants, maxilla, sinus lift, augmentation
679934|NCT00713193|Idiopathic TTP|idiopathic ttp
679935|NCT00713193|Treatment|treatment
679936|NCT00713193|Exacerbation|exacerbation
679937|NCT00713193|Relapse|relapse
679938|NCT00713193|Plasma Exchange|plasma exchange
679939|NCT00713167|Grape Seed Extract|grape seed extract
679940|NCT00713167|Hyperlipidemia|hyperlipidemia
679941|NCT00713154|Radiotherapy|radiotherapy
679942|NCT00713154|induced|induced
679943|NCT00713128|nausea vomiting colorectal cancer|nausea vomiting colorectal cancer
679944|NCT00713115|laparoscopy, needlescopy, adrenalectomy|laparoscopy, needlescopy, adrenalectomy
679945|NCT00713102|in-flight emergency|in-flight emergency
679946|NCT00713089|Eczema|eczema
679947|NCT00713089|Asthma|asthma
679948|NCT00713089|Allergic rhinitis|allergic rhinitis
679949|NCT00713089|Singapore|singapore
679950|NCT00713089|Indonesia|indonesia
679951|NCT00713089|Gastrointestinal Flora|gastrointestinal flora
679952|NCT00713076|multi-purpose solution|multi-purpose solution
679953|NCT00713076|contact lens wearers|contact lens wearers
679954|NCT00713076|Contact lense wearers|contact lense wearers
679955|NCT00713063|smoking cessation|smoking cessation
679956|NCT00713063|exercise|exercise
679957|NCT00713063|physical activity|physical activity
679958|NCT00713063|health education|health education
679959|NCT00713050|stroke|stroke
679960|NCT00713050|aphasia|aphasia
679961|NCT00713050|imitation|imitation
679962|NCT00713050|mirror neuron|mirror neuron
679963|NCT00713037|fluoromisonidazole|fluoromisonidazole
679964|NCT00713037|PET scan|pet scan
679965|NCT00713037|Hypoxia-PET|hypoxia-pet
679966|NCT00713037|IMPT|impt
679967|NCT00713024|Pain; Functional neuroimaging; Neuropathy; Thermal sensation|pain; functional neuroimaging; neuropathy; thermal sensation
679968|NCT00713011|Adalat XL|adalat xl
679969|NCT00713011|Diltiazem|diltiazem
679970|NCT00713011|Tiazac XC|tiazac xc
679971|NCT00713011|Proteinuria|proteinuria
679972|NCT00712998|radiation injuries|radiation injuries
679973|NCT00712998|free radicals|free radicals
679974|NCT00712998|reactive oxygen species|reactive oxygen species
679975|NCT00712998|radiation injury from X-ray computed tomography|radiation injury from x-ray computed tomography
679976|NCT00712998|free radical production|free radical production
679977|NCT00712998|blood reactive oxygen species level|blood reactive oxygen species level
679978|NCT00712985|Breast cancer|breast cancer
679979|NCT00712985|aromatase inhibitors|aromatase inhibitors
679980|NCT00712972|knee injection|knee injection
679981|NCT00712972|parapatellar|parapatellar
679982|NCT00712959|Pertussis|pertussis
679983|NCT00712959|Tetanus|tetanus
679984|NCT00712959|Diphtheria|diphtheria
679985|NCT00712959|Acellular pertussis|acellular pertussis
679986|NCT00712959|ADACEL®,|adacel®,
679987|NCT00712959|Tdap vaccine|tdap vaccine
679988|NCT00712933|SLE|sle
679989|NCT00712933|Belimumab|belimumab
679990|NCT00712933|Antibodies|antibodies
679991|NCT00712933|Systemic Lupus Erythematosus|systemic lupus erythematosus
679992|NCT00712933|Lupus|lupus
679993|NCT00712933|Autoimmune Diseases|autoimmune diseases
679994|NCT00712907|vitamin C|vitamin c
679995|NCT00712907|retinal blood flow|retinal blood flow
679996|NCT00712907|intraocular pressure|intraocular pressure
679997|NCT00712907|retinal vessel diameter|retinal vessel diameter
679998|NCT00712894|Acute myocardial infarction|acute myocardial infarction
679999|NCT00712894|Percutaneous coronary intervention|percutaneous coronary intervention
680000|NCT00712894|No-reflow phenomenon|no-reflow phenomenon
680001|NCT00712894|Vasodilator agents|vasodilator agents
680002|NCT00712855|Liver Cancer|liver cancer
680003|NCT00712842|Diabetes|diabetes
680004|NCT00712842|ocular blood flow|ocular blood flow
680005|NCT00712829|Prostate cancer|prostate cancer
680006|NCT00712829|Imaging|imaging
680007|NCT00712816|osteoarthritis|osteoarthritis
680008|NCT00712816|total knee arthroplasty|total knee arthroplasty
680009|NCT00712816|cryotherapy|cryotherapy
680010|NCT00712790|First line treatment for Hepatocellular Carcinoma|first line treatment for hepatocellular carcinoma
680011|NCT00712777|Brimonidine|brimonidine
680012|NCT00712777|alpha 2 receptor polymorphism|alpha 2 receptor polymorphism
680013|NCT00712777|Intraocular Pressure|intraocular pressure
680014|NCT00712764|Adenosine|adenosine
680015|NCT00712764|Choroidal blood flow|choroidal blood flow
680016|NCT00712764|Suction cup|suction cup
680017|NCT00712751|Rectum|rectum
680018|NCT00712751|Quality of Life|quality of life
680019|NCT00712751|Sexual Health|sexual health
680020|NCT00712751|08-073|08-073
680021|NCT00712738|Nifedipine|nifedipine
680022|NCT00712738|Thalassemia|thalassemia
680023|NCT00712738|Hemochromatosis|hemochromatosis
680024|NCT00712738|Iron Overload|iron overload
680025|NCT00712738|Iron Excretion|iron excretion
680026|NCT00712712|bone metastases|bone metastases
680027|NCT00712712|unspecified adult solid tumor, protocol specific|unspecified adult solid tumor, protocol specific
680028|NCT00712712|pain|pain
680029|NCT00712699|Preschool|preschool
680030|NCT00712699|Children|children
680031|NCT00712699|ADHD|adhd
680032|NCT00712699|Medication|medication
680033|NCT00712699|Controlled Study|controlled study
680034|NCT00712699|Placebo|placebo
680035|NCT00712699|Mixed Amphetamine Salts|mixed amphetamine salts
680036|NCT00712673|hyperglycemia, GLP-1, metformin|hyperglycemia, glp-1, metformin
680037|NCT00712660|prevention|prevention
680038|NCT00712660|relapse|relapse
680039|NCT00712660|schizophrenia|schizophrenia
680040|NCT00712634|cytomegalovirus infection|cytomegalovirus infection
680041|NCT00712621|Genetics Home Reference related topics|genetics home reference related topics
680042|NCT00712621|breast cancer|breast cancer
680043|NCT00712621|breast cancer related to depression|breast cancer related to depression
680044|NCT00712621|Condition|condition
680045|NCT00712621|Stage I-IV Carcinoma of Breast|stage i-iv carcinoma of breast
680046|NCT00712608|Term|term
680047|NCT00712608|Infant|infant
680048|NCT00712608|Formula|formula
680049|NCT00712595|Uterine fibroids|uterine fibroids
680050|NCT00712595|mifepristone|mifepristone
680051|NCT00712595|antiprogestins|antiprogestins
680052|NCT00712582|Non-Hodgkin|non-hodgkin
680053|NCT00712582|Lymphoma|lymphoma
680054|NCT00712582|Rituximab|rituximab
680055|NCT00712582|Cyclophosphamide|cyclophosphamide
680056|NCT00712582|Doxorubicin|doxorubicin
680057|NCT00712582|Vincristine|vincristine
680058|NCT00712582|ifosfamide|ifosfamide
680059|NCT00712582|etoposide|etoposide
680060|NCT00712582|carboplatin|carboplatin
680061|NCT00712582|stem cell transplant|stem cell transplant
680062|NCT00712582|08-026|08-026
862344|NCT00059579|Reward|reward
680063|NCT00712569|Communication|communication
680064|NCT00712569|Internet|internet
680065|NCT00712569|Physician|physician
680066|NCT00712569|Patient|patient
680067|NCT00712569|08-079|08-079
680068|NCT00712556|stage III adult Burkitt lymphoma|stage iii adult burkitt lymphoma
680069|NCT00712556|stage III adult diffuse large cell lymphoma|stage iii adult diffuse large cell lymphoma
680070|NCT00712556|stage III adult diffuse mixed cell lymphoma|stage iii adult diffuse mixed cell lymphoma
680071|NCT00712556|stage III adult diffuse small cleaved cell lymphoma|stage iii adult diffuse small cleaved cell lymphoma
680072|NCT00712556|stage III adult immunoblastic large cell lymphoma|stage iii adult immunoblastic large cell lymphoma
680073|NCT00712556|stage III adult lymphoblastic lymphoma|stage iii adult lymphoblastic lymphoma
680074|NCT00712556|stage III grade 1 follicular lymphoma|stage iii grade 1 follicular lymphoma
680075|NCT00712556|stage III grade 2 follicular lymphoma|stage iii grade 2 follicular lymphoma
680076|NCT00712556|stage III grade 3 follicular lymphoma|stage iii grade 3 follicular lymphoma
680077|NCT00712556|stage III mantle cell lymphoma|stage iii mantle cell lymphoma
680078|NCT00712556|stage III marginal zone lymphoma|stage iii marginal zone lymphoma
680079|NCT00712556|stage III small lymphocytic lymphoma|stage iii small lymphocytic lymphoma
680080|NCT00712556|stage IV adult Burkitt lymphoma|stage iv adult burkitt lymphoma
680081|NCT00712556|stage IV adult diffuse large cell lymphoma|stage iv adult diffuse large cell lymphoma
680082|NCT00712556|stage IV adult diffuse mixed cell lymphoma|stage iv adult diffuse mixed cell lymphoma
680083|NCT00712556|stage IV adult diffuse small cleaved cell lymphoma|stage iv adult diffuse small cleaved cell lymphoma
680084|NCT00712556|stage IV adult immunoblastic large cell lymphoma|stage iv adult immunoblastic large cell lymphoma
680085|NCT00712556|stage IV adult lymphoblastic lymphoma|stage iv adult lymphoblastic lymphoma
680086|NCT00712556|stage IV grade 1 follicular lymphoma|stage iv grade 1 follicular lymphoma
680087|NCT00712556|stage IV grade 2 follicular lymphoma|stage iv grade 2 follicular lymphoma
680088|NCT00712556|stage IV grade 3 follicular lymphoma|stage iv grade 3 follicular lymphoma
680089|NCT00712556|stage IV mantle cell lymphoma|stage iv mantle cell lymphoma
680090|NCT00712556|stage IV marginal zone lymphoma|stage iv marginal zone lymphoma
680091|NCT00712556|stage IV small lymphocytic lymphoma|stage iv small lymphocytic lymphoma
680092|NCT00712556|recurrent adult Burkitt lymphoma|recurrent adult burkitt lymphoma
680093|NCT00712556|recurrent adult diffuse large cell lymphoma|recurrent adult diffuse large cell lymphoma
680094|NCT00712556|recurrent adult diffuse mixed cell lymphoma|recurrent adult diffuse mixed cell lymphoma
680095|NCT00712556|recurrent adult diffuse small cleaved cell lymphoma|recurrent adult diffuse small cleaved cell lymphoma
680096|NCT00712556|recurrent adult immunoblastic large cell lymphoma|recurrent adult immunoblastic large cell lymphoma
680097|NCT00712556|recurrent adult lymphoblastic lymphoma|recurrent adult lymphoblastic lymphoma
680098|NCT00712556|recurrent childhood large cell lymphoma|recurrent childhood large cell lymphoma
680099|NCT00712556|recurrent childhood lymphoblastic lymphoma|recurrent childhood lymphoblastic lymphoma
680100|NCT00712556|recurrent childhood small noncleaved cell lymphoma|recurrent childhood small noncleaved cell lymphoma
680101|NCT00712556|recurrent cutaneous T-cell non-Hodgkin lymphoma|recurrent cutaneous t-cell non-hodgkin lymphoma
680102|NCT00712556|recurrent grade 1 follicular lymphoma|recurrent grade 1 follicular lymphoma
680103|NCT00712556|recurrent grade 2 follicular lymphoma|recurrent grade 2 follicular lymphoma
680104|NCT00712556|recurrent grade 3 follicular lymphoma|recurrent grade 3 follicular lymphoma
680105|NCT00712556|recurrent mantle cell lymphoma|recurrent mantle cell lymphoma
680106|NCT00712556|recurrent marginal zone lymphoma|recurrent marginal zone lymphoma
680107|NCT00712556|recurrent small lymphocytic lymphoma|recurrent small lymphocytic lymphoma
680108|NCT00712556|recurrent mycosis fungoides/Sezary syndrome|recurrent mycosis fungoides/sezary syndrome
680109|NCT00712556|nodal marginal zone B-cell lymphoma|nodal marginal zone b-cell lymphoma
680110|NCT00712556|splenic marginal zone lymphoma|splenic marginal zone lymphoma
680111|NCT00712556|NC stage II adult immunoblastic large cell lymphoma|nc stage ii adult immunoblastic large cell lymphoma
680112|NCT00712556|NC stage II adult lymphoblastic lymphoma|nc stage ii adult lymphoblastic lymphoma
680113|NCT00712556|NC stage II grade 1 follicular lymphoma|nc stage ii grade 1 follicular lymphoma
680114|NCT00712556|NC stage II grade 2 follicular lymphoma|nc stage ii grade 2 follicular lymphoma
680115|NCT00712556|NC stage II grade 3 follicular lymphoma|nc stage ii grade 3 follicular lymphoma
680116|NCT00712556|NC stage II mantle cell lymphoma|nc stage ii mantle cell lymphoma
680117|NCT00712556|NC stage II marginal zone lymphoma|nc stage ii marginal zone lymphoma
680118|NCT00712556|NC stage II small lymphocytic lymphoma|nc stage ii small lymphocytic lymphoma
680119|NCT00712543|constipation|constipation
680120|NCT00712543|laxative|laxative
680121|NCT00712543|lactulose|lactulose
680122|NCT00712543|Kristalose®|kristalose®
680124|NCT00712530|Vaccine|vaccine
680125|NCT00712530|Immune Therapy|immune therapy
680126|NCT00712530|DermaVir|dermavir
680127|NCT00712517|postoperative pain|postoperative pain
680128|NCT00712517|Piritramid|piritramid
680129|NCT00712517|propofol|propofol
680130|NCT00712517|sevoflurane|sevoflurane
680131|NCT00712517|varicose vein|varicose vein
680132|NCT00712517|Anesthesia|anesthesia
710280|NCT00589563|contiguous stage II grade 1 follicular lymphoma|contiguous stage ii grade 1 follicular lymphoma
680133|NCT00712504|advanced solid tumors, non small cell lung cancer, pulmonary neoplasms, sunitinib (SUTENT), docetaxel (Taxotere), Angiogenesis Inhibitors|advanced solid tumors, non small cell lung cancer, pulmonary neoplasms, sunitinib (sutent), docetaxel (taxotere), angiogenesis inhibitors
680134|NCT00712491|wet AMD|wet amd
680135|NCT00712491|CNV|cnv
680136|NCT00712465|Atrial fibrillation|atrial fibrillation
680137|NCT00712465|interaction|interaction
680138|NCT00712465|pharmacokinetic|pharmacokinetic
680139|NCT00712452|fertility|fertility
680140|NCT00712452|chemotherapy|chemotherapy
680141|NCT00712439|DPN,|dpn,
680142|NCT00712439|Diabetic|diabetic
680143|NCT00712439|Peripheral|peripheral
680144|NCT00712439|Neuropathy|neuropathy
680145|NCT00712439|Painful|painful
680146|NCT00712426|Huntington's disease|huntington's disease
680147|NCT00712426|Creatine|creatine
680148|NCT00712426|Mitochondrial Dysfunction|mitochondrial dysfunction
680149|NCT00712426|Total Functional Capacity|total functional capacity
680150|NCT00712426|UHDRS|uhdrs
680151|NCT00712413|Helicobacter pylori infection|helicobacter pylori infection
680152|NCT00712413|Quadruple therapy|quadruple therapy
680153|NCT00712413|Safety|safety
680154|NCT00712413|Efficacy|efficacy
680155|NCT00712413|Tolerability|tolerability
680156|NCT00712413|BID dosing|bid dosing
680157|NCT00712400|Latanoprost|latanoprost
680158|NCT00712400|Choroidal Blood Flow|choroidal blood flow
680159|NCT00712400|Intraocular Pressure|intraocular pressure
680160|NCT00712374|Malaria|malaria
680161|NCT00712374|All causes mortality|all causes mortality
680162|NCT00712374|Cost effectiveness|cost effectiveness
680163|NCT00712361|Invasive|invasive
680164|NCT00712361|Non-Invasive|non-invasive
680165|NCT00712361|Peripheral blood parameters|peripheral blood parameters
680166|NCT00712361|Finger mounted device|finger mounted device
680167|NCT00712361|Blood tissue|blood tissue
680168|NCT00712361|Tissue color distribution|tissue color distribution
680169|NCT00712361|Accuracy|accuracy
680170|NCT00712361|Tissue pigmentation|tissue pigmentation
680171|NCT00712361|pH|ph
680172|NCT00712361|Hemoglobin|hemoglobin
680173|NCT00712361|Hematocrit|hematocrit
680174|NCT00712361|SpO2|spo2
680175|NCT00712361|Blood pressure|blood pressure
680176|NCT00712361|Pulse|pulse
680177|NCT00712361|CO2|co2
680178|NCT00712348|Gaucher disease|gaucher disease
680179|NCT00712348|imiglucerase|imiglucerase
680180|NCT00712348|glucocerebrosidase|glucocerebrosidase
680181|NCT00712348|enzyme replacement therapy|enzyme replacement therapy
680182|NCT00712348|lysosomal storage disorder|lysosomal storage disorder
680183|NCT00712335|asthmatics|asthmatics
680184|NCT00712335|smokers|smokers
680185|NCT00712335|inhaled corticosteroids|inhaled corticosteroids
680186|NCT00712335|leukotriene receptor antagonists|leukotriene receptor antagonists
680187|NCT00712322|Pediatric, Children, Urodynamics, Oral Suspension, Overactive bladder, Dose-finding, Neurogenic Detrusor Overactivity, Meningomyelocele, Spinal cord injury|pediatric, children, urodynamics, oral suspension, overactive bladder, dose-finding, neurogenic detrusor overactivity, meningomyelocele, spinal cord injury
680188|NCT00712309|atherosclerotic|atherosclerotic
680189|NCT00712309|lesions|lesions
680190|NCT00712296|Asthma|asthma
680191|NCT00712296|alternative medicine|alternative medicine
680192|NCT00712296|complementary medicine|complementary medicine
680193|NCT00712296|herbal therapy|herbal therapy
680293|NCT00711997|BC-819|bc-819
680194|NCT00712283|fitness to drive|fitness to drive
680195|NCT00712283|operate machines|operate machines
680196|NCT00712283|To determine the fitness to drive and operate machines.|to determine the fitness to drive and operate machines.
680197|NCT00712270|Schizophrenia|schizophrenia
680198|NCT00712270|Antipsychotic drug treatment response|antipsychotic drug treatment response
680199|NCT00712270|Risperidone|risperidone
680200|NCT00712270|Aripiprazole|aripiprazole
680201|NCT00712270|Fallypride|fallypride
680202|NCT00712270|Positron emission tomography|positron emission tomography
680203|NCT00712270|Magnetic Resonance Imaging|magnetic resonance imaging
680204|NCT00712270|Dopamine D2 Receptors|dopamine d2 receptors
680205|NCT00712257|treatment of superficial femoral artery instent restenosis|treatment of superficial femoral artery instent restenosis
680206|NCT00712244|Discovisc|discovisc
680207|NCT00712244|Ophthalmic Viscosurgical Device|ophthalmic viscosurgical device
680208|NCT00712231|pseudophakic|pseudophakic
680209|NCT00712231|anterior chamber depth|anterior chamber depth
680210|NCT00712231|Pentacam|pentacam
680211|NCT00712218|Ovarian cancer, FIGO stage IIB-IV|ovarian cancer, figo stage iib-iv
680212|NCT00712205|Asthma|asthma
680213|NCT00712205|Vitamin D|vitamin d
680214|NCT00712192|coronary artery bypass grafting|coronary artery bypass grafting
680215|NCT00712192|endoscopic vein harvest|endoscopic vein harvest
680216|NCT00712192|saphenous vein|saphenous vein
680217|NCT00712192|endothelial cells|endothelial cells
680218|NCT00712192|eNOS|enos
680219|NCT00712192|ET-1|et-1
680220|NCT00712179|Stroke|stroke
680221|NCT00712179|walking|walking
680222|NCT00712179|Treadmill|treadmill
680223|NCT00712179|body weight support system|body weight support system
680224|NCT00712166|cystic fibrosis|cystic fibrosis
680225|NCT00712166|pseudomonas aeruginosa|pseudomonas aeruginosa
862596|NCT00059202|PSC|psc
680226|NCT00712166|lung infection|lung infection
680227|NCT00712166|CFQ-R|cfq-r
680228|NCT00712166|inhaled antibiotic|inhaled antibiotic
680229|NCT00712166|aztreonam lysine|aztreonam lysine
680230|NCT00712153|multislice computed tomography|multislice computed tomography
680231|NCT00712153|coronary artery bypass grafting|coronary artery bypass grafting
680232|NCT00712153|Patients|patients
680233|NCT00712153|underwent|underwent
680234|NCT00712153|surgeries|surgeries
680235|NCT00712140|stage IA breast cancer|stage ia breast cancer
680236|NCT00712140|stage IB breast cancer|stage ib breast cancer
680237|NCT00712140|stage II breast cancer|stage ii breast cancer
680238|NCT00712140|stage IIIA breast cancer|stage iiia breast cancer
680239|NCT00712140|HER2-positive breast cancer|her2-positive breast cancer
680240|NCT00712127|Body Fat|body fat
680241|NCT00712127|Exercise|exercise
680242|NCT00712127|Metabolic syndrome|metabolic syndrome
680243|NCT00712127|Obesity|obesity
680244|NCT00712127|Nutrition|nutrition
680245|NCT00712127|Physical Activity|physical activity
680246|NCT00712127|Weight Loss|weight loss
680247|NCT00712114|phase I|phase i
680248|NCT00712114|safety|safety
680249|NCT00712114|tolerance|tolerance
680250|NCT00712114|rheumatoid arthritis|rheumatoid arthritis
680251|NCT00712114|pharmacokinetics|pharmacokinetics
680252|NCT00712114|methotrexate|methotrexate
680253|NCT00712114|anti-inflammatory|anti-inflammatory
680254|NCT00712101|infarction|infarction
680255|NCT00712101|intervention|intervention
680256|NCT00712101|stent|stent
680257|NCT00712101|abciximab|abciximab
680258|NCT00712101|platelets|platelets
680260|NCT00712088|Unsafe Sex|unsafe sex
680261|NCT00712088|High Risk Sex|high risk sex
680262|NCT00712088|HIV Prevention|hiv prevention
680263|NCT00712088|African-American|african-american
680264|NCT00712088|gay|gay
680265|NCT00712088|bisexual|bisexual
680266|NCT00712088|intervention trial|intervention trial
680267|NCT00712075|Cognitive Behavioral Therapy|cognitive behavioral therapy
680268|NCT00712075|Social Skills Training|social skills training
680269|NCT00712075|Experience Sampling Method|experience sampling method
680270|NCT00712075|Computer-assisted therapy|computer-assisted therapy
680271|NCT00712075|schizophrenia|schizophrenia
680272|NCT00712062|PCNSL|pcnsl
680273|NCT00712062|Pemetrexed|pemetrexed
680274|NCT00712062|Alimta|alimta
680275|NCT00712062|Recurrent|recurrent
680276|NCT00712062|Progressive|progressive
680277|NCT00712049|intima-media-thickness|intima-media-thickness
680278|NCT00712049|dyslipidemia|dyslipidemia
680279|NCT00712049|progression of atherosclerosis|progression of atherosclerosis
680280|NCT00712049|peripheral artery disease|peripheral artery disease
680281|NCT00712049|major cardiovascular events|major cardiovascular events
680282|NCT00712036|Heroin dependence|heroin dependence
680283|NCT00712036|Interim Methadone Treatment|interim methadone treatment
680284|NCT00712036|Counseling|counseling
680285|NCT00712023|Hypothermia|hypothermia
680286|NCT00712023|Vascular surgery|vascular surgery
680287|NCT00712023|Forced-air warming mattress|forced-air warming mattress
680288|NCT00712023|Circulating-water mattress|circulating-water mattress
680289|NCT00712010|Glucose|glucose
680290|NCT00712010|Insulin|insulin
680291|NCT00711997|H19 gene, plasmid, diphtheria toxin, pancreatic cancer|h19 gene, plasmid, diphtheria toxin, pancreatic cancer
680292|NCT00711997|inodiftagene vixteplasmid|inodiftagene vixteplasmid
680294|NCT00711984|renal artery stenosis|renal artery stenosis
680295|NCT00711984|stent|stent
680296|NCT00711984|comparison of treatments|comparison of treatments
680297|NCT00711984|progression|progression
680298|NCT00711984|atherosclerosis|atherosclerosis
680299|NCT00711984|peripheral artery disease|peripheral artery disease
680300|NCT00711984|major cardiovascular events|major cardiovascular events
680301|NCT00711958|Chemotherapy associated anemia in cancer patients|chemotherapy associated anemia in cancer patients
680302|NCT00711945|Crohn's disease|crohn's disease
680303|NCT00711945|Relapse|relapse
680304|NCT00711945|outcomes|outcomes
680305|NCT00711945|growth|growth
680306|NCT00711932|Ovarian Cancer|ovarian cancer
680307|NCT00711932|TRA-8|tra-8
680308|NCT00711932|Monoclonal Antibody|monoclonal antibody
680309|NCT00711932|Tissue Slice Technology|tissue slice technology
680310|NCT00711906|Malaria|malaria
680311|NCT00711906|Pregnancy|pregnancy
680312|NCT00711906|HIV|hiv
680313|NCT00711906|Intermittent Preventive Treatment|intermittent preventive treatment
680314|NCT00711906|Safety|safety
680315|NCT00711906|Efficacy|efficacy
680316|NCT00711880|Pain|pain
680317|NCT00711880|Peripheral Neuropathy|peripheral neuropathy
680318|NCT00711854|Staphylococcal infection|staphylococcal infection
680319|NCT00711841|HELLP syndrome|hellp syndrome
680320|NCT00711841|dexamethasone|dexamethasone
680321|NCT00711841|postpartum period|postpartum period
680322|NCT00711841|class I HELLP syndrome|class i hellp syndrome
680323|NCT00711815|Women of the state of Alabama|women of the state of alabama
680324|NCT00711815|CIN 1|cin 1
680325|NCT00711815|negative biopsy|negative biopsy
680326|NCT00711815|normal colposcopy|normal colposcopy
680327|NCT00711815|HPV|hpv
680328|NCT00711802|Complicated|complicated
680329|NCT00711802|Skin|skin
680330|NCT00711802|Structure|structure
680331|NCT00711789|Acute renal failure|acute renal failure
680332|NCT00711789|Septic shock|septic shock
680333|NCT00711789|angiotensin II|angiotensin ii
680334|NCT00711789|neutrophil gelatinase associated lipocalin (NGAL)|neutrophil gelatinase associated lipocalin (ngal)
680335|NCT00711789|cystatin C|cystatin c
680336|NCT00711776|Aciclovir cream 5%|aciclovir cream 5%
680337|NCT00711776|Volunteer|volunteer
680338|NCT00711776|Japanese|japanese
680339|NCT00711776|Male|male
680340|NCT00711776|Bioequivalence|bioequivalence
680341|NCT00711763|Preterm Infant|preterm infant
680342|NCT00711763|Parenteral nutrition cycling|parenteral nutrition cycling
680343|NCT00711763|TPN cycling|tpn cycling
680344|NCT00711763|Hypercalcuria|hypercalcuria
680345|NCT00711750|underwent|underwent
680346|NCT00711750|specific|specific
680347|NCT00711750|creation|creation
680348|NCT00711750|hospital|hospital
680349|NCT00711750|November 2003|november 2003
680350|NCT00711750|October 2005|october 2005
680351|NCT00711737|metabolic parameters|metabolic parameters
680352|NCT00711737|escitalopram|escitalopram
680353|NCT00711737|metabolic syndrome|metabolic syndrome
680354|NCT00711737|antidepressant|antidepressant
680355|NCT00711724|Attention Deficit Hyperactivity Disorder (ADHD)|attention deficit hyperactivity disorder (adhd)
680356|NCT00711724|Adolescent|adolescent
680357|NCT00711711|Physical Therapy - Therapeutics - Edema|physical therapy - therapeutics - edema
680358|NCT00711711|Arthroplasty replacement knee|arthroplasty replacement knee
680359|NCT00711711|Treatment outcome|treatment outcome
680360|NCT00711685|Topical vancomycin|topical vancomycin
680361|NCT00711685|mediastinitis|mediastinitis
680362|NCT00711685|coronary|coronary
680363|NCT00711685|artery|artery
680364|NCT00711685|bypass|bypass
680365|NCT00711685|graft|graft
680366|NCT00711685|Patients|patients
680367|NCT00711672|Personal Communication|personal communication
680368|NCT00711672|Doctor Patient Relations|doctor patient relations
680369|NCT00711672|Narrative Medicine|narrative medicine
680370|NCT00711659|Physical exam|physical exam
680371|NCT00711659|Pediatric clerkship|pediatric clerkship
680372|NCT00711659|Medical students|medical students
680373|NCT00711646|Spasticity|spasticity
680374|NCT00711646|Multiple Sclerosis|multiple sclerosis
680375|NCT00711633|Premature birth,|premature birth,
680376|NCT00711633|infant,|infant,
680377|NCT00711633|infant formula,|infant formula,
680378|NCT00711633|bacterial colonization,|bacterial colonization,
680379|NCT00711633|Bifidobacterium,|bifidobacterium,
680380|NCT00711633|calprotectin|calprotectin
680381|NCT00711620|sepsis|sepsis
680382|NCT00711620|Immunotherapy|immunotherapy
680383|NCT00711620|Thymosin|thymosin
680384|NCT00711607|pharmacokinetics (PK)|pharmacokinetics (pk)
680385|NCT00711607|combined oral contraceptive|combined oral contraceptive
680386|NCT00711607|nomegestrol acetate|nomegestrol acetate
680387|NCT00711607|estradiol|estradiol
680388|NCT00711607|NOMAC|nomac
680389|NCT00711607|E2|e2
680390|NCT00711607|NOMAC-E2|nomac-e2
680391|NCT00711607|pharmacokinetics|pharmacokinetics
680392|NCT00711581|Cholecystectomy|cholecystectomy
680393|NCT00711581|Cholecystectomy, Laparoscopic|cholecystectomy, laparoscopic
680394|NCT00711581|Laparoscopy|laparoscopy
680395|NCT00711568|depression|depression
680396|NCT00711568|magnetic stimulation|magnetic stimulation
680397|NCT00711555|nausea|nausea
680398|NCT00711555|vomiting|vomiting
680399|NCT00711555|multiple days|multiple days
680400|NCT00711555|chemotherapy|chemotherapy
680401|NCT00711555|serotonin receptor antagonist|serotonin receptor antagonist
680402|NCT00711555|quality of life|quality of life
680403|NCT00711555|therapy|therapy
680404|NCT00711555|corticosteroids|corticosteroids
680405|NCT00711555|aprepitant|aprepitant
680406|NCT00711555|rescue therapy|rescue therapy
680407|NCT00711542|intracoronary progenitor cell therapy|intracoronary progenitor cell therapy
680408|NCT00711542|NSTEMI|nstemi
680409|NCT00711542|coronary flow reserve|coronary flow reserve
680410|NCT00711542|randomized doubleblind Placebo-controlled trial|randomized doubleblind placebo-controlled trial
680411|NCT00711529|hot flashes|hot flashes
680412|NCT00711529|breast cancer|breast cancer
680413|NCT00711529|Hypnotherapy|hypnotherapy
680414|NCT00711529|Quality of Life|quality of life
680415|NCT00711529|Gabapentin|gabapentin
680416|NCT00711503|endogenous insulin production|endogenous insulin production
680417|NCT00711503|C-peptide level|c-peptide level
680418|NCT00711503|insulin requirement|insulin requirement
680419|NCT00711490|Diabetic Macular Edema|diabetic macular edema
680420|NCT00711490|Diabetic Retinopathy|diabetic retinopathy
680421|NCT00711490|Rapamycin|rapamycin
680422|NCT00711490|Sirolimus|sirolimus
680423|NCT00711490|Diabetes|diabetes
680424|NCT00711477|obesity|obesity
680425|NCT00711477|overweight|overweight
680426|NCT00711477|magnetic resonance imaging|magnetic resonance imaging
680427|NCT00711477|naltrexone|naltrexone
680428|NCT00711477|bupropion|bupropion
680429|NCT00711464|cognition, pharmacology, memory, attention|cognition, pharmacology, memory, attention
680430|NCT00711451|systemic vascular resistance|systemic vascular resistance
680431|NCT00711451|pregnancy|pregnancy
680432|NCT00711451|scheduled cesarean delivery|scheduled cesarean delivery
680433|NCT00711451|syncytiotrophoblast apoptosis|syncytiotrophoblast apoptosis
680434|NCT00711451|continuous wave Doppler|continuous wave doppler
680435|NCT00711438|Breathlessness|breathlessness
680436|NCT00711438|Dyspnoea|dyspnoea
680437|NCT00711438|Dyspnea|dyspnea
680438|NCT00711438|Palliative care|palliative care
680440|NCT00711438|Randomised controlled trial|randomised controlled trial
680441|NCT00711438|COPD|copd
680442|NCT00711438|Chronic respiratory disease|chronic respiratory disease
680443|NCT00711425|Jaw, Edentulous, Partially (posterior mandible)|jaw, edentulous, partially (posterior mandible)
680444|NCT00711412|adenocarcinoma of the esophagus|adenocarcinoma of the esophagus
680445|NCT00711412|stage I esophageal cancer|stage i esophageal cancer
680446|NCT00711412|stage II esophageal cancer|stage ii esophageal cancer
680447|NCT00711412|stage III esophageal cancer|stage iii esophageal cancer
680448|NCT00711412|stage IV esophageal cancer|stage iv esophageal cancer
680449|NCT00711399|Respiratory sounds|respiratory sounds
680450|NCT00711399|Wheeze|wheeze
680451|NCT00711399|Cough|cough
680452|NCT00711386|pharmacokinetics|pharmacokinetics
680453|NCT00711386|CCR5|ccr5
680454|NCT00711386|Healthy volunteers|healthy volunteers
680455|NCT00711386|GSK706769|gsk706769
680456|NCT00711373|VCA|vca
680457|NCT00711373|composite tissue allotransplantation|composite tissue allotransplantation
680458|NCT00711373|amputation|amputation
680459|NCT00711373|Hand|hand
680460|NCT00711360|heart failure|heart failure
680461|NCT00711360|implantable cardioverter-defibrillator|implantable cardioverter-defibrillator
680462|NCT00711360|intrathoracic impedance|intrathoracic impedance
680463|NCT00711360|cardiac resynchronization therapy|cardiac resynchronization therapy
680464|NCT00711360|home monitoring|home monitoring
680465|NCT00711347|Discovisc|discovisc
680466|NCT00711347|Ophthalmic Visco Surgical Device|ophthalmic visco surgical device
680467|NCT00711321|Alzheimer|alzheimer
680468|NCT00711321|Morbus Alzheimer|morbus alzheimer
680469|NCT00711321|Vaccine|vaccine
680470|NCT00711321|Alzheimer Vaccine|alzheimer vaccine
680471|NCT00711321|A-beta immunotherapy|a-beta immunotherapy
680472|NCT00711308|pulmonary embolism|pulmonary embolism
680473|NCT00711308|low molecular weight heparin|low molecular weight heparin
680474|NCT00711308|vitamin K antagonist|vitamin k antagonist
680475|NCT00711308|Longterm|longterm
680476|NCT00711295|Influenza (Pandemic)|influenza (pandemic)
680477|NCT00711282|Replacement of non-restorable single tooth/teeth|replacement of non-restorable single tooth/teeth
680478|NCT00711256|Sunscreen|sunscreen
680479|NCT00711256|Application|application
680480|NCT00711256|Vitamin D|vitamin d
680481|NCT00711256|Sun protection factor|sun protection factor
680482|NCT00711256|Clothing|clothing
680483|NCT00711243|unspecified adult solid tumor, protocol specific|unspecified adult solid tumor, protocol specific
680484|NCT00711243|adenocarcinoma of the stomach|adenocarcinoma of the stomach
680485|NCT00711243|stage III gastric cancer|stage iii gastric cancer
680486|NCT00711243|stage IV gastric cancer|stage iv gastric cancer
680487|NCT00711230|HIV|hiv
680488|NCT00711230|Vaccine|vaccine
680489|NCT00711230|Immune Therapy|immune therapy
680490|NCT00711230|DermaVir|dermavir
680491|NCT00711204|Severe|severe
680492|NCT00711204|Alzheimer's Disease|alzheimer's disease
680585|NCT00710827|NEBIDO,|nebido,
680493|NCT00711191|pancreas cancer; cancer of the pancreas; gemcitabine; chemotherapy; monoclonal antibody; immunotherapy; CD40|pancreas cancer; cancer of the pancreas; gemcitabine; chemotherapy; monoclonal antibody; immunotherapy; cd40
680494|NCT00711165|Asthma|asthma
680495|NCT00711165|Nitric Oxide|nitric oxide
680496|NCT00711165|Exhaled Breath Condensate|exhaled breath condensate
680497|NCT00711165|Methacholine Challenge|methacholine challenge
680498|NCT00711152|diabetes|diabetes
680499|NCT00711152|protocol-driven structured care|protocol-driven structured care
680500|NCT00711152|web-based|web-based
680501|NCT00711152|joint asia diabetes evaluation|joint asia diabetes evaluation
680502|NCT00711139|Alzheimer|alzheimer
680503|NCT00711139|Morbus Alzheimer|morbus alzheimer
680504|NCT00711139|Alzheimer Vaccine|alzheimer vaccine
680505|NCT00711139|Vaccine|vaccine
680506|NCT00711139|AD|ad
680507|NCT00711139|A-beta immunotherapy|a-beta immunotherapy
680508|NCT00711126|intravenous,|intravenous,
680509|NCT00711126|tolerability|tolerability
680510|NCT00711126|pharmacokinetics,|pharmacokinetics,
680511|NCT00711126|oral,|oral,
680512|NCT00711126|pharmacodynamics,|pharmacodynamics,
680513|NCT00711126|safety,|safety,
680514|NCT00711126|GW642444,|gw642444,
680515|NCT00711126|inhaled,|inhaled,
680516|NCT00711113|Jaw, Edentulous, Partially (posterior maxilla)|jaw, edentulous, partially (posterior maxilla)
680517|NCT00711100|Substitution for cigarettes|substitution for cigarettes
680518|NCT00711100|Oral tobacco products|oral tobacco products
680519|NCT00711087|Spinal Cord Injury|spinal cord injury
680520|NCT00711087|Bladder|bladder
680521|NCT00711087|Botulinum toxin (BOTOX-A|botulinum toxin (botox-a
680522|NCT00711087|Detrusor External Sphincter Dyssynergia|detrusor external sphincter dyssynergia
680523|NCT00711074|pharmacokinetics|pharmacokinetics
680524|NCT00711074|mass balance|mass balance
680525|NCT00711074|radiolabel|radiolabel
680526|NCT00711074|AZD5672|azd5672
680527|NCT00711048|GERD|gerd
680528|NCT00711048|healthy volunteer|healthy volunteer
680529|NCT00711048|esophagus|esophagus
680530|NCT00711048|pain|pain
680531|NCT00711035|CMV|cmv
680532|NCT00711035|Adenovirus|adenovirus
680533|NCT00711035|EBV|ebv
680534|NCT00711035|non-myeloablative transplants|non-myeloablative transplants
680535|NCT00711035|Prior allogeneic hematopoietic stem cell transplant|prior allogeneic hematopoietic stem cell transplant
680536|NCT00711022|Jaw, Edentulous (maxilla, with poor bone quality and quantity)|jaw, edentulous (maxilla, with poor bone quality and quantity)
680537|NCT00711009|Human Immunodeficiency Virus infection|human immunodeficiency virus infection
680538|NCT00710996|AcrySof IQ IOL|acrysof iq iol
680539|NCT00710983|Mortality|mortality
680540|NCT00710983|Morbidity|morbidity
680541|NCT00710983|Growth|growth
680542|NCT00710983|Immunology|immunology
680543|NCT00710970|Urinary Bladder Neoplasms|urinary bladder neoplasms
680544|NCT00710970|Previous Chemotherapy|previous chemotherapy
680545|NCT00710970|Tamoxifen|tamoxifen
680546|NCT00710970|Anti-tumor activity|anti-tumor activity
680547|NCT00710957|Vitamin D|vitamin d
680548|NCT00710957|Physical Function|physical function
680549|NCT00710957|Falls|falls
680550|NCT00710957|Aging|aging
680551|NCT00710957|CHS|chs
680552|NCT00710944|Jaw, Edentulous, Partially (missing/extracted/avulsed teeth in the maxilla within zone 15(4)-25(13))|jaw, edentulous, partially (missing/extracted/avulsed teeth in the maxilla within zone 15(4)-25(13))
680553|NCT00710931|Bilateral Cataract|bilateral cataract
680554|NCT00710931|IOL|iol
680555|NCT00710931|ReSTOR|restor
680556|NCT00710931|Aspheric|aspheric
680557|NCT00710905|Cataract IOL ReSTOR Aspheric|cataract iol restor aspheric
680558|NCT00710905|Bilateral cataract|bilateral cataract
680559|NCT00710892|suicide gene-modified allodepleted donor lymphocytes|suicide gene-modified allodepleted donor lymphocytes
680560|NCT00710892|given to recipients of haploidentical stem cell transplants|given to recipients of haploidentical stem cell transplants
680561|NCT00710892|Stage III|stage iii
680562|NCT00710892|Stage IV|stage iv
680563|NCT00710892|Myelodysplastic syndrome|myelodysplastic syndrome
680564|NCT00710892|AML after first relapse|aml after first relapse
680565|NCT00710892|primary refractory disease|primary refractory disease
680566|NCT00710892|CML|cml
680567|NCT00710892|Hemophagocytic lymphohistiocytosis (HLH)|hemophagocytic lymphohistiocytosis (hlh)
680568|NCT00710892|familial hemophagocytic lymphohistiocytosis (FLH)|familial hemophagocytic lymphohistiocytosis (flh)
680569|NCT00710892|viral-associated hemophagocytic syndrome (VAHS)|viral-associated hemophagocytic syndrome (vahs)
680570|NCT00710892|Severe chronic active Epstein Barr virus infection (SCAEBV)|severe chronic active epstein barr virus infection (scaebv)
680571|NCT00710892|T or NK cell malignancy|t or nk cell malignancy
680572|NCT00710892|X-linked lymphoproliferative disease (XLP)|x-linked lymphoproliferative disease (xlp)
680573|NCT00710879|Efficacy|efficacy
680574|NCT00710866|Influenza Vaccines|influenza vaccines
680575|NCT00710866|Infant|infant
680576|NCT00710866|Dose-Response Relationship, Immunologic|dose-response relationship, immunologic
680577|NCT00710853|Geriatric|geriatric
680578|NCT00710853|Qi gong|qi gong
680579|NCT00710853|Yoga|yoga
680580|NCT00710853|Tai chi|tai chi
680581|NCT00710853|Geriatric Assessment|geriatric assessment
680582|NCT00710840|Knee Replacement|knee replacement
680583|NCT00710840|Knee OA|knee oa
680584|NCT00710840|OA|oa
680586|NCT00710827|Hypogonadism,|hypogonadism,
680587|NCT00710827|Symptomatic late onset,|symptomatic late onset,
680588|NCT00710827|Testosterone deficiency|testosterone deficiency
680589|NCT00710814|Roux-en-Y gastric bypass|roux-en-y gastric bypass
680590|NCT00710814|Leptin|leptin
680591|NCT00710814|Bariatric surgery|bariatric surgery
680592|NCT00710814|Overweight after Roux-en-Y gastric bypass surgery|overweight after roux-en-y gastric bypass surgery
680593|NCT00710801|Hepatitis C Virus|hepatitis c virus
680595|NCT00710801|Liver Transplant|liver transplant
680596|NCT00710801|Cyclosporine|cyclosporine
680597|NCT00710801|Tacrolimus|tacrolimus
680598|NCT00710801|Myfortic|myfortic
680599|NCT00710788|QT interval|qt interval
680600|NCT00710788|QT dispersion|qt dispersion
680601|NCT00710788|arrhythmias|arrhythmias
680603|NCT00710788|TC score|tc score
680604|NCT00710775|Aortic valve stenosis|aortic valve stenosis
680605|NCT00710775|Heart surgery|heart surgery
680606|NCT00710775|Endovascular techniques|endovascular techniques
680607|NCT00710749|Lower urinary tract symptoms leading to lower flow rates|lower urinary tract symptoms leading to lower flow rates
680608|NCT00710697|Bladder Cancer|bladder cancer
680609|NCT00710697|Breast Cancer|breast cancer
680610|NCT00710697|Colorectal Cancer|colorectal cancer
680611|NCT00710697|Gastrointestinal Neoplasm|gastrointestinal neoplasm
680612|NCT00710697|Head and Neck Cancer|head and neck cancer
680613|NCT00710697|Lung Cancer|lung cancer
680614|NCT00710697|Ovarian Cancer|ovarian cancer
680615|NCT00710697|Pancreatic Cancer|pancreatic cancer
680616|NCT00710697|Prostrate Cancer|prostrate cancer
680617|NCT00710684|Alzheimer's disease cognition SB-742457|alzheimer's disease cognition sb-742457
680618|NCT00710671|HIV positive|hiv positive
680619|NCT00710671|YMSM|ymsm
680620|NCT00710671|risk factors|risk factors
680621|NCT00710671|coping|coping
680622|NCT00710671|identity development|identity development
680623|NCT00710671|psychosocial needs|psychosocial needs
680624|NCT00710658|Internet support|internet support
680625|NCT00710658|Tailored information|tailored information
680626|NCT00710658|Self-management|self-management
680627|NCT00710658|Quality of life|quality of life
680628|NCT00710658|Online messaging|online messaging
680629|NCT00710658|Online discussion groups|online discussion groups
680630|NCT00710645|Multiple Sclerosis|multiple sclerosis
680631|NCT00710645|Spasticity|spasticity
680632|NCT00710632|cachexia|cachexia
680633|NCT00710632|lung cancer|lung cancer
680634|NCT00710632|gastrointestinal cancer|gastrointestinal cancer
680635|NCT00710632|unspecified adult solid tumor, protocol specific|unspecified adult solid tumor, protocol specific
680636|NCT00710632|hematopoietic/lymphoid cancer|hematopoietic/lymphoid cancer
680637|NCT00710606|contraceptive ring|contraceptive ring
680638|NCT00710606|obesity|obesity
680639|NCT00710606|pharmacokinetics|pharmacokinetics
680640|NCT00710606|pharmacodynamics|pharmacodynamics
680641|NCT00710606|Pharmacokinetics of the contraceptive ring in obese women.|pharmacokinetics of the contraceptive ring in obese women.
680642|NCT00710593|Highly-active antiretroviral therapy|highly-active antiretroviral therapy
680643|NCT00710593|Human papillomavirus|human papillomavirus
680644|NCT00710593|HPV vaccine|hpv vaccine
680645|NCT00710567|Heart Failure|heart failure
680646|NCT00710567|LVAS|lvas
680647|NCT00710567|LVAD|lvad
680648|NCT00710567|Rotary Pump|rotary pump
680649|NCT00710554|Pain|pain
680650|NCT00710554|Peripheral Neuropathy|peripheral neuropathy
680651|NCT00710554|Allodynia|allodynia
680652|NCT00710541|non invasive ventilation|non invasive ventilation
680653|NCT00710541|COPD|copd
680654|NCT00710541|hypercapnia|hypercapnia
680655|NCT00710541|GOLD stage IV|gold stage iv
680656|NCT00710528|CLL|cll
680657|NCT00710528|NHL|nhl
680658|NCT00710528|AML|aml
680659|NCT00710528|MM|mm
680660|NCT00710528|Phosphatidylinositol 3-kinase|phosphatidylinositol 3-kinase
680661|NCT00710515|Melanoma|melanoma
680662|NCT00710515|Phase I|phase i
680663|NCT00710515|AZD6244|azd6244
680664|NCT00710502|Transvaginal|transvaginal
680665|NCT00710502|NOTES|notes
680666|NCT00710502|Cholecystectomy|cholecystectomy
680667|NCT00710502|Laparoscopic|laparoscopic
680668|NCT00710489|Acne|acne
680669|NCT00710489|Actinic Keratosis|actinic keratosis
680670|NCT00710489|Dysplastic Nevi|dysplastic nevi
680671|NCT00710489|Eczema|eczema
680672|NCT00710489|Psoriasis|psoriasis
680673|NCT00710489|Vitiligo|vitiligo
680674|NCT00710489|Skin Cancer|skin cancer
680675|NCT00710489|Rosacea|rosacea
680676|NCT00710489|Leg or Foot Ulcers|leg or foot ulcers
680677|NCT00710489|Atopic Dermatosis|atopic dermatosis
680678|NCT00710463|COPD|copd
680679|NCT00710463|non invasive ventilation|non invasive ventilation
680680|NCT00710463|pulmonary rehabilitation|pulmonary rehabilitation
680681|NCT00710450|IL13|il13
680682|NCT00710450|leukotriene|leukotriene
680683|NCT00710450|histamine|histamine
680684|NCT00710450|IL4|il4
680685|NCT00710450|Must be allergic asthma or allergic rhinitis|must be allergic asthma or allergic rhinitis
680686|NCT00710437|Dexmedetomidine|dexmedetomidine
680687|NCT00710437|Carotid Endarterectomy|carotid endarterectomy
680688|NCT00710437|Electroencephalogram|electroencephalogram
680689|NCT00710424|Pain|pain
680690|NCT00710424|diabetic neuropathy|diabetic neuropathy
680691|NCT00710411|humans|humans
680692|NCT00710411|patients|patients
680693|NCT00710411|polytrauma|polytrauma
680694|NCT00710411|complement|complement
680695|NCT00710411|inflammation|inflammation
680696|NCT00710411|inflammatory response|inflammatory response
680697|NCT00710411|biomarkers|biomarkers
680698|NCT00710411|cytokines|cytokines
680699|NCT00710411|cell surface markers|cell surface markers
680700|NCT00710411|apoptosis|apoptosis
680701|NCT00710411|NF-kappaB|nf-kappab
680702|NCT00710411|functional polymorphisms|functional polymorphisms
680703|NCT00710411|mesenchymal stem cell|mesenchymal stem cell
680704|NCT00710411|severity of injury|severity of injury
680705|NCT00710411|ISS|iss
680706|NCT00710411|infections|infections
680707|NCT00710411|systemic inflammatory response syndrome|systemic inflammatory response syndrome
680708|NCT00710411|SIRS|sirs
680709|NCT00710411|sepsis|sepsis
680710|NCT00710411|severe sepsis|severe sepsis
680711|NCT00710411|shock|shock
680712|NCT00710411|organ dysfunctions|organ dysfunctions
680713|NCT00710411|SOFA|sofa
680714|NCT00710411|severity of disease|severity of disease
680715|NCT00710411|APACHEII|apacheii
680716|NCT00710411|SAPSII|sapsii
680717|NCT00710411|SPAPS3|spaps3
680718|NCT00710411|length of stay|length of stay
680719|NCT00710411|wound healing|wound healing
680720|NCT00710411|outcome|outcome
680721|NCT00710411|mortality|mortality
680722|NCT00710398|Dairy Products|dairy products
680723|NCT00710398|Dietary Protein|dietary protein
680724|NCT00710398|Body Composition|body composition
680725|NCT00710398|Fat mass loss|fat mass loss
680726|NCT00710398|Lean mass gain|lean mass gain
680727|NCT00710398|Pre-menopausal Women|pre-menopausal women
680728|NCT00710359|Cobalamin deficiency|cobalamin deficiency
680729|NCT00710359|Infant|infant
680730|NCT00710359|Nutrition|nutrition
680731|NCT00710359|Cobalamin supplementation|cobalamin supplementation
680732|NCT00710359|Feeding problems|feeding problems
680733|NCT00710359|Gastrointestinal symptoms|gastrointestinal symptoms
680734|NCT00710346|Leiomyoma|leiomyoma
680735|NCT00710346|Uterus|uterus
680736|NCT00710346|Fibroids|fibroids
680737|NCT00710346|Surgical|surgical
680738|NCT00710320|Children core temperature,|children core temperature,
680739|NCT00710320|Pediatric surgery,|pediatric surgery,
680740|NCT00710320|Anesthesia induction|anesthesia induction
680741|NCT00710294|Refractory Hypertension|refractory hypertension
680742|NCT00710294|High Blood Pressure|high blood pressure
680743|NCT00710294|Uncontrolled Blood Pressure|uncontrolled blood pressure
680744|NCT00710281|Intracranial Aneurysm|intracranial aneurysm
680745|NCT00710281|Subarachnoid arterial aneurysm|subarachnoid arterial aneurysm
680746|NCT00710281|Aneurysm|aneurysm
680747|NCT00710281|Brain Aneurysm|brain aneurysm
680748|NCT00710281|Cerebral Aneurysm|cerebral aneurysm
680749|NCT00710281|Wall Shear Stress(WSS)|wall shear stress(wss)
680750|NCT00710281|Hemodynamic Stress|hemodynamic stress
680751|NCT00710281|Subarachnoid Hemorrhage(SAH)|subarachnoid hemorrhage(sah)
680752|NCT00710268|Bevacizumab|bevacizumab
680753|NCT00710268|Poly(ADP ribose) polymerases|poly(adp ribose) polymerases
680754|NCT00710268|Metastatic Solid Tumours|metastatic solid tumours
680755|NCT00710268|PARP inhibitor|parp inhibitor
680756|NCT00710255|Asthma|asthma
680757|NCT00710255|Exercise induced bronchospasm|exercise induced bronchospasm
680758|NCT00710255|Hyperpnea induced bronchospasm|hyperpnea induced bronchospasm
680759|NCT00710255|leukotrienes|leukotrienes
680760|NCT00710255|adenosine|adenosine
680761|NCT00710255|exhaled breath condensate|exhaled breath condensate
680762|NCT00710242|prolonged labor|prolonged labor
680763|NCT00710229|age related macular degeneration|age related macular degeneration
680764|NCT00710229|Ranibizumab-Lucentis|ranibizumab-lucentis
680765|NCT00710229|Bevacizumab-Avastin|bevacizumab-avastin
680766|NCT00710216|Viral kinetics|viral kinetics
680767|NCT00710216|Viral dynamics|viral dynamics
680768|NCT00710216|Telbivudine|telbivudine
680769|NCT00710216|Lamivudine|lamivudine
680770|NCT00710203|Dermatosis Papulosa Nigra|dermatosis papulosa nigra
680771|NCT00710203|seborrheic keratoses|seborrheic keratoses
680772|NCT00710190|Drug Resistant Hypertension|drug resistant hypertension
680773|NCT00710190|Refractory Hypertension|refractory hypertension
680774|NCT00710190|High Blood Pressure|high blood pressure
680775|NCT00710190|Baroreflex Hypertension Therapy|baroreflex hypertension therapy
680776|NCT00710177|PPHN|pphn
680777|NCT00710177|PTGS1|ptgs1
680778|NCT00710177|NSAID|nsaid
680779|NCT00710151|neurotoxicity|neurotoxicity
680780|NCT00710151|cognition in survivors|cognition in survivors
680781|NCT00710151|diagnostic imaging|diagnostic imaging
680782|NCT00710138|Cobalamin deficiency|cobalamin deficiency
680783|NCT00710138|Infant|infant
680784|NCT00710138|Nutrition|nutrition
680785|NCT00710138|Cobalamin supplementation|cobalamin supplementation
680786|NCT00710138|Neurodevelopment|neurodevelopment
680787|NCT00710138|Neurological symptoms|neurological symptoms
680788|NCT00710112|CLD|cld
680993|NCT00709371|zonisamide|zonisamide
680789|NCT00710112|VLBW infants|vlbw infants
680790|NCT00710112|Toll like Receptors|toll like receptors
680791|NCT00710112|Biomarkers|biomarkers
680792|NCT00710099|iontophoresis|iontophoresis
680793|NCT00710099|cutaneous microcirculation|cutaneous microcirculation
680794|NCT00710099|sildenafil|sildenafil
680795|NCT00710099|Healthy volunteers|healthy volunteers
680796|NCT00710086|Remifentanil|remifentanil
680797|NCT00710086|Patient-controlled analgesia|patient-controlled analgesia
680798|NCT00710086|Intravenous analgesia|intravenous analgesia
680799|NCT00710073|Chronic pelvic pain syndrome|chronic pelvic pain syndrome
680800|NCT00710073|Neuromodulation|neuromodulation
680801|NCT00710060|HIV|hiv
680802|NCT00710060|Popular Opinion Leader|popular opinion leader
680803|NCT00710060|POL|pol
680804|NCT00710060|Behavioral Intervention|behavioral intervention
680805|NCT00710060|STD|std
680806|NCT00710060|STI|sti
680807|NCT00710060|Community|community
680808|NCT00710060|Prevention|prevention
680809|NCT00710060|International|international
680810|NCT00710060|Global|global
680811|NCT00710047|ZD4054|zd4054
680812|NCT00710047|Zibotentan|zibotentan
680813|NCT00710047|Healthy Volunteers|healthy volunteers
680814|NCT00710034|Oral Tobacco Products|oral tobacco products
680815|NCT00710034|Snus|snus
680816|NCT00710034|Smoking Substitution|smoking substitution
680817|NCT00710034|Harm Reduction|harm reduction
680818|NCT00710034|Biomarkers of Tobacco Exposure|biomarkers of tobacco exposure
680819|NCT00710021|Systemic lupus erythematosus|systemic lupus erythematosus
680820|NCT00710021|SLE|sle
680821|NCT00710021|Vitamin D3|vitamin d3
680822|NCT00710021|Vitamin D deficiency|vitamin d deficiency
863162|NCT00057707|HV|hv
680823|NCT00710021|IFN alpha expression|ifn alpha expression
680824|NCT00710008|type 2 diabetes,|type 2 diabetes,
680825|NCT00710008|exercise training,|exercise training,
680826|NCT00710008|ATP-synthesis,|atp-synthesis,
680827|NCT00710008|intramyocellular lipids,|intramyocellular lipids,
680828|NCT00710008|hepatocellular lipids|hepatocellular lipids
680829|NCT00710008|first degree relatives of|first degree relatives of
680830|NCT00710008|patients|patients
680831|NCT00709982|Norgestimate|norgestimate
680832|NCT00709982|Contraceptives, Oral|contraceptives, oral
680833|NCT00709982|Ortho-Cyclen|ortho-cyclen
680834|NCT00709982|Folic Acid|folic acid
680835|NCT00709982|Ethinyl Estradiol|ethinyl estradiol
680836|NCT00709969|Malaria|malaria
680837|NCT00709969|co-artemether|co-artemether
680838|NCT00709969|auditory|auditory
680839|NCT00709969|Plasmodium falciparum|plasmodium falciparum
680840|NCT00709969|marsh fever|marsh fever
680841|NCT00709969|remittent fever|remittent fever
680842|NCT00709969|artemether|artemether
680843|NCT00709969|artemisinins|artemisinins
680844|NCT00709969|lumefantrine|lumefantrine
680845|NCT00709969|child|child
680846|NCT00709969|infant|infant
680847|NCT00709969|Africa|africa
680848|NCT00709956|Ventavis|ventavis
680849|NCT00709956|iloprost|iloprost
680850|NCT00709956|inhaled treatment|inhaled treatment
680851|NCT00709956|pulmonary arterial hypertension|pulmonary arterial hypertension
680852|NCT00709904|venous thromboprophylaxis|venous thromboprophylaxis
680853|NCT00709904|primary prevention|primary prevention
680854|NCT00709904|orthopedic surgery|orthopedic surgery
680855|NCT00709878|skin rash, lapatinib, cetuximab, erlotinib, panitumumab|skin rash, lapatinib, cetuximab, erlotinib, panitumumab
680856|NCT00709865|renal insufficiency|renal insufficiency
680857|NCT00709865|diuretic|diuretic
680858|NCT00709865|congestive heart failure|congestive heart failure
680859|NCT00709865|acute decompensated heart failure|acute decompensated heart failure
680860|NCT00709852|Patients referred for a contrast-enhanced MRI of the CNS|patients referred for a contrast-enhanced mri of the cns
680861|NCT00709852|CNS Imaging|cns imaging
680862|NCT00709839|glucocorticoid|glucocorticoid
680863|NCT00709839|hydrocortisone|hydrocortisone
680864|NCT00709839|carbohydrate metabolism|carbohydrate metabolism
680865|NCT00709839|appetite-regulatory hormones|appetite-regulatory hormones
680866|NCT00709813|Symptom management|symptom management
680867|NCT00709813|Cancer|cancer
680868|NCT00709813|Patient-centered care|patient-centered care
680869|NCT00709800|Pandemic Influenza|pandemic influenza
680870|NCT00709800|Avian Influenza|avian influenza
680871|NCT00709800|DNA Vaccines|dna vaccines
680872|NCT00709800|Antibody|antibody
680873|NCT00709800|T Cells|t cells
680874|NCT00709800|HA/NP/M2|ha/np/m2
680875|NCT00709787|Epidemiology, hypertension, risk factors, coronary heart disease, patient management, compliance with medication|epidemiology, hypertension, risk factors, coronary heart disease, patient management, compliance with medication
680876|NCT00709761|Erbb2|erbb2
680877|NCT00709761|ABRAXANE|abraxane
680878|NCT00709761|MBC|mbc
680879|NCT00709761|first or second line therapy|first or second line therapy
680880|NCT00709761|Metastatic Breast Cancer|metastatic breast cancer
680881|NCT00709761|TYKERB|tykerb
680882|NCT00709748|Transcutaneous electrical nerve stimulation|transcutaneous electrical nerve stimulation
680883|NCT00709748|TENS|tens
680884|NCT00709748|Empi|empi
680885|NCT00709748|Electrotherapy|electrotherapy
680886|NCT00709748|Back pain|back pain
680887|NCT00709748|Lower back pain|lower back pain
680888|NCT00709748|Chronic lower back pain|chronic lower back pain
680889|NCT00709735|stress disorders|stress disorders
680890|NCT00709735|post-traumatic|post-traumatic
680891|NCT00709735|memory|memory
680892|NCT00709735|propranolol|propranolol
680893|NCT00709735|psychophysiology|psychophysiology
680894|NCT00709722|Lupus nephritis|lupus nephritis
680895|NCT00709722|Deoxyspergualin|deoxyspergualin
680896|NCT00709722|Immunosuppression|immunosuppression
680897|NCT00709709|stenosis|stenosis
680898|NCT00709709|coronaropathy|coronaropathy
680899|NCT00709709|stent|stent
680900|NCT00709709|bypass surgery|bypass surgery
680901|NCT00709709|suspect|suspect
680902|NCT00709709|known|known
680903|NCT00709696|Tobacco|tobacco
680904|NCT00709696|nicotine|nicotine
680905|NCT00709696|smoking|smoking
680906|NCT00709696|varenicline|varenicline
680907|NCT00709696|human laboratory study|human laboratory study
680908|NCT00709696|stress tolerance|stress tolerance
680909|NCT00709696|startle response|startle response
680910|NCT00709696|cognitive assessment|cognitive assessment
680911|NCT00709696|progressive ratio|progressive ratio
680912|NCT00709670|MSCT|msct
680913|NCT00709670|Echocardiography|echocardiography
680914|NCT00709670|Coronarography|coronarography
680915|NCT00709670|Acute coronary syndrome without ST segment elevation|acute coronary syndrome without st segment elevation
680916|NCT00709670|normal ECG|normal ecg
680917|NCT00709670|normal troponin|normal troponin
680918|NCT00709670|Acute|acute
680919|NCT00709657|Age-related macular degeneration|age-related macular degeneration
680920|NCT00709657|anti-VEGF|anti-vegf
680921|NCT00709644|Ortho Tri-Cyclen Lo|ortho tri-cyclen lo
680922|NCT00709644|Contraceptives, Oral|contraceptives, oral
680923|NCT00709644|Norgestimate|norgestimate
680924|NCT00709644|Ethinyl Estradiol|ethinyl estradiol
680925|NCT00709644|Folic Acid|folic acid
680926|NCT00709644|Female Contraception|female contraception
680927|NCT00709631|Malignant transformation of leg ulcer|malignant transformation of leg ulcer
680928|NCT00709631|MARJOLIN's ulcer|marjolin's ulcer
680929|NCT00709631|Biopsy|biopsy
680930|NCT00709631|Leg ulcer|leg ulcer
680931|NCT00709631|Chronic wound|chronic wound
680932|NCT00709631|Squamous cell carcinoma|squamous cell carcinoma
680933|NCT00709631|Basal cell carcinoma|basal cell carcinoma
680934|NCT00709618|Erbb2|erbb2
680935|NCT00709618|MBC|mbc
680936|NCT00709618|First or Second line therapy|first or second line therapy
680937|NCT00709618|Metastatic Breast Cancer|metastatic breast cancer
680938|NCT00709618|Vinorelbine|vinorelbine
680939|NCT00709618|Tykerb|tykerb
680940|NCT00709605|HIV Negative|hiv negative
680941|NCT00709605|Healthy|healthy
680942|NCT00709605|Immunity|immunity
680943|NCT00709605|Preventive|preventive
680944|NCT00709605|Virus|virus
680945|NCT00709605|Healthy Volunteer|healthy volunteer
680946|NCT00709605|HV|hv
680947|NCT00709592|total body irradiation|total body irradiation
680948|NCT00709592|Allogeneic Peripheral Blood Stem Cell Transplantation|allogeneic peripheral blood stem cell transplantation
680949|NCT00709592|thymoglobulin|thymoglobulin
680950|NCT00709579|Patients needing an oral corticotherapy|patients needing an oral corticotherapy
680951|NCT00709579|Patients needing a topical corticotherapy|patients needing a topical corticotherapy
680952|NCT00709579|Corticotherapy|corticotherapy
680953|NCT00709566|Hip|hip
680954|NCT00709566|osteoarthritis|osteoarthritis
680955|NCT00709566|exercise|exercise
680956|NCT00709566|manual therapy|manual therapy
680957|NCT00709553|ZD4054|zd4054
680958|NCT00709553|Healthy Volunteers|healthy volunteers
680959|NCT00709527|AMD|amd
680960|NCT00709514|Oneness|oneness
680961|NCT00709514|DCB-WH1|dcb-wh1
680962|NCT00709514|DCB-WH1-CP001|dcb-wh1-cp001
680963|NCT00709514|chronic|chronic
680964|NCT00709514|diabetic|diabetic
680965|NCT00709514|foot ulcers|foot ulcers
680966|NCT00709514|topical ointment|topical ointment
680967|NCT00709501|weight loss|weight loss
680968|NCT00709501|obesity|obesity
680969|NCT00709501|overweight|overweight
680970|NCT00709488|Litx™ BPH System|litx™ bph system
680971|NCT00709488|LS11|ls11
680972|NCT00709488|Talaporfin sodium|talaporfin sodium
680973|NCT00709462|Breast cancer|breast cancer
680974|NCT00709462|Colorectal cancer|colorectal cancer
680975|NCT00709462|Pancreatic cancer|pancreatic cancer
680976|NCT00709462|Bladder cancer|bladder cancer
680977|NCT00709462|Ovarian cancer|ovarian cancer
680978|NCT00709462|Metastatic cancer|metastatic cancer
680979|NCT00709462|Locally advanced cancer|locally advanced cancer
680980|NCT00709462|Cancer Vaccine|cancer vaccine
680981|NCT00709462|Vaccine|vaccine
680982|NCT00709449|Age-related macular degeneration|age-related macular degeneration
680983|NCT00709449|Glaucoma|glaucoma
680984|NCT00709436|orthopedic|orthopedic
680985|NCT00709436|ketamine|ketamine
680986|NCT00709436|pain|pain
680987|NCT00709410|Cholera, Diarrhea, Vaccination, Vaccines|cholera, diarrhea, vaccination, vaccines
680988|NCT00709397|HIV-1|hiv-1
680989|NCT00709397|drug resistance|drug resistance
680990|NCT00709397|raltegravir|raltegravir
680991|NCT00709397|integrase inhibitor|integrase inhibitor
680992|NCT00709371|obesity|obesity
680994|NCT00709371|bupropion|bupropion
680995|NCT00709358|bacteria|bacteria
680996|NCT00709358|fungi|fungi
680997|NCT00709358|real time PCR|real time pcr
680998|NCT00709358|adequate antimicrobial therapy|adequate antimicrobial therapy
680999|NCT00709358|microbial DNA|microbial dna
681000|NCT00709358|microbial diagnosis|microbial diagnosis
681001|NCT00709345|Antipsychotic Medications|antipsychotic medications
681002|NCT00709345|Behavioral Interventions|behavioral interventions
681003|NCT00709332|Norgestimate|norgestimate
681004|NCT00709332|Folic Acid|folic acid
681005|NCT00709332|Ortho-Cyclen|ortho-cyclen
681006|NCT00709332|Female contraception|female contraception
681007|NCT00709332|Ethinyl Estradiol|ethinyl estradiol
681008|NCT00709332|Drug Interactions|drug interactions
681009|NCT00709332|Pharmacokinetics|pharmacokinetics
681010|NCT00709332|Contraceptives, Oral|contraceptives, oral
681011|NCT00709319|Diabetic retinopathy|diabetic retinopathy
681012|NCT00709319|Diabetic macular edema|diabetic macular edema
681013|NCT00709319|dme|dme
681014|NCT00709319|vitrectomy|vitrectomy
681015|NCT00709293|Ischemia Reperfusion Injury|ischemia reperfusion injury
681016|NCT00709293|Pediatric Heart Transplant|pediatric heart transplant
681017|NCT00709293|ATG|atg
681018|NCT00709293|Induction Therapy|induction therapy
681019|NCT00709280|Cystic Fibrosis|cystic fibrosis
681020|NCT00709280|hypertonic saline|hypertonic saline
681021|NCT00709280|inhaled saline|inhaled saline
681022|NCT00709267|Folic Acid|folic acid
681023|NCT00709267|Chemistry, Analytical|chemistry, analytical
681024|NCT00709267|Administration, Oral|administration, oral
681025|NCT00709267|Infusions, Intravenous|infusions, intravenous
681026|NCT00709267|Biological Availability|biological availability
681027|NCT00709267|Safety|safety
681028|NCT00709254|AeroLEF|aerolef
681029|NCT00709254|fentanyl|fentanyl
681030|NCT00709254|pharmacokinetics|pharmacokinetics
681031|NCT00709254|liposome|liposome
681032|NCT00709254|encapsulated|encapsulated
681033|NCT00709241|Heart failure|heart failure
681034|NCT00709241|Psychosocial factors|psychosocial factors
681035|NCT00709241|Depression|depression
681036|NCT00709241|Patient compliance|patient compliance
681037|NCT00709215|refractory TdT-positive leukemia|refractory tdt-positive leukemia
681038|NCT00709215|ALL|all
681039|NCT00709215|AML|aml
681040|NCT00709215|blastic CML|blastic cml
681041|NCT00709189|Pharmacokinetics|pharmacokinetics
681042|NCT00709189|Ethinyl Estradiol|ethinyl estradiol
681043|NCT00709189|Drug Interactions|drug interactions
681044|NCT00709189|Norgestimate|norgestimate
681045|NCT00709189|Contraceptives, Oral|contraceptives, oral
681046|NCT00709189|Ortho-Cyclen|ortho-cyclen
681047|NCT00709189|Folic Acid|folic acid
681048|NCT00709176|Quality of Life|quality of life
681049|NCT00709176|Randomized Clinical Trial|randomized clinical trial
681050|NCT00709176|Advanced Cancer|advanced cancer
681051|NCT00709176|Breast Cancer|breast cancer
681052|NCT00709176|Colorectal Cancer|colorectal cancer
681053|NCT00709176|Lung Cancer|lung cancer
681054|NCT00709176|Prostate Cancer|prostate cancer
681055|NCT00709176|Family caregiver|family caregiver
681056|NCT00709176|cancer survivorship|cancer survivorship
681057|NCT00709176|coping|coping
681058|NCT00709176|communication|communication
681059|NCT00709176|uncertainty|uncertainty
681060|NCT00709176|support|support
681061|NCT00709176|depression|depression
681062|NCT00709176|self-efficacy|self-efficacy
681063|NCT00709176|benefits of illness|benefits of illness
681064|NCT00709176|Caregivers|caregivers
681065|NCT00709163|Pediatric|pediatric
681066|NCT00709163|Dilated Cardiomyopathy|dilated cardiomyopathy
681067|NCT00709163|Nesiritide|nesiritide
681068|NCT00709150|Major Depression|major depression
681069|NCT00709150|Diabetes|diabetes
681070|NCT00709150|Hispanics|hispanics
681071|NCT00709150|Collaborative Depression Care Management|collaborative depression care management
681072|NCT00709137|resistant hypertensions|resistant hypertensions
681073|NCT00709137|spironolactone|spironolactone
681074|NCT00709137|amiloride|amiloride
681075|NCT00709137|ambulatory blood pressure monitoring|ambulatory blood pressure monitoring
681076|NCT00709124|Respiration, Artificial|respiration, artificial
681077|NCT00709124|Critical Illness|critical illness
681078|NCT00709124|Intensive Care Units|intensive care units
681079|NCT00709124|Electric Stimulation Therapy|electric stimulation therapy
681080|NCT00709124|Muscle Weakness|muscle weakness
681081|NCT00709124|Paresis|paresis
681082|NCT00709124|Mechanically|mechanically
681083|NCT00709124|Ventilated|ventilated
681084|NCT00709124|Patients|patients
681085|NCT00709124|Admitted|admitted
681086|NCT00709124|Medical|medical
681087|NCT00709111|CCR5 antagonist|ccr5 antagonist
681088|NCT00709111|CD4 T-cell count|cd4 t-cell count
681089|NCT00709111|immune activation|immune activation
681090|NCT00709111|treatment experienced|treatment experienced
681091|NCT00709098|pulmonary arterial hypertension|pulmonary arterial hypertension
681092|NCT00709098|inhaled treatment|inhaled treatment
681093|NCT00709098|inhalation solution|inhalation solution
681094|NCT00709098|iloprost|iloprost
681095|NCT00709098|Ventavis|ventavis
681096|NCT00709085|single nucleotide polymorphism|single nucleotide polymorphism
681097|NCT00709072|stuttering|stuttering
681098|NCT00709072|relapse|relapse
681099|NCT00709072|Lidcombe Program|lidcombe program
681100|NCT00709072|Preschool children|preschool children
681101|NCT00709059|hepatitis C|hepatitis c
681102|NCT00709046|Endoscopic treatment|endoscopic treatment
681103|NCT00709046|Peptic ulcer|peptic ulcer
681104|NCT00709046|Bleeding|bleeding
681105|NCT00709046|Thermocoagulation|thermocoagulation
681106|NCT00709046|Proton pump inhibitors|proton pump inhibitors
681107|NCT00709033|refractory|refractory
681108|NCT00709033|relapsed|relapsed
681109|NCT00709033|low|low
681110|NCT00709033|intermediate-grade|intermediate-grade
681111|NCT00709033|Non-Hodgkin lymphoma|non-hodgkin lymphoma
681112|NCT00709033|Chronic Lymphocytic Leukemia|chronic lymphocytic leukemia
681113|NCT00709020|cancer survivor|cancer survivor
681114|NCT00709020|breast cancer|breast cancer
681115|NCT00708981|Diabetic Nephropathy|diabetic nephropathy
681116|NCT00708968|randomized clinical trial|randomized clinical trial
681117|NCT00708968|coping|coping
681118|NCT00708968|quality of life|quality of life
681119|NCT00708968|family|family
681120|NCT00708968|family caregiver|family caregiver
681121|NCT00708968|cancer survivorship|cancer survivorship
681122|NCT00708968|communication|communication
681123|NCT00708968|uncertainty|uncertainty
681124|NCT00708968|support|support
681125|NCT00708968|family education|family education
681126|NCT00708968|Caregivers|caregivers
681127|NCT00708955|Evaluation and Treatment|evaluation and treatment
681128|NCT00708955|Eye Diseases|eye diseases
681129|NCT00708942|Cervical intraepithelial neoplasia (CIN)|cervical intraepithelial neoplasia (cin)
681130|NCT00708929|Age-related macular degeneration|age-related macular degeneration
681131|NCT00708929|Complement factor H|complement factor h
681132|NCT00708929|Choroidal blood flow|choroidal blood flow
681133|NCT00708916|Cutaneous lupus|cutaneous lupus
681134|NCT00708916|Intervention|intervention
681135|NCT00708916|Discoid lupus|discoid lupus
681136|NCT00708916|Phosphodiesterase 5 inhibitor|phosphodiesterase 5 inhibitor
681137|NCT00708903|Thorough QTc study|thorough qtc study
681138|NCT00708890|Substance use disorders|substance use disorders
681139|NCT00708890|Self-help groups|self-help groups
681140|NCT00708890|Twelve Step groups|twelve step groups
681141|NCT00708877|cancer|cancer
681142|NCT00708877|cholangiocarcinoma|cholangiocarcinoma
681143|NCT00708851|psoriasis|psoriasis
681144|NCT00708812|Non-small Cell Lung Cancer|non-small cell lung cancer
681145|NCT00708812|Endostar|endostar
681146|NCT00708812|Paclitaxel|paclitaxel
681147|NCT00708812|Carboplatin|carboplatin
681148|NCT00708760|web based learning|web based learning
681149|NCT00708760|moderate sedation|moderate sedation
681150|NCT00708747|Immunoglobulins|immunoglobulins
681151|NCT00708747|inhibitor proteins|inhibitor proteins
681152|NCT00708747|human albumin|human albumin
681153|NCT00708747|systemic inflammatory response syndrome|systemic inflammatory response syndrome
681154|NCT00708747|interleukins|interleukins
681155|NCT00708747|standardized serum-protein solution|standardized serum-protein solution
681156|NCT00708734|exercise|exercise
681157|NCT00708721|hypomethylating therapy|hypomethylating therapy
681158|NCT00708721|CML|cml
681159|NCT00708721|myelodysplastic syndromes|myelodysplastic syndromes
681160|NCT00708708|Plaque-type psoriasis|plaque-type psoriasis
681161|NCT00708695|nurse|nurse
681162|NCT00708695|home visits|home visits
681163|NCT00708695|pregnancy|pregnancy
681164|NCT00708695|welfare|welfare
681165|NCT00708695|child development|child development
681166|NCT00708695|Child Rearing|child rearing
681167|NCT00708695|Reproductive Behavior|reproductive behavior
681168|NCT00708695|Risk Reduction Behavior|risk reduction behavior
681169|NCT00708656|IBD|ibd
681170|NCT00708656|Colitis|colitis
681171|NCT00708656|UC|uc
681172|NCT00708630|yellow fever vaccine|yellow fever vaccine
681173|NCT00708630|patient information|patient information
681174|NCT00708630|symptom reports|symptom reports
681175|NCT00708630|patient satisfaction|patient satisfaction
681176|NCT00708617|Liver fibrosis|liver fibrosis
681177|NCT00708617|Alcoholic liver disease|alcoholic liver disease
681178|NCT00708617|Non invasive diagnostic methods|non invasive diagnostic methods
681179|NCT00708617|Transient elastography|transient elastography
681180|NCT00708617|Fibrotest|fibrotest
681181|NCT00708604|Diabetes Mellitus|diabetes mellitus
681182|NCT00708604|Kidney Transplantation|kidney transplantation
681183|NCT00708604|Islet Transplantation|islet transplantation
681184|NCT00708604|Sirolimus/Tacrolimus/MMF-based Immunosuppressive Regimen|sirolimus/tacrolimus/mmf-based immunosuppressive regimen
681185|NCT00708565|To study the effects of iloprost on hypoxic pulmonary vasoconstriction at high altitude|to study the effects of iloprost on hypoxic pulmonary vasoconstriction at high altitude
681186|NCT00708552|Alzheimer's disease|alzheimer's disease
681187|NCT00708552|Cognition|cognition
681188|NCT00708552|SB-742457|sb-742457
681189|NCT00708526|hypercapnia|hypercapnia
681190|NCT00708526|hyperpnoea|hyperpnoea
681191|NCT00708526|accelerated recovery|accelerated recovery
681192|NCT00708513|Cell Saver|cell saver
681193|NCT00708513|Liver Tumors|liver tumors
681194|NCT00708513|Liver Cancer|liver cancer
681195|NCT00708513|Surgical Oncology|surgical oncology
681196|NCT00708513|Whipple|whipple
681197|NCT00708513|Blood Transfusion|blood transfusion
681198|NCT00708513|Blood salvage|blood salvage
681199|NCT00708513|cancer surgery|cancer surgery
681200|NCT00708513|blood loss|blood loss
681201|NCT00708500|Treatment failure|treatment failure
681202|NCT00708487|in vitro fertilization|in vitro fertilization
681203|NCT00708487|oxygen concentration|oxygen concentration
681204|NCT00708487|blastocyst|blastocyst
681205|NCT00708487|live birth|live birth
681206|NCT00708487|embryo|embryo
681207|NCT00708474|Bone graft|bone graft
681208|NCT00708474|Bone void filler|bone void filler
681209|NCT00708474|Bone plug|bone plug
681210|NCT00708474|OsseoFit™|osseofit™
681211|NCT00708474|knee|knee
681212|NCT00708474|bone graft sites in the knee|bone graft sites in the knee
681213|NCT00708461|obesity|obesity
681214|NCT00708461|obesity prevention|obesity prevention
681215|NCT00708461|worksite|worksite
681216|NCT00708461|environment|environment
681217|NCT00708461|intervention|intervention
681218|NCT00708448|NSCLC|nsclc
681219|NCT00708435|Anticoagulant reversal|anticoagulant reversal
681220|NCT00708435|Prothrombin|prothrombin
681221|NCT00708435|Complex|complex
681222|NCT00708435|Concentrate|concentrate
681223|NCT00708435|Coagulopathy|coagulopathy
681224|NCT00708435|induced by|induced by
681225|NCT00708435|coumarin|coumarin
681226|NCT00708435|derivatives|derivatives
681227|NCT00708435|Kcentra|kcentra
681228|NCT00708422|Ocular surface health|ocular surface health
681229|NCT00708422|OSDI|osdi
681230|NCT00708422|TFBUT|tfbut
681231|NCT00708422|Glaucoma|glaucoma
681232|NCT00708422|Ocular hypertension|ocular hypertension
681233|NCT00708422|Corneal staining|corneal staining
681234|NCT00708409|Ross operation|ross operation
681235|NCT00708409|autograft procedure|autograft procedure
681236|NCT00708409|pulmonary homograft|pulmonary homograft
681237|NCT00708409|root replacement technique|root replacement technique
681238|NCT00708409|subcoronary implantation technique|subcoronary implantation technique
681239|NCT00708396|Patients|patients
681240|NCT00708396|suffer|suffer
681241|NCT00708396|from|from
681242|NCT00708383|embryo development|embryo development
681243|NCT00708383|embryo quality|embryo quality
681244|NCT00708383|implantation|implantation
681245|NCT00708383|IVF/ICSI outcome|ivf/icsi outcome
681246|NCT00708383|multiple pregnancy|multiple pregnancy
681247|NCT00708370|Interventional|interventional
681248|NCT00708370|Non-drug|non-drug
681249|NCT00708370|Disease Management Program|disease management program
681250|NCT00708370|Cardiovascular Risk Control|cardiovascular risk control
681251|NCT00708370|Dyslipidemias|dyslipidemias
681252|NCT00708370|Primary Care Centers|primary care centers
681253|NCT00708357|eNOS Gene Polymorphism|enos gene polymorphism
681254|NCT00708357|ocular blood flow|ocular blood flow
681255|NCT00708331|Cataract|cataract
681256|NCT00708331|Extraction|extraction
681257|NCT00708331|Intraocular Lens|intraocular lens
681258|NCT00708331|Hydrophilic Acrylic|hydrophilic acrylic
681259|NCT00708318|AeroLEF|aerolef
681260|NCT00708318|fentanyl|fentanyl
681261|NCT00708318|pharmacokinetic|pharmacokinetic
681262|NCT00708318|liposome|liposome
681263|NCT00708318|encapsulated|encapsulated
681264|NCT00708305|toothpaste|toothpaste
681265|NCT00708305|plaque fluid|plaque fluid
681266|NCT00708305|fluoride|fluoride
681267|NCT00708292|AUY922|auy922
681268|NCT00708292|Multiple Myeloma|multiple myeloma
681269|NCT00708292|HSP90 inhibitors|hsp90 inhibitors
681270|NCT00708292|Phase I/II|phase i/ii
681271|NCT00708279|angina pectoris, osteopathic manipulation|angina pectoris, osteopathic manipulation
681272|NCT00708266|Obesity|obesity
681273|NCT00708266|Diabetes|diabetes
681274|NCT00708266|Non-esterified fatty acids|non-esterified fatty acids
681275|NCT00708266|Cytokines|cytokines
681276|NCT00708266|Inflammation|inflammation
681277|NCT00708266|Subcutaneous fat|subcutaneous fat
681278|NCT00708266|Adipose tissue|adipose tissue
681279|NCT00708253|balloon assisted enteroscopy|balloon assisted enteroscopy
681280|NCT00708253|single balloon enteroscopy|single balloon enteroscopy
681281|NCT00708253|double balloon enteroscopy|double balloon enteroscopy
681282|NCT00708253|insertion depth|insertion depth
681283|NCT00708227|Asthma|asthma
681284|NCT00708227|Pharmacogenetics|pharmacogenetics
681285|NCT00708227|Salmeterol|salmeterol
681286|NCT00708227|African American|african american
681287|NCT00708227|White|white
681288|NCT00708201|ileus|ileus
681289|NCT00708201|POI|poi
681290|NCT00708188|Stroke, ischemic, etiology, TOAST, CT, multidetector|stroke, ischemic, etiology, toast, ct, multidetector
681291|NCT00708175|Glucose Metabolism Disorder|glucose metabolism disorder
681292|NCT00708175|Dysmetabolic Syndrome|dysmetabolic syndrome
681293|NCT00708175|Type II Diabetes|type ii diabetes
681294|NCT00708175|Diabetes Mellitus|diabetes mellitus
681295|NCT00708175|Lipoatrophic|lipoatrophic
681296|NCT00708175|Postmenopausal|postmenopausal
681297|NCT00708162|HIV|hiv
681298|NCT00708162|HIV I|hiv i
681299|NCT00708162|Treatment Experienced|treatment experienced
681300|NCT00708149|lansoprazole, weaning,stress ulcer prophylaxis|lansoprazole, weaning,stress ulcer prophylaxis
681301|NCT00708136|Falls|falls
681302|NCT00708136|elderly|elderly
681303|NCT00708136|Balance|balance
681304|NCT00708136|speed of stepping|speed of stepping
681305|NCT00708136|Stability|stability
681306|NCT00708136|ELDERLY FALLERS|elderly fallers
681307|NCT00708123|remineralization|remineralization
681308|NCT00708123|enamel|enamel
681309|NCT00708123|fluoride|fluoride
681310|NCT00708123|caries|caries
681311|NCT00708123|in situ|in situ
681312|NCT00708110|dose-ranging study|dose-ranging study
681313|NCT00708110|phase IIa|phase iia
681314|NCT00708110|integrase inhibitor|integrase inhibitor
681315|NCT00708110|HIV-1 infection|hiv-1 infection
681316|NCT00708097|fluoride|fluoride
681317|NCT00708097|in situ|in situ
681318|NCT00708097|remineralization|remineralization
681319|NCT00708097|enamel|enamel
681320|NCT00708097|caries|caries
681321|NCT00708084|Rabies post-exposure prophylaxis|rabies post-exposure prophylaxis
681322|NCT00708084|Monoclonal antibody|monoclonal antibody
681323|NCT00708058|Implanted cardiac defibrillators|implanted cardiac defibrillators
681324|NCT00708058|Congestive Heart Failure|congestive heart failure
681325|NCT00708058|Emergency Department|emergency department
681326|NCT00708045|Breast Cancer|breast cancer
681327|NCT00708019|cancer pain|cancer pain
681328|NCT00708019|bone metastasis|bone metastasis
681329|NCT00708019|psychoeducational intervention|psychoeducational intervention
681330|NCT00708019|nurse coaching|nurse coaching
681331|NCT00708019|patient education|patient education
681332|NCT00708019|breast cancer|breast cancer
681333|NCT00707993|Glucose Metabolism Disorder|glucose metabolism disorder
681334|NCT00707993|Dysmetabolic Syndrome|dysmetabolic syndrome
681335|NCT00707993|Type II Diabetes|type ii diabetes
681336|NCT00707993|Diabetes Mellitus|diabetes mellitus
681337|NCT00707993|Lipoatrophic|lipoatrophic
681338|NCT00707993|Dyslipidemia|dyslipidemia
681339|NCT00707993|Drug Therapy|drug therapy
681340|NCT00707980|Major Depressive Disorder|major depressive disorder
681341|NCT00707980|Depression|depression
681342|NCT00707980|Melancholia|melancholia
681343|NCT00707980|Mood Disorder|mood disorder
681344|NCT00707980|Dysthymic Disorder|dysthymic disorder
681345|NCT00707980|Drug Therapy|drug therapy
681346|NCT00707967|Tuberculosis vaccine|tuberculosis vaccine
681347|NCT00707954|Diabetes|diabetes
681348|NCT00707954|TA-7284|ta-7284
681349|NCT00707941|Influenza like illness|influenza like illness
681350|NCT00707941|Pneumonia|pneumonia
681351|NCT00707941|Bronchiolitis|bronchiolitis
681352|NCT00707941|Upper respiratory tract illness|upper respiratory tract illness
681353|NCT00707941|Otitis media|otitis media
681354|NCT00707941|Viral shedding|viral shedding
681355|NCT00707941|Nasopharyngeal wash|nasopharyngeal wash
681356|NCT00707941|Viral culture|viral culture
681357|NCT00707941|PCR|pcr
681358|NCT00707928|retained placenta|retained placenta
681359|NCT00707915|aged|aged
681360|NCT00707915|benzodiazepines|benzodiazepines
681361|NCT00707915|hypnotics|hypnotics
681362|NCT00707915|cognition|cognition
681363|NCT00707915|posture|posture
681364|NCT00707902|Sore throats,|sore throats,
681365|NCT00707902|Pharyngitis|pharyngitis
681366|NCT00707902|Acute|acute
681367|NCT00707876|Peripheral arterial disease (PAD); Magnetic Resonance Angiography (MRA); Magnetic Resonance Imaging (MRI), imaging agent or biomarker|peripheral arterial disease (pad); magnetic resonance angiography (mra); magnetic resonance imaging (mri), imaging agent or biomarker
681368|NCT00707863|Escitalopram|escitalopram
681369|NCT00707863|Lexapro|lexapro
681370|NCT00707863|fMRI|fmri
681371|NCT00707863|pictures|pictures
681372|NCT00707850|Hepatitis C|hepatitis c
681373|NCT00707850|Thalassemia|thalassemia
681374|NCT00707850|Pegasys|pegasys
681375|NCT00707850|Ribavirin|ribavirin
681376|NCT00707824|pruritus|pruritus
681377|NCT00707824|epidural morphine|epidural morphine
681378|NCT00707811|Dyspnea|dyspnea
681379|NCT00707811|Shortness of Breath|shortness of breath
681380|NCT00707811|Trouble Breathing|trouble breathing
681381|NCT00707811|ST2|st2
681382|NCT00707811|IL-33|il-33
681383|NCT00707798|Young adults|young adults
681384|NCT00707798|Pneumococcal vaccine,|pneumococcal vaccine,
681385|NCT00707798|Streptococcus pneumoniae,|streptococcus pneumoniae,
681386|NCT00707785|vitamin A|vitamin a
681387|NCT00707785|Treatment|treatment
681388|NCT00707785|neonates|neonates
681389|NCT00707785|newborn|newborn
681390|NCT00707785|sepsis|sepsis
681391|NCT00707785|necrotizing enterocolitis|necrotizing enterocolitis
681392|NCT00707785|meningitis|meningitis
681393|NCT00707785|pneumonia|pneumonia
681394|NCT00707772|Hepatitis C|hepatitis c
681395|NCT00707772|Hemophilia|hemophilia
681396|NCT00707772|Pegasys|pegasys
681397|NCT00707772|Ribavirin|ribavirin
681398|NCT00707759|Pediatric renal transplantation,Bone metabolism (DXA-pQCT)|pediatric renal transplantation,bone metabolism (dxa-pqct)
681399|NCT00707759|mRNAFOXP3/IL-17,Steroid withdrawal|mrnafoxp3/il-17,steroid withdrawal
681400|NCT00707746|statin intolerant|statin intolerant
681589|NCT00706836|fMRI|fmri
681401|NCT00707746|hypercholesterolemia|hypercholesterolemia
681402|NCT00707707|breast cancer|breast cancer
681403|NCT00707707|triple negative|triple negative
681404|NCT00707707|metastatic|metastatic
681405|NCT00707694|95 years of age and older|95 years of age and older
681406|NCT00707681|microbio, MS-20, Hepatoma, Advanced Hepatocellular Carcinoma|microbio, ms-20, hepatoma, advanced hepatocellular carcinoma
681407|NCT00707668|Diabetes|diabetes
681408|NCT00707668|metabolic syndrome|metabolic syndrome
681409|NCT00707668|dyslipidemia|dyslipidemia
681410|NCT00707668|osteoporosis|osteoporosis
681411|NCT00707642|West Nile Virus|west nile virus
681412|NCT00707642|West Nile Vaccine|west nile vaccine
681413|NCT00707642|West Nile virus disease|west nile virus disease
681414|NCT00707642|Hawaii Biotech|hawaii biotech
681415|NCT00707629|type 1 diabetes|type 1 diabetes
681416|NCT00707629|neurocognitive measures|neurocognitive measures
681417|NCT00707629|behavioral measures|behavioral measures
681418|NCT00707603|Insulin resistance|insulin resistance
681419|NCT00707603|Liver fat|liver fat
681420|NCT00707603|Muscle fat|muscle fat
681421|NCT00707603|Abdominal fat|abdominal fat
681422|NCT00707603|Cytokines|cytokines
681423|NCT00707577|Worksite Wellness|worksite wellness
681424|NCT00707577|Weight loss and maintenance|weight loss and maintenance
681425|NCT00707577|Physical Activity|physical activity
681426|NCT00707577|Health and Fitness interventions|health and fitness interventions
681427|NCT00707577|Healthy eating|healthy eating
681428|NCT00707577|Weight loss|weight loss
681429|NCT00707577|Maintenance programs|maintenance programs
681430|NCT00707564|hemostasis|hemostasis
681431|NCT00707564|tooth extractions|tooth extractions
681432|NCT00707551|AZD1305|azd1305
681433|NCT00707551|Verapamil|verapamil
681434|NCT00707551|Ketoconazole|ketoconazole
681435|NCT00707551|pharmacokinetics|pharmacokinetics
681436|NCT00707525|aneuploidies, natural cycle, stimulated cycle, preimplantation genetic diagnosis|aneuploidies, natural cycle, stimulated cycle, preimplantation genetic diagnosis
681437|NCT00707486|Hemostasis, tooth extractions, third molar|hemostasis, tooth extractions, third molar
681438|NCT00707460|Diabetes|diabetes
681439|NCT00707460|Cardiovascular|cardiovascular
681440|NCT00707460|Obesity|obesity
681441|NCT00707460|First.Nation|first.nation
681442|NCT00707460|Aboriginal (Health)|aboriginal (health)
681443|NCT00707460|Dietary|dietary
681444|NCT00707460|Intervention|intervention
681445|NCT00707460|Nutrition|nutrition
681446|NCT00707460|Traditional (Diet)|traditional (diet)
681447|NCT00707460|Sandy Lake (Health & Diabetes Project)|sandy lake (health & diabetes project)
681448|NCT00707460|(High) protein|(high) protein
681449|NCT00707460|(High) fibre (er)|(high) fibre (er)
681450|NCT00707460|(Low) carbohydrate|(low) carbohydrate
681451|NCT00707447|diabetes-prevention|diabetes-prevention
681452|NCT00707447|lifestyle modification|lifestyle modification
681453|NCT00707447|behavior therapy|behavior therapy
681454|NCT00707447|self-management|self-management
681455|NCT00707434|Continuous Glucose Monitor|continuous glucose monitor
681456|NCT00707434|Medtronic Guardian|medtronic guardian
681457|NCT00707434|Guardian® blood-sugar monitoring device|guardian® blood-sugar monitoring device
681458|NCT00707434|Glucose Monitoring|glucose monitoring
681459|NCT00707434|Critically Ill|critically ill
681461|NCT00707434|Intensive Care Unit|intensive care unit
681462|NCT00707434|Glycemic Excursions|glycemic excursions
681463|NCT00707434|Glucose Control|glucose control
681464|NCT00707434|Glucose Testing|glucose testing
681465|NCT00707434|Hyperglycemia|hyperglycemia
681466|NCT00707434|Hypoglycemia|hypoglycemia
681467|NCT00707434|Insulin Infusion|insulin infusion
681468|NCT00707382|Pharmacogenetics|pharmacogenetics
681469|NCT00707382|Compliance|compliance
681470|NCT00707382|Antipsychotic drugs|antipsychotic drugs
681471|NCT00707382|Schizophrenia|schizophrenia
681472|NCT00707369|Periodontitis|periodontitis
681473|NCT00707369|Mechanical Debridement|mechanical debridement
681474|NCT00707369|Antibiotics|antibiotics
681475|NCT00707369|Attachment loss|attachment loss
681476|NCT00707369|Randomized controlled trial|randomized controlled trial
681477|NCT00707356|Prostatic disease|prostatic disease
681478|NCT00707356|genital neoplasm, male|genital neoplasm, male
681479|NCT00707356|Urogenital neoplasm|urogenital neoplasm
681480|NCT00707356|Genital disease|genital disease
681481|NCT00707356|male|male
681482|NCT00707356|Male urogenital disease|male urogenital disease
681483|NCT00707356|Neoplasms|neoplasms
681484|NCT00707356|Neoplasm by site|neoplasm by site
681485|NCT00707356|prostatic neoplasm|prostatic neoplasm
681486|NCT00707356|Carcinoma|carcinoma
681487|NCT00707330|oxidative stress|oxidative stress
681488|NCT00707330|8-oxo-deoxyguanine|8-oxo-deoxyguanine
681489|NCT00707330|8-oxodG|8-oxodg
681490|NCT00707330|clarithromycin|clarithromycin
681491|NCT00707330|malondialdehyde|malondialdehyde
681492|NCT00707330|mda|mda
681493|NCT00707330|vitamine C|vitamine c
681494|NCT00707330|ascorbic acid|ascorbic acid
681495|NCT00707317|M. tuberculosis|m. tuberculosis
681496|NCT00707317|latent tuberculosis infection|latent tuberculosis infection
681497|NCT00707317|Quantiferon assay|quantiferon assay
681498|NCT00707317|ELISPOT assay|elispot assay
681499|NCT00707317|tuberculin skin test|tuberculin skin test
681500|NCT00707317|immunocompromised patients|immunocompromised patients
681501|NCT00707304|Non Small Cell Lung Cancer|non small cell lung cancer
681502|NCT00707304|Talactoferrin|talactoferrin
681503|NCT00707304|Dendritic Cell Recruiter and Activator|dendritic cell recruiter and activator
681504|NCT00707304|Immunomodulatory agent|immunomodulatory agent
681505|NCT00707291|contact lens|contact lens
681506|NCT00707291|normal|normal
681507|NCT00707252|Non-small cell lung cancer|non-small cell lung cancer
681508|NCT00707252|Erlotinib|erlotinib
681509|NCT00707252|Polyphenon E|polyphenon e
681510|NCT00707252|Tarceva|tarceva
681511|NCT00707252|Advanced Non-small Cell Lung Cancer Stage IIIb or IV|advanced non-small cell lung cancer stage iiib or iv
681512|NCT00707239|Hospital-acquired pneumonia|hospital-acquired pneumonia
681513|NCT00707239|Ventilator-associated pneumonia|ventilator-associated pneumonia
681514|NCT00707226|Laser Doppler flowmetry|laser doppler flowmetry
681515|NCT00707226|Choroidal blood flow|choroidal blood flow
681516|NCT00707226|Fundus pulsation amplitude|fundus pulsation amplitude
681517|NCT00707226|Intraocular Pressure|intraocular pressure
681518|NCT00707200|severe malarial anemia (SMA)|severe malarial anemia (sma)
681519|NCT00707200|cerebral malarial (CM)|cerebral malarial (cm)
681520|NCT00707200|lactic acidosis|lactic acidosis
681521|NCT00707200|hyperparasitemia|hyperparasitemia
681522|NCT00707200|respiratory distress|respiratory distress
681523|NCT00707200|hypoxia|hypoxia
681524|NCT00707200|death|death
681525|NCT00707200|transfusion|transfusion
681526|NCT00707187|systemic sclerosis|systemic sclerosis
681527|NCT00707187|scleroderma|scleroderma
681528|NCT00707187|raynaud phenomenon|raynaud phenomenon
681529|NCT00707174|Lentigo Maligna|lentigo maligna
681530|NCT00707148|pertussis, diptheria, tetanus, vaccine, Tdap|pertussis, diptheria, tetanus, vaccine, tdap
681531|NCT00707122|serum albumin, severe sepsis, septic shock, fluid therapy, hypoalbuminemia, critically ill|serum albumin, severe sepsis, septic shock, fluid therapy, hypoalbuminemia, critically ill
681532|NCT00707083|untreated childhood acute lymphoblastic leukemia|untreated childhood acute lymphoblastic leukemia
681533|NCT00707083|childhood acute lymphoblastic leukemia in remission|childhood acute lymphoblastic leukemia in remission
681534|NCT00707083|B-cell childhood acute lymphoblastic leukemia|b-cell childhood acute lymphoblastic leukemia
681535|NCT00707083|T-cell childhood acute lymphoblastic leukemia|t-cell childhood acute lymphoblastic leukemia
681536|NCT00707070|psoriasis|psoriasis
681537|NCT00707070|acitretin|acitretin
681538|NCT00707070|efalizumab|efalizumab
681539|NCT00707031|hyperglycemia, GLP-1, metformin|hyperglycemia, glp-1, metformin
681540|NCT00707005|antibiotic susceptibility|antibiotic susceptibility
681541|NCT00707005|bacterial flora|bacterial flora
681542|NCT00707005|fluoroquinolone|fluoroquinolone
681543|NCT00707005|LASIK|lasik
681544|NCT00707005|refractive surgery|refractive surgery
681545|NCT00706992|MART-1 Peptide|mart-1 peptide
681546|NCT00706992|Melanoma|melanoma
681547|NCT00706992|Adjuvant Therapy|adjuvant therapy
681548|NCT00706992|Gene Therapy|gene therapy
681549|NCT00706992|T Cell Persistence|t cell persistence
681550|NCT00706979|smoking|smoking
681551|NCT00706979|smoking cessation|smoking cessation
681552|NCT00706979|nicotine replacement therapy|nicotine replacement therapy
681553|NCT00706966|adenocarcinoma of the prostate|adenocarcinoma of the prostate
681554|NCT00706966|stage IIB prostate cancer|stage iib prostate cancer
681555|NCT00706966|stage IIA prostate cancer|stage iia prostate cancer
681556|NCT00706966|benign prostatic hyperplasia|benign prostatic hyperplasia
681557|NCT00706953|pegylated liposomal doxorubicin|pegylated liposomal doxorubicin
681558|NCT00706953|VELCADE|velcade
681559|NCT00706953|DOXIL|doxil
681560|NCT00706953|relapsed|relapsed
681561|NCT00706953|Multiple Myeloma|multiple myeloma
681562|NCT00706940|dry eye|dry eye
681563|NCT00706940|Optical coherence tomography|optical coherence tomography
681564|NCT00706927|xalacom|xalacom
681565|NCT00706927|combigan|combigan
681566|NCT00706927|ocular blood flow|ocular blood flow
681567|NCT00706914|Airflow Obstruction, Chronic|airflow obstruction, chronic
681568|NCT00706914|Chronic Airflow Obstruction|chronic airflow obstruction
681569|NCT00706914|Chronic Obstructive Pulmonary Disease|chronic obstructive pulmonary disease
681570|NCT00706914|Chronic Obstructive Airway Disease|chronic obstructive airway disease
681571|NCT00706914|Chronic Obstructive Lung Disease|chronic obstructive lung disease
681572|NCT00706914|COPD|copd
681573|NCT00706914|COAD|coad
681574|NCT00706901|MI|mi
681575|NCT00706901|IHMD|ihmd
681576|NCT00706888|Reduction of cardiovascular factor of risk|reduction of cardiovascular factor of risk
681577|NCT00706875|GTD survivors|gtd survivors
681578|NCT00706875|questionnaires|questionnaires
681579|NCT00706875|GTD|gtd
681580|NCT00706862|Non small cell lung cancer|non small cell lung cancer
681581|NCT00706862|Talactoferrin|talactoferrin
681582|NCT00706862|Dendritic cell recruiter and activator|dendritic cell recruiter and activator
681583|NCT00706862|DCRA|dcra
681584|NCT00706862|Immunomodulatory agent|immunomodulatory agent
681585|NCT00706862|Lactoferrin|lactoferrin
681586|NCT00706849|familial hypercholesterolemia|familial hypercholesterolemia
681587|NCT00706836|anxiety|anxiety
681588|NCT00706836|functional magnetic resonance imaging|functional magnetic resonance imaging
681590|NCT00706836|pregabalin|pregabalin
681591|NCT00706836|Lyrica|lyrica
681592|NCT00706823|Endotracheal Intubation|endotracheal intubation
681593|NCT00706823|Supraglottic Airway|supraglottic airway
681594|NCT00706810|Cancer|cancer
681595|NCT00706810|Brain cancer|brain cancer
681596|NCT00706810|Meningioma|meningioma
681597|NCT00706797|Moderate Rheumatoid Arthritis|moderate rheumatoid arthritis
681598|NCT00706784|Healthy women 18-40 years of age|healthy women 18-40 years of age
681599|NCT00706771|sodium bicarbonate|sodium bicarbonate
681600|NCT00706771|serum neutrophil gelatinase associated lipocalin|serum neutrophil gelatinase associated lipocalin
681601|NCT00706771|renal impairment|renal impairment
681602|NCT00706771|renal failure|renal failure
681603|NCT00706771|systemic inflammatory response syndrome|systemic inflammatory response syndrome
681604|NCT00706771|defined|defined
681605|NCT00706771|by serum NGAL ≥ 100 ng/ml.|by serum ngal ≥ 100 ng/ml.
681606|NCT00706758|Irritable bowel syndrome|irritable bowel syndrome
681607|NCT00706758|Patient education|patient education
681608|NCT00706745|atherosclerosis|atherosclerosis
681609|NCT00706745|dietary supplements|dietary supplements
681610|NCT00706745|randomised controlled trial|randomised controlled trial
681611|NCT00706745|arterial stiffness|arterial stiffness
681612|NCT00706745|linoleic acid|linoleic acid
681613|NCT00706732|Influenza|influenza
681615|NCT00706732|A/Wyoming/03/2003|a/wyoming/03/2003
681616|NCT00706732|Alphavirus|alphavirus
681617|NCT00706719|Adult Onset Idiopathic Hypothalamic Hypogonadism (AIHH)|adult onset idiopathic hypothalamic hypogonadism (aihh)
681618|NCT00706719|Secondary hypogonadism|secondary hypogonadism
681619|NCT00706719|Semen volume|semen volume
681620|NCT00706719|Sperm count|sperm count
681621|NCT00706719|Sperm motility|sperm motility
681622|NCT00706706|sunitinib Phase IV metastatic renal cell carcinoma Chinese|sunitinib phase iv metastatic renal cell carcinoma chinese
681623|NCT00706693|hypoglycemia|hypoglycemia
681624|NCT00706693|treatment|treatment
681625|NCT00706693|glucose|glucose
681626|NCT00706693|sucrose|sucrose
681627|NCT00706693|fructose|fructose
681628|NCT00706654|Aripiprazole|aripiprazole
681629|NCT00706654|Intramuscular (IM) depot|intramuscular (im) depot
681630|NCT00706654|Schizophrenia|schizophrenia
681631|NCT00706615|stage IV breast cancer|stage iv breast cancer
681632|NCT00706615|recurrent breast cancer|recurrent breast cancer
681633|NCT00706602|COPD|copd
681634|NCT00706602|prognosis|prognosis
681635|NCT00706602|prediction rule|prediction rule
681636|NCT00706602|health-related quality of life|health-related quality of life
681637|NCT00706602|risk factors|risk factors
681638|NCT00706602|derivation|derivation
681639|NCT00706602|validation|validation
681640|NCT00706602|exacerbation|exacerbation
681641|NCT00706602|mortality|mortality
681642|NCT00706602|primary care|primary care
681643|NCT00706602|treatment|treatment
681644|NCT00706602|decision making|decision making
681645|NCT00706589|Chronic Motor Tic disorder|chronic motor tic disorder
681646|NCT00706589|Chronic Phonic Tic disorder|chronic phonic tic disorder
681647|NCT00706589|Tourette's disorder|tourette's disorder
681648|NCT00706589|Aripiprazole|aripiprazole
681649|NCT00706589|Abilify|abilify
681650|NCT00706589|Children|children
681651|NCT00706589|Adolescent|adolescent
681652|NCT00706576|Hepatocellular cancer|hepatocellular cancer
681653|NCT00706576|HCC|hcc
681654|NCT00706576|Opioid growth factor|opioid growth factor
681655|NCT00706576|OGF|ogf
681656|NCT00706576|Cirrhosis|cirrhosis
681657|NCT00706550|pneumococcal polysaccharide vaccine|pneumococcal polysaccharide vaccine
681658|NCT00706537|Pharmacokinetic safety NASH patients|pharmacokinetic safety nash patients
681659|NCT00706511|OSA|osa
681660|NCT00706511|Diabetes|diabetes
681661|NCT00706511|Metabolism|metabolism
681662|NCT00706511|Gender|gender
681663|NCT00706485|Y-90 plaque applicator|y-90 plaque applicator
681664|NCT00706485|dural brachytherapy|dural brachytherapy
681665|NCT00706446|Asthma|asthma
681666|NCT00706446|Pharmacogenetics|pharmacogenetics
681667|NCT00706446|Beta agonists|beta agonists
681668|NCT00706446|salmeterol|salmeterol
681669|NCT00706446|formoterol|formoterol
681670|NCT00706446|tiotropium|tiotropium
681671|NCT00706446|beta adrenergic receptor|beta adrenergic receptor
681672|NCT00706446|single nucleotide polymorphism|single nucleotide polymorphism
681673|NCT00706433|Photodynamic Therapy|photodynamic therapy
681674|NCT00706420|Diabetes Mellitus|diabetes mellitus
681675|NCT00706420|Islet Transplantation Alone|islet transplantation alone
681676|NCT00706420|Glucocorticoid-free Immunosuppressive Regimen|glucocorticoid-free immunosuppressive regimen
681677|NCT00706394|Powerlink|powerlink
681678|NCT00706394|34mm|34mm
681679|NCT00706394|Abdominal Aortic Aneurysm|abdominal aortic aneurysm
681680|NCT00706394|EVAR|evar
681681|NCT00706381|Deiodinase|deiodinase
681682|NCT00706381|Bile Acids|bile acids
681683|NCT00706381|Cholecystokinin|cholecystokinin
681684|NCT00706381|Thyroid Hormones|thyroid hormones
681685|NCT00706381|Energy Expenditure|energy expenditure
681686|NCT00706381|Health Volunteer|health volunteer
681687|NCT00706381|HV|hv
681688|NCT00706368|Sexually transmitted infections|sexually transmitted infections
681689|NCT00706368|Acceptability|acceptability
681690|NCT00706368|Adolescent vaginitis|adolescent vaginitis
681691|NCT00706342|Adult Refractory Immune Thrombocytopenic Purpura (ITP)|adult refractory immune thrombocytopenic purpura (itp)
681692|NCT00706329|Minimally invasive surgery|minimally invasive surgery
681693|NCT00706329|Umbilical hernia|umbilical hernia
681694|NCT00706329|Infant|infant
681695|NCT00706316|Nasopharygneal Cancer|nasopharygneal cancer
681696|NCT00706316|Epstein Barr Virus|epstein barr virus
681697|NCT00706316|(EBV)-Specific Cytotoxic T-Lymphocytes|(ebv)-specific cytotoxic t-lymphocytes
681698|NCT00706316|Recurrent|recurrent
681699|NCT00706316|Metastatic|metastatic
681700|NCT00706316|EBV-Positive Nasopharygneal Cancer|ebv-positive nasopharygneal cancer
681701|NCT00706303|COPD|copd
681702|NCT00706303|self management|self management
681703|NCT00706290|anxiety|anxiety
681704|NCT00706290|depression|depression
681705|NCT00706290|quality of life|quality of life
681706|NCT00706290|psychosocial effects of cancer and its treatment|psychosocial effects of cancer and its treatment
681707|NCT00706290|advanced cancer|advanced cancer
681708|NCT00706290|metastatic cancer|metastatic cancer
681709|NCT00706290|stage IV cancer|stage iv cancer
681710|NCT00706290|cognitive behavioral therapy|cognitive behavioral therapy
681711|NCT00706277|forced vital capacity|forced vital capacity
681712|NCT00706277|forced expired volume in 1 s|forced expired volume in 1 s
681713|NCT00706264|Short cervix|short cervix
681714|NCT00706264|preterm birth|preterm birth
681715|NCT00706264|arabin pessary|arabin pessary
681716|NCT00706238|metastatic,|metastatic,
681717|NCT00706238|Melanoma,|melanoma,
681718|NCT00706238|Antigen-Specific Cancer Immunotherapeutic,|antigen-specific cancer immunotherapeutic,
681719|NCT00706238|ASCI|asci
681720|NCT00706238|MAGE-A3|mage-a3
681721|NCT00706238|tumor antigen,|tumor antigen,
681722|NCT00706199|bone marrow|bone marrow
681723|NCT00706199|antigen expression|antigen expression
681724|NCT00706199|volunteers|volunteers
681725|NCT00706186|Mild Alzheimer's|mild alzheimer's
681726|NCT00706186|Disease|disease
681727|NCT00706173|Post-traumatic stress disorder|post-traumatic stress disorder
681728|NCT00706173|PTSD|ptsd
681729|NCT00706173|Cortisol|cortisol
681730|NCT00706173|hydrocortisone|hydrocortisone
681731|NCT00706173|pharmacological treatment|pharmacological treatment
681732|NCT00706160|Epilepsy|epilepsy
681733|NCT00706160|Language|language
681734|NCT00706160|fMRI|fmri
681735|NCT00706160|Magnetoencephalogram|magnetoencephalogram
681736|NCT00706160|Temporal Lobe Epilepsy|temporal lobe epilepsy
681737|NCT00706160|Partial Epilepsy|partial epilepsy
681738|NCT00706160|Healthy Volunteer|healthy volunteer
681739|NCT00706160|HV|hv
681740|NCT00706147|Hereditary ALS|hereditary als
681741|NCT00706147|Hereditary neurological disease|hereditary neurological disease
681742|NCT00706147|Lou Gehrig's Disease|lou gehrig's disease
681743|NCT00706147|Motor Neuron Disease|motor neuron disease
681744|NCT00706147|Amyotrophic Lateral Sclerosis (ALS)|amyotrophic lateral sclerosis (als)
681745|NCT00706147|Familial ALS|familial als
681746|NCT00706147|Neuromuscular disease|neuromuscular disease
681747|NCT00706147|SOD1 mutation|sod1 mutation
681748|NCT00706147|Superoxide dismutase|superoxide dismutase
681749|NCT00706147|SOD1 positive ALS|sod1 positive als
681750|NCT00706147|inherited ALS|inherited als
681751|NCT00706134|Hypertension|hypertension
681752|NCT00706134|≥ 65 years|≥ 65 years
681753|NCT00706134|aliskiren|aliskiren
681754|NCT00706134|placebo|placebo
681755|NCT00706134|light meal|light meal
681756|NCT00706121|colon cancer|colon cancer
681757|NCT00706121|rectal cancer|rectal cancer
681758|NCT00706121|adenomatous polyp|adenomatous polyp
681759|NCT00706095|Cancer|cancer
681760|NCT00706095|advanced solid tumors|advanced solid tumors
681761|NCT00706069|Metastatic Breast Cancer|metastatic breast cancer
681762|NCT00706069|Vinorelbine oral|vinorelbine oral
681763|NCT00706069|Capecitabine|capecitabine
681764|NCT00706043|Low back pain|low back pain
681765|NCT00706030|Metastatic breast cancer|metastatic breast cancer
681766|NCT00706030|HKI-272|hki-272
681767|NCT00706030|Neratinib|neratinib
681768|NCT00706030|Nerlynx|nerlynx
681769|NCT00706030|PB-272|pb-272
681770|NCT00706004|constipation|constipation
681771|NCT00706004|cystic fibrosis|cystic fibrosis
681772|NCT00706004|lubiprostone|lubiprostone
681773|NCT00706004|Constipation in adults with cystic fibrosis|constipation in adults with cystic fibrosis
681774|NCT00705978|Pancreatic Exocrine Insufficiency Due to Chronic Pancreatitis|pancreatic exocrine insufficiency due to chronic pancreatitis
681775|NCT00705965|Coronary artery disease|coronary artery disease
681776|NCT00705965|depression|depression
681777|NCT00705965|psychotherapy|psychotherapy
681778|NCT00705965|randomized controlled trial|randomized controlled trial
681779|NCT00705952|No diabetes medications|no diabetes medications
681780|NCT00705952|New onset|new onset
681781|NCT00705939|Gaucher Disease|gaucher disease
681782|NCT00705939|Enzyme replacement therapy|enzyme replacement therapy
681783|NCT00705926|Acute Infection|acute infection
681784|NCT00705926|HIV|hiv
681785|NCT00705926|HAART|haart
681786|NCT00705926|Treatment Naive|treatment naive
681787|NCT00705913|aortic valve|aortic valve
681788|NCT00705913|heart valve|heart valve
681789|NCT00705913|valve replacement|valve replacement
681790|NCT00705913|valve disease|valve disease
681791|NCT00705900|psoriasis|psoriasis
681792|NCT00705887|Ultraviolet Rays|ultraviolet rays
681793|NCT00705887|Motivation|motivation
681794|NCT00705887|Health Education|health education
681795|NCT00705887|Randomized Controlled Trial|randomized controlled trial
681796|NCT00705887|Health Knowledge, Attitudes, Practice|health knowledge, attitudes, practice
681797|NCT00705874|cancer|cancer
681798|NCT00705874|advanced cancer|advanced cancer
681799|NCT00705874|solid tumors|solid tumors
681800|NCT00705874|lymphoma|lymphoma
681801|NCT00705874|CGC-11047|cgc-11047
681802|NCT00705861|Erectile dysfunction|erectile dysfunction
681803|NCT00705861|Diabetes Mellitus|diabetes mellitus
681804|NCT00705861|SK3530|sk3530
681805|NCT00705848|trachea|trachea
681806|NCT00705848|malacia|malacia
681807|NCT00705848|stenosis|stenosis
681808|NCT00705835|Prostate|prostate
681809|NCT00705835|ALHYDROGEL|alhydrogel
681810|NCT00705835|RS-PSMA|rs-psma
681811|NCT00705809|Epidemiology|epidemiology
681812|NCT00705809|Peripheral T-Cell Lymphoma|peripheral t-cell lymphoma
681813|NCT00705796|Hypogonadism|hypogonadism
681814|NCT00705796|Spermatogenesis|spermatogenesis
681815|NCT00705796|Quality of Life|quality of life
681816|NCT00705783|Aripiprazole|aripiprazole
681817|NCT00705783|Intramuscular (IM) depot|intramuscular (im) depot
681818|NCT00705783|Schizophrenia|schizophrenia
681819|NCT00705770|Open-Angle Glaucoma|open-angle glaucoma
681820|NCT00705770|Intraocular Pressure|intraocular pressure
681821|NCT00705770|Anecortave Acetate|anecortave acetate
681822|NCT00705757|periocular skin pigmentation|periocular skin pigmentation
681823|NCT00705757|Lumigan|lumigan
681824|NCT00705757|Travatan|travatan
681825|NCT00705757|Xalatan|xalatan
681826|NCT00705757|latanoprost|latanoprost
681827|NCT00705757|bimatoprost|bimatoprost
681828|NCT00705757|travoprost|travoprost
681829|NCT00705731|Colorectal cancer (CRC)|colorectal cancer (crc)
681830|NCT00705731|Colorectal cancer screening|colorectal cancer screening
681831|NCT00705731|Colonoscopy|colonoscopy
681832|NCT00705731|Fecal occult blood test (FOBT)|fecal occult blood test (fobt)
681833|NCT00705731|Cost-effectiveness|cost-effectiveness
681834|NCT00705718|Endurant Stent Graft System|endurant stent graft system
681835|NCT00705718|Abdominal Aortic Aneurysms|abdominal aortic aneurysms
681836|NCT00705718|Endovascular Treatment|endovascular treatment
681837|NCT00705705|High-Risk Behavior|high-risk behavior
681838|NCT00705705|Men Who Have Sex With Men|men who have sex with men
681839|NCT00705705|HIV Seronegativity|hiv seronegativity
681840|NCT00705692|Tetanus|tetanus
681841|NCT00705692|Vaccines|vaccines
681842|NCT00705692|Renal Dialysis|renal dialysis
681843|NCT00705692|Levamisole|levamisole
681844|NCT00705679|Microbicide|microbicide
681845|NCT00705679|HIV Seronegativity|hiv seronegativity
681846|NCT00705653|cancer|cancer
681847|NCT00705653|advanced cancer|advanced cancer
681848|NCT00705653|solid tumors|solid tumors
681849|NCT00705653|CGC-11047|cgc-11047
681850|NCT00705653|PG-11047|pg-11047
681851|NCT00705640|stage II melanoma|stage ii melanoma
681852|NCT00705640|stage III melanoma|stage iii melanoma
681853|NCT00705640|stage IV melanoma|stage iv melanoma
681854|NCT00705640|ciliary body and choroid melanoma, medium/large size|ciliary body and choroid melanoma, medium/large size
681855|NCT00705640|ciliary body and choroid melanoma, small size|ciliary body and choroid melanoma, small size
681856|NCT00705640|conjunctival melanoma|conjunctival melanoma
681857|NCT00705640|extraocular extension melanoma|extraocular extension melanoma
681858|NCT00705640|iris melanoma|iris melanoma
681859|NCT00705640|metastatic intraocular melanoma|metastatic intraocular melanoma
681860|NCT00705640|recurrent intraocular melanoma|recurrent intraocular melanoma
681861|NCT00705627|nasopharyngeal carcinoma|nasopharyngeal carcinoma
681862|NCT00705627|neoadjuvant chemotherapy|neoadjuvant chemotherapy
681863|NCT00705627|concurrent chemotherapy|concurrent chemotherapy
681864|NCT00705627|randomized controlled clinical trials|randomized controlled clinical trials
681865|NCT00705601|Nonrestorative Sleep, Restorative Sleep Questionnaire Refinement|nonrestorative sleep, restorative sleep questionnaire refinement
681866|NCT00705575|Essential Hypertension|essential hypertension
681867|NCT00705575|Stage II|stage ii
681868|NCT00705549|Advanced|advanced
681869|NCT00705549|NSCLC|nsclc
681870|NCT00705549|ERCC1|ercc1
681871|NCT00705549|RRM1|rrm1
681872|NCT00705549|BCRA1|bcra1
681873|NCT00705549|Alimta|alimta
681874|NCT00705549|Gemcitabine|gemcitabine
681875|NCT00705536|rHuPH20|rhuph20
681876|NCT00705536|Hyaluronidase|hyaluronidase
681877|NCT00705536|Insulin|insulin
681878|NCT00705523|alcohol|alcohol
681879|NCT00705523|treatment|treatment
681880|NCT00705523|nicotinic acetylcholine receptors|nicotinic acetylcholine receptors
681881|NCT00705523|pharmacotherapy|pharmacotherapy
681882|NCT00705523|outpatient|outpatient
681883|NCT00705510|Cyclosporine|cyclosporine
681884|NCT00705510|Unstable tear film|unstable tear film
681885|NCT00705510|Meibomian gland|meibomian gland
681886|NCT00705510|Meibomian gland dysfunction|meibomian gland dysfunction
681979|NCT00704821|VEGF|vegf
681887|NCT00705497|Radiofrequency tumor ablation|radiofrequency tumor ablation
681888|NCT00705497|RFA|rfa
681889|NCT00705458|stress myocardial perfusion imaging|stress myocardial perfusion imaging
681890|NCT00705458|coronary computed tomography angiography|coronary computed tomography angiography
681891|NCT00705445|Malnutrition|malnutrition
681892|NCT00705445|Diarrhea|diarrhea
681893|NCT00705445|Pneumonia|pneumonia
681894|NCT00705445|Growth|growth
681895|NCT00705445|Zinc Supplements|zinc supplements
681896|NCT00705445|Microbiome|microbiome
681897|NCT00705419|Treatment Experienced|treatment experienced
681898|NCT00705354|Sinusitis|sinusitis
681899|NCT00705354|Chronic Sinusitis|chronic sinusitis
681900|NCT00705354|Nasal Surgery|nasal surgery
681901|NCT00705354|Functional Endoscopic Sinus Surgery (FESS)|functional endoscopic sinus surgery (fess)
681902|NCT00705354|Enoscopic Sinus Surgery (ESS)|enoscopic sinus surgery (ess)
681903|NCT00705341|Normal Controls|normal controls
681904|NCT00705328|low-income families|low-income families
681905|NCT00705328|children|children
681906|NCT00705328|recreation|recreation
681907|NCT00705328|family healthy lifestyle|family healthy lifestyle
681908|NCT00705328|linkages to community resources|linkages to community resources
681909|NCT00705328|Families with low incomes|families with low incomes
681910|NCT00705328|working poor|working poor
681911|NCT00705328|welfare recipients|welfare recipients
681912|NCT00705315|breast cancer|breast cancer
681913|NCT00705315|chemotherapy|chemotherapy
681914|NCT00705315|biological therapy|biological therapy
681915|NCT00705302|Chronic Obstructive Pulmonary Disease|chronic obstructive pulmonary disease
681916|NCT00705302|Outpatient|outpatient
681917|NCT00705302|Patient education|patient education
681918|NCT00705302|Pulmonary rehabilitation|pulmonary rehabilitation
681919|NCT00705302|Self-management|self-management
681920|NCT00705250|Bendamustine HCL|bendamustine hcl
681921|NCT00705237|sinusitis|sinusitis
681922|NCT00705185|Major Depressive Disorder|major depressive disorder
681923|NCT00705185|Blood Test|blood test
681924|NCT00705159|Blepharokeratoconjunctivitis|blepharokeratoconjunctivitis
681925|NCT00705146|Osteoarthritis, carpometacarpal joint|osteoarthritis, carpometacarpal joint
681926|NCT00705146|Thumb splints|thumb splints
681927|NCT00705146|AUSCAN-HI 3.1|auscan-hi 3.1
681928|NCT00705146|Grip and pinch strength|grip and pinch strength
681929|NCT00705133|pulmonary hypertension|pulmonary hypertension
681930|NCT00705133|pulmonary fibrosis|pulmonary fibrosis
681931|NCT00705133|interstitial lung disease|interstitial lung disease
681932|NCT00705120|Osteogenesis Imperfecta|osteogenesis imperfecta
681933|NCT00705120|Bone Marrow Cell Transplantation|bone marrow cell transplantation
681934|NCT00705120|Mesenchymal Stem Cells|mesenchymal stem cells
681935|NCT00705120|Stem Cell Transplantation, Mesenchymal|stem cell transplantation, mesenchymal
681936|NCT00705094|cardiovascular risk factors|cardiovascular risk factors
681937|NCT00705094|cardiac function|cardiac function
681938|NCT00705094|VO2peak|vo2peak
681939|NCT00705094|Chemotherapy|chemotherapy
681940|NCT00705055|Anthropometry|anthropometry
681941|NCT00705055|face recognition|face recognition
681942|NCT00705055|genetic disease|genetic disease
681943|NCT00705055|newborn infant|newborn infant
681944|NCT00705016|Randomized treatment|randomized treatment
681945|NCT00705016|open-label|open-label
681946|NCT00705016|controlled|controlled
681947|NCT00705016|recurrent|recurrent
681948|NCT00705016|metastatic|metastatic
681949|NCT00705016|SCCHN|scchn
681950|NCT00705016|suitable|suitable
681951|NCT00705016|for local therapy|for local therapy
681952|NCT00705003|depression|depression
681953|NCT00704990|Attention Deficit Disorder|attention deficit disorder
681954|NCT00704990|Pediatrics|pediatrics
681955|NCT00704990|Attention|attention
681956|NCT00704990|Impulsivity|impulsivity
681957|NCT00704990|Complementary Therapies|complementary therapies
681958|NCT00704938|recurrent renal cell cancer|recurrent renal cell cancer
681959|NCT00704938|stage IV renal cell cancer|stage iv renal cell cancer
681960|NCT00704938|recurrent melanoma|recurrent melanoma
681961|NCT00704938|stage IV melanoma|stage iv melanoma
681962|NCT00704938|unspecified adult solid tumor, protocol specific|unspecified adult solid tumor, protocol specific
681963|NCT00704925|Lambert Eaton Myasthenic Syndrome|lambert eaton myasthenic syndrome
681964|NCT00704925|3,4 DAP|3,4 dap
681965|NCT00704925|3,4 Diaminopyridine|3,4 diaminopyridine
681966|NCT00704912|Polycystic Ovary Syndrome|polycystic ovary syndrome
681967|NCT00704886|dementia|dementia
681968|NCT00704860|healthy volunteers treatment resistant major depression hippocampus atrophy MRI serotonin genotyping|healthy volunteers treatment resistant major depression hippocampus atrophy mri serotonin genotyping
681969|NCT00704847|Osteoarthritis, oral salmon calcitonin, treatment, efficacy,|osteoarthritis, oral salmon calcitonin, treatment, efficacy,
681970|NCT00704847|tolerability|tolerability
681971|NCT00704834|Multiple Sclerosis|multiple sclerosis
681972|NCT00704834|Relapsing Remitting Multiple Sclerosis|relapsing remitting multiple sclerosis
681973|NCT00704834|Chronic Progressive Multiple Sclerosis|chronic progressive multiple sclerosis
681974|NCT00704834|Clinically Isolated Syndrome|clinically isolated syndrome
681975|NCT00704834|Normal Controls|normal controls
681976|NCT00704834|Blood Draw|blood draw
681977|NCT00704821|Cancer|cancer
681978|NCT00704821|PTC299|ptc299
681980|NCT00704821|Angiogenesis|angiogenesis
681981|NCT00704821|Post-transcriptional control|post-transcriptional control
681982|NCT00704821|Docetaxel|docetaxel
681983|NCT00704743|Colles fracture treatment|colles fracture treatment
681984|NCT00704743|Displaced fracture of distal radius|displaced fracture of distal radius
681985|NCT00704743|distal radius fracture treatment|distal radius fracture treatment
681986|NCT00704743|RCT|rct
681987|NCT00704743|Emergency Department|emergency department
681988|NCT00704743|cast|cast
681989|NCT00704743|splint|splint
681990|NCT00704743|treatment|treatment
681991|NCT00704730|Medullary Thyroid Cancer|medullary thyroid cancer
681992|NCT00704730|MTC|mtc
681993|NCT00704704|high risk MDS|high risk mds
681994|NCT00704704|IPSS|ipss
681995|NCT00704704|5-AZA-Cytidine|5-aza-cytidine
681996|NCT00704704|Thalidomide|thalidomide
681997|NCT00704704|response rate|response rate
681998|NCT00704704|cytogenetic response|cytogenetic response
681999|NCT00704704|QOL questionaries|qol questionaries
682000|NCT00704704|INT-2 or High risk MDS|int-2 or high risk mds
682001|NCT00704678|Chronic Kidney Disease|chronic kidney disease
682002|NCT00704678|hemodialysis|hemodialysis
682003|NCT00704678|hyperphosphatemia|hyperphosphatemia
682004|NCT00704678|Asian|asian
682005|NCT00704678|patients|patients
682006|NCT00704665|Diffuse Scleroderma|diffuse scleroderma
682007|NCT00704665|Skin score|skin score
682008|NCT00704639|Head and Neck|head and neck
682009|NCT00704639|Cetuximab|cetuximab
682010|NCT00704639|Carboplatin|carboplatin
682011|NCT00704639|Radiotherapy|radiotherapy
682012|NCT00704626|Multiple Sclerosis|multiple sclerosis
682013|NCT00704626|Autoimmune disease|autoimmune disease
682014|NCT00704626|Inflammatory disease|inflammatory disease
682015|NCT00704626|Myasthenia Gravis|myasthenia gravis
682016|NCT00704626|Transverse Myelitis|transverse myelitis
682017|NCT00704600|Locally advanced rectal cancer|locally advanced rectal cancer
682018|NCT00704600|nelfinavir|nelfinavir
682019|NCT00704600|radiosensitivity|radiosensitivity
682020|NCT00704600|chemoradiation|chemoradiation
682021|NCT00704587|cancer occurence|cancer occurence
682022|NCT00704587|cancer recurrence|cancer recurrence
682023|NCT00704587|neo-adjuvant treatment response measurement|neo-adjuvant treatment response measurement
682024|NCT00704561|Acute Myocardial Infarction|acute myocardial infarction
682025|NCT00704561|Percutaneous Coronary Interventions|percutaneous coronary interventions
682026|NCT00704561|Optical Coherence Tomography|optical coherence tomography
682027|NCT00704561|Thrombus|thrombus
682028|NCT00704509|Schizophrenia|schizophrenia
682029|NCT00704509|Antipsychotic|antipsychotic
682030|NCT00704509|Bifeprunox|bifeprunox
682031|NCT00704496|Sleep, Pseudoephedrine|sleep, pseudoephedrine
682032|NCT00704483|Chronic Kidney Disease|chronic kidney disease
682033|NCT00704483|hemodialysis|hemodialysis
682034|NCT00704483|hyperphosphatemia|hyperphosphatemia
682035|NCT00704483|hemodiafiltration|hemodiafiltration
682036|NCT00704470|Patient Simulation|patient simulation
682037|NCT00704470|Education, Medical, Continuing|education, medical, continuing
682038|NCT00704470|Education, Medical, Graduate|education, medical, graduate
682039|NCT00704470|Stress|stress
682040|NCT00704457|Interstitial Cystitis|interstitial cystitis
682041|NCT00704457|IC|ic
682042|NCT00704457|Sacral Nerve Stimulation|sacral nerve stimulation
682043|NCT00704431|SB-480848|sb-480848
682044|NCT00704431|darapladib|darapladib
682045|NCT00704431|tolerability|tolerability
682046|NCT00704418|Cataract extraction|cataract extraction
682047|NCT00704418|intraocular lens implantation|intraocular lens implantation
682048|NCT00704405|hepatitis C|hepatitis c
682049|NCT00704392|Solid tumors|solid tumors
682050|NCT00704392|NSCLC|nsclc
682051|NCT00704379|traumatic brain injury|traumatic brain injury
682052|NCT00704379|TBI|tbi
682053|NCT00704379|mood disorders|mood disorders
682054|NCT00704379|anxiety disorders|anxiety disorders
682055|NCT00704379|community reintegration|community reintegration
682056|NCT00704379|executive function|executive function
682057|NCT00704379|sertraline|sertraline
682058|NCT00704379|diffusion tensor imaging|diffusion tensor imaging
682059|NCT00704366|Advanced carcinoma|advanced carcinoma
682060|NCT00704327|Cognitive Functions|cognitive functions
682061|NCT00704327|Brain Ischemia|brain ischemia
682062|NCT00704327|Cerebral Atrophy|cerebral atrophy
682063|NCT00704327|Dementia|dementia
682064|NCT00704327|Intracranial atherosclerosis|intracranial atherosclerosis
682065|NCT00704327|Memory impairment|memory impairment
682066|NCT00704314|Insulin resistance|insulin resistance
682067|NCT00704314|Statins|statins
682068|NCT00704314|Muscle and liver triglycerides|muscle and liver triglycerides
682069|NCT00704301|Delirium|delirium
682070|NCT00704301|Confusion|confusion
682071|NCT00704288|GBM|gbm
682072|NCT00704288|Malignant gliomas|malignant gliomas
682073|NCT00704275|dry eye|dry eye
682074|NCT00704249|HIV infection|hiv infection
682075|NCT00704249|nevirapine|nevirapine
682076|NCT00704249|Treatment Experienced|treatment experienced
682077|NCT00704236|Traditional Chinese Treatment|traditional chinese treatment
682078|NCT00704210|Low Back Pain|low back pain
682269|NCT00703274|cerebrovascular stroke|cerebrovascular stroke
682079|NCT00704171|Elective pulmonary resection via open thoracotomy.|elective pulmonary resection via open thoracotomy.
682080|NCT00704158|CR011-vcMMAE|cr011-vcmmae
682081|NCT00704158|locally advanced breast cancer|locally advanced breast cancer
682082|NCT00704158|metastatic breast cancer|metastatic breast cancer
682083|NCT00704158|breast cancer|breast cancer
682084|NCT00704158|CuraGen|curagen
682085|NCT00704145|Drug Eluting Stents|drug eluting stents
682086|NCT00704145|Percutaneous Coronary Interventions|percutaneous coronary interventions
682087|NCT00704145|Optical Coherence Tomography|optical coherence tomography
682088|NCT00704119|Rhudex|rhudex
682089|NCT00704119|pharmacokinetic study|pharmacokinetic study
682090|NCT00704106|Hepatitis B|hepatitis b
682091|NCT00704106|HBV|hbv
682092|NCT00704106|Treatment|treatment
682093|NCT00704093|pacing|pacing
682094|NCT00704093|perfusion|perfusion
682095|NCT00704093|oxidative metabolism|oxidative metabolism
682096|NCT00704093|efficiency|efficiency
682097|NCT00704080|GBM|gbm
682098|NCT00704080|Anaplastic glioma|anaplastic glioma
682099|NCT00704067|vocational rehabilitation|vocational rehabilitation
682100|NCT00704067|supported employment|supported employment
682101|NCT00704067|cognitive training|cognitive training
682102|NCT00704067|cognitive remediation|cognitive remediation
682103|NCT00704067|cognitive rehabilitation|cognitive rehabilitation
682104|NCT00704067|veterans|veterans
682105|NCT00704054|Pediatric|pediatric
682106|NCT00704054|Solid Tumor|solid tumor
682107|NCT00704054|CNS Tumor|cns tumor
682108|NCT00704054|Lymphoma|lymphoma
682109|NCT00704015|Smoking cessation|smoking cessation
682110|NCT00704015|Acute injury|acute injury
682111|NCT00704015|Musculoskeletal|musculoskeletal
682112|NCT00704015|Postoperative complications|postoperative complications
682113|NCT00704002|neck fracture of the fifth metacarpal|neck fracture of the fifth metacarpal
682114|NCT00704002|displacement|displacement
682115|NCT00704002|antegrade intramedullary splinting|antegrade intramedullary splinting
682116|NCT00704002|conservative treatment|conservative treatment
682117|NCT00703989|hyperglycemia|hyperglycemia
682118|NCT00703989|diabetic complications|diabetic complications
682119|NCT00703989|advanced glycation endproducts|advanced glycation endproducts
682120|NCT00703989|hexosamine pathway|hexosamine pathway
682121|NCT00703989|prostacyclin synthase|prostacyclin synthase
682122|NCT00703989|reactive oxygen species|reactive oxygen species
682123|NCT00703976|head and neck cancers|head and neck cancers
682124|NCT00703963|International normalized ratio (INR)|international normalized ratio (inr)
682125|NCT00703950|Sucking patterns|sucking patterns
682126|NCT00703950|preterm infants|preterm infants
682127|NCT00703950|breastfeeding|breastfeeding
682128|NCT00703924|cutaneous leishmaniasis topical treatment safety efficacy|cutaneous leishmaniasis topical treatment safety efficacy
682129|NCT00703898|HIV|hiv
682130|NCT00703898|nevirapine|nevirapine
682131|NCT00703898|durability|durability
682132|NCT00703898|AIDS|aids
682133|NCT00703898|Treatment Naïve|treatment naïve
682134|NCT00703885|functional magnetic resonance imaging|functional magnetic resonance imaging
682135|NCT00703885|fMRI|fmri
682136|NCT00703885|alprazolam|alprazolam
682137|NCT00703885|anxiety disorders|anxiety disorders
682138|NCT00703872|Chronic Hepatitis C|chronic hepatitis c
682139|NCT00703872|Naive|naive
682140|NCT00703872|Nonresponders|nonresponders
682141|NCT00703872|Interferon|interferon
682142|NCT00703872|Patients with Chronic Hepatitis C|patients with chronic hepatitis c
682143|NCT00703859|Radiotherapy plus temozolomide plus DCA|radiotherapy plus temozolomide plus dca
682144|NCT00703859|PK profile of DCA|pk profile of dca
682145|NCT00703859|MGMT promoter methylation status|mgmt promoter methylation status
682146|NCT00703859|Newly diagnosed Glioblastoma multiform tumours|newly diagnosed glioblastoma multiform tumours
682147|NCT00703846|Phase 4|phase 4
682148|NCT00703846|Seborrheic|seborrheic
682149|NCT00703846|Ketoconazole|ketoconazole
682150|NCT00703846|Dermatitis|dermatitis
682151|NCT00703794|ev3 Neurovascular|ev3 neurovascular
682152|NCT00703794|aneurysms|aneurysms
682153|NCT00703794|cerebrovascular|cerebrovascular
682154|NCT00703794|endovascular|endovascular
682155|NCT00703794|neurovascular therapies|neurovascular therapies
682156|NCT00703794|RACER|racer
682157|NCT00703794|AXIUM|axium
682158|NCT00703794|The AXIUM Progressive Coil System|the axium progressive coil system
682159|NCT00703794|ev3|ev3
682160|NCT00703794|MTI|mti
682161|NCT00703794|Micro Therapeutics|micro therapeutics
682162|NCT00703794|FX detachable coil system|fx detachable coil system
682163|NCT00703794|K060747|k060747
682164|NCT00703794|brain diseases|brain diseases
682165|NCT00703781|Cataract extraction with intraocular lens implantation|cataract extraction with intraocular lens implantation
682166|NCT00703768|Quality of Life|quality of life
682167|NCT00703768|Androgen Deprivation Therapy|androgen deprivation therapy
682168|NCT00703768|Goserelin|goserelin
682169|NCT00703755|Diabetes|diabetes
682170|NCT00703755|Hypertriglyceridaemia|hypertriglyceridaemia
682171|NCT00703755|Metabolic Syndrome|metabolic syndrome
682172|NCT00703716|mini-invasive|mini-invasive
682173|NCT00703716|dynamic screw-plate|dynamic screw-plate
682174|NCT00703716|Surfix|surfix
682175|NCT00703716|Lock-screw|lock-screw
682176|NCT00703703|Heart rate, overactive bladder|heart rate, overactive bladder
682177|NCT00703677|progressive supranuclear palsy|progressive supranuclear palsy
682178|NCT00703677|corticobasal degeneration|corticobasal degeneration
682179|NCT00703677|PSP|psp
682180|NCT00703677|CBD|cbd
682181|NCT00703677|lithium|lithium
682182|NCT00703677|tau|tau
682183|NCT00703651|Influenza|influenza
682184|NCT00703651|Orthomyxoviridae Infection|orthomyxoviridae infection
682185|NCT00703651|Inactivated, Split-virion influenza vaccine|inactivated, split-virion influenza vaccine
682186|NCT00703651|Intradermal injection|intradermal injection
682187|NCT00703651|Adults.|adults.
682188|NCT00703612|Diabetes Mellitus|diabetes mellitus
682189|NCT00703612|Adipose-derived stem cells|adipose-derived stem cells
682190|NCT00703612|Adipose stromal vascular fraction|adipose stromal vascular fraction
682191|NCT00703612|Autologous|autologous
682192|NCT00703612|Hyperglycemia|hyperglycemia
682193|NCT00703599|Diabetes Mellitus|diabetes mellitus
682194|NCT00703599|Adipose-derived stem cells|adipose-derived stem cells
682195|NCT00703599|Adipose stromal vascular fraction|adipose stromal vascular fraction
682196|NCT00703599|Autologous|autologous
682197|NCT00703599|Insulin-dependence|insulin-dependence
682198|NCT00703586|Maraviroc|maraviroc
682199|NCT00703586|Treatment Experienced|treatment experienced
682200|NCT00703573|Atopic Dermatitis|atopic dermatitis
682201|NCT00703560|HCV|hcv
682202|NCT00703560|Genotype 1|genotype 1
682203|NCT00703560|HIV co-infection|hiv co-infection
682204|NCT00703560|viral kinetics|viral kinetics
682205|NCT00703560|HCV quasi-species|hcv quasi-species
682206|NCT00703560|Hepatitis C genotype 1|hepatitis c genotype 1
682207|NCT00703560|HIV Infections|hiv infections
682208|NCT00703547|Depression|depression
682209|NCT00703534|GERD|gerd
682210|NCT00703534|Acid Reflux|acid reflux
682211|NCT00703534|Heartburn|heartburn
682212|NCT00703534|Regurgitation|regurgitation
682213|NCT00703534|non-acid reflux|non-acid reflux
682214|NCT00703534|PRO measures|pro measures
682215|NCT00703521|rabies vaccination|rabies vaccination
682216|NCT00703521|pre-exposure prophylaxis|pre-exposure prophylaxis
682217|NCT00703521|rabies virus neutralizing antibody|rabies virus neutralizing antibody
682218|NCT00703521|Antibody response|antibody response
682219|NCT00703521|immunologic memory of rabies vaccination|immunologic memory of rabies vaccination
682220|NCT00703521|Safety of rabies vaccination administered in pre-exposure regimens both intramuscular and intradermal routes|safety of rabies vaccination administered in pre-exposure regimens both intramuscular and intradermal routes
682221|NCT00703508|PCOS|pcos
682222|NCT00703495|traumatic|traumatic
682223|NCT00703495|brain injury|brain injury
682224|NCT00703495|brain regional oxygen saturation (rSO2)|brain regional oxygen saturation (rso2)
682225|NCT00703495|brain tissue oxygenation (PbtO2)|brain tissue oxygenation (pbto2)
682226|NCT00703495|cerebral perfusion pressure (CPP)|cerebral perfusion pressure (cpp)
682227|NCT00703482|Ventricular diastolic Function|ventricular diastolic function
682228|NCT00703482|Diabetes|diabetes
682229|NCT00703469|Hep C|hep c
682230|NCT00703456|Functional ankle instability|functional ankle instability
682231|NCT00703456|Balance training|balance training
682232|NCT00703443|Genetics|genetics
682233|NCT00703443|Dilated Cardiomyopathy|dilated cardiomyopathy
682234|NCT00703443|Hypertrophic Cardiomyopathy|hypertrophic cardiomyopathy
682235|NCT00703443|Mitochondrial Cardiomyopathy|mitochondrial cardiomyopathy
682236|NCT00703443|Noncompaction Cardiomyopathy|noncompaction cardiomyopathy
682237|NCT00703443|Restrictive Cardiomyopathy|restrictive cardiomyopathy
682238|NCT00703443|Heart Failure|heart failure
682239|NCT00703430|Alzheimer's disease, agitation, aggression, dementia|alzheimer's disease, agitation, aggression, dementia
682240|NCT00703417|osteoporosis|osteoporosis
682241|NCT00703417|diabetes|diabetes
682242|NCT00703404|Anti-Retroviral Therapy|anti-retroviral therapy
682243|NCT00703404|HIV|hiv
682244|NCT00703404|Virologic Response|virologic response
682245|NCT00703404|Treatment Naïve|treatment naïve
682246|NCT00703391|Chronic|chronic
682247|NCT00703391|obstructive|obstructive
682248|NCT00703391|pulmonary|pulmonary
682249|NCT00703391|lung|lung
682250|NCT00703391|respiratory disease|respiratory disease
682251|NCT00703391|tolerability|tolerability
682252|NCT00703391|placebo-controlled|placebo-controlled
682253|NCT00703391|pharmacokinetics|pharmacokinetics
682254|NCT00703391|COPD|copd
682255|NCT00703365|Hepatocellular Carcinoma (HCC)|hepatocellular carcinoma (hcc)
682256|NCT00703352|Transposition of the great arteries.|transposition of the great arteries.
682257|NCT00703352|Transposition of the great vessels.|transposition of the great vessels.
682258|NCT00703352|Mustard.|mustard.
682259|NCT00703352|Senning.|senning.
682260|NCT00703339|fibrosis, pulmonary|fibrosis, pulmonary
682261|NCT00703339|hypertension, pulmonary|hypertension, pulmonary
682262|NCT00703339|exercise, aerobic|exercise, aerobic
682263|NCT00703326|Metastatic breast cancer|metastatic breast cancer
682264|NCT00703326|HER2 negative breast cancer|her2 negative breast cancer
682265|NCT00703326|locally recurrent breast cancer|locally recurrent breast cancer
682266|NCT00703313|Study drug concentration in human tears|study drug concentration in human tears
682267|NCT00703274|ischemic stroke|ischemic stroke
682268|NCT00703274|stroke|stroke
682270|NCT00703274|cerebrovascular accident|cerebrovascular accident
682271|NCT00703274|CVA|cva
682272|NCT00703274|community health services|community health services
682273|NCT00703274|community health workers|community health workers
682274|NCT00703274|navigators|navigators
682275|NCT00703274|health education|health education
682276|NCT00703274|barriers to care|barriers to care
682277|NCT00703274|healthcare access|healthcare access
682278|NCT00703274|healthcare disparities|healthcare disparities
682279|NCT00703248|Human Immunodeficiency Virus (HIV)|human immunodeficiency virus (hiv)
682280|NCT00703248|complementary therapies|complementary therapies
682281|NCT00703222|high-risk neuroblastoma|high-risk neuroblastoma
682282|NCT00703222|single autologous stem cell rescue|single autologous stem cell rescue
682283|NCT00703209|symptomatic diabetic neuropathy|symptomatic diabetic neuropathy
682284|NCT00703209|diabetes|diabetes
682285|NCT00703209|burning feet|burning feet
682286|NCT00703209|Diabetic Neuropathy|diabetic neuropathy
682287|NCT00703209|Loss of sensation in the foot|loss of sensation in the foot
682288|NCT00703209|Neuropathy|neuropathy
682289|NCT00703209|Painful Diabetic Neuropathy|painful diabetic neuropathy
682290|NCT00703196|cervical cancer|cervical cancer
682291|NCT00703196|human papilloma virus infection|human papilloma virus infection
682292|NCT00703196|low-grade squamous intraepithelial lesion|low-grade squamous intraepithelial lesion
682293|NCT00703196|high-grade squamous intraepithelial lesion|high-grade squamous intraepithelial lesion
682294|NCT00703196|atypical squamous cells of undetermined significance|atypical squamous cells of undetermined significance
682295|NCT00703196|cervical intraepithelial neoplasia grade 1|cervical intraepithelial neoplasia grade 1
682296|NCT00703196|cervical intraepithelial neoplasia grade 2|cervical intraepithelial neoplasia grade 2
682297|NCT00703196|cervical intraepithelial neoplasia grade 3|cervical intraepithelial neoplasia grade 3
682298|NCT00703144|Pharmacokinetics|pharmacokinetics
682299|NCT00703144|piperacillin/tazobactam.|piperacillin/tazobactam.
682300|NCT00703144|Septic patients|septic patients
682301|NCT00703144|oliguric renal failure|oliguric renal failure
682302|NCT00703144|continuous veno-venous hemodiafiltration.|continuous veno-venous hemodiafiltration.
682303|NCT00703131|fistula|fistula
682304|NCT00703131|anal fistula|anal fistula
682305|NCT00703118|Hepatitis C, Chronic|hepatitis c, chronic
682306|NCT00703118|Telaprevir|telaprevir
682307|NCT00703118|Peg-IFN-alfa-2a|peg-ifn-alfa-2a
682308|NCT00703118|Ribavirin|ribavirin
682309|NCT00703105|ovarian cancer|ovarian cancer
682310|NCT00703105|Tregs|tregs
682311|NCT00703105|vaccine|vaccine
682312|NCT00703105|Recurrent Ovarian Cancer|recurrent ovarian cancer
682313|NCT00703079|Acromegaly|acromegaly
682314|NCT00703079|GH|gh
682315|NCT00703079|IGF-I|igf-i
682316|NCT00703079|Octreotide-LAR|octreotide-lar
682317|NCT00703079|Lanreotide|lanreotide
682318|NCT00703079|Transsphenoidal surgery|transsphenoidal surgery
682319|NCT00703066|Malaria|malaria
682320|NCT00703066|Vaccine|vaccine
682321|NCT00703066|GMZ2|gmz2
682322|NCT00703066|Safety|safety
682323|NCT00703066|African|african
682324|NCT00703066|immunogenicity|immunogenicity
682325|NCT00703053|influenza, H5N1, vaccine, avian influenza, parent protocol|influenza, h5n1, vaccine, avian influenza, parent protocol
682326|NCT00703040|Care engagement|care engagement
682327|NCT00703040|Linkage to care|linkage to care
682328|NCT00703040|HIV Infections|hiv infections
682329|NCT00703027|diabetes mellitus|diabetes mellitus
682330|NCT00703027|care decision|care decision
682331|NCT00703027|data mining|data mining
682332|NCT00703014|Neonatal outcome|neonatal outcome
682333|NCT00703014|Congenital malformations|congenital malformations
682334|NCT00703014|In-Vitro fertilization|in-vitro fertilization
682335|NCT00703014|Controlled ovarian stimulation|controlled ovarian stimulation
682336|NCT00703014|Follow-up|follow-up
682337|NCT00702988|Neonatal outcome|neonatal outcome
682338|NCT00702988|Congenital malformations|congenital malformations
682339|NCT00702988|In-Vitro Fertilization|in-vitro fertilization
682340|NCT00702988|Controlled ovarian stimulation|controlled ovarian stimulation
682341|NCT00702988|Follow-up|follow-up
682342|NCT00702975|phase II|phase ii
682343|NCT00702975|NSCLC|nsclc
682344|NCT00702975|bevacizumab|bevacizumab
682345|NCT00702975|erlotinib|erlotinib
682346|NCT00702975|metastatic NSCLC|metastatic nsclc
682347|NCT00702962|lung cancer|lung cancer
682348|NCT00702962|small cell lung cancer|small cell lung cancer
682349|NCT00702949|breast cancer|breast cancer
682350|NCT00702949|hot flashes|hot flashes
682351|NCT00702923|Stage D0 Prostate Cancer|stage d0 prostate cancer
682352|NCT00702923|Rising PSA|rising psa
682353|NCT00702923|Casodex|casodex
682354|NCT00702923|Tremelimumab|tremelimumab
682355|NCT00702910|Asthma patients|asthma patients
682356|NCT00702910|Magnesium stearate|magnesium stearate
682357|NCT00702910|Tolerability|tolerability
682358|NCT00702910|Safety|safety
682359|NCT00702910|Lactose|lactose
682360|NCT00702910|GW642444M|gw642444m
682361|NCT00702910|Pharmacodynamics|pharmacodynamics
682362|NCT00702910|Efficacy|efficacy
682363|NCT00702910|Pharmacokinetics|pharmacokinetics
682364|NCT00702884|recurrent esophageal cancer|recurrent esophageal cancer
682365|NCT00702884|stage IIIA esophageal cancer|stage iiia esophageal cancer
682366|NCT00702884|stage IIIB esophageal cancer|stage iiib esophageal cancer
682367|NCT00702884|stage IIIC esophageal cancer|stage iiic esophageal cancer
682368|NCT00702884|stage IV esophageal cancer|stage iv esophageal cancer
682369|NCT00702871|Ventilator Associated Pneumonia|ventilator associated pneumonia
682370|NCT00702871|antimicrobial susceptibility pattern|antimicrobial susceptibility pattern
682371|NCT00702871|stress ulcer prophylaxis|stress ulcer prophylaxis
682372|NCT00702858|Breast Cancer|breast cancer
682373|NCT00702858|Joint Pain|joint pain
682374|NCT00702858|Aromatase Inhibitors|aromatase inhibitors
682375|NCT00702845|In vitro fertilization|in vitro fertilization
682376|NCT00702845|Pharmacological effects of drugs|pharmacological effects of drugs
682377|NCT00702845|Hormones|hormones
682378|NCT00702845|Hormone Substitutes and Hormone Antagonists|hormone substitutes and hormone antagonists
682379|NCT00702845|Pharmacological Actions|pharmacological actions
682380|NCT00702845|Randomized|randomized
682381|NCT00702845|Multi-center|multi-center
682382|NCT00702845|Multi-national|multi-national
682383|NCT00702845|Double-blind|double-blind
682384|NCT00702845|Active-controlled|active-controlled
682385|NCT00702845|Equivalence|equivalence
682386|NCT00702832|Vestibular rehabilitation|vestibular rehabilitation
682387|NCT00702832|acute vestibular injury|acute vestibular injury
682388|NCT00702832|Dizziness|dizziness
682389|NCT00702832|Nausea|nausea
682390|NCT00702832|Nystagmus|nystagmus
682391|NCT00702832|Daily life activities|daily life activities
682392|NCT00702832|Balance|balance
682393|NCT00702832|physiotherapy|physiotherapy
682394|NCT00702819|Pan-Vascular Endothelial Growth Factor Blockade|pan-vascular endothelial growth factor blockade
682395|NCT00702819|Safety|safety
682396|NCT00702806|Pharmacological effects of drugs|pharmacological effects of drugs
682397|NCT00702806|Hormones|hormones
682398|NCT00702806|Hormone substitutes and Hormone Antagonists|hormone substitutes and hormone antagonists
682399|NCT00702806|Pharmacological Actions|pharmacological actions
682400|NCT00702806|Randomized|randomized
682401|NCT00702806|Multi-center|multi-center
682402|NCT00702806|Multi-national|multi-national
682403|NCT00702793|Smoking cessation|smoking cessation
682404|NCT00702793|schizophrenia|schizophrenia
682405|NCT00702793|schizoaffective|schizoaffective
682406|NCT00702793|psychosis|psychosis
682407|NCT00702793|varenicline|varenicline
682408|NCT00702793|champix|champix
682409|NCT00702793|chantix|chantix
682410|NCT00702793|nicotine dependence|nicotine dependence
682411|NCT00702780|Alzheimer's disease|alzheimer's disease
682412|NCT00702780|escitalopram|escitalopram
682413|NCT00702780|MRI|mri
682414|NCT00702767|This study was completed in October 2006|this study was completed in october 2006
682415|NCT00702741|Knee|knee
682416|NCT00702741|Meniscus|meniscus
682417|NCT00702741|Meniscectomy|meniscectomy
682418|NCT00702741|Mesenchymal Stem Cells|mesenchymal stem cells
682419|NCT00702741|MSCs|mscs
682420|NCT00702741|Adult Human Stem Cells|adult human stem cells
682421|NCT00702741|Osiris|osiris
682422|NCT00702741|Chondrogen|chondrogen
682423|NCT00702728|Contrast induced nephropathy|contrast induced nephropathy
682424|NCT00702728|Furosemide|furosemide
682425|NCT00702728|Percutaneous coronary interventions|percutaneous coronary interventions
682426|NCT00702728|Saline hydration|saline hydration
682427|NCT00702702|Uterine fibroids|uterine fibroids
682428|NCT00702702|Anemia|anemia
682429|NCT00702689|Skin Sclerosis|skin sclerosis
682430|NCT00702689|Graft Versus Host Disease|graft versus host disease
682431|NCT00702676|Healthy Volunteers|healthy volunteers
682432|NCT00702663|Hepatitis B|hepatitis b
682433|NCT00702663|Hepatitis B vaccination|hepatitis b vaccination
682434|NCT00702663|booster effect|booster effect
682435|NCT00702663|Taiwan|taiwan
682436|NCT00702663|young adults|young adults
682437|NCT00702637|Traumatic Brain Injury|traumatic brain injury
682438|NCT00702637|Fatigue|fatigue
682439|NCT00702637|Modafinil|modafinil
682440|NCT00702637|Somnolence|somnolence
682441|NCT00702624|Neonatal outcome|neonatal outcome
682442|NCT00702624|Congenital malformations|congenital malformations
682443|NCT00702624|In-Vitro fertilization|in-vitro fertilization
682444|NCT00702624|Controlled ovarian stimulation|controlled ovarian stimulation
682445|NCT00702624|Follow-up|follow-up
682446|NCT00702611|Ulcerative Colitis|ulcerative colitis
682447|NCT00702611|Inflammatory Bowel disease|inflammatory bowel disease
682448|NCT00702611|Steroid dependent|steroid dependent
682449|NCT00702611|Adacolumn|adacolumn
682450|NCT00702611|Apheresis|apheresis
682451|NCT00702611|Granulocyte Monocyte apheresis|granulocyte monocyte apheresis
682452|NCT00702611|GMA apheresis|gma apheresis
682453|NCT00702611|Granulocytapheresis|granulocytapheresis
682454|NCT00702598|Depression|depression
682455|NCT00702598|occupational function|occupational function
682456|NCT00702598|rating scales|rating scales
682457|NCT00702598|RCT|rct
682458|NCT00702598|cognitive behaviour therapy|cognitive behaviour therapy
682459|NCT00702598|CBT|cbt
682460|NCT00702598|escitalopram|escitalopram
682461|NCT00702598|antidepressants|antidepressants
682462|NCT00702585|Ovulation Induction|ovulation induction
682463|NCT00702585|Pharmacological effects of drugs|pharmacological effects of drugs
682464|NCT00702585|Hormones|hormones
682465|NCT00702585|Hormone substitutes and Hormone Antagonists|hormone substitutes and hormone antagonists
682466|NCT00702585|Pharmacological Actions|pharmacological actions
682467|NCT00702585|Randomized|randomized
682468|NCT00702585|Multi-center|multi-center
682469|NCT00702585|Multi-national|multi-national
682470|NCT00702572|Phase I|phase i
682471|NCT00702572|Advanced non-small cell lung cancer|advanced non-small cell lung cancer
682472|NCT00702546|In-vitro fertilization|in-vitro fertilization
682473|NCT00702546|Controlled Ovarian Stimulation|controlled ovarian stimulation
682474|NCT00702546|Cumulative pregnancy data|cumulative pregnancy data
682475|NCT00702546|Follow-up|follow-up
682476|NCT00702533|Gastric Acid Output|gastric acid output
682477|NCT00702533|Hyper/Hyposecretion|hyper/hyposecretion
682478|NCT00702533|Gastric Analysis|gastric analysis
682479|NCT00702533|Gastric pH|gastric ph
682480|NCT00702533|SmartPill|smartpill
682481|NCT00702533|ph Monitoring|ph monitoring
682482|NCT00702533|Gastric Secretion|gastric secretion
682483|NCT00702533|Healthy Volunteer|healthy volunteer
865003|NCT00052286|fatigue|fatigue
682484|NCT00702533|HV|hv
682485|NCT00702520|Neonatal outcome|neonatal outcome
682486|NCT00702520|Congenital malformations|congenital malformations
682487|NCT00702520|In-Vitro fertilization|in-vitro fertilization
682488|NCT00702520|Controlled ovarian stimulation|controlled ovarian stimulation
682489|NCT00702520|Follow-up|follow-up
682490|NCT00702507|Diaper dermatitis complicated by candidiasis|diaper dermatitis complicated by candidiasis
682491|NCT00702494|placental growth factor|placental growth factor
682492|NCT00702494|monoclonal antibody|monoclonal antibody
682493|NCT00702494|Phase I|phase i
682494|NCT00702494|solid tumors|solid tumors
682495|NCT00702494|Patients with solid tumors|patients with solid tumors
682496|NCT00702481|Head and Neck Squamous Cell Cancer|head and neck squamous cell cancer
682497|NCT00702481|Chemoradiation|chemoradiation
682498|NCT00702481|EGFR monoclonal antibody|egfr monoclonal antibody
682499|NCT00702468|Spasticity|spasticity
682500|NCT00702468|Multiple Sclerosis|multiple sclerosis
682501|NCT00702455|Weight loss maintenance.|weight loss maintenance.
682502|NCT00702455|Interactive phone and mail-based intervention.|interactive phone and mail-based intervention.
682503|NCT00702442|Nausea, Vomiting|nausea, vomiting
682504|NCT00702442|Vomiting episodes|vomiting episodes
682505|NCT00702416|Analgesia, Patient-controlled|analgesia, patient-controlled
682506|NCT00702416|Anesthesia, Regional|anesthesia, regional
682507|NCT00702416|Ultrasound|ultrasound
682508|NCT00702416|Postoperative Pain|postoperative pain
682509|NCT00702416|Brachial Plexus|brachial plexus
682510|NCT00702364|Attention|attention
682511|NCT00702364|Traumatic Brain INjury|traumatic brain injury
682512|NCT00702364|Atomoxetine|atomoxetine
682513|NCT00702364|Strattera|strattera
682514|NCT00702351|Infertility|infertility
682515|NCT00702351|Pharmacological effects of drugs|pharmacological effects of drugs
682516|NCT00702351|Drug therapy|drug therapy
682517|NCT00702351|Hormones|hormones
682518|NCT00702351|GnRH agonist|gnrh agonist
682519|NCT00702351|RecFSH|recfsh
682520|NCT00702351|Corifollitropin alfa|corifollitropin alfa
682521|NCT00702351|Open-label|open-label
682522|NCT00702338|Neonatal outcome|neonatal outcome
682523|NCT00702338|Congenital malformations|congenital malformations
682524|NCT00702338|Ovulation Induction|ovulation induction
682525|NCT00702338|Follow-up|follow-up
682526|NCT00702325|Asthma|asthma
682527|NCT00702312|Blood pressure|blood pressure
682528|NCT00702299|stage III ovarian epithelial cancer|stage iii ovarian epithelial cancer
682529|NCT00702299|recurrent ovarian epithelial cancer|recurrent ovarian epithelial cancer
682530|NCT00702299|peritoneal cavity cancer|peritoneal cavity cancer
682531|NCT00702299|fallopian tube cancer|fallopian tube cancer
682532|NCT00702286|Surface acoustic ultrasound|surface acoustic ultrasound
682533|NCT00702286|biofilm formation|biofilm formation
682534|NCT00702286|percoutaneous nephrostomy tube|percoutaneous nephrostomy tube
682535|NCT00702286|Patients requiring per coetaneous drainage due to urinary|patients requiring per coetaneous drainage due to urinary
682536|NCT00702286|tract obstruction|tract obstruction
682537|NCT00702286|To evaluate the efficacy of surface acoustic wave in|to evaluate the efficacy of surface acoustic wave in
682538|NCT00702286|reducing pain and improving drainage|reducing pain and improving drainage
682539|NCT00702273|In-vitro fertilization|in-vitro fertilization
682540|NCT00702273|Controlled Ovarian Stimulation|controlled ovarian stimulation
682541|NCT00702273|Cumulative pregnancy data|cumulative pregnancy data
682542|NCT00702273|Follow-up|follow-up
682543|NCT00702247|Multiple Myeloma - Nonmyeloablative transplantation - Autologous Transplant - Graft versus myeloma|multiple myeloma - nonmyeloablative transplantation - autologous transplant - graft versus myeloma
682544|NCT00702247|Newly diagnosed multiple myeloma|newly diagnosed multiple myeloma
682545|NCT00702247|Tandem Auto-Allo Transplant|tandem auto-allo transplant
682546|NCT00702247|Overall survival|overall survival
682547|NCT00702247|Event free survival|event free survival
682548|NCT00702247|Disease response|disease response
682549|NCT00702234|Neonatal outcome|neonatal outcome
682550|NCT00702234|Congenital malformations|congenital malformations
682551|NCT00702234|In-Vitro fertilization|in-vitro fertilization
682552|NCT00702234|Controlled ovarian stimulation|controlled ovarian stimulation
682553|NCT00702234|Follow-up|follow-up
682554|NCT00702221|high blood pressure|high blood pressure
682555|NCT00702221|vaccines|vaccines
682556|NCT00702208|cervical cytology|cervical cytology
682557|NCT00702208|Pap smear|pap smear
682558|NCT00702208|self-sampling|self-sampling
682559|NCT00702208|abnormal|abnormal
682560|NCT00702208|normal|normal
682561|NCT00702195|Neonatal outcome|neonatal outcome
682562|NCT00702195|Congenital malformations|congenital malformations
682563|NCT00702195|In-Vitro Fertilization|in-vitro fertilization
682564|NCT00702195|Controlled ovarian stimulation|controlled ovarian stimulation
682565|NCT00702195|Follow-up|follow-up
682566|NCT00702195|Ovulation Induction|ovulation induction
682567|NCT00702195|Neonates|neonates
682568|NCT00702182|Lung Cancer|lung cancer
682569|NCT00702182|Vinorelbine|vinorelbine
682570|NCT00702182|Erlotinib|erlotinib
682571|NCT00702182|Phase 1|phase 1
682572|NCT00702169|high frequency ventilation monitoring|high frequency ventilation monitoring
682573|NCT00702169|lung disease|lung disease
682574|NCT00702169|Respiratory distress syndrome|respiratory distress syndrome
682575|NCT00702169|lung barotrauma|lung barotrauma
682576|NCT00702169|mechanical ventilation|mechanical ventilation
682577|NCT00702169|endotracheal tube displacement|endotracheal tube displacement
682578|NCT00702169|endotracheal tube occlusion|endotracheal tube occlusion
682579|NCT00702169|one lung intubation|one lung intubation
682580|NCT00702156|Heart Failure|heart failure
682581|NCT00702156|Chronic Obstructive Pulmonary Disease|chronic obstructive pulmonary disease
682582|NCT00702156|Beta-blockers|beta-blockers
682583|NCT00702156|Pulmonary Function|pulmonary function
682584|NCT00702130|Ventilator Associated Pneumonia|ventilator associated pneumonia
682585|NCT00702104|prostate cancer|prostate cancer
682586|NCT00702078|COPD|copd
682587|NCT00702078|home-based treatment|home-based treatment
682588|NCT00702078|early intervention|early intervention
682589|NCT00702065|Multiple Sclerosis Quality of life|multiple sclerosis quality of life
682590|NCT00702052|Mantle Cell Lymphoma|mantle cell lymphoma
682591|NCT00702052|Lymphoma|lymphoma
682592|NCT00702052|B-Cell Lymphoma|b-cell lymphoma
682593|NCT00702052|Mantle Zone Lymphoma|mantle zone lymphoma
682594|NCT00702052|Refractory Lymphoma|refractory lymphoma
682595|NCT00702052|Aggressive Lymphoma|aggressive lymphoma
682596|NCT00702052|PILLAR-1|pillar-1
682597|NCT00702026|Irritable Bowel Syndrome|irritable bowel syndrome
682598|NCT00702026|Hypersensitivity|hypersensitivity
682599|NCT00702026|Probiotics|probiotics
682600|NCT00702026|Multispecies|multispecies
682601|NCT00702013|P-glycoprotein|p-glycoprotein
682602|NCT00702013|lymphocyte|lymphocyte
682603|NCT00702013|HIV|hiv
682604|NCT00702013|children|children
682605|NCT00702013|ontogenesis|ontogenesis
682606|NCT00702013|Ontogenesis P-gp in human lymphocytes|ontogenesis p-gp in human lymphocytes
682607|NCT00702013|Study of the influence of HIV infection|study of the influence of hiv infection
682608|NCT00702013|Antiretroviral treatments on P-gp activity|antiretroviral treatments on p-gp activity
682609|NCT00702013|Expression in human lymphocytes|expression in human lymphocytes
682610|NCT00702000|ICU acquired paresis|icu acquired paresis
682611|NCT00701987|Cutaneous Metastatic Melanoma|cutaneous metastatic melanoma
682612|NCT00701974|Non-inferiority based on efficiency|non-inferiority based on efficiency
682613|NCT00701961|Mefloquine-artesunate|mefloquine-artesunate
682614|NCT00701961|Malaria|malaria
682615|NCT00701961|Pregnancy|pregnancy
682616|NCT00701961|Pharmacokinetics|pharmacokinetics
682617|NCT00701961|Sub-Saharan Africa|sub-saharan africa
682618|NCT00701961|P falciparum malaria infection in pregnancy|p falciparum malaria infection in pregnancy
682619|NCT00701948|Late onset neonatal sepsis|late onset neonatal sepsis
682620|NCT00701948|Nosocomial bacterial infection|nosocomial bacterial infection
682621|NCT00701948|Inflammatory markers|inflammatory markers
682622|NCT00701948|multiplex dosage|multiplex dosage
682623|NCT00701935|diabetes mellitus|diabetes mellitus
682624|NCT00701935|Amylin|amylin
682625|NCT00701935|Lilly|lilly
682626|NCT00701922|lung transplantation|lung transplantation
682627|NCT00701922|Bronchiolitis Obliterans|bronchiolitis obliterans
682628|NCT00701922|Epstein-Barr Virus Infections|epstein-barr virus infections
682629|NCT00701922|Paramyxoviridae Infections|paramyxoviridae infections
682630|NCT00701922|Herpesviridae|herpesviridae
682631|NCT00701909|wound care|wound care
682632|NCT00701909|procedural pain intensity|procedural pain intensity
682633|NCT00701909|procedural hyperalgesia|procedural hyperalgesia
682634|NCT00701909|wound care pain intensity|wound care pain intensity
682635|NCT00701909|wound care hyperalgesia|wound care hyperalgesia
682636|NCT00701909|Wound care pain quality|wound care pain quality
682637|NCT00701909|Level of drowsiness|level of drowsiness
682638|NCT00701909|level of nausea|level of nausea
682639|NCT00701909|Level of vomiting|level of vomiting
682640|NCT00701909|Level of hallucinations|level of hallucinations
682641|NCT00701909|Level of dysphoria|level of dysphoria
682642|NCT00701896|HIV|hiv
682643|NCT00701896|Positive|positive
682644|NCT00701896|Smokers|smokers
682645|NCT00701896|Varenicline|varenicline
682646|NCT00701883|Cholesterol|cholesterol
682647|NCT00701883|Hyperlipidemia|hyperlipidemia
682648|NCT00701883|HDL|hdl
682649|NCT00701883|LDL|ldl
682650|NCT00701883|Triglycerides|triglycerides
682651|NCT00701883|Dyslipidemia|dyslipidemia
682652|NCT00701870|NSCLC|nsclc
682653|NCT00701870|Chemotherapy induced neutropenia|chemotherapy induced neutropenia
682654|NCT00701870|CIN|cin
682655|NCT00701857|stage III esophageal cancer|stage iii esophageal cancer
682656|NCT00701857|stage IV esophageal cancer|stage iv esophageal cancer
682657|NCT00701844|Aplastic Anemia|aplastic anemia
682658|NCT00701844|Lymphatic Diseases|lymphatic diseases
682659|NCT00701844|Leukemia|leukemia
682660|NCT00701844|Leukemia, Lymphoid|leukemia, lymphoid
682661|NCT00701844|Immunoproliferative Disorders|immunoproliferative disorders
682662|NCT00701844|Precursor Cell Lymphoblastic Leukemia-Lymphoma|precursor cell lymphoblastic leukemia-lymphoma
682663|NCT00701844|Anemia|anemia
682664|NCT00701844|Quality of Life|quality of life
682665|NCT00701844|Lymphoproliferative Disorders|lymphoproliferative disorders
682666|NCT00701844|Lymphoma|lymphoma
682667|NCT00701844|Multiple Myeloma|multiple myeloma
682668|NCT00701805|Secondary hyperparathyroidism|secondary hyperparathyroidism
682669|NCT00701805|Hemodialysis|hemodialysis
682670|NCT00701805|paricalcitol|paricalcitol
682671|NCT00701792|cirrhosis transplantation|cirrhosis transplantation
682672|NCT00701779|Benign Prostatic Hyperplasia|benign prostatic hyperplasia
682673|NCT00701779|Dutasteride|dutasteride
682674|NCT00701779|Tamsulosin|tamsulosin
682675|NCT00701753|Pharmacogenetic|pharmacogenetic
682676|NCT00701753|DNA|dna
682677|NCT00701753|RNA|rna
682678|NCT00701753|Antipsychotic|antipsychotic
682679|NCT00701753|Olanzapine|olanzapine
682680|NCT00701753|Risperidone|risperidone
682681|NCT00701753|Quetiapine|quetiapine
682682|NCT00701753|Personalized medicine|personalized medicine
682683|NCT00701740|photoaging|photoaging
682684|NCT00701740|isotretinoin|isotretinoin
682685|NCT00701740|profilometry|profilometry
682686|NCT00701740|digital analysis|digital analysis
682687|NCT00701727|metabolic diseases|metabolic diseases
682688|NCT00701727|metabolic disorder|metabolic disorder
682689|NCT00701727|dyslipidemias|dyslipidemias
682690|NCT00701727|lipid metabolism disorders|lipid metabolism disorders
682691|NCT00701714|Treatment|treatment
682692|NCT00701714|associated|associated
682693|NCT00701714|with CRI|with cri
682694|NCT00701688|Mucositis, Oral|mucositis, oral
682695|NCT00701688|Hematopoietic Stem Cell Transplantation|hematopoietic stem cell transplantation
682696|NCT00701688|Allogeneic Transplantation|allogeneic transplantation
682697|NCT00701688|Pharmacokinetics|pharmacokinetics
682698|NCT00701688|Maximum Tolerated Dose|maximum tolerated dose
682699|NCT00701675|sertraline|sertraline
682700|NCT00701675|pharmacotherapy|pharmacotherapy
682701|NCT00701675|geriatric|geriatric
682702|NCT00701649|mild essential hypertension|mild essential hypertension
682703|NCT00701649|moderate essential hypertension|moderate essential hypertension
682704|NCT00701636|Daptomycin|daptomycin
682705|NCT00701636|Antibiotic Prophylaxis|antibiotic prophylaxis
682706|NCT00701636|Pharmacokinetics|pharmacokinetics
682707|NCT00701636|Surgical Wound Infection|surgical wound infection
682708|NCT00701636|Staphylococcus aureus|staphylococcus aureus
682709|NCT00701636|Cardiopulmonary Bypass Surgery|cardiopulmonary bypass surgery
682710|NCT00701623|The intention of this work is to verify the effectiveness and safety of sodium heparin in the treatment of burns of the skin.|the intention of this work is to verify the effectiveness and safety of sodium heparin in the treatment of burns of the skin.
682711|NCT00701610|Von Willebramd Factor (VWF)|von willebramd factor (vwf)
682712|NCT00701610|All infants born in our hospital since August 2007 ill august 2009 will enter.|all infants born in our hospital since august 2007 ill august 2009 will enter.
682713|NCT00701610|Therombocytopenia, maternal aspirin will be excluded|therombocytopenia, maternal aspirin will be excluded
682714|NCT00701597|ocular blood flow dysregulation, glaucoma, endothelin-1|ocular blood flow dysregulation, glaucoma, endothelin-1
682715|NCT00701584|Phytoestrogens|phytoestrogens
682716|NCT00701584|Isoflavones|isoflavones
682717|NCT00701584|Lignans|lignans
682718|NCT00701584|Breast cancer survival|breast cancer survival
682719|NCT00701584|breast cancer recurrence|breast cancer recurrence
682720|NCT00701571|Virtual Reality|virtual reality
682721|NCT00701571|Oncology|oncology
682722|NCT00701571|Lumbar puncture|lumbar puncture
682723|NCT00701545|von Willebrand disease|von willebrand disease
682724|NCT00701545|VWD, Humate-P®|vwd, humate-p®
682725|NCT00701545|Infusion volume reduced|infusion volume reduced
682726|NCT00701545|ivr|ivr
682727|NCT00701532|Cocaine|cocaine
682728|NCT00701532|Substance abuse|substance abuse
682729|NCT00701532|Addiction|addiction
682730|NCT00701532|Dependence|dependence
682731|NCT00701532|Modafinil|modafinil
682732|NCT00701532|Brain imaging|brain imaging
682733|NCT00701519|CHF,|chf,
682734|NCT00701519|Sleep apnea,|sleep apnea,
682735|NCT00701519|Obstructive sleep apnea,|obstructive sleep apnea,
682736|NCT00701519|Heart failure|heart failure
682737|NCT00701506|Knee|knee
682738|NCT00701506|Osteoarthritis|osteoarthritis
682739|NCT00701506|Treatment|treatment
682740|NCT00701506|Electrostimulation|electrostimulation
682741|NCT00701493|Topiramate|topiramate
682742|NCT00701493|Topiramate oral liquid|topiramate oral liquid
682743|NCT00701493|TOPAMAX Sprinkle capsule|topamax sprinkle capsule
682744|NCT00701493|topiramate capsules|topiramate capsules
682745|NCT00701480|acne|acne
682746|NCT00701480|skin cleanser|skin cleanser
682747|NCT00701480|Hibiscus sabdariffa|hibiscus sabdariffa
682748|NCT00701480|Roselle|roselle
682749|NCT00701480|safety|safety
682750|NCT00701480|efficacy|efficacy
682751|NCT00701467|ICD|icd
682752|NCT00701467|ICD implanted patients|icd implanted patients
682753|NCT00701454|Thai-muslim|thai-muslim
682754|NCT00701454|Thai-HALAL|thai-halal
682755|NCT00701454|Diabetes|diabetes
682756|NCT00701454|Hypertension|hypertension
682757|NCT00701454|Hyperlipidemia|hyperlipidemia
682758|NCT00701454|Metabolic syndrome|metabolic syndrome
682759|NCT00701441|sleep apnea,|sleep apnea,
682760|NCT00701441|oxidative stress|oxidative stress
682761|NCT00701428|Hypertension|hypertension
682762|NCT00701428|Sleep Apnea|sleep apnea
682763|NCT00701428|Angiotensin II antagonist|angiotensin ii antagonist
682764|NCT00701428|CPAP|cpap
682765|NCT00701415|α-GAL, α-Galactosidase-A, r-hαGAL|α-gal, α-galactosidase-a, r-hαgal
682766|NCT00701402|time to lipid-lowering drug implementation|time to lipid-lowering drug implementation
682767|NCT00701402|dyslipidemic patients|dyslipidemic patients
682768|NCT00701376|Gastric Bypass surgery|gastric bypass surgery
682769|NCT00701376|Hepatic disease|hepatic disease
682770|NCT00701376|Hepatic function|hepatic function
682771|NCT00701350|Pregnancy|pregnancy
682772|NCT00701350|Intra-amniotic Infection|intra-amniotic infection
682773|NCT00701350|Preterm Birth|preterm birth
682774|NCT00701350|Preterm Premature Rupture of Membranes|preterm premature rupture of membranes
682775|NCT00701337|Estrogen Replacement Therapy|estrogen replacement therapy
682776|NCT00701337|menopausal women|menopausal women
682777|NCT00701311|Prostatitis|prostatitis
682778|NCT00701311|Pelvic pain|pelvic pain
682779|NCT00701285|heart failure|heart failure
682780|NCT00701285|pitavastatin|pitavastatin
682781|NCT00701285|pravastatin|pravastatin
682782|NCT00701285|statin|statin
682783|NCT00701259|Frequent heartburn, proton pump inhibitor, lansoprazole|frequent heartburn, proton pump inhibitor, lansoprazole
682784|NCT00701259|Treatment of|treatment of
682785|NCT00701259|over 14 days|over 14 days
682786|NCT00701246|Anemia|anemia
682787|NCT00701246|Iron deficiency anemia|iron deficiency anemia
682788|NCT00701246|Infants|infants
682789|NCT00701246|Children|children
682790|NCT00701246|Clinical trials|clinical trials
682791|NCT00701246|Ferrous sulfate|ferrous sulfate
682792|NCT00701246|Folic acid|folic acid
682793|NCT00701246|Daycare centers|daycare centers
682794|NCT00701246|Anaemia in children|anaemia in children
682795|NCT00701246|born at term|born at term
682796|NCT00701246|non-twins|non-twins
682797|NCT00701246|with parental approval for participation in the study|with parental approval for participation in the study
682798|NCT00701246|growth|growth
682799|NCT00701220|Cardiovascular Disease|cardiovascular disease
682800|NCT00701220|Cardiomyopathy|cardiomyopathy
682801|NCT00701220|Heart Disease|heart disease
682802|NCT00701220|Myocardial Disease|myocardial disease
682803|NCT00701220|Myocardial Ischemia|myocardial ischemia
682804|NCT00701207|To determine if nicotine treatment reduces lung inflammation|to determine if nicotine treatment reduces lung inflammation
682805|NCT00701194|placement instability|placement instability
682806|NCT00701194|disruptive behavior disorders|disruptive behavior disorders
682807|NCT00701194|school readiness|school readiness
682808|NCT00701194|developmental delays|developmental delays
682809|NCT00701194|cortisol|cortisol
682810|NCT00701194|executive functioning|executive functioning
682811|NCT00701194|therapeutic foster care|therapeutic foster care
682812|NCT00701194|prevention|prevention
682813|NCT00701194|early intervention|early intervention
682814|NCT00701181|Phase II|phase ii
682815|NCT00701181|Prospective|prospective
682816|NCT00701181|Randomized|randomized
682817|NCT00701181|Diabetic Macular Edema|diabetic macular edema
682818|NCT00701181|PF-04523655|pf-04523655
682819|NCT00701181|Laser|laser
682820|NCT00701129|Glycogenesis 2|glycogenesis 2
682821|NCT00701129|Acid|acid
682822|NCT00701129|Maltase|maltase
682823|NCT00701129|Deficiency|deficiency
682824|NCT00701090|Type 2 Diabetes Mellitus|type 2 diabetes mellitus
682825|NCT00701090|Non Insulin Dependent|non insulin dependent
682826|NCT00701077|Brugada syndrome|brugada syndrome
682827|NCT00701077|Electrophysiological study|electrophysiological study
682828|NCT00701077|Ion channel blockade|ion channel blockade
682829|NCT00701064|posttraumatic stress disorder|posttraumatic stress disorder
682830|NCT00701064|phototherapy|phototherapy
682831|NCT00701064|anxiety|anxiety
682832|NCT00701064|depression|depression
682833|NCT00701064|sleep|sleep
682834|NCT00701064|negative ion generator|negative ion generator
682835|NCT00701038|Sleep apnea,|sleep apnea,
682836|NCT00701038|obstructive sleep apnea,|obstructive sleep apnea,
682837|NCT00701038|heart failure,|heart failure,
682838|NCT00701038|CHF|chf
682839|NCT00701025|inflammation in asthmatic and non-asthmatic participants|inflammation in asthmatic and non-asthmatic participants
682840|NCT00701012|low or high ligation|low or high ligation
682841|NCT00700986|Electroretinography|electroretinography
682842|NCT00700986|Rheumatoid Arthritis|rheumatoid arthritis
682843|NCT00700986|Anti-TNF|anti-tnf
682844|NCT00700986|Disease Modifying Anti-Rheumatic Drugs (DMARD)|disease modifying anti-rheumatic drugs (dmard)
682845|NCT00700973|anger|anger
682846|NCT00700973|psychotherapy, brief|psychotherapy, brief
682847|NCT00700973|diagnosis, dual|diagnosis, dual
682848|NCT00700947|Heart Disease|heart disease
682849|NCT00700947|Mitral Regurgitation|mitral regurgitation
682850|NCT00700947|Heart Valve Disease|heart valve disease
682851|NCT00700947|Mitral Valve Insufficiency|mitral valve insufficiency
682852|NCT00700947|Heart Surgery|heart surgery
682853|NCT00700947|Heart Valve Surgery|heart valve surgery
682854|NCT00700934|FEV1|fev1
682855|NCT00700934|mortality|mortality
682856|NCT00700934|Quality of life|quality of life
682857|NCT00700908|type 2 diabetes|type 2 diabetes
682858|NCT00700908|telephone intervention|telephone intervention
682859|NCT00700908|automated|automated
682860|NCT00700882|stage IV melanoma|stage iv melanoma
682861|NCT00700882|acral lentiginous malignant melanoma|acral lentiginous malignant melanoma
682862|NCT00700882|mucosal melanoma|mucosal melanoma
682863|NCT00700882|recurrent melanoma|recurrent melanoma
682864|NCT00700882|stage IIIA melanoma|stage iiia melanoma
682865|NCT00700882|stage IIIB melanoma|stage iiib melanoma
682866|NCT00700882|stage IIIC melanoma|stage iiic melanoma
682867|NCT00700869|Altered level of consciousness|altered level of consciousness
682868|NCT00700869|Tracheal tube withdrawal|tracheal tube withdrawal
682869|NCT00700869|Respiration|respiration
682870|NCT00700869|Artificial Respiration|artificial respiration
682871|NCT00700869|Physiology|physiology
682872|NCT00700856|diabetes|diabetes
682873|NCT00700856|cardiovascular disease|cardiovascular disease
682874|NCT00700856|pioglitazone|pioglitazone
682875|NCT00700856|sulphonylurea|sulphonylurea
682876|NCT00700856|metformin monotherapy|metformin monotherapy
682877|NCT00700856|hypoglycemic therapy|hypoglycemic therapy
682878|NCT00700843|bariatric surgery|bariatric surgery
682879|NCT00700843|long term follow up|long term follow up
682880|NCT00700843|gastric partitioning surgery|gastric partitioning surgery
682881|NCT00700843|Roux-en-Y gastric bypass surgery|roux-en-y gastric bypass surgery
682882|NCT00700843|obesity|obesity
682883|NCT00700804|Calcium retention|calcium retention
682884|NCT00700804|dietary protein|dietary protein
682885|NCT00700804|dietary calcium|dietary calcium
682886|NCT00700791|Single and bilateral body contouring surgical sites.|single and bilateral body contouring surgical sites.
682887|NCT00700778|breast cancer|breast cancer
682888|NCT00700778|BRCA1 mutation carrier|brca1 mutation carrier
682889|NCT00700739|Cervical|cervical
682890|NCT00700739|Disc|disc
682891|NCT00700739|Arthroplasty|arthroplasty
682892|NCT00700739|Spinal|spinal
682893|NCT00700726|blood test|blood test
682894|NCT00700726|asthma|asthma
682895|NCT00700726|skin test|skin test
682896|NCT00700713|Meningitis|meningitis
682897|NCT00700713|Meningococcemia|meningococcemia
682898|NCT00700713|Neisseria meningitidis|neisseria meningitidis
682899|NCT00700713|Menactra®|menactra®
682900|NCT00700700|Congestive Heart Failure|congestive heart failure
682901|NCT00700700|Cardiac Resynchronization Therapy|cardiac resynchronization therapy
682902|NCT00700700|Dyspnea|dyspnea
682903|NCT00700700|Exercise Tolerance|exercise tolerance
682904|NCT00700687|cardiovascular prophylactic therapy|cardiovascular prophylactic therapy
682905|NCT00700674|EEG entropy|eeg entropy
682906|NCT00700674|Elderly|elderly
682907|NCT00700674|Decreases|decreases
682908|NCT00700674|POCD|pocd
682909|NCT00700674|Use of EEG entropy|use of eeg entropy
682910|NCT00700674|Geriatric|geriatric
682911|NCT00700635|Meningitis; Meningococcal infection, Neisseria meningitidis|meningitis; meningococcal infection, neisseria meningitidis
682912|NCT00700609|Depression|depression
682913|NCT00700609|Family Therapy|family therapy
682914|NCT00700609|Adolescents|adolescents
682915|NCT00700596|Salvia|salvia
682916|NCT00700596|SA|sa
682917|NCT00700596|Salvinorin|salvinorin
682918|NCT00700596|Psychotomimetic Effects|psychotomimetic effects
682919|NCT00700583|nocturia|nocturia
682920|NCT00700583|bladder|bladder
682921|NCT00700583|urination disorders|urination disorders
682922|NCT00700583|hydrochlorothiazide|hydrochlorothiazide
682923|NCT00700583|terazosin|terazosin
682924|NCT00700557|Antibiotic Associated Diarrhea|antibiotic associated diarrhea
682925|NCT00700557|probiotics|probiotics
682926|NCT00700557|treatment|treatment
682927|NCT00700544|AML|aml
682928|NCT00700544|elderly patients|elderly patients
682929|NCT00700544|Treatment outcome|treatment outcome
682930|NCT00700531|Hemodialysis|hemodialysis
682931|NCT00700531|Multiple myeloma|multiple myeloma
682932|NCT00700531|Cast nephropathy|cast nephropathy
682933|NCT00700531|Kidney failure|kidney failure
682934|NCT00700518|Raynaud's Syndrome|raynaud's syndrome
682935|NCT00700518|Raynaud's Disease|raynaud's disease
682936|NCT00700518|RP|rp
682937|NCT00700505|Benign Prostatic Hyperplasia|benign prostatic hyperplasia
682938|NCT00700505|BPH|bph
682939|NCT00700505|Benign Prostatic Hypertrophy|benign prostatic hypertrophy
682940|NCT00700505|Urinary Retention|urinary retention
682941|NCT00700505|Shy Bladder|shy bladder
682942|NCT00700505|Urinary Hesitancy|urinary hesitancy
682943|NCT00700505|Bashful Bladder|bashful bladder
682944|NCT00700505|Paruresis|paruresis
682945|NCT00700492|subfertility|subfertility
682946|NCT00700492|pregnancy rate|pregnancy rate
682947|NCT00700492|miscarriage|miscarriage
682948|NCT00700479|vascular endothelium|vascular endothelium
682949|NCT00700479|nitric oxide|nitric oxide
682950|NCT00700479|aldosterone|aldosterone
682951|NCT00700479|vascular biology|vascular biology
682952|NCT00700466|Outcome assessment, patients;|outcome assessment, patients;
682953|NCT00700466|autonomic nervous system;|autonomic nervous system;
682954|NCT00700466|perioperative care;|perioperative care;
682955|NCT00700466|adrenergic beta antagonist|adrenergic beta antagonist
682956|NCT00700466|Autonomic regulation|autonomic regulation
682957|NCT00700466|Perioperative beta-blockade|perioperative beta-blockade
682958|NCT00700466|outcome|outcome
682959|NCT00700440|Radiotherapy|radiotherapy
682960|NCT00700440|chemotherapy|chemotherapy
682961|NCT00700440|Drug Targeting|drug targeting
682962|NCT00700440|loco-regionally advanced nasopharyngeal carcinoma|loco-regionally advanced nasopharyngeal carcinoma
682963|NCT00700440|Safety.|safety.
682964|NCT00700440|efficacy|efficacy
682965|NCT00700427|ADHD|adhd
682966|NCT00700427|Adult|adult
682967|NCT00700427|long term|long term
682968|NCT00700427|maintenance of response|maintenance of response
682969|NCT00700427|Attention Deficit Hyperactivity Disorder|attention deficit hyperactivity disorder
682970|NCT00700388|Chronic bronchitis|chronic bronchitis
682971|NCT00700388|COPD|copd
682972|NCT00700388|Bronchiectasis|bronchiectasis
682973|NCT00700375|Patients undergoing an emergent coronary procedure|patients undergoing an emergent coronary procedure
682974|NCT00700362|Complications|complications
682975|NCT00700362|Hyperglycemia|hyperglycemia
682976|NCT00700362|Insulin infusion|insulin infusion
682977|NCT00700349|depression|depression
682978|NCT00700349|stress|stress
682979|NCT00700349|microcredit|microcredit
682980|NCT00700349|poverty|poverty
682981|NCT00700349|South Africa|south africa
682982|NCT00700336|malignant pleural mesothelioma|malignant pleural mesothelioma
682983|NCT00700336|solid tumors|solid tumors
682984|NCT00700323|ADHD|adhd
682985|NCT00700323|ADHD diagnosed children|adhd diagnosed children
682986|NCT00700310|Partial onset seizures|partial onset seizures
682987|NCT00700310|E2007|e2007
682988|NCT00700310|perampanel|perampanel
682989|NCT00700310|refractory partial seizures|refractory partial seizures
682990|NCT00700310|adjunctive therapy|adjunctive therapy
682991|NCT00700310|seizure frequency|seizure frequency
682992|NCT00700310|reduction in seizure frequency|reduction in seizure frequency
682993|NCT00700310|safety|safety
682994|NCT00700310|concomitant AED(s)|concomitant aed(s)
682995|NCT00700297|Oral aphthosis|oral aphthosis
682996|NCT00700297|Genital aphthosis|genital aphthosis
682997|NCT00700297|Psuedofolliculitis|psuedofolliculitis
682998|NCT00700297|Erythem nodusom|erythem nodusom
682999|NCT00700297|Joint manifestations|joint manifestations
683000|NCT00700297|Colchicine|colchicine
683001|NCT00700284|HIV-I|hiv-i
683002|NCT00700284|Reverse transcriptase inhibitors|reverse transcriptase inhibitors
683003|NCT00700284|HIV Seronegativity|hiv seronegativity
683004|NCT00700271|Hypertension|hypertension
683005|NCT00700271|ambulatory blood pressure monitoring|ambulatory blood pressure monitoring
683006|NCT00700245|Obese|obese
683007|NCT00700245|Adults|adults
683008|NCT00700232|genetics|genetics
683009|NCT00700232|gene expression|gene expression
683010|NCT00700232|MDR3|mdr3
683011|NCT00700232|estrogens|estrogens
683012|NCT00700232|cholestasis|cholestasis
683013|NCT00700232|pregnancy|pregnancy
683014|NCT00700232|controls|controls
683015|NCT00700219|Preterm Labor|preterm labor
683016|NCT00700219|Preterm Birth|preterm birth
683017|NCT00700219|Intra-amniotic Infection|intra-amniotic infection
683018|NCT00700219|Pregnancy|pregnancy
683019|NCT00700219|Women|women
683020|NCT00700206|Hematology|hematology
683021|NCT00700206|MDS|mds
683022|NCT00700206|Myelodysplastic Syndrome|myelodysplastic syndrome
683023|NCT00700206|Low Risk MDS|low risk mds
683024|NCT00700206|Intermediate-1 risk MDS|intermediate-1 risk mds
683025|NCT00700206|Int-1 risk MDS|int-1 risk mds
683026|NCT00700206|Telintra|telintra
683027|NCT00700206|ezatiostat hydrochloride|ezatiostat hydrochloride
683028|NCT00700206|ezatiostat|ezatiostat
683029|NCT00700206|TLK199|tlk199
683030|NCT00700206|Glutathione|glutathione
683031|NCT00700206|Glutathione analog|glutathione analog
683032|NCT00700206|Glutathione Transferase|glutathione transferase
683033|NCT00700206|Glutathione Transferase inhibitor|glutathione transferase inhibitor
683034|NCT00700206|Glutathione Transferase P1-1 inhibitor|glutathione transferase p1-1 inhibitor
683035|NCT00700206|GSTp1-1 inhibitor|gstp1-1 inhibitor
683036|NCT00700206|Apoptosis|apoptosis
683037|NCT00700206|Differentiation|differentiation
683038|NCT00700206|Enzyme inhibitor|enzyme inhibitor
683039|NCT00700167|ANTIGENBEARING DENDRITIC CELLS|antigenbearing dendritic cells
683040|NCT00700167|98-098|98-098
683041|NCT00700154|Vascular Surgery|vascular surgery
683042|NCT00700154|Complications|complications
683043|NCT00700154|Hyperglycemia|hyperglycemia
683044|NCT00700154|Insulin infusion|insulin infusion
683045|NCT00700154|Diabetic ulcers|diabetic ulcers
683046|NCT00700154|Infection|infection
683047|NCT00700141|Tachosil|tachosil
683048|NCT00700141|thyroid|thyroid
683049|NCT00700141|parathyroid|parathyroid
683050|NCT00700141|fleece-bound hemostasispathologic processes|fleece-bound hemostasispathologic processes
683051|NCT00700141|hemorrhage|hemorrhage
683052|NCT00700141|thyroid surgery|thyroid surgery
683053|NCT00700128|headaches|headaches
683054|NCT00700128|migraines|migraines
683055|NCT00700128|breakthrough bleeding|breakthrough bleeding
683056|NCT00700128|breakthrough spotting|breakthrough spotting
683057|NCT00700128|menstrually associated migraines|menstrually associated migraines
683058|NCT00700128|breakthrough bleeding or breakthrough spotting|breakthrough bleeding or breakthrough spotting
683059|NCT00700115|HAART|haart
683060|NCT00700115|lopinavir/ritonavir|lopinavir/ritonavir
683061|NCT00700115|raltegravir|raltegravir
683062|NCT00700115|HIV/AIDS patients on HAART|hiv/aids patients on haart
683063|NCT00700115|Treatment Experienced|treatment experienced
683064|NCT00700089|Attempted suicide|attempted suicide
683065|NCT00700089|Assertive intervention|assertive intervention
683066|NCT00700089|Prevention|prevention
683067|NCT00700089|Treatment|treatment
683068|NCT00700076|ORG 25935|org 25935
683069|NCT00700076|Ketamine|ketamine
683070|NCT00700076|healthy subjects|healthy subjects
683071|NCT00700063|Peplin|peplin
683072|NCT00700063|Actinic keratosis|actinic keratosis
683073|NCT00700063|PEP005|pep005
683074|NCT00700050|Cystic Fibrosis|cystic fibrosis
683075|NCT00700050|Sex hormones|sex hormones
683076|NCT00700050|Pseudomonas aeruginosa|pseudomonas aeruginosa
683077|NCT00700050|Paediatrics|paediatrics
683078|NCT00700024|Body composition|body composition
683079|NCT00700024|Physical activity|physical activity
683080|NCT00700024|Metabolic syndrome|metabolic syndrome
683081|NCT00700011|Myelodysplastic Syndromes|myelodysplastic syndromes
683082|NCT00699998|ACS|acs
683083|NCT00699985|Psychological Symptoms|psychological symptoms
683084|NCT00699985|Behcet's Disease|behcet's disease
683085|NCT00699972|E2007|e2007
683086|NCT00699972|perampanel|perampanel
683087|NCT00699972|refractory partial seizures|refractory partial seizures
683088|NCT00699972|adjunctive therapy|adjunctive therapy
683089|NCT00699972|seizure frequency|seizure frequency
683090|NCT00699972|partial onset seizures|partial onset seizures
683091|NCT00699972|reduction in seizure frequency|reduction in seizure frequency
683092|NCT00699972|safety|safety
683093|NCT00699972|concomitant AED(s)|concomitant aed(s)
683094|NCT00699959|Coronary patients|coronary patients
683095|NCT00699959|heart failure|heart failure
683096|NCT00699959|dyslipidemia|dyslipidemia
683097|NCT00699946|delirium, atypical antipsychotics, olanzapine, orthopedic|delirium, atypical antipsychotics, olanzapine, orthopedic
683098|NCT00699933|acute pancreatitis|acute pancreatitis
683099|NCT00699933|interventional therapy|interventional therapy
683100|NCT00699933|CT-guided drainage therapy|ct-guided drainage therapy
683101|NCT00699933|percutaneous necrosectomy|percutaneous necrosectomy
683102|NCT00699933|Comparison of different diagnostic procedures: MRI, CT, Ultrasound|comparison of different diagnostic procedures: mri, ct, ultrasound
683103|NCT00699933|Evaluation of interventional therapy including percutaneous drainage techniques und necrosectomies|evaluation of interventional therapy including percutaneous drainage techniques und necrosectomies
683104|NCT00699907|Ovarian epithelial cancer|ovarian epithelial cancer
683105|NCT00699907|High risk|high risk
683106|NCT00699907|Biomarkers|biomarkers
683107|NCT00699894|PONV|ponv
683108|NCT00699894|prevention of postoperative nausea and vomiting|prevention of postoperative nausea and vomiting
683109|NCT00699894|aprepitant|aprepitant
683110|NCT00699894|ondansetron|ondansetron
683111|NCT00699894|orthognathic surgery|orthognathic surgery
683112|NCT00699881|Time to Progression|time to progression
683113|NCT00699881|Toxicity|toxicity
683114|NCT00699881|Overall survival|overall survival
683115|NCT00699881|Response rate|response rate
683116|NCT00699881|Quality of live|quality of live
683117|NCT00699855|Growth Hormon Deficiency and|growth hormon deficiency and
683118|NCT00699855|Turner Syndrome in pre-pubertal children|turner syndrome in pre-pubertal children
683119|NCT00699855|Long term follow-up of predictive markers|long term follow-up of predictive markers
683120|NCT00699842|Myelodysplastic Syndrome|myelodysplastic syndrome
683121|NCT00699842|MDS|mds
683122|NCT00699842|Low to Intermediate-1 MDS|low to intermediate-1 mds
683123|NCT00699842|Non-deletion 5q|non-deletion 5q
683124|NCT00699842|Lenalidomide|lenalidomide
683125|NCT00699790|Diabetes|diabetes
683126|NCT00699790|NOS|nos
683127|NCT00699764|Herpes simplex candidate vaccine|herpes simplex candidate vaccine
683128|NCT00699764|Herpes simplex|herpes simplex
683129|NCT00699751|Hormone Refractory Prostate Cancer|hormone refractory prostate cancer
683130|NCT00699751|Bone Metastases|bone metastases
683131|NCT00699751|Radium-223|radium-223
683132|NCT00699738|Healthy women during pregnancy and in the postpartum period|healthy women during pregnancy and in the postpartum period
683133|NCT00699725|Compliance|compliance
683134|NCT00699725|gastroprotector therapy|gastroprotector therapy
683135|NCT00699725|NSAID|nsaid
683136|NCT00699725|risk factors|risk factors
683137|NCT00699712|ADHF|adhf
683138|NCT00699712|AHF|ahf
683139|NCT00699712|HF|hf
683140|NCT00699699|Chronic Obstructive Pulmonary Disease (COPD)|chronic obstructive pulmonary disease (copd)
683141|NCT00699686|Diabetes|diabetes
683142|NCT00699686|Insulin|insulin
683143|NCT00699686|Endothelium|endothelium
683144|NCT00699686|Cardiovascular disease|cardiovascular disease
683145|NCT00699686|Stem cells|stem cells
683146|NCT00699673|Brain natriuretic peptide|brain natriuretic peptide
683147|NCT00699673|EuroScore|euroscore
683148|NCT00699673|Cardiac surgery|cardiac surgery
683149|NCT00699673|Cardiopulmonary bypass|cardiopulmonary bypass
683150|NCT00699673|Coronary artery disease|coronary artery disease
683151|NCT00699673|Valvular disease|valvular disease
683152|NCT00699673|Risk stratification in cardiac surgery|risk stratification in cardiac surgery
683153|NCT00699660|Disability Examination|disability examination
683154|NCT00699660|Clinician Administered PTSD Scale|clinician administered ptsd scale
683155|NCT00699660|Quality of Care|quality of care
683156|NCT00699634|Neuropathic|neuropathic
683157|NCT00699634|Pain|pain
683158|NCT00699634|Phantom|phantom
683159|NCT00699634|Limb|limb
683160|NCT00699621|Intracerebral hemorrhage|intracerebral hemorrhage
683161|NCT00699621|Hematoma enlargement|hematoma enlargement
683162|NCT00699621|Antiplatelet agent|antiplatelet agent
683163|NCT00699621|Platelet transfusion|platelet transfusion
683164|NCT00699621|Outcome|outcome
683165|NCT00699608|Zopiclone|zopiclone
683166|NCT00699608|Hypnotic|hypnotic
683167|NCT00699608|Residual effects|residual effects
683168|NCT00699608|Eszopiclone|eszopiclone
683169|NCT00699582|E2007 (perampanel)|e2007 (perampanel)
683170|NCT00699582|refractory partial seizures|refractory partial seizures
683171|NCT00699582|adjunctive therapy|adjunctive therapy
683172|NCT00699582|seizure frequency|seizure frequency
683173|NCT00699582|reduction in seizure frequency|reduction in seizure frequency
683174|NCT00699582|partial onset seizures|partial onset seizures
683175|NCT00699582|safety|safety
683176|NCT00699582|concomitant AED(s)|concomitant aed(s)
683177|NCT00699569|hyperimmune colostrum|hyperimmune colostrum
683178|NCT00699569|mucositis|mucositis
683179|NCT00699556|alcohol|alcohol
683180|NCT00699556|nicotine|nicotine
683181|NCT00699556|smoking cessation|smoking cessation
683182|NCT00699556|smoking cessation medications|smoking cessation medications
683183|NCT00699530|Prolactin|prolactin
683184|NCT00699530|Insulin resistance|insulin resistance
683185|NCT00699530|Glucose tolerance|glucose tolerance
683186|NCT00699530|Body Composition|body composition
683187|NCT00699530|Substrate metabolism|substrate metabolism
683188|NCT00699517|tubulin modulator|tubulin modulator
683189|NCT00699517|endothelium|endothelium
683190|NCT00699517|combretastatin|combretastatin
683191|NCT00699517|cisplatin|cisplatin
683192|NCT00699504|ECG|ecg
683193|NCT00699504|QT|qt
683194|NCT00699504|Effect of study drug on healthy volunteers|effect of study drug on healthy volunteers
683195|NCT00699478|vitamin B12 deficiency|vitamin b12 deficiency
683196|NCT00699478|post total gastrectomy|post total gastrectomy
683197|NCT00699478|stomach cancer|stomach cancer
683198|NCT00699465|Thromboprophylaxis|thromboprophylaxis
683199|NCT00699465|Prevention of venous thromboembolism after ICH|prevention of venous thromboembolism after ich
683200|NCT00699465|Enoxaparin|enoxaparin
683201|NCT00699465|Intermittent pneumatic compression|intermittent pneumatic compression
683202|NCT00699452|aortic stenosis|aortic stenosis
683203|NCT00699452|valve|valve
683204|NCT00699452|candesartan|candesartan
683205|NCT00699439|Medical Informatics|medical informatics
683206|NCT00699439|Asthma|asthma
683207|NCT00699439|Emergency Service, Hospital|emergency service, hospital
683208|NCT00699439|Bayesian Method|bayesian method
683209|NCT00699387|Chagas disease|chagas disease
683210|NCT00699387|Pediatrics|pediatrics
683211|NCT00699387|benznidazole|benznidazole
683212|NCT00699387|population pharmacokinetics|population pharmacokinetics
683213|NCT00699387|neglected diseases|neglected diseases
683214|NCT00699387|parasitology|parasitology
683215|NCT00699387|pediatric clinical pharmacology|pediatric clinical pharmacology
683216|NCT00699374|sunitinib|sunitinib
683217|NCT00699374|phase 3|phase 3
683218|NCT00699374|randomized|randomized
683219|NCT00699374|hepatocellular|hepatocellular
683220|NCT00699374|liver|liver
683221|NCT00699361|Pantoprazole|pantoprazole
683222|NCT00699361|congestive heart failure|congestive heart failure
683223|NCT00699335|pain|pain
683224|NCT00699335|fentanyl|fentanyl
683225|NCT00699335|transdermal patch|transdermal patch
683226|NCT00699322|glucose variability|glucose variability
683227|NCT00699322|oxidative stress|oxidative stress
683228|NCT00699322|sitagliptin|sitagliptin
683229|NCT00699322|glimepiride|glimepiride
683230|NCT00699309|Total Hip Replacement|total hip replacement
683231|NCT00699309|Total Hip Arthroplasty|total hip arthroplasty
683232|NCT00699309|Minimally Invasive|minimally invasive
683233|NCT00699309|Microplasty|microplasty
683234|NCT00699309|Hip Arthritis|hip arthritis
683235|NCT00699296|LBH589|lbh589
683236|NCT00699296|HDAC inhibitor|hdac inhibitor
683237|NCT00699296|cutaneous T-ceII lymphoma|cutaneous t-ceii lymphoma
683238|NCT00699296|adult T-cell leukemia|adult t-cell leukemia
683239|NCT00699283|Epilepsy; Monotherapy|epilepsy; monotherapy
683240|NCT00699283|Partial Onset Seizures|partial onset seizures
683241|NCT00699283|Adults and Adolescents|adults and adolescents
683242|NCT00699270|Total Shoulder Arthroplasty|total shoulder arthroplasty
683243|NCT00699270|Total Shoulder Replacement|total shoulder replacement
683244|NCT00699270|Shoulder Arthritis|shoulder arthritis
683245|NCT00699257|Partial Knee Arthroplasty|partial knee arthroplasty
683246|NCT00699257|Partial Knee Replacement|partial knee replacement
683247|NCT00699257|Arthritis of Medial Compartment of the Knee|arthritis of medial compartment of the knee
683248|NCT00699257|Oxford Knee|oxford knee
683250|NCT00699244|hand|hand
683251|NCT00699244|elbow|elbow
683252|NCT00699244|wrist|wrist
683253|NCT00699244|brachial plexus|brachial plexus
683254|NCT00699244|infraclavicular block|infraclavicular block
683255|NCT00699231|Hepatitis B|hepatitis b
683256|NCT00699231|Engerix™-B|engerix™-b
683257|NCT00699231|Recombinant hepatitis B vaccine|recombinant hepatitis b vaccine
683258|NCT00699231|Adjuvant|adjuvant
683259|NCT00699218|Bipolar|bipolar
683260|NCT00699218|Depression|depression
683261|NCT00699218|TMS|tms
683262|NCT00699218|repetitive Transcranial Magnetic Stimulation|repetitive transcranial magnetic stimulation
683263|NCT00699218|treatment|treatment
683264|NCT00699218|Efficacy|efficacy
683265|NCT00699218|Safety|safety
683266|NCT00699192|Blood pressure|blood pressure
683267|NCT00699192|hypertension|hypertension
683268|NCT00699192|elderly|elderly
683269|NCT00699166|IBS|ibs
683270|NCT00699166|Diarrhea|diarrhea
683271|NCT00699166|gastrointestinal functional disorder|gastrointestinal functional disorder
683272|NCT00699166|IBS-D|ibs-d
683273|NCT00699127|anxiety|anxiety
683274|NCT00699127|parents|parents
683275|NCT00699127|NICU|nicu
683276|NCT00699127|prematurity|prematurity
683277|NCT00699127|Anxiety of parents to NICU infants|anxiety of parents to nicu infants
683278|NCT00699114|Pain|pain
683279|NCT00699114|Analgesics|analgesics
683280|NCT00699114|Molar|molar
683281|NCT00699114|Third|third
683282|NCT00699114|Acetaminophen|acetaminophen
683283|NCT00699114|Paracetamol|paracetamol
683284|NCT00699114|Ibuprofen|ibuprofen
683285|NCT00699114|Codeine|codeine
683286|NCT00699114|Placebo|placebo
683287|NCT00699101|Breast Cancer|breast cancer
683288|NCT00699101|Conture®|conture®
683289|NCT00699101|Brachytherapy|brachytherapy
683290|NCT00699088|Total Hip Arthroplasty|total hip arthroplasty
683291|NCT00699088|Total Hip Replacement|total hip replacement
683292|NCT00699088|Minimally Invasive|minimally invasive
683293|NCT00699088|Microplasty|microplasty
683294|NCT00699062|antileukotriene|antileukotriene
683295|NCT00699062|small airway|small airway
683296|NCT00699062|airway remodeling|airway remodeling
683297|NCT00699062|HRCT|hrct
683298|NCT00699049|Alpha blocker|alpha blocker
683299|NCT00699049|Tamsulosin|tamsulosin
683300|NCT00699049|Solifenacin|solifenacin
683301|NCT00699049|Overactive Bladder|overactive bladder
683302|NCT00699049|Urgency incontinence|urgency incontinence
683303|NCT00699036|nonalcoholic steatohepatitis (NASH)|nonalcoholic steatohepatitis (nash)
683304|NCT00699036|fatty liver|fatty liver
683305|NCT00699036|insulin resistance|insulin resistance
683306|NCT00699023|postprandial lipemia|postprandial lipemia
683307|NCT00699023|type 2 diabetes|type 2 diabetes
683308|NCT00699023|ezetimibe|ezetimibe
683309|NCT00699023|hypercholesterolemia|hypercholesterolemia
683310|NCT00699010|Abuse Liability|abuse liability
683311|NCT00699010|Abuse Prevention|abuse prevention
683312|NCT00699010|Abuse Resistance|abuse resistance
683313|NCT00699010|Abuse Deterrence|abuse deterrence
683314|NCT00698997|autism|autism
683315|NCT00698997|autism spectrum disorder|autism spectrum disorder
683316|NCT00698997|intensive intervention for toddlers with autism|intensive intervention for toddlers with autism
683317|NCT00698997|PDD NOS|pdd nos
683318|NCT00698997|early steps study|early steps study
683319|NCT00698997|early start denver model|early start denver model
683320|NCT00698997|early intervention for infants and toddlers with autism|early intervention for infants and toddlers with autism
683321|NCT00698997|toddler treatment|toddler treatment
683322|NCT00698997|Sally Rogers|sally rogers
683323|NCT00698997|University of California, Davis|university of california, davis
683324|NCT00698997|University of Michigan|university of michigan
683325|NCT00698997|MIND Institute|mind institute
683326|NCT00698984|Soy Isoflavones, Bone Mineral Density, Bone Mineral Content, postmenopausal Women, Bone Markers, Bone Health, Phytoestrogens|soy isoflavones, bone mineral density, bone mineral content, postmenopausal women, bone markers, bone health, phytoestrogens
683327|NCT00698958|Respiratory insufficiency|respiratory insufficiency
683328|NCT00698958|Hypercapnic chronic respiratory failure secondary to neuromuscular diseases or alterations of thoracic cage|hypercapnic chronic respiratory failure secondary to neuromuscular diseases or alterations of thoracic cage
683329|NCT00698932|DPP-4 inhibitors|dpp-4 inhibitors
683330|NCT00698932|HBA1c|hba1c
683331|NCT00698932|Incretins|incretins
683332|NCT00698919|Bacterial DNA|bacterial dna
683333|NCT00698919|Systemic inflammatory response syndrome|systemic inflammatory response syndrome
683334|NCT00698919|Infection|infection
683335|NCT00698919|Intensive Care Unit|intensive care unit
683336|NCT00698906|Hepatitis B|hepatitis b
683337|NCT00698906|HBV-MPL|hbv-mpl
683338|NCT00698906|Recombinant Hepatitis B vaccine|recombinant hepatitis b vaccine
683339|NCT00698893|Herpes simplex|herpes simplex
683340|NCT00698893|Herpes simplex candidate (gD) vaccine|herpes simplex candidate (gd) vaccine
683341|NCT00698880|Portal vein embolization|portal vein embolization
683342|NCT00698880|Hepatic vein embolization|hepatic vein embolization
683343|NCT00698880|Liver regeneration|liver regeneration
683344|NCT00698867|Total Elbow Arthroplasty|total elbow arthroplasty
683345|NCT00698867|Total Elbow Replacement|total elbow replacement
683346|NCT00698867|Osteoarthritis|osteoarthritis
683347|NCT00698867|Elbow arthritis|elbow arthritis
683348|NCT00698854|Total Knee Arthroplasty|total knee arthroplasty
683349|NCT00698854|Total Knee Replacement|total knee replacement
683350|NCT00698854|Knee Arthritis|knee arthritis
683351|NCT00698828|Cachexia, COPD, Chronic Obstructive Pulmonary Disease|cachexia, copd, chronic obstructive pulmonary disease
683352|NCT00698763|An ischaemic cerebrovascular event (stroke or TIA)|an ischaemic cerebrovascular event (stroke or tia)
683353|NCT00698750|Fractured Humeral Head|fractured humeral head
683354|NCT00698750|Traumatic Arthritis|traumatic arthritis
683355|NCT00698750|Resurfacing Shoulder|resurfacing shoulder
683356|NCT00698750|Shoulder Replacement|shoulder replacement
683357|NCT00698750|Shoulder Arthritis|shoulder arthritis
683358|NCT00698737|Opioid|opioid
683359|NCT00698737|Cocaine|cocaine
683360|NCT00698711|Prostate cancer|prostate cancer
683361|NCT00698711|MUC-2-KLH|muc-2-klh
683362|NCT00698711|QS 21|qs 21
683363|NCT00698698|tear proteins|tear proteins
683364|NCT00698698|diabetic retinopathy|diabetic retinopathy
683365|NCT00698698|HPLC|hplc
683366|NCT00698698|Mass spectroscopy|mass spectroscopy
683367|NCT00698685|Allogeneic Hematopoietic Cell Transplantation|allogeneic hematopoietic cell transplantation
683368|NCT00698685|Preparative Regimen|preparative regimen
683369|NCT00698685|Pentostatin|pentostatin
683370|NCT00698685|Alemtuzumab|alemtuzumab
683371|NCT00698685|Hodgkin Disease and Lymphoma, non-Hodgkin|hodgkin disease and lymphoma, non-hodgkin
683372|NCT00698685|leukemia, myeloid, acute|leukemia, myeloid, acute
683373|NCT00698685|leukemia, lymphocytic, acute|leukemia, lymphocytic, acute
683374|NCT00698685|leukemia, myeloid, chronic|leukemia, myeloid, chronic
683375|NCT00698685|leukemia, lymphocytic, chronic|leukemia, lymphocytic, chronic
683376|NCT00698685|Multiple Myeloma|multiple myeloma
683377|NCT00698685|Myelodysplastic Syndromes|myelodysplastic syndromes
683378|NCT00698685|Carcinoma, Renal Cell|carcinoma, renal cell
683380|NCT00698646|Systolic blood pressure|systolic blood pressure
683381|NCT00698646|Diastolic blood pressure|diastolic blood pressure
683382|NCT00698646|Valsartan|valsartan
683383|NCT00698646|Hydrochlorothiazide|hydrochlorothiazide
683384|NCT00698633|Hip arthroplasty|hip arthroplasty
683385|NCT00698607|Everolimus|everolimus
683386|NCT00698607|Sirolimus|sirolimus
683387|NCT00698607|drug eluting stent|drug eluting stent
683388|NCT00698607|Clopidogrel|clopidogrel
683389|NCT00698581|Epilepsy; Monotherapy|epilepsy; monotherapy
683390|NCT00698581|Partial Onset Seizures|partial onset seizures
683391|NCT00698581|Adults and Adolescents|adults and adolescents
683392|NCT00698568|Herpes simplex, Herpes simplex candidate vaccine|herpes simplex, herpes simplex candidate vaccine
683393|NCT00698555|Hepatitis B|hepatitis b
683394|NCT00698555|HBV-MPL|hbv-mpl
683395|NCT00698555|Recombinant hepatitis B vaccine|recombinant hepatitis b vaccine
683396|NCT00698542|PSST|psst
683397|NCT00698542|sepsis|sepsis
683398|NCT00698542|Neuro Care Unit|neuro care unit
683399|NCT00698542|Surviving Sepsis Campaign|surviving sepsis campaign
683400|NCT00698542|SSC|ssc
683401|NCT00698529|Technology Transfer|technology transfer
683402|NCT00698529|HIV Seronegativity|hiv seronegativity
683403|NCT00698516|Bevacizumab|bevacizumab
683404|NCT00698516|Small Cell Lung Cancer (SCLC)|small cell lung cancer (sclc)
683405|NCT00698516|Topotecan|topotecan
683406|NCT00698503|Metal on Metal|metal on metal
683407|NCT00698503|Total Hip Arthroplasty|total hip arthroplasty
683408|NCT00698503|Total Hip Replacement|total hip replacement
683409|NCT00698490|Herpes simplex|herpes simplex
683410|NCT00698490|Herpes simplex candidate vaccine|herpes simplex candidate vaccine
683411|NCT00698464|Pasireotide|pasireotide
683412|NCT00698464|PK profile,|pk profile,
683413|NCT00698464|Single dose|single dose
683414|NCT00698464|Pasireotide subcutaneous injection|pasireotide subcutaneous injection
683415|NCT00698464|Safety|safety
683416|NCT00698464|Mild hepatic impaired patients|mild hepatic impaired patients
683417|NCT00698464|Moderate hepatic impaired patients|moderate hepatic impaired patients
683418|NCT00698464|Severe hepatic impaired patients|severe hepatic impaired patients
683419|NCT00698451|Ovarian cancer|ovarian cancer
683420|NCT00698451|fallopian tube cancer|fallopian tube cancer
683421|NCT00698451|primary peritoneal cancer|primary peritoneal cancer
683422|NCT00698451|DOXIL|doxil
683423|NCT00698451|carboplatin|carboplatin
683424|NCT00698451|bevacizumab|bevacizumab
683425|NCT00698438|At least 18 years of age|at least 18 years of age
683426|NCT00698438|Open-angle glaucoma|open-angle glaucoma
683427|NCT00698425|Iontophoresis|iontophoresis
683428|NCT00698425|Ophthalmology|ophthalmology
683429|NCT00698412|Knee osteoarthritis|knee osteoarthritis
683430|NCT00698412|Daily cane use|daily cane use
683431|NCT00698412|Pain|pain
683432|NCT00698412|Function|function
683433|NCT00698412|Quality of life|quality of life
683434|NCT00698412|Energy consumption during the gait|energy consumption during the gait
683435|NCT00698399|liver|liver
683436|NCT00698399|transplant|transplant
683437|NCT00698399|TMAO|tmao
683438|NCT00698399|NGAL|ngal
683439|NCT00698399|cystatin-C|cystatin-c
683440|NCT00698399|Ischemia Reperfusion Injury|ischemia reperfusion injury
683441|NCT00698399|Liver Transplant|liver transplant
683442|NCT00698399|LTx|ltx
683443|NCT00698399|allantion|allantion
683444|NCT00698386|Micronutrient Zinc|micronutrient zinc
683445|NCT00698386|Category I PTB|category i ptb
683446|NCT00698386|RNTCP|rntcp
683447|NCT00698386|DOTS|dots
683448|NCT00698386|Sputum smear conversion|sputum smear conversion
683449|NCT00698386|Reduced relapse|reduced relapse
683450|NCT00698386|Immunopathogenesis|immunopathogenesis
683451|NCT00698386|Category-I|category-i
683452|NCT00698373|Fluorine-18-α-methyltyrosine,|fluorine-18-α-methyltyrosine,
683453|NCT00698373|Positron emission tomography,|positron emission tomography,
683454|NCT00698373|Fluorine-18-fluorodeoxyglucose,|fluorine-18-fluorodeoxyglucose,
683455|NCT00698373|Lung cancer,|lung cancer,
683456|NCT00698360|chronic kidney disease|chronic kidney disease
683457|NCT00698360|melatonin|melatonin
683458|NCT00698360|erythropoietin|erythropoietin
683459|NCT00698360|circadian rhythm|circadian rhythm
683460|NCT00698347|Total Knee Replacement|total knee replacement
683461|NCT00698347|Total Knee Arthroplasty|total knee arthroplasty
683462|NCT00698347|Hip Arthritis|hip arthritis
683463|NCT00698334|HIV infection|hiv infection
683464|NCT00698334|Acquired immunodeficiency syndrome|acquired immunodeficiency syndrome
683465|NCT00698334|Tuberculosis|tuberculosis
683466|NCT00698321|HIV/STD Prevention|hiv/std prevention
683467|NCT00698321|HIV Seronegativity|hiv seronegativity
683468|NCT00698295|schizophrenia|schizophrenia
683469|NCT00698295|atypical antipsychotics|atypical antipsychotics
683470|NCT00698295|EEG|eeg
683471|NCT00698243|OSI-027|osi-027
683472|NCT00698243|Solid tumor|solid tumor
683473|NCT00698243|Lymphoma|lymphoma
683474|NCT00698204|Mucositis|mucositis
683475|NCT00698204|Head and Neck Cancer|head and neck cancer
683476|NCT00698204|Head and Neck Neoplasms|head and neck neoplasms
683477|NCT00698204|Stomatitis|stomatitis
683478|NCT00698191|Lupus Erythematosus,Systemic|lupus erythematosus,systemic
683479|NCT00698191|Lupus Nephritis|lupus nephritis
683480|NCT00698191|Mesenchymal Stem Cells|mesenchymal stem cells
683481|NCT00698191|Transplantation|transplantation
683482|NCT00698178|Gastroesophageal reflux disease|gastroesophageal reflux disease
683483|NCT00698178|Waist circumference|waist circumference
683484|NCT00698178|Body mass index|body mass index
683485|NCT00698178|Obesity|obesity
683486|NCT00698152|Total Hip Arthroplasty|total hip arthroplasty
683487|NCT00698152|Total Hip Replacement|total hip replacement
683488|NCT00698152|Hip Arthritis|hip arthritis
683489|NCT00698152|Polyethylene|polyethylene
683490|NCT00698139|heart failure|heart failure
683491|NCT00698139|chronotropic incompetence|chronotropic incompetence
683492|NCT00698113|anxiety|anxiety
683493|NCT00698113|depression|depression
683494|NCT00698113|stress|stress
683495|NCT00698113|cancer symptoms|cancer symptoms
683496|NCT00698113|pediatric cancer|pediatric cancer
683497|NCT00698113|massage|massage
683498|NCT00698113|parent delivered massage|parent delivered massage
683499|NCT00698100|DNA|dna
683500|NCT00698100|HU & MOUSE|hu & mouse
683501|NCT00698100|TYROSINASE|tyrosinase
683502|NCT00698087|Hepatitis B|hepatitis b
683503|NCT00698087|Engerix™-B|engerix™-b
683504|NCT00698087|Adjuvanted recombinant hepatitis B vaccine|adjuvanted recombinant hepatitis b vaccine
683505|NCT00698061|Hepatitis B|hepatitis b
683506|NCT00698061|Adjuvanted vaccine|adjuvanted vaccine
683507|NCT00698048|Sepsis|sepsis
683508|NCT00698048|Septic Shock|septic shock
683509|NCT00698048|Vasopressin|vasopressin
683510|NCT00698048|Copeptin|copeptin
683511|NCT00698048|Paediatrics|paediatrics
683512|NCT00698035|Vaginal Testosterone Cream|vaginal testosterone cream
683513|NCT00698035|ESTRING|estring
683514|NCT00698022|healthy|healthy
683515|NCT00698022|weight gain|weight gain
683516|NCT00698022|anti-psychotic|anti-psychotic
683517|NCT00698022|risperidone|risperidone
683518|NCT00698022|mifepristone|mifepristone
683519|NCT00698022|mitigation|mitigation
683520|NCT00698022|weight loss|weight loss
683521|NCT00698009|Neuroblastoma|neuroblastoma
683522|NCT00698009|Natural Killer Cell|natural killer cell
683523|NCT00698009|NK Cell Infusion|nk cell infusion
683524|NCT00698009|Haploidentical Natural Killer (NK) Cells|haploidentical natural killer (nk) cells
683525|NCT00698009|Fludarabine|fludarabine
683526|NCT00698009|Fludarabine Phosphate|fludarabine phosphate
683527|NCT00698009|Fludara|fludara
683528|NCT00698009|Cyclophosphamide|cyclophosphamide
683529|NCT00698009|Cytoxan|cytoxan
683530|NCT00698009|Neosar|neosar
683531|NCT00698009|Interleukin-2|interleukin-2
683532|NCT00698009|IL-2|il-2
683533|NCT00698009|Proleukin|proleukin
683534|NCT00698009|Mesna|mesna
683535|NCT00698009|Mesnex|mesnex
683536|NCT00698009|Infusion of NK cells|infusion of nk cells
683537|NCT00698009|Pediatric NK Cell Infusion|pediatric nk cell infusion
683538|NCT00698009|Pediatric Neuroblastoma|pediatric neuroblastoma
683539|NCT00698009|Pediatric NK|pediatric nk
683540|NCT00698009|Pediatric|pediatric
683541|NCT00697983|Osteoporosis|osteoporosis
683543|NCT00697983|Purinergic receptors|purinergic receptors
683544|NCT00697983|Bone mineral density|bone mineral density
683545|NCT00697983|Single nucleotide polymorphism|single nucleotide polymorphism
683546|NCT00697970|Hepatitis B|hepatitis b
683547|NCT00697970|Engerix™-B|engerix™-b
683548|NCT00697970|Recombinant Hepatitis B vaccine|recombinant hepatitis b vaccine
683549|NCT00697970|Adjuvant|adjuvant
683550|NCT00697957|acceleration|acceleration
683551|NCT00697957|bone density|bone density
683552|NCT00697957|cardiovascular diseases|cardiovascular diseases
683553|NCT00697957|exercise|exercise
683554|NCT00697957|female|female
683555|NCT00697957|fragility fractures|fragility fractures
683556|NCT00697957|impact intensity|impact intensity
683557|NCT00697957|intervention studies|intervention studies
683558|NCT00697957|osteoporosis|osteoporosis
683559|NCT00697957|premenopause|premenopause
683560|NCT00697944|FUNGAL INFECTION|fungal infection
683561|NCT00697944|SEPSIS|sepsis
683562|NCT00697944|INTENSIVE CARE|intensive care
683563|NCT00697944|AMBISOME|ambisome
683564|NCT00697944|PREEMPTIVE TREATMENT|preemptive treatment
683565|NCT00697944|Sepsis with candida colonisation|sepsis with candida colonisation
683566|NCT00697931|Hepatitis B|hepatitis b
683567|NCT00697931|Engerix™-B|engerix™-b
683568|NCT00697931|Recombinant Hepatitis B vaccine|recombinant hepatitis b vaccine
683569|NCT00697931|Adjuvant|adjuvant
683570|NCT00697918|Partial onset seizure|partial onset seizure
683571|NCT00697918|Adjunctive therapy|adjunctive therapy
683572|NCT00697905|nasopharyngeal carcinoma|nasopharyngeal carcinoma
683573|NCT00697905|Gemcitabine-Carboplatin|gemcitabine-carboplatin
683574|NCT00697892|Human Immunodeficiency Virus|human immunodeficiency virus
683575|NCT00697892|Drug Interactions|drug interactions
683576|NCT00697879|tumour|tumour
683577|NCT00697879|Solid tumour|solid tumour
683578|NCT00697879|histone deacetylase inhibitor|histone deacetylase inhibitor
683579|NCT00697879|dose escalation|dose escalation
683580|NCT00697879|cancer|cancer
683581|NCT00697866|Adjuvanted hepatitis B vaccine|adjuvanted hepatitis b vaccine
683582|NCT00697866|Hepatitis B|hepatitis b
683583|NCT00697866|Recombinant hepatitis B vaccine|recombinant hepatitis b vaccine
683584|NCT00697853|Hepatitis B|hepatitis b
683585|NCT00697853|Adjuvanted hepatitis B vaccine|adjuvanted hepatitis b vaccine
683586|NCT00697853|Recombinant hepatitis B vaccine|recombinant hepatitis b vaccine
683587|NCT00697840|Hepatitis B|hepatitis b
683588|NCT00697840|Engerix™-B|engerix™-b
683589|NCT00697840|Recombinant hepatitis B vaccine|recombinant hepatitis b vaccine
683590|NCT00697840|Adjuvant|adjuvant
683591|NCT00697814|Hypogonadotropic hypogonadism|hypogonadotropic hypogonadism
683592|NCT00697814|Prolactinoma|prolactinoma
683593|NCT00697788|pediatric|pediatric
683594|NCT00697788|burn|burn
683595|NCT00697788|sedation|sedation
683596|NCT00697775|Hepatitis B|hepatitis b
683597|NCT00697775|Recombinant hepatitis B vaccine|recombinant hepatitis b vaccine
683598|NCT00697775|Adjuvant|adjuvant
683599|NCT00697762|Partial onset seizure|partial onset seizure
683600|NCT00697762|Adjunctive therapy|adjunctive therapy
683601|NCT00697749|Recombinant hepatitis B vaccine|recombinant hepatitis b vaccine
683602|NCT00697749|Adjuvanted hepatitis B vaccine|adjuvanted hepatitis b vaccine
683603|NCT00697749|Hepatitis B|hepatitis b
683604|NCT00697736|Systemic Scleroderma|systemic scleroderma
683605|NCT00697736|Echocardiography|echocardiography
683606|NCT00697723|Coronary artery bypass graft|coronary artery bypass graft
683607|NCT00697723|Intra-aortic balloon pump|intra-aortic balloon pump
683608|NCT00697723|transit-time flowmetry|transit-time flowmetry
683609|NCT00697710|Atopic Dermatitis|atopic dermatitis
683610|NCT00697697|asthmatic children|asthmatic children
683611|NCT00697684|Reduced Intensity Allogeneic Stem Cell Transplant|reduced intensity allogeneic stem cell transplant
683612|NCT00697684|Clofarabine|clofarabine
683613|NCT00697684|Rabbit Antithymocyte Globulin|rabbit antithymocyte globulin
683614|NCT00697684|Total Lymphoid Radiation|total lymphoid radiation
683615|NCT00697671|NK cell infusion|nk cell infusion
683616|NCT00697671|Immunotherapy|immunotherapy
683617|NCT00697671|hematologic malignancy|hematologic malignancy
683618|NCT00697671|Miltenyi Biotec device|miltenyi biotec device
683619|NCT00697671|haploidentical donor|haploidentical donor
683620|NCT00697658|Paliperidone ER|paliperidone er
683621|NCT00697658|Schizophrenia|schizophrenia
683622|NCT00697645|Stroke,|stroke,
683623|NCT00697645|Cerebrovascular disease,|cerebrovascular disease,
683624|NCT00697645|Transcranial magnetic stimulation,|transcranial magnetic stimulation,
683625|NCT00697645|rehabilitation|rehabilitation
683626|NCT00697632|MET|met
683627|NCT00697632|AXL|axl
683628|NCT00697632|VEGFR|vegfr
683629|NCT00697632|NSCLC|nsclc
683630|NCT00697632|HNSCC (Head and neck squamous cell carcinoma)|hnscc (head and neck squamous cell carcinoma)
683631|NCT00697632|Tumor|tumor
683632|NCT00697632|Safety|safety
683633|NCT00697632|Phase 1|phase 1
683634|NCT00697632|Solid tumor|solid tumor
683635|NCT00697606|Seprafilm®|seprafilm®
683636|NCT00697606|cesarean|cesarean
683637|NCT00697606|adhesions|adhesions
683638|NCT00697606|primary|primary
683639|NCT00697606|repeat|repeat
683640|NCT00697593|Efalizumab|efalizumab
683641|NCT00697593|Chronic Plaque Psoriasis|chronic plaque psoriasis
683642|NCT00697593|Transition from systemic therapies on to Efalizumab|transition from systemic therapies on to efalizumab
683643|NCT00697580|Obesity|obesity
683644|NCT00697580|Type 2 Diabetes|type 2 diabetes
683645|NCT00697580|Cardiovascular risk|cardiovascular risk
683646|NCT00697580|Cancer|cancer
683647|NCT00697580|Latino|latino
683648|NCT00697580|Adolescents|adolescents
683649|NCT00697580|Strength Training|strength training
683650|NCT00697580|Circuit Training|circuit training
683651|NCT00697580|Nutrition|nutrition
683652|NCT00697567|Herpes simplex|herpes simplex
683653|NCT00697567|Herpes simplex vaccine|herpes simplex vaccine
683654|NCT00697554|Hepatitis B|hepatitis b
683655|NCT00697554|Adjuvanted hepatitis B vaccine|adjuvanted hepatitis b vaccine
683656|NCT00697541|erythematous rosacea|erythematous rosacea
683657|NCT00697541|facial gel|facial gel
683658|NCT00697541|brimonidine|brimonidine
683659|NCT00697541|ophthalmic solution|ophthalmic solution
683660|NCT00697528|Graves|graves
683661|NCT00697528|Color Doppler Imaging|color doppler imaging
683662|NCT00697528|Graves' Ophthalmopathy|graves' ophthalmopathy
683663|NCT00697528|Orbital Venous Flow|orbital venous flow
683664|NCT00697489|Pelvic organ prolapse|pelvic organ prolapse
683665|NCT00697489|Urinary incontinence|urinary incontinence
683666|NCT00697489|Mesh|mesh
683667|NCT00697476|second line chemotherapy|second line chemotherapy
683668|NCT00697463|Teriparatide|teriparatide
683669|NCT00697463|Forteo|forteo
683670|NCT00697463|Osteopenia|osteopenia
683671|NCT00697463|Osteoporosis|osteoporosis
683672|NCT00697463|Fracture|fracture
683673|NCT00697463|Low Bone Density|low bone density
683674|NCT00697463|Premenopausal women|premenopausal women
683675|NCT00697411|Aicardi syndrome|aicardi syndrome
683676|NCT00697411|Microphthalmia with linear skin defects (MLS) syndrome|microphthalmia with linear skin defects (mls) syndrome
683677|NCT00697411|X-linked disorders|x-linked disorders
683678|NCT00697372|Angioplasty, Transluminal, Percutaneous Coronary|angioplasty, transluminal, percutaneous coronary
683679|NCT00697372|Drug-Eluting Stents|drug-eluting stents
683680|NCT00697359|Atrial fibrillation|atrial fibrillation
683681|NCT00697359|Monitoring|monitoring
683682|NCT00697359|Pulmonary vein isolation|pulmonary vein isolation
683683|NCT00697359|Implantable loop recorder|implantable loop recorder
683684|NCT00697346|Drug therapy|drug therapy
683685|NCT00697333|NSCLC|nsclc
683686|NCT00697333|FDG-PET|fdg-pet
683687|NCT00697333|Radiotherapy|radiotherapy
683688|NCT00697333|planning|planning
683689|NCT00697333|target volumes|target volumes
683690|NCT00697307|bioequivalence|bioequivalence
683691|NCT00697307|contraception|contraception
683692|NCT00697307|contraceptive patch|contraceptive patch
683693|NCT00697307|ORTHO EVRA|ortho evra
683694|NCT00697307|norelgestromin|norelgestromin
683695|NCT00697307|NGMN|ngmn
683696|NCT00697307|ethinyl estradiol|ethinyl estradiol
683697|NCT00697307|EE|ee
683698|NCT00697294|Vitamin D deficiency|vitamin d deficiency
683699|NCT00697294|Infants|infants
683700|NCT00697294|Breast feeding|breast feeding
683701|NCT00697281|allergic rhinitis|allergic rhinitis
683702|NCT00697281|human|human
683703|NCT00697281|clinical trial|clinical trial
683704|NCT00697281|efficacy|efficacy
683705|NCT00697281|safety|safety
683706|NCT00697281|challenge test|challenge test
683707|NCT00697268|Depression|depression
683708|NCT00697268|Depression Treatment|depression treatment
683709|NCT00697268|Unipolar Depression|unipolar depression
683710|NCT00697268|Citalopram|citalopram
683711|NCT00697268|Serotonin|serotonin
683712|NCT00697268|Major Depression|major depression
683713|NCT00697268|Healthy Volunteer|healthy volunteer
683714|NCT00697268|HV|hv
683715|NCT00697255|Pharmacological effects of drugs|pharmacological effects of drugs
683716|NCT00697255|Hormones|hormones
683717|NCT00697255|Hormone Substitutes and Hormone Antagonists|hormone substitutes and hormone antagonists
683718|NCT00697255|Pharmacological Actions|pharmacological actions
683719|NCT00697255|Monofollicular growth|monofollicular growth
683720|NCT00697255|Randomized|randomized
683721|NCT00697255|Open-label|open-label
683722|NCT00697255|Active-controlled|active-controlled
683723|NCT00697242|Hepatitis B|hepatitis b
683724|NCT00697242|Engerix™-B|engerix™-b
683725|NCT00697242|Recombinant Hepatitis B vaccine|recombinant hepatitis b vaccine
683726|NCT00697229|Hepatitis B|hepatitis b
683727|NCT00697229|Engerix™-B|engerix™-b
683728|NCT00697229|Recombinant hepatitis B vaccine|recombinant hepatitis b vaccine
683729|NCT00697216|Hepatitis B|hepatitis b
683730|NCT00697216|Recombinant hepatitis B vaccine|recombinant hepatitis b vaccine
683731|NCT00697216|Adjuvanted hepatitis B vaccine|adjuvanted hepatitis b vaccine
683732|NCT00697177|Gastro-oesophageal reflux|gastro-oesophageal reflux
683733|NCT00697177|24 hour oesophageal pH monitoring|24 hour oesophageal ph monitoring
683734|NCT00697177|Physiotherapy Airway clearance techniques|physiotherapy airway clearance techniques
683735|NCT00697177|Exercise|exercise
683736|NCT00697164|Malaria|malaria
683737|NCT00697164|Treatment|treatment
683738|NCT00697164|Adjunctive|adjunctive
683739|NCT00697164|Erythropoietin|erythropoietin
683740|NCT00697164|Survival|survival
683741|NCT00697151|cerebrovascular diseases|cerebrovascular diseases
683742|NCT00697151|ischemic stroke|ischemic stroke
683743|NCT00697151|patent foramen ovale|patent foramen ovale
683744|NCT00697151|warfarin|warfarin
683745|NCT00697151|aspirin|aspirin
683746|NCT00697151|transesophageal echocardiography|transesophageal echocardiography
683747|NCT00697138|Cocaine|cocaine
683748|NCT00697138|Dependence|dependence
683749|NCT00697138|Pharmacotherapies|pharmacotherapies
683750|NCT00697125|Hepatitis B|hepatitis b
683751|NCT00697125|Engerix™-B|engerix™-b
683752|NCT00697125|Recombinant hepatitis B vaccine|recombinant hepatitis b vaccine
683753|NCT00697099|VTE prevention|vte prevention
683754|NCT00697099|Total Hip Replacement|total hip replacement
683755|NCT00697099|Heparin Low-Molecular-Weight|heparin low-molecular-weight
683756|NCT00697086|Heart disease|heart disease
683757|NCT00697073|Friedreich's Ataxia|friedreich's ataxia
683758|NCT00697073|Idebenone|idebenone
683759|NCT00697073|ICARS|icars
683760|NCT00697060|Metastatic|metastatic
683761|NCT00697060|Previously treated|previously treated
683762|NCT00697047|Colorectal Neoplasms|colorectal neoplasms
683763|NCT00697047|Mass Screening|mass screening
683764|NCT00697047|Population Surveillance|population surveillance
683765|NCT00697047|Randomized controlled trial|randomized controlled trial
683766|NCT00697047|Occult Blood|occult blood
683767|NCT00697047|Colonoscopy|colonoscopy
683768|NCT00697047|Sigmoidoscopy|sigmoidoscopy
683769|NCT00697047|Health Behavior|health behavior
683770|NCT00697047|Colorectal Screening|colorectal screening
683771|NCT00697021|Thromboelastography|thromboelastography
683772|NCT00697021|Aspirin|aspirin
683773|NCT00697021|Clopidogrel|clopidogrel
683774|NCT00697021|Plavix|plavix
683775|NCT00697021|Resistance|resistance
683776|NCT00697021|Platelet|platelet
683777|NCT00697021|Coronary Stenting|coronary stenting
683778|NCT00697021|Bare Metal Stent|bare metal stent
683779|NCT00697021|Dual antiplatelet therapy|dual antiplatelet therapy
683780|NCT00697021|Overreactivity|overreactivity
683781|NCT00697021|Primary Coronary Intervention|primary coronary intervention
683782|NCT00697008|GERD|gerd
683783|NCT00697008|CLINICAL GUIDELINE|clinical guideline
683784|NCT00697008|Symptoms|symptoms
683785|NCT00697008|clinical outcome|clinical outcome
683786|NCT00696982|Arterial stiffness|arterial stiffness
683787|NCT00696982|Augmentation index|augmentation index
683788|NCT00696982|diabetes mellitus|diabetes mellitus
683789|NCT00696956|local drug delivery|local drug delivery
683790|NCT00696956|balloon angioplasty|balloon angioplasty
683791|NCT00696956|safety and tolerance of paclitaxel coated PTA balloons|safety and tolerance of paclitaxel coated pta balloons
683792|NCT00696956|in inhibiting restenosis of below the knee arteries|in inhibiting restenosis of below the knee arteries
683793|NCT00696956|Efficacy of paclitaxel coated PTA balloons|efficacy of paclitaxel coated pta balloons
683794|NCT00696956|in inhibiting restenosis of below the knee arteries (late lumen loss)|in inhibiting restenosis of below the knee arteries (late lumen loss)
683795|NCT00696943|cell death|cell death
683796|NCT00696943|PET imaging|pet imaging
683797|NCT00696943|brain metastases|brain metastases
683798|NCT00696943|stereotactic radiosurgery|stereotactic radiosurgery
683799|NCT00696930|Malignant Carcinoid Tumors|malignant carcinoid tumors
683800|NCT00696917|Hepatitis B|hepatitis b
683801|NCT00696917|Adjuvanted Hepatitis B vaccine|adjuvanted hepatitis b vaccine
683802|NCT00696917|Recombinant Hepatitis B vaccine|recombinant hepatitis b vaccine
683803|NCT00696891|Adjuvanted hepatitis B vaccine, hepatitis B, Engerix™-B|adjuvanted hepatitis b vaccine, hepatitis b, engerix™-b
683804|NCT00696878|Infertility|infertility
683805|NCT00696878|Pharmacological effects of drugs|pharmacological effects of drugs
683806|NCT00696878|Hormones, Hormone Substitutes and Hormone Antagonists|hormones, hormone substitutes and hormone antagonists
683807|NCT00696878|Pharmacological Actions|pharmacological actions
683808|NCT00696878|Multi-center|multi-center
683809|NCT00696865|Safety|safety
683810|NCT00696865|Tolerability|tolerability
683811|NCT00696865|Phase I|phase i
683812|NCT00696852|Mindfulness|mindfulness
683813|NCT00696852|Meditation|meditation
683814|NCT00696852|Yoga|yoga
683815|NCT00696852|Inflammatory Markers|inflammatory markers
683816|NCT00696839|Behavior Therapy|behavior therapy
683817|NCT00696839|Anti-Retroviral Agents|anti-retroviral agents
683818|NCT00696839|Relaxation|relaxation
683819|NCT00696839|Clinical Nursing Research|clinical nursing research
683820|NCT00696839|Complementary Therapies|complementary therapies
683821|NCT00696813|Registry|registry
683822|NCT00696813|Healthcare Utilization|healthcare utilization
683823|NCT00696813|Outcome|outcome
683824|NCT00696813|Safety|safety
683825|NCT00696813|Efficacy|efficacy
683826|NCT00696813|Cost-effectiveness|cost-effectiveness
683827|NCT00696813|Paliperidone ER|paliperidone er
683828|NCT00696813|Invega®|invega®
683829|NCT00696813|Oral antipsychotics|oral antipsychotics
683830|NCT00696800|Infertility|infertility
683831|NCT00696800|Pharmacological effect of drugs|pharmacological effect of drugs
683832|NCT00696800|Hormones|hormones
683833|NCT00696800|Hormone substitutes and hormone antagonists|hormone substitutes and hormone antagonists
683834|NCT00696800|Pharmacological actions|pharmacological actions
683835|NCT00696800|Randomized|randomized
683836|NCT00696800|Multi-center|multi-center
683837|NCT00696800|Multi-national|multi-national
683838|NCT00696800|Double-blind|double-blind
683839|NCT00696800|Active-controlled|active-controlled
683840|NCT00696800|Non-inferiority|non-inferiority
683841|NCT00696761|LUTS|luts
683842|NCT00696761|BPH|bph
683843|NCT00696761|bladder outlet obstruction|bladder outlet obstruction
683844|NCT00696761|bladder contractility|bladder contractility
683845|NCT00696748|metabolic syndrome|metabolic syndrome
683846|NCT00696748|hypogonadism|hypogonadism
683847|NCT00696748|testosterone undecanoate|testosterone undecanoate
683848|NCT00696735|Phase III study patients with follicular lymphoma|phase iii study patients with follicular lymphoma
683849|NCT00696709|Herpes Zoster (Shingles)|herpes zoster (shingles)
683850|NCT00696696|Pancreatic adenocarcinoma|pancreatic adenocarcinoma
683851|NCT00696696|metastatic|metastatic
683852|NCT00696696|EGRF inhibitor|egrf inhibitor
683853|NCT00696696|targeted therapy|targeted therapy
683854|NCT00696696|combined cancer therapy|combined cancer therapy
683855|NCT00696696|kinase inhibitor|kinase inhibitor
683856|NCT00696696|VEGF-R inhibitor|vegf-r inhibitor
683857|NCT00696683|scorpion|scorpion
683858|NCT00696683|sting|sting
683859|NCT00696683|envenomation|envenomation
683860|NCT00696683|antivenom|antivenom
683861|NCT00696631|Heart disease|heart disease
683862|NCT00696631|morbidity|morbidity
683863|NCT00696618|HIV prevention|hiv prevention
683864|NCT00696618|MSM|msm
683865|NCT00696618|Enema|enema
683866|NCT00696618|HIV Seronegativity|hiv seronegativity
683867|NCT00696605|Hypoosmolality|hypoosmolality
683868|NCT00696605|Hyperosmolality|hyperosmolality
683869|NCT00696605|Copeptin|copeptin
683870|NCT00696605|Vasopressin|vasopressin
683871|NCT00696592|Age-Related Macular Degeneration|age-related macular degeneration
683872|NCT00696592|Choroidal Neovascularization|choroidal neovascularization
683873|NCT00696592|Bevacizumab|bevacizumab
683874|NCT00696592|Photodynamic Therapy|photodynamic therapy
683875|NCT00696579|BCG|bcg
683876|NCT00696579|Gemcitabine|gemcitabine
683877|NCT00696579|Intravesical|intravesical
683878|NCT00696579|Therapy|therapy
683879|NCT00696579|Superficial|superficial
683880|NCT00696579|Transitional|transitional
683881|NCT00696579|Cell carcinoma|cell carcinoma
683882|NCT00696566|Thrombosis|thrombosis
683883|NCT00696566|Platelet aggregation inhibitor|platelet aggregation inhibitor
683884|NCT00696566|Blood platelets|blood platelets
683885|NCT00696566|P2 receptor|p2 receptor
683886|NCT00696566|Cytochrome P450|cytochrome p450
683887|NCT00696540|Bronchiolitis, respiratory distress, hypertonic saline|bronchiolitis, respiratory distress, hypertonic saline
683888|NCT00696527|Infiltrative breast cancer-Clinical practice|infiltrative breast cancer-clinical practice
683889|NCT00696527|Women with infiltrative breast cancer|women with infiltrative breast cancer
683890|NCT00696514|fracture|fracture
683891|NCT00696514|cognition|cognition
683892|NCT00696501|Neuromuscular mapping|neuromuscular mapping
683893|NCT00696501|Spinal surgery|spinal surgery
683894|NCT00696501|Neurodiagnostics|neurodiagnostics
683895|NCT00696501|Segmental root innervation|segmental root innervation
683896|NCT00696501|Dermatomal innervation|dermatomal innervation
683897|NCT00696501|Myotomal innervation|myotomal innervation
683898|NCT00696501|Nerve roots|nerve roots
683899|NCT00696501|Sensory|sensory
683900|NCT00696501|Signs and Symptoms|signs and symptoms
683901|NCT00696462|forced-air warming|forced-air warming
683902|NCT00696462|Bair Hugger|bair hugger
683903|NCT00696462|cesarean section|cesarean section
683904|NCT00696462|postoperative infection|postoperative infection
683905|NCT00696462|surgical site infections|surgical site infections
683906|NCT00696436|Essential Hypertension|essential hypertension
683907|NCT00696436|Cardiovascular Disease|cardiovascular disease
683908|NCT00696436|High Blood Pressure|high blood pressure
683909|NCT00696436|Drug Therapy|drug therapy
683910|NCT00696423|Infanrix/Hib|infanrix/hib
683911|NCT00696423|Chinese children|chinese children
683912|NCT00696410|Heart Failure|heart failure
683913|NCT00696410|Cardiomyopathy|cardiomyopathy
683914|NCT00696410|Remodeling|remodeling
683915|NCT00696410|Antioxidant|antioxidant
683916|NCT00696410|Zinc|zinc
683917|NCT00696410|Copper|copper
683918|NCT00696384|Essential Hypertension|essential hypertension
683919|NCT00696384|Cardiovascular Disease|cardiovascular disease
683920|NCT00696384|High Blood Pressure|high blood pressure
683921|NCT00696384|Drug Therapy|drug therapy
683922|NCT00696371|Neuroinflammation|neuroinflammation
683923|NCT00696371|PBR28|pbr28
683924|NCT00696371|PET Imaging|pet imaging
683925|NCT00696371|Health Volunteer|health volunteer
683926|NCT00696371|HV|hv
683927|NCT00696358|Vitiligo|vitiligo
683928|NCT00696345|colorectal cancer|colorectal cancer
683929|NCT00696345|screening|screening
683930|NCT00696345|biomarker|biomarker
683931|NCT00696345|plasma|plasma
683932|NCT00696345|blood|blood
683933|NCT00696332|ALS|als
683934|NCT00696319|Rupture of the anterior cruciate ligament of the knee|rupture of the anterior cruciate ligament of the knee
683935|NCT00696306|Acute Ischemic Stroke|acute ischemic stroke
683936|NCT00696306|Stroke|stroke
683937|NCT00696306|MRI|mri
683938|NCT00696306|DTI|dti
683939|NCT00696306|Diffusion Tensor Imaging|diffusion tensor imaging
683940|NCT00696306|SWI|swi
683941|NCT00696306|Susceptibility Weighted Imaging|susceptibility weighted imaging
683942|NCT00696306|Outcome|outcome
683943|NCT00696306|Axonal Injury|axonal injury
683944|NCT00696280|nausea|nausea
683945|NCT00696280|vomiting|vomiting
683946|NCT00696280|Carboplatin|carboplatin
683947|NCT00696280|cancer|cancer
683948|NCT00696280|delayed emesis following treatment with carboplatin|delayed emesis following treatment with carboplatin
683949|NCT00696241|Essential Hypertension|essential hypertension
683950|NCT00696241|Cardiovascular Disease|cardiovascular disease
683951|NCT00696241|High Blood Pressure|high blood pressure
683952|NCT00696241|Drug Therapy|drug therapy
683953|NCT00696215|Parkinson's disease|parkinson's disease
683954|NCT00696215|rasagiline|rasagiline
683955|NCT00696215|cognition|cognition
683956|NCT00696215|MAO-B|mao-b
683957|NCT00696202|Mirena|mirena
683958|NCT00696202|Levonorgestrel|levonorgestrel
683959|NCT00696202|Intrauterine device|intrauterine device
683960|NCT00696202|Efficacy|efficacy
683961|NCT00696202|Tolerability|tolerability
683962|NCT00696202|First year of use|first year of use
683963|NCT00696189|Post operative visual loss (POVL)|post operative visual loss (povl)
683964|NCT00696189|Intraocular pressure (IOP)|intraocular pressure (iop)
683965|NCT00696189|Nitrous oxide|nitrous oxide
683966|NCT00696176|STAT 3 DECOY|stat 3 decoy
683967|NCT00696150|ultrasound|ultrasound
683968|NCT00696150|hip|hip
683969|NCT00696150|pain|pain
683970|NCT00696137|Chronic Pain|chronic pain
683971|NCT00696137|Ventilatory Response to Hypercapnia (VRH)|ventilatory response to hypercapnia (vrh)
683972|NCT00696124|lower leg ischemia|lower leg ischemia
683973|NCT00696124|peripheral artery disease|peripheral artery disease
683974|NCT00696111|PCOS|pcos
683975|NCT00696111|OSA|osa
683976|NCT00696111|Metabolism|metabolism
683977|NCT00696111|Diabetes|diabetes
683978|NCT00696085|fetal alcohol exposure|fetal alcohol exposure
683979|NCT00696085|blood markers of alcohol use|blood markers of alcohol use
683980|NCT00696085|brief intervention|brief intervention
683981|NCT00696059|Rheumatoid arthritis|rheumatoid arthritis
683982|NCT00696059|Computed tomography|computed tomography
683983|NCT00696059|Magnetic resonance imaging|magnetic resonance imaging
683984|NCT00696059|Radiography|radiography
683985|NCT00696059|Tumor necrosis factor alpha antagonists|tumor necrosis factor alpha antagonists
683986|NCT00696046|CORD BLOOD CELLS|cord blood cells
683987|NCT00696046|INTRA BONE MARROW INJECTION|intra bone marrow injection
683988|NCT00696046|ENGRAFTMENT|engraftment
683989|NCT00696046|transplants|transplants
683990|NCT00696033|Benzodiazepines|benzodiazepines
683991|NCT00696033|Lorazepam|lorazepam
683992|NCT00696033|Diazepam|diazepam
683993|NCT00696033|Memory|memory
683994|NCT00696033|Perceptual priming|perceptual priming
683995|NCT00696033|Functional brain imaging|functional brain imaging
683996|NCT00696033|FMRI|fmri
683997|NCT00696007|Upper GU Tract Transitional Cell Carinoma|upper gu tract transitional cell carinoma
683998|NCT00696007|Nephroureterectomy|nephroureterectomy
683999|NCT00696007|Chemotherapy|chemotherapy
684000|NCT00696007|Gemcitabine|gemcitabine
684001|NCT00696007|Cisplatin|cisplatin
684002|NCT00695981|Rotator cuff|rotator cuff
684003|NCT00695981|Arthroscopic surgery|arthroscopic surgery
684004|NCT00695981|Open surgery|open surgery
684005|NCT00695981|Physiotherapy|physiotherapy
684006|NCT00695981|Physical therapy|physical therapy
684007|NCT00695981|Effectiveness|effectiveness
684008|NCT00695981|RCT|rct
684009|NCT00695981|cost-effectiveness|cost-effectiveness
684010|NCT00695955|Essential Hypertension|essential hypertension
684011|NCT00695955|Cardiovascular Disease|cardiovascular disease
684012|NCT00695955|High Blood Pressure|high blood pressure
684013|NCT00695955|Drug Therapy|drug therapy
684014|NCT00695942|preeclampsia|preeclampsia
684015|NCT00695942|eclampsia|eclampsia
684016|NCT00695942|retroplacental hematoma|retroplacental hematoma
684017|NCT00695942|vascular IUGR|vascular iugr
684018|NCT00695942|IUFD|iufd
684019|NCT00695942|VTE|vte
684020|NCT00695929|cardiac surgery with cardiopulmonary bypass|cardiac surgery with cardiopulmonary bypass
684021|NCT00695903|Gram-positive bacterial infections|gram-positive bacterial infections
684022|NCT00695903|Staph Aureus|staph aureus
684023|NCT00695903|Bacteremia|bacteremia
684024|NCT00695903|MRSA|mrsa
684025|NCT00695903|Infective Endocarditis|infective endocarditis
684026|NCT00695903|Right-sided Infective endocarditis|right-sided infective endocarditis
684027|NCT00695903|SABIE|sabie
684028|NCT00695903|SAIE|saie
684029|NCT00695903|RIE|rie
684030|NCT00695890|Pupillometry|pupillometry
684031|NCT00695890|Sevoflorane|sevoflorane
684032|NCT00695890|Propofol|propofol
684033|NCT00695877|HIV Seronegativity|hiv seronegativity
684034|NCT00695877|HIV Preventive Vaccine|hiv preventive vaccine
684035|NCT00695851|PCK3145|pck3145
684036|NCT00695851|Prostate|prostate
684037|NCT00695838|GERD symptoms- Waist circumference|gerd symptoms- waist circumference
684038|NCT00695838|Patients with symptomatic GERD|patients with symptomatic gerd
684039|NCT00695812|Neurodevelopmental disorders|neurodevelopmental disorders
684040|NCT00695812|Autism Spectrum Disorders|autism spectrum disorders
684041|NCT00695812|Broader autism phenotype|broader autism phenotype
684042|NCT00695812|Siblings|siblings
684043|NCT00695812|Cognitive language and social emotional development|cognitive language and social emotional development
684044|NCT00695812|to identify siblings who manifest any autism or broader autism phenotype characteristics|to identify siblings who manifest any autism or broader autism phenotype characteristics
684045|NCT00695799|Propofol|propofol
684046|NCT00695799|Anesthesia care provider|anesthesia care provider
684047|NCT00695799|Pollution|pollution
684048|NCT00695799|Operating room|operating room
684049|NCT00695799|Environment|environment
684050|NCT00695773|Prostate Cancer Surgery|prostate cancer surgery
684051|NCT00695773|Laparoscopic surgery for Prostate Cancer|laparoscopic surgery for prostate cancer
684052|NCT00695773|Prostatectomy|prostatectomy
684053|NCT00695773|Urologic Surgical Procedures|urologic surgical procedures
684054|NCT00695747|Glaucoma|glaucoma
684055|NCT00695747|Cataracts|cataracts
684056|NCT00695747|Phacoemulsification(IOL)|phacoemulsification(iol)
684057|NCT00695747|Trabeculectomy|trabeculectomy
684058|NCT00695734|hemodialysis|hemodialysis
684059|NCT00695734|end stage renal failure|end stage renal failure
684060|NCT00695734|tuberculosis|tuberculosis
684061|NCT00695734|latent tuberculosis infection|latent tuberculosis infection
684062|NCT00695734|Patients under hemodialysis for end stage renal failure|patients under hemodialysis for end stage renal failure
684063|NCT00695708|schizophrenia|schizophrenia
684064|NCT00695708|neuroplasticity|neuroplasticity
684065|NCT00695708|sensory gating|sensory gating
684066|NCT00695708|cognitive impairment|cognitive impairment
684067|NCT00695708|MEG|meg
684068|NCT00695708|Disorders with Psychotic Features|disorders with psychotic features
684069|NCT00695695|Parents|parents
684070|NCT00695695|Down Syndrome|down syndrome
684071|NCT00695695|Hope|hope
684072|NCT00695695|Uncertainty|uncertainty
684073|NCT00695695|Adaptation|adaptation
684074|NCT00695695|DS|ds
684075|NCT00695695|Survey|survey
684076|NCT00695682|Remicade|remicade
684077|NCT00695682|Infliximab|infliximab
684078|NCT00695682|CSME|csme
684079|NCT00695682|BDR|bdr
684081|NCT00695682|AMD|amd
684082|NCT00695669|H5N1|h5n1
684083|NCT00695669|immunogenicity|immunogenicity
684084|NCT00695669|influenza|influenza
684085|NCT00695669|Avian|avian
684086|NCT00695669|pandemic|pandemic
684087|NCT00695669|vaccines|vaccines
684088|NCT00695669|human|human
684089|NCT00695669|safety|safety
684090|NCT00695656|Hypertension|hypertension
684091|NCT00695656|general practitioner consultation|general practitioner consultation
684092|NCT00695656|Patients with hypertension|patients with hypertension
684093|NCT00695630|conscious sedation|conscious sedation
684094|NCT00695630|dental anxiety/drug therapy|dental anxiety/drug therapy
684095|NCT00695630|behavior/drug effects|behavior/drug effects
684096|NCT00695617|MARS treatment|mars treatment
684097|NCT00695617|Citrate anticoagulation|citrate anticoagulation
684098|NCT00695604|Acute asthma|acute asthma
684099|NCT00695604|fluticasone|fluticasone
684100|NCT00695604|inhaled corticosteroids|inhaled corticosteroids
684101|NCT00695591|Home sleep testing neuromuscular disease|home sleep testing neuromuscular disease
684102|NCT00695591|Neuromuscular disease patients with FEV1<50% of predicted|neuromuscular disease patients with fev1<50% of predicted
684103|NCT00695552|Major depression, exercise|major depression, exercise
684104|NCT00695539|Rosuvastatin|rosuvastatin
684105|NCT00695539|hypercholesterolaemia|hypercholesterolaemia
684106|NCT00695526|cranberry|cranberry
684107|NCT00695526|total to HDL cholesterol ratio|total to hdl cholesterol ratio
684108|NCT00695526|type 2 diabetes|type 2 diabetes
684109|NCT00695513|Food supplement|food supplement
684110|NCT00695513|Haemodialysis|haemodialysis
684111|NCT00695500|Varenicline|varenicline
684112|NCT00695500|Alcohol|alcohol
684113|NCT00695500|Alcohol Use|alcohol use
684114|NCT00695487|Anesthesia|anesthesia
684115|NCT00695487|THC|thc
684116|NCT00695487|Postoperative Nausea|postoperative nausea
684117|NCT00695474|Hypovitaminosis D|hypovitaminosis d
684118|NCT00695474|Type 2 diabetes|type 2 diabetes
684119|NCT00695474|Glycemic control|glycemic control
684120|NCT00695474|Inflammation|inflammation
684121|NCT00695474|Blood pressure|blood pressure
684122|NCT00695461|Colorectal surgery|colorectal surgery
684123|NCT00695461|Probiotics|probiotics
684124|NCT00695461|Lactobacillus|lactobacillus
684125|NCT00695461|Bacterial translocation|bacterial translocation
684126|NCT00695461|Postoperative complications|postoperative complications
684127|NCT00695461|Inflammatory reaction|inflammatory reaction
684128|NCT00695448|Phosphoinositide 3-kinase inhibitor|phosphoinositide 3-kinase inhibitor
684129|NCT00695448|solid tumors|solid tumors
684130|NCT00695435|normal volunteers|normal volunteers
684131|NCT00695435|anti-infective|anti-infective
684132|NCT00695435|tobramycin|tobramycin
684133|NCT00695422|high-grade squamous intraepithelial lesion|high-grade squamous intraepithelial lesion
684134|NCT00695422|low-grade squamous intraepithelial lesion|low-grade squamous intraepithelial lesion
684135|NCT00695422|human papilloma virus infection|human papilloma virus infection
684136|NCT00695422|AIDS-related diffuse large cell lymphoma|aids-related diffuse large cell lymphoma
684137|NCT00695422|AIDS-related diffuse mixed cell lymphoma|aids-related diffuse mixed cell lymphoma
684138|NCT00695422|AIDS-related diffuse small cleaved cell lymphoma|aids-related diffuse small cleaved cell lymphoma
684139|NCT00695422|AIDS-related immunoblastic large cell lymphoma|aids-related immunoblastic large cell lymphoma
684140|NCT00695422|AIDS-related Kaposi sarcoma|aids-related kaposi sarcoma
684141|NCT00695422|AIDS-related lymphoblastic lymphoma|aids-related lymphoblastic lymphoma
684142|NCT00695422|AIDS-related malignancies|aids-related malignancies
710605|NCT00588640|HEENT cancer|heent cancer
684143|NCT00695422|AIDS-related peripheral/systemic lymphoma|aids-related peripheral/systemic lymphoma
684144|NCT00695422|AIDS-related primary CNS lymphoma|aids-related primary cns lymphoma
684145|NCT00695422|AIDS-related small noncleaved cell lymphoma|aids-related small noncleaved cell lymphoma
684146|NCT00695422|multicentric Castleman disease|multicentric castleman disease
684147|NCT00695422|HIV Infections|hiv infections
684148|NCT00695409|recurrent mantle cell lymphoma|recurrent mantle cell lymphoma
684149|NCT00695409|stage III mantle cell lymphoma|stage iii mantle cell lymphoma
684150|NCT00695409|stage IV mantle cell lymphoma|stage iv mantle cell lymphoma
684151|NCT00695409|recurrent adult diffuse large cell lymphoma|recurrent adult diffuse large cell lymphoma
684152|NCT00695409|stage III adult diffuse large cell lymphoma|stage iii adult diffuse large cell lymphoma
684153|NCT00695409|stage IV adult diffuse large cell lymphoma|stage iv adult diffuse large cell lymphoma
684154|NCT00695409|recurrent grade 1 follicular lymphoma|recurrent grade 1 follicular lymphoma
684155|NCT00695409|recurrent grade 2 follicular lymphoma|recurrent grade 2 follicular lymphoma
684156|NCT00695409|recurrent grade 3 follicular lymphoma|recurrent grade 3 follicular lymphoma
684157|NCT00695409|stage III grade 1 follicular lymphoma|stage iii grade 1 follicular lymphoma
684158|NCT00695409|stage III grade 2 follicular lymphoma|stage iii grade 2 follicular lymphoma
684159|NCT00695409|stage III grade 3 follicular lymphoma|stage iii grade 3 follicular lymphoma
684160|NCT00695409|stage IV grade 1 follicular lymphoma|stage iv grade 1 follicular lymphoma
684161|NCT00695409|stage IV grade 2 follicular lymphoma|stage iv grade 2 follicular lymphoma
684162|NCT00695409|stage IV grade 3 follicular lymphoma|stage iv grade 3 follicular lymphoma
684163|NCT00695409|stage III adult immunoblastic large cell lymphoma|stage iii adult immunoblastic large cell lymphoma
684164|NCT00695409|stage IV adult immunoblastic large cell lymphoma|stage iv adult immunoblastic large cell lymphoma
684165|NCT00695409|recurrent adult immunoblastic large cell lymphoma|recurrent adult immunoblastic large cell lymphoma
684166|NCT00695396|MDS|mds
684167|NCT00695396|Myelodysplastic syndromes|myelodysplastic syndromes
684168|NCT00695396|Anemia|anemia
684169|NCT00695396|Epoetin alfa|epoetin alfa
684170|NCT00695396|EPO|epo
684171|NCT00695383|Exercise therapy|exercise therapy
684172|NCT00695383|Physiotherapy|physiotherapy
684173|NCT00695383|Critical illness|critical illness
684174|NCT00695383|Intensive care|intensive care
684175|NCT00695383|Muscle weakness|muscle weakness
684176|NCT00695383|Mechanical ventilation|mechanical ventilation
684177|NCT00695370|Children|children
684178|NCT00695370|cancer|cancer
684179|NCT00695370|Bone marrow transplantation|bone marrow transplantation
684180|NCT00695370|Mobilization|mobilization
684181|NCT00695370|G-CSF|g-csf
684182|NCT00695370|Children with solid malignancies|children with solid malignancies
684183|NCT00695357|Asthma treatment|asthma treatment
684184|NCT00695357|GINA 2006|gina 2006
684185|NCT00695357|patient perception|patient perception
684186|NCT00695344|Effect of everolimus in graft vascular cardiac illness|effect of everolimus in graft vascular cardiac illness
684187|NCT00695331|Labor Augmentation|labor augmentation
684188|NCT00695331|Misoprostol|misoprostol
684189|NCT00695331|Oxytocin|oxytocin
684190|NCT00695318|AMD|amd
684191|NCT00695318|Age-Related Macular Degeneration|age-related macular degeneration
684192|NCT00695318|Geographic Atrophy|geographic atrophy
684193|NCT00695318|GA|ga
684194|NCT00695305|rilapladib,|rilapladib,
684195|NCT00695305|Lp-PLA2,|lp-pla2,
684196|NCT00695305|atherosclerosis|atherosclerosis
684197|NCT00695305|SB-659032,|sb-659032,
684198|NCT00695305|FDG-PET,|fdg-pet,
684199|NCT00695292|Small Cell Lung Cancer|small cell lung cancer
684200|NCT00695292|Extensive Stage|extensive stage
684201|NCT00695292|irinotecan|irinotecan
684202|NCT00695292|carboplatin|carboplatin
684203|NCT00695292|sunitinib|sunitinib
684204|NCT00695279|Gene therapy|gene therapy
684205|NCT00695253|AAA|aaa
684206|NCT00695240|Continuous bupivacaine infusion|continuous bupivacaine infusion
684207|NCT00695240|Analgesia|analgesia
684208|NCT00695227|laryngopharyngeal reflux|laryngopharyngeal reflux
684209|NCT00695227|extraesophageal reflux symptoms|extraesophageal reflux symptoms
684210|NCT00695214|Obstructive Sleep Apnea|obstructive sleep apnea
684211|NCT00695214|Propofol|propofol
684212|NCT00695214|Sleep Endoscopy|sleep endoscopy
684213|NCT00695201|DEXAMETHASONE|dexamethasone
684214|NCT00695201|FLOXURIDINE|floxuridine
684215|NCT00695201|IRINOTECAN (CPT-11) CAMPTOSAR|irinotecan (cpt-11) camptosar
684216|NCT00695201|OXALIPLATIN|oxaliplatin
684217|NCT00695188|rheumatoid arthritis|rheumatoid arthritis
684218|NCT00695188|MTX polyglutamates|mtx polyglutamates
684219|NCT00695188|clinical outcome|clinical outcome
684220|NCT00695175|Hypertension|hypertension
684221|NCT00695175|Private cardiology consultation|private cardiology consultation
684222|NCT00695175|Patients with hypertension|patients with hypertension
684223|NCT00695162|noise|noise
684224|NCT00695162|speech intelligibility|speech intelligibility
684225|NCT00695162|cognition|cognition
684226|NCT00695149|Spinal cord Injury|spinal cord injury
684227|NCT00695149|Central nervous system|central nervous system
684228|NCT00695149|Regeneration|regeneration
684229|NCT00695149|Bone marrow stromal cells|bone marrow stromal cells
684230|NCT00695149|Transplantation|transplantation
684231|NCT00695136|Autism|autism
684232|NCT00695136|Cognitive Disorder|cognitive disorder
684233|NCT00695136|Sleep|sleep
684234|NCT00695136|Autism Spectrum Disorder|autism spectrum disorder
684235|NCT00695136|ASD|asd
684236|NCT00695123|Bone Marrow Transplant|bone marrow transplant
684237|NCT00695123|Sickle Cell Disease|sickle cell disease
684238|NCT00695123|G-CSF|g-csf
684239|NCT00695123|Apheresis|apheresis
684240|NCT00695110|testosterone|testosterone
684241|NCT00695110|male hypogonadism|male hypogonadism
684242|NCT00695110|low testosterone|low testosterone
684243|NCT00695097|Rituximab|rituximab
684244|NCT00695097|Renal Transplant Rejection|renal transplant rejection
684245|NCT00695097|B cells|b cells
684246|NCT00695097|Patients with biopsy proven acute rejection cellular infiltrate, B cells|patients with biopsy proven acute rejection cellular infiltrate, b cells
684247|NCT00695084|multiple sclerosis|multiple sclerosis
684248|NCT00695071|Healthy Volunteers|healthy volunteers
684249|NCT00695058|Stress incontinence|stress incontinence
684250|NCT00695058|urge incontinence|urge incontinence
684251|NCT00695058|overactive bladder syndrome|overactive bladder syndrome
684252|NCT00695058|vibration|vibration
684253|NCT00695058|nerve stimulation|nerve stimulation
684254|NCT00695045|Pain, Postoperative|pain, postoperative
684255|NCT00695045|Arthroplasty, Replacement, Knee|arthroplasty, replacement, knee
684256|NCT00695045|Morphine|morphine
684257|NCT00695045|Injections, Intrathecal|injections, intrathecal
684258|NCT00695032|renal toxicity|renal toxicity
684259|NCT00695032|chemotherapeutic agent toxicity|chemotherapeutic agent toxicity
684260|NCT00695032|unspecified adult solid tumor, protocol specific|unspecified adult solid tumor, protocol specific
684261|NCT00695019|Prevention of Relapse|prevention of relapse
684262|NCT00695019|HCV genotype 1b|hcv genotype 1b
684263|NCT00695019|Recurrence|recurrence
684264|NCT00695006|manual therapy, cervical traction, cervical radiculopathy|manual therapy, cervical traction, cervical radiculopathy
684265|NCT00694993|first time in human|first time in human
684266|NCT00694993|Allergic rhinitis,|allergic rhinitis,
684267|NCT00694980|UC|uc
684268|NCT00694980|Ulcerative Colitis|ulcerative colitis
684269|NCT00694967|short cervix, cervical funneling, spontaneous preterm birth, cerclage, progesterone|short cervix, cervical funneling, spontaneous preterm birth, cerclage, progesterone
684270|NCT00694954|Iron deficiency anemia|iron deficiency anemia
684271|NCT00694954|Wireless capsule endoscopy|wireless capsule endoscopy
684272|NCT00694954|Obscure-occult gastrointestinal bleeding|obscure-occult gastrointestinal bleeding
684273|NCT00694941|ONO-2506PO|ono-2506po
684274|NCT00694941|Amyotrophic Lateral Sclerosis|amyotrophic lateral sclerosis
684275|NCT00694941|ALS|als
684276|NCT00694915|STCC (Superficial Transitional Cell Carcinoma)|stcc (superficial transitional cell carcinoma)
684277|NCT00694902|Healthy Volunteers|healthy volunteers
684278|NCT00694889|Psychosis|psychosis
684279|NCT00694889|First Episode|first episode
684280|NCT00694889|Schizophrenia|schizophrenia
684281|NCT00694889|Cognitive Remediation|cognitive remediation
684282|NCT00694876|Health Literacy|health literacy
684283|NCT00694876|Patient Nonadherence|patient nonadherence
684284|NCT00694876|Patient Noncompliance|patient noncompliance
684285|NCT00694876|Follow Up|follow up
684286|NCT00694876|India|india
684287|NCT00694876|Glaucoma|glaucoma
684288|NCT00694863|high risk for ESRD|high risk for esrd
684289|NCT00694863|immunosuppressive treatment|immunosuppressive treatment
684290|NCT00694863|membranous nephropathy|membranous nephropathy
684291|NCT00694863|ACTH|acth
684292|NCT00694850|Interstitial lung disease associated pulmonary hypertension|interstitial lung disease associated pulmonary hypertension
684293|NCT00694837|glioblastoma|glioblastoma
684294|NCT00694837|nelfinavir|nelfinavir
684295|NCT00694837|functional imaging|functional imaging
684296|NCT00694837|AKT pathway|akt pathway
684297|NCT00694824|Coronary artery calcification|coronary artery calcification
684298|NCT00694824|calcium score|calcium score
684299|NCT00694824|(TGF) b1,|(tgf) b1,
684300|NCT00694824|fetuin A|fetuin a
684301|NCT00694824|osteoprotegerin (OPG)|osteoprotegerin (opg)
684302|NCT00694824|fibroblast growth factor (FGF) 23,|fibroblast growth factor (fgf) 23,
684303|NCT00694824|matrix gla protein (MGP)|matrix gla protein (mgp)
684304|NCT00694824|hemodialysis patients|hemodialysis patients
684305|NCT00694811|Obesity|obesity
684306|NCT00694811|Weight loss|weight loss
684307|NCT00694811|Diet|diet
684308|NCT00694811|Very-low-energy diet|very-low-energy diet
684309|NCT00694811|Predictive factors|predictive factors
684310|NCT00694811|Re-feeding|re-feeding
684311|NCT00694798|STCC|stcc
684312|NCT00694798|Superficial Transitional Cell Carcinoma- BCG refractor|superficial transitional cell carcinoma- bcg refractor
684313|NCT00694772|Obstructive sleep apnea|obstructive sleep apnea
684314|NCT00694772|OSA|osa
684315|NCT00694772|Apnea hypopnea index|apnea hypopnea index
684316|NCT00694772|AHI|ahi
684317|NCT00694772|Coblation|coblation
684318|NCT00694772|Electrocautery|electrocautery
684319|NCT00694772|Tonsillectomy|tonsillectomy
684320|NCT00694772|Tonsillotomy|tonsillotomy
684321|NCT00694759|Polycystic ovary syndrome|polycystic ovary syndrome
684322|NCT00694759|insulin|insulin
684323|NCT00694759|PCOS|pcos
684324|NCT00694759|cortisol regulation|cortisol regulation
684325|NCT00694759|regulation|regulation
684326|NCT00694746|ALT|alt
684327|NCT00694746|Non-Alcoholic Fatty Liver Disease|non-alcoholic fatty liver disease
684328|NCT00694746|Adolescents|adolescents
684329|NCT00694746|Overweight|overweight
684330|NCT00694746|Treatment|treatment
684331|NCT00694733|Obesity|obesity
684332|NCT00694733|Menopausal Syndrome|menopausal syndrome
684333|NCT00694733|Cortisol|cortisol
684334|NCT00694720|Cheyne-stokes breathing|cheyne-stokes breathing
684335|NCT00694694|Malaria|malaria
684336|NCT00694694|Africa|africa
684337|NCT00694694|Child|child
684338|NCT00694681|Telephonic care management|telephonic care management
684339|NCT00694668|Deliberate Self-Harm|deliberate self-harm
684340|NCT00694668|Self-Injurious Behaviour|self-injurious behaviour
684341|NCT00694668|Suicidal Behaviour|suicidal behaviour
684342|NCT00694668|Cognitive behavioural therapy|cognitive behavioural therapy
684343|NCT00694668|Mindfulness Based cognitive therapy|mindfulness based cognitive therapy
684344|NCT00694655|Yellow Fever|yellow fever
684345|NCT00694655|Vaccine|vaccine
684346|NCT00694655|Immunity|immunity
684347|NCT00694655|yellow fever vaccine|yellow fever vaccine
684348|NCT00694655|CD8 T cell responses|cd8 t cell responses
684349|NCT00694642|Refractory angina|refractory angina
684350|NCT00694629|pulmonary tuberculosis|pulmonary tuberculosis
684351|NCT00694629|treatment|treatment
684352|NCT00694616|Obstructive sleep apnea|obstructive sleep apnea
684353|NCT00694616|Metabolic syndrome|metabolic syndrome
684354|NCT00694616|Insulin resistance|insulin resistance
684355|NCT00694616|Hypertension|hypertension
684356|NCT00694616|Dyslipidemia|dyslipidemia
684357|NCT00694616|Continuous positive airway pressure (CPAP)|continuous positive airway pressure (cpap)
684358|NCT00694603|cetuximab|cetuximab
684359|NCT00694603|tyrosine kinase inhibitor|tyrosine kinase inhibitor
684360|NCT00694590|AMD3100|amd3100
684361|NCT00694590|Rituximab|rituximab
684362|NCT00694590|Chronic Lymphocytic Leukemia|chronic lymphocytic leukemia
684363|NCT00694590|CLL|cll
684364|NCT00694590|Small Lymphocytic Lymphoma|small lymphocytic lymphoma
684365|NCT00694590|SLL|sll
684366|NCT00694577|non-invasive breast cancer|non-invasive breast cancer
684367|NCT00694577|early invasive breast cancer|early invasive breast cancer
684368|NCT00694577|radiation|radiation
684369|NCT00694577|PBI|pbi
684370|NCT00694564|abdominal pain|abdominal pain
684371|NCT00694564|children|children
684372|NCT00694551|vaccine|vaccine
684373|NCT00694551|PSMA|psma
684374|NCT00694551|TARP|tarp
684375|NCT00694551|immunology|immunology
684376|NCT00694551|PSA|psa
684377|NCT00694538|Interferential laser therapy|interferential laser therapy
684378|NCT00694525|21OHD|21ohd
684379|NCT00694525|21-hydroxylase deficiency|21-hydroxylase deficiency
684380|NCT00694525|CAH|cah
684381|NCT00694499|Morbidity|morbidity
684382|NCT00694499|Mortality|mortality
684383|NCT00694486|otitis|otitis
684384|NCT00694486|Eustachian tube function|eustachian tube function
684385|NCT00694486|Normal middle ear status|normal middle ear status
684386|NCT00694473|hyperglycemia|hyperglycemia
684387|NCT00694473|hypoglycemia|hypoglycemia
684388|NCT00694473|insulin|insulin
684389|NCT00694473|critical illness|critical illness
684390|NCT00694473|intensive insulin therapy|intensive insulin therapy
684391|NCT00694473|continuous glucose monitoring|continuous glucose monitoring
684392|NCT00694473|CGM|cgm
684393|NCT00694473|interstitial fluid glucose|interstitial fluid glucose
684394|NCT00694473|intensive care unit|intensive care unit
684395|NCT00694473|Blood glucose|blood glucose
684396|NCT00694460|rabies vaccination|rabies vaccination
684397|NCT00694460|pre-exposure prophylaxis|pre-exposure prophylaxis
684398|NCT00694460|rabies virus neutralizing antibody|rabies virus neutralizing antibody
684399|NCT00694434|Cryopreservation|cryopreservation
684400|NCT00694434|Frozen embryo transfer|frozen embryo transfer
684401|NCT00694434|Graduated Embryo Score|graduated embryo score
684402|NCT00694421|otitis|otitis
684403|NCT00694421|Eustachian tube|eustachian tube
684404|NCT00694421|virus|virus
684405|NCT00694421|Middle ear disease|middle ear disease
684406|NCT00694408|End stage liver disease|end stage liver disease
684407|NCT00694408|Paediatric liver transplantation|paediatric liver transplantation
684408|NCT00694408|Steroid free immunosuppression|steroid free immunosuppression
684409|NCT00694395|Qualitative study|qualitative study
684410|NCT00694395|stroke|stroke
684411|NCT00694395|20 patients, Family or caregivers|20 patients, family or caregivers
684412|NCT00694395|acute ischemic stroke|acute ischemic stroke
684413|NCT00694395|delayed to receive thrombolytic therapy.|delayed to receive thrombolytic therapy.
684414|NCT00694382|chemotherapy|chemotherapy
684415|NCT00694369|Postoperative Dental Pain|postoperative dental pain
684416|NCT00694343|Cesarean section|cesarean section
684417|NCT00694343|spinal anesthesia|spinal anesthesia
684418|NCT00694343|hypotension|hypotension
684419|NCT00694330|vaccine|vaccine
684420|NCT00694330|GM-K562|gm-k562
684421|NCT00694330|malignant glioma|malignant glioma
684422|NCT00694304|Major Depressive Disorder|major depressive disorder
684423|NCT00694304|Long-term|long-term
684424|NCT00694304|Safety|safety
684425|NCT00694304|Open-label|open-label
684426|NCT00694291|Rising PSA|rising psa
684427|NCT00694265|Carpal Tunnel Syndrome|carpal tunnel syndrome
684428|NCT00694265|Median Nerve|median nerve
684429|NCT00694265|Ultrasonography|ultrasonography
684430|NCT00694265|Prospective cohort study|prospective cohort study
684431|NCT00694252|Breast cancer|breast cancer
684432|NCT00694252|Tykerb|tykerb
684433|NCT00694252|CTCs|ctcs
684434|NCT00694239|hypertension|hypertension
684435|NCT00694239|compliance|compliance
684436|NCT00694226|Adolescent|adolescent
684437|NCT00694226|Substance use|substance use
684438|NCT00694226|Brief intervention|brief intervention
684439|NCT00694226|Child psychiatry|child psychiatry
684440|NCT00694213|Pandemic Influenza|pandemic influenza
684441|NCT00694213|Avian Influenza|avian influenza
684442|NCT00694213|DNA Vaccines|dna vaccines
684443|NCT00694213|Antibody|antibody
684444|NCT00694213|T Cells|t cells
684445|NCT00694213|HA/NP/M2|ha/np/m2
684446|NCT00694213|Biojector|biojector
684447|NCT00694200|breast cancer|breast cancer
684448|NCT00694200|chemotherapy|chemotherapy
684449|NCT00694200|anti-angiogenesis therapy|anti-angiogenesis therapy
684450|NCT00694174|Procedural Pain in Newborn Infants|procedural pain in newborn infants
684451|NCT00694174|newborn infant|newborn infant
684452|NCT00694174|acute procedural pain|acute procedural pain
684453|NCT00694174|skin blood flow changes|skin blood flow changes
684454|NCT00694174|sucrose analgesia|sucrose analgesia
684455|NCT00694174|laser doppler imager|laser doppler imager
684456|NCT00694174|neonatal infant pain scale|neonatal infant pain scale
684457|NCT00694161|Transthyretin|transthyretin
684458|NCT00694161|TTR|ttr
684459|NCT00694161|ATTR|attr
684460|NCT00694161|TTR amyloidosis|ttr amyloidosis
684461|NCT00694161|cardiomyopathy|cardiomyopathy
684462|NCT00694161|V122I|v122i
684463|NCT00694161|wild-type TTR|wild-type ttr
684464|NCT00694161|SSA|ssa
684465|NCT00694161|Patients with V122I or wild-type TTR amyloid cardiomyopathy|patients with v122i or wild-type ttr amyloid cardiomyopathy
684466|NCT00694148|Treatment of glabellar frown lines|treatment of glabellar frown lines
684467|NCT00694135|Iontophoresis|iontophoresis
684468|NCT00694135|Non-Infectious Acute Anterior Segment Uveitis|non-infectious acute anterior segment uveitis
684469|NCT00694135|Ophthalmology|ophthalmology
684470|NCT00694122|glucose|glucose
684471|NCT00694122|cortisol|cortisol
684472|NCT00694122|growth hormone|growth hormone
684473|NCT00694122|glucagon|glucagon
684474|NCT00694122|insulin|insulin
684475|NCT00694109|Familial Hypercholesterolemia|familial hypercholesterolemia
684476|NCT00694109|FH|fh
684477|NCT00694109|Heterozygous Familial Hypercholesterolemia|heterozygous familial hypercholesterolemia
684478|NCT00694109|HeFH|hefh
684479|NCT00694109|Homozygous Familial Hypercholesterolemia|homozygous familial hypercholesterolemia
684480|NCT00694109|HoFH|hofh
684481|NCT00694057|Type 2 Diabetes Mellitus|type 2 diabetes mellitus
684482|NCT00694057|Metformin|metformin
684483|NCT00694057|HbA1c|hba1c
684484|NCT00694044|Safety, Tolerability, Pharmacokinetics, Cognition|safety, tolerability, pharmacokinetics, cognition
684485|NCT00694031|Mortality|mortality
684486|NCT00694031|Convective therapies|convective therapies
684487|NCT00694031|On-line Hemodiafiltration|on-line hemodiafiltration
684488|NCT00694031|Dialysis Adequacy|dialysis adequacy
684489|NCT00694031|Age 18 or older|age 18 or older
684490|NCT00694031|Undergoing hemodialysis|undergoing hemodialysis
684491|NCT00694018|randomized trial|randomized trial
684492|NCT00694018|walking|walking
684493|NCT00694005|stent|stent
684494|NCT00694005|bifurcation|bifurcation
684495|NCT00694005|balloon angioplasty|balloon angioplasty
684496|NCT00693966|HPV, Vaccine|hpv, vaccine
684497|NCT00693953|Evoked Potentials|evoked potentials
684498|NCT00693953|Evoked Potentials, Auditory|evoked potentials, auditory
684499|NCT00693953|Evoked Potentials, Visual|evoked potentials, visual
684500|NCT00693953|Electroencephalography|electroencephalography
684501|NCT00693953|Brain Mapping|brain mapping
684502|NCT00693940|Peripheral Arterial Disease|peripheral arterial disease
684503|NCT00693940|PAD|pad
684504|NCT00693927|Hematopoietic cell transplantation|hematopoietic cell transplantation
684505|NCT00693927|Allogeneic|allogeneic
684506|NCT00693927|Nonmyeloablative|nonmyeloablative
684507|NCT00693927|CD8-depletion|cd8-depletion
684508|NCT00693927|PBSC|pbsc
684509|NCT00693927|GVHD|gvhd
684510|NCT00693927|Hematological malignancies and renal cell carcinoma|hematological malignancies and renal cell carcinoma
684511|NCT00693914|Brain Tumor|brain tumor
684512|NCT00693914|Cognitive Late Effects|cognitive late effects
684513|NCT00693914|Radiation Therapy|radiation therapy
684514|NCT00693914|Working Memory|working memory
684515|NCT00693888|dementia|dementia
684516|NCT00693888|system of care|system of care
684517|NCT00693888|level of care|level of care
684518|NCT00693888|interventional study|interventional study
684519|NCT00693888|evaluation|evaluation
684520|NCT00693888|dementia diagnostic|dementia diagnostic
684521|NCT00693888|Evaluation of the care study|evaluation of the care study
684522|NCT00693875|incidence|incidence
684523|NCT00693875|awareness|awareness
684524|NCT00693875|general anesthesia|general anesthesia
684525|NCT00693875|relevant factor|relevant factor
684526|NCT00693875|the incidence of intra-operative awareness in China|the incidence of intra-operative awareness in china
684527|NCT00693875|the relevant factors|the relevant factors
684528|NCT00693862|Focus of the study is pharmacokinetics of the study drug|focus of the study is pharmacokinetics of the study drug
684529|NCT00693849|depression|depression
684530|NCT00693849|CNS|cns
684531|NCT00693849|iSPOT|ispot
684532|NCT00693849|MDD|mdd
684533|NCT00693836|stage I non-small cell lung cancer|stage i non-small cell lung cancer
684534|NCT00693836|stage II non-small cell lung cancer|stage ii non-small cell lung cancer
684535|NCT00693836|stage IIIA non-small cell lung cancer|stage iiia non-small cell lung cancer
684536|NCT00693836|stage IIIB non-small cell lung cancer|stage iiib non-small cell lung cancer
684537|NCT00693836|stage IV non-small cell lung cancer|stage iv non-small cell lung cancer
684538|NCT00693836|recurrent non-small cell lung cancer|recurrent non-small cell lung cancer
684539|NCT00693836|extensive stage small cell lung cancer|extensive stage small cell lung cancer
684540|NCT00693836|limited stage small cell lung cancer|limited stage small cell lung cancer
684541|NCT00693836|recurrent small cell lung cancer|recurrent small cell lung cancer
684542|NCT00693823|atherosclerosis|atherosclerosis
684543|NCT00693823|stent|stent
684544|NCT00693823|angioplasty|angioplasty
684545|NCT00693823|covered stent|covered stent
684546|NCT00693797|ventricular hypertrophy|ventricular hypertrophy
684547|NCT00693797|collagen|collagen
684548|NCT00693797|aortic stenosis|aortic stenosis
684549|NCT00693784|Intervertebral Disk|intervertebral disk
684550|NCT00693784|chronic low back pain|chronic low back pain
684551|NCT00693784|internal disc disruption|internal disc disruption
684552|NCT00693784|degenerative disc disease|degenerative disc disease
684553|NCT00693758|MRI|mri
684554|NCT00693758|coronary reactivity|coronary reactivity
684555|NCT00693758|coronary physiology|coronary physiology
684556|NCT00693745|Acutely|acutely
684557|NCT00693719|recurrent breast cancer|recurrent breast cancer
684558|NCT00693719|stage IIIA breast cancer|stage iiia breast cancer
684559|NCT00693719|stage IIIB breast cancer|stage iiib breast cancer
684560|NCT00693719|stage IIIC breast cancer|stage iiic breast cancer
684561|NCT00693719|stage IV breast cancer|stage iv breast cancer
684562|NCT00693706|cell culture|cell culture
684563|NCT00693706|Safety|safety
684564|NCT00693706|Influenza|influenza
684565|NCT00693706|Humans|humans
684566|NCT00693706|Adults|adults
684567|NCT00693706|Immunogenicity|immunogenicity
684568|NCT00693706|Influenza vaccine|influenza vaccine
684569|NCT00693706|Vaccine|vaccine
684570|NCT00693680|depression|depression
684571|NCT00693680|antidepressant treatment|antidepressant treatment
684572|NCT00693680|zinc|zinc
684573|NCT00693680|placebo|placebo
684574|NCT00693667|osteoporosis|osteoporosis
684575|NCT00693667|postmenopausal women|postmenopausal women
684576|NCT00693667|botanical drug|botanical drug
684577|NCT00693654|Uremic Pruritis|uremic pruritis
684578|NCT00693641|Jellyfish|jellyfish
684579|NCT00693641|Cyanea sp|cyanea sp
684580|NCT00693641|Safe Sea|safe sea
684581|NCT00693641|Prevention|prevention
684582|NCT00693641|treatment|treatment
684583|NCT00693641|Pain relief|pain relief
684584|NCT00693641|Prevention of pain|prevention of pain
684585|NCT00693628|volume|volume
684586|NCT00693628|healing|healing
684587|NCT00693628|shrinker|shrinker
684588|NCT00693628|transtibial amputation|transtibial amputation
684589|NCT00693628|individuals who have undergone transtibial amputation|individuals who have undergone transtibial amputation
684590|NCT00693615|HPV, Vaccine|hpv, vaccine
684591|NCT00693589|endothelial function|endothelial function
684592|NCT00693589|flow mediated dilatation|flow mediated dilatation
684593|NCT00693589|rosuvastatin|rosuvastatin
684594|NCT00693589|folic acid|folic acid
684595|NCT00693589|B vitamins|b vitamins
684596|NCT00693576|renal transplant|renal transplant
684597|NCT00693576|panel reactive antibody|panel reactive antibody
684598|NCT00693576|sensitization|sensitization
684599|NCT00693576|simvastatin|simvastatin
684600|NCT00693576|immunological|immunological
684601|NCT00693563|Spinal Cord Injury|spinal cord injury
684602|NCT00693550|lip and oral cavity squamous cell carcinoma|lip and oral cavity squamous cell carcinoma
684603|NCT00693550|oropharyngeal squamous cell carcinoma|oropharyngeal squamous cell carcinoma
684691|NCT00693199|Terazosin|terazosin
684604|NCT00693524|liver allograft transplantation|liver allograft transplantation
684605|NCT00693524|sequential therapy|sequential therapy
684606|NCT00693524|tacrolimus|tacrolimus
684608|NCT00693511|adolescents|adolescents
684609|NCT00693511|adiposity|adiposity
684610|NCT00693511|insulin sensitivity|insulin sensitivity
684611|NCT00693511|type 2 diabetes|type 2 diabetes
684612|NCT00693511|Latino|latino
684613|NCT00693511|circuit training|circuit training
684614|NCT00693511|physical activity|physical activity
684615|NCT00693511|motivational interviewing|motivational interviewing
684616|NCT00693498|pediatrics|pediatrics
684617|NCT00693498|congenital heart disease|congenital heart disease
684618|NCT00693472|Antipsychotic Agents|antipsychotic agents
684619|NCT00693459|Hemorrhoids|hemorrhoids
684620|NCT00693446|Pancreas-kidney allograft|pancreas-kidney allograft
684621|NCT00693446|tacrolimus|tacrolimus
684622|NCT00693446|sirolimus|sirolimus
684623|NCT00693446|Pancreas-kidney allograft recipients|pancreas-kidney allograft recipients
684624|NCT00693381|Transplantation|transplantation
684625|NCT00693381|Graft Rejection|graft rejection
684626|NCT00693381|Renal Transplantation|renal transplantation
684627|NCT00693355|gut health|gut health
684628|NCT00693342|stage IA primary peritoneal cavity cancer|stage ia primary peritoneal cavity cancer
684629|NCT00693342|stage IB primary peritoneal cavity cancer|stage ib primary peritoneal cavity cancer
684630|NCT00693342|stage IC primary peritoneal cavity cancer|stage ic primary peritoneal cavity cancer
684631|NCT00693342|stage IIA primary peritoneal cavity cancer|stage iia primary peritoneal cavity cancer
684632|NCT00693342|stage IIB primary peritoneal cavity cancer|stage iib primary peritoneal cavity cancer
684633|NCT00693342|stage IIC primary peritoneal cavity cancer|stage iic primary peritoneal cavity cancer
684634|NCT00693342|stage IIIA primary peritoneal cavity cancer|stage iiia primary peritoneal cavity cancer
684635|NCT00693342|stage IIIB primary peritoneal cavity cancer|stage iiib primary peritoneal cavity cancer
684636|NCT00693342|stage IIIC primary peritoneal cavity cancer|stage iiic primary peritoneal cavity cancer
684637|NCT00693342|stage IV primary peritoneal cavity cancer|stage iv primary peritoneal cavity cancer
684638|NCT00693342|stage IA fallopian tube cancer|stage ia fallopian tube cancer
684639|NCT00693342|stage IB fallopian tube cancer|stage ib fallopian tube cancer
684640|NCT00693342|stage IC fallopian tube cancer|stage ic fallopian tube cancer
684641|NCT00693342|stage IIA fallopian tube cancer|stage iia fallopian tube cancer
684642|NCT00693342|stage IIB fallopian tube cancer|stage iib fallopian tube cancer
684643|NCT00693342|stage IIC fallopian tube cancer|stage iic fallopian tube cancer
684644|NCT00693342|stage IIIA fallopian tube cancer|stage iiia fallopian tube cancer
684645|NCT00693342|stage IIIB fallopian tube cancer|stage iiib fallopian tube cancer
684646|NCT00693342|stage IIIC fallopian tube cancer|stage iiic fallopian tube cancer
684647|NCT00693342|stage IV fallopian tube cancer|stage iv fallopian tube cancer
684648|NCT00693342|stage IA ovarian epithelial cancer|stage ia ovarian epithelial cancer
684649|NCT00693342|stage IB ovarian epithelial cancer|stage ib ovarian epithelial cancer
684650|NCT00693342|stage IC ovarian epithelial cancer|stage ic ovarian epithelial cancer
684651|NCT00693342|stage IIA ovarian epithelial cancer|stage iia ovarian epithelial cancer
684652|NCT00693342|stage IIB ovarian epithelial cancer|stage iib ovarian epithelial cancer
684653|NCT00693342|stage IIC ovarian epithelial cancer|stage iic ovarian epithelial cancer
684654|NCT00693342|stage IIIA ovarian epithelial cancer|stage iiia ovarian epithelial cancer
684655|NCT00693342|stage IIIB ovarian epithelial cancer|stage iiib ovarian epithelial cancer
684656|NCT00693342|stage IIIC ovarian epithelial cancer|stage iiic ovarian epithelial cancer
684657|NCT00693342|stage IV ovarian epithelial cancer|stage iv ovarian epithelial cancer
684658|NCT00693329|Contrast Induced Nephrophathy (CIN)|contrast induced nephrophathy (cin)
684659|NCT00693329|Kidney|kidney
684660|NCT00693329|NGAL|ngal
684661|NCT00693316|Healthy volunteer study|healthy volunteer study
684662|NCT00693303|single subject|single subject
684663|NCT00693303|quantitative|quantitative
684664|NCT00693290|Colonoscopy|colonoscopy
684665|NCT00693290|Colorectal screening|colorectal screening
684666|NCT00693290|Colon preparation|colon preparation
684667|NCT00693264|Human Volunteers|human volunteers
684668|NCT00693264|Hoodia|hoodia
684669|NCT00693264|Safety|safety
684670|NCT00693251|stent|stent
684671|NCT00693251|bifurcation|bifurcation
684672|NCT00693251|coronary artery stenosis|coronary artery stenosis
684673|NCT00693251|balloon angioplasty|balloon angioplasty
684674|NCT00693238|Prostate Cancer|prostate cancer
684675|NCT00693238|Proton Radiation|proton radiation
684676|NCT00693225|Erosive Esophagitis|erosive esophagitis
684677|NCT00693225|Reflux Esophagitis|reflux esophagitis
684678|NCT00693225|Gastroesophageal reflux disease|gastroesophageal reflux disease
684679|NCT00693225|GERD|gerd
684680|NCT00693225|proton pump inhibitor|proton pump inhibitor
684681|NCT00693225|omeprazole/sodium bicarbonate|omeprazole/sodium bicarbonate
684682|NCT00693212|ADHD|adhd
684683|NCT00693212|Adult|adult
684684|NCT00693212|crossover|crossover
684685|NCT00693212|randomized|randomized
684686|NCT00693212|Long-term|long-term
684687|NCT00693212|Open-label|open-label
684688|NCT00693212|methylphenidate|methylphenidate
684689|NCT00693212|Social adjustment|social adjustment
684690|NCT00693199|Amlodipine|amlodipine
684692|NCT00693199|Lower Urinary Tract Symptoms (LUTS)|lower urinary tract symptoms (luts)
684693|NCT00693199|Essential hypertension|essential hypertension
684694|NCT00693199|International Prostate Symptom Score (IPSS)|international prostate symptom score (ipss)
684695|NCT00693199|Quality Of Life (QOL)|quality of life (qol)
684696|NCT00693173|anal|anal
684697|NCT00693173|cancer|cancer
684698|NCT00693173|rectal|rectal
684699|NCT00693173|IMRT|imrt
684700|NCT00693173|genital|genital
684701|NCT00693173|sparing|sparing
684702|NCT00693173|drop|drop
684703|NCT00693173|technique|technique
684704|NCT00693160|healthy volunteers|healthy volunteers
684705|NCT00693160|analgesia|analgesia
684706|NCT00693160|pain|pain
684707|NCT00693160|Healthy subjects|healthy subjects
684708|NCT00693147|Goiter [C19.874.283]|goiter [c19.874.283]
684709|NCT00693147|Thyroid Neoplasms [C19.874.788]|thyroid neoplasms [c19.874.788]
684710|NCT00693121|Traumatic Brain Injury|traumatic brain injury
684711|NCT00693121|Posttraumatic Confusional State|posttraumatic confusional state
684712|NCT00693121|Delirium|delirium
684713|NCT00693121|Amantadine|amantadine
684714|NCT00693121|Clinical trial|clinical trial
684715|NCT00693108|Poor|poor
684716|NCT00693108|Response|response
684717|NCT00693108|Ovarian|ovarian
684718|NCT00693108|Stimulation|stimulation
684719|NCT00693108|IVF|ivf
684720|NCT00693108|Patients|patients
684721|NCT00693095|Grade IV Glioblastoma Multiforme|grade iv glioblastoma multiforme
684722|NCT00693095|Newly-diagnosed|newly-diagnosed
684723|NCT00693095|CMV positive|cmv positive
684724|NCT00693082|PCOS|pcos
684725|NCT00693082|flaxseed|flaxseed
684726|NCT00693069|angioplasty|angioplasty
684727|NCT00693069|clopidogrel|clopidogrel
684728|NCT00693069|coronary artery disease|coronary artery disease
684729|NCT00693069|platelets|platelets
684730|NCT00693069|Percutaneous coronary intervention|percutaneous coronary intervention
684731|NCT00693056|Erectile Dysfunctions|erectile dysfunctions
684732|NCT00693056|ED|ed
684733|NCT00693043|Pain control|pain control
684734|NCT00693030|Coronary Artery Disease|coronary artery disease
684735|NCT00693030|Percutaneous Coronary Interventions|percutaneous coronary interventions
684736|NCT00693030|Drug-Eluting stents|drug-eluting stents
684737|NCT00693030|Optical Coherence Tomography|optical coherence tomography
684738|NCT00693030|Thrombosis|thrombosis
684739|NCT00693030|Long lesions in native vessel requiring stents in overlap|long lesions in native vessel requiring stents in overlap
684740|NCT00692991|Microvascular Obstruction|microvascular obstruction
684741|NCT00692991|Cardiac MRI|cardiac mri
684742|NCT00692991|Alcohol Ablation|alcohol ablation
684743|NCT00692991|Diagnostic PCI|diagnostic pci
684744|NCT00692978|Monodisperse aerosols|monodisperse aerosols
684745|NCT00692978|Healthy Volunteers|healthy volunteers
684746|NCT00692978|Asthmatics|asthmatics
684747|NCT00692978|Pharmacokinetics|pharmacokinetics
684748|NCT00692978|Randomized|randomized
684749|NCT00692965|HIV|hiv
684750|NCT00692965|Sleep Quality|sleep quality
684751|NCT00692965|Sleep apnea|sleep apnea
684752|NCT00692965|Berlin Questionnaire|berlin questionnaire
684753|NCT00692965|Pittsburgh Sleep Quality Index|pittsburgh sleep quality index
684754|NCT00692952|contraceptive efficacy|contraceptive efficacy
684755|NCT00692939|Stem cell transplantation|stem cell transplantation
684756|NCT00692939|Crohn's Disease|crohn's disease
684757|NCT00692926|ALDHbr|aldhbr
684758|NCT00692926|Umbilical Cord Blood|umbilical cord blood
684759|NCT00692926|Transplantation|transplantation
684760|NCT00692926|Hematological malignancy|hematological malignancy
684761|NCT00692926|MDS|mds
684762|NCT00692926|severe aplastic anemia|severe aplastic anemia
684763|NCT00692926|inborn error of metabolism|inborn error of metabolism
684764|NCT00692926|congenital marrow failure or congenital immunodeficiency syndrome|congenital marrow failure or congenital immunodeficiency syndrome
684765|NCT00692926|Hurler's Disease|hurler's disease
684766|NCT00692926|Tay Sach's|tay sach's
684767|NCT00692926|PMD|pmd
684768|NCT00692926|Hunter's Syndrome|hunter's syndrome
684769|NCT00692926|Krabbe|krabbe
684770|NCT00692926|MLD|mld
684771|NCT00692926|ALD|ald
684772|NCT00692926|ALL|all
684773|NCT00692926|AML|aml
684774|NCT00692887|AMD|amd
684775|NCT00692874|Quality of Life|quality of life
684776|NCT00692861|Celiac Disease|celiac disease
684777|NCT00692861|Ataxia|ataxia
684778|NCT00692861|Adults|adults
684779|NCT00692861|Health Volunteer|health volunteer
684780|NCT00692861|HV|hv
684781|NCT00692848|Procalcitonin|procalcitonin
684782|NCT00692848|Antibiotic|antibiotic
684783|NCT00692848|Fever without source|fever without source
684784|NCT00692848|Fever without focus|fever without focus
684785|NCT00692848|bacteremia|bacteremia
684786|NCT00692848|Urinary tract infection|urinary tract infection
684787|NCT00692835|Goiter [C19.874.283]|goiter [c19.874.283]
684788|NCT00692835|Thyroid Neoplasms [C19.874.788]|thyroid neoplasms [c19.874.788]
684789|NCT00692822|Neisseria gonorrheae|neisseria gonorrheae
684790|NCT00692822|Antimicrobial Susceptibility|antimicrobial susceptibility
684791|NCT00692822|Quinolone Resistance|quinolone resistance
684792|NCT00692822|Sexually transmitted diseases|sexually transmitted diseases
685088|NCT00691613|Hypoxia|hypoxia
684793|NCT00692809|Latent tuberculosis infection|latent tuberculosis infection
684794|NCT00692809|Human immunodeficiency virus|human immunodeficiency virus
684795|NCT00692809|Tuberculosis|tuberculosis
684796|NCT00692809|Natural Killer T Cells|natural killer t cells
684797|NCT00692809|Invariant Natural Killer T Cells|invariant natural killer t cells
684798|NCT00692809|Regulatory T cells|regulatory t cells
684799|NCT00692809|Interferon-gamma|interferon-gamma
684800|NCT00692796|Pulmonary fibrosis|pulmonary fibrosis
684801|NCT00692796|Pulmonary rehabilitation|pulmonary rehabilitation
684803|NCT00692796|Quality of life|quality of life
684804|NCT00692783|candida|candida
684805|NCT00692783|dubliniensis|dubliniensis
684806|NCT00692783|candidiasis|candidiasis
684807|NCT00692783|HIV|hiv
684808|NCT00692783|AIDS|aids
684809|NCT00692783|azole resistance.|azole resistance.
684810|NCT00692770|Hepatocellular carcinoma|hepatocellular carcinoma
684811|NCT00692770|Sorafenib|sorafenib
684812|NCT00692770|Adjuvant|adjuvant
684813|NCT00692770|Surgical resection|surgical resection
684814|NCT00692770|Ablation|ablation
684815|NCT00692770|Nexavar|nexavar
684816|NCT00692770|Adjuvant therapy|adjuvant therapy
684817|NCT00692770|Liver cancer|liver cancer
684819|NCT00692770|STORM|storm
684820|NCT00692757|Hypochlorous Acid|hypochlorous acid
684821|NCT00692757|Colony forming units|colony forming units
684822|NCT00692757|surgical site infection|surgical site infection
684823|NCT00692757|nosocomial infection|nosocomial infection
684824|NCT00692757|bacterial bioburden|bacterial bioburden
684825|NCT00692757|wound healing|wound healing
684826|NCT00692744|Subarachnoid hemorrhage|subarachnoid hemorrhage
684827|NCT00692744|Cerebral aneurysm|cerebral aneurysm
684828|NCT00692744|Elderly|elderly
684829|NCT00692731|green tea,|green tea,
684830|NCT00692731|polyphenols,|polyphenols,
684831|NCT00692731|weight loss,|weight loss,
684832|NCT00692731|body fat|body fat
684833|NCT00692705|Alzheimer´s Disease|alzheimer´s disease
684834|NCT00692705|amyloid deposits|amyloid deposits
684835|NCT00692705|Positron Emission Tomography|positron emission tomography
684836|NCT00692705|phase I|phase i
684837|NCT00692653|Localized prostate cancer|localized prostate cancer
684838|NCT00692653|Treatment decision making|treatment decision making
684839|NCT00692653|Tailored decision aid|tailored decision aid
684840|NCT00692640|Cancer|cancer
684841|NCT00692640|Solid Tumors|solid tumors
684842|NCT00692640|NSCLC|nsclc
684843|NCT00692627|Falciparum|falciparum
684844|NCT00692627|malaria|malaria
684845|NCT00692627|volume|volume
684846|NCT00692627|haemodynamics|haemodynamics
684847|NCT00692601|Acute Exercise protocol|acute exercise protocol
684848|NCT00692601|Crossover design|crossover design
684849|NCT00692601|Oxygen consumption (VO2)|oxygen consumption (vo2)
684850|NCT00692601|Respiratory Exchange Ratio (RER)|respiratory exchange ratio (rer)
684851|NCT00692601|Adrenergic System Agonism|adrenergic system agonism
684852|NCT00692601|Capsiate Natura|capsiate natura
684853|NCT00692601|Young|young
684854|NCT00692601|Male|male
684855|NCT00692588|Alzheimer's Disease|alzheimer's disease
684856|NCT00692588|Magnetic Resonance Imaging|magnetic resonance imaging
684857|NCT00692588|Magnetic Resonance Spectroscopy|magnetic resonance spectroscopy
684858|NCT00692588|Diffusion Tensor Imaging|diffusion tensor imaging
684859|NCT00692588|Susceptibility Weighted Imaging|susceptibility weighted imaging
684860|NCT00692588|Doxycycline|doxycycline
684861|NCT00692588|Rifampicin|rifampicin
684862|NCT00692575|Brain Injuries, Traumatic|brain injuries, traumatic
684863|NCT00692575|Caregivers|caregivers
684864|NCT00692562|Islets of Langerhans Transplantation|islets of langerhans transplantation
684865|NCT00692562|Kidney Transplantation|kidney transplantation
684866|NCT00692562|Type 1 Diabetes Mellitus|type 1 diabetes mellitus
684867|NCT00692562|alemtuzumab|alemtuzumab
684868|NCT00692549|ultrasound|ultrasound
684869|NCT00692549|iv access|iv access
684870|NCT00692549|Patients with difficult iv access in emergency departments.|patients with difficult iv access in emergency departments.
684871|NCT00692536|Obesity|obesity
684872|NCT00692536|Postmenopausal|postmenopausal
684873|NCT00692536|Diet intervention|diet intervention
684874|NCT00692523|Stroke|stroke
684875|NCT00692523|rehabilitation|rehabilitation
684876|NCT00692523|Nintendo Wii|nintendo wii
684877|NCT00692510|AZD3480|azd3480
684878|NCT00692510|Cocktail|cocktail
684879|NCT00692510|caffeine|caffeine
684880|NCT00692510|bupropion|bupropion
684881|NCT00692510|omeprazole|omeprazole
684882|NCT00692510|midazolam|midazolam
684883|NCT00692510|rosiglitazone|rosiglitazone
684884|NCT00692510|metabolism|metabolism
684885|NCT00692510|Drug Drug Interaction|drug drug interaction
684886|NCT00692497|One-Stop|one-stop
684887|NCT00692497|Public Health Research|public health research
684888|NCT00692497|Delivery of Health Care/*standards|delivery of health care/*standards
684889|NCT00692497|Evaluation Studies|evaluation studies
684890|NCT00692497|Referral|referral
684891|NCT00692497|Surgery, Outpatient|surgery, outpatient
684892|NCT00692497|Surgery, Day|surgery, day
684893|NCT00692497|Telemedicine|telemedicine
684894|NCT00692484|Antimicrobial|antimicrobial
684895|NCT00692484|Antisepsis|antisepsis
684896|NCT00692484|Topical antisepsis|topical antisepsis
684897|NCT00692471|Sleep|sleep
684898|NCT00692471|Orthostatic tachycardia|orthostatic tachycardia
684899|NCT00692471|POTS|pots
684900|NCT00692445|depression|depression
684901|NCT00692432|Macrophage Migration Inhibitory Factor|macrophage migration inhibitory factor
684902|NCT00692432|MIF|mif
684903|NCT00692432|Cardiopulmonary bypass|cardiopulmonary bypass
684904|NCT00692432|CPB|cpb
684905|NCT00692432|inflammation|inflammation
684906|NCT00692432|inflammatory marker|inflammatory marker
684907|NCT00692432|myocardial depression|myocardial depression
684908|NCT00692432|myocardial depressant factor|myocardial depressant factor
684909|NCT00692419|pain|pain
684910|NCT00692419|sexual dysfunction|sexual dysfunction
684911|NCT00692419|depression|depression
684912|NCT00692419|symptoms|symptoms
684913|NCT00692380|gated IMRT|gated imrt
684914|NCT00692367|Body fat|body fat
684915|NCT00692367|Exercise|exercise
684916|NCT00692367|Fatty acids|fatty acids
684917|NCT00692367|Impaired glucose tolerance|impaired glucose tolerance
684918|NCT00692367|Insulin resistance|insulin resistance
684919|NCT00692367|Insulin Sensitivity|insulin sensitivity
684920|NCT00692367|Metabolic syndrome|metabolic syndrome
684921|NCT00692367|Obesity|obesity
684922|NCT00692367|Physical activity|physical activity
684923|NCT00692367|Weight Loss|weight loss
684924|NCT00692354|Advanced|advanced
684925|NCT00692354|Solid|solid
684926|NCT00692354|Tumour|tumour
684927|NCT00692354|Tumor|tumor
684928|NCT00692354|Oral|oral
684929|NCT00692341|hepatic impairment|hepatic impairment
684930|NCT00692328|fatigue; TMS; MEP|fatigue; tms; mep
684931|NCT00692315|glutathione|glutathione
684932|NCT00692315|methionine|methionine
684933|NCT00692315|folinic acid|folinic acid
684934|NCT00692315|redox|redox
684935|NCT00692315|oxidative stress|oxidative stress
684936|NCT00692315|behavior|behavior
684937|NCT00692302|Suicide Attempts|suicide attempts
684938|NCT00692302|Adolescents|adolescents
684939|NCT00692302|Suicidal|suicidal
684940|NCT00692302|Adolescent Suicide Attempters|adolescent suicide attempters
684941|NCT00692289|Quality of Life|quality of life
684942|NCT00692263|Healthy subjects|healthy subjects
684943|NCT00692250|Familial Hypercholesterolemia|familial hypercholesterolemia
684944|NCT00692237|Type 2 diabetes mellitus|type 2 diabetes mellitus
684945|NCT00692237|Endothelial dysfunction|endothelial dysfunction
684946|NCT00692237|Sildenafil|sildenafil
684947|NCT00692224|neonatal jaundice|neonatal jaundice
684948|NCT00692224|zinc|zinc
684949|NCT00692224|hyperbilirubinemia|hyperbilirubinemia
684950|NCT00692224|enterohepatic circulation|enterohepatic circulation
684951|NCT00692224|bilirubin|bilirubin
684952|NCT00692211|screening|screening
684953|NCT00692198|COPD|copd
684954|NCT00692185|Anorexia Nervosa|anorexia nervosa
684955|NCT00692172|psoriasis|psoriasis
684956|NCT00692172|alefacept|alefacept
684957|NCT00692172|intramuscular|intramuscular
684958|NCT00692159|TRC102|trc102
684959|NCT00692159|Methoxyamine HCL|methoxyamine hcl
684960|NCT00692159|Pemetrexed|pemetrexed
684961|NCT00692159|Alimta|alimta
684962|NCT00692159|Tracon|tracon
684963|NCT00692159|Phase 1|phase 1
684964|NCT00692159|Cancer|cancer
684965|NCT00692159|BER|ber
684966|NCT00692159|Base Excision Repair|base excision repair
684967|NCT00692159|Small Molecule|small molecule
684968|NCT00692159|Anti-folate|anti-folate
684969|NCT00692159|Solid Tumor|solid tumor
684970|NCT00692159|Neoplastic Processes|neoplastic processes
684971|NCT00692159|Pathologic Processes|pathologic processes
684972|NCT00692159|Pathological Conditions, Signs and Symptoms|pathological conditions, signs and symptoms
684973|NCT00692146|Proof of Mechanism|proof of mechanism
684974|NCT00692146|Capsaicin evoked pain|capsaicin evoked pain
684975|NCT00692133|schizophrenia|schizophrenia
684976|NCT00692133|bipolar disorder|bipolar disorder
684977|NCT00692133|antipsychotic treatment|antipsychotic treatment
684978|NCT00692133|patients´preferences|patients´preferences
684979|NCT00692107|Radiotherapy|radiotherapy
684980|NCT00692107|Dose|dose
684981|NCT00692094|melatonin|melatonin
684982|NCT00692094|circadian rhythms|circadian rhythms
684983|NCT00692094|sleep|sleep
684984|NCT00692081|adolescents|adolescents
684985|NCT00692081|borderline intellectual functioning|borderline intellectual functioning
684986|NCT00692081|social competence training|social competence training
684987|NCT00692081|vocational training|vocational training
684988|NCT00692081|group intervention|group intervention
684989|NCT00692081|cognitive behavioral therapy|cognitive behavioral therapy
684990|NCT00692081|Adolescents with borderline intellectual functioning|adolescents with borderline intellectual functioning
684991|NCT00692068|residual renal function|residual renal function
684992|NCT00692068|oxidative stress|oxidative stress
684993|NCT00692068|carbonyl stress|carbonyl stress
684994|NCT00692068|peritoneal dialysis|peritoneal dialysis
684995|NCT00692042|Safety|safety
684996|NCT00692042|tolerability|tolerability
684997|NCT00692029|Normal|normal
684998|NCT00692029|Healthy Volunteers|healthy volunteers
684999|NCT00692016|Naproxen Sodium|naproxen sodium
685000|NCT00691990|Goiter [C19.874.283]|goiter [c19.874.283]
685001|NCT00691990|Thyroid Neoplasms [C19.874.788]|thyroid neoplasms [c19.874.788]
685002|NCT00691977|Radiation Therapy|radiation therapy
685003|NCT00691938|LBH589|lbh589
685004|NCT00691938|Decitabine|decitabine
685005|NCT00691938|panobinostat|panobinostat
685006|NCT00691938|histone deacetylase|histone deacetylase
685007|NCT00691938|methylation|methylation
685008|NCT00691938|hypomethylation|hypomethylation
685009|NCT00691925|refractive surgery|refractive surgery
685010|NCT00691886|sedation|sedation
685011|NCT00691873|Allergic|allergic
685012|NCT00691873|Asthma|asthma
685013|NCT00691873|Immunotherapy|immunotherapy
685014|NCT00691860|Parastomal hernias|parastomal hernias
685015|NCT00691860|Tolerance of lightweight meshes|tolerance of lightweight meshes
685016|NCT00691860|Paracolostomy hernias|paracolostomy hernias
685017|NCT00691860|Peristomal hernias|peristomal hernias
685018|NCT00691847|Refractive surgery|refractive surgery
685019|NCT00691834|Magnetic resonance Imaging|magnetic resonance imaging
685020|NCT00691821|Negative-Pressure Wound Therapy|negative-pressure wound therapy
685021|NCT00691821|Bandages|bandages
685022|NCT00691821|Community Health Services|community health services
685023|NCT00691795|Analgesia|analgesia
685024|NCT00691795|Epidural|epidural
685025|NCT00691795|Pregnancy|pregnancy
685026|NCT00691795|Labor|labor
685027|NCT00691795|Clonidine|clonidine
685028|NCT00691795|Fentanyl|fentanyl
685029|NCT00691795|Bupivacaine|bupivacaine
685030|NCT00691795|Childbirth|childbirth
685031|NCT00691782|African American females between the ages of 21 and 60|african american females between the ages of 21 and 60
685032|NCT00691769|alopecia|alopecia
685033|NCT00691769|lupus|lupus
685034|NCT00691756|renal failure|renal failure
685035|NCT00691756|thoracoabdominal aortic aneurysm repair|thoracoabdominal aortic aneurysm repair
685036|NCT00691756|cold crystalloid|cold crystalloid
685037|NCT00691756|cold blood|cold blood
685038|NCT00691756|renal perfusion|renal perfusion
685039|NCT00691743|Upper GI Symptoms|upper gi symptoms
685040|NCT00691743|GERD|gerd
685041|NCT00691743|NSAIDs|nsaids
685042|NCT00691717|Anecortave acetate|anecortave acetate
685043|NCT00691717|Open-angle glaucoma|open-angle glaucoma
685044|NCT00691717|IOP|iop
685045|NCT00691717|OHT|oht
685046|NCT00691704|Multiple Myeloma|multiple myeloma
685047|NCT00691691|Liver malignancy|liver malignancy
685048|NCT00691691|Stereotactic Body Radiation Therapy|stereotactic body radiation therapy
685049|NCT00691691|Efficacy of SBRT in liver tumors|efficacy of sbrt in liver tumors
685050|NCT00691691|Hepatic toxicity with SBRT|hepatic toxicity with sbrt
685051|NCT00691678|breast cancer|breast cancer
685052|NCT00691678|aromatase inhibitor|aromatase inhibitor
685053|NCT00691678|supportive care|supportive care
685054|NCT00691665|Rhinitis|rhinitis
685055|NCT00691665|Seasonal Allergic Rhinitis|seasonal allergic rhinitis
685056|NCT00691665|allergies|allergies
685057|NCT00691652|extranodal marginal zone B-cell lymphoma of mucosa-associated lymphoid tissue|extranodal marginal zone b-cell lymphoma of mucosa-associated lymphoid tissue
685058|NCT00691652|nodal marginal zone B-cell lymphoma|nodal marginal zone b-cell lymphoma
685059|NCT00691652|splenic marginal zone lymphoma|splenic marginal zone lymphoma
685060|NCT00691652|recurrent adult Burkitt lymphoma|recurrent adult burkitt lymphoma
685061|NCT00691652|recurrent adult diffuse large cell lymphoma|recurrent adult diffuse large cell lymphoma
685400|NCT00690651|internal fixation|internal fixation
685062|NCT00691652|recurrent adult diffuse mixed cell lymphoma|recurrent adult diffuse mixed cell lymphoma
685063|NCT00691652|recurrent adult diffuse small cleaved cell lymphoma|recurrent adult diffuse small cleaved cell lymphoma
685064|NCT00691652|recurrent adult grade III lymphomatoid granulomatosis|recurrent adult grade iii lymphomatoid granulomatosis
685065|NCT00691652|recurrent adult immunoblastic large cell lymphoma|recurrent adult immunoblastic large cell lymphoma
685066|NCT00691652|recurrent adult lymphoblastic lymphoma|recurrent adult lymphoblastic lymphoma
685067|NCT00691652|recurrent grade 1 follicular lymphoma|recurrent grade 1 follicular lymphoma
685068|NCT00691652|recurrent grade 2 follicular lymphoma|recurrent grade 2 follicular lymphoma
685069|NCT00691652|recurrent grade 3 follicular lymphoma|recurrent grade 3 follicular lymphoma
685070|NCT00691652|recurrent mantle cell lymphoma|recurrent mantle cell lymphoma
685071|NCT00691652|recurrent marginal zone lymphoma|recurrent marginal zone lymphoma
685072|NCT00691652|recurrent small lymphocytic lymphoma|recurrent small lymphocytic lymphoma
685073|NCT00691652|cutaneous B-cell non-Hodgkin lymphoma|cutaneous b-cell non-hodgkin lymphoma
685074|NCT00691639|Open-angle glaucoma|open-angle glaucoma
685075|NCT00691639|IOP|iop
685076|NCT00691626|posttraumatic stress|posttraumatic stress
685077|NCT00691626|nightmares|nightmares
685078|NCT00691626|sleep|sleep
685079|NCT00691626|psychotherapy|psychotherapy
685080|NCT00691626|imagery rehearsal|imagery rehearsal
685081|NCT00691626|insomnia|insomnia
685082|NCT00691626|behavioral treatment|behavioral treatment
685083|NCT00691626|veterans|veterans
685084|NCT00691626|Operation Iraqi Freedom|operation iraqi freedom
685085|NCT00691626|Operation Enduring Freedom|operation enduring freedom
685086|NCT00691613|Apoptosis|apoptosis
685087|NCT00691613|Annexin|annexin
685089|NCT00691613|Ischemia-Reperfusion Injury|ischemia-reperfusion injury
685090|NCT00691600|abscess|abscess
685091|NCT00691600|Abscesses in the pediatric emergency population|abscesses in the pediatric emergency population
685092|NCT00691587|mechanical ventilation|mechanical ventilation
685093|NCT00691587|mechanically ventilated|mechanically ventilated
685094|NCT00691587|Pseudomonas aeruginosa|pseudomonas aeruginosa
685095|NCT00691587|ventilator associated pneumonia|ventilator associated pneumonia
685096|NCT00691574|Smith-Magenis Syndrome|smith-magenis syndrome
685097|NCT00691574|melatonin|melatonin
685098|NCT00691574|circadian rhythm|circadian rhythm
685099|NCT00691574|sleep|sleep
685100|NCT00691561|HIV Prevention|hiv prevention
685101|NCT00691561|African American|african american
685102|NCT00691561|Black|black
685103|NCT00691561|gay|gay
685104|NCT00691561|Men who have sex men|men who have sex men
685105|NCT00691561|HIV Seronegativity|hiv seronegativity
685106|NCT00691548|Stage IV cancer|stage iv cancer
685107|NCT00691522|PERITUMORAL BRAIN EDEMA|peritumoral brain edema
685108|NCT00691522|PRIMARY MALIGNANT BRAIN TUMORS|primary malignant brain tumors
685109|NCT00691522|METASTATIC BRAIN TUMORS|metastatic brain tumors
685110|NCT00691509|breast cancer|breast cancer
685111|NCT00691496|HIV Prevention|hiv prevention
685112|NCT00691496|African-American|african-american
685113|NCT00691496|gay|gay
685114|NCT00691496|bisexual|bisexual
685115|NCT00691496|intervention trial|intervention trial
685116|NCT00691496|HIV Seronegativity|hiv seronegativity
685117|NCT00691483|smoking cessation|smoking cessation
685118|NCT00691483|smoking treatment|smoking treatment
685119|NCT00691483|patient self-selected quit date|patient self-selected quit date
685120|NCT00691470|Anticoagulation|anticoagulation
685121|NCT00691470|Vitamin K-dependent clotting factor inhibitor|vitamin k-dependent clotting factor inhibitor
685122|NCT00691470|Coumadin|coumadin
685123|NCT00691470|Warfarin|warfarin
685124|NCT00691470|Atrial fibrillation|atrial fibrillation
685125|NCT00691470|Prosthetic heart valve|prosthetic heart valve
685126|NCT00691470|Venous thromboembolic disease|venous thromboembolic disease
685127|NCT00691470|Myocardial infarction or cardiomyopathy|myocardial infarction or cardiomyopathy
685128|NCT00691470|Patients with one or more of the following indications for chronic warfarin anticoagulation:|patients with one or more of the following indications for chronic warfarin anticoagulation:
685129|NCT00691470|Atrial fibrillation (paroxysmal, persistent or permanent, not due to a reversible cause, documented by ECG) or atrial flutter;|atrial fibrillation (paroxysmal, persistent or permanent, not due to a reversible cause, documented by ecg) or atrial flutter;
685130|NCT00691470|A prosthetic heart valve in the aortic or mitral position that requires chronic anticoagulation;|a prosthetic heart valve in the aortic or mitral position that requires chronic anticoagulation;
685131|NCT00691470|A history of venous thromboembolic disease (DVT and/or PE) requiring long term anticoagulation (> 6 months);|a history of venous thromboembolic disease (dvt and/or pe) requiring long term anticoagulation (> 6 months);
685132|NCT00691470|A history of myocardial infarction or cardiomyopathy requiring anticoagulation.|a history of myocardial infarction or cardiomyopathy requiring anticoagulation.
685133|NCT00691470|Currently receiving chronic warfarin therapy for another indication not listed, with Sponsor approval.|currently receiving chronic warfarin therapy for another indication not listed, with sponsor approval.
685134|NCT00691457|Contact lens|contact lens
685135|NCT00691457|solution|solution
685136|NCT00691457|confocal microscope|confocal microscope
685137|NCT00691444|melatonin|melatonin
685138|NCT00691444|circadian rhythms|circadian rhythms
685139|NCT00691444|sleep|sleep
685140|NCT00691418|perinatal|perinatal
685141|NCT00691418|premature|premature
685142|NCT00691418|pregnancy|pregnancy
685143|NCT00691418|gestation|gestation
685144|NCT00691405|Arformoterol|arformoterol
685145|NCT00691405|(R,R)-formoterol|(r,r)-formoterol
685146|NCT00691392|Multi-Drug Resistant Tuberculosis|multi-drug resistant tuberculosis
685147|NCT00691392|Extensively Drug Resistant Tuberculosis|extensively drug resistant tuberculosis
685148|NCT00691392|MDR TB|mdr tb
685149|NCT00691392|XDR TB|xdr tb
685150|NCT00691392|MDR|mdr
685151|NCT00691392|XDR|xdr
685152|NCT00691379|Breast cancer|breast cancer
685153|NCT00691379|Triple negative|triple negative
685154|NCT00691379|Chemotherapy|chemotherapy
685155|NCT00691379|Anti-angiogenesis therapy|anti-angiogenesis therapy
685156|NCT00691353|Bipolar Disorder|bipolar disorder
685157|NCT00691353|antipsychotics|antipsychotics
685158|NCT00691353|social functioning|social functioning
685159|NCT00691353|mood stabilizers|mood stabilizers
685160|NCT00691353|Bipolar Disorder Type I|bipolar disorder type i
685161|NCT00691353|atypical antipsychotics|atypical antipsychotics
685162|NCT00691353|monotherapy|monotherapy
685163|NCT00691353|cotherapy|cotherapy
685164|NCT00691340|POAG|poag
685165|NCT00691340|Alzheimer's disease|alzheimer's disease
685166|NCT00691340|cellular proteome|cellular proteome
685167|NCT00691340|human leucocytes|human leucocytes
685168|NCT00691340|vasospasm|vasospasm
685169|NCT00691340|Healthy subjects|healthy subjects
685170|NCT00691327|Revision of augmentation or reconstruction|revision of augmentation or reconstruction
685171|NCT00691314|Stroke|stroke
685172|NCT00691314|Transietn Ischemic Attack|transietn ischemic attack
685173|NCT00691314|Stents|stents
685174|NCT00691314|Stenosis|stenosis
685428|NCT00690547|Activated|activated
685175|NCT00691301|cervical squamous cell carcinoma|cervical squamous cell carcinoma
685176|NCT00691301|recurrent cervical cancer|recurrent cervical cancer
685177|NCT00691301|stage III cervical cancer|stage iii cervical cancer
685178|NCT00691301|stage IVA cervical cancer|stage iva cervical cancer
685179|NCT00691301|stage IVB cervical cancer|stage ivb cervical cancer
685180|NCT00691288|omega-3 fatty acid|omega-3 fatty acid
685181|NCT00691288|hypertriglyceridemia|hypertriglyceridemia
685183|NCT00691288|pediatric|pediatric
685184|NCT00691288|HAART|haart
685185|NCT00691275|dehydration|dehydration
685186|NCT00691275|acute gastroenteritis|acute gastroenteritis
685187|NCT00691275|ondansetron|ondansetron
685188|NCT00691275|rehydration|rehydration
685189|NCT00691262|Atopic dermatitis|atopic dermatitis
685190|NCT00691262|Prograf|prograf
685191|NCT00691262|Tacrolimus|tacrolimus
685192|NCT00691262|FK506|fk506
685193|NCT00691262|Tacrolimus ointment|tacrolimus ointment
685194|NCT00691249|Diabetes|diabetes
685195|NCT00691249|Diet|diet
685196|NCT00691249|Fiber|fiber
685197|NCT00691236|osteosarcoma|osteosarcoma
685198|NCT00691236|zoledronic acid|zoledronic acid
685199|NCT00691236|bisphosphonates|bisphosphonates
685200|NCT00691236|adjuvant to chemotherapy|adjuvant to chemotherapy
685201|NCT00691223|Focal dermal hypoplasia|focal dermal hypoplasia
685202|NCT00691223|Goltz syndrome|goltz syndrome
685203|NCT00691223|X linked disorders|x linked disorders
685204|NCT00691223|PORCN|porcn
685205|NCT00691223|Wnt signaling|wnt signaling
685206|NCT00691210|Hodgkin's Disease|hodgkin's disease
685207|NCT00691210|Non-Hodgkin's Lymphoma|non-hodgkin's lymphoma
685208|NCT00691184|Onychomycosis, Toenail fungal infection, Terbinafine HCl, Pharmacokinetics|onychomycosis, toenail fungal infection, terbinafine hcl, pharmacokinetics
685209|NCT00691171|gastroesophageal reflux disease|gastroesophageal reflux disease
685210|NCT00691171|GERD|gerd
685211|NCT00691171|nonsteroidal anti-inflammatory drugs|nonsteroidal anti-inflammatory drugs
685212|NCT00691171|peptic ulcer|peptic ulcer
685213|NCT00691171|Diagnosed GERD|diagnosed gerd
685214|NCT00691171|Atypical GERD symptoms|atypical gerd symptoms
685215|NCT00691171|chronic NSAID therapy|chronic nsaid therapy
685216|NCT00691171|Risk for ulcer|risk for ulcer
685217|NCT00691145|Atopic dermatitis|atopic dermatitis
685218|NCT00691145|Tacrolimus ointment|tacrolimus ointment
685219|NCT00691132|non-small cell lung cancer|non-small cell lung cancer
685220|NCT00691132|small cell lung cancer|small cell lung cancer
685221|NCT00691132|tobacco use disorder|tobacco use disorder
685222|NCT00691119|breast cancer|breast cancer
685223|NCT00691119|radiation|radiation
685224|NCT00691119|Relaxation and Visualization Therapy|relaxation and visualization therapy
685225|NCT00691119|relaxation|relaxation
685226|NCT00691119|visualization|visualization
685227|NCT00691119|RVT|rvt
685228|NCT00691119|complementary and alternative medicine|complementary and alternative medicine
685229|NCT00691119|CAM|cam
685230|NCT00691119|alternative medicine|alternative medicine
685231|NCT00691093|observational|observational
685232|NCT00691080|Melatonin|melatonin
685233|NCT00691080|Sleep|sleep
685234|NCT00691080|Autism|autism
685235|NCT00691080|ASD|asd
685236|NCT00691080|Sleep problems in children with autism spectrum disorder|sleep problems in children with autism spectrum disorder
685237|NCT00691054|recurrent pancreatic cancer|recurrent pancreatic cancer
685238|NCT00691054|stage III pancreatic cancer|stage iii pancreatic cancer
685239|NCT00691054|stage IV pancreatic cancer|stage iv pancreatic cancer
685240|NCT00691041|HIV Prevention|hiv prevention
685241|NCT00691041|Men who have sex with men|men who have sex with men
685242|NCT00691041|African American|african american
685243|NCT00691041|Unprotected sex|unprotected sex
685244|NCT00691041|HIV Seronegativity|hiv seronegativity
685245|NCT00691028|Rheumatoid Arthritis|rheumatoid arthritis
685246|NCT00691028|RA|ra
685247|NCT00691028|Infliximab|infliximab
685248|NCT00691028|TA-650|ta-650
685249|NCT00691028|Remicade|remicade
685250|NCT00691015|stage III adult Burkitt lymphoma|stage iii adult burkitt lymphoma
685251|NCT00691015|stage III adult diffuse large cell lymphoma|stage iii adult diffuse large cell lymphoma
685252|NCT00691015|stage III adult diffuse mixed cell lymphoma|stage iii adult diffuse mixed cell lymphoma
685253|NCT00691015|stage III adult diffuse small cleaved cell lymphoma|stage iii adult diffuse small cleaved cell lymphoma
685254|NCT00691015|stage III adult Hodgkin lymphoma|stage iii adult hodgkin lymphoma
685255|NCT00691015|stage III adult immunoblastic large cell lymphoma|stage iii adult immunoblastic large cell lymphoma
685256|NCT00691015|stage III adult lymphoblastic lymphoma|stage iii adult lymphoblastic lymphoma
685257|NCT00691015|stage III grade 1 follicular lymphoma|stage iii grade 1 follicular lymphoma
685258|NCT00691015|stage III grade 2 follicular lymphoma|stage iii grade 2 follicular lymphoma
685259|NCT00691015|stage III grade 3 follicular lymphoma|stage iii grade 3 follicular lymphoma
685260|NCT00691015|stage III mantle cell lymphoma|stage iii mantle cell lymphoma
685261|NCT00691015|stage III marginal zone lymphoma|stage iii marginal zone lymphoma
685262|NCT00691015|stage III small lymphocytic lymphoma|stage iii small lymphocytic lymphoma
685263|NCT00691015|stage IV adult Burkitt lymphoma|stage iv adult burkitt lymphoma
685264|NCT00691015|stage IV adult diffuse large cell lymphoma|stage iv adult diffuse large cell lymphoma
685265|NCT00691015|stage IV adult diffuse mixed cell lymphoma|stage iv adult diffuse mixed cell lymphoma
685266|NCT00691015|stage IV adult diffuse small cleaved cell lymphoma|stage iv adult diffuse small cleaved cell lymphoma
685267|NCT00691015|stage IV adult Hodgkin lymphoma|stage iv adult hodgkin lymphoma
685268|NCT00691015|stage IV adult immunoblastic large cell lymphoma|stage iv adult immunoblastic large cell lymphoma
685269|NCT00691015|stage IV adult lymphoblastic lymphoma|stage iv adult lymphoblastic lymphoma
685270|NCT00691015|stage IV grade 1 follicular lymphoma|stage iv grade 1 follicular lymphoma
685271|NCT00691015|stage IV grade 2 follicular lymphoma|stage iv grade 2 follicular lymphoma
685272|NCT00691015|stage IV grade 3 follicular lymphoma|stage iv grade 3 follicular lymphoma
685273|NCT00691015|stage IV mantle cell lymphoma|stage iv mantle cell lymphoma
685274|NCT00691015|stage IV marginal zone lymphoma|stage iv marginal zone lymphoma
685275|NCT00691015|stage IV small lymphocytic lymphoma|stage iv small lymphocytic lymphoma
685276|NCT00691015|extranodal marginal zone B-cell lymphoma of mucosa-associated lymphoid tissue|extranodal marginal zone b-cell lymphoma of mucosa-associated lymphoid tissue
685277|NCT00691015|nodal marginal zone B-cell lymphoma|nodal marginal zone b-cell lymphoma
685278|NCT00691015|splenic marginal zone lymphoma|splenic marginal zone lymphoma
685279|NCT00691015|noncontiguous stage II adult Burkitt lymphoma|noncontiguous stage ii adult burkitt lymphoma
685280|NCT00691015|noncontiguous stage II adult diffuse large cell lymphoma|noncontiguous stage ii adult diffuse large cell lymphoma
685281|NCT00691015|noncontiguous stage II adult diffuse mixed cell lymphoma|noncontiguous stage ii adult diffuse mixed cell lymphoma
685282|NCT00691015|noncontiguous stage II adult diffuse small cleaved cell lymphoma|noncontiguous stage ii adult diffuse small cleaved cell lymphoma
685283|NCT00691015|noncontiguous stage II adult immunoblastic large cell lymphoma|noncontiguous stage ii adult immunoblastic large cell lymphoma
685284|NCT00691015|noncontiguous stage II adult lymphoblastic lymphoma|noncontiguous stage ii adult lymphoblastic lymphoma
685285|NCT00691015|noncontiguous stage II grade 1 follicular lymphoma|noncontiguous stage ii grade 1 follicular lymphoma
685401|NCT00690638|dutogliptin|dutogliptin
685286|NCT00691015|noncontiguous stage II grade 2 follicular lymphoma|noncontiguous stage ii grade 2 follicular lymphoma
685287|NCT00691015|noncontiguous stage II grade 3 follicular lymphoma|noncontiguous stage ii grade 3 follicular lymphoma
685288|NCT00691015|noncontiguous stage II mantle cell lymphoma|noncontiguous stage ii mantle cell lymphoma
685289|NCT00691015|noncontiguous stage II marginal zone lymphoma|noncontiguous stage ii marginal zone lymphoma
685290|NCT00691015|noncontiguous stage II small lymphocytic lymphoma|noncontiguous stage ii small lymphocytic lymphoma
685291|NCT00691015|accelerated phase chronic myelogenous leukemia|accelerated phase chronic myelogenous leukemia
685292|NCT00691015|adult acute lymphoblastic leukemia in remission|adult acute lymphoblastic leukemia in remission
685293|NCT00691015|adult acute myeloid leukemia in remission|adult acute myeloid leukemia in remission
685294|NCT00691015|adult acute myeloid leukemia with 11q23 (MLL) abnormalities|adult acute myeloid leukemia with 11q23 (mll) abnormalities
685295|NCT00691015|adult acute myeloid leukemia with inv(16)(p13;q22)|adult acute myeloid leukemia with inv(16)(p13;q22)
685296|NCT00691015|adult acute myeloid leukemia with t(15;17)(q22;q12)|adult acute myeloid leukemia with t(15;17)(q22;q12)
685297|NCT00691015|adult acute myeloid leukemia with t(16;16)(p13;q22)|adult acute myeloid leukemia with t(16;16)(p13;q22)
685298|NCT00691015|adult acute myeloid leukemia with t(8;21)(q22;q22)|adult acute myeloid leukemia with t(8;21)(q22;q22)
685299|NCT00691015|chronic phase chronic myelogenous leukemia|chronic phase chronic myelogenous leukemia
685300|NCT00691015|recurrent adult acute lymphoblastic leukemia|recurrent adult acute lymphoblastic leukemia
685301|NCT00691015|recurrent adult acute myeloid leukemia|recurrent adult acute myeloid leukemia
685302|NCT00691015|secondary acute myeloid leukemia|secondary acute myeloid leukemia
685303|NCT00691015|stage III chronic lymphocytic leukemia|stage iii chronic lymphocytic leukemia
685304|NCT00691015|stage IV chronic lymphocytic leukemia|stage iv chronic lymphocytic leukemia
685305|NCT00691015|de novo myelodysplastic syndromes|de novo myelodysplastic syndromes
685306|NCT00691015|myelodysplastic/myeloproliferative neoplasm, unclassifiable|myelodysplastic/myeloproliferative neoplasm, unclassifiable
685307|NCT00691015|previously treated myelodysplastic syndromes|previously treated myelodysplastic syndromes
685308|NCT00691015|secondary myelodysplastic syndromes|secondary myelodysplastic syndromes
685309|NCT00691015|stage I multiple myeloma|stage i multiple myeloma
685310|NCT00691015|stage II multiple myeloma|stage ii multiple myeloma
685311|NCT00691015|stage III multiple myeloma|stage iii multiple myeloma
685312|NCT00691015|primary myelofibrosis|primary myelofibrosis
685313|NCT00691015|atypical chronic myeloid leukemia, BCR-ABL negative|atypical chronic myeloid leukemia, bcr-abl negative
685314|NCT00691015|chronic eosinophilic leukemia|chronic eosinophilic leukemia
685315|NCT00691015|chronic myelomonocytic leukemia|chronic myelomonocytic leukemia
685316|NCT00691015|chronic neutrophilic leukemia|chronic neutrophilic leukemia
685317|NCT00690989|Headache|headache
685318|NCT00690989|Adherence|adherence
685319|NCT00690989|Followup|followup
685320|NCT00690976|HIV Seronegativity|hiv seronegativity
685321|NCT00690976|HIV risk behavior|hiv risk behavior
685322|NCT00690976|Unprotected sex|unprotected sex
685323|NCT00690976|men who have sex with men|men who have sex with men
685325|NCT00690976|Latino|latino
685326|NCT00690976|Unsafe Sex|unsafe sex
685327|NCT00690963|Radiotherapy|radiotherapy
685328|NCT00690963|Intensity-Modulated|intensity-modulated
685329|NCT00690963|Dose Fractionation|dose fractionation
685330|NCT00690950|BPH|bph
685429|NCT00690547|Quadriceps|quadriceps
685331|NCT00690937|hypercholesterolemia, bile acid sequestrant, LDL-cholesterol|hypercholesterolemia, bile acid sequestrant, ldl-cholesterol
685332|NCT00690924|lung cancer|lung cancer
685333|NCT00690924|tobacco use disorder|tobacco use disorder
685334|NCT00690924|squamous lung dysplasia|squamous lung dysplasia
685335|NCT00690885|chronic cough|chronic cough
685336|NCT00690885|COPD|copd
685337|NCT00690885|IPF|ipf
685338|NCT00690885|interferon alpha|interferon alpha
685339|NCT00690872|recurrent lymphoepithelioma of the nasopharynx|recurrent lymphoepithelioma of the nasopharynx
685340|NCT00690872|recurrent squamous cell carcinoma of the nasopharynx|recurrent squamous cell carcinoma of the nasopharynx
685341|NCT00690872|stage IV lymphoepithelioma of the nasopharynx|stage iv lymphoepithelioma of the nasopharynx
685342|NCT00690872|stage IV squamous cell carcinoma of the nasopharynx|stage iv squamous cell carcinoma of the nasopharynx
685343|NCT00690859|Bipolar disorders|bipolar disorders
685344|NCT00690859|Predictors of recurrence|predictors of recurrence
685345|NCT00690820|Cystic Fibrosis|cystic fibrosis
685346|NCT00690820|Pancreatic Exocrine Insufficiency|pancreatic exocrine insufficiency
685347|NCT00690807|eczema|eczema
685348|NCT00690781|casein|casein
685349|NCT00690781|milk soluble proteins|milk soluble proteins
685350|NCT00690781|protein feeding pattern|protein feeding pattern
685351|NCT00690781|overweight|overweight
685352|NCT00690781|obesity|obesity
685353|NCT00690781|energy restriction|energy restriction
685354|NCT00690781|protein metabolism|protein metabolism
685355|NCT00690781|lean body mass|lean body mass
685356|NCT00690781|body composition|body composition
685357|NCT00690781|nitrogen balance|nitrogen balance
685358|NCT00690781|protein synthesis|protein synthesis
685359|NCT00690781|proteolysis|proteolysis
685360|NCT00690781|spread|spread
685361|NCT00690781|pulse|pulse
685362|NCT00690768|Diabetic Retinopathy|diabetic retinopathy
685363|NCT00690768|Retinal detachment|retinal detachment
685364|NCT00690768|Vitreous Hemorrhage|vitreous hemorrhage
685365|NCT00690768|Bevacizumab|bevacizumab
685366|NCT00690768|preoperative|preoperative
685367|NCT00690768|pars plana vitrectomy|pars plana vitrectomy
685368|NCT00690755|Diabetic|diabetic
685369|NCT00690716|Nasal CO2|nasal co2
685370|NCT00690716|Phase II|phase ii
685371|NCT00690716|Adaptive|adaptive
685372|NCT00690716|Randomized|randomized
685373|NCT00690716|Double-Blind|double-blind
685374|NCT00690716|Placebo-Controlled|placebo-controlled
685375|NCT00690716|Multiple-Dose|multiple-dose
685376|NCT00690716|Multi-center|multi-center
685377|NCT00690716|Safety|safety
685378|NCT00690716|Efficacy|efficacy
685379|NCT00690716|Mild Headache|mild headache
685380|NCT00690716|Migraineur|migraineur
685381|NCT00690703|non small cell lung cancer|non small cell lung cancer
685382|NCT00690703|pulmonary metastases|pulmonary metastases
685383|NCT00690703|radiofrequency ablation|radiofrequency ablation
685384|NCT00690690|HIV Seronegativity|hiv seronegativity
685385|NCT00690690|HIV risk behavior|hiv risk behavior
685386|NCT00690690|Unprotected sex|unprotected sex
685387|NCT00690690|men who have sex with men|men who have sex with men
685388|NCT00690690|gay|gay
685389|NCT00690690|Latino|latino
685390|NCT00690690|unsafe sex|unsafe sex
685391|NCT00690690|high risk sex|high risk sex
685392|NCT00690677|LBH589|lbh589
685393|NCT00690677|Metastatic Colorectal Cancer|metastatic colorectal cancer
685394|NCT00690677|Refractory Colorectal Cancer|refractory colorectal cancer
685395|NCT00690664|Hair characteristics|hair characteristics
685396|NCT00690651|ankle|ankle
685397|NCT00690651|fracture|fracture
685398|NCT00690651|mobilisation|mobilisation
685399|NCT00690651|bed rest|bed rest
685402|NCT00690638|PHX1149|phx1149
685403|NCT00690638|DPP4 inhibitor|dpp4 inhibitor
685404|NCT00690625|Myofacial pain|myofacial pain
685405|NCT00690625|Omega 3 fatty acids|omega 3 fatty acids
685406|NCT00690612|pediatric|pediatric
685407|NCT00690612|renal disease|renal disease
685408|NCT00690612|high blood pressure|high blood pressure
685409|NCT00690599|Patient satisfaction|patient satisfaction
685410|NCT00690599|Dentist-Patient relations|dentist-patient relations
685411|NCT00690599|Answering services|answering services
685412|NCT00690586|Nephrotic syndrome|nephrotic syndrome
685413|NCT00690586|Underfill and overfill theory|underfill and overfill theory
685414|NCT00690586|Steroid resistance|steroid resistance
685415|NCT00690586|Urine proteomics|urine proteomics
685416|NCT00690586|AVP|avp
685417|NCT00690586|ANP|anp
685418|NCT00690586|Angiotensin II|angiotensin ii
685419|NCT00690586|Renin and Aldosterone|renin and aldosterone
685420|NCT00690573|Juvenile Rheumatoid Arthritis|juvenile rheumatoid arthritis
685421|NCT00690560|contiguous stage II adult diffuse large cell lymphoma|contiguous stage ii adult diffuse large cell lymphoma
685422|NCT00690560|noncontiguous stage II adult diffuse large cell lymphoma|noncontiguous stage ii adult diffuse large cell lymphoma
685423|NCT00690560|stage I adult diffuse large cell lymphoma|stage i adult diffuse large cell lymphoma
685424|NCT00690560|stage III adult diffuse large cell lymphoma|stage iii adult diffuse large cell lymphoma
685425|NCT00690560|stage IV adult diffuse large cell lymphoma|stage iv adult diffuse large cell lymphoma
685426|NCT00690547|Functionality|functionality
685427|NCT00690547|Deliberately|deliberately
685430|NCT00690547|Femoris|femoris
685431|NCT00690547|During|during
685432|NCT00690547|After|after
685433|NCT00690547|Active|active
685434|NCT00690547|Extension|extension
685435|NCT00690534|sarcopenia|sarcopenia
685436|NCT00690534|aging|aging
685437|NCT00690534|muscle metabolism|muscle metabolism
685438|NCT00690521|congestive heart failure|congestive heart failure
685439|NCT00690521|diuretics|diuretics
685440|NCT00690521|combination|combination
685441|NCT00690508|Intubation, Trachea, Sternum,|intubation, trachea, sternum,
685442|NCT00690508|Tube tip, Tube placement, Tube tip palpation,|tube tip, tube placement, tube tip palpation,
685443|NCT00690508|Validate|validate
685445|NCT00690508|SSTTP|ssttp
685446|NCT00690508|corrrect|corrrect
685447|NCT00690508|placement|placement
868000|NCT00026247|pain|pain
685448|NCT00690495|Anesthesia|anesthesia
685449|NCT00690495|Induction|induction
685450|NCT00690495|Pain|pain
685451|NCT00690482|COPD|copd
685452|NCT00690456|Randomized Controlled Trial|randomized controlled trial
685453|NCT00690456|Metformin|metformin
685454|NCT00690443|Hyperlipidemia|hyperlipidemia
685455|NCT00690430|Carcinoid|carcinoid
685456|NCT00690430|neuroendocrine|neuroendocrine
685457|NCT00690430|gastroenteropancreatic|gastroenteropancreatic
685458|NCT00690430|somatostatin analogue|somatostatin analogue
685459|NCT00690430|Symptomatic Refractory Resistant Carcinoid Disease|symptomatic refractory resistant carcinoid disease
685460|NCT00690404|formulation|formulation
685461|NCT00690404|pharmacokinetic|pharmacokinetic
685462|NCT00690404|crossover formulation|crossover formulation
685463|NCT00690404|food effect|food effect
685464|NCT00690404|oral solution|oral solution
685465|NCT00690404|healthy volunteers|healthy volunteers
685466|NCT00690391|surgery|surgery
685467|NCT00690391|prognostic|prognostic
685468|NCT00690391|palliation|palliation
685469|NCT00690365|Switching|switching
685470|NCT00690365|Quetiapine|quetiapine
685471|NCT00690365|schizophrenia|schizophrenia
685472|NCT00690365|unsuccessfully treated|unsuccessfully treated
685473|NCT00690365|antipsychotics|antipsychotics
685474|NCT00690352|Specialized Substance Abuse Supervision|specialized substance abuse supervision
685475|NCT00690352|SSAS|ssas
685476|NCT00690352|substance use disorder|substance use disorder
685477|NCT00690352|felony drug offender|felony drug offender
685478|NCT00690352|probation|probation
685479|NCT00690352|parole|parole
685480|NCT00690352|cognitive behavioral therapy|cognitive behavioral therapy
685481|NCT00690352|CBT|cbt
685482|NCT00690326|physical activity|physical activity
685483|NCT00690326|Diabetes mellitus|diabetes mellitus
685484|NCT00690326|Behavioral change communication|behavioral change communication
685485|NCT00690326|Household physical activity|household physical activity
685486|NCT00690313|Vigamox, topical antibiotics, Intravitreal injections, macular degeneration, endophthalmitis|vigamox, topical antibiotics, intravitreal injections, macular degeneration, endophthalmitis
685487|NCT00690300|adenocarcinoma of the pancreas|adenocarcinoma of the pancreas
685488|NCT00690300|pancreatic cancer|pancreatic cancer
685489|NCT00690300|pancreas carcinoma|pancreas carcinoma
685490|NCT00690300|advanced pancreatic cancer|advanced pancreatic cancer
685491|NCT00690300|metastatic pancreatic cancer|metastatic pancreatic cancer
685492|NCT00690300|second line|second line
685493|NCT00690300|palliative|palliative
685494|NCT00690300|Oxaliplatin|oxaliplatin
685495|NCT00690300|Docetaxel|docetaxel
685496|NCT00690300|Taxotere|taxotere
685497|NCT00690300|Eloxatin|eloxatin
685498|NCT00690300|Cancer of pancreas|cancer of pancreas
685499|NCT00690300|Pancreas cancer|pancreas cancer
685500|NCT00690287|Type 2 diabetes|type 2 diabetes
685501|NCT00690274|schizophrenia|schizophrenia
685502|NCT00690274|cognitive deficients|cognitive deficients
685503|NCT00690274|cognitive enhancing|cognitive enhancing
685504|NCT00690274|antipsychotics|antipsychotics
685505|NCT00690261|tumor associated macrophage|tumor associated macrophage
685506|NCT00690261|lung cancer|lung cancer
685507|NCT00690261|outcome|outcome
685508|NCT00690248|Acute mania|acute mania
685509|NCT00690248|Bipolar disorder|bipolar disorder
685510|NCT00690248|depressive symptoms|depressive symptoms
685511|NCT00690248|mixed mania|mixed mania
685512|NCT00690235|Schizophrenia|schizophrenia
685513|NCT00690235|Schizoaffective|schizoaffective
685514|NCT00690235|Olanzapine|olanzapine
685515|NCT00690235|Zyprexa|zyprexa
685516|NCT00690235|Clozapine|clozapine
685517|NCT00690235|Clozaril|clozaril
685518|NCT00690235|Pramlintide|pramlintide
685519|NCT00690235|Diabetes|diabetes
685520|NCT00690235|Weight Gain|weight gain
685521|NCT00690235|Obesity|obesity
685522|NCT00690235|Metabolic Syndrome|metabolic syndrome
685523|NCT00690222|cataract surgery|cataract surgery
685524|NCT00690222|phacoemulsification|phacoemulsification
685525|NCT00690222|pupil|pupil
685526|NCT00690222|dilation|dilation
685527|NCT00690222|mydriasis|mydriasis
685528|NCT00690222|intracameral|intracameral
685529|NCT00690222|topical|topical
685530|NCT00690222|pseudoexfoliation syndrome|pseudoexfoliation syndrome
685531|NCT00690209|Chronic ischemic cardiomyopathy with residual viability|chronic ischemic cardiomyopathy with residual viability
685532|NCT00690209|surgical coronary revascularization|surgical coronary revascularization
685533|NCT00690209|stem cell therapy|stem cell therapy
685534|NCT00690209|Chronic ischemic heart disease|chronic ischemic heart disease
685535|NCT00690209|severe impairment of global contractility left ventricular dilation|severe impairment of global contractility left ventricular dilation
685536|NCT00690209|residual viability|residual viability
685537|NCT00690183|physical activity|physical activity
685538|NCT00690183|stem cells|stem cells
685539|NCT00690183|lifestyle|lifestyle
685540|NCT00690170|ketamine|ketamine
685541|NCT00690170|nicotine|nicotine
685542|NCT00690170|schizophrenia|schizophrenia
685543|NCT00690170|cognitive deficits|cognitive deficits
685544|NCT00690170|P300 oddball paradigm|p300 oddball paradigm
685545|NCT00690170|Mismatch Negativity|mismatch negativity
685546|NCT00690170|P50 gating|p50 gating
685547|NCT00690157|heart failure, prognosis, markers,heart transplantation|heart failure, prognosis, markers,heart transplantation
685548|NCT00690144|simulation|simulation
685549|NCT00690144|medical education|medical education
685550|NCT00690144|performance of clinical reasoning and skills|performance of clinical reasoning and skills
685551|NCT00690131|Smoking cessation, severe mental illness, behavioral treatment|smoking cessation, severe mental illness, behavioral treatment
685552|NCT00690118|amyotrophic lateral sclerosis|amyotrophic lateral sclerosis
685553|NCT00690118|survival time|survival time
685554|NCT00690118|ALS functioning Rating Scale|als functioning rating scale
685555|NCT00690118|quality of life|quality of life
685556|NCT00690118|non-invasive ventilation|non-invasive ventilation
685557|NCT00690118|clinical tolerability|clinical tolerability
685558|NCT00690118|survival|survival
685559|NCT00690105|Dermatitis, Atopic|dermatitis, atopic
685560|NCT00690105|Dermatologic Agents|dermatologic agents
685561|NCT00690105|Topical Drug Administration|topical drug administration
685562|NCT00690105|Tacrolimus|tacrolimus
685563|NCT00690105|Calcineurin|calcineurin
685564|NCT00690105|Corticosteroid|corticosteroid
685565|NCT00690105|Fluticasone propionate|fluticasone propionate
685566|NCT00690105|Face|face
685567|NCT00690092|Coccidioidin|coccidioidin
685568|NCT00690092|Coccidioidin SD|coccidioidin sd
685569|NCT00690092|Spherule-derived coccidioidin|spherule-derived coccidioidin
685570|NCT00690092|Coccidioidomycosis|coccidioidomycosis
685571|NCT00690092|Valley Fever|valley fever
685572|NCT00690092|Coccidioides immitis|coccidioides immitis
685574|NCT00690079|Multiple ascending dose|multiple ascending dose
685575|NCT00690079|Chronic pain|chronic pain
685576|NCT00690079|pain|pain
685577|NCT00690066|T1DM|t1dm
685578|NCT00690066|Type 1 Diabetes Mellitus|type 1 diabetes mellitus
685579|NCT00690066|Type 1 Diabetes|type 1 diabetes
685580|NCT00690066|Diabetes Mellitus, Insulin-Dependent|diabetes mellitus, insulin-dependent
685581|NCT00690066|Juvenile Diabetes|juvenile diabetes
685582|NCT00690066|Adult Human Stem Cells|adult human stem cells
685583|NCT00690066|Mesenchymal Stem Cells|mesenchymal stem cells
685584|NCT00690066|MSCs|mscs
685585|NCT00690066|Insulin|insulin
685586|NCT00690066|Osiris|osiris
685587|NCT00690066|Prochymal|prochymal
685588|NCT00690053|Toxicity|toxicity
685589|NCT00690053|PET|pet
685590|NCT00690053|HX-4|hx-4
685591|NCT00690053|cancer|cancer
685592|NCT00690040|Induction of labor|induction of labor
685593|NCT00690040|Ripening|ripening
685594|NCT00690040|Single balloon catheter|single balloon catheter
685595|NCT00690040|Double balloon catheter|double balloon catheter
685596|NCT00690014|OAT|oat
685597|NCT00690014|GFR|gfr
685598|NCT00690014|renal function|renal function
685599|NCT00690014|PAH|pah
685600|NCT00690001|HIV-1 infection|hiv-1 infection
685601|NCT00690001|Treatment Experienced|treatment experienced
685602|NCT00689988|Down syndrome|down syndrome
685603|NCT00689988|communication AIDS for disabled|communication aids for disabled
685604|NCT00689988|language development disorders|language development disorders
685605|NCT00689988|vocabulary|vocabulary
685606|NCT00689988|gestures|gestures
685607|NCT00689988|language tests|language tests
685608|NCT00689988|child|child
685609|NCT00689975|stage IA breast cancer|stage ia breast cancer
685610|NCT00689975|stage IB breast cancer|stage ib breast cancer
685611|NCT00689975|stage II breast cancer|stage ii breast cancer
685612|NCT00689975|stage IIIA breast cancer|stage iiia breast cancer
685613|NCT00689975|stage IIIB breast cancer|stage iiib breast cancer
685614|NCT00689975|stage IIIC breast cancer|stage iiic breast cancer
685615|NCT00689962|Lisfranc|lisfranc
685616|NCT00689962|fracture|fracture
685617|NCT00689962|dislocation|dislocation
685618|NCT00689962|bioabsorbable|bioabsorbable
685619|NCT00689949|folic acid|folic acid
685620|NCT00689949|folate|folate
685621|NCT00689949|p-aminobenzoylglutamate|p-aminobenzoylglutamate
685622|NCT00689949|formiminoglutamate|formiminoglutamate
685623|NCT00689949|homocysteine|homocysteine
685624|NCT00689949|experimental validation of a new biomarker|experimental validation of a new biomarker
685625|NCT00689936|newly diagnosed multiple myeloma|newly diagnosed multiple myeloma
685626|NCT00689936|Lenalidomide|lenalidomide
685627|NCT00689936|Revlimid|revlimid
685628|NCT00689936|phase III|phase iii
685629|NCT00689910|pharmacokinetics|pharmacokinetics
685630|NCT00689910|pregnancy|pregnancy
685631|NCT00689910|Raltegravir|raltegravir
685632|NCT00689910|HIV|hiv
685633|NCT00689910|antiretroviral|antiretroviral
685634|NCT00689910|Treatment of HIV in pregnant women with Raltegravir|treatment of hiv in pregnant women with raltegravir
685635|NCT00689897|Primary Dysmenorrhea|primary dysmenorrhea
685636|NCT00689897|Deqi|deqi
685637|NCT00689897|acupuncture|acupuncture
685638|NCT00689897|psychology|psychology
685639|NCT00689858|Healthy volunteers|healthy volunteers
685640|NCT00689845|contiguous stage II adult diffuse large cell lymphoma|contiguous stage ii adult diffuse large cell lymphoma
685641|NCT00689845|noncontiguous stage II adult diffuse large cell lymphoma|noncontiguous stage ii adult diffuse large cell lymphoma
685642|NCT00689845|stage I adult diffuse large cell lymphoma|stage i adult diffuse large cell lymphoma
685643|NCT00689845|stage III adult diffuse large cell lymphoma|stage iii adult diffuse large cell lymphoma
685644|NCT00689845|stage IV adult diffuse large cell lymphoma|stage iv adult diffuse large cell lymphoma
685645|NCT00689832|Dermatitis, Atopic|dermatitis, atopic
685646|NCT00689832|Dermatologic Agents|dermatologic agents
685647|NCT00689832|Topical Drug Administration|topical drug administration
685648|NCT00689832|Tacrolimus|tacrolimus
685649|NCT00689832|Calcineurin|calcineurin
685650|NCT00689832|Corticosteroid|corticosteroid
685651|NCT00689832|Fluticasone propionate|fluticasone propionate
685652|NCT00689832|Child|child
685653|NCT00689819|Hypertension|hypertension
685654|NCT00689819|High blood pressure|high blood pressure
685655|NCT00689819|Pre-clinical cardiac dysfunction|pre-clinical cardiac dysfunction
685656|NCT00689806|Asthma|asthma
685657|NCT00689793|Fatigue|fatigue
685658|NCT00689793|Blood donation|blood donation
685659|NCT00689793|Iron deficiency|iron deficiency
685660|NCT00689793|Ferrous sulphate|ferrous sulphate
685661|NCT00689793|Donation|donation
685662|NCT00689793|Donors|donors
685663|NCT00689793|Iron|iron
685664|NCT00689793|Ferritin|ferritin
685665|NCT00689793|Hemoglobin|hemoglobin
685666|NCT00689793|Anemia|anemia
685667|NCT00689793|Anaemia|anaemia
685668|NCT00689793|Haemoglobin|haemoglobin
685670|NCT00689793|Women blood donors|women blood donors
685671|NCT00689780|Pain|pain
685672|NCT00689780|safety|safety
685673|NCT00689780|chronic low back pain|chronic low back pain
685674|NCT00689767|drug eluting stent|drug eluting stent
685675|NCT00689754|gastrointestinal hemorrhage|gastrointestinal hemorrhage
685676|NCT00689754|gastrointestinal intubation|gastrointestinal intubation
685677|NCT00689754|endoscopy|endoscopy
685678|NCT00689741|HPV|hpv
685679|NCT00689741|vaccine|vaccine
685680|NCT00689715|Cystic tumor|cystic tumor
685681|NCT00689715|Pancreas|pancreas
685682|NCT00689715|EUS|eus
685683|NCT00689702|cetuximab|cetuximab
685684|NCT00689702|capecitabine|capecitabine
685685|NCT00689702|radiotherapy|radiotherapy
685686|NCT00689702|rectal cancer|rectal cancer
685687|NCT00689676|expressive language|expressive language
685688|NCT00689676|cognition|cognition
685689|NCT00689676|early development|early development
685690|NCT00689676|very low birt weight|very low birt weight
685691|NCT00689676|prematurity|prematurity
685692|NCT00689663|cholecystectomy|cholecystectomy
685693|NCT00689637|AZD3480|azd3480
685694|NCT00689637|Warfarin|warfarin
685695|NCT00689637|Drug interaction|drug interaction
685696|NCT00689624|Colorectal Cancer|colorectal cancer
685697|NCT00689624|Cetuximab|cetuximab
685698|NCT00689624|FOLFOXIRI|folfoxiri
685699|NCT00689611|Acute coronary syndrome|acute coronary syndrome
685700|NCT00689611|Myocardial infarction|myocardial infarction
685701|NCT00689611|Smoking cessation|smoking cessation
685702|NCT00689611|Zyban|zyban
685703|NCT00689611|Secondary intervention post-ACS|secondary intervention post-acs
685704|NCT00689598|Atrial fibrillation, spironolactone|atrial fibrillation, spironolactone
685705|NCT00689585|Complex Regional Pain Syndrome|complex regional pain syndrome
685706|NCT00689585|Reflex Sympathetic Dystrophy|reflex sympathetic dystrophy
685707|NCT00689585|RSD|rsd
685708|NCT00689585|Chronic Pain|chronic pain
685709|NCT00689585|Ethosuximide|ethosuximide
685710|NCT00689585|Zarontin|zarontin
685711|NCT00689585|Anticonvulsant|anticonvulsant
685712|NCT00689572|cocaine dependence|cocaine dependence
685713|NCT00689572|cocaine abuse|cocaine abuse
685714|NCT00689572|cocaine|cocaine
685715|NCT00689572|crack|crack
685716|NCT00689559|Alzheimer's disease|alzheimer's disease
685717|NCT00689559|AZD3480|azd3480
685718|NCT00689559|Aripiprazole|aripiprazole
685719|NCT00689533|VEPTR|veptr
685720|NCT00689533|TIS|tis
685721|NCT00689533|scoliosis|scoliosis
685722|NCT00689533|juvenile|juvenile
685723|NCT00689520|Venous thromboembolism|venous thromboembolism
685724|NCT00689520|low molecular weight heparin|low molecular weight heparin
685725|NCT00689520|Vitamin K antagonist|vitamin k antagonist
685726|NCT00689520|Longterm|longterm
685727|NCT00689507|Multiple Myeloma|multiple myeloma
685728|NCT00689507|Relapsed|relapsed
685729|NCT00689507|Refractory|refractory
685730|NCT00689507|Bortezomib|bortezomib
685731|NCT00689507|Velcade|velcade
685732|NCT00689494|Nanopaz device|nanopaz device
685733|NCT00689494|Blood progesterone measure in using the device|blood progesterone measure in using the device
685734|NCT00689494|Delivery progesterone|delivery progesterone
685735|NCT00689494|Progesterone levonorgestrel|progesterone levonorgestrel
685736|NCT00689481|Plaque-type Psoriasis|plaque-type psoriasis
685737|NCT00689481|psoriasis|psoriasis
685738|NCT00689468|Otitis media|otitis media
685739|NCT00689468|Echinacea|echinacea
685740|NCT00689468|Osteopathic Medicine|osteopathic medicine
685741|NCT00689455|Metabolic Syndrome|metabolic syndrome
685742|NCT00689455|Lipids|lipids
685743|NCT00689455|Waist Circumference|waist circumference
685744|NCT00689429|Pilon Fractures|pilon fractures
685745|NCT00689416|imaging biomarkers|imaging biomarkers
685746|NCT00689416|MRI|mri
685747|NCT00689416|FDG-PET/CT scanning|fdg-pet/ct scanning
685748|NCT00689416|Crestor|crestor
685749|NCT00689403|AZD1305|azd1305
685750|NCT00689403|pharmacokinetics|pharmacokinetics
685751|NCT00689403|Properties of different ER formulations|properties of different er formulations
685752|NCT00689377|Peripheral Arterial Disease (PAD)|peripheral arterial disease (pad)
685753|NCT00689377|Cardiovascular Disease (CVD)|cardiovascular disease (cvd)
685754|NCT00689377|Atherosclerotic cardiovascular disease|atherosclerotic cardiovascular disease
685755|NCT00689377|Atherosclerosis|atherosclerosis
685756|NCT00689377|Primary CVD prevention|primary cvd prevention
685757|NCT00689364|Cohort Study|cohort study
685758|NCT00689364|Colorectal Cancer|colorectal cancer
685759|NCT00689364|Traditional Chinese Medicine|traditional chinese medicine
685760|NCT00689364|Risk of recurrence and metastasis|risk of recurrence and metastasis
685761|NCT00689351|Prevention|prevention
685762|NCT00689351|against|against
685763|NCT00689351|pneumococcal|pneumococcal
685764|NCT00689351|disease|disease
685765|NCT00689351|Vaccine|vaccine
685766|NCT00689338|Candida|candida
685767|NCT00689338|Candidemia|candidemia
685768|NCT00689338|Systemic Candidiasis|systemic candidiasis
685769|NCT00689338|ICU|icu
685770|NCT00689338|Intensive Care Unit|intensive care unit
685771|NCT00689338|Critical Care Unit|critical care unit
685772|NCT00689338|Anidulafungin|anidulafungin
685773|NCT00689338|Ecalta|ecalta
685774|NCT00689338|Eraxis|eraxis
685775|NCT00689338|Fluconazole|fluconazole
685776|NCT00689338|Voriconazole|voriconazole
685777|NCT00689325|Schizophrenia|schizophrenia
685778|NCT00689325|remission|remission
685779|NCT00689325|subjective well-being and effectiveness|subjective well-being and effectiveness
685780|NCT00689325|Quality of Life|quality of life
685781|NCT00689312|Gastroenteritis|gastroenteritis
685782|NCT00689312|Pediatrics|pediatrics
685783|NCT00689312|Rehydration therapy|rehydration therapy
685784|NCT00689299|Sublingual Immunotherapy (SLIT)|sublingual immunotherapy (slit)
685785|NCT00689299|Non-seasonal allergic rhinitis|non-seasonal allergic rhinitis
685786|NCT00689299|Immunotherapy|immunotherapy
685787|NCT00689299|Allergic rhinitis|allergic rhinitis
685788|NCT00689299|Cat|cat
685789|NCT00689299|Perennial allergy|perennial allergy
685790|NCT00689299|Non-seasonal allergy|non-seasonal allergy
685791|NCT00689286|Knee Osteoarthritis|knee osteoarthritis
685792|NCT00689286|Neuromuscular stimulator|neuromuscular stimulator
685793|NCT00689273|PF-04136309 CCR2 osteoarthritic pain knee, phase 2 placebo multicenter double-blind placebo-controlled|pf-04136309 ccr2 osteoarthritic pain knee, phase 2 placebo multicenter double-blind placebo-controlled
685794|NCT00689247|AZD1305|azd1305
685795|NCT00689247|ADME|adme
685796|NCT00689247|pharmacokinetic|pharmacokinetic
685797|NCT00689247|Absorption|absorption
685798|NCT00689247|distribution|distribution
685799|NCT00689247|metabolism|metabolism
685800|NCT00689247|excretion|excretion
685801|NCT00689221|newly diagnosed Glioblastoma (WHO Grade IV)|newly diagnosed glioblastoma (who grade iv)
685802|NCT00689221|Cilengitide|cilengitide
685803|NCT00689221|Temozolomide|temozolomide
685804|NCT00689221|Radiotherapy|radiotherapy
685805|NCT00689208|Clamp|clamp
685806|NCT00689195|Curcumin|curcumin
685807|NCT00689195|Ashwagandha|ashwagandha
685808|NCT00689195|osteosarcoma|osteosarcoma
685809|NCT00689195|Pharmacokinetics of curcumin and ashwagandha formulation|pharmacokinetics of curcumin and ashwagandha formulation
685810|NCT00689195|response|response
685811|NCT00689182|iron reduction|iron reduction
685812|NCT00689182|iron overload|iron overload
685813|NCT00689182|phlebotomy|phlebotomy
685814|NCT00689182|hematopoietic stem cell transplant|hematopoietic stem cell transplant
685815|NCT00689169|Lymphoma|lymphoma
685816|NCT00689169|Lymphoma Diffuse|lymphoma diffuse
685817|NCT00689169|B-Cell lymphoma|b-cell lymphoma
685818|NCT00689169|Aggressive lymphoma|aggressive lymphoma
685819|NCT00689156|Epirubicin|epirubicin
685820|NCT00689156|docetaxel|docetaxel
685821|NCT00689156|Adjuvant chemotherapy|adjuvant chemotherapy
685822|NCT00689156|DNA Topoisomerases, Type II|dna topoisomerases, type ii
685823|NCT00689130|Analgesia|analgesia
685824|NCT00689130|Bispectral Index|bispectral index
685825|NCT00689130|BIS Variability|bis variability
685826|NCT00689130|Electroencephalography|electroencephalography
685827|NCT00689130|Electromyography|electromyography
685828|NCT00689130|Monitoring, Intraoperative|monitoring, intraoperative
685829|NCT00689130|Movement|movement
685830|NCT00689130|Pain, Postoperative|pain, postoperative
685831|NCT00689130|Somatic Events|somatic events
685832|NCT00689130|Patients under general anesthesia undergoing a moderately painful procedure.|patients under general anesthesia undergoing a moderately painful procedure.
685833|NCT00689117|Acne Vulgaris|acne vulgaris
685834|NCT00689117|Acne|acne
685835|NCT00689104|Micturition|micturition
685836|NCT00689104|Urinary incontinence|urinary incontinence
685837|NCT00689104|Urinary urge incontinence|urinary urge incontinence
685838|NCT00689104|Overactive bladder (OAB)|overactive bladder (oab)
685839|NCT00689104|Urgency|urgency
685840|NCT00689104|YM178|ym178
685841|NCT00689104|Frequency|frequency
685842|NCT00689091|Awareness|awareness
685843|NCT00689091|BIS Monitor|bis monitor
685844|NCT00689091|electronic alerts|electronic alerts
685845|NCT00689091|minimum|minimum
685846|NCT00689091|alveolar|alveolar
685847|NCT00689091|concentration|concentration
685848|NCT00689078|Allergic conjunctivitis|allergic conjunctivitis
685849|NCT00689065|siRNA|sirna
685850|NCT00689065|RNA interference (RNAi)|rna interference (rnai)
685851|NCT00689065|Cyclodextrin|cyclodextrin
685852|NCT00689065|Cancer|cancer
685853|NCT00689065|Neoplasms|neoplasms
685854|NCT00689065|Solid Tumor|solid tumor
685855|NCT00689065|Ovarian Cancer|ovarian cancer
685856|NCT00689065|Lung Cancer|lung cancer
685857|NCT00689065|Non Small Cell Lung Cancer|non small cell lung cancer
685858|NCT00689065|Pancreatic Cancer|pancreatic cancer
685859|NCT00689065|Breast Cancer|breast cancer
685860|NCT00689065|Colon Cancer|colon cancer
685861|NCT00689065|Endometrial Cancer|endometrial cancer
685862|NCT00689065|Kidney (Renal Cell) Cancer|kidney (renal cell) cancer
685863|NCT00689065|Melanoma|melanoma
685864|NCT00689065|Prostate Cancer|prostate cancer
685865|NCT00689065|Skin Cancer|skin cancer
685866|NCT00689065|Thyroid Cancer|thyroid cancer
685867|NCT00689065|Solid Malignancies|solid malignancies
685868|NCT00689039|AZD1305|azd1305
685869|NCT00689039|safety|safety
685870|NCT00689039|pharmacokinetics|pharmacokinetics
685871|NCT00689039|multiple ascending doses|multiple ascending doses
685872|NCT00689039|Safety and pharmacokinetics|safety and pharmacokinetics
685873|NCT00689026|Colonoscopy|colonoscopy
685874|NCT00689026|Diabetes Mellitus, Type 1|diabetes mellitus, type 1
685875|NCT00689026|Diabetes Mellitus, Type 2|diabetes mellitus, type 2
685876|NCT00689026|Cleansing|cleansing
685877|NCT00689026|Preparation|preparation
685878|NCT00689026|PEG|peg
685879|NCT00689026|Quality|quality
685880|NCT00689013|Herpes Zoster|herpes zoster
685881|NCT00689013|Prevention & control|prevention & control
685882|NCT00689013|Pharmacists|pharmacists
685883|NCT00689013|Pharmacy|pharmacy
685884|NCT00689013|Pharmacies|pharmacies
685885|NCT00689013|Aged|aged
685886|NCT00689013|Immunization|immunization
685887|NCT00689013|Vaccination|vaccination
685888|NCT00689000|Leukemia|leukemia
685889|NCT00689000|AML|aml
685890|NCT00689000|MDS|mds
685891|NCT00689000|MM|mm
685892|NCT00689000|Acute Myeloid Leukemia|acute myeloid leukemia
685893|NCT00689000|Myelodysplastic Syndrome|myelodysplastic syndrome
685894|NCT00689000|Multiple Myeloma|multiple myeloma
685895|NCT00689000|Cancer|cancer
685896|NCT00689000|Hematological malignancies|hematological malignancies
685897|NCT00689000|Elderly|elderly
685898|NCT00689000|Refractory|refractory
685899|NCT00689000|Blood|blood
685900|NCT00688974|type 2 diabetes|type 2 diabetes
685901|NCT00688974|obesity|obesity
685902|NCT00688974|gastric bypass|gastric bypass
685903|NCT00688974|adjustable gastric banding|adjustable gastric banding
685904|NCT00688974|BMI > 35.|bmi > 35.
685905|NCT00688974|obesity for more than 5 years|obesity for more than 5 years
685906|NCT00688961|omega-3 fatty acids|omega-3 fatty acids
685907|NCT00688961|aspirin|aspirin
685908|NCT00688961|platelet aggregation|platelet aggregation
685909|NCT00688961|Healthy volunteers; no disease|healthy volunteers; no disease
685910|NCT00688948|pilot clinical trial|pilot clinical trial
685911|NCT00688935|melatonin|melatonin
685912|NCT00688935|circadian rhythms|circadian rhythms
685913|NCT00688935|sleep|sleep
685914|NCT00688935|sleep disorders|sleep disorders
685915|NCT00688909|breast cancer|breast cancer
685916|NCT00688909|adjuvant treatment in post menopausal women|adjuvant treatment in post menopausal women
685917|NCT00688909|letrozole|letrozole
685918|NCT00688909|arthralgia-myalgia|arthralgia-myalgia
685919|NCT00688883|Fludarabine|fludarabine
685920|NCT00688883|Purine analog|purine analog
685921|NCT00688883|Indolent lymphoma|indolent lymphoma
685922|NCT00688870|Prevention against pneumococcal disease|prevention against pneumococcal disease
685924|NCT00688844|Phenylketonuria|phenylketonuria
685925|NCT00688844|BH4|bh4
685926|NCT00688844|Kuvan|kuvan
685927|NCT00688844|Tetrahydrobiopterin|tetrahydrobiopterin
685928|NCT00688844|Sapropterin Dihydrochloride|sapropterin dihydrochloride
685929|NCT00688844|Nutrition|nutrition
685930|NCT00688844|PHE|phe
685931|NCT00688844|Phenylalanine|phenylalanine
685932|NCT00688844|PAH|pah
685933|NCT00688844|Phenylalanine hydroxylase|phenylalanine hydroxylase
685934|NCT00688844|Neurotransmitters|neurotransmitters
685935|NCT00688844|Serotonin|serotonin
685936|NCT00688844|Catecholamines|catecholamines
685937|NCT00688844|Diet|diet
685938|NCT00688844|Body Fat|body fat
685939|NCT00688844|Bone Density|bone density
685940|NCT00688831|AZD1305|azd1305
685941|NCT00688831|SAD|sad
685942|NCT00688831|safety|safety
685943|NCT00688831|pharmcokinetics|pharmcokinetics
685944|NCT00688831|Safety and tolerability|safety and tolerability
685945|NCT00688818|Co-morbid depressive and anxiety disorders|co-morbid depressive and anxiety disorders
685946|NCT00688818|Quetiapine|quetiapine
685947|NCT00688818|Randomized|randomized
685948|NCT00688818|Placebo-controlled|placebo-controlled
685949|NCT00688818|Double-blind|double-blind
685950|NCT00688818|Major depressive disorder|major depressive disorder
685951|NCT00688818|Dysthymic disorder|dysthymic disorder
685952|NCT00688818|Anxiety disorders|anxiety disorders
685953|NCT00688818|Generalized anxiety disorder|generalized anxiety disorder
685954|NCT00688818|Social anxiety disorder|social anxiety disorder
685955|NCT00688818|Panic disorder|panic disorder
685956|NCT00688818|Post-traumatic stress disorder|post-traumatic stress disorder
685957|NCT00688805|Propanolol|propanolol
685958|NCT00688805|Substance Abuse|substance abuse
685959|NCT00688805|Craving|craving
685960|NCT00688805|Imagery|imagery
685961|NCT00688805|Drug Cues|drug cues
685962|NCT00688805|Cocaine|cocaine
685963|NCT00688792|Asthma|asthma
685964|NCT00688792|Children|children
685965|NCT00688792|Adherence|adherence
685966|NCT00688792|Maternal factors|maternal factors
685967|NCT00688779|Healthy male|healthy male
685968|NCT00688779|allergic rhinitis|allergic rhinitis
685969|NCT00688779|tolerability|tolerability
685970|NCT00688779|safety|safety
685971|NCT00688779|intranasally|intranasally
685972|NCT00688779|Healthy subjects|healthy subjects
685973|NCT00688766|GIST|gist
685974|NCT00688766|Metastatic and/or Unresectable Gastrointestinal Stromal|metastatic and/or unresectable gastrointestinal stromal
685975|NCT00688753|renal cell carcinoma|renal cell carcinoma
685976|NCT00688753|non clear cell carcinoma|non clear cell carcinoma
685977|NCT00688753|papillary cell renal carcinoma|papillary cell renal carcinoma
685978|NCT00688753|adults|adults
685979|NCT00688753|everolimus|everolimus
685980|NCT00688740|adjuvant treatment|adjuvant treatment
685981|NCT00688727|non epileptic seizures|non epileptic seizures
685982|NCT00688727|cognitive behavioural therapy|cognitive behavioural therapy
685983|NCT00688727|dissociative disorders|dissociative disorders
685984|NCT00688727|Seizure disorders|seizure disorders
685985|NCT00688727|randomised controlled trial|randomised controlled trial
685986|NCT00688714|Antiplatelet|antiplatelet
685987|NCT00688701|hyperglycemia, GLP-1|hyperglycemia, glp-1
685988|NCT00688688|Frequency|frequency
685989|NCT00688688|Overactive Bladder|overactive bladder
685990|NCT00688688|Urgency|urgency
685991|NCT00688688|Urinary urge incontinence|urinary urge incontinence
685992|NCT00688688|Urinary incontinence|urinary incontinence
685993|NCT00688688|Micturition|micturition
685994|NCT00688675|GERD|gerd
685995|NCT00688675|Pharmacoepidemiology|pharmacoepidemiology
685996|NCT00688662|Sphincter of Oddi Dysfunction|sphincter of oddi dysfunction
685997|NCT00688662|Pancreatitis|pancreatitis
685998|NCT00688662|Sphincterotomy|sphincterotomy
685999|NCT00688623|Neuroendocrine tumors|neuroendocrine tumors
686000|NCT00688623|non functioning neuroendocrine tumors|non functioning neuroendocrine tumors
686001|NCT00688623|Non syndromic neuroendocrine tumors|non syndromic neuroendocrine tumors
686002|NCT00688623|carcinoids|carcinoids
686003|NCT00688623|non-functioning carcinoids|non-functioning carcinoids
686004|NCT00688623|adults|adults
686005|NCT00688623|everolimus|everolimus
686006|NCT00688623|NET|net
686007|NCT00688623|RAMSETE|ramsete
686008|NCT00688623|CRAD001|crad001
686009|NCT00688623|non-functioning neuroendocrine tumors carcinoids|non-functioning neuroendocrine tumors carcinoids
686010|NCT00688610|primary care|primary care
686011|NCT00688610|procalcitonin|procalcitonin
686012|NCT00688610|antibiotic prescription|antibiotic prescription
686013|NCT00688597|Amicus Therapeutics|amicus therapeutics
686014|NCT00688597|Duvoglustat|duvoglustat
686015|NCT00688597|AT2220|at2220
686016|NCT00688584|problem drinking|problem drinking
686017|NCT00688584|randomized control trial|randomized control trial
686018|NCT00688584|Pamphlet-based personalized alcohol feedback (PAF)|pamphlet-based personalized alcohol feedback (paf)
686019|NCT00688571|Pulmonary Valve|pulmonary valve
686020|NCT00688571|Congenital Heart Disease|congenital heart disease
686021|NCT00688545|Celecoxib|celecoxib
686022|NCT00688545|COX-2|cox-2
686023|NCT00688545|NSAIDs|nsaids
686024|NCT00688545|observational study|observational study
686025|NCT00688545|noninterventional study|noninterventional study
686026|NCT00688545|cohort study|cohort study
686027|NCT00688545|registry|registry
686028|NCT00688545|epidemiologic study|epidemiologic study
686029|NCT00688545|pediatrics|pediatrics
686030|NCT00688545|rheumatology|rheumatology
686031|NCT00688545|phase iv study|phase iv study
686032|NCT00688532|Prostate cancer|prostate cancer
686033|NCT00688532|pharmacoepidemiology study|pharmacoepidemiology study
686034|NCT00688519|Plaque-type Psoriasis|plaque-type psoriasis
686035|NCT00688519|Psoriasis|psoriasis
686134|NCT00688168|Treatment Naive|treatment naive
686036|NCT00688506|Chronic pelvic pain syndrome|chronic pelvic pain syndrome
686037|NCT00688506|Neuromodulation|neuromodulation
686038|NCT00688506|Brain effects|brain effects
686039|NCT00688506|Neuroimaging|neuroimaging
686041|NCT00688493|Healthy volunteers|healthy volunteers
686042|NCT00688480|CKD|ckd
686043|NCT00688480|LVH|lvh
686044|NCT00688480|Echo LVH|echo lvh
686045|NCT00688480|Chronic Stage 3|chronic stage 3
686046|NCT00688467|Neutrophilic Asthma|neutrophilic asthma
686047|NCT00688454|Hyperlipidemia|hyperlipidemia
686048|NCT00688454|Rosuvastatin|rosuvastatin
686049|NCT00688454|Efficacy|efficacy
686050|NCT00688454|tolerability|tolerability
686051|NCT00688454|CRESTOR therapy|crestor therapy
686052|NCT00688441|Randomized|randomized
686053|NCT00688441|Double-Blind|double-blind
686054|NCT00688441|Multi-Center|multi-center
686055|NCT00688441|Placebo-Controlled|placebo-controlled
686056|NCT00688441|Phase II|phase ii
686057|NCT00688441|Nasal Carbon Dioxide|nasal carbon dioxide
686058|NCT00688441|Carbon Dioxide|carbon dioxide
686059|NCT00688441|Efficacy|efficacy
686060|NCT00688441|Safety|safety
686061|NCT00688441|Total Nasal Symptom Score|total nasal symptom score
686062|NCT00688441|RQLQ|rqlq
686063|NCT00688428|esomeprazole|esomeprazole
686064|NCT00688428|upper gi symptoms|upper gi symptoms
686065|NCT00688428|low dose Aspirin treatment|low dose aspirin treatment
686066|NCT00688402|Reflux Inhibitor|reflux inhibitor
686067|NCT00688402|GERD|gerd
686068|NCT00688402|formulations|formulations
686069|NCT00688389|Dengue fever, CLEC5A, Mannose receptor, DC-SIGN, NALP,|dengue fever, clec5a, mannose receptor, dc-sign, nalp,
686070|NCT00688389|decoy receptor 3 (DcR3), Toll-like receptors(TLRs),|decoy receptor 3 (dcr3), toll-like receptors(tlrs),
686071|NCT00688389|(Nod)-like receptors (NLRs)|(nod)-like receptors (nlrs)
686072|NCT00688376|Attention|attention
686073|NCT00688376|cancer|cancer
686074|NCT00688376|chemotherapy|chemotherapy
686075|NCT00688376|donepezil|donepezil
686076|NCT00688376|acetylcholinesterase|acetylcholinesterase
686077|NCT00688376|inhibitor|inhibitor
686078|NCT00688363|Diabetes control|diabetes control
686079|NCT00688363|glycated haemoglobin|glycated haemoglobin
686080|NCT00688363|blood-glucose-self-monitoring|blood-glucose-self-monitoring
686081|NCT00688363|type 2-diabetes|type 2-diabetes
686082|NCT00688363|conventional insulin therapy|conventional insulin therapy
686083|NCT00688350|Hypertension|hypertension
686084|NCT00688350|Aging|aging
686085|NCT00688350|Medication adherence|medication adherence
686086|NCT00688350|Medication compliance|medication compliance
686087|NCT00688337|Breast cancer|breast cancer
686088|NCT00688337|lymph nodes|lymph nodes
686089|NCT00688337|gene-expression|gene-expression
686090|NCT00688337|oncotype|oncotype
686091|NCT00688337|Age over 18|age over 18
686092|NCT00688337|Newly diagnosed breast cancer prior to surgery or treatment.|newly diagnosed breast cancer prior to surgery or treatment.
686093|NCT00688337|No evidence of clinical nodal disease|no evidence of clinical nodal disease
686094|NCT00688324|schizophrenia|schizophrenia
686095|NCT00688324|schizoaffective disorder|schizoaffective disorder
686096|NCT00688324|glutamate|glutamate
686097|NCT00688324|NMDA receptor|nmda receptor
686098|NCT00688324|magnetic resonance spectroscopy|magnetic resonance spectroscopy
686099|NCT00688324|acamprosate|acamprosate
686100|NCT00688311|HIV|hiv
686101|NCT00688311|synbiotic|synbiotic
686102|NCT00688311|probiotic|probiotic
686103|NCT00688311|immune activation|immune activation
686104|NCT00688311|blood CD4 count|blood cd4 count
686105|NCT00688311|bacterial translocation|bacterial translocation
686106|NCT00688311|Human Immunodeficiency Virus|human immunodeficiency virus
686107|NCT00688285|chronic kidney disease|chronic kidney disease
686108|NCT00688285|clinical alerts|clinical alerts
686109|NCT00688285|late referral|late referral
686110|NCT00688285|electronic medical record|electronic medical record
686111|NCT00688285|Computerized clinical decision support systems (CDSS)|computerized clinical decision support systems (cdss)
686112|NCT00688272|Safety|safety
686113|NCT00688272|Photoirritant|photoirritant
686114|NCT00688272|Photosensitivity|photosensitivity
686115|NCT00688272|Placebo control|placebo control
686116|NCT00688272|Ciprofloxacin|ciprofloxacin
686117|NCT00688272|Eltrombopag|eltrombopag
686118|NCT00688259|clinical trials|clinical trials
686119|NCT00688259|psychotherapy|psychotherapy
686120|NCT00688246|osteoporosis|osteoporosis
686121|NCT00688246|breast cancer|breast cancer
686122|NCT00688233|Seifi's Functional, Class II/1, Mandibular Retrognathism|seifi's functional, class ii/1, mandibular retrognathism
686123|NCT00688220|Arthritis|arthritis
686124|NCT00688220|Carpel tunnel syndrome|carpel tunnel syndrome
686125|NCT00688220|Epicondylitis|epicondylitis
686126|NCT00688207|PPAR agonist,|ppar agonist,
686127|NCT00688207|Rosiglitazone XR,|rosiglitazone xr,
686128|NCT00688207|BRL-049653.|brl-049653.
686129|NCT00688207|Alzheimer's disease,|alzheimer's disease,
686130|NCT00688194|stage IV breast cancer|stage iv breast cancer
686131|NCT00688194|recurrent breast cancer|recurrent breast cancer
686132|NCT00688168|Multiple Myeloma|multiple myeloma
686133|NCT00688168|Phone Call|phone call
686135|NCT00688168|Inflammatory Cytokines|inflammatory cytokines
686136|NCT00688168|Questionnaire|questionnaire
686137|NCT00688168|Survey|survey
686138|NCT00688168|Interactive Voice Response|interactive voice response
686139|NCT00688168|Symptom Production|symptom production
686140|NCT00688168|Pain|pain
686141|NCT00688168|IVR|ivr
686142|NCT00688168|MM|mm
686143|NCT00688129|school readiness|school readiness
686144|NCT00688129|foster care|foster care
686145|NCT00688129|maltreatment|maltreatment
686146|NCT00688129|literacy|literacy
686147|NCT00688129|social emotional skills|social emotional skills
686148|NCT00688129|self regulation|self regulation
686149|NCT00688129|caregiver involvement|caregiver involvement
686150|NCT00688116|metastatic cancer|metastatic cancer
686151|NCT00688116|solid tumor|solid tumor
686152|NCT00688116|histologically or cytologically confirmed non-hematological malignancy that is metastatic or unresectable|histologically or cytologically confirmed non-hematological malignancy that is metastatic or unresectable
686153|NCT00688116|STA-9090|sta-9090
686154|NCT00688116|ganetespib|ganetespib
686155|NCT00688090|Immunotherapy, Melanoma, Cancer Vaccine|immunotherapy, melanoma, cancer vaccine
686156|NCT00688077|Fibroblast growth factor - 23|fibroblast growth factor - 23
686157|NCT00688077|Calcitonin|calcitonin
686159|NCT00688051|Cystic Fibrosis|cystic fibrosis
686160|NCT00688051|Adherence to treatment|adherence to treatment
686161|NCT00688038|Advanced Cancer|advanced cancer
686162|NCT00688038|Bone Metastases|bone metastases
686163|NCT00688038|Laser Ablation|laser ablation
686164|NCT00688038|Magnetic Resonance Thermal Imaging|magnetic resonance thermal imaging
686165|NCT00688038|Laser Induced Thermal Therapy|laser induced thermal therapy
686166|NCT00688038|MRTI|mrti
686167|NCT00688038|LITT|litt
686168|NCT00688012|antisense|antisense
686169|NCT00688012|microRna antagonist|microrna antagonist
686170|NCT00688012|anti-miR-122|anti-mir-122
686171|NCT00688012|Safety in healthy volunteers|safety in healthy volunteers
686172|NCT00688012|Hepatitis C|hepatitis c
686173|NCT00687999|Chronic hepatitis C|chronic hepatitis c
686174|NCT00687999|diabetes|diabetes
686175|NCT00687999|Insulin resistance|insulin resistance
686176|NCT00687999|combination therapy|combination therapy
686177|NCT00687986|surgery|surgery
686178|NCT00687986|stereotactic radiotherapy|stereotactic radiotherapy
686179|NCT00687986|tumor control|tumor control
686180|NCT00687986|quality of life|quality of life
686181|NCT00687960|Diabetes|diabetes
686182|NCT00687960|Diet|diet
686183|NCT00687960|Fiber|fiber
686184|NCT00687960|Age|age
686185|NCT00687947|FHM|fhm
686186|NCT00687947|MA|ma
686187|NCT00687947|healthy controls|healthy controls
686188|NCT00687947|CGRP|cgrp
686189|NCT00687934|metastatic cancer|metastatic cancer
686190|NCT00687934|solid tumor|solid tumor
686191|NCT00687934|histologically or cytologically confirmed non-hematological|histologically or cytologically confirmed non-hematological
686192|NCT00687934|malignancy that is metastatic or unresectable for which no|malignancy that is metastatic or unresectable for which no
686193|NCT00687934|standard therapy exists|standard therapy exists
686194|NCT00687934|STA-9090|sta-9090
686195|NCT00687934|ganetespib|ganetespib
686196|NCT00687921|Knee trauma|knee trauma
686197|NCT00687921|MRI|mri
686198|NCT00687921|arthroscopy|arthroscopy
686199|NCT00687921|Patients over the age of 18 who had knee trauma intent to or had MRI assessment scheduled for arthroscopy|patients over the age of 18 who had knee trauma intent to or had mri assessment scheduled for arthroscopy
686200|NCT00687908|Acne|acne
686201|NCT00687895|malaria microscopy primary health care children|malaria microscopy primary health care children
686202|NCT00687882|Venous Thromboembolism|venous thromboembolism
686203|NCT00687882|Postthrombotic Syndrome|postthrombotic syndrome
686204|NCT00687882|Antithrombotic Therapy|antithrombotic therapy
686205|NCT00687882|Duration of Therapy|duration of therapy
686206|NCT00687882|Children|children
686207|NCT00687869|stroke|stroke
686208|NCT00687869|rehabilitation|rehabilitation
686209|NCT00687869|patient care management|patient care management
686210|NCT00687869|patient participation|patient participation
686211|NCT00687856|Left Ventricular Assist Device|left ventricular assist device
686212|NCT00687843|Gastric Cancer|gastric cancer
686213|NCT00687843|TS-1|ts-1
686214|NCT00687843|PSK|psk
686215|NCT00687843|Relapse-free survival|relapse-free survival
686216|NCT00687830|Afternoon colonoscopy|afternoon colonoscopy
686217|NCT00687830|Morning|morning
686218|NCT00687830|Evening|evening
686219|NCT00687830|Bowel Preparation|bowel preparation
686220|NCT00687830|Efficacy|efficacy
686221|NCT00687830|Satisfaction|satisfaction
686222|NCT00687817|NSCLC|nsclc
686223|NCT00687804|DME|dme
686224|NCT00687804|Diabetic|diabetic
686225|NCT00687804|macula|macula
686226|NCT00687804|edema|edema
686227|NCT00687804|ranibizumab|ranibizumab
686228|NCT00687804|RESTORE|restore
686229|NCT00687791|patients with cataract and glaucoma|patients with cataract and glaucoma
686230|NCT00687791|ologen|ologen
686231|NCT00687791|oculusgen|oculusgen
686232|NCT00687791|collagen matrix|collagen matrix
686233|NCT00687791|Phacotrabeculectomy|phacotrabeculectomy
686234|NCT00687791|Aeon Astron|aeon astron
686235|NCT00687791|trabeculectomy|trabeculectomy
686236|NCT00687791|tissue engineering|tissue engineering
686237|NCT00687791|mitomycin-C|mitomycin-c
686238|NCT00687778|C11-Acetate|c11-acetate
686239|NCT00687778|FDG|fdg
686240|NCT00687778|sarcoma|sarcoma
686241|NCT00687778|Measurement of C11-Acetate uptake in tumors which are often non-FDG avid.|measurement of c11-acetate uptake in tumors which are often non-fdg avid.
686242|NCT00687778|Soft tissue sarcomas|soft tissue sarcomas
686243|NCT00687778|well-differentiated thyroid cancer|well-differentiated thyroid cancer
686244|NCT00687778|well-differentiated and bronchoalveolar lung cancer|well-differentiated and bronchoalveolar lung cancer
686245|NCT00687778|indolent lymphomas, neuroendocrine tumors|indolent lymphomas, neuroendocrine tumors
686246|NCT00687778|GIST|gist
686247|NCT00687778|uterine malignancies|uterine malignancies
686248|NCT00687778|mucin-producing cancer|mucin-producing cancer
686249|NCT00687778|teratoma, hepatoma|teratoma, hepatoma
686250|NCT00687778|HCC|hcc
686251|NCT00687778|lobular breast carcinoma|lobular breast carcinoma
686252|NCT00687765|patients with newly diagnosed glioblastoma|patients with newly diagnosed glioblastoma
686253|NCT00687752|fetal deglutition|fetal deglutition
686254|NCT00687752|larynx|larynx
686255|NCT00687752|fetal CNS pathology|fetal cns pathology
686256|NCT00687752|sonography|sonography
686257|NCT00687752|hydramnios|hydramnios
686258|NCT00687739|hormone therapy|hormone therapy
686259|NCT00687739|obesity|obesity
686260|NCT00687739|postmenopause|postmenopause
686261|NCT00687739|disease /disorder proneness /risk|disease /disorder proneness /risk
686262|NCT00687739|insulin sensitivity /resistance|insulin sensitivity /resistance
686263|NCT00687739|metabolic syndrome|metabolic syndrome
686264|NCT00687739|women's health|women's health
686265|NCT00687726|osteoarthritis|osteoarthritis
686266|NCT00687726|knee|knee
686267|NCT00687726|exercise|exercise
686268|NCT00687726|balance|balance
686269|NCT00687700|propranolol|propranolol
686270|NCT00687700|B2-agonist,|b2-agonist,
686271|NCT00687700|B-antagonist,|b-antagonist,
686272|NCT00687687|Patients must have advanced (stage III or IV), persistent or recurrent uterine carcinosarcoma with documented disease progression.|patients must have advanced (stage iii or iv), persistent or recurrent uterine carcinosarcoma with documented disease progression.
686273|NCT00687674|refractory multiple myeloma|refractory multiple myeloma
686274|NCT00687661|Chronic Kidney Failure|chronic kidney failure
686275|NCT00687661|Vascular Calcification|vascular calcification
686276|NCT00687661|Bisphosphonates|bisphosphonates
686277|NCT00687648|stage IV breast cancer|stage iv breast cancer
686278|NCT00687648|recurrent breast cancer|recurrent breast cancer
686279|NCT00687648|HER2-negative breast cancer|her2-negative breast cancer
686280|NCT00687648|estrogen receptor-positive breast cancer|estrogen receptor-positive breast cancer
686281|NCT00687648|progesterone receptor-positive breast cancer|progesterone receptor-positive breast cancer
686282|NCT00687622|MEK inhibitor|mek inhibitor
686283|NCT00687622|solid tumors|solid tumors
686284|NCT00687622|First Time in Human|first time in human
686285|NCT00687622|GSK1120212|gsk1120212
686286|NCT00687622|Oncology|oncology
686287|NCT00687622|melanoma|melanoma
686288|NCT00687609|Attention Deficit Hyperactivity Disorder with Cannabis Abuse|attention deficit hyperactivity disorder with cannabis abuse
686289|NCT00687609|Marihuana Abuse|marihuana abuse
686290|NCT00687609|Comorbid Cannabis Abuse|comorbid cannabis abuse
686291|NCT00687583|pediatrics|pediatrics
686292|NCT00687583|anesthesia|anesthesia
686293|NCT00687583|head movements|head movements
686294|NCT00687583|endotracheal tube|endotracheal tube
686295|NCT00687570|patients with rectal cancer undergoing surgery|patients with rectal cancer undergoing surgery
686296|NCT00687570|Bowel purity degree|bowel purity degree
686297|NCT00687570|Bowel preparation|bowel preparation
686298|NCT00687570|Rectal cancer|rectal cancer
686299|NCT00687570|Nutritional status|nutritional status
686300|NCT00687570|complications with traditional bowel preparation|complications with traditional bowel preparation
686301|NCT00687570|Complications|complications
686302|NCT00687570|Physiological status|physiological status
686303|NCT00687544|HIV|hiv
686304|NCT00687492|hypercholesterolemia|hypercholesterolemia
686305|NCT00687492|NCEP ATP III guidelines|ncep atp iii guidelines
686306|NCT00687492|survey|survey
686307|NCT00687479|insulin sensitivity|insulin sensitivity
686308|NCT00687479|insulin secretion|insulin secretion
686309|NCT00687479|infant outcome|infant outcome
686310|NCT00687466|Cystic Fibrosis|cystic fibrosis
686311|NCT00687466|Glucose Intolerance|glucose intolerance
686312|NCT00687453|Glargine|glargine
686313|NCT00687453|Type 2 diabetes|type 2 diabetes
686314|NCT00687453|Basal insulin|basal insulin
686315|NCT00687414|gene expression|gene expression
686316|NCT00687414|gene sequencing|gene sequencing
686317|NCT00687414|gene encoding|gene encoding
686318|NCT00687414|MPD|mpd
686319|NCT00687414|MDS|mds
686320|NCT00687414|AML|aml
686321|NCT00687414|mDia|mdia
686322|NCT00687388|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors
686323|NCT00687388|Alpha Blockers|alpha blockers
686324|NCT00687388|Treatment Outcome|treatment outcome
686325|NCT00687375|Inguinal|inguinal
686326|NCT00687375|Groin hernia|groin hernia
686327|NCT00687375|TAPP|tapp
686328|NCT00687375|TEP|tep
686329|NCT00687375|Comparing|comparing
686330|NCT00687375|Two|two
686331|NCT00687375|Techniques|techniques
686332|NCT00687349|End-of-Life issues|end-of-life issues
686333|NCT00687349|Talking with your doctor|talking with your doctor
686334|NCT00687349|Coping with chronic illness|coping with chronic illness
686335|NCT00687336|Helicobacter pylori|helicobacter pylori
686336|NCT00687336|Treatment|treatment
686337|NCT00687336|Upper gastrointestinal bleeding|upper gastrointestinal bleeding
686338|NCT00687310|Asthma education|asthma education
686339|NCT00687310|satisfaction adherence|satisfaction adherence
686340|NCT00687310|Quality of Life|quality of life
686341|NCT00687310|PIKO meter cluster|piko meter cluster
686342|NCT00687310|Symbicort® Turbuhaler®|symbicort® turbuhaler®
686343|NCT00687297|Stage IIIB Non Small Cell Lung Cancer|stage iiib non small cell lung cancer
686344|NCT00687297|Stage IV Non Small Cell Lung Cancer|stage iv non small cell lung cancer
686345|NCT00687297|Vandetanib|vandetanib
686346|NCT00687297|Docetaxel plus carboplatin|docetaxel plus carboplatin
686347|NCT00687258|Anemia|anemia
686348|NCT00687258|Oxidative Stress|oxidative stress
686349|NCT00687258|Erythropoietin|erythropoietin
686350|NCT00687258|dialyser membrane|dialyser membrane
686351|NCT00687258|Vitamin E|vitamin e
686352|NCT00687258|Erythropoietin responsiveness|erythropoietin responsiveness
686353|NCT00687258|Erythropoietin resistance|erythropoietin resistance
686354|NCT00687258|hemodialysis|hemodialysis
686355|NCT00687245|children|children
686356|NCT00687245|reflux|reflux
686357|NCT00687245|GERD|gerd
686358|NCT00687245|pediatric|pediatric
686359|NCT00687232|Phase I|phase i
686360|NCT00687232|Japan|japan
686361|NCT00687232|Japanese|japanese
686362|NCT00687232|inhalation|inhalation
686363|NCT00687219|hepatitis C|hepatitis c
686364|NCT00687193|Phase 2 monotherapy in Japan|phase 2 monotherapy in japan
686365|NCT00687180|Prednisolone dosage|prednisolone dosage
686366|NCT00687167|Therapeutic Equivalency|therapeutic equivalency
686367|NCT00687154|DME|dme
686368|NCT00687154|Laser|laser
686369|NCT00687154|macular edema|macular edema
686370|NCT00687154|retinopathy|retinopathy
686371|NCT00687154|scatter photocoagulation|scatter photocoagulation
686372|NCT00687141|Safety|safety
686373|NCT00687141|tolerability|tolerability
686374|NCT00687141|AZD0328|azd0328
686375|NCT00687128|Insulin resistance|insulin resistance
686376|NCT00687128|Metabolic syndrome|metabolic syndrome
686377|NCT00687128|Aerobic exercise|aerobic exercise
686378|NCT00687128|Exercise behavior|exercise behavior
686379|NCT00687115|24 Hour Energy Expenditure|24 hour energy expenditure
686380|NCT00687115|Respiratory Chamber|respiratory chamber
686381|NCT00687115|Obesity|obesity
686382|NCT00687115|Weight Loss|weight loss
686383|NCT00687115|Overfeeding|overfeeding
686384|NCT00687102|breast cancer|breast cancer
686385|NCT00687102|Tamoxifen|tamoxifen
686386|NCT00687102|Raloxifene|raloxifene
686387|NCT00687102|hormone therapy|hormone therapy
686388|NCT00687089|Opiates|opiates
686389|NCT00687089|Subutex|subutex
686390|NCT00687089|Buprenorphine|buprenorphine
686391|NCT00687089|Patients who addicted to opiates|patients who addicted to opiates
686392|NCT00687076|Endovascular Intervention|endovascular intervention
686393|NCT00687076|MRI|mri
686394|NCT00687076|Ultrasound|ultrasound
686395|NCT00687076|Cholesterol Medications|cholesterol medications
686396|NCT00687076|High Cholesterol|high cholesterol
686397|NCT00687076|Peripheral Arterial disease|peripheral arterial disease
686398|NCT00687076|Claudication|claudication
686399|NCT00687076|Leg Pain|leg pain
686400|NCT00687076|Niaspan|niaspan
686401|NCT00687076|Extended Release Niacin|extended release niacin
686402|NCT00687076|Zetia|zetia
686403|NCT00687076|Ezetimibe|ezetimibe
686404|NCT00687076|Simvastatin|simvastatin
686405|NCT00687076|Zocor|zocor
686406|NCT00687076|Atorvastatin|atorvastatin
686407|NCT00687076|Lipitor|lipitor
686408|NCT00687050|end-stage renal disease|end-stage renal disease
686409|NCT00687050|chronic kidney disease|chronic kidney disease
686410|NCT00687037|oral hygiene|oral hygiene
686411|NCT00687024|Epilepsy|epilepsy
686412|NCT00687024|Magnetic Resonance Imaging|magnetic resonance imaging
686413|NCT00687024|Magnetoencephalography|magnetoencephalography
686414|NCT00687011|Antiemetic|antiemetic
686415|NCT00686998|Schizophrenia|schizophrenia
686416|NCT00686985|Docetaxel|docetaxel
686417|NCT00686985|Carboplatin|carboplatin
686418|NCT00686985|chemotherapy|chemotherapy
686419|NCT00686985|relapse SCLC|relapse sclc
686420|NCT00686972|Bariatric Surgery|bariatric surgery
686421|NCT00686972|Glucose Regulation|glucose regulation
686422|NCT00686972|Cardiac Function|cardiac function
686423|NCT00686972|Body Composition|body composition
686424|NCT00686946|Severe mental illness|severe mental illness
686425|NCT00686946|Antipsychotic medications|antipsychotic medications
686426|NCT00686946|Pregnancy|pregnancy
686427|NCT00686946|Evidence-based guidelines|evidence-based guidelines
686428|NCT00686946|Maternal and infant health and wellbeing|maternal and infant health and wellbeing
686429|NCT00686933|Attention-Deficit/Hyperactivity Disorder|attention-deficit/hyperactivity disorder
686430|NCT00686907|melatonin, circadian rhythms, sleep|melatonin, circadian rhythms, sleep
686431|NCT00686881|hepatitis C|hepatitis c
686432|NCT00686868|GSK1841157;|gsk1841157;
686433|NCT00686868|rheumatoid arthritis,|rheumatoid arthritis,
686434|NCT00686868|B-cell depletion|b-cell depletion
686435|NCT00686868|anti-CD20 monoclonal antibody,|anti-cd20 monoclonal antibody,
686436|NCT00686855|tacrolimus|tacrolimus
686437|NCT00686855|dexamethasone|dexamethasone
686438|NCT00686855|oral rinse|oral rinse
686439|NCT00686842|HIV infection|hiv infection
686440|NCT00686842|AIDS-related Kaposi sarcoma|aids-related kaposi sarcoma
686441|NCT00686842|recurrent Kaposi sarcoma|recurrent kaposi sarcoma
686442|NCT00686842|Treatment Experienced|treatment experienced
686443|NCT00686829|HIV|hiv
686444|NCT00686829|Treatment Experienced|treatment experienced
686445|NCT00686816|pre-diabetic|pre-diabetic
686446|NCT00686816|obese|obese
686447|NCT00686803|hypertension|hypertension
686448|NCT00686803|controlled hypertension|controlled hypertension
686449|NCT00686803|hypertensives|hypertensives
686450|NCT00686790|Hepatitis D|hepatitis d
686451|NCT00686790|Hepatitis B|hepatitis b
686452|NCT00686777|hepatitis C|hepatitis c
686453|NCT00686764|trans-femoral amputation|trans-femoral amputation
686454|NCT00686738|osteosarcoma|osteosarcoma
686455|NCT00686738|transforming growth factor-beta 1|transforming growth factor-beta 1
686456|NCT00686738|nuclear factor-kappa B|nuclear factor-kappa b
686457|NCT00686738|positron emission tomography/computed tomography|positron emission tomography/computed tomography
686458|NCT00686738|magnetic resonance spectroscopy|magnetic resonance spectroscopy
686459|NCT00686738|predicting response to neoadjuvant chemotherapy|predicting response to neoadjuvant chemotherapy
686460|NCT00686712|Glargine|glargine
686461|NCT00686712|Type 2 diabetes|type 2 diabetes
686462|NCT00686712|Basal insulin|basal insulin
686463|NCT00686699|Anti-Dyskinesia Agents|anti-dyskinesia agents
686464|NCT00686699|Antipsychotic Agents|antipsychotic agents
686465|NCT00686673|DECISION AIDS|decision aids
686466|NCT00686660|copd|copd
686467|NCT00686660|rehabilitation|rehabilitation
686468|NCT00686660|quality of life|quality of life
686469|NCT00686660|inflammation|inflammation
686470|NCT00686647|Coronary Angioplasty|coronary angioplasty
686471|NCT00686647|Coronary Stents|coronary stents
686472|NCT00686647|Scoring Balloons|scoring balloons
686473|NCT00686647|Coronary Artery Bifurcation Lesions|coronary artery bifurcation lesions
686474|NCT00686634|sitagliptin|sitagliptin
686475|NCT00686634|type 2 diabetes|type 2 diabetes
686476|NCT00686634|combination therapy|combination therapy
686477|NCT00686608|Obesity|obesity
686478|NCT00686556|recurrent adult acute lymphoblastic leukemia|recurrent adult acute lymphoblastic leukemia
686479|NCT00686556|recurrent childhood acute lymphoblastic leukemia|recurrent childhood acute lymphoblastic leukemia
686480|NCT00686556|recurrent adult acute myeloid leukemia|recurrent adult acute myeloid leukemia
686481|NCT00686556|recurrent childhood acute myeloid leukemia|recurrent childhood acute myeloid leukemia
686482|NCT00686556|adult acute myeloid leukemia with 11q23 (MLL) abnormalities|adult acute myeloid leukemia with 11q23 (mll) abnormalities
686483|NCT00686556|adult acute myeloid leukemia with inv(16)(p13;q22)|adult acute myeloid leukemia with inv(16)(p13;q22)
686484|NCT00686556|adult acute myeloid leukemia with t(15;17)(q22;q12)|adult acute myeloid leukemia with t(15;17)(q22;q12)
686485|NCT00686556|adult acute myeloid leukemia with t(16;16)(p13;q22)|adult acute myeloid leukemia with t(16;16)(p13;q22)
686486|NCT00686556|adult acute myeloid leukemia with t(8;21)(q22;q22)|adult acute myeloid leukemia with t(8;21)(q22;q22)
686487|NCT00686556|ALL|all
686488|NCT00686556|MDS|mds
686489|NCT00686543|Antifungal Agents|antifungal agents
686490|NCT00686543|Anti-Infective Agents|anti-infective agents
686491|NCT00686530|Fetal Death|fetal death
686492|NCT00686530|Magnetic Resonance Imaging|magnetic resonance imaging
686493|NCT00686530|Autopsy|autopsy
686494|NCT00686530|Telencephalon|telencephalon
686495|NCT00686530|Pyramidal Tracts|pyramidal tracts
686496|NCT00686504|Pain|pain
686497|NCT00686504|PET|pet
686498|NCT00686504|Phase 1|phase 1
686499|NCT00686504|Analgesia|analgesia
686500|NCT00686504|Positron Emission Tomography|positron emission tomography
686501|NCT00686504|mGlu5 receptor|mglu5 receptor
686502|NCT00686504|Dose finding|dose finding
686503|NCT00686504|Analgesia/Pain|analgesia/pain
686504|NCT00686491|Asthma|asthma
686505|NCT00686491|Environment|environment
686506|NCT00686491|Type of sport|type of sport
686507|NCT00686491|Cardiovascular disease|cardiovascular disease
686508|NCT00686491|Athletes|athletes
686509|NCT00686478|burn|burn
686510|NCT00686478|hypertrophic scar|hypertrophic scar
686511|NCT00686478|fibroproliferative disorder|fibroproliferative disorder
686512|NCT00686465|recurrent cancer|recurrent cancer
686513|NCT00686465|PET/CT|pet/ct
686514|NCT00686465|FDG|fdg
686515|NCT00686465|planned management|planned management
686516|NCT00686465|actual treatment|actual treatment
686517|NCT00686452|Asthma|asthma
686518|NCT00686452|Airway hyperresponsiveness|airway hyperresponsiveness
686519|NCT00686452|Swimmers|swimmers
686520|NCT00686452|Airway inflammation|airway inflammation
686521|NCT00686452|Airway remodelling|airway remodelling
686522|NCT00686439|osteoarthritis|osteoarthritis
686523|NCT00686439|adalimumab|adalimumab
686524|NCT00686439|mri|mri
686525|NCT00686426|Obesity|obesity
686526|NCT00686426|Weight gain|weight gain
686527|NCT00686426|regain|regain
686528|NCT00686426|dairy|dairy
686529|NCT00686426|calcium|calcium
686531|NCT00686413|AZD3480|azd3480
686532|NCT00686413|PET examination|pet examination
686533|NCT00686400|schizophrenia|schizophrenia
686534|NCT00686400|first-episode|first-episode
686535|NCT00686400|infection|infection
686536|NCT00686400|Toxoplasma gondii|toxoplasma gondii
686537|NCT00686400|levels of IgG antibodies to TG|levels of igg antibodies to tg
686538|NCT00686387|Tissue Bank|tissue bank
686539|NCT00686387|Glioblastoma Multiforme|glioblastoma multiforme
686540|NCT00686387|NAT2|nat2
686541|NCT00686387|EGFR|egfr
686542|NCT00686387|MGMT|mgmt
686543|NCT00686387|Brain and Spinal TumorGliomas|brain and spinal tumorgliomas
686544|NCT00686374|Crohn's Disease|crohn's disease
686545|NCT00686374|adalimumab|adalimumab
686546|NCT00686361|Cystic Fibrosis|cystic fibrosis
686547|NCT00686361|choline nutrition|choline nutrition
686548|NCT00686361|choline and methyl metabolism|choline and methyl metabolism
686549|NCT00686361|CF and oxidative stress|cf and oxidative stress
686550|NCT00686348|acromegaly|acromegaly
686551|NCT00686335|asthma|asthma
686552|NCT00686335|nocturnal asthma|nocturnal asthma
686553|NCT00686335|glucocorticoid dependent persistent asthma|glucocorticoid dependent persistent asthma
686554|NCT00686335|signs and symptoms|signs and symptoms
686555|NCT00686335|lung function|lung function
686556|NCT00686335|prednisone|prednisone
686557|NCT00686322|chemotherapy|chemotherapy
686558|NCT00686322|radiotherapy|radiotherapy
686559|NCT00686322|lung cancer|lung cancer
686560|NCT00686309|exhaled NO|exhaled no
686561|NCT00686309|off line|off line
686562|NCT00686309|on line|on line
686563|NCT00686309|comparison|comparison
686564|NCT00686309|Bland altman method|bland altman method
686565|NCT00686296|soft tissue abscess requiring incision and drainage|soft tissue abscess requiring incision and drainage
686566|NCT00686283|Adolescents|adolescents
686567|NCT00686283|Diabetes|diabetes
686568|NCT00686283|Exercise|exercise
686569|NCT00686270|HIV-1 infection|hiv-1 infection
686570|NCT00686270|NRTI resistance|nrti resistance
686571|NCT00686270|M184V mutation|m184v mutation
686572|NCT00686270|reverse transcriptase|reverse transcriptase
686573|NCT00686270|apricitabine|apricitabine
686574|NCT00686270|drug resistance|drug resistance
686575|NCT00686270|safety and tolerability|safety and tolerability
686576|NCT00686270|therapy failure|therapy failure
686577|NCT00686270|Treatment Experienced|treatment experienced
686578|NCT00686257|acute respiratory insufficiency|acute respiratory insufficiency
686579|NCT00686257|noninvasive ventilation|noninvasive ventilation
686580|NCT00686257|oronasal face mask|oronasal face mask
686581|NCT00686257|total face mask|total face mask
686582|NCT00686244|metabolic syndrome|metabolic syndrome
686583|NCT00686244|physical activity|physical activity
686584|NCT00686244|overweight|overweight
686585|NCT00686244|malnutrition|malnutrition
686586|NCT00686244|prevention|prevention
686587|NCT00686231|To determine if topical nitroglycerin acts to vasodilate the radial artery by a direct local action, or by systemic vasodilation|to determine if topical nitroglycerin acts to vasodilate the radial artery by a direct local action, or by systemic vasodilation
686588|NCT00686231|To determine if topical nitroglycerin dilates the radial artery in the presence of local anesthetic agents used in cardiac catheterization|to determine if topical nitroglycerin dilates the radial artery in the presence of local anesthetic agents used in cardiac catheterization
686589|NCT00686218|chronic phase chronic myelogenous leukemia|chronic phase chronic myelogenous leukemia
686590|NCT00686205|healthy donors|healthy donors
686591|NCT00686205|HIV positives|hiv positives
686592|NCT00686192|Obesity|obesity
686593|NCT00686192|Calcium carbonate|calcium carbonate
686594|NCT00686192|Dietary Supplements|dietary supplements
686595|NCT00686192|Lipolysis|lipolysis
686596|NCT00686179|TQT|tqt
686597|NCT00686179|ECG|ecg
686598|NCT00686179|QT|qt
686599|NCT00686179|QTc|qtc
686600|NCT00686179|AZD3480|azd3480
686601|NCT00686179|ECG(QTc effects)|ecg(qtc effects)
686602|NCT00686166|adenocarcinoma of the rectum|adenocarcinoma of the rectum
686603|NCT00686166|stage IIA rectal cancer|stage iia rectal cancer
686604|NCT00686166|stage IIB rectal cancer|stage iib rectal cancer
686605|NCT00686166|stage IIC rectal cancer|stage iic rectal cancer
686606|NCT00686166|stage IIIA rectal cancer|stage iiia rectal cancer
686607|NCT00686166|stage IIIB rectal cancer|stage iiib rectal cancer
686608|NCT00686166|stage IIIC rectal cancer|stage iiic rectal cancer
686609|NCT00686140|Schizophrenia|schizophrenia
686610|NCT00686140|clinical trial|clinical trial
686611|NCT00686140|risperidone|risperidone
686612|NCT00686140|immune|immune
686613|NCT00686140|celecoxib|celecoxib
686614|NCT00686127|breast cancer|breast cancer
686615|NCT00686127|neuropathic pain|neuropathic pain
686616|NCT00686127|topical lidocaine|topical lidocaine
686617|NCT00686127|postmastectomy pain|postmastectomy pain
686618|NCT00686127|breast symptoms|breast symptoms
686619|NCT00686127|breast pain|breast pain
686620|NCT00686114|Esophageal cancer|esophageal cancer
686621|NCT00686114|chemoradiation|chemoradiation
686622|NCT00686114|radiosensitivity|radiosensitivity
686623|NCT00686114|EGFR inhibition|egfr inhibition
686624|NCT00686101|Perception of risk|perception of risk
686625|NCT00686101|Smoking risks|smoking risks
686626|NCT00686101|Smoking consequences|smoking consequences
686627|NCT00686101|Quitting smoking|quitting smoking
686628|NCT00686101|Motivation to quit smoking|motivation to quit smoking
686629|NCT00686101|Schizophrenia|schizophrenia
686630|NCT00686088|prostate cancer|prostate cancer
686631|NCT00686088|locally recurrent|locally recurrent
686632|NCT00686088|PRX302|prx302
686633|NCT00686075|Respiratory Syncytial Virus (RSV)|respiratory syncytial virus (rsv)
686634|NCT00686075|Parainfluenza Virus Type 3 (PIV3)|parainfluenza virus type 3 (piv3)
686635|NCT00686075|MEDI-534|medi-534
686636|NCT00686062|Prenatal testing|prenatal testing
686637|NCT00686062|Amniocentesis|amniocentesis
686638|NCT00686062|Decision making|decision making
686639|NCT00686062|Down syndrome|down syndrome
686640|NCT00686049|HIV Treatment Readiness Measure (HTRM)|hiv treatment readiness measure (htrm)
686641|NCT00686049|Highly Active Antiretroviral Treatment (HAART)|highly active antiretroviral treatment (haart)
686642|NCT00686049|Adherence|adherence
686643|NCT00686049|Treatment readiness|treatment readiness
686644|NCT00686049|HIV|hiv
686645|NCT00686036|prostate cancer|prostate cancer
686646|NCT00686036|hormone treatment|hormone treatment
686647|NCT00686023|pertrochanteric femur fracture|pertrochanteric femur fracture
686648|NCT00686023|DHS|dhs
686649|NCT00686023|IMN|imn
686650|NCT00686010|CETP Inhibitor|cetp inhibitor
686651|NCT00686010|HDL-C|hdl-c
686652|NCT00686010|LDL-C|ldl-c
686653|NCT00686010|Apolipoprotein|apolipoprotein
686654|NCT00685997|Malignant lymphoma|malignant lymphoma
686655|NCT00685997|Hodgkin's disease|hodgkin's disease
686656|NCT00685997|Non-Hodgkin's lymphoma|non-hodgkin's lymphoma
686657|NCT00685997|Imaging|imaging
686658|NCT00685997|Whole-Body MRI|whole-body mri
686659|NCT00685997|CT|ct
686660|NCT00685997|Radiation|radiation
686661|NCT00685984|Type 2 diabetes|type 2 diabetes
686662|NCT00685984|silent myocardial ischemia|silent myocardial ischemia
686663|NCT00685984|endothelial function|endothelial function
686664|NCT00685971|Cystic Fibrosis|cystic fibrosis
686665|NCT00685971|Vitamin D deficiency|vitamin d deficiency
686666|NCT00685958|Blood thinner|blood thinner
686667|NCT00685958|enoxaparin|enoxaparin
686668|NCT00685958|hip fracture surgery|hip fracture surgery
686669|NCT00685958|bleeding|bleeding
686670|NCT00685958|thromboembolism|thromboembolism
686671|NCT00685945|Bradykinin|bradykinin
686672|NCT00685945|Obesity|obesity
686673|NCT00685945|Nitric Oxide Donor|nitric oxide donor
686674|NCT00685945|tissue type plasminogen activator|tissue type plasminogen activator
686675|NCT00685945|isosorbide dinitrate|isosorbide dinitrate
686676|NCT00685945|phosphodiesterase inhibitor|phosphodiesterase inhibitor
686677|NCT00685945|Renin-Angiotensin Aldosterone System|renin-angiotensin aldosterone system
686678|NCT00685945|Fibrinolysis|fibrinolysis
686679|NCT00685945|Angiotensin converting enzyme|angiotensin converting enzyme
686680|NCT00685932|Postpartum pain|postpartum pain
686681|NCT00685932|Post-cesarean pain|post-cesarean pain
686682|NCT00685932|Surgical retractor|surgical retractor
686683|NCT00685932|Elastic retractor|elastic retractor
686684|NCT00685919|Dopamine|dopamine
686685|NCT00685919|Natriuresis|natriuresis
686686|NCT00685919|Catecholamines|catecholamines
686687|NCT00685906|oral contraceptive|oral contraceptive
686688|NCT00685906|birth control|birth control
686689|NCT00685906|Healthy volunteers|healthy volunteers
686690|NCT00685893|End-of-life issues|end-of-life issues
686691|NCT00685893|Talking with your doctor|talking with your doctor
686692|NCT00685893|Coping with chronic illness|coping with chronic illness
686693|NCT00685880|thumb carpo metacarpal joint osteoarthritis|thumb carpo metacarpal joint osteoarthritis
686694|NCT00685880|prolotherapy|prolotherapy
686695|NCT00685880|intra articular steroid|intra articular steroid
686696|NCT00685880|hand therapy|hand therapy
686697|NCT00685867|Staphylococcus aureus|staphylococcus aureus
686698|NCT00685867|Resistance|resistance
686699|NCT00685867|Prevention|prevention
686700|NCT00685854|Macular Telangiectasia|macular telangiectasia
686701|NCT00685854|Vascular Endothelial Growth Factor|vascular endothelial growth factor
686702|NCT00685854|Ranibizumab|ranibizumab
686703|NCT00685841|Chronic obstructive pulmonary disease|chronic obstructive pulmonary disease
686704|NCT00685828|gastrointestinal stromal tumor|gastrointestinal stromal tumor
686705|NCT00685815|IV Iron|iv iron
686706|NCT00685815|Restless Legs Syndrome|restless legs syndrome
686707|NCT00685815|RLS|rls
686708|NCT00685815|Iron|iron
686709|NCT00685789|Bell's palsy，deqi，acupuncture, neuropsychology|bell's palsy，deqi，acupuncture, neuropsychology
686710|NCT00685776|CHD/CHD risk-equivalent disease|chd/chd risk-equivalent disease
686711|NCT00685776|Coronary Heart Disease (CHD)|coronary heart disease (chd)
686712|NCT00685763|Pancreatic cancer|pancreatic cancer
686713|NCT00685763|Unresectable|unresectable
686714|NCT00685763|Proton radiation|proton radiation
686715|NCT00685763|Chemotherapy|chemotherapy
686716|NCT00685750|tumor antigen|tumor antigen
686717|NCT00685750|biomarkers|biomarkers
686718|NCT00685737|Hyperlipidemia|hyperlipidemia
686719|NCT00685724|pathological gambling|pathological gambling
686720|NCT00685724|cognitive-behavioral therapy|cognitive-behavioral therapy
687100|NCT00684099|Pemetrexed|pemetrexed
686721|NCT00685724|motivational enhancement therapy|motivational enhancement therapy
686722|NCT00685711|Cat allergy|cat allergy
686723|NCT00685711|Immunotherapy|immunotherapy
686724|NCT00685711|Cat-PAD|cat-pad
686725|NCT00685698|Diabetic Foot Infections, DFI, Nemonoxacin|diabetic foot infections, dfi, nemonoxacin
686726|NCT00685685|Therapeutic Equivalency|therapeutic equivalency
686727|NCT00685672|labor analgesia|labor analgesia
686728|NCT00685672|fentanyl|fentanyl
686729|NCT00685672|epinephrine|epinephrine
686730|NCT00685659|cocaine dependence|cocaine dependence
686731|NCT00685659|treatment|treatment
686732|NCT00685659|continuing care|continuing care
686733|NCT00685659|outcomes|outcomes
686734|NCT00685659|incentives|incentives
686735|NCT00685659|adaptive|adaptive
686736|NCT00685646|bone metastases|bone metastases
686737|NCT00685646|stage IV prostate cancer|stage iv prostate cancer
686738|NCT00685633|stage I prostate cancer|stage i prostate cancer
686739|NCT00685633|stage II prostate cancer|stage ii prostate cancer
686740|NCT00685633|stage III prostate cancer|stage iii prostate cancer
686741|NCT00685633|recurrent prostate cancer|recurrent prostate cancer
686742|NCT00685607|Pilot Study|pilot study
686743|NCT00685607|Outcome Measures|outcome measures
686744|NCT00685594|diabetes|diabetes
686745|NCT00685594|vitamin D|vitamin d
686746|NCT00685594|cholecalciferol|cholecalciferol
686747|NCT00685594|glucose tolerance|glucose tolerance
686748|NCT00685581|TFA|tfa
686749|NCT00685581|SFA|sfa
686750|NCT00685581|Clinical trial|clinical trial
686751|NCT00685581|fat milk|fat milk
686752|NCT00685568|colon cancer|colon cancer
686753|NCT00685568|rectal cancer|rectal cancer
686754|NCT00685568|familial adenomatous polyposis|familial adenomatous polyposis
686755|NCT00685555|Screen time|screen time
686756|NCT00685555|Fruits and Vegetable Consumption|fruits and vegetable consumption
686757|NCT00685555|Physical Activity|physical activity
686758|NCT00685555|Obesity|obesity
686759|NCT00685555|Overweight|overweight
686760|NCT00685542|diacerein|diacerein
686761|NCT00685542|osteoarthritis|osteoarthritis
686762|NCT00685542|hand|hand
686763|NCT00685529|COPD|copd
686764|NCT00685529|Arformoterol|arformoterol
686765|NCT00685529|formoterol|formoterol
686766|NCT00685516|adenocarcinoma of the prostate|adenocarcinoma of the prostate
686767|NCT00685516|recurrent prostate cancer|recurrent prostate cancer
686768|NCT00685516|stage I prostate cancer|stage i prostate cancer
686769|NCT00685516|stage II prostate cancer|stage ii prostate cancer
686770|NCT00685516|stage III prostate cancer|stage iii prostate cancer
686771|NCT00685516|stage IV prostate cancer|stage iv prostate cancer
686772|NCT00685503|Macular Telangiectasia|macular telangiectasia
686773|NCT00685503|Vascular Endothelial Growth Factor|vascular endothelial growth factor
686774|NCT00685503|Ranibizumab|ranibizumab
686775|NCT00685503|Neovascularization|neovascularization
686776|NCT00685490|branch retinal vein occlusion|branch retinal vein occlusion
686777|NCT00685490|internal limiting membrane|internal limiting membrane
686778|NCT00685490|macular edema|macular edema
686779|NCT00685490|vitrectomy|vitrectomy
686780|NCT00685477|CCK infusion|cck infusion
686781|NCT00685477|Gallbladder ejection fraction|gallbladder ejection fraction
686782|NCT00685477|Normal volunteers|normal volunteers
686783|NCT00685464|Abciximab|abciximab
686784|NCT00685464|Reo-Pro|reo-pro
686785|NCT00685464|Intracoronary|intracoronary
686786|NCT00685464|PCI|pci
686787|NCT00685451|cognitive behavior therapy|cognitive behavior therapy
686788|NCT00685451|addiction|addiction
686789|NCT00685451|PTSD|ptsd
686790|NCT00685438|Environmental Medicine|environmental medicine
686791|NCT00685438|Altitude|altitude
686792|NCT00685438|Ultraviolet Rays|ultraviolet rays
686793|NCT00685438|Antioxidants|antioxidants
686794|NCT00685438|Oxidative Stress|oxidative stress
686795|NCT00685438|Erythema|erythema
686796|NCT00685425|Asthma|asthma
686797|NCT00685425|Exercised induced bronchoconstriction|exercised induced bronchoconstriction
686798|NCT00685412|CIN 2 or 3|cin 2 or 3
686799|NCT00685412|cervical cancer|cervical cancer
686800|NCT00685399|Uveitis|uveitis
686801|NCT00685399|eye|eye
686802|NCT00685399|IL-17|il-17
686803|NCT00685399|IL-17A|il-17a
686804|NCT00685399|IL17|il17
686805|NCT00685399|AIN457|ain457
686806|NCT00685399|Vogt-Koyanagi-Harada|vogt-koyanagi-harada
686807|NCT00685399|Behcet's|behcet's
686808|NCT00685399|Behcet|behcet
686809|NCT00685399|Sympathetic ophthalmia|sympathetic ophthalmia
686810|NCT00685399|Multifocal choroiditis|multifocal choroiditis
686811|NCT00685399|Birdshot|birdshot
686812|NCT00685399|HLA-B27|hla-b27
686813|NCT00685399|Birdshot retinochoroiditis|birdshot retinochoroiditis
686814|NCT00685399|Retinal vasculitis|retinal vasculitis
686815|NCT00685399|Sarcoidosis|sarcoidosis
686816|NCT00685399|Intermediate uveitis|intermediate uveitis
686817|NCT00685399|Panuveitis|panuveitis
686818|NCT00685399|Posterior uveitis|posterior uveitis
686819|NCT00685386|endoscopic retrograde cholangiopancreatography|endoscopic retrograde cholangiopancreatography
686820|NCT00685386|carbon dioxide|carbon dioxide
686821|NCT00685386|randomized controlled clinical trial|randomized controlled clinical trial
687101|NCT00684099|Docetaxel|docetaxel
686822|NCT00685373|Cryopyrin-associated periodic syndromes (CAPS):|cryopyrin-associated periodic syndromes (caps):
686823|NCT00685373|Familial Cold Autoinflammatory Syndrome (FCAS),|familial cold autoinflammatory syndrome (fcas),
686824|NCT00685373|Muckle-Wells Syndrome (MWS),|muckle-wells syndrome (mws),
686825|NCT00685373|MWS with overlapping symptoms of Neonatal Onset Multisystem Inflammatory Disease (NOMID) or Neonatal Onset Multisystem Inflammatory Disease (NOMID),|mws with overlapping symptoms of neonatal onset multisystem inflammatory disease (nomid) or neonatal onset multisystem inflammatory disease (nomid),
686826|NCT00685373|children,|children,
686827|NCT00685373|systemic autoinflammatory disease,|systemic autoinflammatory disease,
686828|NCT00685373|CIAS-1 gene,|cias-1 gene,
686829|NCT00685373|NALP-3,|nalp-3,
686830|NCT00685373|ACZ885,|acz885,
686831|NCT00685373|human monoclonal anti-human interleukin-1beta (IL-1beta),|human monoclonal anti-human interleukin-1beta (il-1beta),
686832|NCT00685373|antibody,|antibody,
686833|NCT00685373|autosomal dominant,|autosomal dominant,
686834|NCT00685373|familial autoinflammatory syndrome|familial autoinflammatory syndrome
686835|NCT00685360|Tuberculosis|tuberculosis
686836|NCT00685360|Pulmonary|pulmonary
686837|NCT00685360|Multidrug resistant|multidrug resistant
686838|NCT00685360|Antitubercular Agents|antitubercular agents
686839|NCT00685360|OPC 67683|opc 67683
686840|NCT00685347|Asthma|asthma
686841|NCT00685347|Exercised induced bronchoconstriction|exercised induced bronchoconstriction
686842|NCT00685334|Atypical Antipsychotics|atypical antipsychotics
686843|NCT00685334|Anorexia Nervosa|anorexia nervosa
686844|NCT00685321|schizophrenia|schizophrenia
686845|NCT00685321|TMS|tms
686846|NCT00685321|brain stimulation|brain stimulation
686847|NCT00685321|negative symptoms|negative symptoms
686848|NCT00685321|clinical improvement|clinical improvement
686849|NCT00685321|cognitive improvement|cognitive improvement
686850|NCT00685308|Atherosclerosis|atherosclerosis
686851|NCT00685308|Intracranial artery|intracranial artery
686852|NCT00685308|Angioplasty|angioplasty
686853|NCT00685308|Stent|stent
686854|NCT00685295|Emergency Department|emergency department
686855|NCT00685295|acute|acute
686856|NCT00685269|Obstructive Sleep Apnea Syndrome|obstructive sleep apnea syndrome
686857|NCT00685269|OSAS|osas
686858|NCT00685256|breast cancer|breast cancer
686859|NCT00685256|hereditary breast/ovarian cancer (BRCA1, BRCA2)|hereditary breast/ovarian cancer (brca1, brca2)
686860|NCT00685243|Fraxel|fraxel
686861|NCT00685243|Pulsed dye laser|pulsed dye laser
686862|NCT00685243|Surgical scars|surgical scars
686863|NCT00685230|scorpion sting|scorpion sting
686864|NCT00685230|envenomation|envenomation
686865|NCT00685230|alacramyn|alacramyn
686866|NCT00685191|Raltegravir|raltegravir
686867|NCT00685191|HIV|hiv
686868|NCT00685191|dynamics|dynamics
686869|NCT00685191|viral load|viral load
686870|NCT00685191|Treatment Experienced|treatment experienced
686871|NCT00685178|addiction|addiction
686872|NCT00685178|drug dependence|drug dependence
686873|NCT00685178|stimulant|stimulant
686874|NCT00685139|Therapeutic Equivalency|therapeutic equivalency
686875|NCT00685126|RAD|rad
686876|NCT00685126|Reactive Airways Disease|reactive airways disease
686877|NCT00685126|Levalbuterol|levalbuterol
686878|NCT00685126|Racemic albuterol|racemic albuterol
686879|NCT00685100|IVTA; CNV; age-related macular degeneration; PDT|ivta; cnv; age-related macular degeneration; pdt
686880|NCT00685087|To define the natural history and the clinical, laboratory and histomorphometric features of chronic pancreatitis (CP).|to define the natural history and the clinical, laboratory and histomorphometric features of chronic pancreatitis (cp).
686881|NCT00685087|To identify clinical and laboratory parameters that correlate with the pathophysiologic state in patients with CP.|to identify clinical and laboratory parameters that correlate with the pathophysiologic state in patients with cp.
686882|NCT00685087|To quantify the behavioral abnormalities associated with CP.|to quantify the behavioral abnormalities associated with cp.
686883|NCT00685087|To determine psychological and behavioral correlates of CP disease progression and outcomes.|to determine psychological and behavioral correlates of cp disease progression and outcomes.
686884|NCT00685074|Motivational Interview|motivational interview
686885|NCT00685074|Computer based intervention|computer based intervention
686886|NCT00685074|Substance abuse|substance abuse
686887|NCT00685074|post-partum|post-partum
686888|NCT00685061|Adult, primary deceased donor kidney transplant recipients|adult, primary deceased donor kidney transplant recipients
686889|NCT00685048|Gambling|gambling
686890|NCT00685048|Brief Therapies|brief therapies
686891|NCT00685048|Substance Abuse|substance abuse
686892|NCT00685035|high frequency chest wall oscillation, cystic fibrosis|high frequency chest wall oscillation, cystic fibrosis
686893|NCT00685022|Asthma|asthma
686894|NCT00685022|Racemic albuterol|racemic albuterol
686895|NCT00685009|Cognition|cognition
686897|NCT00685009|Hormone Therapy|hormone therapy
686898|NCT00684983|IGF-1R|igf-1r
686899|NCT00684983|IMC-A12|imc-a12
686900|NCT00684970|CRPC|crpc
686901|NCT00684970|HRPC|hrpc
686902|NCT00684970|metastatic prostate cancer|metastatic prostate cancer
686903|NCT00684931|Attention|attention
686904|NCT00684931|Deficit|deficit
686905|NCT00684931|Disorder|disorder
686906|NCT00684931|Hyperactivity|hyperactivity
686907|NCT00684931|cerebellum|cerebellum
686908|NCT00684931|alteration|alteration
686909|NCT00684931|fronto-cerebello-frontal loops|fronto-cerebello-frontal loops
686910|NCT00684918|AML, obatoclax|aml, obatoclax
686911|NCT00684905|adenocarcinoma of the prostate|adenocarcinoma of the prostate
686912|NCT00684905|recurrent prostate cancer|recurrent prostate cancer
686913|NCT00684905|stage I prostate cancer|stage i prostate cancer
686914|NCT00684905|stage II prostate cancer|stage ii prostate cancer
686915|NCT00684905|stage III prostate cancer|stage iii prostate cancer
686916|NCT00684892|Emphysema|emphysema
686917|NCT00684892|Endobronchial Lung Volume Reduction|endobronchial lung volume reduction
686918|NCT00684879|Hereditary Hemorrhagic Telangiectasia|hereditary hemorrhagic telangiectasia
686919|NCT00684879|Health Belief Model|health belief model
686920|NCT00684879|Illness Perceptions|illness perceptions
686921|NCT00684879|Screening|screening
686922|NCT00684879|HHT|hht
686923|NCT00684866|Asthma|asthma
686924|NCT00684866|Levalbuterol|levalbuterol
686925|NCT00684866|Racemic Albuterol|racemic albuterol
686926|NCT00684853|AMD|amd
686927|NCT00684853|PDT|pdt
686928|NCT00684853|Avastin|avastin
686929|NCT00684853|Bevacizumab|bevacizumab
686930|NCT00684853|Full fluence|full fluence
686931|NCT00684853|exudative|exudative
686932|NCT00684853|CNV|cnv
686933|NCT00684853|Drusen|drusen
686934|NCT00684853|ARMD|armd
686935|NCT00684853|Vetaporfin|vetaporfin
686936|NCT00684853|efficacy|efficacy
686937|NCT00684853|treatment|treatment
686938|NCT00684840|Behavioral Economics|behavioral economics
686939|NCT00684840|Drug self administration|drug self administration
686940|NCT00684840|Opioid|opioid
686941|NCT00684827|Asthma|asthma
686942|NCT00684827|Racemic albuterol|racemic albuterol
686943|NCT00684814|equivalency|equivalency
686944|NCT00684814|Therapeutic equivalency|therapeutic equivalency
686945|NCT00684801|recurrent non-small cell lung cancer|recurrent non-small cell lung cancer
686946|NCT00684801|recurrent small cell lung cancer|recurrent small cell lung cancer
686947|NCT00684801|stage IIIA non-small cell lung cancer|stage iiia non-small cell lung cancer
686948|NCT00684801|stage IIIB non-small cell lung cancer|stage iiib non-small cell lung cancer
686949|NCT00684801|stage IV non-small cell lung cancer|stage iv non-small cell lung cancer
686950|NCT00684801|extensive stage small cell lung cancer|extensive stage small cell lung cancer
686951|NCT00684801|recurrent pancreatic cancer|recurrent pancreatic cancer
686952|NCT00684801|stage III pancreatic cancer|stage iii pancreatic cancer
686953|NCT00684801|stage IV pancreatic cancer|stage iv pancreatic cancer
686954|NCT00684801|recurrent ovarian epithelial cancer|recurrent ovarian epithelial cancer
686955|NCT00684801|recurrent ovarian germ cell tumor|recurrent ovarian germ cell tumor
686956|NCT00684801|stage III ovarian epithelial cancer|stage iii ovarian epithelial cancer
686957|NCT00684801|stage III ovarian germ cell tumor|stage iii ovarian germ cell tumor
686958|NCT00684801|stage IV ovarian epithelial cancer|stage iv ovarian epithelial cancer
686959|NCT00684801|stage IV ovarian germ cell tumor|stage iv ovarian germ cell tumor
686960|NCT00684801|recurrent colon cancer|recurrent colon cancer
686961|NCT00684801|stage III colon cancer|stage iii colon cancer
686962|NCT00684801|stage IV colon cancer|stage iv colon cancer
686963|NCT00684801|recurrent rectal cancer|recurrent rectal cancer
686964|NCT00684801|stage III rectal cancer|stage iii rectal cancer
686965|NCT00684801|stage IV rectal cancer|stage iv rectal cancer
686966|NCT00684788|opiate dependence|opiate dependence
686967|NCT00684788|naltrexone|naltrexone
686968|NCT00684788|reinforcement|reinforcement
686969|NCT00684788|behavior therapy|behavior therapy
686970|NCT00684788|cocaine dependence|cocaine dependence
686971|NCT00684788|risk reduction behavior|risk reduction behavior
686972|NCT00684749|Mentor BodyLogic TM System|mentor bodylogic tm system
686973|NCT00684749|Breast augmentation|breast augmentation
686974|NCT00684749|Breast implant choice|breast implant choice
686975|NCT00684749|Reoperation rates|reoperation rates
686976|NCT00684736|septic shock|septic shock
686977|NCT00684736|shock|shock
686978|NCT00684736|serotonin|serotonin
686979|NCT00684736|kynurenine|kynurenine
686980|NCT00684736|tryptophan|tryptophan
686981|NCT00684723|Therapeutic Equivalency|therapeutic equivalency
686982|NCT00684710|Alzheimer Disease|alzheimer disease
686983|NCT00684697|premature infants iron neurodevelopment|premature infants iron neurodevelopment
686984|NCT00684684|Bronchoscopy|bronchoscopy
686985|NCT00684684|Clinically indicated for routine diagnostic bronchoscopy|clinically indicated for routine diagnostic bronchoscopy
686986|NCT00684671|Immune memory|immune memory
686987|NCT00684671|Combined hepatitis A and B vaccine|combined hepatitis a and b vaccine
686988|NCT00684671|> 41 years old|> 41 years old
686989|NCT00684658|Type 1 Diabetes|type 1 diabetes
686990|NCT00684658|Children and Teenagers|children and teenagers
686991|NCT00684658|Coping with Chronic Illness|coping with chronic illness
686992|NCT00684658|Adolescence|adolescence
686993|NCT00684658|Internet psychosocial program|internet psychosocial program
686994|NCT00684658|Coping Skills Training|coping skills training
686995|NCT00684645|Safety and tolerability of SUTENT® in patients with metastatic or advanced renal cell carcinoma after failure of cytokines in real-life setting.|safety and tolerability of sutent® in patients with metastatic or advanced renal cell carcinoma after failure of cytokines in real-life setting.
686996|NCT00684632|Pain, cancer|pain, cancer
686997|NCT00684606|Induction of Labor|induction of labor
686998|NCT00684606|Low Bishop Score|low bishop score
687102|NCT00684073|Suboxone|suboxone
686999|NCT00684606|Transcervical Foley Catheter.|transcervical foley catheter.
687000|NCT00684606|IV Oxytocin|iv oxytocin
687001|NCT00684580|St. Jude Alumni|st. jude alumni
687002|NCT00684580|St. Jude Life Participants|st. jude life participants
687003|NCT00684554|Heroin Dependence|heroin dependence
687004|NCT00684554|Opioid Dependence|opioid dependence
687005|NCT00684554|Primary Care|primary care
687006|NCT00684554|Buprenorphine|buprenorphine
687007|NCT00684541|Social Anxiety|social anxiety
687008|NCT00684541|Information Processing|information processing
687009|NCT00684541|Interpretation|interpretation
687010|NCT00684528|DM 2|dm 2
687011|NCT00684528|Metformin|metformin
687012|NCT00684528|Januvia|januvia
687013|NCT00684528|Community setting|community setting
687014|NCT00684528|newly diagnosed diadetics, or diabetes patients not treated during the last year|newly diagnosed diadetics, or diabetes patients not treated during the last year
687015|NCT00684502|Safety|safety
687016|NCT00684502|tolerability|tolerability
687017|NCT00684502|AZD2066|azd2066
687018|NCT00684502|Pain conditions|pain conditions
687019|NCT00684489|hypertension|hypertension
687020|NCT00684489|renin-guided therapeutics|renin-guided therapeutics
687021|NCT00684463|Antiemetic|antiemetic
687022|NCT00684450|titration of protamine|titration of protamine
687023|NCT00684450|exact dose|exact dose
687024|NCT00684450|protamine|protamine
687025|NCT00684450|neutralize heparin|neutralize heparin
687026|NCT00684437|Health Literacy|health literacy
687027|NCT00684437|Smoking Risk|smoking risk
687028|NCT00684437|Focus Group|focus group
687029|NCT00684437|Questionnaire|questionnaire
687030|NCT00684437|Survey|survey
687031|NCT00684411|T NHL|t nhl
687032|NCT00684411|Gleevec|gleevec
687033|NCT00684411|imatinib mesylate|imatinib mesylate
687034|NCT00684398|Neurofibromatosis Type 1|neurofibromatosis type 1
687035|NCT00684398|Quality of Life|quality of life
687036|NCT00684398|Adaptation|adaptation
687037|NCT00684398|Stress and Coping Model|stress and coping model
687038|NCT00684398|NF1|nf1
687039|NCT00684398|Survey|survey
687040|NCT00684359|Patients having PCI with a drug eluting stent|patients having pci with a drug eluting stent
687041|NCT00684346|18FDG-PET imaging|18fdg-pet imaging
687042|NCT00684346|airway inflammation|airway inflammation
687043|NCT00684346|cystic fibrosis|cystic fibrosis
687044|NCT00684346|pediatric|pediatric
687045|NCT00684346|pulmonary exacerbation|pulmonary exacerbation
687046|NCT00684333|painless Injections|painless injections
687047|NCT00684333|Subcutaneous Injections|subcutaneous injections
687048|NCT00684333|Subcutaneous Injections to healthy volunteers|subcutaneous injections to healthy volunteers
687049|NCT00684320|Social Anxiety Disorder|social anxiety disorder
687050|NCT00684320|Information Processing|information processing
687051|NCT00684320|Attention Bias|attention bias
687052|NCT00684307|Anticoagulant Treatment|anticoagulant treatment
687053|NCT00684307|Risk Factors For Stroke|risk factors for stroke
687054|NCT00684294|cancer|cancer
687055|NCT00684294|oncology|oncology
687056|NCT00684294|solid tumor|solid tumor
687057|NCT00684268|silibinin|silibinin
687058|NCT00684268|chronic hepatitis C|chronic hepatitis c
687059|NCT00684268|peginterferon|peginterferon
687060|NCT00684268|ribavirin|ribavirin
687061|NCT00684268|nonresponders|nonresponders
687062|NCT00684268|efficacy of iv. silibinin|efficacy of iv. silibinin
687063|NCT00684268|safety|safety
687064|NCT00684255|Autoimmune Disease|autoimmune disease
687065|NCT00684255|Reduced Intensity Transplant|reduced intensity transplant
687066|NCT00684242|Advanced Cancer|advanced cancer
687067|NCT00684242|Refractory Cancer Pain|refractory cancer pain
687068|NCT00684242|Lenalidomide|lenalidomide
687069|NCT00684242|Revlimid|revlimid
687070|NCT00684242|CC-5103|cc-5103
687071|NCT00684229|Anesthesia; regional|anesthesia; regional
687072|NCT00684229|Cancer recurrence|cancer recurrence
687073|NCT00684229|Anesthesia; inhalational|anesthesia; inhalational
687074|NCT00684229|Analgesia; opioid|analgesia; opioid
687075|NCT00684216|metastatic|metastatic
687076|NCT00684216|ER positive|er positive
687077|NCT00684216|PD during/after first line hormonal treatment|pd during/after first line hormonal treatment
687078|NCT00684190|Reflux Inhibitor|reflux inhibitor
687079|NCT00684190|GERD|gerd
687080|NCT00684190|PPI Interaction|ppi interaction
687081|NCT00684177|infection|infection
687082|NCT00684177|retapamulin|retapamulin
687083|NCT00684177|secondarily-infected traumatic lesions|secondarily-infected traumatic lesions
687084|NCT00684177|placebo|placebo
687085|NCT00684164|Euvolemic Hyponatremia|euvolemic hyponatremia
687086|NCT00684164|Hypervolemic Hyponatremia|hypervolemic hyponatremia
687087|NCT00684164|Neurological injury|neurological injury
687088|NCT00684151|Lipid-lowering|lipid-lowering
687089|NCT00684138|cataract|cataract
687090|NCT00684138|cataract surgery|cataract surgery
687091|NCT00684138|IOL|iol
687092|NCT00684138|intraocular lens|intraocular lens
687093|NCT00684138|ReSTOR|restor
687094|NCT00684138|Replacement of cataract|replacement of cataract
687095|NCT00684125|late cardiac tamponade|late cardiac tamponade
687096|NCT00684112|pediatrics|pediatrics
687097|NCT00684112|Scoliosis|scoliosis
687098|NCT00684112|Gabapentin|gabapentin
687099|NCT00684099|NSCLC|nsclc
687103|NCT00684073|Subutex|subutex
687104|NCT00684073|Buprenorphine|buprenorphine
687105|NCT00684073|Naloxone|naloxone
687106|NCT00684060|Acute Myocardial Infarction|acute myocardial infarction
687107|NCT00684060|Global Left Ventricular Ejection Fraction|global left ventricular ejection fraction
687108|NCT00684060|Regional Left Ventricular Ejection Fraction|regional left ventricular ejection fraction
687109|NCT00684060|Left Ventricular Mass|left ventricular mass
687110|NCT00684060|Infarct Size|infarct size
687111|NCT00684060|End Systolic Volume|end systolic volume
687112|NCT00684060|End Diastolic Volume|end diastolic volume
687113|NCT00684047|Fibrin Sealant|fibrin sealant
687114|NCT00684047|Hemostasis|hemostasis
687115|NCT00684047|Peripheral Vascular Surgery|peripheral vascular surgery
687116|NCT00684034|Redox state in the course of chronic renal insufficiency and hemodialysis.|redox state in the course of chronic renal insufficiency and hemodialysis.
687117|NCT00684021|Acute Myocardial Infarction|acute myocardial infarction
687118|NCT00684021|Global Left Ventricular Ejection Fraction|global left ventricular ejection fraction
687119|NCT00684021|Regional Left Ventricular Ejection Fraction|regional left ventricular ejection fraction
687120|NCT00684021|Left Ventricular Mass|left ventricular mass
687121|NCT00684021|Infarct Size|infarct size
687122|NCT00684021|End Systolic Volume|end systolic volume
687123|NCT00684021|End Diastolic Volume|end diastolic volume
687124|NCT00684008|interleukin-7|interleukin-7
687125|NCT00684008|immune based therapies|immune based therapies
687126|NCT00684008|graft vs host disease|graft vs host disease
687127|NCT00684008|immune reconstitution|immune reconstitution
687128|NCT00684008|infection|infection
687129|NCT00684008|lymphopenia|lymphopenia
687130|NCT00684008|hematopoetic stem cell transplantation|hematopoetic stem cell transplantation
687131|NCT00684008|bone marrow transplantation|bone marrow transplantation
687132|NCT00684008|peripheral blood stem cell transplant|peripheral blood stem cell transplant
687133|NCT00684008|immunosuppression|immunosuppression
687134|NCT00683995|Pain, Cancer|pain, cancer
687135|NCT00683982|nitazoxanide|nitazoxanide
687136|NCT00683982|Probiotics|probiotics
687137|NCT00683982|Diarrhea|diarrhea
687138|NCT00683982|Rotavirus|rotavirus
687139|NCT00683982|Children|children
687140|NCT00683943|Spinocerebellar Ataxia|spinocerebellar ataxia
687141|NCT00683943|Lithium|lithium
687142|NCT00683917|Uterine fibroids|uterine fibroids
687143|NCT00683917|Fibroids|fibroids
687144|NCT00683891|FOCUS|focus
687145|NCT00683891|Weight gain|weight gain
687146|NCT00683891|Sialorrhea|sialorrhea
687147|NCT00683891|Treatment refractory schizophrenia|treatment refractory schizophrenia
687148|NCT00683891|FazaClo|fazaclo
687149|NCT00683891|Treatment resistant schizophrenia|treatment resistant schizophrenia
687150|NCT00683891|clozapine|clozapine
687151|NCT00683891|Hypersalivation|hypersalivation
687152|NCT00683865|Antibiotic treatment|antibiotic treatment
687153|NCT00683865|Pelvic infection|pelvic infection
687154|NCT00683865|Interventional study|interventional study
687155|NCT00683865|Female|female
687156|NCT00683852|Depression|depression
687157|NCT00683839|Tobacco|tobacco
687158|NCT00683839|Smoking|smoking
687159|NCT00683839|Smokeless|smokeless
687160|NCT00683839|Cessation|cessation
687161|NCT00683839|Public health clinic|public health clinic
687162|NCT00683839|Dental patients|dental patients
687163|NCT00683839|5 As|5 as
687165|NCT00683839|Tobacco Quit Line|tobacco quit line
687166|NCT00683839|Smokeless tobacco|smokeless tobacco
687167|NCT00683826|Leucine|leucine
687168|NCT00683826|Weight Loss|weight loss
687169|NCT00683813|cardiac rehabilitation|cardiac rehabilitation
687170|NCT00683813|telehealth|telehealth
687171|NCT00683813|Internet|internet
687172|NCT00683800|Menopause|menopause
687173|NCT00683800|Hot Flush|hot flush
687174|NCT00683800|Hot Flash|hot flash
687175|NCT00683800|Desvenlafaxine succinate Sustained Release|desvenlafaxine succinate sustained release
687176|NCT00683787|recurrent gastric cancer|recurrent gastric cancer
687177|NCT00683787|stage IV gastric cancer|stage iv gastric cancer
687178|NCT00683787|adenocarcinoma of the stomach|adenocarcinoma of the stomach
687179|NCT00683761|High grade recurrent glioma|high grade recurrent glioma
687180|NCT00683761|Phase 2|phase 2
687181|NCT00683761|Phase 1|phase 1
687182|NCT00683761|Multi-center|multi-center
687183|NCT00683761|Open label|open label
687184|NCT00683761|Multiple dose|multiple dose
687185|NCT00683761|Brain Cancer|brain cancer
687186|NCT00683761|Brain Tumor|brain tumor
687187|NCT00683761|GBM|gbm
687188|NCT00683761|glioma|glioma
687189|NCT00683761|glioblastoma|glioblastoma
687190|NCT00683761|astrocytoma|astrocytoma
687191|NCT00683761|oligodendroglioma|oligodendroglioma
687192|NCT00683761|131I-TM601|131i-tm601
687193|NCT00683761|TM601|tm601
687194|NCT00683748|Transplantation|transplantation
687195|NCT00683748|Immunological monitoring|immunological monitoring
687196|NCT00683748|Immunological risk|immunological risk
687197|NCT00683748|T cell reactivity|t cell reactivity
687198|NCT00683748|Cellular immunity|cellular immunity
687199|NCT00683735|Incretin, DPP-4, metformin, sitagliptin, insulin secretion|incretin, dpp-4, metformin, sitagliptin, insulin secretion
687200|NCT00683722|COPD|copd
687588|NCT00682188|Obesity|obesity
687201|NCT00683722|Airflow Obstruction, Chronic|airflow obstruction, chronic
687202|NCT00683722|Chronic Airflow Obstruction|chronic airflow obstruction
687203|NCT00683722|Chronic Obstructive Airway Disease|chronic obstructive airway disease
687204|NCT00683722|Chronic Obstructive Lung Disease|chronic obstructive lung disease
687205|NCT00683722|Chronic Obstructive Pulmonary Disease|chronic obstructive pulmonary disease
687206|NCT00683722|Pulmonary Emphysema|pulmonary emphysema
687207|NCT00683722|Chronic Bronchitis|chronic bronchitis
687208|NCT00683722|Mesenchymal Stem Cells|mesenchymal stem cells
687209|NCT00683722|MSCs|mscs
687210|NCT00683722|Adult Human Stem Cells|adult human stem cells
687211|NCT00683722|Osiris|osiris
687212|NCT00683722|Prochymal|prochymal
687213|NCT00683709|Bipolar and Schizoaffective Disorder|bipolar and schizoaffective disorder
687214|NCT00683709|Clozapine|clozapine
687215|NCT00683709|Metabolic Side Effects|metabolic side effects
687216|NCT00683709|Diet & Exercise|diet & exercise
687217|NCT00683709|BMI|bmi
687218|NCT00683696|Cardiac Resynchronization Therapy|cardiac resynchronization therapy
687219|NCT00683696|Heart Failure|heart failure
687220|NCT00683696|Ventricular Dyssynchrony|ventricular dyssynchrony
687221|NCT00683696|Mechanical Dyssynchrony|mechanical dyssynchrony
687222|NCT00683696|Intraventricular Dyssynchrony|intraventricular dyssynchrony
687223|NCT00683696|Echocardiography|echocardiography
687224|NCT00683696|Normal QRS|normal qrs
687225|NCT00683696|Heart Disease|heart disease
687226|NCT00683696|EchoCRT|echocrt
687227|NCT00683683|cardiac arrest, hypothermia, knowledge translation|cardiac arrest, hypothermia, knowledge translation
687228|NCT00683644|tinnitus, zinc|tinnitus, zinc
687229|NCT00683631|liver cancer|liver cancer
687230|NCT00683631|liver tumor|liver tumor
687231|NCT00683631|HCC|hcc
687232|NCT00683631|hepatocellular carcinoma|hepatocellular carcinoma
687233|NCT00683631|hepatoma|hepatoma
687234|NCT00683618|HMG-CoA|hmg-coa
687235|NCT00683618|LDL-C|ldl-c
687236|NCT00683618|CHD|chd
687237|NCT00683579|HAART|haart
687238|NCT00683579|DHHS guidelines|dhhs guidelines
687239|NCT00683579|Treatment Naive|treatment naive
687240|NCT00683566|parkinson|parkinson
687241|NCT00683553|Acute Renal Failure|acute renal failure
687242|NCT00683553|Acute Kidney Injury|acute kidney injury
687243|NCT00683540|implementation|implementation
687244|NCT00683540|evaluation|evaluation
687245|NCT00683540|research methodology|research methodology
687246|NCT00683540|intervention|intervention
687247|NCT00683527|Iron supplementation|iron supplementation
687248|NCT00683527|Timing|timing
687249|NCT00683527|Serum ferritin|serum ferritin
687250|NCT00683527|Very low birth weight infants|very low birth weight infants
687251|NCT00683514|Untreated locally advanced inoperable stage IIIA or stage IIIB NSCLC amenable to radical radiotherapy to a dose of 66 Gy|untreated locally advanced inoperable stage iiia or stage iiib nsclc amenable to radical radiotherapy to a dose of 66 gy
687252|NCT00683501|ocular hypertension|ocular hypertension
687253|NCT00683501|elevated IOP|elevated iop
687254|NCT00683501|glaucoma|glaucoma
687255|NCT00683501|neuroprotection|neuroprotection
687256|NCT00683488|Substance Abuse|substance abuse
687257|NCT00683488|Adolescent community reinforcement approach|adolescent community reinforcement approach
687258|NCT00683488|Adolescent Risk Behavior Assessment|adolescent risk behavior assessment
687259|NCT00683488|Child and Adolescent Services Assessment|child and adolescent services assessment
687260|NCT00683488|Cognitive behavioral therapy|cognitive behavioral therapy
687261|NCT00683488|Cognitive Therapy Rating Scale|cognitive therapy rating scale
687262|NCT00683488|Individual behavior therapy|individual behavior therapy
687263|NCT00683488|Individual cognitive problem solving|individual cognitive problem solving
687264|NCT00683488|Motivational enhancement therapy|motivational enhancement therapy
687265|NCT00683488|HIV-Positive Youth With Substance Abuse|hiv-positive youth with substance abuse
687266|NCT00683488|Complementary Therapies|complementary therapies
687267|NCT00683475|Prostate Cancer|prostate cancer
687268|NCT00683449|Asthma|asthma
687269|NCT00683449|Dose-Escalation|dose-escalation
687270|NCT00683449|Controlled|controlled
687271|NCT00683449|MN-221|mn-221
687272|NCT00683436|insomnia|insomnia
687273|NCT00683397|assess|assess
687274|NCT00683397|prevalence|prevalence
687275|NCT00683397|thrombophilia|thrombophilia
687276|NCT00683397|common|common
687277|NCT00683397|VTE|vte
687278|NCT00683397|risk factors|risk factors
687279|NCT00683397|patients|patients
687280|NCT00683384|Arthritis|arthritis
687281|NCT00683384|psoriatic|psoriatic
687282|NCT00683371|Chronic Rhinosinusitis|chronic rhinosinusitis
687283|NCT00683371|Sinus Disease|sinus disease
687284|NCT00683371|Allergy|allergy
687285|NCT00683371|Maxillary Sinus|maxillary sinus
687286|NCT00683371|Microarray|microarray
687287|NCT00683358|cancer|cancer
687288|NCT00683358|pancreas|pancreas
687289|NCT00683358|advanced|advanced
687290|NCT00683358|peptide|peptide
687291|NCT00683358|vaccination|vaccination
687292|NCT00683358|VEGFR1|vegfr1
687293|NCT00683358|HLA|hla
687294|NCT00683358|gemcitabine|gemcitabine
687295|NCT00683358|IFA|ifa
687296|NCT00683358|Cancer of Pancreas|cancer of pancreas
687297|NCT00683358|Neoplasms, Pancreatic|neoplasms, pancreatic
687298|NCT00683358|Pancreas Cancer|pancreas cancer
687299|NCT00683332|Observational study|observational study
687300|NCT00683332|Tigecycline|tigecycline
687301|NCT00683332|infection|infection
687302|NCT00683332|skin|skin
687303|NCT00683332|abdominal|abdominal
687304|NCT00683319|long-term effects secondary to cancer therapy in children|long-term effects secondary to cancer therapy in children
687305|NCT00683319|cognitive/functional effects|cognitive/functional effects
687306|NCT00683319|ototoxicity|ototoxicity
687307|NCT00683319|childhood infratentorial ependymoma|childhood infratentorial ependymoma
687308|NCT00683319|childhood supratentorial ependymoma|childhood supratentorial ependymoma
687309|NCT00683293|Laparoscopic Hysterectomy|laparoscopic hysterectomy
687310|NCT00683293|Robot-assisted Laparoscopic Hysterectomy|robot-assisted laparoscopic hysterectomy
687311|NCT00683293|Robot-assisted Surgery|robot-assisted surgery
687312|NCT00683280|Contingency Management|contingency management
687313|NCT00683280|Cigarette Smoking Cessation|cigarette smoking cessation
687314|NCT00683280|varenicline|varenicline
687315|NCT00683267|THA, Total hip arthroplasty, total hip replacement|tha, total hip arthroplasty, total hip replacement
687316|NCT00683254|nasal obstruction|nasal obstruction
687317|NCT00683254|nasal stent|nasal stent
687318|NCT00683241|Vaccine|vaccine
687319|NCT00683241|Ovarian|ovarian
687320|NCT00683241|Peritoneal|peritoneal
687321|NCT00683228|Second hand Smoke|second hand smoke
687322|NCT00683202|Assisted reproduction|assisted reproduction
687323|NCT00683202|Ovarian response|ovarian response
687324|NCT00683202|Uteroplacental hemodynamics|uteroplacental hemodynamics
687325|NCT00683202|Doppler ultrasonography|doppler ultrasonography
687326|NCT00683202|Implantation rate|implantation rate
687327|NCT00683202|Pregnancy rate|pregnancy rate
687328|NCT00683202|Live birth rate|live birth rate
687329|NCT00683189|MLD|mld
687330|NCT00683176|Diabetic Macular Edema|diabetic macular edema
687331|NCT00683176|OCT|oct
687332|NCT00683163|Combination of PTH and ibandronate|combination of pth and ibandronate
687333|NCT00683163|Bone marker formation|bone marker formation
687334|NCT00683163|Postmenopausal|postmenopausal
687335|NCT00683163|Trabecular spine BMD|trabecular spine bmd
687336|NCT00683150|Endothelial Function|endothelial function
687337|NCT00683150|Abdominal Surgery|abdominal surgery
687338|NCT00683150|Thoracic Surgery|thoracic surgery
687339|NCT00683150|Vendy's-DTM Machine|vendy's-dtm machine
687340|NCT00683150|Digital Thermal Monitoring|digital thermal monitoring
687341|NCT00683150|DTM|dtm
687342|NCT00683124|Marfan Syndrome|marfan syndrome
687343|NCT00683124|Losartan|losartan
687344|NCT00683124|Nebivolol|nebivolol
687345|NCT00683124|Transforming Growth Factor Beta|transforming growth factor beta
687346|NCT00683124|Aortic Root Dilation|aortic root dilation
687347|NCT00683111|acute coronary syndrome|acute coronary syndrome
687348|NCT00683111|acute myocardial infarction|acute myocardial infarction
687349|NCT00683111|aspirin|aspirin
687350|NCT00683111|clopidogrel|clopidogrel
687351|NCT00683111|heparin|heparin
687352|NCT00683111|thrombolytic|thrombolytic
687353|NCT00683111|famotidine|famotidine
687354|NCT00683111|esomeprazole|esomeprazole
687355|NCT00683098|recurrent hernia|recurrent hernia
687356|NCT00683098|endoscopic total extraperitoneal repair|endoscopic total extraperitoneal repair
687357|NCT00683098|inguinal pain|inguinal pain
687358|NCT00683098|questionnaire|questionnaire
687359|NCT00683085|cancer|cancer
687360|NCT00683085|pancreas|pancreas
687361|NCT00683085|advanced|advanced
687362|NCT00683085|peptide|peptide
687363|NCT00683085|vaccination|vaccination
687364|NCT00683085|VEGFR1|vegfr1
687365|NCT00683085|HLA|hla
687366|NCT00683085|gemcitabine|gemcitabine
687367|NCT00683085|IFA|ifa
687368|NCT00683085|Cancer of Pancreas|cancer of pancreas
687369|NCT00683085|Neoplasms, Pancreas|neoplasms, pancreas
687370|NCT00683085|Pancreas Cancer|pancreas cancer
687371|NCT00683072|Ventilator|ventilator
687372|NCT00683072|patient-ventilator asynchrony|patient-ventilator asynchrony
687373|NCT00683046|Relapsed or refractory acute myelogenous or lymphoid leukemia.|relapsed or refractory acute myelogenous or lymphoid leukemia.
687374|NCT00683046|Acute myeloid or lymphocytic leukemia in first remission at high-risk for recurrence.Chronic myelogenous leukemia in accelerated phase or blast-crisis.|acute myeloid or lymphocytic leukemia in first remission at high-risk for recurrence.chronic myelogenous leukemia in accelerated phase or blast-crisis.
687375|NCT00683046|Chronic myelogenous leukemia in chronic phase|chronic myelogenous leukemia in chronic phase
687376|NCT00683046|Chronic myelogenous leukemia in accelerated phase or blast-crisis|chronic myelogenous leukemia in accelerated phase or blast-crisis
687377|NCT00683046|Recurrent or refractory malignant lymphoma or Hodgkin's disease.|recurrent or refractory malignant lymphoma or hodgkin's disease.
687378|NCT00683046|Chronic lymphocytic leukemia, relapsed or with poor prognostic features.|chronic lymphocytic leukemia, relapsed or with poor prognostic features.
687379|NCT00683046|Myeloproliferative disorder (polycythemia vera, myelofibrosis) with poor prognostic features.|myeloproliferative disorder (polycythemia vera, myelofibrosis) with poor prognostic features.
687506|NCT00682513|RDP|rdp
687380|NCT00683046|Severe aplastic anemia after failure of immunosuppressive therapy.|severe aplastic anemia after failure of immunosuppressive therapy.
687381|NCT00683046|Myelodysplastic syndromes (including PNH)|myelodysplastic syndromes (including pnh)
687382|NCT00683046|Multiple myeloma at high risk for disease recurrence.|multiple myeloma at high risk for disease recurrence.
687383|NCT00683033|Contingency Management|contingency management
687384|NCT00683033|Cigarette Smoking Cessation|cigarette smoking cessation
687385|NCT00683033|Substance Abusers|substance abusers
687386|NCT00683020|Chronic Diseases|chronic diseases
687387|NCT00683020|Diabetes|diabetes
687388|NCT00683020|Vulnerable population|vulnerable population
687389|NCT00683020|Urban populations|urban populations
687390|NCT00683020|Disease Management|disease management
687391|NCT00683020|Health Information Technology|health information technology
687392|NCT00683020|Safety|safety
687393|NCT00683020|Health Literacy|health literacy
687394|NCT00683020|Level of English Proficiency|level of english proficiency
687395|NCT00683007|TE echo|te echo
687396|NCT00683007|hemodilution|hemodilution
687397|NCT00683007|hypertonic|hypertonic
687398|NCT00683007|saline|saline
687399|NCT00683007|Arterial Pressure Cardiac Output|arterial pressure cardiac output
687400|NCT00682994|Advanced Cancer|advanced cancer
687401|NCT00682994|Family Member|family member
687402|NCT00682994|Palliative Care|palliative care
687403|NCT00682994|Decision Making|decision making
687404|NCT00682994|Information Disclosure|information disclosure
687405|NCT00682994|Interview|interview
687406|NCT00682994|Survey|survey
687407|NCT00682994|Questionnaire|questionnaire
687408|NCT00682981|ES-SCLC|es-sclc
687409|NCT00682981|Obatoclax|obatoclax
687410|NCT00682968|patient non-adherence|patient non-adherence
687411|NCT00682968|antihypertensive agents|antihypertensive agents
687412|NCT00682968|hypertension|hypertension
687413|NCT00682955|Diarrhea|diarrhea
687414|NCT00682955|Zinc Sulphate|zinc sulphate
687415|NCT00682955|Efficacy|efficacy
687416|NCT00682929|cannabis|cannabis
687417|NCT00682929|marijuana|marijuana
687418|NCT00682929|Multiple Sclerosis|multiple sclerosis
687419|NCT00682929|spasticity|spasticity
687420|NCT00682916|Obesity|obesity
687421|NCT00682916|Diabetes|diabetes
687422|NCT00682916|Soluble Fiber|soluble fiber
687423|NCT00682916|Overweight|overweight
687424|NCT00682903|glucose|glucose
687425|NCT00682903|diabetes|diabetes
687426|NCT00682903|glycemia|glycemia
687427|NCT00682877|gastroparesis|gastroparesis
687428|NCT00682877|Digestive|digestive
687429|NCT00682877|Gastrointestinal|gastrointestinal
687430|NCT00682877|Stomach|stomach
687431|NCT00682877|Motility|motility
687432|NCT00682877|Non-Invasive|non-invasive
687433|NCT00682877|Capsule|capsule
687434|NCT00682877|GI|gi
687435|NCT00682877|Device|device
687436|NCT00682877|Digestive System Diseases|digestive system diseases
687437|NCT00682838|Treatment compliance|treatment compliance
687438|NCT00682838|Self-management|self-management
687439|NCT00682838|Telemedicine|telemedicine
687440|NCT00682825|Anesthesia|anesthesia
687441|NCT00682825|Awareness|awareness
687442|NCT00682825|Bispectral|bispectral
687443|NCT00682825|BIS|bis
687444|NCT00682825|Recall|recall
687445|NCT00682799|RC|rc
687446|NCT00682799|RIC|ric
687447|NCT00682799|MDS|mds
687448|NCT00682799|SCT|sct
687449|NCT00682786|rectal|rectal
687450|NCT00682786|rectum|rectum
687451|NCT00682786|cancer|cancer
687452|NCT00682786|carcinoma|carcinoma
687453|NCT00682760|Botulinum Toxin Type A|botulinum toxin type a
687454|NCT00682760|Blepharospasm|blepharospasm
687455|NCT00682747|xerostomia|xerostomia
687456|NCT00682747|hyperbaric oxygenation|hyperbaric oxygenation
687457|NCT00682747|radiotherapy|radiotherapy
687458|NCT00682721|Bacterial Vaginosis|bacterial vaginosis
687459|NCT00682721|Herpes Simplex Virus Type II|herpes simplex virus type ii
687460|NCT00682708|malnutrition|malnutrition
687461|NCT00682708|ready to use food|ready to use food
687462|NCT00682708|Niger|niger
687463|NCT00682695|stroke|stroke
687464|NCT00682695|brain attack|brain attack
687465|NCT00682695|hemorrhagic stroke|hemorrhagic stroke
687466|NCT00682695|risk factors|risk factors
687467|NCT00682682|Pain distraction|pain distraction
687468|NCT00682682|Analgesic interventions|analgesic interventions
687469|NCT00682682|Burn patients|burn patients
687470|NCT00682669|Asthma|asthma
687471|NCT00682669|Mindfulness-based stress reduction|mindfulness-based stress reduction
687472|NCT00682669|Peak expiratory flow rate|peak expiratory flow rate
687473|NCT00682669|Spirometry|spirometry
687474|NCT00682669|Quality of life|quality of life
687475|NCT00682656|cutaneous leishmaniasis|cutaneous leishmaniasis
687476|NCT00682656|azithromycin|azithromycin
687477|NCT00682656|N- methyl glucamine|n- methyl glucamine
687478|NCT00682643|Perennial Allergic Rhinitis|perennial allergic rhinitis
687479|NCT00682643|fluticasone furoate|fluticasone furoate
687480|NCT00682643|ocular safety|ocular safety
687481|NCT00682630|Malaria|malaria
687482|NCT00682630|anti-malarial|anti-malarial
687483|NCT00682630|pyronaridine|pyronaridine
687484|NCT00682630|ACT|act
687485|NCT00682617|hip|hip
687486|NCT00682617|osteoarthritis|osteoarthritis
687487|NCT00682617|exercise|exercise
687488|NCT00682617|disability|disability
687489|NCT00682617|physical function|physical function
687490|NCT00682604|Family Health Program; Food consumption; Nutritional status|family health program; food consumption; nutritional status
687491|NCT00682591|hepatitis C|hepatitis c
687492|NCT00682591|drug substitution|drug substitution
687493|NCT00682591|neurocognitive|neurocognitive
687494|NCT00682591|patients with stable drug substitution therapy|patients with stable drug substitution therapy
687495|NCT00682591|patients with interferon-based antiviral therapy|patients with interferon-based antiviral therapy
687496|NCT00682578|falciparum malaria|falciparum malaria
687497|NCT00682578|vivax malaria|vivax malaria
687498|NCT00682578|dihydroartemisinin-piperaquine|dihydroartemisinin-piperaquine
687499|NCT00682539|diabetic retinopathy|diabetic retinopathy
687500|NCT00682539|macular edema|macular edema
687501|NCT00682539|intravitreal Avastin/ Triamcinolone / Lucentis|intravitreal avastin/ triamcinolone / lucentis
687502|NCT00682526|EMS patients with intention to treat with coronary reperfusion therapy (PCI or thrombolytics) based on their initial presentation|ems patients with intention to treat with coronary reperfusion therapy (pci or thrombolytics) based on their initial presentation
687503|NCT00682513|dystonia|dystonia
687504|NCT00682513|parkinsonism|parkinsonism
687505|NCT00682513|rapid-onset dystonia-parkinsonism|rapid-onset dystonia-parkinsonism
687507|NCT00682513|Alternating Hemiplegia of Childhood|alternating hemiplegia of childhood
687508|NCT00682513|AHC|ahc
687509|NCT00682500|Pneumonia|pneumonia
687510|NCT00682500|Aspiration|aspiration
687511|NCT00682500|Drowning|drowning
687512|NCT00682500|inhalation|inhalation
687513|NCT00682487|Myocardial infarction|myocardial infarction
687514|NCT00682487|Stress|stress
687515|NCT00682487|Hair Cortisol|hair cortisol
687516|NCT00682474|Cigarette smoking|cigarette smoking
687517|NCT00682474|Nicotine dependence|nicotine dependence
687518|NCT00682474|Adolescents|adolescents
687519|NCT00682474|Youth|youth
687520|NCT00682474|School health|school health
687521|NCT00682474|Randomized controlled trial|randomized controlled trial
687522|NCT00682461|Nicotine Tolerability NRT|nicotine tolerability nrt
687523|NCT00682448|Olanzapine|olanzapine
687524|NCT00682448|Zyprexa|zyprexa
687525|NCT00682448|Weight Gain|weight gain
687526|NCT00682448|Antipsychotics|antipsychotics
687527|NCT00682448|Metformin|metformin
687528|NCT00682448|Glucophage|glucophage
687529|NCT00682448|Bipolar Disorder|bipolar disorder
687530|NCT00682448|Schizophrenia|schizophrenia
687531|NCT00682448|Depression|depression
687532|NCT00682448|Diabetes|diabetes
687533|NCT00682448|Side effects|side effects
687534|NCT00682448|Metabolic complications|metabolic complications
687535|NCT00682448|Prevention|prevention
687536|NCT00682448|Treatment|treatment
687537|NCT00682448|Metabolic side effects of olanzapine|metabolic side effects of olanzapine
687538|NCT00682435|Nonelderly patients with acute moderate to severe pain|nonelderly patients with acute moderate to severe pain
687539|NCT00682422|pediatrics, overweight, obese, behavioral intervention|pediatrics, overweight, obese, behavioral intervention
687540|NCT00682383|Advanced NSCLC|advanced nsclc
687541|NCT00682383|Lung Cancer|lung cancer
687542|NCT00682383|Mount Sinai Medical Center CCOP|mount sinai medical center ccop
687543|NCT00682357|Osteoarthritis, intra articular steroids|osteoarthritis, intra articular steroids
687544|NCT00682318|Fish oil|fish oil
687545|NCT00682318|red wine|red wine
687546|NCT00682318|alcohol|alcohol
687547|NCT00682318|oxidative stress|oxidative stress
687548|NCT00682318|Healthy volunteers|healthy volunteers
687549|NCT00682305|Acute Lymphoblastic Leukemia|acute lymphoblastic leukemia
687550|NCT00682305|Hematopoeitic Stem Cell Transplantation|hematopoeitic stem cell transplantation
687551|NCT00682292|Renal transplantation|renal transplantation
687552|NCT00682292|Immunisation|immunisation
687553|NCT00682292|Acute rejection|acute rejection
687554|NCT00682292|Induction therapy|induction therapy
687555|NCT00682292|Thymoglobulin|thymoglobulin
687556|NCT00682292|Daclizumab|daclizumab
687557|NCT00682292|Rejection in sensitized renal transplant recipients|rejection in sensitized renal transplant recipients
687558|NCT00682279|lapatinib|lapatinib
687559|NCT00682279|GW572016|gw572016
687560|NCT00682279|topotecan|topotecan
687561|NCT00682279|oral topotecan|oral topotecan
687562|NCT00682279|SK&F-104864|sk&f-104864
687563|NCT00682279|EGFR|egfr
687564|NCT00682279|ErbB1|erbb1
687565|NCT00682279|HER-2/neu|her-2/neu
687566|NCT00682279|ErbB2|erbb2
687567|NCT00682279|BCRP|bcrp
687568|NCT00682266|Adolescent|adolescent
687569|NCT00682266|Overweight|overweight
687570|NCT00682266|Exercise|exercise
687571|NCT00682266|multidisciplinary approach|multidisciplinary approach
687572|NCT00682266|Oxygen uptake|oxygen uptake
687573|NCT00682266|Flow mediated dilatation|flow mediated dilatation
687574|NCT00682266|Cardiovascular Risk Factors|cardiovascular risk factors
687575|NCT00682253|SPECT/CT|spect/ct
687576|NCT00682253|MRI|mri
687577|NCT00682253|Breast neoplasms|breast neoplasms
687578|NCT00682240|retinal morphology|retinal morphology
687579|NCT00682240|laser treatment|laser treatment
687580|NCT00682240|pascal laser|pascal laser
687581|NCT00682240|HD-OCT|hd-oct
687582|NCT00682227|Epitope peptide, CTL, Esophageal cancer, Vaccination|epitope peptide, ctl, esophageal cancer, vaccination
687583|NCT00682214|25(OH)D, muscle strength|25(oh)d, muscle strength
687584|NCT00682201|Pregnancy|pregnancy
687585|NCT00682201|Blood pressure|blood pressure
687586|NCT00682201|Cardiac output|cardiac output
687587|NCT00682188|Overweight|overweight
687589|NCT00682188|Adolescents|adolescents
687590|NCT00682188|Youth|youth
687591|NCT00682188|School health|school health
687592|NCT00682188|Randomized controlled trial|randomized controlled trial
687593|NCT00682188|Intervention study|intervention study
687594|NCT00682175|Congestive Heart Failure|congestive heart failure
687595|NCT00682162|acupuncture|acupuncture
687596|NCT00682162|randomised controlled trial|randomised controlled trial
687597|NCT00682162|placebo|placebo
687598|NCT00682162|sham laser|sham laser
687599|NCT00682162|vasomotor rhinitis|vasomotor rhinitis
687600|NCT00682149|Oxidative stress|oxidative stress
687601|NCT00682149|malondialdehyde|malondialdehyde
687602|NCT00682149|glutathione|glutathione
687603|NCT00682149|diabetes|diabetes
687604|NCT00682149|polyphenol containing antioxidants|polyphenol containing antioxidants
687605|NCT00682149|diet rich in vegetables|diet rich in vegetables
687606|NCT00682149|weekly aerobic exercise|weekly aerobic exercise
687607|NCT00682136|postoperative analgesia|postoperative analgesia
687608|NCT00682136|abdominal surgery|abdominal surgery
687609|NCT00682136|ropivacaine|ropivacaine
687610|NCT00682136|local anaesthesia|local anaesthesia
687611|NCT00682136|tap block|tap block
687612|NCT00682136|pain management|pain management
687613|NCT00682123|19-norandrostenedione|19-norandrostenedione
687614|NCT00682123|steroids|steroids
687615|NCT00682123|drugs in sport|drugs in sport
687616|NCT00682123|World Anti-Doping Agency|world anti-doping agency
687617|NCT00682110|End-stage liver disease|end-stage liver disease
687618|NCT00682110|Hemodynamic measurements|hemodynamic measurements
687619|NCT00682110|Hyperdynamic circulation|hyperdynamic circulation
687620|NCT00682110|Pulmonary artery catheter|pulmonary artery catheter
687621|NCT00682110|Cardiac output|cardiac output
687622|NCT00682084|Cushing's syndrome|cushing's syndrome
687623|NCT00682084|Glucose tolerance|glucose tolerance
687624|NCT00682084|Insulin sensitivity|insulin sensitivity
687625|NCT00682084|Substrate metabolism|substrate metabolism
687626|NCT00682084|Body composition|body composition
687627|NCT00682071|Ultrasound-guided|ultrasound-guided
687628|NCT00682071|embryo transfer|embryo transfer
687629|NCT00682071|in-vitro fertilization|in-vitro fertilization
687630|NCT00682058|body composition|body composition
687631|NCT00682058|weight loss|weight loss
687633|NCT00682058|fat distribution|fat distribution
687634|NCT00682058|fat free mass|fat free mass
687635|NCT00682058|organ|organ
687636|NCT00682058|resting energy expenditure|resting energy expenditure
687637|NCT00682045|tuberculosis|tuberculosis
687638|NCT00682045|transplantation|transplantation
687639|NCT00682032|NSCLC|nsclc
687640|NCT00682019|Erectile Dysfunction|erectile dysfunction
687641|NCT00682019|Vardenafil|vardenafil
687642|NCT00682006|Omphalitis|omphalitis
687643|NCT00682006|4% Chlorhexidine|4% chlorhexidine
687644|NCT00682006|Newborns|newborns
687645|NCT00681993|cosmetic|cosmetic
687646|NCT00681993|effect|effect
687647|NCT00681993|breast|breast
687648|NCT00681993|irradiation|irradiation
687649|NCT00681993|concurrent|concurrent
687650|NCT00681993|chemotherapy|chemotherapy
687651|NCT00681993|potential acute|potential acute
687652|NCT00681993|late skin|late skin
687653|NCT00681993|subcutaneous toxicities|subcutaneous toxicities
687654|NCT00681980|TSP/HAM, HTLV-1, treatment|tsp/ham, htlv-1, treatment
687655|NCT00681967|squamous cell cancer of the head & neck|squamous cell cancer of the head & neck
687656|NCT00681967|Gefitinib|gefitinib
687657|NCT00681967|IRESSA|iressa
687658|NCT00681967|EGFR Inhibitor|egfr inhibitor
687659|NCT00681967|EGFR-tyrosine kinase inhibitor|egfr-tyrosine kinase inhibitor
687660|NCT00681967|Subjects with histologically proven squamous cell cancer of the head & neck|subjects with histologically proven squamous cell cancer of the head & neck
687661|NCT00681967|Cohort 1:qualifying for postoperative radiotherapy|cohort 1:qualifying for postoperative radiotherapy
687662|NCT00681967|(pT3, pT4, pN2b, pN2c, pN3).|(pt3, pt4, pn2b, pn2c, pn3).
687663|NCT00681967|Cohort 2:qualifying for definite chemoradiotherapy|cohort 2:qualifying for definite chemoradiotherapy
687664|NCT00681967|(Lateral oropharynx, tonsils: T1N2b-3, T2N1-3, T3any N;|(lateral oropharynx, tonsils: t1n2b-3, t2n1-3, t3any n;
687665|NCT00681967|Base of tongue, vallecula: T1N1-3, T2-4 any N; Oral cavity,|base of tongue, vallecula: t1n1-3, t2-4 any n; oral cavity,
687666|NCT00681967|glottic and supraglottic larynx; Any TN1-3, T3-4 any N;|glottic and supraglottic larynx; any tn1-3, t3-4 any n;
687667|NCT00681967|Hypopharynx: T1N1-3, T2-4 and N)|hypopharynx: t1n1-3, t2-4 and n)
687668|NCT00681954|TRALI|trali
687669|NCT00681954|Randomized Autologous Transfusion|randomized autologous transfusion
687670|NCT00681954|Intra-Operative Testing of Pulmonary Function|intra-operative testing of pulmonary function
687671|NCT00681928|stage I breast cancer|stage i breast cancer
687672|NCT00681928|stage II breast cancer|stage ii breast cancer
687673|NCT00681928|stage IIIA breast cancer|stage iiia breast cancer
687674|NCT00681928|stage IIIB breast cancer|stage iiib breast cancer
687675|NCT00681928|stage IIIC breast cancer|stage iiic breast cancer
687676|NCT00681915|Phase I|phase i
687677|NCT00681915|Pharmacokinetics|pharmacokinetics
687678|NCT00681902|Pediatric|pediatric
687679|NCT00681902|Pain|pain
687680|NCT00681902|Needle|needle
687681|NCT00681902|Emergency|emergency
687682|NCT00681902|Phlebotomy|phlebotomy
687683|NCT00681902|Intravenous|intravenous
687684|NCT00681902|Lidocaine|lidocaine
687685|NCT00681902|Local|local
687686|NCT00681902|Anesthesia|anesthesia
687687|NCT00681876|Metastatic colorectal cancer|metastatic colorectal cancer
687688|NCT00681876|Second line|second line
687689|NCT00681876|Irinotecan|irinotecan
687690|NCT00681876|Erbitux (Cetuximab)|erbitux (cetuximab)
687691|NCT00681876|Avastin (Bevacizumab)|avastin (bevacizumab)
687692|NCT00681850|Diabetes|diabetes
687693|NCT00681850|Benchmarking|benchmarking
687694|NCT00681850|quality of patient care|quality of patient care
687695|NCT00681850|Diabetic Population|diabetic population
687696|NCT00681837|gastroesophageal reflux|gastroesophageal reflux
687697|NCT00681837|prevalence|prevalence
687698|NCT00681837|childhood|childhood
687699|NCT00681837|France|france
687700|NCT00681811|Metazyme|metazyme
687701|NCT00681811|Late Infantile Metachromatic Leukodystrophy|late infantile metachromatic leukodystrophy
687702|NCT00681798|pancreatic cancer|pancreatic cancer
687703|NCT00681798|pancreatic adenocarcinoma|pancreatic adenocarcinoma
687704|NCT00681798|pancreas cancer|pancreas cancer
687705|NCT00681798|dose escalation study|dose escalation study
687706|NCT00681798|locally advanced unresectable pancreatic adenocarcinoma|locally advanced unresectable pancreatic adenocarcinoma
687707|NCT00681798|Zactima|zactima
687708|NCT00681798|Vandetanib|vandetanib
687709|NCT00681798|ZD6474|zd6474
687710|NCT00681785|thrombophylaxis and transurethral surgery|thrombophylaxis and transurethral surgery
687711|NCT00681772|Erectile Dysfunction|erectile dysfunction
687712|NCT00681772|Vardenafil|vardenafil
687713|NCT00681759|Low Dose Aspirin (LDA)|low dose aspirin (lda)
687714|NCT00681759|Cardiovascular disease|cardiovascular disease
687715|NCT00681759|Low Dose Aspirin (LDA) use in in subjects with cardiovascular risk or disease|low dose aspirin (lda) use in in subjects with cardiovascular risk or disease
687716|NCT00681746|Anxiety|anxiety
687717|NCT00681746|GABA receptors|gaba receptors
687718|NCT00681746|Positron Emission Tomography|positron emission tomography
687719|NCT00681746|PET|pet
687720|NCT00681746|phase I|phase i
687721|NCT00681733|NASH Pentoxifylline Pioglitazone|nash pentoxifylline pioglitazone
687722|NCT00681720|Anxiety|anxiety
687723|NCT00681720|GABA receptors|gaba receptors
687724|NCT00681720|Positron Emission Tomography|positron emission tomography
687725|NCT00681720|PET|pet
687726|NCT00681720|phase I|phase i
687727|NCT00681707|Hypertension|hypertension
687728|NCT00681707|Post stroke|post stroke
687729|NCT00681707|JNC7|jnc7
687730|NCT00681707|2007 ESH-ESC guidelines|2007 esh-esc guidelines
687731|NCT00681707|survey|survey
687732|NCT00681694|brachytherapy|brachytherapy
687733|NCT00681694|radioactive seed implants|radioactive seed implants
687734|NCT00681681|stroke|stroke
687735|NCT00681681|vascular marker|vascular marker
687736|NCT00681681|stroke risk|stroke risk
687737|NCT00681681|risk factors|risk factors
687738|NCT00681681|sex differences|sex differences
687739|NCT00681668|Postpartum Depression|postpartum depression
687740|NCT00681668|Quetiapine|quetiapine
687741|NCT00681668|Psychotic Symptoms|psychotic symptoms
687742|NCT00681642|Corneal epithelial wound|corneal epithelial wound
687743|NCT00681642|Human autoserum|human autoserum
687744|NCT00681642|Cord blood|cord blood
687745|NCT00681629|Schizophrenia|schizophrenia
687746|NCT00681629|Integrated Care|integrated care
687747|NCT00681629|Quetiapine|quetiapine
687748|NCT00681616|Anterior compartment syndrome|anterior compartment syndrome
687749|NCT00681616|Tibia|tibia
687750|NCT00681616|Trauma|trauma
687751|NCT00681616|Blood circulation|blood circulation
687752|NCT00681616|Nerve compression syndromes|nerve compression syndromes
687753|NCT00681603|corneal neovascularization|corneal neovascularization
687754|NCT00681603|lipid keratopathy|lipid keratopathy
687755|NCT00681603|penetrating keratopathy|penetrating keratopathy
687756|NCT00681603|bevacizumab|bevacizumab
687757|NCT00681603|Avastin|avastin
687758|NCT00681603|subconjunctival injection|subconjunctival injection
687759|NCT00681590|vitamin D|vitamin d
687760|NCT00681590|deficiency|deficiency
687761|NCT00681590|elderly|elderly
687762|NCT00681577|Peptide Vaccine|peptide vaccine
687763|NCT00681577|URLC10|urlc10
687764|NCT00681577|KOC1|koc1
687765|NCT00681577|VEGFR1|vegfr1
687766|NCT00681577|VEGFR2|vegfr2
687767|NCT00681564|Periodontitis|periodontitis
687768|NCT00681564|Oral health|oral health
687769|NCT00681564|Cardiovascular disease|cardiovascular disease
687770|NCT00681551|Detection of brain metastasis by MRI|detection of brain metastasis by mri
687771|NCT00681551|Magnevist|magnevist
687772|NCT00681551|Brain metastasis|brain metastasis
687773|NCT00681551|Meglumine gadopentetate|meglumine gadopentetate
687774|NCT00681538|Spasticity|spasticity
687775|NCT00681538|Multiple Sclerosis|multiple sclerosis
687776|NCT00681512|NSCLC|nsclc
687777|NCT00681512|lung cancer|lung cancer
687778|NCT00681512|non small cell lung cancer|non small cell lung cancer
687779|NCT00681512|lung carcinoma|lung carcinoma
687780|NCT00681499|Quality of Life|quality of life
687781|NCT00681499|Liver Neoplasms|liver neoplasms
687782|NCT00681499|Surgical procedures, Operative|surgical procedures, operative
687783|NCT00681486|Ghrelin|ghrelin
687784|NCT00681486|Nutrition|nutrition
687785|NCT00681486|Cancer patients|cancer patients
687786|NCT00681486|Survival|survival
687787|NCT00681473|proton radiation therapy|proton radiation therapy
687788|NCT00681473|photon radiation therapy|photon radiation therapy
687789|NCT00681460|gestational diabetes|gestational diabetes
687790|NCT00681460|birth weight|birth weight
687791|NCT00681460|fetal growth|fetal growth
687792|NCT00681460|insulin resistance|insulin resistance
687793|NCT00681460|oxidative stress|oxidative stress
687794|NCT00681460|inflammatory reaction|inflammatory reaction
687795|NCT00681460|Fetal Development|fetal development
687796|NCT00681447|lumbar disc herniation|lumbar disc herniation
687797|NCT00681447|discogenic pain|discogenic pain
687798|NCT00681447|lumbar interlaminar epidural|lumbar interlaminar epidural
687799|NCT00681447|injections|injections
687800|NCT00681434|stroke|stroke
687801|NCT00681434|upper extremity|upper extremity
687802|NCT00681434|hemiparesis|hemiparesis
687803|NCT00681421|Peptide Vaccine|peptide vaccine
687804|NCT00681421|URLC10|urlc10
687805|NCT00681421|VEGFR1|vegfr1
687806|NCT00681421|VEGFR2|vegfr2
687807|NCT00681408|Steatohepatitis|steatohepatitis
687808|NCT00681408|NASH|nash
687809|NCT00681408|NAFLD|nafld
687810|NCT00681408|omega 3 fatty acids|omega 3 fatty acids
687811|NCT00681408|Exercise conditioning|exercise conditioning
687812|NCT00681382|Asthma|asthma
687813|NCT00681382|use of asthma medication|use of asthma medication
687814|NCT00681382|asthma control|asthma control
687815|NCT00681382|telephone survey|telephone survey
687816|NCT00681382|patient's perception|patient's perception
687817|NCT00681369|breast cancer|breast cancer
687818|NCT00681369|fulvestrant|fulvestrant
687819|NCT00681369|longitudinal study|longitudinal study
687820|NCT00681369|France|france
687821|NCT00681356|TKA|tka
687822|NCT00681356|Total knee arthroplasty|total knee arthroplasty
687823|NCT00681356|Total knee replacement|total knee replacement
687824|NCT00681356|Knee surgery|knee surgery
687825|NCT00681343|Randomized|randomized
687826|NCT00681343|study|study
687827|NCT00681343|effectiveness/toxicity|effectiveness/toxicity
687828|NCT00681343|induction therapy|induction therapy
687829|NCT00681343|recipients|recipients
687830|NCT00681330|Peptide Vaccine|peptide vaccine
687831|NCT00681330|URLC10|urlc10
687832|NCT00681330|TTK|ttk
687833|NCT00681330|KOC1|koc1
687834|NCT00681317|Phase I|phase i
687835|NCT00681317|Pharmacokinetics|pharmacokinetics
687836|NCT00681304|Resected Breast Cancer|resected breast cancer
687837|NCT00681304|Breast Cancer|breast cancer
687838|NCT00681291|surgical mesh|surgical mesh
687839|NCT00681291|inguinal hernia repair|inguinal hernia repair
687840|NCT00681291|chronic groin pain|chronic groin pain
687841|NCT00681278|Hypertension|hypertension
687842|NCT00681278|Type II DM|type ii dm
687843|NCT00681278|JNC7|jnc7
687844|NCT00681278|2007 ESH-ESC guidelines|2007 esh-esc guidelines
687845|NCT00681278|survey|survey
687846|NCT00681265|ocular lubricants|ocular lubricants
687847|NCT00681252|Peptide Vaccine|peptide vaccine
687848|NCT00681252|URLC10|urlc10
687849|NCT00681252|VEGFR1|vegfr1
687850|NCT00681252|VEGFR2|vegfr2
687851|NCT00681239|childhood|childhood
687852|NCT00681239|epilepsy|epilepsy
687853|NCT00681239|intractable|intractable
687854|NCT00681239|seizures|seizures
687855|NCT00681239|Atkins|atkins
687856|NCT00681239|ketogenic|ketogenic
687857|NCT00681226|peripheral arterial disease|peripheral arterial disease
687858|NCT00681226|angiotensin converting enzyme inhibitors|angiotensin converting enzyme inhibitors
687859|NCT00681226|exercise|exercise
687860|NCT00681200|Blood Pressure Reduction|blood pressure reduction
687861|NCT00681200|Stress Reactivity and Recovery|stress reactivity and recovery
687862|NCT00681200|Meditation|meditation
687863|NCT00681200|Transcendental Meditation|transcendental meditation
687864|NCT00681200|Stress Reduction|stress reduction
687865|NCT00681200|Stress Management|stress management
687866|NCT00681174|Care, Postoperative|care, postoperative
687867|NCT00681174|Analgesia|analgesia
687868|NCT00681174|Analgesics, Opioid|analgesics, opioid
687869|NCT00681174|Morphine|morphine
687870|NCT00681174|Remifentanil|remifentanil
687871|NCT00681174|Oxycodone|oxycodone
687872|NCT00681174|Anesthesia, Regional|anesthesia, regional
687873|NCT00681174|Anesthesia, Intravenous|anesthesia, intravenous
687874|NCT00681174|Preanesthetic Medication|preanesthetic medication
687875|NCT00681174|Analgesia, Patient-Controlled|analgesia, patient-controlled
687876|NCT00681161|obstructive sleep apnea|obstructive sleep apnea
687877|NCT00681161|OSA|osa
687878|NCT00681161|diabetes|diabetes
687879|NCT00681161|pre-diabetic condition|pre-diabetic condition
687880|NCT00681161|obesity|obesity
687881|NCT00681161|blood glucose|blood glucose
687882|NCT00681161|continuous positive airway pressure|continuous positive airway pressure
687883|NCT00681161|CPAP|cpap
687884|NCT00681148|Prostate specific antigen (PSA)|prostate specific antigen (psa)
687885|NCT00681148|Prostate cancer|prostate cancer
687886|NCT00681148|Lower urinary tract symptoms|lower urinary tract symptoms
687887|NCT00681148|Radioactive seed implantation|radioactive seed implantation
688593|NCT00678314|Anesthetics|anesthetics
687888|NCT00681135|orthodontics|orthodontics
687889|NCT00681135|toothbrush|toothbrush
687890|NCT00681135|interdental brush|interdental brush
687891|NCT00681135|oral hygiene|oral hygiene
687892|NCT00681122|Breast Cancer|breast cancer
687893|NCT00681122|hormone therapy|hormone therapy
687894|NCT00681122|aromatase inhibitor|aromatase inhibitor
687895|NCT00681096|Low back pain in nurses|low back pain in nurses
687896|NCT00681083|Obstructive Sleep Apnea|obstructive sleep apnea
687897|NCT00681083|Humidification|humidification
687898|NCT00681083|Continuous Positive Airway Pressure|continuous positive airway pressure
687899|NCT00681070|laceration|laceration
687900|NCT00681070|wound management|wound management
687901|NCT00681070|absorbable sutures|absorbable sutures
687902|NCT00681070|cosmetic outcomes|cosmetic outcomes
687903|NCT00681044|monoclonal immunoglobulin deposition disease|monoclonal immunoglobulin deposition disease
687904|NCT00681044|light chain deposition disease|light chain deposition disease
687905|NCT00681018|premature|premature
687906|NCT00681018|infants|infants
687907|NCT00681005|PPI test|ppi test
687908|NCT00681005|gastroesophageal reflux disease|gastroesophageal reflux disease
687909|NCT00681005|CYP2C19|cyp2c19
687910|NCT00681005|rabeprazole|rabeprazole
687911|NCT00681005|pantoprazole|pantoprazole
687912|NCT00680992|Giant Cell Tumor of Bone|giant cell tumor of bone
687913|NCT00680979|Prevention|prevention
687914|NCT00680979|Obesity|obesity
687915|NCT00680979|Binge Eating|binge eating
687916|NCT00680979|Adolescents|adolescents
687917|NCT00680979|Overweight|overweight
687918|NCT00680979|Weight Gain|weight gain
687919|NCT00680966|Treatment efficacy|treatment efficacy
687920|NCT00680966|Family therapy|family therapy
687921|NCT00680966|Teens|teens
687922|NCT00680966|Substance abuse|substance abuse
687923|NCT00680966|Substance dependence|substance dependence
687924|NCT00680940|NSCLC|nsclc
687925|NCT00680927|Atrial Fibrillation|atrial fibrillation
687926|NCT00680927|Risk of cardiac arrhythmias|risk of cardiac arrhythmias
687927|NCT00680927|Loop recorder|loop recorder
687928|NCT00680914|Streptococcus pneumoniae|streptococcus pneumoniae
687929|NCT00680914|pneumococcal conjugate vaccine|pneumococcal conjugate vaccine
687930|NCT00680901|unresectable|unresectable
687931|NCT00680901|HER2|her2
687932|NCT00680901|TYVERB|tyverb
687933|NCT00680901|ErbB2|erbb2
687934|NCT00680901|TYKERB|tykerb
687935|NCT00680901|capecitabine|capecitabine
687936|NCT00680901|CapeOx|capeox
687937|NCT00680901|gastric/esophageal cancer|gastric/esophageal cancer
687938|NCT00680901|GE junction|ge junction
687939|NCT00680901|metastatic|metastatic
687940|NCT00680901|lapatinib|lapatinib
687941|NCT00680901|oxaliplatin|oxaliplatin
687942|NCT00680888|Psychosis|psychosis
687943|NCT00680888|adolescents|adolescents
687944|NCT00680888|adherence|adherence
687945|NCT00680888|quetiapine|quetiapine
687946|NCT00680875|School Based Services|school based services
687947|NCT00680875|Prevention|prevention
687948|NCT00680875|Children|children
687950|NCT00680862|screening|screening
687951|NCT00680849|Type 2 Diabetes Mellitus|type 2 diabetes mellitus
687952|NCT00680849|Coronary Disease|coronary disease
687953|NCT00680836|Irritable Bowel Syndrome|irritable bowel syndrome
687954|NCT00680836|Diarrhea|diarrhea
687955|NCT00680836|Gulf War|gulf war
687956|NCT00680836|Veterans|veterans
687957|NCT00680836|Small intestinal bacterial overgrowth (SIBO)|small intestinal bacterial overgrowth (sibo)
687958|NCT00680823|Headache|headache
687959|NCT00680823|Migraine|migraine
687960|NCT00680823|Ropivacaine|ropivacaine
687961|NCT00680797|Aging|aging
687962|NCT00680797|Hormones|hormones
687963|NCT00680797|Insulin resistance|insulin resistance
687964|NCT00680784|sprain|sprain
687965|NCT00680784|ankle|ankle
687966|NCT00680784|pain|pain
687967|NCT00680771|Primary Insomnia|primary insomnia
687968|NCT00680771|Insomnia|insomnia
687969|NCT00680771|Good Sleepers|good sleepers
687970|NCT00680771|Hep B|hep b
687971|NCT00680771|Vaccine|vaccine
687972|NCT00680758|male breast cancer|male breast cancer
687973|NCT00680758|stage IV breast cancer|stage iv breast cancer
687974|NCT00680745|Dapagliflozin|dapagliflozin
687975|NCT00680745|efficacy|efficacy
687976|NCT00680745|safety|safety
687977|NCT00680745|sulphonylurea|sulphonylurea
687978|NCT00680745|Type 2 diabetes|type 2 diabetes
687979|NCT00680732|Malaria|malaria
687980|NCT00680732|Pregnancy|pregnancy
687981|NCT00680732|Prevention|prevention
687982|NCT00680732|Chloroquine|chloroquine
687983|NCT00680732|Sulphadoxine pyrimethamine|sulphadoxine pyrimethamine
687984|NCT00680732|Maternal anaemia|maternal anaemia
687985|NCT00680732|Birth weight|birth weight
687986|NCT00680732|Foetal anaemia|foetal anaemia
687987|NCT00680719|substance abuse|substance abuse
687988|NCT00680719|HIV risk|hiv risk
687989|NCT00680719|Behavior and Mental Disorders|behavior and mental disorders
687990|NCT00680719|HIV Seronegativity|hiv seronegativity
687991|NCT00680693|IBS, functional gastrointestinal disease|ibs, functional gastrointestinal disease
688092|NCT00680173|Chronic Hepatitis C|chronic hepatitis c
687992|NCT00680680|Urinary retention secondary to benign prostatic hyperplasia|urinary retention secondary to benign prostatic hyperplasia
687993|NCT00680667|ductal breast carcinoma|ductal breast carcinoma
687994|NCT00680667|stage I breast cancer|stage i breast cancer
687995|NCT00680667|stage II breast cancer|stage ii breast cancer
687996|NCT00680667|stage IIIA breast cancer|stage iiia breast cancer
687997|NCT00680667|stage IIIB breast cancer|stage iiib breast cancer
687998|NCT00680667|stage IIIC breast cancer|stage iiic breast cancer
687999|NCT00680667|estrogen receptor-negative breast cancer|estrogen receptor-negative breast cancer
688000|NCT00680667|progesterone receptor-negative breast cancer|progesterone receptor-negative breast cancer
688001|NCT00680654|Pulmonary hypertension|pulmonary hypertension
688002|NCT00680641|COPD|copd
688003|NCT00680641|Emphysema|emphysema
688004|NCT00680641|Simvastatin|simvastatin
688005|NCT00680628|Pulmonary Embolism|pulmonary embolism
688006|NCT00680628|Tenecteplase|tenecteplase
688007|NCT00680628|Enoxaparin|enoxaparin
688008|NCT00680628|Thrombosis|thrombosis
688009|NCT00680628|Fibrinolytics|fibrinolytics
688010|NCT00680615|Smokeless tobacco|smokeless tobacco
688011|NCT00680602|behavior therapy|behavior therapy
688012|NCT00680602|group therapy|group therapy
688013|NCT00680602|psychopharmacology|psychopharmacology
688014|NCT00680589|TYRP2 DNA Vaccine|tyrp2 dna vaccine
688015|NCT00680576|adolescent substance abuse|adolescent substance abuse
688016|NCT00680550|Atrial Fibrillation|atrial fibrillation
688017|NCT00680550|Risk of cardiac Arrhythmias|risk of cardiac arrhythmias
688018|NCT00680550|Loop recorder|loop recorder
688019|NCT00680537|physical therapy program|physical therapy program
688020|NCT00680524|telephone-based intervention for PTSD|telephone-based intervention for ptsd
688021|NCT00680511|methamphetamine abuse|methamphetamine abuse
688022|NCT00680498|Age-Related Macular Degeneration|age-related macular degeneration
688023|NCT00680498|Ranibizumab|ranibizumab
688024|NCT00680498|Lucentis|lucentis
688025|NCT00680498|Photodynamic Therapy|photodynamic therapy
688026|NCT00680498|Verteporfin|verteporfin
688027|NCT00680498|Visudyne|visudyne
688028|NCT00680485|GSK580416|gsk580416
688029|NCT00680485|ketoconazole interaction|ketoconazole interaction
688030|NCT00680485|pleuromutilin|pleuromutilin
688031|NCT00680485|oral dose|oral dose
688032|NCT00680472|Shoulder pain|shoulder pain
688033|NCT00680472|Pain|pain
688034|NCT00680472|Ketoprofen|ketoprofen
688035|NCT00680472|Topical Patch|topical patch
688036|NCT00680459|central line infection|central line infection
688037|NCT00680459|70% ethanol|70% ethanol
688038|NCT00680459|Sepsis|sepsis
688039|NCT00680446|Primary Immune Deficiency|primary immune deficiency
688040|NCT00680446|Subcutaneous|subcutaneous
688041|NCT00680446|Immunoglobulin G|immunoglobulin g
688042|NCT00680420|pancreas cancer|pancreas cancer
688043|NCT00680420|pancreas cyst|pancreas cyst
688044|NCT00680420|DNA microarray|dna microarray
688045|NCT00680407|NASH|nash
688046|NCT00680407|non-alcoholic steatohepatitis|non-alcoholic steatohepatitis
688047|NCT00680394|abortion|abortion
688048|NCT00680394|medical abortion|medical abortion
688049|NCT00680394|mifepristone|mifepristone
688050|NCT00680394|misoprostol|misoprostol
688051|NCT00680381|adolescent substance abuse|adolescent substance abuse
688052|NCT00680368|Feasibility|feasibility
688053|NCT00680368|Supervision|supervision
688054|NCT00680368|Assessing|assessing
688055|NCT00680355|golden rice carotenoids|golden rice carotenoids
688056|NCT00680355|healthy volunteers|healthy volunteers
688057|NCT00680355|retinol equivalence|retinol equivalence
688058|NCT00680342|hepatitis C|hepatitis c
688059|NCT00680329|Adherence|adherence
688060|NCT00680329|Compliance|compliance
688061|NCT00680329|Glaucoma|glaucoma
688062|NCT00680329|Ocular Hypertension|ocular hypertension
688063|NCT00680316|Pulmozyme|pulmozyme
688064|NCT00680316|CF|cf
688065|NCT00680303|Early Stuttering|early stuttering
688066|NCT00680303|Lidcombe Program|lidcombe program
688067|NCT00680303|Stuttering Treatment|stuttering treatment
688068|NCT00680303|Efficiency|efficiency
688069|NCT00680303|Efficacy|efficacy
688070|NCT00680303|Service Delivery|service delivery
688071|NCT00680303|Models of intervention|models of intervention
688072|NCT00680290|exercise, quality of life, cpx|exercise, quality of life, cpx
688073|NCT00680277|spirulina|spirulina
688074|NCT00680277|carotenoids|carotenoids
688075|NCT00680264|Treatment Outcomes|treatment outcomes
688076|NCT00680264|Scoliosis|scoliosis
688077|NCT00680264|Cerebral Palsy|cerebral palsy
688078|NCT00680238|Pregnancy|pregnancy
688079|NCT00680238|implantation|implantation
688080|NCT00680238|miscarriage|miscarriage
688081|NCT00680238|sHLA-G|shla-g
688082|NCT00680225|Choroidal melanoma|choroidal melanoma
688083|NCT00680225|Lucentis|lucentis
688084|NCT00680225|TTT-ICG|ttt-icg
688085|NCT00680212|dietary beta-carotene|dietary beta-carotene
688086|NCT00680212|vitamin A status|vitamin a status
688087|NCT00680212|intrinsically labeled plant foods|intrinsically labeled plant foods
688088|NCT00680199|Insomnia|insomnia
688089|NCT00680199|Primary Insomnia|primary insomnia
688090|NCT00680199|Good Sleepers|good sleepers
688091|NCT00680199|ERP|erp
688093|NCT00680173|Single nucleotide polymorphisms|single nucleotide polymorphisms
688094|NCT00680173|Sustained virological response|sustained virological response
688095|NCT00680173|Peginterferon|peginterferon
688096|NCT00680173|Ribavirin|ribavirin
688097|NCT00680160|Onychomycosis|onychomycosis
688098|NCT00680160|Fungal Nail|fungal nail
688099|NCT00680147|HPV|hpv
688100|NCT00680147|Gardasil|gardasil
688101|NCT00680147|African-American|african-american
688102|NCT00680147|adolescent|adolescent
688103|NCT00680147|health behavior|health behavior
688104|NCT00680147|sexually transmitted infections|sexually transmitted infections
688105|NCT00680147|This will enroll 300 mothers of teenage girls and boys to identify barriers to HPV vaccination among low-income, African-American teens.|this will enroll 300 mothers of teenage girls and boys to identify barriers to hpv vaccination among low-income, african-american teens.
688106|NCT00680134|Onychomycosis|onychomycosis
688107|NCT00680134|Fungal Nail|fungal nail
688108|NCT00680121|Alcoholism|alcoholism
688109|NCT00680121|Benfotiamine|benfotiamine
688110|NCT00680121|Thiamine|thiamine
688111|NCT00680095|Onychomycosis|onychomycosis
688112|NCT00680095|Fungal Nail|fungal nail
688113|NCT00680082|statins|statins
688114|NCT00680082|rosuvastatin|rosuvastatin
688115|NCT00680082|cross sectional study|cross sectional study
688116|NCT00680082|France|france
688117|NCT00680082|CV risk factors|cv risk factors
688118|NCT00680069|avian influenza,H5N1,Influenza,parent protocol|avian influenza,h5n1,influenza,parent protocol
688119|NCT00680056|Pulmonary Disease, Chronic Obstructive|pulmonary disease, chronic obstructive
688120|NCT00680056|Tiotropium|tiotropium
688121|NCT00680056|Formoterol|formoterol
688122|NCT00680056|Bronchodilator Agents|bronchodilator agents
688123|NCT00680056|Exercise Tolerance|exercise tolerance
688124|NCT00680056|Randomized Controlled Trial [Publication Type]|randomized controlled trial [publication type]
688125|NCT00680056|COPD|copd
688126|NCT00680043|anemia|anemia
688127|NCT00680043|chronic kidney disease|chronic kidney disease
688128|NCT00680043|CKD|ckd
688129|NCT00680043|chronic renal failure|chronic renal failure
688130|NCT00680043|CRF|crf
688131|NCT00680043|erythropoietin|erythropoietin
688132|NCT00680043|EPO|epo
688133|NCT00680043|erythropoiesis stimulating agent|erythropoiesis stimulating agent
688134|NCT00680043|ESA|esa
688135|NCT00680043|Hematide™|hematide™
688136|NCT00680043|hemoglobin|hemoglobin
688137|NCT00680043|Hb|hb
688138|NCT00680043|Hgb|hgb
688139|NCT00680043|Omontys|omontys
688140|NCT00680043|peginesatide|peginesatide
688141|NCT00680043|red blood cell|red blood cell
688142|NCT00680043|red blood cell production|red blood cell production
688143|NCT00680030|impedance|impedance
688144|NCT00680030|manometry|manometry
688145|NCT00680030|motility disorders|motility disorders
688146|NCT00680030|ineffective motility|ineffective motility
688147|NCT00680030|diffuse esophageal spasms|diffuse esophageal spasms
688148|NCT00680030|achlasia-like dysmotility|achlasia-like dysmotility
688149|NCT00680017|Dyslipidemia|dyslipidemia
688150|NCT00680017|Kidney Disease|kidney disease
688151|NCT00680004|Dynamic CTA|dynamic cta
688152|NCT00680004|follow-up|follow-up
688153|NCT00680004|EVAR|evar
688154|NCT00679991|arteriovenous fistula|arteriovenous fistula
688155|NCT00679991|AVF|avf
688156|NCT00679991|hemodialysis|hemodialysis
688157|NCT00679991|vascular access|vascular access
688158|NCT00679991|PRT 201|prt 201
688159|NCT00679991|dose escalation|dose escalation
688160|NCT00679991|dialysis|dialysis
688161|NCT00679991|fistula|fistula
688162|NCT00679991|access|access
688163|NCT00679991|vonapanitase|vonapanitase
688164|NCT00679991|kidney|kidney
688165|NCT00679991|renal|renal
688166|NCT00679978|osteoporosis|osteoporosis
688167|NCT00679978|glucocorticoid|glucocorticoid
688168|NCT00679978|bone mineral density|bone mineral density
688169|NCT00679978|osteonecrosis of the femoral head|osteonecrosis of the femoral head
688170|NCT00679965|Onychomycosis|onychomycosis
688171|NCT00679965|Fungal Nail|fungal nail
688172|NCT00679952|Pancreatic fistula|pancreatic fistula
688173|NCT00679952|Pancreatic duct stent|pancreatic duct stent
688174|NCT00679952|Closed suction drainage|closed suction drainage
688175|NCT00679939|Type 2 diabetes mellitus|type 2 diabetes mellitus
688176|NCT00679939|bone|bone
688177|NCT00679939|x-ray absorptiometry|x-ray absorptiometry
688178|NCT00679939|bone biomarkers|bone biomarkers
688179|NCT00679939|dual-energy|dual-energy
688180|NCT00679939|bone mineral density|bone mineral density
688181|NCT00679926|HIV|hiv
688182|NCT00679926|AIDS|aids
688183|NCT00679926|HIV/AIDS|hiv/aids
688184|NCT00679926|Treatment Naive|treatment naive
688185|NCT00679913|Pancreatic cancer|pancreatic cancer
688186|NCT00679913|Pancreaticoduodenectomy|pancreaticoduodenectomy
688187|NCT00679913|Extended lymphadenectomy|extended lymphadenectomy
688188|NCT00679900|Primary Insomnia|primary insomnia
688189|NCT00679900|Sleep Maintenance Difficulties|sleep maintenance difficulties
688190|NCT00679887|chiropractic|chiropractic
688191|NCT00679887|myofascial trigger points|myofascial trigger points
688192|NCT00679887|ischemic compression|ischemic compression
688193|NCT00679887|shoulder pain|shoulder pain
688194|NCT00679874|Cardiovascular Magnetic Resonance Imaging|cardiovascular magnetic resonance imaging
688195|NCT00679874|Cardiotoxicity|cardiotoxicity
688196|NCT00679874|Anthracyclines|anthracyclines
688197|NCT00679874|Trastuzumab|trastuzumab
688198|NCT00679874|Breast cancer|breast cancer
688199|NCT00679874|Toxicity|toxicity
688200|NCT00679861|primary medical care|primary medical care
688201|NCT00679861|computer expert system|computer expert system
688202|NCT00679861|motivational interviewing|motivational interviewing
688203|NCT00679861|health behavior change counselling|health behavior change counselling
688204|NCT00679861|stages of change|stages of change
688205|NCT00679848|Weight Loss|weight loss
688206|NCT00679848|Transoral Suturing|transoral suturing
688207|NCT00679848|Experimental|experimental
688208|NCT00679822|OSA|osa
688209|NCT00679822|sleep apnea|sleep apnea
688210|NCT00679822|heart failure|heart failure
688211|NCT00679822|CHF|chf
688212|NCT00679822|heart clinic|heart clinic
688213|NCT00679822|clinic|clinic
688214|NCT00679822|obstructive sleep apnea|obstructive sleep apnea
688215|NCT00679809|Resident|resident
688216|NCT00679809|Safety|safety
688217|NCT00679809|Fatigue|fatigue
688218|NCT00679809|Continuity|continuity
688219|NCT00679809|ICU|icu
688220|NCT00679796|varicella|varicella
688221|NCT00679796|case-control|case-control
688222|NCT00679783|Breast cancer|breast cancer
688223|NCT00679783|Ovarian cancer|ovarian cancer
688224|NCT00679783|BRCA|brca
688225|NCT00679783|Triple negative|triple negative
688226|NCT00679783|Poly(ADP ribose) polymerases|poly(adp ribose) polymerases
688227|NCT00679783|Known BRCA or Recurrent High Grade Serious/ Undifferentiated Tubo- Ovarian Carcinoma|known brca or recurrent high grade serious/ undifferentiated tubo- ovarian carcinoma
688228|NCT00679783|Known BRCA or Triple Negative Breast Cancer|known brca or triple negative breast cancer
688229|NCT00679770|Onychomycosis|onychomycosis
688230|NCT00679770|Fungal Nail|fungal nail
688231|NCT00679757|Sleep apnea|sleep apnea
688232|NCT00679757|Obstructive sleep apnea|obstructive sleep apnea
688233|NCT00679757|Wound healing|wound healing
688234|NCT00679757|Non-healing wounds|non-healing wounds
688235|NCT00679744|Tay-Sachs disease.|tay-sachs disease.
688236|NCT00679744|Sandhoff disease.|sandhoff disease.
688237|NCT00679744|GM2 Gangliosidosis.|gm2 gangliosidosis.
688238|NCT00679744|β-hexosaminidase deficiency.|β-hexosaminidase deficiency.
688239|NCT00679744|Hexosaminidase|hexosaminidase
688240|NCT00679744|Phase I clinical trial.|phase i clinical trial.
688241|NCT00679731|Psoriasis|psoriasis
688242|NCT00679705|Hemodynamics and arterial function of healthy females|hemodynamics and arterial function of healthy females
688243|NCT00679692|GH,IGF-1, IGFBP-3|gh,igf-1, igfbp-3
688244|NCT00679679|Polycystic ovary syndrome|polycystic ovary syndrome
688245|NCT00679679|Treatment|treatment
688246|NCT00679679|Metformin|metformin
688247|NCT00679666|keratoconus|keratoconus
688248|NCT00679666|ectasia|ectasia
688249|NCT00679666|cross-linking|cross-linking
688250|NCT00679666|riboflavin|riboflavin
688251|NCT00679666|UVA light|uva light
688252|NCT00679666|cornea|cornea
688253|NCT00679640|candesartan|candesartan
688254|NCT00679640|heart failure|heart failure
688255|NCT00679640|cohort study|cohort study
688256|NCT00679640|France|france
688257|NCT00679627|Alzheimer's Disease|alzheimer's disease
688258|NCT00679627|Galantamine|galantamine
688259|NCT00679627|Dementia, Alzheimer type|dementia, alzheimer type
688260|NCT00679627|Memory loss|memory loss
688261|NCT00679614|Tramacet|tramacet
688262|NCT00679614|naloxone|naloxone
688263|NCT00679614|morphine|morphine
688264|NCT00679614|analgesia|analgesia
688265|NCT00679614|elderly|elderly
688266|NCT00679614|elderly patients|elderly patients
688267|NCT00679601|Onychomycosis|onychomycosis
688268|NCT00679601|Fungal Nail|fungal nail
688269|NCT00679588|Digestive System Surgical Procedure|digestive system surgical procedure
688270|NCT00679588|Urologic Surgical Procedure|urologic surgical procedure
688271|NCT00679588|Prevention of venous thromboembolism|prevention of venous thromboembolism
688272|NCT00679588|Abdominal surgery|abdominal surgery
688273|NCT00679575|statins|statins
688274|NCT00679575|myocardial infarction|myocardial infarction
688275|NCT00679575|case-referent study|case-referent study
688276|NCT00679575|France|france
688277|NCT00679549|Heart Failure|heart failure
688278|NCT00679549|Obstructive Sleep Apnea|obstructive sleep apnea
688279|NCT00679549|OSA|osa
688280|NCT00679549|CHF|chf
688281|NCT00679549|Sleep apnea|sleep apnea
688282|NCT00679549|CHD|chd
688283|NCT00679536|Reduced Toxicity|reduced toxicity
688284|NCT00679536|Toxicity|toxicity
688285|NCT00679536|Event Free Survival|event free survival
688286|NCT00679536|Graft vs Host Disease|graft vs host disease
688287|NCT00679523|Onychomycosis|onychomycosis
688288|NCT00679523|Fungal Nail|fungal nail
688289|NCT00679510|Rheumatoid Arthritis|rheumatoid arthritis
688290|NCT00679510|Rosuvastatin|rosuvastatin
688291|NCT00679510|Cardiovascular|cardiovascular
688292|NCT00679510|Intima media thickness|intima media thickness
688293|NCT00679497|Low risk HIV infection|low risk hiv infection
688294|NCT00679497|HIV Seronegativity|hiv seronegativity
688295|NCT00679497|HIV Preventive Vaccine|hiv preventive vaccine
688296|NCT00679471|pre-term infants|pre-term infants
688297|NCT00679471|full-term infants|full-term infants
688298|NCT00679471|MRI|mri
688299|NCT00679471|brain structure development|brain structure development
688300|NCT00679471|pre term|pre term
688301|NCT00679471|full term|full term
688302|NCT00679458|analgesia|analgesia
688303|NCT00679458|pain|pain
688304|NCT00679458|buprenorphine|buprenorphine
688305|NCT00679458|opioid|opioid
688306|NCT00679458|naloxone|naloxone
688307|NCT00679445|Macular|macular
688308|NCT00679445|Degeneration|degeneration
688309|NCT00679445|AMD|amd
688310|NCT00679445|Wet Age-related macular degeneration|wet age-related macular degeneration
688311|NCT00679432|Ulcerative colitis|ulcerative colitis
688312|NCT00679406|Chronic Insomnia lasting more than 1 month|chronic insomnia lasting more than 1 month
688313|NCT00679393|Calcaneus|calcaneus
688314|NCT00679393|Intra-articular fracture|intra-articular fracture
688315|NCT00679393|open reduction internal fixation|open reduction internal fixation
688316|NCT00679393|primary subtalar fusion|primary subtalar fusion
688317|NCT00679380|Ulcerative colitis|ulcerative colitis
688318|NCT00679367|primary systemic amyloidosis|primary systemic amyloidosis
688319|NCT00679341|HER2-positive breast cancer|her2-positive breast cancer
688320|NCT00679341|HER2|her2
688321|NCT00679341|Herceptin|herceptin
688322|NCT00679341|Taxotere|taxotere
688323|NCT00679341|MBC|mbc
688324|NCT00679341|Breast cancer|breast cancer
688325|NCT00679341|TDM1|tdm1
688326|NCT00679341|TDM-1|tdm-1
688327|NCT00679341|HER2-positive|her2-positive
688328|NCT00679341|HER2+|her2+
688329|NCT00679341|HER2 positive breast cancer|her2 positive breast cancer
688330|NCT00679341|HER2+ breast cancer|her2+ breast cancer
688331|NCT00679341|Armed Herceptin|armed herceptin
688332|NCT00679341|Trastuzumab emtansine|trastuzumab emtansine
688333|NCT00679341|Trastuzumab DM1|trastuzumab dm1
688334|NCT00679315|female voiding dysfunction|female voiding dysfunction
688335|NCT00679315|alpha adrenoreceptor antagonists|alpha adrenoreceptor antagonists
688336|NCT00679315|IPSS or American Urological Association symptom index|ipss or american urological association symptom index
688337|NCT00679302|skin abscess|skin abscess
688338|NCT00679302|CA-MRSA|ca-mrsa
688339|NCT00679289|KW2871|kw2871
688340|NCT00679289|Ecromeximab|ecromeximab
688341|NCT00679289|Anti-ganglioside|anti-ganglioside
688342|NCT00679289|Antibody|antibody
688343|NCT00679289|Interferon alpha|interferon alpha
688344|NCT00679289|Metastatic melanoma|metastatic melanoma
688345|NCT00679276|vaginal prolapse|vaginal prolapse
688346|NCT00679263|asthma|asthma
688347|NCT00679263|randomized|randomized
688348|NCT00679263|placebo controlled|placebo controlled
688349|NCT00679263|dose escalation|dose escalation
688350|NCT00679263|safety|safety
688351|NCT00679263|efficacy|efficacy
688352|NCT00679263|single blind|single blind
688353|NCT00679263|MN-221|mn-221
688354|NCT00679250|allergic rhinitis|allergic rhinitis
688355|NCT00679250|levocetirizine|levocetirizine
688356|NCT00679250|nasal provocation testing|nasal provocation testing
688357|NCT00679250|nasal allergen challenge|nasal allergen challenge
688358|NCT00679250|nasal adenosine monophosphate challenge|nasal adenosine monophosphate challenge
688359|NCT00679224|Pulmonary Arterial Hypertesion|pulmonary arterial hypertesion
688360|NCT00679224|observational safety|observational safety
688361|NCT00679211|HER2-positive breast cancer|her2-positive breast cancer
688362|NCT00679211|HER2|her2
688363|NCT00679211|MBC|mbc
688364|NCT00679211|Trastuzumab emtansine|trastuzumab emtansine
688365|NCT00679198|osteoporosis|osteoporosis
688366|NCT00679198|fracture|fracture
688367|NCT00679198|communication|communication
688368|NCT00679198|prescription medication|prescription medication
688369|NCT00679185|fatigue|fatigue
688370|NCT00679185|stage I breast cancer|stage i breast cancer
688371|NCT00679185|stage II breast cancer|stage ii breast cancer
688372|NCT00679185|stage IIIA breast cancer|stage iiia breast cancer
688373|NCT00679185|stage IIIB breast cancer|stage iiib breast cancer
688374|NCT00679185|stage IIIC breast cancer|stage iiic breast cancer
688375|NCT00679185|lymphedema|lymphedema
688376|NCT00679133|c-Met|c-met
688377|NCT00679133|VEGFR|vegfr
688378|NCT00679133|Ron|ron
688379|NCT00679133|Cancer|cancer
688380|NCT00679133|Tumor|tumor
688381|NCT00679133|Safety|safety
688382|NCT00679133|Phase 1|phase 1
688383|NCT00679120|Unicompartmental osteoarthrosis|unicompartmental osteoarthrosis
688384|NCT00679120|RSA|rsa
688385|NCT00679120|Bone-remodelling|bone-remodelling
688386|NCT00679107|Degenerative Disc Disease|degenerative disc disease
688387|NCT00679068|respiratory mechanics|respiratory mechanics
688388|NCT00679068|bosentan|bosentan
688389|NCT00679068|exercise capacity|exercise capacity
688390|NCT00679042|Diabetes Mellitus Type 1|diabetes mellitus type 1
688391|NCT00679042|Type 1 Diabetes Mellitus|type 1 diabetes mellitus
688392|NCT00679042|Islets of Langerhans Transplantation|islets of langerhans transplantation
688393|NCT00679042|Allogeneic Islet transplantation|allogeneic islet transplantation
688394|NCT00679003|Crohn's disease|crohn's disease
688395|NCT00679003|Ulcerative colitis|ulcerative colitis
688594|NCT00678314|Local|local
688396|NCT00679003|Inflammatory bowel disease|inflammatory bowel disease
688397|NCT00679003|Illness behavior|illness behavior
688398|NCT00679003|Cognitive behavioral therapy|cognitive behavioral therapy
688399|NCT00678990|Islets of Langerhans|islets of langerhans
688400|NCT00678990|islets|islets
688401|NCT00678990|heparin|heparin
688402|NCT00678977|pharmacokinetics|pharmacokinetics
688403|NCT00678977|cisplatin|cisplatin
688404|NCT00678977|pazopanib (GW786034)|pazopanib (gw786034)
688405|NCT00678977|Solid tumors|solid tumors
688406|NCT00678977|anti-angiogenesis|anti-angiogenesis
688407|NCT00678977|gemcitabine|gemcitabine
688408|NCT00678964|NSCLC|nsclc
688409|NCT00678964|Elderly patients|elderly patients
688410|NCT00678938|smoking reduction|smoking reduction
688411|NCT00678938|smoking cessation|smoking cessation
688412|NCT00678938|stages of change|stages of change
688413|NCT00678938|expert system interventions|expert system interventions
688414|NCT00678912|mechanical ventilation|mechanical ventilation
688415|NCT00678912|automated weaning|automated weaning
688416|NCT00678912|children|children
688417|NCT00678899|High frequency severe to profound|high frequency severe to profound
688418|NCT00678886|Type 1 diabetes|type 1 diabetes
688419|NCT00678886|new onset type 1 diabetes|new onset type 1 diabetes
688420|NCT00678886|T1DM|t1dm
688421|NCT00678886|Type l diabetes|type l diabetes
688422|NCT00678886|juvenile diabetes|juvenile diabetes
688423|NCT00678873|Single Incision|single incision
688424|NCT00678873|Single Access|single access
688425|NCT00678873|Surgery|surgery
688426|NCT00678873|Cholecystectomy|cholecystectomy
688427|NCT00678860|Questionnaire|questionnaire
688428|NCT00678860|Computer Assisted Interface|computer assisted interface
688429|NCT00678860|Quality of Life|quality of life
688430|NCT00678860|Dry Eye|dry eye
688431|NCT00678860|Ocular Surface Disease|ocular surface disease
688432|NCT00678860|Healthy Volunteer|healthy volunteer
688433|NCT00678860|HV|hv
688434|NCT00678847|bio-electrical stimulation therapy|bio-electrical stimulation therapy
688435|NCT00678847|chronic venous ulcers|chronic venous ulcers
688436|NCT00678847|microcurrent|microcurrent
688437|NCT00678847|chronic wounds|chronic wounds
688438|NCT00678847|complete healing|complete healing
688439|NCT00678821|Interstitial Lung Disease|interstitial lung disease
688440|NCT00678821|Pulmonary Rehabilitation|pulmonary rehabilitation
688441|NCT00678821|Pulmonary Hypertension|pulmonary hypertension
688442|NCT00678821|Exercise|exercise
688443|NCT00678795|Detrusor overactivity|detrusor overactivity
688444|NCT00678795|Multiple Sclerosis|multiple sclerosis
688445|NCT00678782|knee|knee
688446|NCT00678782|synovitis|synovitis
688447|NCT00678782|arthritis|arthritis
688448|NCT00678782|rheumatoid arthritis|rheumatoid arthritis
688449|NCT00678782|psoriatic arthritis|psoriatic arthritis
688450|NCT00678782|spondyloarthropathies|spondyloarthropathies
688451|NCT00678782|intraarticular|intraarticular
688452|NCT00678782|etanercept|etanercept
688453|NCT00678756|Psoriasis vulgaris,|psoriasis vulgaris,
688454|NCT00678756|vitamin D, UVB-phototherapy, ketokonazol,|vitamin d, uvb-phototherapy, ketokonazol,
688455|NCT00678756|Optical Coherence Tomography,|optical coherence tomography,
688456|NCT00678756|local PASI, Nizoral|local pasi, nizoral
688457|NCT00678743|cholesterol|cholesterol
688458|NCT00678743|dyslipidemia|dyslipidemia
688459|NCT00678743|omega 3|omega 3
688460|NCT00678730|THC|thc
688461|NCT00678730|COMT gene polymorphism|comt gene polymorphism
688462|NCT00678730|schizophrenia|schizophrenia
688463|NCT00678730|cannabis use|cannabis use
688464|NCT00678717|abdominal|abdominal
688465|NCT00678717|Pelvic|pelvic
688466|NCT00678717|Pain|pain
688467|NCT00678717|SCS|scs
688468|NCT00678717|Healthy and Chronic Visceral Pain patients|healthy and chronic visceral pain patients
688469|NCT00678717|Chronic Visceral Pain and spinal cord stimulator|chronic visceral pain and spinal cord stimulator
688470|NCT00678704|Vardenafil|vardenafil
688471|NCT00678704|PDE5 inhibitor|pde5 inhibitor
688472|NCT00678704|Erectile Dysfunction|erectile dysfunction
688473|NCT00678704|Diabetes Mellitus|diabetes mellitus
688474|NCT00678704|Sexual Dysfunction|sexual dysfunction
688475|NCT00678691|fibromyalgia|fibromyalgia
688476|NCT00678691|fatigue|fatigue
688477|NCT00678678|Physiotherapy|physiotherapy
688478|NCT00678678|Breathing exercises|breathing exercises
688479|NCT00678678|Bariatric Surgery|bariatric surgery
688480|NCT00678678|Laparoscopy|laparoscopy
688481|NCT00678665|ecg|ecg
688482|NCT00678665|TSA2000|tsa2000
688483|NCT00678665|Heart rate variability|heart rate variability
688484|NCT00678665|wavelets|wavelets
688485|NCT00678652|Meningococcal vaccine|meningococcal vaccine
688486|NCT00678652|Neisseria meningitidis|neisseria meningitidis
688487|NCT00678639|ACS|acs
688488|NCT00678639|Acute Coronary Syndrome|acute coronary syndrome
688489|NCT00678639|Chest pain|chest pain
688490|NCT00678639|Cardiac MRI|cardiac mri
688491|NCT00678639|CMR|cmr
688492|NCT00678639|Risk Stratification|risk stratification
688493|NCT00678639|Emergency Department|emergency department
688591|NCT00678327|adult mixed cellularity Hodgkin lymphoma|adult mixed cellularity hodgkin lymphoma
688592|NCT00678327|stage II adult Hodgkin lymphoma|stage ii adult hodgkin lymphoma
688494|NCT00678626|Key words: Docetaxel; breast cancer; breast diseases; breast neoplasms; antineoplastic agents; neoplasms;HER-2 negative; Stage IIIB or IV breast cancer.|key words: docetaxel; breast cancer; breast diseases; breast neoplasms; antineoplastic agents; neoplasms;her-2 negative; stage iiib or iv breast cancer.
688495|NCT00678613|probiotics|probiotics
688496|NCT00678613|cirrhosis|cirrhosis
688497|NCT00678613|prophylaxis|prophylaxis
688498|NCT00678613|cirrhotic|cirrhotic
688499|NCT00678613|patients|patients
688500|NCT00678613|with|with
688501|NCT00678613|ascites|ascites
688502|NCT00678613|using|using
688503|NCT00678600|Informatics|informatics
688504|NCT00678600|Alerts|alerts
688505|NCT00678600|Toxicity|toxicity
688506|NCT00678600|Virologic failure|virologic failure
688507|NCT00678600|Suboptimal follow up|suboptimal follow up
688508|NCT00678587|elective invasive procedure.|elective invasive procedure.
688509|NCT00678587|platelet transfusion|platelet transfusion
688510|NCT00678587|chronic liver disease-related thrombocytopenia|chronic liver disease-related thrombocytopenia
688511|NCT00678587|platelets|platelets
688512|NCT00678587|thrombopoietin|thrombopoietin
688513|NCT00678574|hormones|hormones
688514|NCT00678574|menses|menses
688515|NCT00678574|PMS|pms
688516|NCT00678574|PMDD|pmdd
688517|NCT00678561|chronic plaque psoriasis, topical treatment|chronic plaque psoriasis, topical treatment
688518|NCT00678535|1st line treatment for Gastric Cancer|1st line treatment for gastric cancer
688519|NCT00678535|Cetuximab|cetuximab
688520|NCT00678535|Capecitabine|capecitabine
688521|NCT00678535|Xeloda|xeloda
688522|NCT00678535|Cisplatin|cisplatin
688523|NCT00678535|Progression-free survival|progression-free survival
688524|NCT00678522|Atorvastatin|atorvastatin
688525|NCT00678522|Renal function|renal function
688526|NCT00678522|Hemodynamics|hemodynamics
688527|NCT00678522|Diabetes type II|diabetes type ii
688528|NCT00678522|sodium excretion|sodium excretion
688529|NCT00678509|HLA-A*2402|hla-a*2402
688530|NCT00678509|Peptide Vaccine|peptide vaccine
688532|NCT00678496|CBT-software|cbt-software
688533|NCT00678496|Computerised Cognitive Behavioural Therapy|computerised cognitive behavioural therapy
688534|NCT00678496|CCBT|ccbt
688535|NCT00678496|Cognitive Therapy|cognitive therapy
688536|NCT00678496|Therapy, Computer-Assisted|therapy, computer-assisted
688537|NCT00678496|Depression|depression
688538|NCT00678496|Multiple Sclerosis|multiple sclerosis
688539|NCT00678483|Cholesterol|cholesterol
688540|NCT00678483|HDL|hdl
688541|NCT00678483|triglycerides|triglycerides
688542|NCT00678483|insulin|insulin
688543|NCT00678483|blood glucose|blood glucose
688544|NCT00678457|alcohol dependence|alcohol dependence
688545|NCT00678457|alcohol abuse|alcohol abuse
688546|NCT00678457|drinking|drinking
688547|NCT00678457|alcohol|alcohol
688548|NCT00678444|Anxiety|anxiety
688549|NCT00678444|Satisfaction|satisfaction
688550|NCT00678444|Incomplete bladder emptying|incomplete bladder emptying
688551|NCT00678444|Clean Intermittent Self-catheterization|clean intermittent self-catheterization
688552|NCT00678444|Prolapse/incontinence surgery|prolapse/incontinence surgery
688553|NCT00678431|Alzheimer's Disease|alzheimer's disease
688554|NCT00678431|Dementia|dementia
688555|NCT00678431|Nutritional Supplement|nutritional supplement
688556|NCT00678431|Resveratrol|resveratrol
688557|NCT00678418|Addiction|addiction
688558|NCT00678418|Opiate dependence|opiate dependence
688559|NCT00678418|Inpatient detoxification|inpatient detoxification
688560|NCT00678418|opioid dependence|opioid dependence
688561|NCT00678418|heroin dependence|heroin dependence
688562|NCT00678405|Breathlessness|breathlessness
688563|NCT00678405|Dyspnoea|dyspnoea
688564|NCT00678405|Dyspnea|dyspnea
688565|NCT00678405|Palliative care|palliative care
688566|NCT00678405|RCT|rct
688567|NCT00678405|Randomised controlled trial|randomised controlled trial
688568|NCT00678405|Lung cancer|lung cancer
688569|NCT00678405|COPD|copd
688570|NCT00678405|Heart failure|heart failure
688571|NCT00678405|Chronic respiratory disease|chronic respiratory disease
688572|NCT00678392|Axitinib in Second Line Treatment of Patients With Metastatic Renal Cell Cancer|axitinib in second line treatment of patients with metastatic renal cell cancer
688573|NCT00678379|Tonsillectomy|tonsillectomy
688574|NCT00678379|Postoperative Pain|postoperative pain
688575|NCT00678379|Clonidine|clonidine
688576|NCT00678379|Anesthetics, Local|anesthetics, local
688577|NCT00678366|laparoscopy|laparoscopy
688578|NCT00678366|carbon dioxide|carbon dioxide
688579|NCT00678366|oxygen|oxygen
688580|NCT00678366|pain|pain
688581|NCT00678366|inflammation|inflammation
688582|NCT00678353|Degenerative disc disease|degenerative disc disease
688583|NCT00678340|Randomized Controlled Trial|randomized controlled trial
688584|NCT00678340|Single-Blind Study|single-blind study
688585|NCT00678340|Catheter Ablation|catheter ablation
688586|NCT00678327|stage III adult Hodgkin lymphoma|stage iii adult hodgkin lymphoma
688587|NCT00678327|stage IV adult Hodgkin lymphoma|stage iv adult hodgkin lymphoma
688588|NCT00678327|adult nodular sclerosis Hodgkin lymphoma|adult nodular sclerosis hodgkin lymphoma
688589|NCT00678327|adult lymphocyte depletion Hodgkin lymphoma|adult lymphocyte depletion hodgkin lymphoma
688590|NCT00678327|adult lymphocyte predominant Hodgkin lymphoma|adult lymphocyte predominant hodgkin lymphoma
688595|NCT00678314|ropivacaine|ropivacaine
688596|NCT00678314|Surgery|surgery
688597|NCT00678314|Hand|hand
688598|NCT00678314|carpel tunnel|carpel tunnel
688599|NCT00678314|Carpal tunnel surgery|carpal tunnel surgery
688600|NCT00678301|pneumococcal conjugate vaccine|pneumococcal conjugate vaccine
688601|NCT00678301|Streptococcus pneumoniae|streptococcus pneumoniae
688602|NCT00678288|Renal Cell Cancer|renal cell cancer
688603|NCT00678288|Interferon|interferon
688604|NCT00678275|Hematopoietic Stem Cell Transplantation|hematopoietic stem cell transplantation
688605|NCT00678262|pain|pain
688606|NCT00678262|ECG|ecg
688607|NCT00678262|Heart rate variability|heart rate variability
688608|NCT00678262|wavelets|wavelets
688609|NCT00678249|Hemodialysis|hemodialysis
688610|NCT00678249|Vascular Prosthesis|vascular prosthesis
688611|NCT00678249|stenoses|stenoses
688612|NCT00678249|grafts|grafts
688613|NCT00678236|RSA|rsa
688614|NCT00678236|Gonarthritis|gonarthritis
688615|NCT00678236|Bone Cement|bone cement
688616|NCT00678210|dose response; PASI 75 response endpoint; subjects with moderate to severe chronic plaque psoriasis|dose response; pasi 75 response endpoint; subjects with moderate to severe chronic plaque psoriasis
688617|NCT00678197|Quality of care|quality of care
688618|NCT00678197|Access to care|access to care
688619|NCT00678197|Health Outcomes|health outcomes
688620|NCT00678184|Atorvastatin|atorvastatin
688621|NCT00678184|healthy|healthy
688622|NCT00678184|sodium excretion|sodium excretion
688623|NCT00678184|hemodynamics|hemodynamics
688624|NCT00678184|tubular function|tubular function
688625|NCT00678171|Degenerative Disc Disease|degenerative disc disease
688626|NCT00678158|High Does Single Fraction IGRT|high does single fraction igrt
688627|NCT00678158|Bone|bone
688628|NCT00678158|Lymph Nodes|lymph nodes
688629|NCT00678158|Soft Tissue|soft tissue
688630|NCT00678145|Diabetes|diabetes
688631|NCT00678145|Hypoglycemia|hypoglycemia
688632|NCT00678145|HAAF|haaf
688633|NCT00678145|Counterregulation|counterregulation
688634|NCT00678132|PARP Inhibitor|parp inhibitor
688635|NCT00678132|Combination Study|combination study
688636|NCT00678132|Chemotherapy|chemotherapy
688637|NCT00678132|Advanced Cancer|advanced cancer
688638|NCT00678132|Neoplasms|neoplasms
688639|NCT00678132|Cancer|cancer
688640|NCT00678132|Solid Tumor|solid tumor
688641|NCT00678119|Kidney cancer|kidney cancer
688642|NCT00678119|Renal cancer|renal cancer
688643|NCT00678119|Renal Cell Carcinoma|renal cell carcinoma
688644|NCT00678106|dalbavancin adolescent subjects|dalbavancin adolescent subjects
688645|NCT00678093|Low back pain|low back pain
688646|NCT00678093|Manual therapy|manual therapy
688647|NCT00678093|Mulligan snag|mulligan snag
688648|NCT00678080|Type 2 diabetes mellitus|type 2 diabetes mellitus
688649|NCT00678080|Pregnancy|pregnancy
688650|NCT00678080|Metformin|metformin
688651|NCT00678080|Insulin|insulin
688652|NCT00678080|Pregnant women|pregnant women
688653|NCT00678067|Hypercholesterolemic children|hypercholesterolemic children
688654|NCT00678067|Docosahexaenoic acid|docosahexaenoic acid
688655|NCT00678067|Eicosapentaenoic acid|eicosapentaenoic acid
688656|NCT00678067|Blood lipid profile|blood lipid profile
688657|NCT00678041|urinary catheterization|urinary catheterization
688658|NCT00678041|urinary tract infection|urinary tract infection
688659|NCT00678041|urinary incontinence|urinary incontinence
688660|NCT00678041|pelvic floor prolapse|pelvic floor prolapse
688661|NCT00678041|antibiotics|antibiotics
688662|NCT00678028|MBL, UTI|mbl, uti
688663|NCT00678015|NDGA|ndga
688664|NCT00678015|Prostate Cancer|prostate cancer
688665|NCT00678002|solid organ transplant|solid organ transplant
688666|NCT00677989|perforated appendicitis|perforated appendicitis
688667|NCT00677989|laparoscopic appendectomy|laparoscopic appendectomy
688668|NCT00677989|open appendectomy|open appendectomy
688669|NCT00677989|cytokines|cytokines
688670|NCT00677989|free radicals|free radicals
688671|NCT00677989|oxidized proteins|oxidized proteins
688672|NCT00677976|fMRI|fmri
688673|NCT00677976|IBS|ibs
688674|NCT00677976|Brain Activation|brain activation
688675|NCT00677963|carotid|carotid
688676|NCT00677963|atherosclerosis|atherosclerosis
688677|NCT00677963|arteriosclerosis|arteriosclerosis
688678|NCT00677963|plaque|plaque
688679|NCT00677963|neovascularization|neovascularization
688680|NCT00677963|carotid endarterectomy|carotid endarterectomy
688681|NCT00677950|Degenerative Disc Disease|degenerative disc disease
688682|NCT00677937|diabetes mellitus|diabetes mellitus
688683|NCT00677937|prevention|prevention
688684|NCT00677937|education|education
688685|NCT00677937|impaired glucose tolerance|impaired glucose tolerance
688686|NCT00677937|multi-ethnic|multi-ethnic
688687|NCT00677924|Colorectal Neoplasms|colorectal neoplasms
688688|NCT00677924|Colorectal Tumors|colorectal tumors
688689|NCT00677924|Colorectal Carcinoma|colorectal carcinoma
688690|NCT00677911|Chronic pain|chronic pain
688691|NCT00677911|Interleukin-6|interleukin-6
688692|NCT00677911|pain catastrophizing|pain catastrophizing
688693|NCT00677911|cytokines|cytokines
688694|NCT00677911|cortisol|cortisol
688695|NCT00677898|Patient-Centered Care|patient-centered care
689210|NCT00675922|Cerium|cerium
688696|NCT00677898|Adverse effects|adverse effects
688697|NCT00677898|Antipsychotics|antipsychotics
688698|NCT00677885|Alzheimer Disease|alzheimer disease
688699|NCT00677885|Parkinson's Disease|parkinson's disease
688700|NCT00677885|Frontotemporal Dementia|frontotemporal dementia
688701|NCT00677885|PET Imaging|pet imaging
688702|NCT00677885|AD|ad
688703|NCT00677885|Parkinson Disease|parkinson disease
688704|NCT00677885|PD|pd
688705|NCT00677872|Moderate to severe COPD and coincident pulmonary hypertension|moderate to severe copd and coincident pulmonary hypertension
688706|NCT00677859|Leukemia|leukemia
688707|NCT00677859|Graft vs. Host Disease|graft vs. host disease
688708|NCT00677859|Hematopoietic Stem Cell Transplant|hematopoietic stem cell transplant
688709|NCT00677859|Bone Marrow Transplant|bone marrow transplant
688710|NCT00677859|Myelodysplasia|myelodysplasia
688711|NCT00677846|contrast agent ultrasound, vein thrombosis, vascularization|contrast agent ultrasound, vein thrombosis, vascularization
688712|NCT00677833|P. Falciparum Malaria|p. falciparum malaria
688713|NCT00677833|drug treatment|drug treatment
688714|NCT00677833|clinical trial|clinical trial
688715|NCT00677820|Influenza|influenza
688716|NCT00677820|FluMist|flumist
688717|NCT00677820|vaccine|vaccine
688718|NCT00677820|prevention|prevention
688719|NCT00677820|trivalent|trivalent
688720|NCT00677807|COPD|copd
688721|NCT00677807|adults|adults
688722|NCT00677807|β2-agonist|β2-agonist
688723|NCT00677807|indacaterol|indacaterol
688724|NCT00677794|Video Capsule Endoscopy|video capsule endoscopy
688725|NCT00677794|Small Bowel|small bowel
688726|NCT00677768|Biomarkers|biomarkers
688727|NCT00677768|Plasma|plasma
688728|NCT00677768|Cerebrospinal Fluid|cerebrospinal fluid
688729|NCT00677768|DNA|dna
688730|NCT00677768|Serum|serum
688731|NCT00677755|Medical abortion|medical abortion
688732|NCT00677755|emergency contraception|emergency contraception
688733|NCT00677755|mifepristone|mifepristone
688734|NCT00677742|oral contraception|oral contraception
688735|NCT00677742|hormonal contraception|hormonal contraception
688736|NCT00677742|contraceptive behavior|contraceptive behavior
688737|NCT00677742|patient compliance|patient compliance
688738|NCT00677729|bronchiolitis|bronchiolitis
688739|NCT00677729|hypertonic saline|hypertonic saline
688740|NCT00677729|infants|infants
688741|NCT00677716|glioblastoma multiforme|glioblastoma multiforme
688742|NCT00677716|GBM|gbm
688743|NCT00677716|brain cancer|brain cancer
688744|NCT00677716|Cotara|cotara
688745|NCT00677716|radioactive isotope|radioactive isotope
688746|NCT00677716|monoclonal antibody|monoclonal antibody
688747|NCT00677716|Glioblastoma multiforme at first relapse|glioblastoma multiforme at first relapse
688748|NCT00677703|birth control pills|birth control pills
688749|NCT00677703|contraception|contraception
688750|NCT00677703|continuation|continuation
688751|NCT00677703|text messaging|text messaging
688752|NCT00677703|contraceptive continuation|contraceptive continuation
688753|NCT00677703|contraceptive knowledge|contraceptive knowledge
688754|NCT00677690|COPD|copd
688755|NCT00677677|Lung transplant|lung transplant
688756|NCT00677677|Liver transplant|liver transplant
688757|NCT00677677|Kidney transplant|kidney transplant
688758|NCT00677677|Pancreas transplant|pancreas transplant
688759|NCT00677677|HPV|hpv
688760|NCT00677677|Human Papillomavirus Quadrivalent Vaccine|human papillomavirus quadrivalent vaccine
688761|NCT00677664|diabetic retinopathy|diabetic retinopathy
688762|NCT00677664|panretinal photocoagulation|panretinal photocoagulation
688763|NCT00677664|copaxone|copaxone
688764|NCT00677664|nerve fiber layer thickness|nerve fiber layer thickness
688765|NCT00677664|retinal function|retinal function
688766|NCT00677651|adipose|adipose
688767|NCT00677651|lean|lean
688768|NCT00677651|obese|obese
688769|NCT00677651|overweight|overweight
688770|NCT00677651|healthy|healthy
688771|NCT00677625|Liver|liver
688772|NCT00677625|Transplant|transplant
688773|NCT00677612|HLA-A*0201|hla-a*0201
688774|NCT00677612|Peptide Vaccine|peptide vaccine
688775|NCT00677612|VEGFR1|vegfr1
688776|NCT00677612|VEGFR2|vegfr2
688777|NCT00677599|Cardiovascular disease|cardiovascular disease
688778|NCT00677599|type 2 diabetes|type 2 diabetes
688779|NCT00677599|flavonoids|flavonoids
688780|NCT00677599|cocoa|cocoa
688781|NCT00677599|soy|soy
688782|NCT00677599|epicatechin|epicatechin
688783|NCT00677599|postmenopausal|postmenopausal
688784|NCT00677599|carotid intima media thickness|carotid intima media thickness
688785|NCT00677599|plaque volume|plaque volume
688786|NCT00677586|colorectal neoplasms|colorectal neoplasms
688787|NCT00677586|liver metastasis|liver metastasis
688788|NCT00677586|surgery|surgery
688789|NCT00677573|ART|art
688790|NCT00677573|poor responder|poor responder
688791|NCT00677573|GnRH antagonist|gnrh antagonist
688792|NCT00677573|Gonadotropins|gonadotropins
688793|NCT00677560|resistance|resistance
688794|NCT00677560|reactance|reactance
688795|NCT00677560|inflammation|inflammation
688796|NCT00677547|Kidney|kidney
688797|NCT00677547|Influenza vaccine|influenza vaccine
688798|NCT00677547|CMI|cmi
688799|NCT00677534|Endstage renal disease|endstage renal disease
688800|NCT00677534|Vitamin D|vitamin d
688801|NCT00677534|Monocyte function|monocyte function
688802|NCT00677508|Constipation|constipation
688803|NCT00677508|Fecal incontinence|fecal incontinence
688804|NCT00677508|Quality of life|quality of life
688805|NCT00677508|Health related quality of life|health related quality of life
688806|NCT00677495|Gluten-free diet|gluten-free diet
688807|NCT00677495|Celiac Disease|celiac disease
688808|NCT00677495|Genetic predisposition|genetic predisposition
688809|NCT00677495|Phage display library|phage display library
688810|NCT00677495|Autoimmune diseases|autoimmune diseases
688811|NCT00677482|liver transplant|liver transplant
688812|NCT00677482|lung transplant|lung transplant
688813|NCT00677482|kidney transplant|kidney transplant
688814|NCT00677482|heart transplant|heart transplant
688815|NCT00677482|CMV microRNA|cmv microrna
688816|NCT00677469|Hyperthyroidism|hyperthyroidism
688817|NCT00677469|Cholestyramine|cholestyramine
688818|NCT00677456|Gastric Cancer|gastric cancer
688819|NCT00677456|total gastrectomy|total gastrectomy
688820|NCT00677456|reconstruction|reconstruction
688821|NCT00677456|life quality|life quality
688822|NCT00677443|metastatic colorectal cancer|metastatic colorectal cancer
688824|NCT00677443|Capecitabine|capecitabine
688825|NCT00677443|Oxaliplatin|oxaliplatin
688826|NCT00677443|non-inferiority study|non-inferiority study
688827|NCT00677430|Breast Cancer|breast cancer
688828|NCT00677430|Breast Reconstruction|breast reconstruction
688829|NCT00677430|Digital Imaging|digital imaging
688830|NCT00677430|Questionnaire|questionnaire
688831|NCT00677430|Survey|survey
688832|NCT00677404|Peripheral vascular diseases|peripheral vascular diseases
688833|NCT00677404|chronic lower limb ischemia|chronic lower limb ischemia
688834|NCT00677391|Obesity|obesity
688835|NCT00677378|TRPV1|trpv1
688836|NCT00677378|Nerve growth factor|nerve growth factor
688837|NCT00677378|Capsaicin|capsaicin
688838|NCT00677378|TrkA|trka
688839|NCT00677378|Retrosternal pain|retrosternal pain
688840|NCT00677378|Epigastric pain|epigastric pain
688841|NCT00677378|Esophagitis|esophagitis
688842|NCT00677378|Gastrointestinal symptoms|gastrointestinal symptoms
688843|NCT00677352|Panic Disorder|panic disorder
688844|NCT00677339|Tuberculosis|tuberculosis
688845|NCT00677339|Adjunctive therapy|adjunctive therapy
688846|NCT00677339|L-arginine|l-arginine
688847|NCT00677339|Nitric oxide|nitric oxide
688848|NCT00677339|Vitamin D|vitamin d
688849|NCT00677326|HLA-A*0201|hla-a*0201
688850|NCT00677326|Peptide Vaccine|peptide vaccine
688851|NCT00677326|VEGFR1|vegfr1
688852|NCT00677326|VEGFR2|vegfr2
688853|NCT00677313|metreleptin|metreleptin
688854|NCT00677313|leptin|leptin
688855|NCT00677313|Amylin|amylin
688856|NCT00677313|diabetes mellitus|diabetes mellitus
688857|NCT00677313|hypertriglyceridemia|hypertriglyceridemia
688858|NCT00677313|lipodystrophy|lipodystrophy
688859|NCT00677300|HIV|hiv
688860|NCT00677300|Treatment Naive|treatment naive
688861|NCT00677287|HLA-A*2402|hla-a*2402
688862|NCT00677287|Peptide Vaccine|peptide vaccine
688863|NCT00677287|RNF43|rnf43
688864|NCT00677287|TOMM34|tomm34
688865|NCT00677287|VEGFR1|vegfr1
688866|NCT00677287|VEGFR2|vegfr2
688867|NCT00677274|Epidural analgesia|epidural analgesia
688868|NCT00677274|Patient-controlled analgesia|patient-controlled analgesia
688869|NCT00677261|Knee|knee
688870|NCT00677261|Arthroplasty|arthroplasty
688871|NCT00677261|Sciatic|sciatic
688872|NCT00677261|Nerve|nerve
688873|NCT00677261|Block|block
688874|NCT00677261|Regional|regional
688875|NCT00677261|Anesthesia|anesthesia
688876|NCT00677261|Infiltration|infiltration
688877|NCT00677261|Local Anesthetic|local anesthetic
688878|NCT00677261|Analgesia|analgesia
688879|NCT00677248|Eprotirome|eprotirome
688880|NCT00677248|KB2115|kb2115
688881|NCT00677248|dyslipidemia|dyslipidemia
688882|NCT00677248|hypercholesterolemia|hypercholesterolemia
688883|NCT00677248|hypertriglyceridemia|hypertriglyceridemia
688884|NCT00677235|Hemodialysis|hemodialysis
688885|NCT00677235|Vascular Prosthesis|vascular prosthesis
688886|NCT00677235|Stenosis|stenosis
688887|NCT00677235|End-stage Renal Disease (ESRD)|end-stage renal disease (esrd)
688888|NCT00677222|Acute Myocardial Infarction, Heart Attack|acute myocardial infarction, heart attack
688889|NCT00677209|house dust mite|house dust mite
688890|NCT00677209|asthma|asthma
688891|NCT00677209|autovaccine|autovaccine
688892|NCT00677209|allergy|allergy
688893|NCT00677196|PNL|pnl
688894|NCT00677196|Lithoclast|lithoclast
688895|NCT00677196|Stonebreaker|stonebreaker
688896|NCT00677196|efficiency stone fragmentation|efficiency stone fragmentation
688897|NCT00677183|NASH|nash
688898|NCT00677183|Biomarker|biomarker
688899|NCT00677157|Fatigue|fatigue
688900|NCT00677157|Fibromyalgia|fibromyalgia
688901|NCT00677157|Pain|pain
688902|NCT00677157|Complex Regional Pain Syndrome|complex regional pain syndrome
688903|NCT00677157|Reflex Sympathetic Dystrophy|reflex sympathetic dystrophy
688904|NCT00677157|CPRS|cprs
688905|NCT00677157|RSD|rsd
688906|NCT00677144|Colorectal Neoplasm|colorectal neoplasm
688907|NCT00677144|S-1|s-1
688908|NCT00677144|Capecitabine|capecitabine
688909|NCT00677144|Oxaliplatin|oxaliplatin
688910|NCT00677131|pediatrics|pediatrics
688911|NCT00677131|antibiotics|antibiotics
688912|NCT00677131|patient education|patient education
688913|NCT00677118|Nasopharyngeal carcinoma|nasopharyngeal carcinoma
688914|NCT00677118|Concurrent chemoradiotherapy|concurrent chemoradiotherapy
688915|NCT00677118|Adjuvant chemotherapy|adjuvant chemotherapy
688916|NCT00677118|Clinical trial|clinical trial
688917|NCT00677105|Lymphoma|lymphoma
688918|NCT00677105|Neoplasms|neoplasms
688919|NCT00677105|Solid Tumors|solid tumors
688920|NCT00677105|Advanced Cancer|advanced cancer
688921|NCT00677092|Treatment|treatment
688922|NCT00677092|Chronic kidney disease|chronic kidney disease
688923|NCT00677092|Fibrosing disorders|fibrosing disorders
688924|NCT00677092|Imatinib mesylate|imatinib mesylate
688925|NCT00677079|BRCA-1 or BRCA-2 associated advanced epithelial ovarian, fallopian tube, or primary peritoneal cancer|brca-1 or brca-2 associated advanced epithelial ovarian, fallopian tube, or primary peritoneal cancer
688926|NCT00677079|BRCA-1|brca-1
688927|NCT00677079|BRCA-2|brca-2
688928|NCT00677066|bronchiolitis|bronchiolitis
688929|NCT00677066|oxygen|oxygen
688930|NCT00677066|children|children
688931|NCT00677053|Unstable Angina|unstable angina
688932|NCT00677053|Myocardial Infarction|myocardial infarction
688933|NCT00677053|Thrombolysis|thrombolysis
688934|NCT00677053|Anticoagulant|anticoagulant
688935|NCT00677053|Acute Coronary Syndrome|acute coronary syndrome
688936|NCT00677027|Beta-glucan|beta-glucan
688937|NCT00677027|immune system|immune system
688938|NCT00677027|Healthy subjects|healthy subjects
688939|NCT00677014|Heart Failure|heart failure
688940|NCT00677014|HF|hf
688941|NCT00677014|Cardiac Resynchronization Therapy|cardiac resynchronization therapy
688942|NCT00677014|CRT|crt
688943|NCT00677014|Optimization|optimization
688944|NCT00677014|SmartDelay|smartdelay
688945|NCT00677014|Echocardiography|echocardiography
688946|NCT00677014|AV Delay|av delay
688947|NCT00677001|Solid tumors|solid tumors
688948|NCT00677001|solid malignancies|solid malignancies
688949|NCT00677001|neoplasms|neoplasms
688950|NCT00677001|refractory solid tumors|refractory solid tumors
688951|NCT00677001|advanced solid tumors|advanced solid tumors
688952|NCT00676988|Luminal Crohn's Disease|luminal crohn's disease
688953|NCT00676988|Infliximab|infliximab
688954|NCT00676975|Irritable Bowel disease|irritable bowel disease
688955|NCT00676975|Traditional Chinese Medicine|traditional chinese medicine
688956|NCT00676962|Implementation|implementation
688957|NCT00676962|facilitation|facilitation
688958|NCT00676962|psychotherapy|psychotherapy
688959|NCT00676962|training|training
688960|NCT00676949|epitope peptide|epitope peptide
688961|NCT00676949|cyclophosphamide|cyclophosphamide
688962|NCT00676949|interleukin-2|interleukin-2
688963|NCT00676936|Cancer|cancer
688964|NCT00676936|pain|pain
688965|NCT00676936|corticosteroids|corticosteroids
688966|NCT00676936|palliative|palliative
688967|NCT00676936|supportive care|supportive care
688968|NCT00676936|Cancer patients with pain|cancer patients with pain
688969|NCT00676910|Advanced Cancer|advanced cancer
688970|NCT00676910|Malignancies|malignancies
688971|NCT00676910|Neoplasms|neoplasms
688972|NCT00676910|Incurable Solid Cancers|incurable solid cancers
688973|NCT00676897|statin, sepsis, septic shock, simvastatin|statin, sepsis, septic shock, simvastatin
688974|NCT00676884|atopic eczema|atopic eczema
688975|NCT00676884|atopic dermatitis|atopic dermatitis
688976|NCT00676884|allergy|allergy
688977|NCT00676858|Embolism|embolism
688978|NCT00676858|Argon|argon
688979|NCT00676845|Arterial stiffness|arterial stiffness
688980|NCT00676845|Vascular protection|vascular protection
688981|NCT00676832|colitis|colitis
688982|NCT00676832|ulcerative|ulcerative
688983|NCT00676832|moderate|moderate
688984|NCT00676832|severe|severe
688985|NCT00676806|Umbilical cord blood transplantation|umbilical cord blood transplantation
688986|NCT00676806|full ablation conditioning|full ablation conditioning
688987|NCT00676806|reduced intensity conditioning|reduced intensity conditioning
688988|NCT00676793|breast cancer|breast cancer
688989|NCT00676793|EGCG|egcg
688990|NCT00676793|Polyphenon E|polyphenon e
688991|NCT00676793|c-Met|c-met
688992|NCT00676793|VEGF|vegf
688993|NCT00676793|HGF|hgf
688994|NCT00676780|EGCG|egcg
688995|NCT00676780|polyphenols|polyphenols
688996|NCT00676780|biomarkers|biomarkers
688997|NCT00676780|prostate specific antigen|prostate specific antigen
688998|NCT00676767|Aging|aging
688999|NCT00676767|Diabetes|diabetes
689000|NCT00676767|Diet|diet
689001|NCT00676767|Fiber|fiber
689002|NCT00676754|Multidrug-Resistant Tuberculosis, tuberculosis, Peru|multidrug-resistant tuberculosis, tuberculosis, peru
689003|NCT00676728|Advanced or Refractory Leukemia|advanced or refractory leukemia
689004|NCT00676728|Myelodysplastic Syndromes|myelodysplastic syndromes
689005|NCT00676728|JNJ 26481585|jnj 26481585
689006|NCT00676728|Histone-Deacetylase Inhibitor|histone-deacetylase inhibitor
689007|NCT00676728|Advanced Leukemia|advanced leukemia
689008|NCT00676728|Refractory Leukemia|refractory leukemia
689211|NCT00675922|Dakins|dakins
689009|NCT00676702|Pancrelipase|pancrelipase
689010|NCT00676702|PANCREASE MT|pancrease mt
689011|NCT00676702|Cross-Over Studies|cross-over studies
689012|NCT00676702|Duodenum|duodenum
689013|NCT00676702|Intestine, Small|intestine, small
689015|NCT00676702|Amylases|amylases
689016|NCT00676702|Peptide Hydrolases|peptide hydrolases
689017|NCT00676702|Intubation|intubation
689018|NCT00676702|Safety|safety
689019|NCT00676702|Capsules|capsules
689020|NCT00676689|Pulmonic|pulmonic
689021|NCT00676689|Regurgitation|regurgitation
689022|NCT00676689|Pulmonary Valve Conduit|pulmonary valve conduit
689023|NCT00676689|Stenosis|stenosis
689024|NCT00676689|Congenital Heart Defect|congenital heart defect
689025|NCT00676676|Depression|depression
689026|NCT00676676|Major Depressive Disorder|major depressive disorder
689027|NCT00676663|Breast Neoplasms|breast neoplasms
689028|NCT00676663|Breast Tumor|breast tumor
689029|NCT00676663|Mammary Neoplasms|mammary neoplasms
689030|NCT00676650|Docetaxel-refractory mCRPC|docetaxel-refractory mcrpc
689031|NCT00676650|Second-line treatment with sunitinib and prednisone|second-line treatment with sunitinib and prednisone
689032|NCT00676637|Adherence|adherence
689033|NCT00676637|Compliance|compliance
689034|NCT00676637|Glaucoma|glaucoma
689035|NCT00676637|Ocular Hypertension|ocular hypertension
689036|NCT00676624|uveitis|uveitis
689037|NCT00676624|vitrectomy|vitrectomy
689038|NCT00676624|infection|infection
689039|NCT00676624|severe|severe
689040|NCT00676611|Acetabular Fractures|acetabular fractures
689041|NCT00676598|therapeutic hypothermia|therapeutic hypothermia
689042|NCT00676585|Cardiac Arrest, Shock, Steroids|cardiac arrest, shock, steroids
689043|NCT00676572|severe asthma|severe asthma
689044|NCT00676572|corticosteroid insensitivity|corticosteroid insensitivity
689045|NCT00676559|Diabetic|diabetic
689046|NCT00676559|Macular|macular
689047|NCT00676559|Edema|edema
689048|NCT00676559|DME|dme
689049|NCT00676559|Clinically Significant Macular Edema (CSME)|clinically significant macular edema (csme)
689050|NCT00676533|Cipro|cipro
689051|NCT00676533|Urinary Tract Infection|urinary tract infection
689052|NCT00676520|Angioplasty|angioplasty
689053|NCT00676520|Coronary Restenosis|coronary restenosis
689054|NCT00676520|Coronary Artery Disease|coronary artery disease
689055|NCT00676520|Coronary Artery Restenosis|coronary artery restenosis
689056|NCT00676520|Coronary Artery Stenosis|coronary artery stenosis
689057|NCT00676520|Total Artery Occlusion|total artery occlusion
689058|NCT00676520|Stents|stents
689059|NCT00676520|Stent Thrombosis|stent thrombosis
689060|NCT00676520|Total Coronary Occlusion|total coronary occlusion
689061|NCT00676520|Vascular Disease|vascular disease
689062|NCT00676520|Myocardial Ischemia|myocardial ischemia
689063|NCT00676507|Gene therapy|gene therapy
689064|NCT00676507|Flow cytometry|flow cytometry
689065|NCT00676507|Immunoenzyme technique|immunoenzyme technique
689066|NCT00676507|Laboratory biomarker analysis|laboratory biomarker analysis
689067|NCT00676507|Quality-of-life-assessment|quality-of-life-assessment
689068|NCT00676507|Tumor cell-derivative vaccine therapy|tumor cell-derivative vaccine therapy
689069|NCT00676481|Patient Education|patient education
689070|NCT00676481|Emergency Medicine|emergency medicine
689071|NCT00676481|HIV Prevention|hiv prevention
689072|NCT00676481|HIV Seronegativity|hiv seronegativity
689073|NCT00676468|Asthma|asthma
689074|NCT00676468|Inflammation|inflammation
689075|NCT00676468|Airway|airway
689076|NCT00676468|Fish Oil|fish oil
689077|NCT00676468|Singulair|singulair
689078|NCT00676455|CT Software|ct software
689079|NCT00676455|MeVis™|mevis™
689080|NCT00676455|Metastatic pulmonary and hepatic lesion growth|metastatic pulmonary and hepatic lesion growth
689081|NCT00676416|General anesthesia|general anesthesia
689082|NCT00676416|Propofol|propofol
689083|NCT00676416|Immunity|immunity
689084|NCT00676416|Alveolar Macrophages|alveolar macrophages
689085|NCT00676403|pregabalin, RLS, efficacy, safety|pregabalin, rls, efficacy, safety
689086|NCT00676390|Heart Failure|heart failure
689087|NCT00676377|Neostigmine, Post Operative, Ileus|neostigmine, post operative, ileus
689088|NCT00676364|pediatric patients|pediatric patients
689089|NCT00676364|pain|pain
689090|NCT00676364|anxiety|anxiety
689091|NCT00676364|topical anesthetic|topical anesthetic
689092|NCT00676364|randomized control trial|randomized control trial
689093|NCT00676338|Amylin|amylin
689094|NCT00676338|Lilly|lilly
689095|NCT00676338|exenatide once weekly|exenatide once weekly
689096|NCT00676338|Byetta|byetta
689097|NCT00676338|Januvia|januvia
689098|NCT00676338|sitagliptin|sitagliptin
689099|NCT00676338|thiazolidinedione|thiazolidinedione
689100|NCT00676325|anterior vaginal prolapse|anterior vaginal prolapse
689101|NCT00676325|traditional treatment|traditional treatment
689102|NCT00676325|mesh, graft|mesh, graft
689103|NCT00676325|NAZCA TC™ POP REPAIR SYSTEM|nazca tc™ pop repair system
689104|NCT00676325|colporrhaphy|colporrhaphy
689105|NCT00676312|Osteoporosis|osteoporosis
689106|NCT00676312|parathyroid hormone|parathyroid hormone
689107|NCT00676312|pharmacodynamic|pharmacodynamic
689108|NCT00676312|pharmacokinetic|pharmacokinetic
689109|NCT00676299|Advanced Solid Cancers|advanced solid cancers
689110|NCT00676299|Refractory Solid Cancers|refractory solid cancers
689111|NCT00676299|Protein Kinase Inhibitors|protein kinase inhibitors
689112|NCT00676299|Phase 1 Study|phase 1 study
689113|NCT00676299|Oral Chemotherapy|oral chemotherapy
689114|NCT00676286|Prostate cancer active surveillance|prostate cancer active surveillance
689115|NCT00676286|3 Tesla MR biological imaging in prostate cancer|3 tesla mr biological imaging in prostate cancer
689116|NCT00676286|tumor gene re-arrangements in prostate cancer|tumor gene re-arrangements in prostate cancer
689117|NCT00676260|Glucose Metabolism Disorder|glucose metabolism disorder
689118|NCT00676260|Dysmetabolic Syndrome|dysmetabolic syndrome
689119|NCT00676260|Type II Diabetes|type ii diabetes
689120|NCT00676260|Diabetes Mellitus|diabetes mellitus
689121|NCT00676260|Lipoatrophic|lipoatrophic
689122|NCT00676260|Dyslipidemia|dyslipidemia
689123|NCT00676260|Drug Therapy|drug therapy
689124|NCT00676247|Ultrasonography|ultrasonography
689125|NCT00676247|Doppler|doppler
689126|NCT00676247|Hemodynamics|hemodynamics
689127|NCT00676247|Neurobehavioral development|neurobehavioral development
689128|NCT00676234|erythropoietin|erythropoietin
689129|NCT00676221|Renal transplant recipient|renal transplant recipient
689130|NCT00676221|Immunosuppression|immunosuppression
689131|NCT00676221|Gastro-intestinal symptoms|gastro-intestinal symptoms
689132|NCT00676221|Quality of life|quality of life
689133|NCT00676221|Cellcept|cellcept
689134|NCT00676221|Myfortic|myfortic
689135|NCT00676221|Kidney transplant patients.|kidney transplant patients.
689136|NCT00676208|Shared Medical Appointments|shared medical appointments
689137|NCT00676208|Diabetes|diabetes
689138|NCT00676208|Education|education
689139|NCT00676195|N-Acetyl Cysteine|n-acetyl cysteine
689140|NCT00676169|Pseudomonas aeruginosa|pseudomonas aeruginosa
689141|NCT00676169|EPIC|epic
689142|NCT00676156|multiple sclerosis|multiple sclerosis
689143|NCT00676156|lipoic acid|lipoic acid
689144|NCT00676156|LA|la
689145|NCT00676156|pharmacokinetics|pharmacokinetics
689146|NCT00676156|immunological effects|immunological effects
689147|NCT00676143|antibody|antibody
689148|NCT00676143|immunotherapy|immunotherapy
689149|NCT00676130|Cellulitis|cellulitis
689150|NCT00676130|Bactrim|bactrim
689151|NCT00676130|Trimethoprim Sulfamethoxazole|trimethoprim sulfamethoxazole
689152|NCT00676130|MRSA|mrsa
689153|NCT00676130|Methicillin-resistant Staphylococcus aureus|methicillin-resistant staphylococcus aureus
689154|NCT00676117|male|male
689155|NCT00676117|Japan|japan
689156|NCT00676117|Japanese|japanese
689157|NCT00676117|Healthy volunteers|healthy volunteers
689158|NCT00676104|Traumatic Brain Injury|traumatic brain injury
689159|NCT00676104|Trauma|trauma
689160|NCT00676104|Hypothermia|hypothermia
689161|NCT00676091|Pneumococcal conjugate vaccine|pneumococcal conjugate vaccine
689162|NCT00676065|Contraception|contraception
689163|NCT00676065|Thromboembolism|thromboembolism
689164|NCT00676065|Breast Cancer|breast cancer
689165|NCT00676052|COPD|copd
689166|NCT00676052|Multicenter|multicenter
689167|NCT00676052|GSK233705B|gsk233705b
689168|NCT00676052|double-blind|double-blind
689169|NCT00676052|Chronic Obstructive Pulmonary Disease (COPD)|chronic obstructive pulmonary disease (copd)
689170|NCT00676052|randomized|randomized
689171|NCT00676039|Therapeutic Equivalency|therapeutic equivalency
689172|NCT00676039|Human Experimentation|human experimentation
689173|NCT00676039|Bioequivalence|bioequivalence
689174|NCT00676039|Brand name|brand name
689175|NCT00676039|Generic|generic
689176|NCT00676039|Antidepressant|antidepressant
689177|NCT00676039|Healthy volunteers|healthy volunteers
689178|NCT00676026|menses|menses
689179|NCT00676026|women|women
689180|NCT00676026|healthy controls|healthy controls
689181|NCT00676026|Healthy females with regular menstrual cycles|healthy females with regular menstrual cycles
689182|NCT00676013|Burns|burns
689183|NCT00676013|Skin grafting|skin grafting
689184|NCT00676013|AlloDerm|alloderm
689185|NCT00676013|Integra|integra
689186|NCT00676013|Homograft|homograft
689187|NCT00676013|Autograft|autograft
689188|NCT00676013|Burn Scar|burn scar
689189|NCT00675987|Impaired Fasting Glucose FPG >100-<126 mg/dL|impaired fasting glucose fpg >100-<126 mg/dl
689190|NCT00675974|Burn|burn
689191|NCT00675974|Scar|scar
689192|NCT00675974|Pressure garments|pressure garments
689193|NCT00675974|Wound healing|wound healing
689194|NCT00675974|Burn Injury|burn injury
689195|NCT00675961|Tomsk|tomsk
689196|NCT00675961|TB-Alcohol|tb-alcohol
689197|NCT00675961|Alcohol and co-occurring disease|alcohol and co-occurring disease
689198|NCT00675961|Brief counseling intervention|brief counseling intervention
689199|NCT00675961|Naltrexone|naltrexone
689200|NCT00675948|Palliative Care|palliative care
689201|NCT00675948|Pain|pain
689202|NCT00675948|Cancer|cancer
689203|NCT00675935|Patient falls|patient falls
689204|NCT00675935|fall risk|fall risk
689205|NCT00675935|fall prevention|fall prevention
689206|NCT00675922|Burn|burn
689207|NCT00675922|Wounds|wounds
689208|NCT00675922|Wound infection|wound infection
689209|NCT00675922|Topical antimicrobials|topical antimicrobials
689212|NCT00675922|Sulfamylon Soaks|sulfamylon soaks
689213|NCT00675922|Silver Nitrate|silver nitrate
689214|NCT00675909|Sedation|sedation
689215|NCT00675909|Anxiety|anxiety
689216|NCT00675909|Minor procedures|minor procedures
689217|NCT00675909|Emergency Department|emergency department
689218|NCT00675896|major depression with comorbid fibromyalgia.|major depression with comorbid fibromyalgia.
689219|NCT00675870|Acute Promyelocytic Leukemia|acute promyelocytic leukemia
689220|NCT00675870|Cancer|cancer
689221|NCT00675870|Leukemia|leukemia
689222|NCT00675870|APL|apl
689223|NCT00675870|ATRA|atra
689224|NCT00675870|Tretinoid|tretinoid
689225|NCT00675870|Vesanoid|vesanoid
689226|NCT00675870|Retinoic Acid Receptor Alpha|retinoic acid receptor alpha
689227|NCT00675870|All Trans Retinoic Acid|all trans retinoic acid
689228|NCT00675870|Arsenic Trioxide|arsenic trioxide
689229|NCT00675870|Trisenox|trisenox
689230|NCT00675870|Retinoid|retinoid
689231|NCT00675870|Relapsed or Refractory Acute Promyelocytic Leukemia|relapsed or refractory acute promyelocytic leukemia
689232|NCT00675857|Type II diabetes|type ii diabetes
689233|NCT00675857|Metabolic syndrome|metabolic syndrome
689234|NCT00675844|Extension study|extension study
689235|NCT00675844|HIV-1 infection|hiv-1 infection
689236|NCT00675844|Treatment Naive|treatment naive
689237|NCT00675831|CD25+|cd25+
689238|NCT00675831|Tregs|tregs
689239|NCT00675831|DLI|dli
689240|NCT00675831|Donor lymphocyte infusion|donor lymphocyte infusion
689241|NCT00675818|acute kidney injury|acute kidney injury
689242|NCT00675818|renal replacement therapy|renal replacement therapy
689243|NCT00675818|critical care unit|critical care unit
689244|NCT00675818|hemodialysis|hemodialysis
689245|NCT00675818|hemofiltration|hemofiltration
689246|NCT00675805|intravenous immunoglobulin|intravenous immunoglobulin
689247|NCT00675805|IVIG|ivig
689248|NCT00675805|adverse reactions|adverse reactions
689249|NCT00675779|endometriosis|endometriosis
689250|NCT00675779|atorvastatin|atorvastatin
689251|NCT00675779|oral|oral
689252|NCT00675779|contraception|contraception
689253|NCT00675779|pain|pain
689254|NCT00675779|relief|relief
689255|NCT00675779|pelvic pain in women with endometriosis|pelvic pain in women with endometriosis
689256|NCT00675753|Genes|genes
689257|NCT00675753|Ethnology|ethnology
689258|NCT00675753|Cytokines|cytokines
689259|NCT00675753|prematurity|prematurity
689260|NCT00675727|Melanoma|melanoma
689261|NCT00675727|Mycobacterium w|mycobacterium w
689262|NCT00675714|anabolic agents|anabolic agents
689263|NCT00675714|exercise|exercise
689264|NCT00675701|To determine whether lixivaptan administration at supratherapeutic or therapeutic doses results in the prolongation of the QTc interval.|to determine whether lixivaptan administration at supratherapeutic or therapeutic doses results in the prolongation of the qtc interval.
689265|NCT00675688|Menopause|menopause
689266|NCT00675675|Tourette Syndrome|tourette syndrome
689267|NCT00675675|Chronic Tic Disorder|chronic tic disorder
689268|NCT00675675|Tics|tics
689269|NCT00675675|Behavior Therapy|behavior therapy
689270|NCT00675675|Habit Reversal Training|habit reversal training
689271|NCT00675675|Child|child
689272|NCT00675675|Adolescent|adolescent
689273|NCT00675675|Neuroimaging|neuroimaging
689274|NCT00675662|Obesity|obesity
689275|NCT00675662|overweight|overweight
689276|NCT00675662|BMI|bmi
689277|NCT00675662|ifestyle|ifestyle
689278|NCT00675662|diet|diet
689279|NCT00675662|nutrition|nutrition
689280|NCT00675662|physical activity|physical activity
689281|NCT00675662|pre-school|pre-school
689282|NCT00675662|toddlers|toddlers
689283|NCT00675662|children|children
689284|NCT00675662|Prevention of overweight and obesity in pre-school children|prevention of overweight and obesity in pre-school children
689285|NCT00675649|Injections|injections
689286|NCT00675649|Severe, persistent asthma|severe, persistent asthma
689287|NCT00675636|colon cancer|colon cancer
689288|NCT00675636|hereditary non-polyposis colon cancer|hereditary non-polyposis colon cancer
689289|NCT00675636|rectal cancer|rectal cancer
689290|NCT00675636|familial adenomatous polyposis|familial adenomatous polyposis
689291|NCT00675623|Alzheimer's disease, clinical trial, memory loss, mitochondria,|alzheimer's disease, clinical trial, memory loss, mitochondria,
689292|NCT00675623|investigational drug, neurodegenerative disease, dementia|investigational drug, neurodegenerative disease, dementia
689293|NCT00675610|communication|communication
689294|NCT00675610|HIV/AIDS|hiv/aids
689295|NCT00675610|Treatment Experienced|treatment experienced
689296|NCT00675597|Bevacizumab (Avastin)|bevacizumab (avastin)
689297|NCT00675597|Taxotere (Docetaxel)|taxotere (docetaxel)
689298|NCT00675597|Vinorelbine Tartrate (Navelbine)|vinorelbine tartrate (navelbine)
689299|NCT00675597|07-178|07-178
689300|NCT00675558|Obesity|obesity
689301|NCT00675558|morbid obesity|morbid obesity
689302|NCT00675558|bariatric surgery|bariatric surgery
689303|NCT00675532|Opioids, vivitrol, naltrexone, primary care|opioids, vivitrol, naltrexone, primary care
689304|NCT00675519|problem drinkers|problem drinkers
689305|NCT00675506|Growth Hormone Releasing Hormone|growth hormone releasing hormone
689306|NCT00675506|Growth Hormone Pulse|growth hormone pulse
689307|NCT00675506|Visceral Adipose Tissue|visceral adipose tissue
689308|NCT00675506|Carotid Intima-Media Thickness|carotid intima-media thickness
689309|NCT00675480|myocardial infarction, thrombectomy, salvage index|myocardial infarction, thrombectomy, salvage index
689310|NCT00675467|Pediatric Cancer|pediatric cancer
689311|NCT00675467|Focus Group|focus group
689312|NCT00675467|Pediatric cancer patients|pediatric cancer patients
689313|NCT00675467|Parents of Pediatric cancer patients|parents of pediatric cancer patients
689314|NCT00675467|Pediatric Palliative Care Program|pediatric palliative care program
689315|NCT00675454|COPD|copd
689316|NCT00675454|Lung Volume Reduction Surgery|lung volume reduction surgery
689317|NCT00675454|Lung Transplant|lung transplant
689318|NCT00675454|Quality of Life|quality of life
689319|NCT00675441|Chronic Graft-versus-Host Disease|chronic graft-versus-host disease
689320|NCT00675441|cGVHD|cgvhd
689321|NCT00675441|GVHD|gvhd
689322|NCT00675441|Lenalidomide|lenalidomide
689323|NCT00675441|Revlimid|revlimid
689324|NCT00675441|CC-5013|cc-5013
689325|NCT00675441|Stem Cell Transplant|stem cell transplant
689326|NCT00675441|Allogeneic hematopoietic stem cell transplantation|allogeneic hematopoietic stem cell transplantation
689327|NCT00675441|Allogeneic HSCT|allogeneic hsct
689328|NCT00675441|HSCT|hsct
689329|NCT00675441|Post-Transplant Prophylactic Immunosuppressive Therapy|post-transplant prophylactic immunosuppressive therapy
689330|NCT00675441|Steroids|steroids
689331|NCT00675441|Standard-of-care steroid treatment|standard-of-care steroid treatment
689332|NCT00675441|Corticosteroids|corticosteroids
689333|NCT00675441|Prednisone|prednisone
689334|NCT00675441|Medrol|medrol
689335|NCT00675428|Relapsed or refractory Multiple Myeloma|relapsed or refractory multiple myeloma
689336|NCT00675415|Hypoxemia|hypoxemia
689337|NCT00675415|Capnography|capnography
689338|NCT00675415|Apnea|apnea
689339|NCT00675415|Sedation|sedation
689340|NCT00675415|ERCP|ercp
689343|NCT00675389|AIDS|aids
689344|NCT00675389|Community Health Workers|community health workers
689345|NCT00675389|Mobile Phones|mobile phones
689346|NCT00675389|Adherence|adherence
689347|NCT00675389|Antiretroviral Therapy|antiretroviral therapy
689348|NCT00675376|COPD|copd
689349|NCT00675376|Lung Transplant|lung transplant
689350|NCT00675376|Quality of Life|quality of life
689351|NCT00675376|End Stage Lung Disease|end stage lung disease
689352|NCT00675363|ICU|icu
689353|NCT00675363|Sedation strategies|sedation strategies
689354|NCT00675363|Daily sedative interruption|daily sedative interruption
689355|NCT00675363|Sedation protocols|sedation protocols
689356|NCT00675363|Mechanical Ventilation|mechanical ventilation
689357|NCT00675363|Sedation|sedation
689358|NCT00675350|Omacetaxine|omacetaxine
689359|NCT00675350|Homoharringtonine|homoharringtonine
689360|NCT00675350|HHT|hht
689361|NCT00675350|Solid and hematologic malignant tumors|solid and hematologic malignant tumors
689362|NCT00675337|iron stores|iron stores
689363|NCT00675337|anemia|anemia
689364|NCT00675337|iron deficiency|iron deficiency
689365|NCT00675337|infancy|infancy
689366|NCT00675337|placental transfusion|placental transfusion
689367|NCT00675337|iron deficiency in infancy|iron deficiency in infancy
689368|NCT00675337|anemia in infancy|anemia in infancy
689369|NCT00675337|placement of neonate|placement of neonate
689370|NCT00675324|Colonoscopy|colonoscopy
689371|NCT00675324|Bowel preparation|bowel preparation
689372|NCT00675324|Salt and electrolyte balance|salt and electrolyte balance
689373|NCT00675324|Patients undergoing colonoscopy|patients undergoing colonoscopy
689374|NCT00675324|Complication with traditional bowel preparation|complication with traditional bowel preparation
689375|NCT00675324|Bowel purity degree without traditional bowel preparation|bowel purity degree without traditional bowel preparation
689376|NCT00675311|Remote monitoring|remote monitoring
689377|NCT00675311|Type 1 Diabetes|type 1 diabetes
689378|NCT00675311|Type 2 diabetes|type 2 diabetes
689379|NCT00675298|Prostatitis|prostatitis
689380|NCT00675298|Cystitis, Interstitial|cystitis, interstitial
689381|NCT00675298|Urinary Bladder, Overactive|urinary bladder, overactive
689382|NCT00675298|Chronic pelvic pain syndrome|chronic pelvic pain syndrome
689383|NCT00675298|Painful bladder syndrome|painful bladder syndrome
689384|NCT00675298|Urgency|urgency
689385|NCT00675298|Frequency|frequency
689386|NCT00675285|airway inflammation|airway inflammation
689387|NCT00675285|childhood asthma|childhood asthma
689388|NCT00675285|fractional exhaled nitric oxide|fractional exhaled nitric oxide
689389|NCT00675285|leukotriene receptor antagonists|leukotriene receptor antagonists
689390|NCT00675285|lung function|lung function
689391|NCT00675272|brain death|brain death
689392|NCT00675272|subarachnoid hemorrhage|subarachnoid hemorrhage
689393|NCT00675272|traumatic brain injury|traumatic brain injury
689394|NCT00675272|brain injury|brain injury
689395|NCT00675272|intracerebral hemorrhage|intracerebral hemorrhage
689396|NCT00675272|organ donation|organ donation
689397|NCT00675259|stage II breast cancer|stage ii breast cancer
689398|NCT00675259|stage IIIA breast cancer|stage iiia breast cancer
689399|NCT00675259|stage IIIB breast cancer|stage iiib breast cancer
689400|NCT00675259|stage IIIC breast cancer|stage iiic breast cancer
689401|NCT00675246|corticoid therapy|corticoid therapy
689402|NCT00675246|fetal lung maturation|fetal lung maturation
689403|NCT00675246|late preterm|late preterm
689404|NCT00675246|respiratory distress syndrome|respiratory distress syndrome
689405|NCT00675246|neonatal death|neonatal death
689406|NCT00675233|recurrent squamous cell carcinoma of the larynx|recurrent squamous cell carcinoma of the larynx
689407|NCT00675233|stage I squamous cell carcinoma of the larynx|stage i squamous cell carcinoma of the larynx
689408|NCT00675233|stage III squamous cell carcinoma of the larynx|stage iii squamous cell carcinoma of the larynx
689409|NCT00675233|stage IV squamous cell carcinoma of the larynx|stage iv squamous cell carcinoma of the larynx
689410|NCT00675233|stage 0 laryngeal cancer|stage 0 laryngeal cancer
689411|NCT00675207|glaucoma|glaucoma
689412|NCT00675207|ocular hypertension|ocular hypertension
689413|NCT00675207|adjunctive treatment|adjunctive treatment
689414|NCT00675207|prostaglandin|prostaglandin
689415|NCT00675207|prostaglandin analog|prostaglandin analog
689416|NCT00675207|brimonidine|brimonidine
689417|NCT00675207|dorzolamide|dorzolamide
689418|NCT00675207|brinzolamide|brinzolamide
689419|NCT00675207|alpha agonist|alpha agonist
689420|NCT00675207|carbonic anhydrase inhibitor|carbonic anhydrase inhibitor
689421|NCT00675207|intraocular pressure|intraocular pressure
689422|NCT00675194|cisplatin|cisplatin
689423|NCT00675194|capecitabine|capecitabine
689424|NCT00675194|gastric|gastric
689425|NCT00675194|irinotecan|irinotecan
689426|NCT00675194|metastatic|metastatic
689427|NCT00675194|chemotherapy|chemotherapy
689428|NCT00675181|melatonin|melatonin
689429|NCT00675181|skin blood flow|skin blood flow
689430|NCT00675181|choroidal blood flow|choroidal blood flow
689431|NCT00675181|vasospastic subjects|vasospastic subjects
689432|NCT00675181|normal subjects|normal subjects
689433|NCT00675168|Lung Cancer|lung cancer
689434|NCT00675168|PET/CT|pet/ct
689435|NCT00675168|Diagnosis|diagnosis
689436|NCT00675155|Apoplexy|apoplexy
689437|NCT00675155|Cerebral Stroke|cerebral stroke
689438|NCT00675155|Cerebrovascular Accident|cerebrovascular accident
689439|NCT00675155|Cerebrovascular Accident, Acute|cerebrovascular accident, acute
689440|NCT00675155|Cerebrovascular Apoplexy|cerebrovascular apoplexy
689441|NCT00675155|Cerebrovascular Stroke|cerebrovascular stroke
689442|NCT00675142|Infertility|infertility
689443|NCT00675142|Intra-uterine insemination|intra-uterine insemination
689444|NCT00675142|ovarian stimulation|ovarian stimulation
689445|NCT00675116|safety,|safety,
689446|NCT00675116|healthy volunteers,|healthy volunteers,
689447|NCT00675116|GW823296,|gw823296,
689448|NCT00675116|pharmacokinetics|pharmacokinetics
689449|NCT00675103|Gout|gout
689450|NCT00675103|Gouty Arthritis|gouty arthritis
689451|NCT00675103|Anti-Gout preparations|anti-gout preparations
689452|NCT00675090|Alzheimers Disease|alzheimers disease
689453|NCT00675077|Akinetic-Rigid Variant of Huntington Disease|akinetic-rigid variant of huntington disease
689454|NCT00675077|Chorea, Chronic Progressive Hereditary (Huntington)|chorea, chronic progressive hereditary (huntington)
689455|NCT00675077|Chronic Progressive Hereditary Chorea (Huntington)|chronic progressive hereditary chorea (huntington)
689456|NCT00675077|Huntington Chorea|huntington chorea
689457|NCT00675077|Huntington Chronic Progressive Hereditary Chorea|huntington chronic progressive hereditary chorea
689458|NCT00675077|Huntington Disease, Akinetic-Rigid Variant|huntington disease, akinetic-rigid variant
689459|NCT00675077|Huntington Disease, Juvenile|huntington disease, juvenile
689460|NCT00675077|Huntington Disease, Juvenile-Onset|huntington disease, juvenile-onset
689461|NCT00675064|pharmacokinetics,|pharmacokinetics,
689462|NCT00675064|safety|safety
689463|NCT00675064|single ascending dose,|single ascending dose,
689464|NCT00675064|Healthy volunteers,|healthy volunteers,
689465|NCT00675051|To determine if there is a trans-pulmonary gradient in the levels of EMPs in patients with PH|to determine if there is a trans-pulmonary gradient in the levels of emps in patients with ph
689466|NCT00675051|To determine if the EMPs measured at the pulmonary capillary wedge position correlates even more strongly with the severity of PH than the circulating levels|to determine if the emps measured at the pulmonary capillary wedge position correlates even more strongly with the severity of ph than the circulating levels
689467|NCT00675051|To determine if PH therapy with ET-1 receptor blocker will modify EMPs levels|to determine if ph therapy with et-1 receptor blocker will modify emps levels
689468|NCT00675012|NGR-hTNF|ngr-htnf
689469|NCT00675012|Capecitabine|capecitabine
689470|NCT00675012|Oxaliplatin|oxaliplatin
689471|NCT00675012|Colon cancer|colon cancer
689472|NCT00674999|Burn|burn
689473|NCT00674999|Partial thickness burn|partial thickness burn
689474|NCT00674960|Brain Atrophy, Circumscribed Lobar|brain atrophy, circumscribed lobar
689475|NCT00674960|Circumscribed Lobar Atrophy of the Brain|circumscribed lobar atrophy of the brain
689476|NCT00674960|Lobar Atrophy (Brain)|lobar atrophy (brain)
689477|NCT00674960|Pick Disease|pick disease
689478|NCT00674960|Pick's Disease|pick's disease
689479|NCT00674960|Picks Disease of Brain|picks disease of brain
689480|NCT00674947|Relapsed|relapsed
689481|NCT00674947|Refractory|refractory
689482|NCT00674934|MS (Multiple Sclerosis)|ms (multiple sclerosis)
689483|NCT00674934|Multiple Sclerosis, Acute Fulminating|multiple sclerosis, acute fulminating
689484|NCT00674934|Sclerosis, Disseminated|sclerosis, disseminated
689485|NCT00674921|Opportunistic Infections|opportunistic infections
689486|NCT00674921|AIDS|aids
689487|NCT00674921|HIV|hiv
689488|NCT00674921|Treatment Experienced|treatment experienced
689489|NCT00674908|Vaccine|vaccine
689490|NCT00674908|Prevention|prevention
689491|NCT00674908|Diphtheria|diphtheria
689492|NCT00674908|Tetanus|tetanus
689493|NCT00674908|Pertussis|pertussis
689494|NCT00674908|Hepatitis B|hepatitis b
689495|NCT00674908|Haemophilus influenzae type b|haemophilus influenzae type b
689496|NCT00674908|Vaccine interchangeability|vaccine interchangeability
689497|NCT00674908|Single vs mixed sequence|single vs mixed sequence
689498|NCT00674908|Healthy infants|healthy infants
689499|NCT00674895|Idiopathic Parkinson's Disease|idiopathic parkinson's disease
689500|NCT00674895|Lewy Body Parkinson's Disease|lewy body parkinson's disease
689501|NCT00674895|Paralysis Agitans|paralysis agitans
689502|NCT00674895|Parkinson's Disease, Idiopathic|parkinson's disease, idiopathic
689503|NCT00674895|Parkinson's Disease, Lewy Body|parkinson's disease, lewy body
689504|NCT00674895|Primary Parkinsonism|primary parkinsonism
689505|NCT00674882|Hematopoietic stem cell transplant|hematopoietic stem cell transplant
689506|NCT00674882|Follow-up studies|follow-up studies
689507|NCT00674882|Outcomes research|outcomes research
689508|NCT00674882|Data collection|data collection
689509|NCT00674869|sealant|sealant
689510|NCT00674869|pit|pit
689511|NCT00674869|child|child
689512|NCT00674869|over|over
689513|NCT00674869|6 years old|6 years old
689514|NCT00674869|least|least
689515|NCT00674843|MYOTONIC DYSTROPHY|myotonic dystrophy
689516|NCT00674843|MYOPATHIES|myopathies
689517|NCT00674843|Distal Myopathies|distal myopathies
689518|NCT00674843|Muscular Dystrophy, Duchenne|muscular dystrophy, duchenne
689519|NCT00674843|Phosphorylase Deficiency (McArdle Disease)|phosphorylase deficiency (mcardle disease)
689520|NCT00674817|salbutamol,|salbutamol,
689521|NCT00674817|Chronic Obstructive Pulmonary Disease (COPD)|chronic obstructive pulmonary disease (copd)
689522|NCT00674817|GSK961081 muscarinic receptor antagonist,|gsk961081 muscarinic receptor antagonist,
689523|NCT00674817|COPD|copd
689524|NCT00674817|ipratropium bromide,|ipratropium bromide,
689525|NCT00674817|Asthma|asthma
689526|NCT00674817|ß2-adrenergic agonist,|ß2-adrenergic agonist,
689527|NCT00674804|Communicating a Diagnosis|communicating a diagnosis
689528|NCT00674804|Cancer Diagnosis|cancer diagnosis
689529|NCT00674804|Recurrence of Cancer|recurrence of cancer
689530|NCT00674804|Initial Cancer Diagnosis|initial cancer diagnosis
689531|NCT00674791|Immunotherapeutic vaccine|immunotherapeutic vaccine
689532|NCT00674791|breast cancer|breast cancer
689533|NCT00674791|TxN2-3M0 breast cancer|txn2-3m0 breast cancer
689534|NCT00674791|metastatic breast cancer|metastatic breast cancer
689535|NCT00674791|immunotherapy|immunotherapy
689536|NCT00674791|antigen|antigen
689537|NCT00674791|Histologically confirmed, TxN2-3M0 or metastatic breast cancer|histologically confirmed, txn2-3m0 or metastatic breast cancer
689538|NCT00674778|Radial|radial
689539|NCT00674778|Femoral|femoral
689540|NCT00674778|artery|artery
689541|NCT00674778|Invasive cardiology safety|invasive cardiology safety
689542|NCT00674739|external genital warts|external genital warts
689543|NCT00674739|perianal warts|perianal warts
689544|NCT00674739|condylomata acuminata|condylomata acuminata
689545|NCT00674739|venereal warts|venereal warts
689546|NCT00674739|HPV types 6 and 11|hpv types 6 and 11
689547|NCT00674726|appendicitis|appendicitis
689548|NCT00674726|gastroenteritis|gastroenteritis
689549|NCT00674726|temperature|temperature
689550|NCT00674726|fever|fever
689551|NCT00674726|acute abdomen|acute abdomen
689552|NCT00674726|Axilo-rectal temperature in appendicitis|axilo-rectal temperature in appendicitis
689553|NCT00674726|Axilo-rectal temperature in gastroenteritis|axilo-rectal temperature in gastroenteritis
689554|NCT00674713|Patients undergoing laparoscopic cholecystectomy for cholelithiasis|patients undergoing laparoscopic cholecystectomy for cholelithiasis
689555|NCT00674700|House dust mites allergy|house dust mites allergy
689556|NCT00674674|topotecan|topotecan
689557|NCT00674674|pharmacokinetics|pharmacokinetics
689558|NCT00674674|neoplastic|neoplastic
689559|NCT00674674|meningitis|meningitis
689560|NCT00674661|ectasia|ectasia
689561|NCT00674661|cross-linking|cross-linking
689562|NCT00674661|crosslinking|crosslinking
689563|NCT00674661|cornea|cornea
689564|NCT00674661|riboflavin|riboflavin
689565|NCT00674661|UVA|uva
689566|NCT00674648|Multiple Diseases|multiple diseases
689567|NCT00674648|Hematopoietic System|hematopoietic system
689568|NCT00674648|CMV-PP65 PROTEIN SPECIFIC T CELLS|cmv-pp65 protein specific t cells
689569|NCT00674635|adaptive study,|adaptive study,
689570|NCT00674635|DAS28,|das28,
689571|NCT00674635|monoclonal antibody|monoclonal antibody
689572|NCT00674635|GSK315234A;|gsk315234a;
689573|NCT00674635|rheumatoid arthritis,|rheumatoid arthritis,
689574|NCT00674622|Lateral epicondylitis|lateral epicondylitis
689575|NCT00674622|Tennis elbow|tennis elbow
689576|NCT00674622|Prolotherapy|prolotherapy
689577|NCT00674609|Palliative Care|palliative care
689578|NCT00674609|Pain|pain
689579|NCT00674609|Cancer|cancer
689580|NCT00674596|PTX3, ramipril, endothelial dysfunction|ptx3, ramipril, endothelial dysfunction
689581|NCT00674596|1- Diabetic proteinuria|1- diabetic proteinuria
689582|NCT00674596|2- The aim of this study was to find out whether the|2- the aim of this study was to find out whether the
689681|NCT00674323|polyps|polyps
689988|NCT00673114|CML|cml
689583|NCT00674596|beneficial effects of RAS blockage in diabetic|beneficial effects of ras blockage in diabetic
689584|NCT00674596|proteinuria has any relation with the alteration|proteinuria has any relation with the alteration
689585|NCT00674596|of PTX3 levels.|of ptx3 levels.
689586|NCT00674583|Conjugate vaccine|conjugate vaccine
689587|NCT00674583|Meningococcal disease|meningococcal disease
689588|NCT00674583|Immunogenicity|immunogenicity
689589|NCT00674583|Meningococcal vaccine|meningococcal vaccine
689590|NCT00674583|Safety|safety
689591|NCT00674570|Stress Disorders, Posttraumatic|stress disorders, posttraumatic
689592|NCT00674570|Hydrocortisone|hydrocortisone
689593|NCT00674570|Cycloserine|cycloserine
689594|NCT00674570|Extinction, Psychological|extinction, psychological
689595|NCT00674570|PTSD|ptsd
689596|NCT00674570|San Francisco|san francisco
689597|NCT00674557|recurrent breast cancer|recurrent breast cancer
689598|NCT00674557|stage IIIA breast cancer|stage iiia breast cancer
689599|NCT00674557|stage IIIB breast cancer|stage iiib breast cancer
689600|NCT00674557|stage IIIC breast cancer|stage iiic breast cancer
689601|NCT00674557|stage IV breast cancer|stage iv breast cancer
689602|NCT00674557|HER2-negative breast cancer|her2-negative breast cancer
689603|NCT00674557|estrogen receptor-positive breast cancer|estrogen receptor-positive breast cancer
689604|NCT00674557|progesterone receptor-positive breast cancer|progesterone receptor-positive breast cancer
689605|NCT00674544|childhood|childhood
689606|NCT00674544|children|children
689607|NCT00674544|obesity|obesity
689608|NCT00674544|physical activity|physical activity
689609|NCT00674544|nutrition|nutrition
689610|NCT00674544|fitness|fitness
689611|NCT00674544|family|family
689612|NCT00674531|Arteriosclerosis|arteriosclerosis
689613|NCT00674531|Arterial Occlusive Diseases|arterial occlusive diseases
689614|NCT00674531|Enterovirus|enterovirus
689615|NCT00674531|Artery resection|artery resection
689616|NCT00674518|Health Promotion|health promotion
689617|NCT00674518|Health Behavior Change|health behavior change
689618|NCT00674518|Physical Activity|physical activity
689619|NCT00674518|Dietary Change|dietary change
689620|NCT00674518|Weight Loss|weight loss
689621|NCT00674518|Obesity|obesity
689622|NCT00674479|Advanced Hematologic Malignancies|advanced hematologic malignancies
689623|NCT00674479|Cancer|cancer
689624|NCT00674479|Blood|blood
689625|NCT00674479|Bone marrow|bone marrow
689626|NCT00674479|Lymph nodes|lymph nodes
689627|NCT00674479|JAK kinase inhibitor INCB018424 phosphate|jak kinase inhibitor incb018424 phosphate
689628|NCT00674479|Acute Myeloid Leukemia|acute myeloid leukemia
689629|NCT00674479|AML|aml
689630|NCT00674479|Acute Lymphocytic leukemia|acute lymphocytic leukemia
689631|NCT00674479|ALL|all
689632|NCT00674479|Myelodysplastic Syndrome|myelodysplastic syndrome
689633|NCT00674479|MDS|mds
689634|NCT00674479|Chronic myelogenous leukemia - Blast Crisis|chronic myelogenous leukemia - blast crisis
689635|NCT00674479|CML|cml
689636|NCT00674479|INCB018424|incb018424
689637|NCT00674466|GLP-1, incretin, type 2 diabetes|glp-1, incretin, type 2 diabetes
689638|NCT00674453|Osteoporosis|osteoporosis
689639|NCT00674453|lasofoxifene|lasofoxifene
689640|NCT00674453|bone density|bone density
689641|NCT00674453|bone markers|bone markers
689642|NCT00674440|Congenital Hyperinsulinism|congenital hyperinsulinism
689643|NCT00674440|Hyperinsulinism|hyperinsulinism
689644|NCT00674440|Persistent Hyperinsulinemic Hypoglycemia of Infancy|persistent hyperinsulinemic hypoglycemia of infancy
689645|NCT00674440|CHI|chi
689646|NCT00674440|PHHI|phhi
689647|NCT00674440|F-DOPA|f-dopa
689648|NCT00674440|L-fluoro-dihydroxyphenylalanine|l-fluoro-dihydroxyphenylalanine
689649|NCT00674427|AML|aml
689650|NCT00674427|ALL|all
689651|NCT00674427|MDS|mds
689652|NCT00674427|CLL|cll
689653|NCT00674427|Multiple Myeloma|multiple myeloma
689654|NCT00674414|stage IA breast cancer|stage ia breast cancer
689655|NCT00674414|stage IB breast cancer|stage ib breast cancer
689656|NCT00674414|stage II breast cancer|stage ii breast cancer
689657|NCT00674414|stage IIIA breast cancer|stage iiia breast cancer
689658|NCT00674414|HER2-positive breast cancer|her2-positive breast cancer
689659|NCT00674388|Children|children
689660|NCT00674388|Anesthesia|anesthesia
689661|NCT00674388|Surgery|surgery
689662|NCT00674388|Complication|complication
689663|NCT00674375|Chest Pain|chest pain
689664|NCT00674375|Acute Myocardial Infarction|acute myocardial infarction
689665|NCT00674375|Patient Safety|patient safety
689666|NCT00674375|Misdiagnosis|misdiagnosis
689667|NCT00674362|Rheumatoid Arthritis|rheumatoid arthritis
689668|NCT00674362|Moderate to Low Disease activity|moderate to low disease activity
689669|NCT00674362|Certolizumab pegol|certolizumab pegol
689670|NCT00674336|Norovirus|norovirus
689671|NCT00674336|Gastroenteritis|gastroenteritis
689672|NCT00674336|Clinical Trial|clinical trial
689673|NCT00674336|Stomach flu|stomach flu
689674|NCT00674336|Oysters|oysters
689675|NCT00674336|Shellfish|shellfish
689676|NCT00674336|high hydrostatic pressures|high hydrostatic pressures
689677|NCT00674323|Polypoidal choroidal vasculopathy|polypoidal choroidal vasculopathy
689678|NCT00674323|PCV|pcv
689679|NCT00674323|Age-related macular degeneration (AMD) variant|age-related macular degeneration (amd) variant
689680|NCT00674323|vision|vision
689682|NCT00674323|indocyanine green angiography|indocyanine green angiography
689683|NCT00674323|verteporfin|verteporfin
689684|NCT00674323|ranibizumab|ranibizumab
689685|NCT00674323|photodynamic therapy|photodynamic therapy
689686|NCT00674297|Persistently Antiphospholipid Antibody Positive Patients|persistently antiphospholipid antibody positive patients
689687|NCT00674271|Diabetes Mellitus, Type 2|diabetes mellitus, type 2
689688|NCT00674271|Mannose-Binding lectin|mannose-binding lectin
689689|NCT00674271|Toll-Like Receptors|toll-like receptors
689690|NCT00674271|Atherosclerosis|atherosclerosis
689691|NCT00674271|Carotid Arteries|carotid arteries
689692|NCT00674271|Diabetes Complications|diabetes complications
689693|NCT00674271|Diabetic Angiopathies|diabetic angiopathies
689694|NCT00674258|HLA-A*2402|hla-a*2402
689695|NCT00674258|Peptide Vaccine|peptide vaccine
689697|NCT00674258|TTK|ttk
689698|NCT00674258|KOC1|koc1
689699|NCT00674245|heartburn|heartburn
689700|NCT00674245|acid reflux|acid reflux
689701|NCT00674245|GERD|gerd
689702|NCT00674245|spectrum analysis|spectrum analysis
689703|NCT00674245|electroencephalogram|electroencephalogram
689704|NCT00674245|esophagitis|esophagitis
689705|NCT00674245|peptic|peptic
689706|NCT00674232|incomplete abortion|incomplete abortion
689707|NCT00674232|spontaneous miscarriage|spontaneous miscarriage
689708|NCT00674219|Obsessive-compulsive disorder|obsessive-compulsive disorder
689709|NCT00674219|Generalized anxiety disorder|generalized anxiety disorder
689710|NCT00674219|Memantine|memantine
689711|NCT00674219|Namenda|namenda
689712|NCT00674206|Metastatic breast cancer|metastatic breast cancer
689713|NCT00674154|Vitamin D|vitamin d
689714|NCT00674154|Primary hyperparathyroidism|primary hyperparathyroidism
689715|NCT00674154|hypercalcemia|hypercalcemia
689716|NCT00674141|Multiple Sclerosis, relapsing remitting, Dexamethasone|multiple sclerosis, relapsing remitting, dexamethasone
689717|NCT00674128|pacemaker|pacemaker
689718|NCT00674128|cardioverter-defibrillator|cardioverter-defibrillator
689719|NCT00674128|ICD|icd
689720|NCT00674128|cardiac resynchronization device|cardiac resynchronization device
689721|NCT00674128|cyanoacrylate|cyanoacrylate
689722|NCT00674128|suture|suture
689723|NCT00674128|Dermabond|dermabond
689724|NCT00674128|Vicryl|vicryl
689725|NCT00674102|Vascular disrupting agent|vascular disrupting agent
689726|NCT00674102|Non-small cell lung cancer|non-small cell lung cancer
689727|NCT00674089|IMR|imr
689728|NCT00674089|Newborn Mortality|newborn mortality
689729|NCT00674089|Vitamin A Effectiveness|vitamin a effectiveness
689730|NCT00674089|Premature Mortality|premature mortality
689731|NCT00674089|Mortality|mortality
689732|NCT00674063|Chronic Plaque Psoriasis|chronic plaque psoriasis
689733|NCT00674063|Alefacept|alefacept
689734|NCT00674050|Healthy Males or Females subjects|healthy males or females subjects
689735|NCT00674037|recruitment|recruitment
689736|NCT00674037|physicians participating in the recruitment of patients|physicians participating in the recruitment of patients
689737|NCT00674024|Pazopanib|pazopanib
689738|NCT00674024|Tyrosine Kinase Inhibitor|tyrosine kinase inhibitor
689739|NCT00674024|Advanced Cancer|advanced cancer
689740|NCT00674024|Pharmacokinetics|pharmacokinetics
689741|NCT00674024|Cancer|cancer
689742|NCT00674024|Solid Tumor|solid tumor
689743|NCT00674024|Lymphoma|lymphoma
689744|NCT00674011|hypertension|hypertension
689745|NCT00674011|bevacizumab|bevacizumab
689746|NCT00674011|metastatic breast cancer|metastatic breast cancer
689747|NCT00673998|Isokinetic|isokinetic
689748|NCT00673998|Fatigue|fatigue
689749|NCT00673998|Strength|strength
689750|NCT00673998|Older|older
689751|NCT00673985|SFA, Edwards, Popliteal, LifeStent, PTA, Nitinol|sfa, edwards, popliteal, lifestent, pta, nitinol
689752|NCT00673972|Functional dyspepsia|functional dyspepsia
689753|NCT00673972|Gastric emptying|gastric emptying
689754|NCT00673972|Helicobacter pylori|helicobacter pylori
689755|NCT00673972|Lansoprazole|lansoprazole
689756|NCT00673972|Epigastric pain syndrome|epigastric pain syndrome
689757|NCT00673972|Postprandial distress syndrome|postprandial distress syndrome
689758|NCT00673959|Dry eye|dry eye
689759|NCT00673959|artificial tears|artificial tears
689760|NCT00673946|bronchiolitis|bronchiolitis
689761|NCT00673946|hospitalization|hospitalization
689762|NCT00673946|oximetry|oximetry
689763|NCT00673946|pediatrics|pediatrics
689764|NCT00673920|RA|ra
689765|NCT00673907|Wood smoke|wood smoke
689766|NCT00673907|Health effects|health effects
689767|NCT00673907|Human|human
689768|NCT00673907|Airway inflammation|airway inflammation
689769|NCT00673907|Cardiovascular effects|cardiovascular effects
689770|NCT00673855|Dry eye|dry eye
689771|NCT00673855|Artificial tear|artificial tear
689772|NCT00673842|Noninvasive assessment|noninvasive assessment
689773|NCT00673842|Holter|holter
689774|NCT00673829|Breast Cancer|breast cancer
689775|NCT00673829|T cells|t cells
689776|NCT00673829|Gene Transfer|gene transfer
689777|NCT00673816|Von Hippel Lindau|von hippel lindau
689778|NCT00673816|Sunitinib Malate|sunitinib malate
689779|NCT00673816|Sutent|sutent
689780|NCT00673816|Von Hippel-Lindau Syndrome|von hippel-lindau syndrome
689781|NCT00673816|VHL|vhl
689782|NCT00673803|posterior capsule opacification|posterior capsule opacification
689783|NCT00673803|micro incision|micro incision
689784|NCT00673803|sharp optic edge|sharp optic edge
689785|NCT00673790|nebivolol|nebivolol
689786|NCT00673790|BYSTOLIC ™|bystolic ™
689787|NCT00673790|hydrochlorothiazide|hydrochlorothiazide
689788|NCT00673790|lisinopril|lisinopril
689789|NCT00673790|Prinivil (TM)|prinivil (tm)
689790|NCT00673790|Zestril (TM)|zestril (tm)
689791|NCT00673790|losartan|losartan
689792|NCT00673790|Cozaar (TM)|cozaar (tm)
689793|NCT00673790|Impaired Fasting Glucose|impaired fasting glucose
689794|NCT00673790|Impaired Glucose Tolerance|impaired glucose tolerance
689795|NCT00673790|hypertension|hypertension
689796|NCT00673777|HLA-A*0201|hla-a*0201
689797|NCT00673777|Peptide Vaccine|peptide vaccine
689798|NCT00673777|URLC10|urlc10
689799|NCT00673777|VEGFR1|vegfr1
689800|NCT00673777|VEGFR2|vegfr2
689801|NCT00673751|mesenteric blood flow|mesenteric blood flow
689802|NCT00673751|GLP-2|glp-2
689803|NCT00673751|short bowel syndrome|short bowel syndrome
689804|NCT00673751|Glucagon-Like Peptide 2|glucagon-like peptide 2
689805|NCT00673738|Lung|lung
689806|NCT00673738|Thoracic|thoracic
689807|NCT00673738|Immunotherapy|immunotherapy
689808|NCT00673738|Radiotherapy|radiotherapy
689809|NCT00673738|LA - NSCLC|la - nsclc
689810|NCT00673738|Non-Small Cell Lung Cancer|non-small cell lung cancer
689811|NCT00673725|Atopic Dermatitis|atopic dermatitis
689812|NCT00673712|Coronary Artery Bypass Graft Surgery|coronary artery bypass graft surgery
689813|NCT00673712|Pneumonia|pneumonia
689814|NCT00673712|Surgical Site Infection|surgical site infection
689815|NCT00673699|NBI|nbi
689816|NCT00673699|gastroscopy|gastroscopy
689817|NCT00673699|biopsy|biopsy
689818|NCT00673699|intestinal metaplasia|intestinal metaplasia
689819|NCT00673686|Oral contraceptive|oral contraceptive
689820|NCT00673686|Ovulation|ovulation
689821|NCT00673686|Missing pills|missing pills
689822|NCT00673686|Intake compliance|intake compliance
689823|NCT00673686|Cycle control|cycle control
689824|NCT00673660|Statins|statins
689825|NCT00673660|Compliance|compliance
689826|NCT00673660|Dyslipidemia|dyslipidemia
689827|NCT00673647|cannabis|cannabis
689828|NCT00673647|dependence|dependence
689829|NCT00673647|marijuana|marijuana
689830|NCT00673647|CBT|cbt
689831|NCT00673647|efficacy of CBT for cannabis use disorders|efficacy of cbt for cannabis use disorders
689832|NCT00673634|preoxygenation|preoxygenation
689833|NCT00673634|method|method
689834|NCT00673634|efficiency|efficiency
689835|NCT00673634|obesity|obesity
689836|NCT00673634|BiPAP|bipap
689837|NCT00673634|FeO2|feo2
689838|NCT00673621|Asthmatics and non-asthmatic male and female subjects|asthmatics and non-asthmatic male and female subjects
689839|NCT00673608|Haemoglobinopathies,|haemoglobinopathies,
689840|NCT00673608|Myelodysplastic Syndromes,|myelodysplastic syndromes,
689841|NCT00673608|Transfusional iron overload,|transfusional iron overload,
689842|NCT00673608|cardiac iron load|cardiac iron load
689843|NCT00673595|smoking|smoking
689844|NCT00673595|varenicline|varenicline
689845|NCT00673595|flow-mediated dilation|flow-mediated dilation
689846|NCT00673595|blood pressure|blood pressure
689847|NCT00673595|baroreflex|baroreflex
689848|NCT00673582|Statins|statins
689849|NCT00673582|Intima Media Thickness|intima media thickness
689850|NCT00673582|Plaque Area|plaque area
689851|NCT00673569|recurrent non-small cell lung cancer|recurrent non-small cell lung cancer
689852|NCT00673569|stage IV non-small cell lung cancer|stage iv non-small cell lung cancer
689853|NCT00673569|stage IIIA non-small cell lung cancer|stage iiia non-small cell lung cancer
689854|NCT00673569|stage IIIB non-small cell lung cancer|stage iiib non-small cell lung cancer
689855|NCT00673556|Chronic Plaque Psoriasis|chronic plaque psoriasis
689856|NCT00673556|Alefacept|alefacept
689857|NCT00673543|Corticosteroids|corticosteroids
689858|NCT00673543|Pregnancy|pregnancy
689859|NCT00673543|Glucose control|glucose control
689860|NCT00673530|Hospital malnutrition|hospital malnutrition
689861|NCT00673530|Nutritional Status|nutritional status
689862|NCT00673530|Nutrition Assessment|nutrition assessment
689863|NCT00673530|Enteral Nutrition|enteral nutrition
689864|NCT00673530|Parenteral Nutrition|parenteral nutrition
689865|NCT00673530|Severity of illness index|severity of illness index
689866|NCT00673530|cost analysis|cost analysis
689867|NCT00673517|Acute respiratory distress syndrome|acute respiratory distress syndrome
689868|NCT00673517|Ventilator induced lung injury|ventilator induced lung injury
689869|NCT00673517|High frequency oscillation|high frequency oscillation
689870|NCT00673517|Lung protective ventilation|lung protective ventilation
689871|NCT00673517|Biomarkers|biomarkers
689872|NCT00673517|Biotrauma|biotrauma
689873|NCT00673504|cancer|cancer
689874|NCT00673504|pancreatic cancer|pancreatic cancer
689875|NCT00673504|gemcitabine|gemcitabine
689876|NCT00673504|sunitinib|sunitinib
689877|NCT00673504|Phase 2|phase 2
689878|NCT00673491|Critical Pathways|critical pathways
689879|NCT00673491|Stroke|stroke
689880|NCT00673491|Randomized Controlled Trial|randomized controlled trial
689881|NCT00673491|Effectiveness|effectiveness
689987|NCT00673114|ALL|all
689882|NCT00673439|heparin-induced thrombocytopenia|heparin-induced thrombocytopenia
689883|NCT00673439|thrombocytopenia|thrombocytopenia
689884|NCT00673439|HIT|hit
689885|NCT00673439|thrombosis|thrombosis
689886|NCT00673439|blood clot|blood clot
689887|NCT00673439|blood thinner|blood thinner
689888|NCT00673439|anticoagulant|anticoagulant
689889|NCT00673439|heparin|heparin
689890|NCT00673439|warfarin|warfarin
689891|NCT00673439|fondaparinux|fondaparinux
689892|NCT00673439|Arixtra|arixtra
689893|NCT00673426|enoxaparin|enoxaparin
689894|NCT00673426|chronic renal disease|chronic renal disease
689895|NCT00673426|Anticoagulant activity of enoxaparin sodic|anticoagulant activity of enoxaparin sodic
689896|NCT00673413|Perception|perception
689897|NCT00673413|Emotions|emotions
689898|NCT00673413|Adaptation|adaptation
689899|NCT00673413|Estomia|estomia
689900|NCT00673400|Obstructed defecation syndrome|obstructed defecation syndrome
689902|NCT00673400|Rectocele|rectocele
689903|NCT00673400|Intussusception|intussusception
689904|NCT00673400|STARR|starr
689905|NCT00673387|overweight|overweight
689906|NCT00673387|obesity|obesity
689907|NCT00673387|pramlintide|pramlintide
689908|NCT00673387|metreleptin|metreleptin
689909|NCT00673387|Amylin|amylin
689910|NCT00673374|emergency|emergency
689911|NCT00673374|acute|acute
689912|NCT00673374|nontraumatic|nontraumatic
689913|NCT00673374|abdominal pain|abdominal pain
689914|NCT00673374|tenderness|tenderness
689915|NCT00673374|CT scan|ct scan
689916|NCT00673374|radiation|radiation
689917|NCT00673374|diagnosis|diagnosis
689918|NCT00673348|Mycoses|mycoses
689919|NCT00673348|Voriconazole|voriconazole
689920|NCT00673335|breast cancer|breast cancer
689921|NCT00673335|hereditary breast/ovarian cancer (BRCA1, BRCA2)|hereditary breast/ovarian cancer (brca1, brca2)
689922|NCT00673335|BRCA1 mutation carrier|brca1 mutation carrier
689923|NCT00673335|BRCA2 mutation carrier|brca2 mutation carrier
689924|NCT00673322|Colorectal Cancer|colorectal cancer
689925|NCT00673322|T cells|t cells
689926|NCT00673322|Gene Transfer|gene transfer
689927|NCT00673309|burns|burns
689928|NCT00673296|Bevacizumab|bevacizumab
689929|NCT00673296|Diabetic premacular hemorrhage|diabetic premacular hemorrhage
689930|NCT00673296|Intravitreal gas|intravitreal gas
689931|NCT00673283|lung cancer|lung cancer
689932|NCT00673283|nodules|nodules
689933|NCT00673283|radiography|radiography
689934|NCT00673283|CT|ct
689935|NCT00673283|Stereoscopy|stereoscopy
689936|NCT00673257|unspecified childhood solid tumor, protocol specific|unspecified childhood solid tumor, protocol specific
689937|NCT00673244|Renal Replacement Therapy|renal replacement therapy
689938|NCT00673244|Dialysis|dialysis
689939|NCT00673231|Dapagliflozin|dapagliflozin
689940|NCT00673231|efficacy|efficacy
689941|NCT00673231|safety|safety
689942|NCT00673231|add on to insulin|add on to insulin
689943|NCT00673231|Oral AntiDiabetic|oral antidiabetic
689944|NCT00673231|Type 2 diabetes|type 2 diabetes
689945|NCT00673218|IL13|il13
689946|NCT00673218|Cytokines|cytokines
689947|NCT00673218|Basophil stimulation|basophil stimulation
689948|NCT00673205|androgen antagonists|androgen antagonists
689949|NCT00673205|prostate neoplasms|prostate neoplasms
689950|NCT00673179|Doxorubicin|doxorubicin
689951|NCT00673179|AD|ad
689952|NCT00673179|Hydroxydaunomycin hydrochloride|hydroxydaunomycin hydrochloride
689953|NCT00673179|Cisplatin|cisplatin
689954|NCT00673179|Paraplatin®|paraplatin®
689955|NCT00673179|Methotrexate|methotrexate
689956|NCT00673179|Ifosfamide|ifosfamide
689957|NCT00673179|Osteosarcoma|osteosarcoma
689958|NCT00673179|Sargramostim|sargramostim
689959|NCT00673179|Leukine™|leukine™
689960|NCT00673179|Leucovorin|leucovorin
689961|NCT00673179|Gemcitabine|gemcitabine
689962|NCT00673179|Gemzar|gemzar
689963|NCT00673179|Gemcitabine Hydrochloride|gemcitabine hydrochloride
689964|NCT00673179|GM-CSF|gm-csf
689965|NCT00673179|Questionnaire|questionnaire
689966|NCT00673179|Survey|survey
689967|NCT00673166|Staff motivation|staff motivation
689968|NCT00673166|Hospital mortality|hospital mortality
689969|NCT00673166|Perception of quality of care|perception of quality of care
689970|NCT00673140|ALS (Amyotrophic Lateral Sclerosis)|als (amyotrophic lateral sclerosis)
689971|NCT00673140|Amyotrophic Lateral Sclerosis With Dementia|amyotrophic lateral sclerosis with dementia
689972|NCT00673140|Amyotrophic Lateral Sclerosis, Guam Form|amyotrophic lateral sclerosis, guam form
689973|NCT00673140|Dementia With Amyotrophic Lateral Sclerosis|dementia with amyotrophic lateral sclerosis
689974|NCT00673140|Gehrig's Disease|gehrig's disease
689975|NCT00673140|Guam Form of Amyotrophic Lateral Sclerosis|guam form of amyotrophic lateral sclerosis
689976|NCT00673140|Lou Gehrig Disease|lou gehrig disease
689977|NCT00673127|hormone refractory|hormone refractory
689978|NCT00673127|KHAD|khad
689979|NCT00673127|ketoconazole|ketoconazole
689980|NCT00673127|dutasteride|dutasteride
689981|NCT00673127|hydrocortisone|hydrocortisone
689982|NCT00673114|Haplo/cord|haplo/cord
689983|NCT00673114|hematologic malignancy|hematologic malignancy
689984|NCT00673114|MDS|mds
689985|NCT00673114|Aplastic Anemia|aplastic anemia
689986|NCT00673114|AML|aml
689989|NCT00673101|liver fibrosis, cirrhosis|liver fibrosis, cirrhosis
689990|NCT00673101|FibroScan|fibroscan
689991|NCT00673101|transient elastography|transient elastography
689992|NCT00673101|elastometry|elastometry
689993|NCT00673101|methotrexate|methotrexate
689994|NCT00673101|non invasive blood markers|non invasive blood markers
689995|NCT00673101|FibroTest|fibrotest
689996|NCT00673101|treatment|treatment
689997|NCT00673075|carvedilol|carvedilol
689998|NCT00673075|Coreg (TM)|coreg (tm)
689999|NCT00673075|hypertension|hypertension
690000|NCT00673075|blood pressure|blood pressure
690001|NCT00673075|coronary artery disease|coronary artery disease
690002|NCT00673075|Nebivolol|nebivolol
690003|NCT00673075|BYSTOLIC (TM)|bystolic (tm)
690004|NCT00673049|IGR-1R|igr-1r
690005|NCT00673049|Non small cell lung cancer|non small cell lung cancer
690006|NCT00673049|CP-751|cp-751
690007|NCT00673049|871|871
690008|NCT00673049|Figitumumab|figitumumab
690009|NCT00673036|Coronary syndrome|coronary syndrome
690010|NCT00673036|Myocardial infarction|myocardial infarction
690011|NCT00673036|French registry|french registry
690012|NCT00673010|124-IODINE|124-iodine
690013|NCT00673010|I-131 METAIODOBENZ SULF (MIBG)|i-131 metaiodobenz sulf (mibg)
690014|NCT00673010|Thyroid|thyroid
690015|NCT00673010|Parathyroid|parathyroid
690016|NCT00672997|Glaucoma|glaucoma
690017|NCT00672997|Hypertension|hypertension
690018|NCT00672984|QT/QTc|qt/qtc
690019|NCT00672958|Major Depressive Disorder|major depressive disorder
690020|NCT00672958|Depression|depression
690021|NCT00672958|Drug Therapy|drug therapy
690022|NCT00672958|Major Depressive Episode|major depressive episode
690023|NCT00672932|raltegravir|raltegravir
690024|NCT00672932|central nervous system (CNS)|central nervous system (cns)
690025|NCT00672932|HIV-1|hiv-1
690026|NCT00672932|AIDS|aids
690027|NCT00672932|cerebrospinal fluid (CSF)|cerebrospinal fluid (csf)
690028|NCT00672932|immunoactivation|immunoactivation
690029|NCT00672932|antiretroviral therapy|antiretroviral therapy
690030|NCT00672932|suppression|suppression
690031|NCT00672919|Glucose Metabolism Disorder|glucose metabolism disorder
690032|NCT00672919|Dysmetabolic Syndrome|dysmetabolic syndrome
690033|NCT00672919|Type II Diabetes|type ii diabetes
690034|NCT00672919|Diabetes Mellitus, Lipoatrophic|diabetes mellitus, lipoatrophic
690035|NCT00672919|Dyslipidemia|dyslipidemia
690036|NCT00672919|Drug Therapy|drug therapy
690037|NCT00672906|anorexia nervosa|anorexia nervosa
690038|NCT00672906|group parent training|group parent training
690039|NCT00672906|caregiver burden|caregiver burden
690040|NCT00672906|eating disorders|eating disorders
690041|NCT00672906|treatment|treatment
690042|NCT00672893|central airway stenosis, lung sounds, airway obstruction, bronchial obstruction, bronchoscopic treatment|central airway stenosis, lung sounds, airway obstruction, bronchial obstruction, bronchoscopic treatment
690043|NCT00672880|Chronic low back pain accompanied by depression|chronic low back pain accompanied by depression
690044|NCT00672854|parenteral nutrition|parenteral nutrition
690045|NCT00672854|lipid emulsion|lipid emulsion
690046|NCT00672854|nosocomial infection|nosocomial infection
690047|NCT00672854|mortality|mortality
690048|NCT00672854|endothelial function|endothelial function
690049|NCT00672854|inflammatory markers|inflammatory markers
690050|NCT00672854|oxidative stress|oxidative stress
690051|NCT00672854|immune function|immune function
690052|NCT00672854|autonomic nervous system|autonomic nervous system
690053|NCT00672854|insulin sensitivity|insulin sensitivity
690054|NCT00672854|carbohydrate metabolism|carbohydrate metabolism
690055|NCT00672841|candidemia|candidemia
690056|NCT00672841|invasive candidiasis|invasive candidiasis
690057|NCT00672841|preemptive antifungal therapy|preemptive antifungal therapy
690058|NCT00672841|surveillance|surveillance
690059|NCT00672841|β-D-Glucan (BDG)|β-d-glucan (bdg)
690060|NCT00672828|colon cancer|colon cancer
690061|NCT00672828|rectal cancer|rectal cancer
690062|NCT00672815|coordinated school health|coordinated school health
690063|NCT00672815|school health policy evaluation|school health policy evaluation
690064|NCT00672815|physical activity|physical activity
690065|NCT00672802|Chronic Obstructive Pulmonary Disease|chronic obstructive pulmonary disease
690066|NCT00672802|COPD|copd
690067|NCT00672802|Insomnia|insomnia
690068|NCT00672802|Drug Therapy|drug therapy
690069|NCT00672789|Sickle cell anemia|sickle cell anemia
690070|NCT00672789|Children|children
690071|NCT00672789|Hydroxyurea|hydroxyurea
690072|NCT00672789|Treatment Adherence|treatment adherence
690073|NCT00672776|hippocampus|hippocampus
690074|NCT00672776|paroxetine|paroxetine
690075|NCT00672776|stress|stress
690076|NCT00672776|PTSD|ptsd
690077|NCT00672763|Crohn's Disease|crohn's disease
690078|NCT00672763|Inflammatory Bowel Disease|inflammatory bowel disease
690079|NCT00672763|Vitamin D|vitamin d
690080|NCT00672763|Randomised|randomised
690081|NCT00672763|Placebo|placebo
690082|NCT00672750|laparoscopic|laparoscopic
690083|NCT00672750|myomectomy|myomectomy
690084|NCT00672750|menorrhagia|menorrhagia
690085|NCT00672750|pelvic pain|pelvic pain
690086|NCT00672724|Insomnia|insomnia
690087|NCT00672724|Sleep Disorder|sleep disorder
690184|NCT00672295|Paclitaxel|paclitaxel
690088|NCT00672724|Drug Therapy|drug therapy
690089|NCT00672711|Complex Regional Pain Syndrome|complex regional pain syndrome
690090|NCT00672711|Chronic Post-surgical Pain|chronic post-surgical pain
690091|NCT00672711|Genetic susceptibility|genetic susceptibility
690092|NCT00672711|COMT|comt
690093|NCT00672698|SURGICAL RISK|surgical risk
690094|NCT00672698|ELDERLY|elderly
690095|NCT00672698|MAJOR SURGERY|major surgery
690096|NCT00672698|P-POSSUM|p-possum
690097|NCT00672698|SAPS II|saps ii
690098|NCT00672685|Cognitive decline|cognitive decline
690099|NCT00672685|omega-3 fatty acids|omega-3 fatty acids
690100|NCT00672685|nutrition|nutrition
690101|NCT00672685|physical exercise|physical exercise
690102|NCT00672685|cognitive training|cognitive training
690103|NCT00672685|social activities|social activities
690104|NCT00672685|frailty|frailty
690105|NCT00672672|Wound healing of surgical site treated with autologous platlet gel|wound healing of surgical site treated with autologous platlet gel
690106|NCT00672659|Lost of interest, Depressed Mood|lost of interest, depressed mood
690107|NCT00672646|Analgesic effect|analgesic effect
690108|NCT00672633|Omega 3 Fatty Acids|omega 3 fatty acids
690109|NCT00672633|Triglycerides|triglycerides
690110|NCT00672633|Lovaza|lovaza
690111|NCT00672633|Trial|trial
690112|NCT00672620|Major Depressive Disorder|major depressive disorder
690113|NCT00672620|Depression|depression
690114|NCT00672620|Drug Therapy|drug therapy
690115|NCT00672620|Major Depressive Episode|major depressive episode
690116|NCT00672607|premenstual syndrome, PMS, clinical trial|premenstual syndrome, pms, clinical trial
690117|NCT00672581|Hepatic Impairment|hepatic impairment
690118|NCT00672568|Rotator cuff, Shoulder, Arthroscopic shoulder surgery|rotator cuff, shoulder, arthroscopic shoulder surgery
690119|NCT00672555|pilonidal sinus|pilonidal sinus
690120|NCT00672555|recurrence|recurrence
690121|NCT00672555|Limberg flap|limberg flap
690122|NCT00672542|melanoma|melanoma
690123|NCT00672542|dendritic cell|dendritic cell
690124|NCT00672542|immunoproteasome|immunoproteasome
690125|NCT00672542|vaccine|vaccine
690126|NCT00672529|Childhood Asthma|childhood asthma
690127|NCT00672529|Inhaled Corticosteroids|inhaled corticosteroids
690128|NCT00672529|Alternative Medicine|alternative medicine
690129|NCT00672529|Vitamins, minerals, and fish oil as Add-on Treatment|vitamins, minerals, and fish oil as add-on treatment
690130|NCT00672516|hemorrhage|hemorrhage
690131|NCT00672516|cardiopulmonary bypass|cardiopulmonary bypass
690132|NCT00672516|blood component transfusion|blood component transfusion
690133|NCT00672516|hemostasis, surgical|hemostasis, surgical
690134|NCT00672503|indwelling urinary catheters|indwelling urinary catheters
690135|NCT00672503|urinary tract infections|urinary tract infections
690136|NCT00672503|foley-catheter related infections|foley-catheter related infections
690137|NCT00672503|hospital acquired CA-UTI|hospital acquired ca-uti
690138|NCT00672490|Acute Mania|acute mania
690139|NCT00672490|Bipolar Disorder|bipolar disorder
690140|NCT00672490|Quetiapine Fumarate|quetiapine fumarate
690141|NCT00672490|Lithium|lithium
690142|NCT00672477|opioid-induced constipation|opioid-induced constipation
690143|NCT00672464|Schizophrenia|schizophrenia
690144|NCT00672464|Schizoaffective|schizoaffective
690145|NCT00672464|Cardiovascular|cardiovascular
690146|NCT00672464|Olanzapine|olanzapine
690147|NCT00672464|Metformin|metformin
690148|NCT00672464|Simvastatin|simvastatin
690149|NCT00672451|diabetic kidney disease|diabetic kidney disease
690150|NCT00672451|albuminuria|albuminuria
690151|NCT00672412|Treatment Experienced|treatment experienced
690152|NCT00672399|Amylin|amylin
690153|NCT00672399|Eli Lilly|eli lilly
690154|NCT00672399|exenatide|exenatide
690155|NCT00672399|moxifloxacin|moxifloxacin
690156|NCT00672386|Diabetes|diabetes
690157|NCT00672386|Type 2 Diabetes|type 2 diabetes
690158|NCT00672386|Adult-Onset Diabetes Mellitus|adult-onset diabetes mellitus
690159|NCT00672386|Metabolic Syndrome|metabolic syndrome
690160|NCT00672386|HbA1c|hba1c
690161|NCT00672386|Body Weight|body weight
690162|NCT00672386|Metformin|metformin
690163|NCT00672373|Tardive Dyskinesia|tardive dyskinesia
690164|NCT00672373|Schizophrenia|schizophrenia
690165|NCT00672373|Extract of Gingko Biloba|extract of gingko biloba
690166|NCT00672360|Autism Spectrum Disorder|autism spectrum disorder
690167|NCT00672347|caudal anesthesia, clonidine, morphine, bupivacaine|caudal anesthesia, clonidine, morphine, bupivacaine
690168|NCT00672334|Cardiac surgery|cardiac surgery
690169|NCT00672334|Cardiopulmonary bypass|cardiopulmonary bypass
690170|NCT00672334|Oxidative stress|oxidative stress
690171|NCT00672334|Acute renal dysfunction|acute renal dysfunction
690172|NCT00672334|Sodium bicarbonate|sodium bicarbonate
690173|NCT00672321|recurrent melanoma|recurrent melanoma
690174|NCT00672321|stage IB melanoma|stage ib melanoma
690175|NCT00672321|stage II melanoma|stage ii melanoma
690176|NCT00672321|stage IIIA melanoma|stage iiia melanoma
690177|NCT00672308|Cholera, benefiber, ORS|cholera, benefiber, ors
690178|NCT00672295|Ovarian Cancer|ovarian cancer
690179|NCT00672295|Peritoneal Cancer|peritoneal cancer
690180|NCT00672295|Tubal Cancer|tubal cancer
690181|NCT00672295|Fallopian Tube Cancer|fallopian tube cancer
690182|NCT00672295|Dasatinib|dasatinib
690183|NCT00672295|Sprycel|sprycel
690185|NCT00672295|Taxol|taxol
690186|NCT00672295|Carboplatin|carboplatin
690187|NCT00672295|Paraplatin|paraplatin
690188|NCT00672282|androgen antagonists|androgen antagonists
690189|NCT00672282|prostate neoplasms|prostate neoplasms
690190|NCT00672269|carcinoid|carcinoid
690191|NCT00672269|family members|family members
690192|NCT00672269|familial|familial
690193|NCT00672269|tumors|tumors
690194|NCT00672269|cancer|cancer
690195|NCT00672256|Smoking|smoking
690196|NCT00672256|fMRI|fmri
690197|NCT00672243|GBM|gbm
690198|NCT00672243|Brain tumor|brain tumor
690199|NCT00672243|Erlotinib|erlotinib
690200|NCT00672243|Sirolimus|sirolimus
690201|NCT00672243|Glioblastoma multiforme|glioblastoma multiforme
690202|NCT00672243|Glioblastoma|glioblastoma
690203|NCT00672243|Gliosarcoma3|gliosarcoma3
690204|NCT00672243|Tarceva|tarceva
690205|NCT00672243|Rapamune|rapamune
690206|NCT00672230|Lactation|lactation
690207|NCT00672230|Breast milk|breast milk
690208|NCT00672230|Lutein|lutein
690209|NCT00672230|Lutein supplement|lutein supplement
690210|NCT00672217|Breast cancer survivors, insomnia, quality of life|breast cancer survivors, insomnia, quality of life
690211|NCT00672204|Islet transplant|islet transplant
690212|NCT00672204|Diabetes Mellitus|diabetes mellitus
690213|NCT00672204|Hypoglycemia|hypoglycemia
690214|NCT00672191|HIV|hiv
690215|NCT00672191|Human immunodeficiency virus|human immunodeficiency virus
690216|NCT00672191|Immunodeficiency Virus, Human|immunodeficiency virus, human
690217|NCT00672191|HIV-1|hiv-1
690218|NCT00672191|ART|art
690219|NCT00672191|antiretroviral therapy|antiretroviral therapy
690220|NCT00672191|HAART|haart
690221|NCT00672191|highly active retroviral therapy|highly active retroviral therapy
690222|NCT00672191|cluster of differentiation CD 4+ T cell counts|cluster of differentiation cd 4+ t cell counts
690223|NCT00672191|HIV-1 Subjects successfully ART treated|hiv-1 subjects successfully art treated
690224|NCT00672191|Treatment Experienced|treatment experienced
690225|NCT00672178|RCC|rcc
690226|NCT00672178|metastatic|metastatic
690227|NCT00672178|sorafenib|sorafenib
690228|NCT00672165|MAB HUM 195 ACTINIUM-225 LABELED|mab hum 195 actinium-225 labeled
690229|NCT00672165|HEMATOPOIETIC SYSTEM|hematopoietic system
690230|NCT00672165|02-017|02-017
690231|NCT00672152|Autologous transplantation|autologous transplantation
690232|NCT00672152|Allogeneic transplantation|allogeneic transplantation
690233|NCT00672139|Opioid-Induced Constipation|opioid-induced constipation
690234|NCT00672100|Peripheral Nerve Infusion,|peripheral nerve infusion,
690235|NCT00672100|continuous brachial plexus block,|continuous brachial plexus block,
690236|NCT00672100|post-operative pain|post-operative pain
690237|NCT00672100|diaphragmatic paresis|diaphragmatic paresis
690238|NCT00672087|Chronic Prostatitis with Chronic Pelvic Pain Syndrome|chronic prostatitis with chronic pelvic pain syndrome
690239|NCT00672087|Chronic Bacterial Prostatitis|chronic bacterial prostatitis
690240|NCT00672087|Asymptomatic Inflammatory Prostatitis|asymptomatic inflammatory prostatitis
690241|NCT00672087|Painful Bladder Syndrome|painful bladder syndrome
690242|NCT00672087|Cystitis, Interstitial|cystitis, interstitial
690243|NCT00672074|Postoperative Ileus|postoperative ileus
690244|NCT00672061|Sleep Apnea, Obstructive|sleep apnea, obstructive
690245|NCT00672061|Insomnia|insomnia
690246|NCT00672061|Drug Therapy|drug therapy
690247|NCT00672048|glaucoma|glaucoma
690248|NCT00672048|optometrists|optometrists
690249|NCT00672035|LT|lt
690250|NCT00672035|Healthy Adults|healthy adults
690251|NCT00672035|Dose Ranging|dose ranging
690252|NCT00672035|Patch|patch
690253|NCT00672035|Vaccine|vaccine
690254|NCT00672009|prostate cancer|prostate cancer
690255|NCT00672009|radical prostatectomy|radical prostatectomy
690256|NCT00672009|ixabepilone|ixabepilone
690257|NCT00671970|Glioblastoma|glioblastoma
690258|NCT00671970|Gliosarcoma|gliosarcoma
690259|NCT00671970|Recurrent MG|recurrent mg
690260|NCT00671970|Malignant glioma|malignant glioma
690261|NCT00671970|Glioma|glioma
690262|NCT00671970|Glioblastoma multiforme (GBM)|glioblastoma multiforme (gbm)
690263|NCT00671970|GBM|gbm
690264|NCT00671970|Brain tumor|brain tumor
690265|NCT00671970|Anaplastic astrocytoma|anaplastic astrocytoma
690266|NCT00671970|Anaplastic oligodendroglioma|anaplastic oligodendroglioma
690267|NCT00671970|Anaplastic oligoastrocytoma|anaplastic oligoastrocytoma
690268|NCT00671970|Bevacizumab|bevacizumab
690269|NCT00671970|Avastin|avastin
690270|NCT00671970|Erlotinib|erlotinib
690271|NCT00671970|Tarceva|tarceva
690272|NCT00671957|Obesity|obesity
690273|NCT00671957|Bariatric|bariatric
690274|NCT00671957|Surgery|surgery
690275|NCT00671957|Activity|activity
690276|NCT00671944|protein|protein
690277|NCT00671944|calcium|calcium
690278|NCT00671944|parathyroid hormone|parathyroid hormone
690279|NCT00671944|bone markers|bone markers
690280|NCT00671944|calcium kinetics|calcium kinetics
690281|NCT00671944|absorption|absorption
690282|NCT00671931|dexmedetomidine|dexmedetomidine
690283|NCT00671931|neuromonitoring|neuromonitoring
690284|NCT00671931|spine procedures|spine procedures
690285|NCT00671931|safe dose|safe dose
690388|NCT00671606|Sentinel Node Identification|sentinel node identification
690286|NCT00671931|1- safe dose of dexmedetomidine when used in total intravenous anesthesia for procedures require neuromonitoring|1- safe dose of dexmedetomidine when used in total intravenous anesthesia for procedures require neuromonitoring
690287|NCT00671931|2- safe dose of propofol when uses in comination with dexmedetomidine in neuromontoring|2- safe dose of propofol when uses in comination with dexmedetomidine in neuromontoring
710606|NCT00588627|Chronic cough|chronic cough
690288|NCT00671931|3effect of dexmedetomidine on somatosensory evoked potential and motor evoked potentials|3effect of dexmedetomidine on somatosensory evoked potential and motor evoked potentials
690289|NCT00671918|breast cancer|breast cancer
690290|NCT00671918|lymph nodes|lymph nodes
690291|NCT00671918|melanoma|melanoma
690292|NCT00671918|surgery|surgery
690293|NCT00671905|atrial fibrillation|atrial fibrillation
690294|NCT00671905|PV isolation|pv isolation
690295|NCT00671905|ablation|ablation
690296|NCT00671905|ganglionic plexi|ganglionic plexi
690297|NCT00671905|parasympathetic denervation|parasympathetic denervation
690298|NCT00671892|LPS endotoxin|lps endotoxin
690299|NCT00671892|asthma|asthma
690300|NCT00671866|OP|op
690301|NCT00671866|Pesticides|pesticides
690302|NCT00671866|Long-Term Low Level Exposure|long-term low level exposure
690303|NCT00671866|Occupational Health|occupational health
690304|NCT00671866|Neurobehavioral Effects|neurobehavioral effects
690305|NCT00671853|Bipolar Disorder|bipolar disorder
690306|NCT00671853|Anxiety|anxiety
690307|NCT00671853|Anxiety Disorders|anxiety disorders
690308|NCT00671853|Substance Use Disorders|substance use disorders
690309|NCT00671827|Gynecologic Cancer|gynecologic cancer
690310|NCT00671827|Cervical Cancer|cervical cancer
690311|NCT00671827|Endometrial Cancer|endometrial cancer
690312|NCT00671827|Fallopian Tube Cancer|fallopian tube cancer
690313|NCT00671827|Ovarian Cancer|ovarian cancer
690314|NCT00671827|Uterine Cancer|uterine cancer
690315|NCT00671827|Vaginal Cancer|vaginal cancer
690316|NCT00671827|Vulvar Cancer|vulvar cancer
690317|NCT00671827|Questionnaire|questionnaire
690318|NCT00671827|Survey|survey
690319|NCT00671827|Robot-Assisted Surgery|robot-assisted surgery
690320|NCT00671814|antibiotic|antibiotic
690321|NCT00671801|Malignant Gliomas|malignant gliomas
690322|NCT00671801|Glioblastoma Multiforme|glioblastoma multiforme
690323|NCT00671801|Gliosarcoma|gliosarcoma
690324|NCT00671801|Anaplastic Astrocytoma|anaplastic astrocytoma
690325|NCT00671801|Anaplastic Oligodendroglioma|anaplastic oligodendroglioma
690326|NCT00671801|Anaplastic Oligoastrocytoma|anaplastic oligoastrocytoma
690327|NCT00671801|Camptosar|camptosar
690328|NCT00671801|Irinotecan|irinotecan
690329|NCT00671801|CPT-11|cpt-11
690330|NCT00671801|Lenalidomide|lenalidomide
690331|NCT00671801|Revlimid|revlimid
690332|NCT00671801|CC-5013|cc-5013
690333|NCT00671775|Bariatric Surgery|bariatric surgery
690334|NCT00671775|Obesity|obesity
690335|NCT00671775|Cognitive Function|cognitive function
690336|NCT00671736|cystic fibrosis|cystic fibrosis
690337|NCT00671736|Moli1901|moli1901
690338|NCT00671736|Lancovutide|lancovutide
690339|NCT00671736|2622U90|2622u90
690340|NCT00671736|duramycin|duramycin
690341|NCT00671736|lung|lung
690342|NCT00671723|Atelectasis|atelectasis
690343|NCT00671710|malignant glial brain tumors|malignant glial brain tumors
690344|NCT00671697|MDS|mds
690345|NCT00671697|hypomethylating agent|hypomethylating agent
690346|NCT00671697|oxidative stress|oxidative stress
690347|NCT00671684|Hirschsprung's disease|hirschsprung's disease
690348|NCT00671684|Constipation|constipation
690349|NCT00671684|Endoscopy, digestive system|endoscopy, digestive system
690350|NCT00671684|Diagnosis|diagnosis
690351|NCT00671684|Colonoscopy|colonoscopy
690352|NCT00671658|Lymphoma|lymphoma
690353|NCT00671658|HYPER-CVAD|hyper-cvad
690354|NCT00671658|Leukemia|leukemia
690355|NCT00671658|Acute Lymphoblastic Leukemia|acute lymphoblastic leukemia
690356|NCT00671658|ALL|all
690357|NCT00671658|Remission Duration|remission duration
690358|NCT00671658|Chemotherapy|chemotherapy
690359|NCT00671658|Asparaginase|asparaginase
690360|NCT00671658|Cyclophosphamide|cyclophosphamide
690361|NCT00671658|Cytarabine|cytarabine
690362|NCT00671658|Dexamethasone|dexamethasone
690363|NCT00671658|Doxorubicin|doxorubicin
690364|NCT00671658|Leukine|leukine
690365|NCT00671658|Methotrexate|methotrexate
690366|NCT00671658|Rituximab|rituximab
690367|NCT00671658|Vincristine|vincristine
690368|NCT00671645|pilot study|pilot study
690369|NCT00671645|rectal|rectal
690370|NCT00671645|carcinoma|carcinoma
690371|NCT00671645|phase II|phase ii
690372|NCT00671645|preoperative|preoperative
690373|NCT00671645|RadioChemo|radiochemo
690374|NCT00671645|molecular|molecular
690375|NCT00671645|target|target
690376|NCT00671645|therapy|therapy
690377|NCT00671645|T3|t3
690378|NCT00671645|ABCSG|abcsg
690379|NCT00671645|TAKO|tako
690380|NCT00671645|R04|r04
690381|NCT00671645|08|08
690382|NCT00671632|Addiction|addiction
690383|NCT00671619|opthalmology|opthalmology
690384|NCT00671619|antibody fragment|antibody fragment
690385|NCT00671619|TNF alpha|tnf alpha
690386|NCT00671606|Endometrial Cancer|endometrial cancer
690387|NCT00671606|Lymphatic Mapping|lymphatic mapping
690389|NCT00671606|Lymph Node|lymph node
690390|NCT00671606|Intraoperative lymphatic mapping|intraoperative lymphatic mapping
690391|NCT00671606|Total hysterectomy|total hysterectomy
690392|NCT00671606|Bilateral salpingooophorectomy|bilateral salpingooophorectomy
690393|NCT00671606|Lymph node staging|lymph node staging
690394|NCT00671606|Laparotomy|laparotomy
690395|NCT00671606|Laparoscopy|laparoscopy
690396|NCT00671593|Allergy|allergy
690397|NCT00671593|Asthma|asthma
690398|NCT00671593|healthy|healthy
690399|NCT00671593|Normal|normal
690400|NCT00671580|Skin Infections|skin infections
690401|NCT00671580|Complicated Skin and Skin Structure Infections|complicated skin and skin structure infections
690402|NCT00671567|Sleep Disorder|sleep disorder
690403|NCT00671567|Insomnia|insomnia
690404|NCT00671554|Melanoma|melanoma
690405|NCT00671554|Dendritic cells|dendritic cells
690406|NCT00671554|Cell therapy|cell therapy
690407|NCT00671554|BCG vaccine|bcg vaccine
690408|NCT00671528|Impetiginous|impetiginous
690409|NCT00671515|Depressive Disorder, Major|depressive disorder, major
690410|NCT00671515|Metabolic Syndrome X|metabolic syndrome x
690411|NCT00671515|pioglitazone|pioglitazone
690412|NCT00671489|Patients|patients
690413|NCT00671489|high-energy|high-energy
690414|NCT00671489|admitted|admitted
690415|NCT00671489|intensive care unit|intensive care unit
690416|NCT00671489|motor vehicle accident|motor vehicle accident
690417|NCT00671489|falling from height|falling from height
690418|NCT00671489|other accident|other accident
690419|NCT00671476|ductal breast carcinoma in situ|ductal breast carcinoma in situ
690420|NCT00671463|Pancreas surgery|pancreas surgery
690421|NCT00671463|Pancreatic adenocarcinoma|pancreatic adenocarcinoma
690422|NCT00671463|Pancreatic neuroendocrine tumor|pancreatic neuroendocrine tumor
690423|NCT00671463|Pancreatic duct stenting|pancreatic duct stenting
690424|NCT00671437|squamous cell carcinoma of the head and neck|squamous cell carcinoma of the head and neck
690425|NCT00671424|Interaction,|interaction,
690426|NCT00671424|Diabetes,|diabetes,
690427|NCT00671424|healthy male subjects|healthy male subjects
690428|NCT00671424|GSK189075,|gsk189075,
690429|NCT00671424|Diuretics,|diuretics,
690430|NCT00671411|Ultrasound|ultrasound
690432|NCT00671398|Insomnia|insomnia
690433|NCT00671398|Sleep Disorder|sleep disorder
690434|NCT00671398|Drug Therapy|drug therapy
690435|NCT00671385|screening|screening
690436|NCT00671385|compositional analysis|compositional analysis
690437|NCT00671385|metabolism|metabolism
690438|NCT00671385|breast|breast
690439|NCT00671385|breast cyst|breast cyst
690440|NCT00671385|breast infection|breast infection
690441|NCT00671385|breast inflammation|breast inflammation
690442|NCT00671385|lipoma|lipoma
690443|NCT00671385|benign growth|benign growth
690444|NCT00671385|Women without a diagnosis for a region of interest in the breast|women without a diagnosis for a region of interest in the breast
690446|NCT00671372|Metastatic CRC|metastatic crc
690447|NCT00671372|APO2L/TRAIL|apo2l/trail
690448|NCT00671359|Food effects|food effects
690449|NCT00671346|Cancer|cancer
690450|NCT00671346|Coronary artery disease|coronary artery disease
690451|NCT00671346|Myocardial infarction|myocardial infarction
690452|NCT00671346|Cerebrovascular stroke|cerebrovascular stroke
690453|NCT00671346|Homocysteine|homocysteine
690454|NCT00671346|Vitamin B Complex|vitamin b complex
690455|NCT00671346|Folic acid|folic acid
690456|NCT00671346|Vitamin B12|vitamin b12
690457|NCT00671346|Vitamin B6|vitamin b6
690458|NCT00671346|Pyridoxal phosphate|pyridoxal phosphate
690459|NCT00671346|Osteoporotic fractures|osteoporotic fractures
690460|NCT00671346|Diabetes|diabetes
690461|NCT00671333|Randomized|randomized
690462|NCT00671333|Prospective|prospective
690463|NCT00671333|Procedure / Surgery|procedure / surgery
690464|NCT00671320|acute ankle sprain, acute pain, South America|acute ankle sprain, acute pain, south america
690465|NCT00671307|Gelsolin|gelsolin
690466|NCT00671307|Trauma|trauma
690467|NCT00671307|Pneumonia|pneumonia
690468|NCT00671307|Peritonitis|peritonitis
690469|NCT00671307|Burn|burn
690470|NCT00671307|Infection|infection
690471|NCT00671307|Sepsis|sepsis
690472|NCT00671307|Systemic Inflammatory Response Syndrome|systemic inflammatory response syndrome
690473|NCT00671294|Insomnia|insomnia
690474|NCT00671281|FESS|fess
690475|NCT00671281|Tranexamic acid|tranexamic acid
690476|NCT00671281|Hemostasis|hemostasis
690477|NCT00671281|Visualization|visualization
690478|NCT00671268|Grass pollen allergy|grass pollen allergy
690479|NCT00671268|specific immunotherapy|specific immunotherapy
690480|NCT00671255|Chronic Insomnia|chronic insomnia
690481|NCT00671255|Drug Therapy|drug therapy
690482|NCT00671255|Elderly|elderly
690483|NCT00671242|Fluorine-18-α-methyltyrosine,|fluorine-18-α-methyltyrosine,
690484|NCT00671242|Positron emission tomography,|positron emission tomography,
690485|NCT00671242|Fluorine-18-fluorodeoxyglucose,|fluorine-18-fluorodeoxyglucose,
690486|NCT00671242|Lung cancer,|lung cancer,
690487|NCT00671242|Angiogenesis|angiogenesis
690488|NCT00671242|The median VEGF rate was 45% (range, 10-78%).|the median vegf rate was 45% (range, 10-78%).
690489|NCT00671242|High expression was seen in 30 patients (81%, 30/37).|high expression was seen in 30 patients (81%, 30/37).
690490|NCT00671242|VEGF expression was statistically associated with progressively growing microvessel count.|vegf expression was statistically associated with progressively growing microvessel count.
690491|NCT00671229|Healthy|healthy
690492|NCT00671229|Asthma|asthma
690493|NCT00671229|Nitric Oxide|nitric oxide
690494|NCT00671216|safety|safety
690495|NCT00671216|pharmacodynamics|pharmacodynamics
690496|NCT00671216|Muscarinic Receptor Antagonist|muscarinic receptor antagonist
690497|NCT00671216|tolerability|tolerability
690498|NCT00671216|healthy subjects|healthy subjects
690499|NCT00671216|GS642444|gs642444
690500|NCT00671216|GSK233705|gsk233705
690501|NCT00671216|Anticholinergic|anticholinergic
690502|NCT00671216|ß2 agonist|ß2 agonist
690503|NCT00671216|pharmacokinetics|pharmacokinetics
690504|NCT00671203|Tissue oximetry|tissue oximetry
690505|NCT00671203|Ischemia|ischemia
690506|NCT00671203|Aortic Aneurysm Repair|aortic aneurysm repair
690507|NCT00671203|Aortic Stent|aortic stent
690508|NCT00671203|Vascular Stent|vascular stent
690509|NCT00671203|Aortic graft|aortic graft
690510|NCT00671203|Vascular graft|vascular graft
690511|NCT00671190|Sleep Disorder|sleep disorder
690512|NCT00671190|Circadian Rhythm Sleep Disorder|circadian rhythm sleep disorder
690513|NCT00671190|Drug Therapy|drug therapy
690514|NCT00671177|colonoscopy|colonoscopy
690515|NCT00671177|diagnostic techniques|diagnostic techniques
690516|NCT00671177|digestive system|digestive system
690517|NCT00671177|endoscopy|endoscopy
690518|NCT00671177|gastrointestinal|gastrointestinal
690519|NCT00671151|COPD exacerbation|copd exacerbation
690520|NCT00671151|histone|histone
690521|NCT00671151|steroid resistance|steroid resistance
690522|NCT00671151|inflammation|inflammation
690523|NCT00671151|theophylline|theophylline
690524|NCT00671138|Celiac disease|celiac disease
690525|NCT00671138|Parasitic infections|parasitic infections
690526|NCT00671138|necator americanus|necator americanus
690527|NCT00671138|Immunity|immunity
690528|NCT00671125|Sleep Disorder|sleep disorder
690529|NCT00671125|Insomnia|insomnia
690530|NCT00671125|Drug Therapy|drug therapy
690531|NCT00671112|recurrent grade 1 follicular lymphoma|recurrent grade 1 follicular lymphoma
690532|NCT00671112|recurrent grade 2 follicular lymphoma|recurrent grade 2 follicular lymphoma
690533|NCT00671112|recurrent grade 3 follicular lymphoma|recurrent grade 3 follicular lymphoma
690534|NCT00671112|recurrent mantle cell lymphoma|recurrent mantle cell lymphoma
690535|NCT00671112|recurrent marginal zone lymphoma|recurrent marginal zone lymphoma
690536|NCT00671112|recurrent small lymphocytic lymphoma|recurrent small lymphocytic lymphoma
690537|NCT00671112|Waldenstrom's macroglobulinemia|waldenstrom's macroglobulinemia
690538|NCT00671112|extranodal marginal zone B-cell lymphoma of mucosa-associated lymphoid tissue|extranodal marginal zone b-cell lymphoma of mucosa-associated lymphoid tissue
690539|NCT00671112|nodal marginal zone B-cell lymphoma|nodal marginal zone b-cell lymphoma
690540|NCT00671112|splenic marginal zone lymphoma|splenic marginal zone lymphoma
690541|NCT00671112|refractory hairy cell leukemia|refractory hairy cell leukemia
690542|NCT00671112|B-cell chronic lymphocytic leukemia|b-cell chronic lymphocytic leukemia
690543|NCT00671112|refractory chronic lymphocytic leukemia|refractory chronic lymphocytic leukemia
690544|NCT00671112|hairy cell leukemia|hairy cell leukemia
690545|NCT00671112|cutaneous B and T cell lymphoma|cutaneous b and t cell lymphoma
690546|NCT00671112|transformed lymphoma|transformed lymphoma
690547|NCT00671112|transformed B and T cell cutaneous lymphoma|transformed b and t cell cutaneous lymphoma
690548|NCT00671112|relapsed or refractory diffuse large B cell lymphoma|relapsed or refractory diffuse large b cell lymphoma
690549|NCT00671112|extranodal T cell lymphomas|extranodal t cell lymphomas
690550|NCT00671112|anaplastic large cell lymphoma|anaplastic large cell lymphoma
690551|NCT00671112|angioimmunoblastic T cell lymphoma|angioimmunoblastic t cell lymphoma
690552|NCT00671112|PTCL-NOS|ptcl-nos
690553|NCT00671112|nasal or disseminated extranodal T/NK lymphoma|nasal or disseminated extranodal t/nk lymphoma
690554|NCT00671112|enteropathy-associated T cell lymphoma|enteropathy-associated t cell lymphoma
690555|NCT00671112|hepatosplenic gamma/delta T cell lymphoma|hepatosplenic gamma/delta t cell lymphoma
690556|NCT00671112|subcutaneous panniculitis-like T cell lymphoma|subcutaneous panniculitis-like t cell lymphoma
690557|NCT00671112|T-prolymphocytic leukemia|t-prolymphocytic leukemia
690558|NCT00671112|adult T-cell leukemia/lymphoma|adult t-cell leukemia/lymphoma
690559|NCT00671112|large granular lymphocytic leukemia|large granular lymphocytic leukemia
690560|NCT00671112|aggressive NK leukemia|aggressive nk leukemia
690561|NCT00671099|Patients|patients
690562|NCT00671099|with high-energy|with high-energy
690563|NCT00671099|admitted|admitted
690564|NCT00671099|intensive care unit|intensive care unit
690565|NCT00671099|motor vehicle accident|motor vehicle accident
690566|NCT00671099|falling from height|falling from height
690567|NCT00671099|other accident|other accident
690568|NCT00671086|Chronic Insomnia|chronic insomnia
690569|NCT00671086|DIMS (Disorders of Initiating and Maintaining Sleep)|dims (disorders of initiating and maintaining sleep)
690570|NCT00671086|Disorders of Initiating and Maintaining Sleep|disorders of initiating and maintaining sleep
690571|NCT00671086|Insomnia Disorder Sleep Initiation Dysfunction|insomnia disorder sleep initiation dysfunction
690572|NCT00671086|Transient Insomnia|transient insomnia
690573|NCT00671086|Drug Therapy|drug therapy
690848|NCT00669747|Carboplatin|carboplatin
690574|NCT00671086|Sleep Disorders, Intrinsic|sleep disorders, intrinsic
690575|NCT00671073|Airflow Obstruction, Chronic|airflow obstruction, chronic
690576|NCT00671073|Chronic Airflow Obstruction|chronic airflow obstruction
690577|NCT00671073|Chronic Obstructive Pulmonary Disease|chronic obstructive pulmonary disease
690578|NCT00671073|Chronic Obstructive Airway Disease|chronic obstructive airway disease
690579|NCT00671073|Chronic Obstructive Lung Disease|chronic obstructive lung disease
690580|NCT00671073|COPD|copd
690581|NCT00671073|COAD|coad
690582|NCT00671060|intrauterine fetal death|intrauterine fetal death
690583|NCT00671060|misoprostol|misoprostol
690584|NCT00671047|Autoimmune Diseases|autoimmune diseases
690585|NCT00671047|Lupus|lupus
690586|NCT00671021|platelet aggregation|platelet aggregation
690587|NCT00671021|aspirin|aspirin
690588|NCT00670995|Tobacco use among middle and junior high school students remains a concern among health educators.|tobacco use among middle and junior high school students remains a concern among health educators.
690589|NCT00670995|The use of tobacco prevention programs and their integration into school-based curricula has been lacking due to a number of factors.|the use of tobacco prevention programs and their integration into school-based curricula has been lacking due to a number of factors.
690590|NCT00670982|HER2 positive|her2 positive
690591|NCT00670982|bevacizumab|bevacizumab
690592|NCT00670982|vinorelbine|vinorelbine
690593|NCT00670982|trastuzumab|trastuzumab
690594|NCT00670969|Obesity|obesity
690595|NCT00670956|prenatal steroids|prenatal steroids
690596|NCT00670956|hydrops|hydrops
690597|NCT00670956|congenital cystic adenomatoid malformation of the lung|congenital cystic adenomatoid malformation of the lung
690598|NCT00670956|prenatal intervention|prenatal intervention
690599|NCT00670956|betamethasone|betamethasone
690600|NCT00670956|prenatal diagnosis|prenatal diagnosis
690601|NCT00670943|Clopidogrel discontinuation|clopidogrel discontinuation
690602|NCT00670943|Platelet aggregation|platelet aggregation
690603|NCT00670930|Asthma, adults, anti-immunoglobulin E ( IgE), omalizumab, airway inflammation, airway remodeling, allergy|asthma, adults, anti-immunoglobulin e ( ige), omalizumab, airway inflammation, airway remodeling, allergy
690604|NCT00670917|pain|pain
690605|NCT00670917|hematopoietic/lymphoid cancer|hematopoietic/lymphoid cancer
690606|NCT00670904|Smoking cessation|smoking cessation
690607|NCT00670904|Pharmacist-delivered|pharmacist-delivered
690608|NCT00670865|Hospitalization|hospitalization
690609|NCT00670865|Continuity of care|continuity of care
690610|NCT00670865|Discharge summary|discharge summary
690611|NCT00670865|Quality improvement|quality improvement
690612|NCT00670865|Medical records systems|medical records systems
690613|NCT00670865|Hospital information systems|hospital information systems
690614|NCT00670852|Glenoid component|glenoid component
690615|NCT00670852|radiolucent lines|radiolucent lines
690616|NCT00670852|Glenoid loosening|glenoid loosening
690617|NCT00670852|glenohumeral arthritis|glenohumeral arthritis
690618|NCT00670852|autologous bone graft|autologous bone graft
690619|NCT00670839|Hepatitis B vaccination|hepatitis b vaccination
690620|NCT00670839|GenHevac-B Pasteur|genhevac-b pasteur
690621|NCT00670839|HIV infection|hiv infection
690622|NCT00670826|Patient warming|patient warming
690623|NCT00670813|Depression|depression
690624|NCT00670813|(total) sleep deprivation|(total) sleep deprivation
690625|NCT00670813|Modafinil|modafinil
690626|NCT00670813|polysomnography sleep|polysomnography sleep
690627|NCT00670800|Polycystic Ovary Syndrome|polycystic ovary syndrome
690628|NCT00670800|Insulin resistance|insulin resistance
690629|NCT00670800|Metformin|metformin
690630|NCT00670800|Brain function|brain function
690631|NCT00670787|Hypertension|hypertension
690632|NCT00670787|combination pill|combination pill
690633|NCT00670787|compliance|compliance
690634|NCT00670774|Kidney|kidney
690635|NCT00670774|Transplant|transplant
690636|NCT00670774|donor|donor
690637|NCT00670761|misoprostol|misoprostol
690638|NCT00670761|incomplete abortion|incomplete abortion
690639|NCT00670761|sublingual|sublingual
690640|NCT00670761|postabortion care|postabortion care
690642|NCT00670748|Metastatic Cancer|metastatic cancer
690643|NCT00670748|Gene Therapy|gene therapy
690644|NCT00670748|Immunotherapy|immunotherapy
690645|NCT00670748|Tumor Regression|tumor regression
690646|NCT00670748|Metastatic Melanoma|metastatic melanoma
690647|NCT00670748|Metastatic Renal Cell Cancer|metastatic renal cell cancer
690648|NCT00670735|Pediatric Hydrocephalus|pediatric hydrocephalus
690649|NCT00670709|encephalography|encephalography
690650|NCT00670709|quantitative|quantitative
690651|NCT00670709|biomarkers|biomarkers
690652|NCT00670696|Topical anesthesia|topical anesthesia
690653|NCT00670696|Rapydan|rapydan
690654|NCT00670696|Topical anaesthesia for venous cannulation|topical anaesthesia for venous cannulation
690655|NCT00670657|candidemia|candidemia
690656|NCT00670657|invasive candidiasis|invasive candidiasis
690657|NCT00670657|Ambisome|ambisome
690658|NCT00670657|liposomal amphotericin B|liposomal amphotericin b
690659|NCT00670644|male breast cancer|male breast cancer
690660|NCT00670644|recurrent breast cancer|recurrent breast cancer
690661|NCT00670644|stage I breast cancer|stage i breast cancer
690662|NCT00670644|stage II breast cancer|stage ii breast cancer
690663|NCT00670644|stage IIIA breast cancer|stage iiia breast cancer
690664|NCT00670644|stage IIIB breast cancer|stage iiib breast cancer
690665|NCT00670644|stage IIIC breast cancer|stage iiic breast cancer
690666|NCT00670644|stage IV breast cancer|stage iv breast cancer
690667|NCT00670631|Multiple Myeloma|multiple myeloma
690668|NCT00670631|myeloma|myeloma
690669|NCT00670605|unspecified adult solid tumor, protocol specific|unspecified adult solid tumor, protocol specific
690670|NCT00670605|unspecified childhood solid tumor, protocol specific|unspecified childhood solid tumor, protocol specific
690671|NCT00670592|HCD122|hcd122
690672|NCT00670592|CD40|cd40
690673|NCT00670592|NHL|nhl
690674|NCT00670592|HL|hl
690675|NCT00670579|TIVAD|tivad
690676|NCT00670579|complications|complications
690677|NCT00670579|nursing|nursing
690678|NCT00670579|cystic fibrosis|cystic fibrosis
690679|NCT00670579|implanted|implanted
690680|NCT00670553|Prostate,|prostate,
690681|NCT00670553|Head & Neck,|head & neck,
690682|NCT00670553|Esophageal|esophageal
690683|NCT00670540|pulmonary embolism|pulmonary embolism
690684|NCT00670540|duplex ultrasound examination|duplex ultrasound examination
690685|NCT00670540|recurrence|recurrence
690686|NCT00670527|Prostate cancer|prostate cancer
690687|NCT00670527|[18F] Fluorocholine PET/CT|[18f] fluorocholine pet/ct
690688|NCT00670527|FCH|fch
690689|NCT00670527|lymph node metastasis|lymph node metastasis
690690|NCT00670527|staging|staging
690691|NCT00670527|sensitivity|sensitivity
690692|NCT00670527|specificity|specificity
690693|NCT00670527|PROPET|propet
690694|NCT00670514|RCT|rct
690695|NCT00670514|tobacco|tobacco
690696|NCT00670514|treatment intensity|treatment intensity
690697|NCT00670514|dentistry|dentistry
690698|NCT00670514|follow-up|follow-up
690699|NCT00670514|Smoking cessation|smoking cessation
690700|NCT00670514|Cost effectiveness|cost effectiveness
690701|NCT00670475|osteoarthritis|osteoarthritis
690702|NCT00670475|Knee|knee
690703|NCT00670475|virgin olive oil|virgin olive oil
690704|NCT00670475|piroxicam|piroxicam
690705|NCT00670475|Topical|topical
690706|NCT00670462|obesity, weight loss, treatment|obesity, weight loss, treatment
690707|NCT00670449|FTY720|fty720
690708|NCT00670449|multiple sclerosis|multiple sclerosis
690709|NCT00670449|MS|ms
690710|NCT00670423|Tacrolimus|tacrolimus
690711|NCT00670423|Sirolimus|sirolimus
690712|NCT00670423|Bortezomib|bortezomib
690713|NCT00670423|Acute Graft Versus Host Disease|acute graft versus host disease
690714|NCT00670423|Allogeneic Peripheral Blood Stem Cell Transplantation|allogeneic peripheral blood stem cell transplantation
690715|NCT00670410|Neuroblastoma|neuroblastoma
690716|NCT00670410|Autologous Transplant|autologous transplant
690717|NCT00670410|Allogeneic Transplant|allogeneic transplant
690718|NCT00670410|Immunotherapy|immunotherapy
690719|NCT00670397|stage I squamous cell carcinoma of the lip and oral cavity|stage i squamous cell carcinoma of the lip and oral cavity
690720|NCT00670397|recurrent squamous cell carcinoma of the lip and oral cavity|recurrent squamous cell carcinoma of the lip and oral cavity
690721|NCT00670397|stage 0 lip and oral cavity cancer|stage 0 lip and oral cavity cancer
690722|NCT00670384|SLIT|slit
690723|NCT00670384|Immunotherapy|immunotherapy
690724|NCT00670384|Short ragweed|short ragweed
690725|NCT00670384|SAR|sar
690726|NCT00670384|Seasonal allergic rhinitis|seasonal allergic rhinitis
690727|NCT00670371|Caregiver burden|caregiver burden
690728|NCT00670358|contiguous stage II adult diffuse large cell lymphoma|contiguous stage ii adult diffuse large cell lymphoma
690729|NCT00670358|noncontiguous stage II adult diffuse large cell lymphoma|noncontiguous stage ii adult diffuse large cell lymphoma
690730|NCT00670358|stage III adult diffuse large cell lymphoma|stage iii adult diffuse large cell lymphoma
690731|NCT00670358|stage IV adult diffuse large cell lymphoma|stage iv adult diffuse large cell lymphoma
690732|NCT00670358|contiguous stage II grade 3 follicular lymphoma|contiguous stage ii grade 3 follicular lymphoma
690733|NCT00670358|noncontiguous stage II grade 3 follicular lymphoma|noncontiguous stage ii grade 3 follicular lymphoma
690734|NCT00670358|stage III grade 3 follicular lymphoma|stage iii grade 3 follicular lymphoma
690735|NCT00670358|stage IV grade 3 follicular lymphoma|stage iv grade 3 follicular lymphoma
690736|NCT00670345|tranexamic acid|tranexamic acid
690737|NCT00670345|prostatectomy|prostatectomy
690738|NCT00670345|surgery|surgery
690739|NCT00670332|coronary artery disease|coronary artery disease
690740|NCT00670332|echocardiography|echocardiography
690741|NCT00670332|cardiac imaging|cardiac imaging
690742|NCT00670332|heart disease|heart disease
690743|NCT00670332|ultrasound contrast agent|ultrasound contrast agent
690744|NCT00670332|prognosis|prognosis
690745|NCT00670306|Cetrorelix|cetrorelix
690746|NCT00670306|BPH|bph
690747|NCT00670293|Anorexia Nervosa|anorexia nervosa
690748|NCT00670293|PET Imaging|pet imaging
690749|NCT00670293|Dopamine|dopamine
690750|NCT00670280|Neonatal Intensive Care Units|neonatal intensive care units
690751|NCT00670280|Infant Morbidity|infant morbidity
690752|NCT00670280|Low Birth Weight|low birth weight
690753|NCT00670280|Low Income Populations|low income populations
690754|NCT00670280|MCH Research|mch research
690755|NCT00670280|Respiratory Illnesses|respiratory illnesses
690756|NCT00670280|Substance Exposed Infants|substance exposed infants
690757|NCT00670280|Counseling|counseling
690758|NCT00670267|Asthma|asthma
690759|NCT00670267|hyperresponsiveness|hyperresponsiveness
690760|NCT00670254|Sepsis|sepsis
690761|NCT00670254|Septic|septic
690762|NCT00670254|Shock|shock
690763|NCT00670254|Glucocorticoids|glucocorticoids
690764|NCT00670254|Hydrocortisone|hydrocortisone
690765|NCT00670215|Prevention of infectious complications|prevention of infectious complications
690766|NCT00670215|transrectal needle biopsies of the prostate|transrectal needle biopsies of the prostate
690767|NCT00670215|TRNBP|trnbp
690768|NCT00670202|Patients scheduled for elective carotid endarterectomy|patients scheduled for elective carotid endarterectomy
690769|NCT00670163|Men Who Have Sex With Men|men who have sex with men
690770|NCT00670111|Heart failure|heart failure
690771|NCT00670111|exercise capacity|exercise capacity
690772|NCT00670111|ejection fraction|ejection fraction
690773|NCT00670111|Heart failure normal ejection fraction|heart failure normal ejection fraction
690774|NCT00670059|Single embryo transfer/ aneuploidy screening|single embryo transfer/ aneuploidy screening
690775|NCT00670046|recurrent prostate cancer|recurrent prostate cancer
690776|NCT00670046|stage I prostate cancer|stage i prostate cancer
690777|NCT00670046|stage IIB prostate cancer|stage iib prostate cancer
690778|NCT00670046|stage IIA prostate cancer|stage iia prostate cancer
690779|NCT00670046|stage III prostate cancer|stage iii prostate cancer
690780|NCT00670046|stage IV prostate cancer|stage iv prostate cancer
690781|NCT00670033|IOP|iop
690782|NCT00670033|Open-angle glaucoma|open-angle glaucoma
690783|NCT00670033|Ocular Hypertension|ocular hypertension
690784|NCT00670020|Women undergoing Cesarean section after the onset of labor|women undergoing cesarean section after the onset of labor
690785|NCT00670007|Alpha1-proteinase inhibitor deficiency|alpha1-proteinase inhibitor deficiency
690786|NCT00670007|Chronic augmentation and maintenance therapy|chronic augmentation and maintenance therapy
690787|NCT00670007|Emphysema|emphysema
690788|NCT00670007|Emphysema due to Alpha 1-proteinase inhibitor deficiency|emphysema due to alpha 1-proteinase inhibitor deficiency
690789|NCT00669994|UTI|uti
690790|NCT00669994|Urinary Tract Infection|urinary tract infection
690791|NCT00669981|PTSD|ptsd
690792|NCT00669981|Relationship Distress|relationship distress
690793|NCT00669981|Couple Therapy|couple therapy
690794|NCT00669968|PET myocardial perfusion imaging|pet myocardial perfusion imaging
690795|NCT00669968|Cardiac PET|cardiac pet
690796|NCT00669968|Rubidium|rubidium
690797|NCT00669968|Coronary Artery CT Angiogram|coronary artery ct angiogram
690798|NCT00669968|Coronary Flow Reserve|coronary flow reserve
690799|NCT00669968|Adenosine stress test|adenosine stress test
690800|NCT00669955|H. Pylori|h. pylori
690801|NCT00669955|Quadruple therapy|quadruple therapy
690802|NCT00669955|Eradication rate|eradication rate
690803|NCT00669955|Multinational trial|multinational trial
690804|NCT00669955|Resistance to antibiotics|resistance to antibiotics
690805|NCT00669955|Subjects with confirmed Helicobacter Pylori infection|subjects with confirmed helicobacter pylori infection
690806|NCT00669942|Rheumatoid Arthritis|rheumatoid arthritis
690807|NCT00669929|Cost effectiveness analysis of rotavirus vaccination|cost effectiveness analysis of rotavirus vaccination
690808|NCT00669916|Plaque psoriasis|plaque psoriasis
690809|NCT00669890|AML|aml
690810|NCT00669890|JMML|jmml
690811|NCT00669890|MDS|mds
690812|NCT00669890|Allogenic Atem Cell Transplant|allogenic atem cell transplant
690813|NCT00669890|Gemtuzumab Ozogamicin|gemtuzumab ozogamicin
690814|NCT00669877|Burkitt's Lymphoma|burkitt's lymphoma
690815|NCT00669877|Burkitt's Like Lymphoma|burkitt's like lymphoma
690816|NCT00669877|Leukemia|leukemia
690817|NCT00669877|Hyper-CVAD|hyper-cvad
690818|NCT00669877|Rituximab|rituximab
690819|NCT00669877|Methotrexate|methotrexate
690820|NCT00669877|Cytarabine|cytarabine
690821|NCT00669851|coronary artery disease|coronary artery disease
690822|NCT00669851|echocardiography|echocardiography
690823|NCT00669851|cardiac imaging|cardiac imaging
690824|NCT00669851|heart disease|heart disease
690825|NCT00669851|ultrasound contrast agent|ultrasound contrast agent
690826|NCT00669851|myocardial contrast enhancement|myocardial contrast enhancement
690827|NCT00669851|myocardial perfusion|myocardial perfusion
690828|NCT00669838|Anesthesia, Local|anesthesia, local
690829|NCT00669838|Lidocaine|lidocaine
690830|NCT00669838|Dental care|dental care
690831|NCT00669838|Arrhythmias, Cardiac|arrhythmias, cardiac
690832|NCT00669838|Anxiety|anxiety
690833|NCT00669825|Celiac Disease|celiac disease
690834|NCT00669812|small intestine lymphoma|small intestine lymphoma
690835|NCT00669812|stage I adult T-cell leukemia/lymphoma|stage i adult t-cell leukemia/lymphoma
690836|NCT00669812|stage II adult T-cell leukemia/lymphoma|stage ii adult t-cell leukemia/lymphoma
690837|NCT00669812|stage III adult T-cell leukemia/lymphoma|stage iii adult t-cell leukemia/lymphoma
690838|NCT00669812|stage IV adult T-cell leukemia/lymphoma|stage iv adult t-cell leukemia/lymphoma
690839|NCT00669786|Ongoing Pregnancy Rate|ongoing pregnancy rate
690840|NCT00669760|cystic fibrosis|cystic fibrosis
690841|NCT00669760|Staphylococcus aureus|staphylococcus aureus
690842|NCT00669760|persistent colonization-infection|persistent colonization-infection
690843|NCT00669760|clinical status|clinical status
690844|NCT00669760|lung function|lung function
690845|NCT00669747|Ductal Carcinoma In Situ|ductal carcinoma in situ
690846|NCT00669747|DCIS|dcis
690847|NCT00669747|Breast Cancer|breast cancer
690849|NCT00669747|Intraductal|intraductal
690850|NCT00669721|osteoprotegerin|osteoprotegerin
690851|NCT00669721|RANKL|rankl
690852|NCT00669721|heparin|heparin
690853|NCT00669721|hemodialysis|hemodialysis
690854|NCT00669721|anticoagulation|anticoagulation
690855|NCT00669721|vascular calcification|vascular calcification
690856|NCT00669708|dry skin|dry skin
690857|NCT00669708|cooling|cooling
690858|NCT00669708|itch|itch
690859|NCT00669695|statins|statins
690860|NCT00669695|cardiovascular risk|cardiovascular risk
690861|NCT00669695|Obstructive sleep apnea syndrome (OSAS) patients|obstructive sleep apnea syndrome (osas) patients
690862|NCT00669643|Leprosy|leprosy
690863|NCT00669643|Communicable Diseases|communicable diseases
690864|NCT00669643|Skin Diseases|skin diseases
690865|NCT00669643|Multidrug Therapy|multidrug therapy
690866|NCT00669643|MDT|mdt
690867|NCT00669643|Uniform Multidrug Therapy|uniform multidrug therapy
690868|NCT00669643|U-MDT|u-mdt
690869|NCT00669630|Community-based Participatory Research (CBPR)|community-based participatory research (cbpr)
690870|NCT00669630|Vulnerable population|vulnerable population
690871|NCT00669630|High-risk population|high-risk population
690872|NCT00669630|African-Americans|african-americans
690873|NCT00669630|Health Disparities|health disparities
690874|NCT00669630|Clinical Trial|clinical trial
690875|NCT00669617|chronic obstructive pulmonary disease|chronic obstructive pulmonary disease
690876|NCT00669617|COPD|copd
690877|NCT00669617|indacaterol|indacaterol
690878|NCT00669617|adults|adults
690879|NCT00669604|Mother to child transmission of HIV|mother to child transmission of hiv
690880|NCT00669604|HIV infected children|hiv infected children
690881|NCT00669591|breast cancer|breast cancer
690882|NCT00669591|docetaxel chemotherapy|docetaxel chemotherapy
690883|NCT00669591|bavituximab|bavituximab
690884|NCT00669591|monoclonal antibody|monoclonal antibody
690885|NCT00669578|secondary myelofibrosis|secondary myelofibrosis
690886|NCT00669578|polycythemia vera|polycythemia vera
690887|NCT00669578|essential thrombocythemia|essential thrombocythemia
690888|NCT00669578|primary myelofibrosis|primary myelofibrosis
690889|NCT00669565|Locally Advanced or Metastatic Breast Cancer|locally advanced or metastatic breast cancer
690890|NCT00669539|Amblyopia associated with strabismus|amblyopia associated with strabismus
690891|NCT00669539|Refractive error|refractive error
690892|NCT00669526|anxiety|anxiety
690893|NCT00669526|depression|depression
690894|NCT00669526|Major Depressive Disorder|major depressive disorder
690895|NCT00669526|child|child
690896|NCT00669526|adolescent|adolescent
690897|NCT00669526|CBT|cbt
690898|NCT00669526|Cognitive-Behavioral Therapy|cognitive-behavioral therapy
690899|NCT00669526|primary care|primary care
690900|NCT00669513|partial sleep deprivation|partial sleep deprivation
690901|NCT00669513|endothelial dysfunction|endothelial dysfunction
690902|NCT00669513|sympathetic activity|sympathetic activity
690903|NCT00669513|inflammation|inflammation
690904|NCT00669500|dietary intake|dietary intake
690905|NCT00669500|genetic predisposition|genetic predisposition
690906|NCT00669500|body composition|body composition
690907|NCT00669487|HIV/AIDS patients|hiv/aids patients
690908|NCT00669461|Constipation|constipation
690909|NCT00669461|Parkinson's Disease|parkinson's disease
690910|NCT00669448|Multiple chemical sensitivities|multiple chemical sensitivities
690911|NCT00669448|MCS|mcs
690912|NCT00669448|Mindfulness-based cognitive therapy|mindfulness-based cognitive therapy
690913|NCT00669448|MBCT|mbct
690914|NCT00669448|Behavioural intervention|behavioural intervention
690915|NCT00669448|Stress|stress
690916|NCT00669448|Illness perceptions|illness perceptions
690917|NCT00669448|Pilot trial|pilot trial
690918|NCT00669435|Essential hypertension|essential hypertension
690919|NCT00669435|Liver steatosis|liver steatosis
690920|NCT00669422|Ovarian Cancer|ovarian cancer
690921|NCT00669422|Fallopian Tube Cancer|fallopian tube cancer
690922|NCT00669422|Peritoneal Cancer|peritoneal cancer
690923|NCT00669422|Uterine Neoplasms|uterine neoplasms
690924|NCT00669422|Vulvar Cancer|vulvar cancer
690925|NCT00669422|Endometrial Cancer|endometrial cancer
690926|NCT00669422|Cervical Cancer|cervical cancer
690927|NCT00669422|Assay|assay
690928|NCT00669422|Chemotherapy|chemotherapy
690929|NCT00669422|Recurrent|recurrent
690930|NCT00669422|Refractory|refractory
690931|NCT00669422|Persistent|persistent
690932|NCT00669422|Chemoresponse|chemoresponse
690933|NCT00669422|Sensitivity|sensitivity
690934|NCT00669422|Precision Therapeutics|precision therapeutics
690935|NCT00669422|ChemoFx|chemofx
690936|NCT00669409|monoclonal antibody|monoclonal antibody
690937|NCT00669396|contraception|contraception
690938|NCT00669396|emergency contraception|emergency contraception
690939|NCT00669396|pregnancy prevention after unprotected intercourse|pregnancy prevention after unprotected intercourse
690940|NCT00669383|premature delivery|premature delivery
690941|NCT00669383|respiratory distress syndrome|respiratory distress syndrome
690942|NCT00669370|advanced gastric cancer|advanced gastric cancer
690943|NCT00669370|adenocarcinoma|adenocarcinoma
690944|NCT00669357|End stage heart disease|end stage heart disease
690945|NCT00669344|cognition|cognition
690946|NCT00669344|stroke|stroke
690947|NCT00669344|VCI|vci
690948|NCT00669344|VCIND|vcind
690949|NCT00669344|Cognitive Impairment, No Dementia|cognitive impairment, no dementia
690950|NCT00669331|randomized clinical trial|randomized clinical trial
690951|NCT00669331|mannitol|mannitol
690952|NCT00669331|mucoactive|mucoactive
690953|NCT00669318|refractory chronic lymphocytic leukemia|refractory chronic lymphocytic leukemia
690954|NCT00669318|recurrent small lymphocytic lymphoma|recurrent small lymphocytic lymphoma
690955|NCT00669318|B-cell chronic lymphocytic leukemia|b-cell chronic lymphocytic leukemia
690956|NCT00669305|Genetics|genetics
690957|NCT00669305|Blood cells|blood cells
690958|NCT00669305|Vector-mediated gene transfer|vector-mediated gene transfer
690959|NCT00669305|Bone marrow|bone marrow
690960|NCT00669305|CD34 cells|cd34 cells
690961|NCT00669292|esophageal cancer|esophageal cancer
690962|NCT00669292|peptide|peptide
690963|NCT00669292|URLC10|urlc10
690964|NCT00669292|TTK|ttk
690965|NCT00669292|CpG7909|cpg7909
690966|NCT00669214|Raptiva|raptiva
690967|NCT00669214|Moderate plaque psoriasis|moderate plaque psoriasis
690968|NCT00669214|Severe plaque psoriasis|severe plaque psoriasis
690969|NCT00669214|Scalp|scalp
690970|NCT00669201|cartilage|cartilage
690971|NCT00669201|osteoarthritis|osteoarthritis
690972|NCT00669201|T2 mapping|t2 mapping
690973|NCT00669201|MRI|mri
690974|NCT00669201|Wrist|wrist
690975|NCT00669188|Patient Provider Interaction|patient provider interaction
690976|NCT00669188|Physician Training|physician training
690977|NCT00669188|Patient Provider Training|patient provider training
690978|NCT00669175|Naloxone|naloxone
690979|NCT00669175|Neonate|neonate
690980|NCT00669175|Pain|pain
690981|NCT00669149|ptca|ptca
690982|NCT00669149|antiaggregant therapy|antiaggregant therapy
690983|NCT00669149|anticoagulant therapy|anticoagulant therapy
690984|NCT00669136|AFP + GM-CSF Plasmid Prime and AFP Adenoviral Vector Boost|afp + gm-csf plasmid prime and afp adenoviral vector boost
690985|NCT00669136|AFP Immunization|afp immunization
690986|NCT00669123|Chondroitin sulphate|chondroitin sulphate
690987|NCT00669123|Knee osteoarthritis|knee osteoarthritis
690988|NCT00669123|Psoriasis|psoriasis
690989|NCT00669110|MDD|mdd
690990|NCT00669110|Depression|depression
690991|NCT00669110|Pediatrics|pediatrics
690992|NCT00669110|Major Depressive Disorder|major depressive disorder
690993|NCT00669097|ADME|adme
690994|NCT00669097|TKI258|tki258
690995|NCT00669097|RTKs inhibitor|rtks inhibitor
690996|NCT00669097|PDGRF inhibitor|pdgrf inhibitor
690997|NCT00669097|VEGFER inhibitor|vegfer inhibitor
690998|NCT00669084|Innate Immunity|innate immunity
690999|NCT00669084|Malaria|malaria
691000|NCT00669084|Plasmodium|plasmodium
691001|NCT00669084|Hemoglobinopathy|hemoglobinopathy
691002|NCT00669084|G6PD Deficiency|g6pd deficiency
691003|NCT00669058|hygiene|hygiene
691004|NCT00669045|TNKase|tnkase
691005|NCT00669045|AMI|ami
691006|NCT00669006|neuropathic pain|neuropathic pain
691007|NCT00669006|database|database
691008|NCT00669006|prospective|prospective
691009|NCT00669006|national|national
691010|NCT00668980|Down syndrome|down syndrome
691011|NCT00668980|symbolic representation|symbolic representation
691012|NCT00668980|gestures|gestures
691013|NCT00668980|expressive language development|expressive language development
691014|NCT00668967|Cardiovascular Diseases|cardiovascular diseases
691015|NCT00668967|Hypertension|hypertension
691016|NCT00668954|Diabetes|diabetes
691017|NCT00668954|Pomegranate|pomegranate
691018|NCT00668954|Biomarkers|biomarkers
691019|NCT00668954|Antioxidant|antioxidant
691020|NCT00668941|Bone Density|bone density
691021|NCT00668941|Bone Turnover|bone turnover
691022|NCT00668941|Histomorphometry|histomorphometry
691023|NCT00668902|CYP2C19|cyp2c19
691024|NCT00668902|Pantoprazole|pantoprazole
691025|NCT00668902|Genotype|genotype
691026|NCT00668902|Pharmacokinetics|pharmacokinetics
691027|NCT00668902|Metabolism|metabolism
691028|NCT00668889|Hygiene|hygiene
691029|NCT00668876|immunonutrition|immunonutrition
691030|NCT00668876|pancreaticoduodenectomy|pancreaticoduodenectomy
691031|NCT00668876|Th1|th1
691032|NCT00668876|Th2|th2
691033|NCT00668876|Th17|th17
691034|NCT00668837|Paliperidone|paliperidone
691035|NCT00668837|schizophrenia|schizophrenia
691036|NCT00668824|Congenital Heart Disease (CHD)|congenital heart disease (chd)
691037|NCT00668811|thyroid cancer|thyroid cancer
691038|NCT00668811|metastatic thyroid cancer|metastatic thyroid cancer
691039|NCT00668811|differentiated thyroid cancer|differentiated thyroid cancer
691040|NCT00668811|papillary thyroid cancer|papillary thyroid cancer
691041|NCT00668811|follicular thyroid cancer|follicular thyroid cancer
691042|NCT00668811|Histologically confirmed|histologically confirmed
691043|NCT00668811|metastatic stage 2,stage 3, or stage 4 differentiated thyroid cancer|metastatic stage 2,stage 3, or stage 4 differentiated thyroid cancer
691044|NCT00668798|cytomegalovirus breast milk preterm infants transmission|cytomegalovirus breast milk preterm infants transmission
691045|NCT00668798|transmission of CMV via thawed frozen breast milk|transmission of cmv via thawed frozen breast milk
691046|NCT00668785|Ranibizumab|ranibizumab
691047|NCT00668785|Proliferative Diabetic Retinopathy|proliferative diabetic retinopathy
691139|NCT00668304|Sinusitis|sinusitis
691048|NCT00668785|Macular Edema following Panretinal Photocoagulation|macular edema following panretinal photocoagulation
691049|NCT00668785|Safety and Efficacy|safety and efficacy
691050|NCT00668785|Intravitreal Injection|intravitreal injection
691051|NCT00668759|atrial fibrillation|atrial fibrillation
691052|NCT00668759|atrial fib|atrial fib
691053|NCT00668759|AF|af
691054|NCT00668746|chronic periodontitis, antibiotic resistance|chronic periodontitis, antibiotic resistance
691055|NCT00668733|Actinic keratoses|actinic keratoses
691056|NCT00668733|Dermatologic disease|dermatologic disease
691057|NCT00668720|tinnitus|tinnitus
691058|NCT00668720|transcranial magnetic stimulation|transcranial magnetic stimulation
691059|NCT00668707|melatonin|melatonin
691060|NCT00668707|natural health product (NHP)|natural health product (nhp)
691061|NCT00668707|lung cancer|lung cancer
691062|NCT00668707|complementary and alternative medicine (CAM)|complementary and alternative medicine (cam)
691063|NCT00668707|randomized clinical trial|randomized clinical trial
691064|NCT00668694|Psychosocial stimulation in addition to iron supplementation will improve mental and psychomotor development, language, behavior and growth of IDA infants.|psychosocial stimulation in addition to iron supplementation will improve mental and psychomotor development, language, behavior and growth of ida infants.
691065|NCT00668694|With the addition of stimulation IDA infants will catch up to the non-anemic infants.|with the addition of stimulation ida infants will catch up to the non-anemic infants.
691066|NCT00668681|Abdominal Aortic Aneurysm|abdominal aortic aneurysm
691067|NCT00668655|Rosacea, metronidazole|rosacea, metronidazole
691068|NCT00668629|Hygiene|hygiene
691069|NCT00668616|breast cancer with 1-3 afflicted axillary lymph nodes|breast cancer with 1-3 afflicted axillary lymph nodes
691070|NCT00668603|Postmenopausal vasomotor symptoms|postmenopausal vasomotor symptoms
691071|NCT00668603|Hot flush|hot flush
691072|NCT00668603|Vascular function|vascular function
691073|NCT00668603|Cardiac function|cardiac function
691074|NCT00668603|Cardiovascular risk factor|cardiovascular risk factor
691075|NCT00668590|Diabetes|diabetes
691076|NCT00668577|Hygiene|hygiene
691077|NCT00668564|Inborn errors of metabolism|inborn errors of metabolism
691078|NCT00668564|Sphingolipidoses|sphingolipidoses
691079|NCT00668564|Recessive Leukodystrophies- GLD, Krabbe disease, MLD|recessive leukodystrophies- gld, krabbe disease, mld
691080|NCT00668564|Peroxisomal Disorders|peroxisomal disorders
691081|NCT00668564|Wolman syndrome|wolman syndrome
691082|NCT00668564|Niemann-Pick B patients|niemann-pick b patients
691083|NCT00668564|Niemann-Pick C subtype 2|niemann-pick c subtype 2
691084|NCT00668551|Parkinson disease|parkinson disease
691085|NCT00668551|Telemedicine|telemedicine
691086|NCT00668538|Miconazole|miconazole
691087|NCT00668538|CYP1A2|cyp1a2
691088|NCT00668538|CYP3A4|cyp3a4
691089|NCT00668538|Women|women
691090|NCT00668538|Healthy Subjects|healthy subjects
691091|NCT00668525|Depression|depression
691092|NCT00668525|Major Depressive Disorder|major depressive disorder
691093|NCT00668525|Escitalopram|escitalopram
691094|NCT00668512|metastatic cutaneous melanoma|metastatic cutaneous melanoma
691095|NCT00668512|alpha-gal glycolipids|alpha-gal glycolipids
691096|NCT00668486|Hygiene|hygiene
691097|NCT00668473|systemic sclerosis angiogenesis|systemic sclerosis angiogenesis
691098|NCT00668460|hygiene|hygiene
691099|NCT00668447|bone density|bone density
691100|NCT00668447|bone loss|bone loss
691101|NCT00668447|postmenopausal|postmenopausal
691102|NCT00668434|Back Pain|back pain
691103|NCT00668434|Leg Pain|leg pain
691104|NCT00668421|Myelofibrosis|myelofibrosis
691105|NCT00668421|Essential Thrombocythemia|essential thrombocythemia
691106|NCT00668421|Polycythemia Vera|polycythemia vera
691107|NCT00668421|JAK2 V617F Mutation|jak2 v617f mutation
691108|NCT00668421|Lestaurtinib|lestaurtinib
691109|NCT00668408|OTLT|otlt
691110|NCT00668408|COPD|copd
691111|NCT00668408|CHRONIC HYPOXEMIA|chronic hypoxemia
691112|NCT00668408|CHF|chf
691113|NCT00668395|CYP2B6|cyp2b6
691114|NCT00668395|Efavirenz|efavirenz
691115|NCT00668395|Pharmacokinetics|pharmacokinetics
691116|NCT00668395|Pharmacogenetics|pharmacogenetics
691117|NCT00668395|Drug-Interactions|drug-interactions
691118|NCT00668382|Cancerous solid tumors|cancerous solid tumors
691119|NCT00668382|Alpha-Gal Glycosphingolipids|alpha-gal glycosphingolipids
691120|NCT00668369|Liver Transplantation|liver transplantation
691121|NCT00668369|Tolerance|tolerance
691122|NCT00668369|Hepatitis C virus infection|hepatitis c virus infection
691123|NCT00668369|Immune responses|immune responses
691124|NCT00668369|Allograft tolerance|allograft tolerance
691125|NCT00668369|Immunosuppression weaning|immunosuppression weaning
691126|NCT00668369|Immunosuppression minimization|immunosuppression minimization
691127|NCT00668356|HIV disease in children|hiv disease in children
691128|NCT00668356|HIV|hiv
691129|NCT00668356|children|children
691130|NCT00668356|didanosine|didanosine
691131|NCT00668356|bioequivalence|bioequivalence
691132|NCT00668356|pharmacokinetics|pharmacokinetics
691133|NCT00668356|treatment experienced|treatment experienced
691134|NCT00668343|edss attack|edss attack
691135|NCT00668330|Bone mineral density|bone mineral density
691136|NCT00668330|ibandronate|ibandronate
691137|NCT00668330|alfacalcidol|alfacalcidol
691138|NCT00668317|Hyper-responsiveness, reflux cough|hyper-responsiveness, reflux cough
691140|NCT00668291|Endocrinology, CARNEY Complex,|endocrinology, carney complex,
691141|NCT00668291|primary pigmented nodular adrenocortical disease (PPNAD),|primary pigmented nodular adrenocortical disease (ppnad),
691142|NCT00668291|PRKAR1A|prkar1a
691143|NCT00668278|Supraglottic airway|supraglottic airway
691144|NCT00668278|I-gel|i-gel
691145|NCT00668278|Laryngeal mask|laryngeal mask
691146|NCT00668278|Controlled ventilation|controlled ventilation
691147|NCT00668278|Peak airway pressure|peak airway pressure
691148|NCT00668278|Seal pressure|seal pressure
691149|NCT00668278|Anaesthesia|anaesthesia
691150|NCT00668278|Surgery|surgery
691151|NCT00668265|Generalized Anxiety Disorder|generalized anxiety disorder
691152|NCT00668265|Opiate Dependence|opiate dependence
691153|NCT00668265|Methadone-Maintenance|methadone-maintenance
691154|NCT00668265|Drug Addiction Treatment|drug addiction treatment
691155|NCT00668252|endothelial progenitor cells|endothelial progenitor cells
691156|NCT00668252|estrogen|estrogen
691157|NCT00668252|menopause|menopause
691158|NCT00668252|cardiovascular risk|cardiovascular risk
691159|NCT00668239|diffuse macular oedema|diffuse macular oedema
691160|NCT00668239|type 2 diabetes mellitus|type 2 diabetes mellitus
691161|NCT00668239|laser therapy|laser therapy
691162|NCT00668226|Hygiene|hygiene
691163|NCT00668213|Macular Degeneration|macular degeneration
691164|NCT00668200|Paget's|paget's
691165|NCT00668200|hypocalcemia|hypocalcemia
691166|NCT00668200|zoledronic acid|zoledronic acid
691167|NCT00668200|serum calcium|serum calcium
691168|NCT00668187|Tay-Sachs disease|tay-sachs disease
691169|NCT00668187|Sandhoff disease|sandhoff disease
691170|NCT00668187|Late Onset Tay-Sachs disease|late onset tay-sachs disease
691171|NCT00668187|LOTS|lots
691172|NCT00668187|hexosaminidase A deficiency|hexosaminidase a deficiency
691173|NCT00668187|hexosaminidase A and B deficiency|hexosaminidase a and b deficiency
691174|NCT00668187|infantile Tay-Sachs disease|infantile tay-sachs disease
691175|NCT00668187|adult-onset Tay-Sachs disease|adult-onset tay-sachs disease
691176|NCT00668187|prospective|prospective
691177|NCT00668187|natural history|natural history
691178|NCT00668187|GM1 gangliosidosis|gm1 gangliosidosis
691179|NCT00668187|gangliosidoses|gangliosidoses
691180|NCT00668187|β-galactosidase|β-galactosidase
691181|NCT00668187|β-galactosidase deficiency|β-galactosidase deficiency
691182|NCT00668187|hexosaminidase|hexosaminidase
691183|NCT00668187|hexosaminidase deficiency|hexosaminidase deficiency
691184|NCT00668187|Tay-Sachs|tay-sachs
691185|NCT00668187|Sandhoff|sandhoff
691186|NCT00668187|juvenile Tay-Sachs|juvenile tay-sachs
691187|NCT00668187|juvenile Tay-Sachs disease|juvenile tay-sachs disease
691188|NCT00668187|late onset Tay-Sachs|late onset tay-sachs
691189|NCT00668187|juvenile Sandhoff|juvenile sandhoff
691190|NCT00668187|juvenile Sandhoff disease|juvenile sandhoff disease
691191|NCT00668187|GM2 gangliosidosis|gm2 gangliosidosis
691192|NCT00668148|Sarcoma|sarcoma
691193|NCT00668148|Ewing's sarcoma / peripheral neuroectodermal tumor (PNET);|ewing's sarcoma / peripheral neuroectodermal tumor (pnet);
691194|NCT00668148|rhabdomyosarcoma;|rhabdomyosarcoma;
691195|NCT00668148|leiomyosarcoma;|leiomyosarcoma;
691196|NCT00668148|adipocytic sarcoma|adipocytic sarcoma
691197|NCT00668148|synovial sarcoma|synovial sarcoma
691198|NCT00668135|Erectile Dysfunction|erectile dysfunction
691199|NCT00668135|Vardenafil|vardenafil
691200|NCT00668109|Erectile Dysfunction|erectile dysfunction
691201|NCT00668109|Diabetes mellitus|diabetes mellitus
691202|NCT00668109|Hypertension|hypertension
691203|NCT00668109|Hyperlipidemia|hyperlipidemia
691204|NCT00668109|Vardenafil|vardenafil
691205|NCT00668096|Erectile Dysfunction|erectile dysfunction
691206|NCT00668096|PDE5 inhibitors|pde5 inhibitors
691207|NCT00668083|second line|second line
691208|NCT00668083|Prostate Cancer|prostate cancer
691209|NCT00668083|bicalutamide|bicalutamide
691210|NCT00668083|biochemical relapse/progression in patients with Prostate Cancer treated with bicalutamide 150mg|biochemical relapse/progression in patients with prostate cancer treated with bicalutamide 150mg
691211|NCT00668070|NASH|nash
691212|NCT00668070|Chronic liver disease|chronic liver disease
691213|NCT00668057|Male Erectile Dysfunction|male erectile dysfunction
691214|NCT00668044|Ciprofloxacin regimen in compromised patients|ciprofloxacin regimen in compromised patients
691215|NCT00668044|Ciprofloxacin|ciprofloxacin
691216|NCT00668044|Burned patients|burned patients
691217|NCT00668031|Transfusion requirements|transfusion requirements
691218|NCT00668031|Hip replacement surgery|hip replacement surgery
691219|NCT00668031|Prevention of blood loss|prevention of blood loss
691220|NCT00668031|Bloodloss|bloodloss
691221|NCT00668018|Male Erectile Dysfunction|male erectile dysfunction
691222|NCT00668018|Vardenafil|vardenafil
691223|NCT00668005|Erectile Dysfunction|erectile dysfunction
691224|NCT00668005|Arterial hypertension|arterial hypertension
691225|NCT00668005|Vardenafil|vardenafil
691226|NCT00667992|Asthma hyperreactivity|asthma hyperreactivity
691227|NCT00667979|Erectile Dysfunction|erectile dysfunction
691228|NCT00667979|Vardenafil|vardenafil
691229|NCT00667966|Spinal cord injury|spinal cord injury
691230|NCT00667966|Urodynamic|urodynamic
691231|NCT00667966|Erectile dysfunction|erectile dysfunction
691232|NCT00667966|Vardenafil|vardenafil
691233|NCT00667953|Temzolomide|temzolomide
691234|NCT00667953|Gleevec|gleevec
691235|NCT00667953|Melanoma|melanoma
691236|NCT00667953|Advanced melanoma|advanced melanoma
691237|NCT00667953|Phase II|phase ii
691238|NCT00667940|Medical education|medical education
691239|NCT00667940|faculty development|faculty development
691240|NCT00667940|rater training|rater training
691241|NCT00667940|clinical competence|clinical competence
691242|NCT00667940|assessment|assessment
691243|NCT00667927|Autologous bone marrow transplant|autologous bone marrow transplant
691244|NCT00667927|gene marking|gene marking
691245|NCT00667914|Hip-unit|hip-unit
691246|NCT00667914|Geriatric care|geriatric care
691247|NCT00667914|Mobility|mobility
691248|NCT00667914|Site of residence|site of residence
691249|NCT00667901|stage III melanoma|stage iii melanoma
691250|NCT00667901|stage IV melanoma|stage iv melanoma
691251|NCT00667888|Prostate Cancer|prostate cancer
691252|NCT00667888|Radiation|radiation
691253|NCT00667888|Radiotherapy|radiotherapy
691254|NCT00667888|Intensity Modulated Radiotherapy|intensity modulated radiotherapy
691255|NCT00667888|IMRT|imrt
691256|NCT00667888|Hypofractionated Intensity Modulated Radiotherapy|hypofractionated intensity modulated radiotherapy
691257|NCT00667888|HIMRT|himrt
691258|NCT00667875|Alcohol Dependence|alcohol dependence
691259|NCT00667875|Alcoholism|alcoholism
691260|NCT00667875|Naltrexone|naltrexone
691261|NCT00667875|Aripiprazole|aripiprazole
691262|NCT00667875|Substance Abuse|substance abuse
691263|NCT00667862|Prostate|prostate
691264|NCT00667862|Cancer|cancer
691265|NCT00667862|Adenocarcinoma|adenocarcinoma
691266|NCT00667862|Prostate-Specific Antigen|prostate-specific antigen
691267|NCT00667862|metastatic|metastatic
691268|NCT00667862|male|male
691269|NCT00667862|HRPC|hrpc
691270|NCT00667862|DACi|daci
691271|NCT00667849|Tibia|tibia
691272|NCT00667836|Neurofibromatosis Type 1|neurofibromatosis type 1
691273|NCT00667836|NF1|nf1
691274|NCT00667836|Spinal Anomalies|spinal anomalies
691275|NCT00667823|SERAPHIN|seraphin
691276|NCT00667823|Pulmonary Arterial Hypertension|pulmonary arterial hypertension
691277|NCT00667823|ACT-064992|act-064992
691278|NCT00667810|antibody|antibody
691279|NCT00667810|immunotherapy|immunotherapy
691280|NCT00667797|Asthma|asthma
691281|NCT00667797|COPD|copd
691282|NCT00667797|chronic emphysema|chronic emphysema
691283|NCT00667797|chronic bronchitis|chronic bronchitis
691284|NCT00667784|pediatric stem cell donor|pediatric stem cell donor
691285|NCT00667784|emotional sequelae|emotional sequelae
691286|NCT00667784|physical sequelae|physical sequelae
691287|NCT00667784|psychological consequences of minor donation|psychological consequences of minor donation
691288|NCT00667784|Bone Marrow Transplantation|bone marrow transplantation
691289|NCT00667784|Questionnaire|questionnaire
691290|NCT00667784|Survey|survey
691291|NCT00667784|Sibling Donor|sibling donor
691292|NCT00667784|Stem Cell Transplant|stem cell transplant
691293|NCT00667784|Well-Being|well-being
691294|NCT00667771|Alcohol|alcohol
691295|NCT00667771|Naltrexone|naltrexone
691296|NCT00667771|fMRI|fmri
691297|NCT00667771|Alcoholism|alcoholism
691298|NCT00667771|Alcoholics|alcoholics
691299|NCT00667771|Alcohol Dependence|alcohol dependence
691300|NCT00667745|Lithium|lithium
691301|NCT00667745|Symptoms|symptoms
691302|NCT00667745|Medication Changes|medication changes
691303|NCT00667732|diabetes|diabetes
691304|NCT00667732|insulin|insulin
691305|NCT00667732|byetta|byetta
691306|NCT00667732|glucose|glucose
691307|NCT00667732|blood sugar|blood sugar
691308|NCT00667732|metformin|metformin
691309|NCT00667732|A1c|a1c
691310|NCT00667719|essential hypertension|essential hypertension
691311|NCT00667719|high blood pressure|high blood pressure
691312|NCT00667693|intubation|intubation
691313|NCT00667693|obese|obese
691314|NCT00667680|tDCS, major depression|tdcs, major depression
691315|NCT00667667|whole body vibration|whole body vibration
691316|NCT00667667|exercise|exercise
691317|NCT00667667|postmenopausal|postmenopausal
691318|NCT00667667|BMD|bmd
691319|NCT00667667|bone|bone
691320|NCT00667667|elderly females|elderly females
691321|NCT00667667|Caucasian race|caucasian race
691322|NCT00667654|Osteoarthritis, Knee|osteoarthritis, knee
691323|NCT00667641|unspecified adult solid tumor, protocol specific|unspecified adult solid tumor, protocol specific
691324|NCT00667641|recurrent breast cancer|recurrent breast cancer
691325|NCT00667641|stage IV breast cancer|stage iv breast cancer
691326|NCT00667641|recurrent prostate cancer|recurrent prostate cancer
691327|NCT00667641|stage IV prostate cancer|stage iv prostate cancer
691328|NCT00667641|recurrent colon cancer|recurrent colon cancer
691329|NCT00667641|stage IV colon cancer|stage iv colon cancer
691330|NCT00667641|recurrent pancreatic cancer|recurrent pancreatic cancer
691331|NCT00667641|stage IV pancreatic cancer|stage iv pancreatic cancer
691332|NCT00667641|recurrent ovarian epithelial cancer|recurrent ovarian epithelial cancer
691333|NCT00667641|stage IV ovarian epithelial cancer|stage iv ovarian epithelial cancer
691334|NCT00667641|recurrent ovarian germ cell tumor|recurrent ovarian germ cell tumor
691335|NCT00667641|stage IV ovarian germ cell tumor|stage iv ovarian germ cell tumor
691336|NCT00667641|recurrent non-small cell lung cancer|recurrent non-small cell lung cancer
691337|NCT00667641|stage IV non-small cell lung cancer|stage iv non-small cell lung cancer
691338|NCT00667641|recurrent melanoma|recurrent melanoma
691339|NCT00667641|stage IV melanoma|stage iv melanoma
691340|NCT00667641|stage IV papillary thyroid cancer|stage iv papillary thyroid cancer
691341|NCT00667641|recurrent thyroid cancer|recurrent thyroid cancer
691342|NCT00667615|vorinostat|vorinostat
691343|NCT00667615|rituximab|rituximab
691344|NCT00667615|cyclophosphamide|cyclophosphamide
691345|NCT00667615|etoposide|etoposide
691346|NCT00667615|prednisone|prednisone
691347|NCT00667615|Quality of life|quality of life
691348|NCT00667615|08-045|08-045
691349|NCT00667602|Meningococcal|meningococcal
691350|NCT00667602|ACWY|acwy
691351|NCT00667602|Conjugate Vaccine|conjugate vaccine
691352|NCT00667602|Meningitis|meningitis
691353|NCT00667602|Toddlers|toddlers
691354|NCT00667602|Infants|infants
691355|NCT00667602|Concomitant Vaccination|concomitant vaccination
691356|NCT00667589|sorafenib|sorafenib
691357|NCT00667589|rash|rash
691358|NCT00667589|hand foot skin reaction|hand foot skin reaction
691359|NCT00667576|chronic kidney disease|chronic kidney disease
691360|NCT00667576|secondary hyperparathyroidism|secondary hyperparathyroidism
691361|NCT00667576|hemodialysis|hemodialysis
691362|NCT00667576|paricalcitol|paricalcitol
691363|NCT00667576|maxacalcitol|maxacalcitol
691364|NCT00667563|human papilloma virus infection|human papilloma virus infection
691365|NCT00667563|cervical cancer|cervical cancer
691366|NCT00667563|cervical intraepithelial neoplasia|cervical intraepithelial neoplasia
691367|NCT00667563|HIV infection|hiv infection
691368|NCT00667550|Lower urinary tract symptoms|lower urinary tract symptoms
691369|NCT00667550|Colorectal disorders|colorectal disorders
691370|NCT00667550|Urinary incontinence|urinary incontinence
691371|NCT00667550|Fecal incontinence|fecal incontinence
691372|NCT00667550|Voiding dysfunction|voiding dysfunction
691373|NCT00667550|Urgency frequency|urgency frequency
691374|NCT00667550|Sexual dysfunction|sexual dysfunction
691375|NCT00667550|Colorectal malignancies|colorectal malignancies
691376|NCT00667550|Inflammatory bowel disease|inflammatory bowel disease
691377|NCT00667524|Eosinophilic Esophagitis|eosinophilic esophagitis
691378|NCT00667524|Dysphagia|dysphagia
691379|NCT00667524|Esophageal bougienage|esophageal bougienage
691380|NCT00667524|Esophageal Dilation|esophageal dilation
691381|NCT00667511|ESRD|esrd
691382|NCT00667511|End Stage Renal Disease|end stage renal disease
691383|NCT00667511|Daily Hemodialysis|daily hemodialysis
691384|NCT00667511|Nocturnal Hemodialysis|nocturnal hemodialysis
691385|NCT00667511|Hemodialysis|hemodialysis
691386|NCT00667511|Kidney Failure|kidney failure
691387|NCT00667511|Kidney Disease|kidney disease
691388|NCT00667498|Pediatric Obesity|pediatric obesity
691389|NCT00667498|Insulin Resistance|insulin resistance
691390|NCT00667498|Hyperinsulinemia|hyperinsulinemia
691391|NCT00667498|Metformin|metformin
691392|NCT00667498|Glucose Tolerance|glucose tolerance
691393|NCT00667498|Microalbuminuria|microalbuminuria
691394|NCT00667498|Adolescents|adolescents
691395|NCT00667498|Visceral Fat|visceral fat
691396|NCT00667472|port wine stain birthmarks|port wine stain birthmarks
691397|NCT00667459|Cervical Disc|cervical disc
691398|NCT00667446|GnRH analog|gnrh analog
691399|NCT00667446|Luteinizing hormone (LH)|luteinizing hormone (lh)
691400|NCT00667446|Gonadotrophin-releasing hormone agonist(GnRHa)|gonadotrophin-releasing hormone agonist(gnrha)
691401|NCT00667446|Suppression of LH|suppression of lh
691402|NCT00667446|Gonadotrophin-releasing hormone (GnRH)|gonadotrophin-releasing hormone (gnrh)
691403|NCT00667446|CPP|cpp
691404|NCT00667446|Leuprolide acetate|leuprolide acetate
691405|NCT00667446|Central Precocious Puberty|central precocious puberty
691406|NCT00667446|Depot formulation|depot formulation
691407|NCT00667446|Lupron|lupron
691408|NCT00667446|Tanner staging|tanner staging
691409|NCT00667446|Pediatrics|pediatrics
691410|NCT00667433|HIV|hiv
691411|NCT00667433|African American|african american
691412|NCT00667433|treatment naïve|treatment naïve
691413|NCT00667420|gastric|gastric
691414|NCT00667420|esophageal|esophageal
691415|NCT00667420|panitumumab|panitumumab
691416|NCT00667407|Asthma|asthma
691417|NCT00667394|Brain Tumor|brain tumor
691418|NCT00667394|Chemotherapy|chemotherapy
691419|NCT00667394|Radiation|radiation
691420|NCT00667394|Anti-Angiogenesis|anti-angiogenesis
691421|NCT00667394|Glioblastoma|glioblastoma
691422|NCT00667394|Glioma|glioma
691423|NCT00667381|Ultrasound guidance|ultrasound guidance
691424|NCT00667381|Vascular access|vascular access
691425|NCT00667381|Vascular complications|vascular complications
691426|NCT00667368|bacterial vaginosis, women, chlamydia, gonorrhea, mentronidazole, vaginal, children|bacterial vaginosis, women, chlamydia, gonorrhea, mentronidazole, vaginal, children
691427|NCT00667355|Ankylosing Spondylitis|ankylosing spondylitis
691428|NCT00667329|Waldenstrom's Macroglobulinemia|waldenstrom's macroglobulinemia
691429|NCT00667329|Lymphoma|lymphoma
691430|NCT00667329|2CdA|2cda
691431|NCT00667329|Cladribine|cladribine
691432|NCT00667329|Leustatin|leustatin
691433|NCT00667329|Cyclophosphamide|cyclophosphamide
691434|NCT00667329|Cytoxan|cytoxan
691435|NCT00667329|Neosar|neosar
691436|NCT00667329|Rituxan|rituxan
691437|NCT00667329|Rituximab|rituximab
691438|NCT00667316|low back pain|low back pain
691439|NCT00667316|workers|workers
691440|NCT00667316|disability|disability
691441|NCT00667316|sick leave|sick leave
691442|NCT00667303|Hematopoietic stem cell transplant|hematopoietic stem cell transplant
691443|NCT00667290|functional ability|functional ability
691444|NCT00667290|gait|gait
691445|NCT00667290|musculoskeletal disorder therapy|musculoskeletal disorder therapy
691446|NCT00667290|peripheral blood vessel disorder|peripheral blood vessel disorder
691447|NCT00667277|Myelofibrosis|myelofibrosis
691448|NCT00667277|Idiopathic|idiopathic
691449|NCT00667277|Bevacizumab|bevacizumab
691450|NCT00667277|Avastin|avastin
691451|NCT00667277|bone marrow fibrosis|bone marrow fibrosis
691452|NCT00667277|bone marrow angiogenesis|bone marrow angiogenesis
691453|NCT00667277|JAK2|jak2
691454|NCT00667264|pain|pain
691455|NCT00667264|phantom limb|phantom limb
691456|NCT00667264|stump pain|stump pain
691457|NCT00667264|catheter|catheter
691458|NCT00667264|nerve block|nerve block
691459|NCT00667264|peripheral nerve block|peripheral nerve block
691460|NCT00667264|ucsd|ucsd
691461|NCT00667264|Post-amputation phantom limb or stump pain|post-amputation phantom limb or stump pain
691462|NCT00667251|recurrent breast cancer|recurrent breast cancer
691463|NCT00667251|HER2-positive breast cancer|her2-positive breast cancer
691464|NCT00667251|stage IV breast cancer|stage iv breast cancer
691465|NCT00667212|anger|anger
691466|NCT00667212|intermittent|intermittent
691467|NCT00667212|explosive|explosive
691468|NCT00667199|Hormone Refractory Prostate Cancer|hormone refractory prostate cancer
691469|NCT00667199|Bone Metastases|bone metastases
691470|NCT00667199|Radium-223|radium-223
691471|NCT00667199|Palliation of bone pain|palliation of bone pain
691472|NCT00667186|HIV|hiv
691473|NCT00667186|Prevention|prevention
691474|NCT00667186|Public Health|public health
691475|NCT00667186|Screening|screening
691476|NCT00667160|Mild Atopic Dermatitis|mild atopic dermatitis
691477|NCT00667160|Protopic|protopic
691478|NCT00667160|Pediatric|pediatric
691479|NCT00667134|systemic sclerosis autoantibodies|systemic sclerosis autoantibodies
691480|NCT00667121|psychosocial effects of cancer and its treatment|psychosocial effects of cancer and its treatment
691481|NCT00667121|breast cancer|breast cancer
691482|NCT00667121|hot flashes|hot flashes
691483|NCT00667121|depression|depression
691484|NCT00667095|OAB|oab
691485|NCT00667095|Over Active Bladder|over active bladder
691486|NCT00667095|overactive bladder|overactive bladder
691487|NCT00667095|Urinary Urge Incontinence|urinary urge incontinence
691488|NCT00667095|Urinary Incontinence|urinary incontinence
691489|NCT00667095|Botox|botox
691490|NCT00667095|DMSO|dmso
691491|NCT00667095|bladder instillation|bladder instillation
691492|NCT00667095|instillation|instillation
691493|NCT00667095|detrusor hyperreflexia|detrusor hyperreflexia
691494|NCT00667095|urge incontinence|urge incontinence
691495|NCT00667082|Non small Cell Lung Cancer|non small cell lung cancer
691496|NCT00667082|Pancreatic Cancer|pancreatic cancer
691497|NCT00667082|Melanoma|melanoma
691498|NCT00667082|Lymphoma|lymphoma
691499|NCT00667082|Multiple Myeloma|multiple myeloma
691500|NCT00667069|adenocarcinoma of the prostate|adenocarcinoma of the prostate
691501|NCT00667069|stage III prostate cancer|stage iii prostate cancer
691502|NCT00667069|stage IV prostate cancer|stage iv prostate cancer
691503|NCT00667056|Chronic Allergic Contact Dermatitis|chronic allergic contact dermatitis
691504|NCT00667056|Protopic|protopic
691505|NCT00667043|therapeutic hypothermia|therapeutic hypothermia
691506|NCT00667043|cardiac arrest|cardiac arrest
691507|NCT00667043|sedation|sedation
691508|NCT00667043|remifentanil|remifentanil
691509|NCT00667043|propofol|propofol
691510|NCT00667043|fentanyl|fentanyl
691511|NCT00667043|midazolam|midazolam
691512|NCT00667030|Inflammation|inflammation
691514|NCT00667030|Metabolism|metabolism
691515|NCT00667030|Exercise|exercise
691516|NCT00667017|recurrent mycosis fungoides/Sezary syndrome|recurrent mycosis fungoides/sezary syndrome
691517|NCT00667017|recurrent cutaneous T-cell non-Hodgkin lymphoma|recurrent cutaneous t-cell non-hodgkin lymphoma
691518|NCT00666991|ovarian cancer|ovarian cancer
691519|NCT00666991|Mullerian tumors|mullerian tumors
691520|NCT00666991|peritoneal cavity carcinoma|peritoneal cavity carcinoma
691521|NCT00666991|gastrointestinal tract tumor|gastrointestinal tract tumor
691522|NCT00666991|GI tract tumor|gi tract tumor
691523|NCT00666991|pancreatic cancer|pancreatic cancer
691524|NCT00666991|colon cancer|colon cancer
691525|NCT00666978|bladder cancer|bladder cancer
691526|NCT00666978|cervical cancer|cervical cancer
691527|NCT00666978|esophageal cancer|esophageal cancer
691528|NCT00666978|gastric cancer|gastric cancer
691529|NCT00666978|renal cell carcinoma|renal cell carcinoma
691530|NCT00666978|adult primary liver cancer|adult primary liver cancer
691531|NCT00666978|non-small cell lung cancer|non-small cell lung cancer
691532|NCT00666978|small cell lung cancer|small cell lung cancer
691533|NCT00666978|pancreatic cancer|pancreatic cancer
691534|NCT00666978|hypopharyngeal cancer|hypopharyngeal cancer
691535|NCT00666978|laryngeal cancer|laryngeal cancer
691536|NCT00666978|lip and oral cavity cancer|lip and oral cavity cancer
691537|NCT00666978|nasopharyngeal cancer|nasopharyngeal cancer
691538|NCT00666978|oropharyngeal cancer|oropharyngeal cancer
691539|NCT00666978|paranasal sinus and nasal cavity cancer|paranasal sinus and nasal cavity cancer
691540|NCT00666978|adult acute myeloid leukemia|adult acute myeloid leukemia
691541|NCT00666978|tobacco use disorder|tobacco use disorder
691543|NCT00666965|rotigotine|rotigotine
691544|NCT00666965|Idiopathic Restless Legs Syndrome|idiopathic restless legs syndrome
691545|NCT00666965|RLS|rls
691546|NCT00666926|Pancreatic Neoplasm|pancreatic neoplasm
691547|NCT00666926|Head and Neck neoplasm|head and neck neoplasm
691548|NCT00666926|Prostatic neoplasms; Focal Adhesion Kinase|prostatic neoplasms; focal adhesion kinase
691549|NCT00666926|Phase 1|phase 1
691550|NCT00666926|Pharmacodynamics|pharmacodynamics
691551|NCT00666926|FDG-PET|fdg-pet
691552|NCT00666913|breast cancer in situ|breast cancer in situ
691553|NCT00666913|stage I breast cancer|stage i breast cancer
691554|NCT00666913|stage II breast cancer|stage ii breast cancer
691555|NCT00666913|stage IIIA breast cancer|stage iiia breast cancer
691556|NCT00666913|stage IIIB breast cancer|stage iiib breast cancer
691557|NCT00666913|stage IIIC breast cancer|stage iiic breast cancer
691558|NCT00666913|hot flashes|hot flashes
691559|NCT00666887|Multiple Sclerosis|multiple sclerosis
691560|NCT00666887|Clinically Isolated Syndrome|clinically isolated syndrome
691561|NCT00666887|Minocycline|minocycline
691562|NCT00666887|Placebo|placebo
691563|NCT00666874|Obesity, lifestyle, vascular inflammation|obesity, lifestyle, vascular inflammation
691564|NCT00666848|Metabolic syndrome|metabolic syndrome
691565|NCT00666848|Hypertension|hypertension
691566|NCT00666848|Sitagliptin|sitagliptin
691567|NCT00666848|Enalapril|enalapril
691568|NCT00666835|Treatment of anemia in hemodialysis patients|treatment of anemia in hemodialysis patients
691569|NCT00666822|stage I breast cancer|stage i breast cancer
691570|NCT00666822|stage II breast cancer|stage ii breast cancer
691571|NCT00666822|stage IIIA breast cancer|stage iiia breast cancer
691572|NCT00666809|Vardenafil,|vardenafil,
691573|NCT00666809|Tinnitus|tinnitus
691574|NCT00666757|Severe Depressive Episode|severe depressive episode
691575|NCT00666744|exercise|exercise
691576|NCT00666744|frequency|frequency
691577|NCT00666744|duration|duration
691578|NCT00666731|male breast cancer|male breast cancer
691579|NCT00666731|breast cancer|breast cancer
691580|NCT00666731|ductal breast carcinoma in situ|ductal breast carcinoma in situ
691581|NCT00666731|lobular breast carcinoma in situ|lobular breast carcinoma in situ
691582|NCT00666731|atypical ductal breast hyperplasia|atypical ductal breast hyperplasia
691583|NCT00666705|maraviroc|maraviroc
691584|NCT00666705|raltegravir|raltegravir
691585|NCT00666705|drug interaction study|drug interaction study
691586|NCT00666705|healthy volunteers|healthy volunteers
691587|NCT00666692|cancer|cancer
691588|NCT00666692|carcinoma|carcinoma
691589|NCT00666692|monoclonal antibody therapy|monoclonal antibody therapy
691590|NCT00666692|anti-angiogenesis|anti-angiogenesis
691591|NCT00666666|prostate Cancer|prostate cancer
691592|NCT00666666|adenocarcinoma of the prostate|adenocarcinoma of the prostate
691593|NCT00666666|stage IV prostate cancer|stage iv prostate cancer
691594|NCT00666666|newly diagnosed stage IV prostate cancer|newly diagnosed stage iv prostate cancer
691595|NCT00666653|Parkinson's disease|parkinson's disease
691596|NCT00666653|Dopamine Agonist|dopamine agonist
691597|NCT00666653|Levodopa|levodopa
691598|NCT00666653|Pharmacokinetics|pharmacokinetics
691599|NCT00666653|Dyskinesia|dyskinesia
691600|NCT00666640|Osteoporosis|osteoporosis
691601|NCT00666640|Fracture|fracture
691602|NCT00666640|DXA|dxa
691603|NCT00666640|Dual energy x-ray absorptiometry|dual energy x-ray absorptiometry
691604|NCT00666640|Computed tomography|computed tomography
691605|NCT00666640|3D DXA|3d dxa
691606|NCT00666627|Osteoporosis|osteoporosis
691607|NCT00666627|Post-menopausal osteoporosis|post-menopausal osteoporosis
691608|NCT00666627|Bisphosphonates|bisphosphonates
691609|NCT00666627|Alendronate|alendronate
691610|NCT00666627|Ibandronate|ibandronate
691611|NCT00666627|Risedronate|risedronate
691612|NCT00666614|Sleep|sleep
691613|NCT00666614|Fatigue|fatigue
691614|NCT00666614|High Dose Chemotherapy|high dose chemotherapy
691615|NCT00666601|Microdialysis|microdialysis
691616|NCT00666601|Antibiotic|antibiotic
691617|NCT00666601|Healthy subjects|healthy subjects
691618|NCT00666549|Myeloproliferative Disease|myeloproliferative disease
691619|NCT00666549|Myelofibrosis|myelofibrosis
691620|NCT00666549|Idiopathic Myelofibrosis|idiopathic myelofibrosis
691621|NCT00666549|Essential Thrombocythemia|essential thrombocythemia
691622|NCT00666549|Polycythemia Vera|polycythemia vera
691623|NCT00666536|Hypertension|hypertension
691624|NCT00666536|adults|adults
691625|NCT00666536|Valsartan + Amlodipine|valsartan + amlodipine
691626|NCT00666536|Angiotensin Receptor Blockers|angiotensin receptor blockers
691627|NCT00666523|osteoarthritis, knee or hip|osteoarthritis, knee or hip
691628|NCT00666510|nitric oxide|nitric oxide
691629|NCT00666510|bronchospasm|bronchospasm
691630|NCT00666510|anesthesia|anesthesia
691631|NCT00666510|induced sputum|induced sputum
691632|NCT00666510|asthma|asthma
691633|NCT00666497|Acute Myeloid Leukemia|acute myeloid leukemia
691634|NCT00666497|Myelodysplastic Syndrome|myelodysplastic syndrome
691635|NCT00666497|Azacitidine|azacitidine
691636|NCT00666497|Vidaza|vidaza
691637|NCT00666497|MGCD0103|mgcd0103
691638|NCT00666497|Histone deacetylase inhibitor|histone deacetylase inhibitor
691639|NCT00666497|DNA methyltransferase inhibitor|dna methyltransferase inhibitor
691640|NCT00666497|Epigenetic Therapy|epigenetic therapy
691641|NCT00666484|neurotoxicity|neurotoxicity
691642|NCT00666484|stage I adult Hodgkin lymphoma|stage i adult hodgkin lymphoma
691643|NCT00666484|stage II adult Hodgkin lymphoma|stage ii adult hodgkin lymphoma
691644|NCT00666484|stage III adult Hodgkin lymphoma|stage iii adult hodgkin lymphoma
691645|NCT00666484|stage IV adult Hodgkin lymphoma|stage iv adult hodgkin lymphoma
691646|NCT00666484|adult lymphocyte depletion Hodgkin lymphoma|adult lymphocyte depletion hodgkin lymphoma
691647|NCT00666484|adult lymphocyte predominant Hodgkin lymphoma|adult lymphocyte predominant hodgkin lymphoma
691648|NCT00666484|adult mixed cellularity Hodgkin lymphoma|adult mixed cellularity hodgkin lymphoma
691649|NCT00666484|adult nodular sclerosis Hodgkin lymphoma|adult nodular sclerosis hodgkin lymphoma
691650|NCT00666471|epistaxis|epistaxis
691651|NCT00666471|Epistaxis refractory to emergency physician treatment|epistaxis refractory to emergency physician treatment
691652|NCT00666458|Type 2 diabetes|type 2 diabetes
691653|NCT00666458|metformin|metformin
691654|NCT00666445|Alzheimer's Disease|alzheimer's disease
691655|NCT00666445|Diagnosis|diagnosis
691656|NCT00666445|Neuronal function|neuronal function
691657|NCT00666445|Cognitive Impairment|cognitive impairment
691658|NCT00666445|Magnetoencephalography|magnetoencephalography
691659|NCT00666432|schizophrenia|schizophrenia
691660|NCT00666432|bipolar|bipolar
691661|NCT00666432|eye movements|eye movements
691662|NCT00666432|phenotype|phenotype
691663|NCT00666432|biochemical|biochemical
691664|NCT00666432|relatives|relatives
691665|NCT00666419|nonspecific low back pain|nonspecific low back pain
691666|NCT00666419|schoolchildren|schoolchildren
691667|NCT00666419|prevalence|prevalence
691668|NCT00666393|IONSYS™|ionsys™
691669|NCT00666393|Pain, Postoperative|pain, postoperative
691670|NCT00666393|Analgesia, Patient-Controlled|analgesia, patient-controlled
691671|NCT00666393|Opioids|opioids
691672|NCT00666393|Pediatrics|pediatrics
691673|NCT00666380|Malaria|malaria
691674|NCT00666380|Vaccine|vaccine
691675|NCT00666380|MSP-1 (merozoite surface protein-1)|msp-1 (merozoite surface protein-1)
691676|NCT00666380|Phase 1|phase 1
691677|NCT00666367|COPD|copd
691678|NCT00666354|Nail Psoriasis|nail psoriasis
691679|NCT00666354|Psoriasis|psoriasis
691680|NCT00666354|Fingernail Psoriasis|fingernail psoriasis
691681|NCT00666354|Methotrexate|methotrexate
691682|NCT00666328|Hypertension|hypertension
691683|NCT00666328|Hemorrhage|hemorrhage
691684|NCT00666328|Intracranial Pressure|intracranial pressure
691685|NCT00666328|Antihypertensive Agent|antihypertensive agent
691686|NCT00666328|Calcium Channel Blocker|calcium channel blocker
691687|NCT00666315|Consecutive euthyroid patients with multinodular goiter for whom a total Thyroidectomy under general anesthesia is indicated|consecutive euthyroid patients with multinodular goiter for whom a total thyroidectomy under general anesthesia is indicated
691688|NCT00666302|Atopic Dermatitis|atopic dermatitis
691689|NCT00666302|Protopic|protopic
691690|NCT00666302|Elidel|elidel
691691|NCT00666289|polycythemia vera|polycythemia vera
691692|NCT00666289|essential thrombocythemia|essential thrombocythemia
691693|NCT00666289|idiopathic myelofibrosis|idiopathic myelofibrosis
691694|NCT00666289|family clusters|family clusters
691695|NCT00666250|blood pressure|blood pressure
691696|NCT00666250|dyslipidemia|dyslipidemia
691697|NCT00666250|hyperglycemia|hyperglycemia
691698|NCT00666237|Glaucoma|glaucoma
691699|NCT00666237|Tube shunt surgery|tube shunt surgery
691700|NCT00666237|Trabeculectomy|trabeculectomy
691701|NCT00666224|Clinically Definite Multiple Sclerosis|clinically definite multiple sclerosis
691702|NCT00666224|Clinically Isolated Syndrome|clinically isolated syndrome
691703|NCT00666224|Multiple Sclerosis|multiple sclerosis
691704|NCT00666211|pain|pain
691705|NCT00666211|unspecified adult solid tumor, protocol specific|unspecified adult solid tumor, protocol specific
691706|NCT00666211|accelerated phase chronic myelogenous leukemia|accelerated phase chronic myelogenous leukemia
691707|NCT00666211|acute undifferentiated leukemia|acute undifferentiated leukemia
691708|NCT00666211|adult acute lymphoblastic leukemia in remission|adult acute lymphoblastic leukemia in remission
691709|NCT00666211|adult acute myeloid leukemia in remission|adult acute myeloid leukemia in remission
691710|NCT00666211|adult acute myeloid leukemia with 11q23 (MLL) abnormalities|adult acute myeloid leukemia with 11q23 (mll) abnormalities
691711|NCT00666211|adult acute myeloid leukemia with inv(16)(p13;q22)|adult acute myeloid leukemia with inv(16)(p13;q22)
691712|NCT00666211|adult acute myeloid leukemia with t(15;17)(q22;q12)|adult acute myeloid leukemia with t(15;17)(q22;q12)
691713|NCT00666211|adult acute myeloid leukemia with t(16;16)(p13;q22)|adult acute myeloid leukemia with t(16;16)(p13;q22)
691714|NCT00666211|adult acute myeloid leukemia with t(8;21)(q22;q22)|adult acute myeloid leukemia with t(8;21)(q22;q22)
691931|NCT00665847|TMC125-C213|tmc125-c213
691715|NCT00666211|atypical chronic myeloid leukemia, BCR-ABL negative|atypical chronic myeloid leukemia, bcr-abl negative
691716|NCT00666211|blastic phase chronic myelogenous leukemia|blastic phase chronic myelogenous leukemia
691717|NCT00666211|chronic myelomonocytic leukemia|chronic myelomonocytic leukemia
691718|NCT00666211|chronic phase chronic myelogenous leukemia|chronic phase chronic myelogenous leukemia
691719|NCT00666211|mast cell leukemia|mast cell leukemia
691720|NCT00666211|meningeal chronic myelogenous leukemia|meningeal chronic myelogenous leukemia
691721|NCT00666211|progressive hairy cell leukemia, initial treatment|progressive hairy cell leukemia, initial treatment
691722|NCT00666211|prolymphocytic leukemia|prolymphocytic leukemia
691723|NCT00666211|recurrent adult acute lymphoblastic leukemia|recurrent adult acute lymphoblastic leukemia
691724|NCT00666211|recurrent adult acute myeloid leukemia|recurrent adult acute myeloid leukemia
691725|NCT00666211|recurrent adult T-cell leukemia/lymphoma|recurrent adult t-cell leukemia/lymphoma
691726|NCT00666211|refractory chronic lymphocytic leukemia|refractory chronic lymphocytic leukemia
691727|NCT00666211|refractory hairy cell leukemia|refractory hairy cell leukemia
691728|NCT00666211|relapsing chronic myelogenous leukemia|relapsing chronic myelogenous leukemia
691729|NCT00666211|secondary acute myeloid leukemia|secondary acute myeloid leukemia
691730|NCT00666211|stage I adult T-cell leukemia/lymphoma|stage i adult t-cell leukemia/lymphoma
691731|NCT00666211|stage I chronic lymphocytic leukemia|stage i chronic lymphocytic leukemia
691732|NCT00666211|stage II adult T-cell leukemia/lymphoma|stage ii adult t-cell leukemia/lymphoma
691733|NCT00666211|stage II chronic lymphocytic leukemia|stage ii chronic lymphocytic leukemia
691734|NCT00666211|stage III adult T-cell leukemia/lymphoma|stage iii adult t-cell leukemia/lymphoma
691735|NCT00666211|stage III chronic lymphocytic leukemia|stage iii chronic lymphocytic leukemia
691736|NCT00666211|stage IV adult T-cell leukemia/lymphoma|stage iv adult t-cell leukemia/lymphoma
691737|NCT00666211|stage IV chronic lymphocytic leukemia|stage iv chronic lymphocytic leukemia
691738|NCT00666211|T-cell large granular lymphocyte leukemia|t-cell large granular lymphocyte leukemia
691739|NCT00666211|stage I adult Hodgkin lymphoma|stage i adult hodgkin lymphoma
691740|NCT00666211|stage II adult Hodgkin lymphoma|stage ii adult hodgkin lymphoma
691741|NCT00666211|stage III adult Hodgkin lymphoma|stage iii adult hodgkin lymphoma
691742|NCT00666211|stage IV adult Hodgkin lymphoma|stage iv adult hodgkin lymphoma
691743|NCT00666211|anaplastic large cell lymphoma|anaplastic large cell lymphoma
691744|NCT00666211|angioimmunoblastic T-cell lymphoma|angioimmunoblastic t-cell lymphoma
691745|NCT00666211|cutaneous B-cell non-Hodgkin lymphoma|cutaneous b-cell non-hodgkin lymphoma
691746|NCT00666211|recurrent cutaneous T-cell non-Hodgkin lymphoma|recurrent cutaneous t-cell non-hodgkin lymphoma
691747|NCT00666211|stage I cutaneous T-cell non-Hodgkin lymphoma|stage i cutaneous t-cell non-hodgkin lymphoma
691748|NCT00666211|stage II cutaneous T-cell non-Hodgkin lymphoma|stage ii cutaneous t-cell non-hodgkin lymphoma
691749|NCT00666211|stage III cutaneous T-cell non-Hodgkin lymphoma|stage iii cutaneous t-cell non-hodgkin lymphoma
691750|NCT00666211|stage IV cutaneous T-cell non-Hodgkin lymphoma|stage iv cutaneous t-cell non-hodgkin lymphoma
691751|NCT00666211|recurrent mycosis fungoides/Sezary syndrome|recurrent mycosis fungoides/sezary syndrome
691752|NCT00666211|stage I mycosis fungoides/Sezary syndrome|stage i mycosis fungoides/sezary syndrome
691753|NCT00666211|stage II mycosis fungoides/Sezary syndrome|stage ii mycosis fungoides/sezary syndrome
691754|NCT00666211|stage III mycosis fungoides/Sezary syndrome|stage iii mycosis fungoides/sezary syndrome
691755|NCT00666211|stage IV mycosis fungoides/Sezary syndrome|stage iv mycosis fungoides/sezary syndrome
691756|NCT00666211|adult grade III lymphomatoid granulomatosis|adult grade iii lymphomatoid granulomatosis
691757|NCT00666211|adult nasal type extranodal NK/T-cell lymphoma|adult nasal type extranodal nk/t-cell lymphoma
691758|NCT00666211|Waldenstrom macroglobulinemia|waldenstrom macroglobulinemia
691759|NCT00666211|extranodal marginal zone B-cell lymphoma of mucosa-associated lymphoid tissue|extranodal marginal zone b-cell lymphoma of mucosa-associated lymphoid tissue
691760|NCT00666211|nodal marginal zone B-cell lymphoma|nodal marginal zone b-cell lymphoma
691761|NCT00666211|splenic marginal zone lymphoma|splenic marginal zone lymphoma
691762|NCT00666211|contiguous stage II adult Burkitt lymphoma|contiguous stage ii adult burkitt lymphoma
691763|NCT00666211|contiguous stage II adult diffuse large cell lymphoma|contiguous stage ii adult diffuse large cell lymphoma
691764|NCT00666211|contiguous stage II adult diffuse mixed cell lymphoma|contiguous stage ii adult diffuse mixed cell lymphoma
691765|NCT00666211|contiguous stage II adult diffuse small cleaved cell lymphoma|contiguous stage ii adult diffuse small cleaved cell lymphoma
691766|NCT00666211|contiguous stage II adult immunoblastic large cell lymphoma|contiguous stage ii adult immunoblastic large cell lymphoma
691767|NCT00666211|contiguous stage II adult lymphoblastic lymphoma|contiguous stage ii adult lymphoblastic lymphoma
691768|NCT00666211|contiguous stage II grade 1 follicular lymphoma|contiguous stage ii grade 1 follicular lymphoma
691769|NCT00666211|contiguous stage II grade 2 follicular lymphoma|contiguous stage ii grade 2 follicular lymphoma
691770|NCT00666211|contiguous stage II grade 3 follicular lymphoma|contiguous stage ii grade 3 follicular lymphoma
691771|NCT00666211|contiguous stage II mantle cell lymphoma|contiguous stage ii mantle cell lymphoma
691772|NCT00666211|contiguous stage II marginal zone lymphoma|contiguous stage ii marginal zone lymphoma
691773|NCT00666211|stage I adult Burkitt lymphoma|stage i adult burkitt lymphoma
691774|NCT00666211|stage I adult diffuse large cell lymphoma|stage i adult diffuse large cell lymphoma
691775|NCT00666211|stage I adult diffuse mixed cell lymphoma|stage i adult diffuse mixed cell lymphoma
691776|NCT00666211|stage I adult diffuse small cleaved cell lymphoma|stage i adult diffuse small cleaved cell lymphoma
691930|NCT00665847|TMC125-TiDP35-C213|tmc125-tidp35-c213
691777|NCT00666211|stage I adult immunoblastic large cell lymphoma|stage i adult immunoblastic large cell lymphoma
691778|NCT00666211|stage I adult lymphoblastic lymphoma|stage i adult lymphoblastic lymphoma
691779|NCT00666211|stage I grade 1 follicular lymphoma|stage i grade 1 follicular lymphoma
691780|NCT00666211|stage I grade 2 follicular lymphoma|stage i grade 2 follicular lymphoma
691781|NCT00666211|stage I grade 3 follicular lymphoma|stage i grade 3 follicular lymphoma
691782|NCT00666211|stage I mantle cell lymphoma|stage i mantle cell lymphoma
691783|NCT00666211|stage I marginal zone lymphoma|stage i marginal zone lymphoma
691784|NCT00666211|stage I small lymphocytic lymphoma|stage i small lymphocytic lymphoma
691785|NCT00666211|noncontiguous stage II adult Burkitt lymphoma|noncontiguous stage ii adult burkitt lymphoma
691786|NCT00666211|noncontiguous stage II adult diffuse large cell lymphoma|noncontiguous stage ii adult diffuse large cell lymphoma
691787|NCT00666211|noncontiguous stage II adult diffuse mixed cell lymphoma|noncontiguous stage ii adult diffuse mixed cell lymphoma
691788|NCT00666211|noncontiguous stage II adult diffuse small cleaved cell lymphoma|noncontiguous stage ii adult diffuse small cleaved cell lymphoma
691789|NCT00666211|noncontiguous stage II adult immunoblastic large cell lymphoma|noncontiguous stage ii adult immunoblastic large cell lymphoma
691790|NCT00666211|noncontiguous stage II adult lymphoblastic lymphoma|noncontiguous stage ii adult lymphoblastic lymphoma
691791|NCT00666211|noncontiguous stage II grade 1 follicular lymphoma|noncontiguous stage ii grade 1 follicular lymphoma
691792|NCT00666211|noncontiguous stage II grade 2 follicular lymphoma|noncontiguous stage ii grade 2 follicular lymphoma
691793|NCT00666211|noncontiguous stage II grade 3 follicular lymphoma|noncontiguous stage ii grade 3 follicular lymphoma
691794|NCT00666211|noncontiguous stage II mantle cell lymphoma|noncontiguous stage ii mantle cell lymphoma
691795|NCT00666211|noncontiguous stage II marginal zone lymphoma|noncontiguous stage ii marginal zone lymphoma
691796|NCT00666211|noncontiguous stage II small lymphocytic lymphoma|noncontiguous stage ii small lymphocytic lymphoma
691797|NCT00666211|stage III adult Burkitt lymphoma|stage iii adult burkitt lymphoma
691798|NCT00666211|stage III adult diffuse large cell lymphoma|stage iii adult diffuse large cell lymphoma
691799|NCT00666211|stage III adult diffuse mixed cell lymphoma|stage iii adult diffuse mixed cell lymphoma
691800|NCT00666211|stage III adult diffuse small cleaved cell lymphoma|stage iii adult diffuse small cleaved cell lymphoma
691801|NCT00666211|stage III adult immunoblastic large cell lymphoma|stage iii adult immunoblastic large cell lymphoma
691802|NCT00666211|stage III adult lymphoblastic lymphoma|stage iii adult lymphoblastic lymphoma
691803|NCT00666211|stage III grade 1 follicular lymphoma|stage iii grade 1 follicular lymphoma
691804|NCT00666211|stage III grade 2 follicular lymphoma|stage iii grade 2 follicular lymphoma
691805|NCT00666211|stage III grade 3 follicular lymphoma|stage iii grade 3 follicular lymphoma
691806|NCT00666211|stage III mantle cell lymphoma|stage iii mantle cell lymphoma
691807|NCT00666211|stage III marginal zone lymphoma|stage iii marginal zone lymphoma
691808|NCT00666211|stage III small lymphocytic lymphoma|stage iii small lymphocytic lymphoma
691809|NCT00666211|stage IV adult Burkitt lymphoma|stage iv adult burkitt lymphoma
691810|NCT00666211|stage IV adult diffuse large cell lymphoma|stage iv adult diffuse large cell lymphoma
691811|NCT00666211|stage IV adult diffuse mixed cell lymphoma|stage iv adult diffuse mixed cell lymphoma
691812|NCT00666211|stage IV adult diffuse small cleaved cell lymphoma|stage iv adult diffuse small cleaved cell lymphoma
691813|NCT00666211|stage IV adult immunoblastic large cell lymphoma|stage iv adult immunoblastic large cell lymphoma
691814|NCT00666211|stage IV adult lymphoblastic lymphoma|stage iv adult lymphoblastic lymphoma
691815|NCT00666211|stage IV grade 1 follicular lymphoma|stage iv grade 1 follicular lymphoma
691816|NCT00666211|stage IV grade 2 follicular lymphoma|stage iv grade 2 follicular lymphoma
691817|NCT00666211|stage IV grade 3 follicular lymphoma|stage iv grade 3 follicular lymphoma
691818|NCT00666211|stage IV mantle cell lymphoma|stage iv mantle cell lymphoma
691819|NCT00666211|stage IV marginal zone lymphoma|stage iv marginal zone lymphoma
691820|NCT00666211|stage IV small lymphocytic lymphoma|stage iv small lymphocytic lymphoma
691821|NCT00666211|recurrent adult Burkitt lymphoma|recurrent adult burkitt lymphoma
691936|NCT00665821|workers|workers
691822|NCT00666211|recurrent adult diffuse large cell lymphoma|recurrent adult diffuse large cell lymphoma
691823|NCT00666211|recurrent adult diffuse mixed cell lymphoma|recurrent adult diffuse mixed cell lymphoma
691824|NCT00666211|recurrent adult diffuse small cleaved cell lymphoma|recurrent adult diffuse small cleaved cell lymphoma
691825|NCT00666211|recurrent adult grade III lymphomatoid granulomatosis|recurrent adult grade iii lymphomatoid granulomatosis
691826|NCT00666211|recurrent adult immunoblastic large cell lymphoma|recurrent adult immunoblastic large cell lymphoma
691827|NCT00666211|recurrent adult lymphoblastic lymphoma|recurrent adult lymphoblastic lymphoma
691828|NCT00666211|recurrent grade 1 follicular lymphoma|recurrent grade 1 follicular lymphoma
691829|NCT00666211|recurrent grade 2 follicular lymphoma|recurrent grade 2 follicular lymphoma
691830|NCT00666211|recurrent grade 3 follicular lymphoma|recurrent grade 3 follicular lymphoma
691831|NCT00666211|recurrent mantle cell lymphoma|recurrent mantle cell lymphoma
691832|NCT00666211|recurrent marginal zone lymphoma|recurrent marginal zone lymphoma
691833|NCT00666211|recurrent small lymphocytic lymphoma|recurrent small lymphocytic lymphoma
691834|NCT00666211|intraocular lymphoma|intraocular lymphoma
691835|NCT00666211|primary central nervous system non-Hodgkin lymphoma|primary central nervous system non-hodgkin lymphoma
691836|NCT00666211|primary central nervous system Hodgkin lymphoma|primary central nervous system hodgkin lymphoma
691837|NCT00666211|post-transplant lymphoproliferative disorder|post-transplant lymphoproliferative disorder
691838|NCT00666211|chronic eosinophilic leukemia|chronic eosinophilic leukemia
691839|NCT00666211|chronic neutrophilic leukemia|chronic neutrophilic leukemia
691840|NCT00666211|primary myelofibrosis|primary myelofibrosis
691841|NCT00666211|essential thrombocythemia|essential thrombocythemia
691842|NCT00666211|polycythemia vera|polycythemia vera
691843|NCT00666211|extramedullary plasmacytoma|extramedullary plasmacytoma
691844|NCT00666211|isolated plasmacytoma of bone|isolated plasmacytoma of bone
691845|NCT00666211|monoclonal gammopathy of undetermined significance|monoclonal gammopathy of undetermined significance
691846|NCT00666211|stage I multiple myeloma|stage i multiple myeloma
691847|NCT00666211|stage II multiple myeloma|stage ii multiple myeloma
691848|NCT00666211|stage III multiple myeloma|stage iii multiple myeloma
691849|NCT00666211|primary systemic amyloidosis|primary systemic amyloidosis
691850|NCT00666211|refractory multiple myeloma|refractory multiple myeloma
691851|NCT00666211|de novo myelodysplastic syndromes|de novo myelodysplastic syndromes
691852|NCT00666211|previously treated myelodysplastic syndromes|previously treated myelodysplastic syndromes
691853|NCT00666211|secondary myelodysplastic syndromes|secondary myelodysplastic syndromes
691854|NCT00666211|myelodysplastic/myeloproliferative neoplasm, unclassifiable|myelodysplastic/myeloproliferative neoplasm, unclassifiable
691855|NCT00666211|recurrent adult Hodgkin lymphoma|recurrent adult hodgkin lymphoma
691856|NCT00666185|Micafungin|micafungin
691857|NCT00666185|Esophageal Candidiasis|esophageal candidiasis
691858|NCT00666185|Fluconazole|fluconazole
691859|NCT00666172|Women's Health|women's health
691860|NCT00666172|Obesity|obesity
691861|NCT00666172|Metabolic Syndrome|metabolic syndrome
691862|NCT00666172|Arterial Function|arterial function
691863|NCT00666172|Lipoproteins|lipoproteins
691864|NCT00666172|Overweight|overweight
691865|NCT00666159|Atopic Dermatitis|atopic dermatitis
691866|NCT00666159|Protopic|protopic
691867|NCT00666159|Pediatric|pediatric
691868|NCT00666146|Schizophrenia|schizophrenia
691869|NCT00666146|Genetics|genetics
691870|NCT00666146|Eyetracking|eyetracking
691871|NCT00666133|Preeclampsia|preeclampsia
691872|NCT00666133|Eclampsia|eclampsia
691873|NCT00666133|Magnesium Sulfate|magnesium sulfate
691874|NCT00666107|HPV|hpv
691875|NCT00666107|HIV|hiv
691876|NCT00666107|Gardasil|gardasil
691877|NCT00666107|Vaccine|vaccine
691878|NCT00666094|Type 2-diabetes|type 2-diabetes
691879|NCT00666094|exercise therapy|exercise therapy
691880|NCT00666094|RCT|rct
691881|NCT00666094|Norway|norway
691882|NCT00666081|Pazopanib, paclitaxel, carboplatin|pazopanib, paclitaxel, carboplatin
691883|NCT00666068|Patients with hypopituitarism|patients with hypopituitarism
691884|NCT00666055|Sex|sex
691885|NCT00666055|Aging|aging
691886|NCT00666055|Antiretroviral|antiretroviral
691887|NCT00666055|Pharmacokinetics|pharmacokinetics
691888|NCT00666055|post-menopausal women with HIV infection|post-menopausal women with hiv infection
691889|NCT00666055|pre-menopausal women with HIV infection|pre-menopausal women with hiv infection
691890|NCT00666029|metabolic syndrome|metabolic syndrome
691891|NCT00666029|Volunteers recruited from the community|volunteers recruited from the community
691892|NCT00666016|non alcoholic steatohepatitis nash hepatoprotective hepatoprotection ALT AST new drug candidate interventional study TRO19622 Trophos cholest-4-en-3-one oxime|non alcoholic steatohepatitis nash hepatoprotective hepatoprotection alt ast new drug candidate interventional study tro19622 trophos cholest-4-en-3-one oxime
691893|NCT00666003|Hemodynamics|hemodynamics
691894|NCT00665977|Obstructive Sleep Apnea|obstructive sleep apnea
691895|NCT00665977|Nasal Congestion|nasal congestion
691896|NCT00665977|Sinus congestion|sinus congestion
691897|NCT00665964|osteoarthritis|osteoarthritis
691898|NCT00665964|knee|knee
691899|NCT00665964|total knee arthroplasty|total knee arthroplasty
691900|NCT00665964|gonarthrrsis|gonarthrrsis
691901|NCT00665964|polyethylene|polyethylene
691902|NCT00665964|posterior stabilized|posterior stabilized
691903|NCT00665951|pediatric|pediatric
691904|NCT00665951|pharmacokinetics|pharmacokinetics
691905|NCT00665951|HIV infection|hiv infection
691906|NCT00665938|Physical development|physical development
691907|NCT00665899|breast cancer|breast cancer
691908|NCT00665899|couples|couples
691909|NCT00665899|cognitive behavioral therapy|cognitive behavioral therapy
691910|NCT00665899|Women with early stage breast cancer and their partners.|women with early stage breast cancer and their partners.
691911|NCT00665886|Peripheral venous catheter|peripheral venous catheter
691912|NCT00665886|Catheter-related complication|catheter-related complication
691913|NCT00665886|Bacterial Colonization|bacterial colonization
691914|NCT00665886|Dwell time|dwell time
691915|NCT00665886|Closed system|closed system
691916|NCT00665886|Costs|costs
691917|NCT00665886|Polyurethane|polyurethane
691918|NCT00665886|Teflon|teflon
691919|NCT00665873|Totally Implantable Venous Access Devices|totally implantable venous access devices
691920|NCT00665873|Infections|infections
691921|NCT00665873|Chemotherapy|chemotherapy
691922|NCT00665873|Valuated infections TIVAD|valuated infections tivad
691923|NCT00665860|Osteoporosis|osteoporosis
691924|NCT00665860|Soy isoflavones|soy isoflavones
691925|NCT00665860|Postmenopausal women|postmenopausal women
691926|NCT00665860|Safety|safety
691927|NCT00665860|Efficacy|efficacy
691928|NCT00665860|Effective dosage|effective dosage
691929|NCT00665847|HIV-1|hiv-1
691932|NCT00665821|nonspecific low back pain|nonspecific low back pain
691933|NCT00665821|disability|disability
691934|NCT00665821|sick leave|sick leave
691935|NCT00665821|catastrophizing|catastrophizing
691937|NCT00665795|Dysthyroid Optic Neuropathy|dysthyroid optic neuropathy
691938|NCT00665795|multidetector computed tomography|multidetector computed tomography
691939|NCT00665795|color doppler|color doppler
691940|NCT00665795|Grave´s Orbitopathy|grave´s orbitopathy
691941|NCT00665795|Grave´s Disease|grave´s disease
691942|NCT00665795|morphometric analysis|morphometric analysis
691943|NCT00665782|anxiety disorder|anxiety disorder
691944|NCT00665782|depression|depression
691945|NCT00665782|psychosocial effects of cancer and its treatment|psychosocial effects of cancer and its treatment
691946|NCT00665782|ductal breast carcinoma in situ|ductal breast carcinoma in situ
691947|NCT00665782|breast cancer in situ|breast cancer in situ
691948|NCT00665782|stage I breast cancer|stage i breast cancer
691949|NCT00665782|stage II breast cancer|stage ii breast cancer
691950|NCT00665782|stage IIIA breast cancer|stage iiia breast cancer
691951|NCT00665782|stage IIIB breast cancer|stage iiib breast cancer
691952|NCT00665782|stage IIIC breast cancer|stage iiic breast cancer
691953|NCT00665769|hypercapnia|hypercapnia
691954|NCT00665769|normocapnia|normocapnia
691955|NCT00665769|chronic lung disease|chronic lung disease
691956|NCT00665769|periventricular leukomalacia|periventricular leukomalacia
691957|NCT00665769|intraventricular hemorrhage|intraventricular hemorrhage
691958|NCT00665769|hypotension|hypotension
691959|NCT00665769|cerebral autoregulation|cerebral autoregulation
691960|NCT00665769|heart rate variability|heart rate variability
691961|NCT00665769|autonomic nervous system|autonomic nervous system
691962|NCT00665769|detrended fluctuation analysis|detrended fluctuation analysis
691963|NCT00665756|Glaucoma|glaucoma
691964|NCT00665756|Drainage implant|drainage implant
691965|NCT00665756|Ahmed valve|ahmed valve
691966|NCT00665756|Second trabeculectomy|second trabeculectomy
691967|NCT00665717|interaction|interaction
691969|NCT00665717|pharmacokinetics|pharmacokinetics
691970|NCT00665704|Smoking Cessation|smoking cessation
691971|NCT00665704|Internet|internet
691972|NCT00665704|Intervention Studies|intervention studies
691973|NCT00665704|Health Services Accessibility|health services accessibility
691974|NCT00665691|All Malignancies|all malignancies
691975|NCT00665652|Neuropathy|neuropathy
691976|NCT00665652|Nonmalignant Monoclonal Gammopathy of Undetermined Significance (MGUS)|nonmalignant monoclonal gammopathy of undetermined significance (mgus)
691977|NCT00665652|MGUS|mgus
691978|NCT00665639|Micafungin|micafungin
691979|NCT00665639|Esophageal Candidiasis|esophageal candidiasis
691980|NCT00665639|caspofungin|caspofungin
691981|NCT00665613|warfarin use|warfarin use
691982|NCT00665600|COPD|copd
691983|NCT00665600|Chronic Bronchitis|chronic bronchitis
691984|NCT00665600|Chronic Emphysema|chronic emphysema
691985|NCT00665587|Atrial fibrillation|atrial fibrillation
691986|NCT00665587|Maze procedure|maze procedure
691987|NCT00665587|Mid-term results|mid-term results
691988|NCT00665587|Long-term results|long-term results
691989|NCT00665587|Surgical ablation|surgical ablation
691990|NCT00665561|Maraviroc|maraviroc
691991|NCT00665561|HIV-1|hiv-1
691992|NCT00665561|Safety|safety
691993|NCT00665561|Non-interventional|non-interventional
691994|NCT00665548|Knee Osteoarthritis|knee osteoarthritis
691995|NCT00665548|magnetic resonance imaging|magnetic resonance imaging
691996|NCT00665548|x rays|x rays
691997|NCT00665535|Pressure ulcers|pressure ulcers
691998|NCT00665535|Nursing facilities|nursing facilities
691999|NCT00665535|Elderly|elderly
692000|NCT00665535|At risk for pressure ulcers|at risk for pressure ulcers
692001|NCT00665522|Pain|pain
692002|NCT00665522|Postoperative Analgesia|postoperative analgesia
692003|NCT00665522|Patient-Controlled Opioids|patient-controlled opioids
692004|NCT00665509|Influenza|influenza
692005|NCT00665509|Vaccine|vaccine
692006|NCT00665509|CHMP criteria|chmp criteria
692007|NCT00665496|Erectile Dysfunction|erectile dysfunction
692008|NCT00665496|Vardenafil|vardenafil
692009|NCT00665496|Onset of action|onset of action
692010|NCT00665470|Malignant Melanoma|malignant melanoma
692011|NCT00665470|HLA-A2|hla-a2
692012|NCT00665470|Immunotherapy|immunotherapy
692013|NCT00665470|Clinical Response|clinical response
692014|NCT00665470|Skin Cancer|skin cancer
692015|NCT00665457|stage II breast cancer|stage ii breast cancer
692016|NCT00665457|stage IIIA breast cancer|stage iiia breast cancer
692017|NCT00665457|stage IIIB breast cancer|stage iiib breast cancer
692018|NCT00665457|stage IIIC breast cancer|stage iiic breast cancer
692019|NCT00665444|bipolar disorder|bipolar disorder
692020|NCT00665444|sedation|sedation
692021|NCT00665444|overweight|overweight
692022|NCT00665444|Abilify|abilify
692023|NCT00665444|medication|medication
692024|NCT00665418|Anesthesia|anesthesia
692025|NCT00665418|children|children
692026|NCT00665418|Larynx|larynx
692027|NCT00665405|Delivery, obstetric|delivery, obstetric
692028|NCT00665405|Atelectasis|atelectasis
692029|NCT00665392|stage III squamous cell carcinoma of the oropharynx|stage iii squamous cell carcinoma of the oropharynx
692030|NCT00665392|stage IV squamous cell carcinoma of the oropharynx|stage iv squamous cell carcinoma of the oropharynx
692031|NCT00665392|tongue cancer|tongue cancer
692032|NCT00665379|leg lymphedema|leg lymphedema
692033|NCT00665379|volume measurement|volume measurement
692034|NCT00665379|compression therapy|compression therapy
692035|NCT00665379|interface pressure|interface pressure
692036|NCT00665379|static stiffness index (SSI)|static stiffness index (ssi)
692037|NCT00665379|volume change|volume change
692039|NCT00665353|HCV|hcv
692040|NCT00665340|Erectile Dysfunction|erectile dysfunction
692041|NCT00665340|Vardenafil|vardenafil
692042|NCT00665327|Community Acquired Pneumonia|community acquired pneumonia
692043|NCT00665327|Pneumonia,|pneumonia,
692044|NCT00665327|CAP|cap
692045|NCT00665314|Mobilisation stem cells|mobilisation stem cells
692046|NCT00665314|G-CSF Mobilisation Regimen|g-csf mobilisation regimen
692047|NCT00665314|Lymphoma|lymphoma
692048|NCT00665314|Multiple Myeloma|multiple myeloma
692049|NCT00665314|Adult patients with lymphoma (Non Hodgkin's Lymphoma, Hodgkin's Disease) or Multiple Myeloma who previously failed Stem Cell Collections or Collection attempts.|adult patients with lymphoma (non hodgkin's lymphoma, hodgkin's disease) or multiple myeloma who previously failed stem cell collections or collection attempts.
692050|NCT00665301|Non-invasive Cardiac Output|non-invasive cardiac output
692051|NCT00665288|cardiac arrest|cardiac arrest
692052|NCT00665288|heart arrest|heart arrest
692053|NCT00665288|CPR|cpr
692054|NCT00665288|resuscitation|resuscitation
692055|NCT00665288|bystander CPR|bystander cpr
692056|NCT00665275|complementary|complementary
692057|NCT00665275|alternative|alternative
692058|NCT00665275|medicine|medicine
692059|NCT00665262|analgesia|analgesia
692060|NCT00665262|hip arthroplasty|hip arthroplasty
692061|NCT00665262|knee arthroplasty|knee arthroplasty
692062|NCT00665249|problem drinking|problem drinking
692063|NCT00665249|heavy drinking|heavy drinking
692064|NCT00665249|Alcohol|alcohol
692065|NCT00665249|moderation|moderation
692066|NCT00665249|motivational interviewing|motivational interviewing
692067|NCT00665236|Migraine|migraine
692068|NCT00665223|Huntington's Disease|huntington's disease
692069|NCT00665210|hip arthritis|hip arthritis
692070|NCT00665210|implant sizing|implant sizing
692071|NCT00665197|Esophageal cancer|esophageal cancer
692072|NCT00665197|Brachytherapy|brachytherapy
692073|NCT00665197|Radiotherapy|radiotherapy
692074|NCT00665197|Palliation|palliation
692075|NCT00665197|Dysphagia|dysphagia
692076|NCT00665184|Hypokinesia|hypokinesia
692077|NCT00665184|Gait|gait
692078|NCT00665184|Quality of life|quality of life
692079|NCT00665184|Dopamine replacement|dopamine replacement
692080|NCT00665184|Resistance training|resistance training
692081|NCT00665171|Polycystic ovary syndrome|polycystic ovary syndrome
692082|NCT00665171|Single nucleotide polymorphism|single nucleotide polymorphism
692083|NCT00665171|Whole genome analysis|whole genome analysis
692084|NCT00665171|Multigenerational family study|multigenerational family study
692085|NCT00665158|Abdominal obesity, exercise, behaviour modification|abdominal obesity, exercise, behaviour modification
692086|NCT00665145|Diabetes Mellitus, Type 1|diabetes mellitus, type 1
692087|NCT00665145|Diabetes Mellitus, Type 2|diabetes mellitus, type 2
692088|NCT00665145|Diabetic Polyneuropathy|diabetic polyneuropathy
692089|NCT00665145|Stem Cells|stem cells
692090|NCT00665132|wrist|wrist
692091|NCT00665132|hand|hand
692092|NCT00665132|pain|pain
692093|NCT00665132|failed CTR|failed ctr
692094|NCT00665132|carpal tunnel syndrome|carpal tunnel syndrome
692095|NCT00665132|CTS|cts
692096|NCT00665132|CTR|ctr
692097|NCT00665132|carpel tunnel release|carpel tunnel release
692098|NCT00665132|Peripheral nerve|peripheral nerve
692099|NCT00665132|Median nerve|median nerve
692100|NCT00665119|Respiratory Insufficiency|respiratory insufficiency
692101|NCT00665119|Respiration, Artificial|respiration, artificial
692102|NCT00665119|Remifentanil|remifentanil
692103|NCT00665119|Respiratory Mechanics|respiratory mechanics
692104|NCT00665119|Work of Breathing|work of breathing
692105|NCT00665106|Diabetic macular edema|diabetic macular edema
692106|NCT00665106|Diabetes|diabetes
692107|NCT00665106|Diabetic retinopathy|diabetic retinopathy
692108|NCT00665067|Myeloproliferative Disease|myeloproliferative disease
692109|NCT00665067|Myelofibrosis|myelofibrosis
692110|NCT00665067|Idiopathic Myelofibrosis|idiopathic myelofibrosis
692111|NCT00665067|Essential Thrombocythemia|essential thrombocythemia
692112|NCT00665067|Polycythemia Vera|polycythemia vera
692113|NCT00665067|Biomarkers|biomarkers
692114|NCT00665067|Philadelphia Chromosome Negative|philadelphia chromosome negative
692115|NCT00665067|Clonal Hematopoietic malignancies|clonal hematopoietic malignancies
692116|NCT00665054|Vardenafil|vardenafil
692117|NCT00665054|Erectile dysfunction|erectile dysfunction
692118|NCT00665054|SSES-E (sexual self-efficacy scale - erectile function)|sses-e (sexual self-efficacy scale - erectile function)
692119|NCT00665028|Anesthesia|anesthesia
692120|NCT00665028|Postoperative myocardial ischemia|postoperative myocardial ischemia
692121|NCT00665028|ST monitoring|st monitoring
692122|NCT00665015|pleural effusion|pleural effusion
692123|NCT00665015|coronary artery bypass|coronary artery bypass
692124|NCT00665015|heart valve replacement|heart valve replacement
692125|NCT00665002|Myeloid|myeloid
692126|NCT00665002|Monocytic|monocytic
692127|NCT00665002|Hematopoietic|hematopoietic
692128|NCT00665002|Neoplasms|neoplasms
692129|NCT00665002|Acute Myelogenous Leukemia|acute myelogenous leukemia
692130|NCT00665002|AML|aml
692131|NCT00665002|Myelodysplastic Syndrome|myelodysplastic syndrome
692132|NCT00665002|MDS|mds
692133|NCT00664989|Hemiarthroplasty Stemmed Resurfacing Conventional Shoulder|hemiarthroplasty stemmed resurfacing conventional shoulder
692134|NCT00664976|bipolar depression|bipolar depression
692135|NCT00664976|Electroconvulsive therapy|electroconvulsive therapy
692136|NCT00664963|Arterial Occlusive Diseases|arterial occlusive diseases
692137|NCT00664963|Peripheral Vascular Diseases|peripheral vascular diseases
692138|NCT00664963|Drug eluting stent|drug eluting stent
692139|NCT00664963|Restenosis|restenosis
692140|NCT00664963|Below the knee|below the knee
692141|NCT00664963|Intervention|intervention
692142|NCT00664950|intertrochanteric hip fracture fixation|intertrochanteric hip fracture fixation
692143|NCT00664950|interTAN IM Nail|intertan im nail
692144|NCT00664950|sliding hip screw|sliding hip screw
692145|NCT00664924|ICU|icu
692146|NCT00664898|anti-CD40|anti-cd40
692147|NCT00664898|Myeloma|myeloma
692148|NCT00664885|non-psychiatric|non-psychiatric
692149|NCT00664885|clinics|clinics
692150|NCT00664872|case manager|case manager
692151|NCT00664872|suicide|suicide
692152|NCT00664872|attempt|attempt
692153|NCT00664872|effectiveness|effectiveness
692154|NCT00664859|LCP-AtorFen|lcp-atorfen
692155|NCT00664859|Non-HDL cholesterol|non-hdl cholesterol
692156|NCT00664859|Triglycerides|triglycerides
692157|NCT00664859|HDL cholesterol|hdl cholesterol
692158|NCT00664859|LDL cholesterol|ldl cholesterol
692159|NCT00664859|Atorvastatin|atorvastatin
692160|NCT00664859|Fenofibrate|fenofibrate
692161|NCT00664846|Stroke|stroke
692162|NCT00664846|Prevention Therapy|prevention therapy
692163|NCT00664833|Erectile dysfunction|erectile dysfunction
692164|NCT00664833|Phosphodiesterase Type 5 Inhibitors|phosphodiesterase type 5 inhibitors
692165|NCT00664833|Patient education|patient education
692166|NCT00664833|Impotence|impotence
692167|NCT00664833|Vardenafil|vardenafil
692168|NCT00664820|Rheumatoid Arthritics|rheumatoid arthritics
692169|NCT00664820|probiotics|probiotics
692170|NCT00664820|Lactobacillus|lactobacillus
692171|NCT00664781|stage IIIA breast cancer|stage iiia breast cancer
692172|NCT00664781|stage IIIB breast cancer|stage iiib breast cancer
692173|NCT00664781|stage IIIC breast cancer|stage iiic breast cancer
692174|NCT00664781|stage IV breast cancer|stage iv breast cancer
692175|NCT00664781|recurrent breast cancer|recurrent breast cancer
692176|NCT00664781|stage IV ovarian epithelial cancer|stage iv ovarian epithelial cancer
692177|NCT00664781|recurrent ovarian germ cell tumor|recurrent ovarian germ cell tumor
692178|NCT00664781|stage IV ovarian germ cell tumor|stage iv ovarian germ cell tumor
692179|NCT00664781|ovarian stromal cancer|ovarian stromal cancer
692180|NCT00664781|ovarian sarcoma|ovarian sarcoma
692181|NCT00664781|BRCA1 mutation carrier|brca1 mutation carrier
692182|NCT00664781|BRCA2 mutation carrier|brca2 mutation carrier
692183|NCT00664781|stage IIIA ovarian epithelial cancer|stage iiia ovarian epithelial cancer
692184|NCT00664781|stage IIIA ovarian germ cell tumor|stage iiia ovarian germ cell tumor
692185|NCT00664781|stage IIIB ovarian epithelial cancer|stage iiib ovarian epithelial cancer
692186|NCT00664781|stage IIIB ovarian germ cell tumor|stage iiib ovarian germ cell tumor
692187|NCT00664781|stage IIIC ovarian epithelial cancer|stage iiic ovarian epithelial cancer
692188|NCT00664781|stage IIIC ovarian germ cell tumor|stage iiic ovarian germ cell tumor
692189|NCT00664781|ovarian papillary serous carcinoma|ovarian papillary serous carcinoma
692190|NCT00664768|hypoallergenicity|hypoallergenicity
692191|NCT00664768|Cow Milk Allergy|cow milk allergy
692192|NCT00664768|DBPCFC|dbpcfc
692193|NCT00664768|Stool microflora|stool microflora
692194|NCT00664768|Stool characteristics|stool characteristics
692195|NCT00664755|Menstrual Cycle effects|menstrual cycle effects
692196|NCT00664755|Cue Reactivity|cue reactivity
692197|NCT00664755|Smoking Cessation|smoking cessation
692198|NCT00664755|Impulsivity|impulsivity
692199|NCT00664742|Metabolic syndrome,dyslipidemia,fluvastatin extended release|metabolic syndrome,dyslipidemia,fluvastatin extended release
692200|NCT00664729|Abdominal|abdominal
692201|NCT00664729|obesity|obesity
692202|NCT00664729|exercise|exercise
692203|NCT00664729|intensity|intensity
692204|NCT00664729|weight loss|weight loss
692205|NCT00664729|women|women
692206|NCT00664716|Rheumatoid Arthritis|rheumatoid arthritis
692207|NCT00664716|RA|ra
692208|NCT00664716|DMARD inadequate response|dmard inadequate response
692209|NCT00664716|Methotrexate|methotrexate
692210|NCT00664703|Dopamine Uptake Inhibitors|dopamine uptake inhibitors
692211|NCT00664703|Dopamine|dopamine
692212|NCT00664703|Methylphenidate|methylphenidate
692213|NCT00664703|Mental Disorders Diagnosed in Childhood|mental disorders diagnosed in childhood
692214|NCT00664703|Neurologic Manifestations|neurologic manifestations
692215|NCT00664703|Attention Deficit and Disruptive Behavior Disorders|attention deficit and disruptive behavior disorders
692216|NCT00664703|Hyperkinesis|hyperkinesis
692217|NCT00664703|Dyskinesias|dyskinesias
692218|NCT00664690|shoulder surgery|shoulder surgery
692219|NCT00664690|analgesia|analgesia
692220|NCT00664677|Adult|adult
692221|NCT00664677|Leukemia|leukemia
692222|NCT00664677|Terameprocol|terameprocol
692223|NCT00664677|Survivin|survivin
692225|NCT00664677|ALL|all
692226|NCT00664677|ATL|atl
692227|NCT00664677|CML|cml
692228|NCT00664677|CLL|cll
692229|NCT00664677|CMML|cmml
692230|NCT00664677|MDS|mds
692231|NCT00664664|insomnia|insomnia
692232|NCT00664664|sleep maintenance insomnia|sleep maintenance insomnia
692233|NCT00664664|sleep quality|sleep quality
692234|NCT00664664|non-restorative sleep|non-restorative sleep
692235|NCT00664664|multiple awakenings|multiple awakenings
692236|NCT00664651|joint contracture|joint contracture
692237|NCT00664651|total knee arthroplasty|total knee arthroplasty
692238|NCT00664612|Cervical Spine|cervical spine
692239|NCT00664599|Ocular lesions, Visual Acuity, Retinal Vasculitis|ocular lesions, visual acuity, retinal vasculitis
692240|NCT00664586|Terameprocol (EM-1421)|terameprocol (em-1421)
692241|NCT00664586|Phase 1|phase 1
692242|NCT00664586|Infusion|infusion
692243|NCT00664586|Refractory Solid Tumors|refractory solid tumors
692244|NCT00664586|Lymphoma|lymphoma
692245|NCT00664586|Maximum Tolerated Dose|maximum tolerated dose
692246|NCT00664586|Tumor Response|tumor response
692247|NCT00664586|Tumor Markers|tumor markers
692248|NCT00664586|Pharmacokinetics|pharmacokinetics
692249|NCT00664573|Safety|safety
692250|NCT00664573|Rheumatoid Arthritis|rheumatoid arthritis
692251|NCT00664573|Baminercept alfa|baminercept alfa
692252|NCT00664573|Methotrexate|methotrexate
692253|NCT00664573|BG9924|bg9924
692254|NCT00664573|Efficacy|efficacy
692255|NCT00664547|obesity, exercise, diet, insulin resistance|obesity, exercise, diet, insulin resistance
692256|NCT00664508|Arthroplasty|arthroplasty
692257|NCT00664508|Hip Replacement|hip replacement
692258|NCT00664508|motion analysis|motion analysis
692259|NCT00664495|Obesity, exercise, diet, insulin resistance|obesity, exercise, diet, insulin resistance
692260|NCT00664456|stage IIB prostate cancer|stage iib prostate cancer
692261|NCT00664456|stage IIA prostate cancer|stage iia prostate cancer
692262|NCT00664456|stage I prostate cancer|stage i prostate cancer
692263|NCT00664443|cardiac arrest|cardiac arrest
692264|NCT00664443|CPR|cpr
692265|NCT00664443|resuscitation|resuscitation
692266|NCT00664443|bystander CPR|bystander cpr
692267|NCT00664443|dispatch-assisted CPR|dispatch-assisted cpr
692268|NCT00664430|Dialysis|dialysis
692269|NCT00664430|Calcitriol Resistant|calcitriol resistant
692270|NCT00664430|Secondary Hyperparathyroidism|secondary hyperparathyroidism
692271|NCT00664417|Influenza|influenza
692272|NCT00664417|A/H5N1|a/h5n1
692273|NCT00664417|Orthomyxoviridae Infections|orthomyxoviridae infections
692274|NCT00664417|Influenza Pandemics|influenza pandemics
692275|NCT00664404|Smoking|smoking
692276|NCT00664404|Smoking Cessation|smoking cessation
692277|NCT00664404|Nicotine Withdrawal|nicotine withdrawal
692278|NCT00664404|Nicotine Dependence|nicotine dependence
692279|NCT00664404|Neuroregulatory Effects|neuroregulatory effects
692280|NCT00664404|Magnetic Resonance Imaging|magnetic resonance imaging
692281|NCT00664404|MRI|mri
692282|NCT00664378|Multiple myeloma, relapsed, refractory|multiple myeloma, relapsed, refractory
692283|NCT00664365|Premature ejaculation.|premature ejaculation.
692284|NCT00664365|FTIH,|ftih,
692285|NCT00664365|GSK958108,|gsk958108,
692286|NCT00664365|5HT1a antagonist,|5ht1a antagonist,
692287|NCT00664352|Double blind|double blind
692288|NCT00664352|Placebo controlled|placebo controlled
692289|NCT00664352|wound healing|wound healing
692290|NCT00664339|Heart failure,|heart failure,
692291|NCT00664339|infection,|infection,
692292|NCT00664339|immune system,|immune system,
692293|NCT00664339|atherosclerosis|atherosclerosis
692294|NCT00664326|Renal Cell Carcinoma|renal cell carcinoma
692295|NCT00664313|Linezolid|linezolid
692296|NCT00664313|Zyvox|zyvox
692297|NCT00664313|Peripheral Neuropathy|peripheral neuropathy
692298|NCT00664313|Optic Neuropathy|optic neuropathy
692299|NCT00664313|Anemia|anemia
692300|NCT00664313|Thrombocytopenia|thrombocytopenia
692301|NCT00664300|Gilles de la Tourette's syndrome|gilles de la tourette's syndrome
692302|NCT00664300|Facial expression recognition of emotion|facial expression recognition of emotion
692303|NCT00664300|Frequency levels|frequency levels
692556|NCT00663143|stromal cells|stromal cells
692304|NCT00664300|Automatic and voluntary information treatment|automatic and voluntary information treatment
692305|NCT00664300|Patient with Gilles de la Tourette's syndrome|patient with gilles de la tourette's syndrome
692306|NCT00664261|tobacco use disorder|tobacco use disorder
692307|NCT00664235|Pressure Ulcers|pressure ulcers
692308|NCT00664235|Tissue Injury|tissue injury
692309|NCT00664222|heart failure|heart failure
692310|NCT00664222|insulin resistance|insulin resistance
692311|NCT00664222|inflammatory cytokine|inflammatory cytokine
692312|NCT00664222|spironolactone|spironolactone
692313|NCT00664222|furosemide|furosemide
692314|NCT00664209|Parkinson's disease|parkinson's disease
692315|NCT00664209|levodopa|levodopa
692316|NCT00664209|Helicobacter pylori|helicobacter pylori
692317|NCT00664196|Prostate Cancer|prostate cancer
692318|NCT00664196|T cells|t cells
692319|NCT00664196|Gene Transfer|gene transfer
692320|NCT00664183|diabetic retinopathy|diabetic retinopathy
692321|NCT00664157|Idiopathic Parkinson's disease|idiopathic parkinson's disease
692322|NCT00664157|L-Dopa|l-dopa
692323|NCT00664157|Deep Brain stimulation|deep brain stimulation
692324|NCT00664157|Facial expression recognition of emotion|facial expression recognition of emotion
692325|NCT00664157|Frequency levels|frequency levels
692326|NCT00664157|Automatic and voluntary information treatment|automatic and voluntary information treatment
692327|NCT00664157|Patient with an Idiopathic Parkinson's disease|patient with an idiopathic parkinson's disease
692328|NCT00664131|Acute Lymphoblastic Leukemia|acute lymphoblastic leukemia
692329|NCT00664131|ALL survivors|all survivors
692330|NCT00664131|ALL neurologic symptoms|all neurologic symptoms
692331|NCT00664131|ALL neurologic disability|all neurologic disability
692332|NCT00664131|ALL late effects|all late effects
692333|NCT00664118|Doula|doula
692334|NCT00664118|Patient-controlled epidural analgesia|patient-controlled epidural analgesia
692335|NCT00664118|Neuraxial analgesia|neuraxial analgesia
692336|NCT00664118|Labor analgesia|labor analgesia
692337|NCT00664105|stage IIIA non-small cell lung cancer|stage iiia non-small cell lung cancer
692338|NCT00664105|stage IIIB non-small cell lung cancer|stage iiib non-small cell lung cancer
692339|NCT00664092|Substance Abuse|substance abuse
692340|NCT00664092|Ex-Offenders|ex-offenders
692341|NCT00664092|Substance Abuse Recovery|substance abuse recovery
692342|NCT00664079|Thyroid Deficiency|thyroid deficiency
692343|NCT00664079|Thyroid Stimulating Hormone|thyroid stimulating hormone
692344|NCT00664053|bone mineral density|bone mineral density
692345|NCT00664053|bone turnover markers|bone turnover markers
692346|NCT00664053|strength|strength
692347|NCT00664053|balance|balance
692348|NCT00664014|hyponatremia|hyponatremia
692349|NCT00664014|Non-acute and non hypovolemic hyponatremia|non-acute and non hypovolemic hyponatremia
692350|NCT00663988|face transplantation|face transplantation
692351|NCT00663975|cystic fibrosis|cystic fibrosis
692352|NCT00663975|pancreatic insufficiency|pancreatic insufficiency
692353|NCT00663975|pancreatic enzymes|pancreatic enzymes
692354|NCT00663975|pediatrics|pediatrics
692355|NCT00663962|Thoracotomy|thoracotomy
692356|NCT00663962|Post-surgical|post-surgical
692357|NCT00663962|Pregabalin|pregabalin
692358|NCT00663949|diabetes|diabetes
692359|NCT00663949|proteinuria|proteinuria
692360|NCT00663949|pentoxifylline|pentoxifylline
692361|NCT00663936|Alzheimer's Disease|alzheimer's disease
692362|NCT00663936|Alzheimer's|alzheimer's
692363|NCT00663923|Excimer Laser|excimer laser
692364|NCT00663923|photorefractive keratectomy|photorefractive keratectomy
692365|NCT00663923|astigmatism|astigmatism
692366|NCT00663910|basal cell carcinoma of the skin|basal cell carcinoma of the skin
692367|NCT00663910|squamous cell carcinoma of the skin|squamous cell carcinoma of the skin
692368|NCT00663910|recurrent skin cancer|recurrent skin cancer
692369|NCT00663897|functional dyspepsia|functional dyspepsia
692370|NCT00663897|epigastric pain syndrome|epigastric pain syndrome
692371|NCT00663897|postprandial distress syndrome|postprandial distress syndrome
692372|NCT00663897|proton pump inhibitor|proton pump inhibitor
692373|NCT00663897|5 HT-4 receptor agonist|5 ht-4 receptor agonist
692374|NCT00663884|diabetes mellitus, Type 2|diabetes mellitus, type 2
692375|NCT00663884|mitiglinide|mitiglinide
692376|NCT00663871|Fish Oil|fish oil
692377|NCT00663871|Omega-3 fatty acids|omega-3 fatty acids
692378|NCT00663871|Affect|affect
692379|NCT00663871|Depression|depression
692380|NCT00663871|Anger|anger
692381|NCT00663871|Nutrition|nutrition
692382|NCT00663871|Impulsivity|impulsivity
692383|NCT00663871|Aggression|aggression
692384|NCT00663871|Cognition|cognition
692385|NCT00663871|Behavior|behavior
692386|NCT00663845|Male Erectile Dysfunction|male erectile dysfunction
692387|NCT00663845|Dyslipidemia|dyslipidemia
692388|NCT00663845|Vardenafil|vardenafil
692389|NCT00663832|Male|male
692390|NCT00663832|Prostate|prostate
692391|NCT00663832|Cancer|cancer
692392|NCT00663832|HRPC|hrpc
692393|NCT00663832|DACi|daci
692394|NCT00663819|Low anterior colon resection|low anterior colon resection
692395|NCT00663819|Proctectomy|proctectomy
692396|NCT00663819|Proctocolectomy|proctocolectomy
692397|NCT00663819|Anastomosis|anastomosis
692398|NCT00663819|Rectal Cancer|rectal cancer
692399|NCT00663819|Ileostomy|ileostomy
692400|NCT00663806|UTI|uti
692401|NCT00663793|Male Contraception|male contraception
692402|NCT00663793|Hypogonadism|hypogonadism
692403|NCT00663793|Testosterone|testosterone
692404|NCT00663780|pharmacogenomics|pharmacogenomics
692405|NCT00663780|polymorphisms|polymorphisms
692406|NCT00663780|wound healing|wound healing
692407|NCT00663754|Body Image|body image
692408|NCT00663741|Unresectable / recurrent gastric cancer|unresectable / recurrent gastric cancer
692409|NCT00663741|Sorafenib|sorafenib
692410|NCT00663741|S-1|s-1
692411|NCT00663741|Gastric|gastric
692412|NCT00663741|Cisplatin|cisplatin
692413|NCT00663741|CDDP|cddp
692414|NCT00663728|Erectile Dysfunction|erectile dysfunction
692415|NCT00663728|Vardenafil|vardenafil
692416|NCT00663715|Sciatic Nerve|sciatic nerve
692417|NCT00663715|Peripheral Nerve Block|peripheral nerve block
692418|NCT00663715|Lower extremity surgery|lower extremity surgery
692419|NCT00663715|Local Anesthesia|local anesthesia
692420|NCT00663715|Ultrasound guided nerve blocks|ultrasound guided nerve blocks
692421|NCT00663689|erlotinib|erlotinib
692422|NCT00663650|Basal Cell Carcinoma|basal cell carcinoma
692423|NCT00663650|BCC|bcc
692424|NCT00663650|Periocular BCC|periocular bcc
692425|NCT00663650|Frozen Section Control|frozen section control
692426|NCT00663650|Permanent Section Control|permanent section control
692427|NCT00663650|Recurrence Rates|recurrence rates
692428|NCT00663637|endotracheal tube obstruction, occlusion|endotracheal tube obstruction, occlusion
692429|NCT00663637|mechanical ventilation, complication|mechanical ventilation, complication
692430|NCT00663637|work of breathing|work of breathing
692431|NCT00663637|airway resistance|airway resistance
692432|NCT00663637|secretions|secretions
692433|NCT00663637|pneumonia, ventilator associated|pneumonia, ventilator associated
692434|NCT00663637|biofilms|biofilms
692435|NCT00663637|endotracheal tube|endotracheal tube
692436|NCT00663611|Immune Function|immune function
692437|NCT00663611|Metabolism|metabolism
692438|NCT00663611|Pulsatile Growth Hormone|pulsatile growth hormone
692439|NCT00663598|Erectile Dysfunction|erectile dysfunction
692440|NCT00663598|Vardenafil|vardenafil
692441|NCT00663585|Migraine|migraine
692442|NCT00663585|Headache|headache
692443|NCT00663585|Vipassana|vipassana
692444|NCT00663585|Meditation|meditation
692445|NCT00663585|Intensive|intensive
692446|NCT00663572|Newborn|newborn
692447|NCT00663572|nutrition|nutrition
692448|NCT00663572|genetic|genetic
692449|NCT00663572|feeding behaviour|feeding behaviour
692450|NCT00663572|psychomotor development|psychomotor development
692451|NCT00663572|long-term effects|long-term effects
692452|NCT00663572|nutritional imprinting.|nutritional imprinting.
692453|NCT00663559|renal|renal
692454|NCT00663559|Sunitinib|sunitinib
692455|NCT00663559|Unresectable and/or metastatic renal cell cancer|unresectable and/or metastatic renal cell cancer
692456|NCT00663546|Malaria|malaria
692457|NCT00663546|Plasmodium|plasmodium
692458|NCT00663546|Hemoglobin E|hemoglobin e
692459|NCT00663546|Alpha-thalssemia|alpha-thalssemia
692460|NCT00663546|G6PD Deficiency|g6pd deficiency
692461|NCT00663533|Vasectomy|vasectomy
692462|NCT00663533|Contraception|contraception
692463|NCT00663520|Cardiac disease|cardiac disease
692464|NCT00663520|vascular dysfunction|vascular dysfunction
692465|NCT00663520|women|women
692466|NCT00663520|chest pain|chest pain
692467|NCT00663520|echocardiography|echocardiography
692468|NCT00663507|Sickle Cell Disease|sickle cell disease
692469|NCT00663507|Immunosuppression|immunosuppression
692470|NCT00663507|Organ & Tissue Transplantation|organ & tissue transplantation
692471|NCT00663507|Transplantation Immunology|transplantation immunology
692472|NCT00663494|heart failure|heart failure
692473|NCT00663494|MMP|mmp
692474|NCT00663494|coronary sinus|coronary sinus
692475|NCT00663481|CoFactor|cofactor
692476|NCT00663481|ANX-510|anx-510
692477|NCT00663468|determine changes in patient pain level|determine changes in patient pain level
692478|NCT00663468|determine changes in patient functionality|determine changes in patient functionality
692479|NCT00663468|determine changes in patient life quality|determine changes in patient life quality
692480|NCT00663455|kidney transplant recipients|kidney transplant recipients
692481|NCT00663455|children and adolescents with kidney transplants|children and adolescents with kidney transplants
692482|NCT00663442|ADHD|adhd
692483|NCT00663442|side effects|side effects
692484|NCT00663442|sleep|sleep
692485|NCT00663442|dopamine|dopamine
692486|NCT00663442|pharmacogenetics|pharmacogenetics
692487|NCT00663403|daptomycin|daptomycin
692488|NCT00663403|pharmacokinetics|pharmacokinetics
692489|NCT00663403|renal replacement therapy|renal replacement therapy
692490|NCT00663403|critical illness|critical illness
692491|NCT00663403|intensive care units|intensive care units
692492|NCT00663377|Heart Failure|heart failure
692493|NCT00663377|Insulin Resistance|insulin resistance
692494|NCT00663377|Losartan|losartan
692495|NCT00663377|ACE inhibitor|ace inhibitor
692496|NCT00663377|Inflammatory cytokine|inflammatory cytokine
692497|NCT00663364|dry skin|dry skin
692498|NCT00663351|Arthritis|arthritis
692499|NCT00663351|Osteoarthritis|osteoarthritis
692500|NCT00663351|Traumatic Arthritis|traumatic arthritis
692501|NCT00663351|Degenerative Joint Disease|degenerative joint disease
692502|NCT00663351|Avascular Necrosis|avascular necrosis
692503|NCT00663338|Stroke|stroke
692504|NCT00663338|Hemispatial neglect|hemispatial neglect
692505|NCT00663338|Unilateral neglect|unilateral neglect
692506|NCT00663338|Spatial neglect|spatial neglect
692507|NCT00663338|Motor|motor
692508|NCT00663338|Weakness|weakness
692509|NCT00663312|Idiopathic Parkinson's disease|idiopathic parkinson's disease
692510|NCT00663312|Deep Brain stimulation|deep brain stimulation
692511|NCT00663312|Hepatic glucose production|hepatic glucose production
692512|NCT00663312|Insulin|insulin
692513|NCT00663312|Weight gain|weight gain
692514|NCT00663312|Patient with an Idiopathic Parkinson's disease|patient with an idiopathic parkinson's disease
692515|NCT00663299|Intracranial aneurysm|intracranial aneurysm
692516|NCT00663247|Diverticular disease|diverticular disease
692517|NCT00663247|Inflammation|inflammation
692518|NCT00663247|Mesalazine|mesalazine
692519|NCT00663234|Treatment Experienced|treatment experienced
692520|NCT00663221|Osteoporosis prevention|osteoporosis prevention
692521|NCT00663195|heart failure|heart failure
692522|NCT00663195|fibrosis|fibrosis
692523|NCT00663195|MMP|mmp
692524|NCT00663195|spironolactone|spironolactone
692525|NCT00663195|furosemide|furosemide
692526|NCT00663182|Entecavir|entecavir
692527|NCT00663182|cirrhosis|cirrhosis
692528|NCT00663182|anti-viral|anti-viral
692529|NCT00663182|therapy|therapy
692530|NCT00663169|Arthritis Gouty|arthritis gouty
692531|NCT00663169|ACZ885|acz885
692532|NCT00663169|IL1B protein|il1b protein
692533|NCT00663169|Pain|pain
692534|NCT00663156|lipoaugmentation|lipoaugmentation
692535|NCT00663156|breast augmentation|breast augmentation
692536|NCT00663156|fat grafting|fat grafting
692537|NCT00663156|liposuction|liposuction
692538|NCT00663156|lipoinfiltration|lipoinfiltration
692539|NCT00663156|Spear|spear
692540|NCT00663156|breast implants|breast implants
692541|NCT00663156|ASERF|aserf
692542|NCT00663156|Lipivage|lipivage
692543|NCT00663156|Baker|baker
692544|NCT00663156|harvest|harvest
692545|NCT00663156|autologous|autologous
692546|NCT00663156|Georgetown|georgetown
692547|NCT00663143|investigate|investigate
692548|NCT00663143|TZD exposure|tzd exposure
692549|NCT00663143|in vitro|in vitro
692550|NCT00663143|alters|alters
692551|NCT00663143|bone|bone
692552|NCT00663143|formation|formation
692553|NCT00663143|differentiation|differentiation
692554|NCT00663143|capacity|capacity
692555|NCT00663143|bone marrow|bone marrow
692557|NCT00663130|Erectile Dysfunction|erectile dysfunction
692558|NCT00663130|Vardenafil|vardenafil
692559|NCT00663117|naltrexone|naltrexone
692560|NCT00663117|LDN|ldn
692561|NCT00663117|IBD|ibd
692562|NCT00663117|Inflammatory bowel disease|inflammatory bowel disease
692563|NCT00663104|early menopause|early menopause
692564|NCT00663104|exercise|exercise
692565|NCT00663104|phytoestrogen|phytoestrogen
692566|NCT00663104|bone|bone
692567|NCT00663104|CHD-risk factors|chd-risk factors
692568|NCT00663091|WPP-201|wpp-201
692569|NCT00663078|Cognitive Behavioral Therapy|cognitive behavioral therapy
692570|NCT00663078|expert patient programme|expert patient programme
692571|NCT00663078|deprived population|deprived population
692572|NCT00663078|women|women
692573|NCT00663065|Healthy subjects over 65|healthy subjects over 65
692574|NCT00663065|healthy subjects|healthy subjects
692575|NCT00663052|Enbrel|enbrel
692576|NCT00663052|Psoriasis|psoriasis
692577|NCT00663052|Topical Psoriasis|topical psoriasis
692578|NCT00663052|Wyeth Psoriasis|wyeth psoriasis
692579|NCT00663052|Active Psoriasis|active psoriasis
692580|NCT00663039|Schizophrenia|schizophrenia
692581|NCT00663039|Eye movements|eye movements
692582|NCT00663039|phenotype|phenotype
692583|NCT00663039|biochemical|biochemical
692584|NCT00663039|relatives|relatives
692585|NCT00663026|antibody|antibody
692586|NCT00663026|immunotherapy|immunotherapy
692587|NCT00663013|burn|burn
692588|NCT00663013|pain|pain
692589|NCT00663013|anxiety|anxiety
692590|NCT00663000|acromegaly|acromegaly
692591|NCT00663000|diabetes|diabetes
692592|NCT00663000|insulin resistance|insulin resistance
692593|NCT00663000|impaired glucose tolerance|impaired glucose tolerance
692594|NCT00662987|tonsillectomy|tonsillectomy
692595|NCT00662987|antibiotics|antibiotics
692596|NCT00662961|Plastic Surgery|plastic surgery
692597|NCT00662948|Folicular Lymphoma|folicular lymphoma
692598|NCT00662948|Consolidation|consolidation
692599|NCT00662948|Maintenance|maintenance
692600|NCT00662935|deep brain stimulation|deep brain stimulation
692601|NCT00662935|cluster headache|cluster headache
692602|NCT00662935|hypothalamus|hypothalamus
692603|NCT00662922|critical illness|critical illness
692604|NCT00662922|hypoglycemia|hypoglycemia
692605|NCT00662922|neurocognitive dysfunction|neurocognitive dysfunction
692606|NCT00662922|intensive insulin therapy|intensive insulin therapy
692607|NCT00662909|Frequency|frequency
692608|NCT00662909|YM178|ym178
692609|NCT00662909|Overactive bladder (OAB)|overactive bladder (oab)
692610|NCT00662909|Micturition|micturition
692611|NCT00662909|Urgency|urgency
692612|NCT00662909|Urinary urge incontinence|urinary urge incontinence
692613|NCT00662909|Urinary incontinence|urinary incontinence
692614|NCT00662883|ketamine|ketamine
692615|NCT00662883|corticosteroid|corticosteroid
692616|NCT00662883|intranasal|intranasal
692617|NCT00662883|phase I|phase i
692618|NCT00662883|Healthy volunteers|healthy volunteers
692619|NCT00662870|DAPTACEL|daptacel
692620|NCT00662870|Diphtheria|diphtheria
692621|NCT00662870|Tetanus|tetanus
692622|NCT00662870|Whooping Cough|whooping cough
692623|NCT00662870|Polio|polio
692624|NCT00662870|Haemophilus influenzae type b|haemophilus influenzae type b
692625|NCT00662870|Pertussis|pertussis
692626|NCT00662857|Diabetic adult male, diabetic adult female|diabetic adult male, diabetic adult female
692627|NCT00662844|Vitamin D insufficiency,vitamin D3 treatment,young women|vitamin d insufficiency,vitamin d3 treatment,young women
692628|NCT00662831|Diabetic Foot Ulcers Neuroischaemic|diabetic foot ulcers neuroischaemic
692629|NCT00662805|pharmacovigilance|pharmacovigilance
692630|NCT00662805|COPD|copd
692631|NCT00662779|asthma|asthma
692632|NCT00662779|exercise induced bronchospasm|exercise induced bronchospasm
692633|NCT00662779|prevention|prevention
692634|NCT00662779|EIB|eib
692635|NCT00662779|children|children
692636|NCT00662766|Black currant|black currant
692637|NCT00662766|Berry seed|berry seed
692638|NCT00662766|Press residue|press residue
692639|NCT00662766|Tocopherol|tocopherol
692640|NCT00662766|Fatty acids|fatty acids
692641|NCT00662766|Fiber|fiber
692642|NCT00662766|Total phenols|total phenols
692643|NCT00662766|TEAC|teac
692644|NCT00662766|Comet assay|comet assay
692645|NCT00662766|Dihydroxybenzoic acid|dihydroxybenzoic acid
692646|NCT00662753|hypertension|hypertension
692647|NCT00662753|home blood pressure monitoring|home blood pressure monitoring
692648|NCT00662753|nurse telephone follow up|nurse telephone follow up
692649|NCT00662753|medically underserved populations|medically underserved populations
692650|NCT00662727|Extracorporeal Shockwave Therapy|extracorporeal shockwave therapy
692651|NCT00662727|Myocardial Ischemia|myocardial ischemia
692652|NCT00662727|Refractory Angina|refractory angina
692653|NCT00662701|Atrial Fibrillation|atrial fibrillation
692654|NCT00662688|thromboembolism|thromboembolism
692655|NCT00662688|chemotherapeutic agent toxicity|chemotherapeutic agent toxicity
692656|NCT00662688|adenocarcinoma of the pancreas|adenocarcinoma of the pancreas
692657|NCT00662688|stage IV pancreatic cancer|stage iv pancreatic cancer
692658|NCT00662688|recurrent pancreatic cancer|recurrent pancreatic cancer
692659|NCT00662675|Exocrine pancreatic insufficiency|exocrine pancreatic insufficiency
692660|NCT00662675|Steatorrhea|steatorrhea
692661|NCT00662675|Malabsorption syndromes|malabsorption syndromes
692662|NCT00662675|Cystic fibrosis|cystic fibrosis
692663|NCT00662675|Pediatrics|pediatrics
692664|NCT00662675|Adult|adult
692665|NCT00662675|Pancrelipase|pancrelipase
692666|NCT00662662|Oropharyngeal Cancer|oropharyngeal cancer
692667|NCT00662662|Non-Oropharyngeal Cancer|non-oropharyngeal cancer
692668|NCT00662662|Head and Neck Cancer|head and neck cancer
692669|NCT00662662|Squamous Cell Carcinoma|squamous cell carcinoma
692670|NCT00662662|Squamous cell carcinoma of the head and neck|squamous cell carcinoma of the head and neck
692671|NCT00662662|SCCHN|scchn
692672|NCT00662662|HPV-16|hpv-16
692673|NCT00662662|Questionnaire|questionnaire
692674|NCT00662662|Sexual Behavior|sexual behavior
692675|NCT00662662|Survey|survey
692676|NCT00662649|Multiple sclerosis.|multiple sclerosis.
692677|NCT00662649|Relapse-remitting|relapse-remitting
692678|NCT00662649|Fingolimod|fingolimod
692679|NCT00662623|Chronic Obstructive Sleep Apnea|chronic obstructive sleep apnea
692680|NCT00662623|Sleep Apnea|sleep apnea
692681|NCT00662623|Sleep Apnea Treatment|sleep apnea treatment
692682|NCT00662597|Tumor vascular disrupting agent|tumor vascular disrupting agent
692683|NCT00662597|VDA|vda
692684|NCT00662597|ASA404|asa404
692685|NCT00662597|non-small cell lung cancer|non-small cell lung cancer
692686|NCT00662597|NSCLC|nsclc
692687|NCT00662584|repetitive magnetic transcranial stimulation (rTMS)|repetitive magnetic transcranial stimulation (rtms)
692688|NCT00662584|functional magnetic resonance imaging (fMRI)|functional magnetic resonance imaging (fmri)
692689|NCT00662571|nucleotide polymorphisms|nucleotide polymorphisms
692690|NCT00662571|disequilibrium haplotype|disequilibrium haplotype
692691|NCT00662571|acamprosate|acamprosate
692692|NCT00662571|differentiate|differentiate
692693|NCT00662571|pharmacogenomic|pharmacogenomic
692694|NCT00662571|effective individualized treatment|effective individualized treatment
692695|NCT00662571|alcohol dependent|alcohol dependent
692696|NCT00662571|N-methyl-D-aspartate receptor (NMDA)|n-methyl-d-aspartate receptor (nmda)
692697|NCT00662571|metabotropic glutamate receptor|metabotropic glutamate receptor
692698|NCT00662571|decreasing craving|decreasing craving
692699|NCT00662571|abstinence maintenance|abstinence maintenance
692700|NCT00662558|Chronic low back pain|chronic low back pain
692701|NCT00662545|HIV|hiv
692702|NCT00662545|Hepatitis B|hepatitis b
692703|NCT00662545|treatment experienced|treatment experienced
692704|NCT00662532|Peri-implantitis; antibiotic|peri-implantitis; antibiotic
692705|NCT00662493|knee pain|knee pain
692706|NCT00662493|exercise|exercise
692707|NCT00662493|rehabilitation|rehabilitation
692708|NCT00662480|population|population
692709|NCT00662480|screening|screening
692710|NCT00662480|abdominal aortic aneurysms|abdominal aortic aneurysms
692711|NCT00662480|peripheral arterial disease|peripheral arterial disease
692712|NCT00662480|hypertension|hypertension
692713|NCT00662480|Prevention|prevention
692714|NCT00662467|Myocardial Infarction|myocardial infarction
692715|NCT00662467|Hemorrhage|hemorrhage
692716|NCT00662467|Thromboembolism|thromboembolism
692717|NCT00662467|Clopidogrel|clopidogrel
692718|NCT00662467|Aspirin|aspirin
692719|NCT00662467|Warfarin|warfarin
692720|NCT00662454|contraceptive|contraceptive
692721|NCT00662454|efficacy|efficacy
692722|NCT00662454|body weight|body weight
692723|NCT00662441|Erectile Dysfunction|erectile dysfunction
692724|NCT00662441|Vardenafil|vardenafil
692725|NCT00662428|cost-benefit analysis|cost-benefit analysis
692726|NCT00662428|practice guideline|practice guideline
692727|NCT00662428|inpatients|inpatients
692728|NCT00662415|phantom limb pain|phantom limb pain
692729|NCT00662415|fMRI|fmri
692730|NCT00662415|mirror therapy|mirror therapy
692731|NCT00662402|K Grant|k grant
692732|NCT00662402|Career Advancement|career advancement
692733|NCT00662402|Award|award
692734|NCT00662402|Consultation|consultation
692735|NCT00662402|Application|application
692736|NCT00662402|K|k
692737|NCT00662402|The NIH priority score of the reviewed proposal.|the nih priority score of the reviewed proposal.
692738|NCT00662402|Percent of subjects who obtain funding for proposal.|percent of subjects who obtain funding for proposal.
692739|NCT00662402|Percent of subjects who submit proposals for funding.|percent of subjects who submit proposals for funding.
692740|NCT00662389|skin laxity, wrinkles, rhytids|skin laxity, wrinkles, rhytids
692741|NCT00662363|constipation|constipation
692742|NCT00662363|opioid|opioid
692743|NCT00662363|rehabilitation|rehabilitation
692744|NCT00662363|post-operative|post-operative
692745|NCT00662363|orthopedic|orthopedic
692746|NCT00662350|BPH|bph
692747|NCT00662337|Bioequivalence, diphenhydramine hydrochloride|bioequivalence, diphenhydramine hydrochloride
692748|NCT00662298|severe asthma|severe asthma
692749|NCT00662298|prednisolone pharmacokinetics|prednisolone pharmacokinetics
692750|NCT00662298|anti-inflammatory effects|anti-inflammatory effects
692751|NCT00662285|iron status|iron status
692752|NCT00662285|blood donors|blood donors
692753|NCT00662272|Flu|flu
692754|NCT00662272|Influenza vaccine|influenza vaccine
692755|NCT00662272|Adjuvant|adjuvant
692756|NCT00662272|Safety of an adjuvanted vaccine|safety of an adjuvanted vaccine
692757|NCT00662272|Immune response to an adjuvanted vaccine|immune response to an adjuvanted vaccine
692758|NCT00662259|Anxiety disorders|anxiety disorders
692759|NCT00662259|Generalized anxiety|generalized anxiety
692760|NCT00662233|alveolar childhood rhabdomyosarcoma|alveolar childhood rhabdomyosarcoma
692761|NCT00662233|previously treated childhood rhabdomyosarcoma|previously treated childhood rhabdomyosarcoma
692762|NCT00662233|previously untreated childhood rhabdomyosarcoma|previously untreated childhood rhabdomyosarcoma
692763|NCT00662233|recurrent childhood rhabdomyosarcoma|recurrent childhood rhabdomyosarcoma
692764|NCT00662233|nonmetastatic childhood soft tissue sarcoma|nonmetastatic childhood soft tissue sarcoma
692765|NCT00662233|recurrent childhood soft tissue sarcoma|recurrent childhood soft tissue sarcoma
692766|NCT00662233|childhood desmoplastic small round cell tumor|childhood desmoplastic small round cell tumor
692767|NCT00662233|ovarian sarcoma|ovarian sarcoma
692768|NCT00662233|stage II uterine sarcoma|stage ii uterine sarcoma
692769|NCT00662233|stage III uterine sarcoma|stage iii uterine sarcoma
692770|NCT00662233|embryonal childhood rhabdomyosarcoma|embryonal childhood rhabdomyosarcoma
692771|NCT00662220|chronic|chronic
692772|NCT00662220|hepatitis C|hepatitis c
692773|NCT00662220|ribavirin|ribavirin
692774|NCT00662220|SVR|svr
692775|NCT00662220|genotype one|genotype one
692776|NCT00662220|genotype four|genotype four
692777|NCT00662207|electric stimulation|electric stimulation
692778|NCT00662207|urethral obstruction|urethral obstruction
692779|NCT00662207|urodynamics|urodynamics
692780|NCT00662207|urology|urology
692781|NCT00662194|HIV|hiv
692782|NCT00662194|HBV|hbv
692783|NCT00662194|HCV|hcv
692784|NCT00662194|co-infection|co-infection
692785|NCT00662194|innate immunity|innate immunity
692786|NCT00662181|growth hormone|growth hormone
692787|NCT00662181|quality of life|quality of life
692788|NCT00662181|fat redistribution|fat redistribution
692789|NCT00662181|sugar metabolism|sugar metabolism
692790|NCT00662181|fat metabolism|fat metabolism
692791|NCT00662181|cytokines|cytokines
692792|NCT00662168|carcinoid|carcinoid
692793|NCT00662168|familial|familial
692794|NCT00662168|Collect and describe information about the medical and environmental factors associated with each cases of carcinoid carcinoma|collect and describe information about the medical and environmental factors associated with each cases of carcinoid carcinoma
692795|NCT00662168|Develop a genogram representing the family cancer history of cases of Carcinoid.|develop a genogram representing the family cancer history of cases of carcinoid.
692796|NCT00662155|Primary Insomnia|primary insomnia
692797|NCT00662155|Cognitive Behavioral Therapy|cognitive behavioral therapy
692798|NCT00662155|Insomnia|insomnia
692799|NCT00662155|Sleep|sleep
692800|NCT00662155|Zolpidem|zolpidem
692801|NCT00662155|Ambien|ambien
692802|NCT00662155|CBT|cbt
692803|NCT00662155|CBT-I|cbt-i
692804|NCT00662142|DHA|dha
692805|NCT00662142|fMRI|fmri
692806|NCT00662129|stage IV breast cancer|stage iv breast cancer
692807|NCT00662129|male breast cancer|male breast cancer
692808|NCT00662129|recurrent breast cancer|recurrent breast cancer
692809|NCT00662116|diastolic heart failure|diastolic heart failure
692810|NCT00662103|fatigue|fatigue
692811|NCT00662103|long-term effects secondary to cancer therapy in adults|long-term effects secondary to cancer therapy in adults
692812|NCT00662103|psychosocial effects of cancer and its treatment|psychosocial effects of cancer and its treatment
692813|NCT00662103|cancer survivor|cancer survivor
692814|NCT00662103|stage IA breast cancer|stage ia breast cancer
692815|NCT00662103|stage IB breast cancer|stage ib breast cancer
692816|NCT00662103|stage II breast cancer|stage ii breast cancer
692817|NCT00662103|stage IIIA breast cancer|stage iiia breast cancer
692818|NCT00662103|stage IIIB breast cancer|stage iiib breast cancer
692819|NCT00662103|stage IIIC breast cancer|stage iiic breast cancer
692820|NCT00662103|breast cancer in situ|breast cancer in situ
692821|NCT00662090|MDS|mds
692822|NCT00662090|JMML|jmml
692823|NCT00662090|EWOG-MDS|ewog-mds
692824|NCT00662090|Myelodysplastic Syndromes (MDS)|myelodysplastic syndromes (mds)
692825|NCT00662090|Juvenile Myelomonocytic Leukemia (JMML)|juvenile myelomonocytic leukemia (jmml)
692826|NCT00662077|osteoporosis|osteoporosis
692827|NCT00662077|bifosfonates|bifosfonates
692828|NCT00662077|ibandronate|ibandronate
692829|NCT00662064|Lower urinary tract|lower urinary tract
692830|NCT00662064|Physiology|physiology
692831|NCT00662064|Pathology|pathology
692832|NCT00662064|Immunohistochemistry|immunohistochemistry
692833|NCT00662064|Urinary bladder|urinary bladder
692834|NCT00662051|Asthma|asthma
692835|NCT00662051|Exhaled Nitric Oxide|exhaled nitric oxide
692836|NCT00662051|Asthma Control Test|asthma control test
692837|NCT00662038|idiopathic|idiopathic
692838|NCT00662038|pulmonary|pulmonary
692839|NCT00662038|fibrosis|fibrosis
692840|NCT00662012|Leishmaniasis|leishmaniasis
692841|NCT00662012|Sodium stibogluconate|sodium stibogluconate
692842|NCT00662012|Pentostam|pentostam
692843|NCT00662012|sand fly|sand fly
692844|NCT00661999|unspecified adult solid tumor, protocol specific|unspecified adult solid tumor, protocol specific
692845|NCT00661999|monoclonal gammopathy of undetermined significance|monoclonal gammopathy of undetermined significance
692846|NCT00661999|extramedullary plasmacytoma|extramedullary plasmacytoma
692847|NCT00661999|isolated plasmacytoma of bone|isolated plasmacytoma of bone
692848|NCT00661999|refractory multiple myeloma|refractory multiple myeloma
692849|NCT00661999|stage I multiple myeloma|stage i multiple myeloma
692850|NCT00661999|stage II multiple myeloma|stage ii multiple myeloma
692851|NCT00661999|stage III multiple myeloma|stage iii multiple myeloma
692852|NCT00661999|primary systemic amyloidosis|primary systemic amyloidosis
692853|NCT00661999|Waldenstrom macroglobulinemia|waldenstrom macroglobulinemia
692854|NCT00661999|post-transplant lymphoproliferative disorder|post-transplant lymphoproliferative disorder
692855|NCT00661999|stage I adult T-cell leukemia/lymphoma|stage i adult t-cell leukemia/lymphoma
692856|NCT00661999|stage II adult T-cell leukemia/lymphoma|stage ii adult t-cell leukemia/lymphoma
692857|NCT00661999|stage III adult T-cell leukemia/lymphoma|stage iii adult t-cell leukemia/lymphoma
692858|NCT00661999|stage IV adult T-cell leukemia/lymphoma|stage iv adult t-cell leukemia/lymphoma
692859|NCT00661999|recurrent adult T-cell leukemia/lymphoma|recurrent adult t-cell leukemia/lymphoma
692860|NCT00661999|angioimmunoblastic T-cell lymphoma|angioimmunoblastic t-cell lymphoma
692861|NCT00661999|anaplastic large cell lymphoma|anaplastic large cell lymphoma
692862|NCT00661999|stage I cutaneous T-cell non-Hodgkin lymphoma|stage i cutaneous t-cell non-hodgkin lymphoma
692863|NCT00661999|stage II cutaneous T-cell non-Hodgkin lymphoma|stage ii cutaneous t-cell non-hodgkin lymphoma
692864|NCT00661999|stage III cutaneous T-cell non-Hodgkin lymphoma|stage iii cutaneous t-cell non-hodgkin lymphoma
692865|NCT00661999|stage IV cutaneous T-cell non-Hodgkin lymphoma|stage iv cutaneous t-cell non-hodgkin lymphoma
692866|NCT00661999|recurrent cutaneous T-cell non-Hodgkin lymphoma|recurrent cutaneous t-cell non-hodgkin lymphoma
692867|NCT00661999|stage I mycosis fungoides/Sezary syndrome|stage i mycosis fungoides/sezary syndrome
692868|NCT00661999|stage II mycosis fungoides/Sezary syndrome|stage ii mycosis fungoides/sezary syndrome
692869|NCT00661999|stage III mycosis fungoides/Sezary syndrome|stage iii mycosis fungoides/sezary syndrome
692870|NCT00661999|stage IV mycosis fungoides/Sezary syndrome|stage iv mycosis fungoides/sezary syndrome
692871|NCT00661999|recurrent mycosis fungoides/Sezary syndrome|recurrent mycosis fungoides/sezary syndrome
692872|NCT00661999|stage I adult Hodgkin lymphoma|stage i adult hodgkin lymphoma
692873|NCT00661999|stage II adult Hodgkin lymphoma|stage ii adult hodgkin lymphoma
692874|NCT00661999|stage III adult Hodgkin lymphoma|stage iii adult hodgkin lymphoma
692875|NCT00661999|stage IV adult Hodgkin lymphoma|stage iv adult hodgkin lymphoma
692876|NCT00661999|recurrent adult Hodgkin lymphoma|recurrent adult hodgkin lymphoma
692877|NCT00661999|recurrent adult grade III lymphomatoid granulomatosis|recurrent adult grade iii lymphomatoid granulomatosis
692878|NCT00661999|stage I adult Burkitt lymphoma|stage i adult burkitt lymphoma
692879|NCT00661999|stage III adult Burkitt lymphoma|stage iii adult burkitt lymphoma
692880|NCT00661999|stage IV adult Burkitt lymphoma|stage iv adult burkitt lymphoma
692881|NCT00661999|noncontiguous stage II adult Burkitt lymphoma|noncontiguous stage ii adult burkitt lymphoma
692882|NCT00661999|noncontiguous stage II adult diffuse large cell lymphoma|noncontiguous stage ii adult diffuse large cell lymphoma
692883|NCT00661999|noncontiguous stage II adult diffuse mixed cell lymphoma|noncontiguous stage ii adult diffuse mixed cell lymphoma
692884|NCT00661999|noncontiguous stage II adult diffuse small cleaved cell lymphoma|noncontiguous stage ii adult diffuse small cleaved cell lymphoma
692885|NCT00661999|noncontiguous stage II adult immunoblastic large cell lymphoma|noncontiguous stage ii adult immunoblastic large cell lymphoma
692886|NCT00661999|noncontiguous stage II adult lymphoblastic lymphoma|noncontiguous stage ii adult lymphoblastic lymphoma
692887|NCT00661999|noncontiguous stage II grade 1 follicular lymphoma|noncontiguous stage ii grade 1 follicular lymphoma
693230|NCT00660738|dyspnea|dyspnea
692888|NCT00661999|noncontiguous stage II grade 2 follicular lymphoma|noncontiguous stage ii grade 2 follicular lymphoma
692889|NCT00661999|noncontiguous stage II grade 3 follicular lymphoma|noncontiguous stage ii grade 3 follicular lymphoma
692890|NCT00661999|noncontiguous stage II mantle cell lymphoma|noncontiguous stage ii mantle cell lymphoma
692891|NCT00661999|noncontiguous stage II marginal zone lymphoma|noncontiguous stage ii marginal zone lymphoma
692892|NCT00661999|noncontiguous stage II small lymphocytic lymphoma|noncontiguous stage ii small lymphocytic lymphoma
692893|NCT00661999|contiguous stage II adult Burkitt lymphoma|contiguous stage ii adult burkitt lymphoma
692894|NCT00661999|contiguous stage II adult diffuse large cell lymphoma|contiguous stage ii adult diffuse large cell lymphoma
692895|NCT00661999|contiguous stage II adult diffuse mixed cell lymphoma|contiguous stage ii adult diffuse mixed cell lymphoma
692896|NCT00661999|contiguous stage II adult diffuse small cleaved cell lymphoma|contiguous stage ii adult diffuse small cleaved cell lymphoma
692897|NCT00661999|contiguous stage II adult immunoblastic large cell lymphoma|contiguous stage ii adult immunoblastic large cell lymphoma
692898|NCT00661999|contiguous stage II adult lymphoblastic lymphoma|contiguous stage ii adult lymphoblastic lymphoma
692899|NCT00661999|contiguous stage II grade 1 follicular lymphoma|contiguous stage ii grade 1 follicular lymphoma
692900|NCT00661999|contiguous stage II grade 2 follicular lymphoma|contiguous stage ii grade 2 follicular lymphoma
692901|NCT00661999|contiguous stage II grade 3 follicular lymphoma|contiguous stage ii grade 3 follicular lymphoma
692902|NCT00661999|contiguous stage II mantle cell lymphoma|contiguous stage ii mantle cell lymphoma
692903|NCT00661999|contiguous stage II marginal zone lymphoma|contiguous stage ii marginal zone lymphoma
692904|NCT00661999|contiguous stage II small lymphocytic lymphoma|contiguous stage ii small lymphocytic lymphoma
692905|NCT00661999|stage I adult diffuse large cell lymphoma|stage i adult diffuse large cell lymphoma
692906|NCT00661999|stage I adult diffuse mixed cell lymphoma|stage i adult diffuse mixed cell lymphoma
692907|NCT00661999|stage I adult diffuse small cleaved cell lymphoma|stage i adult diffuse small cleaved cell lymphoma
692908|NCT00661999|stage III adult diffuse large cell lymphoma|stage iii adult diffuse large cell lymphoma
692909|NCT00661999|stage III adult diffuse mixed cell lymphoma|stage iii adult diffuse mixed cell lymphoma
692910|NCT00661999|stage III adult diffuse small cleaved cell lymphoma|stage iii adult diffuse small cleaved cell lymphoma
692911|NCT00661999|stage IV adult diffuse large cell lymphoma|stage iv adult diffuse large cell lymphoma
692912|NCT00661999|stage IV adult diffuse mixed cell lymphoma|stage iv adult diffuse mixed cell lymphoma
692913|NCT00661999|stage IV adult diffuse small cleaved cell lymphoma|stage iv adult diffuse small cleaved cell lymphoma
692914|NCT00661999|stage I adult immunoblastic large cell lymphoma|stage i adult immunoblastic large cell lymphoma
692915|NCT00661999|stage III adult immunoblastic large cell lymphoma|stage iii adult immunoblastic large cell lymphoma
692916|NCT00661999|stage IV adult immunoblastic large cell lymphoma|stage iv adult immunoblastic large cell lymphoma
692917|NCT00661999|stage I adult lymphoblastic lymphoma|stage i adult lymphoblastic lymphoma
692918|NCT00661999|stage III adult lymphoblastic lymphoma|stage iii adult lymphoblastic lymphoma
692919|NCT00661999|stage IV adult lymphoblastic lymphoma|stage iv adult lymphoblastic lymphoma
692920|NCT00661999|stage I grade 1 follicular lymphoma|stage i grade 1 follicular lymphoma
692921|NCT00661999|stage I grade 2 follicular lymphoma|stage i grade 2 follicular lymphoma
692922|NCT00661999|stage I grade 3 follicular lymphoma|stage i grade 3 follicular lymphoma
692923|NCT00661999|stage III grade 1 follicular lymphoma|stage iii grade 1 follicular lymphoma
692924|NCT00661999|stage III grade 2 follicular lymphoma|stage iii grade 2 follicular lymphoma
692925|NCT00661999|stage III grade 3 follicular lymphoma|stage iii grade 3 follicular lymphoma
692926|NCT00661999|stage IV grade 1 follicular lymphoma|stage iv grade 1 follicular lymphoma
692927|NCT00661999|stage IV grade 2 follicular lymphoma|stage iv grade 2 follicular lymphoma
692928|NCT00661999|stage IV grade 3 follicular lymphoma|stage iv grade 3 follicular lymphoma
692929|NCT00661999|stage I mantle cell lymphoma|stage i mantle cell lymphoma
692930|NCT00661999|stage I marginal zone lymphoma|stage i marginal zone lymphoma
692931|NCT00661999|stage III mantle cell lymphoma|stage iii mantle cell lymphoma
692932|NCT00661999|stage III marginal zone lymphoma|stage iii marginal zone lymphoma
692933|NCT00661999|stage IV mantle cell lymphoma|stage iv mantle cell lymphoma
692934|NCT00661999|stage IV marginal zone lymphoma|stage iv marginal zone lymphoma
692935|NCT00661999|stage I small lymphocytic lymphoma|stage i small lymphocytic lymphoma
692936|NCT00661999|stage III small lymphocytic lymphoma|stage iii small lymphocytic lymphoma
692937|NCT00661999|stage IV small lymphocytic lymphoma|stage iv small lymphocytic lymphoma
692938|NCT00661999|extranodal marginal zone B-cell lymphoma of mucosa-associated lymphoid tissue|extranodal marginal zone b-cell lymphoma of mucosa-associated lymphoid tissue
692939|NCT00661999|nodal marginal zone B-cell lymphoma|nodal marginal zone b-cell lymphoma
692940|NCT00661999|splenic marginal zone lymphoma|splenic marginal zone lymphoma
692941|NCT00661999|recurrent adult Burkitt lymphoma|recurrent adult burkitt lymphoma
692942|NCT00661999|recurrent adult diffuse large cell lymphoma|recurrent adult diffuse large cell lymphoma
692943|NCT00661999|recurrent adult diffuse mixed cell lymphoma|recurrent adult diffuse mixed cell lymphoma
692944|NCT00661999|recurrent adult diffuse small cleaved cell lymphoma|recurrent adult diffuse small cleaved cell lymphoma
692945|NCT00661999|recurrent adult immunoblastic large cell lymphoma|recurrent adult immunoblastic large cell lymphoma
692946|NCT00661999|recurrent adult lymphoblastic lymphoma|recurrent adult lymphoblastic lymphoma
710607|NCT00588627|Post nasal drip|post nasal drip
692947|NCT00661999|recurrent grade 1 follicular lymphoma|recurrent grade 1 follicular lymphoma
692948|NCT00661999|recurrent grade 2 follicular lymphoma|recurrent grade 2 follicular lymphoma
694474|NCT00655590|Motility|motility
692949|NCT00661999|recurrent grade 3 follicular lymphoma|recurrent grade 3 follicular lymphoma
692950|NCT00661999|recurrent mantle cell lymphoma|recurrent mantle cell lymphoma
692951|NCT00661999|recurrent marginal zone lymphoma|recurrent marginal zone lymphoma
692952|NCT00661999|recurrent small lymphocytic lymphoma|recurrent small lymphocytic lymphoma
692953|NCT00661999|adult acute lymphoblastic leukemia in remission|adult acute lymphoblastic leukemia in remission
692954|NCT00661999|recurrent adult acute lymphoblastic leukemia|recurrent adult acute lymphoblastic leukemia
692955|NCT00661999|untreated adult acute lymphoblastic leukemia|untreated adult acute lymphoblastic leukemia
692956|NCT00661999|stage I chronic lymphocytic leukemia|stage i chronic lymphocytic leukemia
692957|NCT00661999|stage II chronic lymphocytic leukemia|stage ii chronic lymphocytic leukemia
692958|NCT00661999|stage III chronic lymphocytic leukemia|stage iii chronic lymphocytic leukemia
692959|NCT00661999|stage IV chronic lymphocytic leukemia|stage iv chronic lymphocytic leukemia
692960|NCT00661999|refractory chronic lymphocytic leukemia|refractory chronic lymphocytic leukemia
692961|NCT00661999|refractory hairy cell leukemia|refractory hairy cell leukemia
692962|NCT00661999|progressive hairy cell leukemia, initial treatment|progressive hairy cell leukemia, initial treatment
692963|NCT00661999|prolymphocytic leukemia|prolymphocytic leukemia
692964|NCT00661999|anemia|anemia
692965|NCT00661999|T-cell large granular lymphocyte leukemia|t-cell large granular lymphocyte leukemia
692966|NCT00661999|acute undifferentiated leukemia|acute undifferentiated leukemia
692967|NCT00661999|mast cell leukemia|mast cell leukemia
692968|NCT00661999|adult nasal type extranodal NK/T-cell lymphoma|adult nasal type extranodal nk/t-cell lymphoma
692969|NCT00661999|untreated hairy cell leukemia|untreated hairy cell leukemia
692970|NCT00661973|asthma|asthma
692971|NCT00661973|airway smooth muscle|airway smooth muscle
692972|NCT00661973|inhaled corticosteroids|inhaled corticosteroids
692973|NCT00661960|HIV Positive|hiv positive
692974|NCT00661960|AIDS|aids
692975|NCT00661960|Antiretroviral Therapy|antiretroviral therapy
692976|NCT00661960|Gastrointestinal-Associated Lymphoid Tissue|gastrointestinal-associated lymphoid tissue
692977|NCT00661960|Immune Reconstitution|immune reconstitution
692978|NCT00661960|treatment experienced|treatment experienced
692979|NCT00661947|fructose|fructose
692980|NCT00661947|sucrose|sucrose
692981|NCT00661947|high fructose corn syrup|high fructose corn syrup
692982|NCT00661947|serum uric acid|serum uric acid
692983|NCT00661947|lactate|lactate
692984|NCT00661947|glucose|glucose
692985|NCT00661947|triglycerides|triglycerides
692986|NCT00661947|Bioavailability of fructose from two formulations|bioavailability of fructose from two formulations
692987|NCT00661934|Subject undergoing Dialysis and Subject suffering from Cardiac Malfunction|subject undergoing dialysis and subject suffering from cardiac malfunction
692988|NCT00661921|Type 2 Diabetes Mellitus|type 2 diabetes mellitus
692989|NCT00661921|AMG 108|amg 108
692990|NCT00661921|HbA1C|hba1c
692991|NCT00661921|glucose|glucose
692992|NCT00661921|metformin|metformin
692993|NCT00661921|sulfonylurea|sulfonylurea
692994|NCT00661921|IL-1 Inhibitor|il-1 inhibitor
692995|NCT00661921|biologic|biologic
692996|NCT00661921|subcutaneous injection|subcutaneous injection
692997|NCT00661895|African American|african american
692998|NCT00661882|adenocarcinoma of the pancreas|adenocarcinoma of the pancreas
692999|NCT00661882|recurrent pancreatic cancer|recurrent pancreatic cancer
693000|NCT00661882|stage I pancreatic cancer|stage i pancreatic cancer
693001|NCT00661882|stage II pancreatic cancer|stage ii pancreatic cancer
693002|NCT00661882|stage III pancreatic cancer|stage iii pancreatic cancer
693003|NCT00661856|Soy Isoflavones, Bone Mineral Density, Post menopausal women|soy isoflavones, bone mineral density, post menopausal women
693004|NCT00661843|insomnia|insomnia
693005|NCT00661843|geriatric|geriatric
693006|NCT00661843|yoga|yoga
693007|NCT00661843|sleep|sleep
693008|NCT00661843|electrocardiogram|electrocardiogram
693009|NCT00661830|advanced|advanced
693010|NCT00661830|metastatic|metastatic
693012|NCT00661830|tract|tract
693013|NCT00661817|Exercise|exercise
693014|NCT00661817|Physical Fitness|physical fitness
693015|NCT00661817|Patient Compliance|patient compliance
693016|NCT00661817|Health Behavior|health behavior
693017|NCT00661791|preterm infants|preterm infants
693018|NCT00661791|massage|massage
693019|NCT00661791|physical activity|physical activity
693020|NCT00661791|weight gain|weight gain
693021|NCT00661791|length of hospital stay|length of hospital stay
693022|NCT00661791|NICU|nicu
693023|NCT00661765|varenicline bioavailability transdermal smoking cessation|varenicline bioavailability transdermal smoking cessation
693024|NCT00661739|palliative|palliative
693025|NCT00661739|Breast cancer|breast cancer
693026|NCT00661739|metastatic|metastatic
693027|NCT00661739|Bendamustine|bendamustine
693028|NCT00661739|phase I|phase i
693029|NCT00661726|Thalassemia Intermedia|thalassemia intermedia
693030|NCT00661713|Meningococcal disease|meningococcal disease
693031|NCT00661713|Neisseria meningitidis serogroup B|neisseria meningitidis serogroup b
693032|NCT00661713|prevention|prevention
693033|NCT00661713|vaccination|vaccination
693034|NCT00661713|adolescents|adolescents
693035|NCT00661700|Erectile Dysfunction|erectile dysfunction
693036|NCT00661700|Quality of Life|quality of life
693037|NCT00661674|Palonosetron|palonosetron
693038|NCT00661674|Hydroxyzine|hydroxyzine
693039|NCT00661674|Acute opioid withdrawal|acute opioid withdrawal
693040|NCT00661661|Long term open label study in Japan|long term open label study in japan
693041|NCT00661661|CP-690|cp-690
693042|NCT00661661|550|550
693043|NCT00661661|tofacitinib|tofacitinib
693044|NCT00661648|surgery|surgery
693045|NCT00661635|Laparoscopic Cholecystectomy Surgery, Acute Pain, Perioperative Pain|laparoscopic cholecystectomy surgery, acute pain, perioperative pain
693046|NCT00661609|Anti-mitotic|anti-mitotic
693047|NCT00661609|Eg5 Inhibitor|eg5 inhibitor
693048|NCT00661609|Kinesin Spindle Protein Inhibitor|kinesin spindle protein inhibitor
693049|NCT00661609|Urothelial Cancer|urothelial cancer
693050|NCT00661609|Bladder Cancer|bladder cancer
693051|NCT00661609|Renal Pelvis Cancer|renal pelvis cancer
693052|NCT00661609|Urethra Cancer|urethra cancer
693053|NCT00661609|Ureter Cancer|ureter cancer
693054|NCT00661609|Recurrent|recurrent
693055|NCT00661609|Advanced|advanced
693056|NCT00661609|Stage IV|stage iv
693057|NCT00661596|Erectile Dysfunction|erectile dysfunction
693058|NCT00661596|Vardenafil|vardenafil
693059|NCT00661583|trabeculectomy|trabeculectomy
693060|NCT00661583|glaucoma|glaucoma
693061|NCT00661583|ranibizumab|ranibizumab
693062|NCT00661570|laryngectomy|laryngectomy
693063|NCT00661570|larynx cancer|larynx cancer
693064|NCT00661557|Booster vaccination|booster vaccination
693065|NCT00661557|Meningococcal vaccine|meningococcal vaccine
693066|NCT00661557|Meningococcal disease|meningococcal disease
693067|NCT00661557|Safety|safety
693068|NCT00661557|immunogenicity|immunogenicity
693069|NCT00661544|Multiple Myeloma|multiple myeloma
693070|NCT00661544|Ascorbic Acid|ascorbic acid
693071|NCT00661544|Vitamin C|vitamin c
693072|NCT00661544|Arsenic Trioxide|arsenic trioxide
693073|NCT00661544|Trisenox|trisenox
693074|NCT00661544|Melphalan|melphalan
693075|NCT00661544|Autologous Stem Cell Transplant|autologous stem cell transplant
693076|NCT00661544|Stem Cell Transplantation|stem cell transplantation
693077|NCT00661531|Breast cancer|breast cancer
693078|NCT00661531|Metastatic breast cancer|metastatic breast cancer
693079|NCT00661531|ER positive breast cancer|er positive breast cancer
693080|NCT00661531|Hormonal therapy|hormonal therapy
693081|NCT00661492|Androgen-independent prostate cancer(AIPC)|androgen-independent prostate cancer(aipc)
693082|NCT00661466|Gastrointestinal surgery|gastrointestinal surgery
693083|NCT00661466|Post operative pain|post operative pain
693084|NCT00661453|Spinal Muscular Atrophy|spinal muscular atrophy
693085|NCT00661453|SMA|sma
693086|NCT00661453|Valproic Acid|valproic acid
693087|NCT00661427|Head and Neck cancer|head and neck cancer
693088|NCT00661427|Cetuximab|cetuximab
693089|NCT00661414|Cancer|cancer
693090|NCT00661414|Solid tumors|solid tumors
693091|NCT00661401|gammaglobulin|gammaglobulin
693092|NCT00661401|subcutaneous infusion|subcutaneous infusion
693093|NCT00661401|specific antibodies|specific antibodies
693094|NCT00661401|primary antibody deficiency|primary antibody deficiency
693095|NCT00661375|BAY 43-9006|bay 43-9006
693096|NCT00661375|Phase II|phase ii
693097|NCT00661375|Renal cell carcinoma|renal cell carcinoma
693098|NCT00661375|Response rate|response rate
693099|NCT00661362|DPP-4 inhibitors|dpp-4 inhibitors
693100|NCT00661362|HbA1c|hba1c
693101|NCT00661362|Incretins|incretins
693102|NCT00661349|Kaletra|kaletra
693103|NCT00661349|Nevirapina|nevirapina
693104|NCT00661349|HCV chronic infection|hcv chronic infection
693105|NCT00661349|Fibroscan|fibroscan
693106|NCT00661349|hepatic fibrosis|hepatic fibrosis
693107|NCT00661349|treatment experienced|treatment experienced
693108|NCT00661336|stage III melanoma|stage iii melanoma
693109|NCT00661336|recurrent melanoma|recurrent melanoma
693110|NCT00661310|re-admissions|re-admissions
693111|NCT00661310|medicines|medicines
693112|NCT00661310|management|management
693113|NCT00661310|patients|patients
693114|NCT00661310|80 years and older|80 years and older
693115|NCT00661310|acute|acute
693116|NCT00661310|admissions|admissions
693117|NCT00661310|hospital|hospital
693118|NCT00661297|Erectile Dysfunction|erectile dysfunction
693119|NCT00661297|Vardenafil|vardenafil
693120|NCT00661271|mindfulness|mindfulness
693121|NCT00661271|meditation|meditation
693122|NCT00661271|urban youth|urban youth
693123|NCT00661271|stress reduction|stress reduction
693124|NCT00661271|adolescent|adolescent
693125|NCT00661271|Stress reduction for urban youth|stress reduction for urban youth
693126|NCT00661258|HIV antiretroviral treatment adherence intervention China|hiv antiretroviral treatment adherence intervention china
693127|NCT00661258|adherence to antiretroviral treatment|adherence to antiretroviral treatment
693128|NCT00661258|treatment experienced|treatment experienced
693129|NCT00661232|Myocardial Viability|myocardial viability
693130|NCT00661232|Delayed Enhancement Magnetic Resonance Imaging|delayed enhancement magnetic resonance imaging
693131|NCT00661232|Functional Recovery|functional recovery
693132|NCT00661206|Clopidogrel|clopidogrel
693133|NCT00661206|Drug-eluting stent|drug-eluting stent
693134|NCT00661193|recurrent non-small cell lung cancer|recurrent non-small cell lung cancer
693135|NCT00661193|stage IIIB non-small cell lung cancer|stage iiib non-small cell lung cancer
693229|NCT00660738|quality of life|quality of life
693136|NCT00661193|stage IV non-small cell lung cancer|stage iv non-small cell lung cancer
693137|NCT00661193|adenocarcinoma of the lung|adenocarcinoma of the lung
693138|NCT00661193|large cell lung cancer|large cell lung cancer
693139|NCT00661193|squamous cell lung cancer|squamous cell lung cancer
693140|NCT00661141|acetaldehyde|acetaldehyde
693141|NCT00661141|ethanol|ethanol
693142|NCT00661141|ALDH2|aldh2
693143|NCT00661128|Sudden Cardiac Arrest|sudden cardiac arrest
693144|NCT00661115|Erectile dysfunction|erectile dysfunction
693145|NCT00661115|Sexual Dysfunction|sexual dysfunction
693146|NCT00661089|stroke|stroke
693147|NCT00661089|shoulder pain|shoulder pain
693148|NCT00661089|spasticity|spasticity
693149|NCT00661063|neuropathic pain|neuropathic pain
693150|NCT00661063|ketamine|ketamine
693151|NCT00661063|clonidine|clonidine
693152|NCT00661063|association|association
693153|NCT00661024|thyroid surgery|thyroid surgery
693154|NCT00661024|recurrent laryngeal nerves visualization|recurrent laryngeal nerves visualization
693155|NCT00661024|intraoperative neuromonitoring|intraoperative neuromonitoring
693156|NCT00661024|predictive values|predictive values
693157|NCT00661011|Non-small cell lung carcinoma|non-small cell lung carcinoma
693158|NCT00661011|Concomitant radiochemotherapy|concomitant radiochemotherapy
693159|NCT00661011|Cisplatin|cisplatin
693160|NCT00661011|Vinorelbine|vinorelbine
693161|NCT00661011|Radiotherapy|radiotherapy
693162|NCT00661011|Chemotherapy|chemotherapy
693163|NCT00661011|Unresectable stage III non-small cell lung carcinoma|unresectable stage iii non-small cell lung carcinoma
693164|NCT00661011|Surgery|surgery
693165|NCT00661011|Unresectable stage III non-small cell lung carcinoma not suitable for radical radiotherapy after objective response to induction chemotherapy|unresectable stage iii non-small cell lung carcinoma not suitable for radical radiotherapy after objective response to induction chemotherapy
693166|NCT00660998|Erectile dysfunction|erectile dysfunction
693167|NCT00660998|Diabetes mellitus type 1|diabetes mellitus type 1
693168|NCT00660998|Vardenafil|vardenafil
693169|NCT00660985|Acne vulgaris|acne vulgaris
693170|NCT00660985|Differin|differin
693171|NCT00660985|Adapalene|adapalene
693172|NCT00660972|HIV Integrase Inhibitors|hiv integrase inhibitors
693173|NCT00660972|HIV Nucleoside Reverse Transcriptase Inhibitors|hiv nucleoside reverse transcriptase inhibitors
693174|NCT00660972|Treatment Naive|treatment naive
693175|NCT00660972|Viral Load|viral load
693176|NCT00660959|Euvolemic|euvolemic
693177|NCT00660959|Hyponatremia|hyponatremia
693178|NCT00660959|Serum Sodium|serum sodium
693179|NCT00660959|Fluid Overload|fluid overload
693180|NCT00660959|Vasopressin Antagonist|vasopressin antagonist
693181|NCT00660946|anticoagulation in dialysis patients|anticoagulation in dialysis patients
693182|NCT00660946|chronic anticoagulation|chronic anticoagulation
693183|NCT00660946|warfarin|warfarin
693184|NCT00660946|hemodialysis|hemodialysis
693185|NCT00660946|INR|inr
693186|NCT00660946|Point of Care|point of care
693187|NCT00660933|postpartum anemia|postpartum anemia
693188|NCT00660933|intravenous iron|intravenous iron
693189|NCT00660907|Dapagliflozin|dapagliflozin
693190|NCT00660907|efficacy|efficacy
693191|NCT00660907|safety|safety
693192|NCT00660907|metformin|metformin
693193|NCT00660907|Type 2 diabetes|type 2 diabetes
693194|NCT00660894|adenocarcinoma of the colon|adenocarcinoma of the colon
693195|NCT00660894|stage III colon cancer|stage iii colon cancer
693196|NCT00660881|Lupus|lupus
693197|NCT00660881|Monoclonal antibody|monoclonal antibody
693198|NCT00660881|B-Cell immunotherapy|b-cell immunotherapy
693199|NCT00660868|smell|smell
693200|NCT00660868|olfaction|olfaction
693201|NCT00660868|olfactory sensitivity|olfactory sensitivity
693202|NCT00660868|smell loss|smell loss
693203|NCT00660868|chemoreception|chemoreception
693204|NCT00660855|laparoscopy|laparoscopy
693205|NCT00660842|quality of life|quality of life
693206|NCT00660842|weekly therapy|weekly therapy
693207|NCT00660842|neurotoxicity|neurotoxicity
693208|NCT00660816|recurrent non-small cell lung cancer|recurrent non-small cell lung cancer
693209|NCT00660816|stage IIIB non-small cell lung cancer|stage iiib non-small cell lung cancer
693210|NCT00660816|stage IV non-small cell lung cancer|stage iv non-small cell lung cancer
693211|NCT00660803|Advanced Breast Cancer|advanced breast cancer
693212|NCT00660803|Hormone Therapy|hormone therapy
693213|NCT00660790|diabetes mellitus type II, therapy non-responders|diabetes mellitus type ii, therapy non-responders
693214|NCT00660777|oropharyngeal exercises|oropharyngeal exercises
693215|NCT00660777|obstructive sleep apnea|obstructive sleep apnea
693216|NCT00660777|speech therapy|speech therapy
693217|NCT00660764|cholesterol|cholesterol
693218|NCT00660764|coronary heart disease|coronary heart disease
693219|NCT00660764|rosuvastatin|rosuvastatin
693220|NCT00660764|LDL-C goal|ldl-c goal
693221|NCT00660764|hypercholesterolemia|hypercholesterolemia
693222|NCT00660764|secondary prevention|secondary prevention
693223|NCT00660764|primary prevention|primary prevention
693224|NCT00660764|CVA|cva
693225|NCT00660751|Physiology of Serotonergic and Adrenergic systems|physiology of serotonergic and adrenergic systems
693226|NCT00660738|chronic obstructive pulmonary disease|chronic obstructive pulmonary disease
693227|NCT00660738|walking|walking
693228|NCT00660738|exercise test|exercise test
693231|NCT00660738|desaturation|desaturation
693232|NCT00660725|Gemcitabine|gemcitabine
693233|NCT00660725|Oxaliplatin|oxaliplatin
693234|NCT00660725|Vandetanib|vandetanib
693235|NCT00660725|Phase I|phase i
693236|NCT00660712|Bipolar disorder|bipolar disorder
693237|NCT00660712|patient characteristics|patient characteristics
693238|NCT00660712|treatment characteristics|treatment characteristics
693239|NCT00660699|Cholangiocarcinoma|cholangiocarcinoma
693240|NCT00660699|Gallbladder|gallbladder
693241|NCT00660699|Pancreatic|pancreatic
693242|NCT00660699|Ampullary|ampullary
693243|NCT00660699|Cancer|cancer
693244|NCT00660686|randomized clinical trial|randomized clinical trial
693245|NCT00660686|elderly|elderly
693246|NCT00660686|cancer survivor|cancer survivor
693247|NCT00660686|bone health|bone health
693248|NCT00660686|body composition|body composition
693249|NCT00660686|signs and symptoms|signs and symptoms
693250|NCT00660686|Androgen Deprivation Therapy|androgen deprivation therapy
693251|NCT00660673|levodopa/carbidopa intestinal gel|levodopa/carbidopa intestinal gel
693252|NCT00660673|Severe Motor Fluctuations|severe motor fluctuations
693253|NCT00660673|Levodopa|levodopa
693254|NCT00660673|Carbidopa|carbidopa
693255|NCT00660673|Parkinson's Disease|parkinson's disease
693256|NCT00660673|Dyskinesia|dyskinesia
693257|NCT00660660|GERD|gerd
693258|NCT00660660|Esophageal Reflux|esophageal reflux
693259|NCT00660660|Gastro-Esophageal Reflux|gastro-esophageal reflux
693260|NCT00660660|Regurgitation|regurgitation
693261|NCT00660660|Gastric|gastric
693262|NCT00660647|Rheumatoid arthritis, adalimumab, efficacy, adverse events|rheumatoid arthritis, adalimumab, efficacy, adverse events
693263|NCT00660634|Peripheral arterial obstructive disease|peripheral arterial obstructive disease
693264|NCT00660634|Intermittent Claudication|intermittent claudication
693265|NCT00660634|Endovascular treatment|endovascular treatment
693266|NCT00660634|Flow-mediated dilation|flow-mediated dilation
693267|NCT00660621|High Grade|high grade
693268|NCT00660621|Malignant|malignant
693269|NCT00660621|GBM|gbm
693270|NCT00660608|Transfusion regulation|transfusion regulation
693271|NCT00660595|Schizophrenia|schizophrenia
693272|NCT00660595|Schizoaffective psychosis|schizoaffective psychosis
693273|NCT00660595|Schizophreniformic psychosis|schizophreniformic psychosis
693274|NCT00660595|Pilot study|pilot study
693275|NCT00660595|Quetiapine Prolong|quetiapine prolong
693276|NCT00660595|Risperidone|risperidone
693277|NCT00660582|Erbitux|erbitux
693278|NCT00660582|Colorectal cancer|colorectal cancer
693279|NCT00660582|Oxaliplatin|oxaliplatin
693280|NCT00660582|Flox|flox
693281|NCT00660582|Fluorouracil + folinic acid|fluorouracil + folinic acid
693282|NCT00660582|K-RAS|k-ras
693283|NCT00660569|asthma treatment|asthma treatment
693284|NCT00660569|utilization|utilization
693285|NCT00660569|real life practice|real life practice
693286|NCT00660530|stage 5|stage 5
693287|NCT00660530|chronic|chronic
693288|NCT00660530|hemodialysis|hemodialysis
693289|NCT00660504|Extensive Disease-Small Cell Lung Cancer|extensive disease-small cell lung cancer
693290|NCT00660491|flow mediated dilatation|flow mediated dilatation
693291|NCT00660491|maximal oxygen uptake|maximal oxygen uptake
693292|NCT00660491|blood lipid|blood lipid
693293|NCT00660465|Regional BOLD signal dependency on arterial PaCO2.|regional bold signal dependency on arterial paco2.
693294|NCT00660465|Effect of breathing exercises on brain regional O2 level.|effect of breathing exercises on brain regional o2 level.
693295|NCT00660465|Healthy subjects|healthy subjects
693296|NCT00660452|Allergy|allergy
693297|NCT00660452|SLIT|slit
693298|NCT00660452|Asthma|asthma
693299|NCT00660452|House Dust Mites|house dust mites
693300|NCT00660439|PTSD|ptsd
693301|NCT00660426|cancer|cancer
693302|NCT00660426|gastrointestinal|gastrointestinal
693303|NCT00660426|tumor|tumor
693304|NCT00660413|Acceleromyography|acceleromyography
693305|NCT00660413|Mechanomyography|mechanomyography
693306|NCT00660413|Neuromuscular block|neuromuscular block
693307|NCT00660413|Neuromuscular monitoring|neuromuscular monitoring
693308|NCT00660413|Dose-response|dose-response
693309|NCT00660413|Potency|potency
693310|NCT00660413|Rocuronium|rocuronium
693311|NCT00660400|Myeloid|myeloid
693312|NCT00660400|Monocytic|monocytic
693313|NCT00660387|levodopa-carbidopa|levodopa-carbidopa
693314|NCT00660387|Carbidopa|carbidopa
693315|NCT00660387|levodopa|levodopa
693316|NCT00660387|dyskinesia|dyskinesia
693317|NCT00660387|Duodopa|duodopa
693318|NCT00660387|levodopa-carbidopa intestinal gel|levodopa-carbidopa intestinal gel
693319|NCT00660387|Severe Motor Fluctuations|severe motor fluctuations
693320|NCT00660387|levodopa/carbidopa suspension|levodopa/carbidopa suspension
693321|NCT00660387|DUOPA|duopa
693322|NCT00660361|HIV|hiv
693323|NCT00660361|HBV|hbv
693324|NCT00660361|co-infection|co-infection
693325|NCT00660361|drug resistance|drug resistance
693326|NCT00660361|tenofovir|tenofovir
693327|NCT00660361|HIV-HBV co-infection|hiv-hbv co-infection
693328|NCT00660348|recurrent pancreatic cancer|recurrent pancreatic cancer
693329|NCT00660348|stage III pancreatic cancer|stage iii pancreatic cancer
693330|NCT00660348|stage IV pancreatic cancer|stage iv pancreatic cancer
694879|NCT00654173|Cholesterol|cholesterol
693331|NCT00660348|adenocarcinoma of the pancreas|adenocarcinoma of the pancreas
693332|NCT00660348|pain|pain
693333|NCT00660348|stage II pancreatic cancer|stage ii pancreatic cancer
693334|NCT00660335|secretin, RG1068, MRCP, pancreas|secretin, rg1068, mrcp, pancreas
693335|NCT00660322|Asthma|asthma
693336|NCT00660322|Telemedicine|telemedicine
693337|NCT00660322|Randomized controlled trial|randomized controlled trial
693338|NCT00660309|Type 2 diabetes mellitus|type 2 diabetes mellitus
693339|NCT00660309|renal disease|renal disease
693340|NCT00660309|hypertension|hypertension
693341|NCT00660309|renal blood flow|renal blood flow
693342|NCT00660309|retinal blood flow|retinal blood flow
693343|NCT00660309|aliskiren|aliskiren
693344|NCT00660309|irbesartan|irbesartan
693345|NCT00660309|captopril|captopril
693346|NCT00660296|CO2|co2
693347|NCT00660296|pain|pain
693348|NCT00660296|colonoscopy|colonoscopy
693349|NCT00660296|cancer|cancer
693350|NCT00660296|screening|screening
693351|NCT00660283|GBM|gbm
693352|NCT00660283|Newly|newly
693353|NCT00660283|diagnosed|diagnosed
693354|NCT00660283|malignant|malignant
693355|NCT00660283|high grade|high grade
693356|NCT00660270|Chemotherapy|chemotherapy
693357|NCT00660270|Radiation|radiation
693358|NCT00660244|Arimidex|arimidex
693359|NCT00660244|Post menopausal|post menopausal
693360|NCT00660244|arthralgia|arthralgia
693361|NCT00660231|recurrent mycosis fungoides/Sezary syndrome|recurrent mycosis fungoides/sezary syndrome
693362|NCT00660231|stage IB mycosis fungoides/Sezary syndrome|stage ib mycosis fungoides/sezary syndrome
693363|NCT00660231|stage II mycosis fungoides/Sezary syndrome|stage ii mycosis fungoides/sezary syndrome
693364|NCT00660231|stage III mycosis fungoides/Sezary syndrome|stage iii mycosis fungoides/sezary syndrome
693365|NCT00660231|stage IV mycosis fungoides/Sezary syndrome|stage iv mycosis fungoides/sezary syndrome
693366|NCT00660231|recurrent cutaneous T-cell non-Hodgkin lymphoma|recurrent cutaneous t-cell non-hodgkin lymphoma
693367|NCT00660231|stage IB cutaneous T-cell non-Hodgkin lymphoma|stage ib cutaneous t-cell non-hodgkin lymphoma
693368|NCT00660231|stage II cutaneous T-cell non-Hodgkin lymphoma|stage ii cutaneous t-cell non-hodgkin lymphoma
693369|NCT00660231|stage III cutaneous T-cell non-Hodgkin lymphoma|stage iii cutaneous t-cell non-hodgkin lymphoma
693370|NCT00660231|stage IV cutaneous T-cell non-Hodgkin lymphoma|stage iv cutaneous t-cell non-hodgkin lymphoma
693371|NCT00660218|Stage III and IV head and neck cancer|stage iii and iv head and neck cancer
693372|NCT00660205|DVT|dvt
693373|NCT00660205|PE|pe
693374|NCT00660205|D-dimer|d-dimer
693375|NCT00660205|cancer|cancer
693376|NCT00660205|VTE|vte
693501|NCT00659568|stage IV renal cell cancer|stage iv renal cell cancer
693377|NCT00660192|Migraine, refractory migraine, Pain, Botulinum Toxin , Botox|migraine, refractory migraine, pain, botulinum toxin , botox
693378|NCT00660179|pulmonary arterial hypertension SERAPHIN|pulmonary arterial hypertension seraphin
693379|NCT00660166|Natural killer cells|natural killer cells
693380|NCT00660166|autologous stem cell transplant|autologous stem cell transplant
693381|NCT00660166|immunotherapy|immunotherapy
693382|NCT00660153|Advanced Colorectal Cancer and Other Gastrointestinal Cancers|advanced colorectal cancer and other gastrointestinal cancers
693383|NCT00660153|tivozanib|tivozanib
693384|NCT00660153|AV-951|av-951
693385|NCT00660140|Cholangiocarcinoma|cholangiocarcinoma
693386|NCT00660140|Gallbladder|gallbladder
693387|NCT00660140|Cancer|cancer
693388|NCT00660114|Cough variant asthma|cough variant asthma
693389|NCT00660114|Pulmicort® Respules®|pulmicort® respules®
693390|NCT00660114|Chinese patient Eligibility|chinese patient eligibility
693391|NCT00660101|ovarian cancer|ovarian cancer
693392|NCT00660101|vaccine|vaccine
693393|NCT00660101|immunotherapy|immunotherapy
693394|NCT00660101|autologous|autologous
693395|NCT00660075|Diabetes mellitus|diabetes mellitus
693396|NCT00660075|Postprandial|postprandial
693397|NCT00660075|Hyperlipidemia|hyperlipidemia
693398|NCT00660075|Atherosclerosis|atherosclerosis
693399|NCT00660062|Major depression|major depression
693400|NCT00660062|relapse prevention|relapse prevention
693401|NCT00660062|ECT|ect
693402|NCT00660062|escitalopram|escitalopram
693403|NCT00660062|nortriptyline|nortriptyline
693404|NCT00660036|Acute myeloid leukemia|acute myeloid leukemia
693405|NCT00660036|Refractory|refractory
693406|NCT00660036|Relapsed|relapsed
693407|NCT00660036|Second line|second line
693408|NCT00660036|Gemtuzumab ozogamicin|gemtuzumab ozogamicin
693409|NCT00660036|Mitoxantrone|mitoxantrone
693410|NCT00660036|Etoposide|etoposide
693411|NCT00660036|Phase I|phase i
693412|NCT00660036|Phase II|phase ii
693413|NCT00660010|CPP|cpp
693414|NCT00660010|central precocious puberty|central precocious puberty
693415|NCT00660010|pediatrics|pediatrics
693416|NCT00660010|suppression of LH|suppression of lh
693417|NCT00660010|Lupron|lupron
693418|NCT00660010|leuprolide acetate|leuprolide acetate
693419|NCT00660010|depot formulation|depot formulation
693420|NCT00660010|GnRHa|gnrha
875926|NCT00002668|pain|pain
693421|NCT00660010|GnRH agonist|gnrh agonist
693422|NCT00660010|GNRH analog|gnrh analog
693423|NCT00660010|LH|lh
693424|NCT00660010|Tanner staging|tanner staging
693425|NCT00659997|Ascariasis|ascariasis
693426|NCT00659997|Trichuriasis|trichuriasis
693427|NCT00659997|Drug resistance|drug resistance
693428|NCT00659984|recurrent neuroblastoma|recurrent neuroblastoma
693429|NCT00659971|oral candidiasis|oral candidiasis
693430|NCT00659958|zonisamide|zonisamide
693431|NCT00659958|partial onset seizures|partial onset seizures
693432|NCT00659958|effectiveness|effectiveness
693433|NCT00659958|tolerability|tolerability
693434|NCT00659945|Postoperation, nausea, vomiting, anesthesia, plastic surgery|postoperation, nausea, vomiting, anesthesia, plastic surgery
693435|NCT00659932|diabetes|diabetes
693436|NCT00659932|cognitive behavioural therapy|cognitive behavioural therapy
693437|NCT00659906|randomized clinical trial|randomized clinical trial
693438|NCT00659906|cancer survivor|cancer survivor
693439|NCT00659906|bone health|bone health
693440|NCT00659906|body composition|body composition
693441|NCT00659906|signs and symptoms|signs and symptoms
693442|NCT00659893|Peplin|peplin
693443|NCT00659893|PEP005|pep005
693444|NCT00659893|Actinic Keratosis|actinic keratosis
693445|NCT00659880|Meniscus transplant|meniscus transplant
693446|NCT00659880|Meniscal allograft|meniscal allograft
693448|NCT00659880|Knee|knee
693449|NCT00659867|Ulcerative Colitis|ulcerative colitis
693450|NCT00659867|Endomicroscopy|endomicroscopy
693451|NCT00659867|Chromoendoscopy|chromoendoscopy
693452|NCT00659867|Confocal colonoscope|confocal colonoscope
693453|NCT00659867|Surveillance colonoscopy|surveillance colonoscopy
693454|NCT00659854|obstructive sleep apnea syndrome|obstructive sleep apnea syndrome
693455|NCT00659854|The study examines the response of infants diagnosed with obstructive sleep apnea syndrome to diet changes|the study examines the response of infants diagnosed with obstructive sleep apnea syndrome to diet changes
693456|NCT00659841|Seasonal Allergic Rhinitis|seasonal allergic rhinitis
693457|NCT00659841|Ciclesonide|ciclesonide
693458|NCT00659841|Hay Fever|hay fever
693459|NCT00659841|SAR|sar
693460|NCT00659828|Congenital leptin deficiency|congenital leptin deficiency
693461|NCT00659828|Obesity|obesity
693462|NCT00659828|Metabolic Syndrome|metabolic syndrome
693463|NCT00659828|Diabetes|diabetes
693464|NCT00659776|ferumoxytol|ferumoxytol
693465|NCT00659763|IBS|ibs
693466|NCT00659763|Diagnosis|diagnosis
693467|NCT00659750|Perennial Allergic Rhinitis|perennial allergic rhinitis
693468|NCT00659750|Ciclesonide|ciclesonide
693469|NCT00659750|PAR|par
693470|NCT00659737|Post-operative Nausea and Vomiting (PONV)|post-operative nausea and vomiting (ponv)
693471|NCT00659724|Dialyzer|dialyzer
693472|NCT00659698|surgical|surgical
693473|NCT00659698|site|site
693474|NCT00659698|infection|infection
693475|NCT00659685|Bioequivalence|bioequivalence
693476|NCT00659685|Ondansetron ODT|ondansetron odt
693477|NCT00659685|Fasting|fasting
693478|NCT00659685|To Determine Bioequivalence Under Fasting conditions|to determine bioequivalence under fasting conditions
693479|NCT00659672|hypertension|hypertension
693480|NCT00659672|prehypertension|prehypertension
693481|NCT00659672|high blood pressure|high blood pressure
693482|NCT00659672|blood pressure|blood pressure
693483|NCT00659672|heart disease|heart disease
693484|NCT00659646|Diabetes|diabetes
693485|NCT00659646|ulcers|ulcers
693486|NCT00659646|ulcerations|ulcerations
693487|NCT00659646|infection|infection
693488|NCT00659633|lidocaine|lidocaine
693489|NCT00659633|allodynia|allodynia
693490|NCT00659633|chronic regional pain syndrome|chronic regional pain syndrome
693491|NCT00659633|pain|pain
693492|NCT00659620|Kidney Transplant|kidney transplant
693493|NCT00659620|Chronic Allograft Nephropathy|chronic allograft nephropathy
693494|NCT00659620|Mesenchymal Stem Cell infusion|mesenchymal stem cell infusion
693495|NCT00659594|Seasonal Allergic rhinitis|seasonal allergic rhinitis
693496|NCT00659594|Ciclesonide|ciclesonide
693497|NCT00659594|Hay Fever|hay fever
693498|NCT00659594|SAR|sar
693499|NCT00659568|unspecified adult solid tumor, protocol specific|unspecified adult solid tumor, protocol specific
693500|NCT00659568|stage III renal cell cancer|stage iii renal cell cancer
693733|NCT00658853|performance|performance
693502|NCT00659568|recurrent renal cell cancer|recurrent renal cell cancer
693503|NCT00659568|recurrent endometrial carcinoma|recurrent endometrial carcinoma
693504|NCT00659568|stage III endometrial carcinoma|stage iii endometrial carcinoma
693505|NCT00659568|stage IV endometrial carcinoma|stage iv endometrial carcinoma
693506|NCT00659568|recurrent breast cancer|recurrent breast cancer
693507|NCT00659568|stage IIIA breast cancer|stage iiia breast cancer
693508|NCT00659568|stage IIIB breast cancer|stage iiib breast cancer
693509|NCT00659568|stage IIIC breast cancer|stage iiic breast cancer
693510|NCT00659568|stage IV breast cancer|stage iv breast cancer
693511|NCT00659568|recurrent small cell lung cancer|recurrent small cell lung cancer
693512|NCT00659568|extensive stage small cell lung cancer|extensive stage small cell lung cancer
693513|NCT00659568|stage III adult Burkitt lymphoma|stage iii adult burkitt lymphoma
693514|NCT00659568|stage III adult diffuse large cell lymphoma|stage iii adult diffuse large cell lymphoma
693515|NCT00659568|stage III adult diffuse mixed cell lymphoma|stage iii adult diffuse mixed cell lymphoma
693516|NCT00659568|stage III adult diffuse small cleaved cell lymphoma|stage iii adult diffuse small cleaved cell lymphoma
693517|NCT00659568|stage III adult Hodgkin lymphoma|stage iii adult hodgkin lymphoma
693518|NCT00659568|stage III adult immunoblastic large cell lymphoma|stage iii adult immunoblastic large cell lymphoma
693519|NCT00659568|stage III adult lymphoblastic lymphoma|stage iii adult lymphoblastic lymphoma
693520|NCT00659568|stage III adult T-cell leukemia/lymphoma|stage iii adult t-cell leukemia/lymphoma
693521|NCT00659568|stage III cutaneous T-cell non-Hodgkin lymphoma|stage iii cutaneous t-cell non-hodgkin lymphoma
693522|NCT00659568|stage III grade 1 follicular lymphoma|stage iii grade 1 follicular lymphoma
693523|NCT00659568|stage III grade 2 follicular lymphoma|stage iii grade 2 follicular lymphoma
693524|NCT00659568|stage III grade 3 follicular lymphoma|stage iii grade 3 follicular lymphoma
693525|NCT00659568|stage III mantle cell lymphoma|stage iii mantle cell lymphoma
693526|NCT00659568|stage III marginal zone lymphoma|stage iii marginal zone lymphoma
693527|NCT00659568|stage III small lymphocytic lymphoma|stage iii small lymphocytic lymphoma
693528|NCT00659568|stage IV adult Burkitt lymphoma|stage iv adult burkitt lymphoma
693529|NCT00659568|stage IV adult diffuse large cell lymphoma|stage iv adult diffuse large cell lymphoma
693530|NCT00659568|stage IV adult diffuse mixed cell lymphoma|stage iv adult diffuse mixed cell lymphoma
693531|NCT00659568|stage IV adult diffuse small cleaved cell lymphoma|stage iv adult diffuse small cleaved cell lymphoma
693532|NCT00659568|stage IV adult Hodgkin lymphoma|stage iv adult hodgkin lymphoma
693533|NCT00659568|stage IV adult immunoblastic large cell lymphoma|stage iv adult immunoblastic large cell lymphoma
693534|NCT00659568|stage IV adult lymphoblastic lymphoma|stage iv adult lymphoblastic lymphoma
693535|NCT00659568|stage IV adult T-cell leukemia/lymphoma|stage iv adult t-cell leukemia/lymphoma
693536|NCT00659568|stage IV cutaneous T-cell non-Hodgkin lymphoma|stage iv cutaneous t-cell non-hodgkin lymphoma
693537|NCT00659568|stage IV grade 1 follicular lymphoma|stage iv grade 1 follicular lymphoma
693538|NCT00659568|stage IV grade 2 follicular lymphoma|stage iv grade 2 follicular lymphoma
693539|NCT00659568|stage IV grade 3 follicular lymphoma|stage iv grade 3 follicular lymphoma
693540|NCT00659568|stage IV mantle cell lymphoma|stage iv mantle cell lymphoma
693541|NCT00659568|stage IV marginal zone lymphoma|stage iv marginal zone lymphoma
693542|NCT00659568|stage IV small lymphocytic lymphoma|stage iv small lymphocytic lymphoma
693543|NCT00659568|recurrent adult Burkitt lymphoma|recurrent adult burkitt lymphoma
693544|NCT00659568|recurrent adult diffuse large cell lymphoma|recurrent adult diffuse large cell lymphoma
693545|NCT00659568|recurrent adult diffuse mixed cell lymphoma|recurrent adult diffuse mixed cell lymphoma
693546|NCT00659568|recurrent adult diffuse small cleaved cell lymphoma|recurrent adult diffuse small cleaved cell lymphoma
693547|NCT00659568|recurrent adult grade III lymphomatoid granulomatosis|recurrent adult grade iii lymphomatoid granulomatosis
693548|NCT00659568|recurrent adult Hodgkin lymphoma|recurrent adult hodgkin lymphoma
693549|NCT00659568|recurrent adult immunoblastic large cell lymphoma|recurrent adult immunoblastic large cell lymphoma
693550|NCT00659568|recurrent adult lymphoblastic lymphoma|recurrent adult lymphoblastic lymphoma
693551|NCT00659568|recurrent adult T-cell leukemia/lymphoma|recurrent adult t-cell leukemia/lymphoma
693552|NCT00659568|recurrent cutaneous T-cell non-Hodgkin lymphoma|recurrent cutaneous t-cell non-hodgkin lymphoma
693553|NCT00659568|recurrent grade 1 follicular lymphoma|recurrent grade 1 follicular lymphoma
693554|NCT00659568|recurrent grade 2 follicular lymphoma|recurrent grade 2 follicular lymphoma
693555|NCT00659568|recurrent grade 3 follicular lymphoma|recurrent grade 3 follicular lymphoma
693556|NCT00659568|recurrent mantle cell lymphoma|recurrent mantle cell lymphoma
693557|NCT00659568|recurrent marginal zone lymphoma|recurrent marginal zone lymphoma
693558|NCT00659568|recurrent small lymphocytic lymphoma|recurrent small lymphocytic lymphoma
693559|NCT00659568|anaplastic large cell lymphoma|anaplastic large cell lymphoma
693560|NCT00659568|angioimmunoblastic T-cell lymphoma|angioimmunoblastic t-cell lymphoma
693561|NCT00659568|recurrent mycosis fungoides/Sezary syndrome|recurrent mycosis fungoides/sezary syndrome
693562|NCT00659568|stage III mycosis fungoides/Sezary syndrome|stage iii mycosis fungoides/sezary syndrome
693563|NCT00659568|stage IV mycosis fungoides/Sezary syndrome|stage iv mycosis fungoides/sezary syndrome
693564|NCT00659568|adult nasal type extranodal NK/T-cell lymphoma|adult nasal type extranodal nk/t-cell lymphoma
693565|NCT00659568|extranodal marginal zone B-cell lymphoma of mucosa-associated lymphoid tissue|extranodal marginal zone b-cell lymphoma of mucosa-associated lymphoid tissue
693566|NCT00659568|nodal marginal zone B-cell lymphoma|nodal marginal zone b-cell lymphoma
693567|NCT00659568|splenic marginal zone lymphoma|splenic marginal zone lymphoma
693568|NCT00659568|Waldenström macroglobulinemia|waldenström macroglobulinemia
693569|NCT00659555|vascular endothelial growth factor,|vascular endothelial growth factor,
693570|NCT00659555|drug interaction,|drug interaction,
693571|NCT00659555|pharmacokinetics,|pharmacokinetics,
693572|NCT00659555|age-related macular degeneration,|age-related macular degeneration,
693573|NCT00659555|pazopanib,|pazopanib,
693574|NCT00659555|angiogenesis,|angiogenesis,
693575|NCT00659555|ketoconazole|ketoconazole
693576|NCT00659542|inguinal hernia|inguinal hernia
693577|NCT00659542|inguinal hernioplasty|inguinal hernioplasty
693578|NCT00659542|mesh fixation|mesh fixation
693579|NCT00659542|Lichtenstein hernioplasty|lichtenstein hernioplasty
693580|NCT00659529|cystic fibrosis|cystic fibrosis
693581|NCT00659529|inflammation|inflammation
693582|NCT00659529|pH|ph
693583|NCT00659529|EBC|ebc
693584|NCT00659529|sputum biomarkers|sputum biomarkers
693585|NCT00659529|phosphodiesterase inhibitors|phosphodiesterase inhibitors
693586|NCT00659503|Seasonal Allergic Rhinitis|seasonal allergic rhinitis
693587|NCT00659503|Ciclesonide|ciclesonide
693588|NCT00659503|Hay Fever|hay fever
693589|NCT00659503|SAR|sar
693590|NCT00659490|Analgesic effect|analgesic effect
693591|NCT00659490|Molar extraction|molar extraction
693592|NCT00659464|Infrared Spectroscopy|infrared spectroscopy
693593|NCT00659464|Syncope|syncope
693594|NCT00659464|Tilt Table Testing|tilt table testing
693595|NCT00659451|Hypertension|hypertension
693596|NCT00659451|Diabetes mellitus|diabetes mellitus
693597|NCT00659451|Heart|heart
693598|NCT00659425|Moxetumomab pasudotox|moxetumomab pasudotox
693599|NCT00659412|Psoriatic arthritis|psoriatic arthritis
693600|NCT00659412|psoriasis|psoriasis
693601|NCT00659412|Alefacept|alefacept
693602|NCT00659399|Pretreated Ovarian Carcinoma|pretreated ovarian carcinoma
693603|NCT00659386|Heart failure|heart failure
693604|NCT00659386|Parvovirus B19|parvovirus b19
693605|NCT00659386|Intravenous immuneglobulin|intravenous immuneglobulin
693606|NCT00659373|cognitive/functional effects|cognitive/functional effects
693607|NCT00659373|psychosocial effects of cancer and its treatment|psychosocial effects of cancer and its treatment
693608|NCT00659373|fatigue|fatigue
693609|NCT00659373|sleep disorders|sleep disorders
693610|NCT00659373|stage IA breast cancer|stage ia breast cancer
693611|NCT00659373|stage IB breast cancer|stage ib breast cancer
693612|NCT00659373|stage II breast cancer|stage ii breast cancer
693613|NCT00659373|stage IIIA breast cancer|stage iiia breast cancer
693614|NCT00659334|Combidex|combidex
693615|NCT00659334|Diagnostic imaging|diagnostic imaging
693616|NCT00659308|pain|pain
693617|NCT00659308|bullous keratopathy|bullous keratopathy
693618|NCT00659308|amniotic membrane|amniotic membrane
693619|NCT00659308|anterior stromal puncture|anterior stromal puncture
693620|NCT00659269|Vitamin B-12|vitamin b-12
693621|NCT00659269|Vitamin B-6|vitamin b-6
693622|NCT00659269|Chemotherapy-Induced Neuropathy|chemotherapy-induced neuropathy
693623|NCT00659269|Taxanes|taxanes
693624|NCT00659269|Vinca alkaloid|vinca alkaloid
693625|NCT00659269|Heavy metals|heavy metals
693626|NCT00659269|Neuropathy|neuropathy
693627|NCT00659269|Nerve pain|nerve pain
693628|NCT00659256|Hepatitis C Virus|hepatitis c virus
693629|NCT00659256|Atherosclerosis|atherosclerosis
693630|NCT00659256|Intima-Media Thickness|intima-media thickness
693631|NCT00659256|Coronary Artery Calcium Score|coronary artery calcium score
693632|NCT00659256|Hepatitis C|hepatitis c
693633|NCT00659243|Replacement therapy|replacement therapy
693634|NCT00659243|Pasteurized breast milk|pasteurized breast milk
693635|NCT00659243|Preterm infants|preterm infants
693636|NCT00659243|BSSL|bssl
693637|NCT00659230|PTSD|ptsd
693638|NCT00659230|Veterans|veterans
693639|NCT00659230|Nepicastat|nepicastat
693640|NCT00659230|OIF/OEF|oif/oef
693641|NCT00659217|Mesenchymal Stem Cells|mesenchymal stem cells
693642|NCT00659217|lupus Nephritis|lupus nephritis
693643|NCT00659191|Healthy volunteer,|healthy volunteer,
693644|NCT00659191|HIV infected subjects|hiv infected subjects
693645|NCT00659178|Doxil,|doxil,
693646|NCT00659178|pegylated liposomal doxorubicin,|pegylated liposomal doxorubicin,
693647|NCT00659178|ovarian cancer|ovarian cancer
693648|NCT00659178|IL-18,|il-18,
693649|NCT00659178|combination study,|combination study,
693650|NCT00659178|immunotherapy,|immunotherapy,
693651|NCT00659178|cytokine,|cytokine,
693652|NCT00659165|diabetes|diabetes
693653|NCT00659165|insulin dependent diabetes|insulin dependent diabetes
693654|NCT00659165|diabetes mellitus|diabetes mellitus
693655|NCT00659165|detemir|detemir
693656|NCT00659165|levemir|levemir
693657|NCT00659165|glargine|glargine
693658|NCT00659165|lantus|lantus
693659|NCT00659165|insulin|insulin
693660|NCT00659165|appetite|appetite
693661|NCT00659165|satiety|satiety
693662|NCT00659165|centrally acting mediators of satiety|centrally acting mediators of satiety
693663|NCT00659165|three factor eating questionnaire|three factor eating questionnaire
693664|NCT00659165|PYY|pyy
693665|NCT00659165|ghrelin|ghrelin
693666|NCT00659165|leptin|leptin
693667|NCT00659152|ALI/ARDS|ali/ards
693668|NCT00659113|stage IIA esophageal cancer|stage iia esophageal cancer
693669|NCT00659113|stage IIB esophageal cancer|stage iib esophageal cancer
693670|NCT00659113|stage IIIA esophageal cancer|stage iiia esophageal cancer
693671|NCT00659113|stage IIIB esophageal cancer|stage iiib esophageal cancer
693672|NCT00659113|stage IIIC esophageal cancer|stage iiic esophageal cancer
693673|NCT00659113|stage IV esophageal cancer|stage iv esophageal cancer
693674|NCT00659087|Total Knee|total knee
693675|NCT00659087|Range of Motion|range of motion
693676|NCT00659087|Pain|pain
693677|NCT00659074|bioequivalence|bioequivalence
693678|NCT00659074|Ondansetron ODT|ondansetron odt
693679|NCT00659074|Fasting|fasting
693680|NCT00659074|To Determine Bioequivalence Under Fasting Conditions|to determine bioequivalence under fasting conditions
693681|NCT00659061|micronutrients|micronutrients
693682|NCT00659048|Perennial Allergic Rhinitis|perennial allergic rhinitis
693683|NCT00659048|Ciclesonide|ciclesonide
693684|NCT00659048|PAR|par
693685|NCT00659035|driving|driving
693686|NCT00659035|opioids|opioids
693687|NCT00659035|impairment|impairment
693688|NCT00659035|ability|ability
693689|NCT00659035|patients|patients
693690|NCT00659035|receiving|receiving
693691|NCT00659035|oral morphine|oral morphine
693692|NCT00659035|severe|severe
693693|NCT00659022|colorectal cancer|colorectal cancer
693694|NCT00659022|liver metastases|liver metastases
693695|NCT00659022|angiogenesis|angiogenesis
693696|NCT00659022|metabolism|metabolism
693697|NCT00659009|environmental|environmental
693698|NCT00659009|hypobaric hypoxia|hypobaric hypoxia
693699|NCT00659009|sleep|sleep
693700|NCT00659009|respiratory-disturbance|respiratory-disturbance
693701|NCT00659009|neurobehavioral performance|neurobehavioral performance
693702|NCT00659009|Effect of altitude on sleep-related respiratory disturbance|effect of altitude on sleep-related respiratory disturbance
693703|NCT00658970|Open label|open label
693704|NCT00658970|Dose escalation|dose escalation
693705|NCT00658957|Diabetes|diabetes
693706|NCT00658957|Foot Ulcer|foot ulcer
693707|NCT00658944|Stress urinary incontinence|stress urinary incontinence
693708|NCT00658944|Mixed urinary incontinence|mixed urinary incontinence
693709|NCT00658944|surgery|surgery
693710|NCT00658944|trans obturator tape|trans obturator tape
693711|NCT00658944|Maximum urethral closure pressure|maximum urethral closure pressure
693712|NCT00658944|Valsalva leak point pressure|valsalva leak point pressure
693713|NCT00658944|outcome|outcome
693714|NCT00658931|Depression|depression
693715|NCT00658931|Bereavement|bereavement
693716|NCT00658931|Pilot Projects|pilot projects
693717|NCT00658931|Antidepressant Drugs|antidepressant drugs
693718|NCT00658918|Perennial Allergic Rhinitis|perennial allergic rhinitis
693719|NCT00658918|Ciclesonide|ciclesonide
693720|NCT00658918|Hay Fever|hay fever
693721|NCT00658918|PAR|par
693722|NCT00658905|Preterm infants|preterm infants
693723|NCT00658905|Replacement therapy|replacement therapy
693724|NCT00658905|Infant formula|infant formula
693725|NCT00658905|BSSL|bssl
693726|NCT00658905|BSSL is present in fresh mother's milk but not in infant formula.|bssl is present in fresh mother's milk but not in infant formula.
693727|NCT00658892|recurrent melanoma|recurrent melanoma
693728|NCT00658892|stage IV melanoma|stage iv melanoma
693729|NCT00658866|ertapenem tissue PK|ertapenem tissue pk
693730|NCT00658853|COPD|copd
693731|NCT00658853|training|training
693732|NCT00658853|VO2peak|vo2peak
693734|NCT00658853|ventilation|ventilation
693735|NCT00658853|high aerobic intensity treadmill walking|high aerobic intensity treadmill walking
693736|NCT00658853|one leg training by cycling|one leg training by cycling
693737|NCT00658827|Inflammatory Bowel Disease|inflammatory bowel disease
693738|NCT00658827|Rheumatoid Arthritis|rheumatoid arthritis
693739|NCT00658827|Psoriatic Arthritis|psoriatic arthritis
693740|NCT00658827|Ankylosing Spondylitis|ankylosing spondylitis
693741|NCT00658827|Psoriasis|psoriasis
693742|NCT00658827|Pregnant women exposed to infliximab|pregnant women exposed to infliximab
693743|NCT00658775|GERD|gerd
693744|NCT00658775|erosive GERD|erosive gerd
693745|NCT00658775|erosive esophagitis|erosive esophagitis
693746|NCT00658749|AIR645|air645
693747|NCT00658749|Altair Therapeutics|altair therapeutics
693748|NCT00658749|IL4|il4
693749|NCT00658749|IL13|il13
693750|NCT00658749|IL-4|il-4
693751|NCT00658749|IL-13|il-13
693752|NCT00658710|hemiplegia|hemiplegia
693753|NCT00658710|stroke|stroke
693754|NCT00658710|TRIDENT|trident
693755|NCT00658697|Rising PSA|rising psa
693756|NCT00658697|androgen deprivation|androgen deprivation
693757|NCT00658697|bevacizumab (avastin)|bevacizumab (avastin)
693758|NCT00658697|docetaxel|docetaxel
693759|NCT00658697|lupron|lupron
693760|NCT00658697|zoladex|zoladex
693761|NCT00658697|bicalutamide|bicalutamide
693762|NCT00658658|Epidermal Growth Factor|epidermal growth factor
693763|NCT00658658|Pediatric|pediatric
693764|NCT00658658|Solid Tumors|solid tumors
693765|NCT00658658|Panitumumab|panitumumab
693766|NCT00658658|Dose Limiting Toxicity|dose limiting toxicity
693767|NCT00658645|Schizophrenia|schizophrenia
693768|NCT00658645|Antipsychotic|antipsychotic
693769|NCT00658645|Bifeprunox|bifeprunox
693770|NCT00658632|GERD|gerd
693771|NCT00658632|erosive GERD|erosive gerd
693772|NCT00658632|erosive esophagitis|erosive esophagitis
693773|NCT00658606|plaque psoriasis|plaque psoriasis
693774|NCT00658606|alefacept|alefacept
693775|NCT00658606|Amevive|amevive
693776|NCT00658606|narrow band ultraviolet B|narrow band ultraviolet b
693777|NCT00658606|phototherapy|phototherapy
693778|NCT00658593|adenocarcinoma of the extrahepatic bile duct|adenocarcinoma of the extrahepatic bile duct
693779|NCT00658593|unresectable extrahepatic bile duct cancer|unresectable extrahepatic bile duct cancer
693780|NCT00658593|recurrent extrahepatic bile duct cancer|recurrent extrahepatic bile duct cancer
693781|NCT00658593|adenocarcinoma of the gallbladder|adenocarcinoma of the gallbladder
693782|NCT00658593|adenocarcinoma with squamous metaplasia of the gallbladder|adenocarcinoma with squamous metaplasia of the gallbladder
693783|NCT00658593|unresectable gallbladder cancer|unresectable gallbladder cancer
693784|NCT00658593|recurrent gallbladder cancer|recurrent gallbladder cancer
693785|NCT00658593|liver and intrahepatic biliary tract cancer|liver and intrahepatic biliary tract cancer
693786|NCT00658580|Small cell lung carcinoma|small cell lung carcinoma
693787|NCT00658580|Chemotherapy|chemotherapy
693788|NCT00658580|Phase III randomised study|phase iii randomised study
693789|NCT00658528|GERD|gerd
693790|NCT00658528|erosive GERD|erosive gerd
693791|NCT00658528|erosive esophagitis|erosive esophagitis
693792|NCT00658476|Adolescent Depression|adolescent depression
693793|NCT00658476|Depression|depression
693794|NCT00658476|Teenage Depression|teenage depression
693795|NCT00658476|Los Angeles|los angeles
693796|NCT00658463|Diabetes|diabetes
693797|NCT00658463|Triglycerides|triglycerides
693798|NCT00658463|HDL-cholesterol|hdl-cholesterol
693799|NCT00658463|kinetic|kinetic
693800|NCT00658463|rosuvastatin|rosuvastatin
693801|NCT00658450|Malaria, Cerebral|malaria, cerebral
693802|NCT00658437|Melanoma, Stage IV, Phase II|melanoma, stage iv, phase ii
693803|NCT00658411|AML|aml
693804|NCT00658411|ALL|all
693805|NCT00658411|MDS|mds
693806|NCT00658411|iron overload|iron overload
693807|NCT00658411|deferoxamine|deferoxamine
693808|NCT00658398|Alcohol|alcohol
693809|NCT00658398|dependency|dependency
693810|NCT00658385|GCSF|gcsf
693811|NCT00658372|PD 0332334 phase 3 pivotal trial|pd 0332334 phase 3 pivotal trial
693812|NCT00658359|Immunosuppression|immunosuppression
693813|NCT00658359|JAK inhibitor|jak inhibitor
693814|NCT00658359|kidney transplantation|kidney transplantation
693815|NCT00658346|HIV-1 group O|hiv-1 group o
693816|NCT00658346|HIV-1 group M|hiv-1 group m
693817|NCT00658346|Cameroon|cameroon
693818|NCT00658346|HIV-1 infection|hiv-1 infection
693819|NCT00658346|treatment naïve|treatment naïve
693820|NCT00658333|Renal Transplantation|renal transplantation
693821|NCT00658333|Immunosuppression|immunosuppression
693822|NCT00658333|Renal transplant recipients|renal transplant recipients
693823|NCT00658333|Gastrointestinal symptoms associated with MMF therapy|gastrointestinal symptoms associated with mmf therapy
693824|NCT00658320|Renal transplantation|renal transplantation
693825|NCT00658320|everolimus|everolimus
693826|NCT00658320|mycophenolate mofetil|mycophenolate mofetil
693827|NCT00658320|cyclosporine|cyclosporine
693828|NCT00658320|corticosteroid|corticosteroid
693829|NCT00658320|basiliximab|basiliximab
693830|NCT00658320|Banff diagnosis|banff diagnosis
693831|NCT00658320|Acute rejection|acute rejection
693832|NCT00658320|Therapeutic drug monitoring (TDM)|therapeutic drug monitoring (tdm)
693833|NCT00658320|de novo renal transplant recipient|de novo renal transplant recipient
693834|NCT00658307|repetitive transcranial magnetic stimulation|repetitive transcranial magnetic stimulation
693835|NCT00658307|double-blind|double-blind
693836|NCT00658307|sham-controlled|sham-controlled
693837|NCT00658307|randomized|randomized
693838|NCT00658281|Breast Cancer|breast cancer
693839|NCT00658281|On Board Imager Kilovoltage|on board imager kilovoltage
693840|NCT00658281|Cone Beam Computed Tomography|cone beam computed tomography
693841|NCT00658281|Electronic Portal Imaging Device|electronic portal imaging device
693842|NCT00658281|Lymph Nodes|lymph nodes
693843|NCT00658281|CBCT|cbct
693844|NCT00658281|OBI KV|obi kv
693845|NCT00658268|Surgical procedures operative|surgical procedures operative
693846|NCT00658268|Prosthesis implantation|prosthesis implantation
693847|NCT00658268|Arthroplasty replacement|arthroplasty replacement
693848|NCT00658255|stable asthma|stable asthma
693849|NCT00658255|adults|adults
693850|NCT00658255|formoterol|formoterol
693851|NCT00658255|Symbicort|symbicort
693852|NCT00658255|Oxis Turbuhaler|oxis turbuhaler
693853|NCT00658255|bronchodilation|bronchodilation
693854|NCT00658242|craniofacial|craniofacial
693855|NCT00658242|maxillofacial|maxillofacial
693856|NCT00658242|osteotomy|osteotomy
693857|NCT00658242|craniectomy|craniectomy
693858|NCT00658242|craniotomy|craniotomy
693859|NCT00658229|Exercise|exercise
693860|NCT00658229|Prostatic|prostatic
693861|NCT00658229|Neoplasm|neoplasm
693862|NCT00658229|Androgen|androgen
693863|NCT00658229|Deprivation|deprivation
693864|NCT00658216|Diagnosis and prognosis|diagnosis and prognosis
693865|NCT00658216|Very elderly population|very elderly population
693866|NCT00658216|Heart failure|heart failure
693867|NCT00658216|Brain natriuretic peptide|brain natriuretic peptide
693868|NCT00658216|Observational prospective study|observational prospective study
693869|NCT00658216|Older|older
693870|NCT00658216|Dyspneic patients aged 80|dyspneic patients aged 80
693871|NCT00658203|CRT-P|crt-p
693872|NCT00658203|PEA|pea
693873|NCT00658203|Severe Heart Failure (NYHA Class III or IV)|severe heart failure (nyha class iii or iv)
693874|NCT00658203|Cardiomyopathy of any etiology|cardiomyopathy of any etiology
693875|NCT00658203|Sinus rhythm|sinus rhythm
693876|NCT00658203|Reduced Left-Ventricular Ejection Fraction|reduced left-ventricular ejection fraction
693877|NCT00658203|LVEDD>30 mm/m2|lvedd>30 mm/m2
693878|NCT00658203|QRS Duration: > 150 ms or > 120 ms|qrs duration: > 150 ms or > 120 ms
693879|NCT00658203|Aortic Pre-Ejection Delay > 140 ms|aortic pre-ejection delay > 140 ms
693880|NCT00658203|Interventricular Mechanical Delay > 40 ms|interventricular mechanical delay > 40 ms
693881|NCT00658203|Delayed activation of postero-lateral Left Ventricular wall|delayed activation of postero-lateral left ventricular wall
693882|NCT00658203|Optimal and stable pharmacological treatment|optimal and stable pharmacological treatment
693883|NCT00658190|Cervical cancer, automation, Internet, telecytology|cervical cancer, automation, internet, telecytology
693884|NCT00658177|Erectile dysfunction|erectile dysfunction
693885|NCT00658177|Vardenafil|vardenafil
694971|NCT00653939|tumors|tumors
693886|NCT00658164|Nonalcoholic fatty liver disease associated with increased iron stores|nonalcoholic fatty liver disease associated with increased iron stores
693887|NCT00658151|focus|focus
693888|NCT00658151|study|study
693889|NCT00658151|evaluate|evaluate
693890|NCT00658151|sonographic|sonographic
693891|NCT00658151|findings|findings
693892|NCT00658151|colon|colon
693893|NCT00658151|patients|patients
693894|NCT00658151|developed|developed
693895|NCT00658086|ALN-RSV01|aln-rsv01
693896|NCT00658086|Respiratory Syncytial Virus|respiratory syncytial virus
693897|NCT00658073|Kidney transplant|kidney transplant
693898|NCT00658073|Mesenchymal stem cell (MSC)|mesenchymal stem cell (msc)
693899|NCT00658060|FMF, Exertional leg pain|fmf, exertional leg pain
693900|NCT00658047|Arthritis, Rheumatoid|arthritis, rheumatoid
693901|NCT00658047|Phase II|phase ii
693902|NCT00658047|Rheumatoid Arthritis|rheumatoid arthritis
693903|NCT00658034|Cancer|cancer
693904|NCT00658034|Fatigue|fatigue
693905|NCT00658034|Acupuncture|acupuncture
693906|NCT00658021|diabetes|diabetes
693907|NCT00658021|adolescents|adolescents
693908|NCT00658021|exenatide|exenatide
693909|NCT00658021|Astra Zeneca|astra zeneca
693910|NCT00658008|PD 0332334 phase 3 pivotal trial|pd 0332334 phase 3 pivotal trial
693911|NCT00657995|pancreatogenic|pancreatogenic
693912|NCT00657995|diabetes|diabetes
693913|NCT00657995|artificial|artificial
693914|NCT00657995|pancreas|pancreas
693915|NCT00657969|Polymorphism, genetic|polymorphism, genetic
693916|NCT00657969|Risk factors|risk factors
693917|NCT00657969|Carotid Artery, Internal, Dissection|carotid artery, internal, dissection
693918|NCT00657969|Vertebral Artery Dissection|vertebral artery dissection
693919|NCT00657969|Genetic predisposition|genetic predisposition
693920|NCT00657969|Outcome|outcome
693921|NCT00657969|Therapy|therapy
693922|NCT00657956|osteoarthritis|osteoarthritis
693923|NCT00657956|arthroplasty|arthroplasty
693924|NCT00657956|knee joint|knee joint
693925|NCT00657956|radiography|radiography
693926|NCT00657956|surgery|surgery
693927|NCT00657956|Bone Density|bone density
693928|NCT00657956|Outcome Assessment (Health Care)|outcome assessment (health care)
693929|NCT00657943|carotid|carotid
693930|NCT00657943|intima|intima
693931|NCT00657943|media|media
693932|NCT00657943|thickness|thickness
693933|NCT00657943|insulin|insulin
693934|NCT00657943|metformin|metformin
693935|NCT00657917|leishmaniasis|leishmaniasis
693936|NCT00657917|cutaneous|cutaneous
693937|NCT00657917|Old World|old world
693938|NCT00657917|Leishmania major|leishmania major
693939|NCT00657917|Treatment|treatment
693940|NCT00657904|androgen antagonists|androgen antagonists
693941|NCT00657904|prostate neoplasms|prostate neoplasms
693942|NCT00657891|Allergic Asthma|allergic asthma
693943|NCT00657891|Anti IgE|anti ige
693944|NCT00657891|Xolair|xolair
693945|NCT00657891|Basophil|basophil
693946|NCT00657891|IL-13|il-13
693947|NCT00657891|IL-4|il-4
693948|NCT00657891|Histamine|histamine
693949|NCT00657878|platinum free interval|platinum free interval
693950|NCT00657878|chemotherapy|chemotherapy
693951|NCT00657852|pamidronate,bone loss, liver transplantation|pamidronate,bone loss, liver transplantation
693952|NCT00657839|Benign Prostate Hyperplasia|benign prostate hyperplasia
693953|NCT00657839|Vardenafil|vardenafil
693954|NCT00657839|Genital Disease|genital disease
693955|NCT00657839|Male: Signs and symptoms of Benign Prostate Hyperplasia|male: signs and symptoms of benign prostate hyperplasia
693956|NCT00657826|Diseased Heart Valve, Replacement|diseased heart valve, replacement
693957|NCT00657813|Alzheimer|alzheimer
693958|NCT00657813|SPECT|spect
693959|NCT00657800|diabetes, inpatient, education,|diabetes, inpatient, education,
693960|NCT00657787|Posttraumatic Stress Disorder|posttraumatic stress disorder
693961|NCT00657787|Veterans|veterans
693962|NCT00657787|Health Services|health services
693963|NCT00657774|Asthma|asthma
693964|NCT00657774|Mild to Moderate|mild to moderate
693965|NCT00657748|Leukodystrophy|leukodystrophy
693966|NCT00657748|Canavan disease,|canavan disease,
693967|NCT00657748|Aspartoacylase,|aspartoacylase,
693968|NCT00657748|Lithium,|lithium,
693969|NCT00657748|Glyceryl Triacetate|glyceryl triacetate
693970|NCT00657735|bipolar|bipolar
693971|NCT00657735|depression|depression
693972|NCT00657735|prefrontal|prefrontal
693973|NCT00657735|cortex|cortex
693974|NCT00657735|antidepressant|antidepressant
693975|NCT00657735|response|response
693976|NCT00657722|Pulmonary hypertension|pulmonary hypertension
693977|NCT00657722|Chronic thromboembolic pulmonary hypertension|chronic thromboembolic pulmonary hypertension
693978|NCT00657722|Operability|operability
693979|NCT00657722|Thromboendarteriectomy|thromboendarteriectomy
693980|NCT00657722|Operative mortality rate|operative mortality rate
693981|NCT00657722|Technical failure|technical failure
693982|NCT00657722|Pulmonary angiography|pulmonary angiography
693983|NCT00657722|Computed tomography|computed tomography
693984|NCT00657709|infant|infant
693985|NCT00657709|Meningococcal disease|meningococcal disease
693986|NCT00657709|prevention|prevention
693987|NCT00657709|vaccination|vaccination
693988|NCT00657696|primary health care|primary health care
693989|NCT00657696|organizations|organizations
693990|NCT00657696|learning|learning
693991|NCT00657696|quality of health care|quality of health care
693992|NCT00657683|GBS|gbs
693993|NCT00657683|GBS prevention|gbs prevention
693994|NCT00657670|refractive error|refractive error
693995|NCT00657670|spectacles|spectacles
693996|NCT00657670|ready made spectacles|ready made spectacles
693997|NCT00657670|vision|vision
693998|NCT00657670|cost effectiveness|cost effectiveness
693999|NCT00657657|Hepatitis|hepatitis
694000|NCT00657657|vaccine|vaccine
694001|NCT00657644|Erectile Dysfunction|erectile dysfunction
694002|NCT00657631|Acceptance and Commitment Therapy|acceptance and commitment therapy
694003|NCT00657631|Delusions|delusions
694004|NCT00657618|Leishmaniasis, Sodium stibogluconate, Pentostam, sand fly|leishmaniasis, sodium stibogluconate, pentostam, sand fly
694005|NCT00657605|Congenital leptin deficiency|congenital leptin deficiency
694006|NCT00657605|Obesity|obesity
694007|NCT00657605|Metabolic syndrome|metabolic syndrome
694008|NCT00657605|Diabetes|diabetes
694009|NCT00657566|intraabdominal|intraabdominal
694010|NCT00657566|peritonitis|peritonitis
694011|NCT00657566|sepsis|sepsis
694012|NCT00657566|duration|duration
694013|NCT00657566|antibiotics|antibiotics
694014|NCT00657540|black widow spider|black widow spider
694015|NCT00657540|antivenom|antivenom
694016|NCT00657540|latrodectism|latrodectism
694017|NCT00657527|Crestor|crestor
694018|NCT00657527|Rosuvastatin|rosuvastatin
694019|NCT00657527|Cholesterol|cholesterol
694020|NCT00657527|Coronary artery disease|coronary artery disease
694021|NCT00657527|Myocardial ischaemia.|myocardial ischaemia.
694022|NCT00657514|hemoglobin desaturation kinetics|hemoglobin desaturation kinetics
694023|NCT00657514|peripheral arterial disease|peripheral arterial disease
694024|NCT00657514|chronic angina|chronic angina
694025|NCT00657514|exercise tolerance|exercise tolerance
694026|NCT00657501|testosterone|testosterone
694027|NCT00657501|hypoactive sexual desire disorder|hypoactive sexual desire disorder
694028|NCT00657501|menopause|menopause
694029|NCT00657488|Multiple Myeloma, Thalidomide, dose, dexamethasone|multiple myeloma, thalidomide, dose, dexamethasone
694030|NCT00657475|Heparin low dose|heparin low dose
694031|NCT00657475|Inflammation|inflammation
694032|NCT00657475|Blood loss|blood loss
694033|NCT00657462|Medical Informatics Applications|medical informatics applications
694034|NCT00657462|Software|software
694035|NCT00657462|Utilization|utilization
694036|NCT00657449|sprains and strains|sprains and strains
694037|NCT00657436|Acute Coronary Syndrome|acute coronary syndrome
694038|NCT00657436|Myocardial Infarction|myocardial infarction
694039|NCT00657436|Coronary Artery Disease|coronary artery disease
694040|NCT00657423|Lung Neoplasms|lung neoplasms
694041|NCT00657423|Endostatins|endostatins
694042|NCT00657423|Vascular Endothelial Growth Factors|vascular endothelial growth factors
694043|NCT00657423|Fibroblast Growth Factors|fibroblast growth factors
694044|NCT00657423|Survival Rate|survival rate
694045|NCT00657410|idiopathic thrombocytopenic purpura|idiopathic thrombocytopenic purpura
694046|NCT00657397|Methadone|methadone
694047|NCT00657397|Substance Dependence|substance dependence
694048|NCT00657384|Specify the primary condition or disease being studied Major Hepatectomy|specify the primary condition or disease being studied major hepatectomy
694049|NCT00657371|Colorectal Cancer|colorectal cancer
694050|NCT00657371|Colonoscopy|colonoscopy
694051|NCT00657371|Third Eye Retroscope|third eye retroscope
694052|NCT00657371|Third Eye Retroscope Auxiliary Imaging System|third eye retroscope auxiliary imaging system
694053|NCT00657371|Polypectomy|polypectomy
694054|NCT00657358|lidocaine|lidocaine
694055|NCT00657358|allodynia|allodynia
694056|NCT00657358|chronic regional pain syndrome|chronic regional pain syndrome
694057|NCT00657358|pain|pain
694058|NCT00657345|trastuzumab|trastuzumab
694059|NCT00657345|breast cancer|breast cancer
694060|NCT00657345|her2 positive breast cancer|her2 positive breast cancer
694061|NCT00657306|Cirrhosis|cirrhosis
694062|NCT00657306|Ascites|ascites
694063|NCT00657306|Adrenal insufficiency|adrenal insufficiency
694064|NCT00657306|Hepatorenal syndrome|hepatorenal syndrome
694065|NCT00657306|Portal hypertension|portal hypertension
694066|NCT00657293|COPD|copd
694067|NCT00657293|arm training|arm training
694068|NCT00657293|dyspnoea|dyspnoea
694069|NCT00657293|quality of life|quality of life
694070|NCT00657267|recurrent glioblastoma|recurrent glioblastoma
694071|NCT00657267|temodar|temodar
694072|NCT00657267|temozolomide|temozolomide
694073|NCT00657254|Extension|extension
694074|NCT00657254|Sorafenib|sorafenib
694075|NCT00657254|Survival|survival
694076|NCT00657241|cardiac work|cardiac work
694077|NCT00657241|coreg cr|coreg cr
694078|NCT00657241|valsartan|valsartan
694079|NCT00657241|tonometry|tonometry
694080|NCT00657228|Anaphylaxis|anaphylaxis
694081|NCT00657228|Anaphylactoid reactions|anaphylactoid reactions
694082|NCT00657202|NF1|nf1
694083|NCT00657202|neurofibroma|neurofibroma
694084|NCT00657202|ranibizumab|ranibizumab
694085|NCT00657202|Lucentis|lucentis
694086|NCT00657189|Sifalimumab|sifalimumab
694087|NCT00657189|MEDI-545|medi-545
694972|NCT00653939|NSCLC|nsclc
694088|NCT00657189|Lupus erythematosus, systemic|lupus erythematosus, systemic
694089|NCT00657163|Stroke recovery|stroke recovery
694090|NCT00657163|Pharmacological modulation|pharmacological modulation
694091|NCT00657163|Selective Serotonin Reuptake Inhibitor (SSRI)|selective serotonin reuptake inhibitor (ssri)
694092|NCT00657163|Fluoxetine|fluoxetine
694093|NCT00657163|Brain plasticity|brain plasticity
694094|NCT00657163|Ischemic Stroke and Motor impairment|ischemic stroke and motor impairment
694095|NCT00657163|Modulation of recovery and cerebral plasticity by Fluoxetine|modulation of recovery and cerebral plasticity by fluoxetine
694096|NCT00657137|HER2/neu positive|her2/neu positive
694097|NCT00657137|locally advanced or metastatic|locally advanced or metastatic
694099|NCT00657111|influenza, elderly, United Kingdom|influenza, elderly, united kingdom
694100|NCT00657111|Vaxart|vaxart
694101|NCT00657098|Side effects|side effects
694102|NCT00657098|Angiogenesis inhibitors|angiogenesis inhibitors
694103|NCT00657098|Epidermal growth factor receptor inhibitors|epidermal growth factor receptor inhibitors
694104|NCT00657098|Tyrosinekinase inhibitors|tyrosinekinase inhibitors
694105|NCT00657085|Laser hair removal|laser hair removal
694106|NCT00657072|scapholunate instability|scapholunate instability
694107|NCT00657072|neural networks|neural networks
694108|NCT00657072|scaphoid|scaphoid
694109|NCT00657072|lunate|lunate
694110|NCT00657072|Suspected torn scapholunate interosseous ligament|suspected torn scapholunate interosseous ligament
694111|NCT00657072|Suspected other torn wrist ligaments|suspected other torn wrist ligaments
694112|NCT00657059|IgA nephropathy|iga nephropathy
694113|NCT00657059|mycophenolate mofetil|mycophenolate mofetil
694114|NCT00657033|Erectile Dysfunction|erectile dysfunction
694115|NCT00657020|nicotine|nicotine
694116|NCT00657020|therapy|therapy
694117|NCT00657020|fMRI/EEG|fmri/eeg
694118|NCT00657020|replacement|replacement
694119|NCT00657007|lupus|lupus
694120|NCT00657007|SLE|sle
694121|NCT00656994|Sleep Disorder|sleep disorder
694122|NCT00656994|Insomnia|insomnia
694123|NCT00656981|Moderate Acne Vulgaris|moderate acne vulgaris
694124|NCT00656981|Acne|acne
694125|NCT00656968|peptic ulcer disease|peptic ulcer disease
694126|NCT00656968|gastric cancer|gastric cancer
694127|NCT00656968|therapeutics|therapeutics
694128|NCT00656955|Kidney Cancer|kidney cancer
694129|NCT00656955|Molecular Epidemiology|molecular epidemiology
694130|NCT00656955|Survival|survival
694131|NCT00656955|Occupational Exposures|occupational exposures
694132|NCT00656955|Renal Cancer|renal cancer
694133|NCT00656942|Pain|pain
694134|NCT00656929|Vitamin D|vitamin d
694135|NCT00656929|Viral URI|viral uri
694136|NCT00656929|Influenza|influenza
694137|NCT00656929|Colds|colds
694138|NCT00656916|Post-Transplant Constrictive Bronchiolitis|post-transplant constrictive bronchiolitis
694139|NCT00656916|Bronchiolitis|bronchiolitis
694140|NCT00656916|Fluticasone Propionate|fluticasone propionate
694141|NCT00656916|Inhaled Corticosteroids|inhaled corticosteroids
694142|NCT00656916|Lung Condition|lung condition
694143|NCT00656916|PTCB|ptcb
694144|NCT00656903|Lucentis|lucentis
694145|NCT00656903|Indocyanine Green Angiography|indocyanine green angiography
694146|NCT00656903|Choroidal Neovascularization|choroidal neovascularization
694147|NCT00656903|Macular Degeneration|macular degeneration
694148|NCT00656903|Ranibizumab|ranibizumab
694149|NCT00656903|Age-Related Macular Degeneration|age-related macular degeneration
694150|NCT00656903|AMD|amd
694151|NCT00656890|ulcerative colitis, rectal bleeding|ulcerative colitis, rectal bleeding
694152|NCT00656877|Fat Embolism Total Knee Arthroplasty|fat embolism total knee arthroplasty
694153|NCT00656864|Diabetes|diabetes
694154|NCT00656864|pioglitazone|pioglitazone
694155|NCT00656864|GIP|gip
694156|NCT00656851|HIV/AIDS|hiv/aids
694157|NCT00656851|Heart disease|heart disease
694158|NCT00656851|Diabetes|diabetes
694159|NCT00656851|Cardiovascular disease risk|cardiovascular disease risk
694160|NCT00656851|Dyslipidemia|dyslipidemia
694161|NCT00656851|Visceral adiposity|visceral adiposity
694162|NCT00656851|treatment experienced|treatment experienced
694163|NCT00656838|colon|colon
694164|NCT00656838|rectal|rectal
694165|NCT00656838|cancer|cancer
694166|NCT00656838|screening|screening
694167|NCT00656825|P144|p144
694168|NCT00656825|TGF-β1|tgf-β1
694169|NCT00656825|Healthy volunteers|healthy volunteers
694170|NCT00656825|Cutaneous tolerability|cutaneous tolerability
694171|NCT00656825|Skin fibrosis|skin fibrosis
694172|NCT00656825|systemic scleroderma|systemic scleroderma
694173|NCT00656825|systemic sclerosis|systemic sclerosis
694174|NCT00656825|Safety|safety
694175|NCT00656812|advanced MALT lymphoma|advanced malt lymphoma
694176|NCT00656812|Rituximab|rituximab
694177|NCT00656812|2CdA|2cda
694178|NCT00656812|chemotherapy|chemotherapy
694179|NCT00656812|immunotherapy|immunotherapy
694180|NCT00656773|morphine, sufentanil, acute pain, opioid, Prehospital Emergency Care|morphine, sufentanil, acute pain, opioid, prehospital emergency care
694181|NCT00656760|unknown primary, head and neck cancer, squamous cell carcinoma|unknown primary, head and neck cancer, squamous cell carcinoma
694182|NCT00656760|Unknown primary head and neck cancer|unknown primary head and neck cancer
694183|NCT00656747|Chronic Obstructive Pulmonary Disease (COPD)|chronic obstructive pulmonary disease (copd)
694184|NCT00656747|Acute exacerbation of COPD (AECOPD)|acute exacerbation of copd (aecopd)
694185|NCT00656747|chronic bronchitis|chronic bronchitis
694186|NCT00656747|bronchitis|bronchitis
694187|NCT00656747|chest infection|chest infection
694188|NCT00656747|smoking|smoking
694189|NCT00656747|lung disease|lung disease
694190|NCT00656747|lung|lung
694191|NCT00656747|lungs|lungs
694192|NCT00656734|Medarex Inc.|medarex inc.
694193|NCT00656721|bronchiectasis|bronchiectasis
694194|NCT00656721|physiotherapy|physiotherapy
694195|NCT00656721|flutter valve|flutter valve
694196|NCT00656721|impulse oscillation technique|impulse oscillation technique
694197|NCT00656708|Burns|burns
694198|NCT00656708|Wounds|wounds
694199|NCT00656708|Healthcare associated infections|healthcare associated infections
694200|NCT00656708|MRSA|mrsa
694201|NCT00656708|VRE|vre
694202|NCT00656695|Iminoral|iminoral
694203|NCT00656695|Neoral|neoral
694204|NCT00656695|Acute renal transplant rejection|acute renal transplant rejection
694205|NCT00656682|Prevention & Control|prevention & control
694206|NCT00656682|Hyperglycemia|hyperglycemia
694207|NCT00656682|Obesity|obesity
694208|NCT00656682|Diabetes Mellitus|diabetes mellitus
694209|NCT00656682|Cost Benefit Analysis|cost benefit analysis
694210|NCT00656669|newly diagnosed breast cancer|newly diagnosed breast cancer
694211|NCT00656669|neoadjuvant therapy|neoadjuvant therapy
694212|NCT00656656|pemphigus|pemphigus
694213|NCT00656656|rituximab|rituximab
694214|NCT00656656|immunoadsorption|immunoadsorption
694215|NCT00656656|dexamethasone|dexamethasone
694216|NCT00656656|treatment|treatment
694217|NCT00656656|management|management
694218|NCT00656617|Acute Myeloid Leukemia|acute myeloid leukemia
694219|NCT00656617|(AML)|(aml)
694220|NCT00656617|Myelodysplastic syndrome|myelodysplastic syndrome
694221|NCT00656617|(MDS)|(mds)
694222|NCT00656617|Leukemia|leukemia
694223|NCT00656617|Idarubicin|idarubicin
694224|NCT00656617|Cytarabine|cytarabine
694225|NCT00656617|Vorinostat|vorinostat
694226|NCT00656617|Ara-C|ara-c
694227|NCT00656604|recurrent breast cancer|recurrent breast cancer
694228|NCT00656604|stage I breast cancer|stage i breast cancer
694229|NCT00656604|stage II breast cancer|stage ii breast cancer
694230|NCT00656604|stage IIIA breast cancer|stage iiia breast cancer
694231|NCT00656604|stage IIIB breast cancer|stage iiib breast cancer
694232|NCT00656604|stage IIIC breast cancer|stage iiic breast cancer
694233|NCT00656591|Child mortality, Nepal, Community, care practices|child mortality, nepal, community, care practices
694234|NCT00656578|Foot|foot
694235|NCT00656578|Bunion|bunion
694236|NCT00656578|Bunionectomy|bunionectomy
694237|NCT00656578|Hallux Valgus Deformity|hallux valgus deformity
694238|NCT00656578|Surgery for Transpositional first metatarsal osteotomy - Bunionectomy|surgery for transpositional first metatarsal osteotomy - bunionectomy
694239|NCT00656565|measure inspiratory spirometry with dry powder inhaler device in series with the spirometer|measure inspiratory spirometry with dry powder inhaler device in series with the spirometer
694240|NCT00656526|analgesia, postlaminectomy , lidocaine, dorsal root|analgesia, postlaminectomy , lidocaine, dorsal root
694241|NCT00656513|hypopharyngeal cancer|hypopharyngeal cancer
694242|NCT00656513|laryngeal cancer|laryngeal cancer
694243|NCT00656513|lip and oral cavity cancer|lip and oral cavity cancer
694244|NCT00656513|nasopharyngeal cancer|nasopharyngeal cancer
694245|NCT00656513|paranasal sinus and nasal cavity cancer|paranasal sinus and nasal cavity cancer
694246|NCT00656513|oropharyngeal cancer|oropharyngeal cancer
694247|NCT00656513|salivary gland cancer|salivary gland cancer
694248|NCT00656513|metastatic squamous neck cancer with occult primary|metastatic squamous neck cancer with occult primary
694249|NCT00656513|xerostomia|xerostomia
694250|NCT00656513|tongue cancer|tongue cancer
694251|NCT00656500|surgical patients|surgical patients
694252|NCT00656500|cigarette smoking|cigarette smoking
694253|NCT00656500|postoperative complications|postoperative complications
694254|NCT00656500|telephone counseling|telephone counseling
694255|NCT00656500|quitlines|quitlines
694256|NCT00656487|Cannabis Dependence|cannabis dependence
694257|NCT00656487|Marijuana Dependence|marijuana dependence
694258|NCT00656487|Cannabis Withdrawal|cannabis withdrawal
694259|NCT00656487|Rimonabant|rimonabant
694260|NCT00656487|cannabinoid receptor type 1 (CB1) inverse agonist|cannabinoid receptor type 1 (cb1) inverse agonist
694261|NCT00656487|Neuropsychology|neuropsychology
694262|NCT00656487|functional magnetic resonance imaging (fMRI)|functional magnetic resonance imaging (fmri)
694263|NCT00656487|Endocannabinoids|endocannabinoids
694264|NCT00656487|Cortisol|cortisol
694265|NCT00656474|burn wounds|burn wounds
694266|NCT00656474|wound healing|wound healing
694267|NCT00656461|Advanced cancer|advanced cancer
694268|NCT00656448|Acute Myelogenous Leukemia|acute myelogenous leukemia
694269|NCT00656448|AML|aml
694270|NCT00656448|Myelodysplastic Syndrome|myelodysplastic syndrome
694271|NCT00656448|MDS|mds
694272|NCT00656448|Leukemia|leukemia
694273|NCT00656448|Procrit|procrit
694274|NCT00656448|Epoetin Alfa|epoetin alfa
694275|NCT00656448|Epogen|epogen
694276|NCT00656435|proliferative diabetic retinopathy|proliferative diabetic retinopathy
694277|NCT00656435|bevacizumab (Avastin)|bevacizumab (avastin)
694278|NCT00656435|vitreous hemorrhage|vitreous hemorrhage
694279|NCT00656435|long acting gas|long acting gas
694280|NCT00656422|insulin therapy|insulin therapy
694281|NCT00656422|hepatic fat|hepatic fat
694282|NCT00656422|type 2 diabetes|type 2 diabetes
694283|NCT00656422|body composition|body composition
694284|NCT00656422|comparison of insulin detemir and insulin glargine|comparison of insulin detemir and insulin glargine
694285|NCT00656422|Changes in Hepatic Fat|changes in hepatic fat
694286|NCT00656422|Obesity|obesity
694287|NCT00656409|Ataxia telangiectasia,|ataxia telangiectasia,
694288|NCT00656409|Conjugated pneumococcal,|conjugated pneumococcal,
694289|NCT00656409|Prevenar,|prevenar,
694290|NCT00656409|Immunogenicity ,|immunogenicity ,
694291|NCT00656409|Vaccine|vaccine
694292|NCT00656396|Blood loss|blood loss
694293|NCT00656396|Point of care monitoring|point of care monitoring
694294|NCT00656396|FFP|ffp
694295|NCT00656396|Major surgery|major surgery
694296|NCT00656396|Prothrombin Time|prothrombin time
694297|NCT00656396|Blood coagulation tests|blood coagulation tests
694298|NCT00656383|venous ulcer, leg ulcer, stasis ulcer|venous ulcer, leg ulcer, stasis ulcer
694299|NCT00656370|Hylenex|hylenex
694300|NCT00656370|subcutaneous infusion|subcutaneous infusion
694301|NCT00656370|hyaluronidase|hyaluronidase
694302|NCT00656370|rHuPH20|rhuph20
694303|NCT00656370|recombinant human hyaluronidase|recombinant human hyaluronidase
694304|NCT00656344|PTSD|ptsd
694305|NCT00656344|Substance Abuse|substance abuse
694306|NCT00656344|WTC attacks|wtc attacks
694307|NCT00656344|Iraq War|iraq war
694308|NCT00656318|women|women
694309|NCT00656318|menses|menses
694310|NCT00656318|oral contraceptives|oral contraceptives
694311|NCT00656318|Healthy menstruating females|healthy menstruating females
694312|NCT00656305|Bone Cancer|bone cancer
694313|NCT00656305|Pain Palliation|pain palliation
694314|NCT00656305|Metastasis|metastasis
694315|NCT00656305|Multiple Myeloma|multiple myeloma
694316|NCT00656305|Breast Cancer|breast cancer
694317|NCT00656305|Lung Cancer|lung cancer
694318|NCT00656305|Prostate Cancer|prostate cancer
694319|NCT00656305|cancer related Pain|cancer related pain
694320|NCT00656305|Tumors|tumors
694321|NCT00656292|Plasma concentrations of inflammatory markers|plasma concentrations of inflammatory markers
694322|NCT00656292|C-Reactive Protein (CRP)|c-reactive protein (crp)
694323|NCT00656292|Interleukin-6 (IL-6)|interleukin-6 (il-6)
694324|NCT00656292|Tumor Necrosis Factor-Alpha (TNF)|tumor necrosis factor-alpha (tnf)
694325|NCT00656292|Aspartate Aminotransferase (AST)|aspartate aminotransferase (ast)
694326|NCT00656292|Alanine Aminotransferase (ALT)|alanine aminotransferase (alt)
694327|NCT00656292|Creatine Kinase (CK)|creatine kinase (ck)
694328|NCT00656279|chronic kidney disease|chronic kidney disease
694329|NCT00656279|predialysis|predialysis
694330|NCT00656279|hyperphosphatemia|hyperphosphatemia
694331|NCT00656279|dietary intervention|dietary intervention
694332|NCT00656279|intensive dietary education|intensive dietary education
694333|NCT00656279|low phosphorus diet|low phosphorus diet
694334|NCT00656266|renal insufficiency and/or renal failure after liver transplantation|renal insufficiency and/or renal failure after liver transplantation
694335|NCT00656214|Lichen Planus|lichen planus
694336|NCT00656201|Infertility|infertility
694337|NCT00656201|In vitro fertilization|in vitro fertilization
694338|NCT00656201|Embryo transfer|embryo transfer
694339|NCT00656201|Crinone|crinone
694340|NCT00656201|Intramuscular Progesterone|intramuscular progesterone
694341|NCT00656201|Progesterone support|progesterone support
694342|NCT00656188|Erectile Dysfunction|erectile dysfunction
694343|NCT00656188|Vardenafil|vardenafil
694344|NCT00656175|lipodystrophy|lipodystrophy
694345|NCT00656175|fat|fat
694346|NCT00656175|visceral fat|visceral fat
694347|NCT00656175|HIV|hiv
694348|NCT00656175|women|women
694349|NCT00656175|raltegravir|raltegravir
694350|NCT00656175|ART|art
694351|NCT00656175|anti HIV therapy|anti hiv therapy
694352|NCT00656175|NNRTI|nnrti
694353|NCT00656175|Protease inhibitor|protease inhibitor
694354|NCT00656175|integrase inhibitor|integrase inhibitor
694355|NCT00656175|treatment experienced|treatment experienced
694356|NCT00656149|telerehabilitation|telerehabilitation
694357|NCT00656149|functional electrical stimulation|functional electrical stimulation
694358|NCT00656149|spinal cord injury|spinal cord injury
694359|NCT00656149|hand function rehabilitation|hand function rehabilitation
694360|NCT00656123|adenocarcinoma of the colon|adenocarcinoma of the colon
694361|NCT00656123|adenocarcinoma of the rectum|adenocarcinoma of the rectum
694362|NCT00656123|stage IV colon cancer|stage iv colon cancer
694363|NCT00656123|stage IV rectal cancer|stage iv rectal cancer
694364|NCT00656110|Restless legs syndrome|restless legs syndrome
694365|NCT00656110|Morton's neuroma|morton's neuroma
694366|NCT00656110|Randomized controlled trial|randomized controlled trial
694367|NCT00656097|Rabies post-exposure prophylaxis|rabies post-exposure prophylaxis
694368|NCT00656071|ARDS|ards
694369|NCT00656071|Acute respiratory distress syndrome|acute respiratory distress syndrome
694370|NCT00656071|Adult respiratory distress syndrome|adult respiratory distress syndrome
694371|NCT00656071|respiratory distress|respiratory distress
694372|NCT00656058|Leukotriene|leukotriene
694373|NCT00656058|Chronic Graft-Versus-Host Disease|chronic graft-versus-host disease
694374|NCT00656058|Montelukast|montelukast
694375|NCT00656058|Stem Cell Transplant|stem cell transplant
694376|NCT00656058|Bronchiolitis Obliterans|bronchiolitis obliterans
694377|NCT00656045|Obesity|obesity
694378|NCT00656045|Physical Activity|physical activity
694379|NCT00656045|Weight Loss|weight loss
694380|NCT00656045|Exercise|exercise
694381|NCT00656045|Dietary Intake|dietary intake
694382|NCT00656045|Energy|energy
694383|NCT00656045|Behavioral|behavioral
694384|NCT00656045|Healthy Eating|healthy eating
694385|NCT00656032|insulin resistance|insulin resistance
694386|NCT00656032|end stage renal disease|end stage renal disease
694387|NCT00656006|Hepatitis C|hepatitis c
694388|NCT00656006|Chronic|chronic
694389|NCT00656006|Genotype 2 or 3|genotype 2 or 3
694390|NCT00656006|Treatment naive|treatment naive
694391|NCT00655993|COPD|copd
694392|NCT00655993|Inflammation|inflammation
694393|NCT00655993|CRP levels|crp levels
694394|NCT00655993|simvastatin|simvastatin
694395|NCT00655954|COPD|copd
694396|NCT00655954|asthma|asthma
694397|NCT00655954|smokers|smokers
694398|NCT00655954|healthy volunteers|healthy volunteers
694399|NCT00655954|bronchiectasis|bronchiectasis
694400|NCT00655954|cystic fibrosis|cystic fibrosis
694401|NCT00655941|Osteoarthritis|osteoarthritis
694402|NCT00655941|Obesity|obesity
694403|NCT00655941|Weight loss|weight loss
694404|NCT00655941|Dietary instruction|dietary instruction
694405|NCT00655941|Exercise|exercise
694406|NCT00655941|Attention|attention
694407|NCT00655928|Acute lung injury|acute lung injury
694408|NCT00655928|Lung resection|lung resection
694409|NCT00655902|Trans fat|trans fat
694410|NCT00655902|Obesity|obesity
694411|NCT00655902|Insulin sensitivity|insulin sensitivity
694412|NCT00655876|stage IIA esophageal cancer|stage iia esophageal cancer
694413|NCT00655876|stage IIB esophageal cancer|stage iib esophageal cancer
694414|NCT00655876|stage IIIA esophageal cancer|stage iiia esophageal cancer
694415|NCT00655876|stage IIIB esophageal cancer|stage iiib esophageal cancer
694416|NCT00655876|stage IIIC esophageal cancer|stage iiic esophageal cancer
694417|NCT00655876|stage IV esophageal cancer|stage iv esophageal cancer
694418|NCT00655876|squamous cell carcinoma of the esophagus|squamous cell carcinoma of the esophagus
694419|NCT00655863|Glucose Metabolism Disorder|glucose metabolism disorder
694420|NCT00655863|Dysmetabolic Syndrome|dysmetabolic syndrome
694421|NCT00655863|Type II Diabetes|type ii diabetes
694422|NCT00655863|Diabetes Mellitus|diabetes mellitus
694423|NCT00655863|Lipoatrophic; Dyslipidemia|lipoatrophic; dyslipidemia
694424|NCT00655863|Drug Therapy|drug therapy
694425|NCT00655850|Lung Cancer|lung cancer
694426|NCT00655850|Non-Small Cell Lung Cancer|non-small cell lung cancer
694427|NCT00655850|Metronomic Chemotherapy|metronomic chemotherapy
694428|NCT00655837|Antigens, CD40|antigens, cd40
694429|NCT00655837|Antibodies, Monoclonal|antibodies, monoclonal
694430|NCT00655837|Combined Modality Therapy|combined modality therapy
694431|NCT00655837|Lymphoma, Large B-Cell, Diffuse|lymphoma, large b-cell, diffuse
694432|NCT00655837|Lymphoma, Non-Hodgkin|lymphoma, non-hodgkin
694433|NCT00655837|Hematologic Diseases|hematologic diseases
694434|NCT00655837|Immunoproliferative Disorders|immunoproliferative disorders
694435|NCT00655837|Lymphatic Diseases|lymphatic diseases
694436|NCT00655837|Lymphoproliferative Disorders|lymphoproliferative disorders
694437|NCT00655837|Lymphoma|lymphoma
694438|NCT00655811|Healthy volunteers|healthy volunteers
694439|NCT00655785|Epitope peptide|epitope peptide
694440|NCT00655785|CTL|ctl
694441|NCT00655785|Pancreatic cancer|pancreatic cancer
694442|NCT00655785|Vaccination VEGFR1|vaccination vegfr1
694443|NCT00655785|VEGFR2|vegfr2
694444|NCT00655772|chlorine|chlorine
694445|NCT00655772|dioxide|dioxide
694446|NCT00655772|mouthwash|mouthwash
694447|NCT00655772|organoleptic|organoleptic
694448|NCT00655772|measurements|measurements
694449|NCT00655772|volatile|volatile
694450|NCT00655772|sulfur|sulfur
694451|NCT00655772|compounds|compounds
694452|NCT00655746|Healthy Subjects|healthy subjects
694453|NCT00655720|infant formula|infant formula
694454|NCT00655707|Adult stem cell therapy|adult stem cell therapy
694455|NCT00655694|COPD|copd
694456|NCT00655694|smokers|smokers
694457|NCT00655694|healthy volunteers|healthy volunteers
694458|NCT00655681|pediatric osteoporosis|pediatric osteoporosis
694459|NCT00655681|pediatric osteopenia|pediatric osteopenia
694460|NCT00655681|pamidronate|pamidronate
694461|NCT00655681|post operative osteopenia|post operative osteopenia
694462|NCT00655668|NHL, Non-Hodgkin's Lymphoma, T-cell Lymphoma|nhl, non-hodgkin's lymphoma, t-cell lymphoma
694463|NCT00655629|Erectile Dysfunction|erectile dysfunction
694464|NCT00655603|GLP-1|glp-1
694465|NCT00655603|Glucagon secretion|glucagon secretion
694466|NCT00655603|Glucose turn-over|glucose turn-over
694467|NCT00655590|Erectile Dysfunction|erectile dysfunction
694468|NCT00655590|Sildenafil|sildenafil
694469|NCT00655590|Vardenafil|vardenafil
694470|NCT00655590|Spermatogenesis|spermatogenesis
694471|NCT00655590|Sperm concentration|sperm concentration
694472|NCT00655590|Sperm count|sperm count
694473|NCT00655590|Morphology|morphology
694475|NCT00655590|Reproductive hormonal|reproductive hormonal
694476|NCT00655577|Aging|aging
694477|NCT00655577|Osteoporosis|osteoporosis
694478|NCT00655577|Exercise|exercise
694479|NCT00655577|Population based|population based
694480|NCT00655577|Randomized trial|randomized trial
694481|NCT00655577|Falls|falls
694482|NCT00655577|Fractures|fractures
694483|NCT00655551|epilepsy|epilepsy
694484|NCT00655551|seizures|seizures
694485|NCT00655551|Lacosamide|lacosamide
694486|NCT00655551|Vimpat|vimpat
694487|NCT00655551|intravenous|intravenous
694488|NCT00655525|inflammation|inflammation
694489|NCT00655525|end stage renal disease|end stage renal disease
694490|NCT00655512|pimecrolimus|pimecrolimus
694491|NCT00655512|hydrocortison|hydrocortison
694492|NCT00655512|betamethasone|betamethasone
694493|NCT00655512|clobetasol-17-Propionat|clobetasol-17-propionat
694494|NCT00655512|Optical Coherence Tomography|optical coherence tomography
694495|NCT00655512|skin healthy probands|skin healthy probands
694496|NCT00655499|adenocarcinoma of the colon|adenocarcinoma of the colon
694497|NCT00655499|adenocarcinoma of the rectum|adenocarcinoma of the rectum
694498|NCT00655499|stage IV colon cancer|stage iv colon cancer
694499|NCT00655499|recurrent rectal cancer|recurrent rectal cancer
694500|NCT00655499|stage IV rectal cancer|stage iv rectal cancer
694501|NCT00655499|recurrent colon cancer|recurrent colon cancer
694502|NCT00655486|Epilepsy|epilepsy
694503|NCT00655486|seizures|seizures
694504|NCT00655486|antiepileptic|antiepileptic
694505|NCT00655486|Lacosamide|lacosamide
694506|NCT00655486|Vimpat|vimpat
694507|NCT00655486|safety|safety
694508|NCT00655486|adjunctive|adjunctive
694509|NCT00655460|Glucose|glucose
694510|NCT00655460|Insulin|insulin
694511|NCT00655460|computer|computer
694512|NCT00655460|critical care|critical care
694513|NCT00655447|oophorectomy|oophorectomy
694514|NCT00655447|ovarian conservation|ovarian conservation
694515|NCT00655447|stroke|stroke
694516|NCT00655447|breast cancer|breast cancer
694517|NCT00655447|ovarian cancer|ovarian cancer
694518|NCT00655447|other cancer|other cancer
694519|NCT00655447|hip fracture|hip fracture
694520|NCT00655434|Herpes simplex virus 2|herpes simplex virus 2
694521|NCT00655434|HSV 2|hsv 2
694522|NCT00655434|Antibody status to Herpesvirus 2, Human|antibody status to herpesvirus 2, human
694523|NCT00655421|screening|screening
694524|NCT00655421|oral precancers|oral precancers
694525|NCT00655421|tobacco users|tobacco users
694526|NCT00655421|VELScope|velscope
694527|NCT00655421|Visual Inspection|visual inspection
694528|NCT00655421|Toluidine Blue|toluidine blue
694529|NCT00655408|Infants|infants
694530|NCT00655408|Prevalence|prevalence
694531|NCT00655408|Iron|iron
694532|NCT00655408|Deficiency|deficiency
694533|NCT00655408|Treatment|treatment
694534|NCT00655395|Leukemia|leukemia
694536|NCT00655382|dynamic pelvic mri|dynamic pelvic mri
694537|NCT00655382|dynamic mri|dynamic mri
694538|NCT00655382|STARR procedure|starr procedure
694539|NCT00655382|STARR|starr
694540|NCT00655382|ODS|ods
694541|NCT00655382|obstructive defecation syndrome|obstructive defecation syndrome
694542|NCT00655382|outlet obstruction|outlet obstruction
694543|NCT00655382|obstructed defecation|obstructed defecation
694544|NCT00655382|stapled trans anal rectal resection|stapled trans anal rectal resection
694545|NCT00655356|Treatment of moderate to severe bilateral nasolabial fold wrinkles|treatment of moderate to severe bilateral nasolabial fold wrinkles
694546|NCT00655343|GvHD|gvhd
694547|NCT00655343|aGvHD prophylaxis|agvhd prophylaxis
694548|NCT00655343|Matched unrelated donor|matched unrelated donor
694549|NCT00655343|ATG|atg
694550|NCT00655343|SCT|sct
694551|NCT00655343|BMT|bmt
694552|NCT00655343|polyclonal antibody|polyclonal antibody
694553|NCT00655343|GvHD prophylaxis for patients with ALL, AML, CML, MDS, OMF|gvhd prophylaxis for patients with all, aml, cml, mds, omf
694554|NCT00655343|Patients with allogeneic BM or PBSC transplantation|patients with allogeneic bm or pbsc transplantation
694555|NCT00655343|Patients with a matched unrelated donor|patients with a matched unrelated donor
694556|NCT00655330|Type 2 diabetes mellitus|type 2 diabetes mellitus
694557|NCT00655330|Nephropathy|nephropathy
694558|NCT00655330|valsartan|valsartan
694559|NCT00655330|probucol|probucol
694560|NCT00655330|Proteinuria|proteinuria
694561|NCT00655317|acupuncture|acupuncture
694562|NCT00655317|colon surgery|colon surgery
694563|NCT00655317|post operative ileus|post operative ileus
694564|NCT00655317|post ileus|post ileus
694565|NCT00655317|ileus|ileus
694566|NCT00655317|colectomy|colectomy
694567|NCT00655317|colorectal pathology|colorectal pathology
694568|NCT00655291|pain|pain
694569|NCT00655278|Movement Disorder|movement disorder
694570|NCT00655252|Expanded access|expanded access
694571|NCT00655252|metastatic renal cell cancer|metastatic renal cell cancer
694572|NCT00655252|progression despite VEGF receptors|progression despite vegf receptors
694573|NCT00655239|Ultra High Risk of Schizophrenia|ultra high risk of schizophrenia
694574|NCT00655239|Prodrome|prodrome
694575|NCT00655239|Psychosis|psychosis
694576|NCT00655239|Schizophrenia|schizophrenia
694577|NCT00655239|Cognitive Remediation|cognitive remediation
694578|NCT00655226|Cognitive Behavior Therapy|cognitive behavior therapy
694579|NCT00655226|Interferon-alpha|interferon-alpha
694580|NCT00655226|Communicable Diseases|communicable diseases
694581|NCT00655226|Liver Diseases|liver diseases
694582|NCT00655226|Depression|depression
694583|NCT00655226|Hepatitis, Chronic|hepatitis, chronic
694584|NCT00655226|Interferons|interferons
694585|NCT00655226|Ribavirin|ribavirin
694586|NCT00655226|Hepatitis, Viral, Human|hepatitis, viral, human
694587|NCT00655226|Infection|infection
694588|NCT00655226|Hepatitis|hepatitis
694589|NCT00655226|Mood Disorders|mood disorders
694590|NCT00655226|Peginterferon alfa-2a|peginterferon alfa-2a
694591|NCT00655226|Hepatitis C|hepatitis c
694592|NCT00655226|Interferon Alfa-2a|interferon alfa-2a
694593|NCT00655226|Interferon Alfa-2b|interferon alfa-2b
694594|NCT00655226|Depressive Disorder, Major|depressive disorder, major
694595|NCT00655226|Depressive Disorder|depressive disorder
694596|NCT00655213|Pacing, AV conduction disorders, minimized ventricular pacing, AF|pacing, av conduction disorders, minimized ventricular pacing, af
694597|NCT00655174|autism|autism
694598|NCT00655174|fluvoxamine|fluvoxamine
694599|NCT00655174|sertraline|sertraline
694600|NCT00655174|selective seratonin reuptake inhibitors|selective seratonin reuptake inhibitors
694601|NCT00655174|paediatrics|paediatrics
694602|NCT00655161|NSCLC|nsclc
694603|NCT00655161|Cancer Immunotherapy|cancer immunotherapy
694604|NCT00655148|DTaP-IPV|dtap-ipv
694605|NCT00655148|Clinical Trial|clinical trial
694606|NCT00655148|Safety|safety
694607|NCT00655148|Immunogenicity|immunogenicity
694608|NCT00655109|Allergic conjunctivitis|allergic conjunctivitis
694609|NCT00655109|Allergic rhinoconjunctivitis|allergic rhinoconjunctivitis
694610|NCT00655096|Eye|eye
694611|NCT00655096|Photograph|photograph
694612|NCT00655096|Retina|retina
694613|NCT00655083|Infantile colic|infantile colic
694614|NCT00655083|Abdominal Cramps|abdominal cramps
694615|NCT00655083|Colicky Pain|colicky pain
694616|NCT00655083|Functional gastrointestinal disorders|functional gastrointestinal disorders
694617|NCT00655070|Hibernating Myocardium|hibernating myocardium
694618|NCT00655070|Blood Flow|blood flow
694619|NCT00655070|Ultrasound|ultrasound
694620|NCT00655070|PET imaging|pet imaging
694621|NCT00655057|Dopamine Transporter|dopamine transporter
694622|NCT00655057|Biomarker|biomarker
694623|NCT00655057|SPECT Brain Imaging|spect brain imaging
694624|NCT00655057|Antidepressant Therapy|antidepressant therapy
694625|NCT00655031|Punicaceae|punicaceae
694626|NCT00655031|Pomegranate|pomegranate
694627|NCT00655018|Non-Alcoholic Fatty Liver Disease (NAFLD)|non-alcoholic fatty liver disease (nafld)
694628|NCT00655018|Non-Alcoholic Steatohepatitis (NASH)|non-alcoholic steatohepatitis (nash)
694629|NCT00655018|Liver histology|liver histology
694630|NCT00655018|Insulin Resistance|insulin resistance
694631|NCT00655018|Weight loss|weight loss
694632|NCT00655018|Alpha-tocopherol|alpha-tocopherol
694633|NCT00655018|ascorbic acid|ascorbic acid
694634|NCT00655005|head and neck cancer|head and neck cancer
694635|NCT00654966|Urotensin II|urotensin ii
694636|NCT00654966|Soluble epoxide hydrolase|soluble epoxide hydrolase
694637|NCT00654966|Iontophoresis|iontophoresis
694638|NCT00654966|Healthy volunteers|healthy volunteers
694639|NCT00654953|cocaine dependence|cocaine dependence
694640|NCT00654953|depressive symptoms|depressive symptoms
694641|NCT00654953|relapse|relapse
694642|NCT00654953|sertraline|sertraline
694643|NCT00654953|gabapentin|gabapentin
694644|NCT00654927|multiple sclerosis|multiple sclerosis
694645|NCT00654927|MS|ms
694646|NCT00654927|walking|walking
694647|NCT00654927|leg strength|leg strength
694648|NCT00654927|demyelination|demyelination
694649|NCT00654914|Sexual Dysfunction|sexual dysfunction
694650|NCT00654901|Diphtheria|diphtheria
694651|NCT00654901|Tetanus|tetanus
694652|NCT00654901|Pertussis|pertussis
694653|NCT00654901|Hepatitis B|hepatitis b
694654|NCT00654901|Poliomyelitis|poliomyelitis
694655|NCT00654901|Invasive Haemophilus influenzae type b.|invasive haemophilus influenzae type b.
694656|NCT00654901|Haemophilus Influenzae Type B Infection|haemophilus influenzae type b infection
694657|NCT00654888|cataract extraction|cataract extraction
694658|NCT00654888|surgery|surgery
694659|NCT00654888|corneal disease|corneal disease
694660|NCT00654875|Essential Hypertension|essential hypertension
694661|NCT00654849|Electrosurgery|electrosurgery
694662|NCT00654849|Gyrus Pk|gyrus pk
694663|NCT00654849|abdominal hysterectomy|abdominal hysterectomy
694664|NCT00654849|Blood Loss, Surgical|blood loss, surgical
694665|NCT00654849|Length of stay|length of stay
694666|NCT00654849|Overall cost|overall cost
694667|NCT00654836|recurrent breast cancer|recurrent breast cancer
694668|NCT00654836|stage III breast cancer|stage iii breast cancer
694669|NCT00654836|stage IV breast cancer|stage iv breast cancer
694670|NCT00654810|functional ability|functional ability
694671|NCT00654810|gait|gait
694672|NCT00654810|musculoskeletal disorder therapy|musculoskeletal disorder therapy
694673|NCT00654810|peripheral blood vessel disorder|peripheral blood vessel disorder
694674|NCT00654797|Glucose|glucose
694675|NCT00654797|Insulin|insulin
694676|NCT00654797|computer|computer
694677|NCT00654797|critical care|critical care
694678|NCT00654784|Duchenne Muscular Dystrophy|duchenne muscular dystrophy
694679|NCT00654784|DMD|dmd
694680|NCT00654784|Duchenne|duchenne
694681|NCT00654771|protein/creatinine ratio|protein/creatinine ratio
694682|NCT00654771|clean catch urine|clean catch urine
694683|NCT00654771|catheterized urine|catheterized urine
694684|NCT00654758|cancer|cancer
694685|NCT00654758|carcinoma|carcinoma
694686|NCT00654758|chemotherapy|chemotherapy
694687|NCT00654758|monoclonal antibody therapy|monoclonal antibody therapy
694688|NCT00654758|anti-angiogenesis|anti-angiogenesis
694689|NCT00654745|blood pressure reduction|blood pressure reduction
694690|NCT00654719|Heart failure|heart failure
694691|NCT00654719|cachexia|cachexia
694692|NCT00654706|Schizophrenia|schizophrenia
694693|NCT00654706|Cognition|cognition
694694|NCT00654706|MATRICS Consensus Cognitive Battery|matrics consensus cognitive battery
694695|NCT00654693|NTX|ntx
694696|NCT00654693|Nihon Kohden|nihon kohden
694697|NCT00654693|mobile monitoring|mobile monitoring
694698|NCT00654693|monitoring|monitoring
694699|NCT00654693|nihon|nihon
694700|NCT00654693|kohden|kohden
694701|NCT00654693|monitoring device|monitoring device
694702|NCT00654693|remote monitoring|remote monitoring
694703|NCT00654693|wireless|wireless
694704|NCT00654680|Erectile Dysfunction|erectile dysfunction
694705|NCT00654680|Traumatic spinal cord injury|traumatic spinal cord injury
694706|NCT00654680|Vardenafil|vardenafil
694707|NCT00654667|Resveratrol|resveratrol
694708|NCT00654667|Insulin Resistance|insulin resistance
694709|NCT00654667|Metabolic Syndrome|metabolic syndrome
694710|NCT00654667|Sirtuin 1|sirtuin 1
694711|NCT00654667|IGF-1|igf-1
694712|NCT00654667|Satiety|satiety
694713|NCT00654667|Leptin|leptin
694714|NCT00654667|Adiponectin|adiponectin
694715|NCT00654641|Surgical Wound Dehiscence|surgical wound dehiscence
694716|NCT00654641|Wound Infection|wound infection
694717|NCT00654641|Obesity|obesity
694718|NCT00654641|Cesarean Delivery|cesarean delivery
694719|NCT00654641|Wound Closure|wound closure
694720|NCT00654641|Negative Pressure wound closure|negative pressure wound closure
694721|NCT00654615|unstable metaphyseal distal radius fractures|unstable metaphyseal distal radius fractures
694722|NCT00654615|randomized controlled trial|randomized controlled trial
694723|NCT00654615|surgical fixation|surgical fixation
694724|NCT00654615|volar plate|volar plate
694725|NCT00654615|intramedullary distal radius fixation system|intramedullary distal radius fixation system
694726|NCT00654602|cholesterol|cholesterol
694727|NCT00654602|low density lipoproteins|low density lipoproteins
694728|NCT00654602|dyslipidaemia|dyslipidaemia
694729|NCT00654602|Rosuvastatin|rosuvastatin
694730|NCT00654602|Crestor|crestor
694857|NCT00654251|Spinocerebellar ataxia|spinocerebellar ataxia
694731|NCT00654589|Hematopoietic stem cell transplantation|hematopoietic stem cell transplantation
694733|NCT00654589|iron overload|iron overload
694734|NCT00654589|chelators|chelators
694735|NCT00654589|ICL670|icl670
694736|NCT00654589|deferasirox|deferasirox
694737|NCT00654589|serum ferritin|serum ferritin
694738|NCT00654589|LIC|lic
694739|NCT00654589|transfusional hemosiderosis|transfusional hemosiderosis
694740|NCT00654589|blood transfusions|blood transfusions
694741|NCT00654589|adults|adults
694742|NCT00654589|iron chelation|iron chelation
694743|NCT00654589|3-6 months|3-6 months
694744|NCT00654589|allogeneic hematopoietic stem cell transplantation|allogeneic hematopoietic stem cell transplantation
694745|NCT00654576|schizophrenia|schizophrenia
694746|NCT00654576|antipsychotic|antipsychotic
694747|NCT00654576|outcome|outcome
694748|NCT00654576|psychosocial intervention|psychosocial intervention
694749|NCT00654563|Memory Disorders|memory disorders
694750|NCT00654563|Memory loss|memory loss
694751|NCT00654563|Age Associated Memory Impairment|age associated memory impairment
694752|NCT00654550|Photorefractive keratectomy|photorefractive keratectomy
694753|NCT00654550|Re-epithelialization|re-epithelialization
694754|NCT00654550|Nexagon|nexagon
694755|NCT00654550|PRK|prk
694756|NCT00654550|Coda|coda
694757|NCT00654537|Cholesterol|cholesterol
694758|NCT00654537|hypercholesterolemia|hypercholesterolemia
694759|NCT00654537|low density lipoproteins|low density lipoproteins
694760|NCT00654524|Endometriosis|endometriosis
694761|NCT00654524|Recurrence|recurrence
694762|NCT00654524|Pregnancy Rate|pregnancy rate
694763|NCT00654524|Laparoscopy|laparoscopy
694764|NCT00654524|Gonadotropin-Releasing Hormone|gonadotropin-releasing hormone
694765|NCT00654511|Dexmedetomidine,|dexmedetomidine,
694766|NCT00654511|fentanyl,|fentanyl,
694767|NCT00654511|tonsillectomy|tonsillectomy
694768|NCT00654511|and adenoidectomy,|and adenoidectomy,
694769|NCT00654485|Cholesterol|cholesterol
694770|NCT00654485|hypercholesterolemia|hypercholesterolemia
694771|NCT00654485|low density lipoproteins|low density lipoproteins
694772|NCT00654485|metabolic syndrome|metabolic syndrome
694773|NCT00654485|Rosuvastatin|rosuvastatin
694774|NCT00654472|magnetic resonance imaging, mitral valve area|magnetic resonance imaging, mitral valve area
694775|NCT00654446|Cholesterol|cholesterol
694776|NCT00654446|low density lipoproteins|low density lipoproteins
694777|NCT00654446|dyslipidaemia|dyslipidaemia
694778|NCT00654446|Rosuvastatin|rosuvastatin
694779|NCT00654446|Crestor|crestor
694780|NCT00654446|Simvastatin|simvastatin
694781|NCT00654446|Zocor|zocor
694782|NCT00654446|Renal|renal
694783|NCT00654446|kidney|kidney
694784|NCT00654433|Hurler Syndrome|hurler syndrome
694785|NCT00654433|MPS I|mps i
694786|NCT00654433|Hurler-Scheie Syndrome|hurler-scheie syndrome
694787|NCT00654433|Hunter Syndrome|hunter syndrome
694788|NCT00654433|MPS II|mps ii
694789|NCT00654433|Sanfilippo Syndrome|sanfilippo syndrome
694790|NCT00654433|MPS III|mps iii
694791|NCT00654433|Maroteaux-Lamy Syndrome|maroteaux-lamy syndrome
694792|NCT00654433|MPS VI|mps vi
694793|NCT00654433|Krabbe Disease|krabbe disease
694794|NCT00654433|Globoid Leukodystrophy|globoid leukodystrophy
694795|NCT00654433|Metachromatic Leukodystrophy|metachromatic leukodystrophy
694796|NCT00654433|MLD|mld
694797|NCT00654433|Adrenoleukodystrophy|adrenoleukodystrophy
694798|NCT00654433|ALD|ald
694799|NCT00654433|Adrenomyeloneuropathy|adrenomyeloneuropathy
694800|NCT00654433|AMN|amn
694801|NCT00654433|Sandhoff Disease|sandhoff disease
694802|NCT00654433|Tay Sachs Disease|tay sachs disease
694803|NCT00654433|Pelizaeus Merzbacher|pelizaeus merzbacher
694804|NCT00654433|PMD|pmd
694805|NCT00654433|Niemann-Pick Disease A|niemann-pick disease a
694806|NCT00654433|Niemann-Pick Disease B|niemann-pick disease b
694807|NCT00654433|Alpha-mannosidosis|alpha-mannosidosis
694808|NCT00654433|Inherited metabolic diseases|inherited metabolic diseases
694809|NCT00654433|Inborn errors of metabolism|inborn errors of metabolism
694810|NCT00654433|Lysosomal storage diseases|lysosomal storage diseases
694811|NCT00654433|Peroxisomal storage diseases|peroxisomal storage diseases
694812|NCT00654433|Hematopoietic stem cell transplantation|hematopoietic stem cell transplantation
694813|NCT00654433|Umbilical cord blood transplantation|umbilical cord blood transplantation
694814|NCT00654433|Mucopolysaccharidosis|mucopolysaccharidosis
694815|NCT00654433|Mucopolysaccharidosis I|mucopolysaccharidosis i
694816|NCT00654433|Mucopolysaccharidosis II|mucopolysaccharidosis ii
694817|NCT00654433|Mucopolysaccharidosis III|mucopolysaccharidosis iii
694818|NCT00654433|Mucopolysaccharidosis VI|mucopolysaccharidosis vi
694819|NCT00654433|I Cell disease|i cell disease
694820|NCT00654433|Fucosidosis|fucosidosis
694821|NCT00654433|GM1 Gangliosidosis|gm1 gangliosidosis
694822|NCT00654433|Canavan Disease|canavan disease
694823|NCT00654407|Cholesterol|cholesterol
694824|NCT00654407|hypercholesterolemia|hypercholesterolemia
694825|NCT00654407|Coronary Heart disease|coronary heart disease
694826|NCT00654407|low density lipoproteins|low density lipoproteins
694827|NCT00654407|Rosuvastatin|rosuvastatin
694828|NCT00654407|Atorvastatin|atorvastatin
694829|NCT00654407|simvastatin|simvastatin
694830|NCT00654394|Cholesterol|cholesterol
694831|NCT00654394|Carotid Artery Stenosis|carotid artery stenosis
694832|NCT00654394|Hypercholesterolemia|hypercholesterolemia
694833|NCT00654394|Rosuvastatin|rosuvastatin
694834|NCT00654394|Crestor|crestor
694835|NCT00654368|Amgen|amgen
694836|NCT00654355|atopic dermatitis|atopic dermatitis
694837|NCT00654355|eczema|eczema
694838|NCT00654342|Sentinel lymph node-colon cancer|sentinel lymph node-colon cancer
694839|NCT00654329|Dexmedetomidine, transmucosal, myringotomy,|dexmedetomidine, transmucosal, myringotomy,
694840|NCT00654316|TB|tb
694841|NCT00654316|Tuberculosis|tuberculosis
694842|NCT00654316|MVA85A|mva85a
694843|NCT00654316|Vaccine|vaccine
694844|NCT00654316|BCG|bcg
694845|NCT00654303|Cholesterol|cholesterol
694846|NCT00654303|Hypercholesterolaemia|hypercholesterolaemia
694847|NCT00654303|Statins|statins
694848|NCT00654290|Atrial fibrillation|atrial fibrillation
694849|NCT00654290|coronary bypass|coronary bypass
694850|NCT00654290|Amiodarone|amiodarone
694851|NCT00654290|Propranolol|propranolol
694852|NCT00654290|Coronary Artery Bypass Graft (CABG)|coronary artery bypass graft (cabg)
694853|NCT00654277|bioequivalence|bioequivalence
694854|NCT00654277|Ondansetron ODT|ondansetron odt
694855|NCT00654277|Fasting|fasting
694856|NCT00654277|To determine bioequivalence under fasting conditions|to determine bioequivalence under fasting conditions
694858|NCT00654251|Machado-Joseph disease|machado-joseph disease
694859|NCT00654251|Gait monitoring|gait monitoring
694860|NCT00654251|Functional vision assessment|functional vision assessment
694861|NCT00654238|Thyroid Cancer|thyroid cancer
694862|NCT00654238|Anaplastic|anaplastic
694863|NCT00654238|Medullary|medullary
694864|NCT00654238|sorafenib|sorafenib
694865|NCT00654225|Cholesterol|cholesterol
694866|NCT00654225|low density lipoproteins|low density lipoproteins
694867|NCT00654225|dyslipidaemia|dyslipidaemia
694868|NCT00654225|Rosuvastatin|rosuvastatin
694869|NCT00654225|Crestor|crestor
694870|NCT00654225|Atorvastatin|atorvastatin
694871|NCT00654225|Lipitor|lipitor
694872|NCT00654225|South Asian|south asian
694873|NCT00654212|stenting, laparoscopic surgery, colon cancer|stenting, laparoscopic surgery, colon cancer
694874|NCT00654199|CABG|cabg
694875|NCT00654199|Ventricular Asynchrony|ventricular asynchrony
694876|NCT00654199|Normal Sinus Rhythm|normal sinus rhythm
694877|NCT00654186|Androgen Independent Prostate Cancer (AIPC)|androgen independent prostate cancer (aipc)
694878|NCT00654186|Chemo naive|chemo naive
694880|NCT00654173|low density lipoproteins|low density lipoproteins
694881|NCT00654173|dyslipidaemia|dyslipidaemia
694882|NCT00654173|Rosuvastatin|rosuvastatin
694883|NCT00654173|Crestor|crestor
694884|NCT00654173|Atorvastatin|atorvastatin
694885|NCT00654173|Lipitor|lipitor
694886|NCT00654173|Zocor|zocor
694887|NCT00654173|simvastatin|simvastatin
694888|NCT00654160|stage IIIB anal cancer|stage iiib anal cancer
694889|NCT00654160|stage IV anal cancer|stage iv anal cancer
694890|NCT00654160|recurrent anal cancer|recurrent anal cancer
694891|NCT00654160|carcinoma of the appendix|carcinoma of the appendix
694892|NCT00654160|stage III colon cancer|stage iii colon cancer
694893|NCT00654160|stage IV colon cancer|stage iv colon cancer
694894|NCT00654160|recurrent colon cancer|recurrent colon cancer
694895|NCT00654160|stage III rectal cancer|stage iii rectal cancer
694896|NCT00654160|stage IV rectal cancer|stage iv rectal cancer
694897|NCT00654160|recurrent rectal cancer|recurrent rectal cancer
694898|NCT00654160|stage III esophageal cancer|stage iii esophageal cancer
694899|NCT00654160|stage IV esophageal cancer|stage iv esophageal cancer
694900|NCT00654160|recurrent esophageal cancer|recurrent esophageal cancer
694901|NCT00654160|recurrent extrahepatic bile duct cancer|recurrent extrahepatic bile duct cancer
694902|NCT00654160|unresectable extrahepatic bile duct cancer|unresectable extrahepatic bile duct cancer
694903|NCT00654160|unresectable gallbladder cancer|unresectable gallbladder cancer
694904|NCT00654160|recurrent gallbladder cancer|recurrent gallbladder cancer
694905|NCT00654160|stage III gastric cancer|stage iii gastric cancer
694906|NCT00654160|stage IV gastric cancer|stage iv gastric cancer
694907|NCT00654160|recurrent gastric cancer|recurrent gastric cancer
694908|NCT00654160|metastatic gastrointestinal carcinoid tumor|metastatic gastrointestinal carcinoid tumor
694909|NCT00654160|recurrent gastrointestinal carcinoid tumor|recurrent gastrointestinal carcinoid tumor
694910|NCT00654160|regional gastrointestinal carcinoid tumor|regional gastrointestinal carcinoid tumor
694911|NCT00654160|gastrointestinal stromal tumor|gastrointestinal stromal tumor
694912|NCT00654160|advanced adult primary liver cancer|advanced adult primary liver cancer
694913|NCT00654160|localized unresectable adult primary liver cancer|localized unresectable adult primary liver cancer
694914|NCT00654160|recurrent adult primary liver cancer|recurrent adult primary liver cancer
694915|NCT00654160|stage II pancreatic cancer|stage ii pancreatic cancer
694916|NCT00654160|stage III pancreatic cancer|stage iii pancreatic cancer
694917|NCT00654160|stage IV pancreatic cancer|stage iv pancreatic cancer
694918|NCT00654160|recurrent pancreatic cancer|recurrent pancreatic cancer
694919|NCT00654160|recurrent small intestine cancer|recurrent small intestine cancer
694920|NCT00654160|small intestine adenocarcinoma|small intestine adenocarcinoma
694921|NCT00654160|small intestine leiomyosarcoma|small intestine leiomyosarcoma
694922|NCT00654160|small intestine lymphoma|small intestine lymphoma
694924|NCT00654147|antiretroviral therapy naive|antiretroviral therapy naive
694925|NCT00654147|Integrase inhibitor|integrase inhibitor
694926|NCT00654147|HIV/AIDS|hiv/aids
694927|NCT00654147|treatment naïve|treatment naïve
694928|NCT00654121|prevention|prevention
694929|NCT00654108|Escherichia coli, cholera, diarrhea, vaccine|escherichia coli, cholera, diarrhea, vaccine
694930|NCT00654069|Pain|pain
694931|NCT00654056|Type 2 diabetes|type 2 diabetes
694932|NCT00654056|Severe insulin resistance|severe insulin resistance
694933|NCT00654043|Bioequivalence|bioequivalence
694934|NCT00654043|Torsemide Tablets|torsemide tablets
694935|NCT00654043|fed|fed
694936|NCT00654043|To determine bioequivalence under fed conditions.|to determine bioequivalence under fed conditions.
694937|NCT00654030|Lung Cancer Vaccine|lung cancer vaccine
694938|NCT00654030|Early Stage Lung Cancer|early stage lung cancer
694939|NCT00654030|Lung Cancer|lung cancer
694940|NCT00654004|trifunctional|trifunctional
694941|NCT00654004|protein|protein
694942|NCT00654004|deficiency|deficiency
694943|NCT00654004|TFP|tfp
694944|NCT00654004|weight|weight
694945|NCT00654004|regulation|regulation
694946|NCT00653991|HIV/AIDS Prevention|hiv/aids prevention
694947|NCT00653991|Men Who Have Sex With Men (MSM)|men who have sex with men (msm)
694948|NCT00653991|Risky Sexual Behavior|risky sexual behavior
694949|NCT00653991|Socially Optimized Learning in a Virtual Environment (SOLVE)|socially optimized learning in a virtual environment (solve)
694950|NCT00653991|HIV Seronegativity|hiv seronegativity
694951|NCT00653978|ERCP|ercp
694952|NCT00653978|cholangiocarcinoma|cholangiocarcinoma
694953|NCT00653978|hilar stricture|hilar stricture
694954|NCT00653965|Cholesterol|cholesterol
694955|NCT00653965|low density lipoproteins|low density lipoproteins
694956|NCT00653965|dyslipidaemia|dyslipidaemia
694957|NCT00653965|Rosuvastatin|rosuvastatin
694958|NCT00653965|Crestor|crestor
694959|NCT00653965|Atorvastatin|atorvastatin
694960|NCT00653965|Lipitor|lipitor
694961|NCT00653965|Hispanic|hispanic
694962|NCT00653952|Paclitaxel HCl|paclitaxel hcl
694963|NCT00653952|CAELYX|caelyx
694964|NCT00653952|DOXIL|doxil
694965|NCT00653952|Ovarian Carcinoma|ovarian carcinoma
694966|NCT00653952|Doxorubicin HCl|doxorubicin hcl
694967|NCT00653939|non-small cell lung cancer|non-small cell lung cancer
694968|NCT00653939|non-small cell lung carcinoma|non-small cell lung carcinoma
694969|NCT00653939|neoplasms, lung|neoplasms, lung
694970|NCT00653939|lung cancer|lung cancer
694973|NCT00653926|Postoperative pain|postoperative pain
694974|NCT00653926|Local infiltration analgesia|local infiltration analgesia
694975|NCT00653926|Knee arthroplasty|knee arthroplasty
694976|NCT00653926|Postoperative pain management following unicompartmental knee arthroplasty|postoperative pain management following unicompartmental knee arthroplasty
694977|NCT00653900|Verify now|verify now
694978|NCT00653900|platelet function|platelet function
694979|NCT00653900|platelet function testing|platelet function testing
694980|NCT00653900|bleeding risk|bleeding risk
694981|NCT00653900|periprocedural bleeding|periprocedural bleeding
694982|NCT00653900|clopidogrel|clopidogrel
694983|NCT00653900|Our initial goal is to establish if a certain degree of|our initial goal is to establish if a certain degree of
694984|NCT00653900|platelet function abnormality can predict a higher bleeding|platelet function abnormality can predict a higher bleeding
694985|NCT00653900|or higher transfusions.|or higher transfusions.
694986|NCT00653887|Biofeedback|biofeedback
694987|NCT00653887|anal sphincter|anal sphincter
694988|NCT00653887|cortical excitability|cortical excitability
694989|NCT00653887|magnetic stimulation|magnetic stimulation
694990|NCT00653887|incontinence|incontinence
694991|NCT00653887|constipation|constipation
694992|NCT00653874|jaundice|jaundice
694993|NCT00653874|neonates|neonates
694994|NCT00653874|transcutaneous bilirubinometry|transcutaneous bilirubinometry
694995|NCT00653874|clinical assessment of bilirubin|clinical assessment of bilirubin
694996|NCT00653861|Aesthetic correction|aesthetic correction
694997|NCT00653848|Adjuvant treatment, high risk, radical radiotherapy|adjuvant treatment, high risk, radical radiotherapy
694998|NCT00653822|Amevive|amevive
694999|NCT00653822|alefacept|alefacept
695000|NCT00653822|pharmacokinetics|pharmacokinetics
695001|NCT00653822|Japanese|japanese
695002|NCT00653783|Parkinson disease|parkinson disease
695003|NCT00653783|Multiple System Atrophy|multiple system atrophy
695004|NCT00653783|MSA|msa
695005|NCT00653783|Progressive Supranuclear Palsy|progressive supranuclear palsy
695006|NCT00653783|PSP|psp
695007|NCT00653783|observational|observational
695008|NCT00653783|biomarker|biomarker
695009|NCT00653757|stage I prostate cancer|stage i prostate cancer
695010|NCT00653757|stage II prostate cancer|stage ii prostate cancer
695011|NCT00653757|stage III prostate cancer|stage iii prostate cancer
695012|NCT00653757|stage IV prostate cancer|stage iv prostate cancer
695013|NCT00653744|Cholesterol|cholesterol
695014|NCT00653744|low density lipoproteins|low density lipoproteins
695015|NCT00653744|dyslipidaemia|dyslipidaemia
695016|NCT00653744|Rosuvastatin|rosuvastatin
695017|NCT00653744|Crestor|crestor
695018|NCT00653744|Atorvastatin|atorvastatin
695019|NCT00653744|Lipitor|lipitor
695020|NCT00653744|African American|african american
695021|NCT00653731|dementia|dementia
695022|NCT00653731|snoezelen|snoezelen
695023|NCT00653731|structured reminiscence therapy|structured reminiscence therapy
695024|NCT00653731|10-minutes activation|10-minutes activation
695025|NCT00653731|apathy|apathy
695026|NCT00653718|Pain|pain
695027|NCT00653718|Characterize musculoskeletal pain|characterize musculoskeletal pain
695028|NCT00653718|Breast cancer patients treated with aromatase inhibitors|breast cancer patients treated with aromatase inhibitors
695029|NCT00653705|Probiotics|probiotics
695030|NCT00653705|Children|children
695031|NCT00653705|Child Care Center|child care center
695032|NCT00653705|Nutrition|nutrition
695033|NCT00653705|Health promotion|health promotion
695034|NCT00653692|Substance abuse|substance abuse
695035|NCT00653692|fetal development|fetal development
695036|NCT00653692|vagal tone|vagal tone
695037|NCT00653679|exercise|exercise
695038|NCT00653679|muscle protein signalling|muscle protein signalling
695039|NCT00653679|protein synthesis|protein synthesis
695040|NCT00653666|CPT1A|cpt1a
695041|NCT00653666|steatosis|steatosis
695042|NCT00653666|deficiency|deficiency
695043|NCT00653666|metabolic|metabolic
695044|NCT00653666|response|response
695045|NCT00653666|fasting|fasting
695046|NCT00653653|pharmacogenetics|pharmacogenetics
695047|NCT00653653|pharmacoeconomics|pharmacoeconomics
695048|NCT00653653|adverse events|adverse events
695049|NCT00653653|drug metabolism|drug metabolism
695050|NCT00653640|rehabilitation|rehabilitation
695051|NCT00653640|head injury|head injury
695052|NCT00653640|3 months post injury|3 months post injury
695053|NCT00653640|require manual assistance or walking aids to walk|require manual assistance or walking aids to walk
695054|NCT00653640|very slow walking speed|very slow walking speed
695055|NCT00653640|able to follow two step commands|able to follow two step commands
695056|NCT00653614|Oral contraception|oral contraception
695057|NCT00653601|GPI|gpi
695058|NCT00653601|glycoprotein IIb/IIIa inhibitor|glycoprotein iib/iiia inhibitor
695059|NCT00653601|Aggrastat|aggrastat
695060|NCT00653601|Tirofiban|tirofiban
695061|NCT00653601|Verify now|verify now
695062|NCT00653601|platelet function testing|platelet function testing
695063|NCT00653601|bridge therapy|bridge therapy
695064|NCT00653588|Cholesterol|cholesterol
695065|NCT00653588|low density lipoproteins|low density lipoproteins
695066|NCT00653588|Hypercholesterolemia|hypercholesterolemia
695067|NCT00653588|Coronary Heart Disease|coronary heart disease
695068|NCT00653588|Rosuvastatin|rosuvastatin
695069|NCT00653588|Crestor|crestor
695070|NCT00653588|Atorvastatin|atorvastatin
695071|NCT00653588|Lipitor|lipitor
695072|NCT00653575|Sexual Behavior|sexual behavior
695073|NCT00653575|HIV|hiv
695074|NCT00653575|Sexually Transmitted Diseases|sexually transmitted diseases
695075|NCT00653562|polysomnography|polysomnography
695076|NCT00653562|zolpidem|zolpidem
695077|NCT00653562|Sleep disorders|sleep disorders
695078|NCT00653562|adolescent|adolescent
695079|NCT00653549|Bioequivalence|bioequivalence
695080|NCT00653549|Torsemide Tablets|torsemide tablets
695081|NCT00653549|fasting|fasting
695082|NCT00653536|stroke|stroke
695083|NCT00653536|neuroflo|neuroflo
695084|NCT00653536|device|device
695085|NCT00653536|failure to recanalize|failure to recanalize
695086|NCT00653510|Type 2 diabetes|type 2 diabetes
695087|NCT00653510|Dysregulation|dysregulation
695088|NCT00653510|Metabolism|metabolism
695089|NCT00653510|Cardiac output|cardiac output
695090|NCT00653497|Osteoarthritis|osteoarthritis
695091|NCT00653484|colon cancer|colon cancer
695092|NCT00653484|rectal cancer|rectal cancer
695093|NCT00653484|obesity|obesity
695094|NCT00653471|obesity|obesity
695095|NCT00653471|osa|osa
695096|NCT00653471|capnography|capnography
695097|NCT00653471|general anesthesia|general anesthesia
695098|NCT00653458|bioequivalence|bioequivalence
695099|NCT00653458|Ondansetron ODT|ondansetron odt
695100|NCT00653458|fed|fed
695101|NCT00653458|To determine bioequivalence under fed conditions|to determine bioequivalence under fed conditions
695102|NCT00653445|Low density lipoproteins|low density lipoproteins
695103|NCT00653445|Hypercholesterolemia|hypercholesterolemia
695104|NCT00653445|Coronary Heart Disease|coronary heart disease
695105|NCT00653445|Rosuvastatin|rosuvastatin
695106|NCT00653445|Crestor|crestor
695107|NCT00653445|Ezetimibe|ezetimibe
695108|NCT00653432|Treatment|treatment
695109|NCT00653432|Osteoarthritis|osteoarthritis
695110|NCT00653419|bioequivalence|bioequivalence
695111|NCT00653419|buspirone HCl|buspirone hcl
695112|NCT00653419|fasting|fasting
695113|NCT00653406|Schizophrenia|schizophrenia
695114|NCT00653406|Risperidone|risperidone
695115|NCT00653406|Intramuscular injection|intramuscular injection
695116|NCT00653406|Pharmacokinetics|pharmacokinetics
695117|NCT00653393|bioequivalence, single- dose, fasting|bioequivalence, single- dose, fasting
695118|NCT00653380|bioequivalence|bioequivalence
695119|NCT00653380|doxycycline monohydrate|doxycycline monohydrate
695120|NCT00653380|fasting|fasting
695121|NCT00653367|Thoracotomy|thoracotomy
695122|NCT00653367|Nerve section|nerve section
695123|NCT00653367|QST|qst
695124|NCT00653367|Quantitative Sensory Test|quantitative sensory test
695125|NCT00653367|Muscle sparing Posterolateral thoracotomy|muscle sparing posterolateral thoracotomy
695126|NCT00653367|Chest|chest
695127|NCT00653367|Wall|wall
695128|NCT00653367|Surgical|surgical
695129|NCT00653367|Incision|incision
695130|NCT00653367|Tumors or cancer of the lung|tumors or cancer of the lung
695131|NCT00653354|hallux valgus|hallux valgus
695132|NCT00653341|insulin naive|insulin naive
695133|NCT00653328|recurrent ovarian epithelial cancer|recurrent ovarian epithelial cancer
695134|NCT00653328|fallopian tube cancer|fallopian tube cancer
695135|NCT00653328|peritoneal cavity cancer|peritoneal cavity cancer
695136|NCT00653315|Bioequivalence, Tramadol APAP, fasting|bioequivalence, tramadol apap, fasting
695137|NCT00653263|methamphetamine|methamphetamine
695138|NCT00653263|drug abuse|drug abuse
695139|NCT00653263|withdrawal|withdrawal
695140|NCT00653250|stage I non-small cell lung cancer|stage i non-small cell lung cancer
695141|NCT00653250|stage II non-small cell lung cancer|stage ii non-small cell lung cancer
695142|NCT00653250|stage IIIA non-small cell lung cancer|stage iiia non-small cell lung cancer
695143|NCT00653224|levocetirizine|levocetirizine
695144|NCT00653224|Xyzal|xyzal
695145|NCT00653224|Seasonal Allergic Rhinitis|seasonal allergic rhinitis
695146|NCT00653224|total symptom score|total symptom score
695147|NCT00653224|quality of life|quality of life
695148|NCT00653198|Rotavirus severe gastroenteritis (RV SGE)|rotavirus severe gastroenteritis (rv sge)
695149|NCT00653185|Glucose Metabolism Disorder|glucose metabolism disorder
695150|NCT00653185|Dysmetabolic Syndrome|dysmetabolic syndrome
695151|NCT00653185|Type II Diabetes|type ii diabetes
695152|NCT00653185|Diabetes Mellitus, Lipoatrophic|diabetes mellitus, lipoatrophic
695153|NCT00653185|Dyslipidemia|dyslipidemia
695154|NCT00653185|Hyperglycemia|hyperglycemia
695155|NCT00653172|CAP|cap
695156|NCT00653172|community acquired pneumonia|community acquired pneumonia
695157|NCT00653159|Intrauterine device, contraception, unplanned pregnancy|intrauterine device, contraception, unplanned pregnancy
695158|NCT00653146|cervical cancer|cervical cancer
695159|NCT00653146|psychosocial effects of cancer and its treatment|psychosocial effects of cancer and its treatment
695160|NCT00653146|human papilloma virus infection|human papilloma virus infection
695161|NCT00653146|atypical squamous cells of undetermined significance|atypical squamous cells of undetermined significance
695162|NCT00653146|low-grade squamous intraepithelial lesion|low-grade squamous intraepithelial lesion
695163|NCT00653133|ultrasonography|ultrasonography
695164|NCT00653133|peripheral nerve block|peripheral nerve block
695165|NCT00653133|peripheral nerve stimulation|peripheral nerve stimulation
695166|NCT00653120|Bioequivalence, Propranolol ER capsules, fasting|bioequivalence, propranolol er capsules, fasting
695167|NCT00653107|Palliation|palliation
695168|NCT00653107|Cancer oesophagus|cancer oesophagus
695169|NCT00653107|Stent|stent
695170|NCT00653107|Brachytherapy|brachytherapy
695171|NCT00653107|Randomized|randomized
695172|NCT00653094|crohn|crohn
695173|NCT00653094|fistula|fistula
695174|NCT00653094|surgery|surgery
695175|NCT00653094|fibrin glue|fibrin glue
695176|NCT00653094|seton drainage|seton drainage
695177|NCT00653081|Shoulder pain|shoulder pain
695178|NCT00653081|Supervised Exercises|supervised exercises
695179|NCT00653081|Radial Shock Wave Therapy|radial shock wave therapy
695180|NCT00653055|Bioequivalence|bioequivalence
695181|NCT00653055|Cabergoline|cabergoline
695182|NCT00653055|Fasting|fasting
695183|NCT00653042|Myocardial Ischemia|myocardial ischemia
695184|NCT00653042|kidney failure|kidney failure
695185|NCT00653042|CABG|cabg
695186|NCT00653042|cardiopulmonary bypass (CPB) pump|cardiopulmonary bypass (cpb) pump
695187|NCT00653042|Coronary Artery Bypass Surgery|coronary artery bypass surgery
695188|NCT00653042|heart surgery|heart surgery
695189|NCT00653042|nesiritide|nesiritide
695190|NCT00653042|Coronary Heart Disease|coronary heart disease
695191|NCT00653029|Post concussion syndrome|post concussion syndrome
695192|NCT00653029|Mild traumatic brain injury|mild traumatic brain injury
695193|NCT00653029|Effort|effort
695194|NCT00653029|fmri|fmri
695195|NCT00653016|Contraception|contraception
695196|NCT00653016|norelgestromin|norelgestromin
695197|NCT00653016|ethinyl estradiol|ethinyl estradiol
695198|NCT00653016|transdermal contraceptive patch|transdermal contraceptive patch
695199|NCT00653016|EVRA|evra
695200|NCT00653016|ORTHO EVRA|ortho evra
695201|NCT00653003|Bioequivalence, Leflunomide, fed|bioequivalence, leflunomide, fed
695202|NCT00652977|sphincter tears|sphincter tears
695203|NCT00652977|Ritgen maneuver|ritgen maneuver
695204|NCT00652977|perineal tears|perineal tears
695205|NCT00652977|prevention|prevention
695206|NCT00652977|delivery|delivery
695207|NCT00652964|sleep apnea, PHOX2B, hypoventilation, polysomnography|sleep apnea, phox2b, hypoventilation, polysomnography
695208|NCT00652938|Co-administration|co-administration
695209|NCT00652938|HPV vaccine|hpv vaccine
695210|NCT00652938|Cervical cancer|cervical cancer
695211|NCT00652925|arthritis|arthritis
695212|NCT00652925|juvenile|juvenile
695213|NCT00652912|bioequivalence, Clonazepam ODT , fasting|bioequivalence, clonazepam odt , fasting
695214|NCT00652899|recurrent ovarian epithelial cancer|recurrent ovarian epithelial cancer
695215|NCT00652899|recurrent ovarian germ cell tumor|recurrent ovarian germ cell tumor
695216|NCT00652899|stage IV ovarian epithelial cancer|stage iv ovarian epithelial cancer
695217|NCT00652899|stage IV ovarian germ cell tumor|stage iv ovarian germ cell tumor
695218|NCT00652899|fallopian tube cancer|fallopian tube cancer
695219|NCT00652899|peritoneal cavity cancer|peritoneal cavity cancer
695220|NCT00652886|Bioequivalence, Oxandrolone,fasting|bioequivalence, oxandrolone,fasting
695221|NCT00652873|Bioequivalence|bioequivalence
695222|NCT00652873|Cabergoline|cabergoline
695223|NCT00652873|Fed|fed
695224|NCT00652860|lung metastases|lung metastases
695225|NCT00652860|stage III adult soft tissue sarcoma|stage iii adult soft tissue sarcoma
695226|NCT00652834|Renal transplant recipients|renal transplant recipients
695227|NCT00652834|Gastrointestinal findings in small bowel capsule endoscopy|gastrointestinal findings in small bowel capsule endoscopy
695228|NCT00652834|Mycophenolic acid|mycophenolic acid
695229|NCT00652834|Mycophenolate Mofetil|mycophenolate mofetil
695230|NCT00652834|Mycophenolate Sodium|mycophenolate sodium
695231|NCT00652821|bioequivalence, single-dose, fed|bioequivalence, single-dose, fed
695232|NCT00652808|knee, OA patients|knee, oa patients
695233|NCT00652795|bioequivalence|bioequivalence
695234|NCT00652795|doxycycline monohydrate|doxycycline monohydrate
695235|NCT00652795|fasting|fasting
695236|NCT00652769|Lung|lung
695237|NCT00652769|Cancer|cancer
695238|NCT00652769|Staging|staging
695239|NCT00652769|Endobronchial|endobronchial
695240|NCT00652769|Ultrasound|ultrasound
695241|NCT00652769|Endoscopic|endoscopic
695242|NCT00652756|Respiration, Artificial|respiration, artificial
695243|NCT00652756|Transportation of Patients|transportation of patients
695244|NCT00652756|Intubation, Intratracheal|intubation, intratracheal
695245|NCT00652756|Tracheostomy|tracheostomy
695246|NCT00652743|immunogenicity|immunogenicity
695247|NCT00652743|safety|safety
695248|NCT00652743|GSK pandemic candidate vaccine|gsk pandemic candidate vaccine
695249|NCT00652730|bioequivalence|bioequivalence
695250|NCT00652730|buspirone HCl|buspirone hcl
695251|NCT00652730|fed|fed
695252|NCT00652704|Bioequivalence|bioequivalence
695253|NCT00652704|Doxycycline Monohydrate|doxycycline monohydrate
695254|NCT00652704|Fed|fed
695255|NCT00652691|peritoneal cavity cancer|peritoneal cavity cancer
695256|NCT00652691|ovarian clear cell tumor with proliferating activity|ovarian clear cell tumor with proliferating activity
695257|NCT00652691|ovarian endometrioid adenocarcinoma|ovarian endometrioid adenocarcinoma
695258|NCT00652691|ovarian mixed epithelial carcinoma|ovarian mixed epithelial carcinoma
695259|NCT00652691|recurrent ovarian epithelial cancer|recurrent ovarian epithelial cancer
695260|NCT00652691|ovarian mucinous cystadenocarcinoma|ovarian mucinous cystadenocarcinoma
695261|NCT00652691|ovarian serous cystadenocarcinoma|ovarian serous cystadenocarcinoma
695262|NCT00652691|ovarian undifferentiated adenocarcinoma|ovarian undifferentiated adenocarcinoma
695263|NCT00652678|Breast cancer|breast cancer
695264|NCT00652678|Radiation effects|radiation effects
695265|NCT00652665|Bioequivalence, single-dose, fasting|bioequivalence, single-dose, fasting
695266|NCT00652652|Congestive Heart Failure (CHF)|congestive heart failure (chf)
695267|NCT00652652|Heart Failure|heart failure
695268|NCT00652652|Chronic Heart Failure|chronic heart failure
695270|NCT00652652|nesiritide|nesiritide
695271|NCT00652652|Natrecor|natrecor
695272|NCT00652639|bioequivalence, Clonazepam tablets, fasting|bioequivalence, clonazepam tablets, fasting
695273|NCT00652626|MDS|mds
695274|NCT00652626|AML|aml
695275|NCT00652626|Solid Tumors|solid tumors
695276|NCT00652626|Azacitidine|azacitidine
695277|NCT00652626|PK|pk
695278|NCT00652626|Pharmacokinetics|pharmacokinetics
695279|NCT00652626|Renal Impairment|renal impairment
695280|NCT00652626|Multiple Myeloma|multiple myeloma
695281|NCT00652626|Non-Hodgkin's Lymphoma|non-hodgkin's lymphoma
695282|NCT00652626|Hodgkin's Disease|hodgkin's disease
695283|NCT00652613|3DCRT|3dcrt
695284|NCT00652613|IMRT|imrt
695285|NCT00652613|HNSCC|hnscc
695286|NCT00652613|Quality of life|quality of life
695287|NCT00652613|Major salivary gland sparing|major salivary gland sparing
695288|NCT00652613|Pattern of local and loco-regional recurrence|pattern of local and loco-regional recurrence
695289|NCT00652613|Disease Free Survival (DFS) & Overall Survival (OAS)|disease free survival (dfs) & overall survival (oas)
695290|NCT00652613|Dose reduction to normal structures with IMRT|dose reduction to normal structures with imrt
695291|NCT00652600|Bioequivalence, Propranolol ER capsules, fed|bioequivalence, propranolol er capsules, fed
695292|NCT00652587|hepatocellular carcinoma|hepatocellular carcinoma
695293|NCT00652587|hepatectomy|hepatectomy
695294|NCT00652587|chemoembolization|chemoembolization
695295|NCT00652587|randomized controlled trial|randomized controlled trial
695296|NCT00652587|prognosis|prognosis
695297|NCT00652574|Malignant Pleural Mesothelioma|malignant pleural mesothelioma
695298|NCT00652574|Dasatinib|dasatinib
695299|NCT00652574|BMS-354825|bms-354825
695300|NCT00652574|Sprycel|sprycel
695301|NCT00652574|MPM|mpm
695302|NCT00652548|Clavicle|clavicle
695303|NCT00652548|Fracture|fracture
695304|NCT00652548|Ultrasound|ultrasound
695305|NCT00652548|Radiation|radiation
695306|NCT00652522|AF ablation|af ablation
695307|NCT00652522|Pulmonary vein isolation(PVI)|pulmonary vein isolation(pvi)
695308|NCT00652522|reduced LV ejection fraction|reduced lv ejection fraction
695309|NCT00652522|symptomatic atrial fibrillation|symptomatic atrial fibrillation
695310|NCT00652522|persistent AF|persistent af
695311|NCT00652470|infants|infants
695312|NCT00652470|Hydrocephalus|hydrocephalus
695313|NCT00652470|Cerebrospinal Fluid Shunt|cerebrospinal fluid shunt
695314|NCT00652470|Ventriculostomy|ventriculostomy
695315|NCT00652470|neurosurgery|neurosurgery
695316|NCT00652418|Magnevist|magnevist
695317|NCT00652418|Magnetic Resonance Angiography|magnetic resonance angiography
695318|NCT00652418|Meglumine gadopentetate|meglumine gadopentetate
695319|NCT00652418|Determination of effective dose in MRA|determination of effective dose in mra
695320|NCT00652405|cephalic phase reflex|cephalic phase reflex
695321|NCT00652405|gene expression|gene expression
695322|NCT00652405|inflammation|inflammation
695323|NCT00652405|adiponectin|adiponectin
695324|NCT00652405|pancreatic polypeptide|pancreatic polypeptide
695325|NCT00652392|asthma|asthma
695326|NCT00652392|adolescents|adolescents
695327|NCT00652392|adults|adults
695328|NCT00652392|Symbicort|symbicort
695329|NCT00652392|budesonide/formoterol|budesonide/formoterol
695330|NCT00652392|budesonide|budesonide
695331|NCT00652379|Acromegaly|acromegaly
695332|NCT00652379|Insulin sensitivity|insulin sensitivity
695333|NCT00652379|Glucose tolerance|glucose tolerance
695334|NCT00652379|Body composition|body composition
695335|NCT00652379|Growth Hormone|growth hormone
695336|NCT00652353|Clinical decision rule|clinical decision rule
695337|NCT00652353|Ottawa Ankle Rule|ottawa ankle rule
695338|NCT00652353|Ottawa Foot Rule|ottawa foot rule
695339|NCT00652353|Ankle|ankle
695340|NCT00652353|Trauma|trauma
695341|NCT00652353|Education|education
695342|NCT00652353|Foot Trauma|foot trauma
695343|NCT00652314|Hemostatic products|hemostatic products
695344|NCT00652314|Surgical hemostasis|surgical hemostasis
695345|NCT00652314|Thrombi-gel|thrombi-gel
695346|NCT00652314|Gelatin Sponge|gelatin sponge
695347|NCT00652314|Time to hemostasis|time to hemostasis
695348|NCT00652288|Type I Diabetes Mellitus|type i diabetes mellitus
695349|NCT00652275|Malaria|malaria
695350|NCT00652275|vaccine|vaccine
695351|NCT00652275|Merozoite surface Antigene|merozoite surface antigene
695352|NCT00652275|Mali|mali
695353|NCT00652275|Children|children
695354|NCT00652262|Vardenafil|vardenafil
695355|NCT00652262|PDE5 inhibitor|pde5 inhibitor
695356|NCT00652262|Erectile dysfunction|erectile dysfunction
695357|NCT00652262|Spinal cord injury|spinal cord injury
695358|NCT00652249|Hydrocephalus|hydrocephalus
695359|NCT00652249|shunt dysfunction|shunt dysfunction
695360|NCT00652249|shunt flow|shunt flow
695361|NCT00652236|Low back pain|low back pain
695362|NCT00652236|Economics|economics
695363|NCT00652236|Cost-effectiveness|cost-effectiveness
695364|NCT00652210|Bladder cancer|bladder cancer
695365|NCT00652210|prostate cancer|prostate cancer
695366|NCT00652210|multiphoton microscopy|multiphoton microscopy
695367|NCT00652197|Hydrocephalus|hydrocephalus
695368|NCT00652197|shunt dysfunction|shunt dysfunction
695369|NCT00652197|shunt flow|shunt flow
695370|NCT00652184|antiviral|antiviral
695371|NCT00652184|herpes zoster|herpes zoster
695372|NCT00652184|postherpetic neuralgia|postherpetic neuralgia
695373|NCT00652184|varicella zoster virus|varicella zoster virus
695374|NCT00652184|shingles|shingles
695375|NCT00652171|Treatment|treatment
695376|NCT00652171|Augmentation|augmentation
695377|NCT00652171|Resistant depression|resistant depression
695378|NCT00652171|Lamotrigine|lamotrigine
695379|NCT00652145|ulcerative colitis|ulcerative colitis
695380|NCT00652145|inflammatory bowel disease|inflammatory bowel disease
695381|NCT00652132|ototoxicity|ototoxicity
695382|NCT00652132|childhood hepatoblastoma|childhood hepatoblastoma
695383|NCT00652132|stage I childhood liver cancer|stage i childhood liver cancer
695384|NCT00652132|stage II childhood liver cancer|stage ii childhood liver cancer
695385|NCT00652132|stage III childhood liver cancer|stage iii childhood liver cancer
695386|NCT00652119|Ovarian Cancer|ovarian cancer
695387|NCT00652119|Peritoneal Cancer|peritoneal cancer
695388|NCT00652119|Fallopian Tube Cancer|fallopian tube cancer
695389|NCT00652119|Carcinoma of Mullerian Origin|carcinoma of mullerian origin
695390|NCT00652119|Paclitaxel|paclitaxel
695392|NCT00652119|Carboplatin|carboplatin
695393|NCT00652119|Paraplatin®|paraplatin®
695394|NCT00652119|Avastin|avastin
695395|NCT00652119|Bevacizumab|bevacizumab
695396|NCT00652119|Anti-VEGF monoclonal antibody|anti-vegf monoclonal antibody
695397|NCT00652119|rhuMAb-VEGF|rhumab-vegf
695398|NCT00652067|Mycobacterium avium-intracellulare|mycobacterium avium-intracellulare
695399|NCT00652041|Multiple Myeloma|multiple myeloma
695400|NCT00652041|Relapsed|relapsed
695401|NCT00652041|Refractary|refractary
695402|NCT00652028|Pharmacokinetics|pharmacokinetics
695403|NCT00652028|Pharmacodynamics|pharmacodynamics
695404|NCT00652028|Escalating dose|escalating dose
695405|NCT00652028|Dexmedotimidine|dexmedotimidine
695406|NCT00652028|Intubated|intubated
695407|NCT00652028|Mechanically ventilated|mechanically ventilated
695408|NCT00652028|Pediatrics|pediatrics
695409|NCT00652015|in-stent-thrombosis|in-stent-thrombosis
695410|NCT00652015|CD39|cd39
695411|NCT00652015|CD73|cd73
695412|NCT00652015|EPC|epc
695413|NCT00652002|Asthma|asthma
695414|NCT00652002|Symbicort|symbicort
695415|NCT00652002|budesonide/formoterol|budesonide/formoterol
695416|NCT00652002|budesonide|budesonide
695417|NCT00652002|formoterol|formoterol
695418|NCT00651989|optical coherence tomography|optical coherence tomography
695419|NCT00651989|spectral domain|spectral domain
695420|NCT00651989|time domain|time domain
695421|NCT00651976|stage IA breast cancer|stage ia breast cancer
695422|NCT00651976|stage IB breast cancer|stage ib breast cancer
695423|NCT00651976|stage II breast cancer|stage ii breast cancer
695424|NCT00651976|stage III breast cancer|stage iii breast cancer
695425|NCT00651976|HER2-negative breast cancer|her2-negative breast cancer
695426|NCT00651976|estrogen receptor-positive breast cancer|estrogen receptor-positive breast cancer
695427|NCT00651950|Hydrocephalus|hydrocephalus
695428|NCT00651950|shunt dysfunction|shunt dysfunction
695429|NCT00651950|shunt flow|shunt flow
695430|NCT00651937|Multiple Myeloma|multiple myeloma
695431|NCT00651937|Primary Amyloidosis|primary amyloidosis
695432|NCT00651937|Cytokine Modulation|cytokine modulation
695433|NCT00651937|Melphalan|melphalan
695434|NCT00651937|Alkeran|alkeran
695435|NCT00651937|Transplant Induced Symptoms|transplant induced symptoms
695436|NCT00651937|Stem Cell Infusion|stem cell infusion
695437|NCT00651937|Autologous stem cell transplant|autologous stem cell transplant
695438|NCT00651937|ASCT|asct
695439|NCT00651937|Granulocyte-colony stimulating factor|granulocyte-colony stimulating factor
695440|NCT00651937|G-CSF|g-csf
695441|NCT00651937|Apheresis|apheresis
695442|NCT00651924|chronic pain|chronic pain
695443|NCT00651924|IVR|ivr
695444|NCT00651924|cognitive-behavior therapy|cognitive-behavior therapy
695445|NCT00651898|abdominal surgery|abdominal surgery
695446|NCT00651898|hypothermia|hypothermia
695447|NCT00651898|circulating water mattress|circulating water mattress
695448|NCT00651885|UT-15C|ut-15c
695449|NCT00651885|Peripheral Vascular Disease|peripheral vascular disease
695450|NCT00651885|Treprostinil|treprostinil
695451|NCT00651872|Posttraumatic Stress Disorder|posttraumatic stress disorder
695452|NCT00651872|Functional Impairment|functional impairment
695453|NCT00651872|Veterans|veterans
695454|NCT00651872|Military Personnel|military personnel
695455|NCT00651846|Contraception|contraception
695456|NCT00651846|Hemostasis|hemostasis
695457|NCT00651846|Blood Coagulation|blood coagulation
695458|NCT00651820|wound healing|wound healing
695459|NCT00651820|scarring|scarring
695460|NCT00651820|collagenase|collagenase
695462|NCT00651794|Neonatal Resuscitation|neonatal resuscitation
695463|NCT00651794|Patient Care Team|patient care team
695464|NCT00651794|Medical Errors|medical errors
695465|NCT00651781|Acute Myeloid Leukemia|acute myeloid leukemia
695466|NCT00651781|Relapsed|relapsed
695467|NCT00651781|Refractory|refractory
695468|NCT00651768|asthma|asthma
695469|NCT00651768|adults|adults
695470|NCT00651768|adolescents|adolescents
695471|NCT00651768|safety|safety
695472|NCT00651768|Symbicort|symbicort
695473|NCT00651768|budesonide/formoterol|budesonide/formoterol
695474|NCT00651768|budesonide|budesonide
695475|NCT00651755|Non-Hodgkin's Lymphoma|non-hodgkin's lymphoma
695476|NCT00651755|Lymphoma|lymphoma
695477|NCT00651755|Nausea|nausea
695478|NCT00651755|Cyclophosphamide|cyclophosphamide
695479|NCT00651755|Cytoxan|cytoxan
695480|NCT00651755|Neosar|neosar
695481|NCT00651755|Doxorubicin|doxorubicin
695482|NCT00651755|AD|ad
695483|NCT00651755|Hydroxydaunomycin hydrochloride|hydroxydaunomycin hydrochloride
695484|NCT00651755|Vincristine|vincristine
695485|NCT00651755|Prednisone|prednisone
695486|NCT00651755|Rituximab|rituximab
695487|NCT00651755|Rituxan|rituxan
695488|NCT00651755|Aprepitant|aprepitant
695489|NCT00651755|Emend|emend
695490|NCT00651755|L754030|l754030
695491|NCT00651755|MK869|mk869
695492|NCT00651755|Drug Metabolism|drug metabolism
695493|NCT00651755|CHOP|chop
695494|NCT00651755|R-CHOP|r-chop
695495|NCT00651755|NHL|nhl
695496|NCT00651716|stage III adult Burkitt lymphoma|stage iii adult burkitt lymphoma
695497|NCT00651716|stage III adult diffuse large cell lymphoma|stage iii adult diffuse large cell lymphoma
695498|NCT00651716|stage III adult diffuse mixed cell lymphoma|stage iii adult diffuse mixed cell lymphoma
695499|NCT00651716|stage III adult diffuse small cleaved cell lymphoma|stage iii adult diffuse small cleaved cell lymphoma
695500|NCT00651716|stage III adult Hodgkin lymphoma|stage iii adult hodgkin lymphoma
695501|NCT00651716|stage III adult immunoblastic large cell lymphoma|stage iii adult immunoblastic large cell lymphoma
695502|NCT00651716|stage III adult lymphoblastic lymphoma|stage iii adult lymphoblastic lymphoma
695503|NCT00651716|stage III grade 1 follicular lymphoma|stage iii grade 1 follicular lymphoma
695504|NCT00651716|stage III grade 2 follicular lymphoma|stage iii grade 2 follicular lymphoma
695505|NCT00651716|stage III grade 3 follicular lymphoma|stage iii grade 3 follicular lymphoma
695506|NCT00651716|stage III mantle cell lymphoma|stage iii mantle cell lymphoma
695507|NCT00651716|stage III marginal zone lymphoma|stage iii marginal zone lymphoma
695508|NCT00651716|stage III small lymphocytic lymphoma|stage iii small lymphocytic lymphoma
695509|NCT00651716|stage IV adult Burkitt lymphoma|stage iv adult burkitt lymphoma
695510|NCT00651716|stage IV adult diffuse large cell lymphoma|stage iv adult diffuse large cell lymphoma
695511|NCT00651716|stage IV adult diffuse mixed cell lymphoma|stage iv adult diffuse mixed cell lymphoma
695512|NCT00651716|stage IV adult diffuse small cleaved cell lymphoma|stage iv adult diffuse small cleaved cell lymphoma
695513|NCT00651716|stage IV adult Hodgkin lymphoma|stage iv adult hodgkin lymphoma
695514|NCT00651716|stage IV adult immunoblastic large cell lymphoma|stage iv adult immunoblastic large cell lymphoma
695515|NCT00651716|stage IV adult lymphoblastic lymphoma|stage iv adult lymphoblastic lymphoma
695516|NCT00651716|stage IV grade 1 follicular lymphoma|stage iv grade 1 follicular lymphoma
695517|NCT00651716|stage IV grade 2 follicular lymphoma|stage iv grade 2 follicular lymphoma
695518|NCT00651716|stage IV grade 3 follicular lymphoma|stage iv grade 3 follicular lymphoma
695519|NCT00651716|stage IV mantle cell lymphoma|stage iv mantle cell lymphoma
695520|NCT00651716|stage IV marginal zone lymphoma|stage iv marginal zone lymphoma
695521|NCT00651716|stage IV small lymphocytic lymphoma|stage iv small lymphocytic lymphoma
695522|NCT00651716|recurrent adult Burkitt lymphoma|recurrent adult burkitt lymphoma
695523|NCT00651716|recurrent adult diffuse large cell lymphoma|recurrent adult diffuse large cell lymphoma
695524|NCT00651716|recurrent adult diffuse mixed cell lymphoma|recurrent adult diffuse mixed cell lymphoma
695525|NCT00651716|recurrent adult diffuse small cleaved cell lymphoma|recurrent adult diffuse small cleaved cell lymphoma
695526|NCT00651716|recurrent adult Hodgkin lymphoma|recurrent adult hodgkin lymphoma
695527|NCT00651716|recurrent adult immunoblastic large cell lymphoma|recurrent adult immunoblastic large cell lymphoma
695528|NCT00651716|recurrent adult lymphoblastic lymphoma|recurrent adult lymphoblastic lymphoma
695529|NCT00651716|recurrent cutaneous T-cell non-Hodgkin lymphoma|recurrent cutaneous t-cell non-hodgkin lymphoma
695530|NCT00651716|recurrent grade 1 follicular lymphoma|recurrent grade 1 follicular lymphoma
695531|NCT00651716|recurrent grade 2 follicular lymphoma|recurrent grade 2 follicular lymphoma
695532|NCT00651716|recurrent grade 3 follicular lymphoma|recurrent grade 3 follicular lymphoma
695533|NCT00651716|recurrent mantle cell lymphoma|recurrent mantle cell lymphoma
695534|NCT00651716|recurrent marginal zone lymphoma|recurrent marginal zone lymphoma
695535|NCT00651716|recurrent small lymphocytic lymphoma|recurrent small lymphocytic lymphoma
695536|NCT00651716|recurrent mycosis fungoides/Sezary syndrome|recurrent mycosis fungoides/sezary syndrome
695537|NCT00651716|extranodal marginal zone B-cell lymphoma of mucosa-associated lymphoid tissue|extranodal marginal zone b-cell lymphoma of mucosa-associated lymphoid tissue
695538|NCT00651716|nodal marginal zone B-cell lymphoma|nodal marginal zone b-cell lymphoma
695539|NCT00651716|splenic marginal zone lymphoma|splenic marginal zone lymphoma
695540|NCT00651716|noncontiguous stage II adult Burkitt lymphoma|noncontiguous stage ii adult burkitt lymphoma
695541|NCT00651716|noncontiguous stage II adult diffuse large cell lymphoma|noncontiguous stage ii adult diffuse large cell lymphoma
695542|NCT00651716|noncontiguous stage II adult diffuse mixed cell lymphoma|noncontiguous stage ii adult diffuse mixed cell lymphoma
695543|NCT00651716|noncontiguous stage II adult diffuse small cleaved cell lymphoma|noncontiguous stage ii adult diffuse small cleaved cell lymphoma
695544|NCT00651716|noncontiguous stage II adult immunoblastic large cell lymphoma|noncontiguous stage ii adult immunoblastic large cell lymphoma
695545|NCT00651716|noncontiguous stage II adult lymphoblastic lymphoma|noncontiguous stage ii adult lymphoblastic lymphoma
695546|NCT00651716|noncontiguous stage II grade 1 follicular lymphoma|noncontiguous stage ii grade 1 follicular lymphoma
695547|NCT00651716|noncontiguous stage II grade 2 follicular lymphoma|noncontiguous stage ii grade 2 follicular lymphoma
695548|NCT00651716|noncontiguous stage II grade 3 follicular lymphoma|noncontiguous stage ii grade 3 follicular lymphoma
695549|NCT00651716|noncontiguous stage II mantle cell lymphoma|noncontiguous stage ii mantle cell lymphoma
695550|NCT00651716|noncontiguous stage II marginal zone lymphoma|noncontiguous stage ii marginal zone lymphoma
695551|NCT00651716|noncontiguous stage II small lymphocytic lymphoma|noncontiguous stage ii small lymphocytic lymphoma
695552|NCT00651716|accelerated phase chronic myelogenous leukemia|accelerated phase chronic myelogenous leukemia
695553|NCT00651716|adult acute lymphoblastic leukemia in remission|adult acute lymphoblastic leukemia in remission
695554|NCT00651716|adult acute myeloid leukemia in remission|adult acute myeloid leukemia in remission
695555|NCT00651716|adult acute myeloid leukemia with 11q23 (MLL) abnormalities|adult acute myeloid leukemia with 11q23 (mll) abnormalities
695556|NCT00651716|adult acute myeloid leukemia with inv(16)(p13;q22)|adult acute myeloid leukemia with inv(16)(p13;q22)
695557|NCT00651716|adult acute myeloid leukemia with t(15;17)(q22;q12)|adult acute myeloid leukemia with t(15;17)(q22;q12)
695558|NCT00651716|adult acute myeloid leukemia with t(16;16)(p13;q22)|adult acute myeloid leukemia with t(16;16)(p13;q22)
695559|NCT00651716|adult acute myeloid leukemia with t(8;21)(q22;q22)|adult acute myeloid leukemia with t(8;21)(q22;q22)
695560|NCT00651716|atypical chronic myeloid leukemia, BCR-ABL negative|atypical chronic myeloid leukemia, bcr-abl negative
695561|NCT00651716|blastic phase chronic myelogenous leukemia|blastic phase chronic myelogenous leukemia
695562|NCT00651716|chronic myelomonocytic leukemia|chronic myelomonocytic leukemia
695563|NCT00651716|chronic phase chronic myelogenous leukemia|chronic phase chronic myelogenous leukemia
695564|NCT00651716|recurrent adult acute lymphoblastic leukemia|recurrent adult acute lymphoblastic leukemia
695565|NCT00651716|recurrent adult acute myeloid leukemia|recurrent adult acute myeloid leukemia
695566|NCT00651716|refractory chronic lymphocytic leukemia|refractory chronic lymphocytic leukemia
695567|NCT00651716|refractory hairy cell leukemia|refractory hairy cell leukemia
695568|NCT00651716|relapsing chronic myelogenous leukemia|relapsing chronic myelogenous leukemia
695569|NCT00651716|secondary acute myeloid leukemia|secondary acute myeloid leukemia
695570|NCT00651716|stage III chronic lymphocytic leukemia|stage iii chronic lymphocytic leukemia
695571|NCT00651716|stage IV chronic lymphocytic leukemia|stage iv chronic lymphocytic leukemia
695572|NCT00651716|chronic eosinophilic leukemia|chronic eosinophilic leukemia
695573|NCT00651716|primary myelofibrosis|primary myelofibrosis
695574|NCT00651716|chronic neutrophilic leukemia|chronic neutrophilic leukemia
695575|NCT00651716|de novo myelodysplastic syndromes|de novo myelodysplastic syndromes
695576|NCT00651716|disseminated neuroblastoma|disseminated neuroblastoma
695577|NCT00651716|myelodysplastic/myeloproliferative neoplasm, unclassifiable|myelodysplastic/myeloproliferative neoplasm, unclassifiable
695578|NCT00651716|poor prognosis metastatic gestational trophoblastic tumor|poor prognosis metastatic gestational trophoblastic tumor
695579|NCT00651716|previously treated myelodysplastic syndromes|previously treated myelodysplastic syndromes
695580|NCT00651716|recurrent neuroblastoma|recurrent neuroblastoma
695581|NCT00651716|recurrent ovarian epithelial cancer|recurrent ovarian epithelial cancer
695582|NCT00651716|recurrent ovarian germ cell tumor|recurrent ovarian germ cell tumor
695583|NCT00651716|recurrent malignant testicular germ cell tumor|recurrent malignant testicular germ cell tumor
695584|NCT00651716|secondary myelodysplastic syndromes|secondary myelodysplastic syndromes
695585|NCT00651716|stage I multiple myeloma|stage i multiple myeloma
695586|NCT00651716|stage II multiple myeloma|stage ii multiple myeloma
695587|NCT00651716|stage III multiple myeloma|stage iii multiple myeloma
695588|NCT00651716|stage II ovarian epithelial cancer|stage ii ovarian epithelial cancer
695589|NCT00651716|stage III ovarian epithelial cancer|stage iii ovarian epithelial cancer
695590|NCT00651716|stage IV ovarian epithelial cancer|stage iv ovarian epithelial cancer
695591|NCT00651716|stage III malignant testicular germ cell tumor|stage iii malignant testicular germ cell tumor
695592|NCT00651716|stage IIIA breast cancer|stage iiia breast cancer
695593|NCT00651716|stage IIIB breast cancer|stage iiib breast cancer
695594|NCT00651716|stage IIIC breast cancer|stage iiic breast cancer
695595|NCT00651716|stage IV breast cancer|stage iv breast cancer
695596|NCT00651716|refractory multiple myeloma|refractory multiple myeloma
695597|NCT00651677|hand assisted laparoscopy|hand assisted laparoscopy
695598|NCT00651677|rectal cancer|rectal cancer
695599|NCT00651677|short term outcomes|short term outcomes
695600|NCT00651677|straight laparoscopy|straight laparoscopy
695602|NCT00651651|Symbicort|symbicort
695603|NCT00651651|budesonide/formoterol|budesonide/formoterol
695604|NCT00651651|budesonide|budesonide
695605|NCT00651651|formoterol|formoterol
695606|NCT00651638|PK and safety profile of ARQ 197|pk and safety profile of arq 197
695607|NCT00651625|arthrocentesis|arthrocentesis
695608|NCT00651625|injections|injections
695609|NCT00651625|anesthesia|anesthesia
695610|NCT00651625|biopsy|biopsy
695611|NCT00651625|aspiration|aspiration
695612|NCT00651625|syringe|syringe
695613|NCT00651625|safety|safety
695614|NCT00651625|pain|pain
695615|NCT00651599|Vasomotor symptoms|vasomotor symptoms
695616|NCT00651599|Vasomotor System|vasomotor system
695617|NCT00651573|Surgery|surgery
695618|NCT00651573|Cardiopulmonary bypass|cardiopulmonary bypass
695619|NCT00651573|Coronary artery bypass graft|coronary artery bypass graft
695620|NCT00651573|Valve procedure|valve procedure
695621|NCT00651573|Hematocrit level|hematocrit level
695622|NCT00651573|Outcomes|outcomes
695623|NCT00651547|Asthma|asthma
695624|NCT00651547|Symbicort|symbicort
695625|NCT00651547|budesonide/formoterol|budesonide/formoterol
695626|NCT00651547|budesonide|budesonide
695627|NCT00651547|formoterol|formoterol
695628|NCT00651547|children|children
695629|NCT00651534|Formulation Drug Study, healthy postmenopausal|formulation drug study, healthy postmenopausal
695630|NCT00651521|Angiographic CAD|angiographic cad
695631|NCT00651521|Chronic kidney disease|chronic kidney disease
695632|NCT00651521|Left ventricular dysfunction|left ventricular dysfunction
695633|NCT00651521|Body mass index|body mass index
695634|NCT00651521|Cardiovascular mortality|cardiovascular mortality
695635|NCT00651521|Coronary angiography|coronary angiography
695636|NCT00651508|Patients with Advanced or Metastatic stage IIIB/IV Non-Small Cell Lung Cancer|patients with advanced or metastatic stage iiib/iv non-small cell lung cancer
695637|NCT00651495|Decision aids|decision aids
695638|NCT00651495|Seniors|seniors
695639|NCT00651495|Chronic disease management|chronic disease management
695640|NCT00651495|Advance directives|advance directives
695641|NCT00651469|Moderate Acne Vulgaris|moderate acne vulgaris
695642|NCT00651469|Acne|acne
695643|NCT00651443|galiximab|galiximab
695644|NCT00651443|Untreated NHL|untreated nhl
695645|NCT00651443|antibody|antibody
695646|NCT00651443|open-label|open-label
695647|NCT00651430|Balance|balance
695648|NCT00651430|Voluntary stepping|voluntary stepping
695649|NCT00651430|function|function
695650|NCT00651430|disability|disability
695651|NCT00651430|fear of falls|fear of falls
695652|NCT00651430|Total Hip Arthroplasty|total hip arthroplasty
695653|NCT00651417|Organic germanium|organic germanium
695654|NCT00651417|fatigue|fatigue
695655|NCT00651417|radiation therapy|radiation therapy
695656|NCT00651417|breast cancer|breast cancer
695657|NCT00651417|prostate cancer|prostate cancer
695658|NCT00651365|Advanced solid tumors|advanced solid tumors
695659|NCT00651365|Refractory solid tumor|refractory solid tumor
695660|NCT00651365|Antineoplastic protocol|antineoplastic protocol
695661|NCT00651365|Drug therapy|drug therapy
695662|NCT00651365|Pharmacokinetics|pharmacokinetics
695663|NCT00651365|Met inhibitor|met inhibitor
695664|NCT00651352|NRT|nrt
695665|NCT00651352|Bioequivalence|bioequivalence
695666|NCT00651352|Nicotine|nicotine
695667|NCT00651339|Cerebral Palsy|cerebral palsy
695668|NCT00651339|Balance|balance
695669|NCT00651339|Gait|gait
695670|NCT00651326|adenocarcinoma of the prostate|adenocarcinoma of the prostate
695671|NCT00651326|stage I prostate cancer|stage i prostate cancer
695672|NCT00651326|stage II prostate cancer|stage ii prostate cancer
695673|NCT00651326|stage III prostate cancer|stage iii prostate cancer
695674|NCT00651326|stage IV prostate cancer|stage iv prostate cancer
695675|NCT00651313|Dysmenorrhea|dysmenorrhea
695676|NCT00651313|Periods|periods
695677|NCT00651313|Menstrual|menstrual
695678|NCT00651313|Primary dysmenorrhea in women with recurrent dysmenorrhea|primary dysmenorrhea in women with recurrent dysmenorrhea
695679|NCT00651261|adult acute basophilic leukemia|adult acute basophilic leukemia
695680|NCT00651261|adult acute eosinophilic leukemia|adult acute eosinophilic leukemia
695681|NCT00651261|adult acute lymphoblastic leukemia|adult acute lymphoblastic leukemia
695682|NCT00651261|adult acute megakaryoblastic leukemia (M7)|adult acute megakaryoblastic leukemia (m7)
695683|NCT00651261|adult acute minimally differentiated myeloid leukemia (M0)|adult acute minimally differentiated myeloid leukemia (m0)
695684|NCT00651261|adult acute monoblastic leukemia (M5a)|adult acute monoblastic leukemia (m5a)
695685|NCT00651261|adult acute monocytic leukemia (M5b)|adult acute monocytic leukemia (m5b)
695686|NCT00651261|adult acute myeloblastic leukemia with maturation (M2)|adult acute myeloblastic leukemia with maturation (m2)
695687|NCT00651261|adult acute myeloblastic leukemia without maturation (M1)|adult acute myeloblastic leukemia without maturation (m1)
695688|NCT00651261|adult acute myeloid leukemia with 11q23 (MLL) abnormalities|adult acute myeloid leukemia with 11q23 (mll) abnormalities
695689|NCT00651261|adult acute myeloid leukemia with inv(16)(p13;q22)|adult acute myeloid leukemia with inv(16)(p13;q22)
695690|NCT00651261|adult acute myeloid leukemia with t(16;16)(p13;q22)|adult acute myeloid leukemia with t(16;16)(p13;q22)
695691|NCT00651261|adult acute myeloid leukemia with t(8;21)(q22;q22)|adult acute myeloid leukemia with t(8;21)(q22;q22)
695692|NCT00651261|adult acute myelomonocytic leukemia (M4)|adult acute myelomonocytic leukemia (m4)
695693|NCT00651261|adult erythroleukemia (M6a)|adult erythroleukemia (m6a)
695991|NCT00648739|Anti-CD200|anti-cd200
695694|NCT00651261|adult pure erythroid leukemia (M6b)|adult pure erythroid leukemia (m6b)
695695|NCT00651261|untreated adult acute myeloid leukemia|untreated adult acute myeloid leukemia
695696|NCT00651248|Saliva|saliva
695697|NCT00651248|Oral health|oral health
695698|NCT00651248|Aged|aged
695699|NCT00651209|Hepatitis B, chronic|hepatitis b, chronic
695700|NCT00651209|Telbivudine|telbivudine
695701|NCT00651209|Tenofovir|tenofovir
695702|NCT00651209|Roadmap Concept|roadmap concept
695703|NCT00651196|Type 1 diabetes|type 1 diabetes
695704|NCT00651196|bone|bone
695705|NCT00651170|Median block nerve|median block nerve
695706|NCT00651170|Ultrasound|ultrasound
695707|NCT00651131|post-surgical|post-surgical
695708|NCT00651131|wound infection|wound infection
695709|NCT00651131|superficial|superficial
695710|NCT00651131|deep|deep
695711|NCT00651131|surgical|surgical
695712|NCT00651105|Diabetes|diabetes
695713|NCT00651105|Hyperglycemia|hyperglycemia
695714|NCT00651105|Healthy|healthy
695715|NCT00651105|Vildagliptin|vildagliptin
695716|NCT00651105|Adults|adults
695717|NCT00651092|turbinectomy|turbinectomy
695718|NCT00651079|GSK1247303,|gsk1247303,
695719|NCT00651079|Integrase,|integrase,
695720|NCT00651079|First Time in Human|first time in human
695721|NCT00651066|HIV|hiv
695722|NCT00651066|Tuberculosis|tuberculosis
695723|NCT00651066|Rifabutin|rifabutin
695724|NCT00651066|Pharmacokinetics|pharmacokinetics
695725|NCT00651066|Vietnam|vietnam
695726|NCT00651040|Polymyositis|polymyositis
695727|NCT00651040|Dermatomyositis|dermatomyositis
695728|NCT00651040|Glucocorticoids|glucocorticoids
695729|NCT00651040|Methotrexate|methotrexate
695730|NCT00651001|fructose|fructose
695731|NCT00651001|leptin|leptin
695732|NCT00651001|metabolic syndrome|metabolic syndrome
695733|NCT00651001|blood pressure|blood pressure
695734|NCT00651001|inflammation|inflammation
695735|NCT00651001|Relationship of fructose intake to leptin levels|relationship of fructose intake to leptin levels
695736|NCT00651001|Relationship of fructose to metabolic syndrome|relationship of fructose to metabolic syndrome
695737|NCT00651001|Relationship of fructose to inflammation parameters|relationship of fructose to inflammation parameters
695738|NCT00651001|Relationship of fructose to blood pressure|relationship of fructose to blood pressure
695739|NCT00650988|Barrett's Esophagus|barrett's esophagus
695740|NCT00650988|Cryospray ablation|cryospray ablation
695741|NCT00650988|High Grade Dysplasia|high grade dysplasia
695742|NCT00650988|Early Esophageal Cancers|early esophageal cancers
695743|NCT00650988|Esophageal Neoplasms|esophageal neoplasms
695744|NCT00650988|Esophageal Intramucosal Cancer (IMCA)|esophageal intramucosal cancer (imca)
695745|NCT00650988|Esophageal Cancer limited to esophageal wall|esophageal cancer limited to esophageal wall
695746|NCT00650988|Barretts esophagus High Grade Dysplasia (HGD)|barretts esophagus high grade dysplasia (hgd)
695747|NCT00650975|STEMI|stemi
695748|NCT00650975|Laser|laser
695749|NCT00650975|Thrombus|thrombus
695750|NCT00650975|Thrombectomy|thrombectomy
695751|NCT00650962|CPR|cpr
695752|NCT00650962|Preshock CPR|preshock cpr
695753|NCT00650962|OHCA|ohca
695754|NCT00650962|EMS|ems
695755|NCT00650949|Glioblastoma multiforme|glioblastoma multiforme
695756|NCT00650949|Glioma|glioma
695757|NCT00650949|Phase Ib/II|phase ib/ii
695758|NCT00650949|CYT997|cyt997
695759|NCT00650936|Atrial|atrial
695760|NCT00650936|Septal|septal
695761|NCT00650936|Defect|defect
695762|NCT00650910|lapatinib|lapatinib
695763|NCT00650910|Metastatic ErbB2 positive breast cancer|metastatic erbb2 positive breast cancer
695764|NCT00650910|digoxin|digoxin
695765|NCT00650897|Efficacy|efficacy
695766|NCT00650897|Antidepressant|antidepressant
695767|NCT00650897|Escitalopram|escitalopram
695768|NCT00650897|Major Depression|major depression
695769|NCT00650897|Diabetes Mellitus|diabetes mellitus
695770|NCT00650897|Self Care|self care
695771|NCT00650884|Dynamic Splinting for low-load, prolonged-duration stretch|dynamic splinting for low-load, prolonged-duration stretch
695772|NCT00650871|sleep,|sleep,
695773|NCT00650871|polysomnography.|polysomnography.
695774|NCT00650871|GW679769,|gw679769,
695775|NCT00650871|primary insomnia,|primary insomnia,
695776|NCT00650871|cognitive function,|cognitive function,
695777|NCT00650858|Intraventricular hemorrhage (IVH)|intraventricular hemorrhage (ivh)
695778|NCT00650858|rt-PA|rt-pa
695779|NCT00650845|contrast-induced nephropathy, creatinemia|contrast-induced nephropathy, creatinemia
695780|NCT00650832|HIV, anti-infectives|hiv, anti-infectives
695781|NCT00650806|Obesity|obesity
695782|NCT00650806|Overweight|overweight
695783|NCT00650806|Weight loss|weight loss
695784|NCT00650806|Anti-Obesity Agents|anti-obesity agents
695785|NCT00650806|Human|human
695786|NCT00650793|Schizophrenia|schizophrenia
695787|NCT00650793|paliperidone|paliperidone
695788|NCT00650780|Viatmin D, 25-hydroxyvitamin D, Vitamin D binding protein|viatmin d, 25-hydroxyvitamin d, vitamin d binding protein
695789|NCT00650754|DHEA|dhea
695790|NCT00650754|Pregnancy|pregnancy
695791|NCT00650741|Endothelial Dysfunction|endothelial dysfunction
695792|NCT00650741|FMD|fmd
695793|NCT00650728|radiofrequency ablation|radiofrequency ablation
695794|NCT00650715|Fibromyalgia|fibromyalgia
695795|NCT00650715|Whole-Body vibration|whole-body vibration
695796|NCT00650715|Exercise|exercise
695797|NCT00650715|IGF-1|igf-1
695798|NCT00650702|glaucoma, ocular hypertension, IOP|glaucoma, ocular hypertension, iop
695799|NCT00650624|knee osteoarthritis; Japan|knee osteoarthritis; japan
695800|NCT00650598|anterior cruciate ligament, arthroscopy, knee, post-surgical pain|anterior cruciate ligament, arthroscopy, knee, post-surgical pain
695801|NCT00650585|smoking|smoking
695802|NCT00650585|alcohol|alcohol
695803|NCT00650585|prevention|prevention
695804|NCT00650585|prevention & control|prevention & control
695805|NCT00650572|human epidermal growth factor receptor 2|human epidermal growth factor receptor 2
695806|NCT00650572|epidermal growth factor receptor|epidermal growth factor receptor
695807|NCT00650572|EGFR|egfr
695808|NCT00650572|type I receptor tyrosine kinase|type i receptor tyrosine kinase
695809|NCT00650559|COPD|copd
695810|NCT00650559|Emphysema|emphysema
695811|NCT00650559|thorax enlargement|thorax enlargement
695812|NCT00650559|LVRS|lvrs
695813|NCT00650546|Non-alcoholic steatohepatitis|non-alcoholic steatohepatitis
695814|NCT00650546|NASH|nash
695815|NCT00650507|children|children
695816|NCT00650507|cardiac surgery|cardiac surgery
695817|NCT00650507|remote ischemic preconditioning|remote ischemic preconditioning
695818|NCT00650507|SHAM|sham
695819|NCT00650507|ischemia-reperfusion|ischemia-reperfusion
695820|NCT00650468|Renal Transplantation|renal transplantation
695821|NCT00650468|Prograf|prograf
695822|NCT00650455|valdecoxib, severe rheumatoid arthritis|valdecoxib, severe rheumatoid arthritis
695823|NCT00650260|intraoperative warming|intraoperative warming
695824|NCT00650260|anesthesia|anesthesia
695825|NCT00650260|hypothermia|hypothermia
695826|NCT00650260|body temperature|body temperature
695827|NCT00650182|patch|patch
695828|NCT00650182|fentanyl|fentanyl
695829|NCT00650182|chronic pain|chronic pain
695830|NCT00650143|Stem cell|stem cell
695831|NCT00650143|Myocardial infarction|myocardial infarction
695832|NCT00650143|G-CSF|g-csf
695833|NCT00650143|CD26-inhibition|cd26-inhibition
695834|NCT00650130|driving under the influence|driving under the influence
695835|NCT00650130|psychoactive substances|psychoactive substances
695836|NCT00650130|oral fluid|oral fluid
695837|NCT00650130|whole blood|whole blood
695838|NCT00650130|plasma|plasma
695839|NCT00650130|Ratio of psychoactive substances in whole blood-plasma-oral fluid|ratio of psychoactive substances in whole blood-plasma-oral fluid
695840|NCT00650130|Prevalence of psychoactive substances in road traffic|prevalence of psychoactive substances in road traffic
695841|NCT00650104|ropinirole IR|ropinirole ir
695842|NCT00650104|efficacy|efficacy
695843|NCT00650104|safety|safety
695844|NCT00650104|open-label|open-label
695845|NCT00650104|long term safety; REQUIP|long term safety; requip
695846|NCT00650104|ropinirole XL|ropinirole xl
695847|NCT00650104|ropinirole CR|ropinirole cr
695848|NCT00650104|Parkinson's disease|parkinson's disease
695849|NCT00650091|Idiopathic Pulmonary Fibrosis|idiopathic pulmonary fibrosis
695850|NCT00650091|Prednisone|prednisone
695851|NCT00650091|Azathioprine|azathioprine
695852|NCT00650091|NAC|nac
695853|NCT00650091|N-acetylcysteine|n-acetylcysteine
695854|NCT00650078|Signs and Symptoms|signs and symptoms
695855|NCT00650078|Autoimmune Diseases|autoimmune diseases
695856|NCT00650078|Joint Diseases|joint diseases
695857|NCT00650078|Arthritis|arthritis
695858|NCT00650078|Connective Tissue Diseases|connective tissue diseases
695859|NCT00650078|Arthritis, Rheumatoid|arthritis, rheumatoid
695860|NCT00650078|Rheumatic Diseases|rheumatic diseases
695861|NCT00650078|Predniso(lo)ne|predniso(lo)ne
695862|NCT00650039|Post surgical pain|post surgical pain
695863|NCT00650039|Anterior Cruciate ligament reconstruction|anterior cruciate ligament reconstruction
695864|NCT00650039|Arthroscopy|arthroscopy
695865|NCT00650039|Perioperative pain|perioperative pain
695866|NCT00649961|Premature Birth|premature birth
695867|NCT00649961|Brain injury|brain injury
695868|NCT00649961|Neuroprotection|neuroprotection
695869|NCT00649961|Melatonin|melatonin
695870|NCT00649961|Pharmacokinetics|pharmacokinetics
695871|NCT00649922|Vaccines with adalimumab dosing|vaccines with adalimumab dosing
695872|NCT00649909|Diabetes Mellitus|diabetes mellitus
695873|NCT00649909|Type II|type ii
695874|NCT00649909|Aspirin|aspirin
695875|NCT00649909|Resistance|resistance
695876|NCT00649883|Influenza|influenza
695877|NCT00649883|vaccine|vaccine
695878|NCT00649883|children|children
695879|NCT00649792|multiple sclerosis|multiple sclerosis
695880|NCT00649792|MS|ms
695881|NCT00649792|walking|walking
695882|NCT00649792|leg strength|leg strength
695883|NCT00649792|demyelination|demyelination
695884|NCT00649766|tailored health messages|tailored health messages
695885|NCT00649766|glaucoma|glaucoma
695886|NCT00649766|diabetic retinopathy|diabetic retinopathy
695887|NCT00649766|dilated fundus exams|dilated fundus exams
695888|NCT00649766|health behavior|health behavior
695889|NCT00649753|sacroiliac joint dysfunction|sacroiliac joint dysfunction
695890|NCT00649753|algometer|algometer
695891|NCT00649753|Chiropractic|chiropractic
695892|NCT00649753|Manual Therapy|manual therapy
695992|NCT00648687|prematurity|prematurity
695893|NCT00649753|indicator points associated with sacroiliac joint dysfunction|indicator points associated with sacroiliac joint dysfunction
695894|NCT00649701|HIV|hiv
695895|NCT00649701|Internet|internet
695896|NCT00649701|MSM|msm
695897|NCT00649701|Condom Use|condom use
695898|NCT00649701|Disclosure|disclosure
695899|NCT00649610|acute low back pain|acute low back pain
695900|NCT00649584|Antigens, CD30|antigens, cd30
695901|NCT00649584|Antibody-Drug Conjugate|antibody-drug conjugate
695902|NCT00649584|Antibodies, Monoclonal|antibodies, monoclonal
695903|NCT00649584|monomethyl auristatin E|monomethyl auristatin e
695904|NCT00649584|Combined Modality Therapy|combined modality therapy
695905|NCT00649584|Drug Therapy|drug therapy
695906|NCT00649584|Immunotherapy|immunotherapy
695907|NCT00649584|Lymphoma, Non-Hodgkin|lymphoma, non-hodgkin
695908|NCT00649584|Disease, Hodgkin|disease, hodgkin
695909|NCT00649584|Lymphoma, Large-Cell, Anaplastic|lymphoma, large-cell, anaplastic
695910|NCT00649584|Hematologic Diseases|hematologic diseases
695911|NCT00649584|Lymphoma|lymphoma
695912|NCT00649428|Treatment of moderate to severe bilateral nasolabial fold wrinkles|treatment of moderate to severe bilateral nasolabial fold wrinkles
695913|NCT00649337|mammography|mammography
695914|NCT00649337|ultrasound|ultrasound
695915|NCT00649337|breast cancer|breast cancer
695916|NCT00649337|screening|screening
695917|NCT00649298|Randomized Controlled Trial|randomized controlled trial
695918|NCT00649298|Clinical Trial|clinical trial
695919|NCT00649298|Controlled Clinical Trial|controlled clinical trial
695920|NCT00649298|Clinical Trial, Phase IV|clinical trial, phase iv
695921|NCT00649298|Multicenter Study|multicenter study
695922|NCT00649298|End Stage Kidney Disease|end stage kidney disease
695923|NCT00649298|Hemodialysis|hemodialysis
695924|NCT00649298|Renal Dialysis|renal dialysis
695925|NCT00649298|Renal Replacement Therapy|renal replacement therapy
695926|NCT00649298|Nocturnal Dialysis|nocturnal dialysis
695927|NCT00649298|Extended dialysis|extended dialysis
695928|NCT00649298|Quality of Life|quality of life
695929|NCT00649298|Quality Adjusted Life Year|quality adjusted life year
695930|NCT00649298|Hypertrophy, Left Ventricular|hypertrophy, left ventricular
695931|NCT00649298|Blood Pressure|blood pressure
695932|NCT00649298|Hypertension|hypertension
695933|NCT00649298|Anemia|anemia
695934|NCT00649298|Hematinics|hematinics
696062|NCT00647933|Antibodies|antibodies
695935|NCT00649298|Erythropoiesis Stimulating Agents|erythropoiesis stimulating agents
695936|NCT00649298|Cost-utility Analysis|cost-utility analysis
695937|NCT00649298|Economic Evaluation|economic evaluation
695938|NCT00649298|Health Care Utilisation|health care utilisation
695939|NCT00649298|Health Care Costs|health care costs
695940|NCT00649298|Health Expenditures|health expenditures
695941|NCT00649298|Hospitalization|hospitalization
695942|NCT00649298|Cost Analysis|cost analysis
695943|NCT00649298|Cardiovascular Diseases|cardiovascular diseases
695944|NCT00649298|Acute Coronary Syndrome|acute coronary syndrome
695945|NCT00649298|Myocardial Infarction|myocardial infarction
695946|NCT00649298|Stroke|stroke
695947|NCT00649298|Cerebrovascular Disorders|cerebrovascular disorders
695948|NCT00649298|Mortality|mortality
695949|NCT00649298|Arteriovenous Fistula|arteriovenous fistula
695950|NCT00649298|Arteriovenous Shunt, Surgical|arteriovenous shunt, surgical
695951|NCT00649298|Thrombosis|thrombosis
695952|NCT00649298|Infection|infection
695953|NCT00649246|genetics|genetics
695954|NCT00649246|type 1 diabetes|type 1 diabetes
695955|NCT00649246|biomarkers|biomarkers
695956|NCT00649246|autoimmunity|autoimmunity
695957|NCT00649207|WBRT|wbrt
695958|NCT00649207|Brain Metastases|brain metastases
695959|NCT00649207|Radiation|radiation
695960|NCT00649207|ABT-888|abt-888
695961|NCT00649207|PARP|parp
695962|NCT00649142|Groin hernia|groin hernia
695963|NCT00649142|Chronic postsurgical pain|chronic postsurgical pain
695964|NCT00649142|open mesh repair|open mesh repair
695965|NCT00649142|laparoscopic mesh glue fixation|laparoscopic mesh glue fixation
695966|NCT00649142|Sensory changes after groin hernia repair|sensory changes after groin hernia repair
695967|NCT00649025|Asthma|asthma
695968|NCT00649025|Asthma Moderate to Severe|asthma moderate to severe
695969|NCT00648999|Kaletra|kaletra
695970|NCT00648986|brittle nails|brittle nails
695971|NCT00648986|Tazarotene|tazarotene
695972|NCT00648986|Tazorac|tazorac
695973|NCT00648973|Seasonal Allergic Rhinitis, nasal congestion|seasonal allergic rhinitis, nasal congestion
695974|NCT00648908|multiple sclerosis|multiple sclerosis
695976|NCT00648908|walking|walking
695977|NCT00648908|leg strength|leg strength
695978|NCT00648908|demyelination|demyelination
695979|NCT00648895|Hypertension|hypertension
695980|NCT00648895|Blood pressure|blood pressure
695981|NCT00648895|Nebivolol|nebivolol
695982|NCT00648895|Bystolic (TM)|bystolic (tm)
695983|NCT00648895|Metoprolol ER (TM)|metoprolol er (tm)
695984|NCT00648869|pharmaceutical preparations|pharmaceutical preparations
695985|NCT00648817|HIV-1|hiv-1
695986|NCT00648817|tenofovir DF|tenofovir df
695987|NCT00648739|B-cell Chronic Lymphocytic Leukemia|b-cell chronic lymphocytic leukemia
695988|NCT00648739|Leukemia|leukemia
695989|NCT00648739|Multiple Myeloma|multiple myeloma
695990|NCT00648739|CD200|cd200
695993|NCT00648687|retinopathy of prematurity|retinopathy of prematurity
695994|NCT00648687|pain|pain
695995|NCT00648687|very low birth weight infants|very low birth weight infants
695996|NCT00648635|Rectal Cancer|rectal cancer
695997|NCT00648635|Recurrent Rectal Adenocarcinoma|recurrent rectal adenocarcinoma
695998|NCT00648635|Quality of Life|quality of life
695999|NCT00648635|QOL|qol
696000|NCT00648635|Questionnaire|questionnaire
696001|NCT00648635|Survey|survey
696002|NCT00648609|Community based self management of COPD with palliative care|community based self management of copd with palliative care
696003|NCT00648479|Fracture Fixation|fracture fixation
696004|NCT00648453|Fontain II-III stage|fontain ii-iii stage
696005|NCT00648375|Propanolol|propanolol
696006|NCT00648375|Beta Blockers|beta blockers
696007|NCT00648375|Reconsolidation|reconsolidation
696008|NCT00648375|Cognitive Therapy|cognitive therapy
696009|NCT00648375|PTSD|ptsd
696010|NCT00648323|Benign Prostate Hyperplasia|benign prostate hyperplasia
696011|NCT00648284|Type 2 diabetes|type 2 diabetes
696012|NCT00648284|CV risk|cv risk
696013|NCT00648284|rosiglitazone|rosiglitazone
696014|NCT00648284|AVANDIA|avandia
696015|NCT00648258|osteoarthritis, knee|osteoarthritis, knee
696016|NCT00648258|osteoarthritis, hip|osteoarthritis, hip
696017|NCT00648245|chronic obstructive pulmonary disease|chronic obstructive pulmonary disease
696018|NCT00648245|COPD|copd
696019|NCT00648245|Chronic bronchitis|chronic bronchitis
696020|NCT00648232|HIV|hiv
696021|NCT00648232|AIDS|aids
696022|NCT00648232|Prevention|prevention
696023|NCT00648232|VCT|vct
696024|NCT00648232|Voluntary Counseling and Testing|voluntary counseling and testing
696025|NCT00648206|driving under the influence|driving under the influence
696026|NCT00648206|psychoactive substances|psychoactive substances
696027|NCT00648206|blood samples|blood samples
696028|NCT00648206|Prevalence of psychoactive substances in road traffic|prevalence of psychoactive substances in road traffic
696029|NCT00648167|ESRD|esrd
696030|NCT00648167|end-stage renal disease|end-stage renal disease
696031|NCT00648167|end stage renal disease|end stage renal disease
696032|NCT00648167|hemodialysis|hemodialysis
696033|NCT00648167|dialysis|dialysis
696034|NCT00648167|kidney failure|kidney failure
696035|NCT00648167|renal failure|renal failure
696036|NCT00648167|kidney|kidney
696037|NCT00648167|renal|renal
696038|NCT00648167|phosphate binder|phosphate binder
696039|NCT00648167|phosphorus|phosphorus
696040|NCT00648115|Veterans|veterans
696041|NCT00648115|Substance-Related Disorders|substance-related disorders
696042|NCT00648115|Mental Health|mental health
696043|NCT00648102|Breast cancer|breast cancer
696044|NCT00648102|Colorectal cancer|colorectal cancer
696045|NCT00648102|Pancreatic cancer|pancreatic cancer
696046|NCT00648102|Bladder cancer|bladder cancer
696047|NCT00648102|Ovarian cancer|ovarian cancer
696048|NCT00648102|Metastatic cancer|metastatic cancer
696049|NCT00648102|Locally advanced cancer|locally advanced cancer
696050|NCT00648102|Cancer Vaccine|cancer vaccine
696051|NCT00648102|Vaccine|vaccine
696052|NCT00648089|Acute ST Elevation Myocardial Infarction|acute st elevation myocardial infarction
696053|NCT00648037|RITUXIMAB|rituximab
696054|NCT00648037|Lymphoma|lymphoma
696055|NCT00647998|Surgical complications|surgical complications
696056|NCT00647998|Spinal ischemia|spinal ischemia
696057|NCT00647998|Stroke|stroke
696058|NCT00647998|Neuroprotection|neuroprotection
696059|NCT00647946|lipodystrophy|lipodystrophy
696060|NCT00647933|Females|females
696061|NCT00647933|Corifollitropin alfa|corifollitropin alfa
696063|NCT00647933|Pharmacokinetics|pharmacokinetics
696064|NCT00647933|Pharmacodynamics|pharmacodynamics
696065|NCT00647868|pharmacokinetics|pharmacokinetics
696066|NCT00647868|testosterone|testosterone
696067|NCT00647868|hypogonadism|hypogonadism
696068|NCT00647829|pharyngitis, sore throat|pharyngitis, sore throat
696069|NCT00647790|PET imaging|pet imaging
696070|NCT00647790|invasive breast cancer|invasive breast cancer
696071|NCT00647725|Epidural analgesia|epidural analgesia
696072|NCT00647725|Latent analgesia|latent analgesia
696073|NCT00647725|Active analgesia|active analgesia
696074|NCT00647725|Labor delivery|labor delivery
696075|NCT00647699|keratoconus|keratoconus
696076|NCT00647699|cross-linking|cross-linking
696077|NCT00647699|riboflavin|riboflavin
696078|NCT00647699|UVA light|uva light
696079|NCT00647699|cornea|cornea
696080|NCT00647595|Obesity|obesity
696081|NCT00647595|Physical activity|physical activity
696082|NCT00647595|Pregnancy|pregnancy
696083|NCT00647595|Diabetes mellitus|diabetes mellitus
696084|NCT00647582|stage I breast cancer|stage i breast cancer
696085|NCT00647582|stage II breast cancer|stage ii breast cancer
696086|NCT00647569|vertical rectus abdominis musculocutaneus flap|vertical rectus abdominis musculocutaneus flap
696087|NCT00647569|mesh repair|mesh repair
696088|NCT00647569|salvage surgery|salvage surgery
696089|NCT00647530|adenocarcinoma of the colon|adenocarcinoma of the colon
696090|NCT00647530|stage I colon cancer|stage i colon cancer
696091|NCT00647530|stage II colon cancer|stage ii colon cancer
696092|NCT00647530|stage III colon cancer|stage iii colon cancer
696093|NCT00647504|stent thrombosis|stent thrombosis
696094|NCT00647504|stent restenosis|stent restenosis
696095|NCT00647504|intravascular ultrasound|intravascular ultrasound
696096|NCT00647478|Insulin-like Growth Factor|insulin-like growth factor
696097|NCT00647478|Insulin-like Growth Factor binding protein 3|insulin-like growth factor binding protein 3
696098|NCT00647478|Insulin-like Growth Factor-I system component levels|insulin-like growth factor-i system component levels
696099|NCT00647478|Insulin-like Growth Factor-I polymorphism|insulin-like growth factor-i polymorphism
696100|NCT00647478|Alzheimer's disease|alzheimer's disease
696101|NCT00647478|Mild Cognitive Impairment|mild cognitive impairment
696102|NCT00647478|Normal cognitive function|normal cognitive function
696103|NCT00647478|Observational cross sectional study|observational cross sectional study
696104|NCT00647465|Influenza vaccine|influenza vaccine
696105|NCT00647465|interferon|interferon
696106|NCT00647465|adjuvant|adjuvant
696107|NCT00647465|the elderly|the elderly
696108|NCT00647452|Lipid metabolism|lipid metabolism
696109|NCT00647452|VLDL|vldl
696110|NCT00647452|Exercise|exercise
696111|NCT00647452|Lipid metabolism in exercise|lipid metabolism in exercise
696112|NCT00647439|OCULAR INFLAMMATORY DISEASE|ocular inflammatory disease
696113|NCT00647439|Immune Mediated|immune mediated
696114|NCT00647439|Gene Expression Patterns|gene expression patterns
696115|NCT00647439|Diabetic Retinopathy|diabetic retinopathy
696116|NCT00647439|Age-Related Macular Degeneration|age-related macular degeneration
696118|NCT00647439|Uveitis|uveitis
696119|NCT00647426|Stage IIIB/IV|stage iiib/iv
696120|NCT00647413|smoking|smoking
696121|NCT00647413|passive smoking|passive smoking
696122|NCT00647413|exposure to environmental smoke|exposure to environmental smoke
696123|NCT00647413|home smoking ban|home smoking ban
696124|NCT00647413|urinary cotinine|urinary cotinine
696125|NCT00647400|Psoriasis|psoriasis
696126|NCT00647387|muscular|muscular
696127|NCT00647387|ventricular|ventricular
696128|NCT00647387|septal|septal
696129|NCT00647387|defects|defects
696130|NCT00647387|VSD|vsd
696131|NCT00647361|respiratory insufficiency|respiratory insufficiency
696132|NCT00647361|respiration|respiration
696133|NCT00647361|ventilators|ventilators
696134|NCT00647361|diaphragm|diaphragm
696135|NCT00647361|electromyography|electromyography
696136|NCT00647361|mechanical ventilation|mechanical ventilation
696137|NCT00647348|Secondary progressive Multiple Sclerosis|secondary progressive multiple sclerosis
696138|NCT00647348|Simvastatin|simvastatin
696139|NCT00647348|MRI|mri
696140|NCT00647322|Intractable epilepsy, Drug Reduction, Antiepileptic medication|intractable epilepsy, drug reduction, antiepileptic medication
696141|NCT00647296|ALS|als
696142|NCT00647296|Amyotrophic Lateral Sclerosis|amyotrophic lateral sclerosis
696143|NCT00647296|Lou Gehrig|lou gehrig
696144|NCT00647296|Lou Gehrig's|lou gehrig's
696145|NCT00647296|Lou Gehrig's disease|lou gehrig's disease
696146|NCT00647296|Motor Neuron Disease|motor neuron disease
696147|NCT00647296|Nervous System Diseases|nervous system diseases
696148|NCT00647296|KNS-760704|kns-760704
696149|NCT00647283|Liver Transplantation|liver transplantation
696150|NCT00647283|Tolerance|tolerance
696151|NCT00647283|Allograft tolerance|allograft tolerance
696152|NCT00647283|Immunosuppression minimization|immunosuppression minimization
696153|NCT00647283|Immunosuppression weaning|immunosuppression weaning
696154|NCT00647283|Immunological tolerance|immunological tolerance
696155|NCT00647257|Sick Sinus Syndrome; Atrial Fibrillation; Pacemaker|sick sinus syndrome; atrial fibrillation; pacemaker
696156|NCT00647244|Tenofovir|tenofovir
696157|NCT00647244|Abacavir|abacavir
696158|NCT00647244|Antiretroviral therapy|antiretroviral therapy
696159|NCT00647244|HIV|hiv
696160|NCT00647244|Nucleoside analogue reverse transcriptase inhibitor|nucleoside analogue reverse transcriptase inhibitor
696161|NCT00647231|Osteoarthritis,Knee,Ketoprofen,Pain,Patch,Analgesic|osteoarthritis,knee,ketoprofen,pain,patch,analgesic
696162|NCT00647218|stage II breast cancer|stage ii breast cancer
696163|NCT00647218|stage IIIA breast cancer|stage iiia breast cancer
696164|NCT00647218|stage IIIB breast cancer|stage iiib breast cancer
696165|NCT00647218|stage IIIC breast cancer|stage iiic breast cancer
696166|NCT00647205|Interferon, gamma|interferon, gamma
696167|NCT00647205|HIV Infections|hiv infections
696168|NCT00647205|Tuberculosis|tuberculosis
696169|NCT00647192|atrial fibrillation|atrial fibrillation
696170|NCT00647192|electrical cardioversion|electrical cardioversion
696171|NCT00647192|prevention of atrial fibrillation recurrence|prevention of atrial fibrillation recurrence
696172|NCT00647192|mineralocorticoid receptor blocker|mineralocorticoid receptor blocker
696173|NCT00647192|eplerenone|eplerenone
696174|NCT00647192|Recurrence of atrial fibrillation after cardioversion|recurrence of atrial fibrillation after cardioversion
696175|NCT00647179|Acromegaly|acromegaly
696176|NCT00647179|Growth Hormone|growth hormone
696177|NCT00647179|Insulin resistance|insulin resistance
696178|NCT00647179|Glucose tolerance|glucose tolerance
696179|NCT00647179|Body Composition|body composition
696180|NCT00647179|Substrate metabolism|substrate metabolism
696181|NCT00647166|Vasculitis|vasculitis
696182|NCT00647166|Polyarteritis nodosa (PAN)|polyarteritis nodosa (pan)
696183|NCT00647166|Microscopic polyangiitis (MPA)|microscopic polyangiitis (mpa)
696184|NCT00647166|Eosinophilic granulomatosis with polyangiitis (EGPA)|eosinophilic granulomatosis with polyangiitis (egpa)
696185|NCT00647166|Churg Strauss syndrome (CSS)|churg strauss syndrome (css)
696186|NCT00647166|Azathioprine|azathioprine
696187|NCT00647153|stage I colon cancer|stage i colon cancer
696188|NCT00647153|stage II colon cancer|stage ii colon cancer
696189|NCT00647153|stage III colon cancer|stage iii colon cancer
696190|NCT00647153|stage IV colon cancer|stage iv colon cancer
696191|NCT00647153|stage I rectal cancer|stage i rectal cancer
696192|NCT00647153|stage II rectal cancer|stage ii rectal cancer
696193|NCT00647153|stage III rectal cancer|stage iii rectal cancer
696194|NCT00647153|stage IV rectal cancer|stage iv rectal cancer
696195|NCT00647140|Thyroid neoplasm|thyroid neoplasm
696196|NCT00647140|Thyroid carcinoma|thyroid carcinoma
696197|NCT00647140|Medullary carcinoma|medullary carcinoma
696198|NCT00647140|Positron Emission Tomography (PET)|positron emission tomography (pet)
696199|NCT00647140|18F-L DOPA|18f-l dopa
696200|NCT00647140|Calcitonin|calcitonin
696201|NCT00647140|Carcinoembryonic Antibodies|carcinoembryonic antibodies
696202|NCT00647140|Cervical ultrasonography|cervical ultrasonography
696203|NCT00647140|Cervical-chest-abdomen tomography|cervical-chest-abdomen tomography
696204|NCT00647140|Cervical-chest-abdomen magnetic resonance imaging|cervical-chest-abdomen magnetic resonance imaging
696205|NCT00647140|Osseous radionuclide imaging|osseous radionuclide imaging
696206|NCT00647140|Post-PET surgery|post-pet surgery
696207|NCT00647140|Post-PET biopsy|post-pet biopsy
696208|NCT00647140|Post-PET histology|post-pet histology
696209|NCT00647127|Buprenorphine|buprenorphine
696210|NCT00647127|Fentanyl|fentanyl
696211|NCT00647127|Analgesic effect|analgesic effect
696212|NCT00647127|Anti-hyperalgesic effect|anti-hyperalgesic effect
696213|NCT00647127|Experimental pain|experimental pain
696214|NCT00647114|Cancers expressing HER-2 and/or CEA|cancers expressing her-2 and/or cea
696215|NCT00647088|Aortic Valve stenosis|aortic valve stenosis
696216|NCT00647088|Genetic|genetic
696217|NCT00647088|Mineralisation inhibitors|mineralisation inhibitors
696218|NCT00647075|Breast cancer|breast cancer
696219|NCT00647075|undergoing|undergoing
696220|NCT00647075|adjuvant/neoadjuvant chemotherapy|adjuvant/neoadjuvant chemotherapy
696221|NCT00647075|symptomatic therapy|symptomatic therapy
696222|NCT00647036|Parenteral nutrition, Infants, Dipeotiven, Microbial invasion|parenteral nutrition, infants, dipeotiven, microbial invasion
696223|NCT00646997|atrial fibrillation, left atrium, velocity vector imaging|atrial fibrillation, left atrium, velocity vector imaging
696224|NCT00646984|Lipodystrophy|lipodystrophy
696225|NCT00646984|Treatment interruption|treatment interruption
696226|NCT00646984|HIV|hiv
696227|NCT00646971|Isoprostane|isoprostane
696228|NCT00646971|Alkane|alkane
696229|NCT00646971|Exhaled condensate|exhaled condensate
696230|NCT00646971|Peripheral arterial tonometry|peripheral arterial tonometry
696231|NCT00646971|Polysomnography|polysomnography
696232|NCT00646971|Obstructive Sleep Apnea|obstructive sleep apnea
696233|NCT00646971|Hypoxia|hypoxia
696234|NCT00646945|Patient in a oncology unit who has to undergo a painful or invasive procedure|patient in a oncology unit who has to undergo a painful or invasive procedure
696235|NCT00646906|acetaminophen|acetaminophen
696236|NCT00646906|low dose aspirin|low dose aspirin
696237|NCT00646906|cyclooxygenase|cyclooxygenase
696238|NCT00646906|prostaglandin|prostaglandin
696239|NCT00646906|drug interaction|drug interaction
696240|NCT00646906|platelet inhibition|platelet inhibition
696241|NCT00646906|urinary prostaglandin metabolites|urinary prostaglandin metabolites
696242|NCT00646906|oxidant stress|oxidant stress
696243|NCT00646906|smoking|smoking
696244|NCT00646893|aneuploidy|aneuploidy
696245|NCT00646893|miscarriage|miscarriage
696246|NCT00646893|pregnancy loss|pregnancy loss
696247|NCT00646893|PGD|pgd
696248|NCT00646893|PGS|pgs
696249|NCT00646893|Preimplantation Genetic Diagnosis|preimplantation genetic diagnosis
696250|NCT00646893|chromosome abnormalities|chromosome abnormalities
696251|NCT00646893|IVF|ivf
696252|NCT00646893|ART|art
696253|NCT00646867|Tetrix cream, contact dermatitis, effect on burning and itching|tetrix cream, contact dermatitis, effect on burning and itching
696254|NCT00646854|Lymphoma, T-Cell|lymphoma, t-cell
696255|NCT00646854|Lymphoma, T-Cell, Peripheral|lymphoma, t-cell, peripheral
696256|NCT00646854|MabCampath|mabcampath
696257|NCT00646854|Campath|campath
696258|NCT00646854|CHOP-14|chop-14
696259|NCT00646854|CD52 expression|cd52 expression
696260|NCT00646841|Essential hypertension, doxazosin, ambulatory blood pressure monitoring|essential hypertension, doxazosin, ambulatory blood pressure monitoring
696261|NCT00646828|Pseudohypoaldosteronism type 1|pseudohypoaldosteronism type 1
696262|NCT00646828|Mineralocorticoid receptor|mineralocorticoid receptor
696263|NCT00646828|Aldosterone|aldosterone
696264|NCT00646828|Cardiovascular disease|cardiovascular disease
696265|NCT00646815|insulin sensitivity|insulin sensitivity
696266|NCT00646815|substrate metabolism|substrate metabolism
696267|NCT00646815|fatty liver|fatty liver
696268|NCT00646815|intramyocellular lipids|intramyocellular lipids
696269|NCT00646815|growth hormone deficiency|growth hormone deficiency
696270|NCT00646815|Growth hormone deficiency (Adult)|growth hormone deficiency (adult)
696271|NCT00646750|Z-BEAM|z-beam
696272|NCT00646750|Autologous|autologous
696273|NCT00646750|Lymphoma|lymphoma
696274|NCT00646750|GELTAMO|geltamo
696275|NCT00646737|Kidney transplantation|kidney transplantation
696276|NCT00646737|conversion|conversion
696277|NCT00646737|mycophenolate mofetil|mycophenolate mofetil
696278|NCT00646737|mycophenolate sodium,|mycophenolate sodium,
696279|NCT00646737|tacrolimus|tacrolimus
696280|NCT00646724|Islets of Langerhans Transplantation|islets of langerhans transplantation
696281|NCT00646724|Mesenchymal Stem Cells|mesenchymal stem cells
696282|NCT00646724|Type 1 Diabetes Mellitus|type 1 diabetes mellitus
696283|NCT00646698|VLDL-TG kinetics|vldl-tg kinetics
696284|NCT00646698|Obesity|obesity
696285|NCT00646698|Body composition|body composition
696286|NCT00646698|Tracers|tracers
696287|NCT00646698|Tissue biopsies|tissue biopsies
696288|NCT00646672|ECMO|ecmo
696289|NCT00646672|Cerebral Perfusion|cerebral perfusion
696290|NCT00646672|Carotid Artery|carotid artery
696291|NCT00646672|Aneurysm|aneurysm
696292|NCT00646672|Cerebral Circulation|cerebral circulation
696293|NCT00646672|Common Carotid Artery Occlusion|common carotid artery occlusion
696294|NCT00646659|stage III squamous cell carcinoma of the hypopharynx|stage iii squamous cell carcinoma of the hypopharynx
696295|NCT00646659|stage III squamous cell carcinoma of the larynx|stage iii squamous cell carcinoma of the larynx
696296|NCT00646659|stage III squamous cell carcinoma of the lip and oral cavity|stage iii squamous cell carcinoma of the lip and oral cavity
696297|NCT00646659|stage III squamous cell carcinoma of the oropharynx|stage iii squamous cell carcinoma of the oropharynx
696521|NCT00645931|Pediatric|pediatric
696298|NCT00646659|stage IV squamous cell carcinoma of the hypopharynx|stage iv squamous cell carcinoma of the hypopharynx
696299|NCT00646659|stage IV squamous cell carcinoma of the larynx|stage iv squamous cell carcinoma of the larynx
696300|NCT00646659|stage IV squamous cell carcinoma of the lip and oral cavity|stage iv squamous cell carcinoma of the lip and oral cavity
696301|NCT00646659|stage IV squamous cell carcinoma of the oropharynx|stage iv squamous cell carcinoma of the oropharynx
696302|NCT00646659|untreated metastatic squamous neck cancer with occult primary|untreated metastatic squamous neck cancer with occult primary
696303|NCT00646646|Sedation|sedation
696304|NCT00646646|Eye Movements|eye movements
696305|NCT00646633|Cancer|cancer
696306|NCT00646633|Acupuncture|acupuncture
696307|NCT00646620|asthma|asthma
696308|NCT00646620|bronchodilatation|bronchodilatation
696309|NCT00646620|Symbicort|symbicort
696310|NCT00646620|budesonide/formoterol|budesonide/formoterol
696311|NCT00646620|Advair Diskus|advair diskus
696312|NCT00646620|Ventolin|ventolin
696313|NCT00646607|colorectal neoplasm|colorectal neoplasm
696314|NCT00646607|high risk|high risk
696315|NCT00646607|stage II/III|stage ii/iii
696316|NCT00646594|Asthma|asthma
696317|NCT00646594|inhaled cortocisteroids|inhaled cortocisteroids
696318|NCT00646594|Symbicort|symbicort
696319|NCT00646594|budesonide/formoterol|budesonide/formoterol
696320|NCT00646594|Advair|advair
696321|NCT00646594|fluticasone/salmeterol|fluticasone/salmeterol
696322|NCT00646581|Schizophrenia|schizophrenia
696323|NCT00646581|Memory|memory
696324|NCT00646581|Concentration|concentration
696325|NCT00646581|Insulin|insulin
696327|NCT00646568|ovarian reserve|ovarian reserve
696328|NCT00646568|androgens|androgens
696329|NCT00646568|thecal cells|thecal cells
696330|NCT00646568|Fertility Agents, Female|fertility agents, female
696331|NCT00646555|Tissue Samples|tissue samples
696332|NCT00646555|VEGF Receptors|vegf receptors
696333|NCT00646555|VEGF|vegf
696334|NCT00646555|Microvessel Density|microvessel density
696335|NCT00646555|Hypoxia Inducible Factor|hypoxia inducible factor
696336|NCT00646555|Inflammatory Breast Cancer|inflammatory breast cancer
696337|NCT00646555|IBC|ibc
696338|NCT00646542|Type 2 diabetes, vildagliptin|type 2 diabetes, vildagliptin
696339|NCT00646529|asthma|asthma
696340|NCT00646529|children|children
696341|NCT00646529|Symbicort|symbicort
696342|NCT00646529|budesonide/formoterol|budesonide/formoterol
696343|NCT00646529|Pulmicort|pulmicort
696344|NCT00646529|budesonide|budesonide
696345|NCT00646516|Asthma|asthma
696346|NCT00646516|inhaled corticosteroids|inhaled corticosteroids
696347|NCT00646516|Symbicort|symbicort
696348|NCT00646516|budesonide/formoterol|budesonide/formoterol
696349|NCT00646516|budesonide|budesonide
696350|NCT00646503|Hepatitis B, Chronic|hepatitis b, chronic
696351|NCT00646503|Telbivudine|telbivudine
696352|NCT00646503|Polymerase Chain reaction|polymerase chain reaction
696353|NCT00646490|serum, pleural effusion, procalcitonin, pneumonia|serum, pleural effusion, procalcitonin, pneumonia
696354|NCT00646464|CPT|cpt
696355|NCT00646464|ADHD|adhd
696356|NCT00646451|Essential tremor|essential tremor
696357|NCT00646451|Activities of Daily Living (ADL's)|activities of daily living (adl's)
696358|NCT00646438|Diabetes|diabetes
696359|NCT00646438|CABG|cabg
696360|NCT00646425|Non-infectious uveitis|non-infectious uveitis
696361|NCT00646412|randomized, controlled, single-blind study|randomized, controlled, single-blind study
696362|NCT00646412|Adhesion Prophylaxis|adhesion prophylaxis
696363|NCT00646412|Abdominal Surgery|abdominal surgery
696364|NCT00646412|Laparotomy, median|laparotomy, median
696365|NCT00646399|Staphylococcal|staphylococcal
696366|NCT00646399|Coagulase Negative Staphylococcus|coagulase negative staphylococcus
696367|NCT00646399|Monoclonal antibodies|monoclonal antibodies
696368|NCT00646399|Very Low Birth Weight Infants|very low birth weight infants
696369|NCT00646399|Prophylaxis|prophylaxis
696370|NCT00646373|Cardiac surgery|cardiac surgery
696371|NCT00646373|Pump prime|pump prime
696372|NCT00646373|Blood transfusions|blood transfusions
696373|NCT00646360|birth size, gestational age, development, child growth,|birth size, gestational age, development, child growth,
696374|NCT00646360|prenatal nutrition, DHA|prenatal nutrition, dha
696375|NCT00646347|stroke|stroke
696376|NCT00646347|upper limb rehabilitation|upper limb rehabilitation
696377|NCT00646347|treatment|treatment
696378|NCT00646347|movement recovery from sever paralytic upper limb|movement recovery from sever paralytic upper limb
696379|NCT00646347|neuro hand orthosis|neuro hand orthosis
696380|NCT00646347|self practice program|self practice program
696381|NCT00646347|subacute|subacute
696382|NCT00646334|Large Pore Size Propylene Mesh|large pore size propylene mesh
696383|NCT00646334|Incisional Hernia|incisional hernia
696384|NCT00646334|Randomized Controlled Double-blind Study|randomized controlled double-blind study
696385|NCT00646321|asthma|asthma
696386|NCT00646321|children|children
696387|NCT00646321|adolescents|adolescents
696388|NCT00646321|Symbicort|symbicort
696389|NCT00646321|budesonide/ formoterol|budesonide/ formoterol
696390|NCT00646321|budesonide|budesonide
696391|NCT00646308|growth hormone deficiency, pituitary tumors|growth hormone deficiency, pituitary tumors
696392|NCT00646295|TRO|tro
696393|NCT00646269|Dementia ; Alzheimer's Disease ; Non pharmacological treatments ; cognitive training ; reminiscence therapy ; efficacy assessment|dementia ; alzheimer's disease ; non pharmacological treatments ; cognitive training ; reminiscence therapy ; efficacy assessment
696394|NCT00646256|schizoaffective|schizoaffective
696395|NCT00646256|schizotypal|schizotypal
696396|NCT00646243|Heart failure|heart failure
696397|NCT00646243|echocardiography|echocardiography
696398|NCT00646243|cardiac resynchronization therapy|cardiac resynchronization therapy
696399|NCT00646243|left ventricular dyssynchrony|left ventricular dyssynchrony
696400|NCT00646230|recurrent neuroblastoma|recurrent neuroblastoma
696401|NCT00646217|SELF Care Talk|self care talk
696402|NCT00646217|stroke|stroke
696403|NCT00646217|caregivers|caregivers
696404|NCT00646217|Caregiving as experienced by older adults caring for a spouse/partner with a first-ever stroke|caregiving as experienced by older adults caring for a spouse/partner with a first-ever stroke
696405|NCT00646204|Parkinson's disease|parkinson's disease
696406|NCT00646204|non-motor symptoms|non-motor symptoms
696407|NCT00646165|Leukemia, CLL|leukemia, cll
696408|NCT00646152|Antiviral|antiviral
696409|NCT00646152|Influenza|influenza
696410|NCT00646152|Interferon|interferon
696411|NCT00646152|Prophylaxis|prophylaxis
696412|NCT00646152|SARS|sars
696413|NCT00646152|Healthy Volunteer|healthy volunteer
696414|NCT00646152|HV|hv
696415|NCT00646139|unspecified adult solid tumor, protocol specific|unspecified adult solid tumor, protocol specific
696416|NCT00646139|recurrent adult T-cell leukemia/lymphoma|recurrent adult t-cell leukemia/lymphoma
696417|NCT00646139|stage III adult T-cell leukemia/lymphoma|stage iii adult t-cell leukemia/lymphoma
696418|NCT00646139|stage IV adult T-cell leukemia/lymphoma|stage iv adult t-cell leukemia/lymphoma
696419|NCT00646139|adult grade III lymphomatoid granulomatosis|adult grade iii lymphomatoid granulomatosis
696420|NCT00646139|adult nasal type extranodal NK/T-cell lymphoma|adult nasal type extranodal nk/t-cell lymphoma
696421|NCT00646139|anaplastic large cell lymphoma|anaplastic large cell lymphoma
696422|NCT00646139|angioimmunoblastic T-cell lymphoma|angioimmunoblastic t-cell lymphoma
696423|NCT00646139|splenic marginal zone lymphoma|splenic marginal zone lymphoma
696424|NCT00646139|extranodal marginal zone B-cell lymphoma of mucosa-associated lymphoid tissue|extranodal marginal zone b-cell lymphoma of mucosa-associated lymphoid tissue
696425|NCT00646139|nodal marginal zone B-cell lymphoma|nodal marginal zone b-cell lymphoma
696426|NCT00646139|stage III adult Burkitt lymphoma|stage iii adult burkitt lymphoma
696427|NCT00646139|stage III adult diffuse large cell lymphoma|stage iii adult diffuse large cell lymphoma
696428|NCT00646139|stage III adult diffuse mixed cell lymphoma|stage iii adult diffuse mixed cell lymphoma
696429|NCT00646139|stage III adult diffuse small cleaved cell lymphoma|stage iii adult diffuse small cleaved cell lymphoma
696430|NCT00646139|stage III adult Hodgkin lymphoma|stage iii adult hodgkin lymphoma
696431|NCT00646139|stage III adult immunoblastic large cell lymphoma|stage iii adult immunoblastic large cell lymphoma
696432|NCT00646139|stage III adult lymphoblastic lymphoma|stage iii adult lymphoblastic lymphoma
696433|NCT00646139|stage III cutaneous T-cell non-Hodgkin lymphoma|stage iii cutaneous t-cell non-hodgkin lymphoma
696434|NCT00646139|stage III mycosis fungoides/Sezary syndrome|stage iii mycosis fungoides/sezary syndrome
696435|NCT00646139|stage III grade 1 follicular lymphoma|stage iii grade 1 follicular lymphoma
696436|NCT00646139|stage III grade 2 follicular lymphoma|stage iii grade 2 follicular lymphoma
696437|NCT00646139|stage III grade 3 follicular lymphoma|stage iii grade 3 follicular lymphoma
696438|NCT00646139|stage III mantle cell lymphoma|stage iii mantle cell lymphoma
696439|NCT00646139|stage III marginal zone lymphoma|stage iii marginal zone lymphoma
696440|NCT00646139|stage III small lymphocytic lymphoma|stage iii small lymphocytic lymphoma
696441|NCT00646139|stage IV adult Burkitt lymphoma|stage iv adult burkitt lymphoma
696442|NCT00646139|stage IV adult diffuse large cell lymphoma|stage iv adult diffuse large cell lymphoma
696443|NCT00646139|stage IV adult diffuse mixed cell lymphoma|stage iv adult diffuse mixed cell lymphoma
696444|NCT00646139|stage IV adult diffuse small cleaved cell lymphoma|stage iv adult diffuse small cleaved cell lymphoma
696627|NCT00645411|Egg-Derived|egg-derived
696445|NCT00646139|stage IV adult Hodgkin lymphoma|stage iv adult hodgkin lymphoma
696446|NCT00646139|stage IV adult immunoblastic large cell lymphoma|stage iv adult immunoblastic large cell lymphoma
696447|NCT00646139|stage IV adult lymphoblastic lymphoma|stage iv adult lymphoblastic lymphoma
696448|NCT00646139|stage IV cutaneous T-cell non-Hodgkin lymphoma|stage iv cutaneous t-cell non-hodgkin lymphoma
696449|NCT00646139|stage IV mycosis fungoides/Sezary syndrome|stage iv mycosis fungoides/sezary syndrome
696450|NCT00646139|stage IV grade 1 follicular lymphoma|stage iv grade 1 follicular lymphoma
696451|NCT00646139|stage IV grade 2 follicular lymphoma|stage iv grade 2 follicular lymphoma
696452|NCT00646139|stage IV grade 3 follicular lymphoma|stage iv grade 3 follicular lymphoma
696453|NCT00646139|stage IV mantle cell lymphoma|stage iv mantle cell lymphoma
696454|NCT00646139|stage IV marginal zone lymphoma|stage iv marginal zone lymphoma
696455|NCT00646139|stage IV small lymphocytic lymphoma|stage iv small lymphocytic lymphoma
696456|NCT00646139|recurrent adult Hodgkin lymphoma|recurrent adult hodgkin lymphoma
696457|NCT00646139|recurrent adult Burkitt lymphoma|recurrent adult burkitt lymphoma
696458|NCT00646139|recurrent adult diffuse large cell lymphoma|recurrent adult diffuse large cell lymphoma
696459|NCT00646139|recurrent adult diffuse mixed cell lymphoma|recurrent adult diffuse mixed cell lymphoma
696460|NCT00646139|recurrent adult diffuse small cleaved cell lymphoma|recurrent adult diffuse small cleaved cell lymphoma
696461|NCT00646139|recurrent adult grade III lymphomatoid granulomatosis|recurrent adult grade iii lymphomatoid granulomatosis
696462|NCT00646139|recurrent adult immunoblastic large cell lymphoma|recurrent adult immunoblastic large cell lymphoma
696463|NCT00646139|recurrent adult lymphoblastic lymphoma|recurrent adult lymphoblastic lymphoma
696464|NCT00646139|recurrent cutaneous T-cell non-Hodgkin lymphoma|recurrent cutaneous t-cell non-hodgkin lymphoma
696465|NCT00646139|recurrent mycosis fungoides/Sezary syndrome|recurrent mycosis fungoides/sezary syndrome
696466|NCT00646139|recurrent grade 1 follicular lymphoma|recurrent grade 1 follicular lymphoma
696467|NCT00646139|recurrent grade 2 follicular lymphoma|recurrent grade 2 follicular lymphoma
696468|NCT00646139|recurrent grade 3 follicular lymphoma|recurrent grade 3 follicular lymphoma
696469|NCT00646139|recurrent mantle cell lymphoma|recurrent mantle cell lymphoma
696470|NCT00646139|recurrent marginal zone lymphoma|recurrent marginal zone lymphoma
696471|NCT00646139|recurrent small lymphocytic lymphoma|recurrent small lymphocytic lymphoma
696472|NCT00646139|intraocular lymphoma|intraocular lymphoma
880014|NCT00039780|7787|7787
696473|NCT00646139|primary central nervous system non-Hodgkin lymphoma|primary central nervous system non-hodgkin lymphoma
696474|NCT00646139|post-transplant lymphoproliferative disorder|post-transplant lymphoproliferative disorder
696475|NCT00646139|cutaneous B-cell non-Hodgkin lymphoma|cutaneous b-cell non-hodgkin lymphoma
696476|NCT00646139|Waldenstrom macroglobulinemia|waldenstrom macroglobulinemia
696477|NCT00646139|small intestine lymphoma|small intestine lymphoma
696478|NCT00646100|hepatocellular carcinoma|hepatocellular carcinoma
696479|NCT00646100|transcatheter arterial chemoembolization|transcatheter arterial chemoembolization
696480|NCT00646100|prospective control study|prospective control study
696481|NCT00646100|best support care|best support care
696482|NCT00646100|survival|survival
696483|NCT00646074|Caregiver|caregiver
696484|NCT00646074|Alzheimer's disease|alzheimer's disease
696485|NCT00646074|Caregiving as experienced by older adults caring for a spouse with Alzheimer's disease or dementia|caregiving as experienced by older adults caring for a spouse with alzheimer's disease or dementia
696486|NCT00646061|renal colic|renal colic
696487|NCT00646048|Abdominal Aortic Aneurysm|abdominal aortic aneurysm
696488|NCT00646048|AAA|aaa
696489|NCT00646048|TriVascular Stent-Graft System|trivascular stent-graft system
696490|NCT00646048|Stent-Graft|stent-graft
696491|NCT00646022|Neuroendocrine|neuroendocrine
696492|NCT00646022|PET|pet
696493|NCT00646022|Gastrointestinal|gastrointestinal
696494|NCT00646022|Serotonin|serotonin
696495|NCT00646022|Carcinoid Tumor|carcinoid tumor
696496|NCT00646022|Gastrointestinal Carcinoid Tumor|gastrointestinal carcinoid tumor
696497|NCT00646022|Familial Cancer Tumor|familial cancer tumor
696498|NCT00646009|asthma|asthma
696499|NCT00646009|adults|adults
696500|NCT00646009|Symbicort|symbicort
696501|NCT00646009|budesonide/formoterol|budesonide/formoterol
696502|NCT00646009|Advair Diskus|advair diskus
696503|NCT00646009|Ventolin|ventolin
696504|NCT00645996|Probiotics|probiotics
696505|NCT00645996|vaccines|vaccines
696506|NCT00645996|Measles|measles
696507|NCT00645996|Mumps|mumps
696508|NCT00645996|Rubella|rubella
696509|NCT00645983|Chamomile|chamomile
696510|NCT00645983|Anxiety|anxiety
696511|NCT00645983|Complementary and Alternative Medicine|complementary and alternative medicine
696512|NCT00645970|chronic pain|chronic pain
696513|NCT00645970|combat injuries|combat injuries
696514|NCT00645970|pain assessment|pain assessment
696515|NCT00645970|multiple traumas|multiple traumas
696516|NCT00645970|rehabilitation|rehabilitation
696517|NCT00645957|drainage|drainage
696518|NCT00645957|irrigation|irrigation
696519|NCT00645931|Bone Marrow|bone marrow
696520|NCT00645931|Bone Marrow Transplant|bone marrow transplant
696522|NCT00645931|Psychological Impact|psychological impact
696523|NCT00645931|Psychology|psychology
696524|NCT00645918|Platelets|platelets
696525|NCT00645918|Platelet Function Tests|platelet function tests
696526|NCT00645918|Clopidogrel|clopidogrel
696527|NCT00645918|Drug Eluting Stents|drug eluting stents
696528|NCT00645918|Acute Coronary Syndrome|acute coronary syndrome
696529|NCT00645918|Myocardial Ischemia|myocardial ischemia
696530|NCT00645918|Stent Thrombosis|stent thrombosis
696531|NCT00645918|Heart Diseases|heart diseases
696532|NCT00645918|Coronary Disease|coronary disease
696533|NCT00645918|Arterial Occlusive Disease|arterial occlusive disease
696534|NCT00645879|Propionic Acidemia|propionic acidemia
696535|NCT00645879|hyperammonemia|hyperammonemia
696536|NCT00645879|hypotonia|hypotonia
696537|NCT00645879|glutamine|glutamine
696538|NCT00645879|ornithine alpha ketoglutarate|ornithine alpha ketoglutarate
696539|NCT00645879|citrate|citrate
696540|NCT00645866|stage IIIA breast cancer|stage iiia breast cancer
696541|NCT00645866|stage IIIB breast cancer|stage iiib breast cancer
696542|NCT00645866|stage IIIC breast cancer|stage iiic breast cancer
696543|NCT00645840|Type 1 diabetes mellitus|type 1 diabetes mellitus
696544|NCT00645840|IL1 beta|il1 beta
696545|NCT00645840|Anakinra|anakinra
696546|NCT00645827|Insulin|insulin
696547|NCT00645827|Blood Glucose|blood glucose
696548|NCT00645801|Routine screening colonoscopy|routine screening colonoscopy
696549|NCT00645801|Colonoscopy Preparation|colonoscopy preparation
696550|NCT00645801|Amitiza|amitiza
696551|NCT00645801|GoLYTELY|golytely
696552|NCT00645801|Pegylated Electrolytes|pegylated electrolytes
696553|NCT00645801|Preparation Solution|preparation solution
696554|NCT00645801|Colonoscopy Solution|colonoscopy solution
696555|NCT00645788|Ciprofloxacin|ciprofloxacin
696556|NCT00645788|cystic fibrosis|cystic fibrosis
696557|NCT00645788|sweat test|sweat test
696558|NCT00645788|pulmonary function test|pulmonary function test
696559|NCT00645775|Weight loss|weight loss
696560|NCT00645775|Antiobesity|antiobesity
696561|NCT00645775|Metabolic syndrome|metabolic syndrome
696562|NCT00645775|Leptin|leptin
696563|NCT00645762|Chronic rhinosinusitis|chronic rhinosinusitis
696564|NCT00645762|Chronic sinusitis|chronic sinusitis
696565|NCT00645762|Maxillary sinus|maxillary sinus
696566|NCT00645762|Anterior ethmoid sinus|anterior ethmoid sinus
696567|NCT00645762|Ethmoid infundibulum|ethmoid infundibulum
880142|NCT00038857|GVHD|gvhd
696568|NCT00645762|Balloon dilation|balloon dilation
696569|NCT00645762|Endoscopic visualization|endoscopic visualization
696570|NCT00645762|Local anesthesia|local anesthesia
696571|NCT00645762|Canine fossa|canine fossa
696572|NCT00645762|Less invasive|less invasive
696573|NCT00645736|Chronic Hepatitis B|chronic hepatitis b
696574|NCT00645723|Acinetobacter baumanii|acinetobacter baumanii
696575|NCT00645723|Ventilator-associated pneumonia|ventilator-associated pneumonia
696576|NCT00645697|tuberculosis|tuberculosis
696577|NCT00645697|Multifocal serpiginous choroiditis|multifocal serpiginous choroiditis
696578|NCT00645697|histoplasmosis|histoplasmosis
696579|NCT00645697|Harada toxoplasmosis|harada toxoplasmosis
696580|NCT00645684|Gastrointestinal Anastomosis|gastrointestinal anastomosis
696581|NCT00645684|Multicentre|multicentre
696582|NCT00645684|Randomized controlled single-blind study|randomized controlled single-blind study
696583|NCT00645684|synthetic, absorbable, braided and coated suture material|synthetic, absorbable, braided and coated suture material
696584|NCT00645684|Laparotomy|laparotomy
696585|NCT00645645|Holoprosencephaly|holoprosencephaly
696586|NCT00645645|Agenesis of Corpus|agenesis of corpus
696587|NCT00645645|Callosum|callosum
696588|NCT00645645|Genetic Tests|genetic tests
696589|NCT00645632|localized osteosarcoma|localized osteosarcoma
696590|NCT00645619|Pneumonia,viral|pneumonia,viral
696591|NCT00645619|Pneumonia,bacterial|pneumonia,bacterial
696592|NCT00645619|TREM-1 protein,human|trem-1 protein,human
696593|NCT00645606|B-cell chronic lymphocytic leukemia|b-cell chronic lymphocytic leukemia
696594|NCT00645606|Maintenance in first-line treatment|maintenance in first-line treatment
696595|NCT00645606|Elderly patients|elderly patients
696596|NCT00645593|Bladder Cancer|bladder cancer
696597|NCT00645567|Biomechanics|biomechanics
696598|NCT00645567|Ergonomics|ergonomics
696599|NCT00645567|Spinal Cord Injury|spinal cord injury
696600|NCT00645567|Pain|pain
696601|NCT00645567|Shoulder|shoulder
696602|NCT00645554|Galantamine oral solution|galantamine oral solution
696603|NCT00645554|Galantamine tablet|galantamine tablet
696604|NCT00645554|Bioequivalence|bioequivalence
696605|NCT00645541|Breast Cancer|breast cancer
696606|NCT00645541|Carcinoma of the Breast|carcinoma of the breast
696607|NCT00645541|Lymph Nodes|lymph nodes
696608|NCT00645541|Lymphazurin|lymphazurin
696609|NCT00645541|Axillary Reverse Mapping|axillary reverse mapping
696610|NCT00645528|insulin|insulin
696611|NCT00645528|teaching|teaching
696612|NCT00645502|Schizophrenia|schizophrenia
696613|NCT00645502|Risperidone|risperidone
696614|NCT00645502|Orally-disintegrating tablet|orally-disintegrating tablet
696615|NCT00645502|Bioequivalence|bioequivalence
696616|NCT00645489|heart failure intervention|heart failure intervention
696617|NCT00645450|Stress|stress
696618|NCT00645450|Posttraumatic|posttraumatic
696619|NCT00645450|PTSD|ptsd
696620|NCT00645450|Propranolol|propranolol
696621|NCT00645450|Treatment|treatment
696622|NCT00645437|renal diseases|renal diseases
696623|NCT00645437|levofloxacin|levofloxacin
696624|NCT00645411|Influenza|influenza
696626|NCT00645411|Cell Culture-Derived|cell culture-derived
696628|NCT00645411|Healthy Children|healthy children
696629|NCT00645411|Healthy Adolescents|healthy adolescents
696630|NCT00645411|Safety|safety
696631|NCT00645411|Immunogenicity|immunogenicity
696632|NCT00645411|Trivalent|trivalent
696633|NCT00645411|Inactivated|inactivated
696634|NCT00645411|Vaccination|vaccination
696635|NCT00645385|GBM|gbm
696636|NCT00645385|AA|aa
696637|NCT00645385|AO|ao
696638|NCT00645385|Brain|brain
696639|NCT00645385|Tumors|tumors
696640|NCT00645385|Malignant|malignant
696641|NCT00645385|Glioblastoma|glioblastoma
696642|NCT00645385|Multiforme|multiforme
696643|NCT00645385|Carmustine|carmustine
696644|NCT00645385|implant|implant
696645|NCT00645385|BCNU|bcnu
696646|NCT00645385|Gliadel|gliadel
696647|NCT00645385|Wafers|wafers
696648|NCT00645385|MRS|mrs
696649|NCT00645385|Spectroscopy|spectroscopy
696650|NCT00645359|dMRI|dmri
696651|NCT00645359|diffusion MRI|diffusion mri
696652|NCT00645359|Diffuse large B-cell lymphoma|diffuse large b-cell lymphoma
696653|NCT00645359|DLBCL|dlbcl
696654|NCT00645346|GBS|gbs
696655|NCT00645333|breast cancer|breast cancer
696656|NCT00645333|Phase I clinical trial|phase i clinical trial
696657|NCT00645333|cancer stem cells|cancer stem cells
696658|NCT00645333|agents with other mechanisms of action|agents with other mechanisms of action
696659|NCT00645333|Notch inhibitors|notch inhibitors
696660|NCT00645307|paliperidone|paliperidone
696661|NCT00645307|Schizophrenia|schizophrenia
696662|NCT00645294|Hepatitis B|hepatitis b
696663|NCT00645294|Adefovir dipivoxil|adefovir dipivoxil
696664|NCT00645294|Children|children
696665|NCT00645294|Adolescents|adolescents
696666|NCT00645294|Pharmacokinetics|pharmacokinetics
696667|NCT00645190|Alzheimer Disease|alzheimer disease
696668|NCT00645190|galantamine|galantamine
696669|NCT00645177|Breast Cancer|breast cancer
696670|NCT00645164|wound healing|wound healing
696671|NCT00645164|photoallergenicity|photoallergenicity
696672|NCT00645164|Healthy subjects|healthy subjects
696673|NCT00645138|breast carcinoma|breast carcinoma
696674|NCT00645138|breast cancer|breast cancer
696675|NCT00645138|paravertebral block|paravertebral block
696676|NCT00645138|comparison of paravertebral block and general anesthesia|comparison of paravertebral block and general anesthesia
696677|NCT00645138|ultrasound|ultrasound
696678|NCT00645125|pediatric taste test|pediatric taste test
696679|NCT00645125|antibiotic taste test|antibiotic taste test
696680|NCT00645125|cefdinir|cefdinir
696681|NCT00645125|amoxicillin|amoxicillin
696682|NCT00645099|Paliperidone ER|paliperidone er
696683|NCT00645099|Olanzapine|olanzapine
696684|NCT00645099|Schizophrenia|schizophrenia
696685|NCT00645073|Acute Bacterial Sinusitis|acute bacterial sinusitis
696686|NCT00645060|unspecified adult solid tumor, protocol specific|unspecified adult solid tumor, protocol specific
696687|NCT00645047|PTSD|ptsd
696688|NCT00645047|Telemedicine|telemedicine
696689|NCT00645047|Patient-Centered Care|patient-centered care
696690|NCT00645047|Professional Patient Relationship|professional patient relationship
696691|NCT00645047|Psychotherapy|psychotherapy
696692|NCT00645047|Cognitive Therapy|cognitive therapy
696693|NCT00645008|Stressors|stressors
696694|NCT00645008|Patient Satisfaction|patient satisfaction
696695|NCT00645008|Cardiothoracic-Intensive Care Unit|cardiothoracic-intensive care unit
696696|NCT00645008|Coronary bypass patient|coronary bypass patient
696697|NCT00644995|Depression|depression
696698|NCT00644995|Smoking|smoking
696699|NCT00644995|Physical Activity|physical activity
696700|NCT00644930|ARDS,|ards,
696701|NCT00644930|noninvasive ventilation,|noninvasive ventilation,
696702|NCT00644930|intubation,|intubation,
696703|NCT00644930|mortality,|mortality,
696704|NCT00644930|intensive care|intensive care
696705|NCT00644917|wound healing|wound healing
696706|NCT00644917|phototoxicity|phototoxicity
696707|NCT00644917|Healthy Subjects|healthy subjects
696708|NCT00644904|Multiple Sclerosis|multiple sclerosis
696709|NCT00644904|Vitamin D|vitamin d
696710|NCT00644904|Safety|safety
696711|NCT00644891|Pediatric taste test|pediatric taste test
696712|NCT00644891|Antibiotic taste test|antibiotic taste test
696713|NCT00644891|cefdinir|cefdinir
696714|NCT00644891|amoxicillin|amoxicillin
696715|NCT00644878|leukemia|leukemia
696716|NCT00644878|chronic myelogenous leukemia|chronic myelogenous leukemia
696717|NCT00644878|chronic phase|chronic phase
696718|NCT00644878|molecular response|molecular response
696719|NCT00644878|nilotinib|nilotinib
696720|NCT00644878|ENABL|enabl
696721|NCT00644852|Schizophrenia|schizophrenia
696722|NCT00644852|Schizoaffective disorder|schizoaffective disorder
696723|NCT00644852|Risperidone long-acting injectable, Long-term evaluation|risperidone long-acting injectable, long-term evaluation
696724|NCT00644826|randomized controlled trial|randomized controlled trial
696725|NCT00644826|public health|public health
696726|NCT00644826|Preventive Health Services|preventive health services
696727|NCT00644813|Scapula fracture involving glenoid neck|scapula fracture involving glenoid neck
696728|NCT00644813|Forelimb dysfunction|forelimb dysfunction
696729|NCT00644787|Pain|pain
696730|NCT00644787|Cancer|cancer
696731|NCT00644787|Fentanyl|fentanyl
696732|NCT00644787|JNS020QD|jns020qd
696733|NCT00644787|JNS005|jns005
696734|NCT00644774|pediatric taste test|pediatric taste test
696735|NCT00644774|antibiotic taste test|antibiotic taste test
696736|NCT00644774|cefdinir|cefdinir
696737|NCT00644774|azithromycin|azithromycin
696738|NCT00644761|Hepatitis B|hepatitis b
696739|NCT00644761|Post-Liver Transplantation|post-liver transplantation
696740|NCT00644761|Adefovir Dipivoxil|adefovir dipivoxil
696741|NCT00644761|Tacrolimus|tacrolimus
696742|NCT00644761|Cyclosporine|cyclosporine
696743|NCT00644735|Erosive Esophagitis|erosive esophagitis
696744|NCT00644735|Nexium|nexium
696745|NCT00644735|Esomeprazole|esomeprazole
696746|NCT00644735|Lansoprazole|lansoprazole
696747|NCT00644735|Heartburn|heartburn
696748|NCT00644722|Intubation|intubation
696749|NCT00644722|Out-of-hospital|out-of-hospital
696750|NCT00644722|Laryngoscope|laryngoscope
696751|NCT00644722|Blades|blades
696752|NCT00644722|Emergency|emergency
696753|NCT00644696|Neuroblastoma|neuroblastoma
696754|NCT00644696|Irinotecan|irinotecan
696755|NCT00644696|Bortezomib|bortezomib
696756|NCT00644683|premenopausal women with breast cancer|premenopausal women with breast cancer
696757|NCT00644657|Platelets, platelet aggregation inhibitors|platelets, platelet aggregation inhibitors
696758|NCT00644644|NTX|ntx
696759|NCT00644644|Nihon Kohden|nihon kohden
696760|NCT00644644|mobile monitoring|mobile monitoring
696761|NCT00644618|pancreatic cancer|pancreatic cancer
696762|NCT00644618|locally advanced|locally advanced
696763|NCT00644592|Healthy Volunteers|healthy volunteers
696764|NCT00644579|wart|wart
696765|NCT00644579|cutaneous|cutaneous
696766|NCT00644579|transplant|transplant
711022|NCT00586833|Heart Failure, Diastolic|heart failure, diastolic
880404|NCT00038142|VACdxr|vacdxr
696767|NCT00644579|Cutaneous warts in immune suppressed, kidney transplant patients|cutaneous warts in immune suppressed, kidney transplant patients
696768|NCT00644566|ADHD|adhd
696769|NCT00644566|Primary Care|primary care
696770|NCT00644566|Pediatrics|pediatrics
696771|NCT00644566|Health services|health services
696772|NCT00644566|shared care|shared care
696773|NCT00644566|care manager|care manager
696774|NCT00644566|screening|screening
696775|NCT00644540|Influenza|influenza
696776|NCT00644540|vaccines|vaccines
696777|NCT00644540|children|children
696778|NCT00644527|depression|depression
696779|NCT00644527|music|music
696780|NCT00644527|sound|sound
696781|NCT00644527|randomized controlled trial|randomized controlled trial
696782|NCT00644514|LPS endotoxin|lps endotoxin
696783|NCT00644514|Asthma|asthma
696784|NCT00644501|type 1 diabetes|type 1 diabetes
696785|NCT00644501|beta cells|beta cells
696786|NCT00644501|immunomodulation|immunomodulation
696787|NCT00644501|immunointervention|immunointervention
696788|NCT00644475|Hypertension|hypertension
696789|NCT00644475|Insulin sensitivity|insulin sensitivity
696790|NCT00644475|Fibrinolysis|fibrinolysis
696791|NCT00644462|wheeze detection|wheeze detection
696792|NCT00644436|tetrix cream|tetrix cream
696793|NCT00644436|substantivity|substantivity
696794|NCT00644436|resistance to a gentle wash|resistance to a gentle wash
696795|NCT00644436|Tetrix Cream remaining on hands after gentle washing with soap and water.|tetrix cream remaining on hands after gentle washing with soap and water.
696796|NCT00644423|PTSD|ptsd
696797|NCT00644423|Cognition|cognition
696798|NCT00644423|Fish Oil|fish oil
696799|NCT00644423|Omega-3 Fatty Acid|omega-3 fatty acid
696800|NCT00644410|heart failure|heart failure
696801|NCT00644410|stem cell|stem cell
696802|NCT00644410|mesenchymal stromal cell|mesenchymal stromal cell
696803|NCT00644410|mesenchymal stem cell|mesenchymal stem cell
696804|NCT00644397|distal femur fracture|distal femur fracture
696805|NCT00644397|locked plates|locked plates
696806|NCT00644397|functional outcomes|functional outcomes
696807|NCT00644397|cost management|cost management
696808|NCT00644397|femur head|femur head
696809|NCT00644397|femur neck|femur neck
696810|NCT00644384|basal cell carcinoma of the skin|basal cell carcinoma of the skin
696811|NCT00644384|squamous cell carcinoma of the skin|squamous cell carcinoma of the skin
696812|NCT00644371|Allogeneic|allogeneic
696813|NCT00644371|Lymphoma|lymphoma
696814|NCT00644371|GELTAMO|geltamo
696815|NCT00644371|Z-RIC|z-ric
696816|NCT00644345|Microvolt T wave alternans|microvolt t wave alternans
696817|NCT00644345|reproducibility|reproducibility
696818|NCT00644319|malignant pleural effusion|malignant pleural effusion
696819|NCT00644306|Multiple Myeloma, very elderly patients, thalidomide|multiple myeloma, very elderly patients, thalidomide
696820|NCT00644280|Glaucoma,Ahmed Valve|glaucoma,ahmed valve
696821|NCT00644267|hypertension|hypertension
696822|NCT00644267|cardiovascular risk|cardiovascular risk
696823|NCT00644267|risk score|risk score
696824|NCT00644254|Prognosis|prognosis
696825|NCT00644254|Extracapsular lymph node involvement|extracapsular lymph node involvement
696826|NCT00644241|stem cell therapy|stem cell therapy
696827|NCT00644241|T2DM|t2dm
696828|NCT00644241|Efficacy Of Autologous Bone Marrow Derived Stem Cell Transplantation In Patients With Type 2 Diabetes Mellitus|efficacy of autologous bone marrow derived stem cell transplantation in patients with type 2 diabetes mellitus
696829|NCT00644215|injected bleb|injected bleb
696830|NCT00644215|mitomycin drop|mitomycin drop
696831|NCT00644215|5-Fu injection|5-fu injection
696832|NCT00644215|early bleb failure|early bleb failure
696833|NCT00644202|weight control|weight control
696834|NCT00644189|clofarabine|clofarabine
696836|NCT00644189|lymphoma|lymphoma
696837|NCT00644189|NHL|nhl
696838|NCT00644189|oral chemotherapy|oral chemotherapy
696839|NCT00644163|HIV|hiv
696840|NCT00644163|STI|sti
696841|NCT00644163|Risk Reduction|risk reduction
696842|NCT00644163|Couples|couples
696843|NCT00644163|African American|african american
696844|NCT00644163|HIV Seronegativity|hiv seronegativity
696845|NCT00644150|Risk Reduction Counseling|risk reduction counseling
696846|NCT00644150|Anhui, China|anhui, china
696847|NCT00644150|HIV|hiv
696848|NCT00644150|STI|sti
696849|NCT00644137|smoking sensations|smoking sensations
696850|NCT00644137|no cravings|no cravings
696851|NCT00644137|desire to smoke|desire to smoke
696852|NCT00644124|Non-Hodgkin's lymphoma|non-hodgkin's lymphoma
696853|NCT00644124|angiogenesis inhibitors|angiogenesis inhibitors
696854|NCT00644124|CHOP protocol|chop protocol
696855|NCT00644111|Minimally Invasive Decompression and Fusion|minimally invasive decompression and fusion
696856|NCT00644111|Postoperative analgesia|postoperative analgesia
696857|NCT00644111|Epidural|epidural
696858|NCT00644111|Lumbar|lumbar
696859|NCT00644085|IVF and ICSI|ivf and icsi
696860|NCT00644072|Hsp90 Inhibitor|hsp90 inhibitor
696861|NCT00644072|Her2|her2
696862|NCT00644072|Neoplasms|neoplasms
696863|NCT00644072|Advanced Cancer|advanced cancer
696864|NCT00644072|Cancer|cancer
696865|NCT00644072|Solid Tumor|solid tumor
696866|NCT00644072|Lymphoma|lymphoma
696867|NCT00644059|Influenza|influenza
696868|NCT00644059|vaccine|vaccine
696869|NCT00644059|children|children
696870|NCT00644046|Chronic Kidney Disease|chronic kidney disease
696871|NCT00644046|Prevention|prevention
696872|NCT00644046|Cardiovascular disease|cardiovascular disease
696873|NCT00644020|Hepatocellular carcinoma|hepatocellular carcinoma
696874|NCT00644020|recurrence|recurrence
696875|NCT00644007|Erectile dysfunction|erectile dysfunction
696876|NCT00644007|Hypertension|hypertension
696877|NCT00644007|SK3530|sk3530
696878|NCT00643994|Prostate Cancer|prostate cancer
696879|NCT00643994|CyberKnife|cyberknife
696880|NCT00643994|Stereotactic Radiosurgery|stereotactic radiosurgery
696881|NCT00643994|Radiotherapy|radiotherapy
696882|NCT00643994|Radiation|radiation
696883|NCT00643994|Prostate Tumor|prostate tumor
696884|NCT00643994|Prostate Surgery|prostate surgery
696885|NCT00643968|HIV virological control|hiv virological control
696886|NCT00643968|Lipid profile and morphological fat distribution|lipid profile and morphological fat distribution
696887|NCT00643968|Treatment Experienced|treatment experienced
696888|NCT00643955|Evaluation of muscle strength and central activation|evaluation of muscle strength and central activation
696889|NCT00643929|thrombopoietin receptor agonist|thrombopoietin receptor agonist
696890|NCT00643929|ocular safety|ocular safety
696891|NCT00643929|HCV|hcv
696892|NCT00643929|SB-497115-GR|sb-497115-gr
696893|NCT00643929|CIT|cit
696894|NCT00643929|ITP|itp
696895|NCT00643929|cataract|cataract
696896|NCT00643929|eltrombopag olamine|eltrombopag olamine
696897|NCT00643929|lens opacity|lens opacity
696898|NCT00643916|Meningitis; Meningococcal Infection|meningitis; meningococcal infection
696899|NCT00643903|Side Effects|side effects
696900|NCT00643903|Adherence|adherence
696901|NCT00643903|Coping|coping
696902|NCT00643903|HIV|hiv
696903|NCT00643903|AIDS|aids
696904|NCT00643903|Complementary Therapies|complementary therapies
696905|NCT00643890|Keywords:|keywords:
696906|NCT00643890|Parkinson's disease|parkinson's disease
696907|NCT00643890|Gene transfer|gene transfer
696908|NCT00643890|Gene therapy|gene therapy
696909|NCT00643890|Subthalamic nucleus|subthalamic nucleus
696910|NCT00643890|Adeno-associated virus|adeno-associated virus
696911|NCT00643890|Study placed in the following topic categories:|study placed in the following topic categories:
696912|NCT00643890|Ganglion Cysts|ganglion cysts
696913|NCT00643890|Movement Disorders|movement disorders
696914|NCT00643890|Parkinson Disease|parkinson disease
696915|NCT00643890|Basal Ganglia Diseases|basal ganglia diseases
696916|NCT00643890|Central Nervous System Diseases|central nervous system diseases
696917|NCT00643890|Parkinsonian Disorders|parkinsonian disorders
696918|NCT00643890|Neurodegenerative Diseases|neurodegenerative diseases
696919|NCT00643890|Brain Diseases|brain diseases
696920|NCT00643890|Additional relevant MeSH terms:|additional relevant mesh terms:
696921|NCT00643890|Nervous System Diseases|nervous system diseases
696922|NCT00643877|Colorectal Neoplasms|colorectal neoplasms
696923|NCT00643877|Regional|regional
696924|NCT00643877|Liver|liver
696925|NCT00643877|Neoplasm Metastasis|neoplasm metastasis
696926|NCT00643864|mirror training|mirror training
696927|NCT00643864|stroke|stroke
696928|NCT00643864|hemiparesis|hemiparesis
696929|NCT00643864|rehabilitation|rehabilitation
696930|NCT00643825|Temozolomide|temozolomide
696931|NCT00643825|Phase II|phase ii
696932|NCT00643825|Chemotherapy|chemotherapy
696933|NCT00643825|Glioblastoma|glioblastoma
696934|NCT00643825|Progression-free Survival|progression-free survival
696935|NCT00643812|Firearm storage|firearm storage
696936|NCT00643812|Suicide|suicide
696937|NCT00643812|Unintentional injury|unintentional injury
696938|NCT00643812|Alaska Native|alaska native
696939|NCT00643812|Suicide Attempt|suicide attempt
696940|NCT00643773|Elderly|elderly
696941|NCT00643760|Peripheral Diabetic Neuropathy (PDN)|peripheral diabetic neuropathy (pdn)
696942|NCT00643760|Neuropathic Pain|neuropathic pain
696943|NCT00643747|retinal dystrophy|retinal dystrophy
696944|NCT00643747|Leber congenital amaurosis|leber congenital amaurosis
696945|NCT00643747|RPE65|rpe65
696946|NCT00643747|gene therapy|gene therapy
696947|NCT00643721|Young healthy athletes|young healthy athletes
696948|NCT00643708|anovulation|anovulation
696949|NCT00643708|laser|laser
696950|NCT00643708|ovarian interstitial|ovarian interstitial
696951|NCT00643708|polycystic ovary syndrome|polycystic ovary syndrome
696952|NCT00643708|ultrasound-guided|ultrasound-guided
696953|NCT00643695|hepatitis C|hepatitis c
696954|NCT00643695|depression|depression
696955|NCT00643695|exercise|exercise
696956|NCT00643682|colonoscopy|colonoscopy
696957|NCT00643682|bowel preparation|bowel preparation
696958|NCT00643682|patient education|patient education
696959|NCT00643682|polyp detection|polyp detection
696960|NCT00643656|Liver biopsy|liver biopsy
696961|NCT00643643|HIV|hiv
696962|NCT00643643|Treatment Naïve|treatment naïve
696963|NCT00643630|Tetrix crea|tetrix crea
696964|NCT00643630|skin barrier|skin barrier
696965|NCT00643630|antigen reaction|antigen reaction
696966|NCT00643630|prevention|prevention
696967|NCT00643630|The efficacy of Tetrix Cream to prevent an antigen reaction on the skin.|the efficacy of tetrix cream to prevent an antigen reaction on the skin.
696968|NCT00643617|Prostate Cancer|prostate cancer
696969|NCT00643617|CyberKnife|cyberknife
696970|NCT00643617|Stereotactic Radiosurgery|stereotactic radiosurgery
696971|NCT00643617|Radiosurgery|radiosurgery
696972|NCT00643617|Prostate Tumor|prostate tumor
696973|NCT00643617|Prostate Surgery|prostate surgery
696974|NCT00643604|Pulmonary arterial hypertension|pulmonary arterial hypertension
696975|NCT00643604|treatment satisfaction|treatment satisfaction
696976|NCT00643604|rapid switch|rapid switch
696977|NCT00643604|remodulin|remodulin
696978|NCT00643604|Quality of life|quality of life
696979|NCT00643591|high grade glioma|high grade glioma
696980|NCT00643591|FDG-PET-CT|fdg-pet-ct
696981|NCT00643591|blood proteins|blood proteins
696982|NCT00643591|prognosis|prognosis
696983|NCT00643578|formoterol|formoterol
696984|NCT00643578|methacholine challenge|methacholine challenge
696985|NCT00643552|Muscle Strength|muscle strength
696986|NCT00643526|Rheumatoid arthritis|rheumatoid arthritis
696987|NCT00643526|Psoriatic arthritis|psoriatic arthritis
696988|NCT00643526|Ankylosing spondylitis|ankylosing spondylitis
696989|NCT00643526|Psoriasis|psoriasis
696990|NCT00643526|Autoinjector|autoinjector
696991|NCT00643513|QUALITY OF LIFE|quality of life
696992|NCT00643513|POSTMENOPAUSAL WOMEN|postmenopausal women
696993|NCT00643513|HORMONE RECEPTOR POSITIVE DISSEMINATED BREAST CANCER|hormone receptor positive disseminated breast cancer
696994|NCT00643513|FASLODEX|faslodex
696995|NCT00643500|Levetiracetam|levetiracetam
696996|NCT00643500|Keppra|keppra
696997|NCT00643487|Knee physiology|knee physiology
696998|NCT00643487|Anterior compartment knee|anterior compartment knee
696999|NCT00643487|Infrapatellar plica|infrapatellar plica
697000|NCT00643487|Ligamentum mucosum|ligamentum mucosum
697001|NCT00643487|Enthesis organ|enthesis organ
697002|NCT00643487|Fat pad of the knee|fat pad of the knee
697003|NCT00643487|Patellofemoral kinematics|patellofemoral kinematics
697004|NCT00643435|self-efficacy|self-efficacy
697005|NCT00643435|chronic illness|chronic illness
697006|NCT00643435|health behavior|health behavior
697007|NCT00643435|education, medical, residency|education, medical, residency
697008|NCT00643422|normal eyes|normal eyes
697009|NCT00643396|small cell lung cancer|small cell lung cancer
697010|NCT00643396|radiotherapy|radiotherapy
697011|NCT00643370|lung cancer|lung cancer
697012|NCT00643370|tumor motion|tumor motion
697013|NCT00643357|children with burns|children with burns
697014|NCT00643357|Child between 5 and 15 years of age , burned for many days and who has to undergo at least 3 procedures of care|child between 5 and 15 years of age , burned for many days and who has to undergo at least 3 procedures of care
697015|NCT00643344|obesity|obesity
697016|NCT00643344|mindfulness based stress reduction|mindfulness based stress reduction
697017|NCT00643344|diet and exercise|diet and exercise
697018|NCT00643344|mindful eating|mindful eating
697019|NCT00643344|stress|stress
697020|NCT00643331|Osteoporosis|osteoporosis
697021|NCT00643331|Exercise|exercise
697022|NCT00643331|Low bone density|low bone density
697023|NCT00643331|Falls|falls
697024|NCT00643318|lung cancer|lung cancer
697025|NCT00643318|lung tumor|lung tumor
697026|NCT00643318|non-small cell lung cancer|non-small cell lung cancer
697027|NCT00643318|NSCLC|nsclc
697028|NCT00643318|CyberKnife|cyberknife
697029|NCT00643318|radiosurgery|radiosurgery
697030|NCT00643318|lung surgery|lung surgery
697031|NCT00643305|HIV|hiv
697032|NCT00643305|Motivational Interviewing|motivational interviewing
697033|NCT00643305|Skills|skills
697034|NCT00643305|Prevention|prevention
697035|NCT00643305|Mental illness|mental illness
697036|NCT00643305|Risk reduction|risk reduction
697037|NCT00643305|HIV/AIDS|hiv/aids
697038|NCT00643305|HIV Seronegativity|hiv seronegativity
697039|NCT00643279|implantable hemodynamic monitor|implantable hemodynamic monitor
697040|NCT00643279|Intracardiac pressures|intracardiac pressures
697041|NCT00643266|recollection training|recollection training
697042|NCT00643266|aging|aging
697043|NCT00643266|amnestic mild cognitive impairment|amnestic mild cognitive impairment
697044|NCT00643266|fMRI|fmri
697045|NCT00643253|exclusive breastfeeding|exclusive breastfeeding
697046|NCT00643253|breastfeeding promotion|breastfeeding promotion
697047|NCT00643253|health promotion|health promotion
697048|NCT00643240|recurrent adult acute lymphoblastic leukemia|recurrent adult acute lymphoblastic leukemia
697049|NCT00643240|recurrent childhood acute lymphoblastic leukemia|recurrent childhood acute lymphoblastic leukemia
697050|NCT00643240|refractory chronic lymphocytic leukemia|refractory chronic lymphocytic leukemia
697051|NCT00643214|Tetrix Cream|tetrix cream
697052|NCT00643214|Antigen reaction|antigen reaction
697053|NCT00643214|effect on healing|effect on healing
697054|NCT00643214|To determine if application of Tetrix Cream to lesions of contact dermatitis interferes with their rate of healing|to determine if application of tetrix cream to lesions of contact dermatitis interferes with their rate of healing
697055|NCT00643188|Atrial fibrillation|atrial fibrillation
697056|NCT00643188|Ablation|ablation
697057|NCT00643188|Heart failure|heart failure
697058|NCT00643188|Home Monitoring|home monitoring
697059|NCT00643175|The main objective is to have an endocrinologist treat osteoporosis in patients with fragility hip fractures.|the main objective is to have an endocrinologist treat osteoporosis in patients with fragility hip fractures.
697060|NCT00643162|Depression|depression
697061|NCT00643162|Massage|massage
697062|NCT00643162|Lexapro|lexapro
697063|NCT00643162|Alternative Therapy|alternative therapy
697064|NCT00643162|Anti-depressant|anti-depressant
697065|NCT00643123|Bipolar Disorder|bipolar disorder
697066|NCT00643123|Mania|mania
697067|NCT00643123|Mixed mania|mixed mania
697068|NCT00643123|Allopurinol|allopurinol
697069|NCT00643123|Treatment-Resistant mania|treatment-resistant mania
697070|NCT00643110|Hypoglycemia|hypoglycemia
697071|NCT00643097|adult giant cell glioblastoma|adult giant cell glioblastoma
697072|NCT00643097|adult gliosarcoma|adult gliosarcoma
697073|NCT00643097|adult glioblastoma|adult glioblastoma
697074|NCT00643084|Colorectal|colorectal
697075|NCT00643084|Bowel preparation|bowel preparation
697076|NCT00643084|Laparoscopic surgery|laparoscopic surgery
697077|NCT00643071|Ulcerative colitis|ulcerative colitis
697078|NCT00643071|Tacrolimus|tacrolimus
697079|NCT00643071|FK506|fk506
697080|NCT00643071|Treatment outcome|treatment outcome
697081|NCT00643058|LPS endotoxin|lps endotoxin
697082|NCT00643045|Parkinson Disease|parkinson disease
697083|NCT00643019|Sexually Transmitted Infections|sexually transmitted infections
697084|NCT00643019|Secondary Prevention|secondary prevention
697085|NCT00643019|Cognitive Behavioral Intervention|cognitive behavioral intervention
697086|NCT00643006|Fibromyalgia|fibromyalgia
697087|NCT00643006|Physical activity|physical activity
697088|NCT00643006|Function|function
697089|NCT00643006|Pain|pain
697090|NCT00643006|Exercise|exercise
697091|NCT00643006|Inflammation|inflammation
697092|NCT00642980|Pregnancy|pregnancy
697093|NCT00642980|Preterm delivery|preterm delivery
697094|NCT00642980|Bacterial vaginosis|bacterial vaginosis
697095|NCT00642980|Randomized Clinical Trial|randomized clinical trial
697096|NCT00642980|Clindamycin|clindamycin
697097|NCT00642928|Excessive Daytime Sleepiness|excessive daytime sleepiness
697098|NCT00642928|Parkinson's disease|parkinson's disease
697099|NCT00642902|Relapsing Multiple Sclerosis|relapsing multiple sclerosis
697100|NCT00642902|Atacicept|atacicept
697101|NCT00642889|Parkinson's disease|parkinson's disease
697102|NCT00642863|iron deficiency|iron deficiency
697103|NCT00642863|iron deficiency anemia|iron deficiency anemia
697104|NCT00642863|infant|infant
697105|NCT00642863|development|development
697106|NCT00642863|behavior|behavior
697107|NCT00642837|Health-Related Quality of Life|health-related quality of life
697108|NCT00642837|KEQ-5D|keq-5d
697109|NCT00642837|Sleep disturbance|sleep disturbance
697110|NCT00642837|Sleep quality|sleep quality
697111|NCT00642837|SF-1|sf-1
697112|NCT00642837|Pain intensity|pain intensity
697113|NCT00642837|Pain relief|pain relief
697114|NCT00642837|Tramadol|tramadol
697115|NCT00642837|Acetaminophen|acetaminophen
697116|NCT00642811|coronary artery disease (CAD)|coronary artery disease (cad)
697117|NCT00642811|heart attack|heart attack
697118|NCT00642811|stable angina|stable angina
697119|NCT00642785|herpes|herpes
697120|NCT00642785|HSV|hsv
697121|NCT00642785|zoster|zoster
697122|NCT00642785|HZV|hzv
697123|NCT00642785|shingles|shingles
697124|NCT00642772|Osteoarthritis|osteoarthritis
697125|NCT00642772|Veterans|veterans
697126|NCT00642772|Physical Therapy|physical therapy
697127|NCT00642772|Health Services Research|health services research
697128|NCT00642759|NSCLC|nsclc
697129|NCT00642759|Abraxane|abraxane
697130|NCT00642759|Carboplatin|carboplatin
697131|NCT00642759|Bevacizumab|bevacizumab
697132|NCT00642759|Avastin|avastin
697133|NCT00642746|Colon|colon
697134|NCT00642746|Cancer|cancer
697135|NCT00642746|Metastatic|metastatic
697136|NCT00642746|Colorectal|colorectal
697137|NCT00642707|HIV|hiv
697138|NCT00642707|Treatment Naïve|treatment naïve
697139|NCT00642694|MDD|mdd
697140|NCT00642694|Major Depressive Disorder|major depressive disorder
697141|NCT00642694|Depression|depression
697142|NCT00642694|Initial Insomnia|initial insomnia
697143|NCT00642694|sleep|sleep
697144|NCT00642694|difficulty sleeping|difficulty sleeping
697145|NCT00642694|down|down
697146|NCT00642694|sad|sad
697147|NCT00642694|Major Depressive Disorder(MDD) and initial insomnia|major depressive disorder(mdd) and initial insomnia
697148|NCT00642655|IVIG|ivig
697149|NCT00642655|Rituximab|rituximab
697150|NCT00642655|Highly Sensitized|highly sensitized
697151|NCT00642655|Kidney Transplantation|kidney transplantation
697152|NCT00642642|Acne|acne
697153|NCT00642590|Fertility|fertility
697154|NCT00642590|Pregnancy|pregnancy
697155|NCT00642590|Conception|conception
697156|NCT00642590|Infertility|infertility
697157|NCT00642590|Behavioral|behavioral
697158|NCT00642590|Lifestyle|lifestyle
697159|NCT00642590|Nutrition|nutrition
697160|NCT00642564|Epilepsy|epilepsy
697161|NCT00642564|Headache|headache
697162|NCT00642564|Migraine|migraine
697163|NCT00642551|vitamin K2|vitamin k2
697164|NCT00642551|menaquinone-7|menaquinone-7
697165|NCT00642551|bone health|bone health
697166|NCT00642551|vascular health|vascular health
697167|NCT00642538|Diabetic adult male, diabetic postmenopausal women|diabetic adult male, diabetic postmenopausal women
697168|NCT00642525|detection of anastomotic leakage|detection of anastomotic leakage
697169|NCT00642525|esophageal resection|esophageal resection
697170|NCT00642525|diagnostic safety|diagnostic safety
697171|NCT00642512|CINV|cinv
697172|NCT00642512|chemotherapy|chemotherapy
697173|NCT00642512|nausea|nausea
697174|NCT00642512|vomiting|vomiting
697175|NCT00642512|retching|retching
697176|NCT00642499|HIV|hiv
697177|NCT00642499|AIDS|aids
697178|NCT00642499|nausea|nausea
697179|NCT00642499|vomiting|vomiting
697180|NCT00642499|HAART|haart
697181|NCT00642499|Treatment Experienced|treatment experienced
697182|NCT00642499|HIV Infections|hiv infections
697183|NCT00642486|treatment|treatment
697184|NCT00642486|positive airway pressure|positive airway pressure
697185|NCT00642486|compliance|compliance
697186|NCT00642486|cost effectiveness|cost effectiveness
697187|NCT00642486|clinical trial|clinical trial
697188|NCT00642447|noninvasive ventilation|noninvasive ventilation
697189|NCT00642447|helium|helium
697190|NCT00642447|oxygen|oxygen
697191|NCT00642447|sulfur mustard|sulfur mustard
697192|NCT00642447|chronic bronchitis|chronic bronchitis
697193|NCT00642447|bronchiolitis|bronchiolitis
697194|NCT00642434|diabetes blood pressure oxidative stress|diabetes blood pressure oxidative stress
697195|NCT00642421|Acromegaly|acromegaly
697196|NCT00642395|Multiple Myeloma|multiple myeloma
697197|NCT00642395|Autologous Stem Cells Transplantation|autologous stem cells transplantation
697198|NCT00642395|High Dose Melphalan|high dose melphalan
697199|NCT00642395|Bortezomib|bortezomib
697200|NCT00642382|Osteoarthritis|osteoarthritis
697201|NCT00642382|Hyaluronic Acid|hyaluronic acid
697202|NCT00642369|Polysomnograph|polysomnograph
697203|NCT00642356|Idiopathic Parkinson's disease|idiopathic parkinson's disease
697204|NCT00642356|carbidopa/levodopa/entacapone|carbidopa/levodopa/entacapone
697205|NCT00642356|non-motor symptoms|non-motor symptoms
697206|NCT00642356|motor-symptoms|motor-symptoms
697207|NCT00642343|Balance|balance
697208|NCT00642343|Severe, Profound deafness|severe, profound deafness
697209|NCT00642343|Children|children
697210|NCT00642343|unilateral/bilateral cochlear implants|unilateral/bilateral cochlear implants
697211|NCT00642343|unilateral cochlear implant|unilateral cochlear implant
697212|NCT00642343|bilateral cochlear implants|bilateral cochlear implants
697213|NCT00642330|patent|patent
697214|NCT00642330|ductus|ductus
697215|NCT00642330|arteriosus|arteriosus
697216|NCT00642330|ibuprofen|ibuprofen
697217|NCT00642330|premature|premature
697218|NCT00642330|infant|infant
697219|NCT00642317|Healthy Control|healthy control
697220|NCT00642317|Tobacco Use|tobacco use
697221|NCT00642317|Tobacco Initiation|tobacco initiation
697222|NCT00642317|Smoking|smoking
697223|NCT00642317|Questionnaire|questionnaire
697224|NCT00642317|Survey|survey
697225|NCT00642291|Emtricitabine|emtricitabine
697226|NCT00642291|Pediatric|pediatric
697227|NCT00642291|HIV-1|hiv-1
697228|NCT00642291|Treatment of HIV-1|treatment of hiv-1
697229|NCT00642278|Type 2 diabetes mellitus|type 2 diabetes mellitus
697230|NCT00642278|Metformin|metformin
697231|NCT00642278|Hemoglobin A1c|hemoglobin a1c
697232|NCT00642252|remineraliation|remineraliation
697233|NCT00642252|pre-existing white-spot (non-cavitated) enamel lesions|pre-existing white-spot (non-cavitated) enamel lesions
697234|NCT00642239|Sodium Glycididazole, Radiochemotherapy, Esophageal Carcinoma|sodium glycididazole, radiochemotherapy, esophageal carcinoma
697235|NCT00642226|Branch Retinal Vein Occlusion|branch retinal vein occlusion
697236|NCT00642226|BRVO|brvo
697237|NCT00642226|Macular Edema|macular edema
697238|NCT00642226|Triamcinolone|triamcinolone
697239|NCT00642226|Vitrectomy|vitrectomy
697240|NCT00642213|stroke|stroke
697241|NCT00642213|ischemic|ischemic
697242|NCT00642213|TIA|tia
697243|NCT00642213|hemorrhage|hemorrhage
697244|NCT00642213|incidence|incidence
697245|NCT00642213|case-fatality|case-fatality
697246|NCT00642213|risk factors|risk factors
697247|NCT00642213|genetic|genetic
697248|NCT00642187|Asthma|asthma
697249|NCT00642187|Pulmicort|pulmicort
697250|NCT00642187|Turbuhaler|turbuhaler
697251|NCT00642187|Budesonide|budesonide
697252|NCT00642187|Flexhaler|flexhaler
697253|NCT00642161|Asthma|asthma
697254|NCT00642161|Pulmicort|pulmicort
697255|NCT00642161|Children|children
697256|NCT00642161|Paediatrics|paediatrics
697257|NCT00642161|budesonide|budesonide
697258|NCT00642161|Flexhaler|flexhaler
697259|NCT00642148|GW856553|gw856553
697260|NCT00642148|p38 MAPK|p38 mapk
697261|NCT00642148|Chronic Obstructive Pulmonary Disease|chronic obstructive pulmonary disease
697262|NCT00642135|premature|premature
697263|NCT00642135|neonates|neonates
697264|NCT00642135|infants|infants
697265|NCT00642135|children|children
697266|NCT00642135|Mydriasert®|mydriasert®
697267|NCT00642135|mydriasis|mydriasis
697268|NCT00642135|fundus|fundus
697269|NCT00642135|Tropicamide|tropicamide
697270|NCT00642135|Phenylephrine|phenylephrine
697271|NCT00642135|clinical trial|clinical trial
697272|NCT00642135|Infant|infant
697273|NCT00642135|premature newborns|premature newborns
697274|NCT00642135|bilateral diagnosis fundus|bilateral diagnosis fundus
697275|NCT00642122|Asthma|asthma
697276|NCT00642122|Pulmicort|pulmicort
697277|NCT00642122|budesonide|budesonide
697278|NCT00642122|respules|respules
697279|NCT00642122|turbuhaler|turbuhaler
697280|NCT00642096|High blood pressure|high blood pressure
697281|NCT00642096|hypertension|hypertension
697282|NCT00642096|(TOPROL-XL)|(toprol-xl)
697283|NCT00642096|metoprolol succinate|metoprolol succinate
697284|NCT00642096|hydrochlorothiazide|hydrochlorothiazide
697285|NCT00642083|outflow stenosis|outflow stenosis
697286|NCT00642083|stentgraft|stentgraft
697287|NCT00642070|Current symptoms of urinary tract infection|current symptoms of urinary tract infection
697288|NCT00642057|chorea|chorea
697289|NCT00642057|dyskinesia|dyskinesia
697290|NCT00642057|hyperkinetic|hyperkinetic
697291|NCT00642044|Keratoconus|keratoconus
697292|NCT00642031|Hematologic Malignancies|hematologic malignancies
697293|NCT00642031|Leukemia|leukemia
697294|NCT00642031|Chronic Myelomonocytic Leukemia|chronic myelomonocytic leukemia
697295|NCT00642031|Acute Lymphocytic Leukemia|acute lymphocytic leukemia
697296|NCT00642031|Chronic Lymphocytic Leukemia|chronic lymphocytic leukemia
697297|NCT00642031|Chronic Myelogenous Leukemia|chronic myelogenous leukemia
697298|NCT00642031|Agnogenic Myeloid Metaplasia|agnogenic myeloid metaplasia
697299|NCT00642031|Triciribine Phosphate Monohydrate|triciribine phosphate monohydrate
697300|NCT00642031|Triciribine|triciribine
697301|NCT00642031|TCN-PM|tcn-pm
697302|NCT00642031|VD-0002|vd-0002
697303|NCT00642018|Hormone Refractory Prostate Cancer|hormone refractory prostate cancer
697304|NCT00642005|Humidification|humidification
697305|NCT00642005|Laparoscopy|laparoscopy
697306|NCT00642005|Colon|colon
697307|NCT00642005|Hemicolectomy|hemicolectomy
697308|NCT00642005|Warming|warming
697309|NCT00641992|amebic liver abscess|amebic liver abscess
697310|NCT00641992|failure|failure
697311|NCT00641992|prognosis|prognosis
697312|NCT00641979|Allergic rhinitis|allergic rhinitis
697313|NCT00641979|Nasal symptoms|nasal symptoms
697314|NCT00641979|Congestion|congestion
697315|NCT00641979|Rhinorrhea|rhinorrhea
697316|NCT00641979|Sneeze|sneeze
697317|NCT00641979|budesonide|budesonide
697318|NCT00641979|Rhinocort AQUA|rhinocort aqua
697319|NCT00641953|Foot Pain|foot pain
697320|NCT00641953|Diabetic Neuropathy Pain|diabetic neuropathy pain
697321|NCT00641953|Diabetic Peripheral Neuropathy foot pain|diabetic peripheral neuropathy foot pain
697322|NCT00641940|Prevention|prevention
697323|NCT00641940|Girls|girls
697324|NCT00641940|Resilience|resilience
697325|NCT00641927|bipolar disorder|bipolar disorder
697326|NCT00641927|bipolar type II disorder|bipolar type ii disorder
697327|NCT00641927|antidepressant|antidepressant
697328|NCT00641927|mood stabilizer|mood stabilizer
697329|NCT00641927|venlafaxine|venlafaxine
697330|NCT00641927|lithium carbonate|lithium carbonate
697331|NCT00641914|Asthma|asthma
697332|NCT00641914|Pulmicort|pulmicort
697333|NCT00641914|budesonide|budesonide
697334|NCT00641901|gingivitis|gingivitis
697335|NCT00641901|pregnancy|pregnancy
697336|NCT00641901|pre-term birth|pre-term birth
697337|NCT00641888|Cardiovascular risk|cardiovascular risk
697338|NCT00641888|Inflammatory biomarkers|inflammatory biomarkers
697339|NCT00641888|Human immunodeficiency virus|human immunodeficiency virus
697340|NCT00641875|arterial stiffness|arterial stiffness
697341|NCT00641875|artery|artery
697342|NCT00641875|aortic pulse wave velocity|aortic pulse wave velocity
697343|NCT00641875|pulse wave analysis|pulse wave analysis
697344|NCT00641875|augmentation index|augmentation index
697345|NCT00641875|end stage renal disease|end stage renal disease
697346|NCT00641875|nocturnal hemodialysis|nocturnal hemodialysis
697347|NCT00641875|extended hours of hemodialysis|extended hours of hemodialysis
697348|NCT00641875|cardiovascular|cardiovascular
697349|NCT00641875|hemodialysis|hemodialysis
697350|NCT00641862|Pregnancy|pregnancy
697351|NCT00641862|Maternal Nutritional Status|maternal nutritional status
697352|NCT00641862|Vitamin B12|vitamin b12
697353|NCT00641849|BMI|bmi
697354|NCT00641849|Physical Activity|physical activity
697355|NCT00641849|Food|food
697356|NCT00641849|Nutrition|nutrition
697357|NCT00641849|Dietary behaviors|dietary behaviors
697358|NCT00641849|Diet|diet
697359|NCT00641849|Adult|adult
697360|NCT00641849|Adults|adults
697361|NCT00641849|Fat|fat
697362|NCT00641849|Fats|fats
697363|NCT00641849|Self monitoring|self monitoring
697364|NCT00641849|Automated feedback|automated feedback
697365|NCT00641823|Orthopedic Surgical Procedures|orthopedic surgical procedures
697366|NCT00641810|Caffeine|caffeine
697367|NCT00641810|Snoring|snoring
697368|NCT00641810|Sleep|sleep
697369|NCT00641797|Canalith Repositioning Technique|canalith repositioning technique
697370|NCT00641797|Vertigo|vertigo
697371|NCT00641784|Composite Early neonatal Outcome|composite early neonatal outcome
697372|NCT00641784|Late Neurological neonatal outcome|late neurological neonatal outcome
697373|NCT00641758|Coronary Artery Disease|coronary artery disease
697374|NCT00641758|endothelial dysfunction|endothelial dysfunction
697375|NCT00641758|Nitric oxide|nitric oxide
697376|NCT00641745|Lurasidone|lurasidone
697377|NCT00641745|Schizophrenia|schizophrenia
697378|NCT00641745|Latuda|latuda
697379|NCT00641732|venous thromboembolism|venous thromboembolism
697380|NCT00641732|oral anticoagulant|oral anticoagulant
697381|NCT00641732|direct factor Xa inhibitor|direct factor xa inhibitor
697382|NCT00641732|total knee replacement|total knee replacement
697383|NCT00641732|drug therapy|drug therapy
697384|NCT00641693|Allergic rhinitis|allergic rhinitis
697385|NCT00641693|Paediatric|paediatric
697386|NCT00641693|Nasal symptoms|nasal symptoms
697387|NCT00641693|Congestion|congestion
697388|NCT00641693|Rhinorrhea|rhinorrhea
697389|NCT00641693|Sneeze|sneeze
697390|NCT00641693|budesonide|budesonide
697391|NCT00641693|Rhinocort AQUA|rhinocort aqua
697392|NCT00641680|Seasonal allergic rhinitis|seasonal allergic rhinitis
697393|NCT00641680|Nasal symptoms|nasal symptoms
697394|NCT00641680|Congestion|congestion
697395|NCT00641680|Rhinorrhea|rhinorrhea
697396|NCT00641680|Sneeze|sneeze
697397|NCT00641680|budesonide|budesonide
697398|NCT00641680|Rhinocort AQUA|rhinocort aqua
697399|NCT00641680|Fluticasone propionate|fluticasone propionate
697400|NCT00641680|Flonase|flonase
697401|NCT00641667|Pain|pain
697402|NCT00641667|Cancer|cancer
697403|NCT00641667|Fentanyl|fentanyl
697404|NCT00641667|JNS020QD|jns020qd
697405|NCT00641654|Chronic hepatitis C|chronic hepatitis c
697406|NCT00641654|genotype 2 or 3|genotype 2 or 3
697407|NCT00641654|relapse|relapse
697408|NCT00641654|pegylated interferon|pegylated interferon
697409|NCT00641654|ribavirin|ribavirin
697410|NCT00641641|Viral compartments|viral compartments
697411|NCT00641641|integrase inhibitor therapy|integrase inhibitor therapy
697412|NCT00641641|viral species|viral species
697413|NCT00641628|Nipple sparing mastectomy|nipple sparing mastectomy
697414|NCT00641628|NAC conservation|nac conservation
697415|NCT00641602|Erosive Esophagitis|erosive esophagitis
697416|NCT00641602|Nexium|nexium
697417|NCT00641602|Heartburn|heartburn
697418|NCT00641589|Chronic Kidney Disease|chronic kidney disease
697419|NCT00641589|anemia|anemia
697420|NCT00641589|epoetin alfa|epoetin alfa
697421|NCT00641576|Endosseous implants|endosseous implants
697422|NCT00641563|dexmedetomidine|dexmedetomidine
697423|NCT00641563|midazolam|midazolam
697424|NCT00641563|remifentanil|remifentanil
697425|NCT00641563|Electroencephalography|electroencephalography
697426|NCT00641563|Event related potentials|event related potentials
697427|NCT00641563|BIS|bis
697428|NCT00641563|Bispectral Index|bispectral index
697429|NCT00641563|Response Entropy|response entropy
697430|NCT00641563|State Entropy|state entropy
697431|NCT00641550|physical exercise|physical exercise
697432|NCT00641550|maternal complications|maternal complications
697433|NCT00641550|preterm labor|preterm labor
697434|NCT00641550|birthweight|birthweight
697435|NCT00641550|Apgar scores|apgar scores
697436|NCT00641524|Non-alcoholic fatty liver disease|non-alcoholic fatty liver disease
697437|NCT00641524|liver fibrosis|liver fibrosis
697438|NCT00641524|metabolic syndrome|metabolic syndrome
697439|NCT00641524|iron overload|iron overload
697440|NCT00641524|phlebotomy|phlebotomy
697441|NCT00641511|PTSD|ptsd
697442|NCT00641498|suicide|suicide
697443|NCT00641498|parasuicide|parasuicide
697444|NCT00641498|prevention|prevention
697445|NCT00641498|individual supportive psychotherapy|individual supportive psychotherapy
697446|NCT00641472|Asthma|asthma
697447|NCT00641472|Pulmicort|pulmicort
697448|NCT00641472|Children|children
697449|NCT00641472|paediatrics|paediatrics
697450|NCT00641472|budesonide|budesonide
697451|NCT00641459|Behavioral and Psychological Symptoms of Dementia|behavioral and psychological symptoms of dementia
697452|NCT00641459|BPSD|bpsd
697453|NCT00641459|NPI|npi
697454|NCT00641459|CGI|cgi
697455|NCT00641459|MMSE|mmse
697456|NCT00641446|Children|children
697457|NCT00641446|Asthma|asthma
697458|NCT00641446|Varivax|varivax
697459|NCT00641446|varicella|varicella
697460|NCT00641446|Pulmicort|pulmicort
697461|NCT00641446|budesonide|budesonide
697462|NCT00641433|chemocautery|chemocautery
697463|NCT00641420|Acne scarring|acne scarring
697464|NCT00641420|Post inflammatory hyperpigmentation|post inflammatory hyperpigmentation
697465|NCT00641407|Bedtime insulins|bedtime insulins
697466|NCT00641407|Poorly controlled type 2 diabetes|poorly controlled type 2 diabetes
697467|NCT00641407|Glycemic control|glycemic control
697468|NCT00641407|HbA1c|hba1c
697469|NCT00641394|cortisol|cortisol
697470|NCT00641394|hydrocortisone|hydrocortisone
697471|NCT00641394|psychotherapy|psychotherapy
697472|NCT00641394|Emotional Freedom Techniques (EFT)|emotional freedom techniques (eft)
697473|NCT00641394|Cognitive Behavioral Therapy (CBT)|cognitive behavioral therapy (cbt)
697474|NCT00641394|depression|depression
697475|NCT00641394|anxiety|anxiety
697476|NCT00641381|stage III adult Hodgkin lymphoma|stage iii adult hodgkin lymphoma
697477|NCT00641381|stage III childhood Hodgkin lymphoma|stage iii childhood hodgkin lymphoma
697478|NCT00641381|stage IV adult Hodgkin lymphoma|stage iv adult hodgkin lymphoma
697479|NCT00641381|stage IV childhood Hodgkin lymphoma|stage iv childhood hodgkin lymphoma
697480|NCT00641381|recurrent childhood lymphoblastic lymphoma|recurrent childhood lymphoblastic lymphoma
697481|NCT00641381|recurrent mantle cell lymphoma|recurrent mantle cell lymphoma
697482|NCT00641381|recurrent adult Hodgkin lymphoma|recurrent adult hodgkin lymphoma
697483|NCT00641381|recurrent/refractory childhood Hodgkin lymphoma|recurrent/refractory childhood hodgkin lymphoma
697484|NCT00641381|recurrent adult T-cell leukemia/lymphoma|recurrent adult t-cell leukemia/lymphoma
697485|NCT00641381|recurrent cutaneous T-cell non-Hodgkin lymphoma|recurrent cutaneous t-cell non-hodgkin lymphoma
697486|NCT00641381|AIDS-related diffuse large cell lymphoma|aids-related diffuse large cell lymphoma
697487|NCT00641381|AIDS-related diffuse mixed cell lymphoma|aids-related diffuse mixed cell lymphoma
697488|NCT00641381|AIDS-related immunoblastic large cell lymphoma|aids-related immunoblastic large cell lymphoma
697489|NCT00641381|AIDS-related lymphoblastic lymphoma|aids-related lymphoblastic lymphoma
697490|NCT00641381|AIDS-related small noncleaved cell lymphoma|aids-related small noncleaved cell lymphoma
697491|NCT00641381|Burkitt lymphoma|burkitt lymphoma
697492|NCT00641381|stage III adult diffuse large cell lymphoma|stage iii adult diffuse large cell lymphoma
697493|NCT00641381|stage III adult diffuse mixed cell lymphoma|stage iii adult diffuse mixed cell lymphoma
697494|NCT00641381|stage IV adult diffuse large cell lymphoma|stage iv adult diffuse large cell lymphoma
697495|NCT00641381|stage IV adult diffuse mixed cell lymphoma|stage iv adult diffuse mixed cell lymphoma
697496|NCT00641381|stage III grade 3 follicular lymphoma|stage iii grade 3 follicular lymphoma
697497|NCT00641381|stage IV grade 3 follicular lymphoma|stage iv grade 3 follicular lymphoma
697498|NCT00641381|stage III adult immunoblastic large cell lymphoma|stage iii adult immunoblastic large cell lymphoma
697499|NCT00641381|stage IV adult immunoblastic large cell lymphoma|stage iv adult immunoblastic large cell lymphoma
697500|NCT00641381|stage III adult lymphoblastic lymphoma|stage iii adult lymphoblastic lymphoma
697501|NCT00641381|stage III childhood lymphoblastic lymphoma|stage iii childhood lymphoblastic lymphoma
697502|NCT00641381|stage IV adult lymphoblastic lymphoma|stage iv adult lymphoblastic lymphoma
697503|NCT00641381|stage IV childhood lymphoblastic lymphoma|stage iv childhood lymphoblastic lymphoma
697504|NCT00641381|stage III adult Burkitt lymphoma|stage iii adult burkitt lymphoma
697505|NCT00641381|stage IV adult Burkitt lymphoma|stage iv adult burkitt lymphoma
697506|NCT00641381|HIV Infections|hiv infections
697507|NCT00641381|Treatment Experienced|treatment experienced
697508|NCT00641368|Adolescent|adolescent
697509|NCT00641368|Child|child
697510|NCT00641368|Computer|computer
697511|NCT00641368|Depression|depression
697512|NCT00641368|Resilience|resilience
697513|NCT00641342|Parastomal hernia|parastomal hernia
697514|NCT00641342|Onlay mesh|onlay mesh
697515|NCT00641342|Sublay mesh|sublay mesh
697516|NCT00641342|Pain|pain
697517|NCT00641342|Health questionnaire|health questionnaire
697518|NCT00641329|ADHD|adhd
697519|NCT00641329|ADD|add
697520|NCT00641329|Attention Deficit Hyperactivity Disorder|attention deficit hyperactivity disorder
697521|NCT00641329|Attention Deficit|attention deficit
697522|NCT00641329|Clonidine|clonidine
697523|NCT00641329|CLONICEL|clonicel
697524|NCT00641329|Addrenex|addrenex
697525|NCT00641316|Freeze-dried bone allograft|freeze-dried bone allograft
697526|NCT00641316|Platelet-rich plasma|platelet-rich plasma
697527|NCT00641316|Platelet-derived growth factors|platelet-derived growth factors
697528|NCT00641316|Laser-threaded dental implants|laser-threaded dental implants
697529|NCT00641316|Resorbable blast textured dental implants|resorbable blast textured dental implants
697530|NCT00641303|pain|pain
697531|NCT00641303|fatigue|fatigue
697532|NCT00641303|hot flashes|hot flashes
697533|NCT00641303|sleep disorders|sleep disorders
697534|NCT00641303|depression|depression
697535|NCT00641303|anxiety disorder|anxiety disorder
697536|NCT00641303|stage I breast cancer|stage i breast cancer
697537|NCT00641303|stage II breast cancer|stage ii breast cancer
697538|NCT00641303|stage IIIA breast cancer|stage iiia breast cancer
697539|NCT00641303|stage IIIB breast cancer|stage iiib breast cancer
697540|NCT00641303|stage IIIC breast cancer|stage iiic breast cancer
697541|NCT00641290|CABG|cabg
697542|NCT00641290|Valve surgery|valve surgery
697543|NCT00641277|endosseous dental implants|endosseous dental implants
697544|NCT00641277|dental aesthetics|dental aesthetics
697545|NCT00641264|Laryngopharyngeal reflux (LPR)|laryngopharyngeal reflux (lpr)
697546|NCT00641264|Omeprazole|omeprazole
697547|NCT00641264|Losec|losec
697548|NCT00641264|Quality of Life|quality of life
697549|NCT00641264|Laryngitis|laryngitis
697550|NCT00641251|T2 Diabetes|t2 diabetes
697551|NCT00641251|Type 2 diabetes CVD event rates and mortality|type 2 diabetes cvd event rates and mortality
697552|NCT00641238|NSCLC|nsclc
697553|NCT00641238|lung cancer|lung cancer
697554|NCT00641225|Ascending Single Dose|ascending single dose
697555|NCT00641225|Safety|safety
697556|NCT00641225|Pharmacokinetics|pharmacokinetics
697557|NCT00641225|Open-label|open-label
697558|NCT00641212|Allergic rhinitis|allergic rhinitis
697559|NCT00641212|Perennial allergic rhinitis|perennial allergic rhinitis
697560|NCT00641212|Paediatric|paediatric
697561|NCT00641212|Growth|growth
697562|NCT00641212|budesonide|budesonide
697563|NCT00641212|Rhinocort AQUA|rhinocort aqua
697564|NCT00641199|Antibiotic-associated diarrhea|antibiotic-associated diarrhea
697565|NCT00641199|Probiotic|probiotic
697566|NCT00641199|Quality of life|quality of life
697567|NCT00641199|Antibiotics|antibiotics
697568|NCT00641186|excessive daytime somnolence|excessive daytime somnolence
697569|NCT00641186|Parkinson disease|parkinson disease
697570|NCT00641186|sleep disturbance|sleep disturbance
697571|NCT00641173|PTSD|ptsd
697572|NCT00641173|cortisol|cortisol
697573|NCT00641173|hippocampus|hippocampus
697574|NCT00641173|memory|memory
697575|NCT00641160|vinorelbine|vinorelbine
697576|NCT00641160|metronomic dosing|metronomic dosing
697577|NCT00641160|oral administration|oral administration
697578|NCT00641160|nonhematologic malignancies|nonhematologic malignancies
697579|NCT00641160|pharmacokinetics|pharmacokinetics
697580|NCT00641134|Cardiac Rehabilitation|cardiac rehabilitation
697581|NCT00641134|Old age|old age
697582|NCT00641134|Home physical training|home physical training
697583|NCT00641108|SPECT Brain Imaging|spect brain imaging
697584|NCT00641108|Cognitive Therapy|cognitive therapy
697585|NCT00641108|Serotonin Transporter Binding|serotonin transporter binding
697586|NCT00641108|Predictive Biomarker|predictive biomarker
697587|NCT00641095|contiguous stage II mantle cell lymphoma|contiguous stage ii mantle cell lymphoma
697588|NCT00641095|noncontiguous stage II mantle cell lymphoma|noncontiguous stage ii mantle cell lymphoma
697589|NCT00641095|stage I mantle cell lymphoma|stage i mantle cell lymphoma
697590|NCT00641095|stage III mantle cell lymphoma|stage iii mantle cell lymphoma
697591|NCT00641095|stage IV mantle cell lymphoma|stage iv mantle cell lymphoma
697592|NCT00641069|Cardiac arrest|cardiac arrest
697593|NCT00641069|Cardiopulmonary resuscitation|cardiopulmonary resuscitation
697594|NCT00641056|diabetes|diabetes
697595|NCT00641056|exenatide|exenatide
697596|NCT00641056|exenatide once weekly|exenatide once weekly
697597|NCT00641056|metformin|metformin
697598|NCT00641056|sulfonylurea|sulfonylurea
697599|NCT00641056|insulin glargine|insulin glargine
697600|NCT00641056|Amylin|amylin
697601|NCT00641056|Lilly|lilly
697602|NCT00641030|de novo myelodysplastic syndromes|de novo myelodysplastic syndromes
697603|NCT00641030|previously treated myelodysplastic syndromes|previously treated myelodysplastic syndromes
697604|NCT00641030|secondary myelodysplastic syndromes|secondary myelodysplastic syndromes
697605|NCT00641030|adult acute lymphoblastic leukemia in remission|adult acute lymphoblastic leukemia in remission
697606|NCT00641030|adult acute myeloid leukemia with 11q23 (MLL) abnormalities|adult acute myeloid leukemia with 11q23 (mll) abnormalities
697607|NCT00641030|adult acute myeloid leukemia with inv(16)(p13;q22)|adult acute myeloid leukemia with inv(16)(p13;q22)
697608|NCT00641030|adult acute myeloid leukemia with t(15;17)(q22;q12)|adult acute myeloid leukemia with t(15;17)(q22;q12)
697609|NCT00641030|adult acute myeloid leukemia with t(16;16)(p13;q22)|adult acute myeloid leukemia with t(16;16)(p13;q22)
697610|NCT00641030|adult acute myeloid leukemia with t(8;21)(q22;q22)|adult acute myeloid leukemia with t(8;21)(q22;q22)
697611|NCT00641030|adult acute myeloid leukemia in remission|adult acute myeloid leukemia in remission
697612|NCT00641030|recurrent adult acute myeloid leukemia|recurrent adult acute myeloid leukemia
697613|NCT00641030|childhood acute myeloid leukemia in remission|childhood acute myeloid leukemia in remission
697614|NCT00641030|recurrent childhood acute myeloid leukemia|recurrent childhood acute myeloid leukemia
697615|NCT00641030|secondary acute myeloid leukemia|secondary acute myeloid leukemia
697616|NCT00641030|childhood myelodysplastic syndromes|childhood myelodysplastic syndromes
697617|NCT00641030|recurrent adult acute lymphoblastic leukemia|recurrent adult acute lymphoblastic leukemia
697718|NCT00640588|Compliance|compliance
697618|NCT00641030|recurrent childhood acute lymphoblastic leukemia|recurrent childhood acute lymphoblastic leukemia
697619|NCT00641030|childhood acute lymphoblastic leukemia in remission|childhood acute lymphoblastic leukemia in remission
697620|NCT00640991|Clinical Trial|clinical trial
697621|NCT00640991|Insulin|insulin
697622|NCT00640978|Pancreatic Cancer|pancreatic cancer
697623|NCT00640978|Advanced Pancreatic Cancer|advanced pancreatic cancer
697624|NCT00640978|Unresectable|unresectable
697625|NCT00640978|Metastatic|metastatic
697626|NCT00640978|RAD001|rad001
697627|NCT00640978|Everolimus|everolimus
697628|NCT00640978|Erlotinib|erlotinib
697629|NCT00640978|OSI-774|osi-774
697630|NCT00640978|Erlotinib Hydrochloride|erlotinib hydrochloride
697631|NCT00640978|Tarceva|tarceva
697632|NCT00640952|Parkinson's disease|parkinson's disease
697633|NCT00640952|impulse control behaviors|impulse control behaviors
697634|NCT00640952|dopa-dysregulation|dopa-dysregulation
697635|NCT00640939|Tendonitis|tendonitis
697636|NCT00640939|Bursitis|bursitis
881556|NCT00032617|Trauma|trauma
697637|NCT00640913|Defunctioning stoma|defunctioning stoma
697638|NCT00640913|Low anterior resection|low anterior resection
697639|NCT00640913|TME surgery|tme surgery
697640|NCT00640913|Early stoma reversal|early stoma reversal
697641|NCT00640900|overweight|overweight
697642|NCT00640900|obesity|obesity
697643|NCT00640900|weight loss|weight loss
697644|NCT00640900|commercial weight loss program|commercial weight loss program
697646|NCT00640887|Tuberculosis|tuberculosis
697647|NCT00640887|Rifabutin|rifabutin
697648|NCT00640887|Pharmacokinetics|pharmacokinetics
697649|NCT00640887|South Africa|south africa
697650|NCT00640874|Prophylaxis|prophylaxis
697651|NCT00640874|pandemic influenza|pandemic influenza
697652|NCT00640874|influenza A|influenza a
697653|NCT00640874|H5N1 virus|h5n1 virus
697654|NCT00640861|stage II breast cancer|stage ii breast cancer
697655|NCT00640861|stage IIIA breast cancer|stage iiia breast cancer
697656|NCT00640861|stage IIIB breast cancer|stage iiib breast cancer
697657|NCT00640861|stage IIIC breast cancer|stage iiic breast cancer
697658|NCT00640861|stage IA breast cancer|stage ia breast cancer
697659|NCT00640861|stage IB breast cancer|stage ib breast cancer
697660|NCT00640861|triple-negative breast cancer|triple-negative breast cancer
697661|NCT00640861|HER2-positive breast cancer|her2-positive breast cancer
697662|NCT00640835|Opioid dependence|opioid dependence
697663|NCT00640809|Bowel Disease|bowel disease
697664|NCT00640796|Hematologic malignancies, non-B lineage|hematologic malignancies, non-b lineage
697665|NCT00640796|NK cell expansion|nk cell expansion
697666|NCT00640796|CliniMACS device|clinimacs device
697667|NCT00640796|Immunotherapy|immunotherapy
697668|NCT00640783|Metabolic syndrome|metabolic syndrome
697669|NCT00640783|Mediterranean diet|mediterranean diet
697670|NCT00640783|Inflammatory markers|inflammatory markers
697671|NCT00640783|Endothelial function|endothelial function
697672|NCT00640757|Methionine|methionine
697673|NCT00640757|Metabolic syndrome|metabolic syndrome
697674|NCT00640757|Glucose Metabolism|glucose metabolism
697675|NCT00640757|Amino acid|amino acid
697676|NCT00640757|Insulin clamp|insulin clamp
697677|NCT00640744|Atherogenesis|atherogenesis
697678|NCT00640744|Atheroma|atheroma
697679|NCT00640744|Arteriosclerosis|arteriosclerosis
697680|NCT00640731|DVT|dvt
697681|NCT00640731|Peripheral Vascular Disease|peripheral vascular disease
697682|NCT00640731|Venous Thrombosis|venous thrombosis
697683|NCT00640731|Deep Vein Thrombosis|deep vein thrombosis
697684|NCT00640718|heart and respiratory monitoring|heart and respiratory monitoring
697685|NCT00640692|Gastrointestinal stromal tumor|gastrointestinal stromal tumor
697686|NCT00640692|GIST|gist
697687|NCT00640692|Sunitinib|sunitinib
697688|NCT00640692|Imatinib|imatinib
697689|NCT00640679|Clopidogrel|clopidogrel
697690|NCT00640679|Drug-eluting Stent|drug-eluting stent
697691|NCT00640666|Breast cancer|breast cancer
697692|NCT00640666|Exercise|exercise
697693|NCT00640666|Biomarkers|biomarkers
697694|NCT00640653|Sexual Behavior|sexual behavior
697695|NCT00640653|Abstinence|abstinence
697696|NCT00640653|Intervention Studies|intervention studies
697697|NCT00640653|HIV|hiv
697698|NCT00640653|Sexually Transmitted Infection|sexually transmitted infection
697699|NCT00640653|Theory of Planned Behavior|theory of planned behavior
697700|NCT00640653|HIV Seronegativity|hiv seronegativity
697701|NCT00640640|IOP|iop
697702|NCT00640640|OPA|opa
697703|NCT00640640|AMD|amd
697704|NCT00640640|bevacizumab|bevacizumab
697705|NCT00640640|ranibizumab|ranibizumab
697706|NCT00640640|choroidal blood flow|choroidal blood flow
697707|NCT00640640|DCT|dct
697708|NCT00640640|Ocular Pulse Amplitude change following anti VEGF|ocular pulse amplitude change following anti vegf
697709|NCT00640640|Ocular Pulse Amplitude|ocular pulse amplitude
697710|NCT00640614|Dermatitis, Contact|dermatitis, contact
697711|NCT00640601|Seroquel|seroquel
697712|NCT00640601|schizophrenia|schizophrenia
697713|NCT00640601|Extended Release|extended release
697714|NCT00640588|Hepatitis B, chronic|hepatitis b, chronic
697715|NCT00640588|Viral kinetics|viral kinetics
697716|NCT00640588|Telbivudine|telbivudine
697717|NCT00640588|Adefovir|adefovir
697719|NCT00640562|Schizophrenia|schizophrenia
697720|NCT00640562|Depression|depression
697721|NCT00640562|Quetiapine|quetiapine
697722|NCT00640549|LDL-subfractions, HDL-subfractions, non insulin dependent diabetes mellitus (NIDDM), hyperlipidemia, atorvastatin|ldl-subfractions, hdl-subfractions, non insulin dependent diabetes mellitus (niddm), hyperlipidemia, atorvastatin
697723|NCT00640497|acute GVHD|acute gvhd
697724|NCT00640497|immunotoxin|immunotoxin
697725|NCT00640497|anti-CD3|anti-cd3
697726|NCT00640497|anti-CD7|anti-cd7
697728|NCT00640471|recurrent colon cancer|recurrent colon cancer
697729|NCT00640471|stage IV colon cancer|stage iv colon cancer
697730|NCT00640471|recurrent rectal cancer|recurrent rectal cancer
697731|NCT00640471|stage IV rectal cancer|stage iv rectal cancer
697732|NCT00640445|Clinical Trial|clinical trial
697733|NCT00640445|Combat Disorders|combat disorders
697734|NCT00640445|PTSD|ptsd
697735|NCT00640445|Internet-Based Intervention|internet-based intervention
697736|NCT00640445|Mental Health Services|mental health services
697737|NCT00640445|Post-deployment Reintegration|post-deployment reintegration
697738|NCT00640393|Etanercept, UVB, Enbrel, Psoriasis.|etanercept, uvb, enbrel, psoriasis.
697739|NCT00640380|cervical|cervical
697740|NCT00640380|paravertebral|paravertebral
697741|NCT00640380|block|block
697742|NCT00640367|Acute ischemic stroke|acute ischemic stroke
697743|NCT00640367|thrombolysis|thrombolysis
697744|NCT00640367|intra-arterial thrombolysis|intra-arterial thrombolysis
697745|NCT00640354|Automated External Defibrillator|automated external defibrillator
697746|NCT00640354|Resuscitation|resuscitation
697747|NCT00640354|Pediatric|pediatric
697748|NCT00640328|relapsing forms of multiple sclerosis|relapsing forms of multiple sclerosis
697749|NCT00640328|ofatumumab|ofatumumab
697750|NCT00640328|multiple sclerosis|multiple sclerosis
697751|NCT00640315|Chronic obstructive pulmonary disease|chronic obstructive pulmonary disease
697752|NCT00640315|COPD|copd
697753|NCT00640315|Pulmonary hypertension|pulmonary hypertension
697754|NCT00640302|Index cases|index cases
697755|NCT00640302|pandemic influenza|pandemic influenza
697756|NCT00640302|influenza A|influenza a
697757|NCT00640302|H5N1 virus|h5n1 virus
697758|NCT00640289|Factor XIII Deficiency|factor xiii deficiency
697759|NCT00640289|Rare Bleeding Disorder|rare bleeding disorder
697760|NCT00640289|Hemophilia|hemophilia
697761|NCT00640289|Fibrogammin P|fibrogammin p
697762|NCT00640276|pitavastatin|pitavastatin
697763|NCT00640276|metabolic syndrome|metabolic syndrome
697764|NCT00640276|metabolic syndrome risk score|metabolic syndrome risk score
697765|NCT00640276|hypercholesterolemia|hypercholesterolemia
697766|NCT00640263|HIV-1|hiv-1
697767|NCT00640263|Breastfeeding|breastfeeding
697768|NCT00640263|Prevention|prevention
697769|NCT00640263|lamivudine|lamivudine
697770|NCT00640263|lopinavir/ritonavir|lopinavir/ritonavir
697771|NCT00640250|Dermatitis, Contact, Bronopol, Disperse Blue 106|dermatitis, contact, bronopol, disperse blue 106
697772|NCT00640237|Vitamine D State|vitamine d state
697773|NCT00640211|Prophylaxis|prophylaxis
697774|NCT00640211|pandemic influenza|pandemic influenza
697775|NCT00640211|influenza A|influenza a
697776|NCT00640211|H5N1 virus|h5n1 virus
697777|NCT00640198|Aphasia|aphasia
697778|NCT00640198|Memantine|memantine
697779|NCT00640198|Constraint-induced language therapy|constraint-induced language therapy
697780|NCT00640198|Event-related potentials|event-related potentials
697781|NCT00640159|Parkinson's disease|parkinson's disease
697782|NCT00640159|selegiline to Zelapar switch|selegiline to zelapar switch
697783|NCT00640159|orally disintegrating formulation|orally disintegrating formulation
697784|NCT00640133|Deep Brain Stimulation|deep brain stimulation
697785|NCT00640133|Treatment Refractory|treatment refractory
697786|NCT00640133|Ventral Internal Capsule/Ventral Striatum|ventral internal capsule/ventral striatum
697787|NCT00640133|Neurosurgery|neurosurgery
697788|NCT00640133|Neuroimaging|neuroimaging
697789|NCT00640120|wheeze detection|wheeze detection
697790|NCT00640107|Magnetic Resonance Imaging|magnetic resonance imaging
697791|NCT00640094|Melatonin|melatonin
697792|NCT00640094|Acute myocardial infarction|acute myocardial infarction
697793|NCT00640094|Primary angioplasty|primary angioplasty
697794|NCT00640081|adenocarcinoma of the colon|adenocarcinoma of the colon
697795|NCT00640081|stage IV colon cancer|stage iv colon cancer
697796|NCT00640081|adenocarcinoma of the rectum|adenocarcinoma of the rectum
697797|NCT00640081|stage IV rectal cancer|stage iv rectal cancer
697798|NCT00640081|stage III colon cancer|stage iii colon cancer
697799|NCT00640081|stage III rectal cancer|stage iii rectal cancer
697800|NCT00640081|recurrent colon cancer|recurrent colon cancer
697801|NCT00640081|recurrent rectal cancer|recurrent rectal cancer
697802|NCT00640068|coronary artery disease|coronary artery disease
697803|NCT00640068|chest pain|chest pain
697804|NCT00640068|coronary artery bypass graft|coronary artery bypass graft
697805|NCT00640068|stress test|stress test
697806|NCT00640068|Coronary Angiography|coronary angiography
697807|NCT00640055|verbal autopsy|verbal autopsy
697808|NCT00640055|stillbirth|stillbirth
697809|NCT00640055|neonatal death|neonatal death
697810|NCT00640042|pain|pain
697811|NCT00640042|opioid|opioid
697812|NCT00640042|abuse|abuse
697813|NCT00640042|moderate-severe pain requiring continuous, around-the-clock opioid therapy for an extended period of time|moderate-severe pain requiring continuous, around-the-clock opioid therapy for an extended period of time
697814|NCT00640029|Arthroplasty|arthroplasty
697815|NCT00640029|Arthrodesis|arthrodesis
697816|NCT00640029|Prosthesis|prosthesis
697817|NCT00640029|Disc replacement|disc replacement
697818|NCT00640029|Spine|spine
697819|NCT00640029|Lumbar|lumbar
697820|NCT00640029|Cervical|cervical
697821|NCT00640029|Intervertebral disk|intervertebral disk
697822|NCT00640029|Cervical or lumbar intervertebral disk|cervical or lumbar intervertebral disk
697823|NCT00640029|Degenerative pathology|degenerative pathology
697824|NCT00640016|Asthma|asthma
697825|NCT00640016|CAT-354|cat-354
697826|NCT00640016|Tralokinumab|tralokinumab
697827|NCT00640003|AT|at
697828|NCT00640003|Ataxia|ataxia
697829|NCT00640003|Telangiectasia|telangiectasia
697830|NCT00639990|Intraabdominal pressure|intraabdominal pressure
697831|NCT00639977|Intraocular Pressure|intraocular pressure
697832|NCT00639977|Acupuncture|acupuncture
697833|NCT00639977|Healthy Volunteers|healthy volunteers
697834|NCT00639964|diabetes|diabetes
697835|NCT00639964|pregnancy|pregnancy
697836|NCT00639964|macrosomia|macrosomia
697837|NCT00639964|lipidics markers|lipidics markers
697838|NCT00639964|nutritional factors|nutritional factors
697839|NCT00639964|placenta|placenta
697840|NCT00639964|umbilical blood cord|umbilical blood cord
697841|NCT00639951|Snake Bite|snake bite
697842|NCT00639951|Antivenin Treatment|antivenin treatment
697843|NCT00639938|Pregnancy, High-Risk|pregnancy, high-risk
697844|NCT00639938|HIV Seronegativity|hiv seronegativity
697845|NCT00639912|contrast induced nephropathy STEMI PCI|contrast induced nephropathy stemi pci
697846|NCT00639899|Varicocele|varicocele
697847|NCT00639873|Uncomplicated P. falciparum malaria|uncomplicated p. falciparum malaria
697848|NCT00639860|extraction|extraction
697849|NCT00639860|implant|implant
697850|NCT00639860|alveolar ridge preservation|alveolar ridge preservation
697851|NCT00639847|Asthma management|asthma management
697852|NCT00639847|cost|cost
697853|NCT00639847|disease management|disease management
697854|NCT00639847|respiratory care|respiratory care
697855|NCT00639847|nursing|nursing
697856|NCT00639847|health care utilization|health care utilization
697857|NCT00639847|health related quality of life|health related quality of life
697858|NCT00639834|rheumatoid|rheumatoid
697859|NCT00639834|arthritis|arthritis
697860|NCT00639834|RA|ra
697861|NCT00639834|joint inflammation|joint inflammation
697862|NCT00639834|autoimmune|autoimmune
697863|NCT00639834|Medarex|medarex
697864|NCT00639834|Rheumatology|rheumatology
697865|NCT00639821|Gene expression microarray|gene expression microarray
697866|NCT00639821|Inflammatory bowel disease|inflammatory bowel disease
697867|NCT00639821|Infliximab|infliximab
697868|NCT00639808|delayed gastric emptying|delayed gastric emptying
697869|NCT00639808|symptomatic gastroparesis|symptomatic gastroparesis
697870|NCT00639808|diabetes mellitus|diabetes mellitus
697871|NCT00639795|Thoracic paravertebral block|thoracic paravertebral block
697872|NCT00639795|Cytokines|cytokines
697873|NCT00639795|Video assisted thorascopic surgery|video assisted thorascopic surgery
697874|NCT00639795|Pain|pain
697875|NCT00639782|thromboembolism|thromboembolism
697876|NCT00639782|mechanical heart valves|mechanical heart valves
697877|NCT00639782|randomized|randomized
697878|NCT00639769|recurrent squamous cell carcinoma of the hypopharynx|recurrent squamous cell carcinoma of the hypopharynx
697879|NCT00639769|stage IV squamous cell carcinoma of the hypopharynx|stage iv squamous cell carcinoma of the hypopharynx
697880|NCT00639769|stage IV squamous cell carcinoma of the larynx|stage iv squamous cell carcinoma of the larynx
697881|NCT00639769|stage IV verrucous carcinoma of the larynx|stage iv verrucous carcinoma of the larynx
697882|NCT00639769|recurrent squamous cell carcinoma of the larynx|recurrent squamous cell carcinoma of the larynx
697883|NCT00639769|recurrent verrucous carcinoma of the larynx|recurrent verrucous carcinoma of the larynx
697884|NCT00639769|recurrent squamous cell carcinoma of the lip and oral cavity|recurrent squamous cell carcinoma of the lip and oral cavity
697885|NCT00639769|stage IV squamous cell carcinoma of the lip and oral cavity|stage iv squamous cell carcinoma of the lip and oral cavity
697886|NCT00639769|recurrent verrucous carcinoma of the oral cavity|recurrent verrucous carcinoma of the oral cavity
697887|NCT00639769|stage IV verrucous carcinoma of the oral cavity|stage iv verrucous carcinoma of the oral cavity
697888|NCT00639769|metastatic squamous neck cancer with occult primary squamous cell carcinoma|metastatic squamous neck cancer with occult primary squamous cell carcinoma
697889|NCT00639769|recurrent metastatic squamous neck cancer with occult primary|recurrent metastatic squamous neck cancer with occult primary
697890|NCT00639769|untreated metastatic squamous neck cancer with occult primary|untreated metastatic squamous neck cancer with occult primary
697891|NCT00639769|recurrent squamous cell carcinoma of the nasopharynx|recurrent squamous cell carcinoma of the nasopharynx
697892|NCT00639769|stage IV squamous cell carcinoma of the nasopharynx|stage iv squamous cell carcinoma of the nasopharynx
697893|NCT00639769|recurrent squamous cell carcinoma of the oropharynx|recurrent squamous cell carcinoma of the oropharynx
697894|NCT00639769|stage IV squamous cell carcinoma of the oropharynx|stage iv squamous cell carcinoma of the oropharynx
697895|NCT00639769|recurrent squamous cell carcinoma of the paranasal sinus and nasal cavity|recurrent squamous cell carcinoma of the paranasal sinus and nasal cavity
697896|NCT00639769|stage IV squamous cell carcinoma of the paranasal sinus and nasal cavity|stage iv squamous cell carcinoma of the paranasal sinus and nasal cavity
697897|NCT00639769|recurrent salivary gland cancer|recurrent salivary gland cancer
697898|NCT00639769|salivary gland squamous cell carcinoma|salivary gland squamous cell carcinoma
697899|NCT00639769|stage IV salivary gland cancer|stage iv salivary gland cancer
697900|NCT00639756|Uric acid|uric acid
697901|NCT00639756|Fructose|fructose
697902|NCT00639756|Hypertension|hypertension
697903|NCT00639756|Insulin|insulin
697904|NCT00639756|Glucose|glucose
697905|NCT00639756|HOMA|homa
697906|NCT00639743|Pulmonary embolism|pulmonary embolism
697907|NCT00639743|Heparin|heparin
697908|NCT00639743|Thrombolytic therapy|thrombolytic therapy
697909|NCT00639743|Bleeding|bleeding
697910|NCT00639730|Epilepsy|epilepsy
697911|NCT00639717|GVHD|gvhd
697912|NCT00639704|MRI|mri
697913|NCT00639704|SPECT|spect
697914|NCT00639704|Cardiac function|cardiac function
697915|NCT00639691|Asthma, Anti-immunoglobin E, omalizumab|asthma, anti-immunoglobin e, omalizumab
697916|NCT00639678|healthy volunteers|healthy volunteers
697917|NCT00639665|Cocoa, diabetes, polyphenols|cocoa, diabetes, polyphenols
697918|NCT00639652|Carcinoma, Basal Cell|carcinoma, basal cell
697919|NCT00639652|3D-histology|3d-histology
697920|NCT00639652|Micrographic surgery|micrographic surgery
697921|NCT00639652|Mohs surgery|mohs surgery
697922|NCT00639652|Shave excision|shave excision
697923|NCT00639652|Recurrence|recurrence
697924|NCT00639652|Esthetic outcome|esthetic outcome
697925|NCT00639639|adult giant cell glioblastoma|adult giant cell glioblastoma
697926|NCT00639639|adult gliosarcoma|adult gliosarcoma
697927|NCT00639587|Cetirizine|cetirizine
697928|NCT00639587|Zyrtec|zyrtec
697929|NCT00639574|Pain, morphine, nefopam, co analgesia, ureteral calculi, emergency|pain, morphine, nefopam, co analgesia, ureteral calculi, emergency
697930|NCT00639561|digestive system|digestive system
697931|NCT00639561|Diet|diet
697932|NCT00639548|Deep Sedation|deep sedation
697933|NCT00639548|EEG|eeg
697934|NCT00639548|Event-Related Potentials|event-related potentials
697935|NCT00639548|Evoked potentials, auditory|evoked potentials, auditory
697936|NCT00639548|BIS-Index|bis-index
697937|NCT00639548|Entropy|entropy
697938|NCT00639548|ICU|icu
697939|NCT00639535|Radiology|radiology
697940|NCT00639535|MRI|mri
697941|NCT00639535|Positron emission tomography|positron emission tomography
697942|NCT00639535|Breast Abnormalities|breast abnormalities
697943|NCT00639535|Dense Breast Tissue|dense breast tissue
697944|NCT00639522|Liposomal paclitaxel|liposomal paclitaxel
697945|NCT00639522|Maximum tolerated dose|maximum tolerated dose
697946|NCT00639522|Pharmacokinetics|pharmacokinetics
697947|NCT00639522|Gastric carcinoma|gastric carcinoma
697948|NCT00639496|Idiopathic Pulmonary Fibrosis|idiopathic pulmonary fibrosis
697949|NCT00639470|Patient Education Handout|patient education handout
697950|NCT00639470|Parents|parents
697951|NCT00639470|Patient Education|patient education
697952|NCT00639457|PPAR-gamma agonist|ppar-gamma agonist
697953|NCT00639457|glucose metabolism|glucose metabolism
697954|NCT00639457|inflammation|inflammation
697955|NCT00639457|adipose tissue distribution|adipose tissue distribution
697956|NCT00639457|cardiac function|cardiac function
697957|NCT00639457|vascular function|vascular function
697958|NCT00639457|mass spectrometry|mass spectrometry
697959|NCT00639457|Treatment Experienced|treatment experienced
697960|NCT00639431|phantom limb pain|phantom limb pain
697961|NCT00639431|limb amputation|limb amputation
697962|NCT00639431|Amputation|amputation
697963|NCT00639431|Phantom Limb|phantom limb
697964|NCT00639431|Pain|pain
697965|NCT00639405|Parathyroid|parathyroid
697966|NCT00639405|MRI|mri
697967|NCT00639405|SPECT|spect
697968|NCT00639392|Sickle cell disease|sickle cell disease
697969|NCT00639379|toric contact lenses|toric contact lenses
697970|NCT00639379|vision|vision
697971|NCT00639379|comfort|comfort
697972|NCT00639379|toric fit characteristics|toric fit characteristics
697973|NCT00639379|slit lamp findings|slit lamp findings
697974|NCT00639366|recurrent breast cancer|recurrent breast cancer
697975|NCT00639366|stage IIIA breast cancer|stage iiia breast cancer
697976|NCT00639366|stage IIIB breast cancer|stage iiib breast cancer
697977|NCT00639366|stage IIIC breast cancer|stage iiic breast cancer
697978|NCT00639366|stage IV breast cancer|stage iv breast cancer
697979|NCT00639327|Stomach Neoplasms|stomach neoplasms
697980|NCT00639327|Second line chemotherapy|second line chemotherapy
697981|NCT00639327|Refractory to S-1|refractory to s-1
697982|NCT00639327|irinotecan|irinotecan
697983|NCT00639327|S-1 and Irinotecan Combination|s-1 and irinotecan combination
697984|NCT00639327|Phase III study|phase iii study
697985|NCT00639314|pylorus-preserving pancreaticoduodenectomy|pylorus-preserving pancreaticoduodenectomy
697986|NCT00639314|pylorus-resecting pancreaticoduodenectomy|pylorus-resecting pancreaticoduodenectomy
697987|NCT00639314|randomized controlled trial|randomized controlled trial
697988|NCT00639314|delayed gastric empty|delayed gastric empty
697989|NCT00639314|quality of life|quality of life
697990|NCT00639301|Survivor|survivor
697991|NCT00639301|Quality of Life|quality of life
697992|NCT00639301|Eye|eye
697993|NCT00639288|Alcohol Dependence|alcohol dependence
697995|NCT00639288|CPT-C|cpt-c
697996|NCT00639262|Sorafenib|sorafenib
697997|NCT00639262|Radiation Therapy|radiation therapy
697998|NCT00639262|Radiotherapy|radiotherapy
697999|NCT00639262|Temozolomide|temozolomide
698000|NCT00639262|Brain Metastases|brain metastases
698001|NCT00639262|Brain Tumors|brain tumors
698002|NCT00639236|COPD|copd
698003|NCT00639236|Hypertonic saline|hypertonic saline
698004|NCT00639236|Quality of life|quality of life
698005|NCT00639236|Dyspnoea.|dyspnoea.
698006|NCT00639223|Statin related myalgia|statin related myalgia
698007|NCT00639223|Hyperlipidemia|hyperlipidemia
698008|NCT00639223|Red yeast rice|red yeast rice
698009|NCT00639223|Cardiovascular Diseases|cardiovascular diseases
698010|NCT00639223|Nutritional and Metabolic Diseases|nutritional and metabolic diseases
698011|NCT00639210|breast cancer|breast cancer
698012|NCT00639210|exercise|exercise
698013|NCT00639210|osteoporosis|osteoporosis
698014|NCT00639210|fracture|fracture
698015|NCT00639210|quality of life|quality of life
698016|NCT00639197|Tunneling|tunneling
698017|NCT00639197|Short term|short term
698018|NCT00639197|central venous catheters|central venous catheters
698019|NCT00639197|Ultrasound Guided|ultrasound guided
698020|NCT00639197|Internal jugular|internal jugular
698021|NCT00639197|Assess safety and improve technical difficulty|assess safety and improve technical difficulty
698022|NCT00639184|asphyxia|asphyxia
698023|NCT00639184|neurodevelopmental outcome|neurodevelopmental outcome
698024|NCT00639184|home counseling|home counseling
698025|NCT00639171|breast|breast
698026|NCT00639171|diagnostic radiology|diagnostic radiology
698027|NCT00639171|suspicious breast tumors|suspicious breast tumors
698028|NCT00639171|MRI|mri
698029|NCT00639145|HIV|hiv
698030|NCT00639145|Pregnancy|pregnancy
698031|NCT00639145|Antiretrovirals|antiretrovirals
698032|NCT00639145|HIV Seronegativity|hiv seronegativity
698033|NCT00639145|Treatment Experienced|treatment experienced
698034|NCT00639132|Natural History|natural history
698035|NCT00639132|Metachromatic Leukodystrophy|metachromatic leukodystrophy
698036|NCT00639132|Disease Progression|disease progression
698037|NCT00639106|Breast expander|breast expander
698038|NCT00639106|Breast reconstruction|breast reconstruction
698039|NCT00639106|implants|implants
698040|NCT00639106|08-024|08-024
698041|NCT00639093|cigarette smoking|cigarette smoking
698042|NCT00639093|psychoeducational and motivational program|psychoeducational and motivational program
698043|NCT00639093|virtual reality|virtual reality
698044|NCT00639080|Type 2 diabetes|type 2 diabetes
698045|NCT00639080|Dyslipidemia|dyslipidemia
698046|NCT00639067|Cancer of Lung|cancer of lung
698047|NCT00639067|Cancer of the Lung|cancer of the lung
698048|NCT00639067|Lung Cancer|lung cancer
698049|NCT00639067|Neoplasms, Lung|neoplasms, lung
698050|NCT00639067|Neoplasms, Pulmonary|neoplasms, pulmonary
698051|NCT00639067|Pulmonary Cancer|pulmonary cancer
698052|NCT00639067|Pulmonary Neoplasms|pulmonary neoplasms
698053|NCT00639054|classification|classification
698054|NCT00639054|diagnosis|diagnosis
698055|NCT00639054|genetics|genetics
698056|NCT00639054|mortality|mortality
698057|NCT00639054|pathology|pathology
698058|NCT00639041|n-3 LC-PUFA|n-3 lc-pufa
698059|NCT00639041|hypertriglyceridemic|hypertriglyceridemic
698060|NCT00639041|human|human
698061|NCT00639041|TAG|tag
698062|NCT00639028|ankle|ankle
698063|NCT00639028|diagnosis|diagnosis
698064|NCT00639028|sprain|sprain
698065|NCT00639028|care|care
698066|NCT00639028|injury|injury
698067|NCT00639028|stress radiography|stress radiography
698068|NCT00639028|ultrasonography|ultrasonography
698069|NCT00639015|Sepsis|sepsis
698070|NCT00639015|Septic Shock|septic shock
698071|NCT00639015|phenylephrine|phenylephrine
698072|NCT00639015|norepinephrine|norepinephrine
698073|NCT00639015|catecholamine|catecholamine
698074|NCT00638989|Asthma|asthma
698075|NCT00638989|CAT-354|cat-354
698076|NCT00638989|Tralokinumab|tralokinumab
698077|NCT00638989|Healthy|healthy
698078|NCT00638976|Eptifibatide|eptifibatide
698079|NCT00638976|IV eptifibatide|iv eptifibatide
698080|NCT00638976|GP IIB/IIIA inhibitors|gp iib/iiia inhibitors
698081|NCT00638976|DES stent|des stent
698082|NCT00638950|n-3 LC-PUFA|n-3 lc-pufa
698083|NCT00638950|Rheumatoid arthritis|rheumatoid arthritis
698084|NCT00638950|disease activity|disease activity
698085|NCT00638950|inflammation|inflammation
698086|NCT00638950|oxidative stress|oxidative stress
698087|NCT00638950|immune system|immune system
698088|NCT00638924|healthy sedentary women|healthy sedentary women
698089|NCT00638885|PTSD|ptsd
698090|NCT00638885|hippocampus|hippocampus
698091|NCT00638885|twins|twins
698092|NCT00638872|diabetes|diabetes
698093|NCT00638872|foot ulcer|foot ulcer
698094|NCT00638872|polydeoxyribonucleotide|polydeoxyribonucleotide
698095|NCT00638859|Community-Acquired pneumonia|community-acquired pneumonia
698096|NCT00638859|CAP|cap
698097|NCT00638859|children|children
698098|NCT00638859|Child|child
698099|NCT00638846|toric contact lenses|toric contact lenses
698100|NCT00638846|vision|vision
698101|NCT00638846|comfort|comfort
698102|NCT00638846|toric fit characteristics|toric fit characteristics
698103|NCT00638846|slit lamp findings|slit lamp findings
698104|NCT00638833|Multiple Sclerosis|multiple sclerosis
698105|NCT00638820|osteopetrosis|osteopetrosis
698106|NCT00638794|Myocardial Infarction|myocardial infarction
698107|NCT00638794|Myocardial Ischemia|myocardial ischemia
698108|NCT00638781|Acute ischemic stroke|acute ischemic stroke
698109|NCT00638768|physical therapy|physical therapy
698110|NCT00638768|rehabilitation|rehabilitation
698111|NCT00638768|pain|pain
698112|NCT00638768|osteoporosis|osteoporosis
698113|NCT00638768|vertebral fracture|vertebral fracture
698114|NCT00638755|Allergic Rhinitis|allergic rhinitis
698115|NCT00638755|Perennial Allergic Rhinitis|perennial allergic rhinitis
698116|NCT00638755|Allergies to perennial allergens|allergies to perennial allergens
698117|NCT00638755|Allergies to perennial allergens (e.g. dog, cat, dust mites, etc.)|allergies to perennial allergens (e.g. dog, cat, dust mites, etc.)
698118|NCT00638742|Latanoprost Pediatrics Pharmacokinetics Safety|latanoprost pediatrics pharmacokinetics safety
698119|NCT00638729|bispectral index|bispectral index
698120|NCT00638729|sedation|sedation
698121|NCT00638729|stress hormones|stress hormones
698122|NCT00638729|cognitive function|cognitive function
698123|NCT00638716|Type 2 Diabetes Mellitus, incretins, GLP-1, HbA1c, metformin|type 2 diabetes mellitus, incretins, glp-1, hba1c, metformin
698124|NCT00638703|hyperoxaluria|hyperoxaluria
698125|NCT00638703|PH|ph
698126|NCT00638703|oxalate|oxalate
698127|NCT00638690|Metastatic Castration-Resistant Prostate Cancer|metastatic castration-resistant prostate cancer
698128|NCT00638690|CRPC|crpc
698129|NCT00638690|Abiraterone Acetate|abiraterone acetate
698130|NCT00638690|CB7630|cb7630
698131|NCT00638677|Oral microbiology|oral microbiology
698132|NCT00638664|conventional pulse sequences for MR|conventional pulse sequences for mr
698133|NCT00638664|cardiac chambers and walls|cardiac chambers and walls
698134|NCT00638664|cardio-thoracic vasculature|cardio-thoracic vasculature
698135|NCT00638664|the great vessels|the great vessels
698136|NCT00638664|coronary vasculature|coronary vasculature
698137|NCT00638664|cardiac|cardiac
698138|NCT00638664|great vessels|great vessels
698139|NCT00638651|Tattoos|tattoos
698140|NCT00638651|Black/blue tattoos|black/blue tattoos
698141|NCT00638638|Myocardial infarction|myocardial infarction
698142|NCT00638638|Angioplasty|angioplasty
698143|NCT00638638|Coronary stenting|coronary stenting
698144|NCT00638638|Abciximab|abciximab
698145|NCT00638638|Myocardial reperfusion|myocardial reperfusion
698146|NCT00638638|Microcirculation|microcirculation
698147|NCT00638638|EKG|ekg
698148|NCT00638638|ST elevation myocardial infarction within 6 h of symptom onset|st elevation myocardial infarction within 6 h of symptom onset
698149|NCT00638625|Needle biopsy|needle biopsy
698150|NCT00638625|CT Scan|ct scan
698151|NCT00638625|Lung Tumor|lung tumor
698152|NCT00638625|Lung Mass|lung mass
698153|NCT00638612|Immunotherapy|immunotherapy
698154|NCT00638612|Gene Therapy|gene therapy
698155|NCT00638612|Cytotoxicity|cytotoxicity
698156|NCT00638612|Tumor vaccine|tumor vaccine
698157|NCT00638612|Radiation|radiation
698158|NCT00638612|Surgery|surgery
698159|NCT00638612|Chemoradiation|chemoradiation
698160|NCT00638599|Intubation, intratracheal|intubation, intratracheal
698161|NCT00638599|Homeostasis|homeostasis
698162|NCT00638599|Mastectomy, modified radical|mastectomy, modified radical
698163|NCT00638599|Breast Neoplasms|breast neoplasms
698164|NCT00638560|PGC-1alpha|pgc-1alpha
698165|NCT00638560|PPARgamma|ppargamma
698166|NCT00638560|oxidative stress|oxidative stress
698167|NCT00638560|training intervention|training intervention
698168|NCT00638547|Hurler Syndrome|hurler syndrome
698169|NCT00638547|mucopolysaccharidosis type I|mucopolysaccharidosis type i
698170|NCT00638547|Iduronidase deficiency|iduronidase deficiency
698171|NCT00638534|Acute Otitis Media|acute otitis media
698172|NCT00638534|AOM|aom
698173|NCT00638534|children|children
698174|NCT00638534|Child|child
698175|NCT00638521|lipids|lipids
698176|NCT00638521|proteins|proteins
698177|NCT00638521|membrane|membrane
698178|NCT00638521|lipid raft|lipid raft
698179|NCT00638482|Dent's disease|dent's disease
698180|NCT00638482|Nephrolithiasis|nephrolithiasis
698181|NCT00638482|clinical trial|clinical trial
698182|NCT00638482|thiazides|thiazides
698183|NCT00638469|Psoriasis|psoriasis
698184|NCT00638469|Biologic|biologic
698185|NCT00638469|adalimumab|adalimumab
698186|NCT00638469|narrowband UVB|narrowband uvb
698187|NCT00638469|phototherapy|phototherapy
698188|NCT00638469|half-side comparison|half-side comparison
698189|NCT00638456|Eosinophils|eosinophils
698190|NCT00638456|Esophagitis|esophagitis
698191|NCT00638456|Microscopy|microscopy
698192|NCT00638443|Neurogenic claudication, lumbar spinal stenosis, treadmill testing|neurogenic claudication, lumbar spinal stenosis, treadmill testing
698193|NCT00638430|myopia|myopia
698194|NCT00638430|Humphery Matrix 30-2 test|humphery matrix 30-2 test
698195|NCT00638404|Preoperative somatic questions|preoperative somatic questions
698377|NCT00637676|talc pleurodesis|talc pleurodesis
698196|NCT00638404|Preoperative audio tone evaluations|preoperative audio tone evaluations
698197|NCT00638404|Preoperative anxiety and previous experience with postop pain|preoperative anxiety and previous experience with postop pain
698198|NCT00638391|Primary early MCa|primary early mca
698199|NCT00638391|Arimidex|arimidex
698200|NCT00638378|Prostate Cancer|prostate cancer
698201|NCT00638365|Cystic Fibrosis, Pseudomonas aeruginosa, Pulmonary CF|cystic fibrosis, pseudomonas aeruginosa, pulmonary cf
698202|NCT00638352|Core Biopsy|core biopsy
698203|NCT00638352|Needle Biopsy|needle biopsy
698204|NCT00638352|Percutaneous Biopsy|percutaneous biopsy
698205|NCT00638339|Respiration, artificial|respiration, artificial
698206|NCT00638339|respiratory insufficiency|respiratory insufficiency
698207|NCT00638339|noninvasive ventilation|noninvasive ventilation
698208|NCT00638339|sleep deprivation|sleep deprivation
698209|NCT00638339|intensive care units|intensive care units
698210|NCT00638326|Clopidogrel, thrombosis, Percutaneous Transluminal Coronary Angioplasty, stents|clopidogrel, thrombosis, percutaneous transluminal coronary angioplasty, stents
698211|NCT00638313|GLP-1|glp-1
698212|NCT00638300|hemodialysis|hemodialysis
698213|NCT00638300|iron|iron
698214|NCT00638300|inflammation|inflammation
698215|NCT00638300|atomic absorption|atomic absorption
698216|NCT00638300|dialysate|dialysate
698217|NCT00638300|advanced oxidation protein products|advanced oxidation protein products
698218|NCT00638300|large pore dialysate|large pore dialysate
698219|NCT00638300|bicarbonate|bicarbonate
698220|NCT00638300|calcium|calcium
698221|NCT00638300|citrate|citrate
698222|NCT00638300|ligand|ligand
698223|NCT00638287|Subjects with pituitary disease undergoing testing for GH|subjects with pituitary disease undergoing testing for gh
698224|NCT00638287|deficiency|deficiency
698225|NCT00638287|Subjects with suspicion for (or diagnosis of) acromegaly|subjects with suspicion for (or diagnosis of) acromegaly
698226|NCT00638287|undergoing OGTT testing|undergoing ogtt testing
698227|NCT00638287|Normal controls without evidence of pituitary dysfunction|normal controls without evidence of pituitary dysfunction
698228|NCT00638274|Quality of pain relief with 2 different methods of identifying epidural space|quality of pain relief with 2 different methods of identifying epidural space
698229|NCT00638261|Psoriasis|psoriasis
698230|NCT00638261|Biologic|biologic
698231|NCT00638261|Adalimumab|adalimumab
698232|NCT00638261|Narrow-band UVB|narrow-band uvb
698233|NCT00638261|phototherapy|phototherapy
698234|NCT00638261|half-side comparison|half-side comparison
698235|NCT00638248|Acute ischemic stroke|acute ischemic stroke
698236|NCT00638235|Pelvic floor repair|pelvic floor repair
698237|NCT00638235|prolapse|prolapse
698238|NCT00638235|mesh|mesh
698239|NCT00638222|Carvedilol|carvedilol
698240|NCT00638222|Heart Disease|heart disease
698241|NCT00638222|Vascular Disease|vascular disease
698242|NCT00638222|Kidney|kidney
698243|NCT00638196|relapsing multiple sclerosis|relapsing multiple sclerosis
698244|NCT00638196|polyunsaturated fatty acids|polyunsaturated fatty acids
698245|NCT00638196|omega-6 fatty acids|omega-6 fatty acids
698246|NCT00638170|Urinary Tract Infections|urinary tract infections
698247|NCT00638170|Cranberry|cranberry
698248|NCT00638170|Prevention|prevention
698249|NCT00638157|Gram-positive bacterial infections|gram-positive bacterial infections
698250|NCT00638157|Staph Aureus|staph aureus
698251|NCT00638157|endocarditis|endocarditis
698252|NCT00638157|bacteremia|bacteremia
698253|NCT00638157|methicillin-resistant Staphylococcus aureus (MRSA)|methicillin-resistant staphylococcus aureus (mrsa)
698254|NCT00638144|Hepatitis C|hepatitis c
698255|NCT00638144|liver transplantation|liver transplantation
698256|NCT00638144|antibodies mediated neutralization|antibodies mediated neutralization
698257|NCT00638144|monoclonal antibodies|monoclonal antibodies
698258|NCT00638092|hypothyroxinemia|hypothyroxinemia
698259|NCT00638092|preterm infants|preterm infants
698260|NCT00638092|iodine|iodine
698261|NCT00638092|neurodevelopmental outcome|neurodevelopmental outcome
698262|NCT00638092|Iodine supplementation|iodine supplementation
698263|NCT00638092|Randomised controlled trial|randomised controlled trial
698264|NCT00638079|Pharmacokinetics|pharmacokinetics
698265|NCT00638079|Food Effect|food effect
698266|NCT00638079|Bioavailability|bioavailability
698267|NCT00638079|Megace ES|megace es
698268|NCT00638066|vaginismus|vaginismus
698269|NCT00638066|botulinum toxin A|botulinum toxin a
698270|NCT00638066|dyspareunia|dyspareunia
698271|NCT00638066|unconsummated marriage|unconsummated marriage
698272|NCT00638040|hypoxia|hypoxia
698273|NCT00638040|lactate|lactate
698274|NCT00638040|pH|ph
698275|NCT00638040|tumor microenvironments|tumor microenvironments
698276|NCT00638040|survival|survival
698277|NCT00638027|multiple sclerosis|multiple sclerosis
698278|NCT00638014|Sternal wound closure|sternal wound closure
698279|NCT00638014|cardiac surgery|cardiac surgery
698280|NCT00638014|sternal nonunion|sternal nonunion
698281|NCT00638001|patients with haemophilia A moderate or severe|patients with haemophilia a moderate or severe
698282|NCT00638001|patients with haemophilia B moderate or severe|patients with haemophilia b moderate or severe
698283|NCT00637988|Barrett's Esophagus|barrett's esophagus
698284|NCT00637988|Nexium|nexium
698285|NCT00637975|neuropathic pain|neuropathic pain
698286|NCT00637975|oxycodone|oxycodone
698287|NCT00637975|pregabalin|pregabalin
698288|NCT00637975|Patients with cancer and presenting a neuropathic pain|patients with cancer and presenting a neuropathic pain
698289|NCT00637962|HIV|hiv
698290|NCT00637962|AIDS|aids
698291|NCT00637962|Vaccine|vaccine
698292|NCT00637962|intravaginal|intravaginal
698293|NCT00637962|mucosal|mucosal
698294|NCT00637962|HIV Seronegativity|hiv seronegativity
698295|NCT00637949|Osteoarthritis|osteoarthritis
698296|NCT00637949|lumiracoxib|lumiracoxib
698297|NCT00637949|rofecoxib|rofecoxib
698298|NCT00637949|Cox-2|cox-2
698299|NCT00637949|Osteoarthritis (primary osteoarthritis hip, hand, knee or spine (cervical or lumbar)|osteoarthritis (primary osteoarthritis hip, hand, knee or spine (cervical or lumbar)
698300|NCT00637936|perioperative oxygen|perioperative oxygen
698301|NCT00637936|respiratory complications|respiratory complications
698302|NCT00637923|Hepatitis C, Chronic|hepatitis c, chronic
698303|NCT00637910|Advanced NSCLC|advanced nsclc
698304|NCT00637910|EGFR|egfr
698305|NCT00637910|EGFR copy number|egfr copy number
698306|NCT00637910|Kras mutations|kras mutations
698307|NCT00637910|EGRF mutations|egrf mutations
698308|NCT00637910|Docetaxel|docetaxel
698309|NCT00637910|Erlotinib|erlotinib
698310|NCT00637910|Polymorphisms|polymorphisms
698311|NCT00637897|recurrent breast cancer|recurrent breast cancer
698312|NCT00637897|stage IV breast cancer|stage iv breast cancer
698313|NCT00637871|Casodex|casodex
698314|NCT00637871|bicalutamide|bicalutamide
698315|NCT00637871|Tamoxifen|tamoxifen
698316|NCT00637871|Gynaecomastia|gynaecomastia
698317|NCT00637871|Prostate Cancer|prostate cancer
698318|NCT00637845|Nexium|nexium
698319|NCT00637845|Esomeprazole Magnesium|esomeprazole magnesium
698320|NCT00637845|Gastroesophageal Reflux Disease|gastroesophageal reflux disease
698321|NCT00637845|Heartburn|heartburn
698322|NCT00637832|recurrent grade 1 follicular lymphoma|recurrent grade 1 follicular lymphoma
698323|NCT00637832|recurrent grade 2 follicular lymphoma|recurrent grade 2 follicular lymphoma
698324|NCT00637832|recurrent grade 3 follicular lymphoma|recurrent grade 3 follicular lymphoma
698325|NCT00637832|contiguous stage II grade 1 follicular lymphoma|contiguous stage ii grade 1 follicular lymphoma
698326|NCT00637832|contiguous stage II grade 2 follicular lymphoma|contiguous stage ii grade 2 follicular lymphoma
698327|NCT00637832|contiguous stage II grade 3 follicular lymphoma|contiguous stage ii grade 3 follicular lymphoma
698328|NCT00637832|noncontiguous stage II grade 1 follicular lymphoma|noncontiguous stage ii grade 1 follicular lymphoma
698329|NCT00637832|noncontiguous stage II grade 2 follicular lymphoma|noncontiguous stage ii grade 2 follicular lymphoma
698330|NCT00637832|noncontiguous stage II grade 3 follicular lymphoma|noncontiguous stage ii grade 3 follicular lymphoma
698331|NCT00637832|stage III grade 1 follicular lymphoma|stage iii grade 1 follicular lymphoma
698332|NCT00637832|stage III grade 2 follicular lymphoma|stage iii grade 2 follicular lymphoma
698333|NCT00637832|stage III grade 3 follicular lymphoma|stage iii grade 3 follicular lymphoma
698334|NCT00637832|stage IV grade 1 follicular lymphoma|stage iv grade 1 follicular lymphoma
698335|NCT00637832|stage IV grade 2 follicular lymphoma|stage iv grade 2 follicular lymphoma
698336|NCT00637832|stage IV grade 3 follicular lymphoma|stage iv grade 3 follicular lymphoma
698337|NCT00637806|Megestrol acetate|megestrol acetate
698338|NCT00637806|Anorexia|anorexia
698339|NCT00637806|Cachexia|cachexia
698340|NCT00637806|Cancer|cancer
698341|NCT00637806|Unintended weight loss|unintended weight loss
698342|NCT00637806|Body weight|body weight
698343|NCT00637806|Appetite|appetite
698344|NCT00637806|Megace ES|megace es
698345|NCT00637793|Xerostomia|xerostomia
698346|NCT00637793|Sjogren's Syndrome|sjogren's syndrome
698347|NCT00637780|Sulfasalazine delayed release tablets|sulfasalazine delayed release tablets
698348|NCT00637780|azulfidine entabs|azulfidine entabs
698349|NCT00637780|Pharmacokinetics|pharmacokinetics
698350|NCT00637780|Juvenile Idiopathic Arthritis (JIA)|juvenile idiopathic arthritis (jia)
698351|NCT00637767|stage I multiple myeloma|stage i multiple myeloma
698352|NCT00637767|stage II multiple myeloma|stage ii multiple myeloma
698353|NCT00637767|stage III multiple myeloma|stage iii multiple myeloma
698354|NCT00637754|ICD|icd
698355|NCT00637754|Sports|sports
698356|NCT00637741|Peripheral Vascular Disease|peripheral vascular disease
698357|NCT00637741|Intermittent claudication|intermittent claudication
698358|NCT00637741|Critical Limb Ischemia|critical limb ischemia
698359|NCT00637741|TASC|tasc
698360|NCT00637728|Megestrol acetate|megestrol acetate
698361|NCT00637728|Anorexia|anorexia
698362|NCT00637728|Cachexia|cachexia
698363|NCT00637728|Lung cancer|lung cancer
698364|NCT00637728|Pancreatic cancer|pancreatic cancer
698365|NCT00637728|Unintended weight loss|unintended weight loss
698366|NCT00637728|Body weight|body weight
698367|NCT00637728|Appetite|appetite
698368|NCT00637728|Megace ES|megace es
698369|NCT00637689|Chronic graft versus host disease|chronic graft versus host disease
698370|NCT00637689|Allogeneic hematopoietic cell transplantation|allogeneic hematopoietic cell transplantation
698371|NCT00637689|Biomarkers|biomarkers
698372|NCT00637689|Response criteria|response criteria
698373|NCT00637689|Surrogate endpoints|surrogate endpoints
698374|NCT00637689|Natural history|natural history
698375|NCT00637676|malignant pleural effusion|malignant pleural effusion
698376|NCT00637676|subcutaneous tunneled drainage|subcutaneous tunneled drainage
698628|NCT00636935|HIV|hiv
698378|NCT00637663|Chronic hepatitis B|chronic hepatitis b
698379|NCT00637663|Lamivudine|lamivudine
698380|NCT00637663|Entecavir|entecavir
698381|NCT00637637|tumors metastatic to brain|tumors metastatic to brain
698382|NCT00637637|stage IV adenoid cystic carcinoma of the oral cavity|stage iv adenoid cystic carcinoma of the oral cavity
698383|NCT00637637|stage IV adrenocortical carcinoma|stage iv adrenocortical carcinoma
698384|NCT00637637|stage IV adult Burkitt lymphoma|stage iv adult burkitt lymphoma
698385|NCT00637637|stage IV adult diffuse large cell lymphoma|stage iv adult diffuse large cell lymphoma
698386|NCT00637637|stage IV adult diffuse mixed cell lymphoma|stage iv adult diffuse mixed cell lymphoma
698387|NCT00637637|stage IV adult diffuse small cleaved cell lymphoma|stage iv adult diffuse small cleaved cell lymphoma
698388|NCT00637637|stage IV adult Hodgkin lymphoma|stage iv adult hodgkin lymphoma
698389|NCT00637637|stage IV adult immunoblastic large cell lymphoma|stage iv adult immunoblastic large cell lymphoma
698390|NCT00637637|stage IV adult lymphoblastic lymphoma|stage iv adult lymphoblastic lymphoma
698391|NCT00637637|stage IV adult T-cell leukemia/lymphoma|stage iv adult t-cell leukemia/lymphoma
698392|NCT00637637|stage IV anal cancer|stage iv anal cancer
698393|NCT00637637|stage IV basal cell carcinoma of the lip|stage iv basal cell carcinoma of the lip
698394|NCT00637637|stage IV bladder cancer|stage iv bladder cancer
698395|NCT00637637|stage IV borderline ovarian surface epithelial-stromal tumor|stage iv borderline ovarian surface epithelial-stromal tumor
698396|NCT00637637|stage IV breast cancer|stage iv breast cancer
698397|NCT00637637|stage IV childhood anaplastic large cell lymphoma|stage iv childhood anaplastic large cell lymphoma
698398|NCT00637637|stage IV childhood Hodgkin lymphoma|stage iv childhood hodgkin lymphoma
698399|NCT00637637|stage IV childhood large cell lymphoma|stage iv childhood large cell lymphoma
698400|NCT00637637|stage IV childhood liver cancer|stage iv childhood liver cancer
698401|NCT00637637|stage IV childhood lymphoblastic lymphoma|stage iv childhood lymphoblastic lymphoma
698402|NCT00637637|stage IV childhood small noncleaved cell lymphoma|stage iv childhood small noncleaved cell lymphoma
698403|NCT00637637|stage IV chronic lymphocytic leukemia|stage iv chronic lymphocytic leukemia
698404|NCT00637637|stage IV colon cancer|stage iv colon cancer
698405|NCT00637637|stage IV cutaneous T-cell non-Hodgkin lymphoma|stage iv cutaneous t-cell non-hodgkin lymphoma
698406|NCT00637637|stage IV esophageal cancer|stage iv esophageal cancer
698407|NCT00637637|stage IV esthesioneuroblastoma of the paranasal sinus and nasal cavity|stage iv esthesioneuroblastoma of the paranasal sinus and nasal cavity
698408|NCT00637637|stage IV follicular thyroid cancer|stage iv follicular thyroid cancer
698409|NCT00637637|stage IV gastric cancer|stage iv gastric cancer
698410|NCT00637637|stage IV grade 1 follicular lymphoma|stage iv grade 1 follicular lymphoma
698411|NCT00637637|stage IV grade 2 follicular lymphoma|stage iv grade 2 follicular lymphoma
698412|NCT00637637|stage IV grade 3 follicular lymphoma|stage iv grade 3 follicular lymphoma
698413|NCT00637637|stage IV hypopharyngeal cancer|stage iv hypopharyngeal cancer
698414|NCT00637637|stage IV inverted papilloma of the paranasal sinus and nasal cavity|stage iv inverted papilloma of the paranasal sinus and nasal cavity
698415|NCT00637637|stage IV laryngeal cancer|stage iv laryngeal cancer
698416|NCT00637637|stage IV lip and oral cavity cancer|stage iv lip and oral cavity cancer
698417|NCT00637637|stage IV lymphoepithelioma of the nasopharynx|stage iv lymphoepithelioma of the nasopharynx
698418|NCT00637637|stage IV lymphoepithelioma of the oropharynx|stage iv lymphoepithelioma of the oropharynx
698419|NCT00637637|stage IV mantle cell lymphoma|stage iv mantle cell lymphoma
698420|NCT00637637|stage IV marginal zone lymphoma|stage iv marginal zone lymphoma
698421|NCT00637637|stage IV midline lethal granuloma of the paranasal sinus and nasal cavity|stage iv midline lethal granuloma of the paranasal sinus and nasal cavity
698422|NCT00637637|stage IV mucoepidermoid carcinoma of the oral cavity|stage iv mucoepidermoid carcinoma of the oral cavity
698423|NCT00637637|stage IV mycosis fungoides/Sezary syndrome|stage iv mycosis fungoides/sezary syndrome
698424|NCT00637637|stage IV nasopharyngeal cancer|stage iv nasopharyngeal cancer
698425|NCT00637637|stage IV non-small cell lung cancer|stage iv non-small cell lung cancer
698426|NCT00637637|stage IV oropharyngeal cancer|stage iv oropharyngeal cancer
698427|NCT00637637|stage IV ovarian epithelial cancer|stage iv ovarian epithelial cancer
698428|NCT00637637|stage IV pancreatic cancer|stage iv pancreatic cancer
698429|NCT00637637|stage IV papillary thyroid cancer|stage iv papillary thyroid cancer
698430|NCT00637637|stage IV paranasal sinus and nasal cavity cancer|stage iv paranasal sinus and nasal cavity cancer
698431|NCT00637637|stage IV penile cancer|stage iv penile cancer
698432|NCT00637637|stage IV prostate cancer|stage iv prostate cancer
698433|NCT00637637|stage IV rectal cancer|stage iv rectal cancer
698434|NCT00637637|stage IV renal cell cancer|stage iv renal cell cancer
698435|NCT00637637|stage IV salivary gland cancer|stage iv salivary gland cancer
698436|NCT00637637|stage IV small lymphocytic lymphoma|stage iv small lymphocytic lymphoma
698437|NCT00637637|stage IV squamous cell carcinoma of the hypopharynx|stage iv squamous cell carcinoma of the hypopharynx
698438|NCT00637637|stage IV squamous cell carcinoma of the larynx|stage iv squamous cell carcinoma of the larynx
698439|NCT00637637|stage IV squamous cell carcinoma of the lip and oral cavity|stage iv squamous cell carcinoma of the lip and oral cavity
698440|NCT00637637|stage IV squamous cell carcinoma of the nasopharynx|stage iv squamous cell carcinoma of the nasopharynx
698441|NCT00637637|stage IV squamous cell carcinoma of the oropharynx|stage iv squamous cell carcinoma of the oropharynx
698442|NCT00637637|stage IV squamous cell carcinoma of the paranasal sinus and nasal cavity|stage iv squamous cell carcinoma of the paranasal sinus and nasal cavity
698443|NCT00637637|stage IV endometrial carcinoma|stage iv endometrial carcinoma
698444|NCT00637637|stage IV verrucous carcinoma of the larynx|stage iv verrucous carcinoma of the larynx
698445|NCT00637637|stage IV verrucous carcinoma of the oral cavity|stage iv verrucous carcinoma of the oral cavity
698446|NCT00637637|stage IVB vulvar cancer|stage ivb vulvar cancer
698447|NCT00637637|stage IV Wilms tumor|stage iv wilms tumor
698448|NCT00637637|stage IVB cervical cancer|stage ivb cervical cancer
698449|NCT00637637|stage IVB vaginal cancer|stage ivb vaginal cancer
698450|NCT00637637|metastatic adult malignant fibrous histiocytoma of bone|metastatic adult malignant fibrous histiocytoma of bone
698451|NCT00637637|metastatic childhood malignant fibrous histiocytoma of bone|metastatic childhood malignant fibrous histiocytoma of bone
698452|NCT00637637|metastatic gastrointestinal carcinoid tumor|metastatic gastrointestinal carcinoid tumor
698453|NCT00637637|metastatic parathyroid cancer|metastatic parathyroid cancer
698454|NCT00637637|metastatic pheochromocytoma|metastatic pheochromocytoma
698455|NCT00637637|metastatic squamous neck cancer with occult primary squamous cell carcinoma|metastatic squamous neck cancer with occult primary squamous cell carcinoma
698456|NCT00637637|metastatic squamous neck cancer with occult primary|metastatic squamous neck cancer with occult primary
698457|NCT00637637|metastatic transitional cell cancer of the renal pelvis and ureter|metastatic transitional cell cancer of the renal pelvis and ureter
698458|NCT00637637|disseminated neuroblastoma|disseminated neuroblastoma
698459|NCT00637637|unspecified adult solid tumor, protocol specific|unspecified adult solid tumor, protocol specific
698460|NCT00637637|unspecified childhood solid tumor, protocol specific|unspecified childhood solid tumor, protocol specific
698461|NCT00637637|tongue cancer|tongue cancer
698462|NCT00637624|Acetylcysteine|acetylcysteine
698463|NCT00637624|Cisplatin|cisplatin
698464|NCT00637624|Neuropathy|neuropathy
698465|NCT00637624|Antioxidants|antioxidants
698466|NCT00637598|Diagnostic Imaging|diagnostic imaging
698467|NCT00637598|Mammography|mammography
698468|NCT00637598|Breast Tomosynthesis|breast tomosynthesis
698469|NCT00637572|Weight loss|weight loss
698470|NCT00637572|Cachexia|cachexia
698471|NCT00637572|Anorexia|anorexia
698596|NCT00637039|Solid tumour|solid tumour
698472|NCT00637572|Megestrol acetate oral suspension|megestrol acetate oral suspension
698473|NCT00637572|Nanocrystal dispersion|nanocrystal dispersion
698474|NCT00637572|Nanocrystal technology|nanocrystal technology
698475|NCT00637572|Body weight changes|body weight changes
698476|NCT00637572|AIDS wasting|aids wasting
698477|NCT00637572|HIV wasting|hiv wasting
698478|NCT00637572|Emaciation|emaciation
698479|NCT00637572|Megace ES|megace es
698480|NCT00637572|Megace|megace
698481|NCT00637572|Treatment Experienced|treatment experienced
698482|NCT00637559|Nexium|nexium
698483|NCT00637559|Barrett's esophagus|barrett's esophagus
698484|NCT00637546|Treatment|treatment
698485|NCT00637546|Efficacy|efficacy
698486|NCT00637546|Diabetes|diabetes
698487|NCT00637546|Gait|gait
698488|NCT00637546|Balance|balance
698489|NCT00637520|Nonalcoholic Fatty Liver Disease|nonalcoholic fatty liver disease
698490|NCT00637520|Insulin Resistance|insulin resistance
698491|NCT00637520|Lipid Metabolism|lipid metabolism
698492|NCT00637507|High-Frequency Ventilation|high-frequency ventilation
698493|NCT00637507|Tracheal Gas Insufflation|tracheal gas insufflation
698494|NCT00637507|Respiration, Artificial|respiration, artificial
698495|NCT00637507|Respiratory Distress Syndrome|respiratory distress syndrome
698496|NCT00637507|Adult|adult
698497|NCT00637494|psychotic depression|psychotic depression
698498|NCT00637494|major depression with psychotic features|major depression with psychotic features
698499|NCT00637494|psychosis|psychosis
698500|NCT00637416|horseness|horseness
698501|NCT00637403|renal impairment|renal impairment
698502|NCT00637403|end stage renal disease|end stage renal disease
698503|NCT00637403|megestrol acetate|megestrol acetate
698504|NCT00637403|pharmacokinetics|pharmacokinetics
698505|NCT00637403|hemodialysis|hemodialysis
698506|NCT00637403|renal dialysis|renal dialysis
698507|NCT00637403|kidney failure, chronic|kidney failure, chronic
698508|NCT00637403|renal insufficiency|renal insufficiency
698509|NCT00637403|Megace ES|megace es
698510|NCT00637377|Eye diseases|eye diseases
698511|NCT00637377|Vision Impairment and Blindness|vision impairment and blindness
698512|NCT00637377|Eyes and Vision|eyes and vision
698513|NCT00637377|Seniors|seniors
698514|NCT00637377|Neovascular Age-Related Macular Degeneration (AMD)|neovascular age-related macular degeneration (amd)
698515|NCT00637377|Retinal Disease|retinal disease
698516|NCT00637364|pain|pain
698517|NCT00637364|pancreas|pancreas
698518|NCT00637364|pancreatic cancer|pancreatic cancer
698519|NCT00637364|pancreatic adenocarcinoma|pancreatic adenocarcinoma
698520|NCT00637364|ductal adenocarcinoma|ductal adenocarcinoma
698521|NCT00637338|Long-acting GLP-1 Diabetes|long-acting glp-1 diabetes
698522|NCT00637325|trastuzumab optimization in breast cancer|trastuzumab optimization in breast cancer
698523|NCT00637299|COPD|copd
698524|NCT00637286|Zolmitriptan|zolmitriptan
698525|NCT00637286|ZOMIG|zomig
698526|NCT00637286|migraine|migraine
698527|NCT00637286|headache response|headache response
698528|NCT00637286|headache|headache
698529|NCT00637286|headache pain|headache pain
698530|NCT00637286|MIDAS|midas
698531|NCT00637286|HCPC|hcpc
698532|NCT00637273|diabetes|diabetes
698533|NCT00637273|exenatide once weekly|exenatide once weekly
698534|NCT00637273|Byetta|byetta
698535|NCT00637273|sitagliptin|sitagliptin
698536|NCT00637273|Januvia|januvia
698537|NCT00637273|thiazolidinedione|thiazolidinedione
698538|NCT00637273|Amylin|amylin
698539|NCT00637273|Lilly|lilly
698540|NCT00637273|Pioglitazone|pioglitazone
698541|NCT00637260|motorcortex stimulation|motorcortex stimulation
698542|NCT00637260|Parkinson's disease|parkinson's disease
698543|NCT00637260|neuromodulation|neuromodulation
698544|NCT00637247|pancreatic cancer|pancreatic cancer
698545|NCT00637247|metastatic|metastatic
698546|NCT00637247|chemotherapy naive|chemotherapy naive
698547|NCT00637221|Safety|safety
698548|NCT00637221|Tolerability|tolerability
698549|NCT00637208|prostate cancer|prostate cancer
698550|NCT00637208|venography|venography
698551|NCT00637208|male patients|male patients
698552|NCT00637208|Localized microscopic prostate cancer up to Gleason 6 (3+3)|localized microscopic prostate cancer up to gleason 6 (3+3)
698553|NCT00637208|PSA level <14|psa level <14
698554|NCT00637208|presence of varicocele|presence of varicocele
698555|NCT00637195|Human papillomavirus (HPV) vaccine|human papillomavirus (hpv) vaccine
698556|NCT00637195|Hepatitis B|hepatitis b
698557|NCT00637195|Cervical cancer|cervical cancer
698558|NCT00637195|HPV|hpv
698559|NCT00637195|Papillomavirus|papillomavirus
698560|NCT00637182|Gynecomastia|gynecomastia
698561|NCT00637182|Anastrazole|anastrazole
698562|NCT00637182|Arimidex|arimidex
698563|NCT00637182|Pubertal|pubertal
698564|NCT00637182|males|males
698565|NCT00637182|boys|boys
698566|NCT00637169|oxygen therapy|oxygen therapy
698567|NCT00637169|neurodevelopmental impairment|neurodevelopmental impairment
698568|NCT00637156|Symptomatic DDD at Two Adjacent Levels of cervical spine|symptomatic ddd at two adjacent levels of cervical spine
698569|NCT00637143|Renal transplant|renal transplant
698570|NCT00637143|Cyclosporine|cyclosporine
698571|NCT00637143|Tacrolimus|tacrolimus
698572|NCT00637143|Intervention|intervention
698573|NCT00637143|Interstitial Fibrosis Tubular Atrophy|interstitial fibrosis tubular atrophy
698574|NCT00637143|Chronic Renal Allograft Failure|chronic renal allograft failure
698575|NCT00637117|Lymphoma, Dendritic, Vaccine, Radiotherapy|lymphoma, dendritic, vaccine, radiotherapy
698576|NCT00637104|percutaneous transluminal coronary angioplasty|percutaneous transluminal coronary angioplasty
698577|NCT00637104|stents|stents
698578|NCT00637104|restenosis|restenosis
698579|NCT00637104|biocompatible materials|biocompatible materials
698580|NCT00637104|ceramics|ceramics
698581|NCT00637078|hypertension|hypertension
698582|NCT00637078|hypercholesterolemia|hypercholesterolemia
698583|NCT00637078|family physicians|family physicians
698584|NCT00637078|fixed dose combination therapy|fixed dose combination therapy
698585|NCT00637078|cluster randomized controlled trial|cluster randomized controlled trial
698586|NCT00637065|Pulmonary hypertension|pulmonary hypertension
698587|NCT00637065|Interstitial lung disease|interstitial lung disease
698588|NCT00637065|Idiopathic pulmonary fibrosis|idiopathic pulmonary fibrosis
698589|NCT00637065|Nonspecific interstitial pneumonia|nonspecific interstitial pneumonia
698590|NCT00637065|Bosentan|bosentan
698591|NCT00637065|Endothelin receptor antagonists|endothelin receptor antagonists
698592|NCT00637065|Pulmonary vascular resistance|pulmonary vascular resistance
698593|NCT00637052|preleukemia|preleukemia
698594|NCT00637052|dysplasia of myeloid blood cells|dysplasia of myeloid blood cells
698595|NCT00637039|Advanced cancer|advanced cancer
698597|NCT00637039|Solid malignancies|solid malignancies
698598|NCT00637039|Neoplasms|neoplasms
698599|NCT00637026|Iressa, Gefitinib, Breast Cancer, Surgery|iressa, gefitinib, breast cancer, surgery
698600|NCT00637013|Subacromial impingement|subacromial impingement
698601|NCT00637013|Shoulder|shoulder
698603|NCT00637013|Effectiveness|effectiveness
698604|NCT00637013|Cost-effectiveness|cost-effectiveness
698605|NCT00637000|Opioid dependence|opioid dependence
698606|NCT00637000|Opioid withdrawal symptoms|opioid withdrawal symptoms
698607|NCT00636987|aortic valve|aortic valve
698608|NCT00636987|mitral valve|mitral valve
698609|NCT00636987|heart valve|heart valve
698610|NCT00636987|tissue valve|tissue valve
698611|NCT00636987|bioprosthesis|bioprosthesis
698612|NCT00636987|valve disorder|valve disorder
698613|NCT00636987|valve disease|valve disease
698614|NCT00636987|cardiac surgery|cardiac surgery
698615|NCT00636987|aortic valve regurgitation|aortic valve regurgitation
698616|NCT00636987|aortic valve stenosis|aortic valve stenosis
698617|NCT00636987|mitral valve regurgitation|mitral valve regurgitation
698618|NCT00636987|mitral valve stenosis|mitral valve stenosis
698619|NCT00636974|Patients who are going to have regional anaesthesia for lower limbs surgery.|patients who are going to have regional anaesthesia for lower limbs surgery.
698620|NCT00636974|Leg Surgery.|leg surgery.
698621|NCT00636961|COPD, Indacaterol Maleate, Exercise testing|copd, indacaterol maleate, exercise testing
698622|NCT00636948|Rectal cancer surgery|rectal cancer surgery
698623|NCT00636948|Symptomatic anastomotic leakage|symptomatic anastomotic leakage
698624|NCT00636948|Defunctioning stoma|defunctioning stoma
698625|NCT00636948|TME surgery|tme surgery
698626|NCT00636935|Pneumocystis jirovecii Pneumonia|pneumocystis jirovecii pneumonia
698627|NCT00636935|Corticosteroid Therapy|corticosteroid therapy
698629|NCT00636935|Pneumonia|pneumonia
698630|NCT00636935|Pulmonary Function Testing|pulmonary function testing
698631|NCT00636935|Antibiotics|antibiotics
698632|NCT00636935|Prednisone|prednisone
698633|NCT00636935|Human Immunodeficiency Virus|human immunodeficiency virus
698634|NCT00636935|CD4|cd4
698635|NCT00636935|CD8|cd8
698636|NCT00636935|Viral Load|viral load
698637|NCT00636935|Bactrim|bactrim
698638|NCT00636935|Pentamidine|pentamidine
698639|NCT00636935|Atovaquone|atovaquone
698640|NCT00636935|Primaquine/Clindamycin|primaquine/clindamycin
698641|NCT00636935|Trimethoprim/Dapsone|trimethoprim/dapsone
698642|NCT00636922|Acute Myeloid Leukemia|acute myeloid leukemia
698643|NCT00636922|Elderly|elderly
698644|NCT00636922|Unfit|unfit
698645|NCT00636922|Everolimus|everolimus
698646|NCT00636922|RAD001|rad001
698647|NCT00636909|AML|aml
698648|NCT00636909|ALL|all
698649|NCT00636909|CML|cml
698650|NCT00636909|CLL|cll
698651|NCT00636909|MDS|mds
698652|NCT00636909|NHL|nhl
698653|NCT00636909|HODGKIN'S LYMPHOMA|hodgkin's lymphoma
698654|NCT00636909|APLASTIC ANEMIA|aplastic anemia
698655|NCT00636909|MULTIPLE MYELOMA|multiple myeloma
698656|NCT00636909|MYELOPROLIFERATIVE DISORDER|myeloproliferative disorder
698657|NCT00636909|ALLOGENEIC|allogeneic
698658|NCT00636909|STEM CELL TRANSPLANT|stem cell transplant
698659|NCT00636909|HEMATOLOGIC DISORDERS|hematologic disorders
698660|NCT00636909|CYCLOPHOSPHAMIDE|cyclophosphamide
698661|NCT00636909|FLUDARABINE|fludarabine
698662|NCT00636909|CYCLOSPORINE|cyclosporine
698663|NCT00636909|METHOTREXATE|methotrexate
698664|NCT00636909|G-CSF|g-csf
698665|NCT00636909|GVHD|gvhd
698666|NCT00636909|ENGRAFTMENT|engraftment
698667|NCT00636909|CHIMERISM|chimerism
698668|NCT00636896|weight gain|weight gain
698669|NCT00636896|olanzapine|olanzapine
698670|NCT00636896|atypical antipsychotic|atypical antipsychotic
698671|NCT00636883|Pancreatic cancer|pancreatic cancer
698672|NCT00636857|Water-Electrolyte Imbalance|water-electrolyte imbalance
698673|NCT00636844|chemotherapy, cardiotoxicity|chemotherapy, cardiotoxicity
698674|NCT00636831|Prophylactic|prophylactic
698675|NCT00636831|Antibiotic|antibiotic
698676|NCT00636831|Infection|infection
698677|NCT00636831|Primary case|primary case
698678|NCT00636805|Aloxi|aloxi
698679|NCT00636805|Brain Neoplasm, Primary|brain neoplasm, primary
698680|NCT00636805|Brain Neoplasms, Malignant|brain neoplasms, malignant
698681|NCT00636766|cardiovascular events|cardiovascular events
698682|NCT00636753|Metabolic and endocrine changes in schizophrenic patients by antipsychotics treatment.|metabolic and endocrine changes in schizophrenic patients by antipsychotics treatment.
698683|NCT00636740|Prostate cancer, hormone resistant, bisphosphonate|prostate cancer, hormone resistant, bisphosphonate
698684|NCT00636727|arthrocentesis|arthrocentesis
698685|NCT00636727|arthroscopy|arthroscopy
698686|NCT00636727|arthroplasty|arthroplasty
698687|NCT00636714|intensive insulin therapy|intensive insulin therapy
698688|NCT00636714|glucose control|glucose control
698689|NCT00636714|nurse directed|nurse directed
698690|NCT00636714|nomogram directed|nomogram directed
698691|NCT00636701|Cerebrovascular Accident|cerebrovascular accident
698692|NCT00636701|rehabilitation|rehabilitation
698693|NCT00636688|Obesity|obesity
698694|NCT00636688|Lifestyle changes|lifestyle changes
698695|NCT00636675|Accidental falls|accidental falls
698696|NCT00636649|Eating disorder|eating disorder
698697|NCT00636636|Postherpetic Neuralgia (PHN), shingles|postherpetic neuralgia (phn), shingles
698698|NCT00636623|Pilates Exercises|pilates exercises
698699|NCT00636623|Connective Tissue Massage|connective tissue massage
698700|NCT00636610|Hedgehog|hedgehog
698701|NCT00636610|CRC|crc
698702|NCT00636610|Colorectal Cancer|colorectal cancer
698703|NCT00636610|Hedgehog Pathway Inhibitor|hedgehog pathway inhibitor
698704|NCT00636584|sodium nitroprusside|sodium nitroprusside
698705|NCT00636584|thyroid hormones|thyroid hormones
698706|NCT00636584|thoracic surgery|thoracic surgery
698707|NCT00636571|Exercise|exercise
698708|NCT00636571|Non-Small Cell Lung Cancer|non-small cell lung cancer
698709|NCT00636571|Cardiopulmonary Fitness|cardiopulmonary fitness
698710|NCT00636558|coxsackie virus|coxsackie virus
698711|NCT00636558|melanoma|melanoma
698712|NCT00636558|breast cancer|breast cancer
698713|NCT00636558|prostate cancer|prostate cancer
698714|NCT00636545|Genasense|genasense
698715|NCT00636545|oblimersen|oblimersen
698716|NCT00636545|antisense|antisense
698717|NCT00636545|Bcl-2 antisense|bcl-2 antisense
698718|NCT00636545|Solid Tumors|solid tumors
698719|NCT00636519|Botulism Antitoxin,Heptavalent,Bivalent,EDB Muscle,Paralysis|botulism antitoxin,heptavalent,bivalent,edb muscle,paralysis
698720|NCT00636506|Erectile dysfunction|erectile dysfunction
698721|NCT00636506|Impotence|impotence
698722|NCT00636493|retinal vein occlusion|retinal vein occlusion
698723|NCT00636493|sustained drug delivery implant|sustained drug delivery implant
698724|NCT00636493|steroid|steroid
698725|NCT00636493|macular edema|macular edema
698726|NCT00636480|Antimicrobial|antimicrobial
698727|NCT00636480|Antisepsis|antisepsis
698728|NCT00636467|Breast cancer (tumors> 2 cm)|breast cancer (tumors> 2 cm)
698729|NCT00636467|Detection|detection
698832|NCT00635973|Cancer|cancer
698730|NCT00636467|Axillary sentinel lymph node|axillary sentinel lymph node
698731|NCT00636454|OA|oa
698732|NCT00636454|Pain|pain
698733|NCT00636454|Cognitive Therapy|cognitive therapy
698734|NCT00636454|Behavior Therapy|behavior therapy
698735|NCT00636454|Knee OA|knee oa
698736|NCT00636454|Hip OA|hip oa
698737|NCT00636441|Early-Stage Breast Cancer|early-stage breast cancer
698738|NCT00636441|Preoperative systemic chemotherapy (PST)|preoperative systemic chemotherapy (pst)
698739|NCT00636441|Genomic|genomic
698740|NCT00636441|Genomic Predictor|genomic predictor
698741|NCT00636441|Genomic Expression Profiles|genomic expression profiles
698742|NCT00636441|Randomized|randomized
698743|NCT00636441|Pathologic complete response (pCR)|pathologic complete response (pcr)
698744|NCT00636441|HER2 negative|her2 negative
698745|NCT00636441|Doxorubicin and docetaxel|doxorubicin and docetaxel
698746|NCT00636441|Doxorubicin and cyclophosphamide|doxorubicin and cyclophosphamide
698747|NCT00636428|endoscopy|endoscopy
698748|NCT00636428|Midazolam|midazolam
698749|NCT00636428|pediatric|pediatric
698750|NCT00636428|sedation|sedation
698751|NCT00636428|comfort|comfort
698752|NCT00636415|Analgesia|analgesia
698753|NCT00636415|Morphine|morphine
698754|NCT00636415|Bupivacaine|bupivacaine
698755|NCT00636415|Osteoarthritis|osteoarthritis
698756|NCT00636415|Knee|knee
698757|NCT00636402|Vessel Sealing System|vessel sealing system
698758|NCT00636402|Cold Knife|cold knife
698759|NCT00636402|Tonsillectomy|tonsillectomy
698760|NCT00636402|Pain|pain
698761|NCT00636402|Postoperative|postoperative
698762|NCT00636389|Hemodialysis|hemodialysis
698763|NCT00636389|Dialysis, Renal|dialysis, renal
698764|NCT00636389|Dialysis, Extracorporeal|dialysis, extracorporeal
698765|NCT00636389|Extracorporeal Dialysis|extracorporeal dialysis
698766|NCT00636376|elevated intracranial pressure|elevated intracranial pressure
698767|NCT00636376|inadequate cerebral perfusion|inadequate cerebral perfusion
698768|NCT00636376|secondary brain damage|secondary brain damage
698769|NCT00636350|pepper carotenoids|pepper carotenoids
698770|NCT00636350|xanthophylls|xanthophylls
698771|NCT00636350|healthy volunteers|healthy volunteers
698772|NCT00636337|Pediatric|pediatric
698773|NCT00636337|Brain Tumor|brain tumor
698774|NCT00636337|Acute Lymphoblastic Leukemia|acute lymphoblastic leukemia
698775|NCT00636337|Inattention|inattention
698776|NCT00636337|Childhood cancer survivors|childhood cancer survivors
698777|NCT00636324|Respiratory distress syndrome|respiratory distress syndrome
698778|NCT00636324|Preterm infants|preterm infants
698779|NCT00636324|Extubation failure|extubation failure
698780|NCT00636324|Pneumothorax|pneumothorax
698781|NCT00636324|Lung injury|lung injury
698782|NCT00636324|Airway pressure|airway pressure
698783|NCT00636311|Hodgkin disease|hodgkin disease
698784|NCT00636311|Salvage therapy|salvage therapy
698785|NCT00636311|Bortezomib|bortezomib
698786|NCT00636311|Transplantation|transplantation
698787|NCT00636298|esophageal carcinoma|esophageal carcinoma
698788|NCT00636298|cancer of the esophagus|cancer of the esophagus
698789|NCT00636298|locally advanced or metastatic esophageal cancer|locally advanced or metastatic esophageal cancer
698790|NCT00636285|A110|a110
698791|NCT00636285|Safety|safety
698792|NCT00636272|ICD|icd
698793|NCT00636272|CRT-D|crt-d
698794|NCT00636259|Prostate cancer|prostate cancer
698795|NCT00636259|Casodex|casodex
698796|NCT00636233|anencephaly|anencephaly
698797|NCT00636233|acrania|acrania
698798|NCT00636220|HIV-1 Infections|hiv-1 infections
698799|NCT00636155|Small Lymphocytic Lymphoma|small lymphocytic lymphoma
698800|NCT00636155|Chronic Lymphocytic Leukemia|chronic lymphocytic leukemia
698801|NCT00636155|EL625|el625
698802|NCT00636155|cenersen|cenersen
698803|NCT00636129|relaxation|relaxation
698804|NCT00636129|relaxation response|relaxation response
698805|NCT00636129|meditation|meditation
698806|NCT00636129|nitric oxide|nitric oxide
698807|NCT00636129|stress management|stress management
698808|NCT00636129|stress|stress
698809|NCT00636129|Relaxation Techniques|relaxation techniques
698810|NCT00636116|snake bite|snake bite
698811|NCT00636116|antivenin treatment|antivenin treatment
698812|NCT00636103|Traditional Chinese Medicine|traditional chinese medicine
698813|NCT00636103|Asthma|asthma
698814|NCT00636103|Paediatric|paediatric
698815|NCT00636077|Hemodialysis|hemodialysis
698816|NCT00636077|Dialysis, Renal|dialysis, renal
698817|NCT00636051|evidence based practice beliefs|evidence based practice beliefs
698818|NCT00636051|evidence based practice implementation|evidence based practice implementation
698819|NCT00636051|evidence based practice dissemination|evidence based practice dissemination
698820|NCT00636038|beta-carotene|beta-carotene
698821|NCT00636038|yellow maize|yellow maize
698822|NCT00636038|vitamin A|vitamin a
698823|NCT00636012|acupuncture|acupuncture
698824|NCT00636012|Acupuncture points|acupuncture points
698825|NCT00635986|Analgesia|analgesia
698826|NCT00635986|Fentanyl|fentanyl
698827|NCT00635986|Orthopedic|orthopedic
698828|NCT00635986|Mechanism of action|mechanism of action
698829|NCT00635986|Surgery|surgery
698830|NCT00635973|Iressa|iressa
698831|NCT00635973|Gefitinib|gefitinib
698833|NCT00635973|Patients diagnosed with cancer who have previously received Iressa in an Iressa clinical trial|patients diagnosed with cancer who have previously received iressa in an iressa clinical trial
698834|NCT00635960|Amyotrophic Lateral Sclerosis|amyotrophic lateral sclerosis
698835|NCT00635960|ALS|als
698836|NCT00635960|Growth Hormone|growth hormone
698837|NCT00635960|IGF-I|igf-i
698838|NCT00635947|Amniotic fluid index|amniotic fluid index
698839|NCT00635947|maternal hydration|maternal hydration
698840|NCT00635947|isotonic solution|isotonic solution
698841|NCT00635947|Amniotic Fluid|amniotic fluid
698842|NCT00635934|Lumbar Degenerative Disc Disease at One Level from L4-S1|lumbar degenerative disc disease at one level from l4-s1
698843|NCT00635921|Borderline Personality Disorder|borderline personality disorder
698844|NCT00635921|ziprasidone|ziprasidone
698845|NCT00635895|Fibromyalgia|fibromyalgia
698846|NCT00635895|Manual Lymphatic Drainage|manual lymphatic drainage
698847|NCT00635895|Connective Tissue Massage|connective tissue massage
698848|NCT00635895|Pain|pain
698849|NCT00635895|Health Related Quality of Life|health related quality of life
698850|NCT00635895|Randomized Controlled Trial|randomized controlled trial
698851|NCT00635882|mometasone|mometasone
698852|NCT00635882|formoterol|formoterol
698853|NCT00635869|evidence based practice beliefs|evidence based practice beliefs
698854|NCT00635869|evidence based practice implementation|evidence based practice implementation
698855|NCT00635869|evidence based practice knowledge|evidence based practice knowledge
698856|NCT00635869|nurse physician collaboration|nurse physician collaboration
698857|NCT00635856|Iressa|iressa
698858|NCT00635856|Gefitinib|gefitinib
698859|NCT00635856|Prostate Cancer|prostate cancer
698861|NCT00635843|Lumbar degenerative disc disease at one level from L4-S1|lumbar degenerative disc disease at one level from l4-s1
698862|NCT00635817|CPP|cpp
698863|NCT00635817|central precocious puberty|central precocious puberty
698864|NCT00635817|pediatrics|pediatrics
698865|NCT00635817|suppression of luteinizing hormone|suppression of luteinizing hormone
698866|NCT00635817|Lupron|lupron
698867|NCT00635817|leuprolide acetate|leuprolide acetate
698868|NCT00635817|depot formulation|depot formulation
698869|NCT00635817|GnRHa|gnrha
698870|NCT00635817|GnRH agonist|gnrh agonist
698871|NCT00635817|GnRH analog|gnrh analog
698872|NCT00635817|luteinizing hormone|luteinizing hormone
698873|NCT00635791|Malignant Solid Tumour|malignant solid tumour
698874|NCT00635791|Renal cell carcinoma|renal cell carcinoma
698875|NCT00635791|Non small cell lung carcinoma|non small cell lung carcinoma
698876|NCT00635765|Acromegaly|acromegaly
698877|NCT00635752|TF-CBT|tf-cbt
698878|NCT00635752|Effectiveness study|effectiveness study
698879|NCT00635752|Trauma|trauma
698880|NCT00635752|Therapy|therapy
698881|NCT00635739|Whey protein|whey protein
698882|NCT00635739|Resistance exercise|resistance exercise
698883|NCT00635739|Physical activity|physical activity
698884|NCT00635739|Mobility disability|mobility disability
698885|NCT00635739|Physical function|physical function
698886|NCT00635739|Muscle mass|muscle mass
698887|NCT00635739|Muscle strength|muscle strength
698888|NCT00635739|Older Adults|older adults
698889|NCT00635739|Mobility-Limited|mobility-limited
698890|NCT00635726|Bladder Cancer|bladder cancer
698891|NCT00635713|Advanced breast cancer, FASLODEX, ARIMIDEX, Fulvestrant, Anastrozole, postmenopausal|advanced breast cancer, faslodex, arimidex, fulvestrant, anastrozole, postmenopausal
698892|NCT00635700|psychosis|psychosis
698893|NCT00635700|schizophrenia|schizophrenia
698894|NCT00635700|prodrome|prodrome
698895|NCT00635700|ziprasidone|ziprasidone
698896|NCT00635700|placebo|placebo
698897|NCT00635687|variceal bleeding|variceal bleeding
698898|NCT00635687|transient elastography|transient elastography
698899|NCT00635674|sleep apnea|sleep apnea
698900|NCT00635674|risk factors|risk factors
698901|NCT00635674|continuous positive airway pressure|continuous positive airway pressure
698902|NCT00635674|insulin resistance|insulin resistance
698903|NCT00635674|metabolic syndrome|metabolic syndrome
698904|NCT00635674|compliance|compliance
698905|NCT00635661|function|function
698906|NCT00635661|disability|disability
698907|NCT00635635|Stress Disorders, Post-Traumatic|stress disorders, post-traumatic
698908|NCT00635635|Anxiety,|anxiety,
698909|NCT00635635|Depression,|depression,
698910|NCT00635635|Guided Imagery|guided imagery
698911|NCT00635635|Military Sexual Trauma|military sexual trauma
698912|NCT00635622|Bacterial Vaginosis|bacterial vaginosis
698913|NCT00635622|BV|bv
698914|NCT00635622|UCSF|ucsf
698915|NCT00635622|SFGH|sfgh
698916|NCT00635596|MT110|mt110
698917|NCT00635596|solid tumors|solid tumors
698918|NCT00635596|phase I|phase i
698919|NCT00635596|BiTE|bite
698920|NCT00635596|bispecific T-cell engager|bispecific t-cell engager
698921|NCT00635583|Bone|bone
698922|NCT00635583|Dairy Intervention|dairy intervention
698923|NCT00635583|Girls|girls
698924|NCT00635583|Boys|boys
698925|NCT00635583|Calcium|calcium
698926|NCT00635583|Bone Mineralization|bone mineralization
698927|NCT00635583|Peak Bone Mass|peak bone mass
698928|NCT00635583|Bone and Bones|bone and bones
698929|NCT00635583|Female|female
698930|NCT00635583|Male|male
698931|NCT00635583|Adolescent|adolescent
698932|NCT00635583|Healthy|healthy
698933|NCT00635570|Contraception, Compliance, Acceptability|contraception, compliance, acceptability
698934|NCT00635557|Recurrent|recurrent
698935|NCT00635557|Relapsed|relapsed
698936|NCT00635557|Glioblastoma|glioblastoma
698937|NCT00635557|Multiforme|multiforme
698938|NCT00635544|Adolescence|adolescence
698939|NCT00635544|Overweight|overweight
698940|NCT00635544|Dietary Fiber|dietary fiber
698941|NCT00635544|Glycemic Index|glycemic index
698942|NCT00635544|Healthy lifestyle|healthy lifestyle
698943|NCT00635518|Health Plan Implementation|health plan implementation
698944|NCT00635518|Feeding and Eating Disorders of Childhood|feeding and eating disorders of childhood
698945|NCT00635518|Breast Feeding|breast feeding
698946|NCT00635518|Overweight|overweight
698947|NCT00635518|Child|child
698948|NCT00635518|Infant Nutrition Physiology|infant nutrition physiology
698949|NCT00635518|Public Health|public health
698950|NCT00635505|Asthma|asthma
698951|NCT00635505|albuterol|albuterol
698952|NCT00635505|HFA|hfa
698953|NCT00635492|diabetes|diabetes
698954|NCT00635492|insulin|insulin
698955|NCT00635492|exenatide|exenatide
698956|NCT00635492|Byetta|byetta
698957|NCT00635492|Amylin|amylin
698958|NCT00635492|Lilly|lilly
698959|NCT00635479|Fractures|fractures
698960|NCT00635479|Pelvic bones|pelvic bones
698961|NCT00635479|Acetabulum|acetabulum
698962|NCT00635479|Hip bones|hip bones
698963|NCT00635466|laparoscopic surgery, rectal carcinoma, phase II trial|laparoscopic surgery, rectal carcinoma, phase ii trial
698964|NCT00635453|Breast Feeding|breast feeding
698965|NCT00635453|Child|child
698966|NCT00635453|Infant Nutrition Physiology|infant nutrition physiology
698967|NCT00635453|Public Health|public health
698968|NCT00635453|Morbidity|morbidity
698969|NCT00635453|Health Plan Implementation|health plan implementation
698970|NCT00635440|skeletal muscle|skeletal muscle
698971|NCT00635440|ubiquitin|ubiquitin
698972|NCT00635440|proteasome|proteasome
698973|NCT00635440|IGF-1|igf-1
698974|NCT00635440|MGF|mgf
698975|NCT00635440|protein catabolism|protein catabolism
698976|NCT00635440|neuromuscular electrical stimulation|neuromuscular electrical stimulation
698977|NCT00635440|Investigate effect of NMES on muscle metabolism of catabolic patients|investigate effect of nmes on muscle metabolism of catabolic patients
698978|NCT00635427|VPRIV|vpriv
698979|NCT00635427|Enzyme Replacement Therapy|enzyme replacement therapy
698980|NCT00635427|Gaucher disease|gaucher disease
698981|NCT00635427|glucocerebrosidase|glucocerebrosidase
698982|NCT00635427|beta-glucocerebrosidase|beta-glucocerebrosidase
698983|NCT00635427|Acid beta-glucocerebrosidase|acid beta-glucocerebrosidase
698984|NCT00635427|glucosylceramidase|glucosylceramidase
698985|NCT00635427|D-glucosyl-N-acylsphingosine glucohydrolase|d-glucosyl-n-acylsphingosine glucohydrolase
698986|NCT00635427|gene activation|gene activation
698987|NCT00635427|human|human
698988|NCT00635414|Gastroesophageal Reflux Disease (GERD), esomeprazole, Nexium|gastroesophageal reflux disease (gerd), esomeprazole, nexium
698989|NCT00635362|Contraception|contraception
698990|NCT00635362|Contraceptive Devices|contraceptive devices
698991|NCT00635362|Intrauterine Devices|intrauterine devices
698992|NCT00635362|Unplanned Pregnancy|unplanned pregnancy
698993|NCT00635362|Postpartum Period|postpartum period
698994|NCT00635349|WOMAC|womac
698995|NCT00635349|Knee osteoarthritis pain|knee osteoarthritis pain
698996|NCT00635349|Pain intensity|pain intensity
698997|NCT00635349|Tramadol|tramadol
698998|NCT00635349|Acetaminophen|acetaminophen
698999|NCT00635349|Meloxicam|meloxicam
699000|NCT00635349|Aceclofenac|aceclofenac
699001|NCT00635336|Epitope peptide|epitope peptide
699002|NCT00635336|CTL|ctl
699003|NCT00635336|Advanced bladder cancer|advanced bladder cancer
699004|NCT00635336|Vaccination|vaccination
699005|NCT00635336|advanced bladder cancer which showed resistance for standard treatments|advanced bladder cancer which showed resistance for standard treatments
699006|NCT00635310|Chronic hepatitis C|chronic hepatitis c
699007|NCT00635310|Chronic hepatitis B|chronic hepatitis b
699008|NCT00635310|Liver biopsy|liver biopsy
699009|NCT00635310|Hemodialysis|hemodialysis
699010|NCT00635310|1-Deamino-8- D-Arginine Vasopressin|1-deamino-8- d-arginine vasopressin
699011|NCT00635297|osteoporosis|osteoporosis
699012|NCT00635297|vertebroplasty|vertebroplasty
699013|NCT00635297|prophylactic|prophylactic
699014|NCT00635297|vertebrae|vertebrae
699015|NCT00635297|fracture|fracture
699016|NCT00635271|Asthma|asthma
699017|NCT00635271|Biomarker|biomarker
699018|NCT00635271|Exhaled Breath Condensate|exhaled breath condensate
699019|NCT00635271|Cytokine|cytokine
699020|NCT00635271|Healthy Volunteer|healthy volunteer
699021|NCT00635271|HV|hv
699022|NCT00635258|GnRH antagonist|gnrh antagonist
699023|NCT00635258|oocyte donation|oocyte donation
699024|NCT00635258|pregnancy|pregnancy
699025|NCT00635258|implantation|implantation
699026|NCT00635245|stage IA breast cancer|stage ia breast cancer
699027|NCT00635245|stage IB breast cancer|stage ib breast cancer
699028|NCT00635245|stage II breast cancer|stage ii breast cancer
699029|NCT00635232|Hypertension|hypertension
699030|NCT00635232|High Blood Pressure|high blood pressure
699426|NCT00633594|Bortezomib|bortezomib
699031|NCT00635219|Major depressive disorder|major depressive disorder
699032|NCT00635219|Placebo-controlled|placebo-controlled
699033|NCT00635219|Active reference|active reference
699034|NCT00635219|Multicenter study|multicenter study
699035|NCT00635219|Randomised study|randomised study
699036|NCT00635219|Acute treatment|acute treatment
699038|NCT00635193|Ovarian neoplasms|ovarian neoplasms
699039|NCT00635193|Angiogenesis inhibitors|angiogenesis inhibitors
699040|NCT00635193|Angiogenesis|angiogenesis
699041|NCT00635193|Volociximab|volociximab
699042|NCT00635193|Ovarian cancer|ovarian cancer
699043|NCT00635193|Antibody|antibody
699044|NCT00635193|Monoclonals|monoclonals
699045|NCT00635180|Isometric exercise|isometric exercise
699046|NCT00635180|intraocular pressure|intraocular pressure
699047|NCT00635180|Physiological changes in intraocular pressure during isometric exercise|physiological changes in intraocular pressure during isometric exercise
699048|NCT00635167|Prostate cancer|prostate cancer
699049|NCT00635167|prostatic vascularity|prostatic vascularity
699050|NCT00635167|External Beam Radiation treatment|external beam radiation treatment
699051|NCT00635167|Contrast Enhanced transrectal Ultrasound|contrast enhanced transrectal ultrasound
699052|NCT00635154|stage I multiple myeloma|stage i multiple myeloma
699053|NCT00635154|stage II multiple myeloma|stage ii multiple myeloma
699054|NCT00635154|stage III multiple myeloma|stage iii multiple myeloma
699055|NCT00635141|Cystic Fibrosis|cystic fibrosis
699056|NCT00635141|Lung Clearance Index|lung clearance index
699057|NCT00635141|Hypertonic Saline|hypertonic saline
699058|NCT00635141|Pediatrics|pediatrics
699059|NCT00635128|Diphtheria|diphtheria
699060|NCT00635128|vaccine|vaccine
699061|NCT00635128|DTP|dtp
699062|NCT00635128|Poliomyelitis|poliomyelitis
699063|NCT00635128|Pertussis|pertussis
699064|NCT00635128|Booster|booster
699065|NCT00635128|Tetanus|tetanus
699066|NCT00635102|Alcohol Dependence, Alcoholism, Glycine, D-Cycloserine|alcohol dependence, alcoholism, glycine, d-cycloserine
699067|NCT00635089|Eosinophilic Esophagitis|eosinophilic esophagitis
699068|NCT00635089|Cinquil|cinquil
699069|NCT00635063|Cancer Breakthrough Pain|cancer breakthrough pain
699070|NCT00635050|Breast cancer|breast cancer
699071|NCT00635037|Myofascial pain syndrome|myofascial pain syndrome
699072|NCT00635037|Acupuncture|acupuncture
699073|NCT00635037|Nonsteroidal anti-inflammatory agents|nonsteroidal anti-inflammatory agents
699074|NCT00635037|Muscle relaxants, central|muscle relaxants, central
699075|NCT00635037|Quality of life.|quality of life.
699076|NCT00635037|muscle relaxants, analgesia|muscle relaxants, analgesia
699077|NCT00635024|refractory multiple myeloma|refractory multiple myeloma
699078|NCT00635024|stage I multiple myeloma|stage i multiple myeloma
699079|NCT00635024|stage II multiple myeloma|stage ii multiple myeloma
699080|NCT00635024|stage III multiple myeloma|stage iii multiple myeloma
699081|NCT00635011|comorbidity|comorbidity
699082|NCT00635011|Quality of Life|quality of life
699083|NCT00635011|Body Weight Changes|body weight changes
699084|NCT00634998|Vitamin C|vitamin c
699085|NCT00634998|Ascorbic Acid|ascorbic acid
699086|NCT00634998|Diabetic Neuropathies|diabetic neuropathies
699087|NCT00634972|Retinopathy of Prematurity|retinopathy of prematurity
699088|NCT00634972|Premature Infants|premature infants
699089|NCT00634972|ACULAR|acular
699090|NCT00634972|Refresh Tears|refresh tears
699091|NCT00634959|HIV Infections|hiv infections
699092|NCT00634959|Treatment Naïve|treatment naïve
699093|NCT00634946|Chemonucleolysis|chemonucleolysis
699094|NCT00634946|Lumbar Vertebrae|lumbar vertebrae
699095|NCT00634946|Hernia|hernia
699096|NCT00634933|active|active
699097|NCT00634933|rheumatoid|rheumatoid
699098|NCT00634933|arthritis|arthritis
699099|NCT00634933|anti CD20|anti cd20
699100|NCT00634920|De novo renal transplantation|de novo renal transplantation
699101|NCT00634907|Genotyping|genotyping
699102|NCT00634907|Warfarin dosing|warfarin dosing
699103|NCT00634907|arthroplasty|arthroplasty
699104|NCT00634894|Ovarian Cancer|ovarian cancer
699105|NCT00634894|Fallopian Tube Cancer|fallopian tube cancer
699106|NCT00634894|Peritoneal Cancer|peritoneal cancer
699107|NCT00634894|Femara|femara
699108|NCT00634894|Letrozole|letrozole
699109|NCT00634894|Placebo|placebo
699110|NCT00634881|B-cell chronic lymphocytic leukemia|b-cell chronic lymphocytic leukemia
699111|NCT00634881|stage III chronic lymphocytic leukemia|stage iii chronic lymphocytic leukemia
699112|NCT00634881|stage IV chronic lymphocytic leukemia|stage iv chronic lymphocytic leukemia
699113|NCT00634881|stage I chronic lymphocytic leukemia|stage i chronic lymphocytic leukemia
699114|NCT00634881|stage II chronic lymphocytic leukemia|stage ii chronic lymphocytic leukemia
699115|NCT00634868|ulcer wound diabetes|ulcer wound diabetes
699116|NCT00634855|Endothelial progenitor cells|endothelial progenitor cells
699117|NCT00634855|Endothelial dysfunction|endothelial dysfunction
699118|NCT00634777|HNSCC biopsy-proven|hnscc biopsy-proven
699119|NCT00634777|T1-T4 oral cavity oropharynx hypopharynx larynx|t1-t4 oral cavity oropharynx hypopharynx larynx
699120|NCT00634777|N+ scheduled for an organ preservation treatment protocol based on concomitant|n+ scheduled for an organ preservation treatment protocol based on concomitant
699121|NCT00634777|chemoradiation|chemoradiation
699122|NCT00634764|Maternal weight gain|maternal weight gain
699123|NCT00634764|Neonatal birth weight|neonatal birth weight
699124|NCT00634764|Weight gain attitude|weight gain attitude
699125|NCT00634764|Pregnancy|pregnancy
699126|NCT00634764|Body fat|body fat
699127|NCT00634764|Maternal Behavior|maternal behavior
699128|NCT00634764|Birth outcomes|birth outcomes
699129|NCT00634751|advanced pancreatic and biliary tract carcinomas|advanced pancreatic and biliary tract carcinomas
699130|NCT00634738|ischemic compression;carpal tunnel syndrome|ischemic compression;carpal tunnel syndrome
699131|NCT00634725|adenocarcinoma of the pancreas|adenocarcinoma of the pancreas
699132|NCT00634725|stage III pancreatic cancer|stage iii pancreatic cancer
699133|NCT00634712|Congestive Heart Failure|congestive heart failure
699134|NCT00634712|Atacand|atacand
699135|NCT00634712|Candesartan|candesartan
699136|NCT00634686|Omega-3 fatty acids|omega-3 fatty acids
699137|NCT00634686|immune response|immune response
699138|NCT00634673|Serum Fatty Acids|serum fatty acids
699139|NCT00634673|FABP2 Gene|fabp2 gene
699140|NCT00634673|Polymorphism Ala54Thr|polymorphism ala54thr
699141|NCT00634647|Chemotherapy|chemotherapy
699142|NCT00634647|Pharmacokinetics|pharmacokinetics
699143|NCT00634647|Gene Polymorphisms|gene polymorphisms
699144|NCT00634647|Prostate Cancer|prostate cancer
699145|NCT00634634|breast cancer|breast cancer
699146|NCT00634634|Postmenopausal Women with Hormone Receptor-Positive Locally Advanced Breast Cancer|postmenopausal women with hormone receptor-positive locally advanced breast cancer
699147|NCT00634621|Bladder|bladder
699148|NCT00634621|Cancer|cancer
699149|NCT00634621|Cystoscopy|cystoscopy
699150|NCT00634621|Hexaminolevulinate|hexaminolevulinate
699151|NCT00634621|Hexvix|hexvix
699152|NCT00634595|clinical trial|clinical trial
699153|NCT00634595|randomized|randomized
699154|NCT00634595|Endostatin|endostatin
699155|NCT00634595|gene therapy|gene therapy
699156|NCT00634595|head and neck cancer|head and neck cancer
699157|NCT00634595|head and neck squamous carcinoma|head and neck squamous carcinoma
699158|NCT00634582|adenocarcinoma of the prostate|adenocarcinoma of the prostate
699159|NCT00634582|stage IV prostate cancer|stage iv prostate cancer
699160|NCT00634582|recurrent prostate cancer|recurrent prostate cancer
699161|NCT00634582|bone metastases|bone metastases
699162|NCT00634569|CVID, XLA, hyper IgM syndrome, Wiskott-Aldrich Syndrome|cvid, xla, hyper igm syndrome, wiskott-aldrich syndrome
699163|NCT00634556|Tourette Syndrome|tourette syndrome
699164|NCT00634556|fMRI|fmri
699165|NCT00634556|levodopa|levodopa
699166|NCT00634556|working memory|working memory
699167|NCT00634556|dopamine|dopamine
699168|NCT00634543|Diabetic neuropathy|diabetic neuropathy
699169|NCT00634543|Ultracet|ultracet
699170|NCT00634543|Tramadol hydrochloride|tramadol hydrochloride
699171|NCT00634543|Acetaminophen|acetaminophen
699172|NCT00634543|Gabapentin|gabapentin
699173|NCT00634530|Pregnancy|pregnancy
699174|NCT00634530|Prenatal Care|prenatal care
699175|NCT00634530|Weight|weight
699176|NCT00634530|Nutritional Status|nutritional status
699177|NCT00634504|high dose methotrexate|high dose methotrexate
699178|NCT00634504|Voraxaze|voraxaze
699179|NCT00634504|leucovorin|leucovorin
699180|NCT00634504|delayed elimination|delayed elimination
699181|NCT00634504|methotrexate toxicity|methotrexate toxicity
699182|NCT00634504|rescue|rescue
699183|NCT00634504|renal insufficiency|renal insufficiency
699184|NCT00634478|essential tremor|essential tremor
699185|NCT00634478|deep brain stimulation|deep brain stimulation
699186|NCT00634452|Hodgkin's|hodgkin's
699187|NCT00634452|Cancer|cancer
699188|NCT00634452|bi-measurable disease|bi-measurable disease
699189|NCT00634452|Lymphoma|lymphoma
699190|NCT00634439|cerebrovascular accident|cerebrovascular accident
699191|NCT00634439|stroke|stroke
699192|NCT00634439|transient ischemic attack|transient ischemic attack
699193|NCT00634439|TIA|tia
699194|NCT00634439|CVA|cva
699195|NCT00634439|attention deficit hyperactivity disorder|attention deficit hyperactivity disorder
699196|NCT00634439|ADHD|adhd
699197|NCT00634426|Spine|spine
699198|NCT00634426|Neoplasm metastasis|neoplasm metastasis
699199|NCT00634426|Treatment, surgical|treatment, surgical
699200|NCT00634426|Treatment, nonoperative|treatment, nonoperative
699201|NCT00634426|Quality of life|quality of life
699202|NCT00634413|COPD|copd
699203|NCT00634400|Congestive Heart Failure|congestive heart failure
699204|NCT00634400|Atacand|atacand
699205|NCT00634400|Candesartan|candesartan
699206|NCT00634374|Rx medibottle|rx medibottle
699207|NCT00634374|Oral syringe|oral syringe
699208|NCT00634374|Liquid medication|liquid medication
699209|NCT00634374|Bitter-tasting|bitter-tasting
699210|NCT00634374|Infants|infants
699211|NCT00634322|osteosarcoma|osteosarcoma
699212|NCT00634322|high dose methotrexate|high dose methotrexate
699213|NCT00634322|leucovorin|leucovorin
699214|NCT00634309|Congestive Heart Failure|congestive heart failure
699215|NCT00634309|Atacand|atacand
699216|NCT00634309|Candesartan|candesartan
699217|NCT00634296|Heart failure|heart failure
699218|NCT00634296|Systolic dysfunction|systolic dysfunction
699219|NCT00634296|Inspiratory muscle weakness|inspiratory muscle weakness
699220|NCT00634270|Plexiform, Neurofibromatosis Type 1, Sirolimus, Phase II|plexiform, neurofibromatosis type 1, sirolimus, phase ii
699221|NCT00634257|Advanced Cancer|advanced cancer
699222|NCT00634257|Solid Tumors|solid tumors
699223|NCT00634257|Spirituality|spirituality
699224|NCT00634257|Religiosity|religiosity
699225|NCT00634257|Symptom Distress|symptom distress
699226|NCT00634257|Quality of Life|quality of life
699227|NCT00634257|Caregivers|caregivers
699228|NCT00634257|Questionnaire|questionnaire
699229|NCT00634257|Survey|survey
699230|NCT00634244|Acute Myelogenous Leukemia (AML), Carboplatin, Topotecan, Flavopiridol, Mitoxantrone, Cytosine Arabinoside, Sirolimus, Etoposide|acute myelogenous leukemia (aml), carboplatin, topotecan, flavopiridol, mitoxantrone, cytosine arabinoside, sirolimus, etoposide
699231|NCT00634231|Malignant glioma|malignant glioma
699232|NCT00634231|Glioblastoma multiforme|glioblastoma multiforme
699233|NCT00634231|Anaplastic astrocytoma|anaplastic astrocytoma
699234|NCT00634231|Recurrent ependymoma|recurrent ependymoma
699235|NCT00634231|Gene therapy|gene therapy
699236|NCT00634231|Immunotherapy|immunotherapy
699237|NCT00634218|nicotine|nicotine
699238|NCT00634218|smoking|smoking
699239|NCT00634218|smoking cessation|smoking cessation
699240|NCT00634205|Mesothelioma|mesothelioma
699241|NCT00634205|Valproate|valproate
699242|NCT00634205|Doxorubicin|doxorubicin
699243|NCT00634205|Chemotherapy|chemotherapy
699244|NCT00634205|Phase II|phase ii
699245|NCT00634192|Chronic infection with P. aeruginosa in Cystic Fibrosis subjects|chronic infection with p. aeruginosa in cystic fibrosis subjects
699246|NCT00634179|Lymphoma|lymphoma
699247|NCT00634166|thermal injuries|thermal injuries
699248|NCT00634166|burns|burns
699249|NCT00634166|Burn Patients (Subjects with Thermal Injuries Requiring Meshed Autografts)|burn patients (subjects with thermal injuries requiring meshed autografts)
699250|NCT00634140|gallbladder|gallbladder
699251|NCT00634140|ezetimibe for 4 to 6 weeks prior to gallbladder removal|ezetimibe for 4 to 6 weeks prior to gallbladder removal
699252|NCT00634114|Reflux Esophagitis|reflux esophagitis
699253|NCT00634075|Severe sepsis|severe sepsis
699254|NCT00634075|Proinflammatory cytokines|proinflammatory cytokines
699255|NCT00634075|ICU|icu
699256|NCT00634062|Affective Lability|affective lability
699257|NCT00634062|Borderline Personality Disorder|borderline personality disorder
699258|NCT00634062|Pharmacotherapy|pharmacotherapy
699259|NCT00634049|invasive fungal infections caused by rare molds, rare yeasts|invasive fungal infections caused by rare molds, rare yeasts
699260|NCT00634049|BAL8557|bal8557
699261|NCT00634049|Isavuconazole|isavuconazole
699262|NCT00634049|Aspergillosis|aspergillosis
699263|NCT00634049|or by dimorphic fungi|or by dimorphic fungi
699264|NCT00634049|ASP9766|asp9766
699265|NCT00634036|Asthma|asthma
699266|NCT00634036|obesity|obesity
699267|NCT00634036|exacerbation|exacerbation
699268|NCT00634036|asthmatics|asthmatics
699269|NCT00634036|fat|fat
699270|NCT00634036|overweight|overweight
699271|NCT00634036|adipose tissue|adipose tissue
699272|NCT00634036|leptin|leptin
699273|NCT00634036|adiponectin|adiponectin
699274|NCT00634036|pioglitazone|pioglitazone
699275|NCT00634036|Actos|actos
699276|NCT00634036|wheezing|wheezing
699277|NCT00634036|Pittsburgh|pittsburgh
699278|NCT00634036|Pennsylvania|pennsylvania
699279|NCT00634036|pulmonary|pulmonary
699280|NCT00634036|lung|lung
699281|NCT00634010|Advanced Cancer|advanced cancer
699282|NCT00634010|Solid Tumors|solid tumors
699283|NCT00634010|Cancer Pain|cancer pain
699284|NCT00634010|Opioid Pain Killer|opioid pain killer
699285|NCT00634010|Morphine|morphine
699286|NCT00634010|Methadone|methadone
699287|NCT00633997|Diabetes mellitus|diabetes mellitus
699288|NCT00633997|type 2 diabetes|type 2 diabetes
699289|NCT00633997|vildagliptin|vildagliptin
699290|NCT00633997|pharmacokinetics|pharmacokinetics
699291|NCT00633984|Social Anxiety Disorder|social anxiety disorder
699292|NCT00633984|Cognitive Behavioral Group Therapy|cognitive behavioral group therapy
699293|NCT00633984|D-cycloserine|d-cycloserine
699294|NCT00633971|Post thrombotic syndrome|post thrombotic syndrome
699295|NCT00633971|Thrombosis|thrombosis
699296|NCT00633971|Deep vein thrombosis|deep vein thrombosis
699297|NCT00633971|Venous thrombosis|venous thrombosis
699298|NCT00633971|Edema|edema
699299|NCT00633971|stasis ulcers|stasis ulcers
699300|NCT00633958|18F-FLT|18f-flt
699301|NCT00633958|FLT|flt
699302|NCT00633958|PET|pet
699303|NCT00633958|CNS tumors|cns tumors
699304|NCT00633958|Newly|newly
699305|NCT00633958|diagnosed|diagnosed
699306|NCT00633945|Cutaneous Lupus Erythematosus|cutaneous lupus erythematosus
699307|NCT00633945|CLE|cle
699308|NCT00633945|lenalidomide|lenalidomide
699309|NCT00633945|revlimid|revlimid
699310|NCT00633945|thalidomide derivative|thalidomide derivative
699311|NCT00633945|drug|drug
699312|NCT00633945|lupus|lupus
699313|NCT00633932|Reflux Esophagitis|reflux esophagitis
699314|NCT00633919|House dust mites|house dust mites
699315|NCT00633919|Sublingual immunotherapy|sublingual immunotherapy
699316|NCT00633919|Allergy|allergy
699317|NCT00633919|Allergic asthma|allergic asthma
699318|NCT00633906|HIV|hiv
699319|NCT00633906|Sexually Transmitted diseases|sexually transmitted diseases
699320|NCT00633906|Adolescents|adolescents
699321|NCT00633906|Prevention|prevention
699322|NCT00633906|HIV Seronegativity|hiv seronegativity
699323|NCT00633880|NOH|noh
699324|NCT00633880|Neurogenic Orthostatic Hypotension|neurogenic orthostatic hypotension
699325|NCT00633880|Orthostatic hypotension|orthostatic hypotension
699326|NCT00633880|PAF|paf
699327|NCT00633880|Pure Autonomic Failure|pure autonomic failure
699328|NCT00633880|MSA|msa
699329|NCT00633880|Multiple System Atrophy|multiple system atrophy
699330|NCT00633880|Neuropathy|neuropathy
699331|NCT00633880|Autonomic Failure|autonomic failure
699332|NCT00633880|Parkinson|parkinson
699333|NCT00633880|Dopamine Deficiency|dopamine deficiency
699334|NCT00633880|Dopamine|dopamine
699335|NCT00633880|Droxidopa|droxidopa
699336|NCT00633867|Tracheal intubation|tracheal intubation
699337|NCT00633867|Laryngoscopy|laryngoscopy
699338|NCT00633867|videolaryngoscope|videolaryngoscope
699339|NCT00633867|McGrath|mcgrath
699340|NCT00633867|success|success
699341|NCT00633867|time|time
699342|NCT00633854|annular array ultrasound|annular array ultrasound
699343|NCT00633854|ophthalmic ultrasound|ophthalmic ultrasound
699344|NCT00633854|posterior vitreous detachment (PVD)|posterior vitreous detachment (pvd)
699345|NCT00633841|Alzheimer|alzheimer
699346|NCT00633841|Morbus Alzheimer|morbus alzheimer
699347|NCT00633841|Alzheimer Vaccine|alzheimer vaccine
699348|NCT00633841|Vaccine|vaccine
699349|NCT00633841|AD|ad
699350|NCT00633841|Aβ immunotherapy|aβ immunotherapy
699351|NCT00633828|Bone Density|bone density
699352|NCT00633828|Bone mass|bone mass
699353|NCT00633828|Bone mineral density|bone mineral density
699354|NCT00633828|Bone structure|bone structure
699355|NCT00633828|Cardiovascular risk factors|cardiovascular risk factors
699356|NCT00633828|Fat Mass|fat mass
699357|NCT00633828|Adiposity|adiposity
699358|NCT00633815|Supine|supine
699359|NCT00633815|Upright|upright
699360|NCT00633802|Risperidone|risperidone
699361|NCT00633802|Borderlone Personality Disorder|borderlone personality disorder
699362|NCT00633776|Chronic Obstructive Pulmonary Disease|chronic obstructive pulmonary disease
699363|NCT00633776|COPD|copd
699364|NCT00633776|Chronic bronchitis|chronic bronchitis
699365|NCT00633776|Emphysema|emphysema
699366|NCT00633776|Perforomist|perforomist
699367|NCT00633776|Foradil|foradil
699368|NCT00633776|CT|ct
699369|NCT00633776|lung function|lung function
699370|NCT00633763|Diagnostic|diagnostic
699371|NCT00633763|PET/CT imaging of pancreas|pet/ct imaging of pancreas
699372|NCT00633763|Detecting pancreatic beta cell loss during diabetes|detecting pancreatic beta cell loss during diabetes
699373|NCT00633750|stage I breast cancer|stage i breast cancer
699374|NCT00633750|stage II breast cancer|stage ii breast cancer
699375|NCT00633750|stage IIIA breast cancer|stage iiia breast cancer
699376|NCT00633750|stage IIIB breast cancer|stage iiib breast cancer
699377|NCT00633737|Psychology|psychology
699378|NCT00633737|Laparoscopy|laparoscopy
699379|NCT00633737|Cholecystectomy|cholecystectomy
699380|NCT00633737|Psychoneuroimmunology|psychoneuroimmunology
699381|NCT00633737|Wound healing|wound healing
699382|NCT00633737|Preparation for surgery|preparation for surgery
699383|NCT00633737|Stress reduction|stress reduction
699384|NCT00633737|Stress|stress
699385|NCT00633737|Relaxation|relaxation
699386|NCT00633711|OSAS|osas
699387|NCT00633711|blood pressure|blood pressure
699388|NCT00633711|sympathetic nervous system|sympathetic nervous system
699389|NCT00633711|treatment|treatment
699390|NCT00633711|CPAP|cpap
699391|NCT00633698|lipoprotein(a)|lipoprotein(a)
699392|NCT00633698|niacin|niacin
699393|NCT00633698|placebo|placebo
699394|NCT00633698|intervention|intervention
699395|NCT00633685|Posttraumatic Stress Disorder|posttraumatic stress disorder
699396|NCT00633685|Fluoxetine|fluoxetine
699397|NCT00633685|Factors predicting response|factors predicting response
699398|NCT00633685|Resilience|resilience
699399|NCT00633685|Pharmacologic augmentation strategies|pharmacologic augmentation strategies
699400|NCT00633672|NSAID|nsaid
699401|NCT00633672|Nexium|nexium
699402|NCT00633672|esomeprazole|esomeprazole
699403|NCT00633672|Gastric Ulcers|gastric ulcers
699404|NCT00633659|Hemospan|hemospan
699405|NCT00633659|Oxygen carriers|oxygen carriers
699406|NCT00633659|Blood substitutes|blood substitutes
699407|NCT00633659|Ischemia|ischemia
699408|NCT00633659|Tissue oxygenation|tissue oxygenation
699409|NCT00633646|nitrogen balance|nitrogen balance
699410|NCT00633646|malnutrition|malnutrition
699411|NCT00633646|chronic kidney disease|chronic kidney disease
699412|NCT00633646|diet|diet
699413|NCT00633646|glomerular filtration rate|glomerular filtration rate
699414|NCT00633633|Heart Failure|heart failure
699415|NCT00633633|Lifestyle Intervention|lifestyle intervention
699416|NCT00633633|Exercise|exercise
699417|NCT00633633|Diet|diet
699418|NCT00633620|colonoscopy|colonoscopy
699419|NCT00633620|narrow band imaging|narrow band imaging
699420|NCT00633620|adenoma|adenoma
699421|NCT00633620|diagnosis|diagnosis
699422|NCT00633620|colonoscopic adenoma detection|colonoscopic adenoma detection
699423|NCT00633594|Mantle Cell Lymphoma|mantle cell lymphoma
699424|NCT00633594|Rituximab|rituximab
699425|NCT00633594|Lenalidomide|lenalidomide
699427|NCT00633594|Phase 1/2|phase 1/2
699428|NCT00633581|fatigue|fatigue
699429|NCT00633581|ascorbic acid|ascorbic acid
699430|NCT00633581|oxidative stress|oxidative stress
699431|NCT00633568|Non-small cell lung carcinoma|non-small cell lung carcinoma
699432|NCT00633568|Concomitant radiochemotherapy|concomitant radiochemotherapy
699433|NCT00633568|Cisplatin|cisplatin
699434|NCT00633568|Docetaxel|docetaxel
699435|NCT00633568|Radiotherapy|radiotherapy
699436|NCT00633568|Chemotherapy|chemotherapy
699437|NCT00633568|Unresectable stage III non-small cell lung carcinoma|unresectable stage iii non-small cell lung carcinoma
699438|NCT00633542|thalidomide|thalidomide
699439|NCT00633542|maintenance|maintenance
699440|NCT00633542|interferon|interferon
699441|NCT00633542|dexamethasone|dexamethasone
699442|NCT00633542|newly diagnosed multiple myeloma|newly diagnosed multiple myeloma
699443|NCT00633542|relapsed refractory multiple myeloma|relapsed refractory multiple myeloma
699444|NCT00633529|Phase 1b|phase 1b
699445|NCT00633529|Non-Small Cell Lung Cancer|non-small cell lung cancer
699446|NCT00633529|Advanced or Metastatic Disease|advanced or metastatic disease
699447|NCT00633529|Prior chemotherapy|prior chemotherapy
699448|NCT00633516|moles|moles
699449|NCT00633516|melanoma|melanoma
699450|NCT00633503|free tissue transfer|free tissue transfer
699451|NCT00633503|pedicle tissue transfer|pedicle tissue transfer
699452|NCT00633503|complications|complications
699453|NCT00633503|modulated imaging spectroscopy|modulated imaging spectroscopy
699454|NCT00633503|observation|observation
699455|NCT00633503|clinical observation/diagnosis|clinical observation/diagnosis
699456|NCT00633503|tissue defects requiring free tissue transfer|tissue defects requiring free tissue transfer
699457|NCT00633503|tissue defects requiring pedicle tissue transfer|tissue defects requiring pedicle tissue transfer
699458|NCT00633490|Toxicity|toxicity
699459|NCT00633490|Efficacy|efficacy
699460|NCT00633477|Systemic Inflammatory Response Syndrome|systemic inflammatory response syndrome
699461|NCT00633477|Septic Shock|septic shock
699462|NCT00633477|Septicemia|septicemia
699463|NCT00633477|Drug Therapy|drug therapy
699464|NCT00633451|shoulder pain|shoulder pain
699465|NCT00633451|shoulder impingement syndrome|shoulder impingement syndrome
699466|NCT00633451|manual therapy|manual therapy
699467|NCT00633451|rehabilitation|rehabilitation
699468|NCT00633438|Knee Surgery Arthroscopic Surgery|knee surgery arthroscopic surgery
699469|NCT00633412|NSAID|nsaid
699470|NCT00633412|Nexium|nexium
699471|NCT00633412|esomeprazole|esomeprazole
699472|NCT00633412|Gastric Ulcers|gastric ulcers
699473|NCT00633399|Major Depressive Disorder|major depressive disorder
699474|NCT00633399|Major Depression|major depression
699475|NCT00633399|Depression|depression
699476|NCT00633399|Geodon|geodon
699477|NCT00633399|Ziprasidone|ziprasidone
699478|NCT00633399|SSRI Augmentation|ssri augmentation
699479|NCT00633399|Treatment Resistant Depression|treatment resistant depression
699480|NCT00633386|Knee Surgery|knee surgery
699481|NCT00633386|Arthroscopic Surgery|arthroscopic surgery
699482|NCT00633373|lung|lung
699483|NCT00633373|transplant|transplant
699484|NCT00633373|transplant rejection|transplant rejection
699485|NCT00633373|Cyclosporine|cyclosporine
699486|NCT00633373|bronchiolitis obliterans|bronchiolitis obliterans
699487|NCT00633373|aerosol|aerosol
699488|NCT00633360|Women|women
699490|NCT00633360|Depression|depression
699491|NCT00633347|oocyte donation|oocyte donation
699492|NCT00633347|endometrial preparation|endometrial preparation
699493|NCT00633334|Cancer|cancer
699494|NCT00633334|GI|gi
699495|NCT00633334|Tumor|tumor
699496|NCT00633334|Gastrointestinal|gastrointestinal
699497|NCT00633334|high risk|high risk
699498|NCT00633321|smoking cessation|smoking cessation
699499|NCT00633321|quit smoking|quit smoking
699500|NCT00633321|smoking vaccine|smoking vaccine
699501|NCT00633321|nicotine vaccine|nicotine vaccine
699502|NCT00633321|TA-NIC|ta-nic
699503|NCT00633321|Aid for smoking cessation in smokers motivated to quit|aid for smoking cessation in smokers motivated to quit
699504|NCT00633308|hemodialysis|hemodialysis
699505|NCT00633295|GIST|gist
699506|NCT00633295|TKI|tki
699507|NCT00633295|IMATINIB|imatinib
699508|NCT00633295|NILOTINIB|nilotinib
699509|NCT00633295|AMN107|amn107
699510|NCT00633282|Nonalcoholic Fatty Liver Disease|nonalcoholic fatty liver disease
699511|NCT00633282|Pioglitazone|pioglitazone
699512|NCT00633282|Berberine|berberine
699513|NCT00633282|Impaired Glucose Metabolism|impaired glucose metabolism
699514|NCT00633269|Poly(ADP ribose) polymerases|poly(adp ribose) polymerases
699515|NCT00633269|Metastatic Solid Tumours|metastatic solid tumours
699516|NCT00633230|hepatitis C virus|hepatitis c virus
699517|NCT00633230|complementary and alternative medicine|complementary and alternative medicine
699518|NCT00633230|peginterferon alfa and ribavirin|peginterferon alfa and ribavirin
699519|NCT00633217|DISKUS|diskus
699520|NCT00633217|Salmeterol|salmeterol
699521|NCT00633217|Fluticasone Propionate|fluticasone propionate
699522|NCT00633217|Chronic Obstructive Pulmonary Disease (COPD)|chronic obstructive pulmonary disease (copd)
699523|NCT00633217|Hydroflouroalkane|hydroflouroalkane
699524|NCT00633217|COPD|copd
699525|NCT00633217|HFA MDI|hfa mdi
699526|NCT00633204|Epitope peptide, CTL, TUR-Bt, Bladder cancer, Vaccination|epitope peptide, ctl, tur-bt, bladder cancer, vaccination
699527|NCT00633204|Bladder cancer after surgery|bladder cancer after surgery
699528|NCT00633191|Cystic fibrosis|cystic fibrosis
699529|NCT00633191|Prevention|prevention
699530|NCT00633191|Infection|infection
699531|NCT00633191|Pseudomonas aeruginosa|pseudomonas aeruginosa
699532|NCT00633191|Gargle|gargle
699533|NCT00633178|Prenatal Depression|prenatal depression
699534|NCT00633178|Postpartum Depression|postpartum depression
699535|NCT00633178|Fetal Development|fetal development
699536|NCT00633178|Interpersonal Therapy|interpersonal therapy
699537|NCT00633165|sarcoma|sarcoma
699538|NCT00633165|myxoid liposarcoma|myxoid liposarcoma
699539|NCT00633152|complicated skin and skin structure infections|complicated skin and skin structure infections
699540|NCT00633152|linezolid|linezolid
699541|NCT00633152|ceftaroline|ceftaroline
699542|NCT00633152|clinical response|clinical response
699543|NCT00633152|microbiological response|microbiological response
699544|NCT00633152|Cellulitis|cellulitis
699545|NCT00633152|Abscess|abscess
699546|NCT00633152|Wound infection|wound infection
699547|NCT00633152|Deeper soft tissue|deeper soft tissue
699548|NCT00633152|Significant surgical intervention|significant surgical intervention
699549|NCT00633152|Gram-positive bacterial infection|gram-positive bacterial infection
699550|NCT00633152|Gram-negative bacterial infection|gram-negative bacterial infection
699551|NCT00633152|bacterial infection|bacterial infection
699552|NCT00633152|cephalosporin|cephalosporin
699553|NCT00633152|broad-spectrum activity|broad-spectrum activity
699554|NCT00633139|Metazym|metazym
699555|NCT00633139|Late infantile|late infantile
699556|NCT00633139|Metachromatic leukodystrophy|metachromatic leukodystrophy
699557|NCT00633139|Long-term safety|long-term safety
699558|NCT00633126|PK|pk
699559|NCT00633126|Pharmacokinetics|pharmacokinetics
699560|NCT00633113|Total Knee Arthroplasty|total knee arthroplasty
699561|NCT00633113|Minimally Invasive Knee Replacement|minimally invasive knee replacement
699562|NCT00633113|Knee Osteoarthritis|knee osteoarthritis
699563|NCT00633113|Cost effectiveness minimally invasive knee surgery|cost effectiveness minimally invasive knee surgery
699564|NCT00633074|Influenza|influenza
699565|NCT00633061|Childhood Cancer|childhood cancer
699566|NCT00633061|Central Venous Catheter|central venous catheter
699567|NCT00633061|Deep Vein Thrombosis|deep vein thrombosis
699568|NCT00633061|Catheter-related Infection|catheter-related infection
699569|NCT00633061|Catheter-related Occlusion|catheter-related occlusion
699570|NCT00633048|ascending single-dose study|ascending single-dose study
699571|NCT00633048|healthy subjects|healthy subjects
699572|NCT00633035|ulcer|ulcer
699573|NCT00633035|esomeprazole|esomeprazole
699574|NCT00633035|famotidine|famotidine
699575|NCT00633035|Neurosurgery|neurosurgery
699576|NCT00633022|FDG-PET/CT, atherosclerosis|fdg-pet/ct, atherosclerosis
699577|NCT00633009|Leishmaniasis|leishmaniasis
699578|NCT00633009|Delayed-Type Hypersensitivity (DTH)|delayed-type hypersensitivity (dth)
699579|NCT00633009|Skin Test|skin test
699580|NCT00633009|Conversion|conversion
699581|NCT00633009|Prior exposure to Leishmania major|prior exposure to leishmania major
699582|NCT00632996|shoulder pain|shoulder pain
699583|NCT00632996|shoulder impingement syndrome|shoulder impingement syndrome
699584|NCT00632996|manual therapy|manual therapy
699585|NCT00632996|rehabilitation|rehabilitation
699586|NCT00632970|Raltegravir|raltegravir
699587|NCT00632970|Lopinavir|lopinavir
699588|NCT00632918|Image quality|image quality
699589|NCT00632918|Dual-source CT|dual-source ct
699590|NCT00632918|Coronary angiography|coronary angiography
699591|NCT00632918|Heart rate|heart rate
699592|NCT00632905|Prostate Cancer|prostate cancer
699593|NCT00632905|Prostatic adenoma|prostatic adenoma
699594|NCT00632905|Prostatic neoplasm|prostatic neoplasm
699595|NCT00632892|oxidative stress markers in urine|oxidative stress markers in urine
699596|NCT00632892|urine norepinephrine|urine norepinephrine
699597|NCT00632892|renal tubular enzyme markers|renal tubular enzyme markers
699598|NCT00632866|auto-immune diseases|auto-immune diseases
699599|NCT00632866|hydroxychloroquine|hydroxychloroquine
699600|NCT00632866|primary Sjögren's syndrome|primary sjögren's syndrome
699601|NCT00632866|inflammatory arthritides|inflammatory arthritides
699602|NCT00632866|inflammatory rheumatic diseases|inflammatory rheumatic diseases
699603|NCT00632866|dryness|dryness
699604|NCT00632866|joint diseases|joint diseases
699605|NCT00632853|limited stage small cell lung cancer|limited stage small cell lung cancer
699606|NCT00632814|Kogenate,|kogenate,
699607|NCT00632814|Children,|children,
699608|NCT00632814|Factor VIII,|factor viii,
699609|NCT00632814|Hemophilia A,|hemophilia a,
699610|NCT00632814|Prophylactic|prophylactic
699611|NCT00632801|elective laparoscopic colectomy|elective laparoscopic colectomy
699612|NCT00632801|chewing gum|chewing gum
699613|NCT00632801|ileus|ileus
699614|NCT00632801|post-operative care|post-operative care
699615|NCT00632801|colectomy|colectomy
699616|NCT00632788|myocardial infarction|myocardial infarction
699617|NCT00632788|catheterization|catheterization
699618|NCT00632788|angioplasty|angioplasty
699619|NCT00632788|door-to-balloon time|door-to-balloon time
699620|NCT00632775|pediatrics|pediatrics
699621|NCT00632775|Hyponatremia|hyponatremia
699622|NCT00632775|Sodium Chloride|sodium chloride
699623|NCT00632775|maintenance fluids|maintenance fluids
699624|NCT00632762|Amantadine benefit|amantadine benefit
699625|NCT00632762|Dyskinesia|dyskinesia
699626|NCT00632762|Parkinson's disease|parkinson's disease
699627|NCT00632736|ropinirole XL|ropinirole xl
699628|NCT00632736|REQUIP|requip
699629|NCT00632736|Parkinson's disease|parkinson's disease
699630|NCT00632736|long term safety|long term safety
699631|NCT00632736|efficacy|efficacy
699632|NCT00632736|safety|safety
699633|NCT00632736|ropinirole CR|ropinirole cr
699634|NCT00632736|ropinirole IR|ropinirole ir
699635|NCT00632736|open-label|open-label
699636|NCT00632723|oestrogen receptor|oestrogen receptor
699637|NCT00632723|ER negative tumours|er negative tumours
699638|NCT00632723|epidermal growth factor receptor (EGFR)|epidermal growth factor receptor (egfr)
699639|NCT00632710|rheumatoid arthritis|rheumatoid arthritis
699640|NCT00632710|hands|hands
699641|NCT00632710|randomized controlled|randomized controlled
699642|NCT00632710|low level laser|low level laser
699643|NCT00632697|endometriosis|endometriosis
699644|NCT00632697|immunomodulation|immunomodulation
699645|NCT00632697|infertility|infertility
699646|NCT00632697|laparoscopic surgery|laparoscopic surgery
699647|NCT00632697|pentoxifylline|pentoxifylline
699648|NCT00632684|Family Caregiving|family caregiving
699649|NCT00632684|Dementia|dementia
699650|NCT00632671|Obesity cohort|obesity cohort
699651|NCT00632658|cGVHD|cgvhd
699652|NCT00632645|Huntington|huntington
699653|NCT00632645|Neuroleptic|neuroleptic
699654|NCT00632645|Unified Huntington Disease Rating Scale (UHDRS)|unified huntington disease rating scale (uhdrs)
699655|NCT00632645|Independence Scale|independence scale
699656|NCT00632645|Neuroleptic Prescription required|neuroleptic prescription required
699657|NCT00632632|World Trade Center Victims|world trade center victims
699658|NCT00632632|Iraq War Veterans|iraq war veterans
699659|NCT00632632|PTSD|ptsd
699660|NCT00632619|Subthreshold Manic States in Children|subthreshold manic states in children
699661|NCT00632619|ADHD|adhd
699662|NCT00632606|pregnant women|pregnant women
699663|NCT00632593|Early Complications of both techniques|early complications of both techniques
699664|NCT00632593|Fistula rate|fistula rate
699665|NCT00632593|Dehiscence rate|dehiscence rate
699666|NCT00632593|reoperation rate and cause|reoperation rate and cause
699667|NCT00632580|Pain, Postoperative|pain, postoperative
699668|NCT00632567|Anal incontinence|anal incontinence
699669|NCT00632567|First delivery was traumatic|first delivery was traumatic
699670|NCT00632567|No anal incontinence|no anal incontinence
699671|NCT00632528|MEOPA|meopa
699672|NCT00632528|spasticity|spasticity
699673|NCT00632528|multilevel surgery|multilevel surgery
699674|NCT00632528|cerebral palsy|cerebral palsy
699675|NCT00632528|children|children
699676|NCT00632515|Colorectal Cancer|colorectal cancer
699677|NCT00632515|CRC|crc
699678|NCT00632515|Familial CRC|familial crc
699679|NCT00632515|Cancer Screening|cancer screening
699680|NCT00632515|Questionnaire|questionnaire
699681|NCT00632515|First Degree Relatives|first degree relatives
699682|NCT00632515|FDRs|fdrs
699683|NCT00632515|Risk Communication|risk communication
699684|NCT00632489|Refractory Malignancy|refractory malignancy
699685|NCT00632489|Breast Cancer|breast cancer
699686|NCT00632489|LBH589|lbh589
699687|NCT00632489|Capecitabine|capecitabine
699688|NCT00632489|Lapatinib|lapatinib
699689|NCT00632476|Smoking During Pregnancy|smoking during pregnancy
699690|NCT00632476|Vitamin C|vitamin c
699691|NCT00632476|Newborn Lung Function|newborn lung function
699692|NCT00632476|Ascorbic Acid|ascorbic acid
699693|NCT00632463|Transplant|transplant
699694|NCT00632463|Immunosuppression|immunosuppression
699695|NCT00632437|Brain Tumor|brain tumor
699696|NCT00632437|Craniotomy Surgery|craniotomy surgery
699697|NCT00632437|Brain Function|brain function
699698|NCT00632437|Intraoperative Optical Imaging|intraoperative optical imaging
699699|NCT00632437|Speckle-Contrast Imaging|speckle-contrast imaging
699700|NCT00632437|Cortical Mapping|cortical mapping
699701|NCT00632437|Somatosensory Cortex|somatosensory cortex
699702|NCT00632437|Cerebral blood flow|cerebral blood flow
699703|NCT00632437|CBF|cbf
699704|NCT00632437|Laser Speckle Contrast Imaging|laser speckle contrast imaging
699705|NCT00632437|Multi-Spectral Imaging|multi-spectral imaging
699706|NCT00632398|massage|massage
699707|NCT00632398|oncology massage|oncology massage
699708|NCT00632398|palliative care|palliative care
699709|NCT00632398|supportive care|supportive care
699710|NCT00632398|integrative oncology|integrative oncology
699711|NCT00632398|informal caregiving|informal caregiving
699712|NCT00632398|spouse caregiving|spouse caregiving
699713|NCT00632398|family caregiving|family caregiving
699714|NCT00632398|caregiver education|caregiver education
699715|NCT00632398|psychosocial oncology|psychosocial oncology
699716|NCT00632398|caregiver stress|caregiver stress
699717|NCT00632398|coping with cancer|coping with cancer
699718|NCT00632398|quality of life|quality of life
699719|NCT00632398|end of life care|end of life care
699720|NCT00632359|Chronic Lymphocytic Leukemia|chronic lymphocytic leukemia
699721|NCT00632359|CLL|cll
699722|NCT00632359|Lenalidomide|lenalidomide
699723|NCT00632359|Revlimid|revlimid
699724|NCT00632346|childhood abuse|childhood abuse
699725|NCT00632346|overweight|overweight
699726|NCT00632346|obesity|obesity
699727|NCT00632346|BMI as a young adult|bmi as a young adult
699728|NCT00632346|childhood physical abuse|childhood physical abuse
699729|NCT00632346|childhood emotional abuse|childhood emotional abuse
699730|NCT00632346|childhood sexual abuse|childhood sexual abuse
699731|NCT00632346|childhood physical neglect|childhood physical neglect
699732|NCT00632346|childhood emotional neglect|childhood emotional neglect
699733|NCT00632346|childhood witnessing of domestic violence|childhood witnessing of domestic violence
699734|NCT00632346|parental marital discord|parental marital discord
699735|NCT00632346|household members with substance abuse|household members with substance abuse
699736|NCT00632346|household members with mental illness|household members with mental illness
699737|NCT00632346|household members with criminal behavior|household members with criminal behavior
699738|NCT00632346|cumulative adverse childhood experiences|cumulative adverse childhood experiences
699739|NCT00632333|Epitope peptide|epitope peptide
699740|NCT00632333|Vaccination|vaccination
699741|NCT00632333|Chemoradiation|chemoradiation
699742|NCT00632333|Esophageal cancer|esophageal cancer
699743|NCT00632320|Ventilator, mechanical|ventilator, mechanical
699744|NCT00632320|Ventilator weaning|ventilator weaning
699745|NCT00632320|Rapid shallow breathing index|rapid shallow breathing index
699746|NCT00632320|Continuous positive airway pressure|continuous positive airway pressure
699747|NCT00632320|Receiver operating characteristic curve|receiver operating characteristic curve
699748|NCT00632320|COPD|copd
699749|NCT00632307|lung tumor|lung tumor
699750|NCT00632307|pleural tumor|pleural tumor
699751|NCT00632307|interstitial lung disease|interstitial lung disease
699752|NCT00632307|airway infection|airway infection
699753|NCT00632307|COPD|copd
699754|NCT00632307|sleep apnea|sleep apnea
699755|NCT00632307|ion mobility spectrometry|ion mobility spectrometry
699756|NCT00632307|breath analysis|breath analysis
699757|NCT00632294|Bone Cancer|bone cancer
699758|NCT00632294|Allograft Retrieval|allograft retrieval
699759|NCT00632294|Allograft Bone|allograft bone
699760|NCT00632294|Bone Mineral Density|bone mineral density
699761|NCT00632268|mTOR inhibitor|mtor inhibitor
699762|NCT00632268|RAD001|rad001
699763|NCT00632268|everolimus|everolimus
699764|NCT00632268|chemotherapy|chemotherapy
699765|NCT00632268|cisplatin|cisplatin
699766|NCT00632268|high-dose 5-FU|high-dose 5-fu
699767|NCT00632255|Chronic Myeloid Leukemia|chronic myeloid leukemia
699768|NCT00632255|Long term Imatinib therapy compliance|long term imatinib therapy compliance
699769|NCT00632255|Newly diagnosed|newly diagnosed
699770|NCT00632255|Late side effects|late side effects
699771|NCT00632229|Obsessive-Compulsive Disorder; Adults; Medication; Treatment|obsessive-compulsive disorder; adults; medication; treatment
699772|NCT00632190|cervical cancer|cervical cancer
699773|NCT00632190|cervical intraepithelial neoplasia grade 1|cervical intraepithelial neoplasia grade 1
699774|NCT00632190|cervical intraepithelial neoplasia grade 2|cervical intraepithelial neoplasia grade 2
699775|NCT00632190|cervical intraepithelial neoplasia grade 3|cervical intraepithelial neoplasia grade 3
699776|NCT00632138|sexual dysfunction|sexual dysfunction
699777|NCT00632138|psychosocial effects of cancer and its treatment|psychosocial effects of cancer and its treatment
699778|NCT00632138|prostate cancer|prostate cancer
699779|NCT00632138|benign prostatic hyperplasia|benign prostatic hyperplasia
699780|NCT00632138|urinary incontinence|urinary incontinence
699781|NCT00632125|CKD subjects with or without dialysis treatment|ckd subjects with or without dialysis treatment
699782|NCT00632112|large volume nebulizer|large volume nebulizer
699783|NCT00632099|cocaine|cocaine
699784|NCT00632099|treatment|treatment
699785|NCT00632099|progesterone|progesterone
699786|NCT00632086|PK|pk
699787|NCT00632073|HIV Infections|hiv infections
699788|NCT00632073|Acquired Immunodeficiency Syndrome|acquired immunodeficiency syndrome
699789|NCT00632073|treatment experienced|treatment experienced
699790|NCT00632060|Low Back Pain|low back pain
699791|NCT00632060|Manual / Manipulative Therapy|manual / manipulative therapy
699792|NCT00632047|breast cancer|breast cancer
699793|NCT00632047|cervical cancer|cervical cancer
699794|NCT00632034|fracture|fracture
699795|NCT00632034|tibia|tibia
699796|NCT00632034|stem cell|stem cell
699797|NCT00632021|Low Health Literacy|low health literacy
699798|NCT00632021|Medication Errors|medication errors
699799|NCT00632021|Cardiovascular Disease|cardiovascular disease
699800|NCT00632021|Pharmacist|pharmacist
699801|NCT00632021|Care Transition|care transition
699802|NCT00631995|Neisseria meningitidis|neisseria meningitidis
699803|NCT00631982|in vitro maturation oocytes|in vitro maturation oocytes
699804|NCT00631969|Erectile Dysfunction|erectile dysfunction
699805|NCT00631917|Hypertension, aliskiren, ramipril, colonoscopy|hypertension, aliskiren, ramipril, colonoscopy
699806|NCT00631904|Pacemaker|pacemaker
699807|NCT00631878|Staphylococcal|staphylococcal
699808|NCT00631878|Monoclonal antibodies|monoclonal antibodies
699909|NCT00631527|Sutent|sutent
699809|NCT00631878|Very Low Birth Weight Infants|very low birth weight infants
699810|NCT00631878|Prophylaxis|prophylaxis
699811|NCT00631865|melanocytes|melanocytes
699812|NCT00631852|Breast Cancer, Biomarkers, Ginseng Root|breast cancer, biomarkers, ginseng root
699813|NCT00631839|Thoracic Neoplasms|thoracic neoplasms
699814|NCT00631839|Platinum-based chemotherapy|platinum-based chemotherapy
699815|NCT00631839|3-D Conformal Radiotherapy|3-d conformal radiotherapy
699816|NCT00631839|Chemo-radiotherapy induced lung injury|chemo-radiotherapy induced lung injury
699817|NCT00631839|Chemo-radiotherapy induced esophagus injury|chemo-radiotherapy induced esophagus injury
699818|NCT00631826|Shoulder|shoulder
699819|NCT00631826|Injuries|injuries
699820|NCT00631826|Flexiblity|flexiblity
699821|NCT00631826|Rotational resistance|rotational resistance
699822|NCT00631800|Staphylococcal|staphylococcal
699823|NCT00631800|Monoclonal antibodies|monoclonal antibodies
699824|NCT00631800|Very Low Birth Weight Infants|very low birth weight infants
699825|NCT00631800|Prophylaxis|prophylaxis
699826|NCT00631787|Nitric Oxide|nitric oxide
699827|NCT00631787|Hemolysis|hemolysis
699828|NCT00631787|Plasma Hemoglobin|plasma hemoglobin
699829|NCT00631787|Dimethyl Sulfoxide|dimethyl sulfoxide
699830|NCT00631787|Organ Dysfuntion|organ dysfuntion
699831|NCT00631787|Healthy Volunteer|healthy volunteer
699832|NCT00631787|HV|hv
699833|NCT00631774|type 2 diabetes|type 2 diabetes
699834|NCT00631774|meal replacement|meal replacement
699835|NCT00631774|postprandial response|postprandial response
699836|NCT00631774|Glucerna SR|glucerna sr
699837|NCT00631761|urethrocystoscopy|urethrocystoscopy
699838|NCT00631761|cystoscopy|cystoscopy
699839|NCT00631761|objective structured assessment of surgical skills (OSATS)|objective structured assessment of surgical skills (osats)
699840|NCT00631748|cocaine|cocaine
699841|NCT00631748|quetiapine fumarate|quetiapine fumarate
699842|NCT00631748|dependence|dependence
699843|NCT00631748|abuse|abuse
699844|NCT00631748|addiction|addiction
699845|NCT00631748|treatment|treatment
699846|NCT00631735|cancer|cancer
699847|NCT00631735|qualitative|qualitative
699848|NCT00631722|PANSS|panss
699849|NCT00631722|Acute Episode of Schizophrenia|acute episode of schizophrenia
699850|NCT00631696|Healthy males Human volunteers pregabalin or placebo sperm quality and quantity|healthy males human volunteers pregabalin or placebo sperm quality and quantity
699851|NCT00631657|placebo controlled|placebo controlled
699852|NCT00631657|randomized|randomized
699853|NCT00631657|double blind|double blind
699854|NCT00631644|Adolescents|adolescents
699855|NCT00631644|Eating Behavior|eating behavior
699856|NCT00631644|Eating in the Absence of Hunger|eating in the absence of hunger
699857|NCT00631644|Disordered Eating|disordered eating
699858|NCT00631644|Food Intake|food intake
699859|NCT00631644|Macronutrient Composition|macronutrient composition
699860|NCT00631644|Obesity|obesity
699861|NCT00631644|Adolescent|adolescent
699862|NCT00631644|Healthy Volunteer|healthy volunteer
699863|NCT00631644|HV|hv
699864|NCT00631631|Drug Therapy|drug therapy
699865|NCT00631605|eating disorders|eating disorders
699866|NCT00631605|ghrelin|ghrelin
699867|NCT00631605|leptin|leptin
699868|NCT00631605|BIA|bia
699869|NCT00631592|GSK1349572,|gsk1349572,
699870|NCT00631592|healthy volunteers,|healthy volunteers,
699871|NCT00631592|repeat dose,|repeat dose,
699872|NCT00631592|relative bioavailability|relative bioavailability
699873|NCT00631592|Healthy subjects|healthy subjects
699874|NCT00631566|HIV|hiv
699875|NCT00631566|Methicillin-resistant Staphylococcus aureus (MRSA)|methicillin-resistant staphylococcus aureus (mrsa)
699876|NCT00631566|HIV and Staphylococcus aureus infection|hiv and staphylococcus aureus infection
699877|NCT00631540|renal artery stenosis|renal artery stenosis
699878|NCT00631540|hypertension|hypertension
699879|NCT00631540|renovascular|renovascular
699880|NCT00631540|renal artery blockage|renal artery blockage
699881|NCT00631540|renal artery disease|renal artery disease
699882|NCT00631540|renal arteries|renal arteries
699883|NCT00631540|angioplasty renal artery|angioplasty renal artery
699884|NCT00631540|renal artery stent|renal artery stent
699885|NCT00631540|renal artery doppler|renal artery doppler
699886|NCT00631540|renovascular hypertension|renovascular hypertension
699887|NCT00631540|kidney stenosis|kidney stenosis
699888|NCT00631540|renal artery|renal artery
699889|NCT00631540|stent|stent
699890|NCT00631540|stenting|stenting
699891|NCT00631540|kidney disease|kidney disease
699892|NCT00631540|renal failure|renal failure
699893|NCT00631540|atherosclerosis|atherosclerosis
699894|NCT00631540|arterial hypertension|arterial hypertension
699895|NCT00631540|stenosis|stenosis
699896|NCT00631527|Prostate Cancer|prostate cancer
699897|NCT00631527|Radiation Therapy|radiation therapy
699898|NCT00631527|RT|rt
699899|NCT00631527|Radiotherapy|radiotherapy
699900|NCT00631527|Hormone Ablation|hormone ablation
699901|NCT00631527|Sunitinib Malate|sunitinib malate
699902|NCT00631527|Leuprolide|leuprolide
699903|NCT00631527|Lupron|lupron
699904|NCT00631527|Zoladex|zoladex
699905|NCT00631527|Goserelin|goserelin
699906|NCT00631527|Casodex|casodex
699907|NCT00631527|Bicalutamide|bicalutamide
699908|NCT00631527|SU011248|su011248
699910|NCT00631527|Angiogenesis inhibitor|angiogenesis inhibitor
699911|NCT00631514|antihypertensive drugs|antihypertensive drugs
699912|NCT00631514|non-steroidal anti-inflammatory drugs|non-steroidal anti-inflammatory drugs
699913|NCT00631514|interaction|interaction
699914|NCT00631514|family practice|family practice
699915|NCT00631514|arterial blood pressure|arterial blood pressure
699916|NCT00631501|tendinopathy|tendinopathy
699917|NCT00631501|tennis elbow|tennis elbow
699918|NCT00631501|lateral epicondylitis|lateral epicondylitis
699919|NCT00631501|lateral epicondylalgia|lateral epicondylalgia
699920|NCT00631501|MMP-inhibitor|mmp-inhibitor
699921|NCT00631475|Actelion|actelion
699922|NCT00631475|Idiopathic Pulmonary Fibrosis|idiopathic pulmonary fibrosis
699923|NCT00631475|bosentan|bosentan
699924|NCT00631475|Tracleer|tracleer
699925|NCT00631475|Interstitial Lung Disease|interstitial lung disease
699926|NCT00631475|BUILD 3 (NCT00391443)|build 3 (nct00391443)
699927|NCT00631462|primary myelofibrosis|primary myelofibrosis
699928|NCT00631462|post-polycythemia vera myelofibrosis|post-polycythemia vera myelofibrosis
699929|NCT00631462|post-essential thrombocythemia myelofibrosis|post-essential thrombocythemia myelofibrosis
699931|NCT00631449|Treatment intensification|treatment intensification
699932|NCT00631449|Low level viremia|low level viremia
699933|NCT00631449|Suboptimal CD4+ T cell response|suboptimal cd4+ t cell response
699934|NCT00631449|treatment experienced|treatment experienced
699935|NCT00631436|Diffusion Tensor Imaging|diffusion tensor imaging
699936|NCT00631436|Electroencephalography|electroencephalography
699937|NCT00631436|Blast Injury|blast injury
699938|NCT00631436|Traumatic Brain Injury|traumatic brain injury
699939|NCT00631410|Phase 1|phase 1
699940|NCT00631410|CRC|crc
699941|NCT00631410|SU011248|su011248
699942|NCT00631410|Sunitinib|sunitinib
699943|NCT00631410|FOLFOX|folfox
699944|NCT00631410|Colorectal cancer|colorectal cancer
699945|NCT00631410|metastatic carcinoma of the colon or rectum|metastatic carcinoma of the colon or rectum
699946|NCT00631397|weakening of the bones|weakening of the bones
699947|NCT00631384|Voluntary Counseling and Testing|voluntary counseling and testing
699948|NCT00631384|HIV|hiv
699949|NCT00631384|HIV seronegativity|hiv seronegativity
699950|NCT00631371|temsirolimus|temsirolimus
699951|NCT00631371|renal cell carcinoma|renal cell carcinoma
699952|NCT00631371|kidney cancer|kidney cancer
699953|NCT00631371|urogenital cancer|urogenital cancer
699954|NCT00631358|Ocular inflammation|ocular inflammation
699955|NCT00631345|prediabetes|prediabetes
699956|NCT00631345|overweight|overweight
699957|NCT00631345|obesity|obesity
699958|NCT00631345|metabolic syndrome|metabolic syndrome
699959|NCT00631345|community health worker|community health worker
699960|NCT00631332|women, dementia, cognition.|women, dementia, cognition.
699961|NCT00631332|non-demented women at least age 65|non-demented women at least age 65
699962|NCT00631319|OA|oa
699963|NCT00631319|Chronic Pain|chronic pain
699964|NCT00631319|Osteoarthritis|osteoarthritis
699965|NCT00631319|OA Pain|oa pain
699966|NCT00631319|Osteoarthritis Pain|osteoarthritis pain
699967|NCT00631319|Pain|pain
699968|NCT00631319|Hip Pain|hip pain
699969|NCT00631319|Knee Pain|knee pain
699970|NCT00631319|Joint Pain|joint pain
699971|NCT00631293|Healthy volunteers|healthy volunteers
699972|NCT00631280|Decision Aid|decision aid
699973|NCT00631280|Informed Choice|informed choice
699974|NCT00631280|Adherence|adherence
699975|NCT00631267|reduction|reduction
699976|NCT00631267|satisfaction|satisfaction
699977|NCT00631267|visual-analog scale|visual-analog scale
699978|NCT00631267|complications|complications
699979|NCT00631267|functional outcome|functional outcome
699980|NCT00631267|radiological outcome|radiological outcome
699981|NCT00631241|Cervical Cancer|cervical cancer
699982|NCT00631241|Parametrial Lymph Nodes|parametrial lymph nodes
699983|NCT00631241|Sentinel Nodes|sentinel nodes
699984|NCT00631241|Intraoperative Lymphatic Mapping|intraoperative lymphatic mapping
699985|NCT00631241|Single Photon Emission Computed Tomography|single photon emission computed tomography
699986|NCT00631241|SPECT/CT|spect/ct
699987|NCT00631228|drug eluting stents|drug eluting stents
699988|NCT00631228|stents|stents
699989|NCT00631228|Angioplasty|angioplasty
699990|NCT00631228|coronary artery disease|coronary artery disease
699991|NCT00631228|total coronary occlusion|total coronary occlusion
699992|NCT00631228|coronary artery restenosis|coronary artery restenosis
699993|NCT00631228|stent thrombosis|stent thrombosis
699994|NCT00631228|vascular disease|vascular disease
699995|NCT00631228|myocardial ischemia|myocardial ischemia
699996|NCT00631228|coronary artery stenosis|coronary artery stenosis
699997|NCT00631215|Hyperbaric|hyperbaric
699998|NCT00631215|Oxygen|oxygen
699999|NCT00631215|autism|autism
700000|NCT00631202|FRDA|frda
700001|NCT00631202|Erythropoietin|erythropoietin
700002|NCT00631202|Epoetin alfa|epoetin alfa
700003|NCT00631189|dyslipidemia|dyslipidemia
700004|NCT00631176|oral intubation|oral intubation
700005|NCT00631176|just in time|just in time
700006|NCT00631176|simulation education|simulation education
700007|NCT00631176|high fidelity training|high fidelity training
700008|NCT00631176|intubation training|intubation training
700009|NCT00631176|intubation success|intubation success
700010|NCT00631163|Iron Overload,|iron overload,
700011|NCT00631163|Chelation,|chelation,
700012|NCT00631163|MDS,|mds,
700013|NCT00631163|Chronic Anemia,|chronic anemia,
700014|NCT00631163|Deferasirox,|deferasirox,
700015|NCT00631163|Transfusional hemosiderosis,|transfusional hemosiderosis,
700016|NCT00631150|Levetiracetam|levetiracetam
700017|NCT00631150|Keppra|keppra
700018|NCT00631137|musculoskeletal complications|musculoskeletal complications
700019|NCT00631137|adult anaplastic astrocytoma|adult anaplastic astrocytoma
700020|NCT00631137|adult anaplastic oligodendroglioma|adult anaplastic oligodendroglioma
700021|NCT00631137|adult giant cell glioblastoma|adult giant cell glioblastoma
700022|NCT00631137|adult glioblastoma|adult glioblastoma
700023|NCT00631137|adult gliosarcoma|adult gliosarcoma
700024|NCT00631124|Contraception|contraception
700025|NCT00631111|dental pain|dental pain
700026|NCT00631111|analgesic|analgesic
700027|NCT00631111|NSAID|nsaid
700028|NCT00631111|ibuprofen|ibuprofen
700029|NCT00631111|aspirin|aspirin
700030|NCT00631098|Resuscitation|resuscitation
700031|NCT00631098|venous cannulation|venous cannulation
700032|NCT00631098|external jugular vein|external jugular vein
700033|NCT00631098|cubital vein|cubital vein
700034|NCT00631085|healthy nonsmoking nonasthmatic volunteers|healthy nonsmoking nonasthmatic volunteers
700035|NCT00631072|iNKT|inkt
700036|NCT00631072|in vitro autologous iNKT|in vitro autologous inkt
700037|NCT00631059|Hitachi|hitachi
700038|NCT00631059|Leukemia|leukemia
700039|NCT00631059|Relapse|relapse
700040|NCT00631059|Chemotherapy Resistance|chemotherapy resistance
700041|NCT00631046|n-3 LCPUFA|n-3 lcpufa
700042|NCT00631046|Fish oil|fish oil
700043|NCT00631046|essential fatty acids|essential fatty acids
700044|NCT00631046|infant growth|infant growth
700045|NCT00631046|obesity|obesity
700046|NCT00631046|Intestinal microbiota|intestinal microbiota
700047|NCT00631033|obesity|obesity
700048|NCT00631033|hyperinsulinism|hyperinsulinism
700049|NCT00631033|diazoxide|diazoxide
700050|NCT00631033|metformin|metformin
700051|NCT00631020|Youth|youth
700052|NCT00631020|Smoking|smoking
700053|NCT00631020|Tobacco|tobacco
700054|NCT00631020|Adolescent|adolescent
700055|NCT00631020|Dependence|dependence
700056|NCT00631020|Teen smoking|teen smoking
700057|NCT00631020|Smoking and youth|smoking and youth
700058|NCT00631020|Youth and tobacco|youth and tobacco
700059|NCT00631007|Type 2 diabetes|type 2 diabetes
700060|NCT00631007|diabetes|diabetes
700061|NCT00631007|diabetes mellitus|diabetes mellitus
700062|NCT00631007|diabetes mellitus, type 2|diabetes mellitus, type 2
700063|NCT00631007|non-TZD|non-tzd
700064|NCT00631007|thiazolidinedione|thiazolidinedione
700065|NCT00631007|selective peroxisome proliferator-activated receptor gamma modulator|selective peroxisome proliferator-activated receptor gamma modulator
700066|NCT00631007|SPPARM|spparm
700067|NCT00631007|peroxisome proliferator-activated receptor gamma|peroxisome proliferator-activated receptor gamma
700068|NCT00631007|PPAR gamma|ppar gamma
700069|NCT00631007|insulin sensitizer|insulin sensitizer
700070|NCT00631007|glucose control|glucose control
700071|NCT00631007|endocrinopathy|endocrinopathy
700072|NCT00631007|hypoglycemic agent|hypoglycemic agent
700073|NCT00631007|sulfonylurea|sulfonylurea
700074|NCT00631007|metformin|metformin
700075|NCT00631007|pioglitazone|pioglitazone
700076|NCT00631007|nutritional and metabolic diseases|nutritional and metabolic diseases
700077|NCT00630994|primary myelofibrosis|primary myelofibrosis
700078|NCT00630994|secondary myelofibrosis|secondary myelofibrosis
700079|NCT00630994|essential thrombocythemia|essential thrombocythemia
700080|NCT00630994|polycythemia vera|polycythemia vera
700081|NCT00630981|dissociative disorders|dissociative disorders
700082|NCT00630968|Levetiracetam|levetiracetam
700083|NCT00630968|Keppra|keppra
700084|NCT00630955|Alcohol Drinking|alcohol drinking
700085|NCT00630955|Memantine|memantine
700086|NCT00630942|PSC|psc
700087|NCT00630916|Aortic valve insufficiency|aortic valve insufficiency
700088|NCT00630916|Aortic valve|aortic valve
700089|NCT00630916|Aortic disease|aortic disease
700090|NCT00630916|Aortic incompetence|aortic incompetence
700091|NCT00630890|Hilar Cholangiocarcinoma (Klatskin Tumor)|hilar cholangiocarcinoma (klatskin tumor)
700092|NCT00630890|External Beam Radiation|external beam radiation
700093|NCT00630890|Cyberknife|cyberknife
700094|NCT00630890|Capecitabine|capecitabine
700095|NCT00630864|Transthyretin, TTR, amyloidosis, TTR amyloidosis, polyneuropathy|transthyretin, ttr, amyloidosis, ttr amyloidosis, polyneuropathy
700096|NCT00630838|Hirschsprung disease|hirschsprung disease
700097|NCT00630838|enterocolitis|enterocolitis
700098|NCT00630838|probiotics|probiotics
700099|NCT00630812|cystic fibrosis|cystic fibrosis
700100|NCT00630812|mannitol|mannitol
700101|NCT00630812|mucoactive|mucoactive
700102|NCT00630799|prostate|prostate
700103|NCT00630799|cancer|cancer
700104|NCT00630773|CPR|cpr
700105|NCT00630773|compression sensor|compression sensor
700106|NCT00630773|chest compression adjuncts|chest compression adjuncts
700107|NCT00630747|Hunter syndrome|hunter syndrome
700108|NCT00630747|hunters syndrome|hunters syndrome
700109|NCT00630747|hunter's syndrome|hunter's syndrome
700110|NCT00630747|hunter disease|hunter disease
700111|NCT00630747|hunters disease|hunters disease
700112|NCT00630747|hunter's disease|hunter's disease
700113|NCT00630747|MPS II|mps ii
700114|NCT00630747|MPSII|mpsii
700115|NCT00630747|MPS2|mps2
700116|NCT00630747|MPS 2|mps 2
700117|NCT00630747|mucopolysaccharides|mucopolysaccharides
700118|NCT00630747|lysosomal storage disease|lysosomal storage disease
700119|NCT00630747|lysosomal storage disorder|lysosomal storage disorder
700120|NCT00630747|chronic ear infection|chronic ear infection
700121|NCT00630747|enlarged adenoids|enlarged adenoids
700122|NCT00630747|mps symptoms|mps symptoms
700123|NCT00630747|mps diagnosis|mps diagnosis
700124|NCT00630747|mps ii therapy|mps ii therapy
700125|NCT00630747|MPS II treatment|mps ii treatment
700126|NCT00630747|ert treatment|ert treatment
700127|NCT00630747|elaprase|elaprase
700128|NCT00630747|idursulfase|idursulfase
700129|NCT00630747|iduronate sulfatase|iduronate sulfatase
700130|NCT00630747|iduronate 2 sulfatase|iduronate 2 sulfatase
700131|NCT00630747|enzyme replacement therapy|enzyme replacement therapy
700132|NCT00630747|hunter syndrome treatment|hunter syndrome treatment
700133|NCT00630747|hunter's syndrome treatment|hunter's syndrome treatment
700134|NCT00630747|hunter syndrome therapy|hunter syndrome therapy
700135|NCT00630747|hunter's disease treatment|hunter's disease treatment
700136|NCT00630747|mps society|mps society
700137|NCT00630734|HIV|hiv
700138|NCT00630734|Pravastatin|pravastatin
700139|NCT00630734|Darunavir|darunavir
700140|NCT00630734|Ritonavir|ritonavir
700141|NCT00630734|Genetic|genetic
700142|NCT00630708|Renal insufficiency|renal insufficiency
700143|NCT00630708|Benazepril|benazepril
700144|NCT00630708|Losartan|losartan
700145|NCT00630708|combination treatment|combination treatment
700146|NCT00630708|Safety|safety
700147|NCT00630695|Axillary lymphocele breast cancer|axillary lymphocele breast cancer
700148|NCT00630682|Methamphetamine|methamphetamine
700149|NCT00630682|Drug Abuse|drug abuse
700150|NCT00630682|Drug Treatment|drug treatment
700151|NCT00630682|Addiction|addiction
700152|NCT00630682|Meth|meth
700153|NCT00630682|Treatment for Methamphetamine Dependence|treatment for methamphetamine dependence
700154|NCT00630669|Internal hemorrhoids|internal hemorrhoids
700155|NCT00630669|Rubber band ligation|rubber band ligation
700156|NCT00630669|Bipolar coagulation|bipolar coagulation
700157|NCT00630656|sepsis|sepsis
700158|NCT00630656|talactoferrin|talactoferrin
700159|NCT00630656|lactoferrin|lactoferrin
700160|NCT00630656|recombinant human lactoferrin|recombinant human lactoferrin
700161|NCT00630630|Levetiracetam|levetiracetam
700162|NCT00630630|Keppra|keppra
700163|NCT00630617|Obesity|obesity
700164|NCT00630617|Prevention|prevention
700165|NCT00630617|Childhood|childhood
700166|NCT00630617|Children|children
700167|NCT00630617|Primary care-giver|primary care-giver
700168|NCT00630604|ultrasonography|ultrasonography
700169|NCT00630604|knee|knee
700170|NCT00630604|early degeneration|early degeneration
700171|NCT00630604|cartilage|cartilage
700172|NCT00630591|Daughters And MothErS Against Breast Cancer|daughters and mothers against breast cancer
700173|NCT00630591|DAMES|dames
700174|NCT00630591|Breast Cancer|breast cancer
700175|NCT00630591|Weight Loss|weight loss
700176|NCT00630591|Home-based weight loss|home-based weight loss
700177|NCT00630591|Quality of Life|quality of life
700178|NCT00630591|Diet|diet
700179|NCT00630591|Exercise|exercise
700180|NCT00630591|Daughter|daughter
700181|NCT00630591|Mother|mother
700182|NCT00630591|Cancer Prevention|cancer prevention
700183|NCT00630591|Prevention|prevention
700184|NCT00630578|PTSD|ptsd
700185|NCT00630578|Posttraumatic Stress Disorder|posttraumatic stress disorder
700186|NCT00630578|Physical Assault|physical assault
700187|NCT00630578|Physical Abuse|physical abuse
700188|NCT00630578|Sexual Assault|sexual assault
700189|NCT00630578|Sexual Abuse|sexual abuse
700190|NCT00630578|Interpersonal Assault|interpersonal assault
700191|NCT00630578|Cognitive Processing Therapy|cognitive processing therapy
700192|NCT00630565|adult acute myeloid leukemia in remission|adult acute myeloid leukemia in remission
700193|NCT00630565|adult acute myeloid leukemia with inv(16)(p13;q22)|adult acute myeloid leukemia with inv(16)(p13;q22)
700194|NCT00630565|adult acute myeloid leukemia with t(15;17)(q22;q12)|adult acute myeloid leukemia with t(15;17)(q22;q12)
700195|NCT00630565|adult acute myeloid leukemia with t(8;21)(q22;q22)|adult acute myeloid leukemia with t(8;21)(q22;q22)
700196|NCT00630565|adult acute myeloid leukemia with 11q23 (MLL) abnormalities|adult acute myeloid leukemia with 11q23 (mll) abnormalities
700197|NCT00630565|adult acute myeloid leukemia with t(16;16)(p13;q22)|adult acute myeloid leukemia with t(16;16)(p13;q22)
700198|NCT00630565|childhood acute myeloid leukemia in remission|childhood acute myeloid leukemia in remission
700199|NCT00630552|AMG 479|amg 479
700200|NCT00630552|Gemcitabine|gemcitabine
700201|NCT00630552|TR-2|tr-2
700202|NCT00630552|IGF-1R|igf-1r
700203|NCT00630552|AMG 655|amg 655
700204|NCT00630552|Pancreatic cancer|pancreatic cancer
700205|NCT00630552|Adenocarcinoma of the Pancreas|adenocarcinoma of the pancreas
700206|NCT00630552|Metastatic Pancreatic Cancer|metastatic pancreatic cancer
700207|NCT00630539|Menopausal symptoms|menopausal symptoms
700208|NCT00630539|Urogenital atrophy|urogenital atrophy
700209|NCT00630539|Vulvar and vaginal atrophy in postmenopausal women|vulvar and vaginal atrophy in postmenopausal women
700210|NCT00630539|Vaginal atrophy|vaginal atrophy
700211|NCT00630513|localized community acquired intra-abdominal infection (IAI)|localized community acquired intra-abdominal infection (iai)
700212|NCT00630513|antibiotics|antibiotics
700213|NCT00630513|localized peritonitis|localized peritonitis
700214|NCT00630513|ertapenem|ertapenem
700215|NCT00630500|Dementia associated with Parkinson's disease|dementia associated with parkinson's disease
700216|NCT00630500|Dementia with Lewy bodies|dementia with lewy bodies
700217|NCT00630500|Memantine|memantine
700218|NCT00630500|Placebo-controlled|placebo-controlled
700219|NCT00630500|Parallel group|parallel group
700220|NCT00630474|sleep apnea, rhinitis|sleep apnea, rhinitis
700221|NCT00630461|mild asthma, mild allergies|mild asthma, mild allergies
700222|NCT00630435|Premarin®|premarin®
700223|NCT00630422|Rett Syndrome|rett syndrome
700224|NCT00630422|Selfcare|selfcare
700225|NCT00630422|Mobility limitation|mobility limitation
700226|NCT00630422|Interpersonal relations|interpersonal relations
700227|NCT00630422|This study avaliated patients with Rett Syndrome|this study avaliated patients with rett syndrome
700228|NCT00630409|Renal cell carcinoma|renal cell carcinoma
700229|NCT00630409|Kidney Cancer|kidney cancer
700230|NCT00630409|Gemcitabine|gemcitabine
700231|NCT00630409|Doxil|doxil
700232|NCT00630409|Chemotherapy|chemotherapy
700233|NCT00630396|stroke|stroke
700234|NCT00630396|ischemic|ischemic
700235|NCT00630396|neuroprotection|neuroprotection
700236|NCT00630396|minocycline|minocycline
700237|NCT00630396|tissue plasminogen activator (tPA)|tissue plasminogen activator (tpa)
700238|NCT00630396|biomarkers|biomarkers
700239|NCT00630396|pharmacokinetics|pharmacokinetics
700240|NCT00630396|antiapoptotic|antiapoptotic
700241|NCT00630396|anti-inflammatory|anti-inflammatory
700242|NCT00630396|treatment|treatment
700243|NCT00630396|matrix metalloproteinase-9 (MMP-9)|matrix metalloproteinase-9 (mmp-9)
700244|NCT00630396|thrombolysis|thrombolysis
700245|NCT00630396|Minocycline to Improve Neurologic Outcome in Stroke (MINOS)|minocycline to improve neurologic outcome in stroke (minos)
700246|NCT00630396|cerebrovascular stroke|cerebrovascular stroke
700247|NCT00630396|cerebrovascular accident|cerebrovascular accident
700248|NCT00630396|cerebral stroke|cerebral stroke
700249|NCT00630396|cerebrovascular accident (CVA)|cerebrovascular accident (cva)
700250|NCT00630383|Parasite|parasite
700251|NCT00630383|Necator|necator
700252|NCT00630383|immune regulation|immune regulation
700253|NCT00630383|regulatory T cells|regulatory t cells
700254|NCT00630383|foxp3|foxp3
700255|NCT00630383|cytokines|cytokines
700256|NCT00630383|multiple sclerosis|multiple sclerosis
700257|NCT00630383|hygiene hypothesis|hygiene hypothesis
700258|NCT00630357|Levetiracetam|levetiracetam
700259|NCT00630357|Keppra|keppra
700260|NCT00630344|RAD001|rad001
700261|NCT00630344|bicalutamide|bicalutamide
700262|NCT00630344|androgen independent prostate cancer|androgen independent prostate cancer
700263|NCT00630331|Influenza|influenza
700265|NCT00630331|Cell Culture-Derived|cell culture-derived
700266|NCT00630331|Egg-Derived|egg-derived
700267|NCT00630331|Healthy Adults|healthy adults
700268|NCT00630331|Efficacy|efficacy
700269|NCT00630331|Safety|safety
700270|NCT00630331|Immunogenicity|immunogenicity
700271|NCT00630331|Trivalent|trivalent
700272|NCT00630331|Inactivated|inactivated
700273|NCT00630331|Influenza-Like Illness|influenza-like illness
700274|NCT00630331|Vaccination|vaccination
700275|NCT00630318|MR scanning|mr scanning
700276|NCT00630305|toric|toric
700277|NCT00630305|endothelial bleb|endothelial bleb
700278|NCT00630279|pancreatic exocrine insufficiency|pancreatic exocrine insufficiency
700279|NCT00630279|chronic pancreatitis|chronic pancreatitis
700280|NCT00630266|Heart failure|heart failure
700281|NCT00630266|left ventricular dilation|left ventricular dilation
700282|NCT00630266|mitral valve repair|mitral valve repair
700283|NCT00630266|mitral valve replacement|mitral valve replacement
700284|NCT00630253|Fanconi anemia|fanconi anemia
700285|NCT00630240|epirubicin|epirubicin
700286|NCT00630240|mitomycin C|mitomycin c
700287|NCT00630240|cisplatin|cisplatin
700288|NCT00630240|Hepatocellular carcinoma|hepatocellular carcinoma
700289|NCT00630227|emphysema|emphysema
700290|NCT00630227|chronic obstructive pulmonary disease|chronic obstructive pulmonary disease
700291|NCT00630227|lung volume reduction|lung volume reduction
700292|NCT00630214|Total thyroidectomy|total thyroidectomy
700293|NCT00630214|CND|cnd
700294|NCT00630214|hypocalcemia|hypocalcemia
700295|NCT00630214|calcium|calcium
700296|NCT00630214|vitamin D|vitamin d
700297|NCT00630201|opioid dependence|opioid dependence
700298|NCT00630201|opioid addiction|opioid addiction
700299|NCT00630201|buprenorphine|buprenorphine
700300|NCT00630201|methadone|methadone
700301|NCT00630201|heroin|heroin
700302|NCT00630201|implant|implant
700303|NCT00630201|opioid withdrawal|opioid withdrawal
700304|NCT00630201|opioid pain medication|opioid pain medication
700305|NCT00630201|suboxone|suboxone
700306|NCT00630188|prostate cancer screening|prostate cancer screening
700307|NCT00630188|shared decision making|shared decision making
700308|NCT00630188|prostate-specific antigen|prostate-specific antigen
700309|NCT00630188|decision making|decision making
700310|NCT00630188|physician-patient relations|physician-patient relations
700311|NCT00630175|Insomnia|insomnia
700312|NCT00630162|protozoa|protozoa
700313|NCT00630162|Amoeba|amoeba
700314|NCT00630149|Nasopharyngeal Neoplasms|nasopharyngeal neoplasms
700315|NCT00630149|Pemetrexed|pemetrexed
700316|NCT00630110|Non Small Cell Lung|non small cell lung
700317|NCT00630097|methamphetamine addiction, meth dependence|methamphetamine addiction, meth dependence
700318|NCT00630084|chronic hepatitis C|chronic hepatitis c
700319|NCT00630084|sustained virological response|sustained virological response
700320|NCT00630084|peginterferon|peginterferon
700321|NCT00630084|ribavirin|ribavirin
700322|NCT00630084|neoplasms|neoplasms
700323|NCT00630071|Diagnostic Appendicitis|diagnostic appendicitis
700324|NCT00630071|Procalcitonin|procalcitonin
700325|NCT00630058|Chronic Hepatitis C|chronic hepatitis c
700326|NCT00630058|Protease Inhibitor|protease inhibitor
700327|NCT00630058|Telaprevir|telaprevir
700328|NCT00630032|stage II breast cancer|stage ii breast cancer
700329|NCT00630032|stage IIIA breast cancer|stage iiia breast cancer
700330|NCT00630032|stage IIIB breast cancer|stage iiib breast cancer
700331|NCT00630032|stage IIIC breast cancer|stage iiic breast cancer
700332|NCT00630019|Aqueous humor penetration by anti-infectives|aqueous humor penetration by anti-infectives
700333|NCT00629993|cervical cancer screening|cervical cancer screening
700334|NCT00629993|medically underserved women|medically underserved women
700335|NCT00629993|HPV vaccine|hpv vaccine
700336|NCT00629967|chronic hepatitis C|chronic hepatitis c
700337|NCT00629967|genotype 1|genotype 1
700338|NCT00629967|rapid virological response|rapid virological response
700339|NCT00629967|sustained virological response|sustained virological response
700340|NCT00629967|peginterferon|peginterferon
700341|NCT00629967|ribavirin|ribavirin
700342|NCT00629967|treatment duration|treatment duration
700343|NCT00629954|ABUJA HEART STUDY NIGERIA|abuja heart study nigeria
700344|NCT00629954|CARDIOVASCULAR DISEASES|cardiovascular diseases
700345|NCT00629928|NSAID, Nexium, esomeprazole, Gastric Ulcers|nsaid, nexium, esomeprazole, gastric ulcers
700346|NCT00629915|Moyamoya|moyamoya
700347|NCT00629915|stroke|stroke
700348|NCT00629902|Heart valve prosthesis|heart valve prosthesis
700349|NCT00629889|seizure|seizure
700350|NCT00629889|adult anaplastic astrocytoma|adult anaplastic astrocytoma
700351|NCT00629889|adult diffuse astrocytoma|adult diffuse astrocytoma
700352|NCT00629889|adult pineal gland astrocytoma|adult pineal gland astrocytoma
700353|NCT00629889|adult glioblastoma|adult glioblastoma
700354|NCT00629889|adult gliosarcoma|adult gliosarcoma
700355|NCT00629889|adult giant cell glioblastoma|adult giant cell glioblastoma
700356|NCT00629889|adult brain stem glioma|adult brain stem glioma
700357|NCT00629889|adult ependymoblastoma|adult ependymoblastoma
700358|NCT00629889|adult medulloblastoma|adult medulloblastoma
700359|NCT00629889|adult supratentorial primitive neuroectodermal tumor (PNET)|adult supratentorial primitive neuroectodermal tumor (pnet)
700360|NCT00629889|adult ependymoma|adult ependymoma
700361|NCT00629889|adult anaplastic ependymoma|adult anaplastic ependymoma
700362|NCT00629889|adult anaplastic meningioma|adult anaplastic meningioma
700363|NCT00629889|adult anaplastic oligodendroglioma|adult anaplastic oligodendroglioma
700364|NCT00629889|adult oligodendroglioma|adult oligodendroglioma
700365|NCT00629889|adult pineoblastoma|adult pineoblastoma
700366|NCT00629889|adult pineocytoma|adult pineocytoma
700367|NCT00629889|adult mixed glioma|adult mixed glioma
700368|NCT00629889|adult papillary meningioma|adult papillary meningioma
700369|NCT00629889|recurrent adult brain tumor|recurrent adult brain tumor
700370|NCT00629889|adult grade II meningioma|adult grade ii meningioma
700371|NCT00629876|Chemotherapy|chemotherapy
700372|NCT00629876|Drug Therapy|drug therapy
700373|NCT00629863|stage I gastric cancer|stage i gastric cancer
700374|NCT00629863|stage II gastric cancer|stage ii gastric cancer
700375|NCT00629863|stage III gastric cancer|stage iii gastric cancer
700376|NCT00629863|stage I esophageal cancer|stage i esophageal cancer
700377|NCT00629863|stage II esophageal cancer|stage ii esophageal cancer
700378|NCT00629863|stage III esophageal cancer|stage iii esophageal cancer
700379|NCT00629850|spinal cord injury|spinal cord injury
700380|NCT00629850|respiratory muscle training|respiratory muscle training
700381|NCT00629850|sleep quality|sleep quality
700382|NCT00629837|FVIII|fviii
700383|NCT00629837|Long acting|long acting
700384|NCT00629837|pk|pk
700385|NCT00629824|chronic hepatitis C|chronic hepatitis c
700386|NCT00629824|sustained virological response|sustained virological response
700387|NCT00629824|rapid virological response|rapid virological response
700388|NCT00629824|peginterferon|peginterferon
700389|NCT00629824|ribavirin|ribavirin
700390|NCT00629824|old age|old age
700391|NCT00629811|Cicatrix|cicatrix
700392|NCT00629811|Scar|scar
700393|NCT00629811|TGFβ3|tgfβ3
700394|NCT00629811|Avotermin|avotermin
700395|NCT00629811|Juvista|juvista
700396|NCT00629811|RN1001|rn1001
700397|NCT00629798|Busulfan|busulfan
700398|NCT00629798|Melphalan|melphalan
700399|NCT00629798|Fludarabine|fludarabine
700400|NCT00629798|08-008|08-008
700401|NCT00629785|asthma|asthma
700402|NCT00629785|pulmonary function tests|pulmonary function tests
700403|NCT00629785|obesity|obesity
700404|NCT00629772|Palmoplantar psoriasis|palmoplantar psoriasis
700405|NCT00629772|Infliximab|infliximab
700406|NCT00629759|Jennerex|jennerex
700407|NCT00629759|unresectable liver tumors|unresectable liver tumors
700408|NCT00629759|primary liver cancer|primary liver cancer
700409|NCT00629759|metastatic liver cancer|metastatic liver cancer
700410|NCT00629759|oncolytic virus|oncolytic virus
700411|NCT00629759|vaccinia virus|vaccinia virus
700412|NCT00629759|Pexa-Vec|pexa-vec
700413|NCT00629746|Thyroid|thyroid
700414|NCT00629746|RLN|rln
700415|NCT00629746|EMG|emg
700416|NCT00629733|pharmacokinetics|pharmacokinetics
700417|NCT00629733|ultra low molecular weight heparin|ultra low molecular weight heparin
700418|NCT00629720|elevated detrusor leak point pressure|elevated detrusor leak point pressure
700419|NCT00629707|diabetic ketoacidosis|diabetic ketoacidosis
700420|NCT00629707|DKA|dka
700421|NCT00629707|cerebral edema|cerebral edema
700422|NCT00629707|brain edema|brain edema
700423|NCT00629694|adenoidectomy, myringotomy, tubes insertion, otitis media, adenoid hyperthophy|adenoidectomy, myringotomy, tubes insertion, otitis media, adenoid hyperthophy
700424|NCT00629655|fMRI|fmri
700425|NCT00629655|spinal cord|spinal cord
700426|NCT00629655|human|human
700427|NCT00629655|health|health
700428|NCT00629655|cerebral infarction|cerebral infarction
700429|NCT00629655|healthy|healthy
700430|NCT00629642|Neurogenic bladder|neurogenic bladder
700431|NCT00629642|Vesicare|vesicare
700432|NCT00629629|Health Plan Implementation|health plan implementation
700433|NCT00629629|Feeding and Eating Disorders of Childhood|feeding and eating disorders of childhood
700434|NCT00629629|Breastfeeding|breastfeeding
700435|NCT00629629|Complementary feeding|complementary feeding
700436|NCT00629629|Morbidity|morbidity
700437|NCT00629629|Anemia|anemia
700438|NCT00629629|Public policy|public policy
700439|NCT00629616|stage II breast cancer|stage ii breast cancer
700440|NCT00629616|stage IIIA breast cancer|stage iiia breast cancer
700441|NCT00629616|stage IIIB breast cancer|stage iiib breast cancer
700442|NCT00629616|stage IIIC breast cancer|stage iiic breast cancer
700443|NCT00629603|hepatitis C virus infection|hepatitis c virus infection
700444|NCT00629603|chronic liver disease|chronic liver disease
700445|NCT00629603|fibrosis-related cytokine|fibrosis-related cytokine
700446|NCT00629577|cervical cancer|cervical cancer
700447|NCT00629577|cervical intraepithelial neoplasia grade 1|cervical intraepithelial neoplasia grade 1
700448|NCT00629577|cervical intraepithelial neoplasia grade 2|cervical intraepithelial neoplasia grade 2
700449|NCT00629577|cervical intraepithelial neoplasia grade 3|cervical intraepithelial neoplasia grade 3
700450|NCT00629564|Gastroesophageal Reflux Disease (GERD), esomeprazole, Nexium|gastroesophageal reflux disease (gerd), esomeprazole, nexium
700451|NCT00629551|Major Depressive Disorder|major depressive disorder
700452|NCT00629551|Depression|depression
700453|NCT00629551|Major Depressive Episode|major depressive episode
700454|NCT00629551|Antidepressant|antidepressant
700455|NCT00629538|congestive heart failure|congestive heart failure
700456|NCT00629538|thoracentesis|thoracentesis
700457|NCT00629538|transudative pleural effusions|transudative pleural effusions
700458|NCT00629512|NSAID, Nexium, esomeprazole, Gastric Ulcers|nsaid, nexium, esomeprazole, gastric ulcers
700459|NCT00629499|Early Stage Breast Cancer|early stage breast cancer
700460|NCT00629499|Her2-positive|her2-positive
700461|NCT00629499|nab paclitaxel|nab paclitaxel
700462|NCT00629499|cyclophosphamide|cyclophosphamide
700463|NCT00629499|trastuzumab|trastuzumab
700464|NCT00629486|cytokine gene|cytokine gene
700465|NCT00629486|hepatitis B|hepatitis b
700466|NCT00629486|hepatocellular carcinoma|hepatocellular carcinoma
700467|NCT00629486|chronic liver disease|chronic liver disease
700468|NCT00629473|multiple myeloma|multiple myeloma
700469|NCT00629473|leukemias (inc. CLL)|leukemias (inc. cll)
700470|NCT00629473|lymphomas|lymphomas
700471|NCT00629473|cutaneous lymphoma|cutaneous lymphoma
700472|NCT00629473|marginal zone lymphoma|marginal zone lymphoma
700473|NCT00629473|advanced malignancies without standard treatment options|advanced malignancies without standard treatment options
700474|NCT00629460|Pulmonary Nodules|pulmonary nodules
700475|NCT00629447|Primary Brain Tumor|primary brain tumor
700476|NCT00629447|Venous Thromboembolism|venous thromboembolism
700477|NCT00629447|Heparin|heparin
700478|NCT00629434|Diabetes Education|diabetes education
700479|NCT00629434|Telemedicine|telemedicine
700480|NCT00629395|pediatric|pediatric
700481|NCT00629395|brain tumor|brain tumor
700482|NCT00629395|survivors|survivors
700483|NCT00629382|abdominal sepsis|abdominal sepsis
700484|NCT00629382|abdominal surgery|abdominal surgery
700485|NCT00629382|septic shock|septic shock
700486|NCT00629382|polymyxin B|polymyxin b
700487|NCT00629382|hemoperfusion|hemoperfusion
700488|NCT00629382|Endotoxins|endotoxins
700489|NCT00629343|Soft Tissue Sarcoma|soft tissue sarcoma
700490|NCT00629343|Mesothelioma|mesothelioma
700491|NCT00629343|Azacitidine|azacitidine
700492|NCT00629343|Temozolomide|temozolomide
700493|NCT00629343|Temodar|temodar
700494|NCT00629330|prostate cancer|prostate cancer
700495|NCT00629330|prostate cancer screening|prostate cancer screening
700496|NCT00629330|prostate specific antigen|prostate specific antigen
700497|NCT00629330|African American males|african american males
700498|NCT00629317|Skin Aging|skin aging
700499|NCT00629317|Rejuvenation|rejuvenation
700500|NCT00629317|Photodynamic Therapy|photodynamic therapy
700501|NCT00629317|Methyl Aminolevulinate|methyl aminolevulinate
700502|NCT00629304|type 1 diabetes|type 1 diabetes
700503|NCT00629304|PDA phone (Personal Digital Assistant)|pda phone (personal digital assistant)
700504|NCT00629304|HbA1c|hba1c
700505|NCT00629291|iron overload|iron overload
700506|NCT00629291|Thalassemia|thalassemia
700507|NCT00629291|Anemia, Sickle Cell|anemia, sickle cell
700508|NCT00629291|Magnetic Resonance Imaging|magnetic resonance imaging
700509|NCT00629278|stage IA breast cancer|stage ia breast cancer
700510|NCT00629278|stage IB breast cancer|stage ib breast cancer
700511|NCT00629278|stage II breast cancer|stage ii breast cancer
700512|NCT00629278|stage IIIA breast cancer|stage iiia breast cancer
700513|NCT00629278|HER2-positive breast cancer|her2-positive breast cancer
700514|NCT00629265|Dysphagia|dysphagia
700515|NCT00629265|Neuromuscular Electrical Stimulation (NMES)|neuromuscular electrical stimulation (nmes)
700516|NCT00629265|Head & Neck Cancer|head & neck cancer
700517|NCT00629265|Radiation and ChemoTherapy|radiation and chemotherapy
700518|NCT00629252|Schizophrenia|schizophrenia
700519|NCT00629252|PPI|ppi
700520|NCT00629252|P50|p50
700521|NCT00629252|CANTAB|cantab
700522|NCT00629252|sensory gating|sensory gating
700523|NCT00629252|Schizophrenic patients according to DSM-IV|schizophrenic patients according to dsm-iv
700524|NCT00629239|COPD|copd
700525|NCT00629239|tolerability|tolerability
700526|NCT00629239|inhalation|inhalation
700527|NCT00629226|stage IV squamous cell carcinoma of the hypopharynx|stage iv squamous cell carcinoma of the hypopharynx
700528|NCT00629226|stage IV squamous cell carcinoma of the larynx|stage iv squamous cell carcinoma of the larynx
700529|NCT00629226|stage IV squamous cell carcinoma of the lip and oral cavity|stage iv squamous cell carcinoma of the lip and oral cavity
700530|NCT00629226|stage IV squamous cell carcinoma of the oropharynx|stage iv squamous cell carcinoma of the oropharynx
700531|NCT00629226|stage IV squamous cell carcinoma of the paranasal sinus and nasal cavity|stage iv squamous cell carcinoma of the paranasal sinus and nasal cavity
700532|NCT00629226|recurrent squamous cell carcinoma of the hypopharynx|recurrent squamous cell carcinoma of the hypopharynx
700533|NCT00629226|recurrent squamous cell carcinoma of the larynx|recurrent squamous cell carcinoma of the larynx
700534|NCT00629226|recurrent squamous cell carcinoma of the lip and oral cavity|recurrent squamous cell carcinoma of the lip and oral cavity
700535|NCT00629226|recurrent squamous cell carcinoma of the nasopharynx|recurrent squamous cell carcinoma of the nasopharynx
700536|NCT00629226|recurrent squamous cell carcinoma of the oropharynx|recurrent squamous cell carcinoma of the oropharynx
700537|NCT00629226|recurrent squamous cell carcinoma of the paranasal sinus and nasal cavity|recurrent squamous cell carcinoma of the paranasal sinus and nasal cavity
700538|NCT00629213|prevention,|prevention,
700539|NCT00629213|type 2 diabetes,|type 2 diabetes,
700540|NCT00629213|metabolic syndrome,|metabolic syndrome,
700541|NCT00629213|acarbose treatment|acarbose treatment
700542|NCT00629200|Advanced Malignancies|advanced malignancies
700543|NCT00629200|Solid Tumors|solid tumors
700544|NCT00629200|Melanoma|melanoma
700545|NCT00629200|Renal Cell Carcinoma|renal cell carcinoma
700546|NCT00629200|Phase I Studies|phase i studies
700547|NCT00629200|Sodium Stibogluconate|sodium stibogluconate
700548|NCT00629200|Interferon Alpha-2b|interferon alpha-2b
700549|NCT00629200|Intron A|intron a
700550|NCT00629200|SSG|ssg
700551|NCT00629187|Lung Neoplasm|lung neoplasm
700552|NCT00629187|Breast Neoplasm|breast neoplasm
700553|NCT00629187|Melanoma|melanoma
700554|NCT00629187|Central Nervous System Neoplasms|central nervous system neoplasms
700555|NCT00629187|Neoplasm Metastasis|neoplasm metastasis
700556|NCT00629187|Neoplasm Second Primary|neoplasm second primary
700557|NCT00629187|Peripheral Blood Stem Cell Transplantation|peripheral blood stem cell transplantation
700558|NCT00629174|Cognitive function|cognitive function
700559|NCT00629174|Elderly|elderly
700560|NCT00629174|Exercise|exercise
700561|NCT00629174|Mental activity|mental activity
700562|NCT00629148|metastasis|metastasis
700563|NCT00629148|chemotherapy|chemotherapy
700564|NCT00629148|breast cancer|breast cancer
700565|NCT00629148|Vinorelbine|vinorelbine
700566|NCT00629148|Capecitabine|capecitabine
700567|NCT00629148|sequential chemotherapy|sequential chemotherapy
700568|NCT00629148|TTF|ttf
700569|NCT00629135|abscess|abscess
700570|NCT00629135|intraabdominal abscess|intraabdominal abscess
700571|NCT00629135|Moxifloxacine|moxifloxacine
700572|NCT00629135|Moxifloxacin|moxifloxacin
700573|NCT00629135|Metronidazole|metronidazole
700574|NCT00629135|Tazobactam|tazobactam
700575|NCT00629135|Piperacilline|piperacilline
700576|NCT00629135|Piperacillin|piperacillin
700577|NCT00629135|Tazobac|tazobac
700578|NCT00629122|Kidney Transplantation|kidney transplantation
700579|NCT00629122|Tacrolimus (Prograf)|tacrolimus (prograf)
700580|NCT00629122|Pharmacokinetics|pharmacokinetics
700878|NCT00628043|anemia|anemia
700581|NCT00629122|Sublingual administration|sublingual administration
700582|NCT00629122|Drug interactions (Cytochrome P450 and p-glycoprotein)|drug interactions (cytochrome p450 and p-glycoprotein)
700583|NCT00629096|Dilated Cardiomyopathy|dilated cardiomyopathy
700584|NCT00629096|Marrow stem cells|marrow stem cells
700585|NCT00629096|Myocardial regeneration|myocardial regeneration
700586|NCT00629096|Mesenchymal stem cells|mesenchymal stem cells
700587|NCT00629096|Marrow-derived endothelial progenitor cells|marrow-derived endothelial progenitor cells
700588|NCT00629083|SUI|sui
700589|NCT00629083|Bulkamid|bulkamid
700590|NCT00629083|Urinary Incontinence|urinary incontinence
700591|NCT00629070|cerebral palsy|cerebral palsy
700592|NCT00629070|muscle strength|muscle strength
700593|NCT00629070|muscle architecture|muscle architecture
700594|NCT00629070|ultrasound|ultrasound
700595|NCT00629070|rehabilitation|rehabilitation
700596|NCT00629070|rectus femoris|rectus femoris
700597|NCT00629070|quadriceps muscle|quadriceps muscle
700598|NCT00629057|androgen-insensitive, non-metastatic, prostate, cancer|androgen-insensitive, non-metastatic, prostate, cancer
700599|NCT00629031|Visceral leishmaniasis|visceral leishmaniasis
700600|NCT00629031|Paromomycin|paromomycin
700601|NCT00629018|Stem Cells|stem cells
700602|NCT00629018|Heart Failure|heart failure
700603|NCT00629018|Dilated Cardiomyopathy|dilated cardiomyopathy
700604|NCT00629005|rehabilitation|rehabilitation
700605|NCT00629005|upper extremity|upper extremity
700606|NCT00629005|motor skills|motor skills
700607|NCT00628992|COPD: chronic obstructive pulmonary disease and acute respiratory failure|copd: chronic obstructive pulmonary disease and acute respiratory failure
700608|NCT00628966|Heart Attack|heart attack
700609|NCT00628966|ICD|icd
700610|NCT00628966|Risk Stratification|risk stratification
700611|NCT00628966|Arrhythmia|arrhythmia
700612|NCT00628953|Asthma|asthma
700613|NCT00628953|Acid Reflux|acid reflux
700614|NCT00628953|Nexium|nexium
700615|NCT00628953|Esomeprazole|esomeprazole
700616|NCT00628914|Major Depressive Disorder|major depressive disorder
700617|NCT00628914|Insomnia|insomnia
700618|NCT00628914|Escitalopram|escitalopram
700619|NCT00628914|Lexapro|lexapro
700620|NCT00628914|Eszopiclone|eszopiclone
700621|NCT00628914|Lunesta|lunesta
700622|NCT00628914|Cordance|cordance
700623|NCT00628901|Leiomyoma|leiomyoma
700624|NCT00628901|Uterine Fibroids|uterine fibroids
700625|NCT00628901|Uterine Fibroid Embolization (UFE)|uterine fibroid embolization (ufe)
700626|NCT00628901|Uterine Artery Embolization (UAE)|uterine artery embolization (uae)
700627|NCT00628901|Uterine Neoplasms|uterine neoplasms
700628|NCT00628901|Menorrhagia|menorrhagia
700629|NCT00628888|Unipolar Depression|unipolar depression
700630|NCT00628888|Anxiety|anxiety
700631|NCT00628888|Adolescent|adolescent
700632|NCT00628888|Emotion|emotion
700633|NCT00628888|Cognitive Behavioral|cognitive behavioral
700634|NCT00628875|mechanical ventilation|mechanical ventilation
700635|NCT00628875|thoracic impedence|thoracic impedence
700636|NCT00628875|defibrillator pads|defibrillator pads
700637|NCT00628875|ventilation detection|ventilation detection
700638|NCT00628875|pediatric ventilation|pediatric ventilation
700639|NCT00628862|Chronic Obstructive Pulmonary Disease|chronic obstructive pulmonary disease
700640|NCT00628862|COPD|copd
700641|NCT00628849|Mandible|mandible
700642|NCT00628849|fracture|fracture
700643|NCT00628849|Champy|champy
700644|NCT00628849|AO technique|ao technique
700645|NCT00628836|Neuromuscular stimulator|neuromuscular stimulator
700646|NCT00628836|Shoulder subluxation|shoulder subluxation
700647|NCT00628823|Celiac Disease|celiac disease
700648|NCT00628823|Endomysial antibodies|endomysial antibodies
700649|NCT00628823|Mild enteropathy|mild enteropathy
700650|NCT00628823|Treatment|treatment
700651|NCT00628823|Gluten-free diet|gluten-free diet
700652|NCT00628810|adenocarcinoma of the colon|adenocarcinoma of the colon
885560|NCT00002228|HIV-1|hiv-1
700653|NCT00628810|adenocarcinoma of the rectum|adenocarcinoma of the rectum
700654|NCT00628810|stage IV colon cancer|stage iv colon cancer
700655|NCT00628810|stage IV rectal cancer|stage iv rectal cancer
700656|NCT00628810|recurrent colon cancer|recurrent colon cancer
700657|NCT00628810|recurrent rectal cancer|recurrent rectal cancer
700658|NCT00628797|systemic sclerosis|systemic sclerosis
700659|NCT00628797|skin fibrosis|skin fibrosis
700660|NCT00628784|Dysplasia|dysplasia
700661|NCT00628784|Ablation|ablation
700662|NCT00628784|Squamous dysplasia|squamous dysplasia
700663|NCT00628784|Early esophageal adenocarcinoma|early esophageal adenocarcinoma
700664|NCT00628784|Cryotherapy|cryotherapy
700665|NCT00628771|HIV Prevention|hiv prevention
700666|NCT00628771|Teen Pregnancy|teen pregnancy
700667|NCT00628771|Translational Research|translational research
700668|NCT00628771|Group Care|group care
700669|NCT00628771|Prenatal Care|prenatal care
700670|NCT00628771|STD Prevention|std prevention
700671|NCT00628771|Gonorrhea|gonorrhea
700672|NCT00628771|Chlamydia|chlamydia
700673|NCT00628771|Adolescent Health|adolescent health
700674|NCT00628771|Community Health Centers|community health centers
700675|NCT00628771|CenteringPregnancy Plus|centeringpregnancy plus
700676|NCT00628771|HIV seronegativity|hiv seronegativity
700677|NCT00628758|Symbicort|symbicort
700678|NCT00628758|Turbuhaler|turbuhaler
700679|NCT00628758|Persistent Asthma|persistent asthma
700680|NCT00628745|TRANSTHYRETIN|transthyretin
700681|NCT00628745|AMYLOIDOSIS|amyloidosis
700682|NCT00628745|TRANSTHYRETIN AMYLOIDOSIS|transthyretin amyloidosis
700683|NCT00628732|Cyclophosphamide|cyclophosphamide
700684|NCT00628732|Topotecan|topotecan
700685|NCT00628732|Phase II|phase ii
700686|NCT00628732|Children|children
700687|NCT00628732|Relapsed solid tumors|relapsed solid tumors
700688|NCT00628719|Visceral leishmaniasis|visceral leishmaniasis
700689|NCT00628719|India|india
700690|NCT00628719|Liposomal Amphotericin B|liposomal amphotericin b
700691|NCT00628719|Amphotericin B deoxycholate|amphotericin b deoxycholate
700692|NCT00628706|tetrahydrocannabinol|tetrahydrocannabinol
700693|NCT00628706|memory|memory
700694|NCT00628706|reward|reward
700695|NCT00628706|magnetic resonance imaging|magnetic resonance imaging
700696|NCT00628706|endocannabinoids|endocannabinoids
700697|NCT00628693|CPR|cpr
700698|NCT00628680|Renal Disease|renal disease
700699|NCT00628680|Kidney Failure|kidney failure
700700|NCT00628680|End Stage Renal Disease|end stage renal disease
700701|NCT00628667|Chronic Posterior Laryngitis|chronic posterior laryngitis
700702|NCT00628667|CPL|cpl
700703|NCT00628667|Pharyngeal acid reflux|pharyngeal acid reflux
700704|NCT00628667|Esomeprazole|esomeprazole
700705|NCT00628667|Nexium|nexium
700706|NCT00628654|ovarian germ cell tumor|ovarian germ cell tumor
700707|NCT00628654|ovarian epithelial cancer|ovarian epithelial cancer
700708|NCT00628628|Tumor Lysis Syndrome|tumor lysis syndrome
700709|NCT00628628|TLS|tls
700710|NCT00628628|hyperuricemia|hyperuricemia
700711|NCT00628628|Leukemia|leukemia
700712|NCT00628628|Lymphoma|lymphoma
700713|NCT00628628|Acute myeloid leukemia|acute myeloid leukemia
700714|NCT00628628|Chronic myelocytic leukemia|chronic myelocytic leukemia
700715|NCT00628628|CML|cml
700716|NCT00628628|lactate dehydrogenase|lactate dehydrogenase
700717|NCT00628628|LDH|ldh
700718|NCT00628628|Myelodysplastic Syndrome|myelodysplastic syndrome
700719|NCT00628628|Rasburicase|rasburicase
700720|NCT00628628|Elitek™|elitek™
700721|NCT00628615|Urodynamics|urodynamics
700722|NCT00628615|Overactive bladder syndrome|overactive bladder syndrome
700723|NCT00628615|Lower urinary tract symptoms LUTS|lower urinary tract symptoms luts
700724|NCT00628602|Neuromuscular stimulator|neuromuscular stimulator
700725|NCT00628602|Pressure ulcer prevention|pressure ulcer prevention
700726|NCT00628589|schizophrenia, agitation, inhaled loxapine, ADASUVE|schizophrenia, agitation, inhaled loxapine, adasuve
700727|NCT00628576|Deep Venous Thrombosis|deep venous thrombosis
700728|NCT00628576|lower extremities|lower extremities
700729|NCT00628576|Chronic Venous Insufficiency|chronic venous insufficiency
700730|NCT00628576|Postthrombotic Syndrome|postthrombotic syndrome
700731|NCT00628576|Heparins|heparins
700732|NCT00628576|Low-molecular- weight heparin|low-molecular- weight heparin
700733|NCT00628576|Tinzaparin|tinzaparin
700734|NCT00628550|cardiac arrest|cardiac arrest
700735|NCT00628550|cardiopulmonary arrest|cardiopulmonary arrest
700736|NCT00628550|vasopressin|vasopressin
700737|NCT00628550|epinephrine|epinephrine
700738|NCT00628550|pediatrics|pediatrics
700739|NCT00628550|in hospital cardiopulmonary resuscitation|in hospital cardiopulmonary resuscitation
700740|NCT00628537|Neuromuscular stimulator|neuromuscular stimulator
700741|NCT00628537|Flexor deformities of wrist and fingers|flexor deformities of wrist and fingers
700742|NCT00628498|VOD|vod
700743|NCT00628485|swallowing function|swallowing function
700744|NCT00628485|neuromuscular stimulator|neuromuscular stimulator
700745|NCT00628472|botulinum toxin a|botulinum toxin a
700746|NCT00628472|botox|botox
700747|NCT00628472|Decreasing botox injection pain|decreasing botox injection pain
700748|NCT00628472|injections|injections
700749|NCT00628459|iron|iron
700750|NCT00628459|multiple micronutrient|multiple micronutrient
700751|NCT00628459|malaria|malaria
700752|NCT00628459|anemia|anemia
700753|NCT00628459|preschool children|preschool children
700754|NCT00628446|spinal cord injury|spinal cord injury
700755|NCT00628446|Coronary artery calcium|coronary artery calcium
700756|NCT00628446|Dyslipidemia|dyslipidemia
700757|NCT00628433|phase I/II|phase i/ii
700758|NCT00628433|ulcerative colitis|ulcerative colitis
700759|NCT00628433|safety|safety
700760|NCT00628433|tolerance|tolerance
700761|NCT00628433|pharmacokinetics|pharmacokinetics
700762|NCT00628420|Schizophrenia|schizophrenia
700763|NCT00628420|N-desmethylclozapine|n-desmethylclozapine
700764|NCT00628420|clozapine|clozapine
700765|NCT00628420|psychosis|psychosis
700766|NCT00628420|randomized|randomized
700767|NCT00628420|placebo studies|placebo studies
700768|NCT00628407|leaning|leaning
700769|NCT00628407|CPR|cpr
700770|NCT00628407|sternal pressure|sternal pressure
700771|NCT00628407|incomplete release|incomplete release
700772|NCT00628407|chest compressions|chest compressions
700773|NCT00628407|pediatric|pediatric
700774|NCT00628394|Cognition|cognition
700775|NCT00628394|schizophrenia|schizophrenia
700776|NCT00628394|Atomoxetine|atomoxetine
700777|NCT00628394|Strattera|strattera
700778|NCT00628394|cognitive remediation|cognitive remediation
700779|NCT00628381|sepsis|sepsis
700780|NCT00628381|microcirculation|microcirculation
700781|NCT00628381|nitric oxide|nitric oxide
700782|NCT00628381|citrulline|citrulline
700783|NCT00628368|adenocarcinoma of the esophagus|adenocarcinoma of the esophagus
700784|NCT00628368|squamous cell carcinoma of the esophagus|squamous cell carcinoma of the esophagus
700785|NCT00628368|adenocarcinoma of the rectum|adenocarcinoma of the rectum
700786|NCT00628368|recurrent rectal cancer|recurrent rectal cancer
700787|NCT00628368|stage I rectal cancer|stage i rectal cancer
700788|NCT00628368|stage II rectal cancer|stage ii rectal cancer
700789|NCT00628368|stage III rectal cancer|stage iii rectal cancer
700790|NCT00628368|stage IV rectal cancer|stage iv rectal cancer
700791|NCT00628368|recurrent esophageal cancer|recurrent esophageal cancer
700792|NCT00628368|stage I esophageal cancer|stage i esophageal cancer
700793|NCT00628368|stage II esophageal cancer|stage ii esophageal cancer
700794|NCT00628368|stage III esophageal cancer|stage iii esophageal cancer
700795|NCT00628368|stage IV esophageal cancer|stage iv esophageal cancer
700796|NCT00628355|lidocaine|lidocaine
700797|NCT00628355|ischemic compression|ischemic compression
700798|NCT00628355|chronic pelvic pain|chronic pelvic pain
700799|NCT00628355|myofascial pain syndrome|myofascial pain syndrome
700800|NCT00628342|Gastroesophageal Reflux Disease|gastroesophageal reflux disease
700801|NCT00628342|GERD|gerd
700802|NCT00628342|Esomeprazole|esomeprazole
700803|NCT00628342|Heartburn|heartburn
700804|NCT00628342|Nexium|nexium
700805|NCT00628329|asthma, retinol, cis-retinoic acid|asthma, retinol, cis-retinoic acid
700806|NCT00628316|tinnitus|tinnitus
700807|NCT00628316|caffeine|caffeine
700808|NCT00628303|Good health|good health
700809|NCT00628277|Obesity|obesity
700810|NCT00628277|coronary heart disease|coronary heart disease
700811|NCT00628277|coronary risk factors|coronary risk factors
700812|NCT00628277|weight loss|weight loss
700813|NCT00628277|exercise|exercise
700814|NCT00628264|cardiac surgery|cardiac surgery
700815|NCT00628264|coronary artery bypass grafting|coronary artery bypass grafting
700816|NCT00628264|valve surgery|valve surgery
700817|NCT00628264|acute kidney injury|acute kidney injury
700818|NCT00628251|Advanced ovarian cancer|advanced ovarian cancer
700819|NCT00628251|BRCA1 protein|brca1 protein
700820|NCT00628251|BRCA2 protein|brca2 protein
700821|NCT00628251|Poly(ADP ribose) polymerases|poly(adp ribose) polymerases
700822|NCT00628238|Chronic Lymphocytic Leukemia Research Consortium|chronic lymphocytic leukemia research consortium
700823|NCT00628238|Chronic lymphocytic leukemia|chronic lymphocytic leukemia
700824|NCT00628238|CLL|cll
700825|NCT00628238|CLL Research Consortium|cll research consortium
700826|NCT00628238|CRC|crc
700827|NCT00628238|Revlimid|revlimid
700828|NCT00628238|lenalidomide|lenalidomide
700829|NCT00628238|Rituximab|rituximab
700830|NCT00628238|Rituxan|rituxan
700831|NCT00628238|First-line|first-line
700832|NCT00628238|therapy|therapy
700833|NCT00628238|untreated|untreated
700834|NCT00628238|Frontline|frontline
700835|NCT00628225|Smoking cessation|smoking cessation
700836|NCT00628212|insulin resistance|insulin resistance
700837|NCT00628186|pancreaticoduodenectomy|pancreaticoduodenectomy
700838|NCT00628186|stent|stent
700839|NCT00628186|pancreaticojejunostomy|pancreaticojejunostomy
700840|NCT00628186|hospital stay|hospital stay
700841|NCT00628186|complication|complication
700842|NCT00628186|pancreatic fistula|pancreatic fistula
700843|NCT00628160|Septic shock|septic shock
700844|NCT00628160|Cirrhosis|cirrhosis
700845|NCT00628160|Survival|survival
700846|NCT00628147|colonic neoplasms|colonic neoplasms
700847|NCT00628147|colonoscopy|colonoscopy
700848|NCT00628147|narrow band imaging|narrow band imaging
700849|NCT00628147|diagnostic techniques|diagnostic techniques
700850|NCT00628134|cystic fibrosis|cystic fibrosis
700851|NCT00628134|surfactant|surfactant
700852|NCT00628134|aerosol|aerosol
700853|NCT00628134|inhaled drug|inhaled drug
700854|NCT00628134|inhaled antibiotic|inhaled antibiotic
700855|NCT00628121|infertility, menstrual cycle, LH surge|infertility, menstrual cycle, lh surge
700856|NCT00628108|Xyzal|xyzal
700857|NCT00628108|Levocetirizine|levocetirizine
700858|NCT00628108|Allergy|allergy
700859|NCT00628108|Children|children
700860|NCT00628108|Seasonal Allergies|seasonal allergies
700861|NCT00628095|rheumatoid arthritis DMARD methotrexate|rheumatoid arthritis dmard methotrexate
700862|NCT00628082|Cardiac Energetics|cardiac energetics
700863|NCT00628082|Dynamic Diastolic filling Assessment|dynamic diastolic filling assessment
700864|NCT00628082|Heart Failure with Preserved Ejection Fraction|heart failure with preserved ejection fraction
700865|NCT00628082|Arterial and Ventricular Stiffening|arterial and ventricular stiffening
700866|NCT00628069|Orthopedics|orthopedics
700867|NCT00628069|bone fixation|bone fixation
700868|NCT00628056|Perhexiline|perhexiline
700869|NCT00628056|diabetes|diabetes
700870|NCT00628056|diabetic cardiomyopathy|diabetic cardiomyopathy
700871|NCT00628056|high energy phosphate kinetics|high energy phosphate kinetics
700872|NCT00628056|magnetic resonance spectroscopy|magnetic resonance spectroscopy
700873|NCT00628043|Cancer|cancer
700874|NCT00628043|patients|patients
700875|NCT00628043|with|with
700876|NCT00628043|chemotherapy|chemotherapy
700877|NCT00628043|induced|induced
700879|NCT00628030|Behavioral intervention|behavioral intervention
700880|NCT00628030|Obesity prevention|obesity prevention
700881|NCT00628017|polyunsaturated fatty acids|polyunsaturated fatty acids
700882|NCT00628017|Alzheimer's disease|alzheimer's disease
700883|NCT00628017|mild cognitive impairment|mild cognitive impairment
700884|NCT00628017|fish oil|fish oil
700885|NCT00628017|cognition|cognition
700886|NCT00627978|breast|breast
700887|NCT00627965|Sildenafil citrate|sildenafil citrate
700888|NCT00627965|Prevention|prevention
700889|NCT00627965|High Altitude Pulmonary Edema|high altitude pulmonary edema
700890|NCT00627965|Acute Mountain Sickness|acute mountain sickness
700891|NCT00627965|Healthy Lowland Subjects|healthy lowland subjects
700892|NCT00627965|Pulmonary Artery Systolic Pressure|pulmonary artery systolic pressure
700893|NCT00627952|hypertension|hypertension
700894|NCT00627952|intraglomerular pressure|intraglomerular pressure
700895|NCT00627926|Genotype 1|genotype 1
700896|NCT00627913|Floppy Iris Syndrome|floppy iris syndrome
700897|NCT00627900|drug-eluting stents|drug-eluting stents
700898|NCT00627887|Depressive Disorder, Major|depressive disorder, major
700899|NCT00627887|Electroconvulsive Therapy|electroconvulsive therapy
700900|NCT00627887|Lithium Carbonate|lithium carbonate
700901|NCT00627887|venlafaxine|venlafaxine
700902|NCT00627848|Alzheimer's disease|alzheimer's disease
700903|NCT00627848|fmri|fmri
700904|NCT00627848|face recognition|face recognition
700905|NCT00627848|rivastigmine|rivastigmine
700906|NCT00627835|squamous cell carcinoma|squamous cell carcinoma
700907|NCT00627835|head and neck|head and neck
700908|NCT00627835|Neoadjuvant Sorafenib and Concurrent Sorafenib, Cisplatin and Radiation|neoadjuvant sorafenib and concurrent sorafenib, cisplatin and radiation
700909|NCT00627822|Medical students|medical students
700910|NCT00627822|Medical education|medical education
700911|NCT00627822|Private hospital|private hospital
700912|NCT00627822|Patient satisfaction|patient satisfaction
700913|NCT00627822|Questionnaires|questionnaires
700914|NCT00627809|coronary microcirculation|coronary microcirculation
700915|NCT00627809|acut myocardial infarction|acut myocardial infarction
700916|NCT00627809|infarct size|infarct size
700917|NCT00627809|streptokinase|streptokinase
700918|NCT00627809|reperfusion|reperfusion
700919|NCT00627796|GH|gh
700920|NCT00627796|IGF-I|igf-i
700921|NCT00627796|tumor|tumor
700922|NCT00627796|lanreotide|lanreotide
700923|NCT00627770|Physical Therapy - Therapeutics - Edema|physical therapy - therapeutics - edema
700924|NCT00627770|Arthroplasty replacement knee|arthroplasty replacement knee
700925|NCT00627770|Treatment outcome|treatment outcome
700926|NCT00627757|metabolic syndrome|metabolic syndrome
700927|NCT00627757|weight gain|weight gain
700928|NCT00627757|antipsychotic drugs|antipsychotic drugs
700929|NCT00627757|Metabolic syndrome and treatment with antipsychotic drugs|metabolic syndrome and treatment with antipsychotic drugs
700930|NCT00627744|Type 2 diabetes, IGT, Myocardial infarction, Incretins|type 2 diabetes, igt, myocardial infarction, incretins
700931|NCT00627731|Asthma Patients|asthma patients
700932|NCT00627718|Age-related macular degeneration|age-related macular degeneration
700933|NCT00627718|HRT|hrt
700934|NCT00627718|Macular edema|macular edema
700935|NCT00627718|Screening for disease|screening for disease
700936|NCT00627692|Constipation in elderly patients|constipation in elderly patients
700937|NCT00627679|Pediatric asthma|pediatric asthma
700938|NCT00627666|adult acute lymphoblastic leukemia in remission|adult acute lymphoblastic leukemia in remission
700939|NCT00627666|recurrent adult acute lymphoblastic leukemia|recurrent adult acute lymphoblastic leukemia
700940|NCT00627666|untreated adult acute lymphoblastic leukemia|untreated adult acute lymphoblastic leukemia
700941|NCT00627666|adult acute myeloid leukemia in remission|adult acute myeloid leukemia in remission
700942|NCT00627666|recurrent adult acute myeloid leukemia|recurrent adult acute myeloid leukemia
700943|NCT00627666|untreated adult acute myeloid leukemia|untreated adult acute myeloid leukemia
700944|NCT00627666|acute lymphocytic leukemia|acute lymphocytic leukemia
700945|NCT00627666|secondary acute myeloid leukemia|secondary acute myeloid leukemia
701056|NCT00627263|Stress|stress
700946|NCT00627666|acute undifferentiated leukemia|acute undifferentiated leukemia
700947|NCT00627666|mast cell leukemia|mast cell leukemia
700948|NCT00627666|accelerated phase chronic myelogenous leukemia|accelerated phase chronic myelogenous leukemia
700949|NCT00627666|blastic phase chronic myelogenous leukemia|blastic phase chronic myelogenous leukemia
700950|NCT00627666|chronic phase chronic myelogenous leukemia|chronic phase chronic myelogenous leukemia
700951|NCT00627666|meningeal chronic myelogenous leukemia|meningeal chronic myelogenous leukemia
700952|NCT00627666|relapsing chronic myelogenous leukemia|relapsing chronic myelogenous leukemia
700953|NCT00627666|chronic myelomonocytic leukemia|chronic myelomonocytic leukemia
700954|NCT00627666|adult acute myeloid leukemia with 11q23 (MLL) abnormalities|adult acute myeloid leukemia with 11q23 (mll) abnormalities
700955|NCT00627666|adult acute myeloid leukemia with inv(16)(p13;q22)|adult acute myeloid leukemia with inv(16)(p13;q22)
700956|NCT00627666|adult acute myeloid leukemia with t(15;17)(q22;q12)|adult acute myeloid leukemia with t(15;17)(q22;q12)
700957|NCT00627666|adult acute myeloid leukemia with t(16;16)(p13;q22)|adult acute myeloid leukemia with t(16;16)(p13;q22)
700958|NCT00627666|adult acute myeloid leukemia with t(8;21)(q22;q22)|adult acute myeloid leukemia with t(8;21)(q22;q22)
700959|NCT00627666|de novo myelodysplastic syndromes|de novo myelodysplastic syndromes
700960|NCT00627666|previously treated myelodysplastic syndromes|previously treated myelodysplastic syndromes
700961|NCT00627666|secondary myelodysplastic syndromes|secondary myelodysplastic syndromes
700962|NCT00627666|atypical chronic myeloid leukemia, BCR-ABL1 negative|atypical chronic myeloid leukemia, bcr-abl1 negative
700963|NCT00627666|myelodysplastic/myeloproliferative neoplasm, unclassifiable|myelodysplastic/myeloproliferative neoplasm, unclassifiable
700964|NCT00627666|refractory anemia with excess blasts in transformation|refractory anemia with excess blasts in transformation
700965|NCT00627666|refractory anemia with excess blasts|refractory anemia with excess blasts
700967|NCT00627653|PET study|pet study
700968|NCT00627653|heart metabolism|heart metabolism
700969|NCT00627614|stage I breast cancer|stage i breast cancer
700970|NCT00627614|stage II breast cancer|stage ii breast cancer
700971|NCT00627614|stage IIIA breast cancer|stage iiia breast cancer
700972|NCT00627614|stage IIIB breast cancer|stage iiib breast cancer
700973|NCT00627614|stage IIIC breast cancer|stage iiic breast cancer
700974|NCT00627614|stage IV breast cancer|stage iv breast cancer
700975|NCT00627588|ProSavin|prosavin
700976|NCT00627588|Parkinson's Disease|parkinson's disease
700977|NCT00627588|Gene Therapy|gene therapy
700978|NCT00627575|drug interaction|drug interaction
700979|NCT00627575|pharmacokinetics|pharmacokinetics
700980|NCT00627575|healthy volunteers|healthy volunteers
700981|NCT00627562|robotic|robotic
700982|NCT00627562|robot assisted|robot assisted
700983|NCT00627562|minimally invasive|minimally invasive
700984|NCT00627562|tumors of head and neck|tumors of head and neck
700985|NCT00627549|cystocele, anterior repair, mesh|cystocele, anterior repair, mesh
700986|NCT00627536|scarring, Juvista, avotermin, transforming growth factor beta 3, TGFB3|scarring, juvista, avotermin, transforming growth factor beta 3, tgfb3
700987|NCT00627510|Therapeutic Drug Monitoring (TDM)|therapeutic drug monitoring (tdm)
700988|NCT00627510|Antidepressant|antidepressant
700989|NCT00627510|Antipsychotic|antipsychotic
700990|NCT00627510|Treatment adherence|treatment adherence
700991|NCT00627510|Compliance|compliance
700992|NCT00627510|Metabolism|metabolism
700993|NCT00627510|Do patients take their psychiatric medication as prescribed?|do patients take their psychiatric medication as prescribed?
700994|NCT00627510|Do psychiatric patients metabolize their medication faster than expected?|do psychiatric patients metabolize their medication faster than expected?
700995|NCT00627510|What are the exact odds that the patient of a physician prescribing antidepressants or antipsychotics has plasma levels that are BELOW those intended?|what are the exact odds that the patient of a physician prescribing antidepressants or antipsychotics has plasma levels that are below those intended?
700996|NCT00627484|Insulin resistance|insulin resistance
700997|NCT00627484|Insulin sensitivity|insulin sensitivity
700998|NCT00627484|bariatric surgery|bariatric surgery
700999|NCT00627484|diabetes|diabetes
701000|NCT00627484|calorie restriction|calorie restriction
701001|NCT00627484|body composition|body composition
701002|NCT00627458|Hexavalent vaccine|hexavalent vaccine
701003|NCT00627458|Booster|booster
701004|NCT00627432|stage III bladder cancer|stage iii bladder cancer
701005|NCT00627432|stage IV bladder cancer|stage iv bladder cancer
701006|NCT00627432|transitional cell carcinoma of the bladder|transitional cell carcinoma of the bladder
701007|NCT00627406|GnRH antagonist|gnrh antagonist
701008|NCT00627406|GnRH agonist|gnrh agonist
701009|NCT00627406|hCG|hcg
701010|NCT00627406|OHSS|ohss
701011|NCT00627406|In vitro fertilization|in vitro fertilization
701012|NCT00627406|ovulation induction|ovulation induction
701013|NCT00627406|Clinical pregnancy rate|clinical pregnancy rate
701014|NCT00627393|Granulocyte Transfusions|granulocyte transfusions
701015|NCT00627380|HIV|hiv
701016|NCT00627380|AIDS|aids
701017|NCT00627380|insulin resistance|insulin resistance
701018|NCT00627380|diabetes|diabetes
701019|NCT00627380|dyslipidemia|dyslipidemia
701020|NCT00627380|visceral adiposity|visceral adiposity
701021|NCT00627380|subcutaneous adipose wasting|subcutaneous adipose wasting
701022|NCT00627380|cardiovascular disease|cardiovascular disease
701023|NCT00627380|hypertension|hypertension
701024|NCT00627380|endothelial function|endothelial function
701025|NCT00627380|quality of life|quality of life
701026|NCT00627380|Complementary Therapies|complementary therapies
701027|NCT00627367|Acute Pain, Emergency Department, ED, Hydromorphone, Dilaudid Protocolized Nonprotocolized Usual Care|acute pain, emergency department, ed, hydromorphone, dilaudid protocolized nonprotocolized usual care
701028|NCT00627354|stage IV prostate cancer|stage iv prostate cancer
701029|NCT00627354|recurrent prostate cancer|recurrent prostate cancer
701030|NCT00627354|adenocarcinoma of the prostate|adenocarcinoma of the prostate
701031|NCT00627341|Exposure Therapy|exposure therapy
701032|NCT00627341|Relapse Prevention|relapse prevention
701033|NCT00627341|Anorexia Nervosa|anorexia nervosa
701034|NCT00627328|Physiologic Pacing|physiologic pacing
701035|NCT00627328|Dual Chamber Pacing|dual chamber pacing
701036|NCT00627328|Atrioventricular Block|atrioventricular block
701037|NCT00627328|Bradycardia|bradycardia
701038|NCT00627328|Sick Sinus Syndrome|sick sinus syndrome
701039|NCT00627315|Obesity|obesity
701040|NCT00627315|Insulin Resistance|insulin resistance
701041|NCT00627315|Bariatric Surgery|bariatric surgery
701042|NCT00627315|Gastric Banding|gastric banding
701043|NCT00627315|Gastric Bypass|gastric bypass
701044|NCT00627302|Quality of Vision|quality of vision
701045|NCT00627289|Chronic pain|chronic pain
701046|NCT00627289|groin hernia|groin hernia
701047|NCT00627289|neuropathic pain|neuropathic pain
701048|NCT00627289|chronic postoperative pain|chronic postoperative pain
701049|NCT00627289|Postherniotomy pain|postherniotomy pain
701050|NCT00627289|Neuroplastic changes|neuroplastic changes
701051|NCT00627276|ductal breast carcinoma in situ|ductal breast carcinoma in situ
701052|NCT00627276|atypical ductal breast hyperplasia|atypical ductal breast hyperplasia
701054|NCT00627263|Cardiac Arrhythmia|cardiac arrhythmia
701055|NCT00627263|Arrhythmia|arrhythmia
701057|NCT00627263|Anger|anger
701058|NCT00627250|Irritability|irritability
701059|NCT00627250|Aggression|aggression
701060|NCT00627250|Brain Injury|brain injury
701061|NCT00627250|Amantadine|amantadine
701062|NCT00627250|Irritability and Aggression Due to Traumatic Brain Injury|irritability and aggression due to traumatic brain injury
701063|NCT00627237|Brain Injuries|brain injuries
701064|NCT00627237|Cognitive Rehabilitation|cognitive rehabilitation
701065|NCT00627237|Executive Functioning|executive functioning
701066|NCT00627211|quality assessment|quality assessment
701067|NCT00627211|pain reduction|pain reduction
701068|NCT00627211|gastroscopy|gastroscopy
701069|NCT00627211|carbondioxide insufflation|carbondioxide insufflation
701070|NCT00627211|Patient satisfaction|patient satisfaction
701071|NCT00627185|Tobacco control|tobacco control
701072|NCT00627185|Tobacco cessation|tobacco cessation
701073|NCT00627185|Tobacco use|tobacco use
701074|NCT00627172|Coronary artery disease|coronary artery disease
701075|NCT00627172|MDCT|mdct
701076|NCT00627172|Positron emission tomography|positron emission tomography
701077|NCT00627172|Ultrasound|ultrasound
701078|NCT00627159|community-based|community-based
701079|NCT00627159|culturally-sensitive|culturally-sensitive
701080|NCT00627159|high risk assessment|high risk assessment
701081|NCT00627159|education classes|education classes
701082|NCT00627159|cardiovascular risk profile|cardiovascular risk profile
701083|NCT00627159|Indo-Asian population|indo-asian population
701084|NCT00627146|Diabetes Mellitus, type 1|diabetes mellitus, type 1
701085|NCT00627146|ChAgly CD3|chagly cd3
701086|NCT00627133|Alcohol seizure|alcohol seizure
701087|NCT00627120|healthy volunteers|healthy volunteers
701088|NCT00627107|ReWalk, Paraplegia, SCI|rewalk, paraplegia, sci
701089|NCT00627068|cardiovascular|cardiovascular
701090|NCT00627068|vasodilation|vasodilation
701091|NCT00627068|endothelium|endothelium
701092|NCT00627068|Subjects with high cardiovascular risk|subjects with high cardiovascular risk
701093|NCT00627055|Second line antiretroviral therapy|second line antiretroviral therapy
701094|NCT00627055|HIV genotypic resistance|hiv genotypic resistance
701095|NCT00627055|Kaletra monotherapy|kaletra monotherapy
701096|NCT00627055|Thailand|thailand
701097|NCT00627055|48-week efficacy and safety between 2 NRTIs plus lopinavir/ritonavir (LPV/r) and LPV/r monotherapy in patients failing a standard NNRTI-based treatment regimen|48-week efficacy and safety between 2 nrtis plus lopinavir/ritonavir (lpv/r) and lpv/r monotherapy in patients failing a standard nnrti-based treatment regimen
701098|NCT00627055|treatment experienced|treatment experienced
701099|NCT00627042|Liver disease|liver disease
701100|NCT00627042|Neoplasms|neoplasms
701101|NCT00627042|Liver neoplasms|liver neoplasms
701102|NCT00627042|Carcinoma, Hepatocellular|carcinoma, hepatocellular
701103|NCT00627029|Care coordination|care coordination
701104|NCT00627029|Disease management|disease management
701105|NCT00627029|Medicare|medicare
701106|NCT00627029|Fee-for-service|fee-for-service
701107|NCT00627029|Random assignment|random assignment
701108|NCT00627029|Elderly|elderly
701109|NCT00627016|Non-Erosive Gastroesophageal Reflux Disease|non-erosive gastroesophageal reflux disease
701110|NCT00627016|GERD|gerd
701111|NCT00627016|heartburn|heartburn
701112|NCT00627016|sleep disturbance|sleep disturbance
701113|NCT00627016|nocturnal Reflux|nocturnal reflux
701114|NCT00626990|adult anaplastic oligodendroglioma|adult anaplastic oligodendroglioma
701115|NCT00626990|adult anaplastic astrocytoma|adult anaplastic astrocytoma
701116|NCT00626977|Analgesia|analgesia
701117|NCT00626977|Obstetrical|obstetrical
701118|NCT00626977|Anesthesia|anesthesia
701119|NCT00626977|Epidural|epidural
701120|NCT00626977|Newborn|newborn
701121|NCT00626977|Anesthetics, local|anesthetics, local
701122|NCT00626977|Clonidine|clonidine
701123|NCT00626977|Pregnant women|pregnant women
701124|NCT00626977|Infant, newborn|infant, newborn
701125|NCT00626964|Arterial stiffness|arterial stiffness
701126|NCT00626964|PulseWave velocity|pulsewave velocity
701127|NCT00626964|Body composition|body composition
701128|NCT00626964|Bioimpedance|bioimpedance
701129|NCT00626964|Morbid Obesity|morbid obesity
701130|NCT00626964|APO A|apo a
701131|NCT00626964|APO B|apo b
701132|NCT00626964|Framingham risk score|framingham risk score
701133|NCT00626964|Prevention of Coronary Heart Disease|prevention of coronary heart disease
701134|NCT00626964|Lifestyle Intervention|lifestyle intervention
701135|NCT00626964|Bariatric Surgery|bariatric surgery
701136|NCT00626964|Low Energy Diet|low energy diet
701137|NCT00626951|LMA Supreme|lma supreme
701138|NCT00626951|LMA ProSeal|lma proseal
701139|NCT00626951|Laryngeal mask airway|laryngeal mask airway
701140|NCT00626951|Ventilation|ventilation
701141|NCT00626938|sarcoidosis|sarcoidosis
701142|NCT00626938|protein profile|protein profile
701143|NCT00626938|CYP-450|cyp-450
701144|NCT00626938|TNF-alpha polymorphisms|tnf-alpha polymorphisms
701145|NCT00626938|HLA|hla
701146|NCT00626925|Randomized Trial|randomized trial
701147|NCT00626925|Medication for Heavy Drinking|medication for heavy drinking
701148|NCT00626925|Topiramate Treatment|topiramate treatment
701149|NCT00626912|large aneurysm|large aneurysm
701150|NCT00626912|recurrence|recurrence
701151|NCT00626912|hydrocoil|hydrocoil
701152|NCT00626899|Validation of Cardiac Output measurement in hypothermic patients|validation of cardiac output measurement in hypothermic patients
701153|NCT00626886|Herniorrhaphy|herniorrhaphy
701154|NCT00626886|Inguinal Hernia Repair|inguinal hernia repair
701155|NCT00626886|Postoperative pain|postoperative pain
701156|NCT00626873|ovarian germ cell tumor|ovarian germ cell tumor
701157|NCT00626873|ovarian epithelial cancer|ovarian epithelial cancer
701158|NCT00626860|melanoma|melanoma
701159|NCT00626847|primary open angle glaucoma|primary open angle glaucoma
701160|NCT00626847|Nuclear Genetics|nuclear genetics
701161|NCT00626847|Mitochondrial DNA|mitochondrial dna
701162|NCT00626847|POAG|poag
701163|NCT00626834|cocaine addiction|cocaine addiction
701164|NCT00626834|vigabatrin|vigabatrin
701165|NCT00626834|ovation pharmaceuticals|ovation pharmaceuticals
701166|NCT00626834|cocaine|cocaine
701167|NCT00626834|cocaine related disorders|cocaine related disorders
701168|NCT00626834|behavior addictive|behavior addictive
701169|NCT00626834|mental disorders|mental disorders
701170|NCT00626834|therapeutic uses|therapeutic uses
701171|NCT00626834|physiologic effects of drugs|physiologic effects of drugs
701172|NCT00626834|disorder of environmental origin|disorder of environmental origin
701173|NCT00626834|central nervous system stimulants|central nervous system stimulants
701174|NCT00626834|central nervous system agents|central nervous system agents
701175|NCT00626834|pharmacological actions|pharmacological actions
701176|NCT00626834|substance related disorders|substance related disorders
701177|NCT00626821|Stoma|stoma
701178|NCT00626821|Ostomy|ostomy
701179|NCT00626782|glaucoma|glaucoma
701180|NCT00626782|glucoma filtering surgery|glucoma filtering surgery
701181|NCT00626782|ranibizumab|ranibizumab
701182|NCT00626782|mitomycin C|mitomycin c
701183|NCT00626782|patients requiring first time glaucoma filtering surgery|patients requiring first time glaucoma filtering surgery
701184|NCT00626769|Genistein|genistein
701185|NCT00626769|Bone mineral density|bone mineral density
701186|NCT00626769|digital mammography|digital mammography
701187|NCT00626769|safety|safety
701188|NCT00626756|fluid|fluid
701189|NCT00626756|Lidco technology|lidco technology
701190|NCT00626756|guided therapy|guided therapy
701191|NCT00626756|fluid management guided by Lidco technology|fluid management guided by lidco technology
701192|NCT00626730|adult grade II meningioma|adult grade ii meningioma
701193|NCT00626730|adult grade III meningioma|adult grade iii meningioma
701194|NCT00626717|Keratoconus|keratoconus
701195|NCT00626717|Cross linking|cross linking
701196|NCT00626717|Riboflavin|riboflavin
701197|NCT00626704|Sarcoma|sarcoma
701198|NCT00626704|Soft Tissue Sarcoma|soft tissue sarcoma
710281|NCT00589563|contiguous stage II grade 2 follicular lymphoma|contiguous stage ii grade 2 follicular lymphoma
701199|NCT00626704|Locally Advanced or Metastatic, Unresectable Soft Tissue Sarcoma|locally advanced or metastatic, unresectable soft tissue sarcoma
701200|NCT00626704|AMG 655|amg 655
701201|NCT00626704|STS|sts
701202|NCT00626704|Doxorubicin|doxorubicin
701203|NCT00626704|Death receptor|death receptor
701204|NCT00626704|TRAIL receptor|trail receptor
701205|NCT00626704|Apoptosis|apoptosis
701206|NCT00626691|antioxidant|antioxidant
701207|NCT00626691|walnut|walnut
701208|NCT00626691|nutritional status|nutritional status
701209|NCT00626691|Antioxidant capacity|antioxidant capacity
701210|NCT00626678|Pemphigus Vulgaris|pemphigus vulgaris
701211|NCT00626678|Azathioprine|azathioprine
701212|NCT00626678|Prednisone|prednisone
701213|NCT00626665|Raynaud disease|raynaud disease
701214|NCT00626665|Scleroderma|scleroderma
701215|NCT00626639|palifermin|palifermin
701216|NCT00626639|Clinical Trial|clinical trial
701217|NCT00626639|Oncology|oncology
701218|NCT00626639|Head & Neck|head & neck
701219|NCT00626626|leukemia|leukemia
701220|NCT00626626|myelodysplastic syndrome|myelodysplastic syndrome
701221|NCT00626626|chronic myelogenous leukemia|chronic myelogenous leukemia
701222|NCT00626626|lymphoma|lymphoma
701223|NCT00626626|mantle cell lymphoma|mantle cell lymphoma
701224|NCT00626600|Oxycodone Hydrochloride 50mg/mL|oxycodone hydrochloride 50mg/ml
701225|NCT00626600|Observational|observational
701226|NCT00626600|Infusion|infusion
701227|NCT00626600|Severe cancer pain|severe cancer pain
701228|NCT00626587|Endobronchial ultrasonography|endobronchial ultrasonography
701229|NCT00626587|Peripheral pulmonary lesions|peripheral pulmonary lesions
701230|NCT00626587|Transbronchial needle aspiration|transbronchial needle aspiration
701231|NCT00626587|Probe location|probe location
701232|NCT00626587|Diagnostic yield|diagnostic yield
701233|NCT00626587|EBUS guided TBNA for peripheral pulmonary lesions|ebus guided tbna for peripheral pulmonary lesions
701234|NCT00626574|Epoetin alfa|epoetin alfa
701235|NCT00626574|aneurysm|aneurysm
701236|NCT00626574|subarachnoid hemorrhage|subarachnoid hemorrhage
701237|NCT00626561|Cervical Cancer|cervical cancer
701238|NCT00626561|Uterine Cancer|uterine cancer
701239|NCT00626561|Bevacizumab|bevacizumab
701240|NCT00626561|Avastin|avastin
701241|NCT00626561|Anti-VEGF monoclonal antibody|anti-vegf monoclonal antibody
701242|NCT00626561|rhuMAb-VEGF|rhumab-vegf
701243|NCT00626561|Paclitaxel|paclitaxel
701244|NCT00626561|Taxol|taxol
701245|NCT00626548|Hormone Resistant Prostate Cancer|hormone resistant prostate cancer
701246|NCT00626548|Endothelin A Receptor Antagonist|endothelin a receptor antagonist
701247|NCT00626548|Endothelin A|endothelin a
701248|NCT00626548|Endothelin A antagonist|endothelin a antagonist
701249|NCT00626535|Symptomatic Gastroesophageal Reflux Disease (sGERD)|symptomatic gastroesophageal reflux disease (sgerd)
701250|NCT00626535|Nexium|nexium
701251|NCT00626535|Esomeprazole|esomeprazole
701252|NCT00626522|Bronchitis|bronchitis
701253|NCT00626522|Chronic|chronic
701254|NCT00626522|Emphysema|emphysema
701255|NCT00626522|Smokers or ex-Smokers|smokers or ex-smokers
701256|NCT00626509|stage IV renal cell cancer|stage iv renal cell cancer
701257|NCT00626483|adult giant cell glioblastoma|adult giant cell glioblastoma
701258|NCT00626483|adult gliosarcoma|adult gliosarcoma
701259|NCT00626470|Trochanter|trochanter
701260|NCT00626470|Femur|femur
701261|NCT00626470|Fracture|fracture
701262|NCT00626431|Lupron Depot|lupron depot
701263|NCT00626431|prostate cancer|prostate cancer
701264|NCT00626431|leuprolide acetate|leuprolide acetate
701265|NCT00626405|stage IV melanoma|stage iv melanoma
701266|NCT00626379|Coronary Heart Disease|coronary heart disease
701267|NCT00626379|Subclinical Atherosclerosis|subclinical atherosclerosis
701268|NCT00626379|CVD-Related Markers of Inflammation|cvd-related markers of inflammation
701269|NCT00626379|Mortality|mortality
701270|NCT00626366|Nasal Spray|nasal spray
701271|NCT00626366|Nasal Drop|nasal drop
701272|NCT00626366|Intranasal Medication|intranasal medication
701273|NCT00626353|Stroke|stroke
701274|NCT00626353|rehabilitation|rehabilitation
701275|NCT00626353|motor recovery|motor recovery
701276|NCT00626353|cognition|cognition
701277|NCT00626353|quality of life|quality of life
701278|NCT00626340|menopause|menopause
701279|NCT00626340|women|women
701280|NCT00626340|major depressive disorder|major depressive disorder
701281|NCT00626340|Magnetic Resonance Spectroscopy|magnetic resonance spectroscopy
701282|NCT00626327|vaccine|vaccine
701283|NCT00626327|toddlers|toddlers
701284|NCT00626327|healthy|healthy
701285|NCT00626327|meningitis|meningitis
701286|NCT00626327|meningococcal|meningococcal
701287|NCT00626327|measles|measles
701288|NCT00626327|mumps|mumps
701289|NCT00626327|rubella|rubella
701290|NCT00626327|varicella|varicella
701291|NCT00626327|Prevention of Meningococcal disease types ACWY|prevention of meningococcal disease types acwy
701292|NCT00626301|efficacy|efficacy
701293|NCT00626301|safety|safety
701294|NCT00626301|pharmacokinetics|pharmacokinetics
701295|NCT00626301|LPV/r monotherapy|lpv/r monotherapy
701296|NCT00626301|Thai children|thai children
701297|NCT00626301|efficacy safety LPV/r monotherapy maintenance|efficacy safety lpv/r monotherapy maintenance
701298|NCT00626301|treatment experienced|treatment experienced
701299|NCT00626288|Mesalazine in Irritable Bowel Syndrome|mesalazine in irritable bowel syndrome
701300|NCT00626275|Rheumatoid arthritis|rheumatoid arthritis
701301|NCT00626275|arthritis|arthritis
701302|NCT00626262|Gastroesophageal reflux disease|gastroesophageal reflux disease
701303|NCT00626262|Nexium|nexium
701304|NCT00626262|Esomeprazole|esomeprazole
701305|NCT00626262|Administration methods.|administration methods.
701306|NCT00626249|Nephropathy|nephropathy
701307|NCT00626249|Kidney Disease|kidney disease
701308|NCT00626249|Diabetic|diabetic
701309|NCT00626249|Renal|renal
701310|NCT00626249|Diabetics|diabetics
701311|NCT00626236|ADHD and conduct problems|adhd and conduct problems
701312|NCT00626223|ESRD patients|esrd patients
701313|NCT00626223|C-reactive protein|c-reactive protein
701314|NCT00626223|homocysteine|homocysteine
701315|NCT00626223|5-MTHF|5-mthf
701316|NCT00626223|survival|survival
701317|NCT00626223|Hemodialysis patients|hemodialysis patients
701318|NCT00626210|Mild Cognitive Impairment (MCI)|mild cognitive impairment (mci)
701319|NCT00626210|Sleep|sleep
701320|NCT00626210|Fatigue|fatigue
701321|NCT00626210|Memory|memory
701322|NCT00626197|SLE|sle
701323|NCT00626197|Lupus|lupus
701324|NCT00626197|BELONG|belong
701325|NCT00626184|Celiac Disease|celiac disease
701326|NCT00626171|smoking|smoking
701327|NCT00626171|asthma|asthma
701328|NCT00626171|sputum|sputum
701329|NCT00626158|pancreatic cancer|pancreatic cancer
701330|NCT00626158|biliary cancer|biliary cancer
701331|NCT00626158|gemcitabine|gemcitabine
701332|NCT00626158|capecitabine|capecitabine
701333|NCT00626145|BMMNC|bmmnc
701334|NCT00626145|STEMI|stemi
701335|NCT00626145|stem cell|stem cell
701336|NCT00626145|intracoronary delivery|intracoronary delivery
701337|NCT00626132|Blood pressure|blood pressure
701338|NCT00626132|Herbs|herbs
701339|NCT00626132|Food|food
701340|NCT00626119|breast cancer|breast cancer
701341|NCT00626106|postmenopausal|postmenopausal
701342|NCT00626106|hormone receptor positive|hormone receptor positive
701343|NCT00626106|locally advanced|locally advanced
701344|NCT00626106|metastatic|metastatic
701345|NCT00626080|Insulin|insulin
701346|NCT00626080|Detemir|detemir
701347|NCT00626080|Brain|brain
701348|NCT00626080|Glucose metabolism|glucose metabolism
701349|NCT00626067|Travatan Dosing Aid|travatan dosing aid
701350|NCT00626067|compliance monitoring dispenser|compliance monitoring dispenser
701351|NCT00626054|Colonoscopy|colonoscopy
701352|NCT00626054|PEG Solution|peg solution
701353|NCT00626041|Community pharmacies|community pharmacies
701354|NCT00626041|Primary care networks|primary care networks
701355|NCT00626041|Global risk assessment|global risk assessment
701356|NCT00626041|Blood pressure screening|blood pressure screening
701357|NCT00626028|Pulmonary Vasculature|pulmonary vasculature
701358|NCT00626028|Nitric Oxide|nitric oxide
701359|NCT00626028|INOmax®|inomax®
701360|NCT00626028|Acute Lung Injury|acute lung injury
701361|NCT00626028|Pulmonary Vasodilator Testing|pulmonary vasodilator testing
701362|NCT00626028|Idiopathic Pulmonary Arterial Hypertension|idiopathic pulmonary arterial hypertension
701363|NCT00626028|Congenital Heart Disease|congenital heart disease
701364|NCT00626028|reversible pulmonary hypertension|reversible pulmonary hypertension
701365|NCT00626028|vasoreactivity|vasoreactivity
701366|NCT00626015|adult glioblastoma|adult glioblastoma
701367|NCT00626015|adult giant cell glioblastoma|adult giant cell glioblastoma
701368|NCT00626015|adult gliosarcoma|adult gliosarcoma
701369|NCT00626015|adult high grade glioma|adult high grade glioma
701370|NCT00626002|Open label|open label
701371|NCT00625989|asthma|asthma
701372|NCT00625989|atopy|atopy
701373|NCT00625989|allergen challenge|allergen challenge
701374|NCT00625989|sputum myeloid and plasmacytoid dendritic cells|sputum myeloid and plasmacytoid dendritic cells
701375|NCT00625976|Complex regional pain syndrome type I|complex regional pain syndrome type i
701376|NCT00625976|Graded exposure in vivo|graded exposure in vivo
701377|NCT00625976|Physiotherapy|physiotherapy
701378|NCT00625976|Pain-related fear|pain-related fear
701379|NCT00625963|Pulmonary Hypertension;|pulmonary hypertension;
701380|NCT00625963|ILD;|ild;
701381|NCT00625963|CT Imaging;|ct imaging;
701382|NCT00625963|Echocardiogram;|echocardiogram;
701383|NCT00625963|Hemodynamic measurements of RHC.|hemodynamic measurements of rhc.
701384|NCT00625963|Pulmonary Function Tests|pulmonary function tests
701385|NCT00625950|Hyperprolactinemia|hyperprolactinemia
701386|NCT00625950|Endometriosis|endometriosis
701387|NCT00625950|laparoscopy|laparoscopy
701388|NCT00625950|angiogenesis, VEGF|angiogenesis, vegf
701389|NCT00625937|stage III squamous cell carcinoma of the hypopharynx|stage iii squamous cell carcinoma of the hypopharynx
701390|NCT00625937|stage IV squamous cell carcinoma of the hypopharynx|stage iv squamous cell carcinoma of the hypopharynx
701391|NCT00625937|stage III verrucous carcinoma of the oral cavity|stage iii verrucous carcinoma of the oral cavity
701392|NCT00625937|stage IV verrucous carcinoma of the oral cavity|stage iv verrucous carcinoma of the oral cavity
701393|NCT00625937|stage III squamous cell carcinoma of the lip and oral cavity|stage iii squamous cell carcinoma of the lip and oral cavity
701394|NCT00625937|stage IV squamous cell carcinoma of the lip and oral cavity|stage iv squamous cell carcinoma of the lip and oral cavity
701395|NCT00625937|stage III lymphoepithelioma of the nasopharynx|stage iii lymphoepithelioma of the nasopharynx
701396|NCT00625937|stage III squamous cell carcinoma of the nasopharynx|stage iii squamous cell carcinoma of the nasopharynx
701397|NCT00625937|stage IV lymphoepithelioma of the nasopharynx|stage iv lymphoepithelioma of the nasopharynx
701398|NCT00625937|stage IV squamous cell carcinoma of the nasopharynx|stage iv squamous cell carcinoma of the nasopharynx
701399|NCT00625937|stage III lymphoepithelioma of the oropharynx|stage iii lymphoepithelioma of the oropharynx
701400|NCT00625937|stage III squamous cell carcinoma of the oropharynx|stage iii squamous cell carcinoma of the oropharynx
701401|NCT00625937|stage IV lymphoepithelioma of the oropharynx|stage iv lymphoepithelioma of the oropharynx
701402|NCT00625937|stage IV squamous cell carcinoma of the oropharynx|stage iv squamous cell carcinoma of the oropharynx
701403|NCT00625937|tongue cancer|tongue cancer
701404|NCT00625924|Plastic surgery|plastic surgery
701405|NCT00625924|reconstruction|reconstruction
701406|NCT00625911|thoracotomy|thoracotomy
701407|NCT00625911|minimally invasive direct coronary artery bypass|minimally invasive direct coronary artery bypass
701408|NCT00625911|ketamine|ketamine
701409|NCT00625911|pain|pain
701410|NCT00625898|HER2 positive breast cancer|her2 positive breast cancer
701411|NCT00625898|invasive breast cancer|invasive breast cancer
701412|NCT00625898|bevacizumab|bevacizumab
701413|NCT00625898|NSABP|nsabp
701414|NCT00625898|Roche|roche
701415|NCT00625898|CIRG|cirg
701416|NCT00625898|trastuzumab|trastuzumab
701417|NCT00625898|cyclophosphamide|cyclophosphamide
701418|NCT00625898|docetaxel|docetaxel
701419|NCT00625898|carboplatin|carboplatin
701420|NCT00625898|5-fluorouracil|5-fluorouracil
701421|NCT00625898|epirubicin|epirubicin
701422|NCT00625885|Anterior Cruciate Ligament/injuries|anterior cruciate ligament/injuries
701423|NCT00625885|Anterior Cruciate Ligament/surgery|anterior cruciate ligament/surgery
701424|NCT00625885|Knee injuries/surgery|knee injuries/surgery
701425|NCT00625885|Outcomes research|outcomes research
701426|NCT00625885|Prospective Studies|prospective studies
701427|NCT00625859|pharmacodynamics|pharmacodynamics
701428|NCT00625859|Healthy adult male volunteers,|healthy adult male volunteers,
701429|NCT00625859|pharmacokinetics,|pharmacokinetics,
701430|NCT00625820|Kidney Disease|kidney disease
701431|NCT00625820|Albuminuria|albuminuria
701432|NCT00625820|Glomerular filtration rate|glomerular filtration rate
701434|NCT00625807|meditation|meditation
701435|NCT00625807|stress reduction|stress reduction
701436|NCT00625807|fMRI|fmri
701437|NCT00625807|behavioral|behavioral
701438|NCT00625781|Gestational diabetes mellitus|gestational diabetes mellitus
701439|NCT00625781|Impaired glucose Tolerance|impaired glucose tolerance
701440|NCT00625781|Pregnancy|pregnancy
701441|NCT00625781|Fetal macrosomia|fetal macrosomia
701442|NCT00625781|Treatment|treatment
701443|NCT00625781|Perinatal morbidity|perinatal morbidity
701444|NCT00625768|Antibody|antibody
701445|NCT00625768|safety|safety
701446|NCT00625768|tolerability|tolerability
701447|NCT00625768|efficacy|efficacy
701448|NCT00625768|metastatic renal cell carcinoma|metastatic renal cell carcinoma
701449|NCT00625768|metastatic malignant melanoma|metastatic malignant melanoma
701450|NCT00625755|renal cell carcinoma|renal cell carcinoma
701451|NCT00625755|AJCC Stage IV (primary or relasped) renal cell carcinoma|ajcc stage iv (primary or relasped) renal cell carcinoma
701452|NCT00625742|Advanced Cancer|advanced cancer
701453|NCT00625742|Cancer Cachexia|cancer cachexia
701454|NCT00625742|Cachexia|cachexia
701455|NCT00625742|Melatonin|melatonin
701456|NCT00625742|Juven|juven
701457|NCT00625742|Exercise Training|exercise training
701458|NCT00625742|Weight Loss|weight loss
701459|NCT00625729|recurrent adult grade III lymphomatoid granulomatosis|recurrent adult grade iii lymphomatoid granulomatosis
701460|NCT00625729|adult nasal type extranodal NK/T-cell lymphoma|adult nasal type extranodal nk/t-cell lymphoma
701461|NCT00625729|Waldenstrom macroglobulinemia|waldenstrom macroglobulinemia
701462|NCT00625729|recurrent adult Burkitt lymphoma|recurrent adult burkitt lymphoma
701463|NCT00625729|recurrent adult diffuse large cell lymphoma|recurrent adult diffuse large cell lymphoma
701464|NCT00625729|recurrent adult diffuse mixed cell lymphoma|recurrent adult diffuse mixed cell lymphoma
701465|NCT00625729|recurrent adult diffuse small cleaved cell lymphoma|recurrent adult diffuse small cleaved cell lymphoma
701466|NCT00625729|recurrent adult immunoblastic large cell lymphoma|recurrent adult immunoblastic large cell lymphoma
701467|NCT00625729|recurrent adult lymphoblastic lymphoma|recurrent adult lymphoblastic lymphoma
701468|NCT00625729|recurrent grade 1 follicular lymphoma|recurrent grade 1 follicular lymphoma
701469|NCT00625729|recurrent grade 2 follicular lymphoma|recurrent grade 2 follicular lymphoma
701470|NCT00625729|recurrent grade 3 follicular lymphoma|recurrent grade 3 follicular lymphoma
701471|NCT00625729|recurrent mantle cell lymphoma|recurrent mantle cell lymphoma
701472|NCT00625729|recurrent marginal zone lymphoma|recurrent marginal zone lymphoma
701473|NCT00625729|recurrent small lymphocytic lymphoma|recurrent small lymphocytic lymphoma
701474|NCT00625729|refractory chronic lymphocytic leukemia|refractory chronic lymphocytic leukemia
701475|NCT00625703|Pharmacokinetic|pharmacokinetic
701476|NCT00625690|lung cancer|lung cancer
701477|NCT00625677|meningococcal serogroup C vaccine|meningococcal serogroup c vaccine
701478|NCT00625677|reduced dose|reduced dose
701479|NCT00625677|meningococcal serogroup C conjugate vaccine|meningococcal serogroup c conjugate vaccine
701480|NCT00625677|pneumococcal conjugate vaccine|pneumococcal conjugate vaccine
701481|NCT00625664|Cancer|cancer
701482|NCT00625664|Neoplasms|neoplasms
701483|NCT00625664|Bladder|bladder
701484|NCT00625664|Urothelial Tract|urothelial tract
701485|NCT00625651|Colon Cancer|colon cancer
701486|NCT00625651|Colorectal Cancer|colorectal cancer
701487|NCT00625651|Rectal Cancer|rectal cancer
701488|NCT00625651|AMG 655|amg 655
701489|NCT00625651|Bevacizumab|bevacizumab
701490|NCT00625651|Modified FOLFOX6|modified folfox6
701491|NCT00625651|mFOLFOX6|mfolfox6
701492|NCT00625651|FOLFOX|folfox
701493|NCT00625638|Advanced Cancer|advanced cancer
701494|NCT00625638|Caregiver|caregiver
701495|NCT00625638|Interactive Voice Response|interactive voice response
701496|NCT00625638|Symptom Control|symptom control
701497|NCT00625638|IVR System|ivr system
701498|NCT00625638|Questionnaire|questionnaire
701499|NCT00625625|stage I colon cancer|stage i colon cancer
701500|NCT00625625|stage II colon cancer|stage ii colon cancer
701501|NCT00625625|stage III colon cancer|stage iii colon cancer
701502|NCT00625625|stage I rectal cancer|stage i rectal cancer
701503|NCT00625625|stage II rectal cancer|stage ii rectal cancer
701504|NCT00625625|stage III rectal cancer|stage iii rectal cancer
701505|NCT00625586|adenocarcinoma of the pancreas|adenocarcinoma of the pancreas
701506|NCT00625586|stage IV pancreatic cancer|stage iv pancreatic cancer
701507|NCT00625586|recurrent pancreatic cancer|recurrent pancreatic cancer
701508|NCT00625573|Colon Cancer|colon cancer
701509|NCT00625573|Abraxis Oncology|abraxis oncology
701510|NCT00625573|Abraxane|abraxane
701511|NCT00625573|Phase II|phase ii
701512|NCT00625573|Colorectal|colorectal
701513|NCT00625573|Mt. Sinai Medical Center|mt. sinai medical center
701514|NCT00625573|CCOP|ccop
701515|NCT00625560|Chronic hepatitis B|chronic hepatitis b
701516|NCT00625560|Lamivudine|lamivudine
701517|NCT00625560|Entecavir|entecavir
701518|NCT00625534|Hernia|hernia
701519|NCT00625534|Laparoscopy|laparoscopy
701520|NCT00625534|Pain|pain
701521|NCT00625534|Sexual|sexual
701522|NCT00625534|Quality|quality
701523|NCT00625521|Discoid lupus erythematosus|discoid lupus erythematosus
701524|NCT00625495|Gastroesophageal reflux disease|gastroesophageal reflux disease
701525|NCT00625495|Nexium|nexium
701526|NCT00625495|Esomeprazole|esomeprazole
701527|NCT00625495|Administration methods.|administration methods.
701528|NCT00625482|BCG vaccine|bcg vaccine
701529|NCT00625482|Oral polio vaccine|oral polio vaccine
701530|NCT00625482|Vitamin A supplementation|vitamin a supplementation
701531|NCT00625482|Low-birth-weigth|low-birth-weigth
701532|NCT00625482|Sex-differential|sex-differential
701533|NCT00625482|Prevention|prevention
701534|NCT00625482|Immunological parameters|immunological parameters
701535|NCT00625469|pulmonary arterial hypertension|pulmonary arterial hypertension
701536|NCT00625469|idiopathic pulmonary fibrosis|idiopathic pulmonary fibrosis
701537|NCT00625469|bosentan|bosentan
701538|NCT00625456|phase I|phase i
701539|NCT00625456|advanced metastatic solid tumors|advanced metastatic solid tumors
701540|NCT00625456|oncolytic virus|oncolytic virus
701541|NCT00625456|vaccinia virus|vaccinia virus
701542|NCT00625456|melanoma|melanoma
701543|NCT00625456|lung cancer|lung cancer
701544|NCT00625456|renal cell carcinoma|renal cell carcinoma
701545|NCT00625456|squamous cell carcinoma of the head and neck|squamous cell carcinoma of the head and neck
701546|NCT00625456|Pexa-Vec|pexa-vec
701547|NCT00625443|Idiopathic Thrombocytopenic Purpura|idiopathic thrombocytopenic purpura
701548|NCT00625443|ITP|itp
701549|NCT00625443|Chronic Idiopathic Thrombocytopenic Purpura|chronic idiopathic thrombocytopenic purpura
701550|NCT00625430|Prostate Cancer|prostate cancer
701551|NCT00625430|Gene Therapy|gene therapy
701552|NCT00625430|Fludarabine|fludarabine
701553|NCT00625430|Adenovirus|adenovirus
701554|NCT00625430|phase I|phase i
701555|NCT00625417|male breast cancer|male breast cancer
701556|NCT00625417|stage IA breast cancer|stage ia breast cancer
701557|NCT00625417|stage IB breast cancer|stage ib breast cancer
701558|NCT00625417|stage II breast cancer|stage ii breast cancer
701559|NCT00625417|stage IIIA breast cancer|stage iiia breast cancer
701560|NCT00625417|stage IIIB breast cancer|stage iiib breast cancer
701561|NCT00625417|stage IIIC breast cancer|stage iiic breast cancer
701562|NCT00625417|stage IV breast cancer|stage iv breast cancer
701563|NCT00625404|Aspartate Aminotransferase (AST)|aspartate aminotransferase (ast)
701564|NCT00625404|Alanine Aminotransferase (ALT)|alanine aminotransferase (alt)
701565|NCT00625404|HIV|hiv
701566|NCT00625404|HIV Prevention|hiv prevention
701567|NCT00625404|Oral PrEP|oral prep
701568|NCT00625404|Truvada|truvada
701569|NCT00625404|women|women
701570|NCT00625404|Tenofovir|tenofovir
701571|NCT00625404|TDF|tdf
701572|NCT00625404|FTC|ftc
701573|NCT00625404|emtricitabine|emtricitabine
701574|NCT00625404|hepatitis|hepatitis
701575|NCT00625404|Pre-exposure Prophylaxis (PrEP)|pre-exposure prophylaxis (prep)
701576|NCT00625404|HIV Seronegativity|hiv seronegativity
701577|NCT00625391|postmenopausal, bone, dietary supplement, mind-body exercise|postmenopausal, bone, dietary supplement, mind-body exercise
701578|NCT00625378|Cancer|cancer
701579|NCT00625378|Sorafenib|sorafenib
701580|NCT00625378|Extension program|extension program
701581|NCT00625365|DEFINITY|definity
701582|NCT00625365|Safety|safety
701583|NCT00625365|Survelliance|survelliance
701584|NCT00625352|Carcinoma, Non-Small-Cell Lung|carcinoma, non-small-cell lung
701585|NCT00625352|Aged|aged
701586|NCT00625352|Gemcitabine|gemcitabine
701587|NCT00625352|UFT|uft
701588|NCT00625339|Chronic hepatitis B|chronic hepatitis b
701589|NCT00625339|Lamivudine|lamivudine
701590|NCT00625339|Entecavir|entecavir
701591|NCT00625326|psoriasis|psoriasis
701592|NCT00625313|Cataract|cataract
701593|NCT00625313|aphakia|aphakia
701594|NCT00625313|intraocular lens|intraocular lens
701595|NCT00625313|IOL|iol
701596|NCT00625313|Optical correction of aphakia|optical correction of aphakia
701597|NCT00625300|repetitive transcranial stimulation|repetitive transcranial stimulation
701598|NCT00625300|Parkinson's Disease|parkinson's disease
701599|NCT00625274|Nexium|nexium
701600|NCT00625274|esomeprazole|esomeprazole
701601|NCT00625274|lansoprazole|lansoprazole
701602|NCT00625274|pantoprazole|pantoprazole
701603|NCT00625274|Nonsteroidal Anti-Inflammatory Drugs (NSAIDs)|nonsteroidal anti-inflammatory drugs (nsaids)
701604|NCT00625261|Language delay|language delay
701605|NCT00625261|Speech and language disorders|speech and language disorders
701606|NCT00625261|Early language intervention|early language intervention
701607|NCT00625261|Parent-based language intervention|parent-based language intervention
701608|NCT00625235|Obesity|obesity
701609|NCT00625235|Weight loss|weight loss
701610|NCT00625235|Weight maintenance|weight maintenance
701611|NCT00625235|VLED|vled
701612|NCT00625222|Electroencephalography|electroencephalography
701613|NCT00625222|Seizure frequency|seizure frequency
701614|NCT00625222|Seizure severity|seizure severity
701615|NCT00625209|septic shock|septic shock
701616|NCT00625209|coagulation|coagulation
701617|NCT00625209|immunomodulation|immunomodulation
701618|NCT00625209|survival|survival
701619|NCT00625196|Healthy Japanese volunteers|healthy japanese volunteers
701620|NCT00625183|adenocarcinoma of the rectum|adenocarcinoma of the rectum
701621|NCT00625183|stage II rectal cancer|stage ii rectal cancer
701622|NCT00625183|stage III rectal cancer|stage iii rectal cancer
701623|NCT00625170|Antipsychotics|antipsychotics
701624|NCT00625170|Olanzapine|olanzapine
701625|NCT00625170|Haloperidol|haloperidol
701626|NCT00625170|Insulin resistance|insulin resistance
701627|NCT00625170|Dyslipidemia|dyslipidemia
701628|NCT00625131|Stress Disorders, Posttraumatic|stress disorders, posttraumatic
701629|NCT00625131|Tobacco Use Disorder|tobacco use disorder
701630|NCT00625118|Hib conjugate vaccine|hib conjugate vaccine
701631|NCT00625118|reactogenicity|reactogenicity
701632|NCT00625118|local reactions|local reactions
701633|NCT00625118|systemic symptoms|systemic symptoms
701634|NCT00625092|peritoneal cavity cancer|peritoneal cavity cancer
701635|NCT00625079|pulmonary hypertension|pulmonary hypertension
701636|NCT00625079|pulmonary arterial hypertension|pulmonary arterial hypertension
701637|NCT00625079|interstitial lung disease|interstitial lung disease
701638|NCT00625079|idiopathic pulmonary fibrosis|idiopathic pulmonary fibrosis
701639|NCT00625066|precancerous condition|precancerous condition
701640|NCT00625066|colon cancer|colon cancer
701641|NCT00625066|rectal cancer|rectal cancer
701642|NCT00625053|Neuroticism|neuroticism
701643|NCT00625053|Hernia, ventral|hernia, ventral
701644|NCT00625053|Laparoscopy|laparoscopy
701645|NCT00625053|Quality of life|quality of life
701646|NCT00625040|Incretin effect|incretin effect
701647|NCT00625040|Gastric banding|gastric banding
701648|NCT00625040|Glucagon|glucagon
701649|NCT00625040|Glucagon-Like Peptide 1|glucagon-like peptide 1
701650|NCT00625040|Gastric Inhibitory Peptide|gastric inhibitory peptide
701651|NCT00625040|Glucose Intestinal Peptide|glucose intestinal peptide
701652|NCT00625040|Insulin|insulin
701653|NCT00625040|C-peptide|c-peptide
701654|NCT00625027|Emergency Department Visit|emergency department visit
701655|NCT00625027|Telehealth Ontario|telehealth ontario
701656|NCT00625027|Triage Levels|triage levels
701657|NCT00625014|Insulin resistance|insulin resistance
701658|NCT00625014|Dyslipidemia|dyslipidemia
701659|NCT00625014|Haloperidol|haloperidol
701660|NCT00625001|Turner Syndrome|turner syndrome
701661|NCT00625001|bone mineral density|bone mineral density
701662|NCT00625001|estrogen replacement therapy|estrogen replacement therapy
701663|NCT00625001|dual energy x-ray absorptiometry|dual energy x-ray absorptiometry
701664|NCT00624988|Spinal cord injury|spinal cord injury
701665|NCT00624988|vibration therapy|vibration therapy
701666|NCT00624988|bone density|bone density
701667|NCT00624962|childhood soft tissue sarcoma|childhood soft tissue sarcoma
701668|NCT00624962|neuroblastoma|neuroblastoma
701669|NCT00624962|childhood hepatoblastoma|childhood hepatoblastoma
701670|NCT00624962|childhood cerebellar astrocytoma|childhood cerebellar astrocytoma
701671|NCT00624962|childhood ependymoma|childhood ependymoma
701672|NCT00624962|childhood brain stem glioma|childhood brain stem glioma
701673|NCT00624962|childhood meningioma|childhood meningioma
701674|NCT00624962|childhood myelodysplastic syndromes|childhood myelodysplastic syndromes
701675|NCT00624962|unspecified childhood solid tumor, protocol specific|unspecified childhood solid tumor, protocol specific
701676|NCT00624962|childhood acute myeloid leukemia/other myeloid malignancies|childhood acute myeloid leukemia/other myeloid malignancies
701677|NCT00624962|central nervous system neoplasm|central nervous system neoplasm
701678|NCT00624962|Wilms tumor and other childhood kidney tumors|wilms tumor and other childhood kidney tumors
701679|NCT00624962|childhood brain tumor|childhood brain tumor
701680|NCT00624962|childhood medulloblastoma|childhood medulloblastoma
701681|NCT00624949|Turner syndrome|turner syndrome
701682|NCT00624949|aortic dimensions|aortic dimensions
701683|NCT00624949|blood pressure|blood pressure
701684|NCT00624949|aortic dilatation|aortic dilatation
701685|NCT00624949|aortic rupture|aortic rupture
701686|NCT00624936|adult acute myeloid leukemia with 11q23 (MLL) abnormalities|adult acute myeloid leukemia with 11q23 (mll) abnormalities
701687|NCT00624936|adult acute myeloid leukemia with inv(16)(p13;q22)|adult acute myeloid leukemia with inv(16)(p13;q22)
701688|NCT00624936|adult acute myeloid leukemia with t(15;17)(q22;q12)|adult acute myeloid leukemia with t(15;17)(q22;q12)
701689|NCT00624936|adult acute myeloid leukemia with t(16;16)(p13;q22)|adult acute myeloid leukemia with t(16;16)(p13;q22)
701690|NCT00624936|adult acute myeloid leukemia with t(8;21)(q22;q22)|adult acute myeloid leukemia with t(8;21)(q22;q22)
701691|NCT00624936|recurrent adult acute myeloid leukemia|recurrent adult acute myeloid leukemia
701692|NCT00624936|myelodysplastic/myeloproliferative neoplasm, unclassifiable|myelodysplastic/myeloproliferative neoplasm, unclassifiable
701693|NCT00624936|myelodysplastic syndromes|myelodysplastic syndromes
701694|NCT00624936|secondary acute myeloid leukemia|secondary acute myeloid leukemia
701695|NCT00624923|Coronary Artery Disease|coronary artery disease
701696|NCT00624923|Inflammation|inflammation
701697|NCT00624923|Overweight|overweight
701698|NCT00624923|Metabolic Syndrome|metabolic syndrome
701699|NCT00624923|Salsalate|salsalate
701700|NCT00624910|Post Operative Pain|post operative pain
701701|NCT00624910|Hysterectomy|hysterectomy
702265|NCT00622726|Stage 3 ROP|stage 3 rop
701702|NCT00624884|Aortic regurgitation,velocity vector imaging|aortic regurgitation,velocity vector imaging
701703|NCT00624871|Interleukin 1-beta|interleukin 1-beta
701704|NCT00624871|Interleukin 6|interleukin 6
701705|NCT00624871|Vitamin C|vitamin c
701706|NCT00624871|HIE|hie
701707|NCT00624871|neonates|neonates
701708|NCT00624858|Depression|depression
701709|NCT00624858|depressed|depressed
701710|NCT00624858|overweight|overweight
701711|NCT00624858|obese|obese
701712|NCT00624845|Meniscectomy|meniscectomy
701713|NCT00624832|Asthma|asthma
701714|NCT00624832|allergen challenge|allergen challenge
701715|NCT00624832|bronchoprovocation|bronchoprovocation
701716|NCT00624832|Methacholine challenge|methacholine challenge
701717|NCT00624832|serum Immunoglobulin E|serum immunoglobulin e
701718|NCT00624832|Nitric Oxide|nitric oxide
701719|NCT00624832|skin prick test|skin prick test
701720|NCT00624819|Streptococcus pneumoniae|streptococcus pneumoniae
701721|NCT00624819|Haemophilus influenzae|haemophilus influenzae
701722|NCT00624819|Pneumococcal conjugate vaccine|pneumococcal conjugate vaccine
701723|NCT00624819|Antibody persistence|antibody persistence
701724|NCT00624806|Pressure ulcer|pressure ulcer
701725|NCT00624806|Telemedicine|telemedicine
701726|NCT00624793|Nausea|nausea
701727|NCT00624793|Vomiting|vomiting
701728|NCT00624793|Retching|retching
701729|NCT00624793|HIV/AIDS|hiv/aids
701730|NCT00624793|Symptom Management|symptom management
701731|NCT00624793|Complementary Therapies|complementary therapies
701732|NCT00624767|insulin|insulin
701733|NCT00624767|insulin aspart|insulin aspart
701734|NCT00624767|Type 2 Diabetes|type 2 diabetes
701735|NCT00624767|diabetes mellitus|diabetes mellitus
701736|NCT00624754|Obstructive airway disease|obstructive airway disease
701737|NCT00624754|bronchiolitis obliterans|bronchiolitis obliterans
701738|NCT00624754|allogeneic hematopoietic stem cell transplantation|allogeneic hematopoietic stem cell transplantation
701739|NCT00624754|bone marrow transplantation|bone marrow transplantation
701740|NCT00624754|inhaled treatment|inhaled treatment
701741|NCT00624754|Budesonide Formoterol|budesonide formoterol
701742|NCT00624741|Parkinson's disease|parkinson's disease
701743|NCT00624741|Antiparkinsonian|antiparkinsonian
701744|NCT00624741|Compassionate use|compassionate use
701745|NCT00624728|Positron-Emission Tomography|positron-emission tomography
701746|NCT00624728|Alovudine [Substance Name]|alovudine [substance name]
701747|NCT00624728|18F-FLT|18f-flt
701748|NCT00624728|Magnetic Resonance Imaging|magnetic resonance imaging
701749|NCT00624728|Astrocytoma|astrocytoma
701750|NCT00624728|Glioblastoma|glioblastoma
701751|NCT00624702|Asthma, cough, spirometry, maleate, xinafoate, acetate, SDDPI (single dose dry powder inhaler)|asthma, cough, spirometry, maleate, xinafoate, acetate, sddpi (single dose dry powder inhaler)
701752|NCT00624689|Body composition|body composition
701753|NCT00624689|Glucose tolerance|glucose tolerance
701754|NCT00624689|Intima-media thickness|intima-media thickness
701755|NCT00624689|Visual acuity|visual acuity
701756|NCT00624689|Neurological development|neurological development
701757|NCT00624676|Acne|acne
701758|NCT00624676|lipophilic hydroxy acid|lipophilic hydroxy acid
701759|NCT00624676|benzoyl peroxide|benzoyl peroxide
701760|NCT00624663|Rivastigmine, Repeated administration, Healthy Volunteers, organophosphate poisoning, protection, pharmacokinetics, behavioral effects|rivastigmine, repeated administration, healthy volunteers, organophosphate poisoning, protection, pharmacokinetics, behavioral effects
701761|NCT00624650|Acute Lung Injury|acute lung injury
701762|NCT00624650|Extravascular Lung Water|extravascular lung water
701763|NCT00624650|Acute Respiratory Distress Syndrome|acute respiratory distress syndrome
701764|NCT00624637|aromatherapy|aromatherapy
701765|NCT00624637|massage|massage
701766|NCT00624637|comfort|comfort
701767|NCT00624637|postoperative|postoperative
701768|NCT00624637|infants|infants
701769|NCT00624637|craniofacial surgery|craniofacial surgery
701770|NCT00624624|hypogonadotropic hypogonadism|hypogonadotropic hypogonadism
701771|NCT00624624|bariatric surgery|bariatric surgery
701772|NCT00624624|serum androgen levels|serum androgen levels
701773|NCT00624624|bone density|bone density
701774|NCT00624611|CPB|cpb
701775|NCT00624611|red blood cell washing|red blood cell washing
701776|NCT00624585|MDS|mds
701777|NCT00624585|MDS/MPD|mds/mpd
701778|NCT00624585|MDS/AML|mds/aml
701779|NCT00624585|CMML|cmml
701780|NCT00624585|Excess Marrow Blasts|excess marrow blasts
701781|NCT00624572|primary teeth|primary teeth
701782|NCT00624572|chlorexidine|chlorexidine
701783|NCT00624572|root canal therapy|root canal therapy
701784|NCT00624572|Pulpectomy|pulpectomy
701785|NCT00624559|Salt sensitivity of Blood Pressure|salt sensitivity of blood pressure
701786|NCT00624546|GERD|gerd
701787|NCT00624546|gastroesophageal reflux|gastroesophageal reflux
701788|NCT00624546|antireflux surgery|antireflux surgery
701789|NCT00624546|Barrett's|barrett's
701790|NCT00624546|Esophagus|esophagus
701791|NCT00624546|Esophagitis|esophagitis
701792|NCT00624533|Low back Pain|low back pain
701793|NCT00624533|Physical Therapy Modalities|physical therapy modalities
701794|NCT00624533|Exercise Movement Techniques|exercise movement techniques
701795|NCT00624533|Primary Health Care|primary health care
701796|NCT00624520|Stress, Psychological|stress, psychological
701797|NCT00624520|Tachycardia, Ventricular|tachycardia, ventricular
701798|NCT00624520|Defibrillators, Implantable|defibrillators, implantable
701799|NCT00624520|Death, Sudden Cardiac|death, sudden cardiac
701800|NCT00624520|Cognitive Therapy|cognitive therapy
701801|NCT00624520|Anger|anger
701802|NCT00624494|venous oxygen saturation|venous oxygen saturation
701803|NCT00624494|transpulmonary thermodilution|transpulmonary thermodilution
701804|NCT00624481|osteoporosis|osteoporosis
701805|NCT00624481|osteopenia|osteopenia
701806|NCT00624481|bone mineral density|bone mineral density
701807|NCT00624481|teriparatide|teriparatide
701808|NCT00624468|atacicept|atacicept
701809|NCT00624468|neuritis|neuritis
701810|NCT00624455|Gabapentin|gabapentin
701811|NCT00624455|tonsillectomy|tonsillectomy
701812|NCT00624455|post-operative pain|post-operative pain
701813|NCT00624455|morphine requirements|morphine requirements
701814|NCT00624455|randomized double blind|randomized double blind
701815|NCT00624455|adenotonsillectomy|adenotonsillectomy
701816|NCT00624429|Asthma|asthma
701817|NCT00624429|Children|children
701818|NCT00624416|Obesity therapy|obesity therapy
701819|NCT00624416|fat|fat
701820|NCT00624416|drug mechanism|drug mechanism
701821|NCT00624416|adipose tissue|adipose tissue
701822|NCT00624416|cellular pharmacology|cellular pharmacology
701823|NCT00624403|Anesthesia|anesthesia
701824|NCT00624403|Laryngeal mask airway|laryngeal mask airway
701825|NCT00624351|Lupus|lupus
701826|NCT00624351|Monoclonal antibody|monoclonal antibody
701827|NCT00624351|B-Cell immunotherapy|b-cell immunotherapy
701828|NCT00624338|Atacicept 75 and 150 mg|atacicept 75 and 150 mg
701829|NCT00624338|Placebo|placebo
701830|NCT00624325|genotype 1 nonresponders|genotype 1 nonresponders
701831|NCT00624312|Procrit|procrit
701832|NCT00624312|Erythropoietin|erythropoietin
701833|NCT00624312|Patients undergoing major surgical oncology operations|patients undergoing major surgical oncology operations
701834|NCT00624299|botox|botox
701835|NCT00624299|limb reconstructions|limb reconstructions
701836|NCT00624299|limb reconstruction surgery|limb reconstruction surgery
701837|NCT00624286|chronic obstructive pulmonary disease|chronic obstructive pulmonary disease
701838|NCT00624286|COPD|copd
701839|NCT00624286|indacaterol|indacaterol
701840|NCT00624273|digital ulcers,|digital ulcers,
701841|NCT00624273|systemic sclerosis,|systemic sclerosis,
701842|NCT00624273|sildenafil,|sildenafil,
701843|NCT00624273|vasoactive therapies|vasoactive therapies
701844|NCT00624260|Colorectal cancer|colorectal cancer
701845|NCT00624260|Recurrence|recurrence
701846|NCT00624260|Positron Emission Tomography|positron emission tomography
701847|NCT00624260|Colorectal Cancer with high risk of recurrence stage III|colorectal cancer with high risk of recurrence stage iii
701848|NCT00624260|Colorectal Cancer with high risk of recurrence stage IV|colorectal cancer with high risk of recurrence stage iv
701849|NCT00624260|T4N0M0 operated in emergency( because of perforation)|t4n0m0 operated in emergency( because of perforation)
701850|NCT00624247|routine HIV testing|routine hiv testing
701851|NCT00624247|jails|jails
701852|NCT00624247|criminal justice system|criminal justice system
701853|NCT00624247|substance abuse|substance abuse
701854|NCT00624247|mental illness|mental illness
701855|NCT00624247|HIV|hiv
701856|NCT00624234|neurofibromatosis type 1|neurofibromatosis type 1
701857|NCT00624234|reading disabilities|reading disabilities
701858|NCT00624234|NF-1|nf-1
701859|NCT00624234|learning disabilities|learning disabilities
701860|NCT00624234|tutoring intervention|tutoring intervention
701861|NCT00624208|Randomized|randomized
701862|NCT00624208|double-blind|double-blind
701863|NCT00624208|4-group clinical interventional study|4-group clinical interventional study
701864|NCT00624195|HIV Dementia|hiv dementia
701865|NCT00624195|HAART|haart
701866|NCT00624195|Cognitive Impairment|cognitive impairment
701867|NCT00624195|Antiretroviral Regimen|antiretroviral regimen
701868|NCT00624195|Viral Load|viral load
701869|NCT00624195|CNS Drug Penetration|cns drug penetration
701870|NCT00624169|Perforated peptic ulcer|perforated peptic ulcer
701871|NCT00624169|Mortality|mortality
701872|NCT00624156|Breast Cancer|breast cancer
701873|NCT00624143|Antifungal prophylaxis, acute leukemia induction,|antifungal prophylaxis, acute leukemia induction,
701874|NCT00624130|Contraception,|contraception,
701875|NCT00624130|Cycle control,|cycle control,
701876|NCT00624130|Bleeding pattern|bleeding pattern
701877|NCT00624117|shoulder joint|shoulder joint
701878|NCT00624117|recovery of function|recovery of function
701879|NCT00624117|effectiveness of rehabilitation|effectiveness of rehabilitation
701880|NCT00624117|rehabilitation|rehabilitation
701881|NCT00624104|VLDL|vldl
701882|NCT00624104|Kinetics|kinetics
701883|NCT00624104|Hyperinsulinaemia|hyperinsulinaemia
701884|NCT00624104|Obesity|obesity
701885|NCT00624091|Early-surgery, infective endocarditis, in-hospital mortality|early-surgery, infective endocarditis, in-hospital mortality
701886|NCT00624078|faboterapics|faboterapics
701887|NCT00624078|treatment|treatment
701888|NCT00624078|scorpion sting|scorpion sting
701889|NCT00624078|envenomation|envenomation
701890|NCT00624065|target blood pressure|target blood pressure
701891|NCT00624065|hypertension|hypertension
701892|NCT00624065|COREG CR|coreg cr
701893|NCT00624065|carvedilol CR|carvedilol cr
701894|NCT00624065|Stage 1 or 2 essential hypertension|stage 1 or 2 essential hypertension
701895|NCT00624065|lisinopril|lisinopril
701896|NCT00624039|presbyopia|presbyopia
701897|NCT00624013|Diabetes|diabetes
701898|NCT00624013|Depression|depression
701899|NCT00624013|diabetes outcomes|diabetes outcomes
701900|NCT00624013|quality of life|quality of life
701901|NCT00624000|Ischemic Stroke|ischemic stroke
701902|NCT00623987|Residual vein thrombosis|residual vein thrombosis
701903|NCT00623987|Optimal duration|optimal duration
701904|NCT00623987|Oral anticoagulants|oral anticoagulants
701905|NCT00623974|Hypocalcemia|hypocalcemia
701906|NCT00623974|Teriparatide|teriparatide
701907|NCT00623974|Forteo|forteo
701908|NCT00623974|Calcium|calcium
701909|NCT00623974|Calcitriol|calcitriol
701910|NCT00623974|Rocaltrol|rocaltrol
701911|NCT00623961|Neuropathic Pain|neuropathic pain
701912|NCT00623948|Pressure ulcers|pressure ulcers
701913|NCT00623948|Electrical Stimulation|electrical stimulation
701914|NCT00623948|Spinal Cord Injury|spinal cord injury
701915|NCT00623935|AML|aml
701916|NCT00623922|Patient education|patient education
701917|NCT00623922|Nurse consultation|nurse consultation
701918|NCT00623922|Arthritis|arthritis
701919|NCT00623922|Wellbeing|wellbeing
701920|NCT00623922|Coping|coping
701921|NCT00623922|Health related quality of life|health related quality of life
701922|NCT00623909|Laser Therapy|laser therapy
701923|NCT00623909|Post Thoracotomy Pain|post thoracotomy pain
701924|NCT00623909|AvicennaTM laser|avicennatm laser
701925|NCT00623896|Nehb|nehb
701926|NCT00623896|ST Elevation Myocardial Infarcton|st elevation myocardial infarcton
701927|NCT00623896|STEMI|stemi
701928|NCT00623896|ECG|ecg
701929|NCT00623883|Human Colonic Aberrant Crypt Foci|human colonic aberrant crypt foci
701930|NCT00623857|Micronutrients|micronutrients
701931|NCT00623857|Zinc|zinc
701932|NCT00623857|Vitamins|vitamins
701933|NCT00623857|Trace elements|trace elements
701934|NCT00623857|Minerals|minerals
701935|NCT00623857|Vitamin A|vitamin a
701936|NCT00623857|Vitamin B1|vitamin b1
701937|NCT00623857|Vitamin B2|vitamin b2
701938|NCT00623857|Niacin|niacin
701939|NCT00623857|Vitamin B6|vitamin b6
701940|NCT00623857|Folic acid|folic acid
701941|NCT00623857|Vitamin B12|vitamin b12
701942|NCT00623857|Vitamin C|vitamin c
701943|NCT00623857|Vitamin D|vitamin d
701944|NCT00623857|Vitamin E|vitamin e
701945|NCT00623857|Vitamin K|vitamin k
701946|NCT00623857|Iron|iron
701947|NCT00623857|Iodine|iodine
701948|NCT00623857|Copper|copper
701949|NCT00623857|Selenium|selenium
701950|NCT00623857|Magnesium|magnesium
701951|NCT00623857|Calcium|calcium
701952|NCT00623857|Malaria|malaria
701953|NCT00623857|Immunity|immunity
701954|NCT00623857|Anthropometry|anthropometry
701955|NCT00623844|Prevention|prevention
701956|NCT00623844|Physical activity|physical activity
701957|NCT00623844|Obesity|obesity
701958|NCT00623844|Motor skills|motor skills
701959|NCT00623844|Kindergarten|kindergarten
701960|NCT00623831|MBV|mbv
701961|NCT00623831|Mixed Bacterial Vaccine|mixed bacterial vaccine
701962|NCT00623831|NY-ESO-1|ny-eso-1
701963|NCT00623818|Mirror Therapy|mirror therapy
701964|NCT00623818|Phantom Limb Pain|phantom limb pain
701965|NCT00623818|Amputee|amputee
701966|NCT00623818|Healthy Volunteer|healthy volunteer
701967|NCT00623818|HV|hv
701968|NCT00623792|Morbid obesity|morbid obesity
701969|NCT00623792|Diet therapy|diet therapy
701970|NCT00623792|Bariatric Surgery|bariatric surgery
701971|NCT00623792|Gastric bypass|gastric bypass
701972|NCT00623792|Behavior therapy|behavior therapy
701973|NCT00623792|Randomized controlled trial|randomized controlled trial
701974|NCT00623792|Weight loss|weight loss
701975|NCT00623753|Vaccine|vaccine
701976|NCT00623753|Prevention|prevention
701977|NCT00623753|HIV|hiv
701978|NCT00623753|AIDS|aids
701979|NCT00623753|Human Immunodeficiency Virus|human immunodeficiency virus
701980|NCT00623753|HIV Seronegativity, HIV Preventive Vaccine|hiv seronegativity, hiv preventive vaccine
701981|NCT00623740|Hydrocortisone|hydrocortisone
701982|NCT00623740|Very low birth weight|very low birth weight
701983|NCT00623740|Bronchopulmonary dysplasia|bronchopulmonary dysplasia
701984|NCT00623740|Prevention Cerebral palsy|prevention cerebral palsy
701985|NCT00623727|Hemophilia A|hemophilia a
701986|NCT00623727|FVIII disease|fviii disease
701987|NCT00623727|rFVIII|rfviii
701988|NCT00623701|sublingual grass pollen preparation|sublingual grass pollen preparation
701989|NCT00623701|IgE-mediated Allergic Disease attributed to grass pollen|ige-mediated allergic disease attributed to grass pollen
701990|NCT00623688|Metered Dose Inhalers|metered dose inhalers
701991|NCT00623688|Nebulizers|nebulizers
701992|NCT00623688|Randomized Controlled Trial|randomized controlled trial
701993|NCT00623675|zeolites|zeolites
701994|NCT00623675|nutraceuticals|nutraceuticals
701995|NCT00623675|natural supplements|natural supplements
701996|NCT00623675|Healthy volunteers|healthy volunteers
701997|NCT00623662|Glucose infusion|glucose infusion
701998|NCT00623662|Liver function|liver function
701999|NCT00623662|Liver resection|liver resection
702000|NCT00623662|Albumin synthesis|albumin synthesis
702001|NCT00623662|Stable isotopes|stable isotopes
702002|NCT00623636|Migraine|migraine
702003|NCT00623610|Diabetes mellitus, type 1|diabetes mellitus, type 1
702004|NCT00623610|pancreatic beta cell|pancreatic beta cell
702005|NCT00623610|transplantation|transplantation
702006|NCT00623584|penetrating keratoplasty|penetrating keratoplasty
702007|NCT00623584|corneal transplantation|corneal transplantation
702008|NCT00623584|corneal grafting|corneal grafting
702009|NCT00623584|corneal grafts|corneal grafts
702010|NCT00623584|culture media|culture media
702011|NCT00623584|corneal culturing|corneal culturing
702012|NCT00623584|in vitro culturing|in vitro culturing
702013|NCT00623571|frail elderly|frail elderly
702014|NCT00623571|hospital at home|hospital at home
702015|NCT00623571|heart failure|heart failure
702016|NCT00623571|Acute exacerbation of chronic heart failure|acute exacerbation of chronic heart failure
702017|NCT00623558|head and neck neoplasm|head and neck neoplasm
702018|NCT00623558|cetuximab|cetuximab
702019|NCT00623558|docetaxel|docetaxel
702020|NCT00623558|cisplatin|cisplatin
702021|NCT00623558|radiotherapy|radiotherapy
702022|NCT00623545|Exenatide|exenatide
702023|NCT00623545|Byetta|byetta
702024|NCT00623545|weight loss|weight loss
702025|NCT00623545|energy expenditure|energy expenditure
702026|NCT00623545|normal volunteers|normal volunteers
702027|NCT00623532|Tertiary prevention of disability|tertiary prevention of disability
702028|NCT00623519|Adjuvant postmenopausal breast cancer women|adjuvant postmenopausal breast cancer women
702029|NCT00623506|TBI|tbi
702030|NCT00623506|Pregnenolone|pregnenolone
702031|NCT00623506|Cognition|cognition
702032|NCT00623493|Screening|screening
702033|NCT00623493|Suicide|suicide
702034|NCT00623493|Emergency Department|emergency department
702035|NCT00623493|Children and Adolescents|children and adolescents
702036|NCT00623493|Suicide Risk|suicide risk
702037|NCT00623480|Hemophilia A|hemophilia a
702038|NCT00623467|Central Nervous System Imaging|central nervous system imaging
702039|NCT00623467|Diagnostic Imaging|diagnostic imaging
702040|NCT00623454|anxiety|anxiety
702041|NCT00623454|panic disorder|panic disorder
702042|NCT00623454|chest pain|chest pain
702043|NCT00623454|palpitations|palpitations
702044|NCT00623441|Coronary Artery Disease|coronary artery disease
702045|NCT00623441|Drug-eluting stent|drug-eluting stent
702046|NCT00623402|Metastatic melanoma|metastatic melanoma
702047|NCT00623402|Pegylated interferon|pegylated interferon
702048|NCT00623402|Protein Kinase Inhibitors|protein kinase inhibitors
702049|NCT00623402|Sorafenib|sorafenib
702050|NCT00623402|PegIntron|pegintron
702051|NCT00623402|Therapeutic Uses|therapeutic uses
702052|NCT00623402|melanoma (skin)|melanoma (skin)
702053|NCT00623389|Neurologic disorders|neurologic disorders
702054|NCT00623389|Rare disease|rare disease
702055|NCT00623389|Spinal cord injuries|spinal cord injuries
702056|NCT00623389|Stroke|stroke
702057|NCT00623389|Paraplegia|paraplegia
702058|NCT00623389|Tetraplegia|tetraplegia
702059|NCT00623363|Parkinson's Disease|parkinson's disease
702060|NCT00623363|motor complications|motor complications
702061|NCT00623363|dyskinesia|dyskinesia
702062|NCT00623363|Motor complications associated with Parkinson's|motor complications associated with parkinson's
702063|NCT00623350|Telemedicine|telemedicine
702064|NCT00623350|Stroke, Acute|stroke, acute
702065|NCT00623350|Rural|rural
702066|NCT00623350|Thrombolysis|thrombolysis
702067|NCT00623350|Consultation|consultation
702068|NCT00623337|care seeking|care seeking
702069|NCT00623337|pregnancy and childbirth|pregnancy and childbirth
702070|NCT00623337|newborn care practices|newborn care practices
702071|NCT00623337|low birth weight babies|low birth weight babies
702072|NCT00623298|Posttraumatic stress disorder|posttraumatic stress disorder
702073|NCT00623298|depression|depression
702074|NCT00623298|Narrative Exposure Therapy|narrative exposure therapy
702075|NCT00623298|Interpersonal Psychotherapy|interpersonal psychotherapy
702076|NCT00623285|Pain.|pain.
702077|NCT00623285|Postoperative.|postoperative.
702078|NCT00623285|CABG.|cabg.
702079|NCT00623272|The assessment of left ventricular ejection fraction (LVEF)|the assessment of left ventricular ejection fraction (lvef)
702080|NCT00623246|Obstructive Sleep Apnea|obstructive sleep apnea
702081|NCT00623246|OSA|osa
702082|NCT00623246|Adherence|adherence
702083|NCT00623246|CPAP|cpap
702084|NCT00623246|Cognition|cognition
702085|NCT00623233|Breast Neoplasm|breast neoplasm
702086|NCT00623220|pain, retinopathy of prematurity, infant, premature, eye exam, nitrous oxide|pain, retinopathy of prematurity, infant, premature, eye exam, nitrous oxide
702087|NCT00623207|Chest Pain Low work Capacity Rate Incompetence|chest pain low work capacity rate incompetence
702088|NCT00623181|Influenza|influenza
702089|NCT00623181|Influenza virus|influenza virus
702090|NCT00623168|Ribavirin|ribavirin
702091|NCT00623168|Hemorrhagic Fever with Renal Syndrome|hemorrhagic fever with renal syndrome
702092|NCT00623155|malaria|malaria
702093|NCT00623155|intermittent preventive treatment|intermittent preventive treatment
702094|NCT00623155|season|season
702095|NCT00623155|children|children
703397|NCT00618397|sedation|sedation
702096|NCT00623142|Myocardial protection|myocardial protection
702097|NCT00623142|Ischemic Reperfusion Injury|ischemic reperfusion injury
702098|NCT00623142|Hyperbaric Oxygen|hyperbaric oxygen
702099|NCT00623142|Preconditioning|preconditioning
702100|NCT00623129|hypopharyngeal cancer|hypopharyngeal cancer
702101|NCT00623129|lip and oral cavity cancer|lip and oral cavity cancer
702102|NCT00623129|laryngeal cancer|laryngeal cancer
702103|NCT00623129|nasopharyngeal cancer|nasopharyngeal cancer
702104|NCT00623129|oropharyngeal cancer|oropharyngeal cancer
702105|NCT00623129|paranasal sinus and nasal cavity cancer|paranasal sinus and nasal cavity cancer
702106|NCT00623129|salivary gland cancer|salivary gland cancer
702107|NCT00623129|xerostomia|xerostomia
702108|NCT00623129|radiation toxicity|radiation toxicity
702109|NCT00623116|Kallmann Syndrome|kallmann syndrome
702110|NCT00623116|hypogonadotropic hypogonadism|hypogonadotropic hypogonadism
702111|NCT00623103|Parkinson's disease dementia|parkinson's disease dementia
702112|NCT00623103|cholinesterase inhibitor|cholinesterase inhibitor
702113|NCT00623103|rivastigmine|rivastigmine
702114|NCT00623090|prostate cancer screening education|prostate cancer screening education
702115|NCT00623090|behavioral oncology|behavioral oncology
702116|NCT00623090|randomized trial|randomized trial
702117|NCT00623077|metastatic Ewing sarcoma/peripheral primitive neuroectodermal tumor|metastatic ewing sarcoma/peripheral primitive neuroectodermal tumor
702118|NCT00623077|recurrent Ewing sarcoma/peripheral primitive neuroectodermal tumor|recurrent ewing sarcoma/peripheral primitive neuroectodermal tumor
702119|NCT00623077|childhood hepatoblastoma|childhood hepatoblastoma
702120|NCT00623077|recurrent childhood liver cancer|recurrent childhood liver cancer
702121|NCT00623077|stage IV childhood liver cancer|stage iv childhood liver cancer
702122|NCT00623077|adult primary liver cancer|adult primary liver cancer
702123|NCT00623077|previously treated childhood rhabdomyosarcoma|previously treated childhood rhabdomyosarcoma
702124|NCT00623077|recurrent childhood rhabdomyosarcoma|recurrent childhood rhabdomyosarcoma
702125|NCT00623077|previously untreated childhood rhabdomyosarcoma|previously untreated childhood rhabdomyosarcoma
702126|NCT00623077|metastatic childhood soft tissue sarcoma|metastatic childhood soft tissue sarcoma
702127|NCT00623077|recurrent childhood soft tissue sarcoma|recurrent childhood soft tissue sarcoma
702128|NCT00623077|recurrent adult soft tissue sarcoma|recurrent adult soft tissue sarcoma
702129|NCT00623077|stage IV adult soft tissue sarcoma|stage iv adult soft tissue sarcoma
702130|NCT00623077|recurrent Wilms tumor and other childhood kidney tumors|recurrent wilms tumor and other childhood kidney tumors
702131|NCT00623077|stage IV Wilms tumor|stage iv wilms tumor
702132|NCT00623077|stage V Wilms tumor|stage v wilms tumor
702133|NCT00623077|rhabdoid tumor of the kidney|rhabdoid tumor of the kidney
702134|NCT00623077|stage IV renal cell cancer|stage iv renal cell cancer
702135|NCT00623077|childhood mixed glioma|childhood mixed glioma
702136|NCT00623077|recurrent childhood cerebellar astrocytoma|recurrent childhood cerebellar astrocytoma
702137|NCT00623077|recurrent childhood cerebral astrocytoma|recurrent childhood cerebral astrocytoma
702138|NCT00623077|recurrent childhood ependymoma|recurrent childhood ependymoma
702139|NCT00623077|recurrent childhood medulloblastoma|recurrent childhood medulloblastoma
702140|NCT00623077|recurrent childhood pineoblastoma|recurrent childhood pineoblastoma
702141|NCT00623077|recurrent childhood supratentorial primitive neuroectodermal tumor|recurrent childhood supratentorial primitive neuroectodermal tumor
702142|NCT00623077|recurrent childhood visual pathway glioma|recurrent childhood visual pathway glioma
702143|NCT00623077|untreated childhood brain stem glioma|untreated childhood brain stem glioma
702144|NCT00623077|untreated childhood cerebellar astrocytoma|untreated childhood cerebellar astrocytoma
702145|NCT00623077|childhood infratentorial ependymoma|childhood infratentorial ependymoma
702146|NCT00623077|childhood supratentorial ependymoma|childhood supratentorial ependymoma
702147|NCT00623077|childhood high-grade cerebellar astrocytoma|childhood high-grade cerebellar astrocytoma
702148|NCT00623077|childhood high-grade cerebral astrocytoma|childhood high-grade cerebral astrocytoma
702149|NCT00623077|childhood low-grade cerebellar astrocytoma|childhood low-grade cerebellar astrocytoma
702150|NCT00623077|childhood low-grade cerebral astrocytoma|childhood low-grade cerebral astrocytoma
702151|NCT00623077|newly diagnosed childhood ependymoma|newly diagnosed childhood ependymoma
702152|NCT00623077|childhood atypical teratoid/rhabdoid tumor|childhood atypical teratoid/rhabdoid tumor
702153|NCT00623077|recurrent retinoblastoma|recurrent retinoblastoma
702154|NCT00623077|extraocular retinoblastoma|extraocular retinoblastoma
702155|NCT00623077|intraocular retinoblastoma|intraocular retinoblastoma
702156|NCT00623077|childhood renal cell carcinoma|childhood renal cell carcinoma
702157|NCT00623077|clear cell renal cell carcinoma|clear cell renal cell carcinoma
702158|NCT00623077|recurrent renal cell cancer|recurrent renal cell cancer
702159|NCT00623077|recurrent childhood visual pathway and hypothalamic glioma|recurrent childhood visual pathway and hypothalamic glioma
702160|NCT00623077|unspecified adult solid tumor, protocol specific|unspecified adult solid tumor, protocol specific
702161|NCT00623077|unspecified childhood solid tumor, protocol specific|unspecified childhood solid tumor, protocol specific
702162|NCT00623064|transitional cell carcinoma of the bladder|transitional cell carcinoma of the bladder
702163|NCT00623064|stage IV bladder cancer|stage iv bladder cancer
702164|NCT00623064|stage III bladder cancer|stage iii bladder cancer
702165|NCT00623064|metastatic transitional cell cancer of the renal pelvis and ureter|metastatic transitional cell cancer of the renal pelvis and ureter
702266|NCT00622726|Neonatal Intensive Care Unit|neonatal intensive care unit
702166|NCT00623064|regional transitional cell cancer of the renal pelvis and ureter|regional transitional cell cancer of the renal pelvis and ureter
702167|NCT00623051|male circumcision|male circumcision
702168|NCT00623051|HIV|hiv
702169|NCT00623051|sexual behavior|sexual behavior
702170|NCT00623051|HIV prevention|hiv prevention
702171|NCT00623051|HIV Seronegativity|hiv seronegativity
702172|NCT00623038|Apgar score|apgar score
702173|NCT00623038|neonatal assessment|neonatal assessment
702174|NCT00623038|preterm infants|preterm infants
702175|NCT00623038|resuscitation|resuscitation
702176|NCT00623025|HIV|hiv
702177|NCT00623025|Steatorrhea|steatorrhea
702178|NCT00622999|Malnutrition|malnutrition
702179|NCT00622999|Colon cancer|colon cancer
702180|NCT00622999|Colon surgery|colon surgery
702181|NCT00622999|Outcome|outcome
702182|NCT00622999|Complication rate|complication rate
702183|NCT00622973|Prostate cancer|prostate cancer
702184|NCT00622973|Bladder cancer|bladder cancer
702185|NCT00622973|Pelvic lymph node metastases|pelvic lymph node metastases
702186|NCT00622973|Diffusion-weighted MRI|diffusion-weighted mri
702187|NCT00622973|Sinerem (USPIO)-enhanced MRI|sinerem (uspio)-enhanced mri
702188|NCT00622973|Imaging influence on surgery|imaging influence on surgery
702189|NCT00622973|Noninvasive detection of pelvic lymph node metastases|noninvasive detection of pelvic lymph node metastases
702190|NCT00622973|Influence of imaging protocol on surgical outcome|influence of imaging protocol on surgical outcome
702191|NCT00622960|obesity|obesity
702192|NCT00622960|type 2 diabetes|type 2 diabetes
702193|NCT00622960|weight loss|weight loss
702194|NCT00622960|monounsaturated fat|monounsaturated fat
702195|NCT00622960|diet|diet
702196|NCT00622947|Depression|depression
702197|NCT00622947|antidepressant effect|antidepressant effect
702198|NCT00622947|rTMS|rtms
702199|NCT00622947|sham|sham
702200|NCT00622947|cognition|cognition
702201|NCT00622947|saliva cortisol|saliva cortisol
702202|NCT00622947|brain derived neurotropic factor|brain derived neurotropic factor
702203|NCT00622934|multiple trauma|multiple trauma
702204|NCT00622921|PTSD|ptsd
702205|NCT00622921|alcohol dependence|alcohol dependence
702206|NCT00622895|scleroderma|scleroderma
702207|NCT00622895|systemic sclerosis|systemic sclerosis
702208|NCT00622882|Staphylococcus aureus|staphylococcus aureus
702209|NCT00622882|Bacteremia|bacteremia
702210|NCT00622882|Outcome|outcome
702211|NCT00622882|Mortality|mortality
702212|NCT00622882|Recurrence|recurrence
711023|NCT00586833|Dyspnea, Paroxysmal|dyspnea, paroxysmal
702213|NCT00622882|Infectious Diseases specialists|infectious diseases specialists
702214|NCT00622869|Liver transplantation|liver transplantation
702215|NCT00622869|everolimus|everolimus
702216|NCT00622869|calcineurin inhibitors|calcineurin inhibitors
702217|NCT00622869|tacrolimus|tacrolimus
702218|NCT00622869|renal function|renal function
702219|NCT00622869|MDRD formula|mdrd formula
702220|NCT00622869|progression of fibrosis|progression of fibrosis
702221|NCT00622856|diabetes|diabetes
702222|NCT00622856|adolescents|adolescents
702223|NCT00622856|psychological therapy|psychological therapy
702224|NCT00622843|pneumococcal conjugate vaccine|pneumococcal conjugate vaccine
702225|NCT00622843|polysaccharide vaccine|polysaccharide vaccine
702226|NCT00622843|PPV|ppv
702227|NCT00622843|PCV|pcv
702228|NCT00622843|Streptococcus pneumoniae|streptococcus pneumoniae
702229|NCT00622843|Prevnar|prevnar
702230|NCT00622843|Pneumovax|pneumovax
702231|NCT00622843|HIV|hiv
702232|NCT00622830|darapladib,|darapladib,
702233|NCT00622830|SB480848,|sb480848,
702234|NCT00622830|Japanese healthy volunteers|japanese healthy volunteers
702235|NCT00622817|Epinephrine|epinephrine
702236|NCT00622817|Nasal decongestant|nasal decongestant
702237|NCT00622817|RSV|rsv
702238|NCT00622817|xylometazoline|xylometazoline
702239|NCT00622817|Bronchiolitis|bronchiolitis
702240|NCT00622804|Stomach cancer|stomach cancer
702241|NCT00622804|Gastrectomy|gastrectomy
702242|NCT00622804|Postgastrectomy syndrome|postgastrectomy syndrome
702243|NCT00622791|Cardiopulmonary bypass|cardiopulmonary bypass
702244|NCT00622791|coronary artery bypass graft|coronary artery bypass graft
702245|NCT00622791|coronary artery disease|coronary artery disease
702246|NCT00622791|propofol|propofol
702247|NCT00622791|pharmacokinetics|pharmacokinetics
702248|NCT00622791|pharmacodynamics|pharmacodynamics
702249|NCT00622778|intracranial bleeding|intracranial bleeding
702250|NCT00622778|computed tomography scan|computed tomography scan
702251|NCT00622765|Obesity, Overweight, Body Weight, Body Size, Nutritional and Metabolic Diseases|obesity, overweight, body weight, body size, nutritional and metabolic diseases
702252|NCT00622752|Smoking cessation|smoking cessation
702253|NCT00622752|Craving|craving
702254|NCT00622752|Smokers|smokers
702255|NCT00622739|Bipolar Disorder|bipolar disorder
702256|NCT00622739|Children|children
702257|NCT00622739|Adolescents|adolescents
702258|NCT00622739|Treatment|treatment
702259|NCT00622726|Vascular Endothelial Growth Factor|vascular endothelial growth factor
702260|NCT00622726|Angiogenesis Inhibitor|angiogenesis inhibitor
702261|NCT00622726|Premature infants|premature infants
702262|NCT00622726|Bevacizumab|bevacizumab
702263|NCT00622726|Zone I or Posterior Zone II ROP|zone i or posterior zone ii rop
702264|NCT00622726|Aggressive Posterior ROP|aggressive posterior rop
702267|NCT00622713|Alzheimer's disease|alzheimer's disease
702268|NCT00622713|cholinesterase inhibitor|cholinesterase inhibitor
702269|NCT00622713|rivastigmine|rivastigmine
702270|NCT00622700|MS|ms
702271|NCT00622700|Clinically Isolated Syndrome|clinically isolated syndrome
702272|NCT00622700|CIS|cis
702273|NCT00622700|CDMS|cdms
702274|NCT00622700|relapses|relapses
702275|NCT00622687|iloprost|iloprost
702276|NCT00622687|systemic sclerosis|systemic sclerosis
702277|NCT00622687|digital ulcers|digital ulcers
702278|NCT00622687|observational study|observational study
702279|NCT00622687|randomized|randomized
702280|NCT00622674|recurrent breast cancer|recurrent breast cancer
702281|NCT00622674|recurrent non-small cell lung cancer|recurrent non-small cell lung cancer
702282|NCT00622674|recurrent small cell lung cancer|recurrent small cell lung cancer
702283|NCT00622674|recurrent colon cancer|recurrent colon cancer
702284|NCT00622674|recurrent pancreatic cancer|recurrent pancreatic cancer
702285|NCT00622674|recurrent head and neck cancer|recurrent head and neck cancer
702286|NCT00622674|recurrent sarcoma|recurrent sarcoma
702287|NCT00622674|recurrent kidney cancer|recurrent kidney cancer
702288|NCT00622674|recurrent renal cell cancer|recurrent renal cell cancer
702289|NCT00622661|Glycemic response|glycemic response
702290|NCT00622661|Glycemic index|glycemic index
702291|NCT00622661|Obesity|obesity
702292|NCT00622661|Carbohydrates|carbohydrates
702293|NCT00622661|Insulin|insulin
702294|NCT00622661|Blood glucose|blood glucose
702295|NCT00622648|Medical prevention therapy|medical prevention therapy
702296|NCT00622635|chronic obstructive pulmonary disease|chronic obstructive pulmonary disease
702297|NCT00622635|COPD|copd
702298|NCT00622635|indacaterol|indacaterol
702299|NCT00622609|first time in human,|first time in human,
702300|NCT00622609|MAG|mag
702301|NCT00622609|monoclonal antibody,|monoclonal antibody,
702302|NCT00622609|healthy subjects,|healthy subjects,
702303|NCT00622609|GSK249320,|gsk249320,
702304|NCT00622596|opiate dependence|opiate dependence
702305|NCT00622596|buprenorphine|buprenorphine
702306|NCT00622583|Herniorrhaphy|herniorrhaphy
702307|NCT00622570|Traumatic brain injury, barbiturate coma|traumatic brain injury, barbiturate coma
702308|NCT00622544|Microalbuminuria|microalbuminuria
702309|NCT00622544|Proteinuria|proteinuria
702310|NCT00622531|heart failure|heart failure
702311|NCT00622531|BNP|bnp
702312|NCT00622531|natriuretic peptide|natriuretic peptide
702313|NCT00622518|otitis media|otitis media
702314|NCT00622518|children|children
702315|NCT00622505|Multiple myeloma|multiple myeloma
702316|NCT00622505|zoledronic acid|zoledronic acid
702317|NCT00622505|skeletal complications|skeletal complications
702318|NCT00622505|bone|bone
702319|NCT00622492|VV-ECMO|vv-ecmo
702320|NCT00622492|VA-ECMO|va-ecmo
702321|NCT00622492|PPHN|pphn
702322|NCT00622492|organ circulation|organ circulation
702323|NCT00622479|Sorafenib|sorafenib
702324|NCT00622479|Hypophosphatemia|hypophosphatemia
702325|NCT00622479|Left ventricular ejection fraction (LVEF)|left ventricular ejection fraction (lvef)
702326|NCT00622479|Beta-type Natriuretic Peptide (BNP)|beta-type natriuretic peptide (bnp)
702327|NCT00622466|stage IV breast cancer|stage iv breast cancer
702328|NCT00622466|male breast cancer|male breast cancer
702329|NCT00622466|recurrent breast cancer|recurrent breast cancer
702330|NCT00622466|HER2-negative breast cancer|her2-negative breast cancer
702331|NCT00622440|HSIL|hsil
702332|NCT00622440|HGAIN|hgain
702333|NCT00622440|AIN|ain
702334|NCT00622440|neoplasia|neoplasia
702335|NCT00622440|dysplasia|dysplasia
702336|NCT00622440|TCM|tcm
702337|NCT00622440|Traditional Chinese Medicine|traditional chinese medicine
702338|NCT00622401|stage IV breast cancer|stage iv breast cancer
702339|NCT00622401|dendritic cell vaccine|dendritic cell vaccine
702340|NCT00622401|tumor fusion vaccine|tumor fusion vaccine
702341|NCT00622401|IL-12|il-12
702342|NCT00622375|Pharmacokinetic study|pharmacokinetic study
702343|NCT00622375|Healthy subjects|healthy subjects
702344|NCT00622362|Immunotherapy|immunotherapy
702345|NCT00622362|Allergy|allergy
702346|NCT00622362|Allergoid|allergoid
702347|NCT00622362|Depigmented|depigmented
702348|NCT00622362|Polymerized|polymerized
702349|NCT00622362|Allergen-extract|allergen-extract
702350|NCT00622362|mites|mites
702351|NCT00622362|Asthma|asthma
702352|NCT00622349|Randomised phase III|randomised phase iii
702353|NCT00622349|Chemotherapy|chemotherapy
702354|NCT00622349|Advanced non-small cell lung carcinoma|advanced non-small cell lung carcinoma
702355|NCT00622336|Multiple Myeloma|multiple myeloma
702356|NCT00622336|Revlimid|revlimid
702357|NCT00622323|diabetes|diabetes
702358|NCT00622323|exenatide|exenatide
702359|NCT00622323|metformin|metformin
702360|NCT00622323|sulfonylurea|sulfonylurea
702361|NCT00622323|Byetta|byetta
702362|NCT00622323|Amylin|amylin
702363|NCT00622323|Lilly|lilly
702364|NCT00622271|Type 1 Diabetes Mellitus|type 1 diabetes mellitus
702365|NCT00622271|Adolescents and Families|adolescents and families
702366|NCT00622271|Group Therapy Intervention|group therapy intervention
702367|NCT00622258|everolimus|everolimus
702368|NCT00622258|mTOR inhibitor|mtor inhibitor
702369|NCT00622258|non-Hodgkin's lymphoma|non-hodgkin's lymphoma
702370|NCT00622245|Depression|depression
702371|NCT00622245|Bipolar disorder|bipolar disorder
702372|NCT00622245|Placebo-controlled|placebo-controlled
702373|NCT00622245|Double-blind|double-blind
702374|NCT00622245|Multicenter|multicenter
702375|NCT00622245|Clinical study|clinical study
702376|NCT00622245|Mania|mania
702377|NCT00622232|HIV-1|hiv-1
702378|NCT00622232|treatment experienced, complementary therapies|treatment experienced, complementary therapies
702379|NCT00622219|Alcohol abuse|alcohol abuse
702380|NCT00622219|Drug abuse|drug abuse
702381|NCT00622206|Pharmacokinetics|pharmacokinetics
702382|NCT00622206|ritonavir|ritonavir
702383|NCT00622206|saquinavir|saquinavir
702384|NCT00622206|safety and toxicity|safety and toxicity
702385|NCT00622206|treatment experienced|treatment experienced
702386|NCT00622193|NSCLC|nsclc
702387|NCT00622180|Vitiligo|vitiligo
702388|NCT00622180|Light treatment for vitiligo|light treatment for vitiligo
702389|NCT00622180|Excilite|excilite
702390|NCT00622167|Plaque characteristics|plaque characteristics
702391|NCT00622167|DSCT|dsct
702392|NCT00622167|IVUS|ivus
702393|NCT00622141|bioequivalence|bioequivalence
702394|NCT00622141|ritonavir boosted generic GPO saquinavir|ritonavir boosted generic gpo saquinavir
702395|NCT00622141|saftey|saftey
702396|NCT00622141|pharmacokinetics|pharmacokinetics
702397|NCT00622128|Behavioral Research|behavioral research
702398|NCT00622128|Dementia|dementia
702399|NCT00622128|Aggression|aggression
702400|NCT00622102|warfarin|warfarin
702401|NCT00622102|adherence|adherence
702402|NCT00622102|Mechanical heart valves|mechanical heart valves
702403|NCT00622089|diabetes|diabetes
702404|NCT00622089|type 2 diabetes|type 2 diabetes
702405|NCT00622089|cholesterol|cholesterol
702406|NCT00622076|postoperative|postoperative
702407|NCT00622076|Catheterization|catheterization
702408|NCT00622076|colporrhaphy|colporrhaphy
702409|NCT00622076|cystocele|cystocele
702410|NCT00622076|cystitis|cystitis
702411|NCT00622063|cancer, solid tumor|cancer, solid tumor
702412|NCT00622024|Arrhythmia|arrhythmia
702413|NCT00622024|Depression|depression
702414|NCT00622024|Coronary Artery Disease|coronary artery disease
702415|NCT00621998|Risperidone|risperidone
702416|NCT00621998|Olanzapine|olanzapine
702417|NCT00621998|Tardive dyskinesia|tardive dyskinesia
702418|NCT00621972|acute renal failure|acute renal failure
702419|NCT00621972|arteriovenous fistula|arteriovenous fistula
702420|NCT00621972|KIM-1|kim-1
702421|NCT00621972|chronic kidney disease|chronic kidney disease
702422|NCT00621959|levocetirizine|levocetirizine
702423|NCT00621959|Xyzal|xyzal
702424|NCT00621959|Seasonal Allergic Rhinitis|seasonal allergic rhinitis
702425|NCT00621959|total symptom score|total symptom score
702426|NCT00621959|quality of life|quality of life
702427|NCT00621946|Asthma|asthma
702428|NCT00621946|Depression|depression
702429|NCT00621946|Escitalopram|escitalopram
702430|NCT00621907|randomized|randomized
702431|NCT00621907|analgesic|analgesic
702432|NCT00621907|caesarean scars|caesarean scars
702433|NCT00621907|locoregional anaesthesia|locoregional anaesthesia
702434|NCT00621907|infiltration|infiltration
702435|NCT00621907|levobupivacaïne|levobupivacaïne
702436|NCT00621907|Chirocaïne|chirocaïne
702437|NCT00621907|caesarian|caesarian
702438|NCT00621907|unique administration|unique administration
702439|NCT00621907|post-caesarian analgesic|post-caesarian analgesic
702440|NCT00621894|Immune thrombocytopenic purpura|immune thrombocytopenic purpura
702441|NCT00621894|thrombopoietin mimetic|thrombopoietin mimetic
702442|NCT00621894|ITP|itp
702443|NCT00621881|hepatic impairment|hepatic impairment
702444|NCT00621868|Diabetes Mellitus, Type 2|diabetes mellitus, type 2
702445|NCT00621868|ASP1941|asp1941
702446|NCT00621842|Geriatric Psychiatry|geriatric psychiatry
702447|NCT00621842|Aged|aged
702448|NCT00621842|lamotrigine|lamotrigine
702449|NCT00621816|nitroprusside|nitroprusside
702450|NCT00621816|intensive care unit|intensive care unit
702451|NCT00621816|hypertension|hypertension
702452|NCT00621816|blood pressure reduction|blood pressure reduction
702453|NCT00621803|Probiotic|probiotic
702454|NCT00621803|Pseudomonas aeruginosa|pseudomonas aeruginosa
702455|NCT00621803|Gastric colonization|gastric colonization
702456|NCT00621803|Respiratory tract colonization|respiratory tract colonization
702457|NCT00621803|Ventilator aquired pneumoniae|ventilator aquired pneumoniae
702458|NCT00621803|determine the effect of oral administration of this probiotic on gastric and respiratory tract colonisation/infection by P. aeruginosa|determine the effect of oral administration of this probiotic on gastric and respiratory tract colonisation/infection by p. aeruginosa
702459|NCT00621790|fenoldopam|fenoldopam
702460|NCT00621790|acute renal failure|acute renal failure
702461|NCT00621790|renal replacement therapy|renal replacement therapy
702462|NCT00621790|mortality|mortality
702463|NCT00621790|cardiac surgery|cardiac surgery
702464|NCT00621790|cardiac anesthesia|cardiac anesthesia
702465|NCT00621790|intensive care unit|intensive care unit
702466|NCT00621777|schizophrenia|schizophrenia
702467|NCT00621777|bipolar disorder|bipolar disorder
702468|NCT00621777|varenicline|varenicline
702469|NCT00621777|smoking cessation|smoking cessation
702470|NCT00621777|relapse prevention|relapse prevention
702471|NCT00621777|cognitive behavioral therapy|cognitive behavioral therapy
702472|NCT00621764|Japanese encephalitis (JE)|japanese encephalitis (je)
702473|NCT00621764|Hepatitis A|hepatitis a
702474|NCT00621764|Inactivated Mouse-Brain|inactivated mouse-brain
702475|NCT00621751|Brain Injury|brain injury
702476|NCT00621751|Irritability|irritability
702477|NCT00621751|Aggression|aggression
702478|NCT00621738|mental stress|mental stress
702479|NCT00621738|cardiovascular risk factor|cardiovascular risk factor
702480|NCT00621738|platelet adhesion|platelet adhesion
702481|NCT00621725|Advanced cancer|advanced cancer
702482|NCT00621725|metastatic|metastatic
702483|NCT00621725|hepatic impairment|hepatic impairment
702484|NCT00621712|Renal Dialysis|renal dialysis
702485|NCT00621712|Dialysis, Extracorporeal|dialysis, extracorporeal
702486|NCT00621712|Dialysis, Renal|dialysis, renal
702487|NCT00621712|Extracorporeal Dialysis|extracorporeal dialysis
702488|NCT00621699|pharmacokinetics|pharmacokinetics
702489|NCT00621699|drug interactions|drug interactions
702490|NCT00621699|ezetimibe|ezetimibe
702491|NCT00621699|tacrolimus|tacrolimus
702492|NCT00621699|human experimentation|human experimentation
702493|NCT00621686|adult glioblastoma|adult glioblastoma
702494|NCT00621686|adult giant cell glioblastoma|adult giant cell glioblastoma
702495|NCT00621686|adult gliosarcoma|adult gliosarcoma
702496|NCT00621686|recurrent adult brain tumor|recurrent adult brain tumor
702497|NCT00621673|Hemophilia A,|hemophilia a,
702498|NCT00621673|Inhibitor formation,|inhibitor formation,
702499|NCT00621673|rFVIII|rfviii
702500|NCT00621660|Acupuncture therapy|acupuncture therapy
702501|NCT00621660|Cancer|cancer
702502|NCT00621660|Emesis|emesis
702503|NCT00621660|Expectations|expectations
702504|NCT00621660|Placebo|placebo
702505|NCT00621647|Seroquel|seroquel
702506|NCT00621647|dementia|dementia
702507|NCT00621647|agitation symptoms|agitation symptoms
702508|NCT00621647|Alzheimer's disease|alzheimer's disease
702509|NCT00621647|vascular dementia|vascular dementia
702510|NCT00621647|quetiapine fumarate|quetiapine fumarate
702511|NCT00621634|Tardive dyskinesia|tardive dyskinesia
702512|NCT00621634|Schizophrenia|schizophrenia
702513|NCT00621634|Essential fatty acids|essential fatty acids
702514|NCT00621621|atrioventricular nodal reentrant tachycardia|atrioventricular nodal reentrant tachycardia
702515|NCT00621621|AVNRT|avnrt
702516|NCT00621608|Chronic ulcers|chronic ulcers
702517|NCT00621608|Diabetes|diabetes
702518|NCT00621608|Hyperbaric Oxygen Therapy|hyperbaric oxygen therapy
702519|NCT00621595|School Breakfast|school breakfast
702520|NCT00621595|Diet|diet
702521|NCT00621595|Nutrition|nutrition
702522|NCT00621595|Brain Function|brain function
702523|NCT00621595|Cognition|cognition
702524|NCT00621595|USDA|usda
702525|NCT00621595|Healthy Children|healthy children
702526|NCT00621569|Blood Pressure|blood pressure
702527|NCT00621569|Dash Diet|dash diet
702528|NCT00621543|Intrauterine Device|intrauterine device
702529|NCT00621543|Induced Abortion|induced abortion
702530|NCT00621543|Medical Abortion|medical abortion
702531|NCT00621530|Total hip arthroplasty|total hip arthroplasty
702532|NCT00621530|Total hip replacement|total hip replacement
702533|NCT00621530|Pain, postoperative|pain, postoperative
702534|NCT00621530|Ketorolac|ketorolac
702535|NCT00621530|Patients undergoing unilateral total hip arthroplasty|patients undergoing unilateral total hip arthroplasty
702536|NCT00621517|Restless Legs Syndrome|restless legs syndrome
702537|NCT00621517|Bupropion|bupropion
702538|NCT00621504|ceftaroline|ceftaroline
702539|NCT00621504|Community-acquired pneumonia|community-acquired pneumonia
702540|NCT00621504|CAP|cap
702541|NCT00621504|IV (intravenous)|iv (intravenous)
702542|NCT00621504|Streptococcus pneumoniae|streptococcus pneumoniae
702543|NCT00621504|Haemophilus influenzae|haemophilus influenzae
702544|NCT00621504|Mycoplasma pneumoniae|mycoplasma pneumoniae
702545|NCT00621504|Chlamydophila spp|chlamydophila spp
702546|NCT00621504|Legionella spp|legionella spp
702547|NCT00621504|Multi-drug resistant Streptococcus pneumoniae (MDRSP)|multi-drug resistant streptococcus pneumoniae (mdrsp)
702548|NCT00621504|antimicrobial resistance|antimicrobial resistance
702549|NCT00621504|pneumococci|pneumococci
702550|NCT00621504|Ceftriaxone|ceftriaxone
702551|NCT00621504|bacteria|bacteria
702552|NCT00621504|ß-lactam|ß-lactam
702553|NCT00621504|beta-lactam|beta-lactam
702554|NCT00621504|antibiotic|antibiotic
702555|NCT00621491|cardiac pacing|cardiac pacing
702556|NCT00621491|pacing complication|pacing complication
702557|NCT00621491|venous thrombosis|venous thrombosis
702558|NCT00621491|warfarin|warfarin
702559|NCT00621491|anticoagulation|anticoagulation
702560|NCT00621491|randomized trial|randomized trial
702561|NCT00621465|Psychosis|psychosis
702562|NCT00621465|Homelessness|homelessness
702563|NCT00621465|Case Management|case management
702564|NCT00621465|Severe Mental Illness|severe mental illness
702565|NCT00621439|ocular melanoma|ocular melanoma
702566|NCT00621426|T wave alternans (TWA)|t wave alternans (twa)
702567|NCT00621426|dialysis|dialysis
703110|NCT00619541|5 FU|5 fu
702568|NCT00621426|end stage renal disease|end stage renal disease
702569|NCT00621426|sudden cardiac death|sudden cardiac death
702570|NCT00621426|T-wave alternans|t-wave alternans
702571|NCT00621426|Cardiac electrical instability|cardiac electrical instability
702572|NCT00621426|Sympathetic and electrolyte-induced alterations|sympathetic and electrolyte-induced alterations
702573|NCT00621426|Ventricular repolarization|ventricular repolarization
702574|NCT00621413|prostate|prostate
702575|NCT00621413|cancer|cancer
702576|NCT00621413|intermediate risk|intermediate risk
702577|NCT00621413|high risk|high risk
702578|NCT00621413|brachytherapy|brachytherapy
702579|NCT00621413|Cesium-131|cesium-131
702580|NCT00621413|seed brachytherapy|seed brachytherapy
702581|NCT00621413|intermediate and high risk cancer of the prostate|intermediate and high risk cancer of the prostate
702582|NCT00621400|newly-diagnosed light-chain (AL)-amyloidosis|newly-diagnosed light-chain (al)-amyloidosis
702583|NCT00621387|reactive arthritis|reactive arthritis
702584|NCT00621387|antibiotics|antibiotics
702585|NCT00621374|Pain Management|pain management
702586|NCT00621374|Cognitive Behavior Therapy|cognitive behavior therapy
702587|NCT00621374|Hypnosis|hypnosis
702588|NCT00621361|Lung Cancer|lung cancer
702589|NCT00621361|AZD2171|azd2171
702590|NCT00621361|cediranib|cediranib
702591|NCT00621361|RECENTIN|recentin
702592|NCT00621361|etoposide|etoposide
702593|NCT00621361|cisplatin|cisplatin
702594|NCT00621348|maintenance fluids|maintenance fluids
702595|NCT00621348|hyponatremia|hyponatremia
702596|NCT00621348|vasopressin|vasopressin
702597|NCT00621348|children|children
702598|NCT00621335|Open angle glaucoma|open angle glaucoma
702599|NCT00621335|Ocular hypertension|ocular hypertension
702600|NCT00621335|Parallel comparison|parallel comparison
702601|NCT00621335|Combigan|combigan
702602|NCT00621335|Cosopt|cosopt
702603|NCT00621322|Tuberculosis vaccine|tuberculosis vaccine
702604|NCT00621309|drug interactions|drug interactions
702605|NCT00621309|cytochrome P4503A4|cytochrome p4503a4
702606|NCT00621309|Pregnane X-receptor|pregnane x-receptor
702607|NCT00621309|induction|induction
702608|NCT00621309|drug metabolism|drug metabolism
702609|NCT00621296|Chronic Hepatitis C|chronic hepatitis c
702610|NCT00621296|Protease Inhibitor|protease inhibitor
702611|NCT00621270|Major Depression Neurogenesis|major depression neurogenesis
702612|NCT00621270|Major Depressive Disorder with Concomitant Anxiety|major depressive disorder with concomitant anxiety
702613|NCT00621257|IBD|ibd
702614|NCT00621257|Inflammatory Bowel Disease|inflammatory bowel disease
702615|NCT00621257|Crohn's Disease|crohn's disease
702616|NCT00621257|Ulcerative Colitis|ulcerative colitis
702617|NCT00621257|Vitamin D|vitamin d
702618|NCT00621244|HDAC inhibitor|hdac inhibitor
702619|NCT00621244|Oral|oral
702620|NCT00621244|LBH589|lbh589
702621|NCT00621244|Lymphoma|lymphoma
702622|NCT00621244|Leukemia|leukemia
702623|NCT00621244|Multiple myeloma|multiple myeloma
702624|NCT00621231|Protein Function|protein function
702625|NCT00621231|normal versus high protein intake|normal versus high protein intake
702626|NCT00621218|tretinoin, efficacy, safety, rosacea|tretinoin, efficacy, safety, rosacea
702627|NCT00621205|Insulin resistance, weight reduction, adipose tissue, peripheral|insulin resistance, weight reduction, adipose tissue, peripheral
702628|NCT00621205|mononuclear cells, gene expression profile, transcriptomics|mononuclear cells, gene expression profile, transcriptomics
702629|NCT00621192|meropenem|meropenem
702630|NCT00621192|infants|infants
702631|NCT00621192|intra-abdominal infection|intra-abdominal infection
702632|NCT00621192|pharmacokinetics|pharmacokinetics
702633|NCT00621192|safety|safety
702634|NCT00621179|Endometriosis,infertility,in vitro fertilization|endometriosis,infertility,in vitro fertilization
702635|NCT00621166|Generic lopinavir/ritonavir|generic lopinavir/ritonavir
702636|NCT00621166|Pharmacokinetics|pharmacokinetics
702637|NCT00621166|Pregnancy|pregnancy
702638|NCT00621166|Antiviral activity|antiviral activity
702639|NCT00621166|Safety|safety
702640|NCT00621153|Candesartan Cilexetil|candesartan cilexetil
702641|NCT00621153|hydrochlorothiazide|hydrochlorothiazide
702642|NCT00621153|severe hypertension|severe hypertension
702643|NCT00621114|Dialysis, Extracorporeal|dialysis, extracorporeal
702644|NCT00621114|Dialysis, Renal|dialysis, renal
702645|NCT00621114|Extracorporeal Dialysis|extracorporeal dialysis
702646|NCT00621114|Hemodialysis|hemodialysis
702647|NCT00621101|pharmacokinetics|pharmacokinetics
702648|NCT00621101|drug interactions|drug interactions
702649|NCT00621101|ezetimibe|ezetimibe
702650|NCT00621101|sirolimus|sirolimus
702651|NCT00621101|human experimentation|human experimentation
702652|NCT00621075|PAH; V/Q SCAN;RHC;Echo;CT Scans; Angiography;PFTs|pah; v/q scan;rhc;echo;ct scans; angiography;pfts
702653|NCT00621062|varicose|varicose
702654|NCT00621062|vein|vein
702655|NCT00621062|ligation|ligation
702656|NCT00621062|laser|laser
702657|NCT00621062|foam|foam
702658|NCT00621062|sclerotherapy|sclerotherapy
702659|NCT00621062|radiofrequency|radiofrequency
702660|NCT00621062|duplex|duplex
702661|NCT00621062|sf36|sf36
702662|NCT00621062|Aberdeen|aberdeen
702663|NCT00621062|VCSS|vcss
702664|NCT00621062|quality|quality
702665|NCT00621062|recurrence|recurrence
702666|NCT00621049|Non-Small Cell Lung Cancer|non-small cell lung cancer
702667|NCT00621049|Resected|resected
702668|NCT00621049|Carboplatin|carboplatin
702669|NCT00621049|Docetaxel|docetaxel
702670|NCT00621049|Bevacizumab|bevacizumab
702671|NCT00621049|Erlotinib|erlotinib
702672|NCT00621036|primary central nervous system non-Hodgkin lymphoma|primary central nervous system non-hodgkin lymphoma
702673|NCT00621036|primary central nervous system Hodgkin lymphoma|primary central nervous system hodgkin lymphoma
702674|NCT00621036|stage IV adult T-cell leukemia/lymphoma|stage iv adult t-cell leukemia/lymphoma
702675|NCT00621036|adult nasal type extranodal NK/T-cell lymphoma|adult nasal type extranodal nk/t-cell lymphoma
702676|NCT00621036|anaplastic large cell lymphoma|anaplastic large cell lymphoma
702677|NCT00621036|angioimmunoblastic T-cell lymphoma|angioimmunoblastic t-cell lymphoma
702678|NCT00621036|extranodal marginal zone B-cell lymphoma of mucosa-associated lymphoid tissue|extranodal marginal zone b-cell lymphoma of mucosa-associated lymphoid tissue
702679|NCT00621036|stage IV adult Burkitt lymphoma|stage iv adult burkitt lymphoma
702680|NCT00621036|stage IV adult diffuse large cell lymphoma|stage iv adult diffuse large cell lymphoma
702681|NCT00621036|stage IV adult diffuse mixed cell lymphoma|stage iv adult diffuse mixed cell lymphoma
702682|NCT00621036|stage IV adult diffuse small cleaved cell lymphoma|stage iv adult diffuse small cleaved cell lymphoma
702683|NCT00621036|stage IV adult Hodgkin lymphoma|stage iv adult hodgkin lymphoma
702684|NCT00621036|stage IV adult immunoblastic large cell lymphoma|stage iv adult immunoblastic large cell lymphoma
702685|NCT00621036|stage IV adult lymphoblastic lymphoma|stage iv adult lymphoblastic lymphoma
702686|NCT00621036|stage IV cutaneous T-cell non-Hodgkin lymphoma|stage iv cutaneous t-cell non-hodgkin lymphoma
702687|NCT00621036|stage IV mycosis fungoides/Sezary syndrome|stage iv mycosis fungoides/sezary syndrome
702688|NCT00621036|stage IV grade 1 follicular lymphoma|stage iv grade 1 follicular lymphoma
702689|NCT00621036|stage IV grade 2 follicular lymphoma|stage iv grade 2 follicular lymphoma
702690|NCT00621036|stage IV grade 3 follicular lymphoma|stage iv grade 3 follicular lymphoma
702691|NCT00621036|stage IV mantle cell lymphoma|stage iv mantle cell lymphoma
702692|NCT00621036|stage IV marginal zone lymphoma|stage iv marginal zone lymphoma
702693|NCT00621036|stage IV small lymphocytic lymphoma|stage iv small lymphocytic lymphoma
702694|NCT00621036|intraocular lymphoma|intraocular lymphoma
702695|NCT00621036|post-transplant lymphoproliferative disorder|post-transplant lymphoproliferative disorder
702696|NCT00621036|cutaneous B-cell non-Hodgkin lymphoma|cutaneous b-cell non-hodgkin lymphoma
702697|NCT00621036|Waldenström macroglobulinemia|waldenström macroglobulinemia
702698|NCT00621036|small intestine lymphoma|small intestine lymphoma
702699|NCT00621023|Myelodysplastic syndrome|myelodysplastic syndrome
702701|NCT00620997|cornea|cornea
702702|NCT00620997|analgesia|analgesia
702703|NCT00620997|topical|topical
702704|NCT00620997|anesthetic|anesthetic
702705|NCT00620984|Staphylococcus aureus|staphylococcus aureus
702706|NCT00620984|Breastfeeding|breastfeeding
702707|NCT00620984|Lactational Mastitis|lactational mastitis
702708|NCT00620984|Polymerase Chain Reaction (PCR) amplification analysis|polymerase chain reaction (pcr) amplification analysis
702709|NCT00620984|staphylococcal infections|staphylococcal infections
702710|NCT00620984|staphylococcal Carrier State|staphylococcal carrier state
702711|NCT00620971|Non Small Cell Lung Cancer|non small cell lung cancer
702712|NCT00620971|Cisplatin|cisplatin
702713|NCT00620971|VInorelbine|vinorelbine
702714|NCT00620971|Docetaxel|docetaxel
702715|NCT00620971|Gemcitabine|gemcitabine
702716|NCT00620971|Bevacizumab|bevacizumab
702717|NCT00620958|Mediation|mediation
702718|NCT00620958|Outcome|outcome
702719|NCT00620958|CBT|cbt
702720|NCT00620958|Child Anxiety Intervention|child anxiety intervention
702721|NCT00620945|Congenital heart surgery|congenital heart surgery
702722|NCT00620945|Cardiopulmonary bypass|cardiopulmonary bypass
702723|NCT00620945|Phenoxybenzamine|phenoxybenzamine
702724|NCT00620906|manipulation|manipulation
702725|NCT00620906|manual therapy|manual therapy
702726|NCT00620906|Sacroiliac joint|sacroiliac joint
702727|NCT00620906|effects on manipulation on sacroiliac joint|effects on manipulation on sacroiliac joint
702728|NCT00620893|Dry eye signs and symptoms|dry eye signs and symptoms
702729|NCT00620893|refractive regression|refractive regression
702730|NCT00620841|Tacrolimus|tacrolimus
702731|NCT00620841|Renal Transplantation|renal transplantation
702732|NCT00620841|genetic polymorphisms|genetic polymorphisms
702733|NCT00620841|Drug drug interactions|drug drug interactions
702734|NCT00620815|avian flu|avian flu
702735|NCT00620815|seasonal influenza vaccine|seasonal influenza vaccine
702736|NCT00620815|influenza vaccine|influenza vaccine
702737|NCT00620815|prepandemic vaccine|prepandemic vaccine
702738|NCT00620815|virus strain with the potential to cause pandemic|virus strain with the potential to cause pandemic
702739|NCT00620815|tetravalent vaccine|tetravalent vaccine
702740|NCT00620815|Prophylaxis of influenza|prophylaxis of influenza
702741|NCT00620802|Platelet function testing|platelet function testing
702742|NCT00620802|Healthy volunteers|healthy volunteers
702743|NCT00620789|Insomnia|insomnia
702744|NCT00620789|Depression|depression
702745|NCT00620776|Generalized Anxiety Disorder|generalized anxiety disorder
702746|NCT00620776|Cognitive Behavioral Therapy|cognitive behavioral therapy
702747|NCT00620776|Psychotherapy plus medication|psychotherapy plus medication
702748|NCT00620776|Combined treatment|combined treatment
702749|NCT00620763|Meat protein|meat protein
702750|NCT00620763|acid load|acid load
702751|NCT00620763|calcium retention|calcium retention
702752|NCT00620763|postmenopausal women|postmenopausal women
702753|NCT00620750|Alcohol dependence|alcohol dependence
702754|NCT00620711|Hypoxic ischemic encephalopathy|hypoxic ischemic encephalopathy
702755|NCT00620711|HIE|hie
702756|NCT00620711|Neonatal encephalopathy|neonatal encephalopathy
702757|NCT00620711|Cooling|cooling
702758|NCT00620711|hypothermia|hypothermia
702759|NCT00620698|amyotrophic lateral sclerosis|amyotrophic lateral sclerosis
702760|NCT00620698|motor neuron disease|motor neuron disease
702761|NCT00620698|outcome measure|outcome measure
702762|NCT00620698|biomarker|biomarker
702763|NCT00620698|impedance|impedance
702764|NCT00620685|Arthritis, rheumatoid|arthritis, rheumatoid
702765|NCT00620672|n-3 supplementation during pregnancy|n-3 supplementation during pregnancy
702766|NCT00620672|DHA and pregnancy, infant development|dha and pregnancy, infant development
702767|NCT00620672|n-3 status and gestation|n-3 status and gestation
702768|NCT00620672|DHA and visual acuity and cognition during infancy|dha and visual acuity and cognition during infancy
702769|NCT00620646|clopidogrel|clopidogrel
702770|NCT00620646|platelets|platelets
702771|NCT00620646|percutaneous coronary intervention|percutaneous coronary intervention
702772|NCT00620633|Bone Marrow|bone marrow
702773|NCT00620620|Healthy adult volunteers|healthy adult volunteers
702774|NCT00620607|gastric|gastric
702775|NCT00620594|Neoplasms|neoplasms
702776|NCT00620594|breast neoplasms|breast neoplasms
702777|NCT00620594|breast diseases|breast diseases
702778|NCT00620594|solid tumors|solid tumors
702779|NCT00620594|BEZ235|bez235
702780|NCT00620594|breast cancer|breast cancer
702781|NCT00620594|PI3K Inhibitor|pi3k inhibitor
702782|NCT00620594|Phosphatidylinositol 3|phosphatidylinositol 3
702783|NCT00620594|kinase|kinase
702784|NCT00620594|advanced|advanced
702785|NCT00620568|Safety|safety
702786|NCT00620568|Tolerability|tolerability
702787|NCT00620568|Schizophrenia|schizophrenia
702788|NCT00620542|Coronary artery disease|coronary artery disease
702789|NCT00620529|polycystic ovary syndrome|polycystic ovary syndrome
702790|NCT00620529|cardiovascular risk|cardiovascular risk
702791|NCT00620529|metabolism|metabolism
702792|NCT00620529|blood pressure|blood pressure
702793|NCT00620529|liver fat|liver fat
702794|NCT00620529|heart rate variability|heart rate variability
702795|NCT00620503|PK|pk
702796|NCT00620503|Pharmacokinetics|pharmacokinetics
702797|NCT00620490|Epidural analgesia|epidural analgesia
702798|NCT00620490|Contraindications|contraindications
702799|NCT00620490|Paravertebral nerve block analgesia|paravertebral nerve block analgesia
702800|NCT00620490|ropivacaine|ropivacaine
702801|NCT00620490|Visual analogical scale|visual analogical scale
702802|NCT00620490|Morphine|morphine
702803|NCT00620490|Side effects|side effects
702804|NCT00620490|Pain and thoracotomy|pain and thoracotomy
702805|NCT00620451|Treatment|treatment
702806|NCT00620451|Active|active
702807|NCT00620451|Celiac|celiac
702808|NCT00620451|Remission|remission
702809|NCT00620451|Induction|induction
702810|NCT00620438|Lumefantrine|lumefantrine
702811|NCT00620438|Efavirenz|efavirenz
702812|NCT00620438|Nevirapine|nevirapine
702813|NCT00620438|Rifampicin|rifampicin
702814|NCT00620438|HIV|hiv
702815|NCT00620425|sumatriptan|sumatriptan
702816|NCT00620425|Intraject|intraject
702817|NCT00620425|Local Site Reactions|local site reactions
702818|NCT00620412|influenza|influenza
702819|NCT00620412|vaccines|vaccines
702820|NCT00620412|probiotics|probiotics
702821|NCT00620412|LGG|lgg
702822|NCT00620399|lumbar fusion|lumbar fusion
702823|NCT00620386|Intubating conditions|intubating conditions
702824|NCT00620386|Bonfils intubation fiberscope|bonfils intubation fiberscope
702825|NCT00620386|Macintosh laryngoscope|macintosh laryngoscope
702826|NCT00620386|neuromuscular blockade|neuromuscular blockade
702827|NCT00620373|Dense breast tissue|dense breast tissue
702828|NCT00620373|Breast Cancer Screening|breast cancer screening
702829|NCT00620373|Molecular Breast Imaging|molecular breast imaging
702830|NCT00620373|Breast Cancer|breast cancer
702831|NCT00620373|Breast|breast
702832|NCT00620360|dietary fructose|dietary fructose
702833|NCT00620360|plasma lipids|plasma lipids
702834|NCT00620360|healthy humans|healthy humans
702835|NCT00620360|gender differences|gender differences
702836|NCT00620360|hepatic de novo lipogenesis|hepatic de novo lipogenesis
702837|NCT00620347|SCLC (small cell lung cancer)|sclc (small cell lung cancer)
702838|NCT00620347|ED (extensive disease)|ed (extensive disease)
702839|NCT00620347|RR (response rate)|rr (response rate)
702840|NCT00620334|ASTHMA|asthma
702841|NCT00620295|recurrent pancreatic cancer|recurrent pancreatic cancer
702842|NCT00620295|recurrent breast cancer|recurrent breast cancer
702843|NCT00620295|recurrent small cell lung cancer|recurrent small cell lung cancer
702844|NCT00620295|recurrent non-small cell lung cancer|recurrent non-small cell lung cancer
702845|NCT00620295|recurrent colon cancer|recurrent colon cancer
702846|NCT00620295|recurrent prostate cancer|recurrent prostate cancer
703210|NCT00619190|open label|open label
702847|NCT00620295|recurrent head and neck cancer|recurrent head and neck cancer
702848|NCT00620295|ovarian cancer|ovarian cancer
702849|NCT00620295|recurrent uterine cancer|recurrent uterine cancer
702850|NCT00620295|recurrent kidney cancer|recurrent kidney cancer
702851|NCT00620295|recurrent osteosarcoma|recurrent osteosarcoma
702852|NCT00620269|NSCLC|nsclc
702853|NCT00620269|EGFR mutation|egfr mutation
702854|NCT00620269|Erlotinib|erlotinib
702855|NCT00620269|IP chemotherapy|ip chemotherapy
702856|NCT00620269|CCRT|ccrt
702857|NCT00620256|Glaucoma|glaucoma
702858|NCT00620256|Hypertension|hypertension
702859|NCT00620243|Ovarian cancer|ovarian cancer
702860|NCT00620243|PET|pet
702861|NCT00620243|CT|ct
702862|NCT00620243|04-064|04-064
702863|NCT00620230|Allergic rhinitis, anti-interleukin 4|allergic rhinitis, anti-interleukin 4
702864|NCT00620217|heart ischemia|heart ischemia
702865|NCT00620217|coronary artery disease|coronary artery disease
702866|NCT00620217|plasmid|plasmid
702867|NCT00620217|VEGF|vegf
702868|NCT00620217|FGF|fgf
702869|NCT00620217|percutaneous|percutaneous
702870|NCT00620217|gene therapy|gene therapy
702871|NCT00620217|SPECT|spect
702872|NCT00620217|nuclear magnetic resonance|nuclear magnetic resonance
702873|NCT00620204|atorvastatin|atorvastatin
702874|NCT00620204|Angina Pectoris, Variant|angina pectoris, variant
702875|NCT00620204|endothelial dysfunction|endothelial dysfunction
702876|NCT00620191|metformin|metformin
702877|NCT00620191|mild cognitive impairment|mild cognitive impairment
702878|NCT00620191|alzheimer's disease|alzheimer's disease
702879|NCT00620191|overweight|overweight
702880|NCT00620191|insulin|insulin
702881|NCT00620178|candesartan|candesartan
702882|NCT00620178|losartan|losartan
702883|NCT00620178|blood pressure|blood pressure
702884|NCT00620178|cardiovascular disease|cardiovascular disease
702885|NCT00620178|health care consumption|health care consumption
702886|NCT00620165|tremor|tremor
702887|NCT00620165|writing|writing
702888|NCT00620165|feeding|feeding
702889|NCT00620165|pouring|pouring
702890|NCT00620139|head and neck squamous cell carcinoma|head and neck squamous cell carcinoma
702891|NCT00620139|chemoradiotherapy|chemoradiotherapy
702892|NCT00620139|molecular effects|molecular effects
702893|NCT00620139|05-016|05-016
702894|NCT00620126|Inflammatory bowel disease|inflammatory bowel disease
702895|NCT00620126|Ulcerative colitis|ulcerative colitis
702896|NCT00620126|Telemedicine|telemedicine
702897|NCT00620126|Telemanagement|telemanagement
702898|NCT00620126|Chronic disease|chronic disease
702899|NCT00620087|Atypical lobular hyperplasia|atypical lobular hyperplasia
702900|NCT00620087|Atypical ductal hyperplasia|atypical ductal hyperplasia
702901|NCT00620087|Lobular carcinoma in situ|lobular carcinoma in situ
702902|NCT00620087|Molecular Breast Imaging|molecular breast imaging
702903|NCT00620074|invasive aspergillosis, opportunistic mold infection|invasive aspergillosis, opportunistic mold infection
702904|NCT00620048|heart|heart
702905|NCT00620048|stem Cells|stem cells
702906|NCT00620048|low EF|low ef
702907|NCT00620048|heart attack|heart attack
702908|NCT00620048|cardiomyopathy|cardiomyopathy
702909|NCT00620048|congestive heart failure|congestive heart failure
702910|NCT00620048|cardiovascular disease|cardiovascular disease
702911|NCT00620048|Heart Failure|heart failure
702912|NCT00620048|Low Ejection Fraction|low ejection fraction
702913|NCT00620022|indacaterol|indacaterol
702914|NCT00620022|chronic obstructive pulmonary disease|chronic obstructive pulmonary disease
702915|NCT00620022|exercise endurance|exercise endurance
702916|NCT00620022|moderate to severe chronic obstructive pulmonary disease|moderate to severe chronic obstructive pulmonary disease
702917|NCT00620022|COPD|copd
702918|NCT00620009|Empathy|empathy
702919|NCT00620009|Feedback|feedback
702920|NCT00620009|Psychotherapy|psychotherapy
702921|NCT00619996|Prostate Cancer|prostate cancer
702922|NCT00619996|Sorafenib|sorafenib
702923|NCT00619996|Nexavar|nexavar
702924|NCT00619996|Docetaxel|docetaxel
702925|NCT00619996|Pisa|pisa
702926|NCT00619996|Ricci|ricci
702927|NCT00619983|Asymmetric Diabetic Proximal Motor Neuropathy|asymmetric diabetic proximal motor neuropathy
702928|NCT00619983|Diabetic Autonomic Neuropathy|diabetic autonomic neuropathy
702929|NCT00619983|Diabetic Neuralgia|diabetic neuralgia
702930|NCT00619983|Diabetic Neuropathy, Painful|diabetic neuropathy, painful
702931|NCT00619983|Neuralgia, Diabetic|neuralgia, diabetic
702932|NCT00619983|Low back pain, chronic|low back pain, chronic
702933|NCT00619944|HIV|hiv
702934|NCT00619944|lumefantrine|lumefantrine
702935|NCT00619944|lopinavir|lopinavir
702936|NCT00619944|Africa|africa
702937|NCT00619944|Antimalarials|antimalarials
702938|NCT00619944|treatment naïve|treatment naïve
702939|NCT00619931|Healthy adult volunteers|healthy adult volunteers
702940|NCT00619918|bronchiolitis|bronchiolitis
702941|NCT00619918|hypertonic saline|hypertonic saline
702942|NCT00619905|Rheumatoid Arthritis|rheumatoid arthritis
702943|NCT00619905|Anti-interleukin-1 beta|anti-interleukin-1 beta
702944|NCT00619905|ACZ885|acz885
702945|NCT00619892|SSRI Resistant|ssri resistant
702946|NCT00619892|Seroquel SR|seroquel sr
702947|NCT00619892|Seroquel XR|seroquel xr
702948|NCT00619892|Panic Disorder|panic disorder
702949|NCT00619892|Comorbid Panic Disorder|comorbid panic disorder
702950|NCT00619892|Quetiapine SR|quetiapine sr
702951|NCT00619892|Quetiapine XR|quetiapine xr
702952|NCT00619879|Leukemia, Myelogenous, Chronic|leukemia, myelogenous, chronic
702953|NCT00619879|Leukemia, Lymphoblastic, Acute|leukemia, lymphoblastic, acute
702954|NCT00619879|Leukemia, Myelogenous, Acute|leukemia, myelogenous, acute
702955|NCT00619879|Myeloproliferative-Myelodysplastic Diseases|myeloproliferative-myelodysplastic diseases
702956|NCT00619879|Juvenile Myelomonocytic Leukemia|juvenile myelomonocytic leukemia
702957|NCT00619879|Dysmyelopoietic Syndromes|dysmyelopoietic syndromes
702958|NCT00619879|Lymphoma, Malignant|lymphoma, malignant
702959|NCT00619879|Stem Cell Transplantation, Hematopoietic|stem cell transplantation, hematopoietic
702960|NCT00619879|Allogeneic Transplantation|allogeneic transplantation
702961|NCT00619879|Human Leukocyte Antigens|human leukocyte antigens
702962|NCT00619879|Busulfan|busulfan
702963|NCT00619879|Total Body Irradiation|total body irradiation
702964|NCT00619879|VP-16|vp-16
702965|NCT00619879|Etoposide|etoposide
702966|NCT00619879|Cyclophosphamide|cyclophosphamide
702967|NCT00619879|Graft-Versus-Host Disease|graft-versus-host disease
702968|NCT00619866|bone mineral density|bone mineral density
702969|NCT00619866|Pelvic Pain|pelvic pain
702970|NCT00619866|estradiol|estradiol
702971|NCT00619866|NBI-56418|nbi-56418
702972|NCT00619853|Improving the assisting hand function in children with Hemiplegic Cerebral palsy|improving the assisting hand function in children with hemiplegic cerebral palsy
702973|NCT00619840|ADHD|adhd
702974|NCT00619840|Attention Deficit Hyperactivity Disorder|attention deficit hyperactivity disorder
702975|NCT00619840|adult|adult
702976|NCT00619840|methylphenidate hydrochloride|methylphenidate hydrochloride
702977|NCT00619840|Medikinet retard|medikinet retard
702978|NCT00619840|long-term observation|long-term observation
702979|NCT00619840|controlled clinical trial|controlled clinical trial
702980|NCT00619840|safety|safety
702981|NCT00619840|randomized, double-blind, placebo-controlled trial|randomized, double-blind, placebo-controlled trial
702982|NCT00619840|treatment|treatment
702983|NCT00619840|central nervous system stimulants|central nervous system stimulants
702984|NCT00619840|therapeutic uses|therapeutic uses
702985|NCT00619827|Sublingual immunotherapy|sublingual immunotherapy
702986|NCT00619827|Rhinitis|rhinitis
702987|NCT00619827|Conjunctivitis|conjunctivitis
702988|NCT00619827|Allergen challenge|allergen challenge
702989|NCT00619827|Allergen exposition chamber|allergen exposition chamber
702990|NCT00619827|Grass pollen tablet|grass pollen tablet
702991|NCT00619827|Allergic rhinoconjunctivitis|allergic rhinoconjunctivitis
702992|NCT00619814|Colon polyps|colon polyps
702993|NCT00619814|Fecal occult blood test|fecal occult blood test
702994|NCT00619814|Double contrast barium enema|double contrast barium enema
702995|NCT00619814|Colonoscopy|colonoscopy
702996|NCT00619801|Xyzal|xyzal
702997|NCT00619801|Levocetirizine|levocetirizine
702998|NCT00619801|Allergy|allergy
702999|NCT00619801|Children|children
703000|NCT00619801|Seasonal Allergies|seasonal allergies
703001|NCT00619775|Carotid Artery Disease|carotid artery disease
703002|NCT00619775|Embolic Protection|embolic protection
703003|NCT00619762|Breast reconstruction|breast reconstruction
703004|NCT00619736|Healthy|healthy
703005|NCT00619710|skin infections|skin infections
703006|NCT00619710|MERREM|merrem
703007|NCT00619710|PRIMAXIN IV|primaxin iv
703008|NCT00619710|complex abscess|complex abscess
703009|NCT00619710|perirectal abscess|perirectal abscess
703010|NCT00619710|wound infections|wound infections
703011|NCT00619710|infected ischemic/diabetic ulcers|infected ischemic/diabetic ulcers
703012|NCT00619710|cellulitis|cellulitis
703013|NCT00619710|Meropenem|meropenem
703014|NCT00619710|Imipenem-cilastatin|imipenem-cilastatin
703015|NCT00619671|Rituxan|rituxan
703016|NCT00619671|Rituximab|rituximab
703017|NCT00619671|Myasthenia Gravis|myasthenia gravis
703018|NCT00619671|MG|mg
703019|NCT00619658|telephone follow-up|telephone follow-up
703020|NCT00619658|medical abortion|medical abortion
703021|NCT00619658|induced abortion|induced abortion
703022|NCT00619645|recurrent adult acute myeloid leukemia|recurrent adult acute myeloid leukemia
703023|NCT00619645|adult acute lymphoblastic leukemia in remission|adult acute lymphoblastic leukemia in remission
703024|NCT00619645|refractory anemia with excess blasts|refractory anemia with excess blasts
703025|NCT00619645|refractory anemia with ringed sideroblasts|refractory anemia with ringed sideroblasts
703026|NCT00619645|refractory anemia|refractory anemia
703027|NCT00619645|refractory cytopenia with multilineage dysplasia|refractory cytopenia with multilineage dysplasia
703028|NCT00619645|previously treated myelodysplastic syndromes|previously treated myelodysplastic syndromes
703029|NCT00619645|adult acute myeloid leukemia with 11q23 (MLL) abnormalities|adult acute myeloid leukemia with 11q23 (mll) abnormalities
703030|NCT00619645|adult acute myeloid leukemia in remission|adult acute myeloid leukemia in remission
703031|NCT00619645|adult acute myeloid leukemia with inv(16)(p13;q22)|adult acute myeloid leukemia with inv(16)(p13;q22)
703032|NCT00619645|adult acute myeloid leukemia with t(15;17)(q22;q12)|adult acute myeloid leukemia with t(15;17)(q22;q12)
703033|NCT00619645|adult acute myeloid leukemia with t(16;16)(p13;q22)|adult acute myeloid leukemia with t(16;16)(p13;q22)
703563|NCT00617812|Hepatitis B|hepatitis b
703034|NCT00619645|adult acute myeloid leukemia with t(8;21)(q22;q22)|adult acute myeloid leukemia with t(8;21)(q22;q22)
703035|NCT00619645|chronic phase chronic myelogenous leukemia|chronic phase chronic myelogenous leukemia
703036|NCT00619645|relapsing chronic myelogenous leukemia|relapsing chronic myelogenous leukemia
703037|NCT00619645|refractory chronic lymphocytic leukemia|refractory chronic lymphocytic leukemia
703038|NCT00619645|recurrent adult Hodgkin lymphoma|recurrent adult hodgkin lymphoma
703039|NCT00619645|refractory multiple myeloma|refractory multiple myeloma
703040|NCT00619645|recurrent adult acute lymphoblastic leukemia|recurrent adult acute lymphoblastic leukemia
703041|NCT00619645|stage III chronic lymphocytic leukemia|stage iii chronic lymphocytic leukemia
703042|NCT00619645|stage IV chronic lymphocytic leukemia|stage iv chronic lymphocytic leukemia
703043|NCT00619645|stage III adult Hodgkin lymphoma|stage iii adult hodgkin lymphoma
703044|NCT00619645|stage IV adult Hodgkin lymphoma|stage iv adult hodgkin lymphoma
703045|NCT00619645|secondary acute myeloid leukemia|secondary acute myeloid leukemia
703046|NCT00619645|recurrent small lymphocytic lymphoma|recurrent small lymphocytic lymphoma
703047|NCT00619645|stage III small lymphocytic lymphoma|stage iii small lymphocytic lymphoma
703048|NCT00619645|stage IV small lymphocytic lymphoma|stage iv small lymphocytic lymphoma
703049|NCT00619645|stage III grade 1 follicular lymphoma|stage iii grade 1 follicular lymphoma
703050|NCT00619645|stage III grade 2 follicular lymphoma|stage iii grade 2 follicular lymphoma
703051|NCT00619645|stage III grade 3 follicular lymphoma|stage iii grade 3 follicular lymphoma
703052|NCT00619645|stage IV grade 1 follicular lymphoma|stage iv grade 1 follicular lymphoma
703053|NCT00619645|stage IV grade 2 follicular lymphoma|stage iv grade 2 follicular lymphoma
703054|NCT00619645|stage IV grade 3 follicular lymphoma|stage iv grade 3 follicular lymphoma
703055|NCT00619645|recurrent grade 1 follicular lymphoma|recurrent grade 1 follicular lymphoma
703056|NCT00619645|recurrent grade 2 follicular lymphoma|recurrent grade 2 follicular lymphoma
703057|NCT00619645|recurrent grade 3 follicular lymphoma|recurrent grade 3 follicular lymphoma
703058|NCT00619645|stage III adult diffuse large cell lymphoma|stage iii adult diffuse large cell lymphoma
703059|NCT00619645|stage III adult diffuse mixed cell lymphoma|stage iii adult diffuse mixed cell lymphoma
703060|NCT00619645|stage III adult diffuse small cleaved cell lymphoma|stage iii adult diffuse small cleaved cell lymphoma
703061|NCT00619645|stage IV adult diffuse large cell lymphoma|stage iv adult diffuse large cell lymphoma
703062|NCT00619645|stage IV adult diffuse mixed cell lymphoma|stage iv adult diffuse mixed cell lymphoma
703063|NCT00619645|stage IV adult diffuse small cleaved cell lymphoma|stage iv adult diffuse small cleaved cell lymphoma
703064|NCT00619645|recurrent adult diffuse large cell lymphoma|recurrent adult diffuse large cell lymphoma
703065|NCT00619645|recurrent adult diffuse mixed cell lymphoma|recurrent adult diffuse mixed cell lymphoma
703066|NCT00619645|recurrent adult diffuse small cleaved cell lymphoma|recurrent adult diffuse small cleaved cell lymphoma
703067|NCT00619645|stage III adult immunoblastic large cell lymphoma|stage iii adult immunoblastic large cell lymphoma
703068|NCT00619645|stage IV adult immunoblastic large cell lymphoma|stage iv adult immunoblastic large cell lymphoma
703069|NCT00619645|recurrent adult immunoblastic large cell lymphoma|recurrent adult immunoblastic large cell lymphoma
703070|NCT00619645|stage III adult lymphoblastic lymphoma|stage iii adult lymphoblastic lymphoma
703071|NCT00619645|stage IV adult lymphoblastic lymphoma|stage iv adult lymphoblastic lymphoma
703072|NCT00619645|recurrent adult lymphoblastic lymphoma|recurrent adult lymphoblastic lymphoma
703073|NCT00619645|stage III adult Burkitt lymphoma|stage iii adult burkitt lymphoma
703074|NCT00619645|stage IV adult Burkitt lymphoma|stage iv adult burkitt lymphoma
703075|NCT00619645|recurrent adult Burkitt lymphoma|recurrent adult burkitt lymphoma
703076|NCT00619645|stage I multiple myeloma|stage i multiple myeloma
703077|NCT00619645|stage II multiple myeloma|stage ii multiple myeloma
703078|NCT00619645|stage III multiple myeloma|stage iii multiple myeloma
703079|NCT00619645|de novo myelodysplastic syndromes|de novo myelodysplastic syndromes
703080|NCT00619645|secondary myelodysplastic syndromes|secondary myelodysplastic syndromes
703081|NCT00619619|MDD|mdd
703082|NCT00619619|Child|child
703083|NCT00619619|Adolescent|adolescent
703084|NCT00619619|Pharmacokinetic|pharmacokinetic
703085|NCT00619619|Outpatient|outpatient
703086|NCT00619619|Pediatrics|pediatrics
703087|NCT00619619|Depressive Disorder|depressive disorder
703088|NCT00619619|Major|major
703089|NCT00619606|prevention of hypoxia|prevention of hypoxia
703090|NCT00619606|prevention of hypercapnia|prevention of hypercapnia
703091|NCT00619593|Heart failure|heart failure
703092|NCT00619593|Ventricular Fibrillation|ventricular fibrillation
703093|NCT00619593|Sudden cardiac death|sudden cardiac death
703094|NCT00619593|Hospitalization due to heart failure|hospitalization due to heart failure
703095|NCT00619593|Implantable cardioverter-defibrillator|implantable cardioverter-defibrillator
703096|NCT00619593|Risk of 1st heart failure hospitalization|risk of 1st heart failure hospitalization
703097|NCT00619580|E coli|e coli
703098|NCT00619567|Cognition|cognition
703099|NCT00619567|Rehabilitation|rehabilitation
703100|NCT00619567|Cognitive Stimulation|cognitive stimulation
703101|NCT00619567|Human Immunodeficiency Virus|human immunodeficiency virus
703102|NCT00619567|AIDS|aids
703103|NCT00619554|Healthy volunteers|healthy volunteers
703104|NCT00619541|HCC|hcc
703105|NCT00619541|Sorafenib|sorafenib
703106|NCT00619541|Pisa|pisa
703107|NCT00619541|Ricci|ricci
703108|NCT00619541|5-FU|5-fu
703109|NCT00619541|5FU|5fu
703111|NCT00619541|Advanced HCC|advanced hcc
703112|NCT00619528|Transplants|transplants
703113|NCT00619528|Kidney Transplantation|kidney transplantation
703114|NCT00619528|Immunosuppression|immunosuppression
703115|NCT00619528|HLA Antigens|hla antigens
703116|NCT00619528|Stem Cells|stem cells
703117|NCT00619528|Bone Marrow|bone marrow
703118|NCT00619515|adenocarcinoma of the prostate|adenocarcinoma of the prostate
703119|NCT00619515|stage I prostate cancer|stage i prostate cancer
703120|NCT00619515|stage II prostate cancer|stage ii prostate cancer
703121|NCT00619502|Hepatitis B|hepatitis b
703122|NCT00619502|Polio|polio
703123|NCT00619502|Diphtheria|diphtheria
703124|NCT00619502|Pertussis|pertussis
703125|NCT00619502|H.influenzae type b|h.influenzae type b
703126|NCT00619476|Neuropathic Pain|neuropathic pain
703127|NCT00619476|Post-herpetic neuralgia|post-herpetic neuralgia
703129|NCT00619463|Traumatic Brain Injury|traumatic brain injury
703130|NCT00619463|Exercise|exercise
703131|NCT00619463|Cognition|cognition
703132|NCT00619463|Brain Derived Neurotrophic Factor (BDNF)|brain derived neurotrophic factor (bdnf)
703133|NCT00619463|peripheral vascular endothelial growth factor (VEGF)|peripheral vascular endothelial growth factor (vegf)
703134|NCT00619450|atrial fibrillation|atrial fibrillation
703135|NCT00619450|cardiac pacing|cardiac pacing
703136|NCT00619450|CAT scanner|cat scanner
703137|NCT00619437|schizophrenia|schizophrenia
703138|NCT00619437|genetics|genetics
703139|NCT00619437|family|family
703140|NCT00619437|multiplex|multiplex
703141|NCT00619437|haplotypes|haplotypes
703142|NCT00619424|erlotinib|erlotinib
703143|NCT00619424|pharmacokinetics|pharmacokinetics
703144|NCT00619424|Solid tumors|solid tumors
703145|NCT00619424|pemetrexed|pemetrexed
703146|NCT00619424|anti-angiogenesis|anti-angiogenesis
703147|NCT00619424|pazopanib (GW786034)|pazopanib (gw786034)
703148|NCT00619424|cytokine and angiogenic factors|cytokine and angiogenic factors
703149|NCT00619411|Major Depression|major depression
703150|NCT00619411|Dysthymic Disorder|dysthymic disorder
703151|NCT00619411|Adjustment Disorder|adjustment disorder
703152|NCT00619411|With Depressed Mood|with depressed mood
703153|NCT00619411|Depressive|depressive
703154|NCT00619411|Disorder Not|disorder not
703155|NCT00619411|Otherwise|otherwise
703156|NCT00619411|Specified|specified
703157|NCT00619411|Adolescent|adolescent
703158|NCT00619411|Psychotherapy|psychotherapy
703159|NCT00619398|FK506|fk506
703160|NCT00619398|tacrolimus|tacrolimus
703161|NCT00619398|prograf|prograf
703162|NCT00619398|Liver transplantation|liver transplantation
703163|NCT00619385|Pharmacokinetics|pharmacokinetics
703164|NCT00619372|OKT3|okt3
703165|NCT00619372|beta-glucosylceramide|beta-glucosylceramide
703166|NCT00619372|oral tolerance|oral tolerance
703167|NCT00619372|anti-CD3|anti-cd3
703168|NCT00619372|Safety assessment and healthy volunteers|safety assessment and healthy volunteers
703169|NCT00619346|Safety|safety
703170|NCT00619346|Tolerability|tolerability
703171|NCT00619346|Assessment of potential adverse events and/or laboratory abnormalities|assessment of potential adverse events and/or laboratory abnormalities
703172|NCT00619320|HIV primary prevention|hiv primary prevention
703173|NCT00619320|Health promotion|health promotion
703174|NCT00619320|Health behavior|health behavior
703175|NCT00619320|Risk reduction behavior|risk reduction behavior
703176|NCT00619320|Sexual behavior|sexual behavior
703177|NCT00619320|Safe sex|safe sex
703178|NCT00619320|Women's health|women's health
703179|NCT00619320|Minority health|minority health
703180|NCT00619320|Pregnant Women|pregnant women
703181|NCT00619320|HIV seronegativity|hiv seronegativity
703182|NCT00619294|Coronary Vasospasm|coronary vasospasm
703183|NCT00619294|Endothelium, Vascular|endothelium, vascular
703184|NCT00619294|Vasodilation|vasodilation
703185|NCT00619294|Hyperemia|hyperemia
703186|NCT00619281|Cardiac surgery|cardiac surgery
703187|NCT00619281|Low cardiac output syndrome|low cardiac output syndrome
703188|NCT00619281|Mortality|mortality
703189|NCT00619281|Morbidity|morbidity
703190|NCT00619268|Temsirolimus|temsirolimus
703191|NCT00619268|Bevacizumab|bevacizumab
703192|NCT00619268|Metastatic renal cell carcinoma|metastatic renal cell carcinoma
703193|NCT00619268|Non-progression|non-progression
703194|NCT00619255|Adolescents|adolescents
703195|NCT00619255|Quality Assurance and Improvement|quality assurance and improvement
703196|NCT00619255|Substance Abuse|substance abuse
703197|NCT00619255|Posttraumatic Stress|posttraumatic stress
703198|NCT00619255|Family Centered Care|family centered care
703199|NCT00619255|Trauma Systems|trauma systems
703200|NCT00619242|Esophageal cancer|esophageal cancer
703201|NCT00619229|Alprostadil|alprostadil
703202|NCT00619229|prostaglandin E1|prostaglandin e1
703203|NCT00619229|Prostavasin®|prostavasin®
703204|NCT00619229|macular degeneration|macular degeneration
703205|NCT00619216|Orthotopic Liver Transplant Recipients with GI disturbance|orthotopic liver transplant recipients with gi disturbance
703206|NCT00619203|Bacterial meningitis|bacterial meningitis
703207|NCT00619203|glycerol|glycerol
703208|NCT00619203|high dose paracetamol|high dose paracetamol
703209|NCT00619203|children|children
703211|NCT00619190|aripiprazole|aripiprazole
703212|NCT00619190|children|children
703213|NCT00619190|adolescents|adolescents
703214|NCT00619190|autism spectrum disorders|autism spectrum disorders
703215|NCT00619164|Platelet Aggregation Inhibitors|platelet aggregation inhibitors
703216|NCT00619164|Coronary Stenosis|coronary stenosis
703217|NCT00619164|Coronary Thrombosis|coronary thrombosis
703218|NCT00619151|aortic valve|aortic valve
703219|NCT00619151|heart valve|heart valve
703220|NCT00619151|valve replacement|valve replacement
703221|NCT00619151|Valve disease|valve disease
703222|NCT00619138|Cognitive therapy|cognitive therapy
703223|NCT00619138|Stepped care|stepped care
703224|NCT00619138|Self-help|self-help
703225|NCT00619138|Internet|internet
703226|NCT00619138|Anxiety|anxiety
703227|NCT00619112|adult glioblastoma|adult glioblastoma
703228|NCT00619112|adult gliosarcoma|adult gliosarcoma
703229|NCT00619112|adult anaplastic astrocytoma|adult anaplastic astrocytoma
703230|NCT00619112|adult anaplastic oligodendroglioma|adult anaplastic oligodendroglioma
703231|NCT00619112|adult mixed glioma|adult mixed glioma
703232|NCT00619112|recurrent adult brain tumor|recurrent adult brain tumor
703233|NCT00619099|Myelodysplastic Syndrome|myelodysplastic syndrome
703234|NCT00619099|Decitabine|decitabine
703235|NCT00619099|Dacogen|dacogen
703236|NCT00619099|MGI PHARMA, Inc.|mgi pharma, inc.
703237|NCT00619086|thyroidectomy|thyroidectomy
703238|NCT00619086|dexamethasone|dexamethasone
703239|NCT00619086|steroid|steroid
703240|NCT00619086|nausea|nausea
703241|NCT00619073|blood platelets|blood platelets
703242|NCT00619073|platelet aggregation inhibitors|platelet aggregation inhibitors
703243|NCT00619073|antiplatelet drugs|antiplatelet drugs
703244|NCT00619073|clopidogrel|clopidogrel
703245|NCT00619060|skin cancer|skin cancer
703246|NCT00619060|healthy, no evidence of disease|healthy, no evidence of disease
703247|NCT00619021|recurrent non-small cell lung cancer|recurrent non-small cell lung cancer
703248|NCT00619021|stage I non-small cell lung cancer|stage i non-small cell lung cancer
703249|NCT00619021|stage II non-small cell lung cancer|stage ii non-small cell lung cancer
703250|NCT00619008|obesity|obesity
703251|NCT00619008|low carbohydrate diet|low carbohydrate diet
703252|NCT00619008|high complex carbohydrate diet|high complex carbohydrate diet
703253|NCT00619008|weight regulation hormones|weight regulation hormones
703254|NCT00619008|hunger|hunger
703255|NCT00619008|satiety|satiety
703256|NCT00619008|energy expenditure|energy expenditure
703257|NCT00619008|body composition|body composition
703258|NCT00619008|weight loss|weight loss
703259|NCT00618982|Kidney cancer,|kidney cancer,
703260|NCT00618982|Sorafenib,|sorafenib,
703261|NCT00618982|Dose escalation,|dose escalation,
703262|NCT00618982|No previous treatment|no previous treatment
703263|NCT00618969|Haploidentical|haploidentical
703264|NCT00618969|peripheral blood stem cell transplantation|peripheral blood stem cell transplantation
703265|NCT00618969|leukemia|leukemia
703266|NCT00618969|myeloma|myeloma
703267|NCT00618969|Hodgkin's disease|hodgkin's disease
703268|NCT00618969|non-Hodgkin's lymphoma|non-hodgkin's lymphoma
703269|NCT00618956|NSRI|nsri
703270|NCT00618956|milnacipran|milnacipran
703271|NCT00618956|fibromyalgia|fibromyalgia
703272|NCT00618956|blood pressure|blood pressure
703273|NCT00618956|hypertension|hypertension
703274|NCT00618917|NSCLC|nsclc
703275|NCT00618917|lung cancer|lung cancer
703276|NCT00618917|chemotherapy|chemotherapy
703277|NCT00618917|radiation therapy|radiation therapy
703278|NCT00618917|radiation toxicity|radiation toxicity
703279|NCT00618904|Probiotics|probiotics
703280|NCT00618904|Functional Gastrointestinal Symptoms|functional gastrointestinal symptoms
703281|NCT00618865|Omega-3 Fatty Acids|omega-3 fatty acids
703282|NCT00618865|Major Depressive Disorder|major depressive disorder
703283|NCT00618865|Pregnancy|pregnancy
703284|NCT00618865|Women during pregnancy and after childbirth are more vulnerable to psychiatric disorders|women during pregnancy and after childbirth are more vulnerable to psychiatric disorders
703285|NCT00618865|Pharmacotherapy for depression during pregnancy is a clinical dilemma.|pharmacotherapy for depression during pregnancy is a clinical dilemma.
703286|NCT00618865|Omega-3 polyunsaturated fatty acids (PUFAs) might be a promising alternative of treatment for pregnant women with depression.|omega-3 polyunsaturated fatty acids (pufas) might be a promising alternative of treatment for pregnant women with depression.
703287|NCT00618852|Pediatrics|pediatrics
703288|NCT00618852|Erythrocyte Transfusion|erythrocyte transfusion
703289|NCT00618852|Furosemide|furosemide
703290|NCT00618852|Fluid Overload|fluid overload
703291|NCT00618839|Complex skin defects|complex skin defects
703292|NCT00618839|Burns|burns
703293|NCT00618839|Wound infection|wound infection
703294|NCT00618839|Skin trauma|skin trauma
703295|NCT00618826|Breast cancer|breast cancer
703296|NCT00618800|Falls|falls
703297|NCT00618800|Elderly|elderly
703298|NCT00618800|Injury|injury
703299|NCT00618800|Medication|medication
703300|NCT00618800|Pharmacy|pharmacy
703301|NCT00618800|Pharmacist|pharmacist
703302|NCT00618761|glucose clamp|glucose clamp
703303|NCT00618761|beta-cell|beta-cell
703304|NCT00618748|Bipolar|bipolar
703305|NCT00618709|Healthy volunteers|healthy volunteers
703396|NCT00618397|pharmacokinetics|pharmacokinetics
703306|NCT00618696|recurrent adult acute lymphoblastic leukemia|recurrent adult acute lymphoblastic leukemia
703307|NCT00618696|recurrent adult acute myeloid leukemia|recurrent adult acute myeloid leukemia
703308|NCT00618696|secondary acute myeloid leukemia|secondary acute myeloid leukemia
703309|NCT00618696|previously treated myelodysplastic syndromes|previously treated myelodysplastic syndromes
703310|NCT00618696|blastic phase chronic myelogenous leukemia|blastic phase chronic myelogenous leukemia
703311|NCT00618696|relapsing chronic myelogenous leukemia|relapsing chronic myelogenous leukemia
703312|NCT00618696|adult acute myeloid leukemia with 11q23 (MLL) abnormalities|adult acute myeloid leukemia with 11q23 (mll) abnormalities
703313|NCT00618696|adult acute myeloid leukemia with inv(16)(p13;q22)|adult acute myeloid leukemia with inv(16)(p13;q22)
703314|NCT00618696|adult acute myeloid leukemia with t(15;17)(q22;q12)|adult acute myeloid leukemia with t(15;17)(q22;q12)
703315|NCT00618696|adult acute myeloid leukemia with t(16;16)(p13;q22)|adult acute myeloid leukemia with t(16;16)(p13;q22)
703316|NCT00618696|adult acute myeloid leukemia with t(8;21)(q22;q22)|adult acute myeloid leukemia with t(8;21)(q22;q22)
703318|NCT00618683|Atrioventricular|atrioventricular
703319|NCT00618683|nodal reentrant circuit|nodal reentrant circuit
703320|NCT00618683|nodal reentrant tachycardia|nodal reentrant tachycardia
703321|NCT00618683|Paroxysmal supraventricular tachycardia|paroxysmal supraventricular tachycardia
703322|NCT00618670|aging|aging
703323|NCT00618670|gait|gait
703324|NCT00618670|musculoskeletal disorder therapy|musculoskeletal disorder therapy
703325|NCT00618670|peripheral blood vessel disorder|peripheral blood vessel disorder
703326|NCT00618670|muscle function|muscle function
703327|NCT00618670|muscle strength|muscle strength
703328|NCT00618670|quality of life|quality of life
703329|NCT00618657|pre-operative|pre-operative
703330|NCT00618657|neo-adjuvant|neo-adjuvant
703331|NCT00618657|triple negative|triple negative
703332|NCT00618657|HER2 positive|her2 positive
703333|NCT00618657|hormone receptor positive|hormone receptor positive
703334|NCT00618657|breast|breast
703335|NCT00618657|Carboplatin|carboplatin
703336|NCT00618657|Nab-paclitaxel|nab-paclitaxel
703337|NCT00618657|Trastuzumab|trastuzumab
703338|NCT00618657|Bevacizumab|bevacizumab
703339|NCT00618657|Inflammatory|inflammatory
703340|NCT00618631|Smoking|smoking
703341|NCT00618631|Nicotine|nicotine
703342|NCT00618631|Endogenous Opioids|endogenous opioids
703343|NCT00618631|PET Study|pet study
703344|NCT00618631|Carfentanil|carfentanil
703345|NCT00618605|HIV Seronegativity|hiv seronegativity
703346|NCT00618605|HIV Preventative Vaccine|hiv preventative vaccine
703347|NCT00618592|carbohydrate supplementation|carbohydrate supplementation
703348|NCT00618592|cardiac surgery|cardiac surgery
703349|NCT00618592|spine surgery|spine surgery
703350|NCT00618592|insulin resistance|insulin resistance
703351|NCT00618592|insulin sensitivity|insulin sensitivity
703352|NCT00618592|short insulin tolerance test|short insulin tolerance test
703353|NCT00618592|HOMA|homa
703354|NCT00618592|outcomes|outcomes
703355|NCT00618579|Interaction with LMWH or warfarin|interaction with lmwh or warfarin
703356|NCT00618566|Women with physical Disabilities|women with physical disabilities
703357|NCT00618566|Secondary Conditions|secondary conditions
703358|NCT00618566|Depression|depression
703359|NCT00618566|Cognitive Behavioral Therapy|cognitive behavioral therapy
703360|NCT00618566|Consumer Control|consumer control
703361|NCT00618553|Lung Cancer|lung cancer
703362|NCT00618553|Pulmonary Rehabilitation|pulmonary rehabilitation
703363|NCT00618553|Questionnaire|questionnaire
703364|NCT00618553|Survey|survey
703365|NCT00618553|Lung Function|lung function
703366|NCT00618553|Quality of Life|quality of life
703367|NCT00618540|childhood Langerhans cell histiocytosis|childhood langerhans cell histiocytosis
703368|NCT00618527|relapsing remitting multiple sclerosis|relapsing remitting multiple sclerosis
703369|NCT00618527|multiple sclerosis|multiple sclerosis
703370|NCT00618514|Varicose Veins|varicose veins
703371|NCT00618514|Laser Ablation|laser ablation
703372|NCT00618514|Laser Wire Fibers|laser wire fibers
703373|NCT00618501|untreated adult acute lymphoblastic leukemia|untreated adult acute lymphoblastic leukemia
703374|NCT00618488|Probiotics|probiotics
703375|NCT00618488|BB12|bb12
703376|NCT00618488|Gastrointestinal Symptoms|gastrointestinal symptoms
703377|NCT00618475|Depression|depression
703378|NCT00618475|End Stage Renal Disease|end stage renal disease
703379|NCT00618475|Kidney Disease|kidney disease
703380|NCT00618475|Mental Health|mental health
703381|NCT00618462|Cognitive Behavioral Therapy|cognitive behavioral therapy
703382|NCT00618462|Pathological Gambling|pathological gambling
703383|NCT00618449|Trachoma|trachoma
703384|NCT00618449|Chlamydia trachomatis|chlamydia trachomatis
703385|NCT00618436|Seizures|seizures
703386|NCT00618436|Traumatic Brain Injury|traumatic brain injury
703387|NCT00618436|Subarachnoid Hemorrhage|subarachnoid hemorrhage
703388|NCT00618423|Neuropathic pain|neuropathic pain
703389|NCT00618423|Chronic pain|chronic pain
703390|NCT00618423|Acute postoperative pain|acute postoperative pain
703391|NCT00618423|Ketamine|ketamine
703392|NCT00618423|Back surgery|back surgery
703393|NCT00618423|Anesthesia|anesthesia
703394|NCT00618423|Perioperative|perioperative
703395|NCT00618397|ketamine|ketamine
703398|NCT00618397|critical care|critical care
703399|NCT00618397|opioid tolerance|opioid tolerance
703400|NCT00618397|NMDA Antagonist|nmda antagonist
703402|NCT00618384|hepatocellular carcinoma|hepatocellular carcinoma
703403|NCT00618371|Intensification|intensification
703404|NCT00618371|HIV viremia|hiv viremia
703405|NCT00618371|Human Immunodeficiency Virus|human immunodeficiency virus
703406|NCT00618345|refractory multiple myeloma|refractory multiple myeloma
703407|NCT00618293|intraoperative bleeding|intraoperative bleeding
703408|NCT00618293|aortic-valve replacement|aortic-valve replacement
703409|NCT00618293|aortic stenosis|aortic stenosis
703410|NCT00618293|Von Willebrand|von willebrand
703411|NCT00618293|HEAMATE|heamate
703412|NCT00618254|Prevention of nausea and vomiting associated with radiation or chemotherapy|prevention of nausea and vomiting associated with radiation or chemotherapy
703413|NCT00618241|interactions|interactions
703414|NCT00618241|neuropathic pain|neuropathic pain
703415|NCT00618241|pharmacokinetics|pharmacokinetics
703416|NCT00618215|cluster-randomised trial|cluster-randomised trial
703417|NCT00618215|routine oral examination|routine oral examination
703418|NCT00618215|implementation research|implementation research
703419|NCT00618215|practice based research|practice based research
703420|NCT00618215|CPG|cpg
703421|NCT00618215|recall interval assignment for routine oral examination|recall interval assignment for routine oral examination
703422|NCT00618215|prescription bitewing radiographs|prescription bitewing radiographs
710608|NCT00588588|Ventilator associated pneumonia|ventilator associated pneumonia
703423|NCT00618215|preventive advice and feed back oral disease|preventive advice and feed back oral disease
703424|NCT00618176|Acquired Immunodeficiency Syndrome|acquired immunodeficiency syndrome
703425|NCT00618176|adverse effects|adverse effects
703426|NCT00618176|Treatment Outcome|treatment outcome
703427|NCT00618176|Drug Resistance, Viral|drug resistance, viral
703428|NCT00618176|treatment naïve|treatment naïve
703429|NCT00618163|Anti-inflammatory|anti-inflammatory
703430|NCT00618150|GERD|gerd
703431|NCT00618150|Dyspepsia|dyspepsia
703432|NCT00618150|Education|education
703433|NCT00618150|Information|information
703434|NCT00618137|Chronic obstructive pulmonary disease|chronic obstructive pulmonary disease
703435|NCT00618137|Gene expression profiling|gene expression profiling
703436|NCT00618137|Inert dusts|inert dusts
703437|NCT00618137|Natural course|natural course
703438|NCT00618137|Prospective assessment|prospective assessment
703439|NCT00618124|solid tumor malignancy, SU011248, sunitinib, capecitabine, Phase 1|solid tumor malignancy, su011248, sunitinib, capecitabine, phase 1
703440|NCT00618111|Prevention of nausea and vomiting associated with radiation or chemotherapy|prevention of nausea and vomiting associated with radiation or chemotherapy
703441|NCT00618098|anticoagulant reversal|anticoagulant reversal
703442|NCT00618098|urgent surgery|urgent surgery
703443|NCT00618098|invasive procedures|invasive procedures
703444|NCT00618098|vitamin K|vitamin k
703445|NCT00618098|prothrombin complex concentrate|prothrombin complex concentrate
703446|NCT00618072|hyperinsulinemia|hyperinsulinemia
703447|NCT00618072|insulin resistance|insulin resistance
703448|NCT00618072|perimenopause|perimenopause
703449|NCT00618072|obesity|obesity
703450|NCT00618072|overweight|overweight
703451|NCT00618072|women|women
703452|NCT00618033|Hemodialysis|hemodialysis
703453|NCT00618033|ESRD|esrd
703454|NCT00618020|CTO|cto
703455|NCT00618020|Chronic Total Occlusion|chronic total occlusion
703456|NCT00618020|Revascularization|revascularization
703457|NCT00617994|psoriasis|psoriasis
703458|NCT00617981|hepatocellular carcinoma|hepatocellular carcinoma
703459|NCT00617981|liver cancer|liver cancer
703460|NCT00617942|Breast Cancer|breast cancer
703461|NCT00617929|chronic myelogenous leukemia|chronic myelogenous leukemia
703462|NCT00617929|acute lymphoblastic leukemia|acute lymphoblastic leukemia
703463|NCT00617929|chronic myeloid leukemia|chronic myeloid leukemia
703464|NCT00617929|lymphoblastic leukemia|lymphoblastic leukemia
703465|NCT00617929|acute myeloid leukemia|acute myeloid leukemia
703466|NCT00617929|chronic eosinophilic leukemia|chronic eosinophilic leukemia
703467|NCT00617929|primary myelofibrosis|primary myelofibrosis
703468|NCT00617929|chronic myelomonocytic leukemia|chronic myelomonocytic leukemia
703469|NCT00617929|chronic neutrophilic leukemia|chronic neutrophilic leukemia
703470|NCT00617929|de novo myelodysplastic syndromes|de novo myelodysplastic syndromes
703471|NCT00617929|disseminated neuroblastoma|disseminated neuroblastoma
703472|NCT00617929|juvenile myelomonocytic leukemia|juvenile myelomonocytic leukemia
703473|NCT00617929|Burkitt lymphoma|burkitt lymphoma
703474|NCT00617929|rhabdomyosarcoma|rhabdomyosarcoma
703475|NCT00617929|myelodysplastic syndromes|myelodysplastic syndromes
703476|NCT00617929|Hodgkin lymphoma|hodgkin lymphoma
703477|NCT00617929|lymphoblastic lymphoma|lymphoblastic lymphoma
703478|NCT00617929|breast cancer|breast cancer
703479|NCT00617929|follicular lymphoma|follicular lymphoma
703480|NCT00617929|mantle cell lymphoma|mantle cell lymphoma
703481|NCT00617929|marginal zone lymphoma|marginal zone lymphoma
703482|NCT00617929|recurrent neuroblastoma|recurrent neuroblastoma
703483|NCT00617929|recurrent ovarian epithelial cancer|recurrent ovarian epithelial cancer
703484|NCT00617929|recurrent ovarian germ cell tumor|recurrent ovarian germ cell tumor
703485|NCT00617929|recurrent small lymphocytic lymphoma|recurrent small lymphocytic lymphoma
703486|NCT00617929|recurrent malignant testicular germ cell tumor|recurrent malignant testicular germ cell tumor
703487|NCT00617929|recurrent Wilms tumor and other childhood kidney tumors|recurrent wilms tumor and other childhood kidney tumors
703488|NCT00617929|recurrent/refractory childhood Hodgkin lymphoma|recurrent/refractory childhood hodgkin lymphoma
703489|NCT00617929|refractory hairy cell leukemia|refractory hairy cell leukemia
703490|NCT00617929|refractory multiple myeloma|refractory multiple myeloma
703491|NCT00617929|relapsing chronic myelogenous leukemia|relapsing chronic myelogenous leukemia
703492|NCT00617929|secondary acute myeloid leukemia|secondary acute myeloid leukemia
703493|NCT00617929|secondary myelodysplastic syndromes|secondary myelodysplastic syndromes
703494|NCT00617929|splenic marginal zone lymphoma|splenic marginal zone lymphoma
703495|NCT00617929|stage I multiple myeloma|stage i multiple myeloma
703496|NCT00617929|stage II multiple myeloma|stage ii multiple myeloma
703497|NCT00617929|stage III multiple myeloma|stage iii multiple myeloma
703498|NCT00617929|stage II ovarian epithelial cancer|stage ii ovarian epithelial cancer
703499|NCT00617929|stage III adult Burkitt lymphoma|stage iii adult burkitt lymphoma
703500|NCT00617929|stage III adult diffuse large cell lymphoma|stage iii adult diffuse large cell lymphoma
703501|NCT00617929|stage III adult diffuse mixed cell lymphoma|stage iii adult diffuse mixed cell lymphoma
703502|NCT00617929|stage III adult diffuse small cleaved cell lymphoma|stage iii adult diffuse small cleaved cell lymphoma
703503|NCT00617929|stage III adult Hodgkin lymphoma|stage iii adult hodgkin lymphoma
703504|NCT00617929|stage III adult immunoblastic large cell lymphoma|stage iii adult immunoblastic large cell lymphoma
703505|NCT00617929|stage III adult lymphoblastic lymphoma|stage iii adult lymphoblastic lymphoma
703506|NCT00617929|stage III chronic lymphocytic leukemia|stage iii chronic lymphocytic leukemia
703507|NCT00617929|stage III grade 1 follicular lymphoma|stage iii grade 1 follicular lymphoma
703508|NCT00617929|stage III grade 2 follicular lymphoma|stage iii grade 2 follicular lymphoma
703509|NCT00617929|stage III grade 3 follicular lymphoma|stage iii grade 3 follicular lymphoma
703510|NCT00617929|stage III mantle cell lymphoma|stage iii mantle cell lymphoma
703511|NCT00617929|stage III marginal zone lymphoma|stage iii marginal zone lymphoma
703512|NCT00617929|stage III ovarian epithelial cancer|stage iii ovarian epithelial cancer
703513|NCT00617929|stage III small lymphocytic lymphoma|stage iii small lymphocytic lymphoma
703514|NCT00617929|stage III malignant testicular germ cell tumor|stage iii malignant testicular germ cell tumor
703515|NCT00617929|stage IIIA breast cancer|stage iiia breast cancer
703516|NCT00617929|stage IIIB breast cancer|stage iiib breast cancer
703517|NCT00617929|stage IIIC breast cancer|stage iiic breast cancer
703518|NCT00617929|stage IV adult Burkitt lymphoma|stage iv adult burkitt lymphoma
703519|NCT00617929|stage IV adult diffuse large cell lymphoma|stage iv adult diffuse large cell lymphoma
703520|NCT00617929|stage IV adult diffuse mixed cell lymphoma|stage iv adult diffuse mixed cell lymphoma
703521|NCT00617929|stage IV adult diffuse small cleaved cell lymphoma|stage iv adult diffuse small cleaved cell lymphoma
703522|NCT00617929|stage IV adult Hodgkin lymphoma|stage iv adult hodgkin lymphoma
703523|NCT00617929|stage IV adult immunoblastic large cell lymphoma|stage iv adult immunoblastic large cell lymphoma
703524|NCT00617929|stage IV adult lymphoblastic lymphoma|stage iv adult lymphoblastic lymphoma
703525|NCT00617929|stage IV breast cancer|stage iv breast cancer
703526|NCT00617929|stage IV chronic lymphocytic leukemia|stage iv chronic lymphocytic leukemia
703527|NCT00617929|stage IV grade 1 follicular lymphoma|stage iv grade 1 follicular lymphoma
703528|NCT00617929|stage IV grade 2 follicular lymphoma|stage iv grade 2 follicular lymphoma
703529|NCT00617929|stage IV grade 3 follicular lymphoma|stage iv grade 3 follicular lymphoma
703530|NCT00617929|stage IV mantle cell lymphoma|stage iv mantle cell lymphoma
703531|NCT00617929|stage IV marginal zone lymphoma|stage iv marginal zone lymphoma
703532|NCT00617929|stage IV ovarian epithelial cancer|stage iv ovarian epithelial cancer
703533|NCT00617929|stage IV small lymphocytic lymphoma|stage iv small lymphocytic lymphoma
703534|NCT00617929|refractory chronic lymphocytic leukemia|refractory chronic lymphocytic leukemia
703535|NCT00617916|hyperspectral imaging|hyperspectral imaging
703536|NCT00617916|tissue oxygenation|tissue oxygenation
703537|NCT00617916|diabetic foot ulcers|diabetic foot ulcers
703538|NCT00617916|wound healing|wound healing
703539|NCT00617916|prevention|prevention
703541|NCT00617903|papulopustular|papulopustular
703542|NCT00617903|azelaic acid|azelaic acid
703543|NCT00617903|foam|foam
703544|NCT00617890|anti-IGF-1R|anti-igf-1r
703545|NCT00617851|Influenza|influenza
703546|NCT00617851|adults|adults
703547|NCT00617851|different lots|different lots
703548|NCT00617851|trivalent subunit influenza virus vaccine (IVV)|trivalent subunit influenza virus vaccine (ivv)
703549|NCT00617851|trivalent subunit influenza vaccine|trivalent subunit influenza vaccine
703550|NCT00617838|Celiac disease|celiac disease
703551|NCT00617838|genetic risk|genetic risk
703552|NCT00617838|gluten introduction|gluten introduction
703553|NCT00617838|predicting antibodies|predicting antibodies
703554|NCT00617825|chronic venous disorders|chronic venous disorders
703555|NCT00617825|cryotherapy|cryotherapy
703556|NCT00617825|skin microcirculation|skin microcirculation
703557|NCT00617825|skin temperature|skin temperature
703558|NCT00617812|Vaccine|vaccine
703559|NCT00617812|Prevention|prevention
703560|NCT00617812|Diphtheria|diphtheria
703561|NCT00617812|Tetanus|tetanus
703562|NCT00617812|Pertussis|pertussis
703564|NCT00617812|Haemophilus influenzae type b|haemophilus influenzae type b
703565|NCT00617812|Healthy infants|healthy infants
703566|NCT00617799|stage IV renal cell cancer|stage iv renal cell cancer
703567|NCT00617799|stage IV melanoma|stage iv melanoma
703568|NCT00617786|urinary urgency|urinary urgency
703569|NCT00617786|urinary frequency|urinary frequency
703570|NCT00617786|urge incontinence|urge incontinence
703571|NCT00617786|sacral neuromodulation therapy|sacral neuromodulation therapy
703573|NCT00617786|frequency|frequency
703574|NCT00617773|recurrent ovarian epithelial cancer|recurrent ovarian epithelial cancer
703575|NCT00617773|recurrent fallopian tube cancer|recurrent fallopian tube cancer
703576|NCT00617773|recurrent primary peritoneal cancer|recurrent primary peritoneal cancer
703577|NCT00617747|Zolmitriptan|zolmitriptan
703578|NCT00617747|ZOMIG|zomig
703579|NCT00617747|migraine|migraine
703580|NCT00617747|headache response|headache response
703581|NCT00617747|headache|headache
703582|NCT00617747|headache pain|headache pain
703583|NCT00617734|Squamous Cell Carcinoma in Head and Neck|squamous cell carcinoma in head and neck
703584|NCT00617734|Prior Platinum-based chemotherapy|prior platinum-based chemotherapy
703585|NCT00617734|Cetuximab|cetuximab
703586|NCT00617734|Erbitux|erbitux
703587|NCT00617734|IMC-A12|imc-a12
703588|NCT00617721|Defective gene(s) in plasma membrane remodelling.|defective gene(s) in plasma membrane remodelling.
703589|NCT00617721|Scott syndrome,|scott syndrome,
703590|NCT00617721|Reduced prothrombin consumption,|reduced prothrombin consumption,
703591|NCT00617721|Circulating biomakers of scott syndrome|circulating biomakers of scott syndrome
703592|NCT00617695|Zolmitriptan|zolmitriptan
703593|NCT00617695|ZOMIG|zomig
703594|NCT00617695|migraine|migraine
703595|NCT00617695|headache response|headache response
703596|NCT00617695|headache|headache
703597|NCT00617695|headache pain|headache pain
703598|NCT00617682|Maternal immunization|maternal immunization
703599|NCT00617682|Pneumococcal conjugate vaccine|pneumococcal conjugate vaccine
703600|NCT00617682|Otitis media|otitis media
703601|NCT00617669|Hormone Resistant Prostate Cancer|hormone resistant prostate cancer
703602|NCT00617669|Endothelin A Receptor Antagonist|endothelin a receptor antagonist
703603|NCT00617669|Endothelin A|endothelin a
703604|NCT00617669|Endothelin A antagonist|endothelin a antagonist
703605|NCT00617656|LUNG CANCER|lung cancer
703606|NCT00617643|Nevirapine|nevirapine
703607|NCT00617643|Rifampicin|rifampicin
703608|NCT00617643|Pharmacokinetics|pharmacokinetics
703609|NCT00617617|isoflavones|isoflavones
703610|NCT00617617|soy|soy
703611|NCT00617604|kidney transplant|kidney transplant
703612|NCT00617604|alefacept|alefacept
703613|NCT00617591|Lenalidomide|lenalidomide
703614|NCT00617591|Revlimid|revlimid
703615|NCT00617591|Pegylated Liposomal Doxorubicin|pegylated liposomal doxorubicin
703616|NCT00617591|Doxil|doxil
703617|NCT00617591|Dexamethasone|dexamethasone
703618|NCT00617591|Decadron|decadron
703619|NCT00617578|Antitachy pacing|antitachy pacing
703620|NCT00617578|Implantable cardioverter-defibrillator|implantable cardioverter-defibrillator
703621|NCT00617552|postoperative ileus|postoperative ileus
703622|NCT00617552|POI|poi
703623|NCT00617552|major open abdominal surgery|major open abdominal surgery
703624|NCT00617539|recurrent breast cancer|recurrent breast cancer
703625|NCT00617539|stage IV breast cancer|stage iv breast cancer
703626|NCT00617539|male breast cancer|male breast cancer
703627|NCT00617539|tumors metastatic to brain|tumors metastatic to brain
703628|NCT00617526|HIV|hiv
703629|NCT00617526|treatment naïve|treatment naïve
703630|NCT00617500|climacteric|climacteric
703631|NCT00617500|complementary therapy|complementary therapy
703632|NCT00617500|hormonal replacement therapy|hormonal replacement therapy
703633|NCT00617474|erythropoietin|erythropoietin
703634|NCT00617474|kidney allograft survival|kidney allograft survival
703635|NCT00617474|Recombinant Erythropoietin|recombinant erythropoietin
703636|NCT00617474|erythropoietin (Epo)-induced protein 29, human|erythropoietin (epo)-induced protein 29, human
703637|NCT00617461|Post-herpetic neuralgia(PHN)|post-herpetic neuralgia(phn)
703638|NCT00617461|Neuropathic pain|neuropathic pain
703639|NCT00617448|diathermy hemorrhoids|diathermy hemorrhoids
703640|NCT00617448|Ligasure|ligasure
703641|NCT00617448|randomized controlled trial|randomized controlled trial
703642|NCT00617448|Postoperative pain|postoperative pain
703643|NCT00617448|Surgical Procedure, Ambulatory|surgical procedure, ambulatory
703644|NCT00617448|Local Anesthesia|local anesthesia
703645|NCT00617448|Safety procedure long term|safety procedure long term
703646|NCT00617448|Day Surgery|day surgery
703647|NCT00617435|Trans fatty acid|trans fatty acid
703648|NCT00617435|Insulin resistance|insulin resistance
703649|NCT00617435|Skeletal muscle|skeletal muscle
703650|NCT00617435|Adipose tissue|adipose tissue
703651|NCT00617409|SCLC|sclc
703652|NCT00617409|vaccine|vaccine
703653|NCT00617409|immunize|immunize
703654|NCT00617396|Irritable Bowel Syndrome|irritable bowel syndrome
703655|NCT00617396|Seroquel|seroquel
703656|NCT00617396|Abdominal Pain|abdominal pain
703657|NCT00617383|demyelinating disease|demyelinating disease
703658|NCT00617383|multiple sclerosis|multiple sclerosis
703659|NCT00617383|female monozygotic identical twins|female monozygotic identical twins
703661|NCT00617383|non-concordant|non-concordant
703662|NCT00617383|clinically isolated syndrome - CIS|clinically isolated syndrome - cis
703663|NCT00617383|brain MRI|brain mri
703664|NCT00617383|proteomics|proteomics
703665|NCT00617370|CYCLOPHOSPHAMIDE (CYTOXAN)|cyclophosphamide (cytoxan)
703666|NCT00617370|EPIRUBICIN|epirubicin
703667|NCT00617370|PEGFILGRASTIM|pegfilgrastim
703668|NCT00617370|TAXOL (PACLITAXEL)|taxol (paclitaxel)
703669|NCT00617357|incisional hernia|incisional hernia
703670|NCT00617357|abdominal hernia repair|abdominal hernia repair
703671|NCT00617357|Ventral incisional hernia repair|ventral incisional hernia repair
703672|NCT00617344|Dengue fever|dengue fever
703673|NCT00617344|Dengue hemorrhagic fever|dengue hemorrhagic fever
703674|NCT00617344|Dengue virus|dengue virus
703675|NCT00617331|vaccine, priming, influenza, flu, A/H9N2|vaccine, priming, influenza, flu, a/h9n2
703676|NCT00617318|Pomegranate|pomegranate
703677|NCT00617318|Influenza|influenza
703678|NCT00617318|Common Cold|common cold
703679|NCT00617318|Cough|cough
703680|NCT00617318|Severity|severity
703681|NCT00617318|Efficacy|efficacy
703682|NCT00617305|ambrisentan|ambrisentan
703683|NCT00617305|PAH|pah
703684|NCT00617305|combination therapy|combination therapy
703685|NCT00617305|phosphodiesterase type-5 inhibitor (PDE-5i)|phosphodiesterase type-5 inhibitor (pde-5i)
703686|NCT00617305|cardiovascular|cardiovascular
703687|NCT00617305|endothelin receptor antagonist|endothelin receptor antagonist
703688|NCT00617305|ERA|era
703689|NCT00617292|21-hydroxylase deficiency|21-hydroxylase deficiency
703690|NCT00617292|21OHD|21ohd
703691|NCT00617292|CAH|cah
703692|NCT00617266|tobacco, cessation, BPO, RCT, KAP|tobacco, cessation, bpo, rct, kap
703693|NCT00617240|antipsychotic|antipsychotic
703694|NCT00617240|metformin|metformin
703695|NCT00617240|children|children
703696|NCT00617240|adolescents|adolescents
703697|NCT00617227|Enteral vancomycin therapy, serum vancomycin levels, renal failure|enteral vancomycin therapy, serum vancomycin levels, renal failure
703698|NCT00617214|Schizophrenia|schizophrenia
703699|NCT00617214|Integrated care program|integrated care program
703700|NCT00617214|Seroquel|seroquel
703701|NCT00617201|cocaine|cocaine
703702|NCT00617201|dependence|dependence
703703|NCT00617201|stimulants|stimulants
703704|NCT00617188|recurrent ovarian epithelial cancer|recurrent ovarian epithelial cancer
703705|NCT00617175|Implantable Cardiac Defibrillator|implantable cardiac defibrillator
703706|NCT00617175|therapies reduction|therapies reduction
703707|NCT00617175|Shocks|shocks
703708|NCT00617175|Quality of Life|quality of life
703709|NCT00617149|exercise,|exercise,
703710|NCT00617149|excessive weight gain during pregnancy|excessive weight gain during pregnancy
703711|NCT00617136|Surgery|surgery
703712|NCT00617136|Anesthesia|anesthesia
703713|NCT00617136|Hypothermia|hypothermia
703714|NCT00617136|Temperature|temperature
703715|NCT00617136|Perioperative|perioperative
703716|NCT00617136|Temperature Management|temperature management
703717|NCT00617110|diesel exhaust particles|diesel exhaust particles
703718|NCT00617110|live attenuated influenza virus vaccine|live attenuated influenza virus vaccine
703719|NCT00617110|flu vaccine|flu vaccine
703720|NCT00617097|Pain associated with first trimester surgical abortion|pain associated with first trimester surgical abortion
703721|NCT00617084|Drug Eluting Stents|drug eluting stents
703722|NCT00617084|Interventional Cardiology|interventional cardiology
703723|NCT00617071|colon cancer|colon cancer
703724|NCT00617071|rectal cancer|rectal cancer
703725|NCT00617058|antipsychotic|antipsychotic
703726|NCT00617058|metformin|metformin
703727|NCT00617058|children|children
703728|NCT00617058|adolescents|adolescents
703729|NCT00617045|Post Partum Depression|post partum depression
703730|NCT00617006|Anesthesia Workspace|anesthesia workspace
703731|NCT00617006|Hospital Acquired Infections|hospital acquired infections
703732|NCT00617006|Hand Hygiene|hand hygiene
703733|NCT00617006|Alcohol Based Cleanser|alcohol based cleanser
703734|NCT00617006|Bacterial Contamination|bacterial contamination
703735|NCT00616980|PAD|pad
703736|NCT00616980|PVD|pvd
703737|NCT00616980|CLI|cli
703738|NCT00616980|Stem Cells|stem cells
703739|NCT00616967|stage II breast cancer|stage ii breast cancer
703740|NCT00616967|stage IIIA breast cancer|stage iiia breast cancer
703741|NCT00616967|stage IIIB breast cancer|stage iiib breast cancer
703742|NCT00616967|stage IIIC breast cancer|stage iiic breast cancer
703743|NCT00616967|ductal breast carcinoma|ductal breast carcinoma
703744|NCT00616967|lobular breast carcinoma|lobular breast carcinoma
703745|NCT00616954|mismatched|mismatched
703746|NCT00616954|Stem cell transplatation|stem cell transplatation
703747|NCT00616954|Bone marrow transplantation|bone marrow transplantation
703748|NCT00616954|T cell depletion|t cell depletion
703749|NCT00616954|engraftment|engraftment
703750|NCT00616954|Patients undergoing allogeneic haplo-SCT|patients undergoing allogeneic haplo-sct
703751|NCT00616941|NY-ESO-1 OLP4|ny-eso-1 olp4
703752|NCT00616941|Ovarian Cancer|ovarian cancer
703753|NCT00616941|Cancer Vaccine|cancer vaccine
703754|NCT00616928|vaccines|vaccines
703755|NCT00616928|immunogenicity|immunogenicity
703757|NCT00616928|safety|safety
703758|NCT00616928|influenza|influenza
703759|NCT00616915|Wellbutrin SR|wellbutrin sr
703760|NCT00616902|Zemplar, paricalcitol, PRIMO II|zemplar, paricalcitol, primo ii
703761|NCT00616876|lactulose|lactulose
703762|NCT00616876|prebiotic|prebiotic
703763|NCT00616876|premature infant|premature infant
703764|NCT00616876|enteral feeding|enteral feeding
703765|NCT00616876|stools|stools
703766|NCT00616876|lactobacillus|lactobacillus
703767|NCT00616876|nutrition|nutrition
703768|NCT00616876|growth|growth
703769|NCT00616850|Total Knee Arthroplasty|total knee arthroplasty
703770|NCT00616850|Intravenous Lidocaine Infusion|intravenous lidocaine infusion
703771|NCT00616850|Femoral Block Catheter|femoral block catheter
703772|NCT00616837|Remote consultation/*methods|remote consultation/*methods
703773|NCT00616837|Orthopaedics methods|orthopaedics methods
703774|NCT00616837|Telemedicine|telemedicine
703775|NCT00616837|Follow-up study|follow-up study
703776|NCT00616837|Ambulatory care|ambulatory care
703777|NCT00616824|Acellular dermal matrix|acellular dermal matrix
703778|NCT00616824|breast reconstruction|breast reconstruction
703779|NCT00616824|tissue expander|tissue expander
703780|NCT00616824|postoperative pain|postoperative pain
703781|NCT00616824|complication|complication
703782|NCT00616824|pain|pain
703783|NCT00616824|patient satisfaction|patient satisfaction
703784|NCT00616811|Type 2 diabetes, vildagliptin|type 2 diabetes, vildagliptin
703785|NCT00616785|stage IIIA non-small cell lung cancer|stage iiia non-small cell lung cancer
703786|NCT00616785|stage IIIB non-small cell lung cancer|stage iiib non-small cell lung cancer
703787|NCT00616759|Depression|depression
703788|NCT00616759|Electroconvulsive therapy|electroconvulsive therapy
703789|NCT00616746|Alcohol, nicotine|alcohol, nicotine
703790|NCT00616733|Multiple sclerosis, relapsing, secondary progressive, clinically isolated syndrome, MRI|multiple sclerosis, relapsing, secondary progressive, clinically isolated syndrome, mri
703791|NCT00616720|stage I multiple myeloma|stage i multiple myeloma
703792|NCT00616720|stage II multiple myeloma|stage ii multiple myeloma
703793|NCT00616720|stage III multiple myeloma|stage iii multiple myeloma
703794|NCT00616720|refractory multiple myeloma|refractory multiple myeloma
703795|NCT00616707|Inflammation|inflammation
703796|NCT00616707|Oxidative Stress|oxidative stress
703797|NCT00616707|Microalbuminuria|microalbuminuria
703798|NCT00616668|Transtibial amputees due to vascular diseases.|transtibial amputees due to vascular diseases.
703799|NCT00616655|Anxiety|anxiety
703800|NCT00616642|recurrent pituitary tumor|recurrent pituitary tumor
703801|NCT00616642|ACTH-producing pituitary tumor|acth-producing pituitary tumor
703802|NCT00616642|nonfunctioning pituitary tumor|nonfunctioning pituitary tumor
703803|NCT00616616|appendectomy|appendectomy
703804|NCT00616616|cholecystectomy|cholecystectomy
703805|NCT00616616|gastric banding|gastric banding
703806|NCT00616616|adrenalectomy|adrenalectomy
703807|NCT00616616|Gastric lap-band placement|gastric lap-band placement
703808|NCT00616603|Total Knee Arthroplasty.|total knee arthroplasty.
703809|NCT00616603|Sciatic nerve Blocks.|sciatic nerve blocks.
703810|NCT00616603|Dexamethasone.|dexamethasone.
703811|NCT00616590|sleep disorders|sleep disorders
703812|NCT00616590|psychosocial effects of cancer and its treatment|psychosocial effects of cancer and its treatment
703813|NCT00616590|fatigue|fatigue
703814|NCT00616590|recurrent squamous cell carcinoma of the hypopharynx|recurrent squamous cell carcinoma of the hypopharynx
703815|NCT00616590|stage I squamous cell carcinoma of the hypopharynx|stage i squamous cell carcinoma of the hypopharynx
703816|NCT00616590|stage II squamous cell carcinoma of the hypopharynx|stage ii squamous cell carcinoma of the hypopharynx
703817|NCT00616590|stage III squamous cell carcinoma of the hypopharynx|stage iii squamous cell carcinoma of the hypopharynx
703818|NCT00616590|stage IV squamous cell carcinoma of the hypopharynx|stage iv squamous cell carcinoma of the hypopharynx
703819|NCT00616590|recurrent squamous cell carcinoma of the larynx|recurrent squamous cell carcinoma of the larynx
703820|NCT00616590|recurrent verrucous carcinoma of the larynx|recurrent verrucous carcinoma of the larynx
703821|NCT00616590|stage I squamous cell carcinoma of the larynx|stage i squamous cell carcinoma of the larynx
703822|NCT00616590|stage I verrucous carcinoma of the larynx|stage i verrucous carcinoma of the larynx
703823|NCT00616590|stage II squamous cell carcinoma of the larynx|stage ii squamous cell carcinoma of the larynx
703906|NCT00616551|Acromegaly|acromegaly
703824|NCT00616590|stage II verrucous carcinoma of the larynx|stage ii verrucous carcinoma of the larynx
703825|NCT00616590|stage III squamous cell carcinoma of the larynx|stage iii squamous cell carcinoma of the larynx
703826|NCT00616590|stage III verrucous carcinoma of the larynx|stage iii verrucous carcinoma of the larynx
703827|NCT00616590|stage IV squamous cell carcinoma of the larynx|stage iv squamous cell carcinoma of the larynx
703828|NCT00616590|stage IV verrucous carcinoma of the larynx|stage iv verrucous carcinoma of the larynx
703829|NCT00616590|recurrent adenoid cystic carcinoma of the oral cavity|recurrent adenoid cystic carcinoma of the oral cavity
703830|NCT00616590|recurrent mucoepidermoid carcinoma of the oral cavity|recurrent mucoepidermoid carcinoma of the oral cavity
703831|NCT00616590|recurrent verrucous carcinoma of the oral cavity|recurrent verrucous carcinoma of the oral cavity
703832|NCT00616590|stage I adenoid cystic carcinoma of the oral cavity|stage i adenoid cystic carcinoma of the oral cavity
703833|NCT00616590|stage I mucoepidermoid carcinoma of the oral cavity|stage i mucoepidermoid carcinoma of the oral cavity
703834|NCT00616590|stage I verrucous carcinoma of the oral cavity|stage i verrucous carcinoma of the oral cavity
703835|NCT00616590|stage II adenoid cystic carcinoma of the oral cavity|stage ii adenoid cystic carcinoma of the oral cavity
703836|NCT00616590|stage II mucoepidermoid carcinoma of the oral cavity|stage ii mucoepidermoid carcinoma of the oral cavity
703837|NCT00616590|stage II verrucous carcinoma of the oral cavity|stage ii verrucous carcinoma of the oral cavity
703838|NCT00616590|stage III adenoid cystic carcinoma of the oral cavity|stage iii adenoid cystic carcinoma of the oral cavity
703839|NCT00616590|stage III mucoepidermoid carcinoma of the oral cavity|stage iii mucoepidermoid carcinoma of the oral cavity
703840|NCT00616590|stage III verrucous carcinoma of the oral cavity|stage iii verrucous carcinoma of the oral cavity
703841|NCT00616590|stage IV adenoid cystic carcinoma of the oral cavity|stage iv adenoid cystic carcinoma of the oral cavity
703842|NCT00616590|stage IV mucoepidermoid carcinoma of the oral cavity|stage iv mucoepidermoid carcinoma of the oral cavity
703843|NCT00616590|stage IV verrucous carcinoma of the oral cavity|stage iv verrucous carcinoma of the oral cavity
703844|NCT00616590|stage I squamous cell carcinoma of the lip and oral cavity|stage i squamous cell carcinoma of the lip and oral cavity
703845|NCT00616590|stage II squamous cell carcinoma of the lip and oral cavity|stage ii squamous cell carcinoma of the lip and oral cavity
703846|NCT00616590|stage III squamous cell carcinoma of the lip and oral cavity|stage iii squamous cell carcinoma of the lip and oral cavity
703847|NCT00616590|stage IV squamous cell carcinoma of the lip and oral cavity|stage iv squamous cell carcinoma of the lip and oral cavity
703848|NCT00616590|recurrent basal cell carcinoma of the lip|recurrent basal cell carcinoma of the lip
703849|NCT00616590|recurrent squamous cell carcinoma of the lip and oral cavity|recurrent squamous cell carcinoma of the lip and oral cavity
703850|NCT00616590|stage I basal cell carcinoma of the lip|stage i basal cell carcinoma of the lip
703851|NCT00616590|stage II basal cell carcinoma of the lip|stage ii basal cell carcinoma of the lip
703852|NCT00616590|stage III basal cell carcinoma of the lip|stage iii basal cell carcinoma of the lip
703853|NCT00616590|stage IV basal cell carcinoma of the lip|stage iv basal cell carcinoma of the lip
703854|NCT00616590|metastatic squamous neck cancer with occult primary squamous cell carcinoma|metastatic squamous neck cancer with occult primary squamous cell carcinoma
703855|NCT00616590|recurrent metastatic squamous neck cancer with occult primary|recurrent metastatic squamous neck cancer with occult primary
703856|NCT00616590|recurrent lymphoepithelioma of the nasopharynx|recurrent lymphoepithelioma of the nasopharynx
703857|NCT00616590|recurrent squamous cell carcinoma of the nasopharynx|recurrent squamous cell carcinoma of the nasopharynx
703858|NCT00616590|stage I lymphoepithelioma of the nasopharynx|stage i lymphoepithelioma of the nasopharynx
703859|NCT00616590|stage I squamous cell carcinoma of the nasopharynx|stage i squamous cell carcinoma of the nasopharynx
703860|NCT00616590|stage II lymphoepithelioma of the nasopharynx|stage ii lymphoepithelioma of the nasopharynx
703861|NCT00616590|stage II squamous cell carcinoma of the nasopharynx|stage ii squamous cell carcinoma of the nasopharynx
703862|NCT00616590|stage III lymphoepithelioma of the nasopharynx|stage iii lymphoepithelioma of the nasopharynx
703863|NCT00616590|stage III squamous cell carcinoma of the nasopharynx|stage iii squamous cell carcinoma of the nasopharynx
703864|NCT00616590|stage IV lymphoepithelioma of the nasopharynx|stage iv lymphoepithelioma of the nasopharynx
703865|NCT00616590|stage IV squamous cell carcinoma of the nasopharynx|stage iv squamous cell carcinoma of the nasopharynx
703866|NCT00616590|recurrent lymphoepithelioma of the oropharynx|recurrent lymphoepithelioma of the oropharynx
703867|NCT00616590|recurrent squamous cell carcinoma of the oropharynx|recurrent squamous cell carcinoma of the oropharynx
703868|NCT00616590|stage I lymphoepithelioma of the oropharynx|stage i lymphoepithelioma of the oropharynx
703869|NCT00616590|stage I squamous cell carcinoma of the oropharynx|stage i squamous cell carcinoma of the oropharynx
703870|NCT00616590|stage II lymphoepithelioma of the oropharynx|stage ii lymphoepithelioma of the oropharynx
703871|NCT00616590|stage II squamous cell carcinoma of the oropharynx|stage ii squamous cell carcinoma of the oropharynx
703872|NCT00616590|stage III lymphoepithelioma of the oropharynx|stage iii lymphoepithelioma of the oropharynx
703873|NCT00616590|stage III squamous cell carcinoma of the oropharynx|stage iii squamous cell carcinoma of the oropharynx
703874|NCT00616590|stage IV lymphoepithelioma of the oropharynx|stage iv lymphoepithelioma of the oropharynx
703875|NCT00616590|stage IV squamous cell carcinoma of the oropharynx|stage iv squamous cell carcinoma of the oropharynx
703876|NCT00616590|recurrent esthesioneuroblastoma of the paranasal sinus and nasal cavity|recurrent esthesioneuroblastoma of the paranasal sinus and nasal cavity
703877|NCT00616590|recurrent inverted papilloma of the paranasal sinus and nasal cavity|recurrent inverted papilloma of the paranasal sinus and nasal cavity
703878|NCT00616590|recurrent midline lethal granuloma of the paranasal sinus and nasal cavity|recurrent midline lethal granuloma of the paranasal sinus and nasal cavity
703879|NCT00616590|recurrent squamous cell carcinoma of the paranasal sinus and nasal cavity|recurrent squamous cell carcinoma of the paranasal sinus and nasal cavity
703880|NCT00616590|stage I esthesioneuroblastoma of the paranasal sinus and nasal cavity|stage i esthesioneuroblastoma of the paranasal sinus and nasal cavity
703881|NCT00616590|stage I inverted papilloma of the paranasal sinus and nasal cavity|stage i inverted papilloma of the paranasal sinus and nasal cavity
703882|NCT00616590|stage I midline lethal granuloma of the paranasal sinus and nasal cavity|stage i midline lethal granuloma of the paranasal sinus and nasal cavity
703883|NCT00616590|stage I squamous cell carcinoma of the paranasal sinus and nasal cavity|stage i squamous cell carcinoma of the paranasal sinus and nasal cavity
703884|NCT00616590|stage II esthesioneuroblastoma of the paranasal sinus and nasal cavity|stage ii esthesioneuroblastoma of the paranasal sinus and nasal cavity
703885|NCT00616590|stage II inverted papilloma of the paranasal sinus and nasal cavity|stage ii inverted papilloma of the paranasal sinus and nasal cavity
703886|NCT00616590|stage II midline lethal granuloma of the paranasal sinus and nasal cavity|stage ii midline lethal granuloma of the paranasal sinus and nasal cavity
703887|NCT00616590|stage II squamous cell carcinoma of the paranasal sinus and nasal cavity|stage ii squamous cell carcinoma of the paranasal sinus and nasal cavity
703888|NCT00616590|stage III esthesioneuroblastoma of the paranasal sinus and nasal cavity|stage iii esthesioneuroblastoma of the paranasal sinus and nasal cavity
703889|NCT00616590|stage III inverted papilloma of the paranasal sinus and nasal cavity|stage iii inverted papilloma of the paranasal sinus and nasal cavity
703890|NCT00616590|stage III midline lethal granuloma of the paranasal sinus and nasal cavity|stage iii midline lethal granuloma of the paranasal sinus and nasal cavity
703891|NCT00616590|stage III squamous cell carcinoma of the paranasal sinus and nasal cavity|stage iii squamous cell carcinoma of the paranasal sinus and nasal cavity
703892|NCT00616590|stage IV esthesioneuroblastoma of the paranasal sinus and nasal cavity|stage iv esthesioneuroblastoma of the paranasal sinus and nasal cavity
703893|NCT00616590|stage IV inverted papilloma of the paranasal sinus and nasal cavity|stage iv inverted papilloma of the paranasal sinus and nasal cavity
703894|NCT00616590|stage IV midline lethal granuloma of the paranasal sinus and nasal cavity|stage iv midline lethal granuloma of the paranasal sinus and nasal cavity
703895|NCT00616590|stage IV squamous cell carcinoma of the paranasal sinus and nasal cavity|stage iv squamous cell carcinoma of the paranasal sinus and nasal cavity
703896|NCT00616590|recurrent salivary gland cancer|recurrent salivary gland cancer
703897|NCT00616590|stage I salivary gland cancer|stage i salivary gland cancer
703898|NCT00616590|stage II salivary gland cancer|stage ii salivary gland cancer
703899|NCT00616590|stage III salivary gland cancer|stage iii salivary gland cancer
703900|NCT00616590|stage IV salivary gland cancer|stage iv salivary gland cancer
703901|NCT00616577|Caudal Epidural Ropivacaine|caudal epidural ropivacaine
703902|NCT00616564|GM-CSF|gm-csf
703903|NCT00616564|Interleukin|interleukin
703904|NCT00616564|IL-2|il-2
703905|NCT00616564|Sargrostim|sargrostim
703907|NCT00616538|Atopic|atopic
703908|NCT00616538|Dermatitis|dermatitis
703909|NCT00616538|eczema|eczema
703910|NCT00616538|skin barrier|skin barrier
703911|NCT00616538|ceramide|ceramide
703912|NCT00616538|topical|topical
703913|NCT00616538|inflamation|inflamation
703914|NCT00616538|steroid|steroid
703915|NCT00616538|SCORAD|scorad
703916|NCT00616538|glucocorticoids|glucocorticoids
703917|NCT00616538|EpiCeram|epiceram
703918|NCT00616538|Cutivate|cutivate
703919|NCT00616538|fluticasone|fluticasone
703920|NCT00616512|Water|water
703921|NCT00616512|oral care|oral care
703922|NCT00616512|oral hygiene|oral hygiene
703923|NCT00616512|dysphagia|dysphagia
703924|NCT00616512|thin liquid dysphagia|thin liquid dysphagia
703925|NCT00616512|thickened liquids|thickened liquids
703926|NCT00616499|stage IIIA non-small cell lung cancer|stage iiia non-small cell lung cancer
703927|NCT00616499|adenocarcinoma of the lung|adenocarcinoma of the lung
703928|NCT00616499|bronchoalveolar cell lung cancer|bronchoalveolar cell lung cancer
703929|NCT00616499|large cell lung cancer|large cell lung cancer
703930|NCT00616460|safety|safety
703931|NCT00616460|efficacy|efficacy
703932|NCT00616421|vaccine|vaccine
703933|NCT00616421|children|children
703934|NCT00616421|healthy|healthy
703935|NCT00616421|meningitis|meningitis
703936|NCT00616421|meningococcal|meningococcal
703937|NCT00616421|prevention of meningococcal disease serogroups ACWY|prevention of meningococcal disease serogroups acwy
703938|NCT00616421|Menveo|menveo
703939|NCT00616408|GH|gh
703940|NCT00616408|IGF-I|igf-i
703941|NCT00616408|GH-secreting tumors|gh-secreting tumors
703942|NCT00616408|Octreotide|octreotide
703943|NCT00616395|Infant Nutrition|infant nutrition
703944|NCT00616395|Soy Phytochemicals|soy phytochemicals
703945|NCT00616395|Infant Body Composition|infant body composition
703946|NCT00616395|Brain Function|brain function
703947|NCT00616395|Cognition and Development|cognition and development
703948|NCT00616395|Healthy Infants|healthy infants
703949|NCT00616382|PDA|pda
703950|NCT00616382|indomethacin|indomethacin
703951|NCT00616382|pentoxifylline|pentoxifylline
703952|NCT00616382|Patent Ductus Arteriosus [PDA] resistant to therapy|patent ductus arteriosus [pda] resistant to therapy
703953|NCT00616369|pulmonary hypertension|pulmonary hypertension
703954|NCT00616369|hypertension|hypertension
703955|NCT00616369|cardiomyopathy|cardiomyopathy
703956|NCT00616369|arrhythmias|arrhythmias
703957|NCT00616356|Yellow Fever|yellow fever
703958|NCT00616343|ET|et
703959|NCT00616317|Antiphospholipid Syndrome|antiphospholipid syndrome
703960|NCT00616304|severe falciparum malaria|severe falciparum malaria
703961|NCT00616291|recurrent prostate cancer|recurrent prostate cancer
703962|NCT00616291|stage IV prostate cancer|stage iv prostate cancer
703963|NCT00616278|Growth Failure AND|growth failure and
703964|NCT00616278|Chronic Renal Insufficiency OR|chronic renal insufficiency or
703965|NCT00616278|End Stage Renal Disease|end stage renal disease
703966|NCT00616265|Sleep apnea|sleep apnea
703967|NCT00616265|Refractory Hypertension|refractory hypertension
703968|NCT00616265|Difficult-to-treat hypertension|difficult-to-treat hypertension
703969|NCT00616265|CPAP|cpap
703970|NCT00616252|Antiretroviral|antiretroviral
703971|NCT00616252|Pharmacokinetics|pharmacokinetics
703972|NCT00616252|Pregnancy|pregnancy
703973|NCT00616239|Melasma|melasma
704169|NCT00615420|Honey|honey
703974|NCT00616239|Dark spots on the face|dark spots on the face
703975|NCT00616213|unspecified adult solid tumor, protocol specific|unspecified adult solid tumor, protocol specific
703976|NCT00616200|D-IBS (diarrhea predominant irritable bowel syndrome)|d-ibs (diarrhea predominant irritable bowel syndrome)
703977|NCT00616174|Cesarean delivery|cesarean delivery
703978|NCT00616174|Active Warming|active warming
703979|NCT00616174|Neonatal Temperature|neonatal temperature
703980|NCT00616161|Acute Heart Failure|acute heart failure
703981|NCT00616161|Inotropes|inotropes
703982|NCT00616161|Lusitropic agents|lusitropic agents
703983|NCT00616161|Istaroxime|istaroxime
703984|NCT00616161|PST2744|pst2744
703985|NCT00616148|Epilepsy|epilepsy
703986|NCT00616148|Seizures|seizures
703987|NCT00616135|Breast|breast
703988|NCT00616135|Stem Cell|stem cell
703989|NCT00616135|Adipose Derived Stem Cells|adipose derived stem cells
703990|NCT00616135|Adipose Derived Regenerative Cells|adipose derived regenerative cells
703991|NCT00616135|ADRC|adrc
703992|NCT00616135|Reconstructive Breast Surgery|reconstructive breast surgery
703993|NCT00616135|Breast Reconstruction|breast reconstruction
703994|NCT00616135|Cancer|cancer
703995|NCT00616135|Carcinoma|carcinoma
703996|NCT00616135|Autologous fat transplantation|autologous fat transplantation
703997|NCT00616135|Autologous fat|autologous fat
703998|NCT00616135|Cosmetic breast deformities|cosmetic breast deformities
703999|NCT00616135|Functional breast deformity|functional breast deformity
704000|NCT00616135|Lumpectomy|lumpectomy
704001|NCT00616135|Segmental mastectomy|segmental mastectomy
704002|NCT00616135|Quadrantectomy|quadrantectomy
704003|NCT00616135|breast conservation therapy|breast conservation therapy
704004|NCT00616122|recurrent breast cancer|recurrent breast cancer
704005|NCT00616122|stage IV breast cancer|stage iv breast cancer
704006|NCT00616122|male breast cancer|male breast cancer
704007|NCT00616096|Serum Immunoglobulin E above 5000 kU/l|serum immunoglobulin e above 5000 ku/l
704008|NCT00616083|Breast Feeding|breast feeding
704009|NCT00616083|Body Composition|body composition
704010|NCT00616083|Body Fat|body fat
704011|NCT00616083|Infant|infant
704012|NCT00616083|Diet|diet
704013|NCT00616083|Healthy Infants|healthy infants
704014|NCT00616057|fructans supplementation|fructans supplementation
704015|NCT00616044|Spinal Anesthesia|spinal anesthesia
704016|NCT00616044|Epidural Anesthesia|epidural anesthesia
704017|NCT00616044|Orthopedic procedures|orthopedic procedures
704018|NCT00616031|stage IIIB non-small cell lung cancer|stage iiib non-small cell lung cancer
704019|NCT00616031|stage IV non-small cell lung cancer|stage iv non-small cell lung cancer
704020|NCT00616018|acetaminophen|acetaminophen
704021|NCT00616018|protein adducts|protein adducts
704022|NCT00616018|hepatic function|hepatic function
704023|NCT00616018|drug safety|drug safety
704024|NCT00616018|non drinkers|non drinkers
704025|NCT00616005|Glioblastoma|glioblastoma
704026|NCT00616005|GBM|gbm
704027|NCT00616005|Brain tumor|brain tumor
704028|NCT00616005|Temodar|temodar
704029|NCT00616005|Temozolomide|temozolomide
704030|NCT00616005|Irinotecan|irinotecan
704031|NCT00616005|CPT-11|cpt-11
704032|NCT00616005|Camptosar|camptosar
704033|NCT00616005|Malignant glioma|malignant glioma
704034|NCT00616005|Anaplastic astrocytoma|anaplastic astrocytoma
704035|NCT00616005|Glioblastoma multiforme|glioblastoma multiforme
704036|NCT00615979|trauma|trauma
704037|NCT00615979|portable ultrasound|portable ultrasound
704038|NCT00615979|telemedicine|telemedicine
704039|NCT00615979|Department of Defense|department of defense
704040|NCT00615966|kidney transplantation|kidney transplantation
704041|NCT00615966|ischemia-reperfusion injury|ischemia-reperfusion injury
704042|NCT00615966|phosphatidylserine binding|phosphatidylserine binding
704043|NCT00615940|HER2negative|her2negative
704044|NCT00615927|Glioblastoma|glioblastoma
704045|NCT00615927|Gliosarcoma|gliosarcoma
704046|NCT00615927|glioblastoma multiforme (GBM)|glioblastoma multiforme (gbm)
704047|NCT00615927|GBM|gbm
704048|NCT00615927|Imatinib Mesylate|imatinib mesylate
704049|NCT00615927|Gleevec|gleevec
704050|NCT00615927|Hydroxyurea|hydroxyurea
704051|NCT00615927|Droxia|droxia
704052|NCT00615927|Hydrea|hydrea
704053|NCT00615927|Hydroxycarbamide|hydroxycarbamide
704054|NCT00615927|Imatinib|imatinib
704055|NCT00615927|Brain tumor|brain tumor
704056|NCT00615927|Malignant brain tumor|malignant brain tumor
704057|NCT00615927|Recurrent glioblastoma multiforme|recurrent glioblastoma multiforme
704058|NCT00615927|Progressive glioblastoma multiforme|progressive glioblastoma multiforme
704059|NCT00615901|cyclophosphamide|cyclophosphamide
704060|NCT00615901|methotrexate|methotrexate
704061|NCT00615901|fluorouracil|fluorouracil
704062|NCT00615901|PEG-filgrastim|peg-filgrastim
704063|NCT00615888|elective open repair|elective open repair
704064|NCT00615888|complications|complications
704065|NCT00615888|morbidity and mortality|morbidity and mortality
704066|NCT00615888|fast track patient management|fast track patient management
704067|NCT00615875|naproxen|naproxen
704068|NCT00615875|acute pain|acute pain
704069|NCT00615875|postoperative pain|postoperative pain
704070|NCT00615875|thoracic surgery|thoracic surgery
704071|NCT00615875|head and neck surgery|head and neck surgery
704072|NCT00615875|opiate sparing|opiate sparing
704073|NCT00615862|Sepsis, alcoholism, cortisol, delirium, critical care|sepsis, alcoholism, cortisol, delirium, critical care
704074|NCT00615849|pneumothorax, thoracoscopy, pleurodesis|pneumothorax, thoracoscopy, pleurodesis
704075|NCT00615823|Pulmonary Arterial Hypertension|pulmonary arterial hypertension
704076|NCT00615810|LDL|ldl
704077|NCT00615810|HDL|hdl
704078|NCT00615810|triglycerides|triglycerides
704079|NCT00615810|non HDL cholesterol|non hdl cholesterol
704080|NCT00615810|cholesterol|cholesterol
704081|NCT00615810|HIV 1|hiv 1
704082|NCT00615810|Metabolic parameters|metabolic parameters
704083|NCT00615810|treatment experienced|treatment experienced
704084|NCT00615784|Acute Myeloid Leukemia|acute myeloid leukemia
704085|NCT00615784|AML|aml
704086|NCT00615784|Bexarotene|bexarotene
704087|NCT00615758|Erlotinib|erlotinib
704088|NCT00615758|Biological therapy|biological therapy
704089|NCT00615758|Tyrosin Kinase Inhibitor therapy|tyrosin kinase inhibitor therapy
704090|NCT00615745|Human Immunodeficiency Virus|human immunodeficiency virus
704091|NCT00615745|treatment experienced|treatment experienced
704092|NCT00615732|qigong|qigong
704093|NCT00615732|traditional chinese medicine|traditional chinese medicine
704094|NCT00615732|exercise therapy|exercise therapy
704095|NCT00615732|neck pain|neck pain
704096|NCT00615719|Chest Pain|chest pain
704097|NCT00615719|Coronary Angiography|coronary angiography
704098|NCT00615719|Acute Coronary Syndromes|acute coronary syndromes
704099|NCT00615719|Computed Tomography|computed tomography
704100|NCT00615706|asthma, inhaled corticosteroids|asthma, inhaled corticosteroids
704101|NCT00615693|Uveitis|uveitis
704102|NCT00615693|Macular Edema|macular edema
704103|NCT00615667|Refractory Nephrotic syndrome|refractory nephrotic syndrome
704104|NCT00615667|Tacrolimus|tacrolimus
704105|NCT00615654|Hydrotherapy,|hydrotherapy,
704106|NCT00615654|RCT,|rct,
704107|NCT00615641|Children|children
704108|NCT00615641|Nutrition|nutrition
704109|NCT00615641|Body Fat|body fat
704110|NCT00615641|Physical Activity|physical activity
704111|NCT00615641|Diet|diet
704112|NCT00615641|Childhood Obesity|childhood obesity
704113|NCT00615641|Healthy Children|healthy children
704114|NCT00615628|Inheritance of Osteosarcoma & Paget's Disease through Chromosome 18|inheritance of osteosarcoma & paget's disease through chromosome 18
704115|NCT00615615|Levetiracetam|levetiracetam
704116|NCT00615615|Keppra|keppra
704117|NCT00615602|Early breast cancer|early breast cancer
704118|NCT00615602|Axillary node positive|axillary node positive
704119|NCT00615602|HER2 overexpression|her2 overexpression
704120|NCT00615602|Adjuvant chemotherapy|adjuvant chemotherapy
704121|NCT00615602|Dose dense|dose dense
704122|NCT00615602|Docetaxel|docetaxel
704123|NCT00615602|Trastuzumab|trastuzumab
704124|NCT00615602|FEC|fec
704125|NCT00615589|Stage II/III Multiple Myeloma(within 10 months from diagnosis)|stage ii/iii multiple myeloma(within 10 months from diagnosis)
704126|NCT00615589|high risk|high risk
704127|NCT00615589|relapse|relapse
704128|NCT00615589|persistent|persistent
704129|NCT00615576|Smoker,|smoker,
704130|NCT00615576|Male,|male,
704131|NCT00615576|Chronic Obstructive Lung Disease|chronic obstructive lung disease
704132|NCT00615576|Cystic Fibrosis,|cystic fibrosis,
704133|NCT00615576|Healthy Volunteer,|healthy volunteer,
704134|NCT00615550|Preterm|preterm
704135|NCT00615550|Cervix|cervix
704136|NCT00615537|Thyroid Nodule|thyroid nodule
704137|NCT00615537|Thyroid Cancer|thyroid cancer
704138|NCT00615537|Laser Ablation|laser ablation
704139|NCT00615537|LITT|litt
704140|NCT00615537|Nodular Goiter|nodular goiter
704141|NCT00615537|Thyroid Mass|thyroid mass
704142|NCT00615524|Breast cancer|breast cancer
704143|NCT00615524|Advanced|advanced
704144|NCT00615524|Metastatic|metastatic
704145|NCT00615524|Pazopanib|pazopanib
704146|NCT00615524|GW786034|gw786034
704147|NCT00615524|Exemestane|exemestane
704148|NCT00615524|Efficacy|efficacy
704149|NCT00615524|Tolerability|tolerability
704150|NCT00615524|Health-Related Quality of Life|health-related quality of life
704151|NCT00615511|schizophrenia|schizophrenia
704152|NCT00615511|schizoaffective disorder|schizoaffective disorder
704153|NCT00615511|negative symptoms|negative symptoms
704154|NCT00615511|cognition|cognition
704155|NCT00615498|Asthma, obesity, bariatric|asthma, obesity, bariatric
704156|NCT00615485|Examine the risk of osteoporosis in survivors of solid pediatric cancers|examine the risk of osteoporosis in survivors of solid pediatric cancers
704157|NCT00615472|Parkinson's Disease|parkinson's disease
704158|NCT00615472|Deep brain stimulation (DBS)|deep brain stimulation (dbs)
704159|NCT00615472|Subthalamic Nucleus|subthalamic nucleus
704160|NCT00615472|Total Intravenous Anesthesia|total intravenous anesthesia
704161|NCT00615472|Inhalational Anesthesia|inhalational anesthesia
704162|NCT00615459|Chronic obstructive pulmonary disease, indacaterol, tiotropium, placebo controlled|chronic obstructive pulmonary disease, indacaterol, tiotropium, placebo controlled
704163|NCT00615446|solid tumor malignancy, SU011248, sunitinib, neoplasms|solid tumor malignancy, su011248, sunitinib, neoplasms
704164|NCT00615433|Schizophrenia|schizophrenia
704166|NCT00615433|Lurasidone|lurasidone
704167|NCT00615420|Mucositis|mucositis
704168|NCT00615420|Radiation|radiation
704170|NCT00615407|Asthma, alcohol|asthma, alcohol
704171|NCT00615394|cardiomyopathy, stem cell, cardiac failure|cardiomyopathy, stem cell, cardiac failure
704172|NCT00615381|Intracranial Aneurysm, Unruptured|intracranial aneurysm, unruptured
704173|NCT00615381|Craniotomy|craniotomy
704174|NCT00615381|Insulin|insulin
704175|NCT00615381|Neuropsychology|neuropsychology
704176|NCT00615368|Type 1 diabetes|type 1 diabetes
704177|NCT00615368|Hypoglycaemia|hypoglycaemia
704178|NCT00615368|Cognitive function|cognitive function
704179|NCT00615368|Erythropoietin|erythropoietin
704180|NCT00615355|vitiligo|vitiligo
704181|NCT00615355|narrow-band UVB|narrow-band uvb
704182|NCT00615355|ReCell|recell
704183|NCT00615355|transplantation|transplantation
704184|NCT00615355|laser|laser
710609|NCT00588588|Intensive Care|intensive care
704185|NCT00615329|Create tumor specific gene profiles to improve diagnostic accuracy|create tumor specific gene profiles to improve diagnostic accuracy
704186|NCT00615329|Perform gene set validation for diagnostic predictive power|perform gene set validation for diagnostic predictive power
704187|NCT00615329|Define deviant gene list implicated in pathogenesis|define deviant gene list implicated in pathogenesis
704188|NCT00615303|Bowel preparation, colonoscopy, simethicone, air bubble|bowel preparation, colonoscopy, simethicone, air bubble
704189|NCT00615277|Young adults|young adults
704190|NCT00615277|Long-chain polyunsaturated fatty acids|long-chain polyunsaturated fatty acids
704191|NCT00615277|Cognitive function|cognitive function
704192|NCT00615277|Mood|mood
704193|NCT00615277|Supply with omega-3 fatty acids|supply with omega-3 fatty acids
704194|NCT00615251|In vitro fertilization|in vitro fertilization
704195|NCT00615238|overweight, physical activity, body composition, metabolic syndrome|overweight, physical activity, body composition, metabolic syndrome
704196|NCT00615225|brain death|brain death
704197|NCT00615225|inflammation|inflammation
704198|NCT00615225|endotoxin|endotoxin
704199|NCT00615225|transplantation|transplantation
704200|NCT00615225|graft|graft
704201|NCT00615225|apoptosis|apoptosis
704202|NCT00615225|Systemic inflammatory response|systemic inflammatory response
704203|NCT00615225|Apoptosis activation|apoptosis activation
704204|NCT00615225|Graft outcome|graft outcome
704205|NCT00615212|Healthy Subjects,|healthy subjects,
704206|NCT00615212|Cytochrome P450 isoenzymes,|cytochrome p450 isoenzymes,
704207|NCT00615212|Repeat Dose|repeat dose
704208|NCT00615212|GSK376501,|gsk376501,
704209|NCT00615186|Neuradiab|neuradiab
704210|NCT00615186|Locoregional glioblastoma multiforme disease|locoregional glioblastoma multiforme disease
704211|NCT00615186|Anti-tenascin|anti-tenascin
704212|NCT00615186|Radiolabeled antibody therapy|radiolabeled antibody therapy
704213|NCT00615186|Survival|survival
704214|NCT00615173|Tacrolimus|tacrolimus
704215|NCT00615173|lupus nephritis|lupus nephritis
704216|NCT00615160|Metastatic melanoma|metastatic melanoma
704217|NCT00615160|anti angiogenetic treatment|anti angiogenetic treatment
704218|NCT00615147|Any cancer|any cancer
704219|NCT00615147|suspected pulmonary embolism|suspected pulmonary embolism
704220|NCT00615134|treatment experienced|treatment experienced
704221|NCT00615121|Smoking|smoking
704222|NCT00615121|Hypertension|hypertension
704223|NCT00615121|Diabetes|diabetes
704224|NCT00615121|Cardiovascular disease|cardiovascular disease
704225|NCT00615121|Renal Failure|renal failure
704226|NCT00615043|Transurethral resection of bladder tumor|transurethral resection of bladder tumor
704227|NCT00615043|TURBT|turbt
704228|NCT00615030|COPD, bronchodilator, long acting beta agonist, LABA|copd, bronchodilator, long acting beta agonist, laba
704229|NCT00615017|Sepsis|sepsis
704230|NCT00615017|septic shock|septic shock
704231|NCT00615017|Systemic Inflammatory Response Syndrome|systemic inflammatory response syndrome
704232|NCT00615004|Acromegaly|acromegaly
704233|NCT00615004|GH|gh
704234|NCT00615004|IGF-I|igf-i
704235|NCT00615004|Octreotide-LAR|octreotide-lar
704236|NCT00615004|Lanreotide|lanreotide
704237|NCT00615004|Transsphenoidal surgery|transsphenoidal surgery
704238|NCT00614991|Healthy Subjects|healthy subjects
704239|NCT00614991|Pharmacokinetics study|pharmacokinetics study
704240|NCT00614991|Pharmacokinetics of medications|pharmacokinetics of medications
704241|NCT00614978|HER-2 positive; brain metastases|her-2 positive; brain metastases
704242|NCT00614965|Cancer|cancer
704243|NCT00614965|NSCLC|nsclc
704244|NCT00614965|second-line chemotherapy|second-line chemotherapy
704245|NCT00614965|irinotecan|irinotecan
704246|NCT00614965|pemetrexed|pemetrexed
704247|NCT00614939|DPP-4 inhibitors|dpp-4 inhibitors
704248|NCT00614939|HbA1c|hba1c
704249|NCT00614939|incretins|incretins
704250|NCT00614939|Renal Impairment|renal impairment
704251|NCT00614926|Fatigue|fatigue
704252|NCT00614926|low energy|low energy
704253|NCT00614926|ALS|als
704254|NCT00614926|treatment|treatment
704255|NCT00614913|Proton|proton
704256|NCT00614913|Radiotherapy|radiotherapy
704257|NCT00614913|Hepatocellular carcinoma|hepatocellular carcinoma
704258|NCT00614913|Liver Cancer|liver cancer
704259|NCT00614900|COPD|copd
704260|NCT00614900|pulmonary hypertension|pulmonary hypertension
704261|NCT00614900|NT-proBNP|nt-probnp
704262|NCT00614900|6 minutes walk test|6 minutes walk test
704263|NCT00614887|Subarachnoid hemorrhage|subarachnoid hemorrhage
704264|NCT00614887|Pituitary gland|pituitary gland
704464|NCT00613886|NPH|nph
704265|NCT00614887|Adrenal gland|adrenal gland
704266|NCT00614874|Asthma|asthma
704267|NCT00614874|Avandia|avandia
704268|NCT00614861|Non-cancer pain|non-cancer pain
704269|NCT00614861|Pain|pain
704270|NCT00614848|restenosis|restenosis
704271|NCT00614835|Gemcitabine|gemcitabine
704272|NCT00614835|Docetaxel|docetaxel
704273|NCT00614835|uterine sarcoma|uterine sarcoma
704274|NCT00614809|gefitinib|gefitinib
704275|NCT00614809|brain metastasis|brain metastasis
704276|NCT00614796|COPD|copd
704277|NCT00614796|Lifestyle|lifestyle
704278|NCT00614796|Pedometer|pedometer
704279|NCT00614783|Screening|screening
704280|NCT00614770|colonoscopy|colonoscopy
704281|NCT00614744|NICHD Neonatal Research Network|nichd neonatal research network
704282|NCT00614744|Hypoxic-ischemic encephalopathy (HIE)|hypoxic-ischemic encephalopathy (hie)
704283|NCT00614744|Hypothermia|hypothermia
704284|NCT00614744|Neonatal depression|neonatal depression
704285|NCT00614744|Perinatal asphyxia|perinatal asphyxia
704286|NCT00614731|Keyhole Limpet Hemocyanin|keyhole limpet hemocyanin
704287|NCT00614731|KLH|klh
704288|NCT00614731|atopic dermatitis|atopic dermatitis
704289|NCT00614731|IgG antibodies|igg antibodies
704290|NCT00614731|scarification|scarification
704291|NCT00614718|Implantable cardioverter defibrillator|implantable cardioverter defibrillator
704292|NCT00614718|lead failure|lead failure
704293|NCT00614718|pace/sense lead|pace/sense lead
704294|NCT00614718|ICD complication|icd complication
704295|NCT00614718|inappropriate therapy|inappropriate therapy
704296|NCT00614718|Defibrillators|defibrillators
704297|NCT00614679|biofilm|biofilm
704298|NCT00614679|catheter lock solution|catheter lock solution
704299|NCT00614679|catheter salvage|catheter salvage
704300|NCT00614666|coccidioidomycosis|coccidioidomycosis
704301|NCT00614666|Valley Fever|valley fever
704302|NCT00614666|nikkomycin Z|nikkomycin z
704303|NCT00614653|Pancreatic Cancer|pancreatic cancer
704304|NCT00614653|Bevacizumab|bevacizumab
704305|NCT00614653|Avastin™|avastin™
704306|NCT00614653|Anti-VEGF monoclonal antibody|anti-vegf monoclonal antibody
704307|NCT00614653|rhuMAb-VEGF|rhumab-vegf
704308|NCT00614653|Erlotinib|erlotinib
704309|NCT00614653|Erlotinib Hydrochloride|erlotinib hydrochloride
704310|NCT00614653|Tarceva|tarceva
704311|NCT00614653|OSI-774|osi-774
704312|NCT00614653|Capecitabine|capecitabine
704313|NCT00614653|Xeloda|xeloda
704314|NCT00614640|HAART|haart
704315|NCT00614640|Therapeutic vaccine|therapeutic vaccine
704316|NCT00614614|Meningococcal disease|meningococcal disease
704317|NCT00614614|Toddlers|toddlers
704318|NCT00614614|Neisseria meningitidis|neisseria meningitidis
704319|NCT00614614|Meningococcal vaccines|meningococcal vaccines
704320|NCT00614614|Immunogenicity|immunogenicity
704321|NCT00614614|Human serum bactericidal assay|human serum bactericidal assay
704322|NCT00614614|Safety|safety
704323|NCT00614614|Vaccines, conjugate|vaccines, conjugate
704324|NCT00614614|Booster vaccination|booster vaccination
704325|NCT00614601|pancreatic cancer|pancreatic cancer
704326|NCT00614601|vaccine therapy|vaccine therapy
704327|NCT00614588|temperature|temperature
704328|NCT00614588|monitor|monitor
704329|NCT00614588|surgery|surgery
704330|NCT00614562|critical associated illness polyneuropathy or polymyopathy (CIP/M)|critical associated illness polyneuropathy or polymyopathy (cip/m)
704331|NCT00614549|Levetiracetam|levetiracetam
704332|NCT00614549|Keppra|keppra
704333|NCT00614549|Epilepsy|epilepsy
704334|NCT00614549|Efficacy|efficacy
704335|NCT00614549|Safety|safety
704336|NCT00614536|Reflux Symptom Index|reflux symptom index
704337|NCT00614536|Reflux Finding Score|reflux finding score
704338|NCT00614536|Rabeprazole|rabeprazole
704339|NCT00614536|LaryngoPharyngeal Reflux Disease|laryngopharyngeal reflux disease
704340|NCT00614536|GastroEsophageal Reflux Disease|gastroesophageal reflux disease
704341|NCT00614523|MDS|mds
704342|NCT00614523|Low Risk MDS|low risk mds
704343|NCT00614523|Intermediate-1 Risk MDS|intermediate-1 risk mds
704344|NCT00614523|Thrombocytopenia|thrombocytopenia
704345|NCT00614484|Proton|proton
704346|NCT00614484|Radiation|radiation
704347|NCT00614458|latent HIV|latent hiv
704348|NCT00614458|resting CD4+ T cell|resting cd4+ t cell
704349|NCT00614458|valproic acid (VPA)|valproic acid (vpa)
704350|NCT00614458|Raltegravir (MK-0518) intensification|raltegravir (mk-0518) intensification
704351|NCT00614458|HIV replication|hiv replication
704352|NCT00614458|treatment experienced|treatment experienced
704353|NCT00614445|Nausea|nausea
704354|NCT00614445|Vomiting|vomiting
704355|NCT00614445|Pregnancy|pregnancy
704356|NCT00614445|Hyperemesis gravidarum|hyperemesis gravidarum
704357|NCT00614445|Pregnancy complications|pregnancy complications
704358|NCT00614432|anticoagulation|anticoagulation
704359|NCT00614432|surgical abortion|surgical abortion
704360|NCT00614419|Hernioplasty|hernioplasty
704361|NCT00614419|polypropylene|polypropylene
704362|NCT00614419|extracellular matrix|extracellular matrix
704363|NCT00614419|xenograft|xenograft
704364|NCT00614406|Celebrex|celebrex
704365|NCT00614406|prostaglandin inhibitor|prostaglandin inhibitor
704366|NCT00614406|ovulation|ovulation
704367|NCT00614406|menstrual cycles|menstrual cycles
704368|NCT00614367|chromosomal abnormalities in single cells|chromosomal abnormalities in single cells
704369|NCT00614354|99mTc-glucarate imaging to detect acute coronary syndrome|99mtc-glucarate imaging to detect acute coronary syndrome
704370|NCT00614341|diabetes mellitus|diabetes mellitus
704371|NCT00614341|neuropathy|neuropathy
704372|NCT00614341|distal symmetric polyneuropathy|distal symmetric polyneuropathy
704373|NCT00614341|pulsed electric fild|pulsed electric fild
704374|NCT00614328|Alcohol|alcohol
704375|NCT00614328|Alcohol Abuse|alcohol abuse
704376|NCT00614328|Alcohol Drinking|alcohol drinking
710610|NCT00588588|Antibiotics|antibiotics
890511|NCT00018070|AMD|amd
704377|NCT00614289|Mild to Moderate Hand Dermatitis|mild to moderate hand dermatitis
704378|NCT00614289|Hand Eczema|hand eczema
704379|NCT00614276|Sexual Dysfunction|sexual dysfunction
704380|NCT00614276|Cancer-related Sexual Dysfunction|cancer-related sexual dysfunction
704381|NCT00614276|Female Cancer Survivors|female cancer survivors
704382|NCT00614276|Tendrils|tendrils
704383|NCT00614276|Website program|website program
704384|NCT00614276|Self-help tool|self-help tool
704385|NCT00614276|Sexual counseling|sexual counseling
704386|NCT00614276|Questionnaires|questionnaires
704387|NCT00614263|Colonoscopy|colonoscopy
704388|NCT00614263|Sedation levels|sedation levels
704389|NCT00614250|Obstructive sleep apnea|obstructive sleep apnea
704390|NCT00614211|Cervix|cervix
704391|NCT00614211|Cervical|cervical
704392|NCT00614211|Cancer|cancer
704393|NCT00614211|Carcinoma|carcinoma
704394|NCT00614211|Radical hysterectomy|radical hysterectomy
704395|NCT00614211|Hysterectomy|hysterectomy
704396|NCT00614211|Laparoscopy|laparoscopy
704397|NCT00614211|Laparoscopic|laparoscopic
704398|NCT00614211|Robotic|robotic
704399|NCT00614211|Squamous Cell|squamous cell
704400|NCT00614211|Adenosquamous|adenosquamous
704401|NCT00614211|Adenocarcinoma|adenocarcinoma
704402|NCT00614211|Lymphatic Mapping|lymphatic mapping
704403|NCT00614211|IOLM|iolm
704404|NCT00614211|SPECT|spect
704405|NCT00614211|Sentinel Node|sentinel node
704406|NCT00614211|Uterine cervix|uterine cervix
704407|NCT00614198|autism|autism
704408|NCT00614198|autism spectrum disorder|autism spectrum disorder
704409|NCT00614198|diet|diet
704410|NCT00614198|gluten|gluten
704411|NCT00614198|casein|casein
704412|NCT00614198|intervention|intervention
704413|NCT00614198|peptide|peptide
704414|NCT00614198|randomised|randomised
704415|NCT00614198|controlled|controlled
704416|NCT00614198|adaptive design|adaptive design
704417|NCT00614198|Autism Diagnostic Observation Schedule (ADOS)|autism diagnostic observation schedule (ados)
704418|NCT00614198|Gilliam Autism Rating Scale (GARS)|gilliam autism rating scale (gars)
704419|NCT00614198|Vineland Adaptive Behaviour Scale (VABS)|vineland adaptive behaviour scale (vabs)
704420|NCT00614198|Attention-Deficit Hyperactivity Disorder (ADHD)-IV Scale|attention-deficit hyperactivity disorder (adhd)-iv scale
704421|NCT00614172|Proton|proton
704422|NCT00614172|Radiation|radiation
704423|NCT00614172|Breast cancer|breast cancer
704424|NCT00614159|Child age 1-10 years having a GI Endoscopy with sedation|child age 1-10 years having a gi endoscopy with sedation
704425|NCT00614146|liver failure, albumin dialysis, liver support|liver failure, albumin dialysis, liver support
704426|NCT00614133|protein metabolism|protein metabolism
704427|NCT00614133|surgery|surgery
704428|NCT00614133|parenteral nutrition|parenteral nutrition
704429|NCT00614107|Atrial Fibrillation post open heart surgery|atrial fibrillation post open heart surgery
704430|NCT00614094|placenta, hypoglycemia|placenta, hypoglycemia
704431|NCT00614081|Glomerular filtration rate measurement|glomerular filtration rate measurement
704432|NCT00614081|Contrast-enhanced dynamic MR imaging|contrast-enhanced dynamic mr imaging
704433|NCT00614081|Renal transplant recipients|renal transplant recipients
704434|NCT00614068|Treatment|treatment
704435|NCT00614068|PTSD|ptsd
704436|NCT00614042|CLL|cll
704437|NCT00614042|NHL|nhl
704438|NCT00614042|TRU-016|tru-016
704439|NCT00614042|chronic lymphocytic leukemia|chronic lymphocytic leukemia
704440|NCT00614042|non-Hodgkin's lymphoma|non-hodgkin's lymphoma
704441|NCT00614029|sumatriptan|sumatriptan
704442|NCT00614029|Injections|injections
704443|NCT00614029|Subcutaneous|subcutaneous
704444|NCT00614016|healthy volunteers|healthy volunteers
704445|NCT00614003|decisional conflict;|decisional conflict;
704446|NCT00614003|decision quality;|decision quality;
704447|NCT00614003|place of end of life care;|place of end of life care;
704448|NCT00614003|provider education|provider education
704449|NCT00613977|fetal lung maturity|fetal lung maturity
704450|NCT00613977|lamellar body count|lamellar body count
704451|NCT00613964|Natriuretic Peptides|natriuretic peptides
704452|NCT00613964|Heart Failure|heart failure
704453|NCT00613964|Renal Failure|renal failure
704454|NCT00613938|Acute pain|acute pain
704455|NCT00613938|bunionectomy|bunionectomy
704456|NCT00613938|tapentadol|tapentadol
704457|NCT00613925|endometrial biopsy|endometrial biopsy
704458|NCT00613925|pain management|pain management
704459|NCT00613912|Magnetic Resonance Imaging, Magnetic Resonance Spectroscopy, Perfusion, brain|magnetic resonance imaging, magnetic resonance spectroscopy, perfusion, brain
704460|NCT00613899|home care|home care
704461|NCT00613899|home rehabilitation|home rehabilitation
704462|NCT00613899|telemedicine|telemedicine
704463|NCT00613899|ALS|als
704465|NCT00613886|Normal Pressure Hydrocephalus|normal pressure hydrocephalus
704466|NCT00613873|colonoscopy|colonoscopy
704467|NCT00613860|Endoscopic lung volume reduction, heterogeneous emphysema, interventional bronchoscopy|endoscopic lung volume reduction, heterogeneous emphysema, interventional bronchoscopy
704468|NCT00613847|PET Scan|pet scan
704469|NCT00613847|Invasive Solid Tumors|invasive solid tumors
704470|NCT00613834|Essure sterilization|essure sterilization
704471|NCT00613834|pain management|pain management
704472|NCT00613834|intrauterine lidocaine infusion|intrauterine lidocaine infusion
704473|NCT00613821|surgical abortion|surgical abortion
704474|NCT00613821|pain management|pain management
704475|NCT00613808|venous|venous
704476|NCT00613808|leg|leg
704477|NCT00613808|ulcer|ulcer
704478|NCT00613795|pneumonia|pneumonia
704479|NCT00613795|ventilator associated pneumonia|ventilator associated pneumonia
704480|NCT00613795|probiotics|probiotics
704481|NCT00613795|Lactobacillus GG|lactobacillus gg
704482|NCT00613769|Surgical site infections|surgical site infections
704483|NCT00613717|iron deficiency anemia|iron deficiency anemia
704484|NCT00613717|iron deficiency|iron deficiency
704485|NCT00613717|infant|infant
704486|NCT00613717|development|development
704487|NCT00613717|behavior|behavior
704488|NCT00613691|Refractory|refractory
704489|NCT00613691|Progressive|progressive
704490|NCT00613678|pain|pain
704491|NCT00613678|activities of daily living|activities of daily living
704492|NCT00613678|symptoms|symptoms
704493|NCT00613678|self-management|self-management
704494|NCT00613652|solid tumors|solid tumors
704495|NCT00613652|solid malignancies|solid malignancies
704496|NCT00613626|Extensive Stage|extensive stage
704497|NCT00613626|Untreated|untreated
704498|NCT00613600|Safety|safety
704499|NCT00613600|Efficacy|efficacy
704500|NCT00613600|Glucomannan|glucomannan
704501|NCT00613600|Dietary fiber|dietary fiber
704502|NCT00613600|Weight loss|weight loss
704503|NCT00613587|Interleukin 13|interleukin 13
704504|NCT00613587|Interleukin 4|interleukin 4
704505|NCT00613587|Leukotrienes|leukotrienes
704506|NCT00613587|Basophil Histamine Release|basophil histamine release
704507|NCT00613561|Patients with the Severe Immunodeficiency diseases|patients with the severe immunodeficiency diseases
704508|NCT00613561|Severe Immunodeficiency diseases|severe immunodeficiency diseases
704509|NCT00613548|Moderate|moderate
704510|NCT00613548|Mitral|mitral
704511|NCT00613548|Regurgitation|regurgitation
704512|NCT00613548|CABG|cabg
704513|NCT00613535|Partial Meniscectomy|partial meniscectomy
704514|NCT00613535|Partial Thickness Knee Tear|partial thickness knee tear
704515|NCT00613535|MR Imaging|mr imaging
704516|NCT00613535|Mechanical Debridement|mechanical debridement
704517|NCT00613535|Crepitus|crepitus
704518|NCT00613535|Stability|stability
704519|NCT00613535|Coblation|coblation
704520|NCT00613535|Bipolar Radiofrequency|bipolar radiofrequency
704521|NCT00613535|Debridement|debridement
704522|NCT00613535|Recurrent Knee Pain|recurrent knee pain
704523|NCT00613535|meniscectomy|meniscectomy
704524|NCT00613535|meniscus|meniscus
704525|NCT00613535|cartilage lesion|cartilage lesion
704526|NCT00613535|articular cartilage lesion|articular cartilage lesion
704527|NCT00613535|articular cartilage|articular cartilage
704528|NCT00613535|knee|knee
704529|NCT00613522|Sleep apnea, Berlin, Stroke|sleep apnea, berlin, stroke
704530|NCT00613509|Melanoma, Cancer|melanoma, cancer
704531|NCT00613496|Atrial Fibrillation|atrial fibrillation
704532|NCT00613496|irbesartan|irbesartan
704533|NCT00613496|AT-II-antagonist|at-ii-antagonist
704534|NCT00613496|Adhesion Molecules|adhesion molecules
704535|NCT00613496|oxidative stress markers|oxidative stress markers
704536|NCT00613496|hsCRP|hscrp
704537|NCT00613496|ICAM|icam
704538|NCT00613496|VCAM|vcam
704539|NCT00613496|MCP-1|mcp-1
704540|NCT00613496|vWF|vwf
704541|NCT00613496|TGFβ1|tgfβ1
704542|NCT00613496|TNF-α|tnf-α
704543|NCT00613496|Interleukin-6|interleukin-6
704544|NCT00613496|8isoProstaglandinF2α|8isoprostaglandinf2α
704545|NCT00613470|Depression|depression
704546|NCT00613470|Antidepressants|antidepressants
704547|NCT00613444|Acne|acne
704548|NCT00613444|laser|laser
704549|NCT00613431|pharmacodynamics|pharmacodynamics
704550|NCT00613405|substance-related disorders|substance-related disorders
704551|NCT00613392|antioxidant|antioxidant
704552|NCT00613392|oxidant stress|oxidant stress
704553|NCT00613392|trauma|trauma
704554|NCT00613392|free radical|free radical
704555|NCT00613379|HIV|hiv
704556|NCT00613379|treatment naïve|treatment naïve
704557|NCT00613366|intrauterine device|intrauterine device
704558|NCT00613366|cervical dilation|cervical dilation
704559|NCT00613366|nulliparous women|nulliparous women
704560|NCT00613366|pain management|pain management
704561|NCT00613353|Female|female
704562|NCT00613340|Cervical pain|cervical pain
704563|NCT00613340|Zygapophysial joint|zygapophysial joint
704564|NCT00613340|Specificity|specificity
704565|NCT00613327|Overactive bladder|overactive bladder
704566|NCT00613327|Oxybutynin chloride|oxybutynin chloride
704567|NCT00613327|OROS|oros
704568|NCT00613288|acute|acute
704569|NCT00613288|testosterone|testosterone
704570|NCT00613288|experimental|experimental
704571|NCT00613288|hypogonadism|hypogonadism
704572|NCT00613288|lipolysis|lipolysis
704573|NCT00613288|insulin sensitivity|insulin sensitivity
704574|NCT00613288|protein|protein
704575|NCT00613288|metabolism|metabolism
704576|NCT00613288|Experimental hypogonadism|experimental hypogonadism
704577|NCT00613288|Testosterone substitution|testosterone substitution
704578|NCT00613275|PNRP|pnrp
704579|NCT00613275|Navigation|navigation
704580|NCT00613275|Navigator|navigator
704581|NCT00613275|Activation|activation
704582|NCT00613275|Disparities|disparities
704583|NCT00613275|Primary Care|primary care
704584|NCT00613275|Racial and Ethnic Minorities|racial and ethnic minorities
704585|NCT00613262|Narrow Band Imaging|narrow band imaging
704586|NCT00613249|HIV-1 Infection|hiv-1 infection
704587|NCT00613249|HIV Seronegativity|hiv seronegativity
704588|NCT00613223|Malignant Gliomas|malignant gliomas
704589|NCT00613223|Etopophos|etopophos
704590|NCT00613223|Toposar|toposar
704591|NCT00613223|VePesid|vepesid
704592|NCT00613223|Etoposide|etoposide
704593|NCT00613223|Vandetanib|vandetanib
704594|NCT00613223|Zactima|zactima
704595|NCT00613223|ZD6474|zd6474
704596|NCT00613223|VP-16|vp-16
704597|NCT00613223|Brain Tumor|brain tumor
704598|NCT00613223|Recurring Malignant Brain Tumor|recurring malignant brain tumor
704599|NCT00613223|Gliosarcoma|gliosarcoma
704600|NCT00613223|Glioblastoma|glioblastoma
704601|NCT00613223|Glioma|glioma
704602|NCT00613223|Malignant Glioma|malignant glioma
704603|NCT00613223|GBM|gbm
704604|NCT00613210|preterm delivery|preterm delivery
704605|NCT00613210|shory cervix|shory cervix
704606|NCT00613210|amniotic fluid sludge|amniotic fluid sludge
704607|NCT00613210|uterine artery doppler|uterine artery doppler
704608|NCT00613210|singeltone|singeltone
704609|NCT00613210|normal amniotic fluid index|normal amniotic fluid index
704610|NCT00613210|without rupter of membranes|without rupter of membranes
704611|NCT00613210|24-34 weeks of gestation|24-34 weeks of gestation
704612|NCT00613197|Crohn's Disease|crohn's disease
704613|NCT00613184|Respiratory Syncytial virus|respiratory syncytial virus
704614|NCT00613184|Bronchiolitis|bronchiolitis
704615|NCT00613184|Pediatric|pediatric
704616|NCT00613171|Systemic sclerosis, scleroderma, fibrosis, STI571, imatinib|systemic sclerosis, scleroderma, fibrosis, sti571, imatinib
704617|NCT00613158|Subclincal Atherosclerosis|subclincal atherosclerosis
704618|NCT00613145|Refractory Malignancy|refractory malignancy
704619|NCT00613145|Phase I|phase i
704620|NCT00613145|Sorafenib|sorafenib
704621|NCT00613145|Capecitabine|capecitabine
704622|NCT00613132|Glioblastoma|glioblastoma
704623|NCT00613132|Gliosarcoma|gliosarcoma
704624|NCT00613132|GBM|gbm
704625|NCT00613132|Brain tumor|brain tumor
704626|NCT00613132|RAD0001|rad0001
704627|NCT00613132|Hydroxyurea|hydroxyurea
704628|NCT00613132|Gleevec|gleevec
704629|NCT00613132|Imatinib|imatinib
704630|NCT00613132|Droxia|droxia
704631|NCT00613132|Everolimus|everolimus
704632|NCT00613132|Hydrea|hydrea
704633|NCT00613132|Hydroxycarbamide|hydroxycarbamide
704634|NCT00613132|Recurrent GBM|recurrent gbm
704635|NCT00613132|Imatinib mesylate|imatinib mesylate
704636|NCT00613132|Glioblastoma multiforme|glioblastoma multiforme
704637|NCT00613119|Inflammation|inflammation
704638|NCT00613119|Frontotemporal Dementia|frontotemporal dementia
704639|NCT00613119|Dementia|dementia
704640|NCT00613119|PBR28|pbr28
704641|NCT00613119|PET Imaging|pet imaging
704642|NCT00613093|Temodar|temodar
704643|NCT00613093|Temozolomide|temozolomide
704644|NCT00613093|O6-BG|o6-bg
704645|NCT00613093|O6-Benzylguanine|o6-benzylguanine
704646|NCT00613093|NSC 637037|nsc 637037
704647|NCT00613093|Temodar-Resistant Malignant Glioma|temodar-resistant malignant glioma
704648|NCT00613093|Brain tumor|brain tumor
704649|NCT00613093|CNS tumor|cns tumor
704650|NCT00613093|Cerebral glioblastoma|cerebral glioblastoma
704651|NCT00613093|Anaplastic astrocytomas|anaplastic astrocytomas
704652|NCT00613093|Glioma|glioma
704653|NCT00613080|stage III rectal cancer|stage iii rectal cancer
704654|NCT00613080|adenocarcinoma of the rectum|adenocarcinoma of the rectum
704655|NCT00613067|Generalized anxiety disorder|generalized anxiety disorder
704656|NCT00613067|N100|n100
704657|NCT00613067|Central serotonergic activity|central serotonergic activity
704658|NCT00613054|GBM|gbm
704659|NCT00613054|Brain tumor|brain tumor
704660|NCT00613054|Zactima|zactima
704661|NCT00613054|Gleevec|gleevec
704662|NCT00613054|Hydroxyurea|hydroxyurea
704663|NCT00613054|Glioblastoma|glioblastoma
704664|NCT00613054|Gliosarcoma|gliosarcoma
704665|NCT00613054|Recurrent malignant glioma|recurrent malignant glioma
704667|NCT00613054|Malignant glioma|malignant glioma
704668|NCT00613054|Imatinib|imatinib
704669|NCT00613054|Droxia|droxia
704670|NCT00613054|Hydrea|hydrea
704671|NCT00613054|Hydroxycarbamide|hydroxycarbamide
704672|NCT00613054|Vandetanib|vandetanib
704673|NCT00613028|Glioblastoma|glioblastoma
704674|NCT00613028|Gliosarcoma|gliosarcoma
704675|NCT00613028|GBM|gbm
704676|NCT00613028|Bevacizumab|bevacizumab
704677|NCT00613028|Avastin|avastin
704678|NCT00613028|Etoposide|etoposide
704679|NCT00613028|Brain tumor|brain tumor
704680|NCT00613028|Irinotecan|irinotecan
704681|NCT00613028|Glioblastoma multiforme|glioblastoma multiforme
704682|NCT00613028|Temodar|temodar
704683|NCT00613028|Temozolomide|temozolomide
890894|NCT00014976|EMG|emg
704684|NCT00613028|Etopophos|etopophos
704685|NCT00613028|Toposar|toposar
704686|NCT00613028|VePesid|vepesid
704687|NCT00613028|VP-16|vp-16
704688|NCT00613028|Camptosar|camptosar
704689|NCT00613015|Cocaine Addiction|cocaine addiction
704690|NCT00613015|Cocaine Dependence|cocaine dependence
704691|NCT00613002|hypoactive sexual desire disorder|hypoactive sexual desire disorder
704692|NCT00613002|testosterone|testosterone
704693|NCT00613002|menopause|menopause
704694|NCT00612989|Glioblastoma|glioblastoma
704695|NCT00612989|Gliosarcoma|gliosarcoma
704696|NCT00612989|GBM|gbm
704697|NCT00612989|Temodar|temodar
704698|NCT00612989|Temozolomide|temozolomide
704699|NCT00612989|O6-BG|o6-bg
704700|NCT00612989|O6-Benzylguanine|o6-benzylguanine
704701|NCT00612989|Recurrent GBM|recurrent gbm
704702|NCT00612989|Progressive GBM|progressive gbm
704703|NCT00612989|Brain tumor|brain tumor
704704|NCT00612989|Malignant glioma|malignant glioma
704705|NCT00612989|Neulasta|neulasta
704706|NCT00612989|Pegfilgrastim|pegfilgrastim
704707|NCT00612976|treatment of COPD|treatment of copd
704708|NCT00612976|documentation of relevant data|documentation of relevant data
704709|NCT00612976|related to the budesonide/formoterole therapy in patients with COPD.|related to the budesonide/formoterole therapy in patients with copd.
704710|NCT00612963|Candidiasis, Oral|candidiasis, oral
704711|NCT00612963|Thrush|thrush
704712|NCT00612963|Candidiasis|candidiasis
704713|NCT00612937|Group B Streptococci|group b streptococci
704714|NCT00612937|Respiratory Disease|respiratory disease
704715|NCT00612937|Beta Lactam|beta lactam
704716|NCT00612937|Newborn|newborn
704717|NCT00612937|Respiratory Distress|respiratory distress
704718|NCT00612898|HIV infection|hiv infection
704719|NCT00612898|Drug resistance|drug resistance
704720|NCT00612898|Reverse transcriptase inhibitor|reverse transcriptase inhibitor
704721|NCT00612898|Nucleoside analogue|nucleoside analogue
704722|NCT00612898|treatment experienced|treatment experienced
704723|NCT00612859|Levetiracetam|levetiracetam
704724|NCT00612859|Keppra|keppra
704725|NCT00612846|Common Bile Duct Calculi|common bile duct calculi
704726|NCT00612846|Choledocholithiasis|choledocholithiasis
704727|NCT00612846|Endoscopic sphincterotomy|endoscopic sphincterotomy
704728|NCT00612846|Cholecystectomy, laparoscopic|cholecystectomy, laparoscopic
704729|NCT00612846|Laparoscopic bile duct exploration|laparoscopic bile duct exploration
704730|NCT00612833|Vasectomy|vasectomy
704731|NCT00612833|Male contraception|male contraception
704732|NCT00612833|Contraceptive effectiveness|contraceptive effectiveness
704733|NCT00612833|Semen analysis|semen analysis
704734|NCT00612833|Surgical techniques|surgical techniques
704735|NCT00612833|Fascial interposition|fascial interposition
704736|NCT00612833|Cautery|cautery
704737|NCT00612833|The relative contraceptive effectiveness of three methods of occluding the vas, in the context of a no-scalpel vasectomy procedure.|the relative contraceptive effectiveness of three methods of occluding the vas, in the context of a no-scalpel vasectomy procedure.
704738|NCT00612820|Vienna Challenge Chamber|vienna challenge chamber
704739|NCT00612820|Seasonal Allergic Rhinitis,|seasonal allergic rhinitis,
704740|NCT00612807|Older Adults|older adults
704741|NCT00612794|exenatide|exenatide
704742|NCT00612794|Byetta|byetta
704743|NCT00612794|diabetes|diabetes
704744|NCT00612794|Amylin|amylin
704745|NCT00612794|Lilly|lilly
704746|NCT00612781|intraocular lens|intraocular lens
704747|NCT00612781|blue-light filtering intraocular lens|blue-light filtering intraocular lens
704748|NCT00612781|contrast acuity|contrast acuity
704749|NCT00612781|color vision|color vision
704750|NCT00612768|Bioequivalence|bioequivalence
704751|NCT00612768|Thimerosal|thimerosal
704752|NCT00612768|Fragrance Mix|fragrance mix
704753|NCT00612768|PVP formulation|pvp formulation
704754|NCT00612768|Contact dermatitis|contact dermatitis
704755|NCT00612755|chronic hepatitis C|chronic hepatitis c
704756|NCT00612755|co-infection|co-infection
704757|NCT00612755|extend treatment|extend treatment
704758|NCT00612755|co-infected HIV-HCV|co-infected hiv-hcv
704759|NCT00612742|Cardiovascular event|cardiovascular event
704760|NCT00612742|Breast Cancer|breast cancer
704761|NCT00612742|Testosterone|testosterone
704762|NCT00612742|Menopause|menopause
704763|NCT00612742|Hypoactive Sexual Desire Disorder|hypoactive sexual desire disorder
704764|NCT00612729|intraocular lens|intraocular lens
704765|NCT00612729|light filtering intraocular lens|light filtering intraocular lens
704766|NCT00612729|contrast acuity|contrast acuity
704767|NCT00612729|color vision|color vision
704768|NCT00612716|stage I multiple myeloma|stage i multiple myeloma
704769|NCT00612716|stage II multiple myeloma|stage ii multiple myeloma
704770|NCT00612716|stage III multiple myeloma|stage iii multiple myeloma
704771|NCT00612716|refractory multiple myeloma|refractory multiple myeloma
704772|NCT00612716|recurrent adult Hodgkin lymphoma|recurrent adult hodgkin lymphoma
704844|NCT00612638|Irinotecan|irinotecan
704773|NCT00612716|recurrent/refractory childhood Hodgkin lymphoma|recurrent/refractory childhood hodgkin lymphoma
704774|NCT00612716|refractory chronic lymphocytic leukemia|refractory chronic lymphocytic leukemia
704775|NCT00612716|stage III chronic lymphocytic leukemia|stage iii chronic lymphocytic leukemia
704776|NCT00612716|stage IV chronic lymphocytic leukemia|stage iv chronic lymphocytic leukemia
704777|NCT00612716|recurrent adult grade III lymphomatoid granulomatosis|recurrent adult grade iii lymphomatoid granulomatosis
704778|NCT00612716|adult nasal type extranodal NK/T-cell lymphoma|adult nasal type extranodal nk/t-cell lymphoma
704779|NCT00612716|Waldenstrom macroglobulinemia|waldenstrom macroglobulinemia
704780|NCT00612716|recurrent adult Burkitt lymphoma|recurrent adult burkitt lymphoma
704781|NCT00612716|stage I adult Burkitt lymphoma|stage i adult burkitt lymphoma
704782|NCT00612716|stage II adult Burkitt lymphoma|stage ii adult burkitt lymphoma
704783|NCT00612716|stage III adult Burkitt lymphoma|stage iii adult burkitt lymphoma
704784|NCT00612716|stage IV adult Burkitt lymphoma|stage iv adult burkitt lymphoma
704785|NCT00612716|recurrent adult diffuse large cell lymphoma|recurrent adult diffuse large cell lymphoma
704786|NCT00612716|recurrent adult diffuse mixed cell lymphoma|recurrent adult diffuse mixed cell lymphoma
704787|NCT00612716|recurrent adult diffuse small cleaved cell lymphoma|recurrent adult diffuse small cleaved cell lymphoma
704788|NCT00612716|recurrent adult immunoblastic large cell lymphoma|recurrent adult immunoblastic large cell lymphoma
704789|NCT00612716|stage I adult immunoblastic large cell lymphoma|stage i adult immunoblastic large cell lymphoma
704790|NCT00612716|stage II adult immunoblastic large cell lymphoma|stage ii adult immunoblastic large cell lymphoma
704791|NCT00612716|stage III adult immunoblastic large cell lymphoma|stage iii adult immunoblastic large cell lymphoma
704792|NCT00612716|stage IV adult immunoblastic large cell lymphoma|stage iv adult immunoblastic large cell lymphoma
704793|NCT00612716|recurrent adult lymphoblastic lymphoma|recurrent adult lymphoblastic lymphoma
704794|NCT00612716|stage I adult lymphoblastic lymphoma|stage i adult lymphoblastic lymphoma
704795|NCT00612716|stage II adult lymphoblastic lymphoma|stage ii adult lymphoblastic lymphoma
704796|NCT00612716|stage III adult lymphoblastic lymphoma|stage iii adult lymphoblastic lymphoma
704797|NCT00612716|stage IV adult lymphoblastic lymphoma|stage iv adult lymphoblastic lymphoma
704798|NCT00612716|recurrent grade 1 follicular lymphoma|recurrent grade 1 follicular lymphoma
704799|NCT00612716|recurrent grade 2 follicular lymphoma|recurrent grade 2 follicular lymphoma
704800|NCT00612716|recurrent grade 3 follicular lymphoma|recurrent grade 3 follicular lymphoma
704801|NCT00612716|recurrent mantle cell lymphoma|recurrent mantle cell lymphoma
704802|NCT00612716|extranodal marginal zone B-cell lymphoma of mucosa-associated lymphoid tissue|extranodal marginal zone b-cell lymphoma of mucosa-associated lymphoid tissue
704803|NCT00612716|nodal marginal zone B-cell lymphoma|nodal marginal zone b-cell lymphoma
704804|NCT00612716|recurrent marginal zone lymphoma|recurrent marginal zone lymphoma
704805|NCT00612716|splenic marginal zone lymphoma|splenic marginal zone lymphoma
704806|NCT00612716|recurrent small lymphocytic lymphoma|recurrent small lymphocytic lymphoma
704807|NCT00612716|recurrent childhood anaplastic large cell lymphoma|recurrent childhood anaplastic large cell lymphoma
704808|NCT00612716|recurrent childhood grade III lymphomatoid granulomatosis|recurrent childhood grade iii lymphomatoid granulomatosis
704809|NCT00612716|childhood diffuse large cell lymphoma|childhood diffuse large cell lymphoma
704810|NCT00612716|childhood immunoblastic large cell lymphoma|childhood immunoblastic large cell lymphoma
704811|NCT00612716|recurrent childhood large cell lymphoma|recurrent childhood large cell lymphoma
704812|NCT00612716|recurrent childhood lymphoblastic lymphoma|recurrent childhood lymphoblastic lymphoma
704813|NCT00612716|childhood nasal type extranodal NK/T-cell lymphoma|childhood nasal type extranodal nk/t-cell lymphoma
704814|NCT00612716|Burkitt lymphoma|burkitt lymphoma
704815|NCT00612716|recurrent childhood small noncleaved cell lymphoma|recurrent childhood small noncleaved cell lymphoma
704816|NCT00612716|stage I childhood small noncleaved cell lymphoma|stage i childhood small noncleaved cell lymphoma
704817|NCT00612716|stage II childhood small noncleaved cell lymphoma|stage ii childhood small noncleaved cell lymphoma
704818|NCT00612716|stage III childhood small noncleaved cell lymphoma|stage iii childhood small noncleaved cell lymphoma
704819|NCT00612716|stage IV childhood small noncleaved cell lymphoma|stage iv childhood small noncleaved cell lymphoma
704820|NCT00612703|Cancer, oral, erlotinib, tarceva, solid tumor, advanced tumor, phase 1|cancer, oral, erlotinib, tarceva, solid tumor, advanced tumor, phase 1
704821|NCT00612703|Tumor|tumor
704822|NCT00612690|Children|children
704823|NCT00612690|School-Based Mental Health Services|school-based mental health services
704824|NCT00612690|Urban Poverty|urban poverty
704825|NCT00612677|recurrent|recurrent
704826|NCT00612677|non-small cell|non-small cell
704827|NCT00612651|GBM|gbm
704828|NCT00612651|Malignant glioma|malignant glioma
704829|NCT00612651|Brain tumor|brain tumor
704830|NCT00612651|Temodar|temodar
704831|NCT00612651|Temozolomide|temozolomide
704832|NCT00612651|SCH 66336|sch 66336
704833|NCT00612651|Farnesyl transferase inhibitor|farnesyl transferase inhibitor
704834|NCT00612651|Glioblastoma multiforme|glioblastoma multiforme
704835|NCT00612651|Gliosarcoma|gliosarcoma
704836|NCT00612651|Anaplastic astrocytoma|anaplastic astrocytoma
704837|NCT00612651|Anaplastic oligodendroglioma|anaplastic oligodendroglioma
704838|NCT00612651|Anaplastic oligoastrocytoma|anaplastic oligoastrocytoma
704839|NCT00612638|Temodar|temodar
704840|NCT00612638|Temozolomide|temozolomide
704841|NCT00612638|O6-Benzylguanine|o6-benzylguanine
704842|NCT00612638|O6-BG|o6-bg
704843|NCT00612638|NSC 637037|nsc 637037
704845|NCT00612638|CPT-11|cpt-11
704846|NCT00612638|Recurrent cerebral anaplastic glioma|recurrent cerebral anaplastic glioma
704847|NCT00612638|Progressive cerebral anaplastic glioma|progressive cerebral anaplastic glioma
704848|NCT00612638|Malignant glioma|malignant glioma
704849|NCT00612560|breast neoplasms|breast neoplasms
704850|NCT00612560|phytoestrogens|phytoestrogens
704851|NCT00612560|tumor characteristics|tumor characteristics
704852|NCT00612560|proliferation|proliferation
704853|NCT00612560|apoptosis|apoptosis
704854|NCT00612560|estrogen receptor|estrogen receptor
704855|NCT00612560|HER2|her2
704856|NCT00612547|Protozoan Infections|protozoan infections
704857|NCT00612547|Communicable Diseases|communicable diseases
704858|NCT00612547|Malaria Infection|malaria infection
704859|NCT00612547|Malaria, falciparum|malaria, falciparum
704860|NCT00612547|Malaria, vivax|malaria, vivax
704861|NCT00612547|Artesunate Amodiaquine|artesunate amodiaquine
704862|NCT00612521|Coronary artery disease|coronary artery disease
704863|NCT00612521|Coronary artery stenting|coronary artery stenting
704864|NCT00612521|peri-procedural myonecrosis|peri-procedural myonecrosis
704865|NCT00612521|Adenosine|adenosine
704866|NCT00612508|contraception|contraception
704867|NCT00612508|NuvaRing|nuvaring
704868|NCT00612508|Desogen|desogen
704869|NCT00612508|vaginal biopsy|vaginal biopsy
704870|NCT00612482|Substance abuse|substance abuse
704871|NCT00612469|dental caries|dental caries
704872|NCT00612469|vancomycin|vancomycin
704873|NCT00612469|chlorhexidine|chlorhexidine
704874|NCT00612469|sodium fluoride|sodium fluoride
704875|NCT00612469|mutans streptococci|mutans streptococci
704876|NCT00612456|angiogenesis|angiogenesis
704877|NCT00612456|pazopanib,|pazopanib,
704878|NCT00612456|age-related macular degeneration (AMD),|age-related macular degeneration (amd),
704879|NCT00612456|vascular endothelial growth factor (VEGF),|vascular endothelial growth factor (vegf),
704880|NCT00612456|choroidal neovascularization (CNV),|choroidal neovascularization (cnv),
704881|NCT00612443|breast cancer|breast cancer
704882|NCT00612430|Glioblastoma|glioblastoma
704883|NCT00612430|Gliosarcoma|gliosarcoma
704884|NCT00612430|GBM|gbm
704885|NCT00612430|MG|mg
704886|NCT00612430|Brain tumor|brain tumor
704887|NCT00612430|Bevacizumab|bevacizumab
704888|NCT00612430|Avastin|avastin
704889|NCT00612430|Etoposide|etoposide
704890|NCT00612430|VP-16|vp-16
704891|NCT00612430|Etopophos|etopophos
704892|NCT00612430|Toposar|toposar
704893|NCT00612430|VePesid|vepesid
704894|NCT00612430|Glioblastoma multiforme|glioblastoma multiforme
704895|NCT00612430|Recurrent GBM|recurrent gbm
704896|NCT00612430|Anaplastic astrocytoma|anaplastic astrocytoma
704897|NCT00612430|Malignant glioma|malignant glioma
704898|NCT00612417|Interaction with recombinant FVIII|interaction with recombinant fviii
704899|NCT00612404|gastrointestinal disorder|gastrointestinal disorder
704900|NCT00612404|endoscopy|endoscopy
704901|NCT00612404|patient with gastrointestinal disorders for whom an endoscopy is performed and who is treated with esomeprazole afterwards.|patient with gastrointestinal disorders for whom an endoscopy is performed and who is treated with esomeprazole afterwards.
704902|NCT00612391|humerus fracture|humerus fracture
704903|NCT00612378|Glabellar Furrowing|glabellar furrowing
704904|NCT00612365|Body Composition|body composition
704905|NCT00612365|Abdomen|abdomen
704906|NCT00612365|Atherosclerosis|atherosclerosis
704907|NCT00612339|Glioma|glioma
704908|NCT00612339|Temozolomide|temozolomide
704909|NCT00612339|Temodar|temodar
704910|NCT00612339|Avastin|avastin
704911|NCT00612339|Bevacizumab|bevacizumab
704912|NCT00612339|GBM|gbm
704913|NCT00612339|Gliosarcoma|gliosarcoma
704914|NCT00612339|Multifocal GBM|multifocal gbm
704915|NCT00612339|Brain tumor|brain tumor
704916|NCT00612339|Unresectable GBM|unresectable gbm
704917|NCT00612339|Glioblastoma multiforme|glioblastoma multiforme
704918|NCT00612313|Major Depressive Disorder|major depressive disorder
704919|NCT00612313|MDD|mdd
704920|NCT00612313|Children|children
704921|NCT00612313|Adolescents|adolescents
704922|NCT00612313|Antidepressant|antidepressant
704923|NCT00612313|CBT|cbt
704924|NCT00612300|Ambulatory stroke patients|ambulatory stroke patients
704925|NCT00612300|Gait training|gait training
704926|NCT00612300|Lokomat|lokomat
704927|NCT00612300|Physical therapy|physical therapy
704928|NCT00612287|Pain|pain
704929|NCT00612287|Chronic pain|chronic pain
704930|NCT00612287|Buprenorphine|buprenorphine
704931|NCT00612287|Drug addiction|drug addiction
704932|NCT00612274|allogeneic|allogeneic
704933|NCT00612261|Branch retinal vein occlusion; treatment|branch retinal vein occlusion; treatment
704934|NCT00612248|Osteoarthritis|osteoarthritis
704935|NCT00612248|Thumb|thumb
704936|NCT00612248|Splint|splint
704937|NCT00612248|Pain|pain
704938|NCT00612248|Function|function
704939|NCT00612248|Osteoarthritis of the trapeziometacarpal (TMC) joint|osteoarthritis of the trapeziometacarpal (tmc) joint
704940|NCT00612235|epilepsy|epilepsy
704941|NCT00612235|lamotrigine|lamotrigine
704942|NCT00612235|levetiracetam|levetiracetam
704943|NCT00612235|carbamazepine|carbamazepine
704944|NCT00612235|phenytoin|phenytoin
704945|NCT00612235|lamictal|lamictal
704946|NCT00612235|keppra|keppra
704947|NCT00612235|tegretol|tegretol
704948|NCT00612235|carbatrol|carbatrol
704949|NCT00612235|dilantin|dilantin
704950|NCT00612222|Immunotherapy|immunotherapy
704951|NCT00612222|Metastatic Melanoma|metastatic melanoma
704952|NCT00612222|Vaccination|vaccination
704953|NCT00612222|Tumor Regression|tumor regression
704954|NCT00612222|Skin Cancer|skin cancer
704955|NCT00612209|ARQ 197, advanced solid tumors, phase 1, dose escalation, pharmacodynamics, safety|arq 197, advanced solid tumors, phase 1, dose escalation, pharmacodynamics, safety
704956|NCT00612196|Safety and tolerability|safety and tolerability
704957|NCT00612183|non-Hodgkin's lymphoma|non-hodgkin's lymphoma
704958|NCT00612183|mantle cell lymphoma|mantle cell lymphoma
704959|NCT00612170|Phase 3, safety and efficacy study, [S,S[-Reboxetine, Fibromyalgia|phase 3, safety and efficacy study, [s,s[-reboxetine, fibromyalgia
704960|NCT00612157|Obstructive Sleep Apnea|obstructive sleep apnea
704961|NCT00612157|Continuous Positive Airway Pressure|continuous positive airway pressure
704962|NCT00612157|CPAP Compliance|cpap compliance
704963|NCT00612157|Non-benzodiazepine hypnotics|non-benzodiazepine hypnotics
704964|NCT00612144|Type 2 DM|type 2 dm
704965|NCT00612131|medical residents PGY 2 and 3|medical residents pgy 2 and 3
704966|NCT00612118|Allergic rhinitis,|allergic rhinitis,
704967|NCT00612118|Vienna Challenge Chamber|vienna challenge chamber
704968|NCT00612105|Postherpetic Neuralgia, PHN, Shingles,|postherpetic neuralgia, phn, shingles,
704969|NCT00612092|Coronary CT angiography|coronary ct angiography
704970|NCT00612092|Radiation dose estimates|radiation dose estimates
704971|NCT00612079|Sertindole|sertindole
704972|NCT00612079|sensory gating|sensory gating
704973|NCT00612079|PPI|ppi
704974|NCT00612079|P50 suppression|p50 suppression
704975|NCT00612079|CANTAB|cantab
704976|NCT00612079|Effect of Sertindole on sensory gating (P50 suppression)|effect of sertindole on sensory gating (p50 suppression)
704977|NCT00612079|on sensorimotor gating (PPI)|on sensorimotor gating (ppi)
704978|NCT00612079|and cognition (CANTAB)|and cognition (cantab)
704979|NCT00612066|ACTH-producing pituitary tumor|acth-producing pituitary tumor
704980|NCT00612053|cardiovascular disease|cardiovascular disease
704981|NCT00612053|coronary artery bypass grafting (CABG)|coronary artery bypass grafting (cabg)
704982|NCT00612053|coronary artery disease (CAD)|coronary artery disease (cad)
704983|NCT00612053|percutaneous transluminal coronary angioplasty (PCI)|percutaneous transluminal coronary angioplasty (pci)
704984|NCT00612053|unprotected left main disease|unprotected left main disease
704985|NCT00612027|gastrointestinal disorder|gastrointestinal disorder
704986|NCT00612027|acid associated gastrointestinal symptoms.|acid associated gastrointestinal symptoms.
704987|NCT00612027|esomeprazole therapy in patients with gastrointestinal disorders|esomeprazole therapy in patients with gastrointestinal disorders
704988|NCT00612027|patients with acid associated gastrointestinal symptoms|patients with acid associated gastrointestinal symptoms
704989|NCT00612014|delayed gastric emptying|delayed gastric emptying
704990|NCT00612014|symptomatic gastroparesis|symptomatic gastroparesis
704991|NCT00612014|diabetes mellitus|diabetes mellitus
704992|NCT00612001|adult anaplastic astrocytoma|adult anaplastic astrocytoma
704993|NCT00612001|adult glioblastoma|adult glioblastoma
704994|NCT00612001|adult giant cell glioblastoma|adult giant cell glioblastoma
704995|NCT00612001|adult gliosarcoma|adult gliosarcoma
704996|NCT00612001|adult anaplastic oligodendroglioma|adult anaplastic oligodendroglioma
704997|NCT00612001|recurrent adult brain tumor|recurrent adult brain tumor
704998|NCT00612001|adult mixed glioma|adult mixed glioma
704999|NCT00611988|Walking therapy|walking therapy
705000|NCT00611988|Diabetes mellitus|diabetes mellitus
705001|NCT00611988|Peripheral arterial disease|peripheral arterial disease
705002|NCT00611975|Gonadal Steroid Hormones|gonadal steroid hormones
705003|NCT00611975|Healthy Volunteers|healthy volunteers
705004|NCT00611975|Antidepressant Side Effects|antidepressant side effects
705005|NCT00611975|Fluoxetine|fluoxetine
705006|NCT00611975|Bupropion|bupropion
705007|NCT00611975|Prolactin|prolactin
705008|NCT00611975|Testosterone|testosterone
705009|NCT00611975|Estradiol|estradiol
705010|NCT00611975|Progesterone|progesterone
705011|NCT00611975|Sexual Function|sexual function
705012|NCT00611975|Serotonin Reuptake Inhibitors|serotonin reuptake inhibitors
705013|NCT00611975|17-OH Pregnenolone|17-oh pregnenolone
705014|NCT00611949|Geranium oil|geranium oil
705015|NCT00611949|Neuropathy|neuropathy
705016|NCT00611949|Shingles|shingles
705017|NCT00611949|Herpes zoster|herpes zoster
705018|NCT00611936|Atomoxetine|atomoxetine
705019|NCT00611936|Stress|stress
705020|NCT00611936|d-amphetamine|d-amphetamine
705021|NCT00611923|Premenstrual Dysphoric Disorder|premenstrual dysphoric disorder
705022|NCT00611923|PMDD|pmdd
705023|NCT00611923|PMS|pms
705024|NCT00611897|NMDA|nmda
705025|NCT00611897|glutamate|glutamate
705026|NCT00611897|N-acetylcysteine|n-acetylcysteine
705027|NCT00611897|P3|p3
705028|NCT00611858|5-FU|5-fu
705029|NCT00611858|cetuximab|cetuximab
705030|NCT00611858|radiation|radiation
705031|NCT00611858|adenocarcinoma of the rectum|adenocarcinoma of the rectum
705032|NCT00611858|neoadjuvant therapy|neoadjuvant therapy
705033|NCT00611845|CABG surgery requiring CPB and at increased risk of bleeding and blood transfusion|cabg surgery requiring cpb and at increased risk of bleeding and blood transfusion
705034|NCT00611832|behavior problems|behavior problems
705035|NCT00611832|children|children
705036|NCT00611832|prevention|prevention
705037|NCT00611832|television|television
705038|NCT00611832|media|media
705039|NCT00611832|parenting|parenting
705040|NCT00611819|hepatitis|hepatitis
705041|NCT00611819|co-infection|co-infection
705042|NCT00611806|Cognition|cognition
705043|NCT00611806|Folic Acid|folic acid
705044|NCT00611806|B12|b12
705045|NCT00611793|Refractory Malignancy|refractory malignancy
705046|NCT00611793|Advanced Malignancies|advanced malignancies
705047|NCT00611793|PTK787/ZK222584|ptk787/zk222584
705048|NCT00611793|Bevacizumab|bevacizumab
705049|NCT00611780|Coronary CT angiography|coronary ct angiography
705050|NCT00611780|Radiation dose estimates|radiation dose estimates
705051|NCT00611767|Thiopental|thiopental
705052|NCT00611767|Alcohol|alcohol
705053|NCT00611767|Family History|family history
705054|NCT00611767|Vulnerability|vulnerability
705055|NCT00611767|GABA|gaba
705056|NCT00611741|MRS, glutamate, osmolality|mrs, glutamate, osmolality
705057|NCT00611728|Glioblastoma|glioblastoma
705058|NCT00611728|CPT 11|cpt 11
705059|NCT00611728|Sutent|sutent
705060|NCT00611728|Sunitinib|sunitinib
705061|NCT00611728|Sunitinib malate|sunitinib malate
705062|NCT00611728|Malignant Glioma|malignant glioma
705063|NCT00611728|GBM|gbm
705064|NCT00611728|Irinotecan|irinotecan
705065|NCT00611728|Camptosar|camptosar
705066|NCT00611728|Anaplastic astrocytoma|anaplastic astrocytoma
705067|NCT00611728|Anaplastic oligodendroglioma|anaplastic oligodendroglioma
705068|NCT00611728|Anaplastic oligoastrocytoma|anaplastic oligoastrocytoma
705069|NCT00611728|SU011248|su011248
705070|NCT00611728|Brain tumor|brain tumor
705071|NCT00611728|Recurrent malignant glioma|recurrent malignant glioma
705072|NCT00611715|recurrent breast cancer|recurrent breast cancer
705073|NCT00611715|stage IV breast cancer|stage iv breast cancer
705074|NCT00611702|ELISPOT|elispot
705075|NCT00611702|RT-PCR|rt-pcr
705076|NCT00611702|Luminex|luminex
705077|NCT00611702|Genomics|genomics
705078|NCT00611689|Refractory Malignancy|refractory malignancy
705079|NCT00611689|Solid Tumors|solid tumors
705080|NCT00611689|PTK787|ptk787
705081|NCT00611689|ZK222584|zk222584
705082|NCT00611676|osteoarthritis pain|osteoarthritis pain
705083|NCT00611676|activity limitation|activity limitation
705084|NCT00611676|antidepressant|antidepressant
705085|NCT00611676|depression|depression
705086|NCT00611676|single-blind|single-blind
705087|NCT00611663|Pneumococcal vaccine|pneumococcal vaccine
705088|NCT00611663|SLE|sle
705089|NCT00611663|Vaccination|vaccination
705090|NCT00611663|Immunosuppression|immunosuppression
705091|NCT00611663|SLE as defined by the ACR classification|sle as defined by the acr classification
705092|NCT00611663|Stable SLE|stable sle
705093|NCT00611663|SLE treated by systemic corticosteroids|sle treated by systemic corticosteroids
705094|NCT00611650|non-small cell lung cancer|non-small cell lung cancer
705095|NCT00611650|squamous lung dysplasia|squamous lung dysplasia
705096|NCT00611650|tobacco use disorder|tobacco use disorder
705097|NCT00611637|Immunotherapy|immunotherapy
705098|NCT00611624|MammoSite|mammosite
705099|NCT00611624|brachytherapy|brachytherapy
705100|NCT00611572|GABA|gaba
705101|NCT00611572|glutamate|glutamate
705102|NCT00611572|NMDA|nmda
705103|NCT00611572|P300|p300
705104|NCT00611572|MMN|mmn
705105|NCT00611559|Infanrix hexa|infanrix hexa
705106|NCT00611559|combined vaccine|combined vaccine
705107|NCT00611546|preterm|preterm
705108|NCT00611546|parenteral nutrition|parenteral nutrition
705109|NCT00611546|TPN|tpn
705110|NCT00611546|lipid emulsions|lipid emulsions
705111|NCT00611546|photo-protection|photo-protection
705112|NCT00611546|oxidative stress|oxidative stress
705113|NCT00611533|Menopause|menopause
705114|NCT00611533|Cognition|cognition
705115|NCT00611520|treatment of COPD|treatment of copd
705116|NCT00611520|related to the budesonide/formoterole therapy in patients with COPD.|related to the budesonide/formoterole therapy in patients with copd.
705117|NCT00611494|Drug tolerance|drug tolerance
705118|NCT00611494|Quality of Life|quality of life
705119|NCT00611429|Treatment|treatment
705120|NCT00611429|Adherence|adherence
705121|NCT00611429|Intervention|intervention
705122|NCT00611429|Quality of Life|quality of life
705123|NCT00611416|catechins|catechins
705124|NCT00611416|caffeine|caffeine
705125|NCT00611416|energy expenditure|energy expenditure
705126|NCT00611416|fat oxidation|fat oxidation
705127|NCT00611416|appetite|appetite
705128|NCT00611403|LASIK|lasik
705129|NCT00611390|Viral laryngitis;|viral laryngitis;
705130|NCT00611390|Viral tracheitis;|viral tracheitis;
705131|NCT00611390|Herbal medicine;|herbal medicine;
705132|NCT00611390|Traditional medicine;|traditional medicine;
705133|NCT00611390|Aromatic essential oils;|aromatic essential oils;
705134|NCT00611377|delirium|delirium
891566|NCT00009256|HIV|hiv
705135|NCT00611377|mechanical ventilation|mechanical ventilation
705136|NCT00611377|age|age
705137|NCT00611377|severity score|severity score
705138|NCT00611364|Physical therapy|physical therapy
705139|NCT00611364|hypertension|hypertension
705140|NCT00611364|aged|aged
705141|NCT00611364|exercise|exercise
705142|NCT00611364|Physical exercise|physical exercise
705143|NCT00611364|Physical activity|physical activity
705144|NCT00611351|graft versus host disease|graft versus host disease
705145|NCT00611351|adult acute myeloid leukemia with 11q23 (MLL) abnormalities|adult acute myeloid leukemia with 11q23 (mll) abnormalities
705146|NCT00611351|adult acute myeloid leukemia with inv(16)(p13;q22)|adult acute myeloid leukemia with inv(16)(p13;q22)
705147|NCT00611351|adult acute myeloid leukemia with t(15;17)(q22;q12)|adult acute myeloid leukemia with t(15;17)(q22;q12)
705148|NCT00611351|adult acute myeloid leukemia with t(16;16)(p13;q22)|adult acute myeloid leukemia with t(16;16)(p13;q22)
705149|NCT00611351|adult acute myeloid leukemia with t(8;21)(q22;q22)|adult acute myeloid leukemia with t(8;21)(q22;q22)
705150|NCT00611351|recurrent adult acute myeloid leukemia|recurrent adult acute myeloid leukemia
705151|NCT00611351|untreated adult acute myeloid leukemia|untreated adult acute myeloid leukemia
705152|NCT00611351|untreated adult acute lymphoblastic leukemia|untreated adult acute lymphoblastic leukemia
705153|NCT00611351|accelerated phase chronic myelogenous leukemia|accelerated phase chronic myelogenous leukemia
705154|NCT00611351|blastic phase chronic myelogenous leukemia|blastic phase chronic myelogenous leukemia
705155|NCT00611351|chronic phase chronic myelogenous leukemia|chronic phase chronic myelogenous leukemia
705156|NCT00611351|relapsing chronic myelogenous leukemia|relapsing chronic myelogenous leukemia
705157|NCT00611351|stage III multiple myeloma|stage iii multiple myeloma
705158|NCT00611351|refractory multiple myeloma|refractory multiple myeloma
705159|NCT00611351|de novo myelodysplastic syndromes|de novo myelodysplastic syndromes
705160|NCT00611351|myelodysplastic/myeloproliferative disease, unclassifiable|myelodysplastic/myeloproliferative disease, unclassifiable
705161|NCT00611351|previously treated myelodysplastic syndromes|previously treated myelodysplastic syndromes
705162|NCT00611351|secondary myelodysplastic syndromes|secondary myelodysplastic syndromes
705163|NCT00611351|secondary myelofibrosis|secondary myelofibrosis
705164|NCT00611351|secondary acute myeloid leukemia|secondary acute myeloid leukemia
705165|NCT00611351|recurrent adult Burkitt lymphoma|recurrent adult burkitt lymphoma
705166|NCT00611351|recurrent adult diffuse large cell lymphoma|recurrent adult diffuse large cell lymphoma
705167|NCT00611351|recurrent adult diffuse mixed cell lymphoma|recurrent adult diffuse mixed cell lymphoma
705168|NCT00611351|recurrent adult diffuse small cleaved cell lymphoma|recurrent adult diffuse small cleaved cell lymphoma
705169|NCT00611351|recurrent adult Hodgkin lymphoma|recurrent adult hodgkin lymphoma
705170|NCT00611351|recurrent adult immunoblastic large cell lymphoma|recurrent adult immunoblastic large cell lymphoma
705171|NCT00611351|recurrent adult lymphoblastic lymphoma|recurrent adult lymphoblastic lymphoma
705172|NCT00611351|recurrent adult T-cell leukemia/lymphoma|recurrent adult t-cell leukemia/lymphoma
705173|NCT00611351|recurrent cutaneous T-cell non-Hodgkin lymphoma|recurrent cutaneous t-cell non-hodgkin lymphoma
705174|NCT00611351|recurrent grade 1 follicular lymphoma|recurrent grade 1 follicular lymphoma
705175|NCT00611351|recurrent grade 2 follicular lymphoma|recurrent grade 2 follicular lymphoma
705176|NCT00611351|recurrent grade 3 follicular lymphoma|recurrent grade 3 follicular lymphoma
705177|NCT00611351|recurrent mantle cell lymphoma|recurrent mantle cell lymphoma
705178|NCT00611351|recurrent marginal zone lymphoma|recurrent marginal zone lymphoma
705179|NCT00611351|recurrent small lymphocytic lymphoma|recurrent small lymphocytic lymphoma
705180|NCT00611351|recurrent adult acute lymphoblastic leukemia|recurrent adult acute lymphoblastic leukemia
705181|NCT00611351|extranodal marginal zone B-cell lymphoma of mucosa-associated lymphoid tissue|extranodal marginal zone b-cell lymphoma of mucosa-associated lymphoid tissue
705182|NCT00611351|nodal marginal zone B-cell lymphoma|nodal marginal zone b-cell lymphoma
705183|NCT00611351|splenic marginal zone lymphoma|splenic marginal zone lymphoma
705184|NCT00611351|adult nasal type extranodal NK/T-cell lymphoma|adult nasal type extranodal nk/t-cell lymphoma
705185|NCT00611351|stage III adult Hodgkin lymphoma|stage iii adult hodgkin lymphoma
705186|NCT00611351|stage IV adult Hodgkin lymphoma|stage iv adult hodgkin lymphoma
705187|NCT00611351|stage III adult T-cell leukemia/lymphoma|stage iii adult t-cell leukemia/lymphoma
705188|NCT00611351|stage IV adult T-cell leukemia/lymphoma|stage iv adult t-cell leukemia/lymphoma
705189|NCT00611351|stage III adult Burkitt lymphoma|stage iii adult burkitt lymphoma
705190|NCT00611351|stage IV adult Burkitt lymphoma|stage iv adult burkitt lymphoma
705191|NCT00611351|stage III adult diffuse large cell lymphoma|stage iii adult diffuse large cell lymphoma
705192|NCT00611351|stage IV adult diffuse large cell lymphoma|stage iv adult diffuse large cell lymphoma
705193|NCT00611351|stage III adult diffuse mixed cell lymphoma|stage iii adult diffuse mixed cell lymphoma
705194|NCT00611351|stage IV adult diffuse mixed cell lymphoma|stage iv adult diffuse mixed cell lymphoma
705195|NCT00611351|stage III adult immunoblastic large cell lymphoma|stage iii adult immunoblastic large cell lymphoma
705196|NCT00611351|stage IV adult immunoblastic large cell lymphoma|stage iv adult immunoblastic large cell lymphoma
705197|NCT00611351|stage III adult lymphoblastic lymphoma|stage iii adult lymphoblastic lymphoma
705198|NCT00611351|stage IV adult lymphoblastic lymphoma|stage iv adult lymphoblastic lymphoma
705199|NCT00611351|stage III grade 1 follicular lymphoma|stage iii grade 1 follicular lymphoma
705200|NCT00611351|stage III grade 2 follicular lymphoma|stage iii grade 2 follicular lymphoma
705201|NCT00611351|stage III grade 3 follicular lymphoma|stage iii grade 3 follicular lymphoma
705202|NCT00611351|stage IV grade 1 follicular lymphoma|stage iv grade 1 follicular lymphoma
705203|NCT00611351|stage IV grade 2 follicular lymphoma|stage iv grade 2 follicular lymphoma
705204|NCT00611351|stage IV grade 3 follicular lymphoma|stage iv grade 3 follicular lymphoma
705290|NCT00611130|Treatment|treatment
705205|NCT00611351|stage III mantle cell lymphoma|stage iii mantle cell lymphoma
705206|NCT00611351|stage IV mantle cell lymphoma|stage iv mantle cell lymphoma
705207|NCT00611351|stage III marginal zone lymphoma|stage iii marginal zone lymphoma
705208|NCT00611351|stage IV marginal zone lymphoma|stage iv marginal zone lymphoma
705209|NCT00611351|stage III small lymphocytic lymphoma|stage iii small lymphocytic lymphoma
705210|NCT00611351|stage IV small lymphocytic lymphoma|stage iv small lymphocytic lymphoma
705211|NCT00611351|stage III adult diffuse small cleaved cell lymphoma|stage iii adult diffuse small cleaved cell lymphoma
705212|NCT00611351|stage IV adult diffuse small cleaved cell lymphoma|stage iv adult diffuse small cleaved cell lymphoma
705213|NCT00611351|adult acute lymphoblastic leukemia in remission|adult acute lymphoblastic leukemia in remission
705214|NCT00611351|adult acute myeloid leukemia in remission|adult acute myeloid leukemia in remission
705215|NCT00611351|atypical chronic myeloid leukemia|atypical chronic myeloid leukemia
705216|NCT00611351|noncontiguous stage II adult Burkitt lymphoma|noncontiguous stage ii adult burkitt lymphoma
705217|NCT00611351|noncontiguous stage II adult diffuse large cell lymphoma|noncontiguous stage ii adult diffuse large cell lymphoma
705218|NCT00611351|noncontiguous stage II adult diffuse mixed cell lymphoma|noncontiguous stage ii adult diffuse mixed cell lymphoma
705219|NCT00611351|noncontiguous stage II adult diffuse small cleaved cell lymphoma|noncontiguous stage ii adult diffuse small cleaved cell lymphoma
705220|NCT00611351|noncontiguous stage II adult immunoblastic large cell lymphoma|noncontiguous stage ii adult immunoblastic large cell lymphoma
705221|NCT00611351|noncontiguous stage II adult lymphoblastic lymphoma|noncontiguous stage ii adult lymphoblastic lymphoma
705222|NCT00611351|noncontiguous stage II grade 1 follicular lymphoma|noncontiguous stage ii grade 1 follicular lymphoma
705223|NCT00611351|noncontiguous stage II grade 2 follicular lymphoma|noncontiguous stage ii grade 2 follicular lymphoma
705224|NCT00611351|noncontiguous stage II grade 3 follicular lymphoma|noncontiguous stage ii grade 3 follicular lymphoma
705225|NCT00611351|noncontiguous stage II mantle cell lymphoma|noncontiguous stage ii mantle cell lymphoma
705226|NCT00611351|noncontiguous stage II marginal zone lymphoma|noncontiguous stage ii marginal zone lymphoma
705227|NCT00611351|noncontiguous stage II small lymphocytic lymphoma|noncontiguous stage ii small lymphocytic lymphoma
705228|NCT00611351|refractory hairy cell leukemia|refractory hairy cell leukemia
705229|NCT00611351|stage I multiple myeloma|stage i multiple myeloma
705230|NCT00611351|stage II multiple myeloma|stage ii multiple myeloma
705231|NCT00611338|Complementary Therapies|complementary therapies
705232|NCT00611325|Glioblastoma|glioblastoma
705233|NCT00611325|Gliosarcoma|gliosarcoma
705234|NCT00611325|Glioblastoma multiforme|glioblastoma multiforme
705235|NCT00611325|Recurrent malignant glioma|recurrent malignant glioma
705237|NCT00611325|Recurrent GBM|recurrent gbm
705238|NCT00611325|Malignant glioma|malignant glioma
705239|NCT00611325|Brain tumor|brain tumor
705240|NCT00611325|Avastin|avastin
705241|NCT00611325|Bevacizumab|bevacizumab
705242|NCT00611325|Bortezomib|bortezomib
705243|NCT00611325|Velcade|velcade
705244|NCT00611312|Alzheimer's disease|alzheimer's disease
705245|NCT00611312|Cognitive training|cognitive training
705246|NCT00611299|Probiotics|probiotics
705247|NCT00611299|Immune response|immune response
705248|NCT00611299|Blood lipids|blood lipids
705249|NCT00611299|Intestinal microflora|intestinal microflora
705250|NCT00611299|Tolerance|tolerance
705251|NCT00611286|Drug-eluting stent|drug-eluting stent
705252|NCT00611286|clopidogrel|clopidogrel
705253|NCT00611286|bare metal stent|bare metal stent
705254|NCT00611286|landmark analysis|landmark analysis
705255|NCT00611286|Patients with coronary artery disease|patients with coronary artery disease
705256|NCT00611273|Glabellar Furrowing|glabellar furrowing
705257|NCT00611260|Meditation|meditation
705258|NCT00611260|Congestive Heart Failure|congestive heart failure
705259|NCT00611260|ICD|icd
705260|NCT00611260|Cardiac Resynchronization Therapy|cardiac resynchronization therapy
705261|NCT00611221|massage|massage
705262|NCT00611221|labour|labour
705263|NCT00611195|Anesthesia|anesthesia
705264|NCT00611195|Children|children
705265|NCT00611195|Larynx|larynx
705266|NCT00611182|dyspnea|dyspnea
705267|NCT00611182|pulmonary fibrosis|pulmonary fibrosis
705268|NCT00611182|interstitial lung disease|interstitial lung disease
705269|NCT00611182|shortness of breath|shortness of breath
705270|NCT00611169|Angioplasty, Transluminal, Percutaneous Coronary|angioplasty, transluminal, percutaneous coronary
705271|NCT00611169|tirofiban|tirofiban
705272|NCT00611169|Magnetic Resonance Imaging|magnetic resonance imaging
705273|NCT00611169|Myocardial Infarction|myocardial infarction
705274|NCT00611156|Thermogenesis|thermogenesis
705275|NCT00611156|Meal-induced thermogenesis|meal-induced thermogenesis
705276|NCT00611156|energy expenditure|energy expenditure
891757|NCT00007254|Bedsore|bedsore
705277|NCT00611156|fat oxidation|fat oxidation
705278|NCT00611156|bioactive ingredients|bioactive ingredients
705279|NCT00611156|spices|spices
705280|NCT00611156|ginger|ginger
705281|NCT00611156|horseradish|horseradish
705282|NCT00611156|black pepper|black pepper
705283|NCT00611156|mustard|mustard
705284|NCT00611143|Off-pump coronary artery bypass graft|off-pump coronary artery bypass graft
705285|NCT00611143|Atorvastatin|atorvastatin
705286|NCT00611143|Postoperative atrial fibrillation|postoperative atrial fibrillation
705287|NCT00611130|Cocaine|cocaine
705288|NCT00611130|Addiction|addiction
705289|NCT00611130|Dependence|dependence
705291|NCT00611117|adaptation to high fat diet|adaptation to high fat diet
705292|NCT00611117|activity|activity
705293|NCT00611117|exercise|exercise
705294|NCT00611104|breast cancer|breast cancer
705295|NCT00611078|Soft Tissue Sarcoma|soft tissue sarcoma
705296|NCT00611078|environment|environment
705297|NCT00611078|pollutants|pollutants
705298|NCT00611078|04-088|04-088
705299|NCT00611052|Depressive Disorder|depressive disorder
705300|NCT00611052|Depressive Disorder, Major|depressive disorder, major
705301|NCT00611052|Mental Health|mental health
705302|NCT00611052|Prevention|prevention
705303|NCT00611039|Darunavir/ritonavir|darunavir/ritonavir
705304|NCT00611039|virtual inhibitory quotient|virtual inhibitory quotient
705305|NCT00611039|dose reduction|dose reduction
705306|NCT00611026|Treatment of overactive bladder|treatment of overactive bladder
705307|NCT00611013|Development of multi-purpose novel imaging protocols|development of multi-purpose novel imaging protocols
705308|NCT00611000|colon cancer|colon cancer
705309|NCT00611000|rectal cancer|rectal cancer
705310|NCT00610987|Antibiotic Prophylaxis|antibiotic prophylaxis
705311|NCT00610974|Spinal cord injury|spinal cord injury
705312|NCT00610974|walking|walking
705313|NCT00610974|gait training|gait training
705314|NCT00610974|body-weight supported treadmill training|body-weight supported treadmill training
705315|NCT00610974|rehabilitation|rehabilitation
705316|NCT00610961|BK Polyomavirus|bk polyomavirus
705317|NCT00610961|Transplantation, Kidney|transplantation, kidney
705318|NCT00610961|Transplantation, Pancreas|transplantation, pancreas
705319|NCT00610948|unspecified adult solid tumor, protocol specific|unspecified adult solid tumor, protocol specific
705320|NCT00610935|Influenza|influenza
705321|NCT00610935|Subjects with uncomplicated acute influenza|subjects with uncomplicated acute influenza
705322|NCT00610922|Performance of motor skills|performance of motor skills
705323|NCT00610909|IBS|ibs
705324|NCT00610870|Myocardial infarct size|myocardial infarct size
705325|NCT00610870|Atorvastatin|atorvastatin
705326|NCT00610870|SPECT|spect
705327|NCT00610870|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors
705328|NCT00610844|lung cancer|lung cancer
705329|NCT00610844|lung metastasis|lung metastasis
705330|NCT00610844|radiofrequency ablation|radiofrequency ablation
705331|NCT00610805|SLE|sle
705332|NCT00610805|lupus|lupus
705333|NCT00610805|cardiovascular|cardiovascular
705334|NCT00610805|IMT|imt
705335|NCT00610805|Systemic Lupus Erythematosus|systemic lupus erythematosus
705336|NCT00610779|Rhino-sinusitis;|rhino-sinusitis;
705337|NCT00610779|Herbal medicine;|herbal medicine;
705338|NCT00610779|Traditional medicine;|traditional medicine;
705339|NCT00610779|Aromatic essential oils;|aromatic essential oils;
705340|NCT00610766|coronary CT angiography|coronary ct angiography
705341|NCT00610766|radiation dose estimates|radiation dose estimates
705342|NCT00610753|Anorexia nervosa|anorexia nervosa
705343|NCT00610753|Adolescents|adolescents
705344|NCT00610753|Family therapy|family therapy
705345|NCT00610740|recurrent cervical cancer|recurrent cervical cancer
705346|NCT00610740|cervical cancer|cervical cancer
705347|NCT00610740|endometrial carcinoma|endometrial carcinoma
705348|NCT00610740|ovarian epithelial cancer|ovarian epithelial cancer
705349|NCT00610740|recurrent ovarian epithelial cancer|recurrent ovarian epithelial cancer
705350|NCT00610740|recurrent endometrial carcinoma|recurrent endometrial carcinoma
705351|NCT00610727|Migraine, Prochlorperazine aerosol|migraine, prochlorperazine aerosol
705352|NCT00610714|Cancer|cancer
705353|NCT00610714|Tumour|tumour
705354|NCT00610714|Ovarian Neoplasms|ovarian neoplasms
705355|NCT00610714|Ovarian Cancer|ovarian cancer
705356|NCT00610675|Fifty two weeks|fifty two weeks
705357|NCT00610675|Open label|open label
705358|NCT00610675|extension|extension
705359|NCT00610662|cervical cancer|cervical cancer
705360|NCT00610662|cervical intraepithelial neoplasia grade 1|cervical intraepithelial neoplasia grade 1
705361|NCT00610662|cervical intraepithelial neoplasia grade 2|cervical intraepithelial neoplasia grade 2
705362|NCT00610662|cervical intraepithelial neoplasia grade 3|cervical intraepithelial neoplasia grade 3
705363|NCT00610649|randomized|randomized
705364|NCT00610649|placebo controlled|placebo controlled
705365|NCT00610649|maximum tolerated dose|maximum tolerated dose
705366|NCT00610636|FOLFOX-4|folfox-4
705367|NCT00610636|neoadjuvant chemotherapy|neoadjuvant chemotherapy
705368|NCT00610636|colorectal cancer|colorectal cancer
705369|NCT00610636|liver metastasis|liver metastasis
705370|NCT00610636|resectability|resectability
705371|NCT00610623|Pseudomonas aeruginosa|pseudomonas aeruginosa
705372|NCT00610623|Pneumonia|pneumonia
705373|NCT00610623|Ventilator-Associated|ventilator-associated
705374|NCT00610623|Quorum Sensing|quorum sensing
705375|NCT00610610|Fibromyalgia|fibromyalgia
705376|NCT00610610|Paroxetine|paroxetine
705377|NCT00610597|liver|liver
705378|NCT00610597|alcohol|alcohol
705379|NCT00610597|lymphocyte|lymphocyte
705380|NCT00610584|seasonal allergic rhinitis|seasonal allergic rhinitis
705381|NCT00610584|acupuncture|acupuncture
705382|NCT00610584|RCT|rct
705383|NCT00610584|CAM|cam
705384|NCT00610571|Temodar|temodar
705385|NCT00610571|Temozolomide|temozolomide
705386|NCT00610571|Topotecan|topotecan
705387|NCT00610571|Hycamtin|hycamtin
705388|NCT00610571|Malignant Gliomas|malignant gliomas
705389|NCT00610571|Brain tumor|brain tumor
705390|NCT00610571|Anaplastic astrocytoma|anaplastic astrocytoma
705392|NCT00610571|GBM|gbm
705393|NCT00610571|Glioblastoma Multiform|glioblastoma multiform
705394|NCT00610571|Gliosarcoma|gliosarcoma
705395|NCT00610545|ATORVASTATIN|atorvastatin
705396|NCT00610545|VASCULAR SURGERY|vascular surgery
705397|NCT00610545|CARDIOVASCULAR OUTCOMES|cardiovascular outcomes
705398|NCT00610532|pharmacoresistance|pharmacoresistance
705399|NCT00610532|healthy volunteers|healthy volunteers
705400|NCT00610519|Viral pharyngo-tonsillitis;|viral pharyngo-tonsillitis;
705401|NCT00610519|Herbal medicine;|herbal medicine;
705402|NCT00610519|Traditional medicine;|traditional medicine;
705403|NCT00610519|Aromatic essential oils;|aromatic essential oils;
705404|NCT00610506|Atypical Depression|atypical depression
705405|NCT00610493|Advanced Cancer|advanced cancer
705406|NCT00610493|Bevacizumab|bevacizumab
705407|NCT00610493|Temsirolimus|temsirolimus
705408|NCT00610493|Avastin|avastin
705409|NCT00610493|Torisel|torisel
705410|NCT00610493|CCI-779|cci-779
705411|NCT00610493|Anti-VEGF monoclonal antibody|anti-vegf monoclonal antibody
705412|NCT00610493|rhuMAb-VEGF|rhumab-vegf
705413|NCT00610493|dynamic contrast-enhanced magnetic resonance imaging|dynamic contrast-enhanced magnetic resonance imaging
705414|NCT00610493|DCE|dce
705415|NCT00610493|magnetic resonance imaging|magnetic resonance imaging
705416|NCT00610493|MRI|mri
705417|NCT00610480|Dry Eyes|dry eyes
705418|NCT00610480|Tear Film Stability|tear film stability
705419|NCT00610454|Levetiracetam|levetiracetam
705420|NCT00610454|Keppra|keppra
705421|NCT00610441|randomized|randomized
705422|NCT00610441|double blind|double blind
705423|NCT00610441|placebo controlled|placebo controlled
705424|NCT00610428|Migraine, Staccato Prochlorperazine|migraine, staccato prochlorperazine
705425|NCT00610428|Migraine headache with or without aura.|migraine headache with or without aura.
705426|NCT00610376|Handwashing|handwashing
705427|NCT00610376|Randomized controlled trial|randomized controlled trial
705428|NCT00610376|Cluster randomization|cluster randomization
705429|NCT00610376|Community intervention trial|community intervention trial
705430|NCT00610376|Disease prevention|disease prevention
705431|NCT00610376|Pediatric communicable disease|pediatric communicable disease
705432|NCT00610376|Preschool|preschool
705433|NCT00610376|Illness absenteeism|illness absenteeism
705434|NCT00610350|Levosimendan|levosimendan
705435|NCT00610350|pre-conditioning|pre-conditioning
705436|NCT00610350|cardiac surgery|cardiac surgery
705437|NCT00610350|myocardial function|myocardial function
705438|NCT00610350|contractility|contractility
705439|NCT00610350|heart|heart
705440|NCT00610350|ischaemia|ischaemia
705441|NCT00610324|oropharyngeal cleansing|oropharyngeal cleansing
705442|NCT00610324|oral decontamination|oral decontamination
705443|NCT00610324|oropharyngeal bacterial flora|oropharyngeal bacterial flora
705444|NCT00610324|oropharyngeal colonization|oropharyngeal colonization
705445|NCT00610324|critical illness|critical illness
705446|NCT00610324|mechanical ventilation|mechanical ventilation
705447|NCT00610324|tracheal intubation|tracheal intubation
705448|NCT00610324|prophylaxis|prophylaxis
705449|NCT00610311|Metastatic Melanoma|metastatic melanoma
705450|NCT00610311|Immunotherapy|immunotherapy
705451|NCT00610311|Vaccination|vaccination
705452|NCT00610311|Tumor Regression|tumor regression
705453|NCT00610311|Skin Cancer|skin cancer
705454|NCT00610298|disability affecting strength, balance and coordination|disability affecting strength, balance and coordination
705455|NCT00610272|single bone metastasis|single bone metastasis
705456|NCT00610272|multiple bone metastasis|multiple bone metastasis
705457|NCT00610272|pain relief|pain relief
705458|NCT00610272|radiotherapy|radiotherapy
705459|NCT00610259|Depressive disorder|depressive disorder
705460|NCT00610259|Sleep initiation and maintenance disorder|sleep initiation and maintenance disorder
705461|NCT00610259|Behavior therapy|behavior therapy
705462|NCT00610246|Thorax|thorax
705463|NCT00610246|Abdomen|abdomen
705464|NCT00610246|Pelvis|pelvis
705465|NCT00610246|Lesion|lesion
705466|NCT00610246|Cancer|cancer
705467|NCT00610246|Radiation|radiation
705468|NCT00610246|Chemotherapy|chemotherapy
705469|NCT00610246|Phase 1|phase 1
705470|NCT00610246|Advanced Cancer|advanced cancer
705471|NCT00610246|Sorafenib|sorafenib
705472|NCT00610246|Nexavar|nexavar
705473|NCT00610246|BAY43-9006|bay43-9006
705474|NCT00610233|deep brain stimulation|deep brain stimulation
705475|NCT00610233|urodynamics|urodynamics
705476|NCT00610220|pediatrics|pediatrics
705477|NCT00610220|wrist fractures|wrist fractures
705478|NCT00610220|casting|casting
705479|NCT00610220|wrist splint|wrist splint
705480|NCT00610207|Anal fistula|anal fistula
705481|NCT00610207|fistula in ano|fistula in ano
705482|NCT00610207|anorectal fistula|anorectal fistula
705483|NCT00610207|Crohn's Disease|crohn's disease
705484|NCT00610181|Breast Cancer|breast cancer
705485|NCT00610181|Breast Carcinoma|breast carcinoma
705486|NCT00610181|Invasive Lobular Cancer|invasive lobular cancer
705487|NCT00610181|Mixed Invasive Ductal-lobular Carcinoma|mixed invasive ductal-lobular carcinoma
705488|NCT00610181|Magnetic Resonance Imaging|magnetic resonance imaging
705490|NCT00610168|dTpa vaccine|dtpa vaccine
705491|NCT00610168|pertussis|pertussis
705492|NCT00610168|Tdap|tdap
705493|NCT00610168|Boostrix|boostrix
705494|NCT00610168|booster|booster
705495|NCT00610168|tetanus|tetanus
705496|NCT00610168|diphtheria|diphtheria
705497|NCT00610142|atopic dermatitis|atopic dermatitis
705498|NCT00610142|pimecrolimus|pimecrolimus
705499|NCT00610142|hydrocortison|hydrocortison
705500|NCT00610142|Optical Coherence Tomography|optical coherence tomography
705501|NCT00610129|MK-0646|mk-0646
705502|NCT00610090|UNITE|unite
705503|NCT00610090|AAA|aaa
705504|NCT00610090|Abdominal Aortic Aneurysms|abdominal aortic aneurysms
705505|NCT00610090|Stent|stent
705506|NCT00610090|Graft|graft
705507|NCT00610077|Letrozole|letrozole
705508|NCT00610077|Clomiphene citrate|clomiphene citrate
705509|NCT00610077|Anovulatory infertility|anovulatory infertility
705510|NCT00610077|Ovulation induction|ovulation induction
705511|NCT00610064|Refractory lower urinary tract dysfunction|refractory lower urinary tract dysfunction
705512|NCT00610064|Sacral neuromodulation|sacral neuromodulation
705513|NCT00610064|Brain effects|brain effects
705514|NCT00610064|Neuroimaging|neuroimaging
705515|NCT00610064|Neuromodulation|neuromodulation
705516|NCT00610051|severe heart failure|severe heart failure
705517|NCT00610051|transplants|transplants
705518|NCT00610038|neonatal|neonatal
705519|NCT00610038|diabetes mellitus|diabetes mellitus
705520|NCT00610038|mutation|mutation
705521|NCT00610038|KIR6.2|kir6.2
705522|NCT00610038|SUR1|sur1
705523|NCT00610038|Neonatal diabetes mellitus with KIR6.2 or SUR1 mutations|neonatal diabetes mellitus with kir6.2 or sur1 mutations
705524|NCT00610025|NOTES|notes
705525|NCT00610025|transgastric endoscopy|transgastric endoscopy
705526|NCT00610025|obesity surgery|obesity surgery
705527|NCT00610025|Roux-en-Y surgery|roux-en-y surgery
705528|NCT00610012|Advanced Renal Cell Carcinoma|advanced renal cell carcinoma
705529|NCT00610012|MRCC|mrcc
705530|NCT00610012|Therapy-reality|therapy-reality
705531|NCT00610012|Observation|observation
705532|NCT00610012|Registry|registry
705533|NCT00610012|RCC|rcc
705534|NCT00610012|ARCC|arcc
705535|NCT00610012|Germany|germany
705536|NCT00610012|Metastatic Renal Cell Carcinoma|metastatic renal cell carcinoma
705537|NCT00610012|Renal Cell Carcinoma|renal cell carcinoma
705538|NCT00610012|Renal Cell Cancer|renal cell cancer
705539|NCT00610012|Sorafenib|sorafenib
705540|NCT00610012|Sunitinib|sunitinib
705541|NCT00610012|Interferon|interferon
705542|NCT00610012|Interleukin|interleukin
705543|NCT00610012|Temsirolimus|temsirolimus
705544|NCT00610012|Pazopanib|pazopanib
705545|NCT00610012|Cytokines|cytokines
705546|NCT00610012|VEGF|vegf
705547|NCT00609999|Glioblastoma|glioblastoma
705548|NCT00609999|Gliosarcoma|gliosarcoma
705549|NCT00609999|GBM|gbm
705550|NCT00609999|Recurrent MG|recurrent mg
705551|NCT00609999|Erlotinib|erlotinib
705552|NCT00609999|Dasatinib|dasatinib
705553|NCT00609999|Brain tumor|brain tumor
705554|NCT00609999|Malignant glioma|malignant glioma
705555|NCT00609999|Tarceva|tarceva
705556|NCT00609999|Sprycel|sprycel
705557|NCT00609986|Kidney|kidney
705558|NCT00609986|Transplantation|transplantation
705559|NCT00609986|Diabetes|diabetes
705560|NCT00609986|Hyperglycemia|hyperglycemia
705561|NCT00609973|Postoperative recurrence, inflammatory bowel disease|postoperative recurrence, inflammatory bowel disease
705562|NCT00609960|children anesthesia anxiety clowns|children anesthesia anxiety clowns
705563|NCT00609934|renal cell carcinoma|renal cell carcinoma
705564|NCT00609934|kidney cancer|kidney cancer
705565|NCT00609934|bone metastases|bone metastases
705566|NCT00609934|RCC|rcc
705567|NCT00609934|bone pain|bone pain
705568|NCT00609934|palliative radiotherapy|palliative radiotherapy
705569|NCT00609934|sorafenib|sorafenib
705570|NCT00609934|radiation|radiation
705571|NCT00609934|renal cell|renal cell
705572|NCT00609882|Nasal CPAP|nasal cpap
705573|NCT00609882|High flow nasal cannula|high flow nasal cannula
705574|NCT00609882|Neonate|neonate
705575|NCT00609843|Bladder cancer|bladder cancer
705576|NCT00609843|Radiotherapy|radiotherapy
705577|NCT00609843|Tumour delineation|tumour delineation
705578|NCT00609843|Markers|markers
705579|NCT00609830|Glucocorticoids|glucocorticoids
705580|NCT00609830|Osteoporosis|osteoporosis
705581|NCT00609830|Rheumatoid Arthritis|rheumatoid arthritis
705582|NCT00609830|Prevention|prevention
705583|NCT00609830|GIOP|giop
705584|NCT00609830|Patient Education|patient education
705585|NCT00609817|Relapsed Multiple Myeloma|relapsed multiple myeloma
705586|NCT00609817|Refractory Multiple Myeloma|refractory multiple myeloma
705587|NCT00609817|GCS 100|gcs 100
705588|NCT00609804|Non-Small Cell Lung Cancer|non-small cell lung cancer
705589|NCT00609804|Advanced|advanced
705590|NCT00609804|Erlotinib|erlotinib
705591|NCT00609804|Sorafenib|sorafenib
705592|NCT00609804|Progressing on erlotinib|progressing on erlotinib
705593|NCT00609791|recurrent breast cancer|recurrent breast cancer
705594|NCT00609791|stage IV breast cancer|stage iv breast cancer
705595|NCT00609791|male breast cancer|male breast cancer
705596|NCT00609778|CPR|cpr
705597|NCT00609778|Mechanical|mechanical
705598|NCT00609778|Manual|manual
705599|NCT00609778|Survival|survival
705600|NCT00609778|ROSC|rosc
705601|NCT00609765|advanced|advanced
705602|NCT00609765|unresectable|unresectable
705603|NCT00609765|metastatic|metastatic
705604|NCT00609765|endocrine|endocrine
705605|NCT00609765|tumors|tumors
705606|NCT00609752|Crohn Disease|crohn disease
705607|NCT00609752|Children|children
705608|NCT00609752|Bone Density|bone density
705609|NCT00609752|Prednisolone|prednisolone
705610|NCT00609752|Liquid Diet Therapy|liquid diet therapy
705611|NCT00609752|Quality of Life|quality of life
705612|NCT00609752|Metabolic Bone Disease|metabolic bone disease
705613|NCT00609739|juvenile myelomonocytic leukemia|juvenile myelomonocytic leukemia
705614|NCT00609726|Endoscopic Ultrasonography|endoscopic ultrasonography
705615|NCT00609726|Pancreatitis|pancreatitis
705616|NCT00609726|EUS|eus
705617|NCT00609713|Child|child
705618|NCT00609713|Obesity|obesity
705619|NCT00609700|burn injury|burn injury
705620|NCT00609700|volume replacement|volume replacement
705621|NCT00609700|Ringer's Lactate solution|ringer's lactate solution
705622|NCT00609700|Ringer's Acetate solution|ringer's acetate solution
705623|NCT00609700|volume replacement with crystalloids|volume replacement with crystalloids
705624|NCT00609687|sarcoidosis|sarcoidosis
705625|NCT00609687|diagnostic vitrectomy|diagnostic vitrectomy
705626|NCT00609687|vitreous biopsy|vitreous biopsy
705627|NCT00609687|sarcoidosis-associated ocular inflammation|sarcoidosis-associated ocular inflammation
705628|NCT00609674|Perennial allergic rhinitis; fluticasone furoate nasal spray|perennial allergic rhinitis; fluticasone furoate nasal spray
705629|NCT00609661|Mesenchymal Stem Cells, Burn|mesenchymal stem cells, burn
705630|NCT00609648|Dental Anxiety|dental anxiety
705631|NCT00609648|Dental Phobia|dental phobia
705632|NCT00609648|Odontophobia|odontophobia
705633|NCT00609635|Respiratory|respiratory
705634|NCT00609635|RSV-induced respiratory illness|rsv-induced respiratory illness
705635|NCT00609622|metastatic colorectal cancer sunitinib (Sutent) bevacizumab (Avastin) randomized study|metastatic colorectal cancer sunitinib (sutent) bevacizumab (avastin) randomized study
705636|NCT00609609|Allogeneic stem cell grafts|allogeneic stem cell grafts
705637|NCT00609609|Allogeneic bone marrow graft|allogeneic bone marrow graft
705638|NCT00609609|Blood and Marrow Transplantation|blood and marrow transplantation
705639|NCT00609609|Stem cell graft|stem cell graft
705640|NCT00609609|Graft Versus Host Disease|graft versus host disease
705641|NCT00609609|GVHD|gvhd
705642|NCT00609609|Extracorporeal Photopheresis|extracorporeal photopheresis
705643|NCT00609609|ECP|ecp
705644|NCT00609609|Photopheresis|photopheresis
705645|NCT00609609|Methylprednisolone|methylprednisolone
705646|NCT00609609|Medrol|medrol
705647|NCT00609609|Depo-Medrol|depo-medrol
705648|NCT00609609|Solu-Medrol|solu-medrol
705649|NCT00609596|dutasteride|dutasteride
705650|NCT00609596|tamsulosin|tamsulosin
705651|NCT00609596|benign prostatic hyperplasia|benign prostatic hyperplasia
705652|NCT00609570|hypertension|hypertension
705653|NCT00609570|supplement|supplement
705654|NCT00609570|HRV|hrv
705655|NCT00609557|osteoarthritis pain|osteoarthritis pain
705656|NCT00609557|activity limitation|activity limitation
705657|NCT00609557|antidepressant|antidepressant
705658|NCT00609557|depression|depression
705659|NCT00609557|single-blind|single-blind
705660|NCT00609544|Non Dialysis-dependent chronic kidney disease and anemia|non dialysis-dependent chronic kidney disease and anemia
705661|NCT00609531|Restricted repetitive behaviors|restricted repetitive behaviors
705662|NCT00609531|restricted interests|restricted interests
705663|NCT00609531|Aspergers|aspergers
705664|NCT00609531|Autism|autism
705665|NCT00609505|Hereditary Breast and Ovarian Cancer syndrome|hereditary breast and ovarian cancer syndrome
705666|NCT00609505|genetic counseling|genetic counseling
705667|NCT00609505|breast cancer|breast cancer
705668|NCT00609505|ovarian cancer|ovarian cancer
705669|NCT00609505|telemedicine|telemedicine
705670|NCT00609505|Cancer genetic counseling|cancer genetic counseling
705671|NCT00609479|Distal radius fracture|distal radius fracture
892263|NCT00006176|FENIB|fenib
705672|NCT00609479|Colle´s fracture|colle´s fracture
705673|NCT00609479|Internal fixation|internal fixation
705674|NCT00609479|External fixation|external fixation
705675|NCT00609479|DASH|dash
705676|NCT00609479|PRWE|prwe
705677|NCT00609466|Opioid|opioid
705678|NCT00609466|Central acting analgesic|central acting analgesic
705679|NCT00609466|CG5503 IR|cg5503 ir
705680|NCT00609466|Postoperative pain|postoperative pain
705681|NCT00609466|Bunionectomy|bunionectomy
705682|NCT00609466|Morphine|morphine
705683|NCT00609466|Placebo|placebo
705684|NCT00609453|Control participants|control participants
705685|NCT00609440|Morquio's disease; physiotherapy; results|morquio's disease; physiotherapy; results
705686|NCT00609427|cognitive training|cognitive training
705687|NCT00609427|cognitive rehabilitation|cognitive rehabilitation
705688|NCT00609414|Burns|burns
705689|NCT00609414|Albumin|albumin
705690|NCT00609414|Fluid Resuscitation|fluid resuscitation
705691|NCT00609401|Sorafenib|sorafenib
705692|NCT00609401|RCC|rcc
705693|NCT00609401|Metastatic disease|metastatic disease
705694|NCT00609375|Sepsis|sepsis
705695|NCT00609375|Bacteremia|bacteremia
705696|NCT00609375|Intravenous infusions|intravenous infusions
705697|NCT00609375|cefepime|cefepime
705698|NCT00609362|BMD|bmd
705699|NCT00609362|Rosiglitazone|rosiglitazone
705700|NCT00609362|Bone marrow fat|bone marrow fat
705701|NCT00609349|risk factors for pulmonary arterial hypertension|risk factors for pulmonary arterial hypertension
705702|NCT00609323|Pain|pain
705703|NCT00609323|postherpetic neuralgia|postherpetic neuralgia
705704|NCT00609310|clinical trial|clinical trial
705705|NCT00609310|flavonoid treatment|flavonoid treatment
705706|NCT00609310|neoplasia recurrence|neoplasia recurrence
705707|NCT00609310|colorectal cancer|colorectal cancer
705708|NCT00609310|polypectomy|polypectomy
705709|NCT00609310|adenoma in Colon|adenoma in colon
705710|NCT00609310|Neoplasia Recurrence Rates|neoplasia recurrence rates
705711|NCT00609310|postpolypectomy patients|postpolypectomy patients
705712|NCT00609297|unspecified adult solid tumor, protocol specific|unspecified adult solid tumor, protocol specific
705713|NCT00609297|pain|pain
705714|NCT00609284|Stage III|stage iii
705715|NCT00609284|Stage IV|stage iv
705716|NCT00609284|locally advanced|locally advanced
705717|NCT00609245|epilepsy|epilepsy
705718|NCT00609245|photosensitive|photosensitive
705719|NCT00609245|valproic acid|valproic acid
705720|NCT00609219|recurrent nasopharyngeal cancer|recurrent nasopharyngeal cancer
705721|NCT00609219|stage II nasopharyngeal cancer|stage ii nasopharyngeal cancer
705722|NCT00609219|stage III nasopharyngeal cancer|stage iii nasopharyngeal cancer
705723|NCT00609219|stage IV nasopharyngeal cancer|stage iv nasopharyngeal cancer
705724|NCT00609180|Acute Lung Injury|acute lung injury
705725|NCT00609180|Acute Respiratory Distress Syndrome|acute respiratory distress syndrome
705726|NCT00609180|Feeding|feeding
705727|NCT00609180|Critical Care|critical care
705728|NCT00609180|Ventilator|ventilator
705729|NCT00609180|Omega-3 Fatty Acid|omega-3 fatty acid
705730|NCT00609180|Antioxidant|antioxidant
705731|NCT00609167|stage II multiple myeloma|stage ii multiple myeloma
705732|NCT00609167|stage III multiple myeloma|stage iii multiple myeloma
705733|NCT00609154|Type 2 diabetes|type 2 diabetes
705734|NCT00609154|Insulin|insulin
705735|NCT00609154|biosynthesis|biosynthesis
705736|NCT00609154|Non diabetic control|non diabetic control
705737|NCT00609128|tears|tears
705738|NCT00609128|conjunctival epithelial cells|conjunctival epithelial cells
705739|NCT00609128|olopatadine|olopatadine
705740|NCT00609128|eosinophils|eosinophils
705741|NCT00609115|Sub-acute care|sub-acute care
705742|NCT00609115|Robotics|robotics
705743|NCT00609102|Type 2 diabetes|type 2 diabetes
705744|NCT00609089|Family|family
705745|NCT00609089|treatment|treatment
705746|NCT00609089|reinforcement|reinforcement
705747|NCT00609089|substance|substance
705748|NCT00609089|trial|trial
705749|NCT00609089|drug|drug
705750|NCT00609089|abuse|abuse
705751|NCT00609089|HIV|hiv
705752|NCT00609089|risk|risk
705753|NCT00609063|Statins|statins
705754|NCT00609063|Myalgia|myalgia
705755|NCT00609063|Muscle Cramp|muscle cramp
705756|NCT00609050|cystic fibrosis|cystic fibrosis
705757|NCT00609050|exercise|exercise
705758|NCT00609050|perceived exertion|perceived exertion
705759|NCT00609050|aerobic fitness|aerobic fitness
705760|NCT00609050|lung function|lung function
705761|NCT00609050|health related quality of life|health related quality of life
705762|NCT00609050|self-regulated exercise|self-regulated exercise
705763|NCT00609037|Gastric Bypass|gastric bypass
705764|NCT00609037|Body contouring|body contouring
705765|NCT00609037|Excessive weight loss|excessive weight loss
705766|NCT00609011|Melanoma|melanoma
705767|NCT00609011|Metastatic|metastatic
705768|NCT00608998|Chronic renal failure|chronic renal failure
705769|NCT00608998|Vasculopathy|vasculopathy
705770|NCT00608998|Cardiovascular risk|cardiovascular risk
705771|NCT00608998|Chronic renal failure patients|chronic renal failure patients
705772|NCT00608985|sleeplessness|sleeplessness
705773|NCT00608985|orexin receptor antagonist|orexin receptor antagonist
705774|NCT00608985|almorexant|almorexant
705775|NCT00608985|insomnia|insomnia
705776|NCT00608972|negative for a protein called HER2/neu|negative for a protein called her2/neu
705777|NCT00608972|negative for estrogen receptors (ER) and progesterone receptors (PR).|negative for estrogen receptors (er) and progesterone receptors (pr).
705778|NCT00608972|breast cancer|breast cancer
705779|NCT00608959|Skin colonization|skin colonization
705780|NCT00608959|Catheter colonization|catheter colonization
705781|NCT00608959|Catheter site infection|catheter site infection
705782|NCT00608946|efficacy of treatment with copper in patients with mild Alzheimer´s disease|efficacy of treatment with copper in patients with mild alzheimer´s disease
705783|NCT00608946|cognitive status over time|cognitive status over time
705784|NCT00608946|CSF and volumetric data over time (1 year)|csf and volumetric data over time (1 year)
705785|NCT00608933|unspecified adult solid tumor, protocol specific|unspecified adult solid tumor, protocol specific
705786|NCT00608933|unspecified childhood solid tumor, protocol specific|unspecified childhood solid tumor, protocol specific
705787|NCT00608920|SPECT|spect
705788|NCT00608894|Autoimmune hepatitis|autoimmune hepatitis
705789|NCT00608894|Chronic active hepatitis|chronic active hepatitis
705790|NCT00608881|Huntington's disease|huntington's disease
705791|NCT00608881|Huntington disease|huntington disease
705792|NCT00608881|HD|hd
705793|NCT00608881|coenzyme Q10|coenzyme q10
705794|NCT00608881|CoQ|coq
705795|NCT00608868|Carcinoma|carcinoma
705796|NCT00608868|Non Small Cell Lung|non small cell lung
705797|NCT00608868|EGFR mutation|egfr mutation
705798|NCT00608868|Gefitinib|gefitinib
705799|NCT00608855|bone metastases|bone metastases
705800|NCT00608855|pain|pain
705801|NCT00608855|unspecified adult solid tumor, protocol specific|unspecified adult solid tumor, protocol specific
705802|NCT00608816|epinephrine|epinephrine
705803|NCT00608790|Tuberculosis, TB, Mycobacterium tuberculosis, children, South Africa|tuberculosis, tb, mycobacterium tuberculosis, children, south africa
705804|NCT00608777|Localized mild breakthrough|localized mild breakthrough
705805|NCT00608764|Chronic Obstructive Pulmonary Disease|chronic obstructive pulmonary disease
705806|NCT00608764|COPD|copd
705807|NCT00608764|Emphysema|emphysema
705808|NCT00608764|Chronic Bronchitis|chronic bronchitis
705809|NCT00608764|Genetics|genetics
705810|NCT00608764|Association Studies|association studies
705811|NCT00608764|Computed Tomography|computed tomography
705812|NCT00608751|Newly Diagnosed head and neck cancer|newly diagnosed head and neck cancer
705813|NCT00608738|neutropenia|neutropenia
705814|NCT00608738|infection|infection
705815|NCT00608738|radiation toxicity|radiation toxicity
705816|NCT00608738|chemotherapeutic agent toxicity|chemotherapeutic agent toxicity
705817|NCT00608738|malnutrition|malnutrition
705818|NCT00608738|musculoskeletal complications|musculoskeletal complications
705819|NCT00608738|thrombocytopenia|thrombocytopenia
705820|NCT00608738|unspecified adult solid tumor, protocol specific|unspecified adult solid tumor, protocol specific
705821|NCT00608725|heart rate|heart rate
705822|NCT00608725|blood pressure|blood pressure
705823|NCT00608725|blood volume|blood volume
705824|NCT00608725|sympathetic nervous system|sympathetic nervous system
705825|NCT00608725|orthostatic tachycardia|orthostatic tachycardia
705826|NCT00608725|orthostatic intolerance|orthostatic intolerance
705827|NCT00608725|POTS|pots
705828|NCT00608712|bariatric surgery|bariatric surgery
705829|NCT00608712|ulcer prevention|ulcer prevention
705830|NCT00608699|Flushing|flushing
705831|NCT00608699|GSK256073A,|gsk256073a,
705832|NCT00608699|Dose Escalation,|dose escalation,
705833|NCT00608699|Immediate Release Niacin,|immediate release niacin,
705834|NCT00608686|NIAAA|niaaa
705835|NCT00608686|Alcohol|alcohol
705836|NCT00608686|Neurosteroids|neurosteroids
705837|NCT00608686|Intoxication|intoxication
705838|NCT00608673|discoid lupus erythematosus|discoid lupus erythematosus
705839|NCT00608673|pimecrolimus 1% cream|pimecrolimus 1% cream
705840|NCT00608673|betamethasone valerate 0.1% cream|betamethasone valerate 0.1% cream
705841|NCT00608660|Peripheral Facial Paralysis|peripheral facial paralysis
705842|NCT00608660|Acupuncture|acupuncture
705843|NCT00608660|RCT|rct
705844|NCT00608634|actinic keratosis|actinic keratosis
705845|NCT00608621|physostigmine|physostigmine
705846|NCT00608621|postoperative analgesia|postoperative analgesia
705847|NCT00608621|pain|pain
705848|NCT00608621|patient-controlled analgesia|patient-controlled analgesia
705849|NCT00608621|Opioid consumption|opioid consumption
705850|NCT00608621|Pain quality (VAS Score)|pain quality (vas score)
705851|NCT00608621|Hemodynamics|hemodynamics
705852|NCT00608621|Mobilisation|mobilisation
705853|NCT00608621|Side effects|side effects
705854|NCT00608595|adenocarcinoma of the rectum|adenocarcinoma of the rectum
705855|NCT00608595|recurrent rectal cancer|recurrent rectal cancer
705856|NCT00608595|stage I rectal cancer|stage i rectal cancer
705857|NCT00608595|stage II rectal cancer|stage ii rectal cancer
705858|NCT00608595|stage III rectal cancer|stage iii rectal cancer
705859|NCT00608582|Transcranial Magnetic Stimulation, Repetitive|transcranial magnetic stimulation, repetitive
705860|NCT00608582|TMS|tms
705861|NCT00608582|Treat Naming|treat naming
705862|NCT00608582|Aphasia|aphasia
705863|NCT00608582|Chronic Stroke|chronic stroke
705864|NCT00608582|Randomized, Controlled Trial|randomized, controlled trial
705865|NCT00608569|Drug Therapy, Combination|drug therapy, combination
705866|NCT00608569|HIV Non-Nucleoside Reverse Transcriptase Inhibitors|hiv non-nucleoside reverse transcriptase inhibitors
705867|NCT00608569|HIV Protease Inhibitors|hiv protease inhibitors
705868|NCT00608569|Viral Load|viral load
705869|NCT00608569|Virologic Failure|virologic failure
705870|NCT00608556|Heterotaxy|heterotaxy
705871|NCT00608556|Primary Ciliary Dyskinesia|primary ciliary dyskinesia
705872|NCT00608556|Congenital Heart Disease|congenital heart disease
705873|NCT00608556|Genetic Study|genetic study
705874|NCT00608556|Situs Inversus|situs inversus
705875|NCT00608543|cognitive function|cognitive function
705876|NCT00608543|psychosocial function|psychosocial function
705877|NCT00608543|augmentation|augmentation
705878|NCT00608543|treatment refractory depression|treatment refractory depression
705879|NCT00608530|pain|pain
705880|NCT00608530|chronic pain|chronic pain
705881|NCT00608530|chronic back pain|chronic back pain
705882|NCT00608530|randomized clinical trial|randomized clinical trial
705883|NCT00608517|graft versus host disease|graft versus host disease
705884|NCT00608517|accelerated phase chronic myelogenous leukemia|accelerated phase chronic myelogenous leukemia
705885|NCT00608517|adult acute lymphoblastic leukemia in remission|adult acute lymphoblastic leukemia in remission
705886|NCT00608517|adult acute myeloid leukemia in remission|adult acute myeloid leukemia in remission
705887|NCT00608517|adult acute myeloid leukemia with 11q23 (MLL) abnormalities|adult acute myeloid leukemia with 11q23 (mll) abnormalities
705888|NCT00608517|adult acute myeloid leukemia with inv(16)(p13;q22)|adult acute myeloid leukemia with inv(16)(p13;q22)
705889|NCT00608517|adult acute myeloid leukemia with t(15;17)(q22;q12)|adult acute myeloid leukemia with t(15;17)(q22;q12)
705890|NCT00608517|adult acute myeloid leukemia with t(16;16)(p13;q22)|adult acute myeloid leukemia with t(16;16)(p13;q22)
705891|NCT00608517|adult acute myeloid leukemia with t(8;21)(q22;q22)|adult acute myeloid leukemia with t(8;21)(q22;q22)
705892|NCT00608517|blastic phase chronic myelogenous leukemia|blastic phase chronic myelogenous leukemia
705893|NCT00608517|childhood acute lymphoblastic leukemia in remission|childhood acute lymphoblastic leukemia in remission
705894|NCT00608517|childhood acute myeloid leukemia in remission|childhood acute myeloid leukemia in remission
705895|NCT00608517|childhood chronic myelogenous leukemia|childhood chronic myelogenous leukemia
705896|NCT00608517|chronic phase chronic myelogenous leukemia|chronic phase chronic myelogenous leukemia
705897|NCT00608517|de novo myelodysplastic syndromes|de novo myelodysplastic syndromes
705898|NCT00608517|extranodal marginal zone B-cell lymphoma of mucosa-associated lymphoid tissue|extranodal marginal zone b-cell lymphoma of mucosa-associated lymphoid tissue
705899|NCT00608517|myelodysplastic/myeloproliferative disease, unclassifiable|myelodysplastic/myeloproliferative disease, unclassifiable
705900|NCT00608517|nodal marginal zone B-cell lymphoma|nodal marginal zone b-cell lymphoma
705901|NCT00608517|noncontiguous stage II adult Burkitt lymphoma|noncontiguous stage ii adult burkitt lymphoma
705902|NCT00608517|noncontiguous stage II adult diffuse large cell lymphoma|noncontiguous stage ii adult diffuse large cell lymphoma
705903|NCT00608517|noncontiguous stage II adult diffuse mixed cell lymphoma|noncontiguous stage ii adult diffuse mixed cell lymphoma
705904|NCT00608517|noncontiguous stage II adult diffuse small cleaved cell lymphoma|noncontiguous stage ii adult diffuse small cleaved cell lymphoma
705905|NCT00608517|noncontiguous stage II adult immunoblastic large cell lymphoma|noncontiguous stage ii adult immunoblastic large cell lymphoma
705906|NCT00608517|noncontiguous stage II adult lymphoblastic lymphoma|noncontiguous stage ii adult lymphoblastic lymphoma
705907|NCT00608517|noncontiguous stage II adult non-Hodgkin lymphoma|noncontiguous stage ii adult non-hodgkin lymphoma
705908|NCT00608517|noncontiguous stage II grade 1 follicular lymphoma|noncontiguous stage ii grade 1 follicular lymphoma
705909|NCT00608517|noncontiguous stage II grade 2 follicular lymphoma|noncontiguous stage ii grade 2 follicular lymphoma
705910|NCT00608517|noncontiguous stage II grade 3 follicular lymphoma|noncontiguous stage ii grade 3 follicular lymphoma
705911|NCT00608517|noncontiguous stage II mantle cell lymphoma|noncontiguous stage ii mantle cell lymphoma
705912|NCT00608517|noncontiguous stage II marginal zone lymphoma|noncontiguous stage ii marginal zone lymphoma
705913|NCT00608517|noncontiguous stage II small lymphocytic lymphoma|noncontiguous stage ii small lymphocytic lymphoma
705914|NCT00608517|previously treated myelodysplastic syndromes|previously treated myelodysplastic syndromes
705915|NCT00608517|secondary acute myeloid leukemia|secondary acute myeloid leukemia
705916|NCT00608517|secondary myelodysplastic syndromes|secondary myelodysplastic syndromes
705917|NCT00608517|splenic marginal zone lymphoma|splenic marginal zone lymphoma
705918|NCT00608517|stage I multiple myeloma|stage i multiple myeloma
705919|NCT00608517|stage II multiple myeloma|stage ii multiple myeloma
705920|NCT00608517|refractory multiple myeloma|refractory multiple myeloma
705921|NCT00608517|stage III adult Burkitt lymphoma|stage iii adult burkitt lymphoma
705922|NCT00608517|stage III adult Hodgkin lymphoma|stage iii adult hodgkin lymphoma
705923|NCT00608517|stage III adult diffuse large cell lymphoma|stage iii adult diffuse large cell lymphoma
705924|NCT00608517|stage III adult diffuse mixed cell lymphoma|stage iii adult diffuse mixed cell lymphoma
705925|NCT00608517|stage III adult diffuse small cleaved cell lymphoma|stage iii adult diffuse small cleaved cell lymphoma
705926|NCT00608517|stage III adult immunoblastic large cell lymphoma|stage iii adult immunoblastic large cell lymphoma
705927|NCT00608517|stage III adult lymphoblastic lymphoma|stage iii adult lymphoblastic lymphoma
705928|NCT00608517|stage III chronic lymphocytic leukemia|stage iii chronic lymphocytic leukemia
705929|NCT00608517|stage III grade 1 follicular lymphoma|stage iii grade 1 follicular lymphoma
705930|NCT00608517|stage III grade 2 follicular lymphoma|stage iii grade 2 follicular lymphoma
705931|NCT00608517|stage III grade 3 follicular lymphoma|stage iii grade 3 follicular lymphoma
705932|NCT00608517|stage III mantle cell lymphoma|stage iii mantle cell lymphoma
705933|NCT00608517|stage III marginal zone lymphoma|stage iii marginal zone lymphoma
705934|NCT00608517|stage III multiple myeloma|stage iii multiple myeloma
705935|NCT00608517|stage III small lymphocytic lymphoma|stage iii small lymphocytic lymphoma
705936|NCT00608517|stage IV adult Burkitt lymphoma|stage iv adult burkitt lymphoma
705937|NCT00608517|stage IV adult Hodgkin lymphoma|stage iv adult hodgkin lymphoma
705938|NCT00608517|stage IV adult diffuse large cell lymphoma|stage iv adult diffuse large cell lymphoma
705939|NCT00608517|stage IV adult diffuse mixed cell lymphoma|stage iv adult diffuse mixed cell lymphoma
705940|NCT00608517|stage IV adult diffuse small cleaved cell lymphoma|stage iv adult diffuse small cleaved cell lymphoma
705941|NCT00608517|stage IV adult immunoblastic large cell lymphoma|stage iv adult immunoblastic large cell lymphoma
705942|NCT00608517|stage IV adult lymphoblastic lymphoma|stage iv adult lymphoblastic lymphoma
705943|NCT00608517|stage IV chronic lymphocytic leukemia|stage iv chronic lymphocytic leukemia
705944|NCT00608517|stage IV grade 1 follicular lymphoma|stage iv grade 1 follicular lymphoma
705945|NCT00608517|stage IV grade 2 follicular lymphoma|stage iv grade 2 follicular lymphoma
705946|NCT00608517|stage IV grade 3 follicular lymphoma|stage iv grade 3 follicular lymphoma
705947|NCT00608517|stage IV mantle cell lymphoma|stage iv mantle cell lymphoma
705948|NCT00608517|stage IV marginal zone lymphoma|stage iv marginal zone lymphoma
705949|NCT00608517|stage IV small lymphocytic lymphoma|stage iv small lymphocytic lymphoma
705950|NCT00608517|Philadelphia chromosome positive adult precursor acute lymphoblastic leukemia|philadelphia chromosome positive adult precursor acute lymphoblastic leukemia
705951|NCT00608517|Philadelphia chromosome positive childhood precursor acute lymphoblastic leukemia|philadelphia chromosome positive childhood precursor acute lymphoblastic leukemia
705952|NCT00608517|refractory chronic lymphocytic leukemia|refractory chronic lymphocytic leukemia
705953|NCT00608517|childhood myelodysplastic syndromes|childhood myelodysplastic syndromes
705954|NCT00608517|stage III adult T-cell leukemia/lymphoma|stage iii adult t-cell leukemia/lymphoma
705955|NCT00608517|stage IV adult T-cell leukemia/lymphoma|stage iv adult t-cell leukemia/lymphoma
705956|NCT00608517|adult nasal type extranodal NK/T-cell lymphoma|adult nasal type extranodal nk/t-cell lymphoma
705957|NCT00608517|childhood nasal type extranodal NK/T-cell lymphoma|childhood nasal type extranodal nk/t-cell lymphoma
705958|NCT00608517|stage III cutaneous T-cell non-Hodgkin lymphoma|stage iii cutaneous t-cell non-hodgkin lymphoma
705959|NCT00608517|stage IV cutaneous T-cell non-Hodgkin lymphoma|stage iv cutaneous t-cell non-hodgkin lymphoma
705960|NCT00608517|recurrent cutaneous T-cell non-Hodgkin lymphoma|recurrent cutaneous t-cell non-hodgkin lymphoma
705961|NCT00608517|recurrent adult T-cell leukemia/lymphoma|recurrent adult t-cell leukemia/lymphoma
705962|NCT00608504|Behavioral Economics|behavioral economics
705963|NCT00608504|Drug self administration|drug self administration
705964|NCT00608504|Opioid|opioid
705965|NCT00608491|Acute Decompensated Heart Failure|acute decompensated heart failure
705966|NCT00608491|Acute Decompensated Heart Failure With Cardiorenal Syndrome|acute decompensated heart failure with cardiorenal syndrome
705967|NCT00608491|Cardiorenal Syndrome|cardiorenal syndrome
705968|NCT00608491|Persistent Congestion|persistent congestion
705969|NCT00608491|Ultra Filtration|ultra filtration
705970|NCT00608465|Fibrolytic Dysfunction|fibrolytic dysfunction
705971|NCT00608465|Obesity|obesity
705972|NCT00608465|PAI-1|pai-1
705973|NCT00608452|Lung|lung
705974|NCT00608452|Ovarian|ovarian
705975|NCT00608452|Breast|breast
705976|NCT00608452|Hodgkin's|hodgkin's
705977|NCT00608439|CAST|cast
705978|NCT00608439|Centella asiatica|centella asiatica
705979|NCT00608439|Diabetes|diabetes
705980|NCT00608439|Diabetic neuropathy|diabetic neuropathy
705981|NCT00608426|African Americans|african americans
705982|NCT00608426|telephone counseling|telephone counseling
705983|NCT00608426|community health planning|community health planning
705984|NCT00608426|ethnic groups|ethnic groups
705985|NCT00608400|CLA|cla
705986|NCT00608400|PTH|pth
705987|NCT00608400|nutritional supplement|nutritional supplement
705988|NCT00608374|Waldenström macroglobulinemia|waldenström macroglobulinemia
705989|NCT00608374|splenic marginal zone lymphoma|splenic marginal zone lymphoma
705990|NCT00608374|stage I marginal zone lymphoma|stage i marginal zone lymphoma
705991|NCT00608374|stage III marginal zone lymphoma|stage iii marginal zone lymphoma
705992|NCT00608374|stage IV marginal zone lymphoma|stage iv marginal zone lymphoma
705993|NCT00608374|contiguous stage II marginal zone lymphoma|contiguous stage ii marginal zone lymphoma
705994|NCT00608374|noncontiguous stage II marginal zone lymphoma|noncontiguous stage ii marginal zone lymphoma
705995|NCT00608348|exercise|exercise
705996|NCT00608348|hypoglycemia|hypoglycemia
705997|NCT00608348|sympathetic nerve activity|sympathetic nerve activity
705998|NCT00608335|Antifungal|antifungal
705999|NCT00608335|Micafungin|micafungin
706000|NCT00608335|Echinocandin|echinocandin
706001|NCT00608335|Candidiasis|candidiasis
706002|NCT00608322|Sepsis|sepsis
706003|NCT00608322|Severe sepsis|severe sepsis
706004|NCT00608322|Septic shock|septic shock
706005|NCT00608283|Kidney transplant|kidney transplant
706006|NCT00608283|Live donor transplant|live donor transplant
706007|NCT00608244|Tacrolimus|tacrolimus
706008|NCT00608244|Pharmacokinetics|pharmacokinetics
706009|NCT00608244|Liver Transplantation|liver transplantation
706010|NCT00608218|Asthma|asthma
706011|NCT00608218|ciclesonide|ciclesonide
706012|NCT00608218|inhaled steroids|inhaled steroids
706013|NCT00608218|Alvesco|alvesco
706014|NCT00608205|stage III squamous cell carcinoma of the hypopharynx|stage iii squamous cell carcinoma of the hypopharynx
706015|NCT00608205|stage III squamous cell carcinoma of the lip and oral cavity|stage iii squamous cell carcinoma of the lip and oral cavity
706016|NCT00608205|stage III squamous cell carcinoma of the oropharynx|stage iii squamous cell carcinoma of the oropharynx
706017|NCT00608205|stage III squamous cell carcinoma of the larynx|stage iii squamous cell carcinoma of the larynx
706018|NCT00608205|stage IV squamous cell carcinoma of the hypopharynx|stage iv squamous cell carcinoma of the hypopharynx
706019|NCT00608205|stage IV squamous cell carcinoma of the lip and oral cavity|stage iv squamous cell carcinoma of the lip and oral cavity
706020|NCT00608205|stage IV squamous cell carcinoma of the oropharynx|stage iv squamous cell carcinoma of the oropharynx
706021|NCT00608205|stage IV squamous cell carcinoma of the larynx|stage iv squamous cell carcinoma of the larynx
706022|NCT00608192|HIV|hiv
706023|NCT00608192|viral hepatitis|viral hepatitis
706024|NCT00608192|methadone maintenance|methadone maintenance
706025|NCT00608192|case management|case management
706026|NCT00608192|costs|costs
706027|NCT00608192|vaccination|vaccination
706028|NCT00608192|risk reduction education|risk reduction education
706029|NCT00608179|epinephrine|epinephrine
706030|NCT00608179|glucose clamp|glucose clamp
706031|NCT00608153|essential hypertension|essential hypertension
706032|NCT00608153|ARB|arb
706033|NCT00608153|compliance|compliance
706034|NCT00608153|candesartan|candesartan
706035|NCT00608140|Advanced Heart Failure|advanced heart failure
706036|NCT00608140|Non-Ischemic Heart Failure|non-ischemic heart failure
706037|NCT00608140|Mitral Regurgitation|mitral regurgitation
706038|NCT00608140|Mitral Valve Replacement|mitral valve replacement
706039|NCT00608140|Congestive Heart Failure|congestive heart failure
706040|NCT00608140|Surgical Mitral Valvuloplasty|surgical mitral valvuloplasty
706041|NCT00608140|Dilated Cardiomyopathy|dilated cardiomyopathy
706042|NCT00608140|Annular Ring|annular ring
706043|NCT00608101|hypoglycemia|hypoglycemia
706044|NCT00608101|exercise|exercise
706045|NCT00608101|corticosteroids|corticosteroids
706046|NCT00608088|Breast feeding|breast feeding
706047|NCT00608088|breastfeeding|breastfeeding
706048|NCT00608088|randomized clinical trial|randomized clinical trial
706049|NCT00608088|poverty|poverty
706050|NCT00608062|endothelial function|endothelial function
706051|NCT00608062|women|women
706052|NCT00608062|female|female
706053|NCT00608062|estrogen deficiency|estrogen deficiency
706054|NCT00608062|sex hormones|sex hormones
706055|NCT00608062|adiposity|adiposity
706056|NCT00608062|oxidative stress|oxidative stress
706057|NCT00608062|antioxidants|antioxidants
706058|NCT00608049|Blood Pressure|blood pressure
706059|NCT00608049|Diabetes|diabetes
706060|NCT00608049|Nutrition|nutrition
706061|NCT00608049|Dietary Carbohydrate|dietary carbohydrate
706062|NCT00608049|Lipoproteins|lipoproteins
706063|NCT00608049|Insulin Resistance|insulin resistance
706064|NCT00608036|Adolescents|adolescents
706065|NCT00608036|Neighborhood|neighborhood
706066|NCT00608036|Walkability|walkability
706067|NCT00608036|Physical Activity|physical activity
706068|NCT00608036|Quality of Life|quality of life
706069|NCT00608036|Ecological Analysis|ecological analysis
706070|NCT00608036|Dietary Patterns|dietary patterns
706071|NCT00608036|Weight Status|weight status
706072|NCT00608036|Neighborhood Environment|neighborhood environment
706073|NCT00608036|Food Environment|food environment
706074|NCT00608036|Recreation Environment|recreation environment
706076|NCT00608023|Lipodystrophy|lipodystrophy
706077|NCT00608023|Abdominal fat accumulation|abdominal fat accumulation
706078|NCT00608023|Growth hormone releasing hormone|growth hormone releasing hormone
706079|NCT00608023|HIV-associated lipodystrophy|hiv-associated lipodystrophy
706080|NCT00608023|Treatment experienced|treatment experienced
706081|NCT00608010|Preservation of supernumerary embryos in an IVF program|preservation of supernumerary embryos in an ivf program
706082|NCT00607997|Leukemia|leukemia
706083|NCT00607997|Myeloid|myeloid
706084|NCT00607997|Elderly|elderly
706085|NCT00607997|Hematologic|hematologic
706086|NCT00607997|Blood|blood
706087|NCT00607997|Cancer|cancer
706088|NCT00607997|Malignancy|malignancy
706089|NCT00607997|SNS-595|sns-595
706090|NCT00607997|Sunesis|sunesis
706091|NCT00607997|Hematologic Diseases|hematologic diseases
706092|NCT00607997|Myelodysplastic Syndromes|myelodysplastic syndromes
706093|NCT00607997|Older|older
706094|NCT00607997|voreloxin|voreloxin
892866|NCT00005760|Obesity|obesity
706095|NCT00607997|reveal-1|reveal-1
706096|NCT00607984|thiotepa|thiotepa
706097|NCT00607984|melphalan|melphalan
706098|NCT00607984|brain tumor|brain tumor
706099|NCT00607984|tumors of central nervous system and other solid tumors|tumors of central nervous system and other solid tumors
706100|NCT00607971|Constipation predominant irritable bowel syndrome|constipation predominant irritable bowel syndrome
706101|NCT00607958|Tipranavir|tipranavir
706102|NCT00607958|ritonavir|ritonavir
706103|NCT00607958|dose reduction|dose reduction
706104|NCT00607958|inhibitory quotient|inhibitory quotient
706105|NCT00607945|Type 2 diabetes mellitus|type 2 diabetes mellitus
706106|NCT00607945|conjugated linoleic acid|conjugated linoleic acid
706107|NCT00607945|weight loss|weight loss
706108|NCT00607945|rosiglitazone|rosiglitazone
706109|NCT00607945|glucose control|glucose control
706110|NCT00607945|insulin sensitivity|insulin sensitivity
706111|NCT00607932|recurrent prostate cancer|recurrent prostate cancer
706112|NCT00607906|safety|safety
706113|NCT00607906|pharmacodynamics|pharmacodynamics
706114|NCT00607906|diabetes|diabetes
706115|NCT00607906|pharmacokinetics|pharmacokinetics
706116|NCT00607893|Sleep-Disordered Breathing|sleep-disordered breathing
706117|NCT00607880|vascular access device complications|vascular access device complications
706118|NCT00607880|unspecified adult solid tumor, protocol specific|unspecified adult solid tumor, protocol specific
706119|NCT00607867|Diabetes Mellitus (type 2)|diabetes mellitus (type 2)
706120|NCT00607867|Diet|diet
706121|NCT00607867|Glycohemoglobin|glycohemoglobin
706122|NCT00607867|Lipids|lipids
706123|NCT00607867|Kidney Function|kidney function
706124|NCT00607867|Glycemic Index|glycemic index
706125|NCT00607867|Dietary Protein|dietary protein
706126|NCT00607867|Dietary Carbohydrate|dietary carbohydrate
706127|NCT00607854|Zevalin|zevalin
706128|NCT00607854|Reduced intensity conditioning|reduced intensity conditioning
706129|NCT00607854|Allogenic stem cell transplantation|allogenic stem cell transplantation
706130|NCT00607828|adult primary hepatocellular carcinoma|adult primary hepatocellular carcinoma
706131|NCT00607828|advanced adult primary liver cancer|advanced adult primary liver cancer
706132|NCT00607828|localized unresectable adult primary liver cancer|localized unresectable adult primary liver cancer
706133|NCT00607828|recurrent adult primary liver cancer|recurrent adult primary liver cancer
706134|NCT00607815|PTSD|ptsd
706135|NCT00607815|OEF/OIF|oef/oif
706136|NCT00607815|Combat|combat
706137|NCT00607815|Treatment|treatment
706138|NCT00607815|CPT|cpt
706139|NCT00607815|PCT|pct
706140|NCT00607815|Cognitive|cognitive
706141|NCT00607802|unspecified adult solid tumor, protocol specific|unspecified adult solid tumor, protocol specific
706142|NCT00607802|unspecified childhood solid tumor, protocol specific|unspecified childhood solid tumor, protocol specific
706143|NCT00607776|dry, eyes|dry, eyes
706144|NCT00607776|Amelioration of dry eye symptoms|amelioration of dry eye symptoms
706145|NCT00607763|Antifungal|antifungal
706146|NCT00607763|Echinocandin|echinocandin
706147|NCT00607763|Candidiasis|candidiasis
706148|NCT00607763|Micafungin|micafungin
706149|NCT00607750|Wet AMD, Comentis, ATG003, mecamylamine|wet amd, comentis, atg003, mecamylamine
706150|NCT00607724|unspecified adult solid tumor, protocol specific|unspecified adult solid tumor, protocol specific
706151|NCT00607685|Trabeculectomy|trabeculectomy
706152|NCT00607685|Wound healing|wound healing
706153|NCT00607685|5 Fluorouracil|5 fluorouracil
706154|NCT00607685|Hyaluronic acid|hyaluronic acid
706155|NCT00607685|post-operative scarring|post-operative scarring
706156|NCT00607672|Angiotensin Converting Enzyme|angiotensin converting enzyme
706157|NCT00607672|Angiotensin Receptor Blockers|angiotensin receptor blockers
706158|NCT00607672|Cardiopulmonary Bypass|cardiopulmonary bypass
706159|NCT00607672|Fibrinolysis|fibrinolysis
706160|NCT00607672|Inflammation|inflammation
706161|NCT00607659|Chlamydia|chlamydia
706162|NCT00607659|Chlamydia trachomatis|chlamydia trachomatis
706163|NCT00607659|Adolescent Health|adolescent health
706164|NCT00607659|Female Health|female health
706165|NCT00607659|Sexually Transmitted Infections|sexually transmitted infections
706166|NCT00607659|Infertility|infertility
706167|NCT00607659|Pelvic Inflammatory Disease|pelvic inflammatory disease
706168|NCT00607646|hypoglycemia|hypoglycemia
706169|NCT00607646|dehydroepiandrosterone|dehydroepiandrosterone
706170|NCT00607633|essential hypertension|essential hypertension
706171|NCT00607633|ARB|arb
706172|NCT00607633|left ventricular hypertrophy|left ventricular hypertrophy
706173|NCT00607633|candesartan|candesartan
706174|NCT00607620|Alcohol Abuse|alcohol abuse
706175|NCT00607620|Alcohol Dependence|alcohol dependence
706176|NCT00607620|Alcohol Use Disorder|alcohol use disorder
706177|NCT00607620|Screening|screening
706178|NCT00607620|Brief Intervention|brief intervention
706179|NCT00607620|Motivational Interviewing|motivational interviewing
706180|NCT00607607|ovarian cancer|ovarian cancer
706181|NCT00607607|endometrial cancer|endometrial cancer
706182|NCT00607581|amyloidosis|amyloidosis
706183|NCT00607581|lenalidomide|lenalidomide
706184|NCT00607581|cyclophosphamide|cyclophosphamide
706185|NCT00607581|dexamethasone|dexamethasone
706186|NCT00607568|physical stress|physical stress
706187|NCT00607568|psychological stress|psychological stress
706188|NCT00607555|Infant, premature|infant, premature
706189|NCT00607555|Infant, very low birth weight|infant, very low birth weight
706190|NCT00607555|Apnea|apnea
706191|NCT00607555|Feeding methods|feeding methods
706192|NCT00607555|Diaphragm|diaphragm
706193|NCT00607542|spasticity|spasticity
706194|NCT00607542|cerebral palsy|cerebral palsy
706195|NCT00607542|baclofen|baclofen
706196|NCT00607542|pharmacokinetics|pharmacokinetics
706197|NCT00607542|pharmacodynamics|pharmacodynamics
706198|NCT00607542|dosing|dosing
706199|NCT00607542|safety|safety
706200|NCT00607542|efficacy|efficacy
706201|NCT00607529|Multiple Diseases|multiple diseases
706202|NCT00607516|fracture|fracture
706203|NCT00607516|arthroplasty|arthroplasty
706204|NCT00607516|wear|wear
706205|NCT00607516|osteoporosis|osteoporosis
706206|NCT00607516|bone|bone
706207|NCT00607490|Vulvodynia|vulvodynia
706208|NCT00607490|Vulvar pain|vulvar pain
706209|NCT00607490|Dyspareunia|dyspareunia
706210|NCT00607490|Sexual dysfunction|sexual dysfunction
706211|NCT00607490|Vestibulitis|vestibulitis
706212|NCT00607464|Hypothermia, premature infants, Polyethylene occlusive wrap|hypothermia, premature infants, polyethylene occlusive wrap
706213|NCT00607438|Locally Advanced or Metastatic|locally advanced or metastatic
706214|NCT00607425|non-small cell lung cancer|non-small cell lung cancer
706215|NCT00607425|screening|screening
706216|NCT00607425|saliva|saliva
706217|NCT00607425|gene expression|gene expression
706218|NCT00607425|healthy control subject|healthy control subject
706219|NCT00607412|PTSD|ptsd
706220|NCT00607412|substance use disorders|substance use disorders
706221|NCT00607412|psychotherapy|psychotherapy
706222|NCT00607399|Solid tumor|solid tumor
706223|NCT00607399|Advanced Cancer|advanced cancer
706224|NCT00607399|MET Inhibitor|met inhibitor
706225|NCT00607399|Receptor Tyrosine Kinase Inhibitor (RTKI)|receptor tyrosine kinase inhibitor (rtki)
706226|NCT00607386|Hunter syndrome|hunter syndrome
706227|NCT00607386|hunters syndrome|hunters syndrome
706228|NCT00607386|hunter's syndrome|hunter's syndrome
706229|NCT00607386|hunter disease|hunter disease
706230|NCT00607386|hunters disease|hunters disease
706231|NCT00607386|hunter's disease|hunter's disease
706232|NCT00607386|MPS II|mps ii
706233|NCT00607386|MPSII|mpsii
706234|NCT00607386|MPS2|mps2
706235|NCT00607386|MPS 2|mps 2
706236|NCT00607386|mucopolysaccharides|mucopolysaccharides
706237|NCT00607386|lysosomal storage disease|lysosomal storage disease
706238|NCT00607386|lysosomal storage disorder|lysosomal storage disorder
706239|NCT00607386|chronic ear infection|chronic ear infection
706240|NCT00607386|enlarged adenoids|enlarged adenoids
706241|NCT00607386|mps symptoms|mps symptoms
706242|NCT00607386|mps diagnosis|mps diagnosis
706243|NCT00607386|mps ii therapy|mps ii therapy
706244|NCT00607386|MPS II treatment|mps ii treatment
706245|NCT00607386|ert treatment|ert treatment
706246|NCT00607386|elaprase|elaprase
706247|NCT00607386|idursulfase|idursulfase
706248|NCT00607386|iduronate sulfatase|iduronate sulfatase
706249|NCT00607386|iduronate 2 sulfatase|iduronate 2 sulfatase
706250|NCT00607386|enzyme replacement therapy|enzyme replacement therapy
706251|NCT00607386|hunter syndrome treatment|hunter syndrome treatment
706252|NCT00607386|hunter's syndrome treatment|hunter's syndrome treatment
706253|NCT00607386|hunter syndrome therapy|hunter syndrome therapy
706254|NCT00607386|hunter's disease treatment|hunter's disease treatment
706255|NCT00607386|mps society|mps society
706256|NCT00607373|Apolipoprotein B|apolipoprotein b
706257|NCT00607373|Homozygous Familial Hypercholesterolemia|homozygous familial hypercholesterolemia
706258|NCT00607373|LDL-receptor gene|ldl-receptor gene
706259|NCT00607360|cocaine addiction, treatment, contingency management, employment intervention|cocaine addiction, treatment, contingency management, employment intervention
706260|NCT00607347|Keywords by National Institute of General Medical Sciences|keywords by national institute of general medical sciences
706261|NCT00607347|Hypertension|hypertension
706262|NCT00607347|Adverse metabolic effects|adverse metabolic effects
706263|NCT00607347|Beta blockers|beta blockers
706264|NCT00607347|Dyslipidemia|dyslipidemia
706265|NCT00607347|Atenolol|atenolol
706266|NCT00607347|New onset diabetes|new onset diabetes
706267|NCT00607347|Pharmacokinetic study|pharmacokinetic study
706268|NCT00607347|Oral glucose tolerance test|oral glucose tolerance test
706269|NCT00607334|Child Language|child language
706270|NCT00607334|Language Therapy|language therapy
706271|NCT00607334|Vocabulary|vocabulary
706272|NCT00607321|restenosis|restenosis
706273|NCT00607321|Coronary Disease|coronary disease
706274|NCT00607321|Coronary Arteriosclerosis|coronary arteriosclerosis
706275|NCT00607321|Arterial Occlusive Diseases|arterial occlusive diseases
706276|NCT00607295|chemotherapy|chemotherapy
706277|NCT00607295|hormonal therapy|hormonal therapy
706278|NCT00607295|urogenital atrophy|urogenital atrophy
706279|NCT00607269|Drug Abuse|drug abuse
706280|NCT00607269|Contingency management|contingency management
706281|NCT00607269|Voucher-based Reinforcement Therapy|voucher-based reinforcement therapy
706282|NCT00607269|Homosexuality|homosexuality
706283|NCT00607269|Homeless Persons|homeless persons
706284|NCT00607243|Smallpox vaccine efficacy|smallpox vaccine efficacy
706285|NCT00607230|type 1 diabetes mellitus|type 1 diabetes mellitus
706286|NCT00607230|immune modulation|immune modulation
706287|NCT00607230|cure|cure
706288|NCT00607230|autoimmunity|autoimmunity
706289|NCT00607217|Coronary artery diseases|coronary artery diseases
706290|NCT00607217|Myocardial infarction|myocardial infarction
706291|NCT00607217|Stable angina|stable angina
706292|NCT00607217|Influenza|influenza
706293|NCT00607217|Vaccine|vaccine
706294|NCT00607204|Basic Research|basic research
706295|NCT00607204|Individual Sleep Duration|individual sleep duration
706296|NCT00607204|Melatonin|melatonin
706297|NCT00607204|Electroencephalogram|electroencephalogram
706298|NCT00607204|Alertness|alertness
706299|NCT00607204|Mood|mood
706300|NCT00607191|Idiopathic talipes equinovarus (ITEV)|idiopathic talipes equinovarus (itev)
706301|NCT00607178|Influenza|influenza
706302|NCT00607178|Vaccine|vaccine
706303|NCT00607126|impaired ambulation|impaired ambulation
706304|NCT00607113|Neuroendocrine Carcinoma|neuroendocrine carcinoma
706305|NCT00607113|Avastin|avastin
706306|NCT00607113|Bevacizumab|bevacizumab
706307|NCT00607113|RAD001|rad001
706308|NCT00607113|Everolimus|everolimus
706309|NCT00607100|High-Resolution Optical Coherence Tomography|high-resolution optical coherence tomography
706310|NCT00607100|Retinal Nerve Fiber Layer|retinal nerve fiber layer
706311|NCT00607100|Band Atrophy|band atrophy
706312|NCT00607061|Glutathione|glutathione
706313|NCT00607061|Cysteine|cysteine
706314|NCT00607061|Synthesis rate|synthesis rate
706315|NCT00607061|Newborns|newborns
706316|NCT00607061|Low birth weight newborn babies|low birth weight newborn babies
706317|NCT00607022|dental implant|dental implant
706318|NCT00607022|early loading|early loading
706319|NCT00607022|traditional loading|traditional loading
706320|NCT00607022|anterior|anterior
706321|NCT00607022|implant stability|implant stability
706322|NCT00607022|Subjects presenting with one tooth missing in the anterior|subjects presenting with one tooth missing in the anterior
706323|NCT00607022|incisor/canine) or pre-molar regions of the mandible|incisor/canine) or pre-molar regions of the mandible
706324|NCT00607022|or maxilla with existing teeth that were healthy|or maxilla with existing teeth that were healthy
706325|NCT00607022|or adequately restored shall be screened.|or adequately restored shall be screened.
706326|NCT00606996|Drug Abuse|drug abuse
706327|NCT00606996|Drug Dependence|drug dependence
706328|NCT00606996|Alcohol Abuse|alcohol abuse
706329|NCT00606996|Alcohol Dependence|alcohol dependence
706330|NCT00606996|Major Depressive Disorder|major depressive disorder
706331|NCT00606996|Dysthymic Disorder|dysthymic disorder
706332|NCT00606996|Prisoners|prisoners
706334|NCT00606970|Chemotherapy|chemotherapy
706335|NCT00606970|Breast Cancer|breast cancer
706336|NCT00606970|Colon Cancer|colon cancer
706337|NCT00606970|Lung Cancer|lung cancer
706338|NCT00606957|Obesity|obesity
706339|NCT00606957|Metabolism|metabolism
706340|NCT00606944|enhanced recovery program|enhanced recovery program
706341|NCT00606931|biopsy|biopsy
706342|NCT00606931|PET|pet
706343|NCT00606931|image-guidance|image-guidance
706344|NCT00606931|breast cancer|breast cancer
706345|NCT00606931|FDG|fdg
706346|NCT00606931|PEM|pem
706347|NCT00606918|Strength testing|strength testing
706348|NCT00606918|Disease progression|disease progression
706349|NCT00606918|ALS|als
706350|NCT00606918|Healthy Adults|healthy adults
706351|NCT00606905|Recurrent miscarriage|recurrent miscarriage
706352|NCT00606905|Recurrent spontaneous abortion|recurrent spontaneous abortion
706353|NCT00606905|Habitual abortion|habitual abortion
706354|NCT00606905|IVIG|ivig
706355|NCT00606905|Randomized Controlled Trial|randomized controlled trial
706356|NCT00606892|therapeutic effects|therapeutic effects
706357|NCT00606879|Solid tumor|solid tumor
706358|NCT00606879|Advanced Cancer|advanced cancer
706359|NCT00606879|MET inhibitor|met inhibitor
706360|NCT00606879|Receptor Tyrosine Kinase Inhibitor (RTKI)|receptor tyrosine kinase inhibitor (rtki)
706361|NCT00606866|renal, metastatic, carcinoma|renal, metastatic, carcinoma
706362|NCT00606853|Substance abuse|substance abuse
706363|NCT00606853|Contingency Management|contingency management
706364|NCT00606840|overweight|overweight
706365|NCT00606840|prevention of weight gain|prevention of weight gain
706366|NCT00606840|young adults|young adults
706367|NCT00606840|self-regulation|self-regulation
706368|NCT00606840|daily weighing|daily weighing
706369|NCT00606840|weight gain prevention|weight gain prevention
706370|NCT00606827|Contrast-induced nephrophaty|contrast-induced nephrophaty
706371|NCT00606827|Contrast media|contrast media
706372|NCT00606827|Angiography|angiography
706373|NCT00606827|Coronary percutaneous intervention|coronary percutaneous intervention
706374|NCT00606814|Solid Tumors, IPI-504, docetaxel,cancer|solid tumors, ipi-504, docetaxel,cancer
706375|NCT00606801|cognitive enhancers|cognitive enhancers
706376|NCT00606801|Nootropic Agents|nootropic agents
706377|NCT00606788|randomized clinical trials|randomized clinical trials
706378|NCT00606788|intensive care|intensive care
706379|NCT00606788|mechanical ventilation|mechanical ventilation
706380|NCT00606788|ventilator weaning|ventilator weaning
706381|NCT00606788|clinical protocols|clinical protocols
706382|NCT00606788|therapy, computer-assisted|therapy, computer-assisted
706383|NCT00606788|humans|humans
706384|NCT00606788|various surgical diseases requiring mechanical ventilation over 24 hours|various surgical diseases requiring mechanical ventilation over 24 hours
706385|NCT00606775|Adrenergic beta-Antagonists|adrenergic beta-antagonists
706386|NCT00606775|Duchenne Muscular Dystrophy|duchenne muscular dystrophy
706387|NCT00606775|Cardiomyopathies|cardiomyopathies
706388|NCT00606775|Troponin I|troponin i
706389|NCT00606762|laparoscopic cholecystectomy|laparoscopic cholecystectomy
706390|NCT00606762|low pressure pneumoperitoneum|low pressure pneumoperitoneum
706391|NCT00606736|right ventricular outflow tract arrhythmia|right ventricular outflow tract arrhythmia
706392|NCT00606736|sex hormone level|sex hormone level
706393|NCT00606736|menstrual cycle|menstrual cycle
706394|NCT00606736|Gonadal Hormones|gonadal hormones
706395|NCT00606723|relapsed or refractory AML|relapsed or refractory aml
706396|NCT00606723|in children, adolescents and young adults|in children, adolescents and young adults
706397|NCT00606697|Primary Insomnia Adults|primary insomnia adults
706398|NCT00606684|Chronic Obstructive Pulmonary Disease (COPD)|chronic obstructive pulmonary disease (copd)
706399|NCT00606684|COPD|copd
706400|NCT00606684|GW642444|gw642444
706401|NCT00606671|polycystic ovary syndrome (PCOS)|polycystic ovary syndrome (pcos)
706402|NCT00606658|Insomnia|insomnia
706403|NCT00606658|Ayurveda|ayurveda
706404|NCT00606658|Shirodhara|shirodhara
706405|NCT00606658|Quality of Life|quality of life
706406|NCT00606632|Renal Mass|renal mass
706407|NCT00606632|Clear Cell Renal Cell Carcinoma|clear cell renal cell carcinoma
706408|NCT00606632|Cancer of Kidney|cancer of kidney
706409|NCT00606632|Kidney Cancer|kidney cancer
706410|NCT00606632|Neoplasms|neoplasms
706411|NCT00606632|cG250|cg250
706412|NCT00606632|antibody, monoclonal|antibody, monoclonal
706413|NCT00606632|Iodine 124|iodine 124
706414|NCT00606632|Positron-Emission Tomography|positron-emission tomography
706415|NCT00606632|Kidney|kidney
706416|NCT00606632|Renal Cancer|renal cancer
706417|NCT00606632|Renal Neoplasms|renal neoplasms
706418|NCT00606619|Gastrectomy|gastrectomy
706419|NCT00606619|Oral feeding|oral feeding
706420|NCT00606619|Nutrition|nutrition
706421|NCT00606619|Gastric cancer|gastric cancer
706422|NCT00606593|insomnia|insomnia
706423|NCT00606593|elderly|elderly
706424|NCT00606593|sleeplessness|sleeplessness
706425|NCT00606580|cutaneous leishmaniasis, topical treatment, Tunisia|cutaneous leishmaniasis, topical treatment, tunisia
706426|NCT00606567|Defibrillators, Implantable|defibrillators, implantable
706427|NCT00606554|Respiratory Insufficiency|respiratory insufficiency
706428|NCT00606554|Ventilators, Mechanical|ventilators, mechanical
706429|NCT00606554|Ventilator Weaning|ventilator weaning
706430|NCT00606554|Therapy, Computer-Assisted|therapy, computer-assisted
706431|NCT00606541|Social Anxiety Disorder|social anxiety disorder
706432|NCT00606541|Quetiapine XR|quetiapine xr
706433|NCT00606541|Prevention|prevention
706434|NCT00606541|tolerability|tolerability
706435|NCT00606528|Antiviral therapy|antiviral therapy
706436|NCT00606515|Pharmacokinetics|pharmacokinetics
706437|NCT00606515|Liposomal paclitaxel|liposomal paclitaxel
706438|NCT00606502|Stage IIIB/IV non-small cell lung cancer|stage iiib/iv non-small cell lung cancer
706439|NCT00606502|Non-small cell lung cancer|non-small cell lung cancer
706440|NCT00606502|NSCLC|nsclc
706441|NCT00606502|Lung Cancer|lung cancer
706442|NCT00606502|Pralatrexate|pralatrexate
706443|NCT00606502|Erlotinib|erlotinib
706445|NCT00606502|PDX|pdx
706446|NCT00606502|Smoking|smoking
706447|NCT00606502|Smoker|smoker
706448|NCT00606450|plaque psoriasis|plaque psoriasis
706449|NCT00606437|Umbilical Cord Blood Graft|umbilical cord blood graft
706450|NCT00606437|Stem Cell Transplantation|stem cell transplantation
706451|NCT00606424|head and neck cancer|head and neck cancer
706452|NCT00606411|Sleep-Related Eating Disorder|sleep-related eating disorder
706453|NCT00606411|Topiramate|topiramate
706454|NCT00606411|Parasomnia|parasomnia
706455|NCT00606398|colorectal metastases|colorectal metastases
706456|NCT00606385|Recurrence|recurrence
706457|NCT00606385|Survival|survival
706458|NCT00606385|Immunology|immunology
706459|NCT00606385|Laparoscopy|laparoscopy
706460|NCT00606372|Off-pump|off-pump
706461|NCT00606372|OPCAB|opcab
706462|NCT00606372|EuroSCORE|euroscore
706463|NCT00606372|high-risk patients|high-risk patients
706464|NCT00606372|Quality of life|quality of life
706465|NCT00606372|Validity of EuroSCORE|validity of euroscore
706466|NCT00606359|Influenza|influenza
706467|NCT00606359|Orthomyxoviridae Infections|orthomyxoviridae infections
706468|NCT00606359|Renal Transplant|renal transplant
706469|NCT00606346|Crohn's Disease|crohn's disease
706470|NCT00606346|Ulcerative Colitis|ulcerative colitis
706471|NCT00606346|Indeterminate Colitis|indeterminate colitis
706472|NCT00606346|Inflammatory Bowel Diseases|inflammatory bowel diseases
706473|NCT00606346|Immunomodulators|immunomodulators
706474|NCT00606346|infliximab|infliximab
706475|NCT00606346|TNF-alpha|tnf-alpha
706476|NCT00606333|Coronary artery disease|coronary artery disease
706477|NCT00606333|drug-eluting stents|drug-eluting stents
706478|NCT00606333|sirolimus-eluting coronary stents|sirolimus-eluting coronary stents
706479|NCT00606294|Head|head
706480|NCT00606294|Neck|neck
706481|NCT00606294|04-070|04-070
706482|NCT00606268|Antifungal Prophylaxis|antifungal prophylaxis
706483|NCT00606268|Hematopoietic Stem Cell Transplant|hematopoietic stem cell transplant
706484|NCT00606268|HSCT|hsct
706485|NCT00606268|Micafungin|micafungin
706486|NCT00606255|blood pressure|blood pressure
706487|NCT00606255|compliance|compliance
706488|NCT00606255|treatment|treatment
706489|NCT00606216|MRI|mri
706490|NCT00606164|Alzheimer's Disease|alzheimer's disease
706491|NCT00606164|bryostatin 1|bryostatin 1
706492|NCT00606164|bryostatin|bryostatin
706493|NCT00606164|safety|safety
706494|NCT00606164|efficacy|efficacy
706495|NCT00606164|pharmacokinetics|pharmacokinetics
706496|NCT00606164|pharmacodynamics|pharmacodynamics
706497|NCT00606164|protein kinase C|protein kinase c
706498|NCT00606151|drug eluding stents|drug eluding stents
706499|NCT00606151|perioperative bridging|perioperative bridging
706500|NCT00606151|Stents|stents
706501|NCT00606125|Chemotherapy|chemotherapy
706502|NCT00606125|Solid Tumors|solid tumors
706503|NCT00606125|Sorafenib|sorafenib
706504|NCT00606125|Carboplatin|carboplatin
706505|NCT00606125|Paclitaxel|paclitaxel
706506|NCT00606099|Adults|adults
706507|NCT00606099|compensated chronic hepatitis B|compensated chronic hepatitis b
706508|NCT00606099|telbivudin|telbivudin
706509|NCT00606099|aedevofir dipivoxil|aedevofir dipivoxil
706510|NCT00606086|Hepatitis, HCV, Liver disease, HepC|hepatitis, hcv, liver disease, hepc
706511|NCT00606060|Hemophilia,|hemophilia,
706512|NCT00606060|Continuous Infusion|continuous infusion
706513|NCT00606047|femoroacetabular impingement|femoroacetabular impingement
706514|NCT00606034|Type 2 diabetes|type 2 diabetes
706515|NCT00606034|Insulin Resistance|insulin resistance
706516|NCT00606034|Continuous Subcutaneous Insulin Infusion|continuous subcutaneous insulin infusion
706517|NCT00606034|U-500 Insulin|u-500 insulin
706518|NCT00606034|Omnipod|omnipod
706519|NCT00606008|Sutent|sutent
706520|NCT00605995|Schizophrenia|schizophrenia
706521|NCT00605995|Randomized trial|randomized trial
706522|NCT00605995|Statin|statin
706523|NCT00605995|Placebo|placebo
706524|NCT00605982|MRI|mri
706525|NCT00605969|femoroacetabular, impingement|femoroacetabular, impingement
706526|NCT00605956|head lice|head lice
706527|NCT00605956|NatrOVA Creme Rinse - 1% is intended for the treatment of head lice|natrova creme rinse - 1% is intended for the treatment of head lice
706528|NCT00605943|Retinal Disease|retinal disease
706529|NCT00605943|Bevacizumab|bevacizumab
706530|NCT00605943|Ranibizumab|ranibizumab
706531|NCT00605943|Retinal Eye Disease|retinal eye disease
706532|NCT00605943|Macular Degeneration|macular degeneration
706533|NCT00605930|Progressive Supranuclear Palsy|progressive supranuclear palsy
706534|NCT00605930|PSP|psp
706535|NCT00605930|Nutriceutical|nutriceutical
706536|NCT00605930|Pyruvate|pyruvate
706537|NCT00605930|Creatine|creatine
706538|NCT00605930|Niacinamide|niacinamide
706539|NCT00605904|Chemical Stressor|chemical stressor
706540|NCT00605904|Alcoholism|alcoholism
706541|NCT00605904|Yohimbine|yohimbine
706542|NCT00605904|Acamprosate|acamprosate
706543|NCT00605904|Craving|craving
706544|NCT00605878|Atopic Dermatitis (Eczema)|atopic dermatitis (eczema)
706545|NCT00605878|Bacteria|bacteria
706546|NCT00605878|Filaggrin|filaggrin
706547|NCT00605878|Skin|skin
706548|NCT00605878|Microbiome|microbiome
706549|NCT00605878|Atopic Dermatitis|atopic dermatitis
706550|NCT00605878|Eczema|eczema
706551|NCT00605878|Health Volunteer|health volunteer
706552|NCT00605878|HG|hg
706553|NCT00605852|Allergic rhinitis|allergic rhinitis
706554|NCT00605852|first time in human|first time in human
706555|NCT00605839|mobile technology|mobile technology
706556|NCT00605839|cell phones|cell phones
706557|NCT00605839|type 1 diabetes|type 1 diabetes
706558|NCT00605800|Liver resection|liver resection
706559|NCT00605774|catecholamines|catecholamines
706560|NCT00605774|diabetes|diabetes
706561|NCT00605774|exercise|exercise
706562|NCT00605761|Cystic Fibrosis|cystic fibrosis
706563|NCT00605761|Lung function|lung function
706564|NCT00605761|Anti-Inflammatory|anti-inflammatory
706565|NCT00605748|catheter ablation|catheter ablation
706566|NCT00605748|atrial fibrillation|atrial fibrillation
706567|NCT00605748|pulmonary vein|pulmonary vein
706568|NCT00605696|Acute Respiratory Distress Syndrome|acute respiratory distress syndrome
706569|NCT00605696|Acute Lung Injury|acute lung injury
706570|NCT00605657|ALPS|alps
706571|NCT00605657|Valproic Acid|valproic acid
706572|NCT00605657|Lymphadenopathy|lymphadenopathy
706573|NCT00605657|Splenomegaly|splenomegaly
706574|NCT00605657|Histone Deacytelase (HDAC) Inhibitor|histone deacytelase (hdac) inhibitor
706575|NCT00605657|Autoimmune Lymphoproliferative Syndrome|autoimmune lymphoproliferative syndrome
706576|NCT00605631|Pacing|pacing
706577|NCT00605605|endothelial function|endothelial function
706578|NCT00605605|atherosclerosis|atherosclerosis
706579|NCT00605605|smoking|smoking
706580|NCT00605605|inflammation|inflammation
706581|NCT00605605|antioxidant|antioxidant
706582|NCT00605592|Type 1 Diabetes|type 1 diabetes
706583|NCT00605592|Kidney Transplant|kidney transplant
706584|NCT00605592|Hypoglycemic Unawareness|hypoglycemic unawareness
706585|NCT00605592|Islet Transplant|islet transplant
706586|NCT00605592|Pancreatic Islet Cell Transplantation|pancreatic islet cell transplantation
706587|NCT00605592|University of Virginia|university of virginia
706588|NCT00605592|Islet Transplantation|islet transplantation
706589|NCT00605592|Kidney Transplantation|kidney transplantation
706590|NCT00605566|Neuroendocrine|neuroendocrine
706591|NCT00605566|sorafenib|sorafenib
706592|NCT00605566|cyclophosphamide|cyclophosphamide
706593|NCT00605566|pharmacodynamic|pharmacodynamic
706594|NCT00605540|COPD|copd
706595|NCT00605540|Survival|survival
706596|NCT00605540|Exacerbation|exacerbation
706597|NCT00605540|Disease markers|disease markers
706598|NCT00605527|Acute Lung Injury|acute lung injury
706599|NCT00605527|Acute Respiratory Distress Syndrome|acute respiratory distress syndrome
706600|NCT00605514|Hemorrhagic Fever|hemorrhagic fever
706601|NCT00605514|Healthy|healthy
706602|NCT00605514|Immunity|immunity
706603|NCT00605514|T-Cells|t-cells
706604|NCT00605514|Filovirus|filovirus
706605|NCT00605514|Healthy Volunteer|healthy volunteer
706606|NCT00605514|HV|hv
706607|NCT00605488|Pet Scan|pet scan
706608|NCT00605475|Type 2 Diabetes Mellitus|type 2 diabetes mellitus
706609|NCT00605475|Canakinumab|canakinumab
706610|NCT00605475|ACZ885|acz885
706611|NCT00605475|IL-1B antagonist|il-1b antagonist
706612|NCT00605475|metformin|metformin
706613|NCT00605475|glycemic control|glycemic control
706614|NCT00605475|insulin sensitivity|insulin sensitivity
706615|NCT00605449|GSK376501|gsk376501
706616|NCT00605449|Simvastatin|simvastatin
706617|NCT00605449|Healthy Subjects|healthy subjects
706618|NCT00605449|Repeat Dose|repeat dose
706619|NCT00605449|Drug Interaction|drug interaction
706620|NCT00605449|Randomized|randomized
706621|NCT00605449|Pharmacokinetics|pharmacokinetics
706622|NCT00605436|overweight|overweight
706623|NCT00605436|sedentary|sedentary
706624|NCT00605436|metabolic syndrome|metabolic syndrome
706626|NCT00605423|Almera|almera
706627|NCT00605423|Steroid|steroid
706628|NCT00605423|Macular|macular
706629|NCT00605423|ARMD|armd
706630|NCT00605410|Methacholine bronchoprovocation|methacholine bronchoprovocation
706631|NCT00605410|Antimuscarinic|antimuscarinic
706632|NCT00605397|Cu-64 LABELED TRASTUZUMAB|cu-64 labeled trastuzumab
706633|NCT00605371|Healthy volunteers|healthy volunteers
706634|NCT00605371|Bioequivalence|bioequivalence
706635|NCT00605371|Food Effects|food effects
706636|NCT00605358|geriatric depression|geriatric depression
706637|NCT00605319|BPH|bph
706638|NCT00605319|BOO|boo
706639|NCT00605306|Asthma|asthma
706640|NCT00605306|spirometry|spirometry
706641|NCT00605306|lung function|lung function
706642|NCT00605306|serum cortisol|serum cortisol
706643|NCT00605306|serum potassium|serum potassium
706644|NCT00605306|plasma glucose|plasma glucose
706645|NCT00605280|randomized sham-controlled multicenter macular edema|randomized sham-controlled multicenter macular edema
706646|NCT00605267|Breast Cancer|breast cancer
706647|NCT00605267|Breast Neoplasms|breast neoplasms
706648|NCT00605267|Tumors or cancer of the human BREAST|tumors or cancer of the human breast
706649|NCT00605267|Tumor or cancer of the human MAMMARY GLAND|tumor or cancer of the human mammary gland
706650|NCT00605254|P-Glycoprotein|p-glycoprotein
706651|NCT00605254|Positron Emission Tomography|positron emission tomography
706652|NCT00605254|Blood Brain Barrier|blood brain barrier
706653|NCT00605254|Quantitative Imaging|quantitative imaging
706654|NCT00605254|Multi-Drug Transporter|multi-drug transporter
706655|NCT00605254|Healthy Volunteer|healthy volunteer
706656|NCT00605254|HV|hv
706657|NCT00605241|pharmacodynamics,|pharmacodynamics,
706658|NCT00605241|pharmacokinetics,|pharmacokinetics,
706659|NCT00605241|tolerability,|tolerability,
706660|NCT00605241|Safety,|safety,
706661|NCT00605241|single dose,|single dose,
706662|NCT00605241|placebo,|placebo,
706663|NCT00605241|Nicotine reward|nicotine reward
706664|NCT00605241|GSK598809|gsk598809
706665|NCT00605176|Actinic keratosis|actinic keratosis
706666|NCT00605176|Skin disease|skin disease
706667|NCT00605163|Parkinson disease, observational, longitudinal|parkinson disease, observational, longitudinal
706668|NCT00605150|Unresectable HCC|unresectable hcc
706669|NCT00605124|osteoarthritis|osteoarthritis
706670|NCT00605124|knee|knee
706671|NCT00605124|total knee arthroplasty|total knee arthroplasty
706672|NCT00605124|exercise|exercise
706673|NCT00605098|HIV|hiv
706674|NCT00605098|Pregnancy|pregnancy
706675|NCT00605098|Vertical disease transmission|vertical disease transmission
706676|NCT00605098|Pharmacokinetics|pharmacokinetics
706677|NCT00605098|HIV seronegativity|hiv seronegativity
706678|NCT00605072|cognitive disorders|cognitive disorders
706679|NCT00605072|angiotensin receptor blockers|angiotensin receptor blockers
706680|NCT00605059|Alzheimer|alzheimer
706681|NCT00605059|SPECT|spect
706682|NCT00605046|Alzheimer|alzheimer
706683|NCT00605046|SPECT|spect
706684|NCT00605007|COPD|copd
706685|NCT00605007|Diabetes|diabetes
706686|NCT00605007|Respiratory Disorders|respiratory disorders
706687|NCT00604994|Lymphoedema|lymphoedema
706688|NCT00604994|Gynaecology|gynaecology
706689|NCT00604994|Oncology|oncology
706690|NCT00604994|Malignant|malignant
706691|NCT00604994|Benign|benign
706692|NCT00604994|Incidence|incidence
706693|NCT00604955|visceral leishmaniasis|visceral leishmaniasis
706694|NCT00604955|kala-azar|kala-azar
706695|NCT00604955|Bihar, India|bihar, india
706696|NCT00604942|Oesophagus|oesophagus
706697|NCT00604942|Dysphagia|dysphagia
706698|NCT00604942|Impedance|impedance
706699|NCT00604942|High Resolution Manometry|high resolution manometry
706700|NCT00604942|Peristalsis|peristalsis
706701|NCT00604942|Contractile Pressure|contractile pressure
706702|NCT00604942|Coordination of contraction|coordination of contraction
706703|NCT00604942|Bolus transport|bolus transport
706704|NCT00604929|muscle protein synthesis|muscle protein synthesis
706705|NCT00604929|whole-body protein breakdown|whole-body protein breakdown
706706|NCT00604929|nutrition|nutrition
706707|NCT00604916|oral hygiene|oral hygiene
706708|NCT00604890|Double-Blind|double-blind
706709|NCT00604890|Placebo|placebo
706710|NCT00604890|Topical|topical
706711|NCT00604890|Treatment|treatment
706712|NCT00604890|Dose-Ranging|dose-ranging
706713|NCT00604890|sBCC|sbcc
706714|NCT00604877|exercise|exercise
706715|NCT00604877|glucose metabolism|glucose metabolism
706716|NCT00604877|insulin sensitivity|insulin sensitivity
706717|NCT00604877|Vascular Function|vascular function
706718|NCT00604864|deep endometriosis|deep endometriosis
706719|NCT00604864|pelvic pain|pelvic pain
706720|NCT00604864|infliximab|infliximab
706721|NCT00604864|anti TNFa|anti tnfa
706722|NCT00604838|amniotic fluid leakage|amniotic fluid leakage
706723|NCT00604838|urinary incontinence|urinary incontinence
706724|NCT00604838|pregnancy|pregnancy
706725|NCT00604838|home test|home test
706726|NCT00604838|vaginal wetness|vaginal wetness
706727|NCT00604825|menopause|menopause
706728|NCT00604825|hormone therapy|hormone therapy
706729|NCT00604825|hot flashes|hot flashes
706730|NCT00604825|vasomotor symptoms|vasomotor symptoms
706731|NCT00604786|Basophils|basophils
706732|NCT00604786|Mast Cells|mast cells
706733|NCT00604786|IgE|ige
706734|NCT00604786|IgE receptors|ige receptors
706735|NCT00604786|omalizumab|omalizumab
706736|NCT00604773|delirium|delirium
706737|NCT00604773|critical care|critical care
706738|NCT00604773|risk factors|risk factors
706739|NCT00604773|prediction|prediction
706740|NCT00604747|motor learning|motor learning
706741|NCT00604747|hemiplegia|hemiplegia
706742|NCT00604747|stroke|stroke
706743|NCT00604747|practice|practice
706744|NCT00604747|physiotherapy|physiotherapy
706745|NCT00604695|ST-Elevation Myocardial Infarction|st-elevation myocardial infarction
706746|NCT00604695|Acute Myocardial Infarction|acute myocardial infarction
706747|NCT00604695|No Reflow|no reflow
706748|NCT00604682|psoriasis|psoriasis
706749|NCT00604669|Diabetes|diabetes
706750|NCT00604669|Nutrition/Dietics|nutrition/dietics
706751|NCT00604669|clinical outcomes|clinical outcomes
706752|NCT00604669|total parenteral nutrition|total parenteral nutrition
706753|NCT00604643|Abdominal Aneurysm|abdominal aneurysm
706754|NCT00604643|Endovascular Aortic Repair (EVAR)|endovascular aortic repair (evar)
706755|NCT00604643|Endovascular Stent Graft|endovascular stent graft
706756|NCT00604643|Endograft|endograft
706757|NCT00604630|stroke|stroke
706758|NCT00604630|EPO|epo
706759|NCT00604630|erythropoietin|erythropoietin
706760|NCT00604630|ischemia|ischemia
706761|NCT00604630|hypoxia|hypoxia
706762|NCT00604630|antiapoptosis|antiapoptosis
706763|NCT00604630|neuroprotection|neuroprotection
706764|NCT00604630|rtPA|rtpa
706765|NCT00604630|thrombolysis|thrombolysis
706766|NCT00604630|stroke, middle cerebral artery|stroke, middle cerebral artery
706767|NCT00604630|Ischemic stroke in the middle cerebral artery territory|ischemic stroke in the middle cerebral artery territory
706768|NCT00604617|Mycobacterium tuberculosis|mycobacterium tuberculosis
706769|NCT00604617|Tuberculin Test|tuberculin test
706770|NCT00604617|South Africa|south africa
706771|NCT00604591|Dementia Treatment|dementia treatment
706772|NCT00604591|Frontotemporal Dementia|frontotemporal dementia
706773|NCT00604591|Dopamine|dopamine
706774|NCT00604591|Frontotemporal Lobar Degeneration|frontotemporal lobar degeneration
706775|NCT00604578|Pioglitazone|pioglitazone
706776|NCT00604578|Asthma|asthma
706777|NCT00604578|Peroxisome Proliferator-Advanced Receptor Gamma|peroxisome proliferator-advanced receptor gamma
706778|NCT00604578|Airflow Obstruction|airflow obstruction
706779|NCT00604578|Airway Inflammation|airway inflammation
706780|NCT00604565|Hemodialysis|hemodialysis
706781|NCT00604552|Abdominal Aneurysm|abdominal aneurysm
710611|NCT00588588|Mortality|mortality
706782|NCT00604552|Endovascular Aortic Repair (EVAR)|endovascular aortic repair (evar)
706783|NCT00604552|Endovascular Stent Graft|endovascular stent graft
706784|NCT00604552|Endograft|endograft
706785|NCT00604539|Chondroitin sulphate|chondroitin sulphate
706786|NCT00604539|Synovitis|synovitis
706787|NCT00604539|Knee osteoarthritis|knee osteoarthritis
706788|NCT00604539|Magnetic Resonance Imaging|magnetic resonance imaging
706789|NCT00604526|recurrent|recurrent
706790|NCT00604487|induction|induction
706791|NCT00604487|cervix|cervix
706792|NCT00604487|balloon|balloon
706793|NCT00604487|Bishop|bishop
706794|NCT00604474|Deafness|deafness
706795|NCT00604474|Hearing Loss|hearing loss
706796|NCT00604474|Cochlear Implants|cochlear implants
706797|NCT00604474|Advanced Bionics|advanced bionics
706798|NCT00604474|HiResolution Bionic Ear System|hiresolution bionic ear system
706799|NCT00604461|Carboplatin|carboplatin
706800|NCT00604461|Bevacizumab|bevacizumab
706801|NCT00604461|Avastin|avastin
706802|NCT00604461|Pemetrexed|pemetrexed
706803|NCT00604461|Alimta|alimta
706804|NCT00604448|pulses|pulses
706805|NCT00604448|beans|beans
706806|NCT00604448|obesity|obesity
706807|NCT00604448|overweight|overweight
706808|NCT00604448|metabolic syndrome|metabolic syndrome
706809|NCT00604435|breast cancer|breast cancer
706810|NCT00604435|neoadjuvant chemotherapy|neoadjuvant chemotherapy
706811|NCT00604435|docetaxel|docetaxel
706812|NCT00604435|epirubicin|epirubicin
706813|NCT00604435|recombinant human endostatin (endostar)|recombinant human endostatin (endostar)
706814|NCT00604435|chemotherapy|chemotherapy
706815|NCT00604435|endostatin|endostatin
706816|NCT00604422|Colonic disease|colonic disease
706817|NCT00604422|Ulcerative colitis|ulcerative colitis
706818|NCT00604422|suspected or known colonic disease|suspected or known colonic disease
706819|NCT00604357|CNI free|cni free
706820|NCT00604357|mTOR inhibition|mtor inhibition
706821|NCT00604357|induction|induction
706919|NCT00603928|physicians|physicians
706822|NCT00604357|IL2 receptor antibodies|il2 receptor antibodies
706823|NCT00604357|renal function|renal function
706824|NCT00604357|liver transplantation|liver transplantation
706825|NCT00604331|Pyruvic Acid|pyruvic acid
706826|NCT00604331|Shock, Cardiogenic|shock, cardiogenic
706827|NCT00604331|Catecholamines|catecholamines
706828|NCT00604331|Intra-Aortic Balloon Pumping|intra-aortic balloon pumping
706829|NCT00604331|Cardiac Output|cardiac output
706830|NCT00604331|Cardiac Index|cardiac index
706831|NCT00604331|Cardiac Function|cardiac function
706832|NCT00604318|quality of life|quality of life
706833|NCT00604292|Colonic Diseases|colonic diseases
706834|NCT00604279|Schizophrenia|schizophrenia
706835|NCT00604279|Paliperidone|paliperidone
706836|NCT00604279|Paliperidone palmitate|paliperidone palmitate
706837|NCT00604279|Risperidone|risperidone
706838|NCT00604279|Risperidone long acting injection|risperidone long acting injection
706839|NCT00604279|R092670|r092670
706840|NCT00604266|Potentially resectable hilar cholangiocarcinoma as per initial imaging studies.|potentially resectable hilar cholangiocarcinoma as per initial imaging studies.
706841|NCT00604266|Able to undergo PET/CT and MRI with Gadolinium|able to undergo pet/ct and mri with gadolinium
706842|NCT00604240|NICU|nicu
706843|NCT00604240|caregivers|caregivers
706844|NCT00604240|discharge instructions|discharge instructions
706845|NCT00604227|high altitude pulmonary edema|high altitude pulmonary edema
706846|NCT00604227|pulmonary interstitial fluid|pulmonary interstitial fluid
706847|NCT00604227|pulmonary function testing|pulmonary function testing
706848|NCT00604227|hypoxia|hypoxia
706849|NCT00604227|pulmonary endothelial function|pulmonary endothelial function
706850|NCT00604227|high altitude exposure without prior acclimatization|high altitude exposure without prior acclimatization
706851|NCT00604214|Sepsis|sepsis
706852|NCT00604214|Septic shock|septic shock
706853|NCT00604201|Nonmyeloablative|nonmyeloablative
706854|NCT00604201|Haploidentical|haploidentical
706855|NCT00604201|Umbilical Cord Blood|umbilical cord blood
706857|NCT00604201|Severe Aplastic Anemia|severe aplastic anemia
706858|NCT00604201|Myelodysplastic Syndrome|myelodysplastic syndrome
706859|NCT00604201|MDS|mds
706860|NCT00604175|HIV|hiv
706861|NCT00604175|HPV 6|hpv 6
706862|NCT00604175|HPV 11|hpv 11
706863|NCT00604175|HPV 16|hpv 16
706864|NCT00604175|HPV 18|hpv 18
706865|NCT00604175|Vaccine|vaccine
706866|NCT00604162|Suspected colonic disease|suspected colonic disease
706867|NCT00604162|Known colonic disease|known colonic disease
706868|NCT00604136|melanoma|melanoma
706869|NCT00604136|tumor infiltrating lymphocytes|tumor infiltrating lymphocytes
706870|NCT00604136|interleukin-2|interleukin-2
706871|NCT00604123|JNJ-17166864|jnj-17166864
706872|NCT00604123|allergic rhinitis|allergic rhinitis
706873|NCT00604123|pharmacokinetics|pharmacokinetics
706874|NCT00604123|biomarkers|biomarkers
706875|NCT00604123|rhinitis symptoms|rhinitis symptoms
706876|NCT00604123|mountain cedar pollen|mountain cedar pollen
706877|NCT00604110|Biventricular pacing|biventricular pacing
706878|NCT00604110|resynchronisation therapy|resynchronisation therapy
706879|NCT00604110|cardiac surgery|cardiac surgery
706880|NCT00604110|ejection fraction of less 45%|ejection fraction of less 45%
706881|NCT00604097|youth suicide|youth suicide
706882|NCT00604097|family therapy|family therapy
706883|NCT00604097|primary care|primary care
706884|NCT00604097|intervention|intervention
706885|NCT00604084|Scabies|scabies
706886|NCT00604084|Ivermectin|ivermectin
706887|NCT00604084|Lindane|lindane
706888|NCT00604084|Mass Eradication|mass eradication
706889|NCT00604071|HMP, CNV, PHP, HPHP, AMD|hmp, cnv, php, hphp, amd
706890|NCT00604058|Poliomyelitis|poliomyelitis
706891|NCT00604058|intradermal|intradermal
706892|NCT00604045|post traumatic stress disorder|post traumatic stress disorder
706893|NCT00604045|cognitive bias|cognitive bias
706894|NCT00604045|attention|attention
706895|NCT00604045|combat|combat
706896|NCT00604045|neuroimaging|neuroimaging
706897|NCT00604032|Safety when exposed to sunlight|safety when exposed to sunlight
706898|NCT00604019|sepsis|sepsis
706899|NCT00604019|septic shock|septic shock
706900|NCT00604006|Prevention of heart failure in individuals at high risk|prevention of heart failure in individuals at high risk
706901|NCT00603993|Rheumatoid arthritis|rheumatoid arthritis
706902|NCT00603967|Breast Cancer|breast cancer
706903|NCT00603967|Postmenopausal|postmenopausal
706904|NCT00603967|Aromatase|aromatase
706905|NCT00603954|Nonmyeloablative conditioning.|nonmyeloablative conditioning.
706906|NCT00603954|Hematological malignancies.|hematological malignancies.
706907|NCT00603954|GVHD.|gvhd.
706908|NCT00603941|Anaplastic Thyroid Cancer|anaplastic thyroid cancer
706909|NCT00603941|Neoplasm|neoplasm
706910|NCT00603941|Tumor|tumor
706911|NCT00603941|Anti-neoplastic Agent|anti-neoplastic agent
706912|NCT00603941|First-line treatment of advanced Anaplastic thyroid cancer|first-line treatment of advanced anaplastic thyroid cancer
706913|NCT00603928|attitude|attitude
706914|NCT00603928|attitude of health personnel|attitude of health personnel
706915|NCT00603928|ethics|ethics
706916|NCT00603928|bioethics|bioethics
706917|NCT00603928|biomedical ethics|biomedical ethics
706918|NCT00603928|patient care|patient care
706920|NCT00603928|placebo effect|placebo effect
706921|NCT00603928|placebos|placebos
706922|NCT00603928|questionnaires|questionnaires
706923|NCT00603928|therapy|therapy
706924|NCT00603928|general practice|general practice
706925|NCT00603915|gemcitabine|gemcitabine
706926|NCT00603915|carboplatin|carboplatin
706927|NCT00603915|cisplatin|cisplatin
706928|NCT00603915|erlotinib|erlotinib
706929|NCT00603915|tarceva|tarceva
706930|NCT00603915|nasopharyngeal|nasopharyngeal
706931|NCT00603902|Obesity|obesity
706932|NCT00603902|Weight loss|weight loss
706933|NCT00603902|lorcaserin|lorcaserin
706934|NCT00603902|APD356|apd356
706935|NCT00603902|BLOSSOM|blossom
706936|NCT00603902|Hypertension|hypertension
706937|NCT00603902|Dyslipidemia|dyslipidemia
706938|NCT00603902|Sleep apnea|sleep apnea
706939|NCT00603902|glucose tolerance|glucose tolerance
706940|NCT00603902|cardiovascular disease|cardiovascular disease
706941|NCT00603902|Arena|arena
706942|NCT00603889|Hookworm|hookworm
706943|NCT00603889|Allergy|allergy
706944|NCT00603889|Vaccine|vaccine
706945|NCT00603889|Skin test|skin test
706946|NCT00603863|pancreatic cancer|pancreatic cancer
706947|NCT00603863|hPAM4|hpam4
706948|NCT00603863|MUC1 antibody|muc1 antibody
706949|NCT00603863|cancer of the pancreas|cancer of the pancreas
706950|NCT00603850|HMP, PHP, AMD, CNV, HPHP|hmp, php, amd, cnv, hphp
706951|NCT00603837|Hypothermia|hypothermia
706952|NCT00603837|Prevention|prevention
706953|NCT00603837|ELGANs(Extremely low gestational age neonates)|elgans(extremely low gestational age neonates)
706954|NCT00603837|Polyethylene Wrap|polyethylene wrap
706955|NCT00603837|Sodium Acetate Transport Mattress|sodium acetate transport mattress
706956|NCT00603824|heparin-Induced thrombocytopenia|heparin-induced thrombocytopenia
706957|NCT00603824|fondaparinux|fondaparinux
706958|NCT00603811|Influenza vaccines|influenza vaccines
706959|NCT00603811|M2e|m2e
706960|NCT00603798|Actinic keratosis|actinic keratosis
706961|NCT00603798|Dermatologic disease|dermatologic disease
706962|NCT00603785|Chronic sinusitis|chronic sinusitis
706963|NCT00603785|Xolair|xolair
706964|NCT00603785|Nasal Discharge|nasal discharge
706965|NCT00603785|Nasal Obstruction|nasal obstruction
706966|NCT00603785|Facial Pain|facial pain
706967|NCT00603785|Hyposmia|hyposmia
706968|NCT00603772|Tretinoin|tretinoin
706969|NCT00603772|exposure to UV light|exposure to uv light
706970|NCT00603772|phototoxicity|phototoxicity
706971|NCT00603772|Safety when exposed to sunlight|safety when exposed to sunlight
706972|NCT00603759|COX2 inhibitor|cox2 inhibitor
706973|NCT00603759|head and neck cancer|head and neck cancer
706974|NCT00603759|chemoradiation|chemoradiation
706975|NCT00603746|Adolescents|adolescents
706976|NCT00603746|Adults|adults
706977|NCT00603746|Asthma|asthma
706978|NCT00603746|Pharmacokinetics|pharmacokinetics
706979|NCT00603746|Pharmacogenetics|pharmacogenetics
706980|NCT00603746|GW685698X|gw685698x
706981|NCT00603733|Ulcerative Colitis|ulcerative colitis
706982|NCT00603733|5-Aminosalicylate|5-aminosalicylate
706983|NCT00603720|PET|pet
706984|NCT00603720|Heart metabolism|heart metabolism
706985|NCT00603720|Nitric oxide|nitric oxide
706986|NCT00603720|Myocardial remodeling|myocardial remodeling
706987|NCT00603707|capsule|capsule
706988|NCT00603707|constipation|constipation
706989|NCT00603707|whole gut transit|whole gut transit
706990|NCT00603707|colonic transit|colonic transit
706991|NCT00603707|gastric emptying|gastric emptying
706992|NCT00603707|small bowel transit|small bowel transit
706993|NCT00603694|Hippocampus|hippocampus
706994|NCT00603694|Memory|memory
706995|NCT00603694|Radiation|radiation
706996|NCT00603681|constipation|constipation
706997|NCT00603681|aged|aged
706998|NCT00603681|polyethylene glycol|polyethylene glycol
706999|NCT00603668|CLL|cll
707000|NCT00603655|Diet|diet
707001|NCT00603655|glycemic load|glycemic load
707002|NCT00603655|overweight|overweight
707003|NCT00603655|obesity|obesity
707004|NCT00603655|hyperlipidemia|hyperlipidemia
707005|NCT00603642|AMG 531|amg 531
707006|NCT00603642|Idiopathic Thrombocytopenic Purpura|idiopathic thrombocytopenic purpura
707007|NCT00603642|ITP|itp
707008|NCT00603642|Thrombocytopenia|thrombocytopenia
707009|NCT00603642|Japan|japan
707010|NCT00603642|Placebo controlled|placebo controlled
707011|NCT00603642|Phase 3|phase 3
707012|NCT00603629|Acute Asthma|acute asthma
707013|NCT00603616|Inflammatory Bowel Disease|inflammatory bowel disease
707014|NCT00603616|Crohn disease|crohn disease
707015|NCT00603616|Crohn's disease|crohn's disease
707016|NCT00603616|Rifaximin|rifaximin
707017|NCT00603603|C-section|c-section
707018|NCT00603603|Surg Wound Infect|surg wound infect
707019|NCT00603590|Cardiovascular disease|cardiovascular disease
707020|NCT00603590|primary prevention|primary prevention
707021|NCT00603590|Polypill|polypill
707022|NCT00603590|efficacy|efficacy
707023|NCT00603590|safety|safety
707024|NCT00603590|ADR|adr
707025|NCT00603590|Diabetes|diabetes
707026|NCT00603590|Adherence|adherence
707027|NCT00603590|Compliance|compliance
707028|NCT00603564|CPAP|cpap
707029|NCT00603564|community-acquired pneumonia|community-acquired pneumonia
707030|NCT00603564|acute respiratory failure|acute respiratory failure
707031|NCT00603564|hypoxemia|hypoxemia
707032|NCT00603564|Continuous Positive Airway Pressure|continuous positive airway pressure
707033|NCT00603551|Osteoporosis|osteoporosis
707034|NCT00603551|Cancer|cancer
707035|NCT00603551|Chemotherapy|chemotherapy
707036|NCT00603551|Bone Density|bone density
707037|NCT00603551|DXA Scan|dxa scan
707038|NCT00603551|Heel Scan|heel scan
707039|NCT00603538|CP-751,871, Non-small cell lung cancer, Phase 1|cp-751,871, non-small cell lung cancer, phase 1
707040|NCT00603512|Phase II MTX add-on study in Japan|phase ii mtx add-on study in japan
707041|NCT00603499|Diabetes|diabetes
707042|NCT00603499|Hypertension|hypertension
707043|NCT00603499|Hypomagnesemia|hypomagnesemia
707044|NCT00603486|Non-invasive Blood Pressure (NIBP)|non-invasive blood pressure (nibp)
707045|NCT00603486|GE Dinamap|ge dinamap
707046|NCT00603486|SuperSTAT|superstat
707047|NCT00603460|Ovarian Cancer|ovarian cancer
707048|NCT00603460|Peritoneal Cancer|peritoneal cancer
707049|NCT00603434|Methamphetamine|methamphetamine
707050|NCT00603421|borderline personality disorder|borderline personality disorder
707051|NCT00603421|suicide|suicide
707052|NCT00603421|suicidality|suicidality
707053|NCT00603421|suicide attempt|suicide attempt
707054|NCT00603421|suicidal behavior|suicidal behavior
707055|NCT00603421|self-injurious behavior|self-injurious behavior
707056|NCT00603421|self-harm behavior|self-harm behavior
707057|NCT00603421|suicide prevention center|suicide prevention center
707058|NCT00603421|telephone intervention|telephone intervention
707059|NCT00603408|Breast Cancer|breast cancer
707060|NCT00603408|Locally Advanced|locally advanced
707061|NCT00603408|Neoadjuvant|neoadjuvant
707062|NCT00603382|Adults|adults
707063|NCT00603382|Pharmacokinetics|pharmacokinetics
707064|NCT00603382|Pharmacogenetics|pharmacogenetics
707065|NCT00603382|Asthma|asthma
707066|NCT00603382|Adolescents|adolescents
707067|NCT00603382|GW685698X|gw685698x
707068|NCT00603369|HIV prevention|hiv prevention
707069|NCT00603369|HIV seronegativity|hiv seronegativity
707070|NCT00603356|GIST|gist
707071|NCT00603356|Ovarian Cancer|ovarian cancer
707072|NCT00603356|Mesothelioma|mesothelioma
707073|NCT00603356|Renal|renal
707074|NCT00603356|Colorectal Cancer|colorectal cancer
707075|NCT00603356|Sarcoma|sarcoma
707076|NCT00603356|NSCLC|nsclc
707077|NCT00603356|Cancer|cancer
707078|NCT00603343|antimuscarinics|antimuscarinics
707079|NCT00603343|children|children
707080|NCT00603343|overactive bladder|overactive bladder
707081|NCT00603343|propiverine|propiverine
707082|NCT00603343|urinary incontinence|urinary incontinence
707083|NCT00603343|urotherapy|urotherapy
707084|NCT00603330|Mesenchymal stem cells|mesenchymal stem cells
707085|NCT00603330|Graft-versus-host disease|graft-versus-host disease
707086|NCT00603330|Poor graft function|poor graft function
707087|NCT00603330|Chimerism|chimerism
707088|NCT00603330|Hematopoietic cell transplantation recipients|hematopoietic cell transplantation recipients
707089|NCT00603330|Low donor T-cell chimerism|low donor t-cell chimerism
707090|NCT00603317|Warfarin|warfarin
707091|NCT00603317|Drug interaction|drug interaction
707092|NCT00603317|Pharmacogenetics|pharmacogenetics
707093|NCT00603317|Amoxicillin|amoxicillin
707094|NCT00603317|Clavulanic acid|clavulanic acid
707095|NCT00603304|Serenoa repens|serenoa repens
707096|NCT00603304|Urological symptoms|urological symptoms
707097|NCT00603304|hyperplasia|hyperplasia
707099|NCT00603291|obesity|obesity
707100|NCT00603291|weight loss|weight loss
707101|NCT00603291|lorcaserin|lorcaserin
707102|NCT00603291|APD356|apd356
707103|NCT00603291|BLOOM-DM|bloom-dm
707104|NCT00603291|hypertension|hypertension
707105|NCT00603291|dyslipidemia|dyslipidemia
707106|NCT00603291|sleep apnea|sleep apnea
707107|NCT00603291|glucose tolerance|glucose tolerance
707108|NCT00603291|cardiovascular disease|cardiovascular disease
707109|NCT00603291|Arena|arena
707110|NCT00603278|Adolescents|adolescents
707111|NCT00603278|Adults|adults
707112|NCT00603278|Pharmacokinetics|pharmacokinetics
707113|NCT00603278|Asthma|asthma
707114|NCT00603278|GW685698X|gw685698x
707115|NCT00603278|Pharmacogenetics|pharmacogenetics
707116|NCT00603265|Diabetic Peripheral Neuropathy|diabetic peripheral neuropathy
707117|NCT00603265|Neuropathic Pain|neuropathic pain
707118|NCT00603252|combined hepatitis A and B vaccine|combined hepatitis a and b vaccine
707119|NCT00603252|risk factors|risk factors
707120|NCT00603239|diabetes|diabetes
707121|NCT00603239|exenatide|exenatide
707122|NCT00603239|metformin|metformin
707123|NCT00603239|thiazolidinedione|thiazolidinedione
707124|NCT00603239|Byetta|byetta
707125|NCT00603239|Amylin|amylin
707126|NCT00603239|Lilly|lilly
707127|NCT00603226|Coronary slow flow phenomenon|coronary slow flow phenomenon
707128|NCT00603226|Coronary angiography|coronary angiography
707129|NCT00603226|Acute coronary syndrome|acute coronary syndrome
707130|NCT00603226|Chest pain|chest pain
707131|NCT00603226|Unstable angina|unstable angina
707132|NCT00603213|Congestive Heart Failure|congestive heart failure
707133|NCT00603213|Impedance|impedance
707134|NCT00603213|Optivol Thoracid Fluid Status monitoring system|optivol thoracid fluid status monitoring system
707135|NCT00603200|Quality of Life|quality of life
707136|NCT00603187|Male Contraception|male contraception
707137|NCT00603187|Acyline|acyline
707138|NCT00603174|NAVA|nava
707139|NCT00603174|mechanical ventilation|mechanical ventilation
707140|NCT00603174|infants|infants
707141|NCT00603174|pediatric intensive care|pediatric intensive care
707142|NCT00603174|infant|infant
707143|NCT00603148|Genetic Polymorphism|genetic polymorphism
707144|NCT00603148|Integrin alpha2beta1|integrin alpha2beta1
707145|NCT00603148|Phenotype|phenotype
707146|NCT00603122|altitude illness|altitude illness
707147|NCT00603122|hypoxia|hypoxia
707148|NCT00603109|Body weight, fat mass, growth hormone, ghrelin|body weight, fat mass, growth hormone, ghrelin
707149|NCT00603083|Hip Arthroplasty|hip arthroplasty
707150|NCT00603083|Treatment Outcome|treatment outcome
707151|NCT00603083|Local Anesthesia|local anesthesia
707152|NCT00603070|Medication Errors|medication errors
707153|NCT00603070|Adverse Drug Events|adverse drug events
707154|NCT00603070|Patient Safety|patient safety
707155|NCT00603070|Electronic Prescribing Systems|electronic prescribing systems
707156|NCT00603070|Medication Reconciliation|medication reconciliation
707157|NCT00603057|Non Small Cell Lung Cancer|non small cell lung cancer
707158|NCT00603018|eating disorders|eating disorders
707159|NCT00603018|anorexia nervosa|anorexia nervosa
707160|NCT00603018|anorexia|anorexia
707161|NCT00603018|PET|pet
707162|NCT00603018|brain imaging|brain imaging
707163|NCT00603018|serotonin|serotonin
707164|NCT00603018|fMRI|fmri
707165|NCT00603018|Prozac|prozac
707166|NCT00603018|fluoxetine|fluoxetine
707167|NCT00603005|Glaucoma|glaucoma
707168|NCT00603005|Adherence|adherence
707169|NCT00602992|3T MRI|3t mri
707170|NCT00602992|Gamma Knife Radiosurgery|gamma knife radiosurgery
707171|NCT00602979|endotracheal intubation|endotracheal intubation
707172|NCT00602979|intubation|intubation
707173|NCT00602979|laryngoscopy|laryngoscopy
707174|NCT00602979|laryngoscope|laryngoscope
707175|NCT00602979|surgery|surgery
707176|NCT00602966|Oocyte cryopreservation|oocyte cryopreservation
707177|NCT00602966|slow freeze|slow freeze
707178|NCT00602966|vitrification|vitrification
707179|NCT00602940|PCOS|pcos
707180|NCT00602940|ovulation|ovulation
707181|NCT00602940|hormones|hormones
707182|NCT00602940|women|women
707183|NCT00602927|Varenicline, Imaging, fMRI|varenicline, imaging, fmri
707184|NCT00602914|MicronJet (microneedles)|micronjet (microneedles)
707185|NCT00602914|Intradermal|intradermal
707186|NCT00602862|Angiogenesis inhibitors|angiogenesis inhibitors
707187|NCT00602836|B-cell chronic lymphocytic leukemia|b-cell chronic lymphocytic leukemia
707188|NCT00602836|stage I chronic lymphocytic leukemia|stage i chronic lymphocytic leukemia
707189|NCT00602836|stage II chronic lymphocytic leukemia|stage ii chronic lymphocytic leukemia
707190|NCT00602836|stage III chronic lymphocytic leukemia|stage iii chronic lymphocytic leukemia
707191|NCT00602836|stage IV chronic lymphocytic leukemia|stage iv chronic lymphocytic leukemia
707192|NCT00602836|contiguous stage II small lymphocytic lymphoma|contiguous stage ii small lymphocytic lymphoma
707193|NCT00602836|noncontiguous stage II small lymphocytic lymphoma|noncontiguous stage ii small lymphocytic lymphoma
707194|NCT00602836|stage I small lymphocytic lymphoma|stage i small lymphocytic lymphoma
707195|NCT00602836|stage III small lymphocytic lymphoma|stage iii small lymphocytic lymphoma
707196|NCT00602836|stage IV small lymphocytic lymphoma|stage iv small lymphocytic lymphoma
707197|NCT00602758|AIDS|aids
707198|NCT00602758|Adherence|adherence
707199|NCT00602758|Antiretroviral Therapy|antiretroviral therapy
707200|NCT00602758|HIV|hiv
707201|NCT00602745|pancreatic cancer|pancreatic cancer
707202|NCT00602732|Partner Abuse|partner abuse
707203|NCT00602732|Preventive Intervention|preventive intervention
707204|NCT00602732|Postpartum Depression|postpartum depression
707205|NCT00602732|Postpartum PTSD|postpartum ptsd
707206|NCT00602706|refractory multiple myeloma|refractory multiple myeloma
707207|NCT00602706|stage I multiple myeloma|stage i multiple myeloma
707208|NCT00602706|stage II multiple myeloma|stage ii multiple myeloma
707209|NCT00602706|stage III multiple myeloma|stage iii multiple myeloma
707210|NCT00602693|chronic myelogenous leukemia|chronic myelogenous leukemia
707211|NCT00602693|recurrent mantle cell lymphoma|recurrent mantle cell lymphoma
707212|NCT00602693|prolymphocytic leukemia|prolymphocytic leukemia
707213|NCT00602693|advanced chronic lymphocytic leukemia|advanced chronic lymphocytic leukemia
707214|NCT00602693|small lymphocytic lymphoma|small lymphocytic lymphoma
707215|NCT00602693|B-cell lymphoma|b-cell lymphoma
707216|NCT00602693|follicular lymphoma|follicular lymphoma
707217|NCT00602693|diffuse large cell lymphoma|diffuse large cell lymphoma
707218|NCT00602693|anaplastic large cell lymphoma|anaplastic large cell lymphoma
707219|NCT00602693|Hodgkin lymphoma|hodgkin lymphoma
707220|NCT00602693|multiple myeloma|multiple myeloma
707221|NCT00602680|Alzheimer|alzheimer
707222|NCT00602680|cognitive|cognitive
707223|NCT00602667|untreated childhood medulloblastoma|untreated childhood medulloblastoma
707224|NCT00602667|untreated childhood supratentorial primitive neuroectodermal tumor|untreated childhood supratentorial primitive neuroectodermal tumor
707225|NCT00602667|untreated childhood pineoblastoma|untreated childhood pineoblastoma
707226|NCT00602667|childhood atypical teratoid/rhabdoid tumor|childhood atypical teratoid/rhabdoid tumor
707227|NCT00602667|childhood choroid plexus tumor|childhood choroid plexus tumor
707228|NCT00602667|childhood high grade glioma|childhood high grade glioma
707229|NCT00602667|newly diagnosed childhood ependymoma|newly diagnosed childhood ependymoma
707230|NCT00602628|ductal breast carcinoma in situ|ductal breast carcinoma in situ
707231|NCT00602628|invasive ductal breast carcinoma|invasive ductal breast carcinoma
707232|NCT00602628|breast cancer in situ|breast cancer in situ
707233|NCT00602628|stage I breast cancer|stage i breast cancer
707234|NCT00602628|stage II breast cancer|stage ii breast cancer
707235|NCT00602628|stage IIIA breast cancer|stage iiia breast cancer
707236|NCT00602602|stage IV pancreatic cancer|stage iv pancreatic cancer
707237|NCT00602602|recurrent pancreatic cancer|recurrent pancreatic cancer
707238|NCT00602589|open-label|open-label
707239|NCT00602589|randomized|randomized
707240|NCT00602589|crossover|crossover
707241|NCT00602589|bioequivalence|bioequivalence
707242|NCT00602576|recurrent melanoma|recurrent melanoma
707243|NCT00602576|stage III melanoma|stage iii melanoma
707244|NCT00602576|stage IV melanoma|stage iv melanoma
707245|NCT00602563|Generalized Anxiety Disorder|generalized anxiety disorder
707246|NCT00602563|Information Processing|information processing
707247|NCT00602550|HIV|hiv
707248|NCT00602537|Bipolar Type II Disorder|bipolar type ii disorder
707249|NCT00602537|Hypomania|hypomania
707250|NCT00602537|Antidepressant|antidepressant
707251|NCT00602537|Mood Stabilizer|mood stabilizer
707252|NCT00602537|Venlafaxine|venlafaxine
707253|NCT00602537|Lithium Carbonate|lithium carbonate
707254|NCT00602537|Major Depressive Episode|major depressive episode
707255|NCT00602537|Hypomanic Episodes|hypomanic episodes
707256|NCT00602537|Prevention of Depression Relapse|prevention of depression relapse
707257|NCT00602511|Melfalan refractory multiple myeloma|melfalan refractory multiple myeloma
707258|NCT00602511|Multiple myeloma|multiple myeloma
707259|NCT00602511|Relapsing|relapsing
707260|NCT00602511|Refractory|refractory
707261|NCT00602511|Thalidomide|thalidomide
707262|NCT00602511|Bortezomib|bortezomib
707263|NCT00602511|Randomized clinical trial|randomized clinical trial
707264|NCT00602485|adherence, cardiac rehabilitation|adherence, cardiac rehabilitation
707265|NCT00602446|iron overload|iron overload
707266|NCT00602433|advanced nonsmall cell lung cancer|advanced nonsmall cell lung cancer
707267|NCT00602420|pain|pain
707268|NCT00602420|musculoskeletal complications|musculoskeletal complications
707269|NCT00602420|unspecified adult solid tumor, protocol specific|unspecified adult solid tumor, protocol specific
707270|NCT00602368|cervical cancer|cervical cancer
707271|NCT00602368|cervical intraepithelial neoplasia grade 1|cervical intraepithelial neoplasia grade 1
707272|NCT00602368|cervical intraepithelial neoplasia grade 2|cervical intraepithelial neoplasia grade 2
707273|NCT00602368|cervical intraepithelial neoplasia grade 3|cervical intraepithelial neoplasia grade 3
707274|NCT00602355|Postpartum|postpartum
707275|NCT00602355|Depression|depression
707276|NCT00602355|Medication Therapy|medication therapy
707277|NCT00602355|Zoloft|zoloft
707278|NCT00602355|Sertraline|sertraline
707279|NCT00602355|Interpersonal Psychotherapy|interpersonal psychotherapy
707280|NCT00602329|recurrent colon cancer|recurrent colon cancer
707281|NCT00602329|recurrent rectal cancer|recurrent rectal cancer
707282|NCT00602329|stage III colon cancer|stage iii colon cancer
707283|NCT00602329|stage III rectal cancer|stage iii rectal cancer
707284|NCT00602329|stage IV colon cancer|stage iv colon cancer
707285|NCT00602329|stage IV rectal cancer|stage iv rectal cancer
707286|NCT00602329|adenocarcinoma of the colon|adenocarcinoma of the colon
707287|NCT00602329|adenocarcinoma of the rectum|adenocarcinoma of the rectum
707288|NCT00602316|invasive ductal breast carcinoma|invasive ductal breast carcinoma
707289|NCT00602316|stage IA breast cancer|stage ia breast cancer
707290|NCT00602316|stage IB breast cancer|stage ib breast cancer
707291|NCT00602316|stage II breast cancer|stage ii breast cancer
707292|NCT00602316|stage IIIA breast cancer|stage iiia breast cancer
707293|NCT00602290|Major Depression|major depression
707294|NCT00602290|Geriatric Major Unipolar Depression|geriatric major unipolar depression
707295|NCT00602290|Executive Cognitive Dysfunction|executive cognitive dysfunction
707296|NCT00602290|Elderly|elderly
707297|NCT00602290|Geriatric|geriatric
707298|NCT00602290|Executive Cognitive Impairment|executive cognitive impairment
707299|NCT00602290|Quality of Life|quality of life
707300|NCT00602290|Disability|disability
707301|NCT00602290|Comorbidity|comorbidity
707302|NCT00602290|Medical Burden|medical burden
707303|NCT00602290|Safety|safety
707304|NCT00602290|Candidate Genes|candidate genes
707305|NCT00602264|Anorexia nervosa|anorexia nervosa
707306|NCT00602264|Adipokines|adipokines
707307|NCT00602264|Ghrelin|ghrelin
707308|NCT00602264|Fat mass|fat mass
707309|NCT00602212|generalized anxiety disorder (GAD)|generalized anxiety disorder (gad)
707310|NCT00602199|stage IV melanoma|stage iv melanoma
707311|NCT00602186|female voiding dysfunction|female voiding dysfunction
707312|NCT00602186|Tamsolusin|tamsolusin
707313|NCT00602186|prazosin|prazosin
707314|NCT00602160|Food allergy|food allergy
707315|NCT00602160|Chinese Herbs|chinese herbs
707316|NCT00602160|Investigational new drug|investigational new drug
707317|NCT00602160|Herbs|herbs
707318|NCT00602160|Therapeutic medicine|therapeutic medicine
707319|NCT00602160|Traditional Chinese medicine|traditional chinese medicine
707320|NCT00602147|mucositis|mucositis
707321|NCT00602147|stage I multiple myeloma|stage i multiple myeloma
707322|NCT00602147|stage II multiple myeloma|stage ii multiple myeloma
707323|NCT00602147|stage III multiple myeloma|stage iii multiple myeloma
707324|NCT00602147|refractory multiple myeloma|refractory multiple myeloma
707325|NCT00602108|stage I breast cancer|stage i breast cancer
707326|NCT00602108|stage II breast cancer|stage ii breast cancer
707327|NCT00602095|Labor induction|labor induction
707328|NCT00602095|cervical ripening|cervical ripening
707329|NCT00602095|misoprostol|misoprostol
707330|NCT00602095|dinoprostone|dinoprostone
707331|NCT00602095|balloon catheter|balloon catheter
707332|NCT00602095|prostaglandin|prostaglandin
707333|NCT00602082|pancreatic alpha cell adenoma|pancreatic alpha cell adenoma
707334|NCT00602082|pancreatic alpha cell carcinoma|pancreatic alpha cell carcinoma
707335|NCT00602082|pancreatic beta islet cell adenoma|pancreatic beta islet cell adenoma
707336|NCT00602082|pancreatic beta islet cell carcinoma|pancreatic beta islet cell carcinoma
707337|NCT00602082|pancreatic delta cell adenoma|pancreatic delta cell adenoma
707338|NCT00602082|pancreatic delta cell carcinoma|pancreatic delta cell carcinoma
707339|NCT00602082|pancreatic G-cell adenoma|pancreatic g-cell adenoma
707340|NCT00602082|pancreatic G-cell carcinoma|pancreatic g-cell carcinoma
707341|NCT00602082|gastrinoma|gastrinoma
707342|NCT00602082|insulinoma|insulinoma
707343|NCT00602082|glucagonoma|glucagonoma
707344|NCT00602082|pancreatic polypeptide tumor|pancreatic polypeptide tumor
707345|NCT00602082|somatostatinoma|somatostatinoma
707346|NCT00602082|metastatic gastrointestinal carcinoid tumor|metastatic gastrointestinal carcinoid tumor
707347|NCT00602082|recurrent gastrointestinal carcinoid tumor|recurrent gastrointestinal carcinoid tumor
707348|NCT00602082|regional gastrointestinal carcinoid tumor|regional gastrointestinal carcinoid tumor
707349|NCT00602082|islet cell carcinoma|islet cell carcinoma
707350|NCT00602082|recurrent islet cell carcinoma|recurrent islet cell carcinoma
707351|NCT00602069|PTSD|ptsd
707352|NCT00602069|Intimate Partner Violence|intimate partner violence
707353|NCT00602069|Cognitive Behavioral Therapy|cognitive behavioral therapy
707354|NCT00602069|Empowerment|empowerment
707355|NCT00602056|Immunization dropout|immunization dropout
707356|NCT00602056|Immunization card|immunization card
707357|NCT00602056|Center based education|center based education
707358|NCT00602030|lung cancer|lung cancer
707359|NCT00602030|NSCLC|nsclc
707360|NCT00602030|lung neoplasms|lung neoplasms
707361|NCT00602030|respiratory|respiratory
707362|NCT00602004|Arteriovenous fistula|arteriovenous fistula
707363|NCT00602004|hypertrophy|hypertrophy
707364|NCT00602004|losartan|losartan
707365|NCT00601991|untreated adult acute myeloid leukemia|untreated adult acute myeloid leukemia
707366|NCT00601991|recurrent adult acute myeloid leukemia|recurrent adult acute myeloid leukemia
707367|NCT00601978|Parkinson's disease|parkinson's disease
707368|NCT00601978|carbidopa/levodopa/entacapone|carbidopa/levodopa/entacapone
707369|NCT00601978|carbidopa/levodopa|carbidopa/levodopa
707370|NCT00601978|non-motor symptoms|non-motor symptoms
707371|NCT00601978|event-related potential|event-related potential
707372|NCT00601978|ERP|erp
707373|NCT00601978|EEG|eeg
707374|NCT00601978|electroencephalogram|electroencephalogram
707375|NCT00601952|post traumatic stress disorder|post traumatic stress disorder
707376|NCT00601952|cognitive bias|cognitive bias
707377|NCT00601952|attention|attention
707378|NCT00601952|combat|combat
707379|NCT00601939|Abused|abused
707380|NCT00601939|Female|female
707381|NCT00601939|African American|african american
707382|NCT00601939|Group Empowerment Psychoeducational Intervention|group empowerment psychoeducational intervention
707383|NCT00601939|Enhanced Treatment as Usual|enhanced treatment as usual
707384|NCT00601926|papillary renal cell carcinoma|papillary renal cell carcinoma
707385|NCT00601926|stage III renal cell cancer|stage iii renal cell cancer
707386|NCT00601926|stage IV renal cell cancer|stage iv renal cell cancer
707387|NCT00601913|stage I squamous cell carcinoma of the oropharynx|stage i squamous cell carcinoma of the oropharynx
707388|NCT00601913|stage II squamous cell carcinoma of the oropharynx|stage ii squamous cell carcinoma of the oropharynx
707389|NCT00601913|stage I squamous cell carcinoma of the larynx|stage i squamous cell carcinoma of the larynx
707390|NCT00601913|stage II squamous cell carcinoma of the larynx|stage ii squamous cell carcinoma of the larynx
707391|NCT00601913|stage I squamous cell carcinoma of the lip and oral cavity|stage i squamous cell carcinoma of the lip and oral cavity
707392|NCT00601913|stage II squamous cell carcinoma of the lip and oral cavity|stage ii squamous cell carcinoma of the lip and oral cavity
707393|NCT00601913|stage I squamous cell carcinoma of the hypopharynx|stage i squamous cell carcinoma of the hypopharynx
707394|NCT00601913|stage II squamous cell carcinoma of the hypopharynx|stage ii squamous cell carcinoma of the hypopharynx
707395|NCT00601913|stage I verrucous carcinoma of the larynx|stage i verrucous carcinoma of the larynx
707396|NCT00601913|stage I verrucous carcinoma of the oral cavity|stage i verrucous carcinoma of the oral cavity
707397|NCT00601913|stage II verrucous carcinoma of the oral cavity|stage ii verrucous carcinoma of the oral cavity
707398|NCT00601887|Anti-inflammatory|anti-inflammatory
707926|NCT00599742|Children|children
707399|NCT00601848|stage IIIA non-small cell lung cancer|stage iiia non-small cell lung cancer
707400|NCT00601848|stage IIIB non-small cell lung cancer|stage iiib non-small cell lung cancer
707401|NCT00601848|malignant pleural effusion|malignant pleural effusion
707402|NCT00601835|Diphtheria|diphtheria
707403|NCT00601835|Tetanus|tetanus
707404|NCT00601809|Gastrointestinal|gastrointestinal
707405|NCT00601809|Adhesive Small Intestine Obstruction|adhesive small intestine obstruction
707406|NCT00601809|Oral water soluble contrast|oral water soluble contrast
707407|NCT00601809|Non-operative Conservative Management|non-operative conservative management
707408|NCT00601809|Operative rate|operative rate
707409|NCT00601809|Hospital stay|hospital stay
707410|NCT00601796|adenocarcinoma of the lung|adenocarcinoma of the lung
707411|NCT00601796|stage IV non-small cell lung cancer|stage iv non-small cell lung cancer
707412|NCT00601757|Preventive Intervention|preventive intervention
707413|NCT00601757|Postpartum Depression|postpartum depression
707414|NCT00601757|Women on Public Assistance|women on public assistance
707415|NCT00601744|Orbital Exenteration|orbital exenteration
707416|NCT00601744|Eye Cancer|eye cancer
707417|NCT00601744|Social-Psychological Aspects|social-psychological aspects
707418|NCT00601744|Quality of Life|quality of life
707419|NCT00601744|Questionnaire|questionnaire
707420|NCT00601744|Facial Appearance|facial appearance
707421|NCT00601744|Survey|survey
707422|NCT00601744|Interview|interview
707423|NCT00601731|Prevention of Meningococcal disease|prevention of meningococcal disease
707424|NCT00601705|adenocarcinoma of the esophagus|adenocarcinoma of the esophagus
707425|NCT00601705|adenocarcinoma of the stomach|adenocarcinoma of the stomach
707426|NCT00601705|stage III esophageal cancer|stage iii esophageal cancer
707427|NCT00601705|stage IV esophageal cancer|stage iv esophageal cancer
707428|NCT00601705|stage III gastric cancer|stage iii gastric cancer
707429|NCT00601705|stage IV gastric cancer|stage iv gastric cancer
707430|NCT00601705|stage II esophageal cancer|stage ii esophageal cancer
707431|NCT00601705|stage II gastric cancer|stage ii gastric cancer
707432|NCT00601692|squamous cell carcinoma of the esophagus|squamous cell carcinoma of the esophagus
707433|NCT00601692|adenocarcinoma of the esophagus|adenocarcinoma of the esophagus
707434|NCT00601692|stage II esophageal cancer|stage ii esophageal cancer
707435|NCT00601692|stage III esophageal cancer|stage iii esophageal cancer
707436|NCT00601692|stage IV esophageal cancer|stage iv esophageal cancer
707437|NCT00601679|CHF treatment&prognosis,NT-proBNP testing.|chf treatment&prognosis,nt-probnp testing.
707438|NCT00601653|Binge Eating Disorder|binge eating disorder
707439|NCT00601653|BED|bed
707440|NCT00601653|Nutrition|nutrition
707441|NCT00601653|Energy Density|energy density
707442|NCT00601653|Cognitive Behavioral Therapy|cognitive behavioral therapy
707443|NCT00601653|CBT|cbt
707444|NCT00601640|skin cancer|skin cancer
707445|NCT00601627|adenocarcinoma of the pancreas|adenocarcinoma of the pancreas
707446|NCT00601627|stage II pancreatic cancer|stage ii pancreatic cancer
707447|NCT00601627|stage III pancreatic cancer|stage iii pancreatic cancer
707448|NCT00601614|unspecified adult solid tumor, protocol specific|unspecified adult solid tumor, protocol specific
707449|NCT00601601|stage 0 cervical cancer|stage 0 cervical cancer
707450|NCT00601601|cervical intraepithelial neoplasia grade 1|cervical intraepithelial neoplasia grade 1
707451|NCT00601601|cervical intraepithelial neoplasia grade 2|cervical intraepithelial neoplasia grade 2
707452|NCT00601601|cervical intraepithelial neoplasia grade 3|cervical intraepithelial neoplasia grade 3
707453|NCT00601562|HIV|hiv
707454|NCT00601549|Rectal cancer|rectal cancer
707455|NCT00601549|CCRT|ccrt
707456|NCT00601549|Laparoscopic Surgery|laparoscopic surgery
707457|NCT00601549|rectal cancer can be resected by curative and elective surgery|rectal cancer can be resected by curative and elective surgery
707458|NCT00601549|rectal adenocarcinoma below peritoneal reflection|rectal adenocarcinoma below peritoneal reflection
707459|NCT00601549|American Society of Anesthesiology（ASA） classⅠ to Ⅲ lesions|american society of anesthesiology（asa） classⅰ to ⅲ lesions
707460|NCT00601510|stage III gastric cancer|stage iii gastric cancer
707461|NCT00601510|stage IV gastric cancer|stage iv gastric cancer
707462|NCT00601484|Painful Bladder Syndrome, monoclonal antibody|painful bladder syndrome, monoclonal antibody
707463|NCT00601471|ankle sprain|ankle sprain
707464|NCT00601471|ankle injuries|ankle injuries
707465|NCT00601471|sprains and strains|sprains and strains
707466|NCT00601458|Primary, unilateral, first metatarsal bunionectomy with osteotomy|primary, unilateral, first metatarsal bunionectomy with osteotomy
707467|NCT00601445|Changes in sleep with aging|changes in sleep with aging
707468|NCT00601432|open-label|open-label
707469|NCT00601432|randomized|randomized
707470|NCT00601432|crossover|crossover
707471|NCT00601432|food effect|food effect
707472|NCT00601406|male breast cancer|male breast cancer
707473|NCT00601406|stage IA breast cancer|stage ia breast cancer
707474|NCT00601406|stage IB breast cancer|stage ib breast cancer
707475|NCT00601406|stage II breast cancer|stage ii breast cancer
707476|NCT00601406|stage I prostate cancer|stage i prostate cancer
707477|NCT00601406|stage IIB prostate cancer|stage iib prostate cancer
707478|NCT00601406|stage IIA prostate cancer|stage iia prostate cancer
707479|NCT00601406|stage III prostate cancer|stage iii prostate cancer
707480|NCT00601406|stage IA cervical cancer|stage ia cervical cancer
707481|NCT00601406|stage IB cervical cancer|stage ib cervical cancer
708222|NCT00598286|Cannabinoid|cannabinoid
707482|NCT00601406|stage IIA cervical cancer|stage iia cervical cancer
707483|NCT00601406|stage IIB cervical cancer|stage iib cervical cancer
707484|NCT00601406|stage III cervical cancer|stage iii cervical cancer
707485|NCT00601406|stage IVA cervical cancer|stage iva cervical cancer
707486|NCT00601406|stage IVB cervical cancer|stage ivb cervical cancer
707487|NCT00601406|stage I vaginal cancer|stage i vaginal cancer
707488|NCT00601406|stage II vaginal cancer|stage ii vaginal cancer
707489|NCT00601406|stage III vaginal cancer|stage iii vaginal cancer
707490|NCT00601406|stage IVA vaginal cancer|stage iva vaginal cancer
707491|NCT00601406|stage IVB vaginal cancer|stage ivb vaginal cancer
707492|NCT00601406|stage IA vulvar cancer|stage ia vulvar cancer
707493|NCT00601406|stage IB vulvar cancer|stage ib vulvar cancer
707494|NCT00601406|stage II vulvar cancer|stage ii vulvar cancer
707495|NCT00601406|stage IIIC vulvar cancer|stage iiic vulvar cancer
707496|NCT00601406|stage IIIA vulvar cancer|stage iiia vulvar cancer
707497|NCT00601406|stage IIIB vulvar cancer|stage iiib vulvar cancer
707498|NCT00601406|stage IVB vulvar cancer|stage ivb vulvar cancer
707499|NCT00601406|stage IA ovarian epithelial cancer|stage ia ovarian epithelial cancer
707500|NCT00601406|stage IB ovarian epithelial cancer|stage ib ovarian epithelial cancer
707501|NCT00601406|stage IC ovarian epithelial cancer|stage ic ovarian epithelial cancer
707502|NCT00601406|stage IA ovarian germ cell tumor|stage ia ovarian germ cell tumor
707503|NCT00601406|stage IB ovarian germ cell tumor|stage ib ovarian germ cell tumor
707504|NCT00601406|stage IC ovarian germ cell tumor|stage ic ovarian germ cell tumor
707505|NCT00601406|stage IIA ovarian epithelial cancer|stage iia ovarian epithelial cancer
707506|NCT00601406|stage IIB ovarian epithelial cancer|stage iib ovarian epithelial cancer
707507|NCT00601406|stage IIC ovarian epithelial cancer|stage iic ovarian epithelial cancer
707508|NCT00601406|stage IIA ovarian germ cell tumor|stage iia ovarian germ cell tumor
707509|NCT00601406|stage IIB ovarian germ cell tumor|stage iib ovarian germ cell tumor
707510|NCT00601406|stage IIC ovarian germ cell tumor|stage iic ovarian germ cell tumor
707511|NCT00601406|stage IIIA ovarian epithelial cancer|stage iiia ovarian epithelial cancer
707512|NCT00601406|stage IIIB ovarian epithelial cancer|stage iiib ovarian epithelial cancer
707513|NCT00601406|stage IIIC ovarian epithelial cancer|stage iiic ovarian epithelial cancer
707514|NCT00601406|stage IIIA ovarian germ cell tumor|stage iiia ovarian germ cell tumor
707515|NCT00601406|stage IIIB ovarian germ cell tumor|stage iiib ovarian germ cell tumor
707516|NCT00601406|stage IIIC ovarian germ cell tumor|stage iiic ovarian germ cell tumor
707517|NCT00601406|stage IV ovarian epithelial cancer|stage iv ovarian epithelial cancer
707518|NCT00601406|stage IV ovarian germ cell tumor|stage iv ovarian germ cell tumor
707519|NCT00601406|stage II endometrial carcinoma|stage ii endometrial carcinoma
707520|NCT00601406|ovarian stromal cancer|ovarian stromal cancer
707521|NCT00601406|ovarian sarcoma|ovarian sarcoma
707522|NCT00601406|stage IA fallopian tube cancer|stage ia fallopian tube cancer
707523|NCT00601406|stage IB fallopian tube cancer|stage ib fallopian tube cancer
707524|NCT00601406|stage IC fallopian tube cancer|stage ic fallopian tube cancer
707525|NCT00601406|stage IIA fallopian tube cancer|stage iia fallopian tube cancer
707526|NCT00601406|stage IIB fallopian tube cancer|stage iib fallopian tube cancer
707527|NCT00601406|stage IIC fallopian tube cancer|stage iic fallopian tube cancer
707528|NCT00601406|stage IIIA fallopian tube cancer|stage iiia fallopian tube cancer
707529|NCT00601406|stage IIIB fallopian tube cancer|stage iiib fallopian tube cancer
707530|NCT00601406|stage IIIC fallopian tube cancer|stage iiic fallopian tube cancer
707531|NCT00601406|stage IV fallopian tube cancer|stage iv fallopian tube cancer
707532|NCT00601406|recurrent primary peritoneal cavity cancer|recurrent primary peritoneal cavity cancer
707533|NCT00601406|stage IA primary peritoneal cavity cancer|stage ia primary peritoneal cavity cancer
707534|NCT00601406|stage IB primary peritoneal cavity cancer|stage ib primary peritoneal cavity cancer
707535|NCT00601406|stage IC primary peritoneal cavity cancer|stage ic primary peritoneal cavity cancer
707536|NCT00601406|stage IIA primary peritoneal cavity cancer|stage iia primary peritoneal cavity cancer
707537|NCT00601406|stage IIB primary peritoneal cavity cancer|stage iib primary peritoneal cavity cancer
707538|NCT00601406|stage IIC primary peritoneal cavity cancer|stage iic primary peritoneal cavity cancer
707539|NCT00601406|stage IIIA primary peritoneal cavity cancer|stage iiia primary peritoneal cavity cancer
707540|NCT00601406|stage IIIB primary peritoneal cavity cancer|stage iiib primary peritoneal cavity cancer
707541|NCT00601406|stage IIIC primary peritoneal cavity cancer|stage iiic primary peritoneal cavity cancer
707542|NCT00601406|stage IV primary peritoneal cavity cancer|stage iv primary peritoneal cavity cancer
707543|NCT00601406|stage IA endometrial carcinoma|stage ia endometrial carcinoma
707544|NCT00601406|stage IB endometrial carcinoma|stage ib endometrial carcinoma
707545|NCT00601406|stage IIIA endometrial carcinoma|stage iiia endometrial carcinoma
707546|NCT00601406|stage IIIB endometrial carcinoma|stage iiib endometrial carcinoma
707547|NCT00601406|stage IIIC endometrial carcinoma|stage iiic endometrial carcinoma
707548|NCT00601406|stage IVA endometrial carcinoma|stage iva endometrial carcinoma
707549|NCT00601406|stage IVB endometrial carcinoma|stage ivb endometrial carcinoma
707550|NCT00601406|stage IA uterine sarcoma|stage ia uterine sarcoma
707551|NCT00601406|stage IB uterine sarcoma|stage ib uterine sarcoma
707552|NCT00601406|stage IC uterine sarcoma|stage ic uterine sarcoma
707553|NCT00601406|stage IIA uterine sarcoma|stage iia uterine sarcoma
707554|NCT00601406|stage IIB uterine sarcoma|stage iib uterine sarcoma
707555|NCT00601406|stage IIIA uterine sarcoma|stage iiia uterine sarcoma
707556|NCT00601406|stage IIIB uterine sarcoma|stage iiib uterine sarcoma
707557|NCT00601406|stage IIIC uterine sarcoma|stage iiic uterine sarcoma
707558|NCT00601406|stage IVA uterine sarcoma|stage iva uterine sarcoma
707559|NCT00601406|stage IVB uterine sarcoma|stage ivb uterine sarcoma
707560|NCT00601354|Binge Eating|binge eating
707561|NCT00601354|Orlistat|orlistat
707563|NCT00601354|Guided Self-Help|guided self-help
707564|NCT00601341|arthralgia|arthralgia
707565|NCT00601341|joint pain|joint pain
707566|NCT00601341|knee injuries|knee injuries
707567|NCT00601341|knee joint|knee joint
707568|NCT00601341|low back pain|low back pain
707569|NCT00601289|pituitary chromophobe adenoma|pituitary chromophobe adenoma
707570|NCT00601289|recurrent pituitary tumor|recurrent pituitary tumor
707571|NCT00601289|ACTH-producing pituitary tumor|acth-producing pituitary tumor
707572|NCT00601289|growth hormone-producing pituitary tumor|growth hormone-producing pituitary tumor
707573|NCT00601289|prolactin-producing pituitary tumor|prolactin-producing pituitary tumor
707574|NCT00601289|pituitary basophilic adenoma|pituitary basophilic adenoma
707575|NCT00601289|pituitary eosinophilic adenoma|pituitary eosinophilic adenoma
707576|NCT00601289|prolactin secreting adenoma|prolactin secreting adenoma
707577|NCT00601289|nonfunctioning pituitary tumor|nonfunctioning pituitary tumor
707578|NCT00601276|pedophilia|pedophilia
707579|NCT00601276|antiandrogens|antiandrogens
707580|NCT00601276|gonadotropin releasing hormone agonists|gonadotropin releasing hormone agonists
707581|NCT00601263|Chinese Herbal Therapy|chinese herbal therapy
707582|NCT00601263|Asthma|asthma
707583|NCT00601263|Investigational new drug (IND)|investigational new drug (ind)
707584|NCT00601263|Complementary and Alternative Medicine|complementary and alternative medicine
707585|NCT00601237|HIV Prevention|hiv prevention
707586|NCT00601237|Mobile Phone|mobile phone
707587|NCT00601237|Technology-Based Intervention|technology-based intervention
707588|NCT00601237|HIV|hiv
707589|NCT00601237|HIV Seronegativity|hiv seronegativity
707590|NCT00601224|Social Cognition|social cognition
707591|NCT00601224|Group Therapy|group therapy
707592|NCT00601224|Psychosocial Intervention|psychosocial intervention
707593|NCT00601198|Oxaliplatin-induced Neuropathy|oxaliplatin-induced neuropathy
707594|NCT00601198|Colon and rectum|colon and rectum
707595|NCT00601185|06-009|06-009
707596|NCT00601185|Confocal reflectance microscopy|confocal reflectance microscopy
707597|NCT00601185|shave-biopsy|shave-biopsy
707598|NCT00601172|vomiting|vomiting
707599|NCT00601172|colorectal cancer|colorectal cancer
707600|NCT00601172|nausea|nausea
707601|NCT00601172|oxaliplatin|oxaliplatin
707602|NCT00601159|Metastatic Breast Cancer|metastatic breast cancer
707603|NCT00601159|triple-negative Breast Cancer|triple-negative breast cancer
707604|NCT00601159|cisplatin|cisplatin
707605|NCT00601159|chemotherapy|chemotherapy
707606|NCT00601146|Hodgkin's disease|hodgkin's disease
707607|NCT00601146|CT scan|ct scan
707608|NCT00601133|Solid Tumors|solid tumors
707609|NCT00601133|Acute Inpatient Rehabilitation|acute inpatient rehabilitation
707610|NCT00601133|Postural Instability|postural instability
707611|NCT00601133|Balance|balance
707612|NCT00601133|Function|function
707613|NCT00601133|Walking|walking
707614|NCT00601133|Questionnaire|questionnaire
707615|NCT00601133|Survey|survey
707616|NCT00601120|antiangiogenic therapy|antiangiogenic therapy
707617|NCT00601120|RF ablation|rf ablation
707618|NCT00601107|psoriasis|psoriasis
707619|NCT00601107|psoriasis vulgaris|psoriasis vulgaris
707620|NCT00601107|plaque psoriasis|plaque psoriasis
707621|NCT00601107|chronic plaque psoriasis|chronic plaque psoriasis
707622|NCT00601094|stage IIIB non-small cell lung cancer|stage iiib non-small cell lung cancer
707623|NCT00601094|stage IV non-small cell lung cancer|stage iv non-small cell lung cancer
707624|NCT00601094|recurrent non-small cell lung cancer|recurrent non-small cell lung cancer
707625|NCT00601081|Very low birth weight infants|very low birth weight infants
707626|NCT00601081|HMF|hmf
707627|NCT00601081|immune system function|immune system function
707628|NCT00601068|osteonecrosis, jaws, bisphosphonate, fosamax, alendronate|osteonecrosis, jaws, bisphosphonate, fosamax, alendronate
707629|NCT00601055|COPD|copd
707630|NCT00601055|Geriatric Depression|geriatric depression
707631|NCT00601055|Problem-Solving Therapy|problem-solving therapy
707632|NCT00601055|Treatment Adherence|treatment adherence
707633|NCT00601042|smoking reduction|smoking reduction
707634|NCT00601042|smoking cessation|smoking cessation
707635|NCT00601042|randomized trial|randomized trial
707636|NCT00601042|Swedish snus|swedish snus
707637|NCT00601042|smokeless tobacco|smokeless tobacco
707638|NCT00601029|Exertional Rhabdomyolysis|exertional rhabdomyolysis
707639|NCT00601016|Infantile hemangioma|infantile hemangioma
707640|NCT00601016|Hemangioma|hemangioma
707641|NCT00601016|Hemangioma of Infancy|hemangioma of infancy
707642|NCT00601016|benign tumors of infancy|benign tumors of infancy
707643|NCT00601016|Congenital hemangioma|congenital hemangioma
707644|NCT00601016|Capillary|capillary
707645|NCT00600990|post-operative nausea and vomiting|post-operative nausea and vomiting
707646|NCT00600990|PONV|ponv
707647|NCT00600977|ALL|all
707648|NCT00600977|Chemotherapy|chemotherapy
707649|NCT00600977|Pharmacokinetics of doxorubicin (pegylated or not)|pharmacokinetics of doxorubicin (pegylated or not)
707650|NCT00600977|elderly ALL|elderly all
707651|NCT00600964|CLL|cll
707652|NCT00600964|obatoclax|obatoclax
707653|NCT00600938|iron overload|iron overload
707654|NCT00600938|cardiac iron|cardiac iron
707655|NCT00600938|haemosiderosis|haemosiderosis
707656|NCT00600938|myocardial T2*|myocardial t2*
707657|NCT00600938|left ventricular ejection fraction|left ventricular ejection fraction
707658|NCT00600938|LVEF|lvef
707659|NCT00600938|cardiac dysfunction|cardiac dysfunction
707660|NCT00600938|thalassaemia|thalassaemia
707661|NCT00600938|Diamond Blackfan anemia|diamond blackfan anemia
707662|NCT00600938|DBA|dba
707663|NCT00600938|sideroblastic anemia|sideroblastic anemia
707664|NCT00600938|myelodysplastic syndromes|myelodysplastic syndromes
707665|NCT00600938|MDS (low and INT-1 risk as per the IPSS for MDS)|mds (low and int-1 risk as per the ipss for mds)
707666|NCT00600938|liver MRI|liver mri
707667|NCT00600938|deferasirox|deferasirox
707668|NCT00600938|deferoxamine|deferoxamine
707669|NCT00600938|ICL670|icl670
707670|NCT00600938|DFO|dfo
707671|NCT00600938|cardiovascular magnetic resonance imaging|cardiovascular magnetic resonance imaging
707672|NCT00600925|Colorectal surgery|colorectal surgery
707673|NCT00600912|lipid emulsion|lipid emulsion
707674|NCT00600912|fish oil|fish oil
707675|NCT00600912|parenteral nutrition|parenteral nutrition
707676|NCT00600912|leucotriene LTB5|leucotriene ltb5
707677|NCT00600912|hepatic function|hepatic function
707678|NCT00600899|Postoperative pain treatment|postoperative pain treatment
707679|NCT00600886|Acromegaly,|acromegaly,
707680|NCT00600886|adult,|adult,
707681|NCT00600886|growth hormone,|growth hormone,
707682|NCT00600886|insulin-like growth factor I,|insulin-like growth factor i,
707683|NCT00600886|somatostatin analogue|somatostatin analogue
707684|NCT00600873|neuroprotection|neuroprotection
707685|NCT00600873|oxidative stress|oxidative stress
707686|NCT00600860|MDS (all IPSS subtypes)|mds (all ipss subtypes)
707687|NCT00600860|Newly diagnosed|newly diagnosed
707688|NCT00600847|urticaria|urticaria
707689|NCT00600847|cold urticaria|cold urticaria
707690|NCT00600847|acquired cold urticaria|acquired cold urticaria
707691|NCT00600808|SR-hGH, Pharmacokinetics, Pharmacodynamics|sr-hgh, pharmacokinetics, pharmacodynamics
707692|NCT00600795|NPH|nph
707693|NCT00600795|TGF-beta|tgf-beta
707694|NCT00600782|Tuberculosis vaccine|tuberculosis vaccine
707695|NCT00600769|MAC|mac
707696|NCT00600769|NTM|ntm
707697|NCT00600756|schizophrenia|schizophrenia
707698|NCT00600756|SWNK|swnk
707699|NCT00600743|Eating|eating
707700|NCT00600743|Food Intake|food intake
707701|NCT00600743|Appetite|appetite
707702|NCT00600730|fMRi|fmri
707703|NCT00600730|hypoglycemia|hypoglycemia
707704|NCT00600717|Magnetoencephalography(MEG)|magnetoencephalography(meg)
707705|NCT00600717|Electroencephalography (EEG)|electroencephalography (eeg)
707706|NCT00600717|Intracranial recordings (iEEG/ECoG/SEEG)|intracranial recordings (ieeg/ecog/seeg)
707707|NCT00600717|Functional Mapping|functional mapping
707708|NCT00600717|Epilepsy|epilepsy
707709|NCT00600717|Migraine|migraine
707710|NCT00600717|High frequency oscillations (HFOs)|high frequency oscillations (hfos)
707711|NCT00600717|ripples|ripples
707712|NCT00600717|fast ripples|fast ripples
707713|NCT00600717|high-gamma|high-gamma
707714|NCT00600717|very high frequency oscillations (VHFOs)|very high frequency oscillations (vhfos)
707715|NCT00600704|Allogenic Blood Use|allogenic blood use
707716|NCT00600704|Total Blood Loss|total blood loss
707717|NCT00600704|Reinfusion of Washed Shed Blood|reinfusion of washed shed blood
707718|NCT00600691|Finasteride|finasteride
707719|NCT00600691|hematuria|hematuria
707720|NCT00600691|hematospermia|hematospermia
707721|NCT00600691|prostate biopsy|prostate biopsy
707722|NCT00600678|food for special medical purposes|food for special medical purposes
707723|NCT00600665|Sickle Cell Anemia|sickle cell anemia
707724|NCT00600665|Sickle Cell Disease|sickle cell disease
707725|NCT00600652|glucocorticoid-receptor|glucocorticoid-receptor
707726|NCT00600652|flow cytometry|flow cytometry
707727|NCT00600652|glucocorticoid-resistant|glucocorticoid-resistant
707728|NCT00600652|prediction|prediction
707729|NCT00600639|old patients|old patients
707730|NCT00600639|NIV|niv
707731|NCT00600639|Intubation|intubation
707732|NCT00600639|COPD|copd
707733|NCT00600613|Radiation Therapy|radiation therapy
707734|NCT00600587|Carcinoma, Non-Small-Cell Lung|carcinoma, non-small-cell lung
707735|NCT00600587|Genes, erbB-1|genes, erbb-1
707736|NCT00600587|tyrosine kinase inhibitor|tyrosine kinase inhibitor
707737|NCT00600587|Neoadjuvant Therapy|neoadjuvant therapy
707738|NCT00600574|fibromyalgia|fibromyalgia
707739|NCT00600574|physical therapies|physical therapies
707740|NCT00600574|stretching|stretching
707741|NCT00600574|Ai Chi|ai chi
707742|NCT00600561|meditation|meditation
707743|NCT00600561|mindfulness|mindfulness
707744|NCT00600561|HIV|hiv
707745|NCT00600561|CD4|cd4
707746|NCT00600561|Complementary Therapies|complementary therapies
707747|NCT00600548|Cutaneous leishmaniasis|cutaneous leishmaniasis
707748|NCT00600548|Miltefosine|miltefosine
707749|NCT00600548|Meglumine antimoniate|meglumine antimoniate
707750|NCT00600548|L. braziliensis, L. guyanensis|l. braziliensis, l. guyanensis
707751|NCT00600535|Prostate neoplasms|prostate neoplasms
707752|NCT00600535|Abiraterone acetate|abiraterone acetate
707753|NCT00600535|CB7630|cb7630
707754|NCT00600535|Prostate cancer|prostate cancer
707755|NCT00600535|Pharmacokinetics|pharmacokinetics
707756|NCT00600522|intraoperative ultrasonography|intraoperative ultrasonography
707757|NCT00600522|hepatectomy|hepatectomy
707758|NCT00600522|colorectal liver metastases|colorectal liver metastases
707759|NCT00600522|hepatocellular carcinoma|hepatocellular carcinoma
707760|NCT00600522|contrast enhanced intraoperative ultrasonography.|contrast enhanced intraoperative ultrasonography.
707761|NCT00600509|Levetiracetam|levetiracetam
707762|NCT00600509|Keppra|keppra
707763|NCT00600496|ARRY-142886|arry-142886
707764|NCT00600496|AZD6244|azd6244
707765|NCT00600496|Cancer|cancer
707766|NCT00600496|Colon Cancer|colon cancer
707767|NCT00600496|Breast Cancer|breast cancer
707768|NCT00600496|Lung Cancer|lung cancer
707769|NCT00600496|Melanoma|melanoma
707770|NCT00600496|Kidney Cancer|kidney cancer
707771|NCT00600483|obesity|obesity
707772|NCT00600483|diabetes|diabetes
707773|NCT00600470|Behavior Problems|behavior problems
707774|NCT00600470|Behavior Disorders|behavior disorders
707775|NCT00600457|healing time|healing time
707776|NCT00600457|pain|pain
707777|NCT00600457|infection|infection
707778|NCT00600444|permanent venous access|permanent venous access
707779|NCT00600444|chemotherapy|chemotherapy
707780|NCT00600444|parenteral nutrition|parenteral nutrition
707781|NCT00600444|Patients with a benign and/or malignant diseases which demand a safe and permanent venous access, e.g. for chemotherapy and/or parenteral nutrition|patients with a benign and/or malignant diseases which demand a safe and permanent venous access, e.g. for chemotherapy and/or parenteral nutrition
707782|NCT00600444|benign diseases|benign diseases
707783|NCT00600444|malignant diseases|malignant diseases
707784|NCT00600431|nevus count|nevus count
707785|NCT00600431|children|children
707786|NCT00600431|chemotherapy|chemotherapy
707787|NCT00600418|PTSD|ptsd
707788|NCT00600418|DYADIC TREATMENT|dyadic treatment
707789|NCT00600418|WAR AND TERROR|war and terror
707790|NCT00600418|Posttraumatic symptoms among toddlers|posttraumatic symptoms among toddlers
707791|NCT00600405|Nephrolithiasis|nephrolithiasis
707792|NCT00600405|Ureteral Calculi|ureteral calculi
707793|NCT00600379|stroke chronic gait deficits virtual reality training|stroke chronic gait deficits virtual reality training
707794|NCT00600353|nausea|nausea
707795|NCT00600353|cancer|cancer
707796|NCT00600353|CINV|cinv
707797|NCT00600327|Stroke|stroke
707798|NCT00600327|thrombosis|thrombosis
707799|NCT00600327|thromboembolic|thromboembolic
707800|NCT00600327|Transient Ischemic Attack|transient ischemic attack
707801|NCT00600327|TIA|tia
707802|NCT00600314|Graft-Versus-Host Disease|graft-versus-host disease
707803|NCT00600314|Transplantation, Allogeneic|transplantation, allogeneic
707804|NCT00600314|Transplantation, Hematopoietic Stem Cell|transplantation, hematopoietic stem cell
707805|NCT00600314|Calorimetry, Respiration|calorimetry, respiration
707806|NCT00600301|Macula|macula
707807|NCT00600301|Edema|edema
707808|NCT00600275|BGT226|bgt226
707809|NCT00600275|Solid tumors|solid tumors
707810|NCT00600275|Breast cancer|breast cancer
707811|NCT00600275|Cowden Syndrome|cowden syndrome
707812|NCT00600275|Phosphatidylinositol 3'-kinase (PI3K) inhibitor|phosphatidylinositol 3'-kinase (pi3k) inhibitor
707813|NCT00600275|Advanced solid tumors (including sporadic and Cowden Syndrome) (Phase I part)|advanced solid tumors (including sporadic and cowden syndrome) (phase i part)
707814|NCT00600275|Advanced breast cancer (including sporadic and Cowden Syndrome) (Phase II part)|advanced breast cancer (including sporadic and cowden syndrome) (phase ii part)
707815|NCT00600262|severe nonproliferative|severe nonproliferative
707816|NCT00600262|proliferative diabetic retinopathy|proliferative diabetic retinopathy
707817|NCT00600262|active photocoagulated diabetic retinopathy|active photocoagulated diabetic retinopathy
707818|NCT00600262|intravitreal bevacizumab|intravitreal bevacizumab
707819|NCT00600249|Breast cancer.|breast cancer.
707820|NCT00600249|Triple negative.|triple negative.
707821|NCT00600249|Neoadjuvant chemotherapy.|neoadjuvant chemotherapy.
707822|NCT00600249|Targeted therapy.|targeted therapy.
707823|NCT00600236|Diabetes mellitus type 2 with 10 years of diagnosis and no diabetic retinopathy|diabetes mellitus type 2 with 10 years of diagnosis and no diabetic retinopathy
707824|NCT00600236|Diabetes mellitus type 2 with 10 years of diagnosis and proliferative diabetic retinopathy|diabetes mellitus type 2 with 10 years of diagnosis and proliferative diabetic retinopathy
707825|NCT00600171|dose ranging|dose ranging
707826|NCT00600171|placebo|placebo
707827|NCT00600171|asthma|asthma
707828|NCT00600171|safety|safety
707829|NCT00600171|efficacy|efficacy
707830|NCT00600171|pharmacokinetics|pharmacokinetics
707831|NCT00600158|colectomy|colectomy
707832|NCT00600145|Human volunteers|human volunteers
707833|NCT00600145|amphetamine dependence|amphetamine dependence
707834|NCT00600119|NKTR, constipation, opioid, induced, bowel, dysfunction, Naloxol, Naloxone, Narcan, PEG naloxol, OIC, OBD, Nektar|nktr, constipation, opioid, induced, bowel, dysfunction, naloxol, naloxone, narcan, peg naloxol, oic, obd, nektar
707835|NCT00600093|Amantadine|amantadine
707836|NCT00600067|Diabetes|diabetes
707837|NCT00600067|Type 2 Diabetes|type 2 diabetes
707838|NCT00600067|Diabetes Mellitus|diabetes mellitus
707839|NCT00600067|Metabolic Diseases|metabolic diseases
707840|NCT00600067|Glucose Metabolism Disorders|glucose metabolism disorders
707841|NCT00600067|Glycemic Control|glycemic control
707842|NCT00600054|Diffuse intrinsic pontine glioma|diffuse intrinsic pontine glioma
707843|NCT00600054|Common Terminology Criteria|common terminology criteria
707844|NCT00600054|Epidermal Growth factor receptor|epidermal growth factor receptor
707845|NCT00600054|Human antihuman antibody|human antihuman antibody
707846|NCT00600054|pharmacokinetics|pharmacokinetics
707847|NCT00600054|monoclonal antibody|monoclonal antibody
707848|NCT00600054|Informed Consent Form|informed consent form
707849|NCT00600041|Proton Pump Inhibitors|proton pump inhibitors
707850|NCT00600041|pantoprazole|pantoprazole
707851|NCT00600041|Cardiac Output|cardiac output
707852|NCT00600041|Echocardiography|echocardiography
707853|NCT00600041|adverse effects|adverse effects
707854|NCT00600028|idiopathic pulmonary fibrosis cough|idiopathic pulmonary fibrosis cough
707855|NCT00600015|Non-Small Cell Lung Cancer|non-small cell lung cancer
707856|NCT00600015|Advanced|advanced
707857|NCT00600015|Sorafenib|sorafenib
707858|NCT00600015|Erlotinib|erlotinib
707859|NCT00600015|Double-blind|double-blind
707860|NCT00600015|Placebo-controlled|placebo-controlled
707861|NCT00600002|GM-CSF|gm-csf
707862|NCT00600002|Leukine|leukine
707863|NCT00599989|long-term effects secondary to cancer therapy in adults|long-term effects secondary to cancer therapy in adults
707864|NCT00599989|skin reactions secondary to radiation therapy|skin reactions secondary to radiation therapy
707865|NCT00599989|stage I breast cancer|stage i breast cancer
707866|NCT00599989|stage II breast cancer|stage ii breast cancer
707867|NCT00599989|invasive lobular breast carcinoma with predominant in situ component|invasive lobular breast carcinoma with predominant in situ component
707868|NCT00599989|invasive lobular breast carcinoma|invasive lobular breast carcinoma
707869|NCT00599989|comedo ductal breast carcinoma|comedo ductal breast carcinoma
707870|NCT00599989|ductal breast carcinoma in situ|ductal breast carcinoma in situ
707871|NCT00599989|invasive ductal breast carcinoma|invasive ductal breast carcinoma
707872|NCT00599989|medullary ductal breast carcinoma with lymphocytic infiltrate|medullary ductal breast carcinoma with lymphocytic infiltrate
707873|NCT00599989|mucinous ductal breast carcinoma|mucinous ductal breast carcinoma
707874|NCT00599989|papillary ductal breast carcinoma|papillary ductal breast carcinoma
707875|NCT00599989|tubular ductal breast carcinoma|tubular ductal breast carcinoma
707876|NCT00599989|Paget disease of the breast with intraductal carcinoma|paget disease of the breast with intraductal carcinoma
707877|NCT00599989|Paget disease of the breast with invasive ductal carcinoma|paget disease of the breast with invasive ductal carcinoma
707878|NCT00599989|breast cancer in situ|breast cancer in situ
707879|NCT00599950|Mitomycin C|mitomycin c
707880|NCT00599950|Corneal epithelium|corneal epithelium
707881|NCT00599950|Photorefractive keratectomy (PRK)|photorefractive keratectomy (prk)
707882|NCT00599950|Confocal microscope|confocal microscope
707883|NCT00599937|APL|apl
707884|NCT00599924|advanced solid tumors,|advanced solid tumors,
707885|NCT00599924|colorectal cancer,|colorectal cancer,
707886|NCT00599924|sunitinib (SUTENT),|sunitinib (sutent),
707887|NCT00599924|FOLFOX|folfox
707888|NCT00599911|Drug therapy|drug therapy
707889|NCT00599911|Depressive disorder|depressive disorder
707890|NCT00599911|Antidepressive agents|antidepressive agents
707891|NCT00599911|Depressive symptoms|depressive symptoms
707892|NCT00599911|Affective disorders|affective disorders
707893|NCT00599911|Randomized controlled trial|randomized controlled trial
707894|NCT00599911|Placebo-controlled|placebo-controlled
707895|NCT00599911|Double-blind|double-blind
707896|NCT00599911|Active reference|active reference
707897|NCT00599911|Multicenter study|multicenter study
707898|NCT00599898|Preterm labor|preterm labor
707899|NCT00599898|Atosiban|atosiban
707900|NCT00599898|Nifedipine|nifedipine
707901|NCT00599872|Allergy|allergy
707902|NCT00599872|Sublingual Immunotherapy|sublingual immunotherapy
707903|NCT00599872|Allergic Rhinitis|allergic rhinitis
707904|NCT00599859|lactase|lactase
707905|NCT00599859|lactose|lactose
707906|NCT00599859|microflora|microflora
707907|NCT00599846|age-related macular degeneration|age-related macular degeneration
707908|NCT00599846|geographic atrophy|geographic atrophy
707909|NCT00599833|adenocarcinoma of the pancreas|adenocarcinoma of the pancreas
707910|NCT00599833|stage III pancreatic cancer|stage iii pancreatic cancer
707911|NCT00599820|Angioid Streaks|angioid streaks
707912|NCT00599820|Choroidal Neovascularization|choroidal neovascularization
707913|NCT00599820|Bevacizumab|bevacizumab
707914|NCT00599794|Sepsis|sepsis
707915|NCT00599794|Intravascular volume|intravascular volume
707916|NCT00599794|Ultrasound|ultrasound
707917|NCT00599794|Noninvasive measurement|noninvasive measurement
707918|NCT00599781|adenosine deaminase|adenosine deaminase
707919|NCT00599781|SCID|scid
707920|NCT00599781|gene therapy|gene therapy
707921|NCT00599781|retroviral vector|retroviral vector
707922|NCT00599742|Balance disorder|balance disorder
707923|NCT00599742|Vestibular disorder|vestibular disorder
707924|NCT00599742|Generalized anxiety disorder|generalized anxiety disorder
707925|NCT00599742|Separation anxiety disorder|separation anxiety disorder
707927|NCT00599742|Balance training|balance training
707928|NCT00599716|dry eye syndrome|dry eye syndrome
707929|NCT00599716|dry eye disease|dry eye disease
707930|NCT00599716|Vismed|vismed
707931|NCT00599716|dry eye|dry eye
707932|NCT00599716|sodium hyaluronate|sodium hyaluronate
707933|NCT00599716|hyaluronic acid|hyaluronic acid
707934|NCT00599690|Epi-LASIK-LASIK microkeratome|epi-lasik-lasik microkeratome
707935|NCT00599690|Corneal thickness|corneal thickness
707936|NCT00599690|Confocal microscope|confocal microscope
707937|NCT00599677|acupuncture|acupuncture
707938|NCT00599677|meridian|meridian
707939|NCT00599677|acupoint|acupoint
707940|NCT00599664|Urinary Calculi|urinary calculi
707941|NCT00599664|Urinary Stones|urinary stones
707942|NCT00599664|Urinary Tract Stones|urinary tract stones
707943|NCT00599664|Calculi|calculi
707944|NCT00599651|Respiratory Distress Syndrome|respiratory distress syndrome
707945|NCT00599651|Newborn RDS|newborn rds
707946|NCT00599625|Crohn's Disease|crohn's disease
707947|NCT00599612|GW856553,|gw856553,
707948|NCT00599612|radiolabel|radiolabel
707949|NCT00599612|ADME,|adme,
707950|NCT00599599|Prolonged Exposure Therapy|prolonged exposure therapy
707951|NCT00599599|Adherence to HIV Medications|adherence to hiv medications
707952|NCT00599599|Complementary Therapies|complementary therapies
707953|NCT00599586|migraine|migraine
707954|NCT00599586|acupuncture|acupuncture
707955|NCT00599586|efficacy|efficacy
707956|NCT00599586|safety|safety
707957|NCT00599586|meridian|meridian
707958|NCT00599586|acupoint|acupoint
707959|NCT00599573|HIV|hiv
707960|NCT00599573|cocaine dependence|cocaine dependence
707961|NCT00599573|cocaine abuse|cocaine abuse
707962|NCT00599573|cocaine addiction|cocaine addiction
707963|NCT00599573|cocaine users|cocaine users
707964|NCT00599573|cocaine-related disorders|cocaine-related disorders
707965|NCT00599573|HIV Infection|hiv infection
707966|NCT00599560|Meniere's disease|meniere's disease
707967|NCT00599560|stress|stress
707968|NCT00599560|vasopressin|vasopressin
707969|NCT00599560|endolymphatic sac|endolymphatic sac
707970|NCT00599560|V2 receptor|v2 receptor
707971|NCT00599560|cyclic AMP|cyclic amp
707972|NCT00599560|Plasma vasopressin level and V2R mRNA expression level in the endolymphatic sac both were significantly higher in patients with Meniere's disease.|plasma vasopressin level and v2r mrna expression level in the endolymphatic sac both were significantly higher in patients with meniere's disease.
707973|NCT00599560|In Meniere's disease, there were significant negative co-relationships between vasopressin and V2R.|in meniere's disease, there were significant negative co-relationships between vasopressin and v2r.
707974|NCT00599560|The cyclic AMP activity was basically up-regulated in the endolymphatic sac in Meniere's disease..|the cyclic amp activity was basically up-regulated in the endolymphatic sac in meniere's disease..
707975|NCT00599560|The cyclic AMP sensitivity for vasopressin was significantly elevated in the endolymphatic sac in Meniere's disease.|the cyclic amp sensitivity for vasopressin was significantly elevated in the endolymphatic sac in meniere's disease.
707976|NCT00599547|Hematopoietic Stem Cell Transplantation|hematopoietic stem cell transplantation
707977|NCT00599521|Acne Vulgaris|acne vulgaris
707978|NCT00599521|Adapalene|adapalene
707979|NCT00599508|memory|memory
707980|NCT00599508|aging|aging
707981|NCT00599495|Hematopoietic Stem Cell Transplantation|hematopoietic stem cell transplantation
707982|NCT00599495|Multiple Myeloma|multiple myeloma
707983|NCT00599482|HEMOGLOBIN SC DISEASE|hemoglobin sc disease
707984|NCT00599482|HEMOGLOBIN C DISEASE|hemoglobin c disease
707985|NCT00599482|SICKLE CELL TRAIT|sickle cell trait
707986|NCT00599482|THALASSEMIA|thalassemia
707987|NCT00599469|Acute Confusional Senile Dementia|acute confusional senile dementia
707988|NCT00599469|Alzheimer Type Senile Dementia|alzheimer type senile dementia
707989|NCT00599469|SENILE PLAQUES|senile plaques
707990|NCT00599469|NEUROFIBRILLARY TANGLES|neurofibrillary tangles
707991|NCT00599469|NEUROPIL THREADS|neuropil threads
707992|NCT00599456|Hot flashes|hot flashes
707993|NCT00599456|Menopause|menopause
707994|NCT00599456|Omega 3 fatty Acids|omega 3 fatty acids
707995|NCT00599443|Cell-derived subunit influenza vaccine|cell-derived subunit influenza vaccine
707996|NCT00599443|Safety|safety
707997|NCT00599443|Reactogenicity|reactogenicity
707998|NCT00599430|Probiotic|probiotic
707999|NCT00599430|Lactobacillus|lactobacillus
708000|NCT00599430|NCFM|ncfm
708001|NCT00599430|Bifidobacterium|bifidobacterium
708002|NCT00599430|Healthy children|healthy children
708003|NCT00599404|Pharmacokinetics study|pharmacokinetics study
708004|NCT00599391|KIDNEY FAILURE, ACUTE|kidney failure, acute
708005|NCT00599391|KIDNEY FAILURE, CHRONIC|kidney failure, chronic
708006|NCT00599391|RENAL INSUFFICIENCY|renal insufficiency
708007|NCT00599365|adherence|adherence
708008|NCT00599365|pharmacist intervention|pharmacist intervention
708009|NCT00599365|persistence|persistence
708010|NCT00599365|renal clinic|renal clinic
708011|NCT00599365|pill count|pill count
708012|NCT00599352|Hypovitaminosis|hypovitaminosis
708013|NCT00599352|Chronic liver disease|chronic liver disease
708014|NCT00599339|Rotigotine|rotigotine
708015|NCT00599339|Neupro|neupro
708016|NCT00599326|Exjade PCT Study|exjade pct study
708017|NCT00599326|PCT Study|pct study
708018|NCT00599326|Porphyria Cutanea Tarda|porphyria cutanea tarda
708019|NCT00599287|ICU delirium|icu delirium
708020|NCT00599287|Hypoactive delirium|hypoactive delirium
708021|NCT00599287|Haloperidol|haloperidol
708022|NCT00599287|Methylphenidate|methylphenidate
708023|NCT00599287|Rivastigmine|rivastigmine
708024|NCT00599287|Hypoactive ICU delirium|hypoactive icu delirium
708025|NCT00599274|Multiple Sclerosis|multiple sclerosis
708026|NCT00599274|Interferon beta 1a|interferon beta 1a
708027|NCT00599274|Avonex|avonex
708028|NCT00599261|Cardiac Pacemaker, Artificial|cardiac pacemaker, artificial
708029|NCT00599248|osteoarthritis, knee|osteoarthritis, knee
708030|NCT00599235|Hypertension|hypertension
708031|NCT00599235|Exercise capacity|exercise capacity
708032|NCT00599235|PDE5 inhibitors|pde5 inhibitors
708033|NCT00599222|AMD|amd
708034|NCT00599222|macular degeneration|macular degeneration
708035|NCT00599222|anti-VEGF|anti-vegf
708036|NCT00599222|laser treatment|laser treatment
708037|NCT00599196|Rotigotine|rotigotine
708038|NCT00599196|Neupro®|neupro®
708039|NCT00599183|Cervical spine herniation|cervical spine herniation
708040|NCT00599183|MRI cervical spine|mri cervical spine
708041|NCT00599183|Diffusion tensor imaging cervical spine|diffusion tensor imaging cervical spine
708042|NCT00599170|This is a standard phase II trial, in which patients with newly diagnosed diffuse large B cell lymphoma will receive R-CHOP with GM-CSF|this is a standard phase ii trial, in which patients with newly diagnosed diffuse large b cell lymphoma will receive r-chop with gm-csf
708043|NCT00599144|Cholecystectomy|cholecystectomy
708044|NCT00599131|Cancer of Larynx|cancer of larynx
708045|NCT00599118|Atrial Fibrillation|atrial fibrillation
708046|NCT00599118|Genetics|genetics
708047|NCT00599092|pituitary tumor|pituitary tumor
708048|NCT00599092|recurrence|recurrence
708049|NCT00599079|MAC|mac
708050|NCT00599066|M-Entropy|m-entropy
708051|NCT00599053|Ureaplasma|ureaplasma
708052|NCT00599053|Bronchopulmonary dysplasia|bronchopulmonary dysplasia
708053|NCT00599053|very low birthweight|very low birthweight
708054|NCT00599014|Cardiomyopathy, heart failure, DNA,|cardiomyopathy, heart failure, dna,
708055|NCT00599014|echocardiography, messenger RNA, natural history|echocardiography, messenger rna, natural history
708056|NCT00599001|healthy volunteer|healthy volunteer
708057|NCT00599001|research subjects|research subjects
708058|NCT00599001|Immunostimulatory sequence (ISS)|immunostimulatory sequence (iss)
708059|NCT00599001|phase 1|phase 1
708060|NCT00598988|infectious mononucleosis, mono, acupuncture|infectious mononucleosis, mono, acupuncture
708061|NCT00598975|Phase 2a: Multiple solid tumor types|phase 2a: multiple solid tumor types
708062|NCT00598975|Phase 2b: Second-Line Colorectal Cancer (CRC)|phase 2b: second-line colorectal cancer (crc)
708063|NCT00598962|MAC|mac
708064|NCT00598949|Pituitary|pituitary
708065|NCT00598949|Adenoma|adenoma
708066|NCT00598949|Tumor|tumor
708067|NCT00598949|Acromegaly|acromegaly
708068|NCT00598949|Prolactinoma|prolactinoma
708069|NCT00598949|Cushing's|cushing's
708070|NCT00598936|Hypoxia|hypoxia
708071|NCT00598936|Cerebral Hypoxia|cerebral hypoxia
708072|NCT00598923|tbi|tbi
708073|NCT00598923|traumatic brain injury|traumatic brain injury
708074|NCT00598923|epilepsy|epilepsy
708075|NCT00598910|HIV infection|hiv infection
708076|NCT00598897|MAC|mac
708077|NCT00598884|Clinical Protocols|clinical protocols
708078|NCT00598884|Behavioral Research|behavioral research
708079|NCT00598884|Prevention|prevention
708080|NCT00598871|Thymosin beta 4|thymosin beta 4
708081|NCT00598871|Corneal wound healing|corneal wound healing
708082|NCT00598871|Vitrectomy|vitrectomy
708083|NCT00598871|Diabetes|diabetes
708084|NCT00598858|prostate cancer|prostate cancer
708085|NCT00598858|Prostatectomy|prostatectomy
708086|NCT00598845|Endometrial cancer|endometrial cancer
708087|NCT00598845|Molecular markers|molecular markers
708088|NCT00598845|Lymph node metastasis|lymph node metastasis
708089|NCT00598845|Prospective study|prospective study
708090|NCT00598845|Prognosis|prognosis
708091|NCT00598845|Cancer of Endometrium|cancer of endometrium
708092|NCT00598845|Tumor Markers, Biological|tumor markers, biological
708093|NCT00598832|Acne Vulgaris|acne vulgaris
708094|NCT00598832|Adapalene|adapalene
708095|NCT00598819|Cerebral Oxygenation|cerebral oxygenation
708096|NCT00598819|Oxygen Monitoring|oxygen monitoring
708097|NCT00598806|Noninvasive Bladder Cancer|noninvasive bladder cancer
708098|NCT00598780|Levocetirizine|levocetirizine
708099|NCT00598780|Xyzal|xyzal
708100|NCT00598780|Rhinitis allergic persistent|rhinitis allergic persistent
708101|NCT00598780|Rhinitis nonseasonal|rhinitis nonseasonal
708102|NCT00598767|Aortic valve insufficiency|aortic valve insufficiency
708103|NCT00598767|Aortic valve stenosis|aortic valve stenosis
708104|NCT00598767|3D echocardiogram|3d echocardiogram
708105|NCT00598767|3D computed tomography|3d computed tomography
708106|NCT00598754|Aortic valve stenosis|aortic valve stenosis
708107|NCT00598754|Aortic valve insufficiency|aortic valve insufficiency
708108|NCT00598754|Two dimensional echocardiography|two dimensional echocardiography
708109|NCT00598754|Three dimensional echocardiography|three dimensional echocardiography
708110|NCT00598741|Bone|bone
708111|NCT00598741|Sarcoma|sarcoma
708112|NCT00598741|04-083|04-083
708113|NCT00598728|Survivors|survivors
708114|NCT00598728|Quality of Life|quality of life
708115|NCT00598715|In-stent restenosis|in-stent restenosis
708116|NCT00598715|In-DES-restenosis|in-des-restenosis
708117|NCT00598715|paclitaxel|paclitaxel
708118|NCT00598715|sirolimus|sirolimus
708120|NCT00598689|Ocular Lubricants|ocular lubricants
708121|NCT00598689|Corneal Epithelium|corneal epithelium
708122|NCT00598689|Wound Healing|wound healing
708123|NCT00598663|Type 1 diabetes|type 1 diabetes
708124|NCT00598650|Lewy Body Disease|lewy body disease
708125|NCT00598650|Dementia|dementia
708126|NCT00598650|Clinical Trial|clinical trial
708127|NCT00598650|Phase II|phase ii
708128|NCT00598650|E2020|e2020
708129|NCT00598650|donepezil hydrochloride|donepezil hydrochloride
708130|NCT00598637|drug eluting stent|drug eluting stent
708131|NCT00598637|left main disease|left main disease
708132|NCT00598611|urticaria|urticaria
708133|NCT00598598|Aortic valve insufficiency|aortic valve insufficiency
708134|NCT00598598|Aortic valve stenosis|aortic valve stenosis
708135|NCT00598598|3D echocardiogram|3d echocardiogram
708136|NCT00598572|Deferoxamine|deferoxamine
708137|NCT00598572|Safety|safety
708138|NCT00598572|Intracerebral hemorrhage|intracerebral hemorrhage
708139|NCT00598559|Acute pain|acute pain
708140|NCT00598559|Fever|fever
708141|NCT00598559|IV Acetaminophen|iv acetaminophen
708142|NCT00598559|Analgesic|analgesic
708143|NCT00598546|Stomach|stomach
708144|NCT00598546|Gastric|gastric
708145|NCT00598546|Stomach Tumor|stomach tumor
708146|NCT00598546|Stomach Cancer|stomach cancer
708147|NCT00598507|ZK-EPO|zk-epo
708148|NCT00598507|ZK219477|zk219477
708149|NCT00598507|EpothiloneZK|epothilonezk
708150|NCT00598494|effect of bedrest|effect of bedrest
708151|NCT00598494|cardiac atrophy|cardiac atrophy
895624|NCT00001430|MDR|mdr
708152|NCT00598481|SCID|scid
708153|NCT00598481|gene therapy|gene therapy
708154|NCT00598481|Adenosine deaminase|adenosine deaminase
708155|NCT00598481|retroviral vector|retroviral vector
708156|NCT00598455|angiomyolipomata|angiomyolipomata
708157|NCT00598455|tuberous sclerosis complex|tuberous sclerosis complex
708158|NCT00598442|anemia|anemia
708159|NCT00598442|chronic kidney disease|chronic kidney disease
708160|NCT00598442|CKD|ckd
708161|NCT00598442|chronic renal failure|chronic renal failure
708162|NCT00598442|CRF|crf
708163|NCT00598442|erythropoietin|erythropoietin
708164|NCT00598442|EPO|epo
708165|NCT00598442|erythropoiesis stimulating agent|erythropoiesis stimulating agent
708166|NCT00598442|ESA|esa
708167|NCT00598442|Hematide™|hematide™
708168|NCT00598442|hemoglobin|hemoglobin
708169|NCT00598442|Hb|hb
708170|NCT00598442|Hgb|hgb
708171|NCT00598442|Omontys|omontys
708172|NCT00598442|peginesatide|peginesatide
708173|NCT00598442|red blood cell|red blood cell
708174|NCT00598442|red blood cell production|red blood cell production
708175|NCT00598429|NICHD Neonatal Research Network|nichd neonatal research network
708176|NCT00598429|Hypoxemic respiratory failure (HRF)|hypoxemic respiratory failure (hrf)
708177|NCT00598429|Persistent pulmonary hypertension of the newborn (PPHN)|persistent pulmonary hypertension of the newborn (pphn)
708178|NCT00598429|Prostaglandin E1 (PGE1)|prostaglandin e1 (pge1)
708179|NCT00598429|Mechanical ventilation|mechanical ventilation
708180|NCT00598429|Meconium, aspiration|meconium, aspiration
708181|NCT00598416|Hepatitis C|hepatitis c
708182|NCT00598416|Substance Abuse|substance abuse
708183|NCT00598416|Psychoeducation|psychoeducation
708184|NCT00598416|Psychiatric functioning|psychiatric functioning
708185|NCT00598416|Physical Functioning|physical functioning
708186|NCT00598416|Quality of Life|quality of life
708187|NCT00598416|NIAAA|niaaa
708188|NCT00598416|Alcohol|alcohol
708189|NCT00598403|Cystitis|cystitis
708190|NCT00598390|Cannabinoid|cannabinoid
708191|NCT00598390|CB1 Receptor|cb1 receptor
708192|NCT00598390|Brain Imaging|brain imaging
708193|NCT00598390|PET Imaging|pet imaging
708194|NCT00598390|[11C]MePPEP|[11c]meppep
708195|NCT00598390|Healthy Volunteer|healthy volunteer
708196|NCT00598390|HV|hv
708197|NCT00598377|Autosomal dominant polycystic kidney disease|autosomal dominant polycystic kidney disease
708198|NCT00598377|Adrenal functions|adrenal functions
708199|NCT00598377|Renal volume|renal volume
708200|NCT00598377|Glomerular filtration rate|glomerular filtration rate
708201|NCT00598377|Adrenal Cortex Function Tests|adrenal cortex function tests
708202|NCT00598364|thyroid|thyroid
708203|NCT00598364|nodule|nodule
708204|NCT00598364|genetic|genetic
708205|NCT00598364|mutation|mutation
708206|NCT00598364|malignancy|malignancy
708207|NCT00598351|Meningioma|meningioma
708208|NCT00598351|Ependymoma|ependymoma
708209|NCT00598351|Schwannoma|schwannoma
708210|NCT00598351|Acoustic Neuroma|acoustic neuroma
708211|NCT00598351|Vestibular Schwannoma|vestibular schwannoma
708212|NCT00598351|Neurofibromatosis Type 2|neurofibromatosis type 2
708213|NCT00598351|NF2|nf2
708214|NCT00598325|Nicotine|nicotine
708215|NCT00598325|Vaccine|vaccine
708216|NCT00598325|Immunogenicity|immunogenicity
708217|NCT00598325|Tobacco|tobacco
708218|NCT00598325|Habits|habits
708219|NCT00598299|corneal epithelium|corneal epithelium
708220|NCT00598286|CB1 Receptor|cb1 receptor
708221|NCT00598286|PET|pet
708223|NCT00598286|[18F]FMPEP-d2|[18f]fmpep-d2
708224|NCT00598286|Brain Imaging|brain imaging
708225|NCT00598286|Healthy Volunteer|healthy volunteer
708227|NCT00598273|anemia|anemia
708228|NCT00598273|chronic kidney disease|chronic kidney disease
708229|NCT00598273|CKD|ckd
708230|NCT00598273|chronic renal failure|chronic renal failure
708231|NCT00598273|CRF|crf
708232|NCT00598273|erythropoietin|erythropoietin
708233|NCT00598273|EPO|epo
708234|NCT00598273|erythropoiesis stimulating agent|erythropoiesis stimulating agent
708235|NCT00598273|ESA|esa
708236|NCT00598273|Hematide™|hematide™
708237|NCT00598273|hemoglobin|hemoglobin
708238|NCT00598273|Hb|hb
708239|NCT00598273|Hgb|hgb
708240|NCT00598273|Omontys|omontys
708241|NCT00598273|peginesatide|peginesatide
708242|NCT00598273|red blood cell|red blood cell
708243|NCT00598273|red blood cell production|red blood cell production
708244|NCT00598260|active management|active management
708245|NCT00598260|induction of labor|induction of labor
708246|NCT00598260|cesarean delivery|cesarean delivery
708247|NCT00598260|Cesarean|cesarean
708248|NCT00598247|Colon Cancer Rectal Colorectal Women|colon cancer rectal colorectal women
708249|NCT00598208|In-vitro fertilization|in-vitro fertilization
708250|NCT00598195|Ketamine|ketamine
708251|NCT00598195|Phamacokinetics|phamacokinetics
708252|NCT00598195|Cardiopulmonary bypass (CPB)|cardiopulmonary bypass (cpb)
708253|NCT00598195|ketamine/norketamine pharmacokinetic parameters|ketamine/norketamine pharmacokinetic parameters
708254|NCT00598182|Attention Deficit Disorder with Hyperactivity|attention deficit disorder with hyperactivity
708255|NCT00598182|OROS methylphenidate|oros methylphenidate
708256|NCT00598169|AIDS-related diffuse large cell lymphoma|aids-related diffuse large cell lymphoma
708257|NCT00598169|AIDS-related diffuse mixed cell lymphoma|aids-related diffuse mixed cell lymphoma
708258|NCT00598169|AIDS-related diffuse small cleaved cell lymphoma|aids-related diffuse small cleaved cell lymphoma
708259|NCT00598169|AIDS-related immunoblastic large cell lymphoma|aids-related immunoblastic large cell lymphoma
708260|NCT00598169|AIDS-related lymphoblastic lymphoma|aids-related lymphoblastic lymphoma
708261|NCT00598169|AIDS-related peripheral/systemic lymphoma|aids-related peripheral/systemic lymphoma
708262|NCT00598169|AIDS-related primary CNS lymphoma|aids-related primary cns lymphoma
708263|NCT00598169|AIDS-related small noncleaved cell lymphoma|aids-related small noncleaved cell lymphoma
708264|NCT00598130|Patients undergoing elective open partial nephrectomy surgery|patients undergoing elective open partial nephrectomy surgery
708265|NCT00598130|Excision of a kidney|excision of a kidney
708266|NCT00598117|Esophageal|esophageal
708267|NCT00598117|CancerEsophagus|canceresophagus
708268|NCT00598104|Asthma, interleukin-13|asthma, interleukin-13
708269|NCT00598091|Solid Tumors|solid tumors
708270|NCT00598091|Phase I|phase i
708271|NCT00598091|Expanded Cohort|expanded cohort
708272|NCT00598091|Pancreatic Cancer|pancreatic cancer
708273|NCT00598091|Dasatinib|dasatinib
708274|NCT00598091|Gemcitabine|gemcitabine
708275|NCT00598065|lung|lung
708276|NCT00598052|Marijuana dependence withdrawal Escitalopram|marijuana dependence withdrawal escitalopram
708277|NCT00598026|Tele medicine|tele medicine
708278|NCT00598026|ICD follow-up|icd follow-up
708279|NCT00598026|Cost / benefit study|cost / benefit study
708280|NCT00598013|Kidney Transplantation|kidney transplantation
708281|NCT00598013|Thiazolidinediones|thiazolidinediones
708282|NCT00598013|Insulin Resistance|insulin resistance
708283|NCT00598013|Atherosclerosis|atherosclerosis
708284|NCT00598000|Lung cancer|lung cancer
708285|NCT00598000|Quality of Life|quality of life
708286|NCT00598000|VATS|vats
708287|NCT00598000|thoracotomy|thoracotomy
708288|NCT00598000|05-006|05-006
708289|NCT00597987|BRCA1|brca1
708290|NCT00597974|carotid artery stenosis|carotid artery stenosis
708291|NCT00597974|Neuropsychological tests|neuropsychological tests
708292|NCT00597974|Stroke|stroke
708293|NCT00597974|Transient ischemia|transient ischemia
708294|NCT00597974|Stenting|stenting
708295|NCT00597961|Lung|lung
708296|NCT00597961|skin|skin
708297|NCT00597961|melanoma|melanoma
708298|NCT00597948|mental retardation|mental retardation
708299|NCT00597948|downs syndrome|downs syndrome
708300|NCT00597948|autism|autism
708301|NCT00597948|autism spectrum disorder|autism spectrum disorder
708302|NCT00597948|cerebral palsy|cerebral palsy
708303|NCT00597948|developmental disability|developmental disability
708304|NCT00597948|developmental disabilities|developmental disabilities
708305|NCT00597948|intellectual disability|intellectual disability
708306|NCT00597948|intellectual disabilities|intellectual disabilities
708307|NCT00597948|health promotion|health promotion
708308|NCT00597948|disease prevention|disease prevention
708309|NCT00597948|physical health|physical health
708310|NCT00597948|emotional health|emotional health
708311|NCT00597948|behavioral health|behavioral health
708312|NCT00597948|mental health|mental health
708313|NCT00597948|spiritual health|spiritual health
708314|NCT00597948|prevention|prevention
708315|NCT00597935|prolapse|prolapse
708316|NCT00597935|urinary incontinence|urinary incontinence
708317|NCT00597935|uterosacral vaginal vault ligament suspension|uterosacral vaginal vault ligament suspension
708318|NCT00597935|sacrospinous ligament fixation|sacrospinous ligament fixation
708319|NCT00597935|behavioral therapy|behavioral therapy
708320|NCT00597935|pelvic muscle training|pelvic muscle training
708321|NCT00597922|Acute Myocardial Infarction|acute myocardial infarction
708322|NCT00597922|Heart Attack|heart attack
708323|NCT00597922|Gender Differences|gender differences
708324|NCT00597922|Risk Factors|risk factors
708325|NCT00597922|Quality of Care|quality of care
708326|NCT00597909|Ammonul®|ammonul®
708327|NCT00597909|sodium phenylacetate and sodium benzoate|sodium phenylacetate and sodium benzoate
708328|NCT00597909|hepatic encephalopathy|hepatic encephalopathy
708329|NCT00597909|Grade 3 or 4 Hepatic Encephalopathy|grade 3 or 4 hepatic encephalopathy
708330|NCT00597883|carotid endarterectomy|carotid endarterectomy
708331|NCT00597883|Neuropsychological tests|neuropsychological tests
708332|NCT00597883|Stroke|stroke
708333|NCT00597883|Transient ischemia|transient ischemia
708334|NCT00597870|TAA|taa
708335|NCT00597844|type I thyroplasty|type i thyroplasty
708336|NCT00597844|unilateral vocal fold augmentation|unilateral vocal fold augmentation
708337|NCT00597831|depression|depression
708338|NCT00597831|electroconvulsive therapy|electroconvulsive therapy
708339|NCT00597831|Ultrasonography Doppler Transcranial|ultrasonography doppler transcranial
708340|NCT00597831|intracranial pressure|intracranial pressure
708341|NCT00597792|Gastroesophageal Reflux Disease (GERD)|gastroesophageal reflux disease (gerd)
708342|NCT00597792|Plicator|plicator
708343|NCT00597792|Full-thickness Plication|full-thickness plication
708344|NCT00597779|intertrochanteric fractures|intertrochanteric fractures
708345|NCT00597766|CVA|cva
708346|NCT00597766|Hemiplegia|hemiplegia
708347|NCT00597766|Hemiplegic shoulder pain|hemiplegic shoulder pain
708348|NCT00597766|Subacromial steroid injection|subacromial steroid injection
708349|NCT00597753|anemia|anemia
708350|NCT00597753|chronic kidney disease|chronic kidney disease
708351|NCT00597753|CKD|ckd
708352|NCT00597753|chronic renal failure|chronic renal failure
708353|NCT00597753|CRF|crf
708354|NCT00597753|dialysis|dialysis
708355|NCT00597753|erythropoietin|erythropoietin
708356|NCT00597753|EPO|epo
708357|NCT00597753|erythropoiesis stimulating agent|erythropoiesis stimulating agent
708358|NCT00597753|ESA|esa
708359|NCT00597753|Hematide™|hematide™
708360|NCT00597753|hemodialysis|hemodialysis
708361|NCT00597753|hemoglobin|hemoglobin
708362|NCT00597753|Hb|hb
708363|NCT00597753|Hgb|hgb
708364|NCT00597753|Omontys|omontys
708365|NCT00597753|peginesatide|peginesatide
708366|NCT00597753|red blood cell|red blood cell
708367|NCT00597753|red blood cell production|red blood cell production
708368|NCT00597727|Peanut Allergy|peanut allergy
708369|NCT00597727|Sublingual immunotherapy|sublingual immunotherapy
708370|NCT00597714|Stem Cell Transplantation, Non-myeloablative|stem cell transplantation, non-myeloablative
708371|NCT00597701|Alcohol withdrawal|alcohol withdrawal
708372|NCT00597701|Delirium tremors|delirium tremors
708373|NCT00597675|Peanut allergy|peanut allergy
708374|NCT00597636|smokers|smokers
708375|NCT00597623|Osteoarthritis|osteoarthritis
708376|NCT00597623|Hand|hand
708377|NCT00597623|Tumor Necrosis Factor-alpha inhibitors|tumor necrosis factor-alpha inhibitors
708378|NCT00597623|Biological Therapy|biological therapy
708379|NCT00597610|Rectum|rectum
708380|NCT00597610|Rectal|rectal
708381|NCT00597597|Metastatic breast cancer|metastatic breast cancer
708382|NCT00597597|ER and PR hormone receptor negative|er and pr hormone receptor negative
708383|NCT00597597|HER2/neu negative|her2/neu negative
708384|NCT00597597|EGFR positive|egfr positive
708385|NCT00597584|anemia|anemia
708386|NCT00597584|chronic kidney disease|chronic kidney disease
708387|NCT00597584|CKD|ckd
708388|NCT00597584|chronic renal failure|chronic renal failure
708389|NCT00597584|CRF|crf
708390|NCT00597584|dialysis|dialysis
708391|NCT00597584|erythropoietin|erythropoietin
708392|NCT00597584|EPO|epo
708393|NCT00597584|erythropoiesis stimulating agent|erythropoiesis stimulating agent
708395|NCT00597584|Hematide™|hematide™
708396|NCT00597584|hemodialysis|hemodialysis
708397|NCT00597584|hemoglobin|hemoglobin
708398|NCT00597584|Hb|hb
708399|NCT00597584|Hgb|hgb
708400|NCT00597584|Omontys|omontys
708401|NCT00597584|peginesatide|peginesatide
708402|NCT00597584|red blood cell|red blood cell
708403|NCT00597584|red blood cell production|red blood cell production
708404|NCT00597558|Egg allergy|egg allergy
708405|NCT00597545|Carotid Endarterectomy|carotid endarterectomy
708406|NCT00597545|Neuropsychological tests|neuropsychological tests
708407|NCT00597545|Stroke|stroke
708408|NCT00597545|Transient ischemia|transient ischemia
708409|NCT00597545|Hypoperfusion|hypoperfusion
708410|NCT00597545|Ischemia|ischemia
708411|NCT00597532|Breast Cancer|breast cancer
708412|NCT00597532|Soy|soy
708413|NCT00597532|Milk|milk
708414|NCT00597532|Supplementation|supplementation
708415|NCT00597532|02-062|02-062
708416|NCT00597519|Cancer|cancer
708417|NCT00597519|Leukemia|leukemia
708418|NCT00597519|Myelodysplastic Syndrome|myelodysplastic syndrome
708419|NCT00597519|Non-Hodgkin's Lymphoma|non-hodgkin's lymphoma
708420|NCT00597519|Total Body Irradiation|total body irradiation
708421|NCT00597519|Umbilical Cord Blood Grafts|umbilical cord blood grafts
708423|NCT00597506|colorectal|colorectal
708424|NCT00597506|refractory|refractory
708425|NCT00597506|adenocarcinoma|adenocarcinoma
708426|NCT00597506|bevacizumab|bevacizumab
708427|NCT00597506|everolimus|everolimus
708428|NCT00597493|Recurrent Glioblastoma Multiforme|recurrent glioblastoma multiforme
708429|NCT00597493|GBM|gbm
708430|NCT00597493|Glioblastoma|glioblastoma
708431|NCT00597493|Sorafenib|sorafenib
708432|NCT00597493|Temozolomide|temozolomide
708433|NCT00597493|Brain Tumor|brain tumor
708434|NCT00597493|Recurrent GBM|recurrent gbm
708435|NCT00597493|Temodar|temodar
708436|NCT00597493|Gliosarcoma|gliosarcoma
708437|NCT00597493|Glioma|glioma
708438|NCT00597493|Nexavar|nexavar
708439|NCT00597480|Growth hormone|growth hormone
708440|NCT00597480|Child|child
708441|NCT00597480|insulin resistance|insulin resistance
708442|NCT00597480|metabolic syndrome X|metabolic syndrome x
708443|NCT00597480|children born small for gestational age|children born small for gestational age
708444|NCT00597467|myopia|myopia
708445|NCT00597467|hyperopia|hyperopia
708446|NCT00597467|extended wear|extended wear
708447|NCT00597467|ametropia|ametropia
708448|NCT00597454|Breast|breast
708449|NCT00597441|unrelated|unrelated
708450|NCT00597441|umbilical cord blood transplantation|umbilical cord blood transplantation
708451|NCT00597441|thymus transplantation|thymus transplantation
708452|NCT00597415|Osteoarthritis|osteoarthritis
708453|NCT00597415|Knee pain|knee pain
708454|NCT00597402|Avastin|avastin
708455|NCT00597402|Bevacizumab|bevacizumab
708456|NCT00597402|Temozolomide|temozolomide
708457|NCT00597402|Temodar|temodar
708458|NCT00597402|Irinotecan|irinotecan
708459|NCT00597402|Camptosar|camptosar
708460|NCT00597402|GBM|gbm
708461|NCT00597402|Glioblastoma Multiforme|glioblastoma multiforme
708462|NCT00597402|Gliosarcoma|gliosarcoma
708463|NCT00597402|Brain tumor|brain tumor
708464|NCT00597402|Glioma|glioma
708465|NCT00597402|New GBM|new gbm
708466|NCT00597402|Newly diagnosed GBM or gliosarcoma malignant brain tumor|newly diagnosed gbm or gliosarcoma malignant brain tumor
708467|NCT00597389|posttraumatic stress disorder|posttraumatic stress disorder
708468|NCT00597389|propranolol|propranolol
708469|NCT00597389|inderol|inderol
708470|NCT00597389|child|child
708471|NCT00597389|trauma|trauma
708472|NCT00597389|Posttraumatic stress disorders (PTSD)|posttraumatic stress disorders (ptsd)
708473|NCT00597376|memory loss|memory loss
708474|NCT00597363|vascular access site|vascular access site
708475|NCT00597363|arterial puncture|arterial puncture
708476|NCT00597363|femoral pseudoaneurysm|femoral pseudoaneurysm
708477|NCT00597350|Fenugreek|fenugreek
708478|NCT00597350|Trigonella foenum-graecum|trigonella foenum-graecum
708479|NCT00597350|Diabetes mellitus|diabetes mellitus
708480|NCT00597350|Blood sugar|blood sugar
708481|NCT00597350|Insulin|insulin
708482|NCT00597350|Glucose|glucose
708483|NCT00597337|bullying|bullying
708484|NCT00597337|victimisation|victimisation
708485|NCT00597337|aggressive behavior|aggressive behavior
708486|NCT00597324|Allen's test|allen's test
708487|NCT00597324|lactate|lactate
708488|NCT00597324|safety|safety
708489|NCT00597324|radial intervention|radial intervention
708490|NCT00597324|Patients with coronary artery disease|patients with coronary artery disease
708491|NCT00597311|rectal cancer|rectal cancer
708492|NCT00597311|radiotherapy|radiotherapy
708493|NCT00597311|radiochemotherapy|radiochemotherapy
708494|NCT00597298|diaphragmatic paralysis|diaphragmatic paralysis
708495|NCT00597298|cardiac surgery|cardiac surgery
708496|NCT00597298|respiratory muscle training|respiratory muscle training
708497|NCT00597285|18-F-Fluoro-2-Deoxy-D-Glucose (FDG)|18-f-fluoro-2-deoxy-d-glucose (fdg)
708498|NCT00597285|Magnetic Resonance|magnetic resonance
708499|NCT00597285|Epilepsy|epilepsy
708500|NCT00597285|HHV-6B|hhv-6b
708501|NCT00597285|Healthy Volunteer|healthy volunteer
708502|NCT00597285|HV|hv
708503|NCT00597272|melanoma|melanoma
708504|NCT00597272|resected local|resected local
708505|NCT00597272|systemic metastasis|systemic metastasis
708506|NCT00597259|hepatitis B, entecavir, pegylated interferon alfa-2a|hepatitis b, entecavir, pegylated interferon alfa-2a
708507|NCT00597246|Brain|brain
708508|NCT00597246|CNS|cns
708509|NCT00597246|Central Nervous System|central nervous system
708510|NCT00597207|CPR|cpr
708511|NCT00597207|mechanical|mechanical
708512|NCT00597207|manual|manual
708513|NCT00597207|outcome|outcome
708514|NCT00597207|survival|survival
708515|NCT00597207|quality|quality
708516|NCT00597194|inguinal hernia|inguinal hernia
708517|NCT00597194|laparoscopic repair|laparoscopic repair
708518|NCT00597194|open repair|open repair
708519|NCT00597194|randomized|randomized
708520|NCT00597181|Inflammatory response|inflammatory response
708521|NCT00597168|Schizophrenia|schizophrenia
708522|NCT00597168|atypical antipsychotic|atypical antipsychotic
708523|NCT00597168|quality of life|quality of life
708524|NCT00597168|ambulatory setting|ambulatory setting
708525|NCT00597142|renal stent|renal stent
708526|NCT00597142|stent|stent
708527|NCT00597142|atherosclerosis|atherosclerosis
708528|NCT00597142|aortorenal ostium|aortorenal ostium
708529|NCT00597142|renal|renal
708530|NCT00597142|renal artery|renal artery
708531|NCT00597142|PTRA|ptra
708532|NCT00597129|pancreatic cancer|pancreatic cancer
708533|NCT00597129|cancer of the pancreas|cancer of the pancreas
708534|NCT00597129|pancreas cancer|pancreas cancer
708535|NCT00597116|Mesothelioma|mesothelioma
708536|NCT00597116|inoperable|inoperable
708537|NCT00597116|relapsed|relapsed
708538|NCT00597103|Hemodialysis|hemodialysis
708539|NCT00597103|Frequent Hemodialysis|frequent hemodialysis
708540|NCT00597103|Sleep Apnea|sleep apnea
708541|NCT00597103|Restless Leg Syndrome|restless leg syndrome
708542|NCT00597103|Cognitive Function|cognitive function
708543|NCT00597090|Infections|infections
708544|NCT00597090|lymphoma|lymphoma
708545|NCT00597064|asthma|asthma
708546|NCT00597064|asthma control questionnaire|asthma control questionnaire
708547|NCT00597064|oral corticosteroid|oral corticosteroid
708548|NCT00597064|air trapping|air trapping
708549|NCT00597064|AQLQ|aqlq
708550|NCT00597064|control|control
708551|NCT00597064|quality of life|quality of life
708552|NCT00597038|Dasatinib|dasatinib
708553|NCT00597038|Dacarbazine|dacarbazine
708554|NCT00597025|Malnutrition|malnutrition
708555|NCT00597025|Hypoalbuminemia|hypoalbuminemia
708556|NCT00597025|Dietary Supplements|dietary supplements
708557|NCT00597025|Hemodialysis|hemodialysis
708558|NCT00597025|Peritoneal Dialysis|peritoneal dialysis
708559|NCT00597012|Meniscal Tear|meniscal tear
708560|NCT00597012|Osteoarthritis|osteoarthritis
708561|NCT00597012|Arthroscopic Partial Meniscectomy|arthroscopic partial meniscectomy
708562|NCT00597012|Physical Therapy|physical therapy
708563|NCT00596999|Myelodysplastic Syndrome (MDS)|myelodysplastic syndrome (mds)
708564|NCT00596999|Acute myelogenous Leukemia (AML)|acute myelogenous leukemia (aml)
708565|NCT00596999|Acute Lymphocytic Leukemia (ALL)|acute lymphocytic leukemia (all)
708566|NCT00596999|Sickle Cell Disease (SCD)|sickle cell disease (scd)
708567|NCT00596999|Beta Thalassemia|beta thalassemia
708568|NCT00596999|Inborn Errors of Metabolism|inborn errors of metabolism
708569|NCT00596999|Severe Combined Immunodeficiency Disease (SCID)|severe combined immunodeficiency disease (scid)
708570|NCT00596986|Depression|depression
708571|NCT00596986|Duloxetine|duloxetine
708572|NCT00596986|Psychotherapy|psychotherapy
708573|NCT00596986|Magnetic Resonance Imaging|magnetic resonance imaging
708574|NCT00596960|Alcohol Abuse|alcohol abuse
708575|NCT00596960|Alcohol Dependence|alcohol dependence
708576|NCT00596960|Carbohydrate Deficient Transferrin|carbohydrate deficient transferrin
708577|NCT00596960|Drug Dependence|drug dependence
708578|NCT00596960|Hepatitis C|hepatitis c
708579|NCT00596960|Motivation|motivation
708580|NCT00596947|kidney transplantation|kidney transplantation
708581|NCT00596947|tacrolimus|tacrolimus
708582|NCT00596947|Prograf|prograf
708583|NCT00596947|mycophenolate mofetil|mycophenolate mofetil
708584|NCT00596947|CellCept|cellcept
708585|NCT00596947|corticosteroid withdrawal|corticosteroid withdrawal
708586|NCT00596947|prednisone withdrawal|prednisone withdrawal
708587|NCT00596947|prednisone maintenance|prednisone maintenance
708588|NCT00596947|rabbit antithymocyte globulin|rabbit antithymocyte globulin
708589|NCT00596947|Thymoglobulin|thymoglobulin
708590|NCT00596934|Nonalcoholic fatty liver disease|nonalcoholic fatty liver disease
708591|NCT00596934|Insulin resistance|insulin resistance
708592|NCT00596934|Obesity|obesity
708593|NCT00596934|Leptin therapy|leptin therapy
708594|NCT00596934|NASH|nash
708595|NCT00596921|Ultrasonography|ultrasonography
708596|NCT00596921|Central Venous Pressure|central venous pressure
708597|NCT00596921|Noninvasive monitoring|noninvasive monitoring
708598|NCT00596921|Shock|shock
708599|NCT00596921|Resuscitation|resuscitation
708600|NCT00596908|Essential Tremor|essential tremor
708601|NCT00596908|Parkinsonian Tremor|parkinsonian tremor
708602|NCT00596908|Parkinson Disease|parkinson disease
708603|NCT00596908|Upper Extremity Tremor with duration of less than 2 years|upper extremity tremor with duration of less than 2 years
708604|NCT00596895|Isoflavone, PSA, prostate cancer, recurrent, quality of life|isoflavone, psa, prostate cancer, recurrent, quality of life
708605|NCT00596882|smoking cessation|smoking cessation
708606|NCT00596882|nicotine dependence|nicotine dependence
708607|NCT00596882|message prime|message prime
708608|NCT00596882|recruitment|recruitment
708609|NCT00596856|Early childhood caries - ECC|early childhood caries - ecc
708610|NCT00596856|Referral behavior|referral behavior
708611|NCT00596856|Oral health risk assessment|oral health risk assessment
708612|NCT00596856|Guideline development and dissemination|guideline development and dissemination
708613|NCT00596830|IGF-1R inhibitor|igf-1r inhibitor
708614|NCT00596830|Non-small-cell lung carcinoma|non-small-cell lung carcinoma
708615|NCT00596830|CP-751|cp-751
708616|NCT00596830|871|871
708617|NCT00596817|Relapse prevention|relapse prevention
708618|NCT00596817|Antidepressants|antidepressants
708619|NCT00596817|Placebo-controlled|placebo-controlled
708620|NCT00596817|Double-blind|double-blind
708621|NCT00596817|Multicentre study|multicentre study
708622|NCT00596804|NHL|nhl
708623|NCT00596804|Non-Hodgkin's lymphoma|non-hodgkin's lymphoma
708624|NCT00596804|follicular lymphoma|follicular lymphoma
708625|NCT00596804|B-cell lymphoma|b-cell lymphoma
708626|NCT00596804|diffuse large cell lymphoma|diffuse large cell lymphoma
708627|NCT00596804|small lymphoctytic lymphoma|small lymphoctytic lymphoma
708628|NCT00596804|Mantle cell lymphoma|mantle cell lymphoma
708629|NCT00596804|MALT|malt
708630|NCT00596804|marginal zone lymphoma|marginal zone lymphoma
708631|NCT00596804|High-Grade|high-grade
708632|NCT00596804|Intermediate-Grade|intermediate-grade
708633|NCT00596804|Low-Grade|low-grade
708634|NCT00596804|Mixed|mixed
708635|NCT00596778|Physical therapy specialty|physical therapy specialty
708636|NCT00596778|Postoperative period. Abdominal surgery|postoperative period. abdominal surgery
708637|NCT00596778|Anesthesia recovery period|anesthesia recovery period
708638|NCT00596778|Spirometry|spirometry
708639|NCT00596765|Brain Injury|brain injury
708640|NCT00596765|Neuropsychology|neuropsychology
708641|NCT00596765|Cognitive Behavioral Therapy|cognitive behavioral therapy
708642|NCT00596765|Neuropsychological Rehabilitation|neuropsychological rehabilitation
708643|NCT00596752|Alprostadil|alprostadil
708644|NCT00596752|Prostavasin|prostavasin
708645|NCT00596752|PAOD|paod
708646|NCT00596752|Fontaine Stage IV|fontaine stage iv
708770|NCT00596063|pharmacokinetics|pharmacokinetics
710612|NCT00588588|Length of stay|length of stay
708647|NCT00596739|Bariatric surgery, weight loss surgery, male infertility, Roux-En-Y, gastric banding|bariatric surgery, weight loss surgery, male infertility, roux-en-y, gastric banding
708648|NCT00596726|All patients presenting for high-risk cardiac surgery and who might post-operatively meet the study inclusion criteria are potential study candidates.|all patients presenting for high-risk cardiac surgery and who might post-operatively meet the study inclusion criteria are potential study candidates.
708649|NCT00596713|general population|general population
708650|NCT00596700|Capsule endoscopy|capsule endoscopy
708651|NCT00596700|Crohn's disease|crohn's disease
708652|NCT00596700|IBD|ibd
708653|NCT00596700|Activity score|activity score
708654|NCT00596700|Small bowel|small bowel
708655|NCT00596700|Crohn's disease of the small bowel in any stage|crohn's disease of the small bowel in any stage
708656|NCT00596700|Recruiting|recruiting
708657|NCT00596687|diabetes|diabetes
708658|NCT00596687|post-op complications|post-op complications
708659|NCT00596687|inpatient hyperglycemia|inpatient hyperglycemia
708660|NCT00596674|Women|women
708661|NCT00596674|Fibromyalgia Syndrome|fibromyalgia syndrome
708662|NCT00596674|Health Behaviors|health behaviors
708663|NCT00596674|Quality of Life|quality of life
708664|NCT00596661|coronary stent|coronary stent
708665|NCT00596648|Lung Cancer|lung cancer
708666|NCT00596648|Non-Small-Cell Lung Cancer|non-small-cell lung cancer
708667|NCT00596648|NSCLC|nsclc
708668|NCT00596635|UTI|uti
708669|NCT00596635|elderly|elderly
708670|NCT00596635|prevention|prevention
708671|NCT00596635|cranberry|cranberry
708672|NCT00596635|E.Coli|e.coli
708673|NCT00596622|Major Depressive or Manic Episodes|major depressive or manic episodes
708674|NCT00596622|Bipolar|bipolar
708675|NCT00596622|Mania|mania
708676|NCT00596622|Depression|depression
708677|NCT00596622|Lithium|lithium
708678|NCT00596622|fMRI|fmri
708679|NCT00596622|Pictures|pictures
708680|NCT00596622|Brain Scan|brain scan
708681|NCT00596609|Injections, intrathecal|injections, intrathecal
708682|NCT00596609|Transcranial|transcranial
708683|NCT00596609|Spinal Fusion|spinal fusion
708684|NCT00596609|Evoked Potentials, Motor|evoked potentials, motor
708685|NCT00596596|Constipation|constipation
708686|NCT00596596|prucalopride|prucalopride
708687|NCT00596570|Atrial fibrillation|atrial fibrillation
708688|NCT00596570|Oral Anticoagulation|oral anticoagulation
708689|NCT00596570|Percutaneous coronary intervention|percutaneous coronary intervention
708690|NCT00596557|Renal function, heart transplant, everolimus|renal function, heart transplant, everolimus
708691|NCT00596544|sexual dysfunction|sexual dysfunction
708692|NCT00596531|Tinnitus|tinnitus
708693|NCT00596531|acamprosate|acamprosate
708694|NCT00596531|clinical trial|clinical trial
708695|NCT00596505|proliferative diabetic retinopathy|proliferative diabetic retinopathy
708696|NCT00596505|bevacizumab (Avastin)|bevacizumab (avastin)
708697|NCT00596505|vitreous hemorrhage|vitreous hemorrhage
708698|NCT00596505|silicone oil|silicone oil
708699|NCT00596479|CAD|cad
708700|NCT00596479|G-CSF|g-csf
708701|NCT00596479|Collaterals|collaterals
708702|NCT00596479|CFI|cfi
708703|NCT00596479|perfusion|perfusion
708704|NCT00596466|open-label|open-label
708705|NCT00596466|extension study|extension study
708706|NCT00596466|pregabalin|pregabalin
708707|NCT00596466|partial epilepsy|partial epilepsy
708708|NCT00596453|Prostate Specific Antigen (PSA)|prostate specific antigen (psa)
708709|NCT00596453|Elevated Prostate Specific Antigen (PSA)|elevated prostate specific antigen (psa)
708710|NCT00596440|smoking|smoking
708711|NCT00596440|teachable moment|teachable moment
708712|NCT00596440|cancer|cancer
708713|NCT00596427|type two diabetes|type two diabetes
708714|NCT00596427|gluconeogenesis|gluconeogenesis
708715|NCT00596427|glucose|glucose
708716|NCT00596427|lipid synthesis|lipid synthesis
708717|NCT00596427|hepatic insulin sensitivity|hepatic insulin sensitivity
708718|NCT00596427|colesevelam HCl|colesevelam hcl
708719|NCT00596414|liver|liver
708720|NCT00596414|biopsy|biopsy
708721|NCT00596388|HMP, AMD, CNV, PHP, HPHP|hmp, amd, cnv, php, hphp
708722|NCT00596375|Lidocaine|lidocaine
708723|NCT00596375|Infant|infant
708724|NCT00596375|Urinary Catheterization|urinary catheterization
708725|NCT00596375|Emergency Medicine|emergency medicine
708726|NCT00596375|Analgesia|analgesia
708727|NCT00596362|Melanoma|melanoma
708729|NCT00596362|Avastin|avastin
708730|NCT00596349|epithelial Ovarian Cancer|epithelial ovarian cancer
708731|NCT00596349|Quality of Life|quality of life
708732|NCT00596349|Survivorship|survivorship
708733|NCT00596323|antenna|antenna
708734|NCT00596323|continuous glucose monitoring|continuous glucose monitoring
708735|NCT00596323|electromagnetic|electromagnetic
708736|NCT00596310|Lung cancer|lung cancer
708737|NCT00596310|screening|screening
708738|NCT00596297|Diabetic Retinopathy|diabetic retinopathy
708739|NCT00596297|Vitreous Hemorrhage|vitreous hemorrhage
708740|NCT00596297|Bevacizumab|bevacizumab
708741|NCT00596297|pars plana vitrectomy|pars plana vitrectomy
708742|NCT00596297|preoperative|preoperative
708743|NCT00596284|Cognitive Behavior Therapy|cognitive behavior therapy
708744|NCT00596284|Alzheimer's Disease|alzheimer's disease
708745|NCT00596258|Cervical Intraepithelial Neoplasia (CIN)|cervical intraepithelial neoplasia (cin)
708746|NCT00596258|High-grade Cervical Intraepithelial Neoplasia|high-grade cervical intraepithelial neoplasia
708747|NCT00596258|High-grade Squamous Intraepithelial Lesions (HSIL)|high-grade squamous intraepithelial lesions (hsil)
708748|NCT00596258|Human Papilloma Virus (HPV)|human papilloma virus (hpv)
708749|NCT00596258|High-Grade Cervical Intraepithelial Lesions (CIN 2/3)|high-grade cervical intraepithelial lesions (cin 2/3)
708750|NCT00596245|non-smoking healthy volunteers aged 18 - 35|non-smoking healthy volunteers aged 18 - 35
708751|NCT00596219|HEAD|head
708752|NCT00596219|NECK|neck
708753|NCT00596219|SQUAMOUS|squamous
708754|NCT00596219|CARCINOMA|carcinoma
708755|NCT00596193|Hyperalgesia|hyperalgesia
708756|NCT00596193|nociceptors|nociceptors
708757|NCT00596193|Neurons|neurons
708758|NCT00596180|carbon monoxide poisoning|carbon monoxide poisoning
708759|NCT00596180|brain injury|brain injury
708760|NCT00596167|Short-daily hemodialysis|short-daily hemodialysis
708761|NCT00596167|pharmacokinetics|pharmacokinetics
708762|NCT00596167|levofloxacin|levofloxacin
708763|NCT00596167|gentamicin|gentamicin
708764|NCT00596167|vancomycin|vancomycin
708765|NCT00596141|oral periodontal gingival intraoral mucosal mucoperiosteal|oral periodontal gingival intraoral mucosal mucoperiosteal
708766|NCT00596141|Surgery, Oral|surgery, oral
708767|NCT00596128|Blood glucose|blood glucose
708768|NCT00596128|Clinical pathways|clinical pathways
708769|NCT00596076|Low back pain|low back pain
708771|NCT00596063|pharmacodynamics|pharmacodynamics
708772|NCT00596063|recombinant human insulin|recombinant human insulin
708773|NCT00596063|healthy volunteers|healthy volunteers
708774|NCT00596050|procedural sedation|procedural sedation
708775|NCT00596050|fracture reduction|fracture reduction
708776|NCT00596050|pediatric emergency medicine|pediatric emergency medicine
708777|NCT00596050|etomidate|etomidate
708778|NCT00596050|ketamine|ketamine
708779|NCT00596050|analgesia|analgesia
708780|NCT00596037|Growth hormone Deficiency|growth hormone deficiency
708781|NCT00596011|prostate cancer|prostate cancer
708782|NCT00596011|PIN|pin
708783|NCT00596011|polyphenon E|polyphenon e
708784|NCT00596011|EGCG|egcg
708785|NCT00595998|AMD, HMP, PHP|amd, hmp, php
708786|NCT00595985|Time to Progression|time to progression
708787|NCT00595985|Toxicity|toxicity
708788|NCT00595985|Overall survival|overall survival
708789|NCT00595985|Response rate|response rate
708790|NCT00595985|Quality of live|quality of live
708791|NCT00595985|Toxicities|toxicities
708792|NCT00595972|Time to Progression|time to progression
708793|NCT00595972|Overall survival|overall survival
708794|NCT00595972|Response rate|response rate
708795|NCT00595972|Quality of Live|quality of live
708796|NCT00595972|Toxicities|toxicities
708797|NCT00595933|Head and Neck cancer|head and neck cancer
708798|NCT00595933|Radiation therapy|radiation therapy
708799|NCT00595933|Dry mouth remedies|dry mouth remedies
708800|NCT00595933|Dry Mouth|dry mouth
708801|NCT00595933|Xerostomia|xerostomia
708802|NCT00595920|Tovaxin|tovaxin
708803|NCT00595920|Autologous|autologous
708804|NCT00595920|T-cell vaccine (TCV)|t-cell vaccine (tcv)
708805|NCT00595907|tuberculosis|tuberculosis
708806|NCT00595907|interferon gamma release assays|interferon gamma release assays
708807|NCT00595907|treatment|treatment
708808|NCT00595894|rheumatoid arthritis|rheumatoid arthritis
708809|NCT00595894|African Americans|african americans
708810|NCT00595894|osteopenia|osteopenia
708811|NCT00595894|osteoporosis|osteoporosis
708812|NCT00595894|bone mineral density|bone mineral density
708813|NCT00595881|Bedside emergency ultrasound|bedside emergency ultrasound
708814|NCT00595881|Abscess|abscess
708815|NCT00595881|Cellulitis|cellulitis
708816|NCT00595881|Soft tissue infection|soft tissue infection
708817|NCT00595881|Methicillin resistant staphylococcus aureus (MRSA)|methicillin resistant staphylococcus aureus (mrsa)
708818|NCT00595868|Nicotine|nicotine
708819|NCT00595868|Smoking|smoking
708820|NCT00595868|Smoking Cessation|smoking cessation
708821|NCT00595855|glaucoma|glaucoma
708822|NCT00595855|surgery|surgery
708823|NCT00595855|non penetrating procedures|non penetrating procedures
708824|NCT00595855|cataract|cataract
708825|NCT00595842|Mineral trioxide aggregate|mineral trioxide aggregate
708826|NCT00595829|Polycythemia Vera|polycythemia vera
708827|NCT00595829|PV|pv
708828|NCT00595816|low back pain|low back pain
708829|NCT00595816|physical fitness|physical fitness
708830|NCT00595816|injury|injury
708831|NCT00595816|prevention|prevention
708832|NCT00595816|conscripts|conscripts
708833|NCT00595777|Institutional change|institutional change
708834|NCT00595777|Improved pain management|improved pain management
708835|NCT00595764|Buprenorphine|buprenorphine
708836|NCT00595764|Buprenorphine/naloxone|buprenorphine/naloxone
708837|NCT00595764|Counseling|counseling
708838|NCT00595764|Primary care|primary care
708839|NCT00595751|ADHD, Attention Deficit Hyperactivity Disorder|adhd, attention deficit hyperactivity disorder
708840|NCT00595738|Congestive heart failure|congestive heart failure
708841|NCT00595738|Cardiac biomarkers|cardiac biomarkers
708842|NCT00595738|Hemodynamics|hemodynamics
708843|NCT00595738|Tailored therapy|tailored therapy
708844|NCT00595725|Cervix|cervix
708845|NCT00595725|Endometrium|endometrium
708846|NCT00595725|Cervical Carcinoma|cervical carcinoma
708847|NCT00595725|Lymphatic Mapping|lymphatic mapping
708848|NCT00595712|Genovarum|genovarum
708849|NCT00595712|Medial opening-wedge high tibial osteotomy|medial opening-wedge high tibial osteotomy
708850|NCT00595712|allograft|allograft
708851|NCT00595686|Hematologic Malignancies Hsp90 Hematologic Malignancy|hematologic malignancies hsp90 hematologic malignancy
708852|NCT00595673|Perfusion|perfusion
708853|NCT00595673|Echocardiograpy|echocardiograpy
708854|NCT00595673|SPECT|spect
708855|NCT00595673|angiography|angiography
708856|NCT00595673|Chest pain|chest pain
708857|NCT00595660|Palpable Breast Mass|palpable breast mass
708858|NCT00595660|FNA|fna
708859|NCT00595660|Cytology|cytology
708860|NCT00595660|Fine needle aspiration|fine needle aspiration
708861|NCT00595660|Specimen Adequacy|specimen adequacy
708862|NCT00595634|Hip|hip
708863|NCT00595634|Fracture|fracture
708864|NCT00595634|Intertrochanteric|intertrochanteric
708865|NCT00595634|intramedullary|intramedullary
708866|NCT00595608|aftercare|aftercare
708867|NCT00595608|nasal septum|nasal septum
708868|NCT00595608|turbinates|turbinates
708869|NCT00595595|Dental Pulp|dental pulp
708870|NCT00595595|Regenerative Medicine|regenerative medicine
708871|NCT00595595|Odontoblasts|odontoblasts
708872|NCT00595595|Stem Cells|stem cells
708873|NCT00595595|Growth factor differentiation of stem/progenitor cells|growth factor differentiation of stem/progenitor cells
708874|NCT00595595|Odontoblast-specific cell phenotypes|odontoblast-specific cell phenotypes
708875|NCT00595569|flexible insulin therapy|flexible insulin therapy
708876|NCT00595569|diabetes education|diabetes education
708877|NCT00595569|diabetes|diabetes
708878|NCT00595569|insulin|insulin
708879|NCT00595569|Weekly ambulatory sessions|weekly ambulatory sessions
708880|NCT00595556|Zonisamide|zonisamide
708881|NCT00595556|Pharmacotherapy|pharmacotherapy
708882|NCT00595556|Alcohol dependence|alcohol dependence
708883|NCT00595556|anticonvulsant|anticonvulsant
708884|NCT00595530|ketamine|ketamine
708885|NCT00595530|vasoocclusive pain|vasoocclusive pain
708886|NCT00595517|gastrointestinal|gastrointestinal
708887|NCT00595517|GI|gi
708888|NCT00595517|NSAID|nsaid
708889|NCT00595517|Japan|japan
708890|NCT00595517|Japanese|japanese
708891|NCT00595517|Gastric ulcer|gastric ulcer
708892|NCT00595517|duodenal ulcer|duodenal ulcer
708893|NCT00595504|schizophrenia|schizophrenia
708894|NCT00595504|metabolism|metabolism
708895|NCT00595504|antipsychotics|antipsychotics
708896|NCT00595504|diabetes|diabetes
708897|NCT00595504|rozerem|rozerem
708898|NCT00595491|Asthma|asthma
708899|NCT00595491|Inflammation|inflammation
708900|NCT00595491|Allergic|allergic
708901|NCT00595491|Airway|airway
708902|NCT00595491|Challenge|challenge
708903|NCT00595491|Chemokines|chemokines
708904|NCT00595439|Sensory Evoked Potentials (SEPs)|sensory evoked potentials (seps)
708905|NCT00595439|Electromyogram|electromyogram
708906|NCT00595439|Transcranial Magnetic Stimulation (TMS)|transcranial magnetic stimulation (tms)
708907|NCT00595439|Complex Regional Pain Syndrome|complex regional pain syndrome
708908|NCT00595439|Focal Hand Dystonia|focal hand dystonia
708909|NCT00595439|Focal Dystonia|focal dystonia
708910|NCT00595439|Chronic Regional Pain Syndrome|chronic regional pain syndrome
708911|NCT00595439|CRPS|crps
708912|NCT00595426|Knee Arthroplasty|knee arthroplasty
708913|NCT00595426|Factor Xa|factor xa
708915|NCT00595426|Thrombosis|thrombosis
708916|NCT00595426|Anticoagulants|anticoagulants
708917|NCT00595413|Rheumatoid arthritis|rheumatoid arthritis
708918|NCT00595413|Atacicept|atacicept
708919|NCT00595413|Adalimumab|adalimumab
708920|NCT00595413|Humira®|humira®
708921|NCT00595387|Cognitive Behavioral Therapy|cognitive behavioral therapy
708922|NCT00595361|asthma|asthma
708923|NCT00595361|exercise induced asthma|exercise induced asthma
708924|NCT00595361|exercise induced bronchoconstriction|exercise induced bronchoconstriction
708925|NCT00595361|long acting beta agonist|long acting beta agonist
708926|NCT00595361|salmeterol|salmeterol
708927|NCT00595361|exercise challenge|exercise challenge
708928|NCT00595361|bronchoprotection|bronchoprotection
708929|NCT00595361|beta 2 adrenergic receptor polymorphisms|beta 2 adrenergic receptor polymorphisms
708930|NCT00595361|pharmacogenetics|pharmacogenetics
708931|NCT00595335|Thyroid-associated ophthalmopathy|thyroid-associated ophthalmopathy
708932|NCT00595335|Rituximab|rituximab
708933|NCT00595335|Proptosis|proptosis
708934|NCT00595322|Bevacizumab|bevacizumab
708935|NCT00595322|Radiation Treatment|radiation treatment
708936|NCT00595322|Brain Cancer|brain cancer
708937|NCT00595296|BreastCancer|breastcancer
708938|NCT00595296|Sentinel Lymph Nodes|sentinel lymph nodes
708939|NCT00595296|Metastasis|metastasis
708940|NCT00595283|Preschool Onset Major Depressive Disorder|preschool onset major depressive disorder
708941|NCT00595283|Preschool Depression|preschool depression
708942|NCT00595283|Emotion Development|emotion development
708943|NCT00595283|Parent Child Interaction|parent child interaction
708944|NCT00595257|PAD, CLI, Critical Limb Ischemia, bone marrow, stem cell, injection, infusion|pad, cli, critical limb ischemia, bone marrow, stem cell, injection, infusion
708945|NCT00595244|Perfusion|perfusion
708946|NCT00595244|Echocardiograpy|echocardiograpy
708947|NCT00595244|SPECT|spect
708948|NCT00595244|angiography|angiography
708949|NCT00595244|Chest pain|chest pain
708950|NCT00595231|GAD|gad
708951|NCT00595218|Patient Preferences|patient preferences
708952|NCT00595218|Patient Satisfaction|patient satisfaction
708953|NCT00595218|Patient-Doctor Relationship|patient-doctor relationship
708954|NCT00595205|vaccination|vaccination
708955|NCT00595205|intussusception|intussusception
708956|NCT00595205|Rotavirus|rotavirus
708957|NCT00595205|vaccine|vaccine
708958|NCT00595179|Infrared|infrared
708959|NCT00595179|Imaging Techniques|imaging techniques
708960|NCT00595179|Kidney Reperfusion|kidney reperfusion
708961|NCT00595179|Pneumoperitoneum|pneumoperitoneum
708962|NCT00595179|Nephrectomy|nephrectomy
708963|NCT00595166|Women with excessive vaginal tissue that obstruct the examiner's view of the cervix during a vaginal speculum examination|women with excessive vaginal tissue that obstruct the examiner's view of the cervix during a vaginal speculum examination
708964|NCT00595140|Acromegaly,|acromegaly,
708965|NCT00595140|growth hormone receptor antagonist,|growth hormone receptor antagonist,
708966|NCT00595140|somatostatin analogue,|somatostatin analogue,
708967|NCT00595140|combined medical treatment,|combined medical treatment,
708968|NCT00595140|acute effect,|acute effect,
708969|NCT00595140|endogenous GH|endogenous gh
708970|NCT00595127|Fanconi|fanconi
708971|NCT00595127|Anemia|anemia
708972|NCT00595127|Stem Cell|stem cell
708973|NCT00595127|Transplant|transplant
708974|NCT00595114|COPD|copd
708975|NCT00595114|Airway|airway
708976|NCT00595114|Inflammation|inflammation
708977|NCT00595114|Infection|infection
708978|NCT00595114|Lipid Mediators|lipid mediators
708979|NCT00595114|Oxidative Stress|oxidative stress
708980|NCT00595088|Bladder Cancer|bladder cancer
708981|NCT00595088|Refractory|refractory
708982|NCT00595088|inodiftagene vixteplasmid|inodiftagene vixteplasmid
708983|NCT00595075|sleep|sleep
708984|NCT00595075|performance|performance
708985|NCT00595075|night shift|night shift
708986|NCT00595075|Ramelteon|ramelteon
708987|NCT00595075|Healthy Individuals|healthy individuals
708988|NCT00595062|Breast|breast
708989|NCT00595062|Cancer|cancer
708990|NCT00595049|pulmonary|pulmonary
708991|NCT00595049|arterial|arterial
708992|NCT00595049|artery|artery
708993|NCT00595049|hypertension|hypertension
708994|NCT00595049|systemic|systemic
708995|NCT00595049|sclerosis|sclerosis
708996|NCT00595049|scleroderma|scleroderma
708997|NCT00595049|remodelling|remodelling
708998|NCT00595049|bosentan|bosentan
708999|NCT00595049|tracleer|tracleer
709000|NCT00595049|intravascular|intravascular
709001|NCT00595023|Sentinel lymph node|sentinel lymph node
709002|NCT00595023|Metastasis|metastasis
709003|NCT00595010|Child Maltreatment|child maltreatment
709004|NCT00595010|Child Neglect|child neglect
709005|NCT00595010|Child Physical Abuse|child physical abuse
709006|NCT00595010|Evidence-Based Practice|evidence-based practice
709007|NCT00594997|Lyme disease|lyme disease
709008|NCT00594997|educational intervention for children|educational intervention for children
709009|NCT00594997|tick borne illness|tick borne illness
709010|NCT00594997|prophylactic therapy in children|prophylactic therapy in children
709011|NCT00594997|Self-efficacy|self-efficacy
709012|NCT00594997|tick prevention|tick prevention
709013|NCT00594997|tick avoidance|tick avoidance
709014|NCT00594997|health behavior modification|health behavior modification
709015|NCT00594971|Health Services Research|health services research
709016|NCT00594971|Family practice|family practice
709017|NCT00594932|lupus, arthritis, mycophenolate, biomarkers|lupus, arthritis, mycophenolate, biomarkers
709018|NCT00594919|acute kidney injury|acute kidney injury
709019|NCT00594919|ngal|ngal
709020|NCT00594919|cardiac surgery|cardiac surgery
709021|NCT00594906|Fracture Healing|fracture healing
709022|NCT00594906|Teriparatide|teriparatide
709023|NCT00594906|Forteo|forteo
709024|NCT00594906|Pelvic Fractures|pelvic fractures
709026|NCT00594893|Arthroplasty|arthroplasty
709027|NCT00594893|Minimally Invasive|minimally invasive
709028|NCT00594880|HIV|hiv
709029|NCT00594880|HIV-1|hiv-1
709030|NCT00594880|Pegasys|pegasys
709031|NCT00594880|Peg-IFN-Alpha-2A|peg-ifn-alpha-2a
709032|NCT00594880|Viral Suppression|viral suppression
709033|NCT00594880|ART cessation|art cessation
709034|NCT00594880|Immune function|immune function
709035|NCT00594880|Innate Immunity|innate immunity
709036|NCT00594880|Toxicity|toxicity
709037|NCT00594880|Immune-based therapy|immune-based therapy
709038|NCT00594880|Treatment interruption|treatment interruption
709039|NCT00594867|Healthy|healthy
709040|NCT00594867|Volunteer|volunteer
709041|NCT00594854|NSAID|nsaid
709042|NCT00594854|Gastric Ulcer|gastric ulcer
709043|NCT00594854|High risk|high risk
709044|NCT00594854|Arthrotec|arthrotec
709045|NCT00594854|Vimovo|vimovo
709046|NCT00594841|Acromioclavicular Joint|acromioclavicular joint
709047|NCT00594841|Shoulder dislocation|shoulder dislocation
709048|NCT00594841|AC dislocation|ac dislocation
709049|NCT00594828|Patient self-testing|patient self-testing
709050|NCT00594828|Oral anticoagulation therapy|oral anticoagulation therapy
709051|NCT00594828|Expert Systems|expert systems
709052|NCT00594828|Point-of-Care Systems|point-of-care systems
709053|NCT00594828|International Normalized Ratio|international normalized ratio
709054|NCT00594815|Lymphoma|lymphoma
709055|NCT00594815|Central Nervous System|central nervous system
709056|NCT00594802|ALLERGIC REACTION|allergic reaction
709057|NCT00594789|Osteoporosis|osteoporosis
709058|NCT00594789|Fractures|fractures
709059|NCT00594789|Bone densitometry|bone densitometry
709060|NCT00594789|Dual-energy x-ray absorptiometry|dual-energy x-ray absorptiometry
709061|NCT00594776|Cone Beam CT|cone beam ct
709062|NCT00594776|CBCT|cbct
709063|NCT00594776|Bone Tumors|bone tumors
709064|NCT00594776|Autographs|autographs
709065|NCT00594776|Allographs|allographs
709066|NCT00594763|Turner syndrome|turner syndrome
709067|NCT00594763|Thromboembolic disease|thromboembolic disease
709068|NCT00594737|PET|pet
709069|NCT00594737|frontotemporal dementia|frontotemporal dementia
709070|NCT00594737|memantine|memantine
709071|NCT00594737|Pick's disease|pick's disease
709072|NCT00594724|Tongue|tongue
709073|NCT00594724|Carcinoma|carcinoma
709074|NCT00594724|Cancer|cancer
709075|NCT00594724|02-093|02-093
709076|NCT00594711|Psychotherapy|psychotherapy
709077|NCT00594711|depression|depression
709078|NCT00594698|Perfusion|perfusion
709079|NCT00594698|Echocardiography|echocardiography
709080|NCT00594698|Cardiac angiography|cardiac angiography
709081|NCT00594698|SPECT|spect
709082|NCT00594685|Heparin|heparin
709083|NCT00594685|Thromboembolism|thromboembolism
709084|NCT00594685|Thrombosis|thrombosis
709085|NCT00594672|Cataract|cataract
709086|NCT00594672|Age-Related Macular Degeneration|age-related macular degeneration
709087|NCT00594672|Age-Related Macular Degeneration (AMD)|age-related macular degeneration (amd)
709088|NCT00594672|Cataracts|cataracts
709089|NCT00594672|Age Related Macular Degeneration|age related macular degeneration
709090|NCT00594672|AMD|amd
709091|NCT00594659|Marijuana|marijuana
709092|NCT00594659|Treatment|treatment
709093|NCT00594659|Behavioral|behavioral
709094|NCT00594659|Computer|computer
709095|NCT00594659|Internet|internet
709096|NCT00594646|HIV Prevention|hiv prevention
709097|NCT00594646|Non-occupational post-exposure prophylaxis|non-occupational post-exposure prophylaxis
709098|NCT00594646|HIV seronegativity|hiv seronegativity
709099|NCT00594633|Cognitive dysfunction|cognitive dysfunction
709100|NCT00594607|clotting|clotting
709101|NCT00594607|hemodialysis|hemodialysis
709102|NCT00594607|anticoagulation|anticoagulation
709103|NCT00594607|bleeding risk|bleeding risk
709104|NCT00594594|spinal cord injury|spinal cord injury
709105|NCT00594594|urinary tract infection|urinary tract infection
709106|NCT00594594|probiotics|probiotics
709107|NCT00594594|Lactobacilli|lactobacilli
709108|NCT00594581|cicatrix, scarring, TGF-beta3, avotermin, Juvista|cicatrix, scarring, tgf-beta3, avotermin, juvista
709109|NCT00594555|Blood disease, bone marrow|blood disease, bone marrow
709110|NCT00594555|AML|aml
709111|NCT00594555|CML,Blast Crisis|cml,blast crisis
709112|NCT00594542|lidocaine|lidocaine
709113|NCT00594542|local anesthesia|local anesthesia
709114|NCT00594542|Mohs micrographic surgery|mohs micrographic surgery
709115|NCT00594529|Neoadjuvant chemotherapy|neoadjuvant chemotherapy
709116|NCT00594529|Metastatic liver lesions from colorectal cancers|metastatic liver lesions from colorectal cancers
709117|NCT00594516|Low Back Pain|low back pain
709118|NCT00594516|Dose Equivalence|dose equivalence
709119|NCT00594516|Tapentadol (CG5503)|tapentadol (cg5503)
709120|NCT00594516|Tapentadol-IR|tapentadol-ir
709121|NCT00594516|Tapentadol-ER|tapentadol-er
709122|NCT00594503|traumatic brain injury|traumatic brain injury
709123|NCT00594490|Breast, reconstruction, silicone|breast, reconstruction, silicone
709124|NCT00594477|IMRT|imrt
709125|NCT00594477|breast cancer with regional nodal metastasis|breast cancer with regional nodal metastasis
709126|NCT00594464|Rotigotine|rotigotine
709127|NCT00594464|NEUPRO®|neupro®
709128|NCT00594464|Parkinson's Disease (PD)|parkinson's disease (pd)
709129|NCT00594464|perioperative use|perioperative use
709130|NCT00594464|anaesthesia,|anaesthesia,
709131|NCT00594451|rheumatoid arthritis|rheumatoid arthritis
709132|NCT00594451|cigarette smoking|cigarette smoking
709133|NCT00594451|gene-environmental interactions|gene-environmental interactions
709134|NCT00594451|autoimmunity|autoimmunity
709135|NCT00594451|disease severity|disease severity
709136|NCT00594438|Synthes Reamer-Irrigator-Aspirator (RIA)|synthes reamer-irrigator-aspirator (ria)
709137|NCT00594438|Zimmer Sentinal Reamer|zimmer sentinal reamer
709138|NCT00594438|Transesophageal Echocardiogram (TEE)|transesophageal echocardiogram (tee)
709139|NCT00594412|1H-Magnetic Resonance Spectroscopy|1h-magnetic resonance spectroscopy
709140|NCT00594412|Hepatic Steatosis|hepatic steatosis
709141|NCT00594412|Liver Fat|liver fat
709142|NCT00594412|Liver Biopsy|liver biopsy
709143|NCT00594412|Liver|liver
709144|NCT00594412|Hepatitis|hepatitis
709145|NCT00594412|Fatty Liver|fatty liver
709146|NCT00594399|Aging|aging
709147|NCT00594399|Exercise|exercise
709148|NCT00594399|Impaired Glucose Tolerance|impaired glucose tolerance
709149|NCT00594399|Obesity|obesity
709150|NCT00594399|Functional Status|functional status
709151|NCT00594399|Disability|disability
709152|NCT00594399|Health Services Research|health services research
709153|NCT00594399|Randomized Controlled Trial|randomized controlled trial
709154|NCT00594399|Diabetes|diabetes
709155|NCT00594399|Adaptive Randomization Design|adaptive randomization design
709156|NCT00594386|Rotigotine|rotigotine
709157|NCT00594386|Neupro|neupro
709158|NCT00594373|Microbicide|microbicide
709159|NCT00594373|HIV Seronegativity|hiv seronegativity
709160|NCT00594360|Exercise Prescription|exercise prescription
709161|NCT00594360|Self-efficacy|self-efficacy
709162|NCT00594360|Decisional Balance|decisional balance
709163|NCT00594360|Readiness to Change|readiness to change
709164|NCT00594360|Physical Activity|physical activity
709165|NCT00594347|Streptococcus pneumoniae|streptococcus pneumoniae
709166|NCT00594334|osteopenia|osteopenia
709167|NCT00594334|periodontitis|periodontitis
709168|NCT00594321|spinal fractures|spinal fractures
709169|NCT00594269|Antidepressants|antidepressants
709170|NCT00594269|Antipsychotics|antipsychotics
709171|NCT00594269|Dementia|dementia
709172|NCT00594269|Discontinuation study|discontinuation study
709173|NCT00594269|Behavioural- and Psychological Symptoms in Dementia|behavioural- and psychological symptoms in dementia
709174|NCT00594256|Schizophrenia|schizophrenia
709175|NCT00594256|Sleep Architecture|sleep architecture
709176|NCT00594256|Sodium Oxybate|sodium oxybate
709177|NCT00594256|Insomnia|insomnia
709178|NCT00594256|Cognition|cognition
709179|NCT00594230|Myelodysplastic Syndromes (MDS)|myelodysplastic syndromes (mds)
709180|NCT00594230|Refractory|refractory
709181|NCT00594230|LBH589|lbh589
709182|NCT00594217|PCOS|pcos
709183|NCT00594191|Statins|statins
709184|NCT00594191|HMG-CoA reductase inhibitors|hmg-coa reductase inhibitors
709185|NCT00594191|Cirrhosis|cirrhosis
709186|NCT00594191|Portal hypertension|portal hypertension
709187|NCT00594191|Variceal bleeding|variceal bleeding
709188|NCT00594178|spinal cord injury|spinal cord injury
709189|NCT00594165|Rotigotine|rotigotine
709190|NCT00594152|Diabetic autonomic neuropathy|diabetic autonomic neuropathy
709191|NCT00594139|non-neurogenic over active bladder|non-neurogenic over active bladder
709192|NCT00594139|urge predominant incontinence|urge predominant incontinence
709193|NCT00594126|Myeloma|myeloma
709194|NCT00594126|Multiple Myeloma|multiple myeloma
709195|NCT00594126|Relapsed Multiple Myeloma|relapsed multiple myeloma
709196|NCT00594126|Refractory Multiple Myeloma|refractory multiple myeloma
709197|NCT00594126|Relapsed or Refractory Multiple Myeloma|relapsed or refractory multiple myeloma
709198|NCT00594100|carotid artery stenosis|carotid artery stenosis
709199|NCT00594100|embolic protection device|embolic protection device
709200|NCT00594100|GORE Neuro Protection System|gore neuro protection system
709201|NCT00594100|GORE Flow Reversal System|gore flow reversal system
709202|NCT00594100|reverse flow|reverse flow
709203|NCT00594100|proximal occlusion device|proximal occlusion device
709204|NCT00594100|GNPS|gnps
709205|NCT00594100|Parodi|parodi
709206|NCT00594100|EMPiRE|empire
709207|NCT00594100|distal embolization|distal embolization
709208|NCT00594100|minimizing risks of CAS|minimizing risks of cas
709209|NCT00594100|PAES|paes
709210|NCT00594048|high blood pressure|high blood pressure
709211|NCT00594035|Spinal procedure|spinal procedure
709212|NCT00594035|Dura incision|dura incision
709213|NCT00594022|Electric Stimulation|electric stimulation
709214|NCT00594022|Latency to Persistent Sleep (LPS)|latency to persistent sleep (lps)
709215|NCT00594022|Transient Insomnia|transient insomnia
709216|NCT00594022|Insomnia|insomnia
709217|NCT00593970|influenza|influenza
709218|NCT00593970|vaccine|vaccine
709219|NCT00593970|pregnancy|pregnancy
709220|NCT00593957|Rett Syndrome|rett syndrome
709221|NCT00593957|Dextromethorphan|dextromethorphan
709222|NCT00593944|CLL|cll
709223|NCT00593944|Chronic Lymphocytic Leukemia|chronic lymphocytic leukemia
709224|NCT00593944|B cell|b cell
709225|NCT00593944|leukemia|leukemia
709226|NCT00593944|lymphocyte|lymphocyte
709227|NCT00593944|antibody|antibody
709228|NCT00593944|monoclonal|monoclonal
709229|NCT00593944|cancer|cancer
709230|NCT00593944|blood|blood
709231|NCT00593931|Brain functional MRI|brain functional mri
709232|NCT00593918|RSV, asthma, innate immunity, gene, cytokines|rsv, asthma, innate immunity, gene, cytokines
709233|NCT00593905|Pulmonary Arterial Hypertension|pulmonary arterial hypertension
709234|NCT00593905|Pulmonary Hypertension|pulmonary hypertension
709235|NCT00593905|Pharmacogenomics|pharmacogenomics
709236|NCT00593905|DNA Testing|dna testing
709237|NCT00593905|sitaxsentan|sitaxsentan
709238|NCT00593905|bosentan|bosentan
709239|NCT00593905|ambrisentan|ambrisentan
709240|NCT00593905|elevated pulmonary artery pressures|elevated pulmonary artery pressures
709241|NCT00593905|Letairis|letairis
709242|NCT00593905|Tracleer|tracleer
709243|NCT00593905|Thelin|thelin
709244|NCT00593905|Primary Pulmonary Hypertension|primary pulmonary hypertension
709245|NCT00593905|Pulmonary Artery|pulmonary artery
709246|NCT00593892|Cytokine Levels|cytokine levels
709247|NCT00593892|Traumatic Injury|traumatic injury
709248|NCT00593892|Multisystem Organ Failure|multisystem organ failure
709249|NCT00593879|MDD|mdd
709250|NCT00593879|Depression|depression
709251|NCT00593879|Mecamylamine|mecamylamine
709252|NCT00593879|Add-on Therapy|add-on therapy
709253|NCT00593879|Major Depressive Disorder|major depressive disorder
709254|NCT00593866|Patients who have confirmed cancer arising from the pancreas|patients who have confirmed cancer arising from the pancreas
709255|NCT00593853|LHRH-agonist related fatigue|lhrh-agonist related fatigue
709256|NCT00593801|extremely low birth weight infants|extremely low birth weight infants
709257|NCT00593801|transfusion need|transfusion need
709258|NCT00593801|erythropoietin|erythropoietin
709259|NCT00593801|trace elements|trace elements
709260|NCT00593801|antioxidant enzymes|antioxidant enzymes
709261|NCT00593801|reduction of the transfusion need by EPO treatment|reduction of the transfusion need by epo treatment
709262|NCT00593801|trace elements and antioxidant enzymes in blood|trace elements and antioxidant enzymes in blood
709263|NCT00593788|GIN test|gin test
709264|NCT00593788|gap detection|gap detection
709265|NCT00593788|temporal resolution|temporal resolution
709266|NCT00593788|auditory perception|auditory perception
709267|NCT00593788|psychoacoustics|psychoacoustics
709268|NCT00593775|implantation rate|implantation rate
709269|NCT00593762|Peripheral arterial occlusive disease|peripheral arterial occlusive disease
709270|NCT00593762|Aspirin|aspirin
709271|NCT00593762|Clopidogrel|clopidogrel
709272|NCT00593762|Resistance|resistance
709273|NCT00593762|Catheter interventional procedure|catheter interventional procedure
709274|NCT00593762|ASA and clopidogrel resistance|asa and clopidogrel resistance
709275|NCT00593749|obesity prevention|obesity prevention
709276|NCT00593749|corner stores|corner stores
709278|NCT00593736|Delayed sleep phase syndrome; drug therapy|delayed sleep phase syndrome; drug therapy
709279|NCT00593723|IMRT|imrt
709280|NCT00593710|Randomized|randomized
709281|NCT00593710|double-blind superiority trial|double-blind superiority trial
709282|NCT00593697|breast cancer|breast cancer
709283|NCT00593697|adjuvant therapy|adjuvant therapy
709284|NCT00593697|trastuzumab|trastuzumab
709285|NCT00593697|chemotherapy|chemotherapy
709286|NCT00593684|neonate|neonate
709287|NCT00593684|central lines|central lines
709288|NCT00593684|very low birth weight|very low birth weight
709289|NCT00593684|silver alginate|silver alginate
709290|NCT00593671|aneuploidies in 7 chromosomes increased with advanced maternal age|aneuploidies in 7 chromosomes increased with advanced maternal age
709291|NCT00593658|hypoxemia|hypoxemia
709292|NCT00593658|liver transplantation evaluation|liver transplantation evaluation
709293|NCT00593658|cirrhosis|cirrhosis
709294|NCT00593645|Conditioning regimens|conditioning regimens
709295|NCT00593645|Stem Cell Transplantation|stem cell transplantation
709296|NCT00593645|Hematopoietic Stem Cell Transplantation|hematopoietic stem cell transplantation
709297|NCT00593645|Allogeneic Stem Cell Transplantation|allogeneic stem cell transplantation
709298|NCT00593645|Nonmyeloablative conditioning|nonmyeloablative conditioning
709299|NCT00593645|Clofarabine|clofarabine
709300|NCT00593645|Cytarabine|cytarabine
709301|NCT00593645|Anti-thymocyte globulin|anti-thymocyte globulin
709302|NCT00593632|low HDL|low hdl
709303|NCT00593619|Intravenous Iron|intravenous iron
709304|NCT00593619|Safety|safety
709305|NCT00593619|Perioperative|perioperative
709306|NCT00593619|Iron deficiency|iron deficiency
709307|NCT00593619|Non hemodialysis population|non hemodialysis population
709308|NCT00593619|Perioperative blood conservation|perioperative blood conservation
709309|NCT00593606|Rotigotine|rotigotine
709310|NCT00593606|NEUPRO|neupro
709311|NCT00593606|Switching trial from ropinirole to rotigotine,|switching trial from ropinirole to rotigotine,
709312|NCT00593606|safety and tolerability|safety and tolerability
709313|NCT00593606|Parkinson disease|parkinson disease
709314|NCT00593593|benign prostate hyperplasia|benign prostate hyperplasia
709315|NCT00593593|Dutasteride|dutasteride
709316|NCT00593593|pharmacovigilance|pharmacovigilance
709317|NCT00593580|Ovarian cancer|ovarian cancer
709318|NCT00593580|bone mineral density|bone mineral density
709319|NCT00593580|bisphosphonates|bisphosphonates
709320|NCT00593580|chemotherapy|chemotherapy
709321|NCT00593567|Diabetic Foot Ulcer|diabetic foot ulcer
709322|NCT00593541|MRI|mri
709323|NCT00593528|Cirrhosis, STIC TIPS, Portal Hypertension, Transjugular Intrahepatic Portosystemic Shunt , Stents, PTFE|cirrhosis, stic tips, portal hypertension, transjugular intrahepatic portosystemic shunt , stents, ptfe
709324|NCT00593528|cirrhotic HTP|cirrhotic htp
709325|NCT00593502|influenza|influenza
709326|NCT00593502|children|children
709327|NCT00593502|acute otitis media|acute otitis media
709328|NCT00593502|oseltamivir|oseltamivir
709329|NCT00593489|Insulin|insulin
709330|NCT00593489|Diabetes Mellitus|diabetes mellitus
709331|NCT00593489|Practice Behaviour|practice behaviour
709332|NCT00593489|Preceptor|preceptor
709333|NCT00593489|Pharmacy|pharmacy
709334|NCT00593476|Type 2 Diabetes|type 2 diabetes
709335|NCT00593476|Glycemic Control|glycemic control
709336|NCT00593476|Diabetes Support and Education|diabetes support and education
709337|NCT00593476|Portion Control|portion control
709338|NCT00593476|Prepackaged meals|prepackaged meals
709339|NCT00593463|opioid dependence|opioid dependence
709340|NCT00593463|methadone|methadone
709341|NCT00593463|opioid|opioid
709342|NCT00593450|bevacizumab|bevacizumab
709343|NCT00593450|ranibizumab|ranibizumab
709344|NCT00593450|choroidal neovascularization|choroidal neovascularization
709345|NCT00593437|bone density diagnostic equipment discrepancies|bone density diagnostic equipment discrepancies
709346|NCT00593411|MD Analyze|md analyze
709347|NCT00593411|Central Nervous System|central nervous system
709348|NCT00593411|Spine Disease|spine disease
709349|NCT00593411|Peripheral Nerve|peripheral nerve
709350|NCT00593398|Malaria|malaria
709351|NCT00593398|pregnant women|pregnant women
709352|NCT00593398|infants|infants
709353|NCT00593398|Cameroon|cameroon
709354|NCT00593385|Symptomatic claudication or rest pain and angiographic confirmation of either de novo or restenotic lesions in the common and/or external iliac artery.|symptomatic claudication or rest pain and angiographic confirmation of either de novo or restenotic lesions in the common and/or external iliac artery.
709355|NCT00593372|Alzheimer's Disease|alzheimer's disease
709356|NCT00593372|Memory|memory
709357|NCT00593372|Treatment|treatment
709358|NCT00593359|Spinal surgery|spinal surgery
709359|NCT00593359|Prone spinal surgery|prone spinal surgery
709360|NCT00593333|Femur Fracture|femur fracture
709361|NCT00593333|Intramedullary Nailing|intramedullary nailing
709362|NCT00593333|Trochanteric Nailing|trochanteric nailing
709363|NCT00593333|Piriformis Starting Portal|piriformis starting portal
709364|NCT00593333|Trochanteric Insertion Portal|trochanteric insertion portal
709365|NCT00593320|SRS|srs
709366|NCT00593307|glycemic response|glycemic response
709367|NCT00593307|hunger|hunger
709368|NCT00593294|PCOS|pcos
709369|NCT00593294|oral contraceptives|oral contraceptives
709370|NCT00593294|physical exercise|physical exercise
709371|NCT00593294|CVR|cvr
709372|NCT00593281|Hyaluronidase|hyaluronidase
709373|NCT00593281|Hylenex|hylenex
709374|NCT00593281|subcutaneous|subcutaneous
709375|NCT00593281|morphine|morphine
709376|NCT00593281|absorption|absorption
709377|NCT00593281|bioavailability|bioavailability
709378|NCT00593281|PK study of morphine in patients with pain|pk study of morphine in patients with pain
709379|NCT00593242|hypoxic-ischemic encephalopathy|hypoxic-ischemic encephalopathy
709380|NCT00593242|autologous cord blood cells|autologous cord blood cells
709381|NCT00593242|newborn infants|newborn infants
709382|NCT00593229|Thrombotic microangiopathy (TMA)|thrombotic microangiopathy (tma)
709383|NCT00593229|Hemolytic uremic syndrome (HUS)|hemolytic uremic syndrome (hus)
709384|NCT00593229|Thrombotic thrombocytopenic purpura (TTP)|thrombotic thrombocytopenic purpura (ttp)
709385|NCT00593216|functional magnetic Resonance Imaging|functional magnetic resonance imaging
709386|NCT00593216|vertigo|vertigo
709387|NCT00593216|vestibular|vestibular
709388|NCT00593177|Plaque psoriasis|plaque psoriasis
709389|NCT00593177|Psoriasis|psoriasis
709390|NCT00593164|Hypothermia, Induced|hypothermia, induced
709391|NCT00593164|Death, Sudden, Cardiac|death, sudden, cardiac
709392|NCT00593164|Resuscitation|resuscitation
709393|NCT00593164|Coma|coma
709394|NCT00593151|Antimetabolites|antimetabolites
709395|NCT00593151|Virus Diseases|virus diseases
709396|NCT00593151|Anti-Infective Agents|anti-infective agents
709397|NCT00593151|RNA Virus Infections|rna virus infections
709398|NCT00593151|Digestive System Diseases|digestive system diseases
709399|NCT00593151|Flaviviridae Infections|flaviviridae infections
709400|NCT00593151|Antineoplastic Agents|antineoplastic agents
709401|NCT00593151|Therapeutic Uses|therapeutic uses
709402|NCT00593151|Antiviral Agents|antiviral agents
709403|NCT00593151|Molecular Mechanisms of Action|molecular mechanisms of action
709404|NCT00593151|Pharmacologic Actions|pharmacologic actions
709405|NCT00593138|Focalin XR|focalin xr
709406|NCT00593138|Adult|adult
709407|NCT00593138|PET scan|pet scan
709408|NCT00593125|cocaine|cocaine
709409|NCT00593125|opioids|opioids
709410|NCT00593125|heroin|heroin
709411|NCT00593125|levetiracetam|levetiracetam
709412|NCT00593112|HMRS Scanning|hmrs scanning
709414|NCT00593112|Child|child
709415|NCT00593112|Adolescent|adolescent
709416|NCT00593112|HMRS Scans|hmrs scans
709417|NCT00593099|Bipolar Disorder|bipolar disorder
709418|NCT00593099|Nicotine Dependence|nicotine dependence
709419|NCT00593099|Smoking Cessation|smoking cessation
709420|NCT00593099|Bupropion, sustained-release|bupropion, sustained-release
709421|NCT00593086|wound care|wound care
709422|NCT00593060|Temsirolimus|temsirolimus
709423|NCT00593060|cetuximab|cetuximab
709424|NCT00593060|metastatic disease|metastatic disease
709425|NCT00593047|hypercholesterolemia|hypercholesterolemia
709426|NCT00593034|Alcohol abuse|alcohol abuse
709427|NCT00593034|Drug abuse|drug abuse
709428|NCT00593021|Obscure Gastrointestinal Bleeding|obscure gastrointestinal bleeding
709429|NCT00593021|Occult Gastrointestinal Bleeding|occult gastrointestinal bleeding
709430|NCT00593021|Overt Gastrointestinal Bleeding|overt gastrointestinal bleeding
709431|NCT00593021|Capsule Endoscopy|capsule endoscopy
709432|NCT00593021|CT Enterography|ct enterography
709433|NCT00593008|metastatic pancreatic cancer|metastatic pancreatic cancer
709434|NCT00592943|Adults|adults
709435|NCT00592943|Healthy Volunteers|healthy volunteers
709436|NCT00592943|Nuvigil|nuvigil
709437|NCT00592943|Armodafinil|armodafinil
709438|NCT00592943|DAT occupancy in healthy volunteers|dat occupancy in healthy volunteers
709439|NCT00592930|anorexia nervosa, treatment, adolescents, olanzapine|anorexia nervosa, treatment, adolescents, olanzapine
709440|NCT00592917|osteoporosis|osteoporosis
709441|NCT00592917|fractures|fractures
709442|NCT00592917|risk of fracture|risk of fracture
709443|NCT00592917|vitamin-D|vitamin-d
709444|NCT00592917|calcium|calcium
709445|NCT00592917|falls|falls
709446|NCT00592917|bone mineral density|bone mineral density
709447|NCT00592917|bone metabolism|bone metabolism
709448|NCT00592904|Neuralgia|neuralgia
709449|NCT00592904|neuropathy|neuropathy
709450|NCT00592891|brain injury|brain injury
709451|NCT00592891|brain disorders|brain disorders
709452|NCT00592852|bipolar disorder|bipolar disorder
709453|NCT00592852|obsessive compulsive disorder|obsessive compulsive disorder
709454|NCT00592852|Prozac|prozac
709455|NCT00592839|Nocturnal vasomotor symptoms in postmenopausal women|nocturnal vasomotor symptoms in postmenopausal women
709456|NCT00592826|PHP|php
709457|NCT00592826|HMP|hmp
709458|NCT00592826|HPHP|hphp
709459|NCT00592826|AMD|amd
709460|NCT00592826|CNV|cnv
709461|NCT00592813|rehabilitation|rehabilitation
709462|NCT00592813|function|function
709463|NCT00592800|statistics|statistics
709464|NCT00592800|probability|probability
709465|NCT00592774|Post-Herpetic Neuralgia|post-herpetic neuralgia
709466|NCT00592774|PHN)|phn)
709467|NCT00592761|Deglutition Disorders|deglutition disorders
709468|NCT00592761|Mendelsohn Maneuver|mendelsohn maneuver
709469|NCT00592761|SEMG|semg
709470|NCT00592748|charged particle radiation therapy|charged particle radiation therapy
709471|NCT00592696|Adolescent depression|adolescent depression
709472|NCT00592696|Adolescent smoking|adolescent smoking
709473|NCT00592683|bipolar disorder|bipolar disorder
709474|NCT00592683|fish oil|fish oil
709475|NCT00592683|aripiprazole|aripiprazole
709476|NCT00592683|children|children
709477|NCT00592657|retrospective chart review|retrospective chart review
709478|NCT00592657|Jimsonweed ingestion|jimsonweed ingestion
709479|NCT00592644|ectasia|ectasia
709480|NCT00592644|vascular lesions|vascular lesions
709481|NCT00592644|vocal cords|vocal cords
709482|NCT00592644|voice|voice
709483|NCT00592644|pulsed dye laser|pulsed dye laser
709484|NCT00592631|asthma|asthma
709485|NCT00592631|sleep apnea|sleep apnea
709486|NCT00592618|ESRD|esrd
709487|NCT00592618|Hemodialysis|hemodialysis
709488|NCT00592618|Sleep Apnea|sleep apnea
709489|NCT00592592|pediatric rhabdomyosarcoma|pediatric rhabdomyosarcoma
709490|NCT00592592|proton radiation therapy|proton radiation therapy
709491|NCT00592566|Severe leptospirosis|severe leptospirosis
709492|NCT00592566|Pulmonary hemorrhage|pulmonary hemorrhage
709493|NCT00592553|Duchenne muscular dystrophy|duchenne muscular dystrophy
709494|NCT00592553|Becker muscular dystrophy|becker muscular dystrophy
709495|NCT00592553|Nonsense mutation|nonsense mutation
709496|NCT00592553|Premature stop codon|premature stop codon
709497|NCT00592553|DMD/BMD|dmd/bmd
709498|NCT00592553|PTC124|ptc124
709499|NCT00592514|Patients undergoing head and neck surgery that involves the upper aerodigestive tract|patients undergoing head and neck surgery that involves the upper aerodigestive tract
709500|NCT00592501|proton radiation|proton radiation
709501|NCT00592501|photon radiation|photon radiation
709502|NCT00592501|5-FU|5-fu
709503|NCT00592501|cisplatin|cisplatin
709504|NCT00592488|Septic shock|septic shock
709505|NCT00592488|Acetyl-L-carnitine|acetyl-l-carnitine
709506|NCT00592475|conivaptan|conivaptan
709507|NCT00592475|Liver Cirrhosis|liver cirrhosis
709508|NCT00592475|Hypertension, Portal|hypertension, portal
709509|NCT00592462|Breast Cancer|breast cancer
709510|NCT00592462|Whole Body MRI|whole body mri
709511|NCT00592462|Magnetic Resonance Imaging|magnetic resonance imaging
709512|NCT00592462|Metastases|metastases
709513|NCT00592449|Insomnia|insomnia
709514|NCT00592449|Knee pain|knee pain
709515|NCT00592449|Osteoarthritis|osteoarthritis
709516|NCT00592449|Arthritis|arthritis
709517|NCT00592449|Sleep|sleep
709518|NCT00592436|ADHD|adhd
709519|NCT00592436|pediatric|pediatric
709520|NCT00592436|children|children
709521|NCT00592423|Lateral neck rotation|lateral neck rotation
709522|NCT00592423|Continuous Positive Airway Pressure|continuous positive airway pressure
709523|NCT00592397|Dietary Intervention|dietary intervention
709524|NCT00592397|Nutrigenomics|nutrigenomics
709525|NCT00592397|Diet, Carbohydrate-Restricted|diet, carbohydrate-restricted
709526|NCT00592397|Gene Expression|gene expression
709527|NCT00592397|Gene Expression Profiling|gene expression profiling
709528|NCT00592397|Oligonucleotide Array Sequence Analysis|oligonucleotide array sequence analysis
709529|NCT00592397|Biological Markers|biological markers
709530|NCT00592397|Food|food
709531|NCT00592397|Obesity|obesity
709532|NCT00592397|Blood|blood
709533|NCT00592397|Subcutaneous Fat, Abdominal|subcutaneous fat, abdominal
709534|NCT00592384|spinal cord injuries|spinal cord injuries
709535|NCT00592384|major depressive disorder|major depressive disorder
709536|NCT00592384|dysthymia|dysthymia
709537|NCT00592384|antidepressant agents|antidepressant agents
709538|NCT00592384|pain|pain
709539|NCT00592384|quality of life|quality of life
709540|NCT00592384|muscle spasticity|muscle spasticity
709541|NCT00592384|community participation|community participation
709542|NCT00592384|anxiety|anxiety
709543|NCT00592358|bipolar disorder|bipolar disorder
709544|NCT00592358|children|children
709545|NCT00592358|adolescents|adolescents
709546|NCT00592358|Invega|invega
709547|NCT00592345|sarcoma of the thoracic/lumbar/spine/sacrum|sarcoma of the thoracic/lumbar/spine/sacrum
709548|NCT00592345|paraspinal soft tissues|paraspinal soft tissues
709549|NCT00592345|proton radiation therapy|proton radiation therapy
709550|NCT00592345|photon radiation therapy|photon radiation therapy
709551|NCT00592345|radiation applicator plaque|radiation applicator plaque
709552|NCT00592319|Papilloma|papilloma
709553|NCT00592319|pulsed dye laser|pulsed dye laser
709554|NCT00592319|Celebrex|celebrex
709555|NCT00592319|voice|voice
709556|NCT00592306|ATG|atg
709557|NCT00592306|rabbit thymoglobulin|rabbit thymoglobulin
709558|NCT00592306|reperfusion lung injury|reperfusion lung injury
709559|NCT00592306|primary graft dysfunction|primary graft dysfunction
709560|NCT00592306|lung transplantation|lung transplantation
709561|NCT00592293|proton beam radiation|proton beam radiation
709562|NCT00592280|Pancreas transplantation|pancreas transplantation
709563|NCT00592280|graft pancreatitis|graft pancreatitis
709564|NCT00592280|Two-layer method|two-layer method
709565|NCT00592280|organ preservation|organ preservation
709566|NCT00592267|pediatric|pediatric
709567|NCT00592267|bipolar disorder|bipolar disorder
709568|NCT00592254|ADHD|adhd
709569|NCT00592254|Adults|adults
709570|NCT00592241|Insulin Pump|insulin pump
709571|NCT00592228|intermediate lesion|intermediate lesion
709572|NCT00592228|drug-eluting stent|drug-eluting stent
709573|NCT00592228|fractional flow reserve|fractional flow reserve
709574|NCT00592215|Second trimester labor induction|second trimester labor induction
709575|NCT00592202|Morbid obesity|morbid obesity
709576|NCT00592202|Adolescents|adolescents
709577|NCT00592202|Gastric restrictive procedure|gastric restrictive procedure
709578|NCT00592202|Adjustable gastric band|adjustable gastric band
709579|NCT00592202|Treatment|treatment
709580|NCT00592189|Burns|burns
709581|NCT00592189|Wound healing|wound healing
709582|NCT00592189|Amnion|amnion
709583|NCT00592163|Cancer|cancer
709584|NCT00592163|Arsenic|arsenic
709585|NCT00592150|Essential Hypertension|essential hypertension
709586|NCT00592137|calcium carbonate|calcium carbonate
709587|NCT00592137|obesity|obesity
709588|NCT00592137|dairy|dairy
709589|NCT00592137|energy expenditure|energy expenditure
709590|NCT00592124|Microbicide|microbicide
709591|NCT00592124|HIV Seronegativity|hiv seronegativity
709592|NCT00592111|Pediatric|pediatric
709593|NCT00592111|Hodgkin's Disease|hodgkin's disease
709594|NCT00592111|96-016|96-016
709595|NCT00592098|Lower limb amputation at least 6 months prior to inclusion|lower limb amputation at least 6 months prior to inclusion
709596|NCT00592098|Presenting with moderate-to-severe pain intensity|presenting with moderate-to-severe pain intensity
709597|NCT00592098|Outpatients, aged 18 years and above|outpatients, aged 18 years and above
709598|NCT00592085|Tobacco Use|tobacco use
709599|NCT00592085|Smoking|smoking
709600|NCT00592085|Alcohol Use|alcohol use
709601|NCT00592085|Smoking Cessation|smoking cessation
709602|NCT00592072|Diabetes Mellitus, Type 1|diabetes mellitus, type 1
709603|NCT00592072|Medium Chain Fatty Acid|medium chain fatty acid
709604|NCT00592072|Hypoglycemia|hypoglycemia
709605|NCT00592046|Phase I|phase i
709606|NCT00592046|Hematologic Cancers|hematologic cancers
709607|NCT00592046|Blood Cancers|blood cancers
709608|NCT00592046|Leukemia|leukemia
709609|NCT00592046|multiple myeloma|multiple myeloma
709610|NCT00592046|myelodysplasia (MDS)|myelodysplasia (mds)
709706|NCT00591708|bone|bone
709611|NCT00592046|Relapsed/refractory leukemia or lymphoma|relapsed/refractory leukemia or lymphoma
709612|NCT00592033|COPD oxygen|copd oxygen
709613|NCT00592033|COPD rehabilitation|copd rehabilitation
709614|NCT00592033|exercise|exercise
709615|NCT00592020|kidney|kidney
709616|NCT00592020|transplantation|transplantation
709617|NCT00592020|minimal invasive|minimal invasive
709618|NCT00592020|short transverse|short transverse
709619|NCT00592020|hockey stick|hockey stick
709620|NCT00592020|incision|incision
709621|NCT00592020|quality of life|quality of life
709622|NCT00592020|planned kidney transplantation|planned kidney transplantation
709623|NCT00592007|Non Small Cell Lung Cancer|non small cell lung cancer
709624|NCT00592007|Stage IIIB|stage iiib
709625|NCT00592007|Stage IV|stage iv
709626|NCT00592007|Stable on Erlotinib|stable on erlotinib
709627|NCT00592007|Exhibit Positivity for Estrogen or Progesterone Receptor|exhibit positivity for estrogen or progesterone receptor
709628|NCT00591994|tinnitus|tinnitus
709629|NCT00591994|piribedil|piribedil
709630|NCT00591994|acoustic otoemissions|acoustic otoemissions
709631|NCT00591994|ECoG|ecog
709632|NCT00591981|Geriatric|geriatric
709633|NCT00591981|Thoracic|thoracic
709634|NCT00591981|neoplasm|neoplasm
709635|NCT00591981|(Patients over 70 years of age) Geriatric oncology patients with thoracic neoplasms of the lung, esophagus, pleura and thymus.|(patients over 70 years of age) geriatric oncology patients with thoracic neoplasms of the lung, esophagus, pleura and thymus.
709636|NCT00591968|ultrasound|ultrasound
709637|NCT00591968|telediagnosis|telediagnosis
709638|NCT00591968|teleultrasound|teleultrasound
709639|NCT00591968|telesonography|telesonography
709640|NCT00591968|teleultrasonography|teleultrasonography
709641|NCT00591968|teleradiology|teleradiology
709642|NCT00591968|telemedicine|telemedicine
709643|NCT00591968|dominican republic|dominican republic
709644|NCT00591968|puntacana|puntacana
709645|NCT00591968|veron|veron
709646|NCT00591968|store-and-forward|store-and-forward
709647|NCT00591968|asynchronous|asynchronous
709648|NCT00591955|geriatric|geriatric
709649|NCT00591955|sepsis|sepsis
709650|NCT00591955|outcome assessment(healthcare)|outcome assessment(healthcare)
709651|NCT00591942|dental cement|dental cement
709652|NCT00591942|ceramic crowns|ceramic crowns
709653|NCT00591942|three-unit bridges|three-unit bridges
709654|NCT00591942|sensitivity|sensitivity
709655|NCT00591916|burn|burn
709656|NCT00591916|donor site|donor site
709657|NCT00591916|grafting|grafting
709658|NCT00591916|scar|scar
709659|NCT00591903|Diabetes and Cardiac Proteomics|diabetes and cardiac proteomics
709660|NCT00591903|Atrial Appendage and Proteomics|atrial appendage and proteomics
709661|NCT00591903|Diabetic Cardiomyopathy|diabetic cardiomyopathy
709662|NCT00591903|Tissue Sample|tissue sample
709663|NCT00591877|GERDCAM: Complementary and alternative medicine|gerdcam: complementary and alternative medicine
709664|NCT00591877|NERD: non-erosive reflux disease|nerd: non-erosive reflux disease
709665|NCT00591877|GERD: gastroesophageal reflux disease|gerd: gastroesophageal reflux disease
709666|NCT00591877|AC: acupuncture|ac: acupuncture
709667|NCT00591877|SAC: sham acupuncture|sac: sham acupuncture
709668|NCT00591877|LES: lower esophageal sphincter pressure|les: lower esophageal sphincter pressure
709669|NCT00591877|TLESR: transient lower esophageal sphincter relaxation|tlesr: transient lower esophageal sphincter relaxation
709670|NCT00591877|Acupuncture|acupuncture
709671|NCT00591877|Yoga|yoga
709672|NCT00591864|Benign breast disease|benign breast disease
709673|NCT00591864|Breast|breast
709674|NCT00591864|MRI|mri
709675|NCT00591864|Mammography|mammography
709676|NCT00591864|Ultrasound|ultrasound
709677|NCT00591864|Molecular Breast Imaging|molecular breast imaging
709678|NCT00591864|Breast Cancer|breast cancer
709679|NCT00591851|breast cancer|breast cancer
709680|NCT00591851|adenocarcinoma of the breast|adenocarcinoma of the breast
709681|NCT00591851|cardiac safety|cardiac safety
709682|NCT00591851|Breast cancer patients seen at the Memorial Sloan-Kettering Cancer Center|breast cancer patients seen at the memorial sloan-kettering cancer center
709683|NCT00591838|SBRT|sbrt
709684|NCT00591773|Blood pressure|blood pressure
709685|NCT00591773|Blood pressure monitoring, ambulatory|blood pressure monitoring, ambulatory
709686|NCT00591760|Heart Failure|heart failure
709687|NCT00591760|Growth Hormone|growth hormone
709688|NCT00591760|Anabolism|anabolism
709689|NCT00591760|Anabolic Deficiency|anabolic deficiency
709690|NCT00591760|Hormone replacement|hormone replacement
709691|NCT00591747|randomized clinical trial|randomized clinical trial
709692|NCT00591747|elderly|elderly
709693|NCT00591747|cancer survivor|cancer survivor
709694|NCT00591747|bone health|bone health
709695|NCT00591747|body composition|body composition
709696|NCT00591747|signs and symptoms|signs and symptoms
709697|NCT00591734|Metastatic Melanoma|metastatic melanoma
709698|NCT00591734|Everolimus|everolimus
709699|NCT00591734|RAD001|rad001
709700|NCT00591734|Bevacizumab|bevacizumab
709701|NCT00591721|energy conservation education|energy conservation education
709702|NCT00591721|occupational therapy intervention|occupational therapy intervention
709703|NCT00591721|fatigue management|fatigue management
709704|NCT00591721|psychoeducation|psychoeducation
709705|NCT00591708|calcium|calcium
709707|NCT00591708|bone density|bone density
709708|NCT00591708|adolescence|adolescence
709709|NCT00591695|Malignant Colorectal Obstruction|malignant colorectal obstruction
709710|NCT00591695|Stent Bridge to Surgery|stent bridge to surgery
709711|NCT00591669|Inflammatory bowel disease|inflammatory bowel disease
709712|NCT00591669|Crohn's disease|crohn's disease
709713|NCT00591643|Adrenal tumors|adrenal tumors
709714|NCT00591643|Adrenal malignancies|adrenal malignancies
709715|NCT00591643|abnormal hormonal secretions|abnormal hormonal secretions
709716|NCT00591643|electrolytes abnormalities|electrolytes abnormalities
709717|NCT00591643|Imaging|imaging
709718|NCT00591643|Scanning|scanning
709719|NCT00591643|tumor localization|tumor localization
709720|NCT00591630|Diffuse Large Cell Lymphoma|diffuse large cell lymphoma
709721|NCT00591630|Lymphoma|lymphoma
709722|NCT00591630|Zevalin|zevalin
709723|NCT00591630|Ibritumomab|ibritumomab
709724|NCT00591630|IDEC-Y2B8|idec-y2b8
709725|NCT00591630|Carmustine|carmustine
709726|NCT00591630|BCNU|bcnu
709727|NCT00591630|BiCNU|bicnu
709728|NCT00591630|Etoposide|etoposide
709729|NCT00591630|VePesid|vepesid
709730|NCT00591630|Cytarabine|cytarabine
709731|NCT00591630|Ara-C|ara-c
709732|NCT00591630|Cytosar|cytosar
709733|NCT00591630|DepoCyt|depocyt
709734|NCT00591630|Cytosine arabinosine hydrochloride|cytosine arabinosine hydrochloride
709735|NCT00591630|Melphalan|melphalan
709736|NCT00591630|Rituximab|rituximab
709737|NCT00591630|Rituxan|rituxan
709738|NCT00591630|BEAM|beam
709739|NCT00591617|Opioids|opioids
709740|NCT00591617|drug dependence|drug dependence
709741|NCT00591617|drug abuse|drug abuse
709742|NCT00591617|treatment|treatment
709743|NCT00591604|burn|burn
709744|NCT00591604|vitamin D|vitamin d
709745|NCT00591604|nutrition|nutrition
709746|NCT00591604|burn recovery|burn recovery
709747|NCT00591591|Obstructive Sleep Apnea Syndrome|obstructive sleep apnea syndrome
709748|NCT00591591|sleep disordered breathing|sleep disordered breathing
709749|NCT00591591|polysomnography (psg)|polysomnography (psg)
709750|NCT00591591|continuous positive airway pressure (cpap)|continuous positive airway pressure (cpap)
709751|NCT00591591|brain vascular autoregulation|brain vascular autoregulation
709752|NCT00591591|brain tissue oxygenation|brain tissue oxygenation
709753|NCT00591591|near-infrared spectroscopy|near-infrared spectroscopy
709754|NCT00591591|Obstructive Sleep Apnea|obstructive sleep apnea
709755|NCT00591578|Blood pressure|blood pressure
709756|NCT00591578|blood pressure monitoring, ambulatory|blood pressure monitoring, ambulatory
709757|NCT00591565|Anxiety|anxiety
709758|NCT00591565|SSRI|ssri
709759|NCT00591565|SNRI|snri
709760|NCT00591565|Acamprosate|acamprosate
709761|NCT00591552|Lung cancer|lung cancer
709762|NCT00591552|Lymph node dissection|lymph node dissection
709763|NCT00591539|Carotid Artery Disease|carotid artery disease
709764|NCT00591539|Intima-Media Thickening|intima-media thickening
709765|NCT00591539|Carotid Ultrasound|carotid ultrasound
709766|NCT00591539|Pediatric Cancer Survivors|pediatric cancer survivors
709767|NCT00591539|Cancer Survivors|cancer survivors
709768|NCT00591539|Head or Neck Cancer|head or neck cancer
709769|NCT00591539|Radiation Therapy|radiation therapy
709771|NCT00591500|Melanoma|melanoma
709772|NCT00591500|Skin cancer|skin cancer
709773|NCT00591500|Genetic Susceptibility|genetic susceptibility
709774|NCT00591500|polymorphisms|polymorphisms
709775|NCT00591487|suction|suction
709776|NCT00591487|assisted|assisted
709777|NCT00591487|lipectomy|lipectomy
709778|NCT00591487|liposuction|liposuction
709779|NCT00591487|contour|contour
709780|NCT00591487|cosmetic|cosmetic
709781|NCT00591487|plastic|plastic
709782|NCT00591487|surgery|surgery
709783|NCT00591487|Klein|klein
709784|NCT00591487|tumescent|tumescent
709785|NCT00591487|technique|technique
709786|NCT00591487|Healthy women wanting Suction Assisted Lipectomy|healthy women wanting suction assisted lipectomy
709787|NCT00591474|VRE|vre
709788|NCT00591474|Probiotics|probiotics
709789|NCT00591474|colonization|colonization
709790|NCT00591474|gut health|gut health
709791|NCT00591461|Barrett's Esophagus|barrett's esophagus
709792|NCT00591461|Upper Endoscopy|upper endoscopy
709793|NCT00591461|Esophageal biopsies|esophageal biopsies
709794|NCT00591461|Accuracy|accuracy
709795|NCT00591461|Interobserver Agreement|interobserver agreement
709796|NCT00591448|Thermal injury|thermal injury
709797|NCT00591435|Anesthesia|anesthesia
709798|NCT00591435|Surgery|surgery
709799|NCT00591435|Education|education
709800|NCT00591435|Economics|economics
709801|NCT00591422|Arsenic|arsenic
709802|NCT00591422|Cancer|cancer
709803|NCT00591383|Cancer|cancer
709804|NCT00591383|Indibulin|indibulin
709805|NCT00591383|Erlotinib|erlotinib
709806|NCT00591370|Memorial Sloan-Kettering Cancer Center patients with measurable, unresectable stage|memorial sloan-kettering cancer center patients with measurable, unresectable stage
709807|NCT00591370|III or IV melanoma|iii or iv melanoma
709808|NCT00591357|Antibiotic associated diarrhea|antibiotic associated diarrhea
709809|NCT00591357|Clostridium difficile|clostridium difficile
709810|NCT00591357|loperamide|loperamide
709811|NCT00591344|Parkinson's disease|parkinson's disease
709812|NCT00591344|exercise|exercise
709813|NCT00591331|Head Lice|head lice
709814|NCT00591318|Ceftriaxone|ceftriaxone
709815|NCT00591318|Psychosis|psychosis
709816|NCT00591318|Schizophrenia|schizophrenia
709817|NCT00591318|Schizoaffective Disorder|schizoaffective disorder
709818|NCT00591305|papilloma|papilloma
709819|NCT00591305|PDL|pdl
709820|NCT00591305|diindolylmethane|diindolylmethane
709821|NCT00591305|recurrence|recurrence
709822|NCT00591292|cancer|cancer
709823|NCT00591292|tumor|tumor
709824|NCT00591292|solid tumor|solid tumor
709825|NCT00591292|advanced tumor|advanced tumor
709826|NCT00591279|large bowel cancer|large bowel cancer
709827|NCT00591279|polyps|polyps
709828|NCT00591279|colorectal cancer|colorectal cancer
709829|NCT00591266|Blood pressure|blood pressure
709830|NCT00591266|blood pressure monitoring ambulatory|blood pressure monitoring ambulatory
709831|NCT00591266|Drug Therapy|drug therapy
709832|NCT00591253|Blood pressure|blood pressure
709833|NCT00591253|blood pressure monitoring ambulatory|blood pressure monitoring ambulatory
709834|NCT00591253|Drug Therapy|drug therapy
709835|NCT00591240|RNA, ribosomal, 16S|rna, ribosomal, 16s
709836|NCT00591240|Biosensing techniques|biosensing techniques
709837|NCT00591240|Microchip analytical procedures|microchip analytical procedures
709838|NCT00591214|Chronic Hepatitis C|chronic hepatitis c
709839|NCT00591214|Protease Inhibitor|protease inhibitor
709840|NCT00591201|Spondylarthritis|spondylarthritis
709841|NCT00591201|TNF|tnf
709842|NCT00591201|Infliximab|infliximab
709843|NCT00591201|Ankylosing spondylitis|ankylosing spondylitis
709844|NCT00591201|Juvenile SpA|juvenile spa
709845|NCT00591201|Juvenile arthritis|juvenile arthritis
709846|NCT00591188|kidney cancer, capecitabine, interferon|kidney cancer, capecitabine, interferon
709847|NCT00591162|Bone, Dexa, Parathyroid, Diuretic, Tetracycline|bone, dexa, parathyroid, diuretic, tetracycline
709848|NCT00591149|cancer|cancer
709849|NCT00591149|head and neck cancer|head and neck cancer
709850|NCT00591149|squamous cell cancer|squamous cell cancer
709851|NCT00591123|Unresectable|unresectable
709852|NCT00591123|Metastatic|metastatic
709853|NCT00591123|Esophagus|esophagus
709854|NCT00591123|Gastric Cardia|gastric cardia
709855|NCT00591097|urine|urine
709856|NCT00591097|pediatric|pediatric
709857|NCT00591097|Normal urine from healthy pediatric population|normal urine from healthy pediatric population
709858|NCT00591084|randomized trial|randomized trial
709859|NCT00591084|ischemic stroke|ischemic stroke
709860|NCT00591084|Ginsenoside-Rd|ginsenoside-rd
709861|NCT00591071|hyperglycemia|hyperglycemia
709862|NCT00591071|insulin treatment|insulin treatment
709863|NCT00591071|intensive care|intensive care
709864|NCT00591071|hypoglycemia|hypoglycemia
709865|NCT00591071|mechanical ventilation|mechanical ventilation
709866|NCT00591071|critically ill patients|critically ill patients
709867|NCT00591058|recurrent glioma|recurrent glioma
709868|NCT00591058|Phase I|phase i
709869|NCT00591058|Multi-Center|multi-center
709870|NCT00591058|Open label|open label
709871|NCT00591058|Brain Cancer|brain cancer
709872|NCT00591058|Brain tumor|brain tumor
709873|NCT00591058|GBM|gbm
709874|NCT00591058|Glioma|glioma
709875|NCT00591058|Glioblastoma multiforme|glioblastoma multiforme
709876|NCT00591045|gastric adenocarcinoma|gastric adenocarcinoma
709877|NCT00591045|neoadjuvant chemotherapy|neoadjuvant chemotherapy
709878|NCT00591045|efficacy|efficacy
709879|NCT00591045|safety|safety
709880|NCT00591045|chemotherapy|chemotherapy
709881|NCT00591032|Critical illness|critical illness
709882|NCT00591032|Euthyroid sick syndromes|euthyroid sick syndromes
709883|NCT00591032|Intensive care|intensive care
709884|NCT00591032|Non-thyroidal illness syndrome|non-thyroidal illness syndrome
709885|NCT00591032|Low-T3 syndrome|low-t3 syndrome
709886|NCT00591019|P50, Psychomotor Vigilance Test (PVT), Arousal, Reaction Time|p50, psychomotor vigilance test (pvt), arousal, reaction time
709887|NCT00591006|Phenytoin|phenytoin
709888|NCT00591006|Dilantin|dilantin
709889|NCT00591006|Corticosteroid|corticosteroid
709890|NCT00591006|Neuroprotection|neuroprotection
709891|NCT00591006|Mania|mania
709892|NCT00591006|Cognition|cognition
709893|NCT00591006|Mood|mood
709894|NCT00591006|Memory|memory
709895|NCT00591006|Hydrocortisone|hydrocortisone
709896|NCT00591006|Healthy Controls|healthy controls
709897|NCT00591006|MRI|mri
709898|NCT00591006|hippocampal activation|hippocampal activation
709899|NCT00590993|MRSI|mrsi
709900|NCT00590993|MRI|mri
709901|NCT00590993|Prostate Cancer|prostate cancer
709902|NCT00590980|Stroke|stroke
709903|NCT00590980|TIA (transient ischemic attack)|tia (transient ischemic attack)
709904|NCT00590980|Brain|brain
709905|NCT00590980|Blood Flow|blood flow
709906|NCT00590980|Quantitative magnetic resonance angiography (QMRA)|quantitative magnetic resonance angiography (qmra)
709907|NCT00590967|para-aortic lymph nodes|para-aortic lymph nodes
709908|NCT00590954|Malignant Gliomas|malignant gliomas
709909|NCT00590954|CNS|cns
709910|NCT00590954|Brain Cancer|brain cancer
709911|NCT00590954|Cancer|cancer
709912|NCT00590954|Perifosine|perifosine
709913|NCT00590941|Lymphoma|lymphoma
709914|NCT00590941|Rituximab|rituximab
709915|NCT00590941|CHOP|chop
709916|NCT00590915|ALL|all
709917|NCT00590902|non small cell lung cancer|non small cell lung cancer
709918|NCT00590889|artificial heart valve|artificial heart valve
709919|NCT00590889|mitral heart valve|mitral heart valve
709920|NCT00590889|aortic heart valve|aortic heart valve
709921|NCT00590889|endocarditis|endocarditis
709922|NCT00590889|Aortic valve disease requiring replacement|aortic valve disease requiring replacement
709923|NCT00590889|Mitral valve disease requiring replacement|mitral valve disease requiring replacement
709924|NCT00590876|Diabetes Mellitus, Type 1|diabetes mellitus, type 1
709925|NCT00590876|Hypoglycemia|hypoglycemia
709926|NCT00590876|Pancreatic Islet Cell Allotransplantation|pancreatic islet cell allotransplantation
709927|NCT00590863|depression, medication, antidepressant, chronic, recurrent|depression, medication, antidepressant, chronic, recurrent
709928|NCT00590837|AML|aml
709929|NCT00590837|Chemotherapy|chemotherapy
709930|NCT00590837|older|older
709931|NCT00590837|De novo AML|de novo aml
709932|NCT00590824|Melanoma|melanoma
709933|NCT00590824|hu14.18-IL2|hu14.18-il2
709934|NCT00590811|adolescents|adolescents
709935|NCT00590811|young adults|young adults
709936|NCT00590811|dysmenorrhea|dysmenorrhea
709937|NCT00590811|pelvic pain|pelvic pain
709938|NCT00590798|Cardiac Catheterization|cardiac catheterization
709939|NCT00590798|Walk|walk
709940|NCT00590798|Heart Catheterization|heart catheterization
709941|NCT00590798|Coronary Disease|coronary disease
709942|NCT00590798|Heart Disease|heart disease
709943|NCT00590798|Coronary Artery Disease|coronary artery disease
709944|NCT00590785|High Risk|high risk
709945|NCT00590785|Breast Cancer|breast cancer
709946|NCT00590785|Positive Nodes|positive nodes
709947|NCT00590785|Cyclophosphamide|cyclophosphamide
709948|NCT00590785|Doxorubicin|doxorubicin
709949|NCT00590785|96-041|96-041
709950|NCT00590772|sleep|sleep
709951|NCT00590772|somnolence|somnolence
709952|NCT00590772|allergies|allergies
709953|NCT00590772|rhinitis|rhinitis
709954|NCT00590772|fatigue|fatigue
709955|NCT00590720|Asthma|asthma
709956|NCT00590720|Bronchitis|bronchitis
709957|NCT00590707|Hip fractures|hip fractures
709958|NCT00590707|Femoral neck fractures|femoral neck fractures
709959|NCT00590707|Trochanteric fractures|trochanteric fractures
709960|NCT00590707|Intertrochanteric fractures|intertrochanteric fractures
709961|NCT00590707|Subtrochanteric fractures|subtrochanteric fractures
709962|NCT00590707|Delirium|delirium
709963|NCT00590707|Confusion|confusion
709964|NCT00590694|ranibizumab|ranibizumab
709965|NCT00590694|Lucentis|lucentis
709966|NCT00590694|Pigment Epithelial Detachment|pigment epithelial detachment
709967|NCT00590694|Macular Degeneration|macular degeneration
709968|NCT00590694|PrONTO|pronto
709969|NCT00590668|atrial fibrillation|atrial fibrillation
709970|NCT00590668|pulmonary vein ablation|pulmonary vein ablation
709971|NCT00590668|pulmonary vein stenosis|pulmonary vein stenosis
709972|NCT00590655|maintenance therapy|maintenance therapy
709973|NCT00590642|obsessive compulsive disorder|obsessive compulsive disorder
709974|NCT00590642|OCD|ocd
709975|NCT00590642|treatment-resistant|treatment-resistant
709976|NCT00590642|SSRI|ssri
709977|NCT00590629|Women with and without CAD|women with and without cad
709978|NCT00590616|Aortic atheroma|aortic atheroma
709979|NCT00590603|Multiple myeloma|multiple myeloma
709980|NCT00590577|Schizophrenia|schizophrenia
709981|NCT00590577|Long-acting injectable antipsychotic medication|long-acting injectable antipsychotic medication
709982|NCT00590564|Hepatitis C|hepatitis c
709983|NCT00590564|Sho-saiko-to|sho-saiko-to
709984|NCT00590564|SST|sst
709985|NCT00590564|Interferon Therapy|interferon therapy
709986|NCT00590551|Skin Breakdown|skin breakdown
709987|NCT00590551|Skin Damage|skin damage
709988|NCT00590551|Skin Integrity|skin integrity
709989|NCT00590551|Pressure|pressure
709990|NCT00590551|Slings|slings
709991|NCT00590525|hsCRP|hscrp
709992|NCT00590512|dietary salt|dietary salt
709993|NCT00590512|sodium|sodium
709994|NCT00590512|blood vessels|blood vessels
709995|NCT00590512|vascular function|vascular function
709996|NCT00590512|endothelial function|endothelial function
709997|NCT00590512|heart disease risk|heart disease risk
709998|NCT00590512|cardiovascular disease risk|cardiovascular disease risk
709999|NCT00590499|agitation|agitation
710000|NCT00590499|craniotomy|craniotomy
710001|NCT00590499|incidence|incidence
710002|NCT00590499|risk factor|risk factor
710003|NCT00590499|outcome|outcome
710004|NCT00590473|Interstitial Cystitis|interstitial cystitis
710005|NCT00590473|IC|ic
710006|NCT00590473|Neuromodulation|neuromodulation
710007|NCT00590473|Interstim Therapy|interstim therapy
710008|NCT00590460|Allogeneic Stem Cell Transplant|allogeneic stem cell transplant
710009|NCT00590460|Fanconi Anemia|fanconi anemia
710010|NCT00590460|Severe Aplastic Anemia|severe aplastic anemia
710011|NCT00590460|fludarabine|fludarabine
710012|NCT00590460|campath|campath
710013|NCT00590460|anti-CD45|anti-cd45
710014|NCT00590447|1st-line therapy|1st-line therapy
710015|NCT00590447|single agent rituximab|single agent rituximab
710016|NCT00590447|CHOP|chop
710017|NCT00590447|risk stratification|risk stratification
710018|NCT00590434|CRC - Colorectal cancer|crc - colorectal cancer
710019|NCT00590434|CVA - Cerebral Vascular Accident|cva - cerebral vascular accident
710020|NCT00590434|MI - Myocardial Infarction|mi - myocardial infarction
710021|NCT00590434|CAD - Coronary Artery Disease|cad - coronary artery disease
710022|NCT00590434|DM - Diabetes Mellitus|dm - diabetes mellitus
710023|NCT00590434|PVD - Peripheral Vascular Disease|pvd - peripheral vascular disease
710024|NCT00590434|NSAIDS - Non-Steroidal Anti inflammatory Drugs|nsaids - non-steroidal anti inflammatory drugs
710025|NCT00590434|screening|screening
710026|NCT00590434|colonoscopy|colonoscopy
710027|NCT00590408|coenzyme Q10|coenzyme q10
710028|NCT00590408|statin|statin
710029|NCT00590408|myalgia|myalgia
710030|NCT00590395|Cholecystitis|cholecystitis
710031|NCT00590395|FDG PET/CT|fdg pet/ct
710032|NCT00590395|HIDA scan|hida scan
710033|NCT00590356|Device closure|device closure
710034|NCT00590304|Asthma, Children, Rural Population, Morbidity, Endotoxin|asthma, children, rural population, morbidity, endotoxin
710035|NCT00590291|Coronary Artery Disease|coronary artery disease
710036|NCT00590291|Arteriovenous Malformations|arteriovenous malformations
710037|NCT00590291|Myocardial Infarction|myocardial infarction
710038|NCT00590291|CAD|cad
710039|NCT00590291|MI|mi
710040|NCT00590291|Heart Attack|heart attack
710041|NCT00590291|AVM|avm
710042|NCT00590291|genetic|genetic
710043|NCT00590291|familial|familial
710044|NCT00590278|Tomudex|tomudex
710045|NCT00590278|inoperable rectal cancer|inoperable rectal cancer
710046|NCT00590278|recurrent rectal cancer|recurrent rectal cancer
710047|NCT00590265|bipolar type II disorder|bipolar type ii disorder
710048|NCT00590265|depression|depression
710049|NCT00590265|remission|remission
710050|NCT00590265|light-therapy|light-therapy
710051|NCT00590265|efficacy|efficacy
710052|NCT00590265|safety|safety
710053|NCT00590252|Magnetic Resonance|magnetic resonance
710054|NCT00590252|Imaging|imaging
710055|NCT00590252|Spectroscopy|spectroscopy
710056|NCT00590239|Barrett's Esophagus|barrett's esophagus
710057|NCT00590239|Neoplasia|neoplasia
710058|NCT00590239|Endoscopic mucosal resection|endoscopic mucosal resection
710059|NCT00590239|High resolution endoscopy|high resolution endoscopy
710060|NCT00590239|Chromoendoscopy|chromoendoscopy
710061|NCT00590226|type 2 diabetes|type 2 diabetes
710062|NCT00590226|inpatient hyperglycemia|inpatient hyperglycemia
710063|NCT00590226|SQ insulin|sq insulin
710064|NCT00590226|Hospitalized patients with type 2 diabetes|hospitalized patients with type 2 diabetes
710065|NCT00590213|Casodex|casodex
710066|NCT00590213|Prostate Cancer|prostate cancer
710067|NCT00590200|CAD|cad
710068|NCT00590200|Cardiovascular Disease|cardiovascular disease
710069|NCT00590200|CVD|cvd
710070|NCT00590200|MI|mi
710071|NCT00590200|Myocardial Infarction|myocardial infarction
710072|NCT00590200|Heart Attack|heart attack
710073|NCT00590200|CABG|cabg
710074|NCT00590200|Revascularization|revascularization
710075|NCT00590200|genetic|genetic
710076|NCT00590174|stent|stent
710077|NCT00590174|antiplatelet therapy|antiplatelet therapy
710078|NCT00590161|Fatty Liver|fatty liver
710079|NCT00590161|Nonalcoholic fatty liver disease (NALFD)|nonalcoholic fatty liver disease (nalfd)
710080|NCT00590161|NAFLD|nafld
710081|NCT00590161|Nonalcoholic steatohepatitis (NASH)|nonalcoholic steatohepatitis (nash)
710082|NCT00590161|NASH|nash
710083|NCT00590161|pentoxifylline|pentoxifylline
710084|NCT00590135|calcific aortic valve stenosis|calcific aortic valve stenosis
710085|NCT00590135|echocardiography, transthoracic|echocardiography, transthoracic
710086|NCT00590122|Parkinson's disease|parkinson's disease
710087|NCT00590122|"time to on"|"time to on"
710088|NCT00590122|delayed on|delayed on
710089|NCT00590109|Breast Cancer|breast cancer
710090|NCT00590109|Jewish|jewish
710091|NCT00590109|BRCA1|brca1
710092|NCT00590109|BRCA2|brca2
710093|NCT00590109|97-029|97-029
710094|NCT00590096|Neuroblastoma|neuroblastoma
710095|NCT00590096|Pheochromocytoma|pheochromocytoma
710096|NCT00590096|MIBG|mibg
710097|NCT00590083|stem cell transplantation|stem cell transplantation
710098|NCT00590083|adenovirus|adenovirus
710099|NCT00590083|Cytotoxic T-Lymphocytes|cytotoxic t-lymphocytes
710100|NCT00590083|prophylaxis|prophylaxis
710101|NCT00590070|myocardial infarction|myocardial infarction
710102|NCT00590070|no reflow|no reflow
710103|NCT00590070|primary PCI|primary pci
710104|NCT00590070|Coronary no-reflow phenomenon|coronary no-reflow phenomenon
710105|NCT00590070|primary percutaneous coronary intervention (primary PCI)|primary percutaneous coronary intervention (primary pci)
710106|NCT00590044|Diabetic ketoacidosis|diabetic ketoacidosis
710107|NCT00590044|insulin therapy|insulin therapy
710108|NCT00590044|DKA|dka
710109|NCT00590031|Esophageal Carcinoma|esophageal carcinoma
710110|NCT00590031|Cisplatin|cisplatin
710111|NCT00590031|Irinotecan|irinotecan
710112|NCT00590031|Radiation Therapy|radiation therapy
710113|NCT00590031|02-045|02-045
710114|NCT00590018|Congenital heart disease.|congenital heart disease.
710115|NCT00590018|Low cardiac output syndrome.|low cardiac output syndrome.
710116|NCT00590018|Corticosteroids.|corticosteroids.
710117|NCT00590018|Hydrocortisone.|hydrocortisone.
710708|NCT00588224|SPECT|spect
710118|NCT00590018|Blood pressure.|blood pressure.
710119|NCT00590018|Inotropes.|inotropes.
710120|NCT00590005|severe asthma|severe asthma
710121|NCT00590005|poorly controlled asthma|poorly controlled asthma
710122|NCT00589979|Osteoarthritis|osteoarthritis
710123|NCT00589979|Knee|knee
710124|NCT00589979|Lidoderm|lidoderm
710125|NCT00589979|Lidocaine|lidocaine
710126|NCT00589979|Topical patch|topical patch
710127|NCT00589979|Adjunct therapy|adjunct therapy
710128|NCT00589966|prostate cancer treatment|prostate cancer treatment
710129|NCT00589966|treatment side-effects|treatment side-effects
710130|NCT00589966|early diagnosis|early diagnosis
710131|NCT00589966|African American Men|african american men
710132|NCT00589966|coping skills training|coping skills training
710133|NCT00589966|quality of life|quality of life
710134|NCT00589966|Prostate cancer treatment side-effects|prostate cancer treatment side-effects
710135|NCT00589953|Extreme Prematurity|extreme prematurity
710136|NCT00589953|Erythropoietin|erythropoietin
710137|NCT00589953|Perinatal Brain Injury|perinatal brain injury
710138|NCT00589953|Intraventricular Hemorrhage|intraventricular hemorrhage
710139|NCT00589953|Periventricular Leukomalacia|periventricular leukomalacia
710140|NCT00589953|Neurodevelopmental Outcomes|neurodevelopmental outcomes
710141|NCT00589953|Randomized Clinical Trial|randomized clinical trial
710142|NCT00589927|stents|stents
710143|NCT00589927|cilostazol|cilostazol
710144|NCT00589914|Schizophrenia|schizophrenia
710145|NCT00589914|long-acting injectable antipsychotic medication|long-acting injectable antipsychotic medication
710146|NCT00589901|metastatic breast cancer|metastatic breast cancer
710147|NCT00589901|capecitabine|capecitabine
710148|NCT00589901|synergistic effect|synergistic effect
710149|NCT00589901|chemotherapy|chemotherapy
710150|NCT00589888|hypertension|hypertension
710151|NCT00589888|metabolic syndrome|metabolic syndrome
710152|NCT00589888|vascular reactivity|vascular reactivity
710153|NCT00589888|Elevated blood pressure|elevated blood pressure
710154|NCT00589888|lipid toxicity|lipid toxicity
710155|NCT00589875|Immunotherapy|immunotherapy
710156|NCT00589875|Cytotoxicity|cytotoxicity
710157|NCT00589875|Tumor vaccine|tumor vaccine
710158|NCT00589862|Drug Eluting Stents|drug eluting stents
710159|NCT00589862|Clopidogrel Resistance|clopidogrel resistance
710160|NCT00589862|Aspirin Resistance|aspirin resistance
710161|NCT00589849|Myocardial Infarction|myocardial infarction
710162|NCT00589849|Arrhythmia|arrhythmia
710163|NCT00589849|T-wave alternans|t-wave alternans
710164|NCT00589836|HCM|hcm
710165|NCT00589836|HOCM|hocm
710166|NCT00589836|hypertrophic cardiomyopathy|hypertrophic cardiomyopathy
710167|NCT00589836|tissue doppler echocardiography|tissue doppler echocardiography
710168|NCT00589836|myocardial torsion|myocardial torsion
710169|NCT00589823|Pain|pain
710170|NCT00589823|Cancer|cancer
710171|NCT00589823|Breakthrough|breakthrough
710172|NCT00589810|ISR|isr
710173|NCT00589810|in-stent restenosis|in-stent restenosis
710174|NCT00589810|restenosis|restenosis
710175|NCT00589810|BMS|bms
710176|NCT00589810|bare metal stent|bare metal stent
710177|NCT00589810|revascularization|revascularization
710178|NCT00589810|genetic|genetic
710179|NCT00589810|cardiac catheterization|cardiac catheterization
710180|NCT00589797|Degenerative|degenerative
710181|NCT00589797|Disc|disc
710182|NCT00589784|Sunitinib|sunitinib
710183|NCT00589784|Brain Cancer|brain cancer
710184|NCT00589784|CNS Cancer|cns cancer
710185|NCT00589784|meningioma|meningioma
710186|NCT00589784|intracranial hemangiopericytoma|intracranial hemangiopericytoma
710187|NCT00589784|hemangioblastoma|hemangioblastoma
710188|NCT00589784|malignant meningioma|malignant meningioma
710189|NCT00589784|neurofibromatosis|neurofibromatosis
710190|NCT00589784|neurofibromatosis type 1|neurofibromatosis type 1
710191|NCT00589784|neurofibromatosis type 2|neurofibromatosis type 2
710192|NCT00589784|07-135|07-135
710193|NCT00589771|IBS|ibs
710194|NCT00589771|Saccharomyces boulardii|saccharomyces boulardii
710195|NCT00589771|probiotics|probiotics
710196|NCT00589771|cytokine|cytokine
710197|NCT00589771|histology|histology
710198|NCT00589771|Efficacy|efficacy
710199|NCT00589758|Right Ventricle|right ventricle
710200|NCT00589758|Echocardiogram|echocardiogram
710201|NCT00589758|Evaluation of Heart Failure|evaluation of heart failure
710202|NCT00589745|Diagnosis|diagnosis
710203|NCT00589732|stents|stents
710204|NCT00589732|angiotensin-converting enzyme|angiotensin-converting enzyme
710205|NCT00589719|Asthma; minority; low-income; African American; Arkansas|asthma; minority; low-income; african american; arkansas
710206|NCT00589706|high grade gliomas of the brain|high grade gliomas of the brain
710207|NCT00589706|anti-body treatment|anti-body treatment
710208|NCT00589706|survival|survival
710209|NCT00589693|Ventilator-Associated Pneumonia|ventilator-associated pneumonia
710210|NCT00589693|Pneumonia, hospital-acquired|pneumonia, hospital-acquired
710211|NCT00589693|Doripenem|doripenem
710212|NCT00589693|Imipenem-cilastatin|imipenem-cilastatin
710213|NCT00589680|Acidosis, Diabetic|acidosis, diabetic
710214|NCT00589680|Diabetic Acidosis|diabetic acidosis
2774|NCT04179097|Doppler|doppler
2775|NCT04179097|Photoplethysmography|photoplethysmography
2776|NCT04179071|Famotidine|famotidine
2777|NCT04179071|Drug-drug interaction study|drug-drug interaction study
2778|NCT04179071|Small molecule kinase inhibitor|small molecule kinase inhibitor
2779|NCT04179058|Connective tissue disease|connective tissue disease
2780|NCT04179058|Interstitial lung disease|interstitial lung disease
2781|NCT04179058|Interstitial pneumonia with autoimmune features|interstitial pneumonia with autoimmune features
2782|NCT04179045|Bioresorbable Vascular Scaffold System|bioresorbable vascular scaffold system
2783|NCT04179045|Percutaneous Coronary Intervention|percutaneous coronary intervention
2784|NCT04179032|Belimumab|belimumab
2785|NCT04179032|Pediatric|pediatric
2786|NCT04179032|Pharmacokinetics|pharmacokinetics
2787|NCT04179032|Pharmacodynamics|pharmacodynamics
2788|NCT04179032|Safety|safety
2789|NCT04179032|Systemic lupus erythematosus|systemic lupus erythematosus
2793|NCT04178993|Methamphetamine|methamphetamine
2794|NCT04178993|Methylphenidate|methylphenidate
2795|NCT04178993|Duloxetine Hydrochloride|duloxetine hydrochloride
2796|NCT04178993|Central Nervous System Stimulants|central nervous system stimulants
2797|NCT04178993|Physiological Effects of Drugs|physiological effects of drugs
2798|NCT04178993|Dopamine Uptake Inhibitors|dopamine uptake inhibitors
2799|NCT04178993|Serotonin and Noradrenaline Reuptake Inhibitors|serotonin and noradrenaline reuptake inhibitors
2800|NCT04178993|Membrane Transport Modulators|membrane transport modulators
2801|NCT04178993|Neurotransmitter Agents|neurotransmitter agents
2802|NCT04178993|Dopamine Agents|dopamine agents
2803|NCT04178993|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action
2804|NCT04178993|Sensory System Agents|sensory system agents
2805|NCT04178993|Peripheral Nervous System Agents|peripheral nervous system agents
2806|NCT04178993|Vasoconstrictor Agents|vasoconstrictor agents
2807|NCT04178993|Antidepressive Agents|antidepressive agents
2808|NCT04178993|Psychotropic Drugs|psychotropic drugs
2809|NCT04178967|Eczema|eczema
2810|NCT04178967|Dermatitis|dermatitis
2811|NCT04178967|Dermatitis, Atopic|dermatitis, atopic
2812|NCT04178967|Skin Diseases|skin diseases
2814|NCT04178902|Multiple Myeloma (MM)|multiple myeloma (mm)
2829|NCT04178785|remifentanil|remifentanil
2830|NCT04178785|fentanyl|fentanyl
2831|NCT04178785|hysterectomy|hysterectomy
2832|NCT04178759|Liver metastases|liver metastases
2833|NCT04178759|Liver regeneration|liver regeneration
2834|NCT04178759|Markers|markers
2835|NCT04178746|intraventricular hemorrhage|intraventricular hemorrhage
3025|NCT04177732|Cross-linked N-telopeptides|cross-linked n-telopeptides
3026|NCT04177706|Ketamine|ketamine
3027|NCT04177654|parasitology|parasitology
3028|NCT04177654|helminth infections|helminth infections
3029|NCT04177654|Ascaris|ascaris
3030|NCT04177654|Trichuris|trichuris
3031|NCT04177654|hookworm|hookworm
3032|NCT04177654|qPCR|qpcr
3033|NCT04177654|microscopy|microscopy
3034|NCT04177654|drug resistance|drug resistance
3121|NCT04177303|Incretin hormones|incretin hormones
3122|NCT04177303|Inflammation|inflammation
3123|NCT04177303|Microbiome|microbiome
3124|NCT04177277|Dialysis|dialysis
3223|NCT04176692|muscle stiffness|muscle stiffness
3224|NCT04176692|scapulohumeral rhythm|scapulohumeral rhythm
3225|NCT04176692|electromyography|electromyography
3226|NCT04176679|Women|women
3228|NCT04176679|color doppler ultrasound|color doppler ultrasound
3318|NCT04176172|Managed Problem Solving|managed problem solving
3319|NCT04176159|Developmental Coordination Disorder|developmental coordination disorder
3320|NCT04176159|Task-Oriented Training|task-oriented training
3321|NCT04176159|Motor Imagery|motor imagery
3322|NCT04176159|Physical Therapy|physical therapy
3323|NCT04176133|Vaccination|vaccination
3324|NCT04176133|Geriatric|geriatric
3325|NCT04176133|Immunology|immunology
3326|NCT04176133|Influenza|influenza
3327|NCT04176107|Cesarean delivery|cesarean delivery
3328|NCT04176107|Anxiety|anxiety
3329|NCT04176107|Informative-video|informative-video
3330|NCT04176094|health service and systems research|health service and systems research
3331|NCT04176094|population health|population health
3332|NCT04176081|Intraductal carcinoma|intraductal carcinoma
3333|NCT04176081|SChLAP1|schlap1
3360|NCT04175899|Safety|safety
3425|NCT04175626|Drug eluting coronary stents|drug eluting coronary stents
3426|NCT04175626|Sirolimus|sirolimus
3427|NCT04175626|Bioabsorbable polymer|bioabsorbable polymer
3428|NCT04175626|DES|des
3429|NCT04175613|Plaque Psoriasis|plaque psoriasis
3430|NCT04175613|CC-10004|cc-10004
3431|NCT04175613|Apremilast|apremilast
3432|NCT04175613|Pediatric|pediatric
3433|NCT04175613|Age 6 - 17 years|age 6 - 17 years
3440|NCT04175561|Green prescription|green prescription
3518|NCT04174989|Gastrointestinal Hemorrhage|gastrointestinal hemorrhage
3519|NCT04174989|Gastrointestinal Bleeding|gastrointestinal bleeding
3520|NCT04174989|Acute Upper Gastrointestinal Bleeding|acute upper gastrointestinal bleeding
3521|NCT04174989|Plasminogen-Depleted Plasma|plasminogen-depleted plasma
3522|NCT04174989|Plasma Transfusion|plasma transfusion
3523|NCT04174950|Laryngeal cancer|laryngeal cancer
3611|NCT04174417|tissue hypoxia|tissue hypoxia
3612|NCT04174404|Pediatric Surgery Care|pediatric surgery care
3613|NCT04174404|Circumcision|circumcision
3712|NCT04173741|Ultrasound|ultrasound
3816|NCT04173104|Brain cancer|brain cancer
3817|NCT04173104|18FPARPi|18fparpi
3818|NCT04173104|PET scan|pet scan
3819|NCT04173104|MRI|mri
3820|NCT04173104|Memorial Sloan Kettering Cancer Center|memorial sloan kettering cancer center
3821|NCT04173104|19-311|19-311
3822|NCT04173091|tricuspid regurgitation, tricuspid valve, percutaneous treatment, right ventricle|tricuspid regurgitation, tricuspid valve, percutaneous treatment, right ventricle
3823|NCT04173078|distress intolerance|distress intolerance
3824|NCT04173078|stress|stress
3825|NCT04173052|Infertility|infertility
3843|NCT04172831|Pain|pain
3911|NCT04172350|perioperative care|perioperative care
3912|NCT04172350|self-efficacy|self-efficacy
3913|NCT04172350|randomised controlled trial|randomised controlled trial
3914|NCT04172337|nutrition|nutrition
3915|NCT04172337|front-of-pack label|front-of-pack label
3916|NCT04172337|calories|calories
3917|NCT04172337|online grocery store|online grocery store
3918|NCT04172337|Singapore|singapore
3919|NCT04172337|physical activity equivalent|physical activity equivalent
3920|NCT04172324|gait|gait
3921|NCT04172324|biomechanics|biomechanics
3922|NCT04172298|Meridian|meridian
3923|NCT04172298|Internal visceral organs|internal visceral organs
3924|NCT04172298|Zusanli|zusanli
3925|NCT04172298|Shaohai|shaohai
3926|NCT04172298|Acupoint|acupoint
3928|NCT04172272|Laparotomy|laparotomy
4004|NCT04171921|Robotic ventral hernia repair|robotic ventral hernia repair
4005|NCT04171921|Surgical site complications|surgical site complications
4006|NCT04171921|Esthetic satisfaction|esthetic satisfaction
4007|NCT04171921|Pain|pain
4009|NCT04171921|Costs|costs
4109|NCT04171661|Skin Substitute|skin substitute
4110|NCT04171648|diet management|diet management
4111|NCT04171648|weight management|weight management
4112|NCT04171635|Quantitative Susceptibility Mapping|quantitative susceptibility mapping
4113|NCT04171635|Iron chelating therapy|iron chelating therapy
4114|NCT04171635|Iron overload|iron overload
4205|NCT04170933|Magnetic recanalization|magnetic recanalization
4206|NCT04170933|Biliary Anastomotic Stricture|biliary anastomotic stricture
4207|NCT04170933|Biliary Tract Diseases|biliary tract diseases
4208|NCT04170933|Cholestasis, Extrahepatic|cholestasis, extrahepatic
4209|NCT04170920|breast cancer|breast cancer
4402|NCT04169750|Rehabilitation|rehabilitation
4403|NCT04169750|Cognitive impairment|cognitive impairment
4404|NCT04169750|Exergames|exergames
4405|NCT04169750|Neuroplasticity|neuroplasticity
4406|NCT04169750|Clinical Trial|clinical trial
4407|NCT04169698|Denosumab|denosumab
4408|NCT04169698|Alendronate|alendronate
4409|NCT04169698|Osteoporosis|osteoporosis
4505|NCT04169061|Severe or recalcitrant keratitis|severe or recalcitrant keratitis
4506|NCT04169022|AML|aml
4507|NCT04169022|Chimeric Antigen Receptor T Cells|chimeric antigen receptor t cells
4508|NCT04169022|Immunotherapy|immunotherapy
4509|NCT04169009|immunology|immunology
4510|NCT04168944|Hepatocellular Carcinoma|hepatocellular carcinoma
4512|NCT04168931|gastric cancer|gastric cancer
4605|NCT04168385|ALGS|algs
4606|NCT04168385|Maralixibat|maralixibat
4607|NCT04168385|Bile Duct Diseases|bile duct diseases
4608|NCT04168385|Liver Diseases|liver diseases
4609|NCT04168385|Biliary Tract Diseases|biliary tract diseases
4611|NCT04168385|Pediatric|pediatric
4705|NCT04167787|Surgery|surgery
4706|NCT04167774|Immune Checkpoint Inhibitor|immune checkpoint inhibitor
4707|NCT04167774|nb-Paclitaxel|nb-paclitaxel
4708|NCT04167761|Epicardial Adipose Tissue|epicardial adipose tissue
4709|NCT04167761|SGLT2 Inhibitor|sglt2 inhibitor
4710|NCT04167722|Prostate Cancer|prostate cancer
4711|NCT04167722|Obesity|obesity
4712|NCT04167722|Exosomes|exosomes
4806|NCT04167332|Biomarker|biomarker
4807|NCT04167332|Multi-omics|multi-omics
4808|NCT04167319|CIPN|cipn
4809|NCT04167319|QST|qst
4810|NCT04167293|Hepatocellular carcinoma|hepatocellular carcinoma
4811|NCT04167293|immunotherapy|immunotherapy
4906|NCT04166630|Muscular disorders|muscular disorders
4907|NCT04166630|Neuromuscular disorders|neuromuscular disorders
4908|NCT04166630|Rehabilitation|rehabilitation
4909|NCT04166604|trifluridine/ tipiracil|trifluridine/ tipiracil
5203|NCT04165226|Low level light therapy|low level light therapy
5204|NCT04165226|Striae atrophicae|striae atrophicae
5404|NCT04164134|Secondary primary malignancies|secondary primary malignancies
5405|NCT04164134|SPM|spm
5406|NCT04164121|Tolerance|tolerance
5407|NCT04164121|Safety|safety
5410|NCT04164043|Recreation Therapy|recreation therapy
5506|NCT04163666|Therapeutic cognitive exercise|therapeutic cognitive exercise
5507|NCT04163666|Perfetti|perfetti
5519|NCT04163588|diuretics|diuretics
5705|NCT04162522|MDD|mdd
5905|NCT04161456|Acne conglobata|acne conglobata
5906|NCT04161456|Phosphodiesterase (PDE)-Inhibitor|phosphodiesterase (pde)-inhibitor
5907|NCT04161443|MET, Quadratus lumborum, Sacroilliac joint|met, quadratus lumborum, sacroilliac joint
5908|NCT04161430|DBPR108|dbpr108
5909|NCT04161430|Type 2 diabetes mellitus|type 2 diabetes mellitus
5910|NCT04161430|DPP4 inhibitor|dpp4 inhibitor
5911|NCT04161404|Pharmacometabolomic|pharmacometabolomic
5912|NCT04161404|Metformin|metformin
5913|NCT04161404|Andrographis paniculata|andrographis paniculata
5914|NCT04161404|Metabolomics|metabolomics
5915|NCT04161404|Phase 1|phase 1
5916|NCT04161404|Healthy volunteers|healthy volunteers
5917|NCT04161404|Herbal Medicine|herbal medicine
5936|NCT04161365|Urethral Stricture|urethral stricture
5937|NCT04161365|Fat Graft|fat graft
5938|NCT04161365|Direct Visual Urethrotomy|direct visual urethrotomy
5940|NCT04161313|exercise capacity|exercise capacity
6007|NCT04160871|program|program
6110|NCT04160221|Medical Abortion|medical abortion
6111|NCT04160221|Mifepristone|mifepristone
6112|NCT04160221|Misoprostol|misoprostol
6113|NCT04160208|male infertility|male infertility
6114|NCT04160208|DNA fragmentation Index|dna fragmentation index
6115|NCT04160208|DFI|dfi
6121|NCT04160182|Breast cancer|breast cancer
6122|NCT04160182|fatigue|fatigue
6123|NCT04160182|Intervention|intervention
6124|NCT04160169|Counseling|counseling
6405|NCT04158141|Mesothelioma|mesothelioma
6696|NCT04156256|Hematologic Malignancies|hematologic malignancies
6697|NCT04156243|CD19|cd19
6698|NCT04156243|CD19 CAR T cell|cd19 car t cell
6699|NCT04156230|Positron-Emission Tomography|positron-emission tomography
7106|NCT04153994|Erector Spinae Plane Blockade|erector spinae plane blockade
7107|NCT04153994|Pediatric Scoliosis|pediatric scoliosis
7108|NCT04153955|Mobilization|mobilization
7205|NCT04153461|NEPHROLITHOTOMY|nephrolithotomy
7206|NCT04153461|MINIPERC|miniperc
7207|NCT04153461|MINI-PERC|mini-perc
7208|NCT04153461|BLOOD LOSS|blood loss
7209|NCT04153461|NEPHROSTOMY SIZE|nephrostomy size
7210|NCT04153448|Bronchiectasis|bronchiectasis
7211|NCT04153448|Exercise capacity|exercise capacity
7212|NCT04153448|Six-minute walk test|six-minute walk test
7213|NCT04153448|Sit-to-stand test|sit-to-stand test
7214|NCT04153422|Small Fiber Neuropathy|small fiber neuropathy
7215|NCT04153422|Neuropathy|neuropathy
7217|NCT04153422|IVIG|ivig
7310|NCT04153136|HIV|hiv
7311|NCT04153136|Sacubitril/valsartan|sacubitril/valsartan
7312|NCT04153136|Heart Failure with Preserved Ejection Fraction|heart failure with preserved ejection fraction
7313|NCT04153136|Aldosterone|aldosterone
7317|NCT04153123|ocular flow|ocular flow
7598|NCT04151225|Crohns Disease|crohns disease
7599|NCT04151225|Oncostatin M|oncostatin m
7600|NCT04151225|GSK2330811|gsk2330811
7900|NCT04149301|musculoskeletal modelling|musculoskeletal modelling
7901|NCT04149301|gait analysis|gait analysis
7940|NCT04149106|SMC|smc
8163|NCT04147598|UC|uc
8510|NCT04145219|pediatric|pediatric
8511|NCT04145206|ankle|ankle
8512|NCT04145206|dance|dance
8513|NCT04145193|Microsatellite stable|microsatellite stable
8514|NCT04145193|Colon Cancer|colon cancer
8747|NCT04143503|ICU|icu
8911|NCT04142684|Phrenic Nerve|phrenic nerve
8912|NCT04142645|Medication Reconciliation|medication reconciliation
8913|NCT04142645|Aged|aged
8918|NCT04142593|Metabolic Syndrome（MetS）|metabolic syndrome（mets）
8919|NCT04142593|Classification|classification
9012|NCT04142164|Informed Consent Process|informed consent process
9013|NCT04142151|Ischemic stroke, Sanchitongshu, Aspirin, Clopidogrel|ischemic stroke, sanchitongshu, aspirin, clopidogrel
9014|NCT04142138|inpatient|inpatient
9600|NCT04138628|biomarkers|biomarkers
9601|NCT04138628|ctDNA|ctdna
9602|NCT04138628|immunotherapy|immunotherapy
9603|NCT04138628|circulating tumor DNA|circulating tumor dna
9604|NCT04138628|liquid biopsies|liquid biopsies
9605|NCT04138602|Fecal smearing|fecal smearing
9606|NCT04138602|Incomplete defecation|incomplete defecation
9607|NCT04138602|Fecal urgency|fecal urgency
9613|NCT04138563|Exercise|exercise
9701|NCT04138108|Stress|stress
9800|NCT04137536|bispecific antibody-armed activated T cells|bispecific antibody-armed activated t cells
9801|NCT04137536|Pancreatic cancer|pancreatic cancer
9803|NCT04137536|18-463|18-463
9897|NCT04136964|Questionnaire|questionnaire
9898|NCT04136964|Validity|validity
9899|NCT04136964|Reliability|reliability
9900|NCT04136964|Patient-reported outcome measures|patient-reported outcome measures
9901|NCT04136951|home health|home health
9999|NCT04136470|Atezolizumab|atezolizumab
10000|NCT04136470|Stool|stool
10001|NCT04136470|FFPE|ffpe
10002|NCT04136470|PBMC|pbmc
10003|NCT04136470|Intestinal microbiota|intestinal microbiota
10004|NCT04136470|Immuno-Oncology|immuno-oncology
10005|NCT04136444|Padsevonil|padsevonil
10006|NCT04136444|Phase 1|phase 1
10007|NCT04136444|Pharmacokinetic|pharmacokinetic
10008|NCT04136444|PSL|psl
10009|NCT04136379|Warfarin therapy|warfarin therapy
10010|NCT04136379|INR monitoring|inr monitoring
10296|NCT04134598|Health Related Quality of Life|health related quality of life
10297|NCT04134598|Patients Reported Outcome Measures|patients reported outcome measures
10497|NCT04133285|Genotype-Phenotype Correlation|genotype-phenotype correlation
10498|NCT04133285|Multiple Exostoses|multiple exostoses
10499|NCT04133272|Disease Registry|disease registry
10599|NCT04132752|rehabilitation|rehabilitation
10600|NCT04132752|parents|parents
10611|NCT04132648|CKD|ckd
10709|NCT04131855|pumice|pumice
10801|NCT04131140|Brain Death|brain death
10802|NCT04131140|Organ Donation|organ donation
10803|NCT04131140|Critical Illness|critical illness
10804|NCT04131140|Intensive Care Units|intensive care units
10846|NCT04130802|Pain|pain
11000|NCT04129528|T1DM|t1dm
11001|NCT04129515|Melanoma Brain Metastasis|melanoma brain metastasis
11002|NCT04129515|Metastatic Melanoma|metastatic melanoma
11003|NCT04129502|Drug Therapy|drug therapy
11004|NCT04129463|Buphthalmous|buphthalmous
11005|NCT04129463|Iris incarceration|iris incarceration
11193|NCT04128410|S-flurbiprofen, R-flurbiprofen|s-flurbiprofen, r-flurbiprofen
11194|NCT04128410|cerebrospinal fluid|cerebrospinal fluid
11195|NCT04128410|aged|aged
11395|NCT04127097|fear|fear
11396|NCT04127097|nursing|nursing
11397|NCT04127084|Type 2 diabetes|type 2 diabetes
11398|NCT04127084|Diabetic Nephropathy|diabetic nephropathy
11417|NCT04126967|NGS|ngs
11616|NCT04125784|HIV|hiv
11697|NCT04125329|Human umbilical cord mesenchymal stem cells|human umbilical cord mesenchymal stem cells
11698|NCT04125329|Diabetic nephropathy|diabetic nephropathy
11888|NCT04124068|Teeth whitening|teeth whitening
11889|NCT04124068|Teeth bleaching|teeth bleaching
11890|NCT04124068|Tooth discoloration|tooth discoloration
11891|NCT04124042|Inflammation|inflammation
11892|NCT04124042|Pain|pain
11893|NCT04124042|Interleukin|interleukin
11894|NCT04124042|Gene Therapy|gene therapy
11989|NCT04123535|Focused Ultrasound|focused ultrasound
11990|NCT04123535|Sarcoma|sarcoma
11991|NCT04123496|cognition|cognition
11992|NCT04123496|adult|adult
11993|NCT04123496|prefrontal cortex|prefrontal cortex
11994|NCT04123496|Transcranial Magnetic Stimulation|transcranial magnetic stimulation
11995|NCT04123496|Stress, Psychological|stress, psychological
12088|NCT04122872|Sarcoma of Bone|sarcoma of bone
12089|NCT04122872|Registry|registry
12090|NCT04122859|Pediatrics|pediatrics
12091|NCT04122833|next generation sequencing|next generation sequencing
12092|NCT04122820|Specific Learning Disorder|specific learning disorder
12093|NCT04122820|Developmental Coordination Disorder|developmental coordination disorder
12095|NCT04122820|Dyslexia, Developmental|dyslexia, developmental
12184|NCT04122417|maternal attachment|maternal attachment
12185|NCT04122417|preterm baby|preterm baby
12186|NCT04122404|Point-of-care systems|point-of-care systems
12188|NCT04122404|Biomarkers/Urin|biomarkers/urin
12291|NCT04121780|TBI|tbi
13086|NCT04117360|Orthognathic Surgery|orthognathic surgery
13090|NCT04117334|Bracing|bracing
13093|NCT04117321|Mommy|mommy
13478|NCT04114799|fluid responsiveness|fluid responsiveness
13479|NCT04114799|haemodynamical monitoring|haemodynamical monitoring
13480|NCT04114799|ClearSight|clearsight
13598|NCT04114162|ICU|icu
14176|NCT04110353|Prophylactic therapy|prophylactic therapy
14177|NCT04110327|MicroStent|microstent
14178|NCT04110327|Below the Knee|below the knee
14179|NCT04110327|CLI|cli
14197|NCT04110223|NGS|ngs
14374|NCT04109105|Anastomotic leak|anastomotic leak
14375|NCT04109105|Collagen|collagen
14376|NCT04109105|Polyethylene glycol|polyethylene glycol
14377|NCT04109105|Hemopatch|hemopatch
14378|NCT04109092|E7766|e7766
14379|NCT04109092|Non-Muscle Invasive Bladder Cancer|non-muscle invasive bladder cancer
14380|NCT04109092|Intravesical administration|intravesical administration
14381|NCT04109092|Ta or T1 Papillary Disease|ta or t1 papillary disease
14471|NCT04108559|Pain|pain
14870|NCT04106219|aurora kinase A inhibitor|aurora kinase a inhibitor
14871|NCT04106219|kinase inhibitor|kinase inhibitor
14872|NCT04106219|AURKA|aurka
14873|NCT04106219|AurA|aura
15368|NCT04102592|Permethrin|permethrin
15369|NCT04102592|Rapid diagnostic test|rapid diagnostic test
15370|NCT04102566|postoperative pain|postoperative pain
15371|NCT04102566|Transurethral resection of the prostate|transurethral resection of the prostate
15372|NCT04102566|Multimodal pain control|multimodal pain control
15373|NCT04102540|Information Visualization|information visualization
15659|NCT04100356|Triglycerides (TG)|triglycerides (tg)
15660|NCT04100356|Lipids|lipids
15661|NCT04100356|Glucose tolerance (GT)|glucose tolerance (gt)
15662|NCT04100356|Insulin resistance (IR)|insulin resistance (ir)
15758|NCT04099784|Fresh transfer, freeze-only, ASQ-3, health of children|fresh transfer, freeze-only, asq-3, health of children
15759|NCT04099745|FGM|fgm
15760|NCT04099745|CGM|cgm
15761|NCT04099706|Chronic pain|chronic pain
15860|NCT04099303|Whooping Cough|whooping cough
15861|NCT04099290|Squamous Cell Carcinoma|squamous cell carcinoma
15862|NCT04099290|Circulating Tumor DNA|circulating tumor dna
15863|NCT04099277|immunotherapy|immunotherapy
15864|NCT04099277|CD226 agonist|cd226 agonist
15865|NCT04099264|personalized musical intervention|personalized musical intervention
15866|NCT04099264|quasi-experimental study|quasi-experimental study
15867|NCT04099264|dissatisfaction|dissatisfaction
15868|NCT04099264|anxiety|anxiety
15869|NCT04099264|surgical pain|surgical pain
15870|NCT04099264|burden of care|burden of care
15877|NCT04099212|RESORCINOL|resorcinol
15878|NCT04099212|HIDRADENITIS SUPPURATIVA|hidradenitis suppurativa
15879|NCT04099173|mindfulness|mindfulness
15880|NCT04099173|suicide related behavior|suicide related behavior
15881|NCT04099173|Veterans|veterans
15884|NCT04099160|reliability|reliability
16055|NCT04098055|Foot Orthoses|foot orthoses
16056|NCT04098055|Foot|foot
16057|NCT04098055|Pain|pain
16058|NCT04098042|Bioresorbable scaffolds|bioresorbable scaffolds
16059|NCT04098042|Magnesium made bioresorbable scaffolds|magnesium made bioresorbable scaffolds
16060|NCT04098042|Magmaris|magmaris
16061|NCT04098042|coronary artery disease|coronary artery disease
16062|NCT04098042|Percutaneous coronary intervention|percutaneous coronary intervention
16063|NCT04098042|Myocardia infarction|myocardia infarction
16064|NCT04098042|multivessel coronary disease|multivessel coronary disease
16283|NCT04096443|FMT|fmt
16547|NCT04094922|Posttraumatic Stress|posttraumatic stress
16548|NCT04094909|rh-endostatin, Pembrolizumab, EGFR, ALK and NSCLC|rh-endostatin, pembrolizumab, egfr, alk and nsclc
17038|NCT04091841|Vertebral fusion|vertebral fusion
17039|NCT04091841|Enhanced recovery after surgery|enhanced recovery after surgery
17040|NCT04091841|Infection|infection
17041|NCT04091841|Wound healing|wound healing
17042|NCT04091841|Pain|pain
17043|NCT04091815|Enhanced recovery|enhanced recovery
17044|NCT04091815|Multimodal analgesia|multimodal analgesia
17045|NCT04091815|Quality of life|quality of life
17136|NCT04091204|platinum sensitive|platinum sensitive
17137|NCT04091204|recurrent ovarian cancer|recurrent ovarian cancer
17138|NCT04091204|olaparib|olaparib
17139|NCT04091204|maintenance treatment|maintenance treatment
17140|NCT04091165|food diary|food diary
17143|NCT04091152|elderly|elderly
17239|NCT04090515|Eating|eating
17240|NCT04090515|Physical Activity|physical activity
17241|NCT04090515|Exercise|exercise
17242|NCT04090502|pain|pain
17642|NCT04087915|Treatment for high cholesterol|treatment for high cholesterol
17643|NCT04087915|Lowering cholesterol|lowering cholesterol
17644|NCT04087915|Lowering high cholesterol|lowering high cholesterol
17736|NCT04087330|Whole body vibration|whole body vibration
17737|NCT04087291|chronic|chronic
17738|NCT04087291|pain management|pain management
17839|NCT04086641|Prosthetic foot|prosthetic foot
17840|NCT04086641|Crossover foot|crossover foot
17841|NCT04086641|Biomechanics|biomechanics
18131|NCT04084496|pancreatic cancer|pancreatic cancer
18359|NCT04083222|AGT|agt
18524|NCT04082052|self-compassion|self-compassion
18525|NCT04082052|symptom level|symptom level
18526|NCT04082052|single session|single session
18527|NCT04081987|Arterial line|arterial line
18529|NCT04081987|Vital signs|vital signs
18731|NCT04080466|Hip|hip
19421|NCT04076449|Cerebral Cavernous Malformation|cerebral cavernous malformation
19422|NCT04076449|Epilepsy|epilepsy
19482|NCT04076176|PKU|pku
19523|NCT04075929|physiological adaptions|physiological adaptions
19719|NCT04074603|Needle-free jet injection|needle-free jet injection
19720|NCT04074603|Insulin glargine|insulin glargine
19721|NCT04074590|ulcerative colitis, efficacy, safety|ulcerative colitis, efficacy, safety
19722|NCT04074564|MASCT-I|masct-i
19918|NCT04073069|Diprospan|diprospan
19922|NCT04073043|Support|support
20017|NCT04072341|Inflammation|inflammation
20018|NCT04072341|Propolis|propolis
20019|NCT04072341|High-sensitivity C-reactive protein|high-sensitivity c-reactive protein
20020|NCT04072341|Hemodialysis|hemodialysis
20113|NCT04071600|anxiety|anxiety
20114|NCT04071587|BCI|bci
20115|NCT04071587|upper limb|upper limb
20116|NCT04071587|severe paresis|severe paresis
20117|NCT04071587|subacute stroke|subacute stroke
20118|NCT04071587|rehabilitation|rehabilitation
20119|NCT04071574|Infertility; Ovarian; Ovulation; IVF; ICSI; Gonadotropin|infertility; ovarian; ovulation; ivf; icsi; gonadotropin
20209|NCT04071015|non-invasive monitoring|non-invasive monitoring
20210|NCT04071002|Distal radius fracture|distal radius fracture
20211|NCT04071002|functional status|functional status
20212|NCT04071002|activity participation|activity participation
20213|NCT04071002|hand therapy|hand therapy
20214|NCT04070976|hypofractionated radiotherapy|hypofractionated radiotherapy
20215|NCT04070976|Brachytherapy|brachytherapy
20217|NCT04070963|HbA1C|hba1c
20413|NCT04069767|Stroke|stroke
20712|NCT04067921|Nutritional Genomics|nutritional genomics
20713|NCT04067921|Polymorphisms|polymorphisms
20714|NCT04067908|Biological markers|biological markers
20715|NCT04067895|human bone graft screw|human bone graft screw
20716|NCT04067895|epiphysiodesis|epiphysiodesis
20717|NCT04067895|leg length inequality|leg length inequality
20718|NCT04067895|primordial gigantism|primordial gigantism
20724|NCT04067817|elderly|elderly
21110|NCT04065516|Argon Plasma Coagulation|argon plasma coagulation
21111|NCT04065516|Peroral Endoscopic Myotomy|peroral endoscopic myotomy
21112|NCT04065503|probiotic|probiotic
21113|NCT04065503|gut transit time|gut transit time
21114|NCT04065490|Dry age-related macular degeneration|dry age-related macular degeneration
21115|NCT04065490|Photobiomodulation|photobiomodulation
21116|NCT04065490|Visual Acuity|visual acuity
21118|NCT04065490|Drusen|drusen
21533|NCT04063085|gel|gel
21623|NCT04062383|ACS|acs
21916|NCT04060381|Infants|infants
22200|NCT04058639|Time|time
22201|NCT04058639|Relief|relief
22202|NCT04058626|Peripheral Vascular Diseases|peripheral vascular diseases
22203|NCT04058626|Diabetic Foot|diabetic foot
22305|NCT04058015|admission hyperglycemia|admission hyperglycemia
22306|NCT04058015|stress-induced hyperglycemia|stress-induced hyperglycemia
22307|NCT04058015|diabetic hyperglycemia|diabetic hyperglycemia
22308|NCT04058015|diabetes mellitus|diabetes mellitus
22309|NCT04058015|thoracoabdominal trauma|thoracoabdominal trauma
22310|NCT04058015|mortality|mortality
22400|NCT04057534|Executive Control|executive control
22401|NCT04057534|Chess|chess
22402|NCT04057534|fMRI|fmri
22403|NCT04057521|care coordination|care coordination
22404|NCT04057521|Children|children
22405|NCT04057521|Young adults|young adults
22406|NCT04057521|Chronic disease|chronic disease
22499|NCT04056923|Computed Tomography|computed tomography
22500|NCT04056923|Three-Dimensional Printing|three-dimensional printing
22503|NCT04056871|frailty|frailty
22594|NCT04056299|CODIT™ (characterized oral desensitization immunotherapy™)|codit™ (characterized oral desensitization immunotherapy™)
22595|NCT04056299|Hen Egg Allergic Children|hen egg allergic children
22695|NCT04055454|Prevention|prevention
22696|NCT04055454|Vaccine|vaccine
22697|NCT04055454|Phase 1|phase 1
22698|NCT04055454|Lassa Fever|lassa fever
22704|NCT04055402|Alcohol|alcohol
22792|NCT04055012|Metformin|metformin
22793|NCT04055012|Placebo|placebo
22794|NCT04054999|hydroxocobalamin|hydroxocobalamin
22795|NCT04054999|methylene blue|methylene blue
22796|NCT04054986|Breast Cancer|breast cancer
22797|NCT04054986|18F-Var3|18f-var3
22798|NCT04054986|First in human|first in human
22799|NCT04054986|Acidosis imaging|acidosis imaging
22801|NCT04054986|19-147|19-147
23092|NCT04053491|Brachial Plexus Block|brachial plexus block
23100|NCT04053439|Clonal Hematopoiesis of Indeterminate Significance|clonal hematopoiesis of indeterminate significance
23101|NCT04053439|Chemotherapy|chemotherapy
23102|NCT04053439|Lymphoma|lymphoma
23103|NCT04053439|Chemotherapy complications|chemotherapy complications
23104|NCT04053426|RASS|rass
23105|NCT04053426|CAM-ICU|cam-icu
23106|NCT04053387|Tapinarof|tapinarof
23107|NCT04053387|plaque psoriasis,|plaque psoriasis,
23108|NCT04053387|adult|adult
23126|NCT04053270|EPP|epp
23187|NCT04052906|self-efficacy|self-efficacy
23188|NCT04052906|self-care|self-care
23189|NCT04052893|Surgery|surgery
23246|NCT04052581|TIF|tif
23286|NCT04052256|Computational fluid dynamics|computational fluid dynamics
23287|NCT04052256|Plaque characteristics|plaque characteristics
23288|NCT04052230|diaphragm|diaphragm
23289|NCT04052230|ECMO|ecmo
23290|NCT04052230|ICU|icu
23291|NCT04052178|Oropharyngeal dysphagia|oropharyngeal dysphagia
23387|NCT04051515|Exercise|exercise
23687|NCT04049890|adjustment|adjustment
23688|NCT04049890|family functioning|family functioning
23689|NCT04049890|chronic disease|chronic disease
23690|NCT04049890|emotions|emotions
23691|NCT04049864|neuroblastoma|neuroblastoma
23692|NCT04049864|DNA vaccine|dna vaccine
24276|NCT04046770|nurses|nurses
24574|NCT04045041|Cognitive behaviour therapy|cognitive behaviour therapy
24575|NCT04045041|Acceptance and commitment therapy|acceptance and commitment therapy
24576|NCT04045041|Pain|pain
24577|NCT04045041|Internet-based|internet-based
24578|NCT04045041|Vulvodynia|vulvodynia
24579|NCT04045002|'MyPinkMom' educational intervention|'mypinkmom' educational intervention
24580|NCT04045002|haemoglobin level|haemoglobin level
24586|NCT04044989|LED|led
24674|NCT04044430|Microsatellite Status (MSS)|microsatellite status (mss)
24675|NCT04044417|periodontitis|periodontitis
24676|NCT04044417|curcumin|curcumin
24677|NCT04044417|simvastatin|simvastatin
24678|NCT04044417|EDTA|edta
24679|NCT04044404|Ultrasound Elastography|ultrasound elastography
24969|NCT04042779|Cognitive training|cognitive training
24970|NCT04042779|Long-term WM capacity|long-term wm capacity
24971|NCT04042779|near transfer effects of the training|near transfer effects of the training
24972|NCT04042779|far transfer effects of the training|far transfer effects of the training
24973|NCT04042753|Pituitary tumor|pituitary tumor
24974|NCT04042753|Nivolumab|nivolumab
24975|NCT04042753|Ipilimumab|ipilimumab
24976|NCT04042753|19-216|19-216
25107|NCT04042064|CGA|cga
25300|NCT04041050|cancer|cancer
25781|NCT04038567|adults|adults
25976|NCT04037293|Atherosclerosis|atherosclerosis
25977|NCT04037293|carotid intima media thickness|carotid intima media thickness
26449|NCT04034459|AIO|aio
26471|NCT04034355|peripheral neuropathy|peripheral neuropathy
26472|NCT04034355|neuropathy|neuropathy
26473|NCT04034342|RaceRunning;|racerunning;
26474|NCT04034342|cardiometabolic health desease risk|cardiometabolic health desease risk
26475|NCT04034342|functional mobility|functional mobility
26476|NCT04034329|ASVAL|asval
26477|NCT04034329|EVLA|evla
26478|NCT04034329|GSV|gsv
26479|NCT04034329|Long-term efficacy|long-term efficacy
26480|NCT04034316|Mesenchymal Stromal Cells|mesenchymal stromal cells
26481|NCT04034316|Steroid Dependent Nephrotic Syndrome in Children|steroid dependent nephrotic syndrome in children
26764|NCT04032704|NSCLC-squamous|nsclc-squamous
26765|NCT04032704|NSCLC-nonsquamous|nsclc-nonsquamous
26766|NCT04032704|HNSCC|hnscc
26767|NCT04032704|GEJ adenocarcinoma|gej adenocarcinoma
26768|NCT04032678|Cardioversion|cardioversion
26769|NCT04032678|Cardiac Arrythmias|cardiac arrythmias
26864|NCT04032275|histological examination|histological examination
26865|NCT04032262|Brain-Gut Relationship|brain-gut relationship
26866|NCT04032262|Anorectal Manometry|anorectal manometry
26867|NCT04032249|Obesity|obesity
26868|NCT04032249|Self-weighing|self-weighing
26869|NCT04032249|Weight loss|weight loss
26962|NCT04031651|Safety monitoring|safety monitoring
26963|NCT04031638|Thyroid cancer, Iodine treatment|thyroid cancer, iodine treatment
27258|NCT04029571|Traditional Chinese medicine|traditional chinese medicine
27259|NCT04029558|Immune response|immune response
27260|NCT04029558|Plant extracts|plant extracts
27261|NCT04029558|Dietary supplement|dietary supplement
27547|NCT04027686|Laser Therapy|laser therapy
27647|NCT04026880|Menopause|menopause
27648|NCT04026880|Urinary Incontinence|urinary incontinence
27649|NCT04026880|Pelvic Floor Muscles|pelvic floor muscles
27651|NCT04026841|ground-glass nodule|ground-glass nodule
27683|NCT04026607|Muscle|muscle
27791|NCT04026087|DSA|dsa
27840|NCT04025749|Computerized Therapy|computerized therapy
27841|NCT04025749|Quality of Life|quality of life
27842|NCT04025749|Neuroimaging|neuroimaging
27843|NCT04025749|Participation|participation
27844|NCT04025736|Tranexamic Acid|tranexamic acid
27845|NCT04025736|Shoulder Arthroscopy|shoulder arthroscopy
27846|NCT04025736|Visual Clarity|visual clarity
27847|NCT04025736|Hemostasis|hemostasis
27849|NCT04025671|naloxone|naloxone
27968|NCT04025060|obesity|obesity
28831|NCT04019639|ADM|adm
29035|NCT04018339|body composition|body composition
29036|NCT04018326|loss to follow-up|loss to follow-up
29037|NCT04018326|proliferative diabetic retinopathy|proliferative diabetic retinopathy
29038|NCT04018326|diabetic retinopathy|diabetic retinopathy
29039|NCT04018326|panretinal photocoagulation|panretinal photocoagulation
29040|NCT04018326|intravitreal injections|intravitreal injections
29041|NCT04018300|ferrous sulfate|ferrous sulfate
29042|NCT04018300|non-transferrin bound iron|non-transferrin bound iron
29135|NCT04017845|Colorectal cancer|colorectal cancer
29136|NCT04017845|Screening|screening
29137|NCT04017845|Fecal Immunochemical Test|fecal immunochemical test
29138|NCT04017806|arteriovenous fistula maturation|arteriovenous fistula maturation
29139|NCT04017806|End stage renal disease|end stage renal disease
29335|NCT04016467|Spinal Manipulation|spinal manipulation
29336|NCT04016454|handover|handover
29337|NCT04016454|intraoperative|intraoperative
29341|NCT04016428|sleep|sleep
29543|NCT04015271|hemiparesis|hemiparesis
29544|NCT04015258|blueberry|blueberry
29545|NCT04015258|intervention|intervention
29546|NCT04015258|endothelial function|endothelial function
29547|NCT04015258|cognition|cognition
29641|NCT04014608|Clostridium difficile Infection|clostridium difficile infection
29642|NCT04014608|Infection Control|infection control
29643|NCT04014608|Quality Improvement|quality improvement
29644|NCT04014608|Active Surveillance testing|active surveillance testing
29645|NCT04014595|Calcified coronary lesions|calcified coronary lesions
29646|NCT04014582|communal coping|communal coping
29647|NCT04014582|couples coping|couples coping
29648|NCT04014582|adjustment|adjustment
29649|NCT04014530|Mismatch repair|mismatch repair
29650|NCT04014530|Anti PD1|anti pd1
29651|NCT04014530|Immunotherapy|immunotherapy
29652|NCT04014530|Metastatic disease|metastatic disease
29656|NCT04014504|Newborn Hearing Screening|newborn hearing screening
29657|NCT04014504|Otoacoustic emissions|otoacoustic emissions
29834|NCT04013490|physiological parameters|physiological parameters
29835|NCT04013490|consumption safety|consumption safety
29836|NCT04013490|cassava|cassava
29841|NCT04013451|mood|mood
30046|NCT04012229|BRCA1|brca1
30135|NCT04011813|density gradient centrifugation|density gradient centrifugation
30136|NCT04011813|DNA fragmentation, oxidation, chromatin packaging|dna fragmentation, oxidation, chromatin packaging
30138|NCT04011813|cryo-capacitation|cryo-capacitation
30229|NCT04011280|schizophrenia|schizophrenia
30230|NCT04011280|schizoaffective|schizoaffective
30231|NCT04011280|bipolar|bipolar
30232|NCT04011267|exercise therapy|exercise therapy
30233|NCT04011267|diabetic foot|diabetic foot
30234|NCT04011267|preventive care|preventive care
30530|NCT04009330|hyper and hypo-inflammatory|hyper and hypo-inflammatory
30531|NCT04009330|Phenotypes|phenotypes
30532|NCT04009330|POC (point of care)|poc (point of care)
30533|NCT04009304|Nutrition|nutrition
30534|NCT04009304|Physical activity|physical activity
30542|NCT04009278|Pain and discomfort|pain and discomfort
30544|NCT04009265|adjuvant chemotherapy|adjuvant chemotherapy
30636|NCT04008745|Booklet|booklet
30735|NCT04008095|pet/ct|pet/ct
30928|NCT04006951|Colorectal cancer|colorectal cancer
30929|NCT04006951|Biological Specimen Banks|biological specimen banks
30930|NCT04006925|sodium oxybate|sodium oxybate
30931|NCT04006899|Bioelectrical Impedance spectroscopy|bioelectrical impedance spectroscopy
30932|NCT04006899|Body compositions|body compositions
30933|NCT04006899|Segmental Bioelectrical impedance spectroscopy|segmental bioelectrical impedance spectroscopy
30934|NCT04006847|Omega-3 Fatty Acid|omega-3 fatty acid
31328|NCT04004455|cancer|cancer
31333|NCT04004442|avelumab|avelumab
31431|NCT04003961|Lung Cancer|lung cancer
31432|NCT04003961|Obstructive Sleep Apnea|obstructive sleep apnea
31433|NCT04003948|Ibogaine|ibogaine
31434|NCT04003948|Methadone|methadone
31435|NCT04003948|Drug dependence|drug dependence
31436|NCT04003948|Addiction|addiction
31437|NCT04003935|low-grade inflammation|low-grade inflammation
31524|NCT04003467|hPTH(1-34)|hpth(1-34)
31525|NCT04003454|Hepatitis C|hepatitis c
31526|NCT04003454|Screening|screening
31527|NCT04003454|Emergency Department|emergency department
31528|NCT04003454|Risk|risk
31529|NCT04003428|High Intensity Focused Ultrasound (HIFU)|high intensity focused ultrasound (hifu)
31530|NCT04003428|Placenta accreta|placenta accreta
31531|NCT04003428|Feasibility|feasibility
31532|NCT04003428|Safety|safety
31533|NCT04003402|alcohol effect|alcohol effect
32243|NCT03999164|TBI|tbi
32317|NCT03998605|abuse prevention|abuse prevention
32318|NCT03998592|vaccine|vaccine
32319|NCT03998592|peptide|peptide
32320|NCT03998592|Streptococcus pyogenes|streptococcus pyogenes
32322|NCT03998566|Radiation|radiation
32441|NCT03998033|HCC|hcc
32722|NCT03996564|Chronic Back Pain|chronic back pain
32723|NCT03996564|Alternative Medicine,|alternative medicine,
32724|NCT03996551|kidney transplant|kidney transplant
32725|NCT03996551|weight gain prevention|weight gain prevention
32823|NCT03995693|exercise mode|exercise mode
32824|NCT03995680|Mebendazole|mebendazole
32825|NCT03995680|Chewable tablet|chewable tablet
32826|NCT03995680|Hookworm|hookworm
32827|NCT03995680|Soil-transmitted helminths|soil-transmitted helminths
32828|NCT03995680|Efficacy|efficacy
32829|NCT03995680|Safety|safety
33129|NCT03993873|EGFR wild-type (wt)|egfr wild-type (wt)
33224|NCT03993457|depression|depression
33225|NCT03993457|mental health|mental health
33226|NCT03993457|mood disorders|mood disorders
33227|NCT03993457|major depressive episode|major depressive episode
33228|NCT03993457|major depressive disorder|major depressive disorder
33229|NCT03993457|antidepressants|antidepressants
33230|NCT03993457|escitalopram|escitalopram
33848|NCT03989505|CIN|cin
33926|NCT03989219|pulmonary nodule|pulmonary nodule
33927|NCT03989167|Hypercholesterolemia, Familial|hypercholesterolemia, familial
33928|NCT03989167|Primary care|primary care
33932|NCT03989141|Dialysis access|dialysis access
34022|NCT03988686|oligometastasis|oligometastasis
34124|NCT03988036|Trastuzumab|trastuzumab
34125|NCT03988036|Pembrolizumab|pembrolizumab
34126|NCT03988036|Immune checkpoint inhibitor|immune checkpoint inhibitor
34127|NCT03988036|PD-1|pd-1
34128|NCT03988036|PDL-1|pdl-1
34129|NCT03988036|PAM50|pam50
34415|NCT03986164|Angular Shifts|angular shifts
34416|NCT03986164|Satisfaction|satisfaction
34417|NCT03986151|coronary angiography|coronary angiography
34716|NCT03984552|HIV|hiv
34816|NCT03984084|Research Domain Criteria (RDoC)|research domain criteria (rdoc)
34817|NCT03984084|omics|omics
34818|NCT03984084|neuroimaging|neuroimaging
34819|NCT03984084|taxonomy|taxonomy
34820|NCT03984058|Pre-diabetes|pre-diabetes
34821|NCT03984058|Sleep Apnea|sleep apnea
34822|NCT03984058|PAP Therapy|pap therapy
34893|NCT03983681|MS|ms
35530|NCT03979560|Nutritional support|nutritional support
35532|NCT03979560|Undernutrition|undernutrition
35830|NCT03977987|mother-to-children transmission|mother-to-children transmission
35831|NCT03977987|antiviral treatment|antiviral treatment
35832|NCT03977987|immunoprophylaxis|immunoprophylaxis
35834|NCT03977948|preoperative anxiety|preoperative anxiety
36027|NCT03976869|non-steroidal|non-steroidal
36028|NCT03976869|Asthma|asthma
36029|NCT03976869|Adolescents|adolescents
36034|NCT03976830|Malnutrition|malnutrition
36419|NCT03974451|diffractive achromatic technology|diffractive achromatic technology
36420|NCT03974438|post-herpetic neuralgia|post-herpetic neuralgia
36421|NCT03974438|pain|pain
36422|NCT03974438|post herpetic neuralgia|post herpetic neuralgia
36423|NCT03974438|shingles|shingles
36619|NCT03973294|subglottic jet ventilation|subglottic jet ventilation
36620|NCT03973281|Shorten Delivery Time, Pelvic Muscle Injury, Vaginal Delivery, Complications, Childbirth, prevention|shorten delivery time, pelvic muscle injury, vaginal delivery, complications, childbirth, prevention
36929|NCT03971214|PD-1 inhibitor|pd-1 inhibitor
36930|NCT03971201|portal vein invasion|portal vein invasion
36932|NCT03971162|Pathologic myopia|pathologic myopia
37138|NCT03969992|BPD|bpd
38045|NCT03964493|PK|pk
38520|NCT03961763|EPA|epa
38691|NCT03960697|early mobilization|early mobilization
38692|NCT03960606|Aspergillosis|aspergillosis
38693|NCT03960567|Intubation|intubation
38694|NCT03960567|Laryngeal view|laryngeal view
39115|NCT03957850|LPP|lpp
39197|NCT03957330|Online therapy|online therapy
39199|NCT03957317|Surgery|surgery
39791|NCT03953534|Opioids|opioids
39792|NCT03953534|Acute Pain|acute pain
39793|NCT03953495|stress|stress
39794|NCT03953495|stigma-related stress|stigma-related stress
39795|NCT03953495|relationship quality|relationship quality
39796|NCT03953495|depressive symptoms|depressive symptoms
39797|NCT03953495|anxiety|anxiety
39798|NCT03953495|couples|couples
39893|NCT03952819|Diabetes Mellitus|diabetes mellitus
39894|NCT03952819|Renal Failure|renal failure
39895|NCT03952819|Hemodialysis Access Failure|hemodialysis access failure
39896|NCT03952819|Sclerostin|sclerostin
39897|NCT03952806|Multiple System Atrophy (MSA)|multiple system atrophy (msa)
39898|NCT03952780|abdominal aortic aneurysm|abdominal aortic aneurysm
39899|NCT03952780|endovascular repair|endovascular repair
39900|NCT03952780|stent graft|stent graft
39901|NCT03952754|Nutrition|nutrition
39902|NCT03952754|Health|health
39903|NCT03952754|School Children|school children
39904|NCT03952715|Focus analgesia selection test (FAST)|focus analgesia selection test (fast)
40381|NCT03949920|Anderson-Fabry|anderson-fabry
40382|NCT03949920|Migalastat|migalastat
40383|NCT03949907|Parenteral Nutrition (PN)|parenteral nutrition (pn)
40384|NCT03949907|Cancer|cancer
40399|NCT03949842|COPD|copd
40480|NCT03949283|Cytotoxicity assay|cytotoxicity assay
40481|NCT03949283|Cancer Stem Cells|cancer stem cells
40487|NCT03949244|Latanoprost|latanoprost
40580|NCT03948607|Attention deficit|attention deficit
40685|NCT03947801|Bone Turnover|bone turnover
40686|NCT03947801|Greek Yogurt|greek yogurt
40687|NCT03947801|Adolescent Athletes|adolescent athletes
40691|NCT03947775|Vaccine|vaccine
41172|NCT03944837|MRI|mri
42264|NCT03938064|poor responders|poor responders
42265|NCT03938064|IVF/ICSI|ivf/icsi
42266|NCT03938064|Luteal Phase Support|luteal phase support
42267|NCT03938064|GnRH Antagonist Protocol|gnrh antagonist protocol
42277|NCT03937973|sleep|sleep
42359|NCT03937505|robotic-assisted surgery|robotic-assisted surgery
42360|NCT03937505|minimally invasive surgery|minimally invasive surgery
42361|NCT03937492|GMI|gmi
42362|NCT03937492|CRPS|crps
42520|NCT03936621|CRP|crp
42573|NCT03936283|Obesity|obesity
42657|NCT03935594|vancouver scar scale (VSS)|vancouver scar scale (vss)
42659|NCT03935581|MRgFUS|mrgfus
43048|NCT03933384|Viral Hepatitis|viral hepatitis
43049|NCT03933384|Tenofovir alafenamide|tenofovir alafenamide
43050|NCT03933384|Entecavir|entecavir
43051|NCT03933371|colonoscopy|colonoscopy
43052|NCT03933371|capsule|capsule
43053|NCT03933371|Cleansing|cleansing
43054|NCT03933345|Overdose Risk Behaviors|overdose risk behaviors
43055|NCT03933345|Opioids|opioids
43349|NCT03931707|Newborn|newborn
43542|NCT03930407|Antral follicle count|antral follicle count
43544|NCT03930355|Surgery|surgery
43545|NCT03930355|Perioperative|perioperative
43546|NCT03930355|Transfusion|transfusion
43547|NCT03930355|Mortality|mortality
43550|NCT03930303|anxiety|anxiety
43646|NCT03929653|Personalized Therapy|personalized therapy
43647|NCT03929653|Molecular Tumor Board|molecular tumor board
43648|NCT03929614|Brace Treatment|brace treatment
43651|NCT03929588|myopia|myopia
43741|NCT03928899|fetal weight|fetal weight
43742|NCT03928899|Bishop score|bishop score
43743|NCT03928886|discomfort|discomfort
43744|NCT03928886|patient-assisted compression|patient-assisted compression
43745|NCT03928886|breast cancer|breast cancer
43943|NCT03927521|PSMA|psma
44037|NCT03926819|Carbon Monoxide|carbon monoxide
44038|NCT03926819|CO|co
44039|NCT03926819|Heme Oxygenase|heme oxygenase
44040|NCT03926819|HO-1|ho-1
44041|NCT03926806|yoghurt|yoghurt
44042|NCT03926806|vitamins B|vitamins b
44043|NCT03926806|body weight|body weight
44045|NCT03926780|warfarin|warfarin
44189|NCT03925792|police|police
44546|NCT03923686|Walled off necrosis|walled off necrosis
44547|NCT03923686|Acute pancreatitis|acute pancreatitis
44549|NCT03923686|Endoscopic drainage|endoscopic drainage
44750|NCT03922503|Collagen Membrane|collagen membrane
44751|NCT03922503|non-contained intraosseous defects|non-contained intraosseous defects
44752|NCT03922503|one wall intraosseous defects|one wall intraosseous defects
44759|NCT03922425|Severe mental illnesses|severe mental illnesses
44844|NCT03921788|pelvic congestion syndrome|pelvic congestion syndrome
44845|NCT03921788|calcitonin gene-related peptide|calcitonin gene-related peptide
44846|NCT03921788|substance P|substance p
44847|NCT03921762|Cataract surgery|cataract surgery
44851|NCT03921736|hypertension|hypertension
45271|NCT03919084|ACO|aco
45342|NCT03918772|Anaphylaxis|anaphylaxis
45343|NCT03918772|Epinephrine|epinephrine
45438|NCT03918122|Physician Leadership|physician leadership
45439|NCT03918122|Medical Education|medical education
45440|NCT03918109|tinnitus, intratympanic injection, gacyclidine|tinnitus, intratympanic injection, gacyclidine
46040|NCT03914768|neoantigen|neoantigen
46041|NCT03914729|pilonidal sinus|pilonidal sinus
46042|NCT03914729|plasty|plasty
46043|NCT03914729|gluteus muscle fascia|gluteus muscle fascia
46044|NCT03914729|ano-coccygeal plasty|ano-coccygeal plasty
46045|NCT03914716|Hemophilia|hemophilia
46344|NCT03912935|percentage of glottic opening|percentage of glottic opening
46345|NCT03912922|insulin sensitivity|insulin sensitivity
46346|NCT03912922|sitting time|sitting time
46347|NCT03912909|Metabolic Syndrome|metabolic syndrome
46350|NCT03912909|Blood Pressure|blood pressure
46444|NCT03912207|Challenge|challenge
46445|NCT03912129|pediatric Evans Syndrome|pediatric evans syndrome
46450|NCT03912103|Knowledge|knowledge
46644|NCT03911180|Proximal femoral nail|proximal femoral nail
46645|NCT03911180|Proximal locking screw|proximal locking screw
46646|NCT03911180|Distal locking screw|distal locking screw
46743|NCT03910530|metastatic solid tumors|metastatic solid tumors
46744|NCT03910530|INCMGA00012|incmga00012
46745|NCT03910530|INCB001158|incb001158
46746|NCT03910530|Japan|japan
46747|NCT03910530|PD-1 Inhibitor|pd-1 inhibitor
46748|NCT03910530|Arginase Inhibitor|arginase inhibitor
46749|NCT03910517|Musculoskeletal Pain|musculoskeletal pain
46750|NCT03910517|Sleep|sleep
46751|NCT03910517|Training load|training load
46752|NCT03910517|E-sport|e-sport
46753|NCT03910517|Physical activity|physical activity
46754|NCT03910478|Allogeneic|allogeneic
46755|NCT03910478|Cytomegalovirus|cytomegalovirus
46758|NCT03910465|Rare Tumor|rare tumor
46842|NCT03909919|Heart Failure|heart failure
46843|NCT03909919|Kinematics|kinematics
46844|NCT03909919|Validation|validation
46845|NCT03909919|Functional task|functional task
46846|NCT03909906|cognition|cognition
46947|NCT03909178|Tonnis|tonnis
47042|NCT03908619|Helicobacter pylori eradication|helicobacter pylori eradication
47045|NCT03908619|Vonoprazan|vonoprazan
47547|NCT03905473|Physical Activity|physical activity
47548|NCT03905473|Fatigue|fatigue
47549|NCT03905434|Large vessel occlusion|large vessel occlusion
47550|NCT03905434|Acute ischemic stroke|acute ischemic stroke
47551|NCT03905434|microRNA|microrna
47552|NCT03905408|glucose|glucose
47553|NCT03905408|lung surgery|lung surgery
47554|NCT03905408|air leak|air leak
47555|NCT03905408|postoperative|postoperative
47556|NCT03905395|Meditation|meditation
47743|NCT03904173|human epidermal growth factor receptor 2 positive|human epidermal growth factor receptor 2 positive
47844|NCT03903471|ProCore|procore
48059|NCT03901820|Elderly|elderly
48137|NCT03901352|Developmental phase III|developmental phase iii
48138|NCT03901339|Sacituzumab Govitecan|sacituzumab govitecan
48139|NCT03901339|IMMU-132|immu-132
48140|NCT03901339|TPC|tpc
48141|NCT03901339|estrogen receptor|estrogen receptor
48144|NCT03901339|Anti-TROP2|anti-trop2
48754|NCT03898297|Mood disorder|mood disorder
48855|NCT03897582|ceftazidime|ceftazidime
48856|NCT03897582|cefepime|cefepime
48857|NCT03897582|meropenem|meropenem
48955|NCT03896867|Pediatric perioperative temperature management|pediatric perioperative temperature management
48958|NCT03896763|Pediatric Acute Respiratory Distress Syndrome (PARDS)|pediatric acute respiratory distress syndrome (pards)
48959|NCT03896763|Acute Respiratory Distress Syndrome (ARDS)|acute respiratory distress syndrome (ards)
48960|NCT03896763|acute respiratory failure|acute respiratory failure
48961|NCT03896763|child|child
48962|NCT03896763|pediatric intensive care unit|pediatric intensive care unit
48963|NCT03896750|M.tuberculosis|m.tuberculosis
48964|NCT03896750|Pretomanid|pretomanid
48965|NCT03896750|Renal Impairment|renal impairment
48996|NCT03896581|PsA|psa
49055|NCT03896126|Diabetic Gastroparesis|diabetic gastroparesis
49056|NCT03896087|dried blood spots|dried blood spots
49057|NCT03896087|plasma separation card|plasma separation card
49058|NCT03896087|HCV RNA test|hcv rna test
49320|NCT03894384|PG1|pg1
49575|NCT03892278|aging|aging
49732|NCT03891277|TIA|tia
50159|NCT03888430|ICU|icu
50253|NCT03888040|limb power|limb power
50254|NCT03887988|Fracture fixation|fracture fixation
50658|NCT03885830|CML|cml
51028|NCT03883464|Cholecystectomy|cholecystectomy
51029|NCT03883464|Low fat diet|low fat diet
51232|NCT03882294|probiotics|probiotics
51233|NCT03882294|aflatoxin biomarkers|aflatoxin biomarkers
51234|NCT03882294|healthy subjects|healthy subjects
51235|NCT03882294|intervention|intervention
51236|NCT03882281|Chronic Myeloid Leukemia, Chronic Phase|chronic myeloid leukemia, chronic phase
51237|NCT03882281|HQP1351|hqp1351
51238|NCT03882268|Urban|urban
51332|NCT03881462|rotator cuff|rotator cuff
51333|NCT03881449|digital medicine|digital medicine
51334|NCT03881436|Anatomy|anatomy
51335|NCT03881436|Fiber tractography|fiber tractography
51336|NCT03881436|Pelvic floor|pelvic floor
51337|NCT03881436|Diffusion Tensor Imaging (DTI)|diffusion tensor imaging (dti)
51338|NCT03881436|Magnetic Resonance Imaging (MRI)|magnetic resonance imaging (mri)
51339|NCT03881397|internet|internet
51437|NCT03880877|regorafenib|regorafenib
51635|NCT03879811|18-545|18-545
52031|NCT03877107|normal pressure hydrocephalus|normal pressure hydrocephalus
52032|NCT03877107|overactive bladder|overactive bladder
52033|NCT03877094|pain|pain
52034|NCT03877094|virtual reality|virtual reality
52035|NCT03877094|breast biopsy|breast biopsy
52036|NCT03877094|environmental health|environmental health
52037|NCT03877094|patient comfort|patient comfort
52038|NCT03877094|complementary therapies|complementary therapies
52042|NCT03877081|Sepsis|sepsis
52128|NCT03876665|Military|military
52226|NCT03876054|dorsal root ganglion stimulation|dorsal root ganglion stimulation
52329|NCT03875456|Cephalohematoma|cephalohematoma
52330|NCT03875456|Infant, Newborn|infant, newborn
52331|NCT03875456|Perinatal Care|perinatal care
52339|NCT03875417|HCC|hcc
53235|NCT03870061|Infants|infants
53536|NCT03867695|Serratus plane block|serratus plane block
53537|NCT03867695|Analgesia after VATS|analgesia after vats
53538|NCT03867695|Lobectomy VATS|lobectomy vats
53543|NCT03867669|Developmental Disabilities|developmental disabilities
53544|NCT03867669|Follow-Up Studies|follow-up studies
53545|NCT03867669|Infant, Premature|infant, premature
53546|NCT03867669|Intensive Care Units, Neonatal|intensive care units, neonatal
53547|NCT03867669|randomized controlled trial|randomized controlled trial
53735|NCT03866590|Chronic anaemia|chronic anaemia
53736|NCT03866590|Biomarker|biomarker
53829|NCT03865914|Clinical-pathological correlations|clinical-pathological correlations
53830|NCT03865914|differential diagnosis|differential diagnosis
53832|NCT03865901|GDM|gdm
53932|NCT03865420|Genetic testing|genetic testing
53933|NCT03865420|C9orf72|c9orf72
53934|NCT03865420|SOD1|sod1
54352|NCT03862924|HIV|hiv
54509|NCT03862170|RCT|rct
54536|NCT03861949|CPAP|cpap
54537|NCT03861949|Preoxygenation|preoxygenation
54541|NCT03861897|Non instrumental physiotherapy|non instrumental physiotherapy
54542|NCT03861897|Physiotherapy|physiotherapy
54543|NCT03861871|CKDL5 Deficiency Disorder|ckdl5 deficiency disorder
54545|NCT03861858|adolescence|adolescence
55426|NCT03856567|OCD|ocd
55829|NCT03854240|Thoracolumbar Interfascial Plane Block|thoracolumbar interfascial plane block
55830|NCT03854240|Pain Management|pain management
55831|NCT03854240|Lumbar Laminectomy Surgery|lumbar laminectomy surgery
55832|NCT03854214|Spinal Cord Injuries|spinal cord injuries
55833|NCT03854214|MRI, Functional|mri, functional
55834|NCT03854214|Rehabilitation|rehabilitation
55835|NCT03854214|Neuronal Plasticity|neuronal plasticity
55836|NCT03854201|workability, sickness absence, health promotion, costs|workability, sickness absence, health promotion, costs
55837|NCT03854188|acupuncture|acupuncture
55844|NCT03854123|Geriatric population|geriatric population
55845|NCT03854123|EDMUS|edmus
55846|NCT03854123|OFSEP|ofsep
55848|NCT03854097|PAD|pad
56033|NCT03852797|etomidate|etomidate
56034|NCT03852784|Bone and Joint Infection|bone and joint infection
56035|NCT03852784|Streptococcus peumoniae|streptococcus peumoniae
56036|NCT03852758|exercise|exercise
56038|NCT03852706|Hallucinations|hallucinations
56233|NCT03851653|OSA|osa
56570|NCT03849521|MR|mr
56850|NCT03848000|Anxiety|anxiety
56921|NCT03847610|Microneedle array|microneedle array
56922|NCT03847584|Low socioeconomic status population|low socioeconomic status population
56923|NCT03847584|Web-based prospective cohort study|web-based prospective cohort study
56924|NCT03847584|Survey|survey
56925|NCT03847584|Recruitment|recruitment
57574|NCT03843710|ALS|als
57810|NCT03842176|CTC|ctc
57819|NCT03842124|infection|infection
57820|NCT03842124|pacemaker|pacemaker
57821|NCT03842124|ICD|icd
57822|NCT03842124|CRT|crt
57823|NCT03842111|Alaska natives|alaska natives
57824|NCT03842111|child care|child care
58533|NCT03838172|scar|scar
58819|NCT03836365|Patient preparedness|patient preparedness
58820|NCT03836365|Randomized controlled trial|randomized controlled trial
58821|NCT03836352|T cell activation|t cell activation
58822|NCT03836352|Immunotherapy|immunotherapy
58823|NCT03836352|Ovarian|ovarian
58824|NCT03836352|Hepatocellular Carcinoma|hepatocellular carcinoma
58825|NCT03836352|Non-small Cell Lung|non-small cell lung
58826|NCT03836352|Bladder|bladder
58828|NCT03836352|Survivin|survivin
58919|NCT03835884|Vascular endothelial growth factor|vascular endothelial growth factor
58921|NCT03835858|Physical Therapy|physical therapy
59020|NCT03835247|nurse-nurse collaboration|nurse-nurse collaboration
59021|NCT03835208|gestational diabetes|gestational diabetes
59022|NCT03835208|carbohydrate distribution|carbohydrate distribution
59023|NCT03835208|high/low carbohydrate|high/low carbohydrate
59024|NCT03835208|glycemic variability|glycemic variability
59122|NCT03834519|Programmed Death-Ligand 1 (PDL1, PD-L1)|programmed death-ligand 1 (pdl1, pd-l1)
59123|NCT03834506|Programmed Cell Death-1 (PD1, PD-1)|programmed cell death-1 (pd1, pd-1)
59128|NCT03834480|sacroiliac|sacroiliac
59320|NCT03833323|Pulmonary Arterial Hypertension|pulmonary arterial hypertension
59321|NCT03833323|Pulmonary Hypertension|pulmonary hypertension
59322|NCT03833323|Remodulin|remodulin
59323|NCT03833323|treprostinil|treprostinil
59728|NCT03830918|SCLC|sclc
59927|NCT03829410|PCM-075|pcm-075
60121|NCT03828305|Out of hospital cardiac arrest|out of hospital cardiac arrest
60122|NCT03828305|cardiopulmonary resuscitation|cardiopulmonary resuscitation
60123|NCT03828305|automated external defibrillators|automated external defibrillators
60215|NCT03827525|Cognitive and Behavioral Therapy|cognitive and behavioral therapy
60216|NCT03827525|Intellectual Disability|intellectual disability
60217|NCT03827512|Vascular physicians|vascular physicians
60218|NCT03827512|Peripheral artery disease|peripheral artery disease
60315|NCT03827122|Bruxism|bruxism
60411|NCT03826576|restaurant-based intervention|restaurant-based intervention
60412|NCT03826524|out-of-hospital cardiac arrest|out-of-hospital cardiac arrest
60413|NCT03826524|sudden cardiac arrest|sudden cardiac arrest
60532|NCT03825744|SAA|saa
60922|NCT03823521|Cardioplegic Solutions|cardioplegic solutions
60923|NCT03823508|Vegetative state|vegetative state
60924|NCT03823508|Minimally Conscious State|minimally conscious state
60925|NCT03823508|Disorders of consciousness|disorders of consciousness
60928|NCT03823508|Neuromodulation|neuromodulation
61410|NCT03821077|Subcutaneous Immunotherapy (SCIT)|subcutaneous immunotherapy (scit)
61411|NCT03821077|Allergovac Poliplus|allergovac poliplus
61412|NCT03821064|Cancer|cancer
61707|NCT03818828|venous stasis|venous stasis
61708|NCT03818828|VLU|vlu
61709|NCT03818802|NAD boosting therapy|nad boosting therapy
61710|NCT03818802|Nicotinamide Riboside|nicotinamide riboside
62100|NCT03816189|Systemic Scleroderma|systemic scleroderma
62101|NCT03816176|ASP9766|asp9766
62102|NCT03816176|Cresemba|cresemba
62103|NCT03816176|BAL8557|bal8557
62104|NCT03816176|isavuconazonium sulfate|isavuconazonium sulfate
62113|NCT03816137|Antibody|antibody
62114|NCT03816137|Antibody-dependent cell-mediated cytotoxicity|antibody-dependent cell-mediated cytotoxicity
62116|NCT03816124|osteoarthritis|osteoarthritis
62991|NCT03810599|Anxiety|anxiety
63190|NCT03809585|Optical Coherence Tomography (OCT)|optical coherence tomography (oct)
63191|NCT03809585|Angiography|angiography
63297|NCT03808935|cbd|cbd
63388|NCT03808389|Microbiome|microbiome
63601|NCT03806920|GIP|gip
63677|NCT03806517|postural instability and gait difficulty|postural instability and gait difficulty
63678|NCT03806517|akinetic-rigid|akinetic-rigid
63680|NCT03806504|PEEP|peep
63696|NCT03806426|EPA|epa
63778|NCT03805854|pain|pain
63779|NCT03805854|tACS|tacs
63780|NCT03805854|alpha|alpha
63781|NCT03805854|gamma|gamma
63876|NCT03805282|general anesthesia|general anesthesia
63877|NCT03805282|cough|cough
63878|NCT03805282|anesthesia emergence|anesthesia emergence
63889|NCT03805139|HDL|hdl
64178|NCT03803423|Living Donation|living donation
64179|NCT03803423|The Donor App|the donor app
64591|NCT03800719|IM|im
64888|NCT03798873|Obesity|obesity
65484|NCT03795103|Lower Extremity Peripheral Arterial Disease|lower extremity peripheral arterial disease
65485|NCT03795090|Antimicrobial coating, MDRO, MRSA, Patient Privacy Curtains|antimicrobial coating, mdro, mrsa, patient privacy curtains
65486|NCT03795064|Venous Ulcer|venous ulcer
65494|NCT03795025|Muscle|muscle
65585|NCT03794635|18-530|18-530
65981|NCT03791749|stress|stress
66372|NCT03789526|ultrasound|ultrasound
66373|NCT03789526|diabetes mellitus|diabetes mellitus
66374|NCT03789513|HIV infection, HPV infection, cervical cancer, screening algorithms|hiv infection, hpv infection, cervical cancer, screening algorithms
66494|NCT03788811|ERG|erg
66563|NCT03788291|Phase II|phase ii
66956|NCT03785964|PF-03084014|pf-03084014
66957|NCT03785964|GSI|gsi
66958|NCT03785964|gamma secretase inhibitor|gamma secretase inhibitor
66959|NCT03785964|notch pathway|notch pathway
66960|NCT03785951|HbA1c|hba1c
66961|NCT03785951|whey|whey
66962|NCT03785951|postprandial glycaemia|postprandial glycaemia
66963|NCT03785951|cardiometabolic|cardiometabolic
66964|NCT03785951|vascular|vascular
66965|NCT03785951|leucine|leucine
66966|NCT03785951|branched chain amino acids (BCAA)|branched chain amino acids (bcaa)
66967|NCT03785951|glucose control|glucose control
66968|NCT03785951|Milk protein|milk protein
66969|NCT03785938|pediatric|pediatric
66970|NCT03785938|cancer|cancer
66971|NCT03785938|malignant haematology|malignant haematology
66972|NCT03785938|transplant|transplant
66973|NCT03785938|probiotics|probiotics
66974|NCT03785938|mucositis|mucositis
67360|NCT03783429|Digoxin|digoxin
67361|NCT03783429|Atrial fibrillation|atrial fibrillation
67362|NCT03783403|Antibody|antibody
67363|NCT03783403|CC-95251|cc-95251
67364|NCT03783403|SIRPα|sirpα
67365|NCT03783403|Advanced Solid Cancers|advanced solid cancers
67366|NCT03783403|Advanced Hematologic Cancers|advanced hematologic cancers
67368|NCT03783338|Balance|balance
67829|NCT03780569|GBM|gbm
68156|NCT03778710|Lymph node metastasis, Gastric cancer|lymph node metastasis, gastric cancer
68157|NCT03778671|transversus abdominis plane block|transversus abdominis plane block
68158|NCT03778671|Dexmedetomidine|dexmedetomidine
68159|NCT03778671|Fentanyl|fentanyl
68160|NCT03778658|Adolescent/Young Adult|adolescent/young adult
68161|NCT03778658|Cancer|cancer
68162|NCT03778658|Physical Activity|physical activity
68166|NCT03778645|Angiography|angiography
68354|NCT03777150|postoperative care|postoperative care
68550|NCT03775772|chewing efficiency|chewing efficiency
68551|NCT03775772|dementia|dementia
68552|NCT03775772|elderly|elderly
68553|NCT03775772|aged|aged
68554|NCT03775759|Left ventricular assist device|left ventricular assist device
68555|NCT03775759|Tricuspid regurgitation|tricuspid regurgitation
68751|NCT03774589|magnetic compressive technique|magnetic compressive technique
68752|NCT03774589|morbidity|morbidity
69456|NCT03769987|neurosarcoidosis, pulmonary hyeprtension, infliximab, repository corticotropin|neurosarcoidosis, pulmonary hyeprtension, infliximab, repository corticotropin
69457|NCT03769974|motor imagery|motor imagery
69458|NCT03769974|action observation|action observation
69459|NCT03769974|motor learning|motor learning
69460|NCT03769961|essential tremor|essential tremor
69461|NCT03769961|dbs|dbs
69462|NCT03769909|PTOA|ptoa
69466|NCT03769909|Cytokines|cytokines
69745|NCT03768531|Cabiralizumab|cabiralizumab
69746|NCT03768531|Immunotherapy|immunotherapy
69747|NCT03768531|Anti-PD-1|anti-pd-1
69748|NCT03768531|Anti-CSF-1R|anti-csf-1r
69749|NCT03768531|Biliary tract cancers (BTC)|biliary tract cancers (btc)
69750|NCT03768531|Neoadjuvant chemotherapy|neoadjuvant chemotherapy
69753|NCT03768518|Exendin|exendin
69847|NCT03767803|Visual Symptoms|visual symptoms
69848|NCT03767790|Artificial Pancreas|artificial pancreas
69849|NCT03767790|Hyperglycemia|hyperglycemia
69850|NCT03767790|Hypoglycemia|hypoglycemia
69851|NCT03767790|Nutrition|nutrition
70042|NCT03766646|Preoxygenation|preoxygenation
70146|NCT03765905|Cardiovascular disease|cardiovascular disease
70147|NCT03765866|rotational thromboelastometry|rotational thromboelastometry
70148|NCT03765866|viscoelastic test|viscoelastic test
70149|NCT03765866|coagulopathy|coagulopathy
70150|NCT03765866|trauma|trauma
70151|NCT03765866|hemorrhage|hemorrhage
70152|NCT03765814|organ donation|organ donation
70346|NCT03764384|CO2 waveforms|co2 waveforms
70538|NCT03762902|Detection|detection
70539|NCT03762902|Individual|individual
70540|NCT03762902|Machine Learning|machine learning
70567|NCT03762772|HIV|hiv
71436|NCT03757286|maxillary tumors resection\ reconstruction|maxillary tumors resection\ reconstruction
71437|NCT03757286|CAD\CAM|cad\cam
71439|NCT03757286|aesthetic|aesthetic
71656|NCT03755739|HAI|hai
71826|NCT03754751|intraperitoneal anesthesia|intraperitoneal anesthesia
71827|NCT03754751|low pressure pneumoperitoneum|low pressure pneumoperitoneum
71828|NCT03754751|cholecystitis|cholecystitis
71832|NCT03754699|Pain|pain
72066|NCT03753087|HF|hf
72222|NCT03752346|Health Related Quality of Life|health related quality of life
72223|NCT03752320|Postoperative pneumonia|postoperative pneumonia
72224|NCT03752320|Thoracic surgery|thoracic surgery
72436|NCT03751046|HIV|hiv
73006|NCT03747484|Metastatic Merkel Cell Carcinoma|metastatic merkel cell carcinoma
73007|NCT03747484|Unresectable Merkel Cell Carcinoma|unresectable merkel cell carcinoma
73008|NCT03747471|Diabetes|diabetes
73009|NCT03747471|Type 2 Diabetes mellitus|type 2 diabetes mellitus
73304|NCT03745872|Baseline Assessments|baseline assessments
73305|NCT03745872|Follow-up Assessments|follow-up assessments
73306|NCT03745872|Knowledge|knowledge
73505|NCT03744416|pregnant women|pregnant women
73506|NCT03744416|midwife|midwife
73507|NCT03744416|satisfaction|satisfaction
73508|NCT03744364|Dinoprostone|dinoprostone
73509|NCT03744364|Misoprostol|misoprostol
73708|NCT03743363|work performance|work performance
73713|NCT03743324|Chinese|chinese
74115|NCT03740529|BTK|btk
74207|NCT03740256|Bladder|bladder
74208|NCT03740256|Squamous Cell Carcinoma|squamous cell carcinoma
74209|NCT03740256|Salivary Gland|salivary gland
74210|NCT03740256|Lung|lung
74506|NCT03738540|Diet|diet
74507|NCT03738540|Telephone coaching|telephone coaching
74508|NCT03738527|tranexamic acid|tranexamic acid
74509|NCT03738527|mastectomy|mastectomy
74510|NCT03738527|topical|topical
74511|NCT03738514|Dentinal Hypersensitivity|dentinal hypersensitivity
74513|NCT03738501|Food intake|food intake
74613|NCT03737825|MS|ms
75013|NCT03735303|vitamin D deficiency|vitamin d deficiency
75014|NCT03735303|leptin|leptin
75015|NCT03735303|A1C|a1c
75016|NCT03735303|omega-3 fatty acid|omega-3 fatty acid
75025|NCT03735277|Human Umbilical Cord Blood|human umbilical cord blood
75026|NCT03735277|Hematopoietic stem cells|hematopoietic stem cells
75027|NCT03735264|NSCLC Anlotinib Docetaxel|nsclc anlotinib docetaxel
75311|NCT03733262|hemodialysis|hemodialysis
75312|NCT03733262|medication optimization|medication optimization
75313|NCT03733262|medication prescribing patterns|medication prescribing patterns
75314|NCT03733262|patient safety|patient safety
75315|NCT03733262|polypharmacy|polypharmacy
75316|NCT03733262|pill burden|pill burden
75317|NCT03733262|quality improvement activity|quality improvement activity
75318|NCT03733262|chronic kidney disease|chronic kidney disease
75319|NCT03733262|end-stage renal disease|end-stage renal disease
75322|NCT03733249|ALL|all
75513|NCT03732144|Community-based Intervention|community-based intervention
75514|NCT03732144|Social Motivational Theories|social motivational theories
75825|NCT03730194|ASD|asd
75904|NCT03729570|randomized controlled trial|randomized controlled trial
75905|NCT03729557|Kidney donor|kidney donor
75909|NCT03729544|screening|screening
76023|NCT03728933|RLS|rls
76202|NCT03727880|PD-L1|pd-l1
76203|NCT03727880|Pancreatic cancer|pancreatic cancer
76204|NCT03727880|Neoadjuvant chemotherapy|neoadjuvant chemotherapy
76205|NCT03727880|Adjuvant chemotherapy|adjuvant chemotherapy
76206|NCT03727880|PDAC - Pancreatic Ductal Adenocarcinoma|pdac - pancreatic ductal adenocarcinoma
76562|NCT03725904|IVF|ivf
76695|NCT03724916|Drug therapy|drug therapy
76700|NCT03724838|Esomeprazole|esomeprazole
76701|NCT03724838|Sildenafil Citrate|sildenafil citrate
76702|NCT03724838|preterm preeclampsia|preterm preeclampsia
77118|NCT03722030|Obesity|obesity
77479|NCT03719807|rehabilitation|rehabilitation
77480|NCT03719807|post-operative|post-operative
77481|NCT03719807|scoliosis correction|scoliosis correction
77482|NCT03719768|Whole Brain Radiotherapy|whole brain radiotherapy
77579|NCT03719209|Ulcerative Colitis|ulcerative colitis
77580|NCT03719209|Celiac|celiac
77581|NCT03719209|Ulcer|ulcer
77582|NCT03719209|Polyp|polyp
77585|NCT03719209|Virtual Reality|virtual reality
77693|NCT03718416|PWS|pws
77879|NCT03717311|labeled wheat bran|labeled wheat bran
77880|NCT03717298|Nutritional supplement|nutritional supplement
77881|NCT03717298|Advanced Pancreatic adenocarcinoma|advanced pancreatic adenocarcinoma
77882|NCT03717298|Ocoxin-Viusid|ocoxin-viusid
77883|NCT03717298|Oxidative stress|oxidative stress
77884|NCT03717298|Antioxidant|antioxidant
77885|NCT03717285|RIRS|rirs
77886|NCT03717285|Renal stones|renal stones
77975|NCT03716778|Heart failure|heart failure
77976|NCT03716778|eccentric|eccentric
77977|NCT03716778|exercise|exercise
77978|NCT03716778|rehabilitation program|rehabilitation program
77979|NCT03716778|exercise testing|exercise testing
77980|NCT03716778|6 min. walk test|6 min. walk test
77981|NCT03716752|connective tissue wall technique|connective tissue wall technique
77982|NCT03716752|modified connective tissue wall technique with a wing|modified connective tissue wall technique with a wing
77983|NCT03716752|recession defects in posterior teeth|recession defects in posterior teeth
78169|NCT03715335|Sexually Transmitted Infections|sexually transmitted infections
78170|NCT03715335|Sexually Transmitted Diseases|sexually transmitted diseases
78171|NCT03715335|Cost Effectiveness|cost effectiveness
78266|NCT03714711|total knee replacement|total knee replacement
78287|NCT03714464|MRI|mri
78461|NCT03713502|GIP|gip
79143|NCT03709498|Nutritional Status|nutritional status
79144|NCT03709498|Acute Exacerbation|acute exacerbation
79145|NCT03709498|Phase Angle|phase angle
79146|NCT03709485|microbiome|microbiome
79147|NCT03709485|prostate cancer|prostate cancer
79148|NCT03709485|sequencing|sequencing
79249|NCT03708796|ED|ed
79340|NCT03708276|Web-based program|web-based program
79341|NCT03708263|532 nm green Laser|532 nm green laser
79342|NCT03708263|585 nm yellow laser|585 nm yellow laser
79343|NCT03708263|rosacea|rosacea
79345|NCT03708263|skin disease|skin disease
79442|NCT03707587|Human Papilloma Virus (HPV)|human papilloma virus (hpv)
79459|NCT03707470|rugby|rugby
79638|NCT03706287|non small cell lung cancer|non small cell lung cancer
79639|NCT03706287|anlotinib|anlotinib
79640|NCT03706287|pemetrexed|pemetrexed
79641|NCT03706287|T790M negative|t790m negative
79642|NCT03706261|Tau|tau
79643|NCT03706261|Amyloid|amyloid
79644|NCT03706261|MK-6240|mk-6240
79645|NCT03706261|Florbetaben|florbetaben
79737|NCT03705676|Cortical movement preparation|cortical movement preparation
79738|NCT03705663|HIV prevention, PrEP cascade, women|hiv prevention, prep cascade, women
79739|NCT03705650|Disease detection|disease detection
79740|NCT03705650|Medicare aged patients|medicare aged patients
79741|NCT03705650|routine physical examination|routine physical examination
79742|NCT03705650|primary care|primary care
79743|NCT03705650|limited echocardiogram|limited echocardiogram
79744|NCT03705624|falciparum|falciparum
79745|NCT03705624|gametocyte|gametocyte
79746|NCT03705624|elimination|elimination
80058|NCT03703882|DMD|dmd
80436|NCT03701373|First-line treatment|first-line treatment
80437|NCT03701347|Colposcopy|colposcopy
80438|NCT03701347|Simulator|simulator
80439|NCT03701347|Comparison Study|comparison study
80440|NCT03701347|Learning effectiveness|learning effectiveness
80536|NCT03700567|PCI-related myocardial injury|pci-related myocardial injury
80537|NCT03700554|Pneumothorax|pneumothorax
80538|NCT03700554|Iatrogenic|iatrogenic
80539|NCT03700554|Chest tube|chest tube
80646|NCT03699748|cancer|cancer
80729|NCT03699332|image guided surgery|image guided surgery
81141|NCT03696745|brain injury|brain injury
81142|NCT03696680|hemorrhagic|hemorrhagic
81168|NCT03696498|RCT|rct
81353|NCT03695146|HIV|hiv
81752|NCT03692611|hiv|hiv
81949|NCT03691454|S-1|s-1
82119|NCT03690375|RNA|rna
82227|NCT03689478|Hyperthermic intravesical chemotherapy|hyperthermic intravesical chemotherapy
82439|NCT03688074|Asthma|asthma
82624|NCT03686592|body awareness|body awareness
82625|NCT03686592|post-traumatic stress|post-traumatic stress
83140|NCT03683017|Biolux|biolux
83326|NCT03682146|Continence|continence
83327|NCT03682133|Prehabilitation|prehabilitation
83328|NCT03682133|Preoperative care|preoperative care
83336|NCT03682107|Andes Virus DNA|andes virus dna
83337|NCT03682107|ANDV DNA|andv dna
83338|NCT03682107|Hantavirus|hantavirus
83339|NCT03682107|Immunogenicity|immunogenicity
83340|NCT03682107|PharmaJet Stratis|pharmajet stratis
83341|NCT03682107|Pulmonary Syndrome|pulmonary syndrome
83342|NCT03682107|Safety|safety
83343|NCT03682107|Vaccine|vaccine
83429|NCT03681691|postmenopausal|postmenopausal
83430|NCT03681678|Laser Therapy|laser therapy
83431|NCT03681639|Hip resurfacing|hip resurfacing
83641|NCT03680469|Acute|acute
83891|NCT03678909|BNP|bnp
84423|NCT03675243|rectal surgery|rectal surgery
84424|NCT03675243|rectal neoplasm|rectal neoplasm
84425|NCT03675230|TOMO irradiation|tomo irradiation
84426|NCT03675178|Anerning particle|anerning particle
84438|NCT03675126|DMD|dmd
84523|NCT03674723|Adults|adults
84524|NCT03674723|Methionine|methionine
84525|NCT03674710|EUS-FNA|eus-fna
84526|NCT03674684|hydroxyethyl starch, gelatin, ROTEM, coagulation|hydroxyethyl starch, gelatin, rotem, coagulation
84527|NCT03674671|Depression|depression
84528|NCT03674671|MDD|mdd
84747|NCT03673384|IgE|ige
84820|NCT03672968|AAV2 Vectors|aav2 vectors
84821|NCT03672968|Neurodegenerative Disease|neurodegenerative disease
84822|NCT03672968|Atrophy|atrophy
84823|NCT03672942|intimate partner violence|intimate partner violence
85025|NCT03671863|Perinatal outcome|perinatal outcome
85026|NCT03671772|α-synucleinopathy|α-synucleinopathy
85027|NCT03671772|Neurodegeneration|neurodegeneration
85028|NCT03671772|Prodromal markers|prodromal markers
85030|NCT03671759|Caffeine|caffeine
85349|NCT03669900|SERI|seri
85631|NCT03668132|Subcortical aphasia|subcortical aphasia
85632|NCT03668132|Post-stroke aphasia|post-stroke aphasia
85633|NCT03668132|Cortical activation|cortical activation
85634|NCT03668119|TMB-H|tmb-h
85635|NCT03668093|caries prevention|caries prevention
85636|NCT03668093|caries management|caries management
85637|NCT03668080|burnout|burnout
85638|NCT03668080|residents|residents
85639|NCT03668080|surgical residents|surgical residents
85640|NCT03668015|caries|caries
85641|NCT03668015|bacteria|bacteria
85642|NCT03668015|saliva|saliva
85643|NCT03668015|plaque|plaque
85644|NCT03668015|microbial ecology|microbial ecology
85645|NCT03668002|Fistula vs. Graft|fistula vs. graft
85646|NCT03667989|SPECT|spect
85647|NCT03667989|123I-MIBG|123i-mibg
85648|NCT03667989|Chronic heart failure|chronic heart failure
85649|NCT03667989|Cardiac resynchronization therapy|cardiac resynchronization therapy
85651|NCT03667976|cardiovascular disease|cardiovascular disease
85652|NCT03667976|South Asian|south asian
85653|NCT03667976|physical activity|physical activity
85654|NCT03667976|peer support|peer support
85655|NCT03667976|pedometer|pedometer
85657|NCT03667937|Venous Ulcer|venous ulcer
85923|NCT03666351|Aortic Regurgitation|aortic regurgitation
85924|NCT03666351|Hypertension|hypertension
85925|NCT03666351|LVM|lvm
85926|NCT03666351|Left Ventricular Hypertrophy|left ventricular hypertrophy
85927|NCT03666338|early mobilization|early mobilization
85928|NCT03666325|metastatic squamous cell cancer of the skin|metastatic squamous cell cancer of the skin
86475|NCT03662802|ECG|ecg
86522|NCT03662438|Exercise|exercise
86523|NCT03662438|Physical Activity|physical activity
86524|NCT03662438|Respiratory Failure|respiratory failure
86525|NCT03662438|Oxygen Inhalation Therapy|oxygen inhalation therapy
86526|NCT03662425|schizophrenia|schizophrenia
86527|NCT03662425|negative symptoms|negative symptoms
86528|NCT03662425|Oxytocin|oxytocin
86535|NCT03662360|elderly|elderly
87326|NCT03657056|Ultrasound|ultrasound
87327|NCT03657043|Platinum-resistant|platinum-resistant
87328|NCT03657043|Antibody drug conjugate|antibody drug conjugate
87329|NCT03657043|Tisotumab vedotin|tisotumab vedotin
87330|NCT03657043|PROC|proc
87331|NCT03657030|Healthy Volunteers|healthy volunteers
87332|NCT03656978|vascular access|vascular access
87564|NCT03655457|RDS|rds
87838|NCT03653871|Alzheimer Disease|alzheimer disease
87839|NCT03653871|Dementia|dementia
87840|NCT03653871|Caregiver|caregiver
87841|NCT03653871|Performing Arts|performing arts
87842|NCT03653858|Deep Brain Stimulation|deep brain stimulation
87843|NCT03653858|Treatment-resistant depression|treatment-resistant depression
87844|NCT03653858|Medial forebrain bundle|medial forebrain bundle
87845|NCT03653845|Hypertension|hypertension
87846|NCT03653845|Primary Aldosteronism|primary aldosteronism
87873|NCT03653689|IBS|ibs
88742|NCT03649009|Septic shock|septic shock
88743|NCT03648996|arterial stiffness|arterial stiffness
88744|NCT03648996|endothelial dysfunction|endothelial dysfunction
88754|NCT03648918|Family|family
88846|NCT03648398|Online|online
89041|NCT03647293|Central Catheter|central catheter
89044|NCT03647293|Neonate|neonate
89240|NCT03645928|Cell Therapy|cell therapy
89241|NCT03645928|Autologous Adoptive Cell Transfer|autologous adoptive cell transfer
89242|NCT03645928|Autologous Adoptive Cell Therapy|autologous adoptive cell therapy
89243|NCT03645928|Cellular Immuno-therapy|cellular immuno-therapy
89245|NCT03645928|TIL|til
89537|NCT03644459|Humanized Anti-VEGF Monoclonal Antibody|humanized anti-vegf monoclonal antibody
89538|NCT03644459|autocrine loops|autocrine loops
89539|NCT03644459|LYN00101|lyn00101
89654|NCT03643562|NPC|npc
90438|NCT03638531|motor cortex|motor cortex
90439|NCT03638531|motor learning|motor learning
90644|NCT03637049|CYP3A|cyp3a
90743|NCT03636386|Pain Threshold|pain threshold
90744|NCT03636386|Visual Analog Pain Scale|visual analog pain scale
90745|NCT03636347|PiZZ or Null genotype|pizz or null genotype
90842|NCT03635944|growth|growth
90849|NCT03635931|CGF|cgf
90943|NCT03635307|Perioperative optimization|perioperative optimization
90944|NCT03635255|CAD|cad
90945|NCT03635255|miRNA|mirna
90946|NCT03635242|postural control|postural control
90947|NCT03635242|Chronic Low Back Pain|chronic low back pain
90948|NCT03635242|therapeutic excercise|therapeutic excercise
90982|NCT03635021|FOLFOX|folfox
91244|NCT03633318|EIM|eim
91343|NCT03632850|decision aids|decision aids
91344|NCT03632850|web-based decision tool|web-based decision tool
91446|NCT03632226|PET Imaging|pet imaging
91447|NCT03632226|Neurodegeneration|neurodegeneration
91449|NCT03632213|Losartan|losartan
91548|NCT03631615|locally advanced proximal stomach adenocarcinoma|locally advanced proximal stomach adenocarcinoma
91549|NCT03631524|deconditioning, isolation precautions, telerehabilitation|deconditioning, isolation precautions, telerehabilitation
91550|NCT03631511|direct pulp capping, RetroMTA, histological evaluation|direct pulp capping, retromta, histological evaluation
91551|NCT03631498|smoking|smoking
91552|NCT03631498|hypoxia|hypoxia
91553|NCT03631498|apoptosis|apoptosis
91554|NCT03631498|chronic periodontitis|chronic periodontitis
91676|NCT03630744|practice guideline|practice guideline
91555|NCT03631459|Kanglaita Injection/Capsule|kanglaita injection/capsule
91556|NCT03631459|Cancer cachexia|cancer cachexia
91557|NCT03631459|Real-world evidences|real-world evidences
91558|NCT03631459|Overall survival|overall survival
91559|NCT03631407|programmed cell death 1 (PD-1, PD1 )|programmed cell death 1 (pd-1, pd1 )
91560|NCT03631407|programmed cell death ligand 1 (PD-L1, PDL1)|programmed cell death ligand 1 (pd-l1, pdl1)
91564|NCT03631342|Physical Therapy|physical therapy
92136|NCT03627923|Postprandial glucose response|postprandial glucose response
92137|NCT03627923|Mediterranean diet|mediterranean diet
92138|NCT03627923|Personalized nutrition|personalized nutrition
92148|NCT03627871|exercise|exercise
92232|NCT03627377|Diabetes|diabetes
92233|NCT03627377|Lifestyle Risk Reduction|lifestyle risk reduction
92234|NCT03627351|Taste|taste
92235|NCT03627351|Odor|odor
92237|NCT03627351|Flavor|flavor
92337|NCT03626688|Prostacyclin|prostacyclin
92338|NCT03626688|Connective Tissue Disease-Associated|connective tissue disease-associated
92339|NCT03626688|6 Minute Walk Test|6 minute walk test
92340|NCT03626688|6 Minute Walk Distance|6 minute walk distance
93127|NCT03621449|passive leg raising|passive leg raising
93128|NCT03621449|fluid responsiveness|fluid responsiveness
93129|NCT03621449|pulse contour analysis|pulse contour analysis
93887|NCT03616964|SLE|sle
94042|NCT03615872|efficiency|efficiency
94043|NCT03615859|Glucocorticoids|glucocorticoids
94931|NCT03610646|ETDRS Letters.|etdrs letters.
94936|NCT03610568|Gender Norms|gender norms
94937|NCT03610568|Gender-Based Violence|gender-based violence
94938|NCT03610568|Mental Health|mental health
94939|NCT03610568|Sexual & Reproductive Health|sexual & reproductive health
95244|NCT03608553|MRgFUS|mrgfus
95337|NCT03607994|Brain Electrical Activity|brain electrical activity
95338|NCT03607994|Closed-loop|closed-loop
95339|NCT03607994|Acoustic Stimulation|acoustic stimulation
95340|NCT03607994|Allostasis|allostasis
95341|NCT03607994|Insomnia|insomnia
95342|NCT03607994|HIRREM-SOP|hirrem-sop
95537|NCT03606694|metformin|metformin
95538|NCT03606694|type 2 diabetes mellitus|type 2 diabetes mellitus
95539|NCT03606681|Dental Pulp|dental pulp
95542|NCT03606655|kava|kava
95773|NCT03605212|TLS|tls
96571|NCT03600558|FLAG|flag
96743|NCT03599414|Echocardiography|echocardiography
96744|NCT03599414|pulmonary|pulmonary
97133|NCT03596970|MMF|mmf
97039|NCT03597490|Partial Thickness Rotator Cuff Tear|partial thickness rotator cuff tear
97040|NCT03597490|Physical Therapy|physical therapy
97041|NCT03597477|Autism Spectrum Disorder|autism spectrum disorder
97042|NCT03597477|Dexmedetomidine|dexmedetomidine
97047|NCT03597451|walking|walking
97134|NCT03596970|maintenance liver transplant|maintenance liver transplant
97135|NCT03596970|RAD001H|rad001h
97136|NCT03596970|CRAD001H|crad001h
97186|NCT03596593|MSI|msi
97238|NCT03596177|Obesity|obesity
97834|NCT03592342|OLP|olp
98229|NCT03589885|Plaque psoriasis, auto-injector, 2 mL injection, secukinumab|plaque psoriasis, auto-injector, 2 ml injection, secukinumab
98230|NCT03589872|hand function, dual task, Parkinson disease, activities of daily living|hand function, dual task, parkinson disease, activities of daily living
98231|NCT03589859|neurologic rehabilitation|neurologic rehabilitation
98232|NCT03589859|computer games|computer games
98233|NCT03589833|Rheumatoid Arthritis|rheumatoid arthritis
98234|NCT03589833|Methotrexate|methotrexate
98235|NCT03589833|Tripterygium|tripterygium
98236|NCT03589833|TNF inhibitor|tnf inhibitor
98237|NCT03589820|Wilson Disease|wilson disease
98238|NCT03589820|Liver Failure|liver failure
98539|NCT03588078|Azacitidine|azacitidine
98833|NCT03585686|LCH|lch
98955|NCT03585062|S-1|s-1
99031|NCT03584555|Small incision lenticule extraction|small incision lenticule extraction
99032|NCT03584555|Cap thickness|cap thickness
99033|NCT03584542|Zolpidem|zolpidem
99034|NCT03584542|hypnotics and sedatives|hypnotics and sedatives
99131|NCT03583931|VATS Decortication|vats decortication
99132|NCT03583931|Surgical Pleural Decortication|surgical pleural decortication
99133|NCT03583931|Fibrinolytic Therapy|fibrinolytic therapy
99134|NCT03583931|Pneumonia|pneumonia
99135|NCT03583931|Thoracostomy|thoracostomy
99136|NCT03583918|facial wrinkles|facial wrinkles
99137|NCT03583918|skin laxity|skin laxity
99138|NCT03583918|sagging skin|sagging skin
99752|NCT03580070|HPV|hpv
100545|NCT03575351|Non-Hodgkin Lymphomas|non-hodgkin lymphomas
100546|NCT03575351|DLBCL|dlbcl
100858|NCT03573466|ALS|als
100955|NCT03572790|5-HT4|5-ht4
101317|NCT03570372|ASD|asd
101447|NCT03569631|PDE4D|pde4d
101544|NCT03569254|hyperbilirubinemia|hyperbilirubinemia
101545|NCT03569241|Radiotherapy|radiotherapy
101546|NCT03569241|metastasis-directed therapy|metastasis-directed therapy
101547|NCT03569228|hearing loss|hearing loss
101548|NCT03569228|hearing aids|hearing aids
101549|NCT03569202|Lubricant Eye Drops|lubricant eye drops
101550|NCT03569202|Moderate or Severe Dry Eye|moderate or severe dry eye
101551|NCT03569202|Hyaluronic Acid|hyaluronic acid
101552|NCT03569202|Trehalose|trehalose
101553|NCT03569202|Disaccharides|disaccharides
101554|NCT03569202|Polysaccharides|polysaccharides
101555|NCT03569202|Fatty Acids, Omega-3|fatty acids, omega-3
101556|NCT03569202|Tears|tears
101557|NCT03569202|Osmolar Concentration|osmolar concentration
101558|NCT03569202|Anterior Eye Segment|anterior eye segment
101559|NCT03569202|Severity of Illness Index|severity of illness index
101742|NCT03568136|Skin and Connective Tissue Diseases|skin and connective tissue diseases
101743|NCT03568084|elderly|elderly
101829|NCT03567499|SAP|sap
102046|NCT03565796|Brief intervention|brief intervention
102047|NCT03565796|Financial incentive|financial incentive
102048|NCT03565796|Active referral|active referral
102049|NCT03565796|AWARD model|award model
102050|NCT03565770|child|child
102051|NCT03565770|coaching|coaching
102052|NCT03565770|telemedicine|telemedicine
102053|NCT03565770|nurses|nurses
102054|NCT03565770|individual follow-up|individual follow-up
102055|NCT03565757|Stress Management|stress management
102056|NCT03565757|Resilience|resilience
102057|NCT03565744|obesity|obesity
102091|NCT03565575|HIV|hiv
102346|NCT03564067|TRD|trd
102528|NCT03562897|Ocoxin-Viusid|ocoxin-viusid
102529|NCT03562897|Nutritional supplement|nutritional supplement
102530|NCT03562897|Ovarian Cancer|ovarian cancer
102531|NCT03562897|Metastasis|metastasis
102542|NCT03562832|PARP inhibitor|parp inhibitor
102543|NCT03562832|Drug Response Prediction (DRP)|drug response prediction (drp)
102544|NCT03562832|Tankyrase 1/2 inhibitor|tankyrase 1/2 inhibitor
102545|NCT03562832|mRNA biomarker|mrna biomarker
102735|NCT03561610|nutritional supplement|nutritional supplement
102736|NCT03561610|sip feed|sip feed
102737|NCT03561610|nutritional risk|nutritional risk
102738|NCT03561597|stepped care|stepped care
102739|NCT03561597|mobile application|mobile application
102740|NCT03561584|Sclerosing|sclerosing
102758|NCT03561376|Scar|scar
102838|NCT03560817|Time-trade-off method|time-trade-off method
102856|NCT03560687|Anemia|anemia
103404|NCT03557606|CCJ|ccj
103442|NCT03557385|Fractional Flow Reserve|fractional flow reserve
103845|NCT03554655|Patient activation|patient activation
103846|NCT03554655|Schizophrenia|schizophrenia
103847|NCT03554655|First-episode psychosis|first-episode psychosis
103848|NCT03554655|mHealth|mhealth
103849|NCT03554655|Randomized clinical trial|randomized clinical trial
103850|NCT03554616|Malaria|malaria
103851|NCT03554616|Vector Control|vector control
103852|NCT03554616|Long lasting Insecticidal Net|long lasting insecticidal net
103853|NCT03554603|Long term care|long term care
103854|NCT03554603|Urine culture|urine culture
103946|NCT03554057|Angiogram, Coronary Computed Tomographic Angiography|angiogram, coronary computed tomographic angiography
103947|NCT03553992|Tobacco|tobacco
103948|NCT03553992|Gender Identity Minority|gender identity minority
103949|NCT03553992|Sexual Identity Minority|sexual identity minority
104144|NCT03552913|Enhanced Recovery After Surgery|enhanced recovery after surgery
104145|NCT03552913|Fast track|fast track
104146|NCT03552913|Surgery|surgery
104147|NCT03552913|Hysterectomy|hysterectomy
104148|NCT03552913|Left colectomy|left colectomy
104149|NCT03552913|Total knee arthroplasty|total knee arthroplasty
104197|NCT03552523|CGM|cgm
104536|NCT03550261|CAH|cah
105160|NCT03546660|EoE|eoe
105342|NCT03545451|EEG, neurofeedback, fMRI, ALS, surgery, upper limbs|eeg, neurofeedback, fmri, als, surgery, upper limbs
105343|NCT03545425|Parkinson's Disease|parkinson's disease
105784|NCT03542396|CBT|cbt
105837|NCT03541993|Polyphenols|polyphenols
105838|NCT03541980|sickle cell|sickle cell
105839|NCT03541980|acetaminophen in pain crises|acetaminophen in pain crises
106139|NCT03540082|Safe landing|safe landing
106140|NCT03540056|varicocele|varicocele
106141|NCT03540056|testicular growth|testicular growth
106142|NCT03540043|Mild moderate atopic dermatitis|mild moderate atopic dermatitis
106143|NCT03540030|Primary Total Shoulder Arthroplasty|primary total shoulder arthroplasty
106144|NCT03540030|Reverse Total Shoulder Arthroplasty|reverse total shoulder arthroplasty
106145|NCT03540017|Ovarian Cancer|ovarian cancer
106146|NCT03540017|Fallopian Tube Cancer|fallopian tube cancer
106147|NCT03540017|Primary Peritoneal Cancer|primary peritoneal cancer
106148|NCT03539965|Neoadjuvant Chemotherapy|neoadjuvant chemotherapy
106340|NCT03538899|Artemis-deficient Severe Combined Immunodeficiency|artemis-deficient severe combined immunodeficiency
106341|NCT03538899|gene therapy|gene therapy
106342|NCT03538899|autologous stem cell transplant|autologous stem cell transplant
106343|NCT03538886|Coronary revascularization|coronary revascularization
106344|NCT03538873|Subsyndromic symptoms of depression|subsyndromic symptoms of depression
106345|NCT03538873|Subsyndromic symptoms of anxiety|subsyndromic symptoms of anxiety
106346|NCT03538873|Elderly|elderly
106454|NCT03538262|PD|pd
106530|NCT03537807|Amyotrophic Lateral Sclerosis|amyotrophic lateral sclerosis
106531|NCT03537807|ALS|als
106532|NCT03537807|Lou Gehrig Disease|lou gehrig disease
106630|NCT03537326|doping|doping
106815|NCT03536143|DEB|deb
107525|NCT03531190|pre and post-surgical nutrition|pre and post-surgical nutrition
107632|NCT03530358|MRI|mri
107850|NCT03529383|Obesity|obesity
108030|NCT03528161|hypersensitive troponin|hypersensitive troponin
108031|NCT03528161|risk of serious adverse events|risk of serious adverse events
108032|NCT03528161|emergency|emergency
108033|NCT03528148|Post stroke|post stroke
108034|NCT03528148|Gait|gait
108035|NCT03528148|Elliptical cross bike.|elliptical cross bike.
108036|NCT03528148|Postural control|postural control
108037|NCT03528148|Balance|balance
108038|NCT03528122|amniotic membrane|amniotic membrane
109313|NCT03520556|EPA|epa
109342|NCT03520504|18-205|18-205
109473|NCT03519607|Men|men
109636|NCT03518515|energy balance|energy balance
109637|NCT03518437|coronary artery disease|coronary artery disease
109638|NCT03518437|CT|ct
109639|NCT03518437|MACE|mace
109641|NCT03518424|Soccer|soccer
110230|NCT03515109|stress incontinence|stress incontinence
110231|NCT03515109|female|female
110232|NCT03515109|altis|altis
110814|NCT03511820|post marketing surveillance|post marketing surveillance
110817|NCT03511768|18F-AlF-NOTA-octreotide|18f-alf-nota-octreotide
111011|NCT03510455|FGF-23|fgf-23
111147|NCT03509441|MRI|mri
111416|NCT03507491|Rhabdomyosarcoma|rhabdomyosarcoma
111417|NCT03507491|Wilms tumor|wilms tumor
111418|NCT03507491|Hepatoblastoma|hepatoblastoma
111419|NCT03507491|Adolescent and young adult|adolescent and young adult
111712|NCT03505697|maximal inspiratory pressure|maximal inspiratory pressure
111713|NCT03505697|6-minute walk test|6-minute walk test
111714|NCT03505619|home care service|home care service
111715|NCT03505619|reablement service|reablement service
111716|NCT03505619|rehabilitation|rehabilitation
111717|NCT03505606|Amblyopia|amblyopia
111935|NCT03504215|term|term
112026|NCT03503747|INGR1D|ingr1d
112312|NCT03501719|HIV|hiv
112608|NCT03499834|Immune Cell Therapy|immune cell therapy
112609|NCT03499834|IKC|ikc
112610|NCT03499795|High-grade squamous intraepithelial lesions (HSIL)|high-grade squamous intraepithelial lesions (hsil)
112611|NCT03499795|Human papillomavirus (HPV)|human papillomavirus (hpv)
112612|NCT03499795|HPV-16|hpv-16
112613|NCT03499795|HPV-18|hpv-18
112618|NCT03499782|Prognosis|prognosis
112699|NCT03499262|Toddler|toddler
112700|NCT03499262|Pivotal Response Treatment (PRT)|pivotal response treatment (prt)
112701|NCT03499262|Group Intervention|group intervention
112702|NCT03499262|Parent-Mediated|parent-mediated
112703|NCT03499262|Caregiver-Mediated|caregiver-mediated
112704|NCT03499262|Social Communication|social communication
112745|NCT03498924|HE4|he4
113095|NCT03496610|Living donor nephrectomy|living donor nephrectomy
113096|NCT03496571|Eosinophilic Gastritis|eosinophilic gastritis
113097|NCT03496571|Eosinophilic Gastroenteritis|eosinophilic gastroenteritis
113098|NCT03496571|Eosinophil|eosinophil
113099|NCT03496571|EG|eg
113302|NCT03495479|PSA|psa
113560|NCT03493646|MDS|mds
113719|NCT03492411|eHealth|ehealth
114617|NCT03486873|PD1|pd1
115420|NCT03481608|lrh-1|lrh-1
115594|NCT03480282|Life expectancy|life expectancy
115595|NCT03480282|Older adults|older adults
115596|NCT03480282|Primary care|primary care
115597|NCT03480282|Cancer screening|cancer screening
115598|NCT03480256|SHR6390|shr6390
115599|NCT03480256|Pyrotinib|pyrotinib
115602|NCT03480243|Padsevonil|padsevonil
115742|NCT03479372|AMD|amd
115794|NCT03479034|Application|application
115795|NCT03478995|Phase1b|phase1b
115803|NCT03478891|Ebola Virus|ebola virus
115804|NCT03478891|Immune Response|immune response
115805|NCT03478891|Filovirus|filovirus
115806|NCT03478891|Ebola Hemorrhagic Fever|ebola hemorrhagic fever
115807|NCT03478891|First in Human|first in human
115808|NCT03478878|Eye Examinations|eye examinations
116288|NCT03475953|Oesophageal or Gastric Carcinoma|oesophageal or gastric carcinoma
116289|NCT03475953|Biliary Tract cancer|biliary tract cancer
116290|NCT03475953|Hepatocellular Carcinoma|hepatocellular carcinoma
116291|NCT03475953|Soft-tissue sarcoma|soft-tissue sarcoma
116480|NCT03474887|eVisits|evisits
116481|NCT03474887|eConsultation|econsultation
116482|NCT03474887|ehealth|ehealth
116577|NCT03474315|Cardiac resynchronization therapy|cardiac resynchronization therapy
116578|NCT03474315|Implantable cardioverter-defibrillator|implantable cardioverter-defibrillator
116579|NCT03474315|Machine learning|machine learning
116583|NCT03474302|Aging|aging
117203|NCT03470766|SCS|scs
117876|NCT03466190|Mandibular body fractures, PEEK plates, titanium plates.|mandibular body fractures, peek plates, titanium plates.
117877|NCT03466177|Alzheimer's disease|alzheimer's disease
117878|NCT03466177|Dementia|dementia
117879|NCT03466177|Mild cognitive impairment|mild cognitive impairment
117880|NCT03466177|Optical coherence tomography|optical coherence tomography
117881|NCT03466177|Hyperspectral imaging|hyperspectral imaging
117882|NCT03466177|Multimodal retinal imaging|multimodal retinal imaging
117883|NCT03466151|Major Adverse Cardiac Events (MACE)|major adverse cardiac events (mace)
117884|NCT03466151|Myocardial Infarction (MI)|myocardial infarction (mi)
117893|NCT03466112|exercise|exercise
117982|NCT03465696|psoriasis|psoriasis
117983|NCT03465696|biologics|biologics
117984|NCT03465696|treatment decision-making|treatment decision-making
117985|NCT03465670|chlorhexidine|chlorhexidine
117986|NCT03465670|hyaluronic acid|hyaluronic acid
117987|NCT03465670|tooth discoloration|tooth discoloration
117988|NCT03465657|Child Health|child health
117989|NCT03465657|Sodium intake|sodium intake
117990|NCT03465657|Food Sources|food sources
117991|NCT03465657|Blood Pressure|blood pressure
117992|NCT03465657|BMI|bmi
117993|NCT03465657|Urinary sodium excretion|urinary sodium excretion
117994|NCT03465644|antithrombotic strategy|antithrombotic strategy
117995|NCT03465644|dual antiplatelet therapy|dual antiplatelet therapy
118269|NCT03463954|less than or equal to 15 mm|less than or equal to 15 mm
118270|NCT03463941|African American|african american
118271|NCT03463941|Faith institutions|faith institutions
118468|NCT03462498|Acute Coronary Syndrome|acute coronary syndrome
119067|NCT03458494|CRP|crp
119068|NCT03458494|Metabolomics|metabolomics
119069|NCT03458494|gene-diet interaction|gene-diet interaction
119070|NCT03458494|TCF7L2|tcf7l2
119071|NCT03458481|Chronic Genotype 1 HCV Infection|chronic genotype 1 hcv infection
119270|NCT03457324|Trial|trial
119375|NCT03456323|Frailty|frailty
119966|NCT03453073|stroke|stroke
120565|NCT03448809|Community Health Care|community health care
121057|NCT03445767|Medication management|medication management
121058|NCT03445741|Aerobic exercise|aerobic exercise
121059|NCT03445741|Metabolic syndrome|metabolic syndrome
121060|NCT03445741|Pedometer|pedometer
121061|NCT03445676|Hand Hygiene|hand hygiene
121062|NCT03445676|WHO 5-moments|who 5-moments
121067|NCT03445650|ADX-102, Sjögren-Larsson Syndrome|adx-102, sjögren-larsson syndrome
121068|NCT03445637|Metastatic breast cancer, safety, ibrance|metastatic breast cancer, safety, ibrance
121069|NCT03445598|depression|depression
121070|NCT03445598|anxiety|anxiety
121071|NCT03445598|CBT|cbt
121072|NCT03445598|psychotherapy|psychotherapy
121073|NCT03445598|e-health|e-health
121074|NCT03445598|CCBT|ccbt
121075|NCT03445559|Prostate Cancer|prostate cancer
121076|NCT03445559|Imaging|imaging
121094|NCT03445520|Transitions|transitions
121159|NCT03445104|AChEI|achei
121259|NCT03444506|SAR|sar
121481|NCT03443310|TKA|tka
121747|NCT03441776|TBI|tbi
122063|NCT03439956|Gynecological laparoscopy|gynecological laparoscopy
122064|NCT03439904|pharmaceutical care|pharmaceutical care
122065|NCT03439904|adherence|adherence
122066|NCT03439852|physical activity|physical activity
122360|NCT03437928|MDD|mdd
122480|NCT03437343|EOS|eos
123092|NCT03434067|PTH|pth
123223|NCT03433222|RCT|rct
123564|NCT03430518|Recurrent Ovarian cancer|recurrent ovarian cancer
123565|NCT03430518|Her2-negative Metastatic Breast Cancer|her2-negative metastatic breast cancer
123566|NCT03430518|Ovarian cancer|ovarian cancer
123567|NCT03430518|Metastatic Breast Cancer|metastatic breast cancer
123568|NCT03430505|Asthma, noninvasive ventilation|asthma, noninvasive ventilation
123569|NCT03430492|Psychological Resilience|psychological resilience
123666|NCT03429920|Fermented Soy|fermented soy
123882|NCT03428659|Gait|gait
124067|NCT03427593|Neutropenia|neutropenia
124068|NCT03427593|Autoimmunity|autoimmunity
124069|NCT03427593|Lymphoproliferation|lymphoproliferation
124070|NCT03427580|Schizophrenia|schizophrenia
124071|NCT03427580|Psychotherapy|psychotherapy
124072|NCT03427580|Metacognitive abilities|metacognitive abilities
124073|NCT03427580|Session by session assessment|session by session assessment
124362|NCT03425916|Ultrasonography|ultrasonography
124364|NCT03425890|Upper Limb|upper limb
124458|NCT03425162|percutaneous nephrolithotomy|percutaneous nephrolithotomy
124459|NCT03425149|vaccine|vaccine
124460|NCT03425149|prevention|prevention
124461|NCT03425136|Prevention of Mother-to-Child HIV Transmission|prevention of mother-to-child hiv transmission
124462|NCT03425136|HIV|hiv
124463|NCT03425136|PMTCT|pmtct
124464|NCT03425123|Regenerative endodontic procedure (REP)|regenerative endodontic procedure (rep)
124465|NCT03425123|Mineral Trioxide Aggregate (MTA) apexification|mineral trioxide aggregate (mta) apexification
124466|NCT03425123|Calcium Hydroxide -Ca(OH)2|calcium hydroxide -ca(oh)2
124557|NCT03424564|E2007|e2007
124858|NCT03422874|MLN9708|mln9708
124952|NCT03422406|Cause|cause
125273|NCT03420235|eHealth|ehealth
126822|NCT03410771|Distribution Volume|distribution volume
126823|NCT03410771|Antibiotics|antibiotics
126824|NCT03410745|exercise|exercise
126825|NCT03410745|cytokines|cytokines
126826|NCT03410745|collagen|collagen
126827|NCT03410732|dendritic cell|dendritic cell
126926|NCT03409809|Implementation Support|implementation support
127423|NCT03406910|Adventist Health Study|adventist health study
127505|NCT03406429|PPA|ppa
128127|NCT03402048|Pharmacogenomic-driven|pharmacogenomic-driven
128128|NCT03402048|NSCLC|nsclc
128129|NCT03402035|Whole Blood Resuscitation|whole blood resuscitation
128130|NCT03402022|Sport|sport
128131|NCT03402022|competition|competition
128132|NCT03402022|ultra-endurance|ultra-endurance
128133|NCT03402022|trail running|trail running
128134|NCT03402022|doping|doping
128135|NCT03402009|meditation|meditation
128791|NCT03397446|LDX|ldx
128895|NCT03396731|VLU|vlu
129090|NCT03395912|cesarean section pain relief|cesarean section pain relief
129091|NCT03395899|Atezolizumab|atezolizumab
129092|NCT03395899|Bevacizumab|bevacizumab
129093|NCT03395899|Cobimetinib|cobimetinib
129094|NCT03395899|Ipatasertib|ipatasertib
129095|NCT03395899|pre-operative|pre-operative
129096|NCT03395899|Window of opportunity|window of opportunity
129101|NCT03395860|GVHD|gvhd
129102|NCT03395860|ATG|atg
129103|NCT03395860|PTCy|ptcy
129104|NCT03395860|halo-HSCT|halo-hsct
129105|NCT03395821|competency-based education|competency-based education
129106|NCT03395821|gynecology|gynecology
129107|NCT03395821|laparoscopy|laparoscopy
129108|NCT03395821|resident education|resident education
129109|NCT03395821|simulation|simulation
129110|NCT03395821|surgical curriculum|surgical curriculum
129387|NCT03394183|cardiac rehabilitation|cardiac rehabilitation
129388|NCT03394183|cardiorespiratory fitness|cardiorespiratory fitness
129389|NCT03394183|functional capacity|functional capacity
129390|NCT03394183|acute exercise response|acute exercise response
129391|NCT03394183|quality of life|quality of life
129487|NCT03393533|Third molar;|third molar;
129488|NCT03393533|Oral surgery;|oral surgery;
129489|NCT03393533|Pain;|pain;
129490|NCT03393533|Edema;|edema;
129491|NCT03393533|Trismus.|trismus.
129498|NCT03393507|ovarian cancer|ovarian cancer
129499|NCT03393481|biologic,|biologic,
129679|NCT03392402|Indeterminate thyroid nodule|indeterminate thyroid nodule
129680|NCT03392402|Molecular biopsy|molecular biopsy
129681|NCT03392402|Gene expression classifier|gene expression classifier
129682|NCT03392389|mRNA-1653|mrna-1653
129683|NCT03392389|human metapneumovirus|human metapneumovirus
129684|NCT03392389|human parainfluenza vaccine|human parainfluenza vaccine
129685|NCT03392376|ICU Delirium|icu delirium
130265|NCT03388632|T Cells|t cells
130362|NCT03388060|ESWL|eswl
130748|NCT03385590|healthy|healthy
130835|NCT03385044|Endotracheal sealing|endotracheal sealing
130836|NCT03385031|Dose-guided radiation therapy|dose-guided radiation therapy
130837|NCT03385031|CBCT|cbct
130838|NCT03385005|Physical and Rehabilitation Medicine|physical and rehabilitation medicine
130839|NCT03385005|Transcutaneous Electrical Nerve Stimulation|transcutaneous electrical nerve stimulation
131430|NCT03381326|EMT related antigens|emt related antigens
131431|NCT03381274|EGFR mutated, CD73, A2AR, oleclumab, MEDI9447, AZD4635, osimertinib, NSCLC, immunotherapy|egfr mutated, cd73, a2ar, oleclumab, medi9447, azd4635, osimertinib, nsclc, immunotherapy
131432|NCT03381261|chronic migraine|chronic migraine
131439|NCT03381248|knee|knee
131563|NCT03380403|PDT|pdt
131630|NCT03380026|MF|mf
131728|NCT03379311|AKC|akc
132620|NCT03373578|sleep;|sleep;
133124|NCT03370432|GC|gc
133214|NCT03369886|OCTA|octa
133310|NCT03369353|Cellular Therapy|cellular therapy
133311|NCT03369340|Nicotine|nicotine
133312|NCT03369340|Reduced risk product|reduced risk product
133313|NCT03369340|Nicotine-containing product|nicotine-containing product
133314|NCT03369275|Mesenchymal Stem Cells|mesenchymal stem cells
133325|NCT03369262|PGF2α|pgf2α
133594|NCT03367676|adjuvant therapy|adjuvant therapy
133595|NCT03367650|amyotrophic lateral sclerosis|amyotrophic lateral sclerosis
133596|NCT03367650|epidemiology|epidemiology
133597|NCT03367650|genetic|genetic
133598|NCT03367650|environmental factor|environmental factor
133599|NCT03367637|Cancer Pain, Palliative care, Mobile Applications, Rwanda|cancer pain, palliative care, mobile applications, rwanda
133600|NCT03367624|influenza|influenza
133601|NCT03367624|Staphylococcus Aureus|staphylococcus aureus
133898|NCT03365778|SLT|slt
133984|NCT03365115|spinal anesthesia|spinal anesthesia
133985|NCT03365115|morphine|morphine
133986|NCT03365115|fentanyl|fentanyl
133987|NCT03365115|pain|pain
133988|NCT03365115|knee|knee
133989|NCT03365089|Hemodialysis fistula|hemodialysis fistula
133995|NCT03365024|CBT-I|cbt-i
135063|NCT03358407|Double-blinded|double-blinded
135064|NCT03358407|Crossover|crossover
135848|NCT03352908|YSP|ysp
135891|NCT03352609|TMS|tms
136076|NCT03351270|CNM|cnm
136650|NCT03347643|response inhibition|response inhibition
136746|NCT03347110|Psoriatic Arthritis|psoriatic arthritis
136848|NCT03346369|Phosphate Binder|phosphate binder
136849|NCT03346330|Chronic pain|chronic pain
136850|NCT03346330|Neuropathic pain|neuropathic pain
137347|NCT03343301|gastrointestinal cancer|gastrointestinal cancer
137348|NCT03343288|Silver Hydroxiapatite Coating|silver hydroxiapatite coating
137349|NCT03343288|Antimicrobial|antimicrobial
137350|NCT03343288|Medical Device|medical device
137359|NCT03343197|Glioma|glioma
137555|NCT03341806|GBM|gbm
138535|NCT03335839|tPA|tpa
140733|NCT03322917|PRP|prp
140931|NCT03321396|Gel|gel
141499|NCT03317925|ACE|ace
142178|NCT03313778|PCV|pcv
143421|NCT03305536|AVD|avd
144509|NCT03298568|DAO|dao
145223|NCT03293602|MRI|mri
146408|NCT03285854|CKD|ckd
146486|NCT03285464|hip|hip
146581|NCT03284723|ADC|adc
146890|NCT03282799|HIV|hiv
147228|NCT03280810|task|task
147692|NCT03277716|TACE|tace
148486|NCT03272191|MI|mi
148853|NCT03269773|AD|ad
149258|NCT03267173|CEA|cea
150105|NCT03261609|term|term
150380|NCT03259763|Cancer|cancer
151835|NCT03250793|NAVA|nava
151936|NCT03250117|implant|implant
153508|NCT03239730|pH|ph
153998|NCT03236558|Treg|treg
156165|NCT03223194|CN|cn
157563|NCT03213782|Anxiety|anxiety
158097|NCT03210376|NMB|nmb
158969|NCT03204617|HTI|hti
160231|NCT03196700|pain|pain
161133|NCT03191175|HIV|hiv
161740|NCT03187548|WSL|wsl
162019|NCT03185754|surgery|surgery
162922|NCT03180203|Wean|wean
163135|NCT03178773|Latino|latino
163806|NCT03174015|Lusaka|lusaka
164202|NCT03171220|SHR1210|shr1210
164412|NCT03169634|wear|wear
166086|NCT03158857|HIV|hiv
166610|NCT03156244|PROMIS|promis
167650|NCT03149575|GBM|gbm
168085|NCT03146559|EMG|emg
169390|NCT03137277|ADR|adr
169573|NCT03136094|SBIRT|sbirt
169971|NCT03133286|Renal|renal
170234|NCT03131544|MRI|mri
170573|NCT03128905|CPPD|cppd
170975|NCT03126279|Pain|pain
171158|NCT03125265|omega 3|omega 3
171357|NCT03123601|Falls|falls
171902|NCT03119974|ITP|itp
172140|NCT03118544|CTO|cto
172247|NCT03117972|LDH|ldh
173451|NCT03110770|Zika|zika
173966|NCT03107559|labor|labor
174424|NCT03104582|EBD|ebd
174672|NCT03102996|Alkali|alkali
175061|NCT03100539|Massage|massage
175171|NCT03099707|ART|art
175434|NCT03098459|ICU|icu
176312|NCT03093415|HCV|hcv
176565|NCT03091894|Sleep|sleep
177055|NCT03088904|Adults|adults
177728|NCT03084419|RA-ILD|ra-ild
177849|NCT03083730|Eczema|eczema
178169|NCT03081780|AML|aml
178924|NCT03077646|safety|safety
179124|NCT03076411|Pepsin|pepsin
179921|NCT03071562|HIV|hiv
180125|NCT03070418|DHS|dhs
181651|NCT03061136|EEG|eeg
181923|NCT03059238|TACE|tace
182590|NCT03054701|PFP|pfp
182976|NCT03052283|Gut|gut
183134|NCT03051217|PSO|pso
184374|NCT03043352|SAM|sam
184702|NCT03041623|IIPs|iips
185041|NCT03039049|IVF|ivf
185704|NCT03034967|COPD|copd
186468|NCT03030183|PNH|pnh
186700|NCT03028805|COPD|copd
187644|NCT03022825|BCG|bcg
187761|NCT03022253|PDA|pda
188013|NCT03020589|UNC|unc
189936|NCT03008187|AML|aml
189981|NCT03007927|pain|pain
190345|NCT03005379|FMT|fmt
190732|NCT03003130|NLF|nlf
191031|NCT03001232|QoL|qol
192285|NCT02993211|TURBT|turbt
192529|NCT02991586|BPD|bpd
192616|NCT02991118|LDL|ldl
193488|NCT02985879|PSP|psp
193879|NCT02983136|Surgery|surgery
194071|NCT02982395|BCG|bcg
194354|NCT02980497|plaque|plaque
194552|NCT02979496|immune|immune
195154|NCT02976311|TNF|tnf
195766|NCT02972606|HIV|hiv
196847|NCT02965638|LHH|lhh
196944|NCT02964884|NF1|nf1
198045|NCT02957812|Gait|gait
198321|NCT02956330|RVO|rvo
198403|NCT02955849|SLT|slt
198631|NCT02954536|16-937|16-937
198963|NCT02952534|ATM|atm
199802|NCT02947152|ADC|adc
199941|NCT02946138|GM-CSF|gm-csf
200127|NCT02944825|UTI|uti
200170|NCT02944578|HIV|hiv
200899|NCT02939872|BVS|bvs
200965|NCT02939612|App|app
202559|NCT02929017|IPF|ipf
202738|NCT02928185|16-1334|16-1334
203879|NCT02921776|App|app
204135|NCT02920138|Obesity|obesity
204351|NCT02918838|HIV|hiv
204409|NCT02918435|WE CARE|we care
204511|NCT02917954|seniors|seniors
204606|NCT02917447|PTSD|ptsd
204900|NCT02915484|Apathy|apathy
205095|NCT02914665|dropsy|dropsy
205201|NCT02914054|ITP|itp
205800|NCT02909764|Diet|diet
205894|NCT02909049|Pain|pain
206903|NCT02902809|asthma|asthma
207360|NCT02899533|PAH|pah
207709|NCT02896699|HIV|hiv
208089|NCT02894294|malaria|malaria
209070|NCT02888431|pH|ph
209720|NCT02883764|EPA|epa
210011|NCT02882126|PAH|pah
211441|NCT02872363|SMS|sms
211569|NCT02871648|Healthy|healthy
211690|NCT02870777|MRD|mrd
211961|NCT02868853|diet|diet
213281|NCT02860676|CLL|cll
213969|NCT02855944|A4|a4
214049|NCT02855515|BMI|bmi
214170|NCT02854891|Effects|effects
214759|NCT02851056|HCT|hct
215150|NCT02848586|HIV|hiv
215265|NCT02847962|Soy|soy
215668|NCT02845830|elderly|elderly
216872|NCT02838095|nap|nap
217257|NCT02835625|Cost|cost
217651|NCT02833012|AC-1202|ac-1202
218210|NCT02829840|AML|aml
218459|NCT02828592|SAA|saa
218636|NCT02827006|RCT|rct
218673|NCT02826811|kidney|kidney
218766|NCT02826343|COPD|copd
219172|NCT02823886|MRI|mri
220582|NCT02815293|EDE|ede
220844|NCT02813746|Tobacco|tobacco
221524|NCT02809820|ACS|acs
221573|NCT02809443|DNA|dna
222759|NCT02802137|timolol|timolol
223362|NCT02798796|MRI|mri
223958|NCT02796040|MRI|mri
224278|NCT02793934|ICF|icf
224709|NCT02791607|HPV|hpv
224751|NCT02791399|opioid|opioid
224872|NCT02790606|ESRD|esrd
225625|NCT02786342|HCC|hcc
226309|NCT02782338|INR|inr
226461|NCT02781545|Surgery|surgery
227183|NCT02777437|T4|t4
227414|NCT02776189|MRI|mri
227971|NCT02772835|nCPAP|ncpap
228676|NCT02768558|NSCLC|nsclc
229383|NCT02764047|NAFLD|nafld
229477|NCT02763540|ILD|ild
229834|NCT02761369|EEG|eeg
229890|NCT02761174|IPL|ipl
230431|NCT02757963|BPO|bpo
231071|NCT02753712|asthma|asthma
231676|NCT02750085|myPKFiT|mypkfit
232593|NCT02744261|HIV|hiv
233665|NCT02737358|NAC|nac
234097|NCT02734602|PET|pet
234463|NCT02732470|Qi Gong|qi gong
234777|NCT02730520|aging|aging
235113|NCT02728388|NF1|nf1
236469|NCT02720068|PD1|pd1
237264|NCT02715440|elderly|elderly
237786|NCT02712489|Tat|tat
237954|NCT02711371|fMRI|fmri
239246|NCT02703103|adult|adult
239867|NCT02699190|WGS|wgs
240094|NCT02697734|UFC|ufc
240826|NCT02693730|Gut|gut
241346|NCT02690688|NIRS|nirs
241457|NCT02690103|HCV|hcv
242171|NCT02685514|HIFU|hifu
243448|NCT02677168|OSA|osa
243849|NCT02674672|safety|safety
244146|NCT02672657|Cancer|cancer
244350|NCT02671110|Obesity|obesity
245640|NCT02663219|MSM|msm
246350|NCT02659358|Fitbit|fitbit
246881|NCT02656550|AUI|aui
247059|NCT02655367|MRI|mri
247461|NCT02653157|burns|burns
247957|NCT02649972|15-216|15-216
248449|NCT02647281|Safety|safety
248700|NCT02645539|VAD|vad
249225|NCT02642224|trauma|trauma
249589|NCT02640157|HCV|hcv
249631|NCT02639910|CLL|cll
249850|NCT02638532|Fat Pad|fat pad
250542|NCT02634697|AF|af
251313|NCT02630862|aspirin|aspirin
251445|NCT02630108|HCC|hcc
251821|NCT02628067|MSI|msi
252015|NCT02627222|Cassava|cassava
252221|NCT02625961|PD1|pd1
252618|NCT02623855|Nature|nature
253626|NCT02617641|eHealth|ehealth
254023|NCT02614820|sefety|sefety
254225|NCT02613715|Obesity|obesity
256162|NCT02601690|Cat|cat
256353|NCT02600429|NK|nk
257093|NCT02595983|FAP|fap
257335|NCT02594592|Asians|asians
257723|NCT02592473|BPH|bph
258685|NCT02586935|ASD|asd
259703|NCT02580435|outcome|outcome
261019|NCT02573623|Zambia|zambia
261104|NCT02573155|AZD8871|azd8871
262388|NCT02565888|HIV|hiv
262449|NCT02565550|IBS|ibs
263373|NCT02560129|ICU|icu
263485|NCT02559310|CAP|cap
263667|NCT02558192|LGG|lgg
263861|NCT02556905|Korea|korea
264189|NCT02554929|CBT|cbt
265743|NCT02545699|Adenoma|adenoma
266230|NCT02542618|CBT|cbt
266474|NCT02541006|FVC|fvc
267330|NCT02535364|ALL|all
267524|NCT02533947|Fatigue|fatigue
267915|NCT02531867|HPP|hpp
268047|NCT02530892|IVF|ivf
269925|NCT02519036|HTTRx|httrx
270616|NCT02514447|SCLC|sclc
272242|NCT02505165|Parent|parent
272331|NCT02504736|A1c|a1c
272536|NCT02503566|CAV|cav
272633|NCT02503098|App|app
272915|NCT02501473|FL|fl
273427|NCT02498639|outcome|outcome
273834|NCT02496390|Obesity|obesity
274030|NCT02495376|YACS|yacs
274348|NCT02493582|CIK|cik
274490|NCT02492737|AML|aml
274954|NCT02489461|HIV|hiv
275091|NCT02488707|TEM|tem
275128|NCT02488525|LVAD|lvad
275641|NCT02485652|NSCLC|nsclc
275841|NCT02484547|BIIB037|biib037
276411|NCT02481297|CLL|cll
276439|NCT02481193|Myalgia|myalgia
277151|NCT02476955|AKT1|akt1
277556|NCT02474537|INC280,|inc280,
277735|NCT02473497|ALK|alk
277832|NCT02473042|PONV|ponv
278230|NCT02471001|Heart|heart
279236|NCT02465528|IMT|imt
279729|NCT02462824|PAD|pad
281707|NCT02450552|ALS|als
281747|NCT02450240|Anxiety|anxiety
281938|NCT02449239|CIS|cis
282756|NCT02444091|CFS|cfs
283090|NCT02442115|ASD|asd
283138|NCT02442037|UC|uc
283433|NCT02440685|FL|fl
284105|NCT02436603|IBS|ibs
284449|NCT02434549|Adults|adults
284686|NCT02433158|SCD|scd
284744|NCT02432755|stroke|stroke
285754|NCT02427659|VRD|vrd
286333|NCT02424266|Imaging|imaging
286556|NCT02423044|Anxiety|anxiety
286661|NCT02422615|CDK|cdk
287711|NCT02417233|SMS|sms
287752|NCT02417012|diet|diet
288287|NCT02414269|CAR|car
288349|NCT02414048|Hypoxia|hypoxia
288570|NCT02412709|ECG|ecg
289444|NCT02407613|MR-HIFU|mr-hifu
289644|NCT02406131|RCT|rct
289756|NCT02405572|infants|infants
290583|NCT02401061|ITP|itp
290647|NCT02400580|Surgery|surgery
290755|NCT02399995|15-057|15-057
291461|NCT02395380|CRP|crp
291653|NCT02394223|PSA|psa
292346|NCT02389998|IBS|ibs
293460|NCT02383953|IBD|ibd
294669|NCT02377206|PET|pet
294959|NCT02375828|Phase 3|phase 3
295162|NCT02374450|Malaria|malaria
295972|NCT02369471|CBDV|cbdv
296690|NCT02365454|TAA|taa
296941|NCT02363907|CGM|cgm
297515|NCT02360579|TIL|til
299363|NCT02349854|itch|itch
299592|NCT02348489|AML|aml
300258|NCT02344784|ADD|add
301863|NCT02335294|PCA|pca
302078|NCT02334059|obese|obese
302352|NCT02332395|pain|pain
302778|NCT02329821|lactate|lactate
303157|NCT02327546|CKD|ckd
303769|NCT02324426|CNS|cns
303955|NCT02323412|MRI|mri
304248|NCT02322021|E2609|e2609
305445|NCT02315534|GBM|gbm
305750|NCT02313909|Xarelto|xarelto
306327|NCT02310399|ABI|abi
306715|NCT02308228|Muscle|muscle
307049|NCT02306369|IBS|ibs
307723|NCT02302521|MRI|mri
307871|NCT02301871|MNP|mnp
308523|NCT02298309|TB|tb
309089|NCT02294591|Urine|urine
309218|NCT02294136|HIV|hiv
309688|NCT02291809|Vaccine|vaccine
309849|NCT02290886|ALS|als
310305|NCT02288481|TB|tb
310590|NCT02286583|RTM|rtm
310853|NCT02285075|PD/PD|pd/pd
312380|NCT02276547|Mitral|mitral
313026|NCT02272504|HCC|hcc
313597|NCT02269306|AMH|amh
314131|NCT02266433|Toradol|toradol
314312|NCT02265198|ARDS|ards
315015|NCT02260505|KIT +|kit +
315197|NCT02259309|mucosal|mucosal
315500|NCT02257801|Memory|memory
315795|NCT02256085|TMS|tms
316188|NCT02253706|hypoxia|hypoxia
316298|NCT02253238|RT|rt
316488|NCT02252341|NAC|nac
317166|NCT02248688|Obesity|obesity
317267|NCT02248285|PCR|pcr
317579|NCT02247050|Humans|humans
317756|NCT02246361|Scale|scale
317948|NCT02245360|GRAZAX|grazax
318342|NCT02243449|weaning|weaning
319056|NCT02239900|XRT|xrt
319744|NCT02236650|Parents|parents
320147|NCT02234895|knee|knee
320427|NCT02233595|MRI|mri
320744|NCT02232087|pMDI|pmdi
320854|NCT02231632|Vaccine|vaccine
322267|NCT02225496|SCC|scc
322448|NCT02224885|CT|ct
322661|NCT02223975|Optical|optical
324068|NCT02217865|CRC|crc
326070|NCT02208206|HIV|hiv
326246|NCT02207413|Safety|safety
327176|NCT02203214|ACL|acl
327278|NCT02202746|MBC|mbc
327704|NCT02200848|CLL|cll
328147|NCT02198664|OIT|oit
328742|NCT02195856|MRI|mri
329009|NCT02194517|CHO|cho
329920|NCT02190643|HIV|hiv
331262|NCT02185365|DDH|ddh
331358|NCT02184949|PCI|pci
332537|NCT02178098|LDL|ldl
333547|NCT02172001|IDA|ida
333961|NCT02169505|HL|hl
334966|NCT02164630|TMD|tmd
335062|NCT02164292|ALPPS|alpps
335168|NCT02163798|Fitness|fitness
336078|NCT02159872|MDS|mds
336195|NCT02159235|CAD|cad
337354|NCT02153788|HIV|hiv
337785|NCT02151617|PK|pk
338654|NCT02147795|Anemia|anemia
340042|NCT02141373|seroma|seroma
340754|NCT02138162|Phase 1|phase 1
340976|NCT02137057|DM|dm
341524|NCT02134275|obesity|obesity
341614|NCT02134002|cocaine|cocaine
341707|NCT02133586|Ozone|ozone
342240|NCT02130960|RMR|rmr
342626|NCT02129543|SCT|sct
343097|NCT02127515|NIPT|nipt
343776|NCT02124213|PET|pet
344372|NCT02121353|AMD|amd
344931|NCT02119156|PGA|pga
345167|NCT02118051|IVF|ivf
345329|NCT02117375|MRI|mri
345467|NCT02116738|vas|vas
345615|NCT02116049|HIV|hiv
347068|NCT02110238|Supartz|supartz
347493|NCT02108392|PXE|pxe
347572|NCT02107989|MRI|mri
347952|NCT02106611|MRI|mri
348230|NCT02105545|DNA|dna
348550|NCT02104076|Stents|stents
348891|NCT02102412|crc|crc
349176|NCT02101177|SVR|svr
349556|NCT02099487|HGG|hgg
349752|NCT02098551|bet v 1|bet v 1
349956|NCT02097602|MACCEs|macces
350332|NCT02095938|mri|mri
350369|NCT02095678|HCC|hcc
351347|NCT02091167|tDCS|tdcs
351739|NCT02089230|AML|aml
351826|NCT02088749|obesity|obesity
352407|NCT02085590|Sepsis|sepsis
353805|NCT02079389|LUS|lus
354409|NCT02076659|F8|f8
354584|NCT02075983|DNA|dna
354683|NCT02075515|Safety|safety
354783|NCT02075112|Soy|soy
356171|NCT02068625|azilect|azilect
357447|NCT02062658|OCD|ocd
357962|NCT02060448|CBT|cbt
358484|NCT02057978|TLF|tlf
359239|NCT02054806|PD1|pd1
359328|NCT02054455|PPI|ppi
360335|NCT02049905|sarcoma|sarcoma
360556|NCT02048930|GPRD|gprd
361543|NCT02044731|Schools|schools
361961|NCT02043080|HIV|hiv
362841|NCT02039206|TMS|tms
363052|NCT02038192|Hope|hope
363159|NCT02037698|CTO|cto
363455|NCT02036450|stroke|stroke
364417|NCT02031887|infants|infants
365021|NCT02028897|IVF|ivf
366570|NCT02022007|IGT|igt
366618|NCT02021825|relapse|relapse
366963|NCT02019927|TES|tes
367047|NCT02019602|CZP|czp
367216|NCT02018705|LHM|lhm
367327|NCT02018237|Obesity|obesity
367630|NCT02016924|HIV|hiv
369806|NCT02007551|Meals|meals
369901|NCT02007122|HD|hd
370420|NCT02004756|fontan|fontan
370724|NCT02003196|virus|virus
372414|NCT01995942|MRI|mri
373173|NCT01992029|ALS|als
373964|NCT01988220|stroke|stroke
374072|NCT01987817|Peanut|peanut
374986|NCT01983657|PAP|pap
375104|NCT01983189|TMS|tms
375425|NCT01981785|IgG|igg
378398|NCT01968265|T2DM|t2dm
378604|NCT01967407|RCC|rcc
378982|NCT01966133|HCC|hcc
379086|NCT01965535|HCV|hcv
379689|NCT01962857|Fitness|fitness
380060|NCT01961414|AMD|amd
380555|NCT01958970|MHD|mhd
380641|NCT01958502|BMP2|bmp2
381132|NCT01955915|OCT|oct
381627|NCT01953809|safety|safety
381790|NCT01952860|XRT|xrt
382528|NCT01949272|ARDS|ards
382927|NCT01947335|Stent|stent
383210|NCT01946165|Zytiga|zytiga
383799|NCT01943461|Phase 1|phase 1
383958|NCT01942655|HIV|hiv
384456|NCT01940289|VAS|vas
385176|NCT01937013|emotion|emotion
385420|NCT01935674|HIV|hiv
385618|NCT01934855|MRI|mri
385893|NCT01933698|Human|human
386877|NCT01928992|3D|3d
386970|NCT01928550|OCT|oct
387162|NCT01927718|MM|mm
387361|NCT01926769|FOLFOX6|folfox6
390242|NCT01914068|Surgery|surgery
390979|NCT01910129|VNS|vns
392021|NCT01904851|Stents|stents
392300|NCT01903603|MRI|mri
392875|NCT01901016|HIV|hiv
393023|NCT01900314|TMS|tms
393110|NCT01899937|FMD|fmd
393411|NCT01898429|DBS|dbs
393892|NCT01895829|DCI|dci
394690|NCT01892566|HIV|hiv
395091|NCT01890980|MPM|mpm
395250|NCT01890304|TBI|tbi
395464|NCT01889316|ECG|ecg
395667|NCT01888419|Pain|pain
396366|NCT01885026|Alcohol|alcohol
396581|NCT01883973|PD|pd
397055|NCT01882088|GERD|gerd
397356|NCT01881048|Surgery|surgery
397564|NCT01880151|EEG|eeg
397903|NCT01878630|CHF|chf
399381|NCT01872221|MRI|mri
400000|NCT01869062|CRT|crt
401541|NCT01862055|Stress|stress
401752|NCT01861002|ALL|all
401829|NCT01860664|allergy|allergy
401938|NCT01860261|HIV|hiv
402338|NCT01858493|Falls|falls
403847|NCT01852604|HCV|hcv
403953|NCT01852188|Glove|glove
404860|NCT01848223|QoL|qol
405278|NCT01846364|DIM|dim
406254|NCT01841489|CLL|cll
408007|NCT01833390|HXe|hxe
408146|NCT01832766|P50|p50
410822|NCT01820637|SFA|sfa
410889|NCT01820273|GIP|gip
411366|NCT01817842|EMA|ema
412164|NCT01814514|AGV|agv
412252|NCT01814098|Lexapro|lexapro
412838|NCT01811355|ALS|als
413052|NCT01810276|plavix|plavix
413357|NCT01808820|HGG|hgg
413582|NCT01807871|NRT|nrt
413844|NCT01806558|breast|breast
414434|NCT01804192|HR|hr
415035|NCT01801696|Massage|massage
415159|NCT01801254|EEG|eeg
415555|NCT01799265|OSA|osa
415850|NCT01797900|NPC|npc
416959|NCT01793090|VEP|vep
418348|NCT01786395|rp|rp
418609|NCT01785264|Tendon|tendon
420469|NCT01776853|MRI|mri
421345|NCT01772953|AML|aml
421738|NCT01771211|MCI|mci
422050|NCT01769898|HAT|hat
422196|NCT01769144|BCT|bct
422497|NCT01767987|ACS|acs
422836|NCT01766518|LT|lt
423633|NCT01762826|GDM|gdm
423983|NCT01761110|Opioids|opioids
424511|NCT01758588|PMF|pmf
425870|NCT01752166|Candida|candida
426009|NCT01751438|M1|m1
426302|NCT01749800|TBI|tbi
426491|NCT01748955|MDD|mdd
427113|NCT01746147|AML|aml
427387|NCT01744808|Healthy|healthy
427780|NCT01743092|webinar|webinar
428072|NCT01741922|ASA|asa
428892|NCT01738451|QTc|qtc
429086|NCT01737762|dvt|dvt
429597|NCT01735617|adrenal|adrenal
429875|NCT01734330|Smokers|smokers
430272|NCT01732289|Gene|gene
431066|NCT01728610|pain|pain
431807|NCT01725269|PAH|pah
432428|NCT01722214|MRI|mri
434395|NCT01713738|ITP|itp
435107|NCT01710254|MRI|mri
435405|NCT01709058|Oxygen|oxygen
435909|NCT01706939|HPV|hpv
436829|NCT01703195|DWMR|dwmr
437616|NCT01699646|CTG|ctg
437763|NCT01699165|hay|hay
438625|NCT01694875|HPV|hpv
438716|NCT01694381|M5|m5
439016|NCT01693224|TB|tb
439597|NCT01690793|ASTHMA|asthma
439865|NCT01689584|VUS|vus
440003|NCT01688908|China|china
440415|NCT01687062|phytate|phytate
440726|NCT01685619|AML|aml
442014|NCT01680211|Sesame,|sesame,
442685|NCT01677156|GES|ges
443757|NCT01672502|rls|rls
444440|NCT01669486|Pain|pain
445474|NCT01664832|RDS|rds
447132|NCT01656746|SILS|sils
447336|NCT01655823|TTX|ttx
447666|NCT01654263|elderly|elderly
448622|NCT01649869|CMV|cmv
448933|NCT01648257|HIV|hiv
449754|NCT01644019|stroke|stroke
450173|NCT01642485|Fed|fed
450571|NCT01640626|Ascaris|ascaris
450949|NCT01639001|NSCLC|nsclc
451331|NCT01636934|CXRT|cxrt
452913|NCT01629316|HIV|hiv
453331|NCT01627431|PAD|pad
453626|NCT01626053|HbA1C|hba1c
455408|NCT01618331|FSHD|fshd
455624|NCT01617304|CVD|cvd
456857|NCT01611584|ALA|ala
457485|NCT01609465|CVD|cvd
457960|NCT01607463|pain|pain
459626|NCT01600183|MTA|mta
459678|NCT01599910|Scribes|scribes
460357|NCT01597193|MDV3100|mdv3100
460751|NCT01595698|IGF-1|igf-1
461357|NCT01593241|RT|rt
461950|NCT01590615|HBV|hbv
462566|NCT01587547|ART|art
463149|NCT01585025|FXR|fxr
463569|NCT01583426|GBG|gbg
464358|NCT01580033|safety|safety
465080|NCT01576913|music|music
466902|NCT01569373|GVHD|gvhd
467061|NCT01568749|otc|otc
467890|NCT01565226|CO2|co2
468295|NCT01563276|PD|pd
469406|NCT01558466|PPHN|pphn
470431|NCT01554319|Phase 1|phase 1
471628|NCT01549210|gout|gout
471916|NCT01547988|Falls|falls
472517|NCT01545648|DTC|dtc
472765|NCT01544712|hip|hip
473079|NCT01543373|DES|des
474464|NCT01537393|cornea|cornea
474858|NCT01535482|Suicide|suicide
475199|NCT01534104|DTI|dti
475455|NCT01532895|Pain|pain
477191|NCT01525355|EUS|eus
478159|NCT01521065|AMD|amd
478558|NCT01519466|SMBG|smbg
480878|NCT01509794|CME|cme
481931|NCT01505387|Obese|obese
482040|NCT01504919|Latinos|latinos
482405|NCT01503489|Switch.|switch.
483207|NCT01500161|AML|aml
483830|NCT01497405|HIV|hiv
484191|NCT01495897|DYT 11|dyt 11
485202|NCT01491633|NSCLC|nsclc
485528|NCT01490411|SIT|sit
485805|NCT01489254|MRI,|mri,
486406|NCT01486784|AML|aml
487089|NCT01483898|CLI|cli
487606|NCT01481675|PYY|pyy
488096|NCT01479634|ART|art
488577|NCT01477944|Statins|statins
488683|NCT01477450|Oxygen|oxygen
488987|NCT01475981|JTK-853|jtk-853
489496|NCT01473927|SES-CD|ses-cd
490098|NCT01471457|pessary|pessary
491865|NCT01464346|CGM|cgm
493583|NCT01457170|Apelin|apelin
493681|NCT01456780|Zylet|zylet
493786|NCT01456403|Carotid|carotid
494872|NCT01451723|EGCG|egcg
495389|NCT01449487|IBS|ibs
495714|NCT01448161|ICU|icu
495880|NCT01447472|MDMA,|mdma,
496103|NCT01446666|MRI|mri
497267|NCT01441908|Statin|statin
498334|NCT01437930|TAG|tag
498563|NCT01436877|BPH|bph
498567|NCT01436864|)|)
498894|NCT01435512|CBT|cbt
499075|NCT01434745|SLOS|slos
500691|NCT01428739|MRS|mrs
501547|NCT01424956|breast|breast
502440|NCT01421511|ABSSSI|absssi
503140|NCT01418898|iron|iron
503532|NCT01416870|safety|safety
503698|NCT01416233|fat|fat
504724|NCT01412177|Vertigo|vertigo
505241|NCT01410162|Renal|renal
505445|NCT01409226|MRI|mri
505915|NCT01407627|human|human
506114|NCT01406821|PRP|prp
507073|NCT01402817|NF1|nf1
507249|NCT01402141|wheal|wheal
507354|NCT01401699|OCT|oct
508715|NCT01395394|PKU|pku
509630|NCT01391624|craving|craving
509919|NCT01390402|Fludara|fludara
510229|NCT01388933|natural|natural
510854|NCT01386489|HV|hv
510918|NCT01386177|MDMA|mdma
511306|NCT01384292|OIC|oic
511997|NCT01381237|Balance|balance
512085|NCT01381042|Factor|factor
512189|NCT01380613|HIV|hiv
512363|NCT01379846|HIB|hib
512995|NCT01377389|ADT|adt
513649|NCT01374698|PCI|pci
513723|NCT01374360|PNH|pnh
514416|NCT01371240|MRI|mri
514700|NCT01369979|FDG|fdg
515061|NCT01368614|OHS|ohs
515406|NCT01367067|MRI|mri
516612|NCT01362153|Simponi|simponi
517104|NCT01360229|Fatigue|fatigue
517999|NCT01356160|HCV|hcv
518283|NCT01355016|RSV|rsv
518750|NCT01352975|AMD|amd
519299|NCT01350492|pain|pain
519498|NCT01349673|Colitis|colitis
520759|NCT01345006|SMD|smd
521590|NCT01341132|MRI|mri
521789|NCT01340222|MCP-1|mcp-1
522179|NCT01338805|CNS|cns
522691|NCT01336712|CML|cml
522786|NCT01336309|Yoga|yoga
523358|NCT01333982|Drying|drying
524177|NCT01330394|ERP|erp
524372|NCT01329458|FLL|fll
524595|NCT01328561|Placebo|placebo
525389|NCT01325246|repair|repair
526899|NCT01318967|MRI|mri
527165|NCT01317693|ED|ed
527877|NCT01315535|TMD|tmd
528067|NCT01314664|CIS|cis
528161|NCT01314313|TAVI|tavi
528666|NCT01312155|video|video
530165|NCT01305954|UNC|unc
530632|NCT01304043|forum|forum
530989|NCT01302626|RNA|rna
532305|NCT01296984|APR|apr
532422|NCT01296451|MVA|mva
532741|NCT01295242|HPV|hpv
533611|NCT01291758|GWI|gwi
533992|NCT01290263|GBM|gbm
537040|NCT01276860|OSA|osa
537317|NCT01275625|naive|naive
537721|NCT01274078|lipids|lipids
540685|NCT01261598|SUV|suv
541249|NCT01259245|Tai chi|tai chi
541745|NCT01256762|Avastin|avastin
541864|NCT01256203|PDT|pdt
542146|NCT01255007|3T|3t
542419|NCT01253824|FSH|fsh
542532|NCT01253161|lungs|lungs
543126|NCT01250509|Stress|stress
543617|NCT01248234|elderly|elderly
544391|NCT01244672|THD|thd
544692|NCT01243190|SLL|sll
545600|NCT01239394|NHL|nhl
546681|NCT01235234|KCS|kcs
546915|NCT01234194|Pain|pain
546995|NCT01233739|Placebo|placebo
547762|NCT01230281|C3G|c3g
549486|NCT01222052|uPA|upa
549769|NCT01220960|women|women
550170|NCT01219387|AMH|amh
550459|NCT01217944|PM|pm
551247|NCT01214642|Cancer|cancer
551465|NCT01213498|NO|no
551668|NCT01212835|Obesity|obesity
552825|NCT01207778|MRI|mri
553538|NCT01204788|AML|aml
553625|NCT01204437|EC|ec
553912|NCT01203371|LUTS|luts
554489|NCT01201044|BAI|bai
554637|NCT01200498|PMF|pmf
554698|NCT01200342|GCP|gcp
555489|NCT01196949|Ankle|ankle
558391|NCT01185002|CE|ce
559223|NCT01181544|Heparin|heparin
559425|NCT01180816|AA|aa
559734|NCT01179425|stress|stress
560118|NCT01177774|OCD|ocd
560703|NCT01175551|PTB|ptb
561033|NCT01174212|hip|hip
561522|NCT01172067|CRT|crt
561971|NCT01170468|DM|dm
562457|NCT01168687|keppra|keppra
563779|NCT01162850|Melasma|melasma
564660|NCT01159132|HIV|hiv
564697|NCT01158885|MRD|mrd
565138|NCT01156844|Asthma|asthma
565676|NCT01154894|DHA|dha
566014|NCT01153347|MDD|mdd
566244|NCT01152346|MDS|mds
567796|NCT01146132|BMI|bmi
568392|NCT01143519|HV|hv
568780|NCT01141933|QOL|qol
569357|NCT01139515|Korean|korean
569558|NCT01138696|ACL|acl
569730|NCT01138046|ErbB2|erbb2
570549|NCT01135719|Myopia|myopia
570837|NCT01134445|Hip|hip
571100|NCT01133015|FFR|ffr
573476|NCT01123382|Stroke|stroke
574610|NCT01118494|CKD|ckd
575450|NCT01116102|clysis|clysis
576070|NCT01113463|CNS|cns
576530|NCT01111565|MDD|mdd
576941|NCT01109849|BMI|bmi
577119|NCT01109095|HER2|her2
577721|NCT01106534|Stents|stents
577902|NCT01105715|cLDL|cldl
578566|NCT01102803|Heights|heights
578674|NCT01102257|DED|ded
579677|NCT01098708|DMD|dmd
581362|NCT01092078|men|men
581522|NCT01091480|LVH|lvh
581754|NCT01090336|ACS|acs
582059|NCT01089114|HIV|hiv
582599|NCT01087190|kidney|kidney
582983|NCT01085591|CDI|cdi
583400|NCT01083719|MRI|mri
583779|NCT01082328|Kuvan®|kuvan®
584464|NCT01079598|IPV|ipv
584582|NCT01079026|hnp|hnp
584825|NCT01078051|stent|stent
585061|NCT01077401|DME|dme
585493|NCT01075425|Velcade|velcade
586544|NCT01071161|LCQ|lcq
587569|NCT01066663|CLL|cll
588873|NCT01061255|Stress|stress
589519|NCT01058681|LH|lh
590432|NCT01054664|RNA|rna
590768|NCT01053325|HIV|hiv
591031|NCT01052415|HIV|hiv
591121|NCT01052116|Soy|soy
592494|NCT01047735|obese|obese
592714|NCT01047163|Men|men
592919|NCT01046461|cancer|cancer
593259|NCT01044992|MSA|msa
593412|NCT01044381|DSO|dso
593583|NCT01043757|obesity|obesity
593901|NCT01042444|PCI|pci
594841|NCT01038791|COPD|copd
594959|NCT01038323|FMS|fms
595152|NCT01037608|Sativex|sativex
595240|NCT01037231|PH|ph
595541|NCT01035476|ALS|als
596042|NCT01033058|PCI|pci
596165|NCT01032603|IXT|ixt
596973|NCT01029873|p53|p53
597597|NCT01027052|MDA|mda
597958|NCT01025544|Vaccine|vaccine
598058|NCT01025154|Ara-C|ara-c
598175|NCT01024595|HIV|hiv
599793|NCT01017731|QTc|qtc
600386|NCT01015495|CNV|cnv
600447|NCT01015261|ALL|all
600845|NCT01013662|icu|icu
601060|NCT01012674|MRA|mra
601145|NCT01012323|PID|pid
602139|NCT01008410|UC|uc
602659|NCT01006304|Men|men
602857|NCT01005407|HBV|hbv
603080|NCT01004458|women|women
603208|NCT01004029|17P|17p
603468|NCT01002924|Cancer|cancer
603962|NCT01000896|Phase I|phase i
604626|NCT00998270|MM|mm
605489|NCT00995319|mouth|mouth
605604|NCT00994955|SRT|srt
606495|NCT00991731|Female|female
606694|NCT00991068|Pain|pain
607882|NCT00986323|Asthma|asthma
608238|NCT00984997|PCI|pci
608988|NCT00982306|alcohol|alcohol
609238|NCT00981318|HIV|hiv
609314|NCT00981045|IDA|ida
609775|NCT00979199|IHD|ihd
610313|NCT00977210|VDA|vda
610482|NCT00976456|NSCLC|nsclc
610570|NCT00976131|CAM|cam
611694|NCT00972049|safety|safety
612575|NCT00968396|PBPC|pbpc
612677|NCT00968084|HV|hv
613794|NCT00963833|MS|ms
614719|NCT00960297|NSCLC|nsclc
615590|NCT00956878|SNP|snp
615951|NCT00955968|HAART|haart
616042|NCT00955617|MRA|mra
616279|NCT00954720|AML|aml
616459|NCT00953615|PSC|psc
617682|NCT00949481|job aid|job aid
618372|NCT00947440|Phase 1|phase 1
618585|NCT00946478|elidel|elidel
618743|NCT00946231|BNP|bnp
619218|NCT00944294|Angina|angina
619681|NCT00942461|CRP|crp
619905|NCT00941876|ULN|uln
620304|NCT00940134|GLP-1|glp-1
620827|NCT00937638|CVD|cvd
621947|NCT00933582|Placebo|placebo
622243|NCT00932269|Sweden|sweden
622825|NCT00929747|IOL|iol
624501|NCT00923364|GATA2|gata2
624713|NCT00922558|tetrax|tetrax
624942|NCT00921648|EEG|eeg
625081|NCT00921128|PD|pd
625217|NCT00920725|DKA|dka
625299|NCT00920439|IPV|ipv
627225|NCT00912522|reward|reward
627457|NCT00911482|FFA|ffa
627517|NCT00911248|PTC299|ptc299
627623|NCT00910871|TB|tb
627731|NCT00910429|PH|ph
628212|NCT00908466|Uveitis|uveitis
628386|NCT00907777|safety|safety
628781|NCT00906061|ECOG 2|ecog 2
628970|NCT00905268|FRDA|frda
629108|NCT00904826|NMO|nmo
629289|NCT00904436|Dyspnea|dyspnea
632604|NCT00897299|HER-2|her-2
633254|NCT00895310|PSA|psa
633697|NCT00893425|CD95|cd95
634973|NCT00889031|CLL|cll
635486|NCT00886847|FNA|fna
635572|NCT00886509|Stable|stable
635777|NCT00885807|WSR|wsr
636254|NCT00883896|ACR|acr
636328|NCT00883571|flaps|flaps
637507|NCT00878579|DDD|ddd
637608|NCT00878150|CBT|cbt
637719|NCT00877747|PET|pet
637840|NCT00877227|CVA|cva
638503|NCT00874562|ALL|all
638989|NCT00872703|CMV|cmv
640080|NCT00868543|obesity|obesity
640167|NCT00868088|AC|ac
640768|NCT00866034|IVF|ivf
641112|NCT00864578|IOP|iop
641474|NCT00862979|CNI|cni
641730|NCT00861861|CAD|cad
643523|NCT00854165|ECMO|ecmo
643810|NCT00853060|weaning|weaning
644352|NCT00851136|CRC|crc
644484|NCT00850707|AVF|avf
645953|NCT00844532|PAD|pad
646258|NCT00843219|PET|pet
646503|NCT00842296|GSV|gsv
646889|NCT00840788|repair|repair
647486|NCT00838318|CRC|crc
648052|NCT00836108|Dyspnea|dyspnea
648334|NCT00834782|PK|pk
648379|NCT00834548|MRI|mri
648634|NCT00833365|PDA|pda
650124|NCT00827398|MSC|msc
650260|NCT00826969|Asthma|asthma
650548|NCT00825825|Celexa|celexa
651388|NCT00823017|IgA|iga
651584|NCT00822302|stroke|stroke
652083|NCT00820222|ErbB2|erbb2
652175|NCT00819897|MS|ms
652814|NCT00817791|CABG|cabg
653445|NCT00815711|IPF|ipf
653557|NCT00815256|CXL|cxl
653752|NCT00814554|obesity|obesity
653932|NCT00813826|PHN|phn
654567|NCT00811590|Cancer|cancer
655242|NCT00809029|LPL|lpl
655621|NCT00807625|CD4+|cd4+
656433|NCT00804336|SOM230|som230
656852|NCT00802555|HCC|hcc
657760|NCT00799071|CGD|cgd
658328|NCT00796783|Hormone|hormone
659205|NCT00792805|COPD|copd
660706|NCT00787527|AD|ad
662189|NCT00781690|Heparin|heparin
662335|NCT00780962|NAC|nac
662788|NCT00778895|Flu|flu
663377|NCT00776035|PET|pet
663448|NCT00775658|allergy|allergy
664189|NCT00772759|PK|pk
664665|NCT00770822|Primary|primary
664819|NCT00770380|smoking|smoking
664943|NCT00769860|IBM|ibm
666700|NCT00762346|NTX|ntx
667228|NCT00760071|MRI,|mri,
668105|NCT00756028|OHSS|ohss
668675|NCT00753766|A1c|a1c
669685|NCT00750100|IVF|ivf
670336|NCT00748267|pain|pain
670752|NCT00746616|Young,|young,
671052|NCT00745446|effects|effects
671376|NCT00744198|TOT|tot
671444|NCT00743925|ACS|acs
671644|NCT00743158|pft|pft
672392|NCT00740558|HRV|hrv
672873|NCT00738894|TIA|tia
673830|NCT00735436|GBM|gbm
674278|NCT00734136|Ascites|ascites
675212|NCT00730314|BMT|bmt
675249|NCT00730288|Dengue|dengue
675572|NCT00728923|OCD|ocd
675847|NCT00727948|Aspirin|aspirin
676244|NCT00726778|obesity|obesity
676294|NCT00726687|Cancer|cancer
678465|NCT00718666|Humans|humans
679832|NCT00713544|RA|ra
680439|NCT00711438|RCT|rct
680594|NCT00710801|HCV|hcv
681460|NCT00707434|ICU|icu
681614|NCT00706732|Flu|flu
683249|NCT00699244|forearm|forearm
683542|NCT00697983|ATP|atp
684607|NCT00693511|obesity|obesity
684802|NCT00692796|Dyspnea|dyspnea
685182|NCT00691288|HIV|hiv
685324|NCT00690976|gay|gay
685444|NCT00690508|use|use
685573|NCT00690079|MAD|mad
686040|NCT00688493|QT|qt
686530|NCT00686413|PET|pet
687949|NCT00680862|HIV|hiv
688823|NCT00677443|S-1|s-1
689014|NCT00676702|Lipase|lipase
689342|NCT00675389|HIV|hiv
689696|NCT00674258|URLC10|urlc10
690445|NCT00671372|CRC|crc
690641|NCT00670761|MVA|mva
691542|NCT00666965|SPM 962|spm 962
691968|NCT00665717|statins|statins
692224|NCT00664677|AML|aml
693447|NCT00659880|MAT|mat
694098|NCT00657124|AEN|aen
695269|NCT00652652|Dyspnea|dyspnea
695391|NCT00652119|Taxol|taxol
695461|NCT00651820|Santyl|santyl
695601|NCT00651651|Asthma|asthma
696835|NCT00644189|Clolar|clolar
697645|NCT00640887|HIV|hiv
697727|NCT00640497|Ricin A|ricin a
697994|NCT00639288|PTSD|ptsd
699037|NCT00635206|OSA|osa
699489|NCT00633360|PMS|pms
699930|NCT00631449|HIV|hiv
700264|NCT00630331|Flu|flu
700966|NCT00627653|PPAR|ppar
701053|NCT00627263|ICD|icd
701433|NCT00625807|Stress|stress
702700|NCT00621023|MDS|mds
703128|NCT00619476|PHN|phn
703317|NCT00618683|AVNRT|avnrt
703401|NCT00618384|TACE|tace
703540|NCT00617903|rosacea|rosacea
703572|NCT00617786|urgency|urgency
703660|NCT00617383|MS|ms
703756|NCT00616928|human|human
705391|NCT00610571|AA|aa
705489|NCT00610181|MRI|mri
706333|NCT00606996|Women|women
706625|NCT00605423|AMD|amd
707562|NCT00601354|Alli|alli
708119|NCT00598689|LASIK|lasik
708226|NCT00598286|HV|hv
708422|NCT00597519|06-014|06-014
708728|NCT00596362|Eye|eye
709413|NCT00593112|ADHD|adhd
711030|NCT00586807|UC|uc
711283|NCT00585572|MCI|mci
711314|NCT00585312|FAP|fap
711412|NCT00584805|EEE|eee
711621|NCT00583791|septal|septal
712022|NCT00582075|Cancer|cancer
713106|NCT00577759|diet|diet
713347|NCT00576498|GERD|gerd
713994|NCT00573469|GI|gi
714745|NCT00570167|Hip|hip
715659|NCT00566423|PAH|pah
716056|NCT00564603|Opioids|opioids
716443|NCT00562874|HIV|hiv
717024|NCT00560534|MRI|mri
717255|NCT00559338|CHF|chf
718466|NCT00554437|RCT|rct
718551|NCT00554073|3T|3t
719004|NCT00552214|HBV|hbv
719103|NCT00551720|HIV|hiv
719548|NCT00549718|Latuda|latuda
719747|NCT00548717|GVHD|gvhd
721537|NCT00540969|pain|pain
721768|NCT00539747|HD|hd
722973|NCT00536666|Aneamia|aneamia
723272|NCT00535392|Child|child
727458|NCT00519090|cml|cml
727772|NCT00517764|MDD|mdd
727981|NCT00516685|EGF|egf
729450|NCT00511537|AML|aml
729581|NCT00511017|Calcium|calcium
730480|NCT00508326|Liver|liver
731808|NCT00503919|MDC|mdc
732020|NCT00503100|Pain|pain
732753|NCT00500617|CTA|cta
733438|NCT00499278|joint|joint
733515|NCT00498966|Kidney|kidney
733840|NCT00497796|CMV|cmv
734158|NCT00496587|RCC|rcc
734519|NCT00495235|PCOS|pcos
735873|NCT00489931|HV|hv
736326|NCT00488306|cIAI|ciai
737269|NCT00484627|HIV|hiv
737342|NCT00484328|Dosage|dosage
737684|NCT00482937|Safety|safety
738610|NCT00479596|OAB|oab
738951|NCT00478179|PHN|phn
739866|NCT00475046|TTM|ttm
740057|NCT00474344|DNA|dna
740182|NCT00473837|malaria|malaria
742389|NCT00465608|AZF|azf
744790|NCT00456833|RAD|rad
745670|NCT00453505|HV|hv
746778|NCT00449761|adults|adults
747334|NCT00448084|HV|hv
747581|NCT00447005|PK|pk
748141|NCT00445913|safety|safety
748514|NCT00445237|TMS|tms
748669|NCT00444561|Symlin|symlin
749762|NCT00441740|NSCLC|nsclc
749975|NCT00440947|HIV|hiv
750294|NCT00439803|CMV|cmv
751046|NCT00436943|smoking|smoking
751278|NCT00436384|CMV CMI|cmv cmi
751503|NCT00435266|remote|remote
752345|NCT00432588|ROM|rom
752969|NCT00430261|BAC|bac
753463|NCT00428454|QCA|qca
753854|NCT00427167|HV|hv
754642|NCT00424216|HV|hv
755009|NCT00423436|Survey|survey
755939|NCT00419341|PID|pid
756986|NCT00416052|PTH|pth
757195|NCT00415350|Sputum|sputum
757334|NCT00414960|Healthy|healthy
757621|NCT00413621|MRI|mri
758833|NCT00409695|ATG|atg
759032|NCT00408967|Cancer|cancer
759230|NCT00408109|HV|hv
759327|NCT00407576|PET|pet
759426|NCT00407043|Lotemax|lotemax
759731|NCT00405600|BMP-2|bmp-2
760570|NCT00402506|surgery|surgery
761056|NCT00400608|Asthma|asthma
761513|NCT00398580|DHT|dht
761776|NCT00397566|HIV|hiv
762047|NCT00396526|India|india
764925|NCT00385892|IAP|iap
765602|NCT00382785|online|online
766038|NCT00381303|HIV|hiv
766110|NCT00381108|BPH|bph
766424|NCT00379470|GBM|gbm
767582|NCT00376506|Stroke|stroke
768102|NCT00374673|TMS|tms
768379|NCT00373607|Adult|adult
770962|NCT00363974|AML|aml
772361|NCT00358735|SFT|sft
772948|NCT00356798|H5N1|h5n1
773732|NCT00353925|LVH|lvh
774697|NCT00350662|L1|l1
775084|NCT00348933|Ataxia|ataxia
775160|NCT00348608|X-ray|x-ray
779445|NCT00332189|PKU|pku
780133|NCT00329251|HIV|hiv
781725|NCT00323453|Surgery|surgery
782141|NCT00321581|AML|aml
782577|NCT00319930|CLL|cll
783965|NCT00314795|CKD|ckd
784301|NCT00313573|pain|pain
785506|NCT00308711|PGE2|pge2
785900|NCT00307021|Malaria|malaria
787307|NCT00302302|GIP|gip
787613|NCT00301652|ANCA|anca
788236|NCT00299208|Malaria|malaria
790553|NCT00291278|HV|hv
791615|NCT00287820|glucose|glucose
793748|NCT00279539|DNA|dna
793844|NCT00279110|HIV|hiv
794584|NCT00276120|Breast|breast
794989|NCT00274729|Obesity|obesity
795206|NCT00273403|HIV|hiv
795891|NCT00270634|Adult|adult
795988|NCT00270283|HIV|hiv
796323|NCT00269191|Arcoxia|arcoxia
796766|NCT00267241|ALI|ali
798450|NCT00260117|walking|walking
798747|NCT00258791|ECT|ect
799831|NCT00255112|SAD|sad
800495|NCT00253045|HIV|hiv
801084|NCT00250185|HV|hv
801176|NCT00249743|RCT|rct
803867|NCT00238537|MRI|mri
804330|NCT00237289|Mania|mania
804520|NCT00236678|Anemia|anemia
805039|NCT00234299|Cancer|cancer
805460|NCT00231972|HIV|hiv
807898|NCT00221039|ECP|ecp
809175|NCT00213785|ANP|anp
810037|NCT00210301|MS|ms
810708|NCT00207181|PDA|pda
810985|NCT00205660|Obesity|obesity
811178|NCT00204256|anemia|anemia
812300|NCT00198861|HIV|hiv
812833|NCT00196131|SAH|sah
813098|NCT00194675|BPH|bph
813794|NCT00189384|Neonate|neonate
814305|NCT00186784|TMS|tms
814781|NCT00183339|Autism|autism
815012|NCT00182585|HIV|hiv
815562|NCT00179855|ECP|ecp
815769|NCT00179010|AMP|amp
816079|NCT00177307|colon|colon
817504|NCT00170105|Stable|stable
817910|NCT00168259|HIV|hiv
818399|NCT00166179|CAD|cad
819810|NCT00159536|PCOS|pcos
820780|NCT00154856|FEM|fem
821327|NCT00152061|HIV|hiv
821435|NCT00151268|LINCL|lincl
821715|NCT00149747|Sleep|sleep
821846|NCT00149201|MTX|mtx
822407|NCT00146796|RDT|rdt
822553|NCT00146302|BCG|bcg
823857|NCT00139191|PET|pet
824463|NCT00136461|ATRA|atra
824759|NCT00135226|Aspirin|aspirin
825203|NCT00133757|Tobacco|tobacco
825513|NCT00132288|Aging|aging
826633|NCT00128284|GI|gi
826833|NCT00127452|EPA|epa
827557|NCT00124748|CML|cml
828611|NCT00120666|HV|hv
828930|NCT00119444|PET|pet
829347|NCT00117858|FTP|ftp
829378|NCT00117741|DBT|dbt
829656|NCT00116792|CAD|cad
829759|NCT00116467|AML|aml
830180|NCT00115024|CVD|cvd
830269|NCT00114803|DXA|dxa
830820|NCT00113126|STI|sti
831395|NCT00110942|OA|oa
831449|NCT00110721|DAVANAT|davanat
831555|NCT00110305|ARV|arv
832253|NCT00108901|female|female
832373|NCT00108394|Uremia|uremia
832570|NCT00107770|ALS|als
833680|NCT00103766|Empyema|empyema
833845|NCT00102934|HIV|hiv
834794|NCT00099541|NTX|ntx
835113|NCT00098319|Brazil|brazil
837386|NCT00090831|HV|hv
838921|NCT00004215|anemia|anemia
840492|NCT00088218|AML|aml
841255|NCT00087685|RAD001|rad001
841539|NCT00086463|PAH|pah
841811|NCT00086073|PD|pd
842745|NCT00084253|HIV|hiv
842985|NCT00084162|PET|pet
846262|NCT00082043|MRMD|mrmd
849466|NCT00080431|HIV|hiv
849743|NCT00080392|PAD|pad
850960|NCT00003212|adult angiosarcoma|adult angiosarcoma
851459|NCT00078806|SOJRA|sojra
851570|NCT00006253|symptom management|symptom management
851994|NCT00025012|melanoma|melanoma
852035|NCT00020618|pain|pain
852097|NCT00078377|Narcolepsy|narcolepsy
852221|NCT00005026|Brenner tumor|brenner tumor
853320|NCT00077142|Oral TAC-101|oral tac-101
853483|NCT00076843|HAM/TSP|ham/tsp
853569|NCT00076739|HV|hv
853637|NCT00076635|Idiopathic|idiopathic
854249|NCT00075205|Craving|craving
854332|NCT00074984|aGAL|agal
854411|NCT00074763|Platelet Transfusion|platelet transfusion
855526|NCT00072293|stage IA breast cancer|stage ia breast cancer
856037|NCT00070967|TCM|tcm
856136|NCT00070590|Build|build
856589|NCT00070577|Alcohol|alcohol
856703|NCT00069589|Baldness|baldness
856990|NCT00069173|Females|females
857276|NCT00068159|MRI|mri
857592|NCT00067847|obesity|obesity
857927|NCT00067080|iron overload|iron overload
858743|NCT00065728|CNV|cnv
859495|NCT00063804|CXCR4|cxcr4
859663|NCT00063765|RP|rp
859856|NCT00063232|Insulin|insulin
860745|NCT00061607|SMA|sma
861052|NCT00061204|fMRI|fmri
861715|NCT00060346|CHOP|chop
861628|NCT00004180|adult liposarcoma|adult liposarcoma
861672|NCT00060541|Brain Tumor|brain tumor
862225|NCT00059670|UES|ues
862721|NCT00003162|pain|pain
863534|NCT00056394|Pain|pain
863873|NCT00055133|Paxceed|paxceed
864179|NCT00054327|refractory anemia|refractory anemia
864234|NCT00054236|polycythemia vera|polycythemia vera
864414|NCT00053781|stage IV melanoma|stage iv melanoma
864885|NCT00052715|adult gliosarcoma|adult gliosarcoma
865190|NCT00049465|fatigue|fatigue
865236|NCT00049465|recurrent neuroblastoma|recurrent neuroblastoma
865787|NCT00047060|CTCL|ctcl
865905|NCT00045630|stage II bladder cancer|stage ii bladder cancer
866763|NCT00039052|male breast cancer|male breast cancer
866858|NCT00036894|adult glioblastoma|adult glioblastoma
875505|NCT00002996|pain|pain
876924|NCT00005570|ITP|itp
877974|NCT00001298|DAMPA|dampa
878075|NCT00001218|Tongue|tongue
878828|NCT00046293|Stroke|stroke
879031|NCT00044538|NSCLC|nsclc
879138|NCT00044239|OCD|ocd
880556|NCT00037544|A|a
881557|NCT00032591|AF|af
881654|NCT00031473|RSV|rsv
882365|NCT00028184|HV|hv
886809|NCT00001137|HIV-1|hiv-1
886838|NCT00001135|Labor|labor
887413|NCT00001037|HIV-1|hiv-1
887920|NCT00000957|HIV-1|hiv-1
888358|NCT00000894|Eye|eye
888869|NCT00000817|Pain|pain
889976|NCT00000633|HIV-1|hiv-1
890230|NCT00022828|Laser|laser
890430|NCT00018629|Aging|aging
890937|NCT00014794|MRI|mri
891355|NCT00011375|Therapy|therapy
893010|NCT00005013|Herbs|herbs
894458|NCT00001841|Imaging|imaging
894769|NCT00001716|P50|p50
895381|NCT00001526|Uveitis|uveitis
895593|NCT00001452|PPNAD|ppnad
896097|NCT00001282|HIV|hiv
896606|NCT00001154|HDL|hdl
710992|NCT00586924|CAT-8015|cat-8015
898005|NCT00000317|Cocaine|cocaine
710286|NCT00589563|extranodal marginal zone B-cell lymphoma of mucosa-associated lymphoid tissue|extranodal marginal zone b-cell lymphoma of mucosa-associated lymphoid tissue
710287|NCT00589563|nodal marginal zone B-cell lymphoma|nodal marginal zone b-cell lymphoma
710288|NCT00589563|noncontiguous stage II adult Burkitt lymphoma|noncontiguous stage ii adult burkitt lymphoma
710289|NCT00589563|noncontiguous stage II adult diffuse large cell lymphoma|noncontiguous stage ii adult diffuse large cell lymphoma
710290|NCT00589563|noncontiguous stage II adult diffuse mixed cell lymphoma|noncontiguous stage ii adult diffuse mixed cell lymphoma
710352|NCT00589563|stage IV childhood anaplastic large cell lymphoma|stage iv childhood anaplastic large cell lymphoma
710291|NCT00589563|noncontiguous stage II adult diffuse small cleaved cell lymphoma|noncontiguous stage ii adult diffuse small cleaved cell lymphoma
710292|NCT00589563|noncontiguous stage II adult immunoblastic large cell lymphoma|noncontiguous stage ii adult immunoblastic large cell lymphoma
710293|NCT00589563|noncontiguous stage II adult lymphoblastic lymphoma|noncontiguous stage ii adult lymphoblastic lymphoma
710294|NCT00589563|noncontiguous stage II grade 1 follicular lymphoma|noncontiguous stage ii grade 1 follicular lymphoma
710295|NCT00589563|noncontiguous stage II grade 2 follicular lymphoma|noncontiguous stage ii grade 2 follicular lymphoma
710296|NCT00589563|noncontiguous stage II grade 3 follicular lymphoma|noncontiguous stage ii grade 3 follicular lymphoma
710297|NCT00589563|noncontiguous stage II mantle cell lymphoma|noncontiguous stage ii mantle cell lymphoma
710298|NCT00589563|noncontiguous stage II marginal zone lymphoma|noncontiguous stage ii marginal zone lymphoma
710299|NCT00589563|noncontiguous stage II small lymphocytic lymphoma|noncontiguous stage ii small lymphocytic lymphoma
710300|NCT00589563|recurrent adult Burkitt lymphoma|recurrent adult burkitt lymphoma
710301|NCT00589563|recurrent adult diffuse large cell lymphoma|recurrent adult diffuse large cell lymphoma
710302|NCT00589563|recurrent adult diffuse mixed cell lymphoma|recurrent adult diffuse mixed cell lymphoma
710303|NCT00589563|recurrent adult diffuse small cleaved cell lymphoma|recurrent adult diffuse small cleaved cell lymphoma
710304|NCT00589563|recurrent adult grade III lymphomatoid granulomatosis|recurrent adult grade iii lymphomatoid granulomatosis
710305|NCT00589563|recurrent adult immunoblastic large cell lymphoma|recurrent adult immunoblastic large cell lymphoma
710306|NCT00589563|recurrent adult lymphoblastic lymphoma|recurrent adult lymphoblastic lymphoma
710307|NCT00589563|recurrent adult T-cell leukemia/lymphoma|recurrent adult t-cell leukemia/lymphoma
710308|NCT00589563|recurrent childhood anaplastic large cell lymphoma|recurrent childhood anaplastic large cell lymphoma
710309|NCT00589563|recurrent childhood grade III lymphomatoid granulomatosis|recurrent childhood grade iii lymphomatoid granulomatosis
710310|NCT00589563|recurrent childhood lymphoblastic lymphoma|recurrent childhood lymphoblastic lymphoma
710311|NCT00589563|recurrent childhood small noncleaved cell lymphoma|recurrent childhood small noncleaved cell lymphoma
710312|NCT00589563|recurrent grade 1 follicular lymphoma|recurrent grade 1 follicular lymphoma
710313|NCT00589563|recurrent grade 2 follicular lymphoma|recurrent grade 2 follicular lymphoma
710314|NCT00589563|recurrent grade 3 follicular lymphoma|recurrent grade 3 follicular lymphoma
710315|NCT00589563|recurrent grade I lymphomatoid granulomatosis|recurrent grade i lymphomatoid granulomatosis
710316|NCT00589563|recurrent grade II lymphomatoid granulomatosis|recurrent grade ii lymphomatoid granulomatosis
710317|NCT00589563|recurrent mantle cell lymphoma|recurrent mantle cell lymphoma
710318|NCT00589563|recurrent marginal zone lymphoma|recurrent marginal zone lymphoma
710319|NCT00589563|recurrent small lymphocytic lymphoma|recurrent small lymphocytic lymphoma
710320|NCT00589563|small intestine lymphoma|small intestine lymphoma
710321|NCT00589563|splenic marginal zone lymphoma|splenic marginal zone lymphoma
710322|NCT00589563|stage I adult Burkitt lymphoma|stage i adult burkitt lymphoma
710323|NCT00589563|stage I adult diffuse large cell lymphoma|stage i adult diffuse large cell lymphoma
710324|NCT00589563|stage I adult diffuse mixed cell lymphoma|stage i adult diffuse mixed cell lymphoma
710325|NCT00589563|stage I adult diffuse small cleaved cell lymphoma|stage i adult diffuse small cleaved cell lymphoma
710326|NCT00589563|stage I adult immunoblastic large cell lymphoma|stage i adult immunoblastic large cell lymphoma
710327|NCT00589563|stage I adult lymphoblastic lymphoma|stage i adult lymphoblastic lymphoma
710328|NCT00589563|stage I adult T-cell leukemia/lymphoma|stage i adult t-cell leukemia/lymphoma
710329|NCT00589563|stage III adult Burkitt lymphoma|stage iii adult burkitt lymphoma
710330|NCT00589563|stage III adult diffuse large cell lymphoma|stage iii adult diffuse large cell lymphoma
710331|NCT00589563|stage III adult diffuse mixed cell lymphoma|stage iii adult diffuse mixed cell lymphoma
710332|NCT00589563|stage III adult diffuse small cleaved cell lymphoma|stage iii adult diffuse small cleaved cell lymphoma
710333|NCT00589563|stage III adult immunoblastic large cell lymphoma|stage iii adult immunoblastic large cell lymphoma
710334|NCT00589563|stage III adult lymphoblastic lymphoma|stage iii adult lymphoblastic lymphoma
710335|NCT00589563|stage III adult T-cell leukemia/lymphoma|stage iii adult t-cell leukemia/lymphoma
710336|NCT00589563|stage III childhood anaplastic large cell lymphoma|stage iii childhood anaplastic large cell lymphoma
710337|NCT00589563|stage III childhood lymphoblastic lymphoma|stage iii childhood lymphoblastic lymphoma
710338|NCT00589563|stage III childhood small noncleaved cell lymphoma|stage iii childhood small noncleaved cell lymphoma
710339|NCT00589563|stage III grade 1 follicular lymphoma|stage iii grade 1 follicular lymphoma
710340|NCT00589563|stage III grade 2 follicular lymphoma|stage iii grade 2 follicular lymphoma
710341|NCT00589563|stage III grade 3 follicular lymphoma|stage iii grade 3 follicular lymphoma
710342|NCT00589563|stage III mantle cell lymphoma|stage iii mantle cell lymphoma
710343|NCT00589563|stage III marginal zone lymphoma|stage iii marginal zone lymphoma
710417|NCT00589420|stage IV prostate cancer|stage iv prostate cancer
710348|NCT00589563|stage IV adult diffuse small cleaved cell lymphoma|stage iv adult diffuse small cleaved cell lymphoma
710349|NCT00589563|stage IV adult immunoblastic large cell lymphoma|stage iv adult immunoblastic large cell lymphoma
710350|NCT00589563|stage IV adult lymphoblastic lymphoma|stage iv adult lymphoblastic lymphoma
710351|NCT00589563|stage IV adult T-cell leukemia/lymphoma|stage iv adult t-cell leukemia/lymphoma
710353|NCT00589563|stage IV childhood lymphoblastic lymphoma|stage iv childhood lymphoblastic lymphoma
710354|NCT00589563|stage IV childhood small noncleaved cell lymphoma|stage iv childhood small noncleaved cell lymphoma
710355|NCT00589563|stage IV grade 1 follicular lymphoma|stage iv grade 1 follicular lymphoma
710356|NCT00589563|stage IV grade 2 follicular lymphoma|stage iv grade 2 follicular lymphoma
710357|NCT00589563|stage IV grade 3 follicular lymphoma|stage iv grade 3 follicular lymphoma
710358|NCT00589563|stage IV mantle cell lymphoma|stage iv mantle cell lymphoma
710359|NCT00589563|stage IV marginal zone lymphoma|stage iv marginal zone lymphoma
710360|NCT00589563|stage IV small lymphocytic lymphoma|stage iv small lymphocytic lymphoma
710361|NCT00589563|adult acute myeloid leukemia in remission|adult acute myeloid leukemia in remission
710362|NCT00589563|adult acute myeloid leukemia with 11q23 (MLL) abnormalities|adult acute myeloid leukemia with 11q23 (mll) abnormalities
710363|NCT00589563|adult acute myeloid leukemia with inv(16)(p13;q22)|adult acute myeloid leukemia with inv(16)(p13;q22)
710364|NCT00589563|adult acute myeloid leukemia with t(15;17)(q22;q12)|adult acute myeloid leukemia with t(15;17)(q22;q12)
710365|NCT00589563|adult acute myeloid leukemia with t(16;16)(p13;q22)|adult acute myeloid leukemia with t(16;16)(p13;q22)
710366|NCT00589563|adult acute myeloid leukemia with t(8;21)(q22;q22)|adult acute myeloid leukemia with t(8;21)(q22;q22)
710367|NCT00589563|childhood acute myeloid leukemia in remission|childhood acute myeloid leukemia in remission
710368|NCT00589563|recurrent adult acute myeloid leukemia|recurrent adult acute myeloid leukemia
710369|NCT00589563|recurrent childhood acute myeloid leukemia|recurrent childhood acute myeloid leukemia
710370|NCT00589563|secondary acute myeloid leukemia|secondary acute myeloid leukemia
710371|NCT00589563|adult acute lymphoblastic leukemia in remission|adult acute lymphoblastic leukemia in remission
710372|NCT00589563|childhood acute lymphoblastic leukemia in remission|childhood acute lymphoblastic leukemia in remission
710373|NCT00589563|recurrent adult acute lymphoblastic leukemia|recurrent adult acute lymphoblastic leukemia
710374|NCT00589563|recurrent childhood acute lymphoblastic leukemia|recurrent childhood acute lymphoblastic leukemia
710375|NCT00589563|accelerated phase chronic myelogenous leukemia|accelerated phase chronic myelogenous leukemia
710376|NCT00589563|chronic phase chronic myelogenous leukemia|chronic phase chronic myelogenous leukemia
710377|NCT00589563|refractory chronic lymphocytic leukemia|refractory chronic lymphocytic leukemia
710378|NCT00589563|relapsing chronic myelogenous leukemia|relapsing chronic myelogenous leukemia
710379|NCT00589563|stage I chronic lymphocytic leukemia|stage i chronic lymphocytic leukemia
710380|NCT00589563|stage II chronic lymphocytic leukemia|stage ii chronic lymphocytic leukemia
710381|NCT00589563|stage III chronic lymphocytic leukemia|stage iii chronic lymphocytic leukemia
710382|NCT00589563|stage IV chronic lymphocytic leukemia|stage iv chronic lymphocytic leukemia
710383|NCT00589563|stage I multiple myeloma|stage i multiple myeloma
710384|NCT00589563|stage II multiple myeloma|stage ii multiple myeloma
710385|NCT00589563|stage III multiple myeloma|stage iii multiple myeloma
710386|NCT00589563|childhood myelodysplastic syndromes|childhood myelodysplastic syndromes
710387|NCT00589563|de novo myelodysplastic syndromes|de novo myelodysplastic syndromes
710388|NCT00589563|myelodysplastic/myeloproliferative neoplasm, unclassifiable|myelodysplastic/myeloproliferative neoplasm, unclassifiable
710389|NCT00589563|previously treated myelodysplastic syndromes|previously treated myelodysplastic syndromes
710390|NCT00589563|secondary myelodysplastic syndromes|secondary myelodysplastic syndromes
710391|NCT00589563|atypical chronic myeloid leukemia, BCR-ABL negative|atypical chronic myeloid leukemia, bcr-abl negative
710392|NCT00589563|chronic myelomonocytic leukemia|chronic myelomonocytic leukemia
710393|NCT00589563|juvenile myelomonocytic leukemia|juvenile myelomonocytic leukemia
710394|NCT00589563|primary myelofibrosis|primary myelofibrosis
710395|NCT00589563|secondary myelofibrosis|secondary myelofibrosis
710396|NCT00589550|clear cell renal cell carcinoma|clear cell renal cell carcinoma
710397|NCT00589550|stage III renal cell cancer|stage iii renal cell cancer
710398|NCT00589550|stage IV renal cell cancer|stage iv renal cell cancer
710399|NCT00589537|testicular seminoma|testicular seminoma
710400|NCT00589537|stage I malignant testicular germ cell tumor|stage i malignant testicular germ cell tumor
710401|NCT00589524|blocked arteries|blocked arteries
710402|NCT00589524|narrowing arteries|narrowing arteries
710403|NCT00589524|IVUS|ivus
710404|NCT00589524|CT|ct
710405|NCT00589511|Bilateral severe to profound sensorineural hearing loss|bilateral severe to profound sensorineural hearing loss
710406|NCT00589459|undiagnosed diabetes|undiagnosed diabetes
710407|NCT00589459|undiagnosed pre-diabetes|undiagnosed pre-diabetes
710408|NCT00589459|acute coronary syndrome|acute coronary syndrome
710409|NCT00589459|undiagnosed pre-diabetes and undiagnosed diabetes|undiagnosed pre-diabetes and undiagnosed diabetes
710410|NCT00589446|Embryoscopy|embryoscopy
710411|NCT00589446|recurrent miscarriage|recurrent miscarriage
710412|NCT00589446|missed abortion|missed abortion
710413|NCT00589446|Structural anomalies in recurrent miscarriage|structural anomalies in recurrent miscarriage
710414|NCT00589446|Embryoscopically directed biopsy for karyotyping|embryoscopically directed biopsy for karyotyping
710415|NCT00589420|adenocarcinoma of the prostate|adenocarcinoma of the prostate
710416|NCT00589420|recurrent prostate cancer|recurrent prostate cancer
710423|NCT00589381|unspecified adult solid tumor, protocol specific|unspecified adult solid tumor, protocol specific
710424|NCT00589381|recurrent adult Hodgkin lymphoma|recurrent adult hodgkin lymphoma
710425|NCT00589381|recurrent adult T-cell leukemia/lymphoma|recurrent adult t-cell leukemia/lymphoma
710426|NCT00589381|anaplastic large cell lymphoma|anaplastic large cell lymphoma
710427|NCT00589381|angioimmunoblastic T-cell lymphoma|angioimmunoblastic t-cell lymphoma
710428|NCT00589381|recurrent cutaneous T-cell non-Hodgkin lymphoma|recurrent cutaneous t-cell non-hodgkin lymphoma
710429|NCT00589381|recurrent mycosis fungoides/Sezary syndrome|recurrent mycosis fungoides/sezary syndrome
710430|NCT00589381|recurrent adult grade III lymphomatoid granulomatosis|recurrent adult grade iii lymphomatoid granulomatosis
710431|NCT00589381|adult nasal type extranodal NK/T-cell lymphoma|adult nasal type extranodal nk/t-cell lymphoma
710432|NCT00589381|Waldenström macroglobulinemia|waldenström macroglobulinemia
710433|NCT00589381|recurrent adult Burkitt lymphoma|recurrent adult burkitt lymphoma
710434|NCT00589381|recurrent adult diffuse large cell lymphoma|recurrent adult diffuse large cell lymphoma
710435|NCT00589381|recurrent adult diffuse mixed cell lymphoma|recurrent adult diffuse mixed cell lymphoma
710436|NCT00589381|recurrent adult diffuse small cleaved cell lymphoma|recurrent adult diffuse small cleaved cell lymphoma
710437|NCT00589381|recurrent adult immunoblastic large cell lymphoma|recurrent adult immunoblastic large cell lymphoma
710438|NCT00589381|recurrent adult lymphoblastic lymphoma|recurrent adult lymphoblastic lymphoma
710439|NCT00589381|recurrent grade 1 follicular lymphoma|recurrent grade 1 follicular lymphoma
710440|NCT00589381|recurrent grade 2 follicular lymphoma|recurrent grade 2 follicular lymphoma
710441|NCT00589381|recurrent grade 3 follicular lymphoma|recurrent grade 3 follicular lymphoma
710442|NCT00589381|recurrent mantle cell lymphoma|recurrent mantle cell lymphoma
710443|NCT00589381|recurrent marginal zone lymphoma|recurrent marginal zone lymphoma
710444|NCT00589381|extranodal marginal zone B-cell lymphoma of mucosa-associated lymphoid tissue|extranodal marginal zone b-cell lymphoma of mucosa-associated lymphoid tissue
710445|NCT00589381|nodal marginal zone B-cell lymphoma|nodal marginal zone b-cell lymphoma
710446|NCT00589381|splenic marginal zone lymphoma|splenic marginal zone lymphoma
710447|NCT00589381|recurrent small lymphocytic lymphoma|recurrent small lymphocytic lymphoma
710448|NCT00589368|Brain Infarction|brain infarction
710449|NCT00589368|pathology|pathology
710450|NCT00589368|physiopathology|physiopathology
710451|NCT00589368|psychology|psychology
710452|NCT00589368|rehabilitation|rehabilitation
710453|NCT00589368|Fingers|fingers
710454|NCT00589368|Grasp|grasp
710455|NCT00589368|Functional Laterality|functional laterality
710456|NCT00589368|Hand|hand
710457|NCT00589368|Strength|strength
710458|NCT00589368|Neuronal Plasticity|neuronal plasticity
710459|NCT00589368|Psychomotor Performance|psychomotor performance
710460|NCT00589368|Biomechanis|biomechanis
710461|NCT00589368|Touch|touch
710462|NCT00589368|Weight-Bearing|weight-bearing
710463|NCT00589355|c-reactive protein|c-reactive protein
710464|NCT00589355|endothelial dysfunction|endothelial dysfunction
710465|NCT00589355|glucose intolerance|glucose intolerance
710466|NCT00589329|Preterm birth|preterm birth
710467|NCT00589329|antibiotics|antibiotics
710468|NCT00589329|preterm labor|preterm labor
710469|NCT00589329|respiratory distress|respiratory distress
710470|NCT00589329|pergnancy|pergnancy
710471|NCT00589303|Atrial Fibrillation|atrial fibrillation
710472|NCT00589303|Heart Failure|heart failure
710473|NCT00589303|AV Node ablation|av node ablation
710474|NCT00589303|Cardiac pacemaker|cardiac pacemaker
710475|NCT00589303|Antiarrhythmic drug|antiarrhythmic drug
710476|NCT00589290|Histone deacetylase (HDAC) Inhibitors|histone deacetylase (hdac) inhibitors
710477|NCT00589290|Mediastinal Neoplasm|mediastinal neoplasm
710478|NCT00589290|Thymic Carcinoma|thymic carcinoma
710479|NCT00589290|Thymoma|thymoma
710480|NCT00589277|Smoking|smoking
710481|NCT00589277|Tobacco|tobacco
710482|NCT00589277|Message Framing|message framing
710483|NCT00589264|zinc|zinc
710484|NCT00589264|iron|iron
710485|NCT00589264|child development|child development
710486|NCT00589264|visual attention|visual attention
710487|NCT00589264|Peru|peru
710488|NCT00589251|penicillin allergy, penicillin skin test|penicillin allergy, penicillin skin test
710489|NCT00589238|stage II breast cancer|stage ii breast cancer
710490|NCT00589238|stage IIIA breast cancer|stage iiia breast cancer
710491|NCT00589238|stage IIIB breast cancer|stage iiib breast cancer
710492|NCT00589238|stage IIIC breast cancer|stage iiic breast cancer
710493|NCT00589225|PH|ph
710494|NCT00589225|PH type I|ph type i
710495|NCT00589225|Primary Hyperoxaluria|primary hyperoxaluria
710496|NCT00589225|Hyperoxaluria|hyperoxaluria
710497|NCT00589225|Primary Oxalosis|primary oxalosis
710498|NCT00589225|PH type II|ph type ii
710499|NCT00589225|PH type III|ph type iii
710500|NCT00589225|Genetic testing for PH|genetic testing for ph
710501|NCT00589225|Genetic testing for Primary Hyperoxaluria|genetic testing for primary hyperoxaluria
710502|NCT00589225|Hereditary study for PH|hereditary study for ph
710503|NCT00589225|Hereditary study for Primary Hyperoxaluria|hereditary study for primary hyperoxaluria
710504|NCT00589212|GliaSite|gliasite
710505|NCT00589212|Brain metastases|brain metastases
710506|NCT00589212|1-3 METS|1-3 mets
710507|NCT00589186|stage IV squamous cell carcinoma of the nasopharynx|stage iv squamous cell carcinoma of the nasopharynx
710508|NCT00589186|stage IV lymphoepithelioma of the nasopharynx|stage iv lymphoepithelioma of the nasopharynx
710509|NCT00589186|recurrent squamous cell carcinoma of the nasopharynx|recurrent squamous cell carcinoma of the nasopharynx
710510|NCT00589186|recurrent lymphoepithelioma of the nasopharynx|recurrent lymphoepithelioma of the nasopharynx
710511|NCT00589173|Preventive Care|preventive care
710512|NCT00589173|Health information technology|health information technology
710513|NCT00589173|Personal health record|personal health record
710514|NCT00589121|radiation fibrosis|radiation fibrosis
710515|NCT00589121|radiation toxicity|radiation toxicity
710516|NCT00589121|lymphedema|lymphedema
710517|NCT00589121|musculoskeletal complications|musculoskeletal complications
710518|NCT00589121|stage I adult soft tissue sarcoma|stage i adult soft tissue sarcoma
710519|NCT00589121|stage II adult soft tissue sarcoma|stage ii adult soft tissue sarcoma
710520|NCT00589121|adult extraskeletal chondrosarcoma|adult extraskeletal chondrosarcoma
710521|NCT00589121|stage III adult soft tissue sarcoma|stage iii adult soft tissue sarcoma
710522|NCT00589108|knee arthroplasty|knee arthroplasty
710523|NCT00589082|AML|aml
710524|NCT00589082|elderly|elderly
710525|NCT00589082|DaunoXome|daunoxome
710526|NCT00589056|stage IIIA non-small cell lung cancer|stage iiia non-small cell lung cancer
710527|NCT00589056|stage IIIB non-small cell lung cancer|stage iiib non-small cell lung cancer
710528|NCT00589056|recurrent non-small cell lung cancer|recurrent non-small cell lung cancer
710529|NCT00589030|adult primary hepatocellular carcinoma|adult primary hepatocellular carcinoma
710530|NCT00589030|advanced adult primary liver cancer|advanced adult primary liver cancer
710531|NCT00589030|localized unresectable adult primary liver cancer|localized unresectable adult primary liver cancer
710532|NCT00589030|recurrent adult primary liver cancer|recurrent adult primary liver cancer
710533|NCT00588978|c-reactive protein|c-reactive protein
710534|NCT00588978|obesity|obesity
710535|NCT00588978|women's cardiovascular health|women's cardiovascular health
710536|NCT00588965|QT interval|qt interval
710537|NCT00588965|beta-blocker|beta-blocker
710538|NCT00588965|exercise|exercise
710539|NCT00588965|electrocardiogram|electrocardiogram
710540|NCT00588965|repolarizaton|repolarizaton
710541|NCT00588939|reflux|reflux
710542|NCT00588939|heartburn|heartburn
710543|NCT00588926|Deep Brain Stimulation|deep brain stimulation
710544|NCT00588926|Movement Disorders|movement disorders
710545|NCT00588926|Remifentanil|remifentanil
710546|NCT00588926|Sedation|sedation
710547|NCT00588926|Basal Ganglia electrical activity|basal ganglia electrical activity
710548|NCT00588913|recurrent renal cell cancer|recurrent renal cell cancer
710549|NCT00588913|stage IV renal cell cancer|stage iv renal cell cancer
710550|NCT00588913|clear cell renal cell carcinoma|clear cell renal cell carcinoma
710551|NCT00588913|lung metastases|lung metastases
710552|NCT00588900|stage IV colon cancer|stage iv colon cancer
710553|NCT00588900|stage IV rectal cancer|stage iv rectal cancer
710554|NCT00588900|recurrent colon cancer|recurrent colon cancer
710555|NCT00588900|recurrent rectal cancer|recurrent rectal cancer
710556|NCT00588874|male osteoporosis|male osteoporosis
710557|NCT00588874|male osteopenia|male osteopenia
710558|NCT00588874|calciotropic hormones|calciotropic hormones
710559|NCT00588848|Obstructive Sleep Apnea Hypopnea Syndrome|obstructive sleep apnea hypopnea syndrome
710560|NCT00588848|OSA|osa
710561|NCT00588848|Postoperative|postoperative
710562|NCT00588848|CPAP|cpap
710563|NCT00588835|pharmacokinetics|pharmacokinetics
710564|NCT00588835|nausea and vomiting post chemotherapy|nausea and vomiting post chemotherapy
710565|NCT00588822|monoclonal gammopathy of undetermined significance|monoclonal gammopathy of undetermined significance
710566|NCT00588796|fibrinogen|fibrinogen
710567|NCT00588796|burns|burns
710568|NCT00588796|trauma|trauma
710569|NCT00588796|metabolism|metabolism
710570|NCT00588770|Bevacizumab|bevacizumab
710571|NCT00588770|Head and neck cancer|head and neck cancer
710572|NCT00588770|Head and neck squamous cell carcinoma|head and neck squamous cell carcinoma
710573|NCT00588757|IVC filters|ivc filters
710574|NCT00588757|Trauma|trauma
710575|NCT00588757|Dwell time|dwell time
710576|NCT00588718|Necrotizing enterocolitis|necrotizing enterocolitis
710577|NCT00588718|Progressive necrotizing enterocolitis|progressive necrotizing enterocolitis
710578|NCT00588718|Proteomics in blood|proteomics in blood
710579|NCT00588718|Genomics in blood|genomics in blood
710580|NCT00588718|Multi-center|multi-center
710581|NCT00588705|Daughters|daughters
710582|NCT00588705|Communication|communication
710583|NCT00588705|genetic risk|genetic risk
710584|NCT00588705|Genetic Counseling|genetic counseling
710585|NCT00588692|Heart Failure|heart failure
710586|NCT00588692|Afterload Reduction|afterload reduction
710587|NCT00588692|Sphygmocor|sphygmocor
710588|NCT00588679|Prostate Cancer|prostate cancer
710589|NCT00588679|Cancer|cancer
710590|NCT00588679|MRI|mri
710591|NCT00588679|Magnetic Resonance Imaging|magnetic resonance imaging
710592|NCT00588679|06-035|06-035
710593|NCT00588666|Myeloproliferative Disorder|myeloproliferative disorder
710594|NCT00588666|urinary bladder|urinary bladder
710595|NCT00588666|Cancer|cancer
710596|NCT00588666|ureter|ureter
710597|NCT00588666|renal pelvis|renal pelvis
710598|NCT00588666|chemotherapy|chemotherapy
710599|NCT00588653|Crohn's disease|crohn's disease
710629|NCT00588562|Adenine phosphoribosyl transferase deficiency|adenine phosphoribosyl transferase deficiency
710630|NCT00588562|Dent disease|dent disease
710631|NCT00588562|Dent|dent
710632|NCT00588536|Langerhans Cell Histiocytosis|langerhans cell histiocytosis
710633|NCT00588536|LCH|lch
710634|NCT00588536|6-Thioguanine|6-thioguanine
710635|NCT00588536|6-TG|6-tg
710636|NCT00588536|Methotrexate|methotrexate
710637|NCT00588536|MTX|mtx
710638|NCT00588536|94-132|94-132
710639|NCT00588523|Brain|brain
710640|NCT00588523|CNS|cns
710641|NCT00588523|TEMOZOLOMIDE|temozolomide
710642|NCT00588523|Busulfan|busulfan
710643|NCT00588523|Thiotepa|thiotepa
710644|NCT00588510|Sarcoma|sarcoma
710645|NCT00588510|Bone|bone
710646|NCT00588497|female sterilization, micro-insert, hysteroscopy|female sterilization, micro-insert, hysteroscopy
710647|NCT00588484|Carotid artery|carotid artery
710648|NCT00588484|Common carotid artery|common carotid artery
710649|NCT00588484|Measurement|measurement
710650|NCT00588484|Ultrasound|ultrasound
710651|NCT00588458|Primary sclerosing cholangitis|primary sclerosing cholangitis
710652|NCT00588458|Computed tomographic cholangiography|computed tomographic cholangiography
710653|NCT00588458|MELD score|meld score
710654|NCT00588458|Mayo risk score for PSC|mayo risk score for psc
710655|NCT00588445|Lung Cancer|lung cancer
710656|NCT00588445|Non-small cell lung cancer|non-small cell lung cancer
710657|NCT00588445|Gefitnib|gefitnib
710658|NCT00588445|Cancer|cancer
710659|NCT00588445|NSCLC|nsclc
710660|NCT00588445|bronchioloalveolar cancer|bronchioloalveolar cancer
710661|NCT00588445|smoker|smoker
710662|NCT00588432|Stroke|stroke
710663|NCT00588432|Immobilization|immobilization
710664|NCT00588432|Myofacial Pain|myofacial pain
710665|NCT00588432|Hyperthyroid Myopathy|hyperthyroid myopathy
710666|NCT00588419|Breast Cancer|breast cancer
710667|NCT00588419|Cancer|cancer
710668|NCT00588419|Breast Sensation|breast sensation
710669|NCT00588419|Postmastectomy Breast Reconstruction|postmastectomy breast reconstruction
710670|NCT00588406|acute, emergency department|acute, emergency department
710671|NCT00588380|GLP-1|glp-1
710672|NCT00588380|Insulin Secretion|insulin secretion
710673|NCT00588367|Inflammation|inflammation
710674|NCT00588367|Pancreas|pancreas
710675|NCT00588367|Chronic pancreatitis|chronic pancreatitis
710676|NCT00588367|Alcoholic pancreatitis|alcoholic pancreatitis
710677|NCT00588367|Carcinoma, pancreatic ductal|carcinoma, pancreatic ductal
710678|NCT00588367|Pancreatic neoplasms|pancreatic neoplasms
710679|NCT00588354|herniated disk|herniated disk
710680|NCT00588354|radiculopathy|radiculopathy
710681|NCT00588354|clonidine|clonidine
710682|NCT00588354|epidural|epidural
710683|NCT00588354|steroid|steroid
710684|NCT00588354|corticosteroid|corticosteroid
710685|NCT00588354|nucleus pulposus|nucleus pulposus
710686|NCT00588354|transforaminal|transforaminal
710687|NCT00588341|Melanoma|melanoma
710688|NCT00588341|Skin Cancer|skin cancer
710689|NCT00588341|Cancer|cancer
710690|NCT00588341|Temozolamide|temozolamide
710691|NCT00588341|TMZ|tmz
710692|NCT00588302|primary biliary cirrhosis|primary biliary cirrhosis
710693|NCT00588302|ursodeoxycholic acid|ursodeoxycholic acid
710694|NCT00588289|Pediatric Cancers|pediatric cancers
710695|NCT00588289|Oncology|oncology
710696|NCT00588276|measurable disease|measurable disease
710697|NCT00588276|locally advanced disease|locally advanced disease
710698|NCT00588263|Ashkenazi Jewish|ashkenazi jewish
710699|NCT00588263|Cancer|cancer
710700|NCT00588263|00-087|00-087
710701|NCT00588237|ovary|ovary
710702|NCT00588237|BEVACIZUMAB|bevacizumab
710703|NCT00588237|CISPLATIN|cisplatin
710704|NCT00588237|TAXOL|taxol
710705|NCT00588224|stomach|stomach
710706|NCT00588224|accommodation|accommodation
710707|NCT00588224|volume|volume
710709|NCT00588224|3 dimensional ultrasonography|3 dimensional ultrasonography
710710|NCT00588224|healthy volunteers|healthy volunteers
710711|NCT00588211|Cancer related-Risks|cancer related-risks
710712|NCT00588211|Risk Perception|risk perception
710713|NCT00588211|Survey|survey
710714|NCT00588211|Focus Group|focus group
710715|NCT00588211|Smoking cessation|smoking cessation
710716|NCT00588211|tobacco|tobacco
710717|NCT00588198|histologically confirmed melanoma of any site|histologically confirmed melanoma of any site
710718|NCT00588185|Progressive Prostate Cancer|progressive prostate cancer
710719|NCT00588185|[18F]-Fluoro-2-Deoxy-D-Glucose|[18f]-fluoro-2-deoxy-d-glucose
710720|NCT00588185|[18F] Dihydro-Testosterone|[18f] dihydro-testosterone
710721|NCT00588185|Pet Imaging|pet imaging
710722|NCT00588185|Pet scan|pet scan
710723|NCT00588185|00-095|00-095
710724|NCT00588172|Metformin|metformin
710725|NCT00588172|Type 2 diabetes|type 2 diabetes
710726|NCT00588172|Oct1|oct1
710727|NCT00588159|Preoperative gabapentin|preoperative gabapentin
710728|NCT00588159|Acute pain|acute pain
710729|NCT00588159|Post-thoracotomy pain|post-thoracotomy pain
710730|NCT00588159|Epidural analgesia|epidural analgesia
710731|NCT00588146|anemia|anemia
710732|NCT00588146|HHT|hht
710733|NCT00588146|Liver disease|liver disease
710734|NCT00588146|Hypoxemia|hypoxemia
710762|NCT00588042|Angioplasty, Transluminal, Percutaneous Coronary|angioplasty, transluminal, percutaneous coronary
710763|NCT00588042|Coronary Artery Disease|coronary artery disease
710764|NCT00588042|Coronary Occlusion|coronary occlusion
710765|NCT00588029|Family members|family members
710766|NCT00588016|Itraconazole|itraconazole
710767|NCT00588003|Breast|breast
710768|NCT00588003|ANASTROZOLE|anastrozole
710769|NCT00587990|Chronic Ischemic Left Ventricular Dysfunction|chronic ischemic left ventricular dysfunction
710770|NCT00587977|Abdominal aortic aneurysm|abdominal aortic aneurysm
710771|NCT00587964|Cancer|cancer
710772|NCT00587964|Brain Metastasis|brain metastasis
710773|NCT00587964|Radiosurgery|radiosurgery
710774|NCT00587964|Bladder cancer|bladder cancer
710775|NCT00587964|Breast cancer|breast cancer
710776|NCT00587964|Cervical cancer|cervical cancer
710777|NCT00587964|Colon cancer|colon cancer
710778|NCT00587964|HEENT cancer|heent cancer
710779|NCT00587964|Lung cancer|lung cancer
710780|NCT00587964|Melanoma|melanoma
710781|NCT00587964|Pancreatic cancer|pancreatic cancer
710782|NCT00587964|Prostate cancer|prostate cancer
710783|NCT00587964|Rectal cancer|rectal cancer
710784|NCT00587964|Sarcoma|sarcoma
710785|NCT00587964|Testicular cancer|testicular cancer
710786|NCT00587964|Radiation|radiation
710787|NCT00587951|Clinical decision-making|clinical decision-making
710788|NCT00587951|Ictal SPECT|ictal spect
710789|NCT00587951|Epilepsy surgery|epilepsy surgery
710790|NCT00587938|congestive heart failure|congestive heart failure
710791|NCT00587938|Brain naturietic peptide|brain naturietic peptide
710792|NCT00587938|hospital utilization cost|hospital utilization cost
710793|NCT00587925|osteoporosis|osteoporosis
710794|NCT00587912|Kaposi's Sarcoma AIDS Related|kaposi's sarcoma aids related
710795|NCT00587912|Kaposi's Sarcoma Classical|kaposi's sarcoma classical
710796|NCT00587912|Non-Hodgkin's Lymphoma|non-hodgkin's lymphoma
710797|NCT00587912|HEMATOPOIETIC SYSTEM|hematopoietic system
710798|NCT00587912|Cancer|cancer
710799|NCT00587912|AIDS|aids
710800|NCT00587899|Atrial Fibrillation|atrial fibrillation
710801|NCT00587899|AF|af
710802|NCT00587899|A fib|a fib
710803|NCT00587899|cardiac ablation|cardiac ablation
710804|NCT00587899|modified maze procedure|modified maze procedure
710805|NCT00587886|Cancer|cancer
710806|NCT00587886|Endometrial cancer|endometrial cancer
710807|NCT00587886|Ovarian cancer|ovarian cancer
710808|NCT00587886|Corpus Uteri|corpus uteri
710809|NCT00587886|Endometrium|endometrium
710810|NCT00587873|Relapsed|relapsed
710811|NCT00587873|Hodgkin's Disease|hodgkin's disease
710812|NCT00587873|Methotrexate|methotrexate
710813|NCT00587873|6-Thioguanine|6-thioguanine
710814|NCT00587873|94-030|94-030
710815|NCT00587847|leukemia|leukemia
710816|NCT00587821|Breast Cancer|breast cancer
710817|NCT00587821|Breast biopsy|breast biopsy
710818|NCT00587808|Heart Failure|heart failure
710819|NCT00587808|Heart Failure, Diastolic|heart failure, diastolic
710820|NCT00587808|Stroke Volume|stroke volume
710821|NCT00587769|Smoking|smoking
710822|NCT00587769|Smoking cessation|smoking cessation
710823|NCT00587769|Bupropion|bupropion
710824|NCT00587769|Varenicline|varenicline
710825|NCT00587769|Tobacco use disorder|tobacco use disorder
710826|NCT00587756|intraoperative ultrasonography|intraoperative ultrasonography
710827|NCT00587756|colorectal liver metastases|colorectal liver metastases
710828|NCT00587756|hepatectomy|hepatectomy
710829|NCT00587756|portal vein embolization|portal vein embolization
710830|NCT00587756|Liver|liver
710831|NCT00587730|heart disease|heart disease
710832|NCT00587730|cardiac disease|cardiac disease
710833|NCT00587730|chest pain|chest pain
710834|NCT00587730|myocardial infarction|myocardial infarction
710835|NCT00587730|heart attack|heart attack
710836|NCT00587691|Tovaxin|tovaxin
710837|NCT00587691|TCV|tcv
710838|NCT00587691|Autologous|autologous
710839|NCT00587678|PAD|pad
710840|NCT00587665|Pain|pain
710841|NCT00587652|Barrett Esophagus|barrett esophagus
710842|NCT00587652|Methylene blue|methylene blue
710843|NCT00587652|Chromoendoscopy|chromoendoscopy
710844|NCT00587639|Adolescent|adolescent
710845|NCT00587639|Depression|depression
710846|NCT00587639|rTMS|rtms
710847|NCT00587626|neck pain|neck pain
710848|NCT00587626|shoulder pain|shoulder pain
710849|NCT00587626|cervical pain|cervical pain
710850|NCT00587626|chronic|chronic
710851|NCT00587626|recurrent|recurrent
710852|NCT00587600|Barrett's Esophagus|barrett's esophagus
710853|NCT00587600|High Grade Dysplasia|high grade dysplasia
710854|NCT00587600|Photodynamic Therapy|photodynamic therapy
710855|NCT00587574|chronic graft-versus-host disease|chronic graft-versus-host disease
710856|NCT00587561|schizophrenia|schizophrenia
710857|NCT00587561|social cognition|social cognition
710858|NCT00587561|cognition|cognition
710859|NCT00587561|treatment|treatment
710860|NCT00587561|outcome|outcome
710861|NCT00587548|locate the ureters during abdominal surgery|locate the ureters during abdominal surgery
710862|NCT00587535|hemochromatosis|hemochromatosis
710863|NCT00587535|liver cirrhosis|liver cirrhosis
710864|NCT00587535|liver diseases|liver diseases
710894|NCT00587379|testing for Endothelial Dysfunction and coronary angiography|testing for endothelial dysfunction and coronary angiography
710895|NCT00587353|tobacco use cessation|tobacco use cessation
710896|NCT00587353|radiation oncology|radiation oncology
710897|NCT00587353|smoking|smoking
710898|NCT00587314|Photodynamic Therapy|photodynamic therapy
710899|NCT00587314|Barrett's Esophagus|barrett's esophagus
710900|NCT00587314|Early Esophageal Adenocarcinoma|early esophageal adenocarcinoma
710901|NCT00587301|Child Obesity|child obesity
710902|NCT00587288|Cinquil™|cinquil™
710903|NCT00587288|Reslizumab|reslizumab
710904|NCT00587275|Gastroesophageal Reflux Disease|gastroesophageal reflux disease
710905|NCT00587275|GERD|gerd
710906|NCT00587262|Cochlear|cochlear
710907|NCT00587262|Hearing|hearing
710908|NCT00587262|High frequency hearing loss|high frequency hearing loss
710909|NCT00587249|Malaria, Plasmodium falciparium, Hepatitis B Core Antigen, Circumsporozoite Epitopes|malaria, plasmodium falciparium, hepatitis b core antigen, circumsporozoite epitopes
710910|NCT00587236|Autofluorescence|autofluorescence
710911|NCT00587236|Narrow Band|narrow band
710912|NCT00587236|High definition white light|high definition white light
710913|NCT00587210|Crohn Disease|crohn disease
710914|NCT00587210|Inflammatory Bowel Disease|inflammatory bowel disease
710915|NCT00587197|esophageal varices|esophageal varices
710916|NCT00587197|portal hypertension|portal hypertension
710917|NCT00587197|gastric varices|gastric varices
710918|NCT00587197|cost effectiveness|cost effectiveness
710919|NCT00587184|Barrett's Esophagus|barrett's esophagus
710920|NCT00587184|Confocal Microscopy|confocal microscopy
710921|NCT00587171|Amblyopia|amblyopia
710922|NCT00587171|Vision Therapy|vision therapy
710923|NCT00587171|Patching|patching
710924|NCT00587158|Paricalcitol|paricalcitol
710925|NCT00587158|Parathyroid Hormone|parathyroid hormone
710926|NCT00587158|Bone Alkaline Phosphatase|bone alkaline phosphatase
710927|NCT00587158|Chronic Kidney Disease|chronic kidney disease
710928|NCT00587158|Glomerular Filtration Rate|glomerular filtration rate
710929|NCT00587158|Vitamin D Receptor|vitamin d receptor
710930|NCT00587158|Interstitial Fibrosis and Tubular Atrophy|interstitial fibrosis and tubular atrophy
710931|NCT00587158|Zemplar®|zemplar®
710932|NCT00587145|Stomach Neoplasms|stomach neoplasms
710933|NCT00587145|Secondary|secondary
710934|NCT00587145|Combination chemotherapy|combination chemotherapy
710935|NCT00587145|S-1|s-1
710936|NCT00587145|Docetaxel|docetaxel
710937|NCT00587145|oxaliplatin|oxaliplatin
710938|NCT00587132|Diabetes mellitus|diabetes mellitus
710939|NCT00587132|Peutz-Jeghers syndrome|peutz-jeghers syndrome
710940|NCT00587119|Urso|urso
710941|NCT00587119|Budesonide|budesonide
710942|NCT00587119|PBC|pbc
710943|NCT00587119|overlap AIH|overlap aih
710944|NCT00587119|PBC with overlap features of autoimmune hepatitis|pbc with overlap features of autoimmune hepatitis
710945|NCT00587093|Newly diagnosed|newly diagnosed
710946|NCT00587093|CA 125|ca 125
710947|NCT00587093|CT scan|ct scan
710948|NCT00587093|01-048|01-048
710949|NCT00587067|FUDR|fudr
710950|NCT00587067|FLOXORUIDINE|floxoruidine
710951|NCT00587067|DEXAMETHASONE|dexamethasone
710952|NCT00587067|Hepatic|hepatic
710953|NCT00587067|Cancer|cancer
710954|NCT00587067|02-120|02-120
710955|NCT00587054|leukemia|leukemia
710956|NCT00587054|non-Hodgkins|non-hodgkins
710957|NCT00587054|lymphoblastic lymphoma|lymphoblastic lymphoma
710958|NCT00587054|myelodysplastic syndrome|myelodysplastic syndrome
710959|NCT00587054|paroxysmal nocturnal hemoglobinuria (PNH)|paroxysmal nocturnal hemoglobinuria (pnh)
710960|NCT00587054|cytoreductive regimen|cytoreductive regimen
710961|NCT00587054|allogeneic stem cell transplant|allogeneic stem cell transplant
710962|NCT00587041|Synbiotic|synbiotic
710963|NCT00587041|Urine Oxalate|urine oxalate
710964|NCT00587041|Probiotic|probiotic
710965|NCT00587041|Kidney Stone|kidney stone
710966|NCT00587041|Gastric Bypass|gastric bypass
710967|NCT00587041|Crohn's|crohn's
710968|NCT00587041|Stone|stone
710969|NCT00587041|Hyperoxaluria|hyperoxaluria
710970|NCT00587041|Enteric Hyperoxaluria|enteric hyperoxaluria
710971|NCT00587028|Colonography|colonography
710972|NCT00587028|Colonoscopy|colonoscopy
710973|NCT00587028|Virtual|virtual
710974|NCT00587028|Computed Tomographic Colonography|computed tomographic colonography
710975|NCT00587028|Large intestine|large intestine
710976|NCT00587028|colon|colon
710977|NCT00587002|Acute Coronary Syndrome|acute coronary syndrome
710978|NCT00587002|Women|women
710979|NCT00586989|Barrett's Esophagus|barrett's esophagus
710980|NCT00586989|Esophageal Cancer|esophageal cancer
710981|NCT00586989|High Grade Dysplasia|high grade dysplasia
710982|NCT00586976|pain, ropivacaine, infusion, sternotomy|pain, ropivacaine, infusion, sternotomy
710983|NCT00586963|Erosive Esophagitis|erosive esophagitis
710984|NCT00586963|Reflux Esophagitis|reflux esophagitis
710985|NCT00586963|GERD|gerd
710986|NCT00586950|Myocardial Free Fatty Acid metabolism|myocardial free fatty acid metabolism
710987|NCT00586950|High risk patients|high risk patients
710988|NCT00586950|End-stage renal failure|end-stage renal failure
710989|NCT00586950|Cardiovascular events|cardiovascular events
710990|NCT00586950|prognosis|prognosis
710991|NCT00586937|Lung Cancer Survivors|lung cancer survivors
711027|NCT00586820|Non-ST Elevation Myocardial Infarction|non-st elevation myocardial infarction
711028|NCT00586807|Ulcerative colitis|ulcerative colitis
711029|NCT00586807|pediatrics|pediatrics
711031|NCT00586807|protein metabolism|protein metabolism
711032|NCT00586807|energy expenditure|energy expenditure
711033|NCT00586794|Hypertension|hypertension
711034|NCT00586794|Eisenmenger|eisenmenger
711035|NCT00586781|ankle replacement|ankle replacement
711036|NCT00586781|end-stage arthritis of the ankle|end-stage arthritis of the ankle
711037|NCT00586781|degenerative ankle disease|degenerative ankle disease
711038|NCT00586755|Intensive Induction|intensive induction
711039|NCT00586755|High Dose Chemotherapy|high dose chemotherapy
711040|NCT00586755|Bone Marrow Transplantation|bone marrow transplantation
711041|NCT00586755|Mantle Cell Lymphoma|mantle cell lymphoma
711042|NCT00586742|SLAP lesions|slap lesions
711043|NCT00586742|labral repair|labral repair
711044|NCT00586742|bicepstenodesis|bicepstenodesis
711045|NCT00586742|conservative treatment|conservative treatment
711046|NCT00586729|Burn|burn
711047|NCT00586729|Burn wound management|burn wound management
711048|NCT00586729|Burn graft|burn graft
711049|NCT00586703|Stem cell transplant|stem cell transplant
711050|NCT00586703|mismatched donor|mismatched donor
711051|NCT00586703|NK infusion|nk infusion
711052|NCT00586690|Stem cell transplant|stem cell transplant
711053|NCT00586690|matched donor|matched donor
711054|NCT00586690|NK infusion|nk infusion
711055|NCT00586677|child abuse|child abuse
711056|NCT00586677|child neglect|child neglect
711057|NCT00586677|PCIT|pcit
711058|NCT00586677|Lutzker|lutzker
711059|NCT00586677|attachment|attachment
711060|NCT00586677|parenting|parenting
711061|NCT00586638|cognition|cognition
711062|NCT00586638|cognition disorders|cognition disorders
711063|NCT00586638|executive function|executive function
711064|NCT00586638|cognitive control|cognitive control
711065|NCT00586638|attentional control|attentional control
711066|NCT00586638|biomedical enhancement|biomedical enhancement
711067|NCT00586638|cognitive enhancement|cognitive enhancement
711068|NCT00586638|computerized|computerized
711069|NCT00586638|computer-based|computer-based
711070|NCT00586638|video game|video game
711071|NCT00586612|Conjugate vaccine|conjugate vaccine
711072|NCT00586612|Persistence|persistence
711073|NCT00586612|Hib vaccine|hib vaccine
711074|NCT00586612|Combination vaccine|combination vaccine
711075|NCT00586612|Meningococcal vaccine|meningococcal vaccine
711076|NCT00586612|Safety|safety
711077|NCT00586612|Preterm/full-term infants|preterm/full-term infants
711078|NCT00586612|Immunogenicity|immunogenicity
711079|NCT00586599|IBD|ibd
711080|NCT00586599|CD|cd
711081|NCT00586599|UC|uc
711082|NCT00586599|Crohn's Disease|crohn's disease
711083|NCT00586599|Ulcerative Colitis|ulcerative colitis
711084|NCT00586599|Pediatric|pediatric
711085|NCT00586599|inflammatory markers|inflammatory markers
711086|NCT00586573|ADHD|adhd
711087|NCT00586573|Namenda|namenda
711088|NCT00586560|solid tumors|solid tumors
711089|NCT00586547|Haploidentical|haploidentical
711090|NCT00586547|Stem Cell Transplant|stem cell transplant
711091|NCT00586547|Graft-Versus-Host disease|graft-versus-host disease
711092|NCT00586534|crack, cocaine, addiction treatment, virtual reality|crack, cocaine, addiction treatment, virtual reality
711093|NCT00586521|Coagulation Disorders|coagulation disorders
711094|NCT00586495|Sorafenib|sorafenib
711095|NCT00586495|Nexavar|nexavar
711096|NCT00586495|Metastatic RCC|metastatic rcc
711097|NCT00586495|Renal Cell Carcinoma|renal cell carcinoma
711098|NCT00586495|Unresectable RCC|unresectable rcc
711099|NCT00586482|cigarettes, surgery|cigarettes, surgery
711100|NCT00586482|Smokers scheduled for elective surgery|smokers scheduled for elective surgery
711101|NCT00586469|Influenza|influenza
711102|NCT00586443|solid tumors|solid tumors
711103|NCT00586443|avastin|avastin
711104|NCT00586443|Phase I|phase i
711105|NCT00586443|Phase 1|phase 1
711106|NCT00586443|combination therapy|combination therapy
711107|NCT00586443|bevacizumab|bevacizumab
711108|NCT00586443|RAD001|rad001
711109|NCT00586443|everolimus|everolimus
711110|NCT00586443|pantitumumab|pantitumumab
711111|NCT00586430|apolipoprotein E e4|apolipoprotein e e4
711112|NCT00586430|Alzheimer's disease|alzheimer's disease
711113|NCT00586430|somnolence|somnolence
711114|NCT00586430|Early detection|early detection
711115|NCT00586417|angiogenesis|angiogenesis
711116|NCT00586417|tumor angiogenesis|tumor angiogenesis
711117|NCT00586417|biomarkers|biomarkers
711118|NCT00586417|healthy volunteers|healthy volunteers
711119|NCT00586404|Barrett's Esophagus|barrett's esophagus
711120|NCT00586404|Esophageal neoplasms|esophageal neoplasms
711121|NCT00586404|gastroesophageal reflux|gastroesophageal reflux
711122|NCT00586404|gastrointestinal neoplasms|gastrointestinal neoplasms
711123|NCT00586391|B cell Lymphoma|b cell lymphoma
711124|NCT00586391|Cancer|cancer
711125|NCT00586391|Chronic Lymphocytic Leukemia|chronic lymphocytic leukemia
711126|NCT00586391|CD19 CHIMERIC RECEPTOR EXPRESSING T LYMPHOCYTES|cd19 chimeric receptor expressing t lymphocytes
711127|NCT00586391|Acute Lymphocytic Leukemia|acute lymphocytic leukemia
711128|NCT00586365|complex elbow trauma|complex elbow trauma
711137|NCT00586339|Human papillomavirus (HPV) vaccine|human papillomavirus (hpv) vaccine
711138|NCT00586339|Human Immunodeficiency Virus (HIV)|human immunodeficiency virus (hiv)
711139|NCT00586339|Cervical cancer|cervical cancer
711140|NCT00586339|Papillomavirus|papillomavirus
711141|NCT00586326|MammoSite|mammosite
711142|NCT00586326|DCIS|dcis
711143|NCT00586313|EUS Biopsy for Non-alcoholic Fatty Liver Disease|eus biopsy for non-alcoholic fatty liver disease
711144|NCT00586300|Knee pain|knee pain
711145|NCT00586287|Phenprocoumon|phenprocoumon
711146|NCT00586287|Dosing algorithm|dosing algorithm
711147|NCT00586287|loading dose|loading dose
711148|NCT00586274|Stem Cell Transplant|stem cell transplant
711149|NCT00586274|Anemia|anemia
711150|NCT00586274|Fanconi|fanconi
711151|NCT00586261|Kidney Failure, Chronic|kidney failure, chronic
711152|NCT00586261|Renal Insufficiency, Chronic|renal insufficiency, chronic
711153|NCT00586261|Proteinuria|proteinuria
711154|NCT00586261|Albuminuria|albuminuria
711155|NCT00586248|Peripheral nerve stimulator, cardiac pacemaker|peripheral nerve stimulator, cardiac pacemaker
711156|NCT00586235|Fusion|fusion
711157|NCT00586235|Ultrasound|ultrasound
711158|NCT00586235|Computed tomography|computed tomography
711159|NCT00586222|Omega-3 Fatty Acids|omega-3 fatty acids
711160|NCT00586222|Pediatric Bipolar Disorder|pediatric bipolar disorder
711161|NCT00586222|Adolescent Bipolar Disorder|adolescent bipolar disorder
711162|NCT00586222|MRS|mrs
711163|NCT00586209|sickle cell disease|sickle cell disease
711164|NCT00586209|sickle cell anemia|sickle cell anemia
711165|NCT00586209|L-glutamine|l-glutamine
711166|NCT00586209|Sickle Cell Anemia (homozygous and heterozygous)|sickle cell anemia (homozygous and heterozygous)
711167|NCT00586209|Sickle ß0-Thalassemia|sickle ß0-thalassemia
711168|NCT00586196|Delirium|delirium
711169|NCT00586196|Postoperative confusion|postoperative confusion
711170|NCT00586196|Hip fracture|hip fracture
711171|NCT00586196|Long bone fracture|long bone fracture
711172|NCT00586183|Ventricular Remodeling|ventricular remodeling
711173|NCT00586170|nonunion|nonunion
711174|NCT00586170|fracture|fracture
711175|NCT00586157|ADHD|adhd
711176|NCT00586157|Attention Deficit Hyperactivity Disorder|attention deficit hyperactivity disorder
711177|NCT00586157|Daytrana|daytrana
711178|NCT00586157|MTS Patch|mts patch
711179|NCT00586157|Methylphenidate Transdermal System|methylphenidate transdermal system
711180|NCT00586131|end-stage renal disease|end-stage renal disease
711181|NCT00586131|automated peritoneal dialysis|automated peritoneal dialysis
711182|NCT00586131|metabolic acidosis|metabolic acidosis
711183|NCT00586131|nitrogen balances|nitrogen balances
711184|NCT00586118|Sedation|sedation
711185|NCT00586118|Volatile anaesthetic|volatile anaesthetic
711186|NCT00586118|Sevoflurane|sevoflurane
711187|NCT00586118|Propofol|propofol
711188|NCT00586118|Recovery|recovery
711189|NCT00586105|Sorafenib|sorafenib
711190|NCT00586105|Nexavar|nexavar
711191|NCT00586105|Metastatic RCC|metastatic rcc
711192|NCT00586105|Renal Cell Carcinoma|renal cell carcinoma
711193|NCT00586105|Unresectable RCC|unresectable rcc
711194|NCT00586092|Phase I|phase i
711195|NCT00586092|Phase 1|phase 1
711196|NCT00586092|avastin|avastin
711197|NCT00586092|bevacizumab|bevacizumab
711198|NCT00586092|ABT-510|abt-510
711199|NCT00586092|solid tumors|solid tumors
711200|NCT00586092|angiogenesis|angiogenesis
711201|NCT00586066|Bipolar disorder|bipolar disorder
711202|NCT00586066|Cognitive dysfunction|cognitive dysfunction
711203|NCT00586066|Memantine|memantine
711204|NCT00586066|NMDA antagonist|nmda antagonist
711205|NCT00586053|Colonic Polyps|colonic polyps
711206|NCT00586053|Colon|colon
711207|NCT00586053|Large Intestine|large intestine
711208|NCT00586053|Cecum|cecum
711209|NCT00586053|Sigmoid|sigmoid
711210|NCT00586053|Rectum|rectum
711211|NCT00586053|Colonoscopy|colonoscopy
711212|NCT00586053|Virtual Colonoscopy|virtual colonoscopy
711213|NCT00586053|CT Colonography|ct colonography
711214|NCT00586053|Computed Tomographic Colonography|computed tomographic colonography
711215|NCT00586053|Colonography|colonography
711216|NCT00586040|skin cancer|skin cancer
711217|NCT00586040|skin excision|skin excision
711218|NCT00586040|laser|laser
711219|NCT00586040|superficial sutures|superficial sutures
711220|NCT00586040|wound healing|wound healing
711221|NCT00586027|cardiac surgery|cardiac surgery
711222|NCT00586027|low cardiac output|low cardiac output
711223|NCT00586027|natriuretic peptide B|natriuretic peptide b
711224|NCT00586027|mortality|mortality
711225|NCT00586027|morbidity|morbidity
711226|NCT00586014|Multiple myeloma|multiple myeloma
711227|NCT00586014|Autologous Stem Cell Transplant|autologous stem cell transplant
711228|NCT00586001|Anxiety|anxiety
711229|NCT00586001|Emotional Disorders|emotional disorders
711230|NCT00586001|Unified|unified
711231|NCT00586001|Depression|depression
711232|NCT00585962|proton beam radiation|proton beam radiation
711233|NCT00585910|ADHD|adhd
711234|NCT00585910|Attention Deficit Hyperactivity Disorder|attention deficit hyperactivity disorder
711235|NCT00585910|Strattera|strattera
711236|NCT00585910|Concerta|concerta
711237|NCT00585910|Atomoxetine|atomoxetine
711238|NCT00585910|OROS Methylphenidate|oros methylphenidate
711241|NCT00585884|Reconstruction, Silicone prostheses|reconstruction, silicone prostheses
711242|NCT00585871|ICD patients with 5 VTs per 3 month period|icd patients with 5 vts per 3 month period
711243|NCT00585845|Cancer|cancer
711244|NCT00585845|Ovarian cancer|ovarian cancer
711245|NCT00585845|Pancreatic cancer|pancreatic cancer
711246|NCT00585845|Non-small cell lung cancer|non-small cell lung cancer
711247|NCT00585845|Mesothelioma|mesothelioma
711248|NCT00585845|Mesothelin|mesothelin
711249|NCT00585845|Immunotherapy|immunotherapy
711250|NCT00585832|hypertension|hypertension
711251|NCT00585832|pre-hypertension|pre-hypertension
711252|NCT00585832|adolescents|adolescents
711253|NCT00585832|diet|diet
711254|NCT00585832|vascular function|vascular function
711255|NCT00585806|Heart Failure with preserved ejection fraction|heart failure with preserved ejection fraction
711256|NCT00585793|HIV/AIDS|hiv/aids
711257|NCT00585767|Hydronephrosis|hydronephrosis
711258|NCT00585715|Cellulite|cellulite
711259|NCT00585715|Nd:YAG Laser|nd:yag laser
711260|NCT00585702|Bipolar Disorder|bipolar disorder
711261|NCT00585702|Pregnancy|pregnancy
711262|NCT00585702|Infant Development|infant development
711263|NCT00585689|Locally advanced urothelial carcinoma of the bladder|locally advanced urothelial carcinoma of the bladder
711264|NCT00585650|palmoplantar psoriasis|palmoplantar psoriasis
711265|NCT00585650|etanercept|etanercept
711266|NCT00585650|Enbrel|enbrel
711267|NCT00585637|Vitamin D|vitamin d
711268|NCT00585637|Blacks|blacks
711269|NCT00585637|cancer|cancer
711270|NCT00585637|hypertension|hypertension
711271|NCT00585624|Esophagectomy|esophagectomy
711272|NCT00585624|Pancreaticoduodenectomy|pancreaticoduodenectomy
711273|NCT00585624|Whipple|whipple
711274|NCT00585611|Heart Failure, Congestive|heart failure, congestive
711275|NCT00585585|Depression|depression
711276|NCT00585585|Betahistine Dihydrochloride|betahistine dihydrochloride
711277|NCT00585572|Normal Tissues/Brains|normal tissues/brains
711278|NCT00585572|Alzheimer|alzheimer
711279|NCT00585572|Motor Neuron Disease|motor neuron disease
711280|NCT00585572|Dementia|dementia
711281|NCT00585572|Healthy Control Volunteers|healthy control volunteers
711282|NCT00585572|Populations At Risk|populations at risk
711284|NCT00585559|Lipid|lipid
711285|NCT00585559|Peroxidation|peroxidation
711286|NCT00585559|N-Acetylcysteine|n-acetylcysteine
711287|NCT00585559|Acetaminophen|acetaminophen
711288|NCT00585559|Vasospasm|vasospasm
711289|NCT00585546|heart failure|heart failure
711290|NCT00585546|dilated cardiomyopathy|dilated cardiomyopathy
711291|NCT00585546|heart assist device|heart assist device
711292|NCT00585546|clenbuterol|clenbuterol
711293|NCT00585546|adrenergic beta agonists|adrenergic beta agonists
711294|NCT00585546|heart transplantation|heart transplantation
711295|NCT00585507|hormone receptor positive breast cancer|hormone receptor positive breast cancer
711296|NCT00585507|Fulvestrant|fulvestrant
711297|NCT00585481|Epidemiological Study|epidemiological study
711298|NCT00585481|Incidence of severe Respiratory Syncytial Virus|incidence of severe respiratory syncytial virus
711299|NCT00585481|Preterm Brazilian children|preterm brazilian children
711300|NCT00585455|vascular endothelium|vascular endothelium
711301|NCT00585455|nitric oxide|nitric oxide
711302|NCT00585455|depression|depression
711303|NCT00585455|heart failure|heart failure
711304|NCT00585455|vascular biology|vascular biology
711305|NCT00585416|Prostate Cancer|prostate cancer
711306|NCT00585416|Hormone Refractory|hormone refractory
711307|NCT00585416|Metastatic|metastatic
711308|NCT00585364|Allergic Bronchopulmonary Aspergillosis|allergic bronchopulmonary aspergillosis
711309|NCT00585364|Aspergillus fumigatus|aspergillus fumigatus
711310|NCT00585364|cytokine expression|cytokine expression
711311|NCT00585338|facial telangiectasia,|facial telangiectasia,
711312|NCT00585338|leg vein telangiectasia|leg vein telangiectasia
711313|NCT00585338|Port Wine Stain birthmarks|port wine stain birthmarks
711315|NCT00585299|steatosis|steatosis
711316|NCT00585299|fatty liver|fatty liver
711317|NCT00585299|insulin sensitivity|insulin sensitivity
711318|NCT00585299|fatty liver (steatosis)|fatty liver (steatosis)
711319|NCT00585286|acne vulgaris|acne vulgaris
711320|NCT00585286|scarring|scarring
711321|NCT00585286|laser|laser
711322|NCT00585260|asthma|asthma
711323|NCT00585260|bronchoprovocation challenge test|bronchoprovocation challenge test
711324|NCT00585260|mannitol|mannitol
711325|NCT00585260|methacholine|methacholine
711326|NCT00585247|birthmarks|birthmarks
711327|NCT00585221|Gastrointestinal stromal tumors|gastrointestinal stromal tumors
711328|NCT00585221|Imatinib|imatinib
711329|NCT00585221|Peginterferon α-2b|peginterferon α-2b
711330|NCT00585221|Immunotherapy|immunotherapy
711331|NCT00585221|Targeted therapy|targeted therapy
711332|NCT00585208|insomnia|insomnia
711333|NCT00585208|sleep disturbance|sleep disturbance
711334|NCT00585208|bipolar disorder|bipolar disorder
711335|NCT00585195|Crizotinib|crizotinib
711336|NCT00585195|dose-finding|dose-finding
711337|NCT00585195|drug-drug interaction|drug-drug interaction
711338|NCT00585195|ALK rearrangements|alk rearrangements
711339|NCT00585195|c-Met mutations or amplifications|c-met mutations or amplifications
711340|NCT00585195|c-Met dependent tumors|c-met dependent tumors
711355|NCT00585156|Celebrex, Bone Ingrowth, Pain relief|celebrex, bone ingrowth, pain relief
711356|NCT00585143|Dyslipidemia|dyslipidemia
711357|NCT00585078|capecitabine|capecitabine
711358|NCT00585078|oxaliplatin|oxaliplatin
711359|NCT00585052|Ovarian Cancer|ovarian cancer
711360|NCT00585052|Epithelial Ovarian Cancer|epithelial ovarian cancer
711361|NCT00585052|Lovastatin|lovastatin
711362|NCT00585052|Paclitaxel|paclitaxel
711363|NCT00585039|child|child
711364|NCT00585039|emergency department|emergency department
711365|NCT00585026|Refractive error|refractive error
711366|NCT00585026|Asthenopia|asthenopia
711367|NCT00585026|Presbyopia|presbyopia
711368|NCT00585026|Eyeglasses|eyeglasses
711369|NCT00585026|Productivity|productivity
711370|NCT00585026|Visual comfort|visual comfort
711371|NCT00585026|Ergonomics|ergonomics
711372|NCT00585013|Inhaled Nitric Oxide (NO)|inhaled nitric oxide (no)
711373|NCT00585013|Anti-inflammatory|anti-inflammatory
711374|NCT00585013|Anti-reperfusion agent|anti-reperfusion agent
711375|NCT00584974|Depression|depression
711376|NCT00584974|Mental Disorders|mental disorders
711377|NCT00584974|Mood Disorders|mood disorders
711378|NCT00584974|Depressive Disorder, Major|depressive disorder, major
711379|NCT00584974|Dysthymic Disorder|dysthymic disorder
711380|NCT00584961|Metabolic Syndrome, Bipolar Disorder and Cardiovascular Risk Factors|metabolic syndrome, bipolar disorder and cardiovascular risk factors
711381|NCT00584948|FXTAS, Fragile X Premutation|fxtas, fragile x premutation
711382|NCT00584935|Pemphigoid|pemphigoid
711383|NCT00584935|Blistering Diseases|blistering diseases
711384|NCT00584935|Blindness|blindness
711385|NCT00584935|Autoimmune|autoimmune
711386|NCT00584935|Rituximab|rituximab
711387|NCT00584922|Esophageal injury|esophageal injury
711388|NCT00584922|Catheter Ablation|catheter ablation
711389|NCT00584922|Atrial Fibrillation|atrial fibrillation
711390|NCT00584896|heart disease|heart disease
711391|NCT00584896|coronary artery disease|coronary artery disease
711392|NCT00584896|echocardiogram|echocardiogram
711393|NCT00584896|ultrasound|ultrasound
711394|NCT00584896|angiogram|angiogram
711395|NCT00584896|SPECT|spect
711396|NCT00584896|chest pain|chest pain
711397|NCT00584896|perfusion|perfusion
711398|NCT00584883|Patients who have newly diagnosed brain tumors|patients who have newly diagnosed brain tumors
711399|NCT00584844|Live Vaccine Strain (LVS), Bacterial Infections, Ulceroglandular, Oculoglandular|live vaccine strain (lvs), bacterial infections, ulceroglandular, oculoglandular
711400|NCT00584831|astigmatism|astigmatism
711401|NCT00584831|visual acuity|visual acuity
711402|NCT00584831|orientation|orientation
711403|NCT00584831|contact lenses|contact lenses
711404|NCT00584818|coronary artery disease|coronary artery disease
711405|NCT00584818|chest pain|chest pain
711406|NCT00584818|healthy volunteers|healthy volunteers
711407|NCT00584818|SPECT|spect
711408|NCT00584818|angiogram|angiogram
711409|NCT00584818|ultrasound|ultrasound
711410|NCT00584818|echocardiogram|echocardiogram
711411|NCT00584818|perfusion|perfusion
711413|NCT00584792|Prostate Cancer|prostate cancer
711414|NCT00584779|Gabapentin Pharmacokinetics, renal impairment|gabapentin pharmacokinetics, renal impairment
711415|NCT00584753|Breast cancer|breast cancer
711416|NCT00584740|Crohn's disease, moderate, severe, active, AIN457|crohn's disease, moderate, severe, active, ain457
711417|NCT00584727|astigmatism|astigmatism
711418|NCT00584727|visual acuity|visual acuity
711419|NCT00584727|fit|fit
711420|NCT00584727|comfort|comfort
711421|NCT00584727|satisfaction|satisfaction
711422|NCT00584727|contact lens|contact lens
711423|NCT00584714|ultrasound|ultrasound
711424|NCT00584714|perfusion|perfusion
711425|NCT00584714|SPECT|spect
711426|NCT00584714|coronary artery disease|coronary artery disease
711427|NCT00584714|chest pain|chest pain
711428|NCT00584714|low probability|low probability
711429|NCT00584714|angiography|angiography
711430|NCT00584714|clinical outcomes|clinical outcomes
711431|NCT00584688|anorexia|anorexia
711432|NCT00584688|nervosa|nervosa
711433|NCT00584688|eating|eating
711434|NCT00584688|disorder|disorder
711435|NCT00584688|study|study
711436|NCT00584688|research|research
711437|NCT00584688|clinical|clinical
711438|NCT00584688|trial|trial
711439|NCT00584688|psychiatry|psychiatry
711440|NCT00584688|psychiatric|psychiatric
711441|NCT00584675|GERD|gerd
711442|NCT00584675|laryngopharyngeal reflux disease|laryngopharyngeal reflux disease
711443|NCT00584662|Rhinitis|rhinitis
711444|NCT00584649|Inappropriate Sinus Tachycardia|inappropriate sinus tachycardia
711445|NCT00584649|Inappropiate Tachycardia|inappropiate tachycardia
711446|NCT00584649|Sinus Tachycardia|sinus tachycardia
711447|NCT00584649|Palpitations|palpitations
711448|NCT00584649|Fast Heart rate|fast heart rate
711449|NCT00584636|child|child
711450|NCT00584636|emergency department|emergency department
711451|NCT00584623|dysphagia|dysphagia
711452|NCT00584623|videofluoroscopy|videofluoroscopy
711453|NCT00584623|flexible endoscopic evaluation|flexible endoscopic evaluation
711454|NCT00584610|Women's health|women's health
711455|NCT00584597|Radiation-Induced Mucositis|radiation-induced mucositis
711456|NCT00584597|Head and neck cancer|head and neck cancer
711463|NCT00584584|Allergic rhinitis, adults, monoclonal antibody, interleukin-13.|allergic rhinitis, adults, monoclonal antibody, interleukin-13.
711464|NCT00584558|Arrhythmia|arrhythmia
711465|NCT00584558|Catheter Ablation|catheter ablation
711466|NCT00584545|pharyngeal manometry|pharyngeal manometry
711467|NCT00584545|videofluoroscopy|videofluoroscopy
711468|NCT00584532|Localized|localized
711469|NCT00584532|Prostate|prostate
711470|NCT00584532|Cancer|cancer
711471|NCT00584519|Schizophrenia, Overweight, Cardiovascular Risk, Obesity|schizophrenia, overweight, cardiovascular risk, obesity
711472|NCT00584506|orbital fractures|orbital fractures
711473|NCT00584467|GEM|gem
711474|NCT00584467|Arteriosclerosis|arteriosclerosis
711475|NCT00584467|biomarkers|biomarkers
711476|NCT00584467|Atherosclerosis|atherosclerosis
711477|NCT00584454|Coxiella burnetti, Bacterial Infections, Rickettsia, Hepatits, Endocarditis|coxiella burnetti, bacterial infections, rickettsia, hepatits, endocarditis
711478|NCT00584428|Breast Cancer|breast cancer
711479|NCT00584428|Cancer Treatment|cancer treatment
711480|NCT00584428|Breast Cancer Treatment|breast cancer treatment
711481|NCT00584415|Catheter Ablation|catheter ablation
711482|NCT00584415|Atrial Fibrillation|atrial fibrillation
711483|NCT00584402|liver cancer|liver cancer
711484|NCT00584389|Obesity|obesity
711485|NCT00584389|Energy expenditure|energy expenditure
711486|NCT00584389|Fatty acid|fatty acid
711487|NCT00584389|Triglyceride|triglyceride
711488|NCT00584376|Essential tremor|essential tremor
711489|NCT00584376|tremor|tremor
711490|NCT00584376|pregabalin|pregabalin
711491|NCT00584376|lyrica|lyrica
711492|NCT00584350|coronary angiogram|coronary angiogram
711493|NCT00584350|percutaneous coronary intervention|percutaneous coronary intervention
711494|NCT00584337|tomography|tomography
711495|NCT00584337|coronary artery disease|coronary artery disease
711496|NCT00584337|Stress Test|stress test
711497|NCT00584337|Coronary CT Angiography|coronary ct angiography
711498|NCT00584337|Diagnostic Accuracy|diagnostic accuracy
711499|NCT00584337|Non invasive testing|non invasive testing
711500|NCT00584324|elective surgery|elective surgery
711501|NCT00584324|general anesthesia|general anesthesia
711502|NCT00584324|implicit memory|implicit memory
711503|NCT00584298|Barostat|barostat
711504|NCT00584298|distention|distention
711505|NCT00584298|IBS|ibs
711506|NCT00584298|irritable|irritable
711507|NCT00584298|bowel|bowel
711508|NCT00584298|syndrome|syndrome
711509|NCT00584298|colorectal|colorectal
711510|NCT00584298|sensation|sensation
711511|NCT00584298|modulation|modulation
711512|NCT00584298|reproducibility|reproducibility
711513|NCT00584272|cleft palate|cleft palate
711514|NCT00584272|suture materials|suture materials
711515|NCT00584259|GERD|gerd
711516|NCT00584259|Gastro-Esophageal Disease|gastro-esophageal disease
711517|NCT00584246|Restless legs syndrome|restless legs syndrome
711518|NCT00584246|RLS|rls
711519|NCT00584246|Pregabalin|pregabalin
711520|NCT00584246|Lyrica|lyrica
711521|NCT00584233|breast cancer|breast cancer
711522|NCT00584220|Astigmatism|astigmatism
711523|NCT00584220|vision|vision
711524|NCT00584220|comfort|comfort
711525|NCT00584220|satisfaction|satisfaction
711526|NCT00584220|contact lenses|contact lenses
711527|NCT00584207|uterine fibroids|uterine fibroids
711528|NCT00584194|Hemorrhagic Fever, Viral Infections, Neurologic diseases, Arbovirus Infections, RVF|hemorrhagic fever, viral infections, neurologic diseases, arbovirus infections, rvf
711529|NCT00584168|UPPP|uppp
711530|NCT00584168|Dexamethasone|dexamethasone
711531|NCT00584168|Uvulopalatopharyngoplasty|uvulopalatopharyngoplasty
711532|NCT00584168|Pain Management|pain management
711533|NCT00584168|Increasing pain management in patients that have undergone UPPP surgery|increasing pain management in patients that have undergone uppp surgery
711534|NCT00584155|Cisplatin Ototoxicity|cisplatin ototoxicity
711535|NCT00584155|Lactated Ringer's|lactated ringer's
711536|NCT00584155|Ear Cancer|ear cancer
711537|NCT00584155|Hearing loss|hearing loss
711538|NCT00584155|Hearing loss due to Cisplatin Ototoxicity|hearing loss due to cisplatin ototoxicity
711539|NCT00584142|breast cancer|breast cancer
711540|NCT00584142|survivors|survivors
711541|NCT00584129|Cancer|cancer
711542|NCT00584129|Dysphagia|dysphagia
711543|NCT00584129|Radiation|radiation
711544|NCT00584129|Patients with H&N cancer who will be receiving chemoradiation|patients with h&n cancer who will be receiving chemoradiation
711545|NCT00584116|Aortic Valve Replacement|aortic valve replacement
711546|NCT00584116|AVR|avr
711547|NCT00584103|transradial amputation|transradial amputation
711548|NCT00584103|prosthesis|prosthesis
711549|NCT00584103|prefabricated prosthesis|prefabricated prosthesis
711550|NCT00584103|inexpensive|inexpensive
711551|NCT00584103|custom prosthesis|custom prosthesis
711552|NCT00584103|adult transradial amputation|adult transradial amputation
711553|NCT00584090|urinary incontinence|urinary incontinence
711554|NCT00584090|parkinson's disease|parkinson's disease
711555|NCT00584090|vesicare|vesicare
711556|NCT00584090|solifenacin succinate|solifenacin succinate
711557|NCT00584064|patent|patent
711558|NCT00584064|foramen|foramen
711559|NCT00584064|ovale|ovale
711560|NCT00584064|PFO|pfo
711561|NCT00584051|Control group|control group
711573|NCT00583999|leptin, leptin receptors, adiponectin|leptin, leptin receptors, adiponectin
711574|NCT00583986|top mounted|top mounted
711575|NCT00583986|actuation indicator|actuation indicator
711576|NCT00583986|Asthma|asthma
711577|NCT00583986|COPD|copd
711578|NCT00583986|Chronic Obstructive Pulmonary Disease|chronic obstructive pulmonary disease
711579|NCT00583960|swallowing problems|swallowing problems
711580|NCT00583960|tracheal stenosis|tracheal stenosis
711581|NCT00583947|Asthma|asthma
711582|NCT00583947|Respiratory Tract Diseases|respiratory tract diseases
711583|NCT00583934|esophageal cancer, head and neck cancer, dysplasia|esophageal cancer, head and neck cancer, dysplasia
711584|NCT00583921|Atrial Fibrillation|atrial fibrillation
711585|NCT00583921|ICD|icd
711586|NCT00583921|BiV ICD|biv icd
711587|NCT00583921|CHF|chf
711588|NCT00583921|Congestive Heart Failure|congestive heart failure
711589|NCT00583921|AF|af
711590|NCT00583908|astigmatism|astigmatism
711591|NCT00583908|orientation|orientation
711592|NCT00583908|visual acuity|visual acuity
711593|NCT00583908|contact lenses|contact lenses
711594|NCT00583895|dermatitis|dermatitis
711595|NCT00583895|atopic|atopic
711596|NCT00583895|ImCOOH|imcooh
711597|NCT00583895|safety|safety
711598|NCT00583895|tolerability|tolerability
711599|NCT00583895|efficacy|efficacy
711600|NCT00583895|pharmacokinetics|pharmacokinetics
711601|NCT00583882|Central Venous Catheter|central venous catheter
711602|NCT00583882|Guidewire|guidewire
711603|NCT00583882|Burn|burn
711604|NCT00583869|Post-operative Pain|post-operative pain
711605|NCT00583869|Fracture Patients|fracture patients
711606|NCT00583869|Pregabalin|pregabalin
711607|NCT00583869|LYRICA|lyrica
711608|NCT00583856|computer aided design|computer aided design
711609|NCT00583856|maxillofacial fracture|maxillofacial fracture
711610|NCT00583856|orbital design|orbital design
711611|NCT00583843|Lumpectomy|lumpectomy
711612|NCT00583843|Ultrasonography|ultrasonography
711613|NCT00583843|Radiotherapy|radiotherapy
711614|NCT00583830|Lung Cancer|lung cancer
711615|NCT00583804|Spinal Cord Injury|spinal cord injury
711616|NCT00583804|Tetraplegia|tetraplegia
711617|NCT00583804|Functional Electrical Stimulation|functional electrical stimulation
711618|NCT00583804|Neuroprosthesis|neuroprosthesis
711619|NCT00583791|muscular|muscular
711620|NCT00583791|ventricular|ventricular
711622|NCT00583791|defects|defects
711623|NCT00583791|VSD|vsd
711624|NCT00583778|Asthma|asthma
711625|NCT00583778|Bronchodilators|bronchodilators
711626|NCT00583778|Levalbuterol|levalbuterol
711627|NCT00583778|Ipratropium|ipratropium
711628|NCT00583765|Kidney Failure, Acute|kidney failure, acute
711629|NCT00583765|Hemodialysis|hemodialysis
711630|NCT00583765|Hemofiltration|hemofiltration
711631|NCT00583765|Anticoagulation|anticoagulation
711632|NCT00583765|Citrate|citrate
711633|NCT00583752|prostate cancer|prostate cancer
711634|NCT00583752|vaccine|vaccine
711635|NCT00583752|immunotherapy|immunotherapy
711636|NCT00583739|Fatigue|fatigue
711637|NCT00583739|Yoga|yoga
711638|NCT00583739|Anxiety|anxiety
711639|NCT00583739|Quality of Life|quality of life
711640|NCT00583726|chemotherapy|chemotherapy
711641|NCT00583726|exercise|exercise
711642|NCT00583726|diet|diet
711643|NCT00583726|fruit|fruit
711644|NCT00583726|vegetables|vegetables
711645|NCT00583726|low-fat|low-fat
711646|NCT00583700|Breast Neoplasms|breast neoplasms
711647|NCT00583700|Radiotherapy|radiotherapy
711648|NCT00583687|Arterial pulse contour cardiac output|arterial pulse contour cardiac output
711649|NCT00583687|Changing vascular tone|changing vascular tone
711650|NCT00583687|Tissue Oxymetry|tissue oxymetry
711651|NCT00583687|Prediction of Fluid Responsiveness|prediction of fluid responsiveness
711652|NCT00583674|Gastric Cancer|gastric cancer
711653|NCT00583674|Metastatic Gastric, Gastroesophageal Junction, or Distal Esophageal Adenocarcinoma|metastatic gastric, gastroesophageal junction, or distal esophageal adenocarcinoma
711654|NCT00583674|AMG 386|amg 386
711655|NCT00583674|Cisplatin|cisplatin
711656|NCT00583674|Capecitabine|capecitabine
711657|NCT00583661|Ventricular Assist Device|ventricular assist device
711658|NCT00583661|Pediatric Ventricular Assist Device|pediatric ventricular assist device
711659|NCT00583648|urinary tract infections|urinary tract infections
711660|NCT00583648|urine|urine
711661|NCT00583648|urinalysis|urinalysis
711662|NCT00583648|urine protocols|urine protocols
711663|NCT00583648|urinalysis protocols|urinalysis protocols
711664|NCT00583648|nursing protocols|nursing protocols
711665|NCT00583648|Emergency Department|emergency department
711666|NCT00583635|Preeclampsia|preeclampsia
711667|NCT00583635|Prevention|prevention
711668|NCT00583635|Food Supplement|food supplement
711669|NCT00583622|Ovarian Cancer|ovarian cancer
711670|NCT00583622|Epithelial Ovarian Cancer|epithelial ovarian cancer
711671|NCT00583622|Bevacizumab|bevacizumab
711672|NCT00583622|Carboplatin|carboplatin
711673|NCT00583622|Gemcitabine|gemcitabine
711674|NCT00583622|Docetaxel|docetaxel
711675|NCT00583622|Melphalan|melphalan
711676|NCT00583596|patent ductus arteriosus (PDA)|patent ductus arteriosus (pda)
711677|NCT00583557|Rheumatoid Arthritis|rheumatoid arthritis
711681|NCT00583531|Antibiotic-refractory Pouchitis|antibiotic-refractory pouchitis
711682|NCT00583531|Pouchitis|pouchitis
711683|NCT00583531|Ulcerative Colitis|ulcerative colitis
711684|NCT00583505|membranous|membranous
711685|NCT00583505|ventricular|ventricular
711686|NCT00583505|septal|septal
711687|NCT00583505|defects|defects
711688|NCT00583505|VSD|vsd
711689|NCT00583492|Prostatic Neoplasms|prostatic neoplasms
711690|NCT00583492|Prostate Cancer|prostate cancer
711691|NCT00583492|Adenocarinomas|adenocarinomas
711692|NCT00583492|Tumors of the Prostate|tumors of the prostate
711693|NCT00583492|Gene Therapy|gene therapy
711694|NCT00583492|IMRT|imrt
711695|NCT00583466|submucosal cushion|submucosal cushion
711696|NCT00583466|polypectomy|polypectomy
711697|NCT00583466|endoscopic mucosal resection|endoscopic mucosal resection
711698|NCT00583453|Tonsillectomy|tonsillectomy
711699|NCT00583453|Analgesia|analgesia
711700|NCT00583453|Pain measurement|pain measurement
711701|NCT00583453|Celecoxib|celecoxib
711702|NCT00583440|12-step|12-step
711703|NCT00583440|mutual help|mutual help
711704|NCT00583440|dual diagnosis|dual diagnosis
711705|NCT00583440|serious mental illness|serious mental illness
711706|NCT00583401|PFO|pfo
711707|NCT00583401|stroke|stroke
711708|NCT00583388|cardiology|cardiology
711709|NCT00583388|preventive medicine|preventive medicine
711710|NCT00583388|cardiovascular physiology|cardiovascular physiology
711711|NCT00583388|healthy subjects|healthy subjects
711712|NCT00583375|arthritis|arthritis
711713|NCT00583375|ankle pain|ankle pain
711714|NCT00583375|foot pain|foot pain
711715|NCT00583375|hindfoot fracture|hindfoot fracture
711716|NCT00583375|ankle fracture|ankle fracture
711717|NCT00583362|SLE|sle
711718|NCT00583362|Lupus|lupus
711719|NCT00583349|Bladder Cancer|bladder cancer
711720|NCT00583349|Chemotherapy|chemotherapy
711721|NCT00583349|Bladder Neoplasms|bladder neoplasms
711722|NCT00583310|Prehypertension|prehypertension
711723|NCT00583297|Arrhythmia|arrhythmia
711724|NCT00583297|Heart Failure|heart failure
711725|NCT00583297|T-wave Alternans|t-wave alternans
711726|NCT00583297|Implanted Cardioverter Defibrillator|implanted cardioverter defibrillator
711727|NCT00583297|Biological Markers|biological markers
711728|NCT00583297|Molecular Genetics|molecular genetics
711729|NCT00583297|Corus CAD|corus cad
711730|NCT00583297|ASGES|asges
711731|NCT00583297|Age/Sex/Gene Expression Score|age/sex/gene expression score
711732|NCT00583297|Gene Expression|gene expression
711733|NCT00583297|GES|ges
711734|NCT00583297|CVD|cvd
711735|NCT00583297|Precision Medicine|precision medicine
711736|NCT00583297|Sudden Cardiac Death|sudden cardiac death
711737|NCT00583297|Electrophysiology Study|electrophysiology study
711738|NCT00583297|Cardiovascular Disease|cardiovascular disease
711739|NCT00583297|ICD|icd
711740|NCT00583297|EPS|eps
711741|NCT00583297|SCD|scd
711742|NCT00583297|TWA|twa
711743|NCT00583284|delayed enhancement computed tomography|delayed enhancement computed tomography
711744|NCT00583284|ventricular tachycardia ablation|ventricular tachycardia ablation
711745|NCT00583284|ventricular tachycardia|ventricular tachycardia
711746|NCT00583245|Osteoarthritis|osteoarthritis
711747|NCT00583245|Gait training|gait training
711748|NCT00583245|Knee pain|knee pain
711749|NCT00583245|Rehabilitation|rehabilitation
711750|NCT00583245|Physical Therapy|physical therapy
711751|NCT00583232|Pediatric|pediatric
711752|NCT00583232|Crohn's disease|crohn's disease
711753|NCT00583232|protein metabolism|protein metabolism
711754|NCT00583232|energy metabolism|energy metabolism
711755|NCT00583206|sepsis|sepsis
711756|NCT00583206|atrophy|atrophy
711757|NCT00583206|muscle|muscle
711758|NCT00583206|weakness|weakness
711759|NCT00583193|Post Traumatic Stress Disorder|post traumatic stress disorder
711760|NCT00583193|Duloxetine|duloxetine
711761|NCT00583193|Antidepressants|antidepressants
711762|NCT00583180|Primary and/or secondary hyperalgesia|primary and/or secondary hyperalgesia
711763|NCT00583180|hypoesthesia|hypoesthesia
711764|NCT00583167|HIV|hiv
711765|NCT00583167|AIDS|aids
711766|NCT00583167|CNS|cns
711767|NCT00583167|brain|brain
711768|NCT00583167|affects|affects
711769|NCT00583154|constipation|constipation
711770|NCT00583154|laxative|laxative
711771|NCT00583128|IBS|ibs
711772|NCT00583128|Irritable Bowel Syndrome|irritable bowel syndrome
711773|NCT00583102|Acute Myeloid Leukemia|acute myeloid leukemia
711774|NCT00583102|AML|aml
711775|NCT00583102|Lovastatin|lovastatin
711776|NCT00583102|Cytarabine|cytarabine
711777|NCT00583076|Pouchitis|pouchitis
711778|NCT00583076|Active Pouchitis|active pouchitis
711779|NCT00583076|Safety and Efficacy of AST120|safety and efficacy of ast120
711780|NCT00583037|Neurally Adjusted Ventilatory Assist|neurally adjusted ventilatory assist
711781|NCT00583037|Sleep quality|sleep quality
711782|NCT00583037|Adult|adult
711783|NCT00583037|Critical Care|critical care
711784|NCT00583024|prostate cancer|prostate cancer
711785|NCT00583024|vaccine|vaccine
711786|NCT00583024|immunotherapy|immunotherapy
711787|NCT00583011|Amniocentesis|amniocentesis
711889|NCT00582699|Pancreatic|pancreatic
711793|NCT00582998|Vacuum Assisted Closure (VAC)|vacuum assisted closure (vac)
711794|NCT00582998|Calcaneus Fracture|calcaneus fracture
711795|NCT00582998|Pilon Fracture|pilon fracture
711796|NCT00582998|Tibial Plateau Fracture|tibial plateau fracture
711797|NCT00582998|Open Reduction and Internal Fixation|open reduction and internal fixation
711798|NCT00582985|Tracon|tracon
711799|NCT00582985|CD105|cd105
711800|NCT00582985|Anti CD105|anti cd105
711801|NCT00582985|TRC105|trc105
711802|NCT00582985|Phase 1|phase 1
711803|NCT00582985|Cancer|cancer
711804|NCT00582985|Monoclonal antibody|monoclonal antibody
711805|NCT00582985|Solid Tumor|solid tumor
711806|NCT00582972|Calcium Absorption|calcium absorption
711807|NCT00582972|Fractional Calcium Absorption|fractional calcium absorption
711808|NCT00582972|Omeprazole|omeprazole
711809|NCT00582972|Stable Calcium Isotopes|stable calcium isotopes
711810|NCT00582972|Proton Pump Inhibitor|proton pump inhibitor
711811|NCT00582972|Intestinal Absorption of Calcium|intestinal absorption of calcium
711812|NCT00582959|radiology imaging|radiology imaging
711813|NCT00582959|malignancy|malignancy
711814|NCT00582959|undergoing radiation therapy|undergoing radiation therapy
711815|NCT00582946|Hearing Loss, Eardrum, Transducer, Hearing in Noise|hearing loss, eardrum, transducer, hearing in noise
711816|NCT00582933|Cancer|cancer
711817|NCT00582933|Donors|donors
711818|NCT00582933|Leukemia|leukemia
711819|NCT00582933|Myelodysplastic Syndrome|myelodysplastic syndrome
711820|NCT00582933|Non-Hodgkin's Lymphoma|non-hodgkin's lymphoma
711821|NCT00582933|Lymphoma|lymphoma
711822|NCT00582933|AML|aml
711823|NCT00582933|ALL|all
711824|NCT00582933|CML|cml
711825|NCT00582933|Allogeneic marrow transplant|allogeneic marrow transplant
711826|NCT00582933|Bone marrow transplant|bone marrow transplant
711827|NCT00582920|osseous lesions|osseous lesions
711828|NCT00582920|breast cancer|breast cancer
711829|NCT00582920|metastatic breast cancer|metastatic breast cancer
711830|NCT00582907|FMF|fmf
711831|NCT00582907|IL1 Trap (Rilonacept)|il1 trap (rilonacept)
711832|NCT00582907|Periodic fever syndromes|periodic fever syndromes
711833|NCT00582907|Autoinflammatory syndromes|autoinflammatory syndromes
711834|NCT00582907|Familial Mediterranean Fever|familial mediterranean fever
711835|NCT00582907|colchicine|colchicine
711836|NCT00582894|Allogenic stem cell transplant|allogenic stem cell transplant
711837|NCT00582894|Hematologic diseases|hematologic diseases
711838|NCT00582881|Anti-RNP/Sm Autoantibody-Positive|anti-rnp/sm autoantibody-positive
711839|NCT00582881|MCTD|mctd
711840|NCT00582881|SLE|sle
711841|NCT00582868|Subarachnoid hemorrhage|subarachnoid hemorrhage
711842|NCT00582868|Cerebral Vasospasm|cerebral vasospasm
711843|NCT00582868|Cleaved-tau protein|cleaved-tau protein
711844|NCT00582868|Brain oxygen tension level|brain oxygen tension level
711845|NCT00582855|AQW051|aqw051
711846|NCT00582855|Mild Alzheimer's disease|mild alzheimer's disease
711847|NCT00582855|Amnestic Mild Cognitive Impairment|amnestic mild cognitive impairment
711848|NCT00582842|Early Stage|early stage
711849|NCT00582842|Localized|localized
711850|NCT00582829|Colorectal|colorectal
711851|NCT00582829|Cancer|cancer
711852|NCT00582829|Screening|screening
711853|NCT00582829|Intervention|intervention
711854|NCT00582829|Family|family
711855|NCT00582816|Recurrent or Refractory Leukemia or Solid Tumors in Pediatrics|recurrent or refractory leukemia or solid tumors in pediatrics
711856|NCT00582803|breast cancer|breast cancer
711857|NCT00582803|germline mutation|germline mutation
711858|NCT00582803|BRCA1|brca1
711859|NCT00582803|BRCA2|brca2
711860|NCT00582803|family history|family history
711861|NCT00582803|genetic testing|genetic testing
711862|NCT00582803|unaffected women over age 25 who are at elevated risk for|unaffected women over age 25 who are at elevated risk for
711863|NCT00582803|breast cancer by virtue by a hereditary predisposition|breast cancer by virtue by a hereditary predisposition
711864|NCT00582790|Renal Cell Cancer|renal cell cancer
711865|NCT00582790|Metastatic|metastatic
711866|NCT00582777|nocturnal blood pressure|nocturnal blood pressure
711867|NCT00582777|chronic renal disease|chronic renal disease
711868|NCT00582777|hypertensive renal disease|hypertensive renal disease
711869|NCT00582777|African Americans|african americans
711870|NCT00582777|ABPM|abpm
711871|NCT00582764|Breast Lesion|breast lesion
711872|NCT00582764|Lesion|lesion
711873|NCT00582764|Breast|breast
711874|NCT00582764|Cancer|cancer
711875|NCT00582764|05-091|05-091
711876|NCT00582751|Volumetric Analysis|volumetric analysis
711877|NCT00582751|Multiple Diseases|multiple diseases
711878|NCT00582738|Fibrosis progression|fibrosis progression
711879|NCT00582738|recurrent hepatitis C|recurrent hepatitis c
711880|NCT00582738|viral infection|viral infection
711881|NCT00582738|liver transplant recipients|liver transplant recipients
711882|NCT00582738|everolimus|everolimus
711883|NCT00582738|Hepatitis C recurrence after orthotopic liver transplantation (OLT)|hepatitis c recurrence after orthotopic liver transplantation (olt)
711884|NCT00582725|DLBCL, Elderly|dlbcl, elderly
711885|NCT00582725|previously untreated DLBCL in the elderly|previously untreated dlbcl in the elderly
711886|NCT00582712|medullary thyroid cancer|medullary thyroid cancer
711887|NCT00582712|lithium|lithium
711888|NCT00582699|Pancreatic Cancer|pancreatic cancer
711892|NCT00582686|Open Reduction & Internal Fixation|open reduction & internal fixation
711893|NCT00582673|Parkinson's, L-dopa, dyskinesia|parkinson's, l-dopa, dyskinesia
711894|NCT00582634|non small cell lung cancer|non small cell lung cancer
711895|NCT00582634|adjuvant|adjuvant
711896|NCT00582634|cisplatin|cisplatin
711897|NCT00582634|docetaxel|docetaxel
711898|NCT00582621|Genetic Studies|genetic studies
711899|NCT00582621|00-069|00-069
711900|NCT00582621|blood|blood
711901|NCT00582621|saliva|saliva
711902|NCT00582621|buccal cell|buccal cell
711903|NCT00582582|Metastatic|metastatic
711904|NCT00582582|Hormone Refractory|hormone refractory
711905|NCT00582582|Prostate Cancer|prostate cancer
711906|NCT00582569|Breast lesion|breast lesion
711907|NCT00582569|Spectroscopy|spectroscopy
711908|NCT00582569|MRI|mri
711909|NCT00582556|bone mineral density|bone mineral density
711910|NCT00582543|Prostate Cancer|prostate cancer
711911|NCT00582543|Prostate|prostate
711912|NCT00582530|Prostate Cancer|prostate cancer
711913|NCT00582530|Early Prostate Cancer|early prostate cancer
711914|NCT00582530|Radical Prostatectomy|radical prostatectomy
711915|NCT00582517|Orthopaedic Trauma|orthopaedic trauma
711916|NCT00582517|Knee Dislocation|knee dislocation
711917|NCT00582517|Compass Hinge External Fixator|compass hinge external fixator
711918|NCT00582517|External Brace|external brace
711919|NCT00582504|Encephalitis,VEE|encephalitis,vee
711920|NCT00582491|Modafinil|modafinil
711921|NCT00582491|Sleep|sleep
711922|NCT00582491|Cognition|cognition
711923|NCT00582491|Cocaine Dependence|cocaine dependence
711924|NCT00582478|Breast cancer|breast cancer
711925|NCT00582478|Quality of Life|quality of life
711926|NCT00582452|HNPCC|hnpcc
711927|NCT00582452|prophylactic colectomy|prophylactic colectomy
711928|NCT00582439|Orthopaedic Trauma Fractures|orthopaedic trauma fractures
711929|NCT00582439|Orthopaedic Trauma Non-unions|orthopaedic trauma non-unions
711930|NCT00582439|Reamer-Irrigator-Aspirator (RIA)|reamer-irrigator-aspirator (ria)
711931|NCT00582439|Bone Graft|bone graft
711932|NCT00582426|Colorectal cancer|colorectal cancer
711933|NCT00582426|diarrhea|diarrhea
711934|NCT00582426|drug therapy|drug therapy
711935|NCT00582426|octreotide|octreotide
711936|NCT00582426|fluorouracil|fluorouracil
711937|NCT00582426|irinotecan|irinotecan
711938|NCT00582426|capecitabine|capecitabine
711939|NCT00582426|prevention|prevention
711940|NCT00582413|Head and Neck Cancer|head and neck cancer
711941|NCT00582400|livers, hepatocellular carcinoma (HCC)|livers, hepatocellular carcinoma (hcc)
711942|NCT00582374|Periodontal Disease|periodontal disease
711943|NCT00582374|Preterm Birth|preterm birth
711944|NCT00582374|Low Birth Weight|low birth weight
711945|NCT00582374|Pregnancy|pregnancy
711946|NCT00582361|Open Fractures|open fractures
711947|NCT00582361|Vacuum Assisted Closure (VAC) device|vacuum assisted closure (vac) device
711948|NCT00582361|Irrigation and Debridement|irrigation and debridement
711949|NCT00582348|Lung Cancer|lung cancer
711950|NCT00582348|Survivor|survivor
711951|NCT00582348|Lung|lung
711952|NCT00582335|Colorectal cancer|colorectal cancer
711953|NCT00582335|Genetic testing|genetic testing
711954|NCT00582335|Genetic mutations|genetic mutations
711955|NCT00582322|Breast Cancer|breast cancer
711956|NCT00582322|Ovarian Cancer|ovarian cancer
711957|NCT00582322|Family History|family history
711958|NCT00582322|Genetic Studies|genetic studies
711959|NCT00582309|Glycemic Control|glycemic control
711960|NCT00582309|Intravenous Infusion|intravenous infusion
711961|NCT00582309|Standard Insulin infusion algorithm|standard insulin infusion algorithm
711962|NCT00582309|Infusion|infusion
711963|NCT00582309|Critically Ill|critically ill
711964|NCT00582296|Lynch syndrome|lynch syndrome
711965|NCT00582296|04-144|04-144
711966|NCT00582270|non-hodkin's lymphoma|non-hodkin's lymphoma
711967|NCT00582270|follicular|follicular
711968|NCT00582270|non-follicular|non-follicular
711969|NCT00582270|infectious disease|infectious disease
711970|NCT00582257|Gastric Cancer|gastric cancer
711971|NCT00582257|Stomach Cancer|stomach cancer
711972|NCT00582257|05-118|05-118
711973|NCT00582244|Menopausal symptoms|menopausal symptoms
711974|NCT00582244|Quality of Life|quality of life
711975|NCT00582244|Breast cancer|breast cancer
711976|NCT00582244|Multicenter trial|multicenter trial
711977|NCT00582231|Penile injection therapy|penile injection therapy
711978|NCT00582231|Erectile dysfunction|erectile dysfunction
711979|NCT00582231|Radical pelvic surgery|radical pelvic surgery
711980|NCT00582231|Penile Injection Anxiety|penile injection anxiety
711981|NCT00582218|HIV/AIDS|hiv/aids
711982|NCT00582218|Access to care|access to care
711983|NCT00582205|Ovarian Cancer|ovarian cancer
711984|NCT00582205|Fallopian Tube Cancer|fallopian tube cancer
711985|NCT00582205|Primary Peritoneal Carcinoma|primary peritoneal carcinoma
711986|NCT00582205|Uterine Cancer|uterine cancer
711987|NCT00582205|Intraperitoneal Chemotherapy|intraperitoneal chemotherapy
711988|NCT00582205|IP Chemotherapy|ip chemotherapy
711989|NCT00582205|Gynecologic Cancer|gynecologic cancer
711990|NCT00582205|Women's Cancer|women's cancer
711991|NCT00582205|Cisplatin|cisplatin
711992|NCT00582205|Paclitaxel|paclitaxel
711993|NCT00582205|Recurrent Platinum Sensitive Ovarian Cancer|recurrent platinum sensitive ovarian cancer
711994|NCT00582192|Phase I trial|phase i trial
711995|NCT00582192|Oncologists' Communication Styles|oncologists' communication styles
711996|NCT00582179|Draining Hematoma|draining hematoma
711997|NCT00582179|Vacuum Assisted Closure (VAC)|vacuum assisted closure (vac)
711998|NCT00582179|Negative Pressure Wound Therapy (NPWT)|negative pressure wound therapy (npwt)
711999|NCT00582179|Draining Hematoma following orthopaedic surgery|draining hematoma following orthopaedic surgery
712000|NCT00582166|Zevalin, High Tumor Burden Indolent Non-Hodgkin's Lymphoma, Ibritumomab Tiuxetan|zevalin, high tumor burden indolent non-hodgkin's lymphoma, ibritumomab tiuxetan
712001|NCT00582140|Prostate|prostate
712002|NCT00582140|Cancer|cancer
712003|NCT00582140|Stage D0|stage d0
712004|NCT00582140|Non-Metastatic|non-metastatic
712005|NCT00582140|Rising PSA|rising psa
712006|NCT00582127|senile|senile
712007|NCT00582127|dementia|dementia
712008|NCT00582114|Hemodialysis|hemodialysis
712009|NCT00582114|Hypertension|hypertension
712010|NCT00582114|Left ventricular hypertrophy|left ventricular hypertrophy
712011|NCT00582101|HIV|hiv
712012|NCT00582101|prevention|prevention
712013|NCT00582101|families|families
712014|NCT00582101|Latinos|latinos
712015|NCT00582101|communication|communication
712016|NCT00582101|sexuality|sexuality
712017|NCT00582101|monitoring|monitoring
712018|NCT00582101|health promotion|health promotion
712019|NCT00582101|HIV Prevention|hiv prevention
712020|NCT00582101|HIV Seronegativity|hiv seronegativity
712021|NCT00582088|Encephalitis, Viral Infections, Neurologic diseases, Alphavirus Infections, VEE|encephalitis, viral infections, neurologic diseases, alphavirus infections, vee
712023|NCT00582075|Brain metastases|brain metastases
712024|NCT00582075|Gamma Knife Radiosurgery|gamma knife radiosurgery
712025|NCT00582075|Temodar|temodar
712026|NCT00582075|Temozolomide|temozolomide
712027|NCT00582062|Gastric Cancer|gastric cancer
712028|NCT00582062|Pancreatic cancer|pancreatic cancer
712029|NCT00582049|Retinoblastoma|retinoblastoma
712030|NCT00582049|Sporadic heritable retinoblastoma|sporadic heritable retinoblastoma
712031|NCT00582049|Paternal exposures|paternal exposures
712032|NCT00582036|Hyperglycemia|hyperglycemia
712033|NCT00582036|Hematopoietic stem cell transplantation|hematopoietic stem cell transplantation
712034|NCT00582036|Bone marrow transplant|bone marrow transplant
712035|NCT00582036|High blood sugar|high blood sugar
712036|NCT00582023|HIV|hiv
712037|NCT00582023|coping|coping
712038|NCT00582023|emotion|emotion
712039|NCT00582023|affect|affect
712040|NCT00582023|HIV infection|hiv infection
712041|NCT00582023|Complimentary therapies|complimentary therapies
712042|NCT00582010|ischemia-reperfusion|ischemia-reperfusion
712043|NCT00582010|nitric oxide|nitric oxide
712044|NCT00582010|inflammation|inflammation
712045|NCT00582010|cell-death|cell-death
712046|NCT00582010|Liver-function post transplantation|liver-function post transplantation
712047|NCT00581997|Pulmonary fibrosis, systemic sclerosis|pulmonary fibrosis, systemic sclerosis
712048|NCT00581984|breast cancer|breast cancer
712049|NCT00581984|breast reconstruction|breast reconstruction
712050|NCT00581984|silicone implants|silicone implants
712051|NCT00581971|Radiosensitization|radiosensitization
712052|NCT00581971|COX-2 inhibitor|cox-2 inhibitor
712053|NCT00581971|Celecoxib|celecoxib
712054|NCT00581971|Head and Neck Cancer|head and neck cancer
712055|NCT00581971|Chemoradiation|chemoradiation
712056|NCT00581958|total body irradiation|total body irradiation
712057|NCT00581958|Cancer|cancer
712058|NCT00581958|Hematopoietic System|hematopoietic system
712059|NCT00581932|clozapine, schizophrenia|clozapine, schizophrenia
712060|NCT00581919|previously treated multiple myeloma|previously treated multiple myeloma
712061|NCT00581906|Head and Neck Cancer|head and neck cancer
712062|NCT00581906|Head Cancer|head cancer
712063|NCT00581906|Neck Cancer|neck cancer
712064|NCT00581906|Dynamic Contrast Enhanced MRI|dynamic contrast enhanced mri
712065|NCT00581906|Magnetic Resonance Spectroscopy (MRS)|magnetic resonance spectroscopy (mrs)
712066|NCT00581906|Diffusion Weighted MRI (DW-MRI)|diffusion weighted mri (dw-mri)
712067|NCT00581906|06-007|06-007
712068|NCT00581893|epilepsy|epilepsy
712069|NCT00581893|cognitive impairment|cognitive impairment
712070|NCT00581893|driving simulation|driving simulation
712071|NCT00581893|cross-over study|cross-over study
712072|NCT00581880|end stage|end stage
712073|NCT00581880|Terminally Ill|terminally ill
712074|NCT00581854|untreated mantle cell lymphoma|untreated mantle cell lymphoma
712075|NCT00581841|Healthy adult normals|healthy adult normals
712076|NCT00581828|Calcium Absorption|calcium absorption
712077|NCT00581828|Intestinal Absorption of Calcium|intestinal absorption of calcium
712078|NCT00581828|Fractional Calcium Absorption|fractional calcium absorption
712079|NCT00581828|Stable Calcium Isotopes|stable calcium isotopes
712080|NCT00581828|Hypovitaminosis D|hypovitaminosis d
712081|NCT00581828|Vitamin D|vitamin d
712082|NCT00581828|Bone Mineral Density|bone mineral density
712083|NCT00581828|Physical Function|physical function
712084|NCT00581802|CD4-Positive T-Lymphocytes|cd4-positive t-lymphocytes
712085|NCT00581802|Treatment Naive|treatment naive
712086|NCT00581802|Latent HIV Infections|latent hiv infections
712091|NCT00581776|Untreated Mantle Cell Lymphoma|untreated mantle cell lymphoma
712092|NCT00581750|Biopsy|biopsy
712093|NCT00581750|Breast|breast
712094|NCT00581750|01-135|01-135
712095|NCT00581724|breast cancer|breast cancer
712096|NCT00581724|Colorectal cancer|colorectal cancer
712097|NCT00581724|Prostate cancer|prostate cancer
712098|NCT00581724|Head and Neck cancer|head and neck cancer
712099|NCT00581724|Lung cancer|lung cancer
712100|NCT00581724|cancer survivors|cancer survivors
712101|NCT00581724|07-068|07-068
712102|NCT00581724|quality of life|quality of life
712103|NCT00581724|Pain in cancer survivors|pain in cancer survivors
712104|NCT00581711|Electronic Health Record|electronic health record
712105|NCT00581711|Clinical Decision Support|clinical decision support
712106|NCT00581711|Otitis Media|otitis media
712107|NCT00581698|Melanoma|melanoma
712108|NCT00581698|Negative regional lymph nodes|negative regional lymph nodes
712109|NCT00581698|Primary melanomas Clark III and Breslow thickness > 1 mm, or Clark|primary melanomas clark iii and breslow thickness > 1 mm, or clark
712110|NCT00581698|IV-V and any Breslow thickness, and clinically negative regional nodes|iv-v and any breslow thickness, and clinically negative regional nodes
712111|NCT00581685|Chronic pain|chronic pain
712112|NCT00581685|Preemptive analgesia|preemptive analgesia
712113|NCT00581685|Pregabalin|pregabalin
712114|NCT00581685|Celecoxib|celecoxib
712115|NCT00581685|Hip Arthroplasty|hip arthroplasty
712116|NCT00581685|Osteoarthritis|osteoarthritis
712117|NCT00581672|Anxiety|anxiety
712118|NCT00581672|Black men|black men
712119|NCT00581672|Prostate Cancer|prostate cancer
712120|NCT00581672|07-125|07-125
712121|NCT00581633|saline|saline
712122|NCT00581633|sodium|sodium
712123|NCT00581633|kidney|kidney
712124|NCT00581633|tachycardia|tachycardia
712125|NCT00581620|pneumococcus conjugated vaccine|pneumococcus conjugated vaccine
712126|NCT00581607|Sarcoidosis|sarcoidosis
712127|NCT00581594|Pelvic organ prolapse|pelvic organ prolapse
712128|NCT00581594|Posterior wall defects|posterior wall defects
712129|NCT00581594|Graft-augmented repair|graft-augmented repair
712130|NCT00581594|Posterior colporrhaphy|posterior colporrhaphy
712131|NCT00581581|neonatal encephalopathy|neonatal encephalopathy
712132|NCT00581581|therapeutic hypothermia|therapeutic hypothermia
712133|NCT00581581|head cooling|head cooling
712134|NCT00581581|neonatal asphyxia|neonatal asphyxia
712135|NCT00581568|Skin cooling during laser treatment|skin cooling during laser treatment
712136|NCT00581555|Psoriasis|psoriasis
712137|NCT00581529|breast|breast
712138|NCT00581516|Prostate Cancer|prostate cancer
712139|NCT00581516|PCA3|pca3
712140|NCT00581503|early detection of lung and pleural cancer|early detection of lung and pleural cancer
712141|NCT00581503|early detection of prostate cancer|early detection of prostate cancer
712142|NCT00581490|Premature pubarche|premature pubarche
712143|NCT00581490|Adrenal hyperandrogenism|adrenal hyperandrogenism
712144|NCT00581490|Metabolic syndrome|metabolic syndrome
712145|NCT00581477|autonomic nervous system diseases|autonomic nervous system diseases
712146|NCT00581477|blood pressure|blood pressure
712147|NCT00581477|congenital|congenital
712148|NCT00581477|orthostasis|orthostasis
712149|NCT00581477|catecholamines|catecholamines
712150|NCT00581464|Smoking cessation|smoking cessation
712151|NCT00581464|Tobacco dependence|tobacco dependence
712152|NCT00581464|Mindfulness|mindfulness
712153|NCT00581464|fMRI|fmri
712154|NCT00581464|Craving|craving
712155|NCT00581438|Approach Haemophilia A and B|approach haemophilia a and b
712156|NCT00581425|BCC|bcc
712157|NCT00581425|Basal Cell Carcinoma|basal cell carcinoma
712158|NCT00581425|Intron-A|intron-a
712159|NCT00581425|Aldara|aldara
712160|NCT00581425|Basal Cell Carcinoma excluding scalp and face|basal cell carcinoma excluding scalp and face
712161|NCT00581412|Pelvic organ prolapse|pelvic organ prolapse
712162|NCT00581412|Composite biologic/synthetic graft|composite biologic/synthetic graft
712163|NCT00581412|Abdominal sacrocolpopexy|abdominal sacrocolpopexy
712164|NCT00581399|Open heart surgery|open heart surgery
712165|NCT00581399|Cardiopulmonary Bypass|cardiopulmonary bypass
712166|NCT00581399|Coronary Artery Bypass Grafting|coronary artery bypass grafting
712167|NCT00581399|Chest Tube|chest tube
712168|NCT00581399|Valve Replacement|valve replacement
712169|NCT00581399|Valve Repair|valve repair
712170|NCT00581386|Endotracheal Intubation|endotracheal intubation
712171|NCT00581386|Supraglottic Airway|supraglottic airway
712172|NCT00581373|water|water
712173|NCT00581373|orthostatic hypotension|orthostatic hypotension
712174|NCT00581373|blood pressure|blood pressure
712175|NCT00581360|Adenoid cystic carcinoma|adenoid cystic carcinoma
712176|NCT00581360|bortezomib|bortezomib
712177|NCT00581360|doxorubicin|doxorubicin
712178|NCT00581334|Pelvic organ prolapse|pelvic organ prolapse
712179|NCT00581334|Robotic-assisted laparoscopic sacrocolpopexy|robotic-assisted laparoscopic sacrocolpopexy
712180|NCT00581334|Post hysterectomy prolapse|post hysterectomy prolapse
712181|NCT00581334|Symptomatic post hysterectomy prolapse of stage II or greater|symptomatic post hysterectomy prolapse of stage ii or greater
712182|NCT00581321|water|water
712183|NCT00581321|blood pressure|blood pressure
712184|NCT00581321|vascular resistance|vascular resistance
712185|NCT00581321|cardiac transplantation|cardiac transplantation
712186|NCT00581308|atrial septal defect, septal occluder, HELEX|atrial septal defect, septal occluder, helex
712187|NCT00581295|internal bleeding|internal bleeding
712188|NCT00581295|changes in tissue perfusion|changes in tissue perfusion
712189|NCT00581282|Cocaine abstinence|cocaine abstinence
712190|NCT00581282|PET scan|pet scan
712191|NCT00581256|left sided|left sided
712192|NCT00581243|Safety,Tolerability, Schizophrenia|safety,tolerability, schizophrenia
712193|NCT00581230|Endotracheal Intubation|endotracheal intubation
712194|NCT00581230|Rapid Airway Management Positioner|rapid airway management positioner
712195|NCT00581217|Burn injury|burn injury
712196|NCT00581217|Skin graft|skin graft
712197|NCT00581217|Donor site dressing|donor site dressing
712198|NCT00581217|Outcomes|outcomes
712199|NCT00581217|Infection rate|infection rate
712200|NCT00581217|Healing time|healing time
712201|NCT00581217|Cosmetic Result|cosmetic result
712202|NCT00581217|Pain|pain
712203|NCT00581217|Burn injured patients requiring skin grafting|burn injured patients requiring skin grafting
712204|NCT00581204|trauma situations|trauma situations
712205|NCT00581204|Lower Body Negative Pressure (LBNP)|lower body negative pressure (lbnp)
712206|NCT00581191|SAD|sad
712207|NCT00581191|Healthy|healthy
712208|NCT00581178|Ureteral Stent|ureteral stent
712209|NCT00581178|Kidney Stones|kidney stones
712210|NCT00581152|TBX3|tbx3
712211|NCT00581126|BENEFIX|benefix
712212|NCT00581126|Hemophilia B|hemophilia b
712213|NCT00581113|whole brain radiotherapy|whole brain radiotherapy
712214|NCT00581113|neural stem cell|neural stem cell
712215|NCT00581113|brain metastases|brain metastases
712216|NCT00581113|radiosurgery|radiosurgery
712217|NCT00581100|Nail Psoriasis|nail psoriasis
712218|NCT00581100|Plaque Psoriasis|plaque psoriasis
712219|NCT00581087|Hypertension, pulmonary|hypertension, pulmonary
712220|NCT00581087|DHEA|dhea
712221|NCT00581087|six-minute walk test|six-minute walk test
712222|NCT00581087|pulmonary arterial pressure|pulmonary arterial pressure
712223|NCT00581074|obesity|obesity
712224|NCT00581074|diet|diet
712225|NCT00581074|weight loss|weight loss
712226|NCT00581074|metabolic syndrome|metabolic syndrome
712227|NCT00581061|Incontinence|incontinence
712228|NCT00581061|Robotic Prostatectomy|robotic prostatectomy
712229|NCT00581048|Asthma|asthma
712230|NCT00581048|Allergy|allergy
712231|NCT00581048|Atopy|atopy
712232|NCT00581048|Vitamin E|vitamin e
712233|NCT00581048|GSTP1|gstp1
712234|NCT00581048|Oxidative stress|oxidative stress
712235|NCT00581035|Meningococcal disease|meningococcal disease
712236|NCT00581035|pneumococcal disease|pneumococcal disease
712237|NCT00581035|meningitis|meningitis
712238|NCT00581022|postural tachycardia syndrome|postural tachycardia syndrome
712239|NCT00581022|sleep|sleep
712240|NCT00581022|insomnia|insomnia
712241|NCT00581009|Sleep deprivation|sleep deprivation
712242|NCT00581009|antidepressant|antidepressant
712243|NCT00581009|depression|depression
712244|NCT00581009|chronobiological|chronobiological
712245|NCT00580996|water|water
712246|NCT00580996|orthostatic hypotension|orthostatic hypotension
712247|NCT00580996|blood pressure|blood pressure
712248|NCT00580983|Head and Neck cancer|head and neck cancer
712249|NCT00580970|prostate cancer|prostate cancer
712250|NCT00580970|radiation therapy|radiation therapy
712251|NCT00580970|lovastatin|lovastatin
712252|NCT00580970|rectal injury|rectal injury
712253|NCT00580957|Obesity|obesity
712254|NCT00580957|Hypertension|hypertension
712255|NCT00580957|Autonomic Nervous System|autonomic nervous system
712256|NCT00580944|Port wine stain|port wine stain
712257|NCT00580944|progressive malformation of human skin|progressive malformation of human skin
712258|NCT00580931|nutraceutical, dementia, cognition, HDAC inhibitor|nutraceutical, dementia, cognition, hdac inhibitor
712259|NCT00580918|Mild Traumatic Brain Injury|mild traumatic brain injury
712260|NCT00580918|fMRI|fmri
712261|NCT00580905|Adenosine|adenosine
712262|NCT00580905|Cytokines|cytokines
712263|NCT00580905|Inflammation|inflammation
712264|NCT00580905|VEGF|vegf
712265|NCT00580879|Anorectal sphincter laceration|anorectal sphincter laceration
712266|NCT00580879|Pelvic floor dysfunction|pelvic floor dysfunction
712267|NCT00580879|Sphincter tear|sphincter tear
712268|NCT00580866|Elbow|elbow
712269|NCT00580866|Upper Extremity Fractures|upper extremity fractures
712270|NCT00580866|Distal Humerus|distal humerus
712271|NCT00580866|Elbow Injuries|elbow injuries
712272|NCT00580866|Dislocations|dislocations
712273|NCT00580866|Peri-articular Elbow Injuries|peri-articular elbow injuries
712274|NCT00580853|smoking lapse behavior|smoking lapse behavior
712275|NCT00580853|smoking cessation|smoking cessation
712276|NCT00580853|varenicline|varenicline
712277|NCT00580853|bupropion|bupropion
712278|NCT00580853|medication effect on smoking lapse behavior|medication effect on smoking lapse behavior
712279|NCT00580840|Rheumatoid Arthritis|rheumatoid arthritis
712280|NCT00580840|Joint Disease|joint disease
712281|NCT00580840|Arthritis|arthritis
712282|NCT00580840|Certolizumab pegol|certolizumab pegol
712283|NCT00580840|Cimzia|cimzia
712284|NCT00580814|Brookhaven|brookhaven
712285|NCT00580814|ADHD|adhd
712286|NCT00580814|Dopamine|dopamine
712291|NCT00580801|Pegylated-interferon-alfa-2a|pegylated-interferon-alfa-2a
712292|NCT00580801|Pegasys|pegasys
712293|NCT00580801|Ribavirin|ribavirin
712294|NCT00580801|Copegus|copegus
712295|NCT00580788|Endocrine System Diseases|endocrine system diseases
712296|NCT00580788|MusculoSkeletal System Diseases|musculoskeletal system diseases
712297|NCT00580788|Hormones|hormones
712298|NCT00580788|Malignancy|malignancy
712299|NCT00580788|Postmenopausal Women|postmenopausal women
712300|NCT00580788|Bone metabolism|bone metabolism
712301|NCT00580775|Menopause|menopause
712302|NCT00580775|Hormone Replacement Therapy|hormone replacement therapy
712303|NCT00580775|Sudden Cardiac Death|sudden cardiac death
712304|NCT00580749|Pancreatitis|pancreatitis
712305|NCT00580749|enteral feeding|enteral feeding
712306|NCT00580749|distal jejunal feeding|distal jejunal feeding
712307|NCT00580749|naso gastric feeding|naso gastric feeding
712308|NCT00580749|pancreatic rest|pancreatic rest
712309|NCT00580736|sebaceous hyperplasia|sebaceous hyperplasia
712310|NCT00580723|acne|acne
712311|NCT00580723|rosacea|rosacea
712312|NCT00580723|acne rosacea|acne rosacea
712313|NCT00580723|papulopustular rosacea|papulopustular rosacea
712314|NCT00580723|erythema|erythema
712315|NCT00580723|telangiectasia|telangiectasia
712316|NCT00580723|flushing|flushing
712317|NCT00580710|type 1 diabetes|type 1 diabetes
712318|NCT00580710|hypoglycemia|hypoglycemia
712319|NCT00580710|magnetic resonance imaging|magnetic resonance imaging
712320|NCT00580697|Lower urinary tract symptoms|lower urinary tract symptoms
712321|NCT00580697|Gynecologic malignancy|gynecologic malignancy
712322|NCT00580697|Urinary incontinence|urinary incontinence
712323|NCT00580697|Fecal incontinence|fecal incontinence
712324|NCT00580697|Frequency|frequency
712325|NCT00580697|Voiding dysfunction|voiding dysfunction
712326|NCT00580697|Sexual dysfunction|sexual dysfunction
712327|NCT00580684|pneumococcus conjugated vaccine 7 valent|pneumococcus conjugated vaccine 7 valent
712328|NCT00580671|Adolescent Marijuana Abuse|adolescent marijuana abuse
712329|NCT00580658|Dystonia|dystonia
712330|NCT00580658|DBS|dbs
712331|NCT00580645|alcohol|alcohol
712332|NCT00580645|smoking cessation|smoking cessation
712333|NCT00580645|varenicline|varenicline
712334|NCT00580645|bupropion|bupropion
712335|NCT00580645|smoking cessation medications|smoking cessation medications
712336|NCT00580619|Chronic fatigue syndrome|chronic fatigue syndrome
712337|NCT00580619|Postural tachycardia syndrome|postural tachycardia syndrome
712338|NCT00580619|Autonomic nervous system|autonomic nervous system
712339|NCT00580606|Food Allergy|food allergy
712340|NCT00580606|Peanut Allergy|peanut allergy
712341|NCT00580606|Sublingual Immunotherapy|sublingual immunotherapy
712342|NCT00580593|amyotrophic lateral sclerosis|amyotrophic lateral sclerosis
712343|NCT00580593|ALS|als
712344|NCT00580593|nocturnal noninvasive positive pressure ventilation|nocturnal noninvasive positive pressure ventilation
712345|NCT00580593|NIPPV|nippv
712346|NCT00580593|forced vital capacity|forced vital capacity
712347|NCT00580593|FVC|fvc
712348|NCT00580567|Impulsivity|impulsivity
712349|NCT00580567|Gambling|gambling
712350|NCT00580567|Pathological Gamblers|pathological gamblers
712351|NCT00580567|Problem Gamblers|problem gamblers
712352|NCT00580567|Non-Pathological Gamblers|non-pathological gamblers
712353|NCT00580567|Risk-taking|risk-taking
712354|NCT00580567|Inhibition|inhibition
712355|NCT00580567|Gambling Severity|gambling severity
712356|NCT00580515|Cancer|cancer
712357|NCT00580515|Randomized Controlled Trial|randomized controlled trial
712358|NCT00580515|Family Therapy intervention|family therapy intervention
712359|NCT00580502|Obesity, 50 lbs overweight|obesity, 50 lbs overweight
712360|NCT00580489|helicopter|helicopter
712361|NCT00580489|aeromedical|aeromedical
712362|NCT00580489|pain relief|pain relief
712363|NCT00580489|analgesia|analgesia
712364|NCT00580489|fentanyl|fentanyl
712365|NCT00580489|morphine|morphine
712366|NCT00580489|adverse events|adverse events
712367|NCT00580476|Breast Cancer|breast cancer
712368|NCT00580476|Prostate Cancer|prostate cancer
712369|NCT00580463|central nervous system (CNS) tumor|central nervous system (cns) tumor
712370|NCT00580463|tissue collection|tissue collection
712371|NCT00580385|BONE|bone
712372|NCT00580359|Stomach Neoplasms|stomach neoplasms
712373|NCT00580359|Secondary|secondary
712374|NCT00580359|Combination chemotherapy|combination chemotherapy
712376|NCT00580359|Capecitabine|capecitabine
712377|NCT00580346|Aspiration pneumonia|aspiration pneumonia
712378|NCT00580346|Implanted laryngeal stimulator|implanted laryngeal stimulator
712379|NCT00580346|Vocal cord closure|vocal cord closure
712380|NCT00580346|Modified barium swallow|modified barium swallow
712381|NCT00580333|ER negative|er negative
712382|NCT00580333|PR negative|pr negative
712383|NCT00580333|HER2 negative|her2 negative
712384|NCT00580320|melanoma|melanoma
712385|NCT00580320|soft tissue sarcoma|soft tissue sarcoma
712386|NCT00580320|APUD tumor|apud tumor
712387|NCT00580320|dacarbazine|dacarbazine
712388|NCT00580320|bortezomib|bortezomib
712389|NCT00580320|velcade|velcade
712390|NCT00580307|Headache|headache
712391|NCT00580307|Rhinogenic|rhinogenic
712392|NCT00580307|Nose|nose
712402|NCT00580294|Complex Regional Pain Syndromes|complex regional pain syndromes
712403|NCT00580294|Low Back Pain|low back pain
712404|NCT00580294|Neck Pain|neck pain
712405|NCT00580294|Headache|headache
712406|NCT00580294|Back Pain|back pain
712407|NCT00580294|Arthritis|arthritis
712408|NCT00580294|Brachial Plexus Injury (stinger/burner)|brachial plexus injury (stinger/burner)
712409|NCT00580294|Chronic Pain|chronic pain
712410|NCT00580294|Contractures|contractures
712411|NCT00580294|Diabetes|diabetes
712412|NCT00580294|Fibromyalgia|fibromyalgia
712413|NCT00580294|Foot Pain|foot pain
712414|NCT00580294|Fracture|fracture
712415|NCT00580294|Hip|hip
712416|NCT00580294|Herpes Zoster (shingles)|herpes zoster (shingles)
712417|NCT00580294|Migraine|migraine
712418|NCT00580294|Neuropathic Pain|neuropathic pain
712419|NCT00580294|Osteoarthritis|osteoarthritis
712420|NCT00580294|Osteoporosis|osteoporosis
712421|NCT00580294|Rheumatoid Arthritis|rheumatoid arthritis
712422|NCT00580294|Scoliosis|scoliosis
712423|NCT00580294|Nerve pain|nerve pain
712424|NCT00580294|Opana|opana
712425|NCT00580294|Opioid|opioid
712426|NCT00580294|Opioid Rotation|opioid rotation
712427|NCT00580294|Oxymorphone|oxymorphone
712428|NCT00580294|Morphine|morphine
712429|NCT00580294|neuropathic|neuropathic
712430|NCT00580294|oxycodone|oxycodone
712431|NCT00580281|Gastric cancer|gastric cancer
712432|NCT00580281|Leukemia|leukemia
712433|NCT00580281|Chronic Myelogenous Leukemia|chronic myelogenous leukemia
712434|NCT00580281|Imatinib|imatinib
712435|NCT00580281|Gleevec|gleevec
712436|NCT00580255|CHF|chf
712437|NCT00580255|CRT|crt
712438|NCT00580255|Atrial Arrhythmias|atrial arrhythmias
712439|NCT00580255|Ventricular Arrhythmias|ventricular arrhythmias
712440|NCT00580255|BioZ|bioz
712441|NCT00580255|Optivol|optivol
712442|NCT00580242|Myelodysplasia|myelodysplasia
712443|NCT00580229|Rituxan|rituxan
712444|NCT00580229|Rituximab|rituximab
712445|NCT00580216|stroke|stroke
712446|NCT00580216|systemic thromboembolic events|systemic thromboembolic events
712447|NCT00580203|HEENT cancers|heent cancers
712448|NCT00580203|larynx|larynx
712449|NCT00580203|thyroid|thyroid
712450|NCT00580203|sarcoma|sarcoma
712451|NCT00580203|specimen analysis|specimen analysis
712452|NCT00580177|Inguinal hernia|inguinal hernia
712453|NCT00580177|Randomized controlled trial|randomized controlled trial
712454|NCT00580177|Surgery|surgery
712455|NCT00580177|Complications|complications
712456|NCT00580177|Surgical mesh|surgical mesh
712457|NCT00580151|Pain not controled by morphine|pain not controled by morphine
712458|NCT00580151|Anxiety not controled by lorazepam|anxiety not controled by lorazepam
712459|NCT00580138|Deglutition Disorders|deglutition disorders
712460|NCT00580138|Evaluation|evaluation
712461|NCT00580138|Real-time internet|real-time internet
712462|NCT00580112|Breast Neoplasms|breast neoplasms
712463|NCT00580112|Trabectedin|trabectedin
712464|NCT00580112|Yondelis|yondelis
712465|NCT00580099|premature infant, body composition, total energy expenditure|premature infant, body composition, total energy expenditure
712466|NCT00580099|inflammatory growth mediators|inflammatory growth mediators
712467|NCT00580086|Breast cancer|breast cancer
712468|NCT00580086|MR spectroscopy|mr spectroscopy
712469|NCT00580086|Neoadjuvant chemotherapy|neoadjuvant chemotherapy
712470|NCT00580060|AJCC|ajcc
712471|NCT00580060|stage|stage
712472|NCT00580060|IIB|iib
712473|NCT00580060|IIC|iic
712474|NCT00580060|III|iii
712475|NCT00580060|IV|iv
712476|NCT00580060|Melanoma|melanoma
712477|NCT00580060|HLA-A2+|hla-a2+
712478|NCT00580060|Vaccine|vaccine
712479|NCT00580047|bone density|bone density
712480|NCT00580047|osteopenia|osteopenia
712481|NCT00580047|transplant|transplant
712482|NCT00580047|zoledronic acid|zoledronic acid
712483|NCT00580047|alendronate|alendronate
712484|NCT00580034|Allogeneic Stem Cell Transplantation, Campath, HLA-Matched|allogeneic stem cell transplantation, campath, hla-matched
712485|NCT00580021|Ashkenazi ancestry|ashkenazi ancestry
712486|NCT00580021|mutations in BRCA1 or BRCA2|mutations in brca1 or brca2
712487|NCT00580021|Breast Cancer|breast cancer
712488|NCT00580021|Pancreatic Cancer|pancreatic cancer
712489|NCT00580008|tomography|tomography
712490|NCT00580008|coronary artery disease|coronary artery disease
712491|NCT00580008|coronary artery bypass grafting|coronary artery bypass grafting
712492|NCT00580008|vein graft|vein graft
712493|NCT00579982|Mood disorder|mood disorder
712494|NCT00579943|very low birth weight infant|very low birth weight infant
712495|NCT00579943|cerebral autoregulation|cerebral autoregulation
712496|NCT00579943|intraventricular hemorrhage|intraventricular hemorrhage
712497|NCT00579943|carbon dioxide|carbon dioxide
712498|NCT00579943|cerebral blood flow velocity|cerebral blood flow velocity
712499|NCT00579943|ultrasonography, Doppler, transcranial|ultrasonography, doppler, transcranial
712500|NCT00579943|cerebrovascular circulation|cerebrovascular circulation
712501|NCT00579930|Bone|bone
712502|NCT00579930|Soft Tissue|soft tissue
712503|NCT00579917|Survivor|survivor
712504|NCT00579917|Behavioral Intervention|behavioral intervention
712505|NCT00579917|Bone Marrow|bone marrow
712572|NCT00579670|Ziprasidone in patients with schizophrenia|ziprasidone in patients with schizophrenia
712573|NCT00579657|parameters of metabolic syndrome|parameters of metabolic syndrome
712574|NCT00579631|survivors|survivors
712575|NCT00579631|adolescent|adolescent
712576|NCT00579631|pediatric|pediatric
712577|NCT00579618|non-cancer affected volunteers|non-cancer affected volunteers
712578|NCT00579618|aged 60 years or older|aged 60 years or older
712579|NCT00579605|Breastfeeding|breastfeeding
712580|NCT00579605|Self-efficacy|self-efficacy
712581|NCT00579605|Motivational Interviewing|motivational interviewing
712582|NCT00579579|Bowel function|bowel function
712583|NCT00579579|Bladder function|bladder function
712584|NCT00579579|Sexual function|sexual function
712585|NCT00579579|Quality of life|quality of life
712586|NCT00579566|Biochemical Determinants|biochemical determinants
712587|NCT00579566|Molecular Determinants|molecular determinants
712588|NCT00579553|Pre Term|pre term
712589|NCT00579553|Pre Term Birth|pre term birth
712590|NCT00579553|Premature Birth|premature birth
712591|NCT00579553|Premature baby|premature baby
712592|NCT00579553|High risk pregnancy|high risk pregnancy
712593|NCT00579553|Progesterone|progesterone
712594|NCT00579553|IM Progesterone|im progesterone
712595|NCT00579553|Vaginal Progesterone|vaginal progesterone
712596|NCT00579527|DiGeorge Anomaly|digeorge anomaly
712597|NCT00579527|Thymus Transplantation|thymus transplantation
712598|NCT00579527|DiGeorge Syndrome|digeorge syndrome
712599|NCT00579527|Athymia|athymia
712600|NCT00579527|Parathyroid Transplantation|parathyroid transplantation
712601|NCT00579527|Hypocalcemia|hypocalcemia
712602|NCT00579527|Hypoparathyroidism|hypoparathyroidism
712603|NCT00579527|Low T cell numbers|low t cell numbers
712604|NCT00579527|Immunoreconstitution|immunoreconstitution
712605|NCT00579527|Immunodeficiency|immunodeficiency
712606|NCT00579527|Complete DiGeorge Anomaly|complete digeorge anomaly
712607|NCT00579527|Complete Atypical DiGeorge Anomaly|complete atypical digeorge anomaly
712608|NCT00579527|Complete DiGeorge Syndrome|complete digeorge syndrome
712609|NCT00579527|Complete Atypical DiGeorge Syndrome|complete atypical digeorge syndrome
712610|NCT00579501|Myxoid|myxoid
712611|NCT00579501|Liposarcoma|liposarcoma
712612|NCT00579501|Trabectedin|trabectedin
712613|NCT00579501|Dexamethasone|dexamethasone
712614|NCT00579475|mifepristone|mifepristone
712615|NCT00579475|leiomyomas|leiomyomas
712616|NCT00579475|breast epithelial cell proliferation|breast epithelial cell proliferation
712617|NCT00579462|Stage III or IV Lung Cancer|stage iii or iv lung cancer
712618|NCT00579449|child abuse|child abuse
712619|NCT00579449|child neglect|child neglect
712620|NCT00579436|inflammation|inflammation
712621|NCT00579436|obesity|obesity
712622|NCT00579436|diabetes|diabetes
712623|NCT00579423|prostate|prostate
712624|NCT00579423|cancer|cancer
712625|NCT00579423|vaccine|vaccine
712626|NCT00579410|gastric acid|gastric acid
712627|NCT00579410|esophageal reflux|esophageal reflux
712628|NCT00579410|peptic ulcer|peptic ulcer
712629|NCT00579410|heartburn|heartburn
712630|NCT00579397|Markers of Inflammation|markers of inflammation
712631|NCT00579397|acute graft versus host disease|acute graft versus host disease
712632|NCT00579397|predicting aGVHD|predicting agvhd
712633|NCT00579384|Photosensitive epilepsy|photosensitive epilepsy
712634|NCT00579384|Reflex epilepsy|reflex epilepsy
712635|NCT00579384|Epilepsy|epilepsy
712636|NCT00579384|JNJ-26489112|jnj-26489112
712637|NCT00579371|islet transplantation|islet transplantation
712638|NCT00579371|type 1 diabetes mellitus|type 1 diabetes mellitus
712639|NCT00579371|steroid-free immunosuppression|steroid-free immunosuppression
712640|NCT00579371|rabbit anti-thymocyte globulin|rabbit anti-thymocyte globulin
712641|NCT00579358|Congenital heart defects|congenital heart defects
712642|NCT00579332|PSA|psa
712643|NCT00579332|biochemical failure|biochemical failure
712644|NCT00579319|breast cancer|breast cancer
712645|NCT00579306|hypertension|hypertension
712646|NCT00579306|stroke|stroke
712647|NCT00579306|cerebrovascular accident|cerebrovascular accident
712648|NCT00579293|adult survivor of childhood cancer|adult survivor of childhood cancer
712649|NCT00579293|computer assisted screening of survivors (CASS)|computer assisted screening of survivors (cass)
712650|NCT00579280|Randomized|randomized
712651|NCT00579280|Double-Blind|double-blind
712652|NCT00579280|Placebo-Controlled|placebo-controlled
712653|NCT00579280|Quetiapine|quetiapine
712654|NCT00579280|DivalproexSodiumER|divalproexsodiumer
712655|NCT00579280|Bipolar|bipolar
712656|NCT00579280|Anxiety|anxiety
712657|NCT00579280|Panic|panic
712658|NCT00579280|GAD|gad
712659|NCT00579267|MINI-KID|mini-kid
712660|NCT00579267|structured diagnostic interview|structured diagnostic interview
712661|NCT00579267|reliability and validity|reliability and validity
712662|NCT00579267|K-SADS|k-sads
712663|NCT00579267|Sheehan Disability Scale|sheehan disability scale
712664|NCT00579254|Efficacy,safety & tolerability of Caduet In Patients With Cardiovascular Risk Factors|efficacy,safety & tolerability of caduet in patients with cardiovascular risk factors
712665|NCT00579228|Diabetes|diabetes
712666|NCT00579228|Vascular risk|vascular risk
712667|NCT00579228|Inflammation|inflammation
712668|NCT00579215|Cancer|cancer
712673|NCT00579215|Stage III Lung Cancer|stage iii lung cancer
712674|NCT00579215|Stage IV Lung Cancer|stage iv lung cancer
712675|NCT00579202|Dialyzer|dialyzer
712676|NCT00579189|ear tubes|ear tubes
712677|NCT00579189|ear drainage|ear drainage
712678|NCT00579189|ear infection|ear infection
712679|NCT00579189|ear drops|ear drops
712680|NCT00579163|Blood|blood
712681|NCT00579163|Salvia|salvia
712682|NCT00579163|Tissue|tissue
712683|NCT00579150|Birth Defects|birth defects
712684|NCT00579150|High Risk Pregnancy|high risk pregnancy
712685|NCT00579150|Type 2 Diabetes|type 2 diabetes
712686|NCT00579137|Severe Combined Immunodeficiency Disease|severe combined immunodeficiency disease
712687|NCT00579137|Severe Primary Immunodeficiency Disorder|severe primary immunodeficiency disorder
712688|NCT00579137|Undefined T cell Deficiency Disorder|undefined t cell deficiency disorder
712689|NCT00579137|Wiskott-Aldrick Syndrome|wiskott-aldrick syndrome
712690|NCT00579137|Allogeneic stem cell transplant|allogeneic stem cell transplant
712691|NCT00579137|Fludarabine|fludarabine
712692|NCT00579137|monoclonal antibodies|monoclonal antibodies
712693|NCT00579124|Blood and Marrow Transplant|blood and marrow transplant
712694|NCT00579124|T cell Depletion|t cell depletion
712695|NCT00579124|Unrelated|unrelated
712696|NCT00579124|Related|related
712697|NCT00579124|Donor|donor
712698|NCT00579111|Myelodysplastic and Myeloproliferative Disorders|myelodysplastic and myeloproliferative disorders
712699|NCT00579111|Acute Myelogenous Leukemia|acute myelogenous leukemia
712700|NCT00579111|Acute Lymphoblastic Leukemia|acute lymphoblastic leukemia
712701|NCT00579111|Chronic Myelogenous Leukemia|chronic myelogenous leukemia
712702|NCT00579111|Multiple Myeloma|multiple myeloma
712703|NCT00579111|Plasma Cell dyscrasia|plasma cell dyscrasia
712704|NCT00579111|Lymphoproliferative disorders|lymphoproliferative disorders
712705|NCT00579111|Hematologic Diseases|hematologic diseases
712706|NCT00579111|Fludarabine|fludarabine
712707|NCT00579111|Busulfan|busulfan
712708|NCT00579111|Campath|campath
712709|NCT00579111|Alemtuzumab|alemtuzumab
712710|NCT00579111|allogeneic stem cell transplant|allogeneic stem cell transplant
712711|NCT00579098|Atrial Fibrillation|atrial fibrillation
712712|NCT00579098|Arrhythmia|arrhythmia
712713|NCT00579098|Pulmonary Vein Isolation|pulmonary vein isolation
712714|NCT00579098|Left atrial catheter ablation|left atrial catheter ablation
712715|NCT00579098|Inflammation|inflammation
712817|NCT00578591|Rituximab|rituximab
712716|NCT00579098|Endothelial dysfunction|endothelial dysfunction
712717|NCT00579072|Prostate|prostate
712718|NCT00579072|cognitive effects|cognitive effects
712719|NCT00579072|06-084|06-084
712720|NCT00579046|Anemia|anemia
712721|NCT00579046|Chronic obstructive Pulmonary Disease|chronic obstructive pulmonary disease
712722|NCT00579046|Erythropoietin|erythropoietin
712723|NCT00579046|6-minute walk test|6-minute walk test
712724|NCT00579033|somatosensory|somatosensory
712725|NCT00579033|cortex|cortex
712726|NCT00579033|neuroimaging|neuroimaging
712727|NCT00579033|tactile|tactile
712728|NCT00579033|cortical plasticity|cortical plasticity
712729|NCT00579033|dystonia|dystonia
712730|NCT00579020|cornea|cornea
712731|NCT00579020|inflammation|inflammation
712732|NCT00579020|blepharitis|blepharitis
712733|NCT00579020|lid infection|lid infection
712734|NCT00579007|Prophylactic Mastectomy|prophylactic mastectomy
712735|NCT00579007|Prophylactic Oophorectomy|prophylactic oophorectomy
712736|NCT00578994|Unicompartmental Knee|unicompartmental knee
712737|NCT00578994|Partial Knee|partial knee
712738|NCT00578994|Knee arthroplasty|knee arthroplasty
712739|NCT00578981|Osteoporosis, age-related|osteoporosis, age-related
712740|NCT00578981|Osteoporosis, Postmenopausal|osteoporosis, postmenopausal
712741|NCT00578981|Bone Loss|bone loss
712742|NCT00578981|Low Bone Density|low bone density
712743|NCT00578968|COPD|copd
712744|NCT00578968|Tiotropium|tiotropium
712745|NCT00578968|Spiriva|spiriva
712746|NCT00578955|Blepharoconjunctivitis, Ophthalmology|blepharoconjunctivitis, ophthalmology
712747|NCT00578942|Allogeneic Stem Cell Transplantation, Campath, HLA-Matched|allogeneic stem cell transplantation, campath, hla-matched
712748|NCT00578929|allergic rhinitis|allergic rhinitis
712749|NCT00578929|allergies|allergies
712750|NCT00578929|seasonal allergies|seasonal allergies
712751|NCT00578903|Severe Aplastic Anemia|severe aplastic anemia
712752|NCT00578903|Severe|severe
712753|NCT00578890|diabetic foot|diabetic foot
712754|NCT00578890|osteomyelitis|osteomyelitis
712755|NCT00578877|Contraception|contraception
712756|NCT00578877|SILCS Diaphragm|silcs diaphragm
712757|NCT00578877|Contraceptive Gel|contraceptive gel
712758|NCT00578864|Neuroblastoma|neuroblastoma
712759|NCT00578864|Etoposide|etoposide
712760|NCT00578864|Cisplatin|cisplatin
712761|NCT00578864|Adriamycin|adriamycin
712762|NCT00578864|Cyclophosphamide|cyclophosphamide
712763|NCT00578864|Cytoxan|cytoxan
712764|NCT00578851|Hip Arthroplasty|hip arthroplasty
712765|NCT00578851|Hip Arthritis|hip arthritis
712766|NCT00578825|Severe acute respiratory syndrome|severe acute respiratory syndrome
712767|NCT00578799|ulcerative colitis|ulcerative colitis
712768|NCT00578773|ear tubes|ear tubes
712769|NCT00578773|ear infection|ear infection
712771|NCT00578773|ear tube surgery|ear tube surgery
712772|NCT00578773|acute otitis media|acute otitis media
712773|NCT00578760|hearing loss|hearing loss
712774|NCT00578760|ototoxicity|ototoxicity
712775|NCT00578760|cisplatin|cisplatin
712776|NCT00578747|Breast Cancer|breast cancer
712777|NCT00578747|Breast Neoplasms|breast neoplasms
712778|NCT00578747|Targeted Radiotherapy|targeted radiotherapy
712779|NCT00578747|Mastectomy|mastectomy
712780|NCT00578747|Seroma|seroma
712781|NCT00578721|Colorectal cancer|colorectal cancer
712782|NCT00578721|aspirin|aspirin
712783|NCT00578708|membranous|membranous
712784|NCT00578708|ventricular|ventricular
712785|NCT00578708|septal|septal
712786|NCT00578708|defect|defect
712787|NCT00578708|VSD|vsd
712788|NCT00578695|Hyponatremia|hyponatremia
712789|NCT00578695|Serum Sodium|serum sodium
712790|NCT00578695|Fluid Overload|fluid overload
712791|NCT00578695|Heart Failure|heart failure
712792|NCT00578695|Acute Heart Failure|acute heart failure
712793|NCT00578695|Vasopressin Antagonist|vasopressin antagonist
712794|NCT00578669|Smoking Cessation|smoking cessation
712795|NCT00578669|Tobacco Use Cessation|tobacco use cessation
712796|NCT00578669|Antidepressants|antidepressants
712797|NCT00578656|Food Allergy|food allergy
712798|NCT00578656|Milk Allergy|milk allergy
712799|NCT00578643|Stem Cell Transplant|stem cell transplant
712800|NCT00578643|Chronic Granulomatous Disease|chronic granulomatous disease
712801|NCT00578643|Fludarabine|fludarabine
712802|NCT00578643|Busulfan|busulfan
712803|NCT00578643|Cyclophosphamide|cyclophosphamide
712804|NCT00578630|pediatric tumors|pediatric tumors
712805|NCT00578630|genetic test development|genetic test development
712806|NCT00578630|All Pediatric patients with a histologically proven tumor.|all pediatric patients with a histologically proven tumor.
712807|NCT00578617|Atrial fibrillation|atrial fibrillation
712808|NCT00578617|Left Atrial Ablation|left atrial ablation
712809|NCT00578617|Pulmonary Vein Isolation|pulmonary vein isolation
712810|NCT00578617|Catheter Ablation|catheter ablation
712811|NCT00578617|Antiarrhythmic Drug Therapy|antiarrhythmic drug therapy
712812|NCT00578591|Graft Versus Host Disease|graft versus host disease
712813|NCT00578591|GVHD|gvhd
712814|NCT00578591|allogeneic hematopoietic transplant|allogeneic hematopoietic transplant
712815|NCT00578591|AHT|aht
712816|NCT00578591|posttransplant|posttransplant
712818|NCT00578578|Omega3 fatty acids|omega3 fatty acids
712819|NCT00578578|hsCRP|hscrp
712820|NCT00578578|CAD|cad
712821|NCT00578565|Rheumatoid Arthritis|rheumatoid arthritis
712822|NCT00578565|Interstitial Pneumonia|interstitial pneumonia
712823|NCT00578565|Rheumatology|rheumatology
712824|NCT00578565|Rituximab|rituximab
712825|NCT00578552|tobacco|tobacco
712826|NCT00578552|smoking|smoking
712827|NCT00578552|gabapentin|gabapentin
712828|NCT00578552|abstinence|abstinence
712829|NCT00578539|Stem Cell Transplantation|stem cell transplantation
712830|NCT00578526|urothelial cancer|urothelial cancer
712831|NCT00578526|targeted therapy|targeted therapy
712832|NCT00578526|antiangiogenesis therapy|antiangiogenesis therapy
712833|NCT00578526|SU011248|su011248
712834|NCT00578526|clinical trial|clinical trial
712835|NCT00578500|chemotherapy, female, fertility preservation, gonadotoxicity|chemotherapy, female, fertility preservation, gonadotoxicity
712836|NCT00578500|oophorectomy, in vitro maturation, ovarian cryopreservation,|oophorectomy, in vitro maturation, ovarian cryopreservation,
712837|NCT00578500|oocyte cryopreservation, ovarian transplantation|oocyte cryopreservation, ovarian transplantation
712838|NCT00578474|Acute otitis media|acute otitis media
712839|NCT00578474|Tympanostomy tubes|tympanostomy tubes
712840|NCT00578461|Stem Cell Transplant|stem cell transplant
712841|NCT00578461|myeloproliferative disease|myeloproliferative disease
712842|NCT00578461|myelodsyplastic disease|myelodsyplastic disease
712843|NCT00578461|Leukemia|leukemia
712844|NCT00578461|Cancer|cancer
712845|NCT00578461|Lymphoma|lymphoma
712846|NCT00578461|Lymphoma, Hodgkin|lymphoma, hodgkin
712847|NCT00578461|Lymphoma, non-Hodgkin|lymphoma, non-hodgkin
712848|NCT00578435|ERYTHROPOIESIS|erythropoiesis
712849|NCT00578435|Genetic Disorders|genetic disorders
712850|NCT00578435|Sickle Cell Anemia|sickle cell anemia
712851|NCT00578435|Thalassemia|thalassemia
712852|NCT00578435|Diamond Blackfan Anemia|diamond blackfan anemia
712853|NCT00578422|PAD|pad
712854|NCT00578422|Peripheral Artery Disease|peripheral artery disease
712855|NCT00578422|IVUS|ivus
712856|NCT00578422|Plaque|plaque
712857|NCT00578409|castration resistant prostate cancer|castration resistant prostate cancer
712858|NCT00578409|progressive castrate metastatic prostate cancer|progressive castrate metastatic prostate cancer
712859|NCT00578396|Grapes and colon cancer prevention|grapes and colon cancer prevention
712860|NCT00578383|Depression|depression
712861|NCT00578383|Major depression|major depression
712862|NCT00578383|Bipolar Disorder|bipolar disorder
712863|NCT00578383|Bipolar depression|bipolar depression
712864|NCT00578383|LFMS|lfms
712865|NCT00578383|low field magnetic stimulation|low field magnetic stimulation
712866|NCT00578383|mood disorders|mood disorders
712867|NCT00578383|affective disorders|affective disorders
712868|NCT00578370|Ciclosporin|ciclosporin
712869|NCT00578370|Plaque type psoriasis|plaque type psoriasis
712870|NCT00578370|Psoriasis plaque test|psoriasis plaque test
712871|NCT00578370|Sonography|sonography
712872|NCT00578370|Cyclosporin|cyclosporin
712873|NCT00578370|Psoriasis|psoriasis
712874|NCT00578357|problem gambling|problem gambling
712875|NCT00578357|personalized feedback|personalized feedback
712876|NCT00578357|gambling addiction|gambling addiction
712877|NCT00578344|Sickle Cell Disease|sickle cell disease
712878|NCT00578344|SCD|scd
712879|NCT00578344|Hemoglobin SS|hemoglobin ss
712880|NCT00578344|Hemoglobin SC|hemoglobin sc
712881|NCT00578344|Hemoglobin Sb0/+|hemoglobin sb0/+
712882|NCT00578344|HLA genotype|hla genotype
712883|NCT00578344|Severe anemia|severe anemia
712884|NCT00578344|Transfusion therapy|transfusion therapy
712885|NCT00578331|rhinitis|rhinitis
712886|NCT00578331|perennial allergic rhinitis|perennial allergic rhinitis
712887|NCT00578331|allergic rhinitis|allergic rhinitis
712888|NCT00578292|transfusion-dependent|transfusion-dependent
712889|NCT00578292|homozygous b0/+-thalassemia|homozygous b0/+-thalassemia
712890|NCT00578292|severe variants of b0/+-thalassemia|severe variants of b0/+-thalassemia
712891|NCT00578292|chronic transfusion therapy|chronic transfusion therapy
712892|NCT00578292|iron chelating agents|iron chelating agents
712893|NCT00578292|severe|severe
712894|NCT00578292|transfusion-dependent homozygous b0/+-thalassemia or severe variants of b0/+-thalassemia|transfusion-dependent homozygous b0/+-thalassemia or severe variants of b0/+-thalassemia
712895|NCT00578266|Severe Aplastic Anemia (SAA)|severe aplastic anemia (saa)
712896|NCT00578266|Transplant for Severe Aplastic Anemia (SAA)|transplant for severe aplastic anemia (saa)
712897|NCT00578240|benign|benign
712898|NCT00578240|Rising PSA|rising psa
712899|NCT00578240|Clinical Metastases|clinical metastases
712900|NCT00578240|90-040|90-040
712901|NCT00578227|Human papillomavirus infection,|human papillomavirus infection,
712902|NCT00578227|cervical cancer|cervical cancer
712903|NCT00578227|HPV vaccine,|hpv vaccine,
712904|NCT00578214|mohs micrographic surgery|mohs micrographic surgery
712905|NCT00578214|skin cancer|skin cancer
712906|NCT00578214|anxiety|anxiety
712907|NCT00578214|basal cell carcinoma|basal cell carcinoma
712908|NCT00578214|squamous cell carcinoma|squamous cell carcinoma
712909|NCT00578214|midazolam|midazolam
712910|NCT00578214|versed|versed
712911|NCT00578201|Esophageal neoplasms|esophageal neoplasms
712912|NCT00578201|Cetuximab|cetuximab
712913|NCT00578201|Oxaliplatin|oxaliplatin
712914|NCT00578201|Fluorouracil|fluorouracil
712915|NCT00578201|radiotherapy|radiotherapy
712916|NCT00578188|Adolescent Health|adolescent health
712917|NCT00578188|Sexually transmitted infection|sexually transmitted infection
712918|NCT00578188|Women's Health|women's health
712919|NCT00578175|Vaccines|vaccines
712920|NCT00578175|Rubella|rubella
712921|NCT00578175|Varicella Vaccine|varicella vaccine
712922|NCT00578175|Children|children
712923|NCT00578175|Humans|humans
712924|NCT00578175|Mumps|mumps
712925|NCT00578175|Immunogenicity|immunogenicity
712926|NCT00578175|Safety|safety
712927|NCT00578175|Measles|measles
712928|NCT00578175|Combined Vaccine|combined vaccine
712929|NCT00578162|Cancer|cancer
712930|NCT00578162|Survivors|survivors
712931|NCT00578149|chemoradiotherapy|chemoradiotherapy
712932|NCT00578149|Lung cancer|lung cancer
712933|NCT00578136|Rectus Sheath|rectus sheath
712934|NCT00578136|Local infiltration|local infiltration
712935|NCT00578136|Pain Control|pain control
712936|NCT00578123|Prostate|prostate
712937|NCT00578123|Cancer|cancer
712938|NCT00578123|Quality of Life|quality of life
712939|NCT00578123|Questionaires|questionaires
712940|NCT00578123|04-094|04-094
712941|NCT00578110|glaucoma VEP detection device diagnosis vision|glaucoma vep detection device diagnosis vision
712942|NCT00578071|esophageal cancer|esophageal cancer
712943|NCT00578032|head|head
712944|NCT00578032|neck|neck
712945|NCT00578032|cancer|cancer
712946|NCT00578032|reconstruction|reconstruction
712947|NCT00578032|quality of life|quality of life
712948|NCT00578032|07-150|07-150
712949|NCT00578019|Comparative|comparative
712950|NCT00578019|Supracondylar Femur Fracture|supracondylar femur fracture
712951|NCT00578019|Intramedullary nailing|intramedullary nailing
712952|NCT00578019|Less Invasive Stabilization System (LISS) Plating|less invasive stabilization system (liss) plating
712953|NCT00578006|toxicity related symptoms|toxicity related symptoms
712954|NCT00578006|04-020|04-020
712955|NCT00577993|Lymphoma|lymphoma
712956|NCT00577993|Follicular Lymphoma|follicular lymphoma
712957|NCT00577993|Indolent Lymphoma|indolent lymphoma
712958|NCT00577993|Fludarabine|fludarabine
712959|NCT00577993|Novantrone|novantrone
712960|NCT00577993|Mitoxantrone|mitoxantrone
712961|NCT00577993|Decadron|decadron
712962|NCT00577993|Dexamethasone|dexamethasone
712963|NCT00577993|Rituximab|rituximab
712964|NCT00577993|Anti-CD20|anti-cd20
712965|NCT00577993|IDEC-C2B8|idec-c2b8
712966|NCT00577993|Chimeric Anti-CD20 Antibody|chimeric anti-cd20 antibody
712967|NCT00577993|Interferon|interferon
712968|NCT00577993|Interferon Alpha-2b|interferon alpha-2b
712969|NCT00577993|IFN|ifn
712970|NCT00577993|Doxorubicin|doxorubicin
712973|NCT00577993|Cyclophosphamide|cyclophosphamide
712974|NCT00577993|Etoposide|etoposide
712975|NCT00577993|Cisplatin|cisplatin
712976|NCT00577993|Ara-C|ara-c
712977|NCT00577993|Methyl-Prednisolone|methyl-prednisolone
712978|NCT00577993|Procarbazine|procarbazine
712979|NCT00577993|Prednisone|prednisone
712980|NCT00577993|FND|fnd
712981|NCT00577980|Prostate Cancer|prostate cancer
712982|NCT00577980|Castration-Resistant Prostate Cancer|castration-resistant prostate cancer
712983|NCT00577980|Testosterone Replacement Therapy|testosterone replacement therapy
712984|NCT00577980|Testosterone|testosterone
712985|NCT00577980|CRPC|crpc
712986|NCT00577980|TRT|trt
712987|NCT00577967|Uremic pruritis|uremic pruritis
712988|NCT00577954|Coma|coma
712989|NCT00577954|TBI|tbi
712990|NCT00577954|Stroke|stroke
712991|NCT00577954|SAH|sah
712992|NCT00577954|Cerebral Anoxia|cerebral anoxia
712993|NCT00577954|Multimodal MRI|multimodal mri
712994|NCT00577915|Breast cancer|breast cancer
712995|NCT00577915|MRI spectroscopy|mri spectroscopy
712996|NCT00577915|Diagnostic radiology|diagnostic radiology
712997|NCT00577902|head and neck cancer|head and neck cancer
712998|NCT00577824|diabetes|diabetes
712999|NCT00577824|exenatide|exenatide
713000|NCT00577824|LY2148568|ly2148568
713001|NCT00577824|Byetta|byetta
713002|NCT00577824|Lilly|lilly
713003|NCT00577824|Amylin|amylin
713004|NCT00577811|Special Need Plans|special need plans
713005|NCT00577811|Fee for Services|fee for services
713006|NCT00577811|Access to Care|access to care
713007|NCT00577811|Medicaid|medicaid
713008|NCT00577798|chemotherapeutic agent toxicity|chemotherapeutic agent toxicity
713009|NCT00577798|cardiac toxicity|cardiac toxicity
713010|NCT00577798|stage I adult Hodgkin lymphoma|stage i adult hodgkin lymphoma
713011|NCT00577798|stage II adult Hodgkin lymphoma|stage ii adult hodgkin lymphoma
713012|NCT00577798|stage III adult Hodgkin lymphoma|stage iii adult hodgkin lymphoma
713013|NCT00577798|stage IV adult Hodgkin lymphoma|stage iv adult hodgkin lymphoma
713014|NCT00577798|stage I adult T-cell leukemia/lymphoma|stage i adult t-cell leukemia/lymphoma
713015|NCT00577798|stage II adult T-cell leukemia/lymphoma|stage ii adult t-cell leukemia/lymphoma
713016|NCT00577798|stage III adult T-cell leukemia/lymphoma|stage iii adult t-cell leukemia/lymphoma
713232|NCT00577174|Children|children
713017|NCT00577798|stage IV adult T-cell leukemia/lymphoma|stage iv adult t-cell leukemia/lymphoma
713018|NCT00577798|anaplastic large cell lymphoma|anaplastic large cell lymphoma
713019|NCT00577798|angioimmunoblastic T-cell lymphoma|angioimmunoblastic t-cell lymphoma
713020|NCT00577798|cutaneous B-cell non-Hodgkin lymphoma|cutaneous b-cell non-hodgkin lymphoma
713021|NCT00577798|stage I mycosis fungoides/Sezary syndrome|stage i mycosis fungoides/sezary syndrome
713022|NCT00577798|stage II mycosis fungoides/Sezary syndrome|stage ii mycosis fungoides/sezary syndrome
713023|NCT00577798|stage III mycosis fungoides/Sezary syndrome|stage iii mycosis fungoides/sezary syndrome
713024|NCT00577798|stage IV mycosis fungoides/Sezary syndrome|stage iv mycosis fungoides/sezary syndrome
713025|NCT00577798|stage I cutaneous T-cell non-Hodgkin lymphoma|stage i cutaneous t-cell non-hodgkin lymphoma
713026|NCT00577798|stage II cutaneous T-cell non-Hodgkin lymphoma|stage ii cutaneous t-cell non-hodgkin lymphoma
713027|NCT00577798|stage III cutaneous T-cell non-Hodgkin lymphoma|stage iii cutaneous t-cell non-hodgkin lymphoma
713028|NCT00577798|stage IV cutaneous T-cell non-Hodgkin lymphoma|stage iv cutaneous t-cell non-hodgkin lymphoma
713029|NCT00577798|adult grade III lymphomatoid granulomatosis|adult grade iii lymphomatoid granulomatosis
713030|NCT00577798|adult nasal type extranodal NK/T-cell lymphoma|adult nasal type extranodal nk/t-cell lymphoma
713031|NCT00577798|Waldenstrom macroglobulinemia|waldenstrom macroglobulinemia
713032|NCT00577798|contiguous stage II adult Burkitt lymphoma|contiguous stage ii adult burkitt lymphoma
713033|NCT00577798|noncontiguous stage II adult Burkitt lymphoma|noncontiguous stage ii adult burkitt lymphoma
713034|NCT00577798|stage I adult Burkitt lymphoma|stage i adult burkitt lymphoma
713035|NCT00577798|stage III adult Burkitt lymphoma|stage iii adult burkitt lymphoma
713036|NCT00577798|stage IV adult Burkitt lymphoma|stage iv adult burkitt lymphoma
713037|NCT00577798|contiguous stage II adult diffuse large cell lymphoma|contiguous stage ii adult diffuse large cell lymphoma
713038|NCT00577798|noncontiguous stage II adult diffuse large cell lymphoma|noncontiguous stage ii adult diffuse large cell lymphoma
713039|NCT00577798|stage I adult diffuse large cell lymphoma|stage i adult diffuse large cell lymphoma
713040|NCT00577798|stage III adult diffuse large cell lymphoma|stage iii adult diffuse large cell lymphoma
713041|NCT00577798|stage IV adult diffuse large cell lymphoma|stage iv adult diffuse large cell lymphoma
713042|NCT00577798|contiguous stage II adult diffuse mixed cell lymphoma|contiguous stage ii adult diffuse mixed cell lymphoma
713043|NCT00577798|noncontiguous stage II adult diffuse mixed cell lymphoma|noncontiguous stage ii adult diffuse mixed cell lymphoma
713044|NCT00577798|stage I adult diffuse mixed cell lymphoma|stage i adult diffuse mixed cell lymphoma
713045|NCT00577798|stage III adult diffuse mixed cell lymphoma|stage iii adult diffuse mixed cell lymphoma
713046|NCT00577798|stage IV adult diffuse mixed cell lymphoma|stage iv adult diffuse mixed cell lymphoma
713047|NCT00577798|contiguous stage II adult diffuse small cleaved cell lymphoma|contiguous stage ii adult diffuse small cleaved cell lymphoma
713048|NCT00577798|noncontiguous stage II adult diffuse small cleaved cell lymphoma|noncontiguous stage ii adult diffuse small cleaved cell lymphoma
713049|NCT00577798|stage I adult diffuse small cleaved cell lymphoma|stage i adult diffuse small cleaved cell lymphoma
713050|NCT00577798|stage III adult diffuse small cleaved cell lymphoma|stage iii adult diffuse small cleaved cell lymphoma
713051|NCT00577798|stage IV adult diffuse small cleaved cell lymphoma|stage iv adult diffuse small cleaved cell lymphoma
713052|NCT00577798|contiguous stage II adult immunoblastic large cell lymphoma|contiguous stage ii adult immunoblastic large cell lymphoma
713053|NCT00577798|noncontiguous stage II adult immunoblastic large cell lymphoma|noncontiguous stage ii adult immunoblastic large cell lymphoma
713054|NCT00577798|stage I adult immunoblastic large cell lymphoma|stage i adult immunoblastic large cell lymphoma
713055|NCT00577798|stage III adult immunoblastic large cell lymphoma|stage iii adult immunoblastic large cell lymphoma
713056|NCT00577798|stage IV adult immunoblastic large cell lymphoma|stage iv adult immunoblastic large cell lymphoma
713057|NCT00577798|contiguous stage II adult lymphoblastic lymphoma|contiguous stage ii adult lymphoblastic lymphoma
713058|NCT00577798|noncontiguous stage II adult lymphoblastic lymphoma|noncontiguous stage ii adult lymphoblastic lymphoma
713059|NCT00577798|stage I adult lymphoblastic lymphoma|stage i adult lymphoblastic lymphoma
713060|NCT00577798|stage III adult lymphoblastic lymphoma|stage iii adult lymphoblastic lymphoma
713061|NCT00577798|stage IV adult lymphoblastic lymphoma|stage iv adult lymphoblastic lymphoma
713062|NCT00577798|contiguous stage II grade 1 follicular lymphoma|contiguous stage ii grade 1 follicular lymphoma
713063|NCT00577798|noncontiguous stage II grade 1 follicular lymphoma|noncontiguous stage ii grade 1 follicular lymphoma
713064|NCT00577798|stage I grade 1 follicular lymphoma|stage i grade 1 follicular lymphoma
713065|NCT00577798|stage III grade 1 follicular lymphoma|stage iii grade 1 follicular lymphoma
713066|NCT00577798|stage IV grade 1 follicular lymphoma|stage iv grade 1 follicular lymphoma
713067|NCT00577798|contiguous stage II grade 2 follicular lymphoma|contiguous stage ii grade 2 follicular lymphoma
713068|NCT00577798|noncontiguous stage II grade 2 follicular lymphoma|noncontiguous stage ii grade 2 follicular lymphoma
713069|NCT00577798|stage I grade 2 follicular lymphoma|stage i grade 2 follicular lymphoma
713070|NCT00577798|stage III grade 2 follicular lymphoma|stage iii grade 2 follicular lymphoma
713071|NCT00577798|stage IV grade 2 follicular lymphoma|stage iv grade 2 follicular lymphoma
713072|NCT00577798|contiguous stage II grade 3 follicular lymphoma|contiguous stage ii grade 3 follicular lymphoma
713073|NCT00577798|noncontiguous stage II grade 3 follicular lymphoma|noncontiguous stage ii grade 3 follicular lymphoma
713074|NCT00577798|stage I grade 3 follicular lymphoma|stage i grade 3 follicular lymphoma
713075|NCT00577798|stage III grade 3 follicular lymphoma|stage iii grade 3 follicular lymphoma
713076|NCT00577798|stage IV grade 3 follicular lymphoma|stage iv grade 3 follicular lymphoma
713077|NCT00577798|contiguous stage II mantle cell lymphoma|contiguous stage ii mantle cell lymphoma
713078|NCT00577798|noncontiguous stage II mantle cell lymphoma|noncontiguous stage ii mantle cell lymphoma
713079|NCT00577798|stage I mantle cell lymphoma|stage i mantle cell lymphoma
713080|NCT00577798|stage III mantle cell lymphoma|stage iii mantle cell lymphoma
713081|NCT00577798|stage IV mantle cell lymphoma|stage iv mantle cell lymphoma
713082|NCT00577798|extranodal marginal zone B-cell lymphoma of mucosa-associated lymphoid tissue|extranodal marginal zone b-cell lymphoma of mucosa-associated lymphoid tissue
713083|NCT00577798|nodal marginal zone B-cell lymphoma|nodal marginal zone b-cell lymphoma
713084|NCT00577798|splenic marginal zone lymphoma|splenic marginal zone lymphoma
713085|NCT00577798|contiguous stage II marginal zone lymphoma|contiguous stage ii marginal zone lymphoma
713086|NCT00577798|noncontiguous stage II marginal zone lymphoma|noncontiguous stage ii marginal zone lymphoma
713087|NCT00577798|stage I marginal zone lymphoma|stage i marginal zone lymphoma
713088|NCT00577798|stage III marginal zone lymphoma|stage iii marginal zone lymphoma
713089|NCT00577798|stage IV marginal zone lymphoma|stage iv marginal zone lymphoma
713090|NCT00577798|contiguous stage II small lymphocytic lymphoma|contiguous stage ii small lymphocytic lymphoma
713091|NCT00577798|noncontiguous stage II small lymphocytic lymphoma|noncontiguous stage ii small lymphocytic lymphoma
713092|NCT00577798|stage I small lymphocytic lymphoma|stage i small lymphocytic lymphoma
713093|NCT00577798|stage III small lymphocytic lymphoma|stage iii small lymphocytic lymphoma
713094|NCT00577798|stage IV small lymphocytic lymphoma|stage iv small lymphocytic lymphoma
713095|NCT00577785|cystectomy|cystectomy
713096|NCT00577772|SmartPill Capsule|smartpill capsule
713097|NCT00577772|Digestive System Diseases|digestive system diseases
713098|NCT00577772|Small Bowel Bacterial Overgrowth|small bowel bacterial overgrowth
713099|NCT00577772|Gastrointestinal Device|gastrointestinal device
713100|NCT00577772|Oro-cecal|oro-cecal
713101|NCT00577759|Quality assurance, health care|quality assurance, health care
713102|NCT00577759|primary health care|primary health care
713103|NCT00577759|community health services|community health services
713104|NCT00577759|referral and consultation|referral and consultation
713105|NCT00577759|exercise|exercise
713107|NCT00577759|tobacco|tobacco
713108|NCT00577746|Non Small Cell Lung|non small cell lung
713109|NCT00577733|Pulmonary function test|pulmonary function test
713110|NCT00577733|Methacholine challenge|methacholine challenge
713111|NCT00577733|Breathing variability|breathing variability
713112|NCT00577733|Polygraphy|polygraphy
713113|NCT00577707|Lung Cancer|lung cancer
713114|NCT00577707|Erlotinib|erlotinib
713115|NCT00577707|clinical stage IB-IIIA|clinical stage ib-iiia
713116|NCT00577694|recurrent adult acute myeloid leukemia|recurrent adult acute myeloid leukemia
713117|NCT00577681|HIV|hiv
713118|NCT00577681|Lipoproteins|lipoproteins
713119|NCT00577681|Inflammatory Markers|inflammatory markers
713120|NCT00577681|Coagulation Markers|coagulation markers
713285|NCT00576875|Elderly|elderly
713121|NCT00577681|Treatment Experienced|treatment experienced
713122|NCT00577655|Pediatric, asthma, albuterol-HFA and Placebo|pediatric, asthma, albuterol-hfa and placebo
713123|NCT00577642|aminobisphosphonates|aminobisphosphonates
713124|NCT00577629|high risk non-hodgkins lymphoma|high risk non-hodgkins lymphoma
713125|NCT00577629|NHL|nhl
713126|NCT00577629|Bexxar|bexxar
713127|NCT00577629|high dose chemotherapy|high dose chemotherapy
713128|NCT00577616|Endovascular repair|endovascular repair
713129|NCT00577616|Ruptured aorta-iliac aneurysms|ruptured aorta-iliac aneurysms
713130|NCT00577616|Mortality at 30 days|mortality at 30 days
713131|NCT00577603|stoma, hernia, mesh|stoma, hernia, mesh
713132|NCT00577590|Type II Diabetes Mellitus|type ii diabetes mellitus
713133|NCT00577590|Diabetes|diabetes
713134|NCT00577590|PET|pet
713135|NCT00577590|Heart Metabolism|heart metabolism
713136|NCT00577590|Lovaza|lovaza
713137|NCT00577525|LATENT VIRAL INFECTION|latent viral infection
713138|NCT00577525|GENOME HYBRIDIZATION|genome hybridization
713139|NCT00577525|HERPES VIRUS|herpes virus
713140|NCT00577525|ADENOVIRUS|adenovirus
713141|NCT00577499|cystic fibrosis|cystic fibrosis
713142|NCT00577499|constipation|constipation
713143|NCT00577499|lubiprostone|lubiprostone
713144|NCT00577499|nutrition|nutrition
713145|NCT00577499|pulmonary function|pulmonary function
713146|NCT00577447|autism|autism
713147|NCT00577447|omega-3 fatty acids|omega-3 fatty acids
713148|NCT00577447|docosahexaenoic acid|docosahexaenoic acid
713149|NCT00577434|Procedural sedation|procedural sedation
713150|NCT00577434|Sedation for diagnostic imaging|sedation for diagnostic imaging
713151|NCT00577408|Opiate Dependence|opiate dependence
713152|NCT00577408|Heroin Dependence|heroin dependence
713153|NCT00577408|Naltrexone|naltrexone
713154|NCT00577382|Sutent|sutent
713155|NCT00577382|malignant melanoma|malignant melanoma
713156|NCT00577369|arterial line|arterial line
713157|NCT00577369|end-expiratory desflurane|end-expiratory desflurane
713158|NCT00577304|Raynaud's|raynaud's
713159|NCT00577304|Nitroglycerin|nitroglycerin
713160|NCT00577304|Scleroderma|scleroderma
713161|NCT00577278|graft versus host disease|graft versus host disease
713162|NCT00577278|contiguous stage II grade 1 follicular lymphoma|contiguous stage ii grade 1 follicular lymphoma
713163|NCT00577278|contiguous stage II grade 2 follicular lymphoma|contiguous stage ii grade 2 follicular lymphoma
713164|NCT00577278|contiguous stage II grade 3 follicular lymphoma|contiguous stage ii grade 3 follicular lymphoma
713165|NCT00577278|noncontiguous stage II grade 1 follicular lymphoma|noncontiguous stage ii grade 1 follicular lymphoma
713166|NCT00577278|noncontiguous stage II grade 2 follicular lymphoma|noncontiguous stage ii grade 2 follicular lymphoma
713167|NCT00577278|noncontiguous stage II grade 3 follicular lymphoma|noncontiguous stage ii grade 3 follicular lymphoma
713168|NCT00577278|recurrent grade 1 follicular lymphoma|recurrent grade 1 follicular lymphoma
713169|NCT00577278|recurrent grade 2 follicular lymphoma|recurrent grade 2 follicular lymphoma
713170|NCT00577278|recurrent grade 3 follicular lymphoma|recurrent grade 3 follicular lymphoma
713171|NCT00577278|stage I grade 1 follicular lymphoma|stage i grade 1 follicular lymphoma
713172|NCT00577278|stage I grade 2 follicular lymphoma|stage i grade 2 follicular lymphoma
713173|NCT00577278|stage I grade 3 follicular lymphoma|stage i grade 3 follicular lymphoma
713174|NCT00577278|stage III grade 1 follicular lymphoma|stage iii grade 1 follicular lymphoma
713175|NCT00577278|stage III grade 2 follicular lymphoma|stage iii grade 2 follicular lymphoma
713176|NCT00577278|stage III grade 3 follicular lymphoma|stage iii grade 3 follicular lymphoma
713177|NCT00577278|stage IV grade 1 follicular lymphoma|stage iv grade 1 follicular lymphoma
713178|NCT00577278|stage IV grade 2 follicular lymphoma|stage iv grade 2 follicular lymphoma
713179|NCT00577278|stage IV grade 3 follicular lymphoma|stage iv grade 3 follicular lymphoma
713180|NCT00577278|contiguous stage II adult diffuse large cell lymphoma|contiguous stage ii adult diffuse large cell lymphoma
713181|NCT00577278|noncontiguous stage II adult diffuse large cell lymphoma|noncontiguous stage ii adult diffuse large cell lymphoma
713182|NCT00577278|recurrent adult diffuse large cell lymphoma|recurrent adult diffuse large cell lymphoma
713183|NCT00577278|stage I adult diffuse large cell lymphoma|stage i adult diffuse large cell lymphoma
713184|NCT00577278|stage III adult diffuse large cell lymphoma|stage iii adult diffuse large cell lymphoma
713185|NCT00577278|stage IV adult diffuse large cell lymphoma|stage iv adult diffuse large cell lymphoma
713186|NCT00577278|Waldenstrom macroglobulinemia|waldenstrom macroglobulinemia
713187|NCT00577278|contiguous stage II marginal zone lymphoma|contiguous stage ii marginal zone lymphoma
713188|NCT00577278|extranodal marginal zone B-cell lymphoma of mucosa-associated lymphoid tissue|extranodal marginal zone b-cell lymphoma of mucosa-associated lymphoid tissue
713189|NCT00577278|nodal marginal zone B-cell lymphoma|nodal marginal zone b-cell lymphoma
713190|NCT00577278|noncontiguous stage II marginal zone lymphoma|noncontiguous stage ii marginal zone lymphoma
713191|NCT00577278|recurrent marginal zone lymphoma|recurrent marginal zone lymphoma
713192|NCT00577278|stage I marginal zone lymphoma|stage i marginal zone lymphoma
713193|NCT00577278|stage III marginal zone lymphoma|stage iii marginal zone lymphoma
713194|NCT00577278|stage IV marginal zone lymphoma|stage iv marginal zone lymphoma
713195|NCT00577278|B-cell chronic lymphocytic leukemia|b-cell chronic lymphocytic leukemia
713196|NCT00577278|refractory chronic lymphocytic leukemia|refractory chronic lymphocytic leukemia
713197|NCT00577278|stage I chronic lymphocytic leukemia|stage i chronic lymphocytic leukemia
713283|NCT00576888|Angiomatosis|angiomatosis
713198|NCT00577278|stage II chronic lymphocytic leukemia|stage ii chronic lymphocytic leukemia
713199|NCT00577278|stage III chronic lymphocytic leukemia|stage iii chronic lymphocytic leukemia
713200|NCT00577278|stage IV chronic lymphocytic leukemia|stage iv chronic lymphocytic leukemia
713201|NCT00577278|contiguous stage II mantle cell lymphoma|contiguous stage ii mantle cell lymphoma
713202|NCT00577278|noncontiguous stage II mantle cell lymphoma|noncontiguous stage ii mantle cell lymphoma
713203|NCT00577278|recurrent mantle cell lymphoma|recurrent mantle cell lymphoma
713204|NCT00577278|stage I mantle cell lymphoma|stage i mantle cell lymphoma
713205|NCT00577278|stage III mantle cell lymphoma|stage iii mantle cell lymphoma
713206|NCT00577278|stage IV mantle cell lymphoma|stage iv mantle cell lymphoma
713207|NCT00577278|contiguous stage II adult diffuse mixed cell lymphoma|contiguous stage ii adult diffuse mixed cell lymphoma
713208|NCT00577278|noncontiguous stage II adult diffuse mixed cell lymphoma|noncontiguous stage ii adult diffuse mixed cell lymphoma
713209|NCT00577278|recurrent adult diffuse mixed cell lymphoma|recurrent adult diffuse mixed cell lymphoma
713210|NCT00577278|stage I adult diffuse mixed cell lymphoma|stage i adult diffuse mixed cell lymphoma
713211|NCT00577278|stage III adult diffuse mixed cell lymphoma|stage iii adult diffuse mixed cell lymphoma
713212|NCT00577278|stage IV adult diffuse mixed cell lymphoma|stage iv adult diffuse mixed cell lymphoma
713213|NCT00577278|contiguous stage II small lymphocytic lymphoma|contiguous stage ii small lymphocytic lymphoma
713214|NCT00577278|noncontiguous stage II small lymphocytic lymphoma|noncontiguous stage ii small lymphocytic lymphoma
713215|NCT00577278|recurrent small lymphocytic lymphoma|recurrent small lymphocytic lymphoma
713216|NCT00577278|stage I small lymphocytic lymphoma|stage i small lymphocytic lymphoma
713217|NCT00577278|stage III small lymphocytic lymphoma|stage iii small lymphocytic lymphoma
713218|NCT00577278|stage IV small lymphocytic lymphoma|stage iv small lymphocytic lymphoma
713219|NCT00577265|Asthma Control|asthma control
713220|NCT00577252|Cystic fibrosis|cystic fibrosis
713221|NCT00577252|Adolescents|adolescents
713222|NCT00577252|Coping Compliance|coping compliance
713223|NCT00577252|Adjustment|adjustment
713224|NCT00577226|scoliosis, immature spine|scoliosis, immature spine
713225|NCT00577213|Diagnosis|diagnosis
713226|NCT00577213|Hemangiomas|hemangiomas
713227|NCT00577213|Vascular Malformations|vascular malformations
713228|NCT00577213|Venular Malformations|venular malformations
713229|NCT00577213|Venous Malformations|venous malformations
713230|NCT00577213|Lymphatic Malformations|lymphatic malformations
713231|NCT00577213|Arteriovenous Malformations|arteriovenous malformations
713233|NCT00577174|Obesity|obesity
713234|NCT00577174|Insulin resistance|insulin resistance
713235|NCT00577174|Diabetes|diabetes
713236|NCT00577174|Mitochondrial Function|mitochondrial function
713237|NCT00577161|pixantrone|pixantrone
713238|NCT00577161|NHL|nhl
713239|NCT00577161|rituximab|rituximab
713240|NCT00577161|fludarabine|fludarabine
713241|NCT00577148|NASH|nash
713242|NCT00577148|chronic liver disease|chronic liver disease
713243|NCT00577135|Loop Diuretics|loop diuretics
713244|NCT00577135|Furosemide|furosemide
713245|NCT00577135|Fluid Overload|fluid overload
713246|NCT00577135|Cardio Renal Failure|cardio renal failure
713247|NCT00577122|Medroxyprogesterone progesterone acetate (MPA)|medroxyprogesterone progesterone acetate (mpa)
713248|NCT00577122|Cyclophosphamide plus Methotrexate|cyclophosphamide plus methotrexate
713249|NCT00577096|multiple myeloma|multiple myeloma
713250|NCT00577096|polysomnography|polysomnography
713251|NCT00577096|quality of life|quality of life
713252|NCT00577096|exercise|exercise
713253|NCT00577083|miss rates|miss rates
713254|NCT00577057|Nasopharyngeal Carcinoma|nasopharyngeal carcinoma
713255|NCT00577057|Stage III - IVB|stage iii - ivb
713256|NCT00577044|NAFLD|nafld
713257|NCT00577005|GABAergic|gabaergic
713258|NCT00577005|levetiracetam|levetiracetam
713259|NCT00576992|Barrett's Esophagus|barrett's esophagus
713260|NCT00576992|Demographics|demographics
713261|NCT00576992|Questionnaire|questionnaire
713262|NCT00576992|Heartburn|heartburn
713263|NCT00576979|recurrent adult acute lymphoblastic leukemia|recurrent adult acute lymphoblastic leukemia
713264|NCT00576979|recurrent childhood acute lymphoblastic leukemia|recurrent childhood acute lymphoblastic leukemia
713265|NCT00576940|enteral nutrition, immunomodulating nutrition|enteral nutrition, immunomodulating nutrition
713266|NCT00576927|Sleep hygiene|sleep hygiene
713267|NCT00576927|Sleep latency|sleep latency
713268|NCT00576927|Elderly sleep|elderly sleep
713269|NCT00576927|Nursing Home sleep|nursing home sleep
713270|NCT00576914|adjuvant therapy|adjuvant therapy
713271|NCT00576914|non-small cell lung cancer|non-small cell lung cancer
713272|NCT00576914|vinorelbine|vinorelbine
713273|NCT00576914|cisplatin|cisplatin
713274|NCT00576914|recombinant human endostatin(endostar)|recombinant human endostatin(endostar)
713275|NCT00576888|Multifocal lymphangioendoltheliomatosis with thrombocytopenia|multifocal lymphangioendoltheliomatosis with thrombocytopenia
713276|NCT00576888|Cutaneovisceral angiomatosis with thrombocytopenia|cutaneovisceral angiomatosis with thrombocytopenia
713277|NCT00576888|Thrombocytopenia|thrombocytopenia
713278|NCT00576888|Hemangiomas|hemangiomas
713279|NCT00576888|Hemangiomatosis|hemangiomatosis
713280|NCT00576888|Lymphatic malformation|lymphatic malformation
713281|NCT00576888|Kasabach-Merritt|kasabach-merritt
713282|NCT00576888|Blue-rubber bleb nevus|blue-rubber bleb nevus
713284|NCT00576875|Depression|depression
713286|NCT00576875|Neuroimaging|neuroimaging
713287|NCT00576875|Postmortem|postmortem
713288|NCT00576875|Knockout mouse|knockout mouse
713289|NCT00576836|Thymus Transplantation|thymus transplantation
713290|NCT00576836|DiGeorge Syndrome|digeorge syndrome
713291|NCT00576836|DiGeorge Anomaly|digeorge anomaly
713292|NCT00576836|Athymia|athymia
713293|NCT00576836|Parathyroid Transplantation|parathyroid transplantation
713294|NCT00576836|Hypocalcemia|hypocalcemia
713295|NCT00576836|Hypoparathyroidism|hypoparathyroidism
713296|NCT00576836|Low T cell numbers|low t cell numbers
713297|NCT00576836|Immunoreconstitution|immunoreconstitution
713298|NCT00576836|Immunodeficiency|immunodeficiency
713299|NCT00576836|Complete DiGeorge|complete digeorge
713300|NCT00576836|Complete DiGeorge Anomaly|complete digeorge anomaly
713301|NCT00576836|Typical DiGeorge|typical digeorge
713302|NCT00576823|child|child
713303|NCT00576823|bladder|bladder
713304|NCT00576823|neuropathic|neuropathic
713305|NCT00576823|alpha blockers|alpha blockers
713307|NCT00576797|bacteria|bacteria
713308|NCT00576797|microflora|microflora
713309|NCT00576797|bacterial DNA|bacterial dna
713310|NCT00576797|To determine the normal bacteria in the vagina|to determine the normal bacteria in the vagina
713311|NCT00576784|type 2 diabetes|type 2 diabetes
713312|NCT00576784|insulin treatment|insulin treatment
713313|NCT00576784|ß-cell function|ß-cell function
713314|NCT00576745|Sutures|sutures
713315|NCT00576732|Irritability|irritability
713316|NCT00576732|Risperidone|risperidone
713317|NCT00576732|Antipsychotic agent|antipsychotic agent
713318|NCT00576732|Autism|autism
713319|NCT00576732|Adolescents|adolescents
713320|NCT00576732|Children|children
713321|NCT00576706|Patients with rheumatoid arthritis, osteoarthritis, and ankylosing spondylitis or any other arthritis-like disease requiring continuous NSAIDs therapy|patients with rheumatoid arthritis, osteoarthritis, and ankylosing spondylitis or any other arthritis-like disease requiring continuous nsaids therapy
713322|NCT00576693|ischemic stroke|ischemic stroke
713323|NCT00576693|intracranial stenting|intracranial stenting
713324|NCT00576693|vascular risk factor management|vascular risk factor management
713325|NCT00576680|RAD001|rad001
713326|NCT00576680|temozolomide|temozolomide
713327|NCT00576667|NASH|nash
713328|NCT00576667|chronic liver disease|chronic liver disease
713329|NCT00576615|healthy volunteers|healthy volunteers
713330|NCT00576615|amnesic effects|amnesic effects
713331|NCT00576589|Safety in patients with Asymptomatic cholelithiasis/gallstones.|safety in patients with asymptomatic cholelithiasis/gallstones.
713332|NCT00576576|Atherosclerosis, vulnerable plaque, IVUS, shear stress|atherosclerosis, vulnerable plaque, ivus, shear stress
713333|NCT00576563|rectal cancer|rectal cancer
713334|NCT00576563|blood proteins|blood proteins
713335|NCT00576563|irradiation|irradiation
713336|NCT00576563|FDG-PET-CT|fdg-pet-ct
713337|NCT00576550|Hand eczema|hand eczema
713338|NCT00576550|Prevention|prevention
713339|NCT00576537|New/Recurrent Glioblastoma|new/recurrent glioblastoma
713340|NCT00576524|Hypotension during dialysis|hypotension during dialysis
713341|NCT00576524|End Stage Renal Disease|end stage renal disease
713342|NCT00576524|Decrease complications during dialysis|decrease complications during dialysis
713343|NCT00576524|Low Blood Pressure|low blood pressure
713344|NCT00576511|Constipation|constipation
713345|NCT00576511|Prucalopride|prucalopride
713346|NCT00576511|Colonic Transit Time|colonic transit time
713348|NCT00576498|NBI|nbi
713349|NCT00576498|AFI|afi
713350|NCT00576498|IM|im
713351|NCT00576498|SSBE|ssbe
713352|NCT00576498|LSBE|lsbe
713353|NCT00576498|LGD|lgd
713354|NCT00576498|HGD|hgd
713355|NCT00576485|Cataract|cataract
713356|NCT00576485|Intraocular lens|intraocular lens
713357|NCT00576485|Spherical aberration|spherical aberration
713358|NCT00576485|Contrast sensitivity|contrast sensitivity
713359|NCT00576472|Brain Tumor, Acute Lymphoblastic Leukemia, Methylphenidate, Cognitive Late Effects|brain tumor, acute lymphoblastic leukemia, methylphenidate, cognitive late effects
713360|NCT00576407|Thymus Transplantation|thymus transplantation
713361|NCT00576407|DiGeorge Syndrome|digeorge syndrome
713362|NCT00576407|Athymia|athymia
713363|NCT00576407|Low T cell numbers|low t cell numbers
713364|NCT00576407|Immunoreconstitution|immunoreconstitution
713365|NCT00576407|Primary immunodeficiency|primary immunodeficiency
713366|NCT00576407|DiGeorge Anomaly|digeorge anomaly
713367|NCT00576407|Complete DiGeorge|complete digeorge
713368|NCT00576407|Typical DiGeorge|typical digeorge
713369|NCT00576394|Glucose, Insulin|glucose, insulin
713370|NCT00576381|Precedex|precedex
713371|NCT00576381|Open Heart Surgery|open heart surgery
713372|NCT00576381|Dexmedetomidine|dexmedetomidine
713373|NCT00576381|Sedation|sedation
713374|NCT00576355|Adolescent|adolescent
713375|NCT00576355|Psychopathology|psychopathology
713376|NCT00576355|Interpersonal Therapy|interpersonal therapy
713377|NCT00576355|Interpersonal and Social Rhythm Therapy|interpersonal and social rhythm therapy
713378|NCT00576329|vitreoretinal surgery, ketorolac, Acular, mydriasis|vitreoretinal surgery, ketorolac, acular, mydriasis
713379|NCT00576316|Asthma|asthma
713380|NCT00576264|open abdominal surgery|open abdominal surgery
713381|NCT00576264|abdominal laparoscopic surgery|abdominal laparoscopic surgery
713853|NCT00574041|Avonex|avonex
713382|NCT00576264|peritoneal stem cells|peritoneal stem cells
713383|NCT00576264|patients scheduled for any type of elective intra-abdominal surgery at Cedars-Sinai Medical Center with designated surgeons|patients scheduled for any type of elective intra-abdominal surgery at cedars-sinai medical center with designated surgeons
713384|NCT00576251|Ocular inflammation|ocular inflammation
713385|NCT00576251|blepharaconjunctivitis|blepharaconjunctivitis
713386|NCT00576238|Atopic eczema|atopic eczema
713387|NCT00576238|Topical corticosteroid|topical corticosteroid
713388|NCT00576225|NSCLC|nsclc
713389|NCT00576225|women|women
713390|NCT00576225|CT-2103|ct-2103
713391|NCT00576225|paclitaxel|paclitaxel
713392|NCT00576225|carboplatin|carboplatin
713393|NCT00576212|termination fetal anomaly|termination fetal anomaly
713394|NCT00576212|psychological sequelae pregnancy termination for anomalies|psychological sequelae pregnancy termination for anomalies
713395|NCT00576212|supportive follow-up pregnancy termination anomalies|supportive follow-up pregnancy termination anomalies
713396|NCT00576173|Cancer pain|cancer pain
713397|NCT00576173|Breakthrough pain|breakthrough pain
713398|NCT00576173|acetaminophen|acetaminophen
713399|NCT00576173|tramadol hydrochloride|tramadol hydrochloride
713400|NCT00576173|Ultracet|ultracet
713401|NCT00576160|medication adherence|medication adherence
713402|NCT00576147|TBI|tbi
713403|NCT00576147|NIRS|nirs
713404|NCT00576147|Hematoma|hematoma
713405|NCT00576134|Larynx, tracheotomy, titanium beads|larynx, tracheotomy, titanium beads
713406|NCT00576082|Lyme borreliosis|lyme borreliosis
713407|NCT00576082|Erythema migrans|erythema migrans
713408|NCT00576082|Borrelial lymphocytoma|borrelial lymphocytoma
713409|NCT00576082|Acrodermatitis chronica atrophicans|acrodermatitis chronica atrophicans
713410|NCT00576082|Borrelia burgdorferi|borrelia burgdorferi
713411|NCT00576082|Borrelia afzelii|borrelia afzelii
713412|NCT00576082|Borrelia garinii|borrelia garinii
713413|NCT00576069|asthma|asthma
713414|NCT00576069|lung function|lung function
713415|NCT00576069|inflammation|inflammation
713416|NCT00576056|Hepatocellular|hepatocellular
713417|NCT00576056|Carcinoma|carcinoma
713418|NCT00576056|TACE|tace
713419|NCT00576056|Sorafenib|sorafenib
713420|NCT00576056|Transcatheter Arterial Chemoembolization|transcatheter arterial chemoembolization
713421|NCT00576056|Nexavar|nexavar
713422|NCT00576056|Unresectable|unresectable
713423|NCT00576043|training|training
713424|NCT00576043|Patient satisfaction|patient satisfaction
713425|NCT00576043|endoscopy|endoscopy
713426|NCT00576043|simulator|simulator
713427|NCT00576043|Safety|safety
713428|NCT00576017|Cancer pain treatment|cancer pain treatment
713429|NCT00576017|Fentanyl TTS|fentanyl tts
713430|NCT00576017|Dihydrocodeine|dihydrocodeine
713431|NCT00576017|Tramadol|tramadol
713432|NCT00576017|Cancer pain|cancer pain
713433|NCT00576017|Durogesic|durogesic
713434|NCT00576017|Ultram|ultram
713435|NCT00576004|Pelvic organ prolapse, Urinary incontinence, Burch colposuspension, surgery|pelvic organ prolapse, urinary incontinence, burch colposuspension, surgery
713436|NCT00575991|conjugated linoleic acid, body fat, children, overweight|conjugated linoleic acid, body fat, children, overweight
713437|NCT00575978|breast cancer|breast cancer
713438|NCT00575965|simvastatin|simvastatin
713439|NCT00575939|HIV|hiv
713440|NCT00575939|IMT|imt
713441|NCT00575939|coronary|coronary
713442|NCT00575939|Treatment Naive|treatment naive
713443|NCT00575926|Randomized controlled trial|randomized controlled trial
713444|NCT00575926|Lingzhi|lingzhi
713445|NCT00575926|Immune functions|immune functions
713446|NCT00575926|Quality of life|quality of life
713447|NCT00575926|Survival|survival
713448|NCT00575900|Adolescent obesity,|adolescent obesity,
713449|NCT00575900|low carbohydrate diets|low carbohydrate diets
713450|NCT00575900|metabolic risk factors|metabolic risk factors
713451|NCT00575900|BMI|bmi
713452|NCT00575887|Temozolomide|temozolomide
713453|NCT00575887|Brain Tumor, Recurrent|brain tumor, recurrent
713454|NCT00575887|Chemotherapy|chemotherapy
713455|NCT00575874|rivoglitazone HCl|rivoglitazone hcl
713456|NCT00575874|pioglitazone HCl|pioglitazone hcl
713457|NCT00575874|thiazolidinedione|thiazolidinedione
713458|NCT00575874|peroxisome proliferator-activated receptor gamma (PPAR gamma)|peroxisome proliferator-activated receptor gamma (ppar gamma)
713459|NCT00575874|type 2 diabetes mellitus|type 2 diabetes mellitus
713460|NCT00575861|asthma|asthma
713461|NCT00575861|nitric oxide gas exchange|nitric oxide gas exchange
713462|NCT00575861|lung function|lung function
713463|NCT00575848|Schizophrenia|schizophrenia
713464|NCT00575848|Glycine|glycine
713465|NCT00575848|Magnetic Resonance Spectroscopy (MRS)|magnetic resonance spectroscopy (mrs)
713466|NCT00575835|vitamin D|vitamin d
713467|NCT00575835|seasonal variation|seasonal variation
713468|NCT00575835|PTH|pth
713469|NCT00575835|bone markers|bone markers
713470|NCT00575822|GERD|gerd
713471|NCT00575822|Sham|sham
713472|NCT00575822|Randomized Controlled Study|randomized controlled study
713473|NCT00575822|Endoscopic Full-thickness Plication|endoscopic full-thickness plication
713474|NCT00575822|Plicator|plicator
713475|NCT00575809|Mucositis, hematopoietic stem cell transplantation, chemotherapy|mucositis, hematopoietic stem cell transplantation, chemotherapy
713476|NCT00575796|pediatrics|pediatrics
713477|NCT00575796|Low Grade Glioma|low grade glioma
713478|NCT00575796|Vinblastine|vinblastine
713479|NCT00575783|type 1 diabetes|type 1 diabetes
713480|NCT00575783|hypoglycemia|hypoglycemia
713481|NCT00575783|magnetic resonance imaging|magnetic resonance imaging
713482|NCT00575757|Steatosis|steatosis
713483|NCT00575757|NASH|nash
713484|NCT00575744|Sentinel Lymph Node Biopsy|sentinel lymph node biopsy
713485|NCT00575744|Axillary Node Dissection|axillary node dissection
713486|NCT00575744|Intraoperative Injection|intraoperative injection
713487|NCT00575744|Lumpectomy|lumpectomy
713488|NCT00575744|Mastectomy|mastectomy
713489|NCT00575718|Quitting tobacco|quitting tobacco
713490|NCT00575718|tobacco use|tobacco use
713491|NCT00575679|Automobile driving|automobile driving
713492|NCT00575679|Driving under the influence|driving under the influence
713493|NCT00575679|Interview, psychological|interview, psychological
713494|NCT00575679|Brief intervention|brief intervention
713495|NCT00575679|Brief motivational interview|brief motivational interview
713496|NCT00575666|cognition, psychopathology|cognition, psychopathology
713497|NCT00575653|Guillain-Barre Syndrome|guillain-barre syndrome
713498|NCT00575653|Meningococcal vaccines|meningococcal vaccines
713499|NCT00575653|Tetravalent Meningococcal Vaccine|tetravalent meningococcal vaccine
713500|NCT00575653|Vaccination|vaccination
713501|NCT00575653|Vaccines|vaccines
713502|NCT00575653|Vaccines, Conjugate|vaccines, conjugate
713503|NCT00575627|Hepatitis C|hepatitis c
713504|NCT00575627|persistently normal ALT|persistently normal alt
713505|NCT00575627|pNNALT|pnnalt
713506|NCT00575627|Theraphy for Hepatitis C|theraphy for hepatitis c
713507|NCT00575627|Pegylated Interferon|pegylated interferon
713508|NCT00575627|Combined therapy|combined therapy
713509|NCT00575614|Constipation|constipation
713510|NCT00575614|Prucalopride|prucalopride
713511|NCT00575614|Ano-rectal physiology|ano-rectal physiology
713512|NCT00575614|Oro-caecal transit time|oro-caecal transit time
713513|NCT00575614|QOL|qol
713514|NCT00575601|pco|pco
713515|NCT00575601|simvastatin|simvastatin
713516|NCT00575601|ivf|ivf
713517|NCT00575601|embryo transfer|embryo transfer
713518|NCT00575588|DPP-4 Inhibitors|dpp-4 inhibitors
713519|NCT00575588|HbA1c|hba1c
713520|NCT00575588|incretins|incretins
713521|NCT00575575|Suicidal ideation|suicidal ideation
713522|NCT00575575|cognitive behavior therapy|cognitive behavior therapy
713523|NCT00575536|spasticity|spasticity
713524|NCT00575536|rhizotomy|rhizotomy
713525|NCT00575536|surgery|surgery
713526|NCT00575523|atropine|atropine
713527|NCT00575523|percutaneous ethanol instillation|percutaneous ethanol instillation
713528|NCT00575523|hepatoma|hepatoma
713529|NCT00575523|bradycardia|bradycardia
713530|NCT00575523|arrhythmia|arrhythmia
713531|NCT00575510|unified theory of behavior|unified theory of behavior
713532|NCT00575510|Pap test|pap test
713533|NCT00575510|cervical dysplasia|cervical dysplasia
713534|NCT00575510|women's health|women's health
713535|NCT00575497|Hemodialysis|hemodialysis
713536|NCT00575497|Adequacy|adequacy
713537|NCT00575497|Frequency|frequency
713538|NCT00575484|Congestive Heart Failure|congestive heart failure
713539|NCT00575484|Renal Insufficiency|renal insufficiency
713540|NCT00575484|Hypertonic Saline Solution|hypertonic saline solution
713541|NCT00575484|Diuretic Resistance|diuretic resistance
713542|NCT00575484|Cardiorenal Syndrome|cardiorenal syndrome
713543|NCT00575471|rivoglitazone HCl|rivoglitazone hcl
713544|NCT00575471|thiazolidinedione|thiazolidinedione
713545|NCT00575471|peroxisome proliferator-activated receptor gamma (PPARgamma)|peroxisome proliferator-activated receptor gamma (ppargamma)
713546|NCT00575471|diabetes mellitus, type 2|diabetes mellitus, type 2
713547|NCT00575432|magnetic resonance imaging|magnetic resonance imaging
713548|NCT00575432|renal function|renal function
713549|NCT00575432|renal transplant|renal transplant
713550|NCT00575432|urinary calculi|urinary calculi
713551|NCT00575432|healthy controls|healthy controls
713552|NCT00575432|kidney|kidney
713553|NCT00575419|Contrast Induced Nephropathy|contrast induced nephropathy
713554|NCT00575393|stage IIIB non-small cell lung cancer|stage iiib non-small cell lung cancer
713555|NCT00575393|stage IV non-small cell lung cancer|stage iv non-small cell lung cancer
713556|NCT00575393|recurrent non-small cell lung cancer|recurrent non-small cell lung cancer
713557|NCT00575354|Sevoflurane|sevoflurane
713558|NCT00575354|Isoflurane|isoflurane
713559|NCT00575354|Breast tumor|breast tumor
713560|NCT00575354|Anesthesia|anesthesia
713561|NCT00575341|Central Adrenal Insufficiency|central adrenal insufficiency
713562|NCT00575341|DHEA|dhea
713563|NCT00575341|Pubes|pubes
713564|NCT00575328|Sexual Dysfunction|sexual dysfunction
713565|NCT00575328|Bipolar Disorder|bipolar disorder
713566|NCT00575315|HIV-HCV Coinfection|hiv-hcv coinfection
713567|NCT00575315|HIV|hiv
713568|NCT00575315|Histology|histology
713569|NCT00575302|IVF|ivf
713570|NCT00575302|poor responder|poor responder
713571|NCT00575302|recFSH|recfsh
713572|NCT00575302|Fertilization in Vitro|fertilization in vitro
713573|NCT00575302|Poor responders|poor responders
713574|NCT00575276|Pain, Cholecystectomy, Cytokines, Sex Differences|pain, cholecystectomy, cytokines, sex differences
713575|NCT00575263|Pain, Sodium Channel, Dental pulp|pain, sodium channel, dental pulp
713576|NCT00575250|Osteoporosis/prevention & control|osteoporosis/prevention & control
713577|NCT00575250|Osteoporosis Prevention and Self-Management Course|osteoporosis prevention and self-management course
713578|NCT00575250|Patient Education/*trends//Questionnaires|patient education/*trends//questionnaires
713579|NCT00575250|Adult//Aged//Middle Aged|adult//aged//middle aged
713580|NCT00575250|Life Style//|life style//
713581|NCT00575237|Laparoscopic Surgery|laparoscopic surgery
713582|NCT00575237|Shoulder pain|shoulder pain
713583|NCT00575237|PDNV|pdnv
713584|NCT00575237|Anesthesia|anesthesia
713585|NCT00575237|Residual CO2|residual co2
713586|NCT00575237|Postoperative Pain|postoperative pain
713587|NCT00575237|Female ASA 1 and 2 outpatients who were scheduled for elective gynecologic laparoscopic surgery|female asa 1 and 2 outpatients who were scheduled for elective gynecologic laparoscopic surgery
713588|NCT00575224|Hepatitis C|hepatitis c
713589|NCT00575224|Genotype 6|genotype 6
713590|NCT00575224|Novel genoytpe|novel genoytpe
713591|NCT00575224|HCV|hcv
713592|NCT00575224|Treatment|treatment
713593|NCT00575211|New onset cardiomyopathy|new onset cardiomyopathy
713594|NCT00575211|Onset of symptoms less than 6 months|onset of symptoms less than 6 months
713595|NCT00575211|LVEF < 40%|lvef < 40%
713596|NCT00575198|Chest tubes|chest tubes
713597|NCT00575198|Trauma|trauma
713598|NCT00575185|Mono|mono
713599|NCT00575185|Mononucleosis|mononucleosis
713600|NCT00575185|Epstein-Barr virus|epstein-barr virus
713601|NCT00575172|type2 diabetes mellitus|type2 diabetes mellitus
713602|NCT00575172|cardiovascular disease|cardiovascular disease
713603|NCT00575172|macrovascular event|macrovascular event
713604|NCT00575159|type 1 Diabetes mellitus, pharmacokinetics,|type 1 diabetes mellitus, pharmacokinetics,
713605|NCT00575159|pharmacodynamics|pharmacodynamics
713606|NCT00575159|Adult male and females,|adult male and females,
713607|NCT00575146|glioblastoma|glioblastoma
713608|NCT00575146|ketogenic diet|ketogenic diet
713609|NCT00575120|Endothelial Function, MRI, Vascular Biology|endothelial function, mri, vascular biology
713610|NCT00575081|Physiological Brain Atlas, Brain registry, Brain database|physiological brain atlas, brain registry, brain database
713611|NCT00575042|PBC|pbc
713612|NCT00575042|Primary Biliary Cirrhosis|primary biliary cirrhosis
713613|NCT00575042|Fenofibrate|fenofibrate
713614|NCT00575042|Triglide|triglide
713615|NCT00575029|megestrol acetate|megestrol acetate
713616|NCT00575029|adrenal insufficiency|adrenal insufficiency
713617|NCT00575029|adrenal suppression|adrenal suppression
713618|NCT00574990|Interdisciplinary Communication|interdisciplinary communication
713619|NCT00574990|Safety Management|safety management
713620|NCT00574990|Management, Medication Therapy|management, medication therapy
713621|NCT00574990|Cooperative Behavior|cooperative behavior
713622|NCT00574990|Drug Therapy Management|drug therapy management
713623|NCT00574990|Physician Nurse Relationships|physician nurse relationships
713624|NCT00574990|Side Effects|side effects
713625|NCT00574990|Hospital Information Systems|hospital information systems
713626|NCT00574990|Documentation|documentation
713627|NCT00574990|Quality Assurance, Health Care|quality assurance, health care
713628|NCT00574977|vaccinia|vaccinia
713629|NCT00574977|virus|virus
713630|NCT00574977|tumor|tumor
713631|NCT00574977|melanoma|melanoma
713632|NCT00574977|breast cancer|breast cancer
713633|NCT00574977|squamous cell cancer|squamous cell cancer
713634|NCT00574977|colorectal|colorectal
713635|NCT00574977|liver|liver
713636|NCT00574977|pancreatic|pancreatic
713637|NCT00574977|adenocarcinoma|adenocarcinoma
713638|NCT00574951|fallopian tube cancer|fallopian tube cancer
713639|NCT00574951|recurrent ovarian epithelial cancer|recurrent ovarian epithelial cancer
713640|NCT00574951|primary peritoneal cavity cancer|primary peritoneal cavity cancer
713641|NCT00574925|H. pylori|h. pylori
713642|NCT00574912|Type 2 diabetes|type 2 diabetes
713643|NCT00574912|Insulin Glargine|insulin glargine
713644|NCT00574912|Endogenous Glucose Production|endogenous glucose production
713645|NCT00574899|Prostate|prostate
713646|NCT00574873|Bosutinib|bosutinib
713647|NCT00574873|imatinib|imatinib
713648|NCT00574873|CML|cml
713649|NCT00574860|Oral Mucositis|oral mucositis
713650|NCT00574860|Chemoradiation therapy|chemoradiation therapy
713651|NCT00574860|Head and neck cancer|head and neck cancer
713652|NCT00574847|ischemic heart disease|ischemic heart disease
713653|NCT00574847|mental stress-induced myocardial ischemia|mental stress-induced myocardial ischemia
713654|NCT00574847|escitalopram|escitalopram
713655|NCT00574821|Hypertrophic Cardiomyopathy(HCM)|hypertrophic cardiomyopathy(hcm)
713656|NCT00574821|Magnetocardiography (MCG)|magnetocardiography (mcg)
713657|NCT00574808|Primary care|primary care
713658|NCT00574808|Prevention of Cardiovascular Disease|prevention of cardiovascular disease
713659|NCT00574808|Chronic Disease Management|chronic disease management
713660|NCT00574808|Chronic Disease Prevention|chronic disease prevention
713661|NCT00574808|Chronic Care Model|chronic care model
713662|NCT00574808|Outreach Facilitation|outreach facilitation
713663|NCT00574782|cholesterol, coronary heart disease|cholesterol, coronary heart disease
713664|NCT00574782|rosuvastatin|rosuvastatin
713665|NCT00574782|LDL-C goal|ldl-c goal
713666|NCT00574782|hypercholesterolemia|hypercholesterolemia
713667|NCT00574769|RAD001|rad001
713668|NCT00574769|mTOR inhibition|mtor inhibition
713669|NCT00574769|docetaxel|docetaxel
713670|NCT00574769|bevacizumab|bevacizumab
713671|NCT00574769|adenocarcinoma of the prostate|adenocarcinoma of the prostate
713672|NCT00574769|recurrent prostate cancer|recurrent prostate cancer
713673|NCT00574769|stage IV prostate cancer|stage iv prostate cancer
713674|NCT00574769|prostate cancer|prostate cancer
713675|NCT00574769|Metastatic, androgen independent prostate cancer|metastatic, androgen independent prostate cancer
713676|NCT00574743|ERL080A, Heart Transplantation, Mycophenolate, EC-MPS|erl080a, heart transplantation, mycophenolate, ec-mps
713677|NCT00574717|hyperopia|hyperopia
713678|NCT00574717|ocular refraction|ocular refraction
713679|NCT00574717|infant|infant
713680|NCT00574717|vision|vision
713681|NCT00574691|Closure Device|closure device
713682|NCT00574691|Angiography|angiography
713683|NCT00574691|Angioplasty|angioplasty
713684|NCT00574691|Hemostasis|hemostasis
713685|NCT00574691|Heart Catheterization|heart catheterization
713686|NCT00574691|Coronary Angiography|coronary angiography
713687|NCT00574678|Screening tool for cancer|screening tool for cancer
713688|NCT00574665|Type 2 Diabetes|type 2 diabetes
713689|NCT00574665|Endothelial Function|endothelial function
713690|NCT00574665|Fibrinolytic Balance|fibrinolytic balance
713691|NCT00574652|HCV+|hcv+
713692|NCT00574652|cryoglobulinemia|cryoglobulinemia
713693|NCT00574652|Vasculitis|vasculitis
713694|NCT00574652|IL-2 treatment|il-2 treatment
713695|NCT00574652|safety and efficacy|safety and efficacy
713696|NCT00574639|Type 1 Diabetes|type 1 diabetes
713697|NCT00574639|Alprazolam|alprazolam
713698|NCT00574639|Exercise|exercise
713699|NCT00574626|NHL|nhl
713700|NCT00574626|Non Hodgkins Lymphoma|non hodgkins lymphoma
713701|NCT00574626|BMT|bmt
713702|NCT00574626|Bone Marrow Transplant|bone marrow transplant
713703|NCT00574626|PBSCT|pbsct
713704|NCT00574626|Peripheral Blood Stem Cell Transplant|peripheral blood stem cell transplant
713705|NCT00574626|PSCT|psct
713706|NCT00574613|Skin fibrosis|skin fibrosis
713707|NCT00574613|systemic scleroderma|systemic scleroderma
713708|NCT00574613|systemic sclerosis|systemic sclerosis
713709|NCT00574613|P144|p144
713710|NCT00574613|orphan drug|orphan drug
713711|NCT00574613|soluble collagen|soluble collagen
713712|NCT00574613|durometer|durometer
713713|NCT00574613|skin fibrosis in systemic sclerosis|skin fibrosis in systemic sclerosis
713714|NCT00574600|HIV Seronegativity|hiv seronegativity
713715|NCT00574600|HIV Preventive Vaccine|hiv preventive vaccine
713716|NCT00574587|Vorinostat|vorinostat
713717|NCT00574587|Neoadjuvant Chemotherapy|neoadjuvant chemotherapy
713718|NCT00574574|cardiovascular disease|cardiovascular disease
713719|NCT00574574|CVD|cvd
713720|NCT00574574|skin health|skin health
713721|NCT00574574|postmenopausal women|postmenopausal women
713722|NCT00574574|anthocyanin|anthocyanin
713723|NCT00574574|inflammation|inflammation
713724|NCT00574561|CT angiography (CTA)|ct angiography (cta)
713725|NCT00574561|Magnetocardiography (MCG)|magnetocardiography (mcg)
713726|NCT00574561|heart disease|heart disease
713727|NCT00574548|Vaccines, Pneumococcal Conjugate Vaccine|vaccines, pneumococcal conjugate vaccine
713728|NCT00574535|Reproductive Hormones|reproductive hormones
713729|NCT00574522|HIV|hiv
713730|NCT00574522|AIDS|aids
713731|NCT00574522|Radiation|radiation
713732|NCT00574522|Far infrared|far infrared
713733|NCT00574522|Treatment|treatment
713734|NCT00574522|Acquired Immunodeficiency Syndrome|acquired immunodeficiency syndrome
713735|NCT00574522|Complimentary therapies|complimentary therapies
713736|NCT00574509|NHL|nhl
713737|NCT00574509|Non Hodgkins Lymphoma|non hodgkins lymphoma
713738|NCT00574509|131Iodine-Anti-B1 Radioimmunotherapy|131iodine-anti-b1 radioimmunotherapy
713739|NCT00574509|Autologous Hematopoietic Stem Cell Transplant|autologous hematopoietic stem cell transplant
713740|NCT00574509|AHSCT|ahsct
713741|NCT00574496|recurrent adult Hodgkin lymphoma|recurrent adult hodgkin lymphoma
713742|NCT00574496|recurrent/refractory childhood Hodgkin lymphoma|recurrent/refractory childhood hodgkin lymphoma
713743|NCT00574496|adult lymphocyte depletion Hodgkin lymphoma|adult lymphocyte depletion hodgkin lymphoma
713744|NCT00574496|adult nodular sclerosis Hodgkin lymphoma|adult nodular sclerosis hodgkin lymphoma
713745|NCT00574496|adult mixed cellularity Hodgkin lymphoma|adult mixed cellularity hodgkin lymphoma
713746|NCT00574496|childhood lymphocyte depletion Hodgkin lymphoma|childhood lymphocyte depletion hodgkin lymphoma
713747|NCT00574496|childhood mixed cellularity Hodgkin lymphoma|childhood mixed cellularity hodgkin lymphoma
713748|NCT00574496|childhood nodular sclerosis Hodgkin lymphoma|childhood nodular sclerosis hodgkin lymphoma
713749|NCT00574496|stage III adult Hodgkin lymphoma|stage iii adult hodgkin lymphoma
713750|NCT00574496|stage IV adult Hodgkin lymphoma|stage iv adult hodgkin lymphoma
713751|NCT00574496|stage III childhood Hodgkin lymphoma|stage iii childhood hodgkin lymphoma
713752|NCT00574496|stage IV childhood Hodgkin lymphoma|stage iv childhood hodgkin lymphoma
713753|NCT00574483|Renal cell carcinoma|renal cell carcinoma
713754|NCT00574457|Atherosclerosis|atherosclerosis
713755|NCT00574457|Cardiovascular Risk Prevention|cardiovascular risk prevention
713756|NCT00574457|Carotid Ultrasound|carotid ultrasound
713947|NCT00573651|HPV vaccine|hpv vaccine
713757|NCT00574457|Handheld ultrasound|handheld ultrasound
713758|NCT00574457|Office Practice|office practice
713759|NCT00574457|Carotid Intima Media Thickness|carotid intima media thickness
713760|NCT00574457|Carotid Plaque|carotid plaque
713761|NCT00574444|transvaginal peritoneoscopy|transvaginal peritoneoscopy
713762|NCT00574431|Critical care|critical care
713763|NCT00574431|Intensive care unit|intensive care unit
713764|NCT00574431|Early enteral nutrition|early enteral nutrition
713765|NCT00574431|Nutritional management protocol|nutritional management protocol
713766|NCT00574418|Fibroid Tumor|fibroid tumor
713767|NCT00574418|Fibroid Uterus|fibroid uterus
713768|NCT00574418|Fibroids, Uterine|fibroids, uterine
713769|NCT00574418|Fibromyoma|fibromyoma
713770|NCT00574418|Uterine Neoplasms|uterine neoplasms
713771|NCT00574405|Insulin pump|insulin pump
713772|NCT00574405|Beta cell|beta cell
713773|NCT00574392|skin disorders|skin disorders
713774|NCT00574379|Allergic Rhinitis|allergic rhinitis
713775|NCT00574379|Mountain Cedar Pollen|mountain cedar pollen
713776|NCT00574379|Pollen Allergy|pollen allergy
713777|NCT00574379|Rhinoconjunctivitis|rhinoconjunctivitis
713778|NCT00574366|recurrent breast cancer|recurrent breast cancer
713779|NCT00574366|stage IV breast cancer|stage iv breast cancer
713780|NCT00574366|male breast cancer|male breast cancer
713781|NCT00574353|colorectal cancer|colorectal cancer
713782|NCT00574353|07-151|07-151
713783|NCT00574340|Type 2 Diabetes|type 2 diabetes
713784|NCT00574340|Endothelial Function|endothelial function
713785|NCT00574340|Fibrinolytic Balance|fibrinolytic balance
713786|NCT00574340|Hypoglycemia|hypoglycemia
713787|NCT00574327|Role|role
713788|NCT00574327|Registry|registry
713789|NCT00574327|Barrett's Esophagus|barrett's esophagus
713790|NCT00574314|women|women
713791|NCT00574314|Registry|registry
713792|NCT00574301|Image Guided Vacuum Assisted Biopsy|image guided vacuum assisted biopsy
713793|NCT00574301|Radiofrequency Ablation|radiofrequency ablation
713794|NCT00574301|Breast Conservation Therapy|breast conservation therapy
713795|NCT00574301|Mastectomy|mastectomy
713796|NCT00574301|MRI|mri
713797|NCT00574288|Multiple Myeloma|multiple myeloma
713798|NCT00574288|Daratumumab|daratumumab
713799|NCT00574288|Safety|safety
713800|NCT00574288|HuMax-CD38|humax-cd38
713801|NCT00574288|Dose-escalation|dose-escalation
713893|NCT00573872|AVM|avm
713802|NCT00574275|metastatic pancreatic cancer|metastatic pancreatic cancer
713803|NCT00574275|angiogenesis inhibitor|angiogenesis inhibitor
713804|NCT00574275|gemcitabine|gemcitabine
713805|NCT00574262|acute ischemic stroke|acute ischemic stroke
713806|NCT00574262|clinical pathway|clinical pathway
713807|NCT00574262|quality of care|quality of care
713808|NCT00574262|secondary prevention|secondary prevention
713809|NCT00574249|Psoriasis|psoriasis
713810|NCT00574249|Moderate Psoriasis|moderate psoriasis
713811|NCT00574249|Severe Psoriasis|severe psoriasis
713812|NCT00574249|Chronic Plaque Psoriasis|chronic plaque psoriasis
713813|NCT00574249|Severe Chronic Plaque Psoriasis|severe chronic plaque psoriasis
713814|NCT00574210|Seasonal Allergic Rhinitis (SAR)|seasonal allergic rhinitis (sar)
713815|NCT00574210|Environmental Exposure Chamber (EEC)|environmental exposure chamber (eec)
713816|NCT00574210|Therapeutic Uses|therapeutic uses
713817|NCT00574210|Antihistamine Drug|antihistamine drug
713818|NCT00574210|Ragweed Pollen|ragweed pollen
713819|NCT00574197|Heart Transplant|heart transplant
713820|NCT00574197|gastrointestinal|gastrointestinal
713821|NCT00574197|Cellcept|cellcept
713822|NCT00574197|Myfortic|myfortic
713823|NCT00574197|GI|gi
713824|NCT00574197|GI symptoms with Mycophenolate Mofetil after heart transplant|gi symptoms with mycophenolate mofetil after heart transplant
713825|NCT00574184|ED|ed
713826|NCT00574184|Erectile Dysfunction|erectile dysfunction
713827|NCT00574158|ozone|ozone
713828|NCT00574158|inflammatory airway disease|inflammatory airway disease
713829|NCT00574158|polymorphisms|polymorphisms
713830|NCT00574145|fatigue|fatigue
713831|NCT00574145|depression|depression
713832|NCT00574145|psychosocial effects of cancer and its treatment|psychosocial effects of cancer and its treatment
713833|NCT00574145|stage I breast cancer|stage i breast cancer
713834|NCT00574145|stage II breast cancer|stage ii breast cancer
713835|NCT00574145|stage IIIA breast cancer|stage iiia breast cancer
713836|NCT00574145|stage IIIB breast cancer|stage iiib breast cancer
713837|NCT00574145|stage IIIC breast cancer|stage iiic breast cancer
713838|NCT00574145|recurrent breast cancer|recurrent breast cancer
713839|NCT00574119|heart failure|heart failure
713840|NCT00574119|positron emission tomography|positron emission tomography
713841|NCT00574119|magnetic resonance imaging|magnetic resonance imaging
713842|NCT00574119|myocardial energetics|myocardial energetics
713843|NCT00574119|myocardial perfusion|myocardial perfusion
713844|NCT00574106|Cancer|cancer
713845|NCT00574106|Tumors|tumors
713846|NCT00574093|combination therapy|combination therapy
713847|NCT00574093|Lucentis|lucentis
713848|NCT00574093|Visudyne|visudyne
713849|NCT00574054|Familial Dementia|familial dementia
713850|NCT00574054|Semantic Dementia|semantic dementia
713851|NCT00574054|Senile Paranoid Dementia|senile paranoid dementia
713852|NCT00574041|Multiple Sclerosis|multiple sclerosis
713854|NCT00574041|side effects|side effects
713855|NCT00574041|flu like symptoms|flu like symptoms
713856|NCT00574028|IBD Study|ibd study
713857|NCT00574015|toothache|toothache
713858|NCT00574015|regional anesthesia|regional anesthesia
713859|NCT00574015|emergency department|emergency department
713860|NCT00573989|recurrent squamous cell carcinoma of the hypopharynx|recurrent squamous cell carcinoma of the hypopharynx
713861|NCT00573989|recurrent squamous cell carcinoma of the larynx|recurrent squamous cell carcinoma of the larynx
713862|NCT00573989|recurrent verrucous carcinoma of the larynx|recurrent verrucous carcinoma of the larynx
713863|NCT00573989|recurrent squamous cell carcinoma of the lip and oral cavity|recurrent squamous cell carcinoma of the lip and oral cavity
713864|NCT00573989|recurrent verrucous carcinoma of the oral cavity|recurrent verrucous carcinoma of the oral cavity
713865|NCT00573989|metastatic squamous neck cancer with occult primary squamous cell carcinoma|metastatic squamous neck cancer with occult primary squamous cell carcinoma
713866|NCT00573989|recurrent metastatic squamous neck cancer with occult primary|recurrent metastatic squamous neck cancer with occult primary
713867|NCT00573989|recurrent squamous cell carcinoma of the oropharynx|recurrent squamous cell carcinoma of the oropharynx
713868|NCT00573976|SCIM|scim
713869|NCT00573976|SCIM III|scim iii
713870|NCT00573976|Multi-Center|multi-center
713871|NCT00573976|United States|united states
713872|NCT00573963|Cesarean section|cesarean section
713873|NCT00573950|cilostazol|cilostazol
713874|NCT00573950|Type 2 Diabetes mellitus|type 2 diabetes mellitus
713875|NCT00573950|Metabolic Syndrome|metabolic syndrome
713876|NCT00573950|adipocytokines|adipocytokines
713877|NCT00573950|arterial stiffness|arterial stiffness
713878|NCT00573950|Pulse wave velocity|pulse wave velocity
713879|NCT00573937|Neoplasms|neoplasms
713880|NCT00573937|Pain|pain
713881|NCT00573937|Methadone|methadone
713882|NCT00573937|Morphine|morphine
713883|NCT00573911|Barrett's esophagus|barrett's esophagus
713884|NCT00573911|GERD|gerd
713885|NCT00573898|daptomycin|daptomycin
713886|NCT00573885|non-small cell lung cancer|non-small cell lung cancer
713887|NCT00573885|small cell lung cancer|small cell lung cancer
713888|NCT00573885|tobacco use disorder|tobacco use disorder
713889|NCT00573872|Radiosurgery|radiosurgery
713890|NCT00573872|Phase II|phase ii
713891|NCT00573872|Cancer|cancer
713892|NCT00573872|Spinal|spinal
713894|NCT00573859|Smoking|smoking
713895|NCT00573859|ADHD|adhd
713896|NCT00573859|Stimulant medication|stimulant medication
713897|NCT00573846|IBD|ibd
713898|NCT00573833|adenocarcinoma of the prostate|adenocarcinoma of the prostate
713899|NCT00573833|stage IIB prostate cancer|stage iib prostate cancer
713900|NCT00573833|stage IIA prostate cancer|stage iia prostate cancer
713901|NCT00573820|Tumors or cancer of the prostate|tumors or cancer of the prostate
713902|NCT00573820|Cancer of Prostate|cancer of prostate
713903|NCT00573820|Cancer of the Prostate|cancer of the prostate
713904|NCT00573820|Neoplasms, Prostate|neoplasms, prostate
713905|NCT00573820|Neoplasms, Prostatic|neoplasms, prostatic
713906|NCT00573820|Prostate Cancer|prostate cancer
713907|NCT00573820|Prostate Neoplasms|prostate neoplasms
713908|NCT00573820|Prostatic Cancer|prostatic cancer
713909|NCT00573807|Neuralgia, Sciatic|neuralgia, sciatic
713910|NCT00573807|Sciatic Neuralgia|sciatic neuralgia
713911|NCT00573807|Sciatica, Bilateral|sciatica, bilateral
713912|NCT00573807|Lower back pain|lower back pain
713913|NCT00573794|Ulcerative Colitis|ulcerative colitis
713914|NCT00573781|Systems biology|systems biology
713915|NCT00573781|Nutrigenomics|nutrigenomics
713916|NCT00573781|Metabolomics|metabolomics
713917|NCT00573781|Gene expression|gene expression
713918|NCT00573781|Fat tissue|fat tissue
713919|NCT00573781|Peripheral mononuclear cells|peripheral mononuclear cells
713920|NCT00573781|Gene clusters|gene clusters
713921|NCT00573781|Gene expression profiles|gene expression profiles
713922|NCT00573781|Personal diets|personal diets
713923|NCT00573781|Metabolic syndrome|metabolic syndrome
713924|NCT00573781|Type 2 Diabetes|type 2 diabetes
713925|NCT00573781|Atherosclerosis|atherosclerosis
713926|NCT00573768|Ankle, sprain, diclofenac diethylamine|ankle, sprain, diclofenac diethylamine
713927|NCT00573755|stage IV breast cancer|stage iv breast cancer
713928|NCT00573755|recurrent breast cancer|recurrent breast cancer
713929|NCT00573742|hypertension|hypertension
713930|NCT00573729|vascular malformation|vascular malformation
713931|NCT00573716|bone mineral content|bone mineral content
713932|NCT00573716|aripiprazole monotherapy|aripiprazole monotherapy
713933|NCT00573716|risperidone monotherapy|risperidone monotherapy
713934|NCT00573703|Laparoscopic Burch colposuspension|laparoscopic burch colposuspension
713935|NCT00573703|Stress incontinence|stress incontinence
713936|NCT00573703|Surgery|surgery
713937|NCT00573703|TOT|tot
713938|NCT00573703|Treatment|treatment
713939|NCT00573703|Predominant or genuine stress urinary incontinence|predominant or genuine stress urinary incontinence
713940|NCT00573690|unspecified adult solid tumor, protocol specific|unspecified adult solid tumor, protocol specific
713941|NCT00573664|Cesarean section|cesarean section
713942|NCT00573664|Gabapentin|gabapentin
713943|NCT00573651|JIA|jia
713944|NCT00573651|SEA syndrome|sea syndrome
713945|NCT00573651|AS|as
713946|NCT00573651|psoriatic arthritis|psoriatic arthritis
713952|NCT00573638|Patients could range anywhere from 40 to 80 years old|patients could range anywhere from 40 to 80 years old
713953|NCT00573638|Patients must have diagnosis requiring treatment with Xalatan.|patients must have diagnosis requiring treatment with xalatan.
713954|NCT00573638|Patients will be male or female and from any racial/ethnic background.|patients will be male or female and from any racial/ethnic background.
713955|NCT00573612|Fibromyalgia|fibromyalgia
713956|NCT00573612|Fibromyalgia patients|fibromyalgia patients
713957|NCT00573599|Migraine|migraine
713958|NCT00573599|Emergency|emergency
713959|NCT00573599|imitrex|imitrex
713960|NCT00573599|prochlorperazine|prochlorperazine
713961|NCT00573599|Acute Migraine Headache in the Emergency Department|acute migraine headache in the emergency department
713962|NCT00573573|PRIMARY HYPERPARATHYROIDISM|primary hyperparathyroidism
713963|NCT00573573|PARATHYROID NEOPLASMS|parathyroid neoplasms
713964|NCT00573573|SECONDARY HYPERPARATHYROIDISM|secondary hyperparathyroidism
713965|NCT00573573|HYPOCALCEMIA|hypocalcemia
713966|NCT00573560|Heart failure|heart failure
713967|NCT00573560|percutaneous|percutaneous
713968|NCT00573560|interventional cardiology|interventional cardiology
713969|NCT00573560|apical remodeling|apical remodeling
713970|NCT00573560|LV dilatation|lv dilatation
713971|NCT00573560|akinesis|akinesis
713972|NCT00573560|dyskinesis|dyskinesis
713973|NCT00573547|depression|depression
713974|NCT00573547|chronic renal failures|chronic renal failures
713975|NCT00573547|end stage renal disease|end stage renal disease
713976|NCT00573534|Attention Deficit Hyperactivity Disorder|attention deficit hyperactivity disorder
713977|NCT00573534|ADHD|adhd
713978|NCT00573534|ADD|add
713979|NCT00573534|Prevention|prevention
713980|NCT00573534|Substance use|substance use
713981|NCT00573534|Adolescent|adolescent
713982|NCT00573521|ESBL positive cultures|esbl positive cultures
713983|NCT00573508|Overactive Bladder|overactive bladder
713984|NCT00573495|Advanced breast cancer|advanced breast cancer
713985|NCT00573482|weight gain prevention|weight gain prevention
713986|NCT00573482|obesity|obesity
713987|NCT00573482|overweight|overweight
714083|NCT00573131|OncoGel|oncogel
713988|NCT00573482|food environment|food environment
713989|NCT00573482|The intervention group received the education in REDE techniques|the intervention group received the education in rede techniques
713990|NCT00573482|The control group received no intervention at all.|the control group received no intervention at all.
713991|NCT00573482|Both groups were exposed to the food labels and the new lower ED foods.|both groups were exposed to the food labels and the new lower ed foods.
713992|NCT00573482|Only the intervention group received the education sessions and only they were eligible for the price reductions.|only the intervention group received the education sessions and only they were eligible for the price reductions.
713993|NCT00573469|gastrointestinal|gastrointestinal
713995|NCT00573469|Crohn's disease|crohn's disease
713996|NCT00573469|Japan|japan
713997|NCT00573469|Japanese|japanese
713998|NCT00573456|Thye 1 Diabetes|thye 1 diabetes
713999|NCT00573456|Type 2 Diabetes|type 2 diabetes
714000|NCT00573443|Amyotrophic Lateral Sclerosis (Lou Gehrig's disease, ALS)|amyotrophic lateral sclerosis (lou gehrig's disease, als)
714001|NCT00573443|Multiple Sclerosis (MS)|multiple sclerosis (ms)
714002|NCT00573430|Candesartan Cilexetil|candesartan cilexetil
714003|NCT00573430|Non-diabetic Nephropathy|non-diabetic nephropathy
714004|NCT00573430|hypertension|hypertension
714005|NCT00573430|urine protein creatinine ratio|urine protein creatinine ratio
714006|NCT00573417|Schizophrenia|schizophrenia
714007|NCT00573417|Clozapine|clozapine
714008|NCT00573417|Cognition|cognition
714009|NCT00573417|Metabolic Syndrome|metabolic syndrome
714010|NCT00573417|Negative Symptoms|negative symptoms
714011|NCT00573417|Wakefulness|wakefulness
714012|NCT00573417|Fatigue|fatigue
714013|NCT00573404|gastrointestinal stromal tumor|gastrointestinal stromal tumor
714014|NCT00573378|CML|cml
714015|NCT00573365|dermatitis|dermatitis
714016|NCT00573365|skin|skin
714017|NCT00573365|radiation|radiation
714018|NCT00573365|light|light
714019|NCT00573365|LED photomodulation|led photomodulation
714020|NCT00573365|Gentlewaves|gentlewaves
714021|NCT00573352|Arthritis, Degenerative|arthritis, degenerative
714022|NCT00573352|Osteoarthrosis|osteoarthrosis
714023|NCT00573352|Osteoarthrosis Deformans|osteoarthrosis deformans
714024|NCT00573339|Cardiac|cardiac
714025|NCT00573339|MRI|mri
714026|NCT00573339|normal controls|normal controls
714027|NCT00573313|Alcoholic Liver Disease (ALD)|alcoholic liver disease (ald)
714028|NCT00573313|S-adenosylmethionine|s-adenosylmethionine
714029|NCT00573313|SAMe|same
714030|NCT00573300|Schizophrenia|schizophrenia
714031|NCT00573300|Immune System|immune system
714032|NCT00573300|Kynurenate|kynurenate
714033|NCT00573300|tryptophan metabolism|tryptophan metabolism
714034|NCT00573300|NMDA receptor|nmda receptor
714035|NCT00573300|indolamine 2,3-deoxygenase (IDO)|indolamine 2,3-deoxygenase (ido)
714036|NCT00573287|Clozapine, risperidone, first episode,|clozapine, risperidone, first episode,
714037|NCT00573274|Cesarean section|cesarean section
714038|NCT00573274|Cardiac Output|cardiac output
714039|NCT00573274|Physioflow|physioflow
714040|NCT00573274|Cardiography, Impedance|cardiography, impedance
714041|NCT00573261|Diabetic neuropathy|diabetic neuropathy
714042|NCT00573261|Pregabalin|pregabalin
714049|NCT00573235|E coli isolates|e coli isolates
714050|NCT00573222|Asthma|asthma
714051|NCT00573209|Impotence|impotence
714052|NCT00573209|Male Impotence|male impotence
714053|NCT00573209|Male Sexual Impotence|male sexual impotence
714054|NCT00573196|Affective Psychosis, Bipolar|affective psychosis, bipolar
714055|NCT00573196|Depression, Bipolar|depression, bipolar
714056|NCT00573196|Mania|mania
714057|NCT00573196|Manic Disorder|manic disorder
714058|NCT00573196|Manic State|manic state
714059|NCT00573196|Manic-Depressive Psychosis|manic-depressive psychosis
714060|NCT00573196|Psychoses, Manic-Depressive|psychoses, manic-depressive
714061|NCT00573196|Psychosis, Manic-Depressive|psychosis, manic-depressive
714062|NCT00573183|Cocaine, methamphetamine, amphetamine, other stimulant drugs|cocaine, methamphetamine, amphetamine, other stimulant drugs
714063|NCT00573170|Migraine, acute|migraine, acute
714064|NCT00573170|Migraine|migraine
714065|NCT00573170|Butalbital-containing Combination Medication (BCM)|butalbital-containing combination medication (bcm)
714066|NCT00573170|Naproxen sodium|naproxen sodium
714067|NCT00573170|Sumatriptan succinate|sumatriptan succinate
714068|NCT00573170|TREXIMET®|treximet®
714069|NCT00573157|nephritis|nephritis
714070|NCT00573157|atacicept|atacicept
714071|NCT00573131|Esophageal cancer|esophageal cancer
714072|NCT00573131|Localized esophageal cancer|localized esophageal cancer
714073|NCT00573131|Operable esophageal cancer|operable esophageal cancer
714074|NCT00573131|Loco-regional esophageal cancer|loco-regional esophageal cancer
714075|NCT00573131|Esophagectomy|esophagectomy
714076|NCT00573131|Phase 2|phase 2
714077|NCT00573131|Paclitaxel|paclitaxel
714078|NCT00573131|Tumor|tumor
714079|NCT00573131|Local|local
714080|NCT00573131|Chemotherapy|chemotherapy
714081|NCT00573131|radiation therapy|radiation therapy
714082|NCT00573131|surgery|surgery
714084|NCT00573131|Squamous cell carcinoma of the esophagus|squamous cell carcinoma of the esophagus
714085|NCT00573118|Pregnancy complications: preeclampsia , severe IUGR , IUFD or placental abruption (n = 5).|pregnancy complications: preeclampsia , severe iugr , iufd or placental abruption (n = 5).
714086|NCT00573092|Cardiovascular Epidemiology|cardiovascular epidemiology
714087|NCT00573092|Genomics|genomics
714088|NCT00573092|Genome-Wide Association Study|genome-wide association study
714089|NCT00573079|Kidney|kidney
714090|NCT00573079|Infants|infants
714091|NCT00573066|Postoperative from cardiac surgery|postoperative from cardiac surgery
714092|NCT00573066|Dexmedetomidine|dexmedetomidine
714093|NCT00573053|hypercapneic response|hypercapneic response
714094|NCT00573053|hyperoxic response|hyperoxic response
714095|NCT00573053|breathing pattern|breathing pattern
714096|NCT00573053|periodic breathing|periodic breathing
714097|NCT00573053|sighs|sighs
714098|NCT00573040|Radiotherapy|radiotherapy
714099|NCT00573040|NSCLC|nsclc
714100|NCT00573040|Stage III non-small cell lung cancer|stage iii non-small cell lung cancer
714101|NCT00573027|microvascular dysfunction|microvascular dysfunction
714102|NCT00573027|Microvascular|microvascular
714103|NCT00573014|Obtunded blunt trauma patients|obtunded blunt trauma patients
714104|NCT00573001|naive|naive
714105|NCT00573001|HIV-1|hiv-1
714106|NCT00573001|simplified treatment|simplified treatment
714107|NCT00573001|Treatment Experienced|treatment experienced
714108|NCT00572988|symptom management|symptom management
714109|NCT00572988|function status|function status
714110|NCT00572988|physical activity|physical activity
714111|NCT00572988|health care utilization|health care utilization
714112|NCT00572975|New diagnostic test for Cystic Fibrosis.|new diagnostic test for cystic fibrosis.
714113|NCT00572949|heart disease|heart disease
714114|NCT00572949|chest pain|chest pain
714115|NCT00572949|coronary artery disease|coronary artery disease
714116|NCT00572949|atherosclerosis|atherosclerosis
714117|NCT00572936|Glaucoma|glaucoma
714118|NCT00572936|Ocular Hypertension|ocular hypertension
714119|NCT00572936|Timolol®, Latanoprost® and Dorzolamide®|timolol®, latanoprost® and dorzolamide®
714120|NCT00572923|radiotherapy|radiotherapy
714121|NCT00572923|LD-SCLC|ld-sclc
714122|NCT00572923|stage I-III small cell lung cancer|stage i-iii small cell lung cancer
714123|NCT00572897|Myelofibrosis|myelofibrosis
714124|NCT00572897|Myeloproliferative disease|myeloproliferative disease
714125|NCT00572897|Stem Cell Transplant|stem cell transplant
714126|NCT00572897|Allogeneic Transplant|allogeneic transplant
714127|NCT00572897|Conditioning Regimen|conditioning regimen
714128|NCT00572897|Reduced Intensity Regimen|reduced intensity regimen
714129|NCT00572897|Fludarabine|fludarabine
714130|NCT00572897|Melphalan|melphalan
714131|NCT00572897|ATG|atg
714132|NCT00572884|permethrin|permethrin
714133|NCT00572884|pyrethroid|pyrethroid
714134|NCT00572884|pharmacokinetics|pharmacokinetics
714135|NCT00572884|metabolism|metabolism
714136|NCT00572884|accelerator mass spectrometry|accelerator mass spectrometry
714137|NCT00572884|human exposure|human exposure
714138|NCT00572858|Hypo E|hypo e
714139|NCT00572845|Basal Energy Expenditure|basal energy expenditure
714140|NCT00572845|Spasticity|spasticity
714141|NCT00572845|Modified Ashworth Scale|modified ashworth scale
714142|NCT00572845|Penn Spasm Frequency Score|penn spasm frequency score
714143|NCT00572832|Human Papillomavirus Vaccine|human papillomavirus vaccine
714246|NCT00572377|Arousal|arousal
714144|NCT00572819|Hysteroscopy|hysteroscopy
714145|NCT00572819|Misoprostol|misoprostol
714146|NCT00572819|Postmenopausal women|postmenopausal women
714147|NCT00572819|Cervical ripening|cervical ripening
714148|NCT00572819|Dilatation|dilatation
714149|NCT00572819|Sequential trial|sequential trial
714150|NCT00572819|Estradiol|estradiol
714151|NCT00572780|Crohn's Disease|crohn's disease
714152|NCT00572780|CT Enteroclysis|ct enteroclysis
714153|NCT00572767|randomised-controlled trial|randomised-controlled trial
714154|NCT00572767|ischemic stroke|ischemic stroke
714155|NCT00572767|motor recovery|motor recovery
714156|NCT00572767|amphetamine|amphetamine
714157|NCT00572767|motor recovery of patients after a first-ever ischemic stroke|motor recovery of patients after a first-ever ischemic stroke
714158|NCT00572741|Autism|autism
714159|NCT00572741|vitamin B 12|vitamin b 12
714160|NCT00572741|glutathione|glutathione
714161|NCT00572715|kidney|kidney
714162|NCT00572715|neonates|neonates
714163|NCT00572702|Biocompatible Materials|biocompatible materials
714164|NCT00572702|Female|female
714165|NCT00572702|Humans|humans
714166|NCT00572702|Pelvic Floor|pelvic floor
714167|NCT00572702|Polypropylenes|polypropylenes
714168|NCT00572702|Prostheses and Implants|prostheses and implants
714169|NCT00572702|Surgical Mesh|surgical mesh
714170|NCT00572702|Uterine Prolapse/*therapy|uterine prolapse/*therapy
714171|NCT00572689|Exenatide|exenatide
714172|NCT00572689|TCF7L2 polymorphism|tcf7l2 polymorphism
714173|NCT00572689|Pharmacodynamics|pharmacodynamics
714174|NCT00572689|Pharmacokinetics|pharmacokinetics
714175|NCT00572663|Proteinuria|proteinuria
714176|NCT00572663|Antioxidant|antioxidant
714177|NCT00572663|N-acetylcysteine|n-acetylcysteine
714178|NCT00572650|Type-2 diabetes, DPP-4 inhibitor, vildagliptin|type-2 diabetes, dpp-4 inhibitor, vildagliptin
714179|NCT00572624|Heart Metabolism|heart metabolism
714180|NCT00572624|Obesity|obesity
714181|NCT00572624|Weight loss|weight loss
714182|NCT00572624|Gastric bypass surgery|gastric bypass surgery
714183|NCT00572624|Diet and exercise|diet and exercise
714184|NCT00572611|Mass Balance|mass balance
714185|NCT00572611|Metabolism|metabolism
714186|NCT00572611|Absorption|absorption
714187|NCT00572611|Excretion|excretion
714188|NCT00572611|Pharmacokinetics|pharmacokinetics
714190|NCT00572598|multidrug resistance|multidrug resistance
714191|NCT00572598|fluoropaclitaxel|fluoropaclitaxel
714192|NCT00572598|paclitaxel|paclitaxel
714193|NCT00572598|breast cancer|breast cancer
714194|NCT00572598|dosimetry|dosimetry
714195|NCT00572598|imaging feasibility|imaging feasibility
714196|NCT00572585|Ulcerative colitis|ulcerative colitis
714197|NCT00572585|immunosuppressive therapy|immunosuppressive therapy
714198|NCT00572585|AEB071|aeb071
714199|NCT00572585|Modified Baron score|modified baron score
714200|NCT00572585|Partial Mayo score|partial mayo score
714201|NCT00572533|End-Stage Renal Disease|end-stage renal disease
714202|NCT00572533|Chronic Hemodialysis|chronic hemodialysis
714203|NCT00572520|Depressive Disorder|depressive disorder
714204|NCT00572520|Weight Loss|weight loss
714205|NCT00572520|Behavioral Treatment|behavioral treatment
714206|NCT00572520|Behavior Therapy|behavior therapy
714207|NCT00572520|Randomized Clinical Trial|randomized clinical trial
714208|NCT00572507|Absorbable Monofilament Suture Material|absorbable monofilament suture material
714209|NCT00572507|Safety and Efficacy|safety and efficacy
714210|NCT00572507|Abdominal Wall/ Fascia|abdominal wall/ fascia
714211|NCT00572507|Laparotomy|laparotomy
714212|NCT00572494|Tibial arteries|tibial arteries
714213|NCT00572494|Absorbable implants|absorbable implants
714214|NCT00572494|Stents|stents
714215|NCT00572494|Limb salvage|limb salvage
714216|NCT00572481|Sentinel Lymph Node Biopsy|sentinel lymph node biopsy
714217|NCT00572481|Axillary Node Dissection|axillary node dissection
714218|NCT00572481|Prevention of lymphedema|prevention of lymphedema
714219|NCT00572481|Prevention of neuroma|prevention of neuroma
714220|NCT00572481|Prevention of seroma|prevention of seroma
714221|NCT00572468|cancer|cancer
714222|NCT00572468|pre-operative surgery|pre-operative surgery
714223|NCT00572468|prostate|prostate
714224|NCT00572468|prostatectomy|prostatectomy
714225|NCT00572468|radiation|radiation
714226|NCT00572455|Open-Angle Glaucoma|open-angle glaucoma
714227|NCT00572455|Ocular Hypertension|ocular hypertension
714228|NCT00572442|Non-invasive heart scan|non-invasive heart scan
714229|NCT00572442|MCG|mcg
714230|NCT00572442|Cardiac Risk Factors|cardiac risk factors
714231|NCT00572442|healthy volunteers|healthy volunteers
714232|NCT00572429|HIV/AIDS|hiv/aids
714233|NCT00572429|HAART|haart
714234|NCT00572429|high cholesterol|high cholesterol
714235|NCT00572429|exercise|exercise
714236|NCT00572429|L-carnitine|l-carnitine
714237|NCT00572429|Complimentary therapies|complimentary therapies
714238|NCT00572416|fatigue|fatigue
714239|NCT00572416|activity-rest|activity-rest
714240|NCT00572416|sleep-wake|sleep-wake
714241|NCT00572416|psychological distress|psychological distress
714242|NCT00572416|symptom management|symptom management
714243|NCT00572403|microalbuminuria|microalbuminuria
714244|NCT00572403|risk factors|risk factors
714245|NCT00572377|Sexual|sexual
714249|NCT00572364|Advanced solid malignancies|advanced solid malignancies
714250|NCT00572351|Wine|wine
714251|NCT00572325|radiotherapy|radiotherapy
714252|NCT00572325|NSCLC|nsclc
714253|NCT00572325|stage III non-small cell lung cancer|stage iii non-small cell lung cancer
714254|NCT00572312|Proteinuria,|proteinuria,
714255|NCT00572312|atorvastatin|atorvastatin
714256|NCT00572299|glucocorticoids, prednisone, alendronate,osteoclasts|glucocorticoids, prednisone, alendronate,osteoclasts
714257|NCT00572286|heart transplant|heart transplant
714258|NCT00572286|advanced heart failure|advanced heart failure
714259|NCT00572286|orthotropic heart transplantation|orthotropic heart transplantation
714260|NCT00572286|(MCG) magnetocardiograph|(mcg) magnetocardiograph
714261|NCT00572286|echocardiogram|echocardiogram
714262|NCT00572260|MRSA|mrsa
714263|NCT00572260|Increased risk for infection|increased risk for infection
714264|NCT00572234|Methamphetamine|methamphetamine
714265|NCT00572234|Bupropion SR (Sustained Release)|bupropion sr (sustained release)
714266|NCT00572221|CQI|cqi
714267|NCT00572221|QA|qa
714268|NCT00572221|Best Practice|best practice
714269|NCT00572221|Quality Improvement|quality improvement
714270|NCT00572221|Nursing Facilities|nursing facilities
714271|NCT00572221|Nursing Homes|nursing homes
714272|NCT00572221|Care|care
714273|NCT00572195|Epilepsy|epilepsy
714274|NCT00572195|Responsive neurostimulation|responsive neurostimulation
714275|NCT00572195|RNS System|rns system
714276|NCT00572195|NeuroPace|neuropace
714277|NCT00572195|Brain stimulation|brain stimulation
714278|NCT00572195|Seizures|seizures
714279|NCT00572182|recurrent childhood brain stem glioma|recurrent childhood brain stem glioma
714280|NCT00572182|childhood central nervous system germ cell tumor|childhood central nervous system germ cell tumor
714281|NCT00572182|recurrent childhood cerebellar astrocytoma|recurrent childhood cerebellar astrocytoma
714282|NCT00572182|recurrent childhood cerebral astrocytoma|recurrent childhood cerebral astrocytoma
714283|NCT00572182|childhood high-grade cerebral astrocytoma|childhood high-grade cerebral astrocytoma
714284|NCT00572182|childhood choroid plexus tumor|childhood choroid plexus tumor
714285|NCT00572182|childhood craniopharyngioma|childhood craniopharyngioma
714286|NCT00572182|recurrent childhood ependymoma|recurrent childhood ependymoma
714287|NCT00572182|recurrent childhood medulloblastoma|recurrent childhood medulloblastoma
714288|NCT00572182|childhood oligodendroglioma|childhood oligodendroglioma
714289|NCT00572182|recurrent childhood pineoblastoma|recurrent childhood pineoblastoma
714290|NCT00572182|recurrent childhood supratentorial primitive neuroectodermal tumor|recurrent childhood supratentorial primitive neuroectodermal tumor
714291|NCT00572182|childhood atypical teratoid/rhabdoid tumor|childhood atypical teratoid/rhabdoid tumor
714292|NCT00572182|childhood spinal cord neoplasm|childhood spinal cord neoplasm
714293|NCT00572182|childhood infratentorial ependymoma|childhood infratentorial ependymoma
714294|NCT00572182|childhood supratentorial ependymoma|childhood supratentorial ependymoma
714295|NCT00572182|recurrent childhood visual pathway and hypothalamic glioma|recurrent childhood visual pathway and hypothalamic glioma
714296|NCT00572182|childhood grade III meningioma|childhood grade iii meningioma
714297|NCT00572156|IGF-1 Deficiency|igf-1 deficiency
714298|NCT00572156|growth|growth
714299|NCT00572156|ISS|iss
714300|NCT00572156|Constitutional growth delay|constitutional growth delay
714301|NCT00572156|Primary IGFD|primary igfd
714302|NCT00572156|Primary IGF Deficiency|primary igf deficiency
714303|NCT00572143|Colonic Neoplasms/surgery*|colonic neoplasms/surgery*
714304|NCT00572143|Continuity of Patient Care*|continuity of patient care*
714305|NCT00572143|Follow-Up Studies|follow-up studies
714306|NCT00572143|Quality of Life|quality of life
714307|NCT00572143|Patient Satisfaction|patient satisfaction
714308|NCT00572130|Tumor-targeted gene medicine|tumor-targeted gene medicine
714309|NCT00572130|Cyclin G1 gene|cyclin g1 gene
714310|NCT00572130|Osteosarcoma|osteosarcoma
714311|NCT00572117|Bipolar Disorder|bipolar disorder
714312|NCT00572117|Manic Disorder|manic disorder
714313|NCT00572117|Alcoholism|alcoholism
714314|NCT00572117|Alcohol Abuse|alcohol abuse
714315|NCT00572117|Alcohol Dependence|alcohol dependence
714316|NCT00572117|Clinical Trial|clinical trial
714317|NCT00572117|Evaluation Trial|evaluation trial
714318|NCT00572117|Intervention Trial|intervention trial
714319|NCT00572117|Validation Studies|validation studies
714320|NCT00572091|Heart Failure|heart failure
714321|NCT00572091|Mitral Regurgitation|mitral regurgitation
714322|NCT00572078|solid tumor|solid tumor
714323|NCT00572039|Age-Related Macular Degeneration|age-related macular degeneration
714324|NCT00572039|AMD|amd
714325|NCT00572039|Vision Function|vision function
714326|NCT00572039|Problem Solving Treatment|problem solving treatment
714327|NCT00572039|PST|pst
714328|NCT00572026|Attention deficit|attention deficit
714329|NCT00572026|Hyperactivity|hyperactivity
714330|NCT00572026|Attention deficit hyperactivity disorder|attention deficit hyperactivity disorder
714331|NCT00571987|Breast cancer|breast cancer
714332|NCT00571987|Lumpectomy|lumpectomy
714333|NCT00571987|Radiofrequency Ablation|radiofrequency ablation
714334|NCT00571987|Negative margins|negative margins
714335|NCT00571987|Breast Conserving Surgery|breast conserving surgery
714336|NCT00571961|HIV|hiv
714337|NCT00571961|Pharmacokinetics|pharmacokinetics
714338|NCT00571961|Buprenorphine|buprenorphine
714339|NCT00571961|Kaletra|kaletra
714340|NCT00571961|HIV Seronegativity|hiv seronegativity
714341|NCT00571948|infant, complementary food, iron, meat, LC-PUFA, omega-3,|infant, complementary food, iron, meat, lc-pufa, omega-3,
714342|NCT00571948|rapeseed oil, diet|rapeseed oil, diet
714343|NCT00571922|methamphetamine, crystal, treatment|methamphetamine, crystal, treatment
714344|NCT00571909|Polycystic Kidney Disease|polycystic kidney disease
714345|NCT00571909|Chronic Kidney Pain|chronic kidney pain
714346|NCT00571909|Autosomal Dominant Polycystic Kidney|autosomal dominant polycystic kidney
714347|NCT00571909|Kidney Cyst|kidney cyst
714348|NCT00571909|VSPL|vspl
714349|NCT00571909|video thoracoscopic splanchnicectomy|video thoracoscopic splanchnicectomy
714350|NCT00571896|constipation|constipation
714351|NCT00571896|SennaS|sennas
714352|NCT00571883|stage I squamous cell carcinoma of the lip and oral cavity|stage i squamous cell carcinoma of the lip and oral cavity
714353|NCT00571883|stage II squamous cell carcinoma of the lip and oral cavity|stage ii squamous cell carcinoma of the lip and oral cavity
714354|NCT00571883|tongue cancer|tongue cancer
714355|NCT00571844|High Blood Pressure|high blood pressure
714356|NCT00571844|Exercise|exercise
714357|NCT00571844|Diet|diet
714358|NCT00571844|Biomarkers|biomarkers
714359|NCT00571831|macula edema|macula edema
714360|NCT00571831|intraocular lens|intraocular lens
714361|NCT00571831|prospective randomized parallel clinical design|prospective randomized parallel clinical design
714362|NCT00571818|euglycemic|euglycemic
714363|NCT00571818|transplant|transplant
714364|NCT00571818|pancreas|pancreas
714365|NCT00571818|hyperglycemic|hyperglycemic
714366|NCT00571818|kidney|kidney
714367|NCT00571805|cigarette|cigarette
714368|NCT00571805|craving|craving
714369|NCT00571805|reward|reward
714370|NCT00571792|COPD|copd
714371|NCT00571792|The cohort will be comprised of normal non-smoking individuals, those individuals|the cohort will be comprised of normal non-smoking individuals, those individuals
714372|NCT00571792|who smoke who do not exhibit symptoms of COPD and individuals who smoke who do demonstrate|who smoke who do not exhibit symptoms of copd and individuals who smoke who do demonstrate
714373|NCT00571792|symptoms of COPD|symptoms of copd
714374|NCT00571766|chronic hypertension in pregnancy|chronic hypertension in pregnancy
714375|NCT00571766|chronic Hypertension|chronic hypertension
714376|NCT00571753|pulmonary tuberculosis|pulmonary tuberculosis
714377|NCT00571753|NAT2 genotyping|nat2 genotyping
714378|NCT00571753|hepatotoxicity of isoniazid|hepatotoxicity of isoniazid
714379|NCT00571740|stage IV colon cancer|stage iv colon cancer
714380|NCT00571740|stage IV rectal cancer|stage iv rectal cancer
714381|NCT00571740|recurrent colon cancer|recurrent colon cancer
714382|NCT00571740|recurrent rectal cancer|recurrent rectal cancer
714383|NCT00571727|growth|growth
714384|NCT00571727|insulin like growth factor|insulin like growth factor
714385|NCT00571727|Larons syndrome|larons syndrome
714386|NCT00571714|Chronic hepatitis C|chronic hepatitis c
714387|NCT00571714|Pilot Comparison|pilot comparison
714388|NCT00571714|Peginterferon alph-2a|peginterferon alph-2a
714389|NCT00571714|Ribavirin|ribavirin
714390|NCT00571714|Betaine|betaine
714391|NCT00571714|Genotype 1|genotype 1
714392|NCT00571714|Treatment naive|treatment naive
714393|NCT00571701|HPV|hpv
714394|NCT00571701|RRP|rrp
714395|NCT00571688|Bipolar Disorder|bipolar disorder
714396|NCT00571688|Depression, Bipolar|depression, bipolar
714397|NCT00571688|Mania|mania
714398|NCT00571675|Prostate Cancer|prostate cancer
714399|NCT00571675|Hormone Refractory Prostate Cancer|hormone refractory prostate cancer
714400|NCT00571675|HRPC|hrpc
714401|NCT00571675|Docetaxel|docetaxel
714402|NCT00571675|Taxotere|taxotere
714403|NCT00571675|Prednisone|prednisone
714404|NCT00571675|Metastatic (Stage IV) Disease|metastatic (stage iv) disease
714405|NCT00571675|Chemotherapy-naïve metastatic Hormone Refractory Prostate Cancer (HRPC)|chemotherapy-naïve metastatic hormone refractory prostate cancer (hrpc)
714406|NCT00571649|Acute medical illnesses with increased risk for VTE.|acute medical illnesses with increased risk for vte.
714407|NCT00571649|Deep vein thrombosis (DVT)|deep vein thrombosis (dvt)
714408|NCT00571649|Pulmonary embolism (PE),|pulmonary embolism (pe),
714409|NCT00571649|Venous Thromboembolic disease (VTE),|venous thromboembolic disease (vte),
714410|NCT00571649|Medical illness|medical illness
714411|NCT00571636|Opioids infusion|opioids infusion
714412|NCT00571636|mechanical ventilation|mechanical ventilation
714413|NCT00571623|Brain Injury|brain injury
714414|NCT00571623|Intracranial hypertension|intracranial hypertension
714415|NCT00571623|Human subjects|human subjects
714416|NCT00571623|Nursing care|nursing care
714417|NCT00571610|Heart Failure|heart failure
714418|NCT00571610|Mitral Regurgitation|mitral regurgitation
714419|NCT00571597|surgery|surgery
714420|NCT00571597|ablation|ablation
714421|NCT00571597|radiofrequency|radiofrequency
714422|NCT00571597|minimaze|minimaze
714423|NCT00571597|transtelephonic monitoring|transtelephonic monitoring
714424|NCT00571571|Identity difussion|identity difussion
714425|NCT00571571|Adolescent psychotherapy|adolescent psychotherapy
714426|NCT00571571|Transference Focused Psychotherapy for Adolescents|transference focused psychotherapy for adolescents
714427|NCT00571571|Identity|identity
714428|NCT00571571|Identity crisis|identity crisis
714429|NCT00571571|Identity pathology|identity pathology
714430|NCT00571545|Traumatic brain injury|traumatic brain injury
714431|NCT00571545|Depression|depression
714432|NCT00571545|Exercise|exercise
714433|NCT00571506|Diabetes Mellitus, Type 2|diabetes mellitus, type 2
714434|NCT00571506|Vascular Diseases|vascular diseases
714435|NCT00571506|Thiazolidinediones|thiazolidinediones
714436|NCT00571506|Platelet Aggregation|platelet aggregation
714437|NCT00571493|non-hodgkin's lymphoma|non-hodgkin's lymphoma
714438|NCT00571493|mantle cell lymphoma|mantle cell lymphoma
714439|NCT00571493|BEAM|beam
714440|NCT00571493|Velcade|velcade
714441|NCT00571480|auricular acupuncture|auricular acupuncture
714442|NCT00571480|pregnancy related low back pain|pregnancy related low back pain
714443|NCT00571480|acupuncture|acupuncture
714444|NCT00571467|Autoimmune Diseases|autoimmune diseases
714445|NCT00571467|Bleeding Disorders|bleeding disorders
714446|NCT00571467|Blood and Blood Disorders|blood and blood disorders
714447|NCT00571454|depression|depression
714448|NCT00571454|primary care|primary care
714449|NCT00571454|Latino|latino
714450|NCT00571454|telephone|telephone
714451|NCT00571454|care management|care management
714452|NCT00571441|stroke|stroke
714453|NCT00571441|Brain injury|brain injury
714454|NCT00571441|nursing|nursing
714455|NCT00571441|Critical care|critical care
714456|NCT00571428|COPD|copd
714457|NCT00571428|Chronic Bronchitis|chronic bronchitis
714458|NCT00571428|Emphysema|emphysema
714459|NCT00571415|Image guided adaptive radiotherapy|image guided adaptive radiotherapy
714460|NCT00571402|Family Treatment|family treatment
714461|NCT00571402|Pharmacotherapy|pharmacotherapy
714462|NCT00571389|Stage IV|stage iv
714463|NCT00571389|Advanced Stage III|advanced stage iii
714464|NCT00571376|Quality of health care|quality of health care
714465|NCT00571376|Health care costs|health care costs
714466|NCT00571350|Cystocele|cystocele
714467|NCT00571350|tension free vaginal tapes|tension free vaginal tapes
714468|NCT00571350|urinary incontinence|urinary incontinence
714469|NCT00571337|Stop infliximab.|stop infliximab.
714470|NCT00571324|hyperinsulinism|hyperinsulinism
714471|NCT00571324|hypoglycemia|hypoglycemia
714472|NCT00571324|KATP channel|katp channel
714473|NCT00571324|Kir6.2|kir6.2
714474|NCT00571311|Assent|assent
714475|NCT00571311|Adolescent|adolescent
714476|NCT00571311|Informed Consent|informed consent
714477|NCT00571298|Extrapleural pneumonectomy|extrapleural pneumonectomy
714478|NCT00571298|Pleurectomy Decortication|pleurectomy decortication
714479|NCT00571298|Mesothelioma|mesothelioma
714480|NCT00571298|cisplatin|cisplatin
714481|NCT00571298|gemcitabine|gemcitabine
714482|NCT00571298|amifostine|amifostine
714483|NCT00571298|sodium thiosulfate|sodium thiosulfate
714484|NCT00571285|Parkinson's disease|parkinson's disease
714485|NCT00571285|Nutrition|nutrition
714486|NCT00571285|Vitamin supplement|vitamin supplement
714487|NCT00571285|Motor function|motor function
714488|NCT00571285|Non-motor function|non-motor function
714489|NCT00571272|Cholestatic Liver Disease|cholestatic liver disease
714490|NCT00571272|Cholestasis|cholestasis
714491|NCT00571272|Childhood Diseases|childhood diseases
714492|NCT00571272|Genetic Diseases|genetic diseases
714493|NCT00571272|Bile Acid Synthesis and Metabolism Defects|bile acid synthesis and metabolism defects
714494|NCT00571272|Progressive Familial Intrahepatic Cholestasis|progressive familial intrahepatic cholestasis
714495|NCT00571259|Sodium citrate|sodium citrate
714496|NCT00571259|Gentamicin|gentamicin
714497|NCT00571259|Prophylaxis|prophylaxis
714498|NCT00571259|Hemodialysis|hemodialysis
714499|NCT00571259|Central venous catheter|central venous catheter
714500|NCT00571246|treatment|treatment
714501|NCT00571246|Lamotrigine|lamotrigine
714502|NCT00571246|Topiramate|topiramate
714503|NCT00571246|alcohol dependence|alcohol dependence
714504|NCT00571246|post traumatic stress disorder|post traumatic stress disorder
714505|NCT00571233|Single Ventricle|single ventricle
714506|NCT00571233|Congenital Heart Disease|congenital heart disease
714507|NCT00571233|Children|children
714508|NCT00571233|Fontan|fontan
714509|NCT00571233|Tricuspid Atresia|tricuspid atresia
714510|NCT00571233|Hypoplastic Left Heart Syndrome|hypoplastic left heart syndrome
714511|NCT00571233|Heart Failure|heart failure
714512|NCT00571233|Biomarkers|biomarkers
714513|NCT00571233|Single ventricle physiology such as:|single ventricle physiology such as:
714514|NCT00571233|unbalanced AV canal|unbalanced av canal
714515|NCT00571233|Interested in patients both before and after Fontan Surgery|interested in patients both before and after fontan surgery
714516|NCT00571220|gastric bypass|gastric bypass
714517|NCT00571220|diabetes|diabetes
714518|NCT00571220|obesity|obesity
714519|NCT00571220|diet-induced weight loss|diet-induced weight loss
714520|NCT00571220|incretin levels (GLP-1,GIP)|incretin levels (glp-1,gip)
714521|NCT00571220|incretin effect|incretin effect
714522|NCT00571207|driving under the influence of drugs|driving under the influence of drugs
714523|NCT00571207|on-site oral fluid screening devices|on-site oral fluid screening devices
714524|NCT00571207|checklist|checklist
714525|NCT00571194|pravastatin, peritoneal dialysis, pediatric patients|pravastatin, peritoneal dialysis, pediatric patients
714527|NCT00571181|Anesthesia, General/*methods|anesthesia, general/*methods
714528|NCT00571181|Anesthetics, Intravenous/*administration & dosage|anesthetics, intravenous/*administration & dosage
714529|NCT00571181|Drug Delivery Systems/*methods/statistics & numerical data|drug delivery systems/*methods/statistics & numerical data
714530|NCT00571181|Electroencephalography/drug effects/*methods/|electroencephalography/drug effects/*methods/
714531|NCT00571181|Feasibility Studies|feasibility studies
714532|NCT00571181|Propofol/*administration & dosage|propofol/*administration & dosage
714533|NCT00571181|Remifentanil/*administration & dosage|remifentanil/*administration & dosage
714534|NCT00571181|Bronchoscopy/*methods|bronchoscopy/*methods
714535|NCT00571181|Prospective Studies|prospective studies
714536|NCT00571181|Software|software
714537|NCT00571168|chemotherapy induced nausea and vomiting|chemotherapy induced nausea and vomiting
714538|NCT00571168|autologous peripheral blood stemcell transplantation|autologous peripheral blood stemcell transplantation
714539|NCT00571168|high dose chemotherapy|high dose chemotherapy
714540|NCT00571142|edema|edema
714541|NCT00571142|retinal thickness|retinal thickness
714542|NCT00571142|diabetic retinopathy|diabetic retinopathy
714543|NCT00571129|Primary,silicone tube,revision,mitomycin C,endoscopic DCR|primary,silicone tube,revision,mitomycin c,endoscopic dcr
714544|NCT00571116|Metastatic Melanoma|metastatic melanoma
714545|NCT00571116|Disulfiram|disulfiram
714546|NCT00571116|Arsenic Trioxide|arsenic trioxide
714547|NCT00571116|Metastatic Melanoma and at Least One Prior Systemic Therapy|metastatic melanoma and at least one prior systemic therapy
714548|NCT00571103|acamprosate, impulse-control disorders|acamprosate, impulse-control disorders
714549|NCT00571090|Thyroid nodule|thyroid nodule
714550|NCT00571090|Biopsy, Fine-Needle|biopsy, fine-needle
714551|NCT00571077|Thyroid neoplasms|thyroid neoplasms
714552|NCT00571077|thyroid nodules|thyroid nodules
714553|NCT00571077|electrical impedance scanning|electrical impedance scanning
714554|NCT00571051|MEG, mindfulness, tactile perception|meg, mindfulness, tactile perception
714555|NCT00571038|Hypertension|hypertension
714556|NCT00571038|Self-help groups|self-help groups
714557|NCT00571038|Community health networks|community health networks
714558|NCT00571038|Health knowledge, attitudes, practice|health knowledge, attitudes, practice
714559|NCT00571038|Patient participation|patient participation
714560|NCT00571038|Randomized clinical trial|randomized clinical trial
714561|NCT00571025|Mild Cognitive Impairment|mild cognitive impairment
714562|NCT00571025|disease/disorder proneness/risk|disease/disorder proneness/risk
714563|NCT00571025|family genetics|family genetics
714564|NCT00571025|genetic counseling|genetic counseling
714565|NCT00571025|genetic marker|genetic marker
714566|NCT00571025|genetic polymorphism|genetic polymorphism
714567|NCT00571025|genetic susceptibility|genetic susceptibility
714568|NCT00571012|glaucoma|glaucoma
714569|NCT00571012|outflow facility|outflow facility
714570|NCT00571012|Healthy eye function|healthy eye function
714571|NCT00570999|Peripheral blood stem cell transplantation|peripheral blood stem cell transplantation
714572|NCT00570999|Palifermin|palifermin
714573|NCT00570999|Kepivance|kepivance
714574|NCT00570999|Prevenar|prevenar
714575|NCT00570999|Placebo|placebo
714576|NCT00570986|Plaque Psoriasis|plaque psoriasis
714577|NCT00570973|Variceal Bleeding|variceal bleeding
714578|NCT00570973|Cirrhosis|cirrhosis
714579|NCT00570973|Encephalopathy|encephalopathy
714580|NCT00570973|Endoscopic band ligation|endoscopic band ligation
714581|NCT00570973|TIPS|tips
714582|NCT00570960|Peritonitis|peritonitis
714583|NCT00570947|CPR Anytime|cpr anytime
714584|NCT00570921|Breast cancer|breast cancer
714585|NCT00570921|Fulvestrant|fulvestrant
714586|NCT00570921|Everolimus|everolimus
714587|NCT00570908|brain metastasis|brain metastasis
714588|NCT00570908|breast cancer|breast cancer
714589|NCT00570908|metastatic breast cancer|metastatic breast cancer
714590|NCT00570895|Iron|iron
714591|NCT00570895|Absorption|absorption
714592|NCT00570895|Ascorbic Acid|ascorbic acid
714593|NCT00570895|Ferrous Fumarate|ferrous fumarate
714594|NCT00570882|Renal cell carcinoma|renal cell carcinoma
714595|NCT00570882|Sunitinib|sunitinib
714596|NCT00570882|phase II study|phase ii study
714597|NCT00570882|Randomized study|randomized study
714598|NCT00570869|Infant CPR|infant cpr
714599|NCT00570856|Folic Acid|folic acid
714600|NCT00570856|Homocysteine|homocysteine
714601|NCT00570856|intima-media thickness|intima-media thickness
714602|NCT00570817|Methotrexate|methotrexate
714603|NCT00570817|Nephrotoxicity|nephrotoxicity
714604|NCT00570817|Hydration|hydration
714605|NCT00570817|Acute lymphoblastic leukemia|acute lymphoblastic leukemia
714606|NCT00570817|Non-Hodgkin's lymphoma|non-hodgkin's lymphoma
714607|NCT00570817|Medulloblastoma|medulloblastoma
714608|NCT00570817|Ependymoma|ependymoma
714609|NCT00570817|Prolonged elimination time of methotrexate|prolonged elimination time of methotrexate
714610|NCT00570804|Smoking Cessation|smoking cessation
714611|NCT00570804|Puerto Rico Quitline|puerto rico quitline
714612|NCT00570804|Motivational Relapse Prevention|motivational relapse prevention
714613|NCT00570804|Oral Cancer|oral cancer
714614|NCT00570804|Risk Reduction|risk reduction
714615|NCT00570804|Tobacco Use|tobacco use
714616|NCT00570804|Alcohol Use|alcohol use
714617|NCT00570804|MAPS|maps
714618|NCT00570804|Motivation and Problem-Solving|motivation and problem-solving
714619|NCT00570804|Telephone Interview|telephone interview
714620|NCT00570804|Counseling|counseling
714621|NCT00570791|Cornea|cornea
714622|NCT00570791|Tonometers|tonometers
714623|NCT00570791|Goldmann applanation|goldmann applanation
714624|NCT00570791|Tonopen|tonopen
714625|NCT00570791|Shiotz|shiotz
714626|NCT00570791|Pneumatonometer|pneumatonometer
714627|NCT00570778|QVA, Indacaterol, Glycopyrrolate, Concept1, COPD, cross over study, safety and efficacy, trough FEV1|qva, indacaterol, glycopyrrolate, concept1, copd, cross over study, safety and efficacy, trough fev1
714628|NCT00570739|Colesevelam|colesevelam
714629|NCT00570739|Type 2 Diabetes Mellitus|type 2 diabetes mellitus
714630|NCT00570739|Pre-diabetes|pre-diabetes
714631|NCT00570739|Metformin|metformin
714632|NCT00570700|prostate|prostate
714633|NCT00570687|Inhaled Insulin|inhaled insulin
714634|NCT00570674|SSCHN|sschn
714635|NCT00570674|Abraxane|abraxane
714636|NCT00570674|IMRT|imrt
714637|NCT00570648|Corneal transplantation|corneal transplantation
714638|NCT00570635|GIST|gist
714639|NCT00570635|Gastrointestinal Cancer|gastrointestinal cancer
714640|NCT00570622|Cirrhosis|cirrhosis
714641|NCT00570622|oxidative stress|oxidative stress
714642|NCT00570622|pioglitazone|pioglitazone
714643|NCT00570609|CPR|cpr
714644|NCT00570583|Depression|depression
714645|NCT00570583|Cognitive impairment|cognitive impairment
714646|NCT00570583|Dementia|dementia
714647|NCT00570583|Neuroimaging|neuroimaging
714648|NCT00570583|Genetics|genetics
714649|NCT00570570|stroke|stroke
714650|NCT00570570|hemiplegia|hemiplegia
714651|NCT00570570|gait|gait
714652|NCT00570570|Strengthening|strengthening
714653|NCT00570570|Physiotherapy|physiotherapy
714654|NCT00570557|Skill Maintenance|skill maintenance
714655|NCT00570557|Skill Decay|skill decay
714656|NCT00570557|Screening|screening
714657|NCT00570544|copd|copd
714658|NCT00570544|emphysema|emphysema
714659|NCT00570544|tiotropium|tiotropium
714660|NCT00570544|lung function|lung function
714661|NCT00570544|dynamic hyperinflation|dynamic hyperinflation
714662|NCT00570518|driving under the influence|driving under the influence
714663|NCT00570518|psychoactive substances|psychoactive substances
714664|NCT00570518|roadside surveys|roadside surveys
714665|NCT00570518|hospital surveys|hospital surveys
714666|NCT00570518|accident involvement risk estimation|accident involvement risk estimation
714667|NCT00570492|allergic rhinitis|allergic rhinitis
714668|NCT00570492|fluticasone furoate nasal spray|fluticasone furoate nasal spray
714669|NCT00570492|growth|growth
714670|NCT00570479|Retisert|retisert
714671|NCT00570479|Uveitis|uveitis
714672|NCT00570479|glaucoma|glaucoma
714673|NCT00570466|Type 2 Diabetes|type 2 diabetes
714674|NCT00570466|Prevention|prevention
714675|NCT00570466|Children|children
714676|NCT00570466|Diet|diet
714677|NCT00570466|Physical Activity|physical activity
714678|NCT00570440|AE adverse event|ae adverse event
714679|NCT00570440|AIDS acquired immunodeficiency syndrome|aids acquired immunodeficiency syndrome
714680|NCT00570440|ALT (SGPT) alanine aminotransferase|alt (sgpt) alanine aminotransferase
714681|NCT00570440|ART antiretroviral therapy|art antiretroviral therapy
714682|NCT00570440|AST (SGOT) aspartate aminotransferase|ast (sgot) aspartate aminotransferase
714683|NCT00570440|DCF data collection forms|dcf data collection forms
714684|NCT00570440|DMC Data Monitoring Committee|dmc data monitoring committee
714685|NCT00570440|FDA (U.S.) Food and Drug Administration|fda (u.s.) food and drug administration
714686|NCT00570440|GCP Good Clinical Practice guidelines|gcp good clinical practice guidelines
714687|NCT00570440|HB sAg Hepatitis B surface antigen|hb sag hepatitis b surface antigen
714688|NCT00570440|ICH International Conference of Harmonisation|ich international conference of harmonisation
714689|NCT00570440|IND Investigational New Drug Application|ind investigational new drug application
714690|NCT00570440|IRB Institutional Review Board|irb institutional review board
714691|NCT00570440|IU international units|iu international units
714692|NCT00570440|mg milligram(s)|mg milligram(s)
714693|NCT00570440|mm3 cubic millimeter(s)|mm3 cubic millimeter(s)
714694|NCT00570440|PCR polymerase chain reaction|pcr polymerase chain reaction
714695|NCT00570440|SAE serious adverse event|sae serious adverse event
714696|NCT00570440|µg microgram|µg microgram
714697|NCT00570440|ULN upper limit of the normal range|uln upper limit of the normal range
714698|NCT00570440|WB Western Blot|wb western blot
714699|NCT00570427|psychotherapy|psychotherapy
714700|NCT00570427|behavior therapy|behavior therapy
714701|NCT00570427|counseling|counseling
714702|NCT00570427|aging|aging
714703|NCT00570427|medically underserved population|medically underserved population
714704|NCT00570401|adenocarcinoma of the lung|adenocarcinoma of the lung
714705|NCT00570401|stage IIIA non-small cell lung cancer|stage iiia non-small cell lung cancer
714706|NCT00570401|stage IIIB non-small cell lung cancer|stage iiib non-small cell lung cancer
714707|NCT00570401|stage IV non-small cell lung cancer|stage iv non-small cell lung cancer
714708|NCT00570401|recurrent non-small cell lung cancer|recurrent non-small cell lung cancer
714709|NCT00570388|Neurocognitive|neurocognitive
714710|NCT00570388|Alcohol Dependence|alcohol dependence
714711|NCT00570388|Prometa|prometa
714712|NCT00570388|Prometa Protocol|prometa protocol
714713|NCT00570388|Starosta|starosta
714714|NCT00570375|Blood disease, bone marrow|blood disease, bone marrow
714715|NCT00570362|Normal tension glaucoma|normal tension glaucoma
714716|NCT00570362|Glutathione|glutathione
714717|NCT00570362|Antioxidant|antioxidant
714718|NCT00570349|Inhaled Nitric oxide|inhaled nitric oxide
714719|NCT00570349|Cystic Fibrosis|cystic fibrosis
714720|NCT00570336|HCV|hcv
714721|NCT00570336|HCV treatment failure|hcv treatment failure
714722|NCT00570336|Elevated aminotransferases|elevated aminotransferases
714723|NCT00570323|Breast Cancer|breast cancer
714724|NCT00570323|HORMONE RECEPTOR POSITIVE BREAST CANCER|hormone receptor positive breast cancer
714725|NCT00570297|Pediatric|pediatric
714726|NCT00570297|Polymorphism, Genetic|polymorphism, genetic
714727|NCT00570297|Adrenergic beta-Agonists|adrenergic beta-agonists
714728|NCT00570284|Cancer|cancer
714729|NCT00570284|solid tumor|solid tumor
714730|NCT00570284|food effect|food effect
714731|NCT00570284|HDAC inhibitor|hdac inhibitor
714732|NCT00570284|oral|oral
714733|NCT00570284|LBH589|lbh589
714734|NCT00570271|placebo effect|placebo effect
714735|NCT00570271|blood pressure|blood pressure
714736|NCT00570271|autonomic nervous system|autonomic nervous system
714737|NCT00570271|prestige|prestige
714738|NCT00570271|basic research on physiological placebo effects|basic research on physiological placebo effects
714739|NCT00570245|Lung transplantation|lung transplantation
714740|NCT00570232|Resectable, recurrent head and neck cancer|resectable, recurrent head and neck cancer
714741|NCT00570206|Probation|probation
714742|NCT00570206|Motivational|motivational
714743|NCT00570180|newly diagnosed|newly diagnosed
714744|NCT00570167|Osteoarthritis|osteoarthritis
714746|NCT00570167|Artroplasty|artroplasty
714747|NCT00570167|Resurfacing|resurfacing
714748|NCT00570154|Mitochondrial Function in Monocytes|mitochondrial function in monocytes
714749|NCT00570154|Macrophages and Diabetes or Insulin Resistance|macrophages and diabetes or insulin resistance
714750|NCT00570154|Peripheral Blood Mononuclear Cells|peripheral blood mononuclear cells
714751|NCT00570154|Diabetes|diabetes
714752|NCT00570154|Monocyte|monocyte
714753|NCT00570154|Macrophages|macrophages
714754|NCT00570154|Proteome|proteome
714755|NCT00570154|Type 2 Diabetes|type 2 diabetes
714756|NCT00570154|Insulin Resistance|insulin resistance
714757|NCT00570154|Insulin Sensitivity|insulin sensitivity
714758|NCT00570154|Pre-Diabetes|pre-diabetes
714759|NCT00570154|Healthy Volunteer|healthy volunteer
714760|NCT00570154|HV|hv
714761|NCT00570128|Down Syndrome|down syndrome
714762|NCT00570128|trisomy 21|trisomy 21
714763|NCT00570115|Sleep Apnea Syndromes diastolic disfunction left atrium|sleep apnea syndromes diastolic disfunction left atrium
714764|NCT00570102|dietary manipulation|dietary manipulation
714765|NCT00570102|infants|infants
714766|NCT00570102|feasibility|feasibility
714767|NCT00570102|Type 1 Diabetes Mellitus, Beta-cell Autoimmunity|type 1 diabetes mellitus, beta-cell autoimmunity
714768|NCT00570089|Ranolazine|ranolazine
714769|NCT00570089|Myocardial ischemia|myocardial ischemia
714770|NCT00570089|Double blinded|double blinded
714771|NCT00570089|Placebo controlled|placebo controlled
714772|NCT00570063|Schizophrenia|schizophrenia
714773|NCT00570063|acute exacerbation|acute exacerbation
714774|NCT00570063|and PF-02545920|and pf-02545920
714775|NCT00570050|Major Depressive Disorder, Memory, Executive function|major depressive disorder, memory, executive function
714776|NCT00570037|Influenza|influenza
714777|NCT00570037|Vaccine|vaccine
714778|NCT00570037|Children|children
714779|NCT00570024|Acupuncture|acupuncture
714780|NCT00570024|Coronary Artery Disease|coronary artery disease
714781|NCT00569985|AIDS-related diffuse large cell lymphoma|aids-related diffuse large cell lymphoma
714782|NCT00569985|AIDS-related diffuse mixed cell lymphoma|aids-related diffuse mixed cell lymphoma
714783|NCT00569985|AIDS-related diffuse small cleaved cell lymphoma|aids-related diffuse small cleaved cell lymphoma
714784|NCT00569985|AIDS-related immunoblastic large cell lymphoma|aids-related immunoblastic large cell lymphoma
714785|NCT00569985|AIDS-related small noncleaved cell lymphoma|aids-related small noncleaved cell lymphoma
714786|NCT00569985|HIV-associated Hodgkin lymphoma|hiv-associated hodgkin lymphoma
714787|NCT00569985|Treatment Experienced|treatment experienced
714788|NCT00569959|fasting lipid measures|fasting lipid measures
714789|NCT00569959|non-fasting lipid measures|non-fasting lipid measures
714790|NCT00569959|clinical decision-making|clinical decision-making
714791|NCT00569959|LDL-Cholesterol|ldl-cholesterol
714792|NCT00569946|AG-013736|ag-013736
714793|NCT00569946|RCC|rcc
714794|NCT00569946|Phase 2|phase 2
714795|NCT00569933|Hip Surgery|hip surgery
714796|NCT00569933|Perioperative|perioperative
714797|NCT00569933|suggestions/imagery|suggestions/imagery
714798|NCT00569907|type 2 diabetes|type 2 diabetes
714799|NCT00569907|continuous glucose monitoring|continuous glucose monitoring
714800|NCT00569907|exenatide|exenatide
714801|NCT00569907|exenatide use|exenatide use
714802|NCT00569881|Epithelium|epithelium
714803|NCT00569881|Wound Healing|wound healing
714804|NCT00569881|PRK|prk
714805|NCT00569868|PLASMACYTOMA|plasmacytoma
714806|NCT00569829|cognitive behavioral therapy|cognitive behavioral therapy
714807|NCT00569829|anxiety disorders|anxiety disorders
714808|NCT00569829|school-based intervention|school-based intervention
714809|NCT00569829|randomized, controlled trial|randomized, controlled trial
714810|NCT00569816|myocardial protection|myocardial protection
714811|NCT00569816|pharmacological preconditioning|pharmacological preconditioning
714812|NCT00569816|volatile anesthetics|volatile anesthetics
714813|NCT00569816|myocardial injury following CABG surgery|myocardial injury following cabg surgery
714814|NCT00569790|S-1|s-1
714815|NCT00569790|Irinotecan|irinotecan
714816|NCT00569790|Bevacizumab|bevacizumab
714817|NCT00569764|schizophrenia|schizophrenia
714818|NCT00569764|metabolic syndrome|metabolic syndrome
714819|NCT00569764|aripiprazole|aripiprazole
714820|NCT00569751|de novo|de novo
714821|NCT00569751|coronary|coronary
714822|NCT00569751|coronary artery disease|coronary artery disease
714823|NCT00569751|coronary disease|coronary disease
714824|NCT00569738|neuroendocrine tumor|neuroendocrine tumor
714825|NCT00569738|somatostatin analog|somatostatin analog
714826|NCT00569738|Gallium 68|gallium 68
714827|NCT00569738|PET|pet
714828|NCT00569712|non-small cell lung cancer|non-small cell lung cancer
714829|NCT00569712|precancerous condition|precancerous condition
714830|NCT00569699|S-1|s-1
714831|NCT00569699|Bevacizumab|bevacizumab
714832|NCT00569686|PAD|pad
714833|NCT00569686|peripheral artery disease|peripheral artery disease
714834|NCT00569673|recurrent ovarian epithelial cancer|recurrent ovarian epithelial cancer
714835|NCT00569673|fallopian tube cancer|fallopian tube cancer
714836|NCT00569673|primary peritoneal cavity cancer|primary peritoneal cavity cancer
714837|NCT00569660|Myelofibrosis|myelofibrosis
714838|NCT00569660|MF|mf
714839|NCT00569660|Leukemia|leukemia
714840|NCT00569660|Azacitidine|azacitidine
714841|NCT00569660|Vidaza|vidaza
714842|NCT00569647|preoperative anxiety|preoperative anxiety
714843|NCT00569647|burn reconstruction|burn reconstruction
714844|NCT00569634|Venous blood gas|venous blood gas
714845|NCT00569634|Arterial blood gas|arterial blood gas
714846|NCT00569634|pH|ph
714847|NCT00569634|pCO2|pco2
714848|NCT00569634|Bicarbonate|bicarbonate
714849|NCT00569608|Parental stress|parental stress
714850|NCT00569608|Early discharge|early discharge
714851|NCT00569608|Anxiety|anxiety
714852|NCT00569608|Depression|depression
714853|NCT00569608|Neonatal Intensive Care Unit|neonatal intensive care unit
714854|NCT00569595|Prevention of Diabetes and other chronic diseases|prevention of diabetes and other chronic diseases
714855|NCT00569582|Cushing's Disease|cushing's disease
714856|NCT00569582|Cushing's Syndrome|cushing's syndrome
714857|NCT00569582|Cushings|cushings
714858|NCT00569582|Pituitary|pituitary
714859|NCT00569582|ACTH|acth
714860|NCT00569582|Adrenocorticotropic hormone|adrenocorticotropic hormone
714861|NCT00569582|Ectopic|ectopic
714862|NCT00569582|Adrenal adenoma|adrenal adenoma
714863|NCT00569582|Adrenal carcinoma|adrenal carcinoma
714864|NCT00569582|Adrenal autonomy|adrenal autonomy
714865|NCT00569582|Cortisol|cortisol
714866|NCT00569582|Hypercortisolemia|hypercortisolemia
714867|NCT00569582|Cushingoid|cushingoid
714868|NCT00569582|Moon facies|moon facies
714869|NCT00569582|Dorsocervical fat|dorsocervical fat
714870|NCT00569582|Plethora|plethora
714871|NCT00569582|Hirsutism|hirsutism
714872|NCT00569582|Violaceous striae|violaceous striae
714873|NCT00569582|Hormone|hormone
714874|NCT00569582|Contraceptive|contraceptive
714875|NCT00569582|Endocrine|endocrine
714876|NCT00569582|Cushing Syndrome|cushing syndrome
714877|NCT00569582|Ectopic ACTH Secretion|ectopic acth secretion
714878|NCT00569556|Diabetes Mellitus|diabetes mellitus
714879|NCT00569556|Chronic Care Model|chronic care model
714880|NCT00569556|Case Management|case management
714881|NCT00569543|breast cancer in situ|breast cancer in situ
714882|NCT00569543|ductal breast carcinoma in situ|ductal breast carcinoma in situ
714883|NCT00569543|stage I breast cancer|stage i breast cancer
714884|NCT00569543|stage II breast cancer|stage ii breast cancer
714885|NCT00569543|stage IIIA breast cancer|stage iiia breast cancer
714886|NCT00569543|stage IIIB breast cancer|stage iiib breast cancer
714887|NCT00569543|stage IIIC breast cancer|stage iiic breast cancer
714888|NCT00569543|stage IV breast cancer|stage iv breast cancer
714889|NCT00569530|nitric oxide|nitric oxide
714890|NCT00569530|surfactant|surfactant
714891|NCT00569530|bronchopulmonary dysplasia|bronchopulmonary dysplasia
714892|NCT00569530|prematurity|prematurity
714893|NCT00569530|neonates|neonates
714894|NCT00569530|iNO|ino
714895|NCT00569530|Infasurf|infasurf
714896|NCT00569530|lung function|lung function
714897|NCT00569530|ventilated infants|ventilated infants
714898|NCT00569517|obesity|obesity
714899|NCT00569517|CBT|cbt
714900|NCT00569517|Atypical antipsychotics|atypical antipsychotics
714901|NCT00569517|metabolic syndrome|metabolic syndrome
714902|NCT00569504|schizophrenia|schizophrenia
714903|NCT00569504|antipsychotics|antipsychotics
714904|NCT00569504|metabolic syndrome|metabolic syndrome
714905|NCT00569504|prevalence|prevalence
714906|NCT00569478|ICD|icd
714907|NCT00569478|Rehabilitation|rehabilitation
714908|NCT00569465|nitric oxide|nitric oxide
714909|NCT00569465|oxidative stress|oxidative stress
714911|NCT00569465|hypertension|hypertension
714912|NCT00569465|endothelial dysfunction|endothelial dysfunction
714913|NCT00569439|Labor|labor
714914|NCT00569439|Carbohydrate|carbohydrate
714915|NCT00569439|Dystocia|dystocia
714916|NCT00569413|Sex|sex
714917|NCT00569413|brain imaging|brain imaging
714918|NCT00569413|dopamine|dopamine
714919|NCT00569413|sexual disorder|sexual disorder
714920|NCT00569387|pancreatic cancer|pancreatic cancer
714921|NCT00569387|vaccine|vaccine
714922|NCT00569361|allergic rhinitis to dust mite|allergic rhinitis to dust mite
714923|NCT00569361|allergic rhinitis associated with bronchial hyperreactivity|allergic rhinitis associated with bronchial hyperreactivity
714924|NCT00569361|allergic rhinitis associated with asthma|allergic rhinitis associated with asthma
714925|NCT00569335|S-1, Bevacizumab, Irinotecan|s-1, bevacizumab, irinotecan
714926|NCT00569322|ICU|icu
714927|NCT00569322|Admission|admission
714928|NCT00569322|BG|bg
714929|NCT00569309|contiguous stage II mantle cell lymphoma|contiguous stage ii mantle cell lymphoma
714930|NCT00569309|noncontiguous stage II mantle cell lymphoma|noncontiguous stage ii mantle cell lymphoma
714931|NCT00569309|recurrent mantle cell lymphoma|recurrent mantle cell lymphoma
714932|NCT00569309|stage I mantle cell lymphoma|stage i mantle cell lymphoma
714933|NCT00569309|stage III mantle cell lymphoma|stage iii mantle cell lymphoma
714934|NCT00569309|stage IV mantle cell lymphoma|stage iv mantle cell lymphoma
714935|NCT00569309|recurrent adult diffuse large cell lymphoma|recurrent adult diffuse large cell lymphoma
714936|NCT00569309|stage III adult diffuse large cell lymphoma|stage iii adult diffuse large cell lymphoma
714937|NCT00569309|stage IV adult diffuse large cell lymphoma|stage iv adult diffuse large cell lymphoma
714938|NCT00569309|contiguous stage II grade 1 follicular lymphoma|contiguous stage ii grade 1 follicular lymphoma
714939|NCT00569309|contiguous stage II grade 2 follicular lymphoma|contiguous stage ii grade 2 follicular lymphoma
714940|NCT00569309|contiguous stage II grade 3 follicular lymphoma|contiguous stage ii grade 3 follicular lymphoma
714941|NCT00569309|noncontiguous stage II grade 1 follicular lymphoma|noncontiguous stage ii grade 1 follicular lymphoma
714942|NCT00569309|noncontiguous stage II grade 2 follicular lymphoma|noncontiguous stage ii grade 2 follicular lymphoma
714943|NCT00569309|noncontiguous stage II grade 3 follicular lymphoma|noncontiguous stage ii grade 3 follicular lymphoma
714944|NCT00569309|recurrent grade 1 follicular lymphoma|recurrent grade 1 follicular lymphoma
714945|NCT00569309|recurrent grade 2 follicular lymphoma|recurrent grade 2 follicular lymphoma
714946|NCT00569309|recurrent grade 3 follicular lymphoma|recurrent grade 3 follicular lymphoma
714947|NCT00569309|stage I grade 1 follicular lymphoma|stage i grade 1 follicular lymphoma
714948|NCT00569309|stage I grade 2 follicular lymphoma|stage i grade 2 follicular lymphoma
714949|NCT00569309|stage I grade 3 follicular lymphoma|stage i grade 3 follicular lymphoma
714950|NCT00569309|stage III grade 1 follicular lymphoma|stage iii grade 1 follicular lymphoma
714951|NCT00569309|stage III grade 2 follicular lymphoma|stage iii grade 2 follicular lymphoma
714952|NCT00569309|stage III grade 3 follicular lymphoma|stage iii grade 3 follicular lymphoma
714953|NCT00569309|stage IV grade 1 follicular lymphoma|stage iv grade 1 follicular lymphoma
714954|NCT00569309|stage IV grade 2 follicular lymphoma|stage iv grade 2 follicular lymphoma
714955|NCT00569309|stage IV grade 3 follicular lymphoma|stage iv grade 3 follicular lymphoma
714956|NCT00569309|recurrent adult Hodgkin lymphoma|recurrent adult hodgkin lymphoma
714957|NCT00569309|stage I multiple myeloma|stage i multiple myeloma
714958|NCT00569309|stage II multiple myeloma|stage ii multiple myeloma
714959|NCT00569309|stage III multiple myeloma|stage iii multiple myeloma
714960|NCT00569309|refractory multiple myeloma|refractory multiple myeloma
714961|NCT00569309|contiguous stage II adult diffuse large cell lymphoma|contiguous stage ii adult diffuse large cell lymphoma
714962|NCT00569309|noncontiguous stage II adult diffuse large cell lymphoma|noncontiguous stage ii adult diffuse large cell lymphoma
714963|NCT00569309|stage I adult diffuse large cell lymphoma|stage i adult diffuse large cell lymphoma
714964|NCT00569309|adult nasal type extranodal NK/T-cell lymphoma|adult nasal type extranodal nk/t-cell lymphoma
714965|NCT00569309|angioimmunoblastic T-cell lymphoma|angioimmunoblastic t-cell lymphoma
714966|NCT00569309|anaplastic large cell lymphoma|anaplastic large cell lymphoma
714967|NCT00569309|small intestine lymphoma|small intestine lymphoma
714968|NCT00569296|recurrent non-small cell lung cancer|recurrent non-small cell lung cancer
714969|NCT00569296|stage IV non-small cell lung cancer|stage iv non-small cell lung cancer
714970|NCT00569283|adult acute lymphoblastic leukemia in remission|adult acute lymphoblastic leukemia in remission
714971|NCT00569283|adult acute myeloid leukemia in remission|adult acute myeloid leukemia in remission
714972|NCT00569283|adult acute myeloid leukemia with 11q23 (MLL) abnormalities|adult acute myeloid leukemia with 11q23 (mll) abnormalities
714973|NCT00569283|adult acute myeloid leukemia with inv(16)(p13;q22)|adult acute myeloid leukemia with inv(16)(p13;q22)
714974|NCT00569283|adult acute myeloid leukemia with t(15;17)(q22;q12)|adult acute myeloid leukemia with t(15;17)(q22;q12)
714975|NCT00569283|adult acute myeloid leukemia with t(16;16)(p13;q22)|adult acute myeloid leukemia with t(16;16)(p13;q22)
714976|NCT00569283|adult acute myeloid leukemia with t(8;21)(q22;q22)|adult acute myeloid leukemia with t(8;21)(q22;q22)
714977|NCT00569283|accelerated phase chronic myelogenous leukemia|accelerated phase chronic myelogenous leukemia
714978|NCT00569283|atypical chronic myeloid leukemia, BCR-ABL1 negative|atypical chronic myeloid leukemia, bcr-abl1 negative
714979|NCT00569283|blastic phase chronic myelogenous leukemia|blastic phase chronic myelogenous leukemia
714980|NCT00569283|childhood acute lymphoblastic leukemia in remission|childhood acute lymphoblastic leukemia in remission
714981|NCT00569283|childhood acute myeloid leukemia in remission|childhood acute myeloid leukemia in remission
714982|NCT00569283|chronic eosinophilic leukemia|chronic eosinophilic leukemia
714983|NCT00569283|primary myelofibrosis|primary myelofibrosis
714984|NCT00569283|chronic myelomonocytic leukemia|chronic myelomonocytic leukemia
714985|NCT00569283|chronic neutrophilic leukemia|chronic neutrophilic leukemia
715201|NCT00568529|Response rate|response rate
714986|NCT00569283|chronic phase chronic myelogenous leukemia|chronic phase chronic myelogenous leukemia
714987|NCT00569283|de novo myelodysplastic syndromes|de novo myelodysplastic syndromes
714988|NCT00569283|disseminated neuroblastoma|disseminated neuroblastoma
714989|NCT00569283|extranodal marginal zone B-cell lymphoma of mucosa-associated lymphoid tissue|extranodal marginal zone b-cell lymphoma of mucosa-associated lymphoid tissue
714990|NCT00569283|juvenile myelomonocytic leukemia|juvenile myelomonocytic leukemia
714991|NCT00569283|myelodysplastic/myeloproliferative neoplasm, unclassifiable|myelodysplastic/myeloproliferative neoplasm, unclassifiable
714992|NCT00569283|nodal marginal zone B-cell lymphoma|nodal marginal zone b-cell lymphoma
714993|NCT00569283|noncontiguous stage II adult Burkitt lymphoma|noncontiguous stage ii adult burkitt lymphoma
714994|NCT00569283|noncontiguous stage II adult diffuse large cell lymphoma|noncontiguous stage ii adult diffuse large cell lymphoma
714995|NCT00569283|noncontiguous stage II adult diffuse mixed cell lymphoma|noncontiguous stage ii adult diffuse mixed cell lymphoma
714996|NCT00569283|noncontiguous stage II adult diffuse small cleaved cell lymphoma|noncontiguous stage ii adult diffuse small cleaved cell lymphoma
714997|NCT00569283|noncontiguous stage II adult immunoblastic large cell lymphoma|noncontiguous stage ii adult immunoblastic large cell lymphoma
714998|NCT00569283|noncontiguous stage II adult lymphoblastic lymphoma|noncontiguous stage ii adult lymphoblastic lymphoma
714999|NCT00569283|noncontiguous stage II grade 1 follicular lymphoma|noncontiguous stage ii grade 1 follicular lymphoma
715000|NCT00569283|noncontiguous stage II grade 2 follicular lymphoma|noncontiguous stage ii grade 2 follicular lymphoma
715001|NCT00569283|noncontiguous stage II grade 3 follicular lymphoma|noncontiguous stage ii grade 3 follicular lymphoma
715002|NCT00569283|noncontiguous stage II mantle cell lymphoma|noncontiguous stage ii mantle cell lymphoma
715003|NCT00569283|noncontiguous stage II marginal zone lymphoma|noncontiguous stage ii marginal zone lymphoma
715004|NCT00569283|noncontiguous stage II small lymphocytic lymphoma|noncontiguous stage ii small lymphocytic lymphoma
715005|NCT00569283|high risk metastatic gestational trophoblastic tumor|high risk metastatic gestational trophoblastic tumor
715006|NCT00569283|previously treated childhood rhabdomyosarcoma|previously treated childhood rhabdomyosarcoma
715007|NCT00569283|previously treated myelodysplastic syndromes|previously treated myelodysplastic syndromes
715008|NCT00569283|recurrent adult acute lymphoblastic leukemia|recurrent adult acute lymphoblastic leukemia
715009|NCT00569283|recurrent adult acute myeloid leukemia|recurrent adult acute myeloid leukemia
715010|NCT00569283|recurrent adult Burkitt lymphoma|recurrent adult burkitt lymphoma
715011|NCT00569283|recurrent adult diffuse large cell lymphoma|recurrent adult diffuse large cell lymphoma
715012|NCT00569283|recurrent adult diffuse mixed cell lymphoma|recurrent adult diffuse mixed cell lymphoma
715013|NCT00569283|recurrent adult diffuse small cleaved cell lymphoma|recurrent adult diffuse small cleaved cell lymphoma
715014|NCT00569283|recurrent adult Hodgkin lymphoma|recurrent adult hodgkin lymphoma
715015|NCT00569283|recurrent adult immunoblastic large cell lymphoma|recurrent adult immunoblastic large cell lymphoma
715016|NCT00569283|recurrent adult lymphoblastic lymphoma|recurrent adult lymphoblastic lymphoma
715017|NCT00569283|recurrent/refractory childhood Hodgkin lymphoma|recurrent/refractory childhood hodgkin lymphoma
715018|NCT00569283|recurrent childhood acute lymphoblastic leukemia|recurrent childhood acute lymphoblastic leukemia
715019|NCT00569283|recurrent childhood acute myeloid leukemia|recurrent childhood acute myeloid leukemia
715020|NCT00569283|recurrent childhood large cell lymphoma|recurrent childhood large cell lymphoma
715021|NCT00569283|recurrent childhood lymphoblastic lymphoma|recurrent childhood lymphoblastic lymphoma
715022|NCT00569283|recurrent childhood rhabdomyosarcoma|recurrent childhood rhabdomyosarcoma
715023|NCT00569283|recurrent childhood small noncleaved cell lymphoma|recurrent childhood small noncleaved cell lymphoma
715024|NCT00569283|recurrent cutaneous T-cell non-Hodgkin lymphoma|recurrent cutaneous t-cell non-hodgkin lymphoma
715025|NCT00569283|recurrent mycosis fungoides/Sezary syndrome|recurrent mycosis fungoides/sezary syndrome
715026|NCT00569283|recurrent grade 1 follicular lymphoma|recurrent grade 1 follicular lymphoma
715027|NCT00569283|recurrent grade 2 follicular lymphoma|recurrent grade 2 follicular lymphoma
715028|NCT00569283|recurrent grade 3 follicular lymphoma|recurrent grade 3 follicular lymphoma
715029|NCT00569283|stage III grade 1 follicular lymphoma|stage iii grade 1 follicular lymphoma
715030|NCT00569283|stage III grade 2 follicular lymphoma|stage iii grade 2 follicular lymphoma
715031|NCT00569283|stage III grade 3 follicular lymphoma|stage iii grade 3 follicular lymphoma
715032|NCT00569283|stage IV grade 1 follicular lymphoma|stage iv grade 1 follicular lymphoma
715033|NCT00569283|stage IV grade 2 follicular lymphoma|stage iv grade 2 follicular lymphoma
715034|NCT00569283|stage IV grade 3 follicular lymphoma|stage iv grade 3 follicular lymphoma
715035|NCT00569283|recurrent mantle cell lymphoma|recurrent mantle cell lymphoma
715036|NCT00569283|stage III mantle cell lymphoma|stage iii mantle cell lymphoma
715037|NCT00569283|stage IV mantle cell lymphoma|stage iv mantle cell lymphoma
715038|NCT00569283|recurrent marginal zone lymphoma|recurrent marginal zone lymphoma
715039|NCT00569283|splenic marginal zone lymphoma|splenic marginal zone lymphoma
715040|NCT00569283|stage III marginal zone lymphoma|stage iii marginal zone lymphoma
715041|NCT00569283|stage IV marginal zone lymphoma|stage iv marginal zone lymphoma
715042|NCT00569283|recurrent neuroblastoma|recurrent neuroblastoma
715043|NCT00569283|recurrent ovarian epithelial cancer|recurrent ovarian epithelial cancer
715044|NCT00569283|recurrent ovarian germ cell tumor|recurrent ovarian germ cell tumor
715045|NCT00569283|recurrent small lymphocytic lymphoma|recurrent small lymphocytic lymphoma
715046|NCT00569283|stage III small lymphocytic lymphoma|stage iii small lymphocytic lymphoma
715047|NCT00569283|stage IV small lymphocytic lymphoma|stage iv small lymphocytic lymphoma
715048|NCT00569283|recurrent malignant testicular germ cell tumor|recurrent malignant testicular germ cell tumor
715049|NCT00569283|stage III malignant testicular germ cell tumor|stage iii malignant testicular germ cell tumor
715050|NCT00569283|childhood malignant ovarian germ cell tumor|childhood malignant ovarian germ cell tumor
715051|NCT00569283|childhood malignant testicular germ cell tumor|childhood malignant testicular germ cell tumor
715052|NCT00569283|recurrent Wilms tumor and other childhood kidney tumors|recurrent wilms tumor and other childhood kidney tumors
715053|NCT00569283|refractory chronic lymphocytic leukemia|refractory chronic lymphocytic leukemia
715054|NCT00569283|refractory hairy cell leukemia|refractory hairy cell leukemia
715055|NCT00569283|refractory multiple myeloma|refractory multiple myeloma
715056|NCT00569283|relapsing chronic myelogenous leukemia|relapsing chronic myelogenous leukemia
715057|NCT00569283|secondary acute myeloid leukemia|secondary acute myeloid leukemia
715058|NCT00569283|secondary myelodysplastic syndromes|secondary myelodysplastic syndromes
715059|NCT00569283|stage I multiple myeloma|stage i multiple myeloma
715060|NCT00569283|stage II multiple myeloma|stage ii multiple myeloma
715061|NCT00569283|stage II ovarian epithelial cancer|stage ii ovarian epithelial cancer
715062|NCT00569283|stage III adult Burkitt lymphoma|stage iii adult burkitt lymphoma
715063|NCT00569283|stage III adult diffuse large cell lymphoma|stage iii adult diffuse large cell lymphoma
715064|NCT00569283|stage III adult diffuse mixed cell lymphoma|stage iii adult diffuse mixed cell lymphoma
715065|NCT00569283|stage III adult diffuse small cleaved cell lymphoma|stage iii adult diffuse small cleaved cell lymphoma
715066|NCT00569283|stage III adult immunoblastic large cell lymphoma|stage iii adult immunoblastic large cell lymphoma
715067|NCT00569283|stage III adult lymphoblastic lymphoma|stage iii adult lymphoblastic lymphoma
715068|NCT00569283|stage III chronic lymphocytic leukemia|stage iii chronic lymphocytic leukemia
715069|NCT00569283|stage IV chronic lymphocytic leukemia|stage iv chronic lymphocytic leukemia
715070|NCT00569283|stage III ovarian epithelial cancer|stage iii ovarian epithelial cancer
715071|NCT00569283|stage III multiple myeloma|stage iii multiple myeloma
715072|NCT00569283|stage IIIA breast cancer|stage iiia breast cancer
715073|NCT00569283|stage IIIB breast cancer|stage iiib breast cancer
715074|NCT00569283|stage IIIC breast cancer|stage iiic breast cancer
715075|NCT00569283|stage IV breast cancer|stage iv breast cancer
715076|NCT00569283|stage III adult Hodgkin lymphoma|stage iii adult hodgkin lymphoma
715077|NCT00569283|stage IV adult Burkitt lymphoma|stage iv adult burkitt lymphoma
715078|NCT00569283|stage IV adult diffuse large cell lymphoma|stage iv adult diffuse large cell lymphoma
715079|NCT00569283|stage IV adult diffuse mixed cell lymphoma|stage iv adult diffuse mixed cell lymphoma
715080|NCT00569283|stage IV adult diffuse small cleaved cell lymphoma|stage iv adult diffuse small cleaved cell lymphoma
715081|NCT00569283|stage IV adult Hodgkin lymphoma|stage iv adult hodgkin lymphoma
715082|NCT00569283|stage IV adult immunoblastic large cell lymphoma|stage iv adult immunoblastic large cell lymphoma
715083|NCT00569283|stage IV adult lymphoblastic lymphoma|stage iv adult lymphoblastic lymphoma
715084|NCT00569283|stage IV ovarian epithelial cancer|stage iv ovarian epithelial cancer
715085|NCT00569257|LHRH receptor|lhrh receptor
715086|NCT00569257|receptor positive tumors|receptor positive tumors
715087|NCT00569257|platinum resistant ovarian cancer|platinum resistant ovarian cancer
715088|NCT00569244|Primary Dysmenorrhea|primary dysmenorrhea
715089|NCT00569244|Menstrual Pain|menstrual pain
715090|NCT00569244|Oral Contraception|oral contraception
715091|NCT00569231|Warts|warts
715092|NCT00569231|Candida|candida
715093|NCT00569231|HPV|hpv
715094|NCT00569231|Injections, Intralesional|injections, intralesional
715095|NCT00569231|Immune System|immune system
715096|NCT00569192|asthmatic children|asthmatic children
715097|NCT00569179|Myeloid Malignancies|myeloid malignancies
715098|NCT00569179|Bone Marrow Transplant|bone marrow transplant
715099|NCT00569179|AML|aml
715100|NCT00569179|ALL|all
715101|NCT00569179|MDS|mds
715102|NCT00569179|CML|cml
715103|NCT00569166|fatigue|fatigue
715104|NCT00569166|sleep disorders|sleep disorders
715105|NCT00569166|ductal breast carcinoma in situ|ductal breast carcinoma in situ
715106|NCT00569166|lobular breast carcinoma in situ|lobular breast carcinoma in situ
715107|NCT00569166|breast cancer|breast cancer
715108|NCT00569166|hot flashes|hot flashes
715109|NCT00569153|Androgen-independent prostate cancer, metastatic|androgen-independent prostate cancer, metastatic
715110|NCT00569088|hemorrhagic stroke|hemorrhagic stroke
715111|NCT00569088|Chinese Medicine|chinese medicine
715112|NCT00569088|pathogenesis|pathogenesis
715113|NCT00569088|YURE|yure
715114|NCT00569075|Apoptic biomarkers|apoptic biomarkers
715115|NCT00569075|Early detection periodontitis|early detection periodontitis
715116|NCT00569075|Gingival crevicular fluid|gingival crevicular fluid
715117|NCT00569075|Healthy subjects|healthy subjects
715118|NCT00569062|Psychomotor retardation|psychomotor retardation
715119|NCT00569062|cytokines|cytokines
715120|NCT00569062|GW856553|gw856553
715121|NCT00569062|Major Depressive Disorder (MDD)|major depressive disorder (mdd)
715122|NCT00569036|Advanced or Metastatic Solid Tumors or Neoplasms|advanced or metastatic solid tumors or neoplasms
715123|NCT00569023|Beta Carotene|beta carotene
715124|NCT00569023|visual functions|visual functions
715125|NCT00569023|Fundus albipunctatus|fundus albipunctatus
715126|NCT00569023|Night Blindness|night blindness
715127|NCT00569010|Acute Myelogenous Leukemia|acute myelogenous leukemia
715128|NCT00569010|AML|aml
715129|NCT00569010|Myelodysplastic Syndrome|myelodysplastic syndrome
715130|NCT00569010|MDS|mds
715131|NCT00569010|Leukemia|leukemia
715132|NCT00568997|Atopic dermatitis eczema pediatric pimecrolimus malignancy|atopic dermatitis eczema pediatric pimecrolimus malignancy
715133|NCT00568971|DCF|dcf
715134|NCT00568971|Advanced gastric cancer|advanced gastric cancer
715135|NCT00568971|Phase II study|phase ii study
715136|NCT00568971|Efficacy|efficacy
715137|NCT00568971|Toxicity|toxicity
715138|NCT00568958|heavy episodic drinking|heavy episodic drinking
715139|NCT00568958|young adults|young adults
715140|NCT00568958|naltrexone|naltrexone
715141|NCT00568958|BASICS counseling|basics counseling
715142|NCT00568958|alcohol-related consequences|alcohol-related consequences
715143|NCT00568958|double-blind trial|double-blind trial
715144|NCT00568958|randomized clinical trial|randomized clinical trial
715145|NCT00568945|Atrial Fibrillation|atrial fibrillation
715146|NCT00568945|Capadenoson|capadenoson
715147|NCT00568880|stage I multiple myeloma|stage i multiple myeloma
715148|NCT00568880|stage II multiple myeloma|stage ii multiple myeloma
715149|NCT00568880|stage III multiple myeloma|stage iii multiple myeloma
715150|NCT00568880|refractory multiple myeloma|refractory multiple myeloma
715151|NCT00568841|advanced Non-Small-Cell Lung Cancer|advanced non-small-cell lung cancer
715152|NCT00568841|erlotinib|erlotinib
715153|NCT00568841|FDG-PET|fdg-pet
715154|NCT00568841|FLT-PET|flt-pet
715155|NCT00568828|Macular Teleangiectasia|macular teleangiectasia
715156|NCT00568828|Macular Pigment|macular pigment
715157|NCT00568815|DLBCL|dlbcl
715158|NCT00568815|Rituximab|rituximab
715159|NCT00568815|ESHAP|eshap
715160|NCT00568815|Efficacy|efficacy
715161|NCT00568815|Toxicity|toxicity
715162|NCT00568789|Insomnia|insomnia
715163|NCT00568789|Aged|aged
715164|NCT00568789|Postural Balance|postural balance
715165|NCT00568789|Drug Therapy|drug therapy
715166|NCT00568763|stage IV melanoma|stage iv melanoma
715167|NCT00568763|recurrent melanoma|recurrent melanoma
715168|NCT00568750|gastrointestinal stromal tumor|gastrointestinal stromal tumor
715169|NCT00568737|Severe Sepsis|severe sepsis
715170|NCT00568724|Hydronephrosis|hydronephrosis
715171|NCT00568724|Ureteral obstruction|ureteral obstruction
715172|NCT00568711|Doxycycline,|doxycycline,
715173|NCT00568711|Rifampin|rifampin
715174|NCT00568711|Scrub typhus.|scrub typhus.
715175|NCT00568672|Major Depression|major depression
715176|NCT00568672|Olanzapine|olanzapine
715177|NCT00568672|add-on therapy|add-on therapy
715178|NCT00568672|antidepressant|antidepressant
715179|NCT00568672|atypical antipsychotic|atypical antipsychotic
715180|NCT00568659|Gas exchange|gas exchange
715181|NCT00568659|Respiratory mechanics|respiratory mechanics
715182|NCT00568659|Ventilator Induced Lung Injury|ventilator induced lung injury
715183|NCT00568607|NK/T cell lymphoma|nk/t cell lymphoma
715184|NCT00568607|Response Rate|response rate
715185|NCT00568607|TTP|ttp
715186|NCT00568607|OS|os
715187|NCT00568607|Toxicities|toxicities
715188|NCT00568594|Apolipoprotein A-I,|apolipoprotein a-i,
715189|NCT00568594|Atherosclerosis,|atherosclerosis,
715190|NCT00568594|HDL,|hdl,
715191|NCT00568594|Inflammation,|inflammation,
715192|NCT00568568|Growth Hormone|growth hormone
715193|NCT00568568|GH signaling|gh signaling
715194|NCT00568568|Insulin resistance|insulin resistance
715195|NCT00568568|Insulin Signaling|insulin signaling
715196|NCT00568542|cardiomyopathy|cardiomyopathy
715197|NCT00568542|ischemia|ischemia
715198|NCT00568542|percutaneous coronary intervention|percutaneous coronary intervention
715199|NCT00568542|remodeling|remodeling
715200|NCT00568529|Advanced gastric cancer|advanced gastric cancer
715202|NCT00568529|Side effects|side effects
715203|NCT00568529|time to progression|time to progression
715204|NCT00568529|overall survival|overall survival
715205|NCT00568516|ASP3550|asp3550
715206|NCT00568516|Degarelix|degarelix
715207|NCT00568516|Prostate cancer|prostate cancer
715208|NCT00568516|Prostatic neoplasms|prostatic neoplasms
715209|NCT00568503|COPD/TIOTROPIUM/QAX028|copd/tiotropium/qax028
715210|NCT00568477|Rituximab, Heemannn|rituximab, heemannn
715211|NCT00568464|ESFT (Ewing's sarcoma family of tumors)|esft (ewing's sarcoma family of tumors)
715212|NCT00568464|Response rate|response rate
715213|NCT00568464|TTP|ttp
715214|NCT00568464|OS|os
715215|NCT00568464|Toxicity|toxicity
715216|NCT00568451|stage IV melanoma|stage iv melanoma
715217|NCT00568451|recurrent melanoma|recurrent melanoma
715218|NCT00568412|atopic dermatitis|atopic dermatitis
715219|NCT00568399|Coronary|coronary
715220|NCT00568399|Calcification|calcification
715221|NCT00568399|Dialysis|dialysis
715222|NCT00568399|Thiosulfate|thiosulfate
715223|NCT00568399|Cardiovascular|cardiovascular
715224|NCT00568386|Dry eye|dry eye
715225|NCT00568373|Gastroparesis|gastroparesis
715226|NCT00568373|Gastric electrical stimulator|gastric electrical stimulator
715227|NCT00568347|chronic airflow obstruction|chronic airflow obstruction
715228|NCT00568334|chickenpox|chickenpox
715229|NCT00568334|varicella|varicella
715230|NCT00568334|two-dose schedule|two-dose schedule
715231|NCT00568334|second year of life|second year of life
715232|NCT00568321|monoclonal antibody|monoclonal antibody
715233|NCT00568308|Hepatocellular Carcinoma|hepatocellular carcinoma
715234|NCT00568308|PI-88|pi-88
715235|NCT00568308|Phase III|phase iii
715236|NCT00568308|Adjuvant Therapy|adjuvant therapy
715237|NCT00568308|Hepatoma|hepatoma
715238|NCT00568308|Liver Cancer|liver cancer
715239|NCT00568269|Recurrence rate after inguinal hernia repair on primary inguinal herina.|recurrence rate after inguinal hernia repair on primary inguinal herina.
715240|NCT00568256|Ulcerative Colitis|ulcerative colitis
715241|NCT00568256|IBD Flare-Up|ibd flare-up
715242|NCT00568256|Stress|stress
715243|NCT00568243|Visuomotor Integration|visuomotor integration
715244|NCT00568243|Visual Attention|visual attention
715245|NCT00568243|Healthy Volunteer|healthy volunteer
715246|NCT00568243|HV|hv
715247|NCT00568230|heart failure|heart failure
715248|NCT00568230|mitral regurgitation|mitral regurgitation
715249|NCT00568204|pruritus, itching, mexyn-a, clearitch, magicool-plus|pruritus, itching, mexyn-a, clearitch, magicool-plus
715250|NCT00568191|Age-related macular degeneration|age-related macular degeneration
715251|NCT00568191|choroidal neovascularization|choroidal neovascularization
715252|NCT00568191|Stratus OCT|stratus oct
715253|NCT00568191|Cirrus OCT|cirrus oct
715254|NCT00568165|Heart failure, congestive|heart failure, congestive
715255|NCT00568165|Echocardiography|echocardiography
715256|NCT00568165|Patient care team|patient care team
715257|NCT00568152|Apples|apples
715258|NCT00568152|Dietary intervention|dietary intervention
715259|NCT00568152|Procyanidins|procyanidins
715260|NCT00568139|adrenal cancer|adrenal cancer
715261|NCT00568139|mitotane (Lysodren)|mitotane (lysodren)
715262|NCT00568139|adverse events|adverse events
715263|NCT00568126|Antidepressant Induced Sexual Dysfunction|antidepressant induced sexual dysfunction
715264|NCT00568126|Depression|depression
715265|NCT00568126|Sexual Dysfunction|sexual dysfunction
715266|NCT00568113|preterm labour|preterm labour
715267|NCT00568113|n acetyl cysteine|n acetyl cysteine
715268|NCT00568113|bacterial vaginosis|bacterial vaginosis
715269|NCT00568100|gas exchange|gas exchange
715270|NCT00568100|pressure support ventilation|pressure support ventilation
715271|NCT00568100|respiratory mechanics|respiratory mechanics
715272|NCT00568100|COPD|copd
715273|NCT00568100|NAVA|nava
715274|NCT00568087|N-acetylcysteine|n-acetylcysteine
715275|NCT00568087|Alcoholism|alcoholism
715276|NCT00568087|Treatment|treatment
715277|NCT00568061|INOT44|inot44
715278|NCT00568061|NOMI|nomi
715279|NCT00568048|stage IV melanoma|stage iv melanoma
715280|NCT00568048|recurrent melanoma|recurrent melanoma
715281|NCT00568035|diabetic|diabetic
715282|NCT00568035|peripheral|peripheral
715283|NCT00568035|neuropathy|neuropathy
715284|NCT00568009|Congestive Heart Failure|congestive heart failure
715285|NCT00568009|Impaired Renal Function|impaired renal function
715286|NCT00567996|Chronic obstructive pulmonary disease, indacaterol, salmeterol, placebo controlled|chronic obstructive pulmonary disease, indacaterol, salmeterol, placebo controlled
715287|NCT00567970|liver metastases|liver metastases
715288|NCT00567957|pre-eclampsia|pre-eclampsia
715289|NCT00567957|remifentanil|remifentanil
715290|NCT00567957|anesthesia, general|anesthesia, general
715291|NCT00567957|analgesics, opioid|analgesics, opioid
715292|NCT00567957|anesthetics, intravenous|anesthetics, intravenous
715293|NCT00567957|Cesarean section|cesarean section
715294|NCT00567957|newborn|newborn
715295|NCT00567957|maternal haemodynamic|maternal haemodynamic
715296|NCT00567944|Physical Therapy Modalities|physical therapy modalities
715297|NCT00567944|Electric Stimulation|electric stimulation
715298|NCT00567944|Postural Balance|postural balance
715299|NCT00567918|Keratoconjunctivitis|keratoconjunctivitis
715300|NCT00567918|Vernal keratoconjunctivitis|vernal keratoconjunctivitis
715301|NCT00567918|FK506|fk506
715302|NCT00567918|Tacrolimus|tacrolimus
715303|NCT00567905|Type 2 Diabetes|type 2 diabetes
715304|NCT00567905|Green tea extract|green tea extract
715305|NCT00567905|overweight|overweight
715306|NCT00567892|tinnitus|tinnitus
715307|NCT00567892|subjective tinnitus|subjective tinnitus
715308|NCT00567892|therapy|therapy
715309|NCT00567892|repetitive transcranial magnetic stimulation|repetitive transcranial magnetic stimulation
715310|NCT00567892|clinical trial|clinical trial
715311|NCT00567879|Breast Cancer|breast cancer
715312|NCT00567879|HER2 positive|her2 positive
715313|NCT00567879|adult-female|adult-female
715314|NCT00567879|LBH589|lbh589
715315|NCT00567879|HDAC inhibitor|hdac inhibitor
715316|NCT00567879|panobinostat|panobinostat
715317|NCT00567853|mitral valve regurgitation|mitral valve regurgitation
715318|NCT00567853|mitral valve disease|mitral valve disease
715319|NCT00567853|mitral valve repair|mitral valve repair
715320|NCT00567853|mitral valve dysfunction|mitral valve dysfunction
715321|NCT00567853|heart valve|heart valve
715322|NCT00567853|valve disease|valve disease
715323|NCT00567853|cardiac surgery|cardiac surgery
715324|NCT00567840|Early Bactericidal Activity|early bactericidal activity
715325|NCT00567840|EBA|eba
715326|NCT00567840|pulmonary tuberculosis|pulmonary tuberculosis
715327|NCT00567840|PA-824|pa-824
715328|NCT00567840|Pretomanid|pretomanid
715329|NCT00567840|CL-007|cl-007
715330|NCT00567827|Pneumonia|pneumonia
715331|NCT00567814|Cocaine|cocaine
715332|NCT00567814|Dependence|dependence
715333|NCT00567814|Addiction|addiction
715334|NCT00567814|Cortisol|cortisol
715335|NCT00567814|GABA|gaba
715336|NCT00567801|Lower Extremity|lower extremity
715337|NCT00567801|Ischemia|ischemia
715338|NCT00567788|Glaucoma, angle-closure|glaucoma, angle-closure
715339|NCT00567762|Keratoconjunctivitis|keratoconjunctivitis
715340|NCT00567762|vernal keratoconjunctivitis|vernal keratoconjunctivitis
715341|NCT00567762|FK506|fk506
715342|NCT00567762|Tacrolimus|tacrolimus
715343|NCT00567749|HIV-1 Infections|hiv-1 infections
715344|NCT00567736|low back pain|low back pain
715345|NCT00567736|complementary therapies|complementary therapies
715346|NCT00567697|ranibizumab|ranibizumab
715347|NCT00567697|CRVO|crvo
715348|NCT00567697|macular edema|macular edema
715349|NCT00567697|sham|sham
715350|NCT00567684|Transitional Cell Carcinoma|transitional cell carcinoma
715351|NCT00567684|Urothelial Cancer|urothelial cancer
715352|NCT00567684|Bladder Cancer|bladder cancer
715641|NCT00566514|dextrose|dextrose
715353|NCT00567684|Computed Tomography Urography|computed tomography urography
715354|NCT00567684|CTU|ctu
715355|NCT00567684|Intravenous Urography|intravenous urography
715356|NCT00567684|IVU|ivu
715357|NCT00567684|TCC|tcc
715358|NCT00567684|transitional cell carcinomas|transitional cell carcinomas
715359|NCT00567671|keratoconus|keratoconus
715360|NCT00567671|ectasia|ectasia
715361|NCT00567671|cross-linking|cross-linking
715362|NCT00567671|riboflavin|riboflavin
715363|NCT00567671|UVA light|uva light
715364|NCT00567671|cornea|cornea
715365|NCT00567632|Pneumococci|pneumococci
715366|NCT00567632|Antibody|antibody
715367|NCT00567632|Standard laboratory values|standard laboratory values
715368|NCT00567619|GERD|gerd
715369|NCT00567619|NIS|nis
715370|NCT00567580|stage IIB prostate cancer|stage iib prostate cancer
715371|NCT00567580|stage IIA prostate cancer|stage iia prostate cancer
715372|NCT00567580|stage III prostate cancer|stage iii prostate cancer
715373|NCT00567580|adenocarcinoma of the prostate|adenocarcinoma of the prostate
715374|NCT00567554|breast cancer|breast cancer
715375|NCT00567554|primary systemic therapy|primary systemic therapy
715376|NCT00567554|pCR Rates|pcr rates
715377|NCT00567554|Bevacizumab|bevacizumab
715378|NCT00567554|Trastuzumab|trastuzumab
715379|NCT00567554|Lapatinib|lapatinib
715380|NCT00567554|Everolimus|everolimus
715381|NCT00567541|shoulder|shoulder
715382|NCT00567541|pain|pain
715383|NCT00567541|stroke|stroke
715384|NCT00567541|subluxation|subluxation
715385|NCT00567528|Soft tissue injuries|soft tissue injuries
715386|NCT00567528|Topical ibuprofen|topical ibuprofen
715387|NCT00567528|Adolescent athletes|adolescent athletes
715388|NCT00567489|ESRD|esrd
715389|NCT00567489|Diabetes|diabetes
715390|NCT00567489|CAPD|capd
715391|NCT00567489|APD|apd
715392|NCT00567476|Asthma, anti-immunoglobulin E, omalizumab|asthma, anti-immunoglobulin e, omalizumab
715393|NCT00567463|Asthma|asthma
715394|NCT00567463|Bronchial hyperresponsiveness|bronchial hyperresponsiveness
715395|NCT00567463|Methacholine|methacholine
715396|NCT00567463|Induced sputum|induced sputum
715397|NCT00567463|bronchial biopsies|bronchial biopsies
715398|NCT00567450|sciatic block|sciatic block
715399|NCT00567450|ropivacaine|ropivacaine
715400|NCT00567450|mepivacaine|mepivacaine
715401|NCT00567450|locoregional anesthesia|locoregional anesthesia
715402|NCT00567437|aortic stenosis|aortic stenosis
715403|NCT00567437|prognosis|prognosis
715404|NCT00567437|brain natriuretic peptide|brain natriuretic peptide
715405|NCT00567424|epilepsy|epilepsy
715406|NCT00567424|refractory|refractory
715407|NCT00567424|seizure|seizure
715408|NCT00567424|drug interactions|drug interactions
715409|NCT00567424|pharmacokinetics|pharmacokinetics
715410|NCT00567411|Glaucoma|glaucoma
715411|NCT00567411|Laser|laser
715412|NCT00567411|laser trabeculoplasty|laser trabeculoplasty
715413|NCT00567411|selective laser trabeculoplasty|selective laser trabeculoplasty
715414|NCT00567411|intraocular pressure|intraocular pressure
715415|NCT00567398|ESRD|esrd
715416|NCT00567398|Diabetes|diabetes
715417|NCT00567398|CAPD|capd
715418|NCT00567398|APD|apd
715419|NCT00567372|Diffuse diabetic macular edema|diffuse diabetic macular edema
715420|NCT00567372|sub-tenon|sub-tenon
715421|NCT00567372|Bevacizumab|bevacizumab
715422|NCT00567359|NSCLC|nsclc
715423|NCT00567359|erlotinib|erlotinib
715424|NCT00567359|epidermal growth factor receptor|epidermal growth factor receptor
715425|NCT00567359|EGFR|egfr
715426|NCT00567346|randomised|randomised
715427|NCT00567346|double-blind|double-blind
715428|NCT00567346|placebo-controlled|placebo-controlled
715429|NCT00567346|efficacy and safety|efficacy and safety
715430|NCT00567346|Oralgen® Grass Pollen|oralgen® grass pollen
715431|NCT00567346|allergic rhinoconjunctivitis|allergic rhinoconjunctivitis
715432|NCT00567346|Allergy|allergy
715433|NCT00567346|Rhinoconjunctivitis|rhinoconjunctivitis
715434|NCT00567346|Immunotherapy|immunotherapy
715435|NCT00567346|Grass pollen extract|grass pollen extract
715436|NCT00567320|varenicline|varenicline
715437|NCT00567294|Osteoporosis|osteoporosis
715438|NCT00567294|Medication adherence|medication adherence
715439|NCT00567294|Telephonic education|telephonic education
715440|NCT00567294|Motivational interviewing|motivational interviewing
715441|NCT00567281|Schizoaffective disorder|schizoaffective disorder
715442|NCT00567281|Auditory Hallucinations|auditory hallucinations
715443|NCT00567281|Voices|voices
715444|NCT00567281|Repetitive Transcranial Magnetic Stimulation|repetitive transcranial magnetic stimulation
715445|NCT00567281|rTMS|rtms
715446|NCT00567281|Wernicke's Area|wernicke's area
715447|NCT00567281|Middle Temporal Cortex|middle temporal cortex
715448|NCT00567281|Persistent Auditory Hallucinations|persistent auditory hallucinations
715449|NCT00567281|"Previously Participated in Parent rTMS Protocol"|"previously participated in parent rtms protocol"
715450|NCT00567268|Post-Marketing surveillance|post-marketing surveillance
715451|NCT00567255|Obesity|obesity
715452|NCT00567242|aphasia|aphasia
715453|NCT00567242|therapies, investigational|therapies, investigational
715578|NCT00566761|Macular edema|macular edema
715738|NCT00566189|Cytokines|cytokines
715454|NCT00567242|rehabilitation of speech and language disorders|rehabilitation of speech and language disorders
715455|NCT00567242|magnetic resonance imaging, functional|magnetic resonance imaging, functional
715456|NCT00567242|language|language
715457|NCT00567229|refractory multiple myeloma|refractory multiple myeloma
715458|NCT00567190|Herceptin|herceptin
715459|NCT00567190|Breast cancer|breast cancer
715460|NCT00567190|MBC|mbc
715461|NCT00567190|Taxotere|taxotere
715462|NCT00567190|HER2|her2
715463|NCT00567190|HER2 positive breast cancer|her2 positive breast cancer
715464|NCT00567190|HER2 + breast cancer|her2 + breast cancer
715465|NCT00567190|HER2-positive|her2-positive
715466|NCT00567190|HER2-positive metastatic breast cancer|her2-positive metastatic breast cancer
715467|NCT00567164|Oral Contraception|oral contraception
715468|NCT00567164|Birth Control pill|birth control pill
715469|NCT00567164|Healthy women requesting oral contraception|healthy women requesting oral contraception
715470|NCT00567164|Contraceptive efficacy|contraceptive efficacy
715471|NCT00567125|low-pressure pneumoperitoneum|low-pressure pneumoperitoneum
715472|NCT00567125|laparoscopy|laparoscopy
715473|NCT00567125|cytokines|cytokines
715474|NCT00567125|VEGF-A|vegf-a
715475|NCT00567125|endostatin|endostatin
715476|NCT00567099|Psychiatry|psychiatry
715477|NCT00567099|Antipsychotic|antipsychotic
715478|NCT00567099|Psychopharmacology|psychopharmacology
715479|NCT00567099|Clinical Trial|clinical trial
715480|NCT00567099|Open Label|open label
715481|NCT00567099|Schizophrenia|schizophrenia
715482|NCT00567099|Sensory Gating|sensory gating
715483|NCT00567099|Attention|attention
715484|NCT00567099|Memory|memory
715485|NCT00567086|Migraine|migraine
715486|NCT00567073|Glycogen Storage Disease Type II (GSD-II)|glycogen storage disease type ii (gsd-ii)
715487|NCT00567073|GSD-II|gsd-ii
715488|NCT00567073|Pompe Disease|pompe disease
715489|NCT00567073|Pompe Disease (Late-Onset)|pompe disease (late-onset)
715490|NCT00567073|Acid Maltase Deficiency Disease|acid maltase deficiency disease
715491|NCT00567073|Glycogenosis II|glycogenosis ii
715492|NCT00567060|Piracetam|piracetam
715493|NCT00567060|Nootropil|nootropil
715494|NCT00567034|Zyprexa|zyprexa
715495|NCT00567034|naltrexone|naltrexone
715496|NCT00567034|schizophrenia|schizophrenia
715497|NCT00567034|Metabolic Syndrome|metabolic syndrome
715498|NCT00567034|pain|pain
715499|NCT00567021|reflux|reflux
715500|NCT00567021|NSAR treatment|nsar treatment
715501|NCT00567021|Patients with reflux symptoms or gastrointestinal symptoms after NSAR Treatment|patients with reflux symptoms or gastrointestinal symptoms after nsar treatment
715502|NCT00567008|cocaine|cocaine
715503|NCT00567008|crack cocaine|crack cocaine
715504|NCT00567008|cocaine-related disorders|cocaine-related disorders
715505|NCT00567008|substance-related disorders|substance-related disorders
715506|NCT00567008|alpha4beta2 nicotinic acetylcholine receptor|alpha4beta2 nicotinic acetylcholine receptor
715507|NCT00566995|Kidney Tumors|kidney tumors
715508|NCT00566995|Clear Cell Renal Cancer|clear cell renal cancer
715509|NCT00566995|VEGFR Inhibitor|vegfr inhibitor
715510|NCT00566995|EGFR Inhibitor|egfr inhibitor
715511|NCT00566995|VHL|vhl
715512|NCT00566995|Von Hippel Lindau|von hippel lindau
715513|NCT00566995|Kidney Tumor|kidney tumor
715514|NCT00566982|Urogenital atrophy|urogenital atrophy
715515|NCT00566982|Menopausal symptoms|menopausal symptoms
715516|NCT00566982|Vulvar and vaginal atrophy in postmenopausal women|vulvar and vaginal atrophy in postmenopausal women
715517|NCT00566982|Vaginal atrophy|vaginal atrophy
715518|NCT00566969|cocaine, opiate, methadone, carvedilol|cocaine, opiate, methadone, carvedilol
715613|NCT00566618|Dasatinib|dasatinib
715519|NCT00566956|Hydrosalpinx/IVF/Reproductive outcome.|hydrosalpinx/ivf/reproductive outcome.
715520|NCT00566956|Hydrosalpinx|hydrosalpinx
715521|NCT00566943|Staple Line Reinforcement, Buttress|staple line reinforcement, buttress
715522|NCT00566917|Vagina|vagina
715523|NCT00566917|Prolapse|prolapse
715524|NCT00566917|Anterior vaginal wall prolapse|anterior vaginal wall prolapse
715525|NCT00566904|Post-herpetic Neuralgia|post-herpetic neuralgia
715526|NCT00566904|Pain after Shingles|pain after shingles
715527|NCT00566904|Shingles|shingles
715528|NCT00566904|PHN|phn
715529|NCT00566891|percutaneous coronary angioplasty|percutaneous coronary angioplasty
715530|NCT00566891|pci|pci
715531|NCT00566891|tirofiban|tirofiban
715532|NCT00566891|side effects|side effects
715533|NCT00566878|Glycogen Storage Disease|glycogen storage disease
715534|NCT00566878|GSD-II|gsd-ii
715535|NCT00566878|Pompe Disease|pompe disease
715536|NCT00566878|Pompe Disease (Late-Onset)|pompe disease (late-onset)
715537|NCT00566878|Acid Maltase Deficiency Disease|acid maltase deficiency disease
715538|NCT00566878|Glycogenosis II|glycogenosis ii
715539|NCT00566852|cognitive/functional effects|cognitive/functional effects
715540|NCT00566852|neurotoxicity|neurotoxicity
715541|NCT00566852|tumors metastatic to brain|tumors metastatic to brain
715542|NCT00566852|unspecified adult solid tumor, protocol specific|unspecified adult solid tumor, protocol specific
715543|NCT00566839|COPD|copd
715544|NCT00566839|LVRS|lvrs
715545|NCT00566839|Awake surgery|awake surgery
715546|NCT00566839|Thoracic epidural anesthesia|thoracic epidural anesthesia
715547|NCT00566839|One-lung ventilation|one-lung ventilation
715548|NCT00566839|Emphysema|emphysema
715549|NCT00566839|VATS|vats
715550|NCT00566839|Lung surgery|lung surgery
715551|NCT00566826|Physical Function|physical function
715552|NCT00566826|Total Knee Replacement|total knee replacement
715553|NCT00566826|Physical Activity|physical activity
715554|NCT00566826|Behavioral Support|behavioral support
715555|NCT00566826|Arthroplasty|arthroplasty
715556|NCT00566826|Function|function
715557|NCT00566826|Self-Care|self-care
715558|NCT00566813|Diabetes Mellitus, Type 1|diabetes mellitus, type 1
715559|NCT00566813|Islets of Langerhans Transplantation|islets of langerhans transplantation
715560|NCT00566813|Exenatide|exenatide
715561|NCT00566813|Soluble tumor necrosis factor receptor|soluble tumor necrosis factor receptor
715562|NCT00566800|esophageal cancer|esophageal cancer
715563|NCT00566800|Barrett esophagus|barrett esophagus
715564|NCT00566787|AF|af
715565|NCT00566787|Atrial Fibrillation|atrial fibrillation
715566|NCT00566787|afib|afib
715567|NCT00566787|racing heart|racing heart
715568|NCT00566787|cabg|cabg
715569|NCT00566787|valve|valve
715570|NCT00566787|ablation|ablation
715571|NCT00566787|bipolar|bipolar
715572|NCT00566787|radiofrequency|radiofrequency
715573|NCT00566787|rf|rf
715574|NCT00566774|myocardial infarction|myocardial infarction
715575|NCT00566774|secondary prevention|secondary prevention
715576|NCT00566774|health insurance|health insurance
715577|NCT00566774|cost-sharing|cost-sharing
715579|NCT00566761|central retinal vein occlusion|central retinal vein occlusion
715580|NCT00566761|bevacizumab|bevacizumab
715581|NCT00566761|triamcinolone|triamcinolone
715582|NCT00566709|transfusion|transfusion
715583|NCT00566709|NIRS|nirs
715584|NCT00566709|cerebral oxygenation|cerebral oxygenation
715585|NCT00566709|red blood cell|red blood cell
715586|NCT00566709|near infrared spectroscopy|near infrared spectroscopy
715587|NCT00566696|Haploidentical stem cell transplant|haploidentical stem cell transplant
715588|NCT00566696|Allogeneic stem cell transplant|allogeneic stem cell transplant
715589|NCT00566696|Mismatched family member stem cell donor transplant|mismatched family member stem cell donor transplant
715590|NCT00566696|Bone marrow transplant|bone marrow transplant
715591|NCT00566696|High risk hematologic malignancies|high risk hematologic malignancies
715592|NCT00566696|T cell depletion methodology|t cell depletion methodology
715593|NCT00566696|Miltenyi Biotec CliniMACS stem cell selection device|miltenyi biotec clinimacs stem cell selection device
715594|NCT00566696|Campath-1H intravenous|campath-1h intravenous
715595|NCT00566683|Propofol|propofol
715596|NCT00566683|colonoscopy|colonoscopy
715597|NCT00566683|sedation|sedation
715598|NCT00566683|pain|pain
715599|NCT00566683|compare NAPS versus diazemuls in outpatient colonoscopy|compare naps versus diazemuls in outpatient colonoscopy
715600|NCT00566670|Hemodialysis|hemodialysis
715601|NCT00566657|Critical Limb Ischemia|critical limb ischemia
715602|NCT00566657|Peripheral Artery Disease|peripheral artery disease
715603|NCT00566657|Plasmid based gene therapy|plasmid based gene therapy
715604|NCT00566644|endometrial cancer|endometrial cancer
715605|NCT00566644|hereditary non-polyposis colon cancer (hMSH2, hMLH1, hPMS1, hPMS2)|hereditary non-polyposis colon cancer (hmsh2, hmlh1, hpms1, hpms2)
715606|NCT00566631|Schizophrenia|schizophrenia
715607|NCT00566631|Paliperidone Extended Release (ER)|paliperidone extended release (er)
715608|NCT00566631|Invega|invega
715609|NCT00566618|Breast Cancer|breast cancer
715610|NCT00566618|Bone Metastases|bone metastases
715611|NCT00566618|Breast Cancer with Bone Metastases|breast cancer with bone metastases
715612|NCT00566618|Breast Cancer with Metastases to Bone|breast cancer with metastases to bone
715615|NCT00566618|Zoledronic Acid|zoledronic acid
715616|NCT00566618|Zoledronate|zoledronate
715617|NCT00566618|BMS-345825|bms-345825
715618|NCT00566618|Sprycel®|sprycel®
715619|NCT00566579|Human papillomavirus|human papillomavirus
715620|NCT00566579|Clearance|clearance
715621|NCT00566579|Cryotherapy|cryotherapy
715622|NCT00566566|adipocytokines|adipocytokines
715623|NCT00566566|inflammatory markers|inflammatory markers
715624|NCT00566566|cardiovascular disease|cardiovascular disease
715625|NCT00566566|diabetes mellitus|diabetes mellitus
715626|NCT00566566|Leptin|leptin
715627|NCT00566553|Grape Seed Extract|grape seed extract
715628|NCT00566553|Breast Cancer|breast cancer
715629|NCT00566553|Estrogen Levels|estrogen levels
715630|NCT00566553|Aromatase Inhibitor|aromatase inhibitor
715631|NCT00566540|stage III squamous cell carcinoma of the hypopharynx|stage iii squamous cell carcinoma of the hypopharynx
715632|NCT00566540|stage IV squamous cell carcinoma of the hypopharynx|stage iv squamous cell carcinoma of the hypopharynx
715633|NCT00566540|stage III squamous cell carcinoma of the lip and oral cavity|stage iii squamous cell carcinoma of the lip and oral cavity
715634|NCT00566540|stage IV squamous cell carcinoma of the lip and oral cavity|stage iv squamous cell carcinoma of the lip and oral cavity
715635|NCT00566540|stage III squamous cell carcinoma of the oropharynx|stage iii squamous cell carcinoma of the oropharynx
715636|NCT00566540|stage IV squamous cell carcinoma of the oropharynx|stage iv squamous cell carcinoma of the oropharynx
715637|NCT00566540|stage II squamous cell carcinoma of the hypopharynx|stage ii squamous cell carcinoma of the hypopharynx
715638|NCT00566514|fibromyalgia|fibromyalgia
715639|NCT00566514|ribose|ribose
715640|NCT00566514|d-ribose|d-ribose
715642|NCT00566501|Moderate-to-severe|moderate-to-severe
715643|NCT00566501|Alzheimer's|alzheimer's
715644|NCT00566501|Disease|disease
715645|NCT00566488|Thymus Transplantation|thymus transplantation
715646|NCT00566488|Parathyroid Transplantation|parathyroid transplantation
715647|NCT00566488|DiGeorge Syndrome|digeorge syndrome
715648|NCT00566488|Hypoparathyroidism|hypoparathyroidism
715649|NCT00566488|Athymia|athymia
715650|NCT00566449|Attention Deficit Hyperactivity Disorder|attention deficit hyperactivity disorder
715651|NCT00566449|ADHD|adhd
715652|NCT00566449|JNJ-31001074|jnj-31001074
715653|NCT00566436|Peripheral Arterial Occlusive Disease|peripheral arterial occlusive disease
715654|NCT00566436|Superficial Femoral Artery|superficial femoral artery
715655|NCT00566436|Remote Endarterectomy|remote endarterectomy
715656|NCT00566436|Suprageniculate Bypass Surgery|suprageniculate bypass surgery
715657|NCT00566436|Blood Vessel Prosthesis Implantation|blood vessel prosthesis implantation
715658|NCT00566436|Vascular Patency|vascular patency
715660|NCT00566423|Biomarkers|biomarkers
715661|NCT00566423|MIF|mif
715662|NCT00566423|BNP|bnp
715663|NCT00566423|6 Minute Walk (6MW)|6 minute walk (6mw)
715664|NCT00566410|DCA|dca
715665|NCT00566410|Phase I|phase i
715666|NCT00566410|Dose Escalation|dose escalation
715667|NCT00566410|Solid Tumours|solid tumours
715668|NCT00566410|Dichloroacetate|dichloroacetate
715669|NCT00566410|Pharmacokinetic|pharmacokinetic
715670|NCT00566397|RI RI Study Rage Inhibitors|ri ri study rage inhibitors
715671|NCT00566384|Loss of libido|loss of libido
715672|NCT00566384|Acquired, oral contraceptive -associated female sexual dysfunction|acquired, oral contraceptive -associated female sexual dysfunction
715673|NCT00566371|attention deficit hyperactivity disorder|attention deficit hyperactivity disorder
715674|NCT00566371|insomnia|insomnia
715675|NCT00566371|atomoxetine|atomoxetine
715676|NCT00566358|diabetes mellitus, type 2|diabetes mellitus, type 2
715677|NCT00566358|duodenal exclusion|duodenal exclusion
715678|NCT00566358|bariatric surgery|bariatric surgery
715679|NCT00566358|Glucagon-Like Peptide 1|glucagon-like peptide 1
715680|NCT00566358|Gastric Inhibitory Polypeptide|gastric inhibitory polypeptide
715681|NCT00566358|insulin|insulin
715682|NCT00566358|glucagon|glucagon
715683|NCT00566358|ghrelin|ghrelin
715684|NCT00566332|Waldenström Macroglobulinemia|waldenström macroglobulinemia
715685|NCT00566332|Lymphoplasmacytic lymphoma|lymphoplasmacytic lymphoma
715686|NCT00566332|Splenic Marginal Zone Lymphoma|splenic marginal zone lymphoma
715687|NCT00566332|Fludarabine|fludarabine
715688|NCT00566332|Chlorambucil|chlorambucil
715689|NCT00566319|Exercise|exercise
715690|NCT00566306|Clostridium difficile|clostridium difficile
715691|NCT00566306|disinfectant|disinfectant
715692|NCT00566280|MBI|mbi
715693|NCT00566280|Mammogram|mammogram
715694|NCT00566280|Breast Cancer|breast cancer
715695|NCT00566280|Breast Ultrasound|breast ultrasound
715696|NCT00566280|Bloody Nipple Discharge|bloody nipple discharge
715697|NCT00566280|Molecular Breast Imaging|molecular breast imaging
715698|NCT00566254|Epilepsy|epilepsy
715699|NCT00566254|paediatric|paediatric
715700|NCT00566254|partial onset seizures|partial onset seizures
715701|NCT00566241|Body weight|body weight
715702|NCT00566241|Body composition|body composition
715703|NCT00566241|Pulmonary function|pulmonary function
715704|NCT00566241|Carbohydrate tolerance|carbohydrate tolerance
715705|NCT00566228|noncontiguous stage II adult diffuse large cell lymphoma|noncontiguous stage ii adult diffuse large cell lymphoma
715706|NCT00566228|stage III adult diffuse large cell lymphoma|stage iii adult diffuse large cell lymphoma
715707|NCT00566228|stage IV adult diffuse large cell lymphoma|stage iv adult diffuse large cell lymphoma
715708|NCT00566228|recurrent adult diffuse large cell lymphoma|recurrent adult diffuse large cell lymphoma
715709|NCT00566215|diabetes mellitus, type 2|diabetes mellitus, type 2
715710|NCT00566215|Insulin resistance|insulin resistance
715711|NCT00566215|Intra-Abdominal Fat|intra-abdominal fat
715712|NCT00566215|Omentum|omentum
715713|NCT00566215|duodenal exclusion|duodenal exclusion
715714|NCT00566215|bariatric surgery|bariatric surgery
715715|NCT00566215|Glucagon-Like Peptide 1|glucagon-like peptide 1
715716|NCT00566215|Gastric Inhibitory Polypeptide|gastric inhibitory polypeptide
715717|NCT00566215|insulin|insulin
715718|NCT00566215|glucagon|glucagon
715719|NCT00566215|ghrelin|ghrelin
715720|NCT00566215|adiponectin|adiponectin
715721|NCT00566215|Cytokines|cytokines
715722|NCT00566202|Major Depressive Disorder|major depressive disorder
715723|NCT00566202|Depression|depression
715724|NCT00566202|JNJ-18038683|jnj-18038683
715725|NCT00566202|Escitalopram|escitalopram
715726|NCT00566189|diabetes mellitus, type 2|diabetes mellitus, type 2
715727|NCT00566189|Insulin resistance|insulin resistance
715728|NCT00566189|Intra-Abdominal Fat|intra-abdominal fat
715729|NCT00566189|Omentum|omentum
715730|NCT00566189|duodenal exclusion|duodenal exclusion
715731|NCT00566189|bariatric surgery|bariatric surgery
715732|NCT00566189|Glucagon-Like Peptide 1|glucagon-like peptide 1
715733|NCT00566189|Gastric Inhibitory Polypeptide|gastric inhibitory polypeptide
715734|NCT00566189|insulin|insulin
715735|NCT00566189|glucagon|glucagon
715736|NCT00566189|ghrelin|ghrelin
715737|NCT00566189|adiponectin|adiponectin
715739|NCT00566176|Atrial Fibrillation|atrial fibrillation
715740|NCT00566176|AF|af
715741|NCT00566176|AFIB|afib
715742|NCT00566176|racing heart|racing heart
715743|NCT00566176|pulmonary vein isolation|pulmonary vein isolation
715744|NCT00566176|pvi|pvi
715745|NCT00566176|mini maze|mini maze
715746|NCT00566176|maze|maze
715747|NCT00566150|Keppra|keppra
715748|NCT00566150|Levetiracetam|levetiracetam
715749|NCT00566150|Anticonvulsant|anticonvulsant
715750|NCT00566150|Depression|depression
715751|NCT00566150|Bipolar Disorder|bipolar disorder
715752|NCT00566150|Affective Disorders|affective disorders
715753|NCT00566150|Mood Disorders|mood disorders
715754|NCT00566150|Double Blind|double blind
715755|NCT00566150|Acute Antidepressant Effects|acute antidepressant effects
715756|NCT00566137|Scleroderma|scleroderma
715757|NCT00566137|Pulmonary Hypertension|pulmonary hypertension
715758|NCT00566124|Levemir, Lantus, Insulatard, Pharmacodynamics, Healthy humans|levemir, lantus, insulatard, pharmacodynamics, healthy humans
715759|NCT00566111|Ceftriaxone|ceftriaxone
715760|NCT00566111|Acute Antidepressant Effects|acute antidepressant effects
715761|NCT00566111|Glutamatergic System|glutamatergic system
715762|NCT00566111|Double-Blind|double-blind
715763|NCT00566111|Mood Disorders|mood disorders
715764|NCT00566111|Bipolar Disorder|bipolar disorder
715765|NCT00566111|Depression|depression
715766|NCT00566111|Affective Disorders|affective disorders
715767|NCT00566098|stage II multiple myeloma|stage ii multiple myeloma
715768|NCT00566098|stage III multiple myeloma|stage iii multiple myeloma
715769|NCT00566085|MBI|mbi
715770|NCT00566085|Breast Cancer|breast cancer
715771|NCT00566085|Neoadjuvant Therapy|neoadjuvant therapy
715772|NCT00566085|Molecular Breast Imaging|molecular breast imaging
715773|NCT00566072|the effect of information on compliance of medication|the effect of information on compliance of medication
715774|NCT00566059|therapeutic advice|therapeutic advice
715775|NCT00566033|AUDIT|audit
715776|NCT00566033|Chronic kidney disease|chronic kidney disease
715777|NCT00566033|Clinical trial|clinical trial
715778|NCT00566033|Creatinine|creatinine
715779|NCT00566033|Multiple intervents|multiple intervents
715780|NCT00566033|Nephrology guidelines.|nephrology guidelines.
715781|NCT00566020|Open-label extension|open-label extension
715782|NCT00566020|Tolerability|tolerability
715783|NCT00566020|Lamotrigine|lamotrigine
715784|NCT00566020|Safety|safety
715785|NCT00566020|Bipolar I disorder|bipolar i disorder
715786|NCT00566007|disc herniation|disc herniation
715787|NCT00566007|lumbar|lumbar
715788|NCT00566007|ozone therapy|ozone therapy
715789|NCT00565994|hemodialysis|hemodialysis
715790|NCT00565994|Vascular access|vascular access
715791|NCT00565994|arteriovenous fistula|arteriovenous fistula
715792|NCT00565994|indwelling percutaneous catheters|indwelling percutaneous catheters
715793|NCT00565994|arteriovenous grafts|arteriovenous grafts
715794|NCT00565981|B-CLL|b-cll
715795|NCT00565981|refractory|refractory
715796|NCT00565981|molecular profiling|molecular profiling
715797|NCT00565981|alemtuzumab|alemtuzumab
715798|NCT00565981|fludarabinephosphate|fludarabinephosphate
715799|NCT00565968|stage IIIB melanoma|stage iiib melanoma
715800|NCT00565968|stage IIIC melanoma|stage iiic melanoma
715801|NCT00565968|recurrent melanoma|recurrent melanoma
715802|NCT00565955|Montelukast|montelukast
715803|NCT00565955|Acute Asthma|acute asthma
715804|NCT00565942|Integrative medicine|integrative medicine
715805|NCT00565942|Primary care|primary care
715806|NCT00565942|Swedish massage therapy|swedish massage therapy
715807|NCT00565942|Manual therapy|manual therapy
715808|NCT00565942|Naprapathy|naprapathy
715810|NCT00565942|Acupuncture/TCM|acupuncture/tcm
715811|NCT00565942|Qigong|qigong
715812|NCT00565942|Pragmatic RCT|pragmatic rct
715813|NCT00565942|Health services research|health services research
715814|NCT00565929|Variola major, smallpox, vaccine, hematopoietic stem cell transplant|variola major, smallpox, vaccine, hematopoietic stem cell transplant
715815|NCT00565916|Post-Menopausal|post-menopausal
715816|NCT00565916|PET|pet
715817|NCT00565916|Estrogen|estrogen
715818|NCT00565916|Progesterone|progesterone
715819|NCT00565916|Heart Metabolism|heart metabolism
715820|NCT00565916|Cardiovascular Disease|cardiovascular disease
715821|NCT00565903|pleuropulmonary blastoma|pleuropulmonary blastoma
715822|NCT00565903|PPB|ppb
715823|NCT00565903|cystic nephroma|cystic nephroma
715824|NCT00565903|DICER1|dicer1
715825|NCT00565903|miRNA|mirna
715826|NCT00565890|very low birth weight infant|very low birth weight infant
715827|NCT00565890|hypothyroxinemia|hypothyroxinemia
715828|NCT00565890|outcomes|outcomes
715829|NCT00565877|Catheter|catheter
715830|NCT00565877|Peripherally inserted central catheter|peripherally inserted central catheter
715831|NCT00565877|ultrasound|ultrasound
715832|NCT00565877|malposition|malposition
715833|NCT00565864|Hypothyroidism|hypothyroidism
715834|NCT00565864|Cognition|cognition
715835|NCT00565864|Metabolism|metabolism
715836|NCT00565838|Randomized study|randomized study
715837|NCT00565838|surgical treatment|surgical treatment
715838|NCT00565838|autologous fascial sling|autologous fascial sling
715839|NCT00565838|TVT|tvt
715840|NCT00565838|stress urinary incontinence.|stress urinary incontinence.
715841|NCT00565812|knee Osteoarthritis Disease Modifying Osteoarthritis Drug|knee osteoarthritis disease modifying osteoarthritis drug
715842|NCT00565799|DM|dm
715843|NCT00565760|Acute|acute
715844|NCT00565760|Pain|pain
715845|NCT00565747|GM-CSF|gm-csf
715846|NCT00565747|infertility|infertility
715847|NCT00565721|Static PET imaging|static pet imaging
715848|NCT00565721|Dynamic PET imaging|dynamic pet imaging
715849|NCT00565721|Angiogenesis|angiogenesis
715850|NCT00565721|αvβ3 integrins|αvβ3 integrins
715851|NCT00565721|oncology imaging|oncology imaging
715852|NCT00565708|stage II colon cancer|stage ii colon cancer
715853|NCT00565708|stage III colon cancer|stage iii colon cancer
715854|NCT00565708|stage II rectal cancer|stage ii rectal cancer
715855|NCT00565708|stage III rectal cancer|stage iii rectal cancer
715856|NCT00565695|Visual Outcomes|visual outcomes
715857|NCT00565695|Patient Satisfaction|patient satisfaction
715858|NCT00565695|Cataract Extraction|cataract extraction
715859|NCT00565669|Treatment|treatment
715860|NCT00565669|Dry Eye|dry eye
715861|NCT00565656|Myelodysplastic syndromes (int-1, int-2 and high risk according to IPSS) with excess of marrow blasts including CMML with leucocytes<10 000/mm3|myelodysplastic syndromes (int-1, int-2 and high risk according to ipss) with excess of marrow blasts including cmml with leucocytes<10 000/mm3
715862|NCT00565643|Adhesion|adhesion
715863|NCT00565643|Seprafilm|seprafilm
715864|NCT00565643|Cesarean section|cesarean section
715865|NCT00565617|depression|depression
715866|NCT00565617|epidural|epidural
715867|NCT00565617|cortical stimulation|cortical stimulation
715868|NCT00565617|brain stimulation|brain stimulation
715869|NCT00565617|treatment-resistant|treatment-resistant
715870|NCT00565617|deep brain stimulation|deep brain stimulation
715871|NCT00565617|TMS|tms
715872|NCT00565617|DBS|dbs
715873|NCT00565617|ECS|ecs
715874|NCT00565604|Perforator Veins|perforator veins
715875|NCT00565604|Incompetent Veins|incompetent veins
715876|NCT00565604|Varicose Veins|varicose veins
715877|NCT00565591|asthma|asthma
715878|NCT00565591|inhaler device|inhaler device
715879|NCT00565591|albuterol sulfate|albuterol sulfate
715880|NCT00565565|Biventriular chronic heart failure, Pulmonary hypertension|biventriular chronic heart failure, pulmonary hypertension
715881|NCT00565552|silicone gel|silicone gel
715882|NCT00565552|cicatrix|cicatrix
715883|NCT00565552|wound healing|wound healing
715884|NCT00565552|scar|scar
715885|NCT00565552|keloid|keloid
715886|NCT00565539|PEGylated recombinant interleukin 29|pegylated recombinant interleukin 29
715887|NCT00565539|interferon lambda|interferon lambda
715888|NCT00565539|interleukin 29|interleukin 29
715889|NCT00565539|hepatitis C|hepatitis c
715890|NCT00565539|virus|virus
715891|NCT00565539|infection|infection
715892|NCT00565539|liver|liver
715893|NCT00565526|Autonomic Nervous System|autonomic nervous system
715894|NCT00565526|Sjogren's Syndrome|sjogren's syndrome
715895|NCT00565526|Pathogenesis|pathogenesis
715896|NCT00565526|Cholinergic|cholinergic
715897|NCT00565526|Parasympathetic|parasympathetic
715898|NCT00565526|Sjogren Syndrome|sjogren syndrome
715899|NCT00565487|Radiotherapy|radiotherapy
715900|NCT00565487|Non-operable pancreatic cancer|non-operable pancreatic cancer
715901|NCT00565487|locally advanced pancreatic cancer|locally advanced pancreatic cancer
715902|NCT00565474|Renal transplantation|renal transplantation
715903|NCT00565474|fluvastatin|fluvastatin
715904|NCT00565448|Nasopharyngeal carcinoma|nasopharyngeal carcinoma
715905|NCT00565422|Internet addiction|internet addiction
715906|NCT00565422|Problematic internet use|problematic internet use
715907|NCT00565422|Escitalopram|escitalopram
715909|NCT00565409|Active Rheumatoid Arthritis|active rheumatoid arthritis
715910|NCT00565383|Pregnancy|pregnancy
715911|NCT00565383|37 Weeks Gestation|37 weeks gestation
715912|NCT00565383|Breech Presentation|breech presentation
715913|NCT00565383|Version Procedure|version procedure
715914|NCT00565383|Pain Control|pain control
715915|NCT00565383|Neuraxial analgesia|neuraxial analgesia
715916|NCT00565370|Gastric cancer|gastric cancer
715917|NCT00565370|capecitabine|capecitabine
715918|NCT00565370|cisplatin|cisplatin
715919|NCT00565370|sorafenib|sorafenib
715920|NCT00565370|phase I|phase i
715921|NCT00565370|phase II|phase ii
715922|NCT00565357|Postnatal Growth|postnatal growth
715923|NCT00565357|Postnatal Development|postnatal development
715924|NCT00565357|Noise|noise
715925|NCT00565357|Neonatal Intensive Care Unit|neonatal intensive care unit
715926|NCT00565344|Medicaid|medicaid
715927|NCT00565344|Disenrollment|disenrollment
715928|NCT00565318|Benfotiamine|benfotiamine
715929|NCT00565318|Diabetes|diabetes
715930|NCT00565318|Nephropathy|nephropathy
715931|NCT00565305|Healing Touch|healing touch
715932|NCT00565305|NK cytotoxicity|nk cytotoxicity
715933|NCT00565305|cytokines|cytokines
715934|NCT00565305|fatigue|fatigue
715935|NCT00565279|Seborrhoeic dermatitis|seborrhoeic dermatitis
715936|NCT00565253|pulmonary embolism|pulmonary embolism
715937|NCT00565253|inhaled nitric oxide|inhaled nitric oxide
715938|NCT00565240|ovarian synchronization|ovarian synchronization
715939|NCT00565240|folliculogenesis|folliculogenesis
715940|NCT00565214|vitamin supplements|vitamin supplements
715941|NCT00565214|healthy smokers|healthy smokers
715942|NCT00565214|epithelial lung tissue|epithelial lung tissue
715943|NCT00565214|bronchoscopy|bronchoscopy
715944|NCT00565214|antioxidant levels|antioxidant levels
715945|NCT00565201|Stroke, Cerebrovascular accident, Spasticity, Arm, Hand|stroke, cerebrovascular accident, spasticity, arm, hand
715946|NCT00565175|Treatment resistant|treatment resistant
715947|NCT00565175|Chronic|chronic
715948|NCT00565136|Device study|device study
715949|NCT00565136|Pelvic floor weakness|pelvic floor weakness
715950|NCT00565136|Fecal incontinence|fecal incontinence
715951|NCT00565123|bacterial conjunctivitis levofloxacin fluoroquinolone|bacterial conjunctivitis levofloxacin fluoroquinolone
715952|NCT00565097|Polycystic Liver Disease|polycystic liver disease
715953|NCT00565097|Autosomal Dominant Polycystic Kidney Disease|autosomal dominant polycystic kidney disease
715954|NCT00565097|Liver cyst|liver cyst
715955|NCT00565097|Lanreotide|lanreotide
715956|NCT00565071|Cost-effectiveness|cost-effectiveness
715957|NCT00565071|Diagnosis|diagnosis
715958|NCT00565071|Treatment|treatment
715959|NCT00565071|Malaria|malaria
715960|NCT00565045|hand|hand
715961|NCT00565045|stroke|stroke
715962|NCT00565045|hemiplegia|hemiplegia
715963|NCT00565045|electrical stimulation|electrical stimulation
715964|NCT00565045|recovery|recovery
715965|NCT00565032|postpartum depression|postpartum depression
715966|NCT00565032|thyroxine|thyroxine
715967|NCT00565032|thyroid antibodies|thyroid antibodies
715968|NCT00565032|thyroid stimulating hormone|thyroid stimulating hormone
715969|NCT00565032|Edinburgh Postnatal Depression Scale (EPDS)|edinburgh postnatal depression scale (epds)
715970|NCT00564980|Randomized|randomized
715971|NCT00564980|Prospective|prospective
715972|NCT00564980|Procedure / Surgery|procedure / surgery
715973|NCT00564954|ADHD|adhd
715974|NCT00564954|children|children
715975|NCT00564954|laboratory classroom|laboratory classroom
715976|NCT00564954|Attention Deficit Hyperactivity Disorder|attention deficit hyperactivity disorder
715977|NCT00564941|Myelodysplastic Syndromes|myelodysplastic syndromes
715978|NCT00564941|beta-Thalassemia|beta-thalassemia
715979|NCT00564941|Iron Overload|iron overload
715980|NCT00564941|Iron Chelating Agents|iron chelating agents
715981|NCT00564941|deferasirox|deferasirox
715982|NCT00564928|Hormone resistant prostate cancer|hormone resistant prostate cancer
715983|NCT00564928|castrate resistant prostate cancer|castrate resistant prostate cancer
715984|NCT00564928|HRPC|hrpc
715985|NCT00564928|CRPC|crpc
715986|NCT00564915|Epilepsy|epilepsy
715987|NCT00564902|Macular Pigment Optical Density|macular pigment optical density
715988|NCT00564902|Skin Carotenoids|skin carotenoids
715989|NCT00564902|Lipofuscin|lipofuscin
715990|NCT00564902|Photostress (Glare Recovery)|photostress (glare recovery)
715991|NCT00564902|Visual Field Progression|visual field progression
715992|NCT00564902|Contrast Sensitivity|contrast sensitivity
715993|NCT00564902|Color Vision|color vision
715994|NCT00564902|Cognitive Function|cognitive function
715995|NCT00564889|primary systemic amyloidosis|primary systemic amyloidosis
715996|NCT00564876|Non Small Cell Lung Cancer (NSCLC)|non small cell lung cancer (nsclc)
715997|NCT00564876|carcinoma|carcinoma
715998|NCT00564876|dasatinib|dasatinib
715999|NCT00564876|neoadjuvant|neoadjuvant
716000|NCT00564876|adjuvant|adjuvant
716001|NCT00564876|resection|resection
716002|NCT00564876|genomic signature|genomic signature
716003|NCT00564876|predictor|predictor
716004|NCT00564876|microarray|microarray
716005|NCT00564863|Diarrhea|diarrhea
716006|NCT00564863|ETEC|etec
716007|NCT00564837|Anterior cruciate ligament|anterior cruciate ligament
716008|NCT00564837|Reconstruction|reconstruction
716009|NCT00564837|Rehabilitation|rehabilitation
716010|NCT00564837|Home-based|home-based
716011|NCT00564824|coronary disease|coronary disease
716012|NCT00564824|atherosclerosis|atherosclerosis
716013|NCT00564824|endothelial function|endothelial function
716014|NCT00564824|caffeine|caffeine
716015|NCT00564824|cerebrovascular disease|cerebrovascular disease
716016|NCT00564824|prevention|prevention
716017|NCT00564811|Agaricus blazei (Murrill) ss. Heinemann,|agaricus blazei (murrill) ss. heinemann,
716018|NCT00564811|Hepatitis C|hepatitis c
716019|NCT00564811|Nutritional status|nutritional status
716020|NCT00564811|Liver Function Tests|liver function tests
716021|NCT00564811|Antiviral Agents|antiviral agents
716022|NCT00564798|protocoladolescents|protocoladolescents
716023|NCT00564798|children|children
716024|NCT00564798|health behaviours/attitudes|health behaviours/attitudes
716025|NCT00564798|weight loss/management|weight loss/management
716026|NCT00564798|program evaluation|program evaluation
716027|NCT00564772|raltegravir|raltegravir
716028|NCT00564772|lopinavir|lopinavir
716029|NCT00564772|ritonavir|ritonavir
716030|NCT00564772|pharmacokinetics|pharmacokinetics
716031|NCT00564759|CGD|cgd
716032|NCT00564746|SB-681323,|sb-681323,
716033|NCT00564746|ADME,|adme,
716034|NCT00564746|radiolabel|radiolabel
716035|NCT00564694|adenocarcinoma of the colon|adenocarcinoma of the colon
716036|NCT00564694|recurrent colon cancer|recurrent colon cancer
716037|NCT00564694|stage I colon cancer|stage i colon cancer
716038|NCT00564694|stage II colon cancer|stage ii colon cancer
716039|NCT00564694|stage III colon cancer|stage iii colon cancer
716040|NCT00564694|stage IV colon cancer|stage iv colon cancer
716041|NCT00564694|adenocarcinoma of the rectum|adenocarcinoma of the rectum
716042|NCT00564694|recurrent rectal cancer|recurrent rectal cancer
716043|NCT00564694|stage I rectal cancer|stage i rectal cancer
716044|NCT00564694|stage II rectal cancer|stage ii rectal cancer
716045|NCT00564694|stage III rectal cancer|stage iii rectal cancer
716046|NCT00564694|stage IV rectal cancer|stage iv rectal cancer
716047|NCT00564655|pediatrics|pediatrics
716048|NCT00564655|Gastric Tube Insertion|gastric tube insertion
716049|NCT00564655|Anesthesia|anesthesia
716050|NCT00564655|Regional Anesthetic|regional anesthetic
716051|NCT00564655|Transversus Abdominal Plane|transversus abdominal plane
716052|NCT00564616|cardiac arrest|cardiac arrest
716053|NCT00564616|video cell phone|video cell phone
716054|NCT00564616|dispatcher-assisted CPR|dispatcher-assisted cpr
716055|NCT00564603|Glucocorticoid|glucocorticoid
716057|NCT00564603|Balanced analgesia|balanced analgesia
716058|NCT00564577|Diarrhea ETEC|diarrhea etec
716059|NCT00564564|obsessive compulsive disorder|obsessive compulsive disorder
716060|NCT00564564|pharmacological treatment|pharmacological treatment
716061|NCT00564564|quetiapine|quetiapine
716062|NCT00564564|clomipramine|clomipramine
716063|NCT00564564|SSRI|ssri
716064|NCT00564551|Prediabetes|prediabetes
716065|NCT00564551|Type 2 diabetes|type 2 diabetes
716066|NCT00564551|Metabolic syndrome|metabolic syndrome
716067|NCT00564551|Insulin resistance syndrome|insulin resistance syndrome
716068|NCT00564551|Weight loss|weight loss
716069|NCT00564551|Milk products|milk products
716070|NCT00564551|Calcium|calcium
716071|NCT00564538|liver transplant|liver transplant
716072|NCT00564525|children|children
716073|NCT00564525|abdominal pain|abdominal pain
716074|NCT00564525|amitriptyline|amitriptyline
716075|NCT00564512|B-cell chronic lymphocytic leukemia|b-cell chronic lymphocytic leukemia
716076|NCT00564512|stage I chronic lymphocytic leukemia|stage i chronic lymphocytic leukemia
716077|NCT00564512|stage II chronic lymphocytic leukemia|stage ii chronic lymphocytic leukemia
716078|NCT00564512|stage III chronic lymphocytic leukemia|stage iii chronic lymphocytic leukemia
716079|NCT00564512|stage IV chronic lymphocytic leukemia|stage iv chronic lymphocytic leukemia
716080|NCT00564499|COPD|copd
716081|NCT00564499|Symbicort|symbicort
716082|NCT00564499|General Practitioners|general practitioners
716083|NCT00564486|Abdominal Laparoscopic Surgery|abdominal laparoscopic surgery
716084|NCT00564473|internal medicine|internal medicine
716085|NCT00564473|herbal medicine|herbal medicine
716086|NCT00564473|prevalence|prevalence
716087|NCT00564473|attitudes|attitudes
716088|NCT00564473|herb-drug interaction|herb-drug interaction
716089|NCT00564434|delirium|delirium
716090|NCT00564434|pathophysiology|pathophysiology
716091|NCT00564434|risk factors|risk factors
716092|NCT00564434|pain|pain
716093|NCT00564434|dementia|dementia
716094|NCT00564395|blood sugar|blood sugar
716095|NCT00564395|glycemic|glycemic
716096|NCT00564382|Acute coronary syndrome|acute coronary syndrome
716097|NCT00564382|Cardiac Magnetic Resonance Imaging|cardiac magnetic resonance imaging
716098|NCT00564382|Contrast agents|contrast agents
716099|NCT00564382|Gadolinium|gadolinium
716100|NCT00564369|HIV testing|hiv testing
716101|NCT00564369|HIV Seronegativity|hiv seronegativity
716102|NCT00564356|cataract, phacoemulsification, coumadin, antiaggregants|cataract, phacoemulsification, coumadin, antiaggregants
716103|NCT00564343|Balance|balance
716104|NCT00564343|Water based training|water based training
716105|NCT00564343|Physical functioning|physical functioning
716106|NCT00564343|stepping behavior|stepping behavior
716107|NCT00564330|dental erosion|dental erosion
716108|NCT00564330|OCT|oct
716109|NCT00564330|proton pump inhibitor|proton pump inhibitor
716110|NCT00564317|PTSD|ptsd
716111|NCT00564317|Depression|depression
716112|NCT00564317|Suicidality|suicidality
716113|NCT00564317|trauma-focussed treatment|trauma-focussed treatment
716114|NCT00564317|KIDNET|kidnet
716115|NCT00564317|Narrative Exposure Therapy for Children|narrative exposure therapy for children
716116|NCT00564317|Meditation|meditation
716117|NCT00564317|Relaxation|relaxation
716118|NCT00564317|War|war
716119|NCT00564304|Nasal Potential Difference|nasal potential difference
716120|NCT00564291|OCT|oct
716121|NCT00564278|Hispanic Americans|hispanic americans
716122|NCT00564278|Major Depressive Disorder|major depressive disorder
716123|NCT00564278|Antidepressant Therapy|antidepressant therapy
716124|NCT00564278|Motivational Interviewing|motivational interviewing
716125|NCT00564278|Treatment Retention|treatment retention
716126|NCT00564278|Treatment Adherence|treatment adherence
716127|NCT00564265|GIST|gist
716128|NCT00564226|urge urinary incontinence|urge urinary incontinence
716129|NCT00564213|Myopia|myopia
716130|NCT00564213|Mitomycin|mitomycin
716131|NCT00564200|Multiple Myeloma, transplant|multiple myeloma, transplant
716132|NCT00564174|recurrent pregnancy loss|recurrent pregnancy loss
716133|NCT00564174|lupus anticoagulant|lupus anticoagulant
716134|NCT00564174|anti cardiolipin antibodies|anti cardiolipin antibodies
716135|NCT00564174|thrombophilia|thrombophilia
716136|NCT00564174|low molecular weight heparin|low molecular weight heparin
716137|NCT00564174|aspirin|aspirin
716138|NCT00564174|randomized clinical trial|randomized clinical trial
716139|NCT00564148|antiVEGF therapy|antivegf therapy
716140|NCT00564135|hysterectomy|hysterectomy
716141|NCT00564135|laparoscopy|laparoscopy
716142|NCT00564135|urinary retention|urinary retention
716143|NCT00564135|urinary tract infection|urinary tract infection
716144|NCT00564135|catheterization|catheterization
716145|NCT00564122|Murmur|murmur
716146|NCT00564122|Artificial-Intelligence|artificial-intelligence
716147|NCT00564122|Stethoscope|stethoscope
716148|NCT00564122|Congenital Heart Disease|congenital heart disease
716149|NCT00564122|Structural Heart Disease|structural heart disease
716150|NCT00564083|Compare the relative differences between the organic and sythentic materials for sacryl colpopexy.|compare the relative differences between the organic and sythentic materials for sacryl colpopexy.
716151|NCT00564070|Depression|depression
716152|NCT00564070|Diabetes|diabetes
716153|NCT00564070|Adherence|adherence
716154|NCT00564057|HIV|hiv
716155|NCT00564057|blood pressure|blood pressure
716156|NCT00564057|left ventricle|left ventricle
716157|NCT00564057|metabolic profile|metabolic profile
716158|NCT00564057|treatment experienced|treatment experienced
716159|NCT00564044|biofilm-infection-related immune hyperreactivity|biofilm-infection-related immune hyperreactivity
716160|NCT00564044|mesh extrusion|mesh extrusion
716161|NCT00564044|mid-urethral sling|mid-urethral sling
716162|NCT00564044|determine the immune reactivity of biofilms in mesh erosion|determine the immune reactivity of biofilms in mesh erosion
716163|NCT00564031|hormone replacement therapy; endothelial function;|hormone replacement therapy; endothelial function;
716164|NCT00564018|type 1 diabetes, basal-bolus, honeymoon, C-peptide|type 1 diabetes, basal-bolus, honeymoon, c-peptide
716165|NCT00564005|stroke rehabilitation|stroke rehabilitation
716166|NCT00564005|cortical reorganization|cortical reorganization
716167|NCT00564005|kinematic analysis|kinematic analysis
716168|NCT00563979|age related macular degeneration|age related macular degeneration
716169|NCT00563979|supplementation|supplementation
716170|NCT00563979|macular pigment|macular pigment
716171|NCT00563966|smoking pregnancy behaviour polymorphisms|smoking pregnancy behaviour polymorphisms
716172|NCT00563953|Breast|breast
716173|NCT00563953|Cancer|cancer
716174|NCT00563953|Anthracyclines|anthracyclines
716175|NCT00563953|Cardiopathy|cardiopathy
716176|NCT00563940|diabetic macular edema|diabetic macular edema
716177|NCT00563940|OCT|oct
716178|NCT00563927|Nasopharyngeal Carcinoma|nasopharyngeal carcinoma
716179|NCT00563927|T1-4N2-3M0|t1-4n2-3m0
716180|NCT00563914|Malaria|malaria
716181|NCT00563901|CHD|chd
716182|NCT00563901|Combined CHD|combined chd
716183|NCT00563901|Stroke|stroke
716184|NCT00563901|Combined Cardiovascular Disease (CVD)|combined cardiovascular disease (cvd)
716185|NCT00563901|Pharmacogenetics|pharmacogenetics
716186|NCT00563901|End-Stage Renal Disease|end-stage renal disease
716187|NCT00563901|Heart Failure|heart failure
716188|NCT00563901|Hospitalized/Fatal Heart Failure|hospitalized/fatal heart failure
716189|NCT00563901|Angina|angina
716190|NCT00563901|Coronary Revascularizations|coronary revascularizations
716191|NCT00563901|CHD Mortality|chd mortality
716192|NCT00563901|Lisinopril|lisinopril
716193|NCT00563901|Chlorthalidone|chlorthalidone
716194|NCT00563901|Amlodipine|amlodipine
716195|NCT00563901|Doxazosin|doxazosin
716196|NCT00563888|PTSD|ptsd
716197|NCT00563888|torture survivors|torture survivors
716198|NCT00563888|Narrative Exposure Therapy|narrative exposure therapy
716199|NCT00563888|trauma-related memory processes|trauma-related memory processes
716200|NCT00563888|steady state visual evoked fields|steady state visual evoked fields
716202|NCT00563875|Platelet aggregation|platelet aggregation
716203|NCT00563875|Drug resistance|drug resistance
716204|NCT00563875|Aspirin|aspirin
716205|NCT00563875|Diabetes mellitus|diabetes mellitus
716206|NCT00563862|Nasopharyngeal Carcinoma|nasopharyngeal carcinoma
716207|NCT00563862|T3-4N0-1M0|t3-4n0-1m0
716208|NCT00563836|ovarian cancer|ovarian cancer
716209|NCT00563836|catumaxomab|catumaxomab
716210|NCT00563836|phase II|phase ii
716211|NCT00563836|intraoperative|intraoperative
716212|NCT00563836|adjuvant|adjuvant
716213|NCT00563836|trifunctional antibody|trifunctional antibody
716214|NCT00563823|stage IV melanoma|stage iv melanoma
716215|NCT00563823|recurrent melanoma|recurrent melanoma
716216|NCT00563810|Adult|adult
716217|NCT00563810|Aged|aged
716218|NCT00563797|treatment|treatment
716219|NCT00563797|alcohol dependence|alcohol dependence
716220|NCT00563797|depression|depression
716221|NCT00563797|mecamylamine|mecamylamine
716222|NCT00563784|Non-Small Cell Lung Cancer|non-small cell lung cancer
716223|NCT00563784|Lung Cancer|lung cancer
716224|NCT00563784|Squamous Cell Carcinoma|squamous cell carcinoma
716225|NCT00563784|Adenocarcinoma|adenocarcinoma
716226|NCT00563784|Bronchoalveolar Cell Carcinoma|bronchoalveolar cell carcinoma
716227|NCT00563784|Large Cell Anaplastic Carcinoma|large cell anaplastic carcinoma
716228|NCT00563784|Giant Cell Carcinoma|giant cell carcinoma
716229|NCT00563784|Clear Cell Carcinoma|clear cell carcinoma
716230|NCT00563784|Erlotinib|erlotinib
716231|NCT00563784|Erlotinib Hydrocholoride|erlotinib hydrocholoride
716232|NCT00563784|OSI-774|osi-774
716233|NCT00563784|Tarceva|tarceva
716234|NCT00563784|Carboplatin|carboplatin
716235|NCT00563784|Paraplatin|paraplatin
716236|NCT00563784|Paclitaxel|paclitaxel
716237|NCT00563784|Taxol|taxol
716238|NCT00563784|NSCLC|nsclc
716239|NCT00563758|Chronic constipation|chronic constipation
716240|NCT00563745|COPD|copd
716242|NCT00563745|Telemedicine|telemedicine
716243|NCT00563745|mechanical ventilation|mechanical ventilation
716244|NCT00563745|Integrated care|integrated care
716245|NCT00563745|strict follow up|strict follow up
716246|NCT00563745|impact and costs on health care resources|impact and costs on health care resources
716247|NCT00563745|telemedicine programme|telemedicine programme
716248|NCT00563745|home mechanical ventilation (HMV)|home mechanical ventilation (hmv)
716249|NCT00563745|frail patients|frail patients
716250|NCT00563745|chronic respiratory failure (CRF)|chronic respiratory failure (crf)
716251|NCT00563693|heart failure|heart failure
716252|NCT00563693|cheyne stokes respiration|cheyne stokes respiration
716253|NCT00563693|adaptive servo ventilator|adaptive servo ventilator
716254|NCT00563680|AMG 479|amg 479
716255|NCT00563680|IGF-1R|igf-1r
716256|NCT00563680|Insulin-like growth factor|insulin-like growth factor
716257|NCT00563680|Insulin-like growth factor receptor|insulin-like growth factor receptor
716258|NCT00563680|Ewing's|ewing's
716259|NCT00563680|Sarcoma|sarcoma
716260|NCT00563667|Pterygium|pterygium
716261|NCT00563667|Cataract|cataract
716262|NCT00563667|Astigmatism|astigmatism
716263|NCT00563654|Benign Prostatic Hyperplasia (BPH)|benign prostatic hyperplasia (bph)
716264|NCT00563654|Acute Retention of Urine (AUR)|acute retention of urine (aur)
716265|NCT00563641|NCPAP|ncpap
716266|NCT00563641|Very early surfactant|very early surfactant
716267|NCT00563628|Pattern Scan Laser.|pattern scan laser.
716268|NCT00563628|Photocoagulation.|photocoagulation.
716269|NCT00563628|Diabetic retinopathy treatment.|diabetic retinopathy treatment.
716270|NCT00563628|Laser treatment|laser treatment
716271|NCT00563615|Constipation (idiopathic)|constipation (idiopathic)
716272|NCT00563602|Portal hypertension|portal hypertension
716273|NCT00563602|Prevention of rebleeding|prevention of rebleeding
716274|NCT00563602|Complications of cirrhosis|complications of cirrhosis
716275|NCT00563602|Portal hemodynamic|portal hemodynamic
716276|NCT00563602|Prazosine|prazosine
716277|NCT00563602|Nadolol|nadolol
716278|NCT00563602|isosorbide mononitrate|isosorbide mononitrate
716279|NCT00563589|Acute graft-versus-host disease post high risk allogeneic stem cell transplantation|acute graft-versus-host disease post high risk allogeneic stem cell transplantation
716280|NCT00563576|Depo-Provera|depo-provera
716281|NCT00563576|Medroxyprogesterone Acetate|medroxyprogesterone acetate
716282|NCT00563576|Metrorrhagia|metrorrhagia
716283|NCT00563576|Irregular Bleeding|irregular bleeding
716284|NCT00563563|Nicotine-dependence in overweight and obese subjects|nicotine-dependence in overweight and obese subjects
716285|NCT00563537|neurology|neurology
716286|NCT00563537|sclerosis|sclerosis
716287|NCT00563537|imaging|imaging
716288|NCT00563537|tomography|tomography
716289|NCT00563511|smoking cessation|smoking cessation
716290|NCT00563498|Veno-occlusive disease|veno-occlusive disease
716291|NCT00563498|Mucositis|mucositis
716292|NCT00563485|Benign Prostatic Hyperplasia (BPH)|benign prostatic hyperplasia (bph)
716293|NCT00563485|Acute Retention of Urine (AUR)|acute retention of urine (aur)
716294|NCT00563472|Healthy female volunteers will participate in this study|healthy female volunteers will participate in this study
716295|NCT00563459|Epilepsy, seizures|epilepsy, seizures
716296|NCT00563459|partial onset seizures|partial onset seizures
716297|NCT00563459|anti-epileptic drugs (AED)|anti-epileptic drugs (aed)
716298|NCT00563459|carisbamate|carisbamate
716300|NCT00563459|levetiracetam|levetiracetam
716301|NCT00563446|Anemia|anemia
716302|NCT00563446|End-stage renal failure|end-stage renal failure
716303|NCT00563446|Continuous ambulatory peritoneal dialysis|continuous ambulatory peritoneal dialysis
716304|NCT00563433|diabetic|diabetic
716305|NCT00563433|diabetes mellitus|diabetes mellitus
716306|NCT00563433|foot|foot
716307|NCT00563433|ulcers|ulcers
716308|NCT00563433|Floxin|floxin
716309|NCT00563433|oral antibiotic|oral antibiotic
716310|NCT00563433|topical cream|topical cream
716311|NCT00563420|Lung cancer|lung cancer
716312|NCT00563407|skin toxicity prediction|skin toxicity prediction
716313|NCT00563407|cardiac toxicity prediction|cardiac toxicity prediction
716314|NCT00563394|diabetic|diabetic
716315|NCT00563394|diabetes mellitus|diabetes mellitus
716316|NCT00563394|foot|foot
716317|NCT00563394|ulcers|ulcers
716318|NCT00563394|Floxin|floxin
716319|NCT00563394|oral antibiotic|oral antibiotic
716320|NCT00563394|topical cream|topical cream
716321|NCT00563355|chronic kidney disease|chronic kidney disease
716322|NCT00563355|cardiovascular disease|cardiovascular disease
716323|NCT00563342|Ethanol, lock solution, infection|ethanol, lock solution, infection
716413|NCT00562978|stage IV grade 1 follicular lymphoma|stage iv grade 1 follicular lymphoma
716767|NCT00561613|nonoxynol-9|nonoxynol-9
716324|NCT00563329|Smokers who are not willing to quit in the near future but intend to reduce smoking|smokers who are not willing to quit in the near future but intend to reduce smoking
716325|NCT00563316|colorectal cancer|colorectal cancer
716326|NCT00563316|chemotherapy|chemotherapy
716327|NCT00563316|cancer|cancer
716328|NCT00563316|metastatic|metastatic
716329|NCT00563316|irinotecan|irinotecan
716330|NCT00563316|EGFr|egfr
716331|NCT00563316|epidermal growth factor|epidermal growth factor
716332|NCT00563277|Pterygium|pterygium
716333|NCT00563277|Cataract|cataract
716334|NCT00563277|Intraocular lens power calculation accuracy|intraocular lens power calculation accuracy
716335|NCT00563264|obesity|obesity
716336|NCT00563264|parenting|parenting
716337|NCT00563264|postpartum period|postpartum period
716338|NCT00563264|family research|family research
716339|NCT00563251|Bronchiolitis obliterans in bone marrow transplant recipients|bronchiolitis obliterans in bone marrow transplant recipients
716340|NCT00563238|Extubation|extubation
716341|NCT00563212|Lung Diseases, Interstitial|lung diseases, interstitial
716342|NCT00563212|Fibrosis|fibrosis
716343|NCT00563212|Interferons|interferons
716344|NCT00563212|Pulmonary Fibrosis|pulmonary fibrosis
716345|NCT00563212|Pathologic Processes|pathologic processes
716346|NCT00563212|Lung Diseases|lung diseases
716347|NCT00563212|Fibrosing alveolitis|fibrosing alveolitis
716348|NCT00563212|Interferon-gamma, Recombinant|interferon-gamma, recombinant
716349|NCT00563212|Aerosols|aerosols
716350|NCT00563199|smoking cessation|smoking cessation
716351|NCT00563199|smoking behaviors|smoking behaviors
716352|NCT00563186|infection control|infection control
716353|NCT00563186|nosocomial infection|nosocomial infection
716354|NCT00563186|hospital design|hospital design
716355|NCT00563186|physical plant design|physical plant design
716356|NCT00563186|antibiotic resistant organisms|antibiotic resistant organisms
716357|NCT00563186|MRSA|mrsa
716358|NCT00563186|VRE|vre
716359|NCT00563186|CDI|cdi
716360|NCT00563160|lung cancer|lung cancer
716361|NCT00563147|tivozanib|tivozanib
716362|NCT00563147|AV-951|av-951
716363|NCT00563134|Suspected or confirmed severe Gram-negative sepsis|suspected or confirmed severe gram-negative sepsis
716364|NCT00563121|Retinopathy of Prematurity|retinopathy of prematurity
716365|NCT00563121|ROP|rop
716366|NCT00563121|Vascular Endothelial Growth Factor|vascular endothelial growth factor
716367|NCT00563121|VEGF|vegf
716368|NCT00563121|Vitreous|vitreous
716369|NCT00563121|Subretinal Fluid|subretinal fluid
716370|NCT00563121|ELISA|elisa
716371|NCT00563121|VEGF levels in Aqueous, Vitreous and subretinal Fluid|vegf levels in aqueous, vitreous and subretinal fluid
716372|NCT00563108|Acute graft-versus-host disease post allogeneic stem cell transplantation|acute graft-versus-host disease post allogeneic stem cell transplantation
716373|NCT00563095|Hepatocellular carcinoma|hepatocellular carcinoma
716374|NCT00563082|SLE|sle
716375|NCT00563082|Genetics|genetics
716376|NCT00563069|diagnostic and therapeutic rigid cystoscopy|diagnostic and therapeutic rigid cystoscopy
716377|NCT00563056|Formoterol|formoterol
716378|NCT00563056|Fluticasone|fluticasone
716379|NCT00563056|Asthma|asthma
716380|NCT00563043|Pattern Scan Laser.|pattern scan laser.
716381|NCT00563043|Photocoagulation.|photocoagulation.
716382|NCT00563043|Diabetic retinopathy treatment.|diabetic retinopathy treatment.
716383|NCT00563043|Laser treatment.|laser treatment.
716384|NCT00563043|Electroretinogram.|electroretinogram.
716385|NCT00563043|a wave.|a wave.
716386|NCT00563043|b wave.|b wave.
716387|NCT00563043|Implicit time.|implicit time.
716388|NCT00563030|Cardiopulmonary bypass|cardiopulmonary bypass
716389|NCT00563030|Neutrophils|neutrophils
716390|NCT00563030|Coronary artery bypass graft surgery|coronary artery bypass graft surgery
716391|NCT00563017|Catatonic Schizophrenia|catatonic schizophrenia
716392|NCT00563017|Disorganized Schizophrenia|disorganized schizophrenia
716393|NCT00563017|Paranoid Schizophrenia|paranoid schizophrenia
716394|NCT00563017|Undifferentiated Schizophrenia|undifferentiated schizophrenia
716395|NCT00563017|Schizo-affective disorders|schizo-affective disorders
716396|NCT00563004|Diabetes mellitus|diabetes mellitus
716397|NCT00563004|Herbal treatment|herbal treatment
716398|NCT00563004|Food supplement|food supplement
716399|NCT00562991|exhaled NO|exhaled no
716400|NCT00562991|asthma|asthma
716401|NCT00562991|child|child
716402|NCT00562978|recurrent grade 1 follicular lymphoma|recurrent grade 1 follicular lymphoma
716403|NCT00562978|recurrent grade 2 follicular lymphoma|recurrent grade 2 follicular lymphoma
716404|NCT00562978|recurrent grade 3 follicular lymphoma|recurrent grade 3 follicular lymphoma
716405|NCT00562978|recurrent adult diffuse large cell lymphoma|recurrent adult diffuse large cell lymphoma
716406|NCT00562978|recurrent adult diffuse mixed cell lymphoma|recurrent adult diffuse mixed cell lymphoma
716407|NCT00562978|recurrent adult diffuse small cleaved cell lymphoma|recurrent adult diffuse small cleaved cell lymphoma
716408|NCT00562978|recurrent adult immunoblastic large cell lymphoma|recurrent adult immunoblastic large cell lymphoma
716409|NCT00562978|recurrent mantle cell lymphoma|recurrent mantle cell lymphoma
716410|NCT00562978|stage III grade 1 follicular lymphoma|stage iii grade 1 follicular lymphoma
716411|NCT00562978|stage III grade 2 follicular lymphoma|stage iii grade 2 follicular lymphoma
716412|NCT00562978|stage III grade 3 follicular lymphoma|stage iii grade 3 follicular lymphoma
716672|NCT00561938|tolerance|tolerance
716414|NCT00562978|stage IV grade 2 follicular lymphoma|stage iv grade 2 follicular lymphoma
716415|NCT00562978|stage IV grade 3 follicular lymphoma|stage iv grade 3 follicular lymphoma
716416|NCT00562978|stage III adult diffuse large cell lymphoma|stage iii adult diffuse large cell lymphoma
716417|NCT00562978|stage III adult diffuse mixed cell lymphoma|stage iii adult diffuse mixed cell lymphoma
716418|NCT00562978|stage III adult diffuse small cleaved cell lymphoma|stage iii adult diffuse small cleaved cell lymphoma
716419|NCT00562978|stage IV adult diffuse large cell lymphoma|stage iv adult diffuse large cell lymphoma
716420|NCT00562978|stage IV adult diffuse mixed cell lymphoma|stage iv adult diffuse mixed cell lymphoma
716421|NCT00562978|stage IV adult diffuse small cleaved cell lymphoma|stage iv adult diffuse small cleaved cell lymphoma
716422|NCT00562978|stage III mantle cell lymphoma|stage iii mantle cell lymphoma
716423|NCT00562978|stage IV mantle cell lymphoma|stage iv mantle cell lymphoma
716424|NCT00562978|stage III adult immunoblastic large cell lymphoma|stage iii adult immunoblastic large cell lymphoma
716425|NCT00562978|stage IV adult immunoblastic large cell lymphoma|stage iv adult immunoblastic large cell lymphoma
716426|NCT00562952|Natriuretic peptide|natriuretic peptide
716427|NCT00562952|Prognosis|prognosis
716428|NCT00562952|Diabetes|diabetes
716429|NCT00562952|Heart failure|heart failure
716430|NCT00562952|Heart disease|heart disease
716431|NCT00562939|Antibody Formation|antibody formation
716432|NCT00562939|Antibody Affinity|antibody affinity
716433|NCT00562939|Immunity|immunity
716434|NCT00562939|Pneumococcal Vaccines|pneumococcal vaccines
716435|NCT00562939|Oligodeoxyribonucleotides|oligodeoxyribonucleotides
716436|NCT00562926|Schizophrenia|schizophrenia
716437|NCT00562926|Schizophrenia spectrum disorder|schizophrenia spectrum disorder
716438|NCT00562913|Cancer|cancer
716439|NCT00562913|Sorafenib|sorafenib
716440|NCT00562913|Cyclophosphamide|cyclophosphamide
716441|NCT00562913|Doxorubicin|doxorubicin
716442|NCT00562887|Crohn's Disease|crohn's disease
716444|NCT00562874|AIDS|aids
716445|NCT00562874|WOMEN|women
716446|NCT00562874|KENYA|kenya
716447|NCT00562874|NUTRITION|nutrition
716448|NCT00562874|HIV/AIDS|hiv/aids
716449|NCT00562874|treatment naive|treatment naive
716450|NCT00562861|Bipolar Disorder|bipolar disorder
716451|NCT00562861|Bipolar Depression|bipolar depression
716452|NCT00562861|Clinical Trials, Phase II|clinical trials, phase ii
716453|NCT00562861|Clinical Pharmacology|clinical pharmacology
716454|NCT00562848|gastric emptying|gastric emptying
716455|NCT00562848|pharmacokinetic|pharmacokinetic
716456|NCT00562848|tolerability|tolerability
716457|NCT00562848|safety|safety
716458|NCT00562848|GSK962040|gsk962040
716459|NCT00562848|gut motility|gut motility
716460|NCT00562848|First Time in Human|first time in human
716461|NCT00562835|ARDS|ards
716462|NCT00562835|Adult|adult
716463|NCT00562835|Methylprednisolone|methylprednisolone
716464|NCT00562796|Growth Hormone Deficiency|growth hormone deficiency
716465|NCT00562796|Cardiovascular Disease|cardiovascular disease
716466|NCT00562796|Intra-abdominal Fat|intra-abdominal fat
716467|NCT00562796|Insulin Resistance|insulin resistance
716468|NCT00562783|HBV|hbv
716469|NCT00562783|HCV|hcv
716470|NCT00562783|Liver cirrhosis|liver cirrhosis
716471|NCT00562770|Chronic Lymphocytic Leukemia|chronic lymphocytic leukemia
716472|NCT00562770|CLL|cll
716473|NCT00562770|Leukemia|leukemia
716474|NCT00562757|Wedensky modulation|wedensky modulation
716475|NCT00562757|Risk stratification|risk stratification
716476|NCT00562757|Electrophysiology|electrophysiology
716477|NCT00562757|Noninvasive|noninvasive
716478|NCT00562757|Ischemic heart disease|ischemic heart disease
716479|NCT00562757|ICD guidelines|icd guidelines
716480|NCT00562757|Myocardial infarction|myocardial infarction
716481|NCT00562718|stage II breast cancer|stage ii breast cancer
716482|NCT00562718|stage IIIA breast cancer|stage iiia breast cancer
716483|NCT00562718|stage IIIB breast cancer|stage iiib breast cancer
716484|NCT00562718|male breast cancer|male breast cancer
716485|NCT00562718|recurrent breast cancer|recurrent breast cancer
716486|NCT00562705|growth hormone|growth hormone
716487|NCT00562705|eating regulation|eating regulation
716488|NCT00562705|nutritional intervention|nutritional intervention
716489|NCT00562705|short stature|short stature
716490|NCT00562705|ISS|iss
716491|NCT00562705|SGA|sga
716492|NCT00562705|IGHD|ighd
716493|NCT00562705|MPHD|mphd
716494|NCT00562692|Heart failure|heart failure
716495|NCT00562692|OAD|oad
716496|NCT00562692|BNP|bnp
716497|NCT00562692|Heart Failure patients who present to the emergency department|heart failure patients who present to the emergency department
716498|NCT00562679|Patients with coronary artery disease|patients with coronary artery disease
716499|NCT00562666|cell therapy|cell therapy
716500|NCT00562666|T lymphocytes|t lymphocytes
716501|NCT00562666|hepatic intra-arterial injection|hepatic intra-arterial injection
716502|NCT00562653|profile autoantibodies|profile autoantibodies
716503|NCT00562653|clinical symptoms|clinical symptoms
716504|NCT00562640|recurrent ovarian epithelial cancer|recurrent ovarian epithelial cancer
716505|NCT00562640|stage IV ovarian epithelial cancer|stage iv ovarian epithelial cancer
716506|NCT00562640|recurrent primary peritoneal cavity cancer|recurrent primary peritoneal cavity cancer
716507|NCT00562640|stage IIIA primary peritoneal cavity cancer|stage iiia primary peritoneal cavity cancer
716508|NCT00562640|stage IIIB primary peritoneal cavity cancer|stage iiib primary peritoneal cavity cancer
716509|NCT00562640|stage IIIC primary peritoneal cavity cancer|stage iiic primary peritoneal cavity cancer
716510|NCT00562640|stage IV primary peritoneal cavity cancer|stage iv primary peritoneal cavity cancer
716511|NCT00562640|recurrent fallopian tube cancer|recurrent fallopian tube cancer
716512|NCT00562640|stage IIIA fallopian tube cancer|stage iiia fallopian tube cancer
716513|NCT00562640|stage IIIB fallopian tube cancer|stage iiib fallopian tube cancer
716514|NCT00562640|stage IIIC fallopian tube cancer|stage iiic fallopian tube cancer
716515|NCT00562640|stage IV fallopian tube cancer|stage iv fallopian tube cancer
716516|NCT00562640|stage IIIA ovarian epithelial cancer|stage iiia ovarian epithelial cancer
716517|NCT00562640|stage IIIB ovarian epithelial cancer|stage iiib ovarian epithelial cancer
716518|NCT00562640|stage IIIC ovarian epithelial cancer|stage iiic ovarian epithelial cancer
716519|NCT00562640|06-155|06-155
716520|NCT00562627|osteoarthritis|osteoarthritis
716521|NCT00562627|knee arthroplasty|knee arthroplasty
716522|NCT00562627|local infiltration analgesia|local infiltration analgesia
716523|NCT00562627|TKA|tka
716524|NCT00562627|epidural analgesia|epidural analgesia
716525|NCT00562627|operation|operation
716526|NCT00562627|surgery|surgery
716527|NCT00562601|Leukapheresis|leukapheresis
716528|NCT00562601|Plasmapheresis|plasmapheresis
716529|NCT00562601|Lymphocytes|lymphocytes
716530|NCT00562601|Neutrophils|neutrophils
716531|NCT00562536|Umbilical cord clamping|umbilical cord clamping
716532|NCT00562536|Preterm infants|preterm infants
716533|NCT00562536|Randomized controlled trial|randomized controlled trial
716534|NCT00562536|For women giving birth to singleton infants 32 weeks gestational age or less|for women giving birth to singleton infants 32 weeks gestational age or less
716535|NCT00562523|Cancer|cancer
716536|NCT00562523|Docetaxel|docetaxel
716537|NCT00562523|Sorafenib|sorafenib
716538|NCT00562510|HIV-1 infection|hiv-1 infection
716539|NCT00562510|raltegravir|raltegravir
716540|NCT00562510|immune discordance|immune discordance
716541|NCT00562510|treatment experienced|treatment experienced
716542|NCT00562497|Acute GVHD|acute gvhd
716543|NCT00562497|Acute Graft Versus Host Disease|acute graft versus host disease
716544|NCT00562471|adhesions|adhesions
716545|NCT00562471|gynecologic surgery|gynecologic surgery
716546|NCT00562471|laparoscopy|laparoscopy
716547|NCT00562471|laparotomy|laparotomy
716548|NCT00562471|polyethylene glycol|polyethylene glycol
716549|NCT00562471|hydrogel|hydrogel
716550|NCT00562471|Adhesions following gynecologic surgery to remove myomas|adhesions following gynecologic surgery to remove myomas
716551|NCT00562458|Advanced breast cancer|advanced breast cancer
716552|NCT00562458|Advanced breast cancer in postmenopausal women|advanced breast cancer in postmenopausal women
716553|NCT00562445|Adrenal insufficiency|adrenal insufficiency
716554|NCT00562445|GI bleeding|gi bleeding
716555|NCT00562445|Portal hypertension|portal hypertension
716556|NCT00562445|Acute pancreatitis|acute pancreatitis
716557|NCT00562445|Critical emergencies in digestive diseases|critical emergencies in digestive diseases
716558|NCT00562445|Severe acute pancreatitis|severe acute pancreatitis
716559|NCT00562432|atrial fibrillation|atrial fibrillation
716561|NCT00562432|ganglionated plexi|ganglionated plexi
716562|NCT00562406|Macular edema secondary to branch retinal vein occlusion|macular edema secondary to branch retinal vein occlusion
716563|NCT00562380|cutaneous B-cell non-Hodgkin lymphoma|cutaneous b-cell non-hodgkin lymphoma
716564|NCT00562380|angioimmunoblastic T-cell lymphoma|angioimmunoblastic t-cell lymphoma
716565|NCT00562380|stage IV cutaneous T-cell non-Hodgkin lymphoma|stage iv cutaneous t-cell non-hodgkin lymphoma
716566|NCT00562380|adult nasal type extranodal NK/T-cell lymphoma|adult nasal type extranodal nk/t-cell lymphoma
716567|NCT00562380|anaplastic large cell lymphoma|anaplastic large cell lymphoma
716568|NCT00562380|extranodal marginal zone B-cell lymphoma of mucosa-associated lymphoid tissue|extranodal marginal zone b-cell lymphoma of mucosa-associated lymphoid tissue
717402|NCT00558844|CFTR|cftr
716569|NCT00562380|nodal marginal zone B-cell lymphoma|nodal marginal zone b-cell lymphoma
716570|NCT00562380|recurrent adult Burkitt lymphoma|recurrent adult burkitt lymphoma
716571|NCT00562380|recurrent adult diffuse large cell lymphoma|recurrent adult diffuse large cell lymphoma
716572|NCT00562380|recurrent adult diffuse mixed cell lymphoma|recurrent adult diffuse mixed cell lymphoma
716573|NCT00562380|recurrent adult diffuse small cleaved cell lymphoma|recurrent adult diffuse small cleaved cell lymphoma
716574|NCT00562380|recurrent adult grade III lymphomatoid granulomatosis|recurrent adult grade iii lymphomatoid granulomatosis
716575|NCT00562380|recurrent adult immunoblastic large cell lymphoma|recurrent adult immunoblastic large cell lymphoma
716576|NCT00562380|recurrent adult lymphoblastic lymphoma|recurrent adult lymphoblastic lymphoma
716577|NCT00562380|recurrent cutaneous T-cell non-Hodgkin lymphoma|recurrent cutaneous t-cell non-hodgkin lymphoma
716578|NCT00562380|recurrent grade 1 follicular lymphoma|recurrent grade 1 follicular lymphoma
716579|NCT00562380|recurrent grade 2 follicular lymphoma|recurrent grade 2 follicular lymphoma
716580|NCT00562380|recurrent grade 3 follicular lymphoma|recurrent grade 3 follicular lymphoma
716581|NCT00562380|recurrent mantle cell lymphoma|recurrent mantle cell lymphoma
716582|NCT00562380|recurrent marginal zone lymphoma|recurrent marginal zone lymphoma
716583|NCT00562380|recurrent small lymphocytic lymphoma|recurrent small lymphocytic lymphoma
716584|NCT00562380|small intestine lymphoma|small intestine lymphoma
716766|NCT00561613|SILCS|silcs
716585|NCT00562380|splenic marginal zone lymphoma|splenic marginal zone lymphoma
716586|NCT00562380|unspecified adult solid tumor, protocol specific|unspecified adult solid tumor, protocol specific
716587|NCT00562380|recurrent Ewing sarcoma/peripheral primitive neuroectodermal tumor|recurrent ewing sarcoma/peripheral primitive neuroectodermal tumor
716588|NCT00562380|adult desmoplastic small round cell tumor|adult desmoplastic small round cell tumor
716589|NCT00562380|recurrent adult soft tissue sarcoma|recurrent adult soft tissue sarcoma
716590|NCT00562380|recurrent prostate cancer|recurrent prostate cancer
716591|NCT00562354|Vaccines, Pneumococcal Conjugate Vaccine|vaccines, pneumococcal conjugate vaccine
716592|NCT00562341|obesity|obesity
716593|NCT00562341|psa|psa
716594|NCT00562341|prostate cancer|prostate cancer
716595|NCT00562328|stage 0 chronic lymphocytic leukemia|stage 0 chronic lymphocytic leukemia
716596|NCT00562328|stage I chronic lymphocytic leukemia|stage i chronic lymphocytic leukemia
716597|NCT00562328|stage II chronic lymphocytic leukemia|stage ii chronic lymphocytic leukemia
716598|NCT00562302|lung biopsy|lung biopsy
716599|NCT00562289|Stroke|stroke
716600|NCT00562289|Patent Foramen Ovale|patent foramen ovale
716601|NCT00562289|Atrial septal aneurysm|atrial septal aneurysm
716602|NCT00562289|Antiplatelet therapy|antiplatelet therapy
716603|NCT00562289|Oral anticoagulants|oral anticoagulants
716604|NCT00562289|Transcatheter closure|transcatheter closure
716605|NCT00562289|Migraine|migraine
716606|NCT00562276|IUD|iud
716607|NCT00562276|insertion timing|insertion timing
716608|NCT00562263|overweight|overweight
716609|NCT00562263|obesity|obesity
716610|NCT00562263|adolescent|adolescent
716611|NCT00562263|insulin resistance|insulin resistance
716612|NCT00562263|treatment|treatment
716613|NCT00562237|immunogenicity|immunogenicity
716614|NCT00562237|safety|safety
716615|NCT00562237|adjuvanted pandemic vaccine|adjuvanted pandemic vaccine
716616|NCT00562224|PCI-24781|pci-24781
716617|NCT00562224|Neoplasms by site|neoplasms by site
716618|NCT00562224|Lymphoma, non-hodgkin|lymphoma, non-hodgkin
716619|NCT00562224|Hodgkin disease|hodgkin disease
716620|NCT00562224|Multiple myeloma|multiple myeloma
716621|NCT00562224|Leukemia, lymphocytic, chronic|leukemia, lymphocytic, chronic
716622|NCT00562211|children|children
716623|NCT00562185|recurrent ovarian epithelial cancer|recurrent ovarian epithelial cancer
716624|NCT00562185|ovarian sarcoma|ovarian sarcoma
716625|NCT00562185|recurrent ovarian germ cell tumor|recurrent ovarian germ cell tumor
716626|NCT00562185|ovarian stromal cancer|ovarian stromal cancer
716627|NCT00562159|rhinoconjunctivitis|rhinoconjunctivitis
716628|NCT00562159|rhinitis|rhinitis
716629|NCT00562159|conjunctivitis|conjunctivitis
716630|NCT00562159|allergy|allergy
716631|NCT00562159|allergen|allergen
716632|NCT00562159|immunotherapy|immunotherapy
716633|NCT00562146|nutrition|nutrition
716634|NCT00562146|enteral access|enteral access
716635|NCT00562107|Minimized ventricular pacing, clinical outcome, SafeR, AAIsafeR, dual chamber pacemaker therapy, % of ventricular pacing, hospitalizations, symptomatic AF|minimized ventricular pacing, clinical outcome, safer, aaisafer, dual chamber pacemaker therapy, % of ventricular pacing, hospitalizations, symptomatic af
716636|NCT00562094|Pantoprazole|pantoprazole
716637|NCT00562094|eGERD (Erosive Gastroesophageal Reflux Disease)|egerd (erosive gastroesophageal reflux disease)
716638|NCT00562094|NERD (Non-Erosive Reflux Disease)|nerd (non-erosive reflux disease)
716639|NCT00562094|sleep disorders|sleep disorders
716640|NCT00562081|asthma|asthma
716641|NCT00562081|Virtual Asthma Clinic|virtual asthma clinic
716642|NCT00562081|metabolites|metabolites
716643|NCT00562081|asthma education|asthma education
716644|NCT00562068|recurrent adult T-cell leukemia/lymphoma|recurrent adult t-cell leukemia/lymphoma
716645|NCT00562068|stage I adult T-cell leukemia/lymphoma|stage i adult t-cell leukemia/lymphoma
716646|NCT00562068|stage II adult T-cell leukemia/lymphoma|stage ii adult t-cell leukemia/lymphoma
716647|NCT00562068|stage III adult T-cell leukemia/lymphoma|stage iii adult t-cell leukemia/lymphoma
717403|NCT00558831|Acne|acne
716648|NCT00562068|stage IV adult T-cell leukemia/lymphoma|stage iv adult t-cell leukemia/lymphoma
716649|NCT00562068|anaplastic large cell lymphoma|anaplastic large cell lymphoma
716650|NCT00562068|angioimmunoblastic T-cell lymphoma|angioimmunoblastic t-cell lymphoma
716651|NCT00562068|small intestine lymphoma|small intestine lymphoma
716652|NCT00562068|peripheral T-cell lymphoma|peripheral t-cell lymphoma
716653|NCT00562042|pulmonary embolism|pulmonary embolism
716654|NCT00562042|risk stratification|risk stratification
716655|NCT00562042|prognosis|prognosis
716656|NCT00562042|troponin|troponin
716657|NCT00562042|Brain natriuretic peptide|brain natriuretic peptide
716658|NCT00562042|echocardiogram|echocardiogram
716659|NCT00562029|Diabetes Mellitus|diabetes mellitus
716660|NCT00562029|Surgery|surgery
716661|NCT00562029|Duodenal Bypass|duodenal bypass
716662|NCT00562029|Resolution|resolution
716663|NCT00562029|Surgical Procedures|surgical procedures
716664|NCT00562016|Patient undergoing scheduled PCI|patient undergoing scheduled pci
716665|NCT00562003|Ovarian cancer study|ovarian cancer study
716666|NCT00561990|pancreatic cancer|pancreatic cancer
716667|NCT00561977|Nutrition|nutrition
716668|NCT00561977|Dietary Quality|dietary quality
716669|NCT00561977|Weight loss|weight loss
716670|NCT00561938|Confocal laser endomicroscopy|confocal laser endomicroscopy
716671|NCT00561938|cancerous and non-cancerous conditions|cancerous and non-cancerous conditions
716673|NCT00561938|intravenous fluorescein|intravenous fluorescein
716674|NCT00561938|Digestive symptoms or disease requiring an endoscopy procedure (upper GI endoscopy or colonoscopy) performed under general anaesthesia|digestive symptoms or disease requiring an endoscopy procedure (upper gi endoscopy or colonoscopy) performed under general anaesthesia
716675|NCT00561912|Renal Cell Carcinoma|renal cell carcinoma
716676|NCT00561912|Renal Cell Cancer|renal cell cancer
716677|NCT00561912|Clear Cell|clear cell
716678|NCT00561912|Kidney|kidney
716679|NCT00561912|Decitabine|decitabine
716680|NCT00561912|Dacogen|dacogen
716681|NCT00561912|5-Aza-Deoxycytidine|5-aza-deoxycytidine
716682|NCT00561912|Interferon Alfa-2b|interferon alfa-2b
716683|NCT00561912|Intron A®|intron a®
716684|NCT00561912|RCC|rcc
716685|NCT00561899|safety|safety
716686|NCT00561899|tolerability|tolerability
716687|NCT00561899|efficacy|efficacy
716688|NCT00561899|intermittent prevetive treatment|intermittent prevetive treatment
716689|NCT00561899|children|children
716690|NCT00561886|COPD|copd
716691|NCT00561886|lung function|lung function
716692|NCT00561886|dysnpea|dysnpea
716693|NCT00561873|astrocytoma, glioblastoma, intrinsic pontine glioma|astrocytoma, glioblastoma, intrinsic pontine glioma
716694|NCT00561860|Obstructive sleep apnea-hypopnea|obstructive sleep apnea-hypopnea
716695|NCT00561860|Telemedicine|telemedicine
716696|NCT00561834|non-arteritic ischemic optic neuropathy|non-arteritic ischemic optic neuropathy
716697|NCT00561834|ranibizumab|ranibizumab
716698|NCT00561834|naion|naion
716699|NCT00561821|elderly|elderly
716700|NCT00561821|randomized|randomized
716701|NCT00561821|placebo controlled|placebo controlled
716702|NCT00561808|PCO/PCOD|pco/pcod
716703|NCT00561808|IVM|ivm
716704|NCT00561808|Immature Oocytes|immature oocytes
716705|NCT00561795|AGO|ago
716706|NCT00561795|Advanced,|advanced,
716707|NCT00561795|Gynaecologic cancer(s),|gynaecologic cancer(s),
716708|NCT00561795|Genetics|genetics
716709|NCT00561795|GW786034,|gw786034,
716710|NCT00561795|Pazopanib,|pazopanib,
716711|NCT00561782|Spinal Cord Injury Pain|spinal cord injury pain
716712|NCT00561782|Chronic Neuropathic Pain|chronic neuropathic pain
716713|NCT00561782|SCI Pain|sci pain
716714|NCT00561782|Pain, Chronic Neuropathic|pain, chronic neuropathic
716715|NCT00561782|Spectroscopy, Magnetic Resonance|spectroscopy, magnetic resonance
716716|NCT00561782|MRS|mrs
716717|NCT00561782|Traumatic Brain Injury Pain|traumatic brain injury pain
716718|NCT00561769|poor responder|poor responder
716719|NCT00561769|growth hormone|growth hormone
716720|NCT00561769|luteal|luteal
716721|NCT00561756|cutaneous B-cell non-Hodgkin lymphoma|cutaneous b-cell non-hodgkin lymphoma
716722|NCT00561756|recurrent grade 1 follicular lymphoma|recurrent grade 1 follicular lymphoma
716723|NCT00561756|recurrent grade 2 follicular lymphoma|recurrent grade 2 follicular lymphoma
716724|NCT00561756|recurrent grade 3 follicular lymphoma|recurrent grade 3 follicular lymphoma
716725|NCT00561756|extranodal marginal zone B-cell lymphoma of mucosa-associated lymphoid tissue|extranodal marginal zone b-cell lymphoma of mucosa-associated lymphoid tissue
716726|NCT00561756|recurrent marginal zone lymphoma|recurrent marginal zone lymphoma
716727|NCT00561756|recurrent mantle cell lymphoma|recurrent mantle cell lymphoma
716728|NCT00561756|recurrent adult diffuse large cell lymphoma|recurrent adult diffuse large cell lymphoma
716729|NCT00561756|recurrent adult diffuse mixed cell lymphoma|recurrent adult diffuse mixed cell lymphoma
716730|NCT00561743|Multiple myeloma|multiple myeloma
716731|NCT00561743|response rate|response rate
716732|NCT00561743|peripheral stem cell transplant|peripheral stem cell transplant
716733|NCT00561743|safety|safety
716734|NCT00561743|tolerability|tolerability
716735|NCT00561730|PPI (Proton Pump Inhibitor) therapy|ppi (proton pump inhibitor) therapy
716736|NCT00561730|Pantoprazole|pantoprazole
716737|NCT00561730|eGERD (Erosive Gastroesophageal Reflux Disease)|egerd (erosive gastroesophageal reflux disease)
716738|NCT00561730|NERD (Non-Erosive Reflux Disease)|nerd (non-erosive reflux disease)
716739|NCT00561717|Seasonal Allergic Rhinitis|seasonal allergic rhinitis
716740|NCT00561717|Ragweed|ragweed
716741|NCT00561717|Pollen|pollen
716742|NCT00561717|Allergy|allergy
716743|NCT00561704|obese female|obese female
716744|NCT00561704|Type 2 Diabetes|type 2 diabetes
716745|NCT00561704|Diabetic Nephropathy|diabetic nephropathy
716746|NCT00561704|Glucose Metabolism|glucose metabolism
716747|NCT00561704|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers
716748|NCT00561704|Adiponectin|adiponectin
716749|NCT00561691|diffuse instrinsic ponitine glioma, brainstem|diffuse instrinsic ponitine glioma, brainstem
716750|NCT00561678|Postoperative Confusion|postoperative confusion
716751|NCT00561678|Postoperative Delirium|postoperative delirium
716752|NCT00561678|PD|pd
716753|NCT00561678|Postoperative Cognitive Dysfunction|postoperative cognitive dysfunction
716754|NCT00561678|POCD|pocd
716755|NCT00561652|Low back pain|low back pain
716756|NCT00561652|Chiropractic|chiropractic
716757|NCT00561652|Exercise|exercise
716758|NCT00561652|Veterans|veterans
716759|NCT00561639|sepsis|sepsis
716760|NCT00561639|immunosuppressed|immunosuppressed
716761|NCT00561639|multiplex PCR|multiplex pcr
716762|NCT00561639|diagnosis|diagnosis
716763|NCT00561639|therapeutic|therapeutic
716764|NCT00561613|Diaphragm|diaphragm
716765|NCT00561613|postcoital test|postcoital test
716768|NCT00561600|Hip arthroplasty|hip arthroplasty
716769|NCT00561600|Acetabular cup replacement|acetabular cup replacement
716770|NCT00561600|Acetabulum arthroplasty|acetabulum arthroplasty
716771|NCT00561587|novel antipsychotic|novel antipsychotic
716772|NCT00561587|quetiapine|quetiapine
716773|NCT00561587|depression|depression
716774|NCT00561587|psychopathology|psychopathology
716775|NCT00561574|elderly|elderly
716776|NCT00561574|randomized|randomized
716777|NCT00561574|double blind|double blind
716778|NCT00561561|Schizophrenia|schizophrenia
716779|NCT00561561|Prepulse Inhibition|prepulse inhibition
716780|NCT00561561|Acoustic Startle|acoustic startle
716781|NCT00561535|IBS|ibs
716782|NCT00561535|Diarrhea|diarrhea
716783|NCT00561535|Rome III|rome iii
716784|NCT00561522|Recurrence|recurrence
716785|NCT00561522|Metastasis|metastasis
716786|NCT00561522|Hepatocellular Carcinoma|hepatocellular carcinoma
716787|NCT00561522|Radical Hepatic Resection|radical hepatic resection
716788|NCT00561522|Drug Prevention|drug prevention
716789|NCT00561522|Capecitabine|capecitabine
716790|NCT00561522|Surgery|surgery
716791|NCT00561496|HIV prevention|hiv prevention
716792|NCT00561496|Microbicides|microbicides
716793|NCT00561496|Pharmacokinetics|pharmacokinetics
716794|NCT00561496|vaginal biopsies|vaginal biopsies
716795|NCT00561483|Acute heart failure|acute heart failure
716796|NCT00561483|cystatin C|cystatin c
716797|NCT00561483|renal failure|renal failure
716798|NCT00561483|biomarker|biomarker
716799|NCT00561470|colorectal cancer|colorectal cancer
716800|NCT00561470|metastatic|metastatic
716801|NCT00561470|anti-angiogenic|anti-angiogenic
716802|NCT00561470|irinotecan|irinotecan
716803|NCT00561470|5-FU|5-fu
716804|NCT00561470|FOLFIRI|folfiri
716805|NCT00561457|Iliac|iliac
716806|NCT00561457|Artery|artery
716807|NCT00561457|Occlusive|occlusive
716808|NCT00561457|Stenosis|stenosis
716809|NCT00561444|Prostate Cancer|prostate cancer
716810|NCT00561444|Radical retropubic prostatectomy|radical retropubic prostatectomy
716811|NCT00561444|Robotic prostatectomy|robotic prostatectomy
716812|NCT00561444|Photon external beam radiation|photon external beam radiation
716813|NCT00561444|Photon external beam radiation with hormone therapy|photon external beam radiation with hormone therapy
716814|NCT00561444|Proton radiation|proton radiation
716815|NCT00561444|Radioisotopic implant|radioisotopic implant
716816|NCT00561444|Cryotherapy|cryotherapy
716817|NCT00561444|Quality of Life|quality of life
716818|NCT00561444|Questionnaire|questionnaire
716819|NCT00561444|Survey|survey
716820|NCT00561444|QOL|qol
716821|NCT00561431|CVVHDF Dose Study|cvvhdf dose study
716822|NCT00561418|recurrent adult diffuse large cell lymphoma|recurrent adult diffuse large cell lymphoma
716823|NCT00561418|stage III adult diffuse large cell lymphoma|stage iii adult diffuse large cell lymphoma
716824|NCT00561418|stage IV adult diffuse large cell lymphoma|stage iv adult diffuse large cell lymphoma
716825|NCT00561418|recurrent grade 3 follicular lymphoma|recurrent grade 3 follicular lymphoma
716826|NCT00561418|recurrent adult Hodgkin lymphoma|recurrent adult hodgkin lymphoma
716827|NCT00561418|recurrent mantle cell lymphoma|recurrent mantle cell lymphoma
716828|NCT00561418|adult nasal type extranodal NK/T-cell lymphoma|adult nasal type extranodal nk/t-cell lymphoma
716829|NCT00561418|angioimmunoblastic T-cell lymphoma|angioimmunoblastic t-cell lymphoma
716830|NCT00561418|recurrent adult T-cell leukemia/lymphoma|recurrent adult t-cell leukemia/lymphoma
716831|NCT00561418|stage III adult T-cell leukemia/lymphoma|stage iii adult t-cell leukemia/lymphoma
716832|NCT00561418|stage IV adult T-cell leukemia/lymphoma|stage iv adult t-cell leukemia/lymphoma
716833|NCT00561418|small intestine lymphoma|small intestine lymphoma
716834|NCT00561418|anaplastic large cell lymphoma|anaplastic large cell lymphoma
716835|NCT00561405|Stroke|stroke
716836|NCT00561405|Walking|walking
716837|NCT00561405|Motor learning|motor learning
716838|NCT00561405|Skill acquisition|skill acquisition
716839|NCT00561392|Alzheimer's Disease|alzheimer's disease
716840|NCT00561392|Rivastigmine|rivastigmine
716841|NCT00561392|Patch|patch
716842|NCT00561379|Diffuse Large B Cell Lymphoma|diffuse large b cell lymphoma
716843|NCT00561379|not previously treated|not previously treated
716844|NCT00561366|ALS|als
716845|NCT00561366|Lou Gehrig's disease|lou gehrig's disease
716846|NCT00561353|Hepatitis C, Chronic|hepatitis c, chronic
716847|NCT00561353|Tibotec|tibotec
716848|NCT00561353|TMC435350-TiDP16-C201|tmc435350-tidp16-c201
716849|NCT00561353|TMC435350-C201|tmc435350-c201
716850|NCT00561353|TMC435|tmc435
716851|NCT00561353|PEGASYS (peginterferon alpha-2a, PegIFNα-2a)|pegasys (peginterferon alpha-2a, pegifnα-2a)
716852|NCT00561353|COPEGUS (ribavirin)|copegus (ribavirin)
716853|NCT00561340|ADHD|adhd
716854|NCT00561340|Growth|growth
716855|NCT00561340|Atomoxetine|atomoxetine
716856|NCT00561340|Pediasure|pediasure
716857|NCT00561327|hypertension|hypertension
716858|NCT00561327|angiotensin receptor blockers|angiotensin receptor blockers
716859|NCT00561327|peroxisome proliferator activated receptor gamma|peroxisome proliferator activated receptor gamma
716860|NCT00561314|sexual dysfunction|sexual dysfunction
716861|NCT00561314|urinary incontinence|urinary incontinence
716862|NCT00561314|adenocarcinoma of the prostate|adenocarcinoma of the prostate
717052|NCT00560378|Children|children
716863|NCT00561314|stage I prostate cancer|stage i prostate cancer
716864|NCT00561314|stage IIB prostate cancer|stage iib prostate cancer
716865|NCT00561314|stage IIA prostate cancer|stage iia prostate cancer
716866|NCT00561288|Acetaminophen|acetaminophen
716867|NCT00561288|Social Psychology|social psychology
716868|NCT00561288|Affect|affect
716869|NCT00561288|Interpersonal Rejection|interpersonal rejection
716870|NCT00561262|adenocarcinoma of the prostate|adenocarcinoma of the prostate
716871|NCT00561262|stage I prostate cancer|stage i prostate cancer
716872|NCT00561262|stage IIB prostate cancer|stage iib prostate cancer
716873|NCT00561262|stage IIA prostate cancer|stage iia prostate cancer
716874|NCT00561262|stage III prostate cancer|stage iii prostate cancer
716875|NCT00561223|chronic obstructive pulmonary disease|chronic obstructive pulmonary disease
716876|NCT00561223|pulmonary hypertension|pulmonary hypertension
716877|NCT00561210|infections|infections
716878|NCT00561184|H5N1 Pandemic|h5n1 pandemic
716879|NCT00561145|Anorexia of ageing|anorexia of ageing
716880|NCT00561145|Anorexia of aging|anorexia of aging
716881|NCT00561145|Energy balance|energy balance
716882|NCT00561145|Elderly|elderly
716883|NCT00561132|vanadium|vanadium
716884|NCT00561132|insulin sensitivity|insulin sensitivity
716885|NCT00561132|impaired glucose tolerance|impaired glucose tolerance
716886|NCT00561132|triglycerides|triglycerides
716887|NCT00561119|maintenance chemotherapy|maintenance chemotherapy
716888|NCT00561119|metastatic or recurrent breast cancer|metastatic or recurrent breast cancer
716889|NCT00561119|gemcitabine|gemcitabine
716890|NCT00561119|paclitaxel(GP)|paclitaxel(gp)
716891|NCT00561106|Bell´s palsy|bell´s palsy
716892|NCT00561106|prednisone|prednisone
716893|NCT00561106|valacyclovir|valacyclovir
716894|NCT00561093|Hypoalbuminemia|hypoalbuminemia
716895|NCT00561093|Protein-energy malnutrition|protein-energy malnutrition
716896|NCT00561093|Inflammation|inflammation
716897|NCT00561093|Oxidative stress|oxidative stress
716898|NCT00561093|Chronic Kidney disease (CKD) stage 5|chronic kidney disease (ckd) stage 5
716899|NCT00561093|maintenance hemodialysis|maintenance hemodialysis
716900|NCT00561067|Spinal cord injury|spinal cord injury
716901|NCT00561067|spinal shock|spinal shock
716902|NCT00561067|erythropoietin|erythropoietin
716903|NCT00561054|Coimbra|coimbra
716904|NCT00561054|NSCLC|nsclc
716905|NCT00561054|CETUXIMAB|cetuximab
716906|NCT00561041|alcohol|alcohol
716907|NCT00561041|alcohol use disorder|alcohol use disorder
716908|NCT00561041|cognitive-behavioral therapy|cognitive-behavioral therapy
716909|NCT00561041|brief phone aftercare intervention|brief phone aftercare intervention
716910|NCT00561041|individual aftercare therapy|individual aftercare therapy
716911|NCT00561028|Atherosclerosis|atherosclerosis
716912|NCT00561028|Coronary artery disease|coronary artery disease
716913|NCT00561028|Chlamydia pneumoniae|chlamydia pneumoniae
716914|NCT00561028|Mycoplasma pneumoniae|mycoplasma pneumoniae
716915|NCT00561015|Hepatitis C, Chronic|hepatitis c, chronic
716916|NCT00561015|Genotype 2|genotype 2
716917|NCT00561015|Genotype 3|genotype 3
716918|NCT00561015|Telaprevir|telaprevir
716919|NCT00561002|Influenza Vaccine|influenza vaccine
716920|NCT00561002|Influenza Virus|influenza virus
716921|NCT00561002|Orthomyxoviridae Infections|orthomyxoviridae infections
716922|NCT00561002|Fluzone®|fluzone®
716923|NCT00560989|Chronic Beryllium Disease|chronic beryllium disease
716924|NCT00560989|CBD|cbd
716925|NCT00560989|Beryllium|beryllium
716926|NCT00560989|Genetic|genetic
716927|NCT00560989|Environmental|environmental
716928|NCT00560976|neutrophil gelatinase associated lipocalin|neutrophil gelatinase associated lipocalin
716929|NCT00560976|hemodialysis|hemodialysis
716930|NCT00560976|iron|iron
716931|NCT00560976|inflammation|inflammation
716932|NCT00560976|Oxidative Stress|oxidative stress
716933|NCT00560963|Advanced or metastatic pancreas carcinoma|advanced or metastatic pancreas carcinoma
716934|NCT00560963|gemcitabine|gemcitabine
716935|NCT00560963|everolimus|everolimus
716936|NCT00560937|Schizophrenia|schizophrenia
716937|NCT00560937|Pregnenolone|pregnenolone
716938|NCT00560937|Cognition|cognition
716939|NCT00560937|Negative Symptoms|negative symptoms
716940|NCT00560911|oral anticoagulation|oral anticoagulation
716941|NCT00560911|self-management|self-management
716942|NCT00560911|elderly patients|elderly patients
716943|NCT00560911|randomised controlled trial|randomised controlled trial
716944|NCT00560898|staining|staining
716945|NCT00560898|epithelial barrier function|epithelial barrier function
716946|NCT00560885|atrial fibrillation|atrial fibrillation
716947|NCT00560885|af|af
716948|NCT00560885|ablation|ablation
716949|NCT00560885|arrhythmia|arrhythmia
716950|NCT00560885|racing heart|racing heart
716951|NCT00560885|afib|afib
716952|NCT00560885|surgical ablation|surgical ablation
716953|NCT00560872|atrial flutter|atrial flutter
716954|NCT00560872|ablation|ablation
716955|NCT00560872|navigation|navigation
716956|NCT00560859|Sleep disordered breathing|sleep disordered breathing
716957|NCT00560859|Sleep apnea|sleep apnea
716958|NCT00560859|Tonsillectomy|tonsillectomy
716959|NCT00560859|Adenoidectomy|adenoidectomy
716960|NCT00560859|Snoring|snoring
717732|NCT00557492|resectable|resectable
716961|NCT00560859|Neurobehavioral Manifestations|neurobehavioral manifestations
716962|NCT00560859|Obstructive Sleep Apnea Syndrome|obstructive sleep apnea syndrome
716963|NCT00560846|Gastric cancer|gastric cancer
716964|NCT00560846|Esophageal cancer|esophageal cancer
716965|NCT00560846|Surgical complications|surgical complications
716966|NCT00560846|Immunonutrition|immunonutrition
716967|NCT00560820|β-thalassemia|β-thalassemia
716968|NCT00560820|transfusional iron overload|transfusional iron overload
716969|NCT00560820|renal function|renal function
716970|NCT00560820|renal biomarkers|renal biomarkers
716971|NCT00560820|deferasirox|deferasirox
716972|NCT00560807|WAD II|wad ii
716973|NCT00560807|WAD III|wad iii
716974|NCT00560807|mobilization|mobilization
716975|NCT00560807|dosage|dosage
716976|NCT00560807|acute whiplash associated disorders (WAD) II and III (113) with a symptom duration of less than 30 days|acute whiplash associated disorders (wad) ii and iii (113) with a symptom duration of less than 30 days
716977|NCT00560807|neck pain|neck pain
716978|NCT00560794|Minimal Residual Disease|minimal residual disease
716979|NCT00560794|adult ALL|adult all
716980|NCT00560794|immunotherapeutic treatment|immunotherapeutic treatment
716981|NCT00560794|anti-CD19 bispecific antibody derivative|anti-cd19 bispecific antibody derivative
716982|NCT00560794|Blinatumomab|blinatumomab
716983|NCT00560794|MT103|mt103
716984|NCT00560781|PTSD|ptsd
716985|NCT00560781|Pregnenolone|pregnenolone
716986|NCT00560781|Cognition|cognition
716987|NCT00560768|Risk stratification method, negative predictive value, fast ventricular arrhythmias, ICD|risk stratification method, negative predictive value, fast ventricular arrhythmias, icd
716988|NCT00560768|The negative predictive value of the T amplitude variance as a method for risk stratification for patients with an increased risk for SCD.|the negative predictive value of the t amplitude variance as a method for risk stratification for patients with an increased risk for scd.
716989|NCT00560755|Prevention of: measles, mumps, rubella and varicella|prevention of: measles, mumps, rubella and varicella
716990|NCT00560729|elderly people|elderly people
716991|NCT00560690|Hepatitis C|hepatitis c
716992|NCT00560690|metformin|metformin
716993|NCT00560690|Insulin Resistance|insulin resistance
716994|NCT00560677|Schizophrenia|schizophrenia
716995|NCT00560677|PTSD|ptsd
716996|NCT00560677|Cognition|cognition
716997|NCT00560664|knee|knee
716998|NCT00560664|chondral defect|chondral defect
716999|NCT00560664|osteochondral defect|osteochondral defect
717000|NCT00560651|keratoconus|keratoconus
717001|NCT00560651|cornea|cornea
717002|NCT00560651|cross linking|cross linking
717003|NCT00560651|UV-light|uv-light
717004|NCT00560651|riboflavin|riboflavin
717005|NCT00560612|PTSD|ptsd
717006|NCT00560612|Paroxetine|paroxetine
717007|NCT00560612|Subthreshold|subthreshold
717008|NCT00560599|MRSA|mrsa
717009|NCT00560599|Methicillin Resistant Staphylococcus aureus|methicillin resistant staphylococcus aureus
717010|NCT00560599|Staphylococcus aureus|staphylococcus aureus
717011|NCT00560599|Skin Infections|skin infections
717012|NCT00560599|Body Decolonization|body decolonization
717013|NCT00560599|Environmental Decolonization|environmental decolonization
717014|NCT00560586|sleep fragmentation|sleep fragmentation
717015|NCT00560586|apnea|apnea
717016|NCT00560586|hypoxia|hypoxia
717017|NCT00560560|Refractory Colorectal|refractory colorectal
717018|NCT00560560|Single arm|single arm
717019|NCT00560560|Phase 2|phase 2
717020|NCT00560534|Magnetic resonance|magnetic resonance
717021|NCT00560534|whole body|whole body
717022|NCT00560534|angiography|angiography
717023|NCT00560534|venous compression|venous compression
717025|NCT00560521|CPAP|cpap
717026|NCT00560521|Tuberculosis|tuberculosis
717027|NCT00560521|Pleural effusion|pleural effusion
717028|NCT00560521|Physiotherapy|physiotherapy
717707|NCT00557622|Paroxetine|paroxetine
717029|NCT00560495|stage I non-small cell lung cancer|stage i non-small cell lung cancer
717030|NCT00560495|stage II non-small cell lung cancer|stage ii non-small cell lung cancer
717031|NCT00560495|stage IIIA non-small cell lung cancer|stage iiia non-small cell lung cancer
717032|NCT00560495|stage IIIB non-small cell lung cancer|stage iiib non-small cell lung cancer
717033|NCT00560495|adenocarcinoma of the lung|adenocarcinoma of the lung
717034|NCT00560495|adenosquamous cell lung cancer|adenosquamous cell lung cancer
717035|NCT00560495|large cell lung cancer|large cell lung cancer
717036|NCT00560495|squamous cell lung cancer|squamous cell lung cancer
717037|NCT00560482|prostate|prostate
717038|NCT00560482|cancer|cancer
717039|NCT00560482|prostatic cancer|prostatic cancer
717040|NCT00560482|castrate-resistant prostate cancer (CRPC)|castrate-resistant prostate cancer (crpc)
717041|NCT00560469|Adipokines|adipokines
717042|NCT00560469|Inflammation|inflammation
717043|NCT00560469|Metabolic syndrome|metabolic syndrome
717044|NCT00560456|Age, Snoring, Driving simulator, Sleep deprivation, chronic sleep restriction, objective and subjective sleepiness|age, snoring, driving simulator, sleep deprivation, chronic sleep restriction, objective and subjective sleepiness
717045|NCT00560443|bone fracture|bone fracture
717046|NCT00560443|ketorolac|ketorolac
717047|NCT00560443|tramadol|tramadol
717048|NCT00560378|Tacrolimus|tacrolimus
717049|NCT00560378|Administration, topical|administration, topical
717050|NCT00560378|Drug safety|drug safety
717051|NCT00560378|Adults|adults
717053|NCT00560365|stage I colon cancer|stage i colon cancer
717054|NCT00560365|stage II colon cancer|stage ii colon cancer
717055|NCT00560365|stage III colon cancer|stage iii colon cancer
717056|NCT00560365|stage I rectal cancer|stage i rectal cancer
717057|NCT00560365|stage II rectal cancer|stage ii rectal cancer
717058|NCT00560365|stage III rectal cancer|stage iii rectal cancer
717059|NCT00560339|Congestive Heart Failure|congestive heart failure
717060|NCT00560339|Implantable Defibrillators|implantable defibrillators
717061|NCT00560339|Intrathoracic Impedance|intrathoracic impedance
717062|NCT00560326|Paediatric patients|paediatric patients
717063|NCT00560326|Tacrolimus|tacrolimus
717064|NCT00560326|Dermatitis, Atopic|dermatitis, atopic
717065|NCT00560313|Meningococcal disease|meningococcal disease
717066|NCT00560313|prevention|prevention
717067|NCT00560313|vaccination|vaccination
717068|NCT00560287|Amyotrophic Lateral Sclerosis|amyotrophic lateral sclerosis
717069|NCT00560287|Non-invasive ventilation|non-invasive ventilation
717070|NCT00560287|Chronic Respiratory Failure|chronic respiratory failure
717071|NCT00560261|Sickle cell disease;|sickle cell disease;
717072|NCT00560261|Lung capillary blood volume;|lung capillary blood volume;
717073|NCT00560261|Children|children
717074|NCT00560248|Chest Pain|chest pain
717075|NCT00560248|STEMI|stemi
717076|NCT00560248|UA/NSTEMI|ua/nstemi
717077|NCT00560248|ACS|acs
717078|NCT00560248|Emergency Department|emergency department
717079|NCT00560222|randomized controlled trial|randomized controlled trial
717080|NCT00560222|lactoferrin|lactoferrin
717081|NCT00560222|children|children
717082|NCT00560222|diarrhea|diarrhea
717083|NCT00560222|malnutrition|malnutrition
717084|NCT00560222|growth|growth
717085|NCT00560209|ONO-1101|ono-1101
717086|NCT00560209|Coronary Artery Disease|coronary artery disease
717087|NCT00560209|Multi-slice CT|multi-slice ct
717088|NCT00560196|Neuropathic pain|neuropathic pain
717089|NCT00560196|Chronic pain|chronic pain
717090|NCT00560196|Depression|depression
717091|NCT00560196|Anxiety|anxiety
717092|NCT00560183|Acute|acute
717093|NCT00560183|Bunionectomy|bunionectomy
717094|NCT00560170|HMG-CoA Reductase Inhibitors|hmg-coa reductase inhibitors
717095|NCT00560170|endothelial function|endothelial function
717096|NCT00560170|HMG-CoA Reductase Inhibitors on vascular protection|hmg-coa reductase inhibitors on vascular protection
717097|NCT00560157|ICU patients|icu patients
717098|NCT00560118|recurrent melanoma|recurrent melanoma
717099|NCT00560118|stage IV melanoma|stage iv melanoma
717100|NCT00560105|COPD|copd
717101|NCT00560092|Magnesium|magnesium
717102|NCT00560092|Pain|pain
717103|NCT00560092|Morphine|morphine
717104|NCT00560092|Intrathecal|intrathecal
717105|NCT00560092|NMDA|nmda
717106|NCT00560092|Elective total hip replacement under intrathecal anesthesia|elective total hip replacement under intrathecal anesthesia
717107|NCT00560066|influenza|influenza
717108|NCT00560066|vaccine|vaccine
717109|NCT00560053|Multiple Myeloma|multiple myeloma
717110|NCT00560053|Alternating chemotherapy|alternating chemotherapy
717111|NCT00560053|Transplantation|transplantation
717112|NCT00560040|Troponin|troponin
717113|NCT00560040|Natriuretic Peptide, Brain|natriuretic peptide, brain
717114|NCT00560040|Exercise|exercise
717115|NCT00560040|Echocardiography|echocardiography
717116|NCT00560027|postpartum depression|postpartum depression
717117|NCT00560027|intimate partner violence|intimate partner violence
717118|NCT00560001|frail elderly|frail elderly
717119|NCT00560001|medication errors|medication errors
717120|NCT00560001|patient compliance & attitudes|patient compliance & attitudes
717121|NCT00560001|guideline adherence|guideline adherence
717122|NCT00559988|Implanted Cardioverter Defibrillator|implanted cardioverter defibrillator
717404|NCT00558779|Coronary artery bypass|coronary artery bypass
717123|NCT00559988|Cardiac Resynchronization Therapy Defibrillator|cardiac resynchronization therapy defibrillator
717124|NCT00559988|Home Monitoring|home monitoring
717125|NCT00559988|Oral Anticoagulation|oral anticoagulation
717126|NCT00559975|Adjuvanted Influenza Vaccine|adjuvanted influenza vaccine
717127|NCT00559962|LDL|ldl
717128|NCT00559962|hepatic fat|hepatic fat
717129|NCT00559897|bone metastases|bone metastases
717130|NCT00559897|stage IIIB non-small cell lung cancer|stage iiib non-small cell lung cancer
717131|NCT00559897|stage IV non-small cell lung cancer|stage iv non-small cell lung cancer
717132|NCT00559897|recurrent non-small cell lung cancer|recurrent non-small cell lung cancer
717133|NCT00559884|pharmacokinetics,|pharmacokinetics,
717134|NCT00559884|healthy male and females,|healthy male and females,
717135|NCT00559884|pharmacodynamics|pharmacodynamics
717136|NCT00559871|dyskinesia|dyskinesia
717137|NCT00559871|movement disorders|movement disorders
717138|NCT00559871|basal ganglia diseases|basal ganglia diseases
717139|NCT00559871|JP-1730|jp-1730
717140|NCT00559871|Parkinson|parkinson
717141|NCT00559871|end-of-dose wearing off|end-of-dose wearing off
717142|NCT00559871|fluctuations|fluctuations
717143|NCT00559858|palmar-plantar erythrodysesthesia|palmar-plantar erythrodysesthesia
717144|NCT00559858|breast cancer|breast cancer
717145|NCT00559858|male breast cancer|male breast cancer
717146|NCT00559858|colon cancer|colon cancer
717147|NCT00559858|rectal cancer|rectal cancer
717148|NCT00559832|acute mountain sickness|acute mountain sickness
717149|NCT00559832|intermittent hypoxia|intermittent hypoxia
717150|NCT00559832|acclimatization|acclimatization
717151|NCT00559819|Alcohol|alcohol
717152|NCT00559819|Driving|driving
717153|NCT00559819|Impairment|impairment
717154|NCT00559806|immobilisation|immobilisation
717155|NCT00559806|aging|aging
717156|NCT00559806|resistance training|resistance training
717157|NCT00559806|atrophy|atrophy
717158|NCT00559806|The effect of immobilisation in elderly compared to young individuals|the effect of immobilisation in elderly compared to young individuals
717159|NCT00559780|Resistance training|resistance training
717160|NCT00559780|Aging|aging
717161|NCT00559780|hip-surgery|hip-surgery
717162|NCT00559767|Kidney Function|kidney function
717163|NCT00559767|Genes|genes
717164|NCT00559767|Association Analysis|association analysis
717165|NCT00559767|Polymorphisms|polymorphisms
717166|NCT00559767|Diabetes|diabetes
717167|NCT00559741|stage IV colon cancer|stage iv colon cancer
717168|NCT00559741|recurrent colon cancer|recurrent colon cancer
717169|NCT00559741|stage IV rectal cancer|stage iv rectal cancer
717170|NCT00559741|recurrent rectal cancer|recurrent rectal cancer
717171|NCT00559715|bevacizumab|bevacizumab
717172|NCT00559715|ranibizumab|ranibizumab
717173|NCT00559715|macular degeneration|macular degeneration
717174|NCT00559715|age-related|age-related
717175|NCT00559715|neovascular|neovascular
717176|NCT00559715|intravitreal injection|intravitreal injection
717177|NCT00559715|vision loss|vision loss
717178|NCT00559715|outpatient setting|outpatient setting
717179|NCT00559702|natalizumab|natalizumab
717180|NCT00559702|multiple sclerosis|multiple sclerosis
717181|NCT00559702|Tysabri ®|tysabri ®
717182|NCT00559689|asthma patients|asthma patients
717183|NCT00559689|well-controlled|well-controlled
717184|NCT00559676|recurrent colon cancer|recurrent colon cancer
717185|NCT00559676|stage IV colon cancer|stage iv colon cancer
717186|NCT00559676|recurrent rectal cancer|recurrent rectal cancer
717187|NCT00559676|stage IV rectal cancer|stage iv rectal cancer
717188|NCT00559663|Flavonoid|flavonoid
717189|NCT00559663|hsCRP|hscrp
717190|NCT00559663|HDL|hdl
717191|NCT00559663|LDL|ldl
717192|NCT00559663|platelet reactivity|platelet reactivity
717193|NCT00559650|Acute decompensated heart failure|acute decompensated heart failure
717194|NCT00559650|Double blind study,|double blind study,
717195|NCT00559650|BAY58-2667|bay58-2667
717196|NCT00559650|Soluble guanylate cyclase activator|soluble guanylate cyclase activator
717197|NCT00559624|safety|safety
717198|NCT00559624|tolerability|tolerability
717199|NCT00559624|dose-escalation|dose-escalation
717200|NCT00559611|Non-Small Lung Cancer|non-small lung cancer
717201|NCT00559611|Lung Cancer|lung cancer
717202|NCT00559611|Endobronchial Ultrasound|endobronchial ultrasound
717203|NCT00559611|Fine Needle Aspiration|fine needle aspiration
717204|NCT00559611|Mediastinoscopy|mediastinoscopy
717205|NCT00559611|EBUS-FNA|ebus-fna
717206|NCT00559611|EBUS|ebus
717207|NCT00559611|Needle Biopsy|needle biopsy
717208|NCT00559611|NSCLC|nsclc
717209|NCT00559598|pancreatic cancer|pancreatic cancer
717210|NCT00559598|extrahepatic bile duct cancer|extrahepatic bile duct cancer
717211|NCT00559572|Exercise|exercise
717212|NCT00559572|Group Counseling|group counseling
717213|NCT00559572|Obesity|obesity
717214|NCT00559559|Primary and secondary prevention for ventricular tachycardia|primary and secondary prevention for ventricular tachycardia
717215|NCT00559520|Patients|patients
717216|NCT00559520|Suffering|suffering
717217|NCT00559520|Undernutrition|undernutrition
717218|NCT00559520|Requiring|requiring
717219|NCT00559520|Vascular|vascular
717220|NCT00559520|Surgery|surgery
717221|NCT00559494|complete spinal cord injury|complete spinal cord injury
717222|NCT00559494|incomplete spinal cord injury|incomplete spinal cord injury
717223|NCT00559494|central cord spinal cord injury|central cord spinal cord injury
717224|NCT00559494|traumatic|traumatic
717225|NCT00559481|recurrent prostate cancer|recurrent prostate cancer
717226|NCT00559442|high altitude pulmonary edema|high altitude pulmonary edema
717227|NCT00559442|hypoxic pulmonary vasoconstriction|hypoxic pulmonary vasoconstriction
717228|NCT00559442|right ventricular function|right ventricular function
717229|NCT00559442|hypoxia|hypoxia
717230|NCT00559429|Prostate Cancer|prostate cancer
717231|NCT00559416|HIV/AIDS|hiv/aids
717232|NCT00559416|HLA-B*57|hla-b*57
717233|NCT00559416|Cell Transfer|cell transfer
717234|NCT00559416|HIV|hiv
717235|NCT00559416|treatment experienced|treatment experienced
717236|NCT00559403|Human immunodeficiency virus|human immunodeficiency virus
717237|NCT00559403|South Africa|south africa
717238|NCT00559403|Intervention Studies|intervention studies
717239|NCT00559403|Sexual Behavior|sexual behavior
717240|NCT00559403|Adolescents|adolescents
717241|NCT00559403|STD|std
717242|NCT00559403|HIV Seronegativity|hiv seronegativity
717243|NCT00559390|Polycystic Ovary Syndrome|polycystic ovary syndrome
717244|NCT00559390|Metabolic Syndrome|metabolic syndrome
717245|NCT00559390|PCOS|pcos
717246|NCT00559390|children|children
717247|NCT00559390|girls|girls
717248|NCT00559390|daughters|daughters
717249|NCT00559390|sisters|sisters
717250|NCT00559390|irregular periods|irregular periods
717251|NCT00559351|esophagectomy|esophagectomy
717252|NCT00559351|chemotherapy|chemotherapy
717253|NCT00559351|chemoradiotherapy|chemoradiotherapy
717254|NCT00559351|combined modality therapy|combined modality therapy
717256|NCT00559338|Heart Failure|heart failure
717257|NCT00559338|Dyspnea|dyspnea
717258|NCT00559338|Cardiomyopathy|cardiomyopathy
717259|NCT00559312|mild COPD|mild copd
717260|NCT00559312|dyspnea|dyspnea
717261|NCT00559312|exercise|exercise
717262|NCT00559312|combination therapy|combination therapy
717263|NCT00559299|163090|163090
717264|NCT00559299|placebo-controlled|placebo-controlled
717265|NCT00559299|MDD|mdd
717266|NCT00559299|Depression|depression
717267|NCT00559299|Tolerability|tolerability
717268|NCT00559299|MDE|mde
717269|NCT00559286|perfusion|perfusion
717270|NCT00559286|microcirculation|microcirculation
717271|NCT00559286|RBC function|rbc function
717272|NCT00559286|NO metabolism|no metabolism
717273|NCT00559286|AT receptor blocker|at receptor blocker
717274|NCT00559234|Optic Nerve|optic nerve
717275|NCT00559234|Retina|retina
717276|NCT00559234|Cornea|cornea
717277|NCT00559234|Lens|lens
717278|NCT00559234|Ocular Genetic Diseases|ocular genetic diseases
717279|NCT00559234|Inherited Eye Disease|inherited eye disease
717280|NCT00559234|Genetic Eye Disease|genetic eye disease
717281|NCT00559221|AML|aml
717282|NCT00559208|Children and Youth|children and youth
717283|NCT00559208|Families|families
717284|NCT00559208|Differential Response|differential response
717285|NCT00559195|unspecified adult solid tumor, protocol specific|unspecified adult solid tumor, protocol specific
717286|NCT00559195|anemia|anemia
717287|NCT00559195|fatigue|fatigue
717288|NCT00559169|epilepsy|epilepsy
717289|NCT00559169|seizures|seizures
717290|NCT00559169|menstrual cycle|menstrual cycle
717291|NCT00559156|recurrent squamous cell carcinoma of the hypopharynx|recurrent squamous cell carcinoma of the hypopharynx
717292|NCT00559156|stage III squamous cell carcinoma of the hypopharynx|stage iii squamous cell carcinoma of the hypopharynx
717293|NCT00559156|stage IV squamous cell carcinoma of the hypopharynx|stage iv squamous cell carcinoma of the hypopharynx
717294|NCT00559156|stage III squamous cell carcinoma of the larynx|stage iii squamous cell carcinoma of the larynx
717295|NCT00559156|stage IV squamous cell carcinoma of the larynx|stage iv squamous cell carcinoma of the larynx
717296|NCT00559156|recurrent squamous cell carcinoma of the larynx|recurrent squamous cell carcinoma of the larynx
717297|NCT00559156|recurrent squamous cell carcinoma of the lip and oral cavity|recurrent squamous cell carcinoma of the lip and oral cavity
717298|NCT00559156|stage III squamous cell carcinoma of the lip and oral cavity|stage iii squamous cell carcinoma of the lip and oral cavity
717299|NCT00559156|stage IV squamous cell carcinoma of the lip and oral cavity|stage iv squamous cell carcinoma of the lip and oral cavity
717300|NCT00559156|metastatic squamous neck cancer with occult primary squamous cell carcinoma|metastatic squamous neck cancer with occult primary squamous cell carcinoma
717301|NCT00559156|recurrent metastatic squamous neck cancer with occult primary|recurrent metastatic squamous neck cancer with occult primary
717302|NCT00559156|recurrent squamous cell carcinoma of the nasopharynx|recurrent squamous cell carcinoma of the nasopharynx
717303|NCT00559156|stage III squamous cell carcinoma of the nasopharynx|stage iii squamous cell carcinoma of the nasopharynx
717304|NCT00559156|stage IV squamous cell carcinoma of the nasopharynx|stage iv squamous cell carcinoma of the nasopharynx
717305|NCT00559156|recurrent squamous cell carcinoma of the oropharynx|recurrent squamous cell carcinoma of the oropharynx
717306|NCT00559156|stage III squamous cell carcinoma of the oropharynx|stage iii squamous cell carcinoma of the oropharynx
717307|NCT00559156|stage IV squamous cell carcinoma of the oropharynx|stage iv squamous cell carcinoma of the oropharynx
717308|NCT00559156|recurrent squamous cell carcinoma of the paranasal sinus and nasal cavity|recurrent squamous cell carcinoma of the paranasal sinus and nasal cavity
717705|NCT00557622|CAPS|caps
717309|NCT00559156|stage III squamous cell carcinoma of the paranasal sinus and nasal cavity|stage iii squamous cell carcinoma of the paranasal sinus and nasal cavity
717310|NCT00559156|stage IV squamous cell carcinoma of the paranasal sinus and nasal cavity|stage iv squamous cell carcinoma of the paranasal sinus and nasal cavity
717311|NCT00559156|recurrent salivary gland cancer|recurrent salivary gland cancer
717312|NCT00559156|salivary gland squamous cell carcinoma|salivary gland squamous cell carcinoma
717313|NCT00559156|stage III salivary gland cancer|stage iii salivary gland cancer
717314|NCT00559156|stage IV salivary gland cancer|stage iv salivary gland cancer
717315|NCT00559143|AV conduction disturbances|av conduction disturbances
717316|NCT00559143|LV function|lv function
717317|NCT00559143|Biventricular Pacing|biventricular pacing
717318|NCT00559143|Conductance Catheters|conductance catheters
717319|NCT00559130|Acute Respiratory Distress Syndrome|acute respiratory distress syndrome
717320|NCT00559130|Acute Lung Injury|acute lung injury
717321|NCT00559130|Sepsis|sepsis
717322|NCT00559130|Hemoperfusion|hemoperfusion
717323|NCT00559104|stage III adult diffuse mixed cell lymphoma|stage iii adult diffuse mixed cell lymphoma
717324|NCT00559104|stage IV adult diffuse mixed cell lymphoma|stage iv adult diffuse mixed cell lymphoma
717325|NCT00559104|stage III adult immunoblastic large cell lymphoma|stage iii adult immunoblastic large cell lymphoma
717326|NCT00559104|stage IV adult immunoblastic large cell lymphoma|stage iv adult immunoblastic large cell lymphoma
717327|NCT00559104|stage IV mantle cell lymphoma|stage iv mantle cell lymphoma
717328|NCT00559104|stage III mantle cell lymphoma|stage iii mantle cell lymphoma
717329|NCT00559104|stage III adult diffuse large cell lymphoma|stage iii adult diffuse large cell lymphoma
717330|NCT00559104|stage IV adult diffuse large cell lymphoma|stage iv adult diffuse large cell lymphoma
717331|NCT00559104|stage III adult Burkitt lymphoma|stage iii adult burkitt lymphoma
717332|NCT00559104|stage IV adult Burkitt lymphoma|stage iv adult burkitt lymphoma
717333|NCT00559091|AML|aml
717334|NCT00559091|Acute myelocytic leukemia|acute myelocytic leukemia
717335|NCT00559091|leukemia|leukemia
717336|NCT00559091|relapsed|relapsed
717337|NCT00559091|refractory|refractory
717338|NCT00559091|M4|m4
717339|NCT00559091|M5|m5
717340|NCT00559078|Adrenal Hyperplasia, Congenital|adrenal hyperplasia, congenital
717341|NCT00559078|Psychosexual Development|psychosexual development
717342|NCT00559078|Sexual Development|sexual development
717343|NCT00559078|Intersex|intersex
717344|NCT00559078|Qualitative|qualitative
717345|NCT00559078|CAH|cah
717346|NCT00559078|Interview|interview
717347|NCT00559078|Disorder of Sex Development|disorder of sex development
717348|NCT00559078|Telephone|telephone
717349|NCT00559078|Quality of Life|quality of life
717350|NCT00559078|Mental Health|mental health
717351|NCT00559078|Counseling|counseling
717352|NCT00559065|Case-Cohort Study|case-cohort study
717353|NCT00559065|Leukemia|leukemia
717354|NCT00559065|Lymphoma|lymphoma
717355|NCT00559065|Benzene|benzene
717356|NCT00559065|Blood Disorders|blood disorders
717357|NCT00559065|Solvent Exposure|solvent exposure
717358|NCT00559065|Cancer Risk|cancer risk
717359|NCT00559052|Enzymes|enzymes
717360|NCT00559052|VIOKASE|viokase
717361|NCT00559052|Bioavailability|bioavailability
717362|NCT00559039|breast cancer|breast cancer
717363|NCT00559039|unspecified adult solid tumor, protocol specific|unspecified adult solid tumor, protocol specific
717364|NCT00559013|Staple line reinforcement|staple line reinforcement
717365|NCT00559013|Staple line buttress|staple line buttress
717366|NCT00559013|Anastomotic reinforcement|anastomotic reinforcement
717367|NCT00559000|PTSD|ptsd
717368|NCT00559000|Children|children
717369|NCT00559000|trauma-focused Treatment|trauma-focused treatment
717370|NCT00559000|KIDNET|kidnet
717371|NCT00559000|Narrative Exposure Therapy for Children|narrative exposure therapy for children
717372|NCT00558987|Discipline|discipline
717373|NCT00558987|Parenting|parenting
717374|NCT00558987|Primary Care|primary care
717375|NCT00558987|Videos|videos
717376|NCT00558961|CLL|cll
717377|NCT00558961|chronic lymphocytic leukemia|chronic lymphocytic leukemia
717378|NCT00558961|leukemia|leukemia
717379|NCT00558961|gleevec|gleevec
717380|NCT00558961|chlorambucil|chlorambucil
717381|NCT00558948|Bone Marrow Transplant|bone marrow transplant
717382|NCT00558948|Bone Mineral Density|bone mineral density
717383|NCT00558948|Survivors|survivors
717384|NCT00558948|Muscle Strength|muscle strength
717385|NCT00558922|Lung|lung
717386|NCT00558922|Non small cell|non small cell
717387|NCT00558922|antisense|antisense
717388|NCT00558922|oligonucleotide|oligonucleotide
717389|NCT00558922|paclitaxel|paclitaxel
717390|NCT00558922|carboplatin|carboplatin
717391|NCT00558896|stage II multiple myeloma|stage ii multiple myeloma
717392|NCT00558896|stage III multiple myeloma|stage iii multiple myeloma
717393|NCT00558896|refractory multiple myeloma|refractory multiple myeloma
717394|NCT00558870|Solid Tumors|solid tumors
717395|NCT00558870|Morphine|morphine
717396|NCT00558870|Methadone|methadone
717397|NCT00558870|Co-Opioid Analgesic|co-opioid analgesic
717398|NCT00558870|Pain|pain
717399|NCT00558844|Cystic Fibrosis|cystic fibrosis
717400|NCT00558844|Respiratory Infections|respiratory infections
717401|NCT00558844|Pulmonary Cystic Fibrosis|pulmonary cystic fibrosis
717405|NCT00558779|off pump coronary artery bypass grafting (OPCAB)|off pump coronary artery bypass grafting (opcab)
717406|NCT00558766|Disruptive Behavior Disorders|disruptive behavior disorders
717407|NCT00558766|Behavior|behavior
717408|NCT00558766|Gambling|gambling
717409|NCT00558766|Dopaminergic Mechanisms|dopaminergic mechanisms
717410|NCT00558766|Dopamine|dopamine
717411|NCT00558766|Parkinson Disease|parkinson disease
717412|NCT00558766|PD|pd
717413|NCT00558740|Dietary protein|dietary protein
717414|NCT00558740|Fructose|fructose
717415|NCT00558740|VLDL-triglycerides|vldl-triglycerides
717416|NCT00558740|Hepatic de novo lipogenesis|hepatic de novo lipogenesis
717417|NCT00558740|Lipid oxidation|lipid oxidation
717418|NCT00558727|Advanced Solid Tumors|advanced solid tumors
717419|NCT00558727|Solid Tumors|solid tumors
717420|NCT00558727|Tumor|tumor
717421|NCT00558727|Non-Hodgkin's Lymphoma|non-hodgkin's lymphoma
717422|NCT00558727|Chemotherapy|chemotherapy
717423|NCT00558727|Benzoquinone|benzoquinone
717424|NCT00558701|burns|burns
717425|NCT00558701|donor site|donor site
717426|NCT00558701|healing|healing
717427|NCT00558701|microcurrent|microcurrent
717428|NCT00558675|Non-Hodgkins Lymphoma|non-hodgkins lymphoma
717429|NCT00558675|Hodgkins Lymphoma|hodgkins lymphoma
717430|NCT00558675|Acute Lymphoblastic Leukemia|acute lymphoblastic leukemia
717431|NCT00558675|Chronic Myeloid Leukemia|chronic myeloid leukemia
717432|NCT00558675|Chronic Lymphocytic Leukemia|chronic lymphocytic leukemia
717433|NCT00558675|Multiple Myeloma|multiple myeloma
717434|NCT00558675|Immunotherapy|immunotherapy
717435|NCT00558675|Allogeneic Cell Therapy|allogeneic cell therapy
717436|NCT00558662|compression therapy|compression therapy
717437|NCT00558662|venous leg ulcer|venous leg ulcer
717438|NCT00558662|sub bandage pressure|sub bandage pressure
717439|NCT00558636|NSCLC|nsclc
717440|NCT00558623|lead, blood|lead, blood
717441|NCT00558623|pregnancy|pregnancy
717442|NCT00558623|calcium|calcium
717443|NCT00558623|randomized trial|randomized trial
717444|NCT00558623|dietary supplementation|dietary supplementation
717445|NCT00558623|bone resorption|bone resorption
717446|NCT00558597|Proteomics|proteomics
717447|NCT00558597|Lung Transplantation|lung transplantation
717448|NCT00558584|dilated cardiomyopathy|dilated cardiomyopathy
717449|NCT00558584|immunoadsorption|immunoadsorption
717450|NCT00558584|immunoglobulin G|immunoglobulin g
717451|NCT00558558|Solid Tumors|solid tumors
717452|NCT00558558|Cancer-Associated Anorexia|cancer-associated anorexia
717453|NCT00558558|Weight Loss|weight loss
717454|NCT00558558|Haelan|haelan
717455|NCT00558558|Fermented Soy Product|fermented soy product
717456|NCT00558558|Nutrition|nutrition
717457|NCT00558558|Cachexia|cachexia
717458|NCT00558545|Breast|breast
717459|NCT00558545|paclitaxel|paclitaxel
717460|NCT00558545|antisense|antisense
717461|NCT00558545|oligonucleotide|oligonucleotide
717462|NCT00558532|Morbid obesity|morbid obesity
717463|NCT00558532|Omega-3 fatty acid levels|omega-3 fatty acid levels
717464|NCT00558519|B-cell adult acute lymphoblastic leukemia|b-cell adult acute lymphoblastic leukemia
717465|NCT00558519|T-cell adult acute lymphoblastic leukemia|t-cell adult acute lymphoblastic leukemia
717466|NCT00558519|untreated adult acute lymphoblastic leukemia|untreated adult acute lymphoblastic leukemia
717467|NCT00558506|Ankylosing spondylitis|ankylosing spondylitis
717468|NCT00558506|activity|activity
717469|NCT00558506|treatment|treatment
717470|NCT00558506|clinical trial|clinical trial
717471|NCT00558454|Iron supplements|iron supplements
717472|NCT00558454|Infant|infant
717473|NCT00558454|Low birth weight|low birth weight
717474|NCT00558454|Prevention of iron deficiency and its physiological consequences|prevention of iron deficiency and its physiological consequences
717475|NCT00558454|Safety|safety
717476|NCT00558376|Colonoscopy|colonoscopy
717477|NCT00558363|Prostate Cancer|prostate cancer
717478|NCT00558363|AVODART|avodart
717479|NCT00558363|PSA|psa
717480|NCT00558363|dutasteride|dutasteride
717481|NCT00558363|PSADT|psadt
717482|NCT00558363|Prostate specific antigen|prostate specific antigen
717483|NCT00558363|radical therapy|radical therapy
717484|NCT00558363|doubling time|doubling time
717485|NCT00558350|lobectomy|lobectomy
717486|NCT00558350|inflammatory reaction|inflammatory reaction
717487|NCT00558350|intrapulmonary|intrapulmonary
717488|NCT00558350|intrapleural|intrapleural
717489|NCT00558337|Treatment of Parkinson's Disease|treatment of parkinson's disease
717490|NCT00558324|LASIK|lasik
717491|NCT00558324|Confocal microscopy|confocal microscopy
717492|NCT00558324|Flap|flap
717493|NCT00558311|Aneurysmal|aneurysmal
717494|NCT00558311|Subarachnoid|subarachnoid
717495|NCT00558311|Hemorrhage|hemorrhage
717496|NCT00558311|vasospasm|vasospasm
717497|NCT00558311|clazosentan|clazosentan
717498|NCT00558311|PIVLAZ|pivlaz
717499|NCT00558311|Actelion|actelion
717500|NCT00558311|surgical clipping|surgical clipping
717501|NCT00558298|schizophrenia|schizophrenia
717502|NCT00558298|schizoaffective disorder|schizoaffective disorder
717503|NCT00558298|risperidone|risperidone
717504|NCT00558298|intramuscular injection|intramuscular injection
717706|NCT00557622|fMRI|fmri
717505|NCT00558298|long-acting injectable|long-acting injectable
717506|NCT00558285|COPD|copd
717507|NCT00558285|Chronic Obstructive Pulmonary Disease|chronic obstructive pulmonary disease
717508|NCT00558285|Indacaterol|indacaterol
717509|NCT00558285|QVA149|qva149
717510|NCT00558272|breast cancer|breast cancer
717511|NCT00558272|prostate cancer|prostate cancer
717512|NCT00558272|metastatic bone disease|metastatic bone disease
717513|NCT00558272|Subjects with breast cancer or prostate cancer with metastatic bone disease|subjects with breast cancer or prostate cancer with metastatic bone disease
717514|NCT00558246|Breast Lift|breast lift
717515|NCT00558246|Breast Reduction|breast reduction
717516|NCT00558246|Breast Reconstruction|breast reconstruction
717517|NCT00558246|Plastic Surgery|plastic surgery
717518|NCT00558246|Skin Closure|skin closure
717519|NCT00558246|Wound Healing|wound healing
717520|NCT00558246|Dermabond|dermabond
717521|NCT00558233|Colorectal cancer|colorectal cancer
717522|NCT00558233|Screening|screening
717523|NCT00558233|Health literacy|health literacy
717524|NCT00558233|Patient education|patient education
717525|NCT00558233|Computer assisted instruction|computer assisted instruction
717526|NCT00558220|Lymphoma, B-cell|lymphoma, b-cell
717527|NCT00558220|Immunotherapy, passive|immunotherapy, passive
717528|NCT00558220|Remission induction|remission induction
717529|NCT00558220|Autologous transplantation|autologous transplantation
717530|NCT00558207|Pancreatic cancer|pancreatic cancer
717531|NCT00558207|pancreas cancer|pancreas cancer
717532|NCT00558207|Locally advanced or metastatic pancreatic adenocarcioma|locally advanced or metastatic pancreatic adenocarcioma
717533|NCT00558194|Weight loss|weight loss
717534|NCT00558181|B CLL|b cll
717535|NCT00558181|Chronic B Lymphocytic Leukemia|chronic b lymphocytic leukemia
717536|NCT00558181|Methylprednisolone|methylprednisolone
717537|NCT00558181|Rituximab|rituximab
717538|NCT00558168|Anastrazole|anastrazole
717539|NCT00558168|safety|safety
717540|NCT00558168|early breast cancer|early breast cancer
717541|NCT00558155|immunonutrition|immunonutrition
717542|NCT00558155|enteral nutrition|enteral nutrition
717543|NCT00558155|parenteral nutrition|parenteral nutrition
717544|NCT00558155|surgery|surgery
717545|NCT00558142|contrast nephropathy|contrast nephropathy
717546|NCT00558142|radiocontrast-induced nephropathy|radiocontrast-induced nephropathy
717547|NCT00558142|chronic kidney disease|chronic kidney disease
717548|NCT00558142|acetylcysteine|acetylcysteine
717549|NCT00558142|clinical study|clinical study
717550|NCT00558129|Lumbar Spinal Stenosis|lumbar spinal stenosis
717551|NCT00558129|X-STOP® IPD|x-stop® ipd
717552|NCT00558129|Interspinous process decompression|interspinous process decompression
717553|NCT00558129|Neurogenic Intermittent Claudication|neurogenic intermittent claudication
717554|NCT00558116|Carpal Tunnel Syndrome|carpal tunnel syndrome
717555|NCT00558116|Dynamic Splinting|dynamic splinting
717556|NCT00558116|Nerve Conduction Studies|nerve conduction studies
717557|NCT00558116|Splinting|splinting
717558|NCT00558116|Levine Katz Survey|levine katz survey
717559|NCT00558103|GW572016|gw572016
717560|NCT00558103|Breast Cancer|breast cancer
717561|NCT00558103|RECIST|recist
717562|NCT00558103|Inflammatory Breast Cancer|inflammatory breast cancer
717563|NCT00558103|Pazopanib|pazopanib
717564|NCT00558103|ErbB2|erbb2
717565|NCT00558103|Cutaneous Disease|cutaneous disease
717566|NCT00558103|Tykerb|tykerb
717567|NCT00558103|Inflammatory|inflammatory
717568|NCT00558103|Skin|skin
717569|NCT00558103|Her2|her2
717570|NCT00558103|Lapatinib|lapatinib
717571|NCT00558103|GW786034|gw786034
717572|NCT00558090|pain|pain
717573|NCT00558090|Intensive Care Unit|intensive care unit
717574|NCT00558090|morphine|morphine
717575|NCT00558090|pKpD|pkpd
717576|NCT00558090|numerical rating scale|numerical rating scale
717577|NCT00558090|critically ill patients|critically ill patients
717578|NCT00558077|Anovulation|anovulation
717579|NCT00558077|Clomiphene citrate|clomiphene citrate
717580|NCT00558077|Fertility|fertility
717581|NCT00558077|Metformin|metformin
717582|NCT00558077|Ovulation induction|ovulation induction
717583|NCT00558077|PCOS|pcos
717584|NCT00558077|Sterility|sterility
717585|NCT00558077|Treatment|treatment
717586|NCT00558077|Clomiphene citrate-resistance|clomiphene citrate-resistance
717587|NCT00558051|Colorectal Cancer|colorectal cancer
717588|NCT00558051|Colorectal Carcinoma|colorectal carcinoma
717589|NCT00558051|Colorectal Tumors|colorectal tumors
717590|NCT00558051|Neoplasms, Colorectal|neoplasms, colorectal
717591|NCT00558038|Hepatic|hepatic
717592|NCT00558038|Encephalopathy|encephalopathy
717593|NCT00558038|Liver|liver
717594|NCT00558038|Liver Disease|liver disease
717595|NCT00558038|Liver Failure|liver failure
717596|NCT00558038|Lactulose|lactulose
717597|NCT00558038|AST-120|ast-120
717598|NCT00558012|Osteoporosis|osteoporosis
717599|NCT00558012|Bone loss|bone loss
717600|NCT00558012|Frail Geriatric Women|frail geriatric women
717601|NCT00558012|Nursing Home Patients|nursing home patients
717602|NCT00558012|Fragility Fractures|fragility fractures
717603|NCT00557999|Cardiology|cardiology
717604|NCT00557999|Mechanical ventilation|mechanical ventilation
717605|NCT00557999|Intensive care|intensive care
717606|NCT00557986|1-Metastatic breast cancer|1-metastatic breast cancer
717607|NCT00557986|2-Surgery|2-surgery
717608|NCT00557986|3-Survival|3-survival
717609|NCT00557947|Abdominoplasty|abdominoplasty
717610|NCT00557947|Body Lift|body lift
717611|NCT00557947|Plastic Surgery|plastic surgery
717612|NCT00557947|Skin Closure|skin closure
717613|NCT00557947|Wound Healing|wound healing
717614|NCT00557947|Dermabond|dermabond
717615|NCT00557934|tetralogy of Fallot|tetralogy of fallot
717616|NCT00557934|right ventricular dysfunction|right ventricular dysfunction
717617|NCT00557934|pulmonary insufficiency|pulmonary insufficiency
717618|NCT00557934|pulmonary valve replacement|pulmonary valve replacement
717619|NCT00557934|pressure-volume loops|pressure-volume loops
717620|NCT00557934|long-term follow-up in tetralogy of Fallot|long-term follow-up in tetralogy of fallot
717621|NCT00557921|ACS|acs
717622|NCT00557921|CAD|cad
717623|NCT00557921|MI|mi
717624|NCT00557921|PCI|pci
717625|NCT00557921|PTCA|ptca
717626|NCT00557921|NSTEMI|nstemi
717627|NCT00557921|STEMI|stemi
717628|NCT00557921|acute coronary syndrome|acute coronary syndrome
717629|NCT00557921|cerebrovascular disorders|cerebrovascular disorders
717630|NCT00557921|coronary artery stent placement|coronary artery stent placement
717631|NCT00557921|coronary thrombosis|coronary thrombosis
717733|NCT00557466|QMF|qmf
717632|NCT00557921|myocardial infarction|myocardial infarction
717633|NCT00557921|myocardial ischemia|myocardial ischemia
717634|NCT00557921|percutaneous coronary intervention|percutaneous coronary intervention
717635|NCT00557921|percutaneous transluminal coronary angioplasty|percutaneous transluminal coronary angioplasty
717636|NCT00557921|peripheral vascular diseases|peripheral vascular diseases
717637|NCT00557921|duodenal obstruction|duodenal obstruction
717638|NCT00557921|duodenal ulcer|duodenal ulcer
717639|NCT00557921|dyspepsia|dyspepsia
717640|NCT00557921|esophagitis, peptic|esophagitis, peptic
717641|NCT00557921|gastric outlet obstruction|gastric outlet obstruction
717642|NCT00557921|gastroduodenal ulcer|gastroduodenal ulcer
717643|NCT00557921|gastroesophageal reflux disease|gastroesophageal reflux disease
717644|NCT00557921|gastrointestinal hemorrhage|gastrointestinal hemorrhage
717645|NCT00557921|peptic ulcer|peptic ulcer
717646|NCT00557921|peptic ulcer perforation|peptic ulcer perforation
717647|NCT00557908|Von Willebrand Disease|von willebrand disease
717649|NCT00557908|prophylaxis|prophylaxis
717650|NCT00557895|Asthma|asthma
717651|NCT00557895|Hypersensitivity|hypersensitivity
717652|NCT00557895|Peanut Allergy|peanut allergy
717653|NCT00557895|Eosinophilic Esophagitis|eosinophilic esophagitis
717654|NCT00557895|Eosinophilic Gastroenteritis|eosinophilic gastroenteritis
717655|NCT00557882|prolapse|prolapse
717656|NCT00557882|uterus|uterus
717657|NCT00557882|mesh|mesh
717658|NCT00557882|bladder|bladder
717659|NCT00557856|Solid Tumors Transforming Growth Factor Beta Activin Receptor-like Kinase 1|solid tumors transforming growth factor beta activin receptor-like kinase 1
717660|NCT00557843|Bupivacaine|bupivacaine
717661|NCT00557843|Colon|colon
717662|NCT00557843|Surgery|surgery
717663|NCT00557843|Oxygenation|oxygenation
717664|NCT00557830|Renal Cell Carcinoma|renal cell carcinoma
717665|NCT00557830|Kidney Cancer|kidney cancer
717666|NCT00557817|HCT|hct
717667|NCT00557817|autologous|autologous
717668|NCT00557817|erythropoiesis|erythropoiesis
717669|NCT00557817|iron saccharate|iron saccharate
717670|NCT00557817|erythropoietin|erythropoietin
717671|NCT00557817|darbepoetin alpha|darbepoetin alpha
717672|NCT00557804|Congestive Heart Failure|congestive heart failure
717673|NCT00557791|AMD|amd
717674|NCT00557791|ARMD|armd
717675|NCT00557791|Exudative Macular Degeneration|exudative macular degeneration
717676|NCT00557791|Bevasiranib|bevasiranib
717677|NCT00557791|siRNA|sirna
717678|NCT00557778|prevention|prevention
717679|NCT00557778|dyslipidemia|dyslipidemia
717680|NCT00557765|Tuberculosis|tuberculosis
717681|NCT00557765|Latent tuberculosis infection|latent tuberculosis infection
717682|NCT00557765|Interferon gamma release assay|interferon gamma release assay
717683|NCT00557765|Contact tracing|contact tracing
717684|NCT00557739|CRx-191|crx-191
717685|NCT00557739|Plaque|plaque
717686|NCT00557739|Psoriasis|psoriasis
717687|NCT00557739|nortriptyline hydrochloride|nortriptyline hydrochloride
717688|NCT00557739|mometasone furoate|mometasone furoate
717689|NCT00557739|psoriatic infiltrate|psoriatic infiltrate
717690|NCT00557726|Inflammation|inflammation
717691|NCT00557726|Infection|infection
717692|NCT00557726|Fever|fever
717693|NCT00557700|Mild to moderate asthma|mild to moderate asthma
717694|NCT00557687|IVF|ivf
717695|NCT00557687|ovarian reserve|ovarian reserve
717696|NCT00557687|poor response|poor response
717697|NCT00557661|Heart failure|heart failure
717698|NCT00557661|CD-NP|cd-np
717699|NCT00557648|Anxiety|anxiety
717700|NCT00557648|Children|children
717701|NCT00557648|Cognitive-Behavioral Therapy|cognitive-behavioral therapy
717702|NCT00557648|School-Based Interventions|school-based interventions
717703|NCT00557635|pseudo-arthrosis, osseous matrix, cell therapy|pseudo-arthrosis, osseous matrix, cell therapy
717704|NCT00557622|PTSD (Posttraumatic Stress Disorder)|ptsd (posttraumatic stress disorder)
717708|NCT00557609|Microphthalmia transcription (MiT) factor associated tumors|microphthalmia transcription (mit) factor associated tumors
717709|NCT00557609|Alveolar soft part sarcoma (ASPS)|alveolar soft part sarcoma (asps)
717710|NCT00557609|Clear cell sarcoma (CCS)|clear cell sarcoma (ccs)
717711|NCT00557609|Renal cell carcinoma (RCC)|renal cell carcinoma (rcc)
717712|NCT00557596|Pancreatic|pancreatic
717713|NCT00557596|antisense|antisense
717714|NCT00557596|oligonucleotide|oligonucleotide
717715|NCT00557596|gemcitabine|gemcitabine
717716|NCT00557583|VBY-376 Hepatitis C pharmacokinetics safety|vby-376 hepatitis c pharmacokinetics safety
717717|NCT00557570|Antiretroviral|antiretroviral
717718|NCT00557570|Opportunistic Infection|opportunistic infection
717719|NCT00557570|treatment experienced|treatment experienced
717720|NCT00557570|treatment naive|treatment naive
717721|NCT00557557|Colorectal|colorectal
717722|NCT00557557|liver|liver
717723|NCT00557557|cancer|cancer
717724|NCT00557557|metastases|metastases
717725|NCT00557544|migraine|migraine
717726|NCT00557544|metoclopramide|metoclopramide
717727|NCT00557544|ketoprofen|ketoprofen
717728|NCT00557544|child|child
717729|NCT00557492|pancreas|pancreas
717730|NCT00557492|pancreatic|pancreatic
717731|NCT00557492|cancer|cancer
717734|NCT00557466|indacaterol|indacaterol
717735|NCT00557466|TWISTHALER® device|twisthaler® device
717736|NCT00557440|Asthma|asthma
717737|NCT00557440|QMF|qmf
717738|NCT00557440|Indacaterol|indacaterol
717739|NCT00557440|Mometasone|mometasone
717740|NCT00557427|mild to moderate depression according to the DSM-IV scale|mild to moderate depression according to the dsm-iv scale
717741|NCT00557414|acute respiratory distress syndrome|acute respiratory distress syndrome
717742|NCT00557414|soluble triggering receptor expressed on myeloid cells-1|soluble triggering receptor expressed on myeloid cells-1
717743|NCT00557414|prognosis|prognosis
717744|NCT00557388|muscle loss|muscle loss
717745|NCT00557388|aging|aging
717746|NCT00557388|protein|protein
717747|NCT00557388|amino acids|amino acids
717748|NCT00557388|exercise|exercise
717749|NCT00557388|protein synthesis|protein synthesis
717750|NCT00557375|Brain Tumors|brain tumors
717751|NCT00557375|Survey|survey
717752|NCT00557362|Keratitis|keratitis
717753|NCT00557362|Eye Infection, Fungal|eye infection, fungal
717754|NCT00557362|Fungal Eye Infection|fungal eye infection
717755|NCT00557362|Ocular Infection, Fungal|ocular infection, fungal
717756|NCT00557362|Fungal Keratitis|fungal keratitis
717757|NCT00557362|Mycotic Infections, Ocular|mycotic infections, ocular
717758|NCT00557362|Voriconazole|voriconazole
717759|NCT00557362|Natamycin|natamycin
717760|NCT00557349|gastric bypass surgery|gastric bypass surgery
717761|NCT00557349|anastomosis, Roux-en-Y|anastomosis, roux-en-y
717762|NCT00557349|Complication, Postoperative|complication, postoperative
717763|NCT00557310|osteoporosis, teriparatide, postmenopausal, MRI, finite element analysis|osteoporosis, teriparatide, postmenopausal, mri, finite element analysis
717764|NCT00557297|asthma|asthma
717765|NCT00557297|SMART|smart
717766|NCT00557297|inhaled|inhaled
717767|NCT00557297|glucocorticosteroid|glucocorticosteroid
717768|NCT00557297|reliever|reliever
717769|NCT00557297|maintenance|maintenance
717770|NCT00557297|single inhaler|single inhaler
717771|NCT00557284|Atopic Dermatitis (Eczema) associated with food allergies|atopic dermatitis (eczema) associated with food allergies
717772|NCT00557245|HIV infection|hiv infection
717773|NCT00557245|HIV uninfected partners|hiv uninfected partners
717774|NCT00557245|Double Blind|double blind
717775|NCT00557245|Placebo|placebo
717776|NCT00557245|Seroconversion|seroconversion
717777|NCT00557245|TDF|tdf
717778|NCT00557245|FTC TDF|ftc tdf
717779|NCT00557245|Safety|safety
717780|NCT00557245|HIV Seronegativity|hiv seronegativity
717781|NCT00557232|bevacizumab|bevacizumab
717782|NCT00557232|rubeosis iridis|rubeosis iridis
717783|NCT00557232|glaucoma|glaucoma
717784|NCT00557219|cardiac surgery|cardiac surgery
717785|NCT00557219|fenoldopam|fenoldopam
717786|NCT00557219|ketanserin|ketanserin
717787|NCT00557219|renal replacement therapy|renal replacement therapy
717788|NCT00557206|Recurrent Disease|recurrent disease
717789|NCT00557206|Metastatic Disease|metastatic disease
717790|NCT00557206|Squamous Cell Carcinoma|squamous cell carcinoma
717791|NCT00557206|Multicenter|multicenter
717792|NCT00557206|Phase II|phase ii
717793|NCT00557180|Steroid Resistance|steroid resistance
717794|NCT00557180|Inflammation|inflammation
717795|NCT00557154|Pediatrics|pediatrics
717796|NCT00557154|Venous access|venous access
717797|NCT00557154|Emergency|emergency
717798|NCT00557141|Single arm observational retrospective and prospective study|single arm observational retrospective and prospective study
717799|NCT00557128|COREG CR,|coreg cr,
717800|NCT00557128|lisinopril,|lisinopril,
717801|NCT00557128|hypertension,|hypertension,
717802|NCT00557128|dose proportionality,|dose proportionality,
717803|NCT00557128|fixed dose combination (FDC)|fixed dose combination (fdc)
717804|NCT00557115|Quality of life|quality of life
717805|NCT00557115|Quadriceps|quadriceps
717806|NCT00557115|Muscle|muscle
717807|NCT00557115|Exacerbation|exacerbation
717808|NCT00557102|liver metastases|liver metastases
717809|NCT00557102|lung metastases|lung metastases
717810|NCT00557102|recurrent rectal cancer|recurrent rectal cancer
717811|NCT00557102|stage IV rectal cancer|stage iv rectal cancer
717812|NCT00557102|adenocarcinoma of the rectum|adenocarcinoma of the rectum
717813|NCT00557102|adenocarcinoma of the colon|adenocarcinoma of the colon
717814|NCT00557102|recurrent colon cancer|recurrent colon cancer
717815|NCT00557102|stage IV colon cancer|stage iv colon cancer
717816|NCT00557089|Pediatrics|pediatrics
717817|NCT00557089|Cystic Fibrosis|cystic fibrosis
717818|NCT00557089|Lung Clearance Index|lung clearance index
717819|NCT00557089|rhDNAse|rhdnase
717820|NCT00557076|Randomized Clinical Trial|randomized clinical trial
717821|NCT00557076|Auditory Stimulation|auditory stimulation
717822|NCT00557050|Hamstring|hamstring
717823|NCT00557050|Muscle|muscle
717824|NCT00557050|Injury|injury
717825|NCT00557050|Prevention|prevention
717826|NCT00557050|Muscles|muscles
717827|NCT00557037|Castrate and Non-Castrate Prostate Cancer|castrate and non-castrate prostate cancer
717828|NCT00557024|hepatocellular carcinoma|hepatocellular carcinoma
717829|NCT00557024|liver cancer|liver cancer
717830|NCT00557024|radiofrequency ablation|radiofrequency ablation
717831|NCT00557024|radiotherapy|radiotherapy
717832|NCT00557024|adjuvant therapy|adjuvant therapy
717833|NCT00556998|pharmacokinetics and safety data of voriconazole in immunocompromised adolescents|pharmacokinetics and safety data of voriconazole in immunocompromised adolescents
717834|NCT00556959|ADHD|adhd
717835|NCT00556959|Clonidine|clonidine
717836|NCT00556959|Attention Deficit|attention deficit
717837|NCT00556959|Hyperactivity|hyperactivity
717838|NCT00556959|CLONICEL|clonicel
717839|NCT00556959|Addrenex|addrenex
717840|NCT00556946|Vascular Malformation|vascular malformation
717841|NCT00556933|Induction|induction
717842|NCT00556933|rATG|ratg
717843|NCT00556933|Calcineurin-inhibitor withdrawal|calcineurin-inhibitor withdrawal
717844|NCT00556920|Coreg CR|coreg cr
717845|NCT00556907|DCIS|dcis
717846|NCT00556907|To evaluate Preoperative mammagraphy and MRI to select candiates with DCIS for IORT|to evaluate preoperative mammagraphy and mri to select candiates with dcis for iort
717847|NCT00556868|High school students|high school students
717848|NCT00556868|Boarding school|boarding school
717849|NCT00556868|Breakfast|breakfast
717850|NCT00556868|Fasting|fasting
717851|NCT00556868|Memory|memory
717852|NCT00556868|Attention|attention
717853|NCT00556868|Mood|mood
717854|NCT00556855|chronic hand dermatitis|chronic hand dermatitis
717855|NCT00556855|research study|research study
717856|NCT00556855|E-do|e-do
717857|NCT00556855|HK-03|hk-03
717858|NCT00556842|Hemi-Arthroplasty|hemi-arthroplasty
717859|NCT00556842|Total Hip Arthroplasty|total hip arthroplasty
717860|NCT00556816|COPD|copd
717861|NCT00556816|outpatient on demand clinic|outpatient on demand clinic
717862|NCT00556803|hepatocellular carcinoma|hepatocellular carcinoma
717863|NCT00556803|liver cancer|liver cancer
717864|NCT00556803|radiofrequency ablation|radiofrequency ablation
717865|NCT00556803|transcatheter arterial chemoembolization|transcatheter arterial chemoembolization
717866|NCT00556803|adjuvant therapy|adjuvant therapy
717867|NCT00556777|stage I breast cancer|stage i breast cancer
717868|NCT00556764|ANAM|anam
717869|NCT00556764|Parkinson's|parkinson's
717870|NCT00556751|Electrocardiogram|electrocardiogram
717871|NCT00556751|Electrocardiography|electrocardiography
717872|NCT00556751|Cardiovascular Risk Factors|cardiovascular risk factors
717873|NCT00556751|Cholesterol|cholesterol
717874|NCT00556751|Blood Pressure|blood pressure
717875|NCT00556751|Diabetes|diabetes
717876|NCT00556738|HFPV|hfpv
717877|NCT00556738|neonatal respiratory distress|neonatal respiratory distress
717878|NCT00556699|NHL|nhl
717879|NCT00556699|Rituxan|rituxan
717880|NCT00556699|anti-CD40|anti-cd40
717881|NCT00556673|Asthma, QMF149, fixed combination of indacaterol and mometasone furoate|asthma, qmf149, fixed combination of indacaterol and mometasone furoate
717882|NCT00556660|Alzheimer|alzheimer
717883|NCT00556660|SPECT|spect
717884|NCT00556647|fast-track diagnosis|fast-track diagnosis
717885|NCT00556647|PET-CT|pet-ct
717886|NCT00556647|endoscopic techniques|endoscopic techniques
717887|NCT00556647|lung cancer|lung cancer
717889|NCT00556634|efavirenz|efavirenz
717890|NCT00556634|central nervous system|central nervous system
717891|NCT00556634|adverse effects|adverse effects
717892|NCT00556621|stage II bladder cancer|stage ii bladder cancer
717893|NCT00556621|stage III bladder cancer|stage iii bladder cancer
717894|NCT00556621|transitional cell carcinoma of the bladder|transitional cell carcinoma of the bladder
717895|NCT00556595|atrial fibrillation|atrial fibrillation
717896|NCT00556595|paroxysmal|paroxysmal
717897|NCT00556595|symptomatic|symptomatic
717898|NCT00556595|drug-refractory|drug-refractory
717899|NCT00556569|Physical activity|physical activity
717900|NCT00556569|Obesity|obesity
717901|NCT00556543|Rib Fracture|rib fracture
717902|NCT00556543|Rib Fracture Repair|rib fracture repair
717903|NCT00556543|Rib Fracture ORIF|rib fracture orif
717904|NCT00556543|Flail Chest|flail chest
717905|NCT00556543|Implant|implant
717906|NCT00556543|Prosthesis|prosthesis
717907|NCT00556543|Rib fracture non-union|rib fracture non-union
717908|NCT00556543|Chest wall deformity|chest wall deformity
717909|NCT00556530|Congenital Heart Defects|congenital heart defects
717910|NCT00556530|Single Nucleotide Polymorphisms|single nucleotide polymorphisms
717911|NCT00556530|Copy Number Variations|copy number variations
717912|NCT00556530|Whole Genome Association Study|whole genome association study
717913|NCT00556517|Hamstring|hamstring
717914|NCT00556517|Strain|strain
717915|NCT00556517|Rehabilitation|rehabilitation
717916|NCT00556517|muscles|muscles
717917|NCT00556504|add-on treatment|add-on treatment
717918|NCT00556504|botanical drug|botanical drug
717919|NCT00556504|HCV genotype 1|hcv genotype 1
717920|NCT00556504|TCM-700C|tcm-700c
717921|NCT00556504|genotype I|genotype i
717922|NCT00556491|renal|renal
717923|NCT00556491|kidney|kidney
717924|NCT00556491|injury|injury
717925|NCT00556491|acute|acute
717926|NCT00556491|bypass|bypass
717927|NCT00556491|cardiac|cardiac
717928|NCT00556491|minocycline|minocycline
717929|NCT00556491|prevention|prevention
717930|NCT00556491|Acute Kidney Failure|acute kidney failure
717931|NCT00556478|Premature Ejaculation|premature ejaculation
717932|NCT00556478|Lidocaine|lidocaine
717933|NCT00556478|Prilocaine|prilocaine
717934|NCT00556478|EMLA® cream|emla® cream
717935|NCT00556478|topical anesthetics|topical anesthetics
717936|NCT00556465|diabetic nephropathy|diabetic nephropathy
717937|NCT00556465|proteinuria|proteinuria
717938|NCT00556465|antioxidant|antioxidant
717939|NCT00556439|Vasculitis|vasculitis
717940|NCT00556439|Arteritis|arteritis
717941|NCT00556439|Takayasu's|takayasu's
717942|NCT00556439|Temporal Arteritis|temporal arteritis
717943|NCT00556439|Abatacept|abatacept
717944|NCT00556426|Venous Thromboembolic Disease|venous thromboembolic disease
717945|NCT00556426|IVC Filter|ivc filter
717946|NCT00556426|Pulmonary Embolism|pulmonary embolism
717947|NCT00556413|stage IV colon cancer|stage iv colon cancer
717948|NCT00556413|stage IV rectal cancer|stage iv rectal cancer
717949|NCT00556413|recurrent colon cancer|recurrent colon cancer
717950|NCT00556413|recurrent rectal cancer|recurrent rectal cancer
717951|NCT00556400|Uterine Bleeding|uterine bleeding
717952|NCT00556400|Thrombocytopenia|thrombocytopenia
717953|NCT00556400|Aplastic Anemia|aplastic anemia
717954|NCT00556400|Oral Contraceptive Pills|oral contraceptive pills
717955|NCT00556400|Menorrhagia|menorrhagia
717956|NCT00556387|traumatic brain injury|traumatic brain injury
717957|NCT00556374|confirmed adenocarcinoma|confirmed adenocarcinoma
717958|NCT00556374|non-metastatic breast cancer|non-metastatic breast cancer
717959|NCT00556374|estrogen receptor positive|estrogen receptor positive
717960|NCT00556374|progesterone receptor positive|progesterone receptor positive
717961|NCT00556374|non-steroidal aromatase|non-steroidal aromatase
717962|NCT00556374|aromatase inhibitor therapy|aromatase inhibitor therapy
717963|NCT00556374|postmenopausal woman|postmenopausal woman
717964|NCT00556374|adjuvant chemotherapy|adjuvant chemotherapy
717965|NCT00556374|neoadjuvant chemotherapy|neoadjuvant chemotherapy
717966|NCT00556348|bevacizumab|bevacizumab
717967|NCT00556348|AMD|amd
717968|NCT00556348|Complications|complications
717969|NCT00556348|Visual acuity|visual acuity
717970|NCT00556348|OCt|oct
717971|NCT00556348|Age Macular Degeneration|age macular degeneration
717972|NCT00556335|manual aspiration|manual aspiration
717973|NCT00556335|conventional|conventional
717974|NCT00556335|length of stay|length of stay
717975|NCT00556283|outlet obstruction|outlet obstruction
717976|NCT00556283|rectocele|rectocele
717977|NCT00556270|pain|pain
717978|NCT00556270|fentanyl|fentanyl
717979|NCT00556270|transdermal patch|transdermal patch
717980|NCT00556257|Immunosuppression, JAK3 inhibitor, kidney transplantation|immunosuppression, jak3 inhibitor, kidney transplantation
717981|NCT00556231|NIRS|nirs
717982|NCT00556231|cardiac output|cardiac output
717983|NCT00556231|anaerobic threshold|anaerobic threshold
717984|NCT00556231|exercise stress|exercise stress
717985|NCT00556231|congenital heart defect|congenital heart defect
717986|NCT00556218|Breast Cancer|breast cancer
717987|NCT00556218|Tibetan Meditation|tibetan meditation
717988|NCT00556218|Quality of Life|quality of life
717989|NCT00556218|Cognitive Function|cognitive function
717990|NCT00556218|QOL|qol
717991|NCT00556205|mRCC|mrcc
717992|NCT00556205|sunitinib|sunitinib
717993|NCT00556205|bevacizumab|bevacizumab
717994|NCT00556192|SLE|sle
717995|NCT00556192|Rituximab|rituximab
717996|NCT00556192|Methylprednisolone|methylprednisolone
717997|NCT00556192|Cyclophosphamide|cyclophosphamide
717998|NCT00556166|Enterra therapy|enterra therapy
717999|NCT00556166|Gastric Simulation System|gastric simulation system
718000|NCT00556153|brain tumors, children|brain tumors, children
718001|NCT00556127|Large B-cell Lymphoma|large b-cell lymphoma
718002|NCT00556127|Rituximab|rituximab
718003|NCT00556127|ASCT|asct
718004|NCT00556114|eye exam|eye exam
718005|NCT00556114|Retina|retina
718006|NCT00556101|Magnetic resonance|magnetic resonance
718007|NCT00556101|whole body|whole body
718008|NCT00556101|angiography|angiography
718009|NCT00556101|questionnaire|questionnaire
718010|NCT00556088|LBH589|lbh589
718011|NCT00556088|Phase I|phase i
718012|NCT00556088|Solid Tumors|solid tumors
718016|NCT00556088|Dose escalation|dose escalation
718017|NCT00556075|Endometriosis|endometriosis
718018|NCT00556075|Pelvic pain|pelvic pain
718019|NCT00556075|Oral progesterone blocker|oral progesterone blocker
718020|NCT00556049|mRCC|mrcc
718021|NCT00556049|sunitinib|sunitinib
718022|NCT00556049|gemcitabine|gemcitabine
718023|NCT00556036|healthy|healthy
718024|NCT00556036|overweight|overweight
718025|NCT00556036|obese|obese
718026|NCT00556036|anorexia nervosa|anorexia nervosa
718027|NCT00556036|weight|weight
718028|NCT00556036|cortisol|cortisol
718029|NCT00556036|hormone|hormone
718030|NCT00556036|bone density|bone density
718031|NCT00556036|bone|bone
718032|NCT00556036|osteopenia|osteopenia
718033|NCT00556036|osteoporosis|osteoporosis
718034|NCT00556036|amenorrhea|amenorrhea
718035|NCT00556036|menses|menses
718036|NCT00556036|irregular|irregular
718037|NCT00556036|stress|stress
718038|NCT00556036|depression|depression
718039|NCT00556036|exercise|exercise
718040|NCT00556036|diet|diet
718041|NCT00556023|interventional|interventional
718042|NCT00556023|dose-finding|dose-finding
718043|NCT00555997|Major Depressive Disorder|major depressive disorder
718044|NCT00555997|Major Depression|major depression
718045|NCT00555997|Depression|depression
718046|NCT00555997|Geodon|geodon
718047|NCT00555997|Ziprasidone|ziprasidone
718048|NCT00555984|Intracranial tumors|intracranial tumors
718049|NCT00555984|Inflammatory markers|inflammatory markers
718050|NCT00555984|Craniotomy|craniotomy
718051|NCT00555984|Postoperative complications|postoperative complications
718052|NCT00555958|Obesity|obesity
718053|NCT00555958|Bariatric surgery|bariatric surgery
718054|NCT00555958|Excess weight loss|excess weight loss
718055|NCT00555958|Vagus nerve|vagus nerve
718056|NCT00555958|Vagal blocking|vagal blocking
718057|NCT00555958|VBLOC(TM) therapy|vbloc(tm) therapy
718058|NCT00555945|Intertrochanteric fracture|intertrochanteric fracture
718059|NCT00555945|Gamma3 intramedullary nail|gamma3 intramedullary nail
718060|NCT00555945|Sliding hip screw|sliding hip screw
718061|NCT00555932|Intracranial Thrombosis|intracranial thrombosis
718062|NCT00555932|Cerebral Sinovenous Thrombosis|cerebral sinovenous thrombosis
718063|NCT00555932|Pediatrics|pediatrics
718064|NCT00555932|Cranial Ultrasound|cranial ultrasound
718065|NCT00555919|Metastatic breast cancer stage IV|metastatic breast cancer stage iv
718066|NCT00555919|Metastatic breast cancer|metastatic breast cancer
718067|NCT00555919|mBC|mbc
718068|NCT00555919|Stage IV breast cancer|stage iv breast cancer
718069|NCT00555919|Hormone receptor positive breast cancer|hormone receptor positive breast cancer
718070|NCT00555893|randomized|randomized
718071|NCT00555893|blinded|blinded
718072|NCT00555893|controlled|controlled
718073|NCT00555893|efficacy|efficacy
718074|NCT00555867|hormone-receptor positive primary breast cancer|hormone-receptor positive primary breast cancer
718075|NCT00555867|compliance|compliance
718076|NCT00555867|Postmenopausal women|postmenopausal women
718077|NCT00555854|Motivational interviewing,|motivational interviewing,
718078|NCT00555854|Multidisciplinary|multidisciplinary
718079|NCT00555854|Life style changes|life style changes
718080|NCT00555854|Prevention|prevention
718081|NCT00555854|Compliance|compliance
718082|NCT00555854|Self Care|self care
718083|NCT00555854|Behaviour|behaviour
718084|NCT00555841|breast cancer|breast cancer
718085|NCT00555828|Myocardial Infarction|myocardial infarction
718086|NCT00555828|Myocardial infarct|myocardial infarct
718087|NCT00555828|Infarction|infarction
718088|NCT00555802|Low Back Pain|low back pain
718089|NCT00555802|Motor Control Exercise|motor control exercise
718090|NCT00555802|General exercise|general exercise
718091|NCT00555802|Ultrasonography, Multifidus|ultrasonography, multifidus
718092|NCT00555802|Transversus abdominis|transversus abdominis
718093|NCT00555802|Randomized Controlled trial.|randomized controlled trial.
718094|NCT00555789|kidney transplantation|kidney transplantation
718095|NCT00555789|rejection|rejection
718096|NCT00555789|AEB071|aeb071
718097|NCT00555789|tacrolimus|tacrolimus
718098|NCT00555789|mycophenolic acid|mycophenolic acid
718099|NCT00555789|immunosuppression|immunosuppression
718100|NCT00555776|tinnitus|tinnitus
718101|NCT00555776|gabapentin|gabapentin
718102|NCT00555763|Intraocular pressure|intraocular pressure
718103|NCT00555763|Goldmann tonometry|goldmann tonometry
718104|NCT00555763|applanation tonometry|applanation tonometry
718105|NCT00555763|Tonometry, Ocular|tonometry, ocular
718106|NCT00555750|sleep|sleep
718107|NCT00555750|metabolism|metabolism
718108|NCT00555750|insulin|insulin
718109|NCT00555750|glucose|glucose
718110|NCT00555750|actigraphy|actigraphy
718111|NCT00555750|diary|diary
718112|NCT00555750|volumetry|volumetry
718113|NCT00555750|GABA|gaba
718114|NCT00555737|Celiac Disease|celiac disease
718115|NCT00555737|Capsule Endoscopy|capsule endoscopy
718116|NCT00555737|small Bowel Disease|small bowel disease
718117|NCT00555724|Relapsed|relapsed
718118|NCT00555724|refractory|refractory
718119|NCT00555724|solid tumor|solid tumor
718120|NCT00555711|Brain tumor|brain tumor
718121|NCT00555698|DBS|dbs
718123|NCT00555685|Heart Failure|heart failure
718124|NCT00555685|Renal failure|renal failure
718125|NCT00555685|Hyponatremia|hyponatremia
718126|NCT00555659|Degeneration|degeneration
718127|NCT00555659|Spondylosis|spondylosis
718128|NCT00555659|Spondylolisthesis|spondylolisthesis
718129|NCT00555659|Stenosis|stenosis
718130|NCT00555633|Photoprotection|photoprotection
718131|NCT00555633|Sunscreen|sunscreen
718132|NCT00555633|After-sun-lotion|after-sun-lotion
718133|NCT00555633|DNA repair enzymes|dna repair enzymes
718134|NCT00555633|liposomes|liposomes
718135|NCT00555633|skin cancer|skin cancer
718136|NCT00555633|Xeroderma pigmentosum|xeroderma pigmentosum
718137|NCT00555633|Basal cell nevus syndrome|basal cell nevus syndrome
718138|NCT00555607|asthma|asthma
718139|NCT00555607|COPD|copd
718140|NCT00555607|severe|severe
718141|NCT00555607|controlled|controlled
718142|NCT00555607|mild|mild
718143|NCT00555607|biomarker|biomarker
718144|NCT00555607|exacerbation|exacerbation
718145|NCT00555594|corneal neovascularization|corneal neovascularization
718146|NCT00555594|Bevacizumab (Avastin)|bevacizumab (avastin)
718147|NCT00555594|Immunologic rejection|immunologic rejection
718148|NCT00555594|vascular endothelial growth factor|vascular endothelial growth factor
718149|NCT00555581|Systemic Sclerosis|systemic sclerosis
718150|NCT00555568|mental health|mental health
718151|NCT00555568|group processes|group processes
718152|NCT00555555|Factor VIII deficiency|factor viii deficiency
718153|NCT00555555|Von Willebrand disease|von willebrand disease
718154|NCT00555555|FVIII/VWF concentrate|fviii/vwf concentrate
718155|NCT00555555|Bleeding disorders|bleeding disorders
718156|NCT00555555|Blood disorders|blood disorders
718157|NCT00555542|B-cell|b-cell
718158|NCT00555542|rituximab|rituximab
718159|NCT00555542|Rheumatoid Arthritis|rheumatoid arthritis
718160|NCT00555529|COPD|copd
718161|NCT00555529|exhaled breath condensate|exhaled breath condensate
718162|NCT00555529|applanation tonometry|applanation tonometry
718163|NCT00555529|induced sputum|induced sputum
718164|NCT00555529|smokers|smokers
718165|NCT00555529|healthy control|healthy control
718166|NCT00555516|Breast Cancer、 Chemotherapy、 Neutropenia、WBC|breast cancer、 chemotherapy、 neutropenia、wbc
718167|NCT00555503|prospective study|prospective study
718168|NCT00555503|registry|registry
718169|NCT00555503|quality of life|quality of life
718170|NCT00555503|mastectomy|mastectomy
718171|NCT00555503|reconstructive surgical procedures|reconstructive surgical procedures
718172|NCT00555503|BrCa1|brca1
718173|NCT00555503|BrCa2|brca2
718174|NCT00555503|breast cancer prevention|breast cancer prevention
718175|NCT00555490|Soy|soy
718176|NCT00555490|Diabetes|diabetes
718177|NCT00555490|Nephropathy|nephropathy
718178|NCT00555477|premenopausal breast cancer with chemotherapy-induced ovarian failure|premenopausal breast cancer with chemotherapy-induced ovarian failure
718179|NCT00555464|hemangioma, steroid, prednisolone, vincristine|hemangioma, steroid, prednisolone, vincristine
718180|NCT00555451|phase I|phase i
718181|NCT00555451|safety|safety
718182|NCT00555451|tolerance|tolerance
718183|NCT00555451|insulin resistance|insulin resistance
718184|NCT00555451|obese|obese
718185|NCT00555451|pharmacokinetics|pharmacokinetics
718186|NCT00555438|major orthopaedic surgery|major orthopaedic surgery
718187|NCT00555438|venous thromboembolic events prevention|venous thromboembolic events prevention
718188|NCT00555438|renal impairment|renal impairment
718189|NCT00555438|Arixtra|arixtra
718190|NCT00555438|anti-Xa activity|anti-xa activity
718191|NCT00555425|Buprenorphine|buprenorphine
718192|NCT00555425|Buprenorphine/naloxone|buprenorphine/naloxone
718193|NCT00555425|Counseling|counseling
718194|NCT00555425|Primary care|primary care
718195|NCT00555412|pharmacokinetic|pharmacokinetic
718196|NCT00555412|multidose|multidose
718197|NCT00555412|Staccato Loxapine|staccato loxapine
718198|NCT00555399|Glioblastoma Multiforme|glioblastoma multiforme
718199|NCT00555399|Anaplastic Glioma|anaplastic glioma
718200|NCT00555399|Vorinostat|vorinostat
718201|NCT00555399|Suberoylanilide Hydroxamic Acid|suberoylanilide hydroxamic acid
718202|NCT00555399|SAHA|saha
718203|NCT00555399|MSK-390|msk-390
718204|NCT00555399|Zolinza|zolinza
718205|NCT00555399|Isotretinoin|isotretinoin
718206|NCT00555399|Accutane|accutane
718207|NCT00555399|13-cis-Retinoic Acid|13-cis-retinoic acid
718208|NCT00555399|Carboplatin|carboplatin
718209|NCT00555399|Paraplatin|paraplatin
718210|NCT00555399|CBT|cbt
718211|NCT00555399|Temozolomide|temozolomide
718212|NCT00555399|Temodar|temodar
718213|NCT00555386|Selenium|selenium
718214|NCT00555386|Soy|soy
718215|NCT00555386|Breast Cancer Risk|breast cancer risk
718216|NCT00555373|Pediatric|pediatric
718217|NCT00555373|Renal|renal
718218|NCT00555373|Transplant|transplant
718219|NCT00555360|Health Information Technology|health information technology
718220|NCT00555360|Patient Care Management|patient care management
718221|NCT00555360|Self Care|self care
718222|NCT00555360|Quality of Life|quality of life
718223|NCT00555360|Family or non-Family Informal Caregivers|family or non-family informal caregivers
718224|NCT00555347|Sarcoidosis|sarcoidosis
718226|NCT00555334|hepatocellular carcinoma|hepatocellular carcinoma
718227|NCT00555334|liver cancer|liver cancer
718228|NCT00555334|radiofrequency ablation|radiofrequency ablation
718229|NCT00555334|lamivudine|lamivudine
718230|NCT00555308|urolithiasis|urolithiasis
718231|NCT00555308|ultrasound|ultrasound
718232|NCT00555308|hydronephrosis|hydronephrosis
718233|NCT00555282|central venous catheter|central venous catheter
718234|NCT00555282|cvc|cvc
718235|NCT00555282|coated catheter|coated catheter
718236|NCT00555282|bacteriaemia|bacteriaemia
718237|NCT00555282|bloodstream infection|bloodstream infection
718238|NCT00555269|Macular pucker|macular pucker
718239|NCT00555269|Macular hole|macular hole
718240|NCT00555269|Membrane Blue|membrane blue
718241|NCT00555269|Infracyanine Green|infracyanine green
718242|NCT00555269|Peripheral Visual Field|peripheral visual field
718243|NCT00555256|NSCLC|nsclc
718244|NCT00555243|Laparoscopic Surgical Simulation|laparoscopic surgical simulation
718613|NCT00553709|nausea|nausea
718245|NCT00555230|HMG-CoA reductase inhibitors|hmg-coa reductase inhibitors
718246|NCT00555230|Crestor|crestor
718247|NCT00555230|Rosuvastatin|rosuvastatin
718248|NCT00555217|kidney disease|kidney disease
718249|NCT00555217|nephropathy|nephropathy
718250|NCT00555217|type 2 diabetes|type 2 diabetes
718251|NCT00555217|hyperkalemia|hyperkalemia
718252|NCT00555217|acute kidney injury|acute kidney injury
718253|NCT00555204|mild to moderate Alzheimer's disease, memory, cognition, dementia|mild to moderate alzheimer's disease, memory, cognition, dementia
718254|NCT00555191|fructose|fructose
718255|NCT00555191|Irritable bowel syndrome|irritable bowel syndrome
718256|NCT00555191|malabsorption|malabsorption
718257|NCT00555191|Glut5 transporter gene|glut5 transporter gene
718258|NCT00555178|Polymorphic light eruption|polymorphic light eruption
718259|NCT00555178|Regulatory T cells (Tregs)|regulatory t cells (tregs)
718260|NCT00555178|Seasonal fluctuation|seasonal fluctuation
718261|NCT00555178|UV radiation|uv radiation
718262|NCT00555178|Phototherapy|phototherapy
718263|NCT00555165|Macular Degeneration|macular degeneration
718264|NCT00555165|Visual Impairment|visual impairment
718265|NCT00555165|Quality of Life|quality of life
718266|NCT00555165|Implantable Telescope|implantable telescope
718267|NCT00555139|anxiety,|anxiety,
718268|NCT00555139|depression,|depression,
718269|NCT00555139|fMRI|fmri
718270|NCT00555139|CRF-1 antagonists,|crf-1 antagonists,
718271|NCT00555126|Polytrauma|polytrauma
718272|NCT00555126|Hypothermia|hypothermia
718273|NCT00555126|Wound Infection|wound infection
718274|NCT00555126|Blood Loss|blood loss
718275|NCT00555126|Combined perioperative morbidity|combined perioperative morbidity
718276|NCT00555113|pseudoxanthoma elasticum|pseudoxanthoma elasticum
718277|NCT00555113|Visual acuity|visual acuity
718278|NCT00555113|Choroidal neovascularization|choroidal neovascularization
718279|NCT00555113|angioid streaks|angioid streaks
718280|NCT00555087|Erectile dysfunction|erectile dysfunction
718281|NCT00555087|Hypogonadotrophic males|hypogonadotrophic males
718282|NCT00555061|SID|sid
718283|NCT00555061|impetigo|impetigo
718284|NCT00555061|pharmacokinetics|pharmacokinetics
718285|NCT00555061|Retapamulin ointment, 1%|retapamulin ointment, 1%
718286|NCT00555061|Skin abnormalities|skin abnormalities
718287|NCT00555061|Dermatoses|dermatoses
718288|NCT00555061|pediatric|pediatric
718289|NCT00555061|infection|infection
718290|NCT00555061|SITL|sitl
718291|NCT00555048|graft versus host disease|graft versus host disease
718292|NCT00555048|adult acute megakaryoblastic leukemia (M7)|adult acute megakaryoblastic leukemia (m7)
718293|NCT00555048|adult acute monoblastic leukemia (M5a)|adult acute monoblastic leukemia (m5a)
718294|NCT00555048|adult acute monocytic leukemia (M5b)|adult acute monocytic leukemia (m5b)
718295|NCT00555048|adult acute myeloblastic leukemia with maturation (M2)|adult acute myeloblastic leukemia with maturation (m2)
718296|NCT00555048|adult acute myeloblastic leukemia without maturation (M1)|adult acute myeloblastic leukemia without maturation (m1)
718297|NCT00555048|adult acute myeloid leukemia with 11q23 (MLL) abnormalities|adult acute myeloid leukemia with 11q23 (mll) abnormalities
718298|NCT00555048|adult acute myelomonocytic leukemia (M4)|adult acute myelomonocytic leukemia (m4)
718299|NCT00555048|adult acute promyelocytic leukemia (M3)|adult acute promyelocytic leukemia (m3)
718300|NCT00555048|adult erythroleukemia (M6a)|adult erythroleukemia (m6a)
718301|NCT00555048|adult pure erythroid leukemia (M6b)|adult pure erythroid leukemia (m6b)
718302|NCT00555048|childhood acute megakaryocytic leukemia (M7)|childhood acute megakaryocytic leukemia (m7)
718303|NCT00555048|childhood acute monoblastic leukemia (M5a)|childhood acute monoblastic leukemia (m5a)
718304|NCT00555048|childhood acute monocytic leukemia (M5b)|childhood acute monocytic leukemia (m5b)
718305|NCT00555048|childhood acute myeloblastic leukemia with maturation (M2)|childhood acute myeloblastic leukemia with maturation (m2)
718306|NCT00555048|childhood acute myeloblastic leukemia without maturation (M1)|childhood acute myeloblastic leukemia without maturation (m1)
718307|NCT00555048|childhood acute myelomonocytic leukemia (M4)|childhood acute myelomonocytic leukemia (m4)
718308|NCT00555048|childhood acute promyelocytic leukemia (M3)|childhood acute promyelocytic leukemia (m3)
718309|NCT00555048|accelerated phase chronic myelogenous leukemia|accelerated phase chronic myelogenous leukemia
718310|NCT00555048|adult acute lymphoblastic leukemia in remission|adult acute lymphoblastic leukemia in remission
718311|NCT00555048|adult acute myeloid leukemia in remission|adult acute myeloid leukemia in remission
718312|NCT00555048|adult acute myeloid leukemia with inv(16)(p13;q22)|adult acute myeloid leukemia with inv(16)(p13;q22)
718313|NCT00555048|adult acute myeloid leukemia with t(15;17)(q22;q12)|adult acute myeloid leukemia with t(15;17)(q22;q12)
718314|NCT00555048|adult acute myeloid leukemia with t(16;16)(p13;q22)|adult acute myeloid leukemia with t(16;16)(p13;q22)
718315|NCT00555048|adult acute myeloid leukemia with t(8;21)(q22;q22)|adult acute myeloid leukemia with t(8;21)(q22;q22)
718316|NCT00555048|blastic phase chronic myelogenous leukemia|blastic phase chronic myelogenous leukemia
718317|NCT00555048|childhood acute lymphoblastic leukemia in remission|childhood acute lymphoblastic leukemia in remission
718318|NCT00555048|childhood acute myeloid leukemia in remission|childhood acute myeloid leukemia in remission
718319|NCT00555048|childhood chronic myelogenous leukemia|childhood chronic myelogenous leukemia
718320|NCT00555048|chronic phase chronic myelogenous leukemia|chronic phase chronic myelogenous leukemia
718321|NCT00555048|recurrent adult acute lymphoblastic leukemia|recurrent adult acute lymphoblastic leukemia
718416|NCT00554671|guideline adherence|guideline adherence
718322|NCT00555048|recurrent adult acute myeloid leukemia|recurrent adult acute myeloid leukemia
718323|NCT00555048|recurrent childhood acute lymphoblastic leukemia|recurrent childhood acute lymphoblastic leukemia
718324|NCT00555048|recurrent childhood acute myeloid leukemia|recurrent childhood acute myeloid leukemia
718325|NCT00555048|relapsing chronic myelogenous leukemia|relapsing chronic myelogenous leukemia
718326|NCT00555048|secondary acute myeloid leukemia|secondary acute myeloid leukemia
718327|NCT00555048|childhood myelodysplastic syndromes|childhood myelodysplastic syndromes
718328|NCT00555048|de novo myelodysplastic syndromes|de novo myelodysplastic syndromes
718329|NCT00555048|myelodysplastic/myeloproliferative diseases|myelodysplastic/myeloproliferative diseases
718330|NCT00555048|secondary myelodysplastic syndromes|secondary myelodysplastic syndromes
718331|NCT00555035|GSK1349572,|gsk1349572,
718332|NCT00555035|healthy volunteers|healthy volunteers
718333|NCT00555022|Anticholinergic,|anticholinergic,
718334|NCT00555022|FTIH,|ftih,
718335|NCT00555022|Muscarinic Receptor Antagonist,|muscarinic receptor antagonist,
718336|NCT00555022|Plethysmography|plethysmography
718337|NCT00555022|COPD,|copd,
718338|NCT00555009|traumatic brain Injury, cognitive function|traumatic brain injury, cognitive function
718339|NCT00554996|urinary tract infection|urinary tract infection
718340|NCT00554996|urinary catheter|urinary catheter
718341|NCT00554996|Escherichia coli|escherichia coli
718342|NCT00554996|biofilm|biofilm
718343|NCT00554983|Recombinant birch pollen allergy|recombinant birch pollen allergy
718344|NCT00554983|IgE-mediated allergic disease attributed to birch pollen|ige-mediated allergic disease attributed to birch pollen
718345|NCT00554970|Adult Asthmatics|adult asthmatics
718346|NCT00554944|Fluid Management|fluid management
718347|NCT00554944|surgery|surgery
718348|NCT00554944|Obesity|obesity
718349|NCT00554918|adenocarcinoma of the prostate|adenocarcinoma of the prostate
718350|NCT00554918|recurrent prostate cancer|recurrent prostate cancer
718351|NCT00554918|stage IV prostate cancer|stage iv prostate cancer
718352|NCT00554918|bone metastases|bone metastases
718353|NCT00554905|ablation|ablation
718354|NCT00554905|catheter|catheter
718355|NCT00554905|Carcinoma, Hepatocellular|carcinoma, hepatocellular
718356|NCT00554905|therapy|therapy
718357|NCT00554905|Chemoembolization, Therapeutic|chemoembolization, therapeutic
718358|NCT00554905|Humans|humans
718359|NCT00554905|Liver Neoplasms|liver neoplasms
718360|NCT00554892|Rectal cancer|rectal cancer
718361|NCT00554892|Sphincter preservation|sphincter preservation
718362|NCT00554892|Mechanical bowel preparation|mechanical bowel preparation
718363|NCT00554892|Post operative morbidity|post operative morbidity
718364|NCT00554892|Anastomotic leakage|anastomotic leakage
718365|NCT00554827|Relapsed or Refractory Cutaneous T-cell Lymphoma|relapsed or refractory cutaneous t-cell lymphoma
718366|NCT00554827|Lymphoma|lymphoma
718367|NCT00554827|Cutaneous T-cell Lymphoma|cutaneous t-cell lymphoma
718368|NCT00554827|T-cell Lymphoma|t-cell lymphoma
718369|NCT00554827|Mycosis fungoides|mycosis fungoides
718370|NCT00554827|Sézary syndrome|sézary syndrome
718371|NCT00554827|Primary cutaneous anaplastic large cell|primary cutaneous anaplastic large cell
718372|NCT00554814|Iron deficiency|iron deficiency
718373|NCT00554814|Ferritin|ferritin
718374|NCT00554814|Encapsulated iron|encapsulated iron
718375|NCT00554814|Infant formula|infant formula
718376|NCT00554801|Central Auditory Processing|central auditory processing
718377|NCT00554801|Traumatic Brain Injury|traumatic brain injury
718378|NCT00554801|Hearing Loss|hearing loss
718379|NCT00554775|tumors metastatic to brain|tumors metastatic to brain
718380|NCT00554775|stage IV non-small cell lung cancer|stage iv non-small cell lung cancer
718381|NCT00554775|recurrent non-small cell lung cancer|recurrent non-small cell lung cancer
718382|NCT00554762|mechanical pain,|mechanical pain,
718383|NCT00554762|heat pain,|heat pain,
718384|NCT00554762|dose,|dose,
718385|NCT00554762|efficacy|efficacy
718386|NCT00554762|dose response,|dose response,
718387|NCT00554762|GW842166,|gw842166,
718388|NCT00554762|Single,|single,
718389|NCT00554762|pharmacodynamics,|pharmacodynamics,
718390|NCT00554762|repeat dose,|repeat dose,
718391|NCT00554749|Selective mutism|selective mutism
718392|NCT00554749|Children|children
718393|NCT00554749|Treatment|treatment
718394|NCT00554736|Pollen Allergy|pollen allergy
718395|NCT00554736|Allergy|allergy
718396|NCT00554723|Stroke|stroke
718397|NCT00554723|Cerebral infarct|cerebral infarct
718398|NCT00554723|Recovery|recovery
718399|NCT00554723|Double blind|double blind
718400|NCT00554723|Randomized|randomized
718401|NCT00554723|Placebo|placebo
718402|NCT00554723|Traditional Chinese Medicine|traditional chinese medicine
718403|NCT00554723|Neuroaid|neuroaid
718404|NCT00554710|Crohn's disease|crohn's disease
718405|NCT00554710|immunomodulators|immunomodulators
718406|NCT00554710|biologicals|biologicals
718407|NCT00554697|tissue oxygenation|tissue oxygenation
718408|NCT00554697|perioperative|perioperative
718409|NCT00554697|outcome|outcome
718410|NCT00554684|Outcome|outcome
718411|NCT00554684|Elderly|elderly
718412|NCT00554684|ICU|icu
718413|NCT00554684|Quality of Life|quality of life
718414|NCT00554671|Diabetes Mellitus|diabetes mellitus
718415|NCT00554671|Clinical pharmacists|clinical pharmacists
718417|NCT00554671|group medical visits|group medical visits
718418|NCT00554671|behavioral modification|behavioral modification
718419|NCT00554671|pharmacotherapy|pharmacotherapy
718420|NCT00554645|obesity|obesity
718421|NCT00554645|children|children
718422|NCT00554645|psychological intervention|psychological intervention
718423|NCT00554632|Contraceptive|contraceptive
718424|NCT00554632|Venous thrombosis|venous thrombosis
718425|NCT00554632|Coagulation parameter|coagulation parameter
718426|NCT00554619|Pulmonary Arterial Hypertension|pulmonary arterial hypertension
718427|NCT00554619|Ambrisentan|ambrisentan
718428|NCT00554606|Rheumatoid Arthritis|rheumatoid arthritis
718429|NCT00554606|Anit-interleukin-1 beta|anit-interleukin-1 beta
718430|NCT00554606|ACZ885|acz885
718431|NCT00554580|continuous positive airway pressure|continuous positive airway pressure
718432|NCT00554580|outcome measure|outcome measure
718433|NCT00554580|clinical trial|clinical trial
718434|NCT00554567|HIV/AIDS|hiv/aids
718435|NCT00554567|Voluntary Counseling and Testing|voluntary counseling and testing
718436|NCT00554567|Rural India|rural india
718437|NCT00554567|HIV Care|hiv care
718438|NCT00554567|Health Services Research|health services research
718439|NCT00554528|Cervical|cervical
718440|NCT00554528|disc|disc
718441|NCT00554528|prosthesis|prosthesis
718442|NCT00554528|adjacent|adjacent
718443|NCT00554528|disease|disease
718444|NCT00554528|randomized|randomized
718445|NCT00554528|prospective|prospective
718446|NCT00554528|study|study
718447|NCT00554515|Kidney|kidney
718448|NCT00554515|Renal Cell|renal cell
718449|NCT00554515|Metastatic|metastatic
718450|NCT00554515|interleukin-2|interleukin-2
718451|NCT00554515|select|select
718452|NCT00554489|recurrent adult acute myeloid leukemia|recurrent adult acute myeloid leukemia
718453|NCT00554489|adult acute myeloid leukemia with 11q23 (MLL) abnormalities|adult acute myeloid leukemia with 11q23 (mll) abnormalities
718454|NCT00554489|adult acute myeloid leukemia with inv(16)(p13;q22)|adult acute myeloid leukemia with inv(16)(p13;q22)
718455|NCT00554489|adult acute myeloid leukemia with t(15;17)(q22;q12)|adult acute myeloid leukemia with t(15;17)(q22;q12)
718456|NCT00554489|adult acute myeloid leukemia with t(16;16)(p13;q22)|adult acute myeloid leukemia with t(16;16)(p13;q22)
718457|NCT00554489|adult acute myeloid leukemia with t(8;21)(q22;q22)|adult acute myeloid leukemia with t(8;21)(q22;q22)
718458|NCT00554476|Lateral Epicondylitis|lateral epicondylitis
718459|NCT00554476|Treatment|treatment
718460|NCT00554476|Corticosteroid|corticosteroid
718461|NCT00554476|Elbow Cast|elbow cast
718462|NCT00554476|Icing|icing
718463|NCT00554476|NSAIDs|nsaids
718464|NCT00554463|limited stage small cell lung cancer|limited stage small cell lung cancer
718465|NCT00554437|Accidental Falls|accidental falls
718467|NCT00554437|Age 65 and older|age 65 and older
718468|NCT00554437|noninstitualized populations|noninstitualized populations
718469|NCT00554424|oocyte retrieval|oocyte retrieval
718470|NCT00554424|pain relief|pain relief
718471|NCT00554424|Local anaesthetic|local anaesthetic
718472|NCT00554411|Travatan Z|travatan z
718473|NCT00554411|glaucoma|glaucoma
718474|NCT00554411|tear film break up time|tear film break up time
718475|NCT00554398|Raltegravir|raltegravir
718476|NCT00554398|MK-0518|mk-0518
718477|NCT00554398|Treatment intensification|treatment intensification
718478|NCT00554398|HIV-1 latency|hiv-1 latency
718479|NCT00554398|HIV eradication|hiv eradication
718480|NCT00554398|treatment experienced|treatment experienced
718481|NCT00554372|Jennerex|jennerex
718482|NCT00554372|HCC|hcc
718483|NCT00554372|unresectable primary hepatocellular carcinoma|unresectable primary hepatocellular carcinoma
718484|NCT00554372|hepatocellular carcinoma|hepatocellular carcinoma
718485|NCT00554372|liver cancer|liver cancer
718486|NCT00554372|Phase 2|phase 2
718487|NCT00554372|oncolytic virus|oncolytic virus
718488|NCT00554372|Pexa-Vec|pexa-vec
718489|NCT00554359|Acute Kidney Injury|acute kidney injury
718490|NCT00554359|Acute Renal Failure|acute renal failure
718491|NCT00554346|COX-2; post-operative ; sports injury; surgical pain|cox-2; post-operative ; sports injury; surgical pain
718492|NCT00554320|vulvodynia|vulvodynia
718493|NCT00554320|painful bladder syndrome|painful bladder syndrome
718594|NCT00553839|ketamine|ketamine
718494|NCT00554320|myofascial pain syndrome|myofascial pain syndrome
718495|NCT00554320|pelvic floor tension myalgia|pelvic floor tension myalgia
718496|NCT00554307|patent ductus arteriosus|patent ductus arteriosus
718497|NCT00554307|indomethacin|indomethacin
718498|NCT00554307|neoprofen|neoprofen
718499|NCT00554307|blood flow|blood flow
718500|NCT00554294|children|children
718501|NCT00554294|primary prevention|primary prevention
718502|NCT00554294|environmental change|environmental change
718503|NCT00554294|behavioural change|behavioural change
718504|NCT00554294|school setting|school setting
718505|NCT00554294|changing of drinking habits|changing of drinking habits
718506|NCT00554294|promotion of drinking tap water|promotion of drinking tap water
718507|NCT00554281|Type 1 diabetes|type 1 diabetes
718508|NCT00554281|Hypoglycemia|hypoglycemia
718509|NCT00554281|Glucose sensor|glucose sensor
718510|NCT00554268|Advanced Cancers|advanced cancers
718511|NCT00554268|Solid Tumors|solid tumors
718512|NCT00554268|PBI-05204|pbi-05204
718513|NCT00554255|Pharmacodynamics|pharmacodynamics
718514|NCT00554255|Japanese|japanese
718515|NCT00554255|safety|safety
718516|NCT00554255|Pharmacokinetics|pharmacokinetics
718517|NCT00554242|endothelium|endothelium
718518|NCT00554242|antioxidants|antioxidants
718519|NCT00554242|flavonoids|flavonoids
718520|NCT00554229|Hormone Resistant Prostate Cancer|hormone resistant prostate cancer
718521|NCT00554229|Endothelin A Receptor Antagonist|endothelin a receptor antagonist
718522|NCT00554229|Endothelin A|endothelin a
718523|NCT00554229|Endothelin A antagonist|endothelin a antagonist
718524|NCT00554216|Obesity, morbid obesity|obesity, morbid obesity
718525|NCT00554190|rhinosinusitis, ethmoid|rhinosinusitis, ethmoid
718526|NCT00554177|sexual|sexual
718527|NCT00554177|combat|combat
718528|NCT00554177|PTSD|ptsd
718529|NCT00554177|Clinical trial|clinical trial
718530|NCT00554177|Trauma|trauma
718531|NCT00554177|PTSD treatment|ptsd treatment
718532|NCT00554177|PTSD medication|ptsd medication
718533|NCT00554177|Post traumatic stress disorder|post traumatic stress disorder
718534|NCT00554164|Aggressive non-Hodgkin's lymphoma|aggressive non-hodgkin's lymphoma
718535|NCT00554164|Positron emission tomography|positron emission tomography
718536|NCT00554164|Chemotherapy|chemotherapy
718537|NCT00554138|rosuvastatin|rosuvastatin
718538|NCT00554138|dipyridamole|dipyridamole
718539|NCT00554138|caffeine|caffeine
718540|NCT00554125|Sirolimus; Orthotopic liver transplantation; HCC|sirolimus; orthotopic liver transplantation; hcc
718541|NCT00554112|Exercise Training|exercise training
718542|NCT00554112|Glucose Intolerance|glucose intolerance
718543|NCT00554112|Human Aging|human aging
718544|NCT00554112|Insulin Secretion|insulin secretion
718545|NCT00554073|Magnetic resonance|magnetic resonance
718546|NCT00554073|whole body|whole body
718547|NCT00554073|angiography|angiography
718548|NCT00554073|vasovist|vasovist
718549|NCT00554073|gadofosveset|gadofosveset
718550|NCT00554073|blood pool agent|blood pool agent
718552|NCT00554073|1.5T|1.5t
718553|NCT00554073|Field strength|field strength
718554|NCT00554047|Dementia|dementia
718555|NCT00554047|Caregivers|caregivers
718556|NCT00554047|Costs and cost analysis|costs and cost analysis
718557|NCT00554047|Multicenter study|multicenter study
718558|NCT00554047|Randomized controlled trial|randomized controlled trial
718559|NCT00554047|Quality Adjusted Life Years|quality adjusted life years
718560|NCT00554047|Quality of life|quality of life
718561|NCT00554047|Technology assessment, biomedical; Methods|technology assessment, biomedical; methods
718562|NCT00554034|gingivitis, localized treatment|gingivitis, localized treatment
718563|NCT00554021|Central venous catheter|central venous catheter
718564|NCT00554021|nosocomial infection|nosocomial infection
718565|NCT00554008|Appendicitis|appendicitis
718566|NCT00554008|laparoscopy|laparoscopy
718567|NCT00554008|randomized trial|randomized trial
718568|NCT00554008|children|children
718569|NCT00554008|pediatric|pediatric
718570|NCT00553982|Replacement|replacement
718571|NCT00553982|Knee|knee
718572|NCT00553982|Patella|patella
718573|NCT00553982|Arthroplasty|arthroplasty
718574|NCT00553969|cardiovascular disease prevention|cardiovascular disease prevention
718575|NCT00553943|lymphoma|lymphoma
718576|NCT00553943|cerebral lymphoma|cerebral lymphoma
718577|NCT00553943|central nervous system|central nervous system
718578|NCT00553943|cytarabine|cytarabine
718579|NCT00553943|rituximab|rituximab
718580|NCT00553943|Diffuse large B-cell lymphomas, with cerebral or neuromeningeal involvement|diffuse large b-cell lymphomas, with cerebral or neuromeningeal involvement
718581|NCT00553930|HCV/HIV-coinfected patients|hcv/hiv-coinfected patients
718582|NCT00553930|Peginterferon alfa-2a|peginterferon alfa-2a
718583|NCT00553917|Pregnancy|pregnancy
718584|NCT00553917|Depression|depression
718585|NCT00553917|Antidepressants|antidepressants
718586|NCT00553852|Very Severe Obesity|very severe obesity
718587|NCT00553852|Body Composition|body composition
718588|NCT00553852|GH deficiency|gh deficiency
718589|NCT00553852|IGF-I|igf-i
718590|NCT00553852|LASGB|lasgb
718591|NCT00553852|GH therapy|gh therapy
718592|NCT00553839|anesthesia|anesthesia
718593|NCT00553839|children|children
718595|NCT00553839|pharmacokinetics|pharmacokinetics
718596|NCT00553813|Unresectable|unresectable
718597|NCT00553813|Gemcitabine|gemcitabine
718598|NCT00553813|Taxane|taxane
718599|NCT00553813|TPI 287|tpi 287
718600|NCT00553787|Obesity, Type 2 diabetes|obesity, type 2 diabetes
718601|NCT00553774|CAD Patients on Optimal Treatment|cad patients on optimal treatment
718602|NCT00553761|Band atrophy|band atrophy
718603|NCT00553761|Pattern electroretinogram|pattern electroretinogram
718604|NCT00553761|Chiasmal compression|chiasmal compression
718605|NCT00553761|Neural loss|neural loss
718606|NCT00553761|Electrophysiological tests|electrophysiological tests
718607|NCT00553735|Dry Eye|dry eye
718608|NCT00553735|Graft versus Host Disease|graft versus host disease
718609|NCT00553735|GVHD|gvhd
718610|NCT00553722|hypertension|hypertension
718611|NCT00553722|dialysis|dialysis
718612|NCT00553722|hyperaldosteronism|hyperaldosteronism
718614|NCT00553709|vomiting|vomiting
718615|NCT00553709|retching|retching
718616|NCT00553709|emesis|emesis
718617|NCT00553709|surgery|surgery
718618|NCT00553709|anesthesia|anesthesia
718619|NCT00553696|chemotherapy|chemotherapy
718620|NCT00553696|combination|combination
718621|NCT00553683|stage IV pancreatic cancer|stage iv pancreatic cancer
718622|NCT00553683|adult primary hepatocellular carcinoma|adult primary hepatocellular carcinoma
718623|NCT00553683|advanced adult primary liver cancer|advanced adult primary liver cancer
718624|NCT00553683|recurrent adult primary liver cancer|recurrent adult primary liver cancer
718625|NCT00553683|localized unresectable adult primary liver cancer|localized unresectable adult primary liver cancer
718626|NCT00553683|recurrent pancreatic cancer|recurrent pancreatic cancer
718627|NCT00553683|recurrent colon cancer|recurrent colon cancer
718628|NCT00553683|recurrent breast cancer|recurrent breast cancer
718629|NCT00553683|recurrent gastric cancer|recurrent gastric cancer
718630|NCT00553683|recurrent ovarian epithelial cancer|recurrent ovarian epithelial cancer
718631|NCT00553683|recurrent melanoma|recurrent melanoma
718632|NCT00553683|stage IV breast cancer|stage iv breast cancer
718633|NCT00553683|stage IV gastric cancer|stage iv gastric cancer
718634|NCT00553683|stage IV colon cancer|stage iv colon cancer
718635|NCT00553683|stage IV ovarian epithelial cancer|stage iv ovarian epithelial cancer
718636|NCT00553683|stage IV melanoma|stage iv melanoma
718637|NCT00553683|liver metastases|liver metastases
718638|NCT00553670|coronary artery|coronary artery
718639|NCT00553670|bifurcation|bifurcation
718640|NCT00553670|stent|stent
718641|NCT00553670|intravascular ultrasound|intravascular ultrasound
718642|NCT00553670|fractional flow reserve|fractional flow reserve
718643|NCT00553657|Experimental Medicine|experimental medicine
718644|NCT00553631|Enzyme Replacement Therapy|enzyme replacement therapy
718645|NCT00553631|Gaucher disease|gaucher disease
718646|NCT00553631|glucocerebrosidase|glucocerebrosidase
718647|NCT00553631|beta-glucocerebrosidase|beta-glucocerebrosidase
718648|NCT00553631|Acid beta-glucocerebrosidase|acid beta-glucocerebrosidase
718649|NCT00553631|glucosylceramidase|glucosylceramidase
718650|NCT00553631|D-glucosyl-N-acylsphingosine glucohydrolase|d-glucosyl-n-acylsphingosine glucohydrolase
718651|NCT00553631|gene activation|gene activation
718652|NCT00553631|human|human
718653|NCT00553618|Interleukin 2|interleukin 2
718654|NCT00553618|Proleukin|proleukin
718655|NCT00553618|DTIC|dtic
718656|NCT00553618|Dacarbazine|dacarbazine
718657|NCT00553618|metastatic melanoma|metastatic melanoma
718658|NCT00553618|adjuvant|adjuvant
718659|NCT00553605|Renal Colic Pain Urinary Tract Colic|renal colic pain urinary tract colic
718660|NCT00553579|contrast sensitivity, retention time|contrast sensitivity, retention time
718661|NCT00553566|stage 0 bladder cancer|stage 0 bladder cancer
718662|NCT00553566|stage I bladder cancer|stage i bladder cancer
718663|NCT00553566|transitional cell carcinoma of the bladder|transitional cell carcinoma of the bladder
718664|NCT00553553|Intrathecal morphine ITM intravenous morphine remifentanil hepatic resection|intrathecal morphine itm intravenous morphine remifentanil hepatic resection
718665|NCT00553553|Adult|adult
718666|NCT00553553|ASA I-III (stable)|asa i-iii (stable)
718667|NCT00553553|Liver dysfunction requiring primary parenchymal resection|liver dysfunction requiring primary parenchymal resection
718668|NCT00553540|backache|backache
718669|NCT00553540|low backpain|low backpain
718670|NCT00553540|sciatica|sciatica
718671|NCT00553514|Infertility|infertility
718672|NCT00553514|Oligo-anovulation|oligo-anovulation
718673|NCT00553514|GONAL-f®|gonal-f®
718674|NCT00553514|AS900672-Enriched|as900672-enriched
718675|NCT00553514|hyperglycosylated recombinant human follicle stimulating hormone (r-hFSH)|hyperglycosylated recombinant human follicle stimulating hormone (r-hfsh)
718676|NCT00553501|stage II grade 1 follicular lymphoma|stage ii grade 1 follicular lymphoma
718677|NCT00553501|stage II grade 2 follicular lymphoma|stage ii grade 2 follicular lymphoma
718678|NCT00553501|stage II grade 3 follicular lymphoma|stage ii grade 3 follicular lymphoma
718679|NCT00553501|stage III grade 1 follicular lymphoma|stage iii grade 1 follicular lymphoma
718680|NCT00553501|stage III grade 2 follicular lymphoma|stage iii grade 2 follicular lymphoma
718681|NCT00553501|stage III grade 3 follicular lymphoma|stage iii grade 3 follicular lymphoma
718682|NCT00553501|stage IV grade 1 follicular lymphoma|stage iv grade 1 follicular lymphoma
718876|NCT00552643|Recalcitrant ulcers|recalcitrant ulcers
718683|NCT00553501|stage IV grade 2 follicular lymphoma|stage iv grade 2 follicular lymphoma
718684|NCT00553501|stage IV grade 3 follicular lymphoma|stage iv grade 3 follicular lymphoma
718685|NCT00553488|diabetes|diabetes
718686|NCT00553488|insulin|insulin
718687|NCT00553488|subcutaneous|subcutaneous
718688|NCT00553488|intra-dermal|intra-dermal
718689|NCT00553488|blood glucose|blood glucose
718690|NCT00553462|stage IIIA non-small cell lung cancer|stage iiia non-small cell lung cancer
718691|NCT00553462|stage IIIB non-small cell lung cancer|stage iiib non-small cell lung cancer
718692|NCT00553462|adenocarcinoma of the lung|adenocarcinoma of the lung
718693|NCT00553462|bronchoalveolar cell lung cancer|bronchoalveolar cell lung cancer
718694|NCT00553462|large cell lung cancer|large cell lung cancer
718695|NCT00553462|squamous cell lung cancer|squamous cell lung cancer
718696|NCT00553449|nocturnal heartburn|nocturnal heartburn
718697|NCT00553449|day-time heartburn|day-time heartburn
718698|NCT00553449|rabeprazole|rabeprazole
718699|NCT00553449|GERD|gerd
718700|NCT00553436|colon|colon
718701|NCT00553436|rectum|rectum
718702|NCT00553436|polyp|polyp
718703|NCT00553436|EMR|emr
718704|NCT00553436|Established indication for a procedure greater than colonoscopy and colonic polypectomy|established indication for a procedure greater than colonoscopy and colonic polypectomy
718705|NCT00553410|stage IA breast cancer|stage ia breast cancer
718706|NCT00553410|stage IB breast cancer|stage ib breast cancer
718707|NCT00553410|stage II breast cancer|stage ii breast cancer
718708|NCT00553410|stage IIIA breast cancer|stage iiia breast cancer
718709|NCT00553397|Living donor lung transplant|living donor lung transplant
718710|NCT00553397|End stage lung disease|end stage lung disease
718711|NCT00553384|smell|smell
718712|NCT00553384|olfaction|olfaction
718713|NCT00553384|androstadienone|androstadienone
718714|NCT00553384|women|women
718715|NCT00553384|pheromones|pheromones
718716|NCT00553384|Healthy Volunteers|healthy volunteers
718717|NCT00553384|Physiological Effects of Androstadienone Exposure|physiological effects of androstadienone exposure
718718|NCT00553371|stage II malignant testicular germ cell tumor|stage ii malignant testicular germ cell tumor
718719|NCT00553371|stage III malignant testicular germ cell tumor|stage iii malignant testicular germ cell tumor
718720|NCT00553358|Lapatinib|lapatinib
718721|NCT00553358|ErbB2+|erbb2+
718722|NCT00553358|Early Breast Cancer|early breast cancer
718723|NCT00553358|Neoadjuvant|neoadjuvant
718724|NCT00553345|transitional cell carcinoma of the bladder|transitional cell carcinoma of the bladder
718725|NCT00553345|stage 0 bladder cancer|stage 0 bladder cancer
718726|NCT00553345|stage I bladder cancer|stage i bladder cancer
718727|NCT00553319|ADHD|adhd
718728|NCT00553319|Cocaine|cocaine
718729|NCT00553319|Treatment|treatment
718730|NCT00553293|infertility|infertility
718731|NCT00553293|in vitro fertilization|in vitro fertilization
718732|NCT00553293|LH supplementation|lh supplementation
718733|NCT00553293|Benefits|benefits
718734|NCT00553241|TIA|tia
718735|NCT00553241|prognosis|prognosis
718736|NCT00553241|evaluation|evaluation
718737|NCT00553241|management|management
718738|NCT00553228|maternal immunization|maternal immunization
718739|NCT00553228|whooping cough|whooping cough
718740|NCT00553228|pertussis|pertussis
718741|NCT00553215|transitional cell carcinoma of the bladder|transitional cell carcinoma of the bladder
718742|NCT00553215|stage 0 bladder cancer|stage 0 bladder cancer
718743|NCT00553215|stage I bladder cancer|stage i bladder cancer
718744|NCT00553215|stage II bladder cancer|stage ii bladder cancer
718870|NCT00552669|Stent Thrombosis|stent thrombosis
718745|NCT00553202|recurrent childhood acute myeloid leukemia|recurrent childhood acute myeloid leukemia
718746|NCT00553202|childhood myelodysplastic syndromes|childhood myelodysplastic syndromes
718747|NCT00553189|PARP Inhibitor|parp inhibitor
718748|NCT00553189|Advanced Cancer|advanced cancer
718749|NCT00553189|Combination Therapy|combination therapy
718750|NCT00553189|Early Trial|early trial
718751|NCT00553189|DNA Damage Repair|dna damage repair
718752|NCT00553189|Topotecan|topotecan
718753|NCT00553189|Cancer|cancer
718754|NCT00553189|Solid Tumor|solid tumor
718755|NCT00553189|Lymphoma|lymphoma
718756|NCT00553176|Infliximab|infliximab
718757|NCT00553176|Immune disorder|immune disorder
718758|NCT00553176|Remicade|remicade
718759|NCT00553176|Registry|registry
718760|NCT00553176|Crohn's Disease|crohn's disease
718761|NCT00553163|Hypnotherapy|hypnotherapy
718762|NCT00553163|Prevention of relapse|prevention of relapse
718763|NCT00553163|ulcerative colitis|ulcerative colitis
718764|NCT00553150|adult gliosarcoma|adult gliosarcoma
718765|NCT00553150|adult giant cell glioblastoma|adult giant cell glioblastoma
718766|NCT00553150|adult glioblastoma|adult glioblastoma
718767|NCT00553150|adult anaplastic astrocytoma|adult anaplastic astrocytoma
718768|NCT00553150|adult diffuse astrocytoma|adult diffuse astrocytoma
718769|NCT00553150|adult pilocytic astrocytoma|adult pilocytic astrocytoma
718770|NCT00553150|adult subependymal giant cell astrocytoma|adult subependymal giant cell astrocytoma
718771|NCT00553137|oropharyngeal candidiasis|oropharyngeal candidiasis
718772|NCT00553124|stage 0 bladder cancer|stage 0 bladder cancer
718773|NCT00553124|stage I bladder cancer|stage i bladder cancer
718774|NCT00553124|stage II bladder cancer|stage ii bladder cancer
718775|NCT00553124|transitional cell carcinoma of the bladder|transitional cell carcinoma of the bladder
718776|NCT00553111|syphilis|syphilis
718777|NCT00553111|video education|video education
718778|NCT00553111|knowledge|knowledge
718779|NCT00553111|black|black
718780|NCT00553111|hispanic|hispanic
718781|NCT00553085|anxiety disorders|anxiety disorders
718782|NCT00553085|children|children
718783|NCT00553085|neurodevelopmental disorder|neurodevelopmental disorder
718784|NCT00553085|neurodevelopmental delay|neurodevelopmental delay
718785|NCT00553085|temperament|temperament
718786|NCT00553072|Asphyxia|asphyxia
718787|NCT00553072|perinatal|perinatal
718788|NCT00553072|magnesium sulphate|magnesium sulphate
718789|NCT00553059|nausea and vomiting|nausea and vomiting
718790|NCT00553059|unspecified adult solid tumor|unspecified adult solid tumor
718791|NCT00553059|Palonosetron|palonosetron
718792|NCT00553059|Dexamethasone|dexamethasone
718793|NCT00553046|ethics|ethics
718794|NCT00553046|COPD|copd
718795|NCT00553046|end of life|end of life
718796|NCT00553046|mechanical ventilation|mechanical ventilation
718797|NCT00553046|CRF home ventilated patients|crf home ventilated patients
718798|NCT00553033|Patients must be candidable to liver resection|patients must be candidable to liver resection
718799|NCT00553007|Periodontal disease|periodontal disease
718800|NCT00553007|Metabolic Syndrome|metabolic syndrome
718801|NCT00552994|Drug eluting stent|drug eluting stent
718802|NCT00552994|Diabetics|diabetics
718803|NCT00552994|Intravascular ultrasound|intravascular ultrasound
718804|NCT00552994|Pathophysiologic (neointimal hyperplasia and peri-stent remodeling)|pathophysiologic (neointimal hyperplasia and peri-stent remodeling)
718805|NCT00552981|common cold|common cold
718806|NCT00552981|Finnish sauna|finnish sauna
718807|NCT00552981|rct|rct
718808|NCT00552968|trauma|trauma
718809|NCT00552968|pain|pain
718810|NCT00552955|Lymphangioleiomyomatosis|lymphangioleiomyomatosis
718811|NCT00552955|Abdominal Lymphangioleiomyomas|abdominal lymphangioleiomyomas
718812|NCT00552955|Chyle|chyle
718813|NCT00552955|Ascites|ascites
718814|NCT00552955|Tuberous Sclerosis Complex|tuberous sclerosis complex
718815|NCT00552955|LAM|lam
718816|NCT00552942|obesity|obesity
718817|NCT00552942|diabetes|diabetes
718818|NCT00552942|cytokines|cytokines
718819|NCT00552890|obesity|obesity
718820|NCT00552890|atkins|atkins
718821|NCT00552890|weight reduction|weight reduction
718822|NCT00552890|kidney function|kidney function
718823|NCT00552877|PCI|pci
718824|NCT00552877|Drug-eluting stent|drug-eluting stent
718825|NCT00552851|acromegaly|acromegaly
718826|NCT00552851|heart failure|heart failure
718827|NCT00552851|hypertrophy|hypertrophy
718828|NCT00552851|cardiomegaly|cardiomegaly
718829|NCT00552838|Antimicrobial prescribing|antimicrobial prescribing
718830|NCT00552838|Antimicrobial utilization|antimicrobial utilization
718831|NCT00552825|acute lymphoblastic leukemia|acute lymphoblastic leukemia
718832|NCT00552825|long-term lung function|long-term lung function
718833|NCT00552812|Aortic Coarctation|aortic coarctation
718834|NCT00552812|Heart Defects, Congenital|heart defects, congenital
718835|NCT00552812|Stents|stents
718836|NCT00552812|Heart Catheterization|heart catheterization
718837|NCT00552799|cellulitis|cellulitis
718838|NCT00552799|lymphoedema|lymphoedema
718839|NCT00552799|penicillin|penicillin
718840|NCT00552799|clinical trial|clinical trial
718841|NCT00552786|noise|noise
718842|NCT00552786|hearing loss|hearing loss
718843|NCT00552786|temporary threshold shift|temporary threshold shift
718844|NCT00552773|SINUSITIS|sinusitis
718845|NCT00552773|CYCLAMEN|cyclamen
718846|NCT00552747|fenofibrate|fenofibrate
718847|NCT00552747|coronary heart disease|coronary heart disease
718848|NCT00552747|mixed hyperlipidemia|mixed hyperlipidemia
718849|NCT00552734|Type 1 diabetes|type 1 diabetes
718850|NCT00552734|Improved glycemic control|improved glycemic control
718851|NCT00552734|Glucose excursions|glucose excursions
718852|NCT00552734|Target range glucose levels|target range glucose levels
718853|NCT00552734|Insulin guidance software|insulin guidance software
718854|NCT00552734|Advisor|advisor
718855|NCT00552721|Motor control|motor control
718856|NCT00552721|Spasticity|spasticity
718857|NCT00552708|COREG CR|coreg cr
718858|NCT00552695|intravenous catheter|intravenous catheter
718859|NCT00552695|emergency department|emergency department
718860|NCT00552695|pain|pain
718861|NCT00552682|HIV|hiv
718862|NCT00552682|fibromialgy|fibromialgy
718863|NCT00552682|chronic fatigue syndrome|chronic fatigue syndrome
718864|NCT00552682|duloxetine|duloxetine
718865|NCT00552682|pain|pain
718866|NCT00552682|treatment experienced|treatment experienced
718867|NCT00552682|Fibromialgy in patients with HIV-1 infection|fibromialgy in patients with hiv-1 infection
718868|NCT00552669|Drug Eluting Stents|drug eluting stents
718869|NCT00552669|Stents Bare Metal|stents bare metal
718871|NCT00552669|Coronary revascularization|coronary revascularization
718872|NCT00552669|Survival|survival
718873|NCT00552656|Angioplasty, Transluminal, Percutaneous Coronary|angioplasty, transluminal, percutaneous coronary
718874|NCT00552656|Drug-eluting stents|drug-eluting stents
718875|NCT00552656|Treatment Outcome|treatment outcome
718877|NCT00552643|Chronic wounds|chronic wounds
718878|NCT00552643|Venous insufficiency wounds|venous insufficiency wounds
718879|NCT00552643|Ulcers|ulcers
718880|NCT00552643|Exposed bones|exposed bones
718881|NCT00552643|Exposed Tendons|exposed tendons
718882|NCT00552643|Granulation tissue|granulation tissue
718883|NCT00552643|Polyheal 1|polyheal 1
718884|NCT00552643|Wound care|wound care
718885|NCT00552643|Wound healing|wound healing
718886|NCT00552643|Diabetic wounds healing|diabetic wounds healing
718887|NCT00552643|Post trauma|post trauma
718888|NCT00552643|Post surgery complication|post surgery complication
718889|NCT00552643|Recalcitrant wounds including venous, post-operative and post-traumatic chronic wounds with different etiologies including wounds with exposed bone and tendon.|recalcitrant wounds including venous, post-operative and post-traumatic chronic wounds with different etiologies including wounds with exposed bone and tendon.
718890|NCT00552630|lead poisoning|lead poisoning
718891|NCT00552630|chelation|chelation
719095|NCT00551759|docetaxel|docetaxel
718892|NCT00552604|multiple sclerosis|multiple sclerosis
718893|NCT00552604|muscle stiffness|muscle stiffness
718894|NCT00552604|spasticity|spasticity
718895|NCT00552604|pain|pain
718896|NCT00552604|treatment|treatment
718897|NCT00552604|cannabinoids|cannabinoids
718898|NCT00552591|family risk|family risk
718899|NCT00552591|behavior modification|behavior modification
718900|NCT00552591|lifestyle change|lifestyle change
718901|NCT00552591|prevention of CHD|prevention of chd
718902|NCT00552591|health care costs|health care costs
718903|NCT00552578|drug dependence|drug dependence
718904|NCT00552578|substance abuse|substance abuse
718905|NCT00552578|substance use disorders|substance use disorders
718906|NCT00552578|myofascial pain syndrome|myofascial pain syndrome
718907|NCT00552578|neuralgia|neuralgia
718908|NCT00552578|back pain|back pain
718909|NCT00552565|IBS, IBS-D, R-verapamil, Arverpamil, Rezular|ibs, ibs-d, r-verapamil, arverpamil, rezular
718910|NCT00552552|cancer-related fatigue|cancer-related fatigue
718911|NCT00552552|self-management|self-management
718912|NCT00552552|patient education|patient education
718913|NCT00552552|cancer survivors|cancer survivors
718914|NCT00552552|chronic disease|chronic disease
718915|NCT00552539|syphilis|syphilis
718916|NCT00552539|educational video|educational video
718917|NCT00552539|knowledge|knowledge
718918|NCT00552539|black|black
718919|NCT00552539|Hispanic|hispanic
718920|NCT00552526|Epilepsy|epilepsy
718921|NCT00552526|Children|children
718922|NCT00552526|Mental retardation|mental retardation
718923|NCT00552526|Ketogenic diet|ketogenic diet
718924|NCT00552526|Diet|diet
718925|NCT00552513|timing|timing
718926|NCT00552513|intervention|intervention
718927|NCT00552513|early|early
718928|NCT00552513|delayed|delayed
718929|NCT00552513|acute coronary syndromes|acute coronary syndromes
718930|NCT00552513|PCI|pci
718931|NCT00552513|angiography|angiography
718932|NCT00552513|Non ST-segment elevation myocardial infarction|non st-segment elevation myocardial infarction
718933|NCT00552513|unstable angina|unstable angina
718934|NCT00552487|isolated ACTH deficiency|isolated acth deficiency
718935|NCT00552487|Hashimoto disease|hashimoto disease
718936|NCT00552487|Hashimoto thyroiditis|hashimoto thyroiditis
718937|NCT00552487|autoimmune thyroiditis|autoimmune thyroiditis
718938|NCT00552474|Parkinson disease|parkinson disease
718939|NCT00552474|Movement disorders|movement disorders
718940|NCT00552474|Deep Brain Stimulation|deep brain stimulation
718941|NCT00552474|Libra|libra
718942|NCT00552474|l-dopa|l-dopa
718943|NCT00552474|levodopa|levodopa
718944|NCT00552474|neuromodulation|neuromodulation
718945|NCT00552474|neurostimulation|neurostimulation
718946|NCT00552474|Electrical stimulation of the brain|electrical stimulation of the brain
718947|NCT00552474|STN|stn
718948|NCT00552474|Subthalamic nucleus|subthalamic nucleus
718949|NCT00552461|Pulmonary alveolar proteinosis|pulmonary alveolar proteinosis
718950|NCT00552461|Primary Pulmonary alveolar proteinosis|primary pulmonary alveolar proteinosis
718951|NCT00552461|Rituximab|rituximab
718952|NCT00552461|Idiopathic|idiopathic
718953|NCT00552461|Symptomatic|symptomatic
718954|NCT00552461|GM-CSF Antibody|gm-csf antibody
718955|NCT00552448|Pediatric, asthma, pediatric ICU|pediatric, asthma, pediatric icu
718956|NCT00552422|gastroparesis|gastroparesis
718957|NCT00552422|gastroesophageal reflux|gastroesophageal reflux
718958|NCT00552409|Diabetes mellitus|diabetes mellitus
718959|NCT00552409|Type 2 diabetes|type 2 diabetes
718960|NCT00552409|Chronic kidney disease|chronic kidney disease
718961|NCT00552409|Diabetic kidney disease|diabetic kidney disease
718962|NCT00552409|Microalbuminuria|microalbuminuria
718963|NCT00552409|Albuminuria|albuminuria
718964|NCT00552409|Vitamin D|vitamin d
718965|NCT00552409|Cholecalciferol|cholecalciferol
718966|NCT00552409|Kidney|kidney
718967|NCT00552409|Renal|renal
718968|NCT00552409|Cardiovascular|cardiovascular
718969|NCT00552409|Clinical trial|clinical trial
718970|NCT00552409|Placebo|placebo
718971|NCT00552396|multiple myeloma|multiple myeloma
718972|NCT00552396|Anti-KIR (1-7F9)|anti-kir (1-7f9)
718973|NCT00552383|Preterm Infant|preterm infant
718974|NCT00552383|Behaviour|behaviour
718975|NCT00552383|Developmental Care|developmental care
718976|NCT00552383|NIDCAP|nidcap
718977|NCT00552383|Family Centred Care|family centred care
718978|NCT00552383|Neurodevelopmental Outcome, preterm infant|neurodevelopmental outcome, preterm infant
718979|NCT00552344|CDP 870|cdp 870
718980|NCT00552344|Certolizumab Pegol|certolizumab pegol
718981|NCT00552344|CIMZIA|cimzia
718982|NCT00552344|Crohn's Disease|crohn's disease
718983|NCT00552344|Crohn Disease|crohn disease
718984|NCT00552344|CD Induction|cd induction
718985|NCT00552344|Induction|induction
718986|NCT00552344|Clinical response|clinical response
718987|NCT00552344|Clinical remission|clinical remission
718988|NCT00552292|metabolic syndrome|metabolic syndrome
718989|NCT00552292|hypertension|hypertension
718990|NCT00552292|obesity|obesity
718991|NCT00552292|dyslipidemia|dyslipidemia
718992|NCT00552292|hyperglycemia|hyperglycemia
718993|NCT00552292|cardiovascular complications|cardiovascular complications
718994|NCT00552279|HPV|hpv
718995|NCT00552279|cervical cancer|cervical cancer
718996|NCT00552279|papillomavirus|papillomavirus
718997|NCT00552279|Human papillomavirus (HPV) vaccine|human papillomavirus (hpv) vaccine
718998|NCT00552266|Methylphenidate|methylphenidate
718999|NCT00552266|Trichotillomania|trichotillomania
719000|NCT00552266|Attention deficit|attention deficit
719001|NCT00552214|Nucleic acid test|nucleic acid test
719002|NCT00552214|HIV-1|hiv-1
719003|NCT00552214|hepatitis|hepatitis
719005|NCT00552214|HCV|hcv
719006|NCT00552214|TMA|tma
719007|NCT00552214|HIV Seronegativity|hiv seronegativity
719008|NCT00552201|kidney transplantation|kidney transplantation
719009|NCT00552201|Tacrolimus|tacrolimus
719010|NCT00552201|P450 3A5 cytochrome|p450 3a5 cytochrome
719011|NCT00552201|genotype|genotype
719012|NCT00552188|Atherosclerosis|atherosclerosis
719013|NCT00552084|Fish Oil|fish oil
719014|NCT00552071|Acromegaly|acromegaly
719015|NCT00552071|Octreotide LAR|octreotide lar
719016|NCT00552071|Ultrasound guidance|ultrasound guidance
719017|NCT00552058|CDP 870|cdp 870
719018|NCT00552058|Certolizumab Pegol|certolizumab pegol
719019|NCT00552058|CIMZIA ®|cimzia ®
719020|NCT00552058|Crohn's disease|crohn's disease
719021|NCT00552058|Induction|induction
719022|NCT00552058|Clinical remission|clinical remission
719023|NCT00552058|Clinical response|clinical response
719024|NCT00552045|epilepsy|epilepsy
719025|NCT00552045|localization-related epilepsy|localization-related epilepsy
719026|NCT00552045|idiopathic generalized epilepsy|idiopathic generalized epilepsy
719027|NCT00552045|infantile spasms|infantile spasms
719028|NCT00552045|Lennox-Gastaut syndrome|lennox-gastaut syndrome
719029|NCT00552045|polymicrogyria|polymicrogyria
719030|NCT00552045|periventricular heterotopias|periventricular heterotopias
719031|NCT00552045|malformations of cortical development|malformations of cortical development
719032|NCT00552045|phenome|phenome
719033|NCT00552045|genome|genome
719034|NCT00552045|genotype|genotype
719035|NCT00552045|phenotype|phenotype
719036|NCT00552006|PTSD|ptsd
719037|NCT00552006|Treatment|treatment
719038|NCT00552006|Randomized Controlled Clinical Trial|randomized controlled clinical trial
719039|NCT00552006|Combat|combat
719040|NCT00552006|Child Soldiers|child soldiers
719041|NCT00552006|Dissemination|dissemination
719042|NCT00552006|Narrative Exposure Therapy|narrative exposure therapy
719043|NCT00552006|Africa|africa
719044|NCT00551993|laparoscopy|laparoscopy
719045|NCT00551993|robot|robot
719046|NCT00551993|vaginal prolapse|vaginal prolapse
719047|NCT00551993|sacrocolpopexy|sacrocolpopexy
719048|NCT00551993|sacral colpopexy|sacral colpopexy
719049|NCT00551980|Headache|headache
719050|NCT00551980|Cervical Pain|cervical pain
719051|NCT00551980|Cognitive treatment|cognitive treatment
719052|NCT00551980|Relaxation|relaxation
719053|NCT00551980|Exercise|exercise
719054|NCT00551967|clinical outcomes|clinical outcomes
719055|NCT00551967|radiographic outcomes|radiographic outcomes
719056|NCT00551967|total hip arthroplasty|total hip arthroplasty
719057|NCT00551967|survivorship|survivorship
719058|NCT00551928|Multiple Myeloma|multiple myeloma
719059|NCT00551928|Lenalidomide|lenalidomide
719060|NCT00551928|High dose Melphalan|high dose melphalan
719061|NCT00551928|Mobilization|mobilization
719062|NCT00551928|CD34|cd34
719063|NCT00551902|Glaucoma|glaucoma
719064|NCT00551902|trabeculectomy|trabeculectomy
719065|NCT00551902|anterior chamber maintainer|anterior chamber maintainer
719066|NCT00551902|anterior chamber infusion|anterior chamber infusion
719067|NCT00551889|unspecified adult solid tumor, protocol specific|unspecified adult solid tumor, protocol specific
719068|NCT00551863|alcohol, drugs, aggression, substance use disorder treatment|alcohol, drugs, aggression, substance use disorder treatment
719069|NCT00551850|epidermal growth factor inhibitor|epidermal growth factor inhibitor
719070|NCT00551850|solid tumors|solid tumors
719071|NCT00551850|advanced cancer|advanced cancer
719072|NCT00551837|Lung Transplantation|lung transplantation
719073|NCT00551837|Kidney Transplnatation|kidney transplnatation
719074|NCT00551837|Chroinic Kidney Disease|chroinic kidney disease
719075|NCT00551837|Influenza|influenza
719076|NCT00551824|esophageal stricture|esophageal stricture
719077|NCT00551811|SB-656933-AAA,|sb-656933-aaa,
719078|NCT00551811|ozone challenge|ozone challenge
719079|NCT00551811|single dose,|single dose,
719080|NCT00551798|Hodgkin's Disease|hodgkin's disease
719081|NCT00551798|Malignant lymphomas high grade|malignant lymphomas high grade
719082|NCT00551798|Chemoresistance|chemoresistance
719083|NCT00551798|MIBI|mibi
719084|NCT00551798|PGP|pgp
719085|NCT00551798|MRP1|mrp1
719086|NCT00551798|Tumor response|tumor response
719087|NCT00551785|Hypoactive Sexual Desire Disorder|hypoactive sexual desire disorder
719088|NCT00551785|Menopause|menopause
719089|NCT00551785|Androgen|androgen
719090|NCT00551772|Bio-availability, healthy elderly volunteers|bio-availability, healthy elderly volunteers
719091|NCT00551759|adenocarcinoma of the esophagus|adenocarcinoma of the esophagus
719092|NCT00551759|chemoradiotherapy|chemoradiotherapy
719093|NCT00551759|oxaliplatin|oxaliplatin
719094|NCT00551759|cetuximab|cetuximab
719096|NCT00551746|purple grape juice|purple grape juice
719097|NCT00551746|antioxidants|antioxidants
719098|NCT00551746|platelet aggregation|platelet aggregation
719099|NCT00551746|anti-thrombotic|anti-thrombotic
719100|NCT00551733|recurrent non-small cell lung cancer|recurrent non-small cell lung cancer
719101|NCT00551733|stage IIIB non-small cell lung cancer|stage iiib non-small cell lung cancer
719102|NCT00551733|stage IV non-small cell lung cancer|stage iv non-small cell lung cancer
719104|NCT00551720|HIV positive|hiv positive
719105|NCT00551720|AIDS|aids
719106|NCT00551720|smoking cessation|smoking cessation
719107|NCT00551720|smoking|smoking
719108|NCT00551720|smoking counseling|smoking counseling
719109|NCT00551707|CombinatoRx|combinatorx
719110|NCT00551707|CRx-102|crx-102
719111|NCT00551707|Rheumatoid Arthritis|rheumatoid arthritis
719112|NCT00551707|Prednisolone|prednisolone
719113|NCT00551707|Dipyridamole|dipyridamole
719114|NCT00551707|ACR20|acr20
719115|NCT00551694|GSK256073A|gsk256073a
719116|NCT00551681|cardiac resynchronisation therapy|cardiac resynchronisation therapy
719117|NCT00551681|epicardial lead|epicardial lead
719118|NCT00551681|coronary sinus|coronary sinus
719119|NCT00551655|Human Immunodeficiency Viruses|human immunodeficiency viruses
719120|NCT00551655|Glomerular Filtration Rate|glomerular filtration rate
719121|NCT00551655|Tenofovir|tenofovir
719122|NCT00551655|Treatment Experienced|treatment experienced
719123|NCT00551642|Preemie, Inhaled Nitric Oxide|preemie, inhaled nitric oxide
719124|NCT00551603|epoetinum beta once-weekly|epoetinum beta once-weekly
719125|NCT00551603|darbepoetinum once-fortnightly|darbepoetinum once-fortnightly
719126|NCT00551603|anemia correction|anemia correction
719127|NCT00551603|hemoglobin stability|hemoglobin stability
719128|NCT00551590|diabetes mellitus|diabetes mellitus
719129|NCT00551590|DPP-4 inhibitor|dpp-4 inhibitor
719130|NCT00551590|sitagliptin|sitagliptin
719131|NCT00551590|exendin(9-39)|exendin(9-39)
719132|NCT00551590|GLP-1|glp-1
719133|NCT00551577|Ovarian neoplasms,|ovarian neoplasms,
719134|NCT00551577|Neoadjuvant Therapy,|neoadjuvant therapy,
719135|NCT00551577|Docetaxel,|docetaxel,
719136|NCT00551577|Neoplasm, Residual|neoplasm, residual
719137|NCT00551564|total body water|total body water
719138|NCT00551564|T2DM,|t2dm,
719139|NCT00551564|Healthy Obese,|healthy obese,
719140|NCT00551564|Insulin Resistance,|insulin resistance,
719141|NCT00551564|Rosiglitazone maleate,|rosiglitazone maleate,
719142|NCT00551564|Glucose Disposal,|glucose disposal,
719143|NCT00551564|hyperinsulinemic-euglycemic clamp,|hyperinsulinemic-euglycemic clamp,
719144|NCT00551551|Pelvic floor|pelvic floor
719145|NCT00551551|Kegel exercises|kegel exercises
719146|NCT00551551|Quality of Life|quality of life
719147|NCT00551551|Pelvic Pain|pelvic pain
719148|NCT00551538|Diabetes|diabetes
719149|NCT00551538|Diabetic|diabetic
719150|NCT00551538|Insulin|insulin
719151|NCT00551538|Glargine|glargine
719152|NCT00551538|Lispro|lispro
719153|NCT00551525|stage IIB prostate cancer|stage iib prostate cancer
719154|NCT00551525|stage IIA prostate cancer|stage iia prostate cancer
719155|NCT00551525|stage III prostate cancer|stage iii prostate cancer
719156|NCT00551525|stage IV prostate cancer|stage iv prostate cancer
719157|NCT00551512|cancer|cancer
719158|NCT00551512|solid tumors|solid tumors
719159|NCT00551499|Sleep Apnea, CRT|sleep apnea, crt
719160|NCT00551486|Pyrosequencing|pyrosequencing
719161|NCT00551486|BRAFV600E mutation|brafv600e mutation
719162|NCT00551486|Thyroid incidentaloma|thyroid incidentaloma
719163|NCT00551486|Ultrasound-guided fine-needle aspiration biopsy|ultrasound-guided fine-needle aspiration biopsy
719164|NCT00551473|pharmacodynamics,|pharmacodynamics,
719165|NCT00551473|tolerance|tolerance
719166|NCT00551473|H2 antagonist,|h2 antagonist,
719167|NCT00551473|AH23844,|ah23844,
719168|NCT00551473|lavoltidine,|lavoltidine,
719169|NCT00551473|gastroesophageal reflux disease (GERD), pharmacokinetics,|gastroesophageal reflux disease (gerd), pharmacokinetics,
719170|NCT00551460|adult acute promyelocytic leukemia (M3)|adult acute promyelocytic leukemia (m3)
719171|NCT00551460|adult acute myeloid leukemia with t(15;17)(q22;q12)|adult acute myeloid leukemia with t(15;17)(q22;q12)
719172|NCT00551460|adult acute myeloid leukemia with inv(16)(p13;q22)|adult acute myeloid leukemia with inv(16)(p13;q22)
719252|NCT00551122|testicular seminoma|testicular seminoma
719173|NCT00551460|adult acute myeloid leukemia with t(16;16)(p13;q22)|adult acute myeloid leukemia with t(16;16)(p13;q22)
719174|NCT00551460|untreated adult acute myeloid leukemia|untreated adult acute myeloid leukemia
719175|NCT00551395|glaucoma|glaucoma
719176|NCT00551395|laser|laser
719177|NCT00551395|trabeculoplasty|trabeculoplasty
719178|NCT00551382|Montelukast|montelukast
719179|NCT00551382|Upper respiratory tract infection|upper respiratory tract infection
719180|NCT00551382|leukotriene|leukotriene
719181|NCT00551382|Children|children
719182|NCT00551369|stage I non-small cell lung cancer|stage i non-small cell lung cancer
719183|NCT00551369|stage II non-small cell lung cancer|stage ii non-small cell lung cancer
719184|NCT00551369|adenocarcinoma of the lung|adenocarcinoma of the lung
719185|NCT00551369|large cell lung cancer|large cell lung cancer
719186|NCT00551369|squamous cell lung cancer|squamous cell lung cancer
719187|NCT00551369|adenosquamous cell lung cancer|adenosquamous cell lung cancer
719188|NCT00551356|Diabetes|diabetes
719189|NCT00551356|Diabetic|diabetic
719190|NCT00551356|Insulin|insulin
719191|NCT00551356|Humalog|humalog
719192|NCT00551356|Lantus|lantus
719193|NCT00551356|Glargine|glargine
719194|NCT00551356|Lispro|lispro
719195|NCT00551330|Treatment Experienced|treatment experienced
719196|NCT00551317|SB480848,|sb480848,
719197|NCT00551317|Japanese healthy volunteers|japanese healthy volunteers
719198|NCT00551317|darapladib,|darapladib,
719199|NCT00551278|sentinel lymph node|sentinel lymph node
719200|NCT00551278|metastasis|metastasis
719201|NCT00551278|molecular pathology|molecular pathology
719202|NCT00551239|stage I grade 1 follicular lymphoma|stage i grade 1 follicular lymphoma
719203|NCT00551239|stage I grade 2 follicular lymphoma|stage i grade 2 follicular lymphoma
719204|NCT00551239|stage III grade 1 follicular lymphoma|stage iii grade 1 follicular lymphoma
719205|NCT00551239|stage III grade 2 follicular lymphoma|stage iii grade 2 follicular lymphoma
719206|NCT00551239|stage IV grade 1 follicular lymphoma|stage iv grade 1 follicular lymphoma
719207|NCT00551239|stage IV grade 2 follicular lymphoma|stage iv grade 2 follicular lymphoma
719208|NCT00551239|extranodal marginal zone B-cell lymphoma of mucosa-associated lymphoid tissue|extranodal marginal zone b-cell lymphoma of mucosa-associated lymphoid tissue
719209|NCT00551239|nodal marginal zone B-cell lymphoma|nodal marginal zone b-cell lymphoma
719210|NCT00551239|splenic marginal zone lymphoma|splenic marginal zone lymphoma
719211|NCT00551239|contiguous stage II grade 1 follicular lymphoma|contiguous stage ii grade 1 follicular lymphoma
719212|NCT00551239|contiguous stage II grade 2 follicular lymphoma|contiguous stage ii grade 2 follicular lymphoma
719213|NCT00551239|noncontiguous stage II grade 1 follicular lymphoma|noncontiguous stage ii grade 1 follicular lymphoma
719214|NCT00551239|noncontiguous stage II grade 2 follicular lymphoma|noncontiguous stage ii grade 2 follicular lymphoma
719215|NCT00551239|recurrent grade 1 follicular lymphoma|recurrent grade 1 follicular lymphoma
719216|NCT00551239|recurrent grade 2 follicular lymphoma|recurrent grade 2 follicular lymphoma
719217|NCT00551239|contiguous stage II marginal zone lymphoma|contiguous stage ii marginal zone lymphoma
719218|NCT00551239|noncontiguous stage II marginal zone lymphoma|noncontiguous stage ii marginal zone lymphoma
719219|NCT00551239|recurrent marginal zone lymphoma|recurrent marginal zone lymphoma
719220|NCT00551239|stage I marginal zone lymphoma|stage i marginal zone lymphoma
719221|NCT00551239|stage III marginal zone lymphoma|stage iii marginal zone lymphoma
719222|NCT00551239|stage IV marginal zone lymphoma|stage iv marginal zone lymphoma
719223|NCT00551239|contiguous stage II small lymphocytic lymphoma|contiguous stage ii small lymphocytic lymphoma
719224|NCT00551239|noncontiguous stage II small lymphocytic lymphoma|noncontiguous stage ii small lymphocytic lymphoma
719225|NCT00551239|recurrent small lymphocytic lymphoma|recurrent small lymphocytic lymphoma
719226|NCT00551239|stage I small lymphocytic lymphoma|stage i small lymphocytic lymphoma
719227|NCT00551239|stage III small lymphocytic lymphoma|stage iii small lymphocytic lymphoma
719228|NCT00551239|stage IV small lymphocytic lymphoma|stage iv small lymphocytic lymphoma
719229|NCT00551239|refractory chronic lymphocytic leukemia|refractory chronic lymphocytic leukemia
719230|NCT00551239|stage I chronic lymphocytic leukemia|stage i chronic lymphocytic leukemia
719231|NCT00551239|stage II chronic lymphocytic leukemia|stage ii chronic lymphocytic leukemia
719232|NCT00551239|stage III chronic lymphocytic leukemia|stage iii chronic lymphocytic leukemia
719343|NCT00550654|lung metastases|lung metastases
719233|NCT00551239|stage IV chronic lymphocytic leukemia|stage iv chronic lymphocytic leukemia
719234|NCT00551226|TB|tb
719235|NCT00551226|Patients with tuberculosis|patients with tuberculosis
719236|NCT00551213|anti-IGF-1R|anti-igf-1r
719237|NCT00551200|Buphenyl|buphenyl
719238|NCT00551200|Sodium Phenylbutyrate|sodium phenylbutyrate
719239|NCT00551200|Urea Cycle Disorder|urea cycle disorder
719240|NCT00551200|UCD|ucd
719241|NCT00551161|Alzheimer disease|alzheimer disease
719242|NCT00551161|memantine|memantine
719243|NCT00551161|cholinesterase inhibitors|cholinesterase inhibitors
719244|NCT00551161|magnetic resonance spectroscopy|magnetic resonance spectroscopy
719245|NCT00551161|N-acetylaspartate|n-acetylaspartate
719246|NCT00551161|inositol|inositol
719247|NCT00551161|cerebrospinal fluid|cerebrospinal fluid
719248|NCT00551161|tau proteins|tau proteins
719249|NCT00551161|amyloid beta-protein|amyloid beta-protein
719250|NCT00551135|postoperative pain chronic pain|postoperative pain chronic pain
719251|NCT00551122|recurrent malignant testicular germ cell tumor|recurrent malignant testicular germ cell tumor
719253|NCT00551122|recurrent ovarian germ cell tumor|recurrent ovarian germ cell tumor
719254|NCT00551122|stage IV ovarian germ cell tumor|stage iv ovarian germ cell tumor
719255|NCT00551122|stage III malignant testicular germ cell tumor|stage iii malignant testicular germ cell tumor
719256|NCT00551122|testicular choriocarcinoma and seminoma|testicular choriocarcinoma and seminoma
719257|NCT00551122|testicular embryonal carcinoma and seminoma|testicular embryonal carcinoma and seminoma
719258|NCT00551122|testicular embryonal carcinoma and teratoma with seminoma|testicular embryonal carcinoma and teratoma with seminoma
719259|NCT00551122|testicular embryonal carcinoma and yolk sac tumor with seminoma|testicular embryonal carcinoma and yolk sac tumor with seminoma
719260|NCT00551122|testicular yolk sac tumor and teratoma with seminoma|testicular yolk sac tumor and teratoma with seminoma
719261|NCT00551122|recurrent extragonadal non-seminomatous germ cell tumor|recurrent extragonadal non-seminomatous germ cell tumor
719262|NCT00551122|recurrent extragonadal seminoma|recurrent extragonadal seminoma
719442|NCT00550251|Nausea|nausea
719263|NCT00551122|stage IV extragonadal non-seminomatous germ cell tumor|stage iv extragonadal non-seminomatous germ cell tumor
719264|NCT00551122|stage IV extragonadal seminoma|stage iv extragonadal seminoma
719265|NCT00551122|recurrent extragonadal germ cell tumor|recurrent extragonadal germ cell tumor
719266|NCT00551122|ovarian mixed germ cell tumor|ovarian mixed germ cell tumor
719267|NCT00551122|adult central nervous system germ cell tumor|adult central nervous system germ cell tumor
719268|NCT00551096|Advanced Solid Tumors|advanced solid tumors
719269|NCT00551096|Biliary or Pancreatic Malignancies|biliary or pancreatic malignancies
719270|NCT00551044|prostatic neoplasms|prostatic neoplasms
719271|NCT00551044|bicalutamide|bicalutamide
719272|NCT00551044|quality of life|quality of life
719273|NCT00551044|osteoporosis|osteoporosis
719274|NCT00551031|Influenza|influenza
719275|NCT00551031|Orthomyxoviruses|orthomyxoviruses
719276|NCT00551031|Myxovirus Infection|myxovirus infection
719277|NCT00551031|Inactivated Split-virion influenza vaccine|inactivated split-virion influenza vaccine
719278|NCT00551031|Elderly|elderly
719279|NCT00551018|Treatment Naive|treatment naive
719280|NCT00551005|unspecified adult solid tumor, protocol specific|unspecified adult solid tumor, protocol specific
719281|NCT00550992|untreated childhood acute lymphoblastic leukemia|untreated childhood acute lymphoblastic leukemia
719282|NCT00550992|T-cell childhood acute lymphoblastic leukemia|t-cell childhood acute lymphoblastic leukemia
719283|NCT00550992|acute undifferentiated leukemia|acute undifferentiated leukemia
719284|NCT00550979|gestational diabetes mellitus|gestational diabetes mellitus
719285|NCT00550979|cardiovascular disease risk|cardiovascular disease risk
719286|NCT00550979|heart disease risk|heart disease risk
719287|NCT00550966|Fibromyalgia|fibromyalgia
719288|NCT00550966|Quality of life|quality of life
719289|NCT00550966|Primary Care|primary care
719290|NCT00550966|Non-pharmacological treatment|non-pharmacological treatment
719291|NCT00550966|Cost / Cost-efficacy|cost / cost-efficacy
719292|NCT00550940|epilepsy|epilepsy
719293|NCT00550940|attention|attention
719294|NCT00550940|emotion|emotion
719295|NCT00550940|behavior problems|behavior problems
719296|NCT00550940|child|child
719297|NCT00550940|adolescent|adolescent
719298|NCT00550927|unspecified adult solid tumor, protocol specific|unspecified adult solid tumor, protocol specific
719299|NCT00550914|Papilloma, Papillomatosis, Laser, Laser Surgery|papilloma, papillomatosis, laser, laser surgery
719300|NCT00550901|unspecified adult solid tumor, protocol specific|unspecified adult solid tumor, protocol specific
719301|NCT00550888|uterus|uterus
719302|NCT00550888|abdominal delivery|abdominal delivery
719303|NCT00550888|suture techniques|suture techniques
719304|NCT00550875|Allergic rhinoconjunctivitis,|allergic rhinoconjunctivitis,
719305|NCT00550875|Immunotherapy|immunotherapy
719306|NCT00550862|PBC, Primary Biliary Cirrhosis, Liver,|pbc, primary biliary cirrhosis, liver,
719307|NCT00550836|adenocarcinoma of the pancreas|adenocarcinoma of the pancreas
719308|NCT00550836|duct cell adenocarcinoma of the pancreas|duct cell adenocarcinoma of the pancreas
719309|NCT00550836|stage IV pancreatic cancer|stage iv pancreatic cancer
719310|NCT00550810|Sutent|sutent
719311|NCT00550797|Steroid-naive, non-smokers|steroid-naive, non-smokers
719312|NCT00550797|Mild to moderate allergic asthmatic adults|mild to moderate allergic asthmatic adults
719313|NCT00550784|recurrent ovarian epithelial cancer|recurrent ovarian epithelial cancer
719314|NCT00550784|stage III ovarian epithelial cancer|stage iii ovarian epithelial cancer
719315|NCT00550784|stage IV ovarian epithelial cancer|stage iv ovarian epithelial cancer
719316|NCT00550784|fallopian tube cancer|fallopian tube cancer
719317|NCT00550784|peritoneal cavity cancer|peritoneal cavity cancer
719318|NCT00550758|Methacholine challenge; Spirometry, Early childhood|methacholine challenge; spirometry, early childhood
719319|NCT00550732|Triazoles|triazoles
719320|NCT00550706|Prescription point prevalence|prescription point prevalence
719321|NCT00550706|Drug utilization|drug utilization
719322|NCT00550706|Define Daily Dose|define daily dose
719323|NCT00550693|bloodstream infections|bloodstream infections
719324|NCT00550693|hemodialysis catheter|hemodialysis catheter
719325|NCT00550667|Attention-deficit hyperactivity disorder|attention-deficit hyperactivity disorder
719326|NCT00550667|adult|adult
719327|NCT00550667|diagnostic validity|diagnostic validity
719328|NCT00550667|neuropsychological functions|neuropsychological functions
719329|NCT00550667|social functioning|social functioning
719423|NCT00550342|FSGS|fsgs
719330|NCT00550654|unspecified adult solid tumor, protocol specific|unspecified adult solid tumor, protocol specific
719331|NCT00550654|recurrent adult soft tissue sarcoma|recurrent adult soft tissue sarcoma
719332|NCT00550654|recurrent melanoma|recurrent melanoma
719333|NCT00550654|recurrent osteosarcoma|recurrent osteosarcoma
719334|NCT00550654|recurrent renal cell cancer|recurrent renal cell cancer
719335|NCT00550654|recurrent uterine sarcoma|recurrent uterine sarcoma
719336|NCT00550654|stage IV adult soft tissue sarcoma|stage iv adult soft tissue sarcoma
719337|NCT00550654|stage IV melanoma|stage iv melanoma
719338|NCT00550654|stage IV uterine sarcoma|stage iv uterine sarcoma
719339|NCT00550654|ovarian sarcoma|ovarian sarcoma
719340|NCT00550654|chondrosarcoma|chondrosarcoma
719341|NCT00550654|metastatic osteosarcoma|metastatic osteosarcoma
719342|NCT00550654|stage IV renal cell cancer|stage iv renal cell cancer
719344|NCT00550654|liver metastases|liver metastases
719345|NCT00550654|bone metastases|bone metastases
719346|NCT00550641|fibromyalgia|fibromyalgia
719347|NCT00550641|pool-based exercise|pool-based exercise
719348|NCT00550628|neoplasm of uncertain malignant potential|neoplasm of uncertain malignant potential
719349|NCT00550628|colon cancer|colon cancer
719350|NCT00550615|Non-Hodgkins Lymphoma|non-hodgkins lymphoma
719351|NCT00550615|Relapsed Non Hodgkins Lymphoma|relapsed non hodgkins lymphoma
719352|NCT00550615|Refractory Non Hodgkins Lymphoma|refractory non hodgkins lymphoma
719353|NCT00550615|Dasatinib|dasatinib
719354|NCT00550602|Tracheomalacia|tracheomalacia
719355|NCT00550602|Tracheobronchomalacia|tracheobronchomalacia
719356|NCT00550602|Airway Stabilization|airway stabilization
719357|NCT00550602|Bronchoscopy|bronchoscopy
719358|NCT00550602|Stent Placement|stent placement
719359|NCT00550602|Tracheobronchoplasty|tracheobronchoplasty
719360|NCT00550602|COPD|copd
719361|NCT00550589|high-grade squamous intraepithelial lesion|high-grade squamous intraepithelial lesion
719362|NCT00550589|stage 0 anal cancer|stage 0 anal cancer
719363|NCT00550576|Digoxin Antibodies|digoxin antibodies
719364|NCT00550576|Bipolar Disorder|bipolar disorder
719365|NCT00550563|recurrent colon cancer|recurrent colon cancer
719366|NCT00550563|stage I colon cancer|stage i colon cancer
719367|NCT00550563|stage II colon cancer|stage ii colon cancer
719368|NCT00550563|stage III colon cancer|stage iii colon cancer
719369|NCT00550563|stage IV colon cancer|stage iv colon cancer
719370|NCT00550563|recurrent rectal cancer|recurrent rectal cancer
719371|NCT00550563|stage I rectal cancer|stage i rectal cancer
719372|NCT00550563|stage II rectal cancer|stage ii rectal cancer
719373|NCT00550563|stage III rectal cancer|stage iii rectal cancer
719374|NCT00550563|stage IV rectal cancer|stage iv rectal cancer
719375|NCT00550550|rhinoconjunctivitis|rhinoconjunctivitis
719376|NCT00550550|rhinitis|rhinitis
719377|NCT00550550|conjunctivitis|conjunctivitis
719378|NCT00550550|allergy|allergy
719379|NCT00550550|allergen|allergen
719380|NCT00550550|immunotherapy|immunotherapy
719381|NCT00550537|stage IIIB non-small cell lung cancer|stage iiib non-small cell lung cancer
719382|NCT00550537|stage IV non-small cell lung cancer|stage iv non-small cell lung cancer
719383|NCT00550537|recurrent non-small cell lung cancer|recurrent non-small cell lung cancer
719384|NCT00550537|squamous cell lung cancer|squamous cell lung cancer
719385|NCT00550537|adenosquamous cell lung cancer|adenosquamous cell lung cancer
719386|NCT00550537|bronchoalveolar cell lung cancer|bronchoalveolar cell lung cancer
719387|NCT00550537|large cell lung cancer|large cell lung cancer
719388|NCT00550537|adenocarcinoma of the lung|adenocarcinoma of the lung
719389|NCT00550524|Knee osteoarthritis|knee osteoarthritis
719390|NCT00550511|Abdominal pain|abdominal pain
719391|NCT00550511|ultrasound|ultrasound
719392|NCT00550511|surgery|surgery
719393|NCT00550511|emergency department|emergency department
719394|NCT00550511|diagnostic accuracy|diagnostic accuracy
719395|NCT00550498|Retinal Vasculitis|retinal vasculitis
719396|NCT00550498|Retinal Edema|retinal edema
719397|NCT00550498|Behcet's Disease|behcet's disease
719398|NCT00550472|probiotics|probiotics
719399|NCT00550472|atopic dermatitis|atopic dermatitis
719400|NCT00550472|immune system|immune system
719401|NCT00550472|human|human
719402|NCT00550472|Lactobacillus|lactobacillus
719403|NCT00550472|Bifidobacterium|bifidobacterium
719404|NCT00550472|healthy subjects|healthy subjects
719405|NCT00550459|Hyponatremia|hyponatremia
719406|NCT00550459|Cognitive|cognitive
719407|NCT00550459|Neurological Function|neurological function
719408|NCT00550459|Elderly|elderly
719409|NCT00550446|Janus Kinase 3 Clinical Trial|janus kinase 3 clinical trial
719410|NCT00550420|open-label extension|open-label extension
719411|NCT00550420|tolerability|tolerability
719412|NCT00550420|Alzheimer's disease|alzheimer's disease
719413|NCT00550420|Rosiglitazone extended-release (XR)|rosiglitazone extended-release (xr)
719414|NCT00550420|safety|safety
719415|NCT00550420|cognition|cognition
719416|NCT00550420|BRL-049653|brl-049653
719417|NCT00550407|Lamotrigine|lamotrigine
719418|NCT00550407|Prevention of relapse or recurrence of a mood episode|prevention of relapse or recurrence of a mood episode
719419|NCT00550407|Bipolar I disorder|bipolar i disorder
719420|NCT00550394|Adolescents|adolescents
719421|NCT00550381|healthy subjects|healthy subjects
719422|NCT00550342|Focal segmental glomerulosclerosis|focal segmental glomerulosclerosis
719432|NCT00550290|wound infection|wound infection
719433|NCT00550290|wound complication|wound complication
719434|NCT00550290|prophylactic antibiotic|prophylactic antibiotic
719435|NCT00550290|Post-operative wound complications following vulvectomy|post-operative wound complications following vulvectomy
719436|NCT00550277|Renal Cell Carcinoma|renal cell carcinoma
719437|NCT00550277|Refractory|refractory
719438|NCT00550277|LBH589|lbh589
719439|NCT00550264|Hospital Readmission|hospital readmission
719440|NCT00550264|Continuity of Care|continuity of care
719441|NCT00550264|Quality of Health Care|quality of health care
719443|NCT00550251|Vomiting|vomiting
719444|NCT00550251|Emesis|emesis
719445|NCT00550251|Palliative|palliative
719446|NCT00550251|Terminal|terminal
719447|NCT00550251|Cancer|cancer
719448|NCT00550238|Parkinson's Disease Psychosis|parkinson's disease psychosis
719449|NCT00550225|succinate|succinate
719450|NCT00550225|anti-muscarinic|anti-muscarinic
719451|NCT00550225|b-agonist|b-agonist
719452|NCT00550212|healthy subjects|healthy subjects
719453|NCT00550199|Solid Tumors|solid tumors
719454|NCT00550199|Phase I|phase i
719455|NCT00550199|LBH589|lbh589
719456|NCT00550199|Gemcitabine|gemcitabine
719457|NCT00550186|spinal anesthesia|spinal anesthesia
719458|NCT00550186|preload|preload
719459|NCT00550186|diuresis|diuresis
719460|NCT00550186|bladder retention|bladder retention
719461|NCT00550147|ADHD-Combined TypeDisruptive behavior Disorder|adhd-combined typedisruptive behavior disorder
719462|NCT00550134|Breast Cancer|breast cancer
719463|NCT00550134|Quality of life|quality of life
719464|NCT00550108|pancreatic cyst|pancreatic cyst
719465|NCT00550108|ethanol injection|ethanol injection
719466|NCT00550095|Microalbuminuria/proteinuria|microalbuminuria/proteinuria
719467|NCT00550095|hypertensive patients with type 2 diabetes|hypertensive patients with type 2 diabetes
719468|NCT00550095|Valsartan|valsartan
719469|NCT00550095|microalbuminuria/proteinuria in hypertensive patients with type 2 diabetes|microalbuminuria/proteinuria in hypertensive patients with type 2 diabetes
719470|NCT00550082|Anticoagulation|anticoagulation
719471|NCT00550082|High-Risk|high-risk
719472|NCT00550082|Deep Vein Thrombosis|deep vein thrombosis
719473|NCT00550082|Pulmonary Embolism|pulmonary embolism
719474|NCT00550082|Surgery|surgery
719475|NCT00550069|late preterm infants|late preterm infants
719476|NCT00550069|near term infants|near term infants
719477|NCT00550069|outcome|outcome
719478|NCT00550056|PTSD, Posttraumatic Stress Disorder, refugees, war|ptsd, posttraumatic stress disorder, refugees, war
719479|NCT00550043|Rheumatoid arthritis|rheumatoid arthritis
719480|NCT00550030|Psoriasis|psoriasis
719481|NCT00550030|UVB radiation|uvb radiation
719482|NCT00550030|Biologics|biologics
719483|NCT00550030|Etanercept|etanercept
719484|NCT00550030|PASI|pasi
719485|NCT00550004|Unresectable|unresectable
719486|NCT00550004|locally advanced|locally advanced
719487|NCT00550004|metastatic pancreatic adenocarcinoma|metastatic pancreatic adenocarcinoma
719488|NCT00550004|Stage III|stage iii
719489|NCT00550004|Stage IV|stage iv
719490|NCT00549991|High Blood Pressure|high blood pressure
719491|NCT00549978|Safety and Pharmacokinetics in healthy subjects|safety and pharmacokinetics in healthy subjects
719492|NCT00549939|child|child
719493|NCT00549939|bladder|bladder
719494|NCT00549939|neuropathic|neuropathic
719495|NCT00549939|alpha blockers|alpha blockers
719496|NCT00549913|adjacent vertebral levels between L1 and S1|adjacent vertebral levels between l1 and s1
719497|NCT00549900|HPV vaccine,|hpv vaccine,
719498|NCT00549900|Cervical cancer|cervical cancer
719499|NCT00549900|Human papillomavirus infection,|human papillomavirus infection,
719500|NCT00549874|insulin resistance|insulin resistance
719501|NCT00549874|type 2 diabetes|type 2 diabetes
719502|NCT00549874|myocardial perfusion|myocardial perfusion
719503|NCT00549874|nitrosative stress|nitrosative stress
719504|NCT00549874|thiazolidinediones|thiazolidinediones
719505|NCT00549861|Cardiac Magnetic Resonance Imaging|cardiac magnetic resonance imaging
719506|NCT00549861|Contrast agents|contrast agents
719507|NCT00549861|Gadobutrol|gadobutrol
719508|NCT00549861|Fibrosis|fibrosis
719509|NCT00549861|Prognosis|prognosis
719510|NCT00549861|Magnetic Resonance|magnetic resonance
719511|NCT00549861|Gadolinium|gadolinium
719512|NCT00549848|Leukemia|leukemia
719513|NCT00549835|mucositis pain|mucositis pain
719514|NCT00549835|cancer|cancer
719515|NCT00549835|pain|pain
719516|NCT00549835|acupuncture|acupuncture
719517|NCT00549835|mucositis|mucositis
719518|NCT00549835|cancer pain|cancer pain
719519|NCT00549822|aromatase inhibitor|aromatase inhibitor
719520|NCT00549822|CA 15-3|ca 15-3
719521|NCT00549822|Hormone receptor positive|hormone receptor positive
719522|NCT00549809|mechanical ventilation; respiratory failure|mechanical ventilation; respiratory failure
719523|NCT00549796|coronary artery disease|coronary artery disease
719524|NCT00549796|angioplasty|angioplasty
719525|NCT00549796|stent|stent
719526|NCT00549796|percutaneous coronary intervention|percutaneous coronary intervention
719527|NCT00549796|on-site cardiac surgery|on-site cardiac surgery
719528|NCT00549796|randomized trial|randomized trial
719529|NCT00549770|Hypertension, valsartan, LCZ696|hypertension, valsartan, lcz696
719530|NCT00549757|Type 2 diabetes mellitus|type 2 diabetes mellitus
719531|NCT00549757|renal morbidity and mortality|renal morbidity and mortality
719532|NCT00549757|cardiovascular disease|cardiovascular disease
719533|NCT00549757|micro-albuminuria|micro-albuminuria
719534|NCT00549757|macro-albuminuria|macro-albuminuria
719535|NCT00549757|RAAS|raas
719536|NCT00549757|renin inhibitor|renin inhibitor
719537|NCT00549757|Reduced estimated glomerular filtration rate|reduced estimated glomerular filtration rate
719538|NCT00549744|ASTHMA|asthma
719539|NCT00549744|CLINICAL ENDPOINT,|clinical endpoint,
719540|NCT00549731|autism|autism
719541|NCT00549731|autistic|autistic
719542|NCT00549731|language|language
719543|NCT00549731|development|development
719544|NCT00549731|developmental|developmental
719545|NCT00549731|assessment|assessment
719546|NCT00549718|Schizophrenia|schizophrenia
719547|NCT00549718|SM-13496|sm-13496
719549|NCT00549718|Lurasidone|lurasidone
719550|NCT00549705|Anticoagulation|anticoagulation
719551|NCT00549705|Thrombosis|thrombosis
719552|NCT00549705|Bleeding|bleeding
719553|NCT00549705|Clotting|clotting
719554|NCT00549705|Pulmonary Embolism|pulmonary embolism
719555|NCT00549705|Deep Vein Thrombosis|deep vein thrombosis
719556|NCT00549679|Chronic Obstructive Pulmonary Disease (COPD)|chronic obstructive pulmonary disease (copd)
719557|NCT00549679|COPD|copd
719558|NCT00549679|Repeat Dose|repeat dose
719559|NCT00549679|GSK256066|gsk256066
719560|NCT00549666|OC DDI|oc ddi
719561|NCT00549666|lurasidone|lurasidone
719562|NCT00549666|Latuda|latuda
719563|NCT00549666|schizophenia|schizophenia
719564|NCT00549653|GW856553,|gw856553,
719565|NCT00549653|drug-drug interactions,|drug-drug interactions,
719566|NCT00549653|rosuvastatin|rosuvastatin
719567|NCT00549640|nicotine dependence|nicotine dependence
719568|NCT00549640|tobacco dependence|tobacco dependence
719569|NCT00549614|heart failure|heart failure
719570|NCT00549601|Alzheimer's|alzheimer's
719571|NCT00549601|rivastigmine|rivastigmine
719572|NCT00549601|transdermal|transdermal
719573|NCT00549601|safety|safety
719574|NCT00549601|randomized|randomized
719575|NCT00549601|switch|switch
719576|NCT00549601|patch|patch
719577|NCT00549588|Polymorphic light eruption|polymorphic light eruption
719578|NCT00549588|UV radiation|uv radiation
719579|NCT00549588|photoprotection|photoprotection
719580|NCT00549588|sunscreen|sunscreen
719581|NCT00549588|DNA repair enzymes|dna repair enzymes
719582|NCT00549588|after-sun-lotion|after-sun-lotion
719583|NCT00549575|Severe Intra uterine growth retardation below the third centile with abnormal uterine doppler|severe intra uterine growth retardation below the third centile with abnormal uterine doppler
719584|NCT00549575|Severe growth retardation with pathologic uterine Doppler|severe growth retardation with pathologic uterine doppler
719585|NCT00549575|L-Arginine|l-arginine
719586|NCT00549575|Nitric Oxide Donor|nitric oxide donor
719587|NCT00549562|Autistic Disorder|autistic disorder
719588|NCT00549536|calcium supplementation|calcium supplementation
719589|NCT00549536|intracellular ions|intracellular ions
719590|NCT00549536|sodium/hydrogen exchange activity|sodium/hydrogen exchange activity
719592|NCT00549523|Alternative Medicine|alternative medicine
719593|NCT00549523|Complementary Medicine|complementary medicine
719594|NCT00549510|COREG CR,|coreg cr,
719595|NCT00549510|lisinopril,|lisinopril,
719596|NCT00549510|hypertension,|hypertension,
719597|NCT00549510|dose proportionality,|dose proportionality,
719598|NCT00549510|fixed dose combination (FDC)|fixed dose combination (fdc)
719599|NCT00549497|GW870086X, inhaled, asthma, cortisol, pharmacokinetics, osteocalcin|gw870086x, inhaled, asthma, cortisol, pharmacokinetics, osteocalcin
719600|NCT00549484|Thrombocytopenia|thrombocytopenia
719601|NCT00549484|Thrombopoietin|thrombopoietin
719602|NCT00549484|Platelet Transfusion|platelet transfusion
719603|NCT00549484|Platelet Factor 4|platelet factor 4
719604|NCT00549471|children with cerebral palsy ages eight to eleven.|children with cerebral palsy ages eight to eleven.
719605|NCT00549458|Week pelvic floor muscle in females|week pelvic floor muscle in females
719606|NCT00549445|Chronic Obstructive Pulmonary Disease|chronic obstructive pulmonary disease
719607|NCT00549445|COPD|copd
719608|NCT00549445|Exacerbation|exacerbation
719609|NCT00549445|Macrolide|macrolide
719610|NCT00549406|Vision|vision
719611|NCT00549406|Visual attention|visual attention
719612|NCT00549406|Postural balance|postural balance
719613|NCT00549406|Geriatrics|geriatrics
719614|NCT00549393|intensive care unit|intensive care unit
719615|NCT00549393|Healthcare associated infections (HAI)|healthcare associated infections (hai)
719616|NCT00549393|pediatric|pediatric
719617|NCT00549380|Aneurysmal Disease in Thorax, Abdominal or Extremity|aneurysmal disease in thorax, abdominal or extremity
719618|NCT00549367|Nutritional status|nutritional status
719619|NCT00549367|Nutrition counselling|nutrition counselling
719620|NCT00549367|Nutrition assessment|nutrition assessment
719622|NCT00549367|Alternative Medicine|alternative medicine
719623|NCT00549367|Complementary Medicine|complementary medicine
719624|NCT00549354|Abdominal Infrarenal Aortic|abdominal infrarenal aortic
719625|NCT00549354|Aorto-Iliac Aneurysms|aorto-iliac aneurysms
719626|NCT00549341|Torticollis|torticollis
719627|NCT00549341|Cervical Dystonia|cervical dystonia
719628|NCT00549328|anti-angiogenesis|anti-angiogenesis
719629|NCT00549328|Non-small cell lung cancer,|non-small cell lung cancer,
719630|NCT00549328|pazopanib (GW786034)|pazopanib (gw786034)
719631|NCT00549263|Safety|safety
719632|NCT00549263|Pharmacokinetics|pharmacokinetics
719633|NCT00549263|Bioequivalence|bioequivalence
719634|NCT00549250|Human papillomavirus 6/11|human papillomavirus 6/11
719635|NCT00549250|Neonates|neonates
719636|NCT00549250|Human papillomavirus 6 or 11 infection|human papillomavirus 6 or 11 infection
719637|NCT00549237|RYGBP|rygbp
719638|NCT00549237|Early nutrition|early nutrition
719639|NCT00549237|Lean body mass|lean body mass
719640|NCT00549237|Length of stay|length of stay
719641|NCT00549237|Body Composition|body composition
719642|NCT00549211|Healthy Subjects,|healthy subjects,
719643|NCT00549211|Safety,|safety,
719644|NCT00549211|Tolerability,|tolerability,
719645|NCT00549211|Pharmacokinetics|pharmacokinetics
719646|NCT00549198|tenofovir|tenofovir
719647|NCT00549198|HIV|hiv
719648|NCT00549198|efavirenz|efavirenz
719649|NCT00549198|naive|naive
719650|NCT00549198|lamivudine|lamivudine
719651|NCT00549198|abacavir|abacavir
719652|NCT00549198|emtricitabine|emtricitabine
719653|NCT00549198|renal|renal
719654|NCT00549172|Osteoarthritis, Knee|osteoarthritis, knee
719655|NCT00549172|Arthroscopic Surgery|arthroscopic surgery
719656|NCT00549172|Menisci, Medial|menisci, medial
719657|NCT00549172|Placebo Effect|placebo effect
719658|NCT00549172|Treatment Efficacy|treatment efficacy
719659|NCT00549159|menorrhagia|menorrhagia
719660|NCT00549159|dysfunctional uterine bleeding|dysfunctional uterine bleeding
719661|NCT00549159|endometrial ablation|endometrial ablation
719662|NCT00549146|reversibility|reversibility
719663|NCT00549146|COPD|copd
719664|NCT00549146|lung function|lung function
719665|NCT00549133|Microalbuminaria in hypertensive patients with type II diabetes mellitus|microalbuminaria in hypertensive patients with type ii diabetes mellitus
719666|NCT00549120|Healthy Subjects|healthy subjects
719667|NCT00549120|muscarinic receptor antagonist|muscarinic receptor antagonist
719668|NCT00549120|propranolol|propranolol
719669|NCT00549120|beta-blocker|beta-blocker
719670|NCT00549120|beta-agonist|beta-agonist
719671|NCT00549107|low cardiac output syndrome|low cardiac output syndrome
719672|NCT00549107|open heart surgery|open heart surgery
719673|NCT00549107|infants|infants
719674|NCT00549107|Low cardiac output syndrome in infants undergoing corrective open heart surgery|low cardiac output syndrome in infants undergoing corrective open heart surgery
719675|NCT00549081|DHEA|dhea
719676|NCT00549081|IVF|ivf
719677|NCT00549081|low ovarian response|low ovarian response
719678|NCT00549055|Macugen Age-related macular degeneration (AMD) Observational study|macugen age-related macular degeneration (amd) observational study
719679|NCT00549042|Back Pain|back pain
719680|NCT00549042|Chronic Low Back Pain|chronic low back pain
719681|NCT00549042|Chronic Back Pain|chronic back pain
719682|NCT00549042|Pain|pain
719683|NCT00549042|Chronic Pain|chronic pain
719684|NCT00549029|muscle disorder|muscle disorder
719685|NCT00549029|statins|statins
719686|NCT00549029|creatine kinase|creatine kinase
719687|NCT00549016|Aneurysm Exclusion|aneurysm exclusion
719688|NCT00548977|spermatogenesis defect|spermatogenesis defect
719689|NCT00548977|male infertility|male infertility
719690|NCT00548977|azoospermia|azoospermia
719691|NCT00548977|oligozoospermia|oligozoospermia
719692|NCT00548977|Y chromosome markers|y chromosome markers
719693|NCT00548977|estrogen gene|estrogen gene
719694|NCT00548964|Ketamine|ketamine
719695|NCT00548964|glutamate|glutamate
719696|NCT00548964|N-methyl-D-aspartate|n-methyl-d-aspartate
719697|NCT00548964|treatment resistant|treatment resistant
719698|NCT00548964|major depressive disorder|major depressive disorder
719699|NCT00548964|lithium|lithium
719700|NCT00548951|Dementia|dementia
719701|NCT00548938|Brain Tumor|brain tumor
719702|NCT00548938|GBM|gbm
719703|NCT00548938|Glioblastoma Multiforme|glioblastoma multiforme
719704|NCT00548938|Giladel|giladel
719705|NCT00548938|Temozolomide|temozolomide
719706|NCT00548912|Kidney Failure, Chronic|kidney failure, chronic
719707|NCT00548912|Hemodialysis|hemodialysis
719708|NCT00548912|Spironolactone|spironolactone
719709|NCT00548899|Neoadjuvant chemotherapy|neoadjuvant chemotherapy
719710|NCT00548899|Targeted therapy|targeted therapy
719711|NCT00548886|QT Prolongation|qt prolongation
719712|NCT00548886|QT Interval|qt interval
719713|NCT00548886|Epinephrine|epinephrine
719714|NCT00548886|Stress test|stress test
719715|NCT00548847|Leukemia|leukemia
719716|NCT00548834|CDP870|cdp870
719717|NCT00548834|Certolizumab Pegol|certolizumab pegol
719718|NCT00548795|Acute Respiratory Distress Syndrome|acute respiratory distress syndrome
719719|NCT00548795|ARDS|ards
719720|NCT00548795|Neutrophil|neutrophil
719721|NCT00548769|PK,|pk,
719722|NCT00548769|SB-683699,|sb-683699,
719723|NCT00548769|multiple sclerosis|multiple sclerosis
719724|NCT00548769|firategrast,|firategrast,
719725|NCT00548769|surface area,|surface area,
719726|NCT00548756|Brain Cancer|brain cancer
719727|NCT00548756|Whole Brain Radiation Therapy|whole brain radiation therapy
719728|NCT00548756|Quality of Life|quality of life
719729|NCT00548756|QOL|qol
719730|NCT00548756|Questionnaire|questionnaire
719731|NCT00548756|Survey|survey
719732|NCT00548756|WBRT|wbrt
719733|NCT00548743|Depression|depression
719734|NCT00548743|Postpartum|postpartum
719735|NCT00548743|Dyad satisfaction|dyad satisfaction
719736|NCT00548743|Parenting comfort|parenting comfort
719737|NCT00548743|Screening|screening
719738|NCT00548743|Management|management
719739|NCT00548743|Follow up|follow up
719740|NCT00548743|Primary care|primary care
719741|NCT00548743|Practice based research|practice based research
719742|NCT00548730|Bronchoscopy|bronchoscopy
719743|NCT00548730|Endoscopy|endoscopy
719744|NCT00548730|Image Enhancement|image enhancement
719745|NCT00548730|Autofluorescence|autofluorescence
719746|NCT00548730|Narrow Band Image|narrow band image
719748|NCT00548717|Stem cell transplantation|stem cell transplantation
719749|NCT00548717|Sirolimus|sirolimus
719750|NCT00548704|Extravasation|extravasation
719751|NCT00548704|Anthracyclines|anthracyclines
719752|NCT00548678|diclofenac, platelet aggregation, ketorolac, aspirin|diclofenac, platelet aggregation, ketorolac, aspirin
719753|NCT00548665|Atherosclerosis|atherosclerosis
719754|NCT00548665|Smoking cessation|smoking cessation
719755|NCT00548665|Diagnostic techniques, cardiovascular|diagnostic techniques, cardiovascular
719756|NCT00548665|Ultrasonography|ultrasonography
719757|NCT00548665|Health behavior|health behavior
719758|NCT00548652|apathy|apathy
719759|NCT00548652|obesity|obesity
719760|NCT00548652|methylphenidate|methylphenidate
719761|NCT00548652|MOVE|move
719762|NCT00548652|medical crisis counselling|medical crisis counselling
719763|NCT00548626|Pancreatic Cancer|pancreatic cancer
719764|NCT00548626|Endoscopic Ultrasonography|endoscopic ultrasonography
719765|NCT00548626|Fine-Needle Aspiration|fine-needle aspiration
719766|NCT00548626|Cytopathology|cytopathology
719767|NCT00548613|Myocardial Infarction|myocardial infarction
719768|NCT00548613|Heart Attack|heart attack
719769|NCT00548613|Coronary Artery Bypass Grafting|coronary artery bypass grafting
719770|NCT00548600|Prostate Cancer|prostate cancer
719771|NCT00548600|Iridium|iridium
719772|NCT00548600|Implant|implant
719773|NCT00548600|Radiotherapy|radiotherapy
719774|NCT00548587|Acute Coronary Syndrome|acute coronary syndrome
719775|NCT00548561|extravasation|extravasation
719776|NCT00548561|anthracyclines|anthracyclines
719777|NCT00548548|Avastin|avastin
719778|NCT00548548|Metastatic Adenocarcinoma|metastatic adenocarcinoma
719779|NCT00548548|AVAGAST|avagast
719780|NCT00548522|Type 1 Diabetes|type 1 diabetes
719781|NCT00548522|Pregnancy|pregnancy
719782|NCT00548522|Islet Mass|islet mass
719783|NCT00548522|C-peptide|c-peptide
719784|NCT00548496|fractured wrist|fractured wrist
719785|NCT00548496|Distal radial fracture,|distal radial fracture,
719786|NCT00548483|Endotracheal intubation|endotracheal intubation
719787|NCT00548483|Laryngeal edema|laryngeal edema
719788|NCT00548483|Cuff-leak test|cuff-leak test
719789|NCT00548483|Corticosteroids|corticosteroids
719790|NCT00548483|This study was to ascertain whether administration of dexamethasone to critically intubated patients prevent postextubation airway obstruction.|this study was to ascertain whether administration of dexamethasone to critically intubated patients prevent postextubation airway obstruction.
719791|NCT00548483|This study was to compare high dose and low dose dexamethasone in preventing noninvasive ventilation or reintubation among critically ill intubated patients|this study was to compare high dose and low dose dexamethasone in preventing noninvasive ventilation or reintubation among critically ill intubated patients
719792|NCT00548470|schizophrenia|schizophrenia
719793|NCT00548470|varenicline|varenicline
719794|NCT00548470|cognition|cognition
719795|NCT00548470|cigarette smoking|cigarette smoking
719796|NCT00548457|the function of the endothelium of the arteries in patients suffering from ectatic coronary arteries|the function of the endothelium of the arteries in patients suffering from ectatic coronary arteries
719797|NCT00548444|Tuberculosis|tuberculosis
719798|NCT00548444|Lymphocyte kinetics|lymphocyte kinetics
719799|NCT00548444|MVA85A|mva85a
719800|NCT00548444|Deuterium|deuterium
719801|NCT00548431|Leukemia, Lymphocytic, Acute [C04.557.337.428.511]|leukemia, lymphocytic, acute [c04.557.337.428.511]
719802|NCT00548431|6-mercaptopurine|6-mercaptopurine
719803|NCT00548431|methotrexate|methotrexate
719804|NCT00548431|asparaginase|asparaginase
719805|NCT00548405|Multiple Sclerosis|multiple sclerosis
719806|NCT00548392|breast|breast
719807|NCT00548392|cancer|cancer
719808|NCT00548392|ultrasound|ultrasound
719809|NCT00548392|high risk|high risk
719810|NCT00548392|marker clip|marker clip
719811|NCT00548379|vitamin D|vitamin d
719812|NCT00548379|pneumonia|pneumonia
719813|NCT00548366|cirrhosis|cirrhosis
719814|NCT00548366|portal hypertension|portal hypertension
719815|NCT00548366|ascites|ascites
719816|NCT00548366|sodium restriction|sodium restriction
719817|NCT00548327|Genes|genes
719818|NCT00548327|Dorsolateral Prefrontal Cortex|dorsolateral prefrontal cortex
719819|NCT00548327|Dopamine|dopamine
719820|NCT00548327|Functional Magnetic Resonance Imaging|functional magnetic resonance imaging
719821|NCT00548327|Neuropsychological Testing|neuropsychological testing
719822|NCT00548327|Schizophrenia|schizophrenia
719823|NCT00548327|Atomoxetine|atomoxetine
719824|NCT00548327|Cognitive Study|cognitive study
719825|NCT00548327|Pharmacogenetics|pharmacogenetics
719826|NCT00548327|Normal Volunteers|normal volunteers
719827|NCT00548327|Catechol-O-Methyltransferase|catechol-o-methyltransferase
719828|NCT00548327|Healthy Volunteer|healthy volunteer
719829|NCT00548314|Matriderm|matriderm
719830|NCT00548314|Dermal matrix|dermal matrix
719831|NCT00548314|VAC therapy|vac therapy
719832|NCT00548314|Split skin graft|split skin graft
719833|NCT00548314|Burns|burns
719834|NCT00548314|Scar quality|scar quality
719835|NCT00548275|Buprenorphine|buprenorphine
719836|NCT00548275|Drug counseling|drug counseling
719837|NCT00548275|HIV risk reduction counseling|hiv risk reduction counseling
719838|NCT00548275|HIV Seronegativity|hiv seronegativity
719839|NCT00548275|HIV risk behaviors|hiv risk behaviors
719840|NCT00548262|Open-label|open-label
719841|NCT00548262|non-comparative study to evaluate short course of IV anidulafungin|non-comparative study to evaluate short course of iv anidulafungin
719842|NCT00548262|followed by oral voriconazole|followed by oral voriconazole
719843|NCT00548262|for tx of candidemia/invasive candidiasis.|for tx of candidemia/invasive candidiasis.
719844|NCT00548249|Subjects with ESRD receiving chronic Hemodialysis|subjects with esrd receiving chronic hemodialysis
719845|NCT00548236|exercise intervention|exercise intervention
719846|NCT00548236|AACT|aact
719847|NCT00548223|recurrence of stroke|recurrence of stroke
719848|NCT00548223|Dengzhan Shengmai Capsule|dengzhan shengmai capsule
719849|NCT00548223|Traditional Chinese Medicine|traditional chinese medicine
719850|NCT00548210|Hypertrophy|hypertrophy
719851|NCT00548210|scarring|scarring
719852|NCT00548210|scar treatment|scar treatment
719853|NCT00548210|silicone|silicone
719854|NCT00548197|Intravitreal Bevacizumab injection|intravitreal bevacizumab injection
719855|NCT00548197|Pars plana vitrectomy|pars plana vitrectomy
719856|NCT00548197|tractional retinal detachment|tractional retinal detachment
719857|NCT00548197|Diabetic retinopathy|diabetic retinopathy
719858|NCT00548184|primary breast cancers|primary breast cancers
719859|NCT00548184|Locally advanced breast cancers|locally advanced breast cancers
719860|NCT00548158|diabetes|diabetes
719861|NCT00548145|Pitavastatin|pitavastatin
719862|NCT00548145|Statins|statins
719863|NCT00548145|Donepezil|donepezil
719864|NCT00548145|Alzheimer's Disease|alzheimer's disease
719865|NCT00548145|Hypercholesterolemia|hypercholesterolemia
719866|NCT00548145|ADAS-Jcog|adas-jcog
719867|NCT00548145|Alzheimer Disease (MMSE 15-23 and CDR1 or 2)|alzheimer disease (mmse 15-23 and cdr1 or 2)
719868|NCT00548106|infant formula, milk allergy, hydrolized whey|infant formula, milk allergy, hydrolized whey
719869|NCT00548093|non-small cell lung cancer|non-small cell lung cancer
719870|NCT00548093|advanced|advanced
719871|NCT00548093|previously treated|previously treated
719872|NCT00548067|High blood pressure, hypertension, drug interaction, steady state, valsartan, hydrochlorothiazide, amlodipine|high blood pressure, hypertension, drug interaction, steady state, valsartan, hydrochlorothiazide, amlodipine
719873|NCT00548054|cholera|cholera
719874|NCT00548054|vaccine|vaccine
719875|NCT00548054|Kolkata|kolkata
719876|NCT00548054|West Bengal|west bengal
719877|NCT00548054|India|india
719878|NCT00548054|immunogenicity|immunogenicity
719879|NCT00548054|safety|safety
719880|NCT00548054|infants|infants
719881|NCT00548054|expanded programme on immunization|expanded programme on immunization
719882|NCT00548041|HIV|hiv
719883|NCT00548041|Emergency Department|emergency department
719884|NCT00548041|HIV Seronegativity|hiv seronegativity
719885|NCT00548002|Staphylococcus aureus|staphylococcus aureus
719886|NCT00548002|bacteremia|bacteremia
719887|NCT00548002|endocarditis|endocarditis
719888|NCT00548002|sepsis|sepsis
719889|NCT00548002|fluoroquinolone|fluoroquinolone
719890|NCT00548002|rifampin|rifampin
719891|NCT00548002|levofloxacin|levofloxacin
719892|NCT00548002|trovafloxacin|trovafloxacin
719893|NCT00547989|ASA class I and II|asa class i and ii
719894|NCT00547976|Inflammation|inflammation
719895|NCT00547976|Unstable Plaque|unstable plaque
719896|NCT00547976|Macrophage|macrophage
719897|NCT00547976|Thrombosis|thrombosis
719898|NCT00547976|Autoradiography|autoradiography
719899|NCT00547976|Atherosclerosis|atherosclerosis
719900|NCT00547976|Vasculitis|vasculitis
719901|NCT00547963|Alcohol Drinking|alcohol drinking
719902|NCT00547963|Marijuana Smoking|marijuana smoking
719903|NCT00547963|Substance Use|substance use
719904|NCT00547963|Emergency Department (ED)|emergency department (ed)
719905|NCT00547937|Sleep Apnea|sleep apnea
719906|NCT00547937|Oxidative Stress|oxidative stress
719907|NCT00547937|Nitric oxide|nitric oxide
719908|NCT00547937|Cardiovascular disease|cardiovascular disease
719909|NCT00547911|Entacapone|entacapone
719910|NCT00547911|Carbidopa|carbidopa
719911|NCT00547911|Locus Ceruleus/Norepinephrine-Autonomic System|locus ceruleus/norepinephrine-autonomic system
719912|NCT00547911|Norepinephrine|norepinephrine
719913|NCT00547911|Adrenergic Nervous System|adrenergic nervous system
719914|NCT00547898|HIV|hiv
719915|NCT00547898|AIDS|aids
719916|NCT00547898|Diarrhea|diarrhea
719917|NCT00547898|HIV Associated Diarrhea|hiv associated diarrhea
719918|NCT00547885|dihydrocodeine|dihydrocodeine
719919|NCT00547885|opioids, long acting|opioids, long acting
720273|NCT00545974|FTD|ftd
719920|NCT00547885|opioids, short acting|opioids, short acting
719921|NCT00547885|Chronic pain|chronic pain
719922|NCT00547885|non-malignant pain|non-malignant pain
719923|NCT00547859|microcirculation|microcirculation
719924|NCT00547859|cardiac surgery|cardiac surgery
719925|NCT00547859|metabolism|metabolism
719926|NCT00547859|capnometry|capnometry
719927|NCT00547846|Cough|cough
719928|NCT00547846|Antitussive|antitussive
719929|NCT00547846|PDC-748|pdc-748
719930|NCT00547846|PhytoHealth|phytohealth
719931|NCT00547833|language disorders|language disorders
719932|NCT00547833|language learning disabilities|language learning disabilities
719933|NCT00547833|vocabulary|vocabulary
719934|NCT00547833|reading|reading
719935|NCT00547820|radiation dose|radiation dose
719936|NCT00547820|VCUG|vcug
719937|NCT00547820|pediatric patients|pediatric patients
719938|NCT00547807|Pain, neonate, nursing care|pain, neonate, nursing care
719939|NCT00547729|Heart Failure|heart failure
719940|NCT00547729|Left Atrial Pressure Monitoring|left atrial pressure monitoring
719941|NCT00547716|Hepatitis C|hepatitis c
719942|NCT00547716|Omega 3 fatty acids|omega 3 fatty acids
719943|NCT00547716|Omacor|omacor
719944|NCT00547716|Interferon|interferon
719945|NCT00547703|Nonulcer dyspepsia|nonulcer dyspepsia
719946|NCT00547703|Functional dyspepsia|functional dyspepsia
719947|NCT00547703|Antidepressant use in dyspepsia|antidepressant use in dyspepsia
719948|NCT00547703|Nortriptyline|nortriptyline
719949|NCT00547703|Tricyclic antidepressants|tricyclic antidepressants
719950|NCT00547677|liver metastases|liver metastases
719951|NCT00547677|unspecified adult solid tumor, protocol specific|unspecified adult solid tumor, protocol specific
719952|NCT00547664|Hylenex, time tagged pain pain reduction, hospice population|hylenex, time tagged pain pain reduction, hospice population
719953|NCT00547651|Small Cell Lung Cancer|small cell lung cancer
719954|NCT00547651|Lung Cancer|lung cancer
719955|NCT00547651|Limited Disease Sensitive Small Cell Lung Cancer|limited disease sensitive small cell lung cancer
719956|NCT00547651|Extensive Disease Sensitive Small Cell Lung Cancer|extensive disease sensitive small cell lung cancer
719957|NCT00547651|Limited Disease Refractory Small Cell Lung Cancer|limited disease refractory small cell lung cancer
719958|NCT00547651|Extensive Disease Refractory Small Cell Lung Cancer|extensive disease refractory small cell lung cancer
719959|NCT00547651|Refractory Small Cell Lung Cancer|refractory small cell lung cancer
719960|NCT00547651|Sensitive Small Cell Lung Cancer|sensitive small cell lung cancer
719961|NCT00547638|laceration/wound closure|laceration/wound closure
719962|NCT00547638|topical skin adhesive|topical skin adhesive
719963|NCT00547612|adenocarcinoma of the pancreas|adenocarcinoma of the pancreas
719964|NCT00547612|stage I pancreatic cancer|stage i pancreatic cancer
719965|NCT00547612|stage II pancreatic cancer|stage ii pancreatic cancer
719966|NCT00547612|stage III pancreatic cancer|stage iii pancreatic cancer
719967|NCT00547612|stage IV pancreatic cancer|stage iv pancreatic cancer
719968|NCT00547612|recurrent pancreatic cancer|recurrent pancreatic cancer
719969|NCT00547560|Alzheimer Disease|alzheimer disease
719970|NCT00547547|unspecified adult solid tumor, protocol specific|unspecified adult solid tumor, protocol specific
719971|NCT00547534|Bortezomib|bortezomib
719972|NCT00547534|Bendamustine|bendamustine
719973|NCT00547534|Rituximab|rituximab
719974|NCT00547534|Relapsed|relapsed
719975|NCT00547534|Refractory|refractory
719976|NCT00547534|Mantle Cell|mantle cell
719977|NCT00547534|Indolent|indolent
719978|NCT00547482|Type 2 Diabetes|type 2 diabetes
719979|NCT00547482|Overweight|overweight
719980|NCT00547482|Obese|obese
719981|NCT00547469|Irritable Bowel Syndrome|irritable bowel syndrome
719982|NCT00547469|IBS-c|ibs-c
719983|NCT00547469|IBS constipation|ibs constipation
719984|NCT00547469|women with IBS|women with ibs
719985|NCT00547469|women with constipation|women with constipation
719986|NCT00547443|stage IIIA non-small cell lung cancer|stage iiia non-small cell lung cancer
719987|NCT00547443|stage IIIB non-small cell lung cancer|stage iiib non-small cell lung cancer
719988|NCT00547443|recurrent non-small cell lung cancer|recurrent non-small cell lung cancer
719989|NCT00547443|adenocarcinoma of the lung|adenocarcinoma of the lung
719990|NCT00547443|squamous cell lung cancer|squamous cell lung cancer
719991|NCT00547443|large cell lung cancer|large cell lung cancer
719992|NCT00547443|bronchoalveolar cell lung cancer|bronchoalveolar cell lung cancer
719993|NCT00547443|adenosquamous cell lung cancer|adenosquamous cell lung cancer
719994|NCT00547391|adults|adults
719995|NCT00547391|children|children
719996|NCT00547391|tonsillectomy|tonsillectomy
719997|NCT00547378|overactive bladder, urinary incontinence, incontinence,Urgency-frequency|overactive bladder, urinary incontinence, incontinence,urgency-frequency
719998|NCT00547365|primary systemic amyloidosis|primary systemic amyloidosis
719999|NCT00547339|adenocarcinoma of the prostate|adenocarcinoma of the prostate
720000|NCT00547339|stage I prostate cancer|stage i prostate cancer
720001|NCT00547339|stage IIB prostate cancer|stage iib prostate cancer
720002|NCT00547339|stage IIA prostate cancer|stage iia prostate cancer
720003|NCT00547300|Hypertension|hypertension
720004|NCT00547300|Nebivolol|nebivolol
720005|NCT00547300|Beta blocker|beta blocker
720006|NCT00547300|Tolerability|tolerability
720007|NCT00547261|solid tumor|solid tumor
720008|NCT00547261|antimitotic|antimitotic
720009|NCT00547261|tubulin binder|tubulin binder
720010|NCT00547248|Booster vaccination.|booster vaccination.
720011|NCT00547248|Immunogenicity|immunogenicity
720012|NCT00547248|Pneumococcal vaccine|pneumococcal vaccine
720013|NCT00547248|Safety|safety
720014|NCT00547248|Pneumococcal disease|pneumococcal disease
720015|NCT00547235|infection|infection
720016|NCT00547235|precancerous/nonmalignant condition|precancerous/nonmalignant condition
720091|NCT00546988|primary treatment|primary treatment
720017|NCT00547196|refractory chronic lymphocytic leukemia|refractory chronic lymphocytic leukemia
720018|NCT00547196|adult acute myeloid leukemia in remission|adult acute myeloid leukemia in remission
720019|NCT00547196|recurrent adult acute myeloid leukemia|recurrent adult acute myeloid leukemia
720020|NCT00547196|adult acute myeloid leukemia with 11q23 (MLL) abnormalities|adult acute myeloid leukemia with 11q23 (mll) abnormalities
720021|NCT00547196|adult acute myeloid leukemia with inv(16)(p13;q22)|adult acute myeloid leukemia with inv(16)(p13;q22)
720022|NCT00547196|adult acute myeloid leukemia with t(15;17)(q22;q12)|adult acute myeloid leukemia with t(15;17)(q22;q12)
720023|NCT00547196|adult acute myeloid leukemia with t(16;16)(p13;q22)|adult acute myeloid leukemia with t(16;16)(p13;q22)
720024|NCT00547196|adult acute myeloid leukemia with t(8;21)(q22;q22)|adult acute myeloid leukemia with t(8;21)(q22;q22)
720025|NCT00547196|adult acute lymphoblastic leukemia in remission|adult acute lymphoblastic leukemia in remission
720026|NCT00547196|accelerated phase chronic myelogenous leukemia|accelerated phase chronic myelogenous leukemia
720027|NCT00547196|blastic phase chronic myelogenous leukemia|blastic phase chronic myelogenous leukemia
720028|NCT00547196|chronic phase chronic myelogenous leukemia|chronic phase chronic myelogenous leukemia
720029|NCT00547196|de novo myelodysplastic syndromes|de novo myelodysplastic syndromes
720030|NCT00547196|previously treated myelodysplastic syndromes|previously treated myelodysplastic syndromes
720031|NCT00547196|secondary myelodysplastic syndromes|secondary myelodysplastic syndromes
720032|NCT00547196|recurrent adult Burkitt lymphoma|recurrent adult burkitt lymphoma
720033|NCT00547196|recurrent adult diffuse large cell lymphoma|recurrent adult diffuse large cell lymphoma
720034|NCT00547196|recurrent adult diffuse mixed cell lymphoma|recurrent adult diffuse mixed cell lymphoma
720035|NCT00547196|recurrent adult diffuse small cleaved cell lymphoma|recurrent adult diffuse small cleaved cell lymphoma
720036|NCT00547196|recurrent adult grade III lymphomatoid granulomatosis|recurrent adult grade iii lymphomatoid granulomatosis
720037|NCT00547196|recurrent adult immunoblastic large cell lymphoma|recurrent adult immunoblastic large cell lymphoma
720038|NCT00547196|recurrent adult lymphoblastic lymphoma|recurrent adult lymphoblastic lymphoma
720039|NCT00547196|recurrent grade 1 follicular lymphoma|recurrent grade 1 follicular lymphoma
720040|NCT00547196|recurrent grade 2 follicular lymphoma|recurrent grade 2 follicular lymphoma
720041|NCT00547196|recurrent grade 3 follicular lymphoma|recurrent grade 3 follicular lymphoma
720042|NCT00547196|recurrent mantle cell lymphoma|recurrent mantle cell lymphoma
720043|NCT00547196|recurrent marginal zone lymphoma|recurrent marginal zone lymphoma
720044|NCT00547196|recurrent small lymphocytic lymphoma|recurrent small lymphocytic lymphoma
720045|NCT00547196|extranodal marginal zone B-cell lymphoma of mucosa-associated lymphoid tissue|extranodal marginal zone b-cell lymphoma of mucosa-associated lymphoid tissue
720046|NCT00547196|nodal marginal zone B-cell lymphoma|nodal marginal zone b-cell lymphoma
720047|NCT00547196|splenic marginal zone lymphoma|splenic marginal zone lymphoma
720048|NCT00547196|relapsing chronic myelogenous leukemia|relapsing chronic myelogenous leukemia
720049|NCT00547196|recurrent cutaneous T-cell non-Hodgkin lymphoma|recurrent cutaneous t-cell non-hodgkin lymphoma
720050|NCT00547196|secondary acute myeloid leukemia|secondary acute myeloid leukemia
720051|NCT00547170|pelvic infection|pelvic infection
720052|NCT00547170|abortion|abortion
720053|NCT00547170|doxycycline|doxycycline
720054|NCT00547157|head and neck|head and neck
720055|NCT00547157|squamous cell carcinoma|squamous cell carcinoma
720056|NCT00547157|radiotherapy|radiotherapy
720057|NCT00547157|chemoradiotherapy|chemoradiotherapy
720058|NCT00547157|panitumumab|panitumumab
720059|NCT00547157|locally advanced head & neck cancer|locally advanced head & neck cancer
720060|NCT00547157|EGFr|egfr
720061|NCT00547157|epidermal growth factor receptor|epidermal growth factor receptor
720062|NCT00547157|SCCHN|scchn
720063|NCT00547157|locally advanced SCCHN|locally advanced scchn
720064|NCT00547157|HNC|hnc
720065|NCT00547157|epidermal growth factor|epidermal growth factor
720066|NCT00547131|tumors metastatic to brain|tumors metastatic to brain
720067|NCT00547131|recurrent adult brain tumor|recurrent adult brain tumor
720068|NCT00547118|Metabolic abnormalities|metabolic abnormalities
720069|NCT00547118|Safety|safety
720070|NCT00547118|Satiety|satiety
720071|NCT00547105|recurrent non-small cell lung cancer|recurrent non-small cell lung cancer
720072|NCT00547105|stage IIIB non-small cell lung cancer|stage iiib non-small cell lung cancer
720073|NCT00547105|stage IV non-small cell lung cancer|stage iv non-small cell lung cancer
720074|NCT00547105|stage IIIA non-small cell lung cancer|stage iiia non-small cell lung cancer
720075|NCT00547066|ITP|itp
720076|NCT00547066|hA20|ha20
720077|NCT00547066|Treatment|treatment
720078|NCT00547040|calcification|calcification
720079|NCT00547040|bone lesions|bone lesions
720080|NCT00547027|diabetes|diabetes
720081|NCT00547027|physical activity|physical activity
720082|NCT00547027|print-based intervention|print-based intervention
720083|NCT00547027|tailored intervention|tailored intervention
720274|NCT00545974|SD|sd
720084|NCT00547014|treatment, parallel assignment, double blind, randomized, placebo control, safety study,SLE (Systemic Lupus Erythematosus)|treatment, parallel assignment, double blind, randomized, placebo control, safety study,sle (systemic lupus erythematosus)
720085|NCT00547001|Menopause|menopause
720086|NCT00547001|Hot flashes|hot flashes
720087|NCT00547001|vasomotor symptoms|vasomotor symptoms
720088|NCT00547001|tapering regimen|tapering regimen
720089|NCT00547001|hormonal therapy|hormonal therapy
720090|NCT00547001|Other menopausal symptoms including mood changes|other menopausal symptoms including mood changes
720092|NCT00546988|allogeneic stem-cell transplantation|allogeneic stem-cell transplantation
720093|NCT00546988|high-dose therapy|high-dose therapy
720094|NCT00546988|cytogenetics|cytogenetics
720095|NCT00546975|gastrointestinal surgery|gastrointestinal surgery
720096|NCT00546975|nutritional intervention|nutritional intervention
720097|NCT00546975|functional status|functional status
720098|NCT00546975|quality of life|quality of life
720099|NCT00546949|Decompression, Surgical|decompression, surgical
720100|NCT00546949|x-stop|x-stop
720101|NCT00546949|lumbar decompression|lumbar decompression
720102|NCT00546949|spinal stenosis|spinal stenosis
720103|NCT00546949|radiculopathy|radiculopathy
720104|NCT00546936|Histoplasmosis|histoplasmosis
720105|NCT00546884|End of Life|end of life
720106|NCT00546884|Advance Directives|advance directives
720107|NCT00546884|Randomized controlled trial|randomized controlled trial
720108|NCT00546884|End of life care|end of life care
720109|NCT00546884|End of life advance care planning|end of life advance care planning
720110|NCT00546858|Pelvic pain|pelvic pain
720111|NCT00546858|Vulvar pain|vulvar pain
720112|NCT00546806|Rehabilitation,|rehabilitation,
720113|NCT00546806|Treatment outcome,|treatment outcome,
720114|NCT00546806|Whiplash injuries,|whiplash injuries,
720115|NCT00546806|Randomized Clinical Trials|randomized clinical trials
720116|NCT00546793|humanized anti-CD20 veltuzumab (IMMU-106) administered subcutaneously|humanized anti-cd20 veltuzumab (immu-106) administered subcutaneously
720117|NCT00546780|Multiple Myeloma|multiple myeloma
720118|NCT00546780|Heat Shock Protein 90|heat shock protein 90
720119|NCT00546780|Hsp90|hsp90
720120|NCT00546780|KOS-953|kos-953
720121|NCT00546780|17-AAG|17-aag
720122|NCT00546780|bortezomib|bortezomib
720123|NCT00546780|first relapse|first relapse
720124|NCT00546780|tanespimycin|tanespimycin
720125|NCT00546780|TIME-1|time-1
720126|NCT00546741|Diabetes,NOS|diabetes,nos
720127|NCT00546689|HIV|hiv
720128|NCT00546689|aids|aids
720129|NCT00546689|intestinal parasites|intestinal parasites
720130|NCT00546689|eosinophils|eosinophils
720131|NCT00546689|immunoglobulins|immunoglobulins
720132|NCT00546689|HIV/aids|hiv/aids
720133|NCT00546689|Treatment Experienced|treatment experienced
720134|NCT00546663|Cystic Fibrosis, hypertonic saline|cystic fibrosis, hypertonic saline
720135|NCT00546650|Focus of study is to compare pharmacokinetics|focus of study is to compare pharmacokinetics
720136|NCT00546611|PEP005|pep005
720137|NCT00546611|Common Wart(s)|common wart(s)
720138|NCT00546611|Common warts (verruca[e] vulgaris)|common warts (verruca[e] vulgaris)
720139|NCT00546598|Total hip replacement, Total hip arthroplasty|total hip replacement, total hip arthroplasty
720140|NCT00546585|influenza, inactivated influenza A/H7N7 vaccine, parent protocol|influenza, inactivated influenza a/h7n7 vaccine, parent protocol
720141|NCT00546559|Lipophilic statins|lipophilic statins
720142|NCT00546559|Insulin resistance|insulin resistance
720143|NCT00546559|simvastatin and pravastatin may have differential metabolic effects in hypercholesterolemic patients.|simvastatin and pravastatin may have differential metabolic effects in hypercholesterolemic patients.
720144|NCT00546546|Crohn|crohn
720145|NCT00546546|immunosuppressants|immunosuppressants
720146|NCT00546546|natural history|natural history
720147|NCT00546546|steroids|steroids
720148|NCT00546520|Asthma|asthma
720149|NCT00546520|Ciclesonide|ciclesonide
720150|NCT00546520|Airway hyperresponsiveness|airway hyperresponsiveness
720151|NCT00546520|Sputum|sputum
720152|NCT00546520|Nitric oxide|nitric oxide
720153|NCT00546468|stomach cancer|stomach cancer
720154|NCT00546468|laparoscopy|laparoscopy
720155|NCT00546468|gastrectomy|gastrectomy
720156|NCT00546468|QOL|qol
720157|NCT00546468|survival|survival
720158|NCT00546468|clinical study|clinical study
720159|NCT00546455|Obesity|obesity
720160|NCT00546455|insulin resistance|insulin resistance
720161|NCT00546442|insulin resistance|insulin resistance
720162|NCT00546442|chronic hepatitis C|chronic hepatitis c
720163|NCT00546442|genotype 1|genotype 1
720164|NCT00546429|Proximal femoral fracture|proximal femoral fracture
720165|NCT00546429|Trochanteric fracture|trochanteric fracture
720166|NCT00546429|Intramedullary nailing|intramedullary nailing
720167|NCT00546403|Excessive Daytime Sleepiness|excessive daytime sleepiness
720168|NCT00546377|B-cell chronic lymphocytic leukemia|b-cell chronic lymphocytic leukemia
720169|NCT00546377|Waldenstrom macroglobulinemia|waldenstrom macroglobulinemia
720170|NCT00546377|recurrent mantle cell lymphoma|recurrent mantle cell lymphoma
720171|NCT00546377|recurrent small lymphocytic lymphoma|recurrent small lymphocytic lymphoma
720172|NCT00546377|refractory chronic lymphocytic leukemia|refractory chronic lymphocytic leukemia
720173|NCT00546377|recurrent marginal zone lymphoma|recurrent marginal zone lymphoma
720272|NCT00545974|Semantic Dementia|semantic dementia
720174|NCT00546377|recurrent grade 1 follicular lymphoma|recurrent grade 1 follicular lymphoma
720175|NCT00546377|recurrent grade 2 follicular lymphoma|recurrent grade 2 follicular lymphoma
720176|NCT00546377|recurrent grade 3 follicular lymphoma|recurrent grade 3 follicular lymphoma
720177|NCT00546351|Lacosamide|lacosamide
720178|NCT00546299|Ambulatory oxygen therapy|ambulatory oxygen therapy
720179|NCT00546299|COPD|copd
720180|NCT00546299|exertional hypoxemia|exertional hypoxemia
720181|NCT00546273|LTBI (Latent tuberculosis infection)|ltbi (latent tuberculosis infection)
720182|NCT00546273|TB(Tuberculosis)|tb(tuberculosis)
720183|NCT00546273|Vaccine|vaccine
720184|NCT00546260|STEMI|stemi
720185|NCT00546260|ACS|acs
720186|NCT00546234|asthma|asthma
720187|NCT00546234|tiotropium|tiotropium
720188|NCT00546234|smoking|smoking
720189|NCT00546234|eNO|eno
720190|NCT00546234|metabolites|metabolites
720191|NCT00546234|Virtual Asthma Clinic|virtual asthma clinic
720192|NCT00546221|Depression|depression
720193|NCT00546221|Mental health|mental health
720194|NCT00546221|Exercise|exercise
720195|NCT00546221|Prescribed exercise|prescribed exercise
720196|NCT00546221|Physical health|physical health
720197|NCT00546221|Social wellbeing|social wellbeing
720198|NCT00546208|bladder function|bladder function
720199|NCT00546208|cutaneous ureterostomy|cutaneous ureterostomy
720200|NCT00546208|hydronephrosis|hydronephrosis
720201|NCT00546195|Cord Blood|cord blood
720202|NCT00546195|Neutrophils|neutrophils
720203|NCT00546195|Polysaccharide|polysaccharide
720204|NCT00546195|Gene Expression|gene expression
720205|NCT00546182|Lipophilic statins|lipophilic statins
720206|NCT00546182|Insulin resistance|insulin resistance
720207|NCT00546182|hypercholesterolemic patients|hypercholesterolemic patients
720208|NCT00546169|Patients undergoing elective or acute cholecystectomy|patients undergoing elective or acute cholecystectomy
720209|NCT00546156|ER positive|er positive
720210|NCT00546156|PR positive|pr positive
720211|NCT00546143|Asthma, anti-immunoglobulin E, omalizumab|asthma, anti-immunoglobulin e, omalizumab
720212|NCT00546130|ED-SCLC|ed-sclc
720213|NCT00546130|small cell lung cancer|small cell lung cancer
720214|NCT00546130|CPT-11|cpt-11
720215|NCT00546130|irinotecan hydrochloride|irinotecan hydrochloride
720216|NCT00546130|CDDP|cddp
720217|NCT00546130|cisplatin|cisplatin
720218|NCT00546130|PSK|psk
720219|NCT00546130|Krestin|krestin
720220|NCT00546117|otitis media with effusion|otitis media with effusion
720221|NCT00546117|gastroesophageal reflux|gastroesophageal reflux
720222|NCT00546117|ear infection|ear infection
720223|NCT00546117|proton pump inhibitor|proton pump inhibitor
720224|NCT00546104|Advanced Breast Cancer|advanced breast cancer
720225|NCT00546104|Breast cancer|breast cancer
720226|NCT00546104|Dasatinib|dasatinib
720227|NCT00546104|Inoperable Stage III Breast Cancer|inoperable stage iii breast cancer
720228|NCT00546104|Metastatic Breast Cancer|metastatic breast cancer
720229|NCT00546104|Stage IV Breast Cancer|stage iv breast cancer
720230|NCT00546091|Imaging|imaging
720231|NCT00546091|Multi-Spectral Imaging|multi-spectral imaging
720232|NCT00546091|Thermography|thermography
720233|NCT00546091|Laser Doppler Imaging|laser doppler imaging
720234|NCT00546091|Vasculature|vasculature
720235|NCT00546091|Healthy Volunteer|healthy volunteer
720236|NCT00546091|HV|hv
720237|NCT00546078|HPV vaccine|hpv vaccine
720238|NCT00546078|Cervical cancer|cervical cancer
720239|NCT00546078|Human papillomavirus infection|human papillomavirus infection
720240|NCT00546065|Barrett's esophagus|barrett's esophagus
720241|NCT00546065|ablation|ablation
720242|NCT00546065|esomeprazole|esomeprazole
720243|NCT00546065|Barrett's cancer|barrett's cancer
720244|NCT00546065|Ablation of Barrett's esophagus|ablation of barrett's esophagus
720245|NCT00546065|Surveillance of Barrett's esophagus after endoscopic resection of Barrett's cancer|surveillance of barrett's esophagus after endoscopic resection of barrett's cancer
720246|NCT00546065|Recurrence of Barrett's cancer|recurrence of barrett's cancer
720247|NCT00546039|Prostate cancer|prostate cancer
720248|NCT00546039|Localized prostatectomy|localized prostatectomy
720249|NCT00546039|Laparoscopic prostatectomy|laparoscopic prostatectomy
720250|NCT00546039|Chemoprevention|chemoprevention
720251|NCT00546039|Genistein|genistein
720252|NCT00546039|BONISTEIN™|bonistein™
720253|NCT00546026|placental function|placental function
720254|NCT00546026|high-risk pregnancies|high-risk pregnancies
720255|NCT00546026|psychological distress|psychological distress
720256|NCT00546013|abdominal aortic aneurysms|abdominal aortic aneurysms
720257|NCT00546013|pseudoexfoliation syndrome|pseudoexfoliation syndrome
720258|NCT00546013|glaucoma|glaucoma
720259|NCT00545987|HIV vaccine|hiv vaccine
720260|NCT00545987|HIV|hiv
720261|NCT00545987|AIDS|aids
720262|NCT00545987|prevention|prevention
720263|NCT00545987|HIV/AIDS|hiv/aids
720264|NCT00545987|HIV Preventative Vaccine|hiv preventative vaccine
720265|NCT00545987|HIV Seronegativity|hiv seronegativity
720266|NCT00545974|Randomized|randomized
720267|NCT00545974|Double-Blind|double-blind
720268|NCT00545974|Placebo-Controlled|placebo-controlled
720269|NCT00545974|memantine|memantine
720270|NCT00545974|Namenda|namenda
720271|NCT00545974|Frontotemporal Dementia|frontotemporal dementia
720276|NCT00545974|behavioral decline|behavioral decline
720277|NCT00545974|cognitive decline|cognitive decline
720278|NCT00545961|respiratory infection|respiratory infection
720279|NCT00545961|sinusitis|sinusitis
720280|NCT00545961|rhinosinusitis|rhinosinusitis
720281|NCT00545961|children|children
720282|NCT00545961|middle meatal specimens|middle meatal specimens
720283|NCT00545961|respiratory track bacteria|respiratory track bacteria
720284|NCT00545961|amoxicillin-clavulanate|amoxicillin-clavulanate
720285|NCT00545961|pneumococci|pneumococci
720286|NCT00545961|haemophilus|haemophilus
720287|NCT00545961|moraxella|moraxella
720288|NCT00545948|Non-Small-Cell Lung Cancer|non-small-cell lung cancer
720289|NCT00545948|NSCLC|nsclc
720290|NCT00545948|Non-Squamous|non-squamous
720291|NCT00545948|Genomics|genomics
720292|NCT00545948|Guided Therapy|guided therapy
720293|NCT00545948|Directed Therapy|directed therapy
720294|NCT00545948|Genomic Expression Profiles|genomic expression profiles
720295|NCT00545948|Chemotherapy Sensitivity|chemotherapy sensitivity
720296|NCT00545922|chronic obstructive pulmonary disease|chronic obstructive pulmonary disease
720297|NCT00545922|anxiety|anxiety
720298|NCT00545922|depression|depression
720299|NCT00545922|cognitive behavioral therapy|cognitive behavioral therapy
720300|NCT00545883|GERD|gerd
720301|NCT00545883|esophagitis|esophagitis
720302|NCT00545883|PPI|ppi
720303|NCT00545857|Type 1 diabetes|type 1 diabetes
720304|NCT00545857|Insulin dependent diabetes|insulin dependent diabetes
720305|NCT00545857|Juvenile onset diabetes|juvenile onset diabetes
720306|NCT00545857|pioglitazone|pioglitazone
720307|NCT00545831|Home Parenteral Nutrition|home parenteral nutrition
720308|NCT00545831|Sepsis Prevention|sepsis prevention
720309|NCT00545831|Central Venous Catheters|central venous catheters
720310|NCT00545831|Taurolidine|taurolidine
720311|NCT00545805|Insulin resistance|insulin resistance
720312|NCT00545805|Metabolic syndrome X|metabolic syndrome x
720313|NCT00545805|Obesity|obesity
720314|NCT00545805|Intra-Abdominal Fat|intra-abdominal fat
720315|NCT00545805|Omentum|omentum
720316|NCT00545805|Bariatric surgery|bariatric surgery
720317|NCT00545805|Glucose Clamp Technique|glucose clamp technique
720318|NCT00545805|Intravenous Glucose Tolerance Test|intravenous glucose tolerance test
720319|NCT00545805|Adiponectin|adiponectin
720320|NCT00545805|Cytokines|cytokines
720321|NCT00545792|Recurrent Endometrial cancer|recurrent endometrial cancer
720322|NCT00545792|Recurrent Cervical cancer|recurrent cervical cancer
720323|NCT00545792|Recurrent Ovarian cancer|recurrent ovarian cancer
720324|NCT00545792|Recurrent Vaginal cancer|recurrent vaginal cancer
720325|NCT00545792|Recurrent Vulvar cancer|recurrent vulvar cancer
720326|NCT00545792|Vaginal recurrence|vaginal recurrence
720327|NCT00545792|Brachytherapy|brachytherapy
720328|NCT00545792|Radiation Treatment|radiation treatment
720329|NCT00545792|External Beam Radiation|external beam radiation
720330|NCT00545792|Avastin|avastin
720331|NCT00545792|Bevacizumab|bevacizumab
720332|NCT00545766|Prostate Cancer|prostate cancer
720333|NCT00545766|Hormone Refractory|hormone refractory
720334|NCT00545766|Vinflunine|vinflunine
720335|NCT00545766|Salvage Chemotherapy|salvage chemotherapy
720336|NCT00545753|Human Head lice|human head lice
720337|NCT00545727|Diabetes|diabetes
720338|NCT00545727|Children|children
720339|NCT00545727|Adolescents|adolescents
720340|NCT00545727|Diet|diet
720341|NCT00545727|Glycemic index|glycemic index
720342|NCT00545701|Influenza|influenza
720343|NCT00545701|A/H5N1 strain|a/h5n1 strain
720344|NCT00545701|Orthomyxoviridae Infections|orthomyxoviridae infections
720345|NCT00545701|Influenza Pandemics|influenza pandemics
720346|NCT00545662|traumatic brain injury|traumatic brain injury
720347|NCT00545662|cognition|cognition
720348|NCT00545662|behavioral outcome|behavioral outcome
720349|NCT00545662|functional outcome|functional outcome
720350|NCT00545662|treatment|treatment
720351|NCT00545662|early intervention|early intervention
720352|NCT00545662|citicoline|citicoline
720353|NCT00545649|Fibromyalgia|fibromyalgia
720354|NCT00545649|chronic pain|chronic pain
720355|NCT00545649|physical|physical
720356|NCT00545649|exercise|exercise
720357|NCT00545649|activity|activity
720358|NCT00545649|education|education
720359|NCT00545623|HIV/AIDS|hiv/aids
720360|NCT00545623|Alternative Medicine|alternative medicine
720361|NCT00545623|Complementary Medicine|complementary medicine
720362|NCT00545597|adrenoleukodystrophy|adrenoleukodystrophy
720363|NCT00545597|adrenomyeloneuropathy|adrenomyeloneuropathy
720364|NCT00545558|Antiretroviral Therapy, Highly Active|antiretroviral therapy, highly active
720365|NCT00545558|Coinfection|coinfection
720366|NCT00545558|Treatment Naive|treatment naive
720367|NCT00545545|Colorectal|colorectal
720368|NCT00545545|Carcinoma|carcinoma
720369|NCT00545545|Recurrent|recurrent
720370|NCT00545545|Progressive|progressive
720371|NCT00545545|Cetuximab|cetuximab
720372|NCT00545545|Irinotecan|irinotecan
720373|NCT00545545|5-Fluorouracil|5-fluorouracil
720374|NCT00545519|Multiple Myeloma|multiple myeloma
720375|NCT00545519|Thymoglobulin|thymoglobulin
720376|NCT00545506|wound infection|wound infection
720818|NCT00544167|Sorafenib|sorafenib
720377|NCT00545506|tissue oxygen tension|tissue oxygen tension
720378|NCT00545506|local warming|local warming
720379|NCT00545493|Rasmussen encephalitis|rasmussen encephalitis
720380|NCT00545493|Chronic encephalitis|chronic encephalitis
720381|NCT00545493|Cerebral hemiatrophy|cerebral hemiatrophy
720382|NCT00545493|Hemiparesis|hemiparesis
720383|NCT00545493|Epilepsy|epilepsy
720384|NCT00545467|Aripiprazole|aripiprazole
720385|NCT00545467|schizophrenia|schizophrenia
720386|NCT00545467|antipsychotics|antipsychotics
720387|NCT00545467|pharmacogenomics|pharmacogenomics
720388|NCT00545467|cytochrome P450 enzyme|cytochrome p450 enzyme
720389|NCT00545454|Inflammation|inflammation
720390|NCT00545454|anti-cytokine|anti-cytokine
720391|NCT00545454|anti-chemokine|anti-chemokine
720392|NCT00545441|Anal fistula|anal fistula
720393|NCT00545441|fistula in ano|fistula in ano
720394|NCT00545441|anorectal fistula|anorectal fistula
720395|NCT00545428|Nasal acquired diseases|nasal acquired diseases
720396|NCT00545428|Nasal congenital diseases|nasal congenital diseases
720397|NCT00545428|Rhinoplasty|rhinoplasty
720398|NCT00545428|Grafts|grafts
720399|NCT00545415|fruit|fruit
720400|NCT00545415|antioxidant|antioxidant
720401|NCT00545415|Healthy subjects|healthy subjects
720402|NCT00545350|Prevention|prevention
720403|NCT00545350|Falls, accidental falls|falls, accidental falls
720404|NCT00545350|Fractures|fractures
720405|NCT00545350|Physical injuries|physical injuries
720406|NCT00545350|Women|women
720407|NCT00545350|Elderly|elderly
720408|NCT00545350|Physical exercise|physical exercise
720409|NCT00545350|Balance exercise|balance exercise
720410|NCT00545311|multiple inhaled, NVA237, COPD|multiple inhaled, nva237, copd
720411|NCT00545298|Nitric Oxide|nitric oxide
720412|NCT00545298|Venous Leg Ulcers|venous leg ulcers
720413|NCT00545285|clinical outcomes|clinical outcomes
720414|NCT00545285|radiographic outcomes|radiographic outcomes
720415|NCT00545285|total hip arthroplasty|total hip arthroplasty
720416|NCT00545285|survivorship|survivorship
720417|NCT00545272|QMF|qmf
720418|NCT00545272|indacaterol|indacaterol
720419|NCT00545272|Twisthaler®|twisthaler®
720420|NCT00545259|Organ transplant, liver, pharmacokinetics, AEB071, immunosuppression|organ transplant, liver, pharmacokinetics, aeb071, immunosuppression
720421|NCT00545246|VEGF Trap|vegf trap
720422|NCT00545194|Prostaglandin E2|prostaglandin e2
720423|NCT00545194|Intravaginal gel|intravaginal gel
720424|NCT00545194|Bishop score|bishop score
720425|NCT00545194|Induction of labor|induction of labor
720426|NCT00545194|randomized trial|randomized trial
720427|NCT00545194|Vaginal insert|vaginal insert
720428|NCT00545181|bacterial vaginosis|bacterial vaginosis
720429|NCT00545181|vaginal acidifying gel|vaginal acidifying gel
720430|NCT00545181|recurrence|recurrence
720431|NCT00545168|head lice|head lice
720432|NCT00545077|endocrine therapy|endocrine therapy
720433|NCT00545077|bevacizumab|bevacizumab
720434|NCT00545077|breast cancer|breast cancer
720435|NCT00545077|first-line therapy|first-line therapy
720436|NCT00545025|Influenza|influenza
720437|NCT00545025|Influenza vaccine|influenza vaccine
720438|NCT00545012|Levetiracetam|levetiracetam
720440|NCT00544999|recurrent adult acute myeloid leukemia|recurrent adult acute myeloid leukemia
720441|NCT00544999|secondary acute myeloid leukemia|secondary acute myeloid leukemia
720442|NCT00544999|adult acute minimally differentiated myeloid leukemia (M0)|adult acute minimally differentiated myeloid leukemia (m0)
720443|NCT00544999|adult acute myeloblastic leukemia without maturation (M1)|adult acute myeloblastic leukemia without maturation (m1)
720444|NCT00544999|adult acute myeloblastic leukemia with maturation (M2)|adult acute myeloblastic leukemia with maturation (m2)
720445|NCT00544999|adult acute myelomonocytic leukemia (M4)|adult acute myelomonocytic leukemia (m4)
720446|NCT00544999|adult acute monoblastic leukemia (M5a)|adult acute monoblastic leukemia (m5a)
720447|NCT00544999|adult acute monocytic leukemia (M5b)|adult acute monocytic leukemia (m5b)
720448|NCT00544999|adult acute myeloid leukemia with 11q23 (MLL) abnormalities|adult acute myeloid leukemia with 11q23 (mll) abnormalities
720449|NCT00544999|adult acute myeloid leukemia with inv(16)(p13;q22)|adult acute myeloid leukemia with inv(16)(p13;q22)
720450|NCT00544999|adult acute myeloid leukemia with t(16;16)(p13;q22)|adult acute myeloid leukemia with t(16;16)(p13;q22)
720451|NCT00544999|adult acute myeloid leukemia with t(8;21)(q22;q22)|adult acute myeloid leukemia with t(8;21)(q22;q22)
720452|NCT00544986|breast cancer|breast cancer
720453|NCT00544986|post menopausal women|post menopausal women
720454|NCT00544986|Post menopausal women with hormone sensitive advanced breast cancer|post menopausal women with hormone sensitive advanced breast cancer
720455|NCT00544960|AT101|at101
720456|NCT00544960|AT-101|at-101
720457|NCT00544960|cancer|cancer
720458|NCT00544960|lung|lung
720459|NCT00544960|non-small cell|non-small cell
720460|NCT00544960|docetaxel|docetaxel
720461|NCT00544960|bcl|bcl
720462|NCT00544947|Respiratory Depression|respiratory depression
720463|NCT00544947|Caesarean Section|caesarean section
720464|NCT00544947|Diamorphine|diamorphine
720465|NCT00544947|Fentanyl|fentanyl
720466|NCT00544908|stage IV pancreatic cancer|stage iv pancreatic cancer
720467|NCT00544869|Vasopressin antagonist , Cardiac Edema ,Diuretics|vasopressin antagonist , cardiac edema ,diuretics
720468|NCT00544856|mild Alzheimer's disease|mild alzheimer's disease
720469|NCT00544856|mild cognitive impairment|mild cognitive impairment
720470|NCT00544817|Concurrent Radiation Therapy|concurrent radiation therapy
720471|NCT00544817|Temozolomide|temozolomide
720472|NCT00544817|Sorafenib|sorafenib
720473|NCT00544817|First-line|first-line
720474|NCT00544817|Glioblastoma Multiforme|glioblastoma multiforme
720475|NCT00544817|Phase II|phase ii
720476|NCT00544804|recurrent breast cancer|recurrent breast cancer
720989|NCT00543504|BAY 43-9006|bay 43-9006
720477|NCT00544804|stage IIIA breast cancer|stage iiia breast cancer
720478|NCT00544804|stage IIIB breast cancer|stage iiib breast cancer
720479|NCT00544804|stage IIIC breast cancer|stage iiic breast cancer
720480|NCT00544804|stage IV breast cancer|stage iv breast cancer
720481|NCT00544804|bone metastases|bone metastases
720482|NCT00544791|Mild Cognitive Impairment|mild cognitive impairment
720483|NCT00544791|Melatonin|melatonin
720484|NCT00544791|Antioxidant|antioxidant
720485|NCT00544791|Memory|memory
720486|NCT00544791|Alzheimer|alzheimer
720487|NCT00544778|recurrent adult soft tissue sarcoma|recurrent adult soft tissue sarcoma
720488|NCT00544778|stage III adult soft tissue sarcoma|stage iii adult soft tissue sarcoma
720489|NCT00544778|stage IV adult soft tissue sarcoma|stage iv adult soft tissue sarcoma
720490|NCT00544778|metastatic osteosarcoma|metastatic osteosarcoma
720491|NCT00544778|recurrent osteosarcoma|recurrent osteosarcoma
720492|NCT00544778|metastatic Ewing sarcoma/peripheral primitive neuroectodermal tumor|metastatic ewing sarcoma/peripheral primitive neuroectodermal tumor
720493|NCT00544778|recurrent Ewing sarcoma/peripheral primitive neuroectodermal tumor|recurrent ewing sarcoma/peripheral primitive neuroectodermal tumor
720494|NCT00544778|Ewing sarcoma of bone|ewing sarcoma of bone
720495|NCT00544765|Breast cancer|breast cancer
720496|NCT00544765|neoadjuvant therapy|neoadjuvant therapy
720497|NCT00544765|pCR rates|pcr rates
720498|NCT00544752|sleep apnea syndromes, ambient indoor temperature|sleep apnea syndromes, ambient indoor temperature
720499|NCT00544739|Coronary Artery Disease|coronary artery disease
720500|NCT00544739|Premature|premature
720501|NCT00544739|Female|female
720502|NCT00544726|Rehabilitation|rehabilitation
720503|NCT00544700|stage IV colon cancer|stage iv colon cancer
720504|NCT00544700|stage IV rectal cancer|stage iv rectal cancer
720505|NCT00544687|Skin|skin
720506|NCT00544687|Atrophy|atrophy
720507|NCT00544687|CRX-191|crx-191
720508|NCT00544687|mometasone furoate|mometasone furoate
720509|NCT00544687|nortriptyline hydrochloride|nortriptyline hydrochloride
720510|NCT00544687|Skin Thickness in Normal Healthy Volunteers|skin thickness in normal healthy volunteers
720511|NCT00544674|extensive stage small cell lung cancer|extensive stage small cell lung cancer
720512|NCT00544674|limited stage small cell lung cancer|limited stage small cell lung cancer
720513|NCT00544674|recurrent small cell lung cancer|recurrent small cell lung cancer
720514|NCT00544648|stage IV non-small cell lung cancer|stage iv non-small cell lung cancer
720515|NCT00544648|stage IIIB non-small cell lung cancer|stage iiib non-small cell lung cancer
720516|NCT00544622|Stroke treatment|stroke treatment
720517|NCT00544622|Rehabilitation|rehabilitation
720518|NCT00544622|Stroke chain|stroke chain
720519|NCT00544622|Stroke unit|stroke unit
720520|NCT00544609|Bladder|bladder
720521|NCT00544609|Sorafenib|sorafenib
720522|NCT00544609|Radiotherapy|radiotherapy
720523|NCT00544583|Abdominal wall|abdominal wall
720524|NCT00544570|recurrent adult Hodgkin lymphoma|recurrent adult hodgkin lymphoma
720525|NCT00544570|recurrent/refractory childhood Hodgkin lymphoma|recurrent/refractory childhood hodgkin lymphoma
720526|NCT00544544|Bipolar|bipolar
720527|NCT00544544|depression|depression
720528|NCT00544531|MI oocytes, FISH,chromosomal aberrations|mi oocytes, fish,chromosomal aberrations
720529|NCT00544518|type 2 diabetes|type 2 diabetes
720530|NCT00544518|Benfluorex|benfluorex
720531|NCT00544518|Metformin|metformin
720532|NCT00544518|insulin secretion|insulin secretion
720533|NCT00544518|glucose control|glucose control
720534|NCT00544492|arteriovenous fistula|arteriovenous fistula
720535|NCT00544492|dialysis access|dialysis access
720536|NCT00544492|pain|pain
720537|NCT00544492|anxiety|anxiety
720538|NCT00544492|fistula related complications|fistula related complications
720539|NCT00544492|aneurysm|aneurysm
720540|NCT00544466|acute myeloid leukemia with multilineage dysplasia following myelodysplastic syndrome|acute myeloid leukemia with multilineage dysplasia following myelodysplastic syndrome
720541|NCT00544466|adult acute lymphoblastic leukemia in remission|adult acute lymphoblastic leukemia in remission
720542|NCT00544466|adult acute myeloid leukemia in remission|adult acute myeloid leukemia in remission
720543|NCT00544466|adult acute myeloid leukemia with 11q23 (MLL) abnormalities|adult acute myeloid leukemia with 11q23 (mll) abnormalities
720544|NCT00544466|adult acute myeloid leukemia with del(5q)|adult acute myeloid leukemia with del(5q)
720545|NCT00544466|adult acute myeloid leukemia with inv(16)(p13;q22)|adult acute myeloid leukemia with inv(16)(p13;q22)
720546|NCT00544466|adult acute myeloid leukemia with t(15;17)(q22;q12)|adult acute myeloid leukemia with t(15;17)(q22;q12)
720547|NCT00544466|adult acute myeloid leukemia with t(16;16)(p13;q22)|adult acute myeloid leukemia with t(16;16)(p13;q22)
720548|NCT00544466|adult acute myeloid leukemia with t(8;21)(q22;q22)|adult acute myeloid leukemia with t(8;21)(q22;q22)
720549|NCT00544466|untreated adult acute myeloid leukemia|untreated adult acute myeloid leukemia
720550|NCT00544466|recurrent adult acute myeloid leukemia|recurrent adult acute myeloid leukemia
720819|NCT00544154|CDP870|cdp870
720551|NCT00544466|childhood acute myeloid leukemia in remission|childhood acute myeloid leukemia in remission
720552|NCT00544466|recurrent childhood acute myeloid leukemia|recurrent childhood acute myeloid leukemia
720553|NCT00544466|untreated childhood acute myeloid leukemia and other myeloid malignancies|untreated childhood acute myeloid leukemia and other myeloid malignancies
720554|NCT00544466|de novo myelodysplastic syndromes|de novo myelodysplastic syndromes
720555|NCT00544466|previously treated myelodysplastic syndromes|previously treated myelodysplastic syndromes
720631|NCT00544336|stage IV colon cancer|stage iv colon cancer
720556|NCT00544466|secondary myelodysplastic syndromes|secondary myelodysplastic syndromes
720557|NCT00544466|secondary acute myeloid leukemia|secondary acute myeloid leukemia
720558|NCT00544466|childhood acute lymphoblastic leukemia in remission|childhood acute lymphoblastic leukemia in remission
720559|NCT00544466|recurrent adult acute lymphoblastic leukemia|recurrent adult acute lymphoblastic leukemia
720560|NCT00544466|recurrent childhood acute lymphoblastic leukemia|recurrent childhood acute lymphoblastic leukemia
720561|NCT00544466|untreated adult acute lymphoblastic leukemia|untreated adult acute lymphoblastic leukemia
720562|NCT00544466|untreated childhood acute lymphoblastic leukemia|untreated childhood acute lymphoblastic leukemia
720563|NCT00544466|childhood myelodysplastic syndromes|childhood myelodysplastic syndromes
720564|NCT00544453|SPECT|spect
720565|NCT00544453|Alzheimer disease|alzheimer disease
720566|NCT00544440|Prostate neoplasms|prostate neoplasms
720567|NCT00544440|Prostate cancer|prostate cancer
720568|NCT00544440|Castration-resistant prostate cancer|castration-resistant prostate cancer
720569|NCT00544440|Abiraterone acetate|abiraterone acetate
720570|NCT00544440|CB7630|cb7630
720571|NCT00544440|Prednisone|prednisone
720572|NCT00544440|Testosterone|testosterone
720573|NCT00544440|Bone marrow|bone marrow
720574|NCT00544427|Upper Areo-Digestive tract|upper areo-digestive tract
720575|NCT00544414|stage III squamous cell carcinoma of the larynx|stage iii squamous cell carcinoma of the larynx
720576|NCT00544414|stage IV squamous cell carcinoma of the larynx|stage iv squamous cell carcinoma of the larynx
720577|NCT00544414|stage III squamous cell carcinoma of the hypopharynx|stage iii squamous cell carcinoma of the hypopharynx
720578|NCT00544414|stage III squamous cell carcinoma of the oropharynx|stage iii squamous cell carcinoma of the oropharynx
720579|NCT00544414|stage IV squamous cell carcinoma of the hypopharynx|stage iv squamous cell carcinoma of the hypopharynx
720580|NCT00544414|stage IV squamous cell carcinoma of the oropharynx|stage iv squamous cell carcinoma of the oropharynx
720581|NCT00544414|stage III squamous cell carcinoma of the lip and oral cavity|stage iii squamous cell carcinoma of the lip and oral cavity
720582|NCT00544414|stage IV squamous cell carcinoma of the lip and oral cavity|stage iv squamous cell carcinoma of the lip and oral cavity
720583|NCT00544414|stage II squamous cell carcinoma of the larynx|stage ii squamous cell carcinoma of the larynx
720584|NCT00544414|stage II squamous cell carcinoma of the hypopharynx|stage ii squamous cell carcinoma of the hypopharynx
720585|NCT00544414|stage II squamous cell carcinoma of the oropharynx|stage ii squamous cell carcinoma of the oropharynx
720586|NCT00544401|infertility|infertility
720587|NCT00544401|in vitro fertilization|in vitro fertilization
720588|NCT00544401|intracytoplasmic sperm implantation|intracytoplasmic sperm implantation
720589|NCT00544401|acupuncture|acupuncture
720590|NCT00544401|hypnosis|hypnosis
720591|NCT00544401|hypnopuncture|hypnopuncture
720592|NCT00544388|Levocetirizine dihydrochloride|levocetirizine dihydrochloride
720593|NCT00544388|Xyzal tablet|xyzal tablet
720594|NCT00544362|adenocarcinoma of the esophagus|adenocarcinoma of the esophagus
720595|NCT00544362|squamous cell carcinoma of the esophagus|squamous cell carcinoma of the esophagus
720596|NCT00544362|stage IIIA esophageal cancer|stage iiia esophageal cancer
720597|NCT00544362|stage IIIB esophageal cancer|stage iiib esophageal cancer
720598|NCT00544362|stage IIIC esophageal cancer|stage iiic esophageal cancer
720599|NCT00544362|stage IV esophageal cancer|stage iv esophageal cancer
720600|NCT00544349|stage IV colon cancer|stage iv colon cancer
720601|NCT00544349|recurrent colon cancer|recurrent colon cancer
720602|NCT00544349|stage IV rectal cancer|stage iv rectal cancer
720603|NCT00544349|recurrent rectal cancer|recurrent rectal cancer
720604|NCT00544349|liver metastases|liver metastases
720605|NCT00544336|unspecified adult solid tumor, protocol specific|unspecified adult solid tumor, protocol specific
720606|NCT00544336|recurrent breast cancer|recurrent breast cancer
720607|NCT00544336|stage I breast cancer|stage i breast cancer
720608|NCT00544336|stage II breast cancer|stage ii breast cancer
720609|NCT00544336|stage IIIA breast cancer|stage iiia breast cancer
720610|NCT00544336|stage IIIB breast cancer|stage iiib breast cancer
720611|NCT00544336|stage IIIC breast cancer|stage iiic breast cancer
720612|NCT00544336|stage IV breast cancer|stage iv breast cancer
720613|NCT00544336|recurrent prostate cancer|recurrent prostate cancer
720614|NCT00544336|stage I prostate cancer|stage i prostate cancer
720615|NCT00544336|stage II prostate cancer|stage ii prostate cancer
720616|NCT00544336|stage III prostate cancer|stage iii prostate cancer
720617|NCT00544336|stage IV prostate cancer|stage iv prostate cancer
720618|NCT00544336|extensive stage small cell lung cancer|extensive stage small cell lung cancer
720619|NCT00544336|limited stage small cell lung cancer|limited stage small cell lung cancer
720620|NCT00544336|recurrent non-small cell lung cancer|recurrent non-small cell lung cancer
720621|NCT00544336|recurrent small cell lung cancer|recurrent small cell lung cancer
720622|NCT00544336|stage I non-small cell lung cancer|stage i non-small cell lung cancer
720623|NCT00544336|stage II non-small cell lung cancer|stage ii non-small cell lung cancer
720624|NCT00544336|stage IIIA non-small cell lung cancer|stage iiia non-small cell lung cancer
720625|NCT00544336|stage IIIB non-small cell lung cancer|stage iiib non-small cell lung cancer
720626|NCT00544336|stage IV non-small cell lung cancer|stage iv non-small cell lung cancer
720627|NCT00544336|recurrent colon cancer|recurrent colon cancer
720628|NCT00544336|stage I colon cancer|stage i colon cancer
720629|NCT00544336|stage II colon cancer|stage ii colon cancer
720630|NCT00544336|stage III colon cancer|stage iii colon cancer
720632|NCT00544336|recurrent squamous cell carcinoma of the hypopharynx|recurrent squamous cell carcinoma of the hypopharynx
720633|NCT00544336|stage I squamous cell carcinoma of the hypopharynx|stage i squamous cell carcinoma of the hypopharynx
720634|NCT00544336|stage II squamous cell carcinoma of the hypopharynx|stage ii squamous cell carcinoma of the hypopharynx
720635|NCT00544336|stage III squamous cell carcinoma of the hypopharynx|stage iii squamous cell carcinoma of the hypopharynx
720636|NCT00544336|stage IV squamous cell carcinoma of the hypopharynx|stage iv squamous cell carcinoma of the hypopharynx
720637|NCT00544336|recurrent squamous cell carcinoma of the larynx|recurrent squamous cell carcinoma of the larynx
720638|NCT00544336|recurrent verrucous carcinoma of the larynx|recurrent verrucous carcinoma of the larynx
720639|NCT00544336|stage I squamous cell carcinoma of the larynx|stage i squamous cell carcinoma of the larynx
720640|NCT00544336|stage I verrucous carcinoma of the larynx|stage i verrucous carcinoma of the larynx
720641|NCT00544336|stage II squamous cell carcinoma of the larynx|stage ii squamous cell carcinoma of the larynx
720642|NCT00544336|stage II verrucous carcinoma of the larynx|stage ii verrucous carcinoma of the larynx
720643|NCT00544336|stage III squamous cell carcinoma of the larynx|stage iii squamous cell carcinoma of the larynx
720644|NCT00544336|stage III verrucous carcinoma of the larynx|stage iii verrucous carcinoma of the larynx
720645|NCT00544336|stage IV squamous cell carcinoma of the larynx|stage iv squamous cell carcinoma of the larynx
720646|NCT00544336|stage IV verrucous carcinoma of the larynx|stage iv verrucous carcinoma of the larynx
720647|NCT00544336|recurrent adenoid cystic carcinoma of the oral cavity|recurrent adenoid cystic carcinoma of the oral cavity
720648|NCT00544336|recurrent mucoepidermoid carcinoma of the oral cavity|recurrent mucoepidermoid carcinoma of the oral cavity
720649|NCT00544336|recurrent verrucous carcinoma of the oral cavity|recurrent verrucous carcinoma of the oral cavity
720650|NCT00544336|stage I adenoid cystic carcinoma of the oral cavity|stage i adenoid cystic carcinoma of the oral cavity
720651|NCT00544336|stage I mucoepidermoid carcinoma of the oral cavity|stage i mucoepidermoid carcinoma of the oral cavity
720652|NCT00544336|stage I verrucous carcinoma of the oral cavity|stage i verrucous carcinoma of the oral cavity
720653|NCT00544336|stage II adenoid cystic carcinoma of the oral cavity|stage ii adenoid cystic carcinoma of the oral cavity
720654|NCT00544336|stage II mucoepidermoid carcinoma of the oral cavity|stage ii mucoepidermoid carcinoma of the oral cavity
720655|NCT00544336|stage II verrucous carcinoma of the oral cavity|stage ii verrucous carcinoma of the oral cavity
720656|NCT00544336|stage III adenoid cystic carcinoma of the oral cavity|stage iii adenoid cystic carcinoma of the oral cavity
720657|NCT00544336|stage III mucoepidermoid carcinoma of the oral cavity|stage iii mucoepidermoid carcinoma of the oral cavity
720658|NCT00544336|stage III verrucous carcinoma of the oral cavity|stage iii verrucous carcinoma of the oral cavity
720659|NCT00544336|stage IV adenoid cystic carcinoma of the oral cavity|stage iv adenoid cystic carcinoma of the oral cavity
720660|NCT00544336|stage IV mucoepidermoid carcinoma of the oral cavity|stage iv mucoepidermoid carcinoma of the oral cavity
720661|NCT00544336|stage IV verrucous carcinoma of the oral cavity|stage iv verrucous carcinoma of the oral cavity
720662|NCT00544336|stage I squamous cell carcinoma of the lip and oral cavity|stage i squamous cell carcinoma of the lip and oral cavity
720663|NCT00544336|stage II squamous cell carcinoma of the lip and oral cavity|stage ii squamous cell carcinoma of the lip and oral cavity
720664|NCT00544336|stage III squamous cell carcinoma of the lip and oral cavity|stage iii squamous cell carcinoma of the lip and oral cavity
720665|NCT00544336|stage IV squamous cell carcinoma of the lip and oral cavity|stage iv squamous cell carcinoma of the lip and oral cavity
720666|NCT00544336|recurrent basal cell carcinoma of the lip|recurrent basal cell carcinoma of the lip
720667|NCT00544336|recurrent squamous cell carcinoma of the lip and oral cavity|recurrent squamous cell carcinoma of the lip and oral cavity
720668|NCT00544336|stage I basal cell carcinoma of the lip|stage i basal cell carcinoma of the lip
720669|NCT00544336|stage II basal cell carcinoma of the lip|stage ii basal cell carcinoma of the lip
720670|NCT00544336|stage III basal cell carcinoma of the lip|stage iii basal cell carcinoma of the lip
720671|NCT00544336|stage IV basal cell carcinoma of the lip|stage iv basal cell carcinoma of the lip
720672|NCT00544336|metastatic squamous neck cancer with occult primary squamous cell carcinoma|metastatic squamous neck cancer with occult primary squamous cell carcinoma
720673|NCT00544336|recurrent metastatic squamous neck cancer with occult primary|recurrent metastatic squamous neck cancer with occult primary
720674|NCT00544336|untreated metastatic squamous neck cancer with occult primary|untreated metastatic squamous neck cancer with occult primary
720675|NCT00544336|recurrent lymphoepithelioma of the nasopharynx|recurrent lymphoepithelioma of the nasopharynx
720676|NCT00544336|recurrent squamous cell carcinoma of the nasopharynx|recurrent squamous cell carcinoma of the nasopharynx
720677|NCT00544336|stage I lymphoepithelioma of the nasopharynx|stage i lymphoepithelioma of the nasopharynx
720678|NCT00544336|stage I squamous cell carcinoma of the nasopharynx|stage i squamous cell carcinoma of the nasopharynx
720679|NCT00544336|stage II lymphoepithelioma of the nasopharynx|stage ii lymphoepithelioma of the nasopharynx
720680|NCT00544336|stage II squamous cell carcinoma of the nasopharynx|stage ii squamous cell carcinoma of the nasopharynx
720681|NCT00544336|stage III lymphoepithelioma of the nasopharynx|stage iii lymphoepithelioma of the nasopharynx
720682|NCT00544336|stage III squamous cell carcinoma of the nasopharynx|stage iii squamous cell carcinoma of the nasopharynx
720683|NCT00544336|stage IV lymphoepithelioma of the nasopharynx|stage iv lymphoepithelioma of the nasopharynx
720684|NCT00544336|stage IV squamous cell carcinoma of the nasopharynx|stage iv squamous cell carcinoma of the nasopharynx
720685|NCT00544336|recurrent lymphoepithelioma of the oropharynx|recurrent lymphoepithelioma of the oropharynx
720686|NCT00544336|recurrent squamous cell carcinoma of the oropharynx|recurrent squamous cell carcinoma of the oropharynx
720687|NCT00544336|stage I lymphoepithelioma of the oropharynx|stage i lymphoepithelioma of the oropharynx
720688|NCT00544336|stage I squamous cell carcinoma of the oropharynx|stage i squamous cell carcinoma of the oropharynx
720689|NCT00544336|stage II lymphoepithelioma of the oropharynx|stage ii lymphoepithelioma of the oropharynx
720690|NCT00544336|stage II squamous cell carcinoma of the oropharynx|stage ii squamous cell carcinoma of the oropharynx
720691|NCT00544336|stage III lymphoepithelioma of the oropharynx|stage iii lymphoepithelioma of the oropharynx
720692|NCT00544336|stage III squamous cell carcinoma of the oropharynx|stage iii squamous cell carcinoma of the oropharynx
720693|NCT00544336|stage IV lymphoepithelioma of the oropharynx|stage iv lymphoepithelioma of the oropharynx
720694|NCT00544336|stage IV squamous cell carcinoma of the oropharynx|stage iv squamous cell carcinoma of the oropharynx
720695|NCT00544336|recurrent esthesioneuroblastoma of the paranasal sinus and nasal cavity|recurrent esthesioneuroblastoma of the paranasal sinus and nasal cavity
720696|NCT00544336|recurrent inverted papilloma of the paranasal sinus and nasal cavity|recurrent inverted papilloma of the paranasal sinus and nasal cavity
720697|NCT00544336|recurrent midline lethal granuloma of the paranasal sinus and nasal cavity|recurrent midline lethal granuloma of the paranasal sinus and nasal cavity
720698|NCT00544336|recurrent squamous cell carcinoma of the paranasal sinus and nasal cavity|recurrent squamous cell carcinoma of the paranasal sinus and nasal cavity
720699|NCT00544336|stage I esthesioneuroblastoma of the paranasal sinus and nasal cavity|stage i esthesioneuroblastoma of the paranasal sinus and nasal cavity
720700|NCT00544336|stage I inverted papilloma of the paranasal sinus and nasal cavity|stage i inverted papilloma of the paranasal sinus and nasal cavity
720701|NCT00544336|stage I midline lethal granuloma of the paranasal sinus and nasal cavity|stage i midline lethal granuloma of the paranasal sinus and nasal cavity
720702|NCT00544336|stage I squamous cell carcinoma of the paranasal sinus and nasal cavity|stage i squamous cell carcinoma of the paranasal sinus and nasal cavity
720703|NCT00544336|stage II esthesioneuroblastoma of the paranasal sinus and nasal cavity|stage ii esthesioneuroblastoma of the paranasal sinus and nasal cavity
720704|NCT00544336|stage II inverted papilloma of the paranasal sinus and nasal cavity|stage ii inverted papilloma of the paranasal sinus and nasal cavity
720705|NCT00544336|stage II midline lethal granuloma of the paranasal sinus and nasal cavity|stage ii midline lethal granuloma of the paranasal sinus and nasal cavity
720706|NCT00544336|stage II squamous cell carcinoma of the paranasal sinus and nasal cavity|stage ii squamous cell carcinoma of the paranasal sinus and nasal cavity
720707|NCT00544336|stage III esthesioneuroblastoma of the paranasal sinus and nasal cavity|stage iii esthesioneuroblastoma of the paranasal sinus and nasal cavity
720708|NCT00544336|stage III inverted papilloma of the paranasal sinus and nasal cavity|stage iii inverted papilloma of the paranasal sinus and nasal cavity
720709|NCT00544336|stage III midline lethal granuloma of the paranasal sinus and nasal cavity|stage iii midline lethal granuloma of the paranasal sinus and nasal cavity
720710|NCT00544336|stage III squamous cell carcinoma of the paranasal sinus and nasal cavity|stage iii squamous cell carcinoma of the paranasal sinus and nasal cavity
720711|NCT00544336|stage IV esthesioneuroblastoma of the paranasal sinus and nasal cavity|stage iv esthesioneuroblastoma of the paranasal sinus and nasal cavity
720712|NCT00544336|stage IV inverted papilloma of the paranasal sinus and nasal cavity|stage iv inverted papilloma of the paranasal sinus and nasal cavity
720713|NCT00544336|stage IV midline lethal granuloma of the paranasal sinus and nasal cavity|stage iv midline lethal granuloma of the paranasal sinus and nasal cavity
720714|NCT00544336|stage IV squamous cell carcinoma of the paranasal sinus and nasal cavity|stage iv squamous cell carcinoma of the paranasal sinus and nasal cavity
720715|NCT00544336|high-grade salivary gland mucoepidermoid carcinoma|high-grade salivary gland mucoepidermoid carcinoma
720716|NCT00544336|low-grade salivary gland mucoepidermoid carcinoma|low-grade salivary gland mucoepidermoid carcinoma
720717|NCT00544336|recurrent salivary gland cancer|recurrent salivary gland cancer
720718|NCT00544336|salivary gland acinic cell tumor|salivary gland acinic cell tumor
720719|NCT00544336|salivary gland adenocarcinoma|salivary gland adenocarcinoma
720720|NCT00544336|salivary gland adenoid cystic carcinoma|salivary gland adenoid cystic carcinoma
720721|NCT00544336|salivary gland anaplastic carcinoma|salivary gland anaplastic carcinoma
720722|NCT00544336|salivary gland malignant mixed cell type tumor|salivary gland malignant mixed cell type tumor
720723|NCT00544336|salivary gland poorly differentiated carcinoma|salivary gland poorly differentiated carcinoma
720724|NCT00544336|salivary gland squamous cell carcinoma|salivary gland squamous cell carcinoma
720725|NCT00544336|stage I salivary gland cancer|stage i salivary gland cancer
720726|NCT00544336|stage II salivary gland cancer|stage ii salivary gland cancer
720727|NCT00544336|stage III salivary gland cancer|stage iii salivary gland cancer
720728|NCT00544336|stage IV salivary gland cancer|stage iv salivary gland cancer
720729|NCT00544323|alveolar bone|alveolar bone
720730|NCT00544323|radiographic alveolar bone changes around oral implants of various designs 12 m post loading|radiographic alveolar bone changes around oral implants of various designs 12 m post loading
720731|NCT00544297|Actinic Keratosis|actinic keratosis
720732|NCT00544297|Topical|topical
720733|NCT00544297|Dermatology|dermatology
720734|NCT00544297|Hand|hand
720735|NCT00544284|adult glioblastoma|adult glioblastoma
720736|NCT00544284|adult anaplastic astrocytoma|adult anaplastic astrocytoma
720737|NCT00544284|adult giant cell glioblastoma|adult giant cell glioblastoma
720738|NCT00544284|recurrent adult brain tumor|recurrent adult brain tumor
720739|NCT00544284|adult gliosarcoma|adult gliosarcoma
720740|NCT00544284|adult mixed glioma|adult mixed glioma
720741|NCT00544284|adult anaplastic oligodendroglioma|adult anaplastic oligodendroglioma
720742|NCT00544284|primary central nervous system lymphoma|primary central nervous system lymphoma
720743|NCT00544284|adult diffuse astrocytoma|adult diffuse astrocytoma
720744|NCT00544284|adult brain stem glioma|adult brain stem glioma
720745|NCT00544284|adult central nervous system germ cell tumor|adult central nervous system germ cell tumor
720746|NCT00544284|adult choroid plexus tumor|adult choroid plexus tumor
720747|NCT00544284|adult craniopharyngioma|adult craniopharyngioma
720748|NCT00544284|adult ependymoblastoma|adult ependymoblastoma
720749|NCT00544284|adult medulloblastoma|adult medulloblastoma
720750|NCT00544284|adult supratentorial primitive neuroectodermal tumor (PNET)|adult supratentorial primitive neuroectodermal tumor (pnet)
720751|NCT00544284|adult anaplastic ependymoma|adult anaplastic ependymoma
720752|NCT00544284|adult ependymoma|adult ependymoma
720753|NCT00544284|adult myxopapillary ependymoma|adult myxopapillary ependymoma
720754|NCT00544284|adult subependymoma|adult subependymoma
720755|NCT00544284|adult anaplastic meningioma|adult anaplastic meningioma
720756|NCT00544284|adult melanocytic lesion|adult melanocytic lesion
720757|NCT00544284|adult meningeal hemangiopericytoma|adult meningeal hemangiopericytoma
720758|NCT00544284|adult grade I meningioma|adult grade i meningioma
720759|NCT00544284|adult grade II meningioma|adult grade ii meningioma
720760|NCT00544284|adult grade III meningioma|adult grade iii meningioma
720761|NCT00544284|adult papillary meningioma|adult papillary meningioma
720762|NCT00544284|adult oligodendroglioma|adult oligodendroglioma
720763|NCT00544284|adult pineoblastoma|adult pineoblastoma
720764|NCT00544284|adult pineocytoma|adult pineocytoma
720765|NCT00544284|tumors metastatic to brain|tumors metastatic to brain
720766|NCT00544284|unspecified adult solid tumor, protocol specific|unspecified adult solid tumor, protocol specific
720767|NCT00544284|adult pilocytic astrocytoma|adult pilocytic astrocytoma
720768|NCT00544284|adult subependymal giant cell astrocytoma|adult subependymal giant cell astrocytoma
720769|NCT00544271|BOOSTRIX|boostrix
720770|NCT00544271|INFANRIX|infanrix
720771|NCT00544258|Pharmacokinetic study|pharmacokinetic study
720772|NCT00544258|Actinic Keratosis|actinic keratosis
720773|NCT00544258|Topical|topical
720774|NCT00544258|Dermatology|dermatology
720775|NCT00544245|overweight|overweight
720776|NCT00544245|obesity|obesity
720777|NCT00544245|accelerometer|accelerometer
720778|NCT00544245|pedometer|pedometer
720779|NCT00544245|energy balance|energy balance
720780|NCT00544245|weight loss|weight loss
720781|NCT00544245|weight maintenance|weight maintenance
720782|NCT00544232|Breast Cancer|breast cancer
720783|NCT00544232|neoadjuvant therapy|neoadjuvant therapy
720784|NCT00544232|pCR rates|pcr rates
720785|NCT00544219|contiguous stage II adult diffuse large cell lymphoma|contiguous stage ii adult diffuse large cell lymphoma
720786|NCT00544219|noncontiguous stage II adult diffuse large cell lymphoma|noncontiguous stage ii adult diffuse large cell lymphoma
720787|NCT00544219|stage I adult diffuse large cell lymphoma|stage i adult diffuse large cell lymphoma
720788|NCT00544219|stage III adult diffuse large cell lymphoma|stage iii adult diffuse large cell lymphoma
720789|NCT00544219|stage IV adult diffuse large cell lymphoma|stage iv adult diffuse large cell lymphoma
720790|NCT00544193|adenocarcinoma of the extrahepatic bile duct|adenocarcinoma of the extrahepatic bile duct
720791|NCT00544193|adenocarcinoma of the gallbladder|adenocarcinoma of the gallbladder
720792|NCT00544193|adenocarcinoma of the pancreas|adenocarcinoma of the pancreas
720793|NCT00544193|adenocarcinoma of the stomach|adenocarcinoma of the stomach
720794|NCT00544193|stage I pancreatic cancer|stage i pancreatic cancer
720795|NCT00544193|stage II pancreatic cancer|stage ii pancreatic cancer
720796|NCT00544193|stage III pancreatic cancer|stage iii pancreatic cancer
720797|NCT00544193|localized extrahepatic bile duct cancer|localized extrahepatic bile duct cancer
720798|NCT00544193|recurrent extrahepatic bile duct cancer|recurrent extrahepatic bile duct cancer
720799|NCT00544193|unresectable extrahepatic bile duct cancer|unresectable extrahepatic bile duct cancer
720800|NCT00544193|localized gallbladder cancer|localized gallbladder cancer
720801|NCT00544193|recurrent gallbladder cancer|recurrent gallbladder cancer
720802|NCT00544193|unresectable gallbladder cancer|unresectable gallbladder cancer
720803|NCT00544193|recurrent gastric cancer|recurrent gastric cancer
720804|NCT00544193|stage II gastric cancer|stage ii gastric cancer
720805|NCT00544193|stage III gastric cancer|stage iii gastric cancer
720806|NCT00544193|stage IV gastric cancer|stage iv gastric cancer
720807|NCT00544193|stage I gastric cancer|stage i gastric cancer
720808|NCT00544193|recurrent pancreatic cancer|recurrent pancreatic cancer
720809|NCT00544193|small intestine adenocarcinoma|small intestine adenocarcinoma
720810|NCT00544193|stage IV pancreatic cancer|stage iv pancreatic cancer
720811|NCT00544167|Breast Cancer|breast cancer
720812|NCT00544167|Early Stage|early stage
720813|NCT00544167|High Risk|high risk
720814|NCT00544167|Node Positive|node positive
720815|NCT00544167|Doxorubicin|doxorubicin
720816|NCT00544167|Cyclophosphamide|cyclophosphamide
720817|NCT00544167|Paclitaxel|paclitaxel
720820|NCT00544154|Certolizumab pegol|certolizumab pegol
720821|NCT00544141|Temperature measurement|temperature measurement
720822|NCT00544128|HIV|hiv
720823|NCT00544128|initial therapy|initial therapy
720824|NCT00544128|once daily|once daily
720825|NCT00544128|randomized trial|randomized trial
720826|NCT00544128|non inferiority|non inferiority
720827|NCT00544128|Treatment Naive|treatment naive
720828|NCT00544115|graft versus host disease|graft versus host disease
720987|NCT00543504|Avastin|avastin
720829|NCT00544115|recurrent adult acute lymphoblastic leukemia|recurrent adult acute lymphoblastic leukemia
720830|NCT00544115|recurrent childhood acute lymphoblastic leukemia|recurrent childhood acute lymphoblastic leukemia
720831|NCT00544115|untreated adult acute lymphoblastic leukemia|untreated adult acute lymphoblastic leukemia
720832|NCT00544115|untreated childhood acute lymphoblastic leukemia|untreated childhood acute lymphoblastic leukemia
720833|NCT00544115|de novo myelodysplastic syndromes|de novo myelodysplastic syndromes
720834|NCT00544115|previously treated myelodysplastic syndromes|previously treated myelodysplastic syndromes
720835|NCT00544115|secondary myelodysplastic syndromes|secondary myelodysplastic syndromes
720836|NCT00544115|refractory anemia with excess blasts in transformation|refractory anemia with excess blasts in transformation
720837|NCT00544115|refractory anemia with excess blasts|refractory anemia with excess blasts
720838|NCT00544115|atypical chronic myeloid leukemia|atypical chronic myeloid leukemia
720839|NCT00544115|chronic myelomonocytic leukemia|chronic myelomonocytic leukemia
720840|NCT00544115|juvenile myelomonocytic leukemia|juvenile myelomonocytic leukemia
720841|NCT00544115|myelodysplastic/myeloproliferative disease, unclassifiable|myelodysplastic/myeloproliferative disease, unclassifiable
720842|NCT00544115|recurrent adult acute myeloid leukemia|recurrent adult acute myeloid leukemia
720843|NCT00544115|recurrent childhood acute myeloid leukemia|recurrent childhood acute myeloid leukemia
720844|NCT00544115|adult acute myeloid leukemia in remission|adult acute myeloid leukemia in remission
720845|NCT00544115|childhood acute myeloid leukemia in remission|childhood acute myeloid leukemia in remission
720846|NCT00544115|secondary acute myeloid leukemia|secondary acute myeloid leukemia
720847|NCT00544115|adult acute myeloid leukemia with 11q23 (MLL) abnormalities|adult acute myeloid leukemia with 11q23 (mll) abnormalities
720848|NCT00544115|adult acute myeloid leukemia with inv(16)(p13;q22)|adult acute myeloid leukemia with inv(16)(p13;q22)
720849|NCT00544115|adult acute myeloid leukemia with t(15;17)(q22;q12)|adult acute myeloid leukemia with t(15;17)(q22;q12)
720850|NCT00544115|adult acute myeloid leukemia with t(16;16)(p13;q22)|adult acute myeloid leukemia with t(16;16)(p13;q22)
720851|NCT00544115|adult acute myeloid leukemia with t(8;21)(q22;q22)|adult acute myeloid leukemia with t(8;21)(q22;q22)
720852|NCT00544115|accelerated phase chronic myelogenous leukemia|accelerated phase chronic myelogenous leukemia
720853|NCT00544115|blastic phase chronic myelogenous leukemia|blastic phase chronic myelogenous leukemia
720854|NCT00544115|childhood chronic myelogenous leukemia|childhood chronic myelogenous leukemia
720855|NCT00544115|chronic phase chronic myelogenous leukemia|chronic phase chronic myelogenous leukemia
720856|NCT00544115|relapsing chronic myelogenous leukemia|relapsing chronic myelogenous leukemia
720857|NCT00544115|chronic eosinophilic leukemia|chronic eosinophilic leukemia
720858|NCT00544115|chronic idiopathic myelofibrosis|chronic idiopathic myelofibrosis
720859|NCT00544115|chronic neutrophilic leukemia|chronic neutrophilic leukemia
720860|NCT00544115|essential thrombocythemia|essential thrombocythemia
720861|NCT00544115|polycythemia vera|polycythemia vera
720862|NCT00544115|Waldenstrom macroglobulinemia|waldenstrom macroglobulinemia
720863|NCT00544115|extranodal marginal zone B-cell lymphoma of mucosa-associated lymphoid tissue|extranodal marginal zone b-cell lymphoma of mucosa-associated lymphoid tissue
720864|NCT00544115|nodal marginal zone B-cell lymphoma|nodal marginal zone b-cell lymphoma
720865|NCT00544115|recurrent adult Burkitt lymphoma|recurrent adult burkitt lymphoma
720866|NCT00544115|recurrent adult diffuse large cell lymphoma|recurrent adult diffuse large cell lymphoma
720867|NCT00544115|recurrent adult diffuse mixed cell lymphoma|recurrent adult diffuse mixed cell lymphoma
720868|NCT00544115|recurrent adult diffuse small cleaved cell lymphoma|recurrent adult diffuse small cleaved cell lymphoma
720869|NCT00544115|recurrent adult immunoblastic large cell lymphoma|recurrent adult immunoblastic large cell lymphoma
720870|NCT00544115|recurrent adult lymphoblastic lymphoma|recurrent adult lymphoblastic lymphoma
720871|NCT00544115|recurrent grade 1 follicular lymphoma|recurrent grade 1 follicular lymphoma
720872|NCT00544115|recurrent grade 2 follicular lymphoma|recurrent grade 2 follicular lymphoma
720873|NCT00544115|recurrent grade 3 follicular lymphoma|recurrent grade 3 follicular lymphoma
720874|NCT00544115|recurrent mantle cell lymphoma|recurrent mantle cell lymphoma
720875|NCT00544115|recurrent marginal zone lymphoma|recurrent marginal zone lymphoma
720876|NCT00544115|recurrent small lymphocytic lymphoma|recurrent small lymphocytic lymphoma
720877|NCT00544115|splenic marginal zone lymphoma|splenic marginal zone lymphoma
720878|NCT00544115|recurrent childhood grade III lymphomatoid granulomatosis|recurrent childhood grade iii lymphomatoid granulomatosis
720879|NCT00544115|childhood nasal type extranodal NK/T-cell lymphoma|childhood nasal type extranodal nk/t-cell lymphoma
720880|NCT00544115|recurrent childhood large cell lymphoma|recurrent childhood large cell lymphoma
720881|NCT00544115|childhood diffuse large cell lymphoma|childhood diffuse large cell lymphoma
720882|NCT00544115|childhood immunoblastic large cell lymphoma|childhood immunoblastic large cell lymphoma
720883|NCT00544115|recurrent childhood lymphoblastic lymphoma|recurrent childhood lymphoblastic lymphoma
720884|NCT00544115|Burkitt lymphoma|burkitt lymphoma
720975|NCT00543647|inulin clearance|inulin clearance
720885|NCT00544115|recurrent childhood small noncleaved cell lymphoma|recurrent childhood small noncleaved cell lymphoma
720886|NCT00544115|anaplastic large cell lymphoma|anaplastic large cell lymphoma
720887|NCT00544115|angioimmunoblastic T-cell lymphoma|angioimmunoblastic t-cell lymphoma
720888|NCT00544115|recurrent adult T-cell leukemia/lymphoma|recurrent adult t-cell leukemia/lymphoma
720889|NCT00544115|recurrent adult grade III lymphomatoid granulomatosis|recurrent adult grade iii lymphomatoid granulomatosis
720890|NCT00544115|adult nasal type extranodal NK/T-cell lymphoma|adult nasal type extranodal nk/t-cell lymphoma
720988|NCT00543504|Sorafenib|sorafenib
720891|NCT00544115|recurrent adult Hodgkin lymphoma|recurrent adult hodgkin lymphoma
720892|NCT00544115|recurrent/refractory childhood Hodgkin lymphoma|recurrent/refractory childhood hodgkin lymphoma
720893|NCT00544115|refractory chronic lymphocytic leukemia|refractory chronic lymphocytic leukemia
720894|NCT00544115|refractory multiple myeloma|refractory multiple myeloma
720895|NCT00544115|stage III multiple myeloma|stage iii multiple myeloma
720896|NCT00544115|aplastic anemia|aplastic anemia
720897|NCT00544115|paroxysmal nocturnal hemoglobinuria|paroxysmal nocturnal hemoglobinuria
720898|NCT00544115|adult acute lymphoblastic leukemia in remission|adult acute lymphoblastic leukemia in remission
720899|NCT00544115|childhood acute lymphoblastic leukemia in remission|childhood acute lymphoblastic leukemia in remission
720900|NCT00544115|recurrent cutaneous T-cell non-Hodgkin lymphoma|recurrent cutaneous t-cell non-hodgkin lymphoma
720901|NCT00544115|recurrent mycosis fungoides/Sezary syndrome|recurrent mycosis fungoides/sezary syndrome
720902|NCT00544115|stage II multiple myeloma|stage ii multiple myeloma
720903|NCT00544102|Insulin Resistance|insulin resistance
720904|NCT00544102|Systemic Lupus Erythematosus|systemic lupus erythematosus
720905|NCT00544102|Atherosclerosis|atherosclerosis
720906|NCT00544102|Lupus|lupus
720907|NCT00544102|SLE|sle
720908|NCT00544089|azoospermia FISH IL-18 TESTICULAR BIOPSY|azoospermia fish il-18 testicular biopsy
720909|NCT00544063|unspecified adult solid tumor, protocol specific|unspecified adult solid tumor, protocol specific
720910|NCT00544050|Levetiracetam|levetiracetam
720911|NCT00544050|Keppra|keppra
720912|NCT00544024|Mefloquine|mefloquine
720913|NCT00544011|stage IV colon cancer|stage iv colon cancer
720914|NCT00544011|stage IV rectal cancer|stage iv rectal cancer
720915|NCT00544011|adenocarcinoma of the colon|adenocarcinoma of the colon
720916|NCT00544011|adenocarcinoma of the rectum|adenocarcinoma of the rectum
720917|NCT00543998|Sinusitis|sinusitis
720918|NCT00543985|metabolic syndrome|metabolic syndrome
720919|NCT00543985|obesity|obesity
720920|NCT00543985|exercise|exercise
720921|NCT00543907|breast reconstruction|breast reconstruction
720922|NCT00543907|DIEP flap|diep flap
720923|NCT00543894|Antibiotic, ICU, hospital acquired infection.|antibiotic, icu, hospital acquired infection.
720924|NCT00543881|telemedicine|telemedicine
720925|NCT00543881|remote patient monitoring|remote patient monitoring
720926|NCT00543881|chronic heart failure|chronic heart failure
720927|NCT00543881|mortality|mortality
720928|NCT00543881|health economics|health economics
720929|NCT00543855|Lewy Body Disease|lewy body disease
720930|NCT00543855|Dementia|dementia
720931|NCT00543855|Clinical Trial|clinical trial
720932|NCT00543855|Phase II|phase ii
720933|NCT00543855|E2020|e2020
720934|NCT00543855|donepezil hydrochloride|donepezil hydrochloride
720935|NCT00543842|Rectal Cancer|rectal cancer
720936|NCT00543842|Bevacizumab|bevacizumab
720937|NCT00543842|Erlotinib|erlotinib
720938|NCT00543842|Capecitabine|capecitabine
720939|NCT00543829|breast cancer|breast cancer
720940|NCT00543829|doxorubicin|doxorubicin
720941|NCT00543829|docetaxel|docetaxel
720942|NCT00543829|tamoxifen|tamoxifen
720943|NCT00543777|Liver Cancer|liver cancer
720944|NCT00543777|Magnetic Resonance Elastography|magnetic resonance elastography
720945|NCT00543777|2-Point Dixon Magnetic Resonance Imaging|2-point dixon magnetic resonance imaging
720946|NCT00543777|Liver Disease|liver disease
720947|NCT00543777|Fatty Liver|fatty liver
720948|NCT00543777|Liver Fibrosis|liver fibrosis
720949|NCT00543777|Liver Cirrhosis|liver cirrhosis
720951|NCT00543777|2PD MRI|2pd mri
720952|NCT00543777|phase correction algorithm|phase correction algorithm
720953|NCT00543764|Intraoperative Pathway|intraoperative pathway
720954|NCT00543764|Breast Reconstruction|breast reconstruction
720955|NCT00543764|DIEP flap|diep flap
720956|NCT00543725|Antiretroviral|antiretroviral
720957|NCT00543725|HIV-1|hiv-1
720958|NCT00543725|AIDS|aids
720959|NCT00543725|TMC278-C215|tmc278-c215
720960|NCT00543725|TMC278-TiDP6-C215|tmc278-tidp6-c215
720961|NCT00543725|Treatment Naive|treatment naive
720962|NCT00543712|Sarcoma|sarcoma
720963|NCT00543712|synovial sarcoma|synovial sarcoma
720964|NCT00543712|APM4171g|apm4171g
720965|NCT00543686|Pre-School Asthma|pre-school asthma
720966|NCT00543686|Responder Profiles|responder profiles
720967|NCT00543686|Fluticasone|fluticasone
720968|NCT00543686|Montelukast|montelukast
720969|NCT00543686|Leukotriene|leukotriene
720970|NCT00543686|Children with Pre-School Asthma|children with pre-school asthma
720971|NCT00543673|Healthy term infants|healthy term infants
720972|NCT00543660|Corneal transplantation, Descemet membrane, endothelium|corneal transplantation, descemet membrane, endothelium
720973|NCT00543647|Fenofibrate|fenofibrate
720974|NCT00543647|Glomerular filtration rate|glomerular filtration rate
720977|NCT00543647|healthy volunteers|healthy volunteers
720978|NCT00543647|cross-over|cross-over
720979|NCT00543608|pneumonia|pneumonia
720980|NCT00543608|nosocomial pneumonia|nosocomial pneumonia
720981|NCT00543569|kidney transplant|kidney transplant
720982|NCT00543569|alefacept|alefacept
720983|NCT00543530|HIV|hiv
720984|NCT00543530|Treatment Experienced|treatment experienced
720985|NCT00543504|Advanced Cancer|advanced cancer
720986|NCT00543504|Bevacizumab|bevacizumab
720990|NCT00543504|Erlotinib|erlotinib
720991|NCT00543504|OSI-774|osi-774
720992|NCT00543504|Tarceva|tarceva
720993|NCT00543504|Trastuzumab|trastuzumab
720994|NCT00543504|Herceptin|herceptin
720995|NCT00543504|Sunitinib|sunitinib
720996|NCT00543504|SU011248|su011248
720997|NCT00543504|Sutent|sutent
720998|NCT00543504|Cetuximab|cetuximab
720999|NCT00543504|Lapatinib|lapatinib
721000|NCT00543504|Tykerb|tykerb
721001|NCT00543504|Anti-VEGF monoclonal antibody|anti-vegf monoclonal antibody
721002|NCT00543504|rhuMAb-VEGF|rhumab-vegf
721003|NCT00543504|Erlotinib hydrochloride|erlotinib hydrochloride
721004|NCT00543504|GW572016|gw572016
721005|NCT00543504|Sunitinib Malate|sunitinib malate
721006|NCT00543478|Irritable bowel syndrome|irritable bowel syndrome
721007|NCT00543478|Diarrhea|diarrhea
721008|NCT00543478|Probiotics|probiotics
721009|NCT00543426|Fuzheng Huayu Tablets|fuzheng huayu tablets
721010|NCT00543426|Multicenter clinical study|multicenter clinical study
721011|NCT00543400|Percutaneous Coronary Intervention (PCI)|percutaneous coronary intervention (pci)
721012|NCT00543348|BALLOON ANGIOPLASTY|balloon angioplasty
721013|NCT00543348|AUTOGENOUS FISTULA|autogenous fistula
721014|NCT00543335|Non-Small Cell Lung Cancer|non-small cell lung cancer
721015|NCT00543335|Lung Cancer|lung cancer
721016|NCT00543335|NSCLC|nsclc
721017|NCT00543335|Radiation Therapy|radiation therapy
721018|NCT00543335|Sorafenib|sorafenib
721019|NCT00543335|BAY 43-9006|bay 43-9006
721020|NCT00543335|Thoracic Radiation|thoracic radiation
721021|NCT00543309|Fontan Operation|fontan operation
721022|NCT00543309|Cardiopulmonary Bypass|cardiopulmonary bypass
721023|NCT00543309|Heart Defects, Congenital|heart defects, congenital
721024|NCT00543309|Milrinone|milrinone
721025|NCT00543309|Natriuretic peptide, brain|natriuretic peptide, brain
721026|NCT00543296|uveitis|uveitis
721027|NCT00543296|Cystoid Macular Edema (CME)|cystoid macular edema (cme)
721028|NCT00543296|fluocinolone acetonide|fluocinolone acetonide
721029|NCT00543296|non-infectious uveitis affecting the posterior segment|non-infectious uveitis affecting the posterior segment
721030|NCT00543270|EVAR|evar
721031|NCT00543270|AAA|aaa
721032|NCT00543270|Aneurysm|aneurysm
721033|NCT00543270|Powerlink|powerlink
721034|NCT00543244|Chronic hepatitis C|chronic hepatitis c
721035|NCT00543244|Pegylated interferon|pegylated interferon
721036|NCT00543244|Ribavirin|ribavirin
721037|NCT00543244|Virokinetics|virokinetics
721038|NCT00543231|ECOG|ecog
721039|NCT00543231|MRT|mrt
721040|NCT00543231|NCI CTC|nci ctc
721041|NCT00543231|SAE|sae
721042|NCT00543231|Short Intravenous Infusion to Patients with Solid Tumors|short intravenous infusion to patients with solid tumors
721043|NCT00543192|Endometrial Cancer|endometrial cancer
721044|NCT00543192|Sexual Function|sexual function
721045|NCT00543166|Sjögren's syndrome|sjögren's syndrome
721046|NCT00543166|fatigue|fatigue
721047|NCT00543166|salivary gland|salivary gland
721048|NCT00543166|dehydroepiandrosterone|dehydroepiandrosterone
721049|NCT00543153|Advanced Cancer|advanced cancer
721050|NCT00543153|Exceptional Patient|exceptional patient
721051|NCT00543153|Cancer Care|cancer care
721052|NCT00543153|Interview|interview
721053|NCT00543140|Obesity|obesity
721054|NCT00543140|Morbid Obesity|morbid obesity
721055|NCT00543114|CLL|cll
721056|NCT00543114|SLL|sll
721057|NCT00543114|Revlimid|revlimid
721058|NCT00543114|lenalidomide|lenalidomide
721059|NCT00543101|HIV/AIDS|hiv/aids
721060|NCT00543101|darunavir|darunavir
721061|NCT00543101|Protease inhibitors|protease inhibitors
721062|NCT00543101|Dual boosted|dual boosted
721063|NCT00543101|Treatment experienced|treatment experienced
721064|NCT00543088|Schizophrenia|schizophrenia
721065|NCT00543088|Bipolar Disorder|bipolar disorder
721066|NCT00543088|manic episode|manic episode
721067|NCT00543088|atypical antipsychotic|atypical antipsychotic
721068|NCT00543088|Schizophrenia or Bipolar Disorder (currently in a manic episode)|schizophrenia or bipolar disorder (currently in a manic episode)
721069|NCT00543075|Renal Function|renal function
721070|NCT00543075|Adult|adult
721071|NCT00543075|Genasense|genasense
721072|NCT00543075|oblimersen|oblimersen
721073|NCT00543075|G3139|g3139
721074|NCT00543075|Genta|genta
721075|NCT00543075|Pharmacokinetics|pharmacokinetics
721076|NCT00543062|Inhaled prochlorperazine, Thorough Qt/QTc,|inhaled prochlorperazine, thorough qt/qtc,
721077|NCT00543049|platinum refractory|platinum refractory
721078|NCT00543049|epithelial ovarian cancer|epithelial ovarian cancer
721079|NCT00543049|primary cancer of the peritoneum|primary cancer of the peritoneum
721080|NCT00543049|cancer of the fallopian tube|cancer of the fallopian tube
721081|NCT00543036|Cannabis|cannabis
721082|NCT00543036|Addiction|addiction
721085|NCT00542997|Subcutaneous immune globulin|subcutaneous immune globulin
721086|NCT00542997|SCIG|scig
721087|NCT00542971|Leukemia|leukemia
721088|NCT00542971|AML|aml
721089|NCT00542971|High-Risk MDS|high-risk mds
721090|NCT00542971|Acute Myeloid Leukemia|acute myeloid leukemia
721091|NCT00542971|High-Risk Myelodysplastic Disorder|high-risk myelodysplastic disorder
721092|NCT00542971|Idarubicin|idarubicin
721093|NCT00542971|Ara-C|ara-c
721094|NCT00542971|Cytarabine|cytarabine
721095|NCT00542971|Sorafenib|sorafenib
721096|NCT00542971|BAY43-9006|bay43-9006
721097|NCT00542958|Cancer|cancer
721098|NCT00542958|Refractory solid tumor|refractory solid tumor
721099|NCT00542945|Heart Failure|heart failure
721100|NCT00542945|ICD|icd
721101|NCT00542945|Dilated cardiomyopathy|dilated cardiomyopathy
721102|NCT00542932|COPD|copd
721103|NCT00542932|Exercise|exercise
721104|NCT00542932|Home|home
721105|NCT00542906|healthy volunteers|healthy volunteers
721106|NCT00542906|Somatosensory stimuli|somatosensory stimuli
721107|NCT00542906|fMRI|fmri
721108|NCT00542906|second somatosensory area|second somatosensory area
721109|NCT00542906|insular cortex|insular cortex
721110|NCT00542906|functional anatomy|functional anatomy
721111|NCT00542893|bcl-2|bcl-2
721112|NCT00542893|CFR|cfr
721113|NCT00542893|DTIC|dtic
721114|NCT00542893|ECOG|ecog
721115|NCT00542893|EMEA|emea
721116|NCT00542893|MedDRA|meddra
721117|NCT00542893|NCI CTC|nci ctc
721118|NCT00542893|SAE|sae
721119|NCT00542880|COPD|copd
721120|NCT00542880|Symbicort|symbicort
721121|NCT00542880|Seretide|seretide
721122|NCT00542867|Hypercholesterolemia|hypercholesterolemia
721123|NCT00542867|Third Joint European Task Force guidelines|third joint european task force guidelines
721124|NCT00542867|Survey|survey
721125|NCT00542854|arrhythmia|arrhythmia
721126|NCT00542854|pacemaker|pacemaker
721127|NCT00542854|defibrillator|defibrillator
721128|NCT00542854|electromagnetic interference|electromagnetic interference
721129|NCT00542841|Adrenal Hyperplasia, Congenital|adrenal hyperplasia, congenital
721130|NCT00542841|Steroid Biosynthesis Disorders|steroid biosynthesis disorders
721131|NCT00542815|Chronic Kidney Disease|chronic kidney disease
721132|NCT00542815|Dialysis|dialysis
721133|NCT00542815|Hyperphosphatemia|hyperphosphatemia
721134|NCT00542802|post stroke epileptic late onset seizures|post stroke epileptic late onset seizures
721135|NCT00542789|gastrointestinal|gastrointestinal
721136|NCT00542789|GI|gi
721137|NCT00542789|NSAID|nsaid
721138|NCT00542789|Japan|japan
721139|NCT00542789|Japanese|japanese
721140|NCT00542789|Gastric ulcer|gastric ulcer
721141|NCT00542789|duodenal ulcer|duodenal ulcer
721142|NCT00542776|inflammatory bowel disease (IBD)|inflammatory bowel disease (ibd)
721143|NCT00542776|immunosuppressed or non-immunosuppressed|immunosuppressed or non-immunosuppressed
721144|NCT00542776|influenza vaccine|influenza vaccine
721145|NCT00542776|antibody titers|antibody titers
721146|NCT00542776|seroprotective titers|seroprotective titers
721147|NCT00542776|vaccine-associated adverse events|vaccine-associated adverse events
721148|NCT00542763|Sjogren's syndrome|sjogren's syndrome
721149|NCT00542763|Mycophenolate sodium|mycophenolate sodium
721150|NCT00542750|Cannabis|cannabis
721151|NCT00542750|Marijuana|marijuana
721152|NCT00542750|Pharmacotherapy|pharmacotherapy
721153|NCT00542750|Adolescent|adolescent
721154|NCT00542737|Acute Lung Injury|acute lung injury
721155|NCT00542737|Acute Respiratory Distress Syndrome|acute respiratory distress syndrome
721156|NCT00542737|Acute Respiratory Failure|acute respiratory failure
721157|NCT00542737|Web-Based Intervention|web-based intervention
721158|NCT00542737|Lung Preventive Ventilation|lung preventive ventilation
721159|NCT00542724|Insulin|insulin
721160|NCT00542724|Diabetes Mellitus type I|diabetes mellitus type i
721161|NCT00542724|Juvenile diabetes|juvenile diabetes
721162|NCT00542711|Curcumin|curcumin
721163|NCT00542711|Bioavilability|bioavilability
721164|NCT00542711|Healthy subjects|healthy subjects
721165|NCT00542698|Type 2 Diabetes Mellitus|type 2 diabetes mellitus
721166|NCT00542698|Glucose Monitor graphs|glucose monitor graphs
721167|NCT00542698|Physical Activity|physical activity
721168|NCT00542672|Mexican American|mexican american
721169|NCT00542672|Dietary Intake|dietary intake
721170|NCT00542672|Child-Feeding Practices|child-feeding practices
721171|NCT00542672|Weight|weight
721172|NCT00542672|Cultural Values|cultural values
721173|NCT00542659|Atrial fibrillation|atrial fibrillation
721174|NCT00542659|Maze procedure|maze procedure
721175|NCT00542633|Diabetes mellitus type 2|diabetes mellitus type 2
721176|NCT00542633|Diabetes|diabetes
721177|NCT00542633|Insulin|insulin
721178|NCT00542633|NIDDM|niddm
721179|NCT00542633|Rapid acting|rapid acting
721180|NCT00542607|Levocetirizine dihydrochloride|levocetirizine dihydrochloride
721181|NCT00542607|Xyzal tablets|xyzal tablets
721182|NCT00542594|breast cancer|breast cancer
721183|NCT00542594|anastrozole|anastrozole
721184|NCT00542581|Visual Outcomes|visual outcomes
721185|NCT00542581|Patient Satisfaction|patient satisfaction
721186|NCT00542581|Ophthalmology|ophthalmology
721746|NCT00539877|Irinotecan|irinotecan
721187|NCT00542581|Cataractous Lens|cataractous lens
721188|NCT00542542|Breast Cancer|breast cancer
721189|NCT00542542|Reconstructive Surgery|reconstructive surgery
721190|NCT00542542|Paravertebral Block|paravertebral block
721191|NCT00542542|Anesthesia|anesthesia
721192|NCT00542542|Propofol|propofol
721193|NCT00542542|Fentanyl|fentanyl
721194|NCT00542542|Ropivacaine|ropivacaine
721195|NCT00542542|Midazolam|midazolam
721196|NCT00542529|Healthy Subjects|healthy subjects
721197|NCT00542516|Hip Replacement Arthroplasty|hip replacement arthroplasty
721198|NCT00542516|Hydroxyethyl Starch|hydroxyethyl starch
721199|NCT00542516|Hemodilution|hemodilution
721200|NCT00542516|Hetastarch|hetastarch
721201|NCT00542516|Colloids|colloids
721202|NCT00542503|Cardiac Outcomes|cardiac outcomes
721204|NCT00542503|Cardiac Stress Testing|cardiac stress testing
721205|NCT00542490|Endometrial cancer|endometrial cancer
721206|NCT00542490|Gynecologic Cancer|gynecologic cancer
721207|NCT00542490|Vaginal Cuff Brachytherapy|vaginal cuff brachytherapy
721208|NCT00542490|Vaginal radiation|vaginal radiation
721209|NCT00542464|Safety in Healthy Adult Subjects|safety in healthy adult subjects
721210|NCT00542451|node-negative breast cancer|node-negative breast cancer
721211|NCT00542451|HER-2 positive|her-2 positive
721212|NCT00542438|Cardiovascular Disease|cardiovascular disease
721213|NCT00542438|Cancer Prevention|cancer prevention
721214|NCT00542438|Physical Activity|physical activity
721215|NCT00542438|Body Composition|body composition
721216|NCT00542438|Environment|environment
721217|NCT00542438|Exercise|exercise
721218|NCT00542425|osteoporosis|osteoporosis
721219|NCT00542425|postmenopausal|postmenopausal
721220|NCT00542425|bone loss|bone loss
721221|NCT00542399|levemir|levemir
721222|NCT00542399|type 1 diabetes|type 1 diabetes
721223|NCT00542386|Chronic Kidney Disease|chronic kidney disease
721224|NCT00542386|Dialysis|dialysis
721225|NCT00542386|Hyperphosphatemia|hyperphosphatemia
721226|NCT00542386|Dyslipidemia|dyslipidemia
721227|NCT00542386|Phosphate binder|phosphate binder
721228|NCT00542360|Accidental Falls|accidental falls
721229|NCT00542360|Aged|aged
721230|NCT00542360|Social Marketing|social marketing
721231|NCT00542360|Exercise|exercise
721232|NCT00542360|Accident Prevention|accident prevention
721233|NCT00542360|Religion|religion
721234|NCT00542360|Randomized Controlled Trial|randomized controlled trial
721235|NCT00542347|gastric acid|gastric acid
721236|NCT00542347|proton pump inhibitors|proton pump inhibitors
721237|NCT00542347|omeprazole|omeprazole
721238|NCT00542347|esomeprazole|esomeprazole
721239|NCT00542334|Nocturnal Hypoglycemia|nocturnal hypoglycemia
721240|NCT00542334|Type 1 diabetes|type 1 diabetes
721241|NCT00542334|Children|children
721242|NCT00542334|Adolescents|adolescents
721243|NCT00542334|CGMS|cgms
721244|NCT00542321|lateral rotation|lateral rotation
721245|NCT00542321|kinetic therapy|kinetic therapy
721246|NCT00542321|mechanical ventilation|mechanical ventilation
721247|NCT00542321|pulmonary complications|pulmonary complications
721248|NCT00542282|lung sounds,|lung sounds,
721249|NCT00542282|airway obstruction,|airway obstruction,
721250|NCT00542282|asthma,|asthma,
721251|NCT00542282|auscultation|auscultation
721252|NCT00542269|Hypertension|hypertension
721253|NCT00542269|Metabolic Syndrome|metabolic syndrome
721254|NCT00542269|Dual combination therapy|dual combination therapy
721255|NCT00542269|Triple combination therapy|triple combination therapy
721256|NCT00542269|Aliskiren|aliskiren
721257|NCT00542269|Direct Renin inhibitor|direct renin inhibitor
721258|NCT00542256|Apoplexy|apoplexy
721259|NCT00542256|Cerebral Stroke|cerebral stroke
721260|NCT00542256|Cerebrovascular Accident, Acute|cerebrovascular accident, acute
721261|NCT00542256|Cerebrovascular Apoplexy|cerebrovascular apoplexy
721262|NCT00542256|Cerebrovascular Stroke|cerebrovascular stroke
721263|NCT00542256|CVA (Cerebrovascular Accident)|cva (cerebrovascular accident)
721264|NCT00542256|Stroke|stroke
721265|NCT00542256|Stroke, Acute|stroke, acute
721266|NCT00542256|Vascular Accident, Brain|vascular accident, brain
721267|NCT00542243|enlarged prostate|enlarged prostate
721268|NCT00542243|finasteride|finasteride
721269|NCT00542230|Erythrocytes|erythrocytes
721270|NCT00542230|Drug Screen|drug screen
721271|NCT00542230|Sickle Cell Trait|sickle cell trait
721272|NCT00542230|Sickle Hemoglobin|sickle hemoglobin
721273|NCT00542230|Sickle Cell Disease|sickle cell disease
721274|NCT00542217|Healthy Volunteers|healthy volunteers
721275|NCT00542204|Diabetes|diabetes
721276|NCT00542204|Blood Glucose Self-Monitoring|blood glucose self-monitoring
721277|NCT00542204|Home Blood Glucose Monitoring|home blood glucose monitoring
721278|NCT00542204|Internet|internet
721279|NCT00542204|Personal Health Record (PHR)|personal health record (phr)
721280|NCT00542204|Health Information Technology (HIT)|health information technology (hit)
721281|NCT00542204|Care management|care management
721282|NCT00542204|Disease Management|disease management
721283|NCT00542204|Diabetes self-management|diabetes self-management
721284|NCT00542204|Consumer Health Information|consumer health information
721285|NCT00542204|Medical Records Systems, Computerized|medical records systems, computerized
721747|NCT00539864|Influenza|influenza
721286|NCT00542204|Computerized Medical Records System|computerized medical records system
721287|NCT00542204|Automated Medical Records System|automated medical records system
721288|NCT00542204|Electronic Health Record (EHR)|electronic health record (ehr)
721289|NCT00542204|Remote patient monitoring|remote patient monitoring
721290|NCT00542191|Triple negative (ER/PR negative; HER2 negative)|triple negative (er/pr negative; her2 negative)
721291|NCT00542178|Type 2 Diabetes Mellitus|type 2 diabetes mellitus
721754|NCT00539825|COPD,|copd,
721292|NCT00542178|Cardiovascular Diseases|cardiovascular diseases
721293|NCT00542152|IBD|ibd
721294|NCT00542152|Ulcerative colitis|ulcerative colitis
721295|NCT00542152|refractory to steroids|refractory to steroids
721296|NCT00542139|Osteoarthritis|osteoarthritis
721297|NCT00542139|Knee arthroplasty|knee arthroplasty
721298|NCT00542139|Steroid injection|steroid injection
721299|NCT00542139|Rehabilitation|rehabilitation
721300|NCT00542126|GnRH analog, IVF, infertility, frozen-thawed embryos|gnrh analog, ivf, infertility, frozen-thawed embryos
721301|NCT00542113|Parental|parental
721302|NCT00542113|Parents|parents
721303|NCT00542113|Prevention|prevention
721304|NCT00542113|Energy balance|energy balance
721305|NCT00542113|Glucose regulation|glucose regulation
721306|NCT00542113|Healthy lifestyles|healthy lifestyles
721307|NCT00542113|Healthy families|healthy families
721308|NCT00542113|Active living|active living
721309|NCT00542074|Bacterial vaginosis|bacterial vaginosis
721310|NCT00542074|recurrence|recurrence
721311|NCT00542074|male factor|male factor
721312|NCT00542061|COPD|copd
721313|NCT00542061|Asthma|asthma
721314|NCT00542061|Lung function|lung function
721315|NCT00542061|Monitoring|monitoring
721316|NCT00542061|Primary Care|primary care
721317|NCT00542048|Hepatic metastases|hepatic metastases
721318|NCT00542048|Angiogenesis|angiogenesis
721319|NCT00542048|EndoTAG-1|endotag-1
721320|NCT00542048|Pharmacokinetics|pharmacokinetics
721321|NCT00542048|Pharmacodynamics|pharmacodynamics
721322|NCT00542048|Metastases of the liver|metastases of the liver
721323|NCT00542035|Analgesia|analgesia
721324|NCT00542009|Phase 2A, safety and efficacy trial with CE-326,597 in patients with T2DM.|phase 2a, safety and efficacy trial with ce-326,597 in patients with t2dm.
721325|NCT00541983|Diabetes|diabetes
721326|NCT00541983|Type 2|type 2
721327|NCT00541983|Mellitus|mellitus
721328|NCT00541970|viral infections|viral infections
721329|NCT00541970|Human Papillomavirus (HPV) vaccine|human papillomavirus (hpv) vaccine
721330|NCT00541970|safety|safety
721331|NCT00541970|vaccine|vaccine
721332|NCT00541970|immunogenicity|immunogenicity
721333|NCT00541970|cervical cancer|cervical cancer
721334|NCT00541957|Major depression|major depression
721335|NCT00541957|Primary care|primary care
721336|NCT00541944|hyponatremia|hyponatremia
721337|NCT00541944|diagnosis and treatment of hyponatremia|diagnosis and treatment of hyponatremia
721338|NCT00541944|classification of hyponatremia|classification of hyponatremia
721339|NCT00541918|sevoflurane,|sevoflurane,
721340|NCT00541918|propofol,|propofol,
721341|NCT00541918|heart surgery,|heart surgery,
721342|NCT00541918|cardiopulmonary bypass,|cardiopulmonary bypass,
721343|NCT00541918|memory disorders,|memory disorders,
721344|NCT00541892|Cell Culture Techniques|cell culture techniques
721345|NCT00541879|Childhood|childhood
721346|NCT00541879|Prevention|prevention
721347|NCT00541879|Energy balance|energy balance
721348|NCT00541879|Glucose regulation|glucose regulation
721349|NCT00541879|Healthy lifestyle|healthy lifestyle
721350|NCT00541879|Healthy eating|healthy eating
721351|NCT00541879|Active living|active living
721352|NCT00541866|Leukemia|leukemia
721353|NCT00541866|Acute Myeloid|acute myeloid
721354|NCT00541866|Relapsed|relapsed
721355|NCT00541866|Refractory|refractory
721356|NCT00541866|Cancer|cancer
721357|NCT00541866|AML|aml
721358|NCT00541866|Cytarabine|cytarabine
721359|NCT00541866|SNS-595|sns-595
721360|NCT00541866|Phase 1|phase 1
721361|NCT00541866|Voreloxin|voreloxin
721362|NCT00541853|Autosomal Dominant Polycystic Kidney Disease|autosomal dominant polycystic kidney disease
721363|NCT00541853|Hypertension|hypertension
721364|NCT00541853|Angiotensin-2 Receptor Blocker|angiotensin-2 receptor blocker
721365|NCT00541853|Calcium Channel Blocker|calcium channel blocker
721366|NCT00541853|Kidney Volume|kidney volume
721367|NCT00541840|Sarcoma|sarcoma
721368|NCT00541840|Sorafenib|sorafenib
721369|NCT00541840|GEIS|geis
721370|NCT00541827|Sepsis. Shock, septic. Mitochondria.|sepsis. shock, septic. mitochondria.
721371|NCT00541814|Renal Transplantation|renal transplantation
721372|NCT00541814|Calcineurin Inhibitor|calcineurin inhibitor
721373|NCT00541814|Cyclosporine|cyclosporine
721374|NCT00541814|Withdrawal|withdrawal
721375|NCT00541814|Minimisation|minimisation
721376|NCT00541762|Neurotensin|neurotensin
721377|NCT00541762|Human|human
721378|NCT00541762|Physiology of neurotensin|physiology of neurotensin
721379|NCT00541762|fat perfusion|fat perfusion
721380|NCT00541762|healthy subjects|healthy subjects
721381|NCT00541749|SLE|sle
721382|NCT00541736|Familial Hemiplegic Migraine|familial hemiplegic migraine
721383|NCT00541710|menopause|menopause
721384|NCT00541710|genistein|genistein
721385|NCT00541710|pre-diabetes|pre-diabetes
721386|NCT00541671|Narcotics|narcotics
721387|NCT00541671|Nausea|nausea
721388|NCT00541619|hypertension|hypertension
721389|NCT00541619|sympathetic activity|sympathetic activity
721390|NCT00541619|early renal damage|early renal damage
721391|NCT00541606|Diabetes Mellitus, Type 2|diabetes mellitus, type 2
721392|NCT00541606|Pharmaceutical Care|pharmaceutical care
721393|NCT00541606|Collaborative Practice|collaborative practice
721394|NCT00541593|Pancreatic pseudocyst|pancreatic pseudocyst
721395|NCT00541593|NOTES|notes
721396|NCT00541567|Wheight management in T2D|wheight management in t2d
721397|NCT00541515|Type 1 diabetes|type 1 diabetes
721398|NCT00541515|Artificial pancreas|artificial pancreas
721399|NCT00541515|Insulin Pump|insulin pump
721400|NCT00541502|evaluate the effectiveness of improving cognitive function of aripiprazole in treating adolescents and young adults with psychotic disorder in Taiwan|evaluate the effectiveness of improving cognitive function of aripiprazole in treating adolescents and young adults with psychotic disorder in taiwan
721401|NCT00541489|Osteoarthritis|osteoarthritis
721402|NCT00541489|Osteoarthritis, Hip|osteoarthritis, hip
721403|NCT00541463|HIV|hiv
721404|NCT00541463|Treatment Experienced|treatment experienced
721405|NCT00541437|Change from baseline of HbA1c after 16 weeks of treatment|change from baseline of hba1c after 16 weeks of treatment
721406|NCT00541437|Change from baseline of FPG after 16 weeks of treatment|change from baseline of fpg after 16 weeks of treatment
721407|NCT00541437|Change from baseline of diabetes self-care scale by patient on drug administration after 16 weeks of treatment|change from baseline of diabetes self-care scale by patient on drug administration after 16 weeks of treatment
721408|NCT00541424|Mantle Cell Lymphoma|mantle cell lymphoma
721409|NCT00541424|Lymphoma|lymphoma
721410|NCT00541424|CT Colonography|ct colonography
721411|NCT00541424|PET Scan|pet scan
721412|NCT00541424|PET/CT Scan|pet/ct scan
721413|NCT00541424|Gas Insufflation|gas insufflation
721414|NCT00541398|Antipsychotic polypharmacy|antipsychotic polypharmacy
721415|NCT00541398|Schizophrenia|schizophrenia
721416|NCT00541398|Implementation of clinical guidelines|implementation of clinical guidelines
721417|NCT00541385|malaria|malaria
721418|NCT00541385|pediatric|pediatric
721419|NCT00541385|Africa|africa
721420|NCT00541385|Phillipines|phillipines
721421|NCT00541385|Coartem|coartem
721422|NCT00541385|Artesunate|artesunate
721423|NCT00541385|lumefantrine|lumefantrine
721424|NCT00541385|Arthemeter|arthemeter
721425|NCT00541385|pyronaridine|pyronaridine
721426|NCT00541385|Pyramax|pyramax
721427|NCT00541346|Autism|autism
721428|NCT00541346|Autism Spectrum Disorders|autism spectrum disorders
721429|NCT00541346|ADHD|adhd
721430|NCT00541333|Dry Age Related Macular Degeneration|dry age related macular degeneration
721431|NCT00541333|Dry AMD|dry amd
721432|NCT00541320|Anti-thrombolytic direct Factor Xa inhibitor|anti-thrombolytic direct factor xa inhibitor
721433|NCT00541307|Peripheral Arterial Disease|peripheral arterial disease
721434|NCT00541307|Peripheral Vascular Disease|peripheral vascular disease
721435|NCT00541294|Tuberculosis|tuberculosis
721436|NCT00541294|HIV|hiv
721437|NCT00541294|Diagnostics|diagnostics
721438|NCT00541294|Pediatrics|pediatrics
721439|NCT00541281|prostate cancer|prostate cancer
721440|NCT00541281|hormone resistant|hormone resistant
721441|NCT00541281|metastatic|metastatic
721442|NCT00541281|estramustine combine to docetaxel|estramustine combine to docetaxel
721443|NCT00541281|randomized study|randomized study
721444|NCT00541268|Heart Failure|heart failure
721445|NCT00541268|ICD|icd
721446|NCT00541268|Dilated cardiomyopathy|dilated cardiomyopathy
721447|NCT00541255|Bronchial Asthma|bronchial asthma
721448|NCT00541255|Food Allergy|food allergy
721449|NCT00541255|Bronchial Hyperresponsiveness|bronchial hyperresponsiveness
721450|NCT00541216|congenital myasthenia|congenital myasthenia
721451|NCT00541216|ephedrine|ephedrine
721452|NCT00541203|tomography|tomography
721453|NCT00541203|coronary artery disease|coronary artery disease
721454|NCT00541203|Stress Test|stress test
721455|NCT00541203|Coronary Angiography|coronary angiography
721456|NCT00541190|cystic fibrosis|cystic fibrosis
721457|NCT00541190|mucociliary clearance|mucociliary clearance
721458|NCT00541190|outcome measures|outcome measures
721459|NCT00541177|prevention myopia|prevention myopia
721460|NCT00541164|CMT|cmt
721461|NCT00541164|Charcot-Marie Tooth|charcot-marie tooth
721462|NCT00541164|CoQ10|coq10
721463|NCT00541164|Coenzyme Q10|coenzyme q10
721464|NCT00541151|Stress urinary incontinence in Women|stress urinary incontinence in women
721465|NCT00541138|tumors metastatic to brain|tumors metastatic to brain
721466|NCT00541138|recurrent adult brain tumor|recurrent adult brain tumor
721467|NCT00541138|adult anaplastic astrocytoma|adult anaplastic astrocytoma
721468|NCT00541138|adult diffuse astrocytoma|adult diffuse astrocytoma
721469|NCT00541138|adult giant cell glioblastoma|adult giant cell glioblastoma
721470|NCT00541138|adult gliosarcoma|adult gliosarcoma
721471|NCT00541138|adult pilocytic astrocytoma|adult pilocytic astrocytoma
721472|NCT00541138|adult pineal gland astrocytoma|adult pineal gland astrocytoma
721473|NCT00541138|adult subependymal giant cell astrocytoma|adult subependymal giant cell astrocytoma
721474|NCT00541138|adult brain stem glioma|adult brain stem glioma
721475|NCT00541138|adult anaplastic ependymoma|adult anaplastic ependymoma
721476|NCT00541138|adult ependymoma|adult ependymoma
721477|NCT00541138|adult myxopapillary ependymoma|adult myxopapillary ependymoma
721478|NCT00541138|adult subependymoma|adult subependymoma
721479|NCT00541138|adult anaplastic oligodendroglioma|adult anaplastic oligodendroglioma
721480|NCT00541138|adult oligodendroglioma|adult oligodendroglioma
721481|NCT00541138|unspecified adult solid tumor, protocol specific|unspecified adult solid tumor, protocol specific
721482|NCT00541138|adult mixed glioma|adult mixed glioma
721483|NCT00541125|recurrent colon cancer|recurrent colon cancer
721484|NCT00541125|stage IV colon cancer|stage iv colon cancer
721485|NCT00541125|recurrent rectal cancer|recurrent rectal cancer
721486|NCT00541125|stage IV rectal cancer|stage iv rectal cancer
721487|NCT00541125|adenocarcinoma of the colon|adenocarcinoma of the colon
721488|NCT00541125|adenocarcinoma of the rectum|adenocarcinoma of the rectum
721489|NCT00541112|stage III rectal cancer|stage iii rectal cancer
721490|NCT00541112|stage IV rectal cancer|stage iv rectal cancer
721491|NCT00541112|adenocarcinoma of the rectum|adenocarcinoma of the rectum
721492|NCT00541099|stage IIIA non-small cell lung cancer|stage iiia non-small cell lung cancer
721493|NCT00541099|stage IIIB non-small cell lung cancer|stage iiib non-small cell lung cancer
721494|NCT00541099|stage IV non-small cell lung cancer|stage iv non-small cell lung cancer
721495|NCT00541086|stage IA breast cancer|stage ia breast cancer
721496|NCT00541086|stage IB breast cancer|stage ib breast cancer
721497|NCT00541086|stage II breast cancer|stage ii breast cancer
721498|NCT00541086|stage IIIA breast cancer|stage iiia breast cancer
721499|NCT00541086|stage IIIB breast cancer|stage iiib breast cancer
721500|NCT00541086|stage IIIC breast cancer|stage iiic breast cancer
721501|NCT00541086|estrogen receptor-positive breast cancer|estrogen receptor-positive breast cancer
721502|NCT00541086|progesterone receptor-positive breast cancer|progesterone receptor-positive breast cancer
721503|NCT00541073|advanced malignant mesothelioma|advanced malignant mesothelioma
721504|NCT00541073|recurrent malignant mesothelioma|recurrent malignant mesothelioma
721505|NCT00541060|caries susceptibility,enamel matrix,candidate genes,mutation|caries susceptibility,enamel matrix,candidate genes,mutation
721506|NCT00541047|sexual dysfunction|sexual dysfunction
721507|NCT00541047|urinary complications|urinary complications
721508|NCT00541047|gastrointestinal complications|gastrointestinal complications
721509|NCT00541047|adenocarcinoma of the prostate|adenocarcinoma of the prostate
721510|NCT00541047|stage I prostate cancer|stage i prostate cancer
721511|NCT00541047|stage IIB prostate cancer|stage iib prostate cancer
721512|NCT00541047|stage IIA prostate cancer|stage iia prostate cancer
721513|NCT00541047|stage III prostate cancer|stage iii prostate cancer
721514|NCT00541034|B-cell chronic lymphocytic leukemia|b-cell chronic lymphocytic leukemia
721515|NCT00541034|stage I small lymphocytic lymphoma|stage i small lymphocytic lymphoma
721516|NCT00541034|stage II small lymphocytic lymphoma|stage ii small lymphocytic lymphoma
721517|NCT00541034|stage III small lymphocytic lymphoma|stage iii small lymphocytic lymphoma
721518|NCT00541034|stage IV small lymphocytic lymphoma|stage iv small lymphocytic lymphoma
721519|NCT00541034|stage I chronic lymphocytic leukemia|stage i chronic lymphocytic leukemia
721520|NCT00541034|stage II chronic lymphocytic leukemia|stage ii chronic lymphocytic leukemia
721521|NCT00541034|stage III chronic lymphocytic leukemia|stage iii chronic lymphocytic leukemia
721522|NCT00541034|stage IV chronic lymphocytic leukemia|stage iv chronic lymphocytic leukemia
721523|NCT00541021|stage III pancreatic cancer|stage iii pancreatic cancer
721524|NCT00541021|stage IV pancreatic cancer|stage iv pancreatic cancer
721525|NCT00541021|adenocarcinoma of the pancreas|adenocarcinoma of the pancreas
721526|NCT00541021|recurrent pancreatic cancer|recurrent pancreatic cancer
721527|NCT00541008|type 1 papillary renal cell carcinoma|type 1 papillary renal cell carcinoma
721528|NCT00541008|type 2 papillary renal cell carcinoma|type 2 papillary renal cell carcinoma
721529|NCT00541008|stage IV renal cell cancer|stage iv renal cell cancer
721530|NCT00541008|stage III renal cell cancer|stage iii renal cell cancer
721531|NCT00540982|unspecified adult solid tumor, protocol specific|unspecified adult solid tumor, protocol specific
721532|NCT00540982|recurrent non-small cell lung cancer|recurrent non-small cell lung cancer
721533|NCT00540982|stage IIIA non-small cell lung cancer|stage iiia non-small cell lung cancer
721534|NCT00540982|stage IIIB non-small cell lung cancer|stage iiib non-small cell lung cancer
721535|NCT00540982|stage IV non-small cell lung cancer|stage iv non-small cell lung cancer
721536|NCT00540969|bone metastases|bone metastases
721538|NCT00540969|unspecified adult solid tumor, protocol specific|unspecified adult solid tumor, protocol specific
721539|NCT00540969|stage IV melanoma|stage iv melanoma
721540|NCT00540969|stage IV renal cell cancer|stage iv renal cell cancer
721541|NCT00540956|untreated adult acute myeloid leukemia|untreated adult acute myeloid leukemia
721542|NCT00540956|adult acute megakaryoblastic leukemia (M7)|adult acute megakaryoblastic leukemia (m7)
721543|NCT00540956|adult acute minimally differentiated myeloid leukemia (M0)|adult acute minimally differentiated myeloid leukemia (m0)
721544|NCT00540956|adult acute monoblastic leukemia (M5a)|adult acute monoblastic leukemia (m5a)
721545|NCT00540956|adult acute monocytic leukemia (M5b)|adult acute monocytic leukemia (m5b)
721546|NCT00540956|adult acute myeloblastic leukemia with maturation (M2)|adult acute myeloblastic leukemia with maturation (m2)
721668|NCT00540254|Chronic Fatigue|chronic fatigue
721547|NCT00540956|adult acute myeloblastic leukemia without maturation (M1)|adult acute myeloblastic leukemia without maturation (m1)
721548|NCT00540956|adult acute myelomonocytic leukemia (M4)|adult acute myelomonocytic leukemia (m4)
721549|NCT00540956|adult erythroleukemia (M6a)|adult erythroleukemia (m6a)
721550|NCT00540956|adult pure erythroid leukemia (M6b)|adult pure erythroid leukemia (m6b)
721551|NCT00540956|adult acute myeloid leukemia with 11q23 (MLL) abnormalities|adult acute myeloid leukemia with 11q23 (mll) abnormalities
721552|NCT00540956|adult acute myeloid leukemia with inv(16)(p13;q22)|adult acute myeloid leukemia with inv(16)(p13;q22)
721647|NCT00540345|peginterferon|peginterferon
721553|NCT00540956|adult acute myeloid leukemia with t(16;16)(p13;q22)|adult acute myeloid leukemia with t(16;16)(p13;q22)
721554|NCT00540956|adult acute myeloid leukemia with t(8;21)(q22;q22)|adult acute myeloid leukemia with t(8;21)(q22;q22)
721555|NCT00540943|cetuximab|cetuximab
721556|NCT00540943|irinotecan,|irinotecan,
721557|NCT00540943|pazopanib,|pazopanib,
721558|NCT00540943|Colorectal cancer,|colorectal cancer,
721559|NCT00540904|contrast|contrast
721560|NCT00540904|nephropathy|nephropathy
721561|NCT00540904|bicarbonate|bicarbonate
721562|NCT00540904|prevention|prevention
721563|NCT00540878|Formulation Drug Study|formulation drug study
721564|NCT00540865|Homebound Persons|homebound persons
721565|NCT00540865|Case Management|case management
721566|NCT00540865|Problem Solving Therapy|problem solving therapy
721567|NCT00540852|Breast cancer receiving chemotherapy|breast cancer receiving chemotherapy
721568|NCT00540813|bifurcation stenosis|bifurcation stenosis
721569|NCT00540813|Patients with documented ischemia due to a de-novo bifurcation stenosis|patients with documented ischemia due to a de-novo bifurcation stenosis
721570|NCT00540800|anthracycline pre-treated|anthracycline pre-treated
721571|NCT00540800|chemotherapy|chemotherapy
721572|NCT00540800|first-line|first-line
721573|NCT00540800|metastatic breast cancer|metastatic breast cancer
721574|NCT00540800|locally advanced breast cancer|locally advanced breast cancer
721575|NCT00540774|oral cancer|oral cancer
721576|NCT00540774|oral mucositis|oral mucositis
721577|NCT00540774|oral stomatitis|oral stomatitis
721578|NCT00540774|Dry mouth|dry mouth
721579|NCT00540774|Gingivitis|gingivitis
721580|NCT00540761|Coronary Artery Disease|coronary artery disease
721581|NCT00540761|Atherosclerosis|atherosclerosis
721582|NCT00540748|first trimester abortion|first trimester abortion
721583|NCT00540748|oxytocin|oxytocin
721584|NCT00540696|Anemia|anemia
721585|NCT00540696|Non-Myeloid Malignancies|non-myeloid malignancies
721586|NCT00540696|darbepoetin alfa|darbepoetin alfa
721587|NCT00540696|chemotherapy|chemotherapy
721588|NCT00540670|Coronary artery disease|coronary artery disease
721589|NCT00540644|Multiple Myeloma|multiple myeloma
721590|NCT00540644|Revlimid|revlimid
721591|NCT00540631|House Dust Mite Allergen|house dust mite allergen
721592|NCT00540631|Aluminium hydroxide-adsorbed|aluminium hydroxide-adsorbed
721593|NCT00540605|Microbicide|microbicide
721594|NCT00540605|Pregnancy|pregnancy
721595|NCT00540605|HIV Seronegativity|hiv seronegativity
721596|NCT00540592|Influenza vaccine GSK576389A|influenza vaccine gsk576389a
721597|NCT00540592|Influenza infection|influenza infection
721598|NCT00540592|Fluarix|fluarix
721599|NCT00540579|Pancreas|pancreas
721600|NCT00540579|Untreated|untreated
721601|NCT00540579|Advanced|advanced
721602|NCT00540579|Gemcitabine|gemcitabine
721603|NCT00540579|CC-4047|cc-4047
721604|NCT00540553|SARM,|sarm,
721605|NCT00540553|FTIH,|ftih,
721606|NCT00540553|pharmacokinetics|pharmacokinetics
721607|NCT00540527|acute ischemic stroke;thrombolysis;intraarterial thrombolysis|acute ischemic stroke;thrombolysis;intraarterial thrombolysis
721608|NCT00540514|Advanced Non-Small Cell Lung Cancer|advanced non-small cell lung cancer
721609|NCT00540501|zanamivir,|zanamivir,
721610|NCT00540501|influenza virus,|influenza virus,
721611|NCT00540501|healthy volunteer,|healthy volunteer,
721612|NCT00540501|PK, drug interaction,|pk, drug interaction,
721613|NCT00540501|IV, and oseltamivir.|iv, and oseltamivir.
721614|NCT00540475|Idiopathic Pulmonary Fibrosis|idiopathic pulmonary fibrosis
721615|NCT00540475|Interstitial Lung Disease|interstitial lung disease
721616|NCT00540462|Type II Diabetes Mellitus|type ii diabetes mellitus
721617|NCT00540462|Gastric bypass|gastric bypass
721618|NCT00540462|Obese-related diabetes mellitus|obese-related diabetes mellitus
721619|NCT00540462|Sugar control|sugar control
721620|NCT00540462|treatment of obesity related diabetes mellitus|treatment of obesity related diabetes mellitus
721621|NCT00540449|TMC278-C209|tmc278-c209
721622|NCT00540449|Antiretroviral|antiretroviral
721623|NCT00540449|Non-nucleoside reverse transcriptase inhibitor|non-nucleoside reverse transcriptase inhibitor
721624|NCT00540449|HIV-1|hiv-1
721625|NCT00540449|AIDS|aids
721626|NCT00540449|TMC278-TiDP6-C209|tmc278-tidp6-c209
721627|NCT00540449|Treatment Naive|treatment naive
721628|NCT00540436|Ambrisentan|ambrisentan
721629|NCT00540436|Pulmonary Arterial Hypertension|pulmonary arterial hypertension
721630|NCT00540436|6MWD|6mwd
721631|NCT00540423|thrombopoietin,|thrombopoietin,
721632|NCT00540423|immunosuppressive therapy,|immunosuppressive therapy,
721633|NCT00540423|eltrombopag,|eltrombopag,
721634|NCT00540423|idiopathic thrombocytopenic purpura,|idiopathic thrombocytopenic purpura,
721635|NCT00540423|blood platelet,|blood platelet,
721636|NCT00540423|splenectomy|splenectomy
721637|NCT00540384|Anemia|anemia
721638|NCT00540384|Solid tumors|solid tumors
721639|NCT00540384|Multicycle chemotherapy|multicycle chemotherapy
721640|NCT00540384|NESP|nesp
721641|NCT00540371|Port Wine Stain|port wine stain
721642|NCT00540358|Triple negative breast cancer|triple negative breast cancer
721643|NCT00540345|chronic hepatitis C|chronic hepatitis c
721644|NCT00540345|genotype 2|genotype 2
721645|NCT00540345|rapid virological response|rapid virological response
721646|NCT00540345|sustained virological response|sustained virological response
721648|NCT00540345|ribavirin|ribavirin
721649|NCT00540345|treatment duration|treatment duration
721650|NCT00540332|Oncology|oncology
721652|NCT00540332|HNC|hnc
721653|NCT00540332|head and neck|head and neck
721654|NCT00540332|oral mucositis|oral mucositis
721655|NCT00540332|OM|om
721656|NCT00540332|proteinurea|proteinurea
721657|NCT00540332|palifermin|palifermin
721658|NCT00540332|clinical trial|clinical trial
721659|NCT00540319|Risky behaviors|risky behaviors
721660|NCT00540319|Prenatal care|prenatal care
721661|NCT00540319|Substance use|substance use
721662|NCT00540319|Domestic violence|domestic violence
721663|NCT00540306|breast tissue|breast tissue
721664|NCT00540280|NSCLC|nsclc
721665|NCT00540267|Schizophrenia|schizophrenia
721666|NCT00540267|Alcohol Abuse|alcohol abuse
721667|NCT00540267|Bone Density|bone density
721669|NCT00540254|Insomnia|insomnia
721670|NCT00540254|Cognitive Behavioral Therapy|cognitive behavioral therapy
721671|NCT00540228|Influenza|influenza
721672|NCT00540228|Influenza Vaccine|influenza vaccine
721673|NCT00540202|Effectiveness|effectiveness
721674|NCT00540202|Oral quinine|oral quinine
721676|NCT00540202|Uncomplicated malaria|uncomplicated malaria
721677|NCT00540202|Children|children
721678|NCT00540189|appendicitis, perforated, children|appendicitis, perforated, children
721679|NCT00540176|Dichloroacetate|dichloroacetate
721680|NCT00540176|Glioblastoma Multiforme|glioblastoma multiforme
721681|NCT00540176|Glioma|glioma
721682|NCT00540150|Immunotherapy|immunotherapy
721683|NCT00540150|Mite|mite
721684|NCT00540150|Asthma|asthma
721685|NCT00540150|bronchial provocation|bronchial provocation
721686|NCT00540150|SIT|sit
721687|NCT00540150|specific immunotherapy|specific immunotherapy
721688|NCT00540137|Antiretroviral therapy|antiretroviral therapy
721689|NCT00540137|Neurocognitive function|neurocognitive function
721690|NCT00540137|Magnetic resonance spectroscopy|magnetic resonance spectroscopy
721691|NCT00540137|HIV disease|hiv disease
721692|NCT00540137|Treatment Naive|treatment naive
721693|NCT00540111|Soluble fiber|soluble fiber
721694|NCT00540111|HIV/aids|hiv/aids
721695|NCT00540111|Hypertriglyceridemia|hypertriglyceridemia
721696|NCT00540111|Cytokines|cytokines
721697|NCT00540111|Alternative Medicine|alternative medicine
721698|NCT00540111|Complementary Medicine|complementary medicine
721699|NCT00540098|panic disorder|panic disorder
721700|NCT00540098|pharmacotherapy|pharmacotherapy
721701|NCT00540098|non-pharmacological treatment|non-pharmacological treatment
721702|NCT00540098|SSRI|ssri
721703|NCT00540098|paroxetine|paroxetine
721704|NCT00540098|exercise|exercise
721705|NCT00540072|Moderate to Severe Community-Acquired Acute Bacterial Pneumonia Due to S. Pneumoniae|moderate to severe community-acquired acute bacterial pneumonia due to s. pneumoniae
721706|NCT00540059|Prostate carcinoma|prostate carcinoma
721707|NCT00540059|LHRH|lhrh
721708|NCT00540059|Zoladex|zoladex
721709|NCT00540046|IUD|iud
721710|NCT00540046|Second trimester termination|second trimester termination
721711|NCT00540046|Contraception|contraception
721712|NCT00540033|probiotics|probiotics
721713|NCT00540033|necrotizing enterocolitis|necrotizing enterocolitis
721714|NCT00540033|preterm very low birth weight infants (VLBW)|preterm very low birth weight infants (vlbw)
721715|NCT00540020|Brain Injuries|brain injuries
721716|NCT00540020|Cognition|cognition
721717|NCT00540020|Randomized Trials|randomized trials
721718|NCT00540020|Rehabilitation|rehabilitation
721719|NCT00540020|Treatment Outcome|treatment outcome
721720|NCT00540007|Hodgkin Lymphoma|hodgkin lymphoma
721721|NCT00540007|Lenalidomide|lenalidomide
721722|NCT00540007|Anti-neoplastic agents|anti-neoplastic agents
721723|NCT00540007|Thalidomide|thalidomide
721724|NCT00539994|Altabax|altabax
721725|NCT00539994|SB-275833|sb-275833
721726|NCT00539994|retapamulin|retapamulin
721727|NCT00539994|nasal colonization|nasal colonization
721728|NCT00539994|PK|pk
721729|NCT00539994|tolerability|tolerability
721730|NCT00539994|safety|safety
721731|NCT00539994|efficacy|efficacy
721732|NCT00539981|Influenza|influenza
721733|NCT00539955|intimate partner violence|intimate partner violence
721734|NCT00539955|alcohol use|alcohol use
721735|NCT00539955|substance use|substance use
721736|NCT00539942|Randomized Clinical Trials|randomized clinical trials
721737|NCT00539942|Randomized Controlled Trial|randomized controlled trial
721738|NCT00539942|Venous thrombosis|venous thrombosis
721739|NCT00539942|Anticoagulant Drugs|anticoagulant drugs
721740|NCT00539942|Doppler Ultrasound|doppler ultrasound
721741|NCT00539942|Postoperative complications|postoperative complications
721742|NCT00539903|Activity Level|activity level
721743|NCT00539877|Gstric cancer|gstric cancer
721744|NCT00539877|Pritoneal seeding|pritoneal seeding
721745|NCT00539877|Intraperitoneal chemotherapy|intraperitoneal chemotherapy
721748|NCT00539851|Allogenic Stem Cell Transplantation|allogenic stem cell transplantation
721749|NCT00539851|Diabetes Mellitus|diabetes mellitus
721750|NCT00539838|SLE|sle
721751|NCT00539825|Anticholinergic,|anticholinergic,
721752|NCT00539825|Plethysmography|plethysmography
721753|NCT00539825|Muscarinic Receptor Antagonist,|muscarinic receptor antagonist,
721755|NCT00539825|FTIH,|ftih,
721756|NCT00539812|Intimate partner violence|intimate partner violence
721757|NCT00539812|alcohol use|alcohol use
721758|NCT00539812|substance use|substance use
721759|NCT00539799|systemic lupus erythematosus|systemic lupus erythematosus
721760|NCT00539799|lupus nephritis|lupus nephritis
721761|NCT00539786|Patients with extraesophageal manifestation of gastroesophageal reflux disease|patients with extraesophageal manifestation of gastroesophageal reflux disease
721762|NCT00539760|domain antibody|domain antibody
721763|NCT00539760|Rheumatoid Arthritis,|rheumatoid arthritis,
721764|NCT00539747|Presymptomatic|presymptomatic
721765|NCT00539747|Huntington Disease|huntington disease
721766|NCT00539747|Meaning Making|meaning making
721767|NCT00539747|Genetic Testing|genetic testing
721769|NCT00539734|age-related macular degeneration (AMD)|age-related macular degeneration (amd)
721770|NCT00539734|choroidal neovascularization membrane(CNVM)|choroidal neovascularization membrane(cnvm)
721771|NCT00539734|ranibizumab|ranibizumab
721772|NCT00539734|anti-vascular endothelial growth factor|anti-vascular endothelial growth factor
721773|NCT00539734|electrophysiology|electrophysiology
721774|NCT00539734|electroretinography|electroretinography
721775|NCT00539721|Nausea|nausea
721776|NCT00539721|Vomiting|vomiting
721777|NCT00539708|Non-invasive ventilation|non-invasive ventilation
721778|NCT00539708|Hypercapnic respiratory failure|hypercapnic respiratory failure
721779|NCT00539708|Mechanical ventilation|mechanical ventilation
721780|NCT00539708|Respiratory failure after extubation|respiratory failure after extubation
721781|NCT00539695|Stem Cell transplant|stem cell transplant
721782|NCT00539695|Graft verus host disease|graft verus host disease
721783|NCT00539695|IL-2|il-2
721784|NCT00539695|acute lymphoblastic leukemia|acute lymphoblastic leukemia
721785|NCT00539695|ALL|all
721786|NCT00539695|acute myelogenous leukemia|acute myelogenous leukemia
721787|NCT00539695|AML|aml
721788|NCT00539695|chronic myelogenous leukemia|chronic myelogenous leukemia
721789|NCT00539695|myelodysplastic syndrome|myelodysplastic syndrome
721790|NCT00539695|myeloproliferative disorder|myeloproliferative disorder
721791|NCT00539695|Hodgkin lymphoma|hodgkin lymphoma
721792|NCT00539695|non-Hodgkin lymphoma|non-hodgkin lymphoma
721793|NCT00539695|non-malignant diseases requiring allogeneic HSCT|non-malignant diseases requiring allogeneic hsct
721794|NCT00539656|Cord blood stem cell transplantation|cord blood stem cell transplantation
721795|NCT00539656|Ex vivo expansion|ex vivo expansion
721796|NCT00539656|Alternative donor|alternative donor
721797|NCT00539643|Liver Cancer|liver cancer
721798|NCT00539643|Hepatoma|hepatoma
721799|NCT00539643|07-099|07-099
721800|NCT00539617|metastatic esophageal cancer|metastatic esophageal cancer
721801|NCT00539617|erlotinib|erlotinib
721802|NCT00539617|folfox|folfox
721803|NCT00539617|advanced esophageal cancer|advanced esophageal cancer
721804|NCT00539617|unresectable esophageal cancer|unresectable esophageal cancer
721805|NCT00539604|Comparison study between MDCT and coronary angiography|comparison study between mdct and coronary angiography
721806|NCT00539591|Cutaneous Melanoma|cutaneous melanoma
721807|NCT00539565|biliary atresia|biliary atresia
721808|NCT00539565|Kasai portoenterostomy|kasai portoenterostomy
721809|NCT00539565|corticosteroids|corticosteroids
721810|NCT00539513|obsessive-compulsive disorder|obsessive-compulsive disorder
721811|NCT00539513|OCD|ocd
721812|NCT00539513|glutamate|glutamate
721813|NCT00539513|N-Acetylcysteine|n-acetylcysteine
721814|NCT00539513|augmentation|augmentation
721815|NCT00539500|Neuroblastoma|neuroblastoma
721816|NCT00539500|ClinicMACS|clinicmacs
721817|NCT00539500|CliniMACS|clinimacs
721818|NCT00539500|Stem Cell Transplantation|stem cell transplantation
721819|NCT00539500|Blood And Marrow Transplantation|blood and marrow transplantation
721820|NCT00539500|Pediatric|pediatric
721821|NCT00539500|Solid Tumors|solid tumors
721822|NCT00539500|Carboplatin|carboplatin
721823|NCT00539500|Paraplatin|paraplatin
721824|NCT00539500|Etoposide|etoposide
721825|NCT00539500|VePesid|vepesid
721826|NCT00539500|Melphalan|melphalan
721827|NCT00539500|Alkeran|alkeran
721828|NCT00539500|CD133+ Cells|cd133+ cells
721829|NCT00539474|ROLL trial|roll trial
721830|NCT00539474|Minimally invasive surgery|minimally invasive surgery
721831|NCT00539474|Non palpable breast cancer|non palpable breast cancer
721832|NCT00539435|Diabetes Mellitus|diabetes mellitus
721833|NCT00539435|Pulsatile Intravenous Insulin Therapy|pulsatile intravenous insulin therapy
721834|NCT00539435|Diabetic Cardiac Quality of Life|diabetic cardiac quality of life
721835|NCT00539435|Cardiac Disease|cardiac disease
721836|NCT00539422|breast cancer|breast cancer
721837|NCT00539422|cytochrome 450|cytochrome 450
721838|NCT00539422|CYP2D6*4|cyp2d6*4
721839|NCT00539422|Ferritin|ferritin
721840|NCT00539422|oxidative stress|oxidative stress
721841|NCT00539422|cancer|cancer
721842|NCT00539422|cancer breast|cancer breast
721843|NCT00539409|Diabetes Mellitus|diabetes mellitus
721844|NCT00539409|Pulsatile Intravenous Insulin Therapy|pulsatile intravenous insulin therapy
721845|NCT00539409|Diabetic Quality of Life|diabetic quality of life
721846|NCT00539409|Orthostatic Hypotension|orthostatic hypotension
721847|NCT00539409|Brittle or Labile diabetes|brittle or labile diabetes
721848|NCT00539383|Lung cancer|lung cancer
721849|NCT00539383|Breast cancer|breast cancer
721850|NCT00539383|Melanoma|melanoma
721851|NCT00539383|Hepatocellular carcinoma|hepatocellular carcinoma
721852|NCT00539383|Brain metastases|brain metastases
721853|NCT00539370|Scleritis|scleritis
721854|NCT00539370|Intermediate Uveitis|intermediate uveitis
721855|NCT00539370|Posterior Uveitis|posterior uveitis
721856|NCT00539370|Intraocular Inflammatory Disease|intraocular inflammatory disease
721857|NCT00539370|Data Analysis|data analysis
721858|NCT00539370|Data Collection|data collection
721859|NCT00539370|Sample Analysis|sample analysis
721860|NCT00539357|Cranial Electrostimulation Therapy|cranial electrostimulation therapy
721861|NCT00539344|Glioblastoma multiforme|glioblastoma multiforme
721862|NCT00539344|Anaplastic astrocytoma|anaplastic astrocytoma
721863|NCT00539344|Anaplastic oligodendroglioma|anaplastic oligodendroglioma
721864|NCT00539331|Non-small Cell Lung Cancer|non-small cell lung cancer
721865|NCT00539331|NSCLC|nsclc
721866|NCT00539331|AZD2171|azd2171
721867|NCT00539331|Paclitaxel/Carboplatin|paclitaxel/carboplatin
721868|NCT00539331|Non-small Cell Lung Cancer (NSCLC)|non-small cell lung cancer (nsclc)
721869|NCT00539305|selective androgen receptor modulators (SARMs)|selective androgen receptor modulators (sarms)
721870|NCT00539305|hormone replacement therapy|hormone replacement therapy
721871|NCT00539305|age-associated cognitive decline|age-associated cognitive decline
721872|NCT00539305|testosterone supplementation|testosterone supplementation
721873|NCT00539292|pediatrics|pediatrics
721874|NCT00539292|gastroschisis|gastroschisis
721875|NCT00539292|silastic spring-loaded silo|silastic spring-loaded silo
721876|NCT00539279|Cognitive- Behavior Therapy|cognitive- behavior therapy
721877|NCT00539279|Combat Disorders|combat disorders
721878|NCT00539279|Elderly|elderly
721879|NCT00539279|Geriatrics|geriatrics
721880|NCT00539279|Implosive therapy|implosive therapy
721881|NCT00539279|Neuropsychological Test|neuropsychological test
721882|NCT00539279|Post-traumatic Stress Disorder|post-traumatic stress disorder
721883|NCT00539279|Psychotherapy|psychotherapy
721884|NCT00539279|Randomized Controlled Trial|randomized controlled trial
721885|NCT00539279|Relaxation techniques|relaxation techniques
721886|NCT00539266|Claudication|claudication
721887|NCT00539266|Critical limb ischemia|critical limb ischemia
721888|NCT00539266|Cell therapy|cell therapy
721889|NCT00539266|Bone marrow|bone marrow
721890|NCT00539253|liver cancer|liver cancer
721891|NCT00539253|transarterial chemoembolization|transarterial chemoembolization
721892|NCT00539240|acid reflux|acid reflux
721893|NCT00539240|acid regurgitation|acid regurgitation
721894|NCT00539240|esophagitis|esophagitis
721895|NCT00539240|GERD|gerd
721896|NCT00539240|heartburn|heartburn
721897|NCT00539240|pain|pain
721898|NCT00539240|peptic|peptic
721899|NCT00539227|Breast Cancer|breast cancer
721900|NCT00539227|Nipple-Areolar Complex|nipple-areolar complex
721901|NCT00539227|Mastectomy|mastectomy
721902|NCT00539227|Prophylactic mastectomy|prophylactic mastectomy
721903|NCT00539227|Immediate reconstruction|immediate reconstruction
721904|NCT00539227|Reconstructive surgery|reconstructive surgery
721905|NCT00539227|Questionnaire|questionnaire
721906|NCT00539227|Survey|survey
721907|NCT00539227|NAC|nac
721908|NCT00539201|GSK706769,|gsk706769,
721909|NCT00539201|CCR5 inhibitor,|ccr5 inhibitor,
721910|NCT00539201|HIV|hiv
721911|NCT00539188|Borderline Personality Disorder(BPD)|borderline personality disorder(bpd)
721912|NCT00539188|Dialectical Behavioral Therapy (DBT)|dialectical behavioral therapy (dbt)
721913|NCT00539188|glutamate|glutamate
721914|NCT00539188|N-Acetylcysteine|n-acetylcysteine
721915|NCT00539188|Borderline Personality Disorder with Self-Injurious Behavior|borderline personality disorder with self-injurious behavior
721916|NCT00539175|diabetes mellitus|diabetes mellitus
721917|NCT00539175|neuropathy|neuropathy
721918|NCT00539175|diabetic neuropathy|diabetic neuropathy
721919|NCT00539162|Ovarian Cancer|ovarian cancer
721920|NCT00539162|CA 125 Algorithm|ca 125 algorithm
721921|NCT00539162|Cancer Detection|cancer detection
721922|NCT00539162|Questionnaire|questionnaire
721923|NCT00539162|Survey|survey
721924|NCT00539149|Acute otitis media|acute otitis media
721925|NCT00539149|Otitis media with effusion|otitis media with effusion
721926|NCT00539149|Tympanic membrane perforation|tympanic membrane perforation
721927|NCT00539136|GSK561679,|gsk561679,
721928|NCT00539136|Pharmacokinetic,|pharmacokinetic,
721929|NCT00539136|healthy volunteers,|healthy volunteers,
721930|NCT00539136|Gamma Scintigraphy,|gamma scintigraphy,
721931|NCT00539136|PillCam™,|pillcam™,
721932|NCT00539136|acoustic vest|acoustic vest
721933|NCT00539123|buprenorphine|buprenorphine
721934|NCT00539123|drug counseling|drug counseling
721935|NCT00539123|HIV risk reduction counseling|hiv risk reduction counseling
721936|NCT00539097|pediatrics|pediatrics
721937|NCT00539084|microneedles|microneedles
721938|NCT00539084|microneedle|microneedle
721939|NCT00539084|intradermal|intradermal
721940|NCT00539071|schizophrenia|schizophrenia
721941|NCT00539071|schizoaffective disorder|schizoaffective disorder
721942|NCT00539071|long acting injectable|long acting injectable
721943|NCT00539071|treatment resistant|treatment resistant
722967|NCT00536692|Comentis|comentis
721944|NCT00539045|myocardial infarction, thrombus|myocardial infarction, thrombus
721945|NCT00539032|N. meningitidis|n. meningitidis
721946|NCT00539032|Meningitis|meningitis
721947|NCT00539032|Meningococcemia|meningococcemia
721948|NCT00539019|nutrition assessment|nutrition assessment
721949|NCT00539019|pediatric|pediatric
721950|NCT00539006|fluticasone propionate|fluticasone propionate
721951|NCT00539006|seasonal allergic rhinitis|seasonal allergic rhinitis
721952|NCT00539006|fluticasone furoate|fluticasone furoate
721953|NCT00539006|experience|experience
721954|NCT00539006|GW685698X|gw685698x
721955|NCT00539006|preference|preference
721956|NCT00538980|Polycythemia Vera|polycythemia vera
721957|NCT00538980|PV|pv
721958|NCT00538980|P Vera|p vera
721959|NCT00538967|Collagenases|collagenases
721960|NCT00538967|MMP|mmp
721961|NCT00538967|Cathepsins|cathepsins
721962|NCT00538967|Doxycycline|doxycycline
721963|NCT00538967|Aneurysm|aneurysm
721964|NCT00538954|Perioperative|perioperative
721965|NCT00538954|recovery|recovery
721966|NCT00538954|nutrition|nutrition
721967|NCT00538954|enhanced|enhanced
721968|NCT00538954|laxative|laxative
721969|NCT00538941|chocolate,|chocolate,
721970|NCT00538941|heart failure,|heart failure,
721971|NCT00538941|endothelial function,|endothelial function,
721972|NCT00538941|platelet adhesion,|platelet adhesion,
721973|NCT00538941|oxidative stress,|oxidative stress,
721974|NCT00538941|baroreceptor function,|baroreceptor function,
721975|NCT00538928|acute respiratory distress syndrome|acute respiratory distress syndrome
721976|NCT00538928|extracorporeal lung support|extracorporeal lung support
721977|NCT00538928|hypoxia|hypoxia
721978|NCT00538928|hypercapnia|hypercapnia
721979|NCT00538928|acute respiratory distress syndrome (ARDS)|acute respiratory distress syndrome (ards)
721980|NCT00538915|immunodeficiency|immunodeficiency
721981|NCT00538915|humoral immunity|humoral immunity
721982|NCT00538915|antibody deficiency|antibody deficiency
721983|NCT00538915|PID|pid
721984|NCT00538915|PIDD|pidd
721985|NCT00538902|Humira, methotrexate|humira, methotrexate
721986|NCT00538889|Adult|adult
721987|NCT00538850|unspecified adult solid tumor, protocol specific|unspecified adult solid tumor, protocol specific
721988|NCT00538850|pain|pain
721989|NCT00538850|adult acute myeloid leukemia with 11q23 (MLL) abnormalities|adult acute myeloid leukemia with 11q23 (mll) abnormalities
721990|NCT00538850|adult acute myeloid leukemia with inv(16)(p13;q22)|adult acute myeloid leukemia with inv(16)(p13;q22)
721991|NCT00538850|adult acute myeloid leukemia with t(15;17)(q22;q12)|adult acute myeloid leukemia with t(15;17)(q22;q12)
721992|NCT00538850|adult acute myeloid leukemia with t(16;16)(p13;q22)|adult acute myeloid leukemia with t(16;16)(p13;q22)
721993|NCT00538850|adult acute myeloid leukemia with t(8;21)(q22;q22)|adult acute myeloid leukemia with t(8;21)(q22;q22)
721994|NCT00538850|stage IV chronic lymphocytic leukemia|stage iv chronic lymphocytic leukemia
721995|NCT00538850|accelerated phase chronic myelogenous leukemia|accelerated phase chronic myelogenous leukemia
721996|NCT00538850|blastic phase chronic myelogenous leukemia|blastic phase chronic myelogenous leukemia
721997|NCT00538850|chronic myelomonocytic leukemia|chronic myelomonocytic leukemia
721998|NCT00538850|chronic phase chronic myelogenous leukemia|chronic phase chronic myelogenous leukemia
721999|NCT00538850|noncontiguous stage II adult Burkitt lymphoma|noncontiguous stage ii adult burkitt lymphoma
722000|NCT00538850|noncontiguous stage II adult diffuse large cell lymphoma|noncontiguous stage ii adult diffuse large cell lymphoma
722001|NCT00538850|noncontiguous stage II adult diffuse mixed cell lymphoma|noncontiguous stage ii adult diffuse mixed cell lymphoma
722002|NCT00538850|noncontiguous stage II adult diffuse small cleaved cell lymphoma|noncontiguous stage ii adult diffuse small cleaved cell lymphoma
722003|NCT00538850|noncontiguous stage II adult immunoblastic large cell lymphoma|noncontiguous stage ii adult immunoblastic large cell lymphoma
722004|NCT00538850|noncontiguous stage II adult lymphoblastic lymphoma|noncontiguous stage ii adult lymphoblastic lymphoma
722005|NCT00538850|noncontiguous stage II small lymphocytic lymphoma|noncontiguous stage ii small lymphocytic lymphoma
722006|NCT00538850|noncontiguous stage II marginal zone lymphoma|noncontiguous stage ii marginal zone lymphoma
722007|NCT00538850|noncontiguous stage II grade 1 follicular lymphoma|noncontiguous stage ii grade 1 follicular lymphoma
722008|NCT00538850|noncontiguous stage II grade 2 follicular lymphoma|noncontiguous stage ii grade 2 follicular lymphoma
722009|NCT00538850|noncontiguous stage II grade 3 follicular lymphoma|noncontiguous stage ii grade 3 follicular lymphoma
722010|NCT00538850|noncontiguous stage II mantle cell lymphoma|noncontiguous stage ii mantle cell lymphoma
722011|NCT00538850|stage III adult Burkitt lymphoma|stage iii adult burkitt lymphoma
722012|NCT00538850|stage III adult diffuse large cell lymphoma|stage iii adult diffuse large cell lymphoma
722013|NCT00538850|stage III adult diffuse mixed cell lymphoma|stage iii adult diffuse mixed cell lymphoma
722014|NCT00538850|stage III adult diffuse small cleaved cell lymphoma|stage iii adult diffuse small cleaved cell lymphoma
722015|NCT00538850|stage III adult immunoblastic large cell lymphoma|stage iii adult immunoblastic large cell lymphoma
722016|NCT00538850|stage III adult lymphoblastic lymphoma|stage iii adult lymphoblastic lymphoma
722017|NCT00538850|stage III small lymphocytic lymphoma|stage iii small lymphocytic lymphoma
722018|NCT00538850|stage III marginal zone lymphoma|stage iii marginal zone lymphoma
722019|NCT00538850|stage III grade 1 follicular lymphoma|stage iii grade 1 follicular lymphoma
722020|NCT00538850|stage III grade 2 follicular lymphoma|stage iii grade 2 follicular lymphoma
722262|NCT00538850|adult grade III meningioma|adult grade iii meningioma
722021|NCT00538850|stage III grade 3 follicular lymphoma|stage iii grade 3 follicular lymphoma
722022|NCT00538850|stage III mantle cell lymphoma|stage iii mantle cell lymphoma
722023|NCT00538850|stage IV adult Burkitt lymphoma|stage iv adult burkitt lymphoma
722399|NCT00538850|chondrosarcoma|chondrosarcoma
722024|NCT00538850|stage IV adult diffuse large cell lymphoma|stage iv adult diffuse large cell lymphoma
722025|NCT00538850|stage IV adult diffuse mixed cell lymphoma|stage iv adult diffuse mixed cell lymphoma
722026|NCT00538850|stage IV adult diffuse small cleaved cell lymphoma|stage iv adult diffuse small cleaved cell lymphoma
722027|NCT00538850|stage IV adult immunoblastic large cell lymphoma|stage iv adult immunoblastic large cell lymphoma
722028|NCT00538850|stage IV adult lymphoblastic lymphoma|stage iv adult lymphoblastic lymphoma
722029|NCT00538850|stage IV small lymphocytic lymphoma|stage iv small lymphocytic lymphoma
722030|NCT00538850|stage IV marginal zone lymphoma|stage iv marginal zone lymphoma
722031|NCT00538850|stage IV grade 1 follicular lymphoma|stage iv grade 1 follicular lymphoma
722032|NCT00538850|stage IV grade 2 follicular lymphoma|stage iv grade 2 follicular lymphoma
722033|NCT00538850|stage IV grade 3 follicular lymphoma|stage iv grade 3 follicular lymphoma
722034|NCT00538850|stage IV mantle cell lymphoma|stage iv mantle cell lymphoma
722035|NCT00538850|recurrent adult Burkitt lymphoma|recurrent adult burkitt lymphoma
722036|NCT00538850|recurrent adult diffuse large cell lymphoma|recurrent adult diffuse large cell lymphoma
722037|NCT00538850|recurrent adult diffuse mixed cell lymphoma|recurrent adult diffuse mixed cell lymphoma
722038|NCT00538850|recurrent adult diffuse small cleaved cell lymphoma|recurrent adult diffuse small cleaved cell lymphoma
722039|NCT00538850|recurrent adult Hodgkin lymphoma|recurrent adult hodgkin lymphoma
722040|NCT00538850|recurrent adult immunoblastic large cell lymphoma|recurrent adult immunoblastic large cell lymphoma
722041|NCT00538850|recurrent adult lymphoblastic lymphoma|recurrent adult lymphoblastic lymphoma
722042|NCT00538850|recurrent cutaneous T-cell non-Hodgkin lymphoma|recurrent cutaneous t-cell non-hodgkin lymphoma
722043|NCT00538850|recurrent small lymphocytic lymphoma|recurrent small lymphocytic lymphoma
722044|NCT00538850|recurrent marginal zone lymphoma|recurrent marginal zone lymphoma
722045|NCT00538850|recurrent grade 1 follicular lymphoma|recurrent grade 1 follicular lymphoma
722046|NCT00538850|recurrent grade 2 follicular lymphoma|recurrent grade 2 follicular lymphoma
722047|NCT00538850|recurrent grade 3 follicular lymphoma|recurrent grade 3 follicular lymphoma
722048|NCT00538850|recurrent mantle cell lymphoma|recurrent mantle cell lymphoma
722049|NCT00538850|recurrent mycosis fungoides/Sezary syndrome|recurrent mycosis fungoides/sezary syndrome
722050|NCT00538850|stage I multiple myeloma|stage i multiple myeloma
722051|NCT00538850|stage II multiple myeloma|stage ii multiple myeloma
722052|NCT00538850|stage III multiple myeloma|stage iii multiple myeloma
722053|NCT00538850|de novo myelodysplastic syndromes|de novo myelodysplastic syndromes
722054|NCT00538850|myelodysplastic/myeloproliferative neoplasm, unclassifiable|myelodysplastic/myeloproliferative neoplasm, unclassifiable
722055|NCT00538850|previously treated myelodysplastic syndromes|previously treated myelodysplastic syndromes
722056|NCT00538850|secondary myelodysplastic syndromes|secondary myelodysplastic syndromes
722057|NCT00538850|atypical chronic myeloid leukemia, BCR-ABL1 negative|atypical chronic myeloid leukemia, bcr-abl1 negative
722058|NCT00538850|stage II adult Hodgkin lymphoma|stage ii adult hodgkin lymphoma
722059|NCT00538850|stage III adult Hodgkin lymphoma|stage iii adult hodgkin lymphoma
722060|NCT00538850|stage IV adult Hodgkin lymphoma|stage iv adult hodgkin lymphoma
722061|NCT00538850|contiguous stage II adult Burkitt lymphoma|contiguous stage ii adult burkitt lymphoma
722062|NCT00538850|stage I adult Burkitt lymphoma|stage i adult burkitt lymphoma
722063|NCT00538850|contiguous stage II adult diffuse large cell lymphoma|contiguous stage ii adult diffuse large cell lymphoma
722064|NCT00538850|contiguous stage II adult diffuse mixed cell lymphoma|contiguous stage ii adult diffuse mixed cell lymphoma
722065|NCT00538850|contiguous stage II adult diffuse small cleaved cell lymphoma|contiguous stage ii adult diffuse small cleaved cell lymphoma
722066|NCT00538850|contiguous stage II small lymphocytic lymphoma|contiguous stage ii small lymphocytic lymphoma
722067|NCT00538850|contiguous stage II marginal zone lymphoma|contiguous stage ii marginal zone lymphoma
722068|NCT00538850|stage I adult diffuse large cell lymphoma|stage i adult diffuse large cell lymphoma
722069|NCT00538850|stage I adult diffuse mixed cell lymphoma|stage i adult diffuse mixed cell lymphoma
722070|NCT00538850|stage I adult diffuse small cleaved cell lymphoma|stage i adult diffuse small cleaved cell lymphoma
722071|NCT00538850|stage I small lymphocytic lymphoma|stage i small lymphocytic lymphoma
722072|NCT00538850|stage I marginal zone lymphoma|stage i marginal zone lymphoma
722073|NCT00538850|contiguous stage II grade 1 follicular lymphoma|contiguous stage ii grade 1 follicular lymphoma
722074|NCT00538850|contiguous stage II grade 2 follicular lymphoma|contiguous stage ii grade 2 follicular lymphoma
722075|NCT00538850|contiguous stage II grade 3 follicular lymphoma|contiguous stage ii grade 3 follicular lymphoma
722076|NCT00538850|stage I grade 1 follicular lymphoma|stage i grade 1 follicular lymphoma
722077|NCT00538850|stage I grade 2 follicular lymphoma|stage i grade 2 follicular lymphoma
722078|NCT00538850|stage I grade 3 follicular lymphoma|stage i grade 3 follicular lymphoma
722079|NCT00538850|contiguous stage II mantle cell lymphoma|contiguous stage ii mantle cell lymphoma
722080|NCT00538850|stage I mantle cell lymphoma|stage i mantle cell lymphoma
722081|NCT00538850|contiguous stage II adult immunoblastic large cell lymphoma|contiguous stage ii adult immunoblastic large cell lymphoma
722082|NCT00538850|stage I adult immunoblastic large cell lymphoma|stage i adult immunoblastic large cell lymphoma
722083|NCT00538850|contiguous stage II adult lymphoblastic lymphoma|contiguous stage ii adult lymphoblastic lymphoma
722084|NCT00538850|stage I adult lymphoblastic lymphoma|stage i adult lymphoblastic lymphoma
722085|NCT00538850|refractory multiple myeloma|refractory multiple myeloma
722086|NCT00538850|anaplastic large cell lymphoma|anaplastic large cell lymphoma
722087|NCT00538850|angioimmunoblastic T-cell lymphoma|angioimmunoblastic t-cell lymphoma
722088|NCT00538850|recurrent adult T-cell leukemia/lymphoma|recurrent adult t-cell leukemia/lymphoma
722089|NCT00538850|stage I adult T-cell leukemia/lymphoma|stage i adult t-cell leukemia/lymphoma
722090|NCT00538850|stage II adult T-cell leukemia/lymphoma|stage ii adult t-cell leukemia/lymphoma
722091|NCT00538850|stage III adult T-cell leukemia/lymphoma|stage iii adult t-cell leukemia/lymphoma
722092|NCT00538850|stage IV adult T-cell leukemia/lymphoma|stage iv adult t-cell leukemia/lymphoma
722093|NCT00538850|stage I cutaneous T-cell non-Hodgkin lymphoma|stage i cutaneous t-cell non-hodgkin lymphoma
722094|NCT00538850|stage II cutaneous T-cell non-Hodgkin lymphoma|stage ii cutaneous t-cell non-hodgkin lymphoma
722095|NCT00538850|stage III cutaneous T-cell non-Hodgkin lymphoma|stage iii cutaneous t-cell non-hodgkin lymphoma
722096|NCT00538850|stage IV cutaneous T-cell non-Hodgkin lymphoma|stage iv cutaneous t-cell non-hodgkin lymphoma
722097|NCT00538850|stage I mycosis fungoides/Sezary syndrome|stage i mycosis fungoides/sezary syndrome
722098|NCT00538850|stage II mycosis fungoides/Sezary syndrome|stage ii mycosis fungoides/sezary syndrome
722099|NCT00538850|stage III mycosis fungoides/Sezary syndrome|stage iii mycosis fungoides/sezary syndrome
722100|NCT00538850|stage IV mycosis fungoides/Sezary syndrome|stage iv mycosis fungoides/sezary syndrome
722101|NCT00538850|chronic eosinophilic leukemia|chronic eosinophilic leukemia
722102|NCT00538850|primary myelofibrosis|primary myelofibrosis
722103|NCT00538850|chronic neutrophilic leukemia|chronic neutrophilic leukemia
722104|NCT00538850|essential thrombocythemia|essential thrombocythemia
722105|NCT00538850|polycythemia vera|polycythemia vera
722106|NCT00538850|relapsing chronic myelogenous leukemia|relapsing chronic myelogenous leukemia
722107|NCT00538850|T-cell large granular lymphocyte leukemia|t-cell large granular lymphocyte leukemia
722108|NCT00538850|recurrent adult acute lymphoblastic leukemia|recurrent adult acute lymphoblastic leukemia
722109|NCT00538850|recurrent adult acute myeloid leukemia|recurrent adult acute myeloid leukemia
722110|NCT00538850|untreated adult acute lymphoblastic leukemia|untreated adult acute lymphoblastic leukemia
722111|NCT00538850|untreated adult acute myeloid leukemia|untreated adult acute myeloid leukemia
722112|NCT00538850|secondary acute myeloid leukemia|secondary acute myeloid leukemia
722113|NCT00538850|acute undifferentiated leukemia|acute undifferentiated leukemia
722114|NCT00538850|refractory chronic lymphocytic leukemia|refractory chronic lymphocytic leukemia
722115|NCT00538850|stage 0 chronic lymphocytic leukemia|stage 0 chronic lymphocytic leukemia
722116|NCT00538850|stage I chronic lymphocytic leukemia|stage i chronic lymphocytic leukemia
722513|NCT00538655|modafinil|modafinil
722117|NCT00538850|stage II chronic lymphocytic leukemia|stage ii chronic lymphocytic leukemia
722118|NCT00538850|stage III chronic lymphocytic leukemia|stage iii chronic lymphocytic leukemia
722119|NCT00538850|refractory hairy cell leukemia|refractory hairy cell leukemia
722120|NCT00538850|progressive hairy cell leukemia, initial treatment|progressive hairy cell leukemia, initial treatment
722121|NCT00538850|prolymphocytic leukemia|prolymphocytic leukemia
722122|NCT00538850|recurrent adult grade III lymphomatoid granulomatosis|recurrent adult grade iii lymphomatoid granulomatosis
722123|NCT00538850|Waldenström macroglobulinemia|waldenström macroglobulinemia
722124|NCT00538850|extranodal marginal zone B-cell lymphoma of mucosa-associated lymphoid tissue|extranodal marginal zone b-cell lymphoma of mucosa-associated lymphoid tissue
722125|NCT00538850|nodal marginal zone B-cell lymphoma|nodal marginal zone b-cell lymphoma
722126|NCT00538850|splenic marginal zone lymphoma|splenic marginal zone lymphoma
722127|NCT00538850|post-transplant lymphoproliferative disorder|post-transplant lymphoproliferative disorder
722128|NCT00538850|extramedullary plasmacytoma|extramedullary plasmacytoma
722129|NCT00538850|isolated plasmacytoma of bone|isolated plasmacytoma of bone
722130|NCT00538850|monoclonal gammopathy of undetermined significance|monoclonal gammopathy of undetermined significance
722131|NCT00538850|primary systemic amyloidosis|primary systemic amyloidosis
722132|NCT00538850|adult acute lymphoblastic leukemia in remission|adult acute lymphoblastic leukemia in remission
722133|NCT00538850|adult acute myeloid leukemia in remission|adult acute myeloid leukemia in remission
722134|NCT00538850|adult grade III lymphomatoid granulomatosis|adult grade iii lymphomatoid granulomatosis
722135|NCT00538850|AIDS-related peripheral/systemic lymphoma|aids-related peripheral/systemic lymphoma
722136|NCT00538850|AIDS-related primary CNS lymphoma|aids-related primary cns lymphoma
722137|NCT00538850|intraocular lymphoma|intraocular lymphoma
722138|NCT00538850|meningeal chronic myelogenous leukemia|meningeal chronic myelogenous leukemia
722139|NCT00538850|primary central nervous system non-Hodgkin lymphoma|primary central nervous system non-hodgkin lymphoma
722140|NCT00538850|primary central nervous system Hodgkin lymphoma|primary central nervous system hodgkin lymphoma
722141|NCT00538850|stage I adult Hodgkin lymphoma|stage i adult hodgkin lymphoma
722142|NCT00538850|recurrent squamous cell carcinoma of the hypopharynx|recurrent squamous cell carcinoma of the hypopharynx
722143|NCT00538850|stage I squamous cell carcinoma of the hypopharynx|stage i squamous cell carcinoma of the hypopharynx
722256|NCT00538850|adult ependymoblastoma|adult ependymoblastoma
722144|NCT00538850|stage II squamous cell carcinoma of the hypopharynx|stage ii squamous cell carcinoma of the hypopharynx
722145|NCT00538850|stage III squamous cell carcinoma of the hypopharynx|stage iii squamous cell carcinoma of the hypopharynx
722146|NCT00538850|stage IV squamous cell carcinoma of the hypopharynx|stage iv squamous cell carcinoma of the hypopharynx
722147|NCT00538850|recurrent squamous cell carcinoma of the larynx|recurrent squamous cell carcinoma of the larynx
722148|NCT00538850|recurrent verrucous carcinoma of the larynx|recurrent verrucous carcinoma of the larynx
722149|NCT00538850|stage I squamous cell carcinoma of the larynx|stage i squamous cell carcinoma of the larynx
722150|NCT00538850|stage I verrucous carcinoma of the larynx|stage i verrucous carcinoma of the larynx
722151|NCT00538850|stage II squamous cell carcinoma of the larynx|stage ii squamous cell carcinoma of the larynx
722152|NCT00538850|stage II verrucous carcinoma of the larynx|stage ii verrucous carcinoma of the larynx
722153|NCT00538850|stage III squamous cell carcinoma of the larynx|stage iii squamous cell carcinoma of the larynx
722154|NCT00538850|stage III verrucous carcinoma of the larynx|stage iii verrucous carcinoma of the larynx
722155|NCT00538850|stage IV squamous cell carcinoma of the larynx|stage iv squamous cell carcinoma of the larynx
722156|NCT00538850|stage IV verrucous carcinoma of the larynx|stage iv verrucous carcinoma of the larynx
722157|NCT00538850|recurrent adenoid cystic carcinoma of the oral cavity|recurrent adenoid cystic carcinoma of the oral cavity
722158|NCT00538850|recurrent mucoepidermoid carcinoma of the oral cavity|recurrent mucoepidermoid carcinoma of the oral cavity
722159|NCT00538850|recurrent verrucous carcinoma of the oral cavity|recurrent verrucous carcinoma of the oral cavity
722160|NCT00538850|stage I adenoid cystic carcinoma of the oral cavity|stage i adenoid cystic carcinoma of the oral cavity
722161|NCT00538850|stage I mucoepidermoid carcinoma of the oral cavity|stage i mucoepidermoid carcinoma of the oral cavity
722162|NCT00538850|stage I verrucous carcinoma of the oral cavity|stage i verrucous carcinoma of the oral cavity
722163|NCT00538850|stage II adenoid cystic carcinoma of the oral cavity|stage ii adenoid cystic carcinoma of the oral cavity
722164|NCT00538850|stage II mucoepidermoid carcinoma of the oral cavity|stage ii mucoepidermoid carcinoma of the oral cavity
722165|NCT00538850|stage II verrucous carcinoma of the oral cavity|stage ii verrucous carcinoma of the oral cavity
722166|NCT00538850|stage III adenoid cystic carcinoma of the oral cavity|stage iii adenoid cystic carcinoma of the oral cavity
722167|NCT00538850|stage III mucoepidermoid carcinoma of the oral cavity|stage iii mucoepidermoid carcinoma of the oral cavity
722168|NCT00538850|stage III verrucous carcinoma of the oral cavity|stage iii verrucous carcinoma of the oral cavity
722169|NCT00538850|stage IV adenoid cystic carcinoma of the oral cavity|stage iv adenoid cystic carcinoma of the oral cavity
722170|NCT00538850|stage IV mucoepidermoid carcinoma of the oral cavity|stage iv mucoepidermoid carcinoma of the oral cavity
722171|NCT00538850|stage IV verrucous carcinoma of the oral cavity|stage iv verrucous carcinoma of the oral cavity
722172|NCT00538850|stage I squamous cell carcinoma of the lip and oral cavity|stage i squamous cell carcinoma of the lip and oral cavity
722173|NCT00538850|stage II squamous cell carcinoma of the lip and oral cavity|stage ii squamous cell carcinoma of the lip and oral cavity
722174|NCT00538850|stage III squamous cell carcinoma of the lip and oral cavity|stage iii squamous cell carcinoma of the lip and oral cavity
722175|NCT00538850|stage IV squamous cell carcinoma of the lip and oral cavity|stage iv squamous cell carcinoma of the lip and oral cavity
722176|NCT00538850|recurrent basal cell carcinoma of the lip|recurrent basal cell carcinoma of the lip
722177|NCT00538850|recurrent squamous cell carcinoma of the lip and oral cavity|recurrent squamous cell carcinoma of the lip and oral cavity
722178|NCT00538850|stage I basal cell carcinoma of the lip|stage i basal cell carcinoma of the lip
722179|NCT00538850|stage II basal cell carcinoma of the lip|stage ii basal cell carcinoma of the lip
722180|NCT00538850|stage III basal cell carcinoma of the lip|stage iii basal cell carcinoma of the lip
722181|NCT00538850|stage IV basal cell carcinoma of the lip|stage iv basal cell carcinoma of the lip
722182|NCT00538850|metastatic squamous neck cancer with occult primary squamous cell carcinoma|metastatic squamous neck cancer with occult primary squamous cell carcinoma
722183|NCT00538850|recurrent metastatic squamous neck cancer with occult primary|recurrent metastatic squamous neck cancer with occult primary
722184|NCT00538850|untreated metastatic squamous neck cancer with occult primary|untreated metastatic squamous neck cancer with occult primary
722185|NCT00538850|recurrent lymphoepithelioma of the nasopharynx|recurrent lymphoepithelioma of the nasopharynx
722186|NCT00538850|recurrent squamous cell carcinoma of the nasopharynx|recurrent squamous cell carcinoma of the nasopharynx
722187|NCT00538850|stage I lymphoepithelioma of the nasopharynx|stage i lymphoepithelioma of the nasopharynx
722188|NCT00538850|stage I squamous cell carcinoma of the nasopharynx|stage i squamous cell carcinoma of the nasopharynx
722189|NCT00538850|stage II lymphoepithelioma of the nasopharynx|stage ii lymphoepithelioma of the nasopharynx
722190|NCT00538850|stage II squamous cell carcinoma of the nasopharynx|stage ii squamous cell carcinoma of the nasopharynx
722191|NCT00538850|stage III lymphoepithelioma of the nasopharynx|stage iii lymphoepithelioma of the nasopharynx
722192|NCT00538850|stage III squamous cell carcinoma of the nasopharynx|stage iii squamous cell carcinoma of the nasopharynx
722193|NCT00538850|stage IV lymphoepithelioma of the nasopharynx|stage iv lymphoepithelioma of the nasopharynx
722194|NCT00538850|stage IV squamous cell carcinoma of the nasopharynx|stage iv squamous cell carcinoma of the nasopharynx
722195|NCT00538850|recurrent lymphoepithelioma of the oropharynx|recurrent lymphoepithelioma of the oropharynx
722196|NCT00538850|recurrent squamous cell carcinoma of the oropharynx|recurrent squamous cell carcinoma of the oropharynx
722197|NCT00538850|stage I lymphoepithelioma of the oropharynx|stage i lymphoepithelioma of the oropharynx
722198|NCT00538850|stage I squamous cell carcinoma of the oropharynx|stage i squamous cell carcinoma of the oropharynx
722199|NCT00538850|stage II lymphoepithelioma of the oropharynx|stage ii lymphoepithelioma of the oropharynx
722200|NCT00538850|stage II squamous cell carcinoma of the oropharynx|stage ii squamous cell carcinoma of the oropharynx
722201|NCT00538850|stage III lymphoepithelioma of the oropharynx|stage iii lymphoepithelioma of the oropharynx
722202|NCT00538850|stage III squamous cell carcinoma of the oropharynx|stage iii squamous cell carcinoma of the oropharynx
722203|NCT00538850|stage IV lymphoepithelioma of the oropharynx|stage iv lymphoepithelioma of the oropharynx
722204|NCT00538850|stage IV squamous cell carcinoma of the oropharynx|stage iv squamous cell carcinoma of the oropharynx
722205|NCT00538850|recurrent esthesioneuroblastoma of the paranasal sinus and nasal cavity|recurrent esthesioneuroblastoma of the paranasal sinus and nasal cavity
722206|NCT00538850|recurrent inverted papilloma of the paranasal sinus and nasal cavity|recurrent inverted papilloma of the paranasal sinus and nasal cavity
722207|NCT00538850|recurrent midline lethal granuloma of the paranasal sinus and nasal cavity|recurrent midline lethal granuloma of the paranasal sinus and nasal cavity
722208|NCT00538850|recurrent squamous cell carcinoma of the paranasal sinus and nasal cavity|recurrent squamous cell carcinoma of the paranasal sinus and nasal cavity
722209|NCT00538850|stage I esthesioneuroblastoma of the paranasal sinus and nasal cavity|stage i esthesioneuroblastoma of the paranasal sinus and nasal cavity
722210|NCT00538850|stage I inverted papilloma of the paranasal sinus and nasal cavity|stage i inverted papilloma of the paranasal sinus and nasal cavity
722211|NCT00538850|stage I midline lethal granuloma of the paranasal sinus and nasal cavity|stage i midline lethal granuloma of the paranasal sinus and nasal cavity
722212|NCT00538850|stage I squamous cell carcinoma of the paranasal sinus and nasal cavity|stage i squamous cell carcinoma of the paranasal sinus and nasal cavity
722213|NCT00538850|stage II esthesioneuroblastoma of the paranasal sinus and nasal cavity|stage ii esthesioneuroblastoma of the paranasal sinus and nasal cavity
722214|NCT00538850|stage II inverted papilloma of the paranasal sinus and nasal cavity|stage ii inverted papilloma of the paranasal sinus and nasal cavity
722215|NCT00538850|stage II midline lethal granuloma of the paranasal sinus and nasal cavity|stage ii midline lethal granuloma of the paranasal sinus and nasal cavity
722216|NCT00538850|stage II squamous cell carcinoma of the paranasal sinus and nasal cavity|stage ii squamous cell carcinoma of the paranasal sinus and nasal cavity
722217|NCT00538850|stage III esthesioneuroblastoma of the paranasal sinus and nasal cavity|stage iii esthesioneuroblastoma of the paranasal sinus and nasal cavity
722218|NCT00538850|stage III inverted papilloma of the paranasal sinus and nasal cavity|stage iii inverted papilloma of the paranasal sinus and nasal cavity
722219|NCT00538850|stage III midline lethal granuloma of the paranasal sinus and nasal cavity|stage iii midline lethal granuloma of the paranasal sinus and nasal cavity
722220|NCT00538850|stage III squamous cell carcinoma of the paranasal sinus and nasal cavity|stage iii squamous cell carcinoma of the paranasal sinus and nasal cavity
722221|NCT00538850|stage IV esthesioneuroblastoma of the paranasal sinus and nasal cavity|stage iv esthesioneuroblastoma of the paranasal sinus and nasal cavity
722222|NCT00538850|stage IV inverted papilloma of the paranasal sinus and nasal cavity|stage iv inverted papilloma of the paranasal sinus and nasal cavity
722223|NCT00538850|stage IV midline lethal granuloma of the paranasal sinus and nasal cavity|stage iv midline lethal granuloma of the paranasal sinus and nasal cavity
722224|NCT00538850|stage IV squamous cell carcinoma of the paranasal sinus and nasal cavity|stage iv squamous cell carcinoma of the paranasal sinus and nasal cavity
722225|NCT00538850|high-grade salivary gland mucoepidermoid carcinoma|high-grade salivary gland mucoepidermoid carcinoma
722226|NCT00538850|low-grade salivary gland mucoepidermoid carcinoma|low-grade salivary gland mucoepidermoid carcinoma
722227|NCT00538850|recurrent salivary gland cancer|recurrent salivary gland cancer
722228|NCT00538850|salivary gland acinic cell tumor|salivary gland acinic cell tumor
722229|NCT00538850|salivary gland adenocarcinoma|salivary gland adenocarcinoma
722230|NCT00538850|salivary gland adenoid cystic carcinoma|salivary gland adenoid cystic carcinoma
722231|NCT00538850|salivary gland anaplastic carcinoma|salivary gland anaplastic carcinoma
722232|NCT00538850|salivary gland malignant mixed cell type tumor|salivary gland malignant mixed cell type tumor
722233|NCT00538850|salivary gland poorly differentiated carcinoma|salivary gland poorly differentiated carcinoma
722234|NCT00538850|salivary gland squamous cell carcinoma|salivary gland squamous cell carcinoma
722235|NCT00538850|stage I salivary gland cancer|stage i salivary gland cancer
722236|NCT00538850|stage II salivary gland cancer|stage ii salivary gland cancer
722237|NCT00538850|stage III salivary gland cancer|stage iii salivary gland cancer
722238|NCT00538850|stage IV salivary gland cancer|stage iv salivary gland cancer
722239|NCT00538850|adult grade I meningioma|adult grade i meningioma
722240|NCT00538850|adult choroid plexus tumor|adult choroid plexus tumor
722241|NCT00538850|adult craniopharyngioma|adult craniopharyngioma
722242|NCT00538850|adult myxopapillary ependymoma|adult myxopapillary ependymoma
722243|NCT00538850|adult diffuse astrocytoma|adult diffuse astrocytoma
722244|NCT00538850|adult pilocytic astrocytoma|adult pilocytic astrocytoma
722245|NCT00538850|adult pineocytoma|adult pineocytoma
722246|NCT00538850|adult ependymoma|adult ependymoma
722247|NCT00538850|adult subependymoma|adult subependymoma
722248|NCT00538850|adult oligodendroglioma|adult oligodendroglioma
722249|NCT00538850|adult subependymal giant cell astrocytoma|adult subependymal giant cell astrocytoma
722250|NCT00538850|meningeal melanocytoma|meningeal melanocytoma
722251|NCT00538850|adult meningeal hemangiopericytoma|adult meningeal hemangiopericytoma
722252|NCT00538850|adult pineal gland astrocytoma|adult pineal gland astrocytoma
722253|NCT00538850|adult central nervous system germ cell tumor|adult central nervous system germ cell tumor
722254|NCT00538850|adult medulloblastoma|adult medulloblastoma
722255|NCT00538850|adult supratentorial primitive neuroectodermal tumor (PNET)|adult supratentorial primitive neuroectodermal tumor (pnet)
722257|NCT00538850|adult anaplastic astrocytoma|adult anaplastic astrocytoma
722258|NCT00538850|adult anaplastic ependymoma|adult anaplastic ependymoma
722259|NCT00538850|adult glioblastoma|adult glioblastoma
722260|NCT00538850|adult gliosarcoma|adult gliosarcoma
722261|NCT00538850|adult giant cell glioblastoma|adult giant cell glioblastoma
722263|NCT00538850|adult anaplastic oligodendroglioma|adult anaplastic oligodendroglioma
722264|NCT00538850|adult pineoblastoma|adult pineoblastoma
722265|NCT00538850|adult mixed glioma|adult mixed glioma
722266|NCT00538850|recurrent adult brain tumor|recurrent adult brain tumor
722267|NCT00538850|adult anaplastic meningioma|adult anaplastic meningioma
722268|NCT00538850|adult papillary meningioma|adult papillary meningioma
722269|NCT00538850|adult brain stem glioma|adult brain stem glioma
722270|NCT00538850|stage IA cervical cancer|stage ia cervical cancer
722271|NCT00538850|stage IB cervical cancer|stage ib cervical cancer
722272|NCT00538850|stage IIA cervical cancer|stage iia cervical cancer
722273|NCT00538850|stage IIB cervical cancer|stage iib cervical cancer
722274|NCT00538850|stage III cervical cancer|stage iii cervical cancer
722275|NCT00538850|stage IVA cervical cancer|stage iva cervical cancer
722276|NCT00538850|stage IVB cervical cancer|stage ivb cervical cancer
722277|NCT00538850|recurrent cervical cancer|recurrent cervical cancer
722278|NCT00538850|recurrent endometrial carcinoma|recurrent endometrial carcinoma
722279|NCT00538850|stage I endometrial carcinoma|stage i endometrial carcinoma
722280|NCT00538850|stage II endometrial carcinoma|stage ii endometrial carcinoma
722281|NCT00538850|stage III endometrial carcinoma|stage iii endometrial carcinoma
722282|NCT00538850|stage IV endometrial carcinoma|stage iv endometrial carcinoma
722283|NCT00538850|fallopian tube cancer|fallopian tube cancer
722284|NCT00538850|recurrent ovarian epithelial cancer|recurrent ovarian epithelial cancer
722285|NCT00538850|recurrent ovarian germ cell tumor|recurrent ovarian germ cell tumor
722286|NCT00538850|stage I ovarian epithelial cancer|stage i ovarian epithelial cancer
722287|NCT00538850|stage I ovarian germ cell tumor|stage i ovarian germ cell tumor
722288|NCT00538850|stage II ovarian epithelial cancer|stage ii ovarian epithelial cancer
722289|NCT00538850|stage II ovarian germ cell tumor|stage ii ovarian germ cell tumor
722290|NCT00538850|stage III ovarian epithelial cancer|stage iii ovarian epithelial cancer
722291|NCT00538850|stage III ovarian germ cell tumor|stage iii ovarian germ cell tumor
722292|NCT00538850|stage IV ovarian epithelial cancer|stage iv ovarian epithelial cancer
722293|NCT00538850|stage IV ovarian germ cell tumor|stage iv ovarian germ cell tumor
722294|NCT00538850|ovarian sarcoma|ovarian sarcoma
722295|NCT00538850|ovarian stromal cancer|ovarian stromal cancer
722296|NCT00538850|recurrent uterine sarcoma|recurrent uterine sarcoma
722297|NCT00538850|stage I uterine sarcoma|stage i uterine sarcoma
722298|NCT00538850|stage II uterine sarcoma|stage ii uterine sarcoma
722299|NCT00538850|stage III uterine sarcoma|stage iii uterine sarcoma
722300|NCT00538850|stage IV uterine sarcoma|stage iv uterine sarcoma
722301|NCT00538850|recurrent colon cancer|recurrent colon cancer
722302|NCT00538850|stage I colon cancer|stage i colon cancer
722303|NCT00538850|stage II colon cancer|stage ii colon cancer
722304|NCT00538850|stage III colon cancer|stage iii colon cancer
722305|NCT00538850|stage IV colon cancer|stage iv colon cancer
722306|NCT00538850|recurrent bladder cancer|recurrent bladder cancer
722307|NCT00538850|recurrent gallbladder cancer|recurrent gallbladder cancer
722308|NCT00538850|stage I bladder cancer|stage i bladder cancer
722309|NCT00538850|stage II bladder cancer|stage ii bladder cancer
722310|NCT00538850|stage III bladder cancer|stage iii bladder cancer
722311|NCT00538850|stage IV bladder cancer|stage iv bladder cancer
722312|NCT00538850|recurrent gastric cancer|recurrent gastric cancer
722313|NCT00538850|stage I gastric cancer|stage i gastric cancer
722314|NCT00538850|stage II gastric cancer|stage ii gastric cancer
722315|NCT00538850|stage III gastric cancer|stage iii gastric cancer
722316|NCT00538850|stage IV gastric cancer|stage iv gastric cancer
722317|NCT00538850|advanced adult primary liver cancer|advanced adult primary liver cancer
722318|NCT00538850|recurrent small intestine cancer|recurrent small intestine cancer
722319|NCT00538850|localized transitional cell cancer of the renal pelvis and ureter|localized transitional cell cancer of the renal pelvis and ureter
722320|NCT00538850|metastatic transitional cell cancer of the renal pelvis and ureter|metastatic transitional cell cancer of the renal pelvis and ureter
722321|NCT00538850|recurrent renal cell cancer|recurrent renal cell cancer
722322|NCT00538850|recurrent transitional cell cancer of the renal pelvis and ureter|recurrent transitional cell cancer of the renal pelvis and ureter
722323|NCT00538850|regional transitional cell cancer of the renal pelvis and ureter|regional transitional cell cancer of the renal pelvis and ureter
722324|NCT00538850|stage I renal cell cancer|stage i renal cell cancer
722325|NCT00538850|stage II renal cell cancer|stage ii renal cell cancer
722326|NCT00538850|stage III renal cell cancer|stage iii renal cell cancer
722327|NCT00538850|stage IV renal cell cancer|stage iv renal cell cancer
722328|NCT00538850|distal urethral cancer|distal urethral cancer
722329|NCT00538850|proximal urethral cancer|proximal urethral cancer
722330|NCT00538850|recurrent urethral cancer|recurrent urethral cancer
722331|NCT00538850|urethral cancer associated with invasive bladder cancer|urethral cancer associated with invasive bladder cancer
722332|NCT00538850|stage I adrenocortical carcinoma|stage i adrenocortical carcinoma
722333|NCT00538850|stage II adrenocortical carcinoma|stage ii adrenocortical carcinoma
722594|NCT00538291|recurrent rectal cancer|recurrent rectal cancer
722334|NCT00538850|stage III adrenocortical carcinoma|stage iii adrenocortical carcinoma
722335|NCT00538850|stage IV adrenocortical carcinoma|stage iv adrenocortical carcinoma
722336|NCT00538850|recurrent adrenocortical carcinoma|recurrent adrenocortical carcinoma
722337|NCT00538850|extragonadal germ cell tumor|extragonadal germ cell tumor
722338|NCT00538850|localized gastrointestinal carcinoid tumor|localized gastrointestinal carcinoid tumor
722339|NCT00538850|metastatic gastrointestinal carcinoid tumor|metastatic gastrointestinal carcinoid tumor
722340|NCT00538850|recurrent gastrointestinal carcinoid tumor|recurrent gastrointestinal carcinoid tumor
722341|NCT00538850|regional gastrointestinal carcinoid tumor|regional gastrointestinal carcinoid tumor
722342|NCT00538850|gastrinoma|gastrinoma
722343|NCT00538850|insulinoma|insulinoma
722344|NCT00538850|WDHA syndrome|wdha syndrome
722345|NCT00538850|glucagonoma|glucagonoma
722346|NCT00538850|pancreatic polypeptide tumor|pancreatic polypeptide tumor
722347|NCT00538850|somatostatinoma|somatostatinoma
722348|NCT00538850|recurrent islet cell carcinoma|recurrent islet cell carcinoma
722349|NCT00538850|carcinoma of the appendix|carcinoma of the appendix
722350|NCT00538850|localized extrahepatic bile duct cancer|localized extrahepatic bile duct cancer
722351|NCT00538850|recurrent extrahepatic bile duct cancer|recurrent extrahepatic bile duct cancer
722352|NCT00538850|unresectable extrahepatic bile duct cancer|unresectable extrahepatic bile duct cancer
722353|NCT00538850|localized gallbladder cancer|localized gallbladder cancer
722354|NCT00538850|unresectable gallbladder cancer|unresectable gallbladder cancer
722355|NCT00538850|gastrointestinal stromal tumor|gastrointestinal stromal tumor
722356|NCT00538850|localized resectable adult primary liver cancer|localized resectable adult primary liver cancer
722357|NCT00538850|localized unresectable adult primary liver cancer|localized unresectable adult primary liver cancer
722358|NCT00538850|recurrent adult primary liver cancer|recurrent adult primary liver cancer
722359|NCT00538850|stage I pancreatic cancer|stage i pancreatic cancer
722360|NCT00538850|stage II pancreatic cancer|stage ii pancreatic cancer
722361|NCT00538850|stage III pancreatic cancer|stage iii pancreatic cancer
722362|NCT00538850|stage IV pancreatic cancer|stage iv pancreatic cancer
722363|NCT00538850|recurrent pancreatic cancer|recurrent pancreatic cancer
722364|NCT00538850|small intestine adenocarcinoma|small intestine adenocarcinoma
722365|NCT00538850|small intestine leiomyosarcoma|small intestine leiomyosarcoma
722366|NCT00538850|small intestine lymphoma|small intestine lymphoma
722367|NCT00538850|stage I non-small cell lung cancer|stage i non-small cell lung cancer
722368|NCT00538850|stage II non-small cell lung cancer|stage ii non-small cell lung cancer
722369|NCT00538850|stage IIIA non-small cell lung cancer|stage iiia non-small cell lung cancer
722370|NCT00538850|stage IIIB non-small cell lung cancer|stage iiib non-small cell lung cancer
722371|NCT00538850|stage IV non-small cell lung cancer|stage iv non-small cell lung cancer
722372|NCT00538850|recurrent non-small cell lung cancer|recurrent non-small cell lung cancer
722373|NCT00538850|pulmonary carcinoid tumor|pulmonary carcinoid tumor
722374|NCT00538850|extensive stage small cell lung cancer|extensive stage small cell lung cancer
722375|NCT00538850|limited stage small cell lung cancer|limited stage small cell lung cancer
722376|NCT00538850|recurrent small cell lung cancer|recurrent small cell lung cancer
722377|NCT00538850|liver metastases|liver metastases
722378|NCT00538850|lung metastases|lung metastases
722379|NCT00538850|primary peritoneal cavity cancer|primary peritoneal cavity cancer
722380|NCT00538850|lung papilloma|lung papilloma
722381|NCT00538850|peripheral primitive neuroectodermal tumor of the kidney|peripheral primitive neuroectodermal tumor of the kidney
722382|NCT00538850|clear cell sarcoma of the kidney|clear cell sarcoma of the kidney
722383|NCT00538850|rhabdoid tumor of the kidney|rhabdoid tumor of the kidney
722384|NCT00538850|congenital mesoblastic nephroma|congenital mesoblastic nephroma
722385|NCT00538850|stage II breast cancer|stage ii breast cancer
722386|NCT00538850|stage IIIA breast cancer|stage iiia breast cancer
722387|NCT00538850|stage IIIB breast cancer|stage iiib breast cancer
722388|NCT00538850|stage IIIC breast cancer|stage iiic breast cancer
722389|NCT00538850|stage IV breast cancer|stage iv breast cancer
722390|NCT00538850|recurrent breast cancer|recurrent breast cancer
722391|NCT00538850|male breast cancer|male breast cancer
722392|NCT00538850|breast cancer in situ|breast cancer in situ
722393|NCT00538850|localized osteosarcoma|localized osteosarcoma
722394|NCT00538850|metastatic osteosarcoma|metastatic osteosarcoma
722395|NCT00538850|recurrent osteosarcoma|recurrent osteosarcoma
722396|NCT00538850|localized Ewing sarcoma/peripheral primitive neuroectodermal tumor|localized ewing sarcoma/peripheral primitive neuroectodermal tumor
722397|NCT00538850|metastatic Ewing sarcoma/peripheral primitive neuroectodermal tumor|metastatic ewing sarcoma/peripheral primitive neuroectodermal tumor
722398|NCT00538850|recurrent Ewing sarcoma/peripheral primitive neuroectodermal tumor|recurrent ewing sarcoma/peripheral primitive neuroectodermal tumor
722400|NCT00538850|malignant giant cell tumor of bone|malignant giant cell tumor of bone
722401|NCT00538850|desmoid tumor|desmoid tumor
722402|NCT00538850|stage I adult soft tissue sarcoma|stage i adult soft tissue sarcoma
722403|NCT00538850|stage II adult soft tissue sarcoma|stage ii adult soft tissue sarcoma
722404|NCT00538850|stage III adult soft tissue sarcoma|stage iii adult soft tissue sarcoma
722405|NCT00538850|stage IV adult soft tissue sarcoma|stage iv adult soft tissue sarcoma
722406|NCT00538850|recurrent adult soft tissue sarcoma|recurrent adult soft tissue sarcoma
722407|NCT00538850|recurrent thymoma and thymic carcinoma|recurrent thymoma and thymic carcinoma
722785|NCT00537342|Depigmented|depigmented
722408|NCT00538850|advanced malignant mesothelioma|advanced malignant mesothelioma
722409|NCT00538850|localized malignant mesothelioma|localized malignant mesothelioma
722410|NCT00538850|recurrent malignant mesothelioma|recurrent malignant mesothelioma
722411|NCT00538850|phosphaturic mesenchymal tumor|phosphaturic mesenchymal tumor
722412|NCT00538850|stage I malignant testicular germ cell tumor|stage i malignant testicular germ cell tumor
722498|NCT00538720|Vitamin D|vitamin d
722413|NCT00538850|stage II malignant testicular germ cell tumor|stage ii malignant testicular germ cell tumor
722414|NCT00538850|stage III malignant testicular germ cell tumor|stage iii malignant testicular germ cell tumor
722415|NCT00538850|recurrent malignant testicular germ cell tumor|recurrent malignant testicular germ cell tumor
722416|NCT00538850|stage 0 penile cancer|stage 0 penile cancer
722417|NCT00538850|stage I penile cancer|stage i penile cancer
722418|NCT00538850|stage II penile cancer|stage ii penile cancer
722419|NCT00538850|stage III penile cancer|stage iii penile cancer
722420|NCT00538850|stage IV penile cancer|stage iv penile cancer
722421|NCT00538850|recurrent penile cancer|recurrent penile cancer
722422|NCT00538850|stage I prostate cancer|stage i prostate cancer
722423|NCT00538850|stage IIB prostate cancer|stage iib prostate cancer
722424|NCT00538850|stage IIA prostate cancer|stage iia prostate cancer
722425|NCT00538850|stage III prostate cancer|stage iii prostate cancer
722426|NCT00538850|stage IV prostate cancer|stage iv prostate cancer
722427|NCT00538850|recurrent prostate cancer|recurrent prostate cancer
722428|NCT00538850|stage 0 vaginal cancer|stage 0 vaginal cancer
722429|NCT00538850|stage I vaginal cancer|stage i vaginal cancer
722430|NCT00538850|stage II vaginal cancer|stage ii vaginal cancer
722431|NCT00538850|stage III vaginal cancer|stage iii vaginal cancer
722432|NCT00538850|stage IVA vaginal cancer|stage iva vaginal cancer
722433|NCT00538850|stage IVB vaginal cancer|stage ivb vaginal cancer
722434|NCT00538850|recurrent vaginal cancer|recurrent vaginal cancer
722435|NCT00538850|stage 0 vulvar cancer|stage 0 vulvar cancer
722436|NCT00538850|stage I vulvar cancer|stage i vulvar cancer
722437|NCT00538850|stage II vulvar cancer|stage ii vulvar cancer
722438|NCT00538850|stage III vulvar cancer|stage iii vulvar cancer
722439|NCT00538850|stage IVB vulvar cancer|stage ivb vulvar cancer
722440|NCT00538850|recurrent vulvar cancer|recurrent vulvar cancer
722441|NCT00538850|stage 0 anal cancer|stage 0 anal cancer
722442|NCT00538850|stage I anal cancer|stage i anal cancer
722443|NCT00538850|stage II anal cancer|stage ii anal cancer
722444|NCT00538850|stage IIIA anal cancer|stage iiia anal cancer
722445|NCT00538850|stage IIIB anal cancer|stage iiib anal cancer
722446|NCT00538850|stage IV anal cancer|stage iv anal cancer
722447|NCT00538850|recurrent anal cancer|recurrent anal cancer
722448|NCT00538850|stage 0 rectal cancer|stage 0 rectal cancer
722449|NCT00538850|stage I rectal cancer|stage i rectal cancer
722450|NCT00538850|stage II rectal cancer|stage ii rectal cancer
722451|NCT00538850|stage III rectal cancer|stage iii rectal cancer
722452|NCT00538850|stage IV rectal cancer|stage iv rectal cancer
722453|NCT00538850|recurrent rectal cancer|recurrent rectal cancer
722454|NCT00538850|stage 0 esophageal cancer|stage 0 esophageal cancer
722455|NCT00538850|stage I esophageal cancer|stage i esophageal cancer
722456|NCT00538850|stage II esophageal cancer|stage ii esophageal cancer
722457|NCT00538850|stage III esophageal cancer|stage iii esophageal cancer
722458|NCT00538850|stage IV esophageal cancer|stage iv esophageal cancer
722459|NCT00538850|recurrent esophageal cancer|recurrent esophageal cancer
722460|NCT00538850|stage I thymoma|stage i thymoma
722461|NCT00538850|stage II thymoma|stage ii thymoma
722462|NCT00538850|stage III thymoma|stage iii thymoma
722463|NCT00538850|stage IVA thymoma|stage iva thymoma
722464|NCT00538850|stage IVB thymoma|stage ivb thymoma
722465|NCT00538850|recurrent melanoma|recurrent melanoma
722466|NCT00538850|stage 0 melanoma|stage 0 melanoma
722467|NCT00538850|stage IA melanoma|stage ia melanoma
722468|NCT00538850|stage IB melanoma|stage ib melanoma
722469|NCT00538850|stage IIA melanoma|stage iia melanoma
722470|NCT00538850|stage IIB melanoma|stage iib melanoma
722471|NCT00538850|stage IIC melanoma|stage iic melanoma
722472|NCT00538850|stage IIIA melanoma|stage iiia melanoma
722473|NCT00538850|stage IIIB melanoma|stage iiib melanoma
722474|NCT00538850|stage IIIC melanoma|stage iiic melanoma
722475|NCT00538850|stage IV melanoma|stage iv melanoma
722476|NCT00538824|myeloma|myeloma
722477|NCT00538824|relapsed or refractory multiple myeloma|relapsed or refractory multiple myeloma
722478|NCT00538798|Pharmacokinetics|pharmacokinetics
722479|NCT00538798|Binding Potential|binding potential
722480|NCT00538798|Glutamate|glutamate
722481|NCT00538798|Positron Emission Tomography|positron emission tomography
722482|NCT00538798|Metabolic Glutamate Receptors|metabolic glutamate receptors
722483|NCT00538798|Healthy Volunteer|healthy volunteer
722484|NCT00538798|HV|hv
722485|NCT00538785|Synagis, motavizumab, palivizumab, children, MEDI-524, RSV, congenital hear disease|synagis, motavizumab, palivizumab, children, medi-524, rsv, congenital hear disease
722486|NCT00538772|Metastatic Renal Cell Carcinoma|metastatic renal cell carcinoma
722487|NCT00538772|Biomarkers|biomarkers
722488|NCT00538772|Biomarkers in patients with Metastatic Renal Cell Carcinoma Who Have Progressed After Sunitinib Therapy|biomarkers in patients with metastatic renal cell carcinoma who have progressed after sunitinib therapy
722489|NCT00538759|Aortic valve stenosis|aortic valve stenosis
722595|NCT00538291|stage IV rectal cancer|stage iv rectal cancer
722490|NCT00538759|Balloon aortic valvuloplasty|balloon aortic valvuloplasty
722491|NCT00538759|Aortic valve restenosis|aortic valve restenosis
722492|NCT00538733|myeloma|myeloma
722493|NCT00538733|newly diagnosed multiple myeloma|newly diagnosed multiple myeloma
722494|NCT00538720|Primary Hyperparathyroidism|primary hyperparathyroidism
722495|NCT00538720|PHPT|phpt
722496|NCT00538720|Parathyroid glands|parathyroid glands
722497|NCT00538720|Vitamin D deficiency|vitamin d deficiency
722499|NCT00538720|Ergocalciferol|ergocalciferol
722500|NCT00538707|mental stress|mental stress
722501|NCT00538707|platelet adhesion|platelet adhesion
722502|NCT00538707|platelet function|platelet function
722503|NCT00538707|catecholamines|catecholamines
722504|NCT00538694|Moderate to severe community-acquired acute bacterial pneumonia due to S. Pneumoniae|moderate to severe community-acquired acute bacterial pneumonia due to s. pneumoniae
722505|NCT00538668|Prostate|prostate
722506|NCT00538668|Prostate Cancer|prostate cancer
722507|NCT00538668|Prostate Ca|prostate ca
722508|NCT00538655|amphetamine|amphetamine
722509|NCT00538655|methamphetamine|methamphetamine
722510|NCT00538655|addition|addition
722511|NCT00538655|treatment study|treatment study
722512|NCT00538655|drug use|drug use
722514|NCT00538642|schizophrenia|schizophrenia
722515|NCT00538642|antipsychotics|antipsychotics
722516|NCT00538642|diabetes|diabetes
722517|NCT00538642|bipolar disorder|bipolar disorder
722518|NCT00538616|Brain Injury|brain injury
722520|NCT00538590|collagen matrix|collagen matrix
722521|NCT00538590|glaucoma|glaucoma
722522|NCT00538590|trabeculectomy|trabeculectomy
722523|NCT00538590|Mitomycin-C|mitomycin-c
722524|NCT00538577|Necrotizing fasciitis|necrotizing fasciitis
722525|NCT00538564|prolonged, painful erection|prolonged, painful erection
722526|NCT00538564|priapism|priapism
722527|NCT00538564|sickle cell anemia|sickle cell anemia
722528|NCT00538551|HD|hd
722529|NCT00538551|NHL|nhl
722530|NCT00538538|Macular Degeneration|macular degeneration
722531|NCT00538538|AMD|amd
722532|NCT00538538|Hemorrhage|hemorrhage
722533|NCT00538538|Wet AMD|wet amd
722534|NCT00538512|Influenza|influenza
722535|NCT00538512|Live attenuated influenza vaccine|live attenuated influenza vaccine
722536|NCT00538512|Inactivated influenza vaccine|inactivated influenza vaccine
722537|NCT00538512|Vaccine Efficacy|vaccine efficacy
722538|NCT00538499|pain|pain
722539|NCT00538499|perioperative/postoperative complications|perioperative/postoperative complications
722540|NCT00538486|Hypertension|hypertension
722541|NCT00538486|Abdominal obesity|abdominal obesity
722542|NCT00538486|Treatment|treatment
722543|NCT00538473|GSK Bio's influenza vaccine GSK576389A|gsk bio's influenza vaccine gsk576389a
722544|NCT00538473|Influenza Infection|influenza infection
722545|NCT00538473|Fluarix|fluarix
722546|NCT00538460|tomography|tomography
722547|NCT00538460|coronary artery disease|coronary artery disease
722548|NCT00538460|magnetic resonance imaging|magnetic resonance imaging
722549|NCT00538447|CML|cml
722550|NCT00538434|Eosinophilic Esophagitis|eosinophilic esophagitis
722551|NCT00538434|GERD|gerd
722552|NCT00538434|EE|ee
722553|NCT00538434|Reslizumab|reslizumab
722554|NCT00538434|IL-5|il-5
722555|NCT00538434|Interleukin-5|interleukin-5
722556|NCT00538434|Cinquil|cinquil
722557|NCT00538421|propofol|propofol
722558|NCT00538421|Anaesthesia|anaesthesia
722559|NCT00538421|Sevoflurane|sevoflurane
722560|NCT00538421|Abdominal|abdominal
722561|NCT00538421|Aortic|aortic
722562|NCT00538421|Aneurysm|aneurysm
722563|NCT00538408|Magnetic resonance|magnetic resonance
722564|NCT00538408|whole body|whole body
722565|NCT00538408|angiography|angiography
722566|NCT00538408|vasovist|vasovist
722567|NCT00538408|gadofosveset|gadofosveset
722568|NCT00538408|dotarem|dotarem
722569|NCT00538408|blood pool agent|blood pool agent
722570|NCT00538382|Malaria|malaria
722571|NCT00538382|Pregnancy|pregnancy
722572|NCT00538382|Artesunate|artesunate
722573|NCT00538382|Pharmacokinetics|pharmacokinetics
722574|NCT00538382|Pharmacodynamics|pharmacodynamics
722575|NCT00538382|Democratic Republic of Congo|democratic republic of congo
722576|NCT00538369|Nursing|nursing
722577|NCT00538369|critical care|critical care
722578|NCT00538369|sedation assessment|sedation assessment
722579|NCT00538369|Bispectral index|bispectral index
722580|NCT00538356|Heart failure|heart failure
722581|NCT00538356|Rehospitalization:|rehospitalization:
722582|NCT00538356|Packer composite score|packer composite score
722583|NCT00538356|Home Monitoring|home monitoring
722584|NCT00538356|Cardiac resynchronization therapy|cardiac resynchronization therapy
722585|NCT00538356|Implantable cardioverter-defibrillator|implantable cardioverter-defibrillator
722586|NCT00538343|brain metastases|brain metastases
722587|NCT00538343|breast cancer|breast cancer
722588|NCT00538317|Acute myocardial infarction,|acute myocardial infarction,
722589|NCT00538317|GPIIbIIIa inhibitors,|gpiibiiia inhibitors,
722590|NCT00538317|primary angioplasty,|primary angioplasty,
722591|NCT00538317|tirofiban|tirofiban
722592|NCT00538291|recurrent colon cancer|recurrent colon cancer
722593|NCT00538291|stage IV colon cancer|stage iv colon cancer
722596|NCT00538278|AML|aml
722597|NCT00538265|liver transplantation, hepatitis C virus, immunoprophylaxis|liver transplantation, hepatitis c virus, immunoprophylaxis
722598|NCT00538252|drug use, antisocial behavior, early intervention, prevention|drug use, antisocial behavior, early intervention, prevention
722599|NCT00538213|Influenza vaccine GSK576389A|influenza vaccine gsk576389a
722600|NCT00538213|Fluarix|fluarix
722601|NCT00538213|Influenza infection|influenza infection
722602|NCT00538200|Nutrition|nutrition
722603|NCT00538200|COPD|copd
722604|NCT00538161|Acute lung injury|acute lung injury
722605|NCT00538161|cardiac surgery|cardiac surgery
722606|NCT00538161|The incidence of ARDS after elective cardiac surgery is 1-3%|the incidence of ards after elective cardiac surgery is 1-3%
722607|NCT00538161|The impairment of lung function and oxygenation may occur in 20-80% of patients undergoing surgery.|the impairment of lung function and oxygenation may occur in 20-80% of patients undergoing surgery.
722608|NCT00538161|The purpose of this study is to assess the efficacy of low tidal volume ventilation.|the purpose of this study is to assess the efficacy of low tidal volume ventilation.
722609|NCT00538161|Reducing interleukin and cytokine production may prevent or reduce the incidence of acute lung injury.|reducing interleukin and cytokine production may prevent or reduce the incidence of acute lung injury.
722610|NCT00538135|randomised controlled trial|randomised controlled trial
722611|NCT00538135|borderline personality disorder|borderline personality disorder
722612|NCT00538135|cognitive behavioural therapy|cognitive behavioural therapy
722613|NCT00538135|treatment as usual|treatment as usual
722614|NCT00538122|schizophrenia|schizophrenia
722615|NCT00538122|schizoaffective disorder|schizoaffective disorder
722616|NCT00538122|bipolar disorder|bipolar disorder
722617|NCT00538122|antipsychotic drug treatment|antipsychotic drug treatment
722618|NCT00538122|safety|safety
722619|NCT00538122|arrythmias|arrythmias
722620|NCT00538109|CML in Blast Crisis|cml in blast crisis
722621|NCT00538109|Accelerated Phase oe Chronic Phase|accelerated phase oe chronic phase
722622|NCT00538096|B-cell Non-Hodgkin's Lymphoma|b-cell non-hodgkin's lymphoma
722623|NCT00538083|Cocoa|cocoa
722624|NCT00538083|Overweight adults|overweight adults
722625|NCT00538083|Endothelial function|endothelial function
722626|NCT00538083|Blood pressure|blood pressure
722627|NCT00538083|Cardiovascular disease risk|cardiovascular disease risk
722628|NCT00538083|Dark chocolate|dark chocolate
722629|NCT00538083|Sugar|sugar
722630|NCT00538070|Sarcosine|sarcosine
722631|NCT00538070|Glycine|glycine
722632|NCT00538070|Magnetic Resonance Spectroscopy|magnetic resonance spectroscopy
722633|NCT00538070|Schizophrenia|schizophrenia
722634|NCT00538057|Healthy volunteers|healthy volunteers
722635|NCT00538044|pulmonary hypertension|pulmonary hypertension
722636|NCT00538044|simvastatin|simvastatin
722637|NCT00538044|advanced pulmonary hypertension secondary to congenital heart disease|advanced pulmonary hypertension secondary to congenital heart disease
722638|NCT00538044|advanced pulmonary hypertension secondary to chronic pulmonary embolism|advanced pulmonary hypertension secondary to chronic pulmonary embolism
722639|NCT00538005|recurrent melanoma|recurrent melanoma
722640|NCT00538005|stage IV melanoma|stage iv melanoma
722641|NCT00537992|combined surgery,|combined surgery,
722642|NCT00537992|cataract surgery,|cataract surgery,
722643|NCT00537992|vitrectomy,|vitrectomy,
722644|NCT00537992|blue light-filter iols|blue light-filter iols
722645|NCT00537979|Dialysis|dialysis
722646|NCT00537979|Hyperparathyroidism|hyperparathyroidism
722647|NCT00537979|Zemplar|zemplar
722648|NCT00537966|Primary HIV Infection|primary hiv infection
722649|NCT00537953|Leishmaniasis|leishmaniasis
722650|NCT00537953|Cutaneous leishmaniasis|cutaneous leishmaniasis
722651|NCT00537953|Miltefosine|miltefosine
722652|NCT00537953|Glucantime|glucantime
722653|NCT00537953|Antimony|antimony
722654|NCT00537953|Pentavalent antimonials|pentavalent antimonials
722655|NCT00537953|Combination therapy|combination therapy
722656|NCT00537927|laparoscopic correction|laparoscopic correction
722657|NCT00537927|ventral and incisional hernia|ventral and incisional hernia
722658|NCT00537927|mesh fixation|mesh fixation
722659|NCT00537927|postoperative pain|postoperative pain
722660|NCT00537914|Small for Gestational Age, Omnitrope®/Somatropin, rhGH,SGA|small for gestational age, omnitrope®/somatropin, rhgh,sga
722661|NCT00537901|Colon and Rectum Cancer|colon and rectum cancer
722662|NCT00537862|Kidney Transplant Patients|kidney transplant patients
722663|NCT00537862|Immunosuppresion|immunosuppresion
722664|NCT00537862|Enteric-coated mycophenolate sodium|enteric-coated mycophenolate sodium
722665|NCT00537836|Hot flushes|hot flushes
722666|NCT00537836|Therapy of hot flushes|therapy of hot flushes
722667|NCT00537836|17ß-estradiol (E2)|17ß-estradiol (e2)
722668|NCT00537836|Hormone replacement therapy|hormone replacement therapy
722669|NCT00537823|Colorectal Cancer|colorectal cancer
722670|NCT00537823|Metastasis|metastasis
722671|NCT00537823|Neoadjuvant Therapy|neoadjuvant therapy
722672|NCT00537810|Obesity|obesity
722673|NCT00537810|Binge eating|binge eating
722674|NCT00537810|Sibutramine|sibutramine
722675|NCT00537810|Self-help|self-help
722676|NCT00537810|Primary care|primary care
722677|NCT00537797|Thyroid Neoplasms|thyroid neoplasms
722678|NCT00537797|Positron Emission Tomography|positron emission tomography
722679|NCT00537797|18FDG|18fdg
722680|NCT00537784|platelets tendon ligament|platelets tendon ligament
722681|NCT00537771|Early Breast cancer|early breast cancer
722682|NCT00537771|adjuvant therapy|adjuvant therapy
722683|NCT00537771|hormone receptor|hormone receptor
722684|NCT00537771|hormonal therapy|hormonal therapy
722685|NCT00537771|anastrozole|anastrozole
722686|NCT00537771|tamoxifen|tamoxifen
722687|NCT00537758|binge eating disorder|binge eating disorder
722688|NCT00537758|cognitive behavior therapy|cognitive behavior therapy
722689|NCT00537758|combination therapy|combination therapy
722690|NCT00537758|obesity|obesity
722691|NCT00537758|weight loss|weight loss
722692|NCT00537758|body weight|body weight
722693|NCT00537758|clinical trial|clinical trial
722694|NCT00537758|dietary restriction|dietary restriction
722695|NCT00537758|overeating|overeating
722696|NCT00537758|weight control|weight control
722697|NCT00537732|gastro-oesophageal reflux disease|gastro-oesophageal reflux disease
722698|NCT00537719|healthy|healthy
722699|NCT00537719|pharmacodynamics|pharmacodynamics
722700|NCT00537719|glucagon-like peptide 1|glucagon-like peptide 1
722701|NCT00537719|pharmacokinetics|pharmacokinetics
722702|NCT00537719|scintigraphy|scintigraphy
722703|NCT00537719|radiation|radiation
722704|NCT00537719|albiglutide|albiglutide
722705|NCT00537706|Socioeconomic Determinants|socioeconomic determinants
722706|NCT00537706|Health Status|health status
722707|NCT00537706|Low-income|low-income
722708|NCT00537706|Priority-setting|priority-setting
722709|NCT00537706|Group Discussion|group discussion
722710|NCT00537693|Continuous Renal Replacement Therapy (CRRT)|continuous renal replacement therapy (crrt)
722711|NCT00537693|Sepsis|sepsis
722712|NCT00537693|Convection|convection
722713|NCT00537693|Diffusion|diffusion
722714|NCT00537680|Friedreich's Ataxia|friedreich's ataxia
722715|NCT00537680|Idebenone|idebenone
722716|NCT00537680|ICARS|icars
722717|NCT00537667|IL-1ra|il-1ra
722718|NCT00537667|PEG sTNF-RI|peg stnf-ri
722719|NCT00537667|Synovial biopsy|synovial biopsy
722720|NCT00537667|Inflammation|inflammation
722721|NCT00537667|Bone and Cartilage Destruction|bone and cartilage destruction
722722|NCT00537667|Rheumatoid Arthritis|rheumatoid arthritis
722723|NCT00537654|benign prostatic hyperplasia,|benign prostatic hyperplasia,
722724|NCT00537654|AVODART,|avodart,
722725|NCT00537654|FLOMAX|flomax
722726|NCT00537641|noninvasive ventilation|noninvasive ventilation
722727|NCT00537602|cystic fibrosis|cystic fibrosis
722728|NCT00537602|miglustat|miglustat
722729|NCT00537602|Zavesca|zavesca
722730|NCT00537602|Actelion|actelion
722731|NCT00537602|nasal potential difference|nasal potential difference
722732|NCT00537602|transmembrane conductance regulator (CFTR)|transmembrane conductance regulator (cftr)
722733|NCT00537589|arthrocentesis|arthrocentesis
722734|NCT00537589|ultrasound|ultrasound
722735|NCT00537589|emergency|emergency
722736|NCT00537550|ALL|all
722737|NCT00537550|Adult|adult
722738|NCT00537537|Hepatitis B, Chronic, Hepatitis B e Antigen positive, Adults, Telbivudine, Adefovir|hepatitis b, chronic, hepatitis b e antigen positive, adults, telbivudine, adefovir
722739|NCT00537524|Bird flu|bird flu
722740|NCT00537524|seasonal influenza vaccine|seasonal influenza vaccine
722741|NCT00537524|influenza vaccine|influenza vaccine
722742|NCT00537524|prepandemic vaccine|prepandemic vaccine
722743|NCT00537524|virus strain with the potential to cause pandemic|virus strain with the potential to cause pandemic
722744|NCT00537524|toddlers|toddlers
722745|NCT00537524|children|children
722746|NCT00537524|adolescents|adolescents
722747|NCT00537498|urokinase, diabetes, wound healing, major amputation|urokinase, diabetes, wound healing, major amputation
722748|NCT00537485|SPM 962|spm 962
722749|NCT00537485|rotigotine|rotigotine
722750|NCT00537485|Parkinson's disease|parkinson's disease
722751|NCT00537485|monotherapy|monotherapy
722752|NCT00537472|Bupivacaine|bupivacaine
722753|NCT00537472|spinal anesthesia|spinal anesthesia
722754|NCT00537472|total knee arthroplasty|total knee arthroplasty
722755|NCT00537459|Premature ejaculation (PE) ejaculatory latency time (ELT)|premature ejaculation (pe) ejaculatory latency time (elt)
722756|NCT00537446|noninvasive ventilation|noninvasive ventilation
722757|NCT00537433|Medication errors|medication errors
722758|NCT00537433|Patient nonadherence|patient nonadherence
722759|NCT00537433|Literacy|literacy
722760|NCT00537433|Communication|communication
722761|NCT00537420|weight loss|weight loss
722762|NCT00537420|dieting|dieting
722763|NCT00537407|Hepatitis|hepatitis
722764|NCT00537407|Hepatitis C|hepatitis c
722765|NCT00537394|Treatment Experienced|treatment experienced
722766|NCT00537381|Prostatic neoplasms|prostatic neoplasms
722767|NCT00537381|CNTO 95|cnto 95
722768|NCT00537381|Intetumumab|intetumumab
722769|NCT00537381|Docetaxel|docetaxel
722770|NCT00537381|Prednisone|prednisone
722771|NCT00537368|infusion|infusion
722772|NCT00537368|CNTO 888|cnto 888
722773|NCT00537368|Phase 1|phase 1
722774|NCT00537368|solid tumor|solid tumor
722775|NCT00537368|cancer|cancer
722776|NCT00537355|ragweed|ragweed
722777|NCT00537355|ragweed allergy|ragweed allergy
722778|NCT00537355|allergy|allergy
722779|NCT00537355|allergies|allergies
722780|NCT00537355|allergic|allergic
722781|NCT00537355|seasonal allergic rhinitis|seasonal allergic rhinitis
722782|NCT00537355|allergic rhinitis|allergic rhinitis
722783|NCT00537342|Immunotherapy|immunotherapy
722784|NCT00537342|Allergoid|allergoid
722787|NCT00537342|Allergen-extract|allergen-extract
722788|NCT00537342|Rhinoconjunctivitis|rhinoconjunctivitis
722789|NCT00537290|antiphospholipid syndrome|antiphospholipid syndrome
722964|NCT00536692|DME|dme
722790|NCT00537264|health-related quality of life|health-related quality of life
722791|NCT00537264|primary care|primary care
722792|NCT00537264|computer-assisted instruction|computer-assisted instruction
722793|NCT00537238|Epilepsies partial|epilepsies partial
722794|NCT00537238|Partial Seizure Disorder|partial seizure disorder
722795|NCT00537238|Complex Partial Seizure Disorder|complex partial seizure disorder
722796|NCT00537238|Epilepsy|epilepsy
722797|NCT00537225|peripheral arterial disease|peripheral arterial disease
722798|NCT00537225|walking time|walking time
722799|NCT00537225|lifestyle modification|lifestyle modification
722800|NCT00537225|cardiovascular risk reduction|cardiovascular risk reduction
722801|NCT00537225|exercise|exercise
722802|NCT00537225|diet|diet
722803|NCT00537225|claudication|claudication
722804|NCT00537212|Psoriasis|psoriasis
722805|NCT00537212|Weight loss|weight loss
722806|NCT00537212|diet|diet
722807|NCT00537199|Head And Neck|head and neck
722808|NCT00537199|Oropharynx|oropharynx
722809|NCT00537199|Oral Cancer|oral cancer
722810|NCT00537199|OraTest|oratest
722811|NCT00537199|OraTest Dye|oratest dye
722812|NCT00537199|Rinse Staining Procedure|rinse staining procedure
722813|NCT00537199|Visual Examination|visual examination
722814|NCT00537186|Congestive heart failure|congestive heart failure
722815|NCT00537186|Anaemia|anaemia
722816|NCT00537186|Iron oligosaccharide|iron oligosaccharide
722817|NCT00537160|Pediatrics|pediatrics
722818|NCT00537147|Chimeric West Nile Virus|chimeric west nile virus
722819|NCT00537147|West Nile Virus|west nile virus
722820|NCT00537147|Dengue Virus|dengue virus
722821|NCT00537134|Aneurysm|aneurysm
722822|NCT00537134|Brain|brain
722823|NCT00537134|Unruptured|unruptured
722824|NCT00537134|observation|observation
722825|NCT00537134|treatment|treatment
722826|NCT00537134|Endovascular|endovascular
722827|NCT00537121|recurrent gastric cancer|recurrent gastric cancer
722828|NCT00537121|stage IV gastric cancer|stage iv gastric cancer
722829|NCT00537121|recurrent esophageal cancer|recurrent esophageal cancer
722830|NCT00537121|stage IV esophageal cancer|stage iv esophageal cancer
722831|NCT00537121|adenocarcinoma of the esophagus|adenocarcinoma of the esophagus
722832|NCT00537121|adenocarcinoma of the stomach|adenocarcinoma of the stomach
722833|NCT00537121|squamous cell carcinoma of the esophagus|squamous cell carcinoma of the esophagus
722834|NCT00537121|adult primary hepatocellular carcinoma|adult primary hepatocellular carcinoma
722835|NCT00537121|stage III gastric cancer|stage iii gastric cancer
722836|NCT00537121|stage III esophageal cancer|stage iii esophageal cancer
722837|NCT00537121|advanced adult primary liver cancer|advanced adult primary liver cancer
722838|NCT00537121|localized unresectable adult primary liver cancer|localized unresectable adult primary liver cancer
722839|NCT00537121|recurrent adult primary liver cancer|recurrent adult primary liver cancer
722840|NCT00537108|Pregnancy in adolescence|pregnancy in adolescence
722841|NCT00537095|follicular|follicular
722842|NCT00537095|papillary|papillary
722843|NCT00537082|FTY720,|fty720,
722844|NCT00537082|MS|ms
722845|NCT00537043|hypertension,|hypertension,
722846|NCT00537043|carvedilol,|carvedilol,
722847|NCT00537043|repeat-dosing|repeat-dosing
722848|NCT00537004|primary progressive aphasia|primary progressive aphasia
722849|NCT00537004|frontotemporal dementia|frontotemporal dementia
722850|NCT00537004|semantic dementia|semantic dementia
722851|NCT00537004|progressive nonfluent aphasia|progressive nonfluent aphasia
722852|NCT00537004|progressive aphasia|progressive aphasia
722853|NCT00537004|frontotemporal lobar degeneration|frontotemporal lobar degeneration
722854|NCT00536978|Lymphoma|lymphoma
722855|NCT00536978|Leukemia|leukemia
722856|NCT00536978|B-Cell Lymphoid Malignancies|b-cell lymphoid malignancies
722857|NCT00536978|CLL|cll
722858|NCT00536978|Cll/Small Lymphocytic Lymphoma|cll/small lymphocytic lymphoma
722859|NCT00536978|Follicular Lymphoma|follicular lymphoma
722860|NCT00536978|Mantle Cell Lymphoma|mantle cell lymphoma
722861|NCT00536978|Diffuse Large Cell Lymphoma|diffuse large cell lymphoma
722862|NCT00536978|Splenic Lymphoma|splenic lymphoma
722863|NCT00536978|MALT|malt
722864|NCT00536978|Lymphoplasmacytic Lymphoma|lymphoplasmacytic lymphoma
722865|NCT00536978|Burkitt's Lymphoma|burkitt's lymphoma
722866|NCT00536978|ARA-C|ara-c
722867|NCT00536978|BCNU|bcnu
722868|NCT00536978|Campath-1H|campath-1h
722869|NCT00536978|Cytoxan|cytoxan
722870|NCT00536978|Etoposide|etoposide
722871|NCT00536978|Fludarabine|fludarabine
722872|NCT00536978|Melphalan|melphalan
722873|NCT00536978|Rituximab|rituximab
722874|NCT00536978|Allogeneic Stem Cell Transplant|allogeneic stem cell transplant
722875|NCT00536978|T-Cell Cell Adback|t-cell cell adback
722876|NCT00536978|Natural Killer (NK) Cell Adback|natural killer (nk) cell adback
722877|NCT00536965|Hyperlipidemia|hyperlipidemia
722878|NCT00536965|Need-to-treat|need-to-treat
722879|NCT00536965|NIS|nis
722993|NCT00536562|TIA (Transient Ischemic Attack)|tia (transient ischemic attack)
722958|NCT00536718|lobular breast carcinoma in situ|lobular breast carcinoma in situ
722880|NCT00536965|Secondary prevention patients with hyperlipidemia and atherosclerosis (coronary heart disease, carotid stenosis, PVD, etc.) and/or diabetes|secondary prevention patients with hyperlipidemia and atherosclerosis (coronary heart disease, carotid stenosis, pvd, etc.) and/or diabetes
722965|NCT00536692|diabetic|diabetic
722966|NCT00536692|mecamylamine|mecamylamine
722881|NCT00536952|recurrent squamous cell carcinoma of the hypopharynx|recurrent squamous cell carcinoma of the hypopharynx
722882|NCT00536952|stage III squamous cell carcinoma of the hypopharynx|stage iii squamous cell carcinoma of the hypopharynx
722883|NCT00536952|stage IV squamous cell carcinoma of the hypopharynx|stage iv squamous cell carcinoma of the hypopharynx
722884|NCT00536952|stage III squamous cell carcinoma of the larynx|stage iii squamous cell carcinoma of the larynx
722885|NCT00536952|stage IV squamous cell carcinoma of the larynx|stage iv squamous cell carcinoma of the larynx
722886|NCT00536952|recurrent squamous cell carcinoma of the larynx|recurrent squamous cell carcinoma of the larynx
722887|NCT00536952|recurrent squamous cell carcinoma of the lip and oral cavity|recurrent squamous cell carcinoma of the lip and oral cavity
722888|NCT00536952|stage III squamous cell carcinoma of the lip and oral cavity|stage iii squamous cell carcinoma of the lip and oral cavity
722889|NCT00536952|stage IV squamous cell carcinoma of the lip and oral cavity|stage iv squamous cell carcinoma of the lip and oral cavity
722890|NCT00536952|recurrent squamous cell carcinoma of the nasopharynx|recurrent squamous cell carcinoma of the nasopharynx
722891|NCT00536952|stage III squamous cell carcinoma of the nasopharynx|stage iii squamous cell carcinoma of the nasopharynx
722892|NCT00536952|stage IV squamous cell carcinoma of the nasopharynx|stage iv squamous cell carcinoma of the nasopharynx
722893|NCT00536952|recurrent squamous cell carcinoma of the oropharynx|recurrent squamous cell carcinoma of the oropharynx
722894|NCT00536952|stage III squamous cell carcinoma of the oropharynx|stage iii squamous cell carcinoma of the oropharynx
722895|NCT00536952|stage IV squamous cell carcinoma of the oropharynx|stage iv squamous cell carcinoma of the oropharynx
722896|NCT00536926|telemedicine|telemedicine
722897|NCT00536926|lung transplantation|lung transplantation
722898|NCT00536926|home spirometry|home spirometry
722899|NCT00536913|Symbicort pMDI|symbicort pmdi
722900|NCT00536913|spacer|spacer
722901|NCT00536913|children|children
722902|NCT00536900|Substance abuse|substance abuse
722903|NCT00536900|Behavior therapy|behavior therapy
722904|NCT00536900|representative payee|representative payee
722905|NCT00536900|cocaine abuse|cocaine abuse
722906|NCT00536900|alcohol abuse|alcohol abuse
722907|NCT00536900|case management|case management
722908|NCT00536900|dual diagnosis|dual diagnosis
722909|NCT00536874|adenocarcinoma of the pancreas|adenocarcinoma of the pancreas
722910|NCT00536874|stage IA pancreatic cancer|stage ia pancreatic cancer
722911|NCT00536874|stage IB pancreatic cancer|stage ib pancreatic cancer
722912|NCT00536874|stage IIA pancreatic cancer|stage iia pancreatic cancer
722913|NCT00536874|stage IIB pancreatic cancer|stage iib pancreatic cancer
722914|NCT00536874|stage III pancreatic cancer|stage iii pancreatic cancer
722915|NCT00536861|erlotinib|erlotinib
722916|NCT00536861|cranial radiotherapy|cranial radiotherapy
722917|NCT00536848|Probiotics|probiotics
722918|NCT00536848|HIV|hiv
722919|NCT00536848|AIDS|aids
722920|NCT00536848|Diarrhea|diarrhea
722921|NCT00536848|Lactobacillus rhamnosus GR-1|lactobacillus rhamnosus gr-1
722922|NCT00536848|Lactobacillus reuteri RC-14|lactobacillus reuteri rc-14
722923|NCT00536848|Immune system|immune system
722924|NCT00536848|Infectious Diseases|infectious diseases
722925|NCT00536848|Complementary Therapies|complementary therapies
722926|NCT00536848|Treatment Naive|treatment naive
722927|NCT00536835|Non-Hodgkins Lymphoma|non-hodgkins lymphoma
722928|NCT00536835|Cancer|cancer
722929|NCT00536835|First time in human|first time in human
722930|NCT00536835|PLK1 inhibitor|plk1 inhibitor
722931|NCT00536835|Advanced Solid Tumor|advanced solid tumor
722932|NCT00536835|GSK461364|gsk461364
722933|NCT00536822|rehabilitation|rehabilitation
722934|NCT00536822|pediatrics|pediatrics
722935|NCT00536809|Metastatic Colorectal Cancer|metastatic colorectal cancer
722936|NCT00536809|oxaliplatin|oxaliplatin
722937|NCT00536809|fluoropyrimidines cancers|fluoropyrimidines cancers
722938|NCT00536809|Advanced Colorectal Cancer|advanced colorectal cancer
722939|NCT00536809|capecitabine|capecitabine
722940|NCT00536809|lapatinib|lapatinib
722941|NCT00536796|Hyperlipidemia|hyperlipidemia
722942|NCT00536796|Need-to-treat|need-to-treat
722943|NCT00536796|NIS|nis
722944|NCT00536796|Secondary prevention patients with hyperlipidemia and atherosclerosis (coronary heart disease, carotid stenosis, PVD, etc.) and/or diabetes|secondary prevention patients with hyperlipidemia and atherosclerosis (coronary heart disease, carotid stenosis, pvd, etc.) and/or diabetes
722945|NCT00536783|Psychiatry|psychiatry
722946|NCT00536783|Antipsychotic|antipsychotic
722947|NCT00536783|Psychopharmacology|psychopharmacology
722948|NCT00536783|Clinical Trial|clinical trial
722949|NCT00536783|Open Label|open label
722950|NCT00536783|Schizophrenia|schizophrenia
722951|NCT00536783|Sensory Gating|sensory gating
722952|NCT00536783|Attention|attention
722953|NCT00536783|Memory|memory
722954|NCT00536731|Asthma|asthma
722955|NCT00536731|Symbicort|symbicort
722956|NCT00536718|invasive lobular breast carcinoma with predominant in situ component|invasive lobular breast carcinoma with predominant in situ component
722957|NCT00536718|invasive lobular breast carcinoma|invasive lobular breast carcinoma
722959|NCT00536705|asthma|asthma
722961|NCT00536705|transforming growth factor beta(TGF-β)|transforming growth factor beta(tgf-β)
722962|NCT00536705|Leukotriene Antagonists(Montelukast)|leukotriene antagonists(montelukast)
722963|NCT00536692|macular edema|macular edema
722968|NCT00536679|Relative Bioavailability|relative bioavailability
722969|NCT00536679|Randomised|randomised
722970|NCT00536679|GSK163090|gsk163090
722971|NCT00536679|Food Effect|food effect
722972|NCT00536666|Chronic kidney disease|chronic kidney disease
722974|NCT00536666|Iron oligosaccharide|iron oligosaccharide
722975|NCT00536666|Chronic kidney disease patients|chronic kidney disease patients
722976|NCT00536653|prostate cancer|prostate cancer
722977|NCT00536653|bone density|bone density
722978|NCT00536653|osteoporosis|osteoporosis
722979|NCT00536653|androgen antagonists|androgen antagonists
722980|NCT00536640|Non Small Cell Lung Carcinoma (NSCLC Stage III an IV)|non small cell lung carcinoma (nsclc stage iii an iv)
722981|NCT00536627|DNA vaccine|dna vaccine
722982|NCT00536614|pancreatic cancer|pancreatic cancer
722983|NCT00536614|metastatic|metastatic
722984|NCT00536614|EGFR|egfr
722985|NCT00536614|locally advanced pancreatic cancer|locally advanced pancreatic cancer
722986|NCT00536575|Multiple Myeloma|multiple myeloma
722987|NCT00536575|Relapsed|relapsed
722988|NCT00536575|Refractory|refractory
722989|NCT00536575|Sorafenib|sorafenib
722990|NCT00536575|Bortezomib|bortezomib
722991|NCT00536562|Comprehensive Cardiac Rehabilitation|comprehensive cardiac rehabilitation
722992|NCT00536562|Randomized Controlled Trial|randomized controlled trial
722994|NCT00536562|Mild Non-Disabling Stroke|mild non-disabling stroke
722995|NCT00536562|Vascular Protection|vascular protection
722996|NCT00536549|Glucose monitoring system|glucose monitoring system
722997|NCT00536549|life style intervention|life style intervention
722998|NCT00536536|Childhood|childhood
722999|NCT00536536|Obesity|obesity
723000|NCT00536536|Primary Care|primary care
723001|NCT00536523|constipation, impaction, and bowel obstruction|constipation, impaction, and bowel obstruction
723002|NCT00536523|ovarian epithelial cancer|ovarian epithelial cancer
723003|NCT00536523|peritoneal cavity cancer|peritoneal cavity cancer
723004|NCT00536523|fallopian tube cancer|fallopian tube cancer
723005|NCT00536510|High Cholesterol|high cholesterol
723006|NCT00536510|Excess lipids|excess lipids
723007|NCT00536497|GW842166,|gw842166,
723008|NCT00536497|Healthy volunteers,|healthy volunteers,
723009|NCT00536497|Inflammatory Pain.|inflammatory pain.
723010|NCT00536484|Overactive Bladder|overactive bladder
723011|NCT00536458|localized low grade lymphoma|localized low grade lymphoma
723012|NCT00536458|Chemotherapy|chemotherapy
723013|NCT00536458|Radiotherapy|radiotherapy
723014|NCT00536458|Molecular analyses|molecular analyses
723015|NCT00536458|primary|primary
723016|NCT00536445|NAVA|nava
723017|NCT00536445|Preterm|preterm
723018|NCT00536445|Case study|case study
723019|NCT00536406|Geriatric|geriatric
723020|NCT00536406|Nursing Homes|nursing homes
723021|NCT00536393|diffuse larg cells lymphoma|diffuse larg cells lymphoma
723022|NCT00536393|chemotherapy|chemotherapy
723023|NCT00536393|toxicity|toxicity
723024|NCT00536393|diffuse high grade lymphoma|diffuse high grade lymphoma
723025|NCT00536367|Heart Failure, Congestive|heart failure, congestive
723026|NCT00536367|Mortality Prediction Model|mortality prediction model
723027|NCT00536341|Chronic Lymphocytic Leukemia|chronic lymphocytic leukemia
723028|NCT00536341|untreated|untreated
723029|NCT00536341|minimally treated|minimally treated
723030|NCT00536341|fludarabine|fludarabine
723031|NCT00536341|rituximab|rituximab
723032|NCT00536341|lenalidomide|lenalidomide
723033|NCT00536328|Reflux Impact Scale (RIS)|reflux impact scale (ris)
723034|NCT00536328|predictive value|predictive value
723035|NCT00536328|treatment success|treatment success
723036|NCT00536328|patient satisfaction|patient satisfaction
723037|NCT00536328|proton pump inhibitor|proton pump inhibitor
723038|NCT00536328|gastro-esophageal reflux disease|gastro-esophageal reflux disease
723039|NCT00536328|PPU|ppu
723040|NCT00536315|COPD|copd
723041|NCT00536302|OA|oa
723042|NCT00536302|Knee arthritis|knee arthritis
723043|NCT00536302|Osteoarthritis|osteoarthritis
723044|NCT00536302|Nutritional supplement|nutritional supplement
723045|NCT00536302|CAM|cam
723046|NCT00536302|MRI|mri
723047|NCT00536289|Blunt needles|blunt needles
723048|NCT00536289|obstetric lacerations|obstetric lacerations
723049|NCT00536289|Needlestick injuries|needlestick injuries
723050|NCT00536289|Needlestick injuries to physicians|needlestick injuries to physicians
723051|NCT00536276|vitamin D|vitamin d
723052|NCT00536250|Pre-Diabetes|pre-diabetes
723053|NCT00536250|Childhood Obesity|childhood obesity
723054|NCT00536250|Metabolic Syndrome|metabolic syndrome
723055|NCT00536250|insulin resistance|insulin resistance
723056|NCT00536250|Impaired Glucose Tolerance|impaired glucose tolerance
723057|NCT00536250|Non Alcoholic Fatty Liver Disease|non alcoholic fatty liver disease
723058|NCT00536250|High Molecular Weight Adiponectin|high molecular weight adiponectin
723059|NCT00536250|Hypoadiponectinemia|hypoadiponectinemia
723060|NCT00536224|Health promotion|health promotion
723061|NCT00536224|Emergency Medical Services|emergency medical services
723062|NCT00536224|Randomized controlled trial|randomized controlled trial
723063|NCT00536224|Chest pain observation unit|chest pain observation unit
723064|NCT00536224|Cardiovascular risk factors|cardiovascular risk factors
723065|NCT00536211|Exercise|exercise
723066|NCT00536211|Physical Activity|physical activity
723067|NCT00536211|Metformin|metformin
723068|NCT00536211|Hyperinsulinemic-Euglycemic Clamp|hyperinsulinemic-euglycemic clamp
723069|NCT00536211|Muscle Biopsy|muscle biopsy
723070|NCT00536211|Fatty Acid Oxidation|fatty acid oxidation
723071|NCT00536211|Peroxisome proliferator-activated receptor gamma|peroxisome proliferator-activated receptor gamma
723072|NCT00536211|Detraining|detraining
723073|NCT00536211|Inactivity|inactivity
723074|NCT00536211|Skeletal muscle|skeletal muscle
723075|NCT00536198|Premenstrual Syndrome|premenstrual syndrome
723076|NCT00536185|ALOX5|alox5
723077|NCT00536185|5-lipoxygenase|5-lipoxygenase
723078|NCT00536185|Heart Disease|heart disease
723079|NCT00536185|Blacks|blacks
723080|NCT00536172|Antidepressant|antidepressant
723081|NCT00536172|Major depression|major depression
723082|NCT00536172|Prevention|prevention
723083|NCT00536172|Head and neck cancer|head and neck cancer
723084|NCT00536159|nurse-community health worker team|nurse-community health worker team
723085|NCT00536159|perinatal depression|perinatal depression
723086|NCT00536159|stress|stress
723087|NCT00536159|Medicaid enhanced prenatal programs|medicaid enhanced prenatal programs
723088|NCT00536146|Glucocorticoid|glucocorticoid
723089|NCT00536146|Steroids|steroids
723090|NCT00536146|Dose-Responsive Curve|dose-responsive curve
723091|NCT00536146|EC50|ec50
723092|NCT00536146|Stress Response|stress response
723093|NCT00536146|Alcoholism|alcoholism
723094|NCT00536133|zinc|zinc
723095|NCT00536133|aute lower respiratory infections|aute lower respiratory infections
723096|NCT00536120|MS|ms
723097|NCT00536120|Multiple sclerosis|multiple sclerosis
723098|NCT00536120|Relapsing forms of Multiple Sclerosis|relapsing forms of multiple sclerosis
723099|NCT00536107|Non-Small Cell Lung Cancer|non-small cell lung cancer
723100|NCT00536107|Locally Advanced or Metastatic NSCL Cancer|locally advanced or metastatic nscl cancer
723101|NCT00536094|Cognitive behavioral therapy|cognitive behavioral therapy
723102|NCT00536094|Youth|youth
723103|NCT00536094|School|school
723104|NCT00536094|African American|african american
723105|NCT00536081|Breast cancer|breast cancer
723106|NCT00536081|Adjuvant|adjuvant
723107|NCT00536081|Advanced|advanced
723108|NCT00536081|Chemotherapy|chemotherapy
723109|NCT00536081|G-CSF|g-csf
723110|NCT00536081|Pegfilgrastim|pegfilgrastim
723111|NCT00536081|Prevention|prevention
723112|NCT00536081|Febrile neutropenia|febrile neutropenia
723113|NCT00536068|platelet|platelet
723114|NCT00536068|aggregation|aggregation
723115|NCT00536068|aspirin|aspirin
723116|NCT00536055|breast cancer|breast cancer
723117|NCT00536055|prostate cancer|prostate cancer
723118|NCT00536055|dyadic coping|dyadic coping
723119|NCT00536042|minocycline|minocycline
723120|NCT00536042|asthma|asthma
723121|NCT00536042|oral steroids|oral steroids
723122|NCT00536042|IgE|ige
723123|NCT00536029|Melanoma|melanoma
723124|NCT00536029|SIAscope|siascope
723125|NCT00536029|pigmented skin lesions|pigmented skin lesions
723126|NCT00536016|AMD|amd
723127|NCT00536016|Neovascular Age-Related Macular Degeneration|neovascular age-related macular degeneration
723128|NCT00536003|preterm delivery|preterm delivery
723129|NCT00536003|preterm labor|preterm labor
723130|NCT00536003|perinatal morbidity|perinatal morbidity
723131|NCT00536003|perinatal mortality|perinatal mortality
723132|NCT00535990|Cholecystectomy|cholecystectomy
723133|NCT00535990|Appendectomy|appendectomy
723134|NCT00535990|Esophageal|esophageal
723135|NCT00535990|Surgical|surgical
723136|NCT00535990|Procedures|procedures
723137|NCT00535990|Surgery|surgery
723138|NCT00535990|Gastric|gastric
723139|NCT00535990|bypass|bypass
723140|NCT00535977|Gene expression|gene expression
723141|NCT00535977|Prostate|prostate
723142|NCT00535977|Broccoli|broccoli
723143|NCT00535977|Cancer|cancer
723144|NCT00535977|Men diagnosed with high-grade Prostatic Intraepithelia Neoplasia|men diagnosed with high-grade prostatic intraepithelia neoplasia
723145|NCT00535964|Cigarette Smoking|cigarette smoking
723146|NCT00535964|Tobacco Use|tobacco use
723147|NCT00535964|Adolescents|adolescents
723148|NCT00535964|Anxiety Sensitivity (AS)|anxiety sensitivity (as)
723149|NCT00535951|Non-small cell lung cancer|non-small cell lung cancer
723150|NCT00535951|NSCLC|nsclc
723151|NCT00535951|lung cancer|lung cancer
723152|NCT00535951|pleural mesothelioma|pleural mesothelioma
723153|NCT00535951|malignant|malignant
723154|NCT00535951|advanced stage|advanced stage
723155|NCT00535951|mesothelioma|mesothelioma
723156|NCT00535951|phase I|phase i
723157|NCT00535951|LBH589|lbh589
723158|NCT00535951|dextromethorphan|dextromethorphan
723159|NCT00535951|CYP2D6|cyp2d6
723160|NCT00535951|oral|oral
723161|NCT00535925|type 2 diabetes|type 2 diabetes
723162|NCT00535925|nephropathy|nephropathy
723163|NCT00535925|CV events|cv events
723164|NCT00535912|CLL|cll
723165|NCT00535899|Aortic stenosis|aortic stenosis
723166|NCT00535899|Speckle tracking imaging|speckle tracking imaging
723167|NCT00535899|Low ejection fraction|low ejection fraction
723168|NCT00535899|Aortic valve replacement|aortic valve replacement
723169|NCT00535899|Strain|strain
723170|NCT00535886|Trans Fatty Acids|trans fatty acids
723171|NCT00535886|conjugated linoleic acid|conjugated linoleic acid
723172|NCT00535886|vaccenic acid|vaccenic acid
723173|NCT00535886|High Density Lipoprotein Cholesterol|high density lipoprotein cholesterol
723174|NCT00535886|Low Density Lipoprotein Cholesterol|low density lipoprotein cholesterol
723175|NCT00535886|Beef|beef
723176|NCT00535873|Leukemia|leukemia
723177|NCT00535873|CLL|cll
723178|NCT00535873|chronic lymphocytic leukemia|chronic lymphocytic leukemia
723179|NCT00535873|SLL|sll
723180|NCT00535873|small lymphocytic lymphoma|small lymphocytic lymphoma
723181|NCT00535873|Untreated CLL|untreated cll
723182|NCT00535873|Lenalidomide|lenalidomide
723183|NCT00535873|CC-5013|cc-5013
723184|NCT00535873|Revlimid|revlimid
723185|NCT00535873|Oral|oral
723186|NCT00535860|Osteoporosis|osteoporosis
723187|NCT00535860|Transdermal|transdermal
723188|NCT00535860|hPTH(1-34)|hpth(1-34)
723189|NCT00535847|Genotype 1|genotype 1
723190|NCT00535834|stage I prostate cancer|stage i prostate cancer
723191|NCT00535834|stage II prostate cancer|stage ii prostate cancer
723192|NCT00535834|stage III prostate cancer|stage iii prostate cancer
723193|NCT00535834|adenocarcinoma of the prostate|adenocarcinoma of the prostate
723194|NCT00535821|Emergency Department|emergency department
723195|NCT00535821|Hemodynamic Optimization|hemodynamic optimization
723196|NCT00535821|Esophageal Doppler monitoring|esophageal doppler monitoring
723197|NCT00535821|Early Goal-Directed Therapy|early goal-directed therapy
723198|NCT00535769|topical|topical
723199|NCT00535769|medication adherence|medication adherence
723200|NCT00535769|adherence|adherence
723201|NCT00535769|compliance|compliance
723202|NCT00535769|medication compliance|medication compliance
723203|NCT00535769|sunscreen|sunscreen
723204|NCT00535769|reminder|reminder
723205|NCT00535756|Pancreatic Exocrine Insufficiency After Pancreatic Surgery|pancreatic exocrine insufficiency after pancreatic surgery
723206|NCT00535717|Urethral stricture|urethral stricture
723207|NCT00535717|Ayurvedic treatment|ayurvedic treatment
723208|NCT00535717|mutra marg sankoch|mutra marg sankoch
723209|NCT00535717|uttarbasti|uttarbasti
723210|NCT00535717|Sesame oil|sesame oil
723211|NCT00535717|Honey|honey
723212|NCT00535717|Rock salt|rock salt
723213|NCT00535678|Mammography|mammography
723214|NCT00535678|mammogram|mammogram
723215|NCT00535678|breast|breast
723216|NCT00535678|Abnormal and normal breast tissue|abnormal and normal breast tissue
723217|NCT00535639|Tolerability of ALK Tree Tablet in patients with birch pollen induced allergy|tolerability of alk tree tablet in patients with birch pollen induced allergy
723218|NCT00535600|Bariatric Surgery|bariatric surgery
723219|NCT00535600|Insulin Action|insulin action
723220|NCT00535600|Insulin Secretion|insulin secretion
723221|NCT00535600|Insulin Resistance|insulin resistance
723222|NCT00535600|Gut Hormones|gut hormones
723223|NCT00535600|Obesity|obesity
723224|NCT00535587|Fibromyalgia|fibromyalgia
723225|NCT00535587|Exercise|exercise
723226|NCT00535587|Mestinon|mestinon
723227|NCT00535574|retinoids|retinoids
723228|NCT00535574|bexarotene|bexarotene
723229|NCT00535574|schizophrenia|schizophrenia
723230|NCT00535574|PANSS|panss
723231|NCT00535574|Positive and negative symptoms of schizophrenia|positive and negative symptoms of schizophrenia
723232|NCT00535561|iron deficiency anemia|iron deficiency anemia
723233|NCT00535561|anemia|anemia
723234|NCT00535561|hypothyroidism|hypothyroidism
723235|NCT00535561|subclinical hypothyroidism|subclinical hypothyroidism
723236|NCT00535548|Chronic wounds|chronic wounds
723237|NCT00535548|Pressure sores|pressure sores
723238|NCT00535548|Hematopoietic stem cells|hematopoietic stem cells
723239|NCT00535548|Wound healing|wound healing
723240|NCT00535535|Elevated triglycerides|elevated triglycerides
723241|NCT00535535|Diabetes|diabetes
723242|NCT00535535|Cardiovascular disease|cardiovascular disease
723243|NCT00535522|Pharmacokinetics|pharmacokinetics
723244|NCT00535522|pharmacodynamics|pharmacodynamics
723245|NCT00535522|maximal tolerated dose|maximal tolerated dose
723246|NCT00535483|blood microdialysis|blood microdialysis
723247|NCT00535483|glucose monitoring|glucose monitoring
723248|NCT00535483|glucose control|glucose control
723249|NCT00535483|automated blood sampling|automated blood sampling
723250|NCT00535483|online-sensor|online-sensor
723251|NCT00535483|algorithm|algorithm
723252|NCT00535483|type 1 diabetes|type 1 diabetes
723253|NCT00535457|anxiety|anxiety
723254|NCT00535457|maladaptive behavior|maladaptive behavior
723255|NCT00535457|anesthesia|anesthesia
723256|NCT00535457|Anxiety before anesthesia and maladaptive behavior after anesthesia.|anxiety before anesthesia and maladaptive behavior after anesthesia.
723257|NCT00535444|Hypertension|hypertension
723258|NCT00535444|parish nurse|parish nurse
723259|NCT00535431|Asthma|asthma
723260|NCT00535431|allergy|allergy
723261|NCT00535431|interleukin-4|interleukin-4
723262|NCT00535431|interleukin-13|interleukin-13
723263|NCT00535431|IL-4|il-4
723264|NCT00535431|IL-13|il-13
723363|NCT00535028|atopic|atopic
723265|NCT00535418|Breast cancer|breast cancer
723266|NCT00535418|neoadjuvant treatment|neoadjuvant treatment
723267|NCT00535418|treatment duration|treatment duration
723268|NCT00535418|Primary hormone receptor positive|primary hormone receptor positive
723269|NCT00535418|breast cancer in postmenopausal women|breast cancer in postmenopausal women
723270|NCT00535405|High Cholesterol|high cholesterol
723271|NCT00535392|Epilepsy|epilepsy
723273|NCT00535392|Levetiracetam|levetiracetam
723274|NCT00535392|Keppra®|keppra®
723275|NCT00535392|Infusion|infusion
723276|NCT00535392|Intravenous|intravenous
723277|NCT00535379|glioblastoma multiforme|glioblastoma multiforme
723278|NCT00535379|sunitinib|sunitinib
723279|NCT00535379|recurrent|recurrent
723280|NCT00535379|progressive|progressive
723281|NCT00535353|recurrent colon cancer|recurrent colon cancer
723282|NCT00535353|stage IV colon cancer|stage iv colon cancer
723283|NCT00535353|recurrent rectal cancer|recurrent rectal cancer
723284|NCT00535353|stage IV rectal cancer|stage iv rectal cancer
723285|NCT00535353|stage III rectal cancer|stage iii rectal cancer
723286|NCT00535353|stage III colon cancer|stage iii colon cancer
723287|NCT00535340|Anxiety|anxiety
723288|NCT00535340|Anti-Anxiety Agents|anti-anxiety agents
723289|NCT00535327|Mammography|mammography
723290|NCT00535327|mammogram|mammogram
723291|NCT00535327|breast|breast
723292|NCT00535327|Abnormal and normal breast tissue|abnormal and normal breast tissue
723293|NCT00535314|Melanoma|melanoma
723294|NCT00535301|cystocele|cystocele
723295|NCT00535301|uterine prolapse|uterine prolapse
723296|NCT00535301|urinary incontinence|urinary incontinence
723297|NCT00535275|NSCLC relapse after adjuvant chemotherapy|nsclc relapse after adjuvant chemotherapy
723298|NCT00535262|Bipolar|bipolar
723299|NCT00535262|depression|depression
723300|NCT00535236|Prevention of herpes zoster and HZ-related complications|prevention of herpes zoster and hz-related complications
723301|NCT00535223|Cognitive Behavior Therapy|cognitive behavior therapy
723302|NCT00535223|Group therapy|group therapy
723303|NCT00535223|Posttraumatic Stress Disorder|posttraumatic stress disorder
723304|NCT00535223|Randomized Controlled Trial|randomized controlled trial
723305|NCT00535223|Treatment outcome|treatment outcome
723306|NCT00535223|Veterans|veterans
723308|NCT00535210|spinal cord injury|spinal cord injury
723309|NCT00535210|exercise rehabilitation|exercise rehabilitation
723310|NCT00535210|inpatient|inpatient
723311|NCT00535210|RCT|rct
723312|NCT00535210|physical function|physical function
723313|NCT00535197|Stroke|stroke
723314|NCT00535197|Middle Cerebral Artery|middle cerebral artery
723315|NCT00535184|Mammography|mammography
723316|NCT00535184|mammogram|mammogram
723317|NCT00535184|breast|breast
723318|NCT00535184|Abnormal and normal breast tissue|abnormal and normal breast tissue
723319|NCT00535158|Chronic Kidney disease|chronic kidney disease
723320|NCT00535158|Dialysis|dialysis
723321|NCT00535158|Vitamin D|vitamin d
723322|NCT00535158|Chronic kidney disease is associated with impaired muscle strength, pain and fractures.|chronic kidney disease is associated with impaired muscle strength, pain and fractures.
723323|NCT00535145|antipsychotic|antipsychotic
723324|NCT00535145|paliperidone ER|paliperidone er
723325|NCT00535145|liver disease|liver disease
723326|NCT00535145|Schizophrenia|schizophrenia
723327|NCT00535145|Schizoaffective Disorder|schizoaffective disorder
723328|NCT00535145|Invega|invega
723329|NCT00535132|schizophrenia|schizophrenia
723330|NCT00535132|medication satisfaction, Invega|medication satisfaction, invega
723331|NCT00535106|Ventricular fibrillation|ventricular fibrillation
723332|NCT00535106|Cardiac arrest|cardiac arrest
723333|NCT00535106|Automated external defibrillator|automated external defibrillator
723334|NCT00535106|AED|aed
723335|NCT00535106|Waveform based algorithms|waveform based algorithms
723336|NCT00535106|VF waveform analysis|vf waveform analysis
723337|NCT00535093|Pharyngitis|pharyngitis
723338|NCT00535093|Community infections|community infections
723339|NCT00535093|Rapid Testing|rapid testing
723340|NCT00535093|Group A Streptococcus|group a streptococcus
723341|NCT00535080|actinic|actinic
723342|NCT00535080|keratoses|keratoses
723343|NCT00535080|superficial|superficial
723344|NCT00535080|basal|basal
723345|NCT00535080|carcinomas|carcinomas
723346|NCT00535080|Bowen's|bowen's
723347|NCT00535080|large or multiple superficial Basal Carcinomas|large or multiple superficial basal carcinomas
723348|NCT00535067|Breast Cancer|breast cancer
723349|NCT00535067|Questionnaire|questionnaire
723350|NCT00535067|Survey|survey
723351|NCT00535067|Neuropathic Pain|neuropathic pain
723352|NCT00535067|Cancer Survivors|cancer survivors
723353|NCT00535067|Quality of Life|quality of life
723354|NCT00535067|QOL|qol
723355|NCT00535054|Dry Eye Syndrome|dry eye syndrome
723356|NCT00535041|Pilot trial of pre-operative chemo/RT using Xeloda and external beam RT followed by definite surgery in patients with localized rectal CA|pilot trial of pre-operative chemo/rt using xeloda and external beam rt followed by definite surgery in patients with localized rectal ca
723357|NCT00535028|asthma|asthma
723358|NCT00535028|allergy|allergy
723359|NCT00535028|interleukin-4|interleukin-4
723360|NCT00535028|interleukin-13|interleukin-13
723361|NCT00535028|IL-4|il-4
723362|NCT00535028|IL-13|il-13
723364|NCT00535028|late asthmatic response|late asthmatic response
723365|NCT00535028|inflammation|inflammation
723366|NCT00535002|Cocaine Addiction|cocaine addiction
723367|NCT00535002|Cocaine Dependence|cocaine dependence
723368|NCT00534989|NHL and HD|nhl and hd
723369|NCT00534963|sonohysterography, catheter placement|sonohysterography, catheter placement
723370|NCT00534950|Randomized multicenter study of 5 vs 6 weekly fraction of RT in the treatment of SCC of the head and neck|randomized multicenter study of 5 vs 6 weekly fraction of rt in the treatment of scc of the head and neck
723371|NCT00534937|Venous stasis ulcer|venous stasis ulcer
723372|NCT00534937|Compression pump|compression pump
723373|NCT00534937|Randomized trial|randomized trial
723374|NCT00534937|Flexitouch compression|flexitouch compression
723375|NCT00534924|IR injury|ir injury
723376|NCT00534924|MRI|mri
723377|NCT00534924|Vitamin C|vitamin c
723378|NCT00534924|Postconditioning|postconditioning
723379|NCT00534911|Depression|depression
723380|NCT00534911|Physical Illness|physical illness
723381|NCT00534911|Inflammatory Bowel Disease|inflammatory bowel disease
723382|NCT00534911|Cognitive Behavioral Therapy|cognitive behavioral therapy
723383|NCT00534885|inactivated hepatitis A vaccine|inactivated hepatitis a vaccine
723384|NCT00534885|Healive|healive
723385|NCT00534885|safety|safety
723386|NCT00534885|immunogenicity|immunogenicity
723387|NCT00534885|immune persistence|immune persistence
723388|NCT00534872|4 Parallel cohorts|4 parallel cohorts
723389|NCT00534872|Healthy Female|healthy female
723390|NCT00534872|Healthy Elderly|healthy elderly
723391|NCT00534872|Pharmacokinetic|pharmacokinetic
723392|NCT00534872|Safety and Tolerability|safety and tolerability
723393|NCT00534846|premenstrual syndrome|premenstrual syndrome
723394|NCT00534846|mastalgia|mastalgia
723395|NCT00534846|toremifene|toremifene
723396|NCT00534846|selective estrogen receptor modulators|selective estrogen receptor modulators
723397|NCT00534833|Diphtheria|diphtheria
723398|NCT00534833|Tetanus|tetanus
723399|NCT00534833|Pertussis|pertussis
723400|NCT00534833|Hepatitis B Hansenula (HB)|hepatitis b hansenula (hb)
723401|NCT00534833|Haemophilus influenzae type b|haemophilus influenzae type b
723402|NCT00534820|Cytogenetic Analysis of Bone Marrow Specimen in Non-Hodgkin's Lymphoma or Hodgkin's Disease|cytogenetic analysis of bone marrow specimen in non-hodgkin's lymphoma or hodgkin's disease
723403|NCT00534781|Achilles|achilles
723404|NCT00534781|Tendinosis|tendinosis
723405|NCT00534781|Tendinitis|tendinitis
723406|NCT00534781|Achilles Tendinosis|achilles tendinosis
723407|NCT00534781|Achilles Tendinitis|achilles tendinitis
723408|NCT00534781|Coblation|coblation
723409|NCT00534781|Bipolar Radiofrequency|bipolar radiofrequency
723410|NCT00534781|Surgical Debridement|surgical debridement
723411|NCT00534781|Debridement|debridement
723412|NCT00534781|Heel Pain|heel pain
723413|NCT00534781|Achilles Pain|achilles pain
723414|NCT00534742|Siblings|siblings
723415|NCT00534729|Organ Preservation|organ preservation
723416|NCT00534729|Carboplatin|carboplatin
723417|NCT00534729|Taxol|taxol
723418|NCT00534729|RT|rt
723419|NCT00534729|laryngeal & Hypopharyngeal CA|laryngeal & hypopharyngeal ca
723420|NCT00534729|Locally advanced laryngeal & Hypopharyngeal CA|locally advanced laryngeal & hypopharyngeal ca
723421|NCT00534716|Cannabis|cannabis
723422|NCT00534716|doping|doping
723423|NCT00534716|THC|thc
723424|NCT00534716|GC/MS|gc/ms
723425|NCT00534716|Pharmacokinetics|pharmacokinetics
723426|NCT00534716|Volunteers|volunteers
723427|NCT00534690|Pulmonary disease|pulmonary disease
723428|NCT00534690|Intubation, Intratracheal|intubation, intratracheal
723429|NCT00534690|Positive-pressure ventilation|positive-pressure ventilation
723430|NCT00534677|Variceal bleed|variceal bleed
723431|NCT00534677|Cirrhosis|cirrhosis
723432|NCT00534677|Vasoactive agents|vasoactive agents
723433|NCT00534677|Terlipressin|terlipressin
723434|NCT00534677|Octreotide|octreotide
723435|NCT00534677|Safety & Efficacy|safety & efficacy
723436|NCT00534638|HPV vaccine|hpv vaccine
723437|NCT00534638|Healthy adolescents|healthy adolescents
723438|NCT00534638|Cervical cancer|cervical cancer
723439|NCT00534638|Safety|safety
723440|NCT00534638|Immunogenicity|immunogenicity
723441|NCT00534638|Cervarix|cervarix
723442|NCT00534625|Asthma, exacerbation, pulmonary function|asthma, exacerbation, pulmonary function
723443|NCT00534612|Parotid gland neoplasms|parotid gland neoplasms
723444|NCT00534599|Generalized anxiety disorders|generalized anxiety disorders
723445|NCT00534599|anxiety|anxiety
723446|NCT00534599|adjunct treatment in anxiety|adjunct treatment in anxiety
723447|NCT00534599|anxiety disorder|anxiety disorder
723448|NCT00534599|partial or non-responder in anxiety|partial or non-responder in anxiety
723449|NCT00534586|Pain|pain
723450|NCT00534586|SSEP|ssep
723451|NCT00534586|CHEPS|cheps
723452|NCT00534586|Propofol|propofol
723453|NCT00534586|Sevoflurane|sevoflurane
723454|NCT00534586|S-Ketamine|s-ketamine
723455|NCT00534586|Remifentanil|remifentanil
723456|NCT00534586|Healthy volunteers|healthy volunteers
723457|NCT00534534|Pancreatitis|pancreatitis
723458|NCT00534534|acute|acute
723459|NCT00534534|alcoholic|alcoholic
723460|NCT00534534|recurrence|recurrence
723461|NCT00534534|alcoholism|alcoholism
723463|NCT00534534|Acute alcoholic pancreatitis|acute alcoholic pancreatitis
723464|NCT00534521|overactive bladder|overactive bladder
723465|NCT00534521|posterior tibial nerve stimulation|posterior tibial nerve stimulation
723466|NCT00534508|Skin|skin
723467|NCT00534508|Pharmacokinetics|pharmacokinetics
723468|NCT00534508|Tacrolimus|tacrolimus
723469|NCT00534508|dermatitis, atopic|dermatitis, atopic
723470|NCT00534495|Systemic Juvenile Idiopathic Arthritis|systemic juvenile idiopathic arthritis
723471|NCT00534495|Juvenile Rheumatoid Arthritis|juvenile rheumatoid arthritis
723472|NCT00534495|Systemic Juvenile Rheumatoid Arthritis|systemic juvenile rheumatoid arthritis
723473|NCT00534482|fitness|fitness
723474|NCT00534469|adult acute myeloid leukemia in remission|adult acute myeloid leukemia in remission
723475|NCT00534469|adult acute myeloid leukemia with 11q23 (MLL) abnormalities|adult acute myeloid leukemia with 11q23 (mll) abnormalities
723476|NCT00534469|adult acute myeloid leukemia with inv(16)(p13;q22)|adult acute myeloid leukemia with inv(16)(p13;q22)
723477|NCT00534469|adult acute myeloid leukemia with t(16;16)(p13;q22)|adult acute myeloid leukemia with t(16;16)(p13;q22)
723478|NCT00534469|adult acute myeloid leukemia with t(8;21)(q22;q22)|adult acute myeloid leukemia with t(8;21)(q22;q22)
723479|NCT00534469|adult acute basophilic leukemia|adult acute basophilic leukemia
723480|NCT00534469|adult acute eosinophilic leukemia|adult acute eosinophilic leukemia
723481|NCT00534469|adult erythroleukemia (M6a)|adult erythroleukemia (m6a)
723482|NCT00534469|adult pure erythroid leukemia (M6b)|adult pure erythroid leukemia (m6b)
723483|NCT00534469|adult acute megakaryoblastic leukemia (M7)|adult acute megakaryoblastic leukemia (m7)
723484|NCT00534469|adult acute minimally differentiated myeloid leukemia (M0)|adult acute minimally differentiated myeloid leukemia (m0)
723485|NCT00534469|adult acute monoblastic leukemia (M5a)|adult acute monoblastic leukemia (m5a)
723486|NCT00534469|adult acute monocytic leukemia (M5b)|adult acute monocytic leukemia (m5b)
723487|NCT00534469|adult acute myeloblastic leukemia with maturation (M2)|adult acute myeloblastic leukemia with maturation (m2)
723488|NCT00534469|adult acute myeloblastic leukemia without maturation (M1)|adult acute myeloblastic leukemia without maturation (m1)
723489|NCT00534469|adult acute myelomonocytic leukemia (M4)|adult acute myelomonocytic leukemia (m4)
723490|NCT00534456|exploratory study|exploratory study
723491|NCT00534456|anemia|anemia
723492|NCT00534456|pharmacogenetics testing|pharmacogenetics testing
723493|NCT00534456|biomarkers|biomarkers
723494|NCT00534456|echocardiography|echocardiography
723495|NCT00534443|peptic ulcer|peptic ulcer
723496|NCT00534443|gastritis|gastritis
723497|NCT00534443|sTREM-1|strem-1
723498|NCT00534443|cytokines|cytokines
723499|NCT00534443|Changes of inflammatory status in gastric mucosa|changes of inflammatory status in gastric mucosa
723500|NCT00534443|sTREM-1 as a disease marker|strem-1 as a disease marker
723501|NCT00534430|adult acute myeloid leukemia with 11q23 (MLL) abnormalities|adult acute myeloid leukemia with 11q23 (mll) abnormalities
723502|NCT00534430|adult acute myeloid leukemia with inv(16)(p13;q22)|adult acute myeloid leukemia with inv(16)(p13;q22)
723503|NCT00534430|adult acute myeloid leukemia with t(15;17)(q22;q12)|adult acute myeloid leukemia with t(15;17)(q22;q12)
723504|NCT00534430|adult acute myeloid leukemia with t(16;16)(p13;q22)|adult acute myeloid leukemia with t(16;16)(p13;q22)
723505|NCT00534430|adult acute myeloid leukemia with t(8;21)(q22;q22)|adult acute myeloid leukemia with t(8;21)(q22;q22)
723506|NCT00534430|recurrent adult acute myeloid leukemia|recurrent adult acute myeloid leukemia
723507|NCT00534430|adult acute myeloid leukemia in remission|adult acute myeloid leukemia in remission
723508|NCT00534430|recurrent childhood acute myeloid leukemia|recurrent childhood acute myeloid leukemia
723509|NCT00534430|recurrent adult acute lymphoblastic leukemia|recurrent adult acute lymphoblastic leukemia
723510|NCT00534430|recurrent childhood acute lymphoblastic leukemia|recurrent childhood acute lymphoblastic leukemia
723511|NCT00534430|blastic phase chronic myelogenous leukemia|blastic phase chronic myelogenous leukemia
723512|NCT00534430|refractory anemia with excess blasts in transformation|refractory anemia with excess blasts in transformation
723513|NCT00534430|refractory anemia with excess blasts|refractory anemia with excess blasts
723514|NCT00534430|previously treated myelodysplastic syndromes|previously treated myelodysplastic syndromes
723515|NCT00534430|secondary myelodysplastic syndromes|secondary myelodysplastic syndromes
723516|NCT00534417|Hormone|hormone
723517|NCT00534417|Receptor|receptor
723518|NCT00534417|Positive|positive
723519|NCT00534417|Metastatic|metastatic
723520|NCT00534417|Breast|breast
723521|NCT00534417|Cancer|cancer
723522|NCT00534404|Internet-Assisted Tobacco Treatments|internet-assisted tobacco treatments
723523|NCT00534404|Online Smoking Cessation Programs|online smoking cessation programs
723524|NCT00534404|Nicotine Patches|nicotine patches
723525|NCT00534404|Telephone Counseling|telephone counseling
723526|NCT00534404|Smoking Abstinence|smoking abstinence
723527|NCT00534391|Antibiotics|antibiotics
723528|NCT00534391|hordeolum|hordeolum
723529|NCT00534378|Nerve agent|nerve agent
723530|NCT00534378|Midazolam|midazolam
723531|NCT00534378|Seizures|seizures
723532|NCT00534378|Severe recurrent convulsive seizures induced by nerve agent exposure|severe recurrent convulsive seizures induced by nerve agent exposure
723533|NCT00534365|stress urinary incontinence|stress urinary incontinence
723534|NCT00534365|sling procedures|sling procedures
723535|NCT00534365|tension-free vaginal tape|tension-free vaginal tape
723536|NCT00534352|HIV|hiv
723537|NCT00534352|AIDS|aids
723538|NCT00534352|Immunodeficiency Virus, Human|immunodeficiency virus, human
723543|NCT00534352|Protease Inhibitor|protease inhibitor
723544|NCT00534352|Non-Nucleoside Reverse Transcriptase Inhibitor|non-nucleoside reverse transcriptase inhibitor
723545|NCT00534352|Truvada|truvada
723546|NCT00534352|Treatment Naive|treatment naive
723547|NCT00534300|ICD-pacemaker|icd-pacemaker
723548|NCT00534287|sepsis|sepsis
723549|NCT00534287|antibiotics|antibiotics
723550|NCT00534287|carbapenems|carbapenems
723551|NCT00534287|fluoroquinolones|fluoroquinolones
723552|NCT00534287|Severe sepsis and septic shock|severe sepsis and septic shock
723553|NCT00534274|stage II breast cancer|stage ii breast cancer
723554|NCT00534274|stage IIIA breast cancer|stage iiia breast cancer
723555|NCT00534261|Multiple Sclerosis|multiple sclerosis
723556|NCT00534261|Avonex|avonex
723557|NCT00534261|Interferon beta-1a|interferon beta-1a
723558|NCT00534222|Patients with a manic episode|patients with a manic episode
723559|NCT00534222|Patients diagnosed w/schizophrenia, who start a treatment with an atypical antipsychotic & who are at least scored as moderately ill on the CGI at baseline|patients diagnosed w/schizophrenia, who start a treatment with an atypical antipsychotic & who are at least scored as moderately ill on the cgi at baseline
723560|NCT00534209|stage IIIB non-small cell lung cancer|stage iiib non-small cell lung cancer
723561|NCT00534209|stage IV non-small cell lung cancer|stage iv non-small cell lung cancer
723562|NCT00534196|recurrent prostate cancer|recurrent prostate cancer
723563|NCT00534196|stage I prostate cancer|stage i prostate cancer
723564|NCT00534196|stage IIB prostate cancer|stage iib prostate cancer
723565|NCT00534196|stage IIA prostate cancer|stage iia prostate cancer
723566|NCT00534196|stage III prostate cancer|stage iii prostate cancer
723567|NCT00534183|Metabolic syndrome|metabolic syndrome
723568|NCT00534183|Obesity|obesity
723569|NCT00534183|Diabetes|diabetes
723570|NCT00534170|Probiotic|probiotic
723571|NCT00534170|Prevention of diarrhoea|prevention of diarrhoea
723572|NCT00534170|Nutritional status|nutritional status
723573|NCT00534157|intracranial pressure|intracranial pressure
723574|NCT00534157|intraocular pressure|intraocular pressure
723575|NCT00534157|tonometry|tonometry
723576|NCT00534118|accelerated phase chronic myelogenous leukemia|accelerated phase chronic myelogenous leukemia
723577|NCT00534118|chronic phase chronic myelogenous leukemia|chronic phase chronic myelogenous leukemia
723578|NCT00534118|relapsing chronic myelogenous leukemia|relapsing chronic myelogenous leukemia
723579|NCT00534118|childhood chronic myelogenous leukemia|childhood chronic myelogenous leukemia
723580|NCT00534118|previously treated myelodysplastic syndromes|previously treated myelodysplastic syndromes
723581|NCT00534118|recurrent adult acute lymphoblastic leukemia|recurrent adult acute lymphoblastic leukemia
723582|NCT00534118|recurrent childhood acute lymphoblastic leukemia|recurrent childhood acute lymphoblastic leukemia
723583|NCT00534118|adult acute myeloid leukemia with 11q23 (MLL) abnormalities|adult acute myeloid leukemia with 11q23 (mll) abnormalities
723584|NCT00534118|adult acute myeloid leukemia with inv(16)(p13;q22)|adult acute myeloid leukemia with inv(16)(p13;q22)
723585|NCT00534118|adult acute myeloid leukemia with t(15;17)(q22;q12)|adult acute myeloid leukemia with t(15;17)(q22;q12)
723586|NCT00534118|adult acute myeloid leukemia with t(16;16)(p13;q22)|adult acute myeloid leukemia with t(16;16)(p13;q22)
723587|NCT00534118|adult acute myeloid leukemia with t(8;21)(q22;q22)|adult acute myeloid leukemia with t(8;21)(q22;q22)
723588|NCT00534118|recurrent adult acute myeloid leukemia|recurrent adult acute myeloid leukemia
723589|NCT00534118|recurrent childhood acute myeloid leukemia|recurrent childhood acute myeloid leukemia
723590|NCT00534118|stage I multiple myeloma|stage i multiple myeloma
723591|NCT00534118|stage II multiple myeloma|stage ii multiple myeloma
723592|NCT00534118|stage III multiple myeloma|stage iii multiple myeloma
723593|NCT00534118|refractory multiple myeloma|refractory multiple myeloma
723594|NCT00534118|recurrent adult Hodgkin lymphoma|recurrent adult hodgkin lymphoma
723595|NCT00534118|recurrent/refractory childhood Hodgkin lymphoma|recurrent/refractory childhood hodgkin lymphoma
723596|NCT00534118|recurrent adult Burkitt lymphoma|recurrent adult burkitt lymphoma
723597|NCT00534118|recurrent adult diffuse large cell lymphoma|recurrent adult diffuse large cell lymphoma
723598|NCT00534118|recurrent adult diffuse mixed cell lymphoma|recurrent adult diffuse mixed cell lymphoma
723599|NCT00534118|recurrent adult diffuse small cleaved cell lymphoma|recurrent adult diffuse small cleaved cell lymphoma
723600|NCT00534118|recurrent adult immunoblastic large cell lymphoma|recurrent adult immunoblastic large cell lymphoma
723601|NCT00534118|recurrent adult lymphoblastic lymphoma|recurrent adult lymphoblastic lymphoma
723602|NCT00534118|recurrent grade 1 follicular lymphoma|recurrent grade 1 follicular lymphoma
723603|NCT00534118|recurrent grade 2 follicular lymphoma|recurrent grade 2 follicular lymphoma
723604|NCT00534118|recurrent grade 3 follicular lymphoma|recurrent grade 3 follicular lymphoma
723605|NCT00534118|recurrent mantle cell lymphoma|recurrent mantle cell lymphoma
723606|NCT00534118|recurrent marginal zone lymphoma|recurrent marginal zone lymphoma
723607|NCT00534118|recurrent small lymphocytic lymphoma|recurrent small lymphocytic lymphoma
723608|NCT00534118|recurrent adult grade III lymphomatoid granulomatosis|recurrent adult grade iii lymphomatoid granulomatosis
723609|NCT00534118|Waldenstrom macroglobulinemia|waldenstrom macroglobulinemia
723610|NCT00534118|recurrent childhood grade III lymphomatoid granulomatosis|recurrent childhood grade iii lymphomatoid granulomatosis
723611|NCT00534118|recurrent childhood large cell lymphoma|recurrent childhood large cell lymphoma
723612|NCT00534118|recurrent childhood lymphoblastic lymphoma|recurrent childhood lymphoblastic lymphoma
723613|NCT00534118|childhood diffuse large cell lymphoma|childhood diffuse large cell lymphoma
723986|NCT00532480|Depression|depression
723614|NCT00534118|childhood immunoblastic large cell lymphoma|childhood immunoblastic large cell lymphoma
723615|NCT00534118|recurrent childhood small noncleaved cell lymphoma|recurrent childhood small noncleaved cell lymphoma
723616|NCT00534118|de novo myelodysplastic syndromes|de novo myelodysplastic syndromes
723617|NCT00534118|secondary acute myeloid leukemia|secondary acute myeloid leukemia
723618|NCT00534118|secondary myelodysplastic syndromes|secondary myelodysplastic syndromes
723619|NCT00534118|splenic marginal zone lymphoma|splenic marginal zone lymphoma
723620|NCT00534118|extranodal marginal zone B-cell lymphoma of mucosa-associated lymphoid tissue|extranodal marginal zone b-cell lymphoma of mucosa-associated lymphoid tissue
723621|NCT00534118|nodal marginal zone B-cell lymphoma|nodal marginal zone b-cell lymphoma
723622|NCT00534118|recurrent cutaneous T-cell non-Hodgkin lymphoma|recurrent cutaneous t-cell non-hodgkin lymphoma
723623|NCT00534118|recurrent mycosis fungoides/Sezary syndrome|recurrent mycosis fungoides/sezary syndrome
723624|NCT00534118|cutaneous B-cell non-Hodgkin lymphoma|cutaneous b-cell non-hodgkin lymphoma
723625|NCT00534105|Pregnancy|pregnancy
723626|NCT00534105|Gestational diabetes|gestational diabetes
723627|NCT00534105|Hyperlipidemia|hyperlipidemia
723628|NCT00534092|Lumbar Spinal Stenosis|lumbar spinal stenosis
723629|NCT00534092|X STOP|x stop
723630|NCT00534079|Cystic Fibrosis and chronic rhinosinusitis|cystic fibrosis and chronic rhinosinusitis
723631|NCT00534066|Natriuretic Peptide, Brain|natriuretic peptide, brain
723632|NCT00534053|colon cancer screening|colon cancer screening
723633|NCT00534053|mail reminders|mail reminders
723634|NCT00534053|fecal occult blood test|fecal occult blood test
723635|NCT00534053|compliance|compliance
723636|NCT00534027|NSCLC|nsclc
723637|NCT00534027|Non-Small Cell Lung Cancer|non-small cell lung cancer
723638|NCT00534027|Paclitaxel|paclitaxel
723639|NCT00534027|Carboplatin|carboplatin
723640|NCT00534027|AMG 655|amg 655
723641|NCT00534001|bladder cancer|bladder cancer
723642|NCT00534001|cervical cancer|cervical cancer
723643|NCT00534001|esophageal cancer|esophageal cancer
723644|NCT00534001|gastric cancer|gastric cancer
723645|NCT00534001|renal cell carcinoma|renal cell carcinoma
723646|NCT00534001|adult primary liver cancer|adult primary liver cancer
723647|NCT00534001|non-small cell lung cancer|non-small cell lung cancer
723648|NCT00534001|small cell lung cancer|small cell lung cancer
723649|NCT00534001|pancreatic cancer|pancreatic cancer
723650|NCT00534001|hypopharyngeal cancer|hypopharyngeal cancer
723651|NCT00534001|laryngeal cancer|laryngeal cancer
723652|NCT00534001|lip and oral cavity cancer|lip and oral cavity cancer
723653|NCT00534001|nasopharyngeal cancer|nasopharyngeal cancer
723654|NCT00534001|oropharyngeal cancer|oropharyngeal cancer
723655|NCT00534001|paranasal sinus and nasal cavity cancer|paranasal sinus and nasal cavity cancer
723656|NCT00534001|adult acute myeloid leukemia|adult acute myeloid leukemia
723657|NCT00534001|tobacco use disorder|tobacco use disorder
723658|NCT00533988|Central venous catheters|central venous catheters
723659|NCT00533988|Antimicrobial impregnated catheters|antimicrobial impregnated catheters
723660|NCT00533988|Duration of catheter use|duration of catheter use
723661|NCT00533988|Catheter-related infection|catheter-related infection
723662|NCT00533988|Insertion site|insertion site
723663|NCT00533988|Parenteral nutrition|parenteral nutrition
723664|NCT00533988|Critically ill patients (multidisciplinary)|critically ill patients (multidisciplinary)
723665|NCT00533975|Colon Cancer screening|colon cancer screening
723666|NCT00533975|immunofecal occult blood test|immunofecal occult blood test
723667|NCT00533975|colonoscopy|colonoscopy
723668|NCT00533975|diagnostic validity|diagnostic validity
723669|NCT00533962|Glaucoma|glaucoma
723670|NCT00533962|Anecortave Acetate|anecortave acetate
723671|NCT00533962|Intraocular pressure|intraocular pressure
723672|NCT00533962|Advanced glaucoma cases with uncontrolled IOP|advanced glaucoma cases with uncontrolled iop
723673|NCT00533949|radiation toxicity|radiation toxicity
723674|NCT00533949|stage IIIA non-small cell lung cancer|stage iiia non-small cell lung cancer
723675|NCT00533949|stage IIIB non-small cell lung cancer|stage iiib non-small cell lung cancer
723676|NCT00533936|stage II breast cancer|stage ii breast cancer
723677|NCT00533936|stage IIIA breast cancer|stage iiia breast cancer
723678|NCT00533936|stage IIIB breast cancer|stage iiib breast cancer
723679|NCT00533936|stage IIIC breast cancer|stage iiic breast cancer
723680|NCT00533923|Nonmyeloablative Allogeneic Stem Cell Transplantation|nonmyeloablative allogeneic stem cell transplantation
723681|NCT00533923|mini-transplant|mini-transplant
723682|NCT00533923|AML|aml
723683|NCT00533923|ALL|all
723684|NCT00533923|CML|cml
723685|NCT00533923|CLL|cll
723686|NCT00533923|Myelodysplastic syndrome|myelodysplastic syndrome
723687|NCT00533923|Relapsed non-Hodgkin's or Hodgkin's lymphoma|relapsed non-hodgkin's or hodgkin's lymphoma
723688|NCT00533923|Relapsed multiple myeloma|relapsed multiple myeloma
723689|NCT00533923|Aplastic anemia|aplastic anemia
723690|NCT00533923|Myeloproliferative disorder|myeloproliferative disorder
723691|NCT00533923|GM-CSF|gm-csf
723692|NCT00533923|Cyclosporin|cyclosporin
723693|NCT00533923|Fludarabine (FLUDARA)|fludarabine (fludara)
723694|NCT00533923|Cyclophosphamide|cyclophosphamide
723695|NCT00533923|CAMPATH-1H|campath-1h
723696|NCT00533923|GVHD|gvhd
723697|NCT00533923|CMV|cmv
723983|NCT00532493|PTSD|ptsd
723698|NCT00533923|AML in first remission, first relapse or subsequent remission|aml in first remission, first relapse or subsequent remission
723699|NCT00533923|ALL in first relapse, second or subsequent remission|all in first relapse, second or subsequent remission
723700|NCT00533923|ALL in first remission, in a high-risk category|all in first remission, in a high-risk category
723701|NCT00533923|Aplastic anemia characterized by ANC< 1000 and/or platelets < 30 without transfusional support|aplastic anemia characterized by anc< 1000 and/or platelets < 30 without transfusional support
723702|NCT00533923|Myeloproliferative disorder (P Vera, CMML, ET)|myeloproliferative disorder (p vera, cmml, et)
723703|NCT00533910|Minimal hepatic encephalopathy|minimal hepatic encephalopathy
723704|NCT00533897|Rheumatoid Arthritis (RA)|rheumatoid arthritis (ra)
723705|NCT00533884|delirium|delirium
723706|NCT00533884|cognitive/functional effects|cognitive/functional effects
723707|NCT00533884|hypopharyngeal cancer|hypopharyngeal cancer
723708|NCT00533884|laryngeal cancer|laryngeal cancer
723709|NCT00533884|lip and oral cavity cancer|lip and oral cavity cancer
723710|NCT00533884|metastatic squamous neck cancer with occult primary|metastatic squamous neck cancer with occult primary
723711|NCT00533884|nasopharyngeal cancer|nasopharyngeal cancer
723712|NCT00533884|oropharyngeal cancer|oropharyngeal cancer
723713|NCT00533884|paranasal sinus and nasal cavity cancer|paranasal sinus and nasal cavity cancer
723714|NCT00533884|salivary gland cancer|salivary gland cancer
723715|NCT00533884|esophageal cancer|esophageal cancer
723716|NCT00533884|non-small cell lung cancer|non-small cell lung cancer
723717|NCT00533884|small cell lung cancer|small cell lung cancer
723718|NCT00533871|Natriuretic Peptide Brain|natriuretic peptide brain
723719|NCT00533858|Systolic hypertension|systolic hypertension
723720|NCT00533832|depression|depression
723721|NCT00533832|vagus nerve stimulation|vagus nerve stimulation
723722|NCT00533819|Exercise intervention|exercise intervention
723723|NCT00533819|Maths Scores|maths scores
723724|NCT00533819|Blood pressure|blood pressure
723725|NCT00533819|Female school children|female school children
723726|NCT00533819|Body mass index|body mass index
723727|NCT00533806|Cognitive Behavior Therapy|cognitive behavior therapy
723728|NCT00533806|Active Control|active control
723729|NCT00533806|Relaxation Therapy|relaxation therapy
723730|NCT00533806|Young Children|young children
723731|NCT00533793|bone, tibial shaft fracture|bone, tibial shaft fracture
723732|NCT00533767|Hantavirus cardiopulmonary syndrome, Andes virus, Chile|hantavirus cardiopulmonary syndrome, andes virus, chile
723733|NCT00533754|age-related macular degeneration, genetics|age-related macular degeneration, genetics
723734|NCT00533741|Severe Acute Respiratory Syndrome, Coronavirus, vaccine|severe acute respiratory syndrome, coronavirus, vaccine
723735|NCT00533715|Inspiratory Spirometry; Preschool Children; Computer games|inspiratory spirometry; preschool children; computer games
723736|NCT00533715|Health|health
723737|NCT00533702|Phase II|phase ii
723738|NCT00533702|Melanoma|melanoma
723739|NCT00533702|IMC-1121B|imc-1121b
723740|NCT00533702|ImClone|imclone
723741|NCT00533637|Allergic rhinitis|allergic rhinitis
723742|NCT00533637|Nasal spray|nasal spray
723743|NCT00533637|Anti-histamine|anti-histamine
723744|NCT00533637|Tolerability|tolerability
723745|NCT00533624|Gastrointestinal toxicity|gastrointestinal toxicity
723746|NCT00533585|Non-Small Cell Lung Cancer|non-small cell lung cancer
723747|NCT00533585|Lung Cancer|lung cancer
723748|NCT00533585|NSCLC|nsclc
723749|NCT00533585|malignant pleural effusions|malignant pleural effusions
723750|NCT00533585|Sorafenib|sorafenib
723751|NCT00533585|Paclitaxel|paclitaxel
723752|NCT00533585|Taxol|taxol
723753|NCT00533585|Carboplatin|carboplatin
723754|NCT00533585|Paraplatin|paraplatin
723755|NCT00533585|Bevacizumab|bevacizumab
723756|NCT00533585|Avastin|avastin
723757|NCT00533585|BAY 43-9006|bay 43-9006
723758|NCT00533585|Anti-VEGF monoclonal antibody|anti-vegf monoclonal antibody
723759|NCT00533585|rhuMAb-VEGF|rhumab-vegf
723760|NCT00533559|type 2 diabetes|type 2 diabetes
723761|NCT00533559|free fatty acids|free fatty acids
723762|NCT00533559|insulin resistance|insulin resistance
723763|NCT00533559|beta cell lipotoxic effect|beta cell lipotoxic effect
723764|NCT00533546|Acute Ischemic Stroke|acute ischemic stroke
723765|NCT00533533|Docetaxel,Oxaliplatin|docetaxel,oxaliplatin
723766|NCT00533533|Phase I/II study|phase i/ii study
723767|NCT00533533|Advanced gastric cancer|advanced gastric cancer
723768|NCT00533533|First line treatment|first line treatment
723769|NCT00533533|Advanced gastric cancer with measurable disease|advanced gastric cancer with measurable disease
723770|NCT00533507|Pneumococcal vaccine.|pneumococcal vaccine.
723771|NCT00533507|Pneumococcal disease|pneumococcal disease
723772|NCT00533507|Safety|safety
723773|NCT00533507|Immunogenicity|immunogenicity
723774|NCT00533507|Primary vaccination|primary vaccination
723775|NCT00533468|pain|pain
723776|NCT00533468|lumbar puncture|lumbar puncture
723777|NCT00533468|neonates|neonates
723778|NCT00533468|infants|infants
723779|NCT00533468|emergency department|emergency department
723780|NCT00533468|topical anesthesia|topical anesthesia
723781|NCT00533468|LMX4|lmx4
723782|NCT00533455|Antipsychotics, tremor|antipsychotics, tremor
723783|NCT00533442|Rapamycin|rapamycin
723784|NCT00533442|Mycophenolate Mofetil (MMF)|mycophenolate mofetil (mmf)
723785|NCT00533442|Kidney-Pancreas Transplant|kidney-pancreas transplant
725328|NCT00526786|CryoSpray|cryospray
723786|NCT00533416|Myelodyplastic Syndrome (MDS)|myelodyplastic syndrome (mds)
723987|NCT00532480|Duloxetine|duloxetine
723787|NCT00533416|Selective Mitotic Inhibitor|selective mitotic inhibitor
723788|NCT00533416|Targeted Therapy|targeted therapy
723789|NCT00533416|Myelodysplastic Syndrome|myelodysplastic syndrome
723790|NCT00533416|MDS|mds
723791|NCT00533390|efavirenz|efavirenz
723792|NCT00533390|tuberculosis|tuberculosis
723793|NCT00533390|AIDS|aids
723794|NCT00533390|rifampicin|rifampicin
723795|NCT00533390|efficacy|efficacy
723796|NCT00533390|safety|safety
723797|NCT00533390|Treatment Naive|treatment naive
723798|NCT00533338|Breast Cancer|breast cancer
723799|NCT00533338|Cancer Survivors|cancer survivors
723800|NCT00533338|Weight Gain Prevention|weight gain prevention
723801|NCT00533338|Diet|diet
723802|NCT00533338|Exercise|exercise
723803|NCT00533338|Questionnaire|questionnaire
723804|NCT00533338|Survey|survey
723805|NCT00533299|Epigenetics, hydralazine, valproate, ovarian cancer|epigenetics, hydralazine, valproate, ovarian cancer
723806|NCT00533286|physiotherapy|physiotherapy
723807|NCT00533286|Tuebingen concept|tuebingen concept
723808|NCT00533286|benzodiazepines|benzodiazepines
723809|NCT00533286|muscle relaxants|muscle relaxants
723810|NCT00533286|disc herniation|disc herniation
723811|NCT00533260|Patients with a manic episode or patients diagnosed with schizophrenia , patients who are being treated with quetiapine and are on a stable dosing regime|patients with a manic episode or patients diagnosed with schizophrenia , patients who are being treated with quetiapine and are on a stable dosing regime
723812|NCT00533247|Cox-2 Inhibitor|cox-2 inhibitor
723813|NCT00533247|Pre-emptive Pain|pre-emptive pain
723814|NCT00533247|Preoperative Pain|preoperative pain
723815|NCT00533247|Pain Prophylaxis|pain prophylaxis
723816|NCT00533247|Celebrex|celebrex
723817|NCT00533247|Celecoxib|celecoxib
723818|NCT00533234|Elbow fracture|elbow fracture
723819|NCT00533234|Elbow dislocation|elbow dislocation
723820|NCT00533234|Radial head fracture|radial head fracture
723821|NCT00533234|Radial neck fracture|radial neck fracture
723822|NCT00533221|growth hormone|growth hormone
723823|NCT00533221|strength|strength
723824|NCT00533221|Spinal muscular atrophy type II and III|spinal muscular atrophy type ii and iii
723825|NCT00533195|UVA1|uva1
723826|NCT00533195|PUVA|puva
723827|NCT00533195|atopic dermatitis|atopic dermatitis
723828|NCT00533182|Pregnant|pregnant
723829|NCT00533182|Children|children
723830|NCT00533182|Adults|adults
723831|NCT00533182|Flu|flu
723832|NCT00533182|Infection|infection
723833|NCT00533182|Influenza Infection|influenza infection
723834|NCT00533169|Neuroblastoma|neuroblastoma
723835|NCT00533169|ZD6474|zd6474
723836|NCT00533169|Zactima|zactima
723837|NCT00533169|Isotretinoin|isotretinoin
723838|NCT00533169|13-Cis Retinoic Acid|13-cis retinoic acid
723839|NCT00533169|Accutane|accutane
723840|NCT00533169|Pediatric Neuroblastoma|pediatric neuroblastoma
723841|NCT00533156|Closure Device|closure device
723842|NCT00533156|Angiography|angiography
723843|NCT00533156|Angioplasty|angioplasty
723844|NCT00533156|Hemostasis|hemostasis
723845|NCT00533156|Heart Catheterization|heart catheterization
723846|NCT00533156|Vascular Closure|vascular closure
723847|NCT00533156|Peripheral Closure|peripheral closure
723848|NCT00533156|Coronary Angiography|coronary angiography
723849|NCT00533143|Solid cancer patient|solid cancer patient
723850|NCT00533143|Non-invasive ventilation|non-invasive ventilation
723851|NCT00533143|Acute Respiratory Failure|acute respiratory failure
723852|NCT00533130|AO|ao
723853|NCT00533130|Pediatric|pediatric
723854|NCT00533130|Classification|classification
723855|NCT00533130|Long Bones|long bones
723856|NCT00533130|fractures|fractures
723857|NCT00533130|bones|bones
723858|NCT00533117|suicide|suicide
723859|NCT00533117|self-mutilation|self-mutilation
723860|NCT00533117|fluoxetine|fluoxetine
723861|NCT00533117|placebo|placebo
723862|NCT00533117|dialectical behavior therapy|dialectical behavior therapy
723863|NCT00533117|supportive therapy|supportive therapy
723864|NCT00533104|Limb ischemia|limb ischemia
723865|NCT00533104|Cell Therapy|cell therapy
723866|NCT00533078|omega3 fatty acid|omega3 fatty acid
723867|NCT00533078|parenteral nutrition|parenteral nutrition
723868|NCT00533078|chemotherapy|chemotherapy
723869|NCT00533078|infection|infection
723870|NCT00533078|neutropenia|neutropenia
723871|NCT00533065|Aging|aging
723872|NCT00533052|Behavioral weight loss|behavioral weight loss
723873|NCT00532974|HIV|hiv
723874|NCT00532974|Human Immunodeficiency Virus|human immunodeficiency virus
723875|NCT00532974|Vaccines|vaccines
723876|NCT00532974|HIV Vaccines|hiv vaccines
723877|NCT00532974|Peptide|peptide
723878|NCT00532974|Peptide Vaccines|peptide vaccines
723879|NCT00532974|HIV 1|hiv 1
723880|NCT00532883|Sickle Cell Disease|sickle cell disease
723881|NCT00532883|Vaso-occlusive Event|vaso-occlusive event
723882|NCT00532883|Painful Crises|painful crises
723883|NCT00532883|Acute Chest Syndrome|acute chest syndrome
723884|NCT00532870|laparoscopy|laparoscopy
723885|NCT00532870|ventral hernia|ventral hernia
723886|NCT00532870|mesh|mesh
723984|NCT00532493|Sleep Disturbance|sleep disturbance
723985|NCT00532493|Trauma-Related Nightmares|trauma-related nightmares
723887|NCT00532870|Ventral hernias are the second most common type of abdominal hernias after inguinal hernias.|ventral hernias are the second most common type of abdominal hernias after inguinal hernias.
723888|NCT00532870|The majority of ventral hernias are incisional hernias that develop in 11% to 20% of patients who undergo Laparotomy .|the majority of ventral hernias are incisional hernias that develop in 11% to 20% of patients who undergo laparotomy .
723889|NCT00532870|Surgeons have struggled to reduce the morbidity from incarceration (6% to 15% of cases) and strangulation (2%) of these hernias.|surgeons have struggled to reduce the morbidity from incarceration (6% to 15% of cases) and strangulation (2%) of these hernias.
723890|NCT00532857|Patients with HER2 + stage II/III breast cancer|patients with her2 + stage ii/iii breast cancer
723891|NCT00532844|6R-BH4|6r-bh4
723892|NCT00532844|BH4|bh4
723893|NCT00532844|BH4 deficiency|bh4 deficiency
723894|NCT00532844|sapropterin dihydrochloride|sapropterin dihydrochloride
723895|NCT00532844|endothelial dysfunction|endothelial dysfunction
723896|NCT00532844|NO|no
723897|NCT00532844|Hypertension|hypertension
723898|NCT00532844|Nitric Oxide|nitric oxide
723899|NCT00532844|Vitamin C|vitamin c
723900|NCT00532818|Epigenetic therapy|epigenetic therapy
723901|NCT00532818|Hydralazine|hydralazine
723902|NCT00532818|Valproate|valproate
723903|NCT00532818|Cervical cancer|cervical cancer
723904|NCT00532818|Randomized|randomized
723905|NCT00532818|Phase III|phase iii
723906|NCT00532805|Alpha 1-Antitrypsin Deficiency|alpha 1-antitrypsin deficiency
723907|NCT00532792|Avian|avian
723908|NCT00532792|Pandemic|pandemic
723909|NCT00532792|Influenza|influenza
723910|NCT00532792|A/H5N1|a/h5n1
723911|NCT00532779|Obesity|obesity
723912|NCT00532779|Antiobesity agents|antiobesity agents
723913|NCT00532779|Antiobesity drugs|antiobesity drugs
723914|NCT00532779|Overweight drug therapy|overweight drug therapy
723915|NCT00532779|Obese drug therapy|obese drug therapy
723916|NCT00532779|Weight loss drug effects|weight loss drug effects
723917|NCT00532779|Bupropion administration and dosage|bupropion administration and dosage
723918|NCT00532779|Naltrexone administration and dosage|naltrexone administration and dosage
723919|NCT00532779|Double blind method|double blind method
723920|NCT00532779|Combination drug therapy|combination drug therapy
723921|NCT00532779|Delayed action preparations|delayed action preparations
723922|NCT00532766|Healthy subjects|healthy subjects
723923|NCT00532753|empowerment|empowerment
723924|NCT00532753|health|health
723925|NCT00532753|education|education
723926|NCT00532740|liver metastases|liver metastases
723927|NCT00532740|advanced adult primary liver cancer|advanced adult primary liver cancer
723928|NCT00532727|Breast Cancer|breast cancer
723929|NCT00532727|Triple Negative|triple negative
723930|NCT00532701|Chronic hepatitis C|chronic hepatitis c
723931|NCT00532701|Genotype|genotype
723932|NCT00532701|Interferon|interferon
723933|NCT00532701|Ribavirin|ribavirin
723934|NCT00532701|Genotype 2|genotype 2
723935|NCT00532701|Peginterferon|peginterferon
723936|NCT00532688|acetylcysteine|acetylcysteine
723937|NCT00532688|N-acetylcysteine|n-acetylcysteine
723938|NCT00532688|heart failure|heart failure
723939|NCT00532688|renal failure|renal failure
723940|NCT00532675|Myeloma|myeloma
723941|NCT00532675|Multiple Myeloma|multiple myeloma
723942|NCT00532675|Lenalidomide|lenalidomide
723943|NCT00532675|Revlimid|revlimid
723944|NCT00532675|Dexamethasone|dexamethasone
723945|NCT00532675|LBH589|lbh589
723946|NCT00532675|Combination|combination
723947|NCT00532662|Epidural|epidural
723948|NCT00532662|Intravenous|intravenous
723949|NCT00532662|Ketamine|ketamine
723950|NCT00532662|Analgesia|analgesia
723951|NCT00532662|Caudal|caudal
723952|NCT00532662|Pediatric|pediatric
723953|NCT00532662|Regional|regional
723954|NCT00532662|Local Anesthetics|local anesthetics
723955|NCT00532636|Airway|airway
723956|NCT00532636|Airway obstruction|airway obstruction
723957|NCT00532636|Mouth-to-mask resuscitation|mouth-to-mask resuscitation
723958|NCT00532636|Respiration artificial|respiration artificial
723959|NCT00532636|Ventilation|ventilation
723960|NCT00532636|Ventilation of an unprotected airway|ventilation of an unprotected airway
723961|NCT00532636|Safety and efficiency of mask ventilation|safety and efficiency of mask ventilation
723962|NCT00532636|Avoidance of stomach inflation|avoidance of stomach inflation
723963|NCT00532610|Diabetes,|diabetes,
723964|NCT00532610|ECG,|ecg,
723965|NCT00532610|Healthy Volunteers|healthy volunteers
723966|NCT00532610|GSK189075,|gsk189075,
723967|NCT00532597|Vascular Endothelium-Dependent Relaxation|vascular endothelium-dependent relaxation
723968|NCT00532597|Hemodialysis|hemodialysis
723969|NCT00532597|Hemodiafiltration|hemodiafiltration
723970|NCT00532584|COPD|copd
723971|NCT00532584|inhaled steroids|inhaled steroids
723972|NCT00532584|bronchodilator|bronchodilator
723973|NCT00532584|gene expression|gene expression
723974|NCT00532584|smoker's lungs|smoker's lungs
723975|NCT00532571|CoQ10|coq10
723976|NCT00532571|PSP|psp
723977|NCT00532571|CBD|cbd
723978|NCT00532558|Hyperlipidemia|hyperlipidemia
723979|NCT00532558|Drug Therapy|drug therapy
723980|NCT00532532|Multiple sclerosis|multiple sclerosis
723981|NCT00532493|Combat Trauma|combat trauma
723982|NCT00532493|Post traumatic stress disorder|post traumatic stress disorder
723990|NCT00532467|healthy volunteers|healthy volunteers
723991|NCT00532415|Vitrectomy|vitrectomy
723992|NCT00532415|Visualization|visualization
723993|NCT00532402|Monitoring|monitoring
723994|NCT00532402|Breathing Gas|breathing gas
723995|NCT00532402|Propofol|propofol
723996|NCT00532389|Myeloma|myeloma
723997|NCT00532389|Multiple Myeloma|multiple myeloma
723998|NCT00532389|Bortezomib|bortezomib
723999|NCT00532389|LBH589|lbh589
724000|NCT00532389|Combination|combination
724001|NCT00532376|epilepsy|epilepsy
724002|NCT00532376|depression|depression
724003|NCT00532376|fMRI|fmri
724004|NCT00532376|emotion|emotion
724005|NCT00532350|COPD|copd
724006|NCT00532350|pharmacokinetics|pharmacokinetics
724007|NCT00532350|plethysmography|plethysmography
724008|NCT00532350|cycle ergometry|cycle ergometry
724009|NCT00532350|exercise testing|exercise testing
724010|NCT00532350|spirometry|spirometry
724011|NCT00532337|ONO-5334|ono-5334
724012|NCT00532337|osteoporosis|osteoporosis
724013|NCT00532337|osteopenia|osteopenia
724014|NCT00532324|Methicillin resistant Staphylococcus aureus|methicillin resistant staphylococcus aureus
724015|NCT00532324|Staphylococcus aureus|staphylococcus aureus
724016|NCT00532324|Healthy term and near term neonates|healthy term and near term neonates
724017|NCT00532324|Prevention|prevention
724018|NCT00532324|Nasal and Vaginal Colonization rates|nasal and vaginal colonization rates
724019|NCT00532324|Pregnant women|pregnant women
724020|NCT00532311|Hyperlipidemia|hyperlipidemia
724021|NCT00532311|Drug Therapy|drug therapy
724022|NCT00532298|Fluarix|fluarix
724023|NCT00532298|Influenza Infection|influenza infection
724024|NCT00532298|GSK Biologicals' influenza vaccine GSK576389A|gsk biologicals' influenza vaccine gsk576389a
724025|NCT00532259|Lymphoma, Large B-Cell, Diffuse|lymphoma, large b-cell, diffuse
724026|NCT00532259|Transformed Follicular Lymphoma|transformed follicular lymphoma
724027|NCT00532259|Stem cell transplantation|stem cell transplantation
724028|NCT00532259|Relapsed|relapsed
724029|NCT00532259|Refractory|refractory
724030|NCT00532233|Idiopathic Pulmonary Fibrosis|idiopathic pulmonary fibrosis
724031|NCT00532220|osteonecrosis|osteonecrosis
724032|NCT00532220|bone marrow edema|bone marrow edema
724033|NCT00532220|ibandronate|ibandronate
724034|NCT00532220|bisphosphonate|bisphosphonate
724035|NCT00532220|knee|knee
724036|NCT00532194|ovarian cancer|ovarian cancer
724037|NCT00532194|fallopian tube cancer|fallopian tube cancer
724038|NCT00532194|primary serous peritoneal cancer|primary serous peritoneal cancer
724039|NCT00532194|gynaecological carcinoma|gynaecological carcinoma
724040|NCT00532194|randomised controlled trial|randomised controlled trial
724041|NCT00532194|Cediranib|cediranib
724042|NCT00532194|AZD2171|azd2171
724043|NCT00532194|efficacy|efficacy
724044|NCT00532181|Health insurance|health insurance
724045|NCT00532181|Health utilization rates|health utilization rates
724046|NCT00532181|Saving Behavior|saving behavior
724047|NCT00532181|Risk aversion|risk aversion
724048|NCT00532168|advanced HIV-infected patients|advanced hiv-infected patients
724049|NCT00532168|late presenters|late presenters
724050|NCT00532168|antiretroviral therapy|antiretroviral therapy
724051|NCT00532168|immune reconstitution|immune reconstitution
724052|NCT00532168|Treatment Naive|treatment naive
724053|NCT00532155|lung cancer|lung cancer
724054|NCT00532155|angiogenesis inhibitor|angiogenesis inhibitor
724055|NCT00532155|chemotherapy|chemotherapy
724056|NCT00532116|Healthy|healthy
724057|NCT00532116|Elderly|elderly
724058|NCT00532116|Non Elderly|non elderly
724059|NCT00532116|Healthy Volunteers|healthy volunteers
724060|NCT00532103|Suicidal Ideation|suicidal ideation
724061|NCT00532103|Major Depressive Disorder|major depressive disorder
724062|NCT00532103|Suicide Risk|suicide risk
724063|NCT00532103|Antidepressant Medication|antidepressant medication
724064|NCT00532077|renal,|renal,
724065|NCT00532077|pharmacology,|pharmacology,
724066|NCT00532077|Osteoporosis|osteoporosis
724067|NCT00532051|cataract, lasik, laser refractive surgery|cataract, lasik, laser refractive surgery
724068|NCT00532038|Osteoarthritis|osteoarthritis
724069|NCT00532038|Pain|pain
724070|NCT00532025|Sorafenib|sorafenib
724071|NCT00532025|NSCLC|nsclc
724072|NCT00532025|Adjuvant Treatment|adjuvant treatment
724073|NCT00532025|resected Non-Small Cell Lung Carcinoma|resected non-small cell lung carcinoma
724074|NCT00532012|Rheumatoid Arthritis|rheumatoid arthritis
724075|NCT00532012|RhuDex®|rhudex®
724076|NCT00532012|Meglumine|meglumine
724077|NCT00532012|Oral Bioavailability|oral bioavailability
724078|NCT00531999|Raltegravir|raltegravir
724079|NCT00531999|Euglycaemic clamp|euglycaemic clamp
724080|NCT00531999|healthy volunteer|healthy volunteer
724081|NCT00531986|Monotherapy|monotherapy
724082|NCT00531986|Neuropsychological tests|neuropsychological tests
724083|NCT00531986|HIV viral load in ZNS|hiv viral load in zns
724084|NCT00531986|HIV viral load in genital|hiv viral load in genital
724741|NCT00529139|Survival|survival
724085|NCT00531986|Lumbar puncture and HIV viral load in ZNS|lumbar puncture and hiv viral load in zns
724086|NCT00531986|Monotherapy and compartment failure (ZNS and genital)|monotherapy and compartment failure (zns and genital)
724270|NCT00531089|HUS|hus
724087|NCT00531986|ZNS viral load under monotherapy|zns viral load under monotherapy
724088|NCT00531986|Genital viral load under monotherapy|genital viral load under monotherapy
724089|NCT00531986|Neuropsychological tests (HIV Dementia)|neuropsychological tests (hiv dementia)
724090|NCT00531986|Treatment Experienced|treatment experienced
724091|NCT00531973|breast cancer|breast cancer
724092|NCT00531973|echocardiography|echocardiography
724093|NCT00531973|neoplasia|neoplasia
724094|NCT00531947|Mental Health|mental health
724095|NCT00531947|Adolescents|adolescents
724096|NCT00531947|Major Depressive Disorder|major depressive disorder
724097|NCT00531947|Depression|depression
724098|NCT00531947|Adolescent Depression|adolescent depression
724099|NCT00531947|Pediatric Depression|pediatric depression
724100|NCT00531921|Heart Diseases|heart diseases
724101|NCT00531921|Kidney Diseases|kidney diseases
724102|NCT00531921|Liver Diseases|liver diseases
724103|NCT00531921|Liver Failure|liver failure
724104|NCT00531921|Lung Diseases|lung diseases
724105|NCT00531921|Transplant|transplant
724106|NCT00531921|Transplantation, Homologous|transplantation, homologous
724107|NCT00531921|Rejection|rejection
724108|NCT00531921|Kidney Failure|kidney failure
724109|NCT00531908|Growth Hormone|growth hormone
724110|NCT00531908|Epithelial sodium channel|epithelial sodium channel
724111|NCT00531908|Hypertension|hypertension
724112|NCT00531908|A Furosemide|a furosemide
724113|NCT00531908|Nasal Mucosa|nasal mucosa
724114|NCT00531895|major depression|major depression
724115|NCT00531895|chronic headache|chronic headache
724116|NCT00531895|antidepressant|antidepressant
724117|NCT00531895|duloxetine|duloxetine
724118|NCT00531882|healthy volunteers|healthy volunteers
724119|NCT00531882|neutrophil migration|neutrophil migration
724120|NCT00531882|anti inflammatory non-steroidal agent|anti inflammatory non-steroidal agent
724121|NCT00531882|simvastatin|simvastatin
724122|NCT00531882|pioglitazone|pioglitazone
724123|NCT00531869|safewater|safewater
724124|NCT00531869|randomized|randomized
724125|NCT00531856|Kidney Transplant, Carbon Monoxide|kidney transplant, carbon monoxide
724126|NCT00531843|deep vein thrombosis|deep vein thrombosis
724127|NCT00531843|venous thromboembolism|venous thromboembolism
724128|NCT00531843|pulmonary embolism|pulmonary embolism
724129|NCT00531830|children with PDD|children with pdd
724130|NCT00531791|COPD|copd
724131|NCT00531791|exacerbation|exacerbation
724132|NCT00531791|fluticasone|fluticasone
724133|NCT00531791|salmeterol|salmeterol
724134|NCT00531791|steroid|steroid
724135|NCT00531778|Women with increased risk for developing ovarian cancer|women with increased risk for developing ovarian cancer
724136|NCT00531778|early detection|early detection
724137|NCT00531778|biomarker for ovarian cancer|biomarker for ovarian cancer
724138|NCT00531765|contrast-induced-nephropathy,|contrast-induced-nephropathy,
724139|NCT00531765|cardiac cath|cardiac cath
724140|NCT00531765|creatinine|creatinine
724141|NCT00531765|contrast|contrast
724142|NCT00531765|nephropathy|nephropathy
724143|NCT00531739|Surgery|surgery
724144|NCT00531739|Colectomy|colectomy
724145|NCT00531739|Proctocolectomy|proctocolectomy
724146|NCT00531739|Adhesions|adhesions
724147|NCT00531713|hypothyroidism, quality og life, depression|hypothyroidism, quality og life, depression
724148|NCT00531700|influenza|influenza
724149|NCT00531700|risk behaviors|risk behaviors
724150|NCT00531700|immunization|immunization
724151|NCT00531700|knowledge attitudes behaviors|knowledge attitudes behaviors
724152|NCT00531700|personally controlled health record|personally controlled health record
724153|NCT00531700|Indivo|indivo
724154|NCT00531687|relapse|relapse
724155|NCT00531674|Efficacy of public health intervention (nutrition)|efficacy of public health intervention (nutrition)
724156|NCT00531648|Toddlers that having feeding disorders and SPD|toddlers that having feeding disorders and spd
724157|NCT00531635|Mixed hemopoietic chimerism, Fludarabine, TBI, PBSC, immunosuppression, Mycophenolate Mofetil|mixed hemopoietic chimerism, fludarabine, tbi, pbsc, immunosuppression, mycophenolate mofetil
724158|NCT00531622|Depression|depression
724159|NCT00531622|Major Depressive Episode|major depressive episode
724160|NCT00531622|Antidepressant|antidepressant
724161|NCT00531596|Elderly|elderly
724162|NCT00531596|Non Elderly|non elderly
724163|NCT00531596|Healthy Volunteers|healthy volunteers
724164|NCT00531583|AML in 1st & 2nd complete remission w/no HLA matched related donor|aml in 1st & 2nd complete remission w/no hla matched related donor
724165|NCT00531570|Women with ultrasound defined complex pelvic masses|women with ultrasound defined complex pelvic masses
724166|NCT00531557|Darunavir|darunavir
724167|NCT00531557|Euglycaemic clamp|euglycaemic clamp
724168|NCT00531557|HIV|hiv
724169|NCT00531557|Treatment Experienced|treatment experienced
724170|NCT00531531|pulmonary infection|pulmonary infection
724171|NCT00531531|transmission|transmission
724172|NCT00531531|P.Aeruginosa|p.aeruginosa
724173|NCT00531531|surfaces|surfaces
724174|NCT00531518|Schizophrenia|schizophrenia
724175|NCT00531518|Bipolar disorder|bipolar disorder
724176|NCT00531518|Psychosis|psychosis
724742|NCT00529139|Dialysis|dialysis
724177|NCT00531518|Prodromal psychosis|prodromal psychosis
724178|NCT00531518|Family psychoeducation|family psychoeducation
724179|NCT00531518|Supported education|supported education
724180|NCT00531518|Supported employment|supported employment
724181|NCT00531518|Ulra-high-risk for psychosis|ulra-high-risk for psychosis
724182|NCT00531518|Major depression|major depression
724183|NCT00531518|Bipolar disorder, with psychotic features|bipolar disorder, with psychotic features
724184|NCT00531518|Major depression, with psychotic features|major depression, with psychotic features
724185|NCT00531518|Attenuated, prodromal psychotic symptoms|attenuated, prodromal psychotic symptoms
724186|NCT00531505|Obesity|obesity
724187|NCT00531492|Maternal and child health|maternal and child health
724188|NCT00531492|Developing country|developing country
724189|NCT00531492|Skin to skin care|skin to skin care
724190|NCT00531492|Newly born low birth weight infants and their mothers|newly born low birth weight infants and their mothers
724191|NCT00531492|(Delivery at University Hospital Center, Mahajanga, Madagascar)|(delivery at university hospital center, mahajanga, madagascar)
724192|NCT00531466|Spinal cord injury|spinal cord injury
724193|NCT00531440|Renal transplantation, everolimus, Immunosuppressants|renal transplantation, everolimus, immunosuppressants
724194|NCT00531427|Chronic pain,|chronic pain,
724195|NCT00531427|OA of the knee,|oa of the knee,
724196|NCT00531427|opioid,|opioid,
724197|NCT00531427|transdermal|transdermal
724198|NCT00531414|Asthmatic|asthmatic
724199|NCT00531414|healthy|healthy
724200|NCT00531401|Non-Small-Cell Lung|non-small-cell lung
724201|NCT00531362|Atherosclerosis|atherosclerosis
724202|NCT00531362|Aspirin|aspirin
724203|NCT00531362|Resistance,|resistance,
724204|NCT00531362|Acute coronary syndromes|acute coronary syndromes
724205|NCT00531349|Endometrial Cancer|endometrial cancer
724206|NCT00531349|Anesthesia; regional|anesthesia; regional
724207|NCT00531349|cancer recurrence|cancer recurrence
724208|NCT00531349|Analgesia; opioid|analgesia; opioid
724209|NCT00531336|age-related Macular degeneration|age-related macular degeneration
724210|NCT00531336|Macugen|macugen
724211|NCT00531336|Avastin|avastin
724212|NCT00531323|Pharmacokinetic|pharmacokinetic
724213|NCT00531323|TMC125|tmc125
724214|NCT00531323|Healthy volunteers|healthy volunteers
724215|NCT00531323|Efavarinz|efavarinz
724216|NCT00531310|CML|cml
724217|NCT00531310|allogeneic SCT|allogeneic sct
724218|NCT00531310|matched family donor|matched family donor
724219|NCT00531310|unrelated donor|unrelated donor
724220|NCT00531310|cord blood donor|cord blood donor
724221|NCT00531310|persistent disease|persistent disease
724222|NCT00531284|Non-small cell lung carcinoma|non-small cell lung carcinoma
724223|NCT00531284|Small-cell lung carcinoma|small-cell lung carcinoma
724224|NCT00531284|Ovarian Cancer|ovarian cancer
724225|NCT00531284|Renal Cancer|renal cancer
724226|NCT00531284|Other solid tumors|other solid tumors
724227|NCT00531284|multiple myeloma|multiple myeloma
724228|NCT00531284|lymphoma|lymphoma
724229|NCT00531258|Depression|depression
724230|NCT00531258|TBI|tbi
724231|NCT00531258|TMS|tms
724232|NCT00531258|Major Depression resulting from a mild to moderate closed head injury|major depression resulting from a mild to moderate closed head injury
724233|NCT00531245|TS-1 and oxaliplatin|ts-1 and oxaliplatin
724234|NCT00531245|Phase I/II study|phase i/ii study
724235|NCT00531245|Colorectal cancer|colorectal cancer
724236|NCT00531245|First line treatment|first line treatment
724237|NCT00531232|Previously treated Myelodysplastic Syndromes (MDS)|previously treated myelodysplastic syndromes (mds)
724238|NCT00531232|oral clofarabine|oral clofarabine
724239|NCT00531232|Intermediate-1, Intermediate-2 and High Risk Myelodysplastic Syndromes (MDS)|intermediate-1, intermediate-2 and high risk myelodysplastic syndromes (mds)
724240|NCT00531232|secondary AML (with history of MDS)|secondary aml (with history of mds)
724241|NCT00531219|appendicitis|appendicitis
724242|NCT00531219|cholelithiasis|cholelithiasis
724243|NCT00531219|gallstones|gallstones
724244|NCT00531193|Healthy male volunteers|healthy male volunteers
724245|NCT00531180|Esophageal Cancer|esophageal cancer
724246|NCT00531180|Lung Cancer|lung cancer
724247|NCT00531180|Thoracic Malignancies|thoracic malignancies
724248|NCT00531180|4D CT scans|4d ct scans
724249|NCT00531180|Lung Function|lung function
724250|NCT00531167|lamivudine resistant mutations|lamivudine resistant mutations
724251|NCT00531167|rescue therapy|rescue therapy
724252|NCT00531141|age-related macular degeneration|age-related macular degeneration
724253|NCT00531141|optical coherence tomography|optical coherence tomography
724254|NCT00531141|retinal thickness|retinal thickness
724255|NCT00531141|exudative age-related macular degeneration|exudative age-related macular degeneration
724256|NCT00531128|Sitosterol|sitosterol
724257|NCT00531128|Nutrigenomics|nutrigenomics
724258|NCT00531128|Gene Expression|gene expression
724259|NCT00531128|Insulin Resistance|insulin resistance
724260|NCT00531128|Sitosterolemia|sitosterolemia
724261|NCT00531115|metastatic colorectal cancer|metastatic colorectal cancer
724262|NCT00531115|elderly patients|elderly patients
724263|NCT00531115|cetuximab, oxaliplatin, capecitabine|cetuximab, oxaliplatin, capecitabine
724264|NCT00531102|oxygen|oxygen
724265|NCT00531102|continuous positive airway pressure|continuous positive airway pressure
724266|NCT00531102|infant, newborn|infant, newborn
724837|NCT00528762|Body Image|body image
724267|NCT00531102|resuscitation|resuscitation
724268|NCT00531089|TTP|ttp
724269|NCT00531089|thrombotic thrombocytopenic purpura|thrombotic thrombocytopenic purpura
724271|NCT00531089|hemolytic uremic syndrome|hemolytic uremic syndrome
724272|NCT00531089|plasma exchange|plasma exchange
724273|NCT00531076|bevacizumab|bevacizumab
724274|NCT00531076|thoracic radiotherapy|thoracic radiotherapy
724275|NCT00531076|locally-advanced non-small cell lung cancer|locally-advanced non-small cell lung cancer
724276|NCT00531063|Renal transplantation, everolimus, Immunosuppressants|renal transplantation, everolimus, immunosuppressants
724277|NCT00531050|COPD|copd
724278|NCT00531050|cycle ergometry|cycle ergometry
724279|NCT00531050|exercise testing|exercise testing
724280|NCT00531050|spirometry|spirometry
724281|NCT00531050|cardiovascular|cardiovascular
724282|NCT00531050|salbutamol|salbutamol
724283|NCT00531050|indacaterol|indacaterol
724284|NCT00531050|chronic obstructive pulmonary disease|chronic obstructive pulmonary disease
724285|NCT00531037|AV block, SND, BTS, AAIsafeR, SafeR, PM implanted|av block, snd, bts, aaisafer, safer, pm implanted
724286|NCT00531024|Exudative Neovascular|exudative neovascular
724287|NCT00531024|AMD|amd
724288|NCT00531024|Avastin|avastin
724289|NCT00531024|Systemic|systemic
724290|NCT00531024|Exudative Age-Related Macular Degeneration|exudative age-related macular degeneration
724291|NCT00531011|Stents|stents
724292|NCT00531011|Drug-eluting Stent|drug-eluting stent
724293|NCT00531011|Angioplasty|angioplasty
724294|NCT00531011|Coronary Artery stenosis|coronary artery stenosis
724295|NCT00531011|Coronary Artery Stent Restenosis|coronary artery stent restenosis
724296|NCT00531011|Stent Thrombosis|stent thrombosis
724297|NCT00530998|appendicitis|appendicitis
724298|NCT00530998|cholelithiasis|cholelithiasis
724299|NCT00530998|Gallstones|gallstones
724300|NCT00530985|disability|disability
724301|NCT00530985|substance abuse|substance abuse
724302|NCT00530985|vocational rehabilitation|vocational rehabilitation
724303|NCT00530985|case management|case management
724304|NCT00530972|co-infected HCV/HIV|co-infected hcv/hiv
724305|NCT00530972|relapsers|relapsers
724306|NCT00530907|Advanced Cancer|advanced cancer
724307|NCT00530907|Valproic Acid|valproic acid
724308|NCT00530907|Depakene|depakene
724309|NCT00530907|Bevacizumab|bevacizumab
724310|NCT00530907|Avastin|avastin
724311|NCT00530907|Anti-VEGF monoclonal antibody|anti-vegf monoclonal antibody
724312|NCT00530907|rhuMAb-VEGF|rhumab-vegf
724313|NCT00530894|Valvular Heart Disease|valvular heart disease
724314|NCT00530894|Critical/Severe Aortic Stenosis|critical/severe aortic stenosis
724315|NCT00530894|High risk symptomatic patients|high risk symptomatic patients
724316|NCT00530868|Hormonal and antibody therapy for breast cancer|hormonal and antibody therapy for breast cancer
724317|NCT00530868|Hormonal therapy for breast cancer|hormonal therapy for breast cancer
724318|NCT00530868|Antibody therapy for breast cancer|antibody therapy for breast cancer
724319|NCT00530855|Epilepsy|epilepsy
724320|NCT00530855|Partial-onset Seizures|partial-onset seizures
724321|NCT00530855|Lacosamide|lacosamide
724322|NCT00530855|Monotherapy|monotherapy
724323|NCT00530855|Vimpat|vimpat
724324|NCT00530829|diarrhea|diarrhea
724325|NCT00530829|zinc|zinc
724326|NCT00530829|oral rehydration therapy|oral rehydration therapy
724327|NCT00530803|EMLA|emla
724328|NCT00530803|venipuncture|venipuncture
724329|NCT00530803|children|children
724330|NCT00530803|Synera patch|synera patch
724331|NCT00530803|pediatric|pediatric
724332|NCT00530803|Lidocaine/prilocaine|lidocaine/prilocaine
724333|NCT00530790|Restless Legs Syndrome|restless legs syndrome
724334|NCT00530777|Disease Transmission, Vertical|disease transmission, vertical
724335|NCT00530777|valacyclovir|valacyclovir
724336|NCT00530777|Randomized Controlled Trials|randomized controlled trials
724337|NCT00530777|HIV|hiv
724338|NCT00530777|herpes|herpes
724339|NCT00530777|Herpesvirus 2, Human|herpesvirus 2, human
724340|NCT00530777|HIV Seronegativity|hiv seronegativity
724341|NCT00530764|Pain|pain
724342|NCT00530764|Cancer|cancer
724343|NCT00530764|Palliative|palliative
724344|NCT00530751|breast cancer|breast cancer
724345|NCT00530738|HPN|hpn
724346|NCT00530738|lipid emulsion|lipid emulsion
724347|NCT00530738|long term|long term
724348|NCT00530738|insufficient enteral resorption capacity|insufficient enteral resorption capacity
724349|NCT00530725|occult pneumothorax|occult pneumothorax
724350|NCT00530725|mechanical ventilation|mechanical ventilation
724351|NCT00530725|critical care|critical care
724352|NCT00530725|pneumothorax|pneumothorax
724353|NCT00530725|thoracostomy|thoracostomy
724354|NCT00530712|SFA|sfa
724355|NCT00530712|Popliteal|popliteal
724356|NCT00530712|Stent|stent
724357|NCT00530712|EverFlex|everflex
724358|NCT00530699|Acute Myeloid Leukaemia|acute myeloid leukaemia
724359|NCT00530699|Phase 1|phase 1
724360|NCT00530699|AZD1152|azd1152
724361|NCT00530686|Diabetes Mellitus|diabetes mellitus
724362|NCT00530686|Hypoglycemia|hypoglycemia
724363|NCT00530686|Hyperglycemia|hyperglycemia
724364|NCT00530686|Type 1 Diabetes|type 1 diabetes
724365|NCT00530686|Islet cell transplantation|islet cell transplantation
724366|NCT00530660|Pandemic influenza|pandemic influenza
724367|NCT00530647|Brain motor network, Plasticity, functional MRI, Stroke|brain motor network, plasticity, functional mri, stroke
724368|NCT00530634|stage II non-small cell lung cancer|stage ii non-small cell lung cancer
724369|NCT00530634|stage IIIA non-small cell lung cancer|stage iiia non-small cell lung cancer
724370|NCT00530634|stage IIIB non-small cell lung cancer|stage iiib non-small cell lung cancer
724371|NCT00530595|hemodialysis|hemodialysis
724372|NCT00530582|progesterone, postmenopause, sleep-EEG|progesterone, postmenopause, sleep-eeg
724373|NCT00530569|Breast Cancer|breast cancer
724374|NCT00530569|Herceptin Therapy|herceptin therapy
724375|NCT00530543|Robot|robot
724376|NCT00530543|Gait|gait
724377|NCT00530543|Stroke|stroke
724378|NCT00530530|ASP8825|asp8825
724379|NCT00530530|Restless legs Syndrome|restless legs syndrome
724380|NCT00530530|XP13512|xp13512
724381|NCT00530517|migraine|migraine
724382|NCT00530517|sumatripatan|sumatripatan
724383|NCT00530504|Carotid Artery Disease|carotid artery disease
724384|NCT00530504|Embolic Protection|embolic protection
724385|NCT00530491|lung resection|lung resection
724386|NCT00530491|reduced pulmonary function|reduced pulmonary function
724387|NCT00530478|Donepezil|donepezil
724388|NCT00530478|Stroke|stroke
724389|NCT00530478|Cognitive function|cognitive function
724390|NCT00530478|Cognitive neural network|cognitive neural network
724391|NCT00530452|COX-2|cox-2
724392|NCT00530452|carbonic anhydrase|carbonic anhydrase
724393|NCT00530452|osteoarthritis|osteoarthritis
724394|NCT00530452|anti-inflammatory|anti-inflammatory
724395|NCT00530452|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors
724396|NCT00530426|Heart Failure, Congestive|heart failure, congestive
724397|NCT00530426|Registry|registry
724398|NCT00530426|Acute Decompensated Heart Failure|acute decompensated heart failure
724399|NCT00530426|Dyspnea|dyspnea
724400|NCT00530400|Antibiotic prophylaxis|antibiotic prophylaxis
724401|NCT00530400|Bacterial Infections / prevention & control|bacterial infections / prevention & control
724402|NCT00530400|Surgical wound infection / prevention & control|surgical wound infection / prevention & control
724403|NCT00530400|Neurosurgery|neurosurgery
724404|NCT00530400|Postoperative Complications / prevention & control|postoperative complications / prevention & control
724405|NCT00530400|Clinical trial [publication type]|clinical trial [publication type]
724406|NCT00530387|Photocontact|photocontact
724407|NCT00530387|Dermatitis|dermatitis
724408|NCT00530387|NSAID|nsaid
724409|NCT00530387|Sunscreen|sunscreen
724410|NCT00530387|Photopatch|photopatch
724411|NCT00530374|Pediatrics|pediatrics
724412|NCT00530374|Malnutrition|malnutrition
724413|NCT00530374|Iron Deficiency|iron deficiency
724414|NCT00530374|Sprinkles|sprinkles
724415|NCT00530374|Oral Iron Supplementation|oral iron supplementation
724416|NCT00530361|Myocardial Ischemia|myocardial ischemia
724417|NCT00530361|Kidney failure|kidney failure
724418|NCT00530361|CABG|cabg
724419|NCT00530361|Cardiopulmonary bypass (CPB) pump|cardiopulmonary bypass (cpb) pump
724420|NCT00530361|Coronary Artery Bypass Surgery|coronary artery bypass surgery
724421|NCT00530361|Heart surgery|heart surgery
724422|NCT00530361|Nesiritide|nesiritide
724423|NCT00530361|Coronary Heart Disease|coronary heart disease
724424|NCT00530348|Multiple Sclerosis|multiple sclerosis
724425|NCT00530322|Adhesions|adhesions
724426|NCT00530322|Laparoscopy|laparoscopy
724427|NCT00530322|Colorectal surgery|colorectal surgery
724428|NCT00530322|Colorectal disease|colorectal disease
724429|NCT00530309|GLP-1|glp-1
724430|NCT00530309|type 2 diabeted mellitus|type 2 diabeted mellitus
724431|NCT00530309|safety|safety
724432|NCT00530309|GSK716155|gsk716155
724433|NCT00530309|GLP-1 receptor agonist|glp-1 receptor agonist
724434|NCT00530309|tolerability|tolerability
724435|NCT00530309|pharmacokinetics|pharmacokinetics
724436|NCT00530309|pharmacodynamics|pharmacodynamics
724437|NCT00530296|Depression|depression
724438|NCT00530296|End stage renal disease|end stage renal disease
724439|NCT00530296|Quality of Life|quality of life
724440|NCT00530296|Cognitive Behavioral Therapy|cognitive behavioral therapy
724441|NCT00530283|Squamous|squamous
724442|NCT00530283|Unknown Primary|unknown primary
724443|NCT00530283|Patients with Squamous cell cancer neck nodes|patients with squamous cell cancer neck nodes
724444|NCT00530270|Sickle Cell Disease|sickle cell disease
724446|NCT00530270|Acute Chest Syndrome|acute chest syndrome
724447|NCT00530270|Hgb SS|hgb ss
724448|NCT00530270|Hgb Sβ0|hgb sβ0
724449|NCT00530270|Dexamethasone|dexamethasone
724450|NCT00530257|Attention Deficit Hyperactivity Disorder|attention deficit hyperactivity disorder
724451|NCT00530257|Methylphenidate|methylphenidate
724452|NCT00530257|Attention|attention
724453|NCT00530257|Working Memory|working memory
724454|NCT00530244|cystic fibrosis|cystic fibrosis
724455|NCT00530244|fatty acids|fatty acids
724456|NCT00530244|docosahexaenoic acid|docosahexaenoic acid
724457|NCT00530244|infant formula|infant formula
724458|NCT00530244|growth|growth
724459|NCT00530244|pancreatic function|pancreatic function
724460|NCT00530231|Capsule endoscopy|capsule endoscopy
724461|NCT00530231|Missing rate|missing rate
724462|NCT00530205|weight changes|weight changes
724463|NCT00530205|malnutrition|malnutrition
724838|NCT00528762|Focus Group|focus group
724464|NCT00530205|stage III non-small cell lung cancer|stage iii non-small cell lung cancer
724465|NCT00530192|Refractory Cancer|refractory cancer
724466|NCT00530192|Molecular Profile|molecular profile
724467|NCT00530179|Diffuse Large B-Cell Lymphoma|diffuse large b-cell lymphoma
724468|NCT00530179|Positron Emission Tomography|positron emission tomography
724469|NCT00530179|CHOP Chemotherapy protocol|chop chemotherapy protocol
724470|NCT00530179|Stem Cell Transplantation|stem cell transplantation
724471|NCT00530179|Fluorodeoxyglucose F18|fluorodeoxyglucose f18
724472|NCT00530166|Asthma|asthma
724473|NCT00530166|persistant asthma|persistant asthma
724474|NCT00530166|controller medications|controller medications
724475|NCT00530166|FEV1|fev1
724476|NCT00530153|Eating|eating
724477|NCT00530153|Food Habits|food habits
724478|NCT00530153|Adolescent|adolescent
724479|NCT00530153|Dental Research|dental research
724480|NCT00530140|Follicular Lymphoma|follicular lymphoma
724481|NCT00530140|Idiotype vaccine|idiotype vaccine
724482|NCT00530127|Friedreich's ataxia|friedreich's ataxia
724483|NCT00530088|recurrent squamous cell carcinoma of the larynx|recurrent squamous cell carcinoma of the larynx
724484|NCT00530088|recurrent squamous cell carcinoma of the lip and oral cavity|recurrent squamous cell carcinoma of the lip and oral cavity
724485|NCT00530088|stage I squamous cell carcinoma of the larynx|stage i squamous cell carcinoma of the larynx
724486|NCT00530088|stage I squamous cell carcinoma of the lip and oral cavity|stage i squamous cell carcinoma of the lip and oral cavity
724487|NCT00530088|stage 0 laryngeal cancer|stage 0 laryngeal cancer
724488|NCT00530088|stage 0 lip and oral cavity cancer|stage 0 lip and oral cavity cancer
724489|NCT00530075|Wegener Granulomatosis|wegener granulomatosis
724490|NCT00530075|Vasculitis|vasculitis
724491|NCT00530075|Gusperimus|gusperimus
724492|NCT00530075|Immunosuppression|immunosuppression
724493|NCT00530062|Asthma and Poor Coordinators of Asthma Inhalers|asthma and poor coordinators of asthma inhalers
724494|NCT00530049|psychosocial effects of cancer and its treatment|psychosocial effects of cancer and its treatment
724495|NCT00530049|hypopharyngeal cancer|hypopharyngeal cancer
724496|NCT00530049|laryngeal cancer|laryngeal cancer
724497|NCT00530049|lip and oral cavity cancer|lip and oral cavity cancer
724498|NCT00530049|metastatic squamous neck cancer with occult primary|metastatic squamous neck cancer with occult primary
724499|NCT00530049|nasopharyngeal cancer|nasopharyngeal cancer
724500|NCT00530049|oropharyngeal cancer|oropharyngeal cancer
724501|NCT00530049|paranasal sinus and nasal cavity cancer|paranasal sinus and nasal cavity cancer
724502|NCT00530049|salivary gland cancer|salivary gland cancer
724503|NCT00530049|tongue cancer|tongue cancer
724504|NCT00530049|07-098|07-098
724505|NCT00530036|Mortality|mortality
724506|NCT00530036|Patient readmission|patient readmission
724507|NCT00530036|Institutionalization|institutionalization
724508|NCT00530010|adult primary hepatocellular carcinoma|adult primary hepatocellular carcinoma
724509|NCT00530010|localized unresectable adult primary liver cancer|localized unresectable adult primary liver cancer
724510|NCT00530010|advanced adult primary liver cancer|advanced adult primary liver cancer
724511|NCT00529997|Lumbar Spine|lumbar spine
724512|NCT00529997|Lumbar Spinal Stenosis|lumbar spinal stenosis
724513|NCT00529997|Spondylolisthesis|spondylolisthesis
724514|NCT00529997|Dynamic Stabilization|dynamic stabilization
724515|NCT00529997|Motion Preserving|motion preserving
724516|NCT00529997|Arthroplasty|arthroplasty
724517|NCT00529997|Randomized|randomized
724518|NCT00529997|Investigational|investigational
724519|NCT00529997|Back Pain|back pain
724520|NCT00529997|Leg Pain|leg pain
724521|NCT00529984|CEA|cea
724522|NCT00529984|CEA-expressing malignancies|cea-expressing malignancies
724523|NCT00529984|Metastatic malignancies|metastatic malignancies
724524|NCT00529984|VRP Vaccine|vrp vaccine
724525|NCT00529984|Alphavirus replicons|alphavirus replicons
724526|NCT00529984|Molecular therapeutics|molecular therapeutics
724527|NCT00529984|Stage III colon cancer|stage iii colon cancer
724528|NCT00529971|Mindfulness|mindfulness
724529|NCT00529971|HIV|hiv
724530|NCT00529971|Male|male
724531|NCT00529971|Living with HIV|living with hiv
724532|NCT00529971|18-70 years of age|18-70 years of age
724533|NCT00529971|live within one hour of hospital|live within one hour of hospital
724534|NCT00529971|fluent in English|fluent in english
724535|NCT00529971|Complementary Therapies|complementary therapies
724536|NCT00529971|HIV Therapeutic Vaccine|hiv therapeutic vaccine
724537|NCT00529958|Anterior Cruciate Ligament (ACL) Reconstruction|anterior cruciate ligament (acl) reconstruction
724538|NCT00529958|Patellar Tendon|patellar tendon
724539|NCT00529958|Hamstring Tendon|hamstring tendon
724540|NCT00529958|Double-Bundle|double-bundle
724541|NCT00529958|Autograft|autograft
724542|NCT00529945|PFO|pfo
724543|NCT00529945|Stroke|stroke
724544|NCT00529945|Transient Ischemic Attack|transient ischemic attack
724545|NCT00529945|Migraine|migraine
724546|NCT00529945|Decompression Illness|decompression illness
724547|NCT00529932|Acute Myocardial Infarction|acute myocardial infarction
724548|NCT00529932|Celltherapy|celltherapy
724549|NCT00529932|Bone Marrow|bone marrow
724550|NCT00529919|Overweight|overweight
724551|NCT00529919|Obesity|obesity
724552|NCT00529919|Weight loss|weight loss
724553|NCT00529919|Medium chain triglycerides|medium chain triglycerides
725327|NCT00526786|Cryo|cryo
724554|NCT00529919|Cardiovascular disease risk|cardiovascular disease risk
724555|NCT00529906|attention deficit hyperactivity disorder|attention deficit hyperactivity disorder
725603|NCT00525967|Methadone|methadone
724556|NCT00529906|neuropsychological deficits|neuropsychological deficits
724557|NCT00529906|endophenotype|endophenotype
724558|NCT00529906|molecular genetics|molecular genetics
724559|NCT00529906|candidate gene|candidate gene
724560|NCT00529906|family-based association study|family-based association study
724561|NCT00529893|Attention-deficit/Hyperactivity Disorder|attention-deficit/hyperactivity disorder
724562|NCT00529893|neuropsychological functioning|neuropsychological functioning
724563|NCT00529893|Atomoxetine|atomoxetine
724564|NCT00529880|AML|aml
724565|NCT00529867|Artemether/Lumefantrine suspension|artemether/lumefantrine suspension
724566|NCT00529867|P. falciparum malaria|p. falciparum malaria
724567|NCT00529867|children|children
724568|NCT00529867|uncomplicated Plasmodium falciparum malaria|uncomplicated plasmodium falciparum malaria
724569|NCT00529854|Intensive care unit|intensive care unit
724570|NCT00529854|medical documentation|medical documentation
724571|NCT00529854|medical billing|medical billing
724572|NCT00529841|Salt Wasting Congenital Adrenal Hyperplasia|salt wasting congenital adrenal hyperplasia
724573|NCT00529841|Subcutaneous Hydrocortisone|subcutaneous hydrocortisone
724574|NCT00529828|CLA|cla
724575|NCT00529828|Industrial trans fatty acids|industrial trans fatty acids
724576|NCT00529828|Oleic acid|oleic acid
724577|NCT00529828|Controlled dietary trial|controlled dietary trial
724578|NCT00529815|Continuous|continuous
724579|NCT00529815|blood|blood
724580|NCT00529815|glucose|glucose
724581|NCT00529815|monitoring|monitoring
724582|NCT00529815|diabetes|diabetes
724583|NCT00529815|type2|type2
724584|NCT00529802|metastatic|metastatic
724585|NCT00529802|renal|renal
724586|NCT00529802|cell|cell
724587|NCT00529802|carcinoma|carcinoma
724588|NCT00529802|cancer|cancer
724589|NCT00529776|Prevention of ventilator associated pneumonia|prevention of ventilator associated pneumonia
724590|NCT00529763|Chronic Phase, Advanced Phase chronic myeloid leukemia|chronic phase, advanced phase chronic myeloid leukemia
724591|NCT00529763|Philadelphia Chromosome Positive Acute Lymphoblastic Leukemia|philadelphia chromosome positive acute lymphoblastic leukemia
724592|NCT00529737|Breast Cancer|breast cancer
724593|NCT00529737|Marker Clip Migration|marker clip migration
724594|NCT00529737|Vacuum-Assisted Biopsy|vacuum-assisted biopsy
724595|NCT00529737|Postprocedure Mammogram|postprocedure mammogram
724596|NCT00529737|Breast Biopsy|breast biopsy
724597|NCT00529724|Energy metabolism, metabolic syndrome, by chronic bilateral subthalamic stimulation, Parkinson's disease|energy metabolism, metabolic syndrome, by chronic bilateral subthalamic stimulation, parkinson's disease
724598|NCT00529724|Patients with Parkinson's disease and will be treated by chronic bilateral subthalamic stimulation.|patients with parkinson's disease and will be treated by chronic bilateral subthalamic stimulation.
724599|NCT00529711|coronary|coronary
724600|NCT00529711|artery|artery
724601|NCT00529711|bypass|bypass
724602|NCT00529711|grafting|grafting
724603|NCT00529711|IV|iv
724604|NCT00529711|cardiac output|cardiac output
724605|NCT00529698|HIV|hiv
724606|NCT00529698|Tat protein|tat protein
724607|NCT00529698|Preventative vaccine|preventative vaccine
724608|NCT00529698|Healthy volunteers|healthy volunteers
724609|NCT00529698|HIV-1/2 uninfected|hiv-1/2 uninfected
724610|NCT00529698|HIV Preventive Vaccine|hiv preventive vaccine
724611|NCT00529672|endovenous laser therapy|endovenous laser therapy
724612|NCT00529672|sclerotherapy|sclerotherapy
724613|NCT00529672|crossectomy and stripping|crossectomy and stripping
724614|NCT00529672|surgery|surgery
724615|NCT00529672|treatment|treatment
724616|NCT00529672|varicose veins|varicose veins
724617|NCT00529659|Sarcopenia (loss of muscle mass)|sarcopenia (loss of muscle mass)
724618|NCT00529646|Healthy adult volunteers|healthy adult volunteers
724619|NCT00529633|Inflammation|inflammation
724620|NCT00529633|albumin|albumin
724621|NCT00529620|Malaria|malaria
724622|NCT00529620|IPT|ipt
724623|NCT00529620|preventive treatment|preventive treatment
724624|NCT00529607|myocardial infarction, reperfusion injury, echocardiography, magnetic resonance imaging, inflammation, nitric oxide|myocardial infarction, reperfusion injury, echocardiography, magnetic resonance imaging, inflammation, nitric oxide
724625|NCT00529594|Laser Photocoagulation|laser photocoagulation
724626|NCT00529594|Pain relief|pain relief
724627|NCT00529581|multiple sclerosis|multiple sclerosis
724628|NCT00529581|cognitive impairment|cognitive impairment
724629|NCT00529581|cognitive dysfunction|cognitive dysfunction
724630|NCT00529581|Cognitive Dysfunction associated with Multiple Sclerosis|cognitive dysfunction associated with multiple sclerosis
724631|NCT00529568|hepatitis C|hepatitis c
724632|NCT00529568|ribavirin|ribavirin
724633|NCT00529568|Hepatitis C-related thrombocytopenia|hepatitis c-related thrombocytopenia
724634|NCT00529568|thrombopoietin|thrombopoietin
724635|NCT00529568|peginterferon alfa-2b|peginterferon alfa-2b
724636|NCT00529568|platelets|platelets
724637|NCT00529542|Polycystic Ovary Syndrome|polycystic ovary syndrome
724638|NCT00529529|asthma|asthma
724639|NCT00529529|QAB149|qab149
724640|NCT00529529|indacaterol|indacaterol
724641|NCT00529516|Fluarix|fluarix
724642|NCT00529516|GSK Bio's influenza vaccine GSK576389A|gsk bio's influenza vaccine gsk576389a
724643|NCT00529516|Influenza infection|influenza infection
724644|NCT00529503|Lymphoproliferative Disorders|lymphoproliferative disorders
724645|NCT00529503|Lymphoma|lymphoma
724646|NCT00529503|Antigens, CD40|antigens, cd40
724647|NCT00529503|Antibody, Monoclonal|antibody, monoclonal
724648|NCT00529503|Combined Modality Therapy|combined modality therapy
724649|NCT00529503|Lymphoma, Large B-Cell, Diffuse|lymphoma, large b-cell, diffuse
724650|NCT00529503|Lymphoma, Non-Hodgkin|lymphoma, non-hodgkin
724651|NCT00529503|Hematologic Diseases|hematologic diseases
724652|NCT00529503|Immunoproliferative Disorders|immunoproliferative disorders
724653|NCT00529503|Lymphatic Diseases|lymphatic diseases
724654|NCT00529490|coronary|coronary
724655|NCT00529490|artery|artery
724656|NCT00529490|bypass|bypass
724657|NCT00529490|grafting|grafting
724658|NCT00529490|I.V.|i.v.
724659|NCT00529490|cardiac output|cardiac output
724660|NCT00529464|Cervical Intraepithelial Neoplasia|cervical intraepithelial neoplasia
724661|NCT00529464|Cervical Dysplasia|cervical dysplasia
724662|NCT00529464|Cervical Cancer|cervical cancer
724663|NCT00529464|Fluorescence Spectroscopy|fluorescence spectroscopy
724664|NCT00529464|Colposcopy|colposcopy
724665|NCT00529464|Loop Electrical Excision Procedure|loop electrical excision procedure
724666|NCT00529464|LEEP|leep
724667|NCT00529451|Hypertension, Aliskiren, Ramipril|hypertension, aliskiren, ramipril
724668|NCT00529425|Femoral neck fracture|femoral neck fracture
724669|NCT00529425|Hip fracture|hip fracture
724670|NCT00529399|immune tolerance|immune tolerance
724671|NCT00529399|immunotherapy|immunotherapy
724672|NCT00529399|antigen-specific tolerance|antigen-specific tolerance
724673|NCT00529399|vaccine induced tolerance|vaccine induced tolerance
724674|NCT00529399|Beta-cell function|beta-cell function
724675|NCT00529399|T-cells|t-cells
724676|NCT00529399|DPT-1|dpt-1
724677|NCT00529399|treatment of type 1 diabetes|treatment of type 1 diabetes
724678|NCT00529399|new onset type 1 diabetes|new onset type 1 diabetes
724679|NCT00529399|juvenile diabetes|juvenile diabetes
724680|NCT00529399|T1D|t1d
724681|NCT00529399|diabetes mellitus|diabetes mellitus
724682|NCT00529399|Type 1 diabetes TrialNet|type 1 diabetes trialnet
724683|NCT00529399|TrialNet|trialnet
724684|NCT00529386|prostatitis|prostatitis
724685|NCT00529386|Botox|botox
724686|NCT00529360|Acute Leukemia|acute leukemia
724687|NCT00529360|Allogeneic Stem Cell Transplant|allogeneic stem cell transplant
724688|NCT00529360|Clofarabine|clofarabine
724689|NCT00529360|Acute Lymphoblastic Leukemia|acute lymphoblastic leukemia
724690|NCT00529360|Acute Myelogenous Leukemia|acute myelogenous leukemia
724691|NCT00529334|Breast Cancer|breast cancer
724692|NCT00529334|Partial breast irradiation|partial breast irradiation
724693|NCT00529334|Radiosurgery|radiosurgery
724694|NCT00529334|CyberKnife|cyberknife
724695|NCT00529334|Radiotherapy|radiotherapy
724696|NCT00529334|PBI|pbi
724697|NCT00529308|Tourette|tourette
724698|NCT00529308|Tourette's|tourette's
724699|NCT00529295|misoprostol|misoprostol
724700|NCT00529295|labor induction|labor induction
724701|NCT00529282|Low numbers of neutrophils in the blood|low numbers of neutrophils in the blood
724702|NCT00529282|increased body temperature|increased body temperature
724703|NCT00529282|cancer chemotherapy|cancer chemotherapy
724704|NCT00529282|ceftobiprole|ceftobiprole
724705|NCT00529282|pseudomonas infections|pseudomonas infections
724706|NCT00529269|Renal Transplant Patients, GI symptom, Enteric-coated mycophenolate sodium|renal transplant patients, gi symptom, enteric-coated mycophenolate sodium
724707|NCT00529256|Adult smokers|adult smokers
724708|NCT00529243|Treatment Experience|treatment experience
724709|NCT00529243|On enfuvirtide|on enfuvirtide
724710|NCT00529230|Advanced Cancer|advanced cancer
724711|NCT00529230|Chronic Opioid Therapy|chronic opioid therapy
724712|NCT00529230|Secondary Hypogonadism|secondary hypogonadism
724713|NCT00529230|Cancer-Related Pain Syndromes|cancer-related pain syndromes
724714|NCT00529230|Questionnaire|questionnaire
724715|NCT00529217|Dissociative|dissociative
724716|NCT00529217|Dissociation|dissociation
724717|NCT00529217|Depersonalization|depersonalization
724718|NCT00529217|Depersonalization Disorder|depersonalization disorder
724719|NCT00529217|Transcranial Magnetic Stimulation|transcranial magnetic stimulation
724720|NCT00529217|TMS|tms
724721|NCT00529217|Depersonalization Disorder (DPD)|depersonalization disorder (dpd)
724722|NCT00529217|rTMS|rtms
724723|NCT00529204|Fatty Liver|fatty liver
724724|NCT00529204|Nonalcoholic fatty liver disease|nonalcoholic fatty liver disease
724725|NCT00529204|NAFDL|nafdl
724726|NCT00529204|Diabetes|diabetes
724727|NCT00529204|ALT|alt
724728|NCT00529204|exenatide|exenatide
724729|NCT00529191|Type I Diabetes (T1DM)|type i diabetes (t1dm)
724730|NCT00529191|Atorvastatin (Lipitor)|atorvastatin (lipitor)
724731|NCT00529191|Insulin|insulin
724732|NCT00529191|Pancreas|pancreas
724733|NCT00529191|Beta Cells|beta cells
724734|NCT00529165|injection to meal time|injection to meal time
724735|NCT00529165|human insulin|human insulin
724736|NCT00529152|Iron Overload|iron overload
724737|NCT00529139|Extended dialysis|extended dialysis
724738|NCT00529139|Acute kidney injury|acute kidney injury
724739|NCT00529139|Intensive care unit|intensive care unit
724740|NCT00529139|Renal replacement therapy|renal replacement therapy
724743|NCT00529126|hemorrhoidectomy|hemorrhoidectomy
724744|NCT00529126|pain|pain
724745|NCT00529126|Postoperative|postoperative
724746|NCT00529126|analgesia|analgesia
724747|NCT00529113|pancreatic cancer|pancreatic cancer
724748|NCT00529113|gemcitabine|gemcitabine
724749|NCT00529087|Opioid-Induced Constipation|opioid-induced constipation
724750|NCT00529074|Epidural Analgesia|epidural analgesia
724751|NCT00529061|Sickle Cell Disease|sickle cell disease
724752|NCT00529061|Sickle Cell Anemia|sickle cell anemia
724753|NCT00529048|Type 2 diabetes mellitus|type 2 diabetes mellitus
724754|NCT00529048|Incretin effect|incretin effect
724755|NCT00529048|Glucagon-Like Peptide 1|glucagon-like peptide 1
724756|NCT00529048|Gastric Inhibitory Polypeptide|gastric inhibitory polypeptide
724757|NCT00529035|Chronic GVHD|chronic gvhd
724758|NCT00529035|Steroid refractory GVHD|steroid refractory gvhd
724759|NCT00529035|allogeneic stem cell transplantation|allogeneic stem cell transplantation
724760|NCT00529022|Advanced Cancer|advanced cancer
724761|NCT00529022|Solid Tumors|solid tumors
724762|NCT00529022|Ovarian Cancer|ovarian cancer
724763|NCT00529022|Fallopian Tube Cancer|fallopian tube cancer
724764|NCT00529022|Peritoneal Cancer|peritoneal cancer
724765|NCT00529022|Azacitidine|azacitidine
724766|NCT00529022|5-Azacitidine|5-azacitidine
724767|NCT00529022|5-Aza|5-aza
724768|NCT00529022|Vidaza™|vidaza™
724769|NCT00529022|5-AZC|5-azc
724770|NCT00529022|AZA-CR|aza-cr
724771|NCT00529022|Ladakamycin|ladakamycin
724772|NCT00529022|NSC-102816|nsc-102816
724773|NCT00529022|Vidaza|vidaza
724774|NCT00529022|Valproic Acid|valproic acid
724775|NCT00529022|Depakene|depakene
724776|NCT00529022|Carboplatin|carboplatin
724777|NCT00529022|Paraplatin|paraplatin
724778|NCT00529009|PK analysis|pk analysis
724779|NCT00528983|Myelodysplastic Syndromes MDS|myelodysplastic syndromes mds
724780|NCT00528983|Acute Myelogenous Leukemia AML|acute myelogenous leukemia aml
724781|NCT00528983|Chronic Myelomonocytic Leukemia CMML|chronic myelomonocytic leukemia cmml
724782|NCT00528970|POI|poi
724783|NCT00528970|Hernia|hernia
724784|NCT00528970|Ventral Wall Hernia Repair|ventral wall hernia repair
724785|NCT00528970|Post Operative Ileus|post operative ileus
724786|NCT00528957|Phase 3|phase 3
724787|NCT00528957|Randomized, Open-Label|randomized, open-label
724788|NCT00528957|Treatment-Experienced|treatment-experienced
724789|NCT00528957|Highly Active Antiretroviral Therapy|highly active antiretroviral therapy
724790|NCT00528957|HIV|hiv
724791|NCT00528957|Tenofovir DF|tenofovir df
724792|NCT00528957|Pediatrics|pediatrics
724793|NCT00528944|alveolar volume|alveolar volume
724794|NCT00528944|pulmonary function testing|pulmonary function testing
724795|NCT00528944|emphysema|emphysema
724796|NCT00528931|Assessment of AUX I and/or AUX II in human plasma|assessment of aux i and/or aux ii in human plasma
724797|NCT00528918|diabetes|diabetes
724798|NCT00528918|hyperglycemia|hyperglycemia
724799|NCT00528918|insulin|insulin
724800|NCT00528918|Apidra|apidra
724801|NCT00528918|Glargine|glargine
724802|NCT00528905|Schizophrenia|schizophrenia
724803|NCT00528905|Cognitive Deficits|cognitive deficits
724804|NCT00528892|Treatment Experienced|treatment experienced
724805|NCT00528879|Diabetes Mellitus, Type 2|diabetes mellitus, type 2
724806|NCT00528879|Diabetes Mellitus|diabetes mellitus
724807|NCT00528879|Endocrine System Diseases|endocrine system diseases
724808|NCT00528879|Glucose Metabolism Disorders|glucose metabolism disorders
724809|NCT00528879|Metabolic Diseases|metabolic diseases
724810|NCT00528879|Metformin|metformin
724811|NCT00528879|Hypoglycemic Agents|hypoglycemic agents
724812|NCT00528879|Pharmacologic Actions|pharmacologic actions
724813|NCT00528879|Physiological Effects of Drugs|physiological effects of drugs
724814|NCT00528866|adenocarcinoma of the prostate|adenocarcinoma of the prostate
724815|NCT00528866|stage IIB prostate cancer|stage iib prostate cancer
724816|NCT00528866|stage IIA prostate cancer|stage iia prostate cancer
724817|NCT00528866|stage III prostate cancer|stage iii prostate cancer
724818|NCT00528866|stage IV prostate cancer|stage iv prostate cancer
724819|NCT00528853|Bronchiolitis Obliterans Syndrome|bronchiolitis obliterans syndrome
724820|NCT00528827|Hypertension, High Blood Pressure, Pediatric Hypertension, High blood pressure in children|hypertension, high blood pressure, pediatric hypertension, high blood pressure in children
724821|NCT00528814|Hand Sanitizer|hand sanitizer
724822|NCT00528814|Respiratory Infection|respiratory infection
724823|NCT00528801|Sickle Cell Disease|sickle cell disease
724824|NCT00528801|Sickle Cell Anemia|sickle cell anemia
724825|NCT00528801|Hemoglobin SS|hemoglobin ss
724826|NCT00528801|Hemoglobin SB0|hemoglobin sb0
724827|NCT00528775|adenocarcinoma of the lung|adenocarcinoma of the lung
724828|NCT00528775|large cell lung cancer|large cell lung cancer
724829|NCT00528775|squamous cell lung cancer|squamous cell lung cancer
724830|NCT00528775|recurrent non-small cell lung cancer|recurrent non-small cell lung cancer
724831|NCT00528775|stage IIIA non-small cell lung cancer|stage iiia non-small cell lung cancer
724832|NCT00528775|stage IIIB non-small cell lung cancer|stage iiib non-small cell lung cancer
724833|NCT00528775|stage IV non-small cell lung cancer|stage iv non-small cell lung cancer
724834|NCT00528762|Epidemiology|epidemiology
724835|NCT00528762|Puberty|puberty
724836|NCT00528762|Body Weight|body weight
724839|NCT00528749|Respiratory effort|respiratory effort
725604|NCT00525967|Morphine|morphine
724840|NCT00528749|Upper Airway Resistance Syndrome|upper airway resistance syndrome
724841|NCT00528736|preterm infants < 28 weeks|preterm infants < 28 weeks
724842|NCT00528736|B-type natriuretic peptide|b-type natriuretic peptide
724843|NCT00528736|prediction|prediction
724844|NCT00528736|ductus intervention|ductus intervention
724845|NCT00528723|beclomethasone|beclomethasone
724846|NCT00528723|as needed|as needed
724847|NCT00528723|salbutamol|salbutamol
724848|NCT00528723|wheezing|wheezing
724849|NCT00528710|S-Adenosylmethionine|s-adenosylmethionine
724850|NCT00528684|Oncolytics Biotech|oncolytics biotech
724851|NCT00528684|cancer alternative therapies|cancer alternative therapies
724852|NCT00528684|malignant glioma|malignant glioma
724853|NCT00528684|glioblastoma multiforme|glioblastoma multiforme
724854|NCT00528684|oncolytic virus|oncolytic virus
724855|NCT00528684|reovirus|reovirus
724856|NCT00528684|REOLYSIN|reolysin
724857|NCT00528671|phenprocoumon|phenprocoumon
724858|NCT00528671|INR self-management|inr self-management
724859|NCT00528671|mechanical heart valve replacement|mechanical heart valve replacement
724860|NCT00528671|bleeding|bleeding
724861|NCT00528671|thromboembolism|thromboembolism
724862|NCT00528658|Soft Tissue Injuries|soft tissue injuries
724863|NCT00528632|Gallstones|gallstones
724864|NCT00528632|Gallbladder|gallbladder
724865|NCT00528632|Cholesterolosis|cholesterolosis
724866|NCT00528632|Serum cholesterol|serum cholesterol
724867|NCT00528632|triglycerides|triglycerides
724868|NCT00528632|Body Mass Index|body mass index
724869|NCT00528619|Solid tumor malignancy|solid tumor malignancy
724870|NCT00528619|non-small cell lung cancer|non-small cell lung cancer
724871|NCT00528619|sunitinib|sunitinib
724872|NCT00528619|pemetrexed|pemetrexed
724873|NCT00528619|Phase 1|phase 1
724874|NCT00528619|Mesothelioma|mesothelioma
724875|NCT00528593|HIV|hiv
724876|NCT00528593|AIDS|aids
724877|NCT00528593|neuropathy|neuropathy
724878|NCT00528593|Procrit|procrit
724879|NCT00528593|epoetin alfa|epoetin alfa
724880|NCT00528593|erythropoetin|erythropoetin
724881|NCT00528593|Treatment Experienced|treatment experienced
724882|NCT00528580|Sepsis|sepsis
724883|NCT00528580|Statin|statin
724884|NCT00528580|Infection|infection
724885|NCT00528580|Immunomodulatory|immunomodulatory
724886|NCT00528554|CINV|cinv
724887|NCT00528554|chemotherapy induced nausea and vomiting (CINV)|chemotherapy induced nausea and vomiting (cinv)
724888|NCT00528528|Chronic Hepatitis C|chronic hepatitis c
724889|NCT00528528|Genotype 1|genotype 1
724890|NCT00528528|Telaprevir|telaprevir
724891|NCT00528528|Treatment-naïve|treatment-naïve
724892|NCT00528528|VX-950-C208|vx-950-c208
724893|NCT00528528|VX-950-TiDP24-C208|vx-950-tidp24-c208
724894|NCT00528515|anesthesia intravenous|anesthesia intravenous
724895|NCT00528515|propofol|propofol
724896|NCT00528515|anesthesia inhalation|anesthesia inhalation
724897|NCT00528515|desflurane|desflurane
724898|NCT00528515|heart surgery|heart surgery
724899|NCT00528515|coronary artery by-pass off-pump|coronary artery by-pass off-pump
724900|NCT00528515|hemodynamic processes|hemodynamic processes
724901|NCT00528515|anesthesia|anesthesia
724902|NCT00528502|Parathyroid Disease|parathyroid disease
724903|NCT00528502|Minimal Invasive Parathyroid Surgery|minimal invasive parathyroid surgery
724904|NCT00528502|MIPS|mips
724905|NCT00528502|Laryngeal Reflexes|laryngeal reflexes
724906|NCT00528502|Lidocaine|lidocaine
724907|NCT00528502|Saline|saline
724908|NCT00528489|HIV Seronegativity|hiv seronegativity
724909|NCT00528489|DNA Plasmid Vaccine|dna plasmid vaccine
724910|NCT00528489|HIV Preventive Vaccine|hiv preventive vaccine
724911|NCT00528476|pyelonephritis|pyelonephritis
724912|NCT00528476|cystitis|cystitis
724913|NCT00528476|risk factor|risk factor
724914|NCT00528476|children|children
724915|NCT00528476|urodynamics|urodynamics
724916|NCT00528463|Pre-emptive analgesia|pre-emptive analgesia
724917|NCT00528463|Peripheral nerve block (sciatic)|peripheral nerve block (sciatic)
724918|NCT00528463|phantom lomb pain|phantom lomb pain
724919|NCT00528450|adult acute promyelocytic leukemia (M3)|adult acute promyelocytic leukemia (m3)
724920|NCT00528450|adult acute myeloid leukemia with t(15;17)(q22;q12)|adult acute myeloid leukemia with t(15;17)(q22;q12)
724921|NCT00528450|untreated adult acute myeloid leukemia|untreated adult acute myeloid leukemia
724922|NCT00528437|Recurrent or refractory medulloblastoma/PNET|recurrent or refractory medulloblastoma/pnet
724923|NCT00528437|CNS germ cell tumors|cns germ cell tumors
724924|NCT00528437|Ependymomas|ependymomas
724925|NCT00528437|AT/RT|at/rt
724926|NCT00528437|High grade glioma|high grade glioma
724927|NCT00528437|Other malignant brain tumors|other malignant brain tumors
724928|NCT00528411|Coronary artery disease|coronary artery disease
724929|NCT00528411|CAD|cad
724930|NCT00528411|heart attack|heart attack
724931|NCT00528411|stable angina|stable angina
724932|NCT00528411|Stable coronary artery disease|stable coronary artery disease
724933|NCT00528398|adult acute megakaryoblastic leukemia (M7)|adult acute megakaryoblastic leukemia (m7)
724934|NCT00528398|adult acute minimally differentiated myeloid leukemia (M0)|adult acute minimally differentiated myeloid leukemia (m0)
724935|NCT00528398|adult acute monoblastic leukemia (M5a)|adult acute monoblastic leukemia (m5a)
726412|NCT00523133|alcoholism|alcoholism
724936|NCT00528398|adult acute monocytic leukemia (M5b)|adult acute monocytic leukemia (m5b)
724937|NCT00528398|adult acute myeloblastic leukemia with maturation (M2)|adult acute myeloblastic leukemia with maturation (m2)
724938|NCT00528398|adult acute myeloblastic leukemia without maturation (M1)|adult acute myeloblastic leukemia without maturation (m1)
724939|NCT00528398|adult acute myelomonocytic leukemia (M4)|adult acute myelomonocytic leukemia (m4)
724940|NCT00528398|adult erythroleukemia (M6a)|adult erythroleukemia (m6a)
724941|NCT00528398|adult pure erythroid leukemia (M6b)|adult pure erythroid leukemia (m6b)
724942|NCT00528398|adult acute myeloid leukemia with 11q23 (MLL) abnormalities|adult acute myeloid leukemia with 11q23 (mll) abnormalities
724943|NCT00528398|adult acute myeloid leukemia with inv(16)(p13;q22)|adult acute myeloid leukemia with inv(16)(p13;q22)
724944|NCT00528398|adult acute myeloid leukemia with t(16;16)(p13;q22)|adult acute myeloid leukemia with t(16;16)(p13;q22)
724945|NCT00528398|adult acute myeloid leukemia with t(8;21)(q22;q22)|adult acute myeloid leukemia with t(8;21)(q22;q22)
724946|NCT00528398|secondary acute myeloid leukemia|secondary acute myeloid leukemia
724947|NCT00528398|untreated adult acute myeloid leukemia|untreated adult acute myeloid leukemia
724948|NCT00528385|Proteinuria|proteinuria
724949|NCT00528385|Renin-Angiotensin-Aldosterone System|renin-angiotensin-aldosterone system
724950|NCT00528385|Aldosterone Antagonists|aldosterone antagonists
724951|NCT00528359|antipsychotic drugs|antipsychotic drugs
724952|NCT00528359|schizophrenia|schizophrenia
724953|NCT00528359|β-cell function|β-cell function
724954|NCT00528359|insulin resistance|insulin resistance
724955|NCT00528346|chronic pain|chronic pain
724956|NCT00528346|functional magnetic resonance imaging|functional magnetic resonance imaging
724957|NCT00528346|fMRI|fmri
724958|NCT00528346|cognitive training|cognitive training
724959|NCT00528333|Lintuzumab|lintuzumab
724960|NCT00528333|Antigens, CD33|antigens, cd33
724961|NCT00528333|Antibodies, Monoclonal|antibodies, monoclonal
724962|NCT00528333|Leukemia, Myeloid, Acute|leukemia, myeloid, acute
724963|NCT00528333|Hematologic Diseases|hematologic diseases
724964|NCT00528333|Leukemia|leukemia
724965|NCT00528320|Congestive Heart Failure|congestive heart failure
724966|NCT00528320|Heart Failure|heart failure
724967|NCT00528320|Cardiac Resynchronization Therapy|cardiac resynchronization therapy
724968|NCT00528320|ICD|icd
724969|NCT00528320|Implantable Cardioverter-Defibrillator|implantable cardioverter-defibrillator
724970|NCT00528320|Defibrillator|defibrillator
724971|NCT00528307|myocardial perfusion|myocardial perfusion
724972|NCT00528307|His ablation|his ablation
724973|NCT00528307|biventricular pacing|biventricular pacing
724974|NCT00528307|His bundle ablation for atrial fibrillation|his bundle ablation for atrial fibrillation
724975|NCT00528294|Recurrent head and neck tumors|recurrent head and neck tumors
724976|NCT00528281|Non Small Cell Lung Cancer (NSCLC)|non small cell lung cancer (nsclc)
724977|NCT00528281|Pemetrexed,|pemetrexed,
724978|NCT00528281|Lapatinib (GW572016),|lapatinib (gw572016),
724979|NCT00528268|Spinal Muscular Atrophy|spinal muscular atrophy
724980|NCT00528268|SMA|sma
724981|NCT00528268|Sodium Phenylbutyrate|sodium phenylbutyrate
724982|NCT00528255|cervical ripening|cervical ripening
724983|NCT00528255|induction of labor|induction of labor
724984|NCT00528216|Analgesics|analgesics
724985|NCT00528216|Capsaicin|capsaicin
724986|NCT00528203|Sickle Cell Disease|sickle cell disease
724987|NCT00528203|Sickle Cell Anemia|sickle cell anemia
724988|NCT00528203|DNA|dna
724989|NCT00528190|Cystic Fibrosis|cystic fibrosis
724990|NCT00528190|Aspergillus Fumigatus|aspergillus fumigatus
724991|NCT00528190|randomized controlled clinical trials|randomized controlled clinical trials
724992|NCT00528177|kappa-opioid receptor|kappa-opioid receptor
724993|NCT00528177|my-opioid receptor|my-opioid receptor
724994|NCT00528177|oxycodone|oxycodone
724995|NCT00528177|morphine|morphine
724996|NCT00528177|postoperative pain|postoperative pain
724997|NCT00528164|children|children
724998|NCT00528164|overweight|overweight
724999|NCT00528164|obesity|obesity
725000|NCT00528164|family|family
725001|NCT00528164|intervention|intervention
725002|NCT00528164|control|control
725003|NCT00528164|randomized|randomized
725004|NCT00528164|physical activity|physical activity
725005|NCT00528164|diet|diet
725006|NCT00528164|nutrition|nutrition
725007|NCT00528164|behavior|behavior
725008|NCT00528164|body mass index|body mass index
725009|NCT00528151|Curcumin, LHON, antioxidant, visual outcome|curcumin, lhon, antioxidant, visual outcome
725010|NCT00528138|Appendicitis|appendicitis
725011|NCT00528138|Hyperbilirubinemia|hyperbilirubinemia
725012|NCT00528138|CRP|crp
725013|NCT00528138|Values of bilirubin|values of bilirubin
725014|NCT00528138|Values of liver function test|values of liver function test
725015|NCT00528138|Values of white blood cells|values of white blood cells
725016|NCT00528138|Values of CRP|values of crp
725017|NCT00528125|pain prevention|pain prevention
725018|NCT00528125|neonatal pain|neonatal pain
725019|NCT00528125|laser acupuncture|laser acupuncture
725020|NCT00528125|complementary and alternative medicine|complementary and alternative medicine
725021|NCT00528112|Contraception|contraception
725022|NCT00528112|Intrauterine|intrauterine
725023|NCT00528112|IUD|iud
725024|NCT00528112|IUS|ius
725025|NCT00528086|Group visits|group visits
725026|NCT00528073|Rifaximin-EIR|rifaximin-eir
725027|NCT00528073|Crohn's disease|crohn's disease
725028|NCT00528073|remission|remission
725029|NCT00528060|HIV infections|hiv infections
725030|NCT00528060|atazanavir|atazanavir
725031|NCT00528060|Pharmacokinetics|pharmacokinetics
725032|NCT00528060|Treatment Naive|treatment naive
725033|NCT00528047|Cancer|cancer
725034|NCT00528047|Solid Tumor|solid tumor
725035|NCT00528047|Metastatic|metastatic
725036|NCT00528047|Neoplasm, Malignant|neoplasm, malignant
725037|NCT00528034|Vaginal Cancer|vaginal cancer
725038|NCT00528034|Lymphoscintigraphy|lymphoscintigraphy
725039|NCT00528034|Lymphatic Mapping|lymphatic mapping
725040|NCT00528034|Sentinel Lymph Node|sentinel lymph node
725041|NCT00528034|Isosulfan Blue|isosulfan blue
725042|NCT00528034|Lymph|lymph
725043|NCT00528021|Head Lice|head lice
725044|NCT00528021|Lice Infestation|lice infestation
725045|NCT00528021|Pediculosis|pediculosis
725046|NCT00528021|Pediculosis Capitis|pediculosis capitis
725047|NCT00528008|infection|infection
725048|NCT00528008|sepsis|sepsis
725049|NCT00528008|povidone-iodine|povidone-iodine
725050|NCT00528008|chlorhexidine gluconate|chlorhexidine gluconate
725051|NCT00528008|fever|fever
725052|NCT00528008|erythema|erythema
725053|NCT00528008|leukocytosis|leukocytosis
725054|NCT00528008|drainage|drainage
725055|NCT00528008|vaginal discharge|vaginal discharge
725056|NCT00528008|elective cesarean section|elective cesarean section
725057|NCT00527982|Head and Neck Cancer|head and neck cancer
725058|NCT00527982|Lung Cancer|lung cancer
725059|NCT00527982|Non-Small Cell Lung Cancer|non-small cell lung cancer
725060|NCT00527982|Celecoxib|celecoxib
725061|NCT00527982|Celebrex|celebrex
725062|NCT00527969|American ginseng extract|american ginseng extract
725063|NCT00527969|Panax quinquefolius|panax quinquefolius
725064|NCT00527969|Memory enhancement|memory enhancement
725065|NCT00527969|Cognitive function|cognitive function
725066|NCT00527969|Working memory|working memory
725067|NCT00527969|Declarative memory|declarative memory
725068|NCT00527969|Psychomotor speed|psychomotor speed
725069|NCT00527969|Executive skills|executive skills
725070|NCT00527969|Psychosocial adaptation|psychosocial adaptation
725071|NCT00527956|Breastfeeding premature infants|breastfeeding premature infants
725072|NCT00527930|Breast Neoplasms|breast neoplasms
725073|NCT00527930|Oxaliplatin|oxaliplatin
725074|NCT00527930|S1|s1
725075|NCT00527917|IC/PBS|ic/pbs
725076|NCT00527917|Interstitial Cystitis/Painful Bladder Syndrome|interstitial cystitis/painful bladder syndrome
725077|NCT00527904|osteoarthritis|osteoarthritis
725078|NCT00527904|rheumatoid arthritis|rheumatoid arthritis
725079|NCT00527904|ankylosing spondylisit|ankylosing spondylisit
725080|NCT00527904|NSAIDS|nsaids
725081|NCT00527891|Liver Cancer|liver cancer
725082|NCT00527891|Magnetic Resonance Imaging|magnetic resonance imaging
725083|NCT00527891|Signa Excite 3.0T MRI Scan|signa excite 3.0t mri scan
725084|NCT00527878|Hyper-IgE Recurrent Infection Syndrome|hyper-ige recurrent infection syndrome
725085|NCT00527878|Ranitidine Therapy|ranitidine therapy
725086|NCT00527878|Job's Syndrome|job's syndrome
725087|NCT00527878|Cross-Over Study|cross-over study
725088|NCT00527878|Double-Blind Placebo Controlled|double-blind placebo controlled
725089|NCT00527878|Hyper-IgE Syndrome|hyper-ige syndrome
725090|NCT00527878|Job Syndrome|job syndrome
725091|NCT00527878|Immune Deficiency|immune deficiency
725092|NCT00527865|Influenza, Flu, DAS181, Fludase|influenza, flu, das181, fludase
725093|NCT00527852|Flocked swab|flocked swab
725094|NCT00527852|Group A streptococcus pharyngitis|group a streptococcus pharyngitis
725095|NCT00527826|Severe and very severe COPD (GOLD stage III / IV) exacerbations|severe and very severe copd (gold stage iii / iv) exacerbations
725096|NCT00527826|health care utilisation|health care utilisation
725097|NCT00527826|Chronic Obstructive Pulmonary Disease (COPD)|chronic obstructive pulmonary disease (copd)
725098|NCT00527826|quality of life|quality of life
725099|NCT00527826|compliance|compliance
725100|NCT00527826|salmeterol/fluticasone combination|salmeterol/fluticasone combination
725101|NCT00527813|acute respiratory distress syndrome|acute respiratory distress syndrome
725102|NCT00527813|prone position|prone position
725103|NCT00527813|Acute respiratory distress syndrome (ARDS)|acute respiratory distress syndrome (ards)
725104|NCT00527800|Malaria|malaria
725105|NCT00527800|HIV|hiv
725106|NCT00527800|Trimethoprim-sulfamethoxazole|trimethoprim-sulfamethoxazole
725107|NCT00527800|Artemether-lumefantrine|artemether-lumefantrine
725108|NCT00527800|Dihydroartemisinin-piperaquine|dihydroartemisinin-piperaquine
725109|NCT00527800|Acute Infection|acute infection
725110|NCT00527787|NSAID|nsaid
725111|NCT00527787|gastric ulcers|gastric ulcers
725112|NCT00527787|Vimovo|vimovo
725113|NCT00527787|Naproxen|naproxen
725114|NCT00527787|Esomeprazole|esomeprazole
725115|NCT00527774|Hepatitis C|hepatitis c
725116|NCT00527774|malnutrition-inflammation complex syndrome (MICS)|malnutrition-inflammation complex syndrome (mics)
725117|NCT00527774|dialysis|dialysis
725118|NCT00527774|mortality|mortality
725119|NCT00527774|hospitalization|hospitalization
725120|NCT00527774|health-related quality of life (HRQOL)|health-related quality of life (hrqol)
725121|NCT00527774|peripheral arterial occlusive disease (PAOD)|peripheral arterial occlusive disease (paod)
725122|NCT00527761|Metastatic Melanoma|metastatic melanoma
725123|NCT00527761|Temozolomide|temozolomide
725124|NCT00527761|Temodar|temodar
725125|NCT00527761|Taxotere|taxotere
725126|NCT00527761|Cisplatin|cisplatin
725127|NCT00527761|TTC|ttc
725128|NCT00527748|Range of Motion|range of motion
725129|NCT00527748|Ankle Fractures|ankle fractures
725130|NCT00527748|Elderly patients|elderly patients
725131|NCT00527735|Non Small Cell Lung Cancer (NSCLC)|non small cell lung cancer (nsclc)
725132|NCT00527735|Small Cell Lung Cancer (SCLC)|small cell lung cancer (sclc)
725133|NCT00527722|Lung Cancer|lung cancer
725134|NCT00527722|Bio-Seal Track Plug|bio-seal track plug
725135|NCT00527722|Lung Biopsy|lung biopsy
725136|NCT00527722|Lung Plug|lung plug
725137|NCT00527722|Air Leaks|air leaks
725138|NCT00527683|vigabatrin|vigabatrin
725139|NCT00527683|GVG|gvg
725140|NCT00527683|addiction|addiction
725141|NCT00527683|treatment|treatment
725142|NCT00527683|cocaine dependence|cocaine dependence
725143|NCT00527670|Genomics|genomics
725144|NCT00527657|Brain Neoplasms|brain neoplasms
725145|NCT00527657|Melanoma|melanoma
725146|NCT00527657|Metastatic Melanoma|metastatic melanoma
725147|NCT00527657|Brain Metastasis|brain metastasis
725148|NCT00527657|Temozolomide|temozolomide
725149|NCT00527657|Temodar|temodar
725150|NCT00527657|Thalidomide|thalidomide
725151|NCT00527657|Thalomid|thalomid
725152|NCT00527657|Lomustine|lomustine
725153|NCT00527657|CCNU|ccnu
725154|NCT00527657|CeeNU|ceenu
725155|NCT00527644|biliary leaks after laparoscopic cholecystectomy|biliary leaks after laparoscopic cholecystectomy
725156|NCT00527631|advanced ovarian cancer|advanced ovarian cancer
725157|NCT00527631|whole abdominal irradiation|whole abdominal irradiation
725158|NCT00527631|intensity modulated radiotherapy|intensity modulated radiotherapy
725159|NCT00527631|ovarian cancer stage FIGO III|ovarian cancer stage figo iii
725160|NCT00527618|Herpes Simplex Virus Type 2|herpes simplex virus type 2
725161|NCT00527618|Human Immunodeficiency Virus|human immunodeficiency virus
725162|NCT00527618|Treatment Naive|treatment naive
725163|NCT00527605|placebo control|placebo control
725164|NCT00527605|Chinese|chinese
725165|NCT00527605|Dutasteride|dutasteride
725166|NCT00527605|Randomized|randomized
725167|NCT00527605|Benign Prostatic Hyperplasia|benign prostatic hyperplasia
725168|NCT00527605|Double blind|double blind
725169|NCT00527592|Comfort|comfort
725170|NCT00527579|Epilepsy|epilepsy
725171|NCT00527579|Taenia Solium|taenia solium
725172|NCT00527579|Microglia|microglia
725173|NCT00527579|Neuroinflammation|neuroinflammation
725174|NCT00527579|Compartment Model|compartment model
725175|NCT00527579|Neurocysticercosis|neurocysticercosis
725176|NCT00527579|Healthy Volunteer|healthy volunteer
725177|NCT00527579|HV|hv
725178|NCT00527566|Churg Strauss Syndrome|churg strauss syndrome
725179|NCT00527553|Macular pigment|macular pigment
725180|NCT00527553|AMD|amd
725181|NCT00527553|ARM|arm
725182|NCT00527514|Hypertension|hypertension
725183|NCT00527514|Angiotensin Receptor Blocker|angiotensin receptor blocker
725184|NCT00527514|Calcium Channel Blocker|calcium channel blocker
725185|NCT00527514|Stage I and II Hypertension|stage i and ii hypertension
725186|NCT00527501|Open-angle glaucoma|open-angle glaucoma
725187|NCT00527501|ocular hypertension|ocular hypertension
725188|NCT00527488|Benign Prostate Hyperplasia|benign prostate hyperplasia
725189|NCT00527488|BPH|bph
725190|NCT00527488|PK/PD|pk/pd
725191|NCT00527488|GnRH antagonist|gnrh antagonist
725192|NCT00527475|Anti-VEGF therapy|anti-vegf therapy
725193|NCT00527475|photodynamic therapy|photodynamic therapy
725194|NCT00527475|neovascularization|neovascularization
725195|NCT00527462|Asthma GINA 1|asthma gina 1
725196|NCT00527423|VEGF Trap-Eye|vegf trap-eye
725197|NCT00527423|Macular Degeneration|macular degeneration
725198|NCT00527423|AMD|amd
725199|NCT00527423|Neovascular Age-Related Macular Degeneration|neovascular age-related macular degeneration
725200|NCT00527397|Diabetes Mellitus|diabetes mellitus
725201|NCT00527384|Stress|stress
725202|NCT00527371|Benign hyperplasia of the prostate|benign hyperplasia of the prostate
725203|NCT00527358|violence|violence
725204|NCT00527345|Asthma|asthma
725205|NCT00527345|Diesel exhaust|diesel exhaust
725206|NCT00527332|Hospitalization|hospitalization
725207|NCT00527332|Postoperative care|postoperative care
725208|NCT00527332|Quality of Life|quality of life
725209|NCT00527332|Health economy|health economy
725210|NCT00527332|Anesthesia. Spinal|anesthesia. spinal
725211|NCT00527332|Anesthesia, General|anesthesia, general
725212|NCT00527319|NSCLC|nsclc
725213|NCT00527319|anorexia|anorexia
725214|NCT00527319|cachexia|cachexia
725215|NCT00527319|grip strength|grip strength
725216|NCT00527319|lean body mass|lean body mass
725217|NCT00527306|aphthous stomatitis|aphthous stomatitis
725218|NCT00527306|canker sores|canker sores
725219|NCT00527306|multivitamins|multivitamins
725220|NCT00527306|vitamin deficiency|vitamin deficiency
725221|NCT00527293|stage I breast cancer|stage i breast cancer
725222|NCT00527293|stage II breast cancer|stage ii breast cancer
725223|NCT00527293|invasive ductal breast carcinoma|invasive ductal breast carcinoma
725224|NCT00527293|medullary ductal breast carcinoma with lymphocytic infiltrate|medullary ductal breast carcinoma with lymphocytic infiltrate
725225|NCT00527293|mucinous ductal breast carcinoma|mucinous ductal breast carcinoma
725226|NCT00527293|tubular ductal breast carcinoma|tubular ductal breast carcinoma
725227|NCT00527293|papillary ductal breast carcinoma|papillary ductal breast carcinoma
725228|NCT00527280|Allotransplantation:composite tissue|allotransplantation:composite tissue
725229|NCT00527280|Face transplantation|face transplantation
725230|NCT00527241|partner violence, spouse abuse|partner violence, spouse abuse
725231|NCT00527228|Muscular dystrophy|muscular dystrophy
725232|NCT00527228|therapy|therapy
725233|NCT00527228|steroids|steroids
725234|NCT00527228|deflazacort|deflazacort
725235|NCT00527228|dysferlinopathy|dysferlinopathy
725236|NCT00527228|LGMD|lgmd
725237|NCT00527228|MM|mm
725238|NCT00527189|Arthritis|arthritis
725239|NCT00527189|Exercise|exercise
725240|NCT00527189|Balance - Postural Control|balance - postural control
725241|NCT00527176|Systemic Lupus Erythematosus|systemic lupus erythematosus
725242|NCT00527176|Corticosteroid|corticosteroid
725243|NCT00527176|Pulse therapy|pulse therapy
725244|NCT00527176|Diffusion weighted imaging|diffusion weighted imaging
725245|NCT00527176|q Space Imaging|q space imaging
725246|NCT00527163|Echocardiogram|echocardiogram
725247|NCT00527163|Endothelial Dysfunction|endothelial dysfunction
725248|NCT00527163|Malaria|malaria
725249|NCT00527163|Mali|mali
725250|NCT00527163|Screening|screening
725251|NCT00527098|Trauma Resuscitation|trauma resuscitation
725252|NCT00527072|plaque psoriasis|plaque psoriasis
725253|NCT00527072|psoriasis|psoriasis
725254|NCT00527072|infliximab|infliximab
725255|NCT00527072|remicade|remicade
725256|NCT00527072|etanercept|etanercept
725257|NCT00527072|enbrel|enbrel
725258|NCT00527072|psunrise|psunrise
725259|NCT00527072|C0168Z04|c0168z04
725260|NCT00527059|Cardiorenal syndrome|cardiorenal syndrome
725261|NCT00527033|YM178|ym178
725262|NCT00527033|Urinary Bladder, Overactive|urinary bladder, overactive
725263|NCT00527020|qEEG,|qeeg,
725264|NCT00527020|GlyT-1 inhibitor,|glyt-1 inhibitor,
725265|NCT00527020|ERP|erp
725266|NCT00527020|GSK1018921,|gsk1018921,
725267|NCT00527020|FTIH,|ftih,
725268|NCT00527020|schizophrenia,|schizophrenia,
725269|NCT00527020|single-dose,|single-dose,
725270|NCT00527020|healthy volunteers,|healthy volunteers,
725271|NCT00527020|MMN,|mmn,
725272|NCT00527007|Vasopressor|vasopressor
725273|NCT00527007|Epinephrine|epinephrine
725274|NCT00527007|Norepinephrine|norepinephrine
725275|NCT00527007|Cooling|cooling
725276|NCT00527007|Fever|fever
725277|NCT00527007|ICU|icu
725278|NCT00526994|intimate partner violence|intimate partner violence
725279|NCT00526994|domestic violence|domestic violence
725280|NCT00526994|spouse abuse|spouse abuse
725281|NCT00526994|screening|screening
725282|NCT00526955|Manual muscle testing|manual muscle testing
725283|NCT00526942|ACRD|acrd
725284|NCT00526942|Visual Memory|visual memory
725285|NCT00526942|Visual Perception|visual perception
725286|NCT00526942|Speed|speed
725287|NCT00526942|Computerized|computerized
725288|NCT00526942|SAAGE|saage
725289|NCT00526942|Cognitive Decline|cognitive decline
725290|NCT00526916|Epilepsy|epilepsy
725291|NCT00526916|Taenia Solium|taenia solium
725292|NCT00526916|Microglia|microglia
725293|NCT00526916|Neuroinflammation|neuroinflammation
725294|NCT00526916|Compartment Model|compartment model
725295|NCT00526916|Neurocysticercosis|neurocysticercosis
725296|NCT00526916|Healthy Volunteer|healthy volunteer
725297|NCT00526916|HV|hv
725298|NCT00526903|IBS|ibs
725299|NCT00526903|abdominal pain|abdominal pain
725300|NCT00526903|recurrent abdominal pain|recurrent abdominal pain
725301|NCT00526903|irritable bowel syndrome|irritable bowel syndrome
725302|NCT00526903|diarrhea|diarrhea
725303|NCT00526903|constipation|constipation
725304|NCT00526903|bloating|bloating
725305|NCT00526890|squamous cell lung cancer|squamous cell lung cancer
725306|NCT00526890|adenocarcinoma of the lung|adenocarcinoma of the lung
725307|NCT00526890|bronchoalveolar cell lung cancer|bronchoalveolar cell lung cancer
725308|NCT00526890|large cell lung cancer|large cell lung cancer
725309|NCT00526890|stage IIIA non-small cell lung cancer|stage iiia non-small cell lung cancer
725310|NCT00526890|stage IIIB non-small cell lung cancer|stage iiib non-small cell lung cancer
725311|NCT00526890|adenosquamous cell lung cancer|adenosquamous cell lung cancer
725312|NCT00526877|Schizophrenia|schizophrenia
725313|NCT00526877|Schizoaffective disorders|schizoaffective disorders
725314|NCT00526877|Risperidone|risperidone
725315|NCT00526877|Risperdal Consta|risperdal consta
725316|NCT00526864|Burden of Illness for Herpes zoster in Thailand.|burden of illness for herpes zoster in thailand.
725317|NCT00526851|lip and oral cavity cancer|lip and oral cavity cancer
725318|NCT00526851|oropharyngeal cancer|oropharyngeal cancer
725319|NCT00526838|Solid Tumor|solid tumor
725320|NCT00526838|Multiple Myeloma|multiple myeloma
725321|NCT00526786|Low Grade Dysplasia|low grade dysplasia
725322|NCT00526786|High Grade Dysplasia|high grade dysplasia
725323|NCT00526786|Barrett's Esophagus|barrett's esophagus
725324|NCT00526786|Cryospray ablation|cryospray ablation
725325|NCT00526786|ICE|ice
725326|NCT00526786|Cryotherapy|cryotherapy
725329|NCT00526773|motivational therapy|motivational therapy
725330|NCT00526760|Dexmedetomidine, Sedation, Long-term, Phase 3|dexmedetomidine, sedation, long-term, phase 3
725331|NCT00526734|stage I multiple myeloma|stage i multiple myeloma
725332|NCT00526734|stage II multiple myeloma|stage ii multiple myeloma
725333|NCT00526734|stage III multiple myeloma|stage iii multiple myeloma
725334|NCT00526721|Hypercholesterolemia|hypercholesterolemia
725335|NCT00526721|Crestor|crestor
725336|NCT00526721|LDL target goal|ldl target goal
725337|NCT00526721|high risk patients|high risk patients
725338|NCT00526721|Naturalistic|naturalistic
725339|NCT00526721|Observational|observational
725340|NCT00526708|dyslipidemia|dyslipidemia
725341|NCT00526708|hypertension|hypertension
725342|NCT00526708|rosuvastatin|rosuvastatin
725343|NCT00526708|efficacy|efficacy
725344|NCT00526708|Naturalistic|naturalistic
725345|NCT00526708|Observational|observational
725346|NCT00526695|Ischemia/Reperfusion|ischemia/reperfusion
725347|NCT00526695|Organ Protection|organ protection
725348|NCT00526695|Anesthetics|anesthetics
725349|NCT00526682|Antiobesity|antiobesity
725350|NCT00526682|Weight loss|weight loss
725351|NCT00526669|tumor biopsy|tumor biopsy
725352|NCT00526669|capecitabine|capecitabine
725353|NCT00526669|first line|first line
725354|NCT00526669|Gastro Esophageal (GE) Junction Cancer|gastro esophageal (ge) junction cancer
725355|NCT00526669|Gastric cancer|gastric cancer
725356|NCT00526669|newly diagnosed|newly diagnosed
725357|NCT00526669|GE junction|ge junction
725358|NCT00526669|lapatinib|lapatinib
725359|NCT00526669|metastatic or unresectable|metastatic or unresectable
725360|NCT00526656|transitional cell carcinoma of the bladder|transitional cell carcinoma of the bladder
725361|NCT00526656|stage II bladder cancer|stage ii bladder cancer
725362|NCT00526656|stage III bladder cancer|stage iii bladder cancer
725363|NCT00526656|stage IV bladder cancer|stage iv bladder cancer
725364|NCT00526643|stage IIIB|stage iiib
725365|NCT00526643|Stage IV|stage iv
725366|NCT00526643|chemotherapy|chemotherapy
725367|NCT00526643|monotherapy|monotherapy
725368|NCT00526643|combination chemotherapy|combination chemotherapy
725369|NCT00526643|poor performance status|poor performance status
725370|NCT00526630|freezing|freezing
725371|NCT00526630|gait|gait
725372|NCT00526630|festination|festination
725373|NCT00526630|shuffling|shuffling
725374|NCT00526630|balance|balance
725375|NCT00526617|Solid Tumor|solid tumor
725376|NCT00526617|Melanoma|melanoma
725377|NCT00526617|Breast cancer|breast cancer
725378|NCT00526617|Ovarian cancer|ovarian cancer
725379|NCT00526617|Primary peritoneal cancer|primary peritoneal cancer
725380|NCT00526617|Fallopian tube cancer|fallopian tube cancer
725381|NCT00526617|Hepatocellular carcinoma|hepatocellular carcinoma
725382|NCT00526617|HCC|hcc
725383|NCT00526617|BRCA deficient|brca deficient
725384|NCT00526617|BRCA mutation|brca mutation
725385|NCT00526617|Temozolomide|temozolomide
725386|NCT00526617|Temodar|temodar
725387|NCT00526617|TMZ|tmz
725388|NCT00526617|ABT-888|abt-888
725389|NCT00526617|PARP inhibitor|parp inhibitor
725390|NCT00526604|return to work|return to work
725391|NCT00526604|low back pain|low back pain
725392|NCT00526604|work related rehabilitation|work related rehabilitation
725393|NCT00526591|adenocarcinoma of the prostate|adenocarcinoma of the prostate
725394|NCT00526591|stage I prostate cancer|stage i prostate cancer
725395|NCT00526591|stage II prostate cancer|stage ii prostate cancer
725396|NCT00526591|stage III prostate cancer|stage iii prostate cancer
725397|NCT00526578|Pancreatic Cancer|pancreatic cancer
725398|NCT00526578|Pancreatic Cancer Genetic Epidemiology|pancreatic cancer genetic epidemiology
725399|NCT00526578|PACGENE|pacgene
725400|NCT00526578|Healthy Control|healthy control
725401|NCT00526578|Familial Pancreatic Cancer|familial pancreatic cancer
725402|NCT00526578|FPC|fpc
725403|NCT00526578|Questionnaire|questionnaire
725404|NCT00526552|dyslipidemia|dyslipidemia
725405|NCT00526552|rosuvastatin|rosuvastatin
725406|NCT00526552|diabetes|diabetes
725407|NCT00526552|cholesterol|cholesterol
725408|NCT00526552|Naturalistic|naturalistic
725409|NCT00526552|Observational|observational
725410|NCT00526539|THR|thr
725411|NCT00526539|reversed hybrid|reversed hybrid
725412|NCT00526539|wear|wear
725413|NCT00526500|Severe Traumatic Brain Injury|severe traumatic brain injury
725414|NCT00526500|Subarachnoid Hemorrhage|subarachnoid hemorrhage
725415|NCT00526500|Anoxic Brain Injury|anoxic brain injury
725416|NCT00526500|Passive Gait Training|passive gait training
725781|NCT00525421|oral lichen planus|oral lichen planus
725417|NCT00526500|Tilt Table With Integrated Stepping System|tilt table with integrated stepping system
725418|NCT00526500|Electroencephalogram|electroencephalogram
725419|NCT00526500|Event Related Potentials|event related potentials
725420|NCT00526487|Thoracic Dissection|thoracic dissection
725421|NCT00526487|Dissection|dissection
725422|NCT00526487|Endovascular|endovascular
725423|NCT00526461|stage 0 non-small cell lung cancer|stage 0 non-small cell lung cancer
725424|NCT00526461|adenocarcinoma of the lung|adenocarcinoma of the lung
725425|NCT00526461|squamous cell lung cancer|squamous cell lung cancer
725426|NCT00526461|large cell lung cancer|large cell lung cancer
725427|NCT00526448|high dose of ribavirin|high dose of ribavirin
725428|NCT00526448|extend treatment duration|extend treatment duration
725429|NCT00526448|tailoring treatment|tailoring treatment
725430|NCT00526435|Arthritis|arthritis
725431|NCT00526435|osteoarthritis|osteoarthritis
725432|NCT00526435|rheumatoid arthritis|rheumatoid arthritis
725433|NCT00526435|fibromyalgia|fibromyalgia
725434|NCT00526435|lupus|lupus
725435|NCT00526422|Questionnaire, dental caries, diagnosis,treatment|questionnaire, dental caries, diagnosis,treatment
725436|NCT00526409|Acute Lymphoblastic Leukemia|acute lymphoblastic leukemia
725437|NCT00526396|chemotherapy|chemotherapy
725438|NCT00526396|toxicity adjusted dose|toxicity adjusted dose
725439|NCT00526383|Major depressive disorder|major depressive disorder
725440|NCT00526383|Antidepressants|antidepressants
725441|NCT00526383|Weight gain|weight gain
725442|NCT00526383|Metabolic syndromes|metabolic syndromes
725443|NCT00526370|self test|self test
725444|NCT00526370|PAP smear|pap smear
725445|NCT00526370|tampon test|tampon test
725446|NCT00526370|E6/E7|e6/e7
725447|NCT00526370|mRNA|mrna
725448|NCT00526370|HPV|hpv
725449|NCT00526357|omega-3 fatty acids|omega-3 fatty acids
725450|NCT00526357|asthma|asthma
725451|NCT00526357|airway hyperresponsiveness|airway hyperresponsiveness
725452|NCT00526357|inflammation|inflammation
725453|NCT00526344|remission of asthma|remission of asthma
725454|NCT00526331|Perioperative Therapy|perioperative therapy
725455|NCT00526331|Perioperative Hydration|perioperative hydration
725456|NCT00526331|Arterial Pressure Based Cardiac Output|arterial pressure based cardiac output
725457|NCT00526331|Vigileo Monitor|vigileo monitor
725458|NCT00526331|FloTrac Sensor|flotrac sensor
725459|NCT00526331|Fluid Volume|fluid volume
725460|NCT00526331|APCO|apco
725461|NCT00526318|localized resectable neuroblastoma|localized resectable neuroblastoma
725462|NCT00526318|localized unresectable neuroblastoma|localized unresectable neuroblastoma
725463|NCT00526318|regional neuroblastoma|regional neuroblastoma
725464|NCT00526318|stage 4S neuroblastoma|stage 4s neuroblastoma
725465|NCT00526318|disseminated neuroblastoma|disseminated neuroblastoma
725466|NCT00526305|Acute Lymphoblastic Leukemia|acute lymphoblastic leukemia
725467|NCT00526305|Chromosome Philadelphia positive|chromosome philadelphia positive
725468|NCT00526292|recurrent adult acute lymphoblastic leukemia|recurrent adult acute lymphoblastic leukemia
725469|NCT00526292|recurrent adult acute myeloid leukemia|recurrent adult acute myeloid leukemia
725470|NCT00526292|blastic phase chronic myelogenous leukemia|blastic phase chronic myelogenous leukemia
725471|NCT00526292|previously treated myelodysplastic syndromes|previously treated myelodysplastic syndromes
725472|NCT00526292|childhood myelodysplastic syndromes|childhood myelodysplastic syndromes
725473|NCT00526292|recurrent childhood acute lymphoblastic leukemia|recurrent childhood acute lymphoblastic leukemia
725474|NCT00526292|recurrent childhood acute myeloid leukemia|recurrent childhood acute myeloid leukemia
725475|NCT00526292|childhood chronic myelogenous leukemia|childhood chronic myelogenous leukemia
725476|NCT00526292|relapsing chronic myelogenous leukemia|relapsing chronic myelogenous leukemia
725477|NCT00526292|adult acute myeloid leukemia with 11q23 (MLL) abnormalities|adult acute myeloid leukemia with 11q23 (mll) abnormalities
725478|NCT00526292|adult acute myeloid leukemia with inv(16)(p13;q22)|adult acute myeloid leukemia with inv(16)(p13;q22)
725479|NCT00526292|adult acute myeloid leukemia with t(15;17)(q22;q12)|adult acute myeloid leukemia with t(15;17)(q22;q12)
725480|NCT00526292|adult acute myeloid leukemia with t(16;16)(p13;q22)|adult acute myeloid leukemia with t(16;16)(p13;q22)
725481|NCT00526292|adult acute myeloid leukemia with t(8;21)(q22;q22)|adult acute myeloid leukemia with t(8;21)(q22;q22)
725482|NCT00526279|Hypertension|hypertension
725483|NCT00526279|Atacand/Atacand plus|atacand/atacand plus
725484|NCT00526279|COMBAT|combat
725485|NCT00526279|Compliance|compliance
725486|NCT00526279|Naturalistic|naturalistic
725487|NCT00526279|Observational|observational
725488|NCT00526253|Congestive Heart Failure|congestive heart failure
725489|NCT00526253|CHF|chf
725490|NCT00526253|Heart Disease|heart disease
725491|NCT00526253|Heart Attack|heart attack
725492|NCT00526253|Stem Cell|stem cell
725493|NCT00526253|Myoblast|myoblast
725494|NCT00526253|Bioheart|bioheart
725495|NCT00526214|Spontaneous intracerebral hemorrhage|spontaneous intracerebral hemorrhage
725496|NCT00526214|Acute Spontaneous, Supratentorial intracerebral hemorrhage|acute spontaneous, supratentorial intracerebral hemorrhage
725497|NCT00526201|Arthritis|arthritis
725498|NCT00526201|Osteoarthritis|osteoarthritis
725499|NCT00526201|Rheumatoid Arthritis|rheumatoid arthritis
725500|NCT00526201|Fibromyalgia|fibromyalgia
725501|NCT00526201|Lupus|lupus
725502|NCT00526188|Primovist|primovist
725503|NCT00526188|Chinese patients|chinese patients
725504|NCT00526188|Liver MRI|liver mri
725505|NCT00526175|Acute Lymphoblastic Leukemia|acute lymphoblastic leukemia
725506|NCT00526175|Minimal Residual Disease|minimal residual disease
725507|NCT00526149|recurrent squamous cell carcinoma of the hypopharynx|recurrent squamous cell carcinoma of the hypopharynx
725508|NCT00526149|recurrent squamous cell carcinoma of the larynx|recurrent squamous cell carcinoma of the larynx
725509|NCT00526149|recurrent squamous cell carcinoma of the lip and oral cavity|recurrent squamous cell carcinoma of the lip and oral cavity
725510|NCT00526149|recurrent squamous cell carcinoma of the oropharynx|recurrent squamous cell carcinoma of the oropharynx
725511|NCT00526149|recurrent squamous cell carcinoma of the paranasal sinus and nasal cavity|recurrent squamous cell carcinoma of the paranasal sinus and nasal cavity
725512|NCT00526149|metastatic squamous neck cancer with occult primary squamous cell carcinoma|metastatic squamous neck cancer with occult primary squamous cell carcinoma
725513|NCT00526149|recurrent metastatic squamous neck cancer with occult primary|recurrent metastatic squamous neck cancer with occult primary
725514|NCT00526149|recurrent breast cancer|recurrent breast cancer
725515|NCT00526149|stage IV breast cancer|stage iv breast cancer
725516|NCT00526149|recurrent ovarian epithelial cancer|recurrent ovarian epithelial cancer
725517|NCT00526149|stage IV ovarian epithelial cancer|stage iv ovarian epithelial cancer
725518|NCT00526149|stage III ovarian epithelial cancer|stage iii ovarian epithelial cancer
725519|NCT00526149|recurrent adult soft tissue sarcoma|recurrent adult soft tissue sarcoma
725520|NCT00526149|stage III adult soft tissue sarcoma|stage iii adult soft tissue sarcoma
725521|NCT00526149|stage IV adult soft tissue sarcoma|stage iv adult soft tissue sarcoma
725522|NCT00526149|adult leiomyosarcoma|adult leiomyosarcoma
725523|NCT00526149|uterine leiomyosarcoma|uterine leiomyosarcoma
725524|NCT00526149|adult alveolar soft-part sarcoma|adult alveolar soft-part sarcoma
725525|NCT00526149|adult angiosarcoma|adult angiosarcoma
725526|NCT00526149|adult desmoplastic small round cell tumor|adult desmoplastic small round cell tumor
725527|NCT00526149|adult epithelioid sarcoma|adult epithelioid sarcoma
725528|NCT00526149|adult fibrosarcoma|adult fibrosarcoma
725529|NCT00526149|adult liposarcoma|adult liposarcoma
725530|NCT00526149|adult malignant fibrous histiocytoma|adult malignant fibrous histiocytoma
725531|NCT00526149|adult malignant mesenchymoma|adult malignant mesenchymoma
725532|NCT00526149|adult neurofibrosarcoma|adult neurofibrosarcoma
725533|NCT00526149|adult rhabdomyosarcoma|adult rhabdomyosarcoma
725534|NCT00526149|adult synovial sarcoma|adult synovial sarcoma
725535|NCT00526149|endometrial stromal sarcoma|endometrial stromal sarcoma
725536|NCT00526149|ovarian carcinosarcoma|ovarian carcinosarcoma
725537|NCT00526149|ovarian sarcoma|ovarian sarcoma
725538|NCT00526149|recurrent uterine sarcoma|recurrent uterine sarcoma
725539|NCT00526149|stage IV uterine sarcoma|stage iv uterine sarcoma
725540|NCT00526149|recurrent melanoma|recurrent melanoma
725541|NCT00526149|stage IV melanoma|stage iv melanoma
725542|NCT00526136|Atrial Fibrillation|atrial fibrillation
725543|NCT00526123|Dialysis|dialysis
725544|NCT00526123|Dialysis Catheter|dialysis catheter
725545|NCT00526123|Kidney Disease|kidney disease
725546|NCT00526123|Dialysis Clinic|dialysis clinic
725547|NCT00526123|Chronic Catheter|chronic catheter
725548|NCT00526123|Catheter|catheter
725549|NCT00526123|Kidney|kidney
725550|NCT00526110|Gastrointestinal Diseases|gastrointestinal diseases
725551|NCT00526110|Adenocarcinoma of the Stomach|adenocarcinoma of the stomach
725552|NCT00526110|Gastroesophageal Junction Cancer|gastroesophageal junction cancer
725553|NCT00526110|Cancer of the Stomach|cancer of the stomach
725554|NCT00526110|5-Fluorouracil|5-fluorouracil
725555|NCT00526110|5-FU|5-fu
725556|NCT00526110|Adrucil|adrucil
725557|NCT00526110|Efudex|efudex
725558|NCT00526110|Docetaxel|docetaxel
725559|NCT00526110|Oxaliplatin|oxaliplatin
725560|NCT00526110|Eloxatin|eloxatin
725561|NCT00526110|Taxotere|taxotere
725562|NCT00526110|Esophagus|esophagus
725563|NCT00526084|ALL|all
725564|NCT00526084|Healthy subjects|healthy subjects
725565|NCT00526071|Amicus Therapeutics|amicus therapeutics
725566|NCT00526071|AT1001|at1001
725567|NCT00526071|Galafold|galafold
725568|NCT00526071|Migalastat|migalastat
725569|NCT00526071|Substrate|substrate
725570|NCT00526058|Heparin|heparin
725571|NCT00526058|Extracorporeal|extracorporeal
725572|NCT00526058|Low Density Lipo-Protein (LDL) Cholesterol|low density lipo-protein (ldl) cholesterol
725573|NCT00526058|Apheresis|apheresis
725574|NCT00526058|Device|device
725575|NCT00526045|AUY922|auy922
725576|NCT00526045|Solid tumors|solid tumors
725577|NCT00526045|Breast Cancer|breast cancer
725578|NCT00526045|Phase I/II|phase i/ii
725579|NCT00526045|Advanced Solid malignancies (Phase I)|advanced solid malignancies (phase i)
725580|NCT00526045|Breast Cancer ( Phase II )|breast cancer ( phase ii )
725581|NCT00526045|HER2+|her2+
725582|NCT00526045|ER+|er+
725583|NCT00526045|HSP90|hsp90
725584|NCT00526032|Skin Cancer|skin cancer
725585|NCT00526032|Cancerous skin lesions|cancerous skin lesions
725586|NCT00526032|Melanoma Detection|melanoma detection
725587|NCT00526032|Spectroscopic Oblique-Incidence Reflectometry|spectroscopic oblique-incidence reflectometry
725588|NCT00526032|OIR Imaging Probe|oir imaging probe
725589|NCT00526019|remission of asthma|remission of asthma
725590|NCT00526006|Clinical significance of the acid rebound phenomenon after withdrawal of treatment with a PPI|clinical significance of the acid rebound phenomenon after withdrawal of treatment with a ppi
725591|NCT00525993|sports|sports
725592|NCT00525993|ankle|ankle
725593|NCT00525993|sprain|sprain
725594|NCT00525993|etoricoxib|etoricoxib
725595|NCT00525993|antiinflammatory|antiinflammatory
725596|NCT00525993|treatment outcome|treatment outcome
725597|NCT00525980|Breast Cancer|breast cancer
725598|NCT00525980|Cancer Risk|cancer risk
725599|NCT00525980|CD-ROM|cd-rom
725600|NCT00525980|Focus Group|focus group
725601|NCT00525980|Cancer Genetics|cancer genetics
725602|NCT00525967|Cancer Pain|cancer pain
725605|NCT00525967|Acetaminophen|acetaminophen
725606|NCT00525967|Palliative Care|palliative care
725607|NCT00525954|Coronary|coronary
725608|NCT00525954|Artery|artery
725609|NCT00525954|Artheroschlerosis|artheroschlerosis
725610|NCT00525954|Phospholipase|phospholipase
725611|NCT00525954|CAD|cad
725612|NCT00525954|Coronary Artery Disease (CAD)|coronary artery disease (cad)
725613|NCT00525928|craving|craving
725614|NCT00525928|smoking|smoking
725615|NCT00525928|depression|depression
725616|NCT00525915|Esophageal Cancer|esophageal cancer
725617|NCT00525915|Gastroesophageal Cancer|gastroesophageal cancer
725618|NCT00525915|Gastroesophageal Junction|gastroesophageal junction
725619|NCT00525915|Radiation Therapy|radiation therapy
725620|NCT00525915|5-Fluorouracil|5-fluorouracil
725621|NCT00525915|5-FU|5-fu
725622|NCT00525915|Adrucil|adrucil
725623|NCT00525915|Efudex|efudex
725624|NCT00525915|Oxaliplatin|oxaliplatin
725625|NCT00525889|diabetes|diabetes
725626|NCT00525889|juvenile diabetes|juvenile diabetes
725627|NCT00525889|type 1 diabetes|type 1 diabetes
725628|NCT00525889|diabetes mellitus|diabetes mellitus
725629|NCT00525889|recent onset|recent onset
725630|NCT00525889|new onset|new onset
725631|NCT00525876|Mantle Cell Lymphoma|mantle cell lymphoma
725632|NCT00525876|Lymphoma|lymphoma
725633|NCT00525876|Allogeneic Stem Cell Transplant|allogeneic stem cell transplant
725634|NCT00525876|Rituximab|rituximab
725635|NCT00525876|Cyclophosphamide|cyclophosphamide
725636|NCT00525876|Neosar|neosar
725637|NCT00525876|Cytoxan|cytoxan
725638|NCT00525876|Fludarabine|fludarabine
725639|NCT00525876|Fludara|fludara
725640|NCT00525876|Fludarabine phosphate|fludarabine phosphate
725641|NCT00525876|Rituxan|rituxan
725642|NCT00525876|Alemtuzumab|alemtuzumab
725643|NCT00525876|CAMPATH-1H|campath-1h
725644|NCT00525876|Campath|campath
725645|NCT00525876|Total Body Irradiation|total body irradiation
725646|NCT00525876|TBI|tbi
725647|NCT00525863|schizophrenia|schizophrenia
725648|NCT00525863|oxygen therapy|oxygen therapy
725649|NCT00525850|cardiovascular disease|cardiovascular disease
725650|NCT00525850|weight loss|weight loss
725651|NCT00525837|varenicline|varenicline
725652|NCT00525837|depression|depression
725653|NCT00525837|anhedonia|anhedonia
725654|NCT00525837|smoking|smoking
725655|NCT00525824|Hypercholesterolaemia|hypercholesterolaemia
725656|NCT00525824|Coronary Heart Disease (CHD)|coronary heart disease (chd)
725657|NCT00525824|Atherosclerosis|atherosclerosis
725658|NCT00525798|Osteoporosis, oral salmon calcitonin, treatment, efficacy, tolerability|osteoporosis, oral salmon calcitonin, treatment, efficacy, tolerability
725659|NCT00525785|Stomach Cancer|stomach cancer
725660|NCT00525785|Gastric Cancer|gastric cancer
725661|NCT00525785|Adenocarcinoma of the Stomach|adenocarcinoma of the stomach
725662|NCT00525785|Gastroesophageal Junction|gastroesophageal junction
725663|NCT00525785|Esophageal|esophageal
725665|NCT00525785|5-Fluorouracil|5-fluorouracil
725666|NCT00525785|5-FU|5-fu
725667|NCT00525785|Adrucil|adrucil
725668|NCT00525785|Efudex|efudex
725669|NCT00525785|Folinic Acid|folinic acid
725670|NCT00525785|Oxaliplatin|oxaliplatin
725671|NCT00525785|Eloxatin|eloxatin
725672|NCT00525785|Chemoradiotherapy|chemoradiotherapy
725673|NCT00525785|Radiation|radiation
725674|NCT00525785|Radiotherapy|radiotherapy
725675|NCT00525785|XRT|xrt
725676|NCT00525772|asthma|asthma
725677|NCT00525772|exercise induced bronchoconstriction|exercise induced bronchoconstriction
725678|NCT00525772|sputum eosinophils|sputum eosinophils
725679|NCT00525759|Breast cancer|breast cancer
725680|NCT00525759|Zoledronic acid|zoledronic acid
725681|NCT00525759|Neoadjuvant chemotherapy|neoadjuvant chemotherapy
725682|NCT00525759|Synergy|synergy
725683|NCT00525759|Apoptosis|apoptosis
725684|NCT00525746|Acute Myeloid Leukemia|acute myeloid leukemia
725685|NCT00525746|Myelodysplastic Syndrome|myelodysplastic syndrome
725686|NCT00525746|Leukemia|leukemia
725687|NCT00525746|MDS|mds
725688|NCT00525746|AML|aml
725689|NCT00525746|Malignancy|malignancy
725690|NCT00525746|Molecular Epidemiology|molecular epidemiology
725691|NCT00525746|Epidemiologic markers|epidemiologic markers
725692|NCT00525746|Clinical markers|clinical markers
725693|NCT00525746|Constitutional genetic markers|constitutional genetic markers
725694|NCT00525746|Case-comparison study|case-comparison study
725695|NCT00525733|HIV-1|hiv-1
725696|NCT00525733|Acute Infection|acute infection
725697|NCT00525733|Treatment Naive|treatment naive
725698|NCT00525720|Prostate Cancer|prostate cancer
725699|NCT00525720|Prostatic Carcinoma|prostatic carcinoma
725700|NCT00525720|Intermediate prostate cancer|intermediate prostate cancer
725701|NCT00525720|Transperineal Interstitial Permanent Brachytherapy|transperineal interstitial permanent brachytherapy
725702|NCT00525720|Brachytherapy|brachytherapy
725703|NCT00525720|Prostate brachytherapy|prostate brachytherapy
725704|NCT00525720|Prostate implant|prostate implant
725705|NCT00525720|Prostate|prostate
725706|NCT00525720|Questionnaire|questionnaire
725707|NCT00525720|Survey|survey
725708|NCT00525707|acute heart failure|acute heart failure
725709|NCT00525707|Actelion|actelion
725710|NCT00525707|tezosentan|tezosentan
725711|NCT00525707|acute decompensation of chronic heart failure|acute decompensation of chronic heart failure
725712|NCT00525707|New onset of heart failure|new onset of heart failure
725713|NCT00525681|Obese|obese
725714|NCT00525681|Calcineurine inhibitor|calcineurine inhibitor
725715|NCT00525681|Pharmacokinetics|pharmacokinetics
725716|NCT00525681|Interaction|interaction
725717|NCT00525668|multiple sclerosis|multiple sclerosis
725718|NCT00525668|inflammation|inflammation
725719|NCT00525668|neurodegeneration|neurodegeneration
725720|NCT00525668|neuroprotection|neuroprotection
725721|NCT00525655|Familial Adenomatous Polyposis|familial adenomatous polyposis
725722|NCT00525655|Colorectal Cancer|colorectal cancer
725723|NCT00525655|Multimedia Intervention|multimedia intervention
725724|NCT00525655|Questionnaire|questionnaire
725725|NCT00525655|Survey|survey
725726|NCT00525655|FAP|fap
725727|NCT00525642|Breast-adjuvant|breast-adjuvant
725728|NCT00525642|Breast-chemotherapy|breast-chemotherapy
725729|NCT00525642|Combination chemotherapy regimens|combination chemotherapy regimens
725730|NCT00525616|bullous pemphigoid|bullous pemphigoid
725731|NCT00525616|mabthera|mabthera
725732|NCT00525603|Chronic Lymphocytic Leukemia|chronic lymphocytic leukemia
725733|NCT00525603|CML|cml
725734|NCT00525603|Leukemia|leukemia
725735|NCT00525603|Cyclophosphamide|cyclophosphamide
725736|NCT00525603|Fludarabine|fludarabine
725737|NCT00525603|Alemtuzumab|alemtuzumab
725738|NCT00525603|Rituximab|rituximab
725739|NCT00525603|CFAR|cfar
725740|NCT00525590|Gliadel|gliadel
725741|NCT00525577|Type 2 diabetes, glycemic control|type 2 diabetes, glycemic control
725742|NCT00525564|Chronic Obstructive Pulmonary Disease (COPD)|chronic obstructive pulmonary disease (copd)
725743|NCT00525564|Exercise|exercise
725744|NCT00525564|Endurance shuttle walking test|endurance shuttle walking test
725745|NCT00525564|Bronchodilation|bronchodilation
725746|NCT00525564|Salmeterol|salmeterol
725747|NCT00525525|Glioblastoma|glioblastoma
725748|NCT00525525|Gliosarcoma|gliosarcoma
725749|NCT00525525|Bevacizumab|bevacizumab
725750|NCT00525525|Avastin|avastin
725751|NCT00525525|Erlotinib|erlotinib
725752|NCT00525525|Tarceva|tarceva
725753|NCT00525525|Temozolomide|temozolomide
725754|NCT00525525|Temodar|temodar
725755|NCT00525499|acne|acne
725756|NCT00525486|Nifedipine|nifedipine
725757|NCT00525486|Tocolysis|tocolysis
725758|NCT00525486|Maintenance|maintenance
725759|NCT00525486|Preterm delivery|preterm delivery
725760|NCT00525486|extended release nifedipine|extended release nifedipine
725761|NCT00525486|PTL|ptl
725762|NCT00525460|fertility|fertility
725763|NCT00525460|stage I ovarian cancer|stage i ovarian cancer
725764|NCT00525460|stage II ovarian cancer|stage ii ovarian cancer
725765|NCT00525460|fertility sparing|fertility sparing
725766|NCT00525447|Antigens, CD40|antigens, cd40
725767|NCT00525447|Antibodies, Monoclonal|antibodies, monoclonal
725768|NCT00525447|Combined Modality Therapy|combined modality therapy
725769|NCT00525447|Multiple Myeloma|multiple myeloma
725770|NCT00525447|Blood Coagulation Disorders|blood coagulation disorders
725771|NCT00525447|Hematologic Diseases|hematologic diseases
725772|NCT00525447|Hemorrhagic Disorders|hemorrhagic disorders
725773|NCT00525447|Hemostatic Disorders|hemostatic disorders
725774|NCT00525447|Immunoproliferative Disorders|immunoproliferative disorders
725775|NCT00525447|Lymphoproliferative Disorders|lymphoproliferative disorders
725776|NCT00525447|Paraproteinemias|paraproteinemias
725777|NCT00525447|Vascular Diseases|vascular diseases
725778|NCT00525447|Antibody-Dependent Cell Cytotoxicity|antibody-dependent cell cytotoxicity
725779|NCT00525434|Laser bonding soft tissue albumin|laser bonding soft tissue albumin
725780|NCT00525421|curcuminoids|curcuminoids
725782|NCT00525421|c reactive protein|c reactive protein
725783|NCT00525421|interleukin 6|interleukin 6
725784|NCT00525408|HRPC|hrpc
725785|NCT00525408|Metastatic Hormone Refractory Prostate Cancer|metastatic hormone refractory prostate cancer
725786|NCT00525408|Docetaxel|docetaxel
725787|NCT00525408|Mycobacterium w|mycobacterium w
725788|NCT00525395|Phototherapy|phototherapy
725789|NCT00525395|Vitiligo scoring system|vitiligo scoring system
725790|NCT00525382|Levocetirizine dihydrochloride|levocetirizine dihydrochloride
725791|NCT00525382|Xyzal tablets|xyzal tablets
725792|NCT00525356|Aorta|aorta
725793|NCT00525356|Dissection|dissection
725794|NCT00525356|Thoracic|thoracic
725795|NCT00525343|Avonex pivotal trial|avonex pivotal trial
725796|NCT00525343|Avonex|avonex
725797|NCT00525343|Avonex long term follow-up|avonex long term follow-up
725798|NCT00525343|Avonex outcomes|avonex outcomes
725799|NCT00525317|Pregnancy|pregnancy
725800|NCT00525317|Magnesium|magnesium
725801|NCT00525317|Leg Pain|leg pain
725802|NCT00525304|medical co-morbidity|medical co-morbidity
725803|NCT00525304|diabetes|diabetes
725804|NCT00525304|heart disease|heart disease
725805|NCT00525304|respiratory illness|respiratory illness
725806|NCT00525291|Exercise Therapy|exercise therapy
725807|NCT00525291|Biofeedback (Psychology)|biofeedback (psychology)
725808|NCT00525291|Adult|adult
725809|NCT00525291|Fecal Incontinence/*therapy|fecal incontinence/*therapy
725810|NCT00525291|EMG - Biofeedback|emg - biofeedback
725811|NCT00525291|EMG - Triggered Stimulation|emg - triggered stimulation
725812|NCT00525291|Augmented biofeedback|augmented biofeedback
725813|NCT00525278|Levocetirizine dihydrochloride|levocetirizine dihydrochloride
725814|NCT00525278|Xyzal tablets|xyzal tablets
725815|NCT00525265|Vasopressin antagonist|vasopressin antagonist
725816|NCT00525265|Cardiac Edema|cardiac edema
725817|NCT00525265|Diuretics|diuretics
725818|NCT00525252|Liver cirrhosis|liver cirrhosis
725819|NCT00525252|Alcoholism|alcoholism
725820|NCT00525252|Craving|craving
725821|NCT00525239|Lipids|lipids
725822|NCT00525239|lipoproteins|lipoproteins
725823|NCT00525239|VLDL|vldl
725824|NCT00525239|triglycerides|triglycerides
725825|NCT00525239|apo B100|apo b100
725826|NCT00525239|HDL|hdl
725827|NCT00525239|apo A1|apo a1
725828|NCT00525239|endothelial dysfunction|endothelial dysfunction
725829|NCT00525239|insulin secretion|insulin secretion
725830|NCT00525239|hyperglycemic clamp|hyperglycemic clamp
725831|NCT00525239|HIV-seronegative Volunteers|hiv-seronegative volunteers
725832|NCT00525239|HIV-infected subjects starting an efavirenz-based regimen|hiv-infected subjects starting an efavirenz-based regimen
725833|NCT00525239|Treatment Experienced|treatment experienced
725834|NCT00525226|Psychiatry|psychiatry
725835|NCT00525226|Psychology|psychology
725836|NCT00525226|Pregnancy|pregnancy
725837|NCT00525226|Stress|stress
725838|NCT00525226|Anxiety|anxiety
725839|NCT00525213|Rheumatoid Arthritis|rheumatoid arthritis
725840|NCT00525200|predictive marker|predictive marker
725841|NCT00525200|personalized therapy|personalized therapy
725842|NCT00525200|response assessment|response assessment
725843|NCT00525200|p53 genotype|p53 genotype
725844|NCT00525187|onychomycosis|onychomycosis
725845|NCT00525187|diabetic neuropathic patients|diabetic neuropathic patients
725846|NCT00525187|reliability of the diagnostic of onychomycosis|reliability of the diagnostic of onychomycosis
725847|NCT00525174|Amblyopia|amblyopia
725848|NCT00525174|Patching|patching
725849|NCT00525174|Bangerter filters|bangerter filters
725850|NCT00525161|breast cancer|breast cancer
725851|NCT00525161|Sorafenib|sorafenib
725852|NCT00525161|Nexavar|nexavar
725853|NCT00525161|Endocrine Therapy|endocrine therapy
725854|NCT00525122|hyperthyroidism|hyperthyroidism
725855|NCT00525122|radioactive iodine|radioactive iodine
725856|NCT00525122|antithyroid drugs|antithyroid drugs
725857|NCT00525122|Hyperthyroidism, treatment with radioactive iodine without antithyroid drugs|hyperthyroidism, treatment with radioactive iodine without antithyroid drugs
725858|NCT00525109|Cholesterol|cholesterol
725859|NCT00525109|Hyperlipidemia|hyperlipidemia
725860|NCT00525109|Gene array|gene array
725861|NCT00525083|hyperlipidemia|hyperlipidemia
725862|NCT00525083|HDL-C|hdl-c
725863|NCT00525083|low density lipoprotein|low density lipoprotein
725864|NCT00525031|Melanoma|melanoma
725865|NCT00525031|Temozolomide|temozolomide
725866|NCT00525031|Temodar|temodar
725867|NCT00525031|Pegylated Interferon Alpha-2b|pegylated interferon alpha-2b
725868|NCT00525031|PEG-Intron|peg-intron
725869|NCT00525031|PGI|pgi
725870|NCT00525031|Resectable metastatic melanoma|resectable metastatic melanoma
725871|NCT00525031|Surgery|surgery
725872|NCT00525018|Pain|pain
725873|NCT00525018|Functional neuroimaging|functional neuroimaging
725874|NCT00525018|Neuropathy|neuropathy
725875|NCT00525018|Thermal sensation|thermal sensation
725876|NCT00525005|Stomach Neoplasm|stomach neoplasm
725877|NCT00525005|Docetaxel|docetaxel
725878|NCT00525005|Oxaliplatin|oxaliplatin
725879|NCT00525005|S-1|s-1
725880|NCT00524992|Focal Segmental Glomerulosclerosis|focal segmental glomerulosclerosis
725881|NCT00524992|Collapsing Glomerulopathy|collapsing glomerulopathy
725882|NCT00524992|Anti-Retroviral Toxicity|anti-retroviral toxicity
725883|NCT00524992|Lipodystrophy|lipodystrophy
725884|NCT00524992|Metabolic Syndrome|metabolic syndrome
725885|NCT00524992|Tubular Injury|tubular injury
725886|NCT00524992|Renal Biopsy|renal biopsy
725887|NCT00524992|Proteinuria|proteinuria
725888|NCT00524992|Tenofovir Toxicity|tenofovir toxicity
725889|NCT00524992|HAART Toxicity|haart toxicity
725890|NCT00524992|HIV Positive|hiv positive
725891|NCT00524992|HIV-Associated Focal Segmental Glomerulosclerosis|hiv-associated focal segmental glomerulosclerosis
725892|NCT00524953|allogeneic bone marrow transplantation|allogeneic bone marrow transplantation
725893|NCT00524953|non-T-cell depleted|non-t-cell depleted
725894|NCT00524953|UV-c|uv-c
725895|NCT00524953|GVHD|gvhd
725896|NCT00524940|Influenza|influenza
725897|NCT00524940|Orthomyxoviruses|orthomyxoviruses
725898|NCT00524940|Inactivated Split-virion influenza vaccine|inactivated split-virion influenza vaccine
725899|NCT00524927|Incident Pain|incident pain
725900|NCT00524927|Bone Marrow Biopsy|bone marrow biopsy
725901|NCT00524914|Parkinson's disease|parkinson's disease
725902|NCT00524914|Pain|pain
725903|NCT00524914|Nociceptive threshold|nociceptive threshold
725904|NCT00524914|Functional imaging|functional imaging
725905|NCT00524914|Cerebral activity|cerebral activity
725906|NCT00524914|Dopamine agonist.|dopamine agonist.
725907|NCT00524901|Apoptosis|apoptosis
725908|NCT00524901|CABG|cabg
726009|NCT00524550|Appetite|appetite
725909|NCT00524901|Coronary Artery Disease|coronary artery disease
725910|NCT00524901|Three Vessel Disease|three vessel disease
725911|NCT00524901|Erythropoietin|erythropoietin
725912|NCT00524901|EPO-receptor signaling|epo-receptor signaling
725913|NCT00524888|Hand|hand
725914|NCT00524888|Laceration|laceration
725915|NCT00524888|bioadhesive|bioadhesive
725916|NCT00524888|ER|er
725917|NCT00524888|Hand laceration distal to the volar wrist crease|hand laceration distal to the volar wrist crease
725918|NCT00524875|Proliferative diabetic retinopathy|proliferative diabetic retinopathy
725919|NCT00524875|Bevacizumab|bevacizumab
725920|NCT00524875|Early post-vitrectomy vitreous hemorrhage|early post-vitrectomy vitreous hemorrhage
725921|NCT00524862|Implantable Cardioverter Defibrillator|implantable cardioverter defibrillator
725922|NCT00524862|Ejection Fraction|ejection fraction
725923|NCT00524862|QRS duration|qrs duration
725924|NCT00524849|Breast cancer|breast cancer
725925|NCT00524849|Bone metastasis|bone metastasis
725926|NCT00524849|Circulating VEGF|circulating vegf
725927|NCT00524849|Zoledronic acid|zoledronic acid
725928|NCT00524849|Angiogenesis|angiogenesis
725929|NCT00524836|levocetirizine dihydrochloride|levocetirizine dihydrochloride
725930|NCT00524836|Xyzal tablets|xyzal tablets
725931|NCT00524823|Prostate Cancer|prostate cancer
725932|NCT00524823|Hyperplasia - BPH|hyperplasia - bph
725933|NCT00524823|FACS|facs
725934|NCT00524823|Prostate Cancer, Hyperplasia - BPH, Malignancy|prostate cancer, hyperplasia - bph, malignancy
725935|NCT00524797|Myelosuppression,|myelosuppression,
725936|NCT00524797|chemotherapeutic agents,|chemotherapeutic agents,
725937|NCT00524797|leucopenia,|leucopenia,
725938|NCT00524797|thrombocytopenia,|thrombocytopenia,
725939|NCT00524797|Profonycia|profonycia
725940|NCT00524784|GVHD|gvhd
725941|NCT00524784|HSCT|hsct
725942|NCT00524784|BMT|bmt
725943|NCT00524784|APOPTOTIC CELLS|apoptotic cells
725944|NCT00524771|Contraception|contraception
725945|NCT00524771|Contraceptive Vaginal Ring|contraceptive vaginal ring
725946|NCT00524758|ologen|ologen
725947|NCT00524758|oculusgen|oculusgen
725948|NCT00524758|collagen matrix|collagen matrix
725949|NCT00524758|trabeculectomy|trabeculectomy
725950|NCT00524758|filtering surgery|filtering surgery
725951|NCT00524758|mitomycin-C|mitomycin-c
725952|NCT00524758|MMC|mmc
725953|NCT00524758|Aeon Astron|aeon astron
725954|NCT00524745|Gardasil|gardasil
725955|NCT00524745|Human Papillomavirus|human papillomavirus
725956|NCT00524745|HPV vaccine|hpv vaccine
725957|NCT00524745|Cervical cancer|cervical cancer
725958|NCT00524732|Pertussis|pertussis
725959|NCT00524732|Tetanus|tetanus
725960|NCT00524732|Diphtheria|diphtheria
725961|NCT00524706|S-1|s-1
725962|NCT00524706|oral fluoropyrimidine|oral fluoropyrimidine
725963|NCT00524706|tegafur|tegafur
725964|NCT00524706|Gimeracil|gimeracil
725965|NCT00524706|Oteracil Potassium|oteracil potassium
725966|NCT00524706|Leucovorin|leucovorin
725967|NCT00524706|Calcium Folinate|calcium folinate
725968|NCT00524706|Oxaliplatin|oxaliplatin
725969|NCT00524706|L-OHP|l-ohp
725970|NCT00524706|colorectal cancer|colorectal cancer
725971|NCT00524693|Bronchiolitis|bronchiolitis
725972|NCT00524693|controlled clinical trial|controlled clinical trial
725973|NCT00524693|pediatrics|pediatrics
725974|NCT00524693|Infants|infants
725975|NCT00524693|montelukast|montelukast
725976|NCT00524693|Respiratory syncytial virus|respiratory syncytial virus
725977|NCT00524680|adenocarcinoma of the prostate|adenocarcinoma of the prostate
725978|NCT00524680|recurrent prostate cancer|recurrent prostate cancer
725979|NCT00524680|stage I prostate cancer|stage i prostate cancer
725980|NCT00524680|stage II prostate cancer|stage ii prostate cancer
725981|NCT00524680|stage III prostate cancer|stage iii prostate cancer
725982|NCT00524680|stage IV prostate cancer|stage iv prostate cancer
725983|NCT00524667|Active CLL|active cll
725984|NCT00524654|To determine the effects of cervical spine manipulation on postural control.|to determine the effects of cervical spine manipulation on postural control.
725985|NCT00524641|Asthma|asthma
725986|NCT00524641|Symbicort|symbicort
725987|NCT00524641|NIS|nis
725988|NCT00524615|resistant hypertension treatment|resistant hypertension treatment
725989|NCT00524615|spironolactone|spironolactone
725990|NCT00524615|aldosterone antagonists|aldosterone antagonists
725991|NCT00524615|resistant arterial hypertension|resistant arterial hypertension
725992|NCT00524615|refractory arterial hypertension|refractory arterial hypertension
725993|NCT00524602|Stereotaxis|stereotaxis
725994|NCT00524602|Arrythmia|arrythmia
725995|NCT00524602|Catheter ablation|catheter ablation
725996|NCT00524602|Heart|heart
725997|NCT00524589|recurrent prostate cancer|recurrent prostate cancer
725998|NCT00524576|Hepatitis B|hepatitis b
725999|NCT00524576|Persistence|persistence
726000|NCT00524576|Challenge dose|challenge dose
726001|NCT00524563|Acinetobacter|acinetobacter
726002|NCT00524563|bloodstream infection|bloodstream infection
726003|NCT00524563|Isolate|isolate
726004|NCT00524550|Moderate alcohol consumption|moderate alcohol consumption
726005|NCT00524550|insulin secretion|insulin secretion
726006|NCT00524550|insulin sensitivity|insulin sensitivity
726007|NCT00524550|Beta-cell function|beta-cell function
726008|NCT00524550|Adiponectin|adiponectin
726010|NCT00524550|Satiety|satiety
726011|NCT00524550|Alcohol-induced gene expression|alcohol-induced gene expression
726012|NCT00524550|Endocannabinoids|endocannabinoids
726013|NCT00524550|Glucose metabolism|glucose metabolism
726014|NCT00524550|Lipid metabolism|lipid metabolism
726015|NCT00524550|Ratio HMW/total adiponectin|ratio hmw/total adiponectin
726016|NCT00524550|Appetite regulation|appetite regulation
726017|NCT00524550|Alcohol-induced adiponectin increase|alcohol-induced adiponectin increase
726018|NCT00524537|Crohn's Disease|crohn's disease
726019|NCT00524524|solid tumors|solid tumors
726020|NCT00524524|biopsy|biopsy
726021|NCT00524511|cesarean|cesarean
726022|NCT00524511|wound|wound
726023|NCT00524511|Dermabond|dermabond
726024|NCT00524511|superglue|superglue
726025|NCT00524511|staples|staples
726026|NCT00524511|wound complications|wound complications
726027|NCT00524498|OPC-18|opc-18
726028|NCT00524498|Interferon-alpha|interferon-alpha
726029|NCT00524498|Fluorouracil|fluorouracil
726030|NCT00524485|actinic keratosis|actinic keratosis
726031|NCT00524472|Hyperinsulinemic glucose control|hyperinsulinemic glucose control
726032|NCT00524472|cardiac surgery|cardiac surgery
726033|NCT00524472|Outcome|outcome
726034|NCT00524459|stage IIIA breast cancer|stage iiia breast cancer
726035|NCT00524459|stage IIIB breast cancer|stage iiib breast cancer
726036|NCT00524446|Infant|infant
726037|NCT00524446|Sub-Saharan Africa|sub-saharan africa
726038|NCT00524446|Complementary feeding|complementary feeding
726039|NCT00524446|Fortified spread|fortified spread
726040|NCT00524446|Lipid-based nutrient supplement|lipid-based nutrient supplement
726041|NCT00524446|Malnutrition|malnutrition
726042|NCT00524446|Stunting|stunting
726043|NCT00524446|Growth|growth
726044|NCT00524446|Morbidity|morbidity
726045|NCT00524446|Development|development
726046|NCT00524446|Haemoglobin|haemoglobin
726047|NCT00524433|acute heart failure|acute heart failure
726048|NCT00524433|acute decompensation of chronic heart failure|acute decompensation of chronic heart failure
726049|NCT00524433|new onset of heart failure|new onset of heart failure
726050|NCT00524433|tezosentan|tezosentan
726051|NCT00524433|Actelion|actelion
726052|NCT00524420|Pain|pain
726053|NCT00524420|Fatigue|fatigue
726054|NCT00524420|Chronic Fatigue Syndrome|chronic fatigue syndrome
726055|NCT00524420|Chronic Fatigue-Fibromyalgia Syndrome|chronic fatigue-fibromyalgia syndrome
726056|NCT00524420|Depression|depression
726057|NCT00524420|Major Depressive Disorder|major depressive disorder
726058|NCT00524407|Anemia|anemia
726059|NCT00524407|hemoglobin|hemoglobin
726060|NCT00524407|chemotherapy|chemotherapy
726061|NCT00524407|hematologic response|hematologic response
726062|NCT00524407|subcutaneous injection|subcutaneous injection
726063|NCT00524407|Epoetin alfa|epoetin alfa
726064|NCT00524407|FACT-An|fact-an
726065|NCT00524407|LASA|lasa
726066|NCT00524407|PROCRIT|procrit
726067|NCT00524394|VLBW|vlbw
726068|NCT00524394|sepsis|sepsis
726069|NCT00524394|diagnosis|diagnosis
726070|NCT00524394|suspected sepsis|suspected sepsis
726071|NCT00524368|Human immunodeficiency virus - type 1|human immunodeficiency virus - type 1
726072|NCT00524368|HIV-1 Infection|hiv-1 infection
726073|NCT00524368|TMC-114|tmc-114
726074|NCT00524368|Darunavir|darunavir
726075|NCT00524368|Ritonavir|ritonavir
726076|NCT00524355|GERD|gerd
726077|NCT00524355|GIS|gis
726078|NCT00524355|heartburn|heartburn
726079|NCT00524355|NIS|nis
726080|NCT00524355|PPI|ppi
726081|NCT00524342|IL-11|il-11
726082|NCT00524342|von Willebrand disease|von willebrand disease
726083|NCT00524342|von Willebrand factor|von willebrand factor
726084|NCT00524342|VWFmRNA|vwfmrna
726085|NCT00524342|menorrhagia|menorrhagia
726086|NCT00524329|upper GI-symptoms|upper gi-symptoms
726087|NCT00524329|heartburn|heartburn
726088|NCT00524329|NSAID|nsaid
726089|NCT00524329|risk|risk
726090|NCT00524329|PPI|ppi
726091|NCT00524329|Bloating|bloating
726092|NCT00524329|Regurgitation|regurgitation
726093|NCT00524316|adult primary hepatocellular carcinoma|adult primary hepatocellular carcinoma
726094|NCT00524316|advanced adult primary liver cancer|advanced adult primary liver cancer
726095|NCT00524316|localized unresectable adult primary liver cancer|localized unresectable adult primary liver cancer
726096|NCT00524316|recurrent adult primary liver cancer|recurrent adult primary liver cancer
726097|NCT00524303|ErbB2 Overexpressing|erbb2 overexpressing
726098|NCT00524303|ErbB2 Positive|erbb2 positive
726099|NCT00524303|Lapatinib|lapatinib
726100|NCT00524303|Invasive Breast Cancer|invasive breast cancer
726101|NCT00524290|Acinetobacter|acinetobacter
726102|NCT00524290|infection|infection
726103|NCT00524290|isolate|isolate
726104|NCT00524277|stage I breast cancer|stage i breast cancer
726105|NCT00524277|stage II breast cancer|stage ii breast cancer
726106|NCT00524277|stage IIIA breast cancer|stage iiia breast cancer
726107|NCT00524277|stage IIIB breast cancer|stage iiib breast cancer
726108|NCT00524277|stage IIIC breast cancer|stage iiic breast cancer
726109|NCT00524277|male breast cancer|male breast cancer
726110|NCT00524251|Patients with reflux complaints|patients with reflux complaints
726111|NCT00524251|GERD|gerd
726112|NCT00524251|quality of life|quality of life
726113|NCT00524251|lifestyle adjustments|lifestyle adjustments
726114|NCT00524238|hypothyroidism|hypothyroidism
726115|NCT00524238|glucose turnover|glucose turnover
726116|NCT00524238|clamp|clamp
726117|NCT00524238|insulin resistance|insulin resistance
726118|NCT00524238|lipid turnover|lipid turnover
726119|NCT00524238|amino acid turnover|amino acid turnover
726120|NCT00524225|IL-11|il-11
726121|NCT00524225|von Willebrand disease|von willebrand disease
726122|NCT00524225|von Willebrand factor|von willebrand factor
726123|NCT00524225|VWFmRNA|vwfmrna
726124|NCT00524225|surgery|surgery
726125|NCT00524199|homocysteine|homocysteine
726126|NCT00524199|hemodialysis|hemodialysis
726127|NCT00524199|mesna|mesna
726128|NCT00524186|stage III gastric cancer|stage iii gastric cancer
726129|NCT00524186|stage IV gastric cancer|stage iv gastric cancer
726130|NCT00524186|adenocarcinoma of the esophagus|adenocarcinoma of the esophagus
726131|NCT00524186|stage IV esophageal cancer|stage iv esophageal cancer
726132|NCT00524186|recurrent gastric cancer|recurrent gastric cancer
726133|NCT00524186|recurrent esophageal cancer|recurrent esophageal cancer
726134|NCT00524186|adenocarcinoma of the stomach|adenocarcinoma of the stomach
726135|NCT00524173|Emtricitabine|emtricitabine
726136|NCT00524173|Tenofovir|tenofovir
726137|NCT00524173|Antiviral Therapy|antiviral therapy
726138|NCT00524173|Hepatitis B|hepatitis b
726139|NCT00524173|HBV|hbv
726140|NCT00524160|Fentanyl|fentanyl
726141|NCT00524160|opioid analgesics|opioid analgesics
726142|NCT00524160|arthritis|arthritis
726143|NCT00524160|osteoarthritis|osteoarthritis
726144|NCT00524160|rheumatoid arthritis|rheumatoid arthritis
726145|NCT00524160|transdermal administration|transdermal administration
726146|NCT00524147|loculated pleural effusion|loculated pleural effusion
726147|NCT00524147|pigtail drainage|pigtail drainage
726148|NCT00524147|pleural effusion|pleural effusion
726149|NCT00524147|pleural thickening|pleural thickening
726150|NCT00524147|tuberculosis|tuberculosis
726151|NCT00524134|Epilepsy|epilepsy
726152|NCT00524134|Seizure|seizure
726153|NCT00524134|p-glycoprotein|p-glycoprotein
726154|NCT00524121|adenocarcinoma of the esophagus|adenocarcinoma of the esophagus
726155|NCT00524121|squamous cell carcinoma of the esophagus|squamous cell carcinoma of the esophagus
726156|NCT00524121|stage I esophageal cancer|stage i esophageal cancer
726157|NCT00524121|stage II esophageal cancer|stage ii esophageal cancer
726158|NCT00524121|stage III esophageal cancer|stage iii esophageal cancer
726159|NCT00524121|stage IV esophageal cancer|stage iv esophageal cancer
726160|NCT00524108|shunt|shunt
726161|NCT00524108|internal ventriculoperitoneal|internal ventriculoperitoneal
726162|NCT00524095|prophylaxis|prophylaxis
726163|NCT00524095|Antibiotic|antibiotic
726164|NCT00524095|inhaled steroids|inhaled steroids
726165|NCT00524095|bronchiectasis|bronchiectasis
726166|NCT00524095|prevalence|prevalence
726167|NCT00524095|chronic bronchitis|chronic bronchitis
726168|NCT00524069|stage I pancreatic cancer|stage i pancreatic cancer
726169|NCT00524069|stage II pancreatic cancer|stage ii pancreatic cancer
726170|NCT00524069|adenocarcinoma of the pancreas|adenocarcinoma of the pancreas
726171|NCT00524056|Essential Tremor|essential tremor
726172|NCT00524056|Tremor|tremor
726173|NCT00524056|Anti-epileptic drug (AED)|anti-epileptic drug (aed)
726174|NCT00524043|Schizophrenia|schizophrenia
726175|NCT00524030|Epilepsy|epilepsy
726176|NCT00524030|partial seizures|partial seizures
726177|NCT00524030|pregabalin monotherapy|pregabalin monotherapy
726178|NCT00524030|double-blind and randomized trial|double-blind and randomized trial
726179|NCT00524017|hypopharyngeal cancer|hypopharyngeal cancer
726180|NCT00524017|laryngeal cancer|laryngeal cancer
726181|NCT00524017|lip and oral cavity cancer|lip and oral cavity cancer
726182|NCT00524017|nasopharyngeal cancer|nasopharyngeal cancer
726183|NCT00524017|oropharyngeal cancer|oropharyngeal cancer
726184|NCT00524017|paranasal sinus and nasal cavity cancer|paranasal sinus and nasal cavity cancer
726185|NCT00524017|salivary gland cancer|salivary gland cancer
726186|NCT00524017|precancerous condition|precancerous condition
726187|NCT00524004|Passive immunization, Bovine Milk Immunoglobulin|passive immunization, bovine milk immunoglobulin
726188|NCT00523978|Atrial Fibrillation|atrial fibrillation
726189|NCT00523965|Kala-azar|kala-azar
726190|NCT00523965|miltefosine|miltefosine
726191|NCT00523965|liposomal amphotericin B|liposomal amphotericin b
726192|NCT00523952|dermatitis, atopic|dermatitis, atopic
726193|NCT00523952|tacrolimus|tacrolimus
726194|NCT00523952|adult|adult
726195|NCT00523939|Lymphoma|lymphoma
726196|NCT00523939|Leukemia|leukemia
726197|NCT00523939|Leukemic Meningitis|leukemic meningitis
726198|NCT00523939|Lymphomatous Meningitis|lymphomatous meningitis
726199|NCT00523926|Tuberculosis|tuberculosis
726200|NCT00523913|type 2 diabetes mellitus;|type 2 diabetes mellitus;
726201|NCT00523913|diabetes;|diabetes;
726202|NCT00523913|rosiglitazone|rosiglitazone
726203|NCT00523913|Avandia;|avandia;
726204|NCT00523900|malnutrition|malnutrition
726205|NCT00523900|underweight|underweight
726206|NCT00523900|low body weight|low body weight
726207|NCT00523900|BMI under 19|bmi under 19
726208|NCT00523900|under nourished|under nourished
726209|NCT00523900|malnourished|malnourished
726210|NCT00523887|Radiation pain|radiation pain
726211|NCT00523887|Duragesic|duragesic
726212|NCT00523887|Fentanyl|fentanyl
726213|NCT00523887|Pain|pain
726214|NCT00523861|Glucose|glucose
726215|NCT00523861|Insulin sensitivity|insulin sensitivity
726216|NCT00523861|Glucose metabolism|glucose metabolism
726217|NCT00523861|Appetite|appetite
726218|NCT00523861|Satiety|satiety
726219|NCT00523848|stage I multiple myeloma|stage i multiple myeloma
726220|NCT00523848|stage II multiple myeloma|stage ii multiple myeloma
726221|NCT00523848|stage III multiple myeloma|stage iii multiple myeloma
726222|NCT00523822|This study seeks to determine if the correction of a sacroiliac lesion can produce a functional change in cervical spine.|this study seeks to determine if the correction of a sacroiliac lesion can produce a functional change in cervical spine.
726223|NCT00523809|Breast Cancer|breast cancer
726224|NCT00523809|Ovarian Cancer|ovarian cancer
726225|NCT00523809|Stem Cell Transplantation|stem cell transplantation
726226|NCT00523809|Bevacizumab|bevacizumab
726227|NCT00523809|Fludarabine|fludarabine
726228|NCT00523809|Melphalan|melphalan
726229|NCT00523809|Avastin|avastin
726230|NCT00523809|Thymoglobulin|thymoglobulin
726231|NCT00523809|ATG|atg
726232|NCT00523809|Antithymocyte Globulin|antithymocyte globulin
726233|NCT00523809|Allogeneic Hematopoietic Stem Cell Transplantation|allogeneic hematopoietic stem cell transplantation
726234|NCT00523809|AHSCT|ahsct
726235|NCT00523796|dyslipidemia|dyslipidemia
726236|NCT00523796|in practice survey|in practice survey
726237|NCT00523796|Vietnam|vietnam
726238|NCT00523783|Schizophrenia|schizophrenia
726239|NCT00523783|Schizoaffective|schizoaffective
726240|NCT00523783|quetiapine|quetiapine
726241|NCT00523783|long-term efficacy|long-term efficacy
726242|NCT00523783|Naturalistic|naturalistic
726243|NCT00523783|Observational|observational
726244|NCT00523770|Invasive Pneumococcal Diseases|invasive pneumococcal diseases
726245|NCT00523770|Pneumonia|pneumonia
726246|NCT00523757|heart failure|heart failure
726247|NCT00523757|collagen|collagen
726248|NCT00523757|diastolic function|diastolic function
726249|NCT00523744|hypertension, valsartan, amlodipine|hypertension, valsartan, amlodipine
726250|NCT00523731|Stem cells|stem cells
726251|NCT00523731|Rest pain|rest pain
726252|NCT00523731|claudication|claudication
726253|NCT00523731|chronic ischemic or non-healing ulcers|chronic ischemic or non-healing ulcers
726254|NCT00523731|Angiogenesis|angiogenesis
726255|NCT00523731|no-option cases|no-option cases
726256|NCT00523718|obsessive-compulsive disorder|obsessive-compulsive disorder
726257|NCT00523718|OCD|ocd
726258|NCT00523718|glutamate|glutamate
726259|NCT00523718|riluzole|riluzole
726260|NCT00523718|augmentation|augmentation
726261|NCT00523718|treatment|treatment
726262|NCT00523705|premenstrual syndrome|premenstrual syndrome
726263|NCT00523705|PMS|pms
726264|NCT00523705|PMDD|pmdd
726265|NCT00523705|treatment|treatment
726266|NCT00523705|SSRI|ssri
726267|NCT00523692|Early arthritis|early arthritis
726268|NCT00523692|Rheumatoid arthritis|rheumatoid arthritis
726269|NCT00523692|Rheumatoid factor|rheumatoid factor
726270|NCT00523692|Anti CCP antibody|anti ccp antibody
726271|NCT00523692|Remission|remission
726272|NCT00523692|Anti-TNF therapy|anti-tnf therapy
726273|NCT00523692|methotrexate|methotrexate
726274|NCT00523679|Asthma|asthma
726275|NCT00523679|Symbicort|symbicort
726276|NCT00523679|SMART|smart
726277|NCT00523679|inhaler|inhaler
726278|NCT00523679|compliance|compliance
726279|NCT00523679|Naturalistic|naturalistic
726280|NCT00523679|Observational|observational
726281|NCT00523666|Alzheimer's disease|alzheimer's disease
726282|NCT00523666|diffusion tensor imaging|diffusion tensor imaging
726283|NCT00523640|metastatic|metastatic
726284|NCT00523640|renal cell|renal cell
726285|NCT00523640|kidney|kidney
726286|NCT00523640|neoplasm|neoplasm
726287|NCT00523627|Energy Expenditure|energy expenditure
726288|NCT00523627|Adaptive Thermogenesis|adaptive thermogenesis
726289|NCT00523627|Low-protein Overfeeding|low-protein overfeeding
726290|NCT00523627|Fasting|fasting
726291|NCT00523627|Weight Gain|weight gain
726292|NCT00523614|venous thromboembolism|venous thromboembolism
726293|NCT00523601|Bipolar depression|bipolar depression
726294|NCT00523601|quetiapine|quetiapine
726295|NCT00523601|observational|observational
726296|NCT00523601|Naturalistic|naturalistic
726297|NCT00523588|Cutaneous lupus erythematosus|cutaneous lupus erythematosus
726298|NCT00523588|Pulsed dye laser|pulsed dye laser
726299|NCT00523575|Elderly|elderly
726300|NCT00523575|Osteoporosis|osteoporosis
726301|NCT00523575|hip fracture|hip fracture
726302|NCT00523575|malnutrition|malnutrition
726303|NCT00523575|nutritional support|nutritional support
726304|NCT00523562|fructose|fructose
726305|NCT00523562|dietary lipids|dietary lipids
726306|NCT00523562|dietary proteins|dietary proteins
726307|NCT00523562|hepatic steatosis|hepatic steatosis
726308|NCT00523562|insulin resistance|insulin resistance
726309|NCT00523562|Healthy humans|healthy humans
726310|NCT00523562|overweight humans|overweight humans
726311|NCT00523562|obese humans|obese humans
726312|NCT00523549|Hypertension|hypertension
726313|NCT00523549|systolic blood pressure|systolic blood pressure
726314|NCT00523549|diastolic dysfunction|diastolic dysfunction
726315|NCT00523549|valsartan|valsartan
726316|NCT00523549|amlodipine|amlodipine
726317|NCT00523536|High Blood Pressure|high blood pressure
726318|NCT00523536|Cardiovascular|cardiovascular
726319|NCT00523523|Rehabilitation|rehabilitation
726320|NCT00523523|hemiplegia|hemiplegia
726321|NCT00523523|stroke|stroke
726322|NCT00523523|upper extremity|upper extremity
726323|NCT00523523|motor skills|motor skills
726324|NCT00523523|therapy|therapy
726325|NCT00523510|breastmilk|breastmilk
726326|NCT00523510|perinatal HIV|perinatal hiv
726327|NCT00523510|infant feeding|infant feeding
726328|NCT00523510|flash heat|flash heat
726329|NCT00523510|pasteurization|pasteurization
726330|NCT00523510|pmtct|pmtct
726331|NCT00523510|HIV|hiv
726332|NCT00523510|HIV Seronegativity|hiv seronegativity
726333|NCT00523510|Treatment Naive|treatment naive
726334|NCT00523497|Severe community-acquired pneumonia|severe community-acquired pneumonia
726335|NCT00523497|Noninvasive mechanical ventilation|noninvasive mechanical ventilation
726336|NCT00523497|Acute hypoxemic respiratory failure.|acute hypoxemic respiratory failure.
726337|NCT00523484|Beck Anxiety Inventory|beck anxiety inventory
726338|NCT00523484|Prostate Cancer|prostate cancer
726339|NCT00523484|Prostate Specific Antigen|prostate specific antigen
726340|NCT00523484|Naturalistic|naturalistic
726341|NCT00523484|Observational|observational
726342|NCT00523471|prostate cancer|prostate cancer
726343|NCT00523471|gamma H2AX|gamma h2ax
726344|NCT00523471|radiosensitivity|radiosensitivity
726345|NCT00523458|Co-infection|co-infection
726346|NCT00523458|Tuberculosis|tuberculosis
726347|NCT00523458|HIV|hiv
726348|NCT00523458|Drug interactions|drug interactions
726349|NCT00523458|Non nucleoside reverse transcriptase inhibitors|non nucleoside reverse transcriptase inhibitors
726350|NCT00523458|Therapy|therapy
726351|NCT00523458|Treatment Naive|treatment naive
726352|NCT00523445|Schizophrenia|schizophrenia
726353|NCT00523445|Cognition|cognition
726354|NCT00523445|Varenicline|varenicline
726355|NCT00523432|ovarian cancer|ovarian cancer
726356|NCT00523432|cervical cancer|cervical cancer
726357|NCT00523432|uterine cancer|uterine cancer
726358|NCT00523432|fallopian tube cancer|fallopian tube cancer
726359|NCT00523432|endometrial cancer|endometrial cancer
726360|NCT00523432|vaginal cancer|vaginal cancer
726361|NCT00523432|peritoneal cancer|peritoneal cancer
726362|NCT00523432|reproductive cancer|reproductive cancer
726363|NCT00523406|choroidal neovascularisation,|choroidal neovascularisation,
726364|NCT00523406|vision,|vision,
726365|NCT00523406|macula,|macula,
726366|NCT00523406|macular degeneration|macular degeneration
726367|NCT00523406|optical coherence tomography|optical coherence tomography
726368|NCT00523406|neovascular age related macular degeneration|neovascular age related macular degeneration
726369|NCT00523367|Gastro Esophageal Reflux Disease (GERD)|gastro esophageal reflux disease (gerd)
726370|NCT00523367|Chronic Obstructive Pulmonary Disease (COPD)|chronic obstructive pulmonary disease (copd)
726371|NCT00523354|Eosinophilic Esophagitis|eosinophilic esophagitis
726372|NCT00523354|TNF-alpha|tnf-alpha
726373|NCT00523354|TNF-alpha Blockade|tnf-alpha blockade
726374|NCT00523354|Infliximab|infliximab
726375|NCT00523341|postmenopausal osteoporosis|postmenopausal osteoporosis
726376|NCT00523341|low bone density|low bone density
726377|NCT00523341|fractures|fractures
726378|NCT00523341|low bone mass|low bone mass
726379|NCT00523328|Rheumatoid Arthritis|rheumatoid arthritis
726380|NCT00523328|Arthritis|arthritis
726381|NCT00523328|BG9924|bg9924
726382|NCT00523328|methotrexate|methotrexate
726383|NCT00523315|Aromatase Inhibitor|aromatase inhibitor
726384|NCT00523315|Breast Cancer|breast cancer
726385|NCT00523315|compliance|compliance
726386|NCT00523315|Naturalistic|naturalistic
726387|NCT00523315|Observational|observational
726388|NCT00523302|Major Depression|major depression
726389|NCT00523302|Fibromyalgia|fibromyalgia
726390|NCT00523302|TMS|tms
726391|NCT00523289|Ropivacaine|ropivacaine
726392|NCT00523289|Bupivacaine|bupivacaine
726393|NCT00523289|Upper Extremity|upper extremity
726394|NCT00523289|Local anesthetic|local anesthetic
726395|NCT00523276|Severe acute respiratory syndrome, SARS, China|severe acute respiratory syndrome, sars, china
726396|NCT00523250|Glaucoma|glaucoma
726397|NCT00523224|Stem cells|stem cells
726398|NCT00523224|Coronary Artery Bypass grafting|coronary artery bypass grafting
726399|NCT00523224|Congestive Heart Failure|congestive heart failure
726400|NCT00523224|Coronary Artery Disease|coronary artery disease
726401|NCT00523224|Angiogenesis|angiogenesis
726402|NCT00523211|Acquired Immunodeficiency Syndrome|acquired immunodeficiency syndrome
726403|NCT00523211|Treatment Experienced|treatment experienced
726404|NCT00523198|Cortisol|cortisol
726405|NCT00523185|alcohol withdrawal|alcohol withdrawal
726406|NCT00523185|lorazepam|lorazepam
726407|NCT00523185|diazepam|diazepam
726408|NCT00523172|Chiropractic Manipulation|chiropractic manipulation
726409|NCT00523159|clear cell renal cell carcinoma|clear cell renal cell carcinoma
726410|NCT00523146|primary dysmenorrhea|primary dysmenorrhea
726411|NCT00523146|Herbal remedy|herbal remedy
726414|NCT00523133|motivational enhancement therapy|motivational enhancement therapy
726415|NCT00523107|Fatigue|fatigue
726416|NCT00523107|Standard Palliative Care|standard palliative care
726417|NCT00523107|PG2|pg2
726418|NCT00523107|QLQ-C30|qlq-c30
726419|NCT00523107|Compassionate|compassionate
726420|NCT00523081|adolescent depression treatment, cognitive behavioral therapy,|adolescent depression treatment, cognitive behavioral therapy,
726421|NCT00523081|collaborative care|collaborative care
726422|NCT00523068|overactive bladder|overactive bladder
726423|NCT00523068|stress urinary incontinence|stress urinary incontinence
726424|NCT00523068|detrusor overactivity|detrusor overactivity
726425|NCT00523068|urodynamics|urodynamics
726426|NCT00523055|Pain|pain
726427|NCT00523055|Brachial Plexus Anesthesia|brachial plexus anesthesia
726428|NCT00523055|Plasma Lidocaine Levels|plasma lidocaine levels
726429|NCT00523055|Ultrasound|ultrasound
726430|NCT00523029|Self-management programs|self-management programs
726431|NCT00523029|Chronic medical illness|chronic medical illness
726432|NCT00523016|acupuncture|acupuncture
726433|NCT00523016|electroacupuncture|electroacupuncture
726434|NCT00523016|sham acupuncture|sham acupuncture
726435|NCT00523016|spinal cord injury|spinal cord injury
726436|NCT00523016|neuropathic pain|neuropathic pain
726437|NCT00523016|burning pain|burning pain
726438|NCT00523003|weight loss|weight loss
726439|NCT00523003|obesity|obesity
726440|NCT00523003|high protein|high protein
726441|NCT00523003|meal replacement|meal replacement
726442|NCT00522977|Myocardial strain|myocardial strain
726443|NCT00522977|Myocardial function|myocardial function
726444|NCT00522977|Pregnancy|pregnancy
726445|NCT00522977|Postpartum|postpartum
726446|NCT00522977|Echocardiography|echocardiography
726447|NCT00522977|Myocardial adaptation to pregnancy|myocardial adaptation to pregnancy
726448|NCT00522977|Systolic function|systolic function
726449|NCT00522977|Diastolic function|diastolic function
726450|NCT00522964|Chinese-American|chinese-american
726451|NCT00522964|Children|children
726452|NCT00522964|Obesity|obesity
726453|NCT00522964|health behaviors|health behaviors
726454|NCT00522964|Behavioral intervention|behavioral intervention
726455|NCT00522964|normal|normal
726456|NCT00522951|MRI|mri
726457|NCT00522951|Brain Metastasis|brain metastasis
726458|NCT00522951|Gadolinium|gadolinium
726459|NCT00522951|Imaging|imaging
726460|NCT00522951|Diagnostic Agent|diagnostic agent
726461|NCT00522938|Lung|lung
726462|NCT00522938|Cancer|cancer
726463|NCT00522938|Non-small|non-small
726464|NCT00522938|Lung Cancer|lung cancer
726465|NCT00522938|NSCLC|nsclc
726466|NCT00522938|erlotinib|erlotinib
726467|NCT00522938|oral|oral
726468|NCT00522938|Locally Advanced Non-small Cell Lung Cancer|locally advanced non-small cell lung cancer
726469|NCT00522938|Metastatic Non-small Cell Lung Cancer|metastatic non-small cell lung cancer
726470|NCT00522925|hypertension|hypertension
726471|NCT00522925|high blood pressure|high blood pressure
726472|NCT00522912|Trachoma|trachoma
726473|NCT00522912|Trichiasis|trichiasis
726474|NCT00522912|Surgery|surgery
726475|NCT00522912|Epilation|epilation
726476|NCT00522912|Ethiopia|ethiopia
726477|NCT00522899|aged|aged
726478|NCT00522899|exercise|exercise
726479|NCT00522899|cognitive therapy|cognitive therapy
726480|NCT00522899|dementia|dementia
726481|NCT00522899|prevention|prevention
726482|NCT00522886|cetuximab|cetuximab
726483|NCT00522886|concurrent|concurrent
726484|NCT00522886|iso-toxic|iso-toxic
726485|NCT00522886|NSCLC|nsclc
726486|NCT00522873|Postmenopausal Symptoms e.g.|postmenopausal symptoms e.g.
726487|NCT00522873|Hot flushes|hot flushes
726488|NCT00522873|Sweating episodes|sweating episodes
726489|NCT00522873|Vaginal dryness|vaginal dryness
726490|NCT00522860|Trichiasis|trichiasis
726491|NCT00522860|Trachoma|trachoma
726492|NCT00522860|Surgery|surgery
726493|NCT00522860|Suture|suture
726494|NCT00522860|Ethiopia|ethiopia
726495|NCT00522847|Postmenopausal|postmenopausal
726496|NCT00522847|non dry eye|non dry eye
726497|NCT00522834|melanoma|melanoma
726498|NCT00522834|oncology|oncology
726499|NCT00522834|Stage IV Metastatic Melanoma|stage iv metastatic melanoma
726500|NCT00522821|IgG subclass deficiency|igg subclass deficiency
726501|NCT00522821|Anti-polysaccharide deficiency|anti-polysaccharide deficiency
726502|NCT00522821|therapy|therapy
726503|NCT00522821|Immunoglobulins, Intravenous|immunoglobulins, intravenous
726504|NCT00522821|co-trimoxazole|co-trimoxazole
726505|NCT00522808|HCV|hcv
726506|NCT00522808|antiviral|antiviral
726507|NCT00522808|PK|pk
726508|NCT00522808|Safety|safety
726509|NCT00522795|Esophageal Cancer|esophageal cancer
726510|NCT00522769|binge eating|binge eating
726511|NCT00522769|adolescent girls|adolescent girls
726512|NCT00522769|cognitive behavioral therapy|cognitive behavioral therapy
726513|NCT00522756|Kidney Failure, Acute|kidney failure, acute
726514|NCT00522756|Cardiac Surgical Procedures|cardiac surgical procedures
726966|NCT00521274|MVA 5T4|mva 5t4
726515|NCT00522756|Sodium Bicarbonate|sodium bicarbonate
726516|NCT00522756|Sodium Chloride|sodium chloride
726517|NCT00522756|Prevention and control|prevention and control
726518|NCT00522743|SGA|sga
726519|NCT00522743|GH|gh
726520|NCT00522743|GnRHa|gnrha
726521|NCT00522743|IGF-1|igf-1
726522|NCT00522730|Liver failure|liver failure
726523|NCT00522730|Liver cirrhosis|liver cirrhosis
726524|NCT00522730|Parenteral nutrition|parenteral nutrition
726525|NCT00522730|Enteral nutrition|enteral nutrition
726526|NCT00522730|Lipids|lipids
726527|NCT00522730|Safety|safety
726528|NCT00522730|Drug tolerance|drug tolerance
726529|NCT00522704|Arteriovenous fistula|arteriovenous fistula
726530|NCT00522704|Access blood flow|access blood flow
726531|NCT00522704|Extracorporeal blood flow|extracorporeal blood flow
726532|NCT00522704|Dynamic arterial line pressure|dynamic arterial line pressure
726533|NCT00522704|Hemodialysis treatment|hemodialysis treatment
726534|NCT00522691|Fecal incontinence|fecal incontinence
726535|NCT00522691|sacral nerve stimulation|sacral nerve stimulation
726536|NCT00522678|Healthy Volunteers|healthy volunteers
726537|NCT00522652|cancer|cancer
726538|NCT00522652|advanced cancer|advanced cancer
726539|NCT00522652|lymphoma|lymphoma
726540|NCT00522639|lung cancer|lung cancer
726541|NCT00522639|FDG-PET-CT|fdg-pet-ct
726542|NCT00522639|blood proteins|blood proteins
726543|NCT00522639|prognose|prognose
726544|NCT00522626|Fetus|fetus
726545|NCT00522626|Drug abuse|drug abuse
726546|NCT00522626|Fetal development|fetal development
726547|NCT00522626|Substance abuse|substance abuse
726548|NCT00522626|Opioids|opioids
726549|NCT00522626|Methadone|methadone
726550|NCT00522613|recovery|recovery
726551|NCT00522613|serious mental illness|serious mental illness
726552|NCT00522613|bipolar disorder|bipolar disorder
726553|NCT00522613|schizophrenia|schizophrenia
726554|NCT00522613|schizoaffective disorder|schizoaffective disorder
726555|NCT00522600|eyedrops|eyedrops
726556|NCT00522600|compliance|compliance
726557|NCT00522600|glaucoma medications|glaucoma medications
726558|NCT00522600|adherence|adherence
726559|NCT00522574|Myeloproliferative Disorders|myeloproliferative disorders
726560|NCT00522561|Healthy volunteers|healthy volunteers
726561|NCT00522561|running|running
726562|NCT00522561|energetic cost|energetic cost
726563|NCT00522561|limb mechanical characteristics|limb mechanical characteristics
726564|NCT00522561|contractile components|contractile components
726565|NCT00522561|elastic components|elastic components
726566|NCT00522561|healthy men doing regularly physical activities|healthy men doing regularly physical activities
726567|NCT00522548|African American|african american
726568|NCT00522548|Kidney Transplant|kidney transplant
726569|NCT00522535|AAA|aaa
726570|NCT00522535|Abdominal Aortic Aneurysms|abdominal aortic aneurysms
726571|NCT00522535|Endovascular|endovascular
726572|NCT00522535|EVAR|evar
726573|NCT00522535|Aorta|aorta
726574|NCT00522535|Stent Graft|stent graft
726575|NCT00522535|Stent|stent
726576|NCT00522535|Tortuous|tortuous
726577|NCT00522535|High Angle|high angle
726578|NCT00522535|Angled Necks|angled necks
726579|NCT00522522|Naturalistic, retrospective, utilization of care services, diagnosis, epilepsy|naturalistic, retrospective, utilization of care services, diagnosis, epilepsy
726580|NCT00522496|Craniocerebral trauma|craniocerebral trauma
726581|NCT00522496|matrix metalloproteinase|matrix metalloproteinase
726582|NCT00522496|microdialysis|microdialysis
726583|NCT00522457|Breast Cancer|breast cancer
726584|NCT00522457|investigational drug|investigational drug
726585|NCT00522457|drug therapy|drug therapy
726586|NCT00522457|Antineoplastic Protocols|antineoplastic protocols
726587|NCT00522457|Immunotherapy|immunotherapy
726588|NCT00522457|Metastatic breast cancer|metastatic breast cancer
726589|NCT00522457|Advanced breast cancer|advanced breast cancer
726590|NCT00522457|Stage IV breast cancer|stage iv breast cancer
726591|NCT00522457|Her-2/neu expressing breast cancer|her-2/neu expressing breast cancer
726592|NCT00522457|Her-2/neu|her-2/neu
726593|NCT00522457|Trastuzumab refractory|trastuzumab refractory
726594|NCT00522431|Hypogonadism|hypogonadism
726595|NCT00522418|Epilepsy|epilepsy
726596|NCT00522418|VNS Therapy|vns therapy
726597|NCT00522405|Transarterial chemoembolisation|transarterial chemoembolisation
726598|NCT00522405|Thalidomide|thalidomide
726599|NCT00522405|Capecitabine|capecitabine
726600|NCT00522405|Treatment|treatment
726601|NCT00522392|Consolidation therapy|consolidation therapy
726602|NCT00522392|First-line therapy|first-line therapy
726603|NCT00522392|Proteasome inhibitor|proteasome inhibitor
726604|NCT00522392|Thalidomide analogue|thalidomide analogue
726605|NCT00522392|Quality of life|quality of life
726606|NCT00522379|Parkinson's disease|parkinson's disease
726607|NCT00522379|rotigotine|rotigotine
726608|NCT00522379|patch|patch
726609|NCT00522379|transdermal|transdermal
726610|NCT00522379|dopamine agonist|dopamine agonist
726611|NCT00522379|off time|off time
726612|NCT00522379|Neupro|neupro
726613|NCT00522353|obesity|obesity
726614|NCT00522353|weight loss|weight loss
726615|NCT00522353|satiety hormones|satiety hormones
726967|NCT00521274|Trovax®|trovax®
726616|NCT00522353|body composition|body composition
726617|NCT00522353|appetite ratings|appetite ratings
726618|NCT00522340|Implantable Cardioverter Defibrillators|implantable cardioverter defibrillators
726619|NCT00522340|ICD|icd
726620|NCT00522340|Exercise|exercise
726621|NCT00522340|Cardiac|cardiac
726622|NCT00522340|Inflammation|inflammation
726623|NCT00522327|Immigrant|immigrant
726624|NCT00522327|Interpreting|interpreting
726625|NCT00522314|Non-invasive ventilation|non-invasive ventilation
726626|NCT00522314|Airway clearance|airway clearance
726627|NCT00522314|Bronchiectasis|bronchiectasis
726628|NCT00522301|recurrent ovarian epithelial cancer|recurrent ovarian epithelial cancer
726629|NCT00522301|fallopian tube cancer|fallopian tube cancer
726630|NCT00522301|primary peritoneal cavity cancer|primary peritoneal cavity cancer
726631|NCT00522301|stage I ovarian epithelial cancer|stage i ovarian epithelial cancer
726632|NCT00522301|stage II ovarian epithelial cancer|stage ii ovarian epithelial cancer
726633|NCT00522301|stage III ovarian epithelial cancer|stage iii ovarian epithelial cancer
726634|NCT00522301|stage IV ovarian epithelial cancer|stage iv ovarian epithelial cancer
726635|NCT00522288|Myopia|myopia
726636|NCT00522288|Self-Perception|self-perception
726637|NCT00522288|Contact Lenses|contact lenses
726638|NCT00522288|Glasses|glasses
726639|NCT00522288|Randomized|randomized
726640|NCT00522288|Children|children
726641|NCT00522288|Self-esteem|self-esteem
726642|NCT00522275|Adjunctive treatment in epilepsy|adjunctive treatment in epilepsy
726643|NCT00522275|add-on treatment for epilepsy|add-on treatment for epilepsy
726644|NCT00522275|partial seizures|partial seizures
726645|NCT00522275|AEDs|aeds
726646|NCT00522275|antiepileptic drugs|antiepileptic drugs
726647|NCT00522275|seizures|seizures
726648|NCT00522262|Breast Neoplasms|breast neoplasms
726649|NCT00522262|Exercise|exercise
726650|NCT00522262|Physical activity|physical activity
726651|NCT00522262|Estrone|estrone
726652|NCT00522262|Estradiol|estradiol
726653|NCT00522262|Adiposity|adiposity
726654|NCT00522262|Breast density|breast density
726655|NCT00522262|Mammographic density|mammographic density
726656|NCT00522262|Insulin-Like Growth Factor I|insulin-like growth factor i
726657|NCT00522262|Insulin Resistance|insulin resistance
726658|NCT00522262|Women|women
726659|NCT00522262|Postmenopause|postmenopause
726660|NCT00522249|Metastatic Renal Cell Carcinoma|metastatic renal cell carcinoma
726661|NCT00522249|RCC|rcc
726662|NCT00522249|M3thodist|m3thodist
726663|NCT00522249|Pegylated Alfa Interferon|pegylated alfa interferon
726664|NCT00522249|Sunitinib|sunitinib
726665|NCT00522249|Tarceva|tarceva
726666|NCT00522249|Peg IFN|peg ifn
726667|NCT00522236|Adjuvanted Influenza Vaccine|adjuvanted influenza vaccine
726668|NCT00522223|Cervical Cancer|cervical cancer
726669|NCT00522223|Cancer Survivors|cancer survivors
726670|NCT00522223|Cervix Cancer|cervix cancer
726671|NCT00522223|Sexual Functioning|sexual functioning
726672|NCT00522223|Quality Of Life|quality of life
726673|NCT00522223|Questionnaire|questionnaire
726674|NCT00522223|Radiation Therapy|radiation therapy
726675|NCT00522223|Radical Hysterectomy|radical hysterectomy
726676|NCT00522210|type 1 diabetes|type 1 diabetes
726677|NCT00522210|children|children
726678|NCT00522210|long acting insulin analogue|long acting insulin analogue
726679|NCT00522210|hemoglobin A1c|hemoglobin a1c
726680|NCT00522197|non-small cell lung cancer|non-small cell lung cancer
726681|NCT00522197|small cell lung cancer|small cell lung cancer
726682|NCT00522197|squamous lung dysplasia|squamous lung dysplasia
726683|NCT00522184|intra-articular injection|intra-articular injection
726684|NCT00522184|acute synovitis|acute synovitis
726685|NCT00522184|etanercept|etanercept
726686|NCT00522171|Harmonic|harmonic
726687|NCT00522171|Massive Weight Loss|massive weight loss
726688|NCT00522171|Electro Surgery|electro surgery
726689|NCT00522171|Skin and Fat Redundancy after massive weight loss|skin and fat redundancy after massive weight loss
726690|NCT00522171|Obesity|obesity
726691|NCT00522145|Non-Small-Cell Lung Cancer|non-small-cell lung cancer
726692|NCT00522132|intravenous artesunate|intravenous artesunate
726693|NCT00522132|severe malaria|severe malaria
726694|NCT00522132|Plasmodium falciparum|plasmodium falciparum
726695|NCT00522132|Africa|africa
726696|NCT00522132|Severe Plasmodium falciparum Malaria|severe plasmodium falciparum malaria
726697|NCT00522119|Essential Hypertension|essential hypertension
726698|NCT00522119|High Blood Pressure|high blood pressure
726699|NCT00522106|Behavioral graded activity|behavioral graded activity
726700|NCT00522106|Hip|hip
726701|NCT00522106|Knee|knee
726702|NCT00522106|Physical therapy|physical therapy
726703|NCT00522106|Exercise therapy|exercise therapy
726704|NCT00522093|constipation|constipation
726705|NCT00522067|influenza|influenza
726706|NCT00522067|influenza vaccine|influenza vaccine
726707|NCT00522067|adjuvanted influenza vaccine|adjuvanted influenza vaccine
726708|NCT00522067|subunit influenza vaccine|subunit influenza vaccine
726709|NCT00522067|surface antigen|surface antigen
726710|NCT00522054|Exercise|exercise
726711|NCT00522054|Physical function|physical function
726712|NCT00522054|Rheumatoid arthritis|rheumatoid arthritis
726713|NCT00522054|Tai Chi|tai chi
726714|NCT00522041|Pain associated with chronic anal fissure|pain associated with chronic anal fissure
726715|NCT00522028|QoL|qol
726716|NCT00522028|Osteodensitometry|osteodensitometry
726717|NCT00522028|Arterial pressure|arterial pressure
726718|NCT00522028|PTH|pth
726719|NCT00522015|PSP|psp
726720|NCT00522015|dementia|dementia
726721|NCT00522015|neuropsychology|neuropsychology
726722|NCT00522015|treatment|treatment
726723|NCT00522002|Connective tissue diseases|connective tissue diseases
726724|NCT00522002|Blood coagulation disorders|blood coagulation disorders
726725|NCT00522002|Leg ulcers|leg ulcers
726726|NCT00522002|Rheumatoid Arthritis|rheumatoid arthritis
726727|NCT00522002|Systemic Lupus Erythematosus|systemic lupus erythematosus
726728|NCT00522002|Systemic Scleroderma|systemic scleroderma
726729|NCT00522002|Mixed Connective Tissue Disease|mixed connective tissue disease
726730|NCT00521989|Osteoarthritis|osteoarthritis
726731|NCT00521989|Knee|knee
726732|NCT00521989|CRx-102|crx-102
726733|NCT00521989|prednisolone|prednisolone
726734|NCT00521989|dipyridamole|dipyridamole
726735|NCT00521989|CombinatoRx|combinatorx
726736|NCT00521989|WOMAC|womac
726737|NCT00521976|Risk assessment|risk assessment
726738|NCT00521976|Chest pain|chest pain
726739|NCT00521976|Coronary Artery Disease|coronary artery disease
726740|NCT00521976|Acute coronary syndromes|acute coronary syndromes
726741|NCT00521976|Factor XIIa|factor xiia
726742|NCT00521976|B-type natriuretic peptide (BNP)|b-type natriuretic peptide (bnp)
726743|NCT00521976|high-sensitive C-reactive protein (hsCRP)|high-sensitive c-reactive protein (hscrp)
726744|NCT00521976|Omega-3|omega-3
726745|NCT00521963|Intraarticular injection|intraarticular injection
726746|NCT00521963|Infliximab|infliximab
726747|NCT00521950|Pharmacogenetics|pharmacogenetics
726748|NCT00521950|Cost Effectiveness|cost effectiveness
726749|NCT00521950|Inflammatory Bowel Diseases|inflammatory bowel diseases
726750|NCT00521950|Crohn Disease|crohn disease
726751|NCT00521950|Ulcerative Colitis|ulcerative colitis
726752|NCT00521950|Randomized Controlled Trials|randomized controlled trials
726753|NCT00521911|Intervention Studies|intervention studies
726754|NCT00521911|Randomized Controlled Trials|randomized controlled trials
726755|NCT00521911|Cognitive Therapy|cognitive therapy
726756|NCT00521911|Hospitals, General|hospitals, general
726757|NCT00521911|Prevalence|prevalence
726758|NCT00521898|Corneal transplantation, Descemet membrane|corneal transplantation, descemet membrane
726759|NCT00521885|Bleeding rates|bleeding rates
726760|NCT00521885|Prophylaxis for deep vein thrombosis|prophylaxis for deep vein thrombosis
726761|NCT00521872|surgery (STARR operation)|surgery (starr operation)
726762|NCT00521859|Hematologic Malignancies|hematologic malignancies
726763|NCT00521859|Leukemia|leukemia
726764|NCT00521859|Lymphoma|lymphoma
726765|NCT00521859|Myeloma|myeloma
726766|NCT00521859|Hodgkin's Disease|hodgkin's disease
726767|NCT00521859|Hematopoietic Cell Transplantation|hematopoietic cell transplantation
726768|NCT00521859|Cloretazine|cloretazine
726769|NCT00521859|VNP40101M|vnp40101m
726770|NCT00521859|Fludarabine|fludarabine
726771|NCT00521859|Fludarabine Phosphate|fludarabine phosphate
726772|NCT00521859|Fludara|fludara
726773|NCT00521859|ATG|atg
726774|NCT00521859|Antithymocyte|antithymocyte
726775|NCT00521859|Thymoglobulin|thymoglobulin
726776|NCT00521833|Kataract|kataract
726777|NCT00521833|Astigmatism|astigmatism
726778|NCT00521833|phacoemulsification|phacoemulsification
726779|NCT00521820|Glucose Metabolism Disorder|glucose metabolism disorder
726780|NCT00521820|Dysmetabolic Syndrome|dysmetabolic syndrome
726781|NCT00521820|Type II Diabetes|type ii diabetes
726782|NCT00521820|Diabetes Mellitus, Lipoatrophic|diabetes mellitus, lipoatrophic
726783|NCT00521820|Dyslipidemia|dyslipidemia
726784|NCT00521820|Drug Therapy|drug therapy
726785|NCT00521807|Hypnosis,|hypnosis,
726786|NCT00521807|Chronic widespread pain,|chronic widespread pain,
726787|NCT00521807|CWP,|cwp,
726788|NCT00521807|General Practice|general practice
726789|NCT00521794|Arrhythmia|arrhythmia
726790|NCT00521794|Muscle Weakness|muscle weakness
726791|NCT00521794|Periodic Paralysis|periodic paralysis
726792|NCT00521794|Channelopathy|channelopathy
726793|NCT00521781|Unresectable or Metastatic Adenocarcinoma Prostate Cancer|unresectable or metastatic adenocarcinoma prostate cancer
726794|NCT00521781|Hormonal Therapy|hormonal therapy
726795|NCT00521781|Abraxane|abraxane
726796|NCT00521781|M3thodist|m3thodist
726797|NCT00521768|Post traumatic stress disorder|post traumatic stress disorder
726798|NCT00521768|Anxiety disorder|anxiety disorder
726799|NCT00521768|Comunity base intervention|comunity base intervention
726800|NCT00521768|Education|education
726801|NCT00521768|Behavioural treatment|behavioural treatment
726802|NCT00521755|Laser bonding soft tissue albumin|laser bonding soft tissue albumin
726803|NCT00521742|Glucose Metabolism Disorder|glucose metabolism disorder
726804|NCT00521742|Dysmetabolic Syndrome|dysmetabolic syndrome
726805|NCT00521742|Type II Diabetes|type ii diabetes
726806|NCT00521742|Diabetes Mellitus, Lipoatrophic|diabetes mellitus, lipoatrophic
726807|NCT00521742|Dyslipidemia|dyslipidemia
726808|NCT00521742|Drug Therapy|drug therapy
726810|NCT00521729|Thermoregulation|thermoregulation
726968|NCT00521274|Docetaxel|docetaxel
726811|NCT00521729|Catecholamines|catecholamines
726812|NCT00521729|Energy Expenditure|energy expenditure
726814|NCT00521729|Healthy Volunteer|healthy volunteer
726815|NCT00521729|HV|hv
726816|NCT00521716|Hip Prosthesis Implantation|hip prosthesis implantation
726817|NCT00521703|endoscopy, gastrointestinal|endoscopy, gastrointestinal
726818|NCT00521703|lidocaine|lidocaine
726819|NCT00521703|propofol|propofol
726820|NCT00521703|child|child
726821|NCT00521703|adolescent|adolescent
726822|NCT00521677|VAP|vap
726823|NCT00521677|Oral care|oral care
726824|NCT00521677|Acquired pneumonia|acquired pneumonia
726825|NCT00521677|Mortality|mortality
726826|NCT00521677|LOS in ICU|los in icu
726827|NCT00521677|LOS in hospital|los in hospital
726828|NCT00521677|All patients on ventilator in the ICU|all patients on ventilator in the icu
726829|NCT00521664|proof of safety and cost effectiveness of the new therapeutic platelet transfusion strategy|proof of safety and cost effectiveness of the new therapeutic platelet transfusion strategy
726830|NCT00521651|Physical Activity|physical activity
726831|NCT00521651|Cancer Risk|cancer risk
726832|NCT00521612|sevoflurane|sevoflurane
726833|NCT00521612|isoflurane|isoflurane
726834|NCT00521612|anaesthesia|anaesthesia
726835|NCT00521586|Pneumococcal Conjugate Vaccine|pneumococcal conjugate vaccine
726836|NCT00521560|High-Dose Radio-Immuno- and Chemotherapy|high-dose radio-immuno- and chemotherapy
726837|NCT00521560|stem cell transplantation|stem cell transplantation
726838|NCT00521560|90Y-Ibritumomab-Tiuxetan|90y-ibritumomab-tiuxetan
726839|NCT00521547|Acupuncture|acupuncture
726840|NCT00521547|Analgesia|analgesia
726841|NCT00521547|Functional magnetic resonance imaging (fMRI)|functional magnetic resonance imaging (fmri)
726842|NCT00521547|Neuronal Mechanisms|neuronal mechanisms
726843|NCT00521547|Quantitative Peripheral Sensory Testings|quantitative peripheral sensory testings
726844|NCT00521547|Normal Volunteers|normal volunteers
726845|NCT00521534|Sleep related Breathing Disorder|sleep related breathing disorder
726846|NCT00521534|Congestive Heart Failure|congestive heart failure
726847|NCT00521534|Atrial Overdrive Pacing|atrial overdrive pacing
726848|NCT00521534|Cardiac Resynchronization Therapy|cardiac resynchronization therapy
726849|NCT00521508|IgA|iga
726850|NCT00521508|kidney|kidney
726851|NCT00521508|Berger'disease|berger'disease
726852|NCT00521508|regulatory T cells|regulatory t cells
726853|NCT00521508|pathogenesis of Berger's disease|pathogenesis of berger's disease
726854|NCT00521495|static magnetic field|static magnetic field
726855|NCT00521495|permanent magnet|permanent magnet
726856|NCT00521495|carpal tunnel syndrome|carpal tunnel syndrome
726857|NCT00521495|median nerve|median nerve
726858|NCT00521482|recurrent|recurrent
726859|NCT00521482|after standard therapy|after standard therapy
726860|NCT00521469|Disequilibrium|disequilibrium
726861|NCT00521469|Spinal Manipulation|spinal manipulation
726862|NCT00521469|Postural control|postural control
726863|NCT00521430|recurrent childhood grade III lymphomatoid granulomatosis|recurrent childhood grade iii lymphomatoid granulomatosis
726864|NCT00521430|childhood diffuse large cell lymphoma|childhood diffuse large cell lymphoma
726865|NCT00521430|recurrent childhood large cell lymphoma|recurrent childhood large cell lymphoma
726866|NCT00521430|childhood immunoblastic large cell lymphoma|childhood immunoblastic large cell lymphoma
726867|NCT00521430|recurrent childhood lymphoblastic lymphoma|recurrent childhood lymphoblastic lymphoma
726868|NCT00521430|childhood nasal type extranodal NK/T-cell lymphoma|childhood nasal type extranodal nk/t-cell lymphoma
726869|NCT00521430|recurrent childhood small noncleaved cell lymphoma|recurrent childhood small noncleaved cell lymphoma
726870|NCT00521430|adult acute myeloid leukemia in remission|adult acute myeloid leukemia in remission
726871|NCT00521430|adult acute lymphoblastic leukemia in remission|adult acute lymphoblastic leukemia in remission
726872|NCT00521430|aplastic anemia|aplastic anemia
726873|NCT00521430|recurrent childhood acute lymphoblastic leukemia|recurrent childhood acute lymphoblastic leukemia
726874|NCT00521430|childhood acute lymphoblastic leukemia in remission|childhood acute lymphoblastic leukemia in remission
726875|NCT00521430|childhood acute myeloid leukemia in remission|childhood acute myeloid leukemia in remission
726876|NCT00521430|adult acute myeloid leukemia with 11q23 (MLL) abnormalities|adult acute myeloid leukemia with 11q23 (mll) abnormalities
726877|NCT00521430|adult acute myeloid leukemia with inv(16)(p13;q22)|adult acute myeloid leukemia with inv(16)(p13;q22)
726878|NCT00521430|adult acute myeloid leukemia with t(15;17)(q22;q12)|adult acute myeloid leukemia with t(15;17)(q22;q12)
726879|NCT00521430|adult acute myeloid leukemia with t(16;16)(p13;q22)|adult acute myeloid leukemia with t(16;16)(p13;q22)
726880|NCT00521430|adult acute myeloid leukemia with t(8;21)(q22;q22)|adult acute myeloid leukemia with t(8;21)(q22;q22)
726881|NCT00521430|refractory anemia with excess blasts in transformation|refractory anemia with excess blasts in transformation
726882|NCT00521430|refractory anemia with excess blasts|refractory anemia with excess blasts
726883|NCT00521430|refractory anemia with ringed sideroblasts|refractory anemia with ringed sideroblasts
726884|NCT00521430|refractory anemia|refractory anemia
726885|NCT00521430|refractory multiple myeloma|refractory multiple myeloma
726886|NCT00521430|chronic myelomonocytic leukemia|chronic myelomonocytic leukemia
726887|NCT00521430|accelerated phase chronic myelogenous leukemia|accelerated phase chronic myelogenous leukemia
726888|NCT00521430|blastic phase chronic myelogenous leukemia|blastic phase chronic myelogenous leukemia
726889|NCT00521430|chronic phase chronic myelogenous leukemia|chronic phase chronic myelogenous leukemia
726890|NCT00521430|relapsing chronic myelogenous leukemia|relapsing chronic myelogenous leukemia
726891|NCT00521430|recurrent adult Hodgkin lymphoma|recurrent adult hodgkin lymphoma
726892|NCT00521430|recurrent adult T-cell leukemia/lymphoma|recurrent adult t-cell leukemia/lymphoma
726893|NCT00521430|anaplastic large cell lymphoma|anaplastic large cell lymphoma
726894|NCT00521430|angioimmunoblastic T-cell lymphoma|angioimmunoblastic t-cell lymphoma
726895|NCT00521430|recurrent cutaneous T-cell non-Hodgkin lymphoma|recurrent cutaneous t-cell non-hodgkin lymphoma
726896|NCT00521430|recurrent mycosis fungoides/Sezary syndrome|recurrent mycosis fungoides/sezary syndrome
726897|NCT00521430|adult nasal type extranodal NK/T-cell lymphoma|adult nasal type extranodal nk/t-cell lymphoma
726898|NCT00521430|Waldenström macroglobulinemia|waldenström macroglobulinemia
726899|NCT00521430|recurrent adult Burkitt lymphoma|recurrent adult burkitt lymphoma
726900|NCT00521430|recurrent adult diffuse large cell lymphoma|recurrent adult diffuse large cell lymphoma
726901|NCT00521430|recurrent adult diffuse mixed cell lymphoma|recurrent adult diffuse mixed cell lymphoma
726902|NCT00521430|recurrent adult diffuse small cleaved cell lymphoma|recurrent adult diffuse small cleaved cell lymphoma
726903|NCT00521430|recurrent adult grade III lymphomatoid granulomatosis|recurrent adult grade iii lymphomatoid granulomatosis
726904|NCT00521430|recurrent adult immunoblastic large cell lymphoma|recurrent adult immunoblastic large cell lymphoma
726905|NCT00521430|recurrent adult lymphoblastic lymphoma|recurrent adult lymphoblastic lymphoma
726906|NCT00521430|recurrent grade 1 follicular lymphoma|recurrent grade 1 follicular lymphoma
726907|NCT00521430|recurrent grade 2 follicular lymphoma|recurrent grade 2 follicular lymphoma
726908|NCT00521430|recurrent grade 3 follicular lymphoma|recurrent grade 3 follicular lymphoma
726909|NCT00521430|recurrent mantle cell lymphoma|recurrent mantle cell lymphoma
726910|NCT00521430|recurrent marginal zone lymphoma|recurrent marginal zone lymphoma
726911|NCT00521430|recurrent small lymphocytic lymphoma|recurrent small lymphocytic lymphoma
726912|NCT00521430|stage I multiple myeloma|stage i multiple myeloma
726913|NCT00521430|stage II multiple myeloma|stage ii multiple myeloma
726914|NCT00521430|stage III multiple myeloma|stage iii multiple myeloma
726915|NCT00521430|cutaneous B-cell non-Hodgkin lymphoma|cutaneous b-cell non-hodgkin lymphoma
726916|NCT00521430|unspecified adult solid tumor, protocol specific|unspecified adult solid tumor, protocol specific
726917|NCT00521430|childhood chronic myelogenous leukemia|childhood chronic myelogenous leukemia
726918|NCT00521430|extranodal marginal zone B-cell lymphoma of mucosa-associated lymphoid tissue|extranodal marginal zone b-cell lymphoma of mucosa-associated lymphoid tissue
726919|NCT00521430|nodal marginal zone B-cell lymphoma|nodal marginal zone b-cell lymphoma
726920|NCT00521430|splenic marginal zone lymphoma|splenic marginal zone lymphoma
726921|NCT00521430|recurrent adult acute lymphoblastic leukemia|recurrent adult acute lymphoblastic leukemia
726922|NCT00521430|recurrent adult acute myeloid leukemia|recurrent adult acute myeloid leukemia
726923|NCT00521430|recurrent childhood acute myeloid leukemia|recurrent childhood acute myeloid leukemia
726924|NCT00521430|recurrent/refractory childhood Hodgkin lymphoma|recurrent/refractory childhood hodgkin lymphoma
726925|NCT00521430|secondary myelodysplastic syndromes|secondary myelodysplastic syndromes
726926|NCT00521430|de novo myelodysplastic syndromes|de novo myelodysplastic syndromes
726927|NCT00521430|previously treated myelodysplastic syndromes|previously treated myelodysplastic syndromes
726928|NCT00521417|RCT|rct
726929|NCT00521404|Pancreatic cancer|pancreatic cancer
726930|NCT00521404|chemotherapy naive|chemotherapy naive
726931|NCT00521404|unresectable or metastatic pancreatic cancer|unresectable or metastatic pancreatic cancer
726932|NCT00521404|CS1008|cs1008
726933|NCT00521404|Gemcitabine|gemcitabine
726934|NCT00521404|Gemzar|gemzar
726935|NCT00521391|smoking cessation|smoking cessation
726936|NCT00521391|nicotine|nicotine
726937|NCT00521391|physical activity|physical activity
726938|NCT00521378|Diabetes|diabetes
726939|NCT00521378|Type 1 and Type 2 Diabetes|type 1 and type 2 diabetes
726940|NCT00521365|Bipolar Disorder|bipolar disorder
726941|NCT00521365|Bipolar Affective Psychosis|bipolar affective psychosis
726942|NCT00521365|Mania|mania
726943|NCT00521365|Manic Disorder|manic disorder
726944|NCT00521365|Manic State|manic state
726945|NCT00521352|TMS|tms
726946|NCT00521352|Dorsolateral Prefrontal Cortex|dorsolateral prefrontal cortex
726947|NCT00521339|Apremilast,|apremilast,
726948|NCT00521339|Psoriasis,|psoriasis,
726949|NCT00521339|PASI-75,|pasi-75,
726950|NCT00521339|sPGA|spga
726951|NCT00521326|doppler|doppler
726952|NCT00521326|coronary stenosis|coronary stenosis
726953|NCT00521326|non-invasive testing|non-invasive testing
726954|NCT00521326|A prospective study of a new diagnostic method.|a prospective study of a new diagnostic method.
726955|NCT00521326|Study consists of a transthoracic doppler of LAD.|study consists of a transthoracic doppler of lad.
726956|NCT00521326|Doppler to be performed prior to coronary angiography.|doppler to be performed prior to coronary angiography.
726957|NCT00521326|F/U doppler examination for those who undergo PCI.|f/u doppler examination for those who undergo pci.
726958|NCT00521326|Doppler results will be compared with coronary angiography.|doppler results will be compared with coronary angiography.
726959|NCT00521300|Acromegaly|acromegaly
726960|NCT00521287|Immunologic Surveillance|immunologic surveillance
726961|NCT00521287|Vaccination|vaccination
726962|NCT00521287|Immunotherapy|immunotherapy
726963|NCT00521287|Dendritic Cells|dendritic cells
726964|NCT00521274|Progressive Hormone Refractory Prostate Cancer|progressive hormone refractory prostate cancer
726965|NCT00521274|HRPC|hrpc
726969|NCT00521274|M3thodist|m3thodist
726970|NCT00521261|recurrent adult Burkitt lymphoma|recurrent adult burkitt lymphoma
726971|NCT00521261|recurrent adult diffuse large cell lymphoma|recurrent adult diffuse large cell lymphoma
726972|NCT00521261|recurrent adult diffuse mixed cell lymphoma|recurrent adult diffuse mixed cell lymphoma
726973|NCT00521261|recurrent adult diffuse small cleaved cell lymphoma|recurrent adult diffuse small cleaved cell lymphoma
726974|NCT00521261|recurrent adult immunoblastic large cell lymphoma|recurrent adult immunoblastic large cell lymphoma
726975|NCT00521261|recurrent adult lymphoblastic lymphoma|recurrent adult lymphoblastic lymphoma
726976|NCT00521261|recurrent adult T-cell leukemia/lymphoma|recurrent adult t-cell leukemia/lymphoma
726977|NCT00521261|recurrent cutaneous T-cell non-Hodgkin lymphoma|recurrent cutaneous t-cell non-hodgkin lymphoma
726978|NCT00521261|recurrent grade 1 follicular lymphoma|recurrent grade 1 follicular lymphoma
726979|NCT00521261|recurrent grade 2 follicular lymphoma|recurrent grade 2 follicular lymphoma
726980|NCT00521261|recurrent grade 3 follicular lymphoma|recurrent grade 3 follicular lymphoma
726981|NCT00521261|recurrent mantle cell lymphoma|recurrent mantle cell lymphoma
726982|NCT00521261|recurrent marginal zone lymphoma|recurrent marginal zone lymphoma
726983|NCT00521261|recurrent small lymphocytic lymphoma|recurrent small lymphocytic lymphoma
726984|NCT00521261|Waldenstrom macroglobulinemia|waldenstrom macroglobulinemia
726985|NCT00521261|adult nasal type extranodal NK/T-cell lymphoma|adult nasal type extranodal nk/t-cell lymphoma
726986|NCT00521261|recurrent adult grade III lymphomatoid granulomatosis|recurrent adult grade iii lymphomatoid granulomatosis
726987|NCT00521261|cutaneous B-cell non-Hodgkin lymphoma|cutaneous b-cell non-hodgkin lymphoma
726988|NCT00521248|Neonatal Abstinence Syndrome|neonatal abstinence syndrome
726989|NCT00521248|buprenorphine|buprenorphine
726990|NCT00521248|neonatal|neonatal
726991|NCT00521248|opioid withdrawal|opioid withdrawal
726992|NCT00521235|risk factors|risk factors
726993|NCT00521235|metabolic syndrome|metabolic syndrome
726994|NCT00521235|dentists|dentists
726995|NCT00521235|trainers|trainers
726996|NCT00521235|Healthy subjects|healthy subjects
726997|NCT00521235|students|students
726998|NCT00521235|seniors|seniors
726999|NCT00521222|asthma|asthma
727000|NCT00521222|beta agonist|beta agonist
727001|NCT00521222|bronchodilator|bronchodilator
727002|NCT00521222|pulmonary|pulmonary
727003|NCT00521222|genotype|genotype
727004|NCT00521222|pharmacogenomics|pharmacogenomics
727005|NCT00521222|corticosteroid|corticosteroid
727006|NCT00521222|allergy|allergy
727007|NCT00521222|immunology|immunology
727008|NCT00521209|Impoverished Population|impoverished population
727009|NCT00521196|migraine|migraine
727010|NCT00521196|headache|headache
727011|NCT00521196|chronic|chronic
727012|NCT00521196|pain|pain
727013|NCT00521196|brain|brain
727014|NCT00521196|neurology|neurology
727015|NCT00521196|stimulation|stimulation
727016|NCT00521196|noninvasive|noninvasive
727017|NCT00521196|transcranial|transcranial
727018|NCT00521196|direct|direct
727019|NCT00521196|current|current
727020|NCT00521196|tDCS|tdcs
727021|NCT00521196|tms|tms
727022|NCT00521196|rTMS|rtms
727023|NCT00521196|BIDMC|bidmc
727024|NCT00521183|adult tumors metastatic to brain|adult tumors metastatic to brain
727025|NCT00521170|Levocetirizine|levocetirizine
727026|NCT00521170|Wheal and flare|wheal and flare
727027|NCT00521170|Allergic|allergic
727028|NCT00521157|Substance abuse|substance abuse
727029|NCT00521157|Opiate dependency|opiate dependency
727030|NCT00521157|Treatment|treatment
727031|NCT00521157|Relapse prevention|relapse prevention
727032|NCT00521131|Levocetirizine dihydrochloride|levocetirizine dihydrochloride
727033|NCT00521131|Xyzal tablets|xyzal tablets
727034|NCT00521105|Type 1 Diabetes|type 1 diabetes
727035|NCT00521105|Telemedicine|telemedicine
727036|NCT00521105|Children|children
727037|NCT00521092|Treatment Experienced|treatment experienced
727038|NCT00521079|Obesity|obesity
727039|NCT00521079|Bariatric surgery|bariatric surgery
727040|NCT00521079|Excess weight loss|excess weight loss
727041|NCT00521079|Vagus nerve|vagus nerve
727042|NCT00521079|Vagal blocking|vagal blocking
727043|NCT00521079|vBloc(TM) therapy|vbloc(tm) therapy
727044|NCT00521053|immune|immune
727045|NCT00521053|vaccine|vaccine
727046|NCT00521053|systemic|systemic
727047|NCT00521053|Metastatic Melanoma (AJCC Stage III or IV)|metastatic melanoma (ajcc stage iii or iv)
727048|NCT00521040|Levocetirizine dihydrochloride|levocetirizine dihydrochloride
727049|NCT00521040|Xyzal tablets|xyzal tablets
727050|NCT00521027|Debridement|debridement
727051|NCT00521027|hydrosurgery|hydrosurgery
727052|NCT00521027|Versajet|versajet
727053|NCT00521027|leg ulcer|leg ulcer
727054|NCT00521014|recurrent grade 1 follicular lymphoma|recurrent grade 1 follicular lymphoma
727055|NCT00521014|recurrent grade 2 follicular lymphoma|recurrent grade 2 follicular lymphoma
727056|NCT00521014|recurrent grade 3 follicular lymphoma|recurrent grade 3 follicular lymphoma
727057|NCT00521001|stage IV melanoma|stage iv melanoma
727058|NCT00520988|hypertension|hypertension
727059|NCT00520988|intervention|intervention
727060|NCT00520988|disease management|disease management
727061|NCT00520988|telephone-based|telephone-based
727161|NCT00520533|monoclonal antibody G250|monoclonal antibody g250
727062|NCT00520988|Hypertension: diagnosed but uncontrolled|hypertension: diagnosed but uncontrolled
727065|NCT00520975|Metastatic Breast Cancer|metastatic breast cancer
727066|NCT00520975|HER2/NEU|her2/neu
727067|NCT00520962|cardiovascular disease|cardiovascular disease
727068|NCT00520962|glucose intolerance|glucose intolerance
727069|NCT00520962|type 2 diabetes|type 2 diabetes
727070|NCT00520962|endothelial dysfunction|endothelial dysfunction
727071|NCT00520962|inflammation|inflammation
727072|NCT00520962|Age> 30 years, male and female|age> 30 years, male and female
727073|NCT00520962|Fasting glucose below 126 mg/dl|fasting glucose below 126 mg/dl
727074|NCT00520949|H.pylori|h.pylori
727075|NCT00520949|Triple therapy failure|triple therapy failure
727076|NCT00520949|Quadruple therapy|quadruple therapy
727077|NCT00520910|Polypodium leucotomos, Ultraviolet Rays, Heliocare, calaguala, anapsos|polypodium leucotomos, ultraviolet rays, heliocare, calaguala, anapsos
727078|NCT00520910|Skin Aging and Damage|skin aging and damage
727079|NCT00520897|chronic HIV infection|chronic hiv infection
727080|NCT00520897|Human Immunodeficiency Virus|human immunodeficiency virus
727081|NCT00520897|Treatment Experienced|treatment experienced
727082|NCT00520884|frailty|frailty
727083|NCT00520884|ghrelin|ghrelin
727084|NCT00520884|appetite|appetite
727085|NCT00520884|weight loss|weight loss
727086|NCT00520871|Cardiovascular disease|cardiovascular disease
727087|NCT00520871|Blueberruy|blueberruy
727088|NCT00520871|Antioxidants|antioxidants
727089|NCT00520871|Oxidative stress|oxidative stress
727090|NCT00520871|Inflammation|inflammation
727091|NCT00520845|recurrent non-small cell lung cancer|recurrent non-small cell lung cancer
727092|NCT00520845|stage IV non-small cell lung cancer|stage iv non-small cell lung cancer
727093|NCT00520845|stage IIIB non-small cell lung cancer|stage iiib non-small cell lung cancer
727094|NCT00520845|stage IIIA non-small cell lung cancer|stage iiia non-small cell lung cancer
727095|NCT00520832|Primary Insomnia|primary insomnia
727096|NCT00520832|Microcurrent Therapy|microcurrent therapy
727097|NCT00520832|Sleep Surveys|sleep surveys
727098|NCT00520819|Antioxidants|antioxidants
727099|NCT00520819|Phytochemicals|phytochemicals
727100|NCT00520819|Oxidative stress|oxidative stress
727101|NCT00520819|Inflammation|inflammation
727102|NCT00520819|Endothelial function|endothelial function
727103|NCT00520806|Heart failure|heart failure
727104|NCT00520806|Renal dysfunction|renal dysfunction
727105|NCT00520806|Relaxin|relaxin
727106|NCT00520806|Vasodilator|vasodilator
727107|NCT00520780|Chronic Heart Failure|chronic heart failure
727108|NCT00520780|Iron deficiency|iron deficiency
727109|NCT00520780|Iron deficiency anaemia|iron deficiency anaemia
727110|NCT00520780|Anaemia|anaemia
727111|NCT00520780|Heart disease|heart disease
727112|NCT00520767|primary systemic amyloidosis|primary systemic amyloidosis
727113|NCT00520767|light chain deposition disease|light chain deposition disease
727114|NCT00520754|levocetirizine dihydrochloride Xyzal tablets|levocetirizine dihydrochloride xyzal tablets
727115|NCT00520741|Epilepsy|epilepsy
727116|NCT00520741|Partial Onset Seizures|partial onset seizures
727117|NCT00520741|Lacosamide|lacosamide
727118|NCT00520741|Monotherapy|monotherapy
727119|NCT00520741|Vimpat|vimpat
727120|NCT00520728|Schizophrenia|schizophrenia
727121|NCT00520728|Psychosis|psychosis
727122|NCT00520728|Occupational Disengagement|occupational disengagement
727123|NCT00520728|Occupational Imbalance|occupational imbalance
727124|NCT00520715|fluoroquinolone resistance|fluoroquinolone resistance
727125|NCT00520715|commensal flora|commensal flora
727126|NCT00520715|carriage|carriage
727127|NCT00520702|Non-Small Cell Lung Cancer|non-small cell lung cancer
727128|NCT00520702|Lung Cancer|lung cancer
727129|NCT00520702|3-Dimensional Conformal Radiation Therapy|3-dimensional conformal radiation therapy
727130|NCT00520702|Intensity Modulated Radiation Therapy|intensity modulated radiation therapy
727131|NCT00520702|3D CRT|3d crt
727132|NCT00520702|IMRT|imrt
727133|NCT00520702|NSCLC|nsclc
727134|NCT00520702|TRP|trp
727135|NCT00520702|Treatment related pneumonitis|treatment related pneumonitis
727136|NCT00520663|Distribution,|distribution,
727137|NCT00520663|SB-649868,|sb-649868,
727138|NCT00520663|Healthy,|healthy,
727139|NCT00520663|Excretion,|excretion,
727140|NCT00520663|Sleep disturbances|sleep disturbances
727141|NCT00520663|Volunteer,|volunteer,
727142|NCT00520663|Metabolism,|metabolism,
727143|NCT00520663|Absorption,|absorption,
727144|NCT00520624|EIL|eil
727145|NCT00520611|Obesity|obesity
727146|NCT00520611|Weight Loss|weight loss
727147|NCT00520611|Financial Incentives|financial incentives
727148|NCT00520611|Lottery|lottery
727149|NCT00520611|Deposit|deposit
727150|NCT00520585|atorvastatin|atorvastatin
727151|NCT00520585|repolarisation|repolarisation
727152|NCT00520585|cardiomyocytes|cardiomyocytes
727153|NCT00520572|Rheumatoid Arthritis|rheumatoid arthritis
727154|NCT00520546|PET|pet
727155|NCT00520546|MRI|mri
727156|NCT00520546|Choline|choline
727157|NCT00520546|FEC|fec
727158|NCT00520546|prostate cancer|prostate cancer
727159|NCT00520533|Clinical trials|clinical trials
727160|NCT00520533|cG250 mAb|cg250 mab
727162|NCT00520533|sunitinib|sunitinib
727163|NCT00520533|angiogenesis inhibitors|angiogenesis inhibitors
727164|NCT00520533|Positron-Emission Tomography|positron-emission tomography
727165|NCT00520533|Pharmacokinetics|pharmacokinetics
727166|NCT00520533|Pharmacodynamics|pharmacodynamics
727167|NCT00520520|post resuscitation|post resuscitation
727168|NCT00520520|post ventricular fibrillation|post ventricular fibrillation
727169|NCT00520520|patients receiving mild therapeutic hypothermia|patients receiving mild therapeutic hypothermia
727170|NCT00520507|Depression|depression
727171|NCT00520507|Bipolar Disorder|bipolar disorder
727172|NCT00520507|Major|major
727173|NCT00520494|Previously Untreated Patient (PUP)|previously untreated patient (pup)
727174|NCT00520494|Primary Immunodeficiency (PID)|primary immunodeficiency (pid)
727175|NCT00520494|CVID|cvid
727176|NCT00520494|XLA|xla
727177|NCT00520494|Subcutaneous immunoglobulin (SCIG)|subcutaneous immunoglobulin (scig)
727178|NCT00520494|IgG trough level|igg trough level
727179|NCT00520494|Quality of life|quality of life
727180|NCT00520494|Common variable immunodeficiency (CVID)|common variable immunodeficiency (cvid)
727181|NCT00520494|X-linked agammaglobulinemia (XLA)|x-linked agammaglobulinemia (xla)
727182|NCT00520481|prostate cancer|prostate cancer
727183|NCT00520468|Myelodysplastic Syndrome|myelodysplastic syndrome
727184|NCT00520468|MDS|mds
727185|NCT00520468|Erythropoietin|erythropoietin
727186|NCT00520468|Darbepoetin alfa|darbepoetin alfa
727187|NCT00520468|Aranesp|aranesp
727188|NCT00520468|Erythropoiesis stimulating protein|erythropoiesis stimulating protein
727189|NCT00520468|G-CSF|g-csf
727190|NCT00520468|Filgrastim|filgrastim
727191|NCT00520468|Neupogen|neupogen
727192|NCT00520468|Prednisone|prednisone
727193|NCT00520468|Cyclosporin A|cyclosporin a
727194|NCT00520468|Sandimmune|sandimmune
727195|NCT00520468|CYA|cya
727196|NCT00520468|Cyclosporine|cyclosporine
727197|NCT00520442|fracture|fracture
727198|NCT00520429|Depression|depression
727199|NCT00520429|Anxiety|anxiety
727200|NCT00520429|Pulmonary Disease, Chronic Obstructive|pulmonary disease, chronic obstructive
727201|NCT00520429|Heart Failure, Congestive|heart failure, congestive
727202|NCT00520377|Sinus Lift Surgery|sinus lift surgery
727203|NCT00520377|Sinus Floor Augmentation|sinus floor augmentation
727204|NCT00520377|Insufficient Bone Height|insufficient bone height
727205|NCT00520338|celecoxib|celecoxib
727206|NCT00520338|postoperative pain|postoperative pain
727207|NCT00520338|thyroidectomy|thyroidectomy
727208|NCT00520325|MBL deficient oncologic hematologic pediatric fever neutropenia|mbl deficient oncologic hematologic pediatric fever neutropenia
727209|NCT00520312|Peripheral Arterial Disease|peripheral arterial disease
727210|NCT00520312|PAD|pad
727211|NCT00520312|Functional Impairment|functional impairment
727212|NCT00520312|Magnetic Resonance Imaging|magnetic resonance imaging
727213|NCT00520299|metastatic melanoma|metastatic melanoma
727214|NCT00520299|ADI|adi
727215|NCT00520299|ADI-PEG 20|adi-peg 20
727216|NCT00520299|ADI SS PEG 20,000mw|adi ss peg 20,000mw
727217|NCT00520299|arginine|arginine
727218|NCT00520299|enzyme therapy|enzyme therapy
727219|NCT00520286|Methamphetamine Dependence|methamphetamine dependence
727220|NCT00520247|enalapril|enalapril
727221|NCT00520247|folic acid|folic acid
727222|NCT00520247|hyperglycemia|hyperglycemia
727223|NCT00520247|hypertension|hypertension
727224|NCT00520247|fasting plasma glucose|fasting plasma glucose
727225|NCT00520234|Candida|candida
727226|NCT00520234|Prophylaxis|prophylaxis
727227|NCT00520234|High risk adults|high risk adults
727228|NCT00520234|Intensive care unit (ICU)|intensive care unit (icu)
727229|NCT00520221|minocycline|minocycline
727230|NCT00520221|pleurodesis|pleurodesis
727231|NCT00520221|aspiration|aspiration
727232|NCT00520221|pneumothorax|pneumothorax
727233|NCT00520221|Primary spontaneous pneumothorax|primary spontaneous pneumothorax
727234|NCT00520221|First attack|first attack
727235|NCT00520221|Successful aspiration|successful aspiration
727236|NCT00520208|ATRA|atra
727237|NCT00520208|Trisenox|trisenox
727238|NCT00520208|Arsenic|arsenic
727239|NCT00520208|Arsenic Trioxide|arsenic trioxide
727240|NCT00520208|APL|apl
727241|NCT00520169|bioavailability|bioavailability
727242|NCT00520143|GSD-II, Pompe Disease, Glycogen Storage Disease II|gsd-ii, pompe disease, glycogen storage disease ii
727243|NCT00520130|Unrelated Donors|unrelated donors
727244|NCT00520130|Reduced Intensity Stem Cell Transplant|reduced intensity stem cell transplant
727245|NCT00520130|Leukemia|leukemia
727246|NCT00520130|Lymphoma|lymphoma
727247|NCT00520130|Allogeneic Stem Cell Transplant|allogeneic stem cell transplant
727248|NCT00520130|Myelodysplastic Syndrome|myelodysplastic syndrome
727249|NCT00520130|Multiple Myeloma|multiple myeloma
727250|NCT00520091|adenocarcinoma of the esophagus|adenocarcinoma of the esophagus
727251|NCT00520091|squamous cell carcinoma of the esophagus|squamous cell carcinoma of the esophagus
727252|NCT00520091|stage II esophageal cancer|stage ii esophageal cancer
727253|NCT00520091|stage III esophageal cancer|stage iii esophageal cancer
727254|NCT00520091|stage IV esophageal cancer|stage iv esophageal cancer
727255|NCT00520052|bisphosphonates, prostate cancer, bone density, osteoporosis|bisphosphonates, prostate cancer, bone density, osteoporosis
727256|NCT00520039|Otitis Media|otitis media
727257|NCT00520039|Effusion|effusion
727258|NCT00520039|OMM|omm
727259|NCT00520039|OMT|omt
727260|NCT00520039|Resolution|resolution
727265|NCT00520000|unspecified adult solid tumor, protocol specific|unspecified adult solid tumor, protocol specific
727266|NCT00519987|pharmacokinetics|pharmacokinetics
727267|NCT00519974|psychosocial effects of cancer and its treatment|psychosocial effects of cancer and its treatment
727268|NCT00519974|stage I breast cancer|stage i breast cancer
727269|NCT00519974|stage II breast cancer|stage ii breast cancer
727270|NCT00519974|stage IIIA breast cancer|stage iiia breast cancer
727271|NCT00519974|stage IIIB breast cancer|stage iiib breast cancer
727272|NCT00519974|stage IIIC breast cancer|stage iiic breast cancer
727273|NCT00519974|stage IV breast cancer|stage iv breast cancer
727274|NCT00519974|recurrent breast cancer|recurrent breast cancer
727275|NCT00519935|Insulin Dependent Diabetes Mellitus|insulin dependent diabetes mellitus
727276|NCT00519935|family therapy|family therapy
727277|NCT00519935|adolescents|adolescents
727278|NCT00519909|dairy products, calcium, fat excretion, energy excretion|dairy products, calcium, fat excretion, energy excretion
727279|NCT00519883|Anastrozole|anastrozole
727280|NCT00519883|Exercise|exercise
727281|NCT00519870|Pulmonary hypertension|pulmonary hypertension
727282|NCT00519870|Angiotensin receptor blocker|angiotensin receptor blocker
727283|NCT00519870|Calcium channel blocker|calcium channel blocker
727284|NCT00519831|stage IIIB non-small cell lung cancer|stage iiib non-small cell lung cancer
727285|NCT00519831|stage IV non-small cell lung cancer|stage iv non-small cell lung cancer
727286|NCT00519831|recurrent non-small cell lung cancer|recurrent non-small cell lung cancer
727287|NCT00519818|Congenital Adrenal Hyperplasia|congenital adrenal hyperplasia
727288|NCT00519818|Hydrocortisone|hydrocortisone
727289|NCT00519818|Pharmacokinetic|pharmacokinetic
727290|NCT00519818|Pharmacodynamic|pharmacodynamic
727291|NCT00519805|thromboembolism|thromboembolism
727292|NCT00519805|extensive stage small cell lung cancer|extensive stage small cell lung cancer
727293|NCT00519805|limited stage small cell lung cancer|limited stage small cell lung cancer
727294|NCT00519805|stage IV non-small cell lung cancer|stage iv non-small cell lung cancer
727295|NCT00519805|stage II non-small cell lung cancer|stage ii non-small cell lung cancer
727296|NCT00519805|stage IIIA non-small cell lung cancer|stage iiia non-small cell lung cancer
727297|NCT00519805|stage IIIB non-small cell lung cancer|stage iiib non-small cell lung cancer
727298|NCT00519805|stage I non-small cell lung cancer|stage i non-small cell lung cancer
727299|NCT00519792|Relapse|relapse
727300|NCT00519792|HCV|hcv
727301|NCT00519792|Hepatitis C|hepatitis c
727302|NCT00519792|Interferon|interferon
727303|NCT00519792|Ribavirin|ribavirin
727304|NCT00519779|affect|affect
727305|NCT00519779|inflammation|inflammation
727306|NCT00519766|Ratio of 3-Hydroxycotinine to Cotinine|ratio of 3-hydroxycotinine to cotinine
727307|NCT00519766|Nicotine Metabolism|nicotine metabolism
727308|NCT00519766|Pregnancy|pregnancy
727309|NCT00519753|Glaucoma|glaucoma
727310|NCT00519740|grass-pollen|grass-pollen
727311|NCT00519740|allergy|allergy
727312|NCT00519740|bronchial hyperreactivity|bronchial hyperreactivity
727313|NCT00519740|asthma|asthma
727314|NCT00519727|diabetes|diabetes
727315|NCT00519701|sickle cell anemia|sickle cell anemia
727316|NCT00519701|hydroxyurea|hydroxyurea
727317|NCT00519688|tegafur|tegafur
727318|NCT00519688|thalidomide|thalidomide
727319|NCT00519688|advanced hepatocellular carcinoma|advanced hepatocellular carcinoma
727320|NCT00519675|Chronic hand eczema|chronic hand eczema
727321|NCT00519675|Chronic hand dermatitis|chronic hand dermatitis
727322|NCT00519675|Patients with chronic hand eczema, who are refractory to topical corticosteroids|patients with chronic hand eczema, who are refractory to topical corticosteroids
727323|NCT00519662|Solid|solid
727324|NCT00519662|Tumors|tumors
727325|NCT00519662|Advanced|advanced
727326|NCT00519649|Hepatitis B vaccine|hepatitis b vaccine
727327|NCT00519649|Challenge dose|challenge dose
727328|NCT00519636|experience|experience
727329|NCT00519636|GW685698X|gw685698x
727330|NCT00519636|fluticasone furoate|fluticasone furoate
727331|NCT00519636|preference|preference
727332|NCT00519636|seasonal allergic rhinitis|seasonal allergic rhinitis
727333|NCT00519636|fluticasone propionate|fluticasone propionate
727334|NCT00519623|diabetes|diabetes
727335|NCT00519623|insulin|insulin
727336|NCT00519623|blood sugar|blood sugar
727337|NCT00519623|type 1 diabetes|type 1 diabetes
727338|NCT00519623|insulin dependent diabetes|insulin dependent diabetes
727339|NCT00519623|transdermal|transdermal
727340|NCT00519610|portal hypertension, H-graft shunt|portal hypertension, h-graft shunt
727341|NCT00519597|Coronary Artery Disease|coronary artery disease
727342|NCT00519597|Sleep Apnea|sleep apnea
727343|NCT00519597|CPAP|cpap
727344|NCT00519597|Revascularization|revascularization
727345|NCT00519597|Mortality|mortality
727346|NCT00519584|Interscalene nerve block|interscalene nerve block
727347|NCT00519584|Dexamethasone|dexamethasone
727348|NCT00519584|Ropivacaine|ropivacaine
727349|NCT00519571|Dental Implantation, Endosseous|dental implantation, endosseous
727350|NCT00519545|breast|breast
727351|NCT00519545|cancer|cancer
727352|NCT00519545|stage|stage
727353|NCT00519545|one|one
727354|NCT00519545|four|four
727355|NCT00519532|Neupro®|neupro®
727356|NCT00519532|Rotigotine|rotigotine
727357|NCT00519532|Parkinson's Disease|parkinson's disease
728336|NCT00515320|Autism|autism
727358|NCT00519519|Rebleeding after endoscopic therapy|rebleeding after endoscopic therapy
727359|NCT00519506|Pulmonary Embolism|pulmonary embolism
727360|NCT00519506|PE|pe
727361|NCT00519493|Clozex|clozex
727362|NCT00519493|Sutures|sutures
727363|NCT00519480|Tolerability|tolerability
727364|NCT00519480|GSK189075,|gsk189075,
727365|NCT00519480|Metformin,|metformin,
727366|NCT00519480|Safety,|safety,
727367|NCT00519480|Diabetes,|diabetes,
727368|NCT00519467|dose-ranging study|dose-ranging study
727369|NCT00519467|SB-714703|sb-714703
727370|NCT00519467|artesunate,|artesunate,
727371|NCT00519467|malaria|malaria
727372|NCT00519467|CDA,|cda,
727373|NCT00519467|chlorproguanil,|chlorproguanil,
727374|NCT00519467|dapsone,|dapsone,
727375|NCT00519454|Systemic Lupus Erythematosus|systemic lupus erythematosus
727376|NCT00519454|Estrogen receptors|estrogen receptors
727377|NCT00519454|T cells|t cells
727378|NCT00519454|Hormones|hormones
727379|NCT00519454|Female adult SLE|female adult sle
727380|NCT00519441|laparoscopic Heller myotomy, achalasia, reflux|laparoscopic heller myotomy, achalasia, reflux
727381|NCT00519428|depression|depression
727382|NCT00519428|Major Depressive Disorder|major depressive disorder
727383|NCT00519415|Tongue plate|tongue plate
727384|NCT00519415|Facemask|facemask
727385|NCT00519415|class III maxillary deficiency|class iii maxillary deficiency
727386|NCT00519415|orthodontic angle class three|orthodontic angle class three
727387|NCT00519402|partial tonsillectomy|partial tonsillectomy
727388|NCT00519402|complete tonsillectomy|complete tonsillectomy
727389|NCT00519402|tonsillectomy|tonsillectomy
727390|NCT00519402|obstruction sleep disordered breathing OSDB|obstruction sleep disordered breathing osdb
727391|NCT00519402|apnea|apnea
727392|NCT00519376|pharmacodynamics,|pharmacodynamics,
727393|NCT00519376|Chronic Obstructive Pulmonary Disease (COPD)|chronic obstructive pulmonary disease (copd)
727394|NCT00519376|safety,|safety,
727395|NCT00519376|COPD patients|copd patients
727396|NCT00519376|pharmacokinetics,|pharmacokinetics,
727397|NCT00519376|tolerability,|tolerability,
727398|NCT00519376|GW642444,|gw642444,
727399|NCT00519363|Lupus|lupus
727400|NCT00519363|TLR's|tlr's
727401|NCT00519363|Hyperlipidemia|hyperlipidemia
727402|NCT00519363|age eighteen to sixty|age eighteen to sixty
727403|NCT00519363|female with SLE|female with sle
727404|NCT00519363|SLEDAI, greater than four|sledai, greater than four
727405|NCT00519363|LDL cholesterol elevated|ldl cholesterol elevated
727406|NCT00519350|SIRS, sepsis and related syndromes|sirs, sepsis and related syndromes
727407|NCT00519337|Atrial Fibrillation|atrial fibrillation
727408|NCT00519337|cardiac surgery|cardiac surgery
727409|NCT00519337|ascorbic acid|ascorbic acid
727410|NCT00519337|vitamin-c|vitamin-c
727411|NCT00519337|inflammation|inflammation
727412|NCT00519324|Gastric Cancer|gastric cancer
727413|NCT00519324|RAD001|rad001
727414|NCT00519324|mTOR|mtor
727415|NCT00519311|Intellectual disability|intellectual disability
727416|NCT00519311|Health promotion|health promotion
727418|NCT00519298|Alzheimer Disease|alzheimer disease
727419|NCT00519285|metastatic|metastatic
727420|NCT00519285|prostate|prostate
727421|NCT00519285|cancer|cancer
727422|NCT00519272|Cervical Cancer|cervical cancer
727423|NCT00519272|Cervix|cervix
727424|NCT00519272|Precancerous Lesions|precancerous lesions
727425|NCT00519272|Cervical carcinoma in situ|cervical carcinoma in situ
727426|NCT00519272|CIS|cis
727427|NCT00519272|Early cervical cancer detection and treatment|early cervical cancer detection and treatment
727428|NCT00519272|Barriers to Care|barriers to care
727429|NCT00519272|Harris County|harris county
727430|NCT00519272|Questionnaire|questionnaire
727431|NCT00519246|Breast Neoplasms|breast neoplasms
727432|NCT00519246|Non-Steroidal Anti-Inflammatory Agents|non-steroidal anti-inflammatory agents
727433|NCT00519246|Analgesia|analgesia
727434|NCT00519233|HRPC|hrpc
727435|NCT00519233|Advanced hormone refractory prostate cancer|advanced hormone refractory prostate cancer
727436|NCT00519220|achalasia, Heller myotomy|achalasia, heller myotomy
727437|NCT00519207|pediatrics|pediatrics
727438|NCT00519207|pain|pain
727439|NCT00519207|infants|infants
727440|NCT00519207|newborn screening|newborn screening
727441|NCT00519207|venipuncture|venipuncture
727442|NCT00519207|lidocaine|lidocaine
727443|NCT00519207|sucrose|sucrose
727444|NCT00519194|Arrhythmia|arrhythmia
727445|NCT00519194|Atrial Fibrillation|atrial fibrillation
727446|NCT00519181|HTLV|htlv
727447|NCT00519181|HAM/TSP|ham/tsp
727448|NCT00519181|VALPROIC ACID|valproic acid
727449|NCT00519181|PROVIRAL LOAD|proviral load
727450|NCT00519129|Pain|pain
727451|NCT00519129|Patient satisfaction|patient satisfaction
727452|NCT00519103|microarray|microarray
727453|NCT00519103|Inflammtion|inflammtion
727454|NCT00519103|fibrosis|fibrosis
727455|NCT00519090|leukemia|leukemia
727456|NCT00519090|bone marrow|bone marrow
727457|NCT00519090|leukemia symptoms|leukemia symptoms
727459|NCT00519090|complete blood count|complete blood count
727460|NCT00519090|lymphocyte|lymphocyte
727461|NCT00519090|blood cancer|blood cancer
727462|NCT00519090|leukocytes|leukocytes
727463|NCT00519090|chronic leukemia|chronic leukemia
727464|NCT00519090|bone marrow biopsy|bone marrow biopsy
727465|NCT00519090|leukemia research|leukemia research
727466|NCT00519090|leukemia cells|leukemia cells
727467|NCT00519090|bone marrow disease|bone marrow disease
727468|NCT00519090|chronic myeloid leukemia|chronic myeloid leukemia
727469|NCT00519090|blood cancer symptoms|blood cancer symptoms
727470|NCT00519090|white blood cell diseases|white blood cell diseases
727471|NCT00519090|chronic myelogenous leukemia|chronic myelogenous leukemia
727472|NCT00519090|leukemia treatment|leukemia treatment
727473|NCT00519090|leukemia facts|leukemia facts
727474|NCT00519090|leucemia|leucemia
727475|NCT00519090|facts about leukemia|facts about leukemia
727476|NCT00519090|myelogenous leukemia|myelogenous leukemia
727477|NCT00519090|newly diagnosed CML|newly diagnosed cml
727478|NCT00519090|suboptimal response|suboptimal response
727479|NCT00519090|Philadelphia chromosome positive (Ph+)|philadelphia chromosome positive (ph+)
727480|NCT00519090|chronic myelogenous leukemia in chronic phase (CML-CP)|chronic myelogenous leukemia in chronic phase (cml-cp)
727481|NCT00519077|cancer|cancer
727482|NCT00519077|squamous cell|squamous cell
727483|NCT00519077|carcinoma|carcinoma
727484|NCT00519077|head|head
727485|NCT00519077|neck|neck
727486|NCT00519064|influenza|influenza
727487|NCT00519064|influenza vaccine|influenza vaccine
727488|NCT00519064|adjuvanted influenza vaccine|adjuvanted influenza vaccine
727489|NCT00519064|H5N1 influenza antigen|h5n1 influenza antigen
727490|NCT00519051|depression|depression
727491|NCT00519051|primary care|primary care
727492|NCT00519051|pharmacotherapy|pharmacotherapy
727493|NCT00519038|Critical Pathways|critical pathways
727494|NCT00519038|Congestive Heart Failure|congestive heart failure
727495|NCT00519038|Randomized Controlled Trial|randomized controlled trial
727496|NCT00519038|Effectiveness|effectiveness
727497|NCT00519025|Linezolid|linezolid
727498|NCT00519025|Staphylococcus Aureus|staphylococcus aureus
727499|NCT00519025|Infections|infections
727500|NCT00519012|early nonresponse|early nonresponse
727501|NCT00518999|cognition, attention, memory, executive functions, illness-awareness, insight.|cognition, attention, memory, executive functions, illness-awareness, insight.
727502|NCT00518986|Obstructive Sleep Apnea/Hypopnea Syndrome|obstructive sleep apnea/hypopnea syndrome
727503|NCT00518986|Excessive Sleepiness|excessive sleepiness
727504|NCT00518960|ProAlgaZyme|proalgazyme
727505|NCT00518960|Algae|algae
727506|NCT00518960|High density lipoprotein; HDL|high density lipoprotein; hdl
727507|NCT00518960|C-Reactive Protein; CRP|c-reactive protein; crp
727508|NCT00518960|Hyperlipidemia|hyperlipidemia
727509|NCT00518960|Metabolic Syndrome|metabolic syndrome
727510|NCT00518947|Bipolar Disorder|bipolar disorder
727511|NCT00518947|Mania|mania
727512|NCT00518947|Antimanic|antimanic
727513|NCT00518947|Verapamil|verapamil
727514|NCT00518947|Lithium|lithium
727515|NCT00518934|Safety and efficiency of angiogenesis for patients with limb|safety and efficiency of angiogenesis for patients with limb
727516|NCT00518934|ischemia by transplantation of human cord blood mononuclear|ischemia by transplantation of human cord blood mononuclear
727517|NCT00518934|cells|cells
727518|NCT00518921|adenosin agonist|adenosin agonist
727519|NCT00518921|chronic stable angina|chronic stable angina
727520|NCT00518908|Ischemia reperfusion injury|ischemia reperfusion injury
727521|NCT00518908|Organ protection|organ protection
727522|NCT00518895|Melanoma|melanoma
727523|NCT00518895|Advanced Melanoma|advanced melanoma
727524|NCT00518895|Malignant Melanoma|malignant melanoma
727525|NCT00518895|Metastatic Melanoma|metastatic melanoma
727526|NCT00518895|Skin Cancer|skin cancer
727527|NCT00518895|Genasense|genasense
727528|NCT00518895|oblimersen|oblimersen
727529|NCT00518895|antisense|antisense
727530|NCT00518895|Bcl-2 antisense|bcl-2 antisense
727531|NCT00518895|G3139|g3139
727532|NCT00518895|dacarbazine|dacarbazine
727533|NCT00518869|Non-Small Cell Lung Cancer (NSCLC)|non-small cell lung cancer (nsclc)
727534|NCT00518869|Complementary and Alternative Medicine (CAM)|complementary and alternative medicine (cam)
727535|NCT00518869|Chemotherapy|chemotherapy
727536|NCT00518869|Myelosuppression|myelosuppression
727537|NCT00518869|Quality of Life|quality of life
727538|NCT00518869|Fatigue|fatigue
727539|NCT00518869|EORTC QLQ-C30 and LC13|eortc qlq-c30 and lc13
727540|NCT00518856|birth asphyxia|birth asphyxia
727541|NCT00518856|neonatal sepsis|neonatal sepsis
727542|NCT00518856|maternal to child transmission of HIV|maternal to child transmission of hiv
727543|NCT00518843|binge eating|binge eating
727544|NCT00518843|purging|purging
727545|NCT00518830|postnatal depression|postnatal depression
727546|NCT00518830|primary care|primary care
727547|NCT00518830|depressed women|depressed women
727548|NCT00518817|Dystrophy|dystrophy
727549|NCT00518817|Cardiomyopathy|cardiomyopathy
727550|NCT00518791|Integrated health care system|integrated health care system
727551|NCT00518791|Treatment effectiveness|treatment effectiveness
727552|NCT00518791|Cost effectiveness|cost effectiveness
727553|NCT00518791|Program evaluation|program evaluation
727554|NCT00518778|fusariosis|fusariosis
727555|NCT00518778|solid organ transplants|solid organ transplants
727756|NCT00517842|Parkinson's disease|parkinson's disease
727556|NCT00518765|aliskiren, renal hemodynamics, hormonal response, renin pathway, RAAS biomarkers|aliskiren, renal hemodynamics, hormonal response, renin pathway, raas biomarkers
727557|NCT00518752|Ventilator Acquired Pneumonia|ventilator acquired pneumonia
727558|NCT00518752|Oral Hygiene|oral hygiene
727559|NCT00518752|Oral Care|oral care
727560|NCT00518752|Xerostomia|xerostomia
727561|NCT00518726|Adjuvanted Influenza Vaccine|adjuvanted influenza vaccine
727562|NCT00518713|Epilepsy|epilepsy
727563|NCT00518713|Lennox-Gastaut Syndrome|lennox-gastaut syndrome
727564|NCT00518713|Drop seizures|drop seizures
727565|NCT00518713|Clobazam|clobazam
727566|NCT00518674|pain|pain
727567|NCT00518674|local infiltration analgesia|local infiltration analgesia
727568|NCT00518661|quinolone resistance|quinolone resistance
727569|NCT00518661|ESBL|esbl
727570|NCT00518661|Klebsiella species|klebsiella species
727571|NCT00518661|Infection|infection
727572|NCT00518648|Accidental falls|accidental falls
727573|NCT00518648|Prevention|prevention
727574|NCT00518648|Treatment effectiveness|treatment effectiveness
727575|NCT00518635|Growth hormone|growth hormone
727576|NCT00518635|Insulin sensitivity|insulin sensitivity
727577|NCT00518635|Polycystic ovary|polycystic ovary
727578|NCT00518609|Neonatal|neonatal
727579|NCT00518609|Sepsis|sepsis
727580|NCT00518609|Global Network|global network
727581|NCT00518609|Antibiotics|antibiotics
727582|NCT00518609|India|india
727583|NCT00518609|International|international
727584|NCT00518609|Maternal and child health|maternal and child health
727585|NCT00518596|Neonatal|neonatal
727586|NCT00518596|Sepsis|sepsis
727587|NCT00518596|Global Network|global network
727588|NCT00518596|Probiotics|probiotics
727589|NCT00518596|India|india
727590|NCT00518596|International|international
727591|NCT00518596|Maternal and child health|maternal and child health
727592|NCT00518583|Breast cancer|breast cancer
727593|NCT00518583|Over-expressing Her2-neu|over-expressing her2-neu
727594|NCT00518570|PMDD|pmdd
727595|NCT00518570|PMS|pms
727596|NCT00518570|Levetiracetam|levetiracetam
727597|NCT00518557|liver cancer|liver cancer
727598|NCT00518557|interventional radiology|interventional radiology
727599|NCT00518557|Chemoembolization|chemoembolization
727600|NCT00518557|Safety|safety
727601|NCT00518557|Effectiveness|effectiveness
727602|NCT00518544|hydroxyethyl starch, blood type, coagulation|hydroxyethyl starch, blood type, coagulation
727603|NCT00518531|osteoporosis|osteoporosis
727604|NCT00518531|low bone mineral density|low bone mineral density
727605|NCT00518531|alendronate|alendronate
727606|NCT00518531|denosumab|denosumab
727607|NCT00518531|adherence|adherence
727608|NCT00518531|preference|preference
727609|NCT00518531|satisfaction|satisfaction
727610|NCT00518531|postmenopausal|postmenopausal
727611|NCT00518531|women|women
727612|NCT00518518|Asthma|asthma
727613|NCT00518518|Sublingual immunotherapy|sublingual immunotherapy
727614|NCT00518518|Children|children
727615|NCT00518505|GERD, laparoscopic surgery|gerd, laparoscopic surgery
727616|NCT00518479|Hypertension|hypertension
727617|NCT00518479|Left Ventricular Hypertrophy|left ventricular hypertrophy
727618|NCT00518466|Obesity|obesity
727619|NCT00518453|Influenza vaccine|influenza vaccine
727620|NCT00518440|Liver disease|liver disease
727621|NCT00518440|Liver injury|liver injury
727622|NCT00518414|infant, formula, LC PUFA|infant, formula, lc pufa
727623|NCT00518401|A hypoperfusion of the blood through a leg|a hypoperfusion of the blood through a leg
727624|NCT00518401|Stem cells|stem cells
727625|NCT00518401|Stem cell transplantation|stem cell transplantation
727626|NCT00518401|Stem cell autologous transplantation|stem cell autologous transplantation
727627|NCT00518388|Epidemiology|epidemiology
727628|NCT00518388|Cervical Cancer|cervical cancer
727629|NCT00518388|Human Papillomavirus|human papillomavirus
727630|NCT00518388|Focus Group|focus group
727631|NCT00518388|Questionnaire|questionnaire
727632|NCT00518388|Survey|survey
727633|NCT00518388|HPV|hpv
727634|NCT00518362|TW|tw
727635|NCT00518362|Valsartan|valsartan
727636|NCT00518362|treatment|treatment
727637|NCT00518362|diabetic nephropathy|diabetic nephropathy
727638|NCT00518362|Proteinuria|proteinuria
727639|NCT00518323|Schizophrenia|schizophrenia
727640|NCT00518323|Antipsychotic|antipsychotic
727641|NCT00518310|Interstitial lung disease|interstitial lung disease
727642|NCT00518310|Idiopathic pulmonary fibrosis|idiopathic pulmonary fibrosis
727643|NCT00518310|Usual interstitial pneumonia|usual interstitial pneumonia
727644|NCT00518310|Cryptogenic fibrosing alveolitis|cryptogenic fibrosing alveolitis
727645|NCT00518310|Therapy|therapy
727646|NCT00518310|Azathioprine|azathioprine
727647|NCT00518310|Steroids|steroids
727648|NCT00518310|Glucocorticoids|glucocorticoids
727649|NCT00518310|Corticosteroids|corticosteroids
727650|NCT00518310|Prednisone|prednisone
728122|NCT00516191|Doxil|doxil
727651|NCT00518297|Antivirals / HIV|antivirals / hiv
727652|NCT00518284|Restenosis|restenosis
727653|NCT00518284|Superficial Femoral Artery|superficial femoral artery
727654|NCT00518284|Prevention of restenosis|prevention of restenosis
728131|NCT00516165|RAD001|rad001
727655|NCT00518284|Revascularization of the superficial Femoral Artery|revascularization of the superficial femoral artery
727656|NCT00518258|Parkinson's Disease|parkinson's disease
727657|NCT00518258|Magnetic Resonance Imaging (MRI)|magnetic resonance imaging (mri)
727658|NCT00518258|neuropsychological assessment|neuropsychological assessment
727659|NCT00518245|unstable angina|unstable angina
727660|NCT00518245|drug therapy|drug therapy
727661|NCT00518245|myocardial ischemia|myocardial ischemia
727662|NCT00518245|myocardial infarction|myocardial infarction
727663|NCT00518245|hemorrhage|hemorrhage
727664|NCT00518232|Methylphenidate|methylphenidate
727665|NCT00518232|Attention Deficit Hyperactivity Disorder|attention deficit hyperactivity disorder
727666|NCT00518219|TW|tw
727667|NCT00518219|Valsartan|valsartan
727668|NCT00518219|treatment|treatment
727669|NCT00518219|membranous nephropathy|membranous nephropathy
727670|NCT00518219|proteinuria|proteinuria
727671|NCT00518206|Clinical Trial|clinical trial
727672|NCT00518206|Phase 2|phase 2
727673|NCT00518206|Cancer Vaccine|cancer vaccine
727674|NCT00518206|NY-ESO-1 protein, human|ny-eso-1 protein, human
727675|NCT00518206|ISCOMATRIX, immunological adjuvant|iscomatrix, immunological adjuvant
727676|NCT00518206|Cyclophosphamide|cyclophosphamide
727677|NCT00518206|T-Cells, Regulatory|t-cells, regulatory
727678|NCT00518180|Meningococcal|meningococcal
727679|NCT00518180|meningitis|meningitis
727680|NCT00518180|vaccine|vaccine
727681|NCT00518180|adolescents|adolescents
727682|NCT00518167|Type 2 diabetes|type 2 diabetes
727683|NCT00518167|primary prevention|primary prevention
727684|NCT00518167|diet|diet
727685|NCT00518167|physical activity|physical activity
727686|NCT00518167|intervention|intervention
727687|NCT00518167|impaired glucose tolerance|impaired glucose tolerance
727688|NCT00518167|lifestyle|lifestyle
727689|NCT00518167|randomized controlled study|randomized controlled study
727690|NCT00518154|AIDS|aids
727691|NCT00518154|Immunological non-responders|immunological non-responders
727692|NCT00518154|Neuroimmune modulation|neuroimmune modulation
727693|NCT00518154|Pyridostigmine|pyridostigmine
727694|NCT00518154|Treatment Experienced|treatment experienced
727695|NCT00518128|Obstructive Sleep Apnea|obstructive sleep apnea
727696|NCT00518128|Leptin|leptin
727697|NCT00518128|Homocysteine|homocysteine
727698|NCT00518128|C-reactive protein|c-reactive protein
727699|NCT00518115|GLP-1,|glp-1,
727700|NCT00518115|Type 2 Diabetes,|type 2 diabetes,
727701|NCT00518115|pharmacokinetics,|pharmacokinetics,
727702|NCT00518115|pharmacodynamics,|pharmacodynamics,
727703|NCT00518115|GSK716155,|gsk716155,
727704|NCT00518115|metformin,|metformin,
727705|NCT00518115|exenatide|exenatide
727706|NCT00518115|Type 2 Diabetes Mellitus|type 2 diabetes mellitus
727707|NCT00518102|REGRANEX (becaplermin)|regranex (becaplermin)
727708|NCT00518102|Platelet-derived growth factor BB|platelet-derived growth factor bb
727709|NCT00518102|Cancer|cancer
727710|NCT00518102|Cancer incidence|cancer incidence
727711|NCT00518102|Cancer mortality|cancer mortality
727712|NCT00518076|Staphylococcus aureus carriers students nursing|staphylococcus aureus carriers students nursing
727713|NCT00518050|Health Behaviors|health behaviors
727714|NCT00518050|Surveillance|surveillance
727715|NCT00518050|06-128|06-128
727716|NCT00518024|tinnitus|tinnitus
727717|NCT00518024|transcranial magnetic stimulation|transcranial magnetic stimulation
727718|NCT00518024|treatment|treatment
727719|NCT00518024|cortex|cortex
727720|NCT00517998|Lung volume reduction|lung volume reduction
727721|NCT00517998|Bronchoscopy|bronchoscopy
727722|NCT00517998|Emphysema|emphysema
727723|NCT00517998|COPD|copd
727724|NCT00517998|NETT|nett
727725|NCT00517998|Lung disease|lung disease
727726|NCT00517998|COLD|cold
727727|NCT00517998|BLVR|blvr
727728|NCT00517985|perimenopausal depression|perimenopausal depression
727729|NCT00517985|duloxetine|duloxetine
727730|NCT00517985|cymbalta|cymbalta
727731|NCT00517985|major depressive disorder|major depressive disorder
727732|NCT00517985|women|women
727733|NCT00517972|perimenopausal depression|perimenopausal depression
727734|NCT00517972|omacor|omacor
727735|NCT00517972|major depressive disorder|major depressive disorder
727736|NCT00517972|women|women
727737|NCT00517959|Stereotactic radiotherapy|stereotactic radiotherapy
727738|NCT00517959|conformal radiotherapy|conformal radiotherapy
727739|NCT00517959|late sequelae|late sequelae
727740|NCT00517959|cognition|cognition
727741|NCT00517959|endocrine dysfunction|endocrine dysfunction
727742|NCT00517946|anti-allergy.|anti-allergy.
727743|NCT00517946|seasonal allergic rhinitis (SAR),|seasonal allergic rhinitis (sar),
727744|NCT00517946|intranasal allergen challenge,|intranasal allergen challenge,
727745|NCT00517946|MRI,|mri,
727746|NCT00517933|Idiopathic Pulmonary Fibrosis|idiopathic pulmonary fibrosis
727747|NCT00517933|Pulmonary Hypertension|pulmonary hypertension
727748|NCT00517894|lymphoma|lymphoma
727749|NCT00517894|aggressive|aggressive
727750|NCT00517894|chemotherapy|chemotherapy
727751|NCT00517894|dose-dense|dose-dense
727752|NCT00517868|bladder|bladder
727753|NCT00517868|pain|pain
727754|NCT00517868|urgency|urgency
727755|NCT00517868|frequency|frequency
727757|NCT00517829|metastatic gastric or adenocarcinoma of the GE junction|metastatic gastric or adenocarcinoma of the ge junction
727758|NCT00517803|micronutrients|micronutrients
727759|NCT00517803|immunodeficiency|immunodeficiency
727760|NCT00517803|probiotics|probiotics
727761|NCT00517803|yogurt|yogurt
727762|NCT00517803|Healthy|healthy
727763|NCT00517803|Acquired Immunodeficiency Syndrome|acquired immunodeficiency syndrome
727764|NCT00517803|Complementary Therapies|complementary therapies
727765|NCT00517790|Refractory|refractory
727766|NCT00517790|Metastatic|metastatic
727767|NCT00517777|sleep apnea syndrome|sleep apnea syndrome
727768|NCT00517777|metabolic syndrome|metabolic syndrome
727769|NCT00517777|cardiac remodelling|cardiac remodelling
727770|NCT00517777|continuous positive airway pressure ventilation|continuous positive airway pressure ventilation
727771|NCT00517764|major depressive disorder|major depressive disorder
727773|NCT00517764|escitalopram|escitalopram
727774|NCT00517764|open-label|open-label
727775|NCT00517764|major depression|major depression
727776|NCT00517764|serotonin transporter|serotonin transporter
727777|NCT00517764|brain-derived neurotrophic factor|brain-derived neurotrophic factor
727778|NCT00517751|Lumbar Spinal Stenosis|lumbar spinal stenosis
727779|NCT00517751|X-STOP Spacer|x-stop spacer
727780|NCT00517751|Interspinous process decompression|interspinous process decompression
727781|NCT00517751|Neurogenic Intermittent Claudication|neurogenic intermittent claudication
727782|NCT00517725|exercise|exercise
727783|NCT00517725|lung diffusion|lung diffusion
727784|NCT00517725|hypoxia|hypoxia
727785|NCT00517725|chemoreceptor|chemoreceptor
727786|NCT00517725|beta-blockers|beta-blockers
727787|NCT00517725|heart failure|heart failure
727788|NCT00517712|Acute promyelocytic leukemia|acute promyelocytic leukemia
727789|NCT00517712|Arsenic trioxide|arsenic trioxide
727790|NCT00517712|Molecular remission|molecular remission
727791|NCT00517712|Toxicity profile|toxicity profile
727792|NCT00517712|Maintenance therapy|maintenance therapy
727793|NCT00517686|Poor risk factor control|poor risk factor control
727794|NCT00517686|Treatment intensification|treatment intensification
727795|NCT00517686|Medication adherence|medication adherence
727796|NCT00517686|Cardiovascular disease (CVD)|cardiovascular disease (cvd)
727797|NCT00517673|Healthy Volunteer|healthy volunteer
727798|NCT00517660|Healthy subjects|healthy subjects
727799|NCT00517660|Lower Respiratory Tract Infections|lower respiratory tract infections
727800|NCT00517660|Upper Respiratory Tract Infections|upper respiratory tract infections
727801|NCT00517647|ADHD|adhd
727802|NCT00517647|atomoxetine|atomoxetine
727803|NCT00517647|preschool children|preschool children
727804|NCT00517647|efficacy|efficacy
727805|NCT00517647|safety|safety
727806|NCT00517634|asthma|asthma
727807|NCT00517634|allergen challenge|allergen challenge
727808|NCT00517634|IL-5|il-5
727809|NCT00517634|eosinophils|eosinophils
727810|NCT00517621|Peritoneal cancer|peritoneal cancer
727811|NCT00517621|Relapse or progression|relapse or progression
727812|NCT00517595|Non-Small Cell Lung Cancer|non-small cell lung cancer
727813|NCT00517582|ACE Inhibitor|ace inhibitor
727814|NCT00517582|Angioedema|angioedema
727815|NCT00517582|Bradykinin|bradykinin
727816|NCT00517582|Swelling|swelling
727817|NCT00517569|Gene Therapy|gene therapy
727818|NCT00517569|GX-12|gx-12
727819|NCT00517569|HIV-1|hiv-1
727820|NCT00517569|Interleukin|interleukin
727821|NCT00517569|AIDS|aids
727822|NCT00517569|HIV-1 type B infection|hiv-1 type b infection
727823|NCT00517569|Treatment Naive|treatment naive
727824|NCT00517556|Dysmenorrhea|dysmenorrhea
727825|NCT00517556|continuous OCP|continuous ocp
727826|NCT00517543|inflammation|inflammation
727827|NCT00517517|Pandemic influenza|pandemic influenza
727828|NCT00517504|methylphenidate|methylphenidate
727829|NCT00517504|ritalin|ritalin
727830|NCT00517504|attention deficit hyperactivity disorder|attention deficit hyperactivity disorder
727831|NCT00517504|developmental disorder|developmental disorder
727832|NCT00517504|preschool children|preschool children
727833|NCT00517426|heart failure,|heart failure,
727834|NCT00517426|exercise|exercise
727835|NCT00517426|periodic breathing,|periodic breathing,
727836|NCT00517426|acetazolamide|acetazolamide
727837|NCT00517400|PTSD|ptsd
727838|NCT00517387|Depression|depression
727839|NCT00517387|SSRI|ssri
727840|NCT00517387|Atypical Antipsychotic|atypical antipsychotic
727841|NCT00517387|Cognition|cognition
727842|NCT00517387|Mood|mood
727843|NCT00517387|Quality of Life|quality of life
727844|NCT00517348|Adult|adult
727845|NCT00517335|anorexia nervosa|anorexia nervosa
727846|NCT00517335|bulimia nervosa|bulimia nervosa
727847|NCT00517322|left atrial volume|left atrial volume
727848|NCT00517322|hypertension|hypertension
727849|NCT00517322|ramipril|ramipril
727850|NCT00517322|irbesartan|irbesartan
727851|NCT00517322|diastolic function|diastolic function
727852|NCT00517283|diabetes|diabetes
727853|NCT00517283|gastric emptying|gastric emptying
727854|NCT00517283|exenatide|exenatide
727855|NCT00517283|Byetta|byetta
727856|NCT00517283|Amylin|amylin
727857|NCT00517283|Lilly|lilly
727858|NCT00517270|Non-cardiac chest pain|non-cardiac chest pain
727859|NCT00517257|Retinal vein occlusion|retinal vein occlusion
727860|NCT00517257|Retinal vein thrombosis|retinal vein thrombosis
727861|NCT00517257|Central retinal vein occlusion|central retinal vein occlusion
727862|NCT00517257|Branch retinal vein occlusion|branch retinal vein occlusion
727863|NCT00517257|Visual loss|visual loss
727864|NCT00517257|Atorvastatin|atorvastatin
727865|NCT00517257|Statin|statin
727866|NCT00517257|Neovascularization|neovascularization
727867|NCT00517257|Thrombosis|thrombosis
727868|NCT00517244|Children|children
727869|NCT00517244|Healthy Controls|healthy controls
727870|NCT00517244|Assessment|assessment
727871|NCT00517231|Pulmonary tuberculosis|pulmonary tuberculosis
727872|NCT00517231|Mycobacterium tuberculosis|mycobacterium tuberculosis
727873|NCT00517231|Cytokines|cytokines
727874|NCT00517231|Acute Phase Response|acute phase response
727875|NCT00517231|Treatment|treatment
727876|NCT00517218|Evaluate the Effect of Genasense on the Efficacy/Safety of Rituximab/Fludarabine Treatment in Untreated Subjects With Chronic Lymphocyctic Leukemia|evaluate the effect of genasense on the efficacy/safety of rituximab/fludarabine treatment in untreated subjects with chronic lymphocyctic leukemia
727877|NCT00517205|upper ureteric stone|upper ureteric stone
727878|NCT00517179|Benign Prostatic Hyperplasia (BPH)|benign prostatic hyperplasia (bph)
727879|NCT00517179|Erectile Dysfunction (ED)|erectile dysfunction (ed)
727880|NCT00517166|tourniquet|tourniquet
727881|NCT00517166|extremity injury|extremity injury
727882|NCT00517166|hemostatic device|hemostatic device
727883|NCT00517153|Zavesca|zavesca
727884|NCT00517153|miglustat|miglustat
727885|NCT00517153|Niemann-Pick Type C|niemann-pick type c
727886|NCT00517153|Actelion|actelion
727887|NCT00517140|Pregnancy women with a scarred uterus due to previous caesarean section|pregnancy women with a scarred uterus due to previous caesarean section
727888|NCT00517127|Intraoperative care|intraoperative care
727889|NCT00517127|Ringer's lactate|ringer's lactate
727890|NCT00517127|Voluven|voluven
727891|NCT00517127|Cardiovascular diagnostic technique|cardiovascular diagnostic technique
727892|NCT00517127|Doppler effect|doppler effect
727893|NCT00517114|Reflux laryngitis|reflux laryngitis
727894|NCT00517101|spondyloarthropathy|spondyloarthropathy
727895|NCT00517101|inflammatory bowel disease|inflammatory bowel disease
727896|NCT00517101|antibodies|antibodies
727897|NCT00517088|Physical Activity|physical activity
727898|NCT00517088|Breast Cancer|breast cancer
727899|NCT00517075|Transcranial Magnetic Stimulation|transcranial magnetic stimulation
727900|NCT00517075|Repetitive Transcranial Magnetic Stimulation|repetitive transcranial magnetic stimulation
727901|NCT00517075|Schizophrenia|schizophrenia
727902|NCT00517075|Schizoaffective Disorder|schizoaffective disorder
727903|NCT00517075|Treatment|treatment
727904|NCT00517075|Negative Symptoms|negative symptoms
727905|NCT00517075|Social Dysfunction|social dysfunction
727906|NCT00517075|TMS|tms
727907|NCT00517075|rTMS|rtms
727908|NCT00517062|Growth hormone|growth hormone
727909|NCT00517062|insulin sensitivity|insulin sensitivity
727910|NCT00517062|cortisol|cortisol
727911|NCT00517049|NHL|nhl
727912|NCT00517049|Rituxan|rituxan
727913|NCT00517049|Lymphoma|lymphoma
727914|NCT00517049|CD20-positive|cd20-positive
727915|NCT00517049|B-Cell|b-cell
727916|NCT00517049|APM4083g|apm4083g
727917|NCT00517036|Major Depression|major depression
727918|NCT00517036|Omega-3|omega-3
727919|NCT00517036|Major Depressive Disorder|major depressive disorder
727920|NCT00517023|Implantable Loop Recorder|implantable loop recorder
727921|NCT00517023|Home monitoring|home monitoring
727922|NCT00517023|Syncope/ Falls Clinic|syncope/ falls clinic
727923|NCT00517010|Age-related macular degeneration|age-related macular degeneration
727924|NCT00517010|Exudative age-related macular degeneration|exudative age-related macular degeneration
727925|NCT00517010|Wet macular degeneration|wet macular degeneration
727926|NCT00517010|Intravitreal injection|intravitreal injection
727927|NCT00517010|Proton beam irradiation|proton beam irradiation
727928|NCT00517010|Lucentis|lucentis
727929|NCT00517010|Ranibizumab|ranibizumab
727930|NCT00516984|Relationship between Osteopathic Manipulative Therapy (OMT) and the autonomic nervous system|relationship between osteopathic manipulative therapy (omt) and the autonomic nervous system
727931|NCT00516984|LF/HF ratio|lf/hf ratio
727932|NCT00516971|Non-erosive reflux disease|non-erosive reflux disease
727933|NCT00516958|diabetic|diabetic
727934|NCT00516958|ulcer|ulcer
727935|NCT00516958|infection|infection
727936|NCT00516958|topical|topical
727937|NCT00516958|wound|wound
727938|NCT00516945|hepatitis B during cancer chemotherapy|hepatitis b during cancer chemotherapy
727939|NCT00516932|Suicidal Event|suicidal event
727940|NCT00516932|Behavioral Activation|behavioral activation
727941|NCT00516919|Obesity|obesity
727942|NCT00516919|Binge Eating|binge eating
727943|NCT00516919|Monolingual Hispanic Persons|monolingual hispanic persons
727944|NCT00516919|Orlistat|orlistat
727945|NCT00516919|Behavioral Weight Loss Treatment|behavioral weight loss treatment
727946|NCT00516893|natalizumab|natalizumab
727947|NCT00516893|Tysabri|tysabri
727948|NCT00516893|Multiple Sclerosis|multiple sclerosis
727949|NCT00516893|Relapsing Forms of Multiple Sclerosis|relapsing forms of multiple sclerosis
727950|NCT00516880|chronic kidney disease|chronic kidney disease
727951|NCT00516880|cardiovascular disease|cardiovascular disease
727952|NCT00516854|Non-cardiac chest pain|non-cardiac chest pain
727953|NCT00516841|epithelial ovarian cancer|epithelial ovarian cancer
727954|NCT00516841|peritoneal cancer|peritoneal cancer
727955|NCT00516841|platinum-resistant ovarian cancer|platinum-resistant ovarian cancer
727956|NCT00516841|Platinum-Resistant Advanced Epithelial Ovarian Cancer or Primary Peritoneal Cancer|platinum-resistant advanced epithelial ovarian cancer or primary peritoneal cancer
727957|NCT00516828|adult acute myeloid leukemia with 11q23 (MLL) abnormalities|adult acute myeloid leukemia with 11q23 (mll) abnormalities
727958|NCT00516828|adult acute myeloid leukemia with inv(16)(p13;q22)|adult acute myeloid leukemia with inv(16)(p13;q22)
727959|NCT00516828|adult acute myeloid leukemia with t(15;17)(q22;q12)|adult acute myeloid leukemia with t(15;17)(q22;q12)
727960|NCT00516828|adult acute myeloid leukemia with t(16;16)(p13;q22)|adult acute myeloid leukemia with t(16;16)(p13;q22)
727961|NCT00516828|adult acute myeloid leukemia with t(8;21)(q22;q22)|adult acute myeloid leukemia with t(8;21)(q22;q22)
727962|NCT00516828|untreated adult acute myeloid leukemia|untreated adult acute myeloid leukemia
727963|NCT00516828|secondary acute myeloid leukemia|secondary acute myeloid leukemia
727964|NCT00516828|de novo myelodysplastic syndromes|de novo myelodysplastic syndromes
727965|NCT00516828|secondary myelodysplastic syndromes|secondary myelodysplastic syndromes
727966|NCT00516802|Poly(ADP ribose) polymerases|poly(adp ribose) polymerases
727967|NCT00516802|dacarbazine|dacarbazine
727968|NCT00516750|recurrent bladder cancer|recurrent bladder cancer
727969|NCT00516750|stage II bladder cancer|stage ii bladder cancer
727970|NCT00516750|stage III bladder cancer|stage iii bladder cancer
727971|NCT00516750|stage IV bladder cancer|stage iv bladder cancer
727972|NCT00516724|malignant solid tumours|malignant solid tumours
727973|NCT00516724|Poly(ADP ribose) polymerases|poly(adp ribose) polymerases
727974|NCT00516711|Surgery with Pringle maneuver needed for liver resection|surgery with pringle maneuver needed for liver resection
727975|NCT00516698|stage I breast cancer|stage i breast cancer
727976|NCT00516698|stage II breast cancer|stage ii breast cancer
727977|NCT00516698|stage IIIA breast cancer|stage iiia breast cancer
727978|NCT00516698|stage IIIC breast cancer|stage iiic breast cancer
727979|NCT00516685|LUNG CANCER|lung cancer
727980|NCT00516685|NSCLC|nsclc
727982|NCT00516685|CANCER VACCINE|cancer vaccine
727983|NCT00516685|IMMUNOTHERAPY|immunotherapy
727984|NCT00516672|lapatinib,|lapatinib,
727985|NCT00516672|cancer|cancer
727986|NCT00516672|pharmacokinetics,|pharmacokinetics,
727987|NCT00516672|safety,|safety,
727988|NCT00516672|pazopanib,|pazopanib,
727989|NCT00516672|Japanese patients,|japanese patients,
727990|NCT00516659|ETEC|etec
727991|NCT00516659|Traveler's diarrhea|traveler's diarrhea
727992|NCT00516659|TCI|tci
727993|NCT00516659|patch vaccine|patch vaccine
727994|NCT00516659|diarrhea prevention|diarrhea prevention
727995|NCT00516659|epidemiology ETEC|epidemiology etec
727996|NCT00516659|Escherichia coli|escherichia coli
727997|NCT00516646|Advanced Glycation End-products (AGEs)|advanced glycation end-products (ages)
727998|NCT00516646|Alegebrium|alegebrium
727999|NCT00516633|Asthma|asthma
728000|NCT00516633|Adherence|adherence
728001|NCT00516633|Burden of asthma|burden of asthma
728002|NCT00516633|Quality of life|quality of life
728003|NCT00516633|Questionnaires|questionnaires
728004|NCT00516620|Body Weight|body weight
728005|NCT00516607|recurrent adult brain tumor|recurrent adult brain tumor
728006|NCT00516607|adult mixed glioma|adult mixed glioma
728007|NCT00516607|adult anaplastic astrocytoma|adult anaplastic astrocytoma
728008|NCT00516607|adult anaplastic oligodendroglioma|adult anaplastic oligodendroglioma
728009|NCT00516607|adult glioblastoma|adult glioblastoma
728010|NCT00516607|adult anaplastic ependymoma|adult anaplastic ependymoma
728011|NCT00516607|adult giant cell glioblastoma|adult giant cell glioblastoma
728012|NCT00516607|adult gliosarcoma|adult gliosarcoma
728013|NCT00516607|adult pineal gland astrocytoma|adult pineal gland astrocytoma
728014|NCT00516581|Pneumocystis Pneumonia|pneumocystis pneumonia
728015|NCT00516581|Acquired Immune Deficiency Syndrome|acquired immune deficiency syndrome
728016|NCT00516581|Highly Active Antiretroviral Therapy|highly active antiretroviral therapy
728017|NCT00516581|Treatment Experienced|treatment experienced
728018|NCT00516581|Treatment Naive|treatment naive
728019|NCT00516555|Breech Presentation|breech presentation
728020|NCT00516555|External Cephalic version|external cephalic version
728021|NCT00516555|Thyroid Function Tests|thyroid function tests
728022|NCT00516542|stage IV breast cancer|stage iv breast cancer
728023|NCT00516542|recurrent breast cancer|recurrent breast cancer
728024|NCT00516542|male breast cancer|male breast cancer
728025|NCT00516516|muscle cramp|muscle cramp
728026|NCT00516516|pregnancy|pregnancy
728027|NCT00516516|carnitine|carnitine
728028|NCT00516516|randomized controlled clinical trials|randomized controlled clinical trials
728029|NCT00516490|GnRH agonist|gnrh agonist
728030|NCT00516490|IVF/ICSI outcome|ivf/icsi outcome
728031|NCT00516490|luteal phase|luteal phase
728032|NCT00516477|Adeno-Associated Virus (AAV)|adeno-associated virus (aav)
728033|NCT00516477|Leber Congenital Amaurosis|leber congenital amaurosis
728034|NCT00516477|Gene transfer|gene transfer
728035|NCT00516464|Proliferative Diabetic Retinopathy|proliferative diabetic retinopathy
728036|NCT00516464|Vitrectomy|vitrectomy
728037|NCT00516464|Ranibizumab|ranibizumab
728038|NCT00516438|malignant solid tumours|malignant solid tumours
728039|NCT00516438|Poly(ADP ribose)|poly(adp ribose)
728040|NCT00516438|polymerases|polymerases
728041|NCT00516425|stage IA breast cancer|stage ia breast cancer
728042|NCT00516425|stage IB breast cancer|stage ib breast cancer
728043|NCT00516425|stage II breast cancer|stage ii breast cancer
728044|NCT00516425|stage IIIA breast cancer|stage iiia breast cancer
728045|NCT00516412|contiguous stage II mantle cell lymphoma|contiguous stage ii mantle cell lymphoma
728046|NCT00516412|noncontiguous stage II mantle cell lymphoma|noncontiguous stage ii mantle cell lymphoma
728047|NCT00516412|recurrent mantle cell lymphoma|recurrent mantle cell lymphoma
728048|NCT00516412|stage I mantle cell lymphoma|stage i mantle cell lymphoma
728049|NCT00516412|stage III mantle cell lymphoma|stage iii mantle cell lymphoma
728050|NCT00516412|stage IV mantle cell lymphoma|stage iv mantle cell lymphoma
728051|NCT00516399|Fungal keratitis|fungal keratitis
728052|NCT00516399|povidone iodine|povidone iodine
728053|NCT00516399|childhood blindness|childhood blindness
728054|NCT00516399|povidone-iodine|povidone-iodine
728055|NCT00516386|Adolescents|adolescents
728056|NCT00516386|Anorexia nervosa (AN)|anorexia nervosa (an)
728057|NCT00516386|Bone formation markers|bone formation markers
728058|NCT00516386|Insulin like growth factor-1 (IGF-I)|insulin like growth factor-1 (igf-i)
728059|NCT00516373|advanced ovarian cancer|advanced ovarian cancer
728060|NCT00516373|BRCA 1 protein|brca 1 protein
728061|NCT00516373|BRCA 2 protein|brca 2 protein
728062|NCT00516373|Poly(ADP ribose)polymerases|poly(adp ribose)polymerases
728063|NCT00516360|Catheter related bloodstream infections|catheter related bloodstream infections
728064|NCT00516360|Infant, Newborn|infant, newborn
728065|NCT00516360|Intensive Care Units, Neonatal|intensive care units, neonatal
728066|NCT00516360|Neonatal Central Line Infections|neonatal central line infections
728067|NCT00516347|adenocarcinoma of the esophagus|adenocarcinoma of the esophagus
728068|NCT00516347|esophageal cancer|esophageal cancer
728069|NCT00516347|Barrett esophagus|barrett esophagus
728070|NCT00516334|brain|brain
728071|NCT00516334|electroencephalography|electroencephalography
728072|NCT00516334|premature infant|premature infant
728073|NCT00516334|neurodevelopment|neurodevelopment
728074|NCT00516321|thrombopoietin|thrombopoietin
728075|NCT00516321|hepatitis C|hepatitis c
728076|NCT00516321|ribavirin|ribavirin
728077|NCT00516321|platelets|platelets
728078|NCT00516321|Hepatitis C-related thrombocytopenia|hepatitis c-related thrombocytopenia
728079|NCT00516321|peginterferon alfa-2a|peginterferon alfa-2a
728080|NCT00516308|CLI|cli
728081|NCT00516308|Critical Limb Ischemia|critical limb ischemia
728082|NCT00516308|PAD|pad
728083|NCT00516308|Paripheral Arterial Disease|paripheral arterial disease
728084|NCT00516308|Artherosclerosis|artherosclerosis
728085|NCT00516308|Leg pain|leg pain
728086|NCT00516308|Cardiovascular|cardiovascular
728087|NCT00516308|Atherectomy|atherectomy
728088|NCT00516308|NightHawk|nighthawk
728089|NCT00516282|adult glioblastoma|adult glioblastoma
728090|NCT00516282|adult giant cell glioblastoma|adult giant cell glioblastoma
728091|NCT00516282|adult gliosarcoma|adult gliosarcoma
728092|NCT00516282|adult anaplastic astrocytoma|adult anaplastic astrocytoma
728093|NCT00516282|adult anaplastic oligodendroglioma|adult anaplastic oligodendroglioma
728094|NCT00516282|adult mixed glioma|adult mixed glioma
728095|NCT00516269|Breast Cancer|breast cancer
728096|NCT00516269|Gastrointestinal Cancer|gastrointestinal cancer
728097|NCT00516269|GI Cancer|gi cancer
728098|NCT00516269|Fatigue|fatigue
728099|NCT00516269|OROS Methylphenidate HCl|oros methylphenidate hcl
728100|NCT00516269|Methylphenidate|methylphenidate
728101|NCT00516269|Methylphenidate Hydrochloride|methylphenidate hydrochloride
728102|NCT00516269|Concerta|concerta
728103|NCT00516269|Ritalin|ritalin
728104|NCT00516269|Placebo|placebo
728105|NCT00516256|Prostate Cancer|prostate cancer
728106|NCT00516256|Quality of Life|quality of life
728107|NCT00516256|Cancer Information Mentor|cancer information mentor
728108|NCT00516256|CHESS|chess
728109|NCT00516256|the Comprehensive Health Enhancement Support System|the comprehensive health enhancement support system
728110|NCT00516256|Social support|social support
728111|NCT00516256|Skill-building tools|skill-building tools
728112|NCT00516230|Colonic Neoplasms|colonic neoplasms
728113|NCT00516230|Lynch syndrome|lynch syndrome
728114|NCT00516217|recurrent adult Hodgkin lymphoma|recurrent adult hodgkin lymphoma
728115|NCT00516217|adult lymphocyte predominant Hodgkin lymphoma|adult lymphocyte predominant hodgkin lymphoma
728116|NCT00516204|Hyperlipidemia|hyperlipidemia
728117|NCT00516204|Diabetics|diabetics
728118|NCT00516204|NIS|nis
728119|NCT00516204|Diabetics with hyperlipidemia and atherosclerosis (coronary heart disease, carotid stenosis, PAVK, etc.)|diabetics with hyperlipidemia and atherosclerosis (coronary heart disease, carotid stenosis, pavk, etc.)
728120|NCT00516191|Multiple Myeloma|multiple myeloma
728121|NCT00516191|Velcade|velcade
728123|NCT00516191|Melphalan|melphalan
728124|NCT00516178|Fish oil supplement|fish oil supplement
728125|NCT00516178|n-3 PUFA|n-3 pufa
728126|NCT00516178|Cardiac function|cardiac function
728127|NCT00516178|Membrane incorporation|membrane incorporation
728128|NCT00516178|Inflammation|inflammation
728129|NCT00516178|Clinical outcome|clinical outcome
728130|NCT00516165|liver cancer|liver cancer
728132|NCT00516152|Matched Unrelated Donor|matched unrelated donor
728133|NCT00516152|Stem Cell Transplantation|stem cell transplantation
728134|NCT00516152|Busulfan|busulfan
728135|NCT00516152|fludarabine|fludarabine
728136|NCT00516152|Hematopoietic Disorder|hematopoietic disorder
728137|NCT00516139|Epilepsy elderly seizure|epilepsy elderly seizure
728138|NCT00516126|hemostasis monitoring|hemostasis monitoring
728139|NCT00516126|perioperative blood loss|perioperative blood loss
728140|NCT00516113|paroxetine|paroxetine
728141|NCT00516113|onset of action|onset of action
728142|NCT00516113|serotonin reuptake inhibitors|serotonin reuptake inhibitors
728143|NCT00516100|NSCLC|nsclc
728144|NCT00516087|Nasopharyngeal Carcinoma|nasopharyngeal carcinoma
728145|NCT00516074|exenatide|exenatide
728146|NCT00516074|Byetta|byetta
728147|NCT00516074|type 2 diabetes|type 2 diabetes
728148|NCT00516074|heart rate|heart rate
728149|NCT00516074|Amylin|amylin
728150|NCT00516074|Lilly|lilly
728151|NCT00516048|exenatide|exenatide
728152|NCT00516048|Byetta|byetta
728153|NCT00516048|antibodies|antibodies
728154|NCT00516048|Amylin|amylin
728155|NCT00516048|Lilly|lilly
728156|NCT00516035|Bird Flu|bird flu
728157|NCT00516009|RADICULAR PAIN|radicular pain
728158|NCT00516009|DISC HERNIATION|disc herniation
728159|NCT00516009|DEXAMETHASONE|dexamethasone
728160|NCT00516009|VAS|vas
728161|NCT00515996|panic disorder|panic disorder
728162|NCT00515996|paroxetine|paroxetine
728163|NCT00515996|genetic polymorphism|genetic polymorphism
728164|NCT00515996|serotonin|serotonin
728165|NCT00515983|melanoma|melanoma
728166|NCT00515983|dendritic cells|dendritic cells
728167|NCT00515983|apoptotic/necrotic cells|apoptotic/necrotic cells
728168|NCT00515983|therapeutic vaccine|therapeutic vaccine
728169|NCT00515970|Carcinoma, Basal Cell|carcinoma, basal cell
728170|NCT00515970|Curettage|curettage
728171|NCT00515970|Excision|excision
728172|NCT00515970|Recurrence|recurrence
728173|NCT00515970|Complication|complication
728174|NCT00515970|Esthetic outcome|esthetic outcome
728175|NCT00515944|No condition|no condition
728176|NCT00515944|healthy volunteers|healthy volunteers
728177|NCT00515931|Gastrointestinal stromal tumor|gastrointestinal stromal tumor
728178|NCT00515931|GIST|gist
728179|NCT00515931|Sarcoma|sarcoma
728180|NCT00515931|Radiation therapy|radiation therapy
728181|NCT00515931|Radiotherapy|radiotherapy
728182|NCT00515918|Iron deficiency|iron deficiency
728183|NCT00515918|brain|brain
728184|NCT00515918|cognition|cognition
728185|NCT00515918|behavior|behavior
728186|NCT00515879|Generalized subtype|generalized subtype
728187|NCT00515866|Advanced pancreatic cancer|advanced pancreatic cancer
728188|NCT00515866|Poly (ADP ribose) polymerases|poly (adp ribose) polymerases
728189|NCT00515866|Advanced Solid Tumours|advanced solid tumours
728190|NCT00515853|Rectal neoplasms|rectal neoplasms
728191|NCT00515853|Biofeedback (Psychology)|biofeedback (psychology)
728192|NCT00515853|Fecal Incontinence|fecal incontinence
728193|NCT00515853|Aged|aged
728194|NCT00515853|Anterior resection|anterior resection
728195|NCT00515827|Treatment Experienced|treatment experienced
728196|NCT00515814|Legal blindness|legal blindness
728197|NCT00515814|Retinopathy pigmentosa|retinopathy pigmentosa
728198|NCT00515814|Hereditary condition|hereditary condition
728199|NCT00515814|Photo-receptor degeneration|photo-receptor degeneration
728200|NCT00515814|Retina implant|retina implant
728201|NCT00515814|Subretinal implant|subretinal implant
728202|NCT00515801|diabetes mellitus type 1|diabetes mellitus type 1
728203|NCT00515801|hypoglycemia|hypoglycemia
728204|NCT00515801|sulfonylurea|sulfonylurea
728205|NCT00515801|glucagon|glucagon
728206|NCT00515788|Neoplastic Meningitis|neoplastic meningitis
728207|NCT00515788|Leptomeningeal Disease|leptomeningeal disease
728208|NCT00515788|Temozolomide|temozolomide
728209|NCT00515788|Temodar|temodar
728210|NCT00515788|DepoCyt|depocyt
728211|NCT00515788|Liposomal Cytarabine|liposomal cytarabine
728212|NCT00515788|Liposomal ara-C|liposomal ara-c
728213|NCT00515762|persistent alopecia|persistent alopecia
728214|NCT00515762|docetaxel|docetaxel
728215|NCT00515762|breast cancer|breast cancer
728216|NCT00515736|selenium|selenium
728217|NCT00515736|oxidative stress|oxidative stress
728218|NCT00515736|glutathione peroxidase|glutathione peroxidase
728219|NCT00515736|critically ill|critically ill
728220|NCT00515736|outcome|outcome
728221|NCT00515736|supplementation|supplementation
728222|NCT00515723|control|control
728223|NCT00515723|risperidone|risperidone
728224|NCT00515723|olanzapine|olanzapine
728225|NCT00515723|quetiapine|quetiapine
728226|NCT00515723|ziprasidone|ziprasidone
728227|NCT00515710|Hemophilia B|hemophilia b
728228|NCT00515710|Gene Transfer|gene transfer
728229|NCT00515710|Adeno-Associated Virus (AAV)|adeno-associated virus (aav)
728230|NCT00515710|Coagulation Factor IX|coagulation factor ix
728231|NCT00515710|Long-term Follow-up|long-term follow-up
728232|NCT00515710|Delayed Adverse Events|delayed adverse events
728233|NCT00515671|self-management|self-management
728234|NCT00515671|recovery|recovery
728235|NCT00515671|severe mental illness|severe mental illness
728236|NCT00515658|Major depression|major depression
728237|NCT00515658|Theta-burst rTMS|theta-burst rtms
728238|NCT00515658|Cortical excitability|cortical excitability
728239|NCT00515658|Hamilton depression rating scale|hamilton depression rating scale
728240|NCT00515645|Autonomic nervous system|autonomic nervous system
728241|NCT00515645|Immersion|immersion
728242|NCT00515645|Heart rate variability|heart rate variability
728243|NCT00515645|Head-down tilt|head-down tilt
728244|NCT00515645|Healthy volunteers|healthy volunteers
728245|NCT00515632|Type 2 diabetes mellitus on Stable insulin therapy|type 2 diabetes mellitus on stable insulin therapy
728246|NCT00515632|Balaglitazone|balaglitazone
728247|NCT00515632|Pioglitazone (Actos®)|pioglitazone (actos®)
728248|NCT00515632|HbA1c|hba1c
728249|NCT00515632|Weight gain|weight gain
728250|NCT00515632|Oedema|oedema
728251|NCT00515632|Fasting blood glucose|fasting blood glucose
728252|NCT00515593|osteoporosis|osteoporosis
728253|NCT00515593|postmenopausal women|postmenopausal women
728254|NCT00515593|Severe postmenopausal osteoporosis|severe postmenopausal osteoporosis
728255|NCT00515580|obstructive sleep apnea|obstructive sleep apnea
728256|NCT00515580|upper airway resistance syndrome|upper airway resistance syndrome
728257|NCT00515580|tongue suture|tongue suture
728258|NCT00515580|retrolingual tongue collapse|retrolingual tongue collapse
728259|NCT00515580|minimally invasive|minimally invasive
728260|NCT00515567|explanted lungs|explanted lungs
728261|NCT00515567|pulmonary fibrosis|pulmonary fibrosis
728262|NCT00515554|Hodgkin lymphoma|hodgkin lymphoma
728264|NCT00515554|advances stages|advances stages
728265|NCT00515554|Rituximab|rituximab
728266|NCT00515541|Platelet|platelet
728267|NCT00515541|Cardiovascular|cardiovascular
728268|NCT00515541|Lipid|lipid
728269|NCT00515541|Fish Oil|fish oil
728270|NCT00515541|Omega 3|omega 3
728271|NCT00515541|DHA|dha
728272|NCT00515541|EPA|epa
728273|NCT00515541|Bleeding|bleeding
728274|NCT00515541|Clotting|clotting
728275|NCT00515541|platelet function|platelet function
728276|NCT00515541|Lipid profile|lipid profile
728277|NCT00515541|Weight and Bleeding risk|weight and bleeding risk
728278|NCT00515528|metastatic melanoma|metastatic melanoma
728279|NCT00515502|chronic obstructive pulmonary disease,|chronic obstructive pulmonary disease,
728280|NCT00515502|GSK573719,|gsk573719,
728281|NCT00515502|muscarinic receptor antagonist|muscarinic receptor antagonist
728282|NCT00515489|Schizophrenia|schizophrenia
728283|NCT00515489|Schizoaffective Disorder|schizoaffective disorder
728284|NCT00515489|Schizophreniform Disorders|schizophreniform disorders
728285|NCT00515476|metabolic syndrome|metabolic syndrome
728286|NCT00515476|HDL-Cholesterol|hdl-cholesterol
728287|NCT00515476|EPC|epc
728288|NCT00515476|endothelial function|endothelial function
728289|NCT00515476|reduced blood HDL-Cholesterol level|reduced blood hdl-cholesterol level
728290|NCT00515463|Osteopenia|osteopenia
728291|NCT00515463|Osteoporosis|osteoporosis
728292|NCT00515463|AMG 162|amg 162
728293|NCT00515463|Postmenopausal|postmenopausal
728294|NCT00515463|Pre-filled syringe|pre-filled syringe
728295|NCT00515450|Myasthenia Gravis|myasthenia gravis
728296|NCT00515437|Sialorrhea|sialorrhea
728297|NCT00515424|Glaucoma|glaucoma
728298|NCT00515424|Ocular Hypertension|ocular hypertension
728299|NCT00515424|RKI983|rki983
728300|NCT00515424|Primary Open Angle Glaucoma and Ocular Hypertension|primary open angle glaucoma and ocular hypertension
728301|NCT00515411|gastroesophageal junction|gastroesophageal junction
728302|NCT00515411|gastric cancer|gastric cancer
728303|NCT00515411|adenocarcinoma|adenocarcinoma
728304|NCT00515411|unresectable gastric cancer|unresectable gastric cancer
728305|NCT00515411|metastatic gastric|metastatic gastric
728306|NCT00515385|Randomized|randomized
728307|NCT00515385|Double-Blind|double-blind
728308|NCT00515385|Dose-Escalation|dose-escalation
728309|NCT00515385|Cohort Study|cohort study
728310|NCT00515372|Ovarian Cancer|ovarian cancer
728311|NCT00515372|Peritoneal Cancer|peritoneal cancer
728312|NCT00515372|Fallopian Tube Cancer|fallopian tube cancer
728313|NCT00515372|Depression|depression
728314|NCT00515372|Telephone Counseling|telephone counseling
728315|NCT00515372|Quality of Life|quality of life
728316|NCT00515359|Sedation|sedation
728317|NCT00515359|MRI|mri
728318|NCT00515359|pediatric|pediatric
728319|NCT00515359|propofol|propofol
728320|NCT00515359|brain|brain
728321|NCT00515359|spine|spine
728322|NCT00515359|quality of MRI|quality of mri
728323|NCT00515359|Continuous propofol dosing|continuous propofol dosing
728324|NCT00515359|continuous propofol administration|continuous propofol administration
728325|NCT00515359|Intermittent propofol dosing|intermittent propofol dosing
728326|NCT00515359|intermittent propofol administration|intermittent propofol administration
728327|NCT00515359|Sedative agent|sedative agent
728328|NCT00515359|propofol continuous infusions|propofol continuous infusions
728329|NCT00515359|Recovery time|recovery time
728330|NCT00515359|Complications of sedation|complications of sedation
728331|NCT00515359|bolus dosing|bolus dosing
728332|NCT00515346|CLI|cli
728333|NCT00515346|Critical Limb Ischemia|critical limb ischemia
728334|NCT00515333|Alzheimer|alzheimer
728335|NCT00515333|Dementia|dementia
728340|NCT00515320|Autistic Disorder|autistic disorder
728341|NCT00515320|Repetitive behavior|repetitive behavior
728342|NCT00515320|SSRI|ssri
728343|NCT00515320|Selective Serotonin Reuptake Inhibitor|selective serotonin reuptake inhibitor
728344|NCT00515307|Hypercholesterolemia, Familial|hypercholesterolemia, familial
728345|NCT00515307|Bone marrow|bone marrow
728346|NCT00515307|Mesenchymal stem cell|mesenchymal stem cell
728347|NCT00515307|Hepatocyte|hepatocyte
728348|NCT00515294|Caffeine|caffeine
728349|NCT00515294|Alcohol|alcohol
728350|NCT00515294|Alcohol Consumption|alcohol consumption
728351|NCT00515294|Residual Effects|residual effects
728352|NCT00515294|Family History|family history
728353|NCT00515294|Psychomotor Vigilance Test|psychomotor vigilance test
728354|NCT00515294|Driving Simulation|driving simulation
728355|NCT00515294|Reaction Time|reaction time
728356|NCT00515281|prematurity|prematurity
728357|NCT00515281|nitric oxide|nitric oxide
728358|NCT00515281|bronchopulmonary dysplasia|bronchopulmonary dysplasia
728359|NCT00515281|intraventricular hemorrhage|intraventricular hemorrhage
728360|NCT00515281|periventricular leukomalacia|periventricular leukomalacia
728361|NCT00515281|neurodevelopment|neurodevelopment
728362|NCT00515268|LPS challenge,|lps challenge,
728363|NCT00515268|Healthy volunteers|healthy volunteers
728364|NCT00515255|Obsessive Compulsive Disorder|obsessive compulsive disorder
728365|NCT00515255|Neuropharm|neuropharm
728366|NCT00515255|NPL-2003|npl-2003
728367|NCT00515242|massage therapy|massage therapy
728368|NCT00515242|relaxation treatments|relaxation treatments
728369|NCT00515229|cystic fibrosis|cystic fibrosis
728370|NCT00515229|ceramide|ceramide
728371|NCT00515229|amitriptyline|amitriptyline
728372|NCT00515229|Pseudomonas aeruginosa|pseudomonas aeruginosa
728373|NCT00515229|lung function|lung function
728374|NCT00515216|Phase II|phase ii
728375|NCT00515216|Gastric cancer|gastric cancer
728376|NCT00515216|Gastroesophageal cancer|gastroesophageal cancer
728377|NCT00515216|Metastatic|metastatic
728378|NCT00515216|FOLFOX|folfox
728379|NCT00515216|Thymidylate synthase|thymidylate synthase
728380|NCT00515216|Pharmacogenomic|pharmacogenomic
728381|NCT00515203|Immune (Idiopathic) Thrombocytopenic Purpura|immune (idiopathic) thrombocytopenic purpura
728382|NCT00515203|Pediatric Idiopathic Thrombocytopenic Purpura|pediatric idiopathic thrombocytopenic purpura
728383|NCT00515190|Stomach Neoplasms|stomach neoplasms
728384|NCT00515190|Secondary|secondary
728385|NCT00515190|Combination chemotherapy|combination chemotherapy
728386|NCT00515190|S-1|s-1
728387|NCT00515190|oxaliplatin|oxaliplatin
728388|NCT00515177|mindfulness|mindfulness
728389|NCT00515177|meditation|meditation
728390|NCT00515177|MBSR|mbsr
728391|NCT00515177|mindfulness meditation|mindfulness meditation
728392|NCT00515177|sleep|sleep
728393|NCT00515177|insomnia|insomnia
728394|NCT00515177|chronic insomnia|chronic insomnia
728395|NCT00515177|primary insomnia|primary insomnia
728396|NCT00515177|Minnesota|minnesota
728397|NCT00515164|lung volume reduction|lung volume reduction
728398|NCT00515164|emphysema|emphysema
728399|NCT00515164|chronic obstructive pulmonary disease|chronic obstructive pulmonary disease
728400|NCT00515151|Bloodstream Infection|bloodstream infection
728401|NCT00515151|Bacteremia|bacteremia
728402|NCT00515151|Central Venous Catheter|central venous catheter
728403|NCT00515151|Alcohol|alcohol
728404|NCT00515151|Disinfection|disinfection
728405|NCT00515151|Octenidine Dihydrochloride|octenidine dihydrochloride
728406|NCT00515138|B-Cell NHL|b-cell nhl
728407|NCT00515138|Autologous Stem Cell Transplant|autologous stem cell transplant
728408|NCT00515138|RICE|rice
728409|NCT00515125|Quality of life|quality of life
728410|NCT00515125|Supplement|supplement
728411|NCT00515125|Care home|care home
728412|NCT00515125|Elderly|elderly
728413|NCT00515125|Malnutrition|malnutrition
728414|NCT00515112|prostate|prostate
728415|NCT00515112|cancer|cancer
728416|NCT00515112|testosterone replacement|testosterone replacement
728417|NCT00515112|AndroGel|androgel
728418|NCT00515112|prostatic cancer|prostatic cancer
728419|NCT00515112|prostatic neoplasms|prostatic neoplasms
728420|NCT00515099|New-onset Type 1 Diabetes Mellitus|new-onset type 1 diabetes mellitus
728421|NCT00515099|New-onset T1DM|new-onset t1dm
728422|NCT00515099|New-onset Type 1 Diabetes|new-onset type 1 diabetes
728423|NCT00515099|New-onset T1D|new-onset t1d
728424|NCT00515099|Newly Diagnosed Type 1 Diabetes Mellitus|newly diagnosed type 1 diabetes mellitus
728425|NCT00515099|Autoimmune diabetes|autoimmune diabetes
728426|NCT00515099|Thymoglobulin|thymoglobulin
728427|NCT00515099|ATG|atg
728428|NCT00515099|Rabbit antithymocyte globulin|rabbit antithymocyte globulin
728429|NCT00515086|Glioblastoma Multiforme, GBM, RAD001, RAD|glioblastoma multiforme, gbm, rad001, rad
728430|NCT00515073|Endometrial Cancer|endometrial cancer
728431|NCT00515073|Papillary Serous Carcinoma|papillary serous carcinoma
728432|NCT00515073|Pelvic Radiation Therapy|pelvic radiation therapy
728433|NCT00515073|Paclitaxel|paclitaxel
728434|NCT00515073|Taxol|taxol
728435|NCT00515060|Advanced Cancer|advanced cancer
728436|NCT00515060|Therapy-Induced Pain|therapy-induced pain
728437|NCT00515060|Pain Threshold|pain threshold
728438|NCT00515060|Sensory Tests|sensory tests
728441|NCT00515047|Atopic Dermatitis|atopic dermatitis
728442|NCT00515047|Eczema|eczema
728443|NCT00515047|Eczema Herpeticum|eczema herpeticum
728444|NCT00515047|Molluscum Contagiousum|molluscum contagiousum
728445|NCT00515047|Herpes Simplex|herpes simplex
728446|NCT00515047|Vaccinia|vaccinia
728447|NCT00515034|Doripenem|doripenem
728448|NCT00515034|Imipenem|imipenem
728449|NCT00515034|Cilastatin|cilastatin
728450|NCT00515034|Vancomycin|vancomycin
728451|NCT00515034|DORIBAX, DORIPREX, FINIBAX, DURAPTA, PRIMAXIN, Anti Bacterial Agents|doribax, doriprex, finibax, durapta, primaxin, anti bacterial agents
728452|NCT00515034|Ileus|ileus
728453|NCT00515034|Hospitalized|hospitalized
728454|NCT00515034|Fever|fever
728455|NCT00515021|Metabolic syndrome|metabolic syndrome
728456|NCT00515021|Aldosterone inhibitor|aldosterone inhibitor
728457|NCT00515021|Diurnal drug regimen|diurnal drug regimen
728458|NCT00515021|PAI-1 levels|pai-1 levels
728459|NCT00514982|Hermansky-Pudlak Syndrome|hermansky-pudlak syndrome
728460|NCT00514982|Colitis|colitis
728461|NCT00514982|Medical Therapy|medical therapy
728462|NCT00514982|Immunopathogenesis|immunopathogenesis
728463|NCT00514982|Cytokine|cytokine
728464|NCT00514982|Hermansky-Pudlak Syndrome Associated Colitis|hermansky-pudlak syndrome associated colitis
728465|NCT00514982|HPS|hps
728466|NCT00514969|accelerated and blastic phase|accelerated and blastic phase
728467|NCT00514969|STI571|sti571
728468|NCT00514956|Post-Traumatic Stress Syndrome (PTSD)|post-traumatic stress syndrome (ptsd)
728469|NCT00514930|radiofrequency ablation|radiofrequency ablation
728470|NCT00514930|liver cancer|liver cancer
728471|NCT00514930|complications|complications
728472|NCT00514930|liver tumors|liver tumors
728473|NCT00514904|safety|safety
728474|NCT00514904|meningococcal vaccine|meningococcal vaccine
728475|NCT00514904|immunogenicity|immunogenicity
728476|NCT00514878|nausea|nausea
728477|NCT00514878|postoperative nausea and vomiting|postoperative nausea and vomiting
728478|NCT00514878|postoperative pain|postoperative pain
728479|NCT00514865|ONO-2333Ms|ono-2333ms
728480|NCT00514865|Major Depressive Disorder|major depressive disorder
728481|NCT00514839|Prescription drug use disorder|prescription drug use disorder
728482|NCT00514839|Brief intervention|brief intervention
728483|NCT00514839|General hospital|general hospital
728484|NCT00514839|Motivational Interviewing|motivational interviewing
728485|NCT00514800|Home monitoring|home monitoring
728486|NCT00514800|Primary care|primary care
728487|NCT00514800|Hypertension|hypertension
728488|NCT00514800|TIA|tia
728489|NCT00514787|Asthma|asthma
728490|NCT00514787|NIS|nis
728491|NCT00514774|Huntington chorea|huntington chorea
728492|NCT00514774|chorea|chorea
728493|NCT00514774|hereditary|hereditary
728494|NCT00514774|tauroursodeoxycholic acid|tauroursodeoxycholic acid
728495|NCT00514774|ursodeoxycholic acid|ursodeoxycholic acid
728496|NCT00514774|TUDCA|tudca
728497|NCT00514774|UDCA|udca
728498|NCT00514761|colorectal cancer|colorectal cancer
728499|NCT00514761|AZD6244|azd6244
728500|NCT00514748|breast reconstruction|breast reconstruction
728501|NCT00514748|DIEP|diep
728502|NCT00514748|vessel pedicle|vessel pedicle
728503|NCT00514735|atrial fibrillation|atrial fibrillation
728504|NCT00514722|Hematopoietic malignancies|hematopoietic malignancies
728505|NCT00514722|Umbilical cord blood transplantation|umbilical cord blood transplantation
728506|NCT00514722|Lymphoma: diffuse large cell, mantle cell, peripheral T-cell, T-NK cell, or Hodgkin's|lymphoma: diffuse large cell, mantle cell, peripheral t-cell, t-nk cell, or hodgkin's
728507|NCT00514709|Diphtheria|diphtheria
728508|NCT00514709|Tetanus|tetanus
728509|NCT00514709|Pertussis|pertussis
728510|NCT00514709|Hepatitis B Hansenula (HB)|hepatitis b hansenula (hb)
728511|NCT00514709|Haemophilus influenzae type b|haemophilus influenzae type b
728512|NCT00514696|Cancer|cancer
728513|NCT00514696|Leukemia|leukemia
728514|NCT00514696|GCS-100|gcs-100
728515|NCT00514696|CLL|cll
728516|NCT00514670|Prevention of gastrointestinal and respiratory illness|prevention of gastrointestinal and respiratory illness
728517|NCT00514644|Panorama|panorama
728518|NCT00514644|Carotid stenoses|carotid stenoses
728519|NCT00514618|Term Pregnancy|term pregnancy
728520|NCT00514618|Diabetes|diabetes
728521|NCT00514618|Cervical Ripening|cervical ripening
728522|NCT00514618|Induction|induction
728523|NCT00514618|misoprostol|misoprostol
728524|NCT00514618|Term Gestational Diabetics|term gestational diabetics
728525|NCT00514605|HIV 1|hiv 1
728526|NCT00514605|AIDS|aids
728527|NCT00514605|Assay|assay
728528|NCT00514605|Rapid Test|rapid test
728529|NCT00514605|HIV-1|hiv-1
728530|NCT00514605|HIV Seronegativity|hiv seronegativity
728531|NCT00514592|Carotid stenosis|carotid stenosis
728532|NCT00514592|Carotid endarterectomy|carotid endarterectomy
728533|NCT00514579|Cord Blood Stem Cell Transplantation|cord blood stem cell transplantation
728534|NCT00514579|Hematologic Malignancies|hematologic malignancies
728535|NCT00514579|Leukemia|leukemia
728536|NCT00514579|Myelodysplastic Syndrome|myelodysplastic syndrome
728537|NCT00514566|Polyamide|polyamide
728538|NCT00514566|Polydioxanone|polydioxanone
728539|NCT00514566|Midline|midline
728540|NCT00514566|Abdominal|abdominal
728542|NCT00514553|Prenatal Testing|prenatal testing
728543|NCT00514553|Test Decision-Making|test decision-making
728544|NCT00514553|Decision-Making Intervention|decision-making intervention
728545|NCT00514553|Theory of Unconscious Thought|theory of unconscious thought
728546|NCT00514553|Informed Choice|informed choice
728547|NCT00514553|Decision Making|decision making
728548|NCT00514553|Counseling|counseling
728549|NCT00514540|Prostate Cancer|prostate cancer
728550|NCT00514540|Anaplastic Prostate Cancer|anaplastic prostate cancer
728551|NCT00514540|Carboplatin|carboplatin
728552|NCT00514540|Docetaxel|docetaxel
728553|NCT00514540|Taxotere|taxotere
728554|NCT00514540|Paraplatin|paraplatin
728555|NCT00514514|Everolimus|everolimus
728556|NCT00514514|mycophenolate|mycophenolate
728557|NCT00514514|CNI-free|cni-free
728558|NCT00514514|kidney transplantation|kidney transplantation
728559|NCT00514488|chronic myeloid leukemia|chronic myeloid leukemia
728560|NCT00514488|STI 571|sti 571
728561|NCT00514488|CML022|cml022
728562|NCT00514475|Mantle cell lymphoma|mantle cell lymphoma
728563|NCT00514475|Zevalin|zevalin
728564|NCT00514475|90Y-ibritumomab tiuxetan|90y-ibritumomab tiuxetan
728565|NCT00514475|Radioimmunotherapy|radioimmunotherapy
728566|NCT00514475|High-dose therapy|high-dose therapy
728567|NCT00514475|First line|first line
728568|NCT00514436|Asthma|asthma
728569|NCT00514436|children|children
728570|NCT00514436|low-income, underserved|low-income, underserved
728571|NCT00514436|Reduction in hospitalization|reduction in hospitalization
728572|NCT00514410|Depression|depression
728573|NCT00514410|Folate|folate
728574|NCT00514410|Folic acid|folic acid
728575|NCT00514410|Antidepressants|antidepressants
728576|NCT00514397|untreated childhood brain stem glioma|untreated childhood brain stem glioma
728577|NCT00514371|Multiple Myeloma|multiple myeloma
728578|NCT00514371|Heat Shock Protein 90|heat shock protein 90
728579|NCT00514371|Hsp90|hsp90
728580|NCT00514371|KOS-953|kos-953
728581|NCT00514371|17-AAG|17-aag
728582|NCT00514371|bortezomib|bortezomib
728583|NCT00514371|relapsed-refractory|relapsed-refractory
728584|NCT00514371|tanespimycin|tanespimycin
728585|NCT00514358|Fungal|fungal
728586|NCT00514358|Infection|infection
728587|NCT00514358|sepsis|sepsis
728588|NCT00514358|pharmacokinetics|pharmacokinetics
728589|NCT00514345|chemotherapeutic agent toxicity|chemotherapeutic agent toxicity
728590|NCT00514345|localized Ewing sarcoma/peripheral primitive neuroectodermal tumor|localized ewing sarcoma/peripheral primitive neuroectodermal tumor
728591|NCT00514345|metastatic Ewing sarcoma/peripheral primitive neuroectodermal tumor|metastatic ewing sarcoma/peripheral primitive neuroectodermal tumor
728592|NCT00514345|nonmetastatic childhood soft tissue sarcoma|nonmetastatic childhood soft tissue sarcoma
728593|NCT00514345|unspecified childhood solid tumor, protocol specific|unspecified childhood solid tumor, protocol specific
728594|NCT00514345|recurrent Ewing sarcoma/peripheral primitive neuroectodermal tumor|recurrent ewing sarcoma/peripheral primitive neuroectodermal tumor
728595|NCT00514345|metastatic childhood soft tissue sarcoma|metastatic childhood soft tissue sarcoma
728596|NCT00514345|recurrent childhood soft tissue sarcoma|recurrent childhood soft tissue sarcoma
728597|NCT00514345|previously treated childhood rhabdomyosarcoma|previously treated childhood rhabdomyosarcoma
728598|NCT00514345|recurrent childhood rhabdomyosarcoma|recurrent childhood rhabdomyosarcoma
728599|NCT00514332|colorectal stents|colorectal stents
728600|NCT00514332|colonic obstruction|colonic obstruction
728601|NCT00514332|colonic adenocarcinoma|colonic adenocarcinoma
728602|NCT00514332|colorectal surgery|colorectal surgery
728603|NCT00514306|Ovarian Cancer|ovarian cancer
728604|NCT00514306|Advanced Cancer|advanced cancer
728605|NCT00514306|Colorectal cancer|colorectal cancer
728606|NCT00514306|Non-small cell lung cancer|non-small cell lung cancer
728607|NCT00514306|Metastatic Cancer|metastatic cancer
728608|NCT00514306|Renal cancer|renal cancer
728609|NCT00514306|Breast cancer|breast cancer
728610|NCT00514293|recurrent non-small cell lung cancer|recurrent non-small cell lung cancer
728611|NCT00514293|stage IIIB non-small cell lung cancer|stage iiib non-small cell lung cancer
728612|NCT00514293|stage IV non-small cell lung cancer|stage iv non-small cell lung cancer
728613|NCT00514280|Lead and Smoke Study in D.C.|lead and smoke study in d.c.
728614|NCT00514280|Birth Weight|birth weight
728615|NCT00514280|Gestational Age|gestational age
728616|NCT00514280|Lead|lead
728617|NCT00514280|Tobacco Smoke|tobacco smoke
728618|NCT00514267|Prostate Cancer|prostate cancer
728619|NCT00514267|HRPC|hrpc
728973|NCT00513240|cardiac|cardiac
728620|NCT00514267|Hormone Refractory Prostate Cancer|hormone refractory prostate cancer
728621|NCT00514267|YM155|ym155
728622|NCT00514267|Treatment Outcome|treatment outcome
728623|NCT00514267|Solid Tumors|solid tumors
728624|NCT00514254|endometrial cancer|endometrial cancer
728625|NCT00514254|risk factors|risk factors
728626|NCT00514254|questionnaire|questionnaire
728627|NCT00514254|07-093|07-093
728628|NCT00514228|adult primary hepatocellular carcinoma|adult primary hepatocellular carcinoma
728629|NCT00514228|localized unresectable adult primary liver cancer|localized unresectable adult primary liver cancer
728630|NCT00514228|advanced adult primary liver cancer|advanced adult primary liver cancer
728631|NCT00514228|recurrent adult primary liver cancer|recurrent adult primary liver cancer
728632|NCT00514215|lung metastases|lung metastases
728633|NCT00514215|stage I non-small cell lung cancer|stage i non-small cell lung cancer
728634|NCT00514215|stage II non-small cell lung cancer|stage ii non-small cell lung cancer
728635|NCT00514215|stage IIIA non-small cell lung cancer|stage iiia non-small cell lung cancer
728636|NCT00514215|stage IIIB non-small cell lung cancer|stage iiib non-small cell lung cancer
728637|NCT00514215|stage IV non-small cell lung cancer|stage iv non-small cell lung cancer
728638|NCT00514215|recurrent non-small cell lung cancer|recurrent non-small cell lung cancer
728639|NCT00514215|recurrent renal cell cancer|recurrent renal cell cancer
728640|NCT00514215|stage IV renal cell cancer|stage iv renal cell cancer
728641|NCT00514215|unspecified adult solid tumor, protocol specific|unspecified adult solid tumor, protocol specific
728642|NCT00514202|cocaine|cocaine
728643|NCT00514202|ADHD|adhd
728644|NCT00514202|attention|attention
728645|NCT00514202|hyperactivity|hyperactivity
728646|NCT00514202|drug|drug
728647|NCT00514202|dependence|dependence
728648|NCT00514189|Acute Myelogenous Leukemia|acute myelogenous leukemia
728649|NCT00514189|Leukemia|leukemia
728650|NCT00514189|Autologous Dendritic Cells|autologous dendritic cells
728651|NCT00514189|Vaccine|vaccine
728652|NCT00514189|AML|aml
728653|NCT00514189|mRNA|mrna
728654|NCT00514163|pancreatic carcinoma|pancreatic carcinoma
728655|NCT00514163|gemcitabine|gemcitabine
728656|NCT00514163|S-1|s-1
728657|NCT00514163|phaseⅡstudy|phaseⅱstudy
728658|NCT00514150|angiography|angiography
728659|NCT00514150|complications|complications
728660|NCT00514150|contrast media|contrast media
728661|NCT00514150|kidney|kidney
728662|NCT00514150|prevention|prevention
728663|NCT00514098|Microbicide|microbicide
728664|NCT00514098|Seroconversion|seroconversion
728665|NCT00514098|Treatment Experienced|treatment experienced
728666|NCT00514098|Treatment Naive|treatment naive
728667|NCT00514085|recurrent melanoma|recurrent melanoma
728668|NCT00514085|stage IV melanoma|stage iv melanoma
728669|NCT00514072|stage IV prostate cancer|stage iv prostate cancer
728670|NCT00514072|recurrent prostate cancer|recurrent prostate cancer
728671|NCT00514059|Diphteria-tetanus-pertussis-polio vaccine|diphteria-tetanus-pertussis-polio vaccine
728672|NCT00514059|Booster immunization|booster immunization
728673|NCT00514059|Vaccine effect (Diphtheria-tetanus-acellular pertussis-polio)|vaccine effect (diphtheria-tetanus-acellular pertussis-polio)
728674|NCT00514059|Immunity|immunity
728675|NCT00514059|Safety|safety
728676|NCT00514046|Multiple Endocrine Neoplasia (MEN)|multiple endocrine neoplasia (men)
728677|NCT00514046|Medullary Thyroid Carcinoma|medullary thyroid carcinoma
728678|NCT00514046|Molecularly-Targeted Therapy|molecularly-targeted therapy
728679|NCT00514046|Pediatric|pediatric
728680|NCT00514046|Pharmacokinetics|pharmacokinetics
728681|NCT00514046|MTC|mtc
728682|NCT00514046|Multiple Endocrine Neoplasia|multiple endocrine neoplasia
728683|NCT00514046|MEN|men
728684|NCT00514020|adenocarcinoma of the stomach|adenocarcinoma of the stomach
728685|NCT00514020|stage IV gastric cancer|stage iv gastric cancer
728686|NCT00514020|recurrent gastric cancer|recurrent gastric cancer
728687|NCT00514007|Advanced Cancer|advanced cancer
728688|NCT00514007|Colorectal cancer|colorectal cancer
728689|NCT00514007|Ovarian cancer|ovarian cancer
728690|NCT00514007|Renal cancer|renal cancer
728691|NCT00514007|Metastatic cancer|metastatic cancer
728692|NCT00514007|Breast cancer|breast cancer
728693|NCT00514007|Non-small cell lung cancer|non-small cell lung cancer
728694|NCT00513994|Pharmacokinetics|pharmacokinetics
728695|NCT00513994|Nitroglycerin|nitroglycerin
728696|NCT00513994|pharmacokinetics study of nitroglycerin containing treatments|pharmacokinetics study of nitroglycerin containing treatments
728697|NCT00513981|unspecified childhood solid tumor, protocol specific|unspecified childhood solid tumor, protocol specific
728698|NCT00513981|recurrent osteosarcoma|recurrent osteosarcoma
728699|NCT00513981|recurrent childhood soft tissue sarcoma|recurrent childhood soft tissue sarcoma
728700|NCT00513981|recurrent childhood ependymoma|recurrent childhood ependymoma
728701|NCT00513981|untreated childhood brain stem glioma|untreated childhood brain stem glioma
728702|NCT00513981|recurrent childhood brain stem glioma|recurrent childhood brain stem glioma
728703|NCT00513955|recurrent mantle cell lymphoma|recurrent mantle cell lymphoma
728704|NCT00513942|Fetal Movement|fetal movement
728705|NCT00513942|Maternal-Fetal-Attachment|maternal-fetal-attachment
728706|NCT00513942|Fetus|fetus
728707|NCT00513929|Severe Pneumonia|severe pneumonia
728708|NCT00513929|Zinc|zinc
728709|NCT00513929|Associated pathogens|associated pathogens
728710|NCT00513929|Severe Pneumonia by type of associated pathogens|severe pneumonia by type of associated pathogens
728711|NCT00513929|Severe Pneumonia by basal plasma zinc status|severe pneumonia by basal plasma zinc status
728712|NCT00513916|breast cancer|breast cancer
728713|NCT00513916|healthy, no evidence of disease|healthy, no evidence of disease
728714|NCT00513903|Pulmonary Diseases|pulmonary diseases
728715|NCT00513903|Continuity of Pharmacy Care|continuity of pharmacy care
728716|NCT00513890|Bronchiolitis|bronchiolitis
728717|NCT00513890|Esophageal pressure mesurement|esophageal pressure mesurement
728718|NCT00513890|Clinical score|clinical score
728719|NCT00513890|Citical care|citical care
728720|NCT00513890|Infant|infant
729084|NCT00512889|metastatic melanoma|metastatic melanoma
728721|NCT00513877|recurrent malignant mesothelioma|recurrent malignant mesothelioma
728722|NCT00513877|stage IA malignant mesothelioma|stage ia malignant mesothelioma
728723|NCT00513877|stage IB malignant mesothelioma|stage ib malignant mesothelioma
728724|NCT00513877|stage II malignant mesothelioma|stage ii malignant mesothelioma
728725|NCT00513877|stage III malignant mesothelioma|stage iii malignant mesothelioma
728726|NCT00513877|stage IV malignant mesothelioma|stage iv malignant mesothelioma
728727|NCT00513864|Opioid Analgesics|opioid analgesics
728728|NCT00513864|Morphine|morphine
728729|NCT00513864|Codeine|codeine
728730|NCT00513864|Sickle Cell Disease|sickle cell disease
728731|NCT00513851|Advanced Cancer|advanced cancer
728732|NCT00513851|Non-small cell lung cancer|non-small cell lung cancer
728733|NCT00513851|Small cell lung cancer|small cell lung cancer
728734|NCT00513851|Uterine cancer|uterine cancer
728735|NCT00513851|Ovarian cancer|ovarian cancer
728736|NCT00513851|Renal cancer|renal cancer
728737|NCT00513851|Head and neck cancer|head and neck cancer
728738|NCT00513851|Cervical cancer|cervical cancer
728739|NCT00513851|Metastatic cancer|metastatic cancer
728740|NCT00513851|Colorectal cancer|colorectal cancer
728741|NCT00513851|Gastrointestinal stromal tumors|gastrointestinal stromal tumors
728742|NCT00513825|Contrast Nephropathy|contrast nephropathy
728743|NCT00513825|Sodium Bicarbonate|sodium bicarbonate
728744|NCT00513825|Prevention|prevention
728745|NCT00513786|Endometrial Cancer|endometrial cancer
728746|NCT00513786|Advanced Stage Endometrial Cancer|advanced stage endometrial cancer
728747|NCT00513786|Stage 3 or 4 endometrial cancer|stage 3 or 4 endometrial cancer
728748|NCT00513786|Cancer treatment|cancer treatment
728749|NCT00513786|gyn cancer|gyn cancer
728750|NCT00513773|Abdominal Aortic Aneurysm,|abdominal aortic aneurysm,
728751|NCT00513773|Inflammation and Risk Prediction|inflammation and risk prediction
728752|NCT00513773|Diagnostic Tool Efficacy|diagnostic tool efficacy
728753|NCT00513760|Pharmacogenetics|pharmacogenetics
728754|NCT00513760|Singulair|singulair
728755|NCT00513760|montelukast|montelukast
728756|NCT00513760|Leukotriene Antagonists|leukotriene antagonists
728757|NCT00513760|Anti-Asthmatic Agents|anti-asthmatic agents
728758|NCT00513760|Intestinal Absorption|intestinal absorption
728759|NCT00513760|pharmacokinetics|pharmacokinetics
728760|NCT00513760|absorption|absorption
728761|NCT00513760|biochemical transport|biochemical transport
728762|NCT00513760|Membrane Transport Proteins|membrane transport proteins
728763|NCT00513760|Drug Interactions|drug interactions
728764|NCT00513747|B-cell chronic lymphocytic leukemia|b-cell chronic lymphocytic leukemia
728765|NCT00513747|stage 0 chronic lymphocytic leukemia|stage 0 chronic lymphocytic leukemia
728766|NCT00513747|stage I chronic lymphocytic leukemia|stage i chronic lymphocytic leukemia
728767|NCT00513734|keratopathy|keratopathy
728768|NCT00513734|exposure|exposure
728769|NCT00513734|intensive care|intensive care
728770|NCT00513734|eye|eye
728771|NCT00513734|ulcer|ulcer
728772|NCT00513734|Corneal|corneal
728773|NCT00513721|prostate|prostate
728774|NCT00513721|prostate cancer|prostate cancer
728775|NCT00513721|surgical margins|surgical margins
728776|NCT00513721|gleason score|gleason score
728777|NCT00513721|positive lateral biopsies|positive lateral biopsies
728778|NCT00513708|Detoxification|detoxification
728779|NCT00513708|Treatment|treatment
728780|NCT00513682|Cystic Fibrosis|cystic fibrosis
728781|NCT00513682|Pancreatic insufficiency|pancreatic insufficiency
728782|NCT00513682|Steatorrhea|steatorrhea
728783|NCT00513682|Children 7 to 11 years|children 7 to 11 years
728784|NCT00513682|Pancreatic enzyme|pancreatic enzyme
728785|NCT00513669|Malaria|malaria
728786|NCT00513669|Vaccine|vaccine
728787|NCT00513669|Falciparum|falciparum
728788|NCT00513669|Trial|trial
728789|NCT00513669|Phase I|phase i
728790|NCT00513669|Safety|safety
728791|NCT00513669|Immunogenicity|immunogenicity
728792|NCT00513656|Efficacy|efficacy
728793|NCT00513656|chronic|chronic
728794|NCT00513656|cancer|cancer
728795|NCT00513656|pain|pain
728796|NCT00513656|constipation|constipation
728797|NCT00513656|oxycodone|oxycodone
728798|NCT00513656|naloxone|naloxone
728799|NCT00513656|Moderate to severe chronic cancer pain|moderate to severe chronic cancer pain
728800|NCT00513643|euglycaemic glucose clamp|euglycaemic glucose clamp
728801|NCT00513643|duration of action|duration of action
728802|NCT00513643|late metabolic activity|late metabolic activity
728803|NCT00513643|hypoglycaemia|hypoglycaemia
728804|NCT00513617|Sickle Cell Disease|sickle cell disease
728805|NCT00513617|Anemia|anemia
728806|NCT00513617|Nitric Oxide|nitric oxide
728807|NCT00513617|Vaso Occlusive Events|vaso occlusive events
728808|NCT00513617|Arginine Supplementation|arginine supplementation
728809|NCT00513604|Clinical Response|clinical response
728810|NCT00513604|Immunotherapy|immunotherapy
728811|NCT00513604|Cancer|cancer
728812|NCT00513604|Cytokines|cytokines
728813|NCT00513604|Adoptive Cell Therapy|adoptive cell therapy
728814|NCT00513604|Melanoma|melanoma
728815|NCT00513604|Skin Cancer|skin cancer
728816|NCT00513604|Malignant Melanoma|malignant melanoma
728817|NCT00513591|Pregnancy|pregnancy
728984|NCT00513188|anaplastic large cell lymphoma|anaplastic large cell lymphoma
728818|NCT00513591|Lupus (systemic lupus erythematosus or cutaneous lupus)|lupus (systemic lupus erythematosus or cutaneous lupus)
728819|NCT00513591|Rheumatoid Arthritis|rheumatoid arthritis
728820|NCT00513591|Sjogren's Syndrome|sjogren's syndrome
728821|NCT00513591|Scleroderma|scleroderma
728822|NCT00513578|refractory anemia with excess blasts|refractory anemia with excess blasts
728823|NCT00513578|refractory anemia with ringed sideroblasts|refractory anemia with ringed sideroblasts
728824|NCT00513578|refractory anemia|refractory anemia
728825|NCT00513578|refractory cytopenia with multilineage dysplasia|refractory cytopenia with multilineage dysplasia
728826|NCT00513578|de novo myelodysplastic syndromes|de novo myelodysplastic syndromes
728827|NCT00513578|secondary myelodysplastic syndromes|secondary myelodysplastic syndromes
728828|NCT00513565|GSK561679,|gsk561679,
728829|NCT00513565|single,|single,
728830|NCT00513565|dose,|dose,
728831|NCT00513565|lorazepam,|lorazepam,
728832|NCT00513565|fMRI,|fmri,
728833|NCT00513565|BOLD,|bold,
728834|NCT00513565|healthy volunteers|healthy volunteers
728835|NCT00513539|unresectable gallbladder cancer|unresectable gallbladder cancer
728836|NCT00513539|recurrent gallbladder cancer|recurrent gallbladder cancer
728837|NCT00513539|metastatic gallbladder cancer|metastatic gallbladder cancer
728838|NCT00513539|cholangiocarcinoma of the gallbladder|cholangiocarcinoma of the gallbladder
728839|NCT00513539|unresectable extrahepatic bile duct cancer|unresectable extrahepatic bile duct cancer
728840|NCT00513539|recurrent extrahepatic bile duct cancer|recurrent extrahepatic bile duct cancer
728841|NCT00513539|metastatic extrahepatic bile duct cancer|metastatic extrahepatic bile duct cancer
728842|NCT00513539|cholangiocarcinoma of the extrahepatic bile duct|cholangiocarcinoma of the extrahepatic bile duct
728843|NCT00513526|infection|infection
728844|NCT00513526|low-grade squamous intraepithelial lesion|low-grade squamous intraepithelial lesion
728845|NCT00513526|atypical squamous cells of undetermined significance|atypical squamous cells of undetermined significance
728846|NCT00513513|HIV|hiv
728847|NCT00513513|AIDS|aids
728848|NCT00513513|TMC114|tmc114
728849|NCT00513513|Protease inhibitor|protease inhibitor
728850|NCT00513513|Darunavir|darunavir
728851|NCT00513513|Antiretroviral agents|antiretroviral agents
728852|NCT00513513|Treatment Naive|treatment naive
728853|NCT00513500|community health care|community health care
728854|NCT00513500|community health worker|community health worker
728855|NCT00513500|malaria|malaria
728856|NCT00513500|pneumonia|pneumonia
728857|NCT00513500|rapid diagnostic test|rapid diagnostic test
728858|NCT00513487|Allergic Rhinitis|allergic rhinitis
728859|NCT00513487|dust mites|dust mites
728860|NCT00513487|IgE|ige
728861|NCT00513487|IL-13|il-13
728862|NCT00513487|nasal|nasal
728863|NCT00513487|inflammation|inflammation
728864|NCT00513474|graft versus host disease|graft versus host disease
728865|NCT00513474|anaplastic large cell lymphoma|anaplastic large cell lymphoma
728866|NCT00513474|angioimmunoblastic T-cell lymphoma|angioimmunoblastic t-cell lymphoma
728867|NCT00513474|extranodal marginal zone B-cell lymphoma of mucosa-associated lymphoid tissue|extranodal marginal zone b-cell lymphoma of mucosa-associated lymphoid tissue
728868|NCT00513474|nodal marginal zone B-cell lymphoma|nodal marginal zone b-cell lymphoma
728869|NCT00513474|recurrent adult Burkitt lymphoma|recurrent adult burkitt lymphoma
728870|NCT00513474|recurrent adult diffuse large cell lymphoma|recurrent adult diffuse large cell lymphoma
728871|NCT00513474|recurrent adult diffuse mixed cell lymphoma|recurrent adult diffuse mixed cell lymphoma
728872|NCT00513474|recurrent adult diffuse small cleaved cell lymphoma|recurrent adult diffuse small cleaved cell lymphoma
728873|NCT00513474|recurrent adult Hodgkin lymphoma|recurrent adult hodgkin lymphoma
728874|NCT00513474|recurrent adult immunoblastic large cell lymphoma|recurrent adult immunoblastic large cell lymphoma
728875|NCT00513474|recurrent adult lymphoblastic lymphoma|recurrent adult lymphoblastic lymphoma
728876|NCT00513474|recurrent adult T-cell leukemia/lymphoma|recurrent adult t-cell leukemia/lymphoma
728877|NCT00513474|recurrent cutaneous T-cell non-Hodgkin lymphoma|recurrent cutaneous t-cell non-hodgkin lymphoma
728878|NCT00513474|recurrent grade 1 follicular lymphoma|recurrent grade 1 follicular lymphoma
728879|NCT00513474|recurrent grade 2 follicular lymphoma|recurrent grade 2 follicular lymphoma
728880|NCT00513474|recurrent grade 3 follicular lymphoma|recurrent grade 3 follicular lymphoma
728881|NCT00513474|recurrent mantle cell lymphoma|recurrent mantle cell lymphoma
728882|NCT00513474|recurrent marginal zone lymphoma|recurrent marginal zone lymphoma
728883|NCT00513474|recurrent mycosis fungoides/Sezary syndrome|recurrent mycosis fungoides/sezary syndrome
728884|NCT00513474|recurrent small lymphocytic lymphoma|recurrent small lymphocytic lymphoma
728885|NCT00513474|splenic marginal zone lymphoma|splenic marginal zone lymphoma
728886|NCT00513474|Waldenström macroglobulinemia|waldenström macroglobulinemia
728971|NCT00513240|neuroprotection|neuroprotection
728887|NCT00513474|recurrent adult acute lymphoblastic leukemia|recurrent adult acute lymphoblastic leukemia
728888|NCT00513474|refractory chronic lymphocytic leukemia|refractory chronic lymphocytic leukemia
728889|NCT00513474|recurrent adult acute myeloid leukemia|recurrent adult acute myeloid leukemia
728890|NCT00513474|adult acute myeloid leukemia with 11q23 (MLL) abnormalities|adult acute myeloid leukemia with 11q23 (mll) abnormalities
728891|NCT00513474|adult acute myeloid leukemia with inv(16)(p13;q22)|adult acute myeloid leukemia with inv(16)(p13;q22)
728892|NCT00513474|adult acute myeloid leukemia with t(15;17)(q22;q12)|adult acute myeloid leukemia with t(15;17)(q22;q12)
729083|NCT00512889|melanoma|melanoma
728893|NCT00513474|adult acute myeloid leukemia with t(16;16)(p13;q22)|adult acute myeloid leukemia with t(16;16)(p13;q22)
728894|NCT00513474|adult acute myeloid leukemia with t(8;21)(q22;q22)|adult acute myeloid leukemia with t(8;21)(q22;q22)
728895|NCT00513474|accelerated phase chronic myelogenous leukemia|accelerated phase chronic myelogenous leukemia
728896|NCT00513474|blastic phase chronic myelogenous leukemia|blastic phase chronic myelogenous leukemia
728897|NCT00513474|chronic phase chronic myelogenous leukemia|chronic phase chronic myelogenous leukemia
728898|NCT00513474|relapsing chronic myelogenous leukemia|relapsing chronic myelogenous leukemia
728899|NCT00513474|previously treated myelodysplastic syndromes|previously treated myelodysplastic syndromes
728900|NCT00513474|primary myelofibrosis|primary myelofibrosis
728901|NCT00513474|atypical chronic myeloid leukemia, BCR-ABL1 negative|atypical chronic myeloid leukemia, bcr-abl1 negative
728902|NCT00513474|chronic eosinophilic leukemia|chronic eosinophilic leukemia
728903|NCT00513474|chronic myelomonocytic leukemia|chronic myelomonocytic leukemia
728904|NCT00513474|de novo myelodysplastic syndromes|de novo myelodysplastic syndromes
728905|NCT00513474|myelodysplastic/myeloproliferative neoplasm, unclassifiable|myelodysplastic/myeloproliferative neoplasm, unclassifiable
728906|NCT00513474|refractory hairy cell leukemia|refractory hairy cell leukemia
728907|NCT00513474|refractory multiple myeloma|refractory multiple myeloma
728908|NCT00513474|secondary acute myeloid leukemia|secondary acute myeloid leukemia
728909|NCT00513474|secondary myelodysplastic syndromes|secondary myelodysplastic syndromes
728910|NCT00513448|Chronic Disabling Condition|chronic disabling condition
728911|NCT00513448|Comparative Evaluation|comparative evaluation
728912|NCT00513448|Physical Activity|physical activity
728913|NCT00513448|Physical Therapy|physical therapy
728914|NCT00513448|Rehabilitation|rehabilitation
728915|NCT00513422|Osteoarthritis, knee|osteoarthritis, knee
728916|NCT00513422|Glucosamine|glucosamine
728917|NCT00513422|Chondroitin|chondroitin
728918|NCT00513422|Disease progression|disease progression
728919|NCT00513422|NSAIDs|nsaids
728920|NCT00513409|Immunogenicity|immunogenicity
728921|NCT00513409|Pneumococcal disease|pneumococcal disease
728922|NCT00513409|Safety|safety
728923|NCT00513409|Booster vaccination|booster vaccination
728924|NCT00513409|Pneumococcal vaccine|pneumococcal vaccine
728925|NCT00513396|Randomized control trial|randomized control trial
728926|NCT00513396|multidrug resistant tuberculosis|multidrug resistant tuberculosis
728927|NCT00513396|isoniazid|isoniazid
728928|NCT00513396|standardized regimen|standardized regimen
728929|NCT00513396|adjuvant therapy|adjuvant therapy
728930|NCT00513383|basaloid squamous cell carcinoma|basaloid squamous cell carcinoma
728931|NCT00513383|undifferentiated carcinoma|undifferentiated carcinoma
728932|NCT00513383|adenosquamous cell carcinoma|adenosquamous cell carcinoma
728933|NCT00513370|Psoriasis|psoriasis
728934|NCT00513370|adalimumab|adalimumab
728935|NCT00513357|Gastrointestinal Cancer|gastrointestinal cancer
728936|NCT00513357|Lung Cancer|lung cancer
728937|NCT00513357|Cachexia|cachexia
728938|NCT00513357|Melatonin|melatonin
728939|NCT00513357|Placebo|placebo
728940|NCT00513357|Anorexia|anorexia
728941|NCT00513357|Weight Loss|weight loss
728942|NCT00513344|Endothelial function|endothelial function
728943|NCT00513344|Arterial stiffness|arterial stiffness
728944|NCT00513344|Dark chocolate|dark chocolate
728945|NCT00513344|Milk chocolate|milk chocolate
728946|NCT00513344|Polyphenols|polyphenols
728947|NCT00513331|Barrett's Esophagus|barrett's esophagus
728948|NCT00513331|GERD|gerd
728949|NCT00513331|Carcinoma|carcinoma
728950|NCT00513318|Umbilical cord blood transplantation|umbilical cord blood transplantation
728951|NCT00513318|hematopoietic malignancies|hematopoietic malignancies
728952|NCT00513305|acute myeloid leukemia, cytarabine, arsenic trioxide.|acute myeloid leukemia, cytarabine, arsenic trioxide.
728953|NCT00513279|Safety,|safety,
728954|NCT00513279|GSK618334|gsk618334
728955|NCT00513279|pharmacokinetics,|pharmacokinetics,
728956|NCT00513279|repeat dose,|repeat dose,
728957|NCT00513279|tolerability,|tolerability,
728958|NCT00513279|pharmacodynamics,|pharmacodynamics,
728959|NCT00513279|placebo,|placebo,
728960|NCT00513266|recurrent rectal cancer|recurrent rectal cancer
728961|NCT00513266|stage IV rectal cancer|stage iv rectal cancer
728962|NCT00513266|recurrent colon cancer|recurrent colon cancer
728963|NCT00513266|stage IV colon cancer|stage iv colon cancer
728964|NCT00513266|adenocarcinoma of the colon|adenocarcinoma of the colon
728965|NCT00513266|adenocarcinoma of the rectum|adenocarcinoma of the rectum
728966|NCT00513266|liver metastases|liver metastases
728967|NCT00513266|lung metastases|lung metastases
728968|NCT00513253|lapatinib|lapatinib
728969|NCT00513253|Healthy Adult Volunteer|healthy adult volunteer
728970|NCT00513240|erythropoetin|erythropoetin
728972|NCT00513240|neonate|neonate
728974|NCT00513240|magnetic resonance imaging|magnetic resonance imaging
728975|NCT00513240|brain magnetic resonance imaging|brain magnetic resonance imaging
728976|NCT00513240|electroencephalogram|electroencephalogram
728977|NCT00513214|Diabetes|diabetes
728978|NCT00513214|Type 2|type 2
728979|NCT00513214|Mellitus|mellitus
728980|NCT00513201|lyspro|lyspro
728981|NCT00513201|regular insulin|regular insulin
728982|NCT00513201|cirrhotic patients|cirrhotic patients
728983|NCT00513188|angioimmunoblastic T-cell lymphoma|angioimmunoblastic t-cell lymphoma
728985|NCT00513188|adult nasal type extranodal NK/T-cell lymphoma|adult nasal type extranodal nk/t-cell lymphoma
728986|NCT00513188|stage IV mycosis fungoides/Sezary syndrome|stage iv mycosis fungoides/sezary syndrome
728987|NCT00513188|stage IV cutaneous T-cell non-Hodgkin lymphoma|stage iv cutaneous t-cell non-hodgkin lymphoma
728988|NCT00513175|Allogeneic SCT|allogeneic sct
728989|NCT00513175|Matched unrelated donors|matched unrelated donors
728990|NCT00513175|hematologic malignancies|hematologic malignancies
728991|NCT00513175|renal cell carcinoma|renal cell carcinoma
728992|NCT00513175|aplastic anemia|aplastic anemia
728993|NCT00513162|Advanced Cancers|advanced cancers
728994|NCT00513162|Brain|brain
728995|NCT00513162|CNS|cns
728996|NCT00513162|Neural|neural
728997|NCT00513162|Pediatrics|pediatrics
728998|NCT00513162|Spinal|spinal
728999|NCT00513162|Neuroectodermal Tumor|neuroectodermal tumor
729000|NCT00513162|Brain Metastases|brain metastases
729001|NCT00513162|Valproate|valproate
729002|NCT00513162|Valproic Acid|valproic acid
729003|NCT00513162|Depakene|depakene
729004|NCT00513162|Etoposide|etoposide
729005|NCT00513162|VePesid|vepesid
729006|NCT00513149|angioplasty|angioplasty
729007|NCT00513149|clopidogrel|clopidogrel
729008|NCT00513149|coronary artery disease|coronary artery disease
729009|NCT00513149|PFA|pfa
729010|NCT00513136|Fatigue|fatigue
729011|NCT00513136|Breast Cancer|breast cancer
729012|NCT00513136|Behavioral Research|behavioral research
729013|NCT00513136|Quality of Life|quality of life
729014|NCT00513123|Digital Colposcopy for Fluorescence|digital colposcopy for fluorescence
729015|NCT00513123|DCF|dcf
729016|NCT00513123|Fluorescence Spectroscopy|fluorescence spectroscopy
729017|NCT00513123|Digital Colposcopy|digital colposcopy
729018|NCT00513123|DC|dc
729019|NCT00513123|Cervical Intraepithelial Neoplasia|cervical intraepithelial neoplasia
729020|NCT00513123|Cervical Cancer|cervical cancer
729021|NCT00513123|Cervix|cervix
729022|NCT00513123|Vagina|vagina
729023|NCT00513123|Lesions of the cervix|lesions of the cervix
729024|NCT00513123|Precancerous lesions|precancerous lesions
729025|NCT00513110|Endotoxin|endotoxin
729026|NCT00513110|Adenosine|adenosine
729027|NCT00513110|Caffeine|caffeine
729028|NCT00513110|AMPD1 polymorphism|ampd1 polymorphism
729029|NCT00513097|Epidemiology|epidemiology
729030|NCT00513097|Cancer Prevention|cancer prevention
729031|NCT00513097|Smoking Cessation|smoking cessation
729032|NCT00513097|Smoking Prevention|smoking prevention
729033|NCT00513097|Focus Groups|focus groups
729034|NCT00513084|Behavioral,|behavioral,
729035|NCT00513084|Self-Determination Theory,|self-determination theory,
729036|NCT00513084|Motivational Interviewing,|motivational interviewing,
729037|NCT00513084|Exercise, Physical Activity,|exercise, physical activity,
729038|NCT00513084|Motivation,|motivation,
729039|NCT00513084|Moderators,|moderators,
729040|NCT00513084|Mediators,|mediators,
729041|NCT00513084|Predictors,|predictors,
729042|NCT00513084|Weight|weight
729043|NCT00513058|metastatic breast cancer|metastatic breast cancer
729044|NCT00513058|advanced breast cancer|advanced breast cancer
729045|NCT00513045|Nightmares|nightmares
729046|NCT00513045|treatment|treatment
729047|NCT00513045|self-help|self-help
729048|NCT00513032|propofol|propofol
729049|NCT00513032|anaesthesia induction|anaesthesia induction
729050|NCT00513032|parathyroidectomy|parathyroidectomy
729051|NCT00513032|methylene blue|methylene blue
729052|NCT00513032|General anesthesia|general anesthesia
729053|NCT00513019|Neurotic Excoriation|neurotic excoriation
729054|NCT00513019|Pathologic Skin Picking|pathologic skin picking
729055|NCT00513019|Psychogenic Excoriation|psychogenic excoriation
729056|NCT00512993|Postoperative treatment with zoledronic acid|postoperative treatment with zoledronic acid
729057|NCT00512993|Preoperative anthracycline/taxane containing chemotherapy|preoperative anthracycline/taxane containing chemotherapy
729058|NCT00512980|intermediate stages|intermediate stages
729059|NCT00512967|oxidative stress|oxidative stress
729060|NCT00512967|antioxidants|antioxidants
729061|NCT00512967|inflammation|inflammation
729062|NCT00512967|quercetin|quercetin
729063|NCT00512954|airway inflammation|airway inflammation
729064|NCT00512954|susceptibility to infections|susceptibility to infections
729065|NCT00512954|inflammatory response in blood and urine|inflammatory response in blood and urine
729066|NCT00512954|infective exacerbations|infective exacerbations
729067|NCT00512954|asthma|asthma
729068|NCT00512954|COPD|copd
729069|NCT00512928|vitamin K2|vitamin k2
729070|NCT00512928|oral anticoagulation|oral anticoagulation
729071|NCT00512928|interference|interference
729072|NCT00512928|level of anticoagulation|level of anticoagulation
729073|NCT00512928|carboxylation level of osteocalcin and matrix-gla protein|carboxylation level of osteocalcin and matrix-gla protein
729074|NCT00512915|Farfield Sensing|farfield sensing
729075|NCT00512915|Pacing lead|pacing lead
729076|NCT00512915|Postventricular atrial blanking|postventricular atrial blanking
729077|NCT00512915|Bradycardia|bradycardia
729078|NCT00512902|active alveolitis in systemic sclerosis|active alveolitis in systemic sclerosis
729079|NCT00512889|CTL|ctl
729080|NCT00512889|MART-1|mart-1
729081|NCT00512889|Melan-A|melan-a
729082|NCT00512889|artificial APC|artificial apc
729085|NCT00512889|adoptive immunotherapy|adoptive immunotherapy
729086|NCT00512889|adoptive cell transfer|adoptive cell transfer
729087|NCT00512889|immunotherapy|immunotherapy
729088|NCT00512850|Folic acid|folic acid
729089|NCT00512850|Adenoma of Large Intestine|adenoma of large intestine
729090|NCT00512837|Telemedicine|telemedicine
729091|NCT00512837|clinical management|clinical management
729092|NCT00512837|empowerment|empowerment
729093|NCT00512837|engagement|engagement
729094|NCT00512837|education|education
729095|NCT00512824|calcium|calcium
729096|NCT00512824|probiotics|probiotics
729097|NCT00512824|diarrhea|diarrhea
729098|NCT00512824|children|children
729099|NCT00512824|Indonesia|indonesia
729100|NCT00512824|Healthy children|healthy children
729101|NCT00512824|acute diarrhea|acute diarrhea
729102|NCT00512811|furosemide|furosemide
729103|NCT00512811|inhalation|inhalation
729104|NCT00512811|dyspnea|dyspnea
729105|NCT00512811|spirometry|spirometry
729106|NCT00512811|mustard gas|mustard gas
729107|NCT00512811|bronchiolitis|bronchiolitis
729108|NCT00512811|sulfur mustard|sulfur mustard
729109|NCT00512798|stage III melanoma|stage iii melanoma
729110|NCT00512798|stage IV melanoma|stage iv melanoma
729111|NCT00512798|recurrent melanoma|recurrent melanoma
729112|NCT00512798|unspecified adult solid tumor, protocol specific|unspecified adult solid tumor, protocol specific
729113|NCT00512798|recurrent adult brain tumor|recurrent adult brain tumor
729114|NCT00512798|melanoma (skin)|melanoma (skin)
729115|NCT00512785|Imidafenacin|imidafenacin
729116|NCT00512785|KRP-197/ONO-8025|krp-197/ono-8025
729117|NCT00512785|overactive bladder|overactive bladder
729118|NCT00512785|antimuscarinic|antimuscarinic
729119|NCT00512772|Time series|time series
729120|NCT00512772|Implementation|implementation
729121|NCT00512746|small cell lung cancer|small cell lung cancer
729122|NCT00512746|non-small cell lung cancer|non-small cell lung cancer
729123|NCT00512746|precancerous condition|precancerous condition
729124|NCT00512733|Healthy volunteers|healthy volunteers
729125|NCT00512720|PAD|pad
729126|NCT00512720|Peripheral Artery Disease|peripheral artery disease
729127|NCT00512720|PVD|pvd
729128|NCT00512720|Peripheral Vascular Disease|peripheral vascular disease
729129|NCT00512720|Leg Blockage|leg blockage
729130|NCT00512720|Angioplasty|angioplasty
729131|NCT00512720|Stent|stent
729132|NCT00512720|Claudication|claudication
729133|NCT00512707|testosterone|testosterone
729134|NCT00512707|erectile dysfunction|erectile dysfunction
729135|NCT00512707|sildenafil|sildenafil
729136|NCT00512694|Lupus|lupus
729137|NCT00512694|Systemic Lupus Erythematosus|systemic lupus erythematosus
729138|NCT00512694|Cutaneous Lupus|cutaneous lupus
729139|NCT00512681|Stomach Neoplasms|stomach neoplasms
729140|NCT00512681|Secondary|secondary
729141|NCT00512681|Combination chemotherapy|combination chemotherapy
729142|NCT00512681|S-1|s-1
729143|NCT00512681|irinotecan|irinotecan
729144|NCT00512681|oxaliplatin|oxaliplatin
729145|NCT00512655|Fear of falling|fear of falling
729146|NCT00512655|Intraindividual variability|intraindividual variability
729147|NCT00512655|Cognition|cognition
729148|NCT00512655|Fall prevention|fall prevention
729149|NCT00512655|Fear|fear
729150|NCT00512655|Frail elderly|frail elderly
729151|NCT00512655|Intervention|intervention
729152|NCT00512642|Cancer|cancer
729153|NCT00512642|Lymphocytes|lymphocytes
729154|NCT00512642|Genetics|genetics
729155|NCT00512629|PN|pn
729156|NCT00512629|cholestasis|cholestasis
729157|NCT00512629|gastrointestinal disease in infants|gastrointestinal disease in infants
729158|NCT00512629|short bowel syndrome|short bowel syndrome
729159|NCT00512616|Ceftriaxone|ceftriaxone
729160|NCT00512616|Acute Antidepressant Effects|acute antidepressant effects
729161|NCT00512616|Glutamatergic System|glutamatergic system
729162|NCT00512616|Double-Blind|double-blind
729163|NCT00512616|Mood Disorders|mood disorders
729164|NCT00512616|Bipolar Disorder|bipolar disorder
729165|NCT00512616|Depression|depression
729166|NCT00512603|cerebro vascular event|cerebro vascular event
729167|NCT00512590|fibromyalgia|fibromyalgia
729168|NCT00512590|relaxation|relaxation
729169|NCT00512590|imagery|imagery
729170|NCT00512590|pain|pain
729171|NCT00512590|functional status|functional status
729172|NCT00512590|self efficacy|self efficacy
729173|NCT00512590|minority health|minority health
729174|NCT00512577|sickle cell disease|sickle cell disease
729376|NCT00511823|dolasetron,|dolasetron,
729175|NCT00512577|pre-operative transfusion|pre-operative transfusion
729176|NCT00512577|blood transfusion|blood transfusion
729177|NCT00512564|Sickle Cell Anemia|sickle cell anemia
729178|NCT00512564|Sickle Cell Thalassemia|sickle cell thalassemia
729179|NCT00512564|Iron overload|iron overload
729180|NCT00512564|Non transferrin binding iron|non transferrin binding iron
729181|NCT00512564|Hepcidin|hepcidin
729182|NCT00512551|Cervical Cancer|cervical cancer
729183|NCT00512551|DNA Array Analysis|dna array analysis
729184|NCT00512551|Gene Expression|gene expression
729185|NCT00512551|DNA|dna
729186|NCT00512538|Diabetic foot|diabetic foot
729187|NCT00512512|transoral|transoral
729488|NCT00511446|oxaliplatin|oxaliplatin
729188|NCT00512512|transluminal|transluminal
729189|NCT00512512|endoscopic|endoscopic
729190|NCT00512512|laparoscopic|laparoscopic
729191|NCT00512512|liver|liver
729192|NCT00512512|biopsy|biopsy
729193|NCT00512499|Osteoporosis|osteoporosis
729194|NCT00512499|Fragility fractures|fragility fractures
729195|NCT00512499|Fracture clinics|fracture clinics
729196|NCT00512499|Orthopedic surgeons|orthopedic surgeons
729197|NCT00512473|GH, GH receptor blockade, GH signaling, insulin resistance|gh, gh receptor blockade, gh signaling, insulin resistance
729198|NCT00512460|Neoplastic Meningitis|neoplastic meningitis
729199|NCT00512460|Leptomeningeal Disease|leptomeningeal disease
729200|NCT00512460|Solid Tumor|solid tumor
729201|NCT00512460|Lymphoma|lymphoma
729202|NCT00512460|Leukemia|leukemia
729203|NCT00512460|Brain Tumor|brain tumor
729204|NCT00512460|RTA 744|rta 744
729205|NCT00512447|Aging|aging
729206|NCT00512434|tibial|tibial
729207|NCT00512434|shaft|shaft
729208|NCT00512434|fracture|fracture
729209|NCT00512434|open|open
729210|NCT00512434|bone-marrow|bone-marrow
729211|NCT00512434|graft|graft
729212|NCT00512434|injection|injection
729213|NCT00512434|mesenchymal stem cell|mesenchymal stem cell
729214|NCT00512408|To assess the effect of a 12 week testosterone administration on maximal exercise capacity, muscle strength and insulin resistance in elderly CHF patients|to assess the effect of a 12 week testosterone administration on maximal exercise capacity, muscle strength and insulin resistance in elderly chf patients
729215|NCT00512395|laparoscopic colorectal surgery|laparoscopic colorectal surgery
729216|NCT00512395|epidural analgesia|epidural analgesia
729217|NCT00512395|pain score|pain score
729218|NCT00512395|postoperative ileus|postoperative ileus
729219|NCT00512382|GER Gastrointestinal reflux|ger gastrointestinal reflux
729220|NCT00512382|Aspiration|aspiration
729221|NCT00512382|ASHTMA|ashtma
729222|NCT00512382|COUGH|cough
729223|NCT00512382|WHEEZE|wheeze
729224|NCT00512382|PH-IMPEDANCE|ph-impedance
729225|NCT00512382|WEEM Wheezy Monitor|weem wheezy monitor
729226|NCT00512369|Metabolic pathways|metabolic pathways
729227|NCT00512369|Atherosclerosis|atherosclerosis
729228|NCT00512369|Monocyte Function|monocyte function
729229|NCT00512343|Synovial Fluid|synovial fluid
729230|NCT00512343|Arthritis|arthritis
729231|NCT00512343|Paired serum/synovial fluid samples|paired serum/synovial fluid samples
729232|NCT00512330|childhood|childhood
729233|NCT00512330|tuberculosis|tuberculosis
729234|NCT00512330|diagnostic|diagnostic
729235|NCT00512330|lipoarabinomannan|lipoarabinomannan
729236|NCT00512330|ELISA|elisa
729237|NCT00512330|Tuberculosis in Childhood|tuberculosis in childhood
729238|NCT00512317|partial onset epilepsy|partial onset epilepsy
729239|NCT00512317|adult epilepsy|adult epilepsy
729240|NCT00512317|partial seizures|partial seizures
729241|NCT00512317|anticonvulsant|anticonvulsant
729242|NCT00512317|catamenial epilepsy|catamenial epilepsy
729243|NCT00512317|adult partial onset epilepsy|adult partial onset epilepsy
729244|NCT00512291|Advanced Cancer|advanced cancer
729245|NCT00512291|Hyperactive Delirium|hyperactive delirium
729246|NCT00512291|Mixed Delirium|mixed delirium
729247|NCT00512291|Olanzapine|olanzapine
729248|NCT00512278|Hepatitis|hepatitis
729249|NCT00512278|HCV|hcv
729250|NCT00512278|Hepatitis C|hepatitis c
729251|NCT00512265|n-acetylcysteine|n-acetylcysteine
729252|NCT00512265|esophagectomy|esophagectomy
729253|NCT00512265|inflammatory reaction|inflammatory reaction
729254|NCT00512265|pulmonary morbidity|pulmonary morbidity
729255|NCT00512252|Plerixafor|plerixafor
729256|NCT00512252|CXCR4|cxcr4
729257|NCT00512252|Chemosensitization|chemosensitization
729258|NCT00512239|Early Rheumatoid Arthritis|early rheumatoid arthritis
729259|NCT00512239|Early inflammatory arthritis|early inflammatory arthritis
729260|NCT00512239|Biomarkers|biomarkers
729261|NCT00512239|Autoantibodies|autoantibodies
729262|NCT00512239|Anti-Sa antibodies|anti-sa antibodies
729263|NCT00512239|Anti-CCP antibodies|anti-ccp antibodies
729264|NCT00512226|Sickle Cell Anemia|sickle cell anemia
729265|NCT00512226|Sickle Cell Thalassemia|sickle cell thalassemia
729266|NCT00512226|Iron Overload|iron overload
729267|NCT00512226|MRI|mri
729268|NCT00512213|preoperative Immunonutrition|preoperative immunonutrition
729269|NCT00512213|major abdominal surgery|major abdominal surgery
729270|NCT00512213|complication|complication
729271|NCT00512174|Portable Ultrasound Scanner|portable ultrasound scanner
729272|NCT00512174|Non Invasive Bladder Volume Measurement|non invasive bladder volume measurement
729273|NCT00512174|Radical Cystectomy|radical cystectomy
729274|NCT00512174|Bladder Reconstruction|bladder reconstruction
729275|NCT00512161|Any patient undergoing elective cardiac surgery|any patient undergoing elective cardiac surgery
729276|NCT00512122|early parenteral nutrition|early parenteral nutrition
729277|NCT00512122|critical illness|critical illness
729278|NCT00512122|respiratory failure|respiratory failure
729279|NCT00512122|kidney failure|kidney failure
729280|NCT00512122|hepatic failure|hepatic failure
729281|NCT00512122|muscle strength|muscle strength
729282|NCT00512122|rehabilitation|rehabilitation
729283|NCT00512122|overfeeding|overfeeding
729284|NCT00512122|Reduced Oral Intake|reduced oral intake
729285|NCT00512109|vascular risk|vascular risk
729286|NCT00512109|perioperative|perioperative
729287|NCT00512109|vascular events|vascular events
729288|NCT00512109|cohort study|cohort study
729289|NCT00512109|surgery|surgery
729290|NCT00512096|Genitourinary|genitourinary
729291|NCT00512096|Penile Cancer|penile cancer
729292|NCT00512096|Neoadjuvant Chemotherapy|neoadjuvant chemotherapy
729293|NCT00512096|Extirpative Surgery|extirpative surgery
729294|NCT00512096|TanyN2-3M0 Squamous Cell Carcinoma of the Penis|tanyn2-3m0 squamous cell carcinoma of the penis
729295|NCT00512096|Cisplatin|cisplatin
729296|NCT00512096|Platinol-AQ|platinol-aq
729297|NCT00512096|Platinol|platinol
729298|NCT00512096|CDDP|cddp
729299|NCT00512096|Ifosfamide|ifosfamide
729300|NCT00512096|Ifex|ifex
729301|NCT00512096|Paclitaxel|paclitaxel
729302|NCT00512096|Taxol|taxol
729303|NCT00512083|Leukemia, Myeloid + Acute Disease|leukemia, myeloid + acute disease
729304|NCT00512070|schizophrenia|schizophrenia
729305|NCT00512070|schizoaffective disorder|schizoaffective disorder
729306|NCT00512070|bipolar disorder|bipolar disorder
729307|NCT00512070|olanzapine|olanzapine
729308|NCT00512070|melatonin|melatonin
729309|NCT00512070|obesity|obesity
729310|NCT00512070|metabolic syndrome|metabolic syndrome
729311|NCT00512057|cardiac syndrome X|cardiac syndrome x
729312|NCT00512057|endothelial function|endothelial function
729313|NCT00512044|anesthesia, Longo, mucosectomy, hemorrhoids|anesthesia, longo, mucosectomy, hemorrhoids
729314|NCT00512031|atherosclerosis|atherosclerosis
729315|NCT00512031|metabolic pathways|metabolic pathways
729316|NCT00512031|monocyte adhesion,|monocyte adhesion,
729317|NCT00512018|Electric Stimulation|electric stimulation
729318|NCT00512018|Quadriceps Muscle|quadriceps muscle
729319|NCT00512018|Muscle Strength|muscle strength
729320|NCT00512018|Neuromuscular Properties|neuromuscular properties
729321|NCT00512018|Tension-Length Relationship|tension-length relationship
729322|NCT00512018|Healthy young adults|healthy young adults
729323|NCT00512005|Functional Mitral Regurgitation (FMR)|functional mitral regurgitation (fmr)
729324|NCT00512005|Ischemic Mitral Regurgitation|ischemic mitral regurgitation
729325|NCT00512005|Less invasive repair|less invasive repair
729326|NCT00512005|Percutaneous MV repair|percutaneous mv repair
729327|NCT00512005|Mitral Valve Repair|mitral valve repair
729328|NCT00512005|Heart Failure|heart failure
729329|NCT00512005|Left Ventricular Dysfunction|left ventricular dysfunction
729330|NCT00511992|Ovarian Cancer|ovarian cancer
729331|NCT00511992|Gynecologic Cancer|gynecologic cancer
729332|NCT00511992|Ovarian Carcinoma|ovarian carcinoma
729333|NCT00511992|Peritoneal Carcinoma|peritoneal carcinoma
729334|NCT00511992|IP chemotherapy|ip chemotherapy
729335|NCT00511992|Intraperitoneal|intraperitoneal
729336|NCT00511992|Avastin|avastin
729337|NCT00511992|Bevacizumab|bevacizumab
729338|NCT00511979|Healthy Patients|healthy patients
729339|NCT00511966|Gastroesophageal Reflux|gastroesophageal reflux
729340|NCT00511966|Rabeprazole|rabeprazole
729341|NCT00511953|Hot flashes|hot flashes
729342|NCT00511953|Hot flushes|hot flushes
729343|NCT00511953|Postmenopausal symptoms|postmenopausal symptoms
729345|NCT00511927|failure|failure
729346|NCT00511927|growth|growth
729347|NCT00511927|hormone|hormone
729348|NCT00511927|igf|igf
729349|NCT00511927|dilative|dilative
729350|NCT00511927|cardiomyopathy|cardiomyopathy
729351|NCT00511914|Influenza vaccine|influenza vaccine
729352|NCT00511901|anemia|anemia
729353|NCT00511901|function|function
729354|NCT00511901|rehabilitation|rehabilitation
729355|NCT00511888|chronic heart failure|chronic heart failure
729356|NCT00511888|hypertension|hypertension
729357|NCT00511888|beta blockers|beta blockers
729358|NCT00511875|diabetic retinopathy|diabetic retinopathy
729359|NCT00511875|diabetes|diabetes
729360|NCT00511875|diabetic eye studies|diabetic eye studies
729361|NCT00511875|neovascularization|neovascularization
729362|NCT00511862|TheraSphere|therasphere
729363|NCT00511862|radioactive microspheres|radioactive microspheres
729364|NCT00511862|Yttrium-90|yttrium-90
729365|NCT00511862|Yttrium glass microspheres|yttrium glass microspheres
729366|NCT00511836|alcoholism|alcoholism
729367|NCT00511836|addiction|addiction
729368|NCT00511836|alcohol detoxification|alcohol detoxification
729369|NCT00511823|drug-drug interaction,|drug-drug interaction,
729370|NCT00511823|rosiglitazone,|rosiglitazone,
729371|NCT00511823|safety|safety
729372|NCT00511823|CYP2C8,|cyp2c8,
729373|NCT00511823|pharmacokinetics,|pharmacokinetics,
729374|NCT00511823|CYP3A4,|cyp3a4,
729375|NCT00511823|granisetron,|granisetron,
729377|NCT00511823|CYP2D6,|cyp2d6,
729378|NCT00511823|casopitant,|casopitant,
729379|NCT00511810|Sadness|sadness
729380|NCT00511810|Insomnia|insomnia
729381|NCT00511810|Loss of appetite|loss of appetite
729382|NCT00511810|Fatigue|fatigue
729383|NCT00511810|Trouble thinking|trouble thinking
729384|NCT00511797|Dysmenorrhea|dysmenorrhea
729385|NCT00511797|Dysmenorrheal score|dysmenorrheal score
729386|NCT00511797|Drospirenone|drospirenone
729387|NCT00511797|DRSP|drsp
729388|NCT00511797|Ethinylestradiol|ethinylestradiol
729389|NCT00511784|Contraception|contraception
729390|NCT00511784|Hormonal contraception|hormonal contraception
729391|NCT00511784|Oral contraception|oral contraception
729392|NCT00511784|Ethinyl estradiol, Levonorgestrel, Contraception|ethinyl estradiol, levonorgestrel, contraception
729393|NCT00511784|Transdermal|transdermal
729394|NCT00511784|Venous thromboembolism|venous thromboembolism
729395|NCT00511784|Norelgestromin|norelgestromin
729396|NCT00511771|Tegaserod, treatment IND, irritable bowel syndrome with constipation, IBS-C, chronic idiopathic constipation, CIC, chronic constipation, CC|tegaserod, treatment ind, irritable bowel syndrome with constipation, ibs-c, chronic idiopathic constipation, cic, chronic constipation, cc
729397|NCT00511758|Cervical Dysplasia|cervical dysplasia
729398|NCT00511758|Digital Imaging|digital imaging
729399|NCT00511758|Colposcopy|colposcopy
729400|NCT00511758|Cervix|cervix
729401|NCT00511745|Interactions|interactions
729402|NCT00511745|Adjusted doses|adjusted doses
729403|NCT00511745|Duodenal Ulcer|duodenal ulcer
729404|NCT00511745|Gastric Ulcer|gastric ulcer
729405|NCT00511745|Erosive or ulcerate Gastroesophageal Reflux|erosive or ulcerate gastroesophageal reflux
729406|NCT00511745|Rabeprazole|rabeprazole
729407|NCT00511745|Gastroesophageal reflux|gastroesophageal reflux
729408|NCT00511693|fragility fracture|fragility fracture
729409|NCT00511693|management of osteoporosis|management of osteoporosis
729410|NCT00511693|osteoporosis coordinator|osteoporosis coordinator
729411|NCT00511693|small volume hospitals|small volume hospitals
729412|NCT00511654|depression|depression
729413|NCT00511654|NK1 receptor antagonists,|nk1 receptor antagonists,
729414|NCT00511641|Ovarian Cancer|ovarian cancer
729415|NCT00511641|Cancer Screening|cancer screening
729416|NCT00511641|Quality of Life|quality of life
729417|NCT00511641|Questionnaire|questionnaire
729418|NCT00511641|Screening|screening
729419|NCT00511641|Survey|survey
729420|NCT00511628|Schizophrenia|schizophrenia
729421|NCT00511628|Risperidone|risperidone
729422|NCT00511628|Schizoaffective disorder|schizoaffective disorder
729423|NCT00511628|Schizophreniform disorder|schizophreniform disorder
729424|NCT00511628|Weight gain|weight gain
729425|NCT00511615|Cervical Intraepithelial Neoplasia|cervical intraepithelial neoplasia
729426|NCT00511615|Loop Electrosurgical Excision Procedure|loop electrosurgical excision procedure
729427|NCT00511615|Cervical Cancer|cervical cancer
729428|NCT00511615|Colposcopy|colposcopy
729429|NCT00511615|Molecular Imaging|molecular imaging
729430|NCT00511615|LEEP|leep
729431|NCT00511576|Advanced or Metastatic Breast Cancer|advanced or metastatic breast cancer
729432|NCT00511576|Breast Cancer|breast cancer
729433|NCT00511576|Advanced or Metastatic Non-Small-Cell Lung Cancer (NSCLC)|advanced or metastatic non-small-cell lung cancer (nsclc)
729434|NCT00511576|Hormone Refractory Prostate Cancer|hormone refractory prostate cancer
729435|NCT00511576|Prostate Cancer|prostate cancer
729436|NCT00511576|Gastric Cancer|gastric cancer
729437|NCT00511576|Advanced Gastric Adenocarcinoma|advanced gastric adenocarcinoma
729438|NCT00511576|HDAC Inhibitor|hdac inhibitor
729439|NCT00511576|Taxotere|taxotere
729440|NCT00511576|Docetaxel|docetaxel
729441|NCT00511563|Cortisol,|cortisol,
729442|NCT00511563|stress,|stress,
729443|NCT00511563|response,|response,
729444|NCT00511563|Irritable Bowel Syndrome,|irritable bowel syndrome,
729445|NCT00511563|cytokine.|cytokine.
729446|NCT00511550|peripheral blood stem cells|peripheral blood stem cells
729447|NCT00511550|filgrastim-mobilized|filgrastim-mobilized
729448|NCT00511550|allogeneic transplantation|allogeneic transplantation
729449|NCT00511550|Unrelated Donors for allogeneic transplantation|unrelated donors for allogeneic transplantation
729451|NCT00511537|ALL|all
729452|NCT00511537|CML|cml
729453|NCT00511537|Lymphoma|lymphoma
729454|NCT00511537|Myelodysplasia|myelodysplasia
729455|NCT00511537|Unrelated stem cell transplantation|unrelated stem cell transplantation
729456|NCT00511537|Hematopoietic disorders|hematopoietic disorders
729457|NCT00511524|brain,|brain,
729458|NCT00511524|inflammation,|inflammation,
729459|NCT00511524|CB2,|cb2,
729460|NCT00511524|PET|pet
729461|NCT00511524|analgesia,|analgesia,
729462|NCT00511511|hypertension|hypertension
729463|NCT00511511|angiogenesis inhibitors|angiogenesis inhibitors
729464|NCT00511511|tyrosine kinase inhibitor|tyrosine kinase inhibitor
729465|NCT00511511|Sunitinib|sunitinib
729466|NCT00511498|Laparoscopic Radical Prostatectomy|laparoscopic radical prostatectomy
729467|NCT00511498|Nightly sildenafil|nightly sildenafil
729468|NCT00511485|Cancer|cancer
729469|NCT00511485|Adenocarcinoma|adenocarcinoma
729470|NCT00511485|Phase II|phase ii
729471|NCT00511485|Lung|lung
729472|NCT00511485|Non-small cell lung cancer|non-small cell lung cancer
729473|NCT00511485|NSCLC|nsclc
729474|NCT00511485|EC145|ec145
729475|NCT00511485|EC20|ec20
729476|NCT00511459|Randomized|randomized
729477|NCT00511459|4-Arm|4-arm
729478|NCT00511459|Placebo controlled|placebo controlled
729479|NCT00511459|Phase 2 Trial|phase 2 trial
729480|NCT00511459|AMG 386|amg 386
729481|NCT00511459|Paclitaxel|paclitaxel
729482|NCT00511459|Bevacizumab|bevacizumab
729483|NCT00511459|First-line Therapy|first-line therapy
729484|NCT00511459|Her-2 Negative|her-2 negative
729485|NCT00511459|Metastatic or Locally Recurrent Breast Cancer|metastatic or locally recurrent breast cancer
729486|NCT00511446|Stomach neoplasms|stomach neoplasms
729487|NCT00511446|docetaxel|docetaxel
729489|NCT00511446|capecitabine|capecitabine
729490|NCT00511420|cocoa|cocoa
729491|NCT00511420|cardiovascular disease|cardiovascular disease
729492|NCT00511420|blood pressure|blood pressure
729493|NCT00511407|Acute renal failure|acute renal failure
729494|NCT00511407|Bioartificial kidney|bioartificial kidney
729495|NCT00511407|Cell therapy|cell therapy
729496|NCT00511407|Hemofiltration|hemofiltration
729497|NCT00511407|Septic shock|septic shock
729498|NCT00511394|Decompensated Cirrhosis with Ascites|decompensated cirrhosis with ascites
729499|NCT00511381|Hearing Loss|hearing loss
729500|NCT00511381|Late-Onset Hearing Loss|late-onset hearing loss
729501|NCT00511381|Deafness|deafness
729503|NCT00511368|treatment experienced|treatment experienced
729504|NCT00511368|AIDS|aids
729505|NCT00511329|growth hormone|growth hormone
729506|NCT00511329|short stature|short stature
729507|NCT00511329|growth failure|growth failure
729508|NCT00511329|chronic illness|chronic illness
729509|NCT00511303|Philadelphia chromosome|philadelphia chromosome
729510|NCT00511303|protein-tyrosine kinases|protein-tyrosine kinases
729511|NCT00511290|Primary disease or condition being studied: Asthma -COPD-Interstitial Lung Diseases-Occupational Lung Diseases|primary disease or condition being studied: asthma -copd-interstitial lung diseases-occupational lung diseases
729512|NCT00511277|quetiapine|quetiapine
729513|NCT00511277|schizophrenia|schizophrenia
729514|NCT00511277|first-episode psychosis|first-episode psychosis
729515|NCT00511277|depression|depression
729516|NCT00511277|psychopathology|psychopathology
729517|NCT00511264|Laparoscopy|laparoscopy
729518|NCT00511264|Ultrasound|ultrasound
729519|NCT00511264|Cancer|cancer
729520|NCT00511264|Biopsy|biopsy
729521|NCT00511251|IS-SEM|is-sem
729522|NCT00511238|Onyx|onyx
729523|NCT00511238|PR171|pr171
729524|NCT00511238|carfilzomib|carfilzomib
729525|NCT00511238|multiple myeloma|multiple myeloma
729526|NCT00511238|relapsed|relapsed
729527|NCT00511238|refractory|refractory
729528|NCT00511225|dialysis|dialysis
729529|NCT00511225|Vitamin D|vitamin d
729530|NCT00511212|severe peritonitis|severe peritonitis
729531|NCT00511212|SSI|ssi
729532|NCT00511212|lower digestive tract surgery|lower digestive tract surgery
729533|NCT00511212|Severe peritonitis after lower digestive tract surgery|severe peritonitis after lower digestive tract surgery
729534|NCT00511186|Sepsis|sepsis
729535|NCT00511186|Alkaline Phosphatase|alkaline phosphatase
729536|NCT00511186|inflammation|inflammation
729537|NCT00511186|infection|infection
729538|NCT00511186|renal failure|renal failure
729539|NCT00511173|mechanical valve|mechanical valve
729540|NCT00511160|myocarditis|myocarditis
729541|NCT00511160|parvovirus B19 (PVB19)|parvovirus b19 (pvb19)
729542|NCT00511160|human herpes virus 6 (HHV6)|human herpes virus 6 (hhv6)
729543|NCT00511160|cardiac magnetic resonance tomography (CMR)|cardiac magnetic resonance tomography (cmr)
729544|NCT00511147|IVIG|ivig
729545|NCT00511147|ITP|itp
729546|NCT00511134|insomnia|insomnia
729547|NCT00511134|nicotine dependence|nicotine dependence
729548|NCT00511134|smoking|smoking
729549|NCT00511134|smoking cessation|smoking cessation
729550|NCT00511134|zyban|zyban
729551|NCT00511121|chronic myeloid leukemia|chronic myeloid leukemia
729552|NCT00511121|tyrosine kinase|tyrosine kinase
729553|NCT00511108|Type 2 Diabetes Mellitus (T2DM)|type 2 diabetes mellitus (t2dm)
729554|NCT00511095|Hepatitis B vaccine|hepatitis b vaccine
729555|NCT00511095|HBV vaccine|hbv vaccine
729556|NCT00511095|Hepatitis B|hepatitis b
729557|NCT00511095|Hepatitis|hepatitis
729558|NCT00511095|HBV|hbv
729559|NCT00511095|Vaccine|vaccine
729560|NCT00511095|1018|1018
729561|NCT00511095|HBsAg|hbsag
729562|NCT00511069|Bortezomib|bortezomib
729563|NCT00511069|CML033|cml033
729564|NCT00511056|HIV|hiv
729565|NCT00511056|Adherence|adherence
729566|NCT00511056|Compliance|compliance
729567|NCT00511056|Highly Active Antiretroviral Therapy (HAART)|highly active antiretroviral therapy (haart)
729568|NCT00511056|ARV|arv
729569|NCT00511056|ART|art
729570|NCT00511056|Sexual Risk Behavior|sexual risk behavior
729571|NCT00511056|Unsafe|unsafe
729572|NCT00511056|Transmission|transmission
729573|NCT00511043|PTK787|ptk787
729574|NCT00511043|DLCL|dlcl
729575|NCT00511043|Diffuse large cell lymphoma|diffuse large cell lymphoma
729576|NCT00511030|Diabetes|diabetes
729577|NCT00511017|Solid Tumors|solid tumors
729578|NCT00511017|Doxercalciferol|doxercalciferol
729579|NCT00511017|Pediatric Cancer|pediatric cancer
729580|NCT00511017|Recurrent Pediatric Solid Tumors|recurrent pediatric solid tumors
729582|NCT00511017|Vitamin D|vitamin d
729583|NCT00511004|Brugia Malayi|brugia malayi
729584|NCT00511004|Lymphatic Filariasis|lymphatic filariasis
729585|NCT00511004|Albendazole|albendazole
729586|NCT00511004|Diethylcarbamazine|diethylcarbamazine
729587|NCT00510991|ASTHMA|asthma
729588|NCT00510978|Inflammatory Bowel Disease IBD|inflammatory bowel disease ibd
729589|NCT00510978|Ulcerative Colitis|ulcerative colitis
729590|NCT00510978|Crohn's disease|crohn's disease
729591|NCT00510978|Probiotics|probiotics
729592|NCT00510978|Gastrointestinal|gastrointestinal
729593|NCT00510965|choroidal neovascularization|choroidal neovascularization
729594|NCT00510965|angioid streaks|angioid streaks
729595|NCT00510965|pseudoxanthoma elasticum|pseudoxanthoma elasticum
729596|NCT00510965|Groenblad-Strandberg-Syndrome|groenblad-strandberg-syndrome
729597|NCT00510965|therapy|therapy
729598|NCT00510965|ranibizumab|ranibizumab
729599|NCT00510965|lucentis|lucentis
729600|NCT00510965|Choroidal neovascularization in patients with PXE|choroidal neovascularization in patients with pxe
729601|NCT00510952|diabetes|diabetes
729602|NCT00510952|type 2|type 2
729603|NCT00510939|Acute myeloid leukemia|acute myeloid leukemia
729604|NCT00510939|NFkB activity and leukemia|nfkb activity and leukemia
729605|NCT00510939|expression of NFkB|expression of nfkb
729606|NCT00510913|Treatment efficacy|treatment efficacy
729607|NCT00510913|Transplantation rejection|transplantation rejection
729608|NCT00510913|Kidney transplantation|kidney transplantation
729609|NCT00510913|Cyclosporine|cyclosporine
729610|NCT00510913|tacrolimus|tacrolimus
729611|NCT00510887|follicular lymphoma|follicular lymphoma
729612|NCT00510887|Velcade|velcade
729613|NCT00510887|VR-FND|vr-fnd
729614|NCT00510874|Influenza|influenza
729615|NCT00510874|GSK 1557484A vaccine|gsk 1557484a vaccine
729616|NCT00510861|male age, assisted reproduction, sperm, pregnancy outcome|male age, assisted reproduction, sperm, pregnancy outcome
729617|NCT00510835|septic shock|septic shock
729618|NCT00510835|resuscitation|resuscitation
729619|NCT00510835|sepsis|sepsis
729620|NCT00510835|cost-effectiveness|cost-effectiveness
729621|NCT00510835|sepsis-induced organ dysfunction|sepsis-induced organ dysfunction
729622|NCT00510835|early goal directed therapy|early goal directed therapy
729623|NCT00510835|emergency medicine|emergency medicine
729624|NCT00510835|critical care medicine|critical care medicine
729625|NCT00510822|Cimicoxib|cimicoxib
729626|NCT00510822|Cox-2 inhibitor|cox-2 inhibitor
729627|NCT00510822|Sertraline|sertraline
729628|NCT00510796|Hereditary Non-Polyposis Colon Cancer|hereditary non-polyposis colon cancer
729629|NCT00510796|Colon Cancer|colon cancer
729630|NCT00510796|Endometrial Cancer|endometrial cancer
729631|NCT00510796|Cancer Screening|cancer screening
729632|NCT00510796|Interview|interview
729633|NCT00510796|HNPCC|hnpcc
729634|NCT00510783|tonic-clonic seizure|tonic-clonic seizure
729635|NCT00510783|emergency department|emergency department
729636|NCT00510783|IV levetiracetam|iv levetiracetam
729637|NCT00510783|Keppra|keppra
729638|NCT00510783|seizures|seizures
729639|NCT00510783|phenytoin|phenytoin
729640|NCT00510783|Dilantin|dilantin
729641|NCT00510783|Grand Mal seizure|grand mal seizure
729642|NCT00510770|CPAP|cpap
729643|NCT00510770|Post-opreative|post-opreative
729644|NCT00510770|ARF|arf
729645|NCT00510770|liver transplant|liver transplant
729646|NCT00510770|Post-operative hypoxemia in liver transplant|post-operative hypoxemia in liver transplant
729647|NCT00510744|obesity, bariatric surgery, pancreatic secretion|obesity, bariatric surgery, pancreatic secretion
729648|NCT00510731|Ventricular Tachycardia|ventricular tachycardia
729649|NCT00510731|Cardiac Sudden Death|cardiac sudden death
729650|NCT00510731|Ventricular Fibrillation|ventricular fibrillation
729651|NCT00510731|Heart Rate Variability|heart rate variability
729652|NCT00510718|Prostate|prostate
729653|NCT00510718|Cancer|cancer
729654|NCT00510718|Hormone|hormone
729655|NCT00510718|Refractory|refractory
729656|NCT00510718|Castration|castration
729657|NCT00510705|adiposity|adiposity
729658|NCT00510692|Eicosapentaenoic Acid|eicosapentaenoic acid
729659|NCT00510692|EPA|epa
729660|NCT00510692|EPA 99%|epa 99%
729661|NCT00510692|Fatty acid|fatty acid
729662|NCT00510692|omega-3|omega-3
729663|NCT00510692|apoptosis|apoptosis
729664|NCT00510692|cell proliferation|cell proliferation
729665|NCT00510692|colonic mucosa|colonic mucosa
729666|NCT00510692|polyp|polyp
729667|NCT00510692|Familial Adenomatous Polyposis Coli|familial adenomatous polyposis coli
729668|NCT00510692|FAP|fap
729669|NCT00510692|resolvin|resolvin
729670|NCT00510692|Ileo-rectal anastomosis|ileo-rectal anastomosis
729671|NCT00510692|IRA|ira
729672|NCT00510692|PUFA|pufa
729673|NCT00510692|Endoscopy|endoscopy
729674|NCT00510679|Benin|benin
729675|NCT00510679|child health|child health
729676|NCT00510679|developing country|developing country
729677|NCT00510679|health services research|health services research
729678|NCT00510679|health worker performance|health worker performance
729679|NCT00510679|Integrated Management of Childhood Illness|integrated management of childhood illness
729680|NCT00510666|Pain, Postoperative|pain, postoperative
729681|NCT00510666|Analgesics, Opioid|analgesics, opioid
729682|NCT00510666|Analgesia, Patient-Controlled|analgesia, patient-controlled
729683|NCT00510666|Pain Measurement|pain measurement
729684|NCT00510653|Ovarian Cancer|ovarian cancer
729685|NCT00510653|Primary Peritoneal Cancer|primary peritoneal cancer
729686|NCT00510653|Fallopian Tube Cancer|fallopian tube cancer
729687|NCT00510653|Recurrent Platinum-Resistant|recurrent platinum-resistant
729688|NCT00510653|Taxane-Resistant|taxane-resistant
729689|NCT00510653|Epithelial Ovarian Cancer|epithelial ovarian cancer
729690|NCT00510653|Imatinib Mesylate|imatinib mesylate
729691|NCT00510653|Gleevec|gleevec
729692|NCT00510653|STI571|sti571
729693|NCT00510653|Protein tyrosine kinase inhibitor|protein tyrosine kinase inhibitor
729694|NCT00510640|thyroid carcinoma|thyroid carcinoma
729695|NCT00510640|Sunitinib|sunitinib
729696|NCT00510640|RECIST guidelines|recist guidelines
729697|NCT00510627|Metastatic Liver Cancer|metastatic liver cancer
729698|NCT00510627|Colorectal Cancer|colorectal cancer
729699|NCT00510627|Radiofrequency Ablation|radiofrequency ablation
729700|NCT00510627|Chemotherapy|chemotherapy
729701|NCT00510614|Bacterial Vaginosis|bacterial vaginosis
729702|NCT00510614|Recurrent Bacterial Vaginosis|recurrent bacterial vaginosis
729703|NCT00510588|adiposity|adiposity
729704|NCT00510575|Juvenile Scoliosis|juvenile scoliosis
729705|NCT00510575|Adolescent Scoliosis|adolescent scoliosis
729706|NCT00510575|Scoliosis Management|scoliosis management
729707|NCT00510575|Spinal Fusion|spinal fusion
729708|NCT00510575|Scoliosis instrumentation|scoliosis instrumentation
729709|NCT00510575|Juvenile or Adolescent Idiopathic Scoliosis|juvenile or adolescent idiopathic scoliosis
729710|NCT00510562|Cranial manipulation|cranial manipulation
729711|NCT00510562|Visual function|visual function
729712|NCT00510536|Psoriasis, arthritis, arthralgia|psoriasis, arthritis, arthralgia
729713|NCT00510523|MS|ms
729714|NCT00510523|Balance|balance
729715|NCT00510523|Multiple Sclerosis|multiple sclerosis
729716|NCT00510510|COPD|copd
729717|NCT00510510|glycopyrronium bromide|glycopyrronium bromide
729718|NCT00510510|antimuscarinic|antimuscarinic
729719|NCT00510497|dendritic cell|dendritic cell
729720|NCT00510497|therapeutic vaccine|therapeutic vaccine
729721|NCT00510497|HIV-1|hiv-1
729722|NCT00510497|apoptotic cells|apoptotic cells
729723|NCT00510497|Phase I/II|phase i/ii
729724|NCT00510484|Pancreatic exocrine insufficiency|pancreatic exocrine insufficiency
729725|NCT00510484|Cystic Fibrosis|cystic fibrosis
729726|NCT00510445|Non Small Cell Lung Cancer|non small cell lung cancer
729727|NCT00510445|Advanced Non Small Cell Lung Cancer|advanced non small cell lung cancer
729728|NCT00510445|Metastatic Non Small Cell Lung Cancer|metastatic non small cell lung cancer
729729|NCT00510432|heparin|heparin
729730|NCT00510432|heparin-induced thrombocytopenia|heparin-induced thrombocytopenia
729731|NCT00510432|HIT|hit
729732|NCT00510432|allergy|allergy
729733|NCT00510432|skin|skin
729734|NCT00510432|dermatology|dermatology
729735|NCT00510432|DTH|dth
729736|NCT00510432|delayed-type hypersensitivity|delayed-type hypersensitivity
729737|NCT00510432|histology|histology
729738|NCT00510432|Patients receiving sc heparin therapy|patients receiving sc heparin therapy
729739|NCT00510432|Age over 18 years|age over 18 years
729740|NCT00510432|Recruitment will stop when 20 patients with skin lesions are included|recruitment will stop when 20 patients with skin lesions are included
729741|NCT00510419|Migraine|migraine
729742|NCT00510406|Lower Urinary Tract Symptoms|lower urinary tract symptoms
729743|NCT00510406|Treatment|treatment
729744|NCT00510406|Solifenacin succinate|solifenacin succinate
729745|NCT00510406|Tamsulosin hydrochloride|tamsulosin hydrochloride
729746|NCT00510406|Prostatic Hyperplasia|prostatic hyperplasia
729747|NCT00510393|Critical Limb Ischemia|critical limb ischemia
729748|NCT00510393|CLI|cli
729749|NCT00510393|Drug Eluting Stent|drug eluting stent
729750|NCT00510393|DES|des
729751|NCT00510393|Bare Metal Stent|bare metal stent
729752|NCT00510393|BMS|bms
729753|NCT00510367|Breast Cancer|breast cancer
729754|NCT00510367|FAC|fac
729755|NCT00510367|Doxorubicin|doxorubicin
729756|NCT00510367|Adriamycin|adriamycin
729757|NCT00510367|Rubex|rubex
729758|NCT00510367|5-Fluorouracil|5-fluorouracil
729759|NCT00510367|5-FU|5-fu
729760|NCT00510367|Adrucil|adrucil
729761|NCT00510367|Efudex|efudex
729762|NCT00510367|Cyclophosphamide|cyclophosphamide
729763|NCT00510367|Cytoxan|cytoxan
729764|NCT00510367|Neosar|neosar
729765|NCT00510367|Pregnancy|pregnancy
729766|NCT00510354|Progressive GIST|progressive gist
729767|NCT00510354|Resistance to Imatinib mesylate|resistance to imatinib mesylate
729768|NCT00510341|Behavior Change Counseling|behavior change counseling
729769|NCT00510341|Motivational Interviewing|motivational interviewing
729770|NCT00510341|Chronic Care Model|chronic care model
729771|NCT00510341|Communication|communication
729772|NCT00510341|Residency Training|residency training
729773|NCT00510341|Skill Assessment|skill assessment
729774|NCT00510328|whole body vibration|whole body vibration
729775|NCT00510328|muscle physiology|muscle physiology
729776|NCT00510315|leukemia|leukemia
729777|NCT00510315|survivors|survivors
729778|NCT00510315|women|women
729779|NCT00510315|leukemia survivors|leukemia survivors
729780|NCT00510315|cancer or a related illness|cancer or a related illness
729781|NCT00510315|Hodgkin's Lymphoma|hodgkin's lymphoma
729782|NCT00510315|Non-Hodgkin's Lymphoma|non-hodgkin's lymphoma
729783|NCT00510315|myelodysplastic syndrome|myelodysplastic syndrome
729784|NCT00510315|aplastic anemia|aplastic anemia
729785|NCT00510315|treated with total body irradiation|treated with total body irradiation
729786|NCT00510315|followed by an allogeneic or autologous stem cell transplant|followed by an allogeneic or autologous stem cell transplant
729787|NCT00510302|Ultraviolet Radiation|ultraviolet radiation
729788|NCT00510302|Melanoma|melanoma
729789|NCT00510302|Questionnaire|questionnaire
729791|NCT00510302|First Degree Relative|first degree relative
729792|NCT00510302|Interview|interview
729793|NCT00510289|Sorafenib|sorafenib
729794|NCT00510289|Myelodysplastic Syndromes|myelodysplastic syndromes
729795|NCT00510289|MDS|mds
729796|NCT00510263|Prednisolone|prednisolone
729797|NCT00510263|Valacyclovir|valacyclovir
729798|NCT00510250|Cervix Cancer|cervix cancer
729799|NCT00510250|Cervical Cancer|cervical cancer
729800|NCT00510250|Sorafenib|sorafenib
729801|NCT00510250|Cisplatin|cisplatin
729802|NCT00510250|Radiation|radiation
729803|NCT00510250|Radiotherapy|radiotherapy
729804|NCT00510250|Phase I|phase i
729805|NCT00510250|Phase II|phase ii
729806|NCT00510250|Carcinoma|carcinoma
729807|NCT00510250|Cancer|cancer
729808|NCT00510250|Cervix|cervix
729809|NCT00510237|HIV|hiv
729810|NCT00510237|Adolescents newly diagnosed with HIV|adolescents newly diagnosed with hiv
729811|NCT00510198|Heart Disease|heart disease
729812|NCT00510198|Congestive Heart Failure|congestive heart failure
729813|NCT00510198|Thoracic Fluid Monitoring|thoracic fluid monitoring
729814|NCT00510185|coronary artery disease|coronary artery disease
729815|NCT00510185|coronary angioplasty|coronary angioplasty
729816|NCT00510185|coronary artery bypass surgery|coronary artery bypass surgery
729817|NCT00510185|elderly|elderly
729818|NCT00510172|Headache|headache
729819|NCT00510172|Migraine|migraine
729820|NCT00510172|Vasodilatation|vasodilatation
729821|NCT00510159|Schistosoma haematobium|schistosoma haematobium
729822|NCT00510159|Praziquantel|praziquantel
729823|NCT00510159|Artesunate + Sulfamethoxypyrazine/pyrimethamine|artesunate + sulfamethoxypyrazine/pyrimethamine
729824|NCT00510159|Randomized double blind placebo controlled clinical trial|randomized double blind placebo controlled clinical trial
729825|NCT00510120|Attention Deficit and Disruptive Behavior Disorders|attention deficit and disruptive behavior disorders
729826|NCT00510120|Conduct Disorder|conduct disorder
729827|NCT00510120|Behavior Problems in Youth|behavior problems in youth
729828|NCT00510120|Argumentativeness|argumentativeness
729829|NCT00510120|Children|children
729830|NCT00510120|Therapy|therapy
729831|NCT00510120|Attention Deficit Disorder|attention deficit disorder
729832|NCT00510094|Social Skills|social skills
729833|NCT00510094|Anger Management|anger management
729834|NCT00510094|Relational Aggression|relational aggression
729835|NCT00510068|Phase III|phase iii
729836|NCT00510068|Advanced Neuroendocrine Tumor in adults|advanced neuroendocrine tumor in adults
729837|NCT00510068|RAD001|rad001
729838|NCT00510068|NET|net
729839|NCT00510068|everolimus|everolimus
729840|NCT00510068|mTOr|mtor
729841|NCT00510068|islet cell|islet cell
729842|NCT00510068|neuroendocrine|neuroendocrine
729843|NCT00510042|von Willebrand disease|von willebrand disease
729844|NCT00510042|von Willebrand factor|von willebrand factor
729845|NCT00510042|national study|national study
729846|NCT00510042|bleeding disorder|bleeding disorder
729847|NCT00510042|quality of life|quality of life
729849|NCT00510016|opioid withdrawal|opioid withdrawal
729850|NCT00510016|abstinence syndrome|abstinence syndrome
729851|NCT00510016|methadone|methadone
729852|NCT00510016|heroin|heroin
729853|NCT00510003|Atopic dermatitis, children, pimecrolimus, eczema|atopic dermatitis, children, pimecrolimus, eczema
729854|NCT00509990|Atopic dermatitis, pimecrolimus, children|atopic dermatitis, pimecrolimus, children
729855|NCT00509951|Neuroses|neuroses
729856|NCT00509951|Evidence-Based Treatment|evidence-based treatment
729857|NCT00509951|Clinical Investigation|clinical investigation
729858|NCT00509951|Young Patients|young patients
729859|NCT00509951|Phobic Disorders|phobic disorders
729860|NCT00509951|Fear|fear
729861|NCT00509951|Phobias|phobias
729862|NCT00509938|immunocompromized|immunocompromized
729863|NCT00509938|hLF1-11|hlf1-11
729864|NCT00509938|antimicrobial|antimicrobial
729865|NCT00509938|peptide|peptide
729866|NCT00509938|lactoferrin|lactoferrin
729867|NCT00509860|Advanced Sarcomas|advanced sarcomas
729868|NCT00509860|Irinotecan|irinotecan
729869|NCT00509860|Camptosar|camptosar
729870|NCT00509860|CPT-11|cpt-11
729871|NCT00509847|S. epidermidis|s. epidermidis
729872|NCT00509847|Staphylococcus|staphylococcus
729873|NCT00509847|Lactoferrin|lactoferrin
729874|NCT00509847|hLF1-11|hlf1-11
729875|NCT00509847|Bacteraemia|bacteraemia
729876|NCT00509834|hLF1-11|hlf1-11
729877|NCT00509834|Candida|candida
729878|NCT00509834|candidaemia|candidaemia
729879|NCT00509834|lactoferrin|lactoferrin
729880|NCT00509782|Solid Tumors|solid tumors
729881|NCT00509782|Anti-Tumor Effects|anti-tumor effects
729882|NCT00509782|ZIO-101|zio-101
729883|NCT00509769|Trastuzumab emtansine|trastuzumab emtansine
729884|NCT00509769|MBC|mbc
729885|NCT00509769|Breast cancer|breast cancer
729886|NCT00509769|HER2-positive breast cancer|her2-positive breast cancer
729887|NCT00509769|HER2|her2
729888|NCT00509756|healthy subjects|healthy subjects
729889|NCT00509743|Adult volunteers|adult volunteers
729890|NCT00509730|stress urinary incontinence|stress urinary incontinence
729891|NCT00509730|urodynamics|urodynamics
729892|NCT00509730|randomized clinical trial|randomized clinical trial
729893|NCT00509730|surgery|surgery
729894|NCT00509717|quality of health care|quality of health care
729895|NCT00509717|prescriptions, drug|prescriptions, drug
729896|NCT00509717|anticholesteremic agents|anticholesteremic agents
729897|NCT00509717|community pharmacy services|community pharmacy services
729898|NCT00509704|Sutent|sutent
729899|NCT00509704|tumor necrosis|tumor necrosis
729900|NCT00509704|DCE-MRI (Dynamic enhanced magnetic resonance imaging)|dce-mri (dynamic enhanced magnetic resonance imaging)
729901|NCT00509691|infection|infection
729902|NCT00509691|adult acute myeloid leukemia with 11q23 (MLL) abnormalities|adult acute myeloid leukemia with 11q23 (mll) abnormalities
729903|NCT00509691|adult acute myeloid leukemia with inv(16)(p13;q22)|adult acute myeloid leukemia with inv(16)(p13;q22)
729904|NCT00509691|adult acute myeloid leukemia with t(15;17)(q22;q12)|adult acute myeloid leukemia with t(15;17)(q22;q12)
729905|NCT00509691|adult acute myeloid leukemia with t(16;16)(p13;q22)|adult acute myeloid leukemia with t(16;16)(p13;q22)
729906|NCT00509691|adult acute myeloid leukemia with t(8;21)(q22;q22)|adult acute myeloid leukemia with t(8;21)(q22;q22)
729907|NCT00509691|accelerated phase chronic myelogenous leukemia|accelerated phase chronic myelogenous leukemia
729908|NCT00509691|adult acute lymphoblastic leukemia in remission|adult acute lymphoblastic leukemia in remission
729909|NCT00509691|adult acute myeloid leukemia in remission|adult acute myeloid leukemia in remission
729910|NCT00509691|atypical chronic myeloid leukemia, BCR-ABL1 negative|atypical chronic myeloid leukemia, bcr-abl1 negative
729911|NCT00509691|blastic phase chronic myelogenous leukemia|blastic phase chronic myelogenous leukemia
729912|NCT00509691|childhood acute lymphoblastic leukemia in remission|childhood acute lymphoblastic leukemia in remission
729913|NCT00509691|childhood acute myeloid leukemia in remission|childhood acute myeloid leukemia in remission
729914|NCT00509691|childhood chronic myelogenous leukemia|childhood chronic myelogenous leukemia
729915|NCT00509691|chronic eosinophilic leukemia|chronic eosinophilic leukemia
729916|NCT00509691|primary myelofibrosis|primary myelofibrosis
729917|NCT00509691|chronic myelomonocytic leukemia|chronic myelomonocytic leukemia
729918|NCT00509691|chronic neutrophilic leukemia|chronic neutrophilic leukemia
729919|NCT00509691|chronic phase chronic myelogenous leukemia|chronic phase chronic myelogenous leukemia
729920|NCT00509691|de novo myelodysplastic syndromes|de novo myelodysplastic syndromes
729921|NCT00509691|disseminated neuroblastoma|disseminated neuroblastoma
729922|NCT00509691|extranodal marginal zone B-cell lymphoma of mucosa-associated lymphoid tissue|extranodal marginal zone b-cell lymphoma of mucosa-associated lymphoid tissue
729923|NCT00509691|juvenile myelomonocytic leukemia|juvenile myelomonocytic leukemia
729924|NCT00509691|myelodysplastic/myeloproliferative neoplasm, unclassifiable|myelodysplastic/myeloproliferative neoplasm, unclassifiable
729925|NCT00509691|nodal marginal zone B-cell lymphoma|nodal marginal zone b-cell lymphoma
729926|NCT00509691|noncontiguous stage II adult Burkitt lymphoma|noncontiguous stage ii adult burkitt lymphoma
729927|NCT00509691|noncontiguous stage II adult diffuse large cell lymphoma|noncontiguous stage ii adult diffuse large cell lymphoma
729928|NCT00509691|noncontiguous stage II adult diffuse mixed cell lymphoma|noncontiguous stage ii adult diffuse mixed cell lymphoma
729929|NCT00509691|noncontiguous stage II adult diffuse small cleaved cell lymphoma|noncontiguous stage ii adult diffuse small cleaved cell lymphoma
729930|NCT00509691|noncontiguous stage II adult immunoblastic large cell lymphoma|noncontiguous stage ii adult immunoblastic large cell lymphoma
729931|NCT00509691|noncontiguous stage II adult lymphoblastic lymphoma|noncontiguous stage ii adult lymphoblastic lymphoma
729932|NCT00509691|noncontiguous stage II grade 1 follicular lymphoma|noncontiguous stage ii grade 1 follicular lymphoma
729933|NCT00509691|noncontiguous stage II grade 2 follicular lymphoma|noncontiguous stage ii grade 2 follicular lymphoma
729934|NCT00509691|noncontiguous stage II grade 3 follicular lymphoma|noncontiguous stage ii grade 3 follicular lymphoma
729935|NCT00509691|noncontiguous stage II mantle cell lymphoma|noncontiguous stage ii mantle cell lymphoma
729936|NCT00509691|noncontiguous stage II marginal zone lymphoma|noncontiguous stage ii marginal zone lymphoma
729937|NCT00509691|noncontiguous stage II small lymphocytic lymphoma|noncontiguous stage ii small lymphocytic lymphoma
729938|NCT00509691|high risk metastatic gestational trophoblastic tumor|high risk metastatic gestational trophoblastic tumor
729939|NCT00509691|previously treated childhood rhabdomyosarcoma|previously treated childhood rhabdomyosarcoma
729940|NCT00509691|previously treated myelodysplastic syndromes|previously treated myelodysplastic syndromes
729941|NCT00509691|recurrent adult acute lymphoblastic leukemia|recurrent adult acute lymphoblastic leukemia
729942|NCT00509691|recurrent adult acute myeloid leukemia|recurrent adult acute myeloid leukemia
729943|NCT00509691|recurrent adult Burkitt lymphoma|recurrent adult burkitt lymphoma
729944|NCT00509691|recurrent adult Hodgkin lymphoma|recurrent adult hodgkin lymphoma
729945|NCT00509691|recurrent adult diffuse large cell lymphoma|recurrent adult diffuse large cell lymphoma
729946|NCT00509691|recurrent adult diffuse mixed cell lymphoma|recurrent adult diffuse mixed cell lymphoma
729947|NCT00509691|recurrent adult diffuse small cleaved cell lymphoma|recurrent adult diffuse small cleaved cell lymphoma
729948|NCT00509691|recurrent adult immunoblastic large cell lymphoma|recurrent adult immunoblastic large cell lymphoma
729949|NCT00509691|recurrent adult lymphoblastic lymphoma|recurrent adult lymphoblastic lymphoma
729950|NCT00509691|recurrent breast cancer|recurrent breast cancer
729951|NCT00509691|recurrent/refractory childhood Hodgkin lymphoma|recurrent/refractory childhood hodgkin lymphoma
729952|NCT00509691|recurrent childhood acute lymphoblastic leukemia|recurrent childhood acute lymphoblastic leukemia
729953|NCT00509691|recurrent childhood acute myeloid leukemia|recurrent childhood acute myeloid leukemia
729954|NCT00509691|recurrent childhood large cell lymphoma|recurrent childhood large cell lymphoma
730286|NCT00508885|renal osteodystrophy|renal osteodystrophy
729955|NCT00509691|recurrent childhood lymphoblastic lymphoma|recurrent childhood lymphoblastic lymphoma
729956|NCT00509691|recurrent childhood rhabdomyosarcoma|recurrent childhood rhabdomyosarcoma
729957|NCT00509691|recurrent childhood small noncleaved cell lymphoma|recurrent childhood small noncleaved cell lymphoma
729958|NCT00509691|recurrent cutaneous T-cell non-Hodgkin lymphoma|recurrent cutaneous t-cell non-hodgkin lymphoma
729959|NCT00509691|recurrent grade 1 follicular lymphoma|recurrent grade 1 follicular lymphoma
729960|NCT00509691|recurrent grade 2 follicular lymphoma|recurrent grade 2 follicular lymphoma
729961|NCT00509691|recurrent grade 3 follicular lymphoma|recurrent grade 3 follicular lymphoma
729962|NCT00509691|recurrent mantle cell lymphoma|recurrent mantle cell lymphoma
729963|NCT00509691|recurrent marginal zone lymphoma|recurrent marginal zone lymphoma
729964|NCT00509691|recurrent mycosis fungoides/Sezary syndrome|recurrent mycosis fungoides/sezary syndrome
729965|NCT00509691|recurrent neuroblastoma|recurrent neuroblastoma
729966|NCT00509691|recurrent ovarian epithelial cancer|recurrent ovarian epithelial cancer
729967|NCT00509691|recurrent ovarian germ cell tumor|recurrent ovarian germ cell tumor
729968|NCT00509691|recurrent small lymphocytic lymphoma|recurrent small lymphocytic lymphoma
729969|NCT00509691|recurrent malignant testicular germ cell tumor|recurrent malignant testicular germ cell tumor
729970|NCT00509691|recurrent Wilms tumor and other childhood kidney tumors|recurrent wilms tumor and other childhood kidney tumors
729971|NCT00509691|refractory chronic lymphocytic leukemia|refractory chronic lymphocytic leukemia
729972|NCT00509691|refractory hairy cell leukemia|refractory hairy cell leukemia
729973|NCT00509691|refractory multiple myeloma|refractory multiple myeloma
729974|NCT00509691|relapsing chronic myelogenous leukemia|relapsing chronic myelogenous leukemia
729975|NCT00509691|secondary acute myeloid leukemia|secondary acute myeloid leukemia
729976|NCT00509691|secondary myelodysplastic syndromes|secondary myelodysplastic syndromes
729977|NCT00509691|splenic marginal zone lymphoma|splenic marginal zone lymphoma
729978|NCT00509691|stage I multiple myeloma|stage i multiple myeloma
729979|NCT00509691|stage II multiple myeloma|stage ii multiple myeloma
729980|NCT00509691|stage III adult Burkitt lymphoma|stage iii adult burkitt lymphoma
729981|NCT00509691|stage III adult Hodgkin lymphoma|stage iii adult hodgkin lymphoma
729982|NCT00509691|stage III adult diffuse large cell lymphoma|stage iii adult diffuse large cell lymphoma
729983|NCT00509691|stage III adult diffuse mixed cell lymphoma|stage iii adult diffuse mixed cell lymphoma
729984|NCT00509691|stage III adult diffuse small cleaved cell lymphoma|stage iii adult diffuse small cleaved cell lymphoma
729985|NCT00509691|stage III adult immunoblastic large cell lymphoma|stage iii adult immunoblastic large cell lymphoma
729986|NCT00509691|stage III adult lymphoblastic lymphoma|stage iii adult lymphoblastic lymphoma
729987|NCT00509691|stage III chronic lymphocytic leukemia|stage iii chronic lymphocytic leukemia
729988|NCT00509691|stage III grade 1 follicular lymphoma|stage iii grade 1 follicular lymphoma
729989|NCT00509691|stage III grade 2 follicular lymphoma|stage iii grade 2 follicular lymphoma
729990|NCT00509691|stage III grade 3 follicular lymphoma|stage iii grade 3 follicular lymphoma
729991|NCT00509691|stage III mantle cell lymphoma|stage iii mantle cell lymphoma
729992|NCT00509691|stage III marginal zone lymphoma|stage iii marginal zone lymphoma
729993|NCT00509691|stage III multiple myeloma|stage iii multiple myeloma
729994|NCT00509691|stage III small lymphocytic lymphoma|stage iii small lymphocytic lymphoma
729995|NCT00509691|stage III malignant testicular germ cell tumor|stage iii malignant testicular germ cell tumor
729996|NCT00509691|stage IIIA breast cancer|stage iiia breast cancer
729997|NCT00509691|stage IIIB breast cancer|stage iiib breast cancer
729998|NCT00509691|stage IIIC breast cancer|stage iiic breast cancer
729999|NCT00509691|stage IV adult Burkitt lymphoma|stage iv adult burkitt lymphoma
730000|NCT00509691|stage IV adult Hodgkin lymphoma|stage iv adult hodgkin lymphoma
730001|NCT00509691|stage IV adult diffuse large cell lymphoma|stage iv adult diffuse large cell lymphoma
730002|NCT00509691|stage IV adult diffuse mixed cell lymphoma|stage iv adult diffuse mixed cell lymphoma
730003|NCT00509691|stage IV adult diffuse small cleaved cell lymphoma|stage iv adult diffuse small cleaved cell lymphoma
730004|NCT00509691|stage IV adult immunoblastic large cell lymphoma|stage iv adult immunoblastic large cell lymphoma
730005|NCT00509691|stage IV adult lymphoblastic lymphoma|stage iv adult lymphoblastic lymphoma
730006|NCT00509691|stage IV breast cancer|stage iv breast cancer
730007|NCT00509691|stage IV chronic lymphocytic leukemia|stage iv chronic lymphocytic leukemia
730008|NCT00509691|stage IV grade 1 follicular lymphoma|stage iv grade 1 follicular lymphoma
730009|NCT00509691|stage IV grade 2 follicular lymphoma|stage iv grade 2 follicular lymphoma
730010|NCT00509691|stage IV grade 3 follicular lymphoma|stage iv grade 3 follicular lymphoma
730011|NCT00509691|stage IV mantle cell lymphoma|stage iv mantle cell lymphoma
730087|NCT00509496|Refractory|refractory
730012|NCT00509691|stage IV marginal zone lymphoma|stage iv marginal zone lymphoma
730013|NCT00509691|stage IV ovarian epithelial cancer|stage iv ovarian epithelial cancer
730014|NCT00509691|stage IV small lymphocytic lymphoma|stage iv small lymphocytic lymphoma
730015|NCT00509691|stage IIA ovarian epithelial cancer|stage iia ovarian epithelial cancer
730016|NCT00509691|stage IIA ovarian germ cell tumor|stage iia ovarian germ cell tumor
730017|NCT00509691|stage IIB ovarian epithelial cancer|stage iib ovarian epithelial cancer
730018|NCT00509691|stage IIB ovarian germ cell tumor|stage iib ovarian germ cell tumor
730019|NCT00509691|stage IIC ovarian epithelial cancer|stage iic ovarian epithelial cancer
730020|NCT00509691|stage IIC ovarian germ cell tumor|stage iic ovarian germ cell tumor
730021|NCT00509691|stage IIIA ovarian epithelial cancer|stage iiia ovarian epithelial cancer
730022|NCT00509691|stage IIIA ovarian germ cell tumor|stage iiia ovarian germ cell tumor
730023|NCT00509691|stage IIIB ovarian epithelial cancer|stage iiib ovarian epithelial cancer
730024|NCT00509691|stage IIIB ovarian germ cell tumor|stage iiib ovarian germ cell tumor
730025|NCT00509691|stage IIIC ovarian epithelial cancer|stage iiic ovarian epithelial cancer
730026|NCT00509691|stage IIIC ovarian germ cell tumor|stage iiic ovarian germ cell tumor
730027|NCT00509691|stage IV ovarian germ cell tumor|stage iv ovarian germ cell tumor
730028|NCT00509678|Rituximab|rituximab
730030|NCT00509678|Psoriatic Arthritis|psoriatic arthritis
730031|NCT00509678|Arthritis|arthritis
730032|NCT00509665|recurrent squamous cell carcinoma of the hypopharynx|recurrent squamous cell carcinoma of the hypopharynx
730033|NCT00509665|recurrent squamous cell carcinoma of the larynx|recurrent squamous cell carcinoma of the larynx
730034|NCT00509665|recurrent verrucous carcinoma of the larynx|recurrent verrucous carcinoma of the larynx
730035|NCT00509665|recurrent adenoid cystic carcinoma of the oral cavity|recurrent adenoid cystic carcinoma of the oral cavity
730036|NCT00509665|recurrent basal cell carcinoma of the lip|recurrent basal cell carcinoma of the lip
730037|NCT00509665|recurrent mucoepidermoid carcinoma of the oral cavity|recurrent mucoepidermoid carcinoma of the oral cavity
730038|NCT00509665|recurrent squamous cell carcinoma of the lip and oral cavity|recurrent squamous cell carcinoma of the lip and oral cavity
730039|NCT00509665|recurrent verrucous carcinoma of the oral cavity|recurrent verrucous carcinoma of the oral cavity
730040|NCT00509665|recurrent metastatic squamous neck cancer with occult primary|recurrent metastatic squamous neck cancer with occult primary
730041|NCT00509665|recurrent lymphoepithelioma of the nasopharynx|recurrent lymphoepithelioma of the nasopharynx
730042|NCT00509665|recurrent squamous cell carcinoma of the nasopharynx|recurrent squamous cell carcinoma of the nasopharynx
730043|NCT00509665|recurrent esthesioneuroblastoma of the paranasal sinus and nasal cavity|recurrent esthesioneuroblastoma of the paranasal sinus and nasal cavity
730044|NCT00509665|recurrent inverted papilloma of the paranasal sinus and nasal cavity|recurrent inverted papilloma of the paranasal sinus and nasal cavity
730045|NCT00509665|recurrent midline lethal granuloma of the paranasal sinus and nasal cavity|recurrent midline lethal granuloma of the paranasal sinus and nasal cavity
730046|NCT00509665|recurrent squamous cell carcinoma of the paranasal sinus and nasal cavity|recurrent squamous cell carcinoma of the paranasal sinus and nasal cavity
730047|NCT00509665|recurrent salivary gland cancer|recurrent salivary gland cancer
730048|NCT00509665|recurrent lymphoepithelioma of the oropharynx|recurrent lymphoepithelioma of the oropharynx
730049|NCT00509665|recurrent squamous cell carcinoma of the oropharynx|recurrent squamous cell carcinoma of the oropharynx
730050|NCT00509652|Hemochromatosis|hemochromatosis
730051|NCT00509652|Primary hemochromatosis|primary hemochromatosis
730052|NCT00509652|Hereditary hemochromatosis|hereditary hemochromatosis
730053|NCT00509652|Therapy|therapy
730054|NCT00509652|Erythrocyte apheresis|erythrocyte apheresis
730055|NCT00509652|Phlebotomy|phlebotomy
730056|NCT00509652|Apheresis|apheresis
730057|NCT00509652|Efficacy|efficacy
730058|NCT00509626|fatigue|fatigue
730059|NCT00509626|psychosocial effects of cancer and its treatment|psychosocial effects of cancer and its treatment
730060|NCT00509626|weight changes|weight changes
730061|NCT00509626|depression|depression
730062|NCT00509626|stage I breast cancer|stage i breast cancer
730063|NCT00509626|stage II breast cancer|stage ii breast cancer
730064|NCT00509600|Juvenile Myelomonocytic Leukemia|juvenile myelomonocytic leukemia
730065|NCT00509600|JMML|jmml
730066|NCT00509600|Leukemia|leukemia
730067|NCT00509600|Etanercept|etanercept
730068|NCT00509600|Enbrel|enbrel
730069|NCT00509574|Single Nucleotide Polymorphism|single nucleotide polymorphism
730070|NCT00509574|statins|statins
730071|NCT00509574|hyperlipidemia|hyperlipidemia
730072|NCT00509561|adenocarcinoma of the esophagus|adenocarcinoma of the esophagus
730073|NCT00509561|squamous cell carcinoma of the esophagus|squamous cell carcinoma of the esophagus
730074|NCT00509561|stage IA esophageal cancer|stage ia esophageal cancer
730075|NCT00509561|stage IB esophageal cancer|stage ib esophageal cancer
730076|NCT00509561|stage IIA esophageal cancer|stage iia esophageal cancer
730077|NCT00509561|stage IIB esophageal cancer|stage iib esophageal cancer
730078|NCT00509561|stage IIIA esophageal cancer|stage iiia esophageal cancer
730079|NCT00509561|stage IIIB esophageal cancer|stage iiib esophageal cancer
730080|NCT00509561|stage IIIC esophageal cancer|stage iiic esophageal cancer
730081|NCT00509535|Vitreoscilla filiformis extract|vitreoscilla filiformis extract
730082|NCT00509535|SCORAD|scorad
730083|NCT00509535|pruritus|pruritus
730084|NCT00509535|microflora|microflora
730085|NCT00509535|TEWL|tewl
730086|NCT00509509|Hereditary Breast Cancer (BRCA1, BRCA2)|hereditary breast cancer (brca1, brca2)
730088|NCT00509496|Gene Therapy|gene therapy
730089|NCT00509496|HLA-A2 Positive|hla-a2 positive
730090|NCT00509496|Stage IV Melanoma|stage iv melanoma
730091|NCT00509496|Melanoma|melanoma
730092|NCT00509496|Skin Cancer|skin cancer
730093|NCT00509496|Malignant Melanoma|malignant melanoma
730094|NCT00509483|multinodular|multinodular
730095|NCT00509483|goitre|goitre
730096|NCT00509483|recombinant human TSH|recombinant human tsh
730097|NCT00509457|NSCLC, vaccination|nsclc, vaccination
730098|NCT00509457|Inoperable NSCLC stage IIIA/B in good performance status|inoperable nsclc stage iiia/b in good performance status
730099|NCT00509431|adult giant cell glioblastoma|adult giant cell glioblastoma
730100|NCT00509431|adult gliosarcoma|adult gliosarcoma
730101|NCT00509431|adult anaplastic astrocytoma|adult anaplastic astrocytoma
730102|NCT00509431|adult anaplastic oligodendroglioma|adult anaplastic oligodendroglioma
730103|NCT00509431|adult mixed glioma|adult mixed glioma
730104|NCT00509431|recurrent adult brain tumor|recurrent adult brain tumor
730105|NCT00509431|adult glioblastoma|adult glioblastoma
730106|NCT00509431|adult pilocytic astrocytoma|adult pilocytic astrocytoma
730107|NCT00509431|adult diffuse astrocytoma|adult diffuse astrocytoma
730108|NCT00509431|adult subependymal giant cell astrocytoma|adult subependymal giant cell astrocytoma
730109|NCT00509431|adult oligodendroglioma|adult oligodendroglioma
730110|NCT00509418|Nonalcoholic steatohepatitis|nonalcoholic steatohepatitis
730111|NCT00509418|Nonalcoholic Fatty Liver|nonalcoholic fatty liver
730112|NCT00509418|Nutritional supplement|nutritional supplement
730113|NCT00509418|Diet|diet
730114|NCT00509418|Exercise|exercise
730115|NCT00509405|Endogenous acid production|endogenous acid production
730116|NCT00509405|metabolic acidosis|metabolic acidosis
730117|NCT00509405|potassium citrate|potassium citrate
730118|NCT00509405|osteoporosis|osteoporosis
730119|NCT00509405|sarcopenia|sarcopenia
730120|NCT00509405|hypertension|hypertension
730121|NCT00509405|Effect of potassium citrate on bone mineral density and bone mass|effect of potassium citrate on bone mineral density and bone mass
730122|NCT00509392|Varicose veins, venous reflux, GSV disease|varicose veins, venous reflux, gsv disease
730123|NCT00509379|Relapsed/refractory indolent lymphoma|relapsed/refractory indolent lymphoma
730124|NCT00509379|Non-follicular Lymphoma|non-follicular lymphoma
730125|NCT00509379|Mantle cell non-Hodgkin Lymphoma|mantle cell non-hodgkin lymphoma
730126|NCT00509379|Patients naïve or sensitive to rituximab|patients naïve or sensitive to rituximab
730127|NCT00509379|Patients not eligible for high dose chemotherapy with ASCT|patients not eligible for high dose chemotherapy with asct
730128|NCT00509366|genomics|genomics
730129|NCT00509366|genomics predictor|genomics predictor
730130|NCT00509366|genomics analysis|genomics analysis
730131|NCT00509366|squamous|squamous
730132|NCT00509366|non-squamous|non-squamous
730133|NCT00509353|recurrent neuroblastoma|recurrent neuroblastoma
730134|NCT00509340|antiretroviral|antiretroviral
730135|NCT00509340|adherence|adherence
730136|NCT00509340|poor antiretroviral adherence|poor antiretroviral adherence
730137|NCT00509327|postoperative ileus|postoperative ileus
730138|NCT00509327|colorectal surgery|colorectal surgery
730139|NCT00509327|bisacodyl|bisacodyl
730140|NCT00509327|laxatives|laxatives
730141|NCT00509301|brain cancer|brain cancer
730142|NCT00509301|Cotara|cotara
730143|NCT00509301|radioactive isotope|radioactive isotope
730144|NCT00509301|monoclonal antibody|monoclonal antibody
730145|NCT00509301|radiation distribution|radiation distribution
730146|NCT00509288|Refractory|refractory
730147|NCT00509288|Gene Therapy|gene therapy
730148|NCT00509288|HLA-A2 Positive|hla-a2 positive
730149|NCT00509288|Stage IV Melanoma|stage iv melanoma
730150|NCT00509288|Melanoma|melanoma
730151|NCT00509288|Skin Cancer|skin cancer
730152|NCT00509288|Malignant Melanoma|malignant melanoma
730153|NCT00509223|Type 2 diabetes|type 2 diabetes
730154|NCT00509223|Obstructive sleep apnea|obstructive sleep apnea
730155|NCT00509223|Glycemic control|glycemic control
730156|NCT00509223|Insulin resistance|insulin resistance
730157|NCT00509223|Sleep disordered breathing|sleep disordered breathing
730158|NCT00509210|Liver Disease|liver disease
730159|NCT00509197|Asthma|asthma
730160|NCT00509197|Non-eosinophilic Asthma|non-eosinophilic asthma
730161|NCT00509197|sputum eosinophils|sputum eosinophils
730162|NCT00509197|Inhaled Corticosteroids|inhaled corticosteroids
730163|NCT00509184|untreated|untreated
730164|NCT00509171|embolism|embolism
730165|NCT00509171|femur fracture|femur fracture
730166|NCT00509171|lavage|lavage
730167|NCT00509171|TEE|tee
730168|NCT00509171|reamer|reamer
730169|NCT00509171|IM nail|im nail
730170|NCT00509158|safety|safety
730171|NCT00509158|immunogenicity|immunogenicity
730172|NCT00509158|efficacy|efficacy
730173|NCT00509145|Relapsing|relapsing
730174|NCT00509145|Remitting|remitting
730175|NCT00509119|apoplexia|apoplexia
730176|NCT00509119|Intracranial and intraarterial pressure curves in acute apoplectic patients|intracranial and intraarterial pressure curves in acute apoplectic patients
730177|NCT00509106|ceftaroline|ceftaroline
730178|NCT00509106|Community-acquired pneumonia|community-acquired pneumonia
730179|NCT00509106|CAP|cap
730180|NCT00509106|Streptococcus pneumoniae|streptococcus pneumoniae
730181|NCT00509106|Haemophilus influenzae|haemophilus influenzae
730182|NCT00509106|Mycoplasma pneumoniae|mycoplasma pneumoniae
730183|NCT00509106|Chlamydophila spp|chlamydophila spp
730184|NCT00509106|Legionella ssp|legionella ssp
730185|NCT00509106|multi-drug resistant Streptococcus pneumoniae (MDRSP)|multi-drug resistant streptococcus pneumoniae (mdrsp)
730186|NCT00509106|antimicrobial resistance|antimicrobial resistance
730187|NCT00509106|pneumococci|pneumococci
730188|NCT00509106|beta-lactam|beta-lactam
730189|NCT00509106|ceftaroline fosamil|ceftaroline fosamil
730190|NCT00509106|ceftriaxone|ceftriaxone
730191|NCT00509106|antibiotic|antibiotic
730192|NCT00509093|adult acute minimally differentiated myeloid leukemia (M0)|adult acute minimally differentiated myeloid leukemia (m0)
730287|NCT00508872|Colorectal Liver Metastases|colorectal liver metastases
730193|NCT00509093|adult acute myeloblastic leukemia with maturation (M2)|adult acute myeloblastic leukemia with maturation (m2)
730194|NCT00509093|adult acute myeloblastic leukemia without maturation (M1)|adult acute myeloblastic leukemia without maturation (m1)
730195|NCT00509093|adult acute myeloid leukemia with 11q23 (MLL) abnormalities|adult acute myeloid leukemia with 11q23 (mll) abnormalities
730196|NCT00509093|adult acute myeloid leukemia with inv(16)(p13;q22)|adult acute myeloid leukemia with inv(16)(p13;q22)
730197|NCT00509093|adult acute myeloid leukemia with t(16;16)(p13;q22)|adult acute myeloid leukemia with t(16;16)(p13;q22)
730198|NCT00509093|adult acute myeloid leukemia with t(8;21)(q22;q22)|adult acute myeloid leukemia with t(8;21)(q22;q22)
730199|NCT00509093|adult acute myelomonocytic leukemia (M4)|adult acute myelomonocytic leukemia (m4)
730200|NCT00509093|adult acute megakaryoblastic leukemia (M7)|adult acute megakaryoblastic leukemia (m7)
730201|NCT00509093|adult acute monoblastic leukemia (M5a)|adult acute monoblastic leukemia (m5a)
730202|NCT00509093|adult acute monocytic leukemia (M5b)|adult acute monocytic leukemia (m5b)
730203|NCT00509093|adult erythroleukemia (M6a)|adult erythroleukemia (m6a)
730204|NCT00509093|adult pure erythroid leukemia (M6b)|adult pure erythroid leukemia (m6b)
730205|NCT00509093|adult acute basophilic leukemia|adult acute basophilic leukemia
730206|NCT00509093|adult acute eosinophilic leukemia|adult acute eosinophilic leukemia
730207|NCT00509093|adult acute myeloid leukemia in remission|adult acute myeloid leukemia in remission
730208|NCT00509080|mitral regurgitation|mitral regurgitation
730209|NCT00509080|BNP|bnp
730210|NCT00509080|NT-proBNP|nt-probnp
730211|NCT00509080|natriuretic peptides|natriuretic peptides
730212|NCT00509080|valvular heart disease|valvular heart disease
730213|NCT00509067|Schizoaffective Disorder|schizoaffective disorder
730214|NCT00509067|Acetylcholine|acetylcholine
730215|NCT00509067|Nicotinic Receptors|nicotinic receptors
730216|NCT00509067|Nicotine|nicotine
730217|NCT00509067|Galantamine|galantamine
730218|NCT00509067|negative symptoms|negative symptoms
730219|NCT00509054|Parastomal hernia, wound infection, stoma care.|parastomal hernia, wound infection, stoma care.
730220|NCT00509041|advanced malignant mesothelioma|advanced malignant mesothelioma
730221|NCT00509041|epithelial mesothelioma|epithelial mesothelioma
730222|NCT00509041|recurrent malignant mesothelioma|recurrent malignant mesothelioma
730223|NCT00509041|sarcomatous mesothelioma|sarcomatous mesothelioma
730224|NCT00509028|Asthma|asthma
730225|NCT00509028|Bronchial|bronchial
730226|NCT00509015|antimalarials|antimalarials
730227|NCT00509015|malaria transmission|malaria transmission
730228|NCT00509015|mass drug administration|mass drug administration
730229|NCT00509015|artemisinin-based combination therapy|artemisinin-based combination therapy
730230|NCT00509015|primaquine|primaquine
730231|NCT00509015|gametocytes|gametocytes
730232|NCT00509015|QT-NASBA|qt-nasba
730233|NCT00509002|Salivary Gland Cancer|salivary gland cancer
730234|NCT00509002|Iressa|iressa
730235|NCT00509002|ZD1839|zd1839
730236|NCT00508989|Acetylcholine|acetylcholine
730237|NCT00508989|Forearm Blood Flow|forearm blood flow
730238|NCT00508989|HDL|hdl
730239|NCT00508989|L-NMMA|l-nmma
730240|NCT00508989|Sickle Cell Anemia|sickle cell anemia
730241|NCT00508989|Sickle Cell Disease|sickle cell disease
730242|NCT00508976|bupivacaine|bupivacaine
730243|NCT00508976|marcaine|marcaine
730244|NCT00508976|lidocaine|lidocaine
730245|NCT00508976|normal saline|normal saline
730246|NCT00508976|narcotics|narcotics
730247|NCT00508976|analog pain scale|analog pain scale
730248|NCT00508976|postoperative pain|postoperative pain
730249|NCT00508976|preemptive|preemptive
730250|NCT00508976|aerosolization|aerosolization
730251|NCT00508976|streamed|streamed
730252|NCT00508963|New World Cutaneous or Mucocutaneous Leishmaniasis|new world cutaneous or mucocutaneous leishmaniasis
730253|NCT00508950|Vaccines|vaccines
730254|NCT00508950|Pneumococcal Conjugate Vaccine|pneumococcal conjugate vaccine
730255|NCT00508950|Adult|adult
730256|NCT00508937|Diet|diet
730257|NCT00508937|Protein|protein
730258|NCT00508937|Glucose|glucose
730259|NCT00508937|Insulin|insulin
730260|NCT00508937|Cholesterol|cholesterol
730261|NCT00508937|Triglycerides|triglycerides
730262|NCT00508937|LDL subclasses|ldl subclasses
730263|NCT00508924|Argatroban|argatroban
730264|NCT00508924|Direct thrombin inhibitor|direct thrombin inhibitor
730265|NCT00508924|Percutaneous coronary intervention|percutaneous coronary intervention
730266|NCT00508924|Activated clotting time|activated clotting time
730267|NCT00508924|PCI|pci
730268|NCT00508924|ACT|act
730269|NCT00508911|open-label,|open-label,
730270|NCT00508911|oral contraceptive,|oral contraceptive,
730271|NCT00508911|Combine Oral Contraceptives,|combine oral contraceptives,
730272|NCT00508911|single-sequence,|single-sequence,
730273|NCT00508911|volunteers|volunteers
730274|NCT00508911|GW876008,|gw876008,
730275|NCT00508911|repeat-dose,|repeat-dose,
730276|NCT00508911|female,|female,
730277|NCT00508911|pharmacokinetics,|pharmacokinetics,
730278|NCT00508898|lupus nephritis|lupus nephritis
730279|NCT00508898|proteinuria|proteinuria
730280|NCT00508898|chronic kidney diseases|chronic kidney diseases
730281|NCT00508898|SLE|sle
730282|NCT00508885|hyperphosphatemia|hyperphosphatemia
730283|NCT00508885|niacinamide|niacinamide
730284|NCT00508885|ESRD|esrd
730285|NCT00508885|peritoneal dialysis|peritoneal dialysis
730290|NCT00508872|Fluorouracil|fluorouracil
730291|NCT00508872|Leucovorin|leucovorin
730292|NCT00508872|Bevacizumab|bevacizumab
730293|NCT00508872|Anti-VEGF monoclonal antibody|anti-vegf monoclonal antibody
730294|NCT00508872|rhuMAb-VEGF|rhumab-vegf
730295|NCT00508872|Folfox-B|folfox-b
730296|NCT00508872|5-FU|5-fu
730297|NCT00508872|Avastin|avastin
730298|NCT00508859|depression|depression
730299|NCT00508859|adolescents|adolescents
730300|NCT00508859|maintenance treatment|maintenance treatment
730301|NCT00508859|antidepressant|antidepressant
730302|NCT00508846|Hereditary Non-Polyposis Colon Cancer|hereditary non-polyposis colon cancer
730303|NCT00508846|Gynecologic Cancers|gynecologic cancers
730304|NCT00508846|Genetic Counseling|genetic counseling
730305|NCT00508846|Questionnaire|questionnaire
730306|NCT00508846|Survey|survey
730307|NCT00508846|HNPCC|hnpcc
730308|NCT00508833|Adjuvants|adjuvants
730309|NCT00508833|HBsAg|hbsag
730310|NCT00508820|Platelet|platelet
730311|NCT00508820|AMG 531|amg 531
730312|NCT00508820|Thrombopoietin|thrombopoietin
730313|NCT00508820|blood disorder|blood disorder
730314|NCT00508820|bleeding disorder|bleeding disorder
730315|NCT00508820|immune thrombocytopenic purpura|immune thrombocytopenic purpura
730316|NCT00508820|idiopathic thrombocytopenic purpura|idiopathic thrombocytopenic purpura
730317|NCT00508820|immune (idiopathic) thrombocytopenic purpura|immune (idiopathic) thrombocytopenic purpura
730318|NCT00508820|TPO|tpo
730319|NCT00508820|thrombopoietic protein|thrombopoietic protein
730320|NCT00508807|Lymphoid Malignancies|lymphoid malignancies
730321|NCT00508807|Solid Tumors|solid tumors
730322|NCT00508807|RTA 402|rta 402
730323|NCT00508794|Breast Cancer|breast cancer
730324|NCT00508794|Tibetan Yoga|tibetan yoga
730325|NCT00508794|Stretching Program|stretching program
730326|NCT00508794|Yoga|yoga
730327|NCT00508794|Quality of Life|quality of life
730328|NCT00508794|Questionnaire|questionnaire
730329|NCT00508794|Survey|survey
730330|NCT00508768|Rheumatoid Arthritis|rheumatoid arthritis
730331|NCT00508768|Methotrexate|methotrexate
730332|NCT00508755|cerebrovascular accident|cerebrovascular accident
730333|NCT00508755|electrical stimulation|electrical stimulation
730334|NCT00508755|gait training|gait training
730335|NCT00508755|motor learning|motor learning
730336|NCT00508742|Nasopharyngeal Colonization|nasopharyngeal colonization
730337|NCT00508742|Streptococcus pneumoniae|streptococcus pneumoniae
730338|NCT00508742|Healthy Infants|healthy infants
730339|NCT00508742|Vaccines|vaccines
730340|NCT00508742|Pneumococcal Conjugate Vaccine|pneumococcal conjugate vaccine
730341|NCT00508716|Congestive Heart Failure|congestive heart failure
730342|NCT00508716|Health Literacy|health literacy
730343|NCT00508716|Health Education|health education
730344|NCT00508716|Congestive Heart Failure (inpatients)|congestive heart failure (inpatients)
730345|NCT00508703|Uterine Cancer|uterine cancer
730346|NCT00508703|Cervical Cancer|cervical cancer
730347|NCT00508703|Endometrial Cancer|endometrial cancer
730348|NCT00508703|Intensity Modulated Radiotherapy|intensity modulated radiotherapy
730349|NCT00508703|IMRT|imrt
730350|NCT00508703|Computed Tomography|computed tomography
730351|NCT00508703|CT|ct
730352|NCT00508703|CT Scan|ct scan
730353|NCT00508690|Antibiotic Prophylaxis|antibiotic prophylaxis
730354|NCT00508690|Colorectal Surgery|colorectal surgery
730355|NCT00508690|Laparoscopy|laparoscopy
730356|NCT00508677|Attention Deficit Hyperactivity Disorder|attention deficit hyperactivity disorder
730357|NCT00508677|Mazindol|mazindol
730358|NCT00508664|by laryngectomy operable carcinoma of the larynx and the hypopharynx|by laryngectomy operable carcinoma of the larynx and the hypopharynx
730359|NCT00508651|parainfluenza virus, children, vaccine|parainfluenza virus, children, vaccine
730360|NCT00508638|Heart Failure|heart failure
730361|NCT00508612|Blood Pressure|blood pressure
730362|NCT00508612|Systolic Blood Pressure|systolic blood pressure
730363|NCT00508612|Diastolic Blood Pressure|diastolic blood pressure
730364|NCT00508612|Ambulatory Blood Pressure Monitoring|ambulatory blood pressure monitoring
730365|NCT00508612|Relaxation|relaxation
730366|NCT00508612|Meditation|meditation
730367|NCT00508612|Coping Skills|coping skills
730368|NCT00508612|Adolescents|adolescents
730369|NCT00508599|type 2 diabetes|type 2 diabetes
730370|NCT00508599|bed rest|bed rest
730371|NCT00508599|insulin resistance|insulin resistance
730372|NCT00508599|insulin|insulin
730373|NCT00508599|glucose|glucose
730374|NCT00508599|orthostatic response|orthostatic response
730375|NCT00508586|Breast cancer|breast cancer
730376|NCT00508586|PTC299|ptc299
730377|NCT00508586|VEGF|vegf
730378|NCT00508586|Angiogenesis|angiogenesis
730379|NCT00508586|Post-transcriptional control|post-transcriptional control
730380|NCT00508586|Aromatase inhibitors|aromatase inhibitors
730381|NCT00508573|Hereditary Nonpolyposis Colorectal Cancer|hereditary nonpolyposis colorectal cancer
730382|NCT00508573|Lynch Syndrome|lynch syndrome
730383|NCT00508573|HNPCC|hnpcc
730384|NCT00508573|Syndrome Registry|syndrome registry
730385|NCT00508573|Questionnaire|questionnaire
730386|NCT00508573|Endometrial cancer|endometrial cancer
730387|NCT00508573|Ovarian cancer|ovarian cancer
730388|NCT00508560|Contingency management|contingency management
730389|NCT00508560|Smoking cessation|smoking cessation
730390|NCT00508560|Psychotic disorders|psychotic disorders
730391|NCT00508560|Veterans|veterans
730392|NCT00508547|Methotrexate|methotrexate
730393|NCT00508547|Acitretin|acitretin
730394|NCT00508547|Cyclosporine|cyclosporine
730395|NCT00508547|Systemic PUVA|systemic puva
730396|NCT00508547|Infliximab|infliximab
730397|NCT00508547|Adalimumab|adalimumab
730398|NCT00508547|Alefacept|alefacept
730399|NCT00508547|Efalizumab|efalizumab
730400|NCT00508547|Etanercept|etanercept
730401|NCT00508547|Psoriasis|psoriasis
730402|NCT00508547|Psoriatic arthritis|psoriatic arthritis
730403|NCT00508547|Skin disease|skin disease
730404|NCT00508547|Cosentyx|cosentyx
730405|NCT00508534|pharmacokinetic study,|pharmacokinetic study,
730406|NCT00508534|gastric pH|gastric ph
730407|NCT00508521|cerebrovascular accident|cerebrovascular accident
730408|NCT00508521|electrical stimulation|electrical stimulation
730409|NCT00508521|motor learning|motor learning
730410|NCT00508521|upper extremity rehabilitation|upper extremity rehabilitation
730411|NCT00508508|Heart Failure|heart failure
730412|NCT00508508|Peer Support|peer support
730413|NCT00508508|Self Management|self management
730414|NCT00508495|pain, postoperative|pain, postoperative
730415|NCT00508495|replacement, total hip|replacement, total hip
730416|NCT00508495|total hip replacement|total hip replacement
730417|NCT00508495|arthroplasty, replacement, hip|arthroplasty, replacement, hip
730418|NCT00508482|Acupuncture|acupuncture
730419|NCT00508482|Functional constipation|functional constipation
730420|NCT00508469|Intraocular pressure|intraocular pressure
730421|NCT00508469|Open-angle glaucoma|open-angle glaucoma
730422|NCT00508469|Ocular hypertension|ocular hypertension
730423|NCT00508469|Adherence|adherence
730424|NCT00508469|Compliance|compliance
730425|NCT00508456|Glioblastoma Multiforme|glioblastoma multiforme
730426|NCT00508456|Methionine Restriction|methionine restriction
730427|NCT00508456|Hominex-2|hominex-2
730428|NCT00508456|Methionine Restriction Diet|methionine restriction diet
730429|NCT00508456|Hominex-2 Amino Acid-Modified Medical Food|hominex-2 amino acid-modified medical food
730430|NCT00508456|Temozolomide|temozolomide
730431|NCT00508456|Temodar|temodar
730432|NCT00508443|Stereotactic Spine Radiotherapy System|stereotactic spine radiotherapy system
730433|NCT00508443|SSRS|ssrs
730434|NCT00508443|CT-on-Rails|ct-on-rails
730435|NCT00508443|Metastatic Spine Disease|metastatic spine disease
730436|NCT00508443|Spinal Neoplasms|spinal neoplasms
730437|NCT00508443|Radiation Therapy|radiation therapy
730438|NCT00508443|Trilogy|trilogy
730439|NCT00508443|Cancer|cancer
730440|NCT00508443|Breast Cancer|breast cancer
730441|NCT00508443|Gastrointestinal Cancer|gastrointestinal cancer
730442|NCT00508443|Genitourinary Disease|genitourinary disease
730443|NCT00508443|Lung Cancer|lung cancer
730444|NCT00508443|Lymphoma|lymphoma
730445|NCT00508443|Melanoma|melanoma
730446|NCT00508443|Sarcoma|sarcoma
730447|NCT00508443|Spinal Cancer|spinal cancer
730448|NCT00508430|ASP8825|asp8825
730449|NCT00508430|Diabetic Neuropathies|diabetic neuropathies
730450|NCT00508430|Pain|pain
730451|NCT00508417|Malaria Incidence|malaria incidence
730452|NCT00508417|Anemia|anemia
730453|NCT00508417|Clinical Malaria|clinical malaria
730454|NCT00508378|Ovarian Cancer|ovarian cancer
730455|NCT00508378|Quality of Life|quality of life
730456|NCT00508378|Chemotherapy Side-Effects|chemotherapy side-effects
730457|NCT00508378|Interview|interview
730458|NCT00508378|Questionnaire|questionnaire
730459|NCT00508378|Caregivers|caregivers
730460|NCT00508365|lisinopril|lisinopril
730461|NCT00508365|carvedilol|carvedilol
730462|NCT00508365|hypertension|hypertension
730463|NCT00508352|breast|breast
730464|NCT00508352|cancer|cancer
730465|NCT00508352|locoregional|locoregional
730466|NCT00508352|IMRT|imrt
730467|NCT00508352|tomotherapy|tomotherapy
730468|NCT00508339|Soft Tissue Sarcoma|soft tissue sarcoma
730469|NCT00508339|Limb Sparing Surgery|limb sparing surgery
730470|NCT00508339|Toronto Extremity Salvage Score|toronto extremity salvage score
730471|NCT00508339|Radiotherapy|radiotherapy
730472|NCT00508339|Quality of Life|quality of life
730473|NCT00508339|Questionnaire|questionnaire
730474|NCT00508339|Survey|survey
730475|NCT00508339|TESS|tess
730476|NCT00508326|Advanced Cancer|advanced cancer
730477|NCT00508326|Solid Tumor|solid tumor
730478|NCT00508326|Liver Metastasis|liver metastasis
730479|NCT00508326|Hepatic Artery Infusion|hepatic artery infusion
730481|NCT00508326|Paclitaxel|paclitaxel
730482|NCT00508326|Taxol|taxol
730483|NCT00508313|Lung Cancer|lung cancer
730484|NCT00508313|Healthy Control|healthy control
730485|NCT00508313|Thermal Imaging|thermal imaging
730486|NCT00508313|Thermal Signatures|thermal signatures
730487|NCT00508313|Radiation Therapy|radiation therapy
730488|NCT00508313|Chemoradiation Therapy|chemoradiation therapy
730489|NCT00508300|laparoscopic|laparoscopic
730490|NCT00508300|colectomy|colectomy
730491|NCT00508300|Fast Track|fast track
730492|NCT00508300|epidural|epidural
730493|NCT00508274|Advanced Metastatic Breast Cancer|advanced metastatic breast cancer
730494|NCT00508274|breast cancer|breast cancer
730495|NCT00508274|lapatinib|lapatinib
730496|NCT00508274|HER2+ positive|her2+ positive
730497|NCT00508274|TYVERB|tyverb
730498|NCT00508274|TYKERB|tykerb
730499|NCT00508261|Meningococcal vaccine|meningococcal vaccine
730500|NCT00508261|Immunogenicity|immunogenicity
730501|NCT00508261|Routine infancy vaccination|routine infancy vaccination
730502|NCT00508261|Safety|safety
730503|NCT00508248|omega 3fatty acids|omega 3fatty acids
730504|NCT00508235|Neurofibromatosis|neurofibromatosis
730505|NCT00508235|Quality of Friendships|quality of friendships
730506|NCT00508235|Disease Severity|disease severity
730507|NCT00508235|Questionnaire|questionnaire
730508|NCT00508235|NF-1|nf-1
730509|NCT00508222|HIV|hiv
730510|NCT00508222|HCV|hcv
730511|NCT00508222|HIV/HCV Co-infection|hiv/hcv co-infection
730512|NCT00508222|Kaletra Monotherapy|kaletra monotherapy
730513|NCT00508222|Treatment Experienced|treatment experienced
730514|NCT00508209|high-dose melphalan|high-dose melphalan
730515|NCT00508209|bortezomib|bortezomib
730516|NCT00508209|response|response
730517|NCT00508209|toxicity|toxicity
730518|NCT00508209|relapse|relapse
730519|NCT00508196|right ventricular pacing|right ventricular pacing
730520|NCT00508196|endothelial function|endothelial function
730521|NCT00508196|cardiac output|cardiac output
730522|NCT00508183|full thickness rotator cuff tear|full thickness rotator cuff tear
730523|NCT00508170|Head and Neck Cancer|head and neck cancer
730524|NCT00508170|Human Papillomavirus Infection|human papillomavirus infection
730525|NCT00508170|Oropharyngeal Patients|oropharyngeal patients
730526|NCT00508170|Sexual Behavior|sexual behavior
730527|NCT00508170|Questionnaire|questionnaire
730528|NCT00508144|Non-Small Cell Lung Cancer|non-small cell lung cancer
730529|NCT00508144|Lung Cancer|lung cancer
730530|NCT00508144|NSCLC|nsclc
730531|NCT00508144|Malignant pleural effusion|malignant pleural effusion
730532|NCT00508144|Pericardial effusion|pericardial effusion
730533|NCT00508144|Pemetrexed|pemetrexed
730534|NCT00508144|Alimta|alimta
730535|NCT00508144|LY231514|ly231514
730536|NCT00508144|Poor Performance Status|poor performance status
730537|NCT00508144|Asymptomatic Brain Metastases|asymptomatic brain metastases
730538|NCT00508131|Milk fortification|milk fortification
730539|NCT00508131|Effectivness evaluation|effectivness evaluation
730540|NCT00508131|Iron deficiency anemia|iron deficiency anemia
730541|NCT00508131|Stunting|stunting
730542|NCT00508131|Zinc deficiency|zinc deficiency
730543|NCT00508118|Aortic Arch Reconstruction Surgery|aortic arch reconstruction surgery
730544|NCT00508105|Osteoarthritis|osteoarthritis
730545|NCT00508105|Shoulder|shoulder
730546|NCT00508105|tenotomy|tenotomy
730547|NCT00508105|ostotomy|ostotomy
730548|NCT00508092|appendicectomy|appendicectomy
730549|NCT00508092|pain|pain
730550|NCT00508092|local anaesthetic|local anaesthetic
730551|NCT00508092|nerve block|nerve block
730552|NCT00508092|Post operative pain following appendicectomy|post operative pain following appendicectomy
730553|NCT00508079|Venous Disease|venous disease
730554|NCT00508079|Varicose Veins|varicose veins
730555|NCT00508079|Chronic Venous Insufficiency|chronic venous insufficiency
730556|NCT00508079|PAD|pad
730557|NCT00508066|Congenital Scoliosis|congenital scoliosis
730558|NCT00508066|Idiopathic Scoliosis|idiopathic scoliosis
730559|NCT00508066|Spinal Fusion|spinal fusion
730560|NCT00508066|Post-Operative Pain Management|post-operative pain management
730561|NCT00508066|Infusion Catheter|infusion catheter
730562|NCT00508053|wound infection|wound infection
730563|NCT00508053|incisional hernia|incisional hernia
730564|NCT00508053|wound dehiscence|wound dehiscence
730565|NCT00508053|wound healing|wound healing
730566|NCT00508053|postoperative complications|postoperative complications
730567|NCT00508053|surgical techniques|surgical techniques
730568|NCT00508040|Birdshot Retine choroidopathy|birdshot retine choroidopathy
730569|NCT00508040|Macular edema|macular edema
730570|NCT00508040|Prednisone|prednisone
730571|NCT00508040|Interferon alpha 2a|interferon alpha 2a
730572|NCT00508040|Associated with Cystoid macular edema|associated with cystoid macular edema
730573|NCT00508040|With Visual acuity loss|with visual acuity loss
730574|NCT00508027|sickle cell disease|sickle cell disease
730575|NCT00508027|simvastatin|simvastatin
730576|NCT00508027|statin drugs|statin drugs
730577|NCT00508027|nitric oxide donors|nitric oxide donors
730578|NCT00508027|vascular injury|vascular injury
730579|NCT00508014|Cardiovascular disease|cardiovascular disease
730580|NCT00508014|Diabetes|diabetes
730581|NCT00508014|Quality improvement|quality improvement
730582|NCT00508014|Peer review|peer review
730583|NCT00508001|Hepatocellular carcinoma|hepatocellular carcinoma
730584|NCT00508001|Advanced solid, malignant tumour|advanced solid, malignant tumour
730585|NCT00507988|Cognitive Training|cognitive training
730586|NCT00507988|Complex Problem Solving|complex problem solving
730587|NCT00507988|Goal Management|goal management
730588|NCT00507988|Planning|planning
730589|NCT00507975|Smoking|smoking
730590|NCT00507975|pregnancy|pregnancy
730591|NCT00507975|newborn|newborn
730592|NCT00507975|birth weight|birth weight
730593|NCT00507975|nicotine patch|nicotine patch
730595|NCT00507962|Advanced Cancer|advanced cancer
730596|NCT00507962|Dominant Liver Involvement|dominant liver involvement
730597|NCT00507962|Hepatic Intraarterial Cisplatin|hepatic intraarterial cisplatin
730598|NCT00507962|Cisplatin|cisplatin
730599|NCT00507962|Liposomal Doxorubicin|liposomal doxorubicin
730600|NCT00507962|Platinol-AQ|platinol-aq
730601|NCT00507962|Platinol|platinol
730602|NCT00507962|CDDP|cddp
730603|NCT00507962|Doxil|doxil
730604|NCT00507962|Liposomal|liposomal
730605|NCT00507962|Doxorubicin Hydrochloride|doxorubicin hydrochloride
730606|NCT00507949|COPD|copd
730607|NCT00507949|body weight|body weight
730608|NCT00507949|megestrol acetate|megestrol acetate
730609|NCT00507949|cytokines|cytokines
730610|NCT00507936|Diabetic Neuropathy|diabetic neuropathy
730611|NCT00507936|Painful|painful
730612|NCT00507936|Diabetic Polyneuropathy|diabetic polyneuropathy
730613|NCT00507936|Neuralgia|neuralgia
730614|NCT00507936|Diabetic|diabetic
730615|NCT00507936|Diabetic Neuropathies|diabetic neuropathies
730616|NCT00507936|Diabetic Neuralgia|diabetic neuralgia
730617|NCT00507923|Breast Cancer|breast cancer
730618|NCT00507923|Tibetan Yoga|tibetan yoga
730619|NCT00507923|Stretching|stretching
730620|NCT00507923|Yoga|yoga
730621|NCT00507923|Fatigue|fatigue
730622|NCT00507923|Sleep|sleep
730623|NCT00507923|Questionnaire|questionnaire
730624|NCT00507923|Survey|survey
730625|NCT00507910|ankle fracture|ankle fracture
730626|NCT00507910|pes planus|pes planus
730627|NCT00507897|thyroid nodules, blood pressure, thyroid hormones|thyroid nodules, blood pressure, thyroid hormones
730628|NCT00507884|Kidney Neoplasms|kidney neoplasms
730629|NCT00507884|Renal Tumors|renal tumors
730630|NCT00507884|Magnetic Resonance Imaging|magnetic resonance imaging
730631|NCT00507884|3 Tesla MRI|3 tesla mri
730632|NCT00507884|MRI|mri
730633|NCT00507871|cryptosporidiosis, Cryptosporidium, Uganda, diarrhea|cryptosporidiosis, cryptosporidium, uganda, diarrhea
730634|NCT00507858|Head and Neck Cancer|head and neck cancer
730635|NCT00507858|Squamous Cell Cancer|squamous cell cancer
730636|NCT00507858|Alimta|alimta
730637|NCT00507858|Pemetrexed|pemetrexed
730638|NCT00507858|Dexamethasone|dexamethasone
730639|NCT00507858|HNSCC|hnscc
730640|NCT00507858|Decadron|decadron
730641|NCT00507832|Prurigo nodularis|prurigo nodularis
730642|NCT00507819|Other Single Ventricle Anatomy|other single ventricle anatomy
730643|NCT00507819|Hypoplastic Left Heart Syndrome|hypoplastic left heart syndrome
730644|NCT00507819|Tricuspid Atresia|tricuspid atresia
730645|NCT00507806|Acute Ischemic Stroke|acute ischemic stroke
730646|NCT00507806|Microbubbles|microbubbles
730647|NCT00507806|Transcranial Doppler ultrasound|transcranial doppler ultrasound
730648|NCT00507806|TIBI|tibi
730649|NCT00507806|Symptomatic Intracranial Hemorrhage|symptomatic intracranial hemorrhage
730650|NCT00507806|modified Rankin Scale|modified rankin scale
730651|NCT00507806|Recanalization|recanalization
730652|NCT00507806|Perflutren|perflutren
730653|NCT00507780|GnRH Antagonist|gnrh antagonist
730654|NCT00507780|Premature Ovarian Failure|premature ovarian failure
730655|NCT00507780|Fertility|fertility
730656|NCT00507780|Chemotherapy|chemotherapy
730657|NCT00507780|POF|pof
730658|NCT00507754|Advanced Cancer|advanced cancer
730659|NCT00507754|Solid Tumors|solid tumors
730660|NCT00507754|Latent Mycobacterium Tuberculosis|latent mycobacterium tuberculosis
730661|NCT00507754|Tuberculin Skin Test|tuberculin skin test
730662|NCT00507754|Tuberculosis|tuberculosis
730663|NCT00507754|T-SPOT TB test|t-spot tb test
730664|NCT00507754|TB|tb
730665|NCT00507741|Cancer|cancer
730666|NCT00507741|Ovarian|ovarian
730667|NCT00507741|Endometrial|endometrial
730668|NCT00507741|Phase II|phase ii
730669|NCT00507741|EC145|ec145
730670|NCT00507741|EC20|ec20
730671|NCT00507728|Pharmacogenetics|pharmacogenetics
730672|NCT00507728|Emotional Reactivity|emotional reactivity
730673|NCT00507728|Smoking Cessation Counseling|smoking cessation counseling
730674|NCT00507728|Smoking|smoking
730675|NCT00507728|Bupropion|bupropion
730676|NCT00507728|Wellbutrin|wellbutrin
730677|NCT00507728|Wellbutrin SR|wellbutrin sr
730678|NCT00507728|Zyban|zyban
730679|NCT00507728|Varenicline|varenicline
730680|NCT00507728|Chantix|chantix
730681|NCT00507728|Placebo|placebo
730682|NCT00507715|Parkinson's Disease, Idiopathic|parkinson's disease, idiopathic
730683|NCT00507715|l-dopa levels|l-dopa levels
730684|NCT00507715|plantago ovata husk|plantago ovata husk
730685|NCT00507689|Truvada|truvada
730686|NCT00507689|HBIg|hbig
730687|NCT00507689|Chronic Hepatitis B Recurrence|chronic hepatitis b recurrence
730688|NCT00507689|Post Orthotopic Liver Transplant|post orthotopic liver transplant
730689|NCT00507676|Asthma|asthma
730690|NCT00507676|Wheezing|wheezing
730691|NCT00507676|Infant|infant
730692|NCT00507663|beta blocker|beta blocker
730693|NCT00507663|functional recovery|functional recovery
730694|NCT00507650|Pressure ulcers|pressure ulcers
730695|NCT00507650|Geriatrics|geriatrics
730696|NCT00507650|Nursing home|nursing home
730697|NCT00507650|Fluid balance|fluid balance
730698|NCT00507650|Collagen deposition|collagen deposition
730699|NCT00507611|breast|breast
730700|NCT00507611|sentinel lymph node|sentinel lymph node
730701|NCT00507611|node mapping|node mapping
730702|NCT00507598|colorectal cancer|colorectal cancer
730703|NCT00507598|metabolomics|metabolomics
730704|NCT00507585|Liver Cancer|liver cancer
730705|NCT00507585|Liver metastases|liver metastases
730706|NCT00507585|Metastatic advanced solid tumors|metastatic advanced solid tumors
730707|NCT00507585|Advanced solid tumors metastatic to the liver|advanced solid tumors metastatic to the liver
730708|NCT00507585|Hepatic Arterial Infusion|hepatic arterial infusion
730709|NCT00507585|Intra-arterial hepatic oxaliplatin|intra-arterial hepatic oxaliplatin
730710|NCT00507585|Fluorouracil|fluorouracil
730711|NCT00507585|5-FU|5-fu
730712|NCT00507585|Adrucil|adrucil
730713|NCT00507585|Efudex|efudex
730714|NCT00507585|5-fluorouracil|5-fluorouracil
730715|NCT00507585|Avastin|avastin
730716|NCT00507585|Leucovorin|leucovorin
730717|NCT00507585|Oxaliplatin|oxaliplatin
730718|NCT00507585|Bevacizumab|bevacizumab
730719|NCT00507572|Solid Tumors|solid tumors
730720|NCT00507572|Pregnancy|pregnancy
730721|NCT00507572|Data Collection|data collection
730722|NCT00507546|sleep|sleep
730723|NCT00507546|melatonin|melatonin
730724|NCT00507546|spinal cord injury|spinal cord injury
730725|NCT00507546|insomnia|insomnia
730726|NCT00507546|tetraplegia|tetraplegia
730727|NCT00507533|CPAP|cpap
730728|NCT00507533|Hematologic|hematologic
730729|NCT00507533|Neutropenic|neutropenic
730730|NCT00507533|ARF|arf
730731|NCT00507520|RCT|rct
730732|NCT00507520|Almonds|almonds
730733|NCT00507520|Hyperlipidemia|hyperlipidemia
730734|NCT00507520|Blood Lipids|blood lipids
730735|NCT00507507|tenofovir|tenofovir
730736|NCT00507507|monotherapy|monotherapy
730737|NCT00507507|emtricitabine|emtricitabine
730738|NCT00507507|combination|combination
730739|NCT00507507|hepatitis B|hepatitis b
730740|NCT00507494|posttransplant diabetes mellitus|posttransplant diabetes mellitus
730741|NCT00507494|kidney transplantation|kidney transplantation
730742|NCT00507494|filtration fraction|filtration fraction
730743|NCT00507494|proteinuria|proteinuria
730744|NCT00507481|Sleep|sleep
730745|NCT00507481|ICU|icu
730746|NCT00507481|Delirium|delirium
730747|NCT00507481|Post surgical ventilated patients|post surgical ventilated patients
730748|NCT00507481|ICU patients|icu patients
730749|NCT00507468|bone marrow|bone marrow
730750|NCT00507468|autologous|autologous
730751|NCT00507468|ejection fraction|ejection fraction
730752|NCT00507468|left ventricle|left ventricle
730753|NCT00507468|heart attack|heart attack
730754|NCT00507468|myocardial infarction|myocardial infarction
730755|NCT00507468|left ventricular dysfunction post myocardial infarction|left ventricular dysfunction post myocardial infarction
730756|NCT00507455|Lower Urinary Tract Symptoms|lower urinary tract symptoms
730757|NCT00507455|Bladder Outlet Obstruction|bladder outlet obstruction
730758|NCT00507455|Treatment|treatment
730759|NCT00507455|Solifenacin Succinate|solifenacin succinate
730760|NCT00507455|Tamsulosin hydrochloride|tamsulosin hydrochloride
730761|NCT00507442|Treatment for patients with multiple myeloma|treatment for patients with multiple myeloma
730762|NCT00507442|who have received no prior treatment|who have received no prior treatment
730763|NCT00507429|thyroid neoplasms|thyroid neoplasms
730764|NCT00507429|thyroid cancer|thyroid cancer
730765|NCT00507429|thyroid carcinoma|thyroid carcinoma
730766|NCT00507390|fish oils|fish oils
730767|NCT00507377|Esophageal Benign Disease|esophageal benign disease
730768|NCT00507377|Gastroesophageal Reflux Disease|gastroesophageal reflux disease
730769|NCT00507377|Hiatal Hernia|hiatal hernia
730770|NCT00507377|Antireflux Surgery|antireflux surgery
730771|NCT00507377|Short Esophagus|short esophagus
730772|NCT00507351|Breast Cancer|breast cancer
730773|NCT00507351|Colorectal Cancer|colorectal cancer
730774|NCT00507351|Lung Cancer|lung cancer
730775|NCT00507351|Prostate Cancer|prostate cancer
730776|NCT00507351|Pain Management|pain management
730777|NCT00507351|Questionnaire|questionnaire
730778|NCT00507351|Survey|survey
730779|NCT00507338|percutaneous coronary intervention|percutaneous coronary intervention
730780|NCT00507325|Malignant Melanoma|malignant melanoma
730781|NCT00507325|Blood Sample|blood sample
730782|NCT00507325|Tumor Sample|tumor sample
730783|NCT00507325|Long-term storage|long-term storage
730784|NCT00507325|Sample Collection|sample collection
730785|NCT00507312|To assess two new diagnostic devices for detecting early Heart Failure.|to assess two new diagnostic devices for detecting early heart failure.
730786|NCT00507299|Child maltreatment|child maltreatment
730787|NCT00507299|Physician education|physician education
730788|NCT00507299|Prevention|prevention
730789|NCT00507273|Gastrointestinal Stromal Tumors|gastrointestinal stromal tumors
730790|NCT00507273|Gastrointestinal Cancer|gastrointestinal cancer
730791|NCT00507273|GISTs|gists
730792|NCT00507273|GIST Registry|gist registry
730793|NCT00507273|Registry|registry
730794|NCT00507260|Leukemia|leukemia
730795|NCT00507260|Lymphoma|lymphoma
730796|NCT00507260|Post-Allogeneic Blood and Marrow Transplantation|post-allogeneic blood and marrow transplantation
730797|NCT00507260|Blood and Marrow Transplantation|blood and marrow transplantation
730798|NCT00507260|BMT|bmt
730799|NCT00507260|Cancer-Related Fatigue|cancer-related fatigue
730800|NCT00507260|Fatigue|fatigue
730801|NCT00507260|Nutritional Assessment|nutritional assessment
730802|NCT00507260|Nutritional Intervention|nutritional intervention
730803|NCT00507260|Malnutrition|malnutrition
730804|NCT00507247|Catheter-Related Infection|catheter-related infection
730805|NCT00507247|Bloodstream Infections|bloodstream infections
730806|NCT00507247|Staphylococcus Aureus|staphylococcus aureus
730807|NCT00507247|Daptomycin|daptomycin
730808|NCT00507234|COPD|copd
730809|NCT00507221|HIV|hiv
730810|NCT00507221|Helminthiasis|helminthiasis
730811|NCT00507221|Co-infection|co-infection
730812|NCT00507221|Treatment Naive|treatment naive
730813|NCT00507208|trismus|trismus
730814|NCT00507208|head and neck cancer|head and neck cancer
730815|NCT00507195|Postanethesia cognitive recovery|postanethesia cognitive recovery
730816|NCT00507195|Postoperative delirium|postoperative delirium
730817|NCT00507195|hypnotics|hypnotics
730818|NCT00507195|propofol|propofol
730819|NCT00507195|sevoflurane|sevoflurane
730820|NCT00507195|desflurane|desflurane
730821|NCT00507195|postoperative cognitive recovery|postoperative cognitive recovery
730822|NCT00507182|Oral Mucosa Lesions|oral mucosa lesions
730823|NCT00507182|Oral Cancer|oral cancer
730824|NCT00507182|Neoplasia and Dysplasia in oral cavity mucosa|neoplasia and dysplasia in oral cavity mucosa
730825|NCT00507182|Fluorescence Spectroscopy|fluorescence spectroscopy
730826|NCT00507182|Reflectance Spectroscopy|reflectance spectroscopy
730827|NCT00507182|Pre-cancerous lesions|pre-cancerous lesions
730828|NCT00507182|Cancerous lesions|cancerous lesions
730829|NCT00507182|Mouth|mouth
730830|NCT00507143|Colorectal neoplasms|colorectal neoplasms
730831|NCT00507143|Secondary|secondary
730832|NCT00507143|irinotecan|irinotecan
730833|NCT00507143|Pharmacokinetics|pharmacokinetics
730834|NCT00507143|Pharmacodynamics|pharmacodynamics
730835|NCT00507143|SLCO1B1|slco1b1
730836|NCT00507143|PXR|pxr
730837|NCT00507117|Obstructive Sleep Apnea|obstructive sleep apnea
730838|NCT00507117|Polysomnography|polysomnography
730839|NCT00507117|Non-benzodiazepine hypnotics|non-benzodiazepine hypnotics
730840|NCT00507104|traumatic brain injury|traumatic brain injury
730841|NCT00507104|Subarachnoid Hemorrhage|subarachnoid hemorrhage
730842|NCT00507104|Hypopituitarism|hypopituitarism
730843|NCT00507091|ZD6474|zd6474
730844|NCT00507091|Irinotecan|irinotecan
730845|NCT00507091|5-Fluorouracil|5-fluorouracil
730846|NCT00507091|Leucovorin|leucovorin
730847|NCT00507091|colorectal|colorectal
730848|NCT00507078|Obstructive Sleep Apnea|obstructive sleep apnea
730849|NCT00507078|Leptin|leptin
730850|NCT00507078|Homocysteine|homocysteine
730851|NCT00507078|C-reactive Protein|c-reactive protein
730852|NCT00507052|Hemodialysis|hemodialysis
730853|NCT00507052|Residual Renal Function|residual renal function
730854|NCT00507039|PD20 FEV1|pd20 fev1
730855|NCT00507039|grass pollen|grass pollen
730856|NCT00507039|one-step|one-step
730857|NCT00507013|vascular closure device|vascular closure device
730858|NCT00506974|sleep|sleep
730859|NCT00506974|normal sleepers|normal sleepers
730860|NCT00506948|Hematological Malignancies|hematological malignancies
730861|NCT00506948|Myelodysplastic Syndrome|myelodysplastic syndrome
730862|NCT00506948|Graft Versus Host Disease|graft versus host disease
730863|NCT00506948|GVHD|gvhd
730864|NCT00506948|Allogeneic Hematopoietic Stem Cell Transplantation|allogeneic hematopoietic stem cell transplantation
730865|NCT00506948|AHSCT|ahsct
730866|NCT00506948|Leukemia|leukemia
730867|NCT00506948|Lymphoma|lymphoma
730868|NCT00506948|T-Cells|t-cells
730869|NCT00506948|Thymoglobulin|thymoglobulin
730870|NCT00506948|ATG|atg
730871|NCT00506948|rATG|ratg
730872|NCT00506948|Rabbit Antithymocyte Globulin|rabbit antithymocyte globulin
730873|NCT00506948|Rapamune|rapamune
730874|NCT00506948|Sirolimus|sirolimus
730875|NCT00506948|Mycophenolate Mofetil|mycophenolate mofetil
730876|NCT00506948|Cellcept|cellcept
730877|NCT00506948|MMF|mmf
730878|NCT00506935|methamphetamine|methamphetamine
730879|NCT00506935|GVG|gvg
730880|NCT00506935|vigabatrin|vigabatrin
730881|NCT00506935|stimulant|stimulant
731290|NCT00505453|Influenza|influenza
730882|NCT00506922|Graft-Versus-Host Disease|graft-versus-host disease
730883|NCT00506922|GVHD Prevention|gvhd prevention
730884|NCT00506922|Hodgkin's Disease|hodgkin's disease
730885|NCT00506922|Leukemia|leukemia
730886|NCT00506922|Lymphoma|lymphoma
730887|NCT00506922|Methotrexate|methotrexate
730888|NCT00506922|Tacrolimus|tacrolimus
730889|NCT00506922|Pentostatin|pentostatin
730890|NCT00506909|oxytocin|oxytocin
730891|NCT00506896|Rheumatoid Arthritis|rheumatoid arthritis
730892|NCT00506896|glucocorticoid|glucocorticoid
730893|NCT00506896|intraarticular injection|intraarticular injection
730894|NCT00506896|arthritis|arthritis
730895|NCT00506870|Heart Valve Prosthesis Implantation|heart valve prosthesis implantation
730896|NCT00506870|INR self monitoring|inr self monitoring
730897|NCT00506870|cost benefit evaluation|cost benefit evaluation
730898|NCT00506857|Hematologic Malignancies|hematologic malignancies
730899|NCT00506857|Blood And Marrow Transplantation|blood and marrow transplantation
730906|NCT00506857|Fludarabine Phosphate|fludarabine phosphate
730907|NCT00506857|Busulfan|busulfan
730908|NCT00506857|Busulfex|busulfex
730909|NCT00506857|Myleran|myleran
730910|NCT00506857|Progenitor Cell Transplantation|progenitor cell transplantation
730911|NCT00506857|Granulocyte colony stimulating factor|granulocyte colony stimulating factor
730912|NCT00506857|G-CSF|g-csf
730913|NCT00506857|Apheresis|apheresis
730914|NCT00506857|Blood cell infusion|blood cell infusion
730915|NCT00506844|Rectal neoplasms|rectal neoplasms
730916|NCT00506844|Neoadjuvant treatment|neoadjuvant treatment
730917|NCT00506844|Cetuximab|cetuximab
730918|NCT00506844|Irinotecan|irinotecan
730919|NCT00506844|Capecitabine|capecitabine
730920|NCT00506844|Radiotherapy|radiotherapy
730921|NCT00506844|Combination chemotherapy|combination chemotherapy
730922|NCT00506818|emotional symptoms|emotional symptoms
730923|NCT00506818|vascular risk-factors|vascular risk-factors
730924|NCT00506805|solid tumor malignancy; Hsp90|solid tumor malignancy; hsp90
730925|NCT00506792|Cystic fibrosis, QAU145, nasal potential difference|cystic fibrosis, qau145, nasal potential difference
730926|NCT00506779|Uterine Papillary Serous Carcinoma|uterine papillary serous carcinoma
730927|NCT00506779|Uterine Cancer|uterine cancer
730928|NCT00506779|UPSC|upsc
730929|NCT00506779|Taxol|taxol
730930|NCT00506779|Paclitaxel|paclitaxel
730931|NCT00506779|Gleevec|gleevec
730932|NCT00506779|Imatinib Mesylate|imatinib mesylate
730933|NCT00506779|STI571|sti571
730934|NCT00506766|Urinary Incontinence|urinary incontinence
730935|NCT00506766|Self efficacy|self efficacy
730936|NCT00506766|Pelvic floor muscle training|pelvic floor muscle training
730937|NCT00506766|Bladder training|bladder training
730938|NCT00506753|substance abuse|substance abuse
730939|NCT00506714|Osteoarthritis|osteoarthritis
730940|NCT00506714|Walking Sticks|walking sticks
730941|NCT00506714|Canes|canes
730942|NCT00506675|Amblyopia|amblyopia
730943|NCT00506675|Atropine|atropine
730944|NCT00506675|Patching|patching
730945|NCT00506649|protocol|protocol
730946|NCT00506649|analgesia|analgesia
730947|NCT00506649|sedation|sedation
730948|NCT00506649|delirium|delirium
730949|NCT00506649|coma|coma
730950|NCT00506623|Rectal neoplasm|rectal neoplasm
730951|NCT00506623|Neoadjuvant therapy|neoadjuvant therapy
730952|NCT00506623|Radiotherapy|radiotherapy
730953|NCT00506623|Combination chemotherapy|combination chemotherapy
730954|NCT00506623|Irinotecan|irinotecan
730955|NCT00506623|Capecitabine|capecitabine
730956|NCT00506610|Pain|pain
730957|NCT00506610|Postherpetic Neuralgia|postherpetic neuralgia
730958|NCT00506610|Neuralgia, Postherpetic|neuralgia, postherpetic
730959|NCT00506610|Shingles|shingles
730960|NCT00506610|Herpes Zoster|herpes zoster
730961|NCT00506610|Neuropathic Pain|neuropathic pain
730962|NCT00506597|Acute Lymphoblastic Leukemia|acute lymphoblastic leukemia
730963|NCT00506597|Leukemia|leukemia
730964|NCT00506597|Erwinia L-Asparaginase|erwinia l-asparaginase
730965|NCT00506597|Erwinase|erwinase
730966|NCT00506584|Human milk nutritional intervention|human milk nutritional intervention
730967|NCT00506584|Pre-term, very low birth weight|pre-term, very low birth weight
730968|NCT00506584|Fortification of human breast milk|fortification of human breast milk
730969|NCT00506571|colorectal neoplasms|colorectal neoplasms
730970|NCT00506571|secondary|secondary
730971|NCT00506571|Combination chemotherapy|combination chemotherapy
730972|NCT00506571|S-1|s-1
730973|NCT00506571|irinotecan|irinotecan
730974|NCT00506571|oxaliplatin|oxaliplatin
730975|NCT00506558|cervical spondylotic myelopathy|cervical spondylotic myelopathy
730976|NCT00506558|degenerative cervical spondylosis|degenerative cervical spondylosis
730977|NCT00506558|spinal fusion|spinal fusion
730978|NCT00506532|Pulmonary Surfactants|pulmonary surfactants
730979|NCT00506532|Lung transplantation|lung transplantation
730980|NCT00506532|Primary Graft Dysfunction|primary graft dysfunction
730981|NCT00506519|DIC associated with severe sepsis|dic associated with severe sepsis
730982|NCT00506506|N-acetylcysteine|n-acetylcysteine
730983|NCT00506506|Chronic kidney disease|chronic kidney disease
730984|NCT00506506|eGFR|egfr
730985|NCT00506506|Cystatin C|cystatin c
730986|NCT00506506|proteinuria|proteinuria
730987|NCT00506506|Stage 3 chronic kidney disease|stage 3 chronic kidney disease
730988|NCT00506493|Persistent Atrial Fibrillation Surgical RF Ablation|persistent atrial fibrillation surgical rf ablation
730989|NCT00506493|Perisistent Atrial Fibrillation|perisistent atrial fibrillation
730990|NCT00506493|Surgical Ablation|surgical ablation
730991|NCT00506480|Embryo Implantation|embryo implantation
730992|NCT00506480|Endometrium|endometrium
730993|NCT00506480|endometrial implantation|endometrial implantation
730994|NCT00506480|Oocyte Donation|oocyte donation
730995|NCT00506480|in vitro fertilization|in vitro fertilization
730996|NCT00506480|endometrial sampling|endometrial sampling
730997|NCT00506467|Intrathoracic Malignancy|intrathoracic malignancy
730998|NCT00506467|Lung Cancer|lung cancer
730999|NCT00506467|Vibration Response Imaging|vibration response imaging
731000|NCT00506467|VRI|vri
731001|NCT00506454|Fatigue|fatigue
731002|NCT00506454|Hemodialysis|hemodialysis
731003|NCT00506454|Endotoxemia|endotoxemia
731004|NCT00506454|Phospholipid|phospholipid
731005|NCT00506454|Emulsion|emulsion
731006|NCT00506441|Chronic Kidney Disease|chronic kidney disease
731007|NCT00506441|Dialysis|dialysis
731008|NCT00506441|Hyperphosphatemia|hyperphosphatemia
731009|NCT00506441|Phosphate binder|phosphate binder
731010|NCT00506428|aging|aging
731011|NCT00506428|sleep|sleep
731012|NCT00506428|sleep deprivation|sleep deprivation
731013|NCT00506428|performance|performance
731014|NCT00506428|memory|memory
731015|NCT00506428|metabolism|metabolism
731016|NCT00506415|Alzheimer's|alzheimer's
731017|NCT00506415|Patch|patch
731018|NCT00506415|Cognitive|cognitive
731019|NCT00506415|Decline|decline
731020|NCT00506402|Adult patients with refractory leukemias, MDS or AMM|adult patients with refractory leukemias, mds or amm
731021|NCT00506389|Sleep Initiation and Maintenance Disorders, Sleep Disorders, Intrinsic Dyssomnias, Sleep Disorders, Nervous System Diseases, Mental Disorders|sleep initiation and maintenance disorders, sleep disorders, intrinsic dyssomnias, sleep disorders, nervous system diseases, mental disorders
731022|NCT00506376|Cervical Cancer|cervical cancer
731023|NCT00506376|Hysterectomy|hysterectomy
731024|NCT00506376|Interview|interview
731025|NCT00506363|scar|scar
731026|NCT00506363|surgery|surgery
731027|NCT00506363|lasers|lasers
731028|NCT00506324|Intensity Modulated Radiotherapy|intensity modulated radiotherapy
731029|NCT00506324|Chemotherapy|chemotherapy
731030|NCT00506324|Head and Neck Neoplasms|head and neck neoplasms
731031|NCT00506324|Dysphagia|dysphagia
731032|NCT00506311|Superficial Groin Dissection|superficial groin dissection
731033|NCT00506311|Melanoma|melanoma
731034|NCT00506311|Fibrin Tissue Adhesive|fibrin tissue adhesive
731035|NCT00506311|Fibrin Sealant|fibrin sealant
731036|NCT00506311|Tisseel|tisseel
731037|NCT00506311|Seroma|seroma
731038|NCT00506298|Diabetes|diabetes
731039|NCT00506298|CRx-401|crx-401
731040|NCT00506298|Bezafibrate|bezafibrate
731041|NCT00506298|Diflunisal|diflunisal
731042|NCT00506298|Metformin|metformin
731043|NCT00506298|plasma glucose|plasma glucose
731044|NCT00506285|Attention Deficit Hyperactivity Disorder|attention deficit hyperactivity disorder
731045|NCT00506285|ADHD|adhd
731046|NCT00506285|Adult|adult
731047|NCT00506285|Methylphenidate Transdermal System|methylphenidate transdermal system
731048|NCT00506285|Daytrana|daytrana
731049|NCT00506272|diabetes mellitus|diabetes mellitus
731050|NCT00506272|hyperglycemia|hyperglycemia
731051|NCT00506272|hypoglycemia|hypoglycemia
731052|NCT00506272|self care|self care
731053|NCT00506259|Deletion 17p11.2|deletion 17p11.2
731054|NCT00506259|Melatonin|melatonin
731055|NCT00506259|Phototherapy|phototherapy
731056|NCT00506259|Behavioral Phenotype|behavioral phenotype
731057|NCT00506259|Developmental Delay/MR|developmental delay/mr
731058|NCT00506259|Smith-Magenis Syndrome|smith-magenis syndrome
731059|NCT00506259|Sleep Disturbance|sleep disturbance
731060|NCT00506259|SMS|sms
731061|NCT00506259|Sleep Disorder|sleep disorder
731062|NCT00506246|anaesthesia|anaesthesia
731063|NCT00506233|Graft-Versus-Host Disease|graft-versus-host disease
731064|NCT00506233|GVHD|gvhd
731065|NCT00506233|Questionnaire|questionnaire
731066|NCT00506207|Gastrointestinal neoplasms|gastrointestinal neoplasms
731067|NCT00506207|Combination chemotherapy|combination chemotherapy
731068|NCT00506207|S-1|s-1
731069|NCT00506207|Irinotecan|irinotecan
731070|NCT00506207|Oxaliplatin|oxaliplatin
731071|NCT00506194|type 2 diabetes|type 2 diabetes
731072|NCT00506194|oral glucose tolerance test|oral glucose tolerance test
731073|NCT00506194|insulin|insulin
731074|NCT00506194|oral anti-diabetic drug|oral anti-diabetic drug
731075|NCT00506194|ß-cell function|ß-cell function
731076|NCT00506168|Colorectal neoplasms|colorectal neoplasms
731077|NCT00506168|Secondary|secondary
731078|NCT00506168|Drug therapy, combination|drug therapy, combination
731079|NCT00506168|Irinotecan|irinotecan
731080|NCT00506168|Capecitabine|capecitabine
731081|NCT00506155|Bladder Cancer|bladder cancer
731082|NCT00506155|Urothelial Cancer|urothelial cancer
731083|NCT00506155|Avastin|avastin
731084|NCT00506155|Bevacizumab|bevacizumab
731085|NCT00506155|Cisplatin|cisplatin
731086|NCT00506155|Doxorubicin|doxorubicin
731087|NCT00506155|Methotrexate|methotrexate
731088|NCT00506155|Vinblastine|vinblastine
731089|NCT00506155|M-VAC|m-vac
731090|NCT00506129|Cutaneous T-Cell Lymphoma|cutaneous t-cell lymphoma
731091|NCT00506129|CTCL|ctcl
731092|NCT00506129|Allogeneic Transplantation|allogeneic transplantation
731093|NCT00506129|Lymphoma|lymphoma
731094|NCT00506129|Allogeneic peripheral blood progenitor cell|allogeneic peripheral blood progenitor cell
731095|NCT00506129|PBPC|pbpc
731096|NCT00506129|Bone Marrow transplantation|bone marrow transplantation
731097|NCT00506129|Stem Cell Transplant|stem cell transplant
731098|NCT00506129|SCT|sct
731099|NCT00506129|Fludarabine|fludarabine
731100|NCT00506129|Fludarabine Phosphate|fludarabine phosphate
731101|NCT00506129|Fludara|fludara
731102|NCT00506129|Melphalan|melphalan
731103|NCT00506116|Pelvic floor muscle training|pelvic floor muscle training
731104|NCT00506116|Self-directed pushing|self-directed pushing
731616|NCT00504348|Tacrolimus|tacrolimus
731105|NCT00506116|Antenatal perineal massage|antenatal perineal massage
731106|NCT00506103|Thyroidectomy|thyroidectomy
731107|NCT00506103|Central neck dissection|central neck dissection
731108|NCT00506103|Harmonic scalpel|harmonic scalpel
731109|NCT00506103|Perioperative complications|perioperative complications
731110|NCT00506090|scar|scar
731111|NCT00506090|surgery|surgery
731112|NCT00506090|lasers|lasers
731113|NCT00506077|Undifferentiated schizophrenia|undifferentiated schizophrenia
731114|NCT00506077|residual schizophrenia|residual schizophrenia
731115|NCT00506064|Breast Cancer|breast cancer
731116|NCT00506064|Sleep|sleep
731117|NCT00506064|Melatonin|melatonin
731118|NCT00506064|Placebo|placebo
731119|NCT00506064|Survey|survey
731120|NCT00506064|Postoperative Srejic Sleep SAT Survey|postoperative srejic sleep sat survey
731121|NCT00506051|Non-small cell lung cancer|non-small cell lung cancer
731122|NCT00506051|lung cancer|lung cancer
731123|NCT00506051|alimta|alimta
731124|NCT00506051|vandetanib|vandetanib
731125|NCT00506051|phase 1|phase 1
731126|NCT00506038|Calcific Tendinitis|calcific tendinitis
731127|NCT00506025|Pregnancy|pregnancy
731128|NCT00506025|Cranberry|cranberry
731129|NCT00506025|Asymptomatic Bacteruria|asymptomatic bacteruria
731130|NCT00506012|Myoclonus Dystonia|myoclonus dystonia
731131|NCT00506012|Essential Myoclonus|essential myoclonus
731132|NCT00506012|Inherited Myoclonus|inherited myoclonus
731133|NCT00506012|Dyskinesia|dyskinesia
731134|NCT00506012|Movement Disorder|movement disorder
731135|NCT00505999|Multiple Myeloma|multiple myeloma
731136|NCT00505999|Etiology|etiology
731137|NCT00505999|Risk Factors|risk factors
731138|NCT00505999|Healthy Controls|healthy controls
731139|NCT00505999|Questionnaire|questionnaire
731140|NCT00505999|Survey|survey
731141|NCT00505947|macular edema|macular edema
731142|NCT00505947|diabetes mellitus|diabetes mellitus
731143|NCT00505947|visual loss|visual loss
731144|NCT00505947|diabetic retinopathy|diabetic retinopathy
731145|NCT00505947|macula|macula
731146|NCT00505947|maculopathy|maculopathy
731147|NCT00505947|infliximab|infliximab
731148|NCT00505934|Epilepsy|epilepsy
731149|NCT00505934|Child|child
731150|NCT00505934|Levetiracetam|levetiracetam
731151|NCT00505934|Keppra®|keppra®
731152|NCT00505934|Infusion|infusion
731153|NCT00505934|Intravenous|intravenous
731154|NCT00505921|T-Cell Lymphoma|t-cell lymphoma
731155|NCT00505921|Lymphoma|lymphoma
731156|NCT00505921|Campath-1H|campath-1h
731157|NCT00505921|Allogenic Transplantation|allogenic transplantation
731158|NCT00505921|Stem Cell Transplant|stem cell transplant
731159|NCT00505921|Alemtuzumab|alemtuzumab
731160|NCT00505895|Multiple Myeloma|multiple myeloma
731161|NCT00505895|Fludarabine|fludarabine
731162|NCT00505895|Fludara|fludara
731163|NCT00505895|Fludarabine Phosphate|fludarabine phosphate
731164|NCT00505895|Melphalan|melphalan
731165|NCT00505895|Alkeran|alkeran
731166|NCT00505895|Stem Cell Infusion|stem cell infusion
731167|NCT00505895|Stem Cell Transfusion|stem cell transfusion
731168|NCT00505895|SCT|sct
731169|NCT00505895|Allogeneic Peripheral Blood Stem Cell Transfusion|allogeneic peripheral blood stem cell transfusion
731170|NCT00505895|APBSCT|apbsct
731171|NCT00505895|Bone Marrow Transplantation|bone marrow transplantation
731172|NCT00505895|BMT|bmt
731173|NCT00505895|Rituxan|rituxan
731174|NCT00505895|Rituximab|rituximab
731175|NCT00505895|FM140|fm140
731176|NCT00505895|FM100|fm100
731177|NCT00505882|Type 1 diabetes|type 1 diabetes
731178|NCT00505882|Pramlintide|pramlintide
731179|NCT00505882|Weight gain|weight gain
731180|NCT00505882|Intensive insulin therapy|intensive insulin therapy
731181|NCT00505882|Beta cell|beta cell
731182|NCT00505869|Pregnant Smokers|pregnant smokers
731183|NCT00505869|Mood Management Intervention|mood management intervention
731184|NCT00505869|Health & Wellness Intervention|health & wellness intervention
731185|NCT00505869|Smoking Cessation|smoking cessation
731186|NCT00505869|Questionnaire|questionnaire
731187|NCT00505869|Survey|survey
731188|NCT00505830|Asperger Syndrom|asperger syndrom
731189|NCT00505830|Autism Quotient|autism quotient
731190|NCT00505830|French version|french version
731191|NCT00505830|screening|screening
731192|NCT00505830|diagnostic test|diagnostic test
731193|NCT00505830|accuracy|accuracy
731194|NCT00505804|dexmedetomidine|dexmedetomidine
731195|NCT00505804|haloperidol|haloperidol
731196|NCT00505791|Acute decompensated heart failure|acute decompensated heart failure
731197|NCT00505791|Normal left ventricular ejection fraction|normal left ventricular ejection fraction
731198|NCT00505791|Vasodilator therapy|vasodilator therapy
731199|NCT00505765|Cognition|cognition
731200|NCT00505765|Schizophrenia|schizophrenia
731201|NCT00505752|Assisted reproductive technology, follicle stimulating hormone|assisted reproductive technology, follicle stimulating hormone
731202|NCT00505739|Endometrial Cancer|endometrial cancer
731203|NCT00505739|Low Grade Endometrial Stromal Sarcoma|low grade endometrial stromal sarcoma
731204|NCT00505739|RU-486|ru-486
731205|NCT00505739|Mifepristone|mifepristone
731206|NCT00505739|LGESS|lgess
731207|NCT00505726|Cervical Intraepithelial Neoplasia|cervical intraepithelial neoplasia
731208|NCT00505726|Cervical Cancer|cervical cancer
731209|NCT00505726|Reflectance Confocal Imaging|reflectance confocal imaging
731210|NCT00505726|Colposcopy|colposcopy
731211|NCT00505713|Sarcoma|sarcoma
731212|NCT00505713|Rexin-G|rexin-g
731213|NCT00505713|Gene Therapy|gene therapy
731214|NCT00505700|acute myeloid leukemia|acute myeloid leukemia
731215|NCT00505687|Rotigotine|rotigotine
731216|NCT00505687|Neupro®|neupro®
731217|NCT00505661|Ovarian Cancer|ovarian cancer
731218|NCT00505661|Fallopian Tube Cancer|fallopian tube cancer
731219|NCT00505661|Peritoneal Cancer|peritoneal cancer
731220|NCT00505661|Letrozole|letrozole
731221|NCT00505661|Femara|femara
731222|NCT00505648|Hypersensitivity|hypersensitivity
731223|NCT00505648|Syndrome|syndrome
731224|NCT00505648|Tegeline|tegeline
731225|NCT00505635|advanced stage IV melanoma|advanced stage iv melanoma
731226|NCT00505635|unresectable stage III melanoma|unresectable stage iii melanoma
731227|NCT00505635|Melanoma|melanoma
731228|NCT00505635|Temozolomide|temozolomide
731229|NCT00505635|Velban|velban
731230|NCT00505635|Vinblastine|vinblastine
731231|NCT00505635|Cisplatin|cisplatin
731232|NCT00505635|Interleukin-2|interleukin-2
731233|NCT00505635|Intron-A|intron-a
731234|NCT00505635|Interferon Alpha-2b|interferon alpha-2b
731235|NCT00505635|Thalidomide|thalidomide
731236|NCT00505635|Thalomid|thalomid
731237|NCT00505635|Temodar|temodar
731238|NCT00505635|Proleukin|proleukin
731239|NCT00505609|fertility awareness-based method|fertility awareness-based method
731240|NCT00505609|family planning|family planning
731241|NCT00505609|Standard Days Method|standard days method
731242|NCT00505609|Institute for Reproductive Health|institute for reproductive health
731243|NCT00505609|Efficacy|efficacy
731244|NCT00505609|CycleBeads|cyclebeads
731245|NCT00505596|Prenatal testing|prenatal testing
731246|NCT00505596|Decisionmaking|decisionmaking
731247|NCT00505596|Decision aid|decision aid
731248|NCT00505596|Informed choice|informed choice
731249|NCT00505570|Migraine|migraine
731250|NCT00505570|Migraine with aura|migraine with aura
731251|NCT00505570|Patent foramen ovale|patent foramen ovale
731252|NCT00505570|PFO|pfo
731253|NCT00505557|augmentation mammoplasty|augmentation mammoplasty
731254|NCT00505557|Dual plane|dual plane
731255|NCT00505557|Endoscope|endoscope
731256|NCT00505557|Transaxillary incision|transaxillary incision
731257|NCT00505544|Advanced Cancer|advanced cancer
731258|NCT00505544|Questionnaire|questionnaire
731259|NCT00505544|Survey|survey
731260|NCT00505544|Sleep Disturbance|sleep disturbance
731261|NCT00505544|Sleep Quality|sleep quality
731262|NCT00505531|Pain|pain
731263|NCT00505518|Major Depressive Disorder|major depressive disorder
731264|NCT00505518|Telepsychiatry|telepsychiatry
731265|NCT00505518|Chinese American|chinese american
731266|NCT00505518|Nursing Home|nursing home
731267|NCT00505505|Neurointensive care|neurointensive care
731268|NCT00505505|Intensive insulin infusion|intensive insulin infusion
731269|NCT00505505|Hypoglycemia|hypoglycemia
731270|NCT00505505|Postoperative Mortality|postoperative mortality
731271|NCT00505505|Postoperative Morbidity|postoperative morbidity
731272|NCT00505505|Neurologic outcome|neurologic outcome
731273|NCT00505492|Malignant Mixed Mesodermal Tumor|malignant mixed mesodermal tumor
731274|NCT00505492|MMMT|mmmt
731275|NCT00505492|Uterine Neoplasms|uterine neoplasms
731276|NCT00505492|Radiation Therapy|radiation therapy
731277|NCT00505492|Paclitaxel|paclitaxel
731278|NCT00505492|Carboplatin|carboplatin
731279|NCT00505492|Cisplatin|cisplatin
731280|NCT00505492|Taxol|taxol
731281|NCT00505479|Congenital Hypothyroidism|congenital hypothyroidism
731282|NCT00505479|pregnancy|pregnancy
731283|NCT00505479|iodine|iodine
731284|NCT00505479|deficiency|deficiency
731285|NCT00505466|Human Genetics|human genetics
731286|NCT00505466|Genetic Counseling|genetic counseling
731287|NCT00505466|Genetic Testing|genetic testing
731288|NCT00505466|p53 Mutation|p53 mutation
731289|NCT00505466|Genetics|genetics
731291|NCT00505427|PCOS|pcos
731292|NCT00505427|polycystic ovary syndrome|polycystic ovary syndrome
731293|NCT00505427|polycystic ovarian syndrome|polycystic ovarian syndrome
731294|NCT00505427|alpha lipoic acid|alpha lipoic acid
731295|NCT00505427|insulin resistance|insulin resistance
731296|NCT00505427|oxidative stress|oxidative stress
731297|NCT00505414|Chronic Tumor Related Pain|chronic tumor related pain
731298|NCT00505414|Analgesic|analgesic
731299|NCT00505414|Tapentadol Extended Release|tapentadol extended release
731300|NCT00505414|Morphine Sulfate Controlled Release|morphine sulfate controlled release
731301|NCT00505414|Pain assessment|pain assessment
731302|NCT00505414|Placebo|placebo
731304|NCT00505401|Tat protein|tat protein
731305|NCT00505401|HIV Therapeutic Vaccine|hiv therapeutic vaccine
731306|NCT00505388|asthma|asthma
731307|NCT00505388|bronchial|bronchial
731308|NCT00505388|Symbicort|symbicort
731309|NCT00505375|CTLA4-Ig|ctla4-ig
731310|NCT00505375|Abatacept|abatacept
731311|NCT00505375|Beta-cell function|beta-cell function
731312|NCT00505375|T-cells|t-cells
731313|NCT00505375|DPT-1|dpt-1
731314|NCT00505375|treatment|treatment
731315|NCT00505375|treatment of type 1 diabetes|treatment of type 1 diabetes
731316|NCT00505375|new onset type 1 diabetes|new onset type 1 diabetes
731317|NCT00505375|juvenile diabetes|juvenile diabetes
731318|NCT00505375|T1D|t1d
731319|NCT00505375|diabetes mellitus|diabetes mellitus
731320|NCT00505375|Type 1 diabetes TrialNet|type 1 diabetes trialnet
731321|NCT00505375|TrialNet|trialnet
731322|NCT00505349|neurotrophic factors|neurotrophic factors
731323|NCT00505349|cognitive status|cognitive status
731324|NCT00505349|young adults|young adults
731325|NCT00505349|mature adults|mature adults
731326|NCT00505349|cognitive training|cognitive training
731327|NCT00505336|Diastolic heart failure|diastolic heart failure
731328|NCT00505336|Markers of collagen turnover|markers of collagen turnover
731329|NCT00505336|Statins|statins
731330|NCT00505336|Aldosterone receptor blockers|aldosterone receptor blockers
731331|NCT00505323|Cortex stimulation|cortex stimulation
731332|NCT00505323|Focal secondary Dystonia|focal secondary dystonia
731333|NCT00505323|Effectiveness|effectiveness
731334|NCT00505323|Quality of life improvement|quality of life improvement
731335|NCT00505323|Focal dystonias secondary to central grey nuclei lesions|focal dystonias secondary to central grey nuclei lesions
731336|NCT00505310|Kidney Cancer|kidney cancer
731337|NCT00505310|Renal Cell Carcinoma|renal cell carcinoma
731338|NCT00505310|Emotional Expression|emotional expression
731339|NCT00505310|Writing|writing
731340|NCT00505310|Questionnaire|questionnaire
731341|NCT00505310|Survey|survey
731342|NCT00505297|Osteoarthritis (OA)|osteoarthritis (oa)
731343|NCT00505297|Magnetic Resonance Imaging (MRI)|magnetic resonance imaging (mri)
731344|NCT00505297|delayed Gadolinium Enhanced MRI of cartilage (dGEMRIC)|delayed gadolinium enhanced mri of cartilage (dgemric)
731345|NCT00505297|disease modifying osteoarthritis drug (DMOAD)|disease modifying osteoarthritis drug (dmoad)
731346|NCT00505297|Potentially rapidly progressing osteoarthritis|potentially rapidly progressing osteoarthritis
731347|NCT00505297|MRI measurement of cartilage|mri measurement of cartilage
731348|NCT00505284|Diabetic neuropathy|diabetic neuropathy
731349|NCT00505271|Breast Cancer|breast cancer
731350|NCT00505271|Rexin-G|rexin-g
731351|NCT00505271|Gene Therapy|gene therapy
731352|NCT00505258|Bacteremia|bacteremia
731353|NCT00505258|Bloodstream infection|bloodstream infection
731354|NCT00505258|Staphylococcus aureus|staphylococcus aureus
731355|NCT00505258|Staphylococcal Infections|staphylococcal infections
731356|NCT00505258|MRSA|mrsa
731357|NCT00505258|MSSA|mssa
731358|NCT00505232|Y-90 Ibritumomab tiuxetan|y-90 ibritumomab tiuxetan
731359|NCT00505232|Rituximab|rituximab
731360|NCT00505232|Hyper-CVAD|hyper-cvad
731361|NCT00505232|Mantle Cell Lymphoma Patients|mantle cell lymphoma patients
731362|NCT00505232|Zevalin(R)|zevalin(r)
731363|NCT00505219|Osteonecrosis|osteonecrosis
731364|NCT00505180|Hemodialysis|hemodialysis
731365|NCT00505180|Mortality|mortality
731366|NCT00505167|Alzheimer's disease|alzheimer's disease
731367|NCT00505167|Memantine|memantine
731368|NCT00505167|Donepezil|donepezil
731369|NCT00505167|Magnetic resonance Spectroscopy|magnetic resonance spectroscopy
731370|NCT00505167|randomized trial|randomized trial
731371|NCT00505154|Heart failure|heart failure
731372|NCT00505154|inflammation|inflammation
731373|NCT00505154|cytokines|cytokines
731374|NCT00505141|Childhood Brain Cancer|childhood brain cancer
731375|NCT00505141|Childhood Acute Lymphoblastic Leukemia|childhood acute lymphoblastic leukemia
731376|NCT00505128|Biliary pancreatitis|biliary pancreatitis
731377|NCT00505128|Bile duct stones|bile duct stones
731378|NCT00505128|EUS Endoscopic UltraSonography|eus endoscopic ultrasonography
731379|NCT00505128|Endoscopic sphincterotomy|endoscopic sphincterotomy
731380|NCT00505128|ERCP|ercp
731381|NCT00505102|Kidney Diseases|kidney diseases
731382|NCT00505102|Heart Transplantation|heart transplantation
731383|NCT00505102|Everolimus|everolimus
731384|NCT00505102|Cyclosporine Toxicity|cyclosporine toxicity
731385|NCT00505089|pharmacokinetic, pharmacodynamic, subcutaneous, intravenous, ACZ885, patients, rheumatoid, arthritis.|pharmacokinetic, pharmacodynamic, subcutaneous, intravenous, acz885, patients, rheumatoid, arthritis.
731386|NCT00505076|Cognition|cognition
731387|NCT00505076|Schizophrenia|schizophrenia
731388|NCT00505063|vaccine|vaccine
731389|NCT00505063|childhood|childhood
731390|NCT00505063|cancer|cancer
731391|NCT00505050|heart failure, disease program management, treatment, education|heart failure, disease program management, treatment, education
731392|NCT00505037|ASP1585|asp1585
731393|NCT00505037|Renal Dialysis|renal dialysis
731394|NCT00505037|Chronic Kidney Disease|chronic kidney disease
731395|NCT00505037|Hyperphosphatemia|hyperphosphatemia
731396|NCT00505024|Non-Small Cell Lung Cancer|non-small cell lung cancer
731397|NCT00505024|Esophageal Cancer|esophageal cancer
731398|NCT00505024|Lung Cancer|lung cancer
731399|NCT00505024|Interactive Voice Response System|interactive voice response system
731400|NCT00505024|IVRS|ivrs
731401|NCT00505011|susceptibility|susceptibility
731402|NCT00505011|genes|genes
731403|NCT00505011|environment|environment
731404|NCT00505011|ophthalmopathy|ophthalmopathy
731405|NCT00505011|outcome|outcome
731406|NCT00504998|Pancreatic cancer|pancreatic cancer
731407|NCT00504998|Rexin-G|rexin-g
731408|NCT00504998|Treatment|treatment
731409|NCT00504985|Advanced Cancer|advanced cancer
731410|NCT00504985|Hematologic Malignancy|hematologic malignancy
731411|NCT00504985|Fatigue|fatigue
731412|NCT00504985|Emergency Center|emergency center
731413|NCT00504985|Survey|survey
731414|NCT00504959|Age-related macular degeneration (AMD),|age-related macular degeneration (amd),
731415|NCT00504959|choroidal neovascularization (CNV),|choroidal neovascularization (cnv),
731416|NCT00504959|vascular endothelial growth factor (VEGF)|vascular endothelial growth factor (vegf)
731417|NCT00504946|allergen immunotherapy premedication|allergen immunotherapy premedication
731418|NCT00504933|Rhinitis|rhinitis
731419|NCT00504933|Allergic|allergic
731420|NCT00504933|Seasonal|seasonal
731421|NCT00504933|Hay Fever|hay fever
731422|NCT00504933|Pollen Allergy|pollen allergy
731423|NCT00504933|Pollinosis|pollinosis
731424|NCT00504933|Rhinoconjunctivitis|rhinoconjunctivitis
731425|NCT00504920|Leukemia|leukemia
731426|NCT00504920|Myelodysplastic Syndrome|myelodysplastic syndrome
731427|NCT00504920|Acute Myeloblastic Leukemia|acute myeloblastic leukemia
731428|NCT00504920|Symptom-Related Cytokines|symptom-related cytokines
731429|NCT00504920|Blood or Marrow Transplantation|blood or marrow transplantation
731430|NCT00504920|Questionnaire|questionnaire
731431|NCT00504907|RSV|rsv
731432|NCT00504894|N/A healthy volunteers|n/a healthy volunteers
731433|NCT00504881|Epilepsy|epilepsy
731434|NCT00504881|Brivaracetam|brivaracetam
731435|NCT00504881|Partial Onset Seizures|partial onset seizures
731436|NCT00504855|Pressure ulcer|pressure ulcer
731437|NCT00504855|Waterproof|waterproof
731438|NCT00504855|Gortex|gortex
731439|NCT00504855|Cast padding|cast padding
731440|NCT00504855|Pediatric|pediatric
731441|NCT00504855|Heel|heel
731442|NCT00504842|Acute Ischemic Stroke|acute ischemic stroke
731443|NCT00504842|Microbubbles|microbubbles
731444|NCT00504842|Transcranial Doppler ultrasound|transcranial doppler ultrasound
731445|NCT00504842|TIBI|tibi
731446|NCT00504842|Symptomatic Intracranial Hemorrhage|symptomatic intracranial hemorrhage
731447|NCT00504842|modified Rankin Scale|modified rankin scale
731448|NCT00504842|Recanalization|recanalization
731449|NCT00504842|Perflutren|perflutren
731450|NCT00504829|LCP-AtorFen|lcp-atorfen
731451|NCT00504829|Non-HDL cholesterol|non-hdl cholesterol
731452|NCT00504829|Triglycerides|triglycerides
731453|NCT00504829|HDL cholesterol|hdl cholesterol
731454|NCT00504829|LDL cholesterol|ldl cholesterol
731455|NCT00504829|Atorvastatin|atorvastatin
731456|NCT00504829|Fenofibrate|fenofibrate
731457|NCT00504816|healthy female,|healthy female,
731458|NCT00504816|pharmacokinetics,|pharmacokinetics,
731459|NCT00504816|pharmacodynamics|pharmacodynamics
731460|NCT00504816|drug interaction,|drug interaction,
731461|NCT00504803|HCT, nonmyeloablative, mesenchymal stem cells, GVHD|hct, nonmyeloablative, mesenchymal stem cells, gvhd
731462|NCT00504790|GSK923295,|gsk923295,
731463|NCT00504790|First Time in Human,|first time in human,
731464|NCT00504790|pharmacodynamics|pharmacodynamics
731465|NCT00504790|cancer,|cancer,
731466|NCT00504790|maximally tolerated dose, pharmacokinetics,|maximally tolerated dose, pharmacokinetics,
731467|NCT00504790|Refractory Cancer|refractory cancer
731468|NCT00504790|CENPE,|cenpe,
731469|NCT00504790|Phase I,|phase i,
731470|NCT00504764|Relapsed Acute Promyelocytic Leukemia|relapsed acute promyelocytic leukemia
731471|NCT00504764|Arsenic Trioxide|arsenic trioxide
731472|NCT00504751|diffuse large b cell|diffuse large b cell
731473|NCT00504738|lung disease|lung disease
731474|NCT00504738|chronic obstructive pulmonary disease (COPD)|chronic obstructive pulmonary disease (copd)
731475|NCT00504738|asthma|asthma
731476|NCT00504738|smokers|smokers
731477|NCT00504738|non-smokers|non-smokers
731478|NCT00504725|Lobectomy|lobectomy
731479|NCT00504725|VATS|vats
731480|NCT00504712|Testosterone|testosterone
731481|NCT00504712|Hypogonadism|hypogonadism
731482|NCT00504712|Diabetes|diabetes
731483|NCT00504712|PVD|pvd
731484|NCT00504712|RCT|rct
731485|NCT00504699|breast cancer|breast cancer
731486|NCT00504699|ovarian stimulation|ovarian stimulation
731487|NCT00504699|aromatase inhibitors|aromatase inhibitors
731488|NCT00504699|letrozole|letrozole
731489|NCT00504699|fertility preservation|fertility preservation
731490|NCT00504699|recurrence|recurrence
731491|NCT00504660|Anaplastic Glioma|anaplastic glioma
731492|NCT00504660|Glioblastoma Multiforme|glioblastoma multiforme
731493|NCT00504660|Brain Cancer|brain cancer
731494|NCT00504660|6-Thioguanine|6-thioguanine
731495|NCT00504660|Capecitabine|capecitabine
731496|NCT00504660|Celecoxib|celecoxib
731497|NCT00504660|Temozolomide|temozolomide
731498|NCT00504660|Xeloda|xeloda
731499|NCT00504660|Temodar|temodar
731500|NCT00504660|TMZ|tmz
731501|NCT00504660|CCNU|ccnu
731502|NCT00504660|6-TG|6-tg
731503|NCT00504647|Hypertrophic|hypertrophic
731504|NCT00504647|Cardiomyopathy|cardiomyopathy
731505|NCT00504647|Diastolic|diastolic
731506|NCT00504647|Ventricular|ventricular
731507|NCT00504647|Interaction|interaction
731508|NCT00504647|Biventricular|biventricular
731509|NCT00504647|Pacemaker|pacemaker
731510|NCT00504634|Multiple Myeloma|multiple myeloma
731511|NCT00504634|Post Allogeneic Transplantation|post allogeneic transplantation
731512|NCT00504634|Bortezomib|bortezomib
731513|NCT00504634|Velcade|velcade
731514|NCT00504634|PS-341|ps-341
731515|NCT00504621|personality|personality
731516|NCT00504621|fatigue|fatigue
731517|NCT00504621|quality of life|quality of life
731518|NCT00504621|health care consumption|health care consumption
731519|NCT00504595|Rheumatoid Arthritis|rheumatoid arthritis
731520|NCT00504582|Axillary Node Dissection|axillary node dissection
731521|NCT00504582|Fibrin Sealant|fibrin sealant
731522|NCT00504582|Tisseel|tisseel
731523|NCT00504582|Melanoma|melanoma
731524|NCT00504582|Seroma|seroma
731525|NCT00504556|Anti-coagulant|anti-coagulant
731526|NCT00504556|Non-valvular|non-valvular
731527|NCT00504556|Venous Thromboembolism|venous thromboembolism
731528|NCT00504556|Prevention of Blood Clots|prevention of blood clots
731529|NCT00504556|Atrial Fibrillation|atrial fibrillation
731530|NCT00504556|Non-valvular atrial fibrillation|non-valvular atrial fibrillation
731531|NCT00504543|Kidney transplant, AEB071|kidney transplant, aeb071
731532|NCT00504517|Outpatient continuity training|outpatient continuity training
731533|NCT00504517|Relevant, Patient-centered curriculum|relevant, patient-centered curriculum
731534|NCT00504517|Evaluation|evaluation
731535|NCT00504517|New graduation requirements|new graduation requirements
731536|NCT00504504|Hodgkin's Disease|hodgkin's disease
731537|NCT00504504|Lymphoma|lymphoma
731538|NCT00504504|Rituximab|rituximab
731539|NCT00504504|Rituxan|rituxan
731540|NCT00504504|Adriamycin|adriamycin
731541|NCT00504504|Doxorubicin|doxorubicin
731542|NCT00504504|Rubex|rubex
731543|NCT00504504|Bleomycin|bleomycin
731544|NCT00504504|Bleomycin sulfate|bleomycin sulfate
731545|NCT00504504|Blenoxane|blenoxane
731546|NCT00504504|BLM|blm
731547|NCT00504504|Dacarbazine|dacarbazine
731548|NCT00504504|DTIC|dtic
731549|NCT00504504|DTIC-Dome|dtic-dome
731550|NCT00504504|Vincristine|vincristine
731551|NCT00504504|Vinblastine|vinblastine
731552|NCT00504504|Vinblastine Sulfate|vinblastine sulfate
731553|NCT00504504|ABVD|abvd
731554|NCT00504504|ABVD Chemotherapy Treatment|abvd chemotherapy treatment
731555|NCT00504491|Rituximab-CHOP|rituximab-chop
731556|NCT00504491|Alemtuzumab|alemtuzumab
731557|NCT00504491|Chronic lymphocytic leukaemia|chronic lymphocytic leukaemia
731558|NCT00504478|Inflammation|inflammation
731559|NCT00504478|carbohydrates|carbohydrates
731560|NCT00504478|omega-3|omega-3
731561|NCT00504478|overweight|overweight
731562|NCT00504478|diet|diet
731563|NCT00504465|Labor|labor
731564|NCT00504465|Labor induction|labor induction
731565|NCT00504465|Cervical ripening|cervical ripening
731566|NCT00504465|Dinoprostone|dinoprostone
731567|NCT00504465|Fetal safety|fetal safety
731568|NCT00504465|Oxytocin|oxytocin
731569|NCT00504465|Cesarean delivery|cesarean delivery
731570|NCT00504452|HIV|hiv
731571|NCT00504452|viral|viral
731572|NCT00504452|Viral decay acceleration|viral decay acceleration
731573|NCT00504452|ART|art
731574|NCT00504452|HAART|haart
731575|NCT00504452|Treatment Experienced|treatment experienced
731576|NCT00504439|COPD,|copd,
731577|NCT00504439|CD11b,|cd11b,
731578|NCT00504439|CXCR2,|cxcr2,
731579|NCT00504439|safety,|safety,
731580|NCT00504439|repeat dose,|repeat dose,
731581|NCT00504439|tolerability.|tolerability.
731582|NCT00504439|SB-656933,|sb-656933,
731583|NCT00504413|Metabolic Networks and Pathways|metabolic networks and pathways
731584|NCT00504413|Methadone|methadone
731585|NCT00504413|Polymorphism, genetic|polymorphism, genetic
731586|NCT00504413|Cytochrome P-450 Enzyme System|cytochrome p-450 enzyme system
731587|NCT00504400|macular telangiectasia|macular telangiectasia
731588|NCT00504400|parafoveal telangiectasis|parafoveal telangiectasis
731589|NCT00504400|nonproliferative|nonproliferative
731590|NCT00504400|therapy|therapy
731591|NCT00504400|intravitreal injection|intravitreal injection
731592|NCT00504400|ranibizumab|ranibizumab
731593|NCT00504400|lucentis|lucentis
731915|NCT00503672|Pregnancy|pregnancy
731594|NCT00504387|Burning mouth disorder|burning mouth disorder
731595|NCT00504387|Taste disorder|taste disorder
731596|NCT00504387|Quantitative sensory testing|quantitative sensory testing
731597|NCT00504387|Gustatory testing|gustatory testing
731598|NCT00504387|Neuropathic orofacial pain|neuropathic orofacial pain
731599|NCT00504387|Oral burning|oral burning
731600|NCT00504374|Lung Cancer|lung cancer
731601|NCT00504374|Epidemiology|epidemiology
731602|NCT00504374|Symptoms|symptoms
731603|NCT00504374|Gene Polymorphisms|gene polymorphisms
731604|NCT00504374|Questionnaire|questionnaire
731605|NCT00504374|Survey|survey
731606|NCT00504361|Asthma|asthma
731607|NCT00504361|COPD|copd
731608|NCT00504361|Interstitial Lung Disease|interstitial lung disease
731609|NCT00504361|Cystic Fibrosis|cystic fibrosis
731610|NCT00504361|Lung Cancer|lung cancer
731611|NCT00504361|smokers|smokers
731612|NCT00504361|non-smokers|non-smokers
731613|NCT00504348|Interstitial pneumonitis|interstitial pneumonitis
731614|NCT00504348|Polymyositis|polymyositis
731615|NCT00504348|Dermatomyositis|dermatomyositis
731617|NCT00504348|Corticosteroids|corticosteroids
731618|NCT00504335|Acute Radiation Syndrome|acute radiation syndrome
731619|NCT00504335|Hematopoietic Syndrome|hematopoietic syndrome
731620|NCT00504335|Radiation Injury|radiation injury
731621|NCT00504335|BIO 300|bio 300
731622|NCT00504322|Esophageal Neoplasms|esophageal neoplasms
731623|NCT00504309|triglycerides|triglycerides
731624|NCT00504309|hypertriglyceridemia|hypertriglyceridemia
731625|NCT00504309|omega-3|omega-3
731626|NCT00504309|n-3|n-3
731627|NCT00504309|eicosapentaenoic acid|eicosapentaenoic acid
731628|NCT00504309|EPA|epa
731629|NCT00504309|docosahexaenoic acid|docosahexaenoic acid
731630|NCT00504309|DHA|dha
731631|NCT00504309|flow mediated dilation|flow mediated dilation
731632|NCT00504309|fish|fish
731633|NCT00504309|Moderate hypertriglyceridemia|moderate hypertriglyceridemia
731634|NCT00504296|unspecified adult solid tumor, protocol specific|unspecified adult solid tumor, protocol specific
731635|NCT00504283|Renal colic, pain, protocol, emergency department|renal colic, pain, protocol, emergency department
731636|NCT00504257|recurrent ovarian epithelial cancer|recurrent ovarian epithelial cancer
731637|NCT00504257|recurrent primary peritoneal cavity cancer|recurrent primary peritoneal cavity cancer
731638|NCT00504257|recurrent fallopian tube cancer|recurrent fallopian tube cancer
731639|NCT00504244|SLE|sle
731640|NCT00504244|SLEDAI|sledai
731641|NCT00504244|Azathioprine|azathioprine
731642|NCT00504244|Myfortic|myfortic
731643|NCT00504231|influenza|influenza
731644|NCT00504231|prevention|prevention
731645|NCT00504231|intradermal|intradermal
731646|NCT00504231|vaccine|vaccine
731647|NCT00504231|delivery|delivery
731648|NCT00504231|elderly|elderly
731649|NCT00504218|Growth Factor|growth factor
731650|NCT00504218|Hypothalamic-Pituitary Dysfunction|hypothalamic-pituitary dysfunction
731651|NCT00504218|Primary Disorders of the Thyroid|primary disorders of the thyroid
731652|NCT00504218|Decreased Bone Mineral Density|decreased bone mineral density
731653|NCT00504218|Endocrine Side Effects Related to Cancer Therapy|endocrine side effects related to cancer therapy
731654|NCT00504218|Primary Gonadal Dysfunction|primary gonadal dysfunction
731655|NCT00504218|Obesity|obesity
731656|NCT00504218|Impaired Glucose Tolerance|impaired glucose tolerance
731657|NCT00504218|Thyroid Disorder|thyroid disorder
731658|NCT00504218|Cancer Therapy Endocrine Side Effects|cancer therapy endocrine side effects
731659|NCT00504218|Pituitary Dysfunction|pituitary dysfunction
731660|NCT00504218|Childhood Cancer Survivors|childhood cancer survivors
731661|NCT00504205|unspecified adult solid tumor, protocol specific|unspecified adult solid tumor, protocol specific
731662|NCT00504205|anaplastic large cell lymphoma|anaplastic large cell lymphoma
731663|NCT00504205|angioimmunoblastic T-cell lymphoma|angioimmunoblastic t-cell lymphoma
731664|NCT00504205|extranodal marginal zone B-cell lymphoma of mucosa-associated lymphoid tissue|extranodal marginal zone b-cell lymphoma of mucosa-associated lymphoid tissue
731665|NCT00504205|intraocular lymphoma|intraocular lymphoma
731666|NCT00504205|nodal marginal zone B-cell lymphoma|nodal marginal zone b-cell lymphoma
731667|NCT00504205|recurrent adult Burkitt lymphoma|recurrent adult burkitt lymphoma
731668|NCT00504205|recurrent adult diffuse large cell lymphoma|recurrent adult diffuse large cell lymphoma
731669|NCT00504205|recurrent adult diffuse mixed cell lymphoma|recurrent adult diffuse mixed cell lymphoma
731670|NCT00504205|recurrent adult diffuse small cleaved cell lymphoma|recurrent adult diffuse small cleaved cell lymphoma
731671|NCT00504205|recurrent adult Hodgkin lymphoma|recurrent adult hodgkin lymphoma
731672|NCT00504205|recurrent adult immunoblastic large cell lymphoma|recurrent adult immunoblastic large cell lymphoma
731673|NCT00504205|recurrent adult lymphoblastic lymphoma|recurrent adult lymphoblastic lymphoma
731674|NCT00504205|recurrent cutaneous T-cell non-Hodgkin lymphoma|recurrent cutaneous t-cell non-hodgkin lymphoma
731675|NCT00504205|recurrent grade 1 follicular lymphoma|recurrent grade 1 follicular lymphoma
731676|NCT00504205|recurrent grade 2 follicular lymphoma|recurrent grade 2 follicular lymphoma
731677|NCT00504205|recurrent grade 3 follicular lymphoma|recurrent grade 3 follicular lymphoma
731678|NCT00504205|recurrent mantle cell lymphoma|recurrent mantle cell lymphoma
731679|NCT00504205|recurrent marginal zone lymphoma|recurrent marginal zone lymphoma
732019|NCT00503126|bivalirudin|bivalirudin
731680|NCT00504205|recurrent mycosis fungoides/Sezary syndrome|recurrent mycosis fungoides/sezary syndrome
731681|NCT00504205|recurrent small lymphocytic lymphoma|recurrent small lymphocytic lymphoma
731682|NCT00504205|splenic marginal zone lymphoma|splenic marginal zone lymphoma
731683|NCT00504205|stage III adult Burkitt lymphoma|stage iii adult burkitt lymphoma
731684|NCT00504205|stage III adult diffuse large cell lymphoma|stage iii adult diffuse large cell lymphoma
731685|NCT00504205|stage III adult diffuse mixed cell lymphoma|stage iii adult diffuse mixed cell lymphoma
731686|NCT00504205|stage III adult diffuse small cleaved cell lymphoma|stage iii adult diffuse small cleaved cell lymphoma
731687|NCT00504205|stage III adult Hodgkin lymphoma|stage iii adult hodgkin lymphoma
731688|NCT00504205|stage III adult immunoblastic large cell lymphoma|stage iii adult immunoblastic large cell lymphoma
731689|NCT00504205|stage III adult lymphoblastic lymphoma|stage iii adult lymphoblastic lymphoma
731690|NCT00504205|stage III adult T-cell leukemia/lymphoma|stage iii adult t-cell leukemia/lymphoma
731691|NCT00504205|stage III cutaneous T-cell non-Hodgkin lymphoma|stage iii cutaneous t-cell non-hodgkin lymphoma
731692|NCT00504205|stage III grade 1 follicular lymphoma|stage iii grade 1 follicular lymphoma
731693|NCT00504205|stage III grade 2 follicular lymphoma|stage iii grade 2 follicular lymphoma
731694|NCT00504205|stage III grade 3 follicular lymphoma|stage iii grade 3 follicular lymphoma
731695|NCT00504205|stage III mantle cell lymphoma|stage iii mantle cell lymphoma
731696|NCT00504205|stage III marginal zone lymphoma|stage iii marginal zone lymphoma
731697|NCT00504205|stage III mycosis fungoides/Sezary syndrome|stage iii mycosis fungoides/sezary syndrome
731698|NCT00504205|stage III small lymphocytic lymphoma|stage iii small lymphocytic lymphoma
731699|NCT00504205|stage IV adult Burkitt lymphoma|stage iv adult burkitt lymphoma
731700|NCT00504205|stage IV adult diffuse large cell lymphoma|stage iv adult diffuse large cell lymphoma
731701|NCT00504205|stage IV adult diffuse mixed cell lymphoma|stage iv adult diffuse mixed cell lymphoma
731702|NCT00504205|stage IV adult diffuse small cleaved cell lymphoma|stage iv adult diffuse small cleaved cell lymphoma
731703|NCT00504205|stage IV adult Hodgkin lymphoma|stage iv adult hodgkin lymphoma
731704|NCT00504205|stage IV adult immunoblastic large cell lymphoma|stage iv adult immunoblastic large cell lymphoma
731705|NCT00504205|stage IV adult lymphoblastic lymphoma|stage iv adult lymphoblastic lymphoma
731706|NCT00504205|stage IV adult T-cell leukemia/lymphoma|stage iv adult t-cell leukemia/lymphoma
731707|NCT00504205|stage IV cutaneous T-cell non-Hodgkin lymphoma|stage iv cutaneous t-cell non-hodgkin lymphoma
731708|NCT00504205|stage IV grade 1 follicular lymphoma|stage iv grade 1 follicular lymphoma
731709|NCT00504205|stage IV grade 2 follicular lymphoma|stage iv grade 2 follicular lymphoma
731710|NCT00504205|stage IV grade 3 follicular lymphoma|stage iv grade 3 follicular lymphoma
731711|NCT00504205|stage IV mantle cell lymphoma|stage iv mantle cell lymphoma
731712|NCT00504205|stage IV marginal zone lymphoma|stage iv marginal zone lymphoma
731713|NCT00504205|stage IV mycosis fungoides/Sezary syndrome|stage iv mycosis fungoides/sezary syndrome
731714|NCT00504205|stage IV small lymphocytic lymphoma|stage iv small lymphocytic lymphoma
731715|NCT00504205|Waldenstrom macroglobulinemia|waldenstrom macroglobulinemia
731716|NCT00504205|primary central nervous system non-Hodgkin lymphoma|primary central nervous system non-hodgkin lymphoma
731717|NCT00504179|coronary artery bypass graft|coronary artery bypass graft
731718|NCT00504179|osteopathic manipulative treatment|osteopathic manipulative treatment
731719|NCT00504179|cardiovascular disease|cardiovascular disease
731720|NCT00504140|Osteosarcoma|osteosarcoma
731721|NCT00504140|Interferon Alpha|interferon alpha
731722|NCT00504140|IFN-|ifn-
731723|NCT00504140|Roferon|roferon
731724|NCT00504140|Recombinant Interferon Alpha|recombinant interferon alpha
731725|NCT00504140|Etoposide|etoposide
731726|NCT00504140|VP-16|vp-16
731727|NCT00504127|Arthritis|arthritis
731728|NCT00504127|Degenerative|degenerative
731729|NCT00504114|Osteoarthritis, knee|osteoarthritis, knee
731730|NCT00504114|anterior cruciate ligament|anterior cruciate ligament
731731|NCT00504114|Magnetic Resonance Imaging|magnetic resonance imaging
731732|NCT00504101|stage I multiple myeloma|stage i multiple myeloma
731733|NCT00504101|stage II multiple myeloma|stage ii multiple myeloma
731734|NCT00504101|stage III multiple myeloma|stage iii multiple myeloma
731736|NCT00504088|Critical Limb Ischemia|critical limb ischemia
731737|NCT00504088|PAD|pad
731738|NCT00504088|Peripheral Arterial Disease|peripheral arterial disease
731739|NCT00504088|Artherosclerosis|artherosclerosis
731740|NCT00504088|Leg Pain|leg pain
731741|NCT00504088|Cardiovascular|cardiovascular
731742|NCT00504088|Artherectomy|artherectomy
731743|NCT00504088|Bypass|bypass
731744|NCT00504088|Peripheral Bypass|peripheral bypass
731745|NCT00504088|PROOF|proof
731746|NCT00504075|Idiopathic Thrombocytopenic Purpura|idiopathic thrombocytopenic purpura
731747|NCT00504075|Bleeding disorders|bleeding disorders
731748|NCT00504075|Immune System and Disorders|immune system and disorders
731749|NCT00504062|asthma|asthma
731750|NCT00504062|bronchial|bronchial
731751|NCT00504049|Cerebral Palsy|cerebral palsy
731752|NCT00504049|Electromyography|electromyography
731753|NCT00504049|Wavelet Analysis|wavelet analysis
731754|NCT00504036|Obesity|obesity
731755|NCT00504036|Morbid obesity|morbid obesity
731756|NCT00504036|Gastric balloon|gastric balloon
731757|NCT00504036|Gastric by-pass|gastric by-pass
731758|NCT00504036|Morbid obesity with BMI > 45 kg/m²|morbid obesity with bmi > 45 kg/m²
731759|NCT00504023|Paget disease of the vulva|paget disease of the vulva
731760|NCT00504023|recurrent vulvar cancer|recurrent vulvar cancer
731761|NCT00504023|stage 0 vulvar cancer|stage 0 vulvar cancer
731762|NCT00504023|stage I vulvar cancer|stage i vulvar cancer
731763|NCT00504023|stage II vulvar cancer|stage ii vulvar cancer
731764|NCT00504023|stage III vulvar cancer|stage iii vulvar cancer
731765|NCT00504023|imiquimod|imiquimod
731766|NCT00504023|07-029|07-029
731767|NCT00504010|arnica|arnica
731768|NCT00504010|muscle soreness|muscle soreness
731769|NCT00504010|exercise|exercise
731770|NCT00504010|eccentric|eccentric
731771|NCT00503997|stage III squamous cell carcinoma of the hypopharynx|stage iii squamous cell carcinoma of the hypopharynx
731772|NCT00503997|stage III squamous cell carcinoma of the larynx|stage iii squamous cell carcinoma of the larynx
731773|NCT00503997|stage III squamous cell carcinoma of the lip and oral cavity|stage iii squamous cell carcinoma of the lip and oral cavity
731774|NCT00503997|stage III squamous cell carcinoma of the oropharynx|stage iii squamous cell carcinoma of the oropharynx
731775|NCT00503997|stage III squamous cell carcinoma of the paranasal sinus and nasal cavity|stage iii squamous cell carcinoma of the paranasal sinus and nasal cavity
731935|NCT00503594|Primary central nervous system lymphoma|primary central nervous system lymphoma
731776|NCT00503997|stage IV squamous cell carcinoma of the hypopharynx|stage iv squamous cell carcinoma of the hypopharynx
731777|NCT00503997|stage IV squamous cell carcinoma of the larynx|stage iv squamous cell carcinoma of the larynx
731778|NCT00503997|stage IV squamous cell carcinoma of the lip and oral cavity|stage iv squamous cell carcinoma of the lip and oral cavity
731779|NCT00503997|stage IV squamous cell carcinoma of the oropharynx|stage iv squamous cell carcinoma of the oropharynx
731780|NCT00503997|stage IV squamous cell carcinoma of the paranasal sinus and nasal cavity|stage iv squamous cell carcinoma of the paranasal sinus and nasal cavity
731781|NCT00503997|untreated metastatic squamous neck cancer with occult primary|untreated metastatic squamous neck cancer with occult primary
731782|NCT00503984|Adenocarcinoma of the prostate|adenocarcinoma of the prostate
731783|NCT00503984|Recurrent prostate cancer|recurrent prostate cancer
731784|NCT00503984|Stage IV prostate cancer|stage iv prostate cancer
731785|NCT00503984|Pain|pain
731786|NCT00503971|Vorinostat|vorinostat
731787|NCT00503971|NSCLC|nsclc
731788|NCT00503971|EGFR|egfr
731789|NCT00503971|Erlotinib|erlotinib
731790|NCT00503958|non-small cell lung cancer|non-small cell lung cancer
731791|NCT00503958|small cell lung cancer|small cell lung cancer
731792|NCT00503958|health status unknown|health status unknown
731793|NCT00503945|sleep apnea|sleep apnea
731794|NCT00503945|continuous positive airway pressure|continuous positive airway pressure
731795|NCT00503945|echocardiography|echocardiography
731796|NCT00503945|Natriuretic peptide|natriuretic peptide
731797|NCT00503932|Rectal Cancer|rectal cancer
731798|NCT00503932|Capecitabine|capecitabine
731799|NCT00503932|Proton Therapy|proton therapy
731800|NCT00503932|Adenocarcinoma of the rectum|adenocarcinoma of the rectum
731801|NCT00503932|Gastrointestinal|gastrointestinal
731802|NCT00503932|Proton Radiotherapy|proton radiotherapy
731803|NCT00503919|Cervix|cervix
731804|NCT00503919|Cervical dysplasia|cervical dysplasia
731805|NCT00503919|Cervical neoplasia|cervical neoplasia
731806|NCT00503919|Cervical intraepithelial neoplasia|cervical intraepithelial neoplasia
731807|NCT00503919|Multi-spectral Digital Colposcopy|multi-spectral digital colposcopy
731809|NCT00503919|Acetic acid|acetic acid
731810|NCT00503919|Colposcopy|colposcopy
731811|NCT00503919|Spectroscopy|spectroscopy
731812|NCT00503919|Fluorescence Spectroscopy|fluorescence spectroscopy
731813|NCT00503919|Abnormal Pap Smear|abnormal pap smear
731814|NCT00503906|stage IV breast cancer|stage iv breast cancer
731815|NCT00503906|recurrent breast cancer|recurrent breast cancer
731816|NCT00503893|Wilms' Tumor|wilms' tumor
731817|NCT00503893|Genitourinary Anomalies|genitourinary anomalies
731818|NCT00503893|Beckwith-Wiedemann Hemihypertrophy|beckwith-wiedemann hemihypertrophy
731819|NCT00503893|Aniridia|aniridia
731820|NCT00503893|Questionnaire|questionnaire
731821|NCT00503880|de novo myelodysplastic syndromes|de novo myelodysplastic syndromes
731822|NCT00503880|previously treated myelodysplastic syndromes|previously treated myelodysplastic syndromes
731823|NCT00503880|secondary myelodysplastic syndromes|secondary myelodysplastic syndromes
731824|NCT00503867|unresectable hepatocellular carcinoma|unresectable hepatocellular carcinoma
731825|NCT00503867|HCC|hcc
731826|NCT00503867|SIR-Spheres|sir-spheres
731827|NCT00503867|Y-90 Microspheres|y-90 microspheres
731828|NCT00503867|brachytherapy|brachytherapy
731829|NCT00503867|SIRT|sirt
731830|NCT00503867|liver cancer|liver cancer
731831|NCT00503841|stage I breast cancer|stage i breast cancer
731832|NCT00503841|recurrent breast cancer|recurrent breast cancer
731833|NCT00503841|stage II breast cancer|stage ii breast cancer
731834|NCT00503841|stage IIIA breast cancer|stage iiia breast cancer
731835|NCT00503841|stage IIIB breast cancer|stage iiib breast cancer
731836|NCT00503841|stage IIIC breast cancer|stage iiic breast cancer
731837|NCT00503828|Derris Scandens Benth extract|derris scandens benth extract
731838|NCT00503828|Osteoarthritis|osteoarthritis
731839|NCT00503828|WOMAC|womac
731840|NCT00503828|6-minute walk|6-minute walk
731841|NCT00503815|colonoscopy|colonoscopy
731842|NCT00503815|bowel preparation|bowel preparation
731843|NCT00503815|prep|prep
731844|NCT00503802|Sleep Apnea|sleep apnea
731845|NCT00503802|Sleep disordered breathing|sleep disordered breathing
731846|NCT00503802|Nasal Obstruction|nasal obstruction
731847|NCT00503802|Turbinate|turbinate
731848|NCT00503802|Radiofrequency|radiofrequency
731849|NCT00503802|Continuous positive airway pressure|continuous positive airway pressure
731850|NCT00503802|CPAP|cpap
731851|NCT00503802|Sleep surgery|sleep surgery
731852|NCT00503789|Healthy infants|healthy infants
731853|NCT00503776|xerostomia|xerostomia
731854|NCT00503776|mucositis|mucositis
731855|NCT00503776|dysphagia|dysphagia
731856|NCT00503776|radiation toxicity|radiation toxicity
731857|NCT00503776|chemotherapeutic agent toxicity|chemotherapeutic agent toxicity
731858|NCT00503776|stage III squamous cell carcinoma of the hypopharynx|stage iii squamous cell carcinoma of the hypopharynx
731859|NCT00503776|stage IV squamous cell carcinoma of the hypopharynx|stage iv squamous cell carcinoma of the hypopharynx
731860|NCT00503776|recurrent squamous cell carcinoma of the hypopharynx|recurrent squamous cell carcinoma of the hypopharynx
731861|NCT00503776|stage III squamous cell carcinoma of the larynx|stage iii squamous cell carcinoma of the larynx
731862|NCT00503776|stage III verrucous carcinoma of the larynx|stage iii verrucous carcinoma of the larynx
732045|NCT00503035|Rectum|rectum
731863|NCT00503776|stage IV squamous cell carcinoma of the larynx|stage iv squamous cell carcinoma of the larynx
731864|NCT00503776|stage IV verrucous carcinoma of the larynx|stage iv verrucous carcinoma of the larynx
731865|NCT00503776|recurrent squamous cell carcinoma of the larynx|recurrent squamous cell carcinoma of the larynx
731866|NCT00503776|recurrent verrucous carcinoma of the larynx|recurrent verrucous carcinoma of the larynx
731867|NCT00503776|stage III squamous cell carcinoma of the lip and oral cavity|stage iii squamous cell carcinoma of the lip and oral cavity
731868|NCT00503776|stage III verrucous carcinoma of the oral cavity|stage iii verrucous carcinoma of the oral cavity
731869|NCT00503776|stage IV squamous cell carcinoma of the lip and oral cavity|stage iv squamous cell carcinoma of the lip and oral cavity
731870|NCT00503776|stage IV verrucous carcinoma of the oral cavity|stage iv verrucous carcinoma of the oral cavity
731871|NCT00503776|recurrent squamous cell carcinoma of the lip and oral cavity|recurrent squamous cell carcinoma of the lip and oral cavity
731872|NCT00503776|recurrent verrucous carcinoma of the oral cavity|recurrent verrucous carcinoma of the oral cavity
731873|NCT00503776|stage III squamous cell carcinoma of the nasopharynx|stage iii squamous cell carcinoma of the nasopharynx
731874|NCT00503776|stage IV squamous cell carcinoma of the nasopharynx|stage iv squamous cell carcinoma of the nasopharynx
731875|NCT00503776|recurrent squamous cell carcinoma of the nasopharynx|recurrent squamous cell carcinoma of the nasopharynx
731876|NCT00503776|stage III squamous cell carcinoma of the oropharynx|stage iii squamous cell carcinoma of the oropharynx
731877|NCT00503776|stage IV squamous cell carcinoma of the oropharynx|stage iv squamous cell carcinoma of the oropharynx
731878|NCT00503776|recurrent squamous cell carcinoma of the oropharynx|recurrent squamous cell carcinoma of the oropharynx
731879|NCT00503776|salivary gland squamous cell carcinoma|salivary gland squamous cell carcinoma
731880|NCT00503776|stage III salivary gland cancer|stage iii salivary gland cancer
731881|NCT00503776|stage IV salivary gland cancer|stage iv salivary gland cancer
731882|NCT00503776|recurrent salivary gland cancer|recurrent salivary gland cancer
731883|NCT00503763|Smoldering multiple myeloma|smoldering multiple myeloma
731884|NCT00503763|Simvastatin|simvastatin
731885|NCT00503763|Paraprotein|paraprotein
731886|NCT00503750|Breast Cancer|breast cancer
731887|NCT00503737|colorectal cancer screening|colorectal cancer screening
731888|NCT00503737|National Colorectal Cancer Roundtable Toolbox|national colorectal cancer roundtable toolbox
731889|NCT00503724|recurrent childhood brain stem glioma|recurrent childhood brain stem glioma
731890|NCT00503724|childhood central nervous system germ cell tumor|childhood central nervous system germ cell tumor
731891|NCT00503724|recurrent childhood cerebellar astrocytoma|recurrent childhood cerebellar astrocytoma
731892|NCT00503724|recurrent childhood cerebral astrocytoma|recurrent childhood cerebral astrocytoma
731893|NCT00503724|childhood choroid plexus tumor|childhood choroid plexus tumor
731894|NCT00503724|childhood craniopharyngioma|childhood craniopharyngioma
731895|NCT00503724|childhood infratentorial ependymoma|childhood infratentorial ependymoma
731896|NCT00503724|childhood supratentorial ependymoma|childhood supratentorial ependymoma
731897|NCT00503724|recurrent childhood ependymoma|recurrent childhood ependymoma
731898|NCT00503724|recurrent childhood medulloblastoma|recurrent childhood medulloblastoma
731899|NCT00503724|childhood oligodendroglioma|childhood oligodendroglioma
731900|NCT00503724|recurrent childhood supratentorial primitive neuroectodermal tumor|recurrent childhood supratentorial primitive neuroectodermal tumor
731901|NCT00503724|recurrent childhood visual pathway and hypothalamic glioma|recurrent childhood visual pathway and hypothalamic glioma
731902|NCT00503724|recurrent childhood visual pathway glioma|recurrent childhood visual pathway glioma
731903|NCT00503724|childhood grade I meningioma|childhood grade i meningioma
731904|NCT00503724|childhood grade II meningioma|childhood grade ii meningioma
731905|NCT00503724|childhood grade III meningioma|childhood grade iii meningioma
731906|NCT00503724|recurrent childhood subependymal giant cell astrocytoma|recurrent childhood subependymal giant cell astrocytoma
731907|NCT00503724|recurrent childhood pineoblastoma|recurrent childhood pineoblastoma
731908|NCT00503724|recurrent childhood brain tumor|recurrent childhood brain tumor
731909|NCT00503724|disseminated neuroblastoma|disseminated neuroblastoma
731910|NCT00503724|recurrent neuroblastoma|recurrent neuroblastoma
731911|NCT00503711|ZD6474 PK|zd6474 pk
731912|NCT00503685|Metastatic Colorectal Cancer with Disease Progression|metastatic colorectal cancer with disease progression
731913|NCT00503685|Failed prior to Anti-EGFr Therapy|failed prior to anti-egfr therapy
731914|NCT00503672|Motor Activity|motor activity
731916|NCT00503672|Accelerometer|accelerometer
731917|NCT00503659|PC20 FEV1|pc20 fev1
731918|NCT00503659|PD20FEV1|pd20fev1
731919|NCT00503659|bronchial hyperreactivity|bronchial hyperreactivity
731920|NCT00503659|bronchial asthma|bronchial asthma
731921|NCT00503646|psychosocial effects of cancer and its treatment|psychosocial effects of cancer and its treatment
731922|NCT00503646|sexual dysfunction and infertility|sexual dysfunction and infertility
731923|NCT00503646|sexuality and reproductive issues|sexuality and reproductive issues
731924|NCT00503646|stage IIB prostate cancer|stage iib prostate cancer
731925|NCT00503646|stage IIA prostate cancer|stage iia prostate cancer
731926|NCT00503646|stage I prostate cancer|stage i prostate cancer
731927|NCT00503633|sleep disorders|sleep disorders
731928|NCT00503633|genetics|genetics
731929|NCT00503620|Cerebral Palsy|cerebral palsy
731930|NCT00503620|Botulinum Toxin|botulinum toxin
731931|NCT00503620|Neuromuscular Function|neuromuscular function
731932|NCT00503607|colonoscopy|colonoscopy
731933|NCT00503607|bowel preparation|bowel preparation
731934|NCT00503607|prep|prep
731936|NCT00503594|Brain lymphoma|brain lymphoma
731937|NCT00503594|Elderly|elderly
731938|NCT00503594|Chemotherapy|chemotherapy
731939|NCT00503594|Methotrexate|methotrexate
731940|NCT00503594|Temozolomide|temozolomide
731941|NCT00503594|Procarbazine|procarbazine
731942|NCT00503594|Vincristine|vincristine
731943|NCT00503594|Cytarabine|cytarabine
731944|NCT00503568|stage IIIB non-small cell lung cancer|stage iiib non-small cell lung cancer
731945|NCT00503568|stage IV non-small cell lung cancer|stage iv non-small cell lung cancer
731946|NCT00503568|recurrent non-small cell lung cancer|recurrent non-small cell lung cancer
731947|NCT00503555|Primary Health Care|primary health care
731948|NCT00503555|Hispanic Americans|hispanic americans
731949|NCT00503542|Vaginitis|vaginitis
731950|NCT00503542|Bacterial Vaginosis|bacterial vaginosis
731951|NCT00503542|Vaginal trichomoniasis|vaginal trichomoniasis
731952|NCT00503542|Vulvovaginal candidiasis|vulvovaginal candidiasis
731953|NCT00503516|weight loss, appetite, dementia, megestrol acetate|weight loss, appetite, dementia, megestrol acetate
731954|NCT00503477|Japan|japan
731955|NCT00503477|Phase I|phase i
731956|NCT00503477|solid tumor|solid tumor
731957|NCT00503477|AZD2171|azd2171
731958|NCT00503464|guideline|guideline
731959|NCT00503464|adherence|adherence
731960|NCT00503451|Advanced cancer|advanced cancer
731961|NCT00503451|solid tumors|solid tumors
731962|NCT00503451|lymphoma|lymphoma
731963|NCT00503451|HDAC|hdac
731964|NCT00503451|LBH589|lbh589
731965|NCT00503451|adults|adults
731966|NCT00503451|non-Hodgkin's lymphoma|non-hodgkin's lymphoma
731967|NCT00503438|Arthritis|arthritis
731968|NCT00503438|Osteoarthritis|osteoarthritis
731969|NCT00503438|Arthroplasty|arthroplasty
731970|NCT00503412|phase I|phase i
731971|NCT00503412|AZD2171|azd2171
731972|NCT00503412|solid tumor|solid tumor
731973|NCT00503412|metastatic tumor|metastatic tumor
731974|NCT00503399|Glucocorticoid Induced|glucocorticoid induced
731975|NCT00503386|chemotherapy-induced nausea and vomiting|chemotherapy-induced nausea and vomiting
731976|NCT00503386|acute|acute
731977|NCT00503386|delayed|delayed
731978|NCT00503386|emesis|emesis
731979|NCT00503386|antiemetics|antiemetics
731980|NCT00503386|5-HT3 receptor antagonist|5-ht3 receptor antagonist
731981|NCT00503386|granisetron|granisetron
731982|NCT00503386|palonosetron|palonosetron
731983|NCT00503360|Ocular Hypertension|ocular hypertension
731984|NCT00503360|SAD448|sad448
731985|NCT00503347|coinfection with chronic hepatitis C virus and HIV|coinfection with chronic hepatitis c virus and hiv
731986|NCT00503347|Treatment Naive|treatment naive
731987|NCT00503321|gastric cancer, TS-1, PSK|gastric cancer, ts-1, psk
731988|NCT00503308|HIV Seronegativity|hiv seronegativity
731989|NCT00503295|reovirus|reovirus
731990|NCT00503295|oncolytic virus|oncolytic virus
731991|NCT00503295|sarcoma|sarcoma
731992|NCT00503295|REOLYSIN|reolysin
731993|NCT00503295|Oncolytics Biotech|oncolytics biotech
731994|NCT00503269|Haemorrhoidectomy|haemorrhoidectomy
731995|NCT00503269|Local anaesthesia|local anaesthesia
731996|NCT00503256|Chronic Lymphocytic Leukemia|chronic lymphocytic leukemia
731997|NCT00503256|Leukemia|leukemia
731998|NCT00503256|Lymphoma|lymphoma
731999|NCT00503256|Questionnaire|questionnaire
732000|NCT00503256|Survey|survey
732001|NCT00503256|CLL|cll
732002|NCT00503230|tobacco|tobacco
732003|NCT00503230|smoking|smoking
732004|NCT00503230|HIV|hiv
732006|NCT00503217|intrauterine insemination|intrauterine insemination
732007|NCT00503217|GnRH agonist|gnrh agonist
732008|NCT00503217|implantation|implantation
732009|NCT00503204|cancer|cancer
732010|NCT00503204|tumor|tumor
732011|NCT00503204|advance solid tumour|advance solid tumour
732012|NCT00503204|glioblastoma|glioblastoma
732013|NCT00503204|malignant brain tumour|malignant brain tumour
732014|NCT00503191|Autism|autism
732015|NCT00503191|Neurodevelopmental disorder|neurodevelopmental disorder
732016|NCT00503165|Menitorix|menitorix
732017|NCT00503165|vaccine|vaccine
732018|NCT00503126|pediatrics|pediatrics
732021|NCT00503100|Preterm-Born Adolescents|preterm-born adolescents
732022|NCT00503087|Injections|injections
732023|NCT00503087|Vacuum|vacuum
732024|NCT00503087|Pain|pain
732025|NCT00503087|Pneumatic Skin Flattening|pneumatic skin flattening
732026|NCT00503087|PSF|psf
732027|NCT00503074|Diet, reducing|diet, reducing
732028|NCT00503074|Television|television
732029|NCT00503074|Child Behavior|child behavior
732030|NCT00503061|pharmaceopidemiological|pharmaceopidemiological
732031|NCT00503061|Symbicort SMART|symbicort smart
732032|NCT00503061|GPRD|gprd
732033|NCT00503048|atopy|atopy
732034|NCT00503048|atopic diseases|atopic diseases
732035|NCT00503048|children|children
732036|NCT00503048|orphanages|orphanages
732037|NCT00503035|Familial Adenomatous Polyposis|familial adenomatous polyposis
732038|NCT00503035|Colorectal Tumors|colorectal tumors
732039|NCT00503035|Molecular Targeting|molecular targeting
732040|NCT00503035|Celecoxib|celecoxib
732041|NCT00503035|Celebrex|celebrex
732042|NCT00503035|SC-58635|sc-58635
732043|NCT00503035|Apoptosis Induction|apoptosis induction
732044|NCT00503035|Colon|colon
732048|NCT00503022|Wet age-related macular degeneration|wet age-related macular degeneration
732049|NCT00503022|ACZ885|acz885
732050|NCT00503009|Rhinovirus|rhinovirus
732051|NCT00503009|Asthma|asthma
732052|NCT00502983|Acute Myelogenous Leukemia|acute myelogenous leukemia
732053|NCT00502983|Epidemiology|epidemiology
732054|NCT00502983|Leukemia|leukemia
732055|NCT00502983|Healthy Control|healthy control
732056|NCT00502983|Lifestyle Factors|lifestyle factors
732057|NCT00502983|Genetic Susceptibility|genetic susceptibility
732058|NCT00502983|Interview|interview
732059|NCT00502983|AML|aml
732060|NCT00502970|Chronic HCV|chronic hcv
732061|NCT00502970|Treatment|treatment
732062|NCT00502957|biofeedback|biofeedback
732063|NCT00502957|constipation|constipation
732064|NCT00502944|HIV|hiv
732065|NCT00502944|Testing|testing
732066|NCT00502944|HIV Seronegativity|hiv seronegativity
732067|NCT00502905|Acute Myeloid Leukemia|acute myeloid leukemia
732068|NCT00502905|Myelodysplastic Syndromes|myelodysplastic syndromes
732069|NCT00502905|Busulfan|busulfan
732070|NCT00502905|Busulfex|busulfex
732071|NCT00502905|Myleran|myleran
732072|NCT00502905|Fludarabine|fludarabine
732073|NCT00502905|Fludarabine Phosphate|fludarabine phosphate
732074|NCT00502905|Fludara|fludara
732075|NCT00502892|Solid Tumors|solid tumors
732076|NCT00502892|Topotecan|topotecan
732077|NCT00502892|Hycamtin|hycamtin
732078|NCT00502892|Ifosfamide|ifosfamide
732079|NCT00502892|Ifex|ifex
732080|NCT00502892|Carboplatin|carboplatin
732081|NCT00502892|Paraplatin|paraplatin
732082|NCT00502892|Pediatric|pediatric
732083|NCT00502892|Children|children
732084|NCT00502892|Young Adults|young adults
732085|NCT00502866|breastfeeding|breastfeeding
732086|NCT00502866|vitamin D supplementation|vitamin d supplementation
732087|NCT00502866|rickets|rickets
732088|NCT00502827|Human Immunodeficiency Virus|human immunodeficiency virus
732089|NCT00502827|HIV positive|hiv positive
732090|NCT00502827|HIV Positive Smokers|hiv positive smokers
732091|NCT00502827|AIDS|aids
732092|NCT00502827|Cell Phone Intervention|cell phone intervention
732093|NCT00502827|CPI|cpi
732094|NCT00502827|Smoking Cessation|smoking cessation
732095|NCT00502827|Interview|interview
732096|NCT00502814|Breast Cancer|breast cancer
732097|NCT00502814|3-D Optical Surface Scan|3-d optical surface scan
732098|NCT00502814|Soft Tissue Biomechanics|soft tissue biomechanics
732099|NCT00502814|Mechanical Testing|mechanical testing
732100|NCT00502814|Skin Ultrasound|skin ultrasound
732101|NCT00502814|Magnetic Resonance Imaging|magnetic resonance imaging
732102|NCT00502814|CT Scan|ct scan
732103|NCT00502801|Pneumonia|pneumonia
732104|NCT00502801|Lung Infection|lung infection
732105|NCT00502801|Bacterial Infection|bacterial infection
732106|NCT00502801|Hospital-Acquired Infection|hospital-acquired infection
732107|NCT00502801|Ventilator Infection|ventilator infection
732108|NCT00502801|Antibiotic Therapy|antibiotic therapy
732109|NCT00502775|ragweed|ragweed
732110|NCT00502775|once daily|once daily
732111|NCT00502775|fexofenadine|fexofenadine
732112|NCT00502775|fluticasone furoate|fluticasone furoate
732113|NCT00502775|allergic rhinitis|allergic rhinitis
732114|NCT00502762|small-cell lung cancer|small-cell lung cancer
732115|NCT00502762|refractory|refractory
732116|NCT00502762|topotecan|topotecan
732117|NCT00502749|Leukemia|leukemia
732118|NCT00502749|Lymphoma|lymphoma
732119|NCT00502749|Exercise|exercise
732120|NCT00502749|Quality of Life|quality of life
732121|NCT00502749|Questionnaire|questionnaire
732122|NCT00502749|Survey|survey
732123|NCT00502723|Retropubic Prostatectomy|retropubic prostatectomy
732124|NCT00502723|Surgical Procedures|surgical procedures
732125|NCT00502723|Laparoscopic|laparoscopic
732126|NCT00502697|preterm|preterm
732127|NCT00502697|prematurity|prematurity
732128|NCT00502697|home visitation|home visitation
732129|NCT00502697|system of care|system of care
732130|NCT00502684|breast cancer|breast cancer
732131|NCT00502684|surgery|surgery
732132|NCT00502684|immune suppression|immune suppression
732133|NCT00502684|beta blockers|beta blockers
732134|NCT00502684|COX2 inhibitors|cox2 inhibitors
732135|NCT00502658|Overweight|overweight
732136|NCT00502658|Obese|obese
732137|NCT00502658|Dietary Supplements|dietary supplements
732138|NCT00502658|Shakes|shakes
732139|NCT00502658|Nutrition|nutrition
732140|NCT00502658|Overweight and Obese Adults (BMI 25-35)|overweight and obese adults (bmi 25-35)
732141|NCT00502645|algorithm|algorithm
732142|NCT00502645|cs-1 decision support system|cs-1 decision support system
732143|NCT00502645|insulin|insulin
732144|NCT00502645|hyperglycemia|hyperglycemia
732145|NCT00502645|tight glycemic control|tight glycemic control
732146|NCT00502645|intensive care|intensive care
732147|NCT00502645|adults|adults
732148|NCT00502632|Pleural empyema|pleural empyema
732149|NCT00502632|Pleural effusion|pleural effusion
732150|NCT00502632|Dornase alfa|dornase alfa
732151|NCT00502632|Urokinase|urokinase
732152|NCT00502632|Children|children
732153|NCT00502619|Low back pain|low back pain
732154|NCT00502619|acupuncture|acupuncture
732155|NCT00502619|treadmill exercise|treadmill exercise
732156|NCT00502606|provisional restoration|provisional restoration
732157|NCT00502606|antibacterial nanoparticles|antibacterial nanoparticles
732158|NCT00502606|cement|cement
732159|NCT00502606|biofilm|biofilm
732160|NCT00502606|bacteria|bacteria
732161|NCT00502606|flora|flora
732162|NCT00502606|plaque|plaque
732163|NCT00502606|dental|dental
732164|NCT00502606|prosthesis|prosthesis
732165|NCT00502593|Influenza|influenza
732166|NCT00502593|Pandemic Influenza Vaccine (GSK1562902A)|pandemic influenza vaccine (gsk1562902a)
732167|NCT00502580|Oral Cancer|oral cancer
732168|NCT00502580|Multispectral Digital Microscope|multispectral digital microscope
732169|NCT00502580|Multispectral Digital Imaging|multispectral digital imaging
732170|NCT00502580|Interview|interview
732171|NCT00502580|MDM|mdm
732172|NCT00502567|advanced solid tumors|advanced solid tumors
732173|NCT00502567|AZD2171|azd2171
732174|NCT00502567|Phase I|phase i
732175|NCT00502554|lung function|lung function
732176|NCT00502554|FEV1|fev1
732177|NCT00502528|Infarction|infarction
732178|NCT00502528|Endothelin|endothelin
732179|NCT00502528|Perfusion|perfusion
732180|NCT00502515|Diabetes|diabetes
732181|NCT00502515|Neuropathy|neuropathy
732182|NCT00502502|Anal Cancer|anal cancer
732183|NCT00502502|Colorectal Cancer|colorectal cancer
732184|NCT00502502|Esophageal Cancer|esophageal cancer
732185|NCT00502502|Gastric Cancer|gastric cancer
732186|NCT00502502|Lung Cancer|lung cancer
732187|NCT00502502|Questionnaire|questionnaire
732188|NCT00502502|Survey|survey
732189|NCT00502502|Chemoradiation Therapy|chemoradiation therapy
732190|NCT00502502|Symptoms|symptoms
732191|NCT00502502|Cytokines|cytokines
732192|NCT00502489|prolonged mechanical ventilation; weaning;rehabilitation|prolonged mechanical ventilation; weaning;rehabilitation
732193|NCT00502476|MRSA|mrsa
732194|NCT00502476|VRE|vre
732195|NCT00502476|BSI|bsi
732196|NCT00502463|head and neck cancer, stage III/IV|head and neck cancer, stage iii/iv
732197|NCT00502463|no prior radiotherapy of head and neck region|no prior radiotherapy of head and neck region
732198|NCT00502450|Acute mastoiditis|acute mastoiditis
732199|NCT00502450|Hearing loss|hearing loss
732200|NCT00502450|Mastoidectomy|mastoidectomy
732201|NCT00502450|Audiogram|audiogram
732202|NCT00502424|Rheumatoid Arthritis|rheumatoid arthritis
732203|NCT00502424|Hand|hand
732204|NCT00502424|Splint|splint
732205|NCT00502424|Occupational Therapy|occupational therapy
732206|NCT00502411|Soft Tissue Sarcoma|soft tissue sarcoma
732207|NCT00502411|External Beam Radiotherapy|external beam radiotherapy
732208|NCT00502411|Radiation Therapy|radiation therapy
732209|NCT00502411|Extremity and Trunk|extremity and trunk
732210|NCT00502411|EBRT|ebrt
732211|NCT00502411|Sarcoma|sarcoma
732212|NCT00502411|Doxorubicin|doxorubicin
732213|NCT00502411|AD|ad
732214|NCT00502411|Hydroxydaunomycin hydrochloride|hydroxydaunomycin hydrochloride
732215|NCT00502411|XRT|xrt
732216|NCT00502411|RT|rt
732217|NCT00502411|Radiotherapy|radiotherapy
732218|NCT00502385|Phase I|phase i
732219|NCT00502385|AML|aml
732220|NCT00502385|de novo or secondary AML|de novo or secondary aml
732221|NCT00502385|AZD2171|azd2171
732222|NCT00502359|Gestational diabetes, screening, glucose monitoring|gestational diabetes, screening, glucose monitoring
732223|NCT00502346|Pharmacodynamics|pharmacodynamics
732224|NCT00502333|back pain|back pain
732225|NCT00502333|neck pain|neck pain
732226|NCT00502333|prognosis|prognosis
732227|NCT00502333|catastrophizing|catastrophizing
732228|NCT00502333|coping strategies|coping strategies
732229|NCT00502333|disability|disability
732230|NCT00502333|Prognosis for back and neck pain|prognosis for back and neck pain
732231|NCT00502320|Seasonal Affective Disorder|seasonal affective disorder
732232|NCT00502320|Ramelteon|ramelteon
732233|NCT00502320|Psychiatry|psychiatry
732234|NCT00502320|Randomized Controlled Trial|randomized controlled trial
732235|NCT00502320|Hamilton Depression Rating Scale- SAD Version|hamilton depression rating scale- sad version
732236|NCT00502320|Circadian Rhythm|circadian rhythm
732237|NCT00502307|Renal Cell Carcinoma|renal cell carcinoma
732238|NCT00502307|AV-951|av-951
732239|NCT00502307|tivozanib|tivozanib
732240|NCT00502294|Ulcerative Colitis, UC, Intravenous Steroid-Refractory Ulcerative Colitis, IVSR-UC|ulcerative colitis, uc, intravenous steroid-refractory ulcerative colitis, ivsr-uc
732241|NCT00502281|Gonadotropins|gonadotropins
732242|NCT00502281|Infertility|infertility
732243|NCT00502281|Intrauterine insemination|intrauterine insemination
732244|NCT00502281|PCOS|pcos
732245|NCT00502281|Timed intercourse|timed intercourse
732246|NCT00502281|Treatment|treatment
732247|NCT00502268|Coronary Calcification|coronary calcification
732248|NCT00502268|Endstage Renal Disease|endstage renal disease
732249|NCT00502268|Parathyroid hormone|parathyroid hormone
732250|NCT00502255|Telemonitoring|telemonitoring
732251|NCT00502255|Cost-effectiveness|cost-effectiveness
732252|NCT00502255|Heart failure|heart failure
732253|NCT00502255|Case management|case management
732254|NCT00502229|Clomiphene citrate|clomiphene citrate
732255|NCT00502229|Controlled overian stimulation|controlled overian stimulation
732256|NCT00502229|Infertility|infertility
732258|NCT00502229|Polycystic ovary syndrome|polycystic ovary syndrome
732259|NCT00502229|Treatment|treatment
732260|NCT00502216|Tobacco|tobacco
732261|NCT00502216|Smoking|smoking
732262|NCT00502216|Weight|weight
732263|NCT00502216|Naltrexone|naltrexone
732264|NCT00502216|Varenicline|varenicline
732265|NCT00502203|Uterine Neoplasms|uterine neoplasms
732266|NCT00502203|Endometrial Cancer|endometrial cancer
732267|NCT00502203|Paclitaxel|paclitaxel
732268|NCT00502203|Taxol|taxol
732269|NCT00502203|Carboplatin|carboplatin
732270|NCT00502203|Paraplatin|paraplatin
732271|NCT00502203|Malignant Mixed Mullerian Tumors|malignant mixed mullerian tumors
732272|NCT00502203|MMMT|mmmt
732273|NCT00502203|Immunohistochemical markers|immunohistochemical markers
732274|NCT00502190|pessary|pessary
732275|NCT00502190|extending pregnancy|extending pregnancy
732276|NCT00502177|Continuous Hyperthermic Peritoneal Perfusion|continuous hyperthermic peritoneal perfusion
732277|NCT00502177|Peritoneal Neoplasms|peritoneal neoplasms
732278|NCT00502177|Quality of Life|quality of life
732279|NCT00502177|Questionnaire|questionnaire
732280|NCT00502177|Survey|survey
732281|NCT00502177|CHPP|chpp
732282|NCT00502164|Advanced Prostate Cancer|advanced prostate cancer
732283|NCT00502138|diabetes|diabetes
732284|NCT00502138|insulin|insulin
732285|NCT00502138|pramlintide|pramlintide
732286|NCT00502138|IDDM|iddm
732287|NCT00502125|Reflectance Confocal Imaging|reflectance confocal imaging
732288|NCT00502125|Oral Mucosal Lesions|oral mucosal lesions
732289|NCT00502125|Oral Mucosa Disease|oral mucosa disease
732290|NCT00502125|Neoplasia Detection|neoplasia detection
732291|NCT00502112|Lintuzumab|lintuzumab
732292|NCT00502112|Antigens, CD33|antigens, cd33
732293|NCT00502112|Antibodies, Monoclonal|antibodies, monoclonal
732294|NCT00502112|Combined Modality Therapy|combined modality therapy
732295|NCT00502112|Myelodysplastic Syndromes|myelodysplastic syndromes
732296|NCT00502112|Hematologic Diseases|hematologic diseases
732297|NCT00502112|Preleukemia|preleukemia
732298|NCT00502099|Chronic hepatitis C|chronic hepatitis c
732299|NCT00502099|pegylated interferon alfa-2a|pegylated interferon alfa-2a
732300|NCT00502099|ribavirin, rapid virologic response|ribavirin, rapid virologic response
732301|NCT00502099|early virologic response|early virologic response
732302|NCT00502099|sustained virologic response|sustained virologic response
732303|NCT00502086|Chronic hepatitis C|chronic hepatitis c
732304|NCT00502086|Cirrhosis of the liver|cirrhosis of the liver
732305|NCT00502086|Mortality|mortality
732306|NCT00502086|Complications|complications
732307|NCT00502086|Health-related quality of live|health-related quality of live
732308|NCT00502086|Hepatocellular carcinoma|hepatocellular carcinoma
732309|NCT00502086|Nutritional supplement|nutritional supplement
732310|NCT00502060|Phase I|phase i
732311|NCT00502060|AZD2171|azd2171
732312|NCT00502060|ZD1839|zd1839
732313|NCT00502060|solid tumor|solid tumor
732314|NCT00502047|plantago ovata husk|plantago ovata husk
732315|NCT00502047|soluble fibre|soluble fibre
732316|NCT00502047|hypercholesterolemia|hypercholesterolemia
732317|NCT00502047|cardiovascular risk factor|cardiovascular risk factor
732318|NCT00502034|Carcinoma, Renal Cell|carcinoma, renal cell
732319|NCT00502034|Low-dose Interleukin|low-dose interleukin
732320|NCT00502034|Adjuvant Immunotherapy|adjuvant immunotherapy
732321|NCT00502021|obesity|obesity
732322|NCT00502021|alpha linolenic acid|alpha linolenic acid
732323|NCT00502021|flaxseed|flaxseed
732324|NCT00502021|C-reactive protein|c-reactive protein
732325|NCT00502021|inflammation|inflammation
732326|NCT00502008|Diabetes|diabetes
732327|NCT00502008|India|india
732328|NCT00502008|Coccinia Cordifolia|coccinia cordifolia
732329|NCT00502008|Coccinia indica|coccinia indica
732330|NCT00502008|Blood glucose levels|blood glucose levels
732331|NCT00501995|High Dose Cyclophosphamide|high dose cyclophosphamide
732332|NCT00501995|Systemic Sclerosis|systemic sclerosis
732333|NCT00501995|Scleroderma|scleroderma
732334|NCT00501995|immunoablation|immunoablation
732335|NCT00501982|surfactant|surfactant
732336|NCT00501982|RDS|rds
732337|NCT00501982|nCPAP|ncpap
732338|NCT00501982|Mechanical Ventilation|mechanical ventilation
732339|NCT00501982|Premature Infants|premature infants
732340|NCT00501982|Neonatal Respiratory Distress Syndrome (nRDS)|neonatal respiratory distress syndrome (nrds)
732341|NCT00501969|Rotigotine|rotigotine
732342|NCT00501969|Neupro®|neupro®
732343|NCT00501956|chronic renal replacement therapy|chronic renal replacement therapy
732344|NCT00501956|malnutrition anorexia|malnutrition anorexia
732345|NCT00501956|parenteral nutrition|parenteral nutrition
732346|NCT00501930|Dose Escalation;|dose escalation;
732347|NCT00501930|Supratherapeutic;|supratherapeutic;
732348|NCT00501930|GSK189075;|gsk189075;
732349|NCT00501930|Diabetes|diabetes
732350|NCT00501917|acute myocardial infarction|acute myocardial infarction
732351|NCT00501904|Anovulation|anovulation
732352|NCT00501904|Infertility|infertility
732353|NCT00501904|Metformin|metformin
732354|NCT00501904|PCOS|pcos
732355|NCT00501904|Treatment|treatment
732356|NCT00501891|Glioblastoma Multiforme|glioblastoma multiforme
732357|NCT00501891|Brain and Central Nervous System Tumors|brain and central nervous system tumors
732358|NCT00501891|Recurrent Malignant Glioma|recurrent malignant glioma
732359|NCT00501891|Recurrent Glioblastoma Multiforme|recurrent glioblastoma multiforme
732360|NCT00501891|Avastin|avastin
732361|NCT00501891|Bevacizumab|bevacizumab
732362|NCT00501891|Temodar|temodar
732363|NCT00501891|Temozolomide|temozolomide
732364|NCT00501878|phenylephrine|phenylephrine
732365|NCT00501878|mydriasis|mydriasis
732366|NCT00501878|diabetes mellitus|diabetes mellitus
732367|NCT00501865|healthy volunteers|healthy volunteers
732368|NCT00501865|food effect,|food effect,
732369|NCT00501865|quantitative pharmacokinetic analysis,|quantitative pharmacokinetic analysis,
732370|NCT00501865|GW273225,|gw273225,
732371|NCT00501852|COPD, Age≥40 yrs, Glycopyrronium Bromide|copd, age≥40 yrs, glycopyrronium bromide
732372|NCT00501839|Anovulation|anovulation
732373|NCT00501839|Clomiphene citrate|clomiphene citrate
732374|NCT00501839|Infertility|infertility
732375|NCT00501839|PCOS|pcos
732376|NCT00501839|Treatment|treatment
732377|NCT00501813|Hepatocellular carcinoma|hepatocellular carcinoma
732378|NCT00501813|Intrahepatic vessels invasion|intrahepatic vessels invasion
732379|NCT00501813|Hepatectomy|hepatectomy
732380|NCT00501813|Transcatheter arterial chemoembolization|transcatheter arterial chemoembolization
732381|NCT00501813|Local regional treatment|local regional treatment
732382|NCT00501800|Reproductive Health|reproductive health
732383|NCT00501800|Fertility|fertility
732384|NCT00501800|Infertility|infertility
732385|NCT00501800|Genetics|genetics
732386|NCT00501800|Continental Population Groups|continental population groups
732387|NCT00501800|Epidemiology|epidemiology
732388|NCT00501800|Aging|aging
732389|NCT00501800|Health|health
732390|NCT00501787|Anovulation|anovulation
732391|NCT00501787|metformin|metformin
732392|NCT00501787|PCOS|pcos
732393|NCT00501787|treatment|treatment
732394|NCT00501774|Localized vulvodynia|localized vulvodynia
732395|NCT00501774|Helicobacter pylori|helicobacter pylori
732396|NCT00501774|peptic disease|peptic disease
732397|NCT00501774|omeprazole|omeprazole
732398|NCT00501761|Endometrial Cancer|endometrial cancer
732399|NCT00501761|Healthy Controls|healthy controls
732400|NCT00501761|Social Cognitive Theory|social cognitive theory
732401|NCT00501761|Behavioral Intervention|behavioral intervention
732402|NCT00501761|Physical Activity|physical activity
732403|NCT00501761|Exercise Program|exercise program
732404|NCT00501761|Questionnaire|questionnaire
732405|NCT00501748|Neuromyelitis Optica|neuromyelitis optica
732406|NCT00501748|acute transverse myelitis|acute transverse myelitis
732407|NCT00501735|T-Cell|t-cell
732408|NCT00501735|Lymphoma|lymphoma
732409|NCT00501735|Forodesine|forodesine
732410|NCT00501735|Mycosis Fungoides|mycosis fungoides
732411|NCT00501722|cirrhotic ascites|cirrhotic ascites
732412|NCT00501722|hyponatraemia|hyponatraemia
732413|NCT00501683|metabolite profiling|metabolite profiling
732414|NCT00501683|excretion,|excretion,
732415|NCT00501683|radioactivity,|radioactivity,
732416|NCT00501683|pharmacokinetic,|pharmacokinetic,
732417|NCT00501683|mass balance,|mass balance,
732418|NCT00501670|Herpes zoster|herpes zoster
732419|NCT00501670|PCR|pcr
732420|NCT00501670|Varicella zoster Virus (VZV)|varicella zoster virus (vzv)
732421|NCT00501670|Shingles|shingles
732422|NCT00501670|GSK Biologicals|gsk biologicals
732423|NCT00501657|gastric emptying|gastric emptying
732424|NCT00501657|glycemia|glycemia
732425|NCT00501657|appetite|appetite
732426|NCT00501657|incretin hormones|incretin hormones
732427|NCT00501644|Müllerian Carcinomas|müllerian carcinomas
732428|NCT00501644|Ovarian Cancer|ovarian cancer
732429|NCT00501644|Fallopian Tube Cancer|fallopian tube cancer
732430|NCT00501644|Peritoneal Cancer|peritoneal cancer
732431|NCT00501644|Epithelial Ovarian|epithelial ovarian
732432|NCT00501644|Peritoneal|peritoneal
732433|NCT00501644|Fallopian Tube|fallopian tube
732434|NCT00501644|Chemoimmunotherapy|chemoimmunotherapy
732435|NCT00501644|Platinum Sensitive Müllerian|platinum sensitive müllerian
732436|NCT00501644|Carboplatin|carboplatin
732437|NCT00501644|Paraplatin|paraplatin
732438|NCT00501644|GM-CSF|gm-csf
732439|NCT00501644|Sargramostim|sargramostim
732440|NCT00501644|Interferon Gamma|interferon gamma
732441|NCT00501644|Quality of Life|quality of life
732442|NCT00501644|QOL|qol
732443|NCT00501631|Addiction|addiction
732444|NCT00501631|Alcoholism|alcoholism
732445|NCT00501631|Inpatient detoxification|inpatient detoxification
732446|NCT00501618|Schizophrenia|schizophrenia
732447|NCT00501618|Schizoaffective Disorder|schizoaffective disorder
732448|NCT00501618|Orally dissolving clozapine|orally dissolving clozapine
732449|NCT00501618|orally disintegrating clozapine|orally disintegrating clozapine
732450|NCT00501618|bio-equivalence|bio-equivalence
732451|NCT00501618|desmethylclozapine|desmethylclozapine
732452|NCT00501618|clozapine plasma level|clozapine plasma level
732453|NCT00501618|equivalence|equivalence
732454|NCT00501618|fazaclo|fazaclo
732455|NCT00501618|generic clozapine|generic clozapine
732456|NCT00501605|Phase I|phase i
732457|NCT00501605|AZD2171|azd2171
732458|NCT00501605|advanced solid tumors|advanced solid tumors
732664|NCT00500890|Carboplatin|carboplatin
732459|NCT00501592|Farnesoid X receptor agonist|farnesoid x receptor agonist
732460|NCT00501592|Metabolic Disorder|metabolic disorder
732461|NCT00501592|Diabetes|diabetes
732462|NCT00501592|NAFLD|nafld
732463|NCT00501566|cirrhotic ascites|cirrhotic ascites
732464|NCT00501553|Heart Failure,|heart failure,
732465|NCT00501553|Vitamin D status,|vitamin d status,
732466|NCT00501553|NT-proBNP|nt-probnp
732467|NCT00501540|low-grade neuroendocrine tumors|low-grade neuroendocrine tumors
732468|NCT00501540|lithium|lithium
732469|NCT00501527|Allergoid|allergoid
732470|NCT00501527|Depigmented|depigmented
732471|NCT00501527|Polymerized|polymerized
732472|NCT00501527|Allergen-extract|allergen-extract
732473|NCT00501527|Rhinoconjunctivitis|rhinoconjunctivitis
732474|NCT00501527|Asthma|asthma
732475|NCT00501514|chronic heart failure|chronic heart failure
732476|NCT00501514|cardiopulmonary exercise|cardiopulmonary exercise
732477|NCT00501514|oxygen consumption|oxygen consumption
732478|NCT00501514|growth hormone|growth hormone
732479|NCT00501501|Rehospitalization|rehospitalization
732480|NCT00501501|Cesarean|cesarean
732481|NCT00501501|Vaginal delivery|vaginal delivery
732482|NCT00501488|pharmacodynamics|pharmacodynamics
732483|NCT00501488|insulin resistance|insulin resistance
732484|NCT00501488|therapy|therapy
732485|NCT00501488|volunteer|volunteer
732486|NCT00501475|N-acetylcysteine|n-acetylcysteine
732487|NCT00501475|nephropathy|nephropathy
732488|NCT00501475|bicarbonate|bicarbonate
732489|NCT00501462|Type 2 Diabetes Mellitus|type 2 diabetes mellitus
732490|NCT00501462|renal insufficiency|renal insufficiency
732491|NCT00501449|Multiple Endocrine Neoplasia|multiple endocrine neoplasia
732492|NCT00501449|Questionnaire|questionnaire
732493|NCT00501449|Psychosocial|psychosocial
732494|NCT00501449|Surveillance Behaviors|surveillance behaviors
732495|NCT00501449|MEN Syndromes|men syndromes
732496|NCT00501423|antiplatelet drug|antiplatelet drug
732497|NCT00501423|resistance|resistance
732498|NCT00501423|atherothrombosis|atherothrombosis
732499|NCT00501410|Colorectal Cancer|colorectal cancer
732500|NCT00501410|Dual Inhibition of EGFR|dual inhibition of egfr
732501|NCT00501410|FOLFOX Chemotherapy|folfox chemotherapy
732502|NCT00501410|5-FU|5-fu
732503|NCT00501410|Cetuximab|cetuximab
732504|NCT00501410|Dasatinib|dasatinib
732505|NCT00501410|Leucovorin|leucovorin
732506|NCT00501410|Oxaliplatin|oxaliplatin
732507|NCT00501410|5-Fluorouracil|5-fluorouracil
732508|NCT00501410|BMS-354825|bms-354825
732509|NCT00501410|Eloxatin|eloxatin
732510|NCT00501410|Sprycel|sprycel
732511|NCT00501410|C225|c225
732512|NCT00501410|Erbitux|erbitux
732513|NCT00501410|IMC-C225|imc-c225
732514|NCT00501410|Adrucil|adrucil
732515|NCT00501410|Efudex|efudex
732516|NCT00501410|Folinic Acid|folinic acid
732517|NCT00501397|ketoconazole,|ketoconazole,
732518|NCT00501397|drug interaction,|drug interaction,
732519|NCT00501397|pharmacokinetics|pharmacokinetics
732520|NCT00501397|T2DM,|t2dm,
732521|NCT00501384|cirrhotic ascites|cirrhotic ascites
732522|NCT00501371|Benign Prostatic Hyperplasia|benign prostatic hyperplasia
732523|NCT00501371|MCS|mcs
732524|NCT00501371|Lower Urinary Tract Symptoms|lower urinary tract symptoms
732525|NCT00501371|International prostate symptom score|international prostate symptom score
732526|NCT00501371|Voiding|voiding
732527|NCT00501371|Alpha-blockers|alpha-blockers
732528|NCT00501358|SLEEP APNEA|sleep apnea
732529|NCT00501358|venous thromboembolism|venous thromboembolism
732530|NCT00501358|COAGULABILITY|coagulability
732531|NCT00501358|COAGULATION FACTORS|coagulation factors
732532|NCT00501358|HYPOXIA|hypoxia
732533|NCT00501345|Thrombocytopenia|thrombocytopenia
732534|NCT00501345|Platelet Function|platelet function
732535|NCT00501345|Acute Coronary Syndrome|acute coronary syndrome
732536|NCT00501345|Myocardial Infarction|myocardial infarction
732537|NCT00501345|Heart Attack|heart attack
732538|NCT00501345|Aspirin|aspirin
732539|NCT00501332|neutropenia|neutropenia
732540|NCT00501332|breast|breast
732541|NCT00501332|cancer|cancer
732542|NCT00501332|chemotherapy|chemotherapy
732543|NCT00501319|Interactive Voice Response Telephone System|interactive voice response telephone system
732544|NCT00501319|Non-Small Cell Lung Cancer|non-small cell lung cancer
732545|NCT00501319|Lung Cancer|lung cancer
732546|NCT00501319|Questionnaire|questionnaire
732547|NCT00501319|Survey|survey
732548|NCT00501319|NSCLC|nsclc
732549|NCT00501319|IVR|ivr
732550|NCT00501306|Condyloma Accuminata|condyloma accuminata
732551|NCT00501306|Low Grade Squamous Intraepithelial Lesion|low grade squamous intraepithelial lesion
732552|NCT00501306|High Grade Squamous Intraepithelial Lesion|high grade squamous intraepithelial lesion
732553|NCT00501306|Anal Cancer Screening|anal cancer screening
732554|NCT00501280|Epidemiology|epidemiology
732555|NCT00501280|Genetic Susceptibility|genetic susceptibility
732556|NCT00501280|Migrant Farmworker Children|migrant farmworker children
732557|NCT00501280|Migrant Education Program|migrant education program
732558|NCT00501280|Interview|interview
732559|NCT00501280|Questionnaire|questionnaire
732560|NCT00501267|solabegron,|solabegron,
732561|NCT00501267|oxybutynin,|oxybutynin,
732562|NCT00501267|healthy adults,|healthy adults,
732563|NCT00501267|drug interaction|drug interaction
732564|NCT00501254|Slow release ASA|slow release asa
732565|NCT00501254|Platelet functionalism|platelet functionalism
732566|NCT00501254|Secondary cardiovascular prevention|secondary cardiovascular prevention
732567|NCT00501228|Graft-Versus-Host Disease|graft-versus-host disease
732568|NCT00501228|Stem Cell Transplantation|stem cell transplantation
732569|NCT00501228|Tissue Repair|tissue repair
732570|NCT00501228|Organ-Specific Tissue Damage|organ-specific tissue damage
732571|NCT00501228|Filgrastim|filgrastim
732572|NCT00501228|RhG-CSF|rhg-csf
732573|NCT00501215|Primary Hyperparathyroidism|primary hyperparathyroidism
732574|NCT00501215|PHPT|phpt
732575|NCT00501215|Parathyroidectomy|parathyroidectomy
732576|NCT00501215|Polysomnogram|polysomnogram
732577|NCT00501215|PSG|psg
732578|NCT00501215|Sleep Quality|sleep quality
732579|NCT00501215|Interview|interview
732580|NCT00501202|diabetes mellitus|diabetes mellitus
732581|NCT00501202|diabetic microvascular injury|diabetic microvascular injury
732582|NCT00501202|painful polyneuropathy.|painful polyneuropathy.
732583|NCT00501189|Gardasil|gardasil
732584|NCT00501189|Human Papilloma Virus|human papilloma virus
732585|NCT00501189|Papanicolaou Smear|papanicolaou smear
732586|NCT00501189|ASCUS|ascus
732587|NCT00501189|LGSIL|lgsil
732588|NCT00501189|Human Papilloma Virus Vaccine|human papilloma virus vaccine
732589|NCT00501189|Human Papillomavirus Infection|human papillomavirus infection
732590|NCT00501176|Pancreas|pancreas
732591|NCT00501176|cancer|cancer
732592|NCT00501176|SEMS|sems
732593|NCT00501176|Plastic|plastic
732594|NCT00501176|stent|stent
732595|NCT00501176|Whipple|whipple
732596|NCT00501176|Jaundicie|jaundicie
732597|NCT00501163|Schizophrenia|schizophrenia
732598|NCT00501163|Cardiovascular|cardiovascular
732599|NCT00501163|Risk|risk
732600|NCT00501150|linezolid|linezolid
732601|NCT00501150|vancomycin|vancomycin
732602|NCT00501150|glycopeptides|glycopeptides
732603|NCT00501150|methicillin resistant staphylococcus aureus|methicillin resistant staphylococcus aureus
732604|NCT00501150|resistant gram positive infections|resistant gram positive infections
732605|NCT00501137|HPV|hpv
732606|NCT00501137|HPV vaccine|hpv vaccine
732607|NCT00501137|Gardasil|gardasil
732608|NCT00501137|Human Papillomavirus|human papillomavirus
732609|NCT00501137|vaccine|vaccine
732610|NCT00501137|2 dose versus 3|2 dose versus 3
732611|NCT00501111|Dementia|dementia
732612|NCT00501111|Alzheimer Type|alzheimer type
732613|NCT00501111|Alzheimer Disease|alzheimer disease
732614|NCT00501098|Leukemia|leukemia
732615|NCT00501098|Prophylaxis|prophylaxis
732616|NCT00501098|Fungal Infections|fungal infections
732617|NCT00501098|Caspofungin|caspofungin
732618|NCT00501072|hyperglycemia|hyperglycemia
732619|NCT00501072|hypoglycemia|hypoglycemia
732620|NCT00501072|glucose variability|glucose variability
732621|NCT00501072|insulin infusion system; implantable insulin pump|insulin infusion system; implantable insulin pump
732622|NCT00501072|continuous glucose monitoring|continuous glucose monitoring
732623|NCT00501059|Primary prevention of coronary heart disease|primary prevention of coronary heart disease
732624|NCT00501059|Stroke and cardiovascular death|stroke and cardiovascular death
732625|NCT00501059|Aspirin|aspirin
732626|NCT00501046|Kidney Diseases|kidney diseases
732627|NCT00501033|Induction of labor|induction of labor
732628|NCT00501033|Cesarean|cesarean
732629|NCT00501033|Endometritis|endometritis
732630|NCT00501033|Foley|foley
732631|NCT00501033|Infections|infections
732632|NCT00501020|Type 2 Diabetes|type 2 diabetes
732633|NCT00501020|metformin|metformin
732634|NCT00501020|rosiglitazone|rosiglitazone
732635|NCT00500994|Conversion Disorder|conversion disorder
732636|NCT00500994|Psychogenic Movement Disorders|psychogenic movement disorders
732637|NCT00500994|Non-Epileptic Seizure|non-epileptic seizure
732638|NCT00500994|Functional Magnetic Resonance Imaging (fMRI)|functional magnetic resonance imaging (fmri)
732639|NCT00500994|Genetic Polymorphisms|genetic polymorphisms
732640|NCT00500994|Psychogenic Movement Disorder|psychogenic movement disorder
732641|NCT00500994|PMD|pmd
732642|NCT00500994|NES|nes
732643|NCT00500994|Healthy Volunteer|healthy volunteer
732644|NCT00500994|HV|hv
732645|NCT00500981|Fluid responsiveness|fluid responsiveness
732646|NCT00500968|Pancreas|pancreas
732647|NCT00500968|Leakage|leakage
732648|NCT00500968|Fistula|fistula
732649|NCT00500968|tail|tail
732650|NCT00500955|microalbuminuria,|microalbuminuria,
732651|NCT00500955|Type 2 Diabetes|type 2 diabetes
732652|NCT00500955|rosiglitazone,|rosiglitazone,
732653|NCT00500942|Interventional Radiology|interventional radiology
732654|NCT00500942|Pain Quantification|pain quantification
732655|NCT00500942|Pain Management|pain management
732656|NCT00500942|Patient Satisfaction|patient satisfaction
732657|NCT00500942|Questionnaire|questionnaire
732658|NCT00500942|Survey|survey
732659|NCT00500929|OHSP|ohsp
732660|NCT00500929|High risk|high risk
732661|NCT00500929|Geriatrics|geriatrics
732662|NCT00500903|Drug therapy|drug therapy
732663|NCT00500890|Choroid Plexus Tumors|choroid plexus tumors
732665|NCT00500890|Cyclophosphamide|cyclophosphamide
732666|NCT00500890|Etoposide|etoposide
732667|NCT00500890|Vincristine|vincristine
732668|NCT00500890|Paraplatin|paraplatin
732669|NCT00500890|Cytoxan|cytoxan
732670|NCT00500890|Neosar|neosar
732671|NCT00500877|Smoking cessation|smoking cessation
732672|NCT00500877|Phone Counseling|phone counseling
732673|NCT00500864|COPD|copd
732674|NCT00500864|Magnesium|magnesium
732675|NCT00500864|Pulmonary function|pulmonary function
732676|NCT00500864|Exercise Physiology|exercise physiology
732677|NCT00500851|critical illness|critical illness
732678|NCT00500851|enteral nutrition|enteral nutrition
732679|NCT00500851|gastrointestinal intubation|gastrointestinal intubation
732680|NCT00500838|Cardiac Resynchronization Therapy|cardiac resynchronization therapy
732681|NCT00500838|Transthoracic Impedance|transthoracic impedance
732682|NCT00500825|Cardiopulmonary resuscitation|cardiopulmonary resuscitation
732683|NCT00500825|Therapeutic hypothermia|therapeutic hypothermia
732684|NCT00500825|resting energy expenditure|resting energy expenditure
732685|NCT00500812|biologic drug|biologic drug
732686|NCT00500812|transport sequence|transport sequence
732687|NCT00500812|rho|rho
732688|NCT00500812|spinal cord injury|spinal cord injury
732689|NCT00500812|paralysis|paralysis
732690|NCT00500812|paraplegia|paraplegia
732691|NCT00500812|tetraplegia|tetraplegia
732692|NCT00500812|quadraplegia|quadraplegia
732693|NCT00500812|trauma|trauma
732694|NCT00500812|nervous system|nervous system
732695|NCT00500812|fibrin sealant|fibrin sealant
732696|NCT00500812|neurosurgery|neurosurgery
732697|NCT00500799|Transcranial Magnetic Stimulation (TMS)|transcranial magnetic stimulation (tms)
732698|NCT00500799|Blink Reflex|blink reflex
732699|NCT00500799|Blepharospasm|blepharospasm
732700|NCT00500799|Healthy Volunteer|healthy volunteer
732701|NCT00500799|HV|hv
732702|NCT00500773|cardiovascular risc factors|cardiovascular risc factors
732703|NCT00500773|inflammation|inflammation
732704|NCT00500773|aerobic and exertional exercise|aerobic and exertional exercise
732705|NCT00500760|Head and Neck Cancer|head and neck cancer
732706|NCT00500760|panitumumab|panitumumab
732707|NCT00500747|hepatitis C, HCV, vaccine, recombinant vaccine, adjuvant|hepatitis c, hcv, vaccine, recombinant vaccine, adjuvant
732708|NCT00500734|Cardiomyopathy|cardiomyopathy
732709|NCT00500734|Tissue Bank|tissue bank
732710|NCT00500734|Heart Disease|heart disease
732711|NCT00500734|Heart Failure|heart failure
732712|NCT00500734|Congestive Heart Failure|congestive heart failure
732713|NCT00500721|healthy subjects|healthy subjects
732714|NCT00500708|Heart failure|heart failure
732715|NCT00500708|Implanted Cardioverter Defibrillator|implanted cardioverter defibrillator
732716|NCT00500708|Biological Markers|biological markers
732717|NCT00500708|Molecular Genetics|molecular genetics
732718|NCT00500708|Coronary Heart Disease|coronary heart disease
732719|NCT00500708|Gene Expression|gene expression
732720|NCT00500708|GES|ges
732721|NCT00500708|CVD|cvd
732722|NCT00500708|CHD|chd
732723|NCT00500708|Precision Medicine|precision medicine
732724|NCT00500708|Genome-wide association study|genome-wide association study
732725|NCT00500708|Cardiovascular Disease|cardiovascular disease
732726|NCT00500708|CAD|cad
732727|NCT00500708|GWAS|gwas
732728|NCT00500708|DISCERN|discern
732729|NCT00500682|Kidney Diseases|kidney diseases
732730|NCT00500669|Varicose veins|varicose veins
732731|NCT00500669|wound infection|wound infection
732732|NCT00500669|recurrence|recurrence
732733|NCT00500617|Atherosclerosis|atherosclerosis
732734|NCT00500617|Biological Markers|biological markers
732735|NCT00500617|Molecular Genetics|molecular genetics
732736|NCT00500617|Gene Expression|gene expression
732737|NCT00500617|GES|ges
732738|NCT00500617|CAD|cad
732739|NCT00500617|CVD|cvd
732740|NCT00500617|CHD|chd
732741|NCT00500617|Clinical Validity|clinical validity
732742|NCT00500617|Precision Medicine|precision medicine
732743|NCT00500617|ASGES|asges
732744|NCT00500617|CT Angiography|ct angiography
732745|NCT00500617|Corus CAD|corus cad
732746|NCT00500617|Coronary angiorgram|coronary angiorgram
732747|NCT00500617|Age/Sex/Gene expression Score|age/sex/gene expression score
732748|NCT00500617|Coronary Artery Disease|coronary artery disease
732749|NCT00500617|Angina Pectoris|angina pectoris
732750|NCT00500617|Chest Pain|chest pain
732751|NCT00500617|Cardiovascular Disease|cardiovascular disease
732752|NCT00500617|Coronary Heart Disease|coronary heart disease
732754|NCT00500617|PREDICT|predict
732755|NCT00500591|Endometrial Abnormalities|endometrial abnormalities
732756|NCT00500591|Endometrial Cancer|endometrial cancer
732757|NCT00500591|Obesity|obesity
732758|NCT00500591|Survey|survey
732759|NCT00500591|Questionnaire|questionnaire
732760|NCT00500578|Hematological Malignancies|hematological malignancies
732761|NCT00500578|Respiratory Infection|respiratory infection
732762|NCT00500578|Respiratory Syncytial Virus|respiratory syncytial virus
732763|NCT00500578|RSV|rsv
732764|NCT00500578|Ribavirin|ribavirin
732765|NCT00500578|Virazole|virazole
732766|NCT00500565|Breast Cancer|breast cancer
732767|NCT00500565|On-Q Pain Relief System|on-q pain relief system
732868|NCT00500240|Leukemia|leukemia
732768|NCT00500565|Transverse Rectus Abdominous Myocutaneous|transverse rectus abdominous myocutaneous
732769|NCT00500565|Breast Reconstruction|breast reconstruction
732770|NCT00500565|TRAM flap|tram flap
732771|NCT00500565|Bupivicaine|bupivicaine
732772|NCT00500565|Pain Management|pain management
732773|NCT00500552|Perhexiline|perhexiline
732774|NCT00500552|Hypertrophic Cardiomyopathy|hypertrophic cardiomyopathy
732775|NCT00500539|Asthma|asthma
732776|NCT00500539|omalizumab|omalizumab
732777|NCT00500539|safety|safety
732778|NCT00500539|allergic asthma|allergic asthma
732779|NCT00500539|adolescents|adolescents
732780|NCT00500526|COPD|copd
732781|NCT00500526|Pulmonary function|pulmonary function
732782|NCT00500526|Respiratory muscle|respiratory muscle
732783|NCT00500526|Dyspnea|dyspnea
732784|NCT00500526|Quality of life|quality of life
732785|NCT00500513|Lung Cancer|lung cancer
732786|NCT00500513|Respiratory-Induced Tumor Motion|respiratory-induced tumor motion
732787|NCT00500513|Tumor Motion|tumor motion
732788|NCT00500513|Pulmonary Function|pulmonary function
732789|NCT00500513|Fiducial Marker|fiducial marker
732790|NCT00500487|HIV prevention|hiv prevention
732791|NCT00500487|HIV seronegativity|hiv seronegativity
732792|NCT00500474|Meniere's disease|meniere's disease
732793|NCT00500474|inner ear|inner ear
732794|NCT00500474|endolymphatic sac drainage|endolymphatic sac drainage
732795|NCT00500474|steroids|steroids
732796|NCT00500474|declined surgery|declined surgery
732797|NCT00500474|natural course|natural course
732798|NCT00500474|Efficacy of steroids via endolymphatic sac|efficacy of steroids via endolymphatic sac
732799|NCT00500474|for intractable Meniere's disease|for intractable meniere's disease
732800|NCT00500461|Muscarinic Receptor Antagonist,|muscarinic receptor antagonist,
732801|NCT00500461|intravenous infusion,|intravenous infusion,
732802|NCT00500461|pharmacokinetics|pharmacokinetics
732803|NCT00500461|healthy subjects,|healthy subjects,
732804|NCT00500461|safety,|safety,
732805|NCT00500461|tolerability,|tolerability,
732806|NCT00500461|Anticholinergic,|anticholinergic,
732807|NCT00500461|oral dosing,|oral dosing,
732808|NCT00500448|Arthritis, Knee, Quadriceps, Electrical Stimulation, Women|arthritis, knee, quadriceps, electrical stimulation, women
732809|NCT00500435|Cervical Cancer|cervical cancer
732810|NCT00500435|Laparoscopy|laparoscopy
732811|NCT00500435|Lymph Node Dissection|lymph node dissection
732812|NCT00500435|Extraperitoneal Laparoscopic Lymphadenectomy|extraperitoneal laparoscopic lymphadenectomy
732813|NCT00500422|Solid Tumors|solid tumors
732814|NCT00500422|Doxil|doxil
732815|NCT00500422|Adriamycin|adriamycin
732816|NCT00500422|Pegylated Liposomal Doxorubicin|pegylated liposomal doxorubicin
732817|NCT00500422|Liposomal Doxorubicin|liposomal doxorubicin
732818|NCT00500422|Doxorubicin Hydrochloride|doxorubicin hydrochloride
732819|NCT00500422|Gemcitabine|gemcitabine
732820|NCT00500422|Gemzar|gemzar
732821|NCT00500422|Bortezomib|bortezomib
732822|NCT00500422|Velcade|velcade
732823|NCT00500422|PS341|ps341
732824|NCT00500422|PS-341|ps-341
732825|NCT00500422|LDP-341|ldp-341
732826|NCT00500422|MLN341|mln341
732827|NCT00500409|rhPTH(1-34)|rhpth(1-34)
732828|NCT00500409|Osteoporosis|osteoporosis
732829|NCT00500396|Retinopathy of Prematurity.|retinopathy of prematurity.
732830|NCT00500396|ROP.|rop.
732831|NCT00500396|Vascular Endothelial Growth Factor.|vascular endothelial growth factor.
732832|NCT00500396|VEGF.|vegf.
732833|NCT00500396|Vitreous.|vitreous.
732834|NCT00500396|Subretinal Fluid.|subretinal fluid.
732835|NCT00500396|ELISA.|elisa.
732836|NCT00500383|Breast Cancer Risk|breast cancer risk
732837|NCT00500383|BRCA1|brca1
732838|NCT00500383|BRCA2|brca2
732839|NCT00500383|Breast Cancer Susceptibility gene|breast cancer susceptibility gene
732840|NCT00500383|Optical Transillumination Spectroscopy|optical transillumination spectroscopy
732841|NCT00500383|Transillumination Breast Spectroscopy|transillumination breast spectroscopy
732842|NCT00500370|exenatide|exenatide
732843|NCT00500370|obesity|obesity
732844|NCT00500370|diabetes|diabetes
732845|NCT00500370|Amylin|amylin
732846|NCT00500370|Lilly|lilly
732847|NCT00500344|Age-related Macular Degeneration|age-related macular degeneration
732848|NCT00500344|Choroidal Neovascularization|choroidal neovascularization
732849|NCT00500344|Electroretinography|electroretinography
732850|NCT00500344|Retinal Function|retinal function
732851|NCT00500331|Pioglitazone|pioglitazone
732852|NCT00500331|HbA1c|hba1c
732853|NCT00500331|Diabetes mellitus|diabetes mellitus
732854|NCT00500318|Bronchitis, Chronic; Emphysema|bronchitis, chronic; emphysema
732855|NCT00500305|indomethacin therapy|indomethacin therapy
732856|NCT00500305|patent ductus arteriosus|patent ductus arteriosus
732857|NCT00500292|colorectal|colorectal
732858|NCT00500292|cancer|cancer
732859|NCT00500292|zactima|zactima
732860|NCT00500279|Drug-eluting stent|drug-eluting stent
732861|NCT00500279|Restenosis|restenosis
732862|NCT00500279|Celecoxib|celecoxib
732863|NCT00500253|exhaled nitric oxide|exhaled nitric oxide
732864|NCT00500253|asthma|asthma
732865|NCT00500253|children|children
732866|NCT00500253|inhaled glucocorticosteroids|inhaled glucocorticosteroids
732867|NCT00500240|Acute Lymphocytic Leukemia|acute lymphocytic leukemia
732870|NCT00500240|Burkitts Lymphoma|burkitts lymphoma
732871|NCT00500240|Lymphoblastic Leukemia|lymphoblastic leukemia
732872|NCT00500240|Blood Sugar|blood sugar
732873|NCT00500240|Hyperglycemia|hyperglycemia
732874|NCT00500240|Insulin Aspart|insulin aspart
732875|NCT00500240|Insulin Glargine|insulin glargine
732876|NCT00500240|Hyper-CVAD|hyper-cvad
732877|NCT00500214|inguinal hernia|inguinal hernia
732878|NCT00500214|herniorrhaphy|herniorrhaphy
732879|NCT00500214|mesh repair|mesh repair
732880|NCT00500214|ilioinguinal neurectomy|ilioinguinal neurectomy
732881|NCT00500214|postoperative pain in cases and controls during one year.|postoperative pain in cases and controls during one year.
732882|NCT00500214|postoperative hyposthesia in cases and controls during one year.|postoperative hyposthesia in cases and controls during one year.
732883|NCT00500201|Healthy Volunteer|healthy volunteer
732884|NCT00500188|Gastrointestinal Stromal Tumors|gastrointestinal stromal tumors
732885|NCT00500188|GIST|gist
732886|NCT00500188|Kit expression|kit expression
732887|NCT00500188|Resectable|resectable
732888|NCT00500188|Imatinib Mesylate|imatinib mesylate
732889|NCT00500188|Gleevec|gleevec
732890|NCT00500188|STI-571|sti-571
732891|NCT00500188|Imatinib|imatinib
732892|NCT00500188|NSC-716051|nsc-716051
732893|NCT00500175|diabetes|diabetes
732894|NCT00500175|ulceration|ulceration
732895|NCT00500175|amputation|amputation
732896|NCT00500175|pressure sores|pressure sores
732897|NCT00500175|shear friction|shear friction
732898|NCT00500136|bias|bias
732899|NCT00500123|alpha-1|alpha-1
732900|NCT00500123|antitrypsin|antitrypsin
732901|NCT00500123|AAT|aat
732902|NCT00500123|genetic testing|genetic testing
732903|NCT00500123|alpha-1 antitrypsin deficiency|alpha-1 antitrypsin deficiency
732904|NCT00500123|AATD|aatd
732905|NCT00500110|Prostate Cancer|prostate cancer
732906|NCT00500110|Hormonal Ablation|hormonal ablation
732907|NCT00500110|Docetaxel|docetaxel
732908|NCT00500110|Imatinib Mesylate|imatinib mesylate
732909|NCT00500110|STI571|sti571
732910|NCT00500110|Gleevec|gleevec
732911|NCT00500110|Taxotere|taxotere
732912|NCT00500110|Goserelin Acetate|goserelin acetate
732913|NCT00500110|Zoladex|zoladex
732914|NCT00500110|Leuprolide|leuprolide
732915|NCT00500110|Lupron|lupron
732916|NCT00500084|Chronic Pancreatitis|chronic pancreatitis
732917|NCT00500084|Pancreatectomy|pancreatectomy
732918|NCT00500058|Rituximab,|rituximab,
732919|NCT00500058|oncology|oncology
732920|NCT00500058|IL-18,|il-18,
732921|NCT00500058|combination study,|combination study,
732922|NCT00500058|cytokine,|cytokine,
732923|NCT00500045|CRVO|crvo
732924|NCT00500045|HRVO|hrvo
732925|NCT00500045|BRVO|brvo
732926|NCT00500032|Adult|adult
732927|NCT00499980|Breast cancer|breast cancer
732928|NCT00499980|Spectroscopy, Near-Infrared|spectroscopy, near-infrared
732929|NCT00499980|Oximetry|oximetry
732930|NCT00499967|genital warts|genital warts
732931|NCT00499967|venereal warts|venereal warts
732932|NCT00499967|human papilloma virus|human papilloma virus
732933|NCT00499954|microdialysis|microdialysis
732934|NCT00499954|subcutaneous adipose tissue|subcutaneous adipose tissue
732935|NCT00499954|glucose sensor|glucose sensor
732936|NCT00499954|glucose monitoring|glucose monitoring
732937|NCT00499954|type 1 diabetes|type 1 diabetes
732938|NCT00499954|Guardian RT|guardian rt
732939|NCT00499954|Glucoday S|glucoday s
732940|NCT00499941|Alpha 1-Antitrypsin Deficiency|alpha 1-antitrypsin deficiency
732941|NCT00499928|SB-751689|sb-751689
732942|NCT00499928|osteoporosis|osteoporosis
732943|NCT00499928|metabolism|metabolism
732944|NCT00499928|excretion|excretion
732945|NCT00499902|AIS|ais
732946|NCT00499902|acute ischemic stroke|acute ischemic stroke
732947|NCT00499902|stroke|stroke
732948|NCT00499902|alfimeprase|alfimeprase
732949|NCT00499902|blood clot|blood clot
732950|NCT00499902|brain|brain
732951|NCT00499902|thrombus|thrombus
732952|NCT00499902|thrombolytic|thrombolytic
732953|NCT00499902|thrombosis|thrombosis
732954|NCT00499902|plasminogen activator|plasminogen activator
732955|NCT00499902|arterial flow|arterial flow
732956|NCT00499902|neurology|neurology
732957|NCT00499902|intra-arterial|intra-arterial
732958|NCT00499902|intra-thrombus|intra-thrombus
732959|NCT00499902|catheter-directed|catheter-directed
732960|NCT00499902|symptomatic ICH|symptomatic ich
732961|NCT00499902|ICH|ich
732962|NCT00499902|AOL|aol
732963|NCT00499902|arterial occlusive lesion|arterial occlusive lesion
732964|NCT00499902|recanalization|recanalization
732965|NCT00499889|Chronic Myelogenous Leukemia|chronic myelogenous leukemia
732966|NCT00499889|Allogeneic Stem Cell Transplantation|allogeneic stem cell transplantation
732967|NCT00499889|Leukemia|leukemia
732968|NCT00499889|Imatinib Mesylate|imatinib mesylate
732969|NCT00499889|Gleevec|gleevec
732970|NCT00499889|Busulfan|busulfan
732971|NCT00499889|Busulfex|busulfex
732972|NCT00499889|Myleran|myleran
732973|NCT00499889|Fludarabine|fludarabine
732974|NCT00499889|ATG|atg
732975|NCT00499889|STI571|sti571
732976|NCT00499889|Antithymocyte Globulin|antithymocyte globulin
732977|NCT00499889|Thymoglobulin|thymoglobulin
732978|NCT00499876|Human immune deficiency virus|human immune deficiency virus
732979|NCT00499876|Acquired immune deficiency syndrome|acquired immune deficiency syndrome
732980|NCT00499876|malaria|malaria
732981|NCT00499876|mefloquine|mefloquine
732982|NCT00499876|prophylaxis|prophylaxis
732983|NCT00499876|HIV/AIDS|hiv/aids
732984|NCT00499876|Treatment Naive|treatment naive
732985|NCT00499850|ZD6474|zd6474
732986|NCT00499850|FOLFOX|folfox
732987|NCT00499850|colorectal|colorectal
732988|NCT00499850|adenocarcinoma|adenocarcinoma
732989|NCT00500266|pneumococcal conjugate vaccine|pneumococcal conjugate vaccine
732990|NCT00500266|vaccine|vaccine
732991|NCT00499824|Diabetes|diabetes
732992|NCT00499824|Management guidelines|management guidelines
732993|NCT00499824|Efficacy|efficacy
732994|NCT00499798|infertility|infertility
732995|NCT00499798|chemotherapeutic agent toxicity|chemotherapeutic agent toxicity
732996|NCT00499798|adult anaplastic astrocytoma|adult anaplastic astrocytoma
732997|NCT00499798|adult diffuse astrocytoma|adult diffuse astrocytoma
732998|NCT00499798|adult giant cell glioblastoma|adult giant cell glioblastoma
732999|NCT00499798|adult gliosarcoma|adult gliosarcoma
733000|NCT00499798|adult pilocytic astrocytoma|adult pilocytic astrocytoma
733001|NCT00499798|adult brain stem glioma|adult brain stem glioma
733002|NCT00499798|adult central nervous system germ cell tumor|adult central nervous system germ cell tumor
733003|NCT00499798|adult choroid plexus tumor|adult choroid plexus tumor
733004|NCT00499798|adult craniopharyngioma|adult craniopharyngioma
733005|NCT00499798|adult ependymoblastoma|adult ependymoblastoma
733006|NCT00499798|adult medulloblastoma|adult medulloblastoma
733007|NCT00499798|adult supratentorial primitive neuroectodermal tumor (PNET)|adult supratentorial primitive neuroectodermal tumor (pnet)
733008|NCT00499798|adult anaplastic ependymoma|adult anaplastic ependymoma
733009|NCT00499798|adult ependymoma|adult ependymoma
733010|NCT00499798|adult myxopapillary ependymoma|adult myxopapillary ependymoma
733011|NCT00499798|adult subependymoma|adult subependymoma
733012|NCT00499798|adult anaplastic meningioma|adult anaplastic meningioma
733013|NCT00499798|meningeal melanocytoma|meningeal melanocytoma
733014|NCT00499798|adult meningeal hemangiopericytoma|adult meningeal hemangiopericytoma
733015|NCT00499798|adult papillary meningioma|adult papillary meningioma
733016|NCT00499798|adult grade I meningioma|adult grade i meningioma
733017|NCT00499798|adult grade II meningioma|adult grade ii meningioma
733018|NCT00499798|adult grade III meningioma|adult grade iii meningioma
733019|NCT00499798|adult anaplastic oligodendroglioma|adult anaplastic oligodendroglioma
733020|NCT00499798|adult oligodendroglioma|adult oligodendroglioma
733021|NCT00499798|adult pineoblastoma|adult pineoblastoma
733022|NCT00499798|adult pineocytoma|adult pineocytoma
733023|NCT00499798|adult mixed glioma|adult mixed glioma
733024|NCT00499798|recurrent adult brain tumor|recurrent adult brain tumor
733340|NCT00499343|Stem Cell Collection|stem cell collection
733025|NCT00499798|adult subependymal giant cell astrocytoma|adult subependymal giant cell astrocytoma
733026|NCT00499785|depression|depression
733027|NCT00499785|cognitive/functional effects|cognitive/functional effects
733028|NCT00499785|untreated adult acute myeloid leukemia|untreated adult acute myeloid leukemia
733029|NCT00499785|adult acute myeloid leukemia with 11q23 (MLL) abnormalities|adult acute myeloid leukemia with 11q23 (mll) abnormalities
733030|NCT00499785|adult acute myeloid leukemia with inv(16)(p13;q22)|adult acute myeloid leukemia with inv(16)(p13;q22)
733031|NCT00499785|adult acute myeloid leukemia with t(15;17)(q22;q12)|adult acute myeloid leukemia with t(15;17)(q22;q12)
733032|NCT00499785|adult acute myeloid leukemia with t(16;16)(p13;q22)|adult acute myeloid leukemia with t(16;16)(p13;q22)
733033|NCT00499785|adult acute myeloid leukemia with t(8;21)(q22;q22)|adult acute myeloid leukemia with t(8;21)(q22;q22)
733034|NCT00499759|fatigue|fatigue
733035|NCT00499759|depression|depression
733036|NCT00499759|psychosocial effects of cancer and its treatment|psychosocial effects of cancer and its treatment
734007|NCT00497068|pregnancy|pregnancy
733037|NCT00499759|musculoskeletal complications|musculoskeletal complications
733038|NCT00499759|acute undifferentiated leukemia|acute undifferentiated leukemia
733039|NCT00499759|adult acute myeloid leukemia with 11q23 (MLL) abnormalities|adult acute myeloid leukemia with 11q23 (mll) abnormalities
733040|NCT00499759|adult acute myeloid leukemia with inv(16)(p13;q22)|adult acute myeloid leukemia with inv(16)(p13;q22)
733041|NCT00499759|adult acute myeloid leukemia with t(15;17)(q22;q12)|adult acute myeloid leukemia with t(15;17)(q22;q12)
733042|NCT00499759|adult acute myeloid leukemia with t(16;16)(p13;q22)|adult acute myeloid leukemia with t(16;16)(p13;q22)
733043|NCT00499759|adult acute myeloid leukemia with t(8;21)(q22;q22)|adult acute myeloid leukemia with t(8;21)(q22;q22)
733044|NCT00499759|untreated adult acute lymphoblastic leukemia|untreated adult acute lymphoblastic leukemia
733045|NCT00499759|untreated adult acute myeloid leukemia|untreated adult acute myeloid leukemia
733046|NCT00499759|recurrent adult acute myeloid leukemia|recurrent adult acute myeloid leukemia
733047|NCT00499759|secondary acute myeloid leukemia|secondary acute myeloid leukemia
733048|NCT00499759|recurrent adult acute lymphoblastic leukemia|recurrent adult acute lymphoblastic leukemia
733049|NCT00499746|drug discrimination|drug discrimination
733050|NCT00499746|opioid pharmacology|opioid pharmacology
733051|NCT00499746|behavioral pharmacology|behavioral pharmacology
733052|NCT00499746|human research|human research
733053|NCT00499733|carcinoma of unknown primary|carcinoma of unknown primary
733054|NCT00499733|recurrent carcinoma of unknown primary|recurrent carcinoma of unknown primary
733055|NCT00499733|stage IIIA non-small cell lung cancer|stage iiia non-small cell lung cancer
733056|NCT00499733|stage IIIB non-small cell lung cancer|stage iiib non-small cell lung cancer
733057|NCT00499733|stage IV non-small cell lung cancer|stage iv non-small cell lung cancer
733058|NCT00499733|recurrent non-small cell lung cancer|recurrent non-small cell lung cancer
733059|NCT00499733|extensive stage small cell lung cancer|extensive stage small cell lung cancer
733060|NCT00499733|recurrent small cell lung cancer|recurrent small cell lung cancer
733061|NCT00499733|stage III renal cell cancer|stage iii renal cell cancer
733062|NCT00499733|stage IV renal cell cancer|stage iv renal cell cancer
733063|NCT00499733|recurrent renal cell cancer|recurrent renal cell cancer
733064|NCT00499733|stage III prostate cancer|stage iii prostate cancer
733065|NCT00499733|stage IV prostate cancer|stage iv prostate cancer
733066|NCT00499733|recurrent prostate cancer|recurrent prostate cancer
733067|NCT00499733|male breast cancer|male breast cancer
733068|NCT00499733|recurrent breast cancer|recurrent breast cancer
733069|NCT00499733|stage IIIA breast cancer|stage iiia breast cancer
733070|NCT00499733|stage IIIB breast cancer|stage iiib breast cancer
733071|NCT00499733|stage IIIC breast cancer|stage iiic breast cancer
733072|NCT00499733|stage IV breast cancer|stage iv breast cancer
733073|NCT00499733|chondrosarcoma|chondrosarcoma
733074|NCT00499733|metastatic osteosarcoma|metastatic osteosarcoma
733075|NCT00499733|recurrent osteosarcoma|recurrent osteosarcoma
733076|NCT00499733|stage III adult soft tissue sarcoma|stage iii adult soft tissue sarcoma
733077|NCT00499733|stage IV adult soft tissue sarcoma|stage iv adult soft tissue sarcoma
733078|NCT00499733|recurrent adult soft tissue sarcoma|recurrent adult soft tissue sarcoma
733079|NCT00499733|previously treated childhood rhabdomyosarcoma|previously treated childhood rhabdomyosarcoma
733080|NCT00499733|recurrent childhood rhabdomyosarcoma|recurrent childhood rhabdomyosarcoma
733081|NCT00499733|metastatic childhood soft tissue sarcoma|metastatic childhood soft tissue sarcoma
733082|NCT00499733|recurrent childhood soft tissue sarcoma|recurrent childhood soft tissue sarcoma
733083|NCT00499733|ovarian sarcoma|ovarian sarcoma
733084|NCT00499733|stage IIIB uterine sarcoma|stage iiib uterine sarcoma
733085|NCT00499733|stage IIIC uterine sarcoma|stage iiic uterine sarcoma
733086|NCT00499733|stage IIIA uterine sarcoma|stage iiia uterine sarcoma
733087|NCT00499733|stage IVA uterine sarcoma|stage iva uterine sarcoma
733088|NCT00499733|stage IVB uterine sarcoma|stage ivb uterine sarcoma
733089|NCT00499733|metastatic Ewing sarcoma/peripheral primitive neuroectodermal tumor|metastatic ewing sarcoma/peripheral primitive neuroectodermal tumor
733090|NCT00499733|recurrent Ewing sarcoma/peripheral primitive neuroectodermal tumor|recurrent ewing sarcoma/peripheral primitive neuroectodermal tumor
733091|NCT00499733|stage III colon cancer|stage iii colon cancer
733092|NCT00499733|stage IV colon cancer|stage iv colon cancer
733093|NCT00499733|recurrent colon cancer|recurrent colon cancer
733094|NCT00499733|localized unresectable adult primary liver cancer|localized unresectable adult primary liver cancer
733095|NCT00499733|recurrent adult primary liver cancer|recurrent adult primary liver cancer
733096|NCT00499733|recurrent childhood liver cancer|recurrent childhood liver cancer
733097|NCT00499733|stage III childhood liver cancer|stage iii childhood liver cancer
733098|NCT00499733|stage IV childhood liver cancer|stage iv childhood liver cancer
733099|NCT00499733|stage III pancreatic cancer|stage iii pancreatic cancer
733100|NCT00499733|localized osteosarcoma|localized osteosarcoma
733101|NCT00499733|malignant giant cell tumor of bone|malignant giant cell tumor of bone
733102|NCT00499733|stage IV melanoma|stage iv melanoma
733103|NCT00499733|recurrent melanoma|recurrent melanoma
733104|NCT00499733|stage III squamous cell carcinoma of the hypopharynx|stage iii squamous cell carcinoma of the hypopharynx
733105|NCT00499733|stage IV squamous cell carcinoma of the hypopharynx|stage iv squamous cell carcinoma of the hypopharynx
733106|NCT00499733|recurrent squamous cell carcinoma of the hypopharynx|recurrent squamous cell carcinoma of the hypopharynx
733107|NCT00499733|stage III squamous cell carcinoma of the larynx|stage iii squamous cell carcinoma of the larynx
733108|NCT00499733|stage III verrucous carcinoma of the larynx|stage iii verrucous carcinoma of the larynx
733109|NCT00499733|stage IV squamous cell carcinoma of the larynx|stage iv squamous cell carcinoma of the larynx
733110|NCT00499733|stage IV verrucous carcinoma of the larynx|stage iv verrucous carcinoma of the larynx
733111|NCT00499733|recurrent squamous cell carcinoma of the larynx|recurrent squamous cell carcinoma of the larynx
733112|NCT00499733|recurrent verrucous carcinoma of the larynx|recurrent verrucous carcinoma of the larynx
733113|NCT00499733|stage III basal cell carcinoma of the lip|stage iii basal cell carcinoma of the lip
733114|NCT00499733|stage III squamous cell carcinoma of the lip and oral cavity|stage iii squamous cell carcinoma of the lip and oral cavity
733115|NCT00499733|stage III verrucous carcinoma of the oral cavity|stage iii verrucous carcinoma of the oral cavity
733116|NCT00499733|stage IV adenoid cystic carcinoma of the oral cavity|stage iv adenoid cystic carcinoma of the oral cavity
733117|NCT00499733|stage IV squamous cell carcinoma of the lip and oral cavity|stage iv squamous cell carcinoma of the lip and oral cavity
733118|NCT00499733|recurrent adenoid cystic carcinoma of the oral cavity|recurrent adenoid cystic carcinoma of the oral cavity
733119|NCT00499733|recurrent mucoepidermoid carcinoma of the oral cavity|recurrent mucoepidermoid carcinoma of the oral cavity
733120|NCT00499733|recurrent squamous cell carcinoma of the lip and oral cavity|recurrent squamous cell carcinoma of the lip and oral cavity
733564|NCT00498836|Metastatic|metastatic
733121|NCT00499733|recurrent verrucous carcinoma of the oral cavity|recurrent verrucous carcinoma of the oral cavity
733440|NCT00499278|hip|hip
733122|NCT00499733|metastatic squamous neck cancer with occult primary squamous cell carcinoma|metastatic squamous neck cancer with occult primary squamous cell carcinoma
733123|NCT00499733|recurrent metastatic squamous neck cancer with occult primary|recurrent metastatic squamous neck cancer with occult primary
733124|NCT00499733|untreated metastatic squamous neck cancer with occult primary|untreated metastatic squamous neck cancer with occult primary
733125|NCT00499733|stage III squamous cell carcinoma of the nasopharynx|stage iii squamous cell carcinoma of the nasopharynx
733126|NCT00499733|stage IV squamous cell carcinoma of the nasopharynx|stage iv squamous cell carcinoma of the nasopharynx
733127|NCT00499733|recurrent squamous cell carcinoma of the nasopharynx|recurrent squamous cell carcinoma of the nasopharynx
733128|NCT00499733|stage III squamous cell carcinoma of the oropharynx|stage iii squamous cell carcinoma of the oropharynx
733129|NCT00499733|stage IV squamous cell carcinoma of the oropharynx|stage iv squamous cell carcinoma of the oropharynx
733130|NCT00499733|recurrent squamous cell carcinoma of the oropharynx|recurrent squamous cell carcinoma of the oropharynx
733131|NCT00499733|stage III esthesioneuroblastoma of the paranasal sinus and nasal cavity|stage iii esthesioneuroblastoma of the paranasal sinus and nasal cavity
733132|NCT00499733|stage III inverted papilloma of the paranasal sinus and nasal cavity|stage iii inverted papilloma of the paranasal sinus and nasal cavity
733133|NCT00499733|stage III squamous cell carcinoma of the paranasal sinus and nasal cavity|stage iii squamous cell carcinoma of the paranasal sinus and nasal cavity
733134|NCT00499733|stage IV esthesioneuroblastoma of the paranasal sinus and nasal cavity|stage iv esthesioneuroblastoma of the paranasal sinus and nasal cavity
733135|NCT00499733|stage IV squamous cell carcinoma of the paranasal sinus and nasal cavity|stage iv squamous cell carcinoma of the paranasal sinus and nasal cavity
733136|NCT00499733|recurrent squamous cell carcinoma of the paranasal sinus and nasal cavity|recurrent squamous cell carcinoma of the paranasal sinus and nasal cavity
733137|NCT00499733|high-grade salivary gland mucoepidermoid carcinoma|high-grade salivary gland mucoepidermoid carcinoma
733138|NCT00499733|salivary gland adenocarcinoma|salivary gland adenocarcinoma
733139|NCT00499733|salivary gland adenoid cystic carcinoma|salivary gland adenoid cystic carcinoma
733140|NCT00499733|salivary gland anaplastic carcinoma|salivary gland anaplastic carcinoma
733141|NCT00499733|salivary gland malignant mixed cell type tumor|salivary gland malignant mixed cell type tumor
733142|NCT00499733|salivary gland poorly differentiated carcinoma|salivary gland poorly differentiated carcinoma
733143|NCT00499733|salivary gland squamous cell carcinoma|salivary gland squamous cell carcinoma
733144|NCT00499733|low-grade salivary gland mucoepidermoid carcinoma|low-grade salivary gland mucoepidermoid carcinoma
733145|NCT00499733|salivary gland acinic cell tumor|salivary gland acinic cell tumor
733146|NCT00499733|stage III salivary gland cancer|stage iii salivary gland cancer
733147|NCT00499733|stage IV salivary gland cancer|stage iv salivary gland cancer
733148|NCT00499733|recurrent salivary gland cancer|recurrent salivary gland cancer
733149|NCT00499733|intraocular lymphoma|intraocular lymphoma
733150|NCT00499733|recurrent childhood lymphoblastic lymphoma|recurrent childhood lymphoblastic lymphoma
733151|NCT00499733|recurrent pancreatic cancer|recurrent pancreatic cancer
733152|NCT00499733|recurrent uterine sarcoma|recurrent uterine sarcoma
733153|NCT00499733|newly diagnosed carcinoma of unknown primary|newly diagnosed carcinoma of unknown primary
733154|NCT00499733|advanced adult primary liver cancer|advanced adult primary liver cancer
733155|NCT00499733|ciliary body and choroid melanoma, medium/large size|ciliary body and choroid melanoma, medium/large size
733156|NCT00499733|conjunctival melanoma|conjunctival melanoma
733157|NCT00499733|stage IV pancreatic cancer|stage iv pancreatic cancer
733158|NCT00499733|stage IIIA melanoma|stage iiia melanoma
733159|NCT00499733|stage IIIB melanoma|stage iiib melanoma
733160|NCT00499733|stage IIIC melanoma|stage iiic melanoma
733161|NCT00499733|tongue cancer|tongue cancer
733162|NCT00499733|stage IIIA intraocular melanoma|stage iiia intraocular melanoma
733163|NCT00499733|stage IIIB intraocular melanoma|stage iiib intraocular melanoma
733164|NCT00499733|stage IIIC intraocular melanoma|stage iiic intraocular melanoma
733165|NCT00499733|stage IV intraocular melanoma|stage iv intraocular melanoma
733166|NCT00499720|Cystic Fibrosis|cystic fibrosis
734213|NCT00496444|Vidaza|vidaza
733167|NCT00499720|Pseudomonas aeruginosa|pseudomonas aeruginosa
733168|NCT00499720|airway infection|airway infection
733169|NCT00499720|Aztreonam Lysine for Inhalation|aztreonam lysine for inhalation
733170|NCT00499707|HbA1c|hba1c
733171|NCT00499707|Drug-naive|drug-naive
733172|NCT00499707|type 2 diabetes|type 2 diabetes
733173|NCT00499694|stage IV prostate cancer|stage iv prostate cancer
733174|NCT00499694|recurrent prostate cancer|recurrent prostate cancer
733175|NCT00499694|adenocarcinoma of the prostate|adenocarcinoma of the prostate
733176|NCT00499681|stage I breast cancer|stage i breast cancer
733177|NCT00499681|stage II breast cancer|stage ii breast cancer
733178|NCT00499681|stage IIIA breast cancer|stage iiia breast cancer
733179|NCT00499681|stage IIIB breast cancer|stage iiib breast cancer
733180|NCT00499668|unspecified adult solid tumor, protocol specific|unspecified adult solid tumor, protocol specific
733181|NCT00499668|nausea and vomiting|nausea and vomiting
733182|NCT00499668|chronic myelogenous leukemia|chronic myelogenous leukemia
733183|NCT00499668|chronic eosinophilic leukemia|chronic eosinophilic leukemia
733184|NCT00499668|chronic idiopathic myelofibrosis|chronic idiopathic myelofibrosis
733185|NCT00499668|chronic neutrophilic leukemia|chronic neutrophilic leukemia
733186|NCT00499668|essential thrombocythemia|essential thrombocythemia
733187|NCT00499668|polycythemia vera|polycythemia vera
733188|NCT00499668|adult acute lymphoblastic leukemia|adult acute lymphoblastic leukemia
733189|NCT00499668|adult acute myeloid leukemia|adult acute myeloid leukemia
733190|NCT00499668|acute undifferentiated leukemia|acute undifferentiated leukemia
733191|NCT00499668|mast cell leukemia|mast cell leukemia
733192|NCT00499668|adult T-cell leukemia/lymphoma|adult t-cell leukemia/lymphoma
733193|NCT00499668|T-cell large granular lymphocyte leukemia|t-cell large granular lymphocyte leukemia
733194|NCT00499668|chronic lymphocytic leukemia|chronic lymphocytic leukemia
733195|NCT00499668|hairy cell leukemia|hairy cell leukemia
733196|NCT00499668|prolymphocytic leukemia|prolymphocytic leukemia
733197|NCT00499668|AIDS-related lymphoma|aids-related lymphoma
733198|NCT00499668|adult Hodgkin lymphoma|adult hodgkin lymphoma
733199|NCT00499668|anaplastic large cell lymphoma|anaplastic large cell lymphoma
733200|NCT00499668|angioimmunoblastic T-cell lymphoma|angioimmunoblastic t-cell lymphoma
733201|NCT00499668|cutaneous B-cell non-Hodgkin lymphoma|cutaneous b-cell non-hodgkin lymphoma
733202|NCT00499668|cutaneous T-cell non-Hodgkin lymphoma|cutaneous t-cell non-hodgkin lymphoma
733203|NCT00499668|mycosis fungoides/Sezary syndrome|mycosis fungoides/sezary syndrome
733204|NCT00499668|adult grade III lymphomatoid granulomatosis|adult grade iii lymphomatoid granulomatosis
733205|NCT00499668|adult nasal type extranodal NK/T-cell lymphoma|adult nasal type extranodal nk/t-cell lymphoma
733206|NCT00499668|Waldenstrom macroglobulinemia|waldenstrom macroglobulinemia
733207|NCT00499668|adult Burkitt lymphoma|adult burkitt lymphoma
733208|NCT00499668|adult diffuse large cell lymphoma|adult diffuse large cell lymphoma
733209|NCT00499668|adult diffuse mixed cell lymphoma|adult diffuse mixed cell lymphoma
733210|NCT00499668|adult diffuse small cleaved cell lymphoma|adult diffuse small cleaved cell lymphoma
733211|NCT00499668|adult immunoblastic large cell lymphoma|adult immunoblastic large cell lymphoma
733212|NCT00499668|adult lymphoblastic lymphoma|adult lymphoblastic lymphoma
733213|NCT00499668|grade 1 follicular lymphoma|grade 1 follicular lymphoma
733214|NCT00499668|grade 2 follicular lymphoma|grade 2 follicular lymphoma
733215|NCT00499668|grade 3 follicular lymphoma|grade 3 follicular lymphoma
733216|NCT00499668|mantle cell lymphoma|mantle cell lymphoma
733217|NCT00499668|marginal zone lymphoma|marginal zone lymphoma
733218|NCT00499668|extranodal marginal zone B-cell lymphoma of mucosa-associated lymphoid tissue|extranodal marginal zone b-cell lymphoma of mucosa-associated lymphoid tissue
733219|NCT00499668|nodal marginal zone B-cell lymphoma|nodal marginal zone b-cell lymphoma
733220|NCT00499668|splenic marginal zone lymphoma|splenic marginal zone lymphoma
733221|NCT00499668|small lymphocytic lymphoma|small lymphocytic lymphoma
733222|NCT00499668|intraocular lymphoma|intraocular lymphoma
733223|NCT00499668|primary central nervous system lymphoma|primary central nervous system lymphoma
733224|NCT00499668|post-transplant lymphoproliferative disorder|post-transplant lymphoproliferative disorder
733225|NCT00499668|multiple myeloma and other plasma cell neoplasms|multiple myeloma and other plasma cell neoplasms
733226|NCT00499668|myelodysplastic syndromes|myelodysplastic syndromes
733227|NCT00499668|atypical chronic myeloid leukemia|atypical chronic myeloid leukemia
733228|NCT00499668|chronic myelomonocytic leukemia|chronic myelomonocytic leukemia
733229|NCT00499668|myelodysplastic/myeloproliferative disease, unclassifiable|myelodysplastic/myeloproliferative disease, unclassifiable
733230|NCT00499668|chronic myeloproliferative disorders|chronic myeloproliferative disorders
733231|NCT00499668|myelodysplastic/myeloproliferative diseases|myelodysplastic/myeloproliferative diseases
733232|NCT00499642|Healthy Subjects|healthy subjects
733233|NCT00499629|healthy subjects|healthy subjects
733234|NCT00499616|regional neuroblastoma|regional neuroblastoma
733235|NCT00499616|disseminated neuroblastoma|disseminated neuroblastoma
733236|NCT00499616|stage 4S neuroblastoma|stage 4s neuroblastoma
733237|NCT00499616|localized unresectable neuroblastoma|localized unresectable neuroblastoma
733238|NCT00499616|localized resectable neuroblastoma|localized resectable neuroblastoma
733239|NCT00499603|Breast Cancer|breast cancer
733240|NCT00499603|ER negative|er negative
733241|NCT00499603|PR negative|pr negative
733242|NCT00499603|HER2neu negative|her2neu negative
733342|NCT00499330|adenocarcinoma of the lung|adenocarcinoma of the lung
733243|NCT00499603|Tumor Triple Negative Receptors|tumor triple negative receptors
733244|NCT00499603|Paclitaxel|paclitaxel
733245|NCT00499603|Taxol|taxol
733246|NCT00499603|RAD001|rad001
733247|NCT00499603|FEC|fec
733248|NCT00499603|5-Fluorouracil|5-fluorouracil
733249|NCT00499603|5-FU|5-fu
733250|NCT00499603|Adrucil|adrucil
733251|NCT00499603|Efudex|efudex
733252|NCT00499603|Epirubicin|epirubicin
733253|NCT00499603|Cyclophosphamide|cyclophosphamide
733254|NCT00499590|AMD|amd
733255|NCT00499590|Macular Degeneration|macular degeneration
733256|NCT00499590|bevasiranib|bevasiranib
733257|NCT00499590|COBALT study|cobalt study
733258|NCT00499590|age related macular degeneration|age related macular degeneration
733259|NCT00499590|wet AMD|wet amd
733260|NCT00499590|wet age related macular degeneration|wet age related macular degeneration
733261|NCT00499577|stage I multiple myeloma|stage i multiple myeloma
733262|NCT00499577|stage II multiple myeloma|stage ii multiple myeloma
733263|NCT00499577|stage III multiple myeloma|stage iii multiple myeloma
733264|NCT00499577|refractory multiple myeloma|refractory multiple myeloma
733265|NCT00499551|Anterior Uveitis|anterior uveitis
733266|NCT00499551|Posterior Uveitis|posterior uveitis
733267|NCT00499551|Intermediate Uveitis|intermediate uveitis
733268|NCT00499551|Panuveitis|panuveitis
733269|NCT00499551|Iontophoresis|iontophoresis
733270|NCT00499551|Dexamethasone|dexamethasone
733271|NCT00499538|healthy subjects|healthy subjects
733272|NCT00499525|male breast cancer|male breast cancer
733273|NCT00499525|recurrent breast cancer|recurrent breast cancer
733274|NCT00499525|stage IIIB breast cancer|stage iiib breast cancer
733275|NCT00499525|stage IIIC breast cancer|stage iiic breast cancer
733276|NCT00499525|stage IV breast cancer|stage iv breast cancer
733277|NCT00499525|stage IIIA breast cancer|stage iiia breast cancer
733278|NCT00499512|Ovarian Cancer|ovarian cancer
733279|NCT00499512|Peritoneal Cancer|peritoneal cancer
733280|NCT00499512|Fallopian Tube Cancer|fallopian tube cancer
733281|NCT00499512|Spirituality|spirituality
733282|NCT00499512|Religion|religion
733283|NCT00499512|Quality of Life|quality of life
733284|NCT00499512|Questionnaire|questionnaire
733285|NCT00499512|Survey|survey
733286|NCT00499499|Cancer|cancer
733287|NCT00499499|solid tumors|solid tumors
733288|NCT00499486|recurrent pancreatic cancer|recurrent pancreatic cancer
733289|NCT00499486|stage III pancreatic cancer|stage iii pancreatic cancer
733290|NCT00499486|stage IV pancreatic cancer|stage iv pancreatic cancer
733291|NCT00499486|adenocarcinoma of the pancreas|adenocarcinoma of the pancreas
733292|NCT00499460|Healthy, No Evidence of Disease|healthy, no evidence of disease
733293|NCT00499447|stage I non-small cell lung cancer|stage i non-small cell lung cancer
733294|NCT00499447|adenocarcinoma of the lung|adenocarcinoma of the lung
733295|NCT00499447|adenosquamous cell lung cancer|adenosquamous cell lung cancer
733296|NCT00499447|large cell lung cancer|large cell lung cancer
733297|NCT00499447|squamous cell lung cancer|squamous cell lung cancer
733298|NCT00499434|aids|aids
733299|NCT00499421|Prostate Cancer|prostate cancer
733300|NCT00499421|External Beam Radiation Therapy|external beam radiation therapy
733301|NCT00499421|Fiducial Markers|fiducial markers
733302|NCT00499421|Acculoc System|acculoc system
733303|NCT00499421|Center Of Mass|center of mass
733304|NCT00499421|EBRT|ebrt
733305|NCT00499408|adenocarcinoma of the prostate|adenocarcinoma of the prostate
733306|NCT00499408|stage I prostate cancer|stage i prostate cancer
733307|NCT00499408|stage II prostate cancer|stage ii prostate cancer
733308|NCT00499408|stage III prostate cancer|stage iii prostate cancer
733309|NCT00499395|stage IV colon cancer|stage iv colon cancer
733310|NCT00499395|stage IV rectal cancer|stage iv rectal cancer
733311|NCT00499395|recurrent colon cancer|recurrent colon cancer
733312|NCT00499395|recurrent rectal cancer|recurrent rectal cancer
733313|NCT00499395|liver metastases|liver metastases
733314|NCT00499382|Advanced Cancers|advanced cancers
733315|NCT00499382|Cardiac Function|cardiac function
733316|NCT00499382|Nuclear Medicine Cardiac Scan|nuclear medicine cardiac scan
733317|NCT00499382|Positron Emission Tomography|positron emission tomography
733318|NCT00499382|Radionuclide Ventriculography|radionuclide ventriculography
733319|NCT00499382|Ventricular Ejection Fraction|ventricular ejection fraction
733320|NCT00499382|PET/CT|pet/ct
733321|NCT00499382|RNV|rnv
733322|NCT00499356|friction|friction
733323|NCT00499356|pressure|pressure
733324|NCT00499356|insole|insole
733325|NCT00499356|ulcer|ulcer
733326|NCT00499356|prevention|prevention
733327|NCT00499343|Non-Hodgkin's Lymphoma|non-hodgkin's lymphoma
733328|NCT00499343|Lymphoma|lymphoma
733329|NCT00499343|Etoposide|etoposide
733330|NCT00499343|G-CSF|g-csf
733331|NCT00499343|GM-CSF|gm-csf
733332|NCT00499343|Isophosphamide|isophosphamide
733333|NCT00499343|Rituximab|rituximab
733334|NCT00499343|Ifosfamide|ifosfamide
733335|NCT00499343|Sargramostim|sargramostim
733336|NCT00499343|Leukine|leukine
733337|NCT00499343|Filgrastim|filgrastim
733338|NCT00499343|Neupogen|neupogen
733339|NCT00499343|Apheresis|apheresis
733341|NCT00499330|stage IA non-small cell lung cancer|stage ia non-small cell lung cancer
733907|NCT00497445|Angioplasty|angioplasty
733343|NCT00499330|squamous cell lung cancer|squamous cell lung cancer
733344|NCT00499330|large cell lung cancer|large cell lung cancer
733345|NCT00499330|adenosquamous cell lung cancer|adenosquamous cell lung cancer
733346|NCT00499330|bronchoalveolar cell lung cancer|bronchoalveolar cell lung cancer
733347|NCT00499317|Urgency|urgency
733348|NCT00499317|Frequency|frequency
733349|NCT00499317|Pelvic pain|pelvic pain
733350|NCT00499317|Sexual dysfunction|sexual dysfunction
733351|NCT00499317|Erectile dysfunction|erectile dysfunction
733352|NCT00499317|Painful intercourse|painful intercourse
733353|NCT00499304|Forced oscillation Technique (FOT)|forced oscillation technique (fot)
733354|NCT00499304|Expiratory flow limitation (EFL)|expiratory flow limitation (efl)
733355|NCT00499304|Breathing artifacts|breathing artifacts
733356|NCT00499304|COPD|copd
733357|NCT00499291|unspecified adult solid tumor, protocol specific|unspecified adult solid tumor, protocol specific
733358|NCT00499291|recurrent breast cancer|recurrent breast cancer
733359|NCT00499291|stage IIIA breast cancer|stage iiia breast cancer
733360|NCT00499291|stage IIIB breast cancer|stage iiib breast cancer
733361|NCT00499291|stage IIIC breast cancer|stage iiic breast cancer
733362|NCT00499291|recurrent prostate cancer|recurrent prostate cancer
733363|NCT00499291|stage III prostate cancer|stage iii prostate cancer
733364|NCT00499291|stage IV prostate cancer|stage iv prostate cancer
733365|NCT00499291|recurrent non-small cell lung cancer|recurrent non-small cell lung cancer
733366|NCT00499291|stage IIIA non-small cell lung cancer|stage iiia non-small cell lung cancer
733367|NCT00499291|stage IIIB non-small cell lung cancer|stage iiib non-small cell lung cancer
733368|NCT00499291|stage IV non-small cell lung cancer|stage iv non-small cell lung cancer
733369|NCT00499291|extensive stage small cell lung cancer|extensive stage small cell lung cancer
733370|NCT00499291|recurrent small cell lung cancer|recurrent small cell lung cancer
733371|NCT00499291|recurrent bladder cancer|recurrent bladder cancer
733372|NCT00499291|stage III bladder cancer|stage iii bladder cancer
733373|NCT00499291|stage IV bladder cancer|stage iv bladder cancer
733374|NCT00499291|recurrent renal cell cancer|recurrent renal cell cancer
733375|NCT00499291|stage III renal cell cancer|stage iii renal cell cancer
733376|NCT00499291|stage IV renal cell cancer|stage iv renal cell cancer
733377|NCT00499291|clear cell sarcoma of the kidney|clear cell sarcoma of the kidney
733378|NCT00499291|rhabdoid tumor of the kidney|rhabdoid tumor of the kidney
733379|NCT00499291|recurrent malignant testicular germ cell tumor|recurrent malignant testicular germ cell tumor
733380|NCT00499291|stage III malignant testicular germ cell tumor|stage iii malignant testicular germ cell tumor
733381|NCT00499291|recurrent cervical cancer|recurrent cervical cancer
733382|NCT00499291|stage III cervical cancer|stage iii cervical cancer
733383|NCT00499291|stage IVA cervical cancer|stage iva cervical cancer
733384|NCT00499291|stage IVB cervical cancer|stage ivb cervical cancer
733385|NCT00499291|recurrent endometrial carcinoma|recurrent endometrial carcinoma
733386|NCT00499291|stage III endometrial carcinoma|stage iii endometrial carcinoma
733387|NCT00499291|stage IV endometrial carcinoma|stage iv endometrial carcinoma
733388|NCT00499291|fallopian tube cancer|fallopian tube cancer
733389|NCT00499291|recurrent ovarian epithelial cancer|recurrent ovarian epithelial cancer
733390|NCT00499291|stage III ovarian epithelial cancer|stage iii ovarian epithelial cancer
733391|NCT00499291|stage IV ovarian epithelial cancer|stage iv ovarian epithelial cancer
733392|NCT00499291|recurrent ovarian germ cell tumor|recurrent ovarian germ cell tumor
733393|NCT00499291|stage III ovarian germ cell tumor|stage iii ovarian germ cell tumor
733394|NCT00499291|stage IV ovarian germ cell tumor|stage iv ovarian germ cell tumor
733395|NCT00499291|ovarian sarcoma|ovarian sarcoma
733396|NCT00499291|ovarian stromal cancer|ovarian stromal cancer
733397|NCT00499291|recurrent uterine sarcoma|recurrent uterine sarcoma
733398|NCT00499291|stage III uterine sarcoma|stage iii uterine sarcoma
733399|NCT00499291|stage IV uterine sarcoma|stage iv uterine sarcoma
733400|NCT00499291|recurrent hypopharyngeal cancer|recurrent hypopharyngeal cancer
733401|NCT00499291|stage III hypopharyngeal cancer|stage iii hypopharyngeal cancer
733402|NCT00499291|stage IV hypopharyngeal cancer|stage iv hypopharyngeal cancer
733403|NCT00499291|recurrent laryngeal cancer|recurrent laryngeal cancer
733404|NCT00499291|stage III laryngeal cancer|stage iii laryngeal cancer
733405|NCT00499291|stage IV laryngeal cancer|stage iv laryngeal cancer
733406|NCT00499291|recurrent lip and oral cavity cancer|recurrent lip and oral cavity cancer
733407|NCT00499291|stage III lip and oral cavity cancer|stage iii lip and oral cavity cancer
733408|NCT00499291|stage IV lip and oral cavity cancer|stage iv lip and oral cavity cancer
733409|NCT00499291|recurrent metastatic squamous neck cancer with occult primary|recurrent metastatic squamous neck cancer with occult primary
733410|NCT00499291|untreated metastatic squamous neck cancer with occult primary|untreated metastatic squamous neck cancer with occult primary
733411|NCT00499291|recurrent nasopharyngeal cancer|recurrent nasopharyngeal cancer
733412|NCT00499291|stage III nasopharyngeal cancer|stage iii nasopharyngeal cancer
733413|NCT00499291|stage IV nasopharyngeal cancer|stage iv nasopharyngeal cancer
733414|NCT00499291|recurrent oropharyngeal cancer|recurrent oropharyngeal cancer
733415|NCT00499291|stage III oropharyngeal cancer|stage iii oropharyngeal cancer
733416|NCT00499291|stage IV oropharyngeal cancer|stage iv oropharyngeal cancer
733417|NCT00499291|recurrent paranasal sinus and nasal cavity cancer|recurrent paranasal sinus and nasal cavity cancer
733418|NCT00499291|stage III paranasal sinus and nasal cavity cancer|stage iii paranasal sinus and nasal cavity cancer
733419|NCT00499291|stage IV paranasal sinus and nasal cavity cancer|stage iv paranasal sinus and nasal cavity cancer
733420|NCT00499291|recurrent salivary gland cancer|recurrent salivary gland cancer
733421|NCT00499291|stage III salivary gland cancer|stage iii salivary gland cancer
733422|NCT00499291|stage IV salivary gland cancer|stage iv salivary gland cancer
733423|NCT00499291|recurrent esophageal cancer|recurrent esophageal cancer
733424|NCT00499291|stage III esophageal cancer|stage iii esophageal cancer
733425|NCT00499291|stage IV esophageal cancer|stage iv esophageal cancer
733426|NCT00499291|recurrent gastric cancer|recurrent gastric cancer
733427|NCT00499291|stage III gastric cancer|stage iii gastric cancer
733428|NCT00499291|stage IV gastric cancer|stage iv gastric cancer
733429|NCT00499291|adult central nervous system germ cell tumor|adult central nervous system germ cell tumor
733430|NCT00499291|adult teratoma|adult teratoma
733431|NCT00499291|ovarian teratoma|ovarian teratoma
733432|NCT00499291|testicular teratoma|testicular teratoma
733433|NCT00499291|recurrent adult soft tissue sarcoma|recurrent adult soft tissue sarcoma
733434|NCT00499291|stage III adult soft tissue sarcoma|stage iii adult soft tissue sarcoma
733435|NCT00499291|stage IV adult soft tissue sarcoma|stage iv adult soft tissue sarcoma
733436|NCT00499291|recurrent carcinoma of unknown primary|recurrent carcinoma of unknown primary
733437|NCT00499278|Osteoarthritis|osteoarthritis
733439|NCT00499278|knee|knee
733442|NCT00499265|recurrent pancreatic cancer|recurrent pancreatic cancer
733443|NCT00499265|stage III pancreatic cancer|stage iii pancreatic cancer
733444|NCT00499265|adenocarcinoma of the pancreas|adenocarcinoma of the pancreas
733445|NCT00499239|Hematologic Malignancies|hematologic malignancies
733446|NCT00499239|CLL|cll
733447|NCT00499239|NHL|nhl
733448|NCT00499239|Chronic Lymphocytic Leukemia|chronic lymphocytic leukemia
733449|NCT00499239|Non-Hodgkin's Lymphoma|non-hodgkin's lymphoma
733450|NCT00499239|CLL and NHL|cll and nhl
733451|NCT00499239|Multiple Myeloma|multiple myeloma
733453|NCT00499187|Fanconi|fanconi
733454|NCT00499187|Kidney|kidney
733455|NCT00499187|Renal|renal
733456|NCT00499187|HIV|hiv
733457|NCT00499187|HIV-1|hiv-1
733458|NCT00499187|Treatment Experienced|treatment experienced
733459|NCT00499174|stage II prostate cancer|stage ii prostate cancer
733460|NCT00499174|adenocarcinoma of the prostate|adenocarcinoma of the prostate
733461|NCT00499161|Individualized care|individualized care
733462|NCT00499161|Relationship based care|relationship based care
733463|NCT00499161|Negotiated care|negotiated care
733464|NCT00499161|Patient focused care|patient focused care
733465|NCT00499122|stage II breast cancer|stage ii breast cancer
733466|NCT00499122|stage IIIC breast cancer|stage iiic breast cancer
733467|NCT00499122|inflammatory breast cancer|inflammatory breast cancer
733468|NCT00499109|RRM1|rrm1
733469|NCT00499109|ERCC1|ercc1
733470|NCT00499109|Customized Chemotherapy|customized chemotherapy
733471|NCT00499096|Chronic Illness|chronic illness
733472|NCT00499096|Disease management|disease management
733473|NCT00499096|Health Behaviors|health behaviors
733474|NCT00499096|Mood Disorders-Bipolar|mood disorders-bipolar
733475|NCT00499083|stage II breast cancer|stage ii breast cancer
733476|NCT00499083|stage IIIA breast cancer|stage iiia breast cancer
733477|NCT00499083|stage IIIB breast cancer|stage iiib breast cancer
733478|NCT00499083|stage IIIC breast cancer|stage iiic breast cancer
733479|NCT00499070|refractory cytopenia with multilineage dysplasia|refractory cytopenia with multilineage dysplasia
733480|NCT00499070|aplastic anemia|aplastic anemia
733481|NCT00499070|Fanconi anemia|fanconi anemia
733482|NCT00499070|dyskeratosis congenita|dyskeratosis congenita
733483|NCT00499070|Shwachman-Diamond syndrome|shwachman-diamond syndrome
733484|NCT00499070|Pearson marrow-pancreas syndrome|pearson marrow-pancreas syndrome
733485|NCT00499057|early stage breast cancer|early stage breast cancer
733486|NCT00499044|cognition|cognition
733487|NCT00499044|attention|attention
733488|NCT00499044|memory|memory
733489|NCT00499044|concentration|concentration
733490|NCT00499044|schizophrenia|schizophrenia
733491|NCT00499018|Large B-Cell Lymphoma|large b-cell lymphoma
733492|NCT00499018|Rituximab|rituximab
733493|NCT00499018|Autologous Stem Cell Transplantation|autologous stem cell transplantation
733494|NCT00498992|dermatologic complications|dermatologic complications
733495|NCT00498992|unspecified adult solid tumor, protocol specific|unspecified adult solid tumor, protocol specific
733496|NCT00498979|stage IV melanoma|stage iv melanoma
733497|NCT00498979|adult anaplastic astrocytoma|adult anaplastic astrocytoma
733498|NCT00498979|adult diffuse astrocytoma|adult diffuse astrocytoma
733499|NCT00498979|adult glioblastoma|adult glioblastoma
733500|NCT00498979|adult giant cell glioblastoma|adult giant cell glioblastoma
733501|NCT00498979|adult pilocytic astrocytoma|adult pilocytic astrocytoma
733502|NCT00498979|adult brain stem glioma|adult brain stem glioma
733503|NCT00498979|adult anaplastic ependymoma|adult anaplastic ependymoma
733504|NCT00498979|adult ependymoma|adult ependymoma
733505|NCT00498979|adult myxopapillary ependymoma|adult myxopapillary ependymoma
733506|NCT00498979|adult subependymoma|adult subependymoma
733507|NCT00498979|adult anaplastic oligodendroglioma|adult anaplastic oligodendroglioma
733508|NCT00498979|adult oligodendroglioma|adult oligodendroglioma
733509|NCT00498979|mixed gliomas|mixed gliomas
733510|NCT00498979|recurrent adult brain tumor|recurrent adult brain tumor
733511|NCT00498979|recurrent melanoma|recurrent melanoma
733512|NCT00498979|adult gliosarcoma|adult gliosarcoma
733513|NCT00498979|adult subependymal giant cell astrocytoma|adult subependymal giant cell astrocytoma
733514|NCT00498979|adult pineal gland astrocytoma|adult pineal gland astrocytoma
733516|NCT00498966|perifosine|perifosine
733517|NCT00498966|Progression on treatment with sunitinib or sorafenib|progression on treatment with sunitinib or sorafenib
733518|NCT00498953|stage II squamous cell carcinoma of the hypopharynx|stage ii squamous cell carcinoma of the hypopharynx
733519|NCT00498953|stage III squamous cell carcinoma of the hypopharynx|stage iii squamous cell carcinoma of the hypopharynx
733520|NCT00498953|stage IV squamous cell carcinoma of the hypopharynx|stage iv squamous cell carcinoma of the hypopharynx
733521|NCT00498953|stage III squamous cell carcinoma of the larynx|stage iii squamous cell carcinoma of the larynx
733522|NCT00498953|stage IV squamous cell carcinoma of the larynx|stage iv squamous cell carcinoma of the larynx
733523|NCT00498940|LV function, Compliance, wall motion, echocardiography|lv function, compliance, wall motion, echocardiography
733524|NCT00498927|recurrent adult brain tumor|recurrent adult brain tumor
733525|NCT00498927|adult giant cell glioblastoma|adult giant cell glioblastoma
733526|NCT00498927|adult glioblastoma|adult glioblastoma
733527|NCT00498927|adult gliosarcoma|adult gliosarcoma
733528|NCT00498927|adult anaplastic astrocytoma|adult anaplastic astrocytoma
733529|NCT00498927|adult diffuse astrocytoma|adult diffuse astrocytoma
733530|NCT00498927|adult pilocytic astrocytoma|adult pilocytic astrocytoma
733531|NCT00498927|adult subependymal giant cell astrocytoma|adult subependymal giant cell astrocytoma
733532|NCT00498927|adult anaplastic ependymoma|adult anaplastic ependymoma
733533|NCT00498927|adult ependymoma|adult ependymoma
733534|NCT00498927|adult myxopapillary ependymoma|adult myxopapillary ependymoma
733535|NCT00498927|adult subependymoma|adult subependymoma
733536|NCT00498927|adult anaplastic oligodendroglioma|adult anaplastic oligodendroglioma
733537|NCT00498927|adult oligodendroglioma|adult oligodendroglioma
733538|NCT00498927|adult brain stem glioma|adult brain stem glioma
733539|NCT00498927|adult mixed glioma|adult mixed glioma
733540|NCT00498927|adult pineal gland astrocytoma|adult pineal gland astrocytoma
733541|NCT00498914|Lymphoma, Large-Cell, Diffuse|lymphoma, large-cell, diffuse
733542|NCT00498914|Lymphoma, B-Cell|lymphoma, b-cell
733543|NCT00498914|YM155|ym155
733544|NCT00498914|Treatment outcomes|treatment outcomes
733545|NCT00498914|Refractory|refractory
733546|NCT00498901|stage IV breast cancer|stage iv breast cancer
733547|NCT00498901|recurrent breast cancer|recurrent breast cancer
733548|NCT00498888|urge urinary incontinence|urge urinary incontinence
733549|NCT00498888|rehabilitation|rehabilitation
733550|NCT00498888|anticholinergic|anticholinergic
733551|NCT00498875|Oropharyngeal Cancer|oropharyngeal cancer
733552|NCT00498875|Head and Neck Cancer|head and neck cancer
733553|NCT00498875|Depression|depression
733554|NCT00498875|Questionnaire|questionnaire
733555|NCT00498875|Survey|survey
733556|NCT00498875|Interview|interview
733557|NCT00498849|Sleep apnea|sleep apnea
733558|NCT00498849|Continuous positive airway pressure|continuous positive airway pressure
733559|NCT00498849|Microarray|microarray
733560|NCT00498849|Polysomnography|polysomnography
733561|NCT00498836|CP-4055|cp-4055
733562|NCT00498836|Elacyt|elacyt
733563|NCT00498836|Cancer|cancer
733565|NCT00498836|Malignant melanoma|malignant melanoma
733566|NCT00498836|Combination treatment|combination treatment
733567|NCT00498836|Sorafenib|sorafenib
733568|NCT00498836|Nexavar|nexavar
733569|NCT00498797|prostate cancer|prostate cancer
733570|NCT00498797|zactima|zactima
733571|NCT00498797|vandetanib|vandetanib
733572|NCT00498797|metastatic|metastatic
733573|NCT00498784|Intra-uterine contraception|intra-uterine contraception
733574|NCT00498784|Intrauterine Devices|intrauterine devices
733575|NCT00498771|Lymphedema|lymphedema
733576|NCT00498771|Aquatic Exercise|aquatic exercise
733577|NCT00498771|Breast Cancer|breast cancer
733578|NCT00498758|Parkinson's disease|parkinson's disease
733579|NCT00498758|Gait Disturbances|gait disturbances
733580|NCT00498758|Mobility|mobility
733581|NCT00498758|Quality of life|quality of life
733582|NCT00498732|Obstructive sleep apnea syndrome; CPAP, microarray|obstructive sleep apnea syndrome; cpap, microarray
733583|NCT00498719|Leukemia|leukemia
733584|NCT00498719|Lymphoma|lymphoma
733585|NCT00498719|Brain Tumor|brain tumor
733586|NCT00498719|Attention Deficit|attention deficit
733587|NCT00498719|Cognitive Training Program|cognitive training program
733588|NCT00498719|Central Nervous System|central nervous system
733589|NCT00498719|CNS|cns
733590|NCT00498719|CTP|ctp
733591|NCT00498706|Depressive Disorder, Major|depressive disorder, major
733592|NCT00498706|Cognitive Behavioral Therapy|cognitive behavioral therapy
733593|NCT00498706|Psychotherapy|psychotherapy
733594|NCT00498706|Telemedicine|telemedicine
733595|NCT00498706|Primary Care|primary care
733596|NCT00498680|Erectile Dysfunction|erectile dysfunction
733597|NCT00498680|Treatment|treatment
733598|NCT00498680|PDE5i|pde5i
733599|NCT00498667|PET/CT|pet/ct
733600|NCT00498667|Aggressive non-Hodgkin Lymphoma|aggressive non-hodgkin lymphoma
733601|NCT00498654|Prevention of Typhoid Fever in Adult Travelers|prevention of typhoid fever in adult travelers
733602|NCT00498641|perceptual learning|perceptual learning
733603|NCT00498641|occlusion therapy|occlusion therapy
733604|NCT00498628|Alcoholism|alcoholism
733605|NCT00498628|Alcohol dependence|alcohol dependence
733606|NCT00498628|Quetiapine|quetiapine
733607|NCT00498615|scleroderma|scleroderma
733608|NCT00498615|Raynaud's phenomenon|raynaud's phenomenon
733609|NCT00498615|Rho-kinase inhibitor|rho-kinase inhibitor
733610|NCT00498576|hypertension|hypertension
733611|NCT00498576|kidney transplant|kidney transplant
733612|NCT00498576|melatonin|melatonin
733613|NCT00498576|adiponectin|adiponectin
733614|NCT00498563|high altitude|high altitude
733615|NCT00498563|sleep|sleep
733616|NCT00498563|altitude illness|altitude illness
733617|NCT00498563|neurobehavioral manifestations|neurobehavioral manifestations
733618|NCT00498563|psychomotor performance|psychomotor performance
733619|NCT00498563|mood states|mood states
733620|NCT00498550|Clozapine|clozapine
733621|NCT00498550|Schizophrenia|schizophrenia
733622|NCT00498550|Dual Diagnosis|dual diagnosis
733623|NCT00498550|Substance Abuse|substance abuse
733624|NCT00498550|Cannabis Abuse|cannabis abuse
733625|NCT00498537|spironolactone|spironolactone
733626|NCT00498537|aldosterone|aldosterone
733627|NCT00498537|diabetic nephropathy|diabetic nephropathy
733628|NCT00498537|proteinuria|proteinuria
733629|NCT00498537|hyperkalemia|hyperkalemia
733630|NCT00498537|albuminuria|albuminuria
733631|NCT00498537|renal failure|renal failure
733632|NCT00498524|implantable cardioverter-defibrillator|implantable cardioverter-defibrillator
733633|NCT00498524|ischemic cardiomyopathy|ischemic cardiomyopathy
733634|NCT00498524|ventricular arrhythmias|ventricular arrhythmias
733635|NCT00498524|sibling concordance|sibling concordance
733636|NCT00498511|Anemia, Iron-Deficiency|anemia, iron-deficiency
733637|NCT00498511|Endoscopy, Gastrointestinal|endoscopy, gastrointestinal
733638|NCT00498511|Male, aged 18 to 40|male, aged 18 to 40
733639|NCT00498498|severe head injury|severe head injury
733640|NCT00498498|Endothelin|endothelin
733641|NCT00498498|CSF|csf
733642|NCT00498498|Plasma|plasma
733643|NCT00498498|Cellular Apoptosis|cellular apoptosis
733644|NCT00498485|chronic|chronic
733645|NCT00498485|fatigue|fatigue
733646|NCT00498485|pain|pain
733647|NCT00498485|sleep|sleep
733648|NCT00498485|xyrem|xyrem
733649|NCT00498485|must have chronic fatigue syndrome|must have chronic fatigue syndrome
733650|NCT00498485|no hypertension|no hypertension
733651|NCT00498485|no sleep apnea|no sleep apnea
733652|NCT00498472|BNP|bnp
733653|NCT00498472|heart failure|heart failure
733654|NCT00498459|Physical activity|physical activity
733655|NCT00498459|Randomised trial|randomised trial
733656|NCT00498459|Prevention|prevention
733657|NCT00498459|Adolescents|adolescents
733658|NCT00498459|Obesity|obesity
733659|NCT00498459|Cardiovascular risk factors|cardiovascular risk factors
733660|NCT00498433|Aliskiren|aliskiren
733661|NCT00498433|Renin-Angiotensin System (RAS)|renin-angiotensin system (ras)
733662|NCT00498433|Hypertension|hypertension
733663|NCT00498433|Abdominal obesity|abdominal obesity
733664|NCT00498420|HUE-MAN|hue-man
733665|NCT00498420|Rare disorder|rare disorder
733666|NCT00498420|Hepatosplenomegaly|hepatosplenomegaly
733667|NCT00498420|Dysostosis|dysostosis
733668|NCT00498407|CP-4055|cp-4055
733669|NCT00498407|ELACYT(TM)|elacyt(tm)
733670|NCT00498407|Cancer|cancer
733671|NCT00498407|Colorectal cancer|colorectal cancer
733672|NCT00498407|CRC|crc
733673|NCT00498407|Second line therapy|second line therapy
733674|NCT00498394|Obesity|obesity
733675|NCT00498394|Weight loss|weight loss
733676|NCT00498394|Diet fads|diet fads
733677|NCT00498368|Estimated glomerular filtration rate (GFR)|estimated glomerular filtration rate (gfr)
733678|NCT00498368|Proteinuria|proteinuria
733679|NCT00498368|Renal Fibrosis|renal fibrosis
733680|NCT00498355|uveitis|uveitis
733681|NCT00498355|cytoid macular edema|cytoid macular edema
733682|NCT00498355|steroid|steroid
733683|NCT00498355|Lucentis|lucentis
733684|NCT00498329|fMRI|fmri
733685|NCT00498329|Electroencephalogram (EEG)|electroencephalogram (eeg)
733686|NCT00498329|Attention|attention
733687|NCT00498329|Sensorimotor Integration|sensorimotor integration
733688|NCT00498329|Human Brain|human brain
733689|NCT00498329|Healthy Volunteer|healthy volunteer
733690|NCT00498329|HV|hv
733691|NCT00498316|Myelodysplastic Syndrome|myelodysplastic syndrome
733692|NCT00498316|Leukemia|leukemia
733693|NCT00498316|Cord Blood Expansion|cord blood expansion
733694|NCT00498316|Umbilical Cord Blood|umbilical cord blood
733695|NCT00498316|Mesenchymal Stem Cells|mesenchymal stem cells
733696|NCT00498316|Acute Myelogenous Leukemia|acute myelogenous leukemia
733697|NCT00498316|Acute Lymphoblastic Leukemia|acute lymphoblastic leukemia
733698|NCT00498316|ALL|all
733699|NCT00498316|AML|aml
733700|NCT00498316|MDS|mds
733701|NCT00498303|influenza vaccine|influenza vaccine
733702|NCT00498290|Enhanced Recovery After Surgery Protocol(ERAS)|enhanced recovery after surgery protocol(eras)
733703|NCT00498290|Colorectal Surgery|colorectal surgery
733704|NCT00498277|Osteoporosis|osteoporosis
733705|NCT00498277|Magnetic Resonance Imaging|magnetic resonance imaging
733706|NCT00498277|Vertebral Fractures|vertebral fractures
733707|NCT00498277|Quantitative Diffusion|quantitative diffusion
733708|NCT00498277|Fat Imaging|fat imaging
733709|NCT00498277|Spine|spine
733710|NCT00498264|Exercise|exercise
733711|NCT00498264|Rehabilitation|rehabilitation
733712|NCT00498264|Strength exercise|strength exercise
733713|NCT00498264|Aerobic exercise|aerobic exercise
733714|NCT00498264|Pain|pain
733715|NCT00498251|lung injury, acute|lung injury, acute
733716|NCT00498251|thoracic surgical procedures|thoracic surgical procedures
733717|NCT00498251|lung cancer|lung cancer
733718|NCT00498251|salbutamol|salbutamol
733719|NCT00498238|Arterial stiffness, Augmentation index, Subclinical Hypothyroidism|arterial stiffness, augmentation index, subclinical hypothyroidism
733720|NCT00498225|Pancreatic Cancer|pancreatic cancer
733721|NCT00498212|Heplisav|heplisav
733722|NCT00498212|Hepatitis B|hepatitis b
733723|NCT00498212|Hepatitis|hepatitis
733724|NCT00498212|HBV|hbv
733725|NCT00498212|Hepatitis B vaccine|hepatitis b vaccine
733726|NCT00498212|kidney disease|kidney disease
733727|NCT00498212|renal disease|renal disease
733728|NCT00498212|kidney failure|kidney failure
733729|NCT00498212|renal failure|renal failure
733730|NCT00498199|Multiples sclerosis|multiples sclerosis
733731|NCT00498199|oscillopsia|oscillopsia
733732|NCT00498199|eye movements|eye movements
733733|NCT00498199|motion detection|motion detection
733734|NCT00498199|retinal slip|retinal slip
733738|NCT00498173|Autistic Disorder|autistic disorder
733739|NCT00498173|Autism Spectrum Disorder|autism spectrum disorder
733740|NCT00498160|Kidney transplant|kidney transplant
733741|NCT00498160|Tolerance|tolerance
733742|NCT00498160|Marrow/stem cell transplant|marrow/stem cell transplant
733743|NCT00498147|amputation|amputation
733744|NCT00498147|angina|angina
733745|NCT00498147|angiography|angiography
733746|NCT00498147|angioplasty|angioplasty
733747|NCT00498147|arterial disease|arterial disease
733748|NCT00498147|artery disease|artery disease
733749|NCT00498147|bypass|bypass
733750|NCT00498147|CABG|cabg
733751|NCT00498147|cad|cad
733752|NCT00498147|carotid|carotid
733753|NCT00498147|cerebral accident|cerebral accident
733754|NCT00498147|CHF|chf
733755|NCT00498147|CRF|crf
733756|NCT00498147|CVA|cva
733757|NCT00498147|endarterectomy|endarterectomy
733758|NCT00498147|heart attack|heart attack
733759|NCT00498147|heart failure|heart failure
733760|NCT00498147|infarct|infarct
733761|NCT00498147|kidney disease|kidney disease
733762|NCT00498147|kidney failure|kidney failure
733763|NCT00498147|laser|laser
733764|NCT00498147|nephropathy|nephropathy
733765|NCT00498147|neuropathy|neuropathy
733766|NCT00498147|pad|pad
733767|NCT00498147|PCI|pci
733768|NCT00498147|percutaneous coronary|percutaneous coronary
733769|NCT00498147|percutaneous transluminal|percutaneous transluminal
733770|NCT00498147|pvd|pvd
733771|NCT00498147|renal failure|renal failure
733772|NCT00498147|retinopathy|retinopathy
733773|NCT00498147|revascularization|revascularization
733774|NCT00498147|schemia|schemia
733775|NCT00498147|stenosis|stenosis
733776|NCT00498147|stent|stent
733777|NCT00498147|stroke|stroke
733778|NCT00498147|transient|transient
733779|NCT00498147|ulcer|ulcer
733780|NCT00498147|vascular disease|vascular disease
733781|NCT00498134|Gastric cancer|gastric cancer
733782|NCT00498121|Ventilator associated pneumonia.|ventilator associated pneumonia.
733783|NCT00498121|Procalcitonin.|procalcitonin.
733784|NCT00498108|Rotigotine|rotigotine
733785|NCT00498108|Restless Legs Syndrome|restless legs syndrome
733786|NCT00498095|Delayed renal graft function|delayed renal graft function
733787|NCT00498095|Acute renal allograft dysfunction|acute renal allograft dysfunction
733788|NCT00498069|Critical limb ischemia due to peripheral arterial occlusive disease|critical limb ischemia due to peripheral arterial occlusive disease
733789|NCT00498069|Autologous bone marrow concentrate|autologous bone marrow concentrate
733790|NCT00498056|HIV Seronegativity|hiv seronegativity
733791|NCT00498056|HIV Preventive Vaccine|hiv preventive vaccine
733792|NCT00498043|Lymphoma|lymphoma
733793|NCT00498043|PET|pet
733794|NCT00498043|Chemotherapy|chemotherapy
733795|NCT00498043|Rituximab|rituximab
733796|NCT00498030|Insulin Resistance|insulin resistance
733797|NCT00498030|Stress, Psychological|stress, psychological
733798|NCT00498017|Infections|infections
733799|NCT00498004|Quality of Life|quality of life
733800|NCT00498004|Schizophrenia|schizophrenia
733801|NCT00498004|Quetiapine|quetiapine
733802|NCT00498004|Risperidone|risperidone
733803|NCT00497991|AML|aml
733804|NCT00497991|phase I/II|phase i/ii
733805|NCT00497991|AZD1152|azd1152
733806|NCT00497991|Acute Myeloid Leukaemia|acute myeloid leukaemia
733807|NCT00497965|Balance|balance
733808|NCT00497965|Chiropractic|chiropractic
733809|NCT00497965|Older Adults|older adults
733810|NCT00497952|Relapsing-remitting multiple sclerosis|relapsing-remitting multiple sclerosis
733811|NCT00497952|Marrow/Stem cell transplant|marrow/stem cell transplant
733812|NCT00497939|Benign Prostatic Hyperplasia (BPH)|benign prostatic hyperplasia (bph)
733813|NCT00497939|Currently on alpha blocker|currently on alpha blocker
733814|NCT00497926|Kidney transplant|kidney transplant
733815|NCT00497926|Tolerance|tolerance
733816|NCT00497926|Marrow/Enriched Hematopoetic Stem Cell Transplant|marrow/enriched hematopoetic stem cell transplant
733817|NCT00497913|Tennis Elbow|tennis elbow
733818|NCT00497913|Botulinum Toxin|botulinum toxin
733819|NCT00497874|depression|depression
733820|NCT00497874|stage of change|stage of change
733821|NCT00497874|intervention|intervention
733822|NCT00497874|randomized clinical trial|randomized clinical trial
733823|NCT00497874|population-based|population-based
733824|NCT00497874|expert system|expert system
733825|NCT00497861|Low back pain|low back pain
733826|NCT00497861|Chiropractic|chiropractic
733827|NCT00497861|Spinal manipulation|spinal manipulation
733828|NCT00497861|Activator Methods Chiropractic Technique|activator methods chiropractic technique
733829|NCT00497835|motor seizures|motor seizures
733830|NCT00497835|accelerometer|accelerometer
733831|NCT00497835|algorithm|algorithm
733832|NCT00497835|detection|detection
733833|NCT00497835|alert|alert
733834|NCT00497822|Dementia|dementia
733835|NCT00497809|Breast Cancer|breast cancer
733836|NCT00497809|Neutropenia|neutropenia
733837|NCT00497809|Chemotherapy|chemotherapy
733838|NCT00497809|High risk|high risk
733839|NCT00497796|cytomegalovirus|cytomegalovirus
733841|NCT00497796|prophylaxis|prophylaxis
733842|NCT00497796|liver|liver
733843|NCT00497796|liver transplant|liver transplant
733844|NCT00497757|Marrow/hematopoietic stem cell transplant|marrow/hematopoietic stem cell transplant
733845|NCT00497744|CAPD peritonitis|capd peritonitis
733846|NCT00497744|Peritoneal Dialysis, Continuous Ambulatory|peritoneal dialysis, continuous ambulatory
733847|NCT00497731|Advanced solid tumors|advanced solid tumors
733848|NCT00497705|Ebsteins Anomaly|ebsteins anomaly
733849|NCT00497705|Heart Septal Defects, Ventricle|heart septal defects, ventricle
733850|NCT00497705|Heart Defects, Congenital|heart defects, congenital
733851|NCT00497705|Double Outlet Right Ventricle|double outlet right ventricle
733852|NCT00497705|Truncus Arteriosus Persistant|truncus arteriosus persistant
733853|NCT00497705|Ebstein's Anomaly|ebstein's anomaly
733854|NCT00497705|Congenital Heart Disease|congenital heart disease
733855|NCT00497705|Heart Defects|heart defects
733856|NCT00497679|advanced solid tumours|advanced solid tumours
733857|NCT00497666|Diabetes|diabetes
733858|NCT00497666|Diabetic nephropathy|diabetic nephropathy
733859|NCT00497666|renal protection|renal protection
733860|NCT00497640|sleep apnea, titration, CPAP, neural network|sleep apnea, titration, cpap, neural network
733861|NCT00497614|Rheumatoid arthritis|rheumatoid arthritis
733862|NCT00497614|Positron emission tomodensitometry|positron emission tomodensitometry
733863|NCT00497614|Tumor necrosis factor alpha inhibitor|tumor necrosis factor alpha inhibitor
733864|NCT00497601|Visceral Leishmaniasis|visceral leishmaniasis
733865|NCT00497601|Amphotericin B|amphotericin b
733866|NCT00497601|Fat emulsion|fat emulsion
733867|NCT00497588|laryngeal cancer|laryngeal cancer
733868|NCT00497588|RADIOTHERAPY|radiotherapy
733869|NCT00497588|Voice Quality|voice quality
733870|NCT00497575|Congenital Hypothyroidism|congenital hypothyroidism
733871|NCT00497575|diagnosis|diagnosis
733872|NCT00497575|L-thyroxine|l-thyroxine
733873|NCT00497575|newborn screening|newborn screening
733874|NCT00497562|Fibromyalgia|fibromyalgia
733875|NCT00497562|growth hormone|growth hormone
733876|NCT00497562|IGF-1|igf-1
733877|NCT00497562|FIQ|fiq
733878|NCT00497549|Esophagectomy|esophagectomy
733879|NCT00497549|hand sewn anastomosis|hand sewn anastomosis
733880|NCT00497549|side-to-side stapled|side-to-side stapled
733881|NCT00497536|Type 1 Diabetes Mellitus|type 1 diabetes mellitus
733882|NCT00497536|Continuous Subcutaneous Insulin Infusion (CSII)|continuous subcutaneous insulin infusion (csii)
733883|NCT00497523|Asthma|asthma
733884|NCT00497523|Young Children|young children
733885|NCT00497523|Corticosteroids|corticosteroids
733886|NCT00497523|Beclomethasone|beclomethasone
733887|NCT00497523|Salbutamol|salbutamol
733888|NCT00497523|Beclomethasone/Salbutamol fixed combination|beclomethasone/salbutamol fixed combination
733889|NCT00497523|Suspension for nebulisation|suspension for nebulisation
733890|NCT00497510|Balance|balance
733891|NCT00497510|Chiropractic|chiropractic
733892|NCT00497510|Older Adults|older adults
733893|NCT00497497|CRC|crc
733894|NCT00497497|Colon cancer|colon cancer
733895|NCT00497497|Avastin|avastin
733896|NCT00497497|APM4187g|apm4187g
733897|NCT00497471|Plasmodium Falciparum|plasmodium falciparum
733898|NCT00497471|Antimlarial chemoprophylaxis|antimlarial chemoprophylaxis
733899|NCT00497471|Iron supplementation|iron supplementation
733900|NCT00497471|Tanzania|tanzania
733901|NCT00497458|breast|breast
733902|NCT00497458|neoplasms|neoplasms
733903|NCT00497458|anastrazole|anastrazole
733904|NCT00497458|testosterone|testosterone
733905|NCT00497445|Peripheral arterial disease|peripheral arterial disease
733906|NCT00497445|Exercise therapy|exercise therapy
733908|NCT00497445|Bypass surgery|bypass surgery
733909|NCT00497432|Hyperbaric Oxygen|hyperbaric oxygen
733910|NCT00497419|STEMI|stemi
733911|NCT00497419|ST elevation myocardial infarction|st elevation myocardial infarction
733912|NCT00497406|submandibular salivary gland transfer|submandibular salivary gland transfer
733913|NCT00497406|intensity-modulated radiation therapy|intensity-modulated radiation therapy
733914|NCT00497406|helical tomotherapy|helical tomotherapy
733915|NCT00497406|reduction of xerostomia|reduction of xerostomia
733916|NCT00497393|Emergency department, administration, overcrowding|emergency department, administration, overcrowding
733917|NCT00497367|safety|safety
733918|NCT00497367|feasibility|feasibility
733919|NCT00497367|bifurcation|bifurcation
733920|NCT00497367|lesion|lesion
733921|NCT00497367|de novo|de novo
733922|NCT00497367|intervention|intervention
733923|NCT00497354|Ultrasound, Complications, Regional Anesthesia|ultrasound, complications, regional anesthesia
733924|NCT00497341|infection after total knee arthroplasty|infection after total knee arthroplasty
733925|NCT00497328|contrast induced nephropathy|contrast induced nephropathy
733926|NCT00497315|Non-Small Cell Lung Cancer|non-small cell lung cancer
733927|NCT00497315|NSCLC|nsclc
733928|NCT00497315|Chemoradiation|chemoradiation
733929|NCT00497315|locally advanced NSCLC|locally advanced nsclc
733930|NCT00497315|pemetrexed|pemetrexed
733931|NCT00497315|lung cancer|lung cancer
733932|NCT00497302|cocaine|cocaine
733933|NCT00497302|opiate|opiate
733934|NCT00497302|pregnancy|pregnancy
733935|NCT00497302|post-partum|post-partum
733936|NCT00497302|neonatal abstinence syndrome|neonatal abstinence syndrome
733937|NCT00497302|contingency management|contingency management
733938|NCT00497302|Reinforcement Based Treatment|reinforcement based treatment
733941|NCT00497289|parenteral nutrition|parenteral nutrition
733942|NCT00497289|preterm infant|preterm infant
733943|NCT00497276|Adults|adults
733944|NCT00497276|Anesthesia recovery period|anesthesia recovery period
733945|NCT00497276|Comparative study|comparative study
733946|NCT00497276|Electric stimulation|electric stimulation
733947|NCT00497276|Humans|humans
733948|NCT00497276|Nerve blocks/methods/indications|nerve blocks/methods/indications
733949|NCT00497276|Patient satisfaction|patient satisfaction
733950|NCT00497276|Peripheral nerves|peripheral nerves
733951|NCT00497276|Sciatic nerve/ultrasonography|sciatic nerve/ultrasonography
733952|NCT00497276|Ultrasonography|ultrasonography
733953|NCT00497276|Treatment outcome|treatment outcome
733954|NCT00497276|Nerve blocks/economics|nerve blocks/economics
733955|NCT00497250|Phase 1 Clinical Trials|phase 1 clinical trials
733956|NCT00497250|Iressa|iressa
733957|NCT00497250|radiation therapy|radiation therapy
733958|NCT00497250|Chinese|chinese
733959|NCT00497250|NSCLC|nsclc
733960|NCT00497250|chemotherapy|chemotherapy
733961|NCT00497237|Asthma|asthma
733962|NCT00497237|Stepdown|stepdown
733963|NCT00497237|Beclomethasone|beclomethasone
733964|NCT00497237|Formoterol|formoterol
733965|NCT00497237|Corticosteroids|corticosteroids
733966|NCT00497224|Pancreatic Cancer|pancreatic cancer
733967|NCT00497224|Pancreatic Carcinoma|pancreatic carcinoma
733968|NCT00497224|Pancreas|pancreas
733969|NCT00497224|Adenocarcinoma|adenocarcinoma
733970|NCT00497224|Erlotinib|erlotinib
733971|NCT00497224|Tarceva|tarceva
733972|NCT00497224|OSI-774|osi-774
733973|NCT00497224|Phase II|phase ii
733974|NCT00497211|First large acute myocardial infarction|first large acute myocardial infarction
733975|NCT00497198|Type 2 Diabetes|type 2 diabetes
733976|NCT00497198|anion-exchange resin|anion-exchange resin
733977|NCT00497185|Mindfulness-Based Cognitive Therapy|mindfulness-based cognitive therapy
733978|NCT00497185|Somatization Disorder|somatization disorder
733979|NCT00497185|Medically Unexplained Symptoms|medically unexplained symptoms
733980|NCT00497185|Functional Somatic Symptoms|functional somatic symptoms
733981|NCT00497185|SF-36|sf-36
733982|NCT00497159|Trial of Dimebon to treat patients with mild-to-moderate Huntington's disease.|trial of dimebon to treat patients with mild-to-moderate huntington's disease.
733983|NCT00497146|paricalcitol|paricalcitol
733984|NCT00497146|Zemplar|zemplar
733985|NCT00497146|PRIMO|primo
733986|NCT00497146|Chronic Kidney Disease Stage 3B/4|chronic kidney disease stage 3b/4
733987|NCT00497133|glucoseintolerance|glucoseintolerance
733988|NCT00497120|sleep apnea|sleep apnea
733989|NCT00497120|snoring|snoring
733990|NCT00497120|acetazolamide|acetazolamide
733991|NCT00497120|uvulopalatopharyngoplasty|uvulopalatopharyngoplasty
733992|NCT00497120|daytime sleepiness|daytime sleepiness
733993|NCT00497120|upper airway|upper airway
733994|NCT00497107|UFT/LV|uft/lv
733995|NCT00497107|PSK|psk
733996|NCT00497107|Colorectal cancer|colorectal cancer
733997|NCT00497107|Adjuvant therapy|adjuvant therapy
733998|NCT00497094|carotid artery stenting|carotid artery stenting
733999|NCT00497094|atherosclerosis|atherosclerosis
734000|NCT00497094|cerebrovascular|cerebrovascular
734001|NCT00497094|stroke|stroke
734002|NCT00497081|Methamphetamine|methamphetamine
734003|NCT00497081|HIV|hiv
734004|NCT00497081|MSM|msm
734005|NCT00497081|HIV Seronegativity|hiv seronegativity
734006|NCT00497068|smoking|smoking
734008|NCT00497068|neonatal abstinence syndrome|neonatal abstinence syndrome
734009|NCT00497055|Methamphetamine|methamphetamine
734010|NCT00497055|HIV|hiv
734011|NCT00497055|MSM|msm
734012|NCT00497055|HIV Seronegativity|hiv seronegativity
734013|NCT00497029|dental caries|dental caries
734014|NCT00497029|early childhood caries|early childhood caries
734015|NCT00497029|caries prevention|caries prevention
734016|NCT00497029|infants|infants
734017|NCT00497016|hypertension|hypertension
734018|NCT00497016|statin|statin
734019|NCT00497016|sympathetic|sympathetic
734020|NCT00497003|Endothelial function|endothelial function
734021|NCT00497003|Beta blocker|beta blocker
734022|NCT00497003|Type 2 diabetes|type 2 diabetes
734023|NCT00497003|Chronic heart failure|chronic heart failure
734024|NCT00496990|male|male
734025|NCT00496990|female|female
734026|NCT00496990|couple|couple
734027|NCT00496990|cocaine|cocaine
734028|NCT00496990|opiate|opiate
734029|NCT00496990|methadone|methadone
734030|NCT00496990|detoxification|detoxification
734031|NCT00496990|pregnancy|pregnancy
734032|NCT00496977|lung cancer|lung cancer
734033|NCT00496977|CT scan|ct scan
734034|NCT00496977|screening|screening
734035|NCT00496964|Botulinum toxin type A|botulinum toxin type a
734036|NCT00496964|Patellofemoral pain syndrome|patellofemoral pain syndrome
734037|NCT00496964|Knee Injuries|knee injuries
734038|NCT00496964|Exercise Therapy|exercise therapy
734039|NCT00496951|Neonatal abstinence syndrome|neonatal abstinence syndrome
734040|NCT00496951|Methadone|methadone
734041|NCT00496951|Vagal tone|vagal tone
734042|NCT00496938|Stents|stents
734043|NCT00496938|Angioplasty|angioplasty
734044|NCT00496938|Total coronary occlusions|total coronary occlusions
734045|NCT00496938|Coronary restenosis|coronary restenosis
734046|NCT00496938|Stent thrombosis|stent thrombosis
734047|NCT00496938|Everolimus|everolimus
734048|NCT00496899|Labor|labor
734049|NCT00496899|Obstetric|obstetric
734050|NCT00496899|cervical dilatation|cervical dilatation
734051|NCT00496886|Pain|pain
734052|NCT00496886|Nociception|nociception
734053|NCT00496873|Non-Hodgkin's Lymphoma|non-hodgkin's lymphoma
734054|NCT00496873|NHL|nhl
734055|NCT00496873|Lymphoma|lymphoma
734056|NCT00496873|B-cell chronic lymphocytic leukemia|b-cell chronic lymphocytic leukemia
734057|NCT00496873|SLL|sll
734058|NCT00496873|Small Lymphocytic Lymphoma|small lymphocytic lymphoma
734059|NCT00496873|Lymphoplasmacytic lymphoma/immunocytoma|lymphoplasmacytic lymphoma/immunocytoma
734060|NCT00496873|Follicular lymphoma|follicular lymphoma
734061|NCT00496873|Extranodal marginal zone B-cell lymphoma of MALT type|extranodal marginal zone b-cell lymphoma of malt type
734062|NCT00496873|Nodal marginal zone B-cell lymphoma|nodal marginal zone b-cell lymphoma
734063|NCT00496873|Chronic Lymphocytic Leukemia|chronic lymphocytic leukemia
734064|NCT00496873|CLL|cll
734065|NCT00496873|Bulky Lymphoma|bulky lymphoma
734066|NCT00496873|Nipent|nipent
734067|NCT00496873|Cytoxan|cytoxan
734068|NCT00496873|Rituxan|rituxan
734069|NCT00496873|Cyclophosphamide|cyclophosphamide
734070|NCT00496873|Rituximab|rituximab
734071|NCT00496873|Pentostatin|pentostatin
734072|NCT00496860|cancer|cancer
734073|NCT00496860|p53|p53
734074|NCT00496860|immunotherapy|immunotherapy
734075|NCT00496860|targeted|targeted
734076|NCT00496860|metastatic|metastatic
734077|NCT00496860|malignancy|malignancy
734078|NCT00496860|malignancies|malignancies
734079|NCT00496860|interleukin-2|interleukin-2
734080|NCT00496860|IL-2|il-2
734081|NCT00496860|fusion protein|fusion protein
734082|NCT00496860|antitumor|antitumor
734083|NCT00496860|melanoma|melanoma
734084|NCT00496860|renal cancer|renal cancer
734085|NCT00496860|lung cancer|lung cancer
734086|NCT00496860|kidney cancer|kidney cancer
734087|NCT00496860|breast cancer|breast cancer
734088|NCT00496860|colorectal cancer|colorectal cancer
734089|NCT00496860|colon cancer|colon cancer
734090|NCT00496860|renal cell carcinoma|renal cell carcinoma
734091|NCT00496860|advanced cancer|advanced cancer
734092|NCT00496860|head and neck cancer|head and neck cancer
734093|NCT00496860|breast tumors|breast tumors
734094|NCT00496860|cancer of head and neck|cancer of head and neck
734095|NCT00496860|esophagus cancer|esophagus cancer
734096|NCT00496860|lymphoma|lymphoma
734097|NCT00496860|ovarian cancer|ovarian cancer
734098|NCT00496860|ovary cancer|ovary cancer
734099|NCT00496860|bladder cancer|bladder cancer
734100|NCT00496860|stomach cancer|stomach cancer
734101|NCT00496860|TCR|tcr
734102|NCT00496860|T-cell receptor|t-cell receptor
734103|NCT00496860|P53 gene|p53 gene
734104|NCT00496860|p53 tumor suppressor protein|p53 tumor suppressor protein
734105|NCT00496847|rhPDGF,|rhpdgf,
734106|NCT00496847|periodontal disease|periodontal disease
734107|NCT00496821|Respiratory Syncytial Virus|respiratory syncytial virus
734108|NCT00496808|Ductal Carcinoma In Situ|ductal carcinoma in situ
734109|NCT00496808|Breast Cancer|breast cancer
734110|NCT00496808|Herceptin|herceptin
734111|NCT00496808|Trastuzumab|trastuzumab
734112|NCT00496808|DCIS|dcis
734113|NCT00496795|Breast cancer, chemoresistance, predictive markers.|breast cancer, chemoresistance, predictive markers.
734114|NCT00496782|Treatment Experienced|treatment experienced
734115|NCT00496756|clear cell renal cell carcinoma|clear cell renal cell carcinoma
734116|NCT00496756|stage III renal cell cancer|stage iii renal cell cancer
734117|NCT00496756|stage IV renal cell cancer|stage iv renal cell cancer
734118|NCT00496756|recurrent renal cell cancer|recurrent renal cell cancer
734119|NCT00496730|Metabolic Disorder|metabolic disorder
734120|NCT00496717|Calcium scoring/aorta/ cardiovascular risk factor/scann|calcium scoring/aorta/ cardiovascular risk factor/scann
734121|NCT00496717|Patients with at least one cardiovascular risk factor|patients with at least one cardiovascular risk factor
734122|NCT00496704|adenocarcinoma of the colon|adenocarcinoma of the colon
734123|NCT00496704|recurrent colon cancer|recurrent colon cancer
734124|NCT00496704|stage III colon cancer|stage iii colon cancer
734125|NCT00496704|stage IV colon cancer|stage iv colon cancer
734126|NCT00496704|adenocarcinoma of the rectum|adenocarcinoma of the rectum
734127|NCT00496704|recurrent rectal cancer|recurrent rectal cancer
734128|NCT00496704|stage III rectal cancer|stage iii rectal cancer
734129|NCT00496704|stage IV rectal cancer|stage iv rectal cancer
734130|NCT00496691|HIV prevention|hiv prevention
734131|NCT00496691|HIV Seronegativity|hiv seronegativity
734132|NCT00496678|PNRP|pnrp
734133|NCT00496678|navigation|navigation
734134|NCT00496678|navigator|navigator
734135|NCT00496678|activation|activation
734136|NCT00496678|disparities|disparities
734137|NCT00496678|randomized control trial|randomized control trial
734138|NCT00496678|primary care|primary care
734139|NCT00496678|racial and ethnic minorities|racial and ethnic minorities
734140|NCT00496665|Stage IV breast cancer|stage iv breast cancer
734141|NCT00496665|metronomic chemotherapy|metronomic chemotherapy
734142|NCT00496652|Squamous Cell Carcinomas of the Head and Neck|squamous cell carcinomas of the head and neck
734339|NCT00495872|Sunitinib|sunitinib
734143|NCT00496652|Epidermal Growth Factor receptor|epidermal growth factor receptor
734144|NCT00496652|Antibody|antibody
734145|NCT00496652|Radiotherapy|radiotherapy
734146|NCT00496639|hemodialysis|hemodialysis
734147|NCT00496639|arterio-venous grafts|arterio-venous grafts
734148|NCT00496639|angioplasty|angioplasty
734149|NCT00496639|stents|stents
734150|NCT00496639|mechanical thrombectomy|mechanical thrombectomy
734151|NCT00496626|HPV infections|hpv infections
734152|NCT00496613|Breast cancer|breast cancer
734153|NCT00496613|survivor|survivor
734154|NCT00496587|Genitourinary|genitourinary
734155|NCT00496587|Kidney Cancer|kidney cancer
734156|NCT00496587|Sarcomatoid Renal Cell Carcinoma|sarcomatoid renal cell carcinoma
734157|NCT00496587|Renal Cell Carcinoma|renal cell carcinoma
734159|NCT00496587|Sarcomatoid Carcinoma of the Kidney|sarcomatoid carcinoma of the kidney
734160|NCT00496587|Unresectable renal cell carcinoma|unresectable renal cell carcinoma
734161|NCT00496587|Capecitabine|capecitabine
734162|NCT00496587|Xeloda|xeloda
734163|NCT00496587|Gemcitabine|gemcitabine
734164|NCT00496587|Gemzar|gemzar
734165|NCT00496587|Bevacizumab|bevacizumab
734166|NCT00496587|Anti-VEGF monoclonal antibody|anti-vegf monoclonal antibody
734167|NCT00496587|rhuMAb-VEGF|rhumab-vegf
734168|NCT00496587|Avastin|avastin
734169|NCT00496587|Vascular Endothelial Growth Factor|vascular endothelial growth factor
734170|NCT00496587|VEGF|vegf
734171|NCT00496574|asthma|asthma
734172|NCT00496574|immunotherapy|immunotherapy
734173|NCT00496574|efficacy|efficacy
734174|NCT00496574|children|children
734175|NCT00496574|symptoms score|symptoms score
734176|NCT00496574|quality of life|quality of life
734177|NCT00496574|spirometry|spirometry
734178|NCT00496574|PC20M|pc20m
734179|NCT00496561|asthma|asthma
734180|NCT00496561|immunotherapy|immunotherapy
734181|NCT00496561|children|children
734182|NCT00496561|regulatory T cells|regulatory t cells
734183|NCT00496561|ECP|ecp
734184|NCT00496561|PC20M|pc20m
734185|NCT00496561|Quality of Life|quality of life
734186|NCT00496561|Symptoms score|symptoms score
734187|NCT00496561|Spirometry|spirometry
734188|NCT00496548|Crohn's Disease|crohn's disease
734189|NCT00496535|head|head
734190|NCT00496535|neck|neck
734191|NCT00496535|cancer|cancer
734192|NCT00496535|neoplasm|neoplasm
734193|NCT00496522|Skull Base Chondrosarcoma|skull base chondrosarcoma
734194|NCT00496522|Proton Beam Therapy|proton beam therapy
734195|NCT00496522|Chondrosarcoma|chondrosarcoma
734196|NCT00496522|CNS|cns
734197|NCT00496509|ZD6474|zd6474
734198|NCT00496509|Colorectal Cancer|colorectal cancer
734199|NCT00496509|Liver Metastases|liver metastases
734200|NCT00496509|Biomarkers|biomarkers
734201|NCT00496483|Tacrolimus|tacrolimus
734202|NCT00496483|Pharmacokinetics|pharmacokinetics
734203|NCT00496483|Kidney Transplantation|kidney transplantation
734204|NCT00496470|Chronic Obstructive Pulmonary Disease, COPD|chronic obstructive pulmonary disease, copd
734205|NCT00496457|Diabetic Neuropathy|diabetic neuropathy
734206|NCT00496457|Painful Peripheral Diabetic Neuropathy|painful peripheral diabetic neuropathy
734207|NCT00496457|TRO19622|tro19622
734208|NCT00496457|Trophos|trophos
734209|NCT00496444|Advanced Cancers|advanced cancers
734210|NCT00496444|Azacytidine|azacytidine
734211|NCT00496444|5-Azacitidine|5-azacitidine
734212|NCT00496444|5-aza|5-aza
734214|NCT00496444|5-AZC|5-azc
734215|NCT00496444|AZA-CR|aza-cr
734216|NCT00496444|Ladakamycin|ladakamycin
734217|NCT00496444|NSC-102816|nsc-102816
734218|NCT00496444|Valproic Acid|valproic acid
734219|NCT00496444|Depakene|depakene
734220|NCT00496418|colostomy|colostomy
734221|NCT00496418|parastomal|parastomal
734222|NCT00496418|peristomal|peristomal
734223|NCT00496418|hernia|hernia
734224|NCT00496418|mesh|mesh
734225|NCT00496418|surgery|surgery
734226|NCT00496418|Indication for permanent end colostomy|indication for permanent end colostomy
734227|NCT00496405|Vascular endothelial growth factor.|vascular endothelial growth factor.
734228|NCT00496405|Retinal Thickness|retinal thickness
734229|NCT00496405|Diabetic Macular Edema|diabetic macular edema
734230|NCT00496405|Optical Coherent Tomography|optical coherent tomography
734231|NCT00496392|breakthrough pain in patients with cancer|breakthrough pain in patients with cancer
734232|NCT00496379|metastatic breast cancer|metastatic breast cancer
734233|NCT00496379|invasive breast cancer|invasive breast cancer
734234|NCT00496379|brain metastases|brain metastases
734235|NCT00496379|ZK-EPO|zk-epo
734236|NCT00496353|Neoplasm Malignant|neoplasm malignant
734237|NCT00496340|Pentostatin|pentostatin
734238|NCT00496340|Busulfan|busulfan
734239|NCT00496340|Rituxan|rituxan
734240|NCT00496340|Allogeneic Hematopoietic Stem Cell Transplantation|allogeneic hematopoietic stem cell transplantation
734241|NCT00496301|renal|renal
734242|NCT00496301|sorafenib|sorafenib
734243|NCT00496301|Unresectable and/or metastatic renal cell cancer|unresectable and/or metastatic renal cell cancer
734244|NCT00496288|BRCA mutation|brca mutation
734245|NCT00496288|Breast cancer|breast cancer
734246|NCT00496288|Prophylactic breast irradiation|prophylactic breast irradiation
734340|NCT00495872|Valproic Acid|valproic acid
734247|NCT00496288|Prevention of contralateral breast cancer|prevention of contralateral breast cancer
734248|NCT00496275|NSCLC|nsclc
734249|NCT00496275|ZACTIMA|zactima
734250|NCT00496262|Congenital fibrinogen deficiency|congenital fibrinogen deficiency
734251|NCT00496262|Fibrinogen concentrate|fibrinogen concentrate
734252|NCT00496262|Pharmacokinetics|pharmacokinetics
734253|NCT00496262|Thrombelastography|thrombelastography
734254|NCT00496249|Prostate|prostate
734255|NCT00496249|cancer|cancer
734256|NCT00496249|brachytherapy|brachytherapy
734257|NCT00496249|radiation|radiation
734258|NCT00496249|semen|semen
734259|NCT00496249|fertility|fertility
734260|NCT00496236|head|head
734261|NCT00496236|neck|neck
734262|NCT00496236|cancer|cancer
734263|NCT00496236|neoplasm|neoplasm
734264|NCT00496223|Sunitinib|sunitinib
734265|NCT00496223|Dacarbazine|dacarbazine
734266|NCT00496223|Melanoma|melanoma
734267|NCT00496210|Adaptation|adaptation
734268|NCT00496210|Pervasive Developmental Disorder|pervasive developmental disorder
734269|NCT00496210|Autism Spectrum Disorders|autism spectrum disorders
734270|NCT00496210|Pervasive Developmental Disorders|pervasive developmental disorders
734271|NCT00496210|Caregiver Adaptation|caregiver adaptation
734272|NCT00496197|candidemia|candidemia
734273|NCT00496197|invasive candidiasis|invasive candidiasis
734274|NCT00496197|fungal bloodstream infection|fungal bloodstream infection
734275|NCT00496184|Nifedipine treatment|nifedipine treatment
734276|NCT00496184|Vestibulitis|vestibulitis
734277|NCT00496184|Placebo|placebo
734278|NCT00496158|Nucleoside Treatment-Naïve Patients with HBeAg Negative Chronic Hepatitis due to Hepatitis B Virus|nucleoside treatment-naïve patients with hbeag negative chronic hepatitis due to hepatitis b virus
734279|NCT00496158|hepatitis b virus|hepatitis b virus
734280|NCT00496145|diabetes|diabetes
734281|NCT00496145|self management|self management
734282|NCT00496145|patient education|patient education
734283|NCT00496145|telephone reinforcement|telephone reinforcement
734284|NCT00496145|Spanish Diabetes|spanish diabetes
734285|NCT00496145|Tomando Control de su Diabetes|tomando control de su diabetes
734286|NCT00496132|CLL|cll
734287|NCT00496132|Leukemia|leukemia
734288|NCT00496132|Lymph|lymph
734289|NCT00496119|Proton Beam Therapy|proton beam therapy
734290|NCT00496119|Skull Base Chordoma|skull base chordoma
734291|NCT00496119|Chordoma of the Skull Base|chordoma of the skull base
734292|NCT00496119|Chordoma|chordoma
734293|NCT00496080|Menorrhagia associated with Uterine Fibroids|menorrhagia associated with uterine fibroids
734294|NCT00496067|Fibroids|fibroids
734295|NCT00496067|Menorrhagia|menorrhagia
734296|NCT00496067|Menorrhagia associated with uterine fibroids|menorrhagia associated with uterine fibroids
734297|NCT00496041|Stenosis (> 75%) or occlusion of the superficial femoral artery|stenosis (> 75%) or occlusion of the superficial femoral artery
734298|NCT00496028|Solid tumors|solid tumors
734299|NCT00496028|locally advanced or Metastatic Cancer suitable for treatment with carboplatin and/or paclitaxel|locally advanced or metastatic cancer suitable for treatment with carboplatin and/or paclitaxel
734300|NCT00496015|Streptococcus Pneumoniae Vaccines|streptococcus pneumoniae vaccines
734301|NCT00496015|Meningococcal disease|meningococcal disease
734302|NCT00496015|Carriage|carriage
734303|NCT00496015|Prophylactic antipyretic|prophylactic antipyretic
734304|NCT00496015|Safety|safety
734305|NCT00496015|Pneumococcal vaccine|pneumococcal vaccine
734306|NCT00496015|Fever|fever
734307|NCT00496015|Pneumococcal disease|pneumococcal disease
734308|NCT00496015|Immunogenicity|immunogenicity
734309|NCT00496015|Meningococcal vaccine|meningococcal vaccine
734310|NCT00496015|Booster vaccination|booster vaccination
734311|NCT00496002|Hepatitis B virus|hepatitis b virus
734312|NCT00496002|Nucleoside Treatment-Naïve Patients with HBeAg Positive|nucleoside treatment-naïve patients with hbeag positive
734313|NCT00495989|Handicapped individuals|handicapped individuals
734314|NCT00495976|common cold|common cold
734315|NCT00495976|flu|flu
734316|NCT00495976|influenza|influenza
734317|NCT00495963|Mechanical ventilation, Ventilator- associated pneumonia, Bronchoalveolar lavage, Pediatric intensive care unit, Flexible bronchoscopy, Critical care|mechanical ventilation, ventilator- associated pneumonia, bronchoalveolar lavage, pediatric intensive care unit, flexible bronchoscopy, critical care
734318|NCT00495950|Melanoma|melanoma
734319|NCT00495950|Lymphedema|lymphedema
734320|NCT00495950|Limb Swelling|limb swelling
734321|NCT00495950|Questionnaire|questionnaire
734322|NCT00495950|Quality of Life|quality of life
734323|NCT00495950|Physical Function|physical function
734324|NCT00495950|Survey|survey
734325|NCT00495885|Sleep problems|sleep problems
734326|NCT00495885|insomnia|insomnia
734327|NCT00495885|sleeplessness|sleeplessness
734328|NCT00495885|primary insomnia|primary insomnia
734329|NCT00495885|insomnia disorder|insomnia disorder
734330|NCT00495872|Solid Tumors|solid tumors
734331|NCT00495872|Advanced Cancer|advanced cancer
734332|NCT00495872|Dasatinib|dasatinib
734333|NCT00495872|Erlotinib|erlotinib
734334|NCT00495872|Lapatinib|lapatinib
734335|NCT00495872|Lenalidomide|lenalidomide
734336|NCT00495872|Sorafenib|sorafenib
734337|NCT00495872|Erlotinib Hydrochloride|erlotinib hydrochloride
734338|NCT00495872|Sunitinib Malate|sunitinib malate
734342|NCT00495859|Immunonutrition|immunonutrition
734343|NCT00495859|immune enhancing diets|immune enhancing diets
734344|NCT00495859|arginine|arginine
734345|NCT00495859|ω-3 fatty acids|ω-3 fatty acids
734346|NCT00495859|nucleotides|nucleotides
734347|NCT00495859|liver transplantation|liver transplantation
734348|NCT00495859|clinical trial|clinical trial
734349|NCT00495846|Hepatocellular carcinoma|hepatocellular carcinoma
734350|NCT00495846|Somatostatin analogues|somatostatin analogues
734351|NCT00495846|Somatostatin receptors|somatostatin receptors
734352|NCT00495846|Octreotide|octreotide
734353|NCT00495846|Lanreotide|lanreotide
734354|NCT00495846|IGF-I|igf-i
734355|NCT00495846|IGF-II|igf-ii
734356|NCT00495833|Hypertension|hypertension
734357|NCT00495820|Alzheimer's Disease|alzheimer's disease
734358|NCT00495820|Apathy|apathy
734359|NCT00495820|Dementia|dementia
734360|NCT00495820|Methylphenidate|methylphenidate
734361|NCT00495807|Psychological Tests|psychological tests
734362|NCT00495807|Pain, Postoperative|pain, postoperative
734363|NCT00495807|Nurses|nurses
734364|NCT00495794|diabetes|diabetes
734365|NCT00495794|hypertension|hypertension
734366|NCT00495794|adherence|adherence
734367|NCT00495794|implementation|implementation
734368|NCT00495794|medications|medications
734369|NCT00495794|organization of care|organization of care
734370|NCT00495781|functional iron deficiency|functional iron deficiency
734371|NCT00495781|renal anemia|renal anemia
734372|NCT00495781|dialysis|dialysis
734373|NCT00495781|erythropoietin|erythropoietin
734374|NCT00495781|darbepoetin|darbepoetin
734375|NCT00495768|Hepatitis C|hepatitis c
734377|NCT00495768|Depression|depression
734378|NCT00495768|Interferons|interferons
734379|NCT00495768|Ribavirin|ribavirin
734380|NCT00495755|Chronic Graft-vs-Host Disease|chronic graft-vs-host disease
734381|NCT00495729|SB-649868,|sb-649868,
734382|NCT00495729|Simvastatin|simvastatin
734383|NCT00495729|Repeated dose,|repeated dose,
734384|NCT00495703|Cancer survivors|cancer survivors
734385|NCT00495703|Chemotherapy|chemotherapy
734386|NCT00495703|Cognitive function|cognitive function
734387|NCT00495703|Exercise|exercise
734388|NCT00495703|Physical Activity|physical activity
734389|NCT00495690|Zinc recipients|zinc recipients
734390|NCT00495690|Placebo recipients|placebo recipients
734391|NCT00495677|Treatment Experienced|treatment experienced
734392|NCT00495677|Treatment Naive|treatment naive
734393|NCT00495664|titanium|titanium
734394|NCT00495664|paclitaxel|paclitaxel
734395|NCT00495664|stent|stent
734396|NCT00495664|myocardial infarction|myocardial infarction
734397|NCT00495664|angioplasty|angioplasty
734398|NCT00495664|PCI|pci
734399|NCT00495651|HIV|hiv
734400|NCT00495651|HAART|haart
734401|NCT00495651|Early Intervention|early intervention
734402|NCT00495651|Naive patients|naive patients
734403|NCT00495638|6-Minute Walk|6-minute walk
734404|NCT00495638|Chuvash Polycythemia|chuvash polycythemia
734405|NCT00495638|Echocardiogram|echocardiogram
734406|NCT00495638|Sickle Cell Anemia|sickle cell anemia
734407|NCT00495638|Pulmonary Function Tests|pulmonary function tests
734408|NCT00495638|Sickle Cell Disease|sickle cell disease
734409|NCT00495638|SCD|scd
734410|NCT00495638|Pulmonary Hypertension|pulmonary hypertension
734820|NCT00494195|AAV|aav
734411|NCT00495625|Hepatocellular cancer (HCC)|hepatocellular cancer (hcc)
734412|NCT00495625|Sunitinib malate|sunitinib malate
734413|NCT00495625|Vascular endothelial growth factor (VEGF)|vascular endothelial growth factor (vegf)
734414|NCT00495625|Platelet-derived growth factor (PDGF)|platelet-derived growth factor (pdgf)
734415|NCT00495625|Tyrosine kinases|tyrosine kinases
734416|NCT00495625|Liver|liver
734417|NCT00495612|Xolair|xolair
734418|NCT00495612|Allergic asthma|allergic asthma
734419|NCT00495612|Cat allergy|cat allergy
734420|NCT00495599|Obese|obese
734421|NCT00495599|Adipose Tissue|adipose tissue
734422|NCT00495599|Visfatin|visfatin
734423|NCT00495599|Gastric Bypass Surgery|gastric bypass surgery
734424|NCT00495586|COPD|copd
734425|NCT00495586|Antibiotics|antibiotics
734426|NCT00495560|induction|induction
734427|NCT00495560|abortion|abortion
734428|NCT00495560|injection, intra-amniotic|injection, intra-amniotic
734429|NCT00495560|misoprostol|misoprostol
734430|NCT00495547|Myelodysplastic Syndrome|myelodysplastic syndrome
734431|NCT00495547|Red Cell transfusion dependent|red cell transfusion dependent
734432|NCT00495521|Crohn's|crohn's
734433|NCT00495521|Crohn's Disease|crohn's disease
734434|NCT00495521|Acute Flare|acute flare
734435|NCT00495521|Mild to Moderate Crohn's Disease|mild to moderate crohn's disease
734436|NCT00495521|Children|children
734437|NCT00495521|Pediatrics|pediatrics
734438|NCT00495521|Ileo-cecal|ileo-cecal
734439|NCT00495521|Pediatric Crohn's Disease|pediatric crohn's disease
734440|NCT00495521|New Onset Crohn's Disease|new onset crohn's disease
734441|NCT00495521|Recently diagnosed Crohn's Disease|recently diagnosed crohn's disease
734442|NCT00495508|Quinine|quinine
734443|NCT00495508|Artemether|artemether
734444|NCT00495508|Lumefantrine|lumefantrine
734445|NCT00495508|malaria|malaria
734446|NCT00495508|Uganda|uganda
734447|NCT00495508|Artemisinin- based combination therapy|artemisinin- based combination therapy
734448|NCT00495508|pregnancy|pregnancy
734449|NCT00495508|Malaria In Pregnancy|malaria in pregnancy
734450|NCT00495482|Euthanasia|euthanasia
734451|NCT00495482|Assisted Suicide|assisted suicide
734452|NCT00495482|Assisted Dying|assisted dying
734453|NCT00495482|Palliative Care Medicine|palliative care medicine
734454|NCT00495469|Diabetes mellitus HbA1c|diabetes mellitus hba1c
734455|NCT00495456|cardiovascular|cardiovascular
734456|NCT00495456|risk|risk
734457|NCT00495456|longitudinal|longitudinal
734458|NCT00495456|prospective|prospective
734459|NCT00495430|Healthy|healthy
734460|NCT00495430|Lung sounds|lung sounds
734461|NCT00495430|Breath sounds|breath sounds
734462|NCT00495417|Alzheimer|alzheimer
734463|NCT00495417|Morbus Alzheimer|morbus alzheimer
734464|NCT00495417|Alzheimer Vaccine|alzheimer vaccine
734465|NCT00495417|Vaccine|vaccine
734466|NCT00495417|AD|ad
734467|NCT00495417|Aβ immunotherapy|aβ immunotherapy
734468|NCT00495404|chronic non-malignant pain|chronic non-malignant pain
734469|NCT00495404|opiates|opiates
734470|NCT00495404|prescriptions|prescriptions
734471|NCT00495404|addiction|addiction
734472|NCT00495391|Hepatitis C, Chronic|hepatitis c, chronic
734473|NCT00495378|PROCRIT|procrit
734474|NCT00495378|Epoetin alfa|epoetin alfa
734475|NCT00495378|chemotherapy related anemia|chemotherapy related anemia
734476|NCT00495365|Anemia|anemia
734477|NCT00495365|low blood count|low blood count
734478|NCT00495365|chronic kidney disease|chronic kidney disease
734479|NCT00495365|chronic kidney failure|chronic kidney failure
734480|NCT00495365|darbepoetin alfa|darbepoetin alfa
734481|NCT00495365|epoetin alfa|epoetin alfa
734482|NCT00495365|recombinant human erythropoietin|recombinant human erythropoietin
734483|NCT00495352|Schizophrenia|schizophrenia
734484|NCT00495352|NRT|nrt
734485|NCT00495352|Bupropion|bupropion
734486|NCT00495352|Stages of change|stages of change
734487|NCT00495326|drug interactions|drug interactions
734488|NCT00495326|Treatment Naive|treatment naive
734489|NCT00495313|Rosacea|rosacea
734490|NCT00495300|Data Collection|data collection
734491|NCT00495300|CIBMTR Samples|cibmtr samples
734492|NCT00495300|NMDP Repository|nmdp repository
734493|NCT00495300|Hematopoietic Stem Cells|hematopoietic stem cells
734494|NCT00495300|Bone Marrow Transplant Data Collection|bone marrow transplant data collection
734495|NCT00495300|Samples|samples
734496|NCT00495287|Acute myelogenous leukemia|acute myelogenous leukemia
734497|NCT00495287|Adult patients|adult patients
734498|NCT00495287|Cytogenetic risk class|cytogenetic risk class
734499|NCT00495287|Clinico-cytogenetic risk model|clinico-cytogenetic risk model
734500|NCT00495287|Risk-oriented therapy|risk-oriented therapy
734501|NCT00495274|Bioequivalent|bioequivalent
734502|NCT00495274|pharmacodynamic|pharmacodynamic
734503|NCT00495274|Reference formulation|reference formulation
734504|NCT00495274|5 new formulation|5 new formulation
734505|NCT00495274|Food effect|food effect
734506|NCT00495274|Pharmacokinetics|pharmacokinetics
734507|NCT00495261|Gambling|gambling
734508|NCT00495261|Mindfulness|mindfulness
734509|NCT00495261|Cognitive Behavioural Therapy|cognitive behavioural therapy
734510|NCT00495248|group intervention|group intervention
734511|NCT00495248|stroke|stroke
734512|NCT00495248|senior centres|senior centres
734513|NCT00495248|health promotion|health promotion
734514|NCT00495235|Endometrial Cancer|endometrial cancer
734515|NCT00495235|Polycystic Ovarian Syndrome|polycystic ovarian syndrome
734516|NCT00495235|Insulin Resistance|insulin resistance
734517|NCT00495235|Pre-diabetes|pre-diabetes
734518|NCT00495235|Harris County|harris county
734520|NCT00495235|Uterus|uterus
734521|NCT00495235|Questionnaire|questionnaire
734522|NCT00495235|Body mass index|body mass index
734523|NCT00495235|BMI|bmi
734524|NCT00495222|gastrojejunostomy|gastrojejunostomy
734525|NCT00495222|stoma|stoma
734526|NCT00495209|Complementary and Alternative Medicine|complementary and alternative medicine
734527|NCT00495209|Breast Cancer|breast cancer
734528|NCT00495209|Qigong|qigong
734529|NCT00495209|Medical Qigong|medical qigong
734530|NCT00495209|External Qi Therapy|external qi therapy
734531|NCT00495209|EQT|eqt
734532|NCT00495183|cocaine dependence|cocaine dependence
734533|NCT00495183|cocaine use|cocaine use
734534|NCT00495183|CNS stimulants|cns stimulants
734535|NCT00495183|caffeine|caffeine
734536|NCT00495183|biperiden|biperiden
734537|NCT00495183|placebo|placebo
734538|NCT00495170|Non-Small Cell Lung Cancer|non-small cell lung cancer
734539|NCT00495170|Lung Cancer|lung cancer
734540|NCT00495170|Proton Radiotherapy|proton radiotherapy
734541|NCT00495170|Proton Beam|proton beam
734542|NCT00495170|Paclitaxel|paclitaxel
734543|NCT00495170|Taxol|taxol
734544|NCT00495170|Carboplatin|carboplatin
734545|NCT00495170|Paraplatin|paraplatin
734546|NCT00495170|NSCLC|nsclc
734547|NCT00495144|Phase I|phase i
734548|NCT00495144|Advanced Solid Tumors|advanced solid tumors
734549|NCT00495144|Hypoxia|hypoxia
734550|NCT00495144|Prodrug|prodrug
734551|NCT00495144|Multi-Center|multi-center
734552|NCT00495144|Open-Label|open-label
734553|NCT00495144|Dose-Escalation|dose-escalation
734554|NCT00495131|Chronic hepatitis C|chronic hepatitis c
734555|NCT00495131|Genotype 1|genotype 1
734556|NCT00495131|Interferon|interferon
734557|NCT00495131|Ribavirin|ribavirin
734558|NCT00495118|schizophrenia|schizophrenia
734559|NCT00495118|schizoaffective disorder|schizoaffective disorder
734560|NCT00495118|risperidone|risperidone
734561|NCT00495118|intramuscular injection|intramuscular injection
734562|NCT00495118|long-acting injectable|long-acting injectable
734563|NCT00495092|cocaine dependence|cocaine dependence
734564|NCT00495092|cocaine use|cocaine use
734565|NCT00495092|cocaine craving|cocaine craving
734566|NCT00495079|acute|acute
734567|NCT00495079|lymphoblastic|lymphoblastic
734568|NCT00495079|lymphocytic|lymphocytic
734569|NCT00495079|leukemia|leukemia
734570|NCT00495079|leukaemia|leukaemia
734571|NCT00495079|lukemia|lukemia
734572|NCT00495079|leukimia|leukimia
734573|NCT00495079|ALL|all
734574|NCT00495079|Marqibo|marqibo
734575|NCT00495079|Hana Biosciences|hana biosciences
734576|NCT00495079|vincristine|vincristine
734577|NCT00495079|liposomal|liposomal
734578|NCT00495079|liposome|liposome
734579|NCT00495079|optisome|optisome
734580|NCT00495079|hematology|hematology
734581|NCT00495079|malignancy|malignancy
734582|NCT00495079|hematological|hematological
734583|NCT00495079|relapsed|relapsed
734584|NCT00495079|anti-leukemia|anti-leukemia
734585|NCT00495079|adult|adult
734586|NCT00495079|chemotherapy|chemotherapy
734587|NCT00495053|overactive bladder, urinary urgency|overactive bladder, urinary urgency
734588|NCT00495040|Non-Small Cell Lung Cancer|non-small cell lung cancer
734589|NCT00495040|Lung Cancer|lung cancer
734590|NCT00495040|Proton Radiotherapy|proton radiotherapy
734591|NCT00495040|Proton Beam|proton beam
734592|NCT00495040|NSCLC|nsclc
734593|NCT00495027|PTSD|ptsd
734594|NCT00495027|prevention|prevention
734595|NCT00495027|World Wide Web|world wide web
734596|NCT00495027|Behavior Therapy|behavior therapy
734597|NCT00495014|GSK376501,|gsk376501,
734598|NCT00495014|Single Dose,|single dose,
734599|NCT00495014|Dose Escalation,|dose escalation,
734600|NCT00495014|Healthy Overweight/Obese Volunteer|healthy overweight/obese volunteer
734601|NCT00494949|Anesthesia, spinal|anesthesia, spinal
734602|NCT00494949|Blood substitutes|blood substitutes
734603|NCT00494949|Oxygen therapeutics|oxygen therapeutics
734604|NCT00494949|Orthopedic surgery|orthopedic surgery
734605|NCT00494949|Plasma expanders|plasma expanders
734606|NCT00494949|Vasoconstriction|vasoconstriction
734607|NCT00494949|Hemospan|hemospan
734608|NCT00494936|HIV|hiv
734609|NCT00494936|HCV|hcv
734610|NCT00494936|Treatment Naive|treatment naive
734611|NCT00494936|Treatment Experienced|treatment experienced
734612|NCT00494936|HIV and HCV Coinfection|hiv and hcv coinfection
734613|NCT00494910|Palliative Care|palliative care
734614|NCT00494910|Terminally Ill|terminally ill
734615|NCT00494910|Group Therapy|group therapy
734616|NCT00494910|07-094|07-094
734617|NCT00494884|Type 2 diabetes|type 2 diabetes
734618|NCT00494884|vildagliptin|vildagliptin
734619|NCT00494884|metformin combination|metformin combination
734620|NCT00494871|BAY59-7939|bay59-7939
734621|NCT00494871|Rivaroxaban|rivaroxaban
734622|NCT00494871|Non-Valvular Atrial Fibrillation|non-valvular atrial fibrillation
734623|NCT00494871|Japanese Patients|japanese patients
734624|NCT00494871|Phase III|phase iii
734625|NCT00494871|12620|12620
734626|NCT00494858|Bulimia nervosa|bulimia nervosa
734627|NCT00494858|Cognitive Behavioral Therapy|cognitive behavioral therapy
734628|NCT00494858|Personality Disorders|personality disorders
734629|NCT00494845|Mindfulness|mindfulness
734630|NCT00494845|Elderly|elderly
734631|NCT00494845|Chronic Illness|chronic illness
734632|NCT00494845|Back Pain|back pain
734633|NCT00494845|Chronic Low Back Pain|chronic low back pain
734634|NCT00494845|Older adults over the age of sixty-five|older adults over the age of sixty-five
734635|NCT00494845|MMSE score of over 23|mmse score of over 23
734636|NCT00494845|Speaks English|speaks english
734637|NCT00494832|Dexmedetomidine|dexmedetomidine
734638|NCT00494832|Evoked potentials|evoked potentials
734639|NCT00494832|Spine surgery|spine surgery
734640|NCT00494819|ADHD, subtype, methylphenidate, neuropsychological measures|adhd, subtype, methylphenidate, neuropsychological measures
734641|NCT00494806|Postoperative Ileus (POI)|postoperative ileus (poi)
734642|NCT00494806|Rocking Chair|rocking chair
734643|NCT00494806|Abdominal Cancer|abdominal cancer
734644|NCT00494793|Open abdomen|open abdomen
734645|NCT00494793|Fascial closure|fascial closure
734646|NCT00494793|Vacuum assisted wound closure|vacuum assisted wound closure
734647|NCT00494793|Mesh|mesh
734648|NCT00494793|Abdominal compartment syndrome|abdominal compartment syndrome
734649|NCT00494793|Intraabdominal pressure|intraabdominal pressure
734650|NCT00494793|Incisional hernia|incisional hernia
734651|NCT00494780|CHOP (cyclophosphamide,doxorubicin,vincristine,prednisolone)|chop (cyclophosphamide,doxorubicin,vincristine,prednisolone)
734652|NCT00494780|ofatumumab|ofatumumab
734653|NCT00494767|body composition|body composition
734654|NCT00494767|obesity|obesity
734655|NCT00494767|4C model|4c model
734658|NCT00494754|autism spectrum disorder|autism spectrum disorder
734659|NCT00494754|family genetic study|family genetic study
734660|NCT00494754|gene|gene
734661|NCT00494754|phenotype|phenotype
734662|NCT00494754|endophenotype|endophenotype
734663|NCT00494728|Smoking|smoking
734664|NCT00494728|Depression|depression
734665|NCT00494728|Major Depressive Disorder|major depressive disorder
734666|NCT00494728|Cognitive Behavioral Analysis System of Psychotherapy|cognitive behavioral analysis system of psychotherapy
734667|NCT00494728|Smoking Cessation Treatment|smoking cessation treatment
734668|NCT00494728|Nicotine Replacement Therapy|nicotine replacement therapy
734669|NCT00494728|Nicotine Patch|nicotine patch
734670|NCT00494728|CBASP|cbasp
734671|NCT00494728|MDD|mdd
734672|NCT00494702|Asphyxia|asphyxia
734673|NCT00494702|Resuscitation|resuscitation
734674|NCT00494702|Oxidative stress|oxidative stress
734675|NCT00494702|Prematurity|prematurity
734676|NCT00494702|Follow up|follow up
734677|NCT00494689|transcranial sonolysis or monitoring|transcranial sonolysis or monitoring
734678|NCT00494689|rapid magnetic stimulation|rapid magnetic stimulation
734679|NCT00494689|cerebral ischemia|cerebral ischemia
734680|NCT00494689|hydrocephalus|hydrocephalus
734681|NCT00494689|Barthel's index|barthel's index
734682|NCT00494676|Hemianopia|hemianopia
734683|NCT00494676|Mobility|mobility
734684|NCT00494676|Rehabilitation|rehabilitation
734685|NCT00494676|Low vision|low vision
734686|NCT00494663|diabetes|diabetes
734687|NCT00494663|type 2 diabetes|type 2 diabetes
734688|NCT00494663|cholesterol|cholesterol
734689|NCT00494650|PTSD|ptsd
734690|NCT00494650|Schizophrenia|schizophrenia
734691|NCT00494650|Schizoaffective Disorder|schizoaffective disorder
734692|NCT00494650|Bipolar Disorder|bipolar disorder
734693|NCT00494650|Major Depression|major depression
734694|NCT00494624|Wheezing|wheezing
734695|NCT00494624|virus|virus
734696|NCT00494624|child|child
734697|NCT00494598|opioids, cerebral perfusion, arterial pharmacokinetics|opioids, cerebral perfusion, arterial pharmacokinetics
734698|NCT00494585|CEP-701|cep-701
734699|NCT00494585|Leukemia|leukemia
734700|NCT00494585|Myelofibrosis|myelofibrosis
734701|NCT00494585|MF|mf
734702|NCT00494585|JAK2|jak2
734703|NCT00494585|Tyrosine Kinase Inhibitor|tyrosine kinase inhibitor
734704|NCT00494585|Lestaurtinib|lestaurtinib
734705|NCT00494585|Chronic Idiopathic Myelofibrosis|chronic idiopathic myelofibrosis
734706|NCT00494585|CIMF|cimf
734707|NCT00494572|Montelukast|montelukast
734708|NCT00494572|Albuterol|albuterol
734709|NCT00494572|Status Asthmaticus|status asthmaticus
734710|NCT00494572|Asthma|asthma
734711|NCT00494559|Type 2 Diabetes|type 2 diabetes
734712|NCT00494559|Pioglitazone|pioglitazone
734713|NCT00494559|restenosis|restenosis
734714|NCT00494546|prostate|prostate
734715|NCT00494546|brachytherapy|brachytherapy
734716|NCT00494533|pulmonary arterial hypertension|pulmonary arterial hypertension
734717|NCT00494533|prostacyclin analogue|prostacyclin analogue
734718|NCT00494533|intravenous|intravenous
734720|NCT00494520|Aphasia|aphasia
734721|NCT00494520|Traumatic Brain Injury|traumatic brain injury
734821|NCT00494195|AAV1|aav1
734722|NCT00494520|Cerebrovascular Accident|cerebrovascular accident
734723|NCT00494507|periodic paralysis|periodic paralysis
734724|NCT00494507|dichlorphenamide|dichlorphenamide
734725|NCT00494494|cystoid macular edema|cystoid macular edema
734726|NCT00494494|cataract|cataract
734727|NCT00494494|nonsteroidal antiinflammatory drugs|nonsteroidal antiinflammatory drugs
734728|NCT00494494|optical coherence tomography|optical coherence tomography
734729|NCT00494481|Zactima|zactima
734730|NCT00494468|Insomnia|insomnia
734731|NCT00494468|Sleep Disorder|sleep disorder
734732|NCT00494468|Sleep Deprivation|sleep deprivation
734733|NCT00494455|critical illness|critical illness
734734|NCT00494455|hyperglycemia|hyperglycemia
734735|NCT00494455|intensive insulin therapy|intensive insulin therapy
734736|NCT00494455|glucose monitoring|glucose monitoring
734737|NCT00494455|shock|shock
734738|NCT00494442|Advanced ovarian cancer|advanced ovarian cancer
734739|NCT00494442|Poly(ADP ribose) polymerases|poly(adp ribose) polymerases
734740|NCT00494442|KU-0059436|ku-0059436
734741|NCT00494442|AZD2281|azd2281
734742|NCT00494442|BRCA1 protein|brca1 protein
734743|NCT00494442|BRCA2 protein|brca2 protein
734744|NCT00494429|Preterm Neonates|preterm neonates
734745|NCT00494429|Morphine|morphine
734746|NCT00494429|Critically ill|critically ill
734747|NCT00494403|sprain proprioception|sprain proprioception
734748|NCT00494390|Biometry|biometry
734749|NCT00494390|corneal opacity|corneal opacity
734750|NCT00494390|astigmatism|astigmatism
734751|NCT00494390|refraction|refraction
734752|NCT00494364|ear disease|ear disease
734753|NCT00494364|otitis|otitis
734754|NCT00494364|Eustachian tube|eustachian tube
734755|NCT00494364|mastoid air cells|mastoid air cells
734756|NCT00494364|Normal healthy volunteers|normal healthy volunteers
734757|NCT00494351|Hidradenitis Suppurativa|hidradenitis suppurativa
734758|NCT00494351|Nd:YAG laser|nd:yag laser
734861|NCT00493987|Testosterone|testosterone
734862|NCT00493987|Androgens|androgens
734759|NCT00494338|Metastatic Androgen Independent Prostate Cancer (MAIPC)|metastatic androgen independent prostate cancer (maipc)
734760|NCT00494325|age related maculopathy, macular pigment|age related maculopathy, macular pigment
734761|NCT00494312|Glucose Metabolism Disorder|glucose metabolism disorder
734762|NCT00494312|Dysmetabolic Syndrome|dysmetabolic syndrome
734763|NCT00494312|Type II Diabetes|type ii diabetes
734764|NCT00494312|Diabetes Mellitus|diabetes mellitus
734765|NCT00494312|Lipoatrophic|lipoatrophic
734766|NCT00494312|Dyslipidemia|dyslipidemia
734767|NCT00494312|Liver|liver
734768|NCT00494312|Drug Therapy|drug therapy
734769|NCT00494299|HCC|hcc
734770|NCT00494299|Cancer|cancer
734771|NCT00494299|Liver Cancer|liver cancer
734772|NCT00494299|TACE|tace
734773|NCT00494286|Abuse Focused Cognitive Behavioral Therapy|abuse focused cognitive behavioral therapy
734774|NCT00494286|Treatment Effectiveness Research|treatment effectiveness research
734775|NCT00494286|Treatment Dissemination|treatment dissemination
734776|NCT00494273|Haitian American Adolescents|haitian american adolescents
734777|NCT00494273|HIV Prevention|hiv prevention
734778|NCT00494273|Cognitive Behavioral Intervention|cognitive behavioral intervention
734779|NCT00494260|recurrent abdominal pain|recurrent abdominal pain
734780|NCT00494260|illness behavior|illness behavior
734781|NCT00494260|social learning|social learning
734782|NCT00494260|cognitive behavioral therapy|cognitive behavioral therapy
734783|NCT00494247|acute coronary syndromes|acute coronary syndromes
734784|NCT00494247|endothelial progenitor cells|endothelial progenitor cells
734785|NCT00494247|coronary stent|coronary stent
734786|NCT00494234|Advanced breast cancer|advanced breast cancer
734787|NCT00494234|Poly(ADP ribose) polymerases|poly(adp ribose) polymerases
734788|NCT00494234|AZD2281,KU-0059436 (olaparib)|azd2281,ku-0059436 (olaparib)
734789|NCT00494234|BRCA1 protein|brca1 protein
734790|NCT00494234|BRCA2 protein|brca2 protein
734791|NCT00494221|Colorectal cancer|colorectal cancer
734792|NCT00494221|Recentin|recentin
734793|NCT00494221|Metastatic Cancer|metastatic cancer
734794|NCT00494221|FOLFOX|folfox
734795|NCT00494208|androgens|androgens
734796|NCT00494208|testosterone|testosterone
734797|NCT00494208|testosterone deficiency|testosterone deficiency
734798|NCT00494208|women|women
734799|NCT00494208|menopause|menopause
734800|NCT00494208|surgical Menopause|surgical menopause
734801|NCT00494208|hysterectomy|hysterectomy
734802|NCT00494208|oophorectomy|oophorectomy
734803|NCT00494208|ovariectomy|ovariectomy
734804|NCT00494208|sexual dysfunction|sexual dysfunction
734805|NCT00494208|sexual function|sexual function
734806|NCT00494208|muscle function|muscle function
734807|NCT00494208|insulin sensitivity|insulin sensitivity
734808|NCT00494208|body composition|body composition
734809|NCT00494195|limb girdle muscular dystrophy type 2D|limb girdle muscular dystrophy type 2d
734810|NCT00494195|alpha-sarcoglycanopathy|alpha-sarcoglycanopathy
734811|NCT00494195|LGMD|lgmd
734812|NCT00494195|LGMD2D|lgmd2d
734813|NCT00494195|gene therapy|gene therapy
734814|NCT00494195|gene transfer|gene transfer
734815|NCT00494195|muscular dystrophy|muscular dystrophy
734816|NCT00494195|SGCA|sgca
734817|NCT00494195|sarcoglycan|sarcoglycan
734818|NCT00494195|limb girdle|limb girdle
734819|NCT00494195|adeno-associated virus|adeno-associated virus
734822|NCT00494169|Idiopathic Hypogonadotropic Hypogonadism|idiopathic hypogonadotropic hypogonadism
734823|NCT00494169|Kallmann Syndrome|kallmann syndrome
734824|NCT00494169|Puberty|puberty
734825|NCT00494169|Pituitary Abnormalities|pituitary abnormalities
734826|NCT00494169|Hypothalamus|hypothalamus
734827|NCT00494169|GnRH deficiency|gnrh deficiency
734828|NCT00494143|Amputee|amputee
734829|NCT00494143|Economy|economy
734830|NCT00494143|Efficiency|efficiency
734831|NCT00494143|Foot|foot
734832|NCT00494143|Gait|gait
734833|NCT00494143|Kinematics|kinematics
734834|NCT00494143|Kinetics|kinetics
734835|NCT00494143|Prosthesis|prosthesis
734836|NCT00494104|vitamin D deficiency|vitamin d deficiency
734837|NCT00494104|breastfed infant|breastfed infant
734838|NCT00494104|northern latitude|northern latitude
734839|NCT00494104|infant|infant
734840|NCT00494104|breastfed|breastfed
734841|NCT00494104|winter|winter
734842|NCT00494104|vitamin D status|vitamin d status
734843|NCT00494078|critical illness|critical illness
734844|NCT00494078|hyperglycemia|hyperglycemia
734845|NCT00494078|intensive insulin therapy|intensive insulin therapy
734846|NCT00494078|glucose monitoring|glucose monitoring
734847|NCT00494052|Coronary Heart Disease|coronary heart disease
734848|NCT00494052|Choice Behavior|choice behavior
734849|NCT00494052|Risk Factors|risk factors
734850|NCT00494052|Risk Assessment|risk assessment
734851|NCT00494052|Primary Prevention|primary prevention
734852|NCT00494052|Decision Making|decision making
734853|NCT00494052|Decision Aids|decision aids
734854|NCT00494052|Patient Compliance|patient compliance
734855|NCT00494039|prostate|prostate
734856|NCT00494039|cancer|cancer
734857|NCT00494039|radiation|radiation
734858|NCT00494039|brachytherapy|brachytherapy
734859|NCT00494013|diabetes|diabetes
734860|NCT00494013|type 2|type 2
734863|NCT00493987|Dihydrotestosterone|dihydrotestosterone
734864|NCT00493987|5-alpha reductase|5-alpha reductase
734865|NCT00493987|Body Composition|body composition
734866|NCT00493987|Muscle|muscle
734867|NCT00493987|Sexual function|sexual function
734868|NCT00493987|Men|men
734869|NCT00493987|Healthy Men|healthy men
734870|NCT00493974|Chronic Obstructive Pulmonary Disease|chronic obstructive pulmonary disease
734871|NCT00493974|COPD|copd
734872|NCT00493974|Exacerbation|exacerbation
734873|NCT00493974|Anti-leukotriene|anti-leukotriene
734874|NCT00493974|Length of Stay|length of stay
734875|NCT00493974|LOS|los
734876|NCT00493961|Kallmann Syndrome|kallmann syndrome
734877|NCT00493961|Idiopathic Hypogonadotropic Hypogonadism|idiopathic hypogonadotropic hypogonadism
734878|NCT00493961|GnRH deficiency|gnrh deficiency
734879|NCT00493935|bedtime snack|bedtime snack
734880|NCT00493935|hypoglycemia|hypoglycemia
734881|NCT00493935|Diabetes Mellitus, Type I|diabetes mellitus, type i
734882|NCT00493935|glucose monitoring|glucose monitoring
734883|NCT00493922|Malaria|malaria
734884|NCT00493922|Diagnosis|diagnosis
734885|NCT00493922|Rapid diagnostic tests|rapid diagnostic tests
734886|NCT00493922|Microscopy|microscopy
734887|NCT00493922|Clinical diagnosis|clinical diagnosis
734888|NCT00493922|Africa|africa
734889|NCT00493909|thoracotomy|thoracotomy
734890|NCT00493909|pain therapy|pain therapy
734891|NCT00493909|thoracic paravertebral blockade|thoracic paravertebral blockade
734892|NCT00493909|intrathecal opioids|intrathecal opioids
734893|NCT00493909|thoracic epidural analgesia|thoracic epidural analgesia
734894|NCT00493909|Analgesia after thoracotomy|analgesia after thoracotomy
734895|NCT00493896|Venous Thromboembolism Prophylaxis|venous thromboembolism prophylaxis
734896|NCT00493896|VTE prophylaxis|vte prophylaxis
734897|NCT00493883|Therasphere|therasphere
734898|NCT00493883|Yttrium|yttrium
734899|NCT00493883|liver|liver
734900|NCT00493883|cancer|cancer
734901|NCT00493883|radiation|radiation
734902|NCT00493857|Colorectal cancer|colorectal cancer
734903|NCT00493857|Monoclonal antibody|monoclonal antibody
734904|NCT00493857|Anti-EGFR|anti-egfr
734905|NCT00493844|Chest pain|chest pain
734906|NCT00493844|Unstable angina|unstable angina
734907|NCT00493844|NT-proBNP|nt-probnp
734908|NCT00493844|Exercise test.|exercise test.
734909|NCT00493831|smoking reduction|smoking reduction
734910|NCT00493831|inflammation|inflammation
734911|NCT00493831|harm reduction|harm reduction
734912|NCT00493831|lipid biomarkers|lipid biomarkers
734913|NCT00493818|GSK690693,|gsk690693,
734914|NCT00493818|Solid Tumors,|solid tumors,
734915|NCT00493818|Lymphoma,|lymphoma,
734916|NCT00493818|AKT|akt
734917|NCT00493805|homeostasis model assessment of insulin resistance|homeostasis model assessment of insulin resistance
734918|NCT00493766|LBH589|lbh589
734919|NCT00493766|Prostate Cancer|prostate cancer
734920|NCT00493766|HRPC|hrpc
734921|NCT00493766|Hormone Refractory Prostate Cancer|hormone refractory prostate cancer
734922|NCT00493740|Cephalic phase, oncology patients|cephalic phase, oncology patients
734923|NCT00493727|Oxidative stress|oxidative stress
734924|NCT00493727|N-acetylcysteine|n-acetylcysteine
734925|NCT00493727|NAC|nac
734926|NCT00493727|Isoprostane|isoprostane
734927|NCT00493727|Proteinuria|proteinuria
734928|NCT00493727|Diabetes|diabetes
734929|NCT00493727|Mucomyst|mucomyst
734930|NCT00493727|albuminuria|albuminuria
734931|NCT00493714|Advanced Cancer|advanced cancer
734932|NCT00493714|Delirium|delirium
734933|NCT00493714|Restlessness|restlessness
734934|NCT00493714|Confusion|confusion
734935|NCT00493714|Caregivers|caregivers
734936|NCT00493714|Questionnaire|questionnaire
734937|NCT00493688|Abdominal Cancer|abdominal cancer
734938|NCT00493688|Pelvic Cancer|pelvic cancer
734939|NCT00493688|Perioperative Energy Dynamics|perioperative energy dynamics
734940|NCT00493688|Cardiopulmonary Exercise Testing|cardiopulmonary exercise testing
734941|NCT00493688|CPET|cpet
734942|NCT00493675|Cystic duct leakage|cystic duct leakage
734943|NCT00493636|Breast Cancer|breast cancer
734944|NCT00493610|Oxidant stress|oxidant stress
734945|NCT00493610|N-acetylcysteine|n-acetylcysteine
734946|NCT00493610|Hepatitis C|hepatitis c
734947|NCT00493610|Liver disease|liver disease
734948|NCT00493610|Mucomyst|mucomyst
734949|NCT00493610|Isoprostane|isoprostane
734950|NCT00493597|Atherosclerosis|atherosclerosis
734951|NCT00493597|Restenosis|restenosis
734952|NCT00493597|EPC|epc
734953|NCT00493597|DC|dc
734954|NCT00493584|Myocardial Infarction|myocardial infarction
734955|NCT00493584|Myocardial Ischemia|myocardial ischemia
734956|NCT00493584|Myocardial Revascularization|myocardial revascularization
734957|NCT00493584|Telemedicine|telemedicine
734958|NCT00493584|Percutaneous Transluminal Coronary Angioplasty|percutaneous transluminal coronary angioplasty
734959|NCT00493571|Myelodysplastic Syndromes|myelodysplastic syndromes
734960|NCT00493571|MDS|mds
734961|NCT00493571|Gimatecan|gimatecan
734962|NCT00493571|Leukemia|leukemia
734963|NCT00493558|Roentgen Stereophotogrammetric Analysis|roentgen stereophotogrammetric analysis
734964|NCT00493558|Trabecular Metal Posterior Lumbar Interbody Cage|trabecular metal posterior lumbar interbody cage
734965|NCT00493558|Posterior Lumbar Interbody Fusion Cage|posterior lumbar interbody fusion cage
734966|NCT00493558|Posterior Lumbar spine fusion surgery|posterior lumbar spine fusion surgery
734967|NCT00493545|Multicenter|multicenter
734968|NCT00493545|Open-Label|open-label
734969|NCT00493545|Nonrandomized|nonrandomized
734970|NCT00493545|Safety|safety
734971|NCT00493519|Cephalic phase|cephalic phase
734972|NCT00493519|Anorexia nervosa|anorexia nervosa
734973|NCT00493519|Bulimia nervosa|bulimia nervosa
734974|NCT00493519|obese binge eaters|obese binge eaters
734975|NCT00493519|VAS|vas
734976|NCT00493519|EDI|edi
734977|NCT00493519|shame-feed procedure|shame-feed procedure
734978|NCT00493506|ProAlgaZyme|proalgazyme
734979|NCT00493506|HIV|hiv
734980|NCT00493506|HAART|haart
734981|NCT00493506|hsCRP|hscrp
734982|NCT00493506|Oxidative stress|oxidative stress
734983|NCT00493506|CD4+ lymphocytes|cd4+ lymphocytes
734984|NCT00493506|Algae|algae
734985|NCT00493506|HAART adverse effects|haart adverse effects
734986|NCT00493506|HBV|hbv
734987|NCT00493493|Cymetra|cymetra
734988|NCT00493467|Non-Hodgkin's Lymphoma|non-hodgkin's lymphoma
734989|NCT00493467|Lymphoma|lymphoma
734990|NCT00493467|Indolent Lymphomas|indolent lymphomas
734991|NCT00493467|Ibritumomab Tiuxetan|ibritumomab tiuxetan
734992|NCT00493467|Zevalin|zevalin
734993|NCT00493454|Indolent Lymphoma|indolent lymphoma
734994|NCT00493454|Extranodal Marginal|extranodal marginal
734995|NCT00493454|Nodal Marginal Zone|nodal marginal zone
734996|NCT00493454|Splenic Marginal|splenic marginal
734997|NCT00493454|MALT Type|malt type
734998|NCT00493454|Zevalin|zevalin
734999|NCT00493454|Ibritumomab Tiuxetan|ibritumomab tiuxetan
735000|NCT00493454|Rituximab|rituximab
735001|NCT00493428|Hepatocellular Carcinoma|hepatocellular carcinoma
735002|NCT00493428|GABAergic Activity|gabaergic activity
735003|NCT00493428|Baclofen|baclofen
735004|NCT00493415|microcirculation|microcirculation
735005|NCT00493415|sepsis|sepsis
735006|NCT00493415|nitroglycerine|nitroglycerine
735007|NCT00493415|SDF imaging|sdf imaging
735008|NCT00493402|Antineoplastic Agents|antineoplastic agents
735009|NCT00493402|administration & dosage|administration & dosage
735010|NCT00493402|Carcinoma, Hepatocellular|carcinoma, hepatocellular
735011|NCT00493402|Chemoembolization, Therapeutic|chemoembolization, therapeutic
735012|NCT00493402|Humans|humans
735013|NCT00493402|Liver Neoplasms|liver neoplasms
735014|NCT00493402|therapy|therapy
735015|NCT00493389|ACTH stimulation test|acth stimulation test
735016|NCT00493389|cortisol|cortisol
735017|NCT00493389|stress|stress
735018|NCT00493376|tirapazamine|tirapazamine
735019|NCT00493376|DNA damage|dna damage
735020|NCT00493376|comet assay|comet assay
735021|NCT00493363|falciparum malaria|falciparum malaria
735022|NCT00493363|artemisinins|artemisinins
735023|NCT00493363|artesunate|artesunate
735024|NCT00493363|resistance|resistance
735025|NCT00493350|Breast Cancer|breast cancer
735026|NCT00493350|Circulating Tumor Cells|circulating tumor cells
735027|NCT00493350|Gene Profiling|gene profiling
735028|NCT00493350|International Stage Stratification Study|international stage stratification study
735029|NCT00493350|Blood Sample|blood sample
735030|NCT00493350|ISSS|isss
735031|NCT00493337|Adherence|adherence
735032|NCT00493337|Compliance|compliance
735033|NCT00493337|Statins|statins
735034|NCT00493337|Intervention|intervention
735035|NCT00493337|Hypercholesterolemia|hypercholesterolemia
735036|NCT00493324|psoriasis|psoriasis
735037|NCT00493324|alefacept|alefacept
735038|NCT00493324|polyvalent pneumococcal vaccine|polyvalent pneumococcal vaccine
735039|NCT00493324|Immunization|immunization
735040|NCT00493298|disease progression|disease progression
735041|NCT00493298|Multiple Sclerosis|multiple sclerosis
735042|NCT00493298|disease activity|disease activity
735043|NCT00493298|Tysabri|tysabri
735044|NCT00493298|natalizumab|natalizumab
735045|NCT00493298|long-term safety|long-term safety
735046|NCT00493285|Lower Respiratory Tract Illness|lower respiratory tract illness
735047|NCT00493285|RSV and PIV3 infection|rsv and piv3 infection
735048|NCT00493272|Blood coagulation disorder, acquired|blood coagulation disorder, acquired
735049|NCT00493272|Hemodilution|hemodilution
735050|NCT00493272|Fibrinogen|fibrinogen
735051|NCT00493272|Hemostasis|hemostasis
735052|NCT00493272|HES|hes
735053|NCT00493259|Health-Related Quality of Life|health-related quality of life
735054|NCT00493233|schizophrenia|schizophrenia
735055|NCT00493233|antipsychotics|antipsychotics
735056|NCT00493233|polypharmacy|polypharmacy
735057|NCT00493233|double-blind|double-blind
735058|NCT00493233|randomized|randomized
735059|NCT00493220|ceftriaxone|ceftriaxone
735060|NCT00493220|cephalosporins|cephalosporins
735061|NCT00493220|pharmacokinetics|pharmacokinetics
735062|NCT00493220|subcutaneous|subcutaneous
735063|NCT00493220|hyaluronoglucosaminidase|hyaluronoglucosaminidase
735064|NCT00493220|hyaluronidase|hyaluronidase
735065|NCT00493220|hyaluronan|hyaluronan
735066|NCT00493220|rHuPH20|rhuph20
735067|NCT00493194|Cyclosporine toxicity|cyclosporine toxicity
735068|NCT00493194|Interstitial Fibrosis|interstitial fibrosis
735069|NCT00493194|Chronic allograft nephropathy|chronic allograft nephropathy
735070|NCT00493194|Sirolimus|sirolimus
735071|NCT00493181|oprelvekin|oprelvekin
735072|NCT00493181|tyrosine kinase inhibitor|tyrosine kinase inhibitor
735073|NCT00493181|Chronic Myelogenous Leukemia|chronic myelogenous leukemia
735074|NCT00493181|Leukemia|leukemia
735075|NCT00493181|CML|cml
735076|NCT00493181|Thrombocytopenia|thrombocytopenia
735077|NCT00493181|Imatinib|imatinib
735078|NCT00493181|IL-11|il-11
735079|NCT00493181|Interleukin 11|interleukin 11
735080|NCT00493181|Neumega|neumega
735081|NCT00493129|Systemic Mastocytosis|systemic mastocytosis
735082|NCT00493129|SM|sm
735083|NCT00493129|Mast Cell Leukemia|mast cell leukemia
735084|NCT00493129|Leukemia|leukemia
735085|NCT00493129|Denileukin Diftitox|denileukin diftitox
735086|NCT00493129|Ontak|ontak
735087|NCT00493116|recovery of efficacy|recovery of efficacy
735088|NCT00493116|MxA protein|mxa protein
735089|NCT00493116|neutralizing antibodies|neutralizing antibodies
735090|NCT00493116|Multiple sclerosis|multiple sclerosis
735091|NCT00493103|thyroglobulin gene|thyroglobulin gene
735092|NCT00493103|congenital hypothyroidism|congenital hypothyroidism
735093|NCT00493103|gene mutations|gene mutations
735094|NCT00493103|fetal goiter|fetal goiter
735095|NCT00493103|iodine nutrition|iodine nutrition
735096|NCT00493090|Professional|professional
735097|NCT00493090|patient partnership|patient partnership
735098|NCT00493090|patient satisfaction|patient satisfaction
735099|NCT00493090|professional training|professional training
735100|NCT00493077|Multiple Sclerosis|multiple sclerosis
735101|NCT00493077|Neutralizing antibodies|neutralizing antibodies
735102|NCT00493077|Safety|safety
735103|NCT00493077|Low immunogenicity|low immunogenicity
735104|NCT00493077|interferon|interferon
735105|NCT00493077|interferon-beta-1a|interferon-beta-1a
735106|NCT00493051|diabetes|diabetes
735107|NCT00493051|nonhealing|nonhealing
735108|NCT00493051|ulcers|ulcers
735109|NCT00493051|neuropathic|neuropathic
735110|NCT00493038|Treatment of acute bacterial rhinosinusitis|treatment of acute bacterial rhinosinusitis
735111|NCT00493025|adenocarcinoma of the esophagus|adenocarcinoma of the esophagus
735112|NCT00493025|stage II esophageal cancer|stage ii esophageal cancer
735113|NCT00493025|stage III esophageal cancer|stage iii esophageal cancer
735114|NCT00493025|stage IV esophageal cancer|stage iv esophageal cancer
735115|NCT00493012|body weight|body weight
735116|NCT00493012|body compostion|body compostion
735117|NCT00493012|vitamin D|vitamin d
735118|NCT00493012|blood pressure|blood pressure
735119|NCT00492999|recurrent colon cancer|recurrent colon cancer
735120|NCT00492999|stage IV colon cancer|stage iv colon cancer
735121|NCT00492999|recurrent rectal cancer|recurrent rectal cancer
735122|NCT00492999|stage IV rectal cancer|stage iv rectal cancer
735123|NCT00492999|adenocarcinoma of the colon|adenocarcinoma of the colon
735124|NCT00492999|adenocarcinoma of the rectum|adenocarcinoma of the rectum
735125|NCT00492999|liver metastases|liver metastases
735126|NCT00492986|Renal Cell Cancer (RCC)|renal cell cancer (rcc)
735127|NCT00492986|Cancer|cancer
735128|NCT00492973|arthroplasty|arthroplasty
735129|NCT00492973|replacement|replacement
735130|NCT00492973|knee|knee
735131|NCT00492960|larazotide acetate|larazotide acetate
735132|NCT00492947|Phase I|phase i
735133|NCT00492947|dendritic cell|dendritic cell
735134|NCT00492947|vaccine|vaccine
735135|NCT00492947|intra tumoral|intra tumoral
735136|NCT00492947|squamous cell carcinoma|squamous cell carcinoma
735137|NCT00492934|subfertility|subfertility
735138|NCT00492934|endometrium thickness|endometrium thickness
735139|NCT00492934|implantation rate|implantation rate
735140|NCT00492934|embryo cryopreservation|embryo cryopreservation
735141|NCT00492934|embryo transfer|embryo transfer
735142|NCT00492921|graft versus host disease|graft versus host disease
735143|NCT00492908|Coronary Revascularization|coronary revascularization
735144|NCT00492908|Titanium-Nitride-Oxide Coated Stent|titanium-nitride-oxide coated stent
735145|NCT00492908|Zotarolimus-Eluting Stent|zotarolimus-eluting stent
735146|NCT00492882|Polycystic Ovary Syndrome|polycystic ovary syndrome
735147|NCT00492882|Follicular Arrest|follicular arrest
735148|NCT00492882|Anti-Mullerian Hormone|anti-mullerian hormone
735149|NCT00492882|FSH|fsh
735150|NCT00492869|kidney transplantation|kidney transplantation
735151|NCT00492869|rejection|rejection
735152|NCT00492869|AEB071|aeb071
735153|NCT00492869|tacrolimus|tacrolimus
735154|NCT00492869|mycophenolic|mycophenolic
735155|NCT00492869|basiliximab|basiliximab
735156|NCT00492869|immunosuppression|immunosuppression
735157|NCT00492856|adult acute myeloid leukemia with t(15;17)(q22;q12)|adult acute myeloid leukemia with t(15;17)(q22;q12)
735158|NCT00492856|adult acute promyelocytic leukemia (M3)|adult acute promyelocytic leukemia (m3)
735159|NCT00492856|untreated adult acute myeloid leukemia|untreated adult acute myeloid leukemia
735160|NCT00492843|Ibandronate, Lung cancer, bone metastasis|ibandronate, lung cancer, bone metastasis
735161|NCT00492830|Phase 1|phase 1
735162|NCT00492830|TRC093|trc093
735163|NCT00492830|denatured collagen|denatured collagen
735164|NCT00492830|solid tumor|solid tumor
735165|NCT00492830|antibody|antibody
735166|NCT00492830|TRACON|tracon
735268|NCT00492492|quick-DASH,|quick-dash,
735167|NCT00492830|Locally advanced solid tumors|locally advanced solid tumors
735168|NCT00492830|Metastatic solid tumors|metastatic solid tumors
735169|NCT00492817|Spinal Neoplasms|spinal neoplasms
735170|NCT00492817|Paraspinal Metastases|paraspinal metastases
735171|NCT00492817|Stereotactic Body Radiotherapy|stereotactic body radiotherapy
735172|NCT00492817|CT-on-Rails|ct-on-rails
735173|NCT00492817|Spinal Cord|spinal cord
735174|NCT00492817|SBRT|sbrt
735175|NCT00492804|inguinal hernia|inguinal hernia
735176|NCT00492804|chronic pain|chronic pain
735177|NCT00492804|neurectomy|neurectomy
735178|NCT00492804|hypesthesia|hypesthesia
735179|NCT00492791|crohn's disease|crohn's disease
735180|NCT00492791|capsule endoscopes|capsule endoscopes
735181|NCT00492765|Combination therapy|combination therapy
735182|NCT00492765|Simvastatin|simvastatin
735183|NCT00492765|Multiple Sclerosis|multiple sclerosis
735184|NCT00492765|Interferon-beta-1a|interferon-beta-1a
735185|NCT00492739|Orthotopic liver transplantation|orthotopic liver transplantation
735186|NCT00492739|Pediatric|pediatric
735187|NCT00492739|Immunosuppression|immunosuppression
735188|NCT00492739|Varicella vaccine|varicella vaccine
735189|NCT00492739|B cell response|b cell response
735190|NCT00492739|T cell response|t cell response
735191|NCT00492739|Antibodies|antibodies
735192|NCT00492739|Varicella|varicella
735193|NCT00492739|Chickenpox|chickenpox
735194|NCT00492739|transplantation|transplantation
735195|NCT00492726|Complicated Intra-Abdominal Infections|complicated intra-abdominal infections
735196|NCT00492713|Bioavailability|bioavailability
735197|NCT00492713|Dark Chocolate|dark chocolate
735198|NCT00492713|Milk Chocolate|milk chocolate
735199|NCT00492713|Polyphenols|polyphenols
735200|NCT00492700|steatosis,|steatosis,
735201|NCT00492700|fibrosis,|fibrosis,
735202|NCT00492700|diabetes,|diabetes,
735203|NCT00492700|obesity|obesity
735204|NCT00492687|adult anaplastic astrocytoma|adult anaplastic astrocytoma
735205|NCT00492687|adult giant cell glioblastoma|adult giant cell glioblastoma
735206|NCT00492687|adult gliosarcoma|adult gliosarcoma
735207|NCT00492687|adult glioblastoma|adult glioblastoma
735208|NCT00492674|TKA|tka
735209|NCT00492674|Arthroplasty|arthroplasty
735210|NCT00492674|Knee|knee
735211|NCT00492674|Osteoarthritis|osteoarthritis
735212|NCT00492674|Rehabilitation|rehabilitation
735213|NCT00492661|Tacrolimus|tacrolimus
735214|NCT00492661|Prograf|prograf
735215|NCT00492661|PRIDE|pride
735216|NCT00492648|GSK Biologicals|gsk biologicals
735217|NCT00492648|Varicella Zoster Virus (VZV)|varicella zoster virus (vzv)
735218|NCT00492648|Intracellular cytokine staining (ICS)|intracellular cytokine staining (ics)
735219|NCT00492648|Vaccine|vaccine
735220|NCT00492648|Cell mediated immunity (CMI)|cell mediated immunity (cmi)
735221|NCT00492648|Herpes Zoster (HZ)|herpes zoster (hz)
735222|NCT00492648|Shingles|shingles
735223|NCT00492622|Gastroparesis|gastroparesis
735224|NCT00492622|Gastroesophageal reflux disease|gastroesophageal reflux disease
735225|NCT00492622|heartburn|heartburn
735226|NCT00492609|Surgery|surgery
735227|NCT00492609|Navigation|navigation
735228|NCT00492609|ACL|acl
735229|NCT00492609|IKDC|ikdc
735230|NCT00492609|comparative study|comparative study
735231|NCT00492583|probiotic|probiotic
735232|NCT00492583|health|health
735233|NCT00492583|bifidobacterium lactis|bifidobacterium lactis
735234|NCT00492583|BB-12|bb-12
735235|NCT00492570|Multiple Sclerosis|multiple sclerosis
735236|NCT00492570|Cognitive Dysfunction in Multiple sclerosis|cognitive dysfunction in multiple sclerosis
735237|NCT00492570|early treatment|early treatment
735238|NCT00492570|Avonex|avonex
735239|NCT00492570|interferon beta 1a|interferon beta 1a
735240|NCT00492570|Cognitive Dysfunction|cognitive dysfunction
735241|NCT00492557|Pneumococcal Disease|pneumococcal disease
735242|NCT00492557|Pneumococcal Conjugate Vaccine|pneumococcal conjugate vaccine
735243|NCT00492544|Human Papillomavirus (HPV) vaccine|human papillomavirus (hpv) vaccine
735244|NCT00492544|safety|safety
735245|NCT00492544|cervical cancer|cervical cancer
735246|NCT00492544|immunogenicity|immunogenicity
735247|NCT00492544|vaccine|vaccine
735248|NCT00492544|viral infections|viral infections
735249|NCT00492544|pre-adolescent and adolescent females|pre-adolescent and adolescent females
735250|NCT00492531|Interventional Study|interventional study
735251|NCT00492531|6-Minute Walk|6-minute walk
735252|NCT00492531|Sickle Cell Anemia|sickle cell anemia
735253|NCT00492531|Sildenafil/Viagra|sildenafil/viagra
735254|NCT00492531|Tricuspid Regurgitant Velocity|tricuspid regurgitant velocity
735255|NCT00492531|Sickle Cell Disease|sickle cell disease
735256|NCT00492531|Pulmonary Hypertension|pulmonary hypertension
735257|NCT00492518|Contrast Induced Nephropathy|contrast induced nephropathy
735258|NCT00492518|Prophylaxis|prophylaxis
735259|NCT00492518|Theophylline|theophylline
735260|NCT00492518|Acetylcysteine|acetylcysteine
735261|NCT00492518|Coronary angiography|coronary angiography
735262|NCT00492505|stage IIIA melanoma|stage iiia melanoma
735263|NCT00492505|stage IIIB melanoma|stage iiib melanoma
735264|NCT00492505|stage IIIC melanoma|stage iiic melanoma
735265|NCT00492492|radius,|radius,
735266|NCT00492492|pinning,|pinning,
735267|NCT00492492|fixed-angle plate,|fixed-angle plate,
735269|NCT00492492|HERZBERG-score.|herzberg-score.
735270|NCT00492466|Multiple Sclerosis|multiple sclerosis
735271|NCT00492466|antibody|antibody
735272|NCT00492466|Neutralizing antibody|neutralizing antibody
735273|NCT00492466|Binding antibody|binding antibody
735274|NCT00492466|MxA protein|mxa protein
735275|NCT00492440|recurrent renal cell cancer|recurrent renal cell cancer
735276|NCT00492440|stage IV renal cell cancer|stage iv renal cell cancer
735277|NCT00492440|stage III renal cell cancer|stage iii renal cell cancer
735278|NCT00492440|recurrent melanoma|recurrent melanoma
735279|NCT00492440|stage IV melanoma|stage iv melanoma
735280|NCT00492414|Panic disorder (PD)|panic disorder (pd)
735281|NCT00492388|breakthrough|breakthrough
735282|NCT00492388|pain|pain
735283|NCT00492388|cancer|cancer
735284|NCT00492362|hemodialysis|hemodialysis
735285|NCT00492362|exercise|exercise
735286|NCT00492362|physical fitness|physical fitness
735287|NCT00492362|dialysis adequacy|dialysis adequacy
735288|NCT00492349|Varenicline|varenicline
735289|NCT00492349|Neurobiology|neurobiology
735290|NCT00492349|clinical trial|clinical trial
735291|NCT00492349|cognitive deficits|cognitive deficits
735292|NCT00492349|Schizophreniform Disorder|schizophreniform disorder
735293|NCT00492336|Cognitive impairments|cognitive impairments
735294|NCT00492336|Negative symptoms|negative symptoms
735295|NCT00492323|pain following the healing of rashes and blisters|pain following the healing of rashes and blisters
735296|NCT00492323|herpes virus|herpes virus
735297|NCT00492323|rash|rash
735298|NCT00492323|varicella-zoster virus|varicella-zoster virus
735299|NCT00492323|shingles.|shingles.
735300|NCT00492310|Smoking|smoking
735301|NCT00492310|tobacco|tobacco
735302|NCT00492310|women|women
735303|NCT00492310|yoga|yoga
735304|NCT00492284|Macular Degeneration|macular degeneration
735305|NCT00492284|AMD|amd
735306|NCT00492284|CNV|cnv
735307|NCT00492284|Choroidal neovascularization|choroidal neovascularization
735308|NCT00492284|Photodynamic therapy|photodynamic therapy
735309|NCT00492284|CNV Secondary to Age Related Macular Degeneration|cnv secondary to age related macular degeneration
735310|NCT00492271|Friulimicin B|friulimicin b
735311|NCT00492271|Lipopeptide Antibiotic|lipopeptide antibiotic
735312|NCT00492271|First in Man|first in man
735313|NCT00492258|stage II renal cell cancer|stage ii renal cell cancer
735314|NCT00492258|stage III renal cell cancer|stage iii renal cell cancer
735315|NCT00492258|stage IV renal cell cancer|stage iv renal cell cancer
735316|NCT00492258|stage I renal cell cancer|stage i renal cell cancer
735317|NCT00492258|clear cell renal cell carcinoma|clear cell renal cell carcinoma
735318|NCT00492258|papillary renal cell carcinoma|papillary renal cell carcinoma
735319|NCT00492245|PTK|ptk
735320|NCT00492245|corneal opacity|corneal opacity
735321|NCT00492245|mitomycin|mitomycin
735322|NCT00492232|Chronic Insomnia|chronic insomnia
735323|NCT00492232|Sleep Initiation and Maintenance Disorder|sleep initiation and maintenance disorder
735324|NCT00492232|Drug Therapy|drug therapy
735325|NCT00492219|arthroplasty|arthroplasty
735326|NCT00492219|replacement|replacement
735327|NCT00492219|knee|knee
735328|NCT00492219|prosthesis|prosthesis
735329|NCT00492206|Non Small Cell Lung Cancer|non small cell lung cancer
735330|NCT00492206|NSCLC|nsclc
735331|NCT00492206|EGFR Inhibitor|egfr inhibitor
735332|NCT00492206|Radiation Therapy|radiation therapy
735333|NCT00492193|Hand assist laparoscopic partial large bowel resection|hand assist laparoscopic partial large bowel resection
735334|NCT00492193|Laparoscopic partial large bowel resection|laparoscopic partial large bowel resection
735335|NCT00492167|recurrent neuroblastoma|recurrent neuroblastoma
735336|NCT00492167|regional neuroblastoma|regional neuroblastoma
735337|NCT00492167|stage 4S neuroblastoma|stage 4s neuroblastoma
735338|NCT00492167|disseminated neuroblastoma|disseminated neuroblastoma
735339|NCT00492154|FRACTURE OF DISTAL RADIUS|fracture of distal radius
735340|NCT00492141|Ewing's Sarcoma|ewing's sarcoma
735341|NCT00492141|Lung Involvement|lung involvement
735342|NCT00492141|Temozolomide|temozolomide
735343|NCT00492141|Temodar|temodar
735344|NCT00492141|Aerosol Liposomal 9-Nitro-20(S)-Camptothecin|aerosol liposomal 9-nitro-20(s)-camptothecin
735345|NCT00492141|Aerosol L9-NC|aerosol l9-nc
735346|NCT00492141|L9-NC|l9-nc
735347|NCT00492128|hypertension|hypertension
735348|NCT00492128|angiotensin receptor blocker|angiotensin receptor blocker
735349|NCT00492128|diuretic|diuretic
735350|NCT00492128|combination therapy|combination therapy
735351|NCT00492115|sleep|sleep
735352|NCT00492115|dementia|dementia
735353|NCT00492115|apnea|apnea
735354|NCT00492115|memory|memory
735355|NCT00492115|Parkinson's disease|parkinson's disease
735356|NCT00492102|pharmacokinetics|pharmacokinetics
735357|NCT00492102|Montelukast|montelukast
735358|NCT00492102|bronchopulmonary dysplasia|bronchopulmonary dysplasia
735359|NCT00492102|Pharmacokinetics of Montelukast|pharmacokinetics of montelukast
735360|NCT00492076|Specific immunotherapy|specific immunotherapy
735361|NCT00492076|Mite|mite
735362|NCT00492076|Asthma|asthma
735363|NCT00492063|safety|safety
735364|NCT00492063|immunogenicity|immunogenicity
735365|NCT00492063|non-inferiority|non-inferiority
735366|NCT00492063|MDCK|mdck
735367|NCT00492063|cell culture-derived|cell culture-derived
735368|NCT00492063|subunit influenza vaccine|subunit influenza vaccine
735369|NCT00492063|influenza prevention|influenza prevention
735370|NCT00492050|Waldenstrom's Macroglobulinemia|waldenstrom's macroglobulinemia
735371|NCT00492050|Macroglobulinemic Lymphoma|macroglobulinemic lymphoma
735372|NCT00492050|Stem Cell Collection|stem cell collection
735373|NCT00492050|Bortezomib|bortezomib
735374|NCT00492050|LDP-341|ldp-341
735375|NCT00492050|MLN341|mln341
735376|NCT00492050|PS-341|ps-341
735377|NCT00492050|Velcade|velcade
735378|NCT00492050|Rituximab|rituximab
735379|NCT00492050|Rituxan|rituxan
735380|NCT00492037|hyponatremia|hyponatremia
735381|NCT00492037|hypervolemic|hypervolemic
735382|NCT00492037|euvolemic|euvolemic
735383|NCT00492037|conivaptan|conivaptan
735384|NCT00492024|Respiratory Tract Infection|respiratory tract infection
735385|NCT00492024|Bacterial Sinusitis|bacterial sinusitis
735386|NCT00492011|Circadian Rhythm Disorders|circadian rhythm disorders
735387|NCT00492011|Biological Clock Disturbances|biological clock disturbances
735388|NCT00492011|Jet Lag Syndrome|jet lag syndrome
735389|NCT00492011|Time Zone Change Syndrome|time zone change syndrome
735390|NCT00492011|Drug Therapy|drug therapy
735391|NCT00491985|Influenza A/H5N1 Virus|influenza a/h5n1 virus
735392|NCT00491985|Influenza Pandemic|influenza pandemic
735393|NCT00491985|Orthomyxoviridae Infections|orthomyxoviridae infections
735394|NCT00491959|oral mucosa|oral mucosa
735395|NCT00491959|limbal insufficiency|limbal insufficiency
735396|NCT00491959|transplantation|transplantation
735397|NCT00491959|cornea|cornea
735398|NCT00491959|ocular surface|ocular surface
735399|NCT00491946|Cancer|cancer
735400|NCT00491946|Actinomycin|actinomycin
735401|NCT00491946|Vincristine|vincristine
735402|NCT00491920|osteoporosis|osteoporosis
735403|NCT00491920|bone mineral density|bone mineral density
735404|NCT00491920|vitamin D|vitamin d
735405|NCT00491907|folic acid|folic acid
735406|NCT00491907|endothelial function|endothelial function
735407|NCT00491907|baroreceptor function|baroreceptor function
735408|NCT00491907|heart failure|heart failure
735409|NCT00491894|Mental Retardation|mental retardation
735410|NCT00491894|Neurological Impairment|neurological impairment
735411|NCT00491894|Cerebral Palsy|cerebral palsy
735412|NCT00491894|Drooling|drooling
735413|NCT00491894|Neurological Conditions|neurological conditions
735414|NCT00491881|blood pressure|blood pressure
735415|NCT00491881|No added salt diet|no added salt diet
735416|NCT00491881|urinary sodium|urinary sodium
735417|NCT00491855|Advanced Peritoneal Carcinomatosis|advanced peritoneal carcinomatosis
735418|NCT00491855|Peritoneal Cancer|peritoneal cancer
735419|NCT00491855|Bevacizumab|bevacizumab
735420|NCT00491855|Avastin|avastin
735421|NCT00491855|vascular endothelial growth factor|vascular endothelial growth factor
735422|NCT00491855|Anti-VEGF monoclonal antibody|anti-vegf monoclonal antibody
735423|NCT00491855|rhuMAb-VEGF|rhumab-vegf
735424|NCT00491855|Oxaliplatin|oxaliplatin
735425|NCT00491855|Eloxatin|eloxatin
735426|NCT00491855|Paclitaxel|paclitaxel
735427|NCT00491855|Taxol|taxol
735428|NCT00491842|Huntington's Disease|huntington's disease
735429|NCT00491842|Disclosure|disclosure
735430|NCT00491842|Adaptation|adaptation
735431|NCT00491842|Communication|communication
735432|NCT00491842|Huntington Disease|huntington disease
735433|NCT00491842|HD|hd
735434|NCT00491842|Phone Interview|phone interview
735435|NCT00491816|breast|breast
735436|NCT00491816|cancer|cancer
735437|NCT00491816|breast cancer|breast cancer
735438|NCT00491803|COPD|copd
735439|NCT00491790|montelukast|montelukast
735440|NCT00491790|Albuterol|albuterol
735441|NCT00491790|Status Asthmaticus|status asthmaticus
735442|NCT00491790|Asthma|asthma
735443|NCT00491777|Noninvasive|noninvasive
735444|NCT00491777|Hemodynamic|hemodynamic
735445|NCT00491777|Monitoring|monitoring
735446|NCT00491777|Critical Care|critical care
735447|NCT00491777|Swan-Ganz|swan-ganz
735448|NCT00491751|endothelium|endothelium
735449|NCT00491751|nitric oxide|nitric oxide
735450|NCT00491751|statins|statins
735451|NCT00491751|ascorbic acid|ascorbic acid
735452|NCT00491738|RCC|rcc
735453|NCT00491738|Renal cell cancer|renal cell cancer
735454|NCT00491738|Avastin|avastin
735455|NCT00491738|Sutent|sutent
735456|NCT00491712|Glaucoma|glaucoma
735457|NCT00491712|Neovascular Glaucoma|neovascular glaucoma
735458|NCT00491712|Drainage implant devices|drainage implant devices
735459|NCT00491712|Silicone Ahmed Tube|silicone ahmed tube
735460|NCT00491712|Triamcinolone|triamcinolone
735461|NCT00491699|NSCLC|nsclc
735462|NCT00491686|Long-term depression|long-term depression
735463|NCT00491673|Fracture|fracture
735464|NCT00491673|Femoral neck|femoral neck
735465|NCT00491673|Arthroplasty|arthroplasty
735466|NCT00491660|Gravity|gravity
735467|NCT00491660|Mechanical ventilation|mechanical ventilation
735468|NCT00491660|Infants|infants
735469|NCT00491660|Ventilator-associated pneumonia|ventilator-associated pneumonia
735470|NCT00491660|Types of bacterial colonies in subjects at 2-5 days of mechanical ventilation|types of bacterial colonies in subjects at 2-5 days of mechanical ventilation
735471|NCT00491660|Colony count of an organism was cultured|colony count of an organism was cultured
735472|NCT00491647|ADHD, time perception, treatments|adhd, time perception, treatments
735473|NCT00491634|acute myeloid leukemia|acute myeloid leukemia
735474|NCT00491634|myelodysplastic syndrome|myelodysplastic syndrome
735475|NCT00491634|allogeneic stem cell transplantation|allogeneic stem cell transplantation
735476|NCT00491634|reduced-intensity conditioning|reduced-intensity conditioning
735477|NCT00491634|treosulfan|treosulfan
735478|NCT00491621|kidney|kidney
735479|NCT00491621|tumor|tumor
735480|NCT00491621|Molecular Markers|molecular markers
735481|NCT00491621|Cytology|cytology
735482|NCT00491621|Histology|histology
735483|NCT00491621|Cystic kidney tumor|cystic kidney tumor
735484|NCT00491608|Phase 3b|phase 3b
735485|NCT00491608|rThrombin|rthrombin
735486|NCT00491608|spine surgery|spine surgery
735487|NCT00491608|vascular surgery|vascular surgery
735488|NCT00491608|hemostasis|hemostasis
735489|NCT00491608|immunogenicity|immunogenicity
735490|NCT00491608|safety|safety
735491|NCT00491595|Soy isoflavones|soy isoflavones
735492|NCT00491595|Genotoxicity|genotoxicity
735493|NCT00491595|Apoptosis|apoptosis
735494|NCT00491595|Estrogenic effects|estrogenic effects
735495|NCT00491569|Schizophrenia|schizophrenia
735496|NCT00491569|sarcosine|sarcosine
735497|NCT00491569|D-serine|d-serine
735498|NCT00491569|NMDA|nmda
735499|NCT00491556|Atazanavir/Ritonavir (ATV/r)|atazanavir/ritonavir (atv/r)
735500|NCT00491556|highly-active antiretroviral therapy (HAART)|highly-active antiretroviral therapy (haart)
735501|NCT00491556|Treatment Naive|treatment naive
735502|NCT00491491|non-Hodgkin's lymphoma|non-hodgkin's lymphoma
735503|NCT00491491|autologous stem cell transplantation|autologous stem cell transplantation
735504|NCT00491491|radioimmunotherapy|radioimmunotherapy
735505|NCT00491491|zevalin|zevalin
735506|NCT00491478|Repetitive behavior disorder|repetitive behavior disorder
735507|NCT00491478|Stereotypy|stereotypy
735508|NCT00491478|Sertraline|sertraline
735509|NCT00491465|Type 1 Diabetes, physical activity, pediatric, metabolic control|type 1 diabetes, physical activity, pediatric, metabolic control
735510|NCT00491452|Ischemic MR|ischemic mr
735511|NCT00491452|Annuloplasty|annuloplasty
735512|NCT00491439|in vivo confocal microscopy|in vivo confocal microscopy
735513|NCT00491439|vitrectomy|vitrectomy
735514|NCT00491439|corneal transplantation|corneal transplantation
735515|NCT00491439|Epi-LASIK|epi-lasik
735516|NCT00491439|wound healing|wound healing
735517|NCT00491426|Infection|infection
735518|NCT00491426|Anti-Infective Agents|anti-infective agents
735519|NCT00491426|Antifungal Agents|antifungal agents
735520|NCT00491426|Proteomics|proteomics
735521|NCT00491413|neurodevelopmental outcomes|neurodevelopmental outcomes
735522|NCT00491400|endothelium|endothelium
735523|NCT00491400|obesity|obesity
735524|NCT00491400|diabetes mellitus|diabetes mellitus
735525|NCT00491400|dyslipidemia|dyslipidemia
735526|NCT00491387|hypertension|hypertension
735527|NCT00491387|sympathetic nervous system|sympathetic nervous system
735528|NCT00491361|ADHD, SNAP-IV, SDQ, ASRS, reliability, validity|adhd, snap-iv, sdq, asrs, reliability, validity
735529|NCT00491348|Generalized anxiety disorder|generalized anxiety disorder
735530|NCT00491348|fMRI|fmri
735531|NCT00491348|Worry|worry
735532|NCT00491335|AIDS|aids
735533|NCT00491335|Lung Cancer|lung cancer
735534|NCT00491335|Emphysema|emphysema
735535|NCT00491335|Nicotine|nicotine
735536|NCT00491335|HIV Infection|hiv infection
735537|NCT00491335|Smoking|smoking
735538|NCT00491322|Vitamin D|vitamin d
735539|NCT00491322|Vitamin D deficiency|vitamin d deficiency
735540|NCT00491322|Insulin resistance|insulin resistance
735541|NCT00491322|Diabetes|diabetes
735542|NCT00491322|Diabetes mellitus|diabetes mellitus
735543|NCT00491322|FGF-23|fgf-23
735544|NCT00491322|FGF23|fgf23
735545|NCT00491322|Phosphate|phosphate
735546|NCT00491296|S/P Transuretral resection of bladder tumor|s/p transuretral resection of bladder tumor
735547|NCT00491296|Recurrent tumor after BCG Treatment|recurrent tumor after bcg treatment
735548|NCT00491270|Vaginosis, Bacterial|vaginosis, bacterial
735549|NCT00491270|Abortion, Spontaneous|abortion, spontaneous
735550|NCT00491270|Premature Birth|premature birth
735551|NCT00491257|Influenza|influenza
735552|NCT00491257|Orthomyxoviridae Infections|orthomyxoviridae infections
735553|NCT00491257|Orthomyxoviruses|orthomyxoviruses
735554|NCT00491257|Split-virion influenza vaccine|split-virion influenza vaccine
735555|NCT00491244|Chronic hepatitis C|chronic hepatitis c
735556|NCT00491244|Hemodialysis|hemodialysis
735557|NCT00491244|Interferon|interferon
735558|NCT00491244|Ribavirin|ribavirin
735559|NCT00491231|orthostatic hypotension|orthostatic hypotension
735560|NCT00491231|ambulatory blood pressure monitoring|ambulatory blood pressure monitoring
735561|NCT00491218|impact of cardiac computed tomography on outpatient angina evaluation|impact of cardiac computed tomography on outpatient angina evaluation
735562|NCT00491218|downstream resource utilization|downstream resource utilization
735563|NCT00491192|Fever|fever
735564|NCT00491192|Acute cerebral damage|acute cerebral damage
735565|NCT00491192|Normothermia|normothermia
735566|NCT00491192|Diclofenac|diclofenac
735567|NCT00491192|ICU|icu
735569|NCT00491192|Intracranial pressure|intracranial pressure
735570|NCT00491192|Cerebral perfusion pressure|cerebral perfusion pressure
735571|NCT00491192|Traumatic brain injury|traumatic brain injury
735572|NCT00491192|Subarachnoid hemorrhage|subarachnoid hemorrhage
735573|NCT00491179|Chronic hepatitis C|chronic hepatitis c
735574|NCT00491179|hemodialysis|hemodialysis
735575|NCT00491179|interferon|interferon
735576|NCT00491179|ribavirin|ribavirin
735577|NCT00491166|diabetic macular edema|diabetic macular edema
735578|NCT00491166|bromfenac ophthalmic solution|bromfenac ophthalmic solution
735579|NCT00491153|asthma|asthma
735580|NCT00491153|airway hyperresponsiveness|airway hyperresponsiveness
735581|NCT00491153|dry powder mannitol inhalation|dry powder mannitol inhalation
735582|NCT00491153|methacholine|methacholine
735583|NCT00491140|EGFR|egfr
735584|NCT00491140|KRAS|kras
735585|NCT00491140|BRAF|braf
735586|NCT00491140|MET|met
735587|NCT00491140|IGFR1|igfr1
735588|NCT00491101|Asthma Control|asthma control
735589|NCT00491101|Quality of Life|quality of life
735590|NCT00491101|Children|children
735591|NCT00491101|Polish Version of PAQLQ(S) by Juniper|polish version of paqlq(s) by juniper
735592|NCT00491075|Renal Cell Carcinoma|renal cell carcinoma
735593|NCT00491075|Non-Clear Cell|non-clear cell
735594|NCT00491075|Pemetrexed|pemetrexed
735595|NCT00491075|Gemcitabine|gemcitabine
735596|NCT00491075|LY231514|ly231514
735597|NCT00491075|Alimta|alimta
735598|NCT00491075|MTA|mta
735599|NCT00491075|Multitargeted Antifolate|multitargeted antifolate
735600|NCT00491075|NSC-698037|nsc-698037
735601|NCT00491075|Gemcitabine Hydrochloride|gemcitabine hydrochloride
735602|NCT00491075|Gemzar|gemzar
735603|NCT00491075|RCC|rcc
735604|NCT00491062|Parkinson's disease|parkinson's disease
735605|NCT00491062|enteric nervous system|enteric nervous system
735606|NCT00491049|prophylaxis|prophylaxis
735607|NCT00491049|intraocular surgery|intraocular surgery
735608|NCT00491049|endophthalmitis|endophthalmitis
735609|NCT00491049|antibiotic|antibiotic
735610|NCT00491036|Acute myocardial infarction|acute myocardial infarction
735611|NCT00491036|cardiogenic shock|cardiogenic shock
735612|NCT00491036|percutaneous coronary intervention|percutaneous coronary intervention
735613|NCT00491036|intraaortic balloon counterpulsation|intraaortic balloon counterpulsation
735614|NCT00491036|Acute myocardial infarction - cardiogenic shock|acute myocardial infarction - cardiogenic shock
735615|NCT00491010|atrial flutter|atrial flutter
735616|NCT00491010|ablation|ablation
735617|NCT00491010|voltage targeted|voltage targeted
735618|NCT00490997|ketamine|ketamine
735619|NCT00490997|propofol|propofol
735620|NCT00490997|sedation|sedation
735621|NCT00490997|pediatric|pediatric
735622|NCT00490997|emergency department|emergency department
735623|NCT00490997|fracture|fracture
735624|NCT00490984|obstructive sleep apena|obstructive sleep apena
735625|NCT00490984|tongue|tongue
735626|NCT00490984|surgery|surgery
735627|NCT00490971|Bipolar Disorder|bipolar disorder
735628|NCT00490971|Mania|mania
735629|NCT00490971|Depression|depression
735630|NCT00490971|Manic-Depressive Disorder|manic-depressive disorder
735631|NCT00490958|heart Failure|heart failure
735632|NCT00490958|haemodialysis|haemodialysis
735633|NCT00490958|telmisartan|telmisartan
735634|NCT00490958|angiotensin converting enzyme inhibitor|angiotensin converting enzyme inhibitor
735635|NCT00490932|Watery diarrhea|watery diarrhea
735636|NCT00490932|Bloody diarrhea|bloody diarrhea
735637|NCT00490919|Chronic pain|chronic pain
735638|NCT00490919|opioid|opioid
735639|NCT00490919|transdermal|transdermal
735640|NCT00490919|Moderate to severe chronic low back pain|moderate to severe chronic low back pain
735641|NCT00490906|MS (Multiple Sclerosis)|ms (multiple sclerosis)
735642|NCT00490893|counterregulation|counterregulation
735643|NCT00490893|hypoglycemia unawareness|hypoglycemia unawareness
735644|NCT00490893|insulin therapy|insulin therapy
735645|NCT00490828|Cardiac surgery|cardiac surgery
735646|NCT00490828|systemic inflammatory response syndrome|systemic inflammatory response syndrome
735647|NCT00490828|health-related quality of life|health-related quality of life
735648|NCT00490802|Autism|autism
735649|NCT00490802|Treatment|treatment
735650|NCT00490802|Oxytocin|oxytocin
735651|NCT00490802|Adults|adults
735652|NCT00490802|Autism Spectrum Disorder|autism spectrum disorder
735653|NCT00490789|tuberous sclerosis|tuberous sclerosis
735654|NCT00490789|lymphangioleiomyomatosis|lymphangioleiomyomatosis
735655|NCT00490789|sirolimus|sirolimus
735656|NCT00490789|angiomyolioma|angiomyolioma
735657|NCT00490789|rapamycin|rapamycin
735658|NCT00490789|mTOR|mtor
735659|NCT00490776|Cutaneous T-Cell Lymphoma|cutaneous t-cell lymphoma
735660|NCT00490776|adults|adults
735661|NCT00490776|Mycosis Fungoides|mycosis fungoides
735662|NCT00490776|Sézary Syndrome|sézary syndrome
735663|NCT00490776|CTCL|ctcl
735664|NCT00490763|Prostate Cancer|prostate cancer
735665|NCT00490763|Active Surveillance|active surveillance
735666|NCT00490763|Prostate Specific Antigen|prostate specific antigen
735667|NCT00490763|Questionnaire|questionnaire
735668|NCT00490763|Survey|survey
735669|NCT00490750|Heller Dor|heller dor
735670|NCT00490750|Heller Toupet|heller toupet
735674|NCT00490737|hemodialysis|hemodialysis
735675|NCT00490737|continuous ambulatory peritoneal dialysis|continuous ambulatory peritoneal dialysis
735676|NCT00490724|Heart failure, congestive|heart failure, congestive
735677|NCT00490724|Nesiritide and|nesiritide and
735678|NCT00490724|JNS004|jns004
735679|NCT00490698|Kidney Cancer|kidney cancer
735680|NCT00490698|Renal Cell Carcinoma|renal cell carcinoma
735681|NCT00490698|Bone-Targeted Therapy|bone-targeted therapy
735682|NCT00490698|Zoledronate|zoledronate
735683|NCT00490698|Zometa|zometa
735684|NCT00490698|Atorvastatin|atorvastatin
735685|NCT00490698|Lipitor|lipitor
735686|NCT00490698|RCC|rcc
735687|NCT00490672|Hypertension|hypertension
735688|NCT00490672|Diabetes Mellitus|diabetes mellitus
735689|NCT00490672|Hyperlipidaemia|hyperlipidaemia
735690|NCT00490672|Primary Care|primary care
735691|NCT00490672|Community Care|community care
735692|NCT00490672|Multiple Risk Factors Interventional Strategies|multiple risk factors interventional strategies
735693|NCT00490646|Locally advanced and/or metastatic breast cancer|locally advanced and/or metastatic breast cancer
735694|NCT00490633|Influenza|influenza
735695|NCT00490633|Non Pharmaceutical Intervention|non pharmaceutical intervention
735696|NCT00490633|Face Mask|face mask
735697|NCT00490633|Hand Hygiene|hand hygiene
735698|NCT00490620|primary biliary cirrhosis C06.552.630.400|primary biliary cirrhosis c06.552.630.400
735699|NCT00490620|retroviral infection C02.782.815|retroviral infection c02.782.815
735700|NCT00490607|Hemagiomas of infancy|hemagiomas of infancy
735701|NCT00490594|ACL|acl
735702|NCT00490594|ligament|ligament
735703|NCT00490594|ACL injury|acl injury
735704|NCT00490581|Early housing after hospitalization|early housing after hospitalization
735705|NCT00490568|cognition|cognition
735706|NCT00490568|Alzheimer's disease|alzheimer's disease
735707|NCT00490568|Rosiglitazone extended-release (XR)|rosiglitazone extended-release (xr)
735708|NCT00490568|safety|safety
735709|NCT00490568|adjunctive therapy|adjunctive therapy
735710|NCT00490568|BRL-049653|brl-049653
735711|NCT00490568|tolerability|tolerability
735712|NCT00490568|open-label extension|open-label extension
735713|NCT00490555|Male Contraception|male contraception
735714|NCT00490555|Testosterone|testosterone
735715|NCT00490555|Testis|testis
735716|NCT00490555|Contraception|contraception
735717|NCT00490555|Prostate|prostate
735718|NCT00490542|Bipolar Disorder|bipolar disorder
735719|NCT00490542|Major Depression|major depression
735720|NCT00490542|Clinical pharmacology|clinical pharmacology
735721|NCT00490542|Clinical Trial|clinical trial
735722|NCT00490516|Schizophrenia, psychotic disorders|schizophrenia, psychotic disorders
735723|NCT00490503|Breast Cancer|breast cancer
735724|NCT00490503|Magnetic Resonance Imaging|magnetic resonance imaging
735725|NCT00490503|Magnetic Resonance Spectroscopy|magnetic resonance spectroscopy
735726|NCT00490503|DCE-MRI|dce-mri
735727|NCT00490503|DW-MRI|dw-mri
735728|NCT00490503|MRS|mrs
735729|NCT00490503|MRI|mri
735730|NCT00490477|acute renal failure|acute renal failure
735731|NCT00490477|lipopolysaccharide|lipopolysaccharide
735732|NCT00490477|tubular apoptosis|tubular apoptosis
735733|NCT00490477|Polymyxin-B fiber|polymyxin-b fiber
735734|NCT00490477|Severe sepsis from gram negative infection|severe sepsis from gram negative infection
735735|NCT00490464|Patients with SAH or ICH|patients with sah or ich
735736|NCT00490438|perineometry|perineometry
735737|NCT00490438|Modified Oxford Score|modified oxford score
735738|NCT00490438|pelvic muscles evaluation|pelvic muscles evaluation
735739|NCT00490438|urinary incontinence|urinary incontinence
735740|NCT00490438|vaginal palpation|vaginal palpation
735741|NCT00490425|probiotics|probiotics
735742|NCT00490425|LGG|lgg
735743|NCT00490425|praevention|praevention
735744|NCT00490425|allergic asthma|allergic asthma
735745|NCT00490425|children|children
735746|NCT00490412|Vitamin D|vitamin d
735747|NCT00490412|Treatment Experienced|treatment experienced
735748|NCT00490386|Retrospective|retrospective
735749|NCT00490386|Length of Stay|length of stay
735750|NCT00490386|Helicobacter pylori|helicobacter pylori
735751|NCT00490347|VentrAssistTM|ventrassisttm
735752|NCT00490347|LVAD|lvad
735753|NCT00490347|End-stage heart failure|end-stage heart failure
735754|NCT00490347|Cardiomyopathy|cardiomyopathy
735755|NCT00490334|Carcinomas|carcinomas
735756|NCT00490334|Squamous Cel|squamous cel
735757|NCT00490334|Adenocarcinoma|adenocarcinoma
735758|NCT00490334|Acute Lymphocytic Leukemia|acute lymphocytic leukemia
735759|NCT00490321|VentrAssistTM|ventrassisttm
735760|NCT00490321|LVAD|lvad
735761|NCT00490321|End-stage heart failure|end-stage heart failure
735762|NCT00490321|Cardiomyopathy|cardiomyopathy
735763|NCT00490308|luteal|luteal
735764|NCT00490308|phase|phase
735765|NCT00490308|estradiol|estradiol
735766|NCT00490308|pregnancy|pregnancy
735767|NCT00490308|rate|rate
735768|NCT00490295|biomarkers|biomarkers
735769|NCT00490295|brain ischemia|brain ischemia
735770|NCT00490295|neonates|neonates
735771|NCT00490295|cardiac surgery|cardiac surgery
735772|NCT00490295|congenital heart disease|congenital heart disease
735773|NCT00490282|Head and Neck Cancer|head and neck cancer
736367|NCT00488137|SCBM|scbm
735774|NCT00490282|Oropharyngeal Cancer|oropharyngeal cancer
735775|NCT00490282|Adaptive Radiotherapy|adaptive radiotherapy
735776|NCT00490282|Intensity Modulated Radiation Therapy|intensity modulated radiation therapy
735777|NCT00490282|IMRT|imrt
735778|NCT00490282|ART|art
735779|NCT00490269|Marijuana dependence|marijuana dependence
735780|NCT00490256|Selective Cerebral Perfusion|selective cerebral perfusion
735781|NCT00490256|Renal Complications|renal complications
735782|NCT00490256|Gastrointestinal Complications|gastrointestinal complications
735783|NCT00490256|Aortic Arch Reconstruction|aortic arch reconstruction
735784|NCT00490256|Modified Perfusion|modified perfusion
735785|NCT00490256|Cardiopulmonary Bypass|cardiopulmonary bypass
735786|NCT00490256|Pediatrics|pediatrics
735787|NCT00490256|Cardiac Defects|cardiac defects
735788|NCT00490256|intestinal ischemia|intestinal ischemia
735789|NCT00490256|necrotizing entercolitis|necrotizing entercolitis
735790|NCT00490256|Near Infra-red spectroscopy|near infra-red spectroscopy
735791|NCT00490256|Creatinine|creatinine
735792|NCT00490256|C-reactive protein levels|c-reactive protein levels
735793|NCT00490243|Asthma|asthma
735794|NCT00490243|Children|children
735795|NCT00490243|Exercise|exercise
735796|NCT00490243|Pulmonary Function|pulmonary function
735797|NCT00490243|Budesonide|budesonide
735798|NCT00490243|Montelukast|montelukast
735799|NCT00490243|Formoterol|formoterol
735800|NCT00490230|Paromomycin|paromomycin
735801|NCT00490230|Gentamicin|gentamicin
735802|NCT00490217|Spontaneous bacterial peritonitis|spontaneous bacterial peritonitis
735803|NCT00490217|incidence|incidence
735804|NCT00490217|Finland|finland
735805|NCT00490217|etiology|etiology
735806|NCT00490217|liver cirrhosis|liver cirrhosis
735807|NCT00490204|Perennial Allergic Rhinitis|perennial allergic rhinitis
735808|NCT00490204|Placebo control|placebo control
735809|NCT00490204|anti-histamine|anti-histamine
735810|NCT00490204|Cetirizine|cetirizine
735811|NCT00490178|Type II diabetes|type ii diabetes
735812|NCT00490178|dyslipidemia|dyslipidemia
735813|NCT00490178|metformin|metformin
735814|NCT00490178|fenofibrate|fenofibrate
735815|NCT00490178|synordia|synordia
735816|NCT00490152|HIV|hiv
735817|NCT00490152|Microbicide Gel|microbicide gel
735818|NCT00490152|HIV Seronegativity|hiv seronegativity
735819|NCT00490139|Adjuvant|adjuvant
735820|NCT00490139|ErbB2-overexpressing|erbb2-overexpressing
735821|NCT00490139|Early stage breast cancer|early stage breast cancer
735822|NCT00490139|HER2/neu gene amplified|her2/neu gene amplified
735823|NCT00490126|Laparoscopic Surgery|laparoscopic surgery
735824|NCT00490126|Laparoscopy|laparoscopy
735825|NCT00490126|Gynecology|gynecology
735826|NCT00490126|Demographics|demographics
735827|NCT00490126|Perioperative Care|perioperative care
735828|NCT00490100|X-Linked Severe Combined Immune Deficiency (XSCID)|x-linked severe combined immune deficiency (xscid)
735829|NCT00490100|Growth Hormone|growth hormone
735830|NCT00490100|Insulin-Like Growth Factor 1 (IGF)-1|insulin-like growth factor 1 (igf)-1
735831|NCT00490100|Bone Age|bone age
735832|NCT00490100|Growth Failure|growth failure
735833|NCT00490100|XSCID|xscid
736027|NCT00489450|safety|safety
735834|NCT00490100|X-Linked Severe Combined Immunodeficiency|x-linked severe combined immunodeficiency
735835|NCT00490087|Atypical endometrial polyps|atypical endometrial polyps
735836|NCT00490087|Atypical Endometrial Hyperplasia|atypical endometrial hyperplasia
735837|NCT00490087|Hysteroscopic resection|hysteroscopic resection
735838|NCT00490087|Conservative treatment|conservative treatment
735839|NCT00490087|Fertile women|fertile women
735840|NCT00490074|AIDS Vaccines|aids vaccines
735841|NCT00490074|Vaccines, DNA|vaccines, dna
735842|NCT00490074|HIV Preventive Vaccine|hiv preventive vaccine
735843|NCT00490074|HIV Seronegativity|hiv seronegativity
735844|NCT00490048|Ulcerative colits|ulcerative colits
735845|NCT00490048|lung|lung
735846|NCT00490048|Induced sputum|induced sputum
735847|NCT00490048|Our aim to evaluate lung involvement in Ulcerative colitis patients by induced sputum|our aim to evaluate lung involvement in ulcerative colitis patients by induced sputum
735848|NCT00490035|Epilepsy|epilepsy
735849|NCT00490035|Brivaracetam|brivaracetam
735850|NCT00490035|Partial Onset Seizures|partial onset seizures
735851|NCT00490022|Dihydrotestosterone|dihydrotestosterone
735852|NCT00490022|Androgen|androgen
735853|NCT00490022|Prostate|prostate
735854|NCT00489970|Persistence|persistence
735855|NCT00489970|immunogenicity|immunogenicity
735856|NCT00489957|congenital cardiac disorders|congenital cardiac disorders
735857|NCT00489957|echocardiography|echocardiography
735858|NCT00489944|ciliary body and choroid melanoma, medium/large size|ciliary body and choroid melanoma, medium/large size
735859|NCT00489944|extraocular extension melanoma|extraocular extension melanoma
735860|NCT00489944|iris melanoma|iris melanoma
735861|NCT00489944|epithelioid cell intraocular melanoma|epithelioid cell intraocular melanoma
735862|NCT00489944|stage IIB intraocular melanoma|stage iib intraocular melanoma
735863|NCT00489944|stage IIIA intraocular melanoma|stage iiia intraocular melanoma
735864|NCT00489944|stage IIIB intraocular melanoma|stage iiib intraocular melanoma
735865|NCT00489944|stage IIIC intraocular melanoma|stage iiic intraocular melanoma
735866|NCT00489944|stage IV intraocular melanoma|stage iv intraocular melanoma
735867|NCT00489931|Avian Influenza|avian influenza
735869|NCT00489931|Immunity|immunity
735870|NCT00489931|Preventive|preventive
735871|NCT00489931|Bird Flu|bird flu
735872|NCT00489931|Healthy Volunteer|healthy volunteer
735874|NCT00489905|prostate cancer|prostate cancer
735875|NCT00489905|bone mineral density|bone mineral density
735876|NCT00489892|traumatic brain injury|traumatic brain injury
735877|NCT00489892|TBI|tbi
735878|NCT00489892|working memory|working memory
735879|NCT00489892|modafinil|modafinil
735880|NCT00489892|fMRI|fmri
735881|NCT00489892|MRI|mri
735882|NCT00489879|Mobile Health Units|mobile health units
735883|NCT00489879|Chronic Disease|chronic disease
735884|NCT00489866|PTSD|ptsd
735885|NCT00489866|Antidepressant|antidepressant
735886|NCT00489866|Aripiprazole|aripiprazole
735887|NCT00489866|OEF|oef
735888|NCT00489866|OIF|oif
735889|NCT00489853|COPD|copd
735890|NCT00489840|Chronic Central Serous Chorioretinopathy|chronic central serous chorioretinopathy
735891|NCT00489827|Coronary Artery Bypass|coronary artery bypass
735892|NCT00489827|Myocardial Protection|myocardial protection
735893|NCT00489827|Angina, Unstable|angina, unstable
735894|NCT00489827|Myocardial Ischemia|myocardial ischemia
735895|NCT00489827|Myocardial Infarction|myocardial infarction
735896|NCT00489827|Unstable Coronary Artery Disease|unstable coronary artery disease
735897|NCT00489827|Glutamate|glutamate
735898|NCT00489814|Prostate Cancer|prostate cancer
735899|NCT00489814|Prostate Proton Therapy|prostate proton therapy
735900|NCT00489814|Proton Radiation Therapy|proton radiation therapy
735901|NCT00489814|Proton Radiotherapy|proton radiotherapy
735902|NCT00489814|Quality of Life|quality of life
735903|NCT00489814|QOL|qol
735904|NCT00489814|Questionnaire|questionnaire
735905|NCT00489801|Cardiac Rehabilitation|cardiac rehabilitation
735906|NCT00489801|Exercise|exercise
735907|NCT00489801|Heart failure|heart failure
735908|NCT00489801|Coronary heart disease|coronary heart disease
735909|NCT00489788|MRI|mri
735910|NCT00489788|Ventricular Strain|ventricular strain
735911|NCT00489788|Pulmonary Valve Replacement|pulmonary valve replacement
735912|NCT00489788|Post Tetralogy of Fallot|post tetralogy of fallot
735913|NCT00489762|Childhood|childhood
735914|NCT00489762|Asthma|asthma
735915|NCT00489762|Heating|heating
735916|NCT00489762|Insulation|insulation
735917|NCT00489762|Respiratory symptoms|respiratory symptoms
735918|NCT00489749|Achilles tendon rupture|achilles tendon rupture
735919|NCT00489749|Open surgical repair|open surgical repair
735920|NCT00489749|Early functional mobilization|early functional mobilization
735921|NCT00489749|Weightbearing|weightbearing
735922|NCT00489749|Rehabilitation|rehabilitation
735923|NCT00489736|Atrial Fibrillation|atrial fibrillation
735924|NCT00489736|sinus rhythm|sinus rhythm
735925|NCT00489736|amiodarone|amiodarone
735926|NCT00489723|size of stone 1-2 cm|size of stone 1-2 cm
735927|NCT00489723|Pt. with no use of alfa bloker prior ESWL|pt. with no use of alfa bloker prior eswl
735928|NCT00489723|Pt. without internal stent|pt. without internal stent
735929|NCT00489710|stage IV renal cell cancer|stage iv renal cell cancer
735930|NCT00489710|recurrent renal cell cancer|recurrent renal cell cancer
735931|NCT00489697|colorectal cancer|colorectal cancer
735932|NCT00489697|hepatic metastases|hepatic metastases
735933|NCT00489697|bevacizumab|bevacizumab
735934|NCT00489697|anti-angiogenic agent|anti-angiogenic agent
735935|NCT00489697|chemotherapy regimens|chemotherapy regimens
735936|NCT00489697|tumor vascularity|tumor vascularity
735937|NCT00489697|Contrast-enhanced ultrasound|contrast-enhanced ultrasound
735938|NCT00489671|pancreatic cancer|pancreatic cancer
735939|NCT00489671|precancerous condition|precancerous condition
735940|NCT00489658|Human African trypanosomiasis|human african trypanosomiasis
735941|NCT00489658|sleeping sickness|sleeping sickness
735942|NCT00489658|Trypanosoma brucei gambiense|trypanosoma brucei gambiense
735943|NCT00489658|combination|combination
735944|NCT00489658|eflornithine|eflornithine
735945|NCT00489658|nifurtimox|nifurtimox
735946|NCT00489658|Human African trypanosomiasis (sleeping sickness) due to Trypanosoma brucei gambiense in the late stage (stage 2 or meningo-encephalitic)|human african trypanosomiasis (sleeping sickness) due to trypanosoma brucei gambiense in the late stage (stage 2 or meningo-encephalitic)
735947|NCT00489645|pramlintide|pramlintide
735948|NCT00489645|gastric emptying|gastric emptying
735949|NCT00489645|T1DM|t1dm
735950|NCT00489645|postprandial|postprandial
735951|NCT00489632|Leukemia|leukemia
735952|NCT00489632|Pediatrics|pediatrics
735953|NCT00489632|Cancer|cancer
735954|NCT00489632|Coping|coping
735955|NCT00489632|Caregiver|caregiver
735956|NCT00489632|Questionnaire|questionnaire
735957|NCT00489632|Children|children
735958|NCT00489632|Resiliency|resiliency
735959|NCT00489632|Adjustment|adjustment
735960|NCT00489632|Illness-related factors|illness-related factors
735961|NCT00489619|Infectious diseases|infectious diseases
735962|NCT00489619|Democratic Republic of Congo|democratic republic of congo
735963|NCT00489619|Malaria|malaria
735964|NCT00489619|International|international
735965|NCT00489619|Maternal and child health|maternal and child health
735966|NCT00489619|Women's Health|women's health
735967|NCT00489619|Global Network|global network
735968|NCT00489619|Sexually transmitted infections (STIs)|sexually transmitted infections (stis)
735969|NCT00489606|SK3530|sk3530
735970|NCT00489606|tamsulosin|tamsulosin
735971|NCT00489606|hemodynamic interaction|hemodynamic interaction
735972|NCT00489606|safety|safety
735973|NCT00489593|Advanced Cancer|advanced cancer
735974|NCT00489593|Weight Loss|weight loss
735975|NCT00489593|Cachexia|cachexia
735976|NCT00489593|Olanzapine|olanzapine
735977|NCT00489593|Zyprexa|zyprexa
735978|NCT00489593|Fluoxetine|fluoxetine
735979|NCT00489593|Symbyax|symbyax
735980|NCT00489580|stroke|stroke
735981|NCT00489580|weakness|weakness
735982|NCT00489580|motor recovery|motor recovery
735983|NCT00489567|Rotavirus gastroenteritis|rotavirus gastroenteritis
735984|NCT00489554|Primary vaccination|primary vaccination
735985|NCT00489554|Safety|safety
735986|NCT00489554|Pneumococcal vaccine.|pneumococcal vaccine.
735987|NCT00489554|Pneumococcal disease|pneumococcal disease
735988|NCT00489554|Immunogenicity|immunogenicity
735989|NCT00489541|paclitaxel-eluting stent|paclitaxel-eluting stent
735990|NCT00489541|PES|pes
735991|NCT00489528|serostim|serostim
735992|NCT00489528|Dose-Response Relationship, Drug|dose-response relationship, drug
735993|NCT00489528|Body Composition|body composition
735994|NCT00489515|adenocarcinoma of the gallbladder|adenocarcinoma of the gallbladder
735995|NCT00489515|stage I pancreatic cancer|stage i pancreatic cancer
735996|NCT00489515|stage II pancreatic cancer|stage ii pancreatic cancer
735997|NCT00489515|stage III pancreatic cancer|stage iii pancreatic cancer
735998|NCT00489515|stage IV pancreatic cancer|stage iv pancreatic cancer
735999|NCT00489515|stage I colon cancer|stage i colon cancer
736000|NCT00489515|stage II colon cancer|stage ii colon cancer
736001|NCT00489515|stage III colon cancer|stage iii colon cancer
736002|NCT00489515|stage IV colon cancer|stage iv colon cancer
736003|NCT00489515|stage I gastric cancer|stage i gastric cancer
736004|NCT00489515|stage II gastric cancer|stage ii gastric cancer
736005|NCT00489515|stage III gastric cancer|stage iii gastric cancer
736006|NCT00489515|stage IV gastric cancer|stage iv gastric cancer
736007|NCT00489515|localized gallbladder cancer|localized gallbladder cancer
736008|NCT00489515|small intestine adenocarcinoma|small intestine adenocarcinoma
736009|NCT00489515|adenocarcinoma of the colon|adenocarcinoma of the colon
736010|NCT00489515|adenocarcinoma of the pancreas|adenocarcinoma of the pancreas
736011|NCT00489515|adenocarcinoma of the stomach|adenocarcinoma of the stomach
736012|NCT00489489|MS|ms
736013|NCT00489489|interferon-beta|interferon-beta
736014|NCT00489489|adjunctive therapy|adjunctive therapy
736015|NCT00489489|relapses|relapses
736016|NCT00489476|Staccato® Loxapine, Migraine|staccato® loxapine, migraine
736017|NCT00489463|LNG-IUS|lng-ius
736018|NCT00489463|TCu 380A|tcu 380a
736019|NCT00489463|Ultrasonography|ultrasonography
736020|NCT00489463|Doppler color|doppler color
736021|NCT00489463|power Doppler|power doppler
736022|NCT00489463|female|female
736023|NCT00489463|Volunteers|volunteers
736024|NCT00489450|SK3530|sk3530
736025|NCT00489450|alcohol|alcohol
736026|NCT00489450|pharmacokinetics|pharmacokinetics
736028|NCT00489437|diagnosis|diagnosis
736029|NCT00489424|zoledronic acid|zoledronic acid
736030|NCT00489424|post dose symptoms|post dose symptoms
736031|NCT00489424|transient|transient
736032|NCT00489424|acetaminophen|acetaminophen
736033|NCT00489424|fluvastatin|fluvastatin
736034|NCT00489411|unspecified adult solid tumor, protocol specific|unspecified adult solid tumor, protocol specific
736035|NCT00489411|neurotoxicity|neurotoxicity
736036|NCT00489411|pain|pain
736037|NCT00489411|peripheral neuropathy|peripheral neuropathy
736038|NCT00489385|Fibrosis|fibrosis
736039|NCT00489385|Viral Kinetics|viral kinetics
736040|NCT00489385|Hepatotoxicity|hepatotoxicity
736041|NCT00489385|Immunity|immunity
736042|NCT00489385|HIV Infection|hiv infection
736043|NCT00489385|Hepatitis C|hepatitis c
736044|NCT00489385|HCV|hcv
736045|NCT00489385|Treatment Experienced|treatment experienced
736046|NCT00489385|Treatment Naive|treatment naive
736047|NCT00489333|ProAlgaZyme|proalgazyme
736048|NCT00489333|Metabolic syndrome|metabolic syndrome
736049|NCT00489333|Inflammation|inflammation
736050|NCT00489333|Cardiovascular|cardiovascular
736051|NCT00489333|hsCRP|hscrp
736052|NCT00489333|Lipids|lipids
736053|NCT00489333|Algae|algae
736054|NCT00489320|Coronary disease|coronary disease
736055|NCT00489320|Arteries|arteries
736056|NCT00489320|Atherosclerosis|atherosclerosis
736057|NCT00489320|Arteriosclerosis|arteriosclerosis
736058|NCT00489307|Advanced Cancer|advanced cancer
736059|NCT00489307|Solid Tumors|solid tumors
736060|NCT00489307|Fatigue|fatigue
736061|NCT00489307|Pain|pain
736062|NCT00489307|Nausea|nausea
736063|NCT00489307|Anorexia|anorexia
736064|NCT00489307|Dexamethasone|dexamethasone
736065|NCT00489307|Decadron|decadron
736066|NCT00489307|Placebo|placebo
736067|NCT00489294|Human growth hormone|human growth hormone
736068|NCT00489294|idiopathic short stature|idiopathic short stature
736069|NCT00489294|short stature|short stature
736070|NCT00489281|sickle cell disease|sickle cell disease
736071|NCT00489268|Barrett's Esophagus|barrett's esophagus
736072|NCT00489268|Intestinal Metaplasia|intestinal metaplasia
736073|NCT00489268|Radiofrequency Ablation|radiofrequency ablation
736074|NCT00489255|Parkinson's disease|parkinson's disease
736075|NCT00489255|Anti-emetic|anti-emetic
736076|NCT00489255|Nausea|nausea
736077|NCT00489255|Vomiting|vomiting
736078|NCT00489229|Rosiglitazone|rosiglitazone
736079|NCT00489229|Ramipril|ramipril
736080|NCT00489229|Impaired glucose tolerance|impaired glucose tolerance
736081|NCT00489229|Arterial stiffness|arterial stiffness
736082|NCT00489229|Diabetic vasculopathy|diabetic vasculopathy
736083|NCT00489216|Graft Versus Host Disease|graft versus host disease
736084|NCT00489216|GVHD|gvhd
736085|NCT00489216|Efalizumab|efalizumab
736086|NCT00489216|Raptiva|raptiva
736087|NCT00489216|Steroid|steroid
736088|NCT00489216|Refractory|refractory
736089|NCT00489216|Skin|skin
736090|NCT00489216|Liver|liver
736091|NCT00489216|Lineberger|lineberger
736092|NCT00489216|University of North Carolina|university of north carolina
736093|NCT00489177|cardiac resynchronization therapy|cardiac resynchronization therapy
736094|NCT00489177|response|response
736095|NCT00489177|Defibrillators|defibrillators
736096|NCT00489164|DIABETIC PATIENTS WITH NATIVE CORONARY ARTERY LESIONS|diabetic patients with native coronary artery lesions
736097|NCT00489151|HBV|hbv
736098|NCT00489125|long-term effects secondary to cancer therapy in adults|long-term effects secondary to cancer therapy in adults
736099|NCT00489125|recurrent breast cancer|recurrent breast cancer
736100|NCT00489125|stage I breast cancer|stage i breast cancer
736101|NCT00489125|stage II breast cancer|stage ii breast cancer
736102|NCT00489125|stage IIIA breast cancer|stage iiia breast cancer
736103|NCT00489125|stage IIIB breast cancer|stage iiib breast cancer
736104|NCT00489125|stage IIIC breast cancer|stage iiic breast cancer
736105|NCT00489125|stage IV breast cancer|stage iv breast cancer
736106|NCT00489086|nevoid basal cell carcinoma syndrome|nevoid basal cell carcinoma syndrome
736107|NCT00489086|basal cell carcinoma of the skin|basal cell carcinoma of the skin
736108|NCT00489060|Cryoablation|cryoablation
736109|NCT00489060|Radiation|radiation
736110|NCT00489060|Prostate Cancer|prostate cancer
736111|NCT00489034|HIV|hiv
736112|NCT00489034|adolescent females|adolescent females
736113|NCT00489034|adherence|adherence
736114|NCT00489034|clinical care|clinical care
736115|NCT00489034|risk behaviors|risk behaviors
736116|NCT00489021|Subacute care|subacute care
736117|NCT00489021|Activities of Daily Living|activities of daily living
736118|NCT00489021|Cognition assessment|cognition assessment
736119|NCT00489021|Mood assessment|mood assessment
736120|NCT00489021|Incontinence control|incontinence control
736121|NCT00489008|Lung Cancer|lung cancer
736122|NCT00489008|Non-Small Cell|non-small cell
736123|NCT00489008|Stereotactic Body Radiation Therapy|stereotactic body radiation therapy
736124|NCT00489008|SBRT|sbrt
736125|NCT00489008|NSCLC|nsclc
736126|NCT00488995|HIV Therapeutic Vaccine|hiv therapeutic vaccine
736127|NCT00488982|Metastatic Hormone Refractory Prostate Cancer|metastatic hormone refractory prostate cancer
736128|NCT00488969|Morphine|morphine
736129|NCT00488969|Chronic Pain|chronic pain
736130|NCT00488969|Spinal Cord Injury|spinal cord injury
736131|NCT00488969|Neuropathic Pain|neuropathic pain
736132|NCT00488956|foot|foot
736133|NCT00488956|ankle|ankle
736134|NCT00488956|edema|edema
736135|NCT00488943|Stent-Graft|stent-graft
736136|NCT00488943|AAA|aaa
736137|NCT00488943|Abdominal Aortic Anuerysm|abdominal aortic anuerysm
736138|NCT00488943|Zenith|zenith
736139|NCT00488943|Endovascular|endovascular
736140|NCT00488943|Treatment with Zenith Aortic Stent-Graft for repair Abdominal Aortic Aneurysm|treatment with zenith aortic stent-graft for repair abdominal aortic aneurysm
736141|NCT00488930|Obesity|obesity
736142|NCT00488930|Hyperglycemia|hyperglycemia
736143|NCT00488930|Diabetes Mellitus Type I|diabetes mellitus type i
736144|NCT00488930|Diabetes Mellitus Type II|diabetes mellitus type ii
736145|NCT00488917|Liver cirrhosis|liver cirrhosis
736146|NCT00488917|acute liver failure|acute liver failure
736147|NCT00488917|liver transplantation|liver transplantation
736148|NCT00488917|sepsis, infection|sepsis, infection
736149|NCT00488917|endothelium|endothelium
736150|NCT00488917|lipids|lipids
736151|NCT00488917|diagnosis|diagnosis
736152|NCT00488917|prognosis|prognosis
736153|NCT00488904|infection|infection
736154|NCT00488904|colorectalcancer|colorectalcancer
736155|NCT00488904|omega-3 fedtsyre|omega-3 fedtsyre
736156|NCT00488904|complications|complications
736157|NCT00488891|Schizophrenia|schizophrenia
736158|NCT00488891|Paliperdone ER|paliperdone er
736159|NCT00488891|Invega|invega
736160|NCT00488891|Observational|observational
736161|NCT00488891|Antipsychotic agents|antipsychotic agents
736162|NCT00488878|Ovarian Cancer|ovarian cancer
736163|NCT00488878|Ovarian Carcinoma|ovarian carcinoma
736164|NCT00488878|Low-Grade Serous Carcinoma|low-grade serous carcinoma
736165|NCT00488878|Low Malignant Potential|low malignant potential
736166|NCT00488878|Peritoneum Tumors|peritoneum tumors
736167|NCT00488878|Psammocarcinoma|psammocarcinoma
736168|NCT00488878|Data Collection|data collection
736169|NCT00488878|Research Database|research database
736170|NCT00488865|increased risk for PE require caval interruption|increased risk for pe require caval interruption
736171|NCT00488839|Spasticity|spasticity
736172|NCT00488839|Multiple Sclerosis|multiple sclerosis
736173|NCT00488826|Vaccines, Pneumococcal Conjugate Vaccine|vaccines, pneumococcal conjugate vaccine
736174|NCT00488813|Tzh-Chi ESBL study|tzh-chi esbl study
736175|NCT00488800|Pneumococcal Infections/PC (Prevention & Control)|pneumococcal infections/pc (prevention & control)
736176|NCT00488787|dental|dental
736177|NCT00488787|surgery|surgery
736178|NCT00488787|analgesia|analgesia
736179|NCT00488787|2-4 impacted third molars|2-4 impacted third molars
736180|NCT00488774|Colitis, ulcerative|colitis, ulcerative
736181|NCT00488774|Golimumab|golimumab
736182|NCT00488774|CNTO 148|cnto 148
736183|NCT00488761|Tigecycline|tigecycline
736184|NCT00488761|cSSSI|csssi
736185|NCT00488761|complicated skin and skin structure infections|complicated skin and skin structure infections
736186|NCT00488748|MST|mst
736187|NCT00488748|Magnetic Seizure Therapy|magnetic seizure therapy
736188|NCT00488748|ECT|ect
736189|NCT00488748|Electroconvulsive Therapy|electroconvulsive therapy
736190|NCT00488748|Depression|depression
736191|NCT00488748|Magnetic|magnetic
736192|NCT00488735|Randomized controlled trial|randomized controlled trial
736193|NCT00488735|Back pain|back pain
736194|NCT00488735|Neck pain|neck pain
736195|NCT00488735|Rehabilitation|rehabilitation
736196|NCT00488735|Cognitive-behavioral|cognitive-behavioral
736197|NCT00488735|Primary care|primary care
736198|NCT00488735|Sick-listing|sick-listing
736199|NCT00488735|Health-care utilization.|health-care utilization.
736200|NCT00488722|To observe the biological changes under concurrent Zoladex and CEF as neoadjuvant regimen with respect to the ER,PR,cerbB-2 status before and after therapy|to observe the biological changes under concurrent zoladex and cef as neoadjuvant regimen with respect to the er,pr,cerbb-2 status before and after therapy
736201|NCT00488709|Acute Myeloid Leukemia|acute myeloid leukemia
736202|NCT00488709|Multi Drug Resistance|multi drug resistance
736203|NCT00488696|Aneurysm|aneurysm
736204|NCT00488696|Aortic Arch|aortic arch
736205|NCT00488696|Endovascular|endovascular
736206|NCT00488696|Stent-Graft|stent-graft
736207|NCT00488683|Meningococcal disease|meningococcal disease
736208|NCT00488683|Prevention|prevention
736209|NCT00488683|Vaccination|vaccination
736210|NCT00488670|Alzheimer's disease|alzheimer's disease
736211|NCT00488670|elderly|elderly
736212|NCT00488670|open-label|open-label
736213|NCT00488670|escitalopram|escitalopram
736214|NCT00488657|speech|speech
736215|NCT00488657|Parkinson's disease|parkinson's disease
736216|NCT00488657|treatment|treatment
736217|NCT00488657|speech intelligibility|speech intelligibility
736218|NCT00488657|speaking rate|speaking rate
736219|NCT00488644|Hypothyroidism|hypothyroidism
736220|NCT00488644|Brain Tumor|brain tumor
736221|NCT00488644|Levothyroxine|levothyroxine
736222|NCT00488644|Liothyronine|liothyronine
736223|NCT00488644|Synthroid|synthroid
736224|NCT00488644|Cytomel|cytomel
736225|NCT00488631|Colitis, Ulcerative|colitis, ulcerative
736226|NCT00488631|Golimumab|golimumab
736227|NCT00488631|CNTO 148|cnto 148
736228|NCT00488618|Mania|mania
736229|NCT00488618|Bipolar I Disorder|bipolar i disorder
736230|NCT00488618|Acute Mania Associated with Bipolar I Disorder|acute mania associated with bipolar i disorder
736231|NCT00488592|Myelodysplastic Syndrome (MDS)|myelodysplastic syndrome (mds)
736232|NCT00488592|Acute Myeloid Leukemia (AML)|acute myeloid leukemia (aml)
736233|NCT00488592|Chronic Myeloid Leukemia (CML)|chronic myeloid leukemia (cml)
736234|NCT00488592|Wilm's Tumor-1|wilm's tumor-1
736235|NCT00488592|Proteinase-3|proteinase-3
736236|NCT00488592|Myelodysplastic Syndrome|myelodysplastic syndrome
736237|NCT00488592|MDS|mds
736238|NCT00488592|Acute Myeloid Leukemia|acute myeloid leukemia
736239|NCT00488592|AML|aml
736240|NCT00488592|Chronic Myeloid Leukemia|chronic myeloid leukemia
736241|NCT00488592|CML|cml
736242|NCT00488579|iron prophylaxis|iron prophylaxis
736243|NCT00488579|pregnancy|pregnancy
736244|NCT00488579|birth weight|birth weight
736245|NCT00488579|prematurity|prematurity
736246|NCT00488579|perinatal mortality|perinatal mortality
736247|NCT00488566|bipolar disorder,|bipolar disorder,
736248|NCT00488566|single doses,|single doses,
736249|NCT00488566|resting motor threshold|resting motor threshold
736250|NCT00488566|TMS,|tms,
736251|NCT00488553|Lymphoma|lymphoma
736252|NCT00488553|Epidemiology|epidemiology
736253|NCT00488553|Lifestyle Factors|lifestyle factors
736254|NCT00488553|Questionnaire|questionnaire
736255|NCT00488553|Survey|survey
736256|NCT00488540|newborn|newborn
736257|NCT00488540|infant|infant
736258|NCT00488540|pain|pain
736259|NCT00488540|acetaminophen|acetaminophen
736260|NCT00488540|paracetamol|paracetamol
736261|NCT00488540|mode of delivery|mode of delivery
736262|NCT00488540|vacuum extraction|vacuum extraction
736263|NCT00488540|forceps extraction|forceps extraction
736264|NCT00488540|cesarean section|cesarean section
736265|NCT00488540|EDIN scale|edin scale
736266|NCT00488540|Bernese Pain Scale for Neonates|bernese pain scale for neonates
736368|NCT00488137|PAC-SYM|pac-sym
736267|NCT00488540|pain after different modes of delivery in newborn infants|pain after different modes of delivery in newborn infants
736268|NCT00488540|efficacy of acetaminophen as analgesia for newborn infants|efficacy of acetaminophen as analgesia for newborn infants
736269|NCT00488514|Long-term Safety|long-term safety
736270|NCT00488514|Migraine|migraine
736271|NCT00488514|Adolescent Migraine Headache|adolescent migraine headache
736272|NCT00488514|sumatriptan succinate|sumatriptan succinate
736273|NCT00488514|naproxen sodium|naproxen sodium
736274|NCT00488501|intrathoracic impedance|intrathoracic impedance
736275|NCT00488501|cardiac resynchronization therapy|cardiac resynchronization therapy
736276|NCT00488501|heart failure|heart failure
736277|NCT00488462|obstetric hemorrhage|obstetric hemorrhage
736278|NCT00488462|hypovolemic shock|hypovolemic shock
736279|NCT00488462|non-pneumatic anti-shock garment|non-pneumatic anti-shock garment
736280|NCT00488462|safe motherhood|safe motherhood
736281|NCT00488462|maternal mortality|maternal mortality
736282|NCT00488462|maternal morbidity|maternal morbidity
736283|NCT00488449|Dose Escalation|dose escalation
736284|NCT00488449|GSK256073A,|gsk256073a,
736285|NCT00488436|Myelodysplastic Syndrome|myelodysplastic syndrome
736286|NCT00488436|Antithymocyte Globulin|antithymocyte globulin
736287|NCT00488436|Cyclosporine|cyclosporine
736288|NCT00488423|diabetes|diabetes
736289|NCT00488423|MIDAS|midas
736290|NCT00488423|gut hormones|gut hormones
736291|NCT00488423|gastric bypass|gastric bypass
736292|NCT00488423|lap band|lap band
736293|NCT00488410|Chronic heart failure|chronic heart failure
736294|NCT00488410|real time three-dimensional echocardiography|real time three-dimensional echocardiography
736295|NCT00488410|cardiac resynchronization therapy|cardiac resynchronization therapy
736296|NCT00488410|ventricular asynchrony|ventricular asynchrony
736297|NCT00488410|systolic dysynchrony index|systolic dysynchrony index
736298|NCT00488397|Tygacil|tygacil
736299|NCT00488397|microdilution method|microdilution method
736300|NCT00488397|Tigecycline|tigecycline
736301|NCT00488397|In-Vitro|in-vitro
736302|NCT00488384|Squamous cell carcinoma of the skin under hemodialysis|squamous cell carcinoma of the skin under hemodialysis
736303|NCT00488371|Streptococcus pneumoniae nasopharyngeal carriage|streptococcus pneumoniae nasopharyngeal carriage
736304|NCT00488358|abdominal|abdominal
736305|NCT00488358|aortic|aortic
736306|NCT00488358|aneurysm|aneurysm
736307|NCT00488358|Zenith|zenith
736308|NCT00488358|blood pressure|blood pressure
736309|NCT00488345|cIAI|ciai
736310|NCT00488345|cSSSI|csssi
736311|NCT00488345|CAP|cap
736312|NCT00488345|Child|child
736313|NCT00488332|Head and Neck Cancer|head and neck cancer
736314|NCT00488332|Oral Mucositis|oral mucositis
736315|NCT00488332|Optical Coherence Tomography|optical coherence tomography
736316|NCT00488332|Fluorescence Spectroscopy|fluorescence spectroscopy
736317|NCT00488332|Optical Assessment|optical assessment
736318|NCT00488319|Schizophrenia|schizophrenia
736319|NCT00488319|Adolescent|adolescent
736320|NCT00488319|Paliperidone|paliperidone
736321|NCT00488319|Antipsychotic agents|antipsychotic agents
736322|NCT00488319|Antipsychotic drugs|antipsychotic drugs
736323|NCT00488319|Psychosis.|psychosis.
736324|NCT00488306|Tigecycline|tigecycline
736325|NCT00488306|Complicated intra-abdominal infections|complicated intra-abdominal infections
736327|NCT00488293|Telemedicine|telemedicine
736328|NCT00488293|Skin diseases|skin diseases
736329|NCT00488293|Dermatology|dermatology
736330|NCT00488293|Quality of life|quality of life
736331|NCT00488293|Economics|economics
736332|NCT00488280|walking|walking
736333|NCT00488280|walking recovery|walking recovery
736334|NCT00488280|physical therapy|physical therapy
736335|NCT00488280|locomotor training|locomotor training
736336|NCT00488280|body weight support|body weight support
736337|NCT00488280|neuroplasticity|neuroplasticity
736338|NCT00488280|step|step
736339|NCT00488280|treadmill|treadmill
736340|NCT00488280|treadmill training|treadmill training
736341|NCT00488280|locomotion|locomotion
736342|NCT00488267|Osteoarthritis|osteoarthritis
736343|NCT00488267|Pain|pain
736344|NCT00488254|Long QT Syndrome|long qt syndrome
736345|NCT00488254|Romano Ward|romano ward
736346|NCT00488254|Jervell-Lange Nielson Syndrome|jervell-lange nielson syndrome
736347|NCT00488241|Eczema|eczema
736348|NCT00488241|Medical device|medical device
736349|NCT00488215|constipation|constipation
736350|NCT00488215|prucalopride|prucalopride
736351|NCT00488215|MTD|mtd
736352|NCT00488215|cardiovascular safety|cardiovascular safety
736353|NCT00488202|Advanced Ovarian Cancer|advanced ovarian cancer
736354|NCT00488202|Sexual Function|sexual function
736355|NCT00488176|seasonal allergic rhinitis|seasonal allergic rhinitis
736356|NCT00488176|children|children
736357|NCT00488176|montelukast|montelukast
736358|NCT00488176|cetirizine|cetirizine
736359|NCT00488163|schizophrenia|schizophrenia
736360|NCT00488163|cognition|cognition
736361|NCT00488163|atomoxetine|atomoxetine
736362|NCT00488163|norepinephrine|norepinephrine
736363|NCT00488163|dopamine|dopamine
736364|NCT00488137|constipation|constipation
736365|NCT00488137|prucalopride|prucalopride
736366|NCT00488137|QOL|qol
736369|NCT00488124|short stature|short stature
736370|NCT00488111|Regional anesthesia|regional anesthesia
736371|NCT00488111|Fluid Therapy|fluid therapy
736372|NCT00488111|Hemostasis, Surgical|hemostasis, surgical
736373|NCT00488098|Healthy Bioequivalence|healthy bioequivalence
736374|NCT00488085|Crohn’s disease, obesity, REE, body composition, fat absorption|crohn’s disease, obesity, ree, body composition, fat absorption
736375|NCT00488072|Advanced Cancer|advanced cancer
736376|NCT00488072|Anorexia|anorexia
736377|NCT00488072|Weight Loss|weight loss
736378|NCT00488072|Insomnia|insomnia
736379|NCT00488072|Appetite|appetite
736380|NCT00488072|Mirtazapine|mirtazapine
736381|NCT00488072|Placebo|placebo
736382|NCT00488059|Treatment Experienced|treatment experienced
736383|NCT00488046|Bird Flu|bird flu
736384|NCT00488033|Coronary Artery Disease|coronary artery disease
736385|NCT00488033|Diabetes|diabetes
736386|NCT00488033|CT Angiography|ct angiography
736387|NCT00488020|rest pain|rest pain
736388|NCT00488020|ischemic ulcers|ischemic ulcers
736389|NCT00488007|Alzheimer disease|alzheimer disease
736390|NCT00488007|Cognitive impairment|cognitive impairment
736391|NCT00488007|Sensorineural hearing loss|sensorineural hearing loss
736392|NCT00488007|Hearing aids|hearing aids
736393|NCT00487994|Hypercholesterolemia|hypercholesterolemia
736394|NCT00487994|Hyperlipidemia|hyperlipidemia
736395|NCT00487994|Drug Therapy|drug therapy
736396|NCT00487981|Pain|pain
736397|NCT00487981|Implantable stimulation device|implantable stimulation device
736398|NCT00487981|Neuropathy|neuropathy
736399|NCT00487968|healthy adult volunteers|healthy adult volunteers
736400|NCT00487968|eltrombopag|eltrombopag
736401|NCT00487955|gastritis|gastritis
736402|NCT00487955|helicobacter pylori|helicobacter pylori
736403|NCT00487955|REE|ree
736404|NCT00487955|patients with gastritis that refers to helicobacter pylori treatment|patients with gastritis that refers to helicobacter pylori treatment
736405|NCT00487929|sleep apnea|sleep apnea
736406|NCT00487929|morbidity|morbidity
736407|NCT00487929|cardiovascular|cardiovascular
736408|NCT00487929|cpap|cpap
736409|NCT00487929|oxidative stress|oxidative stress
736410|NCT00487916|Blood Stage|blood stage
736411|NCT00487916|Investigational|investigational
736412|NCT00487916|Vaccine|vaccine
736413|NCT00487916|Malaria|malaria
736414|NCT00487916|Healthy Volunteer|healthy volunteer
736415|NCT00487916|HV|hv
736416|NCT00487903|Coronary Artery Disease|coronary artery disease
736417|NCT00487903|Echocardiogram|echocardiogram
736418|NCT00487903|Contrast|contrast
736419|NCT00487903|Perfusion|perfusion
736420|NCT00487903|Ultrasound|ultrasound
736421|NCT00487903|Normal volunteers|normal volunteers
736422|NCT00487890|Geriatric|geriatric
736423|NCT00487890|Abdominal|abdominal
736424|NCT00487890|Surgery|surgery
736425|NCT00487890|gastrointestinal surgery|gastrointestinal surgery
736426|NCT00487890|intrabdominal surgery|intrabdominal surgery
736427|NCT00487877|metabolism, temperature changing, skin, heart rate|metabolism, temperature changing, skin, heart rate
736428|NCT00487851|Pancreatic|pancreatic
736429|NCT00487851|cancer|cancer
736430|NCT00487851|Periampullay|periampullay
736431|NCT00487851|Neoplasms|neoplasms
736432|NCT00487851|Biliary|biliary
736433|NCT00487851|Duodenal|duodenal
736434|NCT00487851|Jaundice|jaundice
736435|NCT00487851|obstruction|obstruction
736436|NCT00487851|pancreas cancer|pancreas cancer
736437|NCT00487851|Pancreatic cancer|pancreatic cancer
736438|NCT00487838|Autofluorescence Imaging|autofluorescence imaging
736439|NCT00487838|Early Age-Related Maculopathy|early age-related maculopathy
736440|NCT00487838|Photochemical Changes|photochemical changes
736441|NCT00487838|Colored Sunglasses|colored sunglasses
736442|NCT00487838|Pseudophakes|pseudophakes
736443|NCT00487838|Fundus Camera|fundus camera
736444|NCT00487838|Confocal Scanning Laser Ophthalmoscope|confocal scanning laser ophthalmoscope
736445|NCT00487838|Molecular Imaging within Retina|molecular imaging within retina
736446|NCT00487838|Spectral Balance among Photochemical Processes|spectral balance among photochemical processes
736447|NCT00487838|Noninvasive Autofluorescence Imaging|noninvasive autofluorescence imaging
736448|NCT00487838|Age-Related Maculopathy (AMD)|age-related maculopathy (amd)
736449|NCT00487838|Age-Related Macular Degeneration|age-related macular degeneration
736450|NCT00487838|AMD|amd
736451|NCT00487838|Age-Related Macular Changes|age-related macular changes
736452|NCT00487838|Early Age-Related Macular Changes|early age-related macular changes
736453|NCT00487825|ACR20, ACR50, ACZ885 (anti-interleukin-1beta monoclonal antibody), rheumatoid arthritis, methotrexate|acr20, acr50, acz885 (anti-interleukin-1beta monoclonal antibody), rheumatoid arthritis, methotrexate
736454|NCT00487812|Acute myocardial infarction|acute myocardial infarction
736455|NCT00487812|left ventricular remodelling|left ventricular remodelling
736456|NCT00487812|SPECT imaging|spect imaging
736457|NCT00487799|Acute Decompensated Heart Failure|acute decompensated heart failure
736458|NCT00487799|ADHF|adhf
736459|NCT00487799|Heart Failure|heart failure
736460|NCT00487786|Antisense|antisense
736461|NCT00487786|Heat Shock Protein|heat shock protein
736462|NCT00487773|asthma|asthma
736463|NCT00487773|children|children
736464|NCT00487773|inhaled glucocorticosteroids|inhaled glucocorticosteroids
736465|NCT00487773|bone metabolism|bone metabolism
736466|NCT00487760|Lung Cancer|lung cancer
736467|NCT00487760|African-American Families|african-american families
736468|NCT00487760|Genetic Risk Communication|genetic risk communication
736469|NCT00487760|Interest in Genetic Testing and Genetics Research|interest in genetic testing and genetics research
736470|NCT00487760|Health Disparities|health disparities
736471|NCT00487760|Smoking Cessation|smoking cessation
736472|NCT00487734|Metabolic Syndrome|metabolic syndrome
736473|NCT00487734|Hypogonadism|hypogonadism
736474|NCT00487734|Insulin Resistance|insulin resistance
736475|NCT00487721|Prostate cancer|prostate cancer
736476|NCT00487708|ACZ885|acz885
736477|NCT00487708|NALP3 mutations|nalp3 mutations
736478|NCT00487708|Interleukin-1beta|interleukin-1beta
736479|NCT00487708|Muckle-Wells Syndrome|muckle-wells syndrome
736480|NCT00487695|Barrett's esophagus|barrett's esophagus
736481|NCT00487695|Esophageal adenocarcinoma|esophageal adenocarcinoma
736482|NCT00487695|Endoscopy|endoscopy
736483|NCT00487695|Confocal laser endomicroscopy|confocal laser endomicroscopy
736484|NCT00487682|Valacyclovir hydrochloride|valacyclovir hydrochloride
736485|NCT00487682|herpes zoster|herpes zoster
736486|NCT00487682|ASP2151|asp2151
736487|NCT00487669|paclitaxel poliglumex|paclitaxel poliglumex
736488|NCT00487669|xyotax|xyotax
736489|NCT00487669|alimta|alimta
736490|NCT00487669|advanced non-small cell lung cancer|advanced non-small cell lung cancer
736491|NCT00487643|Lacritin|lacritin
736492|NCT00487630|Heterozygous females|heterozygous females
736493|NCT00487630|Cardiomyopathy|cardiomyopathy
736494|NCT00487617|Arteriopathy|arteriopathy
736495|NCT00487617|endothelial function|endothelial function
736496|NCT00487617|fruit juice|fruit juice
736497|NCT00487604|Coronary Artery Disease|coronary artery disease
736498|NCT00487604|Drug Eluting Stent|drug eluting stent
736499|NCT00487604|Bare Metal Stent|bare metal stent
736500|NCT00487604|Subacute thrombosis|subacute thrombosis
736501|NCT00487604|Bleeding|bleeding
736502|NCT00487604|Economic|economic
736503|NCT00487591|cholesterol|cholesterol
736504|NCT00487591|dyslipidemia|dyslipidemia
736505|NCT00487591|omega 3|omega 3
736506|NCT00487578|Post traumatic headache|post traumatic headache
736507|NCT00487578|Head trauma|head trauma
736508|NCT00487578|Head injury|head injury
736509|NCT00487578|Headache|headache
736510|NCT00487578|Naratriptan|naratriptan
736511|NCT00487565|Total knee replacement|total knee replacement
736512|NCT00487565|Total knee arthroplasty|total knee arthroplasty
736513|NCT00487565|Osteoarthritis|osteoarthritis
736514|NCT00487565|Rheumatoid or other inflammatory arthritis|rheumatoid or other inflammatory arthritis
736515|NCT00487565|Post-traumatic or juvenile arthritis|post-traumatic or juvenile arthritis
736516|NCT00487552|endoscopy|endoscopy
736517|NCT00487552|esophagogastroduodenoscopy|esophagogastroduodenoscopy
736518|NCT00487552|gastric outlet obstruction|gastric outlet obstruction
736519|NCT00487552|gastro-jejunostomy|gastro-jejunostomy
736520|NCT00487552|gastric malignancy|gastric malignancy
736521|NCT00487552|duodenal stent|duodenal stent
736522|NCT00487552|Malignant Gastric Outlet Obstruction|malignant gastric outlet obstruction
736523|NCT00487539|Colitis, Ulcerative|colitis, ulcerative
736524|NCT00487539|Golimumab|golimumab
736525|NCT00487539|CNTO 148|cnto 148
736526|NCT00487526|Bypass|bypass
736527|NCT00487526|Duodenal jejunal|duodenal jejunal
736528|NCT00487526|type 2 diabetes|type 2 diabetes
736529|NCT00487526|non-obese adults|non-obese adults
736530|NCT00487513|Follicular B Cell lymphoma|follicular b cell lymphoma
736531|NCT00487513|vaccination|vaccination
736532|NCT00487500|Major Depressive Disorder|major depressive disorder
736533|NCT00487500|Electroconvulsive Therapy|electroconvulsive therapy
736534|NCT00487487|Candidates for this study are survivors of paralytic poliomyelitis|candidates for this study are survivors of paralytic poliomyelitis
736535|NCT00487461|SAH|sah
736536|NCT00487461|Vasospasm|vasospasm
736537|NCT00487448|Myelodysplastic Syndrome|myelodysplastic syndrome
736538|NCT00487448|Chemotherapy|chemotherapy
736539|NCT00487448|Peripheral blood stem cells transplantation|peripheral blood stem cells transplantation
736540|NCT00487448|Bone marrow transplantation|bone marrow transplantation
736541|NCT00487448|Secondary Acute Myeloblastic Leukemia|secondary acute myeloblastic leukemia
736542|NCT00487435|CG5503|cg5503
736543|NCT00487435|Tapentadol|tapentadol
736544|NCT00487435|chronic non-malignant pain|chronic non-malignant pain
736545|NCT00487435|osteoarthritis|osteoarthritis
736546|NCT00487435|lower back pain|lower back pain
736547|NCT00487435|analgesic|analgesic
736548|NCT00487435|opioid|opioid
736549|NCT00487422|constipation|constipation
736550|NCT00487422|prucalopride|prucalopride
736551|NCT00487422|QOL|qol
736552|NCT00487422|SCBM|scbm
736553|NCT00487422|PAC-SYM|pac-sym
736554|NCT00487409|Ulcerative colitis|ulcerative colitis
736555|NCT00487409|Crohn's disease|crohn's disease
736556|NCT00487409|Colorectal polyps|colorectal polyps
736557|NCT00487409|Colorectal malignancy|colorectal malignancy
736558|NCT00487409|Endometriosis|endometriosis
736559|NCT00487409|Diverticulitis|diverticulitis
736560|NCT00487409|Colonic inertia|colonic inertia
736561|NCT00487396|capsule endoscopy|capsule endoscopy
736562|NCT00487396|Crohn's disease|crohn's disease
736563|NCT00487396|small bowel disease|small bowel disease
736564|NCT00487396|inflammatory bowel disease|inflammatory bowel disease
736565|NCT00487396|Patients with suspected small bowel Crohn's disease|patients with suspected small bowel crohn's disease
736566|NCT00487383|Cerebellum|cerebellum
736567|NCT00487383|Transcranial Magnetic Stimulation (TMS)|transcranial magnetic stimulation (tms)
736568|NCT00487383|Blepharospasm|blepharospasm
736569|NCT00487383|DYT-1 Generalized Dystonia|dyt-1 generalized dystonia
736570|NCT00487383|Focal Dystonia|focal dystonia
736571|NCT00487383|Dystonia|dystonia
736572|NCT00487383|Healthy Volunteer|healthy volunteer
736573|NCT00487383|HV|hv
736574|NCT00487370|Acupuncture|acupuncture
736575|NCT00487370|Gold implantation|gold implantation
736576|NCT00487370|Osteoarthritis|osteoarthritis
736577|NCT00487370|Knee osteoarthritis|knee osteoarthritis
736578|NCT00487370|Double-blind, randomized controlled trial|double-blind, randomized controlled trial
736579|NCT00487370|Intervention|intervention
736580|NCT00487370|Family practice|family practice
736581|NCT00487357|Epidemiology|epidemiology
736582|NCT00487357|Cancer Prevention|cancer prevention
736583|NCT00487357|Questionnaire|questionnaire
736584|NCT00487357|MATCh|match
736585|NCT00487357|Survey|survey
736586|NCT00487344|medicaid|medicaid
736587|NCT00487344|insurance|insurance
736588|NCT00487344|education|education
736589|NCT00487344|clinical|clinical
736590|NCT00487344|trial|trial
736591|NCT00487344|healthcare|healthcare
736592|NCT00487344|reimburse|reimburse
736593|NCT00487344|pay|pay
736594|NCT00487344|free|free
736595|NCT00487344|assist|assist
736596|NCT00487344|study|study
736597|NCT00487344|oklahoma|oklahoma
736598|NCT00487344|edmond|edmond
736599|NCT00487344|Oklahoma City|oklahoma city
736600|NCT00487344|diet|diet
736601|NCT00487344|nutrition|nutrition
736602|NCT00487344|weight loss|weight loss
736603|NCT00487344|body|body
736604|NCT00487344|fat|fat
736605|NCT00487344|obese|obese
736606|NCT00487344|overweight|overweight
736607|NCT00487344|health|health
736608|NCT00487344|medical|medical
736609|NCT00487344|therapy|therapy
736610|NCT00487344|meal plan|meal plan
736611|NCT00487344|jenny craig|jenny craig
736612|NCT00487344|weight watcher|weight watcher
736613|NCT00487344|LA Weightloss|la weightloss
736614|NCT00487344|Bryan Attebery|bryan attebery
736615|NCT00487344|Results|results
736616|NCT00487344|YMCA|ymca
736617|NCT00487344|UCO|uco
736618|NCT00487344|OSU|osu
736619|NCT00487344|OU|ou
736620|NCT00487344|clinics|clinics
736621|NCT00487344|physicians|physicians
736622|NCT00487344|surgery|surgery
736623|NCT00487344|pills|pills
736624|NCT00487344|financial|financial
736625|NCT00487344|money|money
736626|NCT00487331|Solid Tumors|solid tumors
736627|NCT00487331|Acupuncture|acupuncture
736628|NCT00487331|Uncontrolled Pain|uncontrolled pain
736629|NCT00487331|Pain|pain
736630|NCT00487318|fluvastatin|fluvastatin
736631|NCT00487318|hepatitis C|hepatitis c
736632|NCT00487318|chronic hepatitis C|chronic hepatitis c
736633|NCT00487318|not previously treated with pegylated interferon and ribavirin|not previously treated with pegylated interferon and ribavirin
736634|NCT00487305|GM-CSF|gm-csf
736635|NCT00487305|vaccine|vaccine
736636|NCT00487305|K562|k562
736637|NCT00487292|accidents|accidents
736638|NCT00487292|shift work|shift work
736639|NCT00487292|sleepiness|sleepiness
736640|NCT00487292|naps|naps
736641|NCT00487292|bright light pulses|bright light pulses
736642|NCT00487292|sleep|sleep
736643|NCT00487279|Coronary|coronary
736644|NCT00487279|Artery|artery
736645|NCT00487279|Disease|disease
736646|NCT00487279|Sudden|sudden
736647|NCT00487279|Cardiac|cardiac
736648|NCT00487279|Death|death
736649|NCT00487279|ICD|icd
736650|NCT00487266|Acupuncture|acupuncture
736651|NCT00487266|Torque|torque
736652|NCT00487266|Force Decay|force decay
736653|NCT00487253|Cutaneous Leishmaniasis|cutaneous leishmaniasis
736654|NCT00487253|Leishmania Viannia|leishmania viannia
736655|NCT00487253|Pediatric|pediatric
736656|NCT00487253|Miltefosine|miltefosine
736657|NCT00487253|Randomized|randomized
736658|NCT00487253|Colombia|colombia
736659|NCT00487240|diabetes|diabetes
736660|NCT00487240|type 1|type 1
736661|NCT00487227|caffeine|caffeine
736662|NCT00487227|coffee|coffee
736663|NCT00487227|decaffeinated|decaffeinated
736664|NCT00487227|cognition|cognition
736665|NCT00487227|mood|mood
736666|NCT00487227|autonomic|autonomic
736667|NCT00487201|liver transplantation|liver transplantation
736668|NCT00487201|biliary strictures|biliary strictures
736669|NCT00487201|ERCP|ercp
736670|NCT00487175|Pain|pain
736671|NCT00487175|sensitization|sensitization
736672|NCT00487175|analgesia|analgesia
736673|NCT00487175|Healthy volunteers and pain|healthy volunteers and pain
736674|NCT00487162|glycemic control, diabetes, obesity, comorbidities|glycemic control, diabetes, obesity, comorbidities
736675|NCT00487149|Repeatability|repeatability
736769|NCT00486746|sleep apnea|sleep apnea
736676|NCT00487149|Respiratory Muscle Strength|respiratory muscle strength
736677|NCT00487136|Drug Interaction|drug interaction
736678|NCT00487136|Pharmacokinetics|pharmacokinetics
736679|NCT00487136|Pharmacodynamics|pharmacodynamics
736680|NCT00487123|Hypertension, compliance, Valsartan, hydrochlorothiazide (HCTZ)|hypertension, compliance, valsartan, hydrochlorothiazide (hctz)
736681|NCT00487110|Pain|pain
736682|NCT00487110|serotonin|serotonin
736683|NCT00487110|interaction|interaction
736684|NCT00487110|Patients with postsurgical pain, after ear surgery|patients with postsurgical pain, after ear surgery
736685|NCT00487097|intensive care|intensive care
736686|NCT00487097|critically ill|critically ill
736687|NCT00487097|fish oil|fish oil
736688|NCT00487097|pressure sores|pressure sores
736689|NCT00487084|analgesia|analgesia
736690|NCT00487084|tubal ligation|tubal ligation
736691|NCT00487084|chloroprocaine|chloroprocaine
736692|NCT00487071|Anal fistula|anal fistula
736693|NCT00487071|High-type|high-type
736694|NCT00487071|Anal fistula plug|anal fistula plug
736695|NCT00487071|Efficacy|efficacy
736696|NCT00487071|Recurrence|recurrence
736697|NCT00487058|Gimatecan|gimatecan
736698|NCT00487058|topoisomerase I inhibitor|topoisomerase i inhibitor
736699|NCT00487058|advanced solid tumors|advanced solid tumors
736700|NCT00487045|Hemorrhoids|hemorrhoids
736701|NCT00487045|Thrombosed External Hemorrhoids (TEH)|thrombosed external hemorrhoids (teh)
736702|NCT00487045|Reduction|reduction
736703|NCT00487045|Prevention|prevention
736704|NCT00487045|Stabilizer Device|stabilizer device
736705|NCT00487045|Pregnant|pregnant
736706|NCT00487045|Vaginal Birth|vaginal birth
736707|NCT00487045|Single Birth|single birth
736708|NCT00487045|Asymptomatic Hemorrhoids|asymptomatic hemorrhoids
736709|NCT00487032|allergic rhinitis|allergic rhinitis
736710|NCT00487032|rhinitis medicamentosa|rhinitis medicamentosa
736711|NCT00487032|imidazolines|imidazolines
736712|NCT00487032|corticosteroid|corticosteroid
736713|NCT00487019|ampicillin|ampicillin
736714|NCT00487019|penicillin G|penicillin g
736715|NCT00487019|gentamicin|gentamicin
736716|NCT00487019|neonatal sepsis|neonatal sepsis
736717|NCT00487019|empiric therapy|empiric therapy
736718|NCT00486993|Diet|diet
736719|NCT00486993|Exercise|exercise
736720|NCT00486993|Smoking|smoking
736721|NCT00486993|Stress|stress
736722|NCT00486993|Polyphenols|polyphenols
736723|NCT00486980|influenza|influenza
736724|NCT00486967|Insulin resistance, heart failure, congestive heart failure,|insulin resistance, heart failure, congestive heart failure,
736725|NCT00486967|Peak VO2, Endothelial Function, Leptin, TNF.|peak vo2, endothelial function, leptin, tnf.
736726|NCT00486954|lapatinib|lapatinib
736727|NCT00486954|paclitaxel|paclitaxel
736728|NCT00486954|ErbB2|erbb2
736729|NCT00486954|Gastric cancer|gastric cancer
736730|NCT00486954|Advanced gastric cancer|advanced gastric cancer
736731|NCT00486941|Primary Prevention|primary prevention
736732|NCT00486941|Health Promotion|health promotion
736733|NCT00486941|Diet|diet
736734|NCT00486941|Exercise|exercise
736735|NCT00486941|Risk Factors|risk factors
736736|NCT00486941|Randomized Controlled Trial|randomized controlled trial
736737|NCT00486928|Valves, heart disease, prosthesis.|valves, heart disease, prosthesis.
736738|NCT00486915|Atrial Fibrillation|atrial fibrillation
736739|NCT00486915|Left Atrial Appendage|left atrial appendage
736740|NCT00486915|Surgical Ligation|surgical ligation
736741|NCT00486915|Thromboembolism|thromboembolism
736742|NCT00486915|Cerebrovascular Accident|cerebrovascular accident
736743|NCT00486902|Ketamine|ketamine
736744|NCT00486902|Spinal Anesthesia|spinal anesthesia
736745|NCT00486902|C-section|c-section
736746|NCT00486889|Glycogenesis 2|glycogenesis 2
736747|NCT00486876|Irritable bowel syndrome|irritable bowel syndrome
736748|NCT00486876|Diarrhea predominant Irritable Bowel Syndrome|diarrhea predominant irritable bowel syndrome
736749|NCT00486876|Alternating Irritable Bowel Syndrome|alternating irritable bowel syndrome
736750|NCT00486863|Philippines, Schistosoma japonicum, Schistosomiasis, pregnant women, fetuses, 08-0049|philippines, schistosoma japonicum, schistosomiasis, pregnant women, fetuses, 08-0049
736751|NCT00486850|RDS|rds
736752|NCT00486850|Preterm|preterm
736753|NCT00486850|SIMV|simv
736754|NCT00486850|NIPPV|nippv
736755|NCT00486811|Osteoarthritis|osteoarthritis
736756|NCT00486811|Knee|knee
736757|NCT00486811|Pain Assessment|pain assessment
736758|NCT00486811|CG5503 PR|cg5503 pr
736759|NCT00486811|Centrally acting analgesic|centrally acting analgesic
736760|NCT00486811|Placebo|placebo
736761|NCT00486811|Oxycodone|oxycodone
736762|NCT00486811|Chronic Pain due to knee Osteoarthritis|chronic pain due to knee osteoarthritis
736763|NCT00486811|Tapentadol|tapentadol
736764|NCT00486798|acute schizophrenia|acute schizophrenia
736765|NCT00486798|schizoaffective disorder|schizoaffective disorder
736766|NCT00486798|psychosis Not Otherwise Specified (NOS)|psychosis not otherwise specified (nos)
736767|NCT00486798|bipolar mania with psychotic symptoms|bipolar mania with psychotic symptoms
736768|NCT00486772|This study was designed to investigate whether the suggested beneficial effects of sevelamer on VC were related to fetuin-A levels in patients with CKD.|this study was designed to investigate whether the suggested beneficial effects of sevelamer on vc were related to fetuin-a levels in patients with ckd.
736770|NCT00486746|lifestyle intervention|lifestyle intervention
736771|NCT00486746|cardiovascular|cardiovascular
736772|NCT00486733|extracorporeal shock wave therapy|extracorporeal shock wave therapy
736773|NCT00486733|soft tissue wounds|soft tissue wounds
736774|NCT00486707|Ovarian Cancer|ovarian cancer
736775|NCT00486707|Questionnaire|questionnaire
736776|NCT00486707|Genetic Testing|genetic testing
736777|NCT00486707|Survey|survey
736778|NCT00486694|Malaria, vivax|malaria, vivax
736779|NCT00486694|Afghanistan|afghanistan
736780|NCT00486694|Sulfadoxine-pyrimethamine|sulfadoxine-pyrimethamine
736781|NCT00486694|drug resistance|drug resistance
736782|NCT00486681|Glucose monitoring|glucose monitoring
736783|NCT00486681|Diabetes management|diabetes management
736784|NCT00486681|Information system|information system
736785|NCT00486681|In-patient glycemic control|in-patient glycemic control
736786|NCT00486668|HER2 positive breast cancer|her2 positive breast cancer
736787|NCT00486668|invasive breast cancer|invasive breast cancer
736788|NCT00486668|lapatinib|lapatinib
736789|NCT00486668|neoadjuvant|neoadjuvant
736790|NCT00486668|NSABP|nsabp
736791|NCT00486668|paclitaxel|paclitaxel
736792|NCT00486668|trastuzumab|trastuzumab
736793|NCT00486668|doxorubicin|doxorubicin
736794|NCT00486668|cyclophosphamide|cyclophosphamide
736795|NCT00486655|Cholecystectomy|cholecystectomy
736796|NCT00486655|NOTES|notes
736797|NCT00486655|Transgastric|transgastric
736798|NCT00486629|Exercise|exercise
736799|NCT00486629|Diet|diet
736800|NCT00486629|Pregnancy|pregnancy
736801|NCT00486629|Obesity|obesity
736802|NCT00486629|Macrosomia|macrosomia
736803|NCT00486603|adult glioblastoma|adult glioblastoma
736804|NCT00486603|adult gliosarcoma|adult gliosarcoma
736805|NCT00486603|adult giant cell glioblastoma|adult giant cell glioblastoma
736806|NCT00486590|Human milk fortification|human milk fortification
736807|NCT00486590|Premature neonate|premature neonate
736808|NCT00486590|Very low birth weight|very low birth weight
736809|NCT00486577|Hearing Disorders, Hearing Loss, Hyperacusis, Tinnitus, chronic cortical stimulation, functional magnetic resonance imaging|hearing disorders, hearing loss, hyperacusis, tinnitus, chronic cortical stimulation, functional magnetic resonance imaging
736810|NCT00486564|Treatment|treatment
736811|NCT00486564|Refractory or Relapsed|refractory or relapsed
736812|NCT00486551|Anger control training|anger control training
736813|NCT00486551|Cognitive behavioral therapy|cognitive behavioral therapy
736814|NCT00486551|Behavior therapy|behavior therapy
736815|NCT00486551|Tourette Syndrome|tourette syndrome
736816|NCT00486551|Randomized trial|randomized trial
736817|NCT00486551|Anger|anger
736818|NCT00486551|Aggression|aggression
736819|NCT00486525|fatigue|fatigue
736820|NCT00486525|depression|depression
736821|NCT00486525|pain|pain
736822|NCT00486525|cancer survivor|cancer survivor
736823|NCT00486525|stage IA breast cancer|stage ia breast cancer
736824|NCT00486525|stage IB breast cancer|stage ib breast cancer
736825|NCT00486525|stage II breast cancer|stage ii breast cancer
736826|NCT00486525|stage IIIA breast cancer|stage iiia breast cancer
736827|NCT00486525|breast cancer in situ|breast cancer in situ
736828|NCT00486512|colorectal, adenomas, prevention|colorectal, adenomas, prevention
736829|NCT00486499|radiation|radiation
736830|NCT00486499|brachytherapy|brachytherapy
736831|NCT00486499|prostate|prostate
736832|NCT00486499|cancer|cancer
736833|NCT00486486|24-hour IOP control|24-hour iop control
736834|NCT00486460|Locally advanced or metastatic adenocarcinoma of the|locally advanced or metastatic adenocarcinoma of the
736835|NCT00486460|pancreas|pancreas
736836|NCT00486460|confirmed by histology or cytology|confirmed by histology or cytology
736837|NCT00486460|Inoperatable|inoperatable
736838|NCT00486434|Osteoarthritis, oral salmon calcitonin, treatment, efficacy, tolerability|osteoarthritis, oral salmon calcitonin, treatment, efficacy, tolerability
736839|NCT00486421|idiopathic thrombocytopenic purpura|idiopathic thrombocytopenic purpura
736840|NCT00486408|HIV Seronegativity|hiv seronegativity
736841|NCT00486408|HIV Preventive Vaccine|hiv preventive vaccine
736842|NCT00486408|Adenovirus|adenovirus
736843|NCT00486395|prematurity|prematurity
736844|NCT00486395|randomized trial|randomized trial
736845|NCT00486395|RDS|rds
736846|NCT00486395|surfactant|surfactant
736847|NCT00486395|CPAP|cpap
736848|NCT00486395|ventilation|ventilation
736849|NCT00486382|visceral leishmaniasis|visceral leishmaniasis
736850|NCT00486382|vaccine|vaccine
736851|NCT00486369|Osteoarthritis, oral salmon calcitonin, tolerability, biomarkers|osteoarthritis, oral salmon calcitonin, tolerability, biomarkers
736852|NCT00486356|unspecified adult solid tumor, protocol specific|unspecified adult solid tumor, protocol specific
736853|NCT00486356|recurrent gastric cancer|recurrent gastric cancer
736854|NCT00486356|stage IV gastric cancer|stage iv gastric cancer
736855|NCT00486356|advanced adult primary liver cancer|advanced adult primary liver cancer
736856|NCT00486356|localized unresectable adult primary liver cancer|localized unresectable adult primary liver cancer
736857|NCT00486356|recurrent adult primary liver cancer|recurrent adult primary liver cancer
736858|NCT00486356|recurrent extrahepatic bile duct cancer|recurrent extrahepatic bile duct cancer
736859|NCT00486356|unresectable extrahepatic bile duct cancer|unresectable extrahepatic bile duct cancer
736860|NCT00486356|recurrent gallbladder cancer|recurrent gallbladder cancer
736861|NCT00486356|unresectable gallbladder cancer|unresectable gallbladder cancer
736862|NCT00486343|Asthma|asthma
736863|NCT00486343|ICS|ics
736864|NCT00486343|5-LO Inhibition|5-lo inhibition
736865|NCT00486343|Leukotrienes|leukotrienes
736866|NCT00486343|Asthma control|asthma control
736867|NCT00486343|Asthma exacerbations|asthma exacerbations
736868|NCT00486330|HIV|hiv
736869|NCT00486330|Pharmacokinetics|pharmacokinetics
736870|NCT00486330|Buprenorphine|buprenorphine
736871|NCT00486330|Tipranavir|tipranavir
736872|NCT00486330|HIV Seronegativity|hiv seronegativity
736873|NCT00486317|Osteoarthritis, oral salmon calcitonin, tolerability, biomarkers|osteoarthritis, oral salmon calcitonin, tolerability, biomarkers
736874|NCT00486304|cachexia|cachexia
736875|NCT00486304|weight changes|weight changes
736876|NCT00486304|recurrent oropharyngeal cancer|recurrent oropharyngeal cancer
736877|NCT00486304|stage I oropharyngeal cancer|stage i oropharyngeal cancer
736878|NCT00486304|stage II oropharyngeal cancer|stage ii oropharyngeal cancer
736879|NCT00486304|stage III oropharyngeal cancer|stage iii oropharyngeal cancer
736880|NCT00486304|stage IV oropharyngeal cancer|stage iv oropharyngeal cancer
736881|NCT00486291|Diabetes, Obese diabetics|diabetes, obese diabetics
736882|NCT00486265|Phase I|phase i
736883|NCT00486265|Phase II|phase ii
736884|NCT00486265|acute myelogenous leukemia|acute myelogenous leukemia
736885|NCT00486265|AML|aml
736886|NCT00486265|cancer|cancer
736887|NCT00486239|Epilepsy|epilepsy
736888|NCT00486239|memory|memory
736889|NCT00486239|emotion|emotion
736890|NCT00486213|dermatologic complications|dermatologic complications
736891|NCT00486213|chemotherapeutic agent toxicity|chemotherapeutic agent toxicity
736892|NCT00486213|palmar-plantar erythrodysesthesia|palmar-plantar erythrodysesthesia
736893|NCT00486213|unspecified adult solid tumor, protocol specific|unspecified adult solid tumor, protocol specific
736894|NCT00486200|ASP2151|asp2151
736895|NCT00486200|Herpes Genitalis|herpes genitalis
736896|NCT00486200|Sexually Transmitted Disease|sexually transmitted disease
736897|NCT00486200|Herpes Simplex Virus Genital Infection|herpes simplex virus genital infection
736898|NCT00486200|Treatment Outcome|treatment outcome
736899|NCT00486200|Genital Herpes|genital herpes
736900|NCT00486187|Type 2 Diabetes Mellitus|type 2 diabetes mellitus
736901|NCT00486187|Thiazolidinediones|thiazolidinediones
736902|NCT00486187|Rosiglitazone|rosiglitazone
736903|NCT00486187|Adipokine|adipokine
736904|NCT00486187|Inflammation|inflammation
736905|NCT00486187|Cardiometabolic risk|cardiometabolic risk
736906|NCT00486187|Angiotensin receptor blocker|angiotensin receptor blocker
736907|NCT00486174|Sepsis|sepsis
736908|NCT00486174|Methylene Blue|methylene blue
736909|NCT00486174|Norepinephrine|norepinephrine
736910|NCT00486161|Obesity|obesity
736911|NCT00486161|Ghrelin|ghrelin
736912|NCT00486161|Non-esterified fatty acids|non-esterified fatty acids
736913|NCT00486161|Growth hormone|growth hormone
736914|NCT00486161|Insulin|insulin
736915|NCT00486161|Cycloergometer exercise|cycloergometer exercise
736916|NCT00486148|Formula|formula
736917|NCT00486148|Feeding|feeding
736918|NCT00486148|Healthy|healthy
736919|NCT00486148|Full|full
736920|NCT00486148|Term|term
736921|NCT00486148|Infants|infants
736922|NCT00486135|Cancer|cancer
736923|NCT00486135|Solid tumors|solid tumors
736924|NCT00486135|Lymphoma|lymphoma
736925|NCT00486109|Diabetes|diabetes
736926|NCT00486096|cannulation|cannulation
736927|NCT00486096|infant|infant
736928|NCT00486096|femoral arterial|femoral arterial
736929|NCT00486070|cardiac anomaly|cardiac anomaly
736930|NCT00486070|pulmonary veins|pulmonary veins
736931|NCT00486070|cyanosis|cyanosis
736932|NCT00486070|flow reversal|flow reversal
736933|NCT00486070|TAPAVC|tapavc
736934|NCT00486057|Daclizumab|daclizumab
736935|NCT00486057|Immuno-suppression protocol|immuno-suppression protocol
736936|NCT00486057|Heart Transplant|heart transplant
736937|NCT00486057|Rejection|rejection
736938|NCT00486044|amyloid protein|amyloid protein
736939|NCT00486044|apolipoprotein|apolipoprotein
736940|NCT00486044|cerebrospinal fluid|cerebrospinal fluid
736941|NCT00486044|cerebrovascular circulation|cerebrovascular circulation
736942|NCT00486044|inflammation|inflammation
736943|NCT00486044|magnetic resonance imaging|magnetic resonance imaging
736944|NCT00486044|prevention & control|prevention & control
736945|NCT00486031|IBD|ibd
736946|NCT00486031|UC|uc
736947|NCT00486031|Ulcerative Colitis|ulcerative colitis
736948|NCT00486031|Inflammatory Bowel Disease|inflammatory bowel disease
736949|NCT00486018|Lucentis|lucentis
736950|NCT00486018|RVO|rvo
736951|NCT00486018|BRVO|brvo
736952|NCT00486018|Edema|edema
736953|NCT00485992|blood stream infection|blood stream infection
736954|NCT00485992|CICU|cicu
736955|NCT00485992|pediatric|pediatric
736956|NCT00485992|chlorhexidine swabs|chlorhexidine swabs
736957|NCT00485979|Breast Cancer|breast cancer
736958|NCT00485979|Neoadjuvant therapy|neoadjuvant therapy
736959|NCT00485966|Adult Leukemia|adult leukemia
736960|NCT00485966|CLL|cll
736961|NCT00485966|B-CLL|b-cll
736962|NCT00485966|Chronic Lymphocytic Leukemia|chronic lymphocytic leukemia
736963|NCT00485966|B-cell CLL|b-cell cll
736964|NCT00485953|Osteoporosis|osteoporosis
736965|NCT00485953|breast cancer|breast cancer
736966|NCT00485953|aromatase inhibitors|aromatase inhibitors
736967|NCT00485953|bone loss|bone loss
736968|NCT00485953|bone mineral density|bone mineral density
736969|NCT00485940|constipation|constipation
736970|NCT00485940|prucalopride|prucalopride
736971|NCT00485940|QOL|qol
736972|NCT00485940|SCBM|scbm
736973|NCT00485940|PAC-SYM|pac-sym
736974|NCT00485927|Trauma|trauma
736975|NCT00485927|Stress|stress
736976|NCT00485927|Simulation|simulation
736977|NCT00485914|employment|employment
736978|NCT00485914|work|work
736979|NCT00485836|CRVO|crvo
736980|NCT00485836|RVO|rvo
736981|NCT00485836|Lucentis|lucentis
736982|NCT00485836|Edema|edema
736983|NCT00485797|attention deficit hyperactivity disorder (ADHD)|attention deficit hyperactivity disorder (adhd)
736984|NCT00485797|Dual tasking|dual tasking
736985|NCT00485797|Postural Control|postural control
736986|NCT00485797|Methylphenidate (Ritalin)|methylphenidate (ritalin)
736987|NCT00485797|The focus of the study is To explore the effects of Ritalin on postural control in ADHD Children, during single and dual task conditions.|the focus of the study is to explore the effects of ritalin on postural control in adhd children, during single and dual task conditions.
736988|NCT00485784|Identify in a population of patients with a PE, an IUGR and a FD a modification of circulating endothelial biomarkers compared with normal pregnancy.|identify in a population of patients with a pe, an iugr and a fd a modification of circulating endothelial biomarkers compared with normal pregnancy.
736989|NCT00485745|surgery|surgery
736990|NCT00485745|repeat sternotomy|repeat sternotomy
736991|NCT00485745|pediatrics|pediatrics
736992|NCT00485732|Cervical neoplasia|cervical neoplasia
736993|NCT00485732|AS04|as04
736994|NCT00485732|Randomized|randomized
736995|NCT00485732|Cervical cancer|cervical cancer
736996|NCT00485732|HPV-16/18 L1 VLP AS04|hpv-16/18 l1 vlp as04
736997|NCT00485732|Phase IIIb|phase iiib
736998|NCT00485732|Korea|korea
736999|NCT00485732|HPV|hpv
737000|NCT00485732|Double-blind|double-blind
737001|NCT00485732|Controlled|controlled
737002|NCT00485719|Cancer|cancer
737003|NCT00485719|Solid Tumors|solid tumors
737004|NCT00485706|dialysis|dialysis
737005|NCT00485706|vascular calcification|vascular calcification
737006|NCT00485706|bone mineralism|bone mineralism
737007|NCT00485706|arterial stiffness|arterial stiffness
737008|NCT00485706|bone metabolism|bone metabolism
737009|NCT00485706|chronic kidney disease|chronic kidney disease
737010|NCT00485693|pain|pain
737011|NCT00485693|postoperative|postoperative
737012|NCT00485693|total knee arthroplasty|total knee arthroplasty
737013|NCT00485693|analgesia|analgesia
737014|NCT00485667|pain|pain
737015|NCT00485667|postoperative|postoperative
737016|NCT00485654|Heterotaxy Syndrome|heterotaxy syndrome
737017|NCT00485654|Intestinal Malrotation|intestinal malrotation
737018|NCT00485654|Functional Asplenia|functional asplenia
737019|NCT00485654|Complex Cyanotic heart disease|complex cyanotic heart disease
737020|NCT00485641|Stroke|stroke
737021|NCT00485641|SaeboFlex|saeboflex
737022|NCT00485641|Hand function|hand function
737023|NCT00485615|eicosapentaenoic acid|eicosapentaenoic acid
737024|NCT00485615|fish oil|fish oil
737025|NCT00485615|Omega 3|omega 3
737026|NCT00485615|Social Anxiety Disorder|social anxiety disorder
737027|NCT00485602|malocclusion|malocclusion
737028|NCT00485602|aligner|aligner
737029|NCT00485602|crowding|crowding
737030|NCT00485602|expansion|expansion
737031|NCT00485602|orthodontic treatment|orthodontic treatment
737032|NCT00485589|FILM|film
737033|NCT00485589|RA|ra
737034|NCT00485589|anti-CD20|anti-cd20
737035|NCT00485589|CD20|cd20
737036|NCT00485563|Cancer|cancer
737037|NCT00485563|Vaccine|vaccine
737038|NCT00485563|Phase 2|phase 2
737039|NCT00485563|folate-hapten conjugate|folate-hapten conjugate
737040|NCT00485563|Progressive|progressive
737041|NCT00485563|Metastatic|metastatic
737042|NCT00485563|Experimental|experimental
737043|NCT00485537|GnRH antagonist|gnrh antagonist
737044|NCT00485537|GnRH agonist|gnrh agonist
737045|NCT00485537|ICSI|icsi
737046|NCT00485537|miscarriage rate|miscarriage rate
737047|NCT00485537|pregnancy outcome|pregnancy outcome
737048|NCT00485524|Near Infrared Spectroscopy|near infrared spectroscopy
737049|NCT00485524|Serum Lactate Levels|serum lactate levels
737050|NCT00485524|post operative outcomes|post operative outcomes
737051|NCT00485485|Head and Neck Cancer|head and neck cancer
737052|NCT00485485|Squamous Cell Cancer|squamous cell cancer
737053|NCT00485485|Imatinib Mesylate|imatinib mesylate
737054|NCT00485485|Gleevec|gleevec
737055|NCT00485485|Imatinib|imatinib
737056|NCT00485485|STI571|sti571
737057|NCT00485485|Docetaxel|docetaxel
737058|NCT00485485|Taxotere|taxotere
737059|NCT00485472|Osteoarthritis|osteoarthritis
737060|NCT00485472|lacosamide|lacosamide
737061|NCT00485472|VIMPAT|vimpat
737062|NCT00485433|hernia|hernia
737063|NCT00485433|unilateral|unilateral
737064|NCT00485433|postoperative|postoperative
737065|NCT00485433|analgesia|analgesia
737162|NCT00484991|Hyperphenylalaninaemia|hyperphenylalaninaemia
737066|NCT00485420|Internet based disease management program|internet based disease management program
737067|NCT00485394|AMD|amd
737068|NCT00485394|age-related macular degeneration|age-related macular degeneration
737069|NCT00485394|geographic atrophy|geographic atrophy
737070|NCT00485394|GA|ga
737071|NCT00485368|marfan syndrome|marfan syndrome
737072|NCT00485368|aortic root diameter|aortic root diameter
737073|NCT00485355|hysterectomy|hysterectomy
737074|NCT00485355|Laparoscopy|laparoscopy
737075|NCT00485355|robotics|robotics
737076|NCT00485342|Chronic hepatitis C,Genotype1,Naïf,bitherapy,Ribavirin adaptation,ribavirin AUC|chronic hepatitis c,genotype1,naïf,bitherapy,ribavirin adaptation,ribavirin auc
737077|NCT00485329|Chronic Wounds, Venous Ulcers, Papain, Debridement, Continuous streaming|chronic wounds, venous ulcers, papain, debridement, continuous streaming
737078|NCT00485329|DermaStream-EnzyStream|dermastream-enzystream
737079|NCT00485316|Colorectal carcinoma|colorectal carcinoma
737080|NCT00485316|Rectal carcinoma|rectal carcinoma
737081|NCT00485316|Laparoscopy|laparoscopy
737082|NCT00485316|Laparoscopic surgery|laparoscopic surgery
737083|NCT00485316|Open surgery|open surgery
737084|NCT00485316|Randomized trial|randomized trial
737085|NCT00485303|Prostatic Neoplasms|prostatic neoplasms
737086|NCT00485303|Prostate cancer|prostate cancer
737087|NCT00485303|Abiraterone acetate|abiraterone acetate
737088|NCT00485303|CB7630|cb7630
737089|NCT00485303|Prednisone|prednisone
737090|NCT00485290|cirrhosis, Portal Hypertension, Esophageal Varices, Meal|cirrhosis, portal hypertension, esophageal varices, meal
737091|NCT00485277|Breast cancer|breast cancer
737092|NCT00485277|Vaccine|vaccine
737093|NCT00485277|Metastatic|metastatic
737094|NCT00485277|HER-2-positive|her-2-positive
737095|NCT00485277|Phase I|phase i
737096|NCT00485277|HER-2 Positive Metastatic Breast Cancer|her-2 positive metastatic breast cancer
737097|NCT00485251|operation time in minutes|operation time in minutes
737098|NCT00485251|pain score from 1-10|pain score from 1-10
737099|NCT00485251|recurrence|recurrence
737100|NCT00485251|survival|survival
737101|NCT00485238|glaucoma|glaucoma
737102|NCT00485212|postoperative pain|postoperative pain
737103|NCT00485199|Pneumatic Retinopexy|pneumatic retinopexy
737104|NCT00485199|vitrectomy|vitrectomy
737105|NCT00485199|retinal detachment|retinal detachment
737106|NCT00485199|macular hole|macular hole
737107|NCT00485199|treatment|treatment
737108|NCT00485199|multi-center|multi-center
737109|NCT00485199|Retinal Detachment due to Myopic Macular hole|retinal detachment due to myopic macular hole
737110|NCT00485160|Patent Ductus Arteriosus|patent ductus arteriosus
737111|NCT00485160|Indomethacin|indomethacin
737112|NCT00485160|Ibuprofen|ibuprofen
737113|NCT00485160|Renal effects|renal effects
737114|NCT00485147|Claudication|claudication
737115|NCT00485147|peripheral arterial disease|peripheral arterial disease
737116|NCT00485147|Diagnosis|diagnosis
737117|NCT00485147|Exercise|exercise
737118|NCT00485147|Walking impairment|walking impairment
737119|NCT00485147|Disability|disability
737120|NCT00485121|Ezetimibe|ezetimibe
737121|NCT00485121|Statin|statin
737315|NCT00484419|sitagliptin|sitagliptin
737122|NCT00485121|Low- density lipoprotein cholesterol|low- density lipoprotein cholesterol
737123|NCT00485121|Adipokine|adipokine
737124|NCT00485121|Adiponectin|adiponectin
737125|NCT00485121|C-reactive protein|c-reactive protein
737126|NCT00485121|Coronary artery disease|coronary artery disease
737127|NCT00485121|Metabolic Syndrome|metabolic syndrome
737128|NCT00485121|Obesity|obesity
737129|NCT00485108|primary open angle glaucoma|primary open angle glaucoma
737130|NCT00485108|pseudoexfoliation glaucoma|pseudoexfoliation glaucoma
737131|NCT00485108|selective laser trabeculoplasty|selective laser trabeculoplasty
737132|NCT00485108|intra ocular pressure|intra ocular pressure
737133|NCT00485108|anti-inflammatory therapy|anti-inflammatory therapy
737134|NCT00485108|prednisolone acetate 1%|prednisolone acetate 1%
737135|NCT00485108|ketorolac tromethamine 0.5%|ketorolac tromethamine 0.5%
737136|NCT00485082|Cystic Fibrosis|cystic fibrosis
737137|NCT00485082|Disclosure|disclosure
737138|NCT00485082|Dating Partner|dating partner
737139|NCT00485082|Phone Interview|phone interview
737140|NCT00485069|Ropinirole hydrochloride|ropinirole hydrochloride
737141|NCT00485069|L-dopa|l-dopa
737142|NCT00485069|Parkinson's Disease|parkinson's disease
737143|NCT00485069|Dopamine agonist|dopamine agonist
737144|NCT00485056|Diabetes|diabetes
737145|NCT00485056|Tissue doppler imaging|tissue doppler imaging
737146|NCT00485056|Wave intensity analysis.|wave intensity analysis.
737147|NCT00485043|T'ai Chi|t'ai chi
737148|NCT00485043|Osteoarthritis|osteoarthritis
737149|NCT00485043|Exercise|exercise
737150|NCT00485043|Older adults|older adults
737151|NCT00485030|coronary artery disease|coronary artery disease
737152|NCT00485030|stent|stent
737153|NCT00485030|angioplasty|angioplasty
737154|NCT00485017|Obesity|obesity
737155|NCT00485017|Weight Loss|weight loss
737156|NCT00485004|Coronary artery disease|coronary artery disease
737157|NCT00485004|Stent|stent
737158|NCT00485004|Angioplasty|angioplasty
737159|NCT00484991|Phenylketonuria|phenylketonuria
737160|NCT00484991|PKU|pku
737161|NCT00484991|Phenylketonurias|phenylketonurias
737359|NCT00484185|Safety|safety
737163|NCT00484991|Hydroxylase Deficiency|hydroxylase deficiency
737164|NCT00484978|Stereotactic Radiosurgery|stereotactic radiosurgery
737165|NCT00484978|Surgery|surgery
737166|NCT00484978|Metastatic tumor to brain|metastatic tumor to brain
737167|NCT00484978|radiation|radiation
737168|NCT00484978|Brain Metastases of all pathologies|brain metastases of all pathologies
737169|NCT00484965|Coronary stent|coronary stent
737170|NCT00484965|Inflammation|inflammation
737171|NCT00484965|Atherosclerosis|atherosclerosis
737172|NCT00484965|Immunosuppressive|immunosuppressive
737173|NCT00484952|rotavirus|rotavirus
737174|NCT00484952|diarrheal diseases|diarrheal diseases
737175|NCT00484952|hospitalizations|hospitalizations
737176|NCT00484952|multicenter|multicenter
737177|NCT00484952|children|children
737178|NCT00484952|under five year old|under five year old
737179|NCT00484952|Hospitalization due to diarhheal diseases|hospitalization due to diarhheal diseases
737180|NCT00484952|Hospitalization due to rotavirus gastroenteritis|hospitalization due to rotavirus gastroenteritis
737181|NCT00484952|Nosocomial rotavirus infections|nosocomial rotavirus infections
737182|NCT00484926|coronary disease|coronary disease
737183|NCT00484926|stents|stents
737184|NCT00484926|antiplatelet drugs|antiplatelet drugs
737185|NCT00484926|drug-eluting stents|drug-eluting stents
737186|NCT00484913|healthy subjects|healthy subjects
737187|NCT00484900|Open randomized multi-centre clinical trial in Africa|open randomized multi-centre clinical trial in africa
737188|NCT00484900|Uncomplicated P. falciparum malaria|uncomplicated p. falciparum malaria
737189|NCT00484900|Artemisinin-based Combination Therapy|artemisinin-based combination therapy
737190|NCT00484900|Artesunate + sulfalene + pyrimethamine|artesunate + sulfalene + pyrimethamine
737191|NCT00484900|24 hour treatment|24 hour treatment
737192|NCT00484900|Artemether + lumefantrine|artemether + lumefantrine
737193|NCT00484887|Hernia mesh|hernia mesh
737194|NCT00484887|Implanted mesh material|implanted mesh material
737195|NCT00484887|Explanted mesh material|explanted mesh material
737196|NCT00484874|Hodgkin's lymphoma|hodgkin's lymphoma
737197|NCT00484874|Radioimmunotherapy|radioimmunotherapy
737198|NCT00484874|Bexxar|bexxar
737199|NCT00484874|I-131 Tositumomab|i-131 tositumomab
737200|NCT00484874|Safety|safety
737201|NCT00484874|Efficacy|efficacy
737202|NCT00484874|Nuclear Medicine|nuclear medicine
737203|NCT00484874|Monoclonal antibody|monoclonal antibody
737204|NCT00484874|Radiolabeled|radiolabeled
737205|NCT00484861|Women|women
737206|NCT00484861|Healthy Volunteers|healthy volunteers
737207|NCT00484861|Triglyceride|triglyceride
737208|NCT00484861|Healthy Volunteer|healthy volunteer
737209|NCT00484861|HV|hv
737210|NCT00484848|oncology, medical|oncology, medical
737211|NCT00484848|implantable catheter|implantable catheter
737212|NCT00484848|vascular access ports|vascular access ports
737213|NCT00484848|persistent withdrawal occlusion|persistent withdrawal occlusion
737214|NCT00484848|Vortex®|vortex®
737215|NCT00484848|Celsite®|celsite®
737216|NCT00484848|Vacutainer®|vacutainer®
737217|NCT00484848|venous cut-down|venous cut-down
737218|NCT00484835|Abdominal|abdominal
737219|NCT00484835|Hysterectomy|hysterectomy
737220|NCT00484835|Electrocoagulation forceps|electrocoagulation forceps
737221|NCT00484835|Electrosurgery|electrosurgery
737222|NCT00484835|Gyrus plasma open seal forceps|gyrus plasma open seal forceps
737223|NCT00484835|Patients undergoing abdominal hysterectomy for various reasons|patients undergoing abdominal hysterectomy for various reasons
737224|NCT00484809|rheumatoid arthritis|rheumatoid arthritis
737225|NCT00484809|juvenile rheumatoid arthritis|juvenile rheumatoid arthritis
737226|NCT00484796|Carotid Surgery|carotid surgery
737227|NCT00484796|Cerebral Ischemia|cerebral ischemia
737228|NCT00484796|Cognitive Deficits|cognitive deficits
737229|NCT00484796|Somatosensory-evoked Potentials|somatosensory-evoked potentials
737230|NCT00484796|Neuromonitoring|neuromonitoring
737231|NCT00484783|Laparoscopic Surgical Procedures|laparoscopic surgical procedures
737232|NCT00484783|Endoscopic Surgical Procedures|endoscopic surgical procedures
737233|NCT00484783|Laparoscopic & endoscopic procedures with a gastrotomy|laparoscopic & endoscopic procedures with a gastrotomy
737234|NCT00484783|or opening in bladder or urethra|or opening in bladder or urethra
737235|NCT00484770|heart failure, brain natriuretic peptide|heart failure, brain natriuretic peptide
737236|NCT00484757|Narcolepsy|narcolepsy
737237|NCT00484757|Orexines|orexines
737238|NCT00484757|sleep|sleep
737239|NCT00484757|cognition|cognition
737240|NCT00484757|cytokines|cytokines
737241|NCT00484744|pain|pain
737242|NCT00484744|orthodontic|orthodontic
737243|NCT00484744|acetaminophen|acetaminophen
737244|NCT00484744|ibuprofen|ibuprofen
737245|NCT00484744|separator|separator
737246|NCT00484705|Androgens|androgens
737247|NCT00484705|Menstrual pattern|menstrual pattern
737248|NCT00484705|Insulin resistance|insulin resistance
737249|NCT00484705|Adipocytes|adipocytes
737250|NCT00484705|Obesity|obesity
737251|NCT00484705|Stress|stress
737252|NCT00484705|Muscle sympathetic nerve activity|muscle sympathetic nerve activity
737253|NCT00484705|Psychological distress and quality of life|psychological distress and quality of life
737254|NCT00484692|randomized controlled trial|randomized controlled trial
737255|NCT00484692|smoking cessation|smoking cessation
737256|NCT00484692|nicotine dependence|nicotine dependence
737257|NCT00484692|sustained-release bupropion|sustained-release bupropion
737258|NCT00484692|psychotherapy|psychotherapy
737259|NCT00484692|psychodynamic model training|psychodynamic model training
737260|NCT00484666|recurrent|recurrent
737261|NCT00484666|platinum|platinum
737262|NCT00484666|resistant|resistant
737263|NCT00484666|ovarian|ovarian
737264|NCT00484666|primary|primary
737265|NCT00484666|peritoneal|peritoneal
737266|NCT00484666|cancer|cancer
737267|NCT00484653|To achieve a quality and quantitative molecular biology assay for vaginal flora abnormalities|to achieve a quality and quantitative molecular biology assay for vaginal flora abnormalities
737268|NCT00484627|Exercise|exercise
737270|NCT00484627|Creatine|creatine
737271|NCT00484627|Muscle|muscle
737272|NCT00484614|Breast Cancer, breast conserving surgery|breast cancer, breast conserving surgery
737273|NCT00484588|VAP|vap
737274|NCT00484575|Sevoflurane|sevoflurane
737275|NCT00484575|CABG|cabg
737276|NCT00484575|cardioprotection|cardioprotection
737277|NCT00484575|AnaConDa|anaconda
737278|NCT00484562|oxygen|oxygen
737279|NCT00484562|COPD|copd
737280|NCT00484562|exercise|exercise
737281|NCT00484549|Fabry disease, Screening, Ischemic stroke|fabry disease, screening, ischemic stroke
737282|NCT00484536|CDP323|cdp323
737283|NCT00484536|Relapsing Multiple Sclerosis|relapsing multiple sclerosis
737284|NCT00484536|Magnetic Resonance Imaging|magnetic resonance imaging
737285|NCT00484536|Oral Compound|oral compound
737286|NCT00484536|MS|ms
737287|NCT00484523|To constitute a standardized database of multimode neural imaging.|to constitute a standardized database of multimode neural imaging.
737288|NCT00484510|Ascorbic Acid|ascorbic acid
737289|NCT00484510|Vitamin C|vitamin c
737290|NCT00484510|Charcot Marie Tooth|charcot marie tooth
737291|NCT00484510|CMT|cmt
737292|NCT00484510|CMT1a|cmt1a
737293|NCT00484497|Sleep quality|sleep quality
737294|NCT00484497|food supplement|food supplement
737295|NCT00484497|randomized controlled trial|randomized controlled trial
737296|NCT00484497|actigraphy|actigraphy
737297|NCT00484497|Leeds|leeds
737298|NCT00484497|Volunteers presenting moderate primary insomnia|volunteers presenting moderate primary insomnia
737299|NCT00484484|Cancer|cancer
737300|NCT00484484|Refractory pain|refractory pain
737301|NCT00484484|Uncontrolled pain|uncontrolled pain
737302|NCT00484484|Ketamine|ketamine
737303|NCT00484484|Uncontrolled cancer pain|uncontrolled cancer pain
737304|NCT00484458|Degenerative Disc Disease|degenerative disc disease
737305|NCT00484458|Total Disc Replacement|total disc replacement
737306|NCT00484445|Chronic critical illness|chronic critical illness
737307|NCT00484445|Functional status|functional status
737308|NCT00484445|Outcomes|outcomes
737309|NCT00484445|Post-ICU|post-icu
737310|NCT00484432|NGR-hTNF|ngr-htnf
737311|NCT00484432|Ovarian cancer|ovarian cancer
737312|NCT00484432|Doxorubicin|doxorubicin
737313|NCT00484419|Colesevelam HCl,|colesevelam hcl,
737314|NCT00484419|rosiglitazone|rosiglitazone
737316|NCT00484419|Type 2 diabetes|type 2 diabetes
737317|NCT00484419|metformin|metformin
737318|NCT00484406|Matrix Metalloproteinases|matrix metalloproteinases
737319|NCT00484406|Atherosclerosis|atherosclerosis
737320|NCT00484406|Genetic polymorphism|genetic polymorphism
737321|NCT00484406|Acute coronary syndromes|acute coronary syndromes
737322|NCT00484380|Valvular surgery|valvular surgery
737323|NCT00484380|Diagnostic accuracy of coronary angiography|diagnostic accuracy of coronary angiography
737324|NCT00484380|Coronary stenosis|coronary stenosis
737325|NCT00484380|Coronary revascularisation|coronary revascularisation
737326|NCT00484367|Alcohol abuse|alcohol abuse
737327|NCT00484367|Substance abuse|substance abuse
737328|NCT00484367|Cannabis abuse|cannabis abuse
737329|NCT00484367|Adolescents|adolescents
737330|NCT00484367|Group therapy|group therapy
737331|NCT00484367|Family therapy|family therapy
737332|NCT00484354|Acute Renal Failure|acute renal failure
737333|NCT00484354|Cardiac Surgery|cardiac surgery
737334|NCT00484354|Sodium Bicarbonate|sodium bicarbonate
737335|NCT00484354|Length of Stay|length of stay
737336|NCT00484354|Mortality|mortality
737337|NCT00484341|NGR-hTNF|ngr-htnf
737338|NCT00484341|Doxorubicin|doxorubicin
737339|NCT00484341|Soft Tissue Sarcoma|soft tissue sarcoma
737340|NCT00484328|hepatitis C|hepatitis c
737341|NCT00484328|Ribavirin|ribavirin
737343|NCT00484328|Pharmacokinetics|pharmacokinetics
737344|NCT00484315|drug-eluting stent|drug-eluting stent
737345|NCT00484315|paclitaxel-eluting stent|paclitaxel-eluting stent
737346|NCT00484315|DES|des
737347|NCT00484302|Marijuana Abuse|marijuana abuse
737348|NCT00484302|Psychotic Disorders|psychotic disorders
737349|NCT00484302|Schizophrenia|schizophrenia
737350|NCT00484276|NGR-hTNF|ngr-htnf
737351|NCT00484276|malignant pleural mesothelioma|malignant pleural mesothelioma
737352|NCT00484250|Oral Lichen Planus|oral lichen planus
737353|NCT00484250|Metronidazole|metronidazole
737354|NCT00484250|Doxycycline|doxycycline
737355|NCT00484237|Rheumatoid Arthritis|rheumatoid arthritis
737356|NCT00484211|NGR-hTNF, Hepatocellular Carcinoma (HCC)|ngr-htnf, hepatocellular carcinoma (hcc)
737357|NCT00484185|Hemophilia B|hemophilia b
737358|NCT00484185|BeneFIX|benefix
737362|NCT00484159|Low back pain of suspected lumbar zygapophysial etiology|low back pain of suspected lumbar zygapophysial etiology
737363|NCT00484146|Sepsis|sepsis
737364|NCT00484146|Early Stage|early stage
737365|NCT00484146|Immune System|immune system
737366|NCT00484146|Receptors|receptors
737367|NCT00484146|Cytokines|cytokines
737368|NCT00484133|sepsis|sepsis
737369|NCT00484133|severe sepsis|severe sepsis
737370|NCT00484133|microcirculation|microcirculation
737371|NCT00484133|Orthogonal polarisation spectral|orthogonal polarisation spectral
737372|NCT00484120|Osteoarthritis|osteoarthritis
737373|NCT00484120|Diclofenac|diclofenac
737374|NCT00484120|Nano-emulsion|nano-emulsion
737375|NCT00484094|Rapamune|rapamune
737376|NCT00484094|Safety|safety
737377|NCT00484094|Efficacy|efficacy
737378|NCT00484094|Kidney Transplantation|kidney transplantation
737379|NCT00484081|TESE|tese
737380|NCT00484081|NON-OBSTRUCTIVE|non-obstructive
737381|NCT00484081|MICRODISSECTION|microdissection
737382|NCT00484081|AZOOSPERMIA|azoospermia
737383|NCT00484081|ICSI|icsi
737384|NCT00484068|type 2 diabetes|type 2 diabetes
737385|NCT00484068|microalbuminuria|microalbuminuria
737386|NCT00484068|chicken-based diet|chicken-based diet
737387|NCT00484068|ACE inhibitor|ace inhibitor
737388|NCT00484055|Antibiotic Prophylaxis|antibiotic prophylaxis
737389|NCT00484042|pancreatitis|pancreatitis
737390|NCT00484042|polyamine|polyamine
737391|NCT00484042|cytokine|cytokine
737392|NCT00484029|Temporomandibular Disorders|temporomandibular disorders
737393|NCT00484029|TMD|tmd
737394|NCT00484029|TMJ/TMD|tmj/tmd
737395|NCT00484029|Pain Management|pain management
737396|NCT00484029|Pain|pain
737397|NCT00484029|Headaches|headaches
737398|NCT00484016|adjuvant|adjuvant
737399|NCT00484016|chemotherapy|chemotherapy
737400|NCT00484016|observation|observation
737401|NCT00484016|resected|resected
737402|NCT00484016|cancers|cancers
737403|NCT00484003|Atopic eczema|atopic eczema
737404|NCT00484003|Pimecrolimus|pimecrolimus
737405|NCT00484003|Children|children
737406|NCT00484003|Quality of life|quality of life
737407|NCT00484003|Safety|safety
737408|NCT00484003|Atopic dermatitis|atopic dermatitis
737409|NCT00483990|Phase I Study in healthy subjects|phase i study in healthy subjects
737410|NCT00483964|Schizophrenia|schizophrenia
737411|NCT00483964|Herbal extracts|herbal extracts
737412|NCT00483964|Randomized|randomized
737413|NCT00483964|Controlled|controlled
737414|NCT00483964|Clinical Trial|clinical trial
737415|NCT00483951|Transthoracic echocardiography|transthoracic echocardiography
737416|NCT00483951|Ischemia|ischemia
737417|NCT00483951|Cardiovascular Disease|cardiovascular disease
737418|NCT00483951|Heart Disease|heart disease
737419|NCT00483951|Congenital Heart Disease|congenital heart disease
737420|NCT00483951|Heart Valve Disease|heart valve disease
737421|NCT00483951|Atherosclerosis|atherosclerosis
737422|NCT00483925|Langerhans cell histiocytosis|langerhans cell histiocytosis
737423|NCT00483925|flow mediated dilatation|flow mediated dilatation
737424|NCT00483925|intima media thickness|intima media thickness
737425|NCT00483925|insulin resistance|insulin resistance
737426|NCT00483925|hypopituitarism|hypopituitarism
737427|NCT00483925|glucose and lipid metabolism,|glucose and lipid metabolism,
737428|NCT00483925|structural arterial and functional endothelial properties in patients with multisystem LCH|structural arterial and functional endothelial properties in patients with multisystem lch
737429|NCT00483912|pancreatitis, MARS|pancreatitis, mars
737430|NCT00483912|severe acute pancreatitis with early multiple organ failure|severe acute pancreatitis with early multiple organ failure
737431|NCT00483899|GW870086X Asthma Crossover repeat dose inhaled|gw870086x asthma crossover repeat dose inhaled
737432|NCT00483886|constipation|constipation
737433|NCT00483886|prucalopride|prucalopride
737434|NCT00483886|QOL|qol
737435|NCT00483886|SCBM|scbm
737436|NCT00483886|PAC-SYM|pac-sym
737437|NCT00483873|Cardiac Arrest, Neurological Recovery, EEG, Quantitative EEG|cardiac arrest, neurological recovery, eeg, quantitative eeg
737438|NCT00483860|Cancer|cancer
737439|NCT00483860|Solid tumor,|solid tumor,
737440|NCT00483860|normal renal function|normal renal function
737441|NCT00483860|renal impairment,|renal impairment,
737442|NCT00483860|prior platinum-based chemotherapy,|prior platinum-based chemotherapy,
737443|NCT00483847|TYGRIS - Rest of World (ROW)|tygris - rest of world (row)
737444|NCT00483847|TYSABRI|tysabri
737445|NCT00483847|natalizumab|natalizumab
737446|NCT00483847|Multiple Sclerosis|multiple sclerosis
737447|NCT00483834|Bevacizumab|bevacizumab
737448|NCT00483834|Avastin|avastin
737449|NCT00483834|CPT-11|cpt-11
737450|NCT00483834|Irinotecan|irinotecan
737451|NCT00483834|Camptothecin-11|camptothecin-11
737452|NCT00483834|Capecitabine|capecitabine
737453|NCT00483834|Xeloda|xeloda
737454|NCT00483834|Metastatic|metastatic
737455|NCT00483834|Colorectal|colorectal
737456|NCT00483834|Colon|colon
737457|NCT00483834|Rectal|rectal
737458|NCT00483821|stage I squamous cell carcinoma of the hypopharynx|stage i squamous cell carcinoma of the hypopharynx
737459|NCT00483821|stage II squamous cell carcinoma of the hypopharynx|stage ii squamous cell carcinoma of the hypopharynx
737526|NCT00483756|kidney transplantation.|kidney transplantation.
737460|NCT00483821|stage III squamous cell carcinoma of the hypopharynx|stage iii squamous cell carcinoma of the hypopharynx
737461|NCT00483821|stage IV squamous cell carcinoma of the hypopharynx|stage iv squamous cell carcinoma of the hypopharynx
737462|NCT00483821|stage I squamous cell carcinoma of the larynx|stage i squamous cell carcinoma of the larynx
737463|NCT00483821|stage II squamous cell carcinoma of the larynx|stage ii squamous cell carcinoma of the larynx
737464|NCT00483821|stage III squamous cell carcinoma of the larynx|stage iii squamous cell carcinoma of the larynx
737465|NCT00483821|stage IV squamous cell carcinoma of the larynx|stage iv squamous cell carcinoma of the larynx
737466|NCT00483821|stage I squamous cell carcinoma of the lip and oral cavity|stage i squamous cell carcinoma of the lip and oral cavity
737467|NCT00483821|stage II squamous cell carcinoma of the lip and oral cavity|stage ii squamous cell carcinoma of the lip and oral cavity
737468|NCT00483821|stage III squamous cell carcinoma of the lip and oral cavity|stage iii squamous cell carcinoma of the lip and oral cavity
737469|NCT00483821|stage IV squamous cell carcinoma of the lip and oral cavity|stage iv squamous cell carcinoma of the lip and oral cavity
737470|NCT00483821|stage I squamous cell carcinoma of the oropharynx|stage i squamous cell carcinoma of the oropharynx
737471|NCT00483821|stage II squamous cell carcinoma of the oropharynx|stage ii squamous cell carcinoma of the oropharynx
737472|NCT00483821|stage III squamous cell carcinoma of the oropharynx|stage iii squamous cell carcinoma of the oropharynx
737473|NCT00483821|stage IV squamous cell carcinoma of the oropharynx|stage iv squamous cell carcinoma of the oropharynx
737474|NCT00483821|stage I verrucous carcinoma of the larynx|stage i verrucous carcinoma of the larynx
737475|NCT00483821|stage II verrucous carcinoma of the larynx|stage ii verrucous carcinoma of the larynx
737476|NCT00483821|stage III verrucous carcinoma of the larynx|stage iii verrucous carcinoma of the larynx
737477|NCT00483821|stage IV verrucous carcinoma of the larynx|stage iv verrucous carcinoma of the larynx
737478|NCT00483821|stage I verrucous carcinoma of the oral cavity|stage i verrucous carcinoma of the oral cavity
737479|NCT00483821|stage II verrucous carcinoma of the oral cavity|stage ii verrucous carcinoma of the oral cavity
737480|NCT00483821|stage III verrucous carcinoma of the oral cavity|stage iii verrucous carcinoma of the oral cavity
737481|NCT00483821|stage IV verrucous carcinoma of the oral cavity|stage iv verrucous carcinoma of the oral cavity
737482|NCT00483782|stage IV ovarian epithelial cancer|stage iv ovarian epithelial cancer
737483|NCT00483782|Brenner tumor|brenner tumor
737484|NCT00483782|ovarian carcinosarcoma|ovarian carcinosarcoma
737485|NCT00483782|ovarian clear cell cystadenocarcinoma|ovarian clear cell cystadenocarcinoma
737486|NCT00483782|ovarian endometrioid adenocarcinoma|ovarian endometrioid adenocarcinoma
737487|NCT00483782|ovarian mixed epithelial carcinoma|ovarian mixed epithelial carcinoma
737488|NCT00483782|ovarian mucinous cystadenocarcinoma|ovarian mucinous cystadenocarcinoma
737489|NCT00483782|ovarian serous cystadenocarcinoma|ovarian serous cystadenocarcinoma
737490|NCT00483782|ovarian undifferentiated adenocarcinoma|ovarian undifferentiated adenocarcinoma
737491|NCT00483782|stage IA ovarian epithelial cancer|stage ia ovarian epithelial cancer
737492|NCT00483782|stage IB ovarian epithelial cancer|stage ib ovarian epithelial cancer
737493|NCT00483782|stage IC ovarian epithelial cancer|stage ic ovarian epithelial cancer
737494|NCT00483782|stage IIA ovarian epithelial cancer|stage iia ovarian epithelial cancer
737495|NCT00483782|stage IIB ovarian epithelial cancer|stage iib ovarian epithelial cancer
737496|NCT00483782|stage IIC ovarian epithelial cancer|stage iic ovarian epithelial cancer
737497|NCT00483782|stage IIIA ovarian epithelial cancer|stage iiia ovarian epithelial cancer
737498|NCT00483782|stage IIIB ovarian epithelial cancer|stage iiib ovarian epithelial cancer
737499|NCT00483782|stage IIIC ovarian epithelial cancer|stage iiic ovarian epithelial cancer
737500|NCT00483782|stage IA fallopian tube cancer|stage ia fallopian tube cancer
737501|NCT00483782|stage IB fallopian tube cancer|stage ib fallopian tube cancer
737502|NCT00483782|stage IC fallopian tube cancer|stage ic fallopian tube cancer
737503|NCT00483782|stage IIA fallopian tube cancer|stage iia fallopian tube cancer
737504|NCT00483782|stage IIB fallopian tube cancer|stage iib fallopian tube cancer
737505|NCT00483782|stage IIC fallopian tube cancer|stage iic fallopian tube cancer
737506|NCT00483782|stage IIIA fallopian tube cancer|stage iiia fallopian tube cancer
737507|NCT00483782|stage IIIB fallopian tube cancer|stage iiib fallopian tube cancer
737508|NCT00483782|stage IIIC fallopian tube cancer|stage iiic fallopian tube cancer
737509|NCT00483782|stage IV fallopian tube cancer|stage iv fallopian tube cancer
737510|NCT00483782|stage IA primary peritoneal cavity cancer|stage ia primary peritoneal cavity cancer
737511|NCT00483782|stage IB primary peritoneal cavity cancer|stage ib primary peritoneal cavity cancer
737512|NCT00483782|stage IC primary peritoneal cavity cancer|stage ic primary peritoneal cavity cancer
737513|NCT00483782|stage IIA primary peritoneal cavity cancer|stage iia primary peritoneal cavity cancer
737514|NCT00483782|stage IIB primary peritoneal cavity cancer|stage iib primary peritoneal cavity cancer
737515|NCT00483782|stage IIC primary peritoneal cavity cancer|stage iic primary peritoneal cavity cancer
737516|NCT00483782|stage IIIA primary peritoneal cavity cancer|stage iiia primary peritoneal cavity cancer
737517|NCT00483782|stage IIIB primary peritoneal cavity cancer|stage iiib primary peritoneal cavity cancer
737518|NCT00483782|stage IIIC primary peritoneal cavity cancer|stage iiic primary peritoneal cavity cancer
737519|NCT00483782|stage IV primary peritoneal cavity cancer|stage iv primary peritoneal cavity cancer
737520|NCT00483769|Cystis Fibrosis|cystis fibrosis
737521|NCT00483769|Glucose intolerance|glucose intolerance
737522|NCT00483769|Glargine|glargine
737523|NCT00483769|FEV1%|fev1%
737524|NCT00483756|Immunosuppression|immunosuppression
737525|NCT00483756|JAK3 inhibitor|jak3 inhibitor
737529|NCT00483704|multiple attacks of moderate to severe migraine headaches|multiple attacks of moderate to severe migraine headaches
737530|NCT00483691|Intervention|intervention
737531|NCT00483691|Home Visit|home visit
737532|NCT00483691|Growth|growth
737533|NCT00483691|Child Development|child development
737534|NCT00483678|psychosocial effects of cancer and its treatment|psychosocial effects of cancer and its treatment
737535|NCT00483678|sexual dysfunction|sexual dysfunction
737536|NCT00483678|sexuality and reproductive issues|sexuality and reproductive issues
737537|NCT00483678|recurrent prostate cancer|recurrent prostate cancer
737538|NCT00483678|stage III prostate cancer|stage iii prostate cancer
737539|NCT00483678|stage IV prostate cancer|stage iv prostate cancer
737540|NCT00483665|endoleak|endoleak
737541|NCT00483652|multiple sclerosis|multiple sclerosis
737542|NCT00483652|MS|ms
737543|NCT00483652|walking|walking
737544|NCT00483652|leg strength|leg strength
737545|NCT00483652|demyelination|demyelination
737546|NCT00483639|anxiety disorder|anxiety disorder
737547|NCT00483639|long-term effects secondary to cancer therapy in adults|long-term effects secondary to cancer therapy in adults
737548|NCT00483639|head and neck cancer|head and neck cancer
737549|NCT00483639|non-small cell lung cancer|non-small cell lung cancer
737550|NCT00483639|small cell lung cancer|small cell lung cancer
737551|NCT00483626|hemodynamic|hemodynamic
737552|NCT00483626|pulmonary hypertension|pulmonary hypertension
737553|NCT00483626|sildenafil|sildenafil
737554|NCT00483613|Daily stress|daily stress
737555|NCT00483613|Cognitive-behavioral therapy|cognitive-behavioral therapy
737556|NCT00483613|Quality of life|quality of life
737557|NCT00483613|SLEDAI|sledai
737558|NCT00483600|Fondaparinux|fondaparinux
737559|NCT00483600|Pharmacokinetic|pharmacokinetic
737560|NCT00483587|NSTEMI|nstemi
737561|NCT00483587|Acute coronary syndrome|acute coronary syndrome
737562|NCT00483587|Heme arginate|heme arginate
737563|NCT00483587|HO-1|ho-1
737564|NCT00483587|Heme oxygenase-1|heme oxygenase-1
737565|NCT00483574|Menactra® vaccine|menactra® vaccine
737566|NCT00483574|Meningococcal meningitis|meningococcal meningitis
737567|NCT00483574|Measles|measles
737568|NCT00483574|Mumps|mumps
737569|NCT00483574|Rubella|rubella
737570|NCT00483574|Varicella virus|varicella virus
737571|NCT00483574|Haemophilus influenzae type b|haemophilus influenzae type b
737572|NCT00483574|Pneumococcal conjugate vaccine|pneumococcal conjugate vaccine
737573|NCT00483561|adenocarcinoma of the prostate|adenocarcinoma of the prostate
737574|NCT00483561|recurrent prostate cancer|recurrent prostate cancer
737575|NCT00483561|stage III prostate cancer|stage iii prostate cancer
737576|NCT00483561|stage IV prostate cancer|stage iv prostate cancer
737577|NCT00483535|Gw273225, Oral Contraceptive Interaction|gw273225, oral contraceptive interaction
737578|NCT00483522|Rehabilitation|rehabilitation
737579|NCT00483522|Directive counseling|directive counseling
737580|NCT00483522|Brain injuries|brain injuries
737581|NCT00483509|NGR-hTNF|ngr-htnf
737582|NCT00483509|SCLC|sclc
737583|NCT00483483|HIV|hiv
737584|NCT00483483|Unsafe sex|unsafe sex
737585|NCT00483483|High-risk sex|high-risk sex
737586|NCT00483483|Needle sharing|needle sharing
737587|NCT00483483|STDs|stds
737588|NCT00483470|Hepatitis A|hepatitis a
737589|NCT00483457|unspecified adult solid tumor, protocol specific|unspecified adult solid tumor, protocol specific
737590|NCT00483444|Rehabilitation|rehabilitation
737591|NCT00483444|Brain injuries|brain injuries
737592|NCT00483444|Directive counseling|directive counseling
737593|NCT00483431|vitamin K2|vitamin k2
737594|NCT00483431|dosis-response|dosis-response
737595|NCT00483431|osteocalcin|osteocalcin
737596|NCT00483431|matrix-gla protein|matrix-gla protein
737597|NCT00483418|male|male
737598|NCT00483418|cancer|cancer
737599|NCT00483405|advanced adult primary liver cancer|advanced adult primary liver cancer
737600|NCT00483405|localized unresectable adult primary liver cancer|localized unresectable adult primary liver cancer
737601|NCT00483405|recurrent adult primary liver cancer|recurrent adult primary liver cancer
737602|NCT00483405|adult primary hepatocellular carcinoma|adult primary hepatocellular carcinoma
737603|NCT00483392|insulin|insulin
737604|NCT00483392|rosiglitazone|rosiglitazone
737605|NCT00483392|metformin|metformin
737606|NCT00483392|hiv|hiv
737607|NCT00483392|protease inhibitors|protease inhibitors
737608|NCT00483366|unspecified adult solid tumor, protocol specific|unspecified adult solid tumor, protocol specific
737609|NCT00483327|Well|well
737610|NCT00483327|Moderately|moderately
737611|NCT00483327|Differentiated|differentiated
737612|NCT00483301|Melanoma|melanoma
737613|NCT00483301|Abraxane|abraxane
737614|NCT00483301|Sorafenib|sorafenib
737615|NCT00483301|BAY 43-9006|bay 43-9006
737616|NCT00483301|Abraxis|abraxis
737617|NCT00483288|cervical cancer|cervical cancer
737618|NCT00483275|Accidental Falls|accidental falls
737619|NCT00483275|Accident Prevention|accident prevention
737620|NCT00483275|Patient Education|patient education
737621|NCT00483275|Exercise Training|exercise training
737622|NCT00483275|Alfacalcidol|alfacalcidol
737623|NCT00483262|Temsirolimus|temsirolimus
737624|NCT00483262|Bortezomib|bortezomib
737625|NCT00483249|Thoracoabdominal|thoracoabdominal
737626|NCT00483249|Paravisceral|paravisceral
737627|NCT00483249|Aneurysm|aneurysm
737628|NCT00483249|Endovascular|endovascular
737629|NCT00483249|Stent-Graft|stent-graft
737630|NCT00483249|Aorta|aorta
737631|NCT00483236|Non-Ischaemic Cardiomyopathy|non-ischaemic cardiomyopathy
737632|NCT00483223|ER negative|er negative
737633|NCT00483223|PgR negative|pgr negative
737634|NCT00483223|HER2 negative|her2 negative
737635|NCT00483223|cisplatin|cisplatin
737636|NCT00483223|carboplatinum|carboplatinum
737637|NCT00483223|platinum|platinum
737638|NCT00483223|p63|p63
737639|NCT00483223|p73|p73
737640|NCT00483197|VentrAssistTM|ventrassisttm
737641|NCT00483197|LVAD|lvad
737642|NCT00483197|End-stage heart failure|end-stage heart failure
737643|NCT00483197|Cardiomyopathy|cardiomyopathy
737644|NCT00483158|Helicobacter pylori|helicobacter pylori
737645|NCT00483158|Fluoroquinolones|fluoroquinolones
737646|NCT00483158|First in Man|first in man
737647|NCT00483119|pemphigus vulgaris|pemphigus vulgaris
737648|NCT00483119|IVIg|ivig
737649|NCT00483119|cyclophosphamide|cyclophosphamide
737650|NCT00483119|treatment|treatment
737651|NCT00483119|pemphigus antibodies|pemphigus antibodies
737652|NCT00483106|Attention Deficit Hyperactivity Disorder|attention deficit hyperactivity disorder
737653|NCT00483106|Genetics|genetics
737654|NCT00483106|Pharmacogenetics|pharmacogenetics
737655|NCT00483093|NGR-hTNF|ngr-htnf
737656|NCT00483093|cisplatin|cisplatin
737657|NCT00483093|solid tumors|solid tumors
737658|NCT00483080|NGR-hTNF|ngr-htnf
737659|NCT00483080|CRC|crc
737660|NCT00483067|Idiopathic Hypereosinophilic Syndrome|idiopathic hypereosinophilic syndrome
737661|NCT00483067|Leukemia|leukemia
737662|NCT00483067|2-Chlorodeoxyadenosine|2-chlorodeoxyadenosine
737663|NCT00483067|Cladribine|cladribine
737664|NCT00483067|Cytarabine|cytarabine
737665|NCT00483067|Ara-C|ara-c
737666|NCT00483067|2-CdA|2-cda
737667|NCT00483067|G-CSF|g-csf
737668|NCT00483067|HES|hes
737669|NCT00483054|HIV|hiv
737670|NCT00483054|tuberculosis|tuberculosis
737671|NCT00483054|efavirenz|efavirenz
737672|NCT00483054|nevirapine|nevirapine
737673|NCT00483054|rifampicin|rifampicin
737674|NCT00483054|co-infected HIV and tuberculosis patients|co-infected hiv and tuberculosis patients
737675|NCT00483015|presentation|presentation
737676|NCT00483015|outcome|outcome
737677|NCT00483015|response|response
737678|NCT00483015|never- smokers|never- smokers
737679|NCT00483002|A prospective and observational program to monitor use in real practice including efficacy of Varenicline in Korea.|a prospective and observational program to monitor use in real practice including efficacy of varenicline in korea.
737680|NCT00482963|HIV|hiv
737995|NCT00481897|nutrition|nutrition
737681|NCT00482963|Contraception|contraception
737682|NCT00482963|Antiretroviral agents|antiretroviral agents
737683|NCT00482963|Pharmacokinetics|pharmacokinetics
737685|NCT00482937|Heart Failure|heart failure
737686|NCT00482924|obesity|obesity
737687|NCT00482924|cardiovascular risk profiles|cardiovascular risk profiles
737688|NCT00482924|adipokines|adipokines
737689|NCT00482924|preatherosclerosis|preatherosclerosis
737690|NCT00482924|low grade inflammation|low grade inflammation
737691|NCT00482924|dyslipidemia|dyslipidemia
737692|NCT00482924|insulin resistance|insulin resistance
737693|NCT00482924|brown adipose tissue|brown adipose tissue
737694|NCT00482924|white adipose tissue|white adipose tissue
737695|NCT00482911|recurrent intraocular melanoma|recurrent intraocular melanoma
737696|NCT00482911|metastatic intraocular melanoma|metastatic intraocular melanoma
737697|NCT00482911|ciliary body and choroid melanoma, medium/large size|ciliary body and choroid melanoma, medium/large size
737698|NCT00482911|extraocular extension melanoma|extraocular extension melanoma
737699|NCT00482911|iris melanoma|iris melanoma
737700|NCT00482911|conjunctival melanoma|conjunctival melanoma
737701|NCT00482885|Esophagus|esophagus
737702|NCT00482885|Peristalsis|peristalsis
737703|NCT00482885|Contractile Pressure|contractile pressure
737704|NCT00482885|Coordination of contraction|coordination of contraction
737705|NCT00482885|Bolus transport|bolus transport
737706|NCT00482885|Esophageal function|esophageal function
737707|NCT00482872|stage I squamous cell carcinoma of the hypopharynx|stage i squamous cell carcinoma of the hypopharynx
737708|NCT00482872|stage II squamous cell carcinoma of the hypopharynx|stage ii squamous cell carcinoma of the hypopharynx
737709|NCT00482872|stage III squamous cell carcinoma of the hypopharynx|stage iii squamous cell carcinoma of the hypopharynx
737710|NCT00482872|stage IV squamous cell carcinoma of the hypopharynx|stage iv squamous cell carcinoma of the hypopharynx
737711|NCT00482872|recurrent squamous cell carcinoma of the hypopharynx|recurrent squamous cell carcinoma of the hypopharynx
737712|NCT00482872|stage I squamous cell carcinoma of the larynx|stage i squamous cell carcinoma of the larynx
737713|NCT00482872|stage II squamous cell carcinoma of the larynx|stage ii squamous cell carcinoma of the larynx
737714|NCT00482872|stage III squamous cell carcinoma of the larynx|stage iii squamous cell carcinoma of the larynx
737715|NCT00482872|stage IV squamous cell carcinoma of the larynx|stage iv squamous cell carcinoma of the larynx
737716|NCT00482872|recurrent squamous cell carcinoma of the larynx|recurrent squamous cell carcinoma of the larynx
737851|NCT00482547|urinary tract infection|urinary tract infection
737717|NCT00482872|stage I squamous cell carcinoma of the lip and oral cavity|stage i squamous cell carcinoma of the lip and oral cavity
737718|NCT00482872|stage II squamous cell carcinoma of the lip and oral cavity|stage ii squamous cell carcinoma of the lip and oral cavity
737719|NCT00482872|stage III squamous cell carcinoma of the lip and oral cavity|stage iii squamous cell carcinoma of the lip and oral cavity
737720|NCT00482872|stage IV squamous cell carcinoma of the lip and oral cavity|stage iv squamous cell carcinoma of the lip and oral cavity
737721|NCT00482872|recurrent squamous cell carcinoma of the lip and oral cavity|recurrent squamous cell carcinoma of the lip and oral cavity
737722|NCT00482872|metastatic squamous neck cancer with occult primary squamous cell carcinoma|metastatic squamous neck cancer with occult primary squamous cell carcinoma
737723|NCT00482872|recurrent metastatic squamous neck cancer with occult primary|recurrent metastatic squamous neck cancer with occult primary
737724|NCT00482872|untreated metastatic squamous neck cancer with occult primary|untreated metastatic squamous neck cancer with occult primary
737725|NCT00482872|stage I squamous cell carcinoma of the nasopharynx|stage i squamous cell carcinoma of the nasopharynx
737726|NCT00482872|stage II squamous cell carcinoma of the nasopharynx|stage ii squamous cell carcinoma of the nasopharynx
737727|NCT00482872|stage III squamous cell carcinoma of the nasopharynx|stage iii squamous cell carcinoma of the nasopharynx
737728|NCT00482872|stage IV squamous cell carcinoma of the nasopharynx|stage iv squamous cell carcinoma of the nasopharynx
737729|NCT00482872|recurrent squamous cell carcinoma of the nasopharynx|recurrent squamous cell carcinoma of the nasopharynx
737730|NCT00482872|stage I squamous cell carcinoma of the oropharynx|stage i squamous cell carcinoma of the oropharynx
737731|NCT00482872|stage II squamous cell carcinoma of the oropharynx|stage ii squamous cell carcinoma of the oropharynx
737732|NCT00482872|stage III squamous cell carcinoma of the oropharynx|stage iii squamous cell carcinoma of the oropharynx
737733|NCT00482872|stage IV squamous cell carcinoma of the oropharynx|stage iv squamous cell carcinoma of the oropharynx
737734|NCT00482872|stage I squamous cell carcinoma of the paranasal sinus and nasal cavity|stage i squamous cell carcinoma of the paranasal sinus and nasal cavity
737735|NCT00482872|stage II squamous cell carcinoma of the paranasal sinus and nasal cavity|stage ii squamous cell carcinoma of the paranasal sinus and nasal cavity
737736|NCT00482872|stage III squamous cell carcinoma of the paranasal sinus and nasal cavity|stage iii squamous cell carcinoma of the paranasal sinus and nasal cavity
737737|NCT00482872|stage IV squamous cell carcinoma of the paranasal sinus and nasal cavity|stage iv squamous cell carcinoma of the paranasal sinus and nasal cavity
737738|NCT00482872|recurrent squamous cell carcinoma of the paranasal sinus and nasal cavity|recurrent squamous cell carcinoma of the paranasal sinus and nasal cavity
737739|NCT00482872|salivary gland squamous cell carcinoma|salivary gland squamous cell carcinoma
737740|NCT00482872|recurrent verrucous carcinoma of the larynx|recurrent verrucous carcinoma of the larynx
737741|NCT00482872|recurrent verrucous carcinoma of the oral cavity|recurrent verrucous carcinoma of the oral cavity
737742|NCT00482872|stage I verrucous carcinoma of the larynx|stage i verrucous carcinoma of the larynx
737743|NCT00482872|stage I verrucous carcinoma of the oral cavity|stage i verrucous carcinoma of the oral cavity
737744|NCT00482872|stage II verrucous carcinoma of the larynx|stage ii verrucous carcinoma of the larynx
737745|NCT00482872|stage II verrucous carcinoma of the oral cavity|stage ii verrucous carcinoma of the oral cavity
737746|NCT00482872|stage III verrucous carcinoma of the larynx|stage iii verrucous carcinoma of the larynx
737747|NCT00482872|stage III verrucous carcinoma of the oral cavity|stage iii verrucous carcinoma of the oral cavity
737748|NCT00482872|stage IV verrucous carcinoma of the larynx|stage iv verrucous carcinoma of the larynx
737749|NCT00482872|stage IV verrucous carcinoma of the oral cavity|stage iv verrucous carcinoma of the oral cavity
737750|NCT00482872|recurrent squamous cell carcinoma of the oropharynx|recurrent squamous cell carcinoma of the oropharynx
737751|NCT00482859|Fibromyalgia Syndrome|fibromyalgia syndrome
737752|NCT00482846|mucositis|mucositis
737753|NCT00482846|drug/agent toxicity by tissue/organ|drug/agent toxicity by tissue/organ
737754|NCT00482846|stage II multiple myeloma|stage ii multiple myeloma
737755|NCT00482846|stage III multiple myeloma|stage iii multiple myeloma
737756|NCT00482846|refractory multiple myeloma|refractory multiple myeloma
737757|NCT00482833|adult acute promyelocytic leukemia (M3)|adult acute promyelocytic leukemia (m3)
737758|NCT00482833|adult acute myeloid leukemia with t(15;17)(q22;q12)|adult acute myeloid leukemia with t(15;17)(q22;q12)
737759|NCT00482833|untreated adult acute myeloid leukemia|untreated adult acute myeloid leukemia
737760|NCT00482820|anxiety|anxiety
737761|NCT00482820|attention-biases|attention-biases
737762|NCT00482820|children|children
737763|NCT00482807|stage I prostate cancer|stage i prostate cancer
737764|NCT00482807|stage II prostate cancer|stage ii prostate cancer
737765|NCT00482807|stage III prostate cancer|stage iii prostate cancer
737766|NCT00482807|stage IV prostate cancer|stage iv prostate cancer
737767|NCT00482807|adenocarcinoma of the prostate|adenocarcinoma of the prostate
737768|NCT00482807|recurrent prostate cancer|recurrent prostate cancer
737769|NCT00482794|Antiphospholipid Antibody Syndrome|antiphospholipid antibody syndrome
737770|NCT00482781|Apnea|apnea
737771|NCT00482781|Bradycardia|bradycardia
737772|NCT00482781|Preterm Infant|preterm infant
737773|NCT00482781|Immunization|immunization
737774|NCT00482781|DTaP|dtap
737775|NCT00482768|Diabetes, type II; Primary Health Care; Outpatient Care|diabetes, type ii; primary health care; outpatient care
737776|NCT00482755|male breast cancer|male breast cancer
737777|NCT00482755|stage II breast cancer|stage ii breast cancer
737778|NCT00482755|stage IIIA breast cancer|stage iiia breast cancer
737779|NCT00482742|Chronic Total Occlusion|chronic total occlusion
737780|NCT00482716|unspecified adult solid tumor, protocol specific|unspecified adult solid tumor, protocol specific
737781|NCT00482716|refractory multiple myeloma|refractory multiple myeloma
737782|NCT00482716|stage I multiple myeloma|stage i multiple myeloma
737783|NCT00482716|stage II multiple myeloma|stage ii multiple myeloma
737784|NCT00482716|stage III multiple myeloma|stage iii multiple myeloma
737785|NCT00482716|noncontiguous stage II adult diffuse small cleaved cell lymphoma|noncontiguous stage ii adult diffuse small cleaved cell lymphoma
737786|NCT00482716|noncontiguous stage II grade 1 follicular lymphoma|noncontiguous stage ii grade 1 follicular lymphoma
737787|NCT00482716|noncontiguous stage II grade 2 follicular lymphoma|noncontiguous stage ii grade 2 follicular lymphoma
737788|NCT00482716|noncontiguous stage II marginal zone lymphoma|noncontiguous stage ii marginal zone lymphoma
737789|NCT00482716|noncontiguous stage II small lymphocytic lymphoma|noncontiguous stage ii small lymphocytic lymphoma
737790|NCT00482716|contiguous stage II adult diffuse small cleaved cell lymphoma|contiguous stage ii adult diffuse small cleaved cell lymphoma
737791|NCT00482716|contiguous stage II grade 1 follicular lymphoma|contiguous stage ii grade 1 follicular lymphoma
737792|NCT00482716|contiguous stage II grade 2 follicular lymphoma|contiguous stage ii grade 2 follicular lymphoma
738154|NCT00481299|prolactinoma|prolactinoma
737793|NCT00482716|contiguous stage II marginal zone lymphoma|contiguous stage ii marginal zone lymphoma
737794|NCT00482716|contiguous stage II small lymphocytic lymphoma|contiguous stage ii small lymphocytic lymphoma
737795|NCT00482716|stage I adult diffuse small cleaved cell lymphoma|stage i adult diffuse small cleaved cell lymphoma
737796|NCT00482716|stage III adult diffuse small cleaved cell lymphoma|stage iii adult diffuse small cleaved cell lymphoma
737797|NCT00482716|stage IV adult diffuse small cleaved cell lymphoma|stage iv adult diffuse small cleaved cell lymphoma
737798|NCT00482716|stage I grade 1 follicular lymphoma|stage i grade 1 follicular lymphoma
737799|NCT00482716|stage I grade 2 follicular lymphoma|stage i grade 2 follicular lymphoma
737800|NCT00482716|stage III grade 1 follicular lymphoma|stage iii grade 1 follicular lymphoma
737801|NCT00482716|stage III grade 2 follicular lymphoma|stage iii grade 2 follicular lymphoma
737802|NCT00482716|stage IV grade 1 follicular lymphoma|stage iv grade 1 follicular lymphoma
737803|NCT00482716|stage IV grade 2 follicular lymphoma|stage iv grade 2 follicular lymphoma
737804|NCT00482716|stage I marginal zone lymphoma|stage i marginal zone lymphoma
737805|NCT00482716|stage III marginal zone lymphoma|stage iii marginal zone lymphoma
737806|NCT00482716|stage IV marginal zone lymphoma|stage iv marginal zone lymphoma
737807|NCT00482716|stage I small lymphocytic lymphoma|stage i small lymphocytic lymphoma
737808|NCT00482716|stage III small lymphocytic lymphoma|stage iii small lymphocytic lymphoma
737809|NCT00482716|stage IV small lymphocytic lymphoma|stage iv small lymphocytic lymphoma
737810|NCT00482716|extranodal marginal zone B-cell lymphoma of mucosa-associated lymphoid tissue|extranodal marginal zone b-cell lymphoma of mucosa-associated lymphoid tissue
737811|NCT00482716|nodal marginal zone B-cell lymphoma|nodal marginal zone b-cell lymphoma
737812|NCT00482716|splenic marginal zone lymphoma|splenic marginal zone lymphoma
737813|NCT00482716|recurrent adult diffuse small cleaved cell lymphoma|recurrent adult diffuse small cleaved cell lymphoma
737814|NCT00482716|recurrent grade 1 follicular lymphoma|recurrent grade 1 follicular lymphoma
737815|NCT00482716|recurrent grade 2 follicular lymphoma|recurrent grade 2 follicular lymphoma
737816|NCT00482716|recurrent marginal zone lymphoma|recurrent marginal zone lymphoma
737817|NCT00482716|recurrent small lymphocytic lymphoma|recurrent small lymphocytic lymphoma
737818|NCT00482716|stage I chronic lymphocytic leukemia|stage i chronic lymphocytic leukemia
737819|NCT00482716|stage II chronic lymphocytic leukemia|stage ii chronic lymphocytic leukemia
737820|NCT00482716|stage III chronic lymphocytic leukemia|stage iii chronic lymphocytic leukemia
737821|NCT00482716|stage IV chronic lymphocytic leukemia|stage iv chronic lymphocytic leukemia
737822|NCT00482716|refractory chronic lymphocytic leukemia|refractory chronic lymphocytic leukemia
737823|NCT00482716|anemia|anemia
737824|NCT00482703|Imatinib resistant or intolerant chronic phase CML|imatinib resistant or intolerant chronic phase cml
737825|NCT00482690|Smoking cessation|smoking cessation
737826|NCT00482690|Biomarkers|biomarkers
737827|NCT00482690|Aldehydes|aldehydes
737828|NCT00482690|Exhaled breath|exhaled breath
737829|NCT00482690|Harm Reduction|harm reduction
737830|NCT00482690|Cigarette smoking|cigarette smoking
737831|NCT00482690|cessation|cessation
737832|NCT00482690|reduction|reduction
737833|NCT00482677|adult glioblastoma|adult glioblastoma
737834|NCT00482677|adult giant cell glioblastoma|adult giant cell glioblastoma
737835|NCT00482677|adult gliosarcoma|adult gliosarcoma
737836|NCT00482586|adult primary liver cancer|adult primary liver cancer
737837|NCT00482586|liver metastases|liver metastases
737838|NCT00482573|Electrocardiography, ambulatory/methods|electrocardiography, ambulatory/methods
737839|NCT00482573|Blood Pressure monitoring, ambulatory/methods|blood pressure monitoring, ambulatory/methods
737840|NCT00482573|Cardiotocography/methods|cardiotocography/methods
737841|NCT00482573|Dental restoration, permanent|dental restoration, permanent
737842|NCT00482573|Anesthesia, local /methods|anesthesia, local /methods
737843|NCT00482573|Lidocaine|lidocaine
737844|NCT00482573|Vasoconstrictor Agents|vasoconstrictor agents
737845|NCT00482573|Epinephrine|epinephrine
737846|NCT00482573|Pregnancy|pregnancy
737847|NCT00482573|Rheumatic Heart Disease|rheumatic heart disease
737848|NCT00482560|Sucrose|sucrose
737849|NCT00482560|Breastfeeding|breastfeeding
737850|NCT00482560|Heel lance|heel lance
738040|NCT00481793|Plutonium|plutonium
737852|NCT00482547|urinary catheter|urinary catheter
737853|NCT00482521|unspecified adult solid tumor, protocol specific|unspecified adult solid tumor, protocol specific
737854|NCT00482508|Asthma|asthma
737855|NCT00482508|anti immunoglobulin E|anti immunoglobulin e
737856|NCT00482508|omalizumab|omalizumab
737857|NCT00482495|refractory multiple myeloma|refractory multiple myeloma
737858|NCT00482495|stage I multiple myeloma|stage i multiple myeloma
737859|NCT00482495|stage II multiple myeloma|stage ii multiple myeloma
737860|NCT00482495|stage III multiple myeloma|stage iii multiple myeloma
737861|NCT00482482|Yoga|yoga
737862|NCT00482482|Bipolar disorder|bipolar disorder
737863|NCT00482482|Major depression|major depression
737864|NCT00482482|Dysthymia|dysthymia
737865|NCT00482482|Randomized|randomized
737866|NCT00482469|ischemia-reperfusion|ischemia-reperfusion
737867|NCT00482469|ischemia|ischemia
737868|NCT00482469|reperfusion|reperfusion
737869|NCT00482469|DIEP-flap|diep-flap
737870|NCT00482469|flap|flap
737871|NCT00482456|Nitrous oxide|nitrous oxide
737872|NCT00482456|Homocysteine|homocysteine
737873|NCT00482456|folate|folate
737874|NCT00482456|vitamin B12|vitamin b12
737875|NCT00482430|Undifferentiated schizophrenia|undifferentiated schizophrenia
737876|NCT00482430|Residual schizophrenia|residual schizophrenia
737877|NCT00482391|recurrent breast cancer|recurrent breast cancer
737878|NCT00482391|stage I breast cancer|stage i breast cancer
737879|NCT00482391|stage II breast cancer|stage ii breast cancer
737880|NCT00482391|stage IIIA breast cancer|stage iiia breast cancer
737881|NCT00482391|stage IIIB breast cancer|stage iiib breast cancer
737882|NCT00482391|stage IIIC breast cancer|stage iiic breast cancer
737883|NCT00482391|male breast cancer|male breast cancer
737884|NCT00482378|stage I multiple myeloma|stage i multiple myeloma
737885|NCT00482378|stage II multiple myeloma|stage ii multiple myeloma
737886|NCT00482378|stage III multiple myeloma|stage iii multiple myeloma
737887|NCT00482378|refractory multiple myeloma|refractory multiple myeloma
737888|NCT00482378|pain|pain
737889|NCT00482365|adult primary hepatocellular carcinoma|adult primary hepatocellular carcinoma
737890|NCT00482365|advanced adult primary liver cancer|advanced adult primary liver cancer
737891|NCT00482365|localized resectable adult primary liver cancer|localized resectable adult primary liver cancer
737892|NCT00482365|localized unresectable adult primary liver cancer|localized unresectable adult primary liver cancer
737893|NCT00482365|recurrent adult primary liver cancer|recurrent adult primary liver cancer
737894|NCT00482339|bacterial contamination|bacterial contamination
737895|NCT00482339|platelet concentrates|platelet concentrates
737896|NCT00482339|blood donation|blood donation
737897|NCT00482339|looxster|looxster
737898|NCT00482339|pureprove|pureprove
737899|NCT00482339|bacterial genomic DNA|bacterial genomic dna
738710|NCT00479089|Urothelium|urothelium
737900|NCT00482339|bacterial contamination of platelet concentrates|bacterial contamination of platelet concentrates
737901|NCT00482339|"Preparation of bacterial DNA in blood"|"preparation of bacterial dna in blood"
737902|NCT00482339|comparison of blood culture versus NAT|comparison of blood culture versus nat
737903|NCT00482313|Attention Deficit Hyperactivity Disorder|attention deficit hyperactivity disorder
737904|NCT00482313|ADHD|adhd
737905|NCT00482313|Prison|prison
737906|NCT00482313|Treatment|treatment
737907|NCT00482313|Randomized|randomized
737908|NCT00482313|Double-Blind|double-blind
737909|NCT00482313|Placebo Control|placebo control
737910|NCT00482313|Parallel Assignment|parallel assignment
737911|NCT00482313|Efficacy Study|efficacy study
737912|NCT00482300|Histologically proved endometrial carcinoma preoperatively supposed stage I-II|histologically proved endometrial carcinoma preoperatively supposed stage i-ii
737913|NCT00482274|adenocarcinoma of the prostate|adenocarcinoma of the prostate
737914|NCT00482274|recurrent prostate cancer|recurrent prostate cancer
737915|NCT00482274|stage I prostate cancer|stage i prostate cancer
737916|NCT00482274|stage II prostate cancer|stage ii prostate cancer
737917|NCT00482274|stage III prostate cancer|stage iii prostate cancer
737918|NCT00482274|stage IV prostate cancer|stage iv prostate cancer
737919|NCT00482261|myeloma|myeloma
737920|NCT00482261|relapse|relapse
737921|NCT00482261|refractory|refractory
737922|NCT00482261|elderly|elderly
737923|NCT00482261|lenalidomide|lenalidomide
737924|NCT00482248|Asthma|asthma
737925|NCT00482248|anti-immunoglobulin E|anti-immunoglobulin e
737926|NCT00482248|omalizumab|omalizumab
737927|NCT00482248|allergic asthma|allergic asthma
737928|NCT00482222|adenocarcinoma of the colon|adenocarcinoma of the colon
737929|NCT00482222|stage IV colon cancer|stage iv colon cancer
737930|NCT00482222|adenocarcinoma of the rectum|adenocarcinoma of the rectum
737931|NCT00482222|stage IV rectal cancer|stage iv rectal cancer
737932|NCT00482222|liver metastases|liver metastases
737933|NCT00482222|recurrent colon cancer|recurrent colon cancer
737934|NCT00482222|recurrent rectal cancer|recurrent rectal cancer
737935|NCT00482209|mifepristone, misoprostol, medical abortion|mifepristone, misoprostol, medical abortion
737936|NCT00482183|Bare metal stent|bare metal stent
737937|NCT00482183|Major adverse cardiac events|major adverse cardiac events
737938|NCT00482183|Pioglitazone|pioglitazone
737939|NCT00482183|Restenosis|restenosis
737940|NCT00482183|Sirolimus eluting stent|sirolimus eluting stent
737941|NCT00482144|Pulsed-Dye Laser|pulsed-dye laser
737942|NCT00482118|Air Pollution|air pollution
737943|NCT00482118|Tumor Markers|tumor markers
737944|NCT00482118|Genetic Polymorphisms|genetic polymorphisms
737945|NCT00482118|Molecular Epidemiology|molecular epidemiology
737946|NCT00482118|Environmental Epidemiology|environmental epidemiology
737947|NCT00482118|Lung Cancer|lung cancer
737948|NCT00482105|melanoma|melanoma
737949|NCT00482092|Crohn's disease|crohn's disease
737950|NCT00482092|adult stem cell therapy|adult stem cell therapy
737951|NCT00482066|Wegener's granulomatosis|wegener's granulomatosis
737952|NCT00482066|Microscopic polyangiitis|microscopic polyangiitis
737953|NCT00482066|Churg Strauss Syndrome|churg strauss syndrome
737954|NCT00482066|ANCA|anca
737955|NCT00482040|CPAP|cpap
737956|NCT00482040|Preterm|preterm
737957|NCT00482040|Prematurity|prematurity
737958|NCT00482040|Apnea of prematurity|apnea of prematurity
737959|NCT00482027|HIV vaccine|hiv vaccine
737960|NCT00482027|Adeno-associated virus vactored vaccine|adeno-associated virus vactored vaccine
737961|NCT00482027|HIV-1 subtype C|hiv-1 subtype c
737962|NCT00482027|Safety|safety
737963|NCT00482027|Immunogenicity|immunogenicity
737964|NCT00482027|Biodistribution|biodistribution
737965|NCT00482027|HIV prevention|hiv prevention
737966|NCT00482001|Donepezil|donepezil
737967|NCT00482001|Driving|driving
737968|NCT00482001|Cholinesterase Inhibitors|cholinesterase inhibitors
737969|NCT00482001|Geriatric Psychiatry|geriatric psychiatry
737970|NCT00482001|Psychopharmacology|psychopharmacology
737971|NCT00482001|Aricept|aricept
737972|NCT00481988|depression|depression
737973|NCT00481988|transcranial direct current stimulation|transcranial direct current stimulation
737974|NCT00481988|direct current stimulation|direct current stimulation
737975|NCT00481988|tdcs|tdcs
737976|NCT00481975|binge eating|binge eating
737977|NCT00481975|eating disorders|eating disorders
737978|NCT00481975|obesity|obesity
737979|NCT00481949|Gastro-oesophageal reflux disease|gastro-oesophageal reflux disease
737980|NCT00481949|pH measurement|ph measurement
737981|NCT00481949|symptom association|symptom association
737982|NCT00481949|wireless pH monitoring system|wireless ph monitoring system
737983|NCT00481949|Functional Heartburn|functional heartburn
737984|NCT00481949|Gastro-esophageal reflux disease|gastro-esophageal reflux disease
737985|NCT00481936|Neoplasms|neoplasms
737986|NCT00481936|Neoplasm, Epithelial|neoplasm, epithelial
737987|NCT00481936|Neoplasm, Glandular|neoplasm, glandular
737988|NCT00481923|hypocaloric diet|hypocaloric diet
737989|NCT00481923|energy intake|energy intake
737990|NCT00481897|overweight|overweight
737991|NCT00481897|obesity|obesity
737992|NCT00481897|type 2 diabetes|type 2 diabetes
737993|NCT00481897|diabetes|diabetes
737994|NCT00481897|worksite cost|worksite cost
737996|NCT00481884|Breast Cancer|breast cancer
737997|NCT00481884|Radiation Dermatitis|radiation dermatitis
737998|NCT00481884|RadiaPlexRx Gel|radiaplexrx gel
737999|NCT00481884|Aquaphor|aquaphor
738000|NCT00481871|Lymphoproliferative malignancies|lymphoproliferative malignancies
738001|NCT00481871|Lymphoma|lymphoma
738002|NCT00481871|Hodgkin's lymphoma (HL)|hodgkin's lymphoma (hl)
738003|NCT00481871|Non-Hodgkin's lymphoma (NHL)|non-hodgkin's lymphoma (nhl)
738004|NCT00481871|PTCL|ptcl
738005|NCT00481871|T/NK-cell leukemia/lymphoma|t/nk-cell leukemia/lymphoma
738006|NCT00481871|T-cell lymphoma/leukemia (HTLV 1+)|t-cell lymphoma/leukemia (htlv 1+)
738007|NCT00481871|Angioimmunoblastic T-cell lymphoma|angioimmunoblastic t-cell lymphoma
738008|NCT00481871|Blastic NK lymphoma|blastic nk lymphoma
738009|NCT00481871|Anaplastic large cell lymphoma|anaplastic large cell lymphoma
738010|NCT00481871|T/NK-cell lymphoma|t/nk-cell lymphoma
738011|NCT00481871|Enteropathy-type intestinal lymphoma|enteropathy-type intestinal lymphoma
738012|NCT00481871|Hepatosplenic T-cell lymphoma|hepatosplenic t-cell lymphoma
738013|NCT00481871|Extranodal peripheral T/NK-cell lymphoma|extranodal peripheral t/nk-cell lymphoma
738014|NCT00481871|Subcutaneous panniculitis T-cell lymphoma|subcutaneous panniculitis t-cell lymphoma
738015|NCT00481871|Transformed mycosis fungoides|transformed mycosis fungoides
738016|NCT00481871|PDX|pdx
738017|NCT00481871|Pralatrexate|pralatrexate
738018|NCT00481871|Gemcitabine|gemcitabine
738019|NCT00481871|Gemzar|gemzar
738020|NCT00481871|Vitamin B12|vitamin b12
738021|NCT00481871|Folic acid|folic acid
738022|NCT00481858|chronic lymphocytic leukemia|chronic lymphocytic leukemia
738023|NCT00481858|biomarker|biomarker
738024|NCT00481858|prognosis|prognosis
738025|NCT00481858|apoptosis|apoptosis
738026|NCT00481858|neoplasm/cancer diagnosis|neoplasm/cancer diagnosis
738027|NCT00481858|stable isotope|stable isotope
738028|NCT00481858|diagnosis evaluation|diagnosis evaluation
738029|NCT00481858|outcomes|outcomes
738030|NCT00481858|CD19|cd19
738031|NCT00481858|CD5|cd5
738032|NCT00481819|Kidney Transplantation|kidney transplantation
738033|NCT00481819|Tacrolimus|tacrolimus
738034|NCT00481819|Methylprednisolone|methylprednisolone
738035|NCT00481819|Prednisolone|prednisolone
738036|NCT00481819|Mycophenolate Mofetil|mycophenolate mofetil
738037|NCT00481806|Virchow's Triad|virchow's triad
738038|NCT00481806|Thrombin|thrombin
738039|NCT00481806|Graft Failure|graft failure
738041|NCT00481793|Ionizing Radiation|ionizing radiation
738042|NCT00481793|Polymorphism|polymorphism
738043|NCT00481793|Biological Marker|biological marker
738044|NCT00481793|Russia|russia
738045|NCT00481767|Safety|safety
738046|NCT00481767|Immunogenicity|immunogenicity
738047|NCT00481767|Human Papillomavirus (HPV) vaccine|human papillomavirus (hpv) vaccine
738048|NCT00481754|Endometrium|endometrium
738049|NCT00481754|PTEN|pten
738050|NCT00481754|Hormones|hormones
738051|NCT00481754|Carcinogenesis|carcinogenesis
738052|NCT00481754|Etiology|etiology
738053|NCT00481754|Tissue Evaluation|tissue evaluation
738054|NCT00481754|Questionnaire|questionnaire
738055|NCT00481741|Angioplasty, Percutaneous TransluminalCoronary|angioplasty, percutaneous transluminalcoronary
738056|NCT00481715|Web-Based Weight Loss Program|web-based weight loss program
738057|NCT00481715|Cash Incentive Weight Loss Program|cash incentive weight loss program
738058|NCT00481715|North Carolina|north carolina
738059|NCT00481689|Cipro|cipro
738060|NCT00481689|Complicated UTI|complicated uti
738061|NCT00481689|Pseudomonas aeruginosa|pseudomonas aeruginosa
738062|NCT00481676|Chronic urticaria, omalizumab, thyroperoxidase, IgE|chronic urticaria, omalizumab, thyroperoxidase, ige
738063|NCT00481637|paraneoplastic; autoimmunity;|paraneoplastic; autoimmunity;
738064|NCT00481624|advanced lung cancer|advanced lung cancer
738065|NCT00481624|Procrit|procrit
738066|NCT00481624|Epoetin Alfa|epoetin alfa
738067|NCT00481624|Ferric Gluconate|ferric gluconate
738068|NCT00481624|iron supplementation|iron supplementation
738069|NCT00481611|Industry Hygiene|industry hygiene
738070|NCT00481611|Molecular Epidemiology|molecular epidemiology
738071|NCT00481611|Cancer Susceptibility|cancer susceptibility
738072|NCT00481611|Genotoxicity|genotoxicity
738073|NCT00481611|Immune Function|immune function
738074|NCT00481611|Cancer Susceptability|cancer susceptability
738075|NCT00481585|claudin|claudin
738076|NCT00481585|electrophysiology|electrophysiology
738077|NCT00481585|breast|breast
738078|NCT00481585|screening|screening
738079|NCT00481572|Sepsis|sepsis
738080|NCT00481572|Septic Shock|septic shock
738081|NCT00481572|vasopressin|vasopressin
738082|NCT00481572|terlipressin|terlipressin
738083|NCT00481559|Voraxaze|voraxaze
738084|NCT00481559|glucarpidase|glucarpidase
738085|NCT00481559|carboxypeptidase|carboxypeptidase
738086|NCT00481559|cancer|cancer
738087|NCT00481559|lymphoma|lymphoma
738088|NCT00481559|leukemia|leukemia
738089|NCT00481559|osteosarcoma|osteosarcoma
738090|NCT00481559|methotrexate|methotrexate
738091|NCT00481559|delayed elimination|delayed elimination
738092|NCT00481559|renal insufficiency|renal insufficiency
738093|NCT00481559|toxicity|toxicity
738811|NCT00478738|COPD.|copd.
738094|NCT00481546|Leber congenital amaurosis|leber congenital amaurosis
738095|NCT00481546|LCA|lca
738096|NCT00481546|RPE65|rpe65
738097|NCT00481546|Retinal disease due to RPE65 mutations|retinal disease due to rpe65 mutations
738098|NCT00481546|RPE65-associated Leber congenital amaurosis|rpe65-associated leber congenital amaurosis
738099|NCT00481533|Cesarean Delivery|cesarean delivery
738100|NCT00481533|Uterine Contractility|uterine contractility
738101|NCT00481507|Probiotic|probiotic
738102|NCT00481507|Cultured dairy drink|cultured dairy drink
738103|NCT00481507|Health|health
738104|NCT00481507|10 day antibiotic|10 day antibiotic
738105|NCT00481507|Otherwise healthy|otherwise healthy
738106|NCT00481494|Glaucoma|glaucoma
738107|NCT00481494|Drug compliance|drug compliance
738108|NCT00481494|Personality|personality
738109|NCT00481481|Tacrolimus, Kidney Transplantation|tacrolimus, kidney transplantation
738110|NCT00481468|Coronary artery disease|coronary artery disease
738111|NCT00481468|chest pain|chest pain
738112|NCT00481455|Glioblastoma Multiforme|glioblastoma multiforme
738113|NCT00481455|temozolomide|temozolomide
738114|NCT00481442|Septic shock|septic shock
738115|NCT00481442|Sepsis|sepsis
738116|NCT00481442|Norepinephrine|norepinephrine
738117|NCT00481442|Phenylephrine|phenylephrine
738118|NCT00481429|Biomarker|biomarker
738119|NCT00481429|Glitazone|glitazone
738120|NCT00481429|Diabetes|diabetes
738121|NCT00481416|Esophageal Varices|esophageal varices
738122|NCT00481416|PillCam Eso|pillcam eso
738123|NCT00481416|Capsule Endoscopy|capsule endoscopy
738124|NCT00481416|Given Imaging|given imaging
738125|NCT00481416|Inscope|inscope
738126|NCT00481403|Sperm, male fertility, microarrays|sperm, male fertility, microarrays
738127|NCT00481390|HIV|hiv
738128|NCT00481390|HLA-B*5701|hla-b*5701
738129|NCT00481390|prevalence|prevalence
738130|NCT00481390|Treatment Experienced|treatment experienced
738131|NCT00481390|Treatment Naive|treatment naive
738132|NCT00481377|Ablation|ablation
738133|NCT00481377|Ventricular tachycardia|ventricular tachycardia
738134|NCT00481377|coronary artery disease|coronary artery disease
738135|NCT00481377|Implantable cardioverter defibrillator interventions|implantable cardioverter defibrillator interventions
738136|NCT00481364|hemodialysis|hemodialysis
738137|NCT00481364|endothelial function|endothelial function
738138|NCT00481364|coronary artery calcification|coronary artery calcification
738139|NCT00481364|atherosclerosis|atherosclerosis
738140|NCT00481364|statin|statin
738141|NCT00481351|artificial chilomicrons kinetics|artificial chilomicrons kinetics
738142|NCT00481351|ezetimibe plus statin|ezetimibe plus statin
738143|NCT00481351|lipid lowering therapy|lipid lowering therapy
738144|NCT00481338|Cohort|cohort
738145|NCT00481338|Quality of life|quality of life
738146|NCT00481338|Health resource use|health resource use
738147|NCT00481338|Disability|disability
738148|NCT00481338|Prognosis|prognosis
738149|NCT00481312|Initial Sedation|initial sedation
738150|NCT00481312|Mechanical ventilation|mechanical ventilation
738151|NCT00481299|Insulin|insulin
738152|NCT00481299|glucose|glucose
738153|NCT00481299|lipids|lipids
738155|NCT00481299|hyperprolactinemia|hyperprolactinemia
738156|NCT00481286|Group clinics|group clinics
738157|NCT00481286|Goal setting|goal setting
738158|NCT00481286|Diabetes|diabetes
738159|NCT00481286|Hypertension|hypertension
738160|NCT00481286|Age 50+|age 50+
738161|NCT00481273|MDS|mds
738162|NCT00481260|Hgb C|hgb c
738163|NCT00481260|Screening|screening
738164|NCT00481247|Chronic Phase Philadelphia Chromosome Positive Chronic Myeloid Leukemia|chronic phase philadelphia chromosome positive chronic myeloid leukemia
738165|NCT00481234|Anesthesia, General|anesthesia, general
738166|NCT00481234|Abnormalities, Cardiovascular|abnormalities, cardiovascular
738167|NCT00481234|Heart Rate|heart rate
738168|NCT00481234|Forecasting|forecasting
738169|NCT00481221|Thalassemia|thalassemia
738170|NCT00481221|Iron Deficiency|iron deficiency
738171|NCT00481221|Carrier screening|carrier screening
738172|NCT00481208|open-angle glaucoma|open-angle glaucoma
738173|NCT00481208|diurnal fluctuation|diurnal fluctuation
738174|NCT00481208|intraocular pressure|intraocular pressure
738175|NCT00481208|peripapillary retinal blood flow|peripapillary retinal blood flow
738176|NCT00481208|latent asymmetric intraocular pressure|latent asymmetric intraocular pressure
738177|NCT00481182|PK|pk
738178|NCT00481182|PD|pd
738179|NCT00481182|FPV|fpv
738180|NCT00481182|RTV|rtv
738181|NCT00481182|APV|apv
738182|NCT00481182|ritonavir|ritonavir
738183|NCT00481182|fosamprenavir|fosamprenavir
738184|NCT00481182|amprenavir|amprenavir
738185|NCT00481182|methadone|methadone
738186|NCT00481182|pharmacokinetics|pharmacokinetics
738187|NCT00481182|pharmacodynamics|pharmacodynamics
738188|NCT00481169|Postmenopausal Osteoporosis|postmenopausal osteoporosis
738189|NCT00481143|Myelodysplastic Syndrome|myelodysplastic syndrome
738190|NCT00481143|MDS|mds
738191|NCT00481143|iron overload|iron overload
738192|NCT00481143|chelation|chelation
738193|NCT00481143|chelators|chelators
738194|NCT00481143|ICL670|icl670
738195|NCT00481143|Deferasirox|deferasirox
738196|NCT00481143|serum ferritin|serum ferritin
738197|NCT00481143|LIC|lic
738198|NCT00481143|transfusional hemosiderosis|transfusional hemosiderosis
738199|NCT00481143|Refractory Anemia|refractory anemia
738200|NCT00481143|RA|ra
738201|NCT00481143|Refractory Anemia with Ringed Sideroblasts|refractory anemia with ringed sideroblasts
738202|NCT00481143|RARS|rars
738203|NCT00481143|blood transfusions|blood transfusions
738204|NCT00481143|Mydelodysplastic Syndrome(s)|mydelodysplastic syndrome(s)
738205|NCT00481130|Alport Syndrome|alport syndrome
738206|NCT00481130|x linked|x linked
738207|NCT00481130|autosomal dominant Alport syndrome|autosomal dominant alport syndrome
738208|NCT00481130|glomerular basement membrane|glomerular basement membrane
738209|NCT00481130|hereditary nephritis|hereditary nephritis
738210|NCT00481130|familial benign haematuria|familial benign haematuria
738211|NCT00481130|type IV collagen|type iv collagen
738212|NCT00481130|hereditary nephritis with neurosensory deafness|hereditary nephritis with neurosensory deafness
738213|NCT00481130|vison loss|vison loss
738214|NCT00481104|Obesity|obesity
738215|NCT00481065|Bird flu|bird flu
738216|NCT00481065|influenza vaccine|influenza vaccine
738217|NCT00481065|Seasonal influenza vaccine|seasonal influenza vaccine
738218|NCT00481065|Prepandemic vaccine|prepandemic vaccine
738219|NCT00481052|Adult|adult
738220|NCT00481052|CML|cml
738221|NCT00481052|Philadelphia positive|philadelphia positive
738222|NCT00481052|Nilotinib|nilotinib
738223|NCT00481052|early chronic phase|early chronic phase
738224|NCT00481052|untreated or treated only with Hydroxyurea or Anagrelide|untreated or treated only with hydroxyurea or anagrelide
738225|NCT00481052|Chronic Myeloid Leukemia|chronic myeloid leukemia
738226|NCT00481039|Sickle cell disease|sickle cell disease
738227|NCT00481039|Sickle cell thalassemia|sickle cell thalassemia
738228|NCT00481039|Population screening|population screening
738229|NCT00481013|Spinal Muscular Atrophy|spinal muscular atrophy
738230|NCT00481013|Adult|adult
738231|NCT00481000|Dialectical Cognitive Therapy|dialectical cognitive therapy
738232|NCT00481000|Clinical Psychology|clinical psychology
738233|NCT00480987|High-Risk Myelodysplastic Syndromes|high-risk myelodysplastic syndromes
738234|NCT00480987|Acute Myeloid Leukemia|acute myeloid leukemia
738235|NCT00480987|Leukemia|leukemia
738236|NCT00480987|Oxaliplatin|oxaliplatin
738237|NCT00480987|Fludarabine|fludarabine
738238|NCT00480987|Cytarabine|cytarabine
738239|NCT00480987|AML|aml
738240|NCT00480987|MDS|mds
738241|NCT00480974|Sickle cell anemia|sickle cell anemia
738242|NCT00480974|Sickle cell thalassemia|sickle cell thalassemia
738245|NCT00480948|infant formula|infant formula
738246|NCT00480948|fatty acids|fatty acids
738247|NCT00480948|palmitic acid|palmitic acid
738248|NCT00480948|stool|stool
738249|NCT00480948|calcium|calcium
738250|NCT00480935|Localized|localized
738251|NCT00480935|Renal Cell Carcinoma|renal cell carcinoma
738252|NCT00480935|Neoadjuvant|neoadjuvant
738253|NCT00480935|Sunitinib Malate (Sutent)|sunitinib malate (sutent)
738254|NCT00480922|non-alcoholic fatty liver disease|non-alcoholic fatty liver disease
738255|NCT00480922|steatohepatitis|steatohepatitis
738256|NCT00480922|overweight|overweight
738257|NCT00480922|insulin resistance|insulin resistance
738258|NCT00480896|Dermatitis, atopic|dermatitis, atopic
738259|NCT00480896|Tacrolimus|tacrolimus
738260|NCT00480896|Child|child
738261|NCT00480896|treatment outcomes|treatment outcomes
738262|NCT00480883|cutaneous leishmaniasis of the old world|cutaneous leishmaniasis of the old world
738263|NCT00480870|Alzheimer|alzheimer
738264|NCT00480870|polysomnography|polysomnography
738265|NCT00480870|REM sleep|rem sleep
738266|NCT00480870|donepezil|donepezil
738267|NCT00480870|sleep apnea|sleep apnea
738268|NCT00480870|oxygen saturation|oxygen saturation
738269|NCT00480857|Prostate|prostate
738270|NCT00480857|Radiation|radiation
738271|NCT00480844|schizophrenia|schizophrenia
738272|NCT00480844|Sertindole|sertindole
738273|NCT00480844|Risperidone|risperidone
738274|NCT00480844|cognitive impairment|cognitive impairment
738275|NCT00480831|NSCLC|nsclc
738276|NCT00480831|Cancer|cancer
738277|NCT00480831|Avastin|avastin
738278|NCT00480831|APM4074g|apm4074g
738279|NCT00480792|Hepatitis B vaccination|hepatitis b vaccination
738280|NCT00480792|GenHevac-B Pasteur|genhevac-b pasteur
738281|NCT00480792|HIV Infections|hiv infections
738282|NCT00480779|Prediabetes|prediabetes
738283|NCT00480779|Metabolic syndrome|metabolic syndrome
738284|NCT00480779|Prevention|prevention
738285|NCT00480779|Lifestyle intervention|lifestyle intervention
738286|NCT00480766|Glucocorticoid|glucocorticoid
738287|NCT00480753|Raynaud's phenomenon|raynaud's phenomenon
738288|NCT00480753|Raynaud's Disease|raynaud's disease
738289|NCT00480753|Raynaud's disease secondary to scleroderma|raynaud's disease secondary to scleroderma
738290|NCT00480753|Raynaud's phenomenon secondary to autoimmune disease|raynaud's phenomenon secondary to autoimmune disease
738291|NCT00480740|Dexmedetomidine|dexmedetomidine
738292|NCT00480740|Congenital heart disease|congenital heart disease
738293|NCT00480740|pharmacokinetics|pharmacokinetics
738294|NCT00480740|pharmacodynamics|pharmacodynamics
738295|NCT00480740|pediatric|pediatric
738401|NCT00480376|prophylaxis antibiotic|prophylaxis antibiotic
738296|NCT00480740|Bidirectional cavopulmonary anastomosis|bidirectional cavopulmonary anastomosis
738297|NCT00480740|Fontan physiology|fontan physiology
738298|NCT00480740|Cardiac transplant|cardiac transplant
738299|NCT00480727|Halo Thoracic Orthosis|halo thoracic orthosis
738300|NCT00480727|Re-tension|re-tension
738301|NCT00480727|Pin loosening|pin loosening
738302|NCT00480714|TB|tb
738303|NCT00480714|Vaccine|vaccine
738304|NCT00480714|BCG|bcg
738305|NCT00480701|Alzheimer|alzheimer
738306|NCT00480701|Parkinson|parkinson
738307|NCT00480701|dementia|dementia
738308|NCT00480701|neurologic|neurologic
738309|NCT00480688|TB|tb
738310|NCT00480688|BCG|bcg
738311|NCT00480675|bursitis|bursitis
738312|NCT00480675|injection|injection
738313|NCT00480675|fluoroscopy|fluoroscopy
738314|NCT00480662|Paget's bone disease|paget's bone disease
738315|NCT00480649|SERETIDE|seretide
738316|NCT00480649|asthma|asthma
738317|NCT00480649|Korean|korean
738318|NCT00480649|ACT|act
738319|NCT00480623|Prostate Cancer|prostate cancer
738320|NCT00480623|Biochemical Failure|biochemical failure
738321|NCT00480623|Radical Prostatectomy|radical prostatectomy
738322|NCT00480610|Dermatitis, atopic|dermatitis, atopic
738323|NCT00480610|Tacrolimus|tacrolimus
738324|NCT00480610|Adult|adult
738325|NCT00480610|treatment outcomes|treatment outcomes
738326|NCT00480597|gemcitabine|gemcitabine
738327|NCT00480597|vinorelbine|vinorelbine
738328|NCT00480597|cisplatin|cisplatin
738329|NCT00480597|capecitabine|capecitabine
738330|NCT00480597|pretreated metastatic breast cancer|pretreated metastatic breast cancer
738331|NCT00480584|pancreatic|pancreatic
738332|NCT00480584|gemcitabine|gemcitabine
738333|NCT00480584|erlotinib (HER1/epidermal growth factor receptor [EGFR] tyrosine kinase inhibitor)|erlotinib (her1/epidermal growth factor receptor [egfr] tyrosine kinase inhibitor)
738334|NCT00480584|capecitabine|capecitabine
738335|NCT00480571|chronic schizophrenia or schizo-affective disorder|chronic schizophrenia or schizo-affective disorder
738336|NCT00480558|HIV|hiv
738337|NCT00480558|MVA85A|mva85a
738338|NCT00480558|TB|tb
738339|NCT00480558|Tuberculosis|tuberculosis
738340|NCT00480558|Human Immunodeficiency Virus|human immunodeficiency virus
738341|NCT00480558|Safety|safety
738342|NCT00480558|Immunogenicity|immunogenicity
738343|NCT00480558|Efficacy|efficacy
738344|NCT00480558|Treatment Naive|treatment naive
738345|NCT00480545|Women with bleeding disorders|women with bleeding disorders
738346|NCT00480545|Menstrual cycle|menstrual cycle
738347|NCT00480545|Women|women
738348|NCT00480545|Healthy volunteers|healthy volunteers
738349|NCT00480532|birth control|birth control
738350|NCT00480532|continuous contraception|continuous contraception
738351|NCT00480532|break-through bleeding|break-through bleeding
738352|NCT00480519|meatotomy|meatotomy
738353|NCT00480519|meatal stenosis|meatal stenosis
738354|NCT00480519|local anaesthesia|local anaesthesia
738355|NCT00480519|feasibility|feasibility
738356|NCT00480519|pain control|pain control
738357|NCT00480506|chimerism|chimerism
738358|NCT00480506|allogenic hematopoietic transplantation|allogenic hematopoietic transplantation
738359|NCT00480506|assay|assay
738360|NCT00480480|Trauma|trauma
738361|NCT00480480|Grief|grief
738362|NCT00480480|Depression|depression
738363|NCT00480480|Adolescent|adolescent
738364|NCT00480480|War|war
738365|NCT00480480|Group|group
738366|NCT00480480|Therapy|therapy
738367|NCT00480480|Treatment|treatment
738368|NCT00480480|Intervention|intervention
738369|NCT00480480|School|school
738370|NCT00480480|Development|development
738371|NCT00480454|TB|tb
738372|NCT00480454|Tuberculosis|tuberculosis
738373|NCT00480454|Infants|infants
738374|NCT00480454|EPI|epi
738375|NCT00480441|Marijuana|marijuana
738376|NCT00480441|Addiction|addiction
738377|NCT00480441|Substance Withdrawal Syndrome|substance withdrawal syndrome
738378|NCT00480441|Clinical Trial|clinical trial
738379|NCT00480441|Dronabinol|dronabinol
738380|NCT00480441|Behavioral Therapy|behavioral therapy
738381|NCT00480441|Adults|adults
738382|NCT00480441|Neuroimaging|neuroimaging
738383|NCT00480441|Neuropsychological Testing|neuropsychological testing
738384|NCT00480441|Neurocognitive Testing|neurocognitive testing
738385|NCT00480441|Behavioral Probes|behavioral probes
738386|NCT00480428|Radioactive Fallout|radioactive fallout
738387|NCT00480428|Childhood Exposures|childhood exposures
738388|NCT00480428|External Radiation Dose|external radiation dose
738389|NCT00480428|Internal Radiation Dose to Thyroid Gland|internal radiation dose to thyroid gland
738390|NCT00480428|Pasture-Dairy Animal- Milk- Thyroid Pathway|pasture-dairy animal- milk- thyroid pathway
738391|NCT00480402|preterm birth|preterm birth
738392|NCT00480402|progesterone|progesterone
738393|NCT00480402|twins|twins
738394|NCT00480402|Preterm birth in twin gestations|preterm birth in twin gestations
738395|NCT00480389|Clear cell Renal cell carcinoma|clear cell renal cell carcinoma
738396|NCT00480389|Metastatic|metastatic
738397|NCT00480389|Sorafenib tosylate|sorafenib tosylate
738398|NCT00480389|Preoperative treatment|preoperative treatment
738399|NCT00480376|transrectal biopsy|transrectal biopsy
738400|NCT00480376|prostate|prostate
738402|NCT00480363|Smoldering Multiple Myeloma|smoldering multiple myeloma
738403|NCT00480363|PETHEMA|pethema
738404|NCT00480363|Smoldering|smoldering
738405|NCT00480350|HIV|hiv
738406|NCT00480350|virological response|virological response
738407|NCT00480350|CD4|cd4
738408|NCT00480350|food supplement|food supplement
738409|NCT00480350|Human Immunodeficiency Virus|human immunodeficiency virus
738410|NCT00480350|Complementary Therapies|complementary therapies
738411|NCT00480337|PCOS|pcos
738412|NCT00480337|Fertility Preservation|fertility preservation
738413|NCT00480337|Repeated IVF Failure|repeated ivf failure
738414|NCT00480337|S/P Hyperstimulation|s/p hyperstimulation
738415|NCT00480311|symptomatic|symptomatic
738416|NCT00480311|lumbar spinal stenosis|lumbar spinal stenosis
738417|NCT00480311|disability|disability
738418|NCT00480311|fear avoidance beliefs|fear avoidance beliefs
738419|NCT00480311|quality of life|quality of life
738420|NCT00480285|Gastroesophageal reflux disease|gastroesophageal reflux disease
738421|NCT00480285|Laparoscopic Nissen Fundoplication|laparoscopic nissen fundoplication
738422|NCT00480285|Laparoscopic anterior partial fundoplication|laparoscopic anterior partial fundoplication
738423|NCT00480272|rheumatoid arthritis|rheumatoid arthritis
738424|NCT00480272|clinical remission|clinical remission
738425|NCT00480259|blood urea nitrogen|blood urea nitrogen
738426|NCT00480259|nitrogen balance|nitrogen balance
738427|NCT00480259|nutrition|nutrition
738428|NCT00480259|intensive care|intensive care
738429|NCT00480246|receptor oocupancy|receptor oocupancy
738430|NCT00480233|depression|depression
738431|NCT00480233|screening|screening
738432|NCT00480233|primary care|primary care
738433|NCT00480233|validity|validity
738434|NCT00480233|Hebrew|hebrew
738435|NCT00480233|Primary care and general medical patients|primary care and general medical patients
738436|NCT00480220|specific care|specific care
738437|NCT00480220|assistance plan|assistance plan
738438|NCT00480220|Alzheimer's disease|alzheimer's disease
738439|NCT00480181|Neuropathic pain|neuropathic pain
738440|NCT00480181|Multiple Sclerosis|multiple sclerosis
738441|NCT00480181|Nabilone|nabilone
738442|NCT00480181|Gabapentin|gabapentin
738443|NCT00480168|child|child
738444|NCT00480168|adolescent|adolescent
738445|NCT00480168|weight gain|weight gain
738446|NCT00480168|endocrine disruptors|endocrine disruptors
738447|NCT00480129|grass allergies,|grass allergies,
738448|NCT00480129|ragweed allergies,|ragweed allergies,
738449|NCT00480129|probiotics, lactobacillus,|probiotics, lactobacillus,
739146|NCT00477503|In-111 DTPA|in-111 dtpa
738450|NCT00480129|bifidobacterium,|bifidobacterium,
738451|NCT00480129|functional foods,|functional foods,
738452|NCT00480129|yogurt,|yogurt,
738453|NCT00480129|inflammatory cytokines|inflammatory cytokines
738454|NCT00480116|Consistency|consistency
738455|NCT00480116|Immunogenicity|immunogenicity
738456|NCT00480103|Embryo morphological and chromosomal features|embryo morphological and chromosomal features
738457|NCT00480103|Implantation and pregnancy rate|implantation and pregnancy rate
738458|NCT00480090|Prostate|prostate
738459|NCT00480090|Androgen independent|androgen independent
738460|NCT00480090|Phase II|phase ii
738461|NCT00480090|Second line|second line
738462|NCT00480090|Androgen-independent prostate cancer|androgen-independent prostate cancer
738463|NCT00480077|Heart Failure, randomized, OptiVol® Fluid status monitoring|heart failure, randomized, optivol® fluid status monitoring
738464|NCT00480064|AML|aml
738465|NCT00480064|older patients|older patients
738466|NCT00480064|lomustine|lomustine
738467|NCT00480051|Cardiac Failure|cardiac failure
738468|NCT00480051|Pacemaker|pacemaker
738469|NCT00480051|Dyssynchrony|dyssynchrony
738470|NCT00480051|Cardiac Magnetic Resonance|cardiac magnetic resonance
738471|NCT00480051|Narrow QRS|narrow qrs
738472|NCT00480038|symptomatic|symptomatic
738473|NCT00480038|lumbar disc herniation|lumbar disc herniation
738474|NCT00480038|disability|disability
738475|NCT00480038|fear avoidance beliefs|fear avoidance beliefs
738476|NCT00480038|quality of life|quality of life
738477|NCT00480025|ASCI|asci
738478|NCT00480025|Immunotherapeutic|immunotherapeutic
738479|NCT00480025|MAGRIT|magrit
738480|NCT00480025|Tumor antigen|tumor antigen
738481|NCT00480025|Non-small-cell lung cancer|non-small-cell lung cancer
738482|NCT00480025|Adjuvant cancer therapy|adjuvant cancer therapy
738483|NCT00480012|healthy subjects|healthy subjects
738484|NCT00479999|HIV-Negative|hiv-negative
738485|NCT00479999|Healthy|healthy
738486|NCT00479999|Immunity|immunity
738487|NCT00479999|Preventive|preventive
738488|NCT00479999|Virus|virus
738489|NCT00479999|Healthy Volunteer|healthy volunteer
738490|NCT00479999|HV|hv
738491|NCT00479999|HIV Preventive Vaccine|hiv preventive vaccine
738492|NCT00479986|diabetes mellitus|diabetes mellitus
738493|NCT00479986|monocyte activation|monocyte activation
738494|NCT00479986|cardiovascular risk|cardiovascular risk
738495|NCT00479973|diabetes|diabetes
738496|NCT00479973|non-insulin dependant diabetes|non-insulin dependant diabetes
738497|NCT00479973|type 2 diabetes|type 2 diabetes
738498|NCT00479973|cinnamon|cinnamon
738499|NCT00479973|natural health product|natural health product
738500|NCT00479973|hypercholesterolemia|hypercholesterolemia
738501|NCT00479973|dyslipidemia|dyslipidemia
738502|NCT00479973|elevated cholesterol|elevated cholesterol
738503|NCT00479960|Asthenozoospermia|asthenozoospermia
738504|NCT00479960|Azoospermia|azoospermia
738505|NCT00479960|Oligospermia|oligospermia
738506|NCT00479960|Omega-3|omega-3
738507|NCT00479960|Fatty Acids|fatty acids
738508|NCT00479947|Yeast vaginitis|yeast vaginitis
738509|NCT00479947|Probiotics|probiotics
738510|NCT00479947|Lactobacilli|lactobacilli
738511|NCT00479947|Fluconazole|fluconazole
738512|NCT00479934|scleroderma|scleroderma
738513|NCT00479934|imatinib|imatinib
738514|NCT00479934|PDGFR|pdgfr
738515|NCT00479934|Rodnan|rodnan
738516|NCT00479921|Influenza|influenza
738517|NCT00479921|Vaccine|vaccine
738518|NCT00479921|CHMP criteria|chmp criteria
738519|NCT00479908|Blood pressure|blood pressure
738520|NCT00479908|Angina|angina
738521|NCT00479908|Sildenafil|sildenafil
738522|NCT00479908|Phosphodiesterase type 5|phosphodiesterase type 5
738523|NCT00479908|Organic nitrate|organic nitrate
738524|NCT00479908|Glyceryl trinitrate|glyceryl trinitrate
738525|NCT00479908|Drug interaction|drug interaction
738526|NCT00479895|Percutaneous Coronary Intervention|percutaneous coronary intervention
738527|NCT00479895|Myocardial Ischemia|myocardial ischemia
738528|NCT00479895|Balloon Occlusion|balloon occlusion
738529|NCT00479895|Catheter Lab|catheter lab
738530|NCT00479856|ErbB1|erbb1
738531|NCT00479856|ErbB2|erbb2
738532|NCT00479856|GW572016|gw572016
738533|NCT00479856|lapatinib|lapatinib
738534|NCT00479856|Relapsed breast cancer|relapsed breast cancer
738535|NCT00479856|dual tyrosine kinase inhibitor|dual tyrosine kinase inhibitor
738536|NCT00479856|MBC|mbc
738537|NCT00479856|EGFR|egfr
738538|NCT00479856|Her-2/neu|her-2/neu
738539|NCT00479856|FISH amplification|fish amplification
738540|NCT00479843|Alzheimer Disease|alzheimer disease
738541|NCT00479843|Dementia|dementia
738542|NCT00479843|Elderly|elderly
738543|NCT00479843|Nutrition|nutrition
738544|NCT00479843|Malnutrition|malnutrition
738545|NCT00479843|Weight Loss|weight loss
738546|NCT00479830|Epidemiology|epidemiology
738547|NCT00479830|Health Risks|health risks
738548|NCT00479830|Questionnaire|questionnaire
738549|NCT00479830|Interview|interview
738550|NCT00479830|South Asian|south asian
738551|NCT00479830|Asian Indian|asian indian
738552|NCT00479830|Bangladeshi|bangladeshi
738553|NCT00479830|Pakistani|pakistani
738554|NCT00479830|Sri Lankan|sri lankan
738555|NCT00479817|Advanced Recurrent Epithelial Ovarian, Fallopian Tube, or Primary Peritoneal Cancer|advanced recurrent epithelial ovarian, fallopian tube, or primary peritoneal cancer
738556|NCT00479804|indication for CMR|indication for cmr
738557|NCT00479791|Type 2 diabetes mellitus|type 2 diabetes mellitus
738558|NCT00479791|Fatty acids|fatty acids
738559|NCT00479791|Postprandial response|postprandial response
738560|NCT00479791|Insulin|insulin
738561|NCT00479791|Glucose|glucose
738562|NCT00479791|Triglycerides|triglycerides
738563|NCT00479778|Postmenopause|postmenopause
738564|NCT00479765|glioblastoma multiforme|glioblastoma multiforme
738565|NCT00479765|recurrent|recurrent
738566|NCT00479765|Phase 1|phase 1
738567|NCT00479765|Phase 2|phase 2
738568|NCT00479765|Phase I|phase i
738569|NCT00479765|Phase II|phase ii
738570|NCT00479765|brain|brain
738571|NCT00479765|cancer|cancer
738572|NCT00479765|paclitaxel|paclitaxel
738573|NCT00479765|intracranial|intracranial
738574|NCT00479765|tumor|tumor
738575|NCT00479765|local|local
738576|NCT00479765|chemotherapy|chemotherapy
738577|NCT00479765|brain tumor|brain tumor
738578|NCT00479765|brain cancer|brain cancer
738579|NCT00479765|glioma|glioma
738580|NCT00479765|OncoGel|oncogel
738581|NCT00479739|formoterol/budesonide|formoterol/budesonide
738582|NCT00479739|exacerbations|exacerbations
738583|NCT00479739|Salmeterol/fluticasone propionate|salmeterol/fluticasone propionate
738584|NCT00479739|adjustable maintenance dosing|adjustable maintenance dosing
738585|NCT00479739|asthma control|asthma control
738586|NCT00479713|High Cholesterol|high cholesterol
738587|NCT00479687|Osteoarthritis|osteoarthritis
738588|NCT00479687|Shoulder|shoulder
738589|NCT00479687|HA|ha
738590|NCT00479674|Metastatic Breast Cancer|metastatic breast cancer
738591|NCT00479674|Advanced Breast Cancer|advanced breast cancer
738592|NCT00479674|Hormone Receptor AND Her2/neu Negative|hormone receptor and her2/neu negative
738593|NCT00479674|Triple Negative|triple negative
738594|NCT00479674|Triple Negative Breast Cancer|triple negative breast cancer
738595|NCT00479674|Stage IV or Inoperable Stage III Breast Cancer|stage iv or inoperable stage iii breast cancer
738596|NCT00479661|initial sedation|initial sedation
738597|NCT00479661|mechanical ventilation|mechanical ventilation
738598|NCT00479635|HRPC|hrpc
738599|NCT00479635|TPI 287|tpi 287
738600|NCT00479635|Taxane|taxane
738601|NCT00479635|MDR|mdr
738602|NCT00479635|Hormone Refractory Prostate Cancer|hormone refractory prostate cancer
738603|NCT00479622|Membranous Nephropathy|membranous nephropathy
738604|NCT00479622|Systemic Lupus Erythematosus|systemic lupus erythematosus
738605|NCT00479609|Insulin resistance|insulin resistance
738606|NCT00479609|Glucose tolerance|glucose tolerance
738607|NCT00479609|Type 2 diabetes|type 2 diabetes
738608|NCT00479609|Androgen sensitivity|androgen sensitivity
738609|NCT00479596|Overactive Bladder|overactive bladder
738611|NCT00479596|Refractory OAB|refractory oab
738612|NCT00479596|Botox|botox
738613|NCT00479596|Bladder|bladder
738614|NCT00479583|Cancer (solid tumors)|cancer (solid tumors)
738615|NCT00479557|Alzheimer's Disease|alzheimer's disease
738616|NCT00479557|active immunization|active immunization
738617|NCT00479531|Restless Legs Syndrome|restless legs syndrome
738618|NCT00479531|Sequential Compression Device|sequential compression device
738619|NCT00479531|Sleep Quality|sleep quality
738620|NCT00479531|Quality of Life|quality of life
738621|NCT00479518|stroke|stroke
738622|NCT00479518|transient ischemic attack|transient ischemic attack
738623|NCT00479518|albuminuria|albuminuria
738624|NCT00479518|BNP|bnp
738625|NCT00479518|Cystatin C|cystatin c
738626|NCT00479492|Obesity, weight loss|obesity, weight loss
738627|NCT00479479|cobalamin|cobalamin
738628|NCT00479479|methylmalonic acid|methylmalonic acid
738629|NCT00479479|homocysteine|homocysteine
738630|NCT00479479|folate|folate
738631|NCT00479479|newborns|newborns
738632|NCT00479479|infants|infants
738633|NCT00479479|Deficiency Disease|deficiency disease
738634|NCT00479479|Breastfeeding|breastfeeding
738635|NCT00479479|Infant|infant
738636|NCT00479427|osteoarthritis pain assessments|osteoarthritis pain assessments
738637|NCT00479375|screening|screening
738638|NCT00479375|human papillomavirus|human papillomavirus
738639|NCT00479362|Pacemaker|pacemaker
738640|NCT00479362|Cardioverter-defibrillator|cardioverter-defibrillator
738641|NCT00479362|Hemorrhage|hemorrhage
738642|NCT00479362|Hematoma|hematoma
738643|NCT00479362|Thrombosis|thrombosis
738644|NCT00479362|Embolism|embolism
738645|NCT00479336|OPC-41061|opc-41061
738646|NCT00479336|Tolvaptan|tolvaptan
738647|NCT00479336|ascites|ascites
738648|NCT00479336|Cirrhosis|cirrhosis
738649|NCT00479323|pneumococcal vaccine, Pneumovax, reference sera, serum 89SF|pneumococcal vaccine, pneumovax, reference sera, serum 89sf
738650|NCT00479284|Non-invasive ventilation|non-invasive ventilation
738651|NCT00479284|Polysomnography|polysomnography
738652|NCT00479284|Average volume assured pressure support|average volume assured pressure support
738653|NCT00479271|RCT|rct
738654|NCT00479271|Dementia|dementia
738655|NCT00479271|community trial|community trial
738656|NCT00479271|Homebased care|homebased care
738657|NCT00479271|caregiver burden|caregiver burden
738658|NCT00479271|Behavioural problems|behavioural problems
738659|NCT00479271|Dementia in subjects|dementia in subjects
738660|NCT00479271|behavioral problems in subjects|behavioral problems in subjects
738661|NCT00479271|Mental health of carers|mental health of carers
738662|NCT00479245|nonspecific low back pain|nonspecific low back pain
738663|NCT00479245|disability|disability
738664|NCT00479245|fear avoidance beliefs|fear avoidance beliefs
738665|NCT00479245|quality of life|quality of life
738666|NCT00479232|Leukemia|leukemia
738667|NCT00479232|Myelocytic|myelocytic
738668|NCT00479232|Acute Myelodysplastic Syndromes|acute myelodysplastic syndromes
738669|NCT00479206|artesuante|artesuante
738670|NCT00479206|falciparum malaria|falciparum malaria
738671|NCT00479206|Cambodia|cambodia
738672|NCT00479206|Artemisinin resistance|artemisinin resistance
738673|NCT00479193|Burns|burns
738674|NCT00479193|Dressing change|dressing change
738675|NCT00479180|Hemodialysis access|hemodialysis access
738676|NCT00479180|Arteriovenous graft|arteriovenous graft
738677|NCT00479180|Arteriovenous fistula|arteriovenous fistula
738678|NCT00479180|End stage renal disease|end stage renal disease
738679|NCT00479167|Non-Hodgkin's Lymphoma|non-hodgkin's lymphoma
738680|NCT00479167|Follicular Non-Hodgkin's Lymphoma|follicular non-hodgkin's lymphoma
738681|NCT00479167|Lymphoma|lymphoma
738682|NCT00479154|Restless Leg Syndrome|restless leg syndrome
738683|NCT00479154|Botulinum Toxin|botulinum toxin
738684|NCT00479154|RLS|rls
738685|NCT00479141|Treatment Naive|treatment naive
738686|NCT00479141|Treatment Experienced|treatment experienced
738687|NCT00479141|Complementary Therapies|complementary therapies
738688|NCT00479128|Solid Tumor|solid tumor
738689|NCT00479128|Bladder Cancer|bladder cancer
738690|NCT00479128|Ureteral Cancer|ureteral cancer
738691|NCT00479128|Urothelial Cancer|urothelial cancer
738692|NCT00479128|Urethral Cancer|urethral cancer
738693|NCT00479128|Renal Pelvis Tumor|renal pelvis tumor
738694|NCT00479128|Bortezomib|bortezomib
738695|NCT00479128|Gemcitabine|gemcitabine
738696|NCT00479128|Doxorubicin|doxorubicin
738697|NCT00479128|Gemzar|gemzar
738698|NCT00479128|Adriamycin|adriamycin
738699|NCT00479128|Velcade|velcade
738700|NCT00479128|LDP-341|ldp-341
738701|NCT00479128|MLN341|mln341
738702|NCT00479128|PS-341|ps-341
738703|NCT00479128|Gemcitabine Hydrochloride|gemcitabine hydrochloride
738704|NCT00479128|AD|ad
738705|NCT00479128|Hydroxydaunomycin hydrochloride|hydroxydaunomycin hydrochloride
738706|NCT00479102|Iron supplementation|iron supplementation
738707|NCT00479102|Babies|babies
738708|NCT00479102|Prevention|prevention
738709|NCT00479089|Transitional Cell Carcinoma|transitional cell carcinoma
738711|NCT00479089|Urothelial Cancer|urothelial cancer
738712|NCT00479089|Bladder Cancer|bladder cancer
738713|NCT00479089|Docetaxel|docetaxel
738714|NCT00479089|Taxotere|taxotere
738715|NCT00479089|ZD1839|zd1839
738716|NCT00479089|Gefitinib|gefitinib
738717|NCT00479089|Iressa|iressa
738718|NCT00479089|Consolidation Therapy|consolidation therapy
738719|NCT00479076|antineoplastic agents|antineoplastic agents
738720|NCT00479076|VEGF Trap|vegf trap
738721|NCT00479063|MODIC changes|modic changes
738722|NCT00479063|chronic low back pain|chronic low back pain
738723|NCT00479063|magnetic resonance imaging (MRI)|magnetic resonance imaging (mri)
738724|NCT00479063|vertebrae|vertebrae
738725|NCT00479063|intervertebral disc|intervertebral disc
738726|NCT00479050|Hepatocellular carcinoma,treatment|hepatocellular carcinoma,treatment
738727|NCT00479037|postmenopausal women with primary osteoporosis|postmenopausal women with primary osteoporosis
738728|NCT00479011|fluid management|fluid management
738729|NCT00479011|arterial pulse pressure variation|arterial pulse pressure variation
738730|NCT00479011|high-risk surgery|high-risk surgery
738731|NCT00478998|expulsion therapy|expulsion therapy
738732|NCT00478998|tamsulosin|tamsulosin
738733|NCT00478998|ureterolithiasis|ureterolithiasis
738734|NCT00478998|stents|stents
738735|NCT00478985|Leukemia|leukemia
738736|NCT00478985|Adult Chronic|adult chronic
738737|NCT00478985|Myeloid|myeloid
738738|NCT00478972|obese|obese
738739|NCT00478972|diabetes|diabetes
738740|NCT00478972|cannabinoid-1 receptor|cannabinoid-1 receptor
738741|NCT00478959|Lenalidomide|lenalidomide
738742|NCT00478959|Revlimid|revlimid
738743|NCT00478959|Hodgkin's|hodgkin's
738744|NCT00478959|Hodgkin|hodgkin
738745|NCT00478959|Hodgkin's Lymphoma|hodgkin's lymphoma
738746|NCT00478959|Hodgkin's Disease|hodgkin's disease
738747|NCT00478959|Lymphoma|lymphoma
738748|NCT00478946|colorectal cancer|colorectal cancer
738749|NCT00478946|picoplatin|picoplatin
738750|NCT00478946|FOLFOX|folfox
738751|NCT00478946|FOLPI|folpi
738752|NCT00478946|chemotherapy|chemotherapy
738753|NCT00478933|Arrhythmia|arrhythmia
738754|NCT00478933|Ventricular|ventricular
738755|NCT00478933|Atrial|atrial
738756|NCT00478933|Tachycardia|tachycardia
738757|NCT00478933|Fibrillation|fibrillation
738758|NCT00478933|Flutter|flutter
738759|NCT00478933|GNB3|gnb3
738760|NCT00478933|GNAS|gnas
738761|NCT00478933|GNAQ|gnaq
738762|NCT00478907|oculocardiac reflex; strabismus surgery;|oculocardiac reflex; strabismus surgery;
738763|NCT00478894|Anterior cruciate ligament / injuries|anterior cruciate ligament / injuries
738764|NCT00478894|Anterior cruciate ligament / surgery|anterior cruciate ligament / surgery
738765|NCT00478894|knee injuries / surgery|knee injuries / surgery
738766|NCT00478894|outcomes research|outcomes research
738767|NCT00478894|prospective studies|prospective studies
738768|NCT00478894|osteoarthritis|osteoarthritis
738769|NCT00478868|MODIC changes|modic changes
738770|NCT00478868|chronic low back pain|chronic low back pain
738771|NCT00478868|magnetic resonance imaging (MRI)|magnetic resonance imaging (mri)
738772|NCT00478868|vertebrae|vertebrae
738773|NCT00478868|intervertebral disc|intervertebral disc
738774|NCT00478842|Gilles de la Tourette syndrome|gilles de la tourette syndrome
738775|NCT00478842|Deep brain stimulation|deep brain stimulation
738776|NCT00478842|Globus PALLIDUS|globus pallidus
738777|NCT00478816|Bird flu|bird flu
738778|NCT00478816|influenza vaccine|influenza vaccine
738779|NCT00478816|prepandemic vaccine|prepandemic vaccine
738780|NCT00478803|Standardized surgical procedure|standardized surgical procedure
738781|NCT00478803|Aortic root aneurysm|aortic root aneurysm
738782|NCT00478803|Dystrophic aortic insufficiency|dystrophic aortic insufficiency
738783|NCT00478803|Conservative aortic valve surgery|conservative aortic valve surgery
738784|NCT00478803|Aortic annuloplasty|aortic annuloplasty
738785|NCT00478803|Mechanical aortic valve replacement|mechanical aortic valve replacement
738786|NCT00478803|Sinus of Valsalva|sinus of valsalva
738787|NCT00478803|Cardiac Surgical Procedures|cardiac surgical procedures
738788|NCT00478790|Glaucoma|glaucoma
738789|NCT00478790|Pterygium|pterygium
738790|NCT00478790|collagen matrix|collagen matrix
738791|NCT00478790|OculusGen|oculusgen
738792|NCT00478790|trabeculectomy|trabeculectomy
738793|NCT00478790|Anti scarring|anti scarring
738794|NCT00478790|pterygium recurrence|pterygium recurrence
738795|NCT00478790|tissue engineering|tissue engineering
738796|NCT00478790|ologen|ologen
738797|NCT00478790|Aeon Astron|aeon astron
738798|NCT00478777|CC-5013|cc-5013
738799|NCT00478777|Revlimid|revlimid
738800|NCT00478777|Lenalidomide|lenalidomide
738801|NCT00478777|Celgene|celgene
738802|NCT00478777|Multiple Myeloma|multiple myeloma
738803|NCT00478764|intraocular|intraocular
738804|NCT00478764|triamcinolone|triamcinolone
738805|NCT00478764|gatifloxicin|gatifloxicin
738806|NCT00478764|inflammation|inflammation
738807|NCT00478764|visual acuity|visual acuity
738808|NCT00478751|Visible light, Long UVA,Pigmentation|visible light, long uva,pigmentation
738809|NCT00478751|Normal healthy volunteers with dark skin type.|normal healthy volunteers with dark skin type.
738810|NCT00478738|b-agonist,|b-agonist,
738812|NCT00478738|pharmacodynamic,|pharmacodynamic,
738813|NCT00478738|pharmacokinetic,|pharmacokinetic,
738814|NCT00478738|anti muscarinic,|anti muscarinic,
738815|NCT00478725|Metastatic Cancer|metastatic cancer
738816|NCT00478725|Advanced Cancer|advanced cancer
738817|NCT00478712|Hirschsprung|hirschsprung
738818|NCT00478699|SCAT|scat
738819|NCT00478699|BRCA1|brca1
738820|NCT00478699|BRCA1 mRNA Levels|brca1 mrna levels
738821|NCT00478699|ADJUVANT|adjuvant
738822|NCT00478699|LUNG|lung
738823|NCT00478699|GECP-SCAT|gecp-scat
738824|NCT00478686|Breast Cancer|breast cancer
738825|NCT00478686|Dihydropyrimidine Dehydrogenase|dihydropyrimidine dehydrogenase
738826|NCT00478686|DPYD|dpyd
738827|NCT00478686|DPYD Variants|dpyd variants
738828|NCT00478686|Toxicity|toxicity
738829|NCT00478686|Capecitabine|capecitabine
738830|NCT00478686|Xeloda|xeloda
738831|NCT00478673|NexStent|nexstent
738832|NCT00478673|FilterWire EZ|filterwire ez
738833|NCT00478673|Boston Scientific|boston scientific
738834|NCT00478673|Carotid Artery|carotid artery
738835|NCT00478673|Carotid Endarterectomy|carotid endarterectomy
738836|NCT00478673|Carotid Revascularization|carotid revascularization
738837|NCT00478647|Acid beta-glucocerebrosidase|acid beta-glucocerebrosidase
738838|NCT00478647|human|human
738839|NCT00478647|glucocerebrosidase|glucocerebrosidase
738840|NCT00478647|Gaucher disease|gaucher disease
738841|NCT00478647|Enzyme Replacement Therapy|enzyme replacement therapy
738842|NCT00478647|D-glucosyl-N-acylsphingosine glucohydrolase|d-glucosyl-n-acylsphingosine glucohydrolase
738843|NCT00478647|glucosylceramidase|glucosylceramidase
738844|NCT00478647|gene activation|gene activation
738845|NCT00478647|beta-glucocerebrosidase|beta-glucocerebrosidase
738846|NCT00478634|Colorectal Cancer|colorectal cancer
738847|NCT00478634|Colorectal Carcinoma|colorectal carcinoma
738848|NCT00478634|Colorectal Tumors|colorectal tumors
738849|NCT00478634|Neoplasms, Colorectal|neoplasms, colorectal
738850|NCT00478621|HPV|hpv
738851|NCT00478595|obese|obese
738852|NCT00478595|diabetes|diabetes
738853|NCT00478595|cannabinoid-1 receptor|cannabinoid-1 receptor
738854|NCT00478582|Anemia|anemia
738855|NCT00478582|Visual scale|visual scale
738856|NCT00478582|nephrological patients|nephrological patients
738857|NCT00478582|Anemia in nephrological patients|anemia in nephrological patients
738858|NCT00478556|CT scan|ct scan
738859|NCT00478556|oral contrast|oral contrast
738860|NCT00478543|Loop diuretics|loop diuretics
738861|NCT00478543|Chronic Kidney Disease|chronic kidney disease
738862|NCT00478543|Hypertension|hypertension
738863|NCT00478543|Blood pressure control|blood pressure control
738864|NCT00478543|Left ventricular mass|left ventricular mass
738865|NCT00478517|Spinal trauma|spinal trauma
738866|NCT00478517|erythropoietin|erythropoietin
738867|NCT00478517|dose escalation study|dose escalation study
738868|NCT00478504|anovulation|anovulation
738869|NCT00478504|ovulation induction,|ovulation induction,
738870|NCT00478504|polycystic ovarian syndrome|polycystic ovarian syndrome
738871|NCT00478504|clomifene citrate|clomifene citrate
738872|NCT00478504|letrozole|letrozole
738873|NCT00478478|Stroke|stroke
738874|NCT00478478|Ischemic|ischemic
738875|NCT00478478|Thrombus|thrombus
738876|NCT00478478|Embolectomy|embolectomy
738877|NCT00478478|Thrombectomy|thrombectomy
738878|NCT00478478|Merci|merci
738879|NCT00478478|Concentric|concentric
738880|NCT00478478|Embolus|embolus
738881|NCT00478478|Embolism|embolism
738882|NCT00478478|Mechanical|mechanical
738883|NCT00478465|chronic fatigue syndrome|chronic fatigue syndrome
738884|NCT00478465|fatigue|fatigue
738885|NCT00478465|valganciclovir|valganciclovir
738886|NCT00478465|valcyte|valcyte
738887|NCT00478465|Epstein-Barr virus|epstein-barr virus
738888|NCT00478465|EBV|ebv
738889|NCT00478465|Human herpes virus 6|human herpes virus 6
738890|NCT00478465|HHV 6|hhv 6
738891|NCT00478465|herpes viruses|herpes viruses
738892|NCT00478465|herpes|herpes
738893|NCT00478439|aging|aging
738894|NCT00478439|age-related macular degeneration|age-related macular degeneration
738895|NCT00478439|macular pigment|macular pigment
738896|NCT00478439|dark adaptation|dark adaptation
738897|NCT00478400|Recovery|recovery
738898|NCT00478400|Magnetic resonance imaging|magnetic resonance imaging
738899|NCT00478400|Awareness|awareness
738900|NCT00478400|Neurologic deficits|neurologic deficits
738901|NCT00478387|Advanced Ovarian and Primary Peritoneal Cancer in Remission|advanced ovarian and primary peritoneal cancer in remission
738902|NCT00478348|Postoperative Complications|postoperative complications
738903|NCT00478348|Drainage|drainage
738904|NCT00478348|Infection|infection
738905|NCT00478348|Seroma|seroma
738906|NCT00478348|Hematoma|hematoma
738907|NCT00478348|Recurrence|recurrence
738908|NCT00478348|Abdominal Wall|abdominal wall
738909|NCT00478348|Hernia|hernia
738910|NCT00478348|Surgical Mesh|surgical mesh
738911|NCT00478335|congenital nephrogenic diabetes insipidus|congenital nephrogenic diabetes insipidus
738912|NCT00478335|polyuria|polyuria
738913|NCT00478335|urine osmolality|urine osmolality
738914|NCT00478335|aquaporin-2|aquaporin-2
739096|NCT00477711|Cetuximab|cetuximab
738915|NCT00478335|vasopressin V2 receptor|vasopressin v2 receptor
738916|NCT00478322|Diabetes;|diabetes;
738917|NCT00478322|Type II diabetes;|type ii diabetes;
738918|NCT00478322|Non-insulin dependent diabetes;|non-insulin dependent diabetes;
738919|NCT00478322|Obesity|obesity
738920|NCT00478309|colon cancer|colon cancer
738921|NCT00478309|rectal cancer|rectal cancer
738922|NCT00478309|healthy, no evidence of disease|healthy, no evidence of disease
738923|NCT00478296|Pulmonary hypertension|pulmonary hypertension
738924|NCT00478296|Sildenafil|sildenafil
738925|NCT00478296|Bosentan|bosentan
738926|NCT00478296|Trisomy 21|trisomy 21
738927|NCT00478296|Atrial septal defect|atrial septal defect
738928|NCT00478283|breast cancer|breast cancer
738929|NCT00478257|fatigue|fatigue
738930|NCT00478257|sleep|sleep
738931|NCT00478257|quality of life|quality of life
738932|NCT00478257|light|light
738933|NCT00478257|cancer|cancer
738934|NCT00478244|epidermolysis bullosa|epidermolysis bullosa
738935|NCT00478244|dystrophic epidermolysis bullosa|dystrophic epidermolysis bullosa
738936|NCT00478231|Multicenter|multicenter
738937|NCT00478231|Open Label|open label
738938|NCT00478231|Non-Comparative Safety Study Of Maraviroc|non-comparative safety study of maraviroc
738939|NCT00478231|Treatment Experienced|treatment experienced
738940|NCT00478218|stage I multiple myeloma|stage i multiple myeloma
738941|NCT00478218|stage II multiple myeloma|stage ii multiple myeloma
738942|NCT00478218|stage III multiple myeloma|stage iii multiple myeloma
738943|NCT00478205|Moderate to Severe Alzheimer's Disease|moderate to severe alzheimer's disease
738944|NCT00478192|hyponatremia|hyponatremia
738945|NCT00478192|hypervolemic|hypervolemic
738946|NCT00478192|euvolemic|euvolemic
738947|NCT00478192|edematous|edematous
738948|NCT00478192|conivaptan|conivaptan
738949|NCT00478179|herpes zoster|herpes zoster
738950|NCT00478179|shingles|shingles
738952|NCT00478179|post herpetic neuralgia|post herpetic neuralgia
738953|NCT00478179|neuropathic pain|neuropathic pain
738954|NCT00478114|Renal Cell Carcinoma|renal cell carcinoma
738955|NCT00478114|Sorafenib|sorafenib
738956|NCT00478101|Pain|pain
738957|NCT00478088|Single Level|single level
738958|NCT00478088|Cervical Disc Disease|cervical disc disease
738959|NCT00478075|stage I multiple myeloma|stage i multiple myeloma
738960|NCT00478075|stage II multiple myeloma|stage ii multiple myeloma
738961|NCT00478075|stage III multiple myeloma|stage iii multiple myeloma
738962|NCT00478075|refractory multiple myeloma|refractory multiple myeloma
739147|NCT00477477|overweight|overweight
738963|NCT00478062|stage I adult Hodgkin lymphoma|stage i adult hodgkin lymphoma
738964|NCT00478062|stage II adult Hodgkin lymphoma|stage ii adult hodgkin lymphoma
738965|NCT00478062|stage III adult Hodgkin lymphoma|stage iii adult hodgkin lymphoma
738966|NCT00478062|stage IV adult Hodgkin lymphoma|stage iv adult hodgkin lymphoma
738967|NCT00478049|Non-Small Cell Lung Cancer|non-small cell lung cancer
738968|NCT00478036|glaucoma|glaucoma
738969|NCT00478036|selective laser trabeculoplasty|selective laser trabeculoplasty
738970|NCT00478036|anterior chamber flare|anterior chamber flare
738971|NCT00478023|Opioid|opioid
738972|NCT00478023|Central acting analgesic|central acting analgesic
738973|NCT00478023|Pain postoperative|pain postoperative
738974|NCT00478023|Abdomen acute|abdomen acute
738975|NCT00478023|CG5503 IR|cg5503 ir
738976|NCT00478023|Morphine|morphine
738977|NCT00478023|Placebo|placebo
738978|NCT00478010|psychosocial effects of cancer and its treatment|psychosocial effects of cancer and its treatment
738979|NCT00478010|stage III colon cancer|stage iii colon cancer
738980|NCT00478010|stage IV colon cancer|stage iv colon cancer
738981|NCT00478010|stage III rectal cancer|stage iii rectal cancer
738982|NCT00478010|stage IV rectal cancer|stage iv rectal cancer
738983|NCT00478010|stage II pancreatic cancer|stage ii pancreatic cancer
738984|NCT00478010|stage III pancreatic cancer|stage iii pancreatic cancer
738985|NCT00478010|stage IV pancreatic cancer|stage iv pancreatic cancer
738986|NCT00477997|Growth Hormone|growth hormone
738987|NCT00477997|Insulin Signaling|insulin signaling
738988|NCT00477997|GH signaling|gh signaling
738989|NCT00477984|Alcohol|alcohol
738990|NCT00477984|Driving|driving
738991|NCT00477984|Multitasking|multitasking
738992|NCT00477984|ERP|erp
738993|NCT00477984|social drinkers|social drinkers
738994|NCT00477971|primary systemic amyloidosis|primary systemic amyloidosis
738995|NCT00477958|cognitive/functional effects|cognitive/functional effects
738996|NCT00477958|psychosocial effects of cancer and its treatment|psychosocial effects of cancer and its treatment
738997|NCT00477958|unspecified adult solid tumor, protocol specific|unspecified adult solid tumor, protocol specific
738998|NCT00477945|Non Hodgkin's Lymphoma|non hodgkin's lymphoma
738999|NCT00477945|High Risk or Refractory Non Hodgkin's Lymphoma|high risk or refractory non hodgkin's lymphoma
739000|NCT00477945|APBSCT|apbsct
739001|NCT00477945|clofarabine|clofarabine
739002|NCT00477932|Pentalogy of Cantrell|pentalogy of cantrell
739003|NCT00477932|mutations|mutations
739004|NCT00477932|DNA|dna
739005|NCT00477932|RNA|rna
739006|NCT00477919|stage IV melanoma|stage iv melanoma
739007|NCT00477919|stage IV renal cell cancer|stage iv renal cell cancer
739008|NCT00477919|unresectable extrahepatic bile duct cancer|unresectable extrahepatic bile duct cancer
739009|NCT00477919|advanced malignant mesothelioma|advanced malignant mesothelioma
739010|NCT00477919|stage IV prostate cancer|stage iv prostate cancer
739011|NCT00477919|adult giant cell glioblastoma|adult giant cell glioblastoma
739012|NCT00477919|adult gliosarcoma|adult gliosarcoma
739013|NCT00477919|extensive stage small cell lung cancer|extensive stage small cell lung cancer
739014|NCT00477919|stage IV non-small cell lung cancer|stage iv non-small cell lung cancer
739015|NCT00477919|stage IV colon cancer|stage iv colon cancer
739016|NCT00477919|stage IV gastric cancer|stage iv gastric cancer
739017|NCT00477919|stage IV esophageal cancer|stage iv esophageal cancer
739018|NCT00477919|stage IV bladder cancer|stage iv bladder cancer
739019|NCT00477919|male breast cancer|male breast cancer
739020|NCT00477919|stage IV breast cancer|stage iv breast cancer
739021|NCT00477919|stage IV ovarian epithelial cancer|stage iv ovarian epithelial cancer
739022|NCT00477919|stage IV ovarian germ cell tumor|stage iv ovarian germ cell tumor
739023|NCT00477919|ovarian sarcoma|ovarian sarcoma
739024|NCT00477919|ovarian stromal cancer|ovarian stromal cancer
739025|NCT00477919|fatigue|fatigue
739026|NCT00477919|anorexia|anorexia
739027|NCT00477919|cachexia|cachexia
739028|NCT00477919|pain|pain
739029|NCT00477919|weight changes|weight changes
739030|NCT00477919|depression|depression
739031|NCT00477919|poor performance status|poor performance status
739032|NCT00477919|recurrent adult brain tumor|recurrent adult brain tumor
739033|NCT00477919|clear cell sarcoma of the kidney|clear cell sarcoma of the kidney
739034|NCT00477919|advanced adult primary liver cancer|advanced adult primary liver cancer
739035|NCT00477919|recurrent adult primary liver cancer|recurrent adult primary liver cancer
739036|NCT00477919|recurrent small cell lung cancer|recurrent small cell lung cancer
739037|NCT00477919|recurrent bladder cancer|recurrent bladder cancer
739038|NCT00477919|recurrent breast cancer|recurrent breast cancer
739039|NCT00477919|recurrent colon cancer|recurrent colon cancer
739040|NCT00477919|recurrent esophageal cancer|recurrent esophageal cancer
739041|NCT00477919|recurrent gastric cancer|recurrent gastric cancer
739042|NCT00477919|recurrent melanoma|recurrent melanoma
739043|NCT00477919|recurrent non-small cell lung cancer|recurrent non-small cell lung cancer
739044|NCT00477919|recurrent ovarian epithelial cancer|recurrent ovarian epithelial cancer
739045|NCT00477919|recurrent ovarian germ cell tumor|recurrent ovarian germ cell tumor
739046|NCT00477919|stage IV pancreatic cancer|stage iv pancreatic cancer
739047|NCT00477919|recurrent prostate cancer|recurrent prostate cancer
739048|NCT00477919|recurrent renal cell cancer|recurrent renal cell cancer
739049|NCT00477919|recurrent pancreatic cancer|recurrent pancreatic cancer
739050|NCT00477919|stage IV rectal cancer|stage iv rectal cancer
739051|NCT00477919|recurrent rectal cancer|recurrent rectal cancer
739052|NCT00477919|recurrent malignant mesothelioma|recurrent malignant mesothelioma
739053|NCT00477919|recurrent carcinoma of unknown primary|recurrent carcinoma of unknown primary
739054|NCT00477919|stage IV adult soft tissue sarcoma|stage iv adult soft tissue sarcoma
739055|NCT00477919|recurrent adult soft tissue sarcoma|recurrent adult soft tissue sarcoma
739056|NCT00477919|stage IV uterine sarcoma|stage iv uterine sarcoma
739057|NCT00477919|recurrent uterine sarcoma|recurrent uterine sarcoma
739058|NCT00477919|recurrent extrahepatic bile duct cancer|recurrent extrahepatic bile duct cancer
739059|NCT00477919|unresectable gallbladder cancer|unresectable gallbladder cancer
739060|NCT00477919|recurrent gallbladder cancer|recurrent gallbladder cancer
739061|NCT00477919|adult glioblastoma|adult glioblastoma
739062|NCT00477906|melanoma|melanoma
739063|NCT00477906|vaccine|vaccine
739064|NCT00477906|metastatic|metastatic
739065|NCT00477906|autologous|autologous
739066|NCT00477880|gastric cancer|gastric cancer
739067|NCT00477880|giant hypertrophic gastritis|giant hypertrophic gastritis
739068|NCT00477867|stage III ovarian epithelial cancer|stage iii ovarian epithelial cancer
739069|NCT00477841|esophageal Cancer|esophageal cancer
739070|NCT00477841|Dysphagia|dysphagia
739071|NCT00477841|Stent|stent
739072|NCT00477841|interstitial brachytherapy|interstitial brachytherapy
739073|NCT00477828|sleep apnea|sleep apnea
739074|NCT00477828|dementia|dementia
739075|NCT00477828|excessive sleepiness|excessive sleepiness
739076|NCT00477828|cognition|cognition
739077|NCT00477815|stage I multiple myeloma|stage i multiple myeloma
739078|NCT00477815|refractory multiple myeloma|refractory multiple myeloma
739079|NCT00477815|stage II multiple myeloma|stage ii multiple myeloma
739080|NCT00477815|stage III multiple myeloma|stage iii multiple myeloma
739081|NCT00477802|Parkinson's disease|parkinson's disease
739082|NCT00477802|levodopa-induced cervical dyskinesias|levodopa-induced cervical dyskinesias
739083|NCT00477789|chronic heart failure|chronic heart failure
739084|NCT00477789|diastolic dysfunction|diastolic dysfunction
739085|NCT00477789|uric acid|uric acid
739086|NCT00477776|Beginning of breastfeeding|beginning of breastfeeding
739087|NCT00477750|stage I multiple myeloma|stage i multiple myeloma
739088|NCT00477750|stage II multiple myeloma|stage ii multiple myeloma
739089|NCT00477750|stage III multiple myeloma|stage iii multiple myeloma
739090|NCT00477737|cardioprotection|cardioprotection
739091|NCT00477737|sevoflurane|sevoflurane
739092|NCT00477737|esophageal Doppler|esophageal doppler
739093|NCT00477737|thermodilution|thermodilution
739094|NCT00477737|coronary artery bypass|coronary artery bypass
739095|NCT00477724|latent|latent
739097|NCT00477711|cisplatin|cisplatin
739098|NCT00477711|capecitabine|capecitabine
739099|NCT00477711|first line treatment|first line treatment
739100|NCT00477685|Glaucoma|glaucoma
739101|NCT00477685|Collagen matrix|collagen matrix
739102|NCT00477685|OculusGen|oculusgen
739103|NCT00477685|Phacotrabeculectomy|phacotrabeculectomy
739104|NCT00477685|anti scarring|anti scarring
739105|NCT00477685|tissue engineering|tissue engineering
739106|NCT00477685|ologen|ologen
739107|NCT00477685|Aeon Astron|aeon astron
739108|NCT00477672|Parkinson's disease, psychotic disorders|parkinson's disease, psychotic disorders
739109|NCT00477659|fMRI study; open-label donepezil|fmri study; open-label donepezil
739110|NCT00477646|colon cancer|colon cancer
739111|NCT00477646|rectal cancer|rectal cancer
739112|NCT00477646|breast cancer|breast cancer
739113|NCT00477646|cervical cancer|cervical cancer
739114|NCT00477633|Contraception|contraception
739115|NCT00477620|Myopia|myopia
739116|NCT00477620|Prevention|prevention
739117|NCT00477594|Familial Hypercholesterolemia|familial hypercholesterolemia
739118|NCT00477594|Heterozygous Familial Hypercholesterolemia|heterozygous familial hypercholesterolemia
739119|NCT00477594|Homozygous Familial Hypercholesterolemia|homozygous familial hypercholesterolemia
739120|NCT00477594|ISIS 301012|isis 301012
739121|NCT00477594|mipomersen|mipomersen
739122|NCT00477594|Open Label Extension|open label extension
739123|NCT00477581|diabetes|diabetes
739124|NCT00477581|exenatide|exenatide
739125|NCT00477581|sitagliptin|sitagliptin
739126|NCT00477581|Amylin|amylin
739127|NCT00477581|Lilly|lilly
739128|NCT00477568|Wheelchair users|wheelchair users
739129|NCT00477568|Back pain|back pain
739130|NCT00477568|Prevalence|prevalence
739131|NCT00477568|Risk factors|risk factors
739132|NCT00477555|aortic valve|aortic valve
739133|NCT00477555|concomitant procedures|concomitant procedures
739134|NCT00477555|porcine bioprosthesis|porcine bioprosthesis
739135|NCT00477555|stented valve|stented valve
739136|NCT00477542|Clofarabine|clofarabine
739137|NCT00477542|allogeneic HSCT|allogeneic hsct
739138|NCT00477542|refractory malignancies|refractory malignancies
739139|NCT00477503|Central Nervous System Tumors|central nervous system tumors
739140|NCT00477503|Brain Tumors|brain tumors
739141|NCT00477503|Leptomeningeal Metastasis|leptomeningeal metastasis
739142|NCT00477503|Cerebral Spinal Fluid|cerebral spinal fluid
739143|NCT00477503|Human CSF Flow|human csf flow
739144|NCT00477503|Nuclear Imaging|nuclear imaging
739145|NCT00477503|Gallium-67 Citrate|gallium-67 citrate
739148|NCT00477477|metabolic syndrome|metabolic syndrome
739149|NCT00477477|adolescent|adolescent
739150|NCT00477477|cardiovascular|cardiovascular
739151|NCT00477477|risk factors|risk factors
739152|NCT00477477|hypertension|hypertension
739153|NCT00477477|dyslipidemia|dyslipidemia
739154|NCT00477477|inflammation|inflammation
739155|NCT00477477|coagulopathy|coagulopathy
739156|NCT00477464|dual kinase inhibitor,|dual kinase inhibitor,
739157|NCT00477464|EGFR/ErbB1,|egfr/erbb1,
739158|NCT00477464|ErbB2-overexpressing,|erbb2-overexpressing,
739159|NCT00477464|GW572016,|gw572016,
739160|NCT00477464|advanced/metastatic breast cancer, Lapatinib,|advanced/metastatic breast cancer, lapatinib,
739161|NCT00477464|HER-2/new,|her-2/new,
739162|NCT00477464|pharmacokinetics|pharmacokinetics
739163|NCT00477451|Staccato™ Alprazolam, Panic Attack, Inhaled alprazolam|staccato™ alprazolam, panic attack, inhaled alprazolam
739164|NCT00477425|Avastin|avastin
739165|NCT00477399|Obesity|obesity
739166|NCT00477399|Weight loss maintenance|weight loss maintenance
739167|NCT00477399|QOL|qol
739168|NCT00477399|Life Style|life style
739169|NCT00477399|Follow Up|follow up
739170|NCT00477386|recurrent ovarian cancer|recurrent ovarian cancer
739171|NCT00477386|platinum resistant|platinum resistant
739172|NCT00477386|decitabine|decitabine
739173|NCT00477347|Liver Transplantation|liver transplantation
739174|NCT00477347|Anesthesia, general|anesthesia, general
739175|NCT00477347|Closed-loop|closed-loop
739176|NCT00477334|Recurrent genital herpes|recurrent genital herpes
739177|NCT00477334|Black population|black population
739178|NCT00477321|Interleukin 7|interleukin 7
739179|NCT00477321|Immune Reconstitution|immune reconstitution
739180|NCT00477321|T Cell Turnover|t cell turnover
739181|NCT00477321|CD4 Lymphenia|cd4 lymphenia
739182|NCT00477321|Immune-Based Therapies|immune-based therapies
739183|NCT00477321|HIV Infection|hiv infection
739184|NCT00477308|HIV children|hiv children
739185|NCT00477308|genotypic resistance|genotypic resistance
739186|NCT00477308|dual NRTIs|dual nrtis
739187|NCT00477308|Salvage therapy|salvage therapy
739188|NCT00477308|treatment outcome|treatment outcome
739189|NCT00477308|Salvage therapy based on genotyping results|salvage therapy based on genotyping results
739190|NCT00477308|Treatment Failure|treatment failure
739191|NCT00477295|Epilepsy|epilepsy
739192|NCT00477282|Ovarian|ovarian
739193|NCT00477282|Cancer|cancer
739194|NCT00477282|Advanced Ovarian Cancer|advanced ovarian cancer
739195|NCT00477269|Pulmonary Arterial Hypertension, tyrosine kinase inhibitor, STI571|pulmonary arterial hypertension, tyrosine kinase inhibitor, sti571
739196|NCT00477256|Pediatric Cancer|pediatric cancer
739197|NCT00477256|Child Adjustment|child adjustment
739198|NCT00477256|School Reintegration|school reintegration
739199|NCT00477256|Caregiver|caregiver
739200|NCT00477256|Questionnaire|questionnaire
739201|NCT00477256|Quality of Life|quality of life
739202|NCT00477256|Survey|survey
739203|NCT00477243|Advanced Cancer|advanced cancer
739204|NCT00477243|Palliative Care Patients|palliative care patients
739205|NCT00477243|Spirituality|spirituality
739206|NCT00477243|Locus of Control|locus of control
739207|NCT00477243|Questionnaire|questionnaire
739208|NCT00477230|AF|af
739209|NCT00477230|PAF|paf
739210|NCT00477230|paroxysmal atrial fibrillation|paroxysmal atrial fibrillation
739211|NCT00477230|ablation|ablation
739212|NCT00477230|failed drugs|failed drugs
739213|NCT00477217|Osteonecrosis|osteonecrosis
739214|NCT00477217|zoledronic acid|zoledronic acid
739215|NCT00477217|knee|knee
739216|NCT00477204|Type 1 Diabetes Mellitus|type 1 diabetes mellitus
739217|NCT00477204|dyslipidemia|dyslipidemia
739218|NCT00477204|adolescents|adolescents
739219|NCT00477191|psoriasis|psoriasis
739220|NCT00477191|metabolic syndrome|metabolic syndrome
739221|NCT00477191|Syndrome X|syndrome x
739222|NCT00477191|diabetes|diabetes
739223|NCT00477191|insulin resistance|insulin resistance
739224|NCT00477191|obesity|obesity
739225|NCT00477191|hypertension|hypertension
739226|NCT00477191|hyperlipidemia|hyperlipidemia
739227|NCT00477191|hypercholesterolemia|hypercholesterolemia
739228|NCT00477178|possible problems using codeine when driving|possible problems using codeine when driving
739229|NCT00477165|Irritable bowel syndrome|irritable bowel syndrome
739230|NCT00477165|Antidepressant|antidepressant
739231|NCT00477165|IBS|ibs
739232|NCT00477165|Serotonin-reuptake inhibitor|serotonin-reuptake inhibitor
739233|NCT00477165|SSRI|ssri
739234|NCT00477165|Visceral sensitivity|visceral sensitivity
739235|NCT00477165|Barostat|barostat
739236|NCT00477165|Quality of life|quality of life
739237|NCT00477165|Depression|depression
739238|NCT00477152|dehydration|dehydration
739239|NCT00477152|fluid therapy|fluid therapy
739240|NCT00477152|pediatrics|pediatrics
739241|NCT00477152|emergency medicine|emergency medicine
739242|NCT00477152|hyaluronoglucosaminidase|hyaluronoglucosaminidase
739243|NCT00477152|hyaluronidase|hyaluronidase
739244|NCT00477152|hypodermoclysis|hypodermoclysis
739245|NCT00477152|clysis|clysis
739246|NCT00477152|subcutaneous hydration|subcutaneous hydration
739247|NCT00477152|subcutaneous rehydration|subcutaneous rehydration
739250|NCT00477126|ritonavir generic capsule|ritonavir generic capsule
739251|NCT00477126|Norvir®|norvir®
739252|NCT00477126|Thailand|thailand
739253|NCT00477126|Determine bioequivalence between Norvir and GPO ritonavir|determine bioequivalence between norvir and gpo ritonavir
739254|NCT00477113|natalizumab|natalizumab
739255|NCT00477113|MS|ms
739256|NCT00477113|Tysabri|tysabri
739257|NCT00477113|Multiple Sclerosis|multiple sclerosis
739258|NCT00477113|TYGRIS|tygris
739259|NCT00477074|chronic obstructive pulmonary disease|chronic obstructive pulmonary disease
739260|NCT00477074|emphysema|emphysema
739261|NCT00477074|inflammation|inflammation
739262|NCT00477074|repair|repair
739263|NCT00477061|MORPHINE|morphine
739264|NCT00477061|ANALGESIA|analgesia
739265|NCT00477061|ACUTE APPENDICITS|acute appendicits
739266|NCT00477048|IDV nephrotoxicity|idv nephrotoxicity
739267|NCT00477022|Diabetic Foot Ulcer|diabetic foot ulcer
739268|NCT00477022|Vacuum compression therapy|vacuum compression therapy
739269|NCT00477022|Stereology|stereology
739270|NCT00477022|Ulcer Area|ulcer area
739271|NCT00477022|Vasotrain|vasotrain
739272|NCT00477022|Random Controlled Trial.|random controlled trial.
739273|NCT00477009|Sleep apnea syndromes|sleep apnea syndromes
739274|NCT00477009|Snoring|snoring
739275|NCT00477009|Mandibular advancement|mandibular advancement
739276|NCT00477009|Activator appliances|activator appliances
739277|NCT00477009|Disorders of excessive somnolence|disorders of excessive somnolence
739278|NCT00477009|Blood pressure|blood pressure
739279|NCT00477009|Inflammation|inflammation
739280|NCT00477009|Oxidative stress|oxidative stress
739281|NCT00477009|Hormones|hormones
739282|NCT00477009|Markers of Metabolic Syndrome X|markers of metabolic syndrome x
739283|NCT00476996|RA|ra
739284|NCT00476996|SCRIPT|script
739285|NCT00476996|anti-CD20|anti-cd20
739286|NCT00476996|CD20|cd20
739412|NCT00476593|Macular Thickness|macular thickness
739287|NCT00476983|saquinavir/ritonavir 1500/100 mg once daily|saquinavir/ritonavir 1500/100 mg once daily
739288|NCT00476970|Colorectal Cancer|colorectal cancer
739289|NCT00476970|Cancer Screening|cancer screening
739290|NCT00476970|Patient Navigation|patient navigation
739291|NCT00476970|Low English Proficiency|low english proficiency
739292|NCT00476957|Drug Eluting Stents|drug eluting stents
739293|NCT00476957|Interventional Cardiology|interventional cardiology
739295|NCT00476944|Coronary Artery Disease|coronary artery disease
739296|NCT00476944|Angiomax|angiomax
739297|NCT00476944|Bivalirudin|bivalirudin
739298|NCT00476944|PCI|pci
739299|NCT00476944|MAVE|mave
739300|NCT00476944|Heparin|heparin
739301|NCT00476931|Diabetic neuropathy|diabetic neuropathy
739302|NCT00476931|Diabetes Type 1 or 2|diabetes type 1 or 2
739303|NCT00476931|Moderate to severe sensorimotor diabetic polyneuropathy|moderate to severe sensorimotor diabetic polyneuropathy
739304|NCT00476931|Unmeasurable nerve conduction velocity|unmeasurable nerve conduction velocity
739305|NCT00476918|diabetic macular edema|diabetic macular edema
739306|NCT00476918|triamcinolone acetonide|triamcinolone acetonide
739307|NCT00476918|intravitreal|intravitreal
739308|NCT00476918|steroid|steroid
739309|NCT00476905|Basal Cell Carcinoma|basal cell carcinoma
739310|NCT00476905|Squamous Cell Carcinoma|squamous cell carcinoma
739311|NCT00476905|Pre-Cancer Lesions|pre-cancer lesions
739312|NCT00476905|Pigmented Lesions|pigmented lesions
739313|NCT00476905|Benign Lesions|benign lesions
739314|NCT00476905|Skin Cancer|skin cancer
739315|NCT00476905|Spectral Diagnosis|spectral diagnosis
739316|NCT00476905|Optical Spectroscopy|optical spectroscopy
739317|NCT00476892|Pelvic organ prolapse|pelvic organ prolapse
739318|NCT00476892|Pelvic floor muscle training|pelvic floor muscle training
739319|NCT00476892|Prolapse symptoms|prolapse symptoms
739320|NCT00476892|Urinary symptoms|urinary symptoms
739321|NCT00476892|Sexual function|sexual function
739322|NCT00476892|randomised controlled trial|randomised controlled trial
739323|NCT00476879|Growth hormone|growth hormone
739324|NCT00476879|Fasting|fasting
739325|NCT00476879|Signaltransduction|signaltransduction
739326|NCT00476879|fatty liver|fatty liver
739327|NCT00476879|insulin sensitivity|insulin sensitivity
739328|NCT00476879|forearm model|forearm model
739329|NCT00476879|protein metabolism|protein metabolism
739330|NCT00476879|respiratory quotient|respiratory quotient
739331|NCT00476866|Paraplegia|paraplegia
739332|NCT00476866|tetraplegia|tetraplegia
739333|NCT00476866|lung compliance|lung compliance
739334|NCT00476866|work of breathing|work of breathing
739335|NCT00476866|hyperinflation|hyperinflation
739336|NCT00476866|rehabilitation|rehabilitation
739337|NCT00476853|HIV-TB|hiv-tb
739338|NCT00476853|nevirapine based HAART with rifampin treated TB|nevirapine based haart with rifampin treated tb
739339|NCT00476853|Compare PK profile, efficacy, safety and tolerability of HAART containing nevirapine 400mg/day versus 600 mg/day in HIV/TB co-infected patients|compare pk profile, efficacy, safety and tolerability of haart containing nevirapine 400mg/day versus 600 mg/day in hiv/tb co-infected patients
739340|NCT00476853|Treatment Naive|treatment naive
739341|NCT00476827|Breast Cancer|breast cancer
739342|NCT00476827|Metastatic|metastatic
739343|NCT00476827|Brain|brain
739344|NCT00476827|Anti-angiogenesis|anti-angiogenesis
739345|NCT00476814|cystic fibrosis,|cystic fibrosis,
739346|NCT00476814|nasal potential difference,|nasal potential difference,
739347|NCT00476814|primary sclerosing cholangitis|primary sclerosing cholangitis
739348|NCT00476801|UVA1|uva1
739349|NCT00476801|scleroderma|scleroderma
739350|NCT00476801|keloids|keloids
739351|NCT00476801|light therapy|light therapy
739352|NCT00476801|morphea|morphea
739353|NCT00476788|pediatrics|pediatrics
739354|NCT00476788|CSII|csii
739355|NCT00476788|diabetes|diabetes
739356|NCT00476788|C-peptide|c-peptide
739357|NCT00476788|adverse events|adverse events
739358|NCT00476775|obesity|obesity
739359|NCT00476775|prevention|prevention
739360|NCT00476775|girls|girls
739361|NCT00476775|Latina/Hispanic|latina/hispanic
739362|NCT00476775|Dance|dance
739363|NCT00476775|television|television
739364|NCT00476775|screen time|screen time
739365|NCT00476736|COPD|copd
739366|NCT00476736|Pulmonary function|pulmonary function
739367|NCT00476736|Air trapping|air trapping
739368|NCT00476736|Acetyl cystein|acetyl cystein
739369|NCT00476723|HIV infection|hiv infection
739370|NCT00476723|Hepatitis coinfection|hepatitis coinfection
739371|NCT00476710|Type 2 diabetes mellitus|type 2 diabetes mellitus
739372|NCT00476710|Bile acid|bile acid
739373|NCT00476710|Stable isotope|stable isotope
739374|NCT00476710|Colesevelam HCl|colesevelam hcl
739375|NCT00476710|Impaired Glucose Tolerance|impaired glucose tolerance
739376|NCT00476697|UVA1|uva1
739377|NCT00476697|scleroderma|scleroderma
739378|NCT00476697|keloids|keloids
739379|NCT00476697|morphea|morphea
739380|NCT00476697|light therapy|light therapy
739381|NCT00476684|radiofrequency|radiofrequency
739382|NCT00476671|neuropsychiatric|neuropsychiatric
739383|NCT00476671|neurocognitive|neurocognitive
739384|NCT00476671|psychiatric|psychiatric
739385|NCT00476671|HIV related dementia|hiv related dementia
739386|NCT00476671|MCMD|mcmd
739387|NCT00476671|HIV-1|hiv-1
739388|NCT00476671|Prevalence, risk factors of neurocognitive impairment and psychiatric comorbidities in HIV-1 infected patients with undetectable viral load in the HAART era.|prevalence, risk factors of neurocognitive impairment and psychiatric comorbidities in hiv-1 infected patients with undetectable viral load in the haart era.
739389|NCT00476671|Treatment Experienced|treatment experienced
739390|NCT00476658|Obesity|obesity
739391|NCT00476658|macrophage infiltration|macrophage infiltration
739392|NCT00476658|insulinoresistance|insulinoresistance
739393|NCT00476658|inflammation|inflammation
739394|NCT00476632|Epidemiology|epidemiology
739395|NCT00476632|Questionnaire|questionnaire
739396|NCT00476632|Controls|controls
739397|NCT00476619|Contrast|contrast
739398|NCT00476619|Nephropathy|nephropathy
739399|NCT00476619|acute renal failure|acute renal failure
739400|NCT00476619|Erythropoietin|erythropoietin
739401|NCT00476619|CT scan|ct scan
739402|NCT00476606|HIV children|hiv children
739403|NCT00476606|HAART|haart
739404|NCT00476606|ARV|arv
739405|NCT00476606|Second line HAART|second line haart
739406|NCT00476606|Viral Load|viral load
739407|NCT00476606|Combination drug|combination drug
739408|NCT00476606|Treatment Experienced|treatment experienced
739409|NCT00476606|Treatment Naive|treatment naive
739410|NCT00476593|Uveitis|uveitis
739411|NCT00476593|Iritis|iritis
739413|NCT00476593|HLA-B27 related|hla-b27 related
739414|NCT00476593|Macular edema|macular edema
739415|NCT00476593|Macular thickening|macular thickening
739416|NCT00476593|OCT|oct
739417|NCT00476593|mfERG|mferg
739418|NCT00476593|Eye drops|eye drops
739419|NCT00476593|Dexamethosone|dexamethosone
739420|NCT00476593|Diclofenac|diclofenac
739421|NCT00476593|Retinal aging|retinal aging
739422|NCT00476580|Sri Lankan Sinhalese|sri lankan sinhalese
739423|NCT00476580|Epidemiology|epidemiology
739424|NCT00476580|Cancer Risk|cancer risk
739425|NCT00476580|US Migrant|us migrant
739426|NCT00476580|Questionnaire|questionnaire
739427|NCT00476580|Survey|survey
739428|NCT00476580|Acculturation|acculturation
739429|NCT00476580|Health and Cancer Risks|health and cancer risks
739430|NCT00476580|Health Habits|health habits
739431|NCT00476567|exercise|exercise
739432|NCT00476567|pregnancy|pregnancy
739433|NCT00476567|prevention|prevention
739434|NCT00476567|pregnancy-related diseases|pregnancy-related diseases
739435|NCT00476567|labor|labor
739436|NCT00476567|complications|complications
739437|NCT00476567|physiotherapy|physiotherapy
739438|NCT00476554|CTCL|ctcl
739439|NCT00476541|AML|aml
739440|NCT00476541|Children|children
739441|NCT00476541|Gemtuzumab ozogamicin|gemtuzumab ozogamicin
739442|NCT00476541|Stem cell transplantation|stem cell transplantation
739443|NCT00476528|Posttraumatic amnesia|posttraumatic amnesia
739444|NCT00476528|Early intervention|early intervention
739445|NCT00476528|A systematic nursing programme in the ICU|a systematic nursing programme in the icu
739446|NCT00476528|Early identification of patients with posttraumatic amnesia|early identification of patients with posttraumatic amnesia
739447|NCT00476515|Kidney transplantation|kidney transplantation
739448|NCT00476515|Donor specific antibodies|donor specific antibodies
739449|NCT00476515|Positive cross match|positive cross match
739553|NCT00476164|Antibody|antibody
739450|NCT00476502|genetic polymorphism|genetic polymorphism
739451|NCT00476502|CYP 3A|cyp 3a
739452|NCT00476502|MDR-1|mdr-1
739453|NCT00476502|Thai|thai
739454|NCT00476502|HIV|hiv
739455|NCT00476502|Treatment Experienced|treatment experienced
739456|NCT00476489|secondary adrenal insuffiency|secondary adrenal insuffiency
739457|NCT00476489|hypothalamus-pituitary-adrenal axis impairement|hypothalamus-pituitary-adrenal axis impairement
739458|NCT00476489|topical steroids|topical steroids
739459|NCT00476476|Tarceva|tarceva
739460|NCT00476476|erlotinib|erlotinib
739461|NCT00476476|squamous cell carcinoma of the vulvar|squamous cell carcinoma of the vulvar
739462|NCT00476463|TDF+FTC|tdf+ftc
739463|NCT00476463|FTC|ftc
739464|NCT00476463|HIV/HBV|hiv/hbv
739465|NCT00476463|TDF compared to TDF+FTC in HIV/HBV|tdf compared to tdf+ftc in hiv/hbv
739466|NCT00476463|Treatment Naive|treatment naive
739467|NCT00476450|Oral Microbial Flora|oral microbial flora
739468|NCT00476450|Hematopoietic Stem Cell Transplant|hematopoietic stem cell transplant
739469|NCT00476450|Allogeneic Stem Cell Transplant|allogeneic stem cell transplant
739470|NCT00476424|once daily Efavirenz 400 mg|once daily efavirenz 400 mg
739471|NCT00476424|PK once daily Efavirenz 400 mg versus 600 mg|pk once daily efavirenz 400 mg versus 600 mg
739472|NCT00476424|Treatment Experienced|treatment experienced
739473|NCT00476411|isolated HBc|isolated hbc
739474|NCT00476411|HBV vaccine response|hbv vaccine response
739475|NCT00476411|occult HBV in isolated antiHBC compared HIV to non HIV|occult hbv in isolated antihbc compared hiv to non hiv
739476|NCT00476398|Capsule endoscopy|capsule endoscopy
739477|NCT00476398|Wireless imaging|wireless imaging
739478|NCT00476398|esophagus|esophagus
739479|NCT00476398|stomach|stomach
739480|NCT00476372|neuropsychology|neuropsychology
739481|NCT00476372|cognitive impairment|cognitive impairment
739482|NCT00476372|motor disorder|motor disorder
739483|NCT00476372|parkinson's disease|parkinson's disease
739484|NCT00476359|Lopinavir/r|lopinavir/r
739485|NCT00476359|Saquinavir|saquinavir
739486|NCT00476359|Dual boosted PIs|dual boosted pis
739487|NCT00476359|Pharmacokinetics|pharmacokinetics
739488|NCT00476359|HIV children|hiv children
739489|NCT00476359|C min|c min
739490|NCT00476359|Second line HAART|second line haart
739491|NCT00476359|ARV|arv
739492|NCT00476359|VL failure|vl failure
739493|NCT00476359|Dosage|dosage
739494|NCT00476359|To evaluate treatment response|to evaluate treatment response
739495|NCT00476359|Treatment Experienced|treatment experienced
739496|NCT00476346|physical training|physical training
739497|NCT00476346|military training|military training
739498|NCT00476346|bone|bone
739499|NCT00476346|fracture prevention|fracture prevention
739500|NCT00476346|young adult|young adult
739501|NCT00476333|EMG|emg
739502|NCT00476333|Kinetics|kinetics
739503|NCT00476333|Kinematics|kinematics
739504|NCT00476333|Perturbation|perturbation
739505|NCT00476333|Footwear|footwear
739506|NCT00476320|echocardiography|echocardiography
739507|NCT00476320|myocardial infarction|myocardial infarction
739508|NCT00476320|magnetic resonance imaging|magnetic resonance imaging
739509|NCT00476320|revascularization|revascularization
739510|NCT00476320|viability|viability
739511|NCT00476307|Flu vaccine|flu vaccine
739512|NCT00476294|Multiple Myeloma|multiple myeloma
739513|NCT00476294|Disease-Free Survival|disease-free survival
739514|NCT00476294|AMD3100|amd3100
739515|NCT00476294|G-CSF|g-csf
739516|NCT00476294|Autologous Transplantation|autologous transplantation
739517|NCT00476255|child safety restraint|child safety restraint
739518|NCT00476255|injury prevention|injury prevention
739519|NCT00476255|automotive|automotive
739520|NCT00476242|heroin abuse|heroin abuse
739521|NCT00476242|opiate abuse|opiate abuse
739522|NCT00476242|opioid dependence|opioid dependence
739523|NCT00476242|naltrexone|naltrexone
739524|NCT00476242|memantine|memantine
739525|NCT00476229|Non-Hodgkin's Lymphoma|non-hodgkin's lymphoma
739526|NCT00476229|Chronic Lymphocytic Leukemia|chronic lymphocytic leukemia
739527|NCT00476229|Hodgkin's Lymphoma|hodgkin's lymphoma
739528|NCT00476229|Lymphoma|lymphoma
739529|NCT00476229|Leukemia|leukemia
739530|NCT00476229|Mycophenolate Mofetil|mycophenolate mofetil
739531|NCT00476229|Tacrolimus|tacrolimus
739532|NCT00476229|Thymoglobulin|thymoglobulin
739533|NCT00476229|Total Lymphoid Irradiation|total lymphoid irradiation
739534|NCT00476216|Non-Small Cell Lung Cancer|non-small cell lung cancer
739535|NCT00476216|Venous Thromboembolism|venous thromboembolism
739536|NCT00476216|VTE|vte
739537|NCT00476216|Arixtra|arixtra
739538|NCT00476203|Breast Cancer|breast cancer
739539|NCT00476203|Yoga|yoga
739540|NCT00476203|Quality of Life|quality of life
739541|NCT00476203|Obesity|obesity
739542|NCT00476203|Fatigue|fatigue
739543|NCT00476203|Weight|weight
739544|NCT00476190|ALL|all
739545|NCT00476177|DC|dc
739546|NCT00476177|DLI|dli
739547|NCT00476177|graft vs. host disease|graft vs. host disease
739548|NCT00476177|GVHD|gvhd
739549|NCT00476164|chronic allograft nephropathy|chronic allograft nephropathy
739550|NCT00476164|C4d|c4d
739551|NCT00476164|Anti-CD20|anti-cd20
739552|NCT00476164|B cells|b cells
739557|NCT00476138|Epigallocatechin-Gallate|epigallocatechin-gallate
739558|NCT00476138|Glaucoma|glaucoma
739559|NCT00476138|Optic Nerve|optic nerve
739560|NCT00476138|Pattern Electroretinogram|pattern electroretinogram
739561|NCT00476138|Retinal Ganglion Cells|retinal ganglion cells
739562|NCT00476112|Atrial flutter|atrial flutter
739563|NCT00476112|RSD1235|rsd1235
739564|NCT00476086|oxaliplatin|oxaliplatin
739565|NCT00476086|gemcitabine|gemcitabine
739566|NCT00476086|MMMT|mmmt
739567|NCT00476060|Cirrhosis|cirrhosis
739568|NCT00476060|Bone marrow|bone marrow
739569|NCT00476060|Mesenchymal stem cell|mesenchymal stem cell
739570|NCT00476060|MELD score|meld score
739571|NCT00476060|Quality of life|quality of life
739572|NCT00476034|Osteoarthritis|osteoarthritis
739573|NCT00476034|lumiracoxib|lumiracoxib
739574|NCT00476034|celecoxib|celecoxib
739575|NCT00476034|Cox-2|cox-2
739576|NCT00476034|knee|knee
739577|NCT00476021|postpartum|postpartum
739578|NCT00476021|contraception|contraception
739579|NCT00476021|postplacental IUD|postplacental iud
739580|NCT00476021|intrauterine devices|intrauterine devices
739581|NCT00476008|Alzheimer's Disease|alzheimer's disease
739582|NCT00476008|Mild Alzheimer's Disease|mild alzheimer's disease
739583|NCT00476008|Driving|driving
739584|NCT00476008|Driving Impairment|driving impairment
739585|NCT00475982|Diet|diet
739586|NCT00475982|Insulin-like Growth Factor|insulin-like growth factor
739587|NCT00475982|Weight Loss|weight loss
739588|NCT00475956|Cancer|cancer
739589|NCT00475956|Tumour|tumour
739590|NCT00475956|Advanced Solid Tumour|advanced solid tumour
739591|NCT00475956|Lung Cancer|lung cancer
739592|NCT00475956|Breast Cancer|breast cancer
739593|NCT00475956|Cholangiocarcinoma|cholangiocarcinoma
739594|NCT00475956|Colon Cancer|colon cancer
739595|NCT00475956|Gastric Cancer|gastric cancer
739596|NCT00475956|Choriocarcinoma|choriocarcinoma
739597|NCT00475956|Liver Cancer|liver cancer
739598|NCT00475956|Myeloma|myeloma
739599|NCT00475956|Ovarian Cancer|ovarian cancer
739600|NCT00475956|Pancreatic Cancer|pancreatic cancer
739601|NCT00475956|Peritoneal Cancer|peritoneal cancer
739602|NCT00475943|Swallowing Disorders|swallowing disorders
739603|NCT00475943|Swallowing|swallowing
739604|NCT00475943|Videofluoroscopy|videofluoroscopy
739605|NCT00475943|Dysphagia|dysphagia
739606|NCT00475943|Epiglottis|epiglottis
739607|NCT00475943|Healthy Volunteer|healthy volunteer
739608|NCT00475943|HV|hv
739609|NCT00475930|MRSA|mrsa
739610|NCT00475930|Staphylococcus aureus|staphylococcus aureus
739611|NCT00475917|Advanced malignancies|advanced malignancies
739612|NCT00475917|Solid tumor|solid tumor
739613|NCT00475904|Post Herpetic Neuralgia|post herpetic neuralgia
739614|NCT00475904|PHN|phn
739615|NCT00475904|Neuropathy|neuropathy
739616|NCT00475904|Nerve Pain|nerve pain
739617|NCT00475904|Topical|topical
739618|NCT00475891|isolate|isolate
739619|NCT00475891|infection|infection
739620|NCT00475891|linezolid|linezolid
739621|NCT00475878|opiate use|opiate use
739622|NCT00475878|depression|depression
739623|NCT00475878|buprenorphine|buprenorphine
739624|NCT00475878|escitalopram|escitalopram
739625|NCT00475865|MS|ms
739626|NCT00475865|glatiramer acetate|glatiramer acetate
739627|NCT00475865|adjunctive therapy|adjunctive therapy
739628|NCT00475865|relapses|relapses
739629|NCT00475852|Heart Decompensation|heart decompensation
739630|NCT00475852|Dyspnea|dyspnea
739631|NCT00475852|Heart failure|heart failure
739632|NCT00475852|Nesiritide|nesiritide
739633|NCT00475852|Decompensated|decompensated
739634|NCT00475852|ADHF|adhf
739635|NCT00475839|stress urinary incontinence|stress urinary incontinence
739636|NCT00475839|sling procedures|sling procedures
739637|NCT00475839|tension-free vaginal tape|tension-free vaginal tape
739638|NCT00475839|transobturator|transobturator
739639|NCT00475826|Heterozigous Familial Hypercholesterolemia|heterozigous familial hypercholesterolemia
739640|NCT00475826|Sub-clinical atherosclerosis|sub-clinical atherosclerosis
739641|NCT00475826|Chylomicrons metabolism|chylomicrons metabolism
739642|NCT00475826|Statin plus ezetimibe|statin plus ezetimibe
739643|NCT00475826|Coronary artery calcification|coronary artery calcification
739644|NCT00475813|Paediatric subjects with asthma|paediatric subjects with asthma
739645|NCT00475800|Osteoarthritis|osteoarthritis
739646|NCT00475800|lumiracoxib|lumiracoxib
739647|NCT00475800|celecoxib|celecoxib
739648|NCT00475800|Cox-2|cox-2
739649|NCT00475800|knee|knee
739650|NCT00475787|Older Adults|older adults
739651|NCT00475787|Patient Education|patient education
739652|NCT00475787|Randomized Controlled Trial|randomized controlled trial
739653|NCT00475787|Sham procedure|sham procedure
739654|NCT00475787|Spinal Manipulation|spinal manipulation
739655|NCT00475787|Veterans|veterans
739656|NCT00475761|Breast biopsy|breast biopsy
739657|NCT00475761|Breast imaging|breast imaging
739658|NCT00475761|Breast Cancer|breast cancer
739659|NCT00475761|Mammographic Density|mammographic density
739660|NCT00475761|Breast|breast
739661|NCT00475748|cervical spine|cervical spine
739662|NCT00475748|spinal cord|spinal cord
739663|NCT00475748|trauma|trauma
739664|NCT00475748|spinal cord injury|spinal cord injury
739665|NCT00475748|central cord syndrome|central cord syndrome
739666|NCT00475722|cancer|cancer
739667|NCT00475722|colon|colon
739668|NCT00475722|prevention|prevention
739669|NCT00475722|healthy eating|healthy eating
739670|NCT00475722|Mediterranean diet|mediterranean diet
739671|NCT00475722|PGE2|pge2
739672|NCT00475722|cyclooxygenase|cyclooxygenase
739673|NCT00475722|lipoxygenase|lipoxygenase
739674|NCT00475722|Healthy People 2010 diet|healthy people 2010 diet
739675|NCT00475722|dietary prevention of colon cancer|dietary prevention of colon cancer
739676|NCT00475709|aortic valve|aortic valve
739677|NCT00475709|heart valve|heart valve
739678|NCT00475709|tissue valve|tissue valve
739679|NCT00475709|bioprosthesis|bioprosthesis
739680|NCT00475709|valve disorder|valve disorder
739681|NCT00475709|valve disease|valve disease
739682|NCT00475709|cardiac surgery|cardiac surgery
739683|NCT00475709|aortic valve stenosis|aortic valve stenosis
739684|NCT00475709|aortic valve regurgitation|aortic valve regurgitation
739685|NCT00475683|Doxorubicin|doxorubicin
739686|NCT00475683|Mucositis|mucositis
739687|NCT00475683|Prevention|prevention
739688|NCT00475683|Curcumin|curcumin
739689|NCT00475631|Clubfoot|clubfoot
739690|NCT00475631|Chart review|chart review
739691|NCT00475618|Early chilhood caries|early chilhood caries
739692|NCT00475618|Prevention|prevention
739693|NCT00475618|Fluoride varnish|fluoride varnish
739694|NCT00475618|fluoride toothpaste|fluoride toothpaste
739695|NCT00475618|non fluoride tooth paste|non fluoride tooth paste
739696|NCT00475618|Professional cleaning|professional cleaning
739697|NCT00475605|atopic dermatitis|atopic dermatitis
739698|NCT00475605|child|child
739699|NCT00475605|tacrolimus ointment|tacrolimus ointment
739700|NCT00475605|Protopic Ointment|protopic ointment
739701|NCT00475592|Esophageal Varices|esophageal varices
739702|NCT00475592|Gastric Varices|gastric varices
739703|NCT00475592|Capsule Endoscopy|capsule endoscopy
739704|NCT00475592|Portal Hypertension|portal hypertension
739705|NCT00475592|Cirrhosis|cirrhosis
739706|NCT00475592|Gastrointestinal Hemorrhage|gastrointestinal hemorrhage
739707|NCT00475579|ventilator-associated pneumonia|ventilator-associated pneumonia
739708|NCT00475579|endotracheal tube|endotracheal tube
739709|NCT00475579|polyurethane cuff|polyurethane cuff
739710|NCT00475579|polyvinyl cuff|polyvinyl cuff
739711|NCT00475579|subglottic secretion drainage|subglottic secretion drainage
739712|NCT00475553|spotting|spotting
739713|NCT00475553|PMS|pms
739714|NCT00475553|nuvaring|nuvaring
739715|NCT00475553|birth control|birth control
739716|NCT00475553|pelvic pain|pelvic pain
739717|NCT00475553|headache|headache
739718|NCT00475553|mood swings|mood swings
739719|NCT00475553|continuous use|continuous use
739720|NCT00475540|prolapse|prolapse
739721|NCT00475540|uterus|uterus
739722|NCT00475540|pelvic organ|pelvic organ
739723|NCT00475540|vaginal prolpase|vaginal prolpase
739724|NCT00475514|Menstrually-related Migraine Headache|menstrually-related migraine headache
739725|NCT00475514|'Difficult to Treat' as specified in protocol|'difficult to treat' as specified in protocol
739726|NCT00475501|anabolic effects|anabolic effects
739727|NCT00475501|finasteride|finasteride
739728|NCT00475501|male hypogonadism|male hypogonadism
739729|NCT00475501|sarcopenia|sarcopenia
739730|NCT00475501|testosterone|testosterone
739731|NCT00475488|radial artery|radial artery
739732|NCT00475488|right internal thoracic artery|right internal thoracic artery
739733|NCT00475488|saphenous vein|saphenous vein
739734|NCT00475488|grafts|grafts
739735|NCT00475488|coronary bypass surgery|coronary bypass surgery
739736|NCT00475475|Overweight|overweight
739737|NCT00475475|Obesity|obesity
739738|NCT00475475|Appetite|appetite
739739|NCT00475475|Dietary sugars|dietary sugars
739740|NCT00475475|Fructose|fructose
739741|NCT00475475|Glucose|glucose
739742|NCT00475475|Leptin|leptin
739743|NCT00475475|Insulin|insulin
739744|NCT00475475|Ghrelin|ghrelin
739745|NCT00475462|Metoprolol and Syncope|metoprolol and syncope
739746|NCT00475449|percutaneous coronary intervention|percutaneous coronary intervention
739747|NCT00475449|Stent|stent
739748|NCT00475449|coronary artery bypass grafting|coronary artery bypass grafting
739749|NCT00475436|muscarinic receptor antagonist|muscarinic receptor antagonist
739750|NCT00475436|GSK573719,|gsk573719,
739751|NCT00475436|chronic obstructive pulmonary disease,|chronic obstructive pulmonary disease,
739752|NCT00475410|Autologous adipose-derived stem cells|autologous adipose-derived stem cells
739753|NCT00475410|Complex perianal fistula|complex perianal fistula
739754|NCT00475410|Inflammatory Bowel Disease|inflammatory bowel disease
739755|NCT00475410|Advanced cell therapy|advanced cell therapy
739756|NCT00475410|Fibrin glue|fibrin glue
739757|NCT00475371|Healthy|healthy
739758|NCT00475371|Diabetes Mellitus: Type II|diabetes mellitus: type ii
739759|NCT00475345|Nocturnal hypoglycemia|nocturnal hypoglycemia
739760|NCT00475345|Bedtime snacks|bedtime snacks
739761|NCT00475345|Continuous glucose monitoring|continuous glucose monitoring
739762|NCT00475345|Continuous subcutaneous insulin infusion|continuous subcutaneous insulin infusion
739763|NCT00475345|CSII|csii
739764|NCT00475345|Intensive therapy|intensive therapy
739765|NCT00475319|Dry Eye Syndromes|dry eye syndromes
739766|NCT00475319|OPC-12759|opc-12759
739767|NCT00475306|Metoclopramide|metoclopramide
739768|NCT00475306|Nausea|nausea
739769|NCT00475306|Akathisia|akathisia
739770|NCT00475306|Emergency department|emergency department
739771|NCT00475293|metastatic colorectal cancer|metastatic colorectal cancer
739772|NCT00475293|2nd-line Therapy|2nd-line therapy
739773|NCT00475293|panitumumab|panitumumab
739774|NCT00475293|irinotecan|irinotecan
739775|NCT00475280|geriatric assessment adapted therapy|geriatric assessment adapted therapy
739776|NCT00475280|Leukemia, Lymphoblastic, Acute|leukemia, lymphoblastic, acute
739777|NCT00475280|Older patients|older patients
739778|NCT00475280|> 60 years old|> 60 years old
739779|NCT00475280|Ph negative|ph negative
739780|NCT00475267|aortic valve|aortic valve
739781|NCT00475267|heart valve|heart valve
739782|NCT00475267|tissue valve|tissue valve
739783|NCT00475267|bioprosthesis|bioprosthesis
739784|NCT00475267|valve disorder|valve disorder
739785|NCT00475267|valve disease|valve disease
739786|NCT00475267|cardiac surgery|cardiac surgery
739787|NCT00475267|aortic valve stenosis|aortic valve stenosis
739788|NCT00475267|aortic valve regurgitation|aortic valve regurgitation
739789|NCT00475254|Retinitis Pigmentosa|retinitis pigmentosa
739790|NCT00475254|stress|stress
739791|NCT00475254|sleepiness|sleepiness
739792|NCT00475254|low vision|low vision
739793|NCT00475254|mind-body|mind-body
739794|NCT00475241|Combat Disorders|combat disorders
739795|NCT00475241|Cortisol|cortisol
739796|NCT00475241|Posttraumatic Stress Disorder (PTSD)|posttraumatic stress disorder (ptsd)
739797|NCT00475241|Psychophysiology|psychophysiology
739798|NCT00475241|Therapy|therapy
739799|NCT00475241|Treatment|treatment
739800|NCT00475241|Veterans|veterans
739801|NCT00475228|levonorgestrel IUD|levonorgestrel iud
739802|NCT00475228|IUD|iud
739803|NCT00475228|dilation and evacuation|dilation and evacuation
739804|NCT00475228|contraception|contraception
739805|NCT00475189|birth control|birth control
739806|NCT00475189|PMS|pms
739807|NCT00475189|headaches|headaches
739808|NCT00475189|mood swings|mood swings
739809|NCT00475189|pelvic pain|pelvic pain
739810|NCT00475176|Hepatitis C Virus Genotype 1|hepatitis c virus genotype 1
739811|NCT00475176|Non-Responders|non-responders
739812|NCT00475176|SAMe|same
739813|NCT00475176|Natural Killer Cells|natural killer cells
739814|NCT00475176|Interferon Signaling|interferon signaling
739815|NCT00475176|Ribavirin|ribavirin
739816|NCT00475176|Peginterferon|peginterferon
739817|NCT00475176|Hemolysis|hemolysis
739818|NCT00475176|STAT|stat
739819|NCT00475176|Hepatitis C|hepatitis c
739820|NCT00475163|Obesity|obesity
739821|NCT00475163|Mentoring|mentoring
739822|NCT00475163|Fitness|fitness
739823|NCT00475163|Self-esteem|self-esteem
739824|NCT00475137|Bipolar II Disorder|bipolar ii disorder
739825|NCT00475137|depression|depression
739826|NCT00475137|Lamotrigine|lamotrigine
739827|NCT00475137|Add On antidepressant|add on antidepressant
739828|NCT00475137|randomized|randomized
739829|NCT00475137|single blind|single blind
739830|NCT00475137|parallel group|parallel group
739831|NCT00475124|Pacemaker follow-up|pacemaker follow-up
739832|NCT00475124|Telecardiology|telecardiology
739833|NCT00475124|Home Monitoring|home monitoring
739834|NCT00475111|Cognitive Behavioral Intervention|cognitive behavioral intervention
739835|NCT00475111|Emotion Regulation|emotion regulation
739836|NCT00475111|Pain Management|pain management
739837|NCT00475111|Psychological Adaptation|psychological adaptation
739838|NCT00475111|Coping Efficacy|coping efficacy
739839|NCT00475111|Markers of Disease Activity|markers of disease activity
739840|NCT00475098|Low molecular weight heparin|low molecular weight heparin
739841|NCT00475098|Lung cancer|lung cancer
739842|NCT00475098|Non small cell lung cancer|non small cell lung cancer
739843|NCT00475098|Adjuvant therapy|adjuvant therapy
739844|NCT00475098|Anticoagulants|anticoagulants
739845|NCT00475098|Heparin|heparin
739846|NCT00475085|nausea and vomiting|nausea and vomiting
739847|NCT00475085|recurrent breast cancer|recurrent breast cancer
739848|NCT00475085|stage I breast cancer|stage i breast cancer
739849|NCT00475085|stage II breast cancer|stage ii breast cancer
739850|NCT00475085|stage IIIA breast cancer|stage iiia breast cancer
739851|NCT00475085|stage IIIB breast cancer|stage iiib breast cancer
739852|NCT00475085|stage IIIC breast cancer|stage iiic breast cancer
739853|NCT00475085|stage IV breast cancer|stage iv breast cancer
739854|NCT00475085|inflammatory breast cancer|inflammatory breast cancer
739855|NCT00475085|male breast cancer|male breast cancer
739856|NCT00475059|kidney transplantation|kidney transplantation
739857|NCT00475059|Glomerular filtration rate|glomerular filtration rate
739858|NCT00475059|inulin clearance|inulin clearance
739859|NCT00475059|MDRD equation|mdrd equation
739860|NCT00475059|cystatin C|cystatin c
739861|NCT00475059|cimetidine|cimetidine
739862|NCT00475046|smoking|smoking
739863|NCT00475046|post partum|post partum
739864|NCT00475046|relapse prevention|relapse prevention
739865|NCT00475046|motivational interviewing|motivational interviewing
739867|NCT00475046|implement motivational enhancement interventions in pediatric practices|implement motivational enhancement interventions in pediatric practices
739868|NCT00475046|examine the effectiveness of the intervention|examine the effectiveness of the intervention
739869|NCT00475046|develop measurements appropriate to tailor interventions|develop measurements appropriate to tailor interventions
739870|NCT00475046|analyze further unfavorable and favorable factors outlined by previous research|analyze further unfavorable and favorable factors outlined by previous research
739871|NCT00475020|Idiopathic Myelofibrosis|idiopathic myelofibrosis
739872|NCT00475020|Myelofibrosis|myelofibrosis
739873|NCT00475020|Essential Thrombocythemia|essential thrombocythemia
739874|NCT00475020|Polycythemia Vera|polycythemia vera
739875|NCT00475020|Busulfan|busulfan
739876|NCT00475020|Antithymocyte Globulin|antithymocyte globulin
739877|NCT00475020|ATG|atg
739878|NCT00475020|Fludarabine|fludarabine
739879|NCT00475020|Thymoglobulin|thymoglobulin
739880|NCT00475007|Emphysema|emphysema
739881|NCT00475007|IBV® Valve|ibv® valve
739882|NCT00475007|COPD|copd
739883|NCT00475007|Shortness of Breath|shortness of breath
739884|NCT00475007|Spiration|spiration
739885|NCT00474994|chondrosarcoma|chondrosarcoma
739886|NCT00474994|recurrent osteosarcoma|recurrent osteosarcoma
739887|NCT00474994|localized adult malignant fibrous histiocytoma of bone|localized adult malignant fibrous histiocytoma of bone
739888|NCT00474994|metastatic adult malignant fibrous histiocytoma of bone|metastatic adult malignant fibrous histiocytoma of bone
739889|NCT00474994|recurrent adult malignant fibrous histiocytoma of bone|recurrent adult malignant fibrous histiocytoma of bone
739890|NCT00474994|recurrent Ewing sarcoma/peripheral primitive neuroectodermal tumor|recurrent ewing sarcoma/peripheral primitive neuroectodermal tumor
739891|NCT00474994|recurrent Kaposi sarcoma|recurrent kaposi sarcoma
739892|NCT00474994|recurrent uterine sarcoma|recurrent uterine sarcoma
739893|NCT00474994|adult leiomyosarcoma|adult leiomyosarcoma
739894|NCT00474994|adult malignant fibrous histiocytoma|adult malignant fibrous histiocytoma
739895|NCT00474994|adult rhabdomyosarcoma|adult rhabdomyosarcoma
739896|NCT00474994|dermatofibrosarcoma protuberans|dermatofibrosarcoma protuberans
739897|NCT00474994|stage III adult soft tissue sarcoma|stage iii adult soft tissue sarcoma
739898|NCT00474994|stage IV adult soft tissue sarcoma|stage iv adult soft tissue sarcoma
739899|NCT00474994|ovarian sarcoma|ovarian sarcoma
739900|NCT00474994|uterine leiomyosarcoma|uterine leiomyosarcoma
739901|NCT00474994|stage III uterine sarcoma|stage iii uterine sarcoma
739902|NCT00474994|stage IV uterine sarcoma|stage iv uterine sarcoma
739903|NCT00474994|desmoid tumor|desmoid tumor
739904|NCT00474994|adult angiosarcoma|adult angiosarcoma
739905|NCT00474994|recurrent adult soft tissue sarcoma|recurrent adult soft tissue sarcoma
739906|NCT00474994|uterine carcinosarcoma|uterine carcinosarcoma
739907|NCT00474994|endometrial stromal sarcoma|endometrial stromal sarcoma
739908|NCT00474994|fibrosarcomatous osteosarcoma|fibrosarcomatous osteosarcoma
739909|NCT00474994|chondrosarcomatous osteosarcoma|chondrosarcomatous osteosarcoma
739910|NCT00474994|adult alveolar soft-part sarcoma|adult alveolar soft-part sarcoma
739911|NCT00474994|adult epithelioid sarcoma|adult epithelioid sarcoma
739912|NCT00474994|adult extraskeletal chondrosarcoma|adult extraskeletal chondrosarcoma
739913|NCT00474994|adult extraskeletal osteosarcoma|adult extraskeletal osteosarcoma
739914|NCT00474994|adult fibrosarcoma|adult fibrosarcoma
739915|NCT00474994|adult malignant hemangiopericytoma|adult malignant hemangiopericytoma
740028|NCT00474435|HIV|hiv
739916|NCT00474994|adult malignant mesenchymoma|adult malignant mesenchymoma
739917|NCT00474994|adult neurofibrosarcoma|adult neurofibrosarcoma
739918|NCT00474994|adult synovial sarcoma|adult synovial sarcoma
739919|NCT00474994|adult desmoplastic small round cell tumor|adult desmoplastic small round cell tumor
739920|NCT00474994|adult liposarcoma|adult liposarcoma
739921|NCT00474994|anaplastic osteosarcoma|anaplastic osteosarcoma
739922|NCT00474994|mixed osteosarcoma|mixed osteosarcoma
739923|NCT00474994|small intestine leiomyosarcoma|small intestine leiomyosarcoma
739924|NCT00474994|osteoblastic osteosarcoma|osteoblastic osteosarcoma
739925|NCT00474994|telangiectatic osteosarcoma|telangiectatic osteosarcoma
739926|NCT00474994|classic Kaposi sarcoma|classic kaposi sarcoma
739927|NCT00474994|immunosuppressive treatment related Kaposi sarcoma|immunosuppressive treatment related kaposi sarcoma
739928|NCT00474994|AIDS-related Kaposi sarcoma|aids-related kaposi sarcoma
739929|NCT00474981|neonatal mortality|neonatal mortality
739930|NCT00474981|infant mortality|infant mortality
739931|NCT00474981|newborn caring practices|newborn caring practices
739932|NCT00474942|Hypertension|hypertension
739933|NCT00474942|Metabolic Alkalosis|metabolic alkalosis
739934|NCT00474942|Hypokalemia|hypokalemia
739935|NCT00474929|recurrent adult Hodgkin lymphoma|recurrent adult hodgkin lymphoma
739936|NCT00474929|recurrent cutaneous T-cell non-Hodgkin lymphoma|recurrent cutaneous t-cell non-hodgkin lymphoma
739937|NCT00474929|stage III multiple myeloma|stage iii multiple myeloma
739938|NCT00474929|refractory multiple myeloma|refractory multiple myeloma
739939|NCT00474929|Waldenström macroglobulinemia|waldenström macroglobulinemia
739940|NCT00474929|recurrent adult Burkitt lymphoma|recurrent adult burkitt lymphoma
739941|NCT00474929|recurrent adult diffuse large cell lymphoma|recurrent adult diffuse large cell lymphoma
739942|NCT00474929|recurrent adult diffuse mixed cell lymphoma|recurrent adult diffuse mixed cell lymphoma
739943|NCT00474929|recurrent adult diffuse small cleaved cell lymphoma|recurrent adult diffuse small cleaved cell lymphoma
740540|NCT00472381|Insulin|insulin
739944|NCT00474929|recurrent adult immunoblastic large cell lymphoma|recurrent adult immunoblastic large cell lymphoma
739945|NCT00474929|recurrent adult lymphoblastic lymphoma|recurrent adult lymphoblastic lymphoma
739946|NCT00474929|recurrent grade 1 follicular lymphoma|recurrent grade 1 follicular lymphoma
739947|NCT00474929|recurrent grade 2 follicular lymphoma|recurrent grade 2 follicular lymphoma
739948|NCT00474929|recurrent grade 3 follicular lymphoma|recurrent grade 3 follicular lymphoma
739949|NCT00474929|recurrent mantle cell lymphoma|recurrent mantle cell lymphoma
739950|NCT00474929|recurrent marginal zone lymphoma|recurrent marginal zone lymphoma
739951|NCT00474929|recurrent small lymphocytic lymphoma|recurrent small lymphocytic lymphoma
739952|NCT00474929|cutaneous B-cell non-Hodgkin lymphoma|cutaneous b-cell non-hodgkin lymphoma
739953|NCT00474929|extranodal marginal zone B-cell lymphoma of mucosa-associated lymphoid tissue|extranodal marginal zone b-cell lymphoma of mucosa-associated lymphoid tissue
739954|NCT00474929|nodal marginal zone B-cell lymphoma|nodal marginal zone b-cell lymphoma
739955|NCT00474929|splenic marginal zone lymphoma|splenic marginal zone lymphoma
739956|NCT00474929|recurrent mycosis fungoides/Sezary syndrome|recurrent mycosis fungoides/sezary syndrome
739957|NCT00474929|recurrent adult grade III lymphomatoid granulomatosis|recurrent adult grade iii lymphomatoid granulomatosis
739958|NCT00474916|Neuropathic pain|neuropathic pain
739959|NCT00474916|Cancer|cancer
739960|NCT00474890|Seasonal allergic rhinitis|seasonal allergic rhinitis
739961|NCT00474877|Clinical|clinical
739962|NCT00474877|Splints|splints
739963|NCT00474877|Rheumatoid|rheumatoid
739964|NCT00474864|Endothelial Function,|endothelial function,
739965|NCT00474864|vascular compliance,|vascular compliance,
739966|NCT00474864|atherosclerosis|atherosclerosis
739967|NCT00474851|Endometriosis|endometriosis
739968|NCT00474851|Adolescents|adolescents
739969|NCT00474851|Bone density|bone density
739970|NCT00474851|GnRH Agonist|gnrh agonist
739971|NCT00474851|Add-back therapy|add-back therapy
739972|NCT00474838|type 2 diabetes mellitus|type 2 diabetes mellitus
739973|NCT00474838|intensive insulin therapy|intensive insulin therapy
739974|NCT00474786|Metastatic or Advanced Renal Cell Carcinoma|metastatic or advanced renal cell carcinoma
739975|NCT00474734|hepatocellular carcinoma|hepatocellular carcinoma
739976|NCT00474734|liver transplantation|liver transplantation
739977|NCT00474734|staging|staging
739978|NCT00474734|intravascular ultrasound|intravascular ultrasound
739979|NCT00474721|child|child
739980|NCT00474721|pain|pain
739981|NCT00474721|analgesics|analgesics
739982|NCT00474695|Exudative age-related macular degeneration|exudative age-related macular degeneration
739983|NCT00474682|ferric pyrophosphate, iron bioavailability, fortification,|ferric pyrophosphate, iron bioavailability, fortification,
739984|NCT00474669|Ovarian Carcinoma|ovarian carcinoma
739985|NCT00474656|high frequency oscillation|high frequency oscillation
739986|NCT00474656|lung-protective ventilation|lung-protective ventilation
739987|NCT00474656|ARDS|ards
739988|NCT00474656|ventilator-induced lung injury|ventilator-induced lung injury
739989|NCT00474630|Obesity|obesity
739990|NCT00474630|Overweight|overweight
739991|NCT00474630|Diabetes Mellitus, Type 2|diabetes mellitus, type 2
739992|NCT00474604|breast cancer|breast cancer
739993|NCT00474591|Coronary artery bypass surgery, fondaparinux, graft patency, graft occlusion, graft failure, anticoagulation|coronary artery bypass surgery, fondaparinux, graft patency, graft occlusion, graft failure, anticoagulation
739994|NCT00474565|Catheter,|catheter,
739995|NCT00474565|Aortic root injection,|aortic root injection,
739996|NCT00474565|low dose contrast injection,|low dose contrast injection,
739997|NCT00474565|coronary artery angiogarm and|coronary artery angiogarm and
739998|NCT00474565|coronary artery bypass graft imaging.|coronary artery bypass graft imaging.
739999|NCT00474539|Vaccine|vaccine
740000|NCT00474526|Meningococcal|meningococcal
740001|NCT00474526|meningitis|meningitis
740002|NCT00474526|vaccine|vaccine
740003|NCT00474526|infants|infants
740004|NCT00474526|Meningococcal meningitis|meningococcal meningitis
740005|NCT00474526|Meningococcal disease|meningococcal disease
740006|NCT00474513|AD, H3, Brain, Cognitive Impairment|ad, h3, brain, cognitive impairment
740007|NCT00474500|Iron absorption|iron absorption
740008|NCT00474500|Coca-Cola|coca-cola
740009|NCT00474487|Meningococcal|meningococcal
740010|NCT00474487|meningitis|meningitis
740011|NCT00474487|vaccine|vaccine
740012|NCT00474487|adolescents|adolescents
740013|NCT00474487|adults|adults
740014|NCT00474474|virtual patient|virtual patient
740015|NCT00474474|therapeutic decision making|therapeutic decision making
740016|NCT00474461|coronary artery disease|coronary artery disease
740017|NCT00474461|Heart Attack|heart attack
740018|NCT00474461|Heart failure|heart failure
740019|NCT00474461|Cardiac Stem Cells|cardiac stem cells
740020|NCT00474461|Coronary Artery Bypass|coronary artery bypass
740021|NCT00474448|Hereditary Multiple Exostoses|hereditary multiple exostoses
740022|NCT00474448|Survey|survey
740023|NCT00474448|Quality of Life|quality of life
740024|NCT00474448|Hereditary Multiple Exostoses,|hereditary multiple exostoses,
740025|NCT00474448|also known as Multiple Hereditary Exostoses,|also known as multiple hereditary exostoses,
740026|NCT00474448|also known as Hereditary Multiple Osteochondromas|also known as hereditary multiple osteochondromas
740027|NCT00474435|Tuberculosis|tuberculosis
740029|NCT00474435|Coinfection|coinfection
740542|NCT00472381|MRI|mri
740030|NCT00474435|Pharmacokinetics|pharmacokinetics
740031|NCT00474435|Emtricitabine|emtricitabine
740032|NCT00474435|Tenofovir|tenofovir
740033|NCT00474435|Rifampin|rifampin
740034|NCT00474435|Efavirenz|efavirenz
740035|NCT00474435|Treatment Naive|treatment naive
740036|NCT00474422|breastfeeding|breastfeeding
740037|NCT00474422|support|support
740038|NCT00474409|Vertigo|vertigo
740039|NCT00474409|Posterior circulation infarction|posterior circulation infarction
740040|NCT00474396|Uric acid|uric acid
740041|NCT00474396|Dairy|dairy
740042|NCT00474396|Diet|diet
740043|NCT00474383|Prostate neoplasms|prostate neoplasms
740044|NCT00474383|CB7630|cb7630
740045|NCT00474383|Abiraterone acetate|abiraterone acetate
740046|NCT00474383|Glucocorticoid|glucocorticoid
740047|NCT00474383|Prednisone|prednisone
740048|NCT00474383|Prednisolone|prednisolone
740049|NCT00474370|Acquired Immunodeficiency Syndrome|acquired immunodeficiency syndrome
740050|NCT00474357|Bipolar affective disorder|bipolar affective disorder
740051|NCT00474357|myths|myths
740052|NCT00474357|preconceived notions|preconceived notions
740053|NCT00474357|stigma|stigma
740054|NCT00474357|hope|hope
740055|NCT00474344|Genetics|genetics
740056|NCT00474344|Clubfoot|clubfoot
740058|NCT00474344|Idiopathic Talipes Equinovarus also known as Clubfoot|idiopathic talipes equinovarus also known as clubfoot
740059|NCT00474331|DNA sequencing|dna sequencing
740060|NCT00474331|EXT genes|ext genes
740061|NCT00474331|Hereditary Multiple Exostoses,|hereditary multiple exostoses,
740062|NCT00474331|also known as Multiple Hereditary Exostoses,|also known as multiple hereditary exostoses,
740063|NCT00474331|also known as Hereditary Multiple Osteochondromas|also known as hereditary multiple osteochondromas
740064|NCT00474318|Adolescents|adolescents
740065|NCT00474318|Obesity|obesity
740066|NCT00474318|Bariatrics|bariatrics
740067|NCT00474318|Surgery for Weight Loss|surgery for weight loss
740068|NCT00474318|Teen-LABS|teen-labs
740069|NCT00474305|PTSD|ptsd
740070|NCT00474305|Prolonged Exposure|prolonged exposure
740071|NCT00474305|Virtual Reality|virtual reality
740072|NCT00474292|Stroke|stroke
740073|NCT00474292|Rehabilitation|rehabilitation
740074|NCT00474292|Plasticity|plasticity
740075|NCT00474292|fMRI|fmri
740076|NCT00474292|Reorganization|reorganization
740077|NCT00474279|Growth hormone secretagogue|growth hormone secretagogue
740078|NCT00474279|Body composition|body composition
740079|NCT00474279|Functional ability|functional ability
740080|NCT00474279|Aging|aging
740081|NCT00474279|Sarcopenia|sarcopenia
740082|NCT00474266|MMRV vaccine|mmrv vaccine
740083|NCT00474266|co-administration|co-administration
740084|NCT00474266|immunogenicity|immunogenicity
740085|NCT00474266|meningococcal vaccine|meningococcal vaccine
740086|NCT00474266|conjugate vaccine|conjugate vaccine
740087|NCT00474240|cholesterol|cholesterol
740088|NCT00474227|obesity|obesity
740089|NCT00474227|weight gain|weight gain
740090|NCT00474227|schizophrenia|schizophrenia
740091|NCT00474227|schizoaffective disorder|schizoaffective disorder
740092|NCT00474227|antipsychotic induced weight gain|antipsychotic induced weight gain
740093|NCT00474214|STEMI|stemi
740094|NCT00474214|Primary PCI|primary pci
740095|NCT00474214|Length of Stay|length of stay
740096|NCT00474214|Early Discharge|early discharge
740097|NCT00474201|Pharmacokinetic|pharmacokinetic
740098|NCT00474201|HIV|hiv
740099|NCT00474201|Drug-Drug Interaction|drug-drug interaction
740100|NCT00474201|Lopinavir/Ritonavir|lopinavir/ritonavir
740101|NCT00474201|Gemfibrozil|gemfibrozil
740102|NCT00474201|Healthy Volunteer|healthy volunteer
740103|NCT00474201|HV|hv
740104|NCT00474188|Celgene|celgene
740105|NCT00474188|Revlimid|revlimid
740106|NCT00474188|Lenalidomide|lenalidomide
740107|NCT00474188|Diffuse Large B-cell lymphoma|diffuse large b-cell lymphoma
740108|NCT00474188|Non-Hodgkins lymphoma|non-hodgkins lymphoma
740109|NCT00474188|CC-5013|cc-5013
740110|NCT00474188|Response Rate|response rate
740111|NCT00474188|Tumor Control Rate|tumor control rate
740112|NCT00474188|Duration of Response|duration of response
740113|NCT00474188|Time to Progression|time to progression
740114|NCT00474188|Progression-free survival and safety|progression-free survival and safety
740115|NCT00474162|Cesarean section|cesarean section
740116|NCT00474162|coagulation changes|coagulation changes
740117|NCT00474123|angina|angina
740118|NCT00474123|atherosclerosis|atherosclerosis
740119|NCT00474123|simvastatin|simvastatin
740120|NCT00474123|ezetimibe|ezetimibe
740121|NCT00474123|inflammation|inflammation
740122|NCT00474110|Ketamine|ketamine
740123|NCT00474110|hydromorphone|hydromorphone
740124|NCT00474110|pediatric mucositis|pediatric mucositis
740125|NCT00474097|Colorectal Neoplasms|colorectal neoplasms
740126|NCT00474097|Colitis, Ulcerative|colitis, ulcerative
740127|NCT00474097|Diverticulitis|diverticulitis
740128|NCT00474097|Colonic Polyps|colonic polyps
740129|NCT00474097|Crohn Disease|crohn disease
740130|NCT00474084|Stent|stent
740131|NCT00474084|Hydroxyapatite|hydroxyapatite
740132|NCT00474084|Coronary Artery Stenosis|coronary artery stenosis
740133|NCT00474084|Angioplasty|angioplasty
740134|NCT00474071|Remifentanil|remifentanil
740135|NCT00474071|endotracheal intubation|endotracheal intubation
740136|NCT00474071|pediatrics|pediatrics
740137|NCT00474058|rotigotine|rotigotine
740138|NCT00474058|Neupro®|neupro®
740139|NCT00474058|Parkinson's Disease|parkinson's disease
740140|NCT00474032|Idiopathic clubfoot|idiopathic clubfoot
740141|NCT00474032|Botox injection|botox injection
740142|NCT00474032|Idiopathic Talipes Equinovarus, also known as Idiopathic clubfoot|idiopathic talipes equinovarus, also known as idiopathic clubfoot
740143|NCT00474019|pediatrics|pediatrics
740144|NCT00474019|neonates|neonates
740145|NCT00473993|Hepatitis C|hepatitis c
740146|NCT00473993|Opioid Maintenance Treatment|opioid maintenance treatment
740147|NCT00473993|Methadone|methadone
740148|NCT00473993|Buprenorphine|buprenorphine
740149|NCT00473993|Heroin|heroin
740150|NCT00473993|Interferon, pegylated|interferon, pegylated
740151|NCT00473980|MHC|mhc
740152|NCT00473980|CTLs|ctls
740153|NCT00473980|Colon carcinoma|colon carcinoma
740154|NCT00473980|NSAID|nsaid
740155|NCT00473980|Survival|survival
740156|NCT00473967|Vaccine|vaccine
740157|NCT00473967|Hookworm|hookworm
740158|NCT00473967|Phase 1|phase 1
740159|NCT00473967|Na-ASP-2|na-asp-2
740160|NCT00473941|colorectal cancer|colorectal cancer
740161|NCT00473941|colon cancer|colon cancer
740162|NCT00473941|rectal cancer|rectal cancer
740163|NCT00473928|Macular|macular
740164|NCT00473928|degeration|degeration
740165|NCT00473928|Complement|complement
740166|NCT00473876|Chronic Heart Failure|chronic heart failure
740167|NCT00473876|Insulin Resistance|insulin resistance
740168|NCT00473876|Metformin|metformin
740169|NCT00473876|Peak VO2|peak vo2
740170|NCT00473863|Acute coronary syndrome|acute coronary syndrome
740171|NCT00473863|Acute myocardial infarction|acute myocardial infarction
740172|NCT00473863|Unstable angina|unstable angina
740173|NCT00473863|Coronary computed tomographic angiography|coronary computed tomographic angiography
740174|NCT00473863|Coronary Angiography|coronary angiography
740175|NCT00473863|Tomography, X-Ray Computed|tomography, x-ray computed
740176|NCT00473863|Tomography, Spiral Computed|tomography, spiral computed
740177|NCT00473850|DNA sequencing|dna sequencing
740178|NCT00473850|EXT genes|ext genes
740179|NCT00473850|Hereditary Multiple Exostoses,|hereditary multiple exostoses,
740180|NCT00473850|also known as Multiple Hereditary Exostoses,|also known as multiple hereditary exostoses,
740181|NCT00473850|also known as Hereditary Multiple Osteochondromas|also known as hereditary multiple osteochondromas
740183|NCT00473837|anaemia|anaemia
740184|NCT00473837|chloroquine|chloroquine
740185|NCT00473837|iron delocalisation|iron delocalisation
740186|NCT00473837|macrophages|macrophages
740187|NCT00473824|hepatitis C|hepatitis c
740188|NCT00473824|liver transplantation|liver transplantation
740189|NCT00473824|immune globulin|immune globulin
740190|NCT00473811|Glycemic index|glycemic index
740191|NCT00473811|carbohydrates|carbohydrates
740192|NCT00473811|diabetes mellitus, type 2|diabetes mellitus, type 2
740193|NCT00473811|randomized clinical trial|randomized clinical trial
740194|NCT00473798|Patient Satisfaction|patient satisfaction
740195|NCT00473798|Quality of Life|quality of life
740196|NCT00473798|Psychological Distress|psychological distress
740197|NCT00473798|Cervical Cancer|cervical cancer
740198|NCT00473798|Cervical Cancer Screening|cervical cancer screening
740199|NCT00473798|Questionnaire|questionnaire
740200|NCT00473785|Cardiovascular disease|cardiovascular disease
740201|NCT00473785|Prevention|prevention
740202|NCT00473785|Lifestyle|lifestyle
740203|NCT00473772|cobalt chromium stent|cobalt chromium stent
740204|NCT00473772|paclitaxel coated balloon catheter|paclitaxel coated balloon catheter
740205|NCT00473772|DEBlue|deblue
740206|NCT00473772|drug eluting balloon|drug eluting balloon
740207|NCT00473746|Prostate neoplasms|prostate neoplasms
740208|NCT00473746|Hormone refractory prostate cancer|hormone refractory prostate cancer
740209|NCT00473746|Abiraterone acetate|abiraterone acetate
740210|NCT00473746|CB7630|cb7630
740211|NCT00473733|PATIENTS WITH DIABETES MELLITUS TYPE 2|patients with diabetes mellitus type 2
740212|NCT00473733|UNDERGO UPPER ENDOSCOPY|undergo upper endoscopy
740213|NCT00473733|BIOPSIES FOR GLP RECEPTORS EXPRESSION|biopsies for glp receptors expression
740214|NCT00473733|PCR ANALYSIS|pcr analysis
740215|NCT00473707|Third stage of labor|third stage of labor
740216|NCT00473668|Hepatitis B|hepatitis b
740217|NCT00473668|Tetanus|tetanus
740218|NCT00473668|Diphtheria|diphtheria
740219|NCT00473668|Pertussis|pertussis
740220|NCT00473668|Haemophilus influenzae type b Vaccines|haemophilus influenzae type b vaccines
740221|NCT00473655|Triglycerides|triglycerides
740222|NCT00473655|hypertriglyceridemia|hypertriglyceridemia
740223|NCT00473655|statins|statins
740224|NCT00473655|rosuvastatin|rosuvastatin
740225|NCT00473655|hyperlipoproteinemia|hyperlipoproteinemia
740226|NCT00473655|Fredrickson Type IIb or IV|fredrickson type iib or iv
740227|NCT00473642|Ranibizumab|ranibizumab
740228|NCT00473642|Lucentis|lucentis
740229|NCT00473642|Verteporfin|verteporfin
740230|NCT00473642|Visudyne|visudyne
740231|NCT00473642|Photodynamic therapy|photodynamic therapy
740232|NCT00473616|Phase I|phase i
740233|NCT00473616|solid tumors|solid tumors
740234|NCT00473616|solid malignancies|solid malignancies
740235|NCT00473616|cancer Eligibility|cancer eligibility
740236|NCT00473603|androgens|androgens
740237|NCT00473603|fatty acids|fatty acids
740238|NCT00473590|Avastin|avastin
740239|NCT00473590|AMBER|amber
740240|NCT00473590|Myeloma|myeloma
740241|NCT00473590|Velcade|velcade
740242|NCT00473564|Lesions|lesions
740243|NCT00473564|Biopsy|biopsy
740244|NCT00473564|Surgery|surgery
740245|NCT00473551|Chronic Lymphocytic Leukemia|chronic lymphocytic leukemia
740246|NCT00473551|Lymphoma|lymphoma
740247|NCT00473551|Myeloma|myeloma
740248|NCT00473551|Leukemia|leukemia
740249|NCT00473551|Anti-Third Party Cytolytic Lymphocytes|anti-third party cytolytic lymphocytes
740250|NCT00473551|Indolent Lymphoid Malignancies|indolent lymphoid malignancies
740251|NCT00473551|Fludarabine|fludarabine
740252|NCT00473551|Fludara|fludara
740253|NCT00473551|Rituximab|rituximab
740254|NCT00473551|Rituxan|rituxan
740255|NCT00473551|Cyclophosphamide|cyclophosphamide
740256|NCT00473551|Cytoxan®|cytoxan®
740257|NCT00473551|Neosar®|neosar®
740258|NCT00473551|Stem Cell Transplantation|stem cell transplantation
740259|NCT00473551|T-lymphocytes|t-lymphocytes
740260|NCT00473551|Miltenyi CliniMACS System|miltenyi clinimacs system
740261|NCT00473551|Graft vs. Host Disease|graft vs. host disease
740262|NCT00473551|GVHD|gvhd
740263|NCT00473551|Allogenic Transplant|allogenic transplant
740264|NCT00473551|Sirolimus|sirolimus
740265|NCT00473551|Rapamycin|rapamycin
740266|NCT00473538|Structured exercise training program|structured exercise training program
740267|NCT00473538|Infertility|infertility
740268|NCT00473538|Menstrual cycle|menstrual cycle
740269|NCT00473538|PCOS|pcos
740270|NCT00473538|Treatment|treatment
740271|NCT00473512|Abiraterone acetate|abiraterone acetate
740272|NCT00473512|CB7630|cb7630
740273|NCT00473512|Prostatic neoplasms|prostatic neoplasms
740274|NCT00473512|Hormone refractory prostate cancer|hormone refractory prostate cancer
740275|NCT00473512|Castration resistant prostate cancer|castration resistant prostate cancer
740276|NCT00473512|Castration refractory prostate cancer|castration refractory prostate cancer
740277|NCT00473499|drug eluting balloon|drug eluting balloon
740278|NCT00473499|drug eluting stent|drug eluting stent
740279|NCT00473499|stem cells|stem cells
740280|NCT00473473|homeopathy|homeopathy
740281|NCT00473473|Traumeel|traumeel
740282|NCT00473473|mechanical ventilation|mechanical ventilation
740283|NCT00473473|secretions|secretions
740284|NCT00473460|Chronic bronchitis|chronic bronchitis
740285|NCT00473460|Chronic obstructive pulmonary disease|chronic obstructive pulmonary disease
740286|NCT00473460|Acute exacerbation of chronic bronchitis|acute exacerbation of chronic bronchitis
740287|NCT00473460|Prevention therapy|prevention therapy
740288|NCT00473460|Antibiotics|antibiotics
740289|NCT00473460|Fluoroquinolone|fluoroquinolone
740290|NCT00473460|Moxifloxacin|moxifloxacin
740291|NCT00473460|AECB|aecb
740292|NCT00473447|Rehabilitation|rehabilitation
740293|NCT00473447|Children|children
740294|NCT00473447|Cerebral Palsy|cerebral palsy
740295|NCT00473447|Arm|arm
740296|NCT00473447|Paresis|paresis
740297|NCT00473434|Schizophrenia|schizophrenia
740298|NCT00473434|Drug Therapy|drug therapy
740299|NCT00473434|Treatment Outcome|treatment outcome
740300|NCT00473408|Glioma|glioma
740301|NCT00473408|DCE-MRI|dce-mri
740302|NCT00473408|Angiogenesis|angiogenesis
740303|NCT00473408|Cancer stem cells|cancer stem cells
740304|NCT00473408|Tumor vasculature|tumor vasculature
740305|NCT00473382|Lucentis|lucentis
740306|NCT00473382|DME|dme
740307|NCT00473382|Diabetes|diabetes
740308|NCT00473382|Vision loss|vision loss
740309|NCT00473369|atypical adenoma|atypical adenoma
740310|NCT00473369|Ki-67|ki-67
740311|NCT00473369|p53|p53
740312|NCT00473369|pituitary|pituitary
740313|NCT00473369|prognosis|prognosis
740314|NCT00473356|Morbid obesity|morbid obesity
740315|NCT00473356|Lean body mass|lean body mass
740316|NCT00473356|amino acid supplement|amino acid supplement
740317|NCT00473356|laparoscopic gastric bypass|laparoscopic gastric bypass
740318|NCT00473343|Photodynamic therapy (PDT)|photodynamic therapy (pdt)
740319|NCT00473343|PDT with Metvix cream|pdt with metvix cream
740320|NCT00473343|"High risk BCC"|"high risk bcc"
740321|NCT00473343|Basal Cell carcinoma|basal cell carcinoma
740322|NCT00473343|Histologically confirmed complete response|histologically confirmed complete response
740323|NCT00473330|Lucentis|lucentis
740324|NCT00473330|DME|dme
740325|NCT00473330|Diabetes|diabetes
740326|NCT00473330|Vision loss|vision loss
740327|NCT00473317|sunlight|sunlight
740328|NCT00473317|UVB|uvb
740329|NCT00473317|Vitamin D|vitamin d
740330|NCT00473304|Safety|safety
740331|NCT00473304|Efficacy|efficacy
740332|NCT00473304|Adaptation|adaptation
740333|NCT00473304|myopia and contact lens wear in children|myopia and contact lens wear in children
740334|NCT00473291|pleural effusion|pleural effusion
740335|NCT00473291|lung sounds|lung sounds
740336|NCT00473291|acoustic monitoring|acoustic monitoring
740337|NCT00473278|tear protein|tear protein
740338|NCT00473252|aspergillus infections|aspergillus infections
740339|NCT00473252|immunosuppression|immunosuppression
740340|NCT00473252|kidney transplantation|kidney transplantation
740341|NCT00473252|hemodialysis|hemodialysis
740342|NCT00473252|galactomannan test|galactomannan test
740343|NCT00473252|fine dust|fine dust
740344|NCT00473252|construction activity|construction activity
740345|NCT00473252|airborne aspergillus spores|airborne aspergillus spores
740346|NCT00473239|vitamin D|vitamin d
740347|NCT00473239|cholecalciferol|cholecalciferol
740348|NCT00473239|25-hydroxyvitamin D|25-hydroxyvitamin d
740349|NCT00473213|Multiple Sclerosis|multiple sclerosis
740350|NCT00473213|Interferon|interferon
740351|NCT00473213|Magnetic Resonance|magnetic resonance
740352|NCT00473200|hyperhomocysteinemia|hyperhomocysteinemia
740353|NCT00473200|homocysteine|homocysteine
740354|NCT00473200|S-adenosylmethionine|s-adenosylmethionine
740355|NCT00473200|SAMe|same
740356|NCT00473200|Asymmetric dimethylagrinine (ADMA)|asymmetric dimethylagrinine (adma)
740357|NCT00473187|X-linked dominant hypophosphatemic rickets|x-linked dominant hypophosphatemic rickets
740358|NCT00473187|growth disorders|growth disorders
740359|NCT00473187|anthropometry|anthropometry
740360|NCT00473187|human growth hormone|human growth hormone
740361|NCT00473174|Ramipril|ramipril
740362|NCT00473174|Ambulatory blood pressure monitoring|ambulatory blood pressure monitoring
740363|NCT00473174|Chronotherapy|chronotherapy
740364|NCT00473174|Circadian|circadian
740365|NCT00473174|Non-dipper|non-dipper
740366|NCT00473161|movement disorders|movement disorders
740367|NCT00473161|childhood|childhood
740368|NCT00473148|Duration of weaning from invasive ventilation|duration of weaning from invasive ventilation
740369|NCT00473148|Mechanical ventilation|mechanical ventilation
740370|NCT00473148|Weaning|weaning
740371|NCT00473148|B-type natriuretic peptide|b-type natriuretic peptide
740372|NCT00473148|Fluid balance|fluid balance
740373|NCT00473148|Diuretics|diuretics
740374|NCT00473148|Intubated patient receiving mechanical ventilation|intubated patient receiving mechanical ventilation
740375|NCT00473148|for at least 24 hours|for at least 24 hours
740376|NCT00473148|Respiratory insufficiency|respiratory insufficiency
740377|NCT00473135|Dengue Fever|dengue fever
740378|NCT00473135|Dengue Vaccine|dengue vaccine
740379|NCT00473135|Dengue Virus|dengue virus
740380|NCT00473135|Dengue Hemorrhagic Fever|dengue hemorrhagic fever
740381|NCT00473135|Dengue Shock Syndrome|dengue shock syndrome
740382|NCT00473122|Breast Cancer|breast cancer
740383|NCT00473122|Breast Reconstruction|breast reconstruction
740384|NCT00473122|Delayed-Immediate Reconstruction|delayed-immediate reconstruction
740385|NCT00473122|Postmastectomy Radiation Therapy|postmastectomy radiation therapy
740386|NCT00473122|Mastectomy|mastectomy
740387|NCT00473122|XRT|xrt
740388|NCT00473109|Hemodialysis|hemodialysis
740389|NCT00473109|Heparin|heparin
740390|NCT00473109|Clotting|clotting
740391|NCT00473096|Decision making|decision making
740392|NCT00473096|Patient Education|patient education
740393|NCT00473096|Indigency|indigency
740394|NCT00473096|Minority group|minority group
740395|NCT00473083|Rash|rash
740396|NCT00473083|Erlotinib|erlotinib
740397|NCT00473083|Lung Cancer|lung cancer
740398|NCT00473057|acute stroke|acute stroke
740399|NCT00473057|middle cerebral artery|middle cerebral artery
740400|NCT00473057|autologous transplantation|autologous transplantation
740401|NCT00473057|bone marrow cells|bone marrow cells
740402|NCT00473057|stem cells|stem cells
740403|NCT00473057|cell therapy|cell therapy
740404|NCT00473031|bone mass|bone mass
740405|NCT00473031|calcium absorption|calcium absorption
740406|NCT00473031|bone quality|bone quality
740407|NCT00473031|fracture risk|fracture risk
740408|NCT00473018|postexposure prophylaxis|postexposure prophylaxis
740409|NCT00473018|HIV Seronegativity|hiv seronegativity
740410|NCT00472992|Pregnancy|pregnancy
740411|NCT00472992|TYSABRI|tysabri
740412|NCT00472940|Cancer|cancer
740413|NCT00472940|Hypogonadism|hypogonadism
740414|NCT00472940|testosterone|testosterone
740415|NCT00472940|cachexia|cachexia
740416|NCT00472914|Hypertonia|hypertonia
740417|NCT00472914|Childhood|childhood
740418|NCT00472901|Polymorphic Light Eruption (PLE)|polymorphic light eruption (ple)
740419|NCT00472901|Afamelanotide|afamelanotide
740420|NCT00472901|CUV1647|cuv1647
740421|NCT00472901|photoprotection|photoprotection
740422|NCT00472901|sun poisoning|sun poisoning
740423|NCT00472888|Alpha-adrenergic blockers|alpha-adrenergic blockers
740424|NCT00472888|cataract surgery|cataract surgery
740425|NCT00472888|pseudoexfoliation syndrome|pseudoexfoliation syndrome
740426|NCT00472888|diabetes mellitus|diabetes mellitus
740427|NCT00472888|hypertension|hypertension
740428|NCT00472888|pupil|pupil
740429|NCT00472875|hypoglycaemia|hypoglycaemia
740430|NCT00472875|type 1 diabetes mellitus|type 1 diabetes mellitus
740431|NCT00472849|OFAR 2|ofar 2
740432|NCT00472849|Oxaliplatin|oxaliplatin
740433|NCT00472849|Fludarabine|fludarabine
740434|NCT00472849|Cytarabine|cytarabine
740435|NCT00472849|Ara-C|ara-c
740436|NCT00472849|Rituximab|rituximab
740437|NCT00472849|Richter's Transformation|richter's transformation
740438|NCT00472849|Prolymphocytic Leukemia|prolymphocytic leukemia
740539|NCT00472381|Insulin treatment|insulin treatment
740439|NCT00472849|B-Cell Chronic Lymphocytic Leukemia|b-cell chronic lymphocytic leukemia
740440|NCT00472849|Leukemia|leukemia
740441|NCT00472849|CLL|cll
740442|NCT00472823|cholecalciferol|cholecalciferol
740443|NCT00472823|vitamin D deficiency|vitamin d deficiency
740444|NCT00472823|bone density|bone density
740445|NCT00472823|dietary calcium|dietary calcium
740446|NCT00472823|hypercalcemia|hypercalcemia
740447|NCT00472823|hypercalciuria|hypercalciuria
740448|NCT00472810|Glaucoma|glaucoma
740449|NCT00472810|Collagen matrix|collagen matrix
740450|NCT00472810|ologen|ologen
740451|NCT00472810|OculusGen|oculusgen
740452|NCT00472810|Antifibrotic|antifibrotic
740453|NCT00472810|Trabeculectomy|trabeculectomy
740454|NCT00472810|anti scarring|anti scarring
740455|NCT00472810|tissue engineering|tissue engineering
740456|NCT00472810|high risk patient for trabeculectomy|high risk patient for trabeculectomy
740457|NCT00472810|Aeon Astron|aeon astron
740458|NCT00472771|Recurrent extensive small cell lung cancer|recurrent extensive small cell lung cancer
740459|NCT00472745|bone mass|bone mass
740460|NCT00472745|calcium absorption|calcium absorption
740461|NCT00472745|bone quality|bone quality
740462|NCT00472745|fracture risk|fracture risk
740463|NCT00472745|arthritis|arthritis
740464|NCT00472745|osteoporosis|osteoporosis
740465|NCT00472732|UCD|ucd
740466|NCT00472732|OTCD|otcd
740467|NCT00472732|Ammonia|ammonia
740468|NCT00472732|Urea Metabolism|urea metabolism
740469|NCT00472732|Inborn Errors|inborn errors
740470|NCT00472719|HIV Seronegativity|hiv seronegativity
740471|NCT00472719|HIV Preventive Vaccine|hiv preventive vaccine
740472|NCT00472719|Adenovirus|adenovirus
740473|NCT00472706|Treatment|treatment
740474|NCT00472706|Excision|excision
740475|NCT00472706|Photodynamic therapy|photodynamic therapy
740476|NCT00472706|Recurrence rate|recurrence rate
740477|NCT00472706|Cosmetic outcome|cosmetic outcome
740478|NCT00472693|Breast cancer|breast cancer
740479|NCT00472693|Metastatic breast cancer|metastatic breast cancer
740480|NCT00472693|Second-Line Therapy|second-line therapy
740481|NCT00472693|Triple Negative|triple negative
740482|NCT00472693|Her-2 negative|her-2 negative
740483|NCT00472693|Hormone receptor negative|hormone receptor negative
740484|NCT00472693|Abraxane|abraxane
740485|NCT00472693|Bevacizumab|bevacizumab
740486|NCT00472680|bone mass|bone mass
740487|NCT00472680|calcium absorption|calcium absorption
740488|NCT00472680|bone quality|bone quality
740489|NCT00472680|fracture risk|fracture risk
740490|NCT00472667|Bacterial infections|bacterial infections
740491|NCT00472667|Procalcitonin|procalcitonin
740492|NCT00472667|Intensive care unit|intensive care unit
740493|NCT00472667|Antibiotic therapy|antibiotic therapy
740494|NCT00472667|Suspicion of bacterial infection or proven|suspicion of bacterial infection or proven
740495|NCT00472654|bone mass|bone mass
740496|NCT00472654|calcium absorption|calcium absorption
740497|NCT00472654|bone quality|bone quality
740498|NCT00472654|fracture risk|fracture risk
740499|NCT00472615|Bipolar Disorder|bipolar disorder
740500|NCT00472615|Menstrual Cycle|menstrual cycle
740501|NCT00472615|Depression|depression
740502|NCT00472615|Mania or Hypomania|mania or hypomania
740503|NCT00472615|Predictor|predictor
740504|NCT00472602|Opisthorchis viverrini, liver fluke, Thailand, cancer|opisthorchis viverrini, liver fluke, thailand, cancer
740505|NCT00472576|NMDA Receptor|nmda receptor
740506|NCT00472576|Depression Treatment|depression treatment
740507|NCT00472576|Unipolar Depression|unipolar depression
740508|NCT00472576|Treatment Resistant|treatment resistant
740509|NCT00472576|Glutamatergic|glutamatergic
740510|NCT00472576|Depression|depression
740511|NCT00472576|Major Depression|major depression
740512|NCT00472563|bicarbonate|bicarbonate
740513|NCT00472563|nephropathy|nephropathy
740514|NCT00472563|contrast|contrast
740515|NCT00472550|esomeprazole, gastric emptying, reflux|esomeprazole, gastric emptying, reflux
740516|NCT00472537|Ventral hernia|ventral hernia
740517|NCT00472537|Incisional hernia|incisional hernia
740518|NCT00472498|Cardiac Arrest|cardiac arrest
740519|NCT00472498|Biphasic Defibrillator|biphasic defibrillator
740520|NCT00472472|restenosis|restenosis
740521|NCT00472472|peripheral arterial disease|peripheral arterial disease
740522|NCT00472472|paccocath|paccocath
740523|NCT00472472|drug-coated balloon|drug-coated balloon
740524|NCT00472459|Non-melanoma skin cancer|non-melanoma skin cancer
740525|NCT00472459|Organ transplant recipients|organ transplant recipients
740526|NCT00472459|Photodynamic therapy|photodynamic therapy
740527|NCT00472459|Actinic keratosis|actinic keratosis
740528|NCT00472446|Surgery|surgery
740529|NCT00472446|Thyroid gland|thyroid gland
740530|NCT00472446|cervical block|cervical block
740531|NCT00472446|Pain, Postoperative|pain, postoperative
740532|NCT00472433|Alemtuzumab in autoimmune cytopenias|alemtuzumab in autoimmune cytopenias
740533|NCT00472407|Normal|normal
740534|NCT00472394|Medical abortion|medical abortion
740535|NCT00472394|Preferences|preferences
740536|NCT00472394|Willingness to Pay|willingness to pay
740537|NCT00472381|Acute Ischemic Stroke|acute ischemic stroke
740538|NCT00472381|Post-Stroke Hyperglycaemia|post-stroke hyperglycaemia
740543|NCT00472368|Advanced cancer|advanced cancer
740544|NCT00472368|lymphoma|lymphoma
740545|NCT00472368|chronic hematological malignancies|chronic hematological malignancies
740546|NCT00472368|adult|adult
740547|NCT00472355|Parkinson's disease|parkinson's disease
740548|NCT00472355|PD|pd
740549|NCT00472355|apomorphine|apomorphine
740550|NCT00472342|impaired glucose tolerance|impaired glucose tolerance
740551|NCT00472342|impaired fasting glucose|impaired fasting glucose
740552|NCT00472342|diabetes|diabetes
740553|NCT00472342|adipokine|adipokine
740554|NCT00472342|adiponectin|adiponectin
740555|NCT00472342|RBP-4|rbp-4
740556|NCT00472342|adrenomedullin|adrenomedullin
740557|NCT00472303|Opioid|opioid
740558|NCT00472303|Central acting analgesic|central acting analgesic
740559|NCT00472303|CG5503 PR|cg5503 pr
740560|NCT00472303|Tumor related pain|tumor related pain
740561|NCT00472303|Cancer related pain|cancer related pain
740562|NCT00472303|Morphine|morphine
740563|NCT00472303|Pain assessment|pain assessment
740564|NCT00472303|Placebo|placebo
740565|NCT00472290|Hematology|hematology
740566|NCT00472290|MDS|mds
740567|NCT00472290|Myelodysplastic Syndromes|myelodysplastic syndromes
740568|NCT00472290|Thrombocytopenia|thrombocytopenia
740569|NCT00472264|methodology study, PET Imaging, COPD patients|methodology study, pet imaging, copd patients
740570|NCT00472251|dutasteride|dutasteride
740571|NCT00472251|body mass index|body mass index
740572|NCT00472251|testosterone|testosterone
740573|NCT00472225|Chronic graft-versus-host disease|chronic graft-versus-host disease
740574|NCT00472225|rituximab|rituximab
740575|NCT00472186|Tonsillectomy|tonsillectomy
740576|NCT00472186|Pain|pain
740577|NCT00472173|Apexification|apexification
740578|NCT00472173|Pulp necrosis|pulp necrosis
740579|NCT00472173|Calcium hydroxide|calcium hydroxide
740580|NCT00472173|MTA|mta
740581|NCT00472173|pulp necrosis of an anterior immature tooth|pulp necrosis of an anterior immature tooth
740582|NCT00472160|Preoxygenation|preoxygenation
740583|NCT00472160|Non Invasive Ventilation|non invasive ventilation
740584|NCT00472160|Continuous Positive Airway Pressure,|continuous positive airway pressure,
740585|NCT00472160|Intubation,|intubation,
740586|NCT00472160|Organ failure|organ failure
740587|NCT00472134|Hernia|hernia
740588|NCT00472134|Ventral|ventral
740589|NCT00472134|Laparoscopic Hernia Repair|laparoscopic hernia repair
740590|NCT00472108|Nodular Basal Cell Carcinoma|nodular basal cell carcinoma
740591|NCT00472108|Basal Cell Carcinoma|basal cell carcinoma
740592|NCT00472108|PDT with Metvix 160 mg/g cream|pdt with metvix 160 mg/g cream
740593|NCT00472108|PDT with placebo cream|pdt with placebo cream
740594|NCT00472108|Histological verification|histological verification
740595|NCT00472095|diabetes|diabetes
740596|NCT00472095|fotonovela|fotonovela
740597|NCT00472095|Latino|latino
740598|NCT00472082|Immunosuppression|immunosuppression
740599|NCT00472082|Renal Transplantation|renal transplantation
740600|NCT00472069|Stress Urinary Incontinence|stress urinary incontinence
740601|NCT00472069|striated urethral sphincter insufficiency|striated urethral sphincter insufficiency
740602|NCT00472069|myofibers|myofibers
740603|NCT00472069|satellite cells|satellite cells
740604|NCT00472069|myotubes|myotubes
740605|NCT00472069|urethral|urethral
740606|NCT00472069|Muscle fibres|muscle fibres
740607|NCT00472056|Non-Hodgkin's Lymphoma|non-hodgkin's lymphoma
740608|NCT00472056|Lymphoid Malignancies|lymphoid malignancies
740609|NCT00472056|Lymphoma|lymphoma
740610|NCT00472056|BEAM Chemotherapy|beam chemotherapy
740611|NCT00472056|Carmustine|carmustine
740612|NCT00472056|BCNU|bcnu
740613|NCT00472056|BiCNU|bicnu
740614|NCT00472056|Etoposide|etoposide
740615|NCT00472056|VePesid|vepesid
740616|NCT00472056|Cytarabine|cytarabine
740617|NCT00472056|Cytosar|cytosar
740618|NCT00472056|DepoCyt|depocyt
740619|NCT00472056|Cytosine arabinosine hydrochloride|cytosine arabinosine hydrochloride
740620|NCT00472056|Ara-C|ara-c
740621|NCT00472056|Melphalan|melphalan
740622|NCT00472056|Rituximab|rituximab
740623|NCT00472056|Rituxan|rituxan
740624|NCT00472043|Nodular Basal Cell Carcinoma|nodular basal cell carcinoma
740625|NCT00472043|Basal Cell Carcinoma|basal cell carcinoma
740626|NCT00472043|Photodynamic therapy (PDT)|photodynamic therapy (pdt)
740627|NCT00472043|Metvix|metvix
740628|NCT00472043|Histological verification|histological verification
740629|NCT00472043|PDT with Metvix cream|pdt with metvix cream
740630|NCT00472043|PDT with Placebo cream|pdt with placebo cream
740631|NCT00472030|bullous pemphigoid|bullous pemphigoid
740632|NCT00472030|omalizumab|omalizumab
740633|NCT00472030|xolair|xolair
740634|NCT00472030|IgE|ige
740635|NCT00472030|autoimmunity|autoimmunity
740636|NCT00472030|skin disease|skin disease
740637|NCT00472017|untreated childhood brain stem glioma|untreated childhood brain stem glioma
740638|NCT00471991|Oral contraceptive|oral contraceptive
740639|NCT00471991|ovulation inhibitory effect|ovulation inhibitory effect
740640|NCT00471978|non-small cell lung cancer|non-small cell lung cancer
740641|NCT00471978|small cell lung cancer|small cell lung cancer
740642|NCT00471978|pulmonary carcinoid tumor|pulmonary carcinoid tumor
740643|NCT00471952|Migraine|migraine
740644|NCT00471939|Burn, Meshed skin graft, PDGF|burn, meshed skin graft, pdgf
740645|NCT00471939|deep partial thickness or full thickness burns|deep partial thickness or full thickness burns
740646|NCT00471926|Diabetes Care|diabetes care
740647|NCT00471913|Femur|femur
740648|NCT00471913|Fracture|fracture
740649|NCT00471913|Antegrade|antegrade
740650|NCT00471913|Nailing|nailing
740651|NCT00471913|Shaft|shaft
740652|NCT00471913|Abductor|abductor
740653|NCT00471887|stage III melanoma|stage iii melanoma
740654|NCT00471887|stage IV melanoma|stage iv melanoma
740655|NCT00471887|recurrent melanoma|recurrent melanoma
740656|NCT00471861|Inflammatory Markers|inflammatory markers
740657|NCT00471861|Migraine|migraine
740658|NCT00471848|Thymoglobuline|thymoglobuline
740659|NCT00471848|Rabbit ATG|rabbit atg
740660|NCT00471848|Ciclosporin|ciclosporin
740661|NCT00471848|Aplastic Anemia|aplastic anemia
740662|NCT00471835|stage II non-small cell lung cancer|stage ii non-small cell lung cancer
740663|NCT00471835|stage I non-small cell lung cancer|stage i non-small cell lung cancer
740664|NCT00471835|adenocarcinoma of the lung|adenocarcinoma of the lung
740665|NCT00471835|adenosquamous cell lung cancer|adenosquamous cell lung cancer
740666|NCT00471835|large cell lung cancer|large cell lung cancer
740667|NCT00471835|squamous cell lung cancer|squamous cell lung cancer
740668|NCT00471822|Streptococcus pneumoniae nasopharyngeal carriage|streptococcus pneumoniae nasopharyngeal carriage
740669|NCT00471796|Patients with functional chest pain and functional heartburns|patients with functional chest pain and functional heartburns
740670|NCT00471783|gingivitis|gingivitis
740671|NCT00471783|chlorhexidine|chlorhexidine
740672|NCT00471783|dental floss|dental floss
740673|NCT00471783|RCT|rct
740674|NCT00471783|bleeding on probing|bleeding on probing
740675|NCT00471783|gingival and plaque indices|gingival and plaque indices
740676|NCT00471757|pnuemonia|pnuemonia
740677|NCT00471757|influenca|influenca
740678|NCT00471744|benign epilepsy|benign epilepsy
740679|NCT00471744|pediatrics|pediatrics
740680|NCT00471744|children|children
740681|NCT00471744|rolandic epilepsy|rolandic epilepsy
740682|NCT00471744|levetiracetam|levetiracetam
740683|NCT00471744|sulthiame|sulthiame
740684|NCT00471731|Ocular Surface Disease|ocular surface disease
740685|NCT00471731|Imprinting|imprinting
740686|NCT00471731|Eye Abnormalities|eye abnormalities
740687|NCT00471731|Ovarian Insufficiency|ovarian insufficiency
740688|NCT00471731|Women's Eye Health and Disease|women's eye health and disease
740689|NCT00471731|Turner Syndrome|turner syndrome
740690|NCT00471731|TS|ts
740691|NCT00471731|Premature Ovarian Failure|premature ovarian failure
740692|NCT00471731|POF|pof
740693|NCT00471731|Healthy Volunteer|healthy volunteer
740694|NCT00471731|HV|hv
740695|NCT00471718|adenocarcinoma of the prostate|adenocarcinoma of the prostate
740696|NCT00471718|stage IV prostate cancer|stage iv prostate cancer
740697|NCT00471718|recurrent prostate cancer|recurrent prostate cancer
740698|NCT00471705|Miltefosine|miltefosine
740699|NCT00471705|Leishmaniasis|leishmaniasis
740700|NCT00471705|Glucantime|glucantime
740701|NCT00471705|Thermotherapy|thermotherapy
740702|NCT00471705|Colombia|colombia
740703|NCT00471679|disseminated neuroblastoma|disseminated neuroblastoma
740704|NCT00471679|localized unresectable neuroblastoma|localized unresectable neuroblastoma
740705|NCT00471679|recurrent neuroblastoma|recurrent neuroblastoma
740706|NCT00471679|regional neuroblastoma|regional neuroblastoma
740707|NCT00471679|stage 4S neuroblastoma|stage 4s neuroblastoma
740708|NCT00471666|Malaria|malaria
740709|NCT00471666|Filariasis|filariasis
740710|NCT00471666|Coinfection|coinfection
740711|NCT00471666|Co-Infection|co-infection
740712|NCT00471653|thrombocytopenia|thrombocytopenia
740713|NCT00471653|adult anaplastic oligodendroglioma|adult anaplastic oligodendroglioma
740714|NCT00471653|adult brain stem glioma|adult brain stem glioma
740715|NCT00471653|adult mixed glioma|adult mixed glioma
740716|NCT00471653|adult giant cell glioblastoma|adult giant cell glioblastoma
740717|NCT00471653|adult gliosarcoma|adult gliosarcoma
740718|NCT00471653|adult glioblastoma|adult glioblastoma
740719|NCT00471653|adult anaplastic astrocytoma|adult anaplastic astrocytoma
740720|NCT00471653|adult anaplastic ependymoma|adult anaplastic ependymoma
740721|NCT00471653|adult pineal gland astrocytoma|adult pineal gland astrocytoma
740722|NCT00471640|pneumonia|pneumonia
740723|NCT00471640|dexamethasone|dexamethasone
740724|NCT00471640|community-acquired pneumonia|community-acquired pneumonia
740725|NCT00471614|HIV|hiv
740726|NCT00471614|AIDS|aids
740727|NCT00471614|uridine|uridine
740728|NCT00471614|mitochondria|mitochondria
740729|NCT00471614|insulin resistance|insulin resistance
740730|NCT00471614|Treatment Experienced|treatment experienced
740731|NCT00471601|recurrent breast cancer|recurrent breast cancer
740732|NCT00471601|stage IA breast cancer|stage ia breast cancer
740733|NCT00471601|stage IB breast cancer|stage ib breast cancer
740734|NCT00471601|stage II breast cancer|stage ii breast cancer
740735|NCT00471601|stage IIIA breast cancer|stage iiia breast cancer
740736|NCT00471601|stage IIIB breast cancer|stage iiib breast cancer
740737|NCT00471601|stage IIIC breast cancer|stage iiic breast cancer
740738|NCT00471601|stage IV breast cancer|stage iv breast cancer
740739|NCT00471588|Dopamine|dopamine
740742|NCT00471588|stimulant users|stimulant users
740743|NCT00471575|fatty liver|fatty liver
740744|NCT00471575|pregnancy|pregnancy
740745|NCT00471575|ultra sound|ultra sound
740746|NCT00471575|Pregnant women at the end of pregnancy or immediately after birth.|pregnant women at the end of pregnancy or immediately after birth.
740747|NCT00471575|controls-women with normal liver|controls-women with normal liver
740748|NCT00471575|correlation between ultrasonography and nutritional, obsthetric and laboratory data.|correlation between ultrasonography and nutritional, obsthetric and laboratory data.
740749|NCT00471562|unspecified adult solid tumor, protocol specific|unspecified adult solid tumor, protocol specific
740750|NCT00471549|Diabetes|diabetes
740751|NCT00471549|Dyslipidaemia|dyslipidaemia
740752|NCT00471549|Atherosclerosis|atherosclerosis
740753|NCT00471549|Osteoprotegerin|osteoprotegerin
740754|NCT00471549|Adhesion molecules|adhesion molecules
740755|NCT00471549|Simvastatin|simvastatin
740756|NCT00471523|Anovulation|anovulation
740757|NCT00471523|Clomiphene citrate|clomiphene citrate
740758|NCT00471523|Infertility|infertility
740759|NCT00471523|Metformin|metformin
740760|NCT00471523|PCOS|pcos
740761|NCT00471523|Treatment|treatment
740762|NCT00471510|androgenetic alopecia|androgenetic alopecia
740763|NCT00471510|male pattern hair loss|male pattern hair loss
740764|NCT00471510|male pattern baldness|male pattern baldness
740765|NCT00471510|androgenetic alopecia or male pattern hair loss|androgenetic alopecia or male pattern hair loss
740766|NCT00471497|leukemia|leukemia
740767|NCT00471497|bone marrow|bone marrow
740768|NCT00471497|leukemia symptoms|leukemia symptoms
740769|NCT00471497|lukemia|lukemia
740770|NCT00471497|cml|cml
740771|NCT00471497|complete blood count|complete blood count
740772|NCT00471497|lymphocyte|lymphocyte
740773|NCT00471497|blood cancer|blood cancer
740774|NCT00471497|leukocytes|leukocytes
740775|NCT00471497|chronic leukemia|chronic leukemia
740776|NCT00471497|bone marrow biopsy|bone marrow biopsy
740777|NCT00471497|leukemia research|leukemia research
740778|NCT00471497|leukemia cells|leukemia cells
740779|NCT00471497|bone marrow disease|bone marrow disease
740780|NCT00471497|chronic myeloid leukemia|chronic myeloid leukemia
740781|NCT00471497|blood cancer symptoms|blood cancer symptoms
740782|NCT00471497|white blood cell diseases|white blood cell diseases
740783|NCT00471497|chronic myelogenous leukemia|chronic myelogenous leukemia
740784|NCT00471497|leukemia treatment|leukemia treatment
740785|NCT00471497|leukemia facts|leukemia facts
740786|NCT00471497|leucemia|leucemia
740787|NCT00471497|facts about leukemia|facts about leukemia
740788|NCT00471497|myelogenous leukemia|myelogenous leukemia
740789|NCT00471497|newly diagnosed CML|newly diagnosed cml
740790|NCT00471497|newly diagnosed Philadelphia chromosome positive (Ph+) chronic myelogenous leukemia in chronic phase (CML-CP)|newly diagnosed philadelphia chromosome positive (ph+) chronic myelogenous leukemia in chronic phase (cml-cp)
740791|NCT00471484|adult primary hepatocellular carcinoma|adult primary hepatocellular carcinoma
740792|NCT00471484|localized unresectable adult primary liver cancer|localized unresectable adult primary liver cancer
740793|NCT00471484|advanced adult primary liver cancer|advanced adult primary liver cancer
740794|NCT00471484|childhood hepatocellular carcinoma|childhood hepatocellular carcinoma
740795|NCT00471484|stage III childhood liver cancer|stage iii childhood liver cancer
740796|NCT00471484|stage IV childhood liver cancer|stage iv childhood liver cancer
740797|NCT00471471|recurrent melanoma|recurrent melanoma
740798|NCT00471471|stage IV melanoma|stage iv melanoma
740799|NCT00471471|ciliary body and choroid melanoma, medium/large size|ciliary body and choroid melanoma, medium/large size
740800|NCT00471471|extraocular extension melanoma|extraocular extension melanoma
740801|NCT00471471|iris melanoma|iris melanoma
740802|NCT00471471|recurrent intraocular melanoma|recurrent intraocular melanoma
740803|NCT00471471|metastatic intraocular melanoma|metastatic intraocular melanoma
740804|NCT00471471|conjunctival melanoma|conjunctival melanoma
740805|NCT00471471|stage IIIA melanoma|stage iiia melanoma
740806|NCT00471471|stage IIIB melanoma|stage iiib melanoma
740807|NCT00471471|stage IIIC melanoma|stage iiic melanoma
740808|NCT00471458|Radioiodine|radioiodine
740809|NCT00471458|Hyperthyroidism|hyperthyroidism
740810|NCT00471458|Morbidity|morbidity
740811|NCT00471458|Cardiovascular diseases|cardiovascular diseases
740812|NCT00471445|unspecified adult solid tumor, protocol specific|unspecified adult solid tumor, protocol specific
740813|NCT00471445|pain|pain
740814|NCT00471445|neurotoxicity|neurotoxicity
740815|NCT00471445|peripheral neuropathy|peripheral neuropathy
740816|NCT00471432|recurrent prostate cancer|recurrent prostate cancer
740817|NCT00471432|stage IV prostate cancer|stage iv prostate cancer
740818|NCT00471432|recurrent renal cell cancer|recurrent renal cell cancer
740819|NCT00471432|stage IV renal cell cancer|stage iv renal cell cancer
740820|NCT00471432|recurrent non-small cell lung cancer|recurrent non-small cell lung cancer
740821|NCT00471432|stage IV non-small cell lung cancer|stage iv non-small cell lung cancer
740822|NCT00471432|recurrent bladder cancer|recurrent bladder cancer
740823|NCT00471432|stage IV bladder cancer|stage iv bladder cancer
740824|NCT00471432|recurrent breast cancer|recurrent breast cancer
740825|NCT00471432|stage IV breast cancer|stage iv breast cancer
740826|NCT00471432|recurrent ovarian epithelial cancer|recurrent ovarian epithelial cancer
740827|NCT00471432|stage IV ovarian epithelial cancer|stage iv ovarian epithelial cancer
740828|NCT00471432|unspecified adult solid tumor, protocol specific|unspecified adult solid tumor, protocol specific
740829|NCT00471432|male breast cancer|male breast cancer
740830|NCT00471393|TMJ|tmj
740831|NCT00471393|Osteoarthritis|osteoarthritis
740832|NCT00471393|Degenerative Joint disease|degenerative joint disease
740833|NCT00471367|Phase I|phase i
740834|NCT00471367|AZD4877|azd4877
740835|NCT00471367|Lymphoma|lymphoma
740836|NCT00471367|B-cell non-Hodgkin lymphoma|b-cell non-hodgkin lymphoma
740837|NCT00471341|arteriosclerosis|arteriosclerosis
740838|NCT00471341|coronary disease|coronary disease
740839|NCT00471341|inflammation|inflammation
740840|NCT00471341|COX-2 inhibition|cox-2 inhibition
740841|NCT00471341|hypertension|hypertension
740842|NCT00471328|GIST|gist
740843|NCT00471328|adults|adults
740844|NCT00471328|imatinib resistant|imatinib resistant
740845|NCT00471328|sunitinib resistant|sunitinib resistant
740846|NCT00471328|AMN107|amn107
740847|NCT00471328|nilotinib|nilotinib
740848|NCT00471328|treatment|treatment
740849|NCT00471328|Gastrointestinal stromal tumor (GIST)|gastrointestinal stromal tumor (gist)
740850|NCT00471315|SOD|sod
740851|NCT00471315|Common Bile Duct Diseases|common bile duct diseases
740852|NCT00471315|Sphincterotomy|sphincterotomy
740853|NCT00471315|Cholangiopancreatography, Endoscopic Retrograde|cholangiopancreatography, endoscopic retrograde
740854|NCT00471302|Immunology|immunology
740855|NCT00471302|Mali|mali
740856|NCT00471302|Donor|donor
740857|NCT00471289|Critical Limb Ischemia|critical limb ischemia
740858|NCT00471289|Stents|stents
740859|NCT00471289|Drug Eluting Stents|drug eluting stents
740860|NCT00471289|Peripheral arterial disease|peripheral arterial disease
740861|NCT00471289|PAD|pad
740862|NCT00471289|Paclitaxel|paclitaxel
740863|NCT00471289|TAXUS|taxus
740864|NCT00471289|Infrapopliteal|infrapopliteal
740865|NCT00471289|Infragenicular|infragenicular
740866|NCT00471289|Interventional Radiology|interventional radiology
740867|NCT00471289|CLI|cli
740868|NCT00471289|DES|des
740970|NCT00470743|Ibuprofen|ibuprofen
740869|NCT00471276|Metastatic Breast Cancer|metastatic breast cancer
740870|NCT00471250|Lung Infection Susceptibility|lung infection susceptibility
740871|NCT00471250|Bronchoalveolar Lavage|bronchoalveolar lavage
740872|NCT00471250|Nasal Biopsy|nasal biopsy
740873|NCT00471250|Sputum Sample|sputum sample
740874|NCT00471250|Infection Susceptibility|infection susceptibility
740875|NCT00471250|Healthy Volunteer|healthy volunteer
740876|NCT00471250|HV|hv
740877|NCT00471237|bone mineral density,|bone mineral density,
740878|NCT00471237|Ronacaleret|ronacaleret
740879|NCT00471237|teriparatide|teriparatide
740880|NCT00471237|alendronate,|alendronate,
740881|NCT00471237|Post-menopausal women,|post-menopausal women,
740882|NCT00471237|osteoporosis,|osteoporosis,
740883|NCT00471237|SB-751689|sb-751689
740884|NCT00471185|Male Contraception|male contraception
740885|NCT00471185|Acyline|acyline
740886|NCT00471146|Randomized Study Of Gemcitabine Plus AG-013736 Versus Gemcitabine Plus Placebo For Advanced Pancreatic Cancer.|randomized study of gemcitabine plus ag-013736 versus gemcitabine plus placebo for advanced pancreatic cancer.
740887|NCT00471133|melanoma|melanoma
740888|NCT00471133|DNA vaccine|dna vaccine
740889|NCT00471133|tyrosinase|tyrosinase
740890|NCT00471133|electroporation|electroporation
740891|NCT00471107|Frontal Lobe|frontal lobe
740892|NCT00471107|Language|language
740893|NCT00471107|Dementia|dementia
740894|NCT00471107|Healthy Volunteer|healthy volunteer
740895|NCT00471107|HV|hv
740896|NCT00471094|heartburn|heartburn
740897|NCT00471094|erosive esophagitis|erosive esophagitis
740898|NCT00471094|healing|healing
740899|NCT00471094|population pharmacokinetics|population pharmacokinetics
740900|NCT00471094|Quality of Life (QoL)|quality of life (qol)
740901|NCT00471081|Neisseria meningitidis;|neisseria meningitidis;
740902|NCT00471081|Humans;|humans;
740903|NCT00471081|Meningococcal vaccines;|meningococcal vaccines;
740905|NCT00471081|Vaccines, conjugate;|vaccines, conjugate;
740906|NCT00471081|Toddlers;|toddlers;
740907|NCT00471081|Immunogenicity;|immunogenicity;
740908|NCT00471055|osteoarthritis|osteoarthritis
740909|NCT00471055|knee|knee
740910|NCT00471055|capsaicin gel|capsaicin gel
740911|NCT00471055|capsicum|capsicum
740912|NCT00471042|Heroin Dependence|heroin dependence
740913|NCT00471042|Opioid Dependence|opioid dependence
740914|NCT00471042|Primary Care|primary care
740915|NCT00471042|Buprenorphine|buprenorphine
740916|NCT00471029|pH study, peptic ulcer, proton pump inhibitor|ph study, peptic ulcer, proton pump inhibitor
740917|NCT00471003|Hypertension|hypertension
740918|NCT00470990|IHH|ihh
740919|NCT00470990|Kallmann syndrome|kallmann syndrome
740920|NCT00470990|hypogonadism|hypogonadism
740921|NCT00470964|laser trabeculoplasty, glaucoma, argon, titanium-sapphire|laser trabeculoplasty, glaucoma, argon, titanium-sapphire
740922|NCT00470964|IOP lowering effect|iop lowering effect
740923|NCT00470964|Adverse effects|adverse effects
740924|NCT00470964|IOP spikes|iop spikes
740925|NCT00470951|rectal cancer|rectal cancer
740926|NCT00470951|laparoscopic assisted resection|laparoscopic assisted resection
740927|NCT00470951|open resection|open resection
741178|NCT00470314|Ammonia|ammonia
740928|NCT00470951|preoperative chemoradiation|preoperative chemoradiation
740929|NCT00470951|randomized trial|randomized trial
740930|NCT00470925|Neurological|neurological
740931|NCT00470925|Dopamine|dopamine
740932|NCT00470912|cutaneous lupus erythemaosus|cutaneous lupus erythemaosus
740933|NCT00470912|photoprotection|photoprotection
740934|NCT00470912|photoprovocation|photoprovocation
740935|NCT00470912|Sunscreen RV 2547C|sunscreen rv 2547c
740936|NCT00470899|Feto-maternal transfusion|feto-maternal transfusion
740937|NCT00470899|Kleihauer-Betke|kleihauer-betke
740938|NCT00470847|Herceptin|herceptin
740939|NCT00470847|breast cancer|breast cancer
740940|NCT00470847|radiation therapy|radiation therapy
740941|NCT00470847|stereotactic radiosurgery|stereotactic radiosurgery
740942|NCT00470847|SRS|srs
740943|NCT00470847|whole brain radiation|whole brain radiation
740944|NCT00470847|WBRT|wbrt
740945|NCT00470834|prostate cancer|prostate cancer
740946|NCT00470834|androgen deprivation therapy|androgen deprivation therapy
740947|NCT00470821|melatonin|melatonin
740948|NCT00470821|actigraphy|actigraphy
740949|NCT00470821|sedation|sedation
740950|NCT00470821|critical patients|critical patients
740951|NCT00470821|ICU|icu
740952|NCT00470808|Minors|minors
740953|NCT00470808|Enrollment in another study|enrollment in another study
740954|NCT00470808|Males|males
740955|NCT00470808|HBA1C greater than 7|hba1c greater than 7
740956|NCT00470808|Drug therapy for DM|drug therapy for dm
740957|NCT00470795|diabetes|diabetes
740958|NCT00470795|gastroparesis|gastroparesis
740959|NCT00470795|acupuncture|acupuncture
740960|NCT00470795|symptoms|symptoms
740961|NCT00470795|gastric emptying|gastric emptying
740962|NCT00470782|colonic neoplasms|colonic neoplasms
740963|NCT00470782|exercise|exercise
740964|NCT00470782|body composition|body composition
740965|NCT00470782|anthropometry|anthropometry
740966|NCT00470769|Color-Doppler Ultrasonography|color-doppler ultrasonography
740967|NCT00470769|Renal scintigraphy|renal scintigraphy
740968|NCT00470769|Kidney failure|kidney failure
740969|NCT00470769|GFR|gfr
740971|NCT00470743|Indomethacin|indomethacin
740972|NCT00470743|Infant, very low birth weight|infant, very low birth weight
740973|NCT00470743|Prematurity|prematurity
740974|NCT00470743|Ductus Arteriosus, patent|ductus arteriosus, patent
740975|NCT00470717|late preterm infant|late preterm infant
740976|NCT00470717|breastfeeding|breastfeeding
740977|NCT00470717|formula feeding|formula feeding
740978|NCT00470717|rehospitalization|rehospitalization
740979|NCT00470717|telephone|telephone
740980|NCT00470704|HER2-positive breast cancer|her2-positive breast cancer
740981|NCT00470704|Herceptin|herceptin
740982|NCT00470704|trastuzumab|trastuzumab
740983|NCT00470678|Age-related|age-related
740984|NCT00470678|macular|macular
740985|NCT00470678|degeneration|degeneration
740986|NCT00470678|AMD|amd
740987|NCT00470678|Ranibizumab|ranibizumab
740988|NCT00470678|Anti-VEGF|anti-vegf
740989|NCT00470678|choroidal|choroidal
740990|NCT00470678|neovascularization|neovascularization
740991|NCT00470678|CNV|cnv
740992|NCT00470678|Asian patients|asian patients
740993|NCT00470678|Korea|korea
740994|NCT00470678|Taiwan|taiwan
740995|NCT00470678|associated|associated
740996|NCT00470652|pain|pain
740997|NCT00470652|Pain Measurement|pain measurement
740998|NCT00470652|Decision Making, Computer-Assisted|decision making, computer-assisted
740999|NCT00470652|Informatics|informatics
741000|NCT00470639|TMS|tms
741001|NCT00470639|Treatment|treatment
741002|NCT00470639|Bipolar|bipolar
741003|NCT00470639|Efficacy|efficacy
741004|NCT00470626|Pulmonary Embolism|pulmonary embolism
741005|NCT00470626|Venous Thromboembolism|venous thromboembolism
741006|NCT00470626|Inferior Vena Cava Filter|inferior vena cava filter
741007|NCT00470626|IVC|ivc
741008|NCT00470626|PE|pe
741009|NCT00470613|Neoplasm|neoplasm
741010|NCT00470587|chest pain|chest pain
741011|NCT00470587|myocardial infarction|myocardial infarction
741012|NCT00470587|unstable angina|unstable angina
741013|NCT00470574|recurrent breast cancer|recurrent breast cancer
741014|NCT00470574|stage IV breast cancer|stage iv breast cancer
741015|NCT00470574|male breast cancer|male breast cancer
741016|NCT00470561|mammographic breast density aspirin|mammographic breast density aspirin
741017|NCT00470548|male breast cancer|male breast cancer
741018|NCT00470548|recurrent breast cancer|recurrent breast cancer
741019|NCT00470548|stage IIIA breast cancer|stage iiia breast cancer
741020|NCT00470548|stage IIIB breast cancer|stage iiib breast cancer
741021|NCT00470548|stage IIIC breast cancer|stage iiic breast cancer
741022|NCT00470548|stage IV breast cancer|stage iv breast cancer
741023|NCT00470548|stage IIIA non-small cell lung cancer|stage iiia non-small cell lung cancer
741024|NCT00470548|stage IIIB non-small cell lung cancer|stage iiib non-small cell lung cancer
741025|NCT00470548|stage IV non-small cell lung cancer|stage iv non-small cell lung cancer
741026|NCT00470548|recurrent non-small cell lung cancer|recurrent non-small cell lung cancer
741027|NCT00470548|unspecified adult solid tumor, protocol specific|unspecified adult solid tumor, protocol specific
741028|NCT00470535|adenocarcinoma of the pancreas|adenocarcinoma of the pancreas
741639|NCT00468559|neonates|neonates
741029|NCT00470535|recurrent pancreatic cancer|recurrent pancreatic cancer
741030|NCT00470535|stage III pancreatic cancer|stage iii pancreatic cancer
741031|NCT00470535|stage IV pancreatic cancer|stage iv pancreatic cancer
741032|NCT00470522|methotrexate|methotrexate
741033|NCT00470522|folic acid|folic acid
741034|NCT00470522|systemic lupus erythematosus|systemic lupus erythematosus
741036|NCT00470483|PET|pet
741037|NCT00470483|Social Anxiety Disorder|social anxiety disorder
741038|NCT00470483|fRMI|frmi
741039|NCT00470444|Cardiac Surgery|cardiac surgery
741040|NCT00470444|Transfusion Medicine|transfusion medicine
741041|NCT00470444|Cardiac Anesthesia Risk Evaluation (CARE) Score of 3 or 4|cardiac anesthesia risk evaluation (care) score of 3 or 4
741042|NCT00470444|(Dupuis J-Y et al, Anesthesiology 2001;94: 194-204)|(dupuis j-y et al, anesthesiology 2001;94: 194-204)
741043|NCT00470418|Alzheimer Disease|alzheimer disease
741044|NCT00470418|Alzheimer Type Senile Dementia|alzheimer type senile dementia
741045|NCT00470418|Alzheimer's Disease|alzheimer's disease
741046|NCT00470418|clinical trial|clinical trial
741047|NCT00470418|dementia|dementia
741048|NCT00470418|diabetes|diabetes
741049|NCT00470418|dietary supplements|dietary supplements
741050|NCT00470418|Senile Dementia, Alzheimer Type|senile dementia, alzheimer type
741051|NCT00470418|Therapeutics|therapeutics
741052|NCT00470405|adult solid tumor|adult solid tumor
741053|NCT00470405|unspecified adult solid tumor, protocol specific|unspecified adult solid tumor, protocol specific
741054|NCT00470405|stage IV adult Hodgkin lymphoma|stage iv adult hodgkin lymphoma
741055|NCT00470405|anaplastic large cell lymphoma|anaplastic large cell lymphoma
741056|NCT00470405|angioimmunoblastic T-cell lymphoma|angioimmunoblastic t-cell lymphoma
741057|NCT00470405|cutaneous B-cell non-Hodgkin lymphoma|cutaneous b-cell non-hodgkin lymphoma
741058|NCT00470405|stage IV cutaneous T-cell non-Hodgkin lymphoma|stage iv cutaneous t-cell non-hodgkin lymphoma
741059|NCT00470405|adult nasal type extranodal NK/T-cell lymphoma|adult nasal type extranodal nk/t-cell lymphoma
741060|NCT00470405|adult grade III lymphomatoid granulomatosis|adult grade iii lymphomatoid granulomatosis
741061|NCT00470405|Waldenstrom macroglobulinemia|waldenstrom macroglobulinemia
741062|NCT00470405|stage IV adult Burkitt lymphoma|stage iv adult burkitt lymphoma
742258|NCT00466076|AMD|amd
741063|NCT00470405|stage IV adult diffuse large cell lymphoma|stage iv adult diffuse large cell lymphoma
741064|NCT00470405|stage IV adult diffuse mixed cell lymphoma|stage iv adult diffuse mixed cell lymphoma
741065|NCT00470405|stage IV adult diffuse small cleaved cell lymphoma|stage iv adult diffuse small cleaved cell lymphoma
741066|NCT00470405|stage IV adult immunoblastic large cell lymphoma|stage iv adult immunoblastic large cell lymphoma
741067|NCT00470405|stage IV adult lymphoblastic lymphoma|stage iv adult lymphoblastic lymphoma
741068|NCT00470405|extranodal marginal zone B-cell lymphoma of mucosa-associated lymphoid tissue|extranodal marginal zone b-cell lymphoma of mucosa-associated lymphoid tissue
741069|NCT00470405|stage IV grade 1 follicular lymphoma|stage iv grade 1 follicular lymphoma
741070|NCT00470405|stage IV grade 2 follicular lymphoma|stage iv grade 2 follicular lymphoma
741071|NCT00470405|stage IV grade 3 follicular lymphoma|stage iv grade 3 follicular lymphoma
741072|NCT00470405|stage IV mantle cell lymphoma|stage iv mantle cell lymphoma
741073|NCT00470405|nodal marginal zone B-cell lymphoma|nodal marginal zone b-cell lymphoma
741074|NCT00470405|stage IV marginal zone lymphoma|stage iv marginal zone lymphoma
741075|NCT00470405|stage IV small lymphocytic lymphoma|stage iv small lymphocytic lymphoma
741076|NCT00470405|recurrent adult grade III lymphomatoid granulomatosis|recurrent adult grade iii lymphomatoid granulomatosis
741077|NCT00470405|recurrent adult Burkitt lymphoma|recurrent adult burkitt lymphoma
741078|NCT00470405|recurrent adult diffuse large cell lymphoma|recurrent adult diffuse large cell lymphoma
741079|NCT00470405|recurrent adult diffuse mixed cell lymphoma|recurrent adult diffuse mixed cell lymphoma
741080|NCT00470405|recurrent adult diffuse small cleaved cell lymphoma|recurrent adult diffuse small cleaved cell lymphoma
741081|NCT00470405|recurrent adult Hodgkin lymphoma|recurrent adult hodgkin lymphoma
741082|NCT00470405|recurrent adult immunoblastic large cell lymphoma|recurrent adult immunoblastic large cell lymphoma
741083|NCT00470405|recurrent adult lymphoblastic lymphoma|recurrent adult lymphoblastic lymphoma
741084|NCT00470405|recurrent cutaneous T-cell non-Hodgkin lymphoma|recurrent cutaneous t-cell non-hodgkin lymphoma
741085|NCT00470405|recurrent grade 1 follicular lymphoma|recurrent grade 1 follicular lymphoma
741086|NCT00470405|recurrent grade 2 follicular lymphoma|recurrent grade 2 follicular lymphoma
741087|NCT00470405|recurrent grade 3 follicular lymphoma|recurrent grade 3 follicular lymphoma
741088|NCT00470405|recurrent mantle cell lymphoma|recurrent mantle cell lymphoma
741089|NCT00470405|splenic marginal zone lymphoma|splenic marginal zone lymphoma
741090|NCT00470405|recurrent marginal zone lymphoma|recurrent marginal zone lymphoma
741091|NCT00470405|recurrent small lymphocytic lymphoma|recurrent small lymphocytic lymphoma
741092|NCT00470405|recurrent mycosis fungoides/Sezary syndrome|recurrent mycosis fungoides/sezary syndrome
741093|NCT00470405|stage IV mycosis fungoides/Sezary syndrome|stage iv mycosis fungoides/sezary syndrome
741094|NCT00470392|Erythema|erythema
741095|NCT00470392|optimization|optimization
741096|NCT00470392|Papule|papule
741097|NCT00470392|Plaque|plaque
741098|NCT00470392|pretreatment|pretreatment
741099|NCT00470392|T cells|t cells
741100|NCT00470392|UVB laser light|uvb laser light
741101|NCT00470392|psoriasis|psoriasis
741102|NCT00470392|topical administration|topical administration
741103|NCT00470379|stage II melanoma|stage ii melanoma
741745|NCT00468130|Aggression|aggression
741104|NCT00470379|stage III melanoma|stage iii melanoma
741105|NCT00470379|stage IV melanoma|stage iv melanoma
741106|NCT00470366|stage II malignant testicular germ cell tumor|stage ii malignant testicular germ cell tumor
741107|NCT00470366|stage III malignant testicular germ cell tumor|stage iii malignant testicular germ cell tumor
741108|NCT00470366|testicular choriocarcinoma and embryonal carcinoma|testicular choriocarcinoma and embryonal carcinoma
741109|NCT00470366|testicular choriocarcinoma and seminoma|testicular choriocarcinoma and seminoma
741110|NCT00470366|testicular choriocarcinoma and teratoma|testicular choriocarcinoma and teratoma
741111|NCT00470366|testicular choriocarcinoma and yolk sac tumor|testicular choriocarcinoma and yolk sac tumor
741112|NCT00470366|testicular choriocarcinoma|testicular choriocarcinoma
741113|NCT00470366|testicular embryonal carcinoma and seminoma|testicular embryonal carcinoma and seminoma
741114|NCT00470366|testicular embryonal carcinoma and teratoma with seminoma|testicular embryonal carcinoma and teratoma with seminoma
741115|NCT00470366|testicular embryonal carcinoma and teratoma|testicular embryonal carcinoma and teratoma
741116|NCT00470366|testicular embryonal carcinoma and yolk sac tumor with seminoma|testicular embryonal carcinoma and yolk sac tumor with seminoma
741117|NCT00470366|testicular embryonal carcinoma and yolk sac tumor|testicular embryonal carcinoma and yolk sac tumor
741118|NCT00470366|testicular embryonal carcinoma|testicular embryonal carcinoma
741119|NCT00470366|testicular seminoma|testicular seminoma
741120|NCT00470366|testicular yolk sac tumor and teratoma with seminoma|testicular yolk sac tumor and teratoma with seminoma
741121|NCT00470366|testicular yolk sac tumor and teratoma|testicular yolk sac tumor and teratoma
741122|NCT00470366|testicular yolk sac tumor|testicular yolk sac tumor
741123|NCT00470366|stage I malignant testicular germ cell tumor|stage i malignant testicular germ cell tumor
741124|NCT00470366|adult central nervous system germ cell tumor|adult central nervous system germ cell tumor
741125|NCT00470366|ovarian choriocarcinoma|ovarian choriocarcinoma
741126|NCT00470366|ovarian dysgerminoma|ovarian dysgerminoma
741127|NCT00470366|ovarian embryonal carcinoma|ovarian embryonal carcinoma
741128|NCT00470366|ovarian yolk sac tumor|ovarian yolk sac tumor
741129|NCT00470366|ovarian immature teratoma|ovarian immature teratoma
741130|NCT00470366|ovarian mature teratoma|ovarian mature teratoma
741131|NCT00470366|ovarian monodermal and highly specialized teratoma|ovarian monodermal and highly specialized teratoma
741132|NCT00470366|ovarian polyembryoma|ovarian polyembryoma
741133|NCT00470366|ovarian mixed germ cell tumor|ovarian mixed germ cell tumor
741134|NCT00470366|stage IV ovarian germ cell tumor|stage iv ovarian germ cell tumor
741135|NCT00470366|stage IV extragonadal seminoma|stage iv extragonadal seminoma
741136|NCT00470366|stage I extragonadal non-seminomatous germ cell tumor|stage i extragonadal non-seminomatous germ cell tumor
741137|NCT00470366|stage II extragonadal non-seminomatous germ cell tumor|stage ii extragonadal non-seminomatous germ cell tumor
741138|NCT00470366|stage III extragonadal non-seminomatous germ cell tumor|stage iii extragonadal non-seminomatous germ cell tumor
741139|NCT00470366|stage IV extragonadal non-seminomatous germ cell tumor|stage iv extragonadal non-seminomatous germ cell tumor
741140|NCT00470366|adult teratoma|adult teratoma
741141|NCT00470366|testicular immature teratoma|testicular immature teratoma
741142|NCT00470366|testicular mature teratoma|testicular mature teratoma
741143|NCT00470366|stage IA ovarian germ cell tumor|stage ia ovarian germ cell tumor
741144|NCT00470366|stage IB ovarian germ cell tumor|stage ib ovarian germ cell tumor
741145|NCT00470366|stage IC ovarian germ cell tumor|stage ic ovarian germ cell tumor
741146|NCT00470366|stage IIA ovarian germ cell tumor|stage iia ovarian germ cell tumor
741147|NCT00470366|stage IIB ovarian germ cell tumor|stage iib ovarian germ cell tumor
741148|NCT00470366|stage IIC ovarian germ cell tumor|stage iic ovarian germ cell tumor
741149|NCT00470366|stage IIIA ovarian germ cell tumor|stage iiia ovarian germ cell tumor
741150|NCT00470366|stage IIIB ovarian germ cell tumor|stage iiib ovarian germ cell tumor
741151|NCT00470366|stage IIIC ovarian germ cell tumor|stage iiic ovarian germ cell tumor
741152|NCT00470353|recurrent colon cancer|recurrent colon cancer
741153|NCT00470353|stage I colon cancer|stage i colon cancer
741154|NCT00470353|stage II colon cancer|stage ii colon cancer
741155|NCT00470353|stage III colon cancer|stage iii colon cancer
741156|NCT00470340|Recurrence|recurrence
741157|NCT00470340|Neoplasm Recurrence, Local|neoplasm recurrence, local
741158|NCT00470340|Liver|liver
741159|NCT00470340|Liver Neoplasms|liver neoplasms
741160|NCT00470340|Liver Cirrhosis|liver cirrhosis
741161|NCT00470340|Carcinoma, Hepatocellular|carcinoma, hepatocellular
741162|NCT00470340|Iodized Oil|iodized oil
741163|NCT00470340|gemcitabine [Substance Name]|gemcitabine [substance name]
741164|NCT00470340|oxaliplatin [Substance Name]|oxaliplatin [substance name]
741165|NCT00470340|gemcitabine-oxaliplatin regimen [Substance Name]|gemcitabine-oxaliplatin regimen [substance name]
741166|NCT00470340|Randomized Controlled Trials|randomized controlled trials
741167|NCT00470340|Multicenter Studies|multicenter studies
741168|NCT00470340|Cisplatin|cisplatin
741169|NCT00470340|Injections, Intra-Arterial|injections, intra-arterial
741170|NCT00470340|Injections, Intravenous|injections, intravenous
741171|NCT00470340|Chemotherapy, Adjuvant|chemotherapy, adjuvant
741172|NCT00470327|Interstitial lung diseases|interstitial lung diseases
741173|NCT00470327|idiopathic pulmonary fibrosis|idiopathic pulmonary fibrosis
741174|NCT00470327|Sarcoidosis|sarcoidosis
741175|NCT00470327|mRNA and cytokine expression|mrna and cytokine expression
741176|NCT00470314|Acute liver failure|acute liver failure
741177|NCT00470314|Ornithine Aspartate|ornithine aspartate
741179|NCT00470314|Encephalopathy|encephalopathy
741180|NCT00470288|cesarean delivery|cesarean delivery
741181|NCT00470288|bladder flaps|bladder flaps
741182|NCT00470275|recurrent Ewing sarcoma/peripheral primitive neuroectodermal tumor|recurrent ewing sarcoma/peripheral primitive neuroectodermal tumor
741183|NCT00470262|fatty acid oxidation complex|fatty acid oxidation complex
741184|NCT00470262|fenofibrate|fenofibrate
741185|NCT00470262|Inflammation|inflammation
741186|NCT00470262|Peroxisome Proliferator-Activated Receptors|peroxisome proliferator-activated receptors
741187|NCT00470262|pioglitazone|pioglitazone
741188|NCT00470262|Prediabetic State|prediabetic state
741189|NCT00470262|insulin resistance|insulin resistance
741190|NCT00470249|stage IIIB breast cancer|stage iiib breast cancer
741191|NCT00470249|stage IIIC breast cancer|stage iiic breast cancer
741192|NCT00470249|stage IV breast cancer|stage iv breast cancer
741193|NCT00470249|recurrent breast cancer|recurrent breast cancer
741194|NCT00470249|male breast cancer|male breast cancer
741195|NCT00470249|stage IIIA breast cancer|stage iiia breast cancer
741196|NCT00470236|Ductal carcinoma in-situ|ductal carcinoma in-situ
741197|NCT00470236|Breast conserving therapy|breast conserving therapy
741198|NCT00470236|Whole breast radiation therapy|whole breast radiation therapy
741199|NCT00470236|Tumour bed boost|tumour bed boost
741200|NCT00470236|Fractionation schedules|fractionation schedules
741201|NCT00470236|Completely excised non-low risk DCIS|completely excised non-low risk dcis
741202|NCT00470223|localized osteosarcoma|localized osteosarcoma
741203|NCT00470223|metastatic osteosarcoma|metastatic osteosarcoma
741204|NCT00470210|Ribavirin|ribavirin
741205|NCT00470210|non-responders|non-responders
741206|NCT00470210|HCV co-infected patients|hcv co-infected patients
741207|NCT00470210|sustained virological response|sustained virological response
741208|NCT00470210|Treatment Experienced|treatment experienced
741209|NCT00470184|adenocarcinoma of the esophagus|adenocarcinoma of the esophagus
741210|NCT00470184|squamous cell carcinoma of the esophagus|squamous cell carcinoma of the esophagus
741211|NCT00470184|stage II esophageal cancer|stage ii esophageal cancer
741212|NCT00470184|stage III esophageal cancer|stage iii esophageal cancer
743616|NCT00461240|acromegaly|acromegaly
741213|NCT00470184|stage IV esophageal cancer|stage iv esophageal cancer
741214|NCT00470158|zinc|zinc
741215|NCT00470158|iron|iron
741216|NCT00470158|interaction|interaction
741217|NCT00470158|diarrhea|diarrhea
741218|NCT00470158|delivery|delivery
741219|NCT00470145|unmilled formulation,|unmilled formulation,
741220|NCT00470145|micronised formulation|micronised formulation
741221|NCT00470145|relative bioavailability,|relative bioavailability,
741222|NCT00470132|ventricular shunt|ventricular shunt
741223|NCT00470119|breast cancer|breast cancer
741224|NCT00470119|obesity|obesity
741225|NCT00470119|weight changes|weight changes
741226|NCT00470106|Cognition|cognition
741227|NCT00470106|Remediation|remediation
741228|NCT00470106|Schizophrenia|schizophrenia
741229|NCT00470106|Social Cognition|social cognition
741230|NCT00470093|refractory multiple myeloma|refractory multiple myeloma
741231|NCT00470093|stage I multiple myeloma|stage i multiple myeloma
741232|NCT00470093|stage II multiple myeloma|stage ii multiple myeloma
741233|NCT00470093|stage III multiple myeloma|stage iii multiple myeloma
741234|NCT00470080|Venepuncture|venepuncture
741235|NCT00470080|Pain|pain
741236|NCT00470080|Emla cream|emla cream
741237|NCT00470080|Oral sucrose solution|oral sucrose solution
741238|NCT00470080|Premature infant|premature infant
741239|NCT00470080|Premature infant admitted to the care baby unit were|premature infant admitted to the care baby unit were
741240|NCT00470080|included in the study.|included in the study.
741241|NCT00470080|Programed venepuncture is performed with analgesia.|programed venepuncture is performed with analgesia.
741242|NCT00470067|recurrent endometrial carcinoma|recurrent endometrial carcinoma
741243|NCT00470067|stage III endometrial carcinoma|stage iii endometrial carcinoma
741244|NCT00470067|stage IV endometrial carcinoma|stage iv endometrial carcinoma
741245|NCT00470041|Healthy volunteers|healthy volunteers
741246|NCT00470028|TMS|tms
741247|NCT00470028|Treatment|treatment
741248|NCT00470028|Adolescents|adolescents
741249|NCT00470028|Safety|safety
741250|NCT00470028|Efficacy|efficacy
741251|NCT00470015|stage II melanoma|stage ii melanoma
741252|NCT00470015|stage III melanoma|stage iii melanoma
741253|NCT00470015|stage IV melanoma|stage iv melanoma
741254|NCT00470015|recurrent melanoma|recurrent melanoma
741255|NCT00470002|growth hormone|growth hormone
741256|NCT00470002|nitric oxide|nitric oxide
741257|NCT00470002|nitrate|nitrate
741258|NCT00470002|cyclic guanosine monophosphate|cyclic guanosine monophosphate
741259|NCT00470002|insulin-like growth factor-1|insulin-like growth factor-1
741260|NCT00470002|asymmetric dimethylarginine|asymmetric dimethylarginine
741261|NCT00470002|blood pressure|blood pressure
741262|NCT00470002|endothelial progenitor cells|endothelial progenitor cells
741263|NCT00469989|immune system|immune system
741264|NCT00469989|allergy|allergy
741265|NCT00469989|hookworm infection|hookworm infection
741266|NCT00469989|parasite infection|parasite infection
741267|NCT00469989|asthma|asthma
741268|NCT00469976|stage IIIB non-small cell lung cancer|stage iiib non-small cell lung cancer
741847|NCT00467831|Albinism|albinism
741269|NCT00469976|stage IV non-small cell lung cancer|stage iv non-small cell lung cancer
741270|NCT00469976|recurrent non-small cell lung cancer|recurrent non-small cell lung cancer
741271|NCT00469963|adult primary hepatocellular carcinoma|adult primary hepatocellular carcinoma
741272|NCT00469963|localized unresectable adult primary liver cancer|localized unresectable adult primary liver cancer
741273|NCT00469963|recurrent adult primary liver cancer|recurrent adult primary liver cancer
741274|NCT00469963|advanced adult primary liver cancer|advanced adult primary liver cancer
741275|NCT00469950|PCI|pci
741276|NCT00469950|stent|stent
741277|NCT00469950|training|training
741278|NCT00469950|endothelial function|endothelial function
741279|NCT00469950|restenosis|restenosis
741280|NCT00469950|late luminal loss|late luminal loss
741281|NCT00469950|heart rate variability|heart rate variability
741282|NCT00469950|oxygen uptake capacity|oxygen uptake capacity
741283|NCT00469950|inflammatory markers|inflammatory markers
741284|NCT00469937|radiation toxicity|radiation toxicity
741285|NCT00469937|neurotoxicity|neurotoxicity
741286|NCT00469937|cognitive/functional effects|cognitive/functional effects
741287|NCT00469937|unspecified adult solid tumor, protocol specific|unspecified adult solid tumor, protocol specific
741288|NCT00469937|adult tumors metastatic to brain|adult tumors metastatic to brain
741289|NCT00469924|Informatics|informatics
741290|NCT00469924|Clinical Laboratory Information Systems|clinical laboratory information systems
741291|NCT00469924|Hospital Communication Systems|hospital communication systems
741292|NCT00469924|Laboratory Techniques and Procedures|laboratory techniques and procedures
741293|NCT00469924|Point-of-Care Systems|point-of-care systems
741294|NCT00469924|Therapy, Computer-Assisted|therapy, computer-assisted
741295|NCT00469911|Heart|heart
741296|NCT00469911|Transplant|transplant
741297|NCT00469911|MRS|mrs
741298|NCT00469911|MRI|mri
741299|NCT00469911|Spectroscopy|spectroscopy
741300|NCT00469898|extensive stage small cell lung cancer|extensive stage small cell lung cancer
741301|NCT00469885|Smoking cessation|smoking cessation
741302|NCT00469885|cardiovascular disease|cardiovascular disease
741303|NCT00469885|smoking reduction|smoking reduction
741304|NCT00469885|nicotine replacement|nicotine replacement
741305|NCT00469859|recurrent childhood acute myeloid leukemia|recurrent childhood acute myeloid leukemia
741306|NCT00469859|adult acute myeloid leukemia with t(16;16)(p13;q22)|adult acute myeloid leukemia with t(16;16)(p13;q22)
741307|NCT00469859|adult acute myeloid leukemia with t(8;21)(q22;q22)|adult acute myeloid leukemia with t(8;21)(q22;q22)
741308|NCT00469859|adult acute myeloid leukemia with 11q23 (MLL) abnormalities|adult acute myeloid leukemia with 11q23 (mll) abnormalities
741309|NCT00469859|adult acute myeloid leukemia with inv(16)(p13;q22)|adult acute myeloid leukemia with inv(16)(p13;q22)
741310|NCT00469859|adult acute myeloid leukemia with t(15;17)(q22;q12)|adult acute myeloid leukemia with t(15;17)(q22;q12)
741311|NCT00469859|recurrent adult acute myeloid leukemia|recurrent adult acute myeloid leukemia
741312|NCT00469859|secondary acute myeloid leukemia|secondary acute myeloid leukemia
741313|NCT00469846|Pre-Eclampsia|pre-eclampsia
741314|NCT00469846|Hypertension,pregnancy-induced|hypertension,pregnancy-induced
741315|NCT00469846|Preterm labor|preterm labor
741316|NCT00469833|Diabetes|diabetes
741317|NCT00469833|Glucose Tolerance|glucose tolerance
741318|NCT00469833|Incretin|incretin
741319|NCT00469833|Insulin|insulin
741320|NCT00469820|adult acute myeloid leukemia with 11q23 (MLL) abnormalities|adult acute myeloid leukemia with 11q23 (mll) abnormalities
741321|NCT00469820|adult acute myeloid leukemia with inv(16)(p13;q22)|adult acute myeloid leukemia with inv(16)(p13;q22)
741322|NCT00469820|adult acute myeloid leukemia with t(15;17)(q22;q12)|adult acute myeloid leukemia with t(15;17)(q22;q12)
741323|NCT00469820|adult acute myeloid leukemia with t(16;16)(p13;q22)|adult acute myeloid leukemia with t(16;16)(p13;q22)
741324|NCT00469820|adult acute myeloid leukemia with t(8;21)(q22;q22)|adult acute myeloid leukemia with t(8;21)(q22;q22)
741325|NCT00469820|recurrent adult acute lymphoblastic leukemia|recurrent adult acute lymphoblastic leukemia
741326|NCT00469820|recurrent adult acute myeloid leukemia|recurrent adult acute myeloid leukemia
741327|NCT00469820|secondary acute myeloid leukemia|secondary acute myeloid leukemia
741328|NCT00469820|stage III multiple myeloma|stage iii multiple myeloma
741329|NCT00469820|untreated adult acute lymphoblastic leukemia|untreated adult acute lymphoblastic leukemia
741330|NCT00469820|untreated adult acute myeloid leukemia|untreated adult acute myeloid leukemia
741331|NCT00469820|stage I multiple myeloma|stage i multiple myeloma
741332|NCT00469820|stage II multiple myeloma|stage ii multiple myeloma
741333|NCT00469820|refractory multiple myeloma|refractory multiple myeloma
741334|NCT00469807|Ghrelin|ghrelin
741335|NCT00469807|Pregnancy outcome|pregnancy outcome
741336|NCT00469794|arrhythmias|arrhythmias
741337|NCT00469794|Athletes|athletes
741338|NCT00469794|exercise|exercise
741339|NCT00469768|HIV-1 infection|hiv-1 infection
741340|NCT00469768|HIV Seronegativity|hiv seronegativity
741341|NCT00469742|Cardiology|cardiology
741342|NCT00469742|Pediatrics|pediatrics
741343|NCT00469742|Cardiac Defects|cardiac defects
741344|NCT00469742|Cardiopulmonary Bypass Surgery|cardiopulmonary bypass surgery
741345|NCT00469742|Aprotinin|aprotinin
741346|NCT00469742|thrombosis|thrombosis
741347|NCT00469742|renal dysfunction|renal dysfunction
741348|NCT00469729|Tetraethylenepentamine|tetraethylenepentamine
741349|NCT00469729|Umbilical Cord Blood Stem Cell Transplantation|umbilical cord blood stem cell transplantation
741350|NCT00469729|Hematological Malignancies|hematological malignancies
741351|NCT00469729|Acute Lymphoid Leukemia|acute lymphoid leukemia
741352|NCT00469729|Subjects with high-risk hematologic malignancies who are candidates for allogeneic stem cell transplantation|subjects with high-risk hematologic malignancies who are candidates for allogeneic stem cell transplantation
741353|NCT00469716|Fluid balance|fluid balance
741354|NCT00469716|respiratory function|respiratory function
741355|NCT00469716|cardiac function|cardiac function
741356|NCT00469716|inflammation|inflammation
741357|NCT00469716|Cardiopulmonary bypass|cardiopulmonary bypass
741358|NCT00469703|Pancreatitis|pancreatitis
741359|NCT00469664|Schizophrenia|schizophrenia
741360|NCT00469664|Schizoaffective|schizoaffective
741361|NCT00469664|Cognitive Impairment|cognitive impairment
741362|NCT00469664|Cognition|cognition
741363|NCT00469664|Memory|memory
741364|NCT00469664|Attention|attention
741365|NCT00469664|Concentration|concentration
741366|NCT00469651|Malaria|malaria
741367|NCT00469651|vaccine|vaccine
741368|NCT00469651|MSP3LSP|msp3lsp
741369|NCT00469651|Safety|safety
741370|NCT00469651|children|children
741371|NCT00469651|Tanzania|tanzania
741372|NCT00469638|atrial fibrillation|atrial fibrillation
741373|NCT00469638|paroxysmal|paroxysmal
741374|NCT00469638|persistent|persistent
741375|NCT00469638|symptomatic|symptomatic
741376|NCT00469638|ablation|ablation
741377|NCT00469638|catheter|catheter
741378|NCT00469638|introducer|introducer
741379|NCT00469638|Agilis NxT|agilis nxt
741380|NCT00469638|sinus rhythm|sinus rhythm
741381|NCT00469638|paroxysmal atrial fibrillation|paroxysmal atrial fibrillation
741382|NCT00469638|persistent atrial fibrillation|persistent atrial fibrillation
741383|NCT00469638|symptomatic atrial fibrillation|symptomatic atrial fibrillation
741384|NCT00469612|Myopia|myopia
741385|NCT00469612|NeuroVision|neurovision
741386|NCT00469612|Visual acuity|visual acuity
741387|NCT00469612|Contrast sensitivity|contrast sensitivity
741388|NCT00469599|Hyperparathyroidism, Secondary|hyperparathyroidism, secondary
741389|NCT00469599|Kidney Failure, Chronic|kidney failure, chronic
741390|NCT00469599|Renal Insufficiency, Chronic|renal insufficiency, chronic
741391|NCT00469599|Vitamin D Deficiency|vitamin d deficiency
741392|NCT00469599|Renal Osteodystrophy|renal osteodystrophy
741393|NCT00469599|Hemodialysis|hemodialysis
741394|NCT00469560|MDS|mds
741395|NCT00469560|Chronic transfusional hemosiderosis|chronic transfusional hemosiderosis
741396|NCT00469560|Deferasirox|deferasirox
741397|NCT00469547|ethanol, microbicide, sexually transmitted, Kenya, males|ethanol, microbicide, sexually transmitted, kenya, males
741398|NCT00469547|HIV Seronegativity|hiv seronegativity
741399|NCT00469534|minimized time to beam|minimized time to beam
741400|NCT00469534|hypofractionated 3D CRT plus IMRT|hypofractionated 3d crt plus imrt
741401|NCT00469534|PET-scan|pet-scan
741402|NCT00469508|Methamphetamine|methamphetamine
741403|NCT00469508|Modafinil|modafinil
741404|NCT00469508|Medication|medication
741405|NCT00469508|Contingency Management|contingency management
741406|NCT00469508|Crystal meth|crystal meth
741407|NCT00469508|Los Angeles|los angeles
741408|NCT00469508|Addiction|addiction
741409|NCT00469508|Meth|meth
741410|NCT00469482|Delirium|delirium
741411|NCT00469482|Cognitive Impairment|cognitive impairment
741412|NCT00469482|Sleep|sleep
741413|NCT00469482|Polysomnography|polysomnography
741414|NCT00469482|Sedation|sedation
741415|NCT00469482|Mechanical Ventilation|mechanical ventilation
741416|NCT00469482|Critical Illness|critical illness
741417|NCT00469469|Adrenal Cortex|adrenal cortex
741418|NCT00469469|ACC|acc
741419|NCT00469456|memantine|memantine
741420|NCT00469456|Alzheimer's Disease|alzheimer's disease
741421|NCT00469456|communication|communication
741422|NCT00469443|Metastatic colorectal cancer|metastatic colorectal cancer
741423|NCT00469443|Irinotecan|irinotecan
741424|NCT00469443|Capecitabine|capecitabine
741425|NCT00469443|Bevacizumab|bevacizumab
741426|NCT00469430|appendicitis|appendicitis
741427|NCT00469430|treatment|treatment
741428|NCT00469430|antibiotics|antibiotics
741429|NCT00469417|Methyl aminolevulinate|methyl aminolevulinate
741430|NCT00469417|Photodynamic therapy|photodynamic therapy
741431|NCT00469417|Primary Superficial Basal Cell Carcinoma|primary superficial basal cell carcinoma
741432|NCT00469404|Transdermal patch|transdermal patch
741433|NCT00469404|Centrally acting analgesic|centrally acting analgesic
741434|NCT00469404|Plasma level|plasma level
741435|NCT00469404|Healthy volunteers|healthy volunteers
741436|NCT00469391|Weight Reduction|weight reduction
741437|NCT00469378|firategrast|firategrast
741438|NCT00469378|lymphocytes|lymphocytes
741439|NCT00469378|leukocytes|leukocytes
741440|NCT00469378|SB-683699|sb-683699
741441|NCT00469378|cerebrospinal fluid|cerebrospinal fluid
741442|NCT00469378|relapsing forms of multiple sclerosis|relapsing forms of multiple sclerosis
741443|NCT00469365|clinical trial, medication adherence, pharmacy intervention|clinical trial, medication adherence, pharmacy intervention
741444|NCT00469365|Patients with specific chronic diseases|patients with specific chronic diseases
741445|NCT00469352|Pharmacogenetics|pharmacogenetics
741446|NCT00469352|Genetics|genetics
742603|NCT00464724|3 Tesla|3 tesla
741447|NCT00469352|Treatment response|treatment response
741448|NCT00469352|AMD|amd
741449|NCT00469352|Wet AMD|wet amd
741450|NCT00469352|Age-related macular degeneration|age-related macular degeneration
741451|NCT00469339|Breast Cancer|breast cancer
741452|NCT00469339|Diabetes|diabetes
741453|NCT00469339|Colon Cancer|colon cancer
741454|NCT00469339|Cardiovascular Disease|cardiovascular disease
741455|NCT00469326|coronary artery disease|coronary artery disease
741456|NCT00469326|percutaneous coronary intervention|percutaneous coronary intervention
741457|NCT00469326|atorvastatin|atorvastatin
741458|NCT00469313|copd|copd
741459|NCT00469313|inspiratory muscle training|inspiratory muscle training
741460|NCT00469313|IF|if
741461|NCT00469300|herpes labialis|herpes labialis
741462|NCT00469300|cold sore|cold sore
741463|NCT00469300|acyclovir|acyclovir
741464|NCT00469300|iontophoresis|iontophoresis
741465|NCT00469300|topical|topical
741466|NCT00469287|diabetes mellitus|diabetes mellitus
741467|NCT00469287|blood sugar|blood sugar
741468|NCT00469287|overweight|overweight
741469|NCT00469287|obesity|obesity
741470|NCT00469287|Traditional Chinese medicine|traditional chinese medicine
741471|NCT00469274|Pertussis|pertussis
741472|NCT00469274|Healthcare worker|healthcare worker
741473|NCT00469274|Post-exposure prophylaxis|post-exposure prophylaxis
741474|NCT00469274|Vaccination|vaccination
741475|NCT00469274|Pertussis in healthcare workers following occupational|pertussis in healthcare workers following occupational
741476|NCT00469274|exposure to pertussis|exposure to pertussis
741477|NCT00469261|Myocardial infarction|myocardial infarction
741478|NCT00469261|Ventricular remodeling|ventricular remodeling
741479|NCT00469261|Matrix metalloproteinases|matrix metalloproteinases
741480|NCT00469261|Doxycycline|doxycycline
741481|NCT00469248|Myocardial infarction|myocardial infarction
741482|NCT00469248|Cardiogenic shock|cardiogenic shock
741483|NCT00469248|Systemic inflammatory response syndrome|systemic inflammatory response syndrome
741484|NCT00469248|Percutaneous coronary intervention|percutaneous coronary intervention
741485|NCT00469248|aortic balloon counterpulsation|aortic balloon counterpulsation
741486|NCT00469222|small cell lung cancer|small cell lung cancer
744017|NCT00459719|Tacrolimus|tacrolimus
741487|NCT00469222|radiotherapy dose escalation|radiotherapy dose escalation
741488|NCT00469209|Multiple Myeloma|multiple myeloma
741489|NCT00469209|Melphalan|melphalan
741490|NCT00469209|Trisenox|trisenox
741491|NCT00469209|Arsenic Trioxide|arsenic trioxide
741492|NCT00469209|Ascorbic Acid|ascorbic acid
741493|NCT00469209|Vitamin C|vitamin c
741494|NCT00469209|Velcade|velcade
741495|NCT00469209|Bortezomib|bortezomib
741496|NCT00469196|mesothelioma|mesothelioma
741497|NCT00469196|tomotherapy|tomotherapy
741498|NCT00469170|HIV-1|hiv-1
741499|NCT00469170|HIV seronegativity|hiv seronegativity
741500|NCT00469157|compatibility of Optive after PRK or LASIK|compatibility of optive after prk or lasik
741501|NCT00469144|Stem Cell Transplantation|stem cell transplantation
741502|NCT00469144|Leukemia|leukemia
741503|NCT00469144|Busulfan|busulfan
741504|NCT00469144|Fludarabine|fludarabine
741506|NCT00469144|AML|aml
741507|NCT00469131|liver transplantation,|liver transplantation,
741508|NCT00469131|HCV recurrence,|hcv recurrence,
741509|NCT00469131|immunosuppression|immunosuppression
741510|NCT00469105|Type 2 Diabetes|type 2 diabetes
741511|NCT00469105|Diabetes Education|diabetes education
741512|NCT00469105|Health Literacy|health literacy
741513|NCT00469079|Biomarkers|biomarkers
741514|NCT00469079|Smoking|smoking
741515|NCT00469079|Tobacco|tobacco
741516|NCT00469079|Cessation|cessation
741517|NCT00469066|small cell lung cancer|small cell lung cancer
741518|NCT00469066|bladder cancer|bladder cancer
741519|NCT00469066|conformal radiotherapy|conformal radiotherapy
741520|NCT00469053|Transdermal patch|transdermal patch
741521|NCT00469053|multidose|multidose
741522|NCT00469053|Centrally acting analgesic|centrally acting analgesic
741523|NCT00469053|Plasma level|plasma level
741524|NCT00469053|Healthy volunteers|healthy volunteers
741525|NCT00469040|GW642444,|gw642444,
741526|NCT00469040|healthy subjects|healthy subjects
741527|NCT00469040|magnesium stearate,|magnesium stearate,
741528|NCT00469027|Pulmonary Arterial Hypertension (PAH)|pulmonary arterial hypertension (pah)
741529|NCT00469014|Acute Myeloid Leukemia|acute myeloid leukemia
741530|NCT00469014|AML|aml
741531|NCT00469014|Myelodysplastic Syndrome|myelodysplastic syndrome
741532|NCT00469014|MDS|mds
741533|NCT00469014|Chronic Myeloid Leukemia|chronic myeloid leukemia
741534|NCT00469014|CML|cml
741535|NCT00469014|Busulfan|busulfan
741536|NCT00469014|Busulfex|busulfex
741537|NCT00469014|Myleran|myleran
741538|NCT00469014|Fludarabine|fludarabine
741539|NCT00469014|Fludara|fludara
741540|NCT00469014|Fludarabine Phosphate|fludarabine phosphate
741541|NCT00469014|Clofarabine|clofarabine
741542|NCT00469014|Clofarex|clofarex
741543|NCT00469014|Clolar|clolar
741544|NCT00469014|Allogeneic stem cell transplantation|allogeneic stem cell transplantation
741545|NCT00469014|ASCT|asct
741546|NCT00469014|Stem Cell|stem cell
741547|NCT00469014|Gleevec|gleevec
741548|NCT00469014|Imatinib Mesylate|imatinib mesylate
741549|NCT00469001|Hospitalization and death from exacerbation CHF.|hospitalization and death from exacerbation chf.
741550|NCT00468949|Health-Related Quality of Life|health-related quality of life
741551|NCT00468949|Dupuytren's Disease|dupuytren's disease
741552|NCT00468949|Health Utilities Index|health utilities index
741553|NCT00468949|Short Form-36;|short form-36;
741554|NCT00468949|Michigan Hand Outcomes Questionnaire|michigan hand outcomes questionnaire
741555|NCT00468936|anti-rejection|anti-rejection
741556|NCT00468936|GI side effects|gi side effects
741557|NCT00468936|heart transplant patients|heart transplant patients
741558|NCT00468923|Primary prevention|primary prevention
741559|NCT00468923|Cholesterol lowering|cholesterol lowering
741560|NCT00468923|Blood pressure lowering|blood pressure lowering
741561|NCT00468923|Cardiovascular disease prevention|cardiovascular disease prevention
741562|NCT00468897|Alzheimers Disease|alzheimers disease
741563|NCT00468897|healthy volunteers|healthy volunteers
741564|NCT00468897|bioequivalence|bioequivalence
741565|NCT00468884|Kinetics of GLP-1 and PYY3-36; increasing oral doses|kinetics of glp-1 and pyy3-36; increasing oral doses
741566|NCT00468858|Dengue|dengue
741567|NCT00468858|Virus|virus
741568|NCT00468858|Live-attenuated|live-attenuated
741569|NCT00468858|Vaccine|vaccine
741570|NCT00468858|Dengue viral infection|dengue viral infection
741571|NCT00468858|Dengue Vaccine|dengue vaccine
741572|NCT00468845|pain after hysterectomy|pain after hysterectomy
741573|NCT00468845|amount of opioids used|amount of opioids used
741574|NCT00468819|Contrast-enhanced MRI|contrast-enhanced mri
741575|NCT00468819|MR angiography (MRA) Children 2-17 years|mr angiography (mra) children 2-17 years
741576|NCT00468806|PET scan|pet scan
741577|NCT00468806|Health Males|health males
741578|NCT00468793|central venous saturation|central venous saturation
741579|NCT00468793|bowel surgery|bowel surgery
741580|NCT00468793|morbidity|morbidity
741581|NCT00468793|intravenous infusions|intravenous infusions
741582|NCT00468780|Canadian Triage Acuity Scale|canadian triage acuity scale
741583|NCT00468780|paramedics|paramedics
741584|NCT00468780|triage nurse|triage nurse
741585|NCT00468780|triage levels|triage levels
741586|NCT00468780|inter-rater reliability|inter-rater reliability
744121|NCT00459420|Caffeine|caffeine
741587|NCT00468780|health services outcomes|health services outcomes
741588|NCT00468767|Atrial fibrillation|atrial fibrillation
741589|NCT00468767|RSD1235|rsd1235
741590|NCT00468767|Atrial fibrillation of 3 hours to 7 days duration.|atrial fibrillation of 3 hours to 7 days duration.
741591|NCT00468767|Atrial fibrillation of 3 hours to 45 days duration.|atrial fibrillation of 3 hours to 45 days duration.
741592|NCT00468741|Breast Cancer|breast cancer
741593|NCT00468741|Internet|internet
741594|NCT00468741|Computer|computer
741595|NCT00468741|Support|support
741596|NCT00468741|Information|information
741597|NCT00468741|Education|education
741598|NCT00468741|Control Group: Usual care and Internet access|control group: usual care and internet access
741599|NCT00468741|CHESS Information Services only|chess information services only
741600|NCT00468741|CHESS Social Support & Information Services|chess social support & information services
741601|NCT00468741|CHESS Information, Social Support & Skills Services|chess information, social support & skills services
741602|NCT00468728|CDAD, Clostridium difficile, diarrhea|cdad, clostridium difficile, diarrhea
741603|NCT00468728|Clostridium difficile-Associated Diarrhea|clostridium difficile-associated diarrhea
741604|NCT00468715|stage IV breast cancer|stage iv breast cancer
741605|NCT00468715|recurrent breast cancer|recurrent breast cancer
741606|NCT00468715|male breast cancer|male breast cancer
741607|NCT00468689|SB-751689,|sb-751689,
741608|NCT00468689|Calcium-sensing receptor antagonist (CaR),|calcium-sensing receptor antagonist (car),
741609|NCT00468689|Osteoporosis,|osteoporosis,
741610|NCT00468689|Parathyroid hormone (PTH),|parathyroid hormone (pth),
741611|NCT00468689|Oral dose|oral dose
741612|NCT00468676|major Depressive Disorder|major depressive disorder
741613|NCT00468676|Diabetes|diabetes
741614|NCT00468676|Heart Disease|heart disease
741615|NCT00468663|preeclampsia|preeclampsia
741616|NCT00468663|preterm delivery|preterm delivery
741617|NCT00468663|lipid peroxidation|lipid peroxidation
741618|NCT00468663|inflammation|inflammation
741619|NCT00468637|heart failure|heart failure
741620|NCT00468637|cardiovascular high risk|cardiovascular high risk
741621|NCT00468637|erectile dysfunction|erectile dysfunction
741622|NCT00468637|cardiovascular disease|cardiovascular disease
741623|NCT00468624|Growth hormone|growth hormone
741624|NCT00468624|insulin-like growth factor 1|insulin-like growth factor 1
741625|NCT00468624|pegvisomant|pegvisomant
741626|NCT00468611|Secondary Progressive Multiple Sclerosis|secondary progressive multiple sclerosis
741627|NCT00468611|Multiple Sclerosis|multiple sclerosis
741628|NCT00468598|troponin|troponin
741629|NCT00468598|long-term outcome|long-term outcome
741630|NCT00468598|on-pump cardiac surgery|on-pump cardiac surgery
741631|NCT00468585|Breast cancer|breast cancer
741632|NCT00468585|Metastatic breast cancer|metastatic breast cancer
741633|NCT00468585|Breast|breast
741634|NCT00468585|Metastatic|metastatic
741635|NCT00468572|Emotion|emotion
741636|NCT00468572|Oxytocin|oxytocin
741637|NCT00468572|Cortisol|cortisol
741638|NCT00468559|pediatrics|pediatrics
741640|NCT00468533|Arupiprazole, prolacin, PANSS, CGI, AIMS|arupiprazole, prolacin, panss, cgi, aims
741641|NCT00468520|induction of labor|induction of labor
741642|NCT00468520|cervical ripening|cervical ripening
741643|NCT00468520|Foley catheter|foley catheter
741644|NCT00468520|oxytocin|oxytocin
741645|NCT00468507|CCK release|cck release
741646|NCT00468494|non diabetic|non diabetic
741647|NCT00468494|catabolic energy state|catabolic energy state
741648|NCT00468481|Healthy women requesting contraception|healthy women requesting contraception
741649|NCT00468481|Folic Acid|folic acid
741650|NCT00468468|breast cancer|breast cancer
741651|NCT00468468|Internet|internet
741652|NCT00468468|computer|computer
741653|NCT00468468|support|support
741654|NCT00468468|information|information
741655|NCT00468468|education|education
741656|NCT00468455|Colorectal Surgery|colorectal surgery
741657|NCT00468455|Abdominal Surgery|abdominal surgery
741658|NCT00468455|Diverticulitis|diverticulitis
741659|NCT00468455|Colon Cancer|colon cancer
741660|NCT00468455|Rectal Cancer|rectal cancer
741661|NCT00468455|Colon Polyp|colon polyp
741662|NCT00468455|Rectal Polyp|rectal polyp
741663|NCT00468455|Crohn's Disease|crohn's disease
741664|NCT00468442|Insulin dependence|insulin dependence
741665|NCT00468442|Hypoglycemia|hypoglycemia
741666|NCT00468442|Hypoglycemia unawareness|hypoglycemia unawareness
741667|NCT00468429|Glaucoma|glaucoma
741668|NCT00468429|Bevacizumab|bevacizumab
741669|NCT00468429|Glaucoma Filtration Surgery|glaucoma filtration surgery
741670|NCT00468429|Mitomycin C|mitomycin c
741671|NCT00468429|Intraocular Pressure|intraocular pressure
741672|NCT00468403|Insulin dependence|insulin dependence
741673|NCT00468403|Hypoglycemia|hypoglycemia
741674|NCT00468403|Hypoglycemia unawareness|hypoglycemia unawareness
741675|NCT00468364|Hypoglycemia, bedtime insulin, long-acting insulin|hypoglycemia, bedtime insulin, long-acting insulin
741676|NCT00468351|bevacizumab|bevacizumab
741677|NCT00468351|diabetes|diabetes
741678|NCT00468351|intravitreal|intravitreal
741679|NCT00468351|macular edema|macular edema
741680|NCT00468351|triamcinolone|triamcinolone
741681|NCT00468351|VEGF|vegf
744219|NCT00458887|ototoxicity|ototoxicity
741682|NCT00468338|general anesthesia|general anesthesia
741683|NCT00468338|dental rehabilitation|dental rehabilitation
741684|NCT00468338|mental retardation|mental retardation
741685|NCT00468325|coronary artery disease|coronary artery disease
741686|NCT00468325|chest pain|chest pain
741687|NCT00468325|emergency room|emergency room
741688|NCT00468299|early|early
741689|NCT00468299|pregnancy|pregnancy
741690|NCT00468299|failure|failure
741691|NCT00468299|mifepristone|mifepristone
741692|NCT00468299|misoprostol|misoprostol
741693|NCT00468299|buccal|buccal
741694|NCT00468299|miscarriage|miscarriage
741695|NCT00468299|fetal|fetal
741696|NCT00468299|demise|demise
741697|NCT00468299|anembryonic|anembryonic
741698|NCT00468299|progesterone|progesterone
741699|NCT00468286|Prostate Cancer|prostate cancer
741700|NCT00468273|Deficiency Syndromes, Antibody|deficiency syndromes, antibody
741701|NCT00468273|Antibody Deficiency Syndrome|antibody deficiency syndrome
741702|NCT00468273|Bruton's agammaglobulinemia|bruton's agammaglobulinemia
741703|NCT00468273|Common Variable Immune Deficiency|common variable immune deficiency
741704|NCT00468273|Hyper IgM syndromes|hyper igm syndromes
741705|NCT00468260|Cancer|cancer
741706|NCT00468260|EPO906|epo906
741707|NCT00468260|Patupilone|patupilone
741708|NCT00468247|mean systemic pressure|mean systemic pressure
741709|NCT00468247|fluid therapy|fluid therapy
741710|NCT00468247|closed loop control|closed loop control
741711|NCT00468247|circulation modelling|circulation modelling
741712|NCT00468234|smoking cessation|smoking cessation
741713|NCT00468234|harm reduction|harm reduction
741714|NCT00468234|biomarker|biomarker
741715|NCT00468234|exhaled breath condensate|exhaled breath condensate
741716|NCT00468221|Ozone|ozone
741717|NCT00468221|Healthy Adults|healthy adults
741718|NCT00468208|Vasculitis|vasculitis
741719|NCT00468208|Relapse|relapse
741720|NCT00468208|Wegener's|wegener's
741721|NCT00468208|Treatment|treatment
741722|NCT00468195|tomography|tomography
741723|NCT00468195|coronary artery disease|coronary artery disease
741724|NCT00468195|obesity|obesity
741725|NCT00468182|Multiple sclerosis|multiple sclerosis
741726|NCT00468182|Interferon beta|interferon beta
741727|NCT00468182|plasmacytoid dendritic cells|plasmacytoid dendritic cells
741728|NCT00468169|Cetuximab|cetuximab
741729|NCT00468169|Erbitux|erbitux
741730|NCT00468169|locally|locally
741731|NCT00468169|advanced|advanced
741732|NCT00468169|head|head
741733|NCT00468169|neck|neck
741734|NCT00468169|cancer|cancer
741735|NCT00468169|neoplasms|neoplasms
741736|NCT00468169|squamous|squamous
741737|NCT00468169|carcinoma|carcinoma
741738|NCT00468169|lymphoepithelioma|lymphoepithelioma
741739|NCT00468156|fruit|fruit
741740|NCT00468156|vegetables|vegetables
741741|NCT00468156|prevention|prevention
741742|NCT00468156|cancer|cancer
741743|NCT00468156|counseling|counseling
741744|NCT00468156|cancer risk|cancer risk
741746|NCT00468130|Irritability|irritability
741747|NCT00468130|Global autism severity|global autism severity
741748|NCT00468117|Hypoglycemia|hypoglycemia
741749|NCT00468117|Kidney Transplant|kidney transplant
741750|NCT00468117|Insulin independence|insulin independence
741751|NCT00468117|Islet Transplantation|islet transplantation
741752|NCT00468117|Intensive Insulin Therapy|intensive insulin therapy
741753|NCT00468104|parapneumonic pleural effusion|parapneumonic pleural effusion
741754|NCT00468104|empyema|empyema
741755|NCT00468104|TPA (Activase, Alteplase)|tpa (activase, alteplase)
741756|NCT00468091|GLP-1|glp-1
741757|NCT00468091|exendin(9-39)|exendin(9-39)
741758|NCT00468091|atropine|atropine
741759|NCT00468091|human|human
741760|NCT00468091|motility|motility
741761|NCT00468078|Parkinson's disease|parkinson's disease
741762|NCT00468078|Essential tremor|essential tremor
741763|NCT00468078|F-18 FPCIT|f-18 fpcit
741765|NCT00468065|intravenous|intravenous
741766|NCT00468065|catheter|catheter
741767|NCT00468065|IV|iv
741768|NCT00468052|obstructive sleep apnea|obstructive sleep apnea
741769|NCT00468052|tonsillectomy|tonsillectomy
741770|NCT00468052|adenoidectomy|adenoidectomy
741771|NCT00468039|metformin|metformin
741772|NCT00468039|vildagliptin|vildagliptin
741773|NCT00468039|initial combination|initial combination
741774|NCT00468026|BPH|bph
741775|NCT00468026|Prostate|prostate
741776|NCT00468026|Stent|stent
741777|NCT00468026|Benign prostatic hyperplasia (BPH)|benign prostatic hyperplasia (bph)
741778|NCT00468013|Fibromyalgia|fibromyalgia
741779|NCT00468013|Irritable Bowel|irritable bowel
741780|NCT00468013|Chronic Fatigue|chronic fatigue
741781|NCT00468013|Medically Unexplained Symptoms|medically unexplained symptoms
741782|NCT00468013|Resilience Building Exercises|resilience building exercises
741783|NCT00468013|Depression|depression
741784|NCT00468013|Well-Being|well-being
741785|NCT00468000|Peripheral Arterial Disease|peripheral arterial disease
741786|NCT00468000|Critical Limb Ischemia|critical limb ischemia
741787|NCT00468000|Ischemia|ischemia
741788|NCT00468000|Peripheral Vascular Disease|peripheral vascular disease
741789|NCT00468000|ixmyelocel-T|ixmyelocel-t
741790|NCT00467961|CML (Chronic Myelogenous Leukemia)|cml (chronic myelogenous leukemia)
741791|NCT00467961|CLL (Chronic Lymphocytic Leukemia)|cll (chronic lymphocytic leukemia)
741792|NCT00467961|AML (Acute Myelogenous Leukemia)|aml (acute myelogenous leukemia)
741793|NCT00467961|Leukemia|leukemia
741794|NCT00467961|Chronic Lymphocytic Leukemia|chronic lymphocytic leukemia
741795|NCT00467961|CLL|cll
741796|NCT00467961|Chronic Myelogenous Leukemia|chronic myelogenous leukemia
741797|NCT00467961|CML|cml
741798|NCT00467961|Acute Myelogenous Leukemia|acute myelogenous leukemia
741799|NCT00467961|AML|aml
741800|NCT00467961|Acute B-Lymphoblastic Leukemia|acute b-lymphoblastic leukemia
741801|NCT00467961|ALL|all
741802|NCT00467961|Myelodysplastic Syndrome|myelodysplastic syndrome
741803|NCT00467961|MDS|mds
741804|NCT00467948|clean contaminated, laryngectomy, wound infection|clean contaminated, laryngectomy, wound infection
741805|NCT00467935|amd|amd
741806|NCT00467935|disciform|disciform
741807|NCT00467935|fibrosis|fibrosis
741808|NCT00467935|Lucentis|lucentis
741809|NCT00467935|scotoma|scotoma
741810|NCT00467922|Hand-assisted colorectal surgery|hand-assisted colorectal surgery
741811|NCT00467922|colorectal disease|colorectal disease
741812|NCT00467922|Crohn's|crohn's
741813|NCT00467922|diverticulitis|diverticulitis
741814|NCT00467922|Colorectal resections|colorectal resections
741815|NCT00467909|micronutrients|micronutrients
741816|NCT00467909|cognition|cognition
741817|NCT00467909|DHA|dha
741818|NCT00467909|healthy children|healthy children
741819|NCT00467896|PAH|pah
741820|NCT00467896|iloprost|iloprost
741821|NCT00467896|Ventavis|ventavis
741822|NCT00467896|Pulmonary Arterial Hypertension|pulmonary arterial hypertension
741823|NCT00467896|Actelion Pharmaceuticals|actelion pharmaceuticals
741824|NCT00467896|Cotherix|cotherix
741825|NCT00467883|Zygomycosis|zygomycosis
741826|NCT00467883|High dose liposomal amphotericin B|high dose liposomal amphotericin b
741827|NCT00467870|investigational|investigational
741828|NCT00467870|testosterone|testosterone
741829|NCT00467870|testosterone undecanoate|testosterone undecanoate
741830|NCT00467870|TU|tu
741831|NCT00467870|Hypogonadism|hypogonadism
741832|NCT00467870|primary hypogonadism|primary hypogonadism
741833|NCT00467870|secondary hypogonadism|secondary hypogonadism
741834|NCT00467857|cyanoacrylates|cyanoacrylates
741835|NCT00467857|microbial sealants|microbial sealants
741836|NCT00467857|skin flora contamination|skin flora contamination
741837|NCT00467857|surgery|surgery
741838|NCT00467844|Cachexia|cachexia
741839|NCT00467844|Muscle Wasting|muscle wasting
741840|NCT00467844|Non-Small Cell Lung Cancer|non-small cell lung cancer
741841|NCT00467844|Colorectal Cancer|colorectal cancer
741842|NCT00467844|Non-Hodgkin's Lymphoma|non-hodgkin's lymphoma
741843|NCT00467844|Stage 3 or 4 Breast Cancer|stage 3 or 4 breast cancer
741844|NCT00467844|Chronis Lymphocytic Leukemia|chronis lymphocytic leukemia
741845|NCT00467831|Restrictive Lung Disease|restrictive lung disease
741846|NCT00467831|Pulmonary Fibrosis|pulmonary fibrosis
741848|NCT00467831|Platelet Storage Pool Deficiency|platelet storage pool deficiency
741849|NCT00467831|Metabolic Disease|metabolic disease
741850|NCT00467831|Hermansky-Pudlak Syndrome|hermansky-pudlak syndrome
741851|NCT00467831|HPS|hps
741852|NCT00467831|Lung Disease|lung disease
741853|NCT00467818|Aggression|aggression
741854|NCT00467818|Irritability|irritability
741855|NCT00467818|Global severity|global severity
741856|NCT00467805|Light exposure|light exposure
741857|NCT00467805|light spectrum|light spectrum
741858|NCT00467805|reproductive hormones|reproductive hormones
741859|NCT00467805|women|women
741860|NCT00467792|urticaria pigmentosa|urticaria pigmentosa
741861|NCT00467792|mastocytosis|mastocytosis
741862|NCT00467792|mastocytomas|mastocytomas
741863|NCT00467766|dementia|dementia
741864|NCT00467766|Counseling|counseling
741865|NCT00467753|Irritability|irritability
741866|NCT00467753|Functional Ability|functional ability
741867|NCT00467753|Aggression|aggression
741868|NCT00467753|Mood Instability|mood instability
741869|NCT00467727|Diagnostic Mammography|diagnostic mammography
741870|NCT00467727|Breast Imaging|breast imaging
741871|NCT00467727|Phase Contrast Mammography|phase contrast mammography
741872|NCT00467727|X-Ray Mammography|x-ray mammography
741873|NCT00467714|RHINOPLASTY ,ESTHETIC SURGERY|rhinoplasty ,esthetic surgery
741874|NCT00467701|pneumonia|pneumonia
741875|NCT00467701|Legionnaires disease|legionnaires disease
741876|NCT00467701|risk factors|risk factors
741877|NCT00467688|type 1 diabetes|type 1 diabetes
741878|NCT00467688|glucose excursion|glucose excursion
741879|NCT00467688|hypoglycemia awareness|hypoglycemia awareness
741880|NCT00467688|continuous glucose monitoring|continuous glucose monitoring
741881|NCT00467675|NonDiabetes|nondiabetes
741882|NCT00467675|CGM|cgm
741883|NCT00467649|Symlin|symlin
741884|NCT00467649|Amylin|amylin
741885|NCT00467649|insulin|insulin
741886|NCT00467649|Humalog|humalog
741887|NCT00467649|Novolog|novolog
741888|NCT00467649|Apidra|apidra
741889|NCT00467636|Chronic Obstructive Pulmonary Disease|chronic obstructive pulmonary disease
744483|NCT00458042|Ventavis|ventavis
741890|NCT00467636|Corticosteroid induced hyperglycaemia|corticosteroid induced hyperglycaemia
741891|NCT00467636|Insulin|insulin
741892|NCT00467623|Pregnancy|pregnancy
741893|NCT00467623|holotranscobalamin|holotranscobalamin
741894|NCT00467623|cobalamin|cobalamin
741895|NCT00467623|vitamin B12 analogues|vitamin b12 analogues
741896|NCT00467623|reference interval|reference interval
741897|NCT00467610|myelodysplastic|myelodysplastic
741898|NCT00467610|MDS|mds
741899|NCT00467610|Panhematin|panhematin
741900|NCT00467610|Hemin|hemin
741901|NCT00467597|Dyskinesia|dyskinesia
741902|NCT00467597|Levodopa|levodopa
741903|NCT00467597|Movement Disorders|movement disorders
741904|NCT00467597|Parkinson Disease|parkinson disease
741905|NCT00467571|chronic idiopathic thrombocytopenic purpura|chronic idiopathic thrombocytopenic purpura
741906|NCT00467571|Helicobacter pylori infection|helicobacter pylori infection
741907|NCT00467571|platelet|platelet
741908|NCT00467558|Impulse Control Disorder|impulse control disorder
741909|NCT00467558|Compulsive Sexual Behavior|compulsive sexual behavior
741910|NCT00467545|HBeAg-positive|hbeag-positive
741911|NCT00467545|chronic hepatitis B|chronic hepatitis b
741912|NCT00467545|telbivudine|telbivudine
741913|NCT00467519|Tetanus; Diphtheria; Pertussis; ADACEL; DAPTACEL|tetanus; diphtheria; pertussis; adacel; daptacel
741914|NCT00467506|Recurrence of medullary thyroid carcinoma: abnormal calcitonin level and biomarkers doubling time lower than 5 years after initial surgery|recurrence of medullary thyroid carcinoma: abnormal calcitonin level and biomarkers doubling time lower than 5 years after initial surgery
741915|NCT00467454|Pyromania|pyromania
741916|NCT00467454|Fire Setting|fire setting
741917|NCT00467454|Compulsive Fire Setting|compulsive fire setting
741918|NCT00467428|ADHD|adhd
741919|NCT00467415|Walking|walking
741920|NCT00467415|Treadmill|treadmill
741921|NCT00467415|Partial Weightbearing|partial weightbearing
741922|NCT00467402|agomelatine, Major Depressive Disorder, MDD, depression|agomelatine, major depressive disorder, mdd, depression
741923|NCT00467389|Acetylcholine|acetylcholine
741924|NCT00467389|Acetylcholinesterase|acetylcholinesterase
741925|NCT00467389|Butyrylcholinesterase|butyrylcholinesterase
741926|NCT00467389|Cholinesterase Inhibitor|cholinesterase inhibitor
741927|NCT00467350|constipation|constipation
741928|NCT00467350|treatment|treatment
741929|NCT00467350|fecal impaction|fecal impaction
741930|NCT00467350|pediatric|pediatric
741931|NCT00467337|insole|insole
741932|NCT00467337|osteoarthritis|osteoarthritis
741933|NCT00467337|pain|pain
741934|NCT00467337|valgus knee|valgus knee
741935|NCT00467324|obstructive sleep apnea|obstructive sleep apnea
741936|NCT00467324|surgery|surgery
741937|NCT00467324|tongue|tongue
741938|NCT00467311|Contrast-induced nephropathy|contrast-induced nephropathy
741939|NCT00467311|Cystatin C|cystatin c
741940|NCT00467311|Contrast media|contrast media
741941|NCT00467311|Creatinine|creatinine
741942|NCT00467311|Cardiac Catheterization|cardiac catheterization
741943|NCT00467298|Exercise|exercise
741944|NCT00467298|heart failure|heart failure
742604|NCT00464724|MRSI|mrsi
741945|NCT00467298|chronic obstructive pulmonary disease|chronic obstructive pulmonary disease
741946|NCT00467298|patient education|patient education
741947|NCT00467298|costs|costs
741948|NCT00467298|quality of life|quality of life
741949|NCT00467285|Bone Density|bone density
741950|NCT00467285|C-telopeptide|c-telopeptide
741951|NCT00467285|Dual-Energy X-Ray Absorptiometry|dual-energy x-ray absorptiometry
741952|NCT00467285|N-telopeptide|n-telopeptide
741953|NCT00467285|Osteocalcin|osteocalcin
741954|NCT00467285|Osteoporosis|osteoporosis
741955|NCT00467285|Thiazolidinediones|thiazolidinediones
741956|NCT00467285|Type 2 Diabetes Mellitus|type 2 diabetes mellitus
741957|NCT00467272|Catheter-Related Bloodstream Infections|catheter-related bloodstream infections
741958|NCT00467272|Bloodstream Infection|bloodstream infection
741959|NCT00467272|Daptomycin|daptomycin
741960|NCT00467272|Cubicin|cubicin
741961|NCT00467272|CRBSI|crbsi
741962|NCT00467259|Natural Menopause|natural menopause
741963|NCT00467246|Diabetes emergencies|diabetes emergencies
741964|NCT00467220|Calorie restriction|calorie restriction
741965|NCT00467220|alternate day fasting|alternate day fasting
741966|NCT00467220|calorie intake|calorie intake
741967|NCT00467194|adult primary hepatocellular carcinoma|adult primary hepatocellular carcinoma
741968|NCT00467194|localized unresectable adult primary liver cancer|localized unresectable adult primary liver cancer
741969|NCT00467194|recurrent adult primary liver cancer|recurrent adult primary liver cancer
741970|NCT00467194|advanced adult primary liver cancer|advanced adult primary liver cancer
741971|NCT00467181|cardiac surgery|cardiac surgery
741972|NCT00467181|renal dysfunction|renal dysfunction
741973|NCT00467168|dietary fatty acid composition|dietary fatty acid composition
741974|NCT00467168|postprandial|postprandial
741975|NCT00467168|triglyceride-rich lipoprotein|triglyceride-rich lipoprotein
741976|NCT00467168|type 2 diabetes|type 2 diabetes
741977|NCT00467155|Helicobacter pylori, children, infants, Gambia|helicobacter pylori, children, infants, gambia
741978|NCT00467142|stage IV colon cancer|stage iv colon cancer
741979|NCT00467142|stage IV rectal cancer|stage iv rectal cancer
741980|NCT00467142|adenocarcinoma of the colon|adenocarcinoma of the colon
741981|NCT00467142|adenocarcinoma of the rectum|adenocarcinoma of the rectum
741982|NCT00467142|recurrent colon cancer|recurrent colon cancer
741983|NCT00467142|recurrent rectal cancer|recurrent rectal cancer
741984|NCT00467129|stage IV colon cancer|stage iv colon cancer
741985|NCT00467129|stage IV rectal cancer|stage iv rectal cancer
741986|NCT00467116|stage III pancreatic cancer|stage iii pancreatic cancer
741987|NCT00467116|adenocarcinoma of the pancreas|adenocarcinoma of the pancreas
741988|NCT00467116|stage II pancreatic cancer|stage ii pancreatic cancer
741989|NCT00467116|recurrent pancreatic cancer|recurrent pancreatic cancer
741990|NCT00467103|Adult Aphasia|adult aphasia
741991|NCT00467103|Diffusion Tensor Imaging|diffusion tensor imaging
741992|NCT00467103|functional Magnetic Resonance Imaging|functional magnetic resonance imaging
741993|NCT00467103|Language Recovery|language recovery
741994|NCT00467103|Left Middle Cerebral Artery Stroke|left middle cerebral artery stroke
741995|NCT00467103|Nonfluent Aphasia|nonfluent aphasia
741996|NCT00467090|Parkinson's Disease|parkinson's disease
741997|NCT00467090|Gene|gene
741998|NCT00467090|Genetic|genetic
741999|NCT00467090|Family Studies|family studies
742000|NCT00467090|LRRK-2|lrrk-2
742001|NCT00467090|Parkinson Disease|parkinson disease
742002|NCT00467090|PD|pd
742003|NCT00467077|recurrent renal cell cancer|recurrent renal cell cancer
742004|NCT00467077|stage IV renal cell cancer|stage iv renal cell cancer
742005|NCT00467077|stage III renal cell cancer|stage iii renal cell cancer
742006|NCT00467064|Disease self-management|disease self-management
742007|NCT00467064|Community programs|community programs
742008|NCT00467038|affect|affect
742009|NCT00467038|aggression|aggression
742010|NCT00467038|anger|anger
742011|NCT00467038|behavior therapy|behavior therapy
742012|NCT00467038|borderline personality disorder|borderline personality disorder
742013|NCT00467038|MRI, functional|mri, functional
742014|NCT00467025|Metastatic clear cell carcinoma of the kidney|metastatic clear cell carcinoma of the kidney
742015|NCT00467025|RCC|rcc
742016|NCT00467012|Inoperable metastatic breast cancer|inoperable metastatic breast cancer
742017|NCT00466999|misoprostol|misoprostol
742018|NCT00466999|incomplete abortion|incomplete abortion
742019|NCT00466999|PAC|pac
742020|NCT00466986|recurrent|recurrent
742021|NCT00466986|ovarian|ovarian
742022|NCT00466986|cancer|cancer
742023|NCT00466986|platinum sensitive|platinum sensitive
742024|NCT00466973|Atrial fibrillation|atrial fibrillation
742025|NCT00466973|ablation device comparison|ablation device comparison
742026|NCT00466973|ablation in right atria|ablation in right atria
742027|NCT00466947|Otitis media|otitis media
742028|NCT00466947|Pneumonia|pneumonia
742029|NCT00466947|Community acquired pneumonia (CAP)|community acquired pneumonia (cap)
742030|NCT00466947|Pneumococcal disease|pneumococcal disease
742031|NCT00466947|Booster vaccination|booster vaccination
742032|NCT00466947|Immunogenicity|immunogenicity
742033|NCT00466947|Pneumococcal vaccine|pneumococcal vaccine
742034|NCT00466947|Safety|safety
742035|NCT00466947|Efficacy|efficacy
742036|NCT00466947|Carriage|carriage
742037|NCT00466934|Cerebral Blood Flow|cerebral blood flow
742038|NCT00466934|Cerebral Cortex|cerebral cortex
742039|NCT00466934|Cognition|cognition
742040|NCT00466934|Optical Imaging|optical imaging
742041|NCT00466934|Healthy Volunteer|healthy volunteer
742042|NCT00466934|HV|hv
742043|NCT00466921|recurrent mycosis fungoides/Sezary syndrome|recurrent mycosis fungoides/sezary syndrome
742044|NCT00466921|stage I mycosis fungoides/Sezary syndrome|stage i mycosis fungoides/sezary syndrome
742045|NCT00466921|stage II mycosis fungoides/Sezary syndrome|stage ii mycosis fungoides/sezary syndrome
742046|NCT00466921|stage III mycosis fungoides/Sezary syndrome|stage iii mycosis fungoides/sezary syndrome
742047|NCT00466921|stage IV mycosis fungoides/Sezary syndrome|stage iv mycosis fungoides/sezary syndrome
742048|NCT00466895|Leukemia|leukemia
742049|NCT00466895|Lenalidomide|lenalidomide
742050|NCT00466882|obese|obese
742051|NCT00466882|renal failure|renal failure
742052|NCT00466882|renal transplant candidate|renal transplant candidate
742053|NCT00466882|Hemodialysis BMI between 36 and 42|hemodialysis bmi between 36 and 42
742054|NCT00466856|neoplastic syndrome|neoplastic syndrome
742055|NCT00466856|metastatic gastrointestinal carcinoid tumor|metastatic gastrointestinal carcinoid tumor
742056|NCT00466856|recurrent gastrointestinal carcinoid tumor|recurrent gastrointestinal carcinoid tumor
742057|NCT00466856|thyroid gland medullary carcinoma|thyroid gland medullary carcinoma
742058|NCT00466856|metastatic pheochromocytoma|metastatic pheochromocytoma
742059|NCT00466856|recurrent islet cell carcinoma|recurrent islet cell carcinoma
742060|NCT00466856|liver metastases|liver metastases
742061|NCT00466856|recurrent pheochromocytoma|recurrent pheochromocytoma
742062|NCT00466856|gastrinoma|gastrinoma
742063|NCT00466856|insulinoma|insulinoma
742064|NCT00466856|WDHA syndrome|wdha syndrome
742065|NCT00466856|glucagonoma|glucagonoma
742066|NCT00466856|pancreatic polypeptide tumor|pancreatic polypeptide tumor
742067|NCT00466856|somatostatinoma|somatostatinoma
742068|NCT00466843|Abnormal hematopoiesis|abnormal hematopoiesis
742069|NCT00466843|Leukemia|leukemia
742070|NCT00466843|Autoimmune Disease|autoimmune disease
742071|NCT00466830|pain|pain
742072|NCT00466830|psychosocial effects of cancer and its treatment|psychosocial effects of cancer and its treatment
742073|NCT00466830|stage IIIA breast cancer|stage iiia breast cancer
744484|NCT00458042|iloporst|iloporst
742074|NCT00466830|stage IIIB breast cancer|stage iiib breast cancer
742075|NCT00466830|stage I breast cancer|stage i breast cancer
742076|NCT00466830|stage II breast cancer|stage ii breast cancer
742077|NCT00466830|stage IIIC breast cancer|stage iiic breast cancer
742078|NCT00466817|Cytomegalovirus, congenital, infants|cytomegalovirus, congenital, infants
742079|NCT00466804|heart transplant recipients|heart transplant recipients
742080|NCT00466804|organ transplantation|organ transplantation
742081|NCT00466804|immune biomarkers|immune biomarkers
742082|NCT00466804|transplant rejection|transplant rejection
742083|NCT00466765|Fat Grafting|fat grafting
742084|NCT00466765|Breast Augmentation|breast augmentation
742085|NCT00466765|Liposuctioned Fat Transfer|liposuctioned fat transfer
742086|NCT00466765|Lumpectomy|lumpectomy
742087|NCT00466765|Mastectomy|mastectomy
742088|NCT00466765|Micromastia|micromastia
742089|NCT00466765|Asymmetry|asymmetry
742090|NCT00466765|Post Lumpectomy Filling Defects|post lumpectomy filling defects
742091|NCT00466765|Post implant removal filling defect|post implant removal filling defect
742092|NCT00466765|Post Mastectomy|post mastectomy
742093|NCT00466765|Autologous Fat Transfer|autologous fat transfer
742094|NCT00466765|Tubular breasts|tubular breasts
742095|NCT00466765|Tuberous breasts|tuberous breasts
742096|NCT00466765|Constricted breasts|constricted breasts
742097|NCT00466726|chronic myelogenous leukemia, BCR-ABL1 positive|chronic myelogenous leukemia, bcr-abl1 positive
742098|NCT00466726|accelerated phase chronic myelogenous leukemia|accelerated phase chronic myelogenous leukemia
742099|NCT00466726|blastic phase chronic myelogenous leukemia|blastic phase chronic myelogenous leukemia
742100|NCT00466726|chronic phase chronic myelogenous leukemia|chronic phase chronic myelogenous leukemia
742101|NCT00466726|relapsing chronic myelogenous leukemia|relapsing chronic myelogenous leukemia
742102|NCT00466713|Nonischemic dilated cardiomyopathy|nonischemic dilated cardiomyopathy
742103|NCT00466700|Helicobacter pylori, Gambia, endoscopy, Africa|helicobacter pylori, gambia, endoscopy, africa
742104|NCT00466687|stage IV melanoma|stage iv melanoma
742105|NCT00466687|recurrent melanoma|recurrent melanoma
742106|NCT00466674|Myeloma|myeloma
742107|NCT00466674|RICT|rict
742108|NCT00466674|conditioning|conditioning
742109|NCT00466674|allograft|allograft
742110|NCT00466661|Acamprosate|acamprosate
742111|NCT00466661|Alcoholism|alcoholism
742112|NCT00466661|Bipolar disorder|bipolar disorder
742113|NCT00466661|Comorbidity|comorbidity
742114|NCT00466661|Craving|craving
742115|NCT00466661|Depression|depression
742116|NCT00466661|GABA|gaba
742117|NCT00466661|Glutamate|glutamate
742118|NCT00466661|Mania|mania
742119|NCT00466661|Pharmacotherapy|pharmacotherapy
742120|NCT00466661|Withdrawal|withdrawal
742121|NCT00466648|laparoscopy, port site, closure, Dermabond|laparoscopy, port site, closure, dermabond
742122|NCT00466635|Clostridium difficile Disease|clostridium difficile disease
742123|NCT00466635|Infectious diarrhea|infectious diarrhea
742124|NCT00466635|C. difficile|c. difficile
742125|NCT00466635|CDAD|cdad
742311|NCT00465894|incontinence|incontinence
742126|NCT00466635|Clostridium difficile-associated diarrhea|clostridium difficile-associated diarrhea
742127|NCT00466635|Clostridium difficile diarrhea|clostridium difficile diarrhea
742128|NCT00466635|Antibiotic-Associated Colitis|antibiotic-associated colitis
742129|NCT00466635|Clostridium Enterocolitis|clostridium enterocolitis
742130|NCT00466635|Antibiotic-Associated Diarrhea|antibiotic-associated diarrhea
742131|NCT00466635|Pseudomembranous Colitis|pseudomembranous colitis
742132|NCT00466635|Clostridium difficile|clostridium difficile
742133|NCT00466622|PCOS|pcos
742134|NCT00466622|pregnancy|pregnancy
742135|NCT00466622|metformin|metformin
742136|NCT00466622|blood flow|blood flow
742137|NCT00466622|Pulsatility index|pulsatility index
742138|NCT00466609|clomipramine|clomipramine
742139|NCT00466609|quetiapine|quetiapine
742140|NCT00466609|fluoxetine|fluoxetine
742141|NCT00466609|placebo|placebo
742142|NCT00466609|augmentation|augmentation
742143|NCT00466609|obsessive compulsive disorder|obsessive compulsive disorder
742144|NCT00466596|allergic rhinitis|allergic rhinitis
742145|NCT00466596|mild asthma|mild asthma
742146|NCT00466596|dust mite allergy|dust mite allergy
742147|NCT00466596|gamma tocopherol|gamma tocopherol
742148|NCT00466583|Carcinoma, Lymphoma|carcinoma, lymphoma
742149|NCT00466557|Malaria, Plasmodium falciparum, mosquito, Africa, Anopheles|malaria, plasmodium falciparum, mosquito, africa, anopheles
742150|NCT00466544|Chronic tonsillitis|chronic tonsillitis
742151|NCT00466544|Recurrent tonsillitis|recurrent tonsillitis
742152|NCT00466531|refractory chronic lymphocytic leukemia|refractory chronic lymphocytic leukemia
742153|NCT00466531|06-138|06-138
742154|NCT00466518|Kidney transplant|kidney transplant
742155|NCT00466518|type 2 diabetes|type 2 diabetes
742156|NCT00466518|sitagliptin|sitagliptin
742157|NCT00466505|recurrent colon cancer|recurrent colon cancer
742158|NCT00466505|stage IV colon cancer|stage iv colon cancer
742159|NCT00466505|recurrent rectal cancer|recurrent rectal cancer
742160|NCT00466505|stage IV rectal cancer|stage iv rectal cancer
742161|NCT00466492|Drug Administration Schedule|drug administration schedule
742162|NCT00466492|Intensive Care Units|intensive care units
742163|NCT00466492|Length of Stay|length of stay
742164|NCT00466492|Respiration, Artificial|respiration, artificial
742454|NCT00465348|vascular dysregulation|vascular dysregulation
742165|NCT00466492|Stress Disorders, Post-Traumatic/etiology/*psychology|stress disorders, post-traumatic/etiology/*psychology
742166|NCT00466492|Critical Illness/*psychology|critical illness/*psychology
742167|NCT00466492|Pneumonia/prevention & control|pneumonia/prevention & control
742168|NCT00466492|Hypnotics and Sedatives/*administration & dosage|hypnotics and sedatives/*administration & dosage
742169|NCT00466479|neuroprotection|neuroprotection
742170|NCT00466479|alpha one agonists|alpha one agonists
742171|NCT00466479|glaucoma|glaucoma
742172|NCT00466479|visual field|visual field
742173|NCT00466466|Small-Cell Lung Cancer|small-cell lung cancer
742174|NCT00466466|SCLC|sclc
742175|NCT00466466|Advanced Lung Cancer|advanced lung cancer
742176|NCT00466466|RAD|rad
742177|NCT00466466|RAD001|rad001
742178|NCT00466466|Chemotherapy|chemotherapy
742179|NCT00466466|Cisplatin|cisplatin
742180|NCT00466466|Etoposide|etoposide
742181|NCT00466375|hemangioma|hemangioma
742182|NCT00466375|vascular anomaly|vascular anomaly
742183|NCT00466375|infantile hemangioma|infantile hemangioma
742184|NCT00466362|Obesity|obesity
742185|NCT00466362|Diabetes|diabetes
742186|NCT00466362|Weight|weight
742187|NCT00466362|Lifestyle|lifestyle
742188|NCT00466362|Follow up|follow up
742189|NCT00466349|SMA Type I|sma type i
742190|NCT00466349|SMA Type II|sma type ii
742191|NCT00466349|SMA Type III|sma type iii
742192|NCT00466349|SMN|smn
742193|NCT00466349|Werdnig-Hoffman Disease|werdnig-hoffman disease
742194|NCT00466349|Spinal Muscular Atrophy|spinal muscular atrophy
742195|NCT00466349|Registry|registry
742196|NCT00466349|SMA Type IV|sma type iv
742197|NCT00466336|Chronic hepatitis C|chronic hepatitis c
742198|NCT00466336|Non-invasive diagnosis|non-invasive diagnosis
742199|NCT00466336|Duplex Doppler ultrasonography|duplex doppler ultrasonography
742200|NCT00466336|Biochemical indices|biochemical indices
742201|NCT00466336|Hepatic fibrosis|hepatic fibrosis
742202|NCT00466336|Cirrhosis|cirrhosis
742203|NCT00466323|Mental Illness|mental illness
742204|NCT00466323|Schizophrenia|schizophrenia
742205|NCT00466323|Education|education
742206|NCT00466323|Family member treatment|family member treatment
742207|NCT00466323|Active psychoses|active psychoses
742208|NCT00466310|Schizophrenia|schizophrenia
742209|NCT00466310|Metabolomics|metabolomics
742210|NCT00466297|Interprofessional|interprofessional
742211|NCT00466297|Collaboration|collaboration
742212|NCT00466297|Teamwork|teamwork
742213|NCT00466297|General internal medicine|general internal medicine
742214|NCT00466297|Cluster randomized|cluster randomized
742215|NCT00466271|Chronic hepatitis C|chronic hepatitis c
742216|NCT00466271|Persistently normal alanine aminotransferase levels|persistently normal alanine aminotransferase levels
742217|NCT00466271|Hepatic fibrosis|hepatic fibrosis
742218|NCT00466271|Non-invasive diagnosis|non-invasive diagnosis
742219|NCT00466271|Splenic arterial pulsatility index|splenic arterial pulsatility index
742605|NCT00464724|PFC|pfc
742220|NCT00466258|Diffuse large B cell lymphoma|diffuse large b cell lymphoma
742221|NCT00466258|HIV|hiv
742222|NCT00466258|R-CHOP|r-chop
742223|NCT00466258|Highly active antiretroviral therapy|highly active antiretroviral therapy
742224|NCT00466258|Treatment Experienced|treatment experienced
742225|NCT00466245|MVA Vaccine|mva vaccine
742226|NCT00466232|Small Cell|small cell
742227|NCT00466232|Lung Cancer|lung cancer
742228|NCT00466232|Treatment|treatment
742229|NCT00466219|Presence of HCV RNA in serum|presence of hcv rna in serum
742230|NCT00466219|Absence of graft rejection|absence of graft rejection
742231|NCT00466219|Recurrent hepatitis C after liver transplantation|recurrent hepatitis c after liver transplantation
742232|NCT00466206|pectus excavatum|pectus excavatum
742233|NCT00466206|magnetic alteration|magnetic alteration
742234|NCT00466206|chest wall deformity|chest wall deformity
742235|NCT00466193|Insomnia|insomnia
742236|NCT00466180|Once-a-day|once-a-day
742237|NCT00466180|Adherence|adherence
742238|NCT00466180|Nevirapine|nevirapine
742239|NCT00466180|Patient noncompliance|patient noncompliance
742240|NCT00466180|Administration and dosage|administration and dosage
742241|NCT00466180|Treatment Experienced|treatment experienced
742242|NCT00466154|Aspirin resistance|aspirin resistance
742243|NCT00466154|Platelet activation|platelet activation
742244|NCT00466154|Hypercholesterolemia|hypercholesterolemia
742245|NCT00466128|fetal membranes, preterm rupture|fetal membranes, preterm rupture
742246|NCT00466128|preterm rupture|preterm rupture
742247|NCT00466128|PPROM|pprom
742248|NCT00466102|Breast Cancer|breast cancer
742249|NCT00466102|Bone metastases as only metastatic site|bone metastases as only metastatic site
742250|NCT00466102|Breast cancer, HER2 negative|breast cancer, her2 negative
742251|NCT00466102|Bone metastasis as only metastatic site|bone metastasis as only metastatic site
742252|NCT00466102|Pretreated with endocrine therapy|pretreated with endocrine therapy
742253|NCT00466102|Up to one previous chemotherapy|up to one previous chemotherapy
742254|NCT00466102|Previous treatment with bisphosphonates allowed|previous treatment with bisphosphonates allowed
742255|NCT00466089|NSCLC, lung cancer|nsclc, lung cancer
742256|NCT00466089|Patients with localized-unresectable (IA-IIIB) non-small cell lung cancer non susceptible for chemotherapy treatment.|patients with localized-unresectable (ia-iiib) non-small cell lung cancer non susceptible for chemotherapy treatment.
742257|NCT00466076|Drusen|drusen
742259|NCT00466076|Dry form of Age related Macular Degeneration|dry form of age related macular degeneration
742260|NCT00466063|Iron overload|iron overload
742261|NCT00466063|children|children
742262|NCT00466063|deferasirox|deferasirox
742263|NCT00466063|Transfusion-dependent anemia|transfusion-dependent anemia
742264|NCT00466050|plaque rupture,|plaque rupture,
742265|NCT00466050|acute coronary thrombose,|acute coronary thrombose,
742266|NCT00466050|coronary angiography,|coronary angiography,
742267|NCT00466050|IVUS|ivus
742268|NCT00466037|Rheumatoid|rheumatoid
742269|NCT00466037|rituximab|rituximab
742270|NCT00466037|influenza|influenza
742271|NCT00466024|Asthma|asthma
742272|NCT00466024|persistent|persistent
742273|NCT00466024|children|children
742274|NCT00466024|particulates|particulates
742275|NCT00466024|ETS|ets
742276|NCT00465998|Ultrasound|ultrasound
742277|NCT00465998|Induced labor|induced labor
742278|NCT00465998|Cervical length|cervical length
742279|NCT00465998|Engagement of fetal head|engagement of fetal head
742280|NCT00465998|Occiput posterior|occiput posterior
742281|NCT00465998|Outcome of labor|outcome of labor
742282|NCT00465985|Muckle-Wells Syndrome|muckle-wells syndrome
742283|NCT00465985|children|children
742284|NCT00465985|systemic autoinflammatory disease|systemic autoinflammatory disease
742285|NCT00465985|CIAS-1 gene|cias-1 gene
742286|NCT00465985|NALP-3|nalp-3
742287|NCT00465985|ACZ885|acz885
742288|NCT00465985|human monoclonal anti-human interleukin-1beta (IL-1beta)|human monoclonal anti-human interleukin-1beta (il-1beta)
742289|NCT00465985|antibody|antibody
742290|NCT00465985|autosomal dominant|autosomal dominant
742291|NCT00465985|familial autoinflammatory syndrome|familial autoinflammatory syndrome
742292|NCT00465972|HIV|hiv
742293|NCT00465972|Insomnia|insomnia
742294|NCT00465972|Cytokines|cytokines
742295|NCT00465972|Adherence|adherence
742296|NCT00465959|COPD|copd
742297|NCT00465946|Salt supplementation|salt supplementation
742298|NCT00465946|Vasovagal syncope|vasovagal syncope
742299|NCT00465946|Orthostatic tolerance|orthostatic tolerance
742300|NCT00465946|Healthy volunteers|healthy volunteers
742301|NCT00465933|Acute Promyelocytic Leukemia|acute promyelocytic leukemia
742302|NCT00465933|AIDA|aida
742303|NCT00465920|schizophrenia|schizophrenia
742304|NCT00465920|cognitive behavioural therapy|cognitive behavioural therapy
742305|NCT00465920|early onset psychosis|early onset psychosis
742306|NCT00465920|Psychotic disorders (schizophrenia, schizoaffective disorder, delusional disorder, schizophreniform disorder according to DSM IV) in adolescents|psychotic disorders (schizophrenia, schizoaffective disorder, delusional disorder, schizophreniform disorder according to dsm iv) in adolescents
742307|NCT00465907|lung cancer with malignant pleural effusion|lung cancer with malignant pleural effusion
742308|NCT00465894|overactive bladder|overactive bladder
742309|NCT00465894|urge leakage|urge leakage
742310|NCT00465894|nightime urination|nightime urination
742312|NCT00465894|urinary frequency|urinary frequency
742313|NCT00465881|Diabetes|diabetes
742314|NCT00465881|CGM|cgm
742315|NCT00465868|Acute Myocardial Infarction|acute myocardial infarction
742316|NCT00465868|Coronary Revascularization|coronary revascularization
742317|NCT00465868|Microvascular Obstruction|microvascular obstruction
742318|NCT00465868|Cardiac MR|cardiac mr
742319|NCT00465868|Collagen Turnover|collagen turnover
742320|NCT00465868|Heart failure, post-mi|heart failure, post-mi
742321|NCT00465855|Carbon monoxide poisoning|carbon monoxide poisoning
742322|NCT00465855|Hyperbaric oxygen therapy|hyperbaric oxygen therapy
742323|NCT00465855|Randomized controlled trial|randomized controlled trial
742324|NCT00465855|Clinical investigation|clinical investigation
742325|NCT00465842|Hepatitis|hepatitis
742326|NCT00465842|Liver Cirrhosis|liver cirrhosis
742327|NCT00465842|HCC|hcc
742328|NCT00465829|Obesity|obesity
742329|NCT00465816|non-inferiority|non-inferiority
742330|NCT00465816|adolescents|adolescents
742331|NCT00465816|meningococcal vaccine|meningococcal vaccine
742332|NCT00465803|Open-angle glaucoma or ocular hypertension|open-angle glaucoma or ocular hypertension
742333|NCT00465790|biomarkers|biomarkers
742334|NCT00465790|neuroimaging|neuroimaging
742335|NCT00465790|genetics|genetics
742336|NCT00465790|PET|pet
742337|NCT00465790|Genetic and Idiopathic Parkinson|genetic and idiopathic parkinson
742338|NCT00465790|Multiple Systemic Atrophy|multiple systemic atrophy
742339|NCT00465790|Huntington|huntington
742340|NCT00465790|Dopa Responsive Dystonia|dopa responsive dystonia
742341|NCT00465777|malaria|malaria
742342|NCT00465777|mortality|mortality
742343|NCT00465777|hospital|hospital
742344|NCT00465777|incentive|incentive
742345|NCT00465777|personnel|personnel
742346|NCT00465777|paediatric|paediatric
742347|NCT00465764|healthy infants|healthy infants
742348|NCT00465725|Picoplatin|picoplatin
742349|NCT00465725|tumor|tumor
742350|NCT00465725|cancer|cancer
742351|NCT00465725|sarcoma|sarcoma
742352|NCT00465725|neoplasm|neoplasm
742353|NCT00465725|advanced|advanced
742354|NCT00465725|platinum|platinum
742355|NCT00465725|chemotherapy|chemotherapy
742356|NCT00465725|Solid Tumor|solid tumor
742740|NCT00464230|Pain|pain
742357|NCT00465712|transabdominal amnioinfusion|transabdominal amnioinfusion
742358|NCT00465712|external cephalic version|external cephalic version
742359|NCT00465712|breech presentation|breech presentation
742360|NCT00465699|Eczema|eczema
742361|NCT00465699|Pediatric|pediatric
742362|NCT00465699|Vitamin B12|vitamin b12
742363|NCT00465686|handwriting|handwriting
742364|NCT00465686|child|child
742365|NCT00465686|primary school|primary school
742366|NCT00465686|posture|posture
742367|NCT00465686|assistive device|assistive device
742368|NCT00465673|breast cancer|breast cancer
742369|NCT00465673|brain metastatsis|brain metastatsis
742370|NCT00465673|Lipo-Dox|lipo-dox
742371|NCT00465660|Osteoarthritis|osteoarthritis
742372|NCT00465660|Cartilage|cartilage
742373|NCT00465660|Exercise|exercise
742374|NCT00465660|Progressive Resistance Training|progressive resistance training
742375|NCT00465647|Postoperative pain|postoperative pain
742376|NCT00465647|Hydromorphone oral solution|hydromorphone oral solution
742377|NCT00465647|opioid|opioid
742378|NCT00465647|pharmacokinetics|pharmacokinetics
742379|NCT00465647|pharmacodynamics|pharmacodynamics
742380|NCT00465634|Screening|screening
742381|NCT00465634|uterine artery Doppler|uterine artery doppler
742382|NCT00465634|HELLP syndrome|hellp syndrome
742383|NCT00465634|abruption|abruption
742384|NCT00465621|Open-angle glaucoma|open-angle glaucoma
742385|NCT00465621|ocular hypertension|ocular hypertension
742386|NCT00465608|adults|adults
742387|NCT00465608|PTSD|ptsd
742388|NCT00465608|trauma|trauma
742390|NCT00465608|propranolol|propranolol
742391|NCT00465608|reconsolidation|reconsolidation
742392|NCT00465608|Post traumatic stress disorder|post traumatic stress disorder
742393|NCT00465608|chronic form|chronic form
742394|NCT00465608|PTSD (Post-Traumatic Stress Disorder)|ptsd (post-traumatic stress disorder)
742395|NCT00465582|carriage|carriage
742396|NCT00465582|Neisseria meningitidis|neisseria meningitidis
742397|NCT00465582|risk factors|risk factors
742398|NCT00465569|Food Allergy|food allergy
742399|NCT00465569|Oral Immunotherapy|oral immunotherapy
742400|NCT00465569|Immunoglobulin E|immunoglobulin e
742401|NCT00465543|Nasal polyposis|nasal polyposis
742402|NCT00465543|Mint tea|mint tea
742403|NCT00465543|Double-blind|double-blind
742404|NCT00465543|Placebo-controlled|placebo-controlled
742405|NCT00465543|Crossover|crossover
742406|NCT00465517|Partial onset seizures|partial onset seizures
742407|NCT00465517|Complex-partial seizures|complex-partial seizures
742408|NCT00465517|Anticonvulsant|anticonvulsant
742409|NCT00465517|Partial seizures|partial seizures
742410|NCT00465517|Catamenial epilepsy|catamenial epilepsy
742411|NCT00465504|local analgesia|local analgesia
742412|NCT00465504|intra-articular corticosteroid injection|intra-articular corticosteroid injection
742413|NCT00465504|iontophoresis|iontophoresis
742514|NCT00465101|Benign Prostatic Hyperplasia|benign prostatic hyperplasia
742414|NCT00465504|Local analgesia for intra-articular corticosteroid injection|local analgesia for intra-articular corticosteroid injection
742415|NCT00465491|refractory|refractory
742416|NCT00465491|chemotherapy|chemotherapy
742417|NCT00465491|progressed|progressed
742418|NCT00465491|second-line treatment|second-line treatment
742419|NCT00465491|small cell lung cancer|small cell lung cancer
742420|NCT00465491|best supportive care|best supportive care
742421|NCT00465491|picoplatin|picoplatin
742422|NCT00465478|Diabetes Mellitus|diabetes mellitus
742423|NCT00465478|Bone Marros Mononuclear Cells|bone marros mononuclear cells
742424|NCT00465478|Transplantation|transplantation
742425|NCT00465465|Tuberculosis|tuberculosis
742426|NCT00465465|TB|tb
742427|NCT00465465|MVA 85A|mva 85a
742428|NCT00465465|BCG|bcg
742429|NCT00465439|femoral artery sheath|femoral artery sheath
742430|NCT00465439|vasovagal reaction|vasovagal reaction
742431|NCT00465439|pain|pain
742432|NCT00465439|perception|perception
742433|NCT00465426|HIV Infection|hiv infection
742434|NCT00465426|Cardiovascular Disease|cardiovascular disease
742435|NCT00465426|Antiretroviral Therapy|antiretroviral therapy
742436|NCT00465426|Inflammatory Markers|inflammatory markers
742437|NCT00465426|Treatment Experienced|treatment experienced
742438|NCT00465413|metered-dose inhalers (MDI)|metered-dose inhalers (mdi)
742439|NCT00465413|forced expiratory volume in 1 second (FEV1)|forced expiratory volume in 1 second (fev1)
742440|NCT00465413|forced expiratory flow rate (FEF25-75%)|forced expiratory flow rate (fef25-75%)
742441|NCT00465400|exudative age-related macular degeneration (AMD)|exudative age-related macular degeneration (amd)
742442|NCT00465400|non-exudative age-related macular degeneration (AMD)|non-exudative age-related macular degeneration (amd)
742443|NCT00465400|oxidative stress|oxidative stress
742444|NCT00465400|photodynamic therapy|photodynamic therapy
742445|NCT00465374|ARDS|ards
742446|NCT00465374|Pressure/time curve|pressure/time curve
742447|NCT00465374|Stress Index|stress index
742448|NCT00465361|Growth and Development|growth and development
742449|NCT00465361|Child Development|child development
742450|NCT00465361|Developmental Surveillance|developmental surveillance
742451|NCT00465361|Medical Education|medical education
742452|NCT00465361|Internship and Residency|internship and residency
742453|NCT00465348|normal tension glaucoma|normal tension glaucoma
742455|NCT00465335|computed tomography|computed tomography
742456|NCT00465335|stress test|stress test
742457|NCT00465335|equivocal|equivocal
742458|NCT00465335|catheterization|catheterization
742459|NCT00465309|Respiratory Insufficiency|respiratory insufficiency
742460|NCT00465309|CO2 removal|co2 removal
742461|NCT00465309|protective ventilation|protective ventilation
742462|NCT00465309|ARDS|ards
742463|NCT00466388|dry mouth|dry mouth
742464|NCT00465283|Donepezil, ECT, Memory Disfunction|donepezil, ect, memory disfunction
742465|NCT00465270|Cryptogenic|cryptogenic
742466|NCT00465270|Stroke|stroke
742467|NCT00465270|PFO|pfo
742468|NCT00465270|Patent foramen ovale|patent foramen ovale
742469|NCT00465270|AMPLATZER|amplatzer
742470|NCT00465270|Occluder|occluder
742471|NCT00465244|Prehospital and ED seizures|prehospital and ed seizures
742472|NCT00465231|Induction of labour|induction of labour
742473|NCT00465231|Bupivacaine consumption|bupivacaine consumption
742474|NCT00465231|Prevention|prevention
742475|NCT00465218|Bioprosthesis|bioprosthesis
742476|NCT00465218|Thrombosis|thrombosis
742477|NCT00465218|Cerebral emboli|cerebral emboli
742478|NCT00465218|Transcranial Doppler|transcranial doppler
742479|NCT00465218|Platelet function tests|platelet function tests
742480|NCT00465205|HIV infection|hiv infection
742481|NCT00465205|HIV Shedding|hiv shedding
742482|NCT00465205|HSV suppression|hsv suppression
742483|NCT00465205|Co-infected|co-infected
742484|NCT00465205|Women|women
742485|NCT00465205|Reactivation|reactivation
742486|NCT00465205|Valacyclovir|valacyclovir
742487|NCT00465205|Treatment Naive|treatment naive
742488|NCT00465179|Non-Clear Cell Renal Carcinoma|non-clear cell renal carcinoma
742489|NCT00465179|Non-clear cell renal cell cancer|non-clear cell renal cell cancer
742490|NCT00465179|Renal Cell Cancer|renal cell cancer
742491|NCT00465179|Kidney Cancer|kidney cancer
742492|NCT00465179|Papillary|papillary
742493|NCT00465179|Chromophobe|chromophobe
742494|NCT00465179|Collecting duct carcinoma|collecting duct carcinoma
742495|NCT00465179|CDC|cdc
742496|NCT00465179|Renal medullary carcinoma|renal medullary carcinoma
742497|NCT00465179|RMC|rmc
742498|NCT00465179|Sunitinib Malate|sunitinib malate
742499|NCT00465179|Sutent|sutent
742500|NCT00465179|SU011248|su011248
742501|NCT00465166|Accidental dural puncture|accidental dural puncture
742502|NCT00465166|Labour epidural|labour epidural
742503|NCT00465166|Ultrasound|ultrasound
742504|NCT00465166|Ligamentum flavum|ligamentum flavum
742505|NCT00465153|Inflammation|inflammation
742506|NCT00465153|cytokines|cytokines
742507|NCT00465153|sarcopenia|sarcopenia
742508|NCT00465153|strength|strength
742509|NCT00465153|muscle|muscle
742510|NCT00465153|aging|aging
742511|NCT00465153|exercise|exercise
742512|NCT00465114|Preeclampsia|preeclampsia
742513|NCT00465114|Hemodynamic monitoring|hemodynamic monitoring
742515|NCT00465101|Transurethral resection of the prostate|transurethral resection of the prostate
742516|NCT00465101|Lower urinary tract symptoms|lower urinary tract symptoms
742517|NCT00465101|GreenLight|greenlight
742518|NCT00465101|Laserscope|laserscope
742519|NCT00465101|Photoselective vaporization of the prostate|photoselective vaporization of the prostate
742520|NCT00465101|enlarged prostate|enlarged prostate
742521|NCT00465062|Lysosomal Disease|lysosomal disease
742522|NCT00465062|Lipids|lipids
742523|NCT00465062|B Lymphocytes|b lymphocytes
742524|NCT00465062|Brain Damage|brain damage
742525|NCT00465062|Gaucher Disease|gaucher disease
742526|NCT00465062|GD|gd
742527|NCT00465049|abscess, primary closure, secondary closure|abscess, primary closure, secondary closure
742528|NCT00465036|fat absorption|fat absorption
742529|NCT00465036|fibres|fibres
742530|NCT00465023|proton beam irradiation|proton beam irradiation
742531|NCT00465023|liver cancer|liver cancer
742532|NCT00465010|Adolescence|adolescence
742533|NCT00465010|Sexual health|sexual health
742534|NCT00465010|Communication|communication
742535|NCT00465010|Parenting|parenting
742536|NCT00464997|methotrexate aspirin pharmacokinetics|methotrexate aspirin pharmacokinetics
742537|NCT00464984|Weight loss|weight loss
742538|NCT00464984|Physical fitness|physical fitness
742539|NCT00464984|Quality of life|quality of life
742540|NCT00464958|Fatigue|fatigue
742541|NCT00464958|Spasticity|spasticity
742542|NCT00464958|Sublingual Tizanidine|sublingual tizanidine
742543|NCT00464958|Epworth Sleepiness Scale|epworth sleepiness scale
742544|NCT00464958|Fatigue Severity Scale|fatigue severity scale
742545|NCT00464932|COPD|copd
742546|NCT00464932|Vasoactive Intestinal Peptide|vasoactive intestinal peptide
742547|NCT00464932|Lung Function|lung function
742548|NCT00464919|Advance, hepatocellular carcinoma|advance, hepatocellular carcinoma
742549|NCT00464893|gastric cancer|gastric cancer
742550|NCT00464893|catumaxomab|catumaxomab
742551|NCT00464893|neoadjuvant chemotherapy|neoadjuvant chemotherapy
742552|NCT00464893|phase II|phase ii
742553|NCT00464893|interoperative|interoperative
742554|NCT00464893|trifunctional antibody|trifunctional antibody
742555|NCT00464880|Placebo-controlled study|placebo-controlled study
744485|NCT00458042|Remodulin|remodulin
742556|NCT00464880|assess the renoprotective effect of renin inhibition|assess the renoprotective effect of renin inhibition
742557|NCT00464880|Aliskiren as an alternative to irbesartan|aliskiren as an alternative to irbesartan
742558|NCT00464880|Type 2 diabetes patients|type 2 diabetes patients
742559|NCT00464880|incipient/overt diabetic nephropathy|incipient/overt diabetic nephropathy
742560|NCT00464867|Bifidobacterium breve|bifidobacterium breve
742561|NCT00464867|oral whole cell cholera vaccine|oral whole cell cholera vaccine
742562|NCT00464867|immunogenicity|immunogenicity
742563|NCT00464867|Supplementation with probiotic improves vibriocidal antibody response in 2-5 year old childern given the killed oral cholera vaccine|supplementation with probiotic improves vibriocidal antibody response in 2-5 year old childern given the killed oral cholera vaccine
742564|NCT00464867|Supplementation with probiotics results in improving the ASC responses to CT and LPS of V. cholerae O1|supplementation with probiotics results in improving the asc responses to ct and lps of v. cholerae o1
742565|NCT00464854|Glucose control|glucose control
742566|NCT00464854|Subcutaneous insulin treatment|subcutaneous insulin treatment
742567|NCT00464854|Multiple daily injections|multiple daily injections
742568|NCT00464841|Tsui Test|tsui test
742569|NCT00464841|Combined Spinal Epidural|combined spinal epidural
742570|NCT00464841|Labour|labour
742571|NCT00464828|Central venous cannulation|central venous cannulation
742572|NCT00464828|Internal jugular vein|internal jugular vein
742573|NCT00464828|Ultrasound|ultrasound
742574|NCT00464828|Obstetrics|obstetrics
742575|NCT00464815|immunogenicity|immunogenicity
742576|NCT00464815|safety|safety
742577|NCT00464815|meningococcal vaccine|meningococcal vaccine
742578|NCT00464802|healthy|healthy
742579|NCT00464802|safety|safety
742580|NCT00464789|Postmenopausal|postmenopausal
742581|NCT00464776|Randomized|randomized
742582|NCT00464776|double-blind|double-blind
742583|NCT00464776|cross-over|cross-over
742584|NCT00464776|4-period|4-period
742585|NCT00464776|4 treatment|4 treatment
742586|NCT00464776|within-subject placebo-controlled study|within-subject placebo-controlled study
742829|NCT00464061|Sleep problems|sleep problems
742587|NCT00464776|assess optimal renoprotective dose of Aliskiren|assess optimal renoprotective dose of aliskiren
742588|NCT00464776|hypertensive type 2 diabetes patients|hypertensive type 2 diabetes patients
742589|NCT00464776|incipient or overt nephropathy|incipient or overt nephropathy
742590|NCT00464763|Mental Health|mental health
742591|NCT00464763|Neurological Disease|neurological disease
742592|NCT00464763|Heart Valve Repair Surgery|heart valve repair surgery
742593|NCT00464750|Cardiac output|cardiac output
742594|NCT00464750|Thermodilution|thermodilution
742595|NCT00464737|Fibromyalgia Syndrome|fibromyalgia syndrome
742596|NCT00464737|Rotigotine|rotigotine
742597|NCT00464737|Neupro|neupro
742598|NCT00464724|Prostate Cancer|prostate cancer
742599|NCT00464724|Magnetic Resonance Spectroscopic Imaging|magnetic resonance spectroscopic imaging
742600|NCT00464724|Perfluorocarbon Compound|perfluorocarbon compound
742601|NCT00464724|AIR-MRSI|air-mrsi
742602|NCT00464724|PFC-MRSI|pfc-mrsi
742609|NCT00464698|Obsessive Compulsive Disorder|obsessive compulsive disorder
742610|NCT00464698|Obsessions|obsessions
742611|NCT00464698|Compulsions|compulsions
742612|NCT00464698|Duloxetine|duloxetine
742613|NCT00464698|Cymbalta|cymbalta
742614|NCT00464672|Influenza, Egg-Derived, Healthy Children, Healthy Adolescents, Healthy Adults, Safety, Immunogenicity, Trivalent, Inactivated, Vaccination|influenza, egg-derived, healthy children, healthy adolescents, healthy adults, safety, immunogenicity, trivalent, inactivated, vaccination
742615|NCT00464659|Sleep apnea obstructive syndrome (SAOS)|sleep apnea obstructive syndrome (saos)
742616|NCT00464659|memory deficit|memory deficit
742617|NCT00464659|Continuous Positive Airway Pression (CPAP)|continuous positive airway pression (cpap)
742618|NCT00464659|Sham CPAP|sham cpap
742619|NCT00464646|NSABP|nsabp
742620|NCT00464646|Epirubicin|epirubicin
742621|NCT00464646|Cyclophosphamide|cyclophosphamide
742622|NCT00464646|Docetaxel|docetaxel
742623|NCT00464646|Trastuzumab|trastuzumab
742624|NCT00464646|Bevacizumab|bevacizumab
742625|NCT00464646|Neoadjuvant Therapy|neoadjuvant therapy
742626|NCT00464646|HER2|her2
742627|NCT00464646|Locally Advanced Breast Cancer|locally advanced breast cancer
742628|NCT00464646|Adjuvant Therapy|adjuvant therapy
742629|NCT00464646|Pathologic Stage III Breast Cancer|pathologic stage iii breast cancer
742630|NCT00464646|Inflammatory Breast Cancer|inflammatory breast cancer
742631|NCT00464633|CLL|cll
742632|NCT00464633|PLL|pll
742633|NCT00464633|flavopiridol|flavopiridol
742634|NCT00464620|Dasatinib|dasatinib
742635|NCT00464620|Rhabdomyosarcoma|rhabdomyosarcoma
742636|NCT00464620|Malignant peripheral nerve sheath tumor|malignant peripheral nerve sheath tumor
742637|NCT00464620|Chondrosarcoma|chondrosarcoma
742638|NCT00464620|Ewing's|ewing's
742639|NCT00464620|Alveolar soft part sarcoma (ASPS)|alveolar soft part sarcoma (asps)
742640|NCT00464620|Chordoma|chordoma
742641|NCT00464620|Epithelioid sarcoma|epithelioid sarcoma
742642|NCT00464620|Giant cell tumor of bone|giant cell tumor of bone
742643|NCT00464620|Hemangiopericytoma/solitary fibrous tumor|hemangiopericytoma/solitary fibrous tumor
742644|NCT00464620|Gastrointestinal Stromal Tumor (GIST)|gastrointestinal stromal tumor (gist)
742645|NCT00464594|Japan Early Diabetes Intervention Study|japan early diabetes intervention study
742646|NCT00464581|non-ischemic retinopathy|non-ischemic retinopathy
742647|NCT00464568|Seasonal allergic rhinitis,|seasonal allergic rhinitis,
742648|NCT00464568|hayfever|hayfever
742649|NCT00464555|Allogeneic Islets|allogeneic islets
742650|NCT00464555|Allogeneic Islet Transplantation|allogeneic islet transplantation
742651|NCT00464555|Type 1 diabetes mellitus|type 1 diabetes mellitus
742652|NCT00464555|Type 1 diabetes|type 1 diabetes
742653|NCT00464555|T1D|t1d
742654|NCT00464555|T1DM|t1dm
742655|NCT00464555|Insulin dependence|insulin dependence
742656|NCT00464555|Hypoglycemia unawareness in T1D|hypoglycemia unawareness in t1d
742657|NCT00464555|Islet transplant|islet transplant
742658|NCT00464555|Islet transplantation|islet transplantation
742659|NCT00464555|Islet graft|islet graft
742660|NCT00464542|herpes simplex virus|herpes simplex virus
742661|NCT00464529|blood glucose|blood glucose
742662|NCT00464529|hyperglycemia|hyperglycemia
742663|NCT00464529|hypoglycemia|hypoglycemia
742664|NCT00464529|Perioperative care|perioperative care
742665|NCT00464529|inpatient|inpatient
742666|NCT00464516|Breast cancer (Estrogen Receptor positive)|breast cancer (estrogen receptor positive)
742667|NCT00464503|statins|statins
742668|NCT00464503|proteinuria|proteinuria
742669|NCT00464503|proteomic analysis|proteomic analysis
742670|NCT00464503|healthy volunteers|healthy volunteers
742671|NCT00464490|Weaning|weaning
742672|NCT00464490|Extuvation|extuvation
742673|NCT00464490|Dexmedetomidine|dexmedetomidine
742674|NCT00464477|Autism|autism
742675|NCT00464477|Autistic disorder|autistic disorder
742676|NCT00464477|Pervasive developmental disorder|pervasive developmental disorder
742677|NCT00464477|Asperger syndrome|asperger syndrome
742678|NCT00464477|Childhood disintegrative disorder|childhood disintegrative disorder
742679|NCT00464477|Rett syndrome|rett syndrome
742680|NCT00464464|Parkinson's disease|parkinson's disease
742681|NCT00464464|PD|pd
742682|NCT00464464|depression|depression
742683|NCT00464464|cognitive-behavioral therapy|cognitive-behavioral therapy
742684|NCT00464464|social support|social support
742685|NCT00464425|Electroacupuncture|electroacupuncture
742686|NCT00464425|Postoperative ileus|postoperative ileus
742687|NCT00464425|Colorectal surgery|colorectal surgery
742688|NCT00464425|Laparoscopic surgery|laparoscopic surgery
742689|NCT00464425|Randomised trial|randomised trial
742690|NCT00464412|Osteoporosis|osteoporosis
742691|NCT00464412|Knowledge|knowledge
742692|NCT00464412|Beliefs|beliefs
742693|NCT00464412|Education|education
742694|NCT00464412|Women|women
742695|NCT00464399|De novo renal transplantation|de novo renal transplantation
742696|NCT00464399|CNI-free protocol|cni-free protocol
742697|NCT00464399|adults|adults
742698|NCT00464399|everolimus|everolimus
742699|NCT00464399|rejections|rejections
742700|NCT00464386|Severe burns|severe burns
742701|NCT00464386|Severe Trauma|severe trauma
742702|NCT00464386|Closed loop insulin|closed loop insulin
742703|NCT00464386|continuous glucose monitoring|continuous glucose monitoring
742705|NCT00464373|Chronic Prostatitis with Chronic Pelvic Pain Syndrome|chronic prostatitis with chronic pelvic pain syndrome
742706|NCT00464373|Botulinum Toxin Type A|botulinum toxin type a
742707|NCT00464373|Drug therapy|drug therapy
742830|NCT00464061|Insomnia|insomnia
742708|NCT00464373|Injections, intramuscular|injections, intramuscular
742709|NCT00464347|AMD|amd
742710|NCT00464347|wet AMD|wet amd
742711|NCT00464347|verteporfin PDT|verteporfin pdt
742712|NCT00464347|Avastin|avastin
742713|NCT00464347|TAC-PF|tac-pf
742714|NCT00464308|Gastroesophageal Reflux|gastroesophageal reflux
742715|NCT00464308|Heartburn|heartburn
742716|NCT00464308|Proton pump inhibitor|proton pump inhibitor
742717|NCT00464308|GORD|gord
742718|NCT00464295|Hepatocellular Carcinoma|hepatocellular carcinoma
742719|NCT00464295|Phase 2 Trial|phase 2 trial
742720|NCT00464295|Capecitabine|capecitabine
742721|NCT00464295|Treatment Efficacy|treatment efficacy
742722|NCT00464282|Fluorine–18-α–methyltyrosine,|fluorine–18-α–methyltyrosine,
742723|NCT00464282|Positron emission tomography,|positron emission tomography,
742724|NCT00464282|Fluorodeoxyglucose|fluorodeoxyglucose
742725|NCT00464282|Lung cancer,|lung cancer,
742726|NCT00464282|Amino acid transportor 1,|amino acid transportor 1,
742727|NCT00464282|Ki-67|ki-67
742728|NCT00464282|Proven or suspected non-small cell lung cancer were enrolled in the study|proven or suspected non-small cell lung cancer were enrolled in the study
742729|NCT00464269|Epilepsy|epilepsy
742730|NCT00464269|Brivaracetam|brivaracetam
742731|NCT00464269|Partial Onset Seizures, Adolescents & Adults|partial onset seizures, adolescents & adults
742732|NCT00464256|abstinence|abstinence
742733|NCT00464243|Sleep problems|sleep problems
742734|NCT00464243|Insomnia|insomnia
742735|NCT00464243|Sleeplessness|sleeplessness
742736|NCT00464243|Polysomnographic|polysomnographic
742737|NCT00464230|Displaced Femoral Neck Fractures|displaced femoral neck fractures
742738|NCT00464230|Treatment|treatment
742739|NCT00464230|Function|function
742741|NCT00464230|Quality of life|quality of life
742742|NCT00464230|Complications|complications
742743|NCT00464230|Reoperations|reoperations
742744|NCT00464230|Internal Fixation|internal fixation
742745|NCT00464230|Hemiarthroplasty|hemiarthroplasty
742746|NCT00464230|Activities of Daily Living|activities of daily living
742747|NCT00464217|Acute Myeloblastic Leukaemia|acute myeloblastic leukaemia
742748|NCT00464191|bipolar depression|bipolar depression
742749|NCT00464191|SSRI|ssri
742750|NCT00464191|escitalopram|escitalopram
742751|NCT00464191|bipolar disorder|bipolar disorder
742752|NCT00464191|antidepressant|antidepressant
742753|NCT00464191|treatment trial|treatment trial
742754|NCT00464191|RCT|rct
742755|NCT00464178|multiple myeloma|multiple myeloma
742756|NCT00464178|myeloma|myeloma
742757|NCT00464178|relapsed myeloma|relapsed myeloma
742758|NCT00464178|refractory myeloma|refractory myeloma
742759|NCT00464178|relapsed, refractory myeloma|relapsed, refractory myeloma
742760|NCT00464178|relapsed, refractory multiple myeloma|relapsed, refractory multiple myeloma
742761|NCT00464178|refractory multiple myeloma|refractory multiple myeloma
742762|NCT00464178|relapsed multiple myeloma|relapsed multiple myeloma
742763|NCT00464178|B lymphoid malignancies|b lymphoid malignancies
742764|NCT00464178|Myeloma, Plasma-Cell|myeloma, plasma-cell
742765|NCT00464178|Myeloma Proteins|myeloma proteins
742766|NCT00464178|hnRNP A1|hnrnp a1
742767|NCT00464178|myeloma helix-destabilizing protein, mouse|myeloma helix-destabilizing protein, mouse
742768|NCT00464178|IgC3kappa Jir protein, human|igc3kappa jir protein, human
742769|NCT00464178|gamma 3 myeloma protein Jir, human|gamma 3 myeloma protein jir, human
742770|NCT00464178|M-proteins (Myeloma)|m-proteins (myeloma)
742771|NCT00464178|M315 myeloma protein, mouse|m315 myeloma protein, mouse
742772|NCT00464178|myeloma protein M 315, mouse|myeloma protein m 315, mouse
742773|NCT00464178|McPC603 antibody|mcpc603 antibody
742774|NCT00464178|myeloma protein McPC603 antibody|myeloma protein mcpc603 antibody
742775|NCT00464178|multiple myeloma M-proteins|multiple myeloma m-proteins
742776|NCT00464178|M protein, multiple myeloma|m protein, multiple myeloma
742777|NCT00464178|myeloma cell activator|myeloma cell activator
742778|NCT00464178|myeloma immunoglobulins|myeloma immunoglobulins
742779|NCT00464178|myeloma immunoglobulin M603|myeloma immunoglobulin m603
742780|NCT00464178|myeloma immunoglobulin S15|myeloma immunoglobulin s15
742781|NCT00464178|myeloma protein A48, mouse|myeloma protein a48, mouse
742782|NCT00464178|A48 myeloma protein, mouse|a48 myeloma protein, mouse
742783|NCT00464178|ABPC48 myeloma protein, mouse|abpc48 myeloma protein, mouse
742784|NCT00464178|myeloma protein A 48, mouse|myeloma protein a 48, mouse
742785|NCT00464178|myeloma protein Dob|myeloma protein dob
742786|NCT00464178|myeloma protein M 467|myeloma protein m 467
742787|NCT00464178|myeloma protein M467|myeloma protein m467
742788|NCT00464178|myeloma protein MOPC 141, mouse|myeloma protein mopc 141, mouse
742789|NCT00464178|MOPC141 myeloma protein, mouse|mopc141 myeloma protein, mouse
742790|NCT00464178|myeloma protein MOPC 173|myeloma protein mopc 173
742791|NCT00464178|myeloma protein Rou|myeloma protein rou
742792|NCT00464178|IgA2 myeloma protein Rou|iga2 myeloma protein rou
742793|NCT00464178|myeloma protein TEPC15|myeloma protein tepc15
742794|NCT00464178|myeloma protein T15|myeloma protein t15
742994|NCT00463398|Pain|pain
742795|NCT00464178|myeloma protein TEPC 15|myeloma protein tepc 15
742796|NCT00464178|myeloma protein W3129|myeloma protein w3129
742797|NCT00464178|myeloma protein WIE|myeloma protein wie
742798|NCT00464178|myeloma-associated membrane antigen KMA|myeloma-associated membrane antigen kma
742799|NCT00464178|myeloma antigen KMA|myeloma antigen kma
742800|NCT00464178|MYEOV protein, human|myeov protein, human
742801|NCT00464178|protein 460|protein 460
742802|NCT00464178|myeloma protein MOPC 460|myeloma protein mopc 460
742803|NCT00464178|TRAPPC1 protein, human|trappc1 protein, human
742804|NCT00464178|multiple myeloma protein 2, human|multiple myeloma protein 2, human
742805|NCT00464178|Wis heavy-chain disease protein, human|wis heavy-chain disease protein, human
742806|NCT00464178|myeloma protein Wis, human|myeloma protein wis, human
742807|NCT00464165|abstinence|abstinence
742808|NCT00464139|endometriosis|endometriosis
742809|NCT00464139|prevalence|prevalence
742810|NCT00464139|fertility|fertility
742811|NCT00464139|pain|pain
742812|NCT00464139|ultrasound|ultrasound
742813|NCT00464126|crystalloid|crystalloid
742814|NCT00464126|colloid|colloid
742815|NCT00464126|pediatric|pediatric
742816|NCT00464126|cardiac|cardiac
742817|NCT00464126|resuscitation|resuscitation
742818|NCT00464126|Postoperative|postoperative
742819|NCT00464113|Myeloid Leukemia|myeloid leukemia
742820|NCT00464113|Lymphocytic Leukemia|lymphocytic leukemia
742821|NCT00464113|Ph+ ALL|ph+ all
742822|NCT00464100|Neurodevelopmental outcomes|neurodevelopmental outcomes
742823|NCT00464100|congenital heart disease|congenital heart disease
742824|NCT00464100|NIRS monitoring|nirs monitoring
742825|NCT00464100|hypoxia|hypoxia
742826|NCT00464074|fatigue|fatigue
742827|NCT00464074|Tysabri|tysabri
742828|NCT00464074|cognition|cognition
742831|NCT00464061|Sleeplessness|sleeplessness
742832|NCT00464061|Primary insomnia|primary insomnia
742833|NCT00464061|Insomnia disorder|insomnia disorder
742834|NCT00464035|Obesity|obesity
742835|NCT00464035|Calcium|calcium
742836|NCT00464035|Fat absorption|fat absorption
742837|NCT00464035|Postprandial lipid profile|postprandial lipid profile
742838|NCT00464035|appetite|appetite
742839|NCT00464022|pain, endoscopy|pain, endoscopy
742840|NCT00464022|Pain, endoscopy, randomised trial|pain, endoscopy, randomised trial
742841|NCT00464009|Early childhood caries - ECC|early childhood caries - ecc
742842|NCT00464009|Prevention|prevention
742843|NCT00464009|Continuing medical education|continuing medical education
742844|NCT00464009|Randomized controlled trial|randomized controlled trial
742845|NCT00463996|Ovarian cancer|ovarian cancer
742846|NCT00463996|MRI|mri
742847|NCT00463996|Contrast agent|contrast agent
742848|NCT00463970|Chronic low back pain|chronic low back pain
742849|NCT00463970|Brief cognitive intervention|brief cognitive intervention
742850|NCT00463970|Cognitive behavior therapy|cognitive behavior therapy
742851|NCT00463970|Seal oil|seal oil
742852|NCT00463957|sildenafil|sildenafil
742853|NCT00463957|tadalafil|tadalafil
742854|NCT00463957|phosphodiesterase|phosphodiesterase
742855|NCT00463957|visual persistence|visual persistence
742856|NCT00463957|reaction time|reaction time
742857|NCT00463944|Electronic voting system|electronic voting system
742858|NCT00463931|Schistosomiasis|schistosomiasis
742859|NCT00463931|Soiltransmitted helminthiasis|soiltransmitted helminthiasis
742860|NCT00463931|Community-based volunteer|community-based volunteer
742861|NCT00463931|School based treatment approach|school based treatment approach
742862|NCT00463905|osteoporosis|osteoporosis
742863|NCT00463905|vertebral fractures|vertebral fractures
742864|NCT00463905|randomised controlled trial|randomised controlled trial
742865|NCT00463905|screening|screening
742866|NCT00463892|melanoma|melanoma
742867|NCT00463892|lymph nodes|lymph nodes
742868|NCT00463892|magnetic resonance imaging|magnetic resonance imaging
742869|NCT00463892|screening|screening
742870|NCT00463892|detection|detection
742871|NCT00463879|Schizophrenia|schizophrenia
742872|NCT00463879|Cognition|cognition
742873|NCT00463879|Smoking|smoking
742874|NCT00463879|Galantamine|galantamine
742875|NCT00463879|Nicotine|nicotine
742876|NCT00463879|Cognitive Deficits|cognitive deficits
742877|NCT00463866|Asthma|asthma
742878|NCT00463853|Bone Marrow Cells|bone marrow cells
742879|NCT00463853|Cardiovascular Surgery|cardiovascular surgery
742880|NCT00463853|Coronary Artery Bypass Graft|coronary artery bypass graft
742881|NCT00463853|Phase I Study|phase i study
742882|NCT00463853|Stem Cells|stem cells
742883|NCT00463840|Locally advanced pancreatic cancer|locally advanced pancreatic cancer
742884|NCT00463840|oxaliplatin|oxaliplatin
742885|NCT00463840|chemoradiation|chemoradiation
742886|NCT00463840|5FU|5fu
742887|NCT00463827|asthma|asthma
742888|NCT00463827|smokers|smokers
742889|NCT00463827|statin|statin
742890|NCT00463827|atorvastatin|atorvastatin
742891|NCT00463827|randomised|randomised
742892|NCT00463827|placebo|placebo
742893|NCT00463827|cigarette|cigarette
742894|NCT00463827|blind|blind
742895|NCT00463827|COPD|copd
742896|NCT00463814|Advanced Malignancy|advanced malignancy
742897|NCT00463814|Cancer Eligibility|cancer eligibility
742898|NCT00463814|Malignancy|malignancy
742899|NCT00463801|Complicated Skin and Skin-Structure Infections, Daptomycin, MRSA, Diabetic Foot, Abscess, Cellulitis|complicated skin and skin-structure infections, daptomycin, mrsa, diabetic foot, abscess, cellulitis
742900|NCT00463801|Complicated skin and skin-structure infections|complicated skin and skin-structure infections
742901|NCT00463788|cancer|cancer
742902|NCT00463788|breast|breast
742903|NCT00463788|metastatic|metastatic
742904|NCT00463788|triple negative|triple negative
742905|NCT00463775|Treatment|treatment
742906|NCT00463775|Topiramate|topiramate
742907|NCT00463775|Alcohol Dependence|alcohol dependence
742908|NCT00463775|Borderline Personality Disorder|borderline personality disorder
742909|NCT00463749|primary PCI|primary pci
742910|NCT00463749|nephropathy|nephropathy
742911|NCT00463749|infarct size|infarct size
742912|NCT00463749|infarction|infarction
742913|NCT00463749|ST-elevation myocardial infarction|st-elevation myocardial infarction
742914|NCT00463736|short term tocolysis|short term tocolysis
742915|NCT00463736|preterm premature rupture of membranes|preterm premature rupture of membranes
742916|NCT00463723|penetrating keratoplasty|penetrating keratoplasty
742917|NCT00463723|graft rejection|graft rejection
742918|NCT00463723|immunosuppression|immunosuppression
742919|NCT00463710|MTI, DWI, Avonex, MRI|mti, dwi, avonex, mri
742920|NCT00463697|GW642444,|gw642444,
742921|NCT00463697|magnesium stearate,|magnesium stearate,
742922|NCT00463697|asthmatic patients|asthmatic patients
742923|NCT00463658|Falls|falls
742924|NCT00463658|Home Care|home care
742925|NCT00463658|Aging Population|aging population
742926|NCT00463658|Clinical Effectiveness|clinical effectiveness
742927|NCT00463658|Health Economics|health economics
742928|NCT00463632|schistosomiasis|schistosomiasis
742929|NCT00463632|anaemia|anaemia
742930|NCT00463632|pregnancy|pregnancy
742931|NCT00463593|schistosomiasis|schistosomiasis
742932|NCT00463593|helminthes|helminthes
742933|NCT00463593|anaemia|anaemia
742934|NCT00463580|depression|depression
742935|NCT00463580|TNF-alpha antagonist|tnf-alpha antagonist
742936|NCT00463580|infliximab|infliximab
742937|NCT00463580|treatment resistant depression|treatment resistant depression
742938|NCT00463580|major depressive disorder (MDD)|major depressive disorder (mdd)
742939|NCT00463580|bipolar I disorder|bipolar i disorder
742940|NCT00463580|bipolar II disorder|bipolar ii disorder
742941|NCT00463567|indacaterol|indacaterol
742942|NCT00463567|long acting beta-2 agonist|long acting beta-2 agonist
742943|NCT00463554|Incontinence|incontinence
742944|NCT00463554|Stress Urinary|stress urinary
742945|NCT00463541|Urinary Bladder, Overactive|urinary bladder, overactive
742946|NCT00463541|Urgency|urgency
742947|NCT00463541|VESIcare®|vesicare®
742948|NCT00463541|Solifenacin succinate|solifenacin succinate
742949|NCT00463528|schistosomiasis|schistosomiasis
742950|NCT00463528|gender perspectives|gender perspectives
742951|NCT00463515|Non-Small Cell Lung Cancer|non-small cell lung cancer
742952|NCT00463515|NSCLC|nsclc
742953|NCT00463515|Chemoradiation|chemoradiation
742954|NCT00463515|lung cancer|lung cancer
742955|NCT00463515|induction chemotherapy|induction chemotherapy
742956|NCT00463515|chemo-radiotherapy|chemo-radiotherapy
742957|NCT00463502|The purpose of study was investigated the effect of|the purpose of study was investigated the effect of
742958|NCT00463502|metformin on thyroid hormone metabolism in euthyroid patients|metformin on thyroid hormone metabolism in euthyroid patients
742959|NCT00463502|with type 2 DM. The results revealed significant decreases|with type 2 dm. the results revealed significant decreases
742960|NCT00463502|in TSH and fT4|in tsh and ft4
742961|NCT00463489|lifestyle intervention|lifestyle intervention
742962|NCT00463489|breast|breast
742963|NCT00463489|cancer|cancer
742964|NCT00463489|adjuvant|adjuvant
742965|NCT00463489|letrozole|letrozole
742966|NCT00463489|weight loss|weight loss
742967|NCT00463489|BMI|bmi
742968|NCT00463489|post-menopausal|post-menopausal
742969|NCT00463489|estrogen receptor positive|estrogen receptor positive
742970|NCT00463489|progesterone receptor positive|progesterone receptor positive
742971|NCT00463450|Hormone Replacement Therapy|hormone replacement therapy
742972|NCT00463450|Impaired well-being, mood and sexuality|impaired well-being, mood and sexuality
742973|NCT00463437|Fever.|fever.
742974|NCT00463437|Meningococcal disease.|meningococcal disease.
742975|NCT00463437|Pneumococcal disease.|pneumococcal disease.
742976|NCT00463437|Meningococcal vaccine.|meningococcal vaccine.
742977|NCT00463437|Pneumococcal vaccine.|pneumococcal vaccine.
742978|NCT00463437|Immunogenicity.|immunogenicity.
742979|NCT00463437|Booster vaccination.|booster vaccination.
742980|NCT00463437|Safety.|safety.
742981|NCT00463424|Metacarpophalangeal Joint|metacarpophalangeal joint
742982|NCT00463424|Arthroplasty, Replacement|arthroplasty, replacement
742983|NCT00463424|Range of Motion, Articular|range of motion, articular
742984|NCT00463424|Randomized Controlled Trials|randomized controlled trials
742985|NCT00463424|Swanson|swanson
742986|NCT00463424|NeuFlex|neuflex
742987|NCT00463411|osteoporosis|osteoporosis
742988|NCT00463411|male|male
742989|NCT00463411|fracture risk|fracture risk
742990|NCT00463411|genetical epidemiology|genetical epidemiology
742991|NCT00463398|Endometriosis|endometriosis
742992|NCT00463398|Fertility Surgery|fertility surgery
742993|NCT00463398|Quality of Life|quality of life
742995|NCT00463398|Sexual Function|sexual function
742996|NCT00463398|Health economics|health economics
742997|NCT00463398|Recurrence|recurrence
742998|NCT00463398|Pregnancy|pregnancy
742999|NCT00463385|Celgene|celgene
743000|NCT00463385|CC-4047|cc-4047
743001|NCT00463385|Myelofibrosis|myelofibrosis
743002|NCT00463385|myelofibrosis with myeloid metaplasia|myelofibrosis with myeloid metaplasia
743003|NCT00463385|myeloid metaplasia|myeloid metaplasia
743004|NCT00463385|JAK2|jak2
743005|NCT00463385|CC-4047-MMM-001|cc-4047-mmm-001
743006|NCT00463385|Prednisone|prednisone
743007|NCT00463385|Phase II|phase ii
743008|NCT00463385|pomalidomide|pomalidomide
743009|NCT00463385|bone marrow histology|bone marrow histology
743010|NCT00463385|imids|imids
743011|NCT00463385|MMM|mmm
743012|NCT00463385|Ashkenazi Jewish Population|ashkenazi jewish population
743013|NCT00463385|exposure to Thorotrast|exposure to thorotrast
743014|NCT00463385|exposure to solvents (benzene and toluene)|exposure to solvents (benzene and toluene)
743015|NCT00463385|acute megakaryocytic leukemia|acute megakaryocytic leukemia
743016|NCT00463385|history of polycythemia vera|history of polycythemia vera
743017|NCT00463359|basal cell carcinoma|basal cell carcinoma
743018|NCT00463359|curettage|curettage
743019|NCT00463359|Imiquimod|imiquimod
743020|NCT00463359|treatment|treatment
743021|NCT00463346|Treatment|treatment
743022|NCT00463346|Alcohol Dependence|alcohol dependence
743023|NCT00463346|Schizophrenia|schizophrenia
743024|NCT00463333|postoperative delirium|postoperative delirium
743025|NCT00463333|psychometric testing|psychometric testing
743026|NCT00463333|EEG|eeg
743027|NCT00463333|serum markers|serum markers
743028|NCT00463320|Age-related macular degeneration (AMD),|age-related macular degeneration (amd),
743029|NCT00463320|vascular endothelial growth factor (VEGF)receptor (VEGFR)|vascular endothelial growth factor (vegf)receptor (vegfr)
743030|NCT00463320|choroidal neovascularization,|choroidal neovascularization,
743031|NCT00463307|schistosomiasis|schistosomiasis
743032|NCT00463307|Schistosoma mansoni|schistosoma mansoni
743033|NCT00463307|Circulating cathodic antigen urine dipstick|circulating cathodic antigen urine dipstick
743034|NCT00463294|CABG|cabg
743035|NCT00463294|On-pump|on-pump
743036|NCT00463294|Off-pump|off-pump
743037|NCT00463281|stroke, ischemic|stroke, ischemic
743038|NCT00463281|computed tomography|computed tomography
743039|NCT00463281|thrombolysis|thrombolysis
743040|NCT00463268|osteopenia|osteopenia
743041|NCT00463268|osteoporosis prevention|osteoporosis prevention
743042|NCT00463268|alendronate|alendronate
743043|NCT00463255|Diet|diet
743044|NCT00463255|elderly|elderly
743045|NCT00463255|age-related diseases|age-related diseases
743046|NCT00463255|prevention|prevention
743047|NCT00463255|cognitive decline|cognitive decline
743048|NCT00463255|Clinical study|clinical study
743049|NCT00463242|agomelatine, Major Depressive Disorder, MDD, depression|agomelatine, major depressive disorder, mdd, depression
743050|NCT00463229|stroke|stroke
743051|NCT00463229|rehabilitation|rehabilitation
743052|NCT00463229|home care services|home care services
743053|NCT00463229|effectiveness|effectiveness
743054|NCT00463229|quantitative research|quantitative research
743055|NCT00463229|interdisciplinary|interdisciplinary
743056|NCT00463229|cost|cost
743057|NCT00463229|health services research, integrated|health services research, integrated
743058|NCT00463216|back, neck, pain, sick leave|back, neck, pain, sick leave
743059|NCT00463203|primary malignant brain tumor|primary malignant brain tumor
743060|NCT00463203|grade II glioma|grade ii glioma
743061|NCT00463203|meningeoma|meningeoma
743062|NCT00463203|ependymoma|ependymoma
743063|NCT00463203|Recurrence or progression after standard treatment|recurrence or progression after standard treatment
743064|NCT00463190|Probiotics|probiotics
743065|NCT00463190|Diarrhea|diarrhea
743066|NCT00463190|Enterocolitis|enterocolitis
743067|NCT00463177|Pain|pain
743068|NCT00463177|Chronic pain|chronic pain
743069|NCT00463177|Pain disorder|pain disorder
743070|NCT00463177|Functional MRI|functional mri
743071|NCT00463177|Sensitization|sensitization
743072|NCT00463164|functional MRI|functional mri
743073|NCT00463151|Rebamipide|rebamipide
743074|NCT00463151|Enema|enema
743075|NCT00463151|Ulcerative Colitis|ulcerative colitis
743076|NCT00463138|perceived increase or decrease in symptoms post treatment|perceived increase or decrease in symptoms post treatment
743077|NCT00463138|Satisfaction with the treatment|satisfaction with the treatment
743078|NCT00463125|Scleroderma, systemic|scleroderma, systemic
743079|NCT00463125|therapeutic|therapeutic
743080|NCT00463125|platelet gel|platelet gel
743081|NCT00463112|Obesity|obesity
743082|NCT00463112|Polycystic Ovary Syndrome|polycystic ovary syndrome
743083|NCT00463112|weight loss|weight loss
743084|NCT00463112|Hyperadrogonemia|hyperadrogonemia
743085|NCT00463112|Sibutramine|sibutramine
743086|NCT00463099|Anterior Cruciate Ligament/injuries|anterior cruciate ligament/injuries
743087|NCT00463099|Anterior Cruciate Ligament/surgery|anterior cruciate ligament/surgery
743088|NCT00463099|Knee injuries/surgery|knee injuries/surgery
743089|NCT00463099|Outcomes research|outcomes research
743090|NCT00463099|Prospective Studies|prospective studies
743091|NCT00463086|Tuberculosis|tuberculosis
743093|NCT00463086|Mycobacteria|mycobacteria
743094|NCT00463086|HIV|hiv
743095|NCT00463086|Human immunodeficiency virus|human immunodeficiency virus
743096|NCT00463086|Latent tuberculosis infection|latent tuberculosis infection
743097|NCT00463086|HAART|haart
743098|NCT00463086|Highly active anti-retroviral therapy|highly active anti-retroviral therapy
743099|NCT00463086|Isoniazid preventive therapy|isoniazid preventive therapy
743100|NCT00463086|INH|inh
743101|NCT00463086|Opportunistic infections|opportunistic infections
743102|NCT00463086|HIV-1|hiv-1
743103|NCT00463086|Treatment Experienced|treatment experienced
743104|NCT00463086|AIDS|aids
743105|NCT00463086|Mycobacterium Tuberculosis|mycobacterium tuberculosis
743106|NCT00463073|Progressive primary Glioblastoma multiforme|progressive primary glioblastoma multiforme
743107|NCT00463060|erlotinib|erlotinib
743108|NCT00463060|celecoxib|celecoxib
743109|NCT00463060|radiation|radiation
743110|NCT00463060|progression-free survival|progression-free survival
743111|NCT00463047|Breakthrough pain|breakthrough pain
743112|NCT00463047|Opioid-tolerant|opioid-tolerant
743113|NCT00463047|Chronic pain|chronic pain
743114|NCT00463034|stage IV breast cancer|stage iv breast cancer
743115|NCT00463034|stage I breast cancer|stage i breast cancer
743116|NCT00463034|stage II breast cancer|stage ii breast cancer
743117|NCT00463034|stage IIIA breast cancer|stage iiia breast cancer
743118|NCT00463034|stage IIIB breast cancer|stage iiib breast cancer
743119|NCT00463034|stage IIIC breast cancer|stage iiic breast cancer
743120|NCT00463021|Hectorol (doxercalciferol capsules)|hectorol (doxercalciferol capsules)
743121|NCT00463021|Zemplar (paricalcitol injection)|zemplar (paricalcitol injection)
743122|NCT00463008|adult anaplastic astrocytoma|adult anaplastic astrocytoma
743123|NCT00463008|adult anaplastic oligodendroglioma|adult anaplastic oligodendroglioma
743124|NCT00463008|adult glioblastoma|adult glioblastoma
743125|NCT00463008|recurrent adult brain tumor|recurrent adult brain tumor
743126|NCT00463008|adult gliosarcoma|adult gliosarcoma
743227|NCT00462722|body composition|body composition
743127|NCT00463008|adult giant cell glioblastoma|adult giant cell glioblastoma
743128|NCT00462995|Non Small Cell Lung Cancer|non small cell lung cancer
743129|NCT00462995|Lung Cancer|lung cancer
743130|NCT00462995|Erlotinib|erlotinib
743131|NCT00462995|Neoadjuvant Treatment|neoadjuvant treatment
743132|NCT00462982|stage IV melanoma|stage iv melanoma
743133|NCT00462982|tumors metastatic to brain|tumors metastatic to brain
743134|NCT00462982|stage IV renal cell cancer|stage iv renal cell cancer
743135|NCT00462982|recurrent melanoma|recurrent melanoma
743136|NCT00462982|recurrent renal cell cancer|recurrent renal cell cancer
743137|NCT00462969|Endometrial cancer|endometrial cancer
743138|NCT00462969|Sonohysterography|sonohysterography
743139|NCT00462956|lapatinib|lapatinib
743140|NCT00462956|metastatic breast cancer|metastatic breast cancer
743141|NCT00462956|trastuzumab (Herceptin)|trastuzumab (herceptin)
743142|NCT00462956|Stage IV breast cancer|stage iv breast cancer
743143|NCT00462956|ErbB2|erbb2
743144|NCT00462956|ErbB1|erbb1
743145|NCT00462943|CML|cml
743146|NCT00462943|HHT|hht
743147|NCT00462943|Homoharringtonine|homoharringtonine
743148|NCT00462943|Omacetaxine|omacetaxine
743149|NCT00462917|disease /disorder proneness /risk|disease /disorder proneness /risk
743150|NCT00462917|family genetics|family genetics
743151|NCT00462917|genetic counseling|genetic counseling
743152|NCT00462917|genetic marker|genetic marker
743153|NCT00462917|genetic polymorphism|genetic polymorphism
743154|NCT00462917|genetic screening|genetic screening
743155|NCT00462917|genetic susceptibility|genetic susceptibility
743156|NCT00462891|breast cancer|breast cancer
743157|NCT00462878|Febrile neutropenia|febrile neutropenia
743158|NCT00462865|breast cancer|breast cancer
743159|NCT00462865|neoadjuvant chemotherapy|neoadjuvant chemotherapy
743160|NCT00462865|adjuvant treatment|adjuvant treatment
743161|NCT00462865|consolidation therapy|consolidation therapy
743162|NCT00462865|anti-angiogenesis therapy|anti-angiogenesis therapy
743163|NCT00462852|thromboembolism|thromboembolism
743164|NCT00462852|stage III pancreatic cancer|stage iii pancreatic cancer
743165|NCT00462852|stage IV pancreatic cancer|stage iv pancreatic cancer
743166|NCT00462852|adenocarcinoma of the pancreas|adenocarcinoma of the pancreas
743167|NCT00462852|recurrent pancreatic cancer|recurrent pancreatic cancer
743168|NCT00462852|stage II pancreatic cancer|stage ii pancreatic cancer
743169|NCT00462839|Estimated Blood Loss|estimated blood loss
743170|NCT00462839|Obstetrics|obstetrics
743171|NCT00462839|postpartum hemorrhage|postpartum hemorrhage
743172|NCT00462813|cervical cancer|cervical cancer
743173|NCT00462813|cervical intraepithelial neoplasia grade 2|cervical intraepithelial neoplasia grade 2
743174|NCT00462813|cervical intraepithelial neoplasia grade 3|cervical intraepithelial neoplasia grade 3
743175|NCT00462813|cervical intraepithelial neoplasia grade 1|cervical intraepithelial neoplasia grade 1
743176|NCT00462787|acute undifferentiated leukemia|acute undifferentiated leukemia
743177|NCT00462787|recurrent childhood acute lymphoblastic leukemia|recurrent childhood acute lymphoblastic leukemia
743178|NCT00462787|recurrent childhood acute myeloid leukemia|recurrent childhood acute myeloid leukemia
743179|NCT00462787|recurrent adult acute lymphoblastic leukemia|recurrent adult acute lymphoblastic leukemia
743180|NCT00462787|recurrent adult acute myeloid leukemia|recurrent adult acute myeloid leukemia
743181|NCT00462774|Myocardial infarction|myocardial infarction
743182|NCT00462774|Heart failure|heart failure
743183|NCT00462774|Cell therapy|cell therapy
743184|NCT00462774|Bone marrow|bone marrow
743185|NCT00462774|CD133|cd133
743186|NCT00462774|Bypass surgery|bypass surgery
743187|NCT00462774|Stem cells|stem cells
743188|NCT00462761|RTK|rtk
743189|NCT00462761|kinase|kinase
743190|NCT00462761|inhibitor|inhibitor
743191|NCT00462761|tyrosine|tyrosine
743192|NCT00462761|acute|acute
743193|NCT00462761|FLT3|flt3
743194|NCT00462761|AC220|ac220
743195|NCT00462761|pharmacokinetic|pharmacokinetic
743196|NCT00462761|pharmacokinetics|pharmacokinetics
743197|NCT00462761|PK|pk
743198|NCT00462761|pharmacodynamic|pharmacodynamic
743199|NCT00462761|pharmacodynamics|pharmacodynamics
743200|NCT00462761|mutations|mutations
743201|NCT00462761|PD|pd
743202|NCT00462761|receptor|receptor
743203|NCT00462761|class III|class iii
743204|NCT00462761|relapsed|relapsed
743205|NCT00462761|refractory|refractory
743206|NCT00462761|t(8;21)|t(8;21)
743207|NCT00462761|q22;q22|q22;q22
743208|NCT00462761|AML1/ETO|aml1/eto
743209|NCT00462761|t(16;16|t(16;16
743210|NCT00462761|p13;q22|p13;q22
743211|NCT00462761|CBFbeta/MYH11|cbfbeta/myh11
743212|NCT00462761|inv(16)|inv(16)
743213|NCT00462761|p13q22|p13q22
743214|NCT00462761|11q23|11q23
743215|NCT00462761|dysplasia|dysplasia
743216|NCT00462761|myeloid|myeloid
743217|NCT00462761|myelomonocytic|myelomonocytic
743218|NCT00462761|monoblastic|monoblastic
743219|NCT00462761|monocytic|monocytic
743220|NCT00462761|erythroid|erythroid
743221|NCT00462761|erythroleukemia|erythroleukemia
743222|NCT00462761|megakaryoblastic|megakaryoblastic
743223|NCT00462761|basophilic|basophilic
743224|NCT00462761|panmyelosis|panmyelosis
743225|NCT00462761|myelofibrosis|myelofibrosis
743226|NCT00462735|Cancer of the Nasal Cavity|cancer of the nasal cavity
743228|NCT00462722|bone density|bone density
743229|NCT00462722|cyclooxygenase inhibitor|cyclooxygenase inhibitor
743230|NCT00462722|bone metabolism|bone metabolism
743231|NCT00462722|muscle function|muscle function
743232|NCT00462722|muscle strength|muscle strength
743233|NCT00462709|Hereditary angioedema|hereditary angioedema
743234|NCT00462709|C1 esterase inhibitor (human)|c1 esterase inhibitor (human)
743235|NCT00462696|stage II breast cancer|stage ii breast cancer
743236|NCT00462696|stage IIIA breast cancer|stage iiia breast cancer
743237|NCT00462696|stage IIIB breast cancer|stage iiib breast cancer
743238|NCT00462696|stage IIIC breast cancer|stage iiic breast cancer
743239|NCT00462683|Stroke|stroke
743240|NCT00462683|Anoxia|anoxia
743241|NCT00462683|Brain Injury|brain injury
743242|NCT00462683|Rehabilitation|rehabilitation
743243|NCT00462683|Osteoporosis|osteoporosis
743244|NCT00462683|Osteopenia|osteopenia
743245|NCT00462670|Cardiac edema|cardiac edema
743246|NCT00462670|OPC-41061|opc-41061
743247|NCT00462670|Vasopressin antagonist|vasopressin antagonist
743248|NCT00462657|infection|infection
743249|NCT00462657|adult acute myeloid leukemia with 11q23 (MLL) abnormalities|adult acute myeloid leukemia with 11q23 (mll) abnormalities
743250|NCT00462657|adult acute myeloid leukemia with inv(16)(p13;q22)|adult acute myeloid leukemia with inv(16)(p13;q22)
743251|NCT00462657|adult acute myeloid leukemia with t(15;17)(q22;q12)|adult acute myeloid leukemia with t(15;17)(q22;q12)
743252|NCT00462657|adult acute myeloid leukemia with t(16;16)(p13;q22)|adult acute myeloid leukemia with t(16;16)(p13;q22)
743253|NCT00462657|adult acute myeloid leukemia with t(8;21)(q22;q22)|adult acute myeloid leukemia with t(8;21)(q22;q22)
743254|NCT00462657|adult acute lymphoblastic leukemia in remission|adult acute lymphoblastic leukemia in remission
743255|NCT00462657|adult acute myeloid leukemia in remission|adult acute myeloid leukemia in remission
743256|NCT00462657|de novo myelodysplastic syndromes|de novo myelodysplastic syndromes
743257|NCT00462657|myelodysplastic/myeloproliferative neoplasm, unclassifiable|myelodysplastic/myeloproliferative neoplasm, unclassifiable
743258|NCT00462657|previously treated myelodysplastic syndromes|previously treated myelodysplastic syndromes
743259|NCT00462657|recurrent adult acute lymphoblastic leukemia|recurrent adult acute lymphoblastic leukemia
743260|NCT00462657|recurrent adult acute myeloid leukemia|recurrent adult acute myeloid leukemia
743261|NCT00462657|secondary acute myeloid leukemia|secondary acute myeloid leukemia
743262|NCT00462657|secondary myelodysplastic syndromes|secondary myelodysplastic syndromes
743263|NCT00462657|graft versus host disease|graft versus host disease
743264|NCT00462644|adrenal insufficiency|adrenal insufficiency
743265|NCT00462644|etomidate|etomidate
743266|NCT00462644|rapid sequence induction|rapid sequence induction
743267|NCT00462631|coronary artery|coronary artery
743268|NCT00462631|Diabetes|diabetes
743269|NCT00462618|Insomnia|insomnia
743270|NCT00462618|Elderly|elderly
743271|NCT00462618|Affective disorders|affective disorders
743272|NCT00462592|exercise-induced bronchoconstriction (EIB)|exercise-induced bronchoconstriction (eib)
743273|NCT00462592|airway inflammation|airway inflammation
743274|NCT00462579|carbapenem-resistant acinetobacter baumannii|carbapenem-resistant acinetobacter baumannii
743275|NCT00462579|positive culture|positive culture
743276|NCT00462579|positive culture for carbapenem-resistant acinetobacter|positive culture for carbapenem-resistant acinetobacter
743277|NCT00462566|Motor cortex stimulation|motor cortex stimulation
743278|NCT00462566|neuropathic|neuropathic
743279|NCT00462566|pain|pain
743280|NCT00462566|complex regional pain syndrome|complex regional pain syndrome
743281|NCT00462566|deafferentation facial pain|deafferentation facial pain
743282|NCT00462540|COPD|copd
743283|NCT00462540|Formoterol|formoterol
743284|NCT00462540|Ipratropium|ipratropium
743285|NCT00462540|Crossover|crossover
743286|NCT00462527|Cystatin C|cystatin c
743287|NCT00462527|Acute renal failure|acute renal failure
743288|NCT00462527|Gastroenteritis|gastroenteritis
743289|NCT00462527|Dehydration|dehydration
743290|NCT00462501|stage II rectal cancer|stage ii rectal cancer
743291|NCT00462501|stage III rectal cancer|stage iii rectal cancer
743292|NCT00462501|adenocarcinoma of the rectum|adenocarcinoma of the rectum
743293|NCT00462475|GH|gh
743294|NCT00462475|IGF-I|igf-i
743295|NCT00462475|GH deficiency|gh deficiency
743296|NCT00462475|Atherosclerosis|atherosclerosis
743297|NCT00462475|Insulin resistance syndrome|insulin resistance syndrome
743298|NCT00462449|Botulinum Toxin|botulinum toxin
743299|NCT00462449|Ness H200|ness h200
743300|NCT00462449|Functional Electrical Stimulation|functional electrical stimulation
743301|NCT00462449|Repetitive Task Practice|repetitive task practice
743302|NCT00462436|functional foods|functional foods
743303|NCT00462436|soy|soy
743304|NCT00462436|nuts|nuts
743305|NCT00462436|LDL cholesterol|ldl cholesterol
743306|NCT00462436|fibre|fibre
743307|NCT00462436|secondary prevention|secondary prevention
743308|NCT00462436|risk reduction|risk reduction
743309|NCT00462436|endothelial function|endothelial function
743310|NCT00462436|endothelial progenitor cells|endothelial progenitor cells
743311|NCT00462436|inflammation|inflammation
743312|NCT00462436|glycemic control|glycemic control
743313|NCT00462436|HOMA|homa
743314|NCT00462423|Metastatic malignant melanoma|metastatic malignant melanoma
743315|NCT00462423|First-line therapy|first-line therapy
743412|NCT00462085|emg|emg
743316|NCT00462410|recurrent breast cancer|recurrent breast cancer
743317|NCT00462410|stage I breast cancer|stage i breast cancer
743318|NCT00462410|stage II breast cancer|stage ii breast cancer
743319|NCT00462410|stage IIIA breast cancer|stage iiia breast cancer
743320|NCT00462410|stage IIIB breast cancer|stage iiib breast cancer
743571|NCT00461487|Sexual Behavior|sexual behavior
743321|NCT00462410|stage IIIC breast cancer|stage iiic breast cancer
743322|NCT00462410|stage IV breast cancer|stage iv breast cancer
743323|NCT00462397|cervical adenocarcinoma|cervical adenocarcinoma
743324|NCT00462397|cervical adenosquamous cell carcinoma|cervical adenosquamous cell carcinoma
743325|NCT00462397|cervical squamous cell carcinoma|cervical squamous cell carcinoma
743326|NCT00462397|stage IB cervical cancer|stage ib cervical cancer
743327|NCT00462397|stage IIA cervical cancer|stage iia cervical cancer
743328|NCT00462397|stage IIB cervical cancer|stage iib cervical cancer
743329|NCT00462397|stage III cervical cancer|stage iii cervical cancer
743330|NCT00462397|stage IVA cervical cancer|stage iva cervical cancer
743331|NCT00462397|recurrent cervical cancer|recurrent cervical cancer
743332|NCT00462371|quality of life|quality of life
743333|NCT00462371|child diabetes mellitus type 1|child diabetes mellitus type 1
743334|NCT00462371|Continuous subcutaneous insulin infusion(CSII)|continuous subcutaneous insulin infusion(csii)
743335|NCT00462371|metabolic control|metabolic control
743336|NCT00462332|stage III chronic lymphocytic leukemia|stage iii chronic lymphocytic leukemia
743337|NCT00462332|stage IV chronic lymphocytic leukemia|stage iv chronic lymphocytic leukemia
743338|NCT00462306|Obstructive Sleep Apnea|obstructive sleep apnea
743339|NCT00462306|Pregnancy|pregnancy
743340|NCT00462306|Berlin Questionnaire|berlin questionnaire
743341|NCT00462267|Nutrition|nutrition
743342|NCT00462267|Exercise|exercise
743343|NCT00462267|Body mass index|body mass index
743344|NCT00462267|Lifestyle change|lifestyle change
743345|NCT00462267|Obesity|obesity
743346|NCT00462267|Overweight|overweight
743347|NCT00462267|Adolescents|adolescents
743348|NCT00462267|Teens|teens
743349|NCT00462254|Ramelteon|ramelteon
743350|NCT00462254|Parkinson's disease|parkinson's disease
743351|NCT00462254|Sleep disturbances|sleep disturbances
743352|NCT00462241|Chest pain|chest pain
743353|NCT00462241|Chest wall|chest wall
743354|NCT00462241|Atypical chest pain|atypical chest pain
743355|NCT00462241|Non-cardiac chest pain|non-cardiac chest pain
743356|NCT00462241|Undiagnosed chest pain|undiagnosed chest pain
743357|NCT00462241|Physical examination|physical examination
743358|NCT00462241|Randomized controlled trial|randomized controlled trial
743359|NCT00462241|Treatment study|treatment study
743360|NCT00462241|Chiropractor|chiropractor
743361|NCT00462228|traumatic brain injury|traumatic brain injury
743362|NCT00462228|memory|memory
743363|NCT00462228|attention|attention
743364|NCT00462202|Diabetes|diabetes
743365|NCT00462202|Microalbuminuria|microalbuminuria
743366|NCT00462202|Proteinuria|proteinuria
743367|NCT00462202|Albuminuria|albuminuria
743368|NCT00462202|KRX-101|krx-101
743369|NCT00462202|Sulodexide|sulodexide
743370|NCT00462202|Nephropathy|nephropathy
743371|NCT00462202|Keryx|keryx
743372|NCT00462202|Collaborative Study Group|collaborative study group
743373|NCT00462202|Diabetic nephropathy with persistent microalbuminuria|diabetic nephropathy with persistent microalbuminuria
743374|NCT00462189|CAT-8015|cat-8015
743375|NCT00462189|HA22|ha22
743376|NCT00462189|HCL|hcl
743377|NCT00462189|Relapse|relapse
743378|NCT00462189|Refractory|refractory
743379|NCT00462189|immunotherapy|immunotherapy
743380|NCT00462189|immunotoxin|immunotoxin
743381|NCT00462176|colorectal endometriosis|colorectal endometriosis
743382|NCT00462176|deep infiltrating endometriosis|deep infiltrating endometriosis
743383|NCT00462176|dysmenorroe|dysmenorroe
743384|NCT00462176|dyspareunia|dyspareunia
743385|NCT00462176|quality of life|quality of life
743386|NCT00462150|arthritis, rheumatoid|arthritis, rheumatoid
743387|NCT00462150|expressed emotion|expressed emotion
743388|NCT00462150|randomized controlled trial|randomized controlled trial
743389|NCT00462150|affect|affect
743390|NCT00462150|blood sedimentation|blood sedimentation
743391|NCT00462150|psychophysiology|psychophysiology
743392|NCT00462150|feasibility studies|feasibility studies
743393|NCT00462150|intervention studies|intervention studies
743394|NCT00462150|time management|time management
743395|NCT00462137|GERD|gerd
743396|NCT00462137|Gastroesphageal Reflux Disease (GERD)|gastroesphageal reflux disease (gerd)
743397|NCT00462124|Prostate|prostate
743398|NCT00462124|cancer|cancer
743399|NCT00462124|radiation|radiation
743400|NCT00462124|biodegradable implantable balloon|biodegradable implantable balloon
743401|NCT00462124|intrarectal balloon|intrarectal balloon
743402|NCT00462111|indometacin|indometacin
743403|NCT00462111|reaction time|reaction time
743404|NCT00462111|postural balance|postural balance
743405|NCT00462111|obstacle avoidance|obstacle avoidance
743406|NCT00462111|accidental falls|accidental falls
743407|NCT00462098|Osteonecrosis of the jaw|osteonecrosis of the jaw
743408|NCT00462098|hyperbaric oxygen|hyperbaric oxygen
743409|NCT00462098|bisphosphonates|bisphosphonates
743410|NCT00462085|cerebral palsy|cerebral palsy
743411|NCT00462085|ankle foot orthosis|ankle foot orthosis
743413|NCT00462085|surface electromyography|surface electromyography
743414|NCT00462085|gait analysis|gait analysis
743415|NCT00462059|Transition of care|transition of care
743416|NCT00462059|Continuity of care|continuity of care
743417|NCT00462046|Berberine|berberine
743418|NCT00462046|Type 2 diabetes|type 2 diabetes
743419|NCT00462046|Dyslipidemia|dyslipidemia
743420|NCT00462020|appendicitis, perforation, abscess, treatment|appendicitis, perforation, abscess, treatment
743421|NCT00461994|OBESITY|obesity
743422|NCT00461994|CHILDREN|children
743423|NCT00461994|METABOLIC PARAMETERS|metabolic parameters
743424|NCT00461994|DIET|diet
743425|NCT00461994|EXERCISE|exercise
743426|NCT00461981|Live, attenuated influenza virus vaccine (LAIV)|live, attenuated influenza virus vaccine (laiv)
743427|NCT00461981|Trivalent inactivated influenza virus vaccine (TIV)|trivalent inactivated influenza virus vaccine (tiv)
743428|NCT00461981|FluMist|flumist
743429|NCT00461968|Cholesterol|cholesterol
743430|NCT00461968|LDL|ldl
743431|NCT00461968|Ezetimibe|ezetimibe
743432|NCT00461968|Statin|statin
743433|NCT00461968|Zetia|zetia
743434|NCT00461968|Zocor|zocor
743435|NCT00461968|Simvastin|simvastin
743436|NCT00461955|Symptomatic Multiple Myeloma|symptomatic multiple myeloma
743437|NCT00461955|first line treatment|first line treatment
743438|NCT00461955|first autologous Stem Cell Transplantation|first autologous stem cell transplantation
743439|NCT00461955|ex vivo amplified autologous peripheral blood stem cells|ex vivo amplified autologous peripheral blood stem cells
743440|NCT00461942|Health Food;|health food;
743441|NCT00461942|Green Tea;|green tea;
743442|NCT00461942|Neuroprotection|neuroprotection
743443|NCT00461929|chronic myeloid leukemia|chronic myeloid leukemia
743444|NCT00461929|gastrointestinal stromal cell tumors|gastrointestinal stromal cell tumors
743445|NCT00461929|chromosome abnormality|chromosome abnormality
743446|NCT00461929|imatinib|imatinib
743447|NCT00461929|bone marrow aspiration|bone marrow aspiration
743448|NCT00461916|half-dose depot triptorelin|half-dose depot triptorelin
743449|NCT00461916|reduced-dose daily buserelin|reduced-dose daily buserelin
743450|NCT00461916|controlled ovarian stimulation|controlled ovarian stimulation
743451|NCT00461916|long protocol|long protocol
743452|NCT00461916|ICSI|icsi
743453|NCT00461903|essential hypertension|essential hypertension
743454|NCT00461903|symptomatic paroxysmal or persistent atrial fibrillation|symptomatic paroxysmal or persistent atrial fibrillation
743455|NCT00461890|Alcohol|alcohol
743456|NCT00461890|Veterans|veterans
743457|NCT00461890|Primary Care|primary care
743458|NCT00461890|Naltrexone|naltrexone
743459|NCT00461864|fracture|fracture
743460|NCT00461864|occult|occult
743462|NCT00461851|Advanced/Metastatic Bladder Carcinoma|advanced/metastatic bladder carcinoma
743463|NCT00461838|colorectal endometriosis|colorectal endometriosis
743464|NCT00461838|deep infiltrating endometriosis|deep infiltrating endometriosis
743465|NCT00461838|dysmenorroe|dysmenorroe
743466|NCT00461838|dyspareunia|dyspareunia
743467|NCT00461838|quality of life|quality of life
743468|NCT00461825|Immunosuppression|immunosuppression
743469|NCT00461825|Kidney transplantation|kidney transplantation
743470|NCT00461825|multicenter study|multicenter study
743471|NCT00461799|Crigler-Najjar disease.|crigler-najjar disease.
743472|NCT00461799|Bilirubin.|bilirubin.
743473|NCT00461799|Phototherapy.|phototherapy.
743474|NCT00461799|Orlistat.|orlistat.
743475|NCT00461799|Unconjugated hyperbilirubinemia.|unconjugated hyperbilirubinemia.
743476|NCT00461773|Neoadjuvant treatment|neoadjuvant treatment
743477|NCT00461760|HPV Screening/Testing for cervical cancer screening|hpv screening/testing for cervical cancer screening
743478|NCT00461747|Untreated|untreated
743479|NCT00461747|Transplant|transplant
743480|NCT00461747|Younger|younger
743481|NCT00461734|Right Ventricular High Septal Pacing|right ventricular high septal pacing
743482|NCT00461734|Right Ventricular Apical Pacing|right ventricular apical pacing
743483|NCT00461734|Left Ventricular Dysfunction|left ventricular dysfunction
743484|NCT00461734|Heart Block|heart block
743485|NCT00461734|Pacemaker|pacemaker
743486|NCT00461734|Atrial Fibrillation|atrial fibrillation
743487|NCT00461734|Ejection Fraction|ejection fraction
743488|NCT00461695|Cytomegalovirus (CMV)|cytomegalovirus (cmv)
743489|NCT00461695|Tick-borne encephalitis virus (TBEV)|tick-borne encephalitis virus (tbev)
743490|NCT00461695|Ageing|ageing
743491|NCT00461695|Vaccine|vaccine
743492|NCT00461695|Immunity|immunity
743493|NCT00461682|TRPV1 antagonist|trpv1 antagonist
743494|NCT00461682|Fecal Urgency|fecal urgency
743495|NCT00461682|rectal pain|rectal pain
743496|NCT00461682|IBS|ibs
743497|NCT00461669|hip|hip
743498|NCT00461669|fracture|fracture
743499|NCT00461669|ultrasound|ultrasound
743500|NCT00461656|Antiseptic|antiseptic
743501|NCT00461656|Povidone-Iodine|povidone-iodine
743502|NCT00461643|Anovulation|anovulation
743503|NCT00461643|Clomiphene citrate|clomiphene citrate
743504|NCT00461643|Infertility|infertility
743505|NCT00461643|Metformin|metformin
743506|NCT00461643|PCOS|pcos
743507|NCT00461643|RCT|rct
743508|NCT00461643|Treatment|treatment
743509|NCT00461630|coronary heart disease|coronary heart disease
743510|NCT00461630|cardiovascular disease|cardiovascular disease
743511|NCT00461630|stroke|stroke
743512|NCT00461630|peripheral arterial disease|peripheral arterial disease
743513|NCT00461630|diabetes mellitus|diabetes mellitus
743514|NCT00461630|cholesterol|cholesterol
743515|NCT00461630|HDL cholesterol|hdl cholesterol
743516|NCT00461630|simvastatin|simvastatin
743517|NCT00461630|ezetimibe|ezetimibe
743518|NCT00461630|ER niacin|er niacin
743519|NCT00461630|laropiprant|laropiprant
743520|NCT00461617|diabetes|diabetes
743521|NCT00461617|rapid and short acting insulin secretagogue|rapid and short acting insulin secretagogue
743522|NCT00461617|α-glucosidase inhibitor|α-glucosidase inhibitor
743523|NCT00461617|HbA1C|hba1c
743524|NCT00461617|insulin|insulin
743525|NCT00461604|gastroesophageal reflux disease|gastroesophageal reflux disease
743526|NCT00461604|baclofen|baclofen
743527|NCT00461604|impedance|impedance
743528|NCT00461591|Noninvasive Bladder Cancer|noninvasive bladder cancer
743529|NCT00461578|P.falciparum|p.falciparum
743530|NCT00461578|malaria|malaria
743531|NCT00461578|lapdap+artesunate|lapdap+artesunate
743532|NCT00461578|safety|safety
743533|NCT00461578|efficay|efficay
743534|NCT00461565|Retina|retina
743535|NCT00461565|PDE-5|pde-5
743536|NCT00461565|Levitra|levitra
743537|NCT00461565|Viagra|viagra
743538|NCT00461565|Normal healthy volunteers for evaluation of retinal function|normal healthy volunteers for evaluation of retinal function
743539|NCT00461552|Lipodystrophy|lipodystrophy
743540|NCT00461552|HIV|hiv
743541|NCT00461552|HAART|haart
743542|NCT00461552|HIV Lipodystrophy Syndrome|hiv lipodystrophy syndrome
743543|NCT00461552|Lipodystrophy syndrome|lipodystrophy syndrome
743544|NCT00461552|HIV-Associated Lipodystrophy|hiv-associated lipodystrophy
743545|NCT00461552|HIV-Associated Lipodystrophy Syndrome|hiv-associated lipodystrophy syndrome
743546|NCT00461552|Treatment Experienced|treatment experienced
743547|NCT00461539|Tobacco Use|tobacco use
743548|NCT00461539|Alcohol and Drug Use|alcohol and drug use
743549|NCT00461539|Obesity|obesity
743550|NCT00461539|Risky Sexual Behavior|risky sexual behavior
743551|NCT00461526|IBS|ibs
743552|NCT00461526|d-IBS|d-ibs
743553|NCT00461526|Irritable Bowel Syndrome|irritable bowel syndrome
743554|NCT00461513|Heart Failure, Congestive|heart failure, congestive
743555|NCT00461513|Disease Management|disease management
743556|NCT00461513|Health Status|health status
743557|NCT00461513|Quality of Life|quality of life
743558|NCT00461513|Telemedicine|telemedicine
743559|NCT00461513|Depression|depression
743560|NCT00461500|persistent|persistent
743561|NCT00461500|moderate|moderate
743562|NCT00461500|asthma|asthma
743563|NCT00461500|adults|adults
743564|NCT00461500|Initial|initial
743565|NCT00461500|Maintenance|maintenance
743566|NCT00461500|Therapy|therapy
743567|NCT00461487|Adolescent Behavior|adolescent behavior
743568|NCT00461487|Communication|communication
743569|NCT00461487|Health Behavior|health behavior
743570|NCT00461487|Risk-Taking|risk-taking
743572|NCT00461474|Shoulder pain|shoulder pain
743573|NCT00461474|Chronic Spinal Cord Injury|chronic spinal cord injury
743574|NCT00461474|Exercise|exercise
743575|NCT00461474|Physical therapy techniques|physical therapy techniques
743576|NCT00461474|Motor performance|motor performance
743577|NCT00461448|Potassium supplement|potassium supplement
743578|NCT00461448|Rheumatoid Arthritis|rheumatoid arthritis
743579|NCT00461448|Pain|pain
743580|NCT00461448|Disease Activity|disease activity
743582|NCT00461422|GnRH antagonist|gnrh antagonist
743583|NCT00461396|Relapsing-Remitting Multiple Sclerosis|relapsing-remitting multiple sclerosis
743584|NCT00461396|First demyelinating event|first demyelinating event
743585|NCT00461396|MRI features consistent with MS|mri features consistent with ms
743586|NCT00461370|safety|safety
743587|NCT00461370|Phase 1|phase 1
743588|NCT00461370|pharmacokinetics|pharmacokinetics
743589|NCT00461370|SRX251|srx251
743590|NCT00461370|Azevan|azevan
743591|NCT00461370|safety in healthy volunteers|safety in healthy volunteers
743592|NCT00461357|Old for Old|old for old
743593|NCT00461357|Eurotransplant Senior Program|eurotransplant senior program
743594|NCT00461357|Glomerular Filtration Rate|glomerular filtration rate
743595|NCT00461344|Breast|breast
743596|NCT00461331|Type 1 diabetes mellitus|type 1 diabetes mellitus
743597|NCT00461331|Glycemic control|glycemic control
743598|NCT00461331|Continuous subcutaneous insulin infusion|continuous subcutaneous insulin infusion
743599|NCT00461331|Continuous glucose monitoring system|continuous glucose monitoring system
743600|NCT00461318|vocational rehabilitation|vocational rehabilitation
743601|NCT00461318|psychosis|psychosis
743602|NCT00461318|cross country comparison|cross country comparison
743603|NCT00461305|Dysmenorrhea|dysmenorrhea
743604|NCT00461305|Intracyclic bleeding|intracyclic bleeding
743605|NCT00461305|Drospirenone (DRSP)|drospirenone (drsp)
743606|NCT00461305|Ethinylestradiol|ethinylestradiol
743607|NCT00461279|attachment|attachment
743608|NCT00461279|depression|depression
743609|NCT00461279|IPT|ipt
743610|NCT00461279|CBT|cbt
743611|NCT00461279|pharmacotherapy|pharmacotherapy
743612|NCT00461266|Treatment Experienced|treatment experienced
743613|NCT00461253|breast cancer|breast cancer
743614|NCT00461240|heart|heart
743615|NCT00461240|MRS|mrs
743617|NCT00461240|growth hormone|growth hormone
743618|NCT00461227|Puerto Rican|puerto rican
743619|NCT00461227|Allergies|allergies
743620|NCT00461214|laparoscopy|laparoscopy
743621|NCT00461214|surgery|surgery
743622|NCT00461214|technical skills|technical skills
743623|NCT00461214|outcomes|outcomes
743624|NCT00461214|resident training|resident training
743625|NCT00461201|Health Services Research|health services research
743626|NCT00461201|Nurse Practitioners|nurse practitioners
743627|NCT00461201|Outcome and Process Assessment (Health Care)|outcome and process assessment (health care)
743628|NCT00461201|Patient Acceptance of Health Care|patient acceptance of health care
743629|NCT00461201|Patient Satisfaction|patient satisfaction
743630|NCT00461201|Primary Health Care|primary health care
743631|NCT00461201|Professional Autonomy|professional autonomy
743632|NCT00461188|acromegaly|acromegaly
743633|NCT00461188|gigantism|gigantism
743634|NCT00461188|familial pituitary adenoma|familial pituitary adenoma
743635|NCT00461188|Familial acromegaly|familial acromegaly
743636|NCT00461188|Familial Isolated Pituitary Adenoma|familial isolated pituitary adenoma
743637|NCT00461188|FIPA|fipa
743638|NCT00461188|Pituitary adenoma predisposition|pituitary adenoma predisposition
743639|NCT00461188|PAP|pap
743640|NCT00461175|Uterine Perforation|uterine perforation
743641|NCT00461149|Acromegaly|acromegaly
743642|NCT00461149|GH|gh
743643|NCT00461149|IGF-I|igf-i
743644|NCT00461149|Pituitary tumors|pituitary tumors
743645|NCT00461149|Octreotide|octreotide
743646|NCT00461136|Time course|time course
743647|NCT00461136|antiproteinuric|antiproteinuric
743648|NCT00461136|blood pressure|blood pressure
743649|NCT00461136|lowering effect|lowering effect
743650|NCT00461136|initiation of renin inhibition|initiation of renin inhibition
743651|NCT00461136|Aliskiren in Type 2 diabetes|aliskiren in type 2 diabetes
743652|NCT00461136|incipient and/or established nephropathy|incipient and/or established nephropathy
743653|NCT00461097|Egg Allergy|egg allergy
743654|NCT00461097|Egg Oral Immunotherapy (OIT)|egg oral immunotherapy (oit)
743655|NCT00461097|Food Allergy|food allergy
743656|NCT00461084|Lymphoma|lymphoma
743657|NCT00461084|Advanced Stage|advanced stage
743658|NCT00461084|Untreated|untreated
743659|NCT00461084|Advanced Stage Lymphoma|advanced stage lymphoma
743660|NCT00461084|Untreated Lymphoma|untreated lymphoma
743661|NCT00461084|07-038|07-038
743662|NCT00461071|Bulimia nervosa|bulimia nervosa
743663|NCT00461071|Guided Self-help|guided self-help
743664|NCT00461071|Psycho-education|psycho-education
743665|NCT00461045|multiple myeloma|multiple myeloma
743666|NCT00461045|proteasome inhibitor|proteasome inhibitor
743667|NCT00461045|relapsed|relapsed
743668|NCT00461045|refractory|refractory
743669|NCT00460993|Aging|aging
743670|NCT00460993|Sleep|sleep
743671|NCT00460993|Nursing Home|nursing home
743672|NCT00460993|Sleep in nursing homes|sleep in nursing homes
743673|NCT00460980|resident training|resident training
743674|NCT00460980|laparoscopic skills|laparoscopic skills
743675|NCT00460980|surgical skills assessment|surgical skills assessment
743774|NCT00460590|Tuberculosis|tuberculosis
743676|NCT00460967|non-Exudative (Dry) Age-Related Macular Degeneration|non-exudative (dry) age-related macular degeneration
743677|NCT00460928|congenital heart block|congenital heart block
743678|NCT00460928|neonatal lupus|neonatal lupus
743679|NCT00460928|systemic lupus erythematosus|systemic lupus erythematosus
743680|NCT00460928|Sjogren syndrome|sjogren syndrome
743681|NCT00460928|autoantibodies|autoantibodies
743682|NCT00460928|SSA/Ro|ssa/ro
743683|NCT00460928|SSB/La|ssb/la
743684|NCT00460928|autoimmunity|autoimmunity
743685|NCT00460928|pregnancy|pregnancy
743686|NCT00460928|intravenous immune globulin|intravenous immune globulin
743687|NCT00460928|IVIG|ivig
743688|NCT00460928|immunoglobulin|immunoglobulin
743689|NCT00460915|Lacidipine|lacidipine
743690|NCT00460915|Amlodipine|amlodipine
743691|NCT00460902|TMS|tms
743692|NCT00460902|drug resistant depression|drug resistant depression
743693|NCT00460889|hand assist|hand assist
743694|NCT00460889|laparoscopy|laparoscopy
743695|NCT00460889|renal donor|renal donor
743696|NCT00460889|outcomes|outcomes
743697|NCT00460876|topotecan|topotecan
743698|NCT00460876|periocular|periocular
743699|NCT00460876|chemotherapy|chemotherapy
743700|NCT00460863|sleep|sleep
743701|NCT00460863|hemodialysis|hemodialysis
743702|NCT00460863|daytime sleepiness|daytime sleepiness
743703|NCT00460863|temperature|temperature
743704|NCT00460837|colorectal cancer|colorectal cancer
743705|NCT00460837|bowel preparation regimen|bowel preparation regimen
743706|NCT00460837|patients with symptoms attributable to colorectal cancer|patients with symptoms attributable to colorectal cancer
743707|NCT00460824|transplant|transplant
743708|NCT00460824|HLA antibodies matching|hla antibodies matching
743709|NCT00460824|immunologic mismatching|immunologic mismatching
743710|NCT00460811|Irritable Bowel Syndrome with Constipation|irritable bowel syndrome with constipation
743711|NCT00460811|IBS|ibs
743712|NCT00460811|Irritable Bowel Syndrome|irritable bowel syndrome
743713|NCT00460811|linaclotide acetate|linaclotide acetate
743714|NCT00460811|linaclotide|linaclotide
743715|NCT00460811|MD-1100|md-1100
743716|NCT00460798|Sunitinib|sunitinib
743717|NCT00460798|kidney diseases|kidney diseases
743718|NCT00460798|urogenital neoplasms|urogenital neoplasms
743719|NCT00460798|kidney cancer|kidney cancer
743720|NCT00460759|Mycobacterium tuberculosis, rifapentine, moxifloxacin|mycobacterium tuberculosis, rifapentine, moxifloxacin
743721|NCT00460746|HIV|hiv
743722|NCT00460746|AIDS|aids
743723|NCT00460746|Immunodeficiency Virus, Human|immunodeficiency virus, human
743724|NCT00460746|PREZISTA|prezista
743725|NCT00460746|darunavir|darunavir
743726|NCT00460746|TMC114|tmc114
743727|NCT00460746|TMC125|tmc125
743728|NCT00460746|Protease Inhibitor|protease inhibitor
743729|NCT00460746|Non-Nucleoside Reverse Transcriptase Inhibitor|non-nucleoside reverse transcriptase inhibitor
743730|NCT00460746|enfuvirtide|enfuvirtide
743731|NCT00460746|Treatment Experienced|treatment experienced
743732|NCT00460720|Attention Deficit Hyperactivity Disorder|attention deficit hyperactivity disorder
743733|NCT00460720|ADHD|adhd
743734|NCT00460720|Methylphenidate|methylphenidate
743735|NCT00460720|MPH|mph
743736|NCT00460720|Extended-Release Methylphenidate|extended-release methylphenidate
743737|NCT00460707|GW679769|gw679769
743738|NCT00460707|healthy adult subjects|healthy adult subjects
743739|NCT00460707|casopitant|casopitant
743740|NCT00460707|ketoconazole|ketoconazole
743741|NCT00460694|allogeneic transplant|allogeneic transplant
743742|NCT00460694|haematological malignancies|haematological malignancies
743743|NCT00460694|allogeneic CIK cells|allogeneic cik cells
743744|NCT00460681|Hepatocellular Carcinoma|hepatocellular carcinoma
743745|NCT00460681|Thymopentin|thymopentin
743746|NCT00460681|Recurrence|recurrence
743747|NCT00460681|Resection|resection
743748|NCT00460668|elective thoracotomy|elective thoracotomy
743749|NCT00460668|pulmonary rehabilitation|pulmonary rehabilitation
743750|NCT00460668|quality of life|quality of life
743751|NCT00460655|Post-Stroke|post-stroke
743752|NCT00460655|Lower Limb|lower limb
743753|NCT00460655|botulinum toxin type A|botulinum toxin type a
743754|NCT00460655|Spasticity|spasticity
743755|NCT00460642|Frozen embryo transfers (FET).|frozen embryo transfers (fet).
743756|NCT00460642|Egg donation (ED).|egg donation (ed).
743757|NCT00460642|IVF.|ivf.
743758|NCT00460642|ART.|art.
743759|NCT00460642|Implantation.|implantation.
743760|NCT00460642|GnRH antagonist.|gnrh antagonist.
743761|NCT00460642|Cetrotide.|cetrotide.
743762|NCT00460642|Endometrial response.|endometrial response.
743763|NCT00460642|Infertility treatments:|infertility treatments:
743764|NCT00460642|Transfer of embryos from egg donation (ED) to recipients.|transfer of embryos from egg donation (ed) to recipients.
743765|NCT00460629|Adoptive immunotherapy|adoptive immunotherapy
743766|NCT00460629|BCR-ABL reactive T cells|bcr-abl reactive t cells
743767|NCT00460629|Allogeneic Transplantation|allogeneic transplantation
743768|NCT00460616|Prolactin|prolactin
743769|NCT00460616|Prolactinomas|prolactinomas
743770|NCT00460616|Dopamine-Agonists|dopamine-agonists
743771|NCT00460616|Cabergoline|cabergoline
743772|NCT00460616|Cardiac valve disease|cardiac valve disease
743773|NCT00460603|GI neoplasms (phase 1)|gi neoplasms (phase 1)
743777|NCT00460577|Asthma, Formoterol, Bronchial Obstruction, Children|asthma, formoterol, bronchial obstruction, children
743778|NCT00460564|Spasticity|spasticity
743779|NCT00460564|Post-Stroke|post-stroke
743780|NCT00460564|botulinum toxin type A|botulinum toxin type a
743781|NCT00460564|Upper Limb|upper limb
743782|NCT00460538|Seasonal allergic rhinitis|seasonal allergic rhinitis
743783|NCT00460538|lectranal|lectranal
743784|NCT00460538|allergy|allergy
743785|NCT00460525|malaria, Mali, children, Plasmodium falciparum, vaccine|malaria, mali, children, plasmodium falciparum, vaccine
743786|NCT00460512|Schizophrenia|schizophrenia
743787|NCT00460512|Flexible dosing|flexible dosing
743788|NCT00460512|Non-acute patients|non-acute patients
743789|NCT00460512|Antipsychotic|antipsychotic
743790|NCT00460512|Atypical|atypical
743791|NCT00460512|INVEGA|invega
743792|NCT00460499|Diabetes|diabetes
743793|NCT00460473|Mental Health|mental health
743794|NCT00460473|Neurological Disease|neurological disease
743795|NCT00460473|Hip Injuries and Disorders|hip injuries and disorders
743796|NCT00460460|Phase I|phase i
743797|NCT00460460|cancer|cancer
743798|NCT00460460|lymphoma|lymphoma
743799|NCT00460460|leukemia|leukemia
743800|NCT00460460|myeloma|myeloma
743801|NCT00460460|AML|aml
743802|NCT00460460|ALL|all
743803|NCT00460460|NHL|nhl
743804|NCT00460460|MM|mm
743805|NCT00460447|anti-CD33|anti-cd33
743806|NCT00460447|Immunotoxin|immunotoxin
743807|NCT00460447|Acute myeloid leukemia|acute myeloid leukemia
743808|NCT00460434|Prolapse|prolapse
743809|NCT00460434|Urinary incontinence|urinary incontinence
743810|NCT00460434|TVT|tvt
743811|NCT00460421|Oral Mucositis|oral mucositis
743812|NCT00460421|Acute Lymphoblastic Leukemia|acute lymphoblastic leukemia
743813|NCT00460421|Acute Myeloid Leukemia|acute myeloid leukemia
743814|NCT00460421|Palifermin|palifermin
743815|NCT00460421|Kepivance|kepivance
743816|NCT00460408|Macular degeneration|macular degeneration
743817|NCT00460408|Safety|safety
743818|NCT00460408|Non-interventional|non-interventional
743819|NCT00460408|Non-randomized|non-randomized
743820|NCT00460395|Brain Metastasis|brain metastasis
743821|NCT00460395|Cerebral Metastases|cerebral metastases
743822|NCT00460395|Brain Cancer|brain cancer
743823|NCT00460395|Stereotactic Radiosurgery|stereotactic radiosurgery
743824|NCT00460395|Craniotomy|craniotomy
743825|NCT00460382|HIV infections|hiv infections
743826|NCT00460382|HIV integrase inhibitor|hiv integrase inhibitor
743827|NCT00460382|etravirine|etravirine
743828|NCT00460382|darunavir|darunavir
743829|NCT00460382|MK 0518|mk 0518
743830|NCT00460382|raltegravir|raltegravir
743831|NCT00460382|Treatment Experienced|treatment experienced
743832|NCT00460382|Antiviral drug resistance|antiviral drug resistance
743833|NCT00460369|uncomplicated malaria|uncomplicated malaria
743834|NCT00460369|children|children
743835|NCT00460369|treatment|treatment
743836|NCT00460369|effectiveness|effectiveness
743837|NCT00460343|patient non-adherence|patient non-adherence
743838|NCT00460343|antihypertensive agents|antihypertensive agents
743839|NCT00460343|community pharmacy services|community pharmacy services
743840|NCT00460343|professional roles|professional roles
743841|NCT00460330|diagnosis|diagnosis
743842|NCT00460330|galactomannan|galactomannan
743843|NCT00460330|glucan|glucan
743844|NCT00460330|real-time PCR|real-time pcr
743845|NCT00460330|invasive fungal infection|invasive fungal infection
743846|NCT00460330|aspergillosis|aspergillosis
743847|NCT00460330|Chinese patients|chinese patients
743848|NCT00460317|lung|lung
743849|NCT00460317|cancer|cancer
743850|NCT00460317|chemotherapy|chemotherapy
743851|NCT00460317|paclitaxel|paclitaxel
743852|NCT00460317|carboplatin|carboplatin
743853|NCT00460317|placebo|placebo
743854|NCT00460317|angiogenesis|angiogenesis
743855|NCT00460317|VEGF|vegf
743856|NCT00460317|multi kinase inhibitor|multi kinase inhibitor
743857|NCT00460304|Type I diabetes|type i diabetes
743858|NCT00460304|Insulin pump|insulin pump
743859|NCT00460304|Continuous glucose monitoring|continuous glucose monitoring
743860|NCT00460304|Insulin to carbohydrate ratio|insulin to carbohydrate ratio
743861|NCT00460304|Correction factor|correction factor
743862|NCT00460304|Pramlintide|pramlintide
743863|NCT00460291|PAD|pad
743864|NCT00460291|vein bypass|vein bypass
743865|NCT00460291|supported varicose veins|supported varicose veins
743866|NCT00460278|Cancer|cancer
743867|NCT00460278|Solid Tumors|solid tumors
743868|NCT00460265|Squamous Cell Carcinoma|squamous cell carcinoma
743869|NCT00460265|Epidermal Growth Factor|epidermal growth factor
743870|NCT00460265|Epidermal Growth Factor Receptor|epidermal growth factor receptor
743871|NCT00460265|SCCHN|scchn
743872|NCT00460265|Metastatic Head and Neck Cancer|metastatic head and neck cancer
743873|NCT00460265|EGFr|egfr
743874|NCT00460265|Head and Neck Cancer|head and neck cancer
743875|NCT00460265|Recurrent Head and Neck Cancer|recurrent head and neck cancer
743876|NCT00460252|algorithm|algorithm
743877|NCT00460252|insulin|insulin
743878|NCT00460252|hyperglycemia|hyperglycemia
743879|NCT00460252|tight glycemic control|tight glycemic control
743880|NCT00460252|intensive care|intensive care
743882|NCT00460239|Opioid addiction|opioid addiction
743883|NCT00460239|Opioid dependence|opioid dependence
743884|NCT00460239|Buprenorphine|buprenorphine
743885|NCT00460226|Korean|korean
743886|NCT00460226|Bipolar I disorder|bipolar i disorder
743887|NCT00460226|Non-serious rash|non-serious rash
743888|NCT00460226|Lamotrigine|lamotrigine
743889|NCT00460213|home blood pressure|home blood pressure
743890|NCT00460200|depression|depression
743891|NCT00460200|fatigue|fatigue
743892|NCT00460200|sleep disorders|sleep disorders
743893|NCT00460200|psychosocial effects of cancer and its treatment|psychosocial effects of cancer and its treatment
743894|NCT00460200|ovarian epithelial cancer|ovarian epithelial cancer
743895|NCT00460187|carotid artery, distal protection device, carotid stenting|carotid artery, distal protection device, carotid stenting
743896|NCT00460174|stage I pancreatic cancer|stage i pancreatic cancer
743897|NCT00460174|stage II pancreatic cancer|stage ii pancreatic cancer
743898|NCT00460174|stage III pancreatic cancer|stage iii pancreatic cancer
743899|NCT00460161|acupuncture|acupuncture
743900|NCT00460161|amputation|amputation
743901|NCT00460161|phantom limb pain|phantom limb pain
743902|NCT00460148|ropinirole PR/CR,|ropinirole pr/cr,
743903|NCT00460148|pharmacokinetic,|pharmacokinetic,
743904|NCT00460148|formulation,|formulation,
743905|NCT00460148|food effect,|food effect,
743906|NCT00460148|SK&F101468,|sk&f101468,
743907|NCT00460148|PD|pd
743908|NCT00460135|Resistance|resistance
743909|NCT00460135|Training|training
743910|NCT00460135|Obesity|obesity
743911|NCT00460135|Children|children
743912|NCT00460122|Human Leukocyte Antigens (HLA)|human leukocyte antigens (hla)
743913|NCT00460122|Transfusion Reactions|transfusion reactions
743914|NCT00460122|Platelet Donors|platelet donors
743915|NCT00460109|stage III grade 1 follicular lymphoma|stage iii grade 1 follicular lymphoma
743916|NCT00460109|stage III grade 2 follicular lymphoma|stage iii grade 2 follicular lymphoma
744016|NCT00459719|Liver Transplantation|liver transplantation
743917|NCT00460109|stage IV grade 1 follicular lymphoma|stage iv grade 1 follicular lymphoma
743918|NCT00460109|stage IV grade 2 follicular lymphoma|stage iv grade 2 follicular lymphoma
743919|NCT00460096|Pulmonary Emphysema|pulmonary emphysema
743920|NCT00460083|Atopic Dermatitis|atopic dermatitis
743921|NCT00460083|eczema|eczema
743922|NCT00460083|dermatitis|dermatitis
743923|NCT00460083|skin barrier|skin barrier
743924|NCT00460083|barrier repair|barrier repair
743925|NCT00460083|ceramide|ceramide
743926|NCT00460083|physiologic lipid|physiologic lipid
743927|NCT00460083|pruritus|pruritus
743928|NCT00460083|Elidel|elidel
743929|NCT00460083|Epiceram|epiceram
743930|NCT00460083|topical steroid|topical steroid
743931|NCT00460057|osteoporosis|osteoporosis
743932|NCT00460057|alendronate|alendronate
743933|NCT00460057|bone marker|bone marker
743934|NCT00460044|ADMA|adma
743935|NCT00460044|Preterms|preterms
743936|NCT00460044|infants|infants
743937|NCT00460044|mechanical ventilation|mechanical ventilation
743938|NCT00460044|Preterm infants|preterm infants
743939|NCT00460031|adenocarcinoma of the prostate|adenocarcinoma of the prostate
743940|NCT00460031|stage III prostate cancer|stage iii prostate cancer
743941|NCT00460031|stage IV prostate cancer|stage iv prostate cancer
743942|NCT00460031|recurrent prostate cancer|recurrent prostate cancer
743943|NCT00460018|Gestational Diabetes Mellitus|gestational diabetes mellitus
743944|NCT00460018|Weight Loss|weight loss
743945|NCT00460018|Physical Activity|physical activity
743946|NCT00460018|Breastfeeding|breastfeeding
743947|NCT00460018|Pregnancy|pregnancy
743948|NCT00460018|Postpartum|postpartum
743949|NCT00460018|Intervention|intervention
743950|NCT00460018|Prevention|prevention
743951|NCT00460005|Migraine|migraine
743952|NCT00460005|headache|headache
743953|NCT00460005|observational|observational
743954|NCT00459992|Obesity|obesity
743955|NCT00459992|Weight Gain|weight gain
743956|NCT00459992|Adult|adult
743957|NCT00459992|Histamine|histamine
743958|NCT00459992|Metabolism|metabolism
743959|NCT00459992|Overweight|overweight
743960|NCT00459979|clear cell renal cell carcinoma|clear cell renal cell carcinoma
743961|NCT00459979|stage III renal cell cancer|stage iii renal cell cancer
743962|NCT00459979|stage IV renal cell cancer|stage iv renal cell cancer
743963|NCT00459979|papillary renal cell carcinoma|papillary renal cell carcinoma
743964|NCT00459940|Growth hormone|growth hormone
743965|NCT00459940|Lipolysis|lipolysis
743966|NCT00459940|Insulin resistance|insulin resistance
743967|NCT00459940|Pioglitazone|pioglitazone
743968|NCT00459940|Growth hormone replaced growth hormone deficient adults|growth hormone replaced growth hormone deficient adults
743969|NCT00459927|Adenotonsillectomy|adenotonsillectomy
743970|NCT00459927|Coblation tonsillectomy|coblation tonsillectomy
743971|NCT00459927|Floseal|floseal
743972|NCT00459914|sleep apnea|sleep apnea
743973|NCT00459914|refractory hypertension|refractory hypertension
743974|NCT00459914|continuous positive airway pressure|continuous positive airway pressure
743975|NCT00459901|Metastatic Colorectal Cancer|metastatic colorectal cancer
743976|NCT00459888|CLI|cli
743977|NCT00459888|Critical Limb Ischemia|critical limb ischemia
743978|NCT00459888|Infrapopliteal|infrapopliteal
743980|NCT00459875|recurrent renal cell cancer|recurrent renal cell cancer
743981|NCT00459875|stage IV renal cell cancer|stage iv renal cell cancer
743982|NCT00459849|Melanoma|melanoma
743983|NCT00459849|Brachytherapy|brachytherapy
743984|NCT00459849|Ultrasonography|ultrasonography
743985|NCT00459836|unspecified adult solid tumor, protocol specific|unspecified adult solid tumor, protocol specific
743986|NCT00459823|Cancer|cancer
743987|NCT00459823|solid tumors|solid tumors
743988|NCT00459810|adenocarcinoma of the prostate|adenocarcinoma of the prostate
743989|NCT00459810|recurrent prostate cancer|recurrent prostate cancer
743990|NCT00459810|stage IV prostate cancer|stage iv prostate cancer
743991|NCT00459797|GlideScope|glidescope
743992|NCT00459797|cobalt|cobalt
743993|NCT00459797|single-use|single-use
743994|NCT00459797|intubation|intubation
743995|NCT00459797|airway|airway
743996|NCT00459797|Elective surgical patients requiring orotracheal intubation|elective surgical patients requiring orotracheal intubation
743997|NCT00459784|Improvement|improvement
743998|NCT00459784|Dementia early diagnosis|dementia early diagnosis
743999|NCT00459784|Dementia management|dementia management
744000|NCT00459784|Primary care|primary care
744001|NCT00459771|angiotensin II-receptor (AT1) blocker|angiotensin ii-receptor (at1) blocker
744002|NCT00459771|prevention|prevention
744003|NCT00459771|trastuzumab|trastuzumab
744004|NCT00459771|cardiotoxicity|cardiotoxicity
744005|NCT00459758|hypertension|hypertension
744006|NCT00459758|Hans|hans
744007|NCT00459758|Electrical stimulation|electrical stimulation
744008|NCT00459745|Cardiovascular Disease|cardiovascular disease
744009|NCT00459745|Fenofibrate|fenofibrate
744010|NCT00459745|LDL cholesterol|ldl cholesterol
744011|NCT00459745|HDL cholesterol|hdl cholesterol
744012|NCT00459745|Hyperlipidemia|hyperlipidemia
744013|NCT00459745|Pravastatin|pravastatin
744014|NCT00459745|Triglycerides|triglycerides
744015|NCT00459732|zinc, thalassemia, bone mineral density|zinc, thalassemia, bone mineral density
744018|NCT00459719|Methylprednisolone|methylprednisolone
744019|NCT00459719|Prednisolone|prednisolone
744020|NCT00459706|Rheumatoid Arthritis|rheumatoid arthritis
744021|NCT00459693|HIV-Dementia|hiv-dementia
744022|NCT00459693|Brain|brain
744023|NCT00459693|PET|pet
744024|NCT00459693|PBR28|pbr28
744025|NCT00459693|MCMD|mcmd
744026|NCT00459693|HIV Positive|hiv positive
744027|NCT00459693|HIV Dementia|hiv dementia
744028|NCT00459693|AIDS Related Dementia|aids related dementia
744029|NCT00459693|Minor Cognitive Motor Disorder|minor cognitive motor disorder
744030|NCT00459693|Healthy Volunteer|healthy volunteer
744031|NCT00459693|HV|hv
744032|NCT00459680|hypertension|hypertension
744033|NCT00459680|acupuncture|acupuncture
744034|NCT00459680|laser|laser
744035|NCT00459667|Relapsing multiple sclerosis|relapsing multiple sclerosis
744036|NCT00459667|interferon beta 1b|interferon beta 1b
744037|NCT00459667|Betaferon|betaferon
744038|NCT00459667|Betaseron|betaseron
744039|NCT00459654|HRPC|hrpc
744040|NCT00459654|Recurrent Prostate Cancer|recurrent prostate cancer
744041|NCT00459654|Metastatic Cancer|metastatic cancer
744042|NCT00459641|Osteogenic Gel|osteogenic gel
744043|NCT00459641|Solitary Bone Cysts|solitary bone cysts
744044|NCT00459628|early breast cancer|early breast cancer
744045|NCT00459628|post-operative radiation treatment|post-operative radiation treatment
744046|NCT00459602|laparoscopic surgery|laparoscopic surgery
744047|NCT00459589|Cancer|cancer
744048|NCT00459589|elderly|elderly
744049|NCT00459589|malnutrition|malnutrition
744050|NCT00459589|chemotherapy|chemotherapy
744051|NCT00459589|survival|survival
744052|NCT00459589|comprehensive geriatric assessment|comprehensive geriatric assessment
744053|NCT00459589|morbidity|morbidity
744054|NCT00459576|Asthma|asthma
744055|NCT00459576|Eczema|eczema
744056|NCT00459576|Dermatitis, Atopic|dermatitis, atopic
744057|NCT00459576|Infant|infant
744058|NCT00459563|vitamin D|vitamin d
744059|NCT00459563|blood pressure|blood pressure
744060|NCT00459563|hypertension|hypertension
744061|NCT00459563|Vitamin D insufficient|vitamin d insufficient
744062|NCT00459563|Systolic blood pressure between 130 and 150 mmHg|systolic blood pressure between 130 and 150 mmhg
744063|NCT00459550|Alzheimer's Disease|alzheimer's disease
744064|NCT00459550|First Time in Human (FTIH) Study|first time in human (ftih) study
744065|NCT00459537|Toenail fungus|toenail fungus
744066|NCT00459537|Onychomycosis|onychomycosis
744067|NCT00459537|Nail fungus|nail fungus
744068|NCT00459537|Toenail fungal infection|toenail fungal infection
744069|NCT00459537|Tinea unguium|tinea unguium
744070|NCT00459537|Dermatophytes|dermatophytes
744071|NCT00459537|Foot dermatoses|foot dermatoses
744072|NCT00459524|Acute Myelogenous Leukemia|acute myelogenous leukemia
744073|NCT00459524|Myelodysplastic Syndrome|myelodysplastic syndrome
744074|NCT00459524|Leukemia|leukemia
744075|NCT00459524|Quality of Life|quality of life
744076|NCT00459524|Questionnaire|questionnaire
744078|NCT00459524|Neurocognitive Function|neurocognitive function
744079|NCT00459524|AML|aml
744080|NCT00459524|MDS|mds
744081|NCT00459524|QOL|qol
744082|NCT00459511|Adrenomedullin|adrenomedullin
744083|NCT00459511|Glucose|glucose
744085|NCT00459511|Systemic Inflammatory response Syndrome|systemic inflammatory response syndrome
744086|NCT00459511|Pediatric|pediatric
744087|NCT00459511|Cortisol|cortisol
744088|NCT00459511|ACTH|acth
744089|NCT00459498|NIS|nis
744090|NCT00459498|thyroid adenoma|thyroid adenoma
744091|NCT00459498|thyroid cancer|thyroid cancer
744092|NCT00459498|Iodine uptake|iodine uptake
744093|NCT00459498|expression|expression
744094|NCT00459485|Plasm zinc concentration|plasm zinc concentration
744095|NCT00459485|Zinc supplementation|zinc supplementation
744096|NCT00459485|Assessment of zinc status|assessment of zinc status
744097|NCT00459485|Plasma zinc concentration|plasma zinc concentration
744098|NCT00459472|resident training|resident training
744099|NCT00459472|laparoscopy|laparoscopy
744100|NCT00459472|virtual reality|virtual reality
744101|NCT00459472|surgical education|surgical education
744102|NCT00459446|Magnetic Resonance Imaging|magnetic resonance imaging
744103|NCT00459446|Gadolinium Contrast|gadolinium contrast
744104|NCT00459446|Gadofosveset|gadofosveset
744105|NCT00459446|Atherosclerosis|atherosclerosis
744106|NCT00459446|Chronic Total Arterial Occlusions|chronic total arterial occlusions
744107|NCT00459446|Cardiovascular Disease|cardiovascular disease
744108|NCT00459446|Blocked Arteries|blocked arteries
744109|NCT00459446|Peripheral Artery Disease|peripheral artery disease
744110|NCT00459446|PAD|pad
744111|NCT00459446|Intermittent Claudication|intermittent claudication
744112|NCT00459446|Chronic Total Arterial Occlusion|chronic total arterial occlusion
744113|NCT00459433|Low back pain|low back pain
744114|NCT00459433|Return to work|return to work
744115|NCT00459433|Biopsychosocial|biopsychosocial
744116|NCT00459433|Screening|screening
744117|NCT00459433|SMS|sms
744118|NCT00459433|Non specific low back pain|non specific low back pain
744119|NCT00459420|Parkinson's disease|parkinson's disease
744120|NCT00459420|Excessive Daytime Somnolence|excessive daytime somnolence
744122|NCT00459420|Disease-Modifying|disease-modifying
744123|NCT00459368|asthma|asthma
744124|NCT00459368|patient compliance|patient compliance
744125|NCT00459368|metered dose inhalers|metered dose inhalers
744126|NCT00459368|corticosteroids|corticosteroids
744127|NCT00459368|health behaviour|health behaviour
744128|NCT00459368|prevention & control|prevention & control
744129|NCT00459355|Alzheimer's disease|alzheimer's disease
744130|NCT00459355|Dementia|dementia
744131|NCT00459355|Safety|safety
744132|NCT00459355|Home Care Services|home care services
744133|NCT00459329|Depression|depression
744134|NCT00459329|Epilepsy|epilepsy
744135|NCT00459329|Problem-Solving Therapy|problem-solving therapy
744136|NCT00459329|Mental Health|mental health
744137|NCT00459329|Neurology|neurology
744138|NCT00459329|Home-based health care|home-based health care
744139|NCT00459329|Community-based program|community-based program
744140|NCT00459329|Collaborative care|collaborative care
744141|NCT00459303|cataract|cataract
744142|NCT00459303|aspherical intraocular lenses|aspherical intraocular lenses
744143|NCT00459303|functional vision|functional vision
744144|NCT00459290|recurrent ovarian epithelial cancer|recurrent ovarian epithelial cancer
744145|NCT00459290|primary peritoneal cavity cancer|primary peritoneal cavity cancer
744146|NCT00459290|fallopian tube cancer|fallopian tube cancer
744147|NCT00459277|Pain|pain
744148|NCT00459277|Cancer|cancer
744149|NCT00459264|Folic Acid|folic acid
744150|NCT00459264|Prevention|prevention
744151|NCT00459264|Depression|depression
744152|NCT00459264|Bipolar Disorder|bipolar disorder
744153|NCT00459264|Teenagers|teenagers
744154|NCT00459251|N-acetyltransferase|n-acetyltransferase
744155|NCT00459251|Pharmacogenetics|pharmacogenetics
744156|NCT00459238|unspecified childhood solid tumor, protocol specific|unspecified childhood solid tumor, protocol specific
744157|NCT00459225|Pediatrics|pediatrics
744158|NCT00459225|Cardiac Defect|cardiac defect
744159|NCT00459225|Cardiac Surgery|cardiac surgery
744160|NCT00459225|Single Ventricle|single ventricle
744161|NCT00459225|Anemia|anemia
744162|NCT00459225|blood transfusions|blood transfusions
744163|NCT00459225|red cell volume|red cell volume
744164|NCT00459225|red cell distribution|red cell distribution
744165|NCT00459225|oral iron|oral iron
744166|NCT00459225|ferrous sulfate|ferrous sulfate
744167|NCT00459225|Congenital Cardiac Defects|congenital cardiac defects
744168|NCT00459225|Hemoglobin|hemoglobin
744169|NCT00459225|Iron Deficiency|iron deficiency
744170|NCT00459186|prostate cancer|prostate cancer
744171|NCT00459186|RAD001|rad001
744172|NCT00459186|mTOR inhibition|mtor inhibition
744173|NCT00459186|docetaxel|docetaxel
744174|NCT00459173|abstinence|abstinence
744175|NCT00459173|maintenance|maintenance
744176|NCT00459160|Hypotensive Resuscitation|hypotensive resuscitation
744177|NCT00459160|Hypotensive Anesthesia|hypotensive anesthesia
744178|NCT00459160|Hemorrhagic Shock|hemorrhagic shock
744179|NCT00459160|Penetrating Trauma|penetrating trauma
744180|NCT00459134|sexual dysfunction|sexual dysfunction
744181|NCT00459134|sexuality and reproductive issues|sexuality and reproductive issues
744182|NCT00459134|unspecified adult solid tumor, protocol specific|unspecified adult solid tumor, protocol specific
744183|NCT00459121|stage I non-small cell lung cancer|stage i non-small cell lung cancer
744184|NCT00459121|stage II non-small cell lung cancer|stage ii non-small cell lung cancer
744185|NCT00459121|stage IIIA non-small cell lung cancer|stage iiia non-small cell lung cancer
744186|NCT00459082|Dexmedetomine|dexmedetomine
744187|NCT00459082|Post-operative cardiac surgery|post-operative cardiac surgery
744188|NCT00459069|tumor vaccine|tumor vaccine
744189|NCT00459069|GM-CSF|gm-csf
744190|NCT00459043|SCCHN|scchn
744191|NCT00459030|colon cancer|colon cancer
744192|NCT00459030|rectal cancer|rectal cancer
744193|NCT00459017|24 hour ambulatory blood pressure measurement|24 hour ambulatory blood pressure measurement
744194|NCT00459017|Mean blood pressure|mean blood pressure
744195|NCT00459017|Wrist manometer|wrist manometer
744196|NCT00459017|Frequent measurement|frequent measurement
744197|NCT00459004|weight loss|weight loss
744198|NCT00458991|Recombinant Human Growth Hormone|recombinant human growth hormone
744199|NCT00458991|growth hormone deficiency|growth hormone deficiency
744200|NCT00458991|short stature|short stature
744201|NCT00458991|phenotyping|phenotyping
744203|NCT00458952|iobenguane|iobenguane
744204|NCT00458952|iodine|iodine
744205|NCT00458952|I 131|i 131
744206|NCT00458952|radiotherapy|radiotherapy
744207|NCT00458952|radiopharmaceutical|radiopharmaceutical
744208|NCT00458952|dosimetry|dosimetry
744209|NCT00458952|neuroendocrine tumor|neuroendocrine tumor
744210|NCT00458952|Ultratrace|ultratrace
744211|NCT00458952|no carrier added|no carrier added
744212|NCT00458952|metaiodobenzyl-guanidine|metaiodobenzyl-guanidine
744213|NCT00458926|ventilation, mechanical|ventilation, mechanical
744214|NCT00458926|intubation, endotracheal|intubation, endotracheal
744215|NCT00458926|respiratory insufficiency|respiratory insufficiency
744216|NCT00458913|localized malignant mesothelioma|localized malignant mesothelioma
744217|NCT00458913|recurrent malignant mesothelioma|recurrent malignant mesothelioma
744218|NCT00458913|advanced malignant mesothelioma|advanced malignant mesothelioma
744220|NCT00458887|unspecified childhood solid tumor, protocol specific|unspecified childhood solid tumor, protocol specific
744221|NCT00458874|CV risk factors|cv risk factors
744222|NCT00458874|subclinical atherosclerosis|subclinical atherosclerosis
744223|NCT00458874|lifestyle intervention|lifestyle intervention
744224|NCT00458874|motivation|motivation
744225|NCT00458861|Active Rheumatoid Arthritis (RA)|active rheumatoid arthritis (ra)
744226|NCT00458848|B-cell adult acute lymphoblastic leukemia|b-cell adult acute lymphoblastic leukemia
744227|NCT00458848|T-cell adult acute lymphoblastic leukemia|t-cell adult acute lymphoblastic leukemia
744228|NCT00458848|untreated adult acute lymphoblastic leukemia|untreated adult acute lymphoblastic leukemia
744229|NCT00458848|L1 adult acute lymphoblastic leukemia|l1 adult acute lymphoblastic leukemia
744230|NCT00458848|L2 adult acute lymphoblastic leukemia|l2 adult acute lymphoblastic leukemia
744231|NCT00458848|TdT positive adult acute lymphoblastic leukemia|tdt positive adult acute lymphoblastic leukemia
744232|NCT00458835|Allergic rhinitis|allergic rhinitis
744233|NCT00458822|primary systemic amyloidosis|primary systemic amyloidosis
744234|NCT00458809|recurrent colon cancer|recurrent colon cancer
744235|NCT00458809|stage IV colon cancer|stage iv colon cancer
744236|NCT00458809|carcinoma of the appendix|carcinoma of the appendix
744237|NCT00458809|recurrent rectal cancer|recurrent rectal cancer
744238|NCT00458809|stage IV rectal cancer|stage iv rectal cancer
744239|NCT00458809|primary peritoneal cavity cancer|primary peritoneal cavity cancer
744240|NCT00458796|hypercalcemia of malignancy|hypercalcemia of malignancy
744241|NCT00458796|musculoskeletal complications|musculoskeletal complications
744242|NCT00458796|pain|pain
744243|NCT00458796|stage IV breast cancer|stage iv breast cancer
744244|NCT00458796|male breast cancer|male breast cancer
744245|NCT00458796|recurrent breast cancer|recurrent breast cancer
744246|NCT00458796|bone metastases|bone metastases
744247|NCT00458783|Transfusion|transfusion
744248|NCT00458783|Cardiac|cardiac
744249|NCT00458783|Blood storage duration|blood storage duration
744250|NCT00458770|Comparison of a spontaneous acute cluster headache attack and rest (no pain) in ten patients with cluster headache defined with IHS criteria|comparison of a spontaneous acute cluster headache attack and rest (no pain) in ten patients with cluster headache defined with ihs criteria
744251|NCT00458757|Amputees|amputees
744252|NCT00458757|Affordance|affordance
744253|NCT00458757|Peripersonal space|peripersonal space
744254|NCT00458757|Pseudo neglect|pseudo neglect
744255|NCT00458757|Reaching|reaching
744256|NCT00458757|Spatial|spatial
744257|NCT00458757|visual|visual
744258|NCT00458744|juvenile myelomonocytic leukemia|juvenile myelomonocytic leukemia
744259|NCT00458744|relapsing chronic myelogenous leukemia|relapsing chronic myelogenous leukemia
744260|NCT00458744|unspecified childhood solid tumor, protocol specific|unspecified childhood solid tumor, protocol specific
744261|NCT00458744|childhood chronic myelogenous leukemia|childhood chronic myelogenous leukemia
744262|NCT00458744|childhood acute promyelocytic leukemia (M3)|childhood acute promyelocytic leukemia (m3)
744263|NCT00458744|recurrent childhood acute lymphoblastic leukemia|recurrent childhood acute lymphoblastic leukemia
744264|NCT00458744|recurrent childhood acute myeloid leukemia|recurrent childhood acute myeloid leukemia
744265|NCT00458744|childhood central nervous system germ cell tumor|childhood central nervous system germ cell tumor
744266|NCT00458744|childhood choroid plexus tumor|childhood choroid plexus tumor
744267|NCT00458744|childhood craniopharyngioma|childhood craniopharyngioma
744651|NCT00457392|Phase 3|phase 3
744268|NCT00458744|childhood infratentorial ependymoma|childhood infratentorial ependymoma
744269|NCT00458744|childhood grade I meningioma|childhood grade i meningioma
744270|NCT00458744|childhood grade II meningioma|childhood grade ii meningioma
744271|NCT00458744|childhood grade III meningioma|childhood grade iii meningioma
744272|NCT00458744|childhood supratentorial ependymoma|childhood supratentorial ependymoma
744273|NCT00458744|recurrent childhood brain stem glioma|recurrent childhood brain stem glioma
744274|NCT00458744|recurrent childhood cerebellar astrocytoma|recurrent childhood cerebellar astrocytoma
744275|NCT00458744|recurrent childhood cerebral astrocytoma|recurrent childhood cerebral astrocytoma
744276|NCT00458744|recurrent childhood ependymoma|recurrent childhood ependymoma
744277|NCT00458744|recurrent childhood medulloblastoma|recurrent childhood medulloblastoma
744278|NCT00458744|recurrent childhood supratentorial primitive neuroectodermal tumors|recurrent childhood supratentorial primitive neuroectodermal tumors
744279|NCT00458744|recurrent childhood visual pathway and hypothalamic glioma|recurrent childhood visual pathway and hypothalamic glioma
744280|NCT00458744|recurrent childhood visual pathway glioma|recurrent childhood visual pathway glioma
744281|NCT00458744|high-grade childhood cerebral astrocytoma|high-grade childhood cerebral astrocytoma
744282|NCT00458744|low-grade childhood cerebral astrocytoma|low-grade childhood cerebral astrocytoma
744283|NCT00458744|recurrent childhood brain tumor|recurrent childhood brain tumor
744284|NCT00458744|childhood spinal cord tumor|childhood spinal cord tumor
744285|NCT00458744|recurrent/refractory childhood Hodgkin lymphoma|recurrent/refractory childhood hodgkin lymphoma
744286|NCT00458744|stage IV childhood Hodgkin lymphoma|stage iv childhood hodgkin lymphoma
744287|NCT00458744|recurrent childhood large cell lymphoma|recurrent childhood large cell lymphoma
744288|NCT00458744|stage IV childhood large cell lymphoma|stage iv childhood large cell lymphoma
744289|NCT00458744|recurrent childhood lymphoblastic lymphoma|recurrent childhood lymphoblastic lymphoma
744290|NCT00458744|stage IV childhood lymphoblastic lymphoma|stage iv childhood lymphoblastic lymphoma
744291|NCT00458744|recurrent childhood small noncleaved cell lymphoma|recurrent childhood small noncleaved cell lymphoma
744292|NCT00458744|stage IV childhood small noncleaved cell lymphoma|stage iv childhood small noncleaved cell lymphoma
744293|NCT00458744|childhood grade III lymphomatoid granulomatosis|childhood grade iii lymphomatoid granulomatosis
744294|NCT00458744|childhood nasal type extranodal NK/T-cell lymphoma|childhood nasal type extranodal nk/t-cell lymphoma
744295|NCT00458744|recurrent childhood grade III lymphomatoid granulomatosis|recurrent childhood grade iii lymphomatoid granulomatosis
744296|NCT00458744|recurrent childhood pineoblastoma|recurrent childhood pineoblastoma
744297|NCT00458718|abstinence|abstinence
744298|NCT00458718|nicotine patch|nicotine patch
744299|NCT00458705|stage I multiple myeloma|stage i multiple myeloma
744300|NCT00458705|stage II multiple myeloma|stage ii multiple myeloma
744301|NCT00458705|stage III multiple myeloma|stage iii multiple myeloma
744302|NCT00458705|refractory multiple myeloma|refractory multiple myeloma
744303|NCT00458679|CHRONIC LYMPHOCYTIC LEUKEMIA (B-CLL)|chronic lymphocytic leukemia (b-cll)
744304|NCT00458679|CD40 LIGAND AND IL-2-EXPRESSING TUMOR CELLS|cd40 ligand and il-2-expressing tumor cells
744305|NCT00458666|Amniotic fluid|amniotic fluid
744306|NCT00458666|D-dimer|d-dimer
744307|NCT00458666|coagulation|coagulation
744308|NCT00458666|factor X activation|factor x activation
744309|NCT00458653|DC/tumor cell fusions|dc/tumor cell fusions
744310|NCT00458653|GM-CSF|gm-csf
744311|NCT00458653|high dose chemotherapy|high dose chemotherapy
744312|NCT00458627|Plethysmograpy|plethysmograpy
744313|NCT00458627|preschool|preschool
744314|NCT00458627|methacholine challenge|methacholine challenge
744315|NCT00458627|spirometry|spirometry
744316|NCT00458627|asthma|asthma
744317|NCT00458614|Cystic Fibrosis|cystic fibrosis
744318|NCT00458601|EGFRvIII vaccinetemozolomidecancer vaccineimmunotherapy|egfrviii vaccinetemozolomidecancer vaccineimmunotherapy
744319|NCT00458588|breast cancer|breast cancer
744320|NCT00458575|Retinitis Pigmentosa|retinitis pigmentosa
744321|NCT00458575|Advanced retinitis pigmentosa (RP)|advanced retinitis pigmentosa (rp)
744322|NCT00458575|CNTO 2476|cnto 2476
744323|NCT00458575|Subretinal|subretinal
744324|NCT00458575|Human umbilical tissue-derived cells (hUTC)|human umbilical tissue-derived cells (hutc)
744325|NCT00458575|Light perception (LP)|light perception (lp)
744326|NCT00458575|Hand motion (HM)|hand motion (hm)
744327|NCT00458562|cervical cancer|cervical cancer
744328|NCT00458562|atypical squamous cells of undetermined significance|atypical squamous cells of undetermined significance
744329|NCT00458562|stage 0 cervical cancer|stage 0 cervical cancer
744330|NCT00458562|cervical intraepithelial neoplasia grade 1|cervical intraepithelial neoplasia grade 1
744331|NCT00458562|cervical intraepithelial neoplasia grade 2|cervical intraepithelial neoplasia grade 2
744332|NCT00458562|cervical intraepithelial neoplasia grade 3|cervical intraepithelial neoplasia grade 3
744333|NCT00458549|stage I prostate cancer|stage i prostate cancer
744334|NCT00458549|stage II prostate cancer|stage ii prostate cancer
744335|NCT00458549|stage III prostate cancer|stage iii prostate cancer
744336|NCT00458549|stage IV prostate cancer|stage iv prostate cancer
744337|NCT00458536|GM-CSF|gm-csf
744338|NCT00458536|vaccine|vaccine
744339|NCT00458536|debulking nephrectomy|debulking nephrectomy
744340|NCT00458536|dendritic cells|dendritic cells
744341|NCT00458523|B-cell chronic lymphocytic leukemia|b-cell chronic lymphocytic leukemia
744342|NCT00458523|stage I chronic lymphocytic leukemia|stage i chronic lymphocytic leukemia
744343|NCT00458523|stage II chronic lymphocytic leukemia|stage ii chronic lymphocytic leukemia
744344|NCT00458523|stage III chronic lymphocytic leukemia|stage iii chronic lymphocytic leukemia
744345|NCT00458523|stage 0 chronic lymphocytic leukemia|stage 0 chronic lymphocytic leukemia
744346|NCT00458523|stage IV chronic lymphocytic leukemia|stage iv chronic lymphocytic leukemia
744347|NCT00458510|Pain|pain
744348|NCT00458510|Cancer|cancer
744349|NCT00458510|Breakthrough|breakthrough
744350|NCT00458497|Holofiber|holofiber
744351|NCT00458497|chronic foot pain|chronic foot pain
744352|NCT00458497|sleep quality|sleep quality
744353|NCT00458484|stage I renal cell cancer|stage i renal cell cancer
744354|NCT00458484|stage II renal cell cancer|stage ii renal cell cancer
744355|NCT00458484|stage III renal cell cancer|stage iii renal cell cancer
744356|NCT00458484|stage IV renal cell cancer|stage iv renal cell cancer
744357|NCT00458471|Urinary Catheter|urinary catheter
744358|NCT00458471|Spinal Cord Injury|spinal cord injury
744359|NCT00458471|Escherichia Coli|escherichia coli
744360|NCT00458471|Urinary Tract Infection|urinary tract infection
744361|NCT00458458|Endometriosis|endometriosis
744362|NCT00458458|Dysmenorrhea|dysmenorrhea
744363|NCT00458458|Pelvic Pain|pelvic pain
744364|NCT00458458|Period Pain|period pain
744365|NCT00458458|Menstrual Cramps|menstrual cramps
744366|NCT00458458|Dyspareunia|dyspareunia
744367|NCT00458458|Norethindrone Acetate|norethindrone acetate
744368|NCT00458458|Lupron Depot|lupron depot
744369|NCT00458458|Bone Density|bone density
744370|NCT00458458|Lipid Profile|lipid profile
744371|NCT00458445|Attention-Deficit Hyperactivity Disorder (ADHD)|attention-deficit hyperactivity disorder (adhd)
744372|NCT00458432|fMRI|fmri
744373|NCT00458432|Pavlovian Conditioning|pavlovian conditioning
744374|NCT00458432|Functional Activity|functional activity
744375|NCT00458432|Brain|brain
744376|NCT00458432|Fear|fear
744377|NCT00458432|Healthy Volunteer|healthy volunteer
744378|NCT00458432|HV|hv
744486|NCT00458042|treprostinil|treprostinil
744379|NCT00458419|dyspnea; leg discomfort; exercise duration|dyspnea; leg discomfort; exercise duration
744380|NCT00458406|obstructive sleep apnea|obstructive sleep apnea
744381|NCT00458406|child|child
744382|NCT00458406|CPAP|cpap
744383|NCT00458393|HIV|hiv
744384|NCT00458393|Chemoprophylaxis|chemoprophylaxis
744385|NCT00458393|Hepatitis|hepatitis
744386|NCT00458393|Viral human hepatitis|viral human hepatitis
744387|NCT00458393|HIV Seronegativity|hiv seronegativity
744388|NCT00458380|Doppler ultrasonography|doppler ultrasonography
744389|NCT00458380|Embryos|embryos
744390|NCT00458380|Infertility|infertility
744391|NCT00458380|IVF|ivf
744392|NCT00458380|Oocytes|oocytes
744393|NCT00458380|Tubal factor|tubal factor
744394|NCT00458380|unexplained infertility|unexplained infertility
744395|NCT00458367|PASS|pass
744396|NCT00458367|Safety Assessment|safety assessment
744397|NCT00458367|Efficacy Assessment|efficacy assessment
744398|NCT00458367|long-acting injectable risperidone|long-acting injectable risperidone
744399|NCT00458354|Spinal Sealant|spinal sealant
744400|NCT00458354|Spinal Sealant System|spinal sealant system
744401|NCT00458354|Dural Repair|dural repair
744402|NCT00458354|Spinal Surgery|spinal surgery
744403|NCT00458341|Cystic fibrosis|cystic fibrosis
744404|NCT00458341|Nonsense mutation|nonsense mutation
744405|NCT00458341|Premature stop codon|premature stop codon
744406|NCT00458302|HIV|hiv
744407|NCT00458302|Monotherapy|monotherapy
744408|NCT00458302|Darunavir|darunavir
744409|NCT00458302|Protease inhibitor|protease inhibitor
744410|NCT00458302|Early pre-treated|early pre-treated
744411|NCT00458302|Undetectable|undetectable
744412|NCT00458302|Treatment Experienced|treatment experienced
744413|NCT00458276|Left sided heart disease|left sided heart disease
744414|NCT00458276|Elevated pulmonary arterial pressure|elevated pulmonary arterial pressure
744415|NCT00458276|Right ventricular failure|right ventricular failure
744416|NCT00458276|Cardiac surgery|cardiac surgery
744417|NCT00458276|heart-lung machine|heart-lung machine
744418|NCT00458276|cardiopulmonary bypass|cardiopulmonary bypass
744419|NCT00458276|tezosentan|tezosentan
744420|NCT00458276|Actelion|actelion
744421|NCT00458263|Growth Hormone treatment|growth hormone treatment
744422|NCT00458263|ISS|iss
744423|NCT00458263|Biochemical markers|biochemical markers
744424|NCT00458263|Growth response|growth response
744425|NCT00458250|Hematopoietic Stem Cell Transplantation|hematopoietic stem cell transplantation
744426|NCT00458250|Haploidentical|haploidentical
744427|NCT00458250|Hematologic Neoplasms|hematologic neoplasms
744428|NCT00458250|human, Bone Marrow|human, bone marrow
744429|NCT00458250|Granulocyte Colony-stimulating Factor|granulocyte colony-stimulating factor
744430|NCT00458250|CAMPATH|campath
744431|NCT00458250|Alemtuzumab|alemtuzumab
744432|NCT00458250|AML|aml
744433|NCT00458250|ALL|all
744434|NCT00458250|10. Eligibility|10. eligibility
744435|NCT00458237|HER2 positive|her2 positive
744436|NCT00458237|metastatic breast cancer|metastatic breast cancer
744437|NCT00458237|RAD001|rad001
744438|NCT00458237|Herceptin|herceptin
744439|NCT00458224|overweight|overweight
744440|NCT00458224|obesity|obesity
744441|NCT00458224|child|child
744442|NCT00458211|Schizophrenia|schizophrenia
744443|NCT00458211|Ziprasidone|ziprasidone
744444|NCT00458198|Selective Mutism|selective mutism
744445|NCT00458172|lay theories|lay theories
744446|NCT00458172|health concepts|health concepts
744447|NCT00458172|survey|survey
744448|NCT00458172|internet research|internet research
744449|NCT00458172|Ideas about health|ideas about health
744450|NCT00458159|CC-11006|cc-11006
744451|NCT00458159|RA|ra
744452|NCT00458159|MDS|mds
744453|NCT00458159|Celgene|celgene
744454|NCT00458159|RCMD-RS|rcmd-rs
744455|NCT00458159|RARS|rars
744456|NCT00458159|RAEB-1|raeb-1
744457|NCT00458159|Low-or Intermediate-1-Risk Myelodysplastic Syndrome (MDS)|low-or intermediate-1-risk myelodysplastic syndrome (mds)
744458|NCT00458133|aerobic exercise|aerobic exercise
744459|NCT00458133|resistance exercise|resistance exercise
744460|NCT00458133|type 2 diabetes|type 2 diabetes
744461|NCT00458133|hemoglobin A1C|hemoglobin a1c
744462|NCT00458133|exercise|exercise
744463|NCT00458120|Dengue Fever|dengue fever
744464|NCT00458120|Dengue Hemorrhagic Fever|dengue hemorrhagic fever
744465|NCT00458120|Dengue Vaccination|dengue vaccination
744466|NCT00458107|Pharmacokinetics|pharmacokinetics
744467|NCT00458107|Pharmacodynamics|pharmacodynamics
744468|NCT00458094|Exercise|exercise
744469|NCT00458094|Mental Illness|mental illness
744470|NCT00458094|Community Psychiatry|community psychiatry
744471|NCT00458094|Peer Support|peer support
744472|NCT00458094|Mental Disorders|mental disorders
744473|NCT00458068|preterm infant|preterm infant
744474|NCT00458068|iron supplementation|iron supplementation
744475|NCT00458068|iron deficiency|iron deficiency
744476|NCT00458068|blood transfusion|blood transfusion
744477|NCT00458055|Lipid lowering agents|lipid lowering agents
744478|NCT00458055|Drug treatment|drug treatment
744479|NCT00458055|Statin|statin
744480|NCT00458055|Fibrate|fibrate
744481|NCT00458055|Niacin|niacin
744482|NCT00458055|Cellular cholesterol efflux|cellular cholesterol efflux
744487|NCT00458042|PAH|pah
744488|NCT00458042|prostacyclin|prostacyclin
744489|NCT00458029|type 2 diabetes risk factors|type 2 diabetes risk factors
744490|NCT00458029|obesity|obesity
744491|NCT00458029|prevention|prevention
744492|NCT00458029|adolescence|adolescence
744493|NCT00458029|school based|school based
744494|NCT00458003|Preeclampsia|preeclampsia
744495|NCT00458003|Spinal Anesthesia|spinal anesthesia
744496|NCT00458003|Hypotension|hypotension
744497|NCT00458003|Cesarean Delivery|cesarean delivery
744498|NCT00458003|Phenylephrine|phenylephrine
744499|NCT00458003|Ephedrine|ephedrine
744500|NCT00457990|Neurocognitive outcome|neurocognitive outcome
744501|NCT00457990|preterm infant|preterm infant
744502|NCT00457990|very low birth weight|very low birth weight
744503|NCT00457990|iron deficiency|iron deficiency
744504|NCT00457990|iron supplementation|iron supplementation
744505|NCT00457977|Chronic Obstructive Pulmonary Disease|chronic obstructive pulmonary disease
744506|NCT00457977|COPD|copd
744507|NCT00457977|Pneumococcal|pneumococcal
744508|NCT00457977|Vaccine|vaccine
744509|NCT00457977|Opsonization|opsonization
744510|NCT00457977|Antibodies|antibodies
744511|NCT00457964|Tuberous Sclerosis Complex (TSC)|tuberous sclerosis complex (tsc)
744512|NCT00457964|Lymyphangioleiomyomatosis|lymyphangioleiomyomatosis
744513|NCT00457964|Mammalian Target of Rapamycin (mTOR)|mammalian target of rapamycin (mtor)
744514|NCT00457964|RAD001|rad001
744515|NCT00457964|Angiomyolipmas|angiomyolipmas
744516|NCT00457951|Chronic Obstructive Pulmonary Disease|chronic obstructive pulmonary disease
744517|NCT00457951|COPD|copd
744518|NCT00457951|Heparin|heparin
744519|NCT00457951|ODSH|odsh
744520|NCT00457951|Exacerbations of COPD|exacerbations of copd
744521|NCT00457938|lipodystrophy|lipodystrophy
744522|NCT00457925|absorption,|absorption,
744523|NCT00457925|metabolism,|metabolism,
744524|NCT00457925|excretion|excretion
744525|NCT00457925|distribution,|distribution,
744526|NCT00457899|schizophrenia|schizophrenia
744527|NCT00457899|schizoaffective disorder|schizoaffective disorder
744528|NCT00457899|quetiapine|quetiapine
744529|NCT00457899|seroquel|seroquel
744530|NCT00457899|titration|titration
744531|NCT00457873|surgery|surgery
744532|NCT00457860|CLL|cll
744533|NCT00457860|PLL|pll
744534|NCT00457860|SLL|sll
744535|NCT00457860|Relapse|relapse
744536|NCT00457860|Refractory|refractory
744537|NCT00457860|immunotoxin|immunotoxin
744538|NCT00457860|HA22|ha22
744539|NCT00457860|CAT-8015|cat-8015
744540|NCT00457860|immunotherapy|immunotherapy
744541|NCT00457847|PGD|pgd
744542|NCT00457834|Heart failure|heart failure
744543|NCT00457834|Dyssynchrony|dyssynchrony
744544|NCT00457834|Cardiac resynchronization therapy|cardiac resynchronization therapy
744545|NCT00457834|Atrial fibrillation|atrial fibrillation
744546|NCT00457834|RVOT|rvot
744547|NCT00457834|RVapex|rvapex
744548|NCT00457821|G551D mutation|g551d mutation
744549|NCT00457821|Fibrosis|fibrosis
744550|NCT00457821|Pancreatic Diseases|pancreatic diseases
744551|NCT00457821|Digestive System Diseases|digestive system diseases
744552|NCT00457821|Lung Diseases|lung diseases
744553|NCT00457821|Respiratory Tract Diseases|respiratory tract diseases
744554|NCT00457821|Genetic Diseases, Inborn|genetic diseases, inborn
744555|NCT00457821|Infant, Newborn, Diseases|infant, newborn, diseases
744556|NCT00457821|Pathologic Processes|pathologic processes
744557|NCT00457808|TSC and LAM|tsc and lam
744558|NCT00457808|Tuberous Sclerosis Complex and sporadic LAM|tuberous sclerosis complex and sporadic lam
744559|NCT00457782|Cancer|cancer
744560|NCT00457782|Blood disorders|blood disorders
744561|NCT00457782|Leukaemia, Adult Chronic|leukaemia, adult chronic
744562|NCT00457782|Lymphoma|lymphoma
744563|NCT00457782|Multiple Myeloma|multiple myeloma
744564|NCT00457769|Aricept|aricept
744565|NCT00457769|Donepezil|donepezil
744566|NCT00457769|Memory|memory
744567|NCT00457769|vascular dementia|vascular dementia
744568|NCT00457769|stroke|stroke
744569|NCT00457769|functional tasks|functional tasks
744570|NCT00457769|self-generation|self-generation
744571|NCT00457756|LDL cholesterol|ldl cholesterol
744572|NCT00457756|HDL cholesterol|hdl cholesterol
744573|NCT00457756|natural supplement|natural supplement
744574|NCT00457756|guar gum|guar gum
744575|NCT00457756|phytosterols|phytosterols
744576|NCT00457756|policosanol|policosanol
744577|NCT00457756|chrysanthemum|chrysanthemum
744578|NCT00457743|Evaluate of RTD for Japanese GIST patients|evaluate of rtd for japanese gist patients
744579|NCT00457730|Multiple Sclerosis|multiple sclerosis
744580|NCT00457730|Duloxetine|duloxetine
744581|NCT00457730|Pain|pain
744582|NCT00457717|myopia, auricular acupoint, atropine, RCT|myopia, auricular acupoint, atropine, rct
744583|NCT00457704|MRSA|mrsa
744584|NCT00457704|Home Care|home care
744585|NCT00457704|Risk factors|risk factors
744586|NCT00457704|transmissions|transmissions
744587|NCT00457704|observational study|observational study
744588|NCT00457691|colorectal neoplasms|colorectal neoplasms
744589|NCT00457678|Vision loss|vision loss
744590|NCT00457678|Retina|retina
744591|NCT00457678|VEG-F|veg-f
744592|NCT00457678|Fovea|fovea
744593|NCT00457678|AMD|amd
744594|NCT00457665|HIV|hiv
744595|NCT00457665|Lipodystrophy|lipodystrophy
744596|NCT00457665|Treatment Experienced|treatment experienced
744597|NCT00457652|Rosuvastatin|rosuvastatin
744598|NCT00457652|Caffeine|caffeine
744599|NCT00457652|Ischemia|ischemia
744600|NCT00457652|Reperfusion|reperfusion
744601|NCT00457639|lipodystrophy|lipodystrophy
744602|NCT00457626|Children|children
744603|NCT00457626|pediatrics|pediatrics
744604|NCT00457626|High Blood Pressure|high blood pressure
744605|NCT00457626|Hypertension|hypertension
744606|NCT00457626|Valsartan|valsartan
744607|NCT00457613|alkaline phosphatase|alkaline phosphatase
744608|NCT00457613|sepsis|sepsis
744609|NCT00457613|kidney function|kidney function
744610|NCT00457600|information technology|information technology
744611|NCT00457600|emergency department|emergency department
744612|NCT00457600|medication error|medication error
744613|NCT00457600|quality of care|quality of care
744614|NCT00457600|patient-centered care|patient-centered care
744615|NCT00457561|The relationship between all-cause mortality in patients introduced hemodialysis and recombinant human erythropoietin dose and serum adiponectin level|the relationship between all-cause mortality in patients introduced hemodialysis and recombinant human erythropoietin dose and serum adiponectin level
744616|NCT00457548|Alcohol use|alcohol use
744617|NCT00457548|Brief Interventions|brief interventions
744618|NCT00457548|Injuries|injuries
744619|NCT00457548|Emergency Department Patients|emergency department patients
744620|NCT00457548|Harmful and hazardous alcohol use among ED injured patients|harmful and hazardous alcohol use among ed injured patients
744621|NCT00457535|recombinant human erythropoietin|recombinant human erythropoietin
744622|NCT00457535|adiponectin|adiponectin
744623|NCT00457535|mortality|mortality
744624|NCT00457522|intimate partner violence|intimate partner violence
744625|NCT00457522|depression|depression
744626|NCT00457522|PTSD|ptsd
744627|NCT00457522|fatigue|fatigue
744628|NCT00457509|Pandemic influenza|pandemic influenza
744629|NCT00457509|Avian influenza|avian influenza
744630|NCT00457509|Orthomyxoviridae Infections|orthomyxoviridae infections
744631|NCT00457509|A/H5N1|a/h5n1
744632|NCT00457496|Behavior Therapy|behavior therapy
744633|NCT00457496|Relaxation Techniques|relaxation techniques
744634|NCT00457496|Cognitive Therapy|cognitive therapy
744635|NCT00457496|Exercise Movement Techniques|exercise movement techniques
744636|NCT00457483|hypertension|hypertension
744637|NCT00457483|diuretic|diuretic
744638|NCT00457483|angiotensin receptor blockers|angiotensin receptor blockers
744639|NCT00457483|prediction|prediction
744640|NCT00457457|With or without erectile dysfunction|with or without erectile dysfunction
744641|NCT00457431|in-hospital cardiac arrest|in-hospital cardiac arrest
744642|NCT00457431|resuscitation|resuscitation
744643|NCT00457431|mild therapeutic hypothermia|mild therapeutic hypothermia
744644|NCT00457405|ischemia-reperfusion injury|ischemia-reperfusion injury
744645|NCT00457405|atherosclerosis|atherosclerosis
744646|NCT00457405|dipyridamole|dipyridamole
744647|NCT00457405|annexin A5 targeting|annexin a5 targeting
744648|NCT00457392|Non-small cell lung cancer|non-small cell lung cancer
744649|NCT00457392|sunitinib|sunitinib
744650|NCT00457392|erlotinib|erlotinib
744652|NCT00457379|Coronary artery disease|coronary artery disease
744653|NCT00457379|HDL-Cholesterol|hdl-cholesterol
744654|NCT00457379|Endothelial Function|endothelial function
744655|NCT00457379|Endothelial Progenitor Cells|endothelial progenitor cells
744656|NCT00457379|normal blood HDL-Cholesterol level|normal blood hdl-cholesterol level
744657|NCT00457340|Tachycardia, Ventricular|tachycardia, ventricular
744658|NCT00457340|Ventricular Fibrillation|ventricular fibrillation
744659|NCT00457327|protective ileostomy|protective ileostomy
744660|NCT00457327|rectal cancer|rectal cancer
744661|NCT00457327|low anterior resection|low anterior resection
744662|NCT00457314|single-large scale deletions|single-large scale deletions
744663|NCT00457314|point mutations in mtDNA|point mutations in mtdna
744664|NCT00457301|Lung transplantation, health-related quality of life.|lung transplantation, health-related quality of life.
744665|NCT00457288|Cutaneous Mastocytosis|cutaneous mastocytosis
744666|NCT00457288|Topical treatment|topical treatment
744667|NCT00457262|paraoxonase1 activity|paraoxonase1 activity
744668|NCT00457262|LDL|ldl
744669|NCT00457262|HDL|hdl
744670|NCT00457262|postmenopausal women|postmenopausal women
744671|NCT00457262|postmenopausal women and hyperlipidemia|postmenopausal women and hyperlipidemia
744672|NCT00457249|Pertussis|pertussis
744673|NCT00457249|Tetanus|tetanus
744674|NCT00457249|Diphtheria|diphtheria
744675|NCT00457249|Tdap|tdap
744676|NCT00457236|Clopidogrel|clopidogrel
744677|NCT00457236|Coronary Artery Disease|coronary artery disease
744678|NCT00457236|Dose-Response Relationship, Drug|dose-response relationship, drug
744679|NCT00457236|Drug Resistance|drug resistance
744680|NCT00457236|PCI|pci
744681|NCT00457223|pterygium|pterygium
744682|NCT00457223|pterygia|pterygia
744683|NCT00457223|excision|excision
744684|NCT00457223|amniotic membrane transplantation|amniotic membrane transplantation
744685|NCT00457223|fibrin glue|fibrin glue
744686|NCT00457223|suture|suture
744687|NCT00457210|Psychology|psychology
744688|NCT00457197|bipolar disorder|bipolar disorder
744689|NCT00457197|alcohol dependence|alcohol dependence
744690|NCT00457197|mania|mania
744691|NCT00457197|manic disorder|manic disorder
744692|NCT00457197|depression|depression
744693|NCT00457184|Migraine|migraine
744694|NCT00457184|Thrombosis|thrombosis
744695|NCT00457184|Thrombophilia|thrombophilia
744696|NCT00457171|GI-270384 colitis patients ECAM oral|gi-270384 colitis patients ecam oral
744697|NCT00457158|pulmonary embolism|pulmonary embolism
744698|NCT00457158|inferior vena cava filters|inferior vena cava filters
744699|NCT00457158|venous thrombosis|venous thrombosis
744700|NCT00457158|randomized controlled trial|randomized controlled trial
744701|NCT00457145|Hyperfluorescence on Fluorescein|hyperfluorescence on fluorescein
744702|NCT00457145|Idiopathic Juxtafoveal Telangiectasia|idiopathic juxtafoveal telangiectasia
744703|NCT00457145|Retinal Edema/Thinning|retinal edema/thinning
744704|NCT00457145|Vascular Endothelial Growth Factor|vascular endothelial growth factor
744705|NCT00457145|Macular Telangiectasia|macular telangiectasia
744706|NCT00457132|Knee|knee
744707|NCT00457132|Osteoarthritis|osteoarthritis
744708|NCT00457132|WOMAC|womac
744709|NCT00457132|ALF|alf
744710|NCT00457132|Wedging|wedging
744711|NCT00457119|Non Small Cell Lung Cancer|non small cell lung cancer
744712|NCT00457119|NSCLC|nsclc
744713|NCT00457119|Advanced Lung Cancer|advanced lung cancer
744714|NCT00457119|RAD|rad
744715|NCT00457119|RAD001|rad001
744716|NCT00457119|chemotherapy|chemotherapy
744717|NCT00457119|carboplatin|carboplatin
744718|NCT00457119|paclitaxel|paclitaxel
744719|NCT00457119|bevacizumab|bevacizumab
744720|NCT00457106|panic|panic
744721|NCT00457093|Type 2 Diabetes|type 2 diabetes
744722|NCT00457093|continuous glucose monitoring|continuous glucose monitoring
744723|NCT00457093|basal insulin|basal insulin
744724|NCT00457080|capnography|capnography
744725|NCT00457080|safety|safety
744726|NCT00457080|opioids|opioids
744727|NCT00457080|respiratory depression|respiratory depression
744728|NCT00457080|postoperative|postoperative
744729|NCT00457080|orthopedic|orthopedic
744730|NCT00457080|OSA|osa
744731|NCT00457080|apnea|apnea
744732|NCT00457067|Hyperfluorescence on Fluorescein|hyperfluorescence on fluorescein
744733|NCT00457067|Idiopathic Juxtafoveal Telangiectasia|idiopathic juxtafoveal telangiectasia
744734|NCT00457067|Retinal Edema/Thinning|retinal edema/thinning
744735|NCT00457067|Vascular Endothelial Growth Factor|vascular endothelial growth factor
744736|NCT00457067|Macular Telangiectasia|macular telangiectasia
744737|NCT00457054|Mood Regulating Circuit|mood regulating circuit
744738|NCT00457054|Lithium|lithium
744739|NCT00457054|fMRI|fmri
744740|NCT00457041|Trust|trust
744741|NCT00457041|Decision Making|decision making
744742|NCT00457041|Vulnerability|vulnerability
744743|NCT00457041|Survey|survey
744744|NCT00457028|Obsessive Compulsive Disorder|obsessive compulsive disorder
744745|NCT00457028|Anxiety|anxiety
744746|NCT00457028|Treatment efficacy|treatment efficacy
744747|NCT00457002|Prevention of deep vein thrombosis and pulmonary embolism with acutely ill hospitalized patients|prevention of deep vein thrombosis and pulmonary embolism with acutely ill hospitalized patients
744748|NCT00456989|Androgen Independent|androgen independent
744749|NCT00456989|Prostate Cancer|prostate cancer
744750|NCT00456989|Taxotere|taxotere
744751|NCT00456989|Doxil|doxil
744752|NCT00456989|AIPC|aipc
744753|NCT00456989|Advanced Androgen-Independent Prostate Cancer|advanced androgen-independent prostate cancer
744754|NCT00456976|Seligiline|seligiline
744755|NCT00456976|Negative symptoms|negative symptoms
744756|NCT00456976|Schizopherenia|schizopherenia
744757|NCT00456963|angiotensin converting enzyme inhibitors|angiotensin converting enzyme inhibitors
744758|NCT00456963|angiotensin receptor blockers|angiotensin receptor blockers
744759|NCT00456963|diabetes|diabetes
744760|NCT00456963|hypertension|hypertension
744761|NCT00456963|therapeutic strategies|therapeutic strategies
744762|NCT00456950|coronary atherosclerosis|coronary atherosclerosis
744763|NCT00456950|magnetic resonance imaging|magnetic resonance imaging
744764|NCT00456950|vulnerable plaque|vulnerable plaque
744765|NCT00456924|progesterone receptor modulator|progesterone receptor modulator
744766|NCT00456911|obesity|obesity
744767|NCT00456911|prevention|prevention
744768|NCT00456911|children|children
744769|NCT00456911|adults|adults
744770|NCT00456911|family|family
744771|NCT00456911|dietary|dietary
744772|NCT00456911|coaching|coaching
744773|NCT00456911|body mass index|body mass index
744774|NCT00456911|fat mass|fat mass
744775|NCT00456885|obesity|obesity
744776|NCT00456885|double blind|double blind
744777|NCT00456885|placebo controlled|placebo controlled
744778|NCT00456885|weight loss|weight loss
744779|NCT00456885|appetite|appetite
744780|NCT00456885|energy expenditure|energy expenditure
744781|NCT00456872|Pain during injection of the pre-procedure anesthetic|pain during injection of the pre-procedure anesthetic
744782|NCT00456859|chronic kidney disease|chronic kidney disease
744783|NCT00456859|oral carbonaceous adsorbent|oral carbonaceous adsorbent
744784|NCT00456859|randomized clinical trial|randomized clinical trial
744785|NCT00456859|composite endpoint|composite endpoint
744786|NCT00456846|Metastatic Breast Cancer, ABI-007, Abraxane|metastatic breast cancer, abi-007, abraxane
744787|NCT00456833|Non Small Cell Lung Cancer|non small cell lung cancer
744788|NCT00456833|NSCLC|nsclc
744789|NCT00456833|Advanced lung cancer|advanced lung cancer
744791|NCT00456833|RAD001|rad001
744792|NCT00456833|erlotinib|erlotinib
744793|NCT00456820|Mood Regulating Circuit|mood regulating circuit
744794|NCT00456820|SSRI|ssri
744795|NCT00456820|fMRI|fmri
744796|NCT00456807|Human Papillomavirus|human papillomavirus
744797|NCT00456794|Parkinson's disease|parkinson's disease
744798|NCT00456794|Levodopa|levodopa
744799|NCT00456794|End of dose wearing off|end of dose wearing off
744800|NCT00456794|OFF time|off time
744801|NCT00456781|rotator cuff|rotator cuff
744802|NCT00456781|randomized clinical trial|randomized clinical trial
744803|NCT00456768|Panic Disorder|panic disorder
744804|NCT00456768|Anxiety|anxiety
744805|NCT00456768|Treatment efficacy|treatment efficacy
744806|NCT00456755|Perennial Allergic rhinitis|perennial allergic rhinitis
744807|NCT00456755|Traditional Chinese Medicine|traditional chinese medicine
744808|NCT00456742|Generalized Anxiety Disorder|generalized anxiety disorder
744809|NCT00456742|Anxiety|anxiety
744810|NCT00456742|Treatment efficacy|treatment efficacy
744811|NCT00456729|Iron deficiency|iron deficiency
744812|NCT00456729|Malabsorption|malabsorption
744813|NCT00456729|Giardiasis|giardiasis
744814|NCT00456716|BAC lung cancer|bac lung cancer
744815|NCT00456716|adenocarcinoma of the lung|adenocarcinoma of the lung
744816|NCT00456703|fluids,|fluids,
744817|NCT00456703|restriction,|restriction,
744818|NCT00456703|infection,|infection,
744819|NCT00456703|bowel surgery,|bowel surgery,
744820|NCT00456703|open abdominal|open abdominal
744821|NCT00456690|Thalassemia|thalassemia
744822|NCT00456690|Nutrition|nutrition
744823|NCT00456690|Endocrine|endocrine
744824|NCT00456690|BMI|bmi
744825|NCT00456677|minocycline|minocycline
744826|NCT00456677|asthma|asthma
744827|NCT00456677|oral corticosteroids|oral corticosteroids
744828|NCT00456664|CMV|cmv
744829|NCT00456664|IRIS|iris
744830|NCT00456651|Sleep Apnea|sleep apnea
744831|NCT00456651|Obesity|obesity
744832|NCT00456651|Neuropeptides|neuropeptides
744833|NCT00456651|Hormones|hormones
744834|NCT00456638|OP-CABG|op-cabg
744835|NCT00456638|Depodur traditional drug|depodur traditional drug
744836|NCT00456625|Hepatitis B vaccine|hepatitis b vaccine
744837|NCT00456625|Challenge dose|challenge dose
744838|NCT00456586|Parkinson's disease|parkinson's disease
744839|NCT00456586|Levodopa therapy|levodopa therapy
744840|NCT00456586|End of dose wearing off|end of dose wearing off
744841|NCT00456586|Off time|off time
744842|NCT00456573|Pediatric Obstructive sleep apnea syndrome|pediatric obstructive sleep apnea syndrome
744843|NCT00456547|Cesarean hysterectomy|cesarean hysterectomy
744844|NCT00456547|Postpartum hemorrhage|postpartum hemorrhage
744845|NCT00456547|Coagulation|coagulation
744846|NCT00456534|Smoking|smoking
744847|NCT00456521|Obesity|obesity
744848|NCT00456521|Behavior Modification|behavior modification
744849|NCT00456469|TB|tb
744850|NCT00456469|latent|latent
744851|NCT00456469|infection|infection
744852|NCT00456469|Ethiopia|ethiopia
744854|NCT00456443|Sickle cell anemia|sickle cell anemia
744855|NCT00456443|Splenectomy|splenectomy
744856|NCT00456443|Infections|infections
744857|NCT00456443|Streptococcal Pneumonia|streptococcal pneumonia
744858|NCT00456417|Neurological|neurological
744859|NCT00456417|Alzheimers|alzheimers
744860|NCT00456404|peppermint water|peppermint water
744861|NCT00456404|nipple crack|nipple crack
744862|NCT00456404|lactating women|lactating women
744863|NCT00456391|Brain CT scan|brain ct scan
744864|NCT00456391|Pediatric emergency room|pediatric emergency room
744865|NCT00456365|Autosomal dominant polycystic kidney disease|autosomal dominant polycystic kidney disease
744866|NCT00456365|Cystic kidney disease|cystic kidney disease
744867|NCT00456365|High blood pressure|high blood pressure
744868|NCT00456365|Statin|statin
744869|NCT00456339|Obstructive sleep apnea syndrome (OSAS) in children|obstructive sleep apnea syndrome (osas) in children
744870|NCT00456326|Heparin|heparin
744871|NCT00456326|Unfractionated Heparin|unfractionated heparin
744872|NCT00456326|Low Molecular Weight Heparin|low molecular weight heparin
744873|NCT00456326|Anticoagulation|anticoagulation
744874|NCT00456326|Thrombocytopenia|thrombocytopenia
744875|NCT00456326|Thrombosis|thrombosis
744876|NCT00456326|Venous Thrombosis|venous thrombosis
744877|NCT00456326|Pulmonary Embolism|pulmonary embolism
744878|NCT00456313|asthma|asthma
744879|NCT00456313|fluticasone propionate|fluticasone propionate
744880|NCT00456313|salmeterol/fluticasone propionate|salmeterol/fluticasone propionate
744881|NCT00456313|combination product|combination product
744882|NCT00456313|innate immune response|innate immune response
744883|NCT00456313|neutrophil priming|neutrophil priming
744884|NCT00456300|Hypoglycemia|hypoglycemia
744885|NCT00456300|Hyperglycemia|hyperglycemia
744886|NCT00456287|Sleep Apnea|sleep apnea
744887|NCT00456287|Clotting- fibrinolysis patterns|clotting- fibrinolysis patterns
744888|NCT00456287|Platelet function markers|platelet function markers
744889|NCT00456287|Endothelial dysfunction|endothelial dysfunction
744890|NCT00456274|Hypothalamic Amenorrhea|hypothalamic amenorrhea
744891|NCT00456274|Idiopathic hypogonadotropic hypogonadism|idiopathic hypogonadotropic hypogonadism
744892|NCT00456274|Acquired hypogonadotropic hypogonadism|acquired hypogonadotropic hypogonadism
744893|NCT00456274|Kallmann's Syndrome|kallmann's syndrome
744894|NCT00456274|Amenorrhea|amenorrhea
744895|NCT00456274|Gonadotropin Releasing Hormone|gonadotropin releasing hormone
744896|NCT00456261|Non Small Cell Lung Cancer|non small cell lung cancer
744897|NCT00456248|Chronic Hepatitis C|chronic hepatitis c
744898|NCT00456248|Liver|liver
744899|NCT00456248|Pegylated|pegylated
744900|NCT00456248|Interferon|interferon
744901|NCT00456248|Ribavirin|ribavirin
744902|NCT00456248|Combination|combination
744903|NCT00456248|Nonresponder|nonresponder
744904|NCT00456248|Relapser|relapser
744905|NCT00456248|HCV|hcv
744906|NCT00456248|Infergen|infergen
744907|NCT00456248|SVR|svr
744908|NCT00456222|Sleep|sleep
744909|NCT00456222|Circadian rhythms|circadian rhythms
744910|NCT00456222|Menstrual cycle|menstrual cycle
744911|NCT00456209|Lived Experiences|lived experiences
744912|NCT00456209|Adolescents|adolescents
744913|NCT00456209|Cancer Treatment|cancer treatment
744914|NCT00456209|Occupations|occupations
744915|NCT00456196|COPD|copd
744916|NCT00456196|Thrombosis|thrombosis
744917|NCT00456196|Cancer|cancer
744918|NCT00456196|Renal|renal
744919|NCT00456196|Elderly|elderly
744920|NCT00456196|Surgery|surgery
744921|NCT00456196|Orthopedic Surgery|orthopedic surgery
744922|NCT00456196|Medically Ill|medically ill
744923|NCT00456196|Deep Vein Thrombosis|deep vein thrombosis
744924|NCT00456196|Pulmonary Embolism|pulmonary embolism
744925|NCT00456196|Anticoagulation|anticoagulation
744926|NCT00456183|Tuberculosis|tuberculosis
744927|NCT00456183|Latent|latent
744928|NCT00456183|TB|tb
744929|NCT00456183|Vaccine|vaccine
744930|NCT00456183|MVA 85A|mva 85a
744931|NCT00456170|Vaginal|vaginal
744932|NCT00456170|Hysterectomy|hysterectomy
744933|NCT00456170|Harmonic|harmonic
744934|NCT00456170|Ligasure|ligasure
744935|NCT00456170|Sutures|sutures
744936|NCT00456170|Modern|modern
744937|NCT00456170|Patients undergoing vaginal hysterectomy for various reasons|patients undergoing vaginal hysterectomy for various reasons
744938|NCT00456157|Osteoarthritis|osteoarthritis
744939|NCT00456157|Osteophytes|osteophytes
744940|NCT00456157|Knee|knee
744941|NCT00456157|Intra-articular|intra-articular
744942|NCT00456157|OP-1|op-1
744943|NCT00456144|GnRH|gnrh
744944|NCT00456144|Insulin sensitivity|insulin sensitivity
744945|NCT00456118|recurrent pregnancy losses|recurrent pregnancy losses
744946|NCT00456118|preeclampsia|preeclampsia
744947|NCT00456118|intervillositis|intervillositis
744948|NCT00456118|maternofetal alloimmunization|maternofetal alloimmunization
744949|NCT00456105|Type 2 diabetes|type 2 diabetes
744950|NCT00456105|Post-op dysglycemia|post-op dysglycemia
744951|NCT00456105|Peripheral vascular disease|peripheral vascular disease
744952|NCT00456105|Infrainguinal bypass surgery|infrainguinal bypass surgery
744953|NCT00456092|psoriatic arthritis|psoriatic arthritis
744954|NCT00456092|ACR|acr
744955|NCT00456092|PASI|pasi
744957|NCT00456092|pharmacokinetic|pharmacokinetic
744958|NCT00456092|biopsy|biopsy
744959|NCT00456066|Acute myocardial infarction|acute myocardial infarction
744960|NCT00456066|Thromboaspiration|thromboaspiration
744961|NCT00456066|Infarct size|infarct size
744962|NCT00456066|Left ventricular remodelling|left ventricular remodelling
744963|NCT00456053|Renal Anemia|renal anemia
744964|NCT00456053|Renal Failure|renal failure
744965|NCT00456053|Kidney Disease|kidney disease
744966|NCT00456053|Human EPO|human epo
744967|NCT00456040|amyloidosis|amyloidosis
744968|NCT00456040|heart failure|heart failure
744969|NCT00456040|heart transplant|heart transplant
744970|NCT00456040|stem cell transplant|stem cell transplant
744971|NCT00456027|Type 2 Diabetes|type 2 diabetes
744972|NCT00456027|LADA|lada
744973|NCT00456027|Latent Autoimmune Diabetes in Adult|latent autoimmune diabetes in adult
744974|NCT00456027|Autoimmunity|autoimmunity
744975|NCT00456027|HbA1c|hba1c
744976|NCT00456027|C-peptide|c-peptide
744977|NCT00456014|Major Depression|major depression
744978|NCT00456014|Antidepressants|antidepressants
744979|NCT00456001|heparin|heparin
744980|NCT00456001|low molecular weight heparin|low molecular weight heparin
744981|NCT00456001|enoxaparin|enoxaparin
744982|NCT00456001|anticoagulation|anticoagulation
744983|NCT00456001|thrombosis|thrombosis
744984|NCT00456001|venous thrombosis|venous thrombosis
744985|NCT00456001|thromboembolism|thromboembolism
744986|NCT00456001|pulmonary embolism|pulmonary embolism
744987|NCT00456001|medication|medication
744988|NCT00455988|questionnaire developement|questionnaire developement
744989|NCT00455988|regularity|regularity
744990|NCT00455988|lifestyle|lifestyle
744991|NCT00455988|type 2 diabetes|type 2 diabetes
744992|NCT00455975|Kidney Cancer|kidney cancer
744993|NCT00455975|Renal Cancer|renal cancer
744994|NCT00455975|Clear Cell Carcinoma|clear cell carcinoma
744995|NCT00455962|estrogen|estrogen
744996|NCT00455962|progesterone|progesterone
744997|NCT00455962|African-American|african-american
744998|NCT00455962|Caucasian|caucasian
744999|NCT00455962|infusion|infusion
745000|NCT00455962|gonadotropins|gonadotropins
745001|NCT00455962|healthy|healthy
745002|NCT00455936|Adenocarcinoma|adenocarcinoma
745003|NCT00455936|NSCLC|nsclc
745004|NCT00455936|gemcitabine|gemcitabine
745005|NCT00455936|Cisplatin|cisplatin
745006|NCT00455936|Gefitinib|gefitinib
745007|NCT00455936|Never smoker|never smoker
745008|NCT00455923|asthma|asthma
745009|NCT00455923|exacerbation|exacerbation
745010|NCT00455923|persistent|persistent
745011|NCT00455923|bronchial hyperresponsiveness|bronchial hyperresponsiveness
745012|NCT00455923|mild|mild
745013|NCT00455923|GINAII|ginaii
745014|NCT00455910|Low risk myelodysplastic syndromes|low risk myelodysplastic syndromes
745015|NCT00455910|MDS|mds
745016|NCT00455910|Bone marrow diseases|bone marrow diseases
745017|NCT00455910|Thalidomide|thalidomide
745018|NCT00455910|Cytopenias|cytopenias
745019|NCT00455910|Anemia|anemia
745020|NCT00455897|granulocyte monocyte colony stimulating factor|granulocyte monocyte colony stimulating factor
745021|NCT00455897|Leukine|leukine
745022|NCT00455897|Sargramostim|sargramostim
745023|NCT00455897|Diffuse large B cell lymphoma|diffuse large b cell lymphoma
745024|NCT00455897|non-Hodgkin's lymphoma|non-hodgkin's lymphoma
745025|NCT00455871|macular degeneration|macular degeneration
745026|NCT00455845|Endometriosis|endometriosis
745027|NCT00455845|Lng IUD|lng iud
745028|NCT00455832|sperm chromatin structure integrity|sperm chromatin structure integrity
745029|NCT00455832|sperm concentration|sperm concentration
745030|NCT00455832|sperm motility|sperm motility
745031|NCT00455832|sperm morphology|sperm morphology
745032|NCT00455832|peginterferon|peginterferon
745033|NCT00455832|ribavirin|ribavirin
745034|NCT00455832|hepatitis C|hepatitis c
745035|NCT00455819|pulmonary embolism|pulmonary embolism
745036|NCT00455819|pro-BNP|pro-bnp
745037|NCT00455819|home treatment|home treatment
745038|NCT00455806|Helicobacter pylori|helicobacter pylori
745039|NCT00455806|rescue therapy|rescue therapy
745040|NCT00455806|eradication therapy|eradication therapy
745041|NCT00455806|esomeprazole|esomeprazole
745042|NCT00455806|moxifloxacin|moxifloxacin
745043|NCT00455806|resistance|resistance
745044|NCT00455793|HIV|hiv
745045|NCT00455793|atherosclerosis|atherosclerosis
745046|NCT00455780|Eating|eating
745047|NCT00455780|Dieting|dieting
745048|NCT00455780|Meal replacements|meal replacements
745049|NCT00455780|Energy Density|energy density
745050|NCT00455780|Weight Loss Maintenance|weight loss maintenance
745051|NCT00455767|persistent ARDS|persistent ards
745052|NCT00455767|alveolar inflammation|alveolar inflammation
745053|NCT00455767|early pulmonary fibrosis|early pulmonary fibrosis
745054|NCT00455767|mechanichal ventilation|mechanichal ventilation
745055|NCT00455767|P/V curve|p/v curve
745056|NCT00455767|Static compliance|static compliance
745057|NCT00455767|elastase activity|elastase activity
745058|NCT00455767|inhibitor of Human Neutrophil Elastase|inhibitor of human neutrophil elastase
745059|NCT00455741|menopause|menopause
745060|NCT00455741|estrogen|estrogen
745061|NCT00455741|progesterone|progesterone
745062|NCT00455741|hormone replacement|hormone replacement
745063|NCT00455741|aging|aging
745064|NCT00455741|PET|pet
745065|NCT00455715|Schizophrenia|schizophrenia
745066|NCT00455715|Cognition|cognition
745067|NCT00455715|Sildenafil|sildenafil
745068|NCT00455715|PDE5 Inhibitor|pde5 inhibitor
745069|NCT00455702|schizophrenia|schizophrenia
745070|NCT00455702|cognition|cognition
745071|NCT00455702|d-cycloserine|d-cycloserine
745072|NCT00455702|memory|memory
745073|NCT00455689|Lupron|lupron
745074|NCT00455689|Premenopausal|premenopausal
745075|NCT00455689|Hot flashes|hot flashes
745076|NCT00455676|Scarf Osteotomy|scarf osteotomy
745077|NCT00455676|Chevron Osteotomy|chevron osteotomy
745078|NCT00455676|Comparison|comparison
745079|NCT00455663|Schizoaffective Disorder|schizoaffective disorder
745080|NCT00455663|Medication Adherence|medication adherence
745081|NCT00455650|schizophrenia|schizophrenia
745082|NCT00455650|cognition|cognition
745083|NCT00455650|nicotinic receptors|nicotinic receptors
745084|NCT00455650|mecamylamine|mecamylamine
745085|NCT00455650|varenicline|varenicline
745086|NCT00455624|androgen deprivation therapy|androgen deprivation therapy
745087|NCT00455624|insulin resistance|insulin resistance
745088|NCT00455611|Heart Failure, Congestive|heart failure, congestive
745089|NCT00455611|Continuous Positive Airway Pressure|continuous positive airway pressure
745090|NCT00455611|Baroreflex|baroreflex
745091|NCT00455611|Echocardiography|echocardiography
745092|NCT00455598|Diabetes|diabetes
745093|NCT00455585|Pharmacokinetics|pharmacokinetics
745094|NCT00455585|Antiretrovirals|antiretrovirals
745095|NCT00455585|Uganda|uganda
745096|NCT00455585|HIV|hiv
745097|NCT00455585|Treatment Experienced|treatment experienced
745098|NCT00455572|Immunotherapeutic|immunotherapeutic
745099|NCT00455572|Adjuvant cancer therapy|adjuvant cancer therapy
745100|NCT00455572|Non-small-cell lung cancer|non-small-cell lung cancer
745101|NCT00455572|ASCI|asci
745102|NCT00455559|Resistant Gastrointestinal Stromal Tumor|resistant gastrointestinal stromal tumor
745103|NCT00455559|GIST|gist
745104|NCT00455559|Perifosine|perifosine
745105|NCT00455559|Gleevec|gleevec
745106|NCT00455546|Coronary|coronary
745107|NCT00455546|Artery|artery
745108|NCT00455546|Atherosclerosis|atherosclerosis
745109|NCT00455546|Phospholipase|phospholipase
745110|NCT00455546|CAD|cad
745111|NCT00455533|Early Breast Cancer|early breast cancer
745112|NCT00455520|Diabetic neuropathy|diabetic neuropathy
745113|NCT00455520|Painful Diabetic Polyneuropathy|painful diabetic polyneuropathy
745114|NCT00455520|Polyneuropathy|polyneuropathy
745115|NCT00455520|Peripheral neuropathy|peripheral neuropathy
745116|NCT00455507|Parkinson's disease|parkinson's disease
745117|NCT00455507|levodopa|levodopa
745118|NCT00455507|end of dose wearing off|end of dose wearing off
745119|NCT00455507|OFF time|off time
745120|NCT00455494|Drug-resistant malaria|drug-resistant malaria
745121|NCT00455494|Bioavailability|bioavailability
745122|NCT00455494|Food-effect study|food-effect study
745123|NCT00455468|Severe pneumonia|severe pneumonia
745124|NCT00455468|children|children
745125|NCT00455468|day care management|day care management
745126|NCT00455468|hospitalized management|hospitalized management
745127|NCT00455468|Randomized controlled trial|randomized controlled trial
745128|NCT00455468|Under five children|under five children
745129|NCT00455429|Atopic Dermatitis|atopic dermatitis
745130|NCT00455429|JNJ-26113100|jnj-26113100
745131|NCT00455416|Low grade lymphoma|low grade lymphoma
745132|NCT00455416|Diet|diet
745133|NCT00455416|Antioxidants|antioxidants
745134|NCT00455416|Non Hodgkin Lymphoma - Follicular Lymphoma grade 1&2 stage III/IV|non hodgkin lymphoma - follicular lymphoma grade 1&2 stage iii/iv
745135|NCT00455403|Metabolic Syndrome|metabolic syndrome
745136|NCT00455403|Atherosclerosis|atherosclerosis
745137|NCT00455390|Post immediate Psychotherapeutic Intervention|post immediate psychotherapeutic intervention
745138|NCT00455390|Psychotraumatic disorders|psychotraumatic disorders
745139|NCT00455390|PTSD post traumatic syndrome disorder|ptsd post traumatic syndrome disorder
745140|NCT00455390|CUMP Cellules d’Urgence Médico Psychologique|cump cellules d’urgence médico psychologique
745141|NCT00455377|Cement dust exposure|cement dust exposure
745142|NCT00455377|Induced sputum|induced sputum
745143|NCT00455377|Airway inflammation|airway inflammation
745144|NCT00455377|Peripheral blood inflammation markers|peripheral blood inflammation markers
745145|NCT00455364|Fungal infection prophylaxis|fungal infection prophylaxis
745146|NCT00455364|Lung transplant|lung transplant
745147|NCT00455364|Fungal infection post lung transplant|fungal infection post lung transplant
745148|NCT00455351|Palliative treatment|palliative treatment
745149|NCT00455351|Max. tolerable dose|max. tolerable dose
745150|NCT00455338|meal|meal
745151|NCT00455338|composition|composition
745152|NCT00455338|postprandial|postprandial
745153|NCT00455338|PCOS|pcos
745154|NCT00455338|androgen|androgen
745155|NCT00455325|Insulin Resistance|insulin resistance
745156|NCT00455325|Atherosclerosis|atherosclerosis
745157|NCT00455325|Metabolic Syndrome|metabolic syndrome
745158|NCT00455312|Dyskeratosis Congenita|dyskeratosis congenita
745913|NCT00453180|treatment|treatment
745159|NCT00455312|Hematopoietic Stem Cell Transplantation|hematopoietic stem cell transplantation
745160|NCT00455312|Severe Aplastic Anemia|severe aplastic anemia
745161|NCT00455299|Laparoscopy, ventral, hernia, repair, surgery|laparoscopy, ventral, hernia, repair, surgery
745162|NCT00455286|CNS Lymphoma|cns lymphoma
745163|NCT00455273|Breast Cancer|breast cancer
745164|NCT00455273|DCE MRI|dce mri
745165|NCT00455234|Aggression|aggression
745166|NCT00455234|Violent behaviour in people with psychotic illness|violent behaviour in people with psychotic illness
745167|NCT00455221|CML|cml
745168|NCT00455221|Imatinib|imatinib
745169|NCT00455221|vaccine|vaccine
745170|NCT00455221|peptide|peptide
745171|NCT00455221|gene|gene
745172|NCT00455221|MRD|mrd
745173|NCT00455221|DNA|dna
745174|NCT00455182|Acupuncture|acupuncture
745175|NCT00455182|Hip Arthroplasty|hip arthroplasty
745176|NCT00455182|Knee Arthroplasty|knee arthroplasty
745177|NCT00455182|Pain Management|pain management
745178|NCT00455169|Influenza|influenza
745179|NCT00455169|Infant, Premature|infant, premature
745180|NCT00455169|Immunization|immunization
745181|NCT00455169|Vaccination|vaccination
745182|NCT00455156|Contraception|contraception
745183|NCT00455156|Vaginal Ring|vaginal ring
745184|NCT00455143|Postoperative delirium|postoperative delirium
745185|NCT00455143|PD|pd
745186|NCT00455143|Postoperative cognitive dysfunction|postoperative cognitive dysfunction
745187|NCT00455143|POCD|pocd
745188|NCT00455130|mannitol|mannitol
745189|NCT00455130|cystic fibrosis|cystic fibrosis
745190|NCT00455130|mucolytic|mucolytic
745191|NCT00455130|mucoactive|mucoactive
745192|NCT00455117|analgesia|analgesia
745193|NCT00455117|pain|pain
745194|NCT00455117|neurosurgery|neurosurgery
745195|NCT00455117|NSAIDS|nsaids
745196|NCT00455117|parecoxib|parecoxib
745197|NCT00455117|morphine consumption|morphine consumption
745198|NCT00455104|Fabry Disease|fabry disease
745199|NCT00455104|National Registry|national registry
745200|NCT00455091|Post-operative Hepatocellular Carcinoma.|post-operative hepatocellular carcinoma.
745201|NCT00455078|Gastric reflux|gastric reflux
745202|NCT00455078|Lung transplant|lung transplant
745203|NCT00455078|chronic rejection|chronic rejection
745204|NCT00455078|Gastric reflux in lung transplant as it relates to chronic rejection|gastric reflux in lung transplant as it relates to chronic rejection
745205|NCT00455065|whole grain|whole grain
745206|NCT00455065|metabolic syndrome|metabolic syndrome
745207|NCT00455065|weight loss|weight loss
745208|NCT00455052|XMT-1001|xmt-1001
745209|NCT00455052|cancer|cancer
745210|NCT00455052|tumor|tumor
745211|NCT00455052|camptothecin|camptothecin
745212|NCT00455052|Fleximer|fleximer
745213|NCT00455052|polymer|polymer
745214|NCT00455052|Phase 1|phase 1
745215|NCT00455052|safety|safety
745216|NCT00455052|pharmacokinetics|pharmacokinetics
745217|NCT00455052|maximum tolerated dose|maximum tolerated dose
745218|NCT00455052|NSCLC|nsclc
745219|NCT00455052|non-small cell lung cancer|non-small cell lung cancer
745220|NCT00455052|SCLC|sclc
745221|NCT00455052|small cell lung cancer|small cell lung cancer
745222|NCT00455039|neoadjuvant, HER2, Breast,GSK,lapatinib|neoadjuvant, her2, breast,gsk,lapatinib
745223|NCT00455013|Kidney transplant|kidney transplant
745224|NCT00454987|antibody persistence|antibody persistence
745225|NCT00454987|Meningococcal serogroup C vaccine|meningococcal serogroup c vaccine
745226|NCT00454987|conjugate vaccine|conjugate vaccine
745227|NCT00454987|Haemophilus influenzae type b vaccine|haemophilus influenzae type b vaccine
745228|NCT00454974|end stage renal failure|end stage renal failure
745229|NCT00454974|dialysis|dialysis
745230|NCT00454974|wearable artificial kidney|wearable artificial kidney
745231|NCT00454961|Malaria|malaria
745232|NCT00454961|Plasmodium falciparum|plasmodium falciparum
745233|NCT00454961|artemether-lumefantrine|artemether-lumefantrine
745234|NCT00454961|effectiveness|effectiveness
745235|NCT00454948|Obesity prevention|obesity prevention
745236|NCT00454948|Dietary intake|dietary intake
745237|NCT00454948|Physical activity|physical activity
745238|NCT00454948|Mexican American|mexican american
745239|NCT00454948|Family Characteristics|family characteristics
745240|NCT00454935|epilepsy|epilepsy
745241|NCT00454935|glioma|glioma
745242|NCT00454922|glaucoma|glaucoma
745243|NCT00454922|patient educator|patient educator
745244|NCT00454909|Meningococcal Serogroups A, C, W-135 and/or Y Disease|meningococcal serogroups a, c, w-135 and/or y disease
745245|NCT00454896|Urinary Bladder, Overactive|urinary bladder, overactive
745246|NCT00454896|Urgency|urgency
745247|NCT00454896|VESIcare®|vesicare®
745248|NCT00454896|Solifenacin succinate|solifenacin succinate
745249|NCT00454883|Safety of ziprasidone, efficacy of ziprasidone, manic episodes in bipolar disorder, mixed episodes in bipolar disorder, schizoaffective disorder.|safety of ziprasidone, efficacy of ziprasidone, manic episodes in bipolar disorder, mixed episodes in bipolar disorder, schizoaffective disorder.
745250|NCT00454870|Alzheimer's Disease|alzheimer's disease
745251|NCT00454870|Cognition|cognition
745252|NCT00454870|Cognitive impairment|cognitive impairment
745253|NCT00454857|Thrombocytopenia|thrombocytopenia
745254|NCT00454857|Chart Review|chart review
745255|NCT00454857|Platelet|platelet
745256|NCT00454857|Retrospective|retrospective
745257|NCT00454857|Prospective|prospective
745258|NCT00454857|Non-interventional|non-interventional
745259|NCT00454857|Health Resource Utilization (HRU)|health resource utilization (hru)
745260|NCT00454857|Quality of Life (QOL)|quality of life (qol)
745261|NCT00454857|Immune Thrombocytopenic Purpura (ITP)|immune thrombocytopenic purpura (itp)
745262|NCT00454857|Idiopathic Thrombocytopenic Purpura (ITP)|idiopathic thrombocytopenic purpura (itp)
745263|NCT00454857|Immune (Idiopathic) Thrombocytopenic Purpura (ITP)|immune (idiopathic) thrombocytopenic purpura (itp)
745264|NCT00454857|Observational|observational
745265|NCT00454831|Hypercholesterolemia|hypercholesterolemia
745266|NCT00454831|LDL-cholesterol|ldl-cholesterol
745267|NCT00454831|chitosan|chitosan
745268|NCT00454831|HEP-40|hep-40
745269|NCT00454805|Advanced Breast Cancer|advanced breast cancer
745270|NCT00454792|Low back pain|low back pain
745271|NCT00454792|Modic changes|modic changes
745272|NCT00454779|SCCHNC|scchnc
745273|NCT00454779|Metastatic|metastatic
745274|NCT00454779|Recurrent|recurrent
745275|NCT00454766|Patient Education|patient education
745276|NCT00454766|Cervical Dysplasia|cervical dysplasia
745277|NCT00454766|Questionnaire|questionnaire
745278|NCT00454753|Myeloid, Chronic|myeloid, chronic
745279|NCT00454753|Lymphocytic, Acute|lymphocytic, acute
745280|NCT00454740|Urinary Bladder, Overactive|urinary bladder, overactive
745281|NCT00454740|Urgency|urgency
745282|NCT00454740|VESIcare®|vesicare®
745283|NCT00454740|Solifenacin succinate|solifenacin succinate
745284|NCT00454701|Psoriasis|psoriasis
745285|NCT00454701|Alefacept|alefacept
745286|NCT00454701|Amevive®|amevive®
745287|NCT00454701|Drug exposure|drug exposure
745288|NCT00454688|Irritable Bowel Syndrome|irritable bowel syndrome
745289|NCT00454688|Asimadoline|asimadoline
745290|NCT00454675|Smokers|smokers
745291|NCT00454675|Chronic Bronchitis|chronic bronchitis
745292|NCT00454675|Pulmonary Function Test Abnormalities|pulmonary function test abnormalities
745293|NCT00454675|COPD|copd
745294|NCT00454662|Elderly|elderly
745295|NCT00454662|Hypertension|hypertension
745296|NCT00454662|Cardiovascular Diseases|cardiovascular diseases
745297|NCT00454662|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers
745298|NCT00454662|Calcium Channel Blockers|calcium channel blockers
745299|NCT00454662|Diuretics|diuretics
745300|NCT00454662|Combination Drug Therapy|combination drug therapy
745301|NCT00454662|Diabetes|diabetes
745302|NCT00454649|axitinib|axitinib
745303|NCT00454649|chemotherapy|chemotherapy
745304|NCT00454649|anti-angiogenesis|anti-angiogenesis
745305|NCT00454649|VEGF inhibition|vegf inhibition
745306|NCT00454623|Adiponectin|adiponectin
745307|NCT00454623|diabetes|diabetes
745308|NCT00454623|metabolism|metabolism
745309|NCT00454623|Adiponectin levels|adiponectin levels
745310|NCT00454610|Pediatric|pediatric
745311|NCT00454610|Overweight|overweight
745312|NCT00454610|Obesity|obesity
745313|NCT00454610|Intervention|intervention
745314|NCT00454610|Prevention|prevention
745315|NCT00454610|Mexican American|mexican american
745316|NCT00454584|Psoriasis|psoriasis
745317|NCT00454584|CNTO 1275|cnto 1275
745318|NCT00454584|Etanercept|etanercept
745319|NCT00454584|Immune diorder|immune diorder
745320|NCT00454584|Skin disorder|skin disorder
745321|NCT00454558|Pulmonary Arterial Hypertension (PAH)|pulmonary arterial hypertension (pah)
745322|NCT00454558|Chronic Thromboembolic Pulmonary Hypertension (CTEPH)|chronic thromboembolic pulmonary hypertension (cteph)
745323|NCT00454532|Breast Cancer|breast cancer
745324|NCT00454532|Bionovo|bionovo
745325|NCT00454532|BZL101|bzl101
745326|NCT00454532|Chinese Herbs|chinese herbs
745327|NCT00454519|peritoneal carcinomatosis|peritoneal carcinomatosis
745328|NCT00454519|cisplatin|cisplatin
745329|NCT00454519|mitomycin|mitomycin
745330|NCT00454519|gastric cancer|gastric cancer
745331|NCT00454519|colorectal cancer|colorectal cancer
745332|NCT00454493|omacor|omacor
745333|NCT00454493|fish oil|fish oil
745334|NCT00454493|omega 3|omega 3
745335|NCT00454493|fatty acids|fatty acids
745336|NCT00454493|coronary artery disease|coronary artery disease
745337|NCT00454493|endothelial function|endothelial function
745338|NCT00454493|heart rate variability|heart rate variability
745339|NCT00454493|carotid intimal media thickness|carotid intimal media thickness
745340|NCT00454493|QT dispersion|qt dispersion
745341|NCT00454480|untreated adult acute myeloid leukemia|untreated adult acute myeloid leukemia
745342|NCT00454480|de novo myelodysplastic syndromes|de novo myelodysplastic syndromes
745343|NCT00454480|secondary acute myeloid leukemia|secondary acute myeloid leukemia
745344|NCT00454480|secondary myelodysplastic syndromes|secondary myelodysplastic syndromes
745345|NCT00454480|previously treated myelodysplastic syndromes|previously treated myelodysplastic syndromes
745346|NCT00454480|refractory anemia with excess blasts|refractory anemia with excess blasts
745347|NCT00454480|adult acute basophilic leukemia|adult acute basophilic leukemia
745348|NCT00454480|adult acute eosinophilic leukemia|adult acute eosinophilic leukemia
745349|NCT00454480|adult acute megakaryoblastic leukemia (M7)|adult acute megakaryoblastic leukemia (m7)
745350|NCT00454480|adult acute minimally differentiated myeloid leukemia (M0)|adult acute minimally differentiated myeloid leukemia (m0)
745351|NCT00454480|adult acute monoblastic leukemia (M5a)|adult acute monoblastic leukemia (m5a)
745352|NCT00454480|adult acute monocytic leukemia (M5b)|adult acute monocytic leukemia (m5b)
745353|NCT00454480|adult acute myeloblastic leukemia with maturation (M2)|adult acute myeloblastic leukemia with maturation (m2)
745354|NCT00454480|adult acute myeloblastic leukemia without maturation (M1)|adult acute myeloblastic leukemia without maturation (m1)
745355|NCT00454480|adult erythroleukemia (M6a)|adult erythroleukemia (m6a)
745356|NCT00454480|adult pure erythroid leukemia (M6b)|adult pure erythroid leukemia (m6b)
745357|NCT00454480|adult acute myeloid leukemia with 11q23 (MLL) abnormalities|adult acute myeloid leukemia with 11q23 (mll) abnormalities
745358|NCT00454480|adult acute myeloid leukemia with inv(16)(p13;q22)|adult acute myeloid leukemia with inv(16)(p13;q22)
745359|NCT00454480|adult acute myeloid leukemia with t(16;16)(p13;q22)|adult acute myeloid leukemia with t(16;16)(p13;q22)
745360|NCT00454480|adult acute myeloid leukemia with t(8;21)(q22;q22)|adult acute myeloid leukemia with t(8;21)(q22;q22)
745361|NCT00454480|adult acute myelomonocytic leukemia (M4)|adult acute myelomonocytic leukemia (m4)
745362|NCT00454480|childhood myelodysplastic syndromes|childhood myelodysplastic syndromes
745363|NCT00454454|memory|memory
745364|NCT00454454|display enhanced testing|display enhanced testing
745365|NCT00454441|Sleep Quality|sleep quality
745366|NCT00454441|Menopausal Symptoms|menopausal symptoms
745367|NCT00454441|Actigraph|actigraph
745368|NCT00454441|Bionovo|bionovo
745369|NCT00454441|MF101|mf101
745370|NCT00454428|Bypass Surgery|bypass surgery
745371|NCT00454428|Coronary Artery|coronary artery
745372|NCT00454415|Diet|diet
745373|NCT00454415|Body Mass Index|body mass index
745374|NCT00454415|BMI|bmi
745375|NCT00454389|Macular|macular
745376|NCT00454389|Degeneration|degeneration
745377|NCT00454389|AMD|amd
745378|NCT00454389|Wet Age-Related macular degeneration|wet age-related macular degeneration
745379|NCT00454376|metastatic gastrointestinal carcinoid tumor|metastatic gastrointestinal carcinoid tumor
745565|NCT00453765|cough|cough
745380|NCT00454376|recurrent gastrointestinal carcinoid tumor|recurrent gastrointestinal carcinoid tumor
745381|NCT00454376|pulmonary carcinoid tumor|pulmonary carcinoid tumor
745382|NCT00454376|gastrinoma|gastrinoma
745383|NCT00454376|insulinoma|insulinoma
745384|NCT00454376|WDHA syndrome|wdha syndrome
745385|NCT00454376|pancreatic polypeptide tumor|pancreatic polypeptide tumor
745386|NCT00454376|somatostatinoma|somatostatinoma
745387|NCT00454376|glucagonoma|glucagonoma
745388|NCT00454376|liver metastases|liver metastases
745389|NCT00454350|Hectorol (doxercalciferol injection)|hectorol (doxercalciferol injection)
745390|NCT00454350|Zemplar (paricalcitol injection)|zemplar (paricalcitol injection)
745391|NCT00454337|HIV-1 infection|hiv-1 infection
745392|NCT00454337|enfuvirtide|enfuvirtide
745393|NCT00454337|raltegravir|raltegravir
745394|NCT00454337|treatment experienced|treatment experienced
745395|NCT00454324|Lung cancer|lung cancer
745396|NCT00454324|Small cell lung cancer|small cell lung cancer
745397|NCT00454324|Abraxane|abraxane
745398|NCT00454324|Paclitaxel|paclitaxel
745399|NCT00454324|Carboplatin|carboplatin
745400|NCT00454324|Phase II|phase ii
745401|NCT00454324|Randomized|randomized
745402|NCT00454324|Lineberger|lineberger
745403|NCT00454324|LCCC|lccc
745404|NCT00454311|Pregnancy and implantation rates|pregnancy and implantation rates
745405|NCT00454311|Efficiency and accuracy of the genetic testing|efficiency and accuracy of the genetic testing
745406|NCT00454298|Severe Osteoarthritis|severe osteoarthritis
745407|NCT00454298|Arthritis|arthritis
745408|NCT00454285|bacteremia,cultures, infective endocarditis, prophylaxis|bacteremia,cultures, infective endocarditis, prophylaxis
745409|NCT00454272|febrile|febrile
745410|NCT00454272|neutropenia|neutropenia
745411|NCT00454272|cancer|cancer
745412|NCT00454272|Gram positive infection|gram positive infection
745413|NCT00454259|Postoperative Hyperalgesia|postoperative hyperalgesia
745414|NCT00454259|Human volunteer|human volunteer
745415|NCT00454259|Fentanyl|fentanyl
745416|NCT00454259|Randomized Controlled Trial|randomized controlled trial
745417|NCT00454259|Pain chronicisation|pain chronicisation
745418|NCT00454259|Predictive test|predictive test
745419|NCT00454233|Diabetes Mellitus Type 2|diabetes mellitus type 2
745420|NCT00454233|YM543|ym543
745421|NCT00454233|Treatment|treatment
745422|NCT00454233|Safety|safety
745423|NCT00454233|efficacy|efficacy
745424|NCT00454207|Pulmonary Arterial Hypertension, PAH|pulmonary arterial hypertension, pah
745425|NCT00454194|recurrent non-small cell lung cancer|recurrent non-small cell lung cancer
745426|NCT00454194|stage IIIB non-small cell lung cancer|stage iiib non-small cell lung cancer
745427|NCT00454194|stage IV non-small cell lung cancer|stage iv non-small cell lung cancer
745428|NCT00454194|adenosquamous cell lung cancer|adenosquamous cell lung cancer
745429|NCT00454194|adenocarcinoma of the lung|adenocarcinoma of the lung
745430|NCT00454181|human immunodeficiency virus|human immunodeficiency virus
745431|NCT00454181|human papilloma virus|human papilloma virus
745432|NCT00454181|warts, oral|warts, oral
745433|NCT00454181|papillomatosis|papillomatosis
745434|NCT00454181|treatment experienced|treatment experienced
745435|NCT00454168|adult acute minimally differentiated myeloid leukemia (M0)|adult acute minimally differentiated myeloid leukemia (m0)
745436|NCT00454168|adult acute myeloblastic leukemia with maturation (M2)|adult acute myeloblastic leukemia with maturation (m2)
745437|NCT00454168|adult acute myeloblastic leukemia without maturation (M1)|adult acute myeloblastic leukemia without maturation (m1)
745438|NCT00454168|adult acute myeloid leukemia in remission|adult acute myeloid leukemia in remission
745439|NCT00454168|adult acute myeloid leukemia with 11q23 (MLL) abnormalities|adult acute myeloid leukemia with 11q23 (mll) abnormalities
745440|NCT00454168|adult acute myeloid leukemia with inv(16)(p13;q22)|adult acute myeloid leukemia with inv(16)(p13;q22)
745441|NCT00454168|adult acute myeloid leukemia with t(15;17)(q22;q12)|adult acute myeloid leukemia with t(15;17)(q22;q12)
745442|NCT00454168|adult acute myeloid leukemia with t(16;16)(p13;q22)|adult acute myeloid leukemia with t(16;16)(p13;q22)
745443|NCT00454168|adult acute myeloid leukemia with t(8;21)(q22;q22)|adult acute myeloid leukemia with t(8;21)(q22;q22)
745444|NCT00454168|adult acute myelomonocytic leukemia (M4)|adult acute myelomonocytic leukemia (m4)
745445|NCT00454168|adult acute promyelocytic leukemia (M3)|adult acute promyelocytic leukemia (m3)
745446|NCT00454168|secondary acute myeloid leukemia|secondary acute myeloid leukemia
745447|NCT00454168|adult acute monoblastic leukemia (M5a)|adult acute monoblastic leukemia (m5a)
745448|NCT00454168|adult acute monocytic leukemia (M5b)|adult acute monocytic leukemia (m5b)
745449|NCT00454168|adult erythroleukemia (M6a)|adult erythroleukemia (m6a)
745450|NCT00454168|adult pure erythroid leukemia (M6b)|adult pure erythroid leukemia (m6b)
745451|NCT00454168|adult acute megakaryoblastic leukemia (M7)|adult acute megakaryoblastic leukemia (m7)
745452|NCT00454155|HSCT|hsct
745453|NCT00454155|AGVHD|agvhd
745454|NCT00454155|Myeloablative|myeloablative
745455|NCT00454155|Allogeneic|allogeneic
745456|NCT00454155|Hematopoietic|hematopoietic
745457|NCT00454155|Stem|stem
745458|NCT00454155|Cell|cell
745459|NCT00454155|Transplantation|transplantation
745460|NCT00454129|Feasibilty of cholangiography via double-balloon enteroscopy|feasibilty of cholangiography via double-balloon enteroscopy
745461|NCT00454116|Colon Cancer|colon cancer
745462|NCT00454116|Rectal Cancer|rectal cancer
745463|NCT00454103|adrenocortical carcinoma (ACC)|adrenocortical carcinoma (acc)
745464|NCT00454103|adrenal tumor|adrenal tumor
745465|NCT00454103|metastastic adrenocortical carcinoma|metastastic adrenocortical carcinoma
745466|NCT00454090|Advanced Malignancies|advanced malignancies
745467|NCT00454077|thyroid cancer; rhTSH; thyroid ablation|thyroid cancer; rhtsh; thyroid ablation
745468|NCT00454064|cognitive-behavioral therapy|cognitive-behavioral therapy
745469|NCT00454064|back pain|back pain
745470|NCT00454064|low back pain|low back pain
745471|NCT00454064|biofeedback|biofeedback
745472|NCT00454064|randomized controlled study|randomized controlled study
745473|NCT00454064|EMG biofeedback|emg biofeedback
745474|NCT00454051|Asthma, anti-immunoglobulin E, omalizumab, IgE receptors|asthma, anti-immunoglobulin e, omalizumab, ige receptors
745475|NCT00454038|cystectomy|cystectomy
745476|NCT00454038|augmentation|augmentation
745477|NCT00454038|sinus|sinus
745478|NCT00454038|amputation|amputation
745479|NCT00454038|implant|implant
745480|NCT00454025|glaucoma|glaucoma
745481|NCT00454025|intraocular pressure|intraocular pressure
745482|NCT00454025|postural changes|postural changes
745483|NCT00454012|non reassuring fetal heart rate tracing|non reassuring fetal heart rate tracing
745484|NCT00454012|biophysical profile|biophysical profile
745485|NCT00454012|assessing fetal wellbeing|assessing fetal wellbeing
745486|NCT00453999|influenza|influenza
745487|NCT00453999|flu|flu
745488|NCT00453986|immunogenicity|immunogenicity
745489|NCT00453986|Meningococcal serogroups A, C, W-135 and/or Y disease|meningococcal serogroups a, c, w-135 and/or y disease
745490|NCT00453986|co-administration|co-administration
745491|NCT00453986|meningococcal vaccine|meningococcal vaccine
745492|NCT00453986|lot-to-lot consistency|lot-to-lot consistency
745493|NCT00453986|conjugate vaccine|conjugate vaccine
745494|NCT00453973|anemia|anemia
745495|NCT00453973|chronic kidney disease|chronic kidney disease
745496|NCT00453973|CKD|ckd
745497|NCT00453973|chronic renal failure|chronic renal failure
745498|NCT00453973|CRF|crf
745499|NCT00453973|dialysis|dialysis
745500|NCT00453973|erythropoietin|erythropoietin
745501|NCT00453973|EPO|epo
745502|NCT00453973|erythropoiesis stimulating agent|erythropoiesis stimulating agent
745503|NCT00453973|ESA|esa
745504|NCT00453973|Hematide™|hematide™
745505|NCT00453973|hemodialysis|hemodialysis
745506|NCT00453973|hemoglobin|hemoglobin
745507|NCT00453973|Hb|hb
745508|NCT00453973|Hgb|hgb
745509|NCT00453973|Omontys|omontys
745510|NCT00453973|peginesatide|peginesatide
745511|NCT00453973|red blood cell|red blood cell
745512|NCT00453973|red blood cell production|red blood cell production
745513|NCT00453960|Endometrial hyperplasia|endometrial hyperplasia
745514|NCT00453960|Genistein|genistein
745515|NCT00453960|Isoflavones|isoflavones
745516|NCT00453960|dysfunctional uterine bleeding|dysfunctional uterine bleeding
745517|NCT00453934|Diabetes|diabetes
745518|NCT00453934|Type 1 Diabetes|type 1 diabetes
745519|NCT00453934|Type 2 Diabetes|type 2 diabetes
745520|NCT00453934|Physiologic Insulin|physiologic insulin
745521|NCT00453934|Basal Insulin|basal insulin
745522|NCT00453934|Bolus Insulin|bolus insulin
745523|NCT00453934|Mealtime insulin|mealtime insulin
745524|NCT00453934|Insulin patch|insulin patch
745525|NCT00453934|Multiple daily injections|multiple daily injections
745526|NCT00453921|TBI|tbi
745527|NCT00453921|Memory|memory
745528|NCT00453921|Methylphenidate|methylphenidate
745529|NCT00453921|Ritalin|ritalin
745530|NCT00453921|Memory and Attention Training|memory and attention training
745531|NCT00453895|Adrenal cancer refractory to cytotoxic therapy|adrenal cancer refractory to cytotoxic therapy
745532|NCT00453895|Sunitinib|sunitinib
745533|NCT00453895|Multitargeted tyrosine-kinase inhibitor|multitargeted tyrosine-kinase inhibitor
745534|NCT00453869|Liver fibrosis|liver fibrosis
745535|NCT00453869|Hepatitis B virus and C virus|hepatitis b virus and c virus
745536|NCT00453869|FibroMeter|fibrometer
745537|NCT00453869|FibroScan®|fibroscan®
745538|NCT00453856|Malaria|malaria
745539|NCT00453856|Sulfadoxine|sulfadoxine
745540|NCT00453856|Pyrimethamine|pyrimethamine
745541|NCT00453856|Resistance|resistance
745542|NCT00453856|Gabon|gabon
745543|NCT00453843|Stroke|stroke
745544|NCT00453843|movement therapy|movement therapy
745545|NCT00453843|robotics|robotics
745546|NCT00453843|rehabilitation robotics|rehabilitation robotics
745547|NCT00453843|shoulder, elbow, wrist|shoulder, elbow, wrist
745548|NCT00453830|Diverticulitis; laparoscopy; short term outcome|diverticulitis; laparoscopy; short term outcome
745549|NCT00453817|islet transplantation|islet transplantation
745550|NCT00453817|imaging|imaging
745551|NCT00453817|graft monitoring|graft monitoring
745552|NCT00453817|magnetic resonance imaging|magnetic resonance imaging
745553|NCT00453804|Alcohol dependence|alcohol dependence
745554|NCT00453804|Major Mental Illness|major mental illness
745555|NCT00453804|Injectable naltrexone|injectable naltrexone
745556|NCT00453791|GW805858|gw805858
745557|NCT00453791|MDI|mdi
745558|NCT00453791|asthma|asthma
745559|NCT00453791|surfactant|surfactant
745560|NCT00453778|mild asthma|mild asthma
745561|NCT00453778|FLIXOTIDE|flixotide
745562|NCT00453778|methacholine|methacholine
745563|NCT00453778|bronchial challenge|bronchial challenge
745564|NCT00453778|leukotriene D4|leukotriene d4
745566|NCT00453765|hyperreactivity|hyperreactivity
745567|NCT00453765|montelukast|montelukast
745568|NCT00453752|systemic sclerosis|systemic sclerosis
745569|NCT00453752|pulmonary hypertension|pulmonary hypertension
745570|NCT00453752|echocardiography|echocardiography
745571|NCT00453752|N-Terminal proBNP|n-terminal probnp
745572|NCT00453726|Natriuretic peptide brain|natriuretic peptide brain
745573|NCT00453726|Continuous positive airway pressure|continuous positive airway pressure
745574|NCT00453726|Intermittent positive pressure breathing|intermittent positive pressure breathing
745575|NCT00453726|Respiratory insufficiency|respiratory insufficiency
745576|NCT00453713|Idiopathic pulmonary fibrosis|idiopathic pulmonary fibrosis
745577|NCT00453713|Interstitial lung disease|interstitial lung disease
745578|NCT00453713|Diffuse parenchymal lung disease|diffuse parenchymal lung disease
745579|NCT00453713|Health disparities|health disparities
745580|NCT00453700|chagas|chagas
745581|NCT00453700|trypanosoma cruzi|trypanosoma cruzi
745582|NCT00453687|COPD|copd
745583|NCT00453687|GSK233705,|gsk233705,
745584|NCT00453687|Magnesium Stearate,|magnesium stearate,
745585|NCT00453674|Adrenal cancer|adrenal cancer
745586|NCT00453674|Treatment|treatment
745587|NCT00453674|Surgery|surgery
745588|NCT00453674|Mitotane|mitotane
745589|NCT00453661|Breast Cancer|breast cancer
745590|NCT00453661|Cervical Cancer|cervical cancer
745591|NCT00453661|Prostate Cancer|prostate cancer
745592|NCT00453661|Colorectal Cancer|colorectal cancer
745593|NCT00453661|Lung Cancer|lung cancer
745594|NCT00453661|Cancer Prevention|cancer prevention
745595|NCT00453661|Treatment Demonstration for Ethnic and Racial Minorities|treatment demonstration for ethnic and racial minorities
745596|NCT00453661|Centers for Medicare and Medicaid Services|centers for medicare and medicaid services
745597|NCT00453661|CMS|cms
745598|NCT00453661|Hispanic American|hispanic american
745599|NCT00453661|Cancer Screening Assessment|cancer screening assessment
745600|NCT00453661|Annual Questionnaire|annual questionnaire
745601|NCT00453661|Patient Navigator|patient navigator
745602|NCT00453661|Educational Materials|educational materials
745603|NCT00453648|stable isotopes|stable isotopes
745604|NCT00453648|vitamin A|vitamin a
745605|NCT00453648|beta-carotene|beta-carotene
745606|NCT00453648|orange-fleshed sweet potatoes|orange-fleshed sweet potatoes
745607|NCT00453648|iron|iron
745608|NCT00453648|zinc|zinc
745609|NCT00453648|absorption|absorption
745610|NCT00453648|bioavailability|bioavailability
745611|NCT00453648|vitamin A equivalency|vitamin a equivalency
745612|NCT00453648|Bangladesh|bangladesh
745613|NCT00453648|women|women
745614|NCT00453635|Cancer|cancer
745615|NCT00453635|Breast cancer|breast cancer
745616|NCT00453635|First line treatment|first line treatment
745617|NCT00453635|Docetaxel|docetaxel
745618|NCT00453635|Carboplatin|carboplatin
745619|NCT00453635|Herceptin|herceptin
745620|NCT00453635|Vinorelbine|vinorelbine
745621|NCT00453622|Heart Failure|heart failure
745622|NCT00453622|Cardiac Resynchronization Therapy|cardiac resynchronization therapy
745623|NCT00453622|Risk stratification|risk stratification
745624|NCT00453622|Prediction|prediction
745625|NCT00453622|Proteomics|proteomics
745626|NCT00453622|Chemokine|chemokine
745627|NCT00453622|cardiac enzymes|cardiac enzymes
746187|NCT00452036|plain x ray|plain x ray
745628|NCT00453622|Brain Natriuretic Peptide|brain natriuretic peptide
745629|NCT00453609|Bipolar Disorders|bipolar disorders
745630|NCT00453609|Schizophrenia|schizophrenia
745631|NCT00453609|Schizoaffective Disorders|schizoaffective disorders
745632|NCT00453609|Alcohol Dependence|alcohol dependence
745633|NCT00453609|Long-lasting injectable naltrexone|long-lasting injectable naltrexone
745634|NCT00453596|infertile women|infertile women
745635|NCT00453596|thin endometrial thickness|thin endometrial thickness
745636|NCT00453596|implantation failure|implantation failure
745637|NCT00453583|Pediatric|pediatric
745638|NCT00453583|Allergies|allergies
745639|NCT00453583|Antihistamines|antihistamines
745640|NCT00453583|Non-interventional|non-interventional
745641|NCT00453570|Diphteria|diphteria
745642|NCT00453570|Tetanus|tetanus
745643|NCT00453570|Haemophilus influenzae type b|haemophilus influenzae type b
745644|NCT00453570|Poliomyelitis|poliomyelitis
745645|NCT00453570|Pertussis|pertussis
745646|NCT00453557|growth hormone, obesity, visceral adiposity|growth hormone, obesity, visceral adiposity
745647|NCT00453544|computer assisted instruction|computer assisted instruction
745648|NCT00453544|decision making|decision making
745649|NCT00453544|educational resource design /development|educational resource design /development
745650|NCT00453544|executive function|executive function
745651|NCT00453531|Forearm Ischemia|forearm ischemia
745652|NCT00453531|Endothelial Function|endothelial function
745653|NCT00453531|Acetyicholine Vasodilation|acetyicholine vasodilation
745654|NCT00453531|Venous Plethysmography|venous plethysmography
745655|NCT00453531|Healthy Volunteer|healthy volunteer
745656|NCT00453531|HV|hv
745657|NCT00453518|SVG|svg
745658|NCT00453518|Saphenous Vein Graft|saphenous vein graft
745659|NCT00453518|Embolic Protection|embolic protection
745660|NCT00453518|Distal Protection|distal protection
745661|NCT00453518|EPD|epd
745662|NCT00453518|FiberNet|fibernet
746323|NCT00451451|relapsing|relapsing
745663|NCT00453518|Saphenous Vein Graft intervention|saphenous vein graft intervention
745664|NCT00453505|Transcranial Direct Current Stimulation (TDCS)|transcranial direct current stimulation (tdcs)
745665|NCT00453505|Transcranial Magnetic Stimulation (TMS)|transcranial magnetic stimulation (tms)
745666|NCT00453505|Peripheral Nerve Stimulation|peripheral nerve stimulation
745667|NCT00453505|Primary Motor Cortex|primary motor cortex
745668|NCT00453505|Corticomotor Excitability|corticomotor excitability
745669|NCT00453505|Healthy Volunteer|healthy volunteer
745671|NCT00453479|muscarinic receptor,|muscarinic receptor,
745672|NCT00453479|bronchodilators|bronchodilators
745673|NCT00453479|Chronic obstructive pulmonary disease,|chronic obstructive pulmonary disease,
745674|NCT00453466|women experiencing domestic violence|women experiencing domestic violence
745675|NCT00453453|Congestive heart failure|congestive heart failure
745676|NCT00453453|observation unit|observation unit
745677|NCT00453453|nesiritide|nesiritide
745678|NCT00453440|HIV|hiv
745679|NCT00453440|HLA-B*5701|hla-b*5701
745680|NCT00453440|Abacavir hypersensitivity reaction|abacavir hypersensitivity reaction
745681|NCT00453440|HIV Infection|hiv infection
745682|NCT00453427|PTL NOS|ptl nos
745683|NCT00453427|AILD|aild
745684|NCT00453427|NHL|nhl
745685|NCT00453427|CHOP|chop
745686|NCT00453414|PAH|pah
745687|NCT00453414|Pediatric|pediatric
745688|NCT00453414|Pulmonary Arterial Hypertension|pulmonary arterial hypertension
745689|NCT00453401|cold sore|cold sore
745690|NCT00453375|Diabetic|diabetic
745691|NCT00453375|Diabetes|diabetes
745692|NCT00453375|Type 1 Diabetes|type 1 diabetes
745693|NCT00453375|Type 1 Diabetes Mellitus|type 1 diabetes mellitus
745694|NCT00453375|autoimmune disease|autoimmune disease
745695|NCT00453362|NSCLC|nsclc
745696|NCT00453362|Tarceva|tarceva
745697|NCT00453362|Positron emission technology|positron emission technology
745698|NCT00453362|PET|pet
745699|NCT00453362|Computerized tomography|computerized tomography
745700|NCT00453362|CT|ct
745701|NCT00453349|Uncomplicated pelvic inflammatory disease|uncomplicated pelvic inflammatory disease
745702|NCT00453336|recurrent squamous cell carcinoma of the lip and oral cavity|recurrent squamous cell carcinoma of the lip and oral cavity
745703|NCT00453336|stage II squamous cell carcinoma of the lip and oral cavity|stage ii squamous cell carcinoma of the lip and oral cavity
745704|NCT00453336|stage III squamous cell carcinoma of the lip and oral cavity|stage iii squamous cell carcinoma of the lip and oral cavity
745705|NCT00453336|stage IV squamous cell carcinoma of the lip and oral cavity|stage iv squamous cell carcinoma of the lip and oral cavity
745706|NCT00453336|recurrent squamous cell carcinoma of the oropharynx|recurrent squamous cell carcinoma of the oropharynx
745707|NCT00453336|stage II squamous cell carcinoma of the oropharynx|stage ii squamous cell carcinoma of the oropharynx
745708|NCT00453336|stage III squamous cell carcinoma of the oropharynx|stage iii squamous cell carcinoma of the oropharynx
745709|NCT00453336|stage IV squamous cell carcinoma of the oropharynx|stage iv squamous cell carcinoma of the oropharynx
745710|NCT00453336|recurrent squamous cell carcinoma of the larynx|recurrent squamous cell carcinoma of the larynx
745711|NCT00453336|stage II squamous cell carcinoma of the larynx|stage ii squamous cell carcinoma of the larynx
745712|NCT00453336|stage III squamous cell carcinoma of the larynx|stage iii squamous cell carcinoma of the larynx
745713|NCT00453336|stage IV squamous cell carcinoma of the larynx|stage iv squamous cell carcinoma of the larynx
746285|NCT00451659|PTSD|ptsd
745714|NCT00453336|stage I squamous cell carcinoma of the larynx|stage i squamous cell carcinoma of the larynx
745715|NCT00453336|stage I squamous cell carcinoma of the lip and oral cavity|stage i squamous cell carcinoma of the lip and oral cavity
745716|NCT00453336|stage I squamous cell carcinoma of the oropharynx|stage i squamous cell carcinoma of the oropharynx
745717|NCT00453336|oral leukoplakia|oral leukoplakia
745718|NCT00453323|Esophageal Cancer|esophageal cancer
745719|NCT00453323|Phase II|phase ii
745720|NCT00453323|Metastatic esophageal cancer|metastatic esophageal cancer
745721|NCT00453323|Recurrent esophageal cancer|recurrent esophageal cancer
745722|NCT00453310|recurrent ovarian germ cell tumor|recurrent ovarian germ cell tumor
745723|NCT00453310|stage IV ovarian germ cell tumor|stage iv ovarian germ cell tumor
745724|NCT00453310|ovarian choriocarcinoma|ovarian choriocarcinoma
745725|NCT00453310|ovarian immature teratoma|ovarian immature teratoma
745726|NCT00453310|ovarian mature teratoma|ovarian mature teratoma
745727|NCT00453310|recurrent malignant testicular germ cell tumor|recurrent malignant testicular germ cell tumor
745728|NCT00453310|testicular choriocarcinoma|testicular choriocarcinoma
745729|NCT00453310|testicular seminoma|testicular seminoma
745730|NCT00453310|testicular yolk sac tumor|testicular yolk sac tumor
745731|NCT00453310|ovarian dysgerminoma|ovarian dysgerminoma
745732|NCT00453310|ovarian embryonal carcinoma|ovarian embryonal carcinoma
745733|NCT00453310|ovarian yolk sac tumor|ovarian yolk sac tumor
745734|NCT00453310|ovarian monodermal and highly specialized teratoma|ovarian monodermal and highly specialized teratoma
745735|NCT00453310|ovarian polyembryoma|ovarian polyembryoma
745736|NCT00453310|stage III malignant testicular germ cell tumor|stage iii malignant testicular germ cell tumor
745737|NCT00453310|ovarian mixed germ cell tumor|ovarian mixed germ cell tumor
745738|NCT00453310|testicular choriocarcinoma and embryonal carcinoma|testicular choriocarcinoma and embryonal carcinoma
745739|NCT00453310|testicular choriocarcinoma and seminoma|testicular choriocarcinoma and seminoma
745740|NCT00453310|testicular choriocarcinoma and teratoma|testicular choriocarcinoma and teratoma
745741|NCT00453310|testicular choriocarcinoma and yolk sac tumor|testicular choriocarcinoma and yolk sac tumor
745742|NCT00453310|testicular embryonal carcinoma and seminoma|testicular embryonal carcinoma and seminoma
745743|NCT00453310|testicular embryonal carcinoma and teratoma with seminoma|testicular embryonal carcinoma and teratoma with seminoma
745744|NCT00453310|testicular embryonal carcinoma and teratoma|testicular embryonal carcinoma and teratoma
745745|NCT00453310|testicular embryonal carcinoma and yolk sac tumor with seminoma|testicular embryonal carcinoma and yolk sac tumor with seminoma
745746|NCT00453310|testicular embryonal carcinoma and yolk sac tumor|testicular embryonal carcinoma and yolk sac tumor
745747|NCT00453310|testicular yolk sac tumor and teratoma with seminoma|testicular yolk sac tumor and teratoma with seminoma
745748|NCT00453310|testicular yolk sac tumor and teratoma|testicular yolk sac tumor and teratoma
745749|NCT00453310|testicular embryonal carcinoma|testicular embryonal carcinoma
745750|NCT00453310|recurrent extragonadal non-seminomatous germ cell tumor|recurrent extragonadal non-seminomatous germ cell tumor
745751|NCT00453310|recurrent extragonadal seminoma|recurrent extragonadal seminoma
745752|NCT00453310|stage IV extragonadal non-seminomatous germ cell tumor|stage iv extragonadal non-seminomatous germ cell tumor
745753|NCT00453310|stage IV extragonadal seminoma|stage iv extragonadal seminoma
745754|NCT00453310|recurrent extragonadal germ cell tumor|recurrent extragonadal germ cell tumor
745755|NCT00453310|testicular immature teratoma|testicular immature teratoma
745756|NCT00453310|testicular mature teratoma|testicular mature teratoma
745757|NCT00453310|adult teratoma|adult teratoma
745758|NCT00453297|Bionovo|bionovo
745759|NCT00453297|MF101|mf101
745760|NCT00453297|Herbs|herbs
745761|NCT00453297|The primary goal of this study is to identify the highest safe oral dose of MF101 that is well tolerated in humans.|the primary goal of this study is to identify the highest safe oral dose of mf101 that is well tolerated in humans.
745762|NCT00453271|chronic persistent infection of the nail bed or plate|chronic persistent infection of the nail bed or plate
745763|NCT00453258|ocular proteomics|ocular proteomics
745764|NCT00453258|eye disease|eye disease
745765|NCT00453258|proteomics|proteomics
745766|NCT00453232|stage III malignant testicular germ cell tumor|stage iii malignant testicular germ cell tumor
745767|NCT00453232|testicular choriocarcinoma and seminoma|testicular choriocarcinoma and seminoma
745768|NCT00453232|testicular embryonal carcinoma and seminoma|testicular embryonal carcinoma and seminoma
745769|NCT00453232|testicular choriocarcinoma and embryonal carcinoma|testicular choriocarcinoma and embryonal carcinoma
745770|NCT00453232|testicular choriocarcinoma and teratoma|testicular choriocarcinoma and teratoma
745771|NCT00453232|testicular choriocarcinoma|testicular choriocarcinoma
745772|NCT00453232|testicular choriocarcinoma and yolk sac tumor|testicular choriocarcinoma and yolk sac tumor
745864|NCT00453206|stage IV grade 3 follicular lymphoma|stage iv grade 3 follicular lymphoma
745773|NCT00453232|testicular embryonal carcinoma and teratoma with seminoma|testicular embryonal carcinoma and teratoma with seminoma
745774|NCT00453232|testicular embryonal carcinoma and teratoma|testicular embryonal carcinoma and teratoma
745775|NCT00453232|testicular embryonal carcinoma and yolk sac tumor with seminoma|testicular embryonal carcinoma and yolk sac tumor with seminoma
745776|NCT00453232|testicular embryonal carcinoma and yolk sac tumor|testicular embryonal carcinoma and yolk sac tumor
745777|NCT00453232|testicular embryonal carcinoma|testicular embryonal carcinoma
745778|NCT00453232|testicular seminoma|testicular seminoma
745779|NCT00453232|testicular yolk sac tumor|testicular yolk sac tumor
745780|NCT00453232|testicular yolk sac tumor and teratoma with seminoma|testicular yolk sac tumor and teratoma with seminoma
745781|NCT00453232|testicular yolk sac tumor and teratoma|testicular yolk sac tumor and teratoma
745782|NCT00453232|recurrent malignant testicular germ cell tumor|recurrent malignant testicular germ cell tumor
745783|NCT00453232|recurrent extragonadal non-seminomatous germ cell tumor|recurrent extragonadal non-seminomatous germ cell tumor
745784|NCT00453232|recurrent extragonadal seminoma|recurrent extragonadal seminoma
745785|NCT00453232|stage IV extragonadal non-seminomatous germ cell tumor|stage iv extragonadal non-seminomatous germ cell tumor
745786|NCT00453232|stage IV extragonadal seminoma|stage iv extragonadal seminoma
745787|NCT00453232|adult teratoma|adult teratoma
745788|NCT00453232|testicular immature teratoma|testicular immature teratoma
745789|NCT00453232|testicular mature teratoma|testicular mature teratoma
745790|NCT00453232|recurrent extragonadal germ cell tumor|recurrent extragonadal germ cell tumor
745791|NCT00453206|adult acute myeloid leukemia with 11q23 (MLL) abnormalities|adult acute myeloid leukemia with 11q23 (mll) abnormalities
745792|NCT00453206|adult acute myeloid leukemia with inv(16)(p13;q22)|adult acute myeloid leukemia with inv(16)(p13;q22)
745793|NCT00453206|adult acute myeloid leukemia with t(15;17)(q22;q12)|adult acute myeloid leukemia with t(15;17)(q22;q12)
745794|NCT00453206|adult acute myeloid leukemia with t(16;16)(p13;q22)|adult acute myeloid leukemia with t(16;16)(p13;q22)
745795|NCT00453206|adult acute myeloid leukemia with t(8;21)(q22;q22)|adult acute myeloid leukemia with t(8;21)(q22;q22)
745796|NCT00453206|accelerated phase chronic myelogenous leukemia|accelerated phase chronic myelogenous leukemia
745797|NCT00453206|adult acute myeloid leukemia in remission|adult acute myeloid leukemia in remission
745798|NCT00453206|blastic phase chronic myelogenous leukemia|blastic phase chronic myelogenous leukemia
745799|NCT00453206|primary myelofibrosis|primary myelofibrosis
745800|NCT00453206|chronic phase chronic myelogenous leukemia|chronic phase chronic myelogenous leukemia
745801|NCT00453206|extranodal marginal zone B-cell lymphoma of mucosa-associated lymphoid tissue|extranodal marginal zone b-cell lymphoma of mucosa-associated lymphoid tissue
745802|NCT00453206|de novo myelodysplastic syndromes|de novo myelodysplastic syndromes
745803|NCT00453206|nodal marginal zone B-cell lymphoma|nodal marginal zone b-cell lymphoma
745804|NCT00453206|noncontiguous stage II adult Burkitt lymphoma|noncontiguous stage ii adult burkitt lymphoma
745805|NCT00453206|noncontiguous stage II adult diffuse large cell lymphoma|noncontiguous stage ii adult diffuse large cell lymphoma
745806|NCT00453206|noncontiguous stage II adult diffuse mixed cell lymphoma|noncontiguous stage ii adult diffuse mixed cell lymphoma
745807|NCT00453206|noncontiguous stage II adult diffuse small cleaved cell lymphoma|noncontiguous stage ii adult diffuse small cleaved cell lymphoma
745808|NCT00453206|noncontiguous stage II adult immunoblastic large cell lymphoma|noncontiguous stage ii adult immunoblastic large cell lymphoma
745809|NCT00453206|noncontiguous stage II adult lymphoblastic lymphoma|noncontiguous stage ii adult lymphoblastic lymphoma
745810|NCT00453206|noncontiguous stage II grade 1 follicular lymphoma|noncontiguous stage ii grade 1 follicular lymphoma
745811|NCT00453206|noncontiguous stage II grade 2 follicular lymphoma|noncontiguous stage ii grade 2 follicular lymphoma
745812|NCT00453206|noncontiguous stage II grade 3 follicular lymphoma|noncontiguous stage ii grade 3 follicular lymphoma
745813|NCT00453206|noncontiguous stage II mantle cell lymphoma|noncontiguous stage ii mantle cell lymphoma
745814|NCT00453206|noncontiguous stage II marginal zone lymphoma|noncontiguous stage ii marginal zone lymphoma
745815|NCT00453206|noncontiguous stage II small lymphocytic lymphoma|noncontiguous stage ii small lymphocytic lymphoma
745816|NCT00453206|previously treated myelodysplastic syndromes|previously treated myelodysplastic syndromes
745817|NCT00453206|prolymphocytic leukemia|prolymphocytic leukemia
745818|NCT00453206|recurrent adult acute myeloid leukemia|recurrent adult acute myeloid leukemia
745819|NCT00453206|recurrent adult Burkitt lymphoma|recurrent adult burkitt lymphoma
745820|NCT00453206|recurrent adult Hodgkin lymphoma|recurrent adult hodgkin lymphoma
745821|NCT00453206|recurrent adult diffuse large cell lymphoma|recurrent adult diffuse large cell lymphoma
745822|NCT00453206|recurrent adult diffuse mixed cell lymphoma|recurrent adult diffuse mixed cell lymphoma
745823|NCT00453206|recurrent adult diffuse small cleaved cell lymphoma|recurrent adult diffuse small cleaved cell lymphoma
745824|NCT00453206|recurrent adult immunoblastic large cell lymphoma|recurrent adult immunoblastic large cell lymphoma
745825|NCT00453206|recurrent adult lymphoblastic lymphoma|recurrent adult lymphoblastic lymphoma
745826|NCT00453206|recurrent grade 1 follicular lymphoma|recurrent grade 1 follicular lymphoma
745827|NCT00453206|recurrent grade 2 follicular lymphoma|recurrent grade 2 follicular lymphoma
745828|NCT00453206|recurrent grade 3 follicular lymphoma|recurrent grade 3 follicular lymphoma
745829|NCT00453206|recurrent mantle cell lymphoma|recurrent mantle cell lymphoma
745830|NCT00453206|recurrent marginal zone lymphoma|recurrent marginal zone lymphoma
745831|NCT00453206|recurrent small lymphocytic lymphoma|recurrent small lymphocytic lymphoma
745832|NCT00453206|refractory chronic lymphocytic leukemia|refractory chronic lymphocytic leukemia
745833|NCT00453206|refractory multiple myeloma|refractory multiple myeloma
745834|NCT00453206|relapsing chronic myelogenous leukemia|relapsing chronic myelogenous leukemia
745835|NCT00453206|secondary acute myeloid leukemia|secondary acute myeloid leukemia
745836|NCT00453206|secondary myelodysplastic syndromes|secondary myelodysplastic syndromes
745837|NCT00453206|splenic marginal zone lymphoma|splenic marginal zone lymphoma
745838|NCT00453206|stage I multiple myeloma|stage i multiple myeloma
745839|NCT00453206|stage II multiple myeloma|stage ii multiple myeloma
745840|NCT00453206|stage III adult Burkitt lymphoma|stage iii adult burkitt lymphoma
745841|NCT00453206|stage III adult Hodgkin lymphoma|stage iii adult hodgkin lymphoma
745842|NCT00453206|stage III adult diffuse large cell lymphoma|stage iii adult diffuse large cell lymphoma
746286|NCT00451659|Veterans|veterans
745843|NCT00453206|stage III adult diffuse mixed cell lymphoma|stage iii adult diffuse mixed cell lymphoma
745844|NCT00453206|stage III adult diffuse small cleaved cell lymphoma|stage iii adult diffuse small cleaved cell lymphoma
745845|NCT00453206|stage III adult immunoblastic large cell lymphoma|stage iii adult immunoblastic large cell lymphoma
745846|NCT00453206|stage III adult lymphoblastic lymphoma|stage iii adult lymphoblastic lymphoma
745847|NCT00453206|stage III grade 1 follicular lymphoma|stage iii grade 1 follicular lymphoma
745848|NCT00453206|stage III grade 2 follicular lymphoma|stage iii grade 2 follicular lymphoma
745849|NCT00453206|stage III grade 3 follicular lymphoma|stage iii grade 3 follicular lymphoma
745850|NCT00453206|stage III mantle cell lymphoma|stage iii mantle cell lymphoma
745851|NCT00453206|stage III marginal zone lymphoma|stage iii marginal zone lymphoma
745852|NCT00453206|stage III multiple myeloma|stage iii multiple myeloma
745853|NCT00453206|stage III small lymphocytic lymphoma|stage iii small lymphocytic lymphoma
745854|NCT00453206|stage IV adult Burkitt lymphoma|stage iv adult burkitt lymphoma
745855|NCT00453206|stage IV adult Hodgkin lymphoma|stage iv adult hodgkin lymphoma
745856|NCT00453206|stage IV adult diffuse large cell lymphoma|stage iv adult diffuse large cell lymphoma
745857|NCT00453206|stage IV adult diffuse mixed cell lymphoma|stage iv adult diffuse mixed cell lymphoma
745858|NCT00453206|stage IV adult diffuse small cleaved cell lymphoma|stage iv adult diffuse small cleaved cell lymphoma
745859|NCT00453206|stage IV adult immunoblastic large cell lymphoma|stage iv adult immunoblastic large cell lymphoma
745860|NCT00453206|stage IV adult lymphoblastic lymphoma|stage iv adult lymphoblastic lymphoma
745861|NCT00453206|stage IV chronic lymphocytic leukemia|stage iv chronic lymphocytic leukemia
745862|NCT00453206|stage IV grade 1 follicular lymphoma|stage iv grade 1 follicular lymphoma
745863|NCT00453206|stage IV grade 2 follicular lymphoma|stage iv grade 2 follicular lymphoma
746087|NCT00452439|Bone Loss|bone loss
745865|NCT00453206|stage IV mantle cell lymphoma|stage iv mantle cell lymphoma
745866|NCT00453206|stage IV marginal zone lymphoma|stage iv marginal zone lymphoma
745867|NCT00453206|stage IV small lymphocytic lymphoma|stage iv small lymphocytic lymphoma
745868|NCT00453206|polycythemia vera|polycythemia vera
745869|NCT00453206|stage III chronic lymphocytic leukemia|stage iii chronic lymphocytic leukemia
745870|NCT00453206|recurrent/refractory childhood Hodgkin lymphoma|recurrent/refractory childhood hodgkin lymphoma
745871|NCT00453206|stage I childhood Hodgkin lymphoma|stage i childhood hodgkin lymphoma
745872|NCT00453206|stage II childhood Hodgkin lymphoma|stage ii childhood hodgkin lymphoma
745873|NCT00453206|stage III childhood Hodgkin lymphoma|stage iii childhood hodgkin lymphoma
745874|NCT00453206|stage IV childhood Hodgkin lymphoma|stage iv childhood hodgkin lymphoma
745875|NCT00453206|recurrent childhood anaplastic large cell lymphoma|recurrent childhood anaplastic large cell lymphoma
745876|NCT00453206|stage I childhood anaplastic large cell lymphoma|stage i childhood anaplastic large cell lymphoma
745877|NCT00453206|stage II childhood anaplastic large cell lymphoma|stage ii childhood anaplastic large cell lymphoma
745878|NCT00453206|stage III childhood anaplastic large cell lymphoma|stage iii childhood anaplastic large cell lymphoma
745879|NCT00453206|stage IV childhood anaplastic large cell lymphoma|stage iv childhood anaplastic large cell lymphoma
745880|NCT00453206|recurrent childhood grade III lymphomatoid granulomatosis|recurrent childhood grade iii lymphomatoid granulomatosis
745881|NCT00453206|recurrent childhood large cell lymphoma|recurrent childhood large cell lymphoma
745882|NCT00453206|stage I childhood large cell lymphoma|stage i childhood large cell lymphoma
745883|NCT00453206|stage II childhood large cell lymphoma|stage ii childhood large cell lymphoma
745884|NCT00453206|stage III childhood large cell lymphoma|stage iii childhood large cell lymphoma
745885|NCT00453206|stage IV childhood large cell lymphoma|stage iv childhood large cell lymphoma
745886|NCT00453206|recurrent childhood lymphoblastic lymphoma|recurrent childhood lymphoblastic lymphoma
745887|NCT00453206|stage I childhood lymphoblastic lymphoma|stage i childhood lymphoblastic lymphoma
745888|NCT00453206|stage II childhood lymphoblastic lymphoma|stage ii childhood lymphoblastic lymphoma
745889|NCT00453206|stage III childhood lymphoblastic lymphoma|stage iii childhood lymphoblastic lymphoma
745890|NCT00453206|stage IV childhood lymphoblastic lymphoma|stage iv childhood lymphoblastic lymphoma
745891|NCT00453206|childhood nasal type extranodal NK/T-cell lymphoma|childhood nasal type extranodal nk/t-cell lymphoma
745892|NCT00453206|recurrent childhood small noncleaved cell lymphoma|recurrent childhood small noncleaved cell lymphoma
745893|NCT00453206|stage I childhood small noncleaved cell lymphoma|stage i childhood small noncleaved cell lymphoma
745894|NCT00453206|stage II childhood small noncleaved cell lymphoma|stage ii childhood small noncleaved cell lymphoma
745895|NCT00453206|stage III childhood small noncleaved cell lymphoma|stage iii childhood small noncleaved cell lymphoma
745896|NCT00453206|stage IV childhood small noncleaved cell lymphoma|stage iv childhood small noncleaved cell lymphoma
745897|NCT00453193|T-Cell Neoplasms|t-cell neoplasms
745898|NCT00453193|Alemtuzumab|alemtuzumab
745899|NCT00453193|Pentostatin|pentostatin
745900|NCT00453193|Campath-1H|campath-1h
745901|NCT00453193|Deoxycoformycin|deoxycoformycin
745902|NCT00453193|Lymphoma|lymphoma
745903|NCT00453193|Leukemia|leukemia
745904|NCT00453180|Autistic Disorder|autistic disorder
745905|NCT00453180|Asperger's|asperger's
745906|NCT00453180|PDD NOS|pdd nos
745907|NCT00453180|Pervasive Developmental Disorder|pervasive developmental disorder
745908|NCT00453180|Autism|autism
745909|NCT00453180|N-acetylcysteine|n-acetylcysteine
745910|NCT00453180|acetylcysteine|acetylcysteine
745911|NCT00453180|NAC|nac
745912|NCT00453180|antioxidant|antioxidant
745914|NCT00453180|core symptoms|core symptoms
745915|NCT00453180|Autism Spectrum Disorders|autism spectrum disorders
745916|NCT00453180|Asperger's Disorder|asperger's disorder
745917|NCT00453180|Pervasive Developmental Disorder Not Otherwise Specified|pervasive developmental disorder not otherwise specified
745918|NCT00453180|Pervasive Developmental Disorders|pervasive developmental disorders
745919|NCT00453167|Small cell lung cancer|small cell lung cancer
745920|NCT00453167|second-line therapy|second-line therapy
745921|NCT00453141|Betamethasone for preterm labor|betamethasone for preterm labor
745922|NCT00453141|Preterm delivery|preterm delivery
745923|NCT00453141|Infant Respiratory Distress Syndrome|infant respiratory distress syndrome
745924|NCT00453128|Calcium Pyrophosphate|calcium pyrophosphate
745925|NCT00453128|associated conditions|associated conditions
745926|NCT00453115|Non small cell lung cancer|non small cell lung cancer
745927|NCT00453115|advanced stage IIIB|advanced stage iiib
745928|NCT00453115|Stage IV|stage iv
745929|NCT00453102|Marginal Zone Lymphoma|marginal zone lymphoma
745930|NCT00453102|Non-gastric extranodal Marginal Zone Lymphoma|non-gastric extranodal marginal zone lymphoma
745931|NCT00453102|Splenic Marginal Zone Lymphoma|splenic marginal zone lymphoma
745932|NCT00453102|Nodal Marginal Zone Lymphoma|nodal marginal zone lymphoma
745933|NCT00453102|Gastric Marginal Zone Lymphoma|gastric marginal zone lymphoma
745934|NCT00453102|MZL|mzl
745935|NCT00453102|Non-gastric extranodal MZL|non-gastric extranodal mzl
745936|NCT00453102|Splenic MZL|splenic mzl
745937|NCT00453102|Nodal MZL|nodal mzl
745938|NCT00453102|Gastric MZL|gastric mzl
745939|NCT00453089|Chinese Herbs|chinese herbs
745940|NCT00453089|Postmenopausal|postmenopausal
745941|NCT00453089|Vaginal Atrophy|vaginal atrophy
745942|NCT00453089|Vulvar Atrophy|vulvar atrophy
745943|NCT00453089|Symptoms|symptoms
745944|NCT00453089|Bionovo|bionovo
745945|NCT00453089|VG101|vg101
745946|NCT00453076|Biliary Obstruction|biliary obstruction
745947|NCT00453050|stage III melanoma|stage iii melanoma
745948|NCT00453050|stage IV melanoma|stage iv melanoma
745949|NCT00453050|skin metastases|skin metastases
745950|NCT00453037|hypertension|hypertension
745951|NCT00453037|self measurement of blood pressure|self measurement of blood pressure
745952|NCT00453037|education program|education program
745953|NCT00453037|life style|life style
745954|NCT00453024|Advanced glaucoma|advanced glaucoma
745955|NCT00453024|Ahmed glaucoma implant|ahmed glaucoma implant
745956|NCT00453024|Anterior segment optical coherence tomography|anterior segment optical coherence tomography
745957|NCT00453024|Pericardial patch graft|pericardial patch graft
745958|NCT00453024|Tissue glue|tissue glue
745959|NCT00453024|Scleral flap|scleral flap
745960|NCT00453024|Sutures|sutures
745961|NCT00453011|vitreous loss|vitreous loss
745962|NCT00453011|intraocular lenses|intraocular lenses
745963|NCT00453011|Patients undergoing extracapsular cataract surgery|patients undergoing extracapsular cataract surgery
745964|NCT00453011|Vitreous loss with sufficient capsular support for an unsutured posterior chamber lens|vitreous loss with sufficient capsular support for an unsutured posterior chamber lens
745965|NCT00453011|5% random sample of patients with no vitreous loss|5% random sample of patients with no vitreous loss
745966|NCT00452998|Sequential Laser Iridotomy|sequential laser iridotomy
745967|NCT00452998|Q-Switched 532 nm Laser|q-switched 532 nm laser
745968|NCT00452998|Frequency Doubled Neodymium Yag Laser|frequency doubled neodymium yag laser
745969|NCT00452972|Cesarean delivery|cesarean delivery
745970|NCT00452972|Spinal anesthesia|spinal anesthesia
745971|NCT00452972|Nausea|nausea
745972|NCT00452972|Vomiting|vomiting
745973|NCT00452972|Pain|pain
745974|NCT00452920|cervical squamous cell carcinoma|cervical squamous cell carcinoma
745975|NCT00452920|stage IIB cervical cancer|stage iib cervical cancer
745976|NCT00452920|stage III cervical cancer|stage iii cervical cancer
745977|NCT00452920|stage IVA cervical cancer|stage iva cervical cancer
745978|NCT00452881|Non-small cell lung cancer|non-small cell lung cancer
745979|NCT00452881|adjuvant chemotherapy|adjuvant chemotherapy
745980|NCT00452868|cognitive/functional effects|cognitive/functional effects
745981|NCT00452868|neurotoxicity|neurotoxicity
745982|NCT00452868|long-term effects secondary to cancer therapy in children|long-term effects secondary to cancer therapy in children
745983|NCT00452868|psychosocial effects of cancer and its treatment|psychosocial effects of cancer and its treatment
745984|NCT00452868|radiation toxicity|radiation toxicity
745985|NCT00452868|childhood central nervous system germ cell tumor|childhood central nervous system germ cell tumor
745986|NCT00452868|childhood choroid plexus tumor|childhood choroid plexus tumor
745987|NCT00452868|childhood craniopharyngioma|childhood craniopharyngioma
745988|NCT00452868|childhood grade I meningioma|childhood grade i meningioma
745989|NCT00452868|childhood grade II meningioma|childhood grade ii meningioma
745990|NCT00452868|childhood grade III meningioma|childhood grade iii meningioma
745991|NCT00452868|childhood spinal cord neoplasm|childhood spinal cord neoplasm
745992|NCT00452868|childhood brain stem glioma|childhood brain stem glioma
745993|NCT00452868|childhood cerebellar astrocytoma|childhood cerebellar astrocytoma
745994|NCT00452868|childhood medulloblastoma|childhood medulloblastoma
745995|NCT00452868|childhood supratentorial primitive neuroectodermal tumor|childhood supratentorial primitive neuroectodermal tumor
745996|NCT00452868|childhood visual pathway and hypothalamic glioma|childhood visual pathway and hypothalamic glioma
745997|NCT00452868|childhood subependymal giant cell astrocytoma|childhood subependymal giant cell astrocytoma
745998|NCT00452868|childhood ependymoma|childhood ependymoma
745999|NCT00452868|childhood cerebral astrocytoma/malignant glioma|childhood cerebral astrocytoma/malignant glioma
746000|NCT00452855|Nausea|nausea
746001|NCT00452855|Vomiting|vomiting
746002|NCT00452855|Post operative|post operative
746003|NCT00452855|Propofol remifentanil anaesthesia|propofol remifentanil anaesthesia
746004|NCT00452855|Sevoflurane remifentanil anaesthesia|sevoflurane remifentanil anaesthesia
746005|NCT00452816|Chronic Disease|chronic disease
746006|NCT00452816|Employer Health Costs|employer health costs
746007|NCT00452816|Health Promotion|health promotion
746008|NCT00452816|Insurance Benefits|insurance benefits
746009|NCT00452816|Marketing of Health Services|marketing of health services
746010|NCT00452816|Mass Screening|mass screening
746011|NCT00452816|Prevention & Control|prevention & control
746012|NCT00452816|Tobacco Use Cessation|tobacco use cessation
746013|NCT00452816|Workplace|workplace
746014|NCT00452803|Non small cell lung cancer|non small cell lung cancer
746015|NCT00452790|Vaccines, Pneumococcal|vaccines, pneumococcal
746016|NCT00452777|Diabetic neuropathy, painful|diabetic neuropathy, painful
746017|NCT00452777|Adenosine A2A receptor|adenosine a2a receptor
746018|NCT00452764|COPD|copd
746019|NCT00452764|Healthy|healthy
746020|NCT00452764|Regulatory T cell|regulatory t cell
746021|NCT00452764|Heme oxygenase-1|heme oxygenase-1
746022|NCT00452764|peripheral blood|peripheral blood
746023|NCT00452751|gastric cancer|gastric cancer
746024|NCT00452751|laparoscopic surgery|laparoscopic surgery
746025|NCT00452751|survival|survival
746026|NCT00452751|preoperative staging|preoperative staging
746027|NCT00452751|morbidity|morbidity
746028|NCT00452751|quality of life|quality of life
746029|NCT00452751|acute inflammatory reaction|acute inflammatory reaction
746030|NCT00452751|cost|cost
746031|NCT00452738|animal-assisted intervention|animal-assisted intervention
746032|NCT00452738|pre surgery anxiety|pre surgery anxiety
746033|NCT00452738|post surgery pain medication consumption|post surgery pain medication consumption
746034|NCT00452712|orthostatism|orthostatism
746035|NCT00452712|fever|fever
746036|NCT00452699|fluticasone propionate|fluticasone propionate
746037|NCT00452699|long-term study|long-term study
746038|NCT00452699|Salmeterol|salmeterol
746039|NCT00452699|FLOVENT 250|flovent 250
746040|NCT00452699|Asthma|asthma
746041|NCT00452699|ADVAIR 250|advair 250
746042|NCT00452686|Chinese DT vaccin|chinese dt vaccin
746043|NCT00452660|IRON|iron
746044|NCT00452660|oxidative stress|oxidative stress
746046|NCT00452647|Condition: No specific disease is being studied, few procedures are excluded.|condition: no specific disease is being studied, few procedures are excluded.
746047|NCT00452647|Focus: To obtain blood pressure data and detect any trends to a statistically significant degree.|focus: to obtain blood pressure data and detect any trends to a statistically significant degree.
746048|NCT00452634|Irinotecan|irinotecan
746049|NCT00452634|cisplatin|cisplatin
746050|NCT00452634|Simvastatin|simvastatin
746051|NCT00452634|Extensive disease|extensive disease
746052|NCT00452634|SCLC|sclc
746053|NCT00452621|blood draw five years after booster-immunization with TBE vaccine to investigate immunogenicity in children|blood draw five years after booster-immunization with tbe vaccine to investigate immunogenicity in children
746054|NCT00452621|TBE|tbe
746055|NCT00452582|ischemic stroke|ischemic stroke
746056|NCT00452582|recovery|recovery
746057|NCT00452582|sildenafil|sildenafil
746058|NCT00452569|Relapsed Refractory Multiple Myeloma|relapsed refractory multiple myeloma
746059|NCT00452556|Prostatic Neoplasms|prostatic neoplasms
746060|NCT00452556|Radiotherapy|radiotherapy
746061|NCT00452556|Docetaxel|docetaxel
746062|NCT00452556|Leuprolide Acetate|leuprolide acetate
746063|NCT00452543|Major depressive disorder|major depressive disorder
746064|NCT00452543|Alcoholism|alcoholism
746065|NCT00452543|Alcohol abuse|alcohol abuse
746066|NCT00452543|Alcohol dependence|alcohol dependence
746067|NCT00452530|Prevention of deep vein thrombosis and pulmonary embolism after total knee replacement surgery|prevention of deep vein thrombosis and pulmonary embolism after total knee replacement surgery
746068|NCT00452517|bare metal stents|bare metal stents
746069|NCT00452517|sirolimus-eluting stents|sirolimus-eluting stents
746070|NCT00452517|coronary polytetrafluoroethylene stent graft|coronary polytetrafluoroethylene stent graft
746071|NCT00452517|acute coronary syndrome|acute coronary syndrome
746072|NCT00452517|quantitative coronary angiography analysis|quantitative coronary angiography analysis
746073|NCT00452517|major adverse cardiac events|major adverse cardiac events
746074|NCT00452517|in-stent restenosis|in-stent restenosis
746075|NCT00452517|target lesion revascularisation|target lesion revascularisation
746076|NCT00452478|Hyperphosphataemia|hyperphosphataemia
746077|NCT00452465|Elderly|elderly
746078|NCT00452465|Nursing care plan|nursing care plan
746079|NCT00452465|Quality of Life|quality of life
746080|NCT00452452|Pneumococcal Vaccines|pneumococcal vaccines
746081|NCT00452439|Leukemia|leukemia
746082|NCT00452439|Lymphoma|lymphoma
746083|NCT00452439|Acute Lymphocytic Leukemia|acute lymphocytic leukemia
746084|NCT00452439|Lymphoblastic Lymphoma|lymphoblastic lymphoma
746085|NCT00452439|Actonel|actonel
746086|NCT00452439|Risedronate|risedronate
746088|NCT00452439|Osteoporosis|osteoporosis
746089|NCT00452426|Propofol|propofol
746090|NCT00452426|Diprivan|diprivan
746091|NCT00452426|Colonoscopy|colonoscopy
746092|NCT00452426|Endoscopy, Digestive System|endoscopy, digestive system
746093|NCT00452426|Conscious Sedation|conscious sedation
746094|NCT00452387|Prostate Cancer|prostate cancer
746095|NCT00452374|B-cell chronic lymphocytic leukemia|b-cell chronic lymphocytic leukemia
746096|NCT00452374|Chronic Lymphocytic Leukemia|chronic lymphocytic leukemia
746098|NCT00452374|Prolymphocytic Leukemia|prolymphocytic leukemia
746099|NCT00452374|PLL|pll
746100|NCT00452374|Richter's Transformation|richter's transformation
746101|NCT00452374|High-grade non-Hodgkin's lymphoma|high-grade non-hodgkin's lymphoma
746102|NCT00452374|Hodgkin's disease|hodgkin's disease
746103|NCT00452374|Acute leukemia|acute leukemia
746104|NCT00452374|Small lymphocytic lymphoma|small lymphocytic lymphoma
746105|NCT00452374|Oxaliplatin|oxaliplatin
746106|NCT00452374|Eloxatin|eloxatin
746107|NCT00452374|Fludarabine|fludarabine
746108|NCT00452374|Cytarabine|cytarabine
746109|NCT00452374|Ara-C|ara-c
746110|NCT00452374|Cytosar|cytosar
746111|NCT00452374|DepoCyt|depocyt
746112|NCT00452374|Cytosine arabinosine hydrochloride|cytosine arabinosine hydrochloride
746113|NCT00452374|Rituximab|rituximab
746114|NCT00452374|Rituxan|rituxan
746115|NCT00452348|FLOVENT|flovent
746116|NCT00452348|fluticasone|fluticasone
746117|NCT00452348|12 month|12 month
746118|NCT00452348|salmeterol|salmeterol
746119|NCT00452348|asthma|asthma
746120|NCT00452348|ADVAIR|advair
746121|NCT00452322|Testosterone|testosterone
746122|NCT00452322|Hypogonadism|hypogonadism
746123|NCT00452322|Safety|safety
746124|NCT00452309|peripheral arterial disease|peripheral arterial disease
746125|NCT00452309|pad|pad
746126|NCT00452309|ankle brachial index|ankle brachial index
746127|NCT00452309|abi|abi
746128|NCT00452296|inpatients with COPD|inpatients with copd
747614|NCT00446875|Infant|infant
746129|NCT00452296|glucose control|glucose control
746130|NCT00452270|Common cold, xylometazoline|common cold, xylometazoline
746131|NCT00452244|Gefitinib|gefitinib
746132|NCT00452244|Simvastatin|simvastatin
746133|NCT00452244|NSCLC|nsclc
746134|NCT00452244|Advanced NSCLC|advanced nsclc
746135|NCT00452231|Post-traumatic Stress Disorder|post-traumatic stress disorder
746136|NCT00452231|Cognitive-Behavioral Therapy|cognitive-behavioral therapy
746137|NCT00452218|Pulmonary Arterial Hypertension|pulmonary arterial hypertension
746138|NCT00452218|PAH|pah
746139|NCT00452205|bone marrow-derived stem cell|bone marrow-derived stem cell
746140|NCT00452205|bone marrow transplantation|bone marrow transplantation
746141|NCT00452205|graft versus host disease|graft versus host disease
746142|NCT00452205|gastrointestinal cancer|gastrointestinal cancer
746143|NCT00452205|after receiving bone marrow transplantation|after receiving bone marrow transplantation
746144|NCT00452192|Metabolic syndrome|metabolic syndrome
746145|NCT00452179|Sleep maintenance|sleep maintenance
746146|NCT00452179|Insomnia|insomnia
746147|NCT00452179|Sleep Consolidation|sleep consolidation
746148|NCT00452179|Sleep|sleep
746149|NCT00452179|Insomnia, primarily sleep maintenance|insomnia, primarily sleep maintenance
746150|NCT00452153|legionellosis|legionellosis
746151|NCT00452153|diagnosis of legionellosis|diagnosis of legionellosis
746152|NCT00452153|PCR|pcr
746153|NCT00452140|Breast Cancer|breast cancer
746154|NCT00452140|investigational drug|investigational drug
746155|NCT00452140|drug therapy|drug therapy
746156|NCT00452140|Antineoplastic Protocols|antineoplastic protocols
746157|NCT00452140|Immunotherapy|immunotherapy
746158|NCT00452140|Metastatic breast cancer|metastatic breast cancer
746159|NCT00452140|Advanced breast cancer|advanced breast cancer
746160|NCT00452140|Stage III to IV breast cancer|stage iii to iv breast cancer
746161|NCT00452140|Hormonal therapy refractory|hormonal therapy refractory
746162|NCT00452140|Failure of hormonal therapy|failure of hormonal therapy
746163|NCT00452140|Her-2/neu expressing breast cancer|her-2/neu expressing breast cancer
746164|NCT00452140|Her-2/neu|her-2/neu
746165|NCT00452127|NHL|nhl
746166|NCT00452127|Indolent|indolent
746167|NCT00452127|Follicular|follicular
746168|NCT00452114|Bronchiectasis|bronchiectasis
746169|NCT00452101|Osteoarthritis|osteoarthritis
746170|NCT00452101|Clinical trial|clinical trial
746171|NCT00452101|Aquamin F|aquamin f
746172|NCT00452101|Glucosamine|glucosamine
746173|NCT00452088|Malaria vaccine|malaria vaccine
746174|NCT00452088|Safety of MSP 3 LSP|safety of msp 3 lsp
746175|NCT00452088|Immunogenicity of MSP 3 LSP|immunogenicity of msp 3 lsp
746176|NCT00452088|Burkina Faso children|burkina faso children
746177|NCT00452075|EGFR expression|egfr expression
746178|NCT00452075|erlotinib|erlotinib
746179|NCT00452062|cuff-leak test|cuff-leak test
746180|NCT00452062|intubation|intubation
746181|NCT00452062|corticosteroids|corticosteroids
746182|NCT00452062|dexamethasone to reduce the occurrence of post-extubation airway obstruction|dexamethasone to reduce the occurrence of post-extubation airway obstruction
746183|NCT00452049|parathyroidectomy|parathyroidectomy
746184|NCT00452049|arterial stiffness|arterial stiffness
746185|NCT00452049|renal function|renal function
746186|NCT00452036|risk factors|risk factors
746188|NCT00452036|cranial computed tomography|cranial computed tomography
746189|NCT00452036|minor head injury|minor head injury
746190|NCT00452023|Myeloproliferative Disorders|myeloproliferative disorders
746191|NCT00452023|Essential Thrombocythemia|essential thrombocythemia
746192|NCT00452023|Polycythemia Vera|polycythemia vera
746193|NCT00452023|Pegasys|pegasys
746194|NCT00452023|IFN-alpha2a|ifn-alpha2a
746195|NCT00452023|Pegylated-Interferon Alpha-2A|pegylated-interferon alpha-2a
746196|NCT00452023|PEG-IFNa-2a|peg-ifna-2a
746197|NCT00452010|TENS|tens
746198|NCT00452010|chronic low back pain|chronic low back pain
746199|NCT00452010|chronic lumbo-radiculalgia|chronic lumbo-radiculalgia
746200|NCT00452010|placebo|placebo
746201|NCT00452010|Roland scale|roland scale
746202|NCT00451997|AML|aml
746203|NCT00451997|MDS|mds
746204|NCT00451997|Gleevec|gleevec
746205|NCT00451997|Ara-C|ara-c
746206|NCT00451997|C-Kit Positive Acute Myeloid Leukemia|c-kit positive acute myeloid leukemia
746207|NCT00451997|High-Risk Myelodysplastic Syndromes|high-risk myelodysplastic syndromes
746208|NCT00451984|interleukin-2|interleukin-2
746209|NCT00451984|vaccination|vaccination
746210|NCT00451984|treatment experienced|treatment experienced
746211|NCT00451958|Degarelix|degarelix
746212|NCT00451958|prostate cancer|prostate cancer
746213|NCT00451932|Malononitrilamide|malononitrilamide
746214|NCT00451932|Immunosuppression|immunosuppression
746215|NCT00451932|treatment efficacy|treatment efficacy
746216|NCT00451932|treatment effectiveness|treatment effectiveness
746217|NCT00451919|MRI|mri
746218|NCT00451919|Neuropsychology|neuropsychology
746219|NCT00451893|Inguinal hernia|inguinal hernia
746220|NCT00451893|polypropylene mesh|polypropylene mesh
746221|NCT00451893|heavy-weight mesh|heavy-weight mesh
746222|NCT00451893|light-weight mesh|light-weight mesh
746223|NCT00451880|Cancer|cancer
746224|NCT00451880|Solid Tumors|solid tumors
746225|NCT00451880|NSCLC|nsclc
746226|NCT00451867|interstitial cystitis research|interstitial cystitis research
746227|NCT00451867|painful bladder syndrome research|painful bladder syndrome research
746228|NCT00451867|pelvic pain research|pelvic pain research
746229|NCT00451867|interstitial cystitis and autoimmune|interstitial cystitis and autoimmune
746230|NCT00451867|interstitial cystitis and cellcept|interstitial cystitis and cellcept
746231|NCT00451867|interstitial cystitis and mycophenolate mofetil|interstitial cystitis and mycophenolate mofetil
746232|NCT00451867|interstitial cystitis and MMF|interstitial cystitis and mmf
746233|NCT00451867|interstitial cystitis and inflammation|interstitial cystitis and inflammation
746234|NCT00451867|inflammatory diseases and immunosupression|inflammatory diseases and immunosupression
746235|NCT00451854|Drug testing|drug testing
746236|NCT00451854|Adolescence|adolescence
746237|NCT00451854|Student athlete|student athlete
746238|NCT00451854|Substance abuse|substance abuse
746239|NCT00451854|Alcohol use|alcohol use
746240|NCT00451854|Drug use|drug use
746241|NCT00451841|Cough|cough
746242|NCT00451841|Gastroesophageal reflux|gastroesophageal reflux
746243|NCT00451841|Exhaled breath condensate|exhaled breath condensate
746244|NCT00451828|Statins|statins
746245|NCT00451828|Cholesterol|cholesterol
746246|NCT00451828|Pharmacogenetics|pharmacogenetics
746247|NCT00451802|Biotechnology|biotechnology
746248|NCT00451802|Specimen|specimen
746249|NCT00451802|Health Management Center|health management center
746250|NCT00451789|Minor head injury|minor head injury
746251|NCT00451789|iintracranial bleeding|iintracranial bleeding
746252|NCT00451789|traumatic brain injury|traumatic brain injury
746253|NCT00451789|Cranial computed tomography|cranial computed tomography
746254|NCT00451789|anticoagulatory drugs|anticoagulatory drugs
746255|NCT00451776|cardiac surgery|cardiac surgery
746256|NCT00451776|adrenal insufficiency|adrenal insufficiency
746257|NCT00451776|etomidate|etomidate
746258|NCT00451776|propofol|propofol
746259|NCT00451763|Fovea centralis/pathology|fovea centralis/pathology
746260|NCT00451763|Fundus oculi|fundus oculi
746261|NCT00451763|Retinal neovascularization|retinal neovascularization
746262|NCT00451763|Telangiectasis/diagnosis|telangiectasis/diagnosis
746263|NCT00451763|Tomography, optical coherence|tomography, optical coherence
746264|NCT00451763|Vitreous Body/drug effects|vitreous body/drug effects
746265|NCT00451750|phobia|phobia
746266|NCT00451750|cortisol|cortisol
746267|NCT00451750|memory|memory
746268|NCT00451750|treatment|treatment
746269|NCT00451737|Six-minute walk test|six-minute walk test
746270|NCT00451737|Neuromuscular system|neuromuscular system
746271|NCT00451737|Influence factors|influence factors
746272|NCT00451724|Prospective|prospective
746273|NCT00451724|Randomized|randomized
746274|NCT00451724|Double blinded|double blinded
746275|NCT00451724|Sedation|sedation
746276|NCT00451724|Ketamine|ketamine
746277|NCT00451724|Intranasal|intranasal
746278|NCT00451711|Prophylaxis|prophylaxis
746279|NCT00451711|Liposomal Amphotericin B|liposomal amphotericin b
746280|NCT00451711|Acute myeloid leukaemia|acute myeloid leukaemia
746281|NCT00451711|Invasive Fungal Infections|invasive fungal infections
746282|NCT00451698|Erythropoietin|erythropoietin
746283|NCT00451698|Congenital heart surgery|congenital heart surgery
746284|NCT00451672|aldosteronism, bromocriptin, hypertension|aldosteronism, bromocriptin, hypertension
746288|NCT00451620|Type 2 diabetes|type 2 diabetes
746289|NCT00451620|Hypoglycemia|hypoglycemia
746290|NCT00451620|Oral hypoglycemic agents|oral hypoglycemic agents
746291|NCT00451620|Insulin levels|insulin levels
746292|NCT00451607|premature|premature
746293|NCT00451607|newborn|newborn
746294|NCT00451607|heart rate variability|heart rate variability
746295|NCT00451607|individualized sensorimotor care|individualized sensorimotor care
746296|NCT00451607|noise|noise
746297|NCT00451594|ITP|itp
746298|NCT00451581|Endoscopic papillary balloon dilatation|endoscopic papillary balloon dilatation
746299|NCT00451581|Endoscopic sphincterotomy|endoscopic sphincterotomy
746300|NCT00451581|Choledocholithiasis|choledocholithiasis
746301|NCT00451581|Efficacy|efficacy
746302|NCT00451581|Complication|complication
746303|NCT00451568|Polycystic ovary syndrome|polycystic ovary syndrome
746304|NCT00451542|Bipolar Disorder|bipolar disorder
746305|NCT00451542|Relapse|relapse
746306|NCT00451542|Retrospective|retrospective
746307|NCT00451516|Plant, medicine|plant, medicine
746308|NCT00451516|Psychiatry|psychiatry
746309|NCT00451516|Major depressive disorder|major depressive disorder
746310|NCT00451516|Anxiety|anxiety
746311|NCT00451516|Major Depressive Disorder with comorbid anxiety|major depressive disorder with comorbid anxiety
746312|NCT00451503|Hearing|hearing
746313|NCT00451503|Auditory rehabilitation|auditory rehabilitation
746314|NCT00451503|Middle ear implant|middle ear implant
746315|NCT00451503|Surgery|surgery
746316|NCT00451490|agomelatin|agomelatin
746317|NCT00451490|prozac|prozac
746318|NCT00451490|heart rate variability|heart rate variability
746319|NCT00451490|major depression|major depression
746320|NCT00451490|sleep|sleep
746321|NCT00451490|depressive symptoms|depressive symptoms
746322|NCT00451464|Apolipoprotein, Gene polymorphism, Hyperlipidemia|apolipoprotein, gene polymorphism, hyperlipidemia
746324|NCT00451451|multiple sclerosis|multiple sclerosis
746325|NCT00451451|oral|oral
746326|NCT00451451|remitting|remitting
746327|NCT00451438|patellofemoral pain syndrome|patellofemoral pain syndrome
746328|NCT00451438|electromyography|electromyography
746329|NCT00451438|gluteus medius|gluteus medius
746330|NCT00451438|tensor fascia lata|tensor fascia lata
746331|NCT00451425|pregnancy|pregnancy
746332|NCT00451425|weight gain|weight gain
746333|NCT00451425|obesity|obesity
746334|NCT00451425|macrosomia|macrosomia
746335|NCT00451412|Venous thromboembolism|venous thromboembolism
746336|NCT00451412|Medical patients|medical patients
746337|NCT00451412|Heparin|heparin
746338|NCT00451412|Low molecular weight heparin|low molecular weight heparin
746339|NCT00451412|Deep vein thrombosis|deep vein thrombosis
746340|NCT00451412|Certoparin|certoparin
746341|NCT00451412|Embolism and Thrombosis|embolism and thrombosis
746342|NCT00451399|Weight gain|weight gain
746343|NCT00451399|antipsychotic|antipsychotic
746344|NCT00451399|lifestyle interventions|lifestyle interventions
746345|NCT00451399|metformin|metformin
746346|NCT00451399|antipsychotic-induced weight gain.|antipsychotic-induced weight gain.
746347|NCT00451373|ARF, dialysis, cytokine, free radical, major operations|arf, dialysis, cytokine, free radical, major operations
746348|NCT00451360|Diacerein|diacerein
746349|NCT00451360|Hip osteoarthritis|hip osteoarthritis
746350|NCT00451360|Structure-modifying effect / Chondromodulating effect|structure-modifying effect / chondromodulating effect
746351|NCT00451360|Double blind study|double blind study
746352|NCT00451321|type 1 diabetes mellitus|type 1 diabetes mellitus
746353|NCT00451321|diabetes mellitus type 1|diabetes mellitus type 1
746354|NCT00451321|type 1 diabetes|type 1 diabetes
746355|NCT00451321|diabetes mellitus|diabetes mellitus
746356|NCT00451321|diabetes|diabetes
746357|NCT00451308|Induction of labor|induction of labor
746358|NCT00451308|vaginal delivery|vaginal delivery
746359|NCT00451308|cesarean section|cesarean section
746360|NCT00451308|foley balloon cathether|foley balloon cathether
746361|NCT00451308|method of labor induction|method of labor induction
746362|NCT00451308|perinatal outcomes|perinatal outcomes
746363|NCT00451295|Chronic Kidney Disease|chronic kidney disease
746364|NCT00451295|Dialysis|dialysis
746365|NCT00451295|Hyperphosphatemia|hyperphosphatemia
746366|NCT00451269|Malaria|malaria
746367|NCT00451269|Diagnosis|diagnosis
746368|NCT00451269|RDT|rdt
746369|NCT00451269|pLDH|pldh
746370|NCT00451269|HRP2|hrp2
746371|NCT00451269|Patients with fever and history of travel in a malaria|patients with fever and history of travel in a malaria
746372|NCT00451269|country|country
746373|NCT00451256|coronary artery bypass|coronary artery bypass
746374|NCT00451256|cardiovascular disease|cardiovascular disease
746375|NCT00451243|psoriatic arthritis|psoriatic arthritis
746376|NCT00451230|craving, insulin, leptin|craving, insulin, leptin
746377|NCT00451204|Multiple sclerosis|multiple sclerosis
746378|NCT00451204|estrogen|estrogen
746379|NCT00451204|estriol|estriol
746380|NCT00451204|progesterone|progesterone
746381|NCT00451191|benign prostatic hyperplasia|benign prostatic hyperplasia
746382|NCT00451191|BPH|bph
746383|NCT00451191|botulinum toxin|botulinum toxin
746384|NCT00451191|BoNT/A|bont/a
746385|NCT00451165|Laparoscopic|laparoscopic
746386|NCT00451165|Colon|colon
746387|NCT00451165|Rectal|rectal
746389|NCT00451165|Urinary function|urinary function
746390|NCT00451165|Sexual function|sexual function
746391|NCT00451165|Bowel function|bowel function
746392|NCT00451165|Male|male
746393|NCT00451152|glaucoma|glaucoma
746394|NCT00451126|emotion|emotion
746395|NCT00451126|personality|personality
746396|NCT00451126|social stress|social stress
746397|NCT00451126|appraisal|appraisal
746398|NCT00451113|Type 2 diabetes|type 2 diabetes
746399|NCT00451113|Older adults|older adults
746400|NCT00451113|Incretins|incretins
746401|NCT00451113|Hyperglycemia|hyperglycemia
746402|NCT00451113|Insulin resistance|insulin resistance
746403|NCT00451087|mechanical properties|mechanical properties
746404|NCT00451087|electromechanical delay|electromechanical delay
746405|NCT00451087|viscoelasticity|viscoelasticity
746406|NCT00451087|VMO|vmo
746407|NCT00451087|patellofemoral pain syndrome|patellofemoral pain syndrome
746408|NCT00451074|Stop codon mutations|stop codon mutations
746409|NCT00451061|distal ureterolithiasis|distal ureterolithiasis
746410|NCT00451061|α adrenoreceptors antagonist|α adrenoreceptors antagonist
746411|NCT00451035|Refractory Chronic Myeloid Leukemia in Chronic Phase|refractory chronic myeloid leukemia in chronic phase
746412|NCT00451035|adults|adults
746413|NCT00451035|oral LBH589|oral lbh589
746414|NCT00451022|Gene Therapy|gene therapy
746415|NCT00451022|Long Term Survivor|long term survivor
746416|NCT00451022|Research Specimen|research specimen
746417|NCT00451009|IVF|ivf
746418|NCT00451009|Male factor infertility|male factor infertility
746419|NCT00451009|Cryopreservation|cryopreservation
746420|NCT00451009|Cryoprotective agents|cryoprotective agents
746421|NCT00451009|Egg Freezing|egg freezing
746422|NCT00450983|graft versus host disease|graft versus host disease
746591|NCT00450463|Combination Therapy|combination therapy
746423|NCT00450983|adult acute lymphoblastic leukemia in remission|adult acute lymphoblastic leukemia in remission
746424|NCT00450983|recurrent adult acute lymphoblastic leukemia|recurrent adult acute lymphoblastic leukemia
746425|NCT00450983|childhood acute lymphoblastic leukemia in remission|childhood acute lymphoblastic leukemia in remission
746426|NCT00450983|recurrent childhood acute lymphoblastic leukemia|recurrent childhood acute lymphoblastic leukemia
746427|NCT00450983|adult acute myeloid leukemia with 11q23 (MLL) abnormalities|adult acute myeloid leukemia with 11q23 (mll) abnormalities
746428|NCT00450983|adult acute myeloid leukemia in remission|adult acute myeloid leukemia in remission
746429|NCT00450983|recurrent adult acute myeloid leukemia|recurrent adult acute myeloid leukemia
746430|NCT00450983|childhood acute myeloid leukemia in remission|childhood acute myeloid leukemia in remission
746431|NCT00450983|recurrent childhood acute myeloid leukemia|recurrent childhood acute myeloid leukemia
746432|NCT00450983|secondary acute myeloid leukemia|secondary acute myeloid leukemia
746433|NCT00450983|de novo myelodysplastic syndromes|de novo myelodysplastic syndromes
746434|NCT00450983|previously treated myelodysplastic syndromes|previously treated myelodysplastic syndromes
746435|NCT00450983|secondary myelodysplastic syndromes|secondary myelodysplastic syndromes
746436|NCT00450983|accelerated phase chronic myelogenous leukemia|accelerated phase chronic myelogenous leukemia
746437|NCT00450983|blastic phase chronic myelogenous leukemia|blastic phase chronic myelogenous leukemia
746438|NCT00450983|childhood chronic myelogenous leukemia|childhood chronic myelogenous leukemia
746439|NCT00450983|relapsing chronic myelogenous leukemia|relapsing chronic myelogenous leukemia
746440|NCT00450983|adult acute myeloid leukemia with inv(16)(p13;q22)|adult acute myeloid leukemia with inv(16)(p13;q22)
746441|NCT00450983|adult acute myeloid leukemia with t(15;17)(q22;q12)|adult acute myeloid leukemia with t(15;17)(q22;q12)
746442|NCT00450983|adult acute myeloid leukemia with t(16;16)(p13;q22)|adult acute myeloid leukemia with t(16;16)(p13;q22)
746443|NCT00450983|adult acute myeloid leukemia with t(8;21)(q22;q22)|adult acute myeloid leukemia with t(8;21)(q22;q22)
746444|NCT00450983|childhood myelodysplastic syndromes|childhood myelodysplastic syndromes
746445|NCT00450970|Hormone Refractory Prostate Cancer (HRPC)|hormone refractory prostate cancer (hrpc)
746446|NCT00450970|Hormone Refractory Prostate Cancer|hormone refractory prostate cancer
746447|NCT00450970|Unlimited Prior Cytotoxic Chemotherapy Regimens|unlimited prior cytotoxic chemotherapy regimens
746448|NCT00450944|B-cell adult acute lymphoblastic leukemia|b-cell adult acute lymphoblastic leukemia
746449|NCT00450944|recurrent adult acute lymphoblastic leukemia|recurrent adult acute lymphoblastic leukemia
746450|NCT00450931|health status unknown|health status unknown
746451|NCT00450918|Kartagener Syndrome|kartagener syndrome
746452|NCT00450905|Chronic musculoskeletal pain secondary to Fibromyalgia|chronic musculoskeletal pain secondary to fibromyalgia
746453|NCT00450892|inflammatory breast cancer|inflammatory breast cancer
746454|NCT00450892|stage II breast cancer|stage ii breast cancer
746455|NCT00450892|stage IIIA breast cancer|stage iiia breast cancer
746456|NCT00450892|stage IIIB breast cancer|stage iiib breast cancer
746457|NCT00450892|stage IIIC breast cancer|stage iiic breast cancer
746458|NCT00450866|recurrent breast cancer|recurrent breast cancer
746459|NCT00450866|stage IV breast cancer|stage iv breast cancer
746460|NCT00450866|tumors metastatic to brain|tumors metastatic to brain
746461|NCT00450866|leptomeningeal metastases|leptomeningeal metastases
746462|NCT00450866|male breast cancer|male breast cancer
746463|NCT00450853|emesis|emesis
746464|NCT00450853|granisetron|granisetron
746465|NCT00450853|pharmacokinetics|pharmacokinetics
746466|NCT00450853|subcutaneous.|subcutaneous.
746467|NCT00450840|septic shock|septic shock
746469|NCT00450827|recurrent neuroblastoma|recurrent neuroblastoma
746470|NCT00450801|contiguous stage II mantle cell lymphoma|contiguous stage ii mantle cell lymphoma
746471|NCT00450801|noncontiguous stage II mantle cell lymphoma|noncontiguous stage ii mantle cell lymphoma
746472|NCT00450801|stage I mantle cell lymphoma|stage i mantle cell lymphoma
746473|NCT00450801|stage III mantle cell lymphoma|stage iii mantle cell lymphoma
746474|NCT00450801|stage IV mantle cell lymphoma|stage iv mantle cell lymphoma
746475|NCT00450788|Etiology|etiology
746476|NCT00450788|Carcinogens|carcinogens
746477|NCT00450788|Esophageal Cancer|esophageal cancer
746478|NCT00450762|pretreated|pretreated
746479|NCT00450762|metastatic|metastatic
746480|NCT00450736|chondrosarcoma|chondrosarcoma
746481|NCT00450736|adult angiosarcoma|adult angiosarcoma
746482|NCT00450736|adult fibrosarcoma|adult fibrosarcoma
746483|NCT00450736|adult leiomyosarcoma|adult leiomyosarcoma
746484|NCT00450736|adult liposarcoma|adult liposarcoma
746485|NCT00450736|adult neurofibrosarcoma|adult neurofibrosarcoma
746486|NCT00450736|adult synovial sarcoma|adult synovial sarcoma
746487|NCT00450736|childhood angiosarcoma|childhood angiosarcoma
746488|NCT00450736|childhood fibrosarcoma|childhood fibrosarcoma
746489|NCT00450736|childhood leiomyosarcoma|childhood leiomyosarcoma
746490|NCT00450736|childhood liposarcoma|childhood liposarcoma
746491|NCT00450736|childhood neurofibrosarcoma|childhood neurofibrosarcoma
746492|NCT00450736|childhood synovial sarcoma|childhood synovial sarcoma
746493|NCT00450736|nonmetastatic childhood soft tissue sarcoma|nonmetastatic childhood soft tissue sarcoma
746494|NCT00450736|stage II adult soft tissue sarcoma|stage ii adult soft tissue sarcoma
746495|NCT00450736|stage III adult soft tissue sarcoma|stage iii adult soft tissue sarcoma
746496|NCT00450736|adult malignant fibrous histiocytoma|adult malignant fibrous histiocytoma
746678|NCT00450151|Pediatric|pediatric
746497|NCT00450736|adult malignant hemangiopericytoma|adult malignant hemangiopericytoma
746498|NCT00450736|childhood malignant hemangiopericytoma|childhood malignant hemangiopericytoma
746499|NCT00450736|localized childhood malignant fibrous histiocytoma of bone|localized childhood malignant fibrous histiocytoma of bone
746500|NCT00450723|stage I breast cancer|stage i breast cancer
746501|NCT00450723|stage II breast cancer|stage ii breast cancer
746502|NCT00450723|male breast cancer|male breast cancer
746503|NCT00450697|Feeding intolerance in premature infants|feeding intolerance in premature infants
746504|NCT00450697|Bolus feeding every 4 hours versus every 3 hours|bolus feeding every 4 hours versus every 3 hours
746505|NCT00450697|Feeding method in premature infants|feeding method in premature infants
746506|NCT00450671|Fistula-in-ano|fistula-in-ano
746507|NCT00450671|Anal fistula|anal fistula
746508|NCT00450671|Perirectal fistula|perirectal fistula
746509|NCT00450671|Collagen plug|collagen plug
746510|NCT00450671|Surgisis|surgisis
746511|NCT00450671|Seton|seton
746512|NCT00450658|ibuprofen|ibuprofen
746513|NCT00450658|famotidine|famotidine
746514|NCT00450658|ulcers|ulcers
746515|NCT00450658|NSAIDS|nsaids
746516|NCT00450658|pain|pain
746517|NCT00450658|arthritis|arthritis
746518|NCT00450658|chronic regional pain syndrome|chronic regional pain syndrome
746519|NCT00450658|chronic soft tissue pain|chronic soft tissue pain
746520|NCT00450658|osteoarthritis|osteoarthritis
746521|NCT00450658|rheumatoid arthritis|rheumatoid arthritis
746522|NCT00450658|chronic low back pain|chronic low back pain
746523|NCT00450645|Cancer|cancer
746524|NCT00450645|Residual vein thrombosis|residual vein thrombosis
746525|NCT00450645|Low Molecular Weight Heparin|low molecular weight heparin
746526|NCT00450645|Optimal duration|optimal duration
746527|NCT00450632|meningococcal infections|meningococcal infections
746528|NCT00450632|biotheque|biotheque
746529|NCT00450632|genetic markers|genetic markers
746530|NCT00450619|Radionuclide|radionuclide
746531|NCT00450619|Immunotherapy|immunotherapy
746532|NCT00450619|Radiation|radiation
746533|NCT00450619|PSA|psa
746534|NCT00450619|Hormone Refractory Prostate Cancer|hormone refractory prostate cancer
746535|NCT00450619|Prostate Cancer|prostate cancer
746536|NCT00450593|melanoma|melanoma
746537|NCT00450593|hereditary multiple melanoma|hereditary multiple melanoma
746538|NCT00450593|recurrent melanoma|recurrent melanoma
746539|NCT00450593|stage 0 melanoma|stage 0 melanoma
746540|NCT00450593|stage IV melanoma|stage iv melanoma
746541|NCT00450593|stage IA melanoma|stage ia melanoma
746542|NCT00450593|stage IB melanoma|stage ib melanoma
746543|NCT00450593|stage IIA melanoma|stage iia melanoma
746544|NCT00450593|stage IIB melanoma|stage iib melanoma
746545|NCT00450593|stage IIC melanoma|stage iic melanoma
746546|NCT00450593|stage IIIA melanoma|stage iiia melanoma
746547|NCT00450593|stage IIIB melanoma|stage iiib melanoma
746548|NCT00450593|stage IIIC melanoma|stage iiic melanoma
746549|NCT00450580|protease inhibitor,|protease inhibitor,
746550|NCT00450580|HIV-1,|hiv-1,
746551|NCT00450580|Fosamprenavir,|fosamprenavir,
746552|NCT00450580|non-HDL cholesterol|non-hdl cholesterol
746553|NCT00450580|ritonavir,|ritonavir,
746554|NCT00450580|naive,|naive,
746555|NCT00450567|recurrent non-small cell lung cancer|recurrent non-small cell lung cancer
746556|NCT00450567|stage I non-small cell lung cancer|stage i non-small cell lung cancer
746557|NCT00450567|stage II non-small cell lung cancer|stage ii non-small cell lung cancer
747378|NCT00447928|tendonitis|tendonitis
746558|NCT00450567|stage IIIA non-small cell lung cancer|stage iiia non-small cell lung cancer
746559|NCT00450567|stage IIIB non-small cell lung cancer|stage iiib non-small cell lung cancer
746560|NCT00450567|stage IV non-small cell lung cancer|stage iv non-small cell lung cancer
746561|NCT00450554|Neisseria meningitidis B:14, P1-7, 16|neisseria meningitidis b:14, p1-7, 16
746562|NCT00450554|Serum bactericidal activity|serum bactericidal activity
746563|NCT00450554|Menbvac|menbvac
746564|NCT00450541|Advanced Cancer|advanced cancer
746565|NCT00450541|Fatigue|fatigue
746566|NCT00450541|Interview|interview
746567|NCT00450541|Questionnaire|questionnaire
746568|NCT00450541|Survey|survey
746569|NCT00450528|D-dimers|d-dimers
746570|NCT00450528|surgery|surgery
746571|NCT00450528|kinetics|kinetics
746572|NCT00450515|recurrent breast cancer|recurrent breast cancer
746573|NCT00450515|stage IV breast cancer|stage iv breast cancer
746574|NCT00450515|male breast cancer|male breast cancer
746575|NCT00450502|Cytotoxic|cytotoxic
746576|NCT00450502|Pharmacokinetics|pharmacokinetics
746577|NCT00450502|Toxicity|toxicity
746578|NCT00450502|Neoplasms|neoplasms
746579|NCT00450502|Pharmacogenomics|pharmacogenomics
746580|NCT00450502|Solid Tumor|solid tumor
746581|NCT00450502|Lymphoma|lymphoma
746582|NCT00450489|Type 1 Diabetes Mellitus|type 1 diabetes mellitus
746583|NCT00450489|Quality of Life|quality of life
746584|NCT00450489|Satisfaction of medical care delivery|satisfaction of medical care delivery
746585|NCT00450476|ventilator associated pneumonia|ventilator associated pneumonia
746586|NCT00450476|prevention|prevention
746587|NCT00450476|endotracheal intubation|endotracheal intubation
746588|NCT00450476|mechanical ventilation|mechanical ventilation
746589|NCT00450463|Immunotherapy|immunotherapy
746590|NCT00450463|Hormonal Therapy|hormonal therapy
746960|NCT00448903|neuropathy|neuropathy
746592|NCT00450463|Prostate Specific Antigen|prostate specific antigen
746593|NCT00450463|Immunoassay|immunoassay
746594|NCT00450463|Prostate Cancer|prostate cancer
746595|NCT00450437|Meningococcal|meningococcal
746596|NCT00450437|meningitis|meningitis
746597|NCT00450437|vaccine|vaccine
746598|NCT00450437|adolescents|adolescents
746599|NCT00450437|adults|adults
746600|NCT00450424|colon cancer|colon cancer
746601|NCT00450424|rectal cancer|rectal cancer
746602|NCT00450424|hereditary non-polyposis colon cancer|hereditary non-polyposis colon cancer
746603|NCT00450424|recurrent colon cancer|recurrent colon cancer
746604|NCT00450424|stage I colon cancer|stage i colon cancer
746605|NCT00450424|stage IIA colon cancer|stage iia colon cancer
746606|NCT00450424|stage IIB colon cancer|stage iib colon cancer
746607|NCT00450424|stage IIIA colon cancer|stage iiia colon cancer
746608|NCT00450424|stage IIIB colon cancer|stage iiib colon cancer
746609|NCT00450424|stage IIIC colon cancer|stage iiic colon cancer
746610|NCT00450424|stage IVA colon cancer|stage iva colon cancer
746611|NCT00450424|stage IVB colon cancer|stage ivb colon cancer
746612|NCT00450424|recurrent rectal cancer|recurrent rectal cancer
746613|NCT00450424|stage I rectal cancer|stage i rectal cancer
746614|NCT00450424|stage IIA rectal cancer|stage iia rectal cancer
746615|NCT00450424|stage IIB rectal cancer|stage iib rectal cancer
746616|NCT00450424|stage IIC rectal cancer|stage iic rectal cancer
746617|NCT00450424|stage IIIA rectal cancer|stage iiia rectal cancer
746618|NCT00450424|stage IIIB rectal cancer|stage iiib rectal cancer
746619|NCT00450424|stage IIIC rectal cancer|stage iiic rectal cancer
746620|NCT00450424|stage IVA rectal cancer|stage iva rectal cancer
746621|NCT00450424|stage IVB rectal cancer|stage ivb rectal cancer
746622|NCT00450411|adenocarcinoma of the prostate|adenocarcinoma of the prostate
746623|NCT00450411|recurrent prostate cancer|recurrent prostate cancer
746624|NCT00450411|stage I prostate cancer|stage i prostate cancer
746625|NCT00450411|stage IIB prostate cancer|stage iib prostate cancer
746626|NCT00450411|stage IIA prostate cancer|stage iia prostate cancer
746627|NCT00450398|Delayed graft function|delayed graft function
746628|NCT00450385|recurrent adult diffuse large cell lymphoma|recurrent adult diffuse large cell lymphoma
746629|NCT00450385|stage III adult diffuse large cell lymphoma|stage iii adult diffuse large cell lymphoma
746630|NCT00450385|stage IV adult diffuse large cell lymphoma|stage iv adult diffuse large cell lymphoma
746631|NCT00450385|contiguous stage II adult diffuse large cell lymphoma|contiguous stage ii adult diffuse large cell lymphoma
746632|NCT00450385|noncontiguous stage II adult diffuse large cell lymphoma|noncontiguous stage ii adult diffuse large cell lymphoma
746633|NCT00450385|stage I adult diffuse large cell lymphoma|stage i adult diffuse large cell lymphoma
746634|NCT00450372|recurrent melanoma|recurrent melanoma
746635|NCT00450372|stage IV melanoma|stage iv melanoma
746636|NCT00450359|breast cancer|breast cancer
746637|NCT00450333|Chronic|chronic
746638|NCT00450320|AIDS-related Kaposi sarcoma|aids-related kaposi sarcoma
746639|NCT00450320|recurrent Kaposi sarcoma|recurrent kaposi sarcoma
746640|NCT00450307|recurrent neuroblastoma|recurrent neuroblastoma
746641|NCT00450307|stage 4S neuroblastoma|stage 4s neuroblastoma
746642|NCT00450307|disseminated neuroblastoma|disseminated neuroblastoma
746643|NCT00450307|localized unresectable neuroblastoma|localized unresectable neuroblastoma
746644|NCT00450307|regional neuroblastoma|regional neuroblastoma
746645|NCT00450281|stage IIIB non-small cell lung cancer|stage iiib non-small cell lung cancer
746646|NCT00450281|stage IIIA non-small cell lung cancer|stage iiia non-small cell lung cancer
746647|NCT00450281|stage IA non-small cell lung cancer|stage ia non-small cell lung cancer
746648|NCT00450281|stage IB non-small cell lung cancer|stage ib non-small cell lung cancer
746649|NCT00450281|stage IIA non-small cell lung cancer|stage iia non-small cell lung cancer
746650|NCT00450281|stage IIB non-small cell lung cancer|stage iib non-small cell lung cancer
746651|NCT00450268|Graft versus host disease|graft versus host disease
746652|NCT00450268|Allogeneic hematpoietic stem cell transplantation|allogeneic hematpoietic stem cell transplantation
746653|NCT00450242|vulvar vestibulitis|vulvar vestibulitis
746654|NCT00450242|vestibulitis|vestibulitis
746655|NCT00450216|ibuprofen|ibuprofen
746656|NCT00450216|famotidine|famotidine
746657|NCT00450216|ulcers|ulcers
746658|NCT00450216|NSAIDS|nsaids
746659|NCT00450216|pain|pain
746660|NCT00450216|arthritis|arthritis
746661|NCT00450216|chronic regional pain syndrome|chronic regional pain syndrome
746662|NCT00450216|chronic soft tissue pain|chronic soft tissue pain
746663|NCT00450216|osteoarthritis|osteoarthritis
746664|NCT00450216|rheumatoid arthritis|rheumatoid arthritis
746665|NCT00450216|chronic low back pain|chronic low back pain
746666|NCT00450203|adenocarcinoma of the stomach|adenocarcinoma of the stomach
746667|NCT00450203|adenocarcinoma of the gastro oesophageal junction|adenocarcinoma of the gastro oesophageal junction
746668|NCT00450203|adenocarcinoma of the lower oesophagus|adenocarcinoma of the lower oesophagus
746669|NCT00450190|Growth disorders|growth disorders
746670|NCT00450177|iron|iron
746671|NCT00450177|critical illness|critical illness
746672|NCT00450177|anemia|anemia
746673|NCT00450177|infection|infection
746674|NCT00450164|Variceal bleeding|variceal bleeding
746675|NCT00450164|Secondary profilaxis|secondary profilaxis
746676|NCT00450164|Hemodynamic|hemodynamic
746677|NCT00450164|Portal hypertension|portal hypertension
746679|NCT00450151|Cardiopulmonary bypass Surgery|cardiopulmonary bypass surgery
746680|NCT00450151|Cardiac Surgery|cardiac surgery
746681|NCT00450151|Platelet|platelet
746682|NCT00450151|Platelet Activation Markers|platelet activation markers
746683|NCT00450151|Platelet Factor4|platelet factor4
746684|NCT00450151|Transforming Growth Factor Beta|transforming growth factor beta
746685|NCT00450138|Squamous Cell Carcinoma|squamous cell carcinoma
746686|NCT00450125|Lung Cancer|lung cancer
746687|NCT00450125|Lung Resection|lung resection
746688|NCT00450125|Exercise Stress Test|exercise stress test
746689|NCT00450125|Six-Minute Walk Test|six-minute walk test
746690|NCT00450099|Epidural|epidural
746691|NCT00450099|Labor Analgesia|labor analgesia
746692|NCT00450099|Bupivacaine|bupivacaine
746693|NCT00450099|Dose-response|dose-response
746694|NCT00450099|Minimum effective volume|minimum effective volume
746695|NCT00450060|postlumbar puncture headache|postlumbar puncture headache
746696|NCT00450060|atraumatic needle|atraumatic needle
746697|NCT00450060|Sprotte|sprotte
746698|NCT00450060|Quincke|quincke
746699|NCT00450060|lumbar puncture|lumbar puncture
746700|NCT00450060|headache|headache
746701|NCT00450060|backache|backache
746702|NCT00450047|cognitive impairment, ergometer, speed-feedback therapy|cognitive impairment, ergometer, speed-feedback therapy
746703|NCT00450034|Frail Elderly|frail elderly
746704|NCT00450034|Patient Education|patient education
746705|NCT00450034|Drug optimization|drug optimization
746706|NCT00450034|Underuse|underuse
746707|NCT00450034|Vulnerable|vulnerable
746708|NCT00450034|Drug related hospitalization|drug related hospitalization
746709|NCT00450034|Medical intervention|medical intervention
746710|NCT00450021|PET|pet
746711|NCT00450021|CB1 Receptor|cb1 receptor
746712|NCT00450021|Cannabinoid|cannabinoid
746713|NCT00450021|[11C] MePPEP|[11c] meppep
746714|NCT00450021|Brain Imaging|brain imaging
746715|NCT00450021|Healthy Volunteer|healthy volunteer
746716|NCT00450021|HV|hv
746717|NCT00450008|Prostate Cancer|prostate cancer
746718|NCT00450008|Hormone-Naïve Prostate Cancer|hormone-naïve prostate cancer
746719|NCT00450008|adenocarcinoma of the prostate|adenocarcinoma of the prostate
746720|NCT00449982|Genital warts|genital warts
746721|NCT00449982|Condylomata acuminata|condylomata acuminata
746722|NCT00449982|Human Papillomavirus|human papillomavirus
746723|NCT00449982|Polyphenon E|polyphenon e
746724|NCT00449982|Green tea extract|green tea extract
746725|NCT00449982|Vulva|vulva
746726|NCT00449982|Penis|penis
746727|NCT00449982|Anus|anus
746728|NCT00449969|AED (automated external defibrillation)|aed (automated external defibrillation)
746729|NCT00449969|feedback|feedback
746730|NCT00449969|out of hospital resuscitation|out of hospital resuscitation
746731|NCT00449943|Cardiac Invasive Catheterization Angiography|cardiac invasive catheterization angiography
746732|NCT00449943|Single Photon Emission Computed Tomography|single photon emission computed tomography
746733|NCT00449943|Computed Tomography Angiography|computed tomography angiography
746734|NCT00449917|visual caracteristics|visual caracteristics
746735|NCT00449917|macular pigment optical density|macular pigment optical density
746736|NCT00449917|visual acuity|visual acuity
746737|NCT00449917|contrast sensibility|contrast sensibility
746738|NCT00449917|lutein|lutein
746739|NCT00449917|docosahexaenoic acid (DHA)|docosahexaenoic acid (dha)
746740|NCT00449904|Cystic fibrosis-related exocrine pancreatic insufficiency|cystic fibrosis-related exocrine pancreatic insufficiency
746741|NCT00449891|Type 1 diabetes mellitus|type 1 diabetes mellitus
746742|NCT00449878|cystic fibrosis-related pancreatic insufficiency|cystic fibrosis-related pancreatic insufficiency
746743|NCT00449865|Parkinson's disease|parkinson's disease
746744|NCT00449865|creatine|creatine
746745|NCT00449865|NET-PD|net-pd
746746|NCT00449865|neuroprotection|neuroprotection
746747|NCT00449865|PD|pd
746748|NCT00449852|Randomized Control Trial|randomized control trial
746749|NCT00449852|Smoking Cessation|smoking cessation
746750|NCT00449852|Secondary Prevention|secondary prevention
746751|NCT00449852|Rehabilitation|rehabilitation
746752|NCT00449852|Counseling|counseling
746753|NCT00449839|Insulin pump treatment CSII|insulin pump treatment csii
746754|NCT00449839|Absorption|absorption
746755|NCT00449839|Insulin Aspart|insulin aspart
746756|NCT00449826|ACS|acs
746757|NCT00449826|Unstable Angina|unstable angina
746758|NCT00449826|NSTEMI|nstemi
746759|NCT00449813|Gastroesophageal reflux disease (GERD)|gastroesophageal reflux disease (gerd)
746760|NCT00449813|Non erosive reflux disease (NERD)|non erosive reflux disease (nerd)
746761|NCT00449800|Sepsis|sepsis
746762|NCT00449800|Ceftriaxone|ceftriaxone
746763|NCT00449800|Pharmacokinetic|pharmacokinetic
746764|NCT00449800|Intensive care unit|intensive care unit
746765|NCT00449787|Emergency department|emergency department
746766|NCT00449787|headache|headache
746767|NCT00449787|migraine|migraine
746768|NCT00449774|Food effect|food effect
746769|NCT00449774|Safety|safety
746770|NCT00449774|Tolerability|tolerability
746771|NCT00449774|Water effect|water effect
746772|NCT00449774|Bioequivalence|bioequivalence
746773|NCT00449761|Refractory|refractory
746774|NCT00449761|Chronic Myeloid|chronic myeloid
746775|NCT00449761|Leukemia|leukemia
746776|NCT00449761|accelerated phase|accelerated phase
746777|NCT00449761|blast phase (blast crisis)|blast phase (blast crisis)
746779|NCT00449761|oral LBH589|oral lbh589
746780|NCT00449748|Systemic Mastocytosis|systemic mastocytosis
746781|NCT00449748|RAD001|rad001
746782|NCT00449735|positive isolates|positive isolates
746783|NCT00449735|ecoli|ecoli
746784|NCT00449735|blood cultures|blood cultures
746785|NCT00449735|positive cultures for ecoli|positive cultures for ecoli
746786|NCT00449735|blood stream infections|blood stream infections
746787|NCT00449709|Pre-term labor,|pre-term labor,
746788|NCT00449709|modified release formulation|modified release formulation
746789|NCT00449709|pharmacokinetics,|pharmacokinetics,
746790|NCT00449683|Depressive Disorders|depressive disorders
746791|NCT00449683|Excessive Sweating|excessive sweating
746792|NCT00449683|Sweating caused by antidepressants for those a depressive disorder|sweating caused by antidepressants for those a depressive disorder
746793|NCT00449670|Influenza|influenza
746794|NCT00449670|Influenza Vaccine|influenza vaccine
746795|NCT00449644|Tuberculosis|tuberculosis
746796|NCT00449644|MDR TB|mdr tb
746797|NCT00449631|Glaucoma|glaucoma
746798|NCT00449631|Drug Resistance, Multiple|drug resistance, multiple
746799|NCT00449631|Trabeculectomy|trabeculectomy
746800|NCT00449618|Aspirin|aspirin
746801|NCT00449618|Ambulatory blood pressure monitoring|ambulatory blood pressure monitoring
746802|NCT00449618|Chronotherapy|chronotherapy
746803|NCT00449618|Circadian|circadian
746804|NCT00449605|Diabetes|diabetes
746805|NCT00449605|Metformin|metformin
746806|NCT00449592|Stem cell transplantation|stem cell transplantation
746807|NCT00449592|Mucositis|mucositis
746808|NCT00449592|Zinc|zinc
746809|NCT00449579|Ischemia|ischemia
746810|NCT00449579|Myocardial|myocardial
746811|NCT00449579|HF-ECG|hf-ecg
746812|NCT00449566|Magnetic Resonance Imaging|magnetic resonance imaging
746813|NCT00449566|Diffusion Tensor Imaging|diffusion tensor imaging
746814|NCT00449553|Glucose Metabolism Disorder|glucose metabolism disorder
746815|NCT00449553|Dysmetabolic Syndrome|dysmetabolic syndrome
746816|NCT00449553|Type II Diabetes|type ii diabetes
746817|NCT00449553|Diabetes Mellitus, Lipoatrophic|diabetes mellitus, lipoatrophic
746818|NCT00449553|Dyslipidemia|dyslipidemia
746819|NCT00449553|Drug Therapy|drug therapy
746820|NCT00449540|Migraine with aura|migraine with aura
746821|NCT00449540|aura|aura
746822|NCT00449540|TMS|tms
746823|NCT00449527|Mild asthma|mild asthma
746824|NCT00449527|Moderate asthma|moderate asthma
746825|NCT00449514|infertility|infertility
746826|NCT00449514|ovulation dysfunction|ovulation dysfunction
746827|NCT00449514|endometrium|endometrium
746828|NCT00449514|tamoxifen|tamoxifen
746829|NCT00449514|clomiphene citrate|clomiphene citrate
746830|NCT00449501|Mild Asthma|mild asthma
746831|NCT00449501|Moderate Asthma|moderate asthma
746832|NCT00449488|erythropoietin|erythropoietin
746833|NCT00449488|myocardial infarction|myocardial infarction
746834|NCT00449488|PCI|pci
746835|NCT00449488|left ventricular function|left ventricular function
746836|NCT00449462|CLA|cla
746837|NCT00449462|liver|liver
746838|NCT00449462|kidney|kidney
746839|NCT00449449|Pertubation, tubal flushing, intrauterine insemination.|pertubation, tubal flushing, intrauterine insemination.
746840|NCT00449436|treatment experienced|treatment experienced
746841|NCT00449436|HIV|hiv
746842|NCT00449423|Acute heart failure|acute heart failure
747781|NCT00446251|Diabetes|diabetes
746843|NCT00449423|Metabolic modulation|metabolic modulation
746844|NCT00449410|Atrial Fibrillation|atrial fibrillation
746845|NCT00449410|elderly|elderly
746846|NCT00449410|cholesterol lowering|cholesterol lowering
746847|NCT00449410|neurocognitive function|neurocognitive function
746848|NCT00449410|cerebrovascular lesion|cerebrovascular lesion
746849|NCT00449397|First Episode Psychosis|first episode psychosis
746850|NCT00449384|Severe Impairment Battery|severe impairment battery
746851|NCT00449384|Clinical Dementia Rating|clinical dementia rating
746852|NCT00449358|bcc|bcc
746853|NCT00449345|Latent tuberculosis infection|latent tuberculosis infection
746854|NCT00449345|Health care workers|health care workers
746855|NCT00449345|Tuberculin skin test|tuberculin skin test
746856|NCT00449345|Mantoux skin test|mantoux skin test
746857|NCT00449345|Interferon gamma|interferon gamma
746858|NCT00449345|Quantiferon|quantiferon
746859|NCT00449345|Cost effectiveness|cost effectiveness
746860|NCT00449332|Chronic rejection, lung transplant, cytokines, bos|chronic rejection, lung transplant, cytokines, bos
746861|NCT00449319|AML|aml
746862|NCT00449319|adult|adult
746863|NCT00449319|Hydroxyurea|hydroxyurea
746864|NCT00449319|Transplant|transplant
746865|NCT00449319|Toevaluate biological characteristics at diagnosis.|toevaluate biological characteristics at diagnosis.
746866|NCT00449319|To identify genetic alterations with prognostic relevance.|to identify genetic alterations with prognostic relevance.
746867|NCT00449319|To follow up cases monitoring minimal disease during remission.|to follow up cases monitoring minimal disease during remission.
746868|NCT00449319|To evaluate pretreatment therapy in terms of response rate and toxicity.|to evaluate pretreatment therapy in terms of response rate and toxicity.
746869|NCT00449319|Disease free survival.|disease free survival.
746870|NCT00449319|Overal survival.|overal survival.
746871|NCT00449306|Atherosclerosis|atherosclerosis
746872|NCT00449306|Carotid plaque|carotid plaque
746873|NCT00449306|Abdominal aortic aneurysm|abdominal aortic aneurysm
746874|NCT00449306|Vulnerable plaque|vulnerable plaque
746875|NCT00449306|Angiogenesis|angiogenesis
746876|NCT00449306|Intraplaque hemorrhage|intraplaque hemorrhage
746877|NCT00449306|Carotid artery atherosclerosis|carotid artery atherosclerosis
746878|NCT00449293|Smoking cessation|smoking cessation
746879|NCT00449293|Tobacco dependence|tobacco dependence
746880|NCT00449293|Mindfulness|mindfulness
746881|NCT00449293|fMRI|fmri
746882|NCT00449293|Craving|craving
746883|NCT00449280|metastatic|metastatic
746884|NCT00449280|advanced disease|advanced disease
746885|NCT00449280|phase I|phase i
746886|NCT00449267|Lenses, Intraocular|lenses, intraocular
746887|NCT00449267|Prospective Studies|prospective studies
746888|NCT00449267|Visual acuity|visual acuity
746889|NCT00449267|Clinical Trial|clinical trial
746890|NCT00449241|Acupuncture, Endoscopy|acupuncture, endoscopy
746891|NCT00449228|Osteoarthritis,|osteoarthritis,
746892|NCT00449228|hip replacement,|hip replacement,
746893|NCT00449228|education,|education,
746894|NCT00449228|randomized controlled trial,|randomized controlled trial,
746895|NCT00449228|mini-invasive surgery|mini-invasive surgery
746896|NCT00449215|Peak Bone Mass; Male; Genetic Polymorphisms|peak bone mass; male; genetic polymorphisms
746897|NCT00449176|Low Back Pain|low back pain
746898|NCT00449176|Chronic Pain|chronic pain
746899|NCT00449176|Pain Assessment|pain assessment
746900|NCT00449176|Tapentadol|tapentadol
746901|NCT00449163|stage IV colon cancer|stage iv colon cancer
746902|NCT00449163|stage IV rectal cancer|stage iv rectal cancer
746903|NCT00449163|adenocarcinoma of the colon|adenocarcinoma of the colon
746904|NCT00449163|adenocarcinoma of the rectum|adenocarcinoma of the rectum
746905|NCT00449150|Cetrorelix|cetrorelix
746906|NCT00449137|recurrent colon cancer|recurrent colon cancer
746907|NCT00449137|stage IV colon cancer|stage iv colon cancer
746908|NCT00449137|recurrent rectal cancer|recurrent rectal cancer
746909|NCT00449137|stage IV rectal cancer|stage iv rectal cancer
746910|NCT00449124|hepatitis C, vaccine, TG4040|hepatitis c, vaccine, tg4040
746911|NCT00449098|Glaucoma|glaucoma
746912|NCT00449098|Collagen matrix|collagen matrix
746913|NCT00449098|ologen|ologen
746914|NCT00449098|OculusGen|oculusgen
746915|NCT00449098|Trabeculectomy|trabeculectomy
746916|NCT00449098|anti scarring|anti scarring
746917|NCT00449098|tissue engineering|tissue engineering
746918|NCT00449098|high risk patient for trabeculectomy|high risk patient for trabeculectomy
746919|NCT00449098|Aeon Astron|aeon astron
746920|NCT00449059|heart transplantation|heart transplantation
746921|NCT00449059|cyclosporine|cyclosporine
746922|NCT00449059|hypertension|hypertension
746923|NCT00449059|nitroglycerin|nitroglycerin
746924|NCT00449046|salmeterol/fluticasone propionate combination|salmeterol/fluticasone propionate combination
746925|NCT00449046|pediatric bronchial asthma|pediatric bronchial asthma
746926|NCT00449033|Non-Small Cell Lung Cancer (NSCLC)|non-small cell lung cancer (nsclc)
746927|NCT00449033|Cancer|cancer
746928|NCT00449020|stage IIIA non-small cell lung cancer|stage iiia non-small cell lung cancer
746929|NCT00449020|stage IIIB non-small cell lung cancer|stage iiib non-small cell lung cancer
746930|NCT00449007|Major depressive disorder|major depressive disorder
746931|NCT00449007|Alcohol abuse|alcohol abuse
746932|NCT00449007|Alcohol dependence|alcohol dependence
746933|NCT00449007|Suicide|suicide
749727|NCT00441909|Vaginal Gel|vaginal gel
746934|NCT00448994|adenovirus, fungal, diagnostics, children|adenovirus, fungal, diagnostics, children
746935|NCT00448981|Preventing upper respiratory tract infections|preventing upper respiratory tract infections
746936|NCT00448981|Preventing influenza|preventing influenza
746937|NCT00448981|Preventing the common cold|preventing the common cold
746938|NCT00448981|Hand hygiene and upper respiratory infections|hand hygiene and upper respiratory infections
746939|NCT00448981|Mask use in preventing upper respiratory infections|mask use in preventing upper respiratory infections
746940|NCT00448968|Sepsis|sepsis
746941|NCT00448968|Ischemia Modified Albumin|ischemia modified albumin
746942|NCT00448968|Systemic Inflammatory Response Syndrome|systemic inflammatory response syndrome
746943|NCT00448942|Staphylococcus aureus [B03.510.400.790.750.100]|staphylococcus aureus [b03.510.400.790.750.100]
746944|NCT00448942|Enterococcus faecalis [B03.510.400.800.280.280]|enterococcus faecalis [b03.510.400.800.280.280]
746945|NCT00448942|Enterococcus faecium [B03.510.400.800.280.300]|enterococcus faecium [b03.510.400.800.280.300]
746946|NCT00448942|Bacteremia [C01.252.100]|bacteremia [c01.252.100]
746947|NCT00448942|Fungemia [C01.703.360]|fungemia [c01.703.360]
746948|NCT00448942|Infection Control [G03.850.780.200.450]|infection control [g03.850.780.200.450]
746949|NCT00448942|Antisepsis [G03.850.780.200.450.150]|antisepsis [g03.850.780.200.450.150]
746950|NCT00448929|Glaucoma|glaucoma
746951|NCT00448929|Collagen matrix|collagen matrix
746952|NCT00448929|ologen|ologen
746953|NCT00448929|OculusGen|oculusgen
746954|NCT00448929|Trabeculectomy|trabeculectomy
746955|NCT00448916|Partial-onset seizures; epilepsy; pediatric; pregabalin; 1 year extension study; safety; tolerability|partial-onset seizures; epilepsy; pediatric; pregabalin; 1 year extension study; safety; tolerability
746956|NCT00448903|diabetic|diabetic
746957|NCT00448903|foot|foot
746958|NCT00448903|ulcer|ulcer
746959|NCT00448903|bemiparin|bemiparin
746961|NCT00448903|neuroishemic|neuroishemic
746962|NCT00448903|diabetes|diabetes
746963|NCT00448890|AMPA positive modulator, healthy volunteers|ampa positive modulator, healthy volunteers
746964|NCT00448877|No specific disease is being studied, few procedures are excluded.|no specific disease is being studied, few procedures are excluded.
746965|NCT00448877|The focus of the study is to rule out the efficacy of the device, so the aim is to include as wide a variety of procedures as possible.|the focus of the study is to rule out the efficacy of the device, so the aim is to include as wide a variety of procedures as possible.
746966|NCT00448851|asthma|asthma
746967|NCT00448851|allergy|allergy
746968|NCT00448838|recurrent pancreatic cancer|recurrent pancreatic cancer
746969|NCT00448838|stage III pancreatic cancer|stage iii pancreatic cancer
746970|NCT00448838|stage IV pancreatic cancer|stage iv pancreatic cancer
746971|NCT00448838|stage II pancreatic cancer|stage ii pancreatic cancer
746972|NCT00448825|alcohol dependence|alcohol dependence
746973|NCT00448825|alcoholism|alcoholism
746974|NCT00448825|cocaine addiction|cocaine addiction
746975|NCT00448825|cocaine dependence|cocaine dependence
746976|NCT00448799|neurological|neurological
746977|NCT00448799|alzheimers|alzheimers
746978|NCT00448786|gallbladder|gallbladder
746979|NCT00448786|AMG 706|amg 706
746980|NCT00448786|solid tumors|solid tumors
746981|NCT00448786|Phase 1b|phase 1b
746982|NCT00448786|Amgen|amgen
746983|NCT00448760|stage II esophageal cancer|stage ii esophageal cancer
746984|NCT00448760|stage III esophageal cancer|stage iii esophageal cancer
746985|NCT00448760|adenocarcinoma of the esophagus|adenocarcinoma of the esophagus
746986|NCT00448747|Ghrelin mimetic, growth hormone secretagogue|ghrelin mimetic, growth hormone secretagogue
746987|NCT00448734|metastatic|metastatic
746988|NCT00448734|hormone-refractory|hormone-refractory
746989|NCT00448734|prostate cancer|prostate cancer
746990|NCT00448734|picoplatin|picoplatin
746991|NCT00448734|platinum drug|platinum drug
746992|NCT00448734|chemotherapy|chemotherapy
746993|NCT00448734|docetaxel|docetaxel
746994|NCT00448721|renal cell carcinoma|renal cell carcinoma
746995|NCT00448721|tyrosine kinase inhibitor failure|tyrosine kinase inhibitor failure
746996|NCT00448708|Hemodialysis Access|hemodialysis access
746997|NCT00448695|MRI|mri
746998|NCT00448695|Laser Thermal Therapy|laser thermal therapy
746999|NCT00448695|Focal Ablation|focal ablation
747000|NCT00448695|Prostate Cancer|prostate cancer
747001|NCT00448682|recurrent gastric cancer|recurrent gastric cancer
747002|NCT00448682|stage IV gastric cancer|stage iv gastric cancer
747003|NCT00448682|adenocarcinoma of the stomach|adenocarcinoma of the stomach
747004|NCT00448669|HIV incidence|hiv incidence
747005|NCT00448669|HIV prevention|hiv prevention
747006|NCT00448669|Tenofovir|tenofovir
747007|NCT00448669|Emtricitabine|emtricitabine
747008|NCT00448669|Botswana|botswana
747009|NCT00448669|HIV seronegativity|hiv seronegativity
747010|NCT00448656|atrial fibrillation|atrial fibrillation
747011|NCT00448656|epicardial ablation pulmonary veins|epicardial ablation pulmonary veins
747012|NCT00448656|video assisted thoracic surgery|video assisted thoracic surgery
747013|NCT00448643|endometrial adenocarcinoma|endometrial adenocarcinoma
747014|NCT00448643|endometrial clear cell carcinoma|endometrial clear cell carcinoma
747015|NCT00448643|endometrial papillary carcinoma|endometrial papillary carcinoma
747016|NCT00448643|stage III endometrial carcinoma|stage iii endometrial carcinoma
747017|NCT00448643|stage IV endometrial carcinoma|stage iv endometrial carcinoma
747018|NCT00448630|Atypical antipsychotics, Metabolic syndrome, Safety|atypical antipsychotics, metabolic syndrome, safety
747019|NCT00448617|live attenuated influenza virus|live attenuated influenza virus
747020|NCT00448617|inflammation|inflammation
747021|NCT00448617|flu vaccine|flu vaccine
747022|NCT00448617|FluMist|flumist
747023|NCT00448617|smokers|smokers
747024|NCT00448604|procalcitonin|procalcitonin
747025|NCT00448604|acute exacerbation|acute exacerbation
747026|NCT00448604|RT-PCR|rt-pcr
747027|NCT00448604|Biological Markers|biological markers
747028|NCT00448578|Acute Mania|acute mania
747029|NCT00448565|extubation|extubation
747030|NCT00448565|prediction|prediction
747031|NCT00448552|recurrent squamous cell carcinoma of the hypopharynx|recurrent squamous cell carcinoma of the hypopharynx
747032|NCT00448552|stage IV squamous cell carcinoma of the hypopharynx|stage iv squamous cell carcinoma of the hypopharynx
747033|NCT00448552|recurrent squamous cell carcinoma of the larynx|recurrent squamous cell carcinoma of the larynx
747034|NCT00448552|recurrent verrucous carcinoma of the larynx|recurrent verrucous carcinoma of the larynx
747035|NCT00448552|stage IV squamous cell carcinoma of the larynx|stage iv squamous cell carcinoma of the larynx
747036|NCT00448552|stage IV verrucous carcinoma of the larynx|stage iv verrucous carcinoma of the larynx
747037|NCT00448552|recurrent squamous cell carcinoma of the lip and oral cavity|recurrent squamous cell carcinoma of the lip and oral cavity
747038|NCT00448552|stage IV squamous cell carcinoma of the lip and oral cavity|stage iv squamous cell carcinoma of the lip and oral cavity
747039|NCT00448552|recurrent basal cell carcinoma of the lip|recurrent basal cell carcinoma of the lip
747040|NCT00448552|stage IV basal cell carcinoma of the lip|stage iv basal cell carcinoma of the lip
747041|NCT00448552|recurrent adenoid cystic carcinoma of the oral cavity|recurrent adenoid cystic carcinoma of the oral cavity
747042|NCT00448552|recurrent mucoepidermoid carcinoma of the oral cavity|recurrent mucoepidermoid carcinoma of the oral cavity
747111|NCT00448357|stage IV adult diffuse mixed cell lymphoma|stage iv adult diffuse mixed cell lymphoma
747043|NCT00448552|recurrent verrucous carcinoma of the oral cavity|recurrent verrucous carcinoma of the oral cavity
747044|NCT00448552|stage IV adenoid cystic carcinoma of the oral cavity|stage iv adenoid cystic carcinoma of the oral cavity
747045|NCT00448552|stage IV mucoepidermoid carcinoma of the oral cavity|stage iv mucoepidermoid carcinoma of the oral cavity
747046|NCT00448552|stage IV verrucous carcinoma of the oral cavity|stage iv verrucous carcinoma of the oral cavity
747047|NCT00448552|recurrent metastatic squamous neck cancer with occult primary|recurrent metastatic squamous neck cancer with occult primary
747048|NCT00448552|recurrent lymphoepithelioma of the nasopharynx|recurrent lymphoepithelioma of the nasopharynx
747049|NCT00448552|recurrent squamous cell carcinoma of the nasopharynx|recurrent squamous cell carcinoma of the nasopharynx
747050|NCT00448552|stage IV lymphoepithelioma of the nasopharynx|stage iv lymphoepithelioma of the nasopharynx
747051|NCT00448552|stage IV squamous cell carcinoma of the nasopharynx|stage iv squamous cell carcinoma of the nasopharynx
747052|NCT00448552|recurrent lymphoepithelioma of the oropharynx|recurrent lymphoepithelioma of the oropharynx
747053|NCT00448552|recurrent squamous cell carcinoma of the oropharynx|recurrent squamous cell carcinoma of the oropharynx
747054|NCT00448552|stage IV lymphoepithelioma of the oropharynx|stage iv lymphoepithelioma of the oropharynx
747055|NCT00448552|stage IV squamous cell carcinoma of the oropharynx|stage iv squamous cell carcinoma of the oropharynx
747056|NCT00448552|recurrent esthesioneuroblastoma of the paranasal sinus and nasal cavity|recurrent esthesioneuroblastoma of the paranasal sinus and nasal cavity
747057|NCT00448552|recurrent inverted papilloma of the paranasal sinus and nasal cavity|recurrent inverted papilloma of the paranasal sinus and nasal cavity
747058|NCT00448552|recurrent midline lethal granuloma of the paranasal sinus and nasal cavity|recurrent midline lethal granuloma of the paranasal sinus and nasal cavity
747059|NCT00448552|recurrent squamous cell carcinoma of the paranasal sinus and nasal cavity|recurrent squamous cell carcinoma of the paranasal sinus and nasal cavity
747060|NCT00448552|stage IV esthesioneuroblastoma of the paranasal sinus and nasal cavity|stage iv esthesioneuroblastoma of the paranasal sinus and nasal cavity
747061|NCT00448552|stage IV inverted papilloma of the paranasal sinus and nasal cavity|stage iv inverted papilloma of the paranasal sinus and nasal cavity
747062|NCT00448552|stage IV midline lethal granuloma of the paranasal sinus and nasal cavity|stage iv midline lethal granuloma of the paranasal sinus and nasal cavity
747063|NCT00448552|stage IV squamous cell carcinoma of the paranasal sinus and nasal cavity|stage iv squamous cell carcinoma of the paranasal sinus and nasal cavity
747064|NCT00448552|recurrent salivary gland cancer|recurrent salivary gland cancer
747065|NCT00448552|stage IV salivary gland cancer|stage iv salivary gland cancer
747066|NCT00448552|untreated metastatic squamous neck cancer with occult primary|untreated metastatic squamous neck cancer with occult primary
747067|NCT00448552|metastatic squamous neck cancer with occult primary squamous cell carcinoma|metastatic squamous neck cancer with occult primary squamous cell carcinoma
747068|NCT00448539|Refractory Partial Onset Seizures, epilepsy|refractory partial onset seizures, epilepsy
747069|NCT00448526|Low protein diet, type 2 Diabetic nephropathy|low protein diet, type 2 diabetic nephropathy
747070|NCT00448526|Comparing the effect of Low protein Diet on diabetic nephropathy to that of normal protein diet|comparing the effect of low protein diet on diabetic nephropathy to that of normal protein diet
747071|NCT00448513|catechin|catechin
747072|NCT00448513|oxidative stress|oxidative stress
747073|NCT00448513|chromosome damage|chromosome damage
747074|NCT00448513|aged|aged
747075|NCT00448500|COPD|copd
747076|NCT00448500|exhaled breath condenate|exhaled breath condenate
747077|NCT00448500|Exhaled breath condenate, acute exacerbation of COPD|exhaled breath condenate, acute exacerbation of copd
747078|NCT00448487|Diabetes|diabetes
747079|NCT00448487|Cardiovascular Disease|cardiovascular disease
747080|NCT00448487|Haptoglobin|haptoglobin
747081|NCT00448474|Disease self-management|disease self-management
747082|NCT00448474|Community program|community program
747083|NCT00448461|coronary artery disease|coronary artery disease
747084|NCT00448461|percutaneous coronary interventions|percutaneous coronary interventions
747085|NCT00448448|adolescent idiopathic scoliosis|adolescent idiopathic scoliosis
747086|NCT00448448|orthotics|orthotics
747087|NCT00448448|bracing|bracing
747088|NCT00448448|partially randomized preference design|partially randomized preference design
747089|NCT00448435|Salmeterol|salmeterol
747090|NCT00448435|Fluticasone propionate|fluticasone propionate
747091|NCT00448435|Salmeterol/Fluticasone propionate combination|salmeterol/fluticasone propionate combination
747092|NCT00448435|Pediatric bronchial asthma|pediatric bronchial asthma
747093|NCT00448422|Traveler's|traveler's
747094|NCT00448422|Diarrhea|diarrhea
747095|NCT00448409|Prostate cancer|prostate cancer
747096|NCT00448409|hormone refractory prostate cancer|hormone refractory prostate cancer
747097|NCT00448409|androgen resistant prostate cancer|androgen resistant prostate cancer
747098|NCT00448396|Cancer|cancer
747100|NCT00448396|Patupilone|patupilone
747101|NCT00448396|Solid tumors|solid tumors
747102|NCT00448396|Advanced malignancies|advanced malignancies
747103|NCT00448370|Anemia, sickle cell|anemia, sickle cell
747104|NCT00448357|refractory multiple myeloma|refractory multiple myeloma
747105|NCT00448357|relapsing chronic myelogenous leukemia|relapsing chronic myelogenous leukemia
747106|NCT00448357|secondary acute myeloid leukemia|secondary acute myeloid leukemia
747107|NCT00448357|stage II multiple myeloma|stage ii multiple myeloma
747108|NCT00448357|stage III multiple myeloma|stage iii multiple myeloma
747109|NCT00448357|stage IV adult Burkitt lymphoma|stage iv adult burkitt lymphoma
747110|NCT00448357|stage IV adult diffuse large cell lymphoma|stage iv adult diffuse large cell lymphoma
747112|NCT00448357|stage IV adult diffuse small cleaved cell lymphoma|stage iv adult diffuse small cleaved cell lymphoma
747113|NCT00448357|stage IV adult immunoblastic large cell lymphoma|stage iv adult immunoblastic large cell lymphoma
747114|NCT00448357|stage IV adult lymphoblastic lymphoma|stage iv adult lymphoblastic lymphoma
747115|NCT00448357|stage IV adult Hodgkin lymphoma|stage iv adult hodgkin lymphoma
747116|NCT00448357|stage IV grade 1 follicular lymphoma|stage iv grade 1 follicular lymphoma
747117|NCT00448357|stage IV grade 2 follicular lymphoma|stage iv grade 2 follicular lymphoma
747118|NCT00448357|stage IV grade 3 follicular lymphoma|stage iv grade 3 follicular lymphoma
747119|NCT00448357|stage IV mantle cell lymphoma|stage iv mantle cell lymphoma
747120|NCT00448357|stage IV marginal zone lymphoma|stage iv marginal zone lymphoma
747121|NCT00448357|stage IV small lymphocytic lymphoma|stage iv small lymphocytic lymphoma
747122|NCT00448357|Waldenstrom macroglobulinemia|waldenstrom macroglobulinemia
747123|NCT00448357|accelerated phase chronic myelogenous leukemia|accelerated phase chronic myelogenous leukemia
747124|NCT00448357|adult acute myeloid leukemia in remission|adult acute myeloid leukemia in remission
747125|NCT00448357|blastic phase chronic myelogenous leukemia|blastic phase chronic myelogenous leukemia
747126|NCT00448357|chronic eosinophilic leukemia|chronic eosinophilic leukemia
747127|NCT00448357|chronic neutrophilic leukemia|chronic neutrophilic leukemia
747128|NCT00448357|extranodal marginal zone B-cell lymphoma of mucosa-associated lymphoid tissue|extranodal marginal zone b-cell lymphoma of mucosa-associated lymphoid tissue
747129|NCT00448357|nodal marginal zone B-cell lymphoma|nodal marginal zone b-cell lymphoma
747130|NCT00448357|recurrent adult Burkitt lymphoma|recurrent adult burkitt lymphoma
747131|NCT00448357|recurrent adult diffuse large cell lymphoma|recurrent adult diffuse large cell lymphoma
747132|NCT00448357|recurrent adult diffuse mixed cell lymphoma|recurrent adult diffuse mixed cell lymphoma
747133|NCT00448357|recurrent adult diffuse small cleaved cell lymphoma|recurrent adult diffuse small cleaved cell lymphoma
747134|NCT00448357|recurrent adult Hodgkin lymphoma|recurrent adult hodgkin lymphoma
747135|NCT00448357|recurrent adult immunoblastic large cell lymphoma|recurrent adult immunoblastic large cell lymphoma
747136|NCT00448357|recurrent adult lymphoblastic lymphoma|recurrent adult lymphoblastic lymphoma
747137|NCT00448357|recurrent grade 1 follicular lymphoma|recurrent grade 1 follicular lymphoma
747138|NCT00448357|recurrent grade 2 follicular lymphoma|recurrent grade 2 follicular lymphoma
747139|NCT00448357|recurrent grade 3 follicular lymphoma|recurrent grade 3 follicular lymphoma
747140|NCT00448357|recurrent mantle cell lymphoma|recurrent mantle cell lymphoma
747141|NCT00448357|recurrent marginal zone lymphoma|recurrent marginal zone lymphoma
747142|NCT00448357|recurrent small lymphocytic lymphoma|recurrent small lymphocytic lymphoma
747143|NCT00448357|stage III adult Burkitt lymphoma|stage iii adult burkitt lymphoma
747144|NCT00448357|stage III adult diffuse large cell lymphoma|stage iii adult diffuse large cell lymphoma
747145|NCT00448357|stage III adult diffuse mixed cell lymphoma|stage iii adult diffuse mixed cell lymphoma
747146|NCT00448357|stage III adult diffuse small cleaved cell lymphoma|stage iii adult diffuse small cleaved cell lymphoma
747147|NCT00448357|stage III adult Hodgkin lymphoma|stage iii adult hodgkin lymphoma
747148|NCT00448357|stage III adult immunoblastic large cell lymphoma|stage iii adult immunoblastic large cell lymphoma
747149|NCT00448357|stage III adult lymphoblastic lymphoma|stage iii adult lymphoblastic lymphoma
747150|NCT00448357|stage III grade 1 follicular lymphoma|stage iii grade 1 follicular lymphoma
747151|NCT00448357|stage III grade 2 follicular lymphoma|stage iii grade 2 follicular lymphoma
747152|NCT00448357|stage III grade 3 follicular lymphoma|stage iii grade 3 follicular lymphoma
747153|NCT00448357|stage III mantle cell lymphoma|stage iii mantle cell lymphoma
747379|NCT00447928|nitroglycerin|nitroglycerin
747154|NCT00448357|stage III marginal zone lymphoma|stage iii marginal zone lymphoma
747155|NCT00448357|stage III small lymphocytic lymphoma|stage iii small lymphocytic lymphoma
747156|NCT00448357|adult acute myeloid leukemia with 11q23 (MLL) abnormalities|adult acute myeloid leukemia with 11q23 (mll) abnormalities
747157|NCT00448357|adult acute myeloid leukemia with inv(16)(p13;q22)|adult acute myeloid leukemia with inv(16)(p13;q22)
747158|NCT00448357|adult acute myeloid leukemia with t(15;17)(q22;q12)|adult acute myeloid leukemia with t(15;17)(q22;q12)
747159|NCT00448357|adult acute myeloid leukemia with t(16;16)(p13;q22)|adult acute myeloid leukemia with t(16;16)(p13;q22)
747160|NCT00448357|adult acute myeloid leukemia with t(8;21)(q22;q22)|adult acute myeloid leukemia with t(8;21)(q22;q22)
747161|NCT00448357|primary myelofibrosis|primary myelofibrosis
747162|NCT00448357|chronic phase chronic myelogenous leukemia|chronic phase chronic myelogenous leukemia
747163|NCT00448357|de novo myelodysplastic syndromes|de novo myelodysplastic syndromes
747164|NCT00448357|previously treated myelodysplastic syndromes|previously treated myelodysplastic syndromes
747165|NCT00448357|prolymphocytic leukemia|prolymphocytic leukemia
747166|NCT00448357|recurrent adult acute lymphoblastic leukemia|recurrent adult acute lymphoblastic leukemia
747167|NCT00448357|recurrent adult acute myeloid leukemia|recurrent adult acute myeloid leukemia
747168|NCT00448357|refractory chronic lymphocytic leukemia|refractory chronic lymphocytic leukemia
747169|NCT00448357|secondary myelodysplastic syndromes|secondary myelodysplastic syndromes
747170|NCT00448357|stage III chronic lymphocytic leukemia|stage iii chronic lymphocytic leukemia
747171|NCT00448357|stage IV chronic lymphocytic leukemia|stage iv chronic lymphocytic leukemia
747172|NCT00448357|adult acute lymphoblastic leukemia in remission|adult acute lymphoblastic leukemia in remission
747173|NCT00448357|polycythemia vera|polycythemia vera
747174|NCT00448357|essential thrombocythemia|essential thrombocythemia
747175|NCT00448357|splenic marginal zone lymphoma|splenic marginal zone lymphoma
747415|NCT00447759|PROBE design|probe design
747176|NCT00448357|recurrent mycosis fungoides/Sezary syndrome|recurrent mycosis fungoides/sezary syndrome
747177|NCT00448357|recurrent cutaneous T-cell non-Hodgkin lymphoma|recurrent cutaneous t-cell non-hodgkin lymphoma
747178|NCT00448357|stage I multiple myeloma|stage i multiple myeloma
747179|NCT00448357|recurrent adult grade III lymphomatoid granulomatosis|recurrent adult grade iii lymphomatoid granulomatosis
747180|NCT00448357|adult nasal type extranodal natural killer (NK)/T-cell lymphoma|adult nasal type extranodal natural killer (nk)/t-cell lymphoma
747181|NCT00448344|veterans|veterans
747182|NCT00448344|smoking cessation|smoking cessation
747183|NCT00448331|Mental Disorders|mental disorders
747184|NCT00448331|Mentally Ill Persons|mentally ill persons
747185|NCT00448331|Emergency Medicine|emergency medicine
747186|NCT00448331|Emergency Department|emergency department
747187|NCT00448331|Screening|screening
747188|NCT00448318|Controlled clinical trial|controlled clinical trial
747189|NCT00448305|breast cancer|breast cancer
747190|NCT00448305|metastatic|metastatic
747191|NCT00448305|relapsed|relapsed
747192|NCT00448305|triple-receptor negative|triple-receptor negative
747193|NCT00448305|EndoTAG-1|endotag-1
747194|NCT00448305|metastatic or relapsed breast neoplasm|metastatic or relapsed breast neoplasm
747195|NCT00448292|Depression|depression
747196|NCT00448292|Major Depressive Disorder|major depressive disorder
747197|NCT00448292|Major Depression|major depression
747198|NCT00448292|MDD|mdd
747199|NCT00448266|Breast cancer|breast cancer
747200|NCT00448266|high-dose chemotherapy|high-dose chemotherapy
747201|NCT00448266|Homologous Recombination Deficiency|homologous recombination deficiency
747202|NCT00448266|Alkylator therapy|alkylator therapy
747203|NCT00448266|Peripheral Blood Progenitor Cell Support|peripheral blood progenitor cell support
747204|NCT00448253|Inhalational Anthrax|inhalational anthrax
747205|NCT00448253|Human Immune globulin|human immune globulin
747206|NCT00448227|Infants, Herpes simplex infection|infants, herpes simplex infection
747207|NCT00448214|Factor Xa inhibitor|factor xa inhibitor
747208|NCT00448214|Atrial fibrillation|atrial fibrillation
747209|NCT00448214|Stroke|stroke
747210|NCT00448214|Ischemic attack|ischemic attack
747211|NCT00448214|thromboembolism|thromboembolism
747212|NCT00448214|Prevention and control|prevention and control
747213|NCT00448201|adult acute myeloid leukemia with 11q23 (MLL) abnormalities|adult acute myeloid leukemia with 11q23 (mll) abnormalities
747214|NCT00448201|adult acute myeloid leukemia with inv(16)(p13;q22)|adult acute myeloid leukemia with inv(16)(p13;q22)
747215|NCT00448201|adult acute myeloid leukemia with t(15;17)(q22;q12)|adult acute myeloid leukemia with t(15;17)(q22;q12)
747216|NCT00448201|adult acute myeloid leukemia with t(16;16)(p13;q22)|adult acute myeloid leukemia with t(16;16)(p13;q22)
747217|NCT00448201|adult acute myeloid leukemia with t(8;21)(q22;q22)|adult acute myeloid leukemia with t(8;21)(q22;q22)
747218|NCT00448201|prolymphocytic leukemia|prolymphocytic leukemia
747219|NCT00448201|accelerated phase chronic myelogenous leukemia|accelerated phase chronic myelogenous leukemia
747220|NCT00448201|adult acute lymphoblastic leukemia in remission|adult acute lymphoblastic leukemia in remission
747221|NCT00448201|adult acute myeloid leukemia in remission|adult acute myeloid leukemia in remission
747222|NCT00448201|blastic phase chronic myelogenous leukemia|blastic phase chronic myelogenous leukemia
747223|NCT00448201|childhood acute lymphoblastic leukemia in remission|childhood acute lymphoblastic leukemia in remission
747224|NCT00448201|childhood acute myeloid leukemia in remission|childhood acute myeloid leukemia in remission
747225|NCT00448201|childhood chronic myelogenous leukemia|childhood chronic myelogenous leukemia
747684|NCT00446628|pandemic|pandemic
747226|NCT00448201|chronic phase chronic myelogenous leukemia|chronic phase chronic myelogenous leukemia
747227|NCT00448201|de novo myelodysplastic syndromes|de novo myelodysplastic syndromes
747228|NCT00448201|extranodal marginal zone B-cell lymphoma of mucosa-associated lymphoid tissue|extranodal marginal zone b-cell lymphoma of mucosa-associated lymphoid tissue
747229|NCT00448201|nodal marginal zone B-cell lymphoma|nodal marginal zone b-cell lymphoma
747230|NCT00448201|noncontiguous stage II adult Burkitt lymphoma|noncontiguous stage ii adult burkitt lymphoma
747231|NCT00448201|noncontiguous stage II adult diffuse large cell lymphoma|noncontiguous stage ii adult diffuse large cell lymphoma
747232|NCT00448201|noncontiguous stage II adult diffuse mixed cell lymphoma|noncontiguous stage ii adult diffuse mixed cell lymphoma
747233|NCT00448201|noncontiguous stage II adult diffuse small cleaved cell lymphoma|noncontiguous stage ii adult diffuse small cleaved cell lymphoma
747234|NCT00448201|noncontiguous stage II adult immunoblastic large cell lymphoma|noncontiguous stage ii adult immunoblastic large cell lymphoma
747235|NCT00448201|noncontiguous stage II adult lymphoblastic lymphoma|noncontiguous stage ii adult lymphoblastic lymphoma
747236|NCT00448201|noncontiguous stage II grade 1 follicular lymphoma|noncontiguous stage ii grade 1 follicular lymphoma
747237|NCT00448201|noncontiguous stage II grade 2 follicular lymphoma|noncontiguous stage ii grade 2 follicular lymphoma
747238|NCT00448201|noncontiguous stage II grade 3 follicular lymphoma|noncontiguous stage ii grade 3 follicular lymphoma
747239|NCT00448201|noncontiguous stage II mantle cell lymphoma|noncontiguous stage ii mantle cell lymphoma
747240|NCT00448201|noncontiguous stage II marginal zone lymphoma|noncontiguous stage ii marginal zone lymphoma
747241|NCT00448201|noncontiguous stage II small lymphocytic lymphoma|noncontiguous stage ii small lymphocytic lymphoma
747242|NCT00448201|previously treated myelodysplastic syndromes|previously treated myelodysplastic syndromes
747243|NCT00448201|recurrent adult acute lymphoblastic leukemia|recurrent adult acute lymphoblastic leukemia
747244|NCT00448201|recurrent adult Burkitt lymphoma|recurrent adult burkitt lymphoma
747245|NCT00448201|recurrent adult Hodgkin lymphoma|recurrent adult hodgkin lymphoma
747246|NCT00448201|recurrent adult diffuse large cell lymphoma|recurrent adult diffuse large cell lymphoma
747247|NCT00448201|recurrent adult diffuse mixed cell lymphoma|recurrent adult diffuse mixed cell lymphoma
747248|NCT00448201|recurrent adult diffuse small cleaved cell lymphoma|recurrent adult diffuse small cleaved cell lymphoma
747249|NCT00448201|recurrent adult immunoblastic large cell lymphoma|recurrent adult immunoblastic large cell lymphoma
747250|NCT00448201|recurrent adult lymphoblastic lymphoma|recurrent adult lymphoblastic lymphoma
747251|NCT00448201|recurrent adult acute myeloid leukemia|recurrent adult acute myeloid leukemia
747252|NCT00448201|recurrent childhood acute myeloid leukemia|recurrent childhood acute myeloid leukemia
747253|NCT00448201|recurrent/refractory childhood Hodgkin lymphoma|recurrent/refractory childhood hodgkin lymphoma
747254|NCT00448201|recurrent childhood acute lymphoblastic leukemia|recurrent childhood acute lymphoblastic leukemia
747255|NCT00448201|recurrent childhood large cell lymphoma|recurrent childhood large cell lymphoma
747256|NCT00448201|recurrent childhood lymphoblastic lymphoma|recurrent childhood lymphoblastic lymphoma
747257|NCT00448201|recurrent childhood small noncleaved cell lymphoma|recurrent childhood small noncleaved cell lymphoma
747258|NCT00448201|recurrent cutaneous T-cell non-Hodgkin lymphoma|recurrent cutaneous t-cell non-hodgkin lymphoma
747259|NCT00448201|recurrent grade 1 follicular lymphoma|recurrent grade 1 follicular lymphoma
747260|NCT00448201|recurrent grade 2 follicular lymphoma|recurrent grade 2 follicular lymphoma
747261|NCT00448201|recurrent grade 3 follicular lymphoma|recurrent grade 3 follicular lymphoma
747262|NCT00448201|recurrent mantle cell lymphoma|recurrent mantle cell lymphoma
747263|NCT00448201|recurrent marginal zone lymphoma|recurrent marginal zone lymphoma
747264|NCT00448201|recurrent mycosis fungoides/Sezary syndrome|recurrent mycosis fungoides/sezary syndrome
747265|NCT00448201|recurrent small lymphocytic lymphoma|recurrent small lymphocytic lymphoma
747266|NCT00448201|refractory chronic lymphocytic leukemia|refractory chronic lymphocytic leukemia
747267|NCT00448201|refractory multiple myeloma|refractory multiple myeloma
747268|NCT00448201|relapsing chronic myelogenous leukemia|relapsing chronic myelogenous leukemia
747269|NCT00448201|secondary acute myeloid leukemia|secondary acute myeloid leukemia
747270|NCT00448201|secondary myelodysplastic syndromes|secondary myelodysplastic syndromes
747271|NCT00448201|splenic marginal zone lymphoma|splenic marginal zone lymphoma
747272|NCT00448201|stage I multiple myeloma|stage i multiple myeloma
747273|NCT00448201|stage II multiple myeloma|stage ii multiple myeloma
747274|NCT00448201|stage III adult Burkitt lymphoma|stage iii adult burkitt lymphoma
747275|NCT00448201|stage III adult Hodgkin lymphoma|stage iii adult hodgkin lymphoma
747276|NCT00448201|stage III adult diffuse large cell lymphoma|stage iii adult diffuse large cell lymphoma
747277|NCT00448201|stage III adult diffuse mixed cell lymphoma|stage iii adult diffuse mixed cell lymphoma
747278|NCT00448201|stage III adult diffuse small cleaved cell lymphoma|stage iii adult diffuse small cleaved cell lymphoma
747279|NCT00448201|stage III adult immunoblastic large cell lymphoma|stage iii adult immunoblastic large cell lymphoma
747280|NCT00448201|stage III adult lymphoblastic lymphoma|stage iii adult lymphoblastic lymphoma
747281|NCT00448201|stage III chronic lymphocytic leukemia|stage iii chronic lymphocytic leukemia
747282|NCT00448201|stage III grade 1 follicular lymphoma|stage iii grade 1 follicular lymphoma
747283|NCT00448201|stage III grade 2 follicular lymphoma|stage iii grade 2 follicular lymphoma
747284|NCT00448201|stage III grade 3 follicular lymphoma|stage iii grade 3 follicular lymphoma
747285|NCT00448201|stage III mantle cell lymphoma|stage iii mantle cell lymphoma
747286|NCT00448201|stage III marginal zone lymphoma|stage iii marginal zone lymphoma
747287|NCT00448201|stage III multiple myeloma|stage iii multiple myeloma
747288|NCT00448201|stage III small lymphocytic lymphoma|stage iii small lymphocytic lymphoma
747289|NCT00448201|stage IV adult Burkitt lymphoma|stage iv adult burkitt lymphoma
747290|NCT00448201|stage IV adult Hodgkin lymphoma|stage iv adult hodgkin lymphoma
747291|NCT00448201|stage IV adult diffuse large cell lymphoma|stage iv adult diffuse large cell lymphoma
747292|NCT00448201|stage IV adult diffuse mixed cell lymphoma|stage iv adult diffuse mixed cell lymphoma
747293|NCT00448201|stage IV adult diffuse small cleaved cell lymphoma|stage iv adult diffuse small cleaved cell lymphoma
747294|NCT00448201|stage IV adult immunoblastic large cell lymphoma|stage iv adult immunoblastic large cell lymphoma
747295|NCT00448201|stage IV adult lymphoblastic lymphoma|stage iv adult lymphoblastic lymphoma
747296|NCT00448201|stage IV chronic lymphocytic leukemia|stage iv chronic lymphocytic leukemia
747297|NCT00448201|stage IV grade 1 follicular lymphoma|stage iv grade 1 follicular lymphoma
747298|NCT00448201|stage IV grade 2 follicular lymphoma|stage iv grade 2 follicular lymphoma
747299|NCT00448201|stage IV grade 3 follicular lymphoma|stage iv grade 3 follicular lymphoma
747300|NCT00448201|stage IV mantle cell lymphoma|stage iv mantle cell lymphoma
747301|NCT00448201|stage IV marginal zone lymphoma|stage iv marginal zone lymphoma
747302|NCT00448201|stage IV small lymphocytic lymphoma|stage iv small lymphocytic lymphoma
747303|NCT00448201|primary myelofibrosis|primary myelofibrosis
747304|NCT00448201|Waldenstrom macroglobulinemia|waldenstrom macroglobulinemia
747305|NCT00448201|adult nasal type extranodal natural killer (NK)/T-cell lymphoma|adult nasal type extranodal natural killer (nk)/t-cell lymphoma
747306|NCT00448201|recurrent adult grade III lymphomatoid granulomatosis|recurrent adult grade iii lymphomatoid granulomatosis
747307|NCT00448201|childhood myelodysplastic syndromes|childhood myelodysplastic syndromes
747308|NCT00448188|central venous catheter|central venous catheter
747309|NCT00448188|international normalized ratio|international normalized ratio
747310|NCT00448188|thrombocytes|thrombocytes
747311|NCT00448188|bleeding risk|bleeding risk
747613|NCT00446875|Sucrose|sucrose
747312|NCT00448188|all patients in need of central venous line|all patients in need of central venous line
747313|NCT00448188|comparison of patients with normal hemostasis to such with disorders in hemostasis|comparison of patients with normal hemostasis to such with disorders in hemostasis
747314|NCT00448175|OAB symptoms of urgency, frequency, and urge incontinence|oab symptoms of urgency, frequency, and urge incontinence
747315|NCT00448162|hypertension, ENaC, Liddle's syndrome, variation|hypertension, enac, liddle's syndrome, variation
747316|NCT00448149|Kidney cancer|kidney cancer
747317|NCT00448149|Renal cell carcinoma|renal cell carcinoma
747318|NCT00448149|Metastatic RCC|metastatic rcc
747319|NCT00448123|Kidney Stones|kidney stones
747320|NCT00448123|Ureteral Stones|ureteral stones
747321|NCT00448123|Flomax|flomax
747322|NCT00448123|Emergency Medicine|emergency medicine
747323|NCT00448123|Urology|urology
747324|NCT00448097|Adenocarcinoma of the Prostate|adenocarcinoma of the prostate
747325|NCT00448097|Prostate cancer|prostate cancer
747326|NCT00448097|Pre-Prostatectomy|pre-prostatectomy
747327|NCT00448097|Neoadjuvant|neoadjuvant
747328|NCT00448084|Psychogenic Movement Disorders|psychogenic movement disorders
747329|NCT00448084|Volition|volition
747330|NCT00448084|fMRI|fmri
747331|NCT00448084|Functional MRI|functional mri
747332|NCT00448084|Functional Movement Disorder|functional movement disorder
747333|NCT00448084|Healthy Volunteer|healthy volunteer
747335|NCT00448071|Hypotension|hypotension
747336|NCT00448071|End Stage Renal Disease|end stage renal disease
747337|NCT00448071|Intra Dialytic Hypotension|intra dialytic hypotension
747338|NCT00448071|ESRD|esrd
747339|NCT00448071|Blood Pressure|blood pressure
747340|NCT00448071|Dialysis|dialysis
747341|NCT00448058|Flexible-dose|flexible-dose
747342|NCT00448058|GSK372475|gsk372475
747343|NCT00448058|MDD|mdd
747344|NCT00448058|Venlafaxine XR|venlafaxine xr
747345|NCT00448058|Major Depressive Disorder|major depressive disorder
747346|NCT00448045|Spinal cord injuries|spinal cord injuries
747347|NCT00448045|Cough|cough
747348|NCT00448045|Peak cough flow|peak cough flow
747349|NCT00448045|Respiratory therapy|respiratory therapy
747350|NCT00448045|Rehabilitation|rehabilitation
747351|NCT00448019|Chronic Lymphocytic Leukemia|chronic lymphocytic leukemia
747352|NCT00448019|Fludarabine|fludarabine
747353|NCT00448019|Cyclophosphamide|cyclophosphamide
747354|NCT00448019|Rituximab|rituximab
747355|NCT00448019|Bevacizumab|bevacizumab
747356|NCT00448019|CLL|cll
747357|NCT00448006|common|common
747358|NCT00448006|bile|bile
747359|NCT00448006|duct|duct
747360|NCT00448006|biliary|biliary
747361|NCT00448006|malignant|malignant
747362|NCT00448006|obstruction|obstruction
747363|NCT00448006|stent|stent
747364|NCT00447993|Retinitis Pigmentosa|retinitis pigmentosa
747365|NCT00447993|eye disease|eye disease
747366|NCT00447993|retinal disorder|retinal disorder
747367|NCT00447993|CNTF|cntf
747368|NCT00447980|Retinitis Pigmentosa|retinitis pigmentosa
747369|NCT00447980|eye disease|eye disease
747370|NCT00447980|retinal disorder|retinal disorder
747371|NCT00447980|CNTF|cntf
747372|NCT00447967|Metastatic Gastric Cancer|metastatic gastric cancer
747373|NCT00447967|Oxaliplatin|oxaliplatin
747374|NCT00447967|Irinotecan|irinotecan
747375|NCT00447954|eye disease|eye disease
747376|NCT00447954|retinal disorder|retinal disorder
747377|NCT00447954|CNTF|cntf
747380|NCT00447928|nitric oxide|nitric oxide
747381|NCT00447928|lateral epicondylitis|lateral epicondylitis
747382|NCT00447902|treatment experienced|treatment experienced
747383|NCT00447837|Chronic Sinusitis|chronic sinusitis
747384|NCT00447824|Pain|pain
747385|NCT00447824|Neonates|neonates
747386|NCT00447824|NIDCAP|nidcap
747387|NCT00447824|Venous|venous
747388|NCT00447824|Capillary|capillary
747389|NCT00447811|Methadone|methadone
747390|NCT00447798|HIV positive|hiv positive
747391|NCT00447798|crack cocaine user|crack cocaine user
747392|NCT00447798|inpatient hospital setting|inpatient hospital setting
747393|NCT00447798|HIV knowledge|hiv knowledge
747394|NCT00447798|motivation|motivation
747395|NCT00447798|perceived self-efficacy|perceived self-efficacy
747396|NCT00447798|risky sexual behavior|risky sexual behavior
747397|NCT00447798|HIV seronegativity|hiv seronegativity
747398|NCT00447785|alcoholism|alcoholism
747399|NCT00447785|nutrition|nutrition
747400|NCT00447785|craving|craving
747401|NCT00447785|energy supplies|energy supplies
747402|NCT00447785|water supplies|water supplies
747403|NCT00447772|Dysport, Cervical Dystonia|dysport, cervical dystonia
747404|NCT00447759|Celecoxib|celecoxib
747405|NCT00447759|Celebrex|celebrex
747406|NCT00447759|Ibuprofen|ibuprofen
747407|NCT00447759|Diclofenac|diclofenac
747408|NCT00447759|NSAID|nsaid
747409|NCT00447759|Osteoarthritis|osteoarthritis
747410|NCT00447759|Rheumatoid Arthritis|rheumatoid arthritis
747411|NCT00447759|Arthritis|arthritis
747412|NCT00447759|Safety study|safety study
747413|NCT00447759|Cardiovascular safety|cardiovascular safety
747414|NCT00447759|Clinical trial|clinical trial
747416|NCT00447759|University of Dundee|university of dundee
747417|NCT00447759|Medicines Monitoring Unit|medicines monitoring unit
747418|NCT00447759|MEMO|memo
747419|NCT00447759|Professor Tom MacDonald|professor tom macdonald
747420|NCT00447746|Comparison between D1 and D2 lymphadenectomy for gastric cancer|comparison between d1 and d2 lymphadenectomy for gastric cancer
747421|NCT00447733|mental health|mental health
747422|NCT00447733|substance use|substance use
747423|NCT00447733|treatment|treatment
747424|NCT00447720|HIV prevention skills|hiv prevention skills
747425|NCT00447720|Seriously Mentally Ill (SMI)|seriously mentally ill (smi)
747426|NCT00447720|Substance abuse|substance abuse
747427|NCT00447720|Philadelphia|philadelphia
747428|NCT00447720|HIV seronegativity|hiv seronegativity
747429|NCT00447707|Substance use|substance use
747430|NCT00447707|Unprotected sex|unprotected sex
747431|NCT00447707|Behavioral intervention|behavioral intervention
747432|NCT00447707|HIV care|hiv care
747433|NCT00447707|Prevention with Positives|prevention with positives
747434|NCT00447707|HIV seronegativity|hiv seronegativity
747435|NCT00447694|Iron Chelation|iron chelation
747436|NCT00447694|Deferasirox|deferasirox
747437|NCT00447694|Chelator|chelator
747438|NCT00447694|Desferal|desferal
747439|NCT00447694|beta-thalassemia|beta-thalassemia
747440|NCT00447694|Iron overload|iron overload
747441|NCT00447668|Chronic Low Back Pain|chronic low back pain
747442|NCT00447668|Yoga|yoga
747443|NCT00447655|Amputation|amputation
747444|NCT00447655|Self-management|self-management
747445|NCT00447655|Rehabilitation|rehabilitation
747446|NCT00447655|Peer support|peer support
747447|NCT00447642|immunology|immunology
747448|NCT00447642|cornea|cornea
747449|NCT00447642|allograft|allograft
747450|NCT00447642|corneal allograft rejection|corneal allograft rejection
747451|NCT00447642|graft failure|graft failure
747452|NCT00447616|Prostate Cancer|prostate cancer
747453|NCT00447616|Prostatectomy|prostatectomy
747454|NCT00447564|opioid dependence|opioid dependence
747455|NCT00447564|opioid addiction|opioid addiction
747456|NCT00447564|buprenorphine|buprenorphine
747457|NCT00447564|methadone|methadone
747458|NCT00447564|heroin|heroin
747459|NCT00447564|implant|implant
747460|NCT00447564|opioid withdrawal|opioid withdrawal
747461|NCT00447564|opioid pain medication|opioid pain medication
747462|NCT00447564|suboxone|suboxone
747463|NCT00447551|Aesthetic facial volume enhancement|aesthetic facial volume enhancement
747464|NCT00447525|Prevention of : Diphtheria, Tetanus and Poliomyelitis|prevention of : diphtheria, tetanus and poliomyelitis
747465|NCT00447499|Acromegaly|acromegaly
747466|NCT00447499|Somatostatin Analogs|somatostatin analogs
747467|NCT00447499|Somatuline® Autogel®|somatuline® autogel®
747468|NCT00447499|lanreotide|lanreotide
747469|NCT00447499|growth hormone|growth hormone
747470|NCT00447499|IGF-1|igf-1
747471|NCT00447499|Inappropriate Growth Hormone Secretion Syndrome|inappropriate growth hormone secretion syndrome
747472|NCT00447499|Somatotropin Hypersecretion Syndrome|somatotropin hypersecretion syndrome
747473|NCT00447499|Inappropriate GH Secretion Syndrome|inappropriate gh secretion syndrome
747474|NCT00447486|Osteoarthritis,|osteoarthritis,
747475|NCT00447486|knee,|knee,
747476|NCT00447486|GW842166,|gw842166,
747477|NCT00447486|pain,|pain,
747478|NCT00447486|efficacy,|efficacy,
747479|NCT00447486|safety|safety
747480|NCT00447473|Prostate Cancer|prostate cancer
747481|NCT00447473|progressive hormone refractory prostate cancer|progressive hormone refractory prostate cancer
747482|NCT00447460|Graft-vs-host disease (GVHD)|graft-vs-host disease (gvhd)
747483|NCT00447460|Mesenchymal stem cell (MSC)|mesenchymal stem cell (msc)
747484|NCT00447460|Allogeneic hematopoietic stem cell transplant|allogeneic hematopoietic stem cell transplant
747485|NCT00447460|Allotransplant|allotransplant
747486|NCT00447460|Allogenic|allogenic
747487|NCT00447460|Refractory|refractory
747488|NCT00447460|CSM/EICH2005|csm/eich2005
747489|NCT00447434|Nattokinase|nattokinase
747490|NCT00447434|fibrinolytic factors|fibrinolytic factors
747491|NCT00447434|blood lipids|blood lipids
747492|NCT00447434|nutrimental supplement|nutrimental supplement
747493|NCT00447408|hemodialysis|hemodialysis
747494|NCT00447408|dietary adherence|dietary adherence
747495|NCT00447408|sodium|sodium
747496|NCT00447369|pregabalin|pregabalin
747497|NCT00447369|Valproic acid|valproic acid
747498|NCT00447369|migraine|migraine
747499|NCT00447369|prophylaxis|prophylaxis
747500|NCT00447369|prevention|prevention
747501|NCT00447369|treatment|treatment
747502|NCT00447343|Functional MRI|functional mri
747503|NCT00447343|Cervical myelopathy|cervical myelopathy
747504|NCT00447343|Cervical radiculopathy|cervical radiculopathy
747505|NCT00447343|Brain plasticity and regeneration|brain plasticity and regeneration
747506|NCT00447330|metastatic esophagogastric adenocarcinomas|metastatic esophagogastric adenocarcinomas
747507|NCT00447330|ESOPHAGEAL CANCER|esophageal cancer
747508|NCT00447330|GASTRIC CANCER|gastric cancer
747509|NCT00447330|ADENOCARCINOMA|adenocarcinoma
747510|NCT00447330|TARGTED THERAPY|targted therapy
747511|NCT00447330|BEVACIZUMAB|bevacizumab
747512|NCT00447330|CAPECITBAINE|capecitbaine
747513|NCT00447330|OXALIPLATIN|oxaliplatin
747514|NCT00447330|METASTATIC|metastatic
747515|NCT00447317|peritoneal dialysis|peritoneal dialysis
747516|NCT00447317|diet|diet
747517|NCT00447317|sodium|sodium
747518|NCT00447304|acute cholecystitis|acute cholecystitis
747519|NCT00447304|cholecystectomy|cholecystectomy
747520|NCT00447304|antibiotic treatment|antibiotic treatment
747521|NCT00447304|moxifloxacin|moxifloxacin
747522|NCT00447304|intraabdominal infection|intraabdominal infection
747523|NCT00447304|morbidity and mortality of patients with acute cholecystitis, early surgery versus conservative therapy|morbidity and mortality of patients with acute cholecystitis, early surgery versus conservative therapy
747524|NCT00447291|Overweight|overweight
747525|NCT00447291|Obesity|obesity
747526|NCT00447291|Fish Oil|fish oil
747527|NCT00447252|bereavement|bereavement
747528|NCT00447252|grief|grief
747529|NCT00447239|mechanical ventilated|mechanical ventilated
747530|NCT00447239|surgical patients|surgical patients
747531|NCT00447239|pneumonia|pneumonia
747532|NCT00447239|blood glucose|blood glucose
747533|NCT00447239|insulin infusion|insulin infusion
747534|NCT00447239|hospital stay|hospital stay
747535|NCT00447226|Ovarian Cancer|ovarian cancer
747536|NCT00447226|Bladder Cancer|bladder cancer
747537|NCT00447226|ErbB2 positive|erbb2 positive
747538|NCT00447226|Lapatinib|lapatinib
747539|NCT00447226|Gastric/Esophageal Cancer|gastric/esophageal cancer
747540|NCT00447226|Uterine Serous Papillary Cancer|uterine serous papillary cancer
747541|NCT00447200|Stroke volume|stroke volume
747542|NCT00447200|SV variation|sv variation
747543|NCT00447200|Esophagus Doppler|esophagus doppler
747544|NCT00447200|Goal Directed Therapy|goal directed therapy
747545|NCT00447187|corneal graft failure|corneal graft failure
747546|NCT00447187|corneal graft rejection|corneal graft rejection
747547|NCT00447187|corneal transplant rejection|corneal transplant rejection
747548|NCT00447174|Grief|grief
747549|NCT00447174|parental bereavement|parental bereavement
747550|NCT00447135|Elderly|elderly
747551|NCT00447135|Trauma|trauma
747552|NCT00447135|Polymorphonuclear Leukocyte|polymorphonuclear leukocyte
747553|NCT00447135|Immunity|immunity
747554|NCT00447122|Pancreatic Cancer|pancreatic cancer
747555|NCT00447096|Bipolar Type II|bipolar type ii
747556|NCT00447096|Depression|depression
747557|NCT00447096|rTMS|rtms
747558|NCT00447083|Tanning|tanning
747559|NCT00447083|Musculoskeletal|musculoskeletal
747560|NCT00447083|Fibromyalgia Syndrome|fibromyalgia syndrome
747561|NCT00447070|HIV-infection|hiv-infection
747562|NCT00447070|Dyslipidemia|dyslipidemia
747563|NCT00447070|Endothelial Dysfunction|endothelial dysfunction
747564|NCT00447070|Atherosclerosis|atherosclerosis
747565|NCT00447070|Protease inhibitor|protease inhibitor
747566|NCT00447070|treatment experienced|treatment experienced
747567|NCT00447057|nonsquamous|nonsquamous
747568|NCT00447044|Muscle loss and Maintenance of Muscle function|muscle loss and maintenance of muscle function
747569|NCT00447031|age related macular degeneration|age related macular degeneration
747570|NCT00447031|intravitreal bevacizumab|intravitreal bevacizumab
747571|NCT00447031|intravitreal triamcinolone acetonide|intravitreal triamcinolone acetonide
747572|NCT00447031|neovascular age related macular degeneration|neovascular age related macular degeneration
747573|NCT00447018|intracranial pressure|intracranial pressure
747574|NCT00447018|mannitol|mannitol
747575|NCT00447018|hypertonic saline solution|hypertonic saline solution
747576|NCT00447018|brain injury|brain injury
747577|NCT00447018|traumatic brain injury|traumatic brain injury
747578|NCT00447018|Adult patients|adult patients
747579|NCT00447018|With elevation of intracranial pressure (ICP > 20 mmHg)|with elevation of intracranial pressure (icp > 20 mmhg)
747580|NCT00447005|Safety|safety
747582|NCT00447005|Biomarker|biomarker
747583|NCT00446992|Schizophrenia|schizophrenia
747584|NCT00446992|Schizoaffective|schizoaffective
747585|NCT00446992|psychosis|psychosis
747586|NCT00446992|olanzapine|olanzapine
747587|NCT00446979|Microbicides|microbicides
747588|NCT00446979|HIV seronegativity|hiv seronegativity
747589|NCT00446966|atrial fibrillation|atrial fibrillation
747590|NCT00446966|coronary artery disease bypass graft surgery|coronary artery disease bypass graft surgery
747591|NCT00446953|Caesarean section|caesarean section
747592|NCT00446953|Corticosteroids|corticosteroids
747593|NCT00446953|Betamethasone|betamethasone
747594|NCT00446953|Neonatal distress|neonatal distress
747595|NCT00446927|Pediatrics|pediatrics
747596|NCT00446927|Cardiology|cardiology
747597|NCT00446927|Cardiopulmonary Bypass|cardiopulmonary bypass
747598|NCT00446927|Heart Surgery|heart surgery
747599|NCT00446927|Cardiac Catheterization|cardiac catheterization
747600|NCT00446927|Echocardiography|echocardiography
747601|NCT00446927|Imaging|imaging
747602|NCT00446927|ICG green dye|icg green dye
747603|NCT00446914|Hypertension|hypertension
747604|NCT00446914|Blood Pressure|blood pressure
747605|NCT00446901|Prostate Cancer|prostate cancer
747606|NCT00446901|Selenium|selenium
747607|NCT00446901|Chemoprevention|chemoprevention
747608|NCT00446901|Gene expression|gene expression
747609|NCT00446888|cancer|cancer
747610|NCT00446888|metastasis|metastasis
747611|NCT00446875|Pain|pain
747612|NCT00446875|Procedural pain|procedural pain
747615|NCT00446862|Definition: Fabry disease|definition: fabry disease
747616|NCT00446862|Definition: Progression|definition: progression
747617|NCT00446862|Definition: MDRD GFR|definition: mdrd gfr
747618|NCT00446862|Definition: Chronic Kidney Disease|definition: chronic kidney disease
747619|NCT00446862|Definition: Proteinuria|definition: proteinuria
747620|NCT00446862|Definition: Enzyme Replacement Therapy|definition: enzyme replacement therapy
747621|NCT00446862|Definition: Anti-proteinuric therapy|definition: anti-proteinuric therapy
747622|NCT00446849|ulcerative colitis|ulcerative colitis
747623|NCT00446849|compliance|compliance
747624|NCT00446849|mesalamine|mesalamine
747625|NCT00446849|clinical study|clinical study
747626|NCT00446849|clinical trial|clinical trial
747627|NCT00446849|clinical research|clinical research
747628|NCT00446849|maintenance|maintenance
747629|NCT00446849|long term|long term
747630|NCT00446849|uc study|uc study
747631|NCT00446849|uc trial|uc trial
747632|NCT00446849|uc research|uc research
747633|NCT00446849|open label|open label
747634|NCT00446849|once a day|once a day
747635|NCT00446849|once|once
747636|NCT00446849|daily|daily
747637|NCT00446849|daily dosing|daily dosing
747638|NCT00446849|simple|simple
747639|NCT00446849|oral|oral
747640|NCT00446836|Adenocarcinoma of the prostate|adenocarcinoma of the prostate
747641|NCT00446836|Recurrent prostate cancer|recurrent prostate cancer
747642|NCT00446836|Hormone refractory prostate cancer|hormone refractory prostate cancer
747643|NCT00446823|Wound healing|wound healing
747644|NCT00446823|Venous stasis ulcer|venous stasis ulcer
747645|NCT00446823|Cellulose dressing|cellulose dressing
747646|NCT00446823|Gauze dressing|gauze dressing
747647|NCT00446823|Chronic wound|chronic wound
747648|NCT00446810|diabetes|diabetes
747649|NCT00446810|endothelial dysfunction|endothelial dysfunction
747650|NCT00446810|benfotiamine|benfotiamine
747651|NCT00446810|postprandial|postprandial
747652|NCT00446810|autonomic neuropathy|autonomic neuropathy
747653|NCT00446810|advanced glycation end products|advanced glycation end products
747654|NCT00446797|Ankle sprain, acute pain, NSAID, celecoxib,|ankle sprain, acute pain, nsaid, celecoxib,
747655|NCT00446758|Zinc|zinc
747656|NCT00446758|HIV|hiv
747657|NCT00446758|Infants|infants
747658|NCT00446758|Children|children
747659|NCT00446758|Morbidity|morbidity
747660|NCT00446758|Child health outcomes|child health outcomes
747661|NCT00446758|treatment naive|treatment naive
747662|NCT00446758|treatment experienced|treatment experienced
747663|NCT00446745|Nutritional and Metabolic Diseases|nutritional and metabolic diseases
747664|NCT00446745|Insulin resistance|insulin resistance
747665|NCT00446745|Energy Metabolisms|energy metabolisms
747666|NCT00446745|Skeletal muscle|skeletal muscle
747667|NCT00446745|Visceral Adipose Tissue|visceral adipose tissue
747668|NCT00446719|major depression|major depression
747669|NCT00446719|antidepressant|antidepressant
747670|NCT00446719|quality of life|quality of life
747671|NCT00446719|anxiety|anxiety
747672|NCT00446706|Intrinsic PEEP|intrinsic peep
747673|NCT00446680|Mannitol|mannitol
747674|NCT00446680|Cystic Fibrosis|cystic fibrosis
747675|NCT00446680|Mucolytic|mucolytic
747676|NCT00446680|Exacerbation|exacerbation
747677|NCT00446680|FEV1|fev1
747678|NCT00446680|Quality of Life|quality of life
747679|NCT00446641|Infarction, Cerebral|infarction, cerebral
747680|NCT00446641|Cilostazol|cilostazol
747681|NCT00446641|Aspirin Resistance|aspirin resistance
747682|NCT00446628|Non-pharmaceutical|non-pharmaceutical
747683|NCT00446628|influenza|influenza
747685|NCT00446615|computer decision support|computer decision support
747686|NCT00446615|primary care|primary care
747687|NCT00446615|kidney disease, chronic|kidney disease, chronic
747688|NCT00446615|prescribing|prescribing
747689|NCT00446602|PROCRIT|procrit
747690|NCT00446602|Epoetin alfa|epoetin alfa
747691|NCT00446602|Myelodysplastic Syndromes|myelodysplastic syndromes
747692|NCT00446602|MDS|mds
747693|NCT00446576|Anemia|anemia
747694|NCT00446576|early renal insufficiency|early renal insufficiency
747695|NCT00446563|Left ventricular hypertrophy, hypertension, valsartan, amlodipine|left ventricular hypertrophy, hypertension, valsartan, amlodipine
747696|NCT00446550|Amicus Therapeutics|amicus therapeutics
747697|NCT00446550|afegostat tartrate|afegostat tartrate
747698|NCT00446550|isofagomine tartrate|isofagomine tartrate
747699|NCT00446550|AT2101|at2101
747700|NCT00446537|Skill Acquisition and the Evolution of Long Term Procedural Memory in participants with ADHD: The Effect of Methylphenidate|skill acquisition and the evolution of long term procedural memory in participants with adhd: the effect of methylphenidate
747701|NCT00446524|Hypertension, Valsartan, Amlodipine, high blood pressure|hypertension, valsartan, amlodipine, high blood pressure
747702|NCT00446511|children|children
747703|NCT00446511|pediatrics|pediatrics
747704|NCT00446511|high blood pressure|high blood pressure
747705|NCT00446511|hypertension|hypertension
747706|NCT00446511|valsartan|valsartan
747707|NCT00446511|enalapril|enalapril
747708|NCT00446485|ginkgo biloba|ginkgo biloba
747709|NCT00446485|cerebrovascular insufficiency|cerebrovascular insufficiency
747710|NCT00446485|mild cognitive impairment|mild cognitive impairment
747813|NCT00446173|Filgrastim|filgrastim
747711|NCT00446485|concentration impairment|concentration impairment
747712|NCT00446472|diabetes mellitus|diabetes mellitus
747713|NCT00446472|diabetic neuropathies|diabetic neuropathies
747714|NCT00446472|peripheral vascular diseases|peripheral vascular diseases
747715|NCT00446459|CellCept|cellcept
747716|NCT00446459|Dialysis|dialysis
747717|NCT00446459|Kidney|kidney
747718|NCT00446459|Renal|renal
747719|NCT00446459|Nephropathy|nephropathy
747720|NCT00446459|Glomerulonephropathy|glomerulonephropathy
747721|NCT00446459|Immunosuppression|immunosuppression
747722|NCT00446459|Allograft|allograft
747723|NCT00446459|Compatibility|compatibility
747724|NCT00446459|HLA|hla
747725|NCT00446459|PRA|pra
747726|NCT00446459|Transplant|transplant
747727|NCT00446459|Sensitization|sensitization
747728|NCT00446459|Antibodies|antibodies
747729|NCT00446459|Diabetes|diabetes
747730|NCT00446459|Hypertension|hypertension
747731|NCT00446459|Transplantation, Kidney|transplantation, kidney
747732|NCT00446407|Depression|depression
747733|NCT00446407|Primary Care|primary care
747734|NCT00446407|Developing Countries|developing countries
747735|NCT00446407|Common mental disorders (depressive and anxiety disorders)|common mental disorders (depressive and anxiety disorders)
747736|NCT00446394|cognition disorder|cognition disorder
747737|NCT00446394|functional ability|functional ability
747738|NCT00446394|psychomotor function|psychomotor function
747739|NCT00446394|psychopathology|psychopathology
747740|NCT00446394|quality of life|quality of life
747741|NCT00446381|Proliferative Diabetic Retinopathy|proliferative diabetic retinopathy
747742|NCT00446381|Clinically Significant Diabetic Macular Edema|clinically significant diabetic macular edema
747743|NCT00446381|VEGF|vegf
747744|NCT00446381|Macugen (pegaptanib)|macugen (pegaptanib)
747745|NCT00446368|metastatic kidney cancer|metastatic kidney cancer
747746|NCT00446368|metastatic renal cell cancer|metastatic renal cell cancer
747747|NCT00446355|C diff|c diff
747748|NCT00446355|antibiotics|antibiotics
747749|NCT00446342|leukemia|leukemia
747750|NCT00446342|lymphoma|lymphoma
747751|NCT00446342|myeloma|myeloma
747752|NCT00446342|non-Hodgkin's|non-hodgkin's
747753|NCT00446342|CLL|cll
747754|NCT00446342|MCL|mcl
747755|NCT00446342|MM|mm
747756|NCT00446342|Phase 1|phase 1
747757|NCT00446342|hematological malignancy|hematological malignancy
747758|NCT00446316|Pharmacokinetics|pharmacokinetics
747759|NCT00446316|Healthy volunteers|healthy volunteers
747760|NCT00446316|No condition|no condition
747761|NCT00446316|Pharmacokinetics study|pharmacokinetics study
747762|NCT00446303|MDS|mds
747763|NCT00446303|Myelodysplastic Syndromes|myelodysplastic syndromes
747764|NCT00446303|AML|aml
747765|NCT00446303|Intensive chemotherapy|intensive chemotherapy
747766|NCT00446303|azacitidine|azacitidine
747767|NCT00446290|To determine maximal tolerated dose of DXO regimen|to determine maximal tolerated dose of dxo regimen
747768|NCT00446277|cataract surgery, endothelial cell, cell loss, diabetes|cataract surgery, endothelial cell, cell loss, diabetes
747769|NCT00446277|mellitus type II|mellitus type ii
747770|NCT00446264|diabetes|diabetes
747771|NCT00446264|hypoglycemia|hypoglycemia
747772|NCT00446251|Dialysis|dialysis
747773|NCT00446251|Kidney|kidney
747774|NCT00446251|Renal|renal
747775|NCT00446251|Nephropathy|nephropathy
747776|NCT00446251|Glomerulonephropathy|glomerulonephropathy
747777|NCT00446251|Immunosuppression|immunosuppression
747778|NCT00446251|Graft|graft
747779|NCT00446251|Compatibility|compatibility
747780|NCT00446251|Transplant|transplant
747782|NCT00446251|Hypertension|hypertension
747783|NCT00446251|Transplantation, Kidney|transplantation, kidney
747784|NCT00446238|Depression|depression
747785|NCT00446238|Physical Illness|physical illness
747786|NCT00446238|Inflammatory Bowel Disease|inflammatory bowel disease
747787|NCT00446238|Cognitive Behavioral Therapy|cognitive behavioral therapy
747788|NCT00446225|Lung|lung
747789|NCT00446225|cancer|cancer
747790|NCT00446225|EGFR|egfr
747791|NCT00446225|Epidermal Growth Factor Receptor|epidermal growth factor receptor
747792|NCT00446225|tyrosine kinase|tyrosine kinase
747793|NCT00446225|Tarceva®|tarceva®
747794|NCT00446225|Erlotinib|erlotinib
747795|NCT00446212|anaesthesia|anaesthesia
747796|NCT00446212|propofol|propofol
747797|NCT00446212|desflurane|desflurane
747798|NCT00446212|dreaming|dreaming
747799|NCT00446212|electroencephalography|electroencephalography
747800|NCT00446199|Vasomotor symptom relief|vasomotor symptom relief
747801|NCT00446199|Postmenopausal women|postmenopausal women
747802|NCT00446199|Severe to Moderate Vasomotor symptoms|severe to moderate vasomotor symptoms
747803|NCT00446173|Chronic Myelogenous Leukemia|chronic myelogenous leukemia
747804|NCT00446173|Leukemia|leukemia
747805|NCT00446173|Philadelphia (Ph) chromosome positive CML|philadelphia (ph) chromosome positive cml
747806|NCT00446173|Busulfan|busulfan
747807|NCT00446173|Busulfex|busulfex
747808|NCT00446173|Myleran|myleran
747809|NCT00446173|Cyclophosphamide|cyclophosphamide
747810|NCT00446173|Cytoxan|cytoxan
747811|NCT00446173|Neosar|neosar
747812|NCT00446173|G-CSF|g-csf
747814|NCT00446173|Neupogen|neupogen
747815|NCT00446173|GM-CSF|gm-csf
747816|NCT00446173|Sargramostim|sargramostim
747817|NCT00446173|Leukine|leukine
747818|NCT00446160|Congenital Heart Disease|congenital heart disease
747819|NCT00446160|Surgery|surgery
747820|NCT00446160|Adult|adult
747821|NCT00446147|hand-foot syndrome|hand-foot syndrome
747822|NCT00446147|capecitabine|capecitabine
747823|NCT00446147|pyridoxine|pyridoxine
747824|NCT00446147|prevention|prevention
747825|NCT00446134|Phase 2b Dose-Ranging Study|phase 2b dose-ranging study
747826|NCT00446121|COPD|copd
747827|NCT00446108|Pulmonary Stenosis|pulmonary stenosis
747828|NCT00446108|Right Ventricular Dilation|right ventricular dilation
747829|NCT00446108|Right Heart Failure|right heart failure
747830|NCT00446108|Imaging|imaging
747831|NCT00446108|Tetralogy of Fallot|tetralogy of fallot
747832|NCT00446095|DLCL|dlcl
747833|NCT00446095|Nodular lymphoma|nodular lymphoma
747834|NCT00446095|Mantle cell lymphoma|mantle cell lymphoma
747835|NCT00446095|Syk kinase|syk kinase
747836|NCT00446082|Refractory/ resistant carcinoid disease|refractory/ resistant carcinoid disease
747837|NCT00446082|acromegaly|acromegaly
747838|NCT00446082|adults|adults
747839|NCT00446082|pasireotide LAR|pasireotide lar
747840|NCT00446082|somatostatin analogue|somatostatin analogue
747842|NCT00446082|pharmacokinetics|pharmacokinetics
747843|NCT00446082|Refractory or resistant carcinoid disease and acromegaly|refractory or resistant carcinoid disease and acromegaly
747844|NCT00446043|Acne Vulgaris|acne vulgaris
747845|NCT00446043|Adapalene|adapalene
747846|NCT00446043|Benzoyl Peroxide|benzoyl peroxide
747847|NCT00446017|coronary artery bypass grafting|coronary artery bypass grafting
747848|NCT00446017|inotropes|inotropes
747849|NCT00446017|metabolism|metabolism
747850|NCT00446017|renal failure|renal failure
747851|NCT00446004|Pharmacokinetics|pharmacokinetics
747852|NCT00446004|Healthy volunteers|healthy volunteers
747853|NCT00446004|No condition|no condition
747854|NCT00446004|Pharmacokinetics study|pharmacokinetics study
747855|NCT00445978|Sickle Cell Disease|sickle cell disease
747856|NCT00445978|SCD|scd
747857|NCT00445978|6R-BH4|6r-bh4
747858|NCT00445978|BH4|bh4
747859|NCT00445978|sapropterin dihydrochloride|sapropterin dihydrochloride
747860|NCT00445978|endothelial dysfunction|endothelial dysfunction
747861|NCT00445978|Nitric Oxide|nitric oxide
747862|NCT00445978|NO|no
747863|NCT00445965|recurrent childhood medulloblastoma|recurrent childhood medulloblastoma
747864|NCT00445965|untreated childhood medulloblastoma|untreated childhood medulloblastoma
747865|NCT00445965|adult supratentorial primitive neuroectodermal tumor (PNET)|adult supratentorial primitive neuroectodermal tumor (pnet)
747866|NCT00445965|recurrent childhood supratentorial primitive neuroectodermal tumor|recurrent childhood supratentorial primitive neuroectodermal tumor
747867|NCT00445965|untreated childhood supratentorial primitive neuroectodermal tumor|untreated childhood supratentorial primitive neuroectodermal tumor
747868|NCT00445965|adult anaplastic astrocytoma|adult anaplastic astrocytoma
747869|NCT00445965|adult diffuse astrocytoma|adult diffuse astrocytoma
747870|NCT00445965|adult pilocytic astrocytoma|adult pilocytic astrocytoma
747871|NCT00445965|adult subependymal giant cell astrocytoma|adult subependymal giant cell astrocytoma
747872|NCT00445965|recurrent childhood subependymal giant cell astrocytoma|recurrent childhood subependymal giant cell astrocytoma
747873|NCT00445965|untreated childhood subependymal giant cell astrocytoma|untreated childhood subependymal giant cell astrocytoma
747874|NCT00445965|recurrent childhood cerebellar astrocytoma|recurrent childhood cerebellar astrocytoma
747875|NCT00445965|recurrent childhood cerebral astrocytoma|recurrent childhood cerebral astrocytoma
747876|NCT00445965|untreated childhood cerebellar astrocytoma|untreated childhood cerebellar astrocytoma
747877|NCT00445965|adult brain stem glioma|adult brain stem glioma
747878|NCT00445965|adult mixed glioma|adult mixed glioma
747879|NCT00445965|childhood mixed glioma|childhood mixed glioma
747880|NCT00445965|recurrent childhood brain stem glioma|recurrent childhood brain stem glioma
747881|NCT00445965|recurrent childhood visual pathway and hypothalamic glioma|recurrent childhood visual pathway and hypothalamic glioma
747882|NCT00445965|recurrent childhood visual pathway glioma|recurrent childhood visual pathway glioma
747883|NCT00445965|untreated childhood brain stem glioma|untreated childhood brain stem glioma
747884|NCT00445965|untreated childhood visual pathway and hypothalamic glioma|untreated childhood visual pathway and hypothalamic glioma
747885|NCT00445965|untreated childhood visual pathway glioma|untreated childhood visual pathway glioma
747886|NCT00445965|regional neuroblastoma|regional neuroblastoma
747887|NCT00445965|disseminated neuroblastoma|disseminated neuroblastoma
747888|NCT00445965|recurrent neuroblastoma|recurrent neuroblastoma
747889|NCT00445965|extraocular retinoblastoma|extraocular retinoblastoma
747890|NCT00445965|recurrent retinoblastoma|recurrent retinoblastoma
747891|NCT00445965|adult anaplastic ependymoma|adult anaplastic ependymoma
747892|NCT00445965|adult ependymoblastoma|adult ependymoblastoma
747893|NCT00445965|adult ependymoma|adult ependymoma
747894|NCT00445965|adult myxopapillary ependymoma|adult myxopapillary ependymoma
747895|NCT00445965|adult subependymoma|adult subependymoma
747896|NCT00445965|childhood infratentorial ependymoma|childhood infratentorial ependymoma
747897|NCT00445965|childhood supratentorial ependymoma|childhood supratentorial ependymoma
747898|NCT00445965|recurrent childhood ependymoma|recurrent childhood ependymoma
748447|NCT00445458|HKI-272|hki-272
747899|NCT00445965|childhood atypical teratoid/rhabdoid tumor|childhood atypical teratoid/rhabdoid tumor
747900|NCT00445965|recurrent melanoma|recurrent melanoma
747901|NCT00445965|stage IV melanoma|stage iv melanoma
747902|NCT00445965|adult medulloblastoma|adult medulloblastoma
747903|NCT00445965|chondrosarcoma|chondrosarcoma
747904|NCT00445965|metastatic osteosarcoma|metastatic osteosarcoma
747905|NCT00445965|recurrent osteosarcoma|recurrent osteosarcoma
747906|NCT00445965|metastatic childhood soft tissue sarcoma|metastatic childhood soft tissue sarcoma
747907|NCT00445965|ovarian sarcoma|ovarian sarcoma
747908|NCT00445965|recurrent childhood soft tissue sarcoma|recurrent childhood soft tissue sarcoma
747909|NCT00445965|stage III adult soft tissue sarcoma|stage iii adult soft tissue sarcoma
747910|NCT00445965|stage IV adult soft tissue sarcoma|stage iv adult soft tissue sarcoma
747911|NCT00445965|stage III uterine sarcoma|stage iii uterine sarcoma
747912|NCT00445965|stage IV uterine sarcoma|stage iv uterine sarcoma
747913|NCT00445965|previously treated childhood rhabdomyosarcoma|previously treated childhood rhabdomyosarcoma
747914|NCT00445965|recurrent childhood rhabdomyosarcoma|recurrent childhood rhabdomyosarcoma
747915|NCT00445965|adult anaplastic oligodendroglioma|adult anaplastic oligodendroglioma
747916|NCT00445965|adult desmoplastic small round cell tumor|adult desmoplastic small round cell tumor
747917|NCT00445965|adult oligodendroglioma|adult oligodendroglioma
747918|NCT00445965|adult giant cell glioblastoma|adult giant cell glioblastoma
747919|NCT00445965|adult gliosarcoma|adult gliosarcoma
747920|NCT00445965|tumors metastatic to brain|tumors metastatic to brain
747921|NCT00445965|adult rhabdomyosarcoma|adult rhabdomyosarcoma
747922|NCT00445965|childhood oligodendroglioma|childhood oligodendroglioma
747923|NCT00445965|childhood desmoplastic small round cell tumor|childhood desmoplastic small round cell tumor
747924|NCT00445965|extensive stage small cell lung cancer|extensive stage small cell lung cancer
747925|NCT00445965|intraocular retinoblastoma|intraocular retinoblastoma
747926|NCT00445965|recurrent adult brain tumor|recurrent adult brain tumor
747927|NCT00445965|recurrent adult soft tissue sarcoma|recurrent adult soft tissue sarcoma
747928|NCT00445965|recurrent uterine sarcoma|recurrent uterine sarcoma
747929|NCT00445965|small intestine leiomyosarcoma|small intestine leiomyosarcoma
747930|NCT00445965|recurrent small intestine cancer|recurrent small intestine cancer
747931|NCT00445965|recurrent small cell lung cancer|recurrent small cell lung cancer
747932|NCT00445965|extraocular extension melanoma|extraocular extension melanoma
747933|NCT00445965|recurrent intraocular melanoma|recurrent intraocular melanoma
747934|NCT00445965|metastatic intraocular melanoma|metastatic intraocular melanoma
747935|NCT00445965|iris melanoma|iris melanoma
747936|NCT00445965|ciliary body and choroid melanoma, medium/large size|ciliary body and choroid melanoma, medium/large size
747937|NCT00445965|newly diagnosed childhood ependymoma|newly diagnosed childhood ependymoma
747938|NCT00445965|adult glioblastoma|adult glioblastoma
747939|NCT00445965|metastatic Ewing sarcoma/peripheral primitive neuroectodermal tumor|metastatic ewing sarcoma/peripheral primitive neuroectodermal tumor
747940|NCT00445965|recurrent Ewing sarcoma/peripheral primitive neuroectodermal tumor|recurrent ewing sarcoma/peripheral primitive neuroectodermal tumor
747941|NCT00445965|recurrent childhood pineoblastoma|recurrent childhood pineoblastoma
747942|NCT00445965|untreated childhood pineoblastoma|untreated childhood pineoblastoma
747943|NCT00445965|adult pineal gland astrocytoma|adult pineal gland astrocytoma
747944|NCT00445965|stage IIIA melanoma|stage iiia melanoma
747945|NCT00445965|stage IIIB melanoma|stage iiib melanoma
747946|NCT00445965|stage IIIC melanoma|stage iiic melanoma
747947|NCT00445965|recurrent childhood anaplastic astrocytoma|recurrent childhood anaplastic astrocytoma
747948|NCT00445965|untreated childhood anaplastic astrocytoma|untreated childhood anaplastic astrocytoma
747949|NCT00445965|recurrent childhood anaplastic oligoastrocytoma|recurrent childhood anaplastic oligoastrocytoma
747950|NCT00445965|recurrent childhood anaplastic oligodendroglioma|recurrent childhood anaplastic oligodendroglioma
747951|NCT00445965|untreated childhood anaplastic oligoastrocytoma|untreated childhood anaplastic oligoastrocytoma
747952|NCT00445965|untreated childhood anaplastic oligodendroglioma|untreated childhood anaplastic oligodendroglioma
747953|NCT00445965|recurrent childhood giant cell glioblastoma|recurrent childhood giant cell glioblastoma
747954|NCT00445965|recurrent childhood glioblastoma|recurrent childhood glioblastoma
747955|NCT00445965|untreated childhood giant cell glioblastoma|untreated childhood giant cell glioblastoma
747956|NCT00445965|untreated childhood glioblastoma|untreated childhood glioblastoma
747957|NCT00445965|recurrent childhood gliosarcoma|recurrent childhood gliosarcoma
747958|NCT00445965|untreated childhood gliosarcoma|untreated childhood gliosarcoma
747959|NCT00445965|recurrent childhood gliomatosis cerebri|recurrent childhood gliomatosis cerebri
747960|NCT00445965|untreated childhood gliomatosis cerebri|untreated childhood gliomatosis cerebri
747961|NCT00445965|childhood high-grade cerebellar astrocytoma|childhood high-grade cerebellar astrocytoma
747962|NCT00445965|childhood high-grade cerebral astrocytoma|childhood high-grade cerebral astrocytoma
747963|NCT00445952|breast cancer in situ|breast cancer in situ
747964|NCT00445952|stage I breast cancer|stage i breast cancer
747965|NCT00445952|stage II breast cancer|stage ii breast cancer
747966|NCT00445952|stage IIIA breast cancer|stage iiia breast cancer
747967|NCT00445952|stage IIIB breast cancer|stage iiib breast cancer
747968|NCT00445952|stage IIIC breast cancer|stage iiic breast cancer
747969|NCT00445952|stage IV breast cancer|stage iv breast cancer
747970|NCT00445952|recurrent breast cancer|recurrent breast cancer
747971|NCT00445952|male breast cancer|male breast cancer
747972|NCT00445952|recurrent non-small cell lung cancer|recurrent non-small cell lung cancer
747973|NCT00445952|stage I non-small cell lung cancer|stage i non-small cell lung cancer
747974|NCT00445952|stage II non-small cell lung cancer|stage ii non-small cell lung cancer
747975|NCT00445952|stage IIIA non-small cell lung cancer|stage iiia non-small cell lung cancer
747976|NCT00445952|stage IIIB non-small cell lung cancer|stage iiib non-small cell lung cancer
747977|NCT00445952|stage IV non-small cell lung cancer|stage iv non-small cell lung cancer
747978|NCT00445952|extensive stage small cell lung cancer|extensive stage small cell lung cancer
747979|NCT00445952|recurrent colon cancer|recurrent colon cancer
747980|NCT00445952|stage I colon cancer|stage i colon cancer
747981|NCT00445952|stage II colon cancer|stage ii colon cancer
747982|NCT00445952|stage III colon cancer|stage iii colon cancer
747983|NCT00445952|stage IV colon cancer|stage iv colon cancer
747984|NCT00445952|unspecified adult solid tumor, protocol specific|unspecified adult solid tumor, protocol specific
747985|NCT00445952|adult acute myeloid leukemia with 11q23 (MLL) abnormalities|adult acute myeloid leukemia with 11q23 (mll) abnormalities
747986|NCT00445952|adult acute myeloid leukemia with inv(16)(p13;q22)|adult acute myeloid leukemia with inv(16)(p13;q22)
747987|NCT00445952|adult acute myeloid leukemia with t(15;17)(q22;q12)|adult acute myeloid leukemia with t(15;17)(q22;q12)
747988|NCT00445952|adult acute myeloid leukemia with t(16;16)(p13;q22)|adult acute myeloid leukemia with t(16;16)(p13;q22)
747989|NCT00445952|adult acute myeloid leukemia with t(8;21)(q22;q22)|adult acute myeloid leukemia with t(8;21)(q22;q22)
747990|NCT00445952|stage IV chronic lymphocytic leukemia|stage iv chronic lymphocytic leukemia
747991|NCT00445952|accelerated phase chronic myelogenous leukemia|accelerated phase chronic myelogenous leukemia
747992|NCT00445952|blastic phase chronic myelogenous leukemia|blastic phase chronic myelogenous leukemia
747993|NCT00445952|chronic myelomonocytic leukemia|chronic myelomonocytic leukemia
747994|NCT00445952|chronic phase chronic myelogenous leukemia|chronic phase chronic myelogenous leukemia
747995|NCT00445952|noncontiguous stage II adult Burkitt lymphoma|noncontiguous stage ii adult burkitt lymphoma
747996|NCT00445952|noncontiguous stage II adult diffuse large cell lymphoma|noncontiguous stage ii adult diffuse large cell lymphoma
747997|NCT00445952|noncontiguous stage II adult diffuse mixed cell lymphoma|noncontiguous stage ii adult diffuse mixed cell lymphoma
747998|NCT00445952|noncontiguous stage II adult diffuse small cleaved cell lymphoma|noncontiguous stage ii adult diffuse small cleaved cell lymphoma
747999|NCT00445952|noncontiguous stage II adult immunoblastic large cell lymphoma|noncontiguous stage ii adult immunoblastic large cell lymphoma
748000|NCT00445952|noncontiguous stage II adult lymphoblastic lymphoma|noncontiguous stage ii adult lymphoblastic lymphoma
748001|NCT00445952|noncontiguous stage II small lymphocytic lymphoma|noncontiguous stage ii small lymphocytic lymphoma
748002|NCT00445952|noncontiguous stage II marginal zone lymphoma|noncontiguous stage ii marginal zone lymphoma
748003|NCT00445952|noncontiguous stage II grade 1 follicular lymphoma|noncontiguous stage ii grade 1 follicular lymphoma
748004|NCT00445952|noncontiguous stage II grade 2 follicular lymphoma|noncontiguous stage ii grade 2 follicular lymphoma
748005|NCT00445952|noncontiguous stage II grade 3 follicular lymphoma|noncontiguous stage ii grade 3 follicular lymphoma
748006|NCT00445952|noncontiguous stage II mantle cell lymphoma|noncontiguous stage ii mantle cell lymphoma
748007|NCT00445952|stage III adult Burkitt lymphoma|stage iii adult burkitt lymphoma
748008|NCT00445952|stage III adult diffuse large cell lymphoma|stage iii adult diffuse large cell lymphoma
748009|NCT00445952|stage III adult diffuse mixed cell lymphoma|stage iii adult diffuse mixed cell lymphoma
748010|NCT00445952|stage III adult diffuse small cleaved cell lymphoma|stage iii adult diffuse small cleaved cell lymphoma
748011|NCT00445952|stage III adult immunoblastic large cell lymphoma|stage iii adult immunoblastic large cell lymphoma
748012|NCT00445952|stage III adult lymphoblastic lymphoma|stage iii adult lymphoblastic lymphoma
748013|NCT00445952|stage III small lymphocytic lymphoma|stage iii small lymphocytic lymphoma
748014|NCT00445952|stage III marginal zone lymphoma|stage iii marginal zone lymphoma
748015|NCT00445952|stage III grade 1 follicular lymphoma|stage iii grade 1 follicular lymphoma
748016|NCT00445952|stage III grade 2 follicular lymphoma|stage iii grade 2 follicular lymphoma
748017|NCT00445952|stage III grade 3 follicular lymphoma|stage iii grade 3 follicular lymphoma
748018|NCT00445952|stage III mantle cell lymphoma|stage iii mantle cell lymphoma
748019|NCT00445952|stage IV adult Burkitt lymphoma|stage iv adult burkitt lymphoma
748020|NCT00445952|stage IV adult diffuse large cell lymphoma|stage iv adult diffuse large cell lymphoma
748021|NCT00445952|stage IV adult diffuse mixed cell lymphoma|stage iv adult diffuse mixed cell lymphoma
748022|NCT00445952|stage IV adult diffuse small cleaved cell lymphoma|stage iv adult diffuse small cleaved cell lymphoma
748023|NCT00445952|stage IV adult immunoblastic large cell lymphoma|stage iv adult immunoblastic large cell lymphoma
748024|NCT00445952|stage IV adult lymphoblastic lymphoma|stage iv adult lymphoblastic lymphoma
748025|NCT00445952|stage IV small lymphocytic lymphoma|stage iv small lymphocytic lymphoma
748026|NCT00445952|stage IV marginal zone lymphoma|stage iv marginal zone lymphoma
748027|NCT00445952|stage IV grade 1 follicular lymphoma|stage iv grade 1 follicular lymphoma
748028|NCT00445952|stage IV grade 2 follicular lymphoma|stage iv grade 2 follicular lymphoma
748029|NCT00445952|stage IV grade 3 follicular lymphoma|stage iv grade 3 follicular lymphoma
748030|NCT00445952|stage IV mantle cell lymphoma|stage iv mantle cell lymphoma
748031|NCT00445952|recurrent adult Burkitt lymphoma|recurrent adult burkitt lymphoma
748032|NCT00445952|recurrent adult diffuse large cell lymphoma|recurrent adult diffuse large cell lymphoma
748033|NCT00445952|recurrent adult diffuse mixed cell lymphoma|recurrent adult diffuse mixed cell lymphoma
748448|NCT00445458|neratinib|neratinib
748034|NCT00445952|recurrent adult diffuse small cleaved cell lymphoma|recurrent adult diffuse small cleaved cell lymphoma
748035|NCT00445952|recurrent adult Hodgkin lymphoma|recurrent adult hodgkin lymphoma
748036|NCT00445952|recurrent adult immunoblastic large cell lymphoma|recurrent adult immunoblastic large cell lymphoma
748037|NCT00445952|recurrent adult lymphoblastic lymphoma|recurrent adult lymphoblastic lymphoma
748548|NCT00445081|ciclosporine|ciclosporine
748038|NCT00445952|recurrent cutaneous T-cell non-Hodgkin lymphoma|recurrent cutaneous t-cell non-hodgkin lymphoma
748039|NCT00445952|recurrent small lymphocytic lymphoma|recurrent small lymphocytic lymphoma
748040|NCT00445952|recurrent marginal zone lymphoma|recurrent marginal zone lymphoma
748041|NCT00445952|recurrent grade 1 follicular lymphoma|recurrent grade 1 follicular lymphoma
748042|NCT00445952|recurrent grade 2 follicular lymphoma|recurrent grade 2 follicular lymphoma
748043|NCT00445952|recurrent grade 3 follicular lymphoma|recurrent grade 3 follicular lymphoma
748044|NCT00445952|recurrent mantle cell lymphoma|recurrent mantle cell lymphoma
748045|NCT00445952|recurrent mycosis fungoides/Sezary syndrome|recurrent mycosis fungoides/sezary syndrome
748046|NCT00445952|stage I multiple myeloma|stage i multiple myeloma
748047|NCT00445952|stage II multiple myeloma|stage ii multiple myeloma
748048|NCT00445952|stage III multiple myeloma|stage iii multiple myeloma
748049|NCT00445952|de novo myelodysplastic syndromes|de novo myelodysplastic syndromes
748050|NCT00445952|myelodysplastic/myeloproliferative neoplasm, unclassifiable|myelodysplastic/myeloproliferative neoplasm, unclassifiable
748051|NCT00445952|previously treated myelodysplastic syndromes|previously treated myelodysplastic syndromes
748052|NCT00445952|secondary myelodysplastic syndromes|secondary myelodysplastic syndromes
748053|NCT00445952|atypical chronic myeloid leukemia, BCR-ABL1 negative|atypical chronic myeloid leukemia, bcr-abl1 negative
748054|NCT00445952|stage II adult Hodgkin lymphoma|stage ii adult hodgkin lymphoma
748055|NCT00445952|stage III adult Hodgkin lymphoma|stage iii adult hodgkin lymphoma
748056|NCT00445952|stage IV adult Hodgkin lymphoma|stage iv adult hodgkin lymphoma
748057|NCT00445952|contiguous stage II adult Burkitt lymphoma|contiguous stage ii adult burkitt lymphoma
748058|NCT00445952|stage I adult Burkitt lymphoma|stage i adult burkitt lymphoma
748059|NCT00445952|contiguous stage II adult diffuse large cell lymphoma|contiguous stage ii adult diffuse large cell lymphoma
748060|NCT00445952|contiguous stage II adult diffuse mixed cell lymphoma|contiguous stage ii adult diffuse mixed cell lymphoma
748061|NCT00445952|contiguous stage II adult diffuse small cleaved cell lymphoma|contiguous stage ii adult diffuse small cleaved cell lymphoma
748062|NCT00445952|contiguous stage II small lymphocytic lymphoma|contiguous stage ii small lymphocytic lymphoma
748063|NCT00445952|contiguous stage II marginal zone lymphoma|contiguous stage ii marginal zone lymphoma
748064|NCT00445952|stage I adult diffuse large cell lymphoma|stage i adult diffuse large cell lymphoma
748065|NCT00445952|stage I adult diffuse mixed cell lymphoma|stage i adult diffuse mixed cell lymphoma
748066|NCT00445952|stage I adult diffuse small cleaved cell lymphoma|stage i adult diffuse small cleaved cell lymphoma
748067|NCT00445952|stage I small lymphocytic lymphoma|stage i small lymphocytic lymphoma
748068|NCT00445952|stage I marginal zone lymphoma|stage i marginal zone lymphoma
748069|NCT00445952|contiguous stage II grade 1 follicular lymphoma|contiguous stage ii grade 1 follicular lymphoma
748070|NCT00445952|contiguous stage II grade 2 follicular lymphoma|contiguous stage ii grade 2 follicular lymphoma
748071|NCT00445952|contiguous stage II grade 3 follicular lymphoma|contiguous stage ii grade 3 follicular lymphoma
748072|NCT00445952|stage I grade 1 follicular lymphoma|stage i grade 1 follicular lymphoma
748073|NCT00445952|stage I grade 2 follicular lymphoma|stage i grade 2 follicular lymphoma
748074|NCT00445952|stage I grade 3 follicular lymphoma|stage i grade 3 follicular lymphoma
748075|NCT00445952|contiguous stage II mantle cell lymphoma|contiguous stage ii mantle cell lymphoma
748076|NCT00445952|stage I mantle cell lymphoma|stage i mantle cell lymphoma
748077|NCT00445952|contiguous stage II adult immunoblastic large cell lymphoma|contiguous stage ii adult immunoblastic large cell lymphoma
748078|NCT00445952|stage I adult immunoblastic large cell lymphoma|stage i adult immunoblastic large cell lymphoma
748079|NCT00445952|contiguous stage II adult lymphoblastic lymphoma|contiguous stage ii adult lymphoblastic lymphoma
748080|NCT00445952|stage I adult lymphoblastic lymphoma|stage i adult lymphoblastic lymphoma
748081|NCT00445952|refractory multiple myeloma|refractory multiple myeloma
748082|NCT00445952|anaplastic large cell lymphoma|anaplastic large cell lymphoma
748083|NCT00445952|angioimmunoblastic T-cell lymphoma|angioimmunoblastic t-cell lymphoma
748084|NCT00445952|recurrent adult T-cell leukemia/lymphoma|recurrent adult t-cell leukemia/lymphoma
748085|NCT00445952|stage I adult T-cell leukemia/lymphoma|stage i adult t-cell leukemia/lymphoma
748086|NCT00445952|stage II adult T-cell leukemia/lymphoma|stage ii adult t-cell leukemia/lymphoma
748087|NCT00445952|stage III adult T-cell leukemia/lymphoma|stage iii adult t-cell leukemia/lymphoma
748088|NCT00445952|stage IV adult T-cell leukemia/lymphoma|stage iv adult t-cell leukemia/lymphoma
748089|NCT00445952|stage I cutaneous T-cell non-Hodgkin lymphoma|stage i cutaneous t-cell non-hodgkin lymphoma
748090|NCT00445952|stage II cutaneous T-cell non-Hodgkin lymphoma|stage ii cutaneous t-cell non-hodgkin lymphoma
748091|NCT00445952|stage III cutaneous T-cell non-Hodgkin lymphoma|stage iii cutaneous t-cell non-hodgkin lymphoma
748092|NCT00445952|stage IV cutaneous T-cell non-Hodgkin lymphoma|stage iv cutaneous t-cell non-hodgkin lymphoma
748093|NCT00445952|stage I mycosis fungoides/Sezary syndrome|stage i mycosis fungoides/sezary syndrome
748094|NCT00445952|stage II mycosis fungoides/Sezary syndrome|stage ii mycosis fungoides/sezary syndrome
748095|NCT00445952|stage III mycosis fungoides/Sezary syndrome|stage iii mycosis fungoides/sezary syndrome
748310|NCT00445562|stage IA breast cancer|stage ia breast cancer
748096|NCT00445952|stage IV mycosis fungoides/Sezary syndrome|stage iv mycosis fungoides/sezary syndrome
748097|NCT00445952|chronic eosinophilic leukemia|chronic eosinophilic leukemia
748098|NCT00445952|primary myelofibrosis|primary myelofibrosis
748099|NCT00445952|chronic neutrophilic leukemia|chronic neutrophilic leukemia
748100|NCT00445952|essential thrombocythemia|essential thrombocythemia
748101|NCT00445952|polycythemia vera|polycythemia vera
748102|NCT00445952|relapsing chronic myelogenous leukemia|relapsing chronic myelogenous leukemia
748103|NCT00445952|recurrent adult acute lymphoblastic leukemia|recurrent adult acute lymphoblastic leukemia
748104|NCT00445952|recurrent adult acute myeloid leukemia|recurrent adult acute myeloid leukemia
748105|NCT00445952|untreated adult acute lymphoblastic leukemia|untreated adult acute lymphoblastic leukemia
748106|NCT00445952|untreated adult acute myeloid leukemia|untreated adult acute myeloid leukemia
748107|NCT00445952|secondary acute myeloid leukemia|secondary acute myeloid leukemia
748108|NCT00445952|acute undifferentiated leukemia|acute undifferentiated leukemia
748109|NCT00445952|refractory chronic lymphocytic leukemia|refractory chronic lymphocytic leukemia
748110|NCT00445952|stage I chronic lymphocytic leukemia|stage i chronic lymphocytic leukemia
748111|NCT00445952|stage II chronic lymphocytic leukemia|stage ii chronic lymphocytic leukemia
748112|NCT00445952|stage III chronic lymphocytic leukemia|stage iii chronic lymphocytic leukemia
748113|NCT00445952|refractory hairy cell leukemia|refractory hairy cell leukemia
748114|NCT00445952|progressive hairy cell leukemia, initial treatment|progressive hairy cell leukemia, initial treatment
748115|NCT00445952|prolymphocytic leukemia|prolymphocytic leukemia
748116|NCT00445952|recurrent adult grade III lymphomatoid granulomatosis|recurrent adult grade iii lymphomatoid granulomatosis
748117|NCT00445952|Waldenstrom macroglobulinemia|waldenstrom macroglobulinemia
748118|NCT00445952|extranodal marginal zone B-cell lymphoma of mucosa-associated lymphoid tissue|extranodal marginal zone b-cell lymphoma of mucosa-associated lymphoid tissue
748119|NCT00445952|nodal marginal zone B-cell lymphoma|nodal marginal zone b-cell lymphoma
748120|NCT00445952|splenic marginal zone lymphoma|splenic marginal zone lymphoma
748121|NCT00445952|post-transplant lymphoproliferative disorder|post-transplant lymphoproliferative disorder
748122|NCT00445952|extramedullary plasmacytoma|extramedullary plasmacytoma
748123|NCT00445952|monoclonal gammopathy of undetermined significance|monoclonal gammopathy of undetermined significance
748124|NCT00445952|primary systemic amyloidosis|primary systemic amyloidosis
748125|NCT00445952|adult acute lymphoblastic leukemia in remission|adult acute lymphoblastic leukemia in remission
748126|NCT00445952|adult acute myeloid leukemia in remission|adult acute myeloid leukemia in remission
748127|NCT00445952|adult grade III lymphomatoid granulomatosis|adult grade iii lymphomatoid granulomatosis
748128|NCT00445952|AIDS-related peripheral/systemic lymphoma|aids-related peripheral/systemic lymphoma
748129|NCT00445952|AIDS-related primary CNS lymphoma|aids-related primary cns lymphoma
748130|NCT00445952|intraocular lymphoma|intraocular lymphoma
748131|NCT00445952|meningeal chronic myelogenous leukemia|meningeal chronic myelogenous leukemia
748132|NCT00445952|primary central nervous system non-Hodgkin lymphoma|primary central nervous system non-hodgkin lymphoma
748133|NCT00445952|stage I adult Hodgkin lymphoma|stage i adult hodgkin lymphoma
748134|NCT00445952|adult nasal type extranodal NK/T-cell lymphoma|adult nasal type extranodal nk/t-cell lymphoma
748135|NCT00445952|infection|infection
748136|NCT00445952|limited stage small cell lung cancer|limited stage small cell lung cancer
748137|NCT00445952|T-cell large granular lymphocyte leukemia|t-cell large granular lymphocyte leukemia
748138|NCT00445913|type 1 diabetes|type 1 diabetes
748139|NCT00445913|dendritic cells|dendritic cells
748140|NCT00445913|cell vaccine|cell vaccine
748142|NCT00445913|reversal|reversal
748143|NCT00445900|primary myelofibrosis|primary myelofibrosis
749936|NCT00441116|phase 3|phase 3
748144|NCT00445900|essential thrombocythemia|essential thrombocythemia
748145|NCT00445900|polycythemia vera|polycythemia vera
748146|NCT00445900|secondary myelofibrosis|secondary myelofibrosis
748147|NCT00445874|allergic conjunctivitis, ophthalmology, multicenter, controlled|allergic conjunctivitis, ophthalmology, multicenter, controlled
748148|NCT00445861|adenocarcinoma of the esophagus|adenocarcinoma of the esophagus
748149|NCT00445861|squamous cell carcinoma of the esophagus|squamous cell carcinoma of the esophagus
748150|NCT00445861|stage II esophageal cancer|stage ii esophageal cancer
748151|NCT00445861|stage III esophageal cancer|stage iii esophageal cancer
748152|NCT00445848|stage IIIB non-small cell lung cancer|stage iiib non-small cell lung cancer
748153|NCT00445848|stage IV non-small cell lung cancer|stage iv non-small cell lung cancer
748154|NCT00445848|adenocarcinoma of the lung|adenocarcinoma of the lung
748155|NCT00445835|coronary artery disease|coronary artery disease
748156|NCT00445835|myocardial infarction|myocardial infarction
748157|NCT00445835|atherothrombosis|atherothrombosis
748158|NCT00445835|atherosclerosis|atherosclerosis
748159|NCT00445822|CML|cml
748160|NCT00445822|Children|children
748161|NCT00445822|Imatinib|imatinib
748162|NCT00445822|bcr-abl|bcr-abl
748163|NCT00445822|Response|response
748164|NCT00445822|Imatinib mesylate|imatinib mesylate
748165|NCT00445809|Kidney|kidney
748166|NCT00445809|Renal|renal
748167|NCT00445809|Cardiac Surgery with bypass|cardiac surgery with bypass
748168|NCT00445809|Cardiovascular surgery with cardiopulmonary bypass|cardiovascular surgery with cardiopulmonary bypass
748169|NCT00445783|lentigo maligna malignant melanoma|lentigo maligna malignant melanoma
748170|NCT00445783|stage IV melanoma|stage iv melanoma
748171|NCT00445783|acral lentiginous malignant melanoma|acral lentiginous malignant melanoma
748172|NCT00445783|nodular malignant melanoma|nodular malignant melanoma
748173|NCT00445783|stage IA melanoma|stage ia melanoma
748174|NCT00445783|stage IB melanoma|stage ib melanoma
748175|NCT00445783|stage IIA melanoma|stage iia melanoma
748176|NCT00445783|stage IIB melanoma|stage iib melanoma
748177|NCT00445783|stage IIC melanoma|stage iic melanoma
748178|NCT00445783|stage IIIA melanoma|stage iiia melanoma
748179|NCT00445783|stage IIIB melanoma|stage iiib melanoma
748180|NCT00445783|stage IIIC melanoma|stage iiic melanoma
748181|NCT00445770|Rheumatoid Arthritis|rheumatoid arthritis
748182|NCT00445770|Arthritis|arthritis
748183|NCT00445757|stage I renal cell cancer|stage i renal cell cancer
748184|NCT00445757|stage II renal cell cancer|stage ii renal cell cancer
748185|NCT00445731|poor performance status|poor performance status
748186|NCT00445731|unspecified adult solid tumor, protocol specific|unspecified adult solid tumor, protocol specific
748187|NCT00445731|adult acute myeloid leukemia with 11q23 (MLL) abnormalities|adult acute myeloid leukemia with 11q23 (mll) abnormalities
748188|NCT00445731|adult acute myeloid leukemia with inv(16)(p13;q22)|adult acute myeloid leukemia with inv(16)(p13;q22)
748189|NCT00445731|adult acute myeloid leukemia with t(15;17)(q22;q12)|adult acute myeloid leukemia with t(15;17)(q22;q12)
748190|NCT00445731|adult acute myeloid leukemia with t(16;16)(p13;q22)|adult acute myeloid leukemia with t(16;16)(p13;q22)
748191|NCT00445731|adult acute myeloid leukemia with t(8;21)(q22;q22)|adult acute myeloid leukemia with t(8;21)(q22;q22)
748192|NCT00445731|accelerated phase chronic myelogenous leukemia|accelerated phase chronic myelogenous leukemia
748193|NCT00445731|adult acute lymphoblastic leukemia in remission|adult acute lymphoblastic leukemia in remission
748194|NCT00445731|adult acute myeloid leukemia in remission|adult acute myeloid leukemia in remission
748195|NCT00445731|atypical chronic myeloid leukemia|atypical chronic myeloid leukemia
748196|NCT00445731|blastic phase chronic myelogenous leukemia|blastic phase chronic myelogenous leukemia
748197|NCT00445731|chronic eosinophilic leukemia|chronic eosinophilic leukemia
748198|NCT00445731|chronic idiopathic myelofibrosis|chronic idiopathic myelofibrosis
748199|NCT00445731|chronic myelomonocytic leukemia|chronic myelomonocytic leukemia
748200|NCT00445731|chronic neutrophilic leukemia|chronic neutrophilic leukemia
748201|NCT00445731|chronic phase chronic myelogenous leukemia|chronic phase chronic myelogenous leukemia
748202|NCT00445731|de novo myelodysplastic syndromes|de novo myelodysplastic syndromes
748203|NCT00445731|disseminated neuroblastoma|disseminated neuroblastoma
748204|NCT00445731|extranodal marginal zone B-cell lymphoma of mucosa-associated lymphoid tissue|extranodal marginal zone b-cell lymphoma of mucosa-associated lymphoid tissue
748205|NCT00445731|myelodysplastic/myeloproliferative disease, unclassifiable|myelodysplastic/myeloproliferative disease, unclassifiable
748206|NCT00445731|nodal marginal zone B-cell lymphoma|nodal marginal zone b-cell lymphoma
748207|NCT00445731|noncontiguous stage II adult Burkitt lymphoma|noncontiguous stage ii adult burkitt lymphoma
748208|NCT00445731|noncontiguous stage II adult diffuse large cell lymphoma|noncontiguous stage ii adult diffuse large cell lymphoma
748209|NCT00445731|noncontiguous stage II adult diffuse mixed cell lymphoma|noncontiguous stage ii adult diffuse mixed cell lymphoma
748210|NCT00445731|noncontiguous stage II adult diffuse small cleaved cell lymphoma|noncontiguous stage ii adult diffuse small cleaved cell lymphoma
748211|NCT00445731|noncontiguous stage II adult immunoblastic large cell lymphoma|noncontiguous stage ii adult immunoblastic large cell lymphoma
748212|NCT00445731|noncontiguous stage II adult lymphoblastic lymphoma|noncontiguous stage ii adult lymphoblastic lymphoma
748213|NCT00445731|noncontiguous stage II grade 1 follicular lymphoma|noncontiguous stage ii grade 1 follicular lymphoma
748214|NCT00445731|noncontiguous stage II grade 2 follicular lymphoma|noncontiguous stage ii grade 2 follicular lymphoma
748215|NCT00445731|noncontiguous stage II grade 3 follicular lymphoma|noncontiguous stage ii grade 3 follicular lymphoma
748216|NCT00445731|noncontiguous stage II mantle cell lymphoma|noncontiguous stage ii mantle cell lymphoma
748217|NCT00445731|noncontiguous stage II marginal zone lymphoma|noncontiguous stage ii marginal zone lymphoma
748218|NCT00445731|noncontiguous stage II small lymphocytic lymphoma|noncontiguous stage ii small lymphocytic lymphoma
748219|NCT00445731|poor prognosis metastatic gestational trophoblastic tumor|poor prognosis metastatic gestational trophoblastic tumor
748220|NCT00445731|previously treated myelodysplastic syndromes|previously treated myelodysplastic syndromes
748221|NCT00445731|recurrent adult acute lymphoblastic leukemia|recurrent adult acute lymphoblastic leukemia
748222|NCT00445731|recurrent adult acute myeloid leukemia|recurrent adult acute myeloid leukemia
748223|NCT00445731|recurrent adult Burkitt lymphoma|recurrent adult burkitt lymphoma
748224|NCT00445731|recurrent adult Hodgkin lymphoma|recurrent adult hodgkin lymphoma
748225|NCT00445731|recurrent adult diffuse large cell lymphoma|recurrent adult diffuse large cell lymphoma
748226|NCT00445731|recurrent adult diffuse mixed cell lymphoma|recurrent adult diffuse mixed cell lymphoma
748227|NCT00445731|recurrent adult diffuse small cleaved cell lymphoma|recurrent adult diffuse small cleaved cell lymphoma
748228|NCT00445731|recurrent adult immunoblastic large cell lymphoma|recurrent adult immunoblastic large cell lymphoma
748229|NCT00445731|recurrent adult lymphoblastic lymphoma|recurrent adult lymphoblastic lymphoma
748230|NCT00445731|recurrent breast cancer|recurrent breast cancer
748549|NCT00445081|SCORAD|scorad
748231|NCT00445731|recurrent cutaneous T-cell non-Hodgkin lymphoma|recurrent cutaneous t-cell non-hodgkin lymphoma
748232|NCT00445731|recurrent grade 1 follicular lymphoma|recurrent grade 1 follicular lymphoma
748233|NCT00445731|recurrent grade 2 follicular lymphoma|recurrent grade 2 follicular lymphoma
748234|NCT00445731|recurrent grade 3 follicular lymphoma|recurrent grade 3 follicular lymphoma
748235|NCT00445731|recurrent mantle cell lymphoma|recurrent mantle cell lymphoma
748236|NCT00445731|recurrent marginal zone lymphoma|recurrent marginal zone lymphoma
748237|NCT00445731|recurrent mycosis fungoides/Sezary syndrome|recurrent mycosis fungoides/sezary syndrome
748238|NCT00445731|recurrent neuroblastoma|recurrent neuroblastoma
748239|NCT00445731|recurrent ovarian epithelial cancer|recurrent ovarian epithelial cancer
748240|NCT00445731|recurrent ovarian germ cell tumor|recurrent ovarian germ cell tumor
748241|NCT00445731|recurrent small lymphocytic lymphoma|recurrent small lymphocytic lymphoma
748242|NCT00445731|recurrent malignant testicular germ cell tumor|recurrent malignant testicular germ cell tumor
748243|NCT00445731|refractory chronic lymphocytic leukemia|refractory chronic lymphocytic leukemia
748244|NCT00445731|refractory hairy cell leukemia|refractory hairy cell leukemia
748245|NCT00445731|refractory multiple myeloma|refractory multiple myeloma
748246|NCT00445731|relapsing chronic myelogenous leukemia|relapsing chronic myelogenous leukemia
748247|NCT00445731|secondary acute myeloid leukemia|secondary acute myeloid leukemia
748248|NCT00445731|secondary myelodysplastic syndromes|secondary myelodysplastic syndromes
748249|NCT00445731|splenic marginal zone lymphoma|splenic marginal zone lymphoma
748250|NCT00445731|stage I multiple myeloma|stage i multiple myeloma
748251|NCT00445731|stage II multiple myeloma|stage ii multiple myeloma
748252|NCT00445731|stage II ovarian epithelial cancer|stage ii ovarian epithelial cancer
748253|NCT00445731|stage III adult Burkitt lymphoma|stage iii adult burkitt lymphoma
748254|NCT00445731|stage III adult Hodgkin lymphoma|stage iii adult hodgkin lymphoma
748255|NCT00445731|stage III adult diffuse large cell lymphoma|stage iii adult diffuse large cell lymphoma
748256|NCT00445731|stage III adult diffuse mixed cell lymphoma|stage iii adult diffuse mixed cell lymphoma
748257|NCT00445731|stage III adult diffuse small cleaved cell lymphoma|stage iii adult diffuse small cleaved cell lymphoma
748258|NCT00445731|stage III adult immunoblastic large cell lymphoma|stage iii adult immunoblastic large cell lymphoma
748259|NCT00445731|stage III adult lymphoblastic lymphoma|stage iii adult lymphoblastic lymphoma
748260|NCT00445731|stage III chronic lymphocytic leukemia|stage iii chronic lymphocytic leukemia
748261|NCT00445731|stage III grade 1 follicular lymphoma|stage iii grade 1 follicular lymphoma
748262|NCT00445731|stage III grade 2 follicular lymphoma|stage iii grade 2 follicular lymphoma
748263|NCT00445731|stage III grade 3 follicular lymphoma|stage iii grade 3 follicular lymphoma
748264|NCT00445731|stage III mantle cell lymphoma|stage iii mantle cell lymphoma
748265|NCT00445731|stage III marginal zone lymphoma|stage iii marginal zone lymphoma
748266|NCT00445731|stage III multiple myeloma|stage iii multiple myeloma
748267|NCT00445731|stage III ovarian epithelial cancer|stage iii ovarian epithelial cancer
748268|NCT00445731|stage III small lymphocytic lymphoma|stage iii small lymphocytic lymphoma
748269|NCT00445731|stage III malignant testicular germ cell tumor|stage iii malignant testicular germ cell tumor
748270|NCT00445731|stage IIIA breast cancer|stage iiia breast cancer
748271|NCT00445731|stage IIIB breast cancer|stage iiib breast cancer
748272|NCT00445731|stage IIIC breast cancer|stage iiic breast cancer
748273|NCT00445731|stage IV adult Burkitt lymphoma|stage iv adult burkitt lymphoma
748274|NCT00445731|stage IV adult Hodgkin lymphoma|stage iv adult hodgkin lymphoma
748275|NCT00445731|stage IV adult diffuse large cell lymphoma|stage iv adult diffuse large cell lymphoma
748276|NCT00445731|stage IV adult diffuse mixed cell lymphoma|stage iv adult diffuse mixed cell lymphoma
748277|NCT00445731|stage IV adult diffuse small cleaved cell lymphoma|stage iv adult diffuse small cleaved cell lymphoma
748278|NCT00445731|stage IV adult immunoblastic large cell lymphoma|stage iv adult immunoblastic large cell lymphoma
748279|NCT00445731|stage IV adult lymphoblastic lymphoma|stage iv adult lymphoblastic lymphoma
748280|NCT00445731|stage IV breast cancer|stage iv breast cancer
748281|NCT00445731|stage IV chronic lymphocytic leukemia|stage iv chronic lymphocytic leukemia
748282|NCT00445731|stage IV grade 1 follicular lymphoma|stage iv grade 1 follicular lymphoma
748283|NCT00445731|stage IV grade 2 follicular lymphoma|stage iv grade 2 follicular lymphoma
748284|NCT00445731|stage IV grade 3 follicular lymphoma|stage iv grade 3 follicular lymphoma
748285|NCT00445731|stage IV mantle cell lymphoma|stage iv mantle cell lymphoma
748286|NCT00445731|stage IV marginal zone lymphoma|stage iv marginal zone lymphoma
748287|NCT00445731|stage IV ovarian epithelial cancer|stage iv ovarian epithelial cancer
748288|NCT00445731|stage IV small lymphocytic lymphoma|stage iv small lymphocytic lymphoma
748289|NCT00445679|major depressive disorder|major depressive disorder
748291|NCT00445679|depression|depression
748292|NCT00445653|Barrett esophagus|barrett esophagus
748293|NCT00445627|Type 2 Diabetes|type 2 diabetes
748294|NCT00445627|Obesity|obesity
748295|NCT00445627|Overweight|overweight
748296|NCT00445614|nutrition|nutrition
748297|NCT00445614|cardiovascular risk|cardiovascular risk
748298|NCT00445614|inflammation|inflammation
748299|NCT00445614|vascular function|vascular function
748300|NCT00445601|transitional cell carcinoma of the bladder|transitional cell carcinoma of the bladder
748301|NCT00445601|stage 0 bladder cancer|stage 0 bladder cancer
748302|NCT00445601|stage I bladder cancer|stage i bladder cancer
748303|NCT00445601|recurrent bladder cancer|recurrent bladder cancer
748304|NCT00445575|fibrous dysplasia of bone|fibrous dysplasia of bone
748305|NCT00445575|Mac Cune Albright syndrome|mac cune albright syndrome
748306|NCT00445575|bisphosphonates|bisphosphonates
748307|NCT00445575|risedronate|risedronate
748308|NCT00445562|male breast cancer|male breast cancer
748309|NCT00445562|recurrent breast cancer|recurrent breast cancer
748311|NCT00445562|stage IB breast cancer|stage ib breast cancer
748312|NCT00445562|stage II breast cancer|stage ii breast cancer
748313|NCT00445562|stage IIIA breast cancer|stage iiia breast cancer
748314|NCT00445562|stage IIIB breast cancer|stage iiib breast cancer
748315|NCT00445562|stage IIIC breast cancer|stage iiic breast cancer
748316|NCT00445562|stage IV breast cancer|stage iv breast cancer
748317|NCT00445549|Ovarian|ovarian
748318|NCT00445549|VEGFR2|vegfr2
748319|NCT00445549|EGFR|egfr
748320|NCT00445549|Angiogenesis|angiogenesis
748321|NCT00445549|Tyrosine Kinase|tyrosine kinase
748322|NCT00445549|Protein Phosphorylation|protein phosphorylation
748323|NCT00445549|Vandetanib|vandetanib
748324|NCT00445549|Ovarian Cancer|ovarian cancer
748325|NCT00445549|Fallopian Tube Cancer|fallopian tube cancer
748326|NCT00445549|Peritoneal Cancer|peritoneal cancer
748327|NCT00445523|Advanced renal cancer|advanced renal cancer
748328|NCT00445523|metastatic renal cancer|metastatic renal cancer
748329|NCT00445523|RCC|rcc
748330|NCT00445523|kidney cancer|kidney cancer
748331|NCT00445523|M3thodist|m3thodist
748332|NCT00445510|GSK256066,|gsk256066,
748333|NCT00445510|allergen,|allergen,
748334|NCT00445510|challenge,|challenge,
748335|NCT00445510|repeat dose,|repeat dose,
748336|NCT00445510|AMP,|amp,
748337|NCT00445510|mild asthmatics|mild asthmatics
748338|NCT00445497|psychosocial effects of cancer and its treatment|psychosocial effects of cancer and its treatment
748339|NCT00445497|anaplastic large cell lymphoma|anaplastic large cell lymphoma
748340|NCT00445497|angioimmunoblastic T-cell lymphoma|angioimmunoblastic t-cell lymphoma
748341|NCT00445497|extranodal marginal zone B-cell lymphoma of mucosa-associated lymphoid tissue|extranodal marginal zone b-cell lymphoma of mucosa-associated lymphoid tissue
748342|NCT00445497|intraocular lymphoma|intraocular lymphoma
748343|NCT00445497|nodal marginal zone B-cell lymphoma|nodal marginal zone b-cell lymphoma
748344|NCT00445497|primary central nervous system non-Hodgkin lymphoma|primary central nervous system non-hodgkin lymphoma
748345|NCT00445497|primary central nervous system Hodgkin lymphoma|primary central nervous system hodgkin lymphoma
748346|NCT00445497|recurrent adult Burkitt lymphoma|recurrent adult burkitt lymphoma
748347|NCT00445497|recurrent adult diffuse large cell lymphoma|recurrent adult diffuse large cell lymphoma
748348|NCT00445497|recurrent adult diffuse mixed cell lymphoma|recurrent adult diffuse mixed cell lymphoma
748349|NCT00445497|recurrent adult diffuse small cleaved cell lymphoma|recurrent adult diffuse small cleaved cell lymphoma
748350|NCT00445497|recurrent adult Hodgkin lymphoma|recurrent adult hodgkin lymphoma
748351|NCT00445497|recurrent adult immunoblastic large cell lymphoma|recurrent adult immunoblastic large cell lymphoma
748352|NCT00445497|recurrent adult lymphoblastic lymphoma|recurrent adult lymphoblastic lymphoma
748353|NCT00445497|recurrent cutaneous T-cell non-Hodgkin lymphoma|recurrent cutaneous t-cell non-hodgkin lymphoma
748354|NCT00445497|recurrent grade 1 follicular lymphoma|recurrent grade 1 follicular lymphoma
748355|NCT00445497|recurrent grade 2 follicular lymphoma|recurrent grade 2 follicular lymphoma
748356|NCT00445497|recurrent grade 3 follicular lymphoma|recurrent grade 3 follicular lymphoma
748357|NCT00445497|recurrent mantle cell lymphoma|recurrent mantle cell lymphoma
748358|NCT00445497|recurrent marginal zone lymphoma|recurrent marginal zone lymphoma
748359|NCT00445497|recurrent mycosis fungoides/Sezary syndrome|recurrent mycosis fungoides/sezary syndrome
748360|NCT00445497|recurrent small lymphocytic lymphoma|recurrent small lymphocytic lymphoma
748361|NCT00445497|small intestine lymphoma|small intestine lymphoma
748362|NCT00445497|splenic marginal zone lymphoma|splenic marginal zone lymphoma
748363|NCT00445497|stage III adult Burkitt lymphoma|stage iii adult burkitt lymphoma
748364|NCT00445497|stage III adult diffuse large cell lymphoma|stage iii adult diffuse large cell lymphoma
750246|NCT00439946|PAH|pah
748365|NCT00445497|stage III adult diffuse mixed cell lymphoma|stage iii adult diffuse mixed cell lymphoma
748366|NCT00445497|stage III adult diffuse small cleaved cell lymphoma|stage iii adult diffuse small cleaved cell lymphoma
748367|NCT00445497|stage III adult Hodgkin lymphoma|stage iii adult hodgkin lymphoma
748368|NCT00445497|stage III adult immunoblastic large cell lymphoma|stage iii adult immunoblastic large cell lymphoma
748369|NCT00445497|stage III adult lymphoblastic lymphoma|stage iii adult lymphoblastic lymphoma
748370|NCT00445497|stage III adult T-cell leukemia/lymphoma|stage iii adult t-cell leukemia/lymphoma
748371|NCT00445497|stage III cutaneous T-cell non-Hodgkin lymphoma|stage iii cutaneous t-cell non-hodgkin lymphoma
748372|NCT00445497|stage III grade 1 follicular lymphoma|stage iii grade 1 follicular lymphoma
748373|NCT00445497|stage III grade 2 follicular lymphoma|stage iii grade 2 follicular lymphoma
748374|NCT00445497|stage III grade 3 follicular lymphoma|stage iii grade 3 follicular lymphoma
748375|NCT00445497|stage III mantle cell lymphoma|stage iii mantle cell lymphoma
748376|NCT00445497|stage III marginal zone lymphoma|stage iii marginal zone lymphoma
748377|NCT00445497|stage III mycosis fungoides/Sezary syndrome|stage iii mycosis fungoides/sezary syndrome
748378|NCT00445497|stage III small lymphocytic lymphoma|stage iii small lymphocytic lymphoma
748379|NCT00445497|stage IV adult Burkitt lymphoma|stage iv adult burkitt lymphoma
748380|NCT00445497|stage IV adult diffuse large cell lymphoma|stage iv adult diffuse large cell lymphoma
748381|NCT00445497|stage IV adult diffuse mixed cell lymphoma|stage iv adult diffuse mixed cell lymphoma
748382|NCT00445497|stage IV adult diffuse small cleaved cell lymphoma|stage iv adult diffuse small cleaved cell lymphoma
748383|NCT00445497|stage IV adult Hodgkin lymphoma|stage iv adult hodgkin lymphoma
748384|NCT00445497|stage IV adult immunoblastic large cell lymphoma|stage iv adult immunoblastic large cell lymphoma
748385|NCT00445497|stage IV adult lymphoblastic lymphoma|stage iv adult lymphoblastic lymphoma
748386|NCT00445497|stage IV adult T-cell leukemia/lymphoma|stage iv adult t-cell leukemia/lymphoma
748387|NCT00445497|stage IV cutaneous T-cell non-Hodgkin lymphoma|stage iv cutaneous t-cell non-hodgkin lymphoma
748388|NCT00445497|stage IV grade 1 follicular lymphoma|stage iv grade 1 follicular lymphoma
748389|NCT00445497|stage IV grade 2 follicular lymphoma|stage iv grade 2 follicular lymphoma
748390|NCT00445497|stage IV grade 3 follicular lymphoma|stage iv grade 3 follicular lymphoma
748391|NCT00445497|stage IV mantle cell lymphoma|stage iv mantle cell lymphoma
748392|NCT00445497|stage IV marginal zone lymphoma|stage iv marginal zone lymphoma
748393|NCT00445497|stage IV mycosis fungoides/Sezary syndrome|stage iv mycosis fungoides/sezary syndrome
748394|NCT00445497|stage IV small lymphocytic lymphoma|stage iv small lymphocytic lymphoma
748395|NCT00445497|Waldenström macroglobulinemia|waldenström macroglobulinemia
748396|NCT00445497|unspecified adult solid tumor, protocol specific|unspecified adult solid tumor, protocol specific
748397|NCT00445497|neutropenia|neutropenia
748398|NCT00445497|stage I adult Burkitt lymphoma|stage i adult burkitt lymphoma
748399|NCT00445497|stage I adult diffuse large cell lymphoma|stage i adult diffuse large cell lymphoma
748400|NCT00445497|stage I adult diffuse mixed cell lymphoma|stage i adult diffuse mixed cell lymphoma
748401|NCT00445497|stage I adult diffuse small cleaved cell lymphoma|stage i adult diffuse small cleaved cell lymphoma
748402|NCT00445497|stage I adult Hodgkin lymphoma|stage i adult hodgkin lymphoma
748403|NCT00445497|stage I adult immunoblastic large cell lymphoma|stage i adult immunoblastic large cell lymphoma
748404|NCT00445497|stage I adult lymphoblastic lymphoma|stage i adult lymphoblastic lymphoma
748405|NCT00445497|stage II adult Hodgkin lymphoma|stage ii adult hodgkin lymphoma
748406|NCT00445497|stage I mycosis fungoides/Sezary syndrome|stage i mycosis fungoides/sezary syndrome
748407|NCT00445497|stage II mycosis fungoides/Sezary syndrome|stage ii mycosis fungoides/sezary syndrome
748408|NCT00445497|stage I cutaneous T-cell non-Hodgkin lymphoma|stage i cutaneous t-cell non-hodgkin lymphoma
748409|NCT00445497|stage II cutaneous T-cell non-Hodgkin lymphoma|stage ii cutaneous t-cell non-hodgkin lymphoma
748410|NCT00445497|contiguous stage II adult Burkitt lymphoma|contiguous stage ii adult burkitt lymphoma
748411|NCT00445497|contiguous stage II adult diffuse large cell lymphoma|contiguous stage ii adult diffuse large cell lymphoma
748412|NCT00445497|contiguous stage II adult diffuse mixed cell lymphoma|contiguous stage ii adult diffuse mixed cell lymphoma
748413|NCT00445497|contiguous stage II adult diffuse small cleaved cell lymphoma|contiguous stage ii adult diffuse small cleaved cell lymphoma
748414|NCT00445497|contiguous stage II adult immunoblastic large cell lymphoma|contiguous stage ii adult immunoblastic large cell lymphoma
748415|NCT00445497|contiguous stage II adult lymphoblastic lymphoma|contiguous stage ii adult lymphoblastic lymphoma
748416|NCT00445497|contiguous stage II grade 1 follicular lymphoma|contiguous stage ii grade 1 follicular lymphoma
748417|NCT00445497|contiguous stage II grade 2 follicular lymphoma|contiguous stage ii grade 2 follicular lymphoma
748418|NCT00445497|contiguous stage II grade 3 follicular lymphoma|contiguous stage ii grade 3 follicular lymphoma
748419|NCT00445497|contiguous stage II mantle cell lymphoma|contiguous stage ii mantle cell lymphoma
748420|NCT00445497|contiguous stage II marginal zone lymphoma|contiguous stage ii marginal zone lymphoma
748421|NCT00445497|contiguous stage II small lymphocytic lymphoma|contiguous stage ii small lymphocytic lymphoma
748422|NCT00445497|noncontiguous stage II adult Burkitt lymphoma|noncontiguous stage ii adult burkitt lymphoma
748423|NCT00445497|noncontiguous stage II adult diffuse large cell lymphoma|noncontiguous stage ii adult diffuse large cell lymphoma
748424|NCT00445497|noncontiguous stage II adult diffuse mixed cell lymphoma|noncontiguous stage ii adult diffuse mixed cell lymphoma
748425|NCT00445497|noncontiguous stage II adult diffuse small cleaved cell lymphoma|noncontiguous stage ii adult diffuse small cleaved cell lymphoma
748516|NCT00445224|Rehabilitation|rehabilitation
748426|NCT00445497|noncontiguous stage II adult immunoblastic large cell lymphoma|noncontiguous stage ii adult immunoblastic large cell lymphoma
748427|NCT00445497|noncontiguous stage II adult lymphoblastic lymphoma|noncontiguous stage ii adult lymphoblastic lymphoma
748428|NCT00445497|noncontiguous stage II grade 1 follicular lymphoma|noncontiguous stage ii grade 1 follicular lymphoma
748429|NCT00445497|noncontiguous stage II grade 2 follicular lymphoma|noncontiguous stage ii grade 2 follicular lymphoma
748430|NCT00445497|noncontiguous stage II grade 3 follicular lymphoma|noncontiguous stage ii grade 3 follicular lymphoma
748431|NCT00445497|noncontiguous stage II mantle cell lymphoma|noncontiguous stage ii mantle cell lymphoma
748432|NCT00445497|noncontiguous stage II marginal zone lymphoma|noncontiguous stage ii marginal zone lymphoma
748433|NCT00445497|noncontiguous stage II small lymphocytic lymphoma|noncontiguous stage ii small lymphocytic lymphoma
748434|NCT00445497|recurrent adult T-cell leukemia/lymphoma|recurrent adult t-cell leukemia/lymphoma
748435|NCT00445497|stage I adult T-cell leukemia/lymphoma|stage i adult t-cell leukemia/lymphoma
748436|NCT00445497|stage II adult T-cell leukemia/lymphoma|stage ii adult t-cell leukemia/lymphoma
748437|NCT00445497|adult grade III lymphomatoid granulomatosis|adult grade iii lymphomatoid granulomatosis
748438|NCT00445497|recurrent adult grade III lymphomatoid granulomatosis|recurrent adult grade iii lymphomatoid granulomatosis
748439|NCT00445497|adult nasal type extranodal NK/T-cell lymphoma|adult nasal type extranodal nk/t-cell lymphoma
748440|NCT00445484|stage II multiple myeloma|stage ii multiple myeloma
748441|NCT00445484|stage III multiple myeloma|stage iii multiple myeloma
748442|NCT00445484|refractory multiple myeloma|refractory multiple myeloma
748443|NCT00445471|Autism Spectrum Disorder|autism spectrum disorder
748444|NCT00445471|Autistic Disorder|autistic disorder
748445|NCT00445471|Pervasive Developmental Disorder|pervasive developmental disorder
748446|NCT00445458|cancer|cancer
748449|NCT00445458|paclitaxel|paclitaxel
748450|NCT00445458|Taxol|taxol
748451|NCT00445458|breast cancer|breast cancer
748452|NCT00445458|Nerlynx|nerlynx
748453|NCT00445445|stage I breast cancer|stage i breast cancer
748454|NCT00445445|stage II breast cancer|stage ii breast cancer
748455|NCT00445445|stage IIIA breast cancer|stage iiia breast cancer
748456|NCT00445445|stage IIIB breast cancer|stage iiib breast cancer
748457|NCT00445445|stage IIIC breast cancer|stage iiic breast cancer
748458|NCT00445445|stage IV breast cancer|stage iv breast cancer
748459|NCT00445445|recurrent breast cancer|recurrent breast cancer
748460|NCT00445445|breast cancer in situ|breast cancer in situ
748461|NCT00445419|Hepatitis C|hepatitis c
748462|NCT00445419|Liver disease|liver disease
748463|NCT00445419|Viral infection|viral infection
748464|NCT00445419|Virosome|virosome
748465|NCT00445419|Vaccine|vaccine
748466|NCT00445419|therapeutic vaccine|therapeutic vaccine
748467|NCT00445419|Chronic hepatitis C virus infection|chronic hepatitis c virus infection
748468|NCT00445406|recurrent breast cancer|recurrent breast cancer
748469|NCT00445406|stage IV breast cancer|stage iv breast cancer
748470|NCT00445393|Observation|observation
748471|NCT00445393|Mental health|mental health
748472|NCT00445393|Scoliosis|scoliosis
748473|NCT00445393|Screening|screening
748474|NCT00445393|Adolescent idiopathic scoliosis|adolescent idiopathic scoliosis
748475|NCT00445367|Multiple Sclerosis|multiple sclerosis
748476|NCT00445367|Clinically Isolated Syndrome|clinically isolated syndrome
748477|NCT00445367|Transverse Myelitis|transverse myelitis
748478|NCT00445367|Neuromyelitis Optica|neuromyelitis optica
748479|NCT00445367|Acute Disseminated Encephalomyelitis|acute disseminated encephalomyelitis
748480|NCT00445367|Optic Neuritis|optic neuritis
748481|NCT00445367|Repository|repository
748482|NCT00445367|Biobank|biobank
748483|NCT00445354|cinnamon|cinnamon
748484|NCT00445354|diabetes|diabetes
748485|NCT00445354|hemoglobin a1c|hemoglobin a1c
748486|NCT00445341|Microarray|microarray
748487|NCT00445341|Proteomics|proteomics
748488|NCT00445341|Hybrid Schedule|hybrid schedule
748489|NCT00445341|Tumor Lysis Syndrome|tumor lysis syndrome
748490|NCT00445341|Cyclin D1|cyclin d1
748491|NCT00445341|Lymphoma|lymphoma
748492|NCT00445341|Mantle Cell Lymphoma|mantle cell lymphoma
748494|NCT00445341|Diffuse Large B-Cell Lymphoma|diffuse large b-cell lymphoma
748495|NCT00445341|DLBCL|dlbcl
748496|NCT00445328|hospitalised acutely medically ill patients; Venous Thromboembolism, Infection, Inflammatory Bowel Diseases, Heart Failure, Congestive, Sciatica|hospitalised acutely medically ill patients; venous thromboembolism, infection, inflammatory bowel diseases, heart failure, congestive, sciatica
748497|NCT00445302|AMD3100|amd3100
748498|NCT00445289|mechanical ventilation|mechanical ventilation
748499|NCT00445289|ventilator weaning|ventilator weaning
748500|NCT00445289|closed-loop|closed-loop
748501|NCT00445289|ventilation time|ventilation time
748502|NCT00445276|Osteoarthritis|osteoarthritis
748503|NCT00445276|Knee|knee
748504|NCT00445276|Diacerein|diacerein
748505|NCT00445276|Painful osteoarthritis|painful osteoarthritis
748506|NCT00445276|Clinical trial|clinical trial
748507|NCT00445263|CORONARY DISEASE|coronary disease
748508|NCT00445250|Calcipotriol|calcipotriol
748509|NCT00445250|Breast|breast
748510|NCT00445250|Cancer|cancer
748511|NCT00445250|Radiotherapy|radiotherapy
748512|NCT00445250|Radiodermatitis in Breast Cancer|radiodermatitis in breast cancer
748513|NCT00445237|major depression|major depression
748515|NCT00445224|Knee pain|knee pain
748517|NCT00445211|Intraaortic balloon pumping|intraaortic balloon pumping
748518|NCT00445211|Heparin|heparin
748519|NCT00445211|Limb ischemia|limb ischemia
748520|NCT00445211|Bleeding|bleeding
748521|NCT00445198|SCLC|sclc
748522|NCT00445185|Dialysis|dialysis
748523|NCT00445185|Pre-dialysis|pre-dialysis
748524|NCT00445185|Hepatitis B vaccine|hepatitis b vaccine
748525|NCT00445185|vaccine|vaccine
748526|NCT00445172|Amyotrophic Lateral Sclerosis|amyotrophic lateral sclerosis
748527|NCT00445172|Motor Neurons|motor neurons
748528|NCT00445172|Muscular Atrophy|muscular atrophy
748529|NCT00445159|UT-15C SR, Peripheral Vascular Disease, treprostinil|ut-15c sr, peripheral vascular disease, treprostinil
748530|NCT00445146|Phase 2|phase 2
748531|NCT00445146|Open-label|open-label
748532|NCT00445146|Rollover|rollover
748533|NCT00445146|Integrase Inhibitor|integrase inhibitor
748534|NCT00445146|Antiretroviral Agents|antiretroviral agents
748535|NCT00445146|Highly Active Antiretroviral Activity|highly active antiretroviral activity
748536|NCT00445146|HAART|haart
748537|NCT00445146|HIV, HIV-1, AIDS virus, Human Immunodeficiency Virus|hiv, hiv-1, aids virus, human immunodeficiency virus
748538|NCT00445146|Acquired Immune Deficiency Syndrome Virus|acquired immune deficiency syndrome virus
748539|NCT00445146|treatment experienced|treatment experienced
748540|NCT00445133|Neck Pain/Lumbar pain/Magnets/sleep deficiency/ insomnia/|neck pain/lumbar pain/magnets/sleep deficiency/ insomnia/
748541|NCT00445120|Vernal keratoconjunctivitis|vernal keratoconjunctivitis
748542|NCT00445120|probiotic|probiotic
748543|NCT00445120|Lactobacillus Rhamnosus GG|lactobacillus rhamnosus gg
748544|NCT00445120|Children|children
748545|NCT00445120|Clinical trial|clinical trial
748546|NCT00445081|atopic dermatitis|atopic dermatitis
748547|NCT00445081|prednisolone|prednisolone
748550|NCT00445081|DLQI|dlqi
748551|NCT00445081|QALY|qaly
748553|NCT00445068|Multiple myeloma|multiple myeloma
748554|NCT00445068|adults|adults
748555|NCT00445068|LBH589|lbh589
748556|NCT00445068|refractory|refractory
748557|NCT00445055|Thyroidectomy|thyroidectomy
748558|NCT00445055|Nausea|nausea
748559|NCT00445055|Vomiting|vomiting
748560|NCT00445055|Droperidol|droperidol
748561|NCT00445042|Metastatic Renal Cell Carcinoma|metastatic renal cell carcinoma
748562|NCT00445042|Metastatic RCC|metastatic rcc
748563|NCT00445042|Kidney Cancer|kidney cancer
748564|NCT00445042|M3thodist|m3thodist
748565|NCT00445029|Allergic contact dermatitis|allergic contact dermatitis
748566|NCT00445029|para-phenylenediamine|para-phenylenediamine
748567|NCT00445029|effector cells|effector cells
748568|NCT00445029|regulatory cells|regulatory cells
748569|NCT00445029|pathophysiology|pathophysiology
748570|NCT00445016|peripheral regional anesthesia|peripheral regional anesthesia
748571|NCT00445016|nerve damage|nerve damage
748572|NCT00445016|adverse effects|adverse effects
748573|NCT00445016|neurologic complication|neurologic complication
748574|NCT00445016|neuropathy|neuropathy
748575|NCT00445003|Diabetic Retinopathy|diabetic retinopathy
748576|NCT00445003|Diabetic Macular Edema|diabetic macular edema
748577|NCT00445003|Lucentis|lucentis
748578|NCT00445003|Ranibizumab|ranibizumab
748579|NCT00445003|Triamcinolone|triamcinolone
748580|NCT00445003|Panretinal Photocoagulation|panretinal photocoagulation
748581|NCT00445003|Combination Therapy|combination therapy
748582|NCT00445003|pdr|pdr
748583|NCT00444990|Lumbar pain|lumbar pain
748584|NCT00444990|magnets|magnets
748585|NCT00444990|Reduce low back pain|reduce low back pain
748586|NCT00444977|HIV positive persons|hiv positive persons
748587|NCT00444977|Not received oral health care in the preceding 12 months.|not received oral health care in the preceding 12 months.
748588|NCT00444977|treatment naive|treatment naive
748589|NCT00444977|treatment experienced|treatment experienced
748590|NCT00444951|N meningitidis|n meningitidis
748591|NCT00444912|AMD3100|amd3100
748592|NCT00444912|stem cell mobilization|stem cell mobilization
748593|NCT00444912|autologous transplant|autologous transplant
748594|NCT00444912|Non-Hodgkin Lymphoma|non-hodgkin lymphoma
748595|NCT00444912|Hodgkin Disease|hodgkin disease
748596|NCT00444899|Intensive treatment|intensive treatment
748597|NCT00444899|dietician|dietician
748598|NCT00444886|Thoracic Outlet Syndrome (TOS)|thoracic outlet syndrome (tos)
748599|NCT00444886|Botulinum Toxin|botulinum toxin
748600|NCT00444886|Botox|botox
748601|NCT00444886|Pain|pain
748602|NCT00444873|Inappropriate Growth Hormone Secretion Syndrome (Acromegaly)|inappropriate growth hormone secretion syndrome (acromegaly)
748603|NCT00444847|AIDS|aids
748604|NCT00444847|HIV|hiv
748605|NCT00444847|Hyperbaric Chamber|hyperbaric chamber
748606|NCT00444847|treatment experienced|treatment experienced
748607|NCT00444821|AAA|aaa
748608|NCT00444821|Aneurysm|aneurysm
748609|NCT00444821|AneuRx|aneurx
748610|NCT00444821|Talent|talent
748611|NCT00444808|Rib fracture|rib fracture
748612|NCT00444808|Pain|pain
748613|NCT00444808|intranasal calcitonin|intranasal calcitonin
748614|NCT00444795|SUTENE|sutene
748615|NCT00444795|post-marketing surveillance|post-marketing surveillance
748616|NCT00444795|GIST|gist
748617|NCT00444795|RCC|rcc
748618|NCT00444795|Korea|korea
748720|NCT00444379|HHV-8|hhv-8
748619|NCT00444782|Advanced Carcinoma, Hepatocellular|advanced carcinoma, hepatocellular
748620|NCT00444769|analgesia|analgesia
748621|NCT00444769|post-operative pain|post-operative pain
748622|NCT00444769|GW842166|gw842166
748623|NCT00444769|non-cannabinoid agonist|non-cannabinoid agonist
748624|NCT00444769|third molar tooth extraction|third molar tooth extraction
748625|NCT00444756|local anesthesia|local anesthesia
748626|NCT00444756|analgesia|analgesia
748627|NCT00444756|peripheral IV|peripheral iv
748628|NCT00444756|Local anesthesia prior to peripheral IV insertion|local anesthesia prior to peripheral iv insertion
748629|NCT00444730|Prostate Cancer|prostate cancer
748630|NCT00444730|Prostatectomy|prostatectomy
748631|NCT00444730|Pelvic pain|pelvic pain
748632|NCT00444730|urgency|urgency
748633|NCT00444730|incontinence|incontinence
748634|NCT00444730|frequency|frequency
748635|NCT00444717|statin|statin
748636|NCT00444717|metabolic syndrome|metabolic syndrome
748637|NCT00444717|oxidative stress|oxidative stress
748638|NCT00444717|inflammation|inflammation
748639|NCT00444691|synovitis score|synovitis score
748640|NCT00444691|sensitivity to change|sensitivity to change
748641|NCT00444691|clinical examination|clinical examination
748642|NCT00444691|ultra-sonography|ultra-sonography
748643|NCT00444678|Previously untreated metastatic colorectal cancer|previously untreated metastatic colorectal cancer
748644|NCT00444678|Metastatic Colorectal Cancer|metastatic colorectal cancer
748645|NCT00444678|combined therapy|combined therapy
748646|NCT00444678|biologics therapy|biologics therapy
748647|NCT00444678|antibody|antibody
748648|NCT00444678|chemotherapy|chemotherapy
748649|NCT00444678|EGFR|egfr
748650|NCT00444665|Glaucoma|glaucoma
748651|NCT00444652|Thromboprophylaxis|thromboprophylaxis
748652|NCT00444652|Bariatric surgery|bariatric surgery
748653|NCT00444652|prevention of venous thromboembolism in bariatric surgery|prevention of venous thromboembolism in bariatric surgery
748654|NCT00444626|nasolabial folds|nasolabial folds
748655|NCT00444626|facial wrinkles|facial wrinkles
748656|NCT00444613|Amyotrophic Lateral Sclerosis (ALS)|amyotrophic lateral sclerosis (als)
748657|NCT00444613|motor neurons|motor neurons
748658|NCT00444613|muscular atrophy|muscular atrophy
748659|NCT00444613|Lou Gehrig's Disease|lou gehrig's disease
748660|NCT00444600|Diabetic Retinopathy|diabetic retinopathy
748661|NCT00444600|Diabetic Macular Edema|diabetic macular edema
748662|NCT00444600|Lucentis|lucentis
748663|NCT00444600|Ranibizumab|ranibizumab
748664|NCT00444600|Triamcinolone|triamcinolone
748665|NCT00444600|Laser photocoagulation|laser photocoagulation
748666|NCT00444600|Combination Therapy|combination therapy
748667|NCT00444574|Attention Deficit Hyperactivity Disorder (ADHD)|attention deficit hyperactivity disorder (adhd)
748668|NCT00444561|pramlintide|pramlintide
748670|NCT00444561|Amylin|amylin
748671|NCT00444548|Equipment|equipment
748672|NCT00444548|Supplies|supplies
748673|NCT00444535|VEGF|vegf
748674|NCT00444535|Tyrosine kinase|tyrosine kinase
748675|NCT00444535|ErbB2|erbb2
748676|NCT00444535|Her2-neu|her2-neu
748677|NCT00444535|metastatic breast cancer|metastatic breast cancer
748678|NCT00444535|EGFR|egfr
748679|NCT00444535|ErbB1|erbb1
748680|NCT00444535|bevacizumab|bevacizumab
748681|NCT00444535|lapatinib|lapatinib
748682|NCT00444522|Panic attacks, Staccato® Alprazolam|panic attacks, staccato® alprazolam
748683|NCT00444509|Asthmatic Patients|asthmatic patients
748684|NCT00444470|tranexamic acid|tranexamic acid
748685|NCT00444470|safety|safety
748686|NCT00444470|efficacy|efficacy
748687|NCT00444470|spine surgery|spine surgery
748688|NCT00444470|spinal fusion and decompression|spinal fusion and decompression
748689|NCT00444470|adult|adult
748690|NCT00444470|perioperative|perioperative
748691|NCT00444470|blood loss|blood loss
748692|NCT00444470|bleeding|bleeding
748693|NCT00444470|blood transfusion|blood transfusion
748694|NCT00444457|Vaccine|vaccine
748695|NCT00444457|Infants|infants
748696|NCT00444457|Pneumococcal Conjugate Vaccines|pneumococcal conjugate vaccines
748697|NCT00444457|Vaccines, Pneumococcal|vaccines, pneumococcal
748698|NCT00444444|Autoimmune pancreatitis, HLA, relapse, Sequence-based typing|autoimmune pancreatitis, hla, relapse, sequence-based typing
748699|NCT00444418|Drinking|drinking
748700|NCT00444418|Alcohol problems|alcohol problems
748701|NCT00444418|Alcoholism|alcoholism
748702|NCT00444418|Gay men|gay men
748703|NCT00444418|Bisexual men|bisexual men
748704|NCT00444418|Moderation-oriented treatment|moderation-oriented treatment
748705|NCT00444418|Controlled drinking|controlled drinking
748706|NCT00444418|Non-abstinence based treatment|non-abstinence based treatment
748707|NCT00444405|lumbar|lumbar
748708|NCT00444405|disc|disc
748709|NCT00444405|herniation|herniation
748710|NCT00444405|discectomy|discectomy
748711|NCT00444405|fusion|fusion
748712|NCT00444405|spine|spine
748713|NCT00444392|Obese|obese
748714|NCT00444392|type 2 Diabetes Mellitus|type 2 diabetes mellitus
748715|NCT00444392|Gastric Bypass Surgery|gastric bypass surgery
748716|NCT00444392|Risk of CVD|risk of cvd
748717|NCT00444379|Kaposi's sarcoma|kaposi's sarcoma
748718|NCT00444379|KSHV|kshv
748719|NCT00444379|AIDS|aids
748721|NCT00444379|treatment naive|treatment naive
748722|NCT00444327|single nucleotide polymorphism|single nucleotide polymorphism
748723|NCT00444301|Heart failure|heart failure
748724|NCT00444301|Pain|pain
748725|NCT00444301|Symptoms|symptoms
748726|NCT00444301|Advanced heart failure|advanced heart failure
748727|NCT00444301|Pain frequency, severity, location, treatments|pain frequency, severity, location, treatments
748728|NCT00444301|Shortness of breath, anxiety, depression, cognitive function|shortness of breath, anxiety, depression, cognitive function
748729|NCT00444301|Social support, other conditions and illnesses|social support, other conditions and illnesses
748730|NCT00444288|Cystic Ovaries|cystic ovaries
748731|NCT00444288|Hyperandrogenism|hyperandrogenism
748732|NCT00444288|Anovulation|anovulation
748733|NCT00444288|Concordance Rates|concordance rates
748734|NCT00444288|Baseline Heritability|baseline heritability
748735|NCT00444288|Polycystic Ovary Syndrome|polycystic ovary syndrome
748736|NCT00444288|POS|pos
748737|NCT00444275|Gastroesophageal Reflux Disease|gastroesophageal reflux disease
748738|NCT00444275|Acid Reflux|acid reflux
748739|NCT00444262|Hemodynamic optimisation|hemodynamic optimisation
748740|NCT00444262|Esophageal Doppler|esophageal doppler
748741|NCT00444262|Hydroxy ethyl starch|hydroxy ethyl starch
748742|NCT00444262|Hip fracture|hip fracture
748743|NCT00444262|Outcome|outcome
748744|NCT00444262|Elderly subjects (≥ 70 year old)|elderly subjects (≥ 70 year old)
748745|NCT00444262|General anesthesia|general anesthesia
748746|NCT00444249|age-related macular degeneration|age-related macular degeneration
748747|NCT00444249|melatonin|melatonin
748748|NCT00444249|blue-light filter|blue-light filter
748749|NCT00444236|asthma|asthma
748750|NCT00444236|GERD|gerd
748751|NCT00444236|reflux|reflux
748752|NCT00444236|exercise|exercise
748753|NCT00444223|stage IIIA non-small cell lung cancer|stage iiia non-small cell lung cancer
748754|NCT00444223|stage IIIB non-small cell lung cancer|stage iiib non-small cell lung cancer
748755|NCT00444223|stage IV non-small cell lung cancer|stage iv non-small cell lung cancer
748756|NCT00444184|travoprost/timolol fixed combination|travoprost/timolol fixed combination
748757|NCT00444171|critically ill|critically ill
748758|NCT00444171|insulin resistance|insulin resistance
748759|NCT00444171|intensive insulin therapy|intensive insulin therapy
748760|NCT00444171|computer algorithm|computer algorithm
748761|NCT00444158|opioids|opioids
748762|NCT00444158|chronic pain|chronic pain
748763|NCT00444132|clopidogrel|clopidogrel
748764|NCT00444132|platelets|platelets
748765|NCT00444132|acute coronary syndrome|acute coronary syndrome
748766|NCT00444132|percutaneous coronary intervention|percutaneous coronary intervention
748767|NCT00444119|adrenal insufficiency|adrenal insufficiency
748768|NCT00444119|subjective health status|subjective health status
748769|NCT00444119|quality of life|quality of life
748770|NCT00444119|adrenal crisis|adrenal crisis
748771|NCT00444119|hormone replacement|hormone replacement
748772|NCT00444119|DHEA|dhea
748773|NCT00444106|Malaria|malaria
748774|NCT00444106|hearing|hearing
748775|NCT00444106|co-artemether|co-artemether
748776|NCT00444106|auditory|auditory
748777|NCT00444106|Plasmodium falciparum|plasmodium falciparum
748778|NCT00444106|marsh fever|marsh fever
748779|NCT00444106|Plasmodium infections|plasmodium infections
748780|NCT00444106|remittent fever|remittent fever
748781|NCT00444106|paludism|paludism
748782|NCT00444106|artemether|artemether
748783|NCT00444106|artemisinins|artemisinins
748784|NCT00444106|benflumetol|benflumetol
748785|NCT00444106|lumefantrine|lumefantrine
748786|NCT00444093|radiation therapy|radiation therapy
748787|NCT00444093|diarrhea|diarrhea
748788|NCT00444093|enteritis|enteritis
748789|NCT00444093|supportive therapy|supportive therapy
748790|NCT00444093|therapy associated diarrhea|therapy associated diarrhea
748791|NCT00444093|therapy associated enteritis|therapy associated enteritis
748792|NCT00444093|radiation therapy of the small pelvis|radiation therapy of the small pelvis
748793|NCT00444080|Ex-PRESS|ex-press
748794|NCT00444080|TRABECULECTOMY|trabeculectomy
748795|NCT00444067|Prevention of CSF leak|prevention of csf leak
748796|NCT00444054|Diet|diet
748797|NCT00444054|Cancer|cancer
748798|NCT00444054|Alternative|alternative
748799|NCT00444054|Breast|breast
748800|NCT00444054|Colon|colon
748801|NCT00444054|Cervix|cervix
748802|NCT00444054|Uterus|uterus
748803|NCT00444054|Ovary|ovary
748804|NCT00444054|Metastatic|metastatic
748805|NCT00444054|Nutrition|nutrition
748806|NCT00444054|Carbohydrate|carbohydrate
748807|NCT00444041|metastatic colorectal cancer|metastatic colorectal cancer
748808|NCT00444041|surgery|surgery
748809|NCT00444041|chemotherapy|chemotherapy
748810|NCT00444028|Schizophrenia, Staccato Loxapine|schizophrenia, staccato loxapine
748811|NCT00444015|Erlotinib|erlotinib
748812|NCT00444015|Dasatinib|dasatinib
748813|NCT00444015|Epidermal growth factor receptor (EGFR)|epidermal growth factor receptor (egfr)
748814|NCT00444015|Tyrosine kinase|tyrosine kinase
748815|NCT00444015|NSCLC|nsclc
748816|NCT00444015|Pharmacokinetics (PK)|pharmacokinetics (pk)
748817|NCT00444015|Lung|lung
748818|NCT00444002|Hepatitis C|hepatitis c
748819|NCT00444002|Steatosis|steatosis
748820|NCT00444002|Oxidative Stress|oxidative stress
748821|NCT00444002|Antioxidants|antioxidants
748822|NCT00444002|Inflammation|inflammation
748823|NCT00444002|Fatty acids|fatty acids
748824|NCT00443989|Perioperative Myocardial Infarction|perioperative myocardial infarction
748825|NCT00443989|Stroke|stroke
748826|NCT00443989|Cardiac Death|cardiac death
748827|NCT00443989|Cardiac Arrest|cardiac arrest
748828|NCT00443989|Troponin-T|troponin-t
748829|NCT00443989|Non-Cardiac surgery|non-cardiac surgery
748830|NCT00443989|Death|death
748831|NCT00443976|unspecified adult solid tumor, protocol specific|unspecified adult solid tumor, protocol specific
748832|NCT00443976|recurrent adult Burkitt lymphoma|recurrent adult burkitt lymphoma
748833|NCT00443976|stage III adult Burkitt lymphoma|stage iii adult burkitt lymphoma
748834|NCT00443976|stage IV adult Burkitt lymphoma|stage iv adult burkitt lymphoma
748835|NCT00443976|recurrent grade 2 follicular lymphoma|recurrent grade 2 follicular lymphoma
748836|NCT00443976|stage III grade 2 follicular lymphoma|stage iii grade 2 follicular lymphoma
748837|NCT00443976|stage IV grade 2 follicular lymphoma|stage iv grade 2 follicular lymphoma
748838|NCT00443976|recurrent grade 3 follicular lymphoma|recurrent grade 3 follicular lymphoma
748839|NCT00443976|stage III grade 3 follicular lymphoma|stage iii grade 3 follicular lymphoma
748840|NCT00443976|stage IV grade 3 follicular lymphoma|stage iv grade 3 follicular lymphoma
748841|NCT00443976|recurrent mantle cell lymphoma|recurrent mantle cell lymphoma
748842|NCT00443976|stage III mantle cell lymphoma|stage iii mantle cell lymphoma
748843|NCT00443976|stage IV mantle cell lymphoma|stage iv mantle cell lymphoma
749458|NCT00003552|cancer|cancer
748844|NCT00443976|recurrent adult diffuse large cell lymphoma|recurrent adult diffuse large cell lymphoma
748845|NCT00443976|stage III adult diffuse large cell lymphoma|stage iii adult diffuse large cell lymphoma
748846|NCT00443976|stage IV adult diffuse large cell lymphoma|stage iv adult diffuse large cell lymphoma
748847|NCT00443976|recurrent adult diffuse mixed cell lymphoma|recurrent adult diffuse mixed cell lymphoma
748848|NCT00443976|stage III adult diffuse mixed cell lymphoma|stage iii adult diffuse mixed cell lymphoma
748849|NCT00443976|stage IV adult diffuse mixed cell lymphoma|stage iv adult diffuse mixed cell lymphoma
748850|NCT00443976|recurrent adult diffuse small cleaved cell lymphoma|recurrent adult diffuse small cleaved cell lymphoma
748851|NCT00443976|stage III adult diffuse small cleaved cell lymphoma|stage iii adult diffuse small cleaved cell lymphoma
748852|NCT00443976|stage IV adult diffuse small cleaved cell lymphoma|stage iv adult diffuse small cleaved cell lymphoma
748853|NCT00443976|recurrent adult immunoblastic large cell lymphoma|recurrent adult immunoblastic large cell lymphoma
748854|NCT00443976|stage III adult immunoblastic large cell lymphoma|stage iii adult immunoblastic large cell lymphoma
748855|NCT00443976|stage IV adult immunoblastic large cell lymphoma|stage iv adult immunoblastic large cell lymphoma
748856|NCT00443976|recurrent adult lymphoblastic lymphoma|recurrent adult lymphoblastic lymphoma
748857|NCT00443976|stage III adult lymphoblastic lymphoma|stage iii adult lymphoblastic lymphoma
748858|NCT00443976|stage IV adult lymphoblastic lymphoma|stage iv adult lymphoblastic lymphoma
748859|NCT00443976|recurrent grade 1 follicular lymphoma|recurrent grade 1 follicular lymphoma
748860|NCT00443976|stage III grade 1 follicular lymphoma|stage iii grade 1 follicular lymphoma
748861|NCT00443976|stage IV grade 1 follicular lymphoma|stage iv grade 1 follicular lymphoma
748862|NCT00443976|extranodal marginal zone B-cell lymphoma of mucosa-associated lymphoid tissue|extranodal marginal zone b-cell lymphoma of mucosa-associated lymphoid tissue
748863|NCT00443976|nodal marginal zone B-cell lymphoma|nodal marginal zone b-cell lymphoma
748864|NCT00443976|splenic marginal zone lymphoma|splenic marginal zone lymphoma
748865|NCT00443976|recurrent marginal zone lymphoma|recurrent marginal zone lymphoma
748866|NCT00443976|stage III marginal zone lymphoma|stage iii marginal zone lymphoma
748867|NCT00443976|stage IV marginal zone lymphoma|stage iv marginal zone lymphoma
748868|NCT00443976|recurrent small lymphocytic lymphoma|recurrent small lymphocytic lymphoma
748869|NCT00443976|stage III small lymphocytic lymphoma|stage iii small lymphocytic lymphoma
748870|NCT00443976|stage IV small lymphocytic lymphoma|stage iv small lymphocytic lymphoma
748871|NCT00443976|recurrent adult grade III lymphomatoid granulomatosis|recurrent adult grade iii lymphomatoid granulomatosis
748872|NCT00443976|adult grade III lymphomatoid granulomatosis|adult grade iii lymphomatoid granulomatosis
748873|NCT00443976|Waldenstrom macroglobulinemia|waldenstrom macroglobulinemia
748874|NCT00443963|Dyspepsia in patients taking NSAIDs|dyspepsia in patients taking nsaids
748875|NCT00443950|Arthritis|arthritis
748876|NCT00443950|Chinese|chinese
748877|NCT00443937|Kidney Transplantation|kidney transplantation
748878|NCT00443937|Renal Transplantation|renal transplantation
748879|NCT00443937|Mycophenolate|mycophenolate
748880|NCT00443937|Cyclosporine|cyclosporine
748881|NCT00443937|Everolimus|everolimus
748882|NCT00443924|Bilateral ocular hypertension or early primary open angle glaucoma|bilateral ocular hypertension or early primary open angle glaucoma
748883|NCT00443911|age-related macular degeneration, rheopheresis, lutein|age-related macular degeneration, rheopheresis, lutein
748884|NCT00443898|Toenail fungus|toenail fungus
748885|NCT00443898|Onychomycosis|onychomycosis
748886|NCT00443898|Nail fungus|nail fungus
748887|NCT00443898|Toenail fungal infection|toenail fungal infection
748888|NCT00443898|Tinea unguium|tinea unguium
748889|NCT00443898|Dermatophytes|dermatophytes
748890|NCT00443898|Foot dermatoses|foot dermatoses
748891|NCT00443885|meropenem|meropenem
748892|NCT00443885|imipenem|imipenem
750247|NCT00439946|Remodulin|remodulin
748893|NCT00443885|gram negative organism|gram negative organism
748894|NCT00443872|Parkinson's disease|parkinson's disease
748895|NCT00443872|Dopamine agonist adverse effects|dopamine agonist adverse effects
748896|NCT00443872|MAO-B inhibitor|mao-b inhibitor
748897|NCT00443872|orally disintegrating selegiline|orally disintegrating selegiline
748898|NCT00443872|Zelapar|zelapar
748899|NCT00443859|Persistent Pulmonary Hypertension|persistent pulmonary hypertension
748900|NCT00443859|N-terminal pro brain natriuretic peptide|n-terminal pro brain natriuretic peptide
748901|NCT00443846|Prevention of Gastroenteritis due to rotavirus infection. And prevention of Invasive disease caused by Neisseria meningitidis serogroup C.|prevention of gastroenteritis due to rotavirus infection. and prevention of invasive disease caused by neisseria meningitidis serogroup c.
748902|NCT00443833|Thyrotoxicosis|thyrotoxicosis
748903|NCT00443833|genetic association study|genetic association study
748904|NCT00443833|periodic paralysis|periodic paralysis
748905|NCT00443833|whole genome scan|whole genome scan
748906|NCT00443820|Toenail fungus|toenail fungus
748907|NCT00443820|Onychomycosis|onychomycosis
748908|NCT00443820|Nail fungus|nail fungus
748909|NCT00443820|Toenail fungal infection|toenail fungal infection
748910|NCT00443820|Tinea unguium|tinea unguium
748911|NCT00443820|Dermatophytes|dermatophytes
748912|NCT00443820|Foot dermatoses|foot dermatoses
748913|NCT00443794|POLYCAP, Primary Prevention,CVD|polycap, primary prevention,cvd
748914|NCT00443781|low back pain, degenerative disc disease|low back pain, degenerative disc disease
748915|NCT00443768|Medication|medication
748916|NCT00443768|Diagnosis|diagnosis
748917|NCT00443768|Community|community
749459|NCT00003552|melanoma|melanoma
748918|NCT00443755|Inflammatory cytokine|inflammatory cytokine
748919|NCT00443755|Cardiovascular Disease|cardiovascular disease
748920|NCT00443755|Thrombotic factors|thrombotic factors
748921|NCT00443755|Dyslipidemia|dyslipidemia
748922|NCT00443742|Depression|depression
748923|NCT00443742|Validation|validation
748924|NCT00443742|Adolescent|adolescent
748925|NCT00443742|Validation of three key questions and questionnaire|validation of three key questions and questionnaire
748926|NCT00443729|treatment experienced|treatment experienced
748927|NCT00443703|treatment experienced|treatment experienced
748928|NCT00443690|heart failure|heart failure
748929|NCT00443690|diuretic|diuretic
748930|NCT00443690|renal impairment|renal impairment
748931|NCT00443690|renal function|renal function
748932|NCT00443664|Primary Open Angle Glaucoma|primary open angle glaucoma
748934|NCT00443651|RA|ra
748935|NCT00443651|DMARD|dmard
748936|NCT00443651|Active Rheumatoid Arthritis|active rheumatoid arthritis
748937|NCT00443625|SK3530|sk3530
748938|NCT00443625|Food effect|food effect
748939|NCT00443625|Pharmacokinetics|pharmacokinetics
748940|NCT00443599|Congenital Heart Defects|congenital heart defects
748941|NCT00443599|Insulin|insulin
748942|NCT00443599|Euglycemia|euglycemia
748943|NCT00443599|Normoglycemia|normoglycemia
748944|NCT00443586|Nurse|nurse
748945|NCT00443586|Home Visitation|home visitation
748946|NCT00443586|Welfare|welfare
748947|NCT00443586|Social Behavior|social behavior
748948|NCT00443573|metastatic colorectal carcinoma (mCRC)|metastatic colorectal carcinoma (mcrc)
748949|NCT00443573|colorectal carcinoma (CRC)|colorectal carcinoma (crc)
748950|NCT00443573|tissue factor|tissue factor
748951|NCT00443573|factor VIIa|factor viia
748952|NCT00443573|rNAPc2|rnapc2
748953|NCT00443573|adenocarcinoma|adenocarcinoma
748954|NCT00443573|targeted therapy|targeted therapy
748955|NCT00443573|coagulation-dependent|coagulation-dependent
748956|NCT00443573|RECIST|recist
748957|NCT00443573|5-FU-based chemotherapy|5-fu-based chemotherapy
748958|NCT00443573|FOLFOX|folfox
748959|NCT00443573|FOLFIRI|folfiri
748960|NCT00443573|leucovorin|leucovorin
748961|NCT00443573|XELOX|xelox
748962|NCT00443560|Labor|labor
748963|NCT00443560|Epidural Analgesia|epidural analgesia
748964|NCT00443560|delivery|delivery
748965|NCT00443560|vacuum extraction|vacuum extraction
748966|NCT00443560|obstetrical Forceps|obstetrical forceps
748967|NCT00443547|Prospective|prospective
748968|NCT00443547|Degenerative Disc Disease|degenerative disc disease
748969|NCT00443547|Cervical|cervical
748970|NCT00443547|Translational Plate|translational plate
748971|NCT00443521|Diabetes Mellitus/ complications|diabetes mellitus/ complications
748972|NCT00443521|Diabetic Retinopathy|diabetic retinopathy
748973|NCT00443521|Triamcinolone|triamcinolone
748974|NCT00443521|Laser coagulation|laser coagulation
748975|NCT00443521|Tomography, optical coherence|tomography, optical coherence
748976|NCT00443508|everolimus|everolimus
748977|NCT00443508|renal transplant|renal transplant
748978|NCT00443508|tacrolimus|tacrolimus
748979|NCT00443508|Certican|certican
748980|NCT00443508|CHRONIC ALLOGRAFT NEPHROPATHY|chronic allograft nephropathy
748981|NCT00443508|Renal transplant patients|renal transplant patients
748982|NCT00443482|Asthma|asthma
748983|NCT00443482|adults|adults
748984|NCT00443482|B2 agonist|b2 agonist
748985|NCT00443482|formoterol|formoterol
748986|NCT00443469|magnetic stimulation|magnetic stimulation
748987|NCT00443469|neuropathic pain|neuropathic pain
748988|NCT00443469|spinal|spinal
748989|NCT00443469|lower limb|lower limb
748990|NCT00443469|clinical trial|clinical trial
748991|NCT00443443|Rituximab|rituximab
748992|NCT00443443|RA|ra
748993|NCT00443443|Sunstone|sunstone
748994|NCT00443443|anti-TNF|anti-tnf
748995|NCT00443443|Rituxan|rituxan
748996|NCT00443430|Childhood Arthritis|childhood arthritis
748997|NCT00443430|Juvenile Arthritis|juvenile arthritis
748998|NCT00443430|Juvenile Arthritis Treatment|juvenile arthritis treatment
748999|NCT00443430|Childhood Arthritis Drug Treatment|childhood arthritis drug treatment
749000|NCT00443430|Juvenile Arthritis Remission|juvenile arthritis remission
749001|NCT00443430|Inactive Disease in Juvenile Arthritis|inactive disease in juvenile arthritis
749002|NCT00443430|Childhood Polyarthritis|childhood polyarthritis
749003|NCT00443430|Extended Oligoarthritis|extended oligoarthritis
749004|NCT00443404|phantom|phantom
749005|NCT00443404|amputation|amputation
749006|NCT00443404|analgesia|analgesia
749007|NCT00443404|pain|pain
749008|NCT00443404|preemptive|preemptive
749009|NCT00443404|perioperative|perioperative
749010|NCT00443404|lower limb amputation|lower limb amputation
749011|NCT00443404|intensity of phantom limb pain|intensity of phantom limb pain
749012|NCT00443404|preemptive analgesia reduces phantom pain|preemptive analgesia reduces phantom pain
749013|NCT00443404|perioperative analgesia reduces phantom pain|perioperative analgesia reduces phantom pain
749014|NCT00443404|Severe Phantom Limb Pain (VAS>70 mm)|severe phantom limb pain (vas>70 mm)
749015|NCT00443404|resistant to medical treatment one week before amputation|resistant to medical treatment one week before amputation
749016|NCT00443391|ADHD|adhd
749017|NCT00443378|computer counseling|computer counseling
749018|NCT00443378|HIV|hiv
749019|NCT00443378|antiretroviral adherence|antiretroviral adherence
749020|NCT00443378|sexual behavior|sexual behavior
749021|NCT00443378|prevention with positives|prevention with positives
749022|NCT00443378|HIV seronegativity|hiv seronegativity
749023|NCT00443339|Myelodysplastic syndromes with IPSS Low or Int-1|myelodysplastic syndromes with ipss low or int-1
749024|NCT00443339|Anemia|anemia
749025|NCT00020475|adult solid tumor|adult solid tumor
749026|NCT00020475|body system/site cancer|body system/site cancer
749027|NCT00020475|cancer|cancer
749028|NCT00020475|extraocular extension melanoma|extraocular extension melanoma
749029|NCT00020475|eye cancer|eye cancer
749030|NCT00020475|intraocular melanoma|intraocular melanoma
749031|NCT00020475|recurrent intraocular melanoma|recurrent intraocular melanoma
749032|NCT00020475|solid tumor|solid tumor
749033|NCT00020475|stage, intraocular melanoma|stage, intraocular melanoma
749034|NCT00020371|adult solid tumor|adult solid tumor
749035|NCT00020371|bone marrow suppression|bone marrow suppression
749036|NCT00020371|cancer|cancer
749037|NCT00020371|cancer-related problem/condition|cancer-related problem/condition
749038|NCT00020371|neutropenia|neutropenia
749039|NCT00020371|solid tumor|solid tumor
749040|NCT00020371|unspecified adult solid tumor, protocol specific|unspecified adult solid tumor, protocol specific
749041|NCT00020345|adenocarcinoma of the pancreas|adenocarcinoma of the pancreas
749042|NCT00020345|adult solid tumor|adult solid tumor
749043|NCT00020345|body system/site cancer|body system/site cancer
749044|NCT00020345|cancer|cancer
749045|NCT00020345|cellular diagnosis, pancreatic cancer|cellular diagnosis, pancreatic cancer
749046|NCT00020345|gastrointestinal cancer|gastrointestinal cancer
749047|NCT00020345|pancreatic cancer|pancreatic cancer
749048|NCT00020345|solid tumor|solid tumor
749049|NCT00020345|stage III pancreatic cancer|stage iii pancreatic cancer
749050|NCT00020345|stage IV pancreatic cancer|stage iv pancreatic cancer
749051|NCT00020345|stage IVA pancreatic cancer|stage iva pancreatic cancer
749052|NCT00020345|stage, pancreatic cancer|stage, pancreatic cancer
749053|NCT00020267|Ewing's family of tumors|ewing's family of tumors
749054|NCT00020267|adult soft tissue sarcoma|adult soft tissue sarcoma
749055|NCT00020267|adult solid tumor|adult solid tumor
749056|NCT00020267|body system/site cancer|body system/site cancer
749057|NCT00020267|bone cancer|bone cancer
749058|NCT00020267|breast cancer|breast cancer
749059|NCT00020267|cancer|cancer
749060|NCT00020267|childhood cancer|childhood cancer
749061|NCT00020267|childhood solid tumor|childhood solid tumor
749062|NCT00020267|ciliary body and choroid melanoma, medium/large size|ciliary body and choroid melanoma, medium/large size
749063|NCT00020267|colon cancer|colon cancer
749064|NCT00020267|colorectal cancer|colorectal cancer
749065|NCT00020267|extraocular extension melanoma|extraocular extension melanoma
749066|NCT00020267|eye cancer|eye cancer
749067|NCT00020267|female reproductive cancer|female reproductive cancer
749068|NCT00020267|gastrointestinal cancer|gastrointestinal cancer
749069|NCT00020267|genetic condition|genetic condition
749070|NCT00020267|intraocular melanoma|intraocular melanoma
749071|NCT00020267|lung cancer|lung cancer
749072|NCT00020267|male breast cancer|male breast cancer
749073|NCT00020267|melanoma|melanoma
749074|NCT00020267|metastatic osteosarcoma|metastatic osteosarcoma
749075|NCT00020267|metastatic tumors of the Ewing's family|metastatic tumors of the ewing's family
749076|NCT00020267|muscle cancer|muscle cancer
749077|NCT00020267|musculoskeletal cancer|musculoskeletal cancer
749078|NCT00020267|non-small cell lung cancer|non-small cell lung cancer
749079|NCT00020267|osteosarcoma|osteosarcoma
749166|NCT00443170|pharmacokinetic,|pharmacokinetic,
749080|NCT00020267|osteosarcoma/malignant fibrous histiocytoma of bone|osteosarcoma/malignant fibrous histiocytoma of bone
749081|NCT00020267|ovarian sarcoma|ovarian sarcoma
749082|NCT00020267|rectal cancer|rectal cancer
749083|NCT00020267|recurrent adult soft tissue sarcoma|recurrent adult soft tissue sarcoma
749084|NCT00020267|recurrent breast cancer|recurrent breast cancer
749085|NCT00020267|recurrent colon cancer|recurrent colon cancer
749086|NCT00020267|recurrent intraocular melanoma|recurrent intraocular melanoma
749087|NCT00020267|recurrent melanoma|recurrent melanoma
749088|NCT00020267|recurrent non-small cell lung cancer|recurrent non-small cell lung cancer
749089|NCT00020267|recurrent osteosarcoma|recurrent osteosarcoma
749090|NCT00020267|recurrent rectal cancer|recurrent rectal cancer
749091|NCT00020267|recurrent tumors of the Ewing's family|recurrent tumors of the ewing's family
749092|NCT00020267|recurrent uterine sarcoma|recurrent uterine sarcoma
749093|NCT00020267|skin tumor|skin tumor
749094|NCT00020267|solid tumor|solid tumor
749095|NCT00020267|stage IIIB, IV, recurrent, and metastatic breast cancer|stage iiib, iv, recurrent, and metastatic breast cancer
749096|NCT00020267|stage IV adult soft tissue sarcoma|stage iv adult soft tissue sarcoma
749097|NCT00020267|stage IV breast cancer|stage iv breast cancer
749098|NCT00020267|stage IV colon cancer|stage iv colon cancer
749099|NCT00020267|stage IV melanoma|stage iv melanoma
749100|NCT00020267|stage IV non-small cell lung cancer|stage iv non-small cell lung cancer
749101|NCT00020267|stage IV rectal cancer|stage iv rectal cancer
749102|NCT00020267|stage IV uterine sarcoma|stage iv uterine sarcoma
749103|NCT00020267|stage IVA adult soft tissue sarcoma|stage iva adult soft tissue sarcoma
749104|NCT00020267|stage IVB adult soft tissue sarcoma|stage ivb adult soft tissue sarcoma
749105|NCT00020267|stage, Ewing's family of tumors|stage, ewing's family of tumors
749106|NCT00020267|stage, adult soft tissue sarcoma|stage, adult soft tissue sarcoma
749107|NCT00020267|stage, breast cancer|stage, breast cancer
749108|NCT00020267|stage, colon cancer|stage, colon cancer
749109|NCT00020267|stage, intraocular melanoma|stage, intraocular melanoma
749110|NCT00020267|stage, melanoma|stage, melanoma
749111|NCT00020267|stage, non-small cell lung cancer|stage, non-small cell lung cancer
749112|NCT00020267|stage, osteosarcoma|stage, osteosarcoma
749113|NCT00020267|stage, rectal cancer|stage, rectal cancer
749114|NCT00020267|stage, uterine sarcoma|stage, uterine sarcoma
749115|NCT00020267|thorax/respiratory cancer|thorax/respiratory cancer
749116|NCT00020267|uterine sarcoma|uterine sarcoma
749117|NCT00019643|adult solid tumor|adult solid tumor
749118|NCT00019643|body system/site cancer|body system/site cancer
749119|NCT00019643|breast cancer|breast cancer
749120|NCT00019643|cancer|cancer
749121|NCT00019643|cancer-related problem/condition|cancer-related problem/condition
749122|NCT00019643|depression|depression
749123|NCT00019643|depression and suicide|depression and suicide
749124|NCT00019643|nutrition|nutrition
749125|NCT00019643|psychosocial effects/treatment|psychosocial effects/treatment
749126|NCT00019643|quality of life|quality of life
749127|NCT00019643|solid tumor|solid tumor
749128|NCT00019643|stage I breast cancer|stage i breast cancer
749129|NCT00019643|stage I, II, and IIIA breast cancer|stage i, ii, and iiia breast cancer
749130|NCT00019643|stage II breast cancer|stage ii breast cancer
749131|NCT00019643|stage III breast cancer|stage iii breast cancer
749132|NCT00019643|stage IIIA breast cancer|stage iiia breast cancer
749133|NCT00019643|stage IIIB, IV, recurrent, and metastatic breast cancer|stage iiib, iv, recurrent, and metastatic breast cancer
749134|NCT00019643|stage, breast cancer|stage, breast cancer
749135|NCT00443326|Psoriasis|psoriasis
749136|NCT00443326|PASI|pasi
749137|NCT00443326|Skin Biopsy|skin biopsy
749138|NCT00443326|Human Monoclonal Antibody|human monoclonal antibody
749139|NCT00443313|Cervical neoplasia|cervical neoplasia
749140|NCT00443313|Screening|screening
749141|NCT00443313|HPV|hpv
749142|NCT00443313|Cervical Cancer Screening|cervical cancer screening
749143|NCT00443300|AML|aml
749144|NCT00443300|MDS|mds
749145|NCT00443300|Protected Environment|protected environment
749146|NCT00443287|Peripheral|peripheral
749147|NCT00443287|Artery|artery
749148|NCT00443287|Disease|disease
749149|NCT00443261|Head and Neck Cancer|head and neck cancer
749150|NCT00443235|Older patients|older patients
749151|NCT00443235|untreated patients|untreated patients
749152|NCT00443222|infliximab|infliximab
749153|NCT00443222|polymyositis|polymyositis
749154|NCT00443222|dermatomyositis|dermatomyositis
749155|NCT00443222|inclusion body myositis|inclusion body myositis
749156|NCT00443196|Chemosensitivity|chemosensitivity
749157|NCT00443196|Ovarian Cancer|ovarian cancer
749158|NCT00443196|Chemotherapy|chemotherapy
749159|NCT00443196|Fallopian Adenocarcinoma|fallopian adenocarcinoma
749160|NCT00443196|Peritoneal Adenocarcinoma|peritoneal adenocarcinoma
749161|NCT00443196|Patients with pathological diagnoses of ovarian, fallopian and primary peritoneal adenocarcinomas.|patients with pathological diagnoses of ovarian, fallopian and primary peritoneal adenocarcinomas.
749162|NCT00443196|Patients with de novo malignancies and no previous chemotherapy|patients with de novo malignancies and no previous chemotherapy
749163|NCT00443196|Patients with advanced refractory malignancies who received no more than 2 standard chemotherapy treatment protocols.|patients with advanced refractory malignancies who received no more than 2 standard chemotherapy treatment protocols.
749164|NCT00443170|repeat dose,|repeat dose,
749165|NCT00443170|GSK626616AC,|gsk626616ac,
749167|NCT00443170|single dose,|single dose,
749168|NCT00443170|cytochrome P450,|cytochrome p450,
749169|NCT00443170|First time in human,|first time in human,
749170|NCT00443170|healthy volunteers|healthy volunteers
749171|NCT00443157|meningococcal B vaccine|meningococcal b vaccine
749172|NCT00443144|growth hormone receptor polymorphism|growth hormone receptor polymorphism
749173|NCT00443144|pharmacogenomics|pharmacogenomics
749174|NCT00443144|growth promoting therapy|growth promoting therapy
749175|NCT00443131|Adjuvant|adjuvant
749177|NCT00443131|Safety|safety
749178|NCT00443131|Immunogenicity|immunogenicity
749179|NCT00443118|Bag and mask|bag and mask
749180|NCT00443118|Neopuff|neopuff
749181|NCT00443118|Resuscitation|resuscitation
749182|NCT00443118|Newborn|newborn
749183|NCT00443118|Intubation|intubation
749184|NCT00443118|devices|devices
749185|NCT00443118|PEEP|peep
749186|NCT00443092|osteoarthritis|osteoarthritis
749187|NCT00443092|gout|gout
749188|NCT00443092|pain|pain
749189|NCT00443092|uric acid|uric acid
749190|NCT00443092|tart cherry|tart cherry
749191|NCT00443092|alternative medicine|alternative medicine
749192|NCT00443092|knees|knees
749193|NCT00443079|Clinical Trials|clinical trials
749194|NCT00443079|Pilot Projects|pilot projects
749195|NCT00443079|Milk Thistle|milk thistle
749196|NCT00443079|Liver Function Tests|liver function tests
749197|NCT00443066|pediatric|pediatric
749198|NCT00443066|neuromuscular disease|neuromuscular disease
749199|NCT00443053|superficial vein thrombosis|superficial vein thrombosis
749200|NCT00443053|superficial thrombophlebitis|superficial thrombophlebitis
749201|NCT00443053|fondaparinux|fondaparinux
749202|NCT00443053|deep vein thrombosis|deep vein thrombosis
749203|NCT00443053|venous thromboembolism treatment|venous thromboembolism treatment
749204|NCT00443053|thrombosis|thrombosis
749205|NCT00443014|Stimulation therapy|stimulation therapy
749206|NCT00443014|Acetylcholinesterase inhibitors|acetylcholinesterase inhibitors
749207|NCT00443014|Synergetic|synergetic
749208|NCT00443001|Non-Invasive Blood Pressure|non-invasive blood pressure
749209|NCT00443001|Sinus Rhythm|sinus rhythm
749210|NCT00443001|Oscillometric|oscillometric
749211|NCT00443001|Invasive Blood Pressure|invasive blood pressure
749212|NCT00443001|AAMI/ANSI SP10 Standard|aami/ansi sp10 standard
749213|NCT00443001|Compliance with ANSI/AAMI SP10 2002 standard|compliance with ansi/aami sp10 2002 standard
749214|NCT00442988|NODAT|nodat
749215|NCT00442988|OGTT|ogtt
749216|NCT00442988|FPG|fpg
749217|NCT00442988|Renal Transplanation|renal transplanation
749218|NCT00442988|Risk Factors|risk factors
749219|NCT00442988|Predictive value|predictive value
749220|NCT00442975|Influenza Vaccine|influenza vaccine
749221|NCT00442975|CMV|cmv
749222|NCT00442949|Acute coronary syndrome|acute coronary syndrome
749223|NCT00442949|Angioplasty|angioplasty
749224|NCT00442949|Abciximab|abciximab
749225|NCT00442949|Troponin release|troponin release
749226|NCT00442923|Methamphetamine|methamphetamine
749227|NCT00442923|Coreg|coreg
749228|NCT00442923|Withdrawal|withdrawal
749229|NCT00442923|anxiety|anxiety
749230|NCT00442923|Substance Addiction|substance addiction
749231|NCT00442910|Safety and Acceptability|safety and acceptability
749232|NCT00442897|Hypercholesterolaemia|hypercholesterolaemia
749233|NCT00442884|glucose control in acute stress|glucose control in acute stress
749234|NCT00442871|Renal Impairment,|renal impairment,
749235|NCT00442871|chronic immune thrombocytopenia purpura,|chronic immune thrombocytopenia purpura,
749236|NCT00442871|thrombocytopenia,|thrombocytopenia,
749237|NCT00442871|chemotherapy induced thrombocytopenia|chemotherapy induced thrombocytopenia
749238|NCT00442858|cardiac disease|cardiac disease
749239|NCT00442858|cerebrovascular disease|cerebrovascular disease
749240|NCT00442858|GH deficiency|gh deficiency
749241|NCT00442858|diabetes mellitus|diabetes mellitus
749242|NCT00442858|hypertension|hypertension
749243|NCT00442858|GH therapy|gh therapy
749244|NCT00442858|GH deficiency and hypopituitarims|gh deficiency and hypopituitarims
749245|NCT00020202|adult solid tumor|adult solid tumor
749246|NCT00020202|body system/site cancer|body system/site cancer
749247|NCT00020202|cancer|cancer
749248|NCT00020202|extensive stage small cell lung cancer|extensive stage small cell lung cancer
749249|NCT00020202|genetic condition|genetic condition
749250|NCT00020202|lung cancer|lung cancer
749251|NCT00020202|non-small cell lung cancer|non-small cell lung cancer
749252|NCT00020202|recurrent non-small cell lung cancer|recurrent non-small cell lung cancer
749253|NCT00020202|recurrent small cell lung cancer|recurrent small cell lung cancer
749254|NCT00020202|small cell lung cancer|small cell lung cancer
749255|NCT00020202|solid tumor|solid tumor
749256|NCT00020202|stage III non-small cell lung cancer|stage iii non-small cell lung cancer
749257|NCT00020202|stage IIIA non-small cell lung cancer|stage iiia non-small cell lung cancer
749258|NCT00020202|stage IIIB non-small cell lung cancer|stage iiib non-small cell lung cancer
749259|NCT00020202|stage IV non-small cell lung cancer|stage iv non-small cell lung cancer
749260|NCT00020202|stage, non-small cell lung cancer|stage, non-small cell lung cancer
749261|NCT00020202|stage, small cell lung cancer|stage, small cell lung cancer
749262|NCT00020202|thorax/respiratory cancer|thorax/respiratory cancer
749263|NCT00020046|adenocarcinoma of the prostate|adenocarcinoma of the prostate
749264|NCT00020046|adult solid tumor|adult solid tumor
749265|NCT00020046|body system/site cancer|body system/site cancer
749266|NCT00020046|cancer|cancer
749267|NCT00020046|cellular diagnosis, prostate cancer|cellular diagnosis, prostate cancer
749268|NCT00020046|genetic condition|genetic condition
749269|NCT00020046|male reproductive cancer|male reproductive cancer
749270|NCT00020046|prostate cancer|prostate cancer
749271|NCT00020046|recurrent prostate cancer|recurrent prostate cancer
749272|NCT00020046|solid tumor|solid tumor
749273|NCT00020046|stage IV prostate cancer|stage iv prostate cancer
749274|NCT00020046|stage, prostate cancer|stage, prostate cancer
749275|NCT00019968|adult soft tissue sarcoma|adult soft tissue sarcoma
749276|NCT00019968|adult solid tumor|adult solid tumor
749277|NCT00019968|body system/site cancer|body system/site cancer
749278|NCT00019968|cancer|cancer
749279|NCT00019968|muscle cancer|muscle cancer
749280|NCT00019968|musculoskeletal cancer|musculoskeletal cancer
749281|NCT00019968|recurrent adult soft tissue sarcoma|recurrent adult soft tissue sarcoma
749282|NCT00019968|solid tumor|solid tumor
749283|NCT00019968|stage IA, IB, and IIA adult soft tissue sarcoma|stage ia, ib, and iia adult soft tissue sarcoma
749284|NCT00019968|stage II adult soft tissue sarcoma|stage ii adult soft tissue sarcoma
749285|NCT00019968|stage IIB adult soft tissue sarcoma|stage iib adult soft tissue sarcoma
749286|NCT00019968|stage IIB, IIC, and III adult soft tissue sarcoma|stage iib, iic, and iii adult soft tissue sarcoma
749287|NCT00019968|stage IIC adult soft tissue sarcoma|stage iic adult soft tissue sarcoma
749288|NCT00019968|stage III adult soft tissue sarcoma|stage iii adult soft tissue sarcoma
749460|NCT00003552|recurrent melanoma|recurrent melanoma
749289|NCT00019968|stage IV adult soft tissue sarcoma|stage iv adult soft tissue sarcoma
749290|NCT00019968|stage IVA adult soft tissue sarcoma|stage iva adult soft tissue sarcoma
749291|NCT00019968|stage IVB adult soft tissue sarcoma|stage ivb adult soft tissue sarcoma
749292|NCT00019968|stage, adult soft tissue sarcoma|stage, adult soft tissue sarcoma
749293|NCT00019890|adult solid tumor|adult solid tumor
749294|NCT00019890|body system/site cancer|body system/site cancer
749295|NCT00019890|cancer|cancer
749296|NCT00019890|melanoma|melanoma
749297|NCT00019890|recurrent melanoma|recurrent melanoma
749298|NCT00019890|skin tumor|skin tumor
749299|NCT00019890|solid tumor|solid tumor
749300|NCT00019890|stage III melanoma|stage iii melanoma
749301|NCT00019890|stage IV melanoma|stage iv melanoma
749302|NCT00019890|stage, melanoma|stage, melanoma
749303|NCT00019760|adult solid tumor|adult solid tumor
749304|NCT00019760|body system/site cancer|body system/site cancer
749305|NCT00019760|cancer|cancer
749306|NCT00019760|colon cancer|colon cancer
749307|NCT00019760|colorectal cancer|colorectal cancer
749308|NCT00019760|gastrointestinal cancer|gastrointestinal cancer
749309|NCT00019760|genetic condition|genetic condition
749310|NCT00019760|liver and intrahepatic biliary tract cancer|liver and intrahepatic biliary tract cancer
749311|NCT00019760|liver metastases|liver metastases
749312|NCT00019760|metastatic cancer|metastatic cancer
749313|NCT00019760|rectal cancer|rectal cancer
749314|NCT00019760|recurrent colon cancer|recurrent colon cancer
749315|NCT00019760|recurrent rectal cancer|recurrent rectal cancer
749316|NCT00019760|site, metastatic cancer|site, metastatic cancer
749317|NCT00019760|solid tumor|solid tumor
749318|NCT00019760|stage IV colon cancer|stage iv colon cancer
749319|NCT00019760|stage IV rectal cancer|stage iv rectal cancer
749320|NCT00019760|stage, colon cancer|stage, colon cancer
749321|NCT00019760|stage, rectal cancer|stage, rectal cancer
749322|NCT00019760|unclassified/other cancer|unclassified/other cancer
749323|NCT00019695|adenocarcinoma of the prostate|adenocarcinoma of the prostate
749324|NCT00019695|adult solid tumor|adult solid tumor
749325|NCT00019695|body system/site cancer|body system/site cancer
749326|NCT00019695|bone metastases|bone metastases
749327|NCT00019695|cancer|cancer
749328|NCT00019695|cellular diagnosis, prostate cancer|cellular diagnosis, prostate cancer
749329|NCT00019695|genetic condition|genetic condition
749330|NCT00019695|male reproductive cancer|male reproductive cancer
749331|NCT00019695|metastatic cancer|metastatic cancer
749332|NCT00019695|prostate cancer|prostate cancer
749333|NCT00019695|recurrent prostate cancer|recurrent prostate cancer
749334|NCT00019695|site, metastatic cancer|site, metastatic cancer
749335|NCT00019695|solid tumor|solid tumor
749336|NCT00019695|stage IV prostate cancer|stage iv prostate cancer
749337|NCT00019695|stage, prostate cancer|stage, prostate cancer
749338|NCT00019695|unclassified/other cancer|unclassified/other cancer
749339|NCT00019630|Ewing's family of tumors|ewing's family of tumors
749340|NCT00019630|Wilms' tumor|wilms' tumor
749341|NCT00019630|adult solid tumor|adult solid tumor
749342|NCT00019630|body system/site cancer|body system/site cancer
749343|NCT00019630|bone cancer|bone cancer
749344|NCT00019630|brain tumor|brain tumor
749345|NCT00019630|cancer|cancer
749346|NCT00019630|central nervous system cancer|central nervous system cancer
749347|NCT00019630|childhood brain stem glioma|childhood brain stem glioma
749348|NCT00019630|childhood brain tumor|childhood brain tumor
749349|NCT00019630|childhood cancer|childhood cancer
749350|NCT00019630|childhood central nervous system germ cell tumor|childhood central nervous system germ cell tumor
749726|NCT00441909|UC-781|uc-781
749351|NCT00019630|childhood cerebellar astrocytoma|childhood cerebellar astrocytoma
749352|NCT00019630|childhood cerebral astrocytoma|childhood cerebral astrocytoma
749353|NCT00019630|childhood choroid plexus tumor|childhood choroid plexus tumor
749354|NCT00019630|childhood craniopharyngioma|childhood craniopharyngioma
749355|NCT00019630|childhood ependymoma|childhood ependymoma
749356|NCT00019630|childhood extracranial germ cell tumor|childhood extracranial germ cell tumor
749357|NCT00019630|childhood extragonadal malignant germ cell tumor|childhood extragonadal malignant germ cell tumor
749358|NCT00019630|childhood liver cancer|childhood liver cancer
749359|NCT00019630|childhood malignant ovarian germ cell tumor|childhood malignant ovarian germ cell tumor
749360|NCT00019630|childhood malignant testicular germ cell tumor|childhood malignant testicular germ cell tumor
749361|NCT00019630|childhood mature and immature teratomas|childhood mature and immature teratomas
749362|NCT00019630|childhood medulloblastoma|childhood medulloblastoma
749363|NCT00019630|childhood meningioma|childhood meningioma
749364|NCT00019630|childhood oligodendroglioma|childhood oligodendroglioma
749365|NCT00019630|childhood rhabdomyosarcoma|childhood rhabdomyosarcoma
749366|NCT00019630|childhood soft tissue sarcoma|childhood soft tissue sarcoma
749367|NCT00019630|childhood solid tumor|childhood solid tumor
749368|NCT00019630|childhood supratentorial primitive neuroectodermal and pineal tumors|childhood supratentorial primitive neuroectodermal and pineal tumors
749369|NCT00019630|childhood visual pathway and hypothalamic glioma|childhood visual pathway and hypothalamic glioma
749370|NCT00019630|endocrine cancer|endocrine cancer
749371|NCT00019630|gastrointestinal cancer|gastrointestinal cancer
749372|NCT00019630|genetic condition|genetic condition
749373|NCT00019630|kidney tumor|kidney tumor
749374|NCT00019630|kidney/urinary cancer|kidney/urinary cancer
749375|NCT00019630|liver and intrahepatic biliary tract cancer|liver and intrahepatic biliary tract cancer
749376|NCT00019630|muscle cancer|muscle cancer
749377|NCT00019630|musculoskeletal cancer|musculoskeletal cancer
749378|NCT00019630|neuroblastoma|neuroblastoma
749379|NCT00019630|osteosarcoma|osteosarcoma
749380|NCT00019630|osteosarcoma/malignant fibrous histiocytoma of bone|osteosarcoma/malignant fibrous histiocytoma of bone
749381|NCT00019630|pediatric germ cell tumor|pediatric germ cell tumor
749382|NCT00019630|previously treated childhood rhabdomyosarcoma|previously treated childhood rhabdomyosarcoma
749383|NCT00019630|recurrent Wilms' tumor|recurrent wilms' tumor
749384|NCT00019630|recurrent childhood brain stem glioma|recurrent childhood brain stem glioma
749385|NCT00019630|recurrent childhood brain tumor|recurrent childhood brain tumor
749386|NCT00019630|recurrent childhood cerebellar astrocytoma|recurrent childhood cerebellar astrocytoma
749387|NCT00019630|recurrent childhood cerebral astrocytoma|recurrent childhood cerebral astrocytoma
749388|NCT00019630|recurrent childhood ependymoma|recurrent childhood ependymoma
749389|NCT00019630|recurrent childhood liver cancer|recurrent childhood liver cancer
749390|NCT00019630|recurrent childhood malignant germ cell tumor|recurrent childhood malignant germ cell tumor
749391|NCT00019630|recurrent childhood medulloblastoma|recurrent childhood medulloblastoma
749392|NCT00019630|recurrent childhood rhabdomyosarcoma|recurrent childhood rhabdomyosarcoma
749393|NCT00019630|recurrent childhood soft tissue sarcoma|recurrent childhood soft tissue sarcoma
749394|NCT00019630|recurrent childhood supratentorial primitive neuroectodermal and pineal tumors|recurrent childhood supratentorial primitive neuroectodermal and pineal tumors
749395|NCT00019630|recurrent childhood visual pathway and hypothalamic glioma|recurrent childhood visual pathway and hypothalamic glioma
749396|NCT00019630|recurrent neuroblastoma|recurrent neuroblastoma
749397|NCT00019630|recurrent osteosarcoma|recurrent osteosarcoma
749398|NCT00019630|recurrent tumors of the Ewing's family|recurrent tumors of the ewing's family
749399|NCT00019630|solid tumor|solid tumor
749400|NCT00019630|stage, Ewing's family of tumors|stage, ewing's family of tumors
749401|NCT00019630|stage, Wilms' tumor|stage, wilms' tumor
749402|NCT00019630|stage, childhood extracranial germ cell tumor|stage, childhood extracranial germ cell tumor
749403|NCT00019630|stage, childhood liver cancer|stage, childhood liver cancer
749404|NCT00019630|stage, childhood medulloblastoma|stage, childhood medulloblastoma
749405|NCT00019630|stage, childhood rhabdomyosarcoma|stage, childhood rhabdomyosarcoma
749406|NCT00019630|stage, childhood soft tissue sarcoma|stage, childhood soft tissue sarcoma
749407|NCT00019630|stage, neuroblastoma|stage, neuroblastoma
749408|NCT00019630|stage, osteosarcoma|stage, osteosarcoma
749409|NCT00019630|stage/type, childhood brain tumor|stage/type, childhood brain tumor
749410|NCT00019630|unspecified childhood solid tumor, protocol specific|unspecified childhood solid tumor, protocol specific
749411|NCT00019448|adult solid tumor|adult solid tumor
749412|NCT00019448|body system/site cancer|body system/site cancer
749413|NCT00019448|cancer|cancer
749414|NCT00019448|melanoma|melanoma
749415|NCT00019448|recurrent melanoma|recurrent melanoma
749416|NCT00019448|skin tumor|skin tumor
749417|NCT00019448|solid tumor|solid tumor
749418|NCT00019448|stage IV melanoma|stage iv melanoma
749419|NCT00019448|stage, melanoma|stage, melanoma
749420|NCT00019396|adult solid tumor|adult solid tumor
749421|NCT00019396|body system/site cancer|body system/site cancer
749422|NCT00019396|cancer|cancer
749423|NCT00019396|kidney tumor|kidney tumor
749424|NCT00019396|kidney/urinary cancer|kidney/urinary cancer
749425|NCT00019396|melanoma|melanoma
749426|NCT00019396|recurrent melanoma|recurrent melanoma
749427|NCT00019396|recurrent renal cell cancer|recurrent renal cell cancer
749428|NCT00019396|renal cell cancer|renal cell cancer
749429|NCT00019396|skin tumor|skin tumor
749430|NCT00019396|solid tumor|solid tumor
749431|NCT00019396|stage IV melanoma|stage iv melanoma
749432|NCT00019396|stage IV renal cell cancer|stage iv renal cell cancer
749433|NCT00019396|stage, melanoma|stage, melanoma
749434|NCT00019396|stage, renal cell cancer|stage, renal cell cancer
749435|NCT00019188|AIDS-related malignancies|aids-related malignancies
749436|NCT00019188|Kaposi's sarcoma|kaposi's sarcoma
749437|NCT00019188|adult solid tumor|adult solid tumor
749438|NCT00019188|body system/site cancer|body system/site cancer
749439|NCT00019188|cancer|cancer
749440|NCT00019188|epidemic Kaposi's sarcoma|epidemic kaposi's sarcoma
749441|NCT00019188|recurrent Kaposi's sarcoma|recurrent kaposi's sarcoma
749442|NCT00019188|skin tumor|skin tumor
749443|NCT00019188|solid tumor|solid tumor
749444|NCT00019188|stage, Kaposi's sarcoma|stage, kaposi's sarcoma
749445|NCT00019097|body system/site cancer|body system/site cancer
749446|NCT00019097|cancer|cancer
749447|NCT00019097|genetic condition|genetic condition
749448|NCT00019097|hematopoietic/lymphoid cancer|hematopoietic/lymphoid cancer
749449|NCT00019097|multiple myeloma|multiple myeloma
749450|NCT00019097|multiple myeloma and other plasma cell neoplasms|multiple myeloma and other plasma cell neoplasms
749451|NCT00019097|plasma cell neoplasm|plasma cell neoplasm
749452|NCT00019097|refractory plasma cell neoplasm|refractory plasma cell neoplasm
749453|NCT00019097|stage II multiple myeloma|stage ii multiple myeloma
749454|NCT00019097|stage III multiple myeloma|stage iii multiple myeloma
749455|NCT00019097|stage, plasma cell neoplasm|stage, plasma cell neoplasm
749456|NCT00003552|adult solid tumor|adult solid tumor
749457|NCT00003552|body system/site cancer|body system/site cancer
749461|NCT00003552|skin tumor|skin tumor
749462|NCT00003552|solid tumor|solid tumor
749463|NCT00003552|stage IV melanoma|stage iv melanoma
749464|NCT00003552|stage, melanoma|stage, melanoma
749465|NCT00442832|cSSSI|csssi
749466|NCT00442832|Staph|staph
749467|NCT00442832|MRSA|mrsa
749468|NCT00442819|Uremic Pruritus|uremic pruritus
749469|NCT00442819|Cytokines|cytokines
749470|NCT00442819|Polymethylmethacrylate Artificial Kidney|polymethylmethacrylate artificial kidney
749471|NCT00442819|Hemodialysis|hemodialysis
749472|NCT00442806|ADRC|adrc
749473|NCT00442806|Stem Cells|stem cells
749474|NCT00442806|Myocardial Infarction|myocardial infarction
749475|NCT00442806|STEMI|stemi
749476|NCT00442806|Heart Disease|heart disease
749477|NCT00442806|Coronary Artery Disease|coronary artery disease
749478|NCT00442806|Coronary Disease|coronary disease
749479|NCT00442806|ST-Elevation|st-elevation
749480|NCT00442806|AMI|ami
749481|NCT00442806|Interventional Cardiology|interventional cardiology
749482|NCT00442806|Heart Attack|heart attack
749483|NCT00442780|early Parkinson's Disease|early parkinson's disease
749484|NCT00442780|MOBILE|mobile
749485|NCT00442780|BIIB014|biib014
749486|NCT00442767|pediatric|pediatric
749487|NCT00442767|juvenile|juvenile
749488|NCT00442767|diabetes mellitus|diabetes mellitus
749489|NCT00442767|Pediatric type 1 diabetes mellitus|pediatric type 1 diabetes mellitus
749490|NCT00442754|dendritic cell|dendritic cell
749491|NCT00442754|tumor vaccine|tumor vaccine
749492|NCT00442754|NSCLC|nsclc
749493|NCT00442741|Cancer|cancer
749494|NCT00442741|EPO906|epo906
749495|NCT00442741|Patupilone|patupilone
749496|NCT00442728|Functional electrical stimulation|functional electrical stimulation
749497|NCT00442728|muscular atrophy|muscular atrophy
749498|NCT00442728|intensive care|intensive care
749499|NCT00442715|Exercise-induced asthma,|exercise-induced asthma,
749500|NCT00442715|early childhood;|early childhood;
749501|NCT00442715|spirometry,|spirometry,
749502|NCT00442715|exercise challenge|exercise challenge
749503|NCT00442715|Data from preschool children who were referred to the Pediatric|data from preschool children who were referred to the pediatric
749504|NCT00442715|Pulmonary Clinic over a 1-year period were recruited|pulmonary clinic over a 1-year period were recruited
749505|NCT00442689|Polycystic Ovary Syndrome|polycystic ovary syndrome
749506|NCT00442689|Metabolic Syndrome|metabolic syndrome
749507|NCT00442689|PCOS|pcos
749508|NCT00442689|overweight|overweight
749509|NCT00442689|infertility|infertility
749510|NCT00442689|Insulin Resistance|insulin resistance
749511|NCT00442689|menstrual cycle|menstrual cycle
749512|NCT00442663|Labor Induction|labor induction
749513|NCT00442663|Cervical Ripening|cervical ripening
749514|NCT00442663|Foley Catheter|foley catheter
749515|NCT00442637|CAIRO3|cairo3
749516|NCT00442637|DCCG|dccg
749517|NCT00442637|colorectal cancer|colorectal cancer
749518|NCT00442637|induction|induction
749519|NCT00442637|metronomic chemotherapy|metronomic chemotherapy
749520|NCT00442637|observation|observation
749521|NCT00442637|capecitabine|capecitabine
749522|NCT00442637|bevacizumab|bevacizumab
749523|NCT00442637|oxaliplatin|oxaliplatin
749524|NCT00442624|insomnia|insomnia
749525|NCT00442624|glucose metabolism|glucose metabolism
749526|NCT00442624|insulin resistance|insulin resistance
749527|NCT00442598|Ovarian|ovarian
749528|NCT00442598|Cancer|cancer
749529|NCT00442598|CA-125|ca-125
749530|NCT00442598|Third-line|third-line
749531|NCT00442598|Glufosfamide|glufosfamide
749532|NCT00442546|opioid|opioid
749533|NCT00442533|Carcinoid|carcinoid
749534|NCT00442533|Islet Cell Cancer|islet cell cancer
749535|NCT00442533|Paraganglioma|paraganglioma
749536|NCT00442533|Pheochromocytoma|pheochromocytoma
749537|NCT00442507|Esophagus|esophagus
749538|NCT00442507|Esophagogastric Junction|esophagogastric junction
749539|NCT00442507|Avastin|avastin
749540|NCT00442507|Bevacizumab|bevacizumab
749541|NCT00442507|Erlotinib|erlotinib
749542|NCT00442494|Atrial fibrillation after cardiac surgery|atrial fibrillation after cardiac surgery
749543|NCT00442481|MDD|mdd
749544|NCT00442481|Escitalopram|escitalopram
749545|NCT00442481|Cipralex|cipralex
749546|NCT00442481|Sleep|sleep
749547|NCT00442481|REM|rem
749548|NCT00442481|SWS|sws
749549|NCT00442481|Polysomnography|polysomnography
749550|NCT00442468|Chronic Obstructive Pulmonary Disease (COPD)|chronic obstructive pulmonary disease (copd)
749551|NCT00442468|Chronic Bronchitis|chronic bronchitis
749552|NCT00442468|Spirometry|spirometry
749553|NCT00442455|Head Neck Carcinoma Erlotinib|head neck carcinoma erlotinib
749554|NCT00442442|Malaria|malaria
749555|NCT00442442|mosquito control|mosquito control
749556|NCT00442442|mosquito coils|mosquito coils
749557|NCT00442442|LLIN|llin
749558|NCT00442429|depression; dialysis; kidney failure, chronic|depression; dialysis; kidney failure, chronic
749559|NCT00019578|adult brain stem glioma|adult brain stem glioma
749560|NCT00019578|adult brain tumor|adult brain tumor
749561|NCT00019578|adult central nervous system germ cell tumor|adult central nervous system germ cell tumor
749562|NCT00019578|adult craniopharyngioma|adult craniopharyngioma
749563|NCT00019578|adult ependymoma|adult ependymoma
749564|NCT00019578|adult infiltrating astrocytoma|adult infiltrating astrocytoma
749565|NCT00019578|adult malignant meningioma|adult malignant meningioma
749566|NCT00019578|adult medulloblastoma|adult medulloblastoma
749567|NCT00019578|adult meningioma|adult meningioma
749568|NCT00019578|adult noninfiltrating astrocytoma|adult noninfiltrating astrocytoma
749569|NCT00019578|adult oligodendroglioma|adult oligodendroglioma
749570|NCT00019578|adult pineal parenchymal tumor|adult pineal parenchymal tumor
749571|NCT00019578|adult solid tumor|adult solid tumor
749572|NCT00019578|body system/site cancer|body system/site cancer
749573|NCT00019578|brain metastases|brain metastases
749574|NCT00019578|brain tumor|brain tumor
749575|NCT00019578|cancer|cancer
749576|NCT00019578|central nervous system cancer|central nervous system cancer
749577|NCT00019578|genetic condition|genetic condition
749578|NCT00019578|metastatic cancer|metastatic cancer
749579|NCT00019578|mixed gliomas|mixed gliomas
749580|NCT00019578|site, metastatic cancer|site, metastatic cancer
749581|NCT00019578|solid tumor|solid tumor
749582|NCT00019578|stage IV peripheral primitive neuroectodermal tumor|stage iv peripheral primitive neuroectodermal tumor
749583|NCT00019578|stage/type, adult brain tumor|stage/type, adult brain tumor
749584|NCT00019578|unclassified/other cancer|unclassified/other cancer
749585|NCT00019006|adult solid tumor|adult solid tumor
749586|NCT00019006|body system/site cancer|body system/site cancer
749587|NCT00019006|cancer|cancer
749588|NCT00019006|colon cancer|colon cancer
749589|NCT00019006|colorectal cancer|colorectal cancer
749590|NCT00019006|extensive stage small cell lung cancer|extensive stage small cell lung cancer
749591|NCT00019006|gastrointestinal cancer|gastrointestinal cancer
749592|NCT00019006|genetic condition|genetic condition
749593|NCT00019006|limited stage small cell lung cancer|limited stage small cell lung cancer
749594|NCT00019006|lung cancer|lung cancer
749595|NCT00019006|non-small cell lung cancer|non-small cell lung cancer
749596|NCT00019006|pancreatic cancer|pancreatic cancer
749597|NCT00019006|rectal cancer|rectal cancer
749598|NCT00019006|recurrent colon cancer|recurrent colon cancer
749599|NCT00019006|recurrent pancreatic cancer|recurrent pancreatic cancer
749600|NCT00019006|recurrent rectal cancer|recurrent rectal cancer
749601|NCT00019006|small cell lung cancer|small cell lung cancer
749602|NCT00019006|solid tumor|solid tumor
749603|NCT00019006|stage I pancreatic cancer|stage i pancreatic cancer
749604|NCT00019006|stage II non-small cell lung cancer|stage ii non-small cell lung cancer
749605|NCT00019006|stage II pancreatic cancer|stage ii pancreatic cancer
749606|NCT00019006|stage III colon cancer|stage iii colon cancer
749607|NCT00019006|stage III non-small cell lung cancer|stage iii non-small cell lung cancer
749608|NCT00019006|stage III pancreatic cancer|stage iii pancreatic cancer
749609|NCT00019006|stage III rectal cancer|stage iii rectal cancer
749610|NCT00019006|stage IV pancreatic cancer|stage iv pancreatic cancer
749611|NCT00019006|stage IVA pancreatic cancer|stage iva pancreatic cancer
749612|NCT00019006|stage IVB pancreatic cancer|stage ivb pancreatic cancer
749613|NCT00019006|stage, colon cancer|stage, colon cancer
749614|NCT00019006|stage, non-small cell lung cancer|stage, non-small cell lung cancer
749615|NCT00019006|stage, pancreatic cancer|stage, pancreatic cancer
749616|NCT00019006|stage, rectal cancer|stage, rectal cancer
749617|NCT00019006|stage, small cell lung cancer|stage, small cell lung cancer
749618|NCT00019006|thorax/respiratory cancer|thorax/respiratory cancer
749619|NCT00442403|Malaria|malaria
749620|NCT00442403|Plasmodium falciparum|plasmodium falciparum
749621|NCT00442403|Chemotherapy|chemotherapy
749622|NCT00442403|Chloroquine|chloroquine
749623|NCT00442403|Dehydroepiandrosterone sulphate|dehydroepiandrosterone sulphate
749624|NCT00442390|Cortisol|cortisol
749625|NCT00442390|adrenal insufficiency|adrenal insufficiency
749626|NCT00442390|glucose metabolism|glucose metabolism
749627|NCT00442390|protein metabolism|protein metabolism
749628|NCT00442390|lipid metabolism|lipid metabolism
749629|NCT00442390|insulin sensitivity.|insulin sensitivity.
749630|NCT00442377|Falciparum|falciparum
749631|NCT00442377|Plasmodium|plasmodium
749632|NCT00442377|Malaria|malaria
749633|NCT00442364|PFO|pfo
749634|NCT00442364|Patent Foramen Ovale|patent foramen ovale
749635|NCT00442364|Right-to-Left Shunt|right-to-left shunt
749636|NCT00442364|Sclerotherapy|sclerotherapy
749637|NCT00442312|Combigan|combigan
749638|NCT00442299|hemodialysis, urmeic retention solute, biocompatibility|hemodialysis, urmeic retention solute, biocompatibility
749639|NCT00442286|Hypertension|hypertension
749640|NCT00442286|High Blood Pressure|high blood pressure
749641|NCT00442286|Blood Pressure|blood pressure
749642|NCT00442286|Cardiovascular Disease|cardiovascular disease
749643|NCT00442286|Resistant Hypertension|resistant hypertension
749644|NCT00442286|Stage 2 Hypertension|stage 2 hypertension
749645|NCT00442286|Hypertension that is resistant to treatment|hypertension that is resistant to treatment
749646|NCT00442260|breast cancer|breast cancer
749647|NCT00442260|advanced breast cancer|advanced breast cancer
749648|NCT00442247|anterior vaginal wall prolapse, Pelvicol, biomesh|anterior vaginal wall prolapse, pelvicol, biomesh
749649|NCT00442247|Anterior vaginal wall prolapse|anterior vaginal wall prolapse
749650|NCT00442234|Acute|acute
749651|NCT00442234|pulmonary|pulmonary
749652|NCT00442234|embolism|embolism
749653|NCT00442234|accompanying|accompanying
749654|NCT00442234|hemodynamic|hemodynamic
749655|NCT00442234|instability|instability
749656|NCT00442221|Migrane headaches|migrane headaches
749657|NCT00442208|Healthy adults|healthy adults
749658|NCT00442208|Phase I|phase i
749659|NCT00442195|Tissue Procurement|tissue procurement
749660|NCT00442195|Sample Collection|sample collection
749661|NCT00442195|Biologic Samples|biologic samples
749662|NCT00442195|Laboratory Research Specimens|laboratory research specimens
749663|NCT00442195|Healthy Volunteer|healthy volunteer
749664|NCT00442195|HV|hv
749665|NCT00442182|autoinflammatory syndromes|autoinflammatory syndromes
749666|NCT00442169|West Nile Disease|west nile disease
749667|NCT00442169|Antibody response|antibody response
749668|NCT00442169|Viremia|viremia
749669|NCT00442169|Safety|safety
749670|NCT00442169|Tolerability|tolerability
749671|NCT00442169|Prevention|prevention
749672|NCT00442156|Laser photocoagulation|laser photocoagulation
749673|NCT00442143|CLI|cli
749674|NCT00442143|PAOD|paod
749675|NCT00442143|Severe lower limb ischemia|severe lower limb ischemia
749676|NCT00442130|GM-CSF|gm-csf
749677|NCT00442130|GM-K562|gm-k562
749678|NCT00442130|vaccine|vaccine
749679|NCT00442104|infantile spasms|infantile spasms
749680|NCT00442104|anticonvulsant|anticonvulsant
749681|NCT00442104|pediatric epilepsy|pediatric epilepsy
749682|NCT00442104|West Syndrome|west syndrome
749683|NCT00442104|epileptic spasms|epileptic spasms
749684|NCT00442091|Dandelion|dandelion
749685|NCT00442091|herbal remedy|herbal remedy
749686|NCT00442091|hand eczema|hand eczema
749687|NCT00442091|Compositae|compositae
749688|NCT00442078|Incontinence|incontinence
749689|NCT00442078|Urinary|urinary
749690|NCT00442078|Male|male
749691|NCT00442078|Tape|tape
749692|NCT00442078|Transobturator|transobturator
749693|NCT00442065|Abdominal aortic aneurysm study|abdominal aortic aneurysm study
749694|NCT00442052|Gastroprotective effects|gastroprotective effects
749695|NCT00442052|Aspirin|aspirin
749696|NCT00442039|Mania, Lithium, Bipolar, BPCA, pediatrics|mania, lithium, bipolar, bpca, pediatrics
749697|NCT00442026|Cancer|cancer
749698|NCT00442026|NSCLC|nsclc
749699|NCT00442026|Elderly|elderly
749700|NCT00442026|Chemotherapy|chemotherapy
749701|NCT00442026|Docetaxel|docetaxel
749702|NCT00442026|Gemcitabine|gemcitabine
749703|NCT00442000|Prostate Cancer|prostate cancer
749704|NCT00442000|Prostatectomy|prostatectomy
749705|NCT00441987|Japanese|japanese
749706|NCT00441987|Healthy|healthy
749707|NCT00441987|Alzheimers Disease|alzheimers disease
749708|NCT00441974|adefovir dipivoxil|adefovir dipivoxil
749709|NCT00441974|compensated|compensated
749710|NCT00441974|chronic hepatitis B|chronic hepatitis b
749711|NCT00441974|Chinese|chinese
749712|NCT00441961|Eosinophilic fasciitis, Shulman's syndrome, methotrexate|eosinophilic fasciitis, shulman's syndrome, methotrexate
749713|NCT00441948|Hirsutism|hirsutism
749714|NCT00441948|Hypertrichosis|hypertrichosis
749715|NCT00441935|Urinary Retention|urinary retention
749716|NCT00441935|Urinary Incontinence|urinary incontinence
749717|NCT00441935|Pelvic Pain|pelvic pain
749718|NCT00441922|Cancer|cancer
749719|NCT00441922|Elderly|elderly
749720|NCT00441922|Chemotherapy|chemotherapy
749721|NCT00441922|Docetaxel|docetaxel
749722|NCT00441922|Vinorelbine|vinorelbine
749723|NCT00441909|Anti-Infective Agents, Local|anti-infective agents, local
749724|NCT00441909|Healthy Women|healthy women
749725|NCT00441909|Microbicides|microbicides
749728|NCT00441909|HIV Seronegativity|hiv seronegativity
749729|NCT00441896|infantile spasms|infantile spasms
749730|NCT00441896|anticonvulsant|anticonvulsant
749731|NCT00441896|pediatric epilepsy|pediatric epilepsy
749732|NCT00441896|West Syndrome|west syndrome
749733|NCT00441896|epileptic spasms|epileptic spasms
749734|NCT00441870|Cancer|cancer
749735|NCT00441870|Phase 1|phase 1
749736|NCT00441870|EC0225|ec0225
749737|NCT00441870|EC20|ec20
749738|NCT00441870|Refractory|refractory
749739|NCT00441870|Metastatic|metastatic
749740|NCT00441870|Experimental|experimental
749741|NCT00441857|plant sterols|plant sterols
749742|NCT00441857|plant stanols|plant stanols
749743|NCT00441857|cholesterol absorption|cholesterol absorption
749744|NCT00441844|diabetes, statin, monocyte, crp, inflammation|diabetes, statin, monocyte, crp, inflammation
749745|NCT00441831|Helicobacter pylori infection|helicobacter pylori infection
749746|NCT00441831|peptic ulcer disease|peptic ulcer disease
749747|NCT00441831|distal partial gastrectomy|distal partial gastrectomy
749748|NCT00441831|bile reflux|bile reflux
749749|NCT00441831|gastritis|gastritis
749750|NCT00441831|gastrectomy|gastrectomy
749751|NCT00441805|Acne|acne
749752|NCT00441805|RadioFrequency|radiofrequency
749753|NCT00441792|Sepsis|sepsis
749754|NCT00441792|Etomidate|etomidate
749755|NCT00441792|midazolam|midazolam
749756|NCT00441792|ketamine|ketamine
749757|NCT00441779|Microchimerism|microchimerism
749758|NCT00441779|Injuries|injuries
749759|NCT00441779|Burns|burns
749760|NCT00441779|Orthopedic Surgery|orthopedic surgery
749761|NCT00441779|Leukocytes|leukocytes
749763|NCT00441740|1st line treatment|1st line treatment
749764|NCT00441740|Gemcitabine|gemcitabine
749765|NCT00441740|Vinorelbine|vinorelbine
749766|NCT00441740|Docetaxel|docetaxel
749767|NCT00441727|Peptic ulcer|peptic ulcer
749768|NCT00441727|low-dose ASA|low-dose asa
749769|NCT00441714|cardiovascular disease|cardiovascular disease
749770|NCT00441714|ischemia-reperfusion injury|ischemia-reperfusion injury
749771|NCT00441714|postconditioning|postconditioning
749772|NCT00441714|annexin targeting|annexin targeting
749773|NCT00441688|Human Immunodeficiency virus|human immunodeficiency virus
749774|NCT00441688|HLAgenetics polymorphism|hlagenetics polymorphism
749775|NCT00441675|Adolescents|adolescents
749776|NCT00441675|Asthma|asthma
749777|NCT00441675|long-term follow-up|long-term follow-up
749778|NCT00441675|symptoms|symptoms
749779|NCT00441675|bronchial hyperresponsiveness|bronchial hyperresponsiveness
749780|NCT00441662|Melanoma|melanoma
749781|NCT00441662|Uvea|uvea
749782|NCT00441662|Macula|macula
749783|NCT00441662|Edema|edema
749784|NCT00441662|Plaque radiotherapy|plaque radiotherapy
749785|NCT00441662|Brachytherapy|brachytherapy
749786|NCT00441662|Triamcinolone|triamcinolone
749787|NCT00441649|ADHD|adhd
749788|NCT00441636|depression|depression
749789|NCT00441636|CPAP|cpap
749790|NCT00441636|obstructive sleep apnea|obstructive sleep apnea
749791|NCT00441623|chronic kidney disease|chronic kidney disease
749792|NCT00441623|cardiovascular disease|cardiovascular disease
749793|NCT00441623|risk stratification|risk stratification
749794|NCT00441610|Gimatecan|gimatecan
749795|NCT00441610|topoisomerase I inhibitor|topoisomerase i inhibitor
749796|NCT00441610|advanced solid tumors|advanced solid tumors
749797|NCT00441597|ischemia reperfusion injury|ischemia reperfusion injury
749798|NCT00441597|atorvastatine|atorvastatine
749799|NCT00441597|preconditioning|preconditioning
749800|NCT00441597|cardiovascular disease|cardiovascular disease
749801|NCT00441571|prostate cancer|prostate cancer
749802|NCT00441571|radiolabeled antibody|radiolabeled antibody
749803|NCT00441532|prostate|prostate
749804|NCT00441519|Gastroprotective effects|gastroprotective effects
749805|NCT00441519|Aspirin|aspirin
749806|NCT00441506|interruption|interruption
749807|NCT00441506|critically ill|critically ill
749808|NCT00441506|sedation|sedation
749809|NCT00441506|pediatrics|pediatrics
749810|NCT00441506|critically ill, ventilated children|critically ill, ventilated children
749811|NCT00441493|Hepatitis C|hepatitis c
749812|NCT00441493|fluvastatin|fluvastatin
749813|NCT00441480|Hypercholesterolemia|hypercholesterolemia
749814|NCT00441480|Hypertriglyceridemia|hypertriglyceridemia
749815|NCT00441480|Plant sterol|plant sterol
749816|NCT00441480|Cholesterol|cholesterol
749817|NCT00441480|Fish oil|fish oil
749818|NCT00441454|stress urinary incontinence|stress urinary incontinence
749819|NCT00441454|surgery|surgery
749820|NCT00441454|tension-free vaginal tape|tension-free vaginal tape
749821|NCT00441454|retropubic|retropubic
749822|NCT00441454|transobturator|transobturator
749823|NCT00441454|quality-of-life|quality-of-life
749824|NCT00441441|asthma|asthma
749825|NCT00441441|fluticasone propionate|fluticasone propionate
749826|NCT00441441|children|children
749827|NCT00441441|fluticasone propionate/salmeterol|fluticasone propionate/salmeterol
749828|NCT00441389|Bacteria|bacteria
749829|NCT00441389|Viruses|viruses
749830|NCT00441389|COPD|copd
749831|NCT00441389|infectious etiology for acute exacerbation of COPD|infectious etiology for acute exacerbation of copd
750805|NCT00438152|Lopinavir|lopinavir
749832|NCT00441376|Radiofrequency ablation|radiofrequency ablation
749833|NCT00441376|RFA|rfa
749834|NCT00441376|Doxorubicin|doxorubicin
749835|NCT00441376|Liposome|liposome
749836|NCT00441376|HCC|hcc
749837|NCT00441376|MLC|mlc
749838|NCT00441376|hepatocellular carcinoma|hepatocellular carcinoma
749839|NCT00441376|liver tumor|liver tumor
749840|NCT00441376|tumor|tumor
749841|NCT00441376|ablation|ablation
749842|NCT00441376|heat therapy|heat therapy
749843|NCT00441376|anti-tumor|anti-tumor
749844|NCT00441376|liver cancer|liver cancer
749845|NCT00441376|metastatic liver cancer (MLC)|metastatic liver cancer (mlc)
749846|NCT00441363|diabetes|diabetes
749847|NCT00441363|diabetes mellitus|diabetes mellitus
749848|NCT00441337|malignancies|malignancies
749849|NCT00441337|cancer|cancer
749850|NCT00441337|non small cell lung cancer|non small cell lung cancer
749851|NCT00441337|lung cancer|lung cancer
749852|NCT00441337|colorectal cancer|colorectal cancer
749853|NCT00441337|adenocarcinoma|adenocarcinoma
749854|NCT00441337|melanoma|melanoma
749855|NCT00441337|malignant melanoma|malignant melanoma
749856|NCT00441337|renal cancer|renal cancer
749857|NCT00441337|renal carcinoma|renal carcinoma
749858|NCT00441337|carcinoma|carcinoma
749859|NCT00441337|prostate cancer|prostate cancer
749860|NCT00441337|prostate adenocarcinoma|prostate adenocarcinoma
749861|NCT00441337|Recurrent or treatment refractory malignancies|recurrent or treatment refractory malignancies
749862|NCT00441324|Ovarian follicle|ovarian follicle
749863|NCT00441324|Thecal cells|thecal cells
749864|NCT00441324|Androgens|androgens
749865|NCT00441324|FSH sensitivity|fsh sensitivity
749866|NCT00441311|colorectal cancer screening|colorectal cancer screening
749867|NCT00441311|primary care physicians|primary care physicians
749868|NCT00441311|health disparities|health disparities
749869|NCT00441311|stratified randomized clinical trial|stratified randomized clinical trial
749870|NCT00441298|microbicides|microbicides
749871|NCT00441298|safety|safety
749872|NCT00441298|effectiveness|effectiveness
749873|NCT00441298|Tenofovir gel|tenofovir gel
749874|NCT00441298|HIV|hiv
749875|NCT00441298|young women|young women
749876|NCT00441298|HIV Seronegativity|hiv seronegativity
749877|NCT00441285|neurocysticercosis|neurocysticercosis
749878|NCT00441285|NCC|ncc
749879|NCT00441285|praziquantel|praziquantel
749880|NCT00441285|PZQ|pzq
749881|NCT00441285|albendazole|albendazole
749882|NCT00441285|ABZ|abz
749883|NCT00441285|parasite|parasite
749884|NCT00441285|pig tapeworm|pig tapeworm
749885|NCT00441285|Taenia solium|taenia solium
749886|NCT00441285|epilepsy|epilepsy
749887|NCT00441285|late-onset epilepsy|late-onset epilepsy
749888|NCT00441285|acquired epilepsy|acquired epilepsy
749889|NCT00441272|Pioglitazone|pioglitazone
749890|NCT00441272|Hepatic Steatosis|hepatic steatosis
749891|NCT00441272|Liver Toxicity|liver toxicity
749892|NCT00441272|Liver Biopsy|liver biopsy
749893|NCT00441272|HIV|hiv
749894|NCT00441272|Treatment Experienced|treatment experienced
749895|NCT00441272|Treatment Naive|treatment naive
749896|NCT00441259|Japanese Encephalitis|japanese encephalitis
749897|NCT00441246|Acute Respiratory Infection|acute respiratory infection
749898|NCT00441246|Bronchitis|bronchitis
749899|NCT00441246|Rhinosinusitis|rhinosinusitis
749900|NCT00441220|Genetic polymorphisms|genetic polymorphisms
749901|NCT00441220|Cyclophosphamide|cyclophosphamide
749902|NCT00441220|Cytochrome p450 CYP2C19 (Human)|cytochrome p450 cyp2c19 (human)
749903|NCT00441220|Systemic Lupus Erythematosus|systemic lupus erythematosus
749904|NCT00441207|IV Ascorbic Acid|iv ascorbic acid
749905|NCT00441207|IV Vitamin C|iv vitamin c
749906|NCT00441207|Cancer|cancer
749907|NCT00441207|Advanced Solid Tumors|advanced solid tumors
749908|NCT00441194|Perimetry|perimetry
749909|NCT00441194|Visual Field|visual field
749910|NCT00441194|Octopus|octopus
749911|NCT00441181|Neovascular glaucoma|neovascular glaucoma
749912|NCT00441181|Travoprost|travoprost
749913|NCT00441168|Multiple Myeloma|multiple myeloma
749914|NCT00441168|bortezomib|bortezomib
749915|NCT00441168|Cancer|cancer
749916|NCT00441168|Hematology|hematology
749917|NCT00441168|bone marrow|bone marrow
749918|NCT00441168|immunoglobulin|immunoglobulin
749919|NCT00441168|relapse|relapse
749920|NCT00441168|refractory|refractory
749921|NCT00441168|plasma cell|plasma cell
749922|NCT00441168|Velcade|velcade
749923|NCT00441168|adriamycin|adriamycin
749924|NCT00441168|dexamethasone|dexamethasone
749925|NCT00441168|vincristine|vincristine
749926|NCT00441155|Oncology|oncology
749927|NCT00441155|Cancer|cancer
749928|NCT00441155|Imatinib-Resistant Gastrointestinal Stromal Tumors|imatinib-resistant gastrointestinal stromal tumors
749929|NCT00441155|GIST|gist
749930|NCT00441155|Nilotinib|nilotinib
749931|NCT00441155|Imatinib-Resistant Gastrointestinal Stromal Tumors (GIST)|imatinib-resistant gastrointestinal stromal tumors (gist)
749932|NCT00441142|Newly diagnosed malignant brain tumors.|newly diagnosed malignant brain tumors.
749933|NCT00441129|Improvement of the blood glucose control|improvement of the blood glucose control
749934|NCT00441116|dutasteride|dutasteride
749935|NCT00441116|Androgenic alopecia|androgenic alopecia
749937|NCT00441103|Subjects with relapsing remitting multiple sclerosis|subjects with relapsing remitting multiple sclerosis
749938|NCT00441090|Chronic Idiopathic Thrombocytopenic Purpura|chronic idiopathic thrombocytopenic purpura
749939|NCT00441090|Idiopathic Thrombocytopenic Purpura|idiopathic thrombocytopenic purpura
749940|NCT00441090|ITP|itp
749941|NCT00441077|Genetics|genetics
749942|NCT00441077|Family History|family history
749943|NCT00441077|Latino|latino
749944|NCT00441077|Information Seeking|information seeking
749945|NCT00441077|Lay Health Advisors|lay health advisors
749946|NCT00441077|Cancer|cancer
749947|NCT00441077|Heart Disease|heart disease
749948|NCT00441077|Diabetes|diabetes
749949|NCT00441077|Information|information
749950|NCT00441064|High blood pressure, hypertension, aliskiren, low sodium diet|high blood pressure, hypertension, aliskiren, low sodium diet
749951|NCT00441051|Sunburn, diclofenac, topical NSAID|sunburn, diclofenac, topical nsaid
749952|NCT00441038|Low back pain|low back pain
749953|NCT00441038|disability|disability
749954|NCT00441038|health education|health education
749955|NCT00441025|MabCampath + CHOP in PTCL|mabcampath + chop in ptcl
749956|NCT00441012|Haemophilus Influenza, type b and Hepatitis B|haemophilus influenza, type b and hepatitis b
749957|NCT00440999|P vivax|p vivax
749958|NCT00440999|malaria|malaria
749959|NCT00440999|ACT|act
749960|NCT00440986|Clinical Management|clinical management
749961|NCT00440986|Phlebotomy|phlebotomy
749962|NCT00440986|Eritrocytoapheresis|eritrocytoapheresis
749963|NCT00440973|kidney cancer|kidney cancer
749964|NCT00440973|M3thodist|m3thodist
749965|NCT00440960|alfentanil|alfentanil
749966|NCT00440960|anesthesia|anesthesia
749967|NCT00440960|bronchoscopy|bronchoscopy
749968|NCT00440960|lidocaine|lidocaine
749969|NCT00440960|midazolam|midazolam
749970|NCT00440960|propofol.|propofol.
749971|NCT00440947|NORVIR|norvir
749972|NCT00440947|ARIES|aries
749973|NCT00440947|EPZICOM|epzicom
749974|NCT00440947|REYATAZ|reyataz
749976|NCT00440947|simplification|simplification
749977|NCT00440947|Antiretroviral-naive|antiretroviral-naive
749978|NCT00440934|carcinoma, hepatocellular|carcinoma, hepatocellular
749979|NCT00440934|electromagnetic fields|electromagnetic fields
749980|NCT00440921|fibrin sealnat|fibrin sealnat
749981|NCT00440921|knee replacement|knee replacement
749982|NCT00440921|hip replacement|hip replacement
749983|NCT00440921|woud healing|woud healing
749984|NCT00440921|blood loss|blood loss
749985|NCT00440921|clinical trial|clinical trial
749986|NCT00440921|randomized|randomized
749987|NCT00440908|Dialyzer reuse|dialyzer reuse
749988|NCT00440908|Inflammatory markers|inflammatory markers
749989|NCT00440908|Nutritional status|nutritional status
749990|NCT00440895|Coronary artery stenting|coronary artery stenting
749991|NCT00440895|Trans-radial|trans-radial
749992|NCT00440895|Intracoronary|intracoronary
749993|NCT00440895|Rescue-PCI|rescue-pci
749994|NCT00440869|N-acetylcysteine|n-acetylcysteine
749995|NCT00440869|oxidative stress|oxidative stress
749996|NCT00440869|muscle fatigue|muscle fatigue
749997|NCT00440869|end-stage renal disease|end-stage renal disease
749998|NCT00440869|hemodialysis|hemodialysis
749999|NCT00440856|Intervertebral disc|intervertebral disc
750000|NCT00440856|Lumbar discectomy|lumbar discectomy
750001|NCT00440856|Outcome|outcome
750002|NCT00440856|Radiculopathy due to prolapsed intervertebral disc.|radiculopathy due to prolapsed intervertebral disc.
750003|NCT00440843|schizophrenia|schizophrenia
750004|NCT00440843|attention|attention
750005|NCT00440843|task engagement|task engagement
750006|NCT00440843|antipsychotics|antipsychotics
750007|NCT00440843|cognition|cognition
750008|NCT00440843|cognitive rehabilitation|cognitive rehabilitation
750009|NCT00440830|acute pain|acute pain
750010|NCT00440830|nicotine|nicotine
750011|NCT00440830|nausea|nausea
750012|NCT00440830|sedation|sedation
750013|NCT00440817|Lymphoma|lymphoma
750014|NCT00440817|Rheumatoid arthritis|rheumatoid arthritis
750015|NCT00440817|Crohn's disease|crohn's disease
750016|NCT00440817|Remicade|remicade
750017|NCT00440817|Infliximab|infliximab
750018|NCT00440804|patent ductus arterious|patent ductus arterious
750019|NCT00440791|Colon|colon
750020|NCT00440791|colonic disease|colonic disease
750021|NCT00440791|capsule endoscopy|capsule endoscopy
750022|NCT00440791|Suspected or known colonic disease|suspected or known colonic disease
750023|NCT00440778|Coronary artery stenting|coronary artery stenting
750024|NCT00440778|Trans-radial|trans-radial
750025|NCT00440778|Intracoronary|intracoronary
750026|NCT00440765|Multiple Myeloma|multiple myeloma
750027|NCT00440765|hematological Neoplasms|hematological neoplasms
750028|NCT00440765|chemotherapy|chemotherapy
750029|NCT00440765|efficacy|efficacy
750030|NCT00440765|safety|safety
750031|NCT00440765|bortezomib|bortezomib
750032|NCT00440765|proteasome inhibitor|proteasome inhibitor
750033|NCT00440752|Artemether-lumefantrine|artemether-lumefantrine
750034|NCT00440752|Plasmodium falciparum|plasmodium falciparum
750035|NCT00440752|drug resistance genes|drug resistance genes
750036|NCT00440739|postoperative pain, etoticoxib, etoricoxib|postoperative pain, etoticoxib, etoricoxib
750140|NCT00440349|Periaortic fibrosis|periaortic fibrosis
750037|NCT00440739|Pain relief after transurethral resection of prostate.|pain relief after transurethral resection of prostate.
750038|NCT00440726|Acute Lymphoblastic Leukemia|acute lymphoblastic leukemia
750039|NCT00440726|Pediatrics|pediatrics
750040|NCT00440726|Relapsed|relapsed
750041|NCT00440726|Recurrence|recurrence
750042|NCT00440726|Bortezomib|bortezomib
750043|NCT00440726|Velcade|velcade
750044|NCT00440726|Therapeutic Advances in Childhood Leukemia|therapeutic advances in childhood leukemia
750045|NCT00440726|Investigational|investigational
750046|NCT00440726|Childhood|childhood
750047|NCT00440726|ALL|all
750048|NCT00440726|Relapsed ALL|relapsed all
750049|NCT00440726|Refractory ALL|refractory all
750050|NCT00440726|Relapsed pediatric ALL|relapsed pediatric all
750051|NCT00440726|Refractory pediatric ALL|refractory pediatric all
750052|NCT00440726|TACL|tacl
750053|NCT00440726|Recurrent Pediatric ALL|recurrent pediatric all
750054|NCT00440713|Posttraumatic Stress Disorder|posttraumatic stress disorder
750055|NCT00440713|Depression|depression
750056|NCT00440713|Anxiety|anxiety
750057|NCT00440713|Efficacy|efficacy
750058|NCT00440700|Ventilator|ventilator
750059|NCT00440700|chronic obstructive pulmonary disease|chronic obstructive pulmonary disease
750060|NCT00440700|Anxiety|anxiety
750061|NCT00440687|chronic obstructive pulmonary disease|chronic obstructive pulmonary disease
750062|NCT00440687|primary care|primary care
750063|NCT00440687|randomised trials|randomised trials
750064|NCT00440687|therapeutic interventions|therapeutic interventions
750065|NCT00440674|Direct Stenting|direct stenting
750066|NCT00440674|Angioplasty|angioplasty
750067|NCT00440674|Pre-dilatation|pre-dilatation
750068|NCT00440674|Drug-eluting stent|drug-eluting stent
750069|NCT00440661|Osteoarthritis, IL-1|osteoarthritis, il-1
750070|NCT00440635|Multiple myeloma|multiple myeloma
750071|NCT00440635|bortezomib, Hematology|bortezomib, hematology
750072|NCT00440622|Cancer|cancer
750073|NCT00440622|Metastatic Breast cancer|metastatic breast cancer
750074|NCT00440622|Her-2 expression|her-2 expression
750075|NCT00440622|Gemcitabine|gemcitabine
750076|NCT00440622|Capecitabine|capecitabine
750077|NCT00440622|Herceptin|herceptin
750078|NCT00440583|CHOP-Z|chop-z
750079|NCT00440570|cancer|cancer
750080|NCT00440570|electromagnetic fields|electromagnetic fields
750081|NCT00440570|treatment|treatment
750082|NCT00440557|Anemia|anemia
750083|NCT00440557|Chronic Kidney disease|chronic kidney disease
750084|NCT00440557|Kidney disease|kidney disease
750085|NCT00440557|Epoetin alfa|epoetin alfa
750086|NCT00440557|Procrit|procrit
750087|NCT00440544|Tuberculosis|tuberculosis
750088|NCT00440544|vaccine|vaccine
750089|NCT00440544|nasal immunization|nasal immunization
750090|NCT00440518|Lacosamide|lacosamide
750091|NCT00440518|migraine prophylaxis|migraine prophylaxis
750092|NCT00440518|Vimpat|vimpat
750093|NCT00440505|chronic pain|chronic pain
750094|NCT00440505|pelvic pain|pelvic pain
750095|NCT00440505|nicotine patch|nicotine patch
750096|NCT00440479|Multiple Myeloma|multiple myeloma
750097|NCT00440479|hematological neoplasms|hematological neoplasms
750098|NCT00440479|chemotherapy|chemotherapy
750099|NCT00440479|efficacy|efficacy
750100|NCT00440479|safety|safety
750101|NCT00440479|bortezomib|bortezomib
750102|NCT00440479|proteasome inhibitor|proteasome inhibitor
750103|NCT00440466|Anemia|anemia
750104|NCT00440466|Reduction in the number of erythrocytes|reduction in the number of erythrocytes
750105|NCT00440466|Hemoglobin low level|hemoglobin low level
750106|NCT00440466|Red blood cell deficiency|red blood cell deficiency
750107|NCT00440466|Procrit|procrit
750108|NCT00440466|Epoetin alfa|epoetin alfa
750109|NCT00440466|Chronic kidney disease|chronic kidney disease
750110|NCT00440453|Internal medicine patients|internal medicine patients
750111|NCT00440440|hypogonadism|hypogonadism
750112|NCT00440440|diabetes|diabetes
750113|NCT00440440|visceral fat|visceral fat
750114|NCT00440440|hepatic fat|hepatic fat
750115|NCT00440440|lean mass|lean mass
750116|NCT00440427|Major Depressive Disorder|major depressive disorder
750117|NCT00440427|MDD|mdd
750118|NCT00440414|Cancer|cancer
750119|NCT00440414|Non-small-cell lung cancer|non-small-cell lung cancer
750120|NCT00440414|Chemotherapy|chemotherapy
750121|NCT00440414|Pemetrexed|pemetrexed
750122|NCT00440414|Erlotinib|erlotinib
750123|NCT00440401|Surgical treatment of haemorrhage|surgical treatment of haemorrhage
750124|NCT00440388|cancer|cancer
750125|NCT00440388|lymphoma|lymphoma
750126|NCT00440388|Non-Hodgkin's|non-hodgkin's
750127|NCT00440388|Non-Hodgkins|non-hodgkins
750128|NCT00440388|AT-101|at-101
750129|NCT00440388|AT101|at101
750130|NCT00440388|Rituxan|rituxan
750131|NCT00440388|Rituximab|rituximab
750132|NCT00440362|Influenza|influenza
750133|NCT00440362|Flu|flu
750134|NCT00440362|A/Wyoming/03/2003|a/wyoming/03/2003
750135|NCT00440362|Alphavirus|alphavirus
750265|NCT00439907|Anal sphincter|anal sphincter
750136|NCT00440349|Retroperitoneal fibrosis|retroperitoneal fibrosis
750137|NCT00440349|Tamoxifen|tamoxifen
750138|NCT00440349|Corticosteroids|corticosteroids
750139|NCT00440349|Obstructive uropathy|obstructive uropathy
750141|NCT00440349|Chronic periaortitis|chronic periaortitis
750142|NCT00440336|IOP|iop
750143|NCT00440336|SLT|slt
750144|NCT00440336|Laser|laser
750145|NCT00440336|Cosopt|cosopt
750146|NCT00440323|Noise induced Situational insomnia,|noise induced situational insomnia,
750147|NCT00440323|healthy volunteers|healthy volunteers
750148|NCT00440323|SB-649868,|sb-649868,
750149|NCT00440323|Zolpidem,|zolpidem,
750150|NCT00440310|Liver neoplasms|liver neoplasms
750151|NCT00440310|Liver metastases|liver metastases
750152|NCT00440310|MCRC|mcrc
750153|NCT00440310|Litx™|litx™
750154|NCT00440310|LS11|ls11
750155|NCT00440310|Colorectal cancer with recurrent liver metastases|colorectal cancer with recurrent liver metastases
750156|NCT00440297|hepatitis B virus|hepatitis b virus
750157|NCT00440284|conventional insulin therapy|conventional insulin therapy
750158|NCT00440284|intensive insulin therapy|intensive insulin therapy
750159|NCT00440284|self-management|self-management
750160|NCT00440284|patient education|patient education
750161|NCT00440284|RCT|rct
750162|NCT00440284|glycosylated hemoglobin|glycosylated hemoglobin
750163|NCT00440284|hypoglycemia|hypoglycemia
750164|NCT00440284|patient preference|patient preference
750165|NCT00440258|Ovarian hyperstimulation syndrome, dopamine agonists, cabergoline, hemoconcentration, ascites, ovarian perfusion, dopamine receptor 2|ovarian hyperstimulation syndrome, dopamine agonists, cabergoline, hemoconcentration, ascites, ovarian perfusion, dopamine receptor 2
750166|NCT00440219|Nasal polyps|nasal polyps
750167|NCT00440219|Steroids|steroids
750168|NCT00440219|Prednisone|prednisone
750169|NCT00440219|Nasal polypectomy|nasal polypectomy
750170|NCT00440219|Blood loss, surgical|blood loss, surgical
750171|NCT00440206|HIV|hiv
750172|NCT00440206|Immune Markers|immune markers
750173|NCT00440180|Obesity|obesity
750174|NCT00440180|Low sperm count|low sperm count
750175|NCT00440180|Male infertility|male infertility
750176|NCT00440167|capecitabine|capecitabine
750177|NCT00440167|gemcitabine|gemcitabine
750178|NCT00440167|Erlotinib|erlotinib
750179|NCT00440167|pancreatic cancer|pancreatic cancer
750180|NCT00440167|advanced|advanced
750181|NCT00440128|Casopitant,|casopitant,
750182|NCT00440128|Neurokinin-1 Receptor Antagonist,|neurokinin-1 receptor antagonist,
750183|NCT00440128|Drug-Interaction,|drug-interaction,
750184|NCT00440128|CYP3A|cyp3a
750185|NCT00440128|NK-1 Receptor Antagonist,|nk-1 receptor antagonist,
750186|NCT00440128|GW679769,|gw679769,
750187|NCT00440128|Docetaxel,|docetaxel,
750188|NCT00440102|ETOMIDATE|etomidate
750189|NCT00440102|KETAMINE|ketamine
750190|NCT00440102|RAPID SEQUENCE INTUBATION|rapid sequence intubation
750191|NCT00440102|PREHOSPITAL|prehospital
750192|NCT00440102|During rapid sequence intubation|during rapid sequence intubation
750193|NCT00440089|Cancer|cancer
750194|NCT00440089|Fatigue|fatigue
750195|NCT00440089|Breast Cancer|breast cancer
750196|NCT00440089|Healing|healing
750197|NCT00440089|Energy Healing|energy healing
750198|NCT00440089|Complementary|complementary
750199|NCT00440089|Alternative|alternative
750200|NCT00440089|Immune|immune
750201|NCT00440089|Cytokine|cytokine
750202|NCT00440089|Hormone|hormone
750203|NCT00440089|Cortisol|cortisol
750204|NCT00440089|Placebo|placebo
750205|NCT00440089|Mock Healing|mock healing
750206|NCT00440076|MDS|mds
750207|NCT00440076|Velcade|velcade
750208|NCT00440050|fish oil|fish oil
750209|NCT00440050|omega-3 fatty acids|omega-3 fatty acids
750210|NCT00440050|EPA|epa
750211|NCT00440037|AMG 531|amg 531
750212|NCT00440037|ITP|itp
750213|NCT00440037|Long term treatment|long term treatment
750214|NCT00440037|Japanese|japanese
750215|NCT00440037|Romiplostim|romiplostim
750216|NCT00440024|Sun-Damaged Skin|sun-damaged skin
750217|NCT00440024|Retinoid Intolerance|retinoid intolerance
750218|NCT00440024|Tazarotene Cream|tazarotene cream
750219|NCT00440024|Dove facial cleanser|dove facial cleanser
750220|NCT00440024|Dove moisturizer|dove moisturizer
750221|NCT00439998|Ultrasound|ultrasound
750222|NCT00439998|Obesity|obesity
750223|NCT00439998|Needle Depth|needle depth
750224|NCT00439985|Type 1 Diabetes Mellitus (T1DM)|type 1 diabetes mellitus (t1dm)
750225|NCT00439985|Metabolic Control|metabolic control
750226|NCT00439985|Adherence|adherence
750227|NCT00439985|Optimism|optimism
750228|NCT00439985|Parent-Child Collaboration|parent-child collaboration
750229|NCT00439985|Prevention|prevention
750230|NCT00439972|Lipoproteins|lipoproteins
750231|NCT00439972|Apolipoproteins|apolipoproteins
750232|NCT00439972|Insulin sensitivity|insulin sensitivity
750233|NCT00439972|Inflammation|inflammation
750234|NCT00439972|Clotting|clotting
750235|NCT00439972|Antioxidant status|antioxidant status
750236|NCT00439972|Vascular reactivity|vascular reactivity
750237|NCT00439972|Metabolism|metabolism
750238|NCT00439959|GSK625433,|gsk625433,
750239|NCT00439959|Hepatitis C,|hepatitis c,
750240|NCT00439959|metabolic probe,|metabolic probe,
750241|NCT00439959|food-effect,|food-effect,
750242|NCT00439959|HCV,|hcv,
750243|NCT00439959|FTIH|ftih
750244|NCT00439959|polymerase,|polymerase,
750245|NCT00439946|pulmonary hypertension|pulmonary hypertension
750248|NCT00439946|treprostinil|treprostinil
750249|NCT00439946|Quality of Life|quality of life
750250|NCT00439946|rapid switch|rapid switch
750251|NCT00439933|Obesity|obesity
750252|NCT00439933|Children|children
750253|NCT00439933|Weight loss|weight loss
750254|NCT00439933|Endothelial dysfunction|endothelial dysfunction
750255|NCT00439933|Intervention|intervention
750256|NCT00439920|ALL|all
750257|NCT00439907|Anal sphincter Delivery|anal sphincter delivery
750258|NCT00439907|Primary repair|primary repair
750259|NCT00439907|End-to-end repair|end-to-end repair
750260|NCT00439907|Over-lap repair|over-lap repair
750261|NCT00439907|Anal manometry|anal manometry
750262|NCT00439907|Anal sonography|anal sonography
750263|NCT00439907|Weksner Score|weksner score
750264|NCT00439907|Rupture of the external anal sphincter during delivery|rupture of the external anal sphincter during delivery
750266|NCT00439907|Anal sphincter rupture|anal sphincter rupture
750267|NCT00439894|Rheumatoid Arthritis|rheumatoid arthritis
750268|NCT00439894|etanercept|etanercept
750269|NCT00439894|Enbrel|enbrel
750270|NCT00439894|Amgen|amgen
750271|NCT00439881|inflammation,|inflammation,
750272|NCT00439881|intravenous,|intravenous,
750273|NCT00439881|Chronic Obstructive Pulmonary Disease,|chronic obstructive pulmonary disease,
750274|NCT00439881|P38 inhibitor|p38 inhibitor
750275|NCT00439881|SB-681323,|sb-681323,
750276|NCT00439881|rheumatoid arthritis,|rheumatoid arthritis,
750277|NCT00439868|WELLBUTRIN XL, intraocular pressure, healthy volunteers|wellbutrin xl, intraocular pressure, healthy volunteers
750278|NCT00439855|Enoxaparin, heparin, hemorrhages|enoxaparin, heparin, hemorrhages
750279|NCT00439829|follicle|follicle
750280|NCT00439829|ovary|ovary
750281|NCT00439829|poor responder|poor responder
750282|NCT00439829|stimulation|stimulation
750283|NCT00439829|follicle wave emergence|follicle wave emergence
750284|NCT00439816|Hypertension Outcomes|hypertension outcomes
750285|NCT00439816|Health Outcomes|health outcomes
750286|NCT00439816|Outpatient|outpatient
750287|NCT00439816|Racial Preference|racial preference
750288|NCT00439816|Blood Pressure Control|blood pressure control
750289|NCT00439816|Clinical Trial|clinical trial
750290|NCT00439816|Intervention|intervention
750291|NCT00439816|Lifestyle modifications|lifestyle modifications
750292|NCT00439816|Ethnic Differences|ethnic differences
750293|NCT00439816|Randomized|randomized
750295|NCT00439803|cytomegalovirus|cytomegalovirus
750296|NCT00439803|Alphavirus|alphavirus
750297|NCT00439790|implantable cardioverter defibrillator|implantable cardioverter defibrillator
750298|NCT00439790|Heart failure|heart failure
750299|NCT00439790|Sudden Cardiac Arrest|sudden cardiac arrest
750300|NCT00439790|appropriate shock|appropriate shock
750301|NCT00439790|Defibrillators, Implantable|defibrillators, implantable
750302|NCT00439764|Low back pain, health education, physical therapy|low back pain, health education, physical therapy
750303|NCT00439751|Prostate Cancer|prostate cancer
750304|NCT00439751|Androgen Deprivation Therapy|androgen deprivation therapy
750305|NCT00439751|Recurrence|recurrence
750306|NCT00439751|Biochemical Failure|biochemical failure
750307|NCT00439751|Goserelin|goserelin
750308|NCT00439738|Obesity, hypertension, valsartan/hydrochlorothiazide|obesity, hypertension, valsartan/hydrochlorothiazide
750309|NCT00439699|Essential Tremor|essential tremor
750310|NCT00439699|Memantine|memantine
750311|NCT00439699|Clinical Trial|clinical trial
750312|NCT00439673|MDS|mds
750313|NCT00439673|5-Azacytidine|5-azacytidine
750314|NCT00439673|valproic acid|valproic acid
750315|NCT00439673|atra|atra
750316|NCT00439673|intermediate or high risk|intermediate or high risk
750317|NCT00439673|Age ≥18 yearsAge|age ≥18 yearsage
750318|NCT00439660|Rotavirus, diarrhea, vaccine|rotavirus, diarrhea, vaccine
750319|NCT00439647|Osteoporosis|osteoporosis
750320|NCT00439647|males|males
750321|NCT00439647|vertebral fractures|vertebral fractures
750322|NCT00439647|clinical fractures|clinical fractures
750323|NCT00439647|bone mineral density|bone mineral density
750324|NCT00439647|bone biomarkers|bone biomarkers
750325|NCT00439647|zoledronic acid|zoledronic acid
750326|NCT00439634|psychometrics|psychometrics
750327|NCT00439634|schizophrenia|schizophrenia
750328|NCT00439621|immunotherapy|immunotherapy
750329|NCT00439621|allergy|allergy
750330|NCT00439608|esophageal cancer|esophageal cancer
750331|NCT00439608|gastroesophageal cancer|gastroesophageal cancer
750332|NCT00439608|gastric cancer|gastric cancer
750333|NCT00439595|Anaemia|anaemia
750334|NCT00439595|Diagnosis|diagnosis
750335|NCT00439595|Primary|primary
750336|NCT00439595|Care|care
750337|NCT00439595|Treatment|treatment
750338|NCT00439582|Lipoproteins|lipoproteins
750339|NCT00439582|Milk fat|milk fat
750340|NCT00439582|Public health nutrition|public health nutrition
750341|NCT00439582|trans fatty acid|trans fatty acid
750342|NCT00439569|spinal muscular atrophy type II/III|spinal muscular atrophy type ii/iii
750343|NCT00439569|SMA type II/III|sma type ii/iii
750344|NCT00439569|spinal muscular atrophy|spinal muscular atrophy
750345|NCT00439569|SMA|sma
750346|NCT00439569|sodium phenylbutyrate|sodium phenylbutyrate
750347|NCT00439569|motor neuron disease|motor neuron disease
750348|NCT00439569|neuromuscular|neuromuscular
750349|NCT00439569|survival motor neuron|survival motor neuron
750350|NCT00439569|SMN|smn
750351|NCT00439569|dose escalation|dose escalation
750352|NCT00439543|Pulmonary fibrosis|pulmonary fibrosis
750353|NCT00439543|pulmonary hypertension|pulmonary hypertension
750354|NCT00439543|Iloprost|iloprost
750355|NCT00439543|Efficacy|efficacy
750356|NCT00439530|oseltamivir|oseltamivir
750357|NCT00439530|pharmacokinetics|pharmacokinetics
750358|NCT00439530|probenecid|probenecid
750359|NCT00439530|avian influenza|avian influenza
750360|NCT00439517|Cancer|cancer
750361|NCT00439517|Colorectal|colorectal
750362|NCT00439517|Metastatic|metastatic
750363|NCT00439517|Untreated|untreated
750364|NCT00439491|Obesity|obesity
750365|NCT00439491|Insulin resistance|insulin resistance
750366|NCT00439491|Hypocaloric diet|hypocaloric diet
750367|NCT00439491|Adipose tissue|adipose tissue
750368|NCT00439491|adipocytokine|adipocytokine
750369|NCT00439478|Radioiodine, Thyroid Cancer, Sialadenitis, Xerostomia|radioiodine, thyroid cancer, sialadenitis, xerostomia
750370|NCT00439387|Serotonin|serotonin
750371|NCT00439387|Epilepsy|epilepsy
750372|NCT00439387|Healthy Volunteer|healthy volunteer
750373|NCT00439387|HV|hv
750374|NCT00439374|nulliparous|nulliparous
750375|NCT00439374|pregnancy|pregnancy
750376|NCT00439374|short cervix|short cervix
750377|NCT00439374|progesterone|progesterone
750378|NCT00439361|Hodgkin Lymphoma|hodgkin lymphoma
750379|NCT00439361|HL|hl
750380|NCT00439361|Relapsed Classical Hodgkin Lymphoma|relapsed classical hodgkin lymphoma
750381|NCT00439361|Refractory|refractory
750382|NCT00439361|Lymphoma|lymphoma
750383|NCT00439361|Nodular sclerosis|nodular sclerosis
750384|NCT00439361|Mixed cellularity|mixed cellularity
750385|NCT00439361|Lymphocyte-rich classical HL|lymphocyte-rich classical hl
750386|NCT00439361|Bortezomib|bortezomib
750387|NCT00439361|Velcade|velcade
750388|NCT00439361|LDP-341|ldp-341
750389|NCT00439361|MLN341|mln341
750390|NCT00439361|PS-341|ps-341
750391|NCT00439361|Carboplatin|carboplatin
750392|NCT00439361|Paraplatin|paraplatin
750393|NCT00439361|Etoposide|etoposide
750394|NCT00439361|VePesid®|vepesid®
750395|NCT00439361|Ifosfamide|ifosfamide
750397|NCT00439361|Mesnex|mesnex
750398|NCT00439361|ICE|ice
750399|NCT00439348|Calcium|calcium
750400|NCT00439348|Compliance|compliance
750401|NCT00439348|Medication compliance|medication compliance
750402|NCT00439348|electronic prescription|electronic prescription
750403|NCT00439348|over-the-counter medications|over-the-counter medications
750404|NCT00439348|OTC medications|otc medications
750405|NCT00439335|Influenza, vaccine, A/H5N1|influenza, vaccine, a/h5n1
750406|NCT00439322|PTSD|ptsd
750407|NCT00439296|Acute Lymphoblastic Leukemia|acute lymphoblastic leukemia
750408|NCT00439296|Pediatrics|pediatrics
750409|NCT00439296|Relapsed|relapsed
750410|NCT00439296|Recurrence|recurrence
750411|NCT00439296|ABT-751|abt-751
750412|NCT00439296|Therapeutic Advances in Childhood Leukemia|therapeutic advances in childhood leukemia
750413|NCT00439296|Investigational|investigational
750414|NCT00439296|Childhood|childhood
750415|NCT00439296|ALL|all
750416|NCT00439296|Relapsed ALL|relapsed all
750417|NCT00439296|Refractory ALL|refractory all
750418|NCT00439296|Relapsed pediatric ALL|relapsed pediatric all
750419|NCT00439296|Refractory pediatric ALL|refractory pediatric all
750420|NCT00439296|TACL|tacl
750421|NCT00439283|Ankylosing spondylitis|ankylosing spondylitis
750422|NCT00439283|infliximab|infliximab
750423|NCT00439283|Systematic regimen|systematic regimen
750424|NCT00439283|On-demand regimen|on-demand regimen
750425|NCT00439270|Metastatic hormone refractory prostate cancer|metastatic hormone refractory prostate cancer
750426|NCT00439244|Bone Mineral Density (BMD)|bone mineral density (bmd)
750427|NCT00439244|C-Telopeptides (CTx)|c-telopeptides (ctx)
750428|NCT00439244|dual x-ray absorptiometry (DXA)|dual x-ray absorptiometry (dxa)
750429|NCT00439244|pro-collagen type 1 N-propeptide (P1NP)|pro-collagen type 1 n-propeptide (p1np)
750430|NCT00439244|teriparatide|teriparatide
750431|NCT00439244|zoledronic acid|zoledronic acid
750432|NCT00439244|Osteoporosis|osteoporosis
750433|NCT00439244|postmenopausal women|postmenopausal women
750434|NCT00439231|Monoclonal Antibody Therapy|monoclonal antibody therapy
750435|NCT00439231|Biologic Response Modifier Therapy|biologic response modifier therapy
750436|NCT00439231|CLL|cll
750437|NCT00439231|SLL|sll
750438|NCT00439231|chemo-care (CC) 5013- Revlimid|chemo-care (cc) 5013- revlimid
750439|NCT00439231|Chronic Lymphocytic Leukemia|chronic lymphocytic leukemia
750440|NCT00439231|Small Lymphocytic Leukemia|small lymphocytic leukemia
750441|NCT00439218|spinal muscular atrophy type I|spinal muscular atrophy type i
750442|NCT00439218|SMA type I|sma type i
750443|NCT00439218|spinal muscular atrophy|spinal muscular atrophy
750444|NCT00439218|SMA|sma
750445|NCT00439218|sodium phenylbutyrate|sodium phenylbutyrate
750446|NCT00439218|motor neuron disease|motor neuron disease
750447|NCT00439218|neuromuscular|neuromuscular
750448|NCT00439218|survival motor neuron|survival motor neuron
750449|NCT00439218|SMN|smn
750450|NCT00439218|dose escalation|dose escalation
750451|NCT00439205|Oral Tumors|oral tumors
750806|NCT00438152|Saquinavir|saquinavir
750452|NCT00439205|Oral Margin Spectroscopy|oral margin spectroscopy
750453|NCT00439205|Oral Spectroscopy|oral spectroscopy
750454|NCT00439205|Optical Spectroscopy|optical spectroscopy
750455|NCT00439205|Oral neoplastic lesions|oral neoplastic lesions
750456|NCT00439205|FastEEM4 System|fasteem4 system
750457|NCT00439205|Multispectral Digital Microscope|multispectral digital microscope
750458|NCT00439205|MDM|mdm
750459|NCT00439205|Nonstandard imaging technology|nonstandard imaging technology
750460|NCT00439192|OAB, proof of concept|oab, proof of concept
750461|NCT00439192|Overactive Bladder (OAB)|overactive bladder (oab)
750462|NCT00439192|with incontinence|with incontinence
750463|NCT00439179|Pancreatic Cancer|pancreatic cancer
750464|NCT00439166|doxycycline|doxycycline
750465|NCT00439166|rifampicin|rifampicin
750466|NCT00439166|cerebrospinal fluid|cerebrospinal fluid
750467|NCT00439166|biomarkers|biomarkers
750468|NCT00439166|beta amyloid|beta amyloid
750469|NCT00439166|tau|tau
750470|NCT00439127|thyroglobulin|thyroglobulin
750471|NCT00439127|thyroid carcinoma|thyroid carcinoma
750472|NCT00439127|tumour marker|tumour marker
750473|NCT00439127|radioiodine|radioiodine
750474|NCT00439127|recombinant human TSH|recombinant human tsh
750475|NCT00439114|Corneal topography, corneal opacity, keratitis, trachoma|corneal topography, corneal opacity, keratitis, trachoma
750476|NCT00439101|weight loss|weight loss
750477|NCT00439101|malignancy|malignancy
750478|NCT00439101|corticosteroids|corticosteroids
750479|NCT00439101|supplemental feeding|supplemental feeding
750480|NCT00439101|adrenal insufficiency|adrenal insufficiency
750481|NCT00439101|diabetes|diabetes
750482|NCT00439088|Ambulation|ambulation
750483|NCT00439088|Ambulatory Monitoring|ambulatory monitoring
750484|NCT00439088|Activities of Daily Living|activities of daily living
750485|NCT00439088|Pedometer|pedometer
750486|NCT00439088|Validation Studies [PT]|validation studies [pt]
750487|NCT00439075|pulmonary disease|pulmonary disease
750488|NCT00439075|CPO|cpo
750489|NCT00439075|CPAP|cpap
750490|NCT00439075|oxygenation|oxygenation
750491|NCT00439075|out-of-hospital intervention|out-of-hospital intervention
750492|NCT00439062|Roxithromycin,Rheumatoid arthritis,Macrolides|roxithromycin,rheumatoid arthritis,macrolides
750493|NCT00439049|Substance Abuse|substance abuse
750494|NCT00439049|Treatment|treatment
750495|NCT00439049|Eligibility|eligibility
750496|NCT00439036|Opiate|opiate
750497|NCT00439036|Behavior Therapy|behavior therapy
750498|NCT00439036|Methadone|methadone
750499|NCT00439036|Acceptance and Commitment Therapy (ACT)|acceptance and commitment therapy (act)
750500|NCT00439023|Chronic renal failure, dialysis, hemodialysis,|chronic renal failure, dialysis, hemodialysis,
750501|NCT00439010|neurological|neurological
750502|NCT00439010|alzheimer|alzheimer
750503|NCT00438971|Panic Disorder|panic disorder
750504|NCT00438971|Anxiety Disorder|anxiety disorder
750505|NCT00438971|Duloxetine|duloxetine
750506|NCT00438958|graft versus host disease|graft versus host disease
750507|NCT00438958|adult acute myeloid leukemia in remission|adult acute myeloid leukemia in remission
750508|NCT00438958|adult acute myeloid leukemia with 11q23 (MLL) abnormalities|adult acute myeloid leukemia with 11q23 (mll) abnormalities
750509|NCT00438958|adult acute myeloid leukemia with inv(16)(p13;q22)|adult acute myeloid leukemia with inv(16)(p13;q22)
750510|NCT00438958|adult acute myeloid leukemia with t(15;17)(q22;q12)|adult acute myeloid leukemia with t(15;17)(q22;q12)
750511|NCT00438958|adult acute myeloid leukemia with t(16;16)(p13;q22)|adult acute myeloid leukemia with t(16;16)(p13;q22)
750512|NCT00438958|adult acute myeloid leukemia with t(8;21)(q22;q22)|adult acute myeloid leukemia with t(8;21)(q22;q22)
750513|NCT00438958|accelerated phase chronic myelogenous leukemia|accelerated phase chronic myelogenous leukemia
750514|NCT00438958|chronic phase chronic myelogenous leukemia|chronic phase chronic myelogenous leukemia
750515|NCT00438958|refractory anemia with excess blasts in transformation|refractory anemia with excess blasts in transformation
750516|NCT00438958|refractory anemia with excess blasts|refractory anemia with excess blasts
750517|NCT00438958|refractory anemia with ringed sideroblasts|refractory anemia with ringed sideroblasts
750518|NCT00438958|refractory anemia|refractory anemia
750519|NCT00438958|chronic myelomonocytic leukemia|chronic myelomonocytic leukemia
750520|NCT00438958|de novo myelodysplastic syndromes|de novo myelodysplastic syndromes
750521|NCT00438958|previously treated myelodysplastic syndromes|previously treated myelodysplastic syndromes
750522|NCT00438958|secondary myelodysplastic syndromes|secondary myelodysplastic syndromes
750523|NCT00438958|refractory chronic lymphocytic leukemia|refractory chronic lymphocytic leukemia
750524|NCT00438958|stage III chronic lymphocytic leukemia|stage iii chronic lymphocytic leukemia
750525|NCT00438958|stage IV chronic lymphocytic leukemia|stage iv chronic lymphocytic leukemia
750526|NCT00438958|primary myelofibrosis|primary myelofibrosis
750527|NCT00438958|secondary myelofibrosis|secondary myelofibrosis
750528|NCT00438958|extranodal marginal zone B-cell lymphoma of mucosa-associated lymphoid tissue|extranodal marginal zone b-cell lymphoma of mucosa-associated lymphoid tissue
750529|NCT00438958|nodal marginal zone B-cell lymphoma|nodal marginal zone b-cell lymphoma
750530|NCT00438958|recurrent adult Burkitt lymphoma|recurrent adult burkitt lymphoma
750531|NCT00438958|recurrent adult diffuse large cell lymphoma|recurrent adult diffuse large cell lymphoma
750532|NCT00438958|recurrent adult diffuse mixed cell lymphoma|recurrent adult diffuse mixed cell lymphoma
750533|NCT00438958|recurrent adult diffuse small cleaved cell lymphoma|recurrent adult diffuse small cleaved cell lymphoma
750534|NCT00438958|recurrent adult Hodgkin lymphoma|recurrent adult hodgkin lymphoma
750535|NCT00438958|recurrent adult immunoblastic large cell lymphoma|recurrent adult immunoblastic large cell lymphoma
750536|NCT00438958|recurrent adult lymphoblastic lymphoma|recurrent adult lymphoblastic lymphoma
750537|NCT00438958|recurrent cutaneous T-cell non-Hodgkin lymphoma|recurrent cutaneous t-cell non-hodgkin lymphoma
750538|NCT00438958|recurrent grade 1 follicular lymphoma|recurrent grade 1 follicular lymphoma
750539|NCT00438958|recurrent grade 2 follicular lymphoma|recurrent grade 2 follicular lymphoma
750540|NCT00438958|recurrent grade 3 follicular lymphoma|recurrent grade 3 follicular lymphoma
750541|NCT00438958|recurrent mantle cell lymphoma|recurrent mantle cell lymphoma
750542|NCT00438958|recurrent marginal zone lymphoma|recurrent marginal zone lymphoma
750543|NCT00438958|recurrent mycosis fungoides/Sezary syndrome|recurrent mycosis fungoides/sezary syndrome
750544|NCT00438958|recurrent small lymphocytic lymphoma|recurrent small lymphocytic lymphoma
750545|NCT00438958|splenic marginal zone lymphoma|splenic marginal zone lymphoma
750546|NCT00438958|stage III adult Burkitt lymphoma|stage iii adult burkitt lymphoma
750547|NCT00438958|stage III adult diffuse large cell lymphoma|stage iii adult diffuse large cell lymphoma
750548|NCT00438958|stage III adult diffuse mixed cell lymphoma|stage iii adult diffuse mixed cell lymphoma
750549|NCT00438958|stage III adult diffuse small cleaved cell lymphoma|stage iii adult diffuse small cleaved cell lymphoma
750550|NCT00438958|stage III adult Hodgkin lymphoma|stage iii adult hodgkin lymphoma
750551|NCT00438958|stage III adult immunoblastic large cell lymphoma|stage iii adult immunoblastic large cell lymphoma
750552|NCT00438958|stage III adult lymphoblastic lymphoma|stage iii adult lymphoblastic lymphoma
750553|NCT00438958|stage III grade 1 follicular lymphoma|stage iii grade 1 follicular lymphoma
750554|NCT00438958|stage III grade 2 follicular lymphoma|stage iii grade 2 follicular lymphoma
750555|NCT00438958|stage III grade 3 follicular lymphoma|stage iii grade 3 follicular lymphoma
750556|NCT00438958|stage III mantle cell lymphoma|stage iii mantle cell lymphoma
750557|NCT00438958|stage III marginal zone lymphoma|stage iii marginal zone lymphoma
750558|NCT00438958|stage III small lymphocytic lymphoma|stage iii small lymphocytic lymphoma
750559|NCT00438958|stage IV adult Burkitt lymphoma|stage iv adult burkitt lymphoma
750560|NCT00438958|stage IV adult diffuse large cell lymphoma|stage iv adult diffuse large cell lymphoma
750561|NCT00438958|stage IV adult diffuse mixed cell lymphoma|stage iv adult diffuse mixed cell lymphoma
750562|NCT00438958|stage IV adult diffuse small cleaved cell lymphoma|stage iv adult diffuse small cleaved cell lymphoma
750563|NCT00438958|stage IV adult Hodgkin lymphoma|stage iv adult hodgkin lymphoma
750564|NCT00438958|stage IV adult immunoblastic large cell lymphoma|stage iv adult immunoblastic large cell lymphoma
750565|NCT00438958|stage IV adult lymphoblastic lymphoma|stage iv adult lymphoblastic lymphoma
750566|NCT00438958|stage IV grade 1 follicular lymphoma|stage iv grade 1 follicular lymphoma
750567|NCT00438958|stage IV grade 2 follicular lymphoma|stage iv grade 2 follicular lymphoma
750568|NCT00438958|stage IV grade 3 follicular lymphoma|stage iv grade 3 follicular lymphoma
750569|NCT00438958|stage IV mantle cell lymphoma|stage iv mantle cell lymphoma
750570|NCT00438958|stage IV marginal zone lymphoma|stage iv marginal zone lymphoma
750571|NCT00438958|stage IV small lymphocytic lymphoma|stage iv small lymphocytic lymphoma
750572|NCT00438958|Waldenström macroglobulinemia|waldenström macroglobulinemia
750573|NCT00438958|secondary acute myeloid leukemia|secondary acute myeloid leukemia
750574|NCT00438958|childhood myelodysplastic syndromes|childhood myelodysplastic syndromes
750575|NCT00438932|phosphate, phosphorus, FGF-23, PTH, 1,25D|phosphate, phosphorus, fgf-23, pth, 1,25d
750576|NCT00438906|pancreatic lesions|pancreatic lesions
750577|NCT00438906|pancreatic cancer|pancreatic cancer
750578|NCT00438906|peutz-jeghers syndrome|peutz-jeghers syndrome
750579|NCT00438906|BRCA 2 gene mutation|brca 2 gene mutation
750580|NCT00438906|FAMMM/p16|fammm/p16
750581|NCT00438906|Genes, BRCA2|genes, brca2
750582|NCT00438893|Viscous dietary fiber|viscous dietary fiber
750583|NCT00438893|Soy protein|soy protein
750584|NCT00438893|Nuts|nuts
750585|NCT00438893|Plant sterols|plant sterols
750586|NCT00438893|Dietary Portfolio|dietary portfolio
750587|NCT00438893|Compliance|compliance
750588|NCT00438893|Blood lipids|blood lipids
750589|NCT00438893|Blood pressure|blood pressure
750590|NCT00438867|angina|angina
750591|NCT00438867|FGF-4|fgf-4
750592|NCT00438867|angiogenesis|angiogenesis
750593|NCT00438867|growth factor|growth factor
750594|NCT00438867|myocardia ischemia|myocardia ischemia
750595|NCT00438867|revascularization|revascularization
750596|NCT00438854|dasatinib|dasatinib
750597|NCT00438854|BMS-354825|bms-354825
750599|NCT00438854|SLL|sll
750600|NCT00438854|LYN kinase|lyn kinase
750601|NCT00438841|stage I multiple myeloma|stage i multiple myeloma
750602|NCT00438841|stage II multiple myeloma|stage ii multiple myeloma
750603|NCT00438841|stage III multiple myeloma|stage iii multiple myeloma
750604|NCT00438828|radiation therapy|radiation therapy
750605|NCT00438828|palliative|palliative
750606|NCT00438828|pain|pain
750607|NCT00438815|Hereditary angioedema|hereditary angioedema
750608|NCT00438815|C1 esterase inhibitor (human)|c1 esterase inhibitor (human)
750609|NCT00438802|recurrent cutaneous T-cell non-Hodgkin lymphoma|recurrent cutaneous t-cell non-hodgkin lymphoma
750610|NCT00438802|angioimmunoblastic T-cell lymphoma|angioimmunoblastic t-cell lymphoma
750611|NCT00438802|anaplastic large cell lymphoma|anaplastic large cell lymphoma
750707|NCT00438451|focal epilepsy|focal epilepsy
750612|NCT00438802|adult nasal type extranodal NK/T-cell lymphoma|adult nasal type extranodal nk/t-cell lymphoma
750613|NCT00438802|recurrent mycosis fungoides/Sezary syndrome|recurrent mycosis fungoides/sezary syndrome
750614|NCT00438763|CMC arthritis|cmc arthritis
750615|NCT00438763|splint treatment|splint treatment
750616|NCT00438763|patient satisfaction|patient satisfaction
750617|NCT00438763|DASH questionnaire|dash questionnaire
750618|NCT00438750|distal radius fracture|distal radius fracture
750619|NCT00438750|rehabilitation|rehabilitation
750620|NCT00438750|volar plate fixation|volar plate fixation
750621|NCT00438750|DASH questionnaire|dash questionnaire
750622|NCT00438737|liver metastases|liver metastases
750623|NCT00438737|stage IV colon cancer|stage iv colon cancer
750624|NCT00438737|stage IV rectal cancer|stage iv rectal cancer
750625|NCT00438737|recurrent colon cancer|recurrent colon cancer
750626|NCT00438737|recurrent rectal cancer|recurrent rectal cancer
750627|NCT00438724|Caregivers|caregivers
750628|NCT00438724|Caregiving|caregiving
750629|NCT00438724|Spousal relationships|spousal relationships
750630|NCT00438724|cognition disorders|cognition disorders
750631|NCT00438724|therapy|therapy
750632|NCT00438724|mental health|mental health
750633|NCT00438724|psychosocial|psychosocial
750634|NCT00438698|Nutrition|nutrition
750635|NCT00438698|Type 2 Diabetes|type 2 diabetes
750636|NCT00438685|Substance-Related Disorders|substance-related disorders
750637|NCT00438685|Depressive Disorder|depressive disorder
750638|NCT00438685|Anxiety Disorder|anxiety disorder
750639|NCT00438685|Adolescent|adolescent
750640|NCT00438685|Behavior Therapy|behavior therapy
750641|NCT00438685|Cognitive Therapy|cognitive therapy
750642|NCT00438685|Outpatients|outpatients
750643|NCT00438685|Family Relations|family relations
750644|NCT00438685|Systems Theory|systems theory
750645|NCT00438672|lateral elbow pain|lateral elbow pain
750646|NCT00438672|tennis elbow|tennis elbow
750647|NCT00438672|pain|pain
750648|NCT00438672|psychology|psychology
750649|NCT00438659|dermatologic complications|dermatologic complications
750650|NCT00438659|skin reactions secondary to radiation therapy|skin reactions secondary to radiation therapy
750651|NCT00438659|radiation toxicity|radiation toxicity
750652|NCT00438659|breast cancer in situ|breast cancer in situ
750653|NCT00438659|recurrent breast cancer|recurrent breast cancer
750654|NCT00438659|stage I breast cancer|stage i breast cancer
750655|NCT00438659|stage II breast cancer|stage ii breast cancer
750656|NCT00438659|stage IIIA breast cancer|stage iiia breast cancer
750657|NCT00438659|stage IIIB breast cancer|stage iiib breast cancer
750658|NCT00438659|stage IIIC breast cancer|stage iiic breast cancer
750659|NCT00438659|male breast cancer|male breast cancer
750660|NCT00438659|ductal breast carcinoma in situ|ductal breast carcinoma in situ
750661|NCT00438659|stage IV breast cancer|stage iv breast cancer
750662|NCT00438646|Allergy|allergy
750663|NCT00438646|Asthma|asthma
750664|NCT00438646|Eczema|eczema
750665|NCT00438646|Hay Fever|hay fever
750666|NCT00438646|Epidemiology|epidemiology
750667|NCT00438633|proximal humerus fracture|proximal humerus fracture
750668|NCT00438633|rehabilitation|rehabilitation
750669|NCT00438633|non-operative treatment|non-operative treatment
750670|NCT00438633|DASH and Constant instruments|dash and constant instruments
750671|NCT00438607|Moderate to late stage Parkinson's Disease|moderate to late stage parkinson's disease
750672|NCT00438594|nurse|nurse
750673|NCT00438594|paraprofessional|paraprofessional
750674|NCT00438594|home visits|home visits
750675|NCT00438594|pregnancy|pregnancy
750676|NCT00438594|welfare|welfare
750677|NCT00438594|child development|child development
750678|NCT00438581|Zevalin|zevalin
750679|NCT00438581|Autologous one Marrow Transplant|autologous one marrow transplant
750680|NCT00438581|Non-Hodgkin's Lymphoma|non-hodgkin's lymphoma
750681|NCT00438568|amyloid protein|amyloid protein
750682|NCT00438568|brain metabolism|brain metabolism
750683|NCT00438568|glucose metabolism|glucose metabolism
750684|NCT00438568|insulin sensitivity /resistance|insulin sensitivity /resistance
750685|NCT00438568|cognition disorders|cognition disorders
750686|NCT00438555|obesity,prevention,pediatric|obesity,prevention,pediatric
750687|NCT00438542|Adiponectin, cord blood, pre-eclampsia|adiponectin, cord blood, pre-eclampsia
750688|NCT00438516|home visits|home visits
750689|NCT00438516|pregnancy|pregnancy
750690|NCT00438516|welfare|welfare
750691|NCT00438516|child development|child development
750692|NCT00438516|mortality|mortality
750693|NCT00438503|Hemodialysis, diabetes mellitus,|hemodialysis, diabetes mellitus,
750694|NCT00438503|Chronic renal failure, dialysis ,|chronic renal failure, dialysis ,
750695|NCT00438490|galactorrhea|galactorrhea
750696|NCT00438490|prolactin|prolactin
750697|NCT00438490|bone turnover|bone turnover
750698|NCT00438490|menstrual cycle|menstrual cycle
750699|NCT00438490|Control Groups|control groups
750700|NCT00438490|Women|women
750701|NCT00438477|recurrent breast cancer|recurrent breast cancer
750702|NCT00438477|stage IIIA breast cancer|stage iiia breast cancer
750703|NCT00438477|stage IIIB breast cancer|stage iiib breast cancer
750704|NCT00438477|stage IIIC breast cancer|stage iiic breast cancer
750705|NCT00438477|stage II breast cancer|stage ii breast cancer
750706|NCT00438451|elderly|elderly
750708|NCT00438451|anticonvulsive|anticonvulsive
750709|NCT00438451|treatment|treatment
750710|NCT00438451|levetiracetam|levetiracetam
750711|NCT00438451|lamotrigine|lamotrigine
750712|NCT00438451|carbamazepine|carbamazepine
750713|NCT00438438|forced desynchrony|forced desynchrony
750714|NCT00438438|circadian rhythms|circadian rhythms
750715|NCT00438438|sleep restriction|sleep restriction
750716|NCT00438438|sleep homeostasis|sleep homeostasis
750717|NCT00438438|neurobehavioral performance|neurobehavioral performance
750718|NCT00438425|Hyperlipidemia|hyperlipidemia
750719|NCT00438425|Hypercholesterolemia|hypercholesterolemia
750720|NCT00438425|Dietary modification|dietary modification
750721|NCT00438425|Portfolio|portfolio
750722|NCT00438412|Noradrenalin|noradrenalin
750723|NCT00438412|Endothelin-1|endothelin-1
750724|NCT00438412|Angiotensin II|angiotensin ii
750725|NCT00438412|Arginine vasopressin|arginine vasopressin
750726|NCT00438412|Aldosterone|aldosterone
750727|NCT00438412|Renin|renin
750728|NCT00438412|Atrial natriuretic peptide|atrial natriuretic peptide
750729|NCT00438412|Brain natriuretic peptide|brain natriuretic peptide
750730|NCT00438412|Blood pressure|blood pressure
750731|NCT00438412|Apnea|apnea
750732|NCT00438399|1 Galderma,|1 galderma,
750733|NCT00438399|2 Scalp Psoriasis|2 scalp psoriasis
750734|NCT00438399|3 Subject preference|3 subject preference
750735|NCT00438399|4 Clobetasol propionate|4 clobetasol propionate
750736|NCT00438399|5 Shampoo|5 shampoo
750737|NCT00438386|Generalized Anxiety Disorder|generalized anxiety disorder
750738|NCT00438386|Panic Disorder|panic disorder
750739|NCT00438386|Anxiety Disorder|anxiety disorder
750740|NCT00438386|Aripiprazole|aripiprazole
750741|NCT00438373|Subfertility, Luteinizing hormone, receptor|subfertility, luteinizing hormone, receptor
750742|NCT00438360|Cyclosporine, chronic plaque psoriasis, intermittent therapy|cyclosporine, chronic plaque psoriasis, intermittent therapy
750743|NCT00438347|Mild Cognitive Impairment|mild cognitive impairment
750744|NCT00438347|cognition disorders|cognition disorders
750745|NCT00438347|brain health|brain health
750746|NCT00438347|psychological aspect of aging|psychological aspect of aging
750747|NCT00438347|exercise|exercise
750748|NCT00438347|physical fitness|physical fitness
750749|NCT00438334|Benefit|benefit
750750|NCT00438334|Directional microphones|directional microphones
750751|NCT00438334|Hearing|hearing
750752|NCT00438334|Hearing aids|hearing aids
750753|NCT00438334|Hearing loss|hearing loss
750754|NCT00438334|Noise|noise
750755|NCT00438334|Objective benefit|objective benefit
750756|NCT00438334|Signal-to-noise ratio|signal-to-noise ratio
750757|NCT00438334|Speech understanding|speech understanding
750758|NCT00438334|Subjective benefit|subjective benefit
750759|NCT00438321|Overweight|overweight
750760|NCT00438321|obesity|obesity
750761|NCT00438321|testosterone|testosterone
750762|NCT00438321|diabetes|diabetes
750763|NCT00438321|metabolic syndrome|metabolic syndrome
750764|NCT00438321|aging|aging
750765|NCT00438308|distal radius fracture|distal radius fracture
750766|NCT00438308|rehabilitation|rehabilitation
750767|NCT00438308|volar plate fixation|volar plate fixation
750768|NCT00438308|DASH questionnaire|dash questionnaire
750769|NCT00438295|glucose in dialysis water, dialysis treatment, temperature|glucose in dialysis water, dialysis treatment, temperature
750770|NCT00438282|nurse|nurse
750771|NCT00438282|home visits|home visits
750772|NCT00438282|pregnancy|pregnancy
750773|NCT00438282|welfare|welfare
750774|NCT00438282|child development|child development
750775|NCT00438269|Infection|infection
750776|NCT00438269|Empiric|empiric
750777|NCT00438269|Antibiotics|antibiotics
750778|NCT00438269|Nosocomial|nosocomial
750779|NCT00438269|Pyrexia|pyrexia
750780|NCT00438269|Leukocytosis|leukocytosis
750781|NCT00438269|Resistance|resistance
750782|NCT00438256|accelerated short course|accelerated short course
750783|NCT00438256|proton beam radiation|proton beam radiation
750784|NCT00438243|Pseudophakic macular edema|pseudophakic macular edema
750785|NCT00438230|Residual vein thrombosis|residual vein thrombosis
750786|NCT00438230|Optimal duration|optimal duration
750787|NCT00438230|Oral anticoagulants|oral anticoagulants
750788|NCT00438217|precocious puberty, genetics, environmental factors|precocious puberty, genetics, environmental factors
750789|NCT00438204|stage IIIB non-small cell lung cancer|stage iiib non-small cell lung cancer
750790|NCT00438204|stage IV non-small cell lung cancer|stage iv non-small cell lung cancer
750791|NCT00438204|adenocarcinoma of the lung|adenocarcinoma of the lung
750792|NCT00438204|bronchoalveolar cell lung cancer|bronchoalveolar cell lung cancer
750793|NCT00438204|large cell lung cancer|large cell lung cancer
750794|NCT00438204|recurrent non-small cell lung cancer|recurrent non-small cell lung cancer
750795|NCT00438191|DeQuervain's tenosynovitis|dequervain's tenosynovitis
750796|NCT00438191|splinting|splinting
750797|NCT00438191|grip strength|grip strength
750798|NCT00438191|satisfaction|satisfaction
750799|NCT00438191|DASH questionnaire|dash questionnaire
750800|NCT00438165|nurse|nurse
750801|NCT00438165|home visits|home visits
750802|NCT00438165|pregnancy|pregnancy
750803|NCT00438165|welfare|welfare
750804|NCT00438165|child development|child development
750809|NCT00438152|Treatment Experienced|treatment experienced
750810|NCT00438139|marijuana dependence|marijuana dependence
750811|NCT00438126|diabetes|diabetes
750812|NCT00438126|Prevention|prevention
750813|NCT00438126|American Indian|american indian
750814|NCT00438113|blood pressure|blood pressure
750815|NCT00438113|atrial fibrillation|atrial fibrillation
750816|NCT00438113|catheter ablation|catheter ablation
750817|NCT00438100|Breast Neoplasms|breast neoplasms
750818|NCT00438100|Drug Therapy|drug therapy
750819|NCT00438087|Facial palsy|facial palsy
750820|NCT00438087|Vestibular schwannoma|vestibular schwannoma
750821|NCT00438087|Anti-inflammatory drugs|anti-inflammatory drugs
750822|NCT00438087|Post surgery of vestibular schwannoma|post surgery of vestibular schwannoma
750823|NCT00438087|or of cranial base tumors|or of cranial base tumors
750824|NCT00438074|Breast Cancer|breast cancer
750825|NCT00438074|Diffuse Optical Spectroscopy|diffuse optical spectroscopy
750826|NCT00438061|Lipoprotein metabolism|lipoprotein metabolism
750827|NCT00438061|Cardiovascular disease|cardiovascular disease
750828|NCT00438061|Obesity|obesity
750829|NCT00438048|Pilocarpine|pilocarpine
750830|NCT00438048|Artificial saliva|artificial saliva
750831|NCT00438048|Xerostomia|xerostomia
750832|NCT00438048|Xerostomy|xerostomy
750833|NCT00438048|Primary Sjogren|primary sjogren
750834|NCT00438048|Secondary Sjogren|secondary sjogren
750835|NCT00438035|Postoperative pain|postoperative pain
750836|NCT00438035|Heart rate variability, sympathetic, parasympathetic|heart rate variability, sympathetic, parasympathetic
750837|NCT00438035|Visual analog pain scale|visual analog pain scale
750838|NCT00438035|Spectral analysis of ECG|spectral analysis of ecg
750839|NCT00438022|Atopic Dermatitis|atopic dermatitis
750840|NCT00438022|Eczema Herpeticum|eczema herpeticum
750841|NCT00438009|coxsackievirus type a21|coxsackievirus type a21
750842|NCT00438009|oncolytic virus|oncolytic virus
750843|NCT00438009|melanoma|melanoma
750844|NCT00437996|Labor analgesia - clonidine - epidural|labor analgesia - clonidine - epidural
750845|NCT00437957|histone deacetylase|histone deacetylase
750846|NCT00437957|unresectable brain metastases|unresectable brain metastases
750847|NCT00437931|hypothyroidism|hypothyroidism
750848|NCT00437931|hyperthyroidism|hyperthyroidism
750849|NCT00437931|thyroid dysfunction|thyroid dysfunction
750850|NCT00437931|ultrasound|ultrasound
750851|NCT00437931|doppler|doppler
750852|NCT00437905|peripheral vascular disease|peripheral vascular disease
750853|NCT00437905|percutaneous transluminal angioplasty|percutaneous transluminal angioplasty
750854|NCT00437905|cutting balloon|cutting balloon
750855|NCT00437905|balloon angioplasty|balloon angioplasty
750856|NCT00437905|randomized controlled trial|randomized controlled trial
750857|NCT00437905|restenosis|restenosis
750858|NCT00437905|inflammation|inflammation
750859|NCT00437892|Statins|statins
750860|NCT00437892|secondary prevention|secondary prevention
750861|NCT00437892|venous thromboembolism|venous thromboembolism
750862|NCT00437892|d-dimer|d-dimer
750863|NCT00437879|Breast Cancer|breast cancer
750864|NCT00437879|Ultrasound|ultrasound
750865|NCT00437840|healthy volunteers,|healthy volunteers,
750866|NCT00437840|tolerability,|tolerability,
750867|NCT00437840|pharmacokinetics,|pharmacokinetics,
750868|NCT00437840|pharmacodynamics|pharmacodynamics
750869|NCT00437840|safety,|safety,
750870|NCT00437840|smoking,|smoking,
750871|NCT00437827|Depression|depression
750872|NCT00437814|Ketamine|ketamine
750873|NCT00437814|Traumatic Brain Injury|traumatic brain injury
750874|NCT00437814|Intracranial Hypertension|intracranial hypertension
750875|NCT00437788|imaging|imaging
750876|NCT00437775|Diabetes Mellitus type 2|diabetes mellitus type 2
750877|NCT00437775|ACE Inhibitors|ace inhibitors
750878|NCT00437775|ARBs|arbs
750879|NCT00437775|Adverse drug effect|adverse drug effect
750880|NCT00437762|Lateral epicondylitis, tennis elbow, treatment|lateral epicondylitis, tennis elbow, treatment
750881|NCT00437749|Non small cell lung cancer|non small cell lung cancer
750882|NCT00437749|Advanced|advanced
750883|NCT00437749|Inoperable|inoperable
750884|NCT00437749|taxanes|taxanes
750885|NCT00437749|carboplatin|carboplatin
750886|NCT00437749|multi-drug resistance|multi-drug resistance
750887|NCT00437736|solid tumor|solid tumor
750888|NCT00437736|phase I study|phase i study
750889|NCT00437736|dose-escalation|dose-escalation
750890|NCT00437710|bone marrow, cell transplantation, stem cells, PTCA|bone marrow, cell transplantation, stem cells, ptca
750891|NCT00437697|dalteparin, critically ill, thromboprophylaxis|dalteparin, critically ill, thromboprophylaxis
750892|NCT00437684|HIV/HCV|hiv/hcv
750893|NCT00437684|HIV and HCV coinfected patients|hiv and hcv coinfected patients
750894|NCT00437684|Treatment Experienced|treatment experienced
750895|NCT00437671|trismus|trismus
750896|NCT00437671|lockjaw|lockjaw
750897|NCT00437645|Essential hypertension|essential hypertension
750898|NCT00437645|blood pressure|blood pressure
750899|NCT00437645|edema|edema
750900|NCT00437645|valsartan|valsartan
750901|NCT00437645|amlodipine|amlodipine
750902|NCT00437645|combination treatment|combination treatment
750903|NCT00437632|repeat dose,|repeat dose,
750904|NCT00437632|placebo,|placebo,
750905|NCT00437632|Safety,|safety,
750906|NCT00437632|pharmacodynamics,|pharmacodynamics,
750907|NCT00437632|tolerability,|tolerability,
750908|NCT00437632|GSK598809|gsk598809
750909|NCT00437632|pharmacokinetics,|pharmacokinetics,
750910|NCT00437593|preretinal membrane|preretinal membrane
750911|NCT00437593|vitrectomy|vitrectomy
750912|NCT00437593|uhr-oct|uhr-oct
750913|NCT00437593|hd-oct|hd-oct
750914|NCT00437580|Vancomycin Resistant Enterococcus, probiotic|vancomycin resistant enterococcus, probiotic
750915|NCT00437567|galacto-oligosaccharides|galacto-oligosaccharides
750916|NCT00437567|prebiotics|prebiotics
750917|NCT00437567|NEC|nec
750918|NCT00437541|Insulation|insulation
750919|NCT00437541|Warmth|warmth
750920|NCT00437541|Humidity|humidity
750921|NCT00437541|Damp|damp
750922|NCT00437541|Cold|cold
750923|NCT00437541|Respiratory|respiratory
750924|NCT00437541|Mould|mould
750925|NCT00437528|Heat flow|heat flow
750926|NCT00437528|Sensor|sensor
750927|NCT00437528|Overactive bladder|overactive bladder
750928|NCT00437528|Urinary incontinence|urinary incontinence
750929|NCT00437502|Immunotherapeutic vaccine|immunotherapeutic vaccine
750930|NCT00437502|Ovarian cancer|ovarian cancer
750931|NCT00437502|epithelial ovarian cancer|epithelial ovarian cancer
750932|NCT00437502|tubal cancer|tubal cancer
750933|NCT00437502|peritoneal cancer|peritoneal cancer
750934|NCT00437502|immunotherapy|immunotherapy
750935|NCT00437476|HIV/HCV|hiv/hcv
750936|NCT00437476|HIV and HCV coinfected patients|hiv and hcv coinfected patients
750937|NCT00437476|Treatment Naive|treatment naive
750938|NCT00437450|Anemia|anemia
750939|NCT00437450|myelodysplastic syndromes|myelodysplastic syndromes
750940|NCT00437450|Low risk|low risk
750941|NCT00437450|Bone Marrow diseases|bone marrow diseases
750942|NCT00437437|Advanced or metastatic solid tumors|advanced or metastatic solid tumors
750943|NCT00437424|Hepatocellular cancer|hepatocellular cancer
750944|NCT00437424|Other advanced solid malignancies|other advanced solid malignancies
750945|NCT00437411|Fibromyalgia|fibromyalgia
750946|NCT00437411|Affect|affect
750947|NCT00437411|Pain|pain
750948|NCT00437411|Fatigue|fatigue
750949|NCT00437411|Sleep|sleep
750950|NCT00437411|Stress|stress
750951|NCT00437411|Quality of Life|quality of life
750952|NCT00437411|Stress, Psychological|stress, psychological
750953|NCT00437411|Psychophysiology|psychophysiology
750954|NCT00437411|Randomized Controlled Trials|randomized controlled trials
750955|NCT00437398|hypoglycemic unawareness|hypoglycemic unawareness
750956|NCT00437385|therapy resistant depression, severe depression|therapy resistant depression, severe depression
750957|NCT00437372|solid tumor|solid tumor
750958|NCT00437372|central nervous system|central nervous system
750959|NCT00437372|head and neck|head and neck
750960|NCT00437372|thorax|thorax
750961|NCT00437372|pelvic area|pelvic area
750962|NCT00437359|Breast Neoplasms|breast neoplasms
750963|NCT00437359|Drug Therapy|drug therapy
750964|NCT00437346|dyspepsia|dyspepsia
750965|NCT00437346|functional dyspepsia|functional dyspepsia
750966|NCT00437346|treatment|treatment
750967|NCT00437346|drug therapy|drug therapy
750968|NCT00437346|information|information
750969|NCT00437333|Insulin sensitivity|insulin sensitivity
750970|NCT00437333|Insulin-sensitizing drug|insulin-sensitizing drug
750971|NCT00437333|Metformin|metformin
750972|NCT00437333|PCOS|pcos
750973|NCT00437333|Treatment|treatment
750974|NCT00437320|PDT|pdt
750975|NCT00437320|Photoaging|photoaging
750976|NCT00437320|Galderma|galderma
750977|NCT00437281|Partial-onset seizures; epilepsy; pediatric; pregabalin; safety; tolerability; pharmacokinetics|partial-onset seizures; epilepsy; pediatric; pregabalin; safety; tolerability; pharmacokinetics
750978|NCT00437242|interval,|interval,
750979|NCT00437242|atrial fibrillation|atrial fibrillation
750980|NCT00437242|QT,|qt,
750981|NCT00437242|odiparcil,|odiparcil,
750982|NCT00437229|GW679769,|gw679769,
750983|NCT00437229|Casopitant,|casopitant,
750984|NCT00437229|Dexamethasone,|dexamethasone,
750985|NCT00437229|Healthy Human Volunteer|healthy human volunteer
750986|NCT00437229|Ondansetron,|ondansetron,
750987|NCT00437203|Advanced cancer|advanced cancer
750988|NCT00437190|Cervical Disc Replacement|cervical disc replacement
750989|NCT00437190|Spondylotic radiculopathy|spondylotic radiculopathy
750990|NCT00437190|Spondylotic myelopathy|spondylotic myelopathy
750991|NCT00437190|Myelopathy|myelopathy
750992|NCT00437190|Radiculopathy|radiculopathy
750993|NCT00437177|alcoholism|alcoholism
750994|NCT00437177|apomorphine|apomorphine
750995|NCT00437177|iodobenzamide|iodobenzamide
750996|NCT00437177|imaging|imaging
750997|NCT00437177|spect|spect
750998|NCT00437177|relapse|relapse
750999|NCT00437164|NaBr|nabr
751000|NCT00437164|Sodium Bromide|sodium bromide
751001|NCT00437164|DEXA Deuterium|dexa deuterium
751002|NCT00437164|Total Body Water|total body water
751003|NCT00437164|Insulin|insulin
751004|NCT00437164|D2O|d2o
751005|NCT00437164|GW677954|gw677954
751006|NCT00437164|Randomized Withdrawal|randomized withdrawal
751007|NCT00437164|T2DM|t2dm
751008|NCT00437138|Air pollution|air pollution
751009|NCT00437138|Myocardial ischemia|myocardial ischemia
751010|NCT00437138|Endothelium|endothelium
751107|NCT00436670|IL-13|il-13
751011|NCT00437138|Fibrinolysis|fibrinolysis
751012|NCT00437138|Pathophysiology|pathophysiology
751013|NCT00437138|Diesel exhaust|diesel exhaust
751014|NCT00437086|chronic myelomonocytic leukemia|chronic myelomonocytic leukemia
751015|NCT00437086|primary myelofibrosis|primary myelofibrosis
751016|NCT00437073|brain metastases|brain metastases
751017|NCT00437073|ErbB2|erbb2
751018|NCT00437073|lapatinib|lapatinib
751019|NCT00437073|Breast Cancer|breast cancer
751020|NCT00437073|HYCAMTIN|hycamtin
751021|NCT00437073|topotecan|topotecan
751022|NCT00437073|capecitabine|capecitabine
751023|NCT00437073|metastatic breast cancer|metastatic breast cancer
751024|NCT00437073|TYKERB|tykerb
751025|NCT00437073|XELODA|xeloda
751026|NCT00437021|smallpox, vaccine, IMVAMUNE®|smallpox, vaccine, imvamune®
751027|NCT00437008|endothelial dysfunction|endothelial dysfunction
751028|NCT00437008|flow-mediated dilatation|flow-mediated dilatation
751029|NCT00437008|advanced glycation end products|advanced glycation end products
751030|NCT00437008|postprandial|postprandial
751031|NCT00436995|Dialysis|dialysis
751032|NCT00436995|Anaemia|anaemia
751033|NCT00436969|Orthovisc|orthovisc
751034|NCT00436969|Osteoarthritis|osteoarthritis
751035|NCT00436969|Shoulder|shoulder
751036|NCT00436969|Randomized|randomized
751037|NCT00436956|VEGF|vegf
751038|NCT00436956|Angiogenesis|angiogenesis
751039|NCT00436956|Hormone-Refractory|hormone-refractory
751040|NCT00436956|Bone Metastases|bone metastases
751041|NCT00436956|Docetaxel-Resistant|docetaxel-resistant
751042|NCT00436956|Prostate Cancer|prostate cancer
751043|NCT00436943|smoking cessation|smoking cessation
751044|NCT00436943|nicotine replacement therapy|nicotine replacement therapy
751045|NCT00436943|bupropion|bupropion
751047|NCT00436930|recurrent melanoma|recurrent melanoma
751048|NCT00436930|stage IV melanoma|stage iv melanoma
751049|NCT00436917|stage I breast cancer|stage i breast cancer
751050|NCT00436917|stage II breast cancer|stage ii breast cancer
751051|NCT00436917|stage IIIA breast cancer|stage iiia breast cancer
751052|NCT00436917|osteoporosis|osteoporosis
751053|NCT00436904|stage 0 chronic lymphocytic leukemia|stage 0 chronic lymphocytic leukemia
751054|NCT00436904|stage I chronic lymphocytic leukemia|stage i chronic lymphocytic leukemia
751055|NCT00436904|stage II chronic lymphocytic leukemia|stage ii chronic lymphocytic leukemia
751056|NCT00436904|B-cell chronic lymphocytic leukemia|b-cell chronic lymphocytic leukemia
751057|NCT00436891|Group A Streptococcus, scabies, pyoderma, Fiji|group a streptococcus, scabies, pyoderma, fiji
751058|NCT00436878|Eating Behavior|eating behavior
751059|NCT00436878|Children|children
751060|NCT00436878|Portion size|portion size
751061|NCT00436878|Experimental|experimental
751062|NCT00436826|Multiple Sclerosis|multiple sclerosis
751063|NCT00436826|Relapsing forms|relapsing forms
751064|NCT00436826|Interferon-beta therapy|interferon-beta therapy
751065|NCT00436787|Anticoagulation Prophylaxis|anticoagulation prophylaxis
751066|NCT00436787|Venous Thrombosis|venous thrombosis
751067|NCT00436787|Deep Vein Thrombosis|deep vein thrombosis
751068|NCT00436787|Pulmonary Embolism|pulmonary embolism
751069|NCT00436787|Fondaparinux Sodium|fondaparinux sodium
751070|NCT00436787|Arixtra|arixtra
751071|NCT00436787|Pharmakinetics|pharmakinetics
751072|NCT00436774|long-term effects secondary to cancer therapy in children|long-term effects secondary to cancer therapy in children
751073|NCT00436774|neurotoxicity|neurotoxicity
751074|NCT00436774|gastrointestinal complications|gastrointestinal complications
751075|NCT00436774|pulmonary complications|pulmonary complications
751076|NCT00436774|sexual dysfunction|sexual dysfunction
751077|NCT00436774|infertility|infertility
751078|NCT00436774|urinary complications|urinary complications
751079|NCT00436774|childhood extragonadal germ cell tumor|childhood extragonadal germ cell tumor
751080|NCT00436774|childhood malignant ovarian germ cell tumor|childhood malignant ovarian germ cell tumor
751081|NCT00436774|childhood malignant testicular germ cell tumor|childhood malignant testicular germ cell tumor
751082|NCT00436774|childhood teratoma|childhood teratoma
751083|NCT00436761|unspecified childhood solid tumor, protocol specific|unspecified childhood solid tumor, protocol specific
751084|NCT00436748|Chronic Kidney Disease|chronic kidney disease
751085|NCT00436748|Dialysis|dialysis
751086|NCT00436748|Anemia|anemia
751087|NCT00436748|Nephrology|nephrology
751088|NCT00436748|Pediatric|pediatric
751089|NCT00436748|Hemodialysis|hemodialysis
751090|NCT00436748|Peritoneal Dialysis|peritoneal dialysis
751091|NCT00436748|Chronic Renal Insufficiency|chronic renal insufficiency
751092|NCT00436722|Liver|liver
751093|NCT00436722|Transplantation|transplantation
751094|NCT00436722|Tolerance|tolerance
751095|NCT00436722|Induction|induction
751096|NCT00436722|Tacrolimus|tacrolimus
751097|NCT00436722|Liver transplantation|liver transplantation
751098|NCT00436722|Adult|adult
751099|NCT00436709|male breast cancer|male breast cancer
751100|NCT00436709|stage I breast cancer|stage i breast cancer
751101|NCT00436709|stage II breast cancer|stage ii breast cancer
751102|NCT00436709|stage IIIA breast cancer|stage iiia breast cancer
751103|NCT00436683|Hyperphosphataemia|hyperphosphataemia
751104|NCT00436683|Phosphate binder|phosphate binder
751105|NCT00436670|Asthma|asthma
751106|NCT00436670|Allergy|allergy
751112|NCT00436657|Peritoneal Tumor|peritoneal tumor
751113|NCT00436657|Retroperitoneal Tumor|retroperitoneal tumor
751114|NCT00436657|Gastrointestinal Adenocarcinoma|gastrointestinal adenocarcinoma
751115|NCT00436657|Desmoplastic Round Cell Tumor|desmoplastic round cell tumor
751116|NCT00436657|Neuroblastoma|neuroblastoma
751117|NCT00436657|Ovarian Germ Cell|ovarian germ cell
751118|NCT00436657|Sarcoma|sarcoma
751119|NCT00436657|Adrenocorticocarcinoma|adrenocorticocarcinoma
751120|NCT00436657|Wilms' Tumor|wilms' tumor
751121|NCT00436657|Rhabdomyosarcoma|rhabdomyosarcoma
751122|NCT00436657|Desmoplastic Small Round Cell Tumor|desmoplastic small round cell tumor
751123|NCT00436657|Recurrent Tumors|recurrent tumors
751124|NCT00436657|Cisplatin|cisplatin
751125|NCT00436657|Platinol®-AQ|platinol®-aq
751126|NCT00436657|Platinol®|platinol®
751127|NCT00436657|CDDP|cddp
751128|NCT00436657|Abdominal Wash|abdominal wash
751129|NCT00436657|Hyperthermic Perfusion|hyperthermic perfusion
751130|NCT00436657|Continuous Hyperthermic Peritoneal Perfusion|continuous hyperthermic peritoneal perfusion
751131|NCT00436657|CHPP|chpp
751132|NCT00436644|recurrent ovarian epithelial cancer|recurrent ovarian epithelial cancer
751133|NCT00436644|peritoneal cavity cancer|peritoneal cavity cancer
751134|NCT00436631|epilepsy|epilepsy
751135|NCT00436631|seizures|seizures
751136|NCT00436631|intractable|intractable
751137|NCT00436631|ketosis|ketosis
751138|NCT00436631|ketogenic|ketogenic
751139|NCT00436631|diet|diet
751140|NCT00436618|recurrent adult Burkitt lymphoma|recurrent adult burkitt lymphoma
751141|NCT00436618|recurrent adult Hodgkin lymphoma|recurrent adult hodgkin lymphoma
751142|NCT00436618|anaplastic large cell lymphoma|anaplastic large cell lymphoma
751143|NCT00436618|angioimmunoblastic T-cell lymphoma|angioimmunoblastic t-cell lymphoma
751144|NCT00436618|extranodal marginal zone B-cell lymphoma of mucosa-associated lymphoid tissue|extranodal marginal zone b-cell lymphoma of mucosa-associated lymphoid tissue
751145|NCT00436618|nodal marginal zone B-cell lymphoma|nodal marginal zone b-cell lymphoma
751146|NCT00436618|splenic marginal zone lymphoma|splenic marginal zone lymphoma
751147|NCT00436618|small intestine lymphoma|small intestine lymphoma
751148|NCT00436618|recurrent adult diffuse mixed cell lymphoma|recurrent adult diffuse mixed cell lymphoma
751149|NCT00436618|recurrent adult T-cell leukemia/lymphoma|recurrent adult t-cell leukemia/lymphoma
751150|NCT00436618|recurrent grade 3 follicular lymphoma|recurrent grade 3 follicular lymphoma
751151|NCT00436618|recurrent marginal zone lymphoma|recurrent marginal zone lymphoma
751152|NCT00436618|refractory chronic lymphocytic leukemia|refractory chronic lymphocytic leukemia
751153|NCT00436618|recurrent small lymphocytic lymphoma|recurrent small lymphocytic lymphoma
751154|NCT00436618|recurrent mycosis fungoides/Sezary syndrome|recurrent mycosis fungoides/sezary syndrome
751155|NCT00436618|adult nasal type extranodal NK/T-cell lymphoma|adult nasal type extranodal nk/t-cell lymphoma
751156|NCT00436618|Waldenstrom macroglobulinemia|waldenstrom macroglobulinemia
751157|NCT00436618|recurrent adult diffuse large cell lymphoma|recurrent adult diffuse large cell lymphoma
751158|NCT00436618|recurrent adult lymphoblastic lymphoma|recurrent adult lymphoblastic lymphoma
751159|NCT00436618|recurrent mantle cell lymphoma|recurrent mantle cell lymphoma
751160|NCT00436618|recurrent grade 1 follicular lymphoma|recurrent grade 1 follicular lymphoma
751161|NCT00436618|recurrent grade 2 follicular lymphoma|recurrent grade 2 follicular lymphoma
751162|NCT00436618|primary central nervous system non-Hodgkin lymphoma|primary central nervous system non-hodgkin lymphoma
751163|NCT00436618|primary central nervous system Hodgkin lymphoma|primary central nervous system hodgkin lymphoma
751164|NCT00436618|post-transplant lymphoproliferative disorder|post-transplant lymphoproliferative disorder
751165|NCT00436618|recurrent adult diffuse small cleaved cell lymphoma|recurrent adult diffuse small cleaved cell lymphoma
751166|NCT00436592|acute|acute
751167|NCT00436592|ischemic|ischemic
751168|NCT00436592|stroke|stroke
751169|NCT00436592|device|device
751170|NCT00436592|treatment|treatment
751171|NCT00436566|cardiac toxicity|cardiac toxicity
751172|NCT00436566|male breast cancer|male breast cancer
751173|NCT00436566|stage I breast cancer|stage i breast cancer
751174|NCT00436566|stage II breast cancer|stage ii breast cancer
751175|NCT00436566|stage IIIA breast cancer|stage iiia breast cancer
751176|NCT00436553|Age-related macular degeneration; AMD|age-related macular degeneration; amd
751177|NCT00436553|choroidal neovascularization|choroidal neovascularization
751178|NCT00436553|verteporfin|verteporfin
751179|NCT00436553|ranibizumab|ranibizumab
751180|NCT00436514|patients|patients
751181|NCT00436514|medium risk|medium risk
751182|NCT00436514|asymptomatic|asymptomatic
751183|NCT00436514|between 50 and 74 years old|between 50 and 74 years old
751184|NCT00436514|high risk|high risk
751185|NCT00436514|case|case
751186|NCT00436514|history of neoplastic colic|history of neoplastic colic
751187|NCT00436514|cancers|cancers
751188|NCT00436514|polyps|polyps
751189|NCT00436501|primary peritoneal cavity cancer|primary peritoneal cavity cancer
751190|NCT00436501|Ovarian Epithelial Cancer|ovarian epithelial cancer
751191|NCT00436501|Peritoneal Cancer|peritoneal cancer
751192|NCT00436501|Fallopian Tube Cancer|fallopian tube cancer
751193|NCT00436501|VEGF Trap|vegf trap
751194|NCT00436501|aflibercept|aflibercept
751195|NCT00436501|vascular endothelial growth factor trap|vascular endothelial growth factor trap
751196|NCT00436501|Zaltrap|zaltrap
751203|NCT00436488|Gene variants|gene variants
751204|NCT00436475|Glucose intolerance|glucose intolerance
751205|NCT00436475|Type 2 diabetes mellitus|type 2 diabetes mellitus
751206|NCT00436475|Metabolic syndrome|metabolic syndrome
751207|NCT00436462|Steroid receptors|steroid receptors
751208|NCT00436462|Endometrium|endometrium
751209|NCT00436462|IVF|ivf
751210|NCT00436462|Follicular phase|follicular phase
751211|NCT00436436|adult giant cell glioblastoma|adult giant cell glioblastoma
751212|NCT00436436|adult gliosarcoma|adult gliosarcoma
751213|NCT00436436|recurrent adult brain tumor|recurrent adult brain tumor
751214|NCT00436436|adult glioblastoma|adult glioblastoma
751215|NCT00436423|pancreatic neoplasm|pancreatic neoplasm
751216|NCT00436423|drug therapy|drug therapy
751217|NCT00436423|gemcitabine|gemcitabine
751218|NCT00436423|TS-1|ts-1
751302|NCT00436215|Sorafenib|sorafenib
751219|NCT00436410|stage IV colon cancer|stage iv colon cancer
751220|NCT00436410|stage IV rectal cancer|stage iv rectal cancer
751221|NCT00436410|adult primary hepatocellular carcinoma|adult primary hepatocellular carcinoma
751222|NCT00436410|stage IV pancreatic cancer|stage iv pancreatic cancer
751223|NCT00436410|male breast cancer|male breast cancer
751224|NCT00436410|stage IV breast cancer|stage iv breast cancer
751225|NCT00436410|stage IV melanoma|stage iv melanoma
751226|NCT00436410|stage I breast cancer|stage i breast cancer
751227|NCT00436410|stage II breast cancer|stage ii breast cancer
751228|NCT00436410|stage IIIA breast cancer|stage iiia breast cancer
751229|NCT00436410|stage IIIB breast cancer|stage iiib breast cancer
751230|NCT00436410|stage IIIC breast cancer|stage iiic breast cancer
751231|NCT00436410|recurrent breast cancer|recurrent breast cancer
751232|NCT00436410|recurrent adrenocortical carcinoma|recurrent adrenocortical carcinoma
751233|NCT00436410|stage I adrenocortical carcinoma|stage i adrenocortical carcinoma
751234|NCT00436410|stage II adrenocortical carcinoma|stage ii adrenocortical carcinoma
751235|NCT00436410|stage III adrenocortical carcinoma|stage iii adrenocortical carcinoma
751236|NCT00436410|stage IV adrenocortical carcinoma|stage iv adrenocortical carcinoma
751237|NCT00436410|recurrent colon cancer|recurrent colon cancer
751238|NCT00436410|stage I colon cancer|stage i colon cancer
751239|NCT00436410|stage II colon cancer|stage ii colon cancer
751240|NCT00436410|stage III colon cancer|stage iii colon cancer
751241|NCT00436410|recurrent rectal cancer|recurrent rectal cancer
751242|NCT00436410|stage I rectal cancer|stage i rectal cancer
751243|NCT00436410|stage II rectal cancer|stage ii rectal cancer
751244|NCT00436410|stage III rectal cancer|stage iii rectal cancer
751245|NCT00436410|advanced adult primary liver cancer|advanced adult primary liver cancer
751246|NCT00436410|localized resectable adult primary liver cancer|localized resectable adult primary liver cancer
751247|NCT00436410|recurrent adult primary liver cancer|recurrent adult primary liver cancer
751248|NCT00436410|recurrent pancreatic cancer|recurrent pancreatic cancer
751249|NCT00436410|stage I pancreatic cancer|stage i pancreatic cancer
751250|NCT00436410|stage II pancreatic cancer|stage ii pancreatic cancer
751251|NCT00436410|stage III pancreatic cancer|stage iii pancreatic cancer
751252|NCT00436410|recurrent melanoma|recurrent melanoma
751253|NCT00436410|stage I melanoma|stage i melanoma
751254|NCT00436410|stage II melanoma|stage ii melanoma
751255|NCT00436410|stage III melanoma|stage iii melanoma
751256|NCT00436410|stage I renal cell cancer|stage i renal cell cancer
751257|NCT00436410|stage II renal cell cancer|stage ii renal cell cancer
751258|NCT00436410|stage III renal cell cancer|stage iii renal cell cancer
751259|NCT00436410|stage IV renal cell cancer|stage iv renal cell cancer
751260|NCT00436410|recurrent renal cell cancer|recurrent renal cell cancer
751261|NCT00436410|recurrent ovarian epithelial cancer|recurrent ovarian epithelial cancer
751262|NCT00436410|stage I ovarian epithelial cancer|stage i ovarian epithelial cancer
751263|NCT00436410|stage II ovarian epithelial cancer|stage ii ovarian epithelial cancer
751264|NCT00436410|stage III ovarian epithelial cancer|stage iii ovarian epithelial cancer
751265|NCT00436410|stage IV ovarian epithelial cancer|stage iv ovarian epithelial cancer
751266|NCT00436410|gastrointestinal cancer|gastrointestinal cancer
751267|NCT00436410|adult fibrosarcoma|adult fibrosarcoma
751268|NCT00436410|recurrent adult soft tissue sarcoma|recurrent adult soft tissue sarcoma
751269|NCT00436410|stage I adult soft tissue sarcoma|stage i adult soft tissue sarcoma
751270|NCT00436410|stage II adult soft tissue sarcoma|stage ii adult soft tissue sarcoma
751271|NCT00436410|stage III adult soft tissue sarcoma|stage iii adult soft tissue sarcoma
751272|NCT00436410|stage IV adult soft tissue sarcoma|stage iv adult soft tissue sarcoma
751273|NCT00436397|unspecified adult solid tumor, protocol specific|unspecified adult solid tumor, protocol specific
751274|NCT00436384|liver transplant|liver transplant
751275|NCT00436384|lung transplant|lung transplant
751276|NCT00436384|kidney transplant|kidney transplant
751277|NCT00436384|heart transplant|heart transplant
751279|NCT00436358|Mexico|mexico
751280|NCT00436358|Intussusception|intussusception
751281|NCT00436358|Epidemiology|epidemiology
751282|NCT00436345|analgesia|analgesia
751283|NCT00436345|Mechanical ventilation|mechanical ventilation
751284|NCT00436345|pharmaco-economic|pharmaco-economic
751285|NCT00436345|ICU|icu
751286|NCT00436332|recurrent non-small cell lung cancer|recurrent non-small cell lung cancer
751287|NCT00436332|stage IIIB non-small cell lung cancer|stage iiib non-small cell lung cancer
751288|NCT00436332|stage IV non-small cell lung cancer|stage iv non-small cell lung cancer
751289|NCT00436332|bronchoalveolar cell lung cancer|bronchoalveolar cell lung cancer
751290|NCT00436332|adenocarcinoma of the lung|adenocarcinoma of the lung
751291|NCT00436319|Infertility, downregulation, stimulation, agonists, long|infertility, downregulation, stimulation, agonists, long
751292|NCT00436306|prevention|prevention
751293|NCT00436306|behavior|behavior
751294|NCT00436306|risk reduction behavior|risk reduction behavior
751295|NCT00436267|recurrent pancreatic cancer|recurrent pancreatic cancer
751296|NCT00436267|stage IV pancreatic cancer|stage iv pancreatic cancer
751297|NCT00436267|liver metastases|liver metastases
751298|NCT00436228|healthy volunteer,|healthy volunteer,
751299|NCT00436228|Bioavailability,|bioavailability,
751300|NCT00436228|safety|safety
751301|NCT00436228|Phase I,|phase i,
751303|NCT00436215|Ovarian Cancer|ovarian cancer
751304|NCT00436215|Fallopian Cancer|fallopian cancer
751305|NCT00436215|Bevacizumab|bevacizumab
751306|NCT00436215|Peritoneal Cancer|peritoneal cancer
751307|NCT00436215|Fallopian Tube Cancer|fallopian tube cancer
751308|NCT00436202|Anemia|anemia
751309|NCT00436202|Iron|iron
751310|NCT00436202|Supplement|supplement
751311|NCT00436189|Ovarian|ovarian
751312|NCT00436189|Cancer|cancer
751313|NCT00436189|Pelvic|pelvic
751314|NCT00436189|Mass|mass
751315|NCT00436189|Tumor|tumor
751316|NCT00436189|Adnexal|adnexal
751317|NCT00436189|Proteomics|proteomics
751318|NCT00436176|Diabetes mellitus|diabetes mellitus
751319|NCT00436176|Quality of Health Care|quality of health care
751320|NCT00436176|Cultural Competency|cultural competency
751321|NCT00436176|Performance Feedback|performance feedback
751322|NCT00436176|Health navigator|health navigator
751323|NCT00436176|Health disparities|health disparities
751324|NCT00436176|Racial disparities|racial disparities
751325|NCT00436150|Adolescents|adolescents
751326|NCT00436150|Depression, postpartum|depression, postpartum
751327|NCT00436137|Colorectal cancer|colorectal cancer
751328|NCT00436137|Fecal occult blood test|fecal occult blood test
751329|NCT00436137|Abnormal test result|abnormal test result
751330|NCT00436137|Missed diagnosis|missed diagnosis
751331|NCT00436137|Delayed diagnosis|delayed diagnosis
751332|NCT00436111|hyperprolactinemia|hyperprolactinemia
751333|NCT00436111|autoantibody|autoantibody
751334|NCT00436098|congenital heart disease|congenital heart disease
751335|NCT00436098|exercise training|exercise training
751336|NCT00436098|motorpedagogical exercise|motorpedagogical exercise
751337|NCT00436098|children|children
751338|NCT00436098|CHD: hemodynamically not significant defects|chd: hemodynamically not significant defects
751339|NCT00436098|CHD: acyanotic defects after repair|chd: acyanotic defects after repair
751340|NCT00436098|CHD: cyanotic defects after repair|chd: cyanotic defects after repair
751341|NCT00436072|ZD6474|zd6474
751342|NCT00436072|cetuximab|cetuximab
751343|NCT00436072|irinotecan|irinotecan
751344|NCT00436046|interferon, vaccine, influenza|interferon, vaccine, influenza
751345|NCT00436020|clinical trial|clinical trial
751346|NCT00436020|TMS|tms
751347|NCT00436020|depression|depression
751348|NCT00436020|bipolar disorder|bipolar disorder
751349|NCT00436007|Africa|africa
751350|NCT00436007|Plasmodium falciparum|plasmodium falciparum
751351|NCT00436007|Malaria|malaria
751352|NCT00435994|Infant|infant
751353|NCT00435994|Respiratory Syncytial Virus|respiratory syncytial virus
751354|NCT00435994|Bronchiolitis|bronchiolitis
751355|NCT00435981|Type 1 diabetes|type 1 diabetes
751356|NCT00435981|GAD65|gad65
751357|NCT00435981|Autoimmunity|autoimmunity
751358|NCT00435981|C-peptide|c-peptide
751359|NCT00435981|Children|children
751360|NCT00435968|NK Cells|nk cells
751361|NCT00435968|Cytokines|cytokines
751362|NCT00435968|Lymphocytes|lymphocytes
751363|NCT00435968|Immunoglobulins|immunoglobulins
751364|NCT00435968|Th1 response|th1 response
751365|NCT00435955|Follicular lymphoma|follicular lymphoma
751366|NCT00435955|age adjusted IPI >1|age adjusted ipi >1
751367|NCT00435955|IIL score > 2|iil score > 2
751368|NCT00435955|Molecular remission|molecular remission
751369|NCT00435955|High dose chemotherapy and autologous transplantation|high dose chemotherapy and autologous transplantation
751370|NCT00435955|Rituximab|rituximab
751371|NCT00435929|Treatment Naive|treatment naive
751372|NCT00435916|Antigens, CD40|antigens, cd40
751373|NCT00435916|Antibody, Monoclonal|antibody, monoclonal
751374|NCT00435916|Lymphoma, Large B-Cell, Diffuse|lymphoma, large b-cell, diffuse
751375|NCT00435916|Lymphoma, Non-Hodgkin|lymphoma, non-hodgkin
751376|NCT00435916|Hematologic Diseases|hematologic diseases
751377|NCT00435916|Immunoproliferative Disorders|immunoproliferative disorders
751378|NCT00435916|Lymphatic Diseases|lymphatic diseases
751379|NCT00435916|Lymphoproliferative Disorders|lymphoproliferative disorders
751380|NCT00435916|Lymphoma|lymphoma
751381|NCT00435903|smoking|smoking
751382|NCT00435903|self-monitoring|self-monitoring
751383|NCT00435903|major mental illness|major mental illness
751384|NCT00435903|palm pilots|palm pilots
751385|NCT00435903|subjects with DSM-IV Axis I diagnosis|subjects with dsm-iv axis i diagnosis
751386|NCT00435890|ED Overcrowding|ed overcrowding
751485|NCT00435357|knee|knee
751387|NCT00435890|Length of stay|length of stay
751388|NCT00435890|Emergency triage|emergency triage
751389|NCT00435890|triage|triage
751390|NCT00435877|Connective Tissue|connective tissue
751391|NCT00435877|Stromal Cells|stromal cells
751392|NCT00435877|Surgical Waste|surgical waste
751393|NCT00435877|In Vivo Studies|in vivo studies
751394|NCT00435877|Tissue Analysis|tissue analysis
751395|NCT00435864|recipient of a HSC graft in Acute Myeloblastic Leukemia therapy|recipient of a hsc graft in acute myeloblastic leukemia therapy
751396|NCT00435864|recipient of a HSC graft in others pathologies treated in hematology of Nantes university hospital or Angers university hospital|recipient of a hsc graft in others pathologies treated in hematology of nantes university hospital or angers university hospital
751397|NCT00435864|donors are healthy subjects|donors are healthy subjects
751398|NCT00435838|HLa-B*5701 Abacavir|hla-b*5701 abacavir
751399|NCT00435812|HBV vaccine|hbv vaccine
751400|NCT00435812|Hepatitis B vaccine|hepatitis b vaccine
751401|NCT00435812|Hepatitis B|hepatitis b
751402|NCT00435812|Hepatitis|hepatitis
751403|NCT00435812|HBV|hbv
751404|NCT00435812|Immunostimulatory sequence (ISS)|immunostimulatory sequence (iss)
751405|NCT00435799|keratoconus|keratoconus
751406|NCT00435799|corneal cross-linking|corneal cross-linking
751407|NCT00435799|riboflavine|riboflavine
751408|NCT00435799|ultraviolet type A rays (UVA)|ultraviolet type a rays (uva)
751409|NCT00435773|Osteoarthritis|osteoarthritis
751410|NCT00435773|Leeching|leeching
751411|NCT00435773|Randomized Controlled Trial|randomized controlled trial
751412|NCT00435773|Arthralgia|arthralgia
751413|NCT00435760|COPD|copd
751414|NCT00435721|schizophrenia|schizophrenia
751415|NCT00435721|family psychoeducation|family psychoeducation
751416|NCT00435708|COPD|copd
751417|NCT00435708|Fruit|fruit
751418|NCT00435708|Vegetables|vegetables
751419|NCT00435708|Oxidative stress|oxidative stress
751420|NCT00435708|Inflammation|inflammation
751421|NCT00435695|PET scan|pet scan
751422|NCT00435695|healthy males|healthy males
751423|NCT00435682|The trial is performed on healthy normal males.|the trial is performed on healthy normal males.
751424|NCT00435669|Advanced or metastatic solid tumors|advanced or metastatic solid tumors
751425|NCT00435656|Human immunodeficiency virus|human immunodeficiency virus
751426|NCT00435643|Sleep apnea,|sleep apnea,
751427|NCT00435643|adiponectin ,|adiponectin ,
751428|NCT00435643|HPA axis|hpa axis
751429|NCT00435630|Education|education
751430|NCT00435630|Virtual Reality|virtual reality
751431|NCT00435630|Laparoscopic Surgery|laparoscopic surgery
751432|NCT00435630|Learning Curve|learning curve
751433|NCT00435617|stroke rehabilitation|stroke rehabilitation
751434|NCT00435617|stroke therapy|stroke therapy
751435|NCT00435617|hand therapy|hand therapy
751436|NCT00435617|stroke|stroke
751437|NCT00435617|cerebrovascular stroke|cerebrovascular stroke
751438|NCT00435617|cerebral stroke|cerebral stroke
751439|NCT00435604|hyaluronidase|hyaluronidase
751440|NCT00435604|subcutaneous drug delivery|subcutaneous drug delivery
751441|NCT00435604|Volunteer Subjects|volunteer subjects
751442|NCT00435591|Hyponatremia|hyponatremia
751443|NCT00435591|Euvolemia|euvolemia
751444|NCT00435591|Hypervolemia|hypervolemia
751445|NCT00435591|Conivaptan|conivaptan
751446|NCT00435591|Vaprisol®|vaprisol®
751447|NCT00435591|YM087|ym087
751448|NCT00435578|Recurrent Sensitive Small-Cell Lung Cancer|recurrent sensitive small-cell lung cancer
751449|NCT00435539|Vitreomacular Traction|vitreomacular traction
751450|NCT00435539|Maculopathy|maculopathy
751451|NCT00435539|VMT|vmt
751452|NCT00435539|PVD|pvd
751453|NCT00435526|traveler's diarrhea|traveler's diarrhea
751454|NCT00435526|ETEC diarrhea|etec diarrhea
751455|NCT00435526|passive immunization|passive immunization
751456|NCT00435526|bovine milk prophylaxis|bovine milk prophylaxis
751457|NCT00435500|Dental caries, topical fluorides|dental caries, topical fluorides
751458|NCT00435487|Non-ST Elevation Acute Coronary Syndromes coronary interventions|non-st elevation acute coronary syndromes coronary interventions
751459|NCT00435474|Cancer|cancer
751460|NCT00435474|Malignant wounds|malignant wounds
751461|NCT00435474|Quality of life|quality of life
751462|NCT00435474|Body-Image|body-image
751463|NCT00435474|Cancer patients|cancer patients
751464|NCT00435461|once daily|once daily
751465|NCT00435461|mountain cedar|mountain cedar
751466|NCT00435461|fexofenadine|fexofenadine
751467|NCT00435461|allergic rhinitis|allergic rhinitis
751468|NCT00435461|fluticasone furoate|fluticasone furoate
751469|NCT00435448|Benign Prostatic Hyperplasia|benign prostatic hyperplasia
751470|NCT00435448|BPH|bph
751471|NCT00435448|Enlarged Prostate|enlarged prostate
751472|NCT00435435|Alcoholism|alcoholism
751473|NCT00435435|Dependence|dependence
751474|NCT00435435|Randomization|randomization
751475|NCT00435435|Effect|effect
751476|NCT00435435|Disulfiram|disulfiram
751477|NCT00435435|Naltrexone|naltrexone
751478|NCT00435435|Acamprosate|acamprosate
751479|NCT00435383|Caudal Block|caudal block
751480|NCT00435383|Oxygen Saturation|oxygen saturation
751481|NCT00435383|Uni or Bilateral Orchidopexy|uni or bilateral orchidopexy
751482|NCT00435357|Mobile-bearing|mobile-bearing
751483|NCT00435357|arthroplasty|arthroplasty
751484|NCT00435357|fixed-bearing|fixed-bearing
751487|NCT00435357|posterior stabilized TKA|posterior stabilized tka
751488|NCT00435344|Pediatric practice|pediatric practice
751489|NCT00435344|Smoking cessation|smoking cessation
751490|NCT00435344|Smoking prevention|smoking prevention
751491|NCT00435344|Adolescents|adolescents
751492|NCT00435331|Pulmonary Arterial Hypertension|pulmonary arterial hypertension
751493|NCT00435331|PPH|pph
751494|NCT00435305|continuous infusion|continuous infusion
751495|NCT00435305|epithelial lining fluid|epithelial lining fluid
751496|NCT00435305|antibiotics|antibiotics
751497|NCT00435305|pneumonia|pneumonia
751498|NCT00435305|critical illness|critical illness
751499|NCT00435279|Insomnia|insomnia
751500|NCT00435279|Depression|depression
751501|NCT00435279|Major Depressive Disorder|major depressive disorder
751502|NCT00435266|myocardial infarction|myocardial infarction
751504|NCT00435266|preconditioning|preconditioning
751505|NCT00435266|perconditioning|perconditioning
751506|NCT00435266|cardioprotection|cardioprotection
751507|NCT00435253|emphysema|emphysema
751508|NCT00435253|COPD|copd
751509|NCT00435253|lung volume reduction|lung volume reduction
751510|NCT00435253|NETT|nett
751511|NCT00435253|BLVR|blvr
751512|NCT00435253|biologic lung volume reduction|biologic lung volume reduction
751513|NCT00435253|bronchoscopic lung volume reduction|bronchoscopic lung volume reduction
751514|NCT00435227|Respiratory Syncytial Viruses|respiratory syncytial viruses
751515|NCT00435214|Cytology|cytology
751516|NCT00435214|papilloma virus|papilloma virus
751517|NCT00435214|CIN|cin
751518|NCT00435214|Screening|screening
751519|NCT00435214|Cervix|cervix
751520|NCT00435214|Cervical Cancer|cervical cancer
751521|NCT00435188|Aging|aging
751522|NCT00435188|Cost analysis|cost analysis
751523|NCT00435188|Counseling|counseling
751524|NCT00435188|Disabled Persons|disabled persons
751525|NCT00435188|Health Promotion|health promotion
751526|NCT00435188|Mobility Limitation|mobility limitation
751527|NCT00435188|Physical Activity|physical activity
751528|NCT00435188|Primary Care|primary care
751529|NCT00435188|Randomized Clinical Trial|randomized clinical trial
751530|NCT00435188|Veterans|veterans
751531|NCT00435175|Estradiol|estradiol
751532|NCT00435175|Lipolysis|lipolysis
751533|NCT00435175|Estrogen receptor|estrogen receptor
751534|NCT00435175|Adrenergic receptors|adrenergic receptors
751535|NCT00435175|UCP2|ucp2
751536|NCT00435175|Postmenopausal women|postmenopausal women
751537|NCT00435162|Children|children
751538|NCT00435162|pediatrics|pediatrics
751539|NCT00435162|High Blood Pressure|high blood pressure
751540|NCT00435162|Hypertension|hypertension
751541|NCT00435162|Valsartan|valsartan
751542|NCT00435123|Malnutrition|malnutrition
751543|NCT00435123|ESRD|esrd
751544|NCT00435123|Hemodialysis|hemodialysis
751545|NCT00435110|ARDS|ards
751546|NCT00435110|ALI|ali
751547|NCT00435110|Mechanical Ventilation|mechanical ventilation
751548|NCT00435110|Outcome|outcome
751549|NCT00435097|colon cancer|colon cancer
751550|NCT00435097|metastatic colorectal cancer|metastatic colorectal cancer
751551|NCT00435097|MRI|mri
751552|NCT00435097|Magnetic resonance imaging|magnetic resonance imaging
751553|NCT00435097|Early cancer detection|early cancer detection
751554|NCT00435097|medical image processing|medical image processing
751555|NCT00435097|machine learning|machine learning
751556|NCT00435097|disease modeling|disease modeling
751557|NCT00435097|Colon Cancer Stage III|colon cancer stage iii
751558|NCT00435084|Refractory B-CLL|refractory b-cll
751559|NCT00435084|phase I/II|phase i/ii
751560|NCT00435084|CD38|cd38
751561|NCT00435058|intraocular pressure|intraocular pressure
751562|NCT00435058|contrast sensitivity|contrast sensitivity
751563|NCT00435058|visual function|visual function
751564|NCT00435045|Lovaza|lovaza
751565|NCT00435045|Hyperlipidemias|hyperlipidemias
751566|NCT00435045|Triglycerides|triglycerides
751567|NCT00435045|Lipids|lipids
751568|NCT00435045|omega-3 fatty acids|omega-3 fatty acids
751569|NCT00435045|Hypercholesterolemia|hypercholesterolemia
751570|NCT00435045|Hypertriglyceridemia|hypertriglyceridemia
751571|NCT00435045|omega-3-acid ethyl esters|omega-3-acid ethyl esters
751572|NCT00435045|Omacor|omacor
751573|NCT00435045|Dyslipidemias|dyslipidemias
751574|NCT00435032|ruptured appendicitis|ruptured appendicitis
751575|NCT00435032|children|children
751576|NCT00435032|surgery|surgery
751577|NCT00435032|randomized trial|randomized trial
751578|NCT00434993|Acute Lung Injury|acute lung injury
751579|NCT00434993|Acute Respiratory Distress Syndrome|acute respiratory distress syndrome
751580|NCT00434993|Albuterol|albuterol
751581|NCT00434993|Aerosolized|aerosolized
751582|NCT00434993|Critical Care|critical care
751583|NCT00434993|Ventilator|ventilator
751584|NCT00434980|Cognitive adaption|cognitive adaption
751585|NCT00434980|Schizophrenia|schizophrenia
751586|NCT00434980|Cognitive rehabilitation|cognitive rehabilitation
751587|NCT00434980|Family treatment|family treatment
751588|NCT00434980|Cognitive deficits|cognitive deficits
751589|NCT00434980|Serious mental illness|serious mental illness
751590|NCT00434967|Blood pressure reduction|blood pressure reduction
751591|NCT00434967|combination therapy|combination therapy
751592|NCT00434967|candesartan cilexetil|candesartan cilexetil
751593|NCT00434967|hydrochlorothiazide|hydrochlorothiazide
751594|NCT00434954|diabetes|diabetes
751595|NCT00434954|exenatide|exenatide
751596|NCT00434954|Byetta|byetta
751597|NCT00434954|Amylin|amylin
751598|NCT00434954|Lilly|lilly
751599|NCT00434941|Administration of capecitabine concomitant to radiotherapy|administration of capecitabine concomitant to radiotherapy
751600|NCT00434941|Her2: negative|her2: negative
751601|NCT00434928|observational|observational
751602|NCT00434928|dietary intake|dietary intake
751603|NCT00434928|nutrient status|nutrient status
751604|NCT00434928|serum assessors|serum assessors
751605|NCT00434928|Attention-Deficit/Hyperactivity Disorder (ADHD)|attention-deficit/hyperactivity disorder (adhd)
751606|NCT00434902|Doppler Echocardiography|doppler echocardiography
751607|NCT00434902|Pulmonary hypertension|pulmonary hypertension
751608|NCT00434902|Sickle cell disease|sickle cell disease
751609|NCT00434889|dementia|dementia
751610|NCT00434889|falls|falls
751611|NCT00434889|risk factors|risk factors
751612|NCT00434876|Alcoholism|alcoholism
751613|NCT00434876|Insomnia|insomnia
751614|NCT00434876|Quetiapine|quetiapine
751615|NCT00434876|Seroquel|seroquel
751616|NCT00434863|botulinum toxin type A|botulinum toxin type a
751617|NCT00434863|Dysport®|dysport®
751618|NCT00434863|Botox®|botox®
751619|NCT00434863|hyperfunctional forehead lines|hyperfunctional forehead lines
751620|NCT00434863|randomized controlled trial|randomized controlled trial
751621|NCT00434863|double-blinded trial|double-blinded trial
751622|NCT00434863|electromyogram (EMG)|electromyogram (emg)
751623|NCT00434850|Insulin dependence|insulin dependence
751624|NCT00434850|Hypoglycemia|hypoglycemia
751625|NCT00434850|Hyperglycemia unawareness|hyperglycemia unawareness
751626|NCT00434837|Knee|knee
751627|NCT00434837|Ligament|ligament
751628|NCT00434837|ACL|acl
751629|NCT00434837|Reconstruction|reconstruction
751630|NCT00434837|Cartilage|cartilage
751631|NCT00434837|Osteoarthritis|osteoarthritis
751632|NCT00434811|Insulin dependence|insulin dependence
751633|NCT00434811|Hypoglycemia|hypoglycemia
751634|NCT00434811|Hypoglycemia unawareness|hypoglycemia unawareness
751635|NCT00434798|Campylobacter infections|campylobacter infections
751636|NCT00434772|hypoglycemia|hypoglycemia
751637|NCT00434772|glucagon|glucagon
751638|NCT00434772|neonatal|neonatal
751639|NCT00434772|gestational diabetes|gestational diabetes
751640|NCT00434772|insulin|insulin
751641|NCT00434772|glyburide|glyburide
751642|NCT00434759|randomized controlled trial|randomized controlled trial
751643|NCT00434759|stepped-care program|stepped-care program
751644|NCT00434759|cognitive therapy of social phobia according to D.M. Clark|cognitive therapy of social phobia according to d.m. clark
751645|NCT00434733|Influenza H5N1, pandemic|influenza h5n1, pandemic
751646|NCT00434720|GlideScope|glidescope
751647|NCT00434720|Stylet|stylet
751648|NCT00434707|glaucoma|glaucoma
751649|NCT00434707|catarat|catarat
751650|NCT00434707|small pupils|small pupils
751651|NCT00434694|Atrial Fibrillation|atrial fibrillation
751652|NCT00434694|Catheter ablation|catheter ablation
751653|NCT00434694|Pulmonary Vein|pulmonary vein
751654|NCT00434668|Non-Small Cell Lung Cancer|non-small cell lung cancer
751655|NCT00434668|NSCLC|nsclc
751656|NCT00434668|Adjuvant chemotherapy for completely resected NSCLC|adjuvant chemotherapy for completely resected nsclc
751657|NCT00434655|Morbid obesity|morbid obesity
751658|NCT00434655|Bariatric surgery|bariatric surgery
751659|NCT00434655|Obesity surgery|obesity surgery
751660|NCT00434655|Gastric banding|gastric banding
751661|NCT00434655|Sleeve gastrectomy|sleeve gastrectomy
751662|NCT00434642|Avastin|avastin
751663|NCT00434642|Ovarian carcinoma|ovarian carcinoma
751664|NCT00434642|Peritoneal carcinoma|peritoneal carcinoma
751665|NCT00434642|Peritoneal cancer|peritoneal cancer
751666|NCT00434642|Fallopian tube cancer|fallopian tube cancer
751667|NCT00434642|Fallopian tube carcinoma|fallopian tube carcinoma
751668|NCT00434642|OCEANS|oceans
751669|NCT00434629|lymphoma|lymphoma
751670|NCT00434629|Non-Hodgkin's lymphoma|non-hodgkin's lymphoma
751671|NCT00434629|B-cell lymphoma|b-cell lymphoma
751672|NCT00434629|Radioimmunotherapy|radioimmunotherapy
751673|NCT00434629|Bexxar|bexxar
751674|NCT00434629|tositumomab|tositumomab
751675|NCT00434629|autologous hematopoietic stem cell transplantation|autologous hematopoietic stem cell transplantation
751676|NCT00434616|angiogenesis|angiogenesis
751677|NCT00434616|Arterial Occlusive Diseases|arterial occlusive diseases
751678|NCT00434616|Leg Ulcer|leg ulcer
751679|NCT00434616|Gangrene|gangrene
751680|NCT00434616|Ischemia|ischemia
751681|NCT00434616|PAOD|paod
751682|NCT00434616|Amputation|amputation
751683|NCT00434616|bone marrow|bone marrow
751684|NCT00434590|Kidney Transplantation|kidney transplantation
751685|NCT00434590|Mycophenolic Acid|mycophenolic acid
751686|NCT00434590|Immunosuppression|immunosuppression
751687|NCT00434590|Cyclosporine|cyclosporine
751688|NCT00434577|GSK Biologicals|gsk biologicals
751689|NCT00434577|Herpes Zoster (HZ)|herpes zoster (hz)
751690|NCT00434577|Vaccine|vaccine
751691|NCT00434577|Varicella Zoster Virus (VZV)|varicella zoster virus (vzv)
751692|NCT00434577|Shingles|shingles
751693|NCT00434564|Stress nuclear scan|stress nuclear scan
751694|NCT00434564|Acute chest pain|acute chest pain
751695|NCT00434551|small bowel Crohn's disease|small bowel crohn's disease
751696|NCT00434551|capsule endoscopy|capsule endoscopy
751697|NCT00434551|PillCam SB|pillcam sb
751698|NCT00434551|Patients with suspected small bowel Crohn's disease|patients with suspected small bowel crohn's disease
751699|NCT00434538|Diabetic|diabetic
751700|NCT00434538|Foot|foot
751701|NCT00434538|Ulcer|ulcer
751702|NCT00434538|Neuropathic|neuropathic
751703|NCT00434538|Chitosan|chitosan
751704|NCT00434525|Morbid obesity|morbid obesity
751705|NCT00434525|Bariatric Surgery|bariatric surgery
751706|NCT00434525|Obesity Surgery|obesity surgery
751707|NCT00434525|Omentectomy|omentectomy
751708|NCT00434525|Sleeve gastrectomy|sleeve gastrectomy
751709|NCT00434512|Gag|gag
751710|NCT00434512|vaccine|vaccine
751711|NCT00434512|adjuvant|adjuvant
751712|NCT00434512|HIV|hiv
751713|NCT00434512|Pol|pol
751714|NCT00434512|Nef|nef
751715|NCT00434499|Green Tea|green tea
751716|NCT00434499|Insulin Resistance|insulin resistance
751717|NCT00434499|Endothelial Dysfunction|endothelial dysfunction
751718|NCT00434499|Nitric Oxide|nitric oxide
751719|NCT00434499|Inflammation|inflammation
751720|NCT00434499|Obesity|obesity
751721|NCT00434499|Overweight|overweight
751722|NCT00434499|Diabetes Type 2|diabetes type 2
751723|NCT00434499|High Blood Pressure|high blood pressure
751724|NCT00434499|Healthy Volunteer|healthy volunteer
751725|NCT00434499|HV|hv
751726|NCT00434460|Ventilator Associated Pneumonia|ventilator associated pneumonia
751727|NCT00434460|Knowledge Translation|knowledge translation
751728|NCT00434460|Clinical Practice Guidelines|clinical practice guidelines
751729|NCT00434460|Education|education
751730|NCT00434460|Behaviour Change|behaviour change
751731|NCT00434447|Prostate Cancer|prostate cancer
751732|NCT00434447|Breast Cancer|breast cancer
751733|NCT00434447|Multiple Myeloma|multiple myeloma
751734|NCT00434447|Zoledronic acid|zoledronic acid
751735|NCT00434447|Bone metastases|bone metastases
751736|NCT00434447|Skeletal Related Events (SREs)|skeletal related events (sres)
751737|NCT00434447|Renal Impairment|renal impairment
751738|NCT00434447|Osteonecrosis of the Jaw (ONJ)|osteonecrosis of the jaw (onj)
751739|NCT00434447|Bone involvement|bone involvement
751740|NCT00434447|Multiple Myeloma (MM)|multiple myeloma (mm)
751741|NCT00434434|AQUA|aqua
751742|NCT00434434|anti-CD11|anti-cd11
751743|NCT00434434|CD11a|cd11a
751744|NCT00434434|Asthma|asthma
751745|NCT00434434|Allergy|allergy
751746|NCT00434421|Perennial Allergic Rhinitis|perennial allergic rhinitis
751747|NCT00434421|Asthma|asthma
751748|NCT00434421|Sublingual Immunotherapy (SLIT)|sublingual immunotherapy (slit)
751749|NCT00434408|omphalitis|omphalitis
751750|NCT00434408|neonates|neonates
751751|NCT00434408|umbilical cord|umbilical cord
751752|NCT00434408|infection|infection
751753|NCT00434408|infant mortality|infant mortality
751754|NCT00434408|neonate morbidity|neonate morbidity
751755|NCT00434408|chlorhexidine|chlorhexidine
751756|NCT00434382|auditory evoked potentials|auditory evoked potentials
751757|NCT00434382|sensory processing|sensory processing
751758|NCT00434382|monitoring|monitoring
751759|NCT00434382|general anesthesia|general anesthesia
751760|NCT00434356|Avastin|avastin
751761|NCT00434356|MBC|mbc
751762|NCT00434356|Breast Cancer|breast cancer
751763|NCT00434356|Sutent|sutent
751764|NCT00434343|Interstitial Cystitis|interstitial cystitis
751765|NCT00434343|Painful Bladder Syndrome|painful bladder syndrome
751766|NCT00434343|Chronic Prostatitis|chronic prostatitis
751767|NCT00434343|Chronic Pelvic Pain Syndrome|chronic pelvic pain syndrome
751768|NCT00434330|anemia|anemia
751769|NCT00434330|chronic kidney disease|chronic kidney disease
751770|NCT00434330|CKD|ckd
751771|NCT00434330|chronic renal failure|chronic renal failure
751772|NCT00434330|CRF|crf
751773|NCT00434330|dialysis|dialysis
751774|NCT00434330|erythropoietin|erythropoietin
751775|NCT00434330|EPO|epo
751776|NCT00434330|erythropoiesis stimulating agent|erythropoiesis stimulating agent
751777|NCT00434330|ESA|esa
751778|NCT00434330|Hematide™|hematide™
751779|NCT00434330|hemodialysis|hemodialysis
751780|NCT00434330|hemoglobin|hemoglobin
751781|NCT00434330|Hb|hb
751782|NCT00434330|Hgb|hgb
751783|NCT00434330|Omontys|omontys
751784|NCT00434330|peginesatide|peginesatide
751785|NCT00434330|red blood cell|red blood cell
751786|NCT00434330|red blood cell production|red blood cell production
751787|NCT00434317|Metastasis|metastasis
751788|NCT00434317|Neoplasm|neoplasm
751789|NCT00434317|pain|pain
751790|NCT00434317|breast cancer|breast cancer
751791|NCT00434317|prostate cancer|prostate cancer
751792|NCT00434317|bone metastasis|bone metastasis
751793|NCT00434304|Parkinson's Disease|parkinson's disease
751794|NCT00434304|PD|pd
751795|NCT00434291|Community-acquired Pneumonia|community-acquired pneumonia
751796|NCT00434291|fluoroquinolone|fluoroquinolone
751797|NCT00434291|TG-873870|tg-873870
751799|NCT00434278|Lung disease|lung disease
751800|NCT00434278|CF|cf
751801|NCT00434278|Pulmozyme|pulmozyme
751802|NCT00434265|Obesity|obesity
751803|NCT00434265|Exercise|exercise
751804|NCT00434265|Fat oxidation|fat oxidation
751805|NCT00434265|Overweigh (IMC>25 and IMC<30)|overweigh (imc>25 and imc<30)
751806|NCT00434252|Avastin|avastin
751807|NCT00434252|BEAM|beam
751808|NCT00434252|Metastatic melanoma|metastatic melanoma
751809|NCT00434239|Myelodysplasia|myelodysplasia
751810|NCT00434239|Lenalidomide|lenalidomide
751811|NCT00434239|Ancestim|ancestim
751812|NCT00434239|Pilot trial|pilot trial
751813|NCT00434239|Biomarkers|biomarkers
751814|NCT00434226|SABER-L|saber-l
751815|NCT00434226|NSCLC|nsclc
751816|NCT00434226|Avastin|avastin
751817|NCT00434226|Sutent|sutent
751818|NCT00434200|rheumatoid arthritis|rheumatoid arthritis
751819|NCT00434200|exercise|exercise
751820|NCT00434200|damage|damage
751821|NCT00434187|healthy|healthy
751822|NCT00434174|Lung cancer|lung cancer
751823|NCT00434174|Non small cell lung cancer|non small cell lung cancer
751824|NCT00434174|NSCLC|nsclc
751825|NCT00434174|RAD001|rad001
751826|NCT00434174|Everolimus|everolimus
751827|NCT00434174|Afinitor|afinitor
751828|NCT00434174|Pemetrexed|pemetrexed
751829|NCT00434161|Palifermin|palifermin
751830|NCT00434161|KGF|kgf
751831|NCT00434161|Clinical Trial|clinical trial
751832|NCT00434161|Oncology|oncology
751833|NCT00434161|Oral Mucositis|oral mucositis
751834|NCT00434161|Multiple Myeloma|multiple myeloma
751835|NCT00434161|Cataract|cataract
751836|NCT00434148|Cushing's Disease|cushing's disease
751837|NCT00434148|pasireotide|pasireotide
751838|NCT00434148|SOM230|som230
751839|NCT00434135|gemcitabine|gemcitabine
751840|NCT00434135|pemetrexed|pemetrexed
751841|NCT00434135|non-small cell lung cancer|non-small cell lung cancer
751842|NCT00434122|Assisted Reproductive Technology (ART)|assisted reproductive technology (art)
751843|NCT00434122|oocyte donors undergoing controlled ovarian hyperstimulation for assisted reproductive technologies|oocyte donors undergoing controlled ovarian hyperstimulation for assisted reproductive technologies
751844|NCT00434109|Carcinoid|carcinoid
751845|NCT00434109|Pancreatic|pancreatic
751846|NCT00434109|Metastatic|metastatic
751847|NCT00434109|Neuroendocrine|neuroendocrine
751848|NCT00434109|Tumors|tumors
751849|NCT00434109|Hepatic|hepatic
751850|NCT00434109|Artery|artery
751851|NCT00434109|Embolization|embolization
751852|NCT00434109|Angiogenesis|angiogenesis
751853|NCT00434109|Sunitinib|sunitinib
751854|NCT00434109|Malate|malate
751855|NCT00434109|Sutent|sutent
751856|NCT00434109|Tyrosine|tyrosine
751857|NCT00434109|Kinase|kinase
751858|NCT00434109|Inhibitor|inhibitor
751859|NCT00434096|Obesity disease|obesity disease
751860|NCT00434096|cannabinoid-1 receptor|cannabinoid-1 receptor
751861|NCT00434083|TREXIMA|trexima
751862|NCT00434083|MIGRAINE HEADACHES|migraine headaches
751988|NCT00433719|Tuberculous meningitis|tuberculous meningitis
751863|NCT00434083|Subjects may be enrolled if they are 18-65 years of age, have a demonstrated history of migraine headaches|subjects may be enrolled if they are 18-65 years of age, have a demonstrated history of migraine headaches
751864|NCT00434070|HIV|hiv
751865|NCT00434070|Antiretrovial Therapy|antiretrovial therapy
751866|NCT00434070|Resistance|resistance
751867|NCT00434070|Monitoring|monitoring
751868|NCT00434070|TAMS|tams
751869|NCT00434070|Treatment Experienced|treatment experienced
751870|NCT00434057|Pigmented Skin Lesions|pigmented skin lesions
751871|NCT00434057|Dermatology|dermatology
751872|NCT00434057|Skin Cancer|skin cancer
751873|NCT00434057|Melanoma|melanoma
751874|NCT00434057|MelaFind|melafind
751875|NCT00434031|locally advanced|locally advanced
751876|NCT00434031|stage II|stage ii
751877|NCT00434031|stage IIIa|stage iiia
751878|NCT00434031|stage IIIb|stage iiib
751879|NCT00434031|HER-2 positive|her-2 positive
751880|NCT00434031|primary|primary
751881|NCT00434018|Wheelchairs|wheelchairs
751882|NCT00434018|Safety|safety
751883|NCT00434005|Air pollution|air pollution
751884|NCT00434005|diesel|diesel
751885|NCT00434005|antioxidant|antioxidant
751886|NCT00434005|oxidative stress|oxidative stress
751887|NCT00434005|endothelial|endothelial
751888|NCT00434005|HRV|hrv
751889|NCT00434005|BAR|bar
751890|NCT00433992|Mitochondria|mitochondria
751891|NCT00433992|Fat apoptosis|fat apoptosis
751892|NCT00433992|Lipoatrophy|lipoatrophy
751893|NCT00433992|Lipodystrophy|lipodystrophy
751894|NCT00433992|Thymidine|thymidine
751895|NCT00433992|Treatment experienced|treatment experienced
751896|NCT00433979|Anti-HIV agents|anti-hiv agents
751897|NCT00433979|Physiological Effects of Drugs|physiological effects of drugs
751898|NCT00433979|ARV-associated Adverse Events|arv-associated adverse events
751899|NCT00433979|HAART|haart
751900|NCT00433979|Pharmacokinetics|pharmacokinetics
751901|NCT00433979|Protease Inhibitors|protease inhibitors
751902|NCT00433979|Non-nucleoside Reverse Transcriptase Inhibitors|non-nucleoside reverse transcriptase inhibitors
751903|NCT00433979|Women|women
751904|NCT00433966|Myocardial Infarction|myocardial infarction
751906|NCT00433966|Myocardial Ischemia|myocardial ischemia
751907|NCT00433966|Myocardial Reperfusion|myocardial reperfusion
751908|NCT00433966|Stents|stents
751909|NCT00433966|Heart Disease|heart disease
751910|NCT00433953|Pediatric Kidney Transplant|pediatric kidney transplant
751911|NCT00433953|Kidney Transplant|kidney transplant
751912|NCT00433953|CellCept|cellcept
751913|NCT00433953|Mycophenolate Mofetil|mycophenolate mofetil
751914|NCT00433953|Mycophenolic Acid|mycophenolic acid
751915|NCT00433940|Hemangioma|hemangioma
751916|NCT00433940|Corticosteroid|corticosteroid
751917|NCT00433940|Prednisone|prednisone
751918|NCT00433927|metastatic|metastatic
751919|NCT00433914|Meningococcal disease, prevention, vaccination|meningococcal disease, prevention, vaccination
751920|NCT00433901|obesity in children|obesity in children
751921|NCT00433901|childhood disorders|childhood disorders
751922|NCT00433901|overweight children|overweight children
751923|NCT00433901|physical activity|physical activity
751924|NCT00433901|home environment|home environment
751925|NCT00433862|Polycythemia Vera|polycythemia vera
751926|NCT00433862|Essential Thrombocytosis|essential thrombocytosis
751927|NCT00433862|Idiopathic Myelofibrosis|idiopathic myelofibrosis
751928|NCT00433862|Janus Kinase 2|janus kinase 2
751929|NCT00433862|CD177|cd177
751930|NCT00433862|Chronic Myeloproliferative Disorders|chronic myeloproliferative disorders
751931|NCT00433862|PV|pv
751932|NCT00433862|Essential Thrombocythemia|essential thrombocythemia
751933|NCT00433862|ET|et
751934|NCT00433862|IM|im
751935|NCT00433836|Children|children
751936|NCT00433836|pediatrics|pediatrics
751937|NCT00433836|High Blood Pressure|high blood pressure
751938|NCT00433836|Hypertension|hypertension
751939|NCT00433836|Valsartan|valsartan
751940|NCT00433836|enalapril|enalapril
751941|NCT00433823|Very low level of LDL|very low level of ldl
751942|NCT00433823|Steroid hormones|steroid hormones
751943|NCT00433823|Atorvastatin|atorvastatin
751944|NCT00433823|Ezetimibe|ezetimibe
751945|NCT00433823|Lipoprotein-a|lipoprotein-a
751946|NCT00433810|obesity|obesity
751947|NCT00433810|bariatric surgery|bariatric surgery
751948|NCT00433810|30-day mortality|30-day mortality
751949|NCT00433797|Prostate cancer|prostate cancer
751950|NCT00433797|PSA|psa
751951|NCT00433797|antioxidant|antioxidant
751952|NCT00433797|phytochemical|phytochemical
751953|NCT00433797|tomatoes|tomatoes
751954|NCT00433797|PUFA|pufa
751955|NCT00433797|selenium|selenium
751956|NCT00433797|soy|soy
751957|NCT00433797|pomegranate|pomegranate
751958|NCT00433797|grapes|grapes
751959|NCT00433784|clopidogrel|clopidogrel
751960|NCT00433784|platelet aggregation|platelet aggregation
751961|NCT00433784|CYP3A|cyp3a
751962|NCT00433784|H2 haplotype|h2 haplotype
751963|NCT00433784|polymorphisms|polymorphisms
751964|NCT00433771|Malignant|malignant
751965|NCT00433771|Cholestasis, Extrahepatic|cholestasis, extrahepatic
751966|NCT00433771|Biliary obstruction|biliary obstruction
751967|NCT00433758|Diabetes|diabetes
751968|NCT00433758|Blood glucose monitoring|blood glucose monitoring
751969|NCT00433758|Non invasive Blood glucose monitoring|non invasive blood glucose monitoring
751970|NCT00433745|Myelodysplastic Syndrome (MDS)|myelodysplastic syndrome (mds)
751971|NCT00433745|Acute Myelogenous Leukemia (AML)|acute myelogenous leukemia (aml)
751972|NCT00433745|Chronic Myelogenous Leukemia (CML)|chronic myelogenous leukemia (cml)
751973|NCT00433745|Acute Lymphoblastic Leukemia (ALL)|acute lymphoblastic leukemia (all)
751974|NCT00433745|Wilm's Tumor-1 Peptide|wilm's tumor-1 peptide
751975|NCT00433745|Leukemia|leukemia
751976|NCT00433745|Myelodysplastic Syndrome|myelodysplastic syndrome
751977|NCT00433745|MDS|mds
751978|NCT00433745|Acute Myelogenous Leukemia|acute myelogenous leukemia
751979|NCT00433745|AML|aml
751980|NCT00433745|Chronic Myelogenous Leukemia|chronic myelogenous leukemia
751981|NCT00433745|CML|cml
751982|NCT00433745|Acute Lymphoblastic Leukemia|acute lymphoblastic leukemia
751983|NCT00433745|ALL|all
751984|NCT00433732|TREXIMA|trexima
751985|NCT00433732|MIGRAINE HEADACHES|migraine headaches
751986|NCT00433732|Subjects may be enrolled if they are 18-65 years of age, have a demonstrated history of migraine headaches|subjects may be enrolled if they are 18-65 years of age, have a demonstrated history of migraine headaches
751987|NCT00433719|Human immunodeficiency virus|human immunodeficiency virus
751989|NCT00433719|Treatment Naive|treatment naive
751990|NCT00433706|Prostate adenocarcinoma treated by radiotherapy|prostate adenocarcinoma treated by radiotherapy
751991|NCT00433680|adolescent|adolescent
751992|NCT00433680|female|female
751993|NCT00433680|obesity|obesity
751994|NCT00433680|body dissatisfaction|body dissatisfaction
751995|NCT00433667|RWJ-333369|rwj-333369
751996|NCT00433667|anticonvulsants|anticonvulsants
751997|NCT00433667|antiepileptic drugs|antiepileptic drugs
751998|NCT00433654|Bradycardia|bradycardia
751999|NCT00433654|Slow heart beat|slow heart beat
752000|NCT00433654|Magnetic resonance imaging (MRI)|magnetic resonance imaging (mri)
752001|NCT00433641|obesity|obesity
752002|NCT00433641|pharmacogenetics|pharmacogenetics
752003|NCT00433641|sibutramine|sibutramine
752004|NCT00433641|adrenergic|adrenergic
752005|NCT00433641|serotonergic|serotonergic
752843|NCT00430729|Roflumilast|roflumilast
752006|NCT00433641|body composition|body composition
752007|NCT00433641|gastric emptying|gastric emptying
752008|NCT00433628|Hemoglobin A1C|hemoglobin a1c
752009|NCT00433628|HIV|hiv
752010|NCT00433628|Diabetes|diabetes
752011|NCT00433628|Diabetes Type 2|diabetes type 2
752012|NCT00433628|Hyperglycemia|hyperglycemia
752013|NCT00433602|thromboembolism|thromboembolism
752014|NCT00433602|recurrent breast cancer|recurrent breast cancer
752015|NCT00433602|stage IV breast cancer|stage iv breast cancer
752016|NCT00433602|recurrent colon cancer|recurrent colon cancer
752017|NCT00433602|stage I colon cancer|stage i colon cancer
752018|NCT00433602|stage II colon cancer|stage ii colon cancer
752019|NCT00433602|stage III colon cancer|stage iii colon cancer
752020|NCT00433602|stage IV colon cancer|stage iv colon cancer
752021|NCT00433602|recurrent rectal cancer|recurrent rectal cancer
752022|NCT00433602|stage I rectal cancer|stage i rectal cancer
752023|NCT00433602|stage II rectal cancer|stage ii rectal cancer
752024|NCT00433602|stage III rectal cancer|stage iii rectal cancer
752025|NCT00433602|stage IV rectal cancer|stage iv rectal cancer
752026|NCT00433602|recurrent gastric cancer|recurrent gastric cancer
752027|NCT00433602|stage I gastric cancer|stage i gastric cancer
752028|NCT00433602|stage II gastric cancer|stage ii gastric cancer
752029|NCT00433602|stage III gastric cancer|stage iii gastric cancer
752030|NCT00433602|stage IV gastric cancer|stage iv gastric cancer
752031|NCT00433602|recurrent non-small cell lung cancer|recurrent non-small cell lung cancer
752032|NCT00433602|stage I non-small cell lung cancer|stage i non-small cell lung cancer
752033|NCT00433602|stage II non-small cell lung cancer|stage ii non-small cell lung cancer
752034|NCT00433602|stage IIIA non-small cell lung cancer|stage iiia non-small cell lung cancer
752035|NCT00433602|stage IIIB non-small cell lung cancer|stage iiib non-small cell lung cancer
752036|NCT00433602|stage IV non-small cell lung cancer|stage iv non-small cell lung cancer
752037|NCT00433602|recurrent small cell lung cancer|recurrent small cell lung cancer
752038|NCT00433602|recurrent ovarian epithelial cancer|recurrent ovarian epithelial cancer
752039|NCT00433602|stage I ovarian epithelial cancer|stage i ovarian epithelial cancer
752040|NCT00433602|stage II ovarian epithelial cancer|stage ii ovarian epithelial cancer
752041|NCT00433602|stage III ovarian epithelial cancer|stage iii ovarian epithelial cancer
752042|NCT00433602|stage IV ovarian epithelial cancer|stage iv ovarian epithelial cancer
752043|NCT00433602|recurrent ovarian germ cell tumor|recurrent ovarian germ cell tumor
752044|NCT00433602|stage I ovarian germ cell tumor|stage i ovarian germ cell tumor
752045|NCT00433602|stage II ovarian germ cell tumor|stage ii ovarian germ cell tumor
752046|NCT00433602|stage III ovarian germ cell tumor|stage iii ovarian germ cell tumor
752047|NCT00433602|stage IV ovarian germ cell tumor|stage iv ovarian germ cell tumor
752048|NCT00433602|ovarian sarcoma|ovarian sarcoma
752049|NCT00433602|ovarian stromal cancer|ovarian stromal cancer
752050|NCT00433602|recurrent pancreatic cancer|recurrent pancreatic cancer
752051|NCT00433602|stage I pancreatic cancer|stage i pancreatic cancer
752052|NCT00433602|stage II pancreatic cancer|stage ii pancreatic cancer
752053|NCT00433602|stage III pancreatic cancer|stage iii pancreatic cancer
752054|NCT00433602|stage IV pancreatic cancer|stage iv pancreatic cancer
752055|NCT00433602|recurrent prostate cancer|recurrent prostate cancer
752056|NCT00433602|stage III prostate cancer|stage iii prostate cancer
752057|NCT00433602|stage IV prostate cancer|stage iv prostate cancer
752058|NCT00433602|extensive stage small cell lung cancer|extensive stage small cell lung cancer
752059|NCT00433602|limited stage small cell lung cancer|limited stage small cell lung cancer
752060|NCT00433602|stage IIB prostate cancer|stage iib prostate cancer
752061|NCT00433602|stage IIA prostate cancer|stage iia prostate cancer
752062|NCT00433602|male breast cancer|male breast cancer
752063|NCT00433589|invasive ductal breast carcinoma|invasive ductal breast carcinoma
752064|NCT00433589|invasive lobular breast carcinoma|invasive lobular breast carcinoma
752065|NCT00433589|stage IA breast cancer|stage ia breast cancer
752066|NCT00433589|stage IB breast cancer|stage ib breast cancer
752067|NCT00433589|stage II breast cancer|stage ii breast cancer
752068|NCT00433589|estrogen receptor-positive breast cancer|estrogen receptor-positive breast cancer
752069|NCT00433589|progesterone receptor-positive breast cancer|progesterone receptor-positive breast cancer
752070|NCT00433563|limited stage small cell lung cancer|limited stage small cell lung cancer
752071|NCT00433524|unspecified adult solid tumor, protocol specific|unspecified adult solid tumor, protocol specific
752072|NCT00433498|extensive stage small cell lung cancer|extensive stage small cell lung cancer
752073|NCT00433498|limited stage small cell lung cancer|limited stage small cell lung cancer
752074|NCT00433485|basal cell carcinoma of the skin|basal cell carcinoma of the skin
752075|NCT00433485|nevoid basal cell carcinoma syndrome|nevoid basal cell carcinoma syndrome
752076|NCT00433472|adult anaplastic oligodendroglioma|adult anaplastic oligodendroglioma
752077|NCT00433472|adult giant cell glioblastoma|adult giant cell glioblastoma
752078|NCT00433472|adult anaplastic astrocytoma|adult anaplastic astrocytoma
752079|NCT00433472|recurrent adult brain tumor|recurrent adult brain tumor
752080|NCT00433472|adult glioblastoma|adult glioblastoma
752081|NCT00433472|adult gliosarcoma|adult gliosarcoma
752082|NCT00433459|childhood lymphocyte depletion Hodgkin lymphoma|childhood lymphocyte depletion hodgkin lymphoma
752083|NCT00433459|childhood mixed cellularity Hodgkin lymphoma|childhood mixed cellularity hodgkin lymphoma
752940|NCT00430365|Myeloma|myeloma
752084|NCT00433459|childhood nodular sclerosis Hodgkin lymphoma|childhood nodular sclerosis hodgkin lymphoma
752085|NCT00433459|stage I childhood Hodgkin lymphoma|stage i childhood hodgkin lymphoma
752086|NCT00433459|stage II childhood Hodgkin lymphoma|stage ii childhood hodgkin lymphoma
752087|NCT00433459|stage III childhood Hodgkin lymphoma|stage iii childhood hodgkin lymphoma
752088|NCT00433459|stage IV childhood Hodgkin lymphoma|stage iv childhood hodgkin lymphoma
752089|NCT00433446|adenocarcinoma of the prostate|adenocarcinoma of the prostate
752090|NCT00433446|stage IV prostate cancer|stage iv prostate cancer
752091|NCT00433446|recurrent prostate cancer|recurrent prostate cancer
752092|NCT00433433|adult mixed cellularity Hodgkin lymphoma|adult mixed cellularity hodgkin lymphoma
752286|NCT00432822|children|children
752093|NCT00433433|adult nodular sclerosis Hodgkin lymphoma|adult nodular sclerosis hodgkin lymphoma
752094|NCT00433433|stage I adult Hodgkin lymphoma|stage i adult hodgkin lymphoma
752095|NCT00433433|stage II adult Hodgkin lymphoma|stage ii adult hodgkin lymphoma
752096|NCT00433433|adult lymphocyte depletion Hodgkin lymphoma|adult lymphocyte depletion hodgkin lymphoma
752097|NCT00433420|stage II breast cancer|stage ii breast cancer
752098|NCT00433420|stage IIIA breast cancer|stage iiia breast cancer
752099|NCT00433420|stage IIIB breast cancer|stage iiib breast cancer
752100|NCT00433420|stage IIIC breast cancer|stage iiic breast cancer
752101|NCT00433407|unspecified adult solid tumor, protocol specific|unspecified adult solid tumor, protocol specific
752102|NCT00433407|stage I breast cancer|stage i breast cancer
752103|NCT00433407|stage II breast cancer|stage ii breast cancer
752104|NCT00433407|stage IIIA breast cancer|stage iiia breast cancer
752105|NCT00433407|stage IIIB breast cancer|stage iiib breast cancer
752106|NCT00433407|stage IIIC breast cancer|stage iiic breast cancer
752107|NCT00433407|stage IV breast cancer|stage iv breast cancer
752108|NCT00433407|male breast cancer|male breast cancer
752109|NCT00433407|recurrent breast cancer|recurrent breast cancer
752110|NCT00433407|stage I ovarian epithelial cancer|stage i ovarian epithelial cancer
752111|NCT00433407|stage II ovarian epithelial cancer|stage ii ovarian epithelial cancer
752112|NCT00433407|stage III ovarian epithelial cancer|stage iii ovarian epithelial cancer
752113|NCT00433407|stage IV ovarian epithelial cancer|stage iv ovarian epithelial cancer
752114|NCT00433407|recurrent ovarian epithelial cancer|recurrent ovarian epithelial cancer
752115|NCT00433407|stage I non-small cell lung cancer|stage i non-small cell lung cancer
752116|NCT00433407|stage II non-small cell lung cancer|stage ii non-small cell lung cancer
752117|NCT00433407|stage IIIA non-small cell lung cancer|stage iiia non-small cell lung cancer
752118|NCT00433407|stage IIIB non-small cell lung cancer|stage iiib non-small cell lung cancer
752119|NCT00433407|stage IV non-small cell lung cancer|stage iv non-small cell lung cancer
752120|NCT00433407|recurrent non-small cell lung cancer|recurrent non-small cell lung cancer
752121|NCT00433407|extensive stage small cell lung cancer|extensive stage small cell lung cancer
752122|NCT00433407|limited stage small cell lung cancer|limited stage small cell lung cancer
752123|NCT00433407|recurrent small cell lung cancer|recurrent small cell lung cancer
752124|NCT00433407|stage I prostate cancer|stage i prostate cancer
752125|NCT00433407|stage IIB prostate cancer|stage iib prostate cancer
752126|NCT00433407|stage IIA prostate cancer|stage iia prostate cancer
752127|NCT00433407|stage III prostate cancer|stage iii prostate cancer
752128|NCT00433407|stage IV prostate cancer|stage iv prostate cancer
752129|NCT00433407|recurrent prostate cancer|recurrent prostate cancer
752130|NCT00433407|stage I uterine sarcoma|stage i uterine sarcoma
752131|NCT00433407|stage II uterine sarcoma|stage ii uterine sarcoma
752132|NCT00433407|stage III uterine sarcoma|stage iii uterine sarcoma
752133|NCT00433407|stage IV uterine sarcoma|stage iv uterine sarcoma
752134|NCT00433407|recurrent uterine sarcoma|recurrent uterine sarcoma
752135|NCT00433394|unspecified childhood solid tumor, protocol specific|unspecified childhood solid tumor, protocol specific
752136|NCT00433368|L-ornithine-L-aspartate,|l-ornithine-l-aspartate,
752137|NCT00433368|porto-systemic encephalopathy,|porto-systemic encephalopathy,
752138|NCT00433368|hepatic encephalopathy,|hepatic encephalopathy,
752139|NCT00433368|liver cirrhosis,|liver cirrhosis,
752140|NCT00433368|mental state|mental state
752141|NCT00433355|Chronic Fatigue Syndrome|chronic fatigue syndrome
752142|NCT00433355|Epstein-Barr Virus|epstein-barr virus
752143|NCT00433342|Antibiotic|antibiotic
752144|NCT00433342|p-cresol|p-cresol
752145|NCT00433342|peritoneal dialysis|peritoneal dialysis
752146|NCT00433329|pulmonary arterial hypertension|pulmonary arterial hypertension
752147|NCT00433329|bosentan|bosentan
752148|NCT00433329|sildenafil|sildenafil
752149|NCT00433329|combination therapy|combination therapy
752150|NCT00433329|Compass 3|compass 3
752151|NCT00433316|ropivacaine|ropivacaine
752152|NCT00433316|laparoscopy|laparoscopy
752153|NCT00433316|intraperitoneal|intraperitoneal
752154|NCT00433316|nebulization|nebulization
752156|NCT00433316|local analgesic|local analgesic
752157|NCT00433316|gynecology|gynecology
752158|NCT00433264|peritoneal dialysis|peritoneal dialysis
752159|NCT00433264|endothelium|endothelium
752160|NCT00433264|endothelial dysfunction|endothelial dysfunction
752161|NCT00433238|elderly|elderly
752162|NCT00433238|Chinese|chinese
752163|NCT00433238|community living|community living
752164|NCT00433238|measurement|measurement
752165|NCT00433238|depression|depression
752166|NCT00433238|dementia|dementia
752167|NCT00433238|Geriatric Depression Scale|geriatric depression scale
752168|NCT00433238|MiniCog|minicog
752169|NCT00433212|prematurity|prematurity
752170|NCT00433212|respiratory insufficiency|respiratory insufficiency
752171|NCT00433212|non-invasive ventilation|non-invasive ventilation
752172|NCT00433212|bronchopulmonary dysplasia|bronchopulmonary dysplasia
752173|NCT00433212|hyaline membrane disease|hyaline membrane disease
752174|NCT00433199|Hypogonadism|hypogonadism
752175|NCT00433199|Testosterone Deficiency|testosterone deficiency
752176|NCT00433186|Scleroderma|scleroderma
752177|NCT00433173|testosterone|testosterone
752178|NCT00433173|insulin sensitivity|insulin sensitivity
752179|NCT00433173|insulin resistance|insulin resistance
752180|NCT00433173|metabolic disorders|metabolic disorders
752181|NCT00433147|afegostat tartrate|afegostat tartrate
752182|NCT00433147|isofagomine tartrate|isofagomine tartrate
752183|NCT00433147|AT2101|at2101
752184|NCT00433147|Amicus Therapeutics|amicus therapeutics
752185|NCT00433134|renal transplant recipient|renal transplant recipient
752186|NCT00433134|adherence|adherence
752187|NCT00433134|compliance|compliance
752188|NCT00433134|immunosuppression|immunosuppression
752189|NCT00433121|Antidepressive Agents|antidepressive agents
752190|NCT00433121|Neuroleptica|neuroleptica
752191|NCT00433121|Dementia|dementia
752192|NCT00433121|Discontinuation study|discontinuation study
752193|NCT00433121|Behavioural- and Psychological Symptoms in Dementia|behavioural- and psychological symptoms in dementia
752194|NCT00433108|Hepatitis C|hepatitis c
752195|NCT00433108|antioxidant|antioxidant
752196|NCT00433108|liver enzymes|liver enzymes
752197|NCT00433108|ALT|alt
752198|NCT00433095|Navelbine|navelbine
752199|NCT00433095|Herceptin|herceptin
752200|NCT00433095|oral|oral
752201|NCT00433095|breast cancer|breast cancer
752202|NCT00433082|Metabolic syndrome,Ramadan,Fasting,Inflammatory markers,|metabolic syndrome,ramadan,fasting,inflammatory markers,
752203|NCT00433082|Iran|iran
752204|NCT00433069|Chronic hepatitis C|chronic hepatitis c
752205|NCT00433069|Insulin resistance|insulin resistance
752206|NCT00433069|Pioglitazone|pioglitazone
752207|NCT00433069|Non-responders|non-responders
752208|NCT00433056|STI|sti
752209|NCT00433056|HIV|hiv
752210|NCT00433056|CD4|cd4
752211|NCT00433056|HIV-RNA|hiv-rna
752212|NCT00433056|HAART|haart
752213|NCT00433043|Heart Failure|heart failure
752214|NCT00433043|Beta blockers|beta blockers
752215|NCT00433043|Resynchronization|resynchronization
752216|NCT00433043|Congestive Heart Failure, NYHA III-IV|congestive heart failure, nyha iii-iv
752217|NCT00433043|Candidate for BIVPM|candidate for bivpm
752218|NCT00433043|Not on Target Dose (Coreg 25 Bid or Toprol XL 200 qd)|not on target dose (coreg 25 bid or toprol xl 200 qd)
752219|NCT00433030|Highly Active Antiretroviral Therapy|highly active antiretroviral therapy
752220|NCT00433030|HIV Viral load|hiv viral load
752221|NCT00433030|HIV drug Resistance|hiv drug resistance
752222|NCT00433030|Thailand|thailand
752223|NCT00433017|Age-related macular degeneration|age-related macular degeneration
752224|NCT00433017|AMD|amd
752225|NCT00433017|Choroidal neovascularization|choroidal neovascularization
752226|NCT00433017|Verteporfin|verteporfin
752227|NCT00433017|Ranibizumab|ranibizumab
752228|NCT00433004|Teen|teen
752229|NCT00433004|Plan B|plan b
752230|NCT00433004|Post Partum|post partum
752231|NCT00433004|Emergency Contraception|emergency contraception
752232|NCT00432991|Nausea|nausea
752233|NCT00432991|Vomiting|vomiting
752234|NCT00432991|Cesarean Section|cesarean section
752235|NCT00432978|hypoxia|hypoxia
752236|NCT00432978|endothelin|endothelin
752237|NCT00432978|exercise|exercise
752238|NCT00432965|Wound closure|wound closure
752239|NCT00432965|Accelerated healing|accelerated healing
752240|NCT00432952|Cardiovascular Heart Disease|cardiovascular heart disease
752241|NCT00432939|Primary Hyperparathyroidism|primary hyperparathyroidism
752242|NCT00432926|HIV|hiv
752243|NCT00432926|STDs|stds
752244|NCT00432926|Methamphetamine abuse|methamphetamine abuse
752245|NCT00432926|MSM|msm
752246|NCT00432926|HIV Seronegativity|hiv seronegativity
752247|NCT00432913|Eicosapentaenoic acid|eicosapentaenoic acid
752248|NCT00432913|EPA|epa
752249|NCT00432913|EPA 99%|epa 99%
752250|NCT00432913|Fatty acid|fatty acid
752251|NCT00432913|omega-3|omega-3
752252|NCT00432913|apoptosis|apoptosis
752253|NCT00432913|cell proliferation|cell proliferation
752254|NCT00432913|colonic mucosa|colonic mucosa
752255|NCT00432913|polyps|polyps
752256|NCT00432913|adenomatous polyps|adenomatous polyps
752257|NCT00432913|endoscopy|endoscopy
752258|NCT00432913|PUFA|pufa
752259|NCT00432900|Inflammation|inflammation
752260|NCT00432900|Neuroimmunology|neuroimmunology
752261|NCT00432900|Multiple Sclerosis|multiple sclerosis
752262|NCT00432900|MS|ms
752263|NCT00432900|Healthy Volunteer|healthy volunteer
752264|NCT00432900|HV|hv
752265|NCT00432887|caffeine|caffeine
752266|NCT00432887|coffee|coffee
752267|NCT00432887|glucose|glucose
752268|NCT00432887|insulin|insulin
752269|NCT00432861|cystic fibrosis|cystic fibrosis
752270|NCT00432861|pancreatic insufficiency|pancreatic insufficiency
752271|NCT00432861|PANCRECARB® MS-16 (pancrelipase)|pancrecarb® ms-16 (pancrelipase)
752272|NCT00432861|steatorrhea|steatorrhea
752273|NCT00432835|Nausea|nausea
752274|NCT00432835|Vomiting|vomiting
752275|NCT00432835|Delayed gastric emptying|delayed gastric emptying
752276|NCT00432835|Diabetes Mellitus|diabetes mellitus
752277|NCT00432835|Post-Surgical|post-surgical
752278|NCT00432835|Idiopathic|idiopathic
752279|NCT00432822|phenylketonuria|phenylketonuria
752280|NCT00432822|phenylalanine hydroxylase deficiency|phenylalanine hydroxylase deficiency
752281|NCT00432822|BH4|bh4
752282|NCT00432822|responsive|responsive
752283|NCT00432822|tetrahydrobiopterin|tetrahydrobiopterin
752284|NCT00432822|newborns|newborns
752285|NCT00432822|infants|infants
752287|NCT00432822|adolescents|adolescents
752288|NCT00432809|Diabetes Mellitus, Type 2|diabetes mellitus, type 2
752289|NCT00432809|Obesity|obesity
752290|NCT00432796|Anticoagulation|anticoagulation
752291|NCT00432796|Prosthetic heart valves|prosthetic heart valves
752292|NCT00432796|Atrial fibrillation|atrial fibrillation
752293|NCT00432796|Bridging Therapy|bridging therapy
752294|NCT00432796|Thromboembolism|thromboembolism
752295|NCT00432796|Warfarin|warfarin
752296|NCT00432796|Low Molecular Weight Heparin|low molecular weight heparin
752297|NCT00432783|HIV, antiretroviral therapy, adherence, ritonavir|hiv, antiretroviral therapy, adherence, ritonavir
752298|NCT00432757|allergic conjunctivitis, ophthalmology, multicenter, controlled|allergic conjunctivitis, ophthalmology, multicenter, controlled
752299|NCT00432744|mitochondrial diseases|mitochondrial diseases
752300|NCT00432744|respiratory chain complex I deficiencies|respiratory chain complex i deficiencies
752301|NCT00432744|respiratory chain complex II deficiencies|respiratory chain complex ii deficiencies
752302|NCT00432744|respiratory chain complex III deficiencies|respiratory chain complex iii deficiencies
752303|NCT00432744|respiratory chain complex IV deficiencies|respiratory chain complex iv deficiencies
752304|NCT00432744|mutations of a gene coding for a respiratory chain component|mutations of a gene coding for a respiratory chain component
752305|NCT00432731|Prevention of : Varicella|prevention of : varicella
752306|NCT00432731|Measles|measles
752307|NCT00432731|Mumps|mumps
752308|NCT00432731|Rubella|rubella
752309|NCT00432718|Pneumonia|pneumonia
752310|NCT00432718|Ventilator Associated Pneumonia|ventilator associated pneumonia
752311|NCT00432718|Prevention|prevention
752312|NCT00432705|ankle|ankle
752313|NCT00432705|sensorimotor|sensorimotor
752314|NCT00432705|reflex|reflex
752315|NCT00432705|training|training
752316|NCT00432692|osteoporosis|osteoporosis
752317|NCT00432692|falls|falls
752318|NCT00432692|prevention|prevention
752319|NCT00432692|elderly|elderly
752320|NCT00432692|exercise|exercise
752321|NCT00432692|incidence|incidence
752322|NCT00432692|obstacle avoidance|obstacle avoidance
752323|NCT00432679|rosiglitazone|rosiglitazone
752324|NCT00432679|Avandia|avandia
752325|NCT00432679|type 2 diabetes mellitus|type 2 diabetes mellitus
752326|NCT00432679|diabetes|diabetes
752327|NCT00432653|ankylosing spondylitis|ankylosing spondylitis
752328|NCT00432653|rituximab|rituximab
752329|NCT00432653|therapy|therapy
752330|NCT00432653|magnetic resonance imaging|magnetic resonance imaging
752331|NCT00432640|(suspected) Non Small Cell Lung Cancer|(suspected) non small cell lung cancer
752332|NCT00432627|Hepatic impairment|hepatic impairment
752333|NCT00432627|adults|adults
752334|NCT00432627|deferasirox|deferasirox
752335|NCT00432614|Mental Disorder|mental disorder
752336|NCT00432614|Mood Disorder|mood disorder
752337|NCT00432614|Depressive Disorder|depressive disorder
752338|NCT00432601|decision aid|decision aid
752339|NCT00432601|prostate cancer|prostate cancer
752340|NCT00432601|patient-physician communication|patient-physician communication
752341|NCT00432601|decision making|decision making
752342|NCT00432601|literacy|literacy
752343|NCT00432588|IUFD|iufd
752344|NCT00432588|POSTTERM|postterm
752346|NCT00432575|tobacco use cessation|tobacco use cessation
752347|NCT00432575|cigarette smokers|cigarette smokers
752348|NCT00432549|Medication overuse|medication overuse
752349|NCT00432536|Neuro-monitoring|neuro-monitoring
752350|NCT00432536|Quality Improvement|quality improvement
752351|NCT00432536|Cerebral emboli|cerebral emboli
752352|NCT00432536|Cerebral desaturation|cerebral desaturation
752353|NCT00432536|Hypotension|hypotension
752354|NCT00432523|Prevention of : Measles, Mumps, Rubella and Varicella diseases|prevention of : measles, mumps, rubella and varicella diseases
752355|NCT00432510|Hereditary angioedema|hereditary angioedema
752356|NCT00432510|C1 esterase inhibitor (human)|c1 esterase inhibitor (human)
752357|NCT00432484|Lingzhi|lingzhi
752358|NCT00432484|Sen Miao San|sen miao san
752359|NCT00432484|Rheumatoid Arthritis|rheumatoid arthritis
752360|NCT00432471|Skin Cancer|skin cancer
752361|NCT00432471|Non-Melanoma Skin Cancer|non-melanoma skin cancer
752362|NCT00432471|Optical Imaging|optical imaging
752363|NCT00432471|Multispectral Digital Microscope System|multispectral digital microscope system
752364|NCT00432471|MDM|mdm
752365|NCT00432458|stage I multiple myeloma|stage i multiple myeloma
752366|NCT00432445|Children with retinoblastoma|children with retinoblastoma
752367|NCT00432445|Retinoblastoma|retinoblastoma
752368|NCT00432445|Pediatrics|pediatrics
752369|NCT00432445|Proton Beam Radiation Therapy|proton beam radiation therapy
752370|NCT00432445|Radiation Therapy|radiation therapy
752371|NCT00432445|Tumor of the Eye|tumor of the eye
752372|NCT00432445|Ophthalmic EUA|ophthalmic eua
752373|NCT00432445|Examination under anesthesia|examination under anesthesia
752374|NCT00432445|Bilateral retinoblastoma|bilateral retinoblastoma
752375|NCT00432445|Unilateral retinoblastoma|unilateral retinoblastoma
752376|NCT00432445|Extraocular disease|extraocular disease
752377|NCT00432445|Intraocular procedure|intraocular procedure
752378|NCT00432432|Ankylosing Spondylitis|ankylosing spondylitis
752379|NCT00432432|MTX|mtx
752380|NCT00432432|Infliximab|infliximab
752381|NCT00432419|HIV|hiv
752382|NCT00432419|Non-Hodgkin's lymphoma|non-hodgkin's lymphoma
752383|NCT00432419|Peripheral blood stem cells transplantation|peripheral blood stem cells transplantation
752384|NCT00432406|Psoriatic Arthritis|psoriatic arthritis
752385|NCT00432406|TNF-α|tnf-α
752386|NCT00432406|Cardiovascular risk|cardiovascular risk
752387|NCT00432406|Immunomodulatory activities|immunomodulatory activities
752388|NCT00432380|Placebo|placebo
752389|NCT00432380|Double blind|double blind
752390|NCT00432380|Gastroenteritis|gastroenteritis
752391|NCT00432380|Randomized|randomized
752392|NCT00432380|Oral live attenuated human rotavirus liquid vaccine|oral live attenuated human rotavirus liquid vaccine
752393|NCT00432367|Malaria in pregnancy|malaria in pregnancy
752394|NCT00432367|Case management|case management
752395|NCT00432367|Screening|screening
752396|NCT00432367|RDT|rdt
752397|NCT00432367|IPTp|iptp
752398|NCT00432367|Amodiaquine|amodiaquine
752399|NCT00432367|Artesunate|artesunate
752400|NCT00432354|statin|statin
752401|NCT00432354|systemic lupus erythematosus|systemic lupus erythematosus
752402|NCT00432354|microcirculation|microcirculation
752403|NCT00432302|Cancer|cancer
752404|NCT00432302|Tumor|tumor
752405|NCT00432302|Malignancy|malignancy
752406|NCT00432302|Mass Balance|mass balance
752407|NCT00432302|Chemotherapy|chemotherapy
752408|NCT00432302|Drug|drug
752409|NCT00432302|Cancer Treatment|cancer treatment
752410|NCT00432302|Intravenous Infusion|intravenous infusion
752411|NCT00432302|Epothilone|epothilone
752412|NCT00432302|Solid Tumor|solid tumor
752413|NCT00432289|neurological function|neurological function
752414|NCT00432276|Glucose Metabolism Disorder|glucose metabolism disorder
752415|NCT00432276|Dysmetabolic Syndrome|dysmetabolic syndrome
752416|NCT00432276|Type II Diabetes|type ii diabetes
752417|NCT00432276|Diabetes Mellitus, Lipoatrophic|diabetes mellitus, lipoatrophic
752418|NCT00432276|Dyslipidemia|dyslipidemia
752419|NCT00432276|Hyperglycemia|hyperglycemia
752420|NCT00432276|Drug Therapy|drug therapy
752421|NCT00432250|Preterm labor|preterm labor
752422|NCT00432250|Cervical ultrasonography|cervical ultrasonography
752423|NCT00432250|Hospital stay|hospital stay
752424|NCT00432198|Insomnia|insomnia
752425|NCT00432198|Zolpidem|zolpidem
752426|NCT00432198|Adolescent|adolescent
752427|NCT00432185|sBCC|sbcc
752428|NCT00432185|Topical|topical
752429|NCT00432185|Dermatology|dermatology
752430|NCT00432172|Her2neu negative breast cancer.|her2neu negative breast cancer.
752431|NCT00432172|Neoadjuvant treatment.|neoadjuvant treatment.
752432|NCT00432159|cervical|cervical
752433|NCT00432159|spinal|spinal
752434|NCT00432159|arthroplasty|arthroplasty
752435|NCT00432159|disc|disc
752436|NCT00432159|surgical|surgical
752437|NCT00432159|ACDF|acdf
752438|NCT00432159|DDD|ddd
752439|NCT00432146|Graves' disease, Lugol's solution|graves' disease, lugol's solution
752440|NCT00432133|Physical Activity|physical activity
752441|NCT00432133|Behavior Change|behavior change
752442|NCT00432133|Mechanism|mechanism
752443|NCT00432133|Environmental|environmental
752444|NCT00432133|Ecological Model of Physical Activity|ecological model of physical activity
752445|NCT00432107|Advanced cutaneous melanoma|advanced cutaneous melanoma
752446|NCT00432107|Phase II study|phase ii study
752447|NCT00432094|childhood extragonadal germ cell tumor|childhood extragonadal germ cell tumor
752448|NCT00432094|childhood malignant ovarian germ cell tumor|childhood malignant ovarian germ cell tumor
752449|NCT00432094|childhood malignant testicular germ cell tumor|childhood malignant testicular germ cell tumor
752450|NCT00432094|stage III malignant testicular germ cell tumor|stage iii malignant testicular germ cell tumor
752451|NCT00432094|testicular choriocarcinoma and seminoma|testicular choriocarcinoma and seminoma
752452|NCT00432094|testicular embryonal carcinoma and seminoma|testicular embryonal carcinoma and seminoma
752453|NCT00432094|testicular embryonal carcinoma and teratoma with seminoma|testicular embryonal carcinoma and teratoma with seminoma
752454|NCT00432094|testicular embryonal carcinoma and yolk sac tumor with seminoma|testicular embryonal carcinoma and yolk sac tumor with seminoma
752455|NCT00432094|testicular yolk sac tumor and teratoma with seminoma|testicular yolk sac tumor and teratoma with seminoma
752456|NCT00432094|testicular choriocarcinoma and embryonal carcinoma|testicular choriocarcinoma and embryonal carcinoma
752457|NCT00432094|testicular choriocarcinoma and teratoma|testicular choriocarcinoma and teratoma
752458|NCT00432094|testicular choriocarcinoma and yolk sac tumor|testicular choriocarcinoma and yolk sac tumor
752459|NCT00432094|testicular choriocarcinoma|testicular choriocarcinoma
752460|NCT00432094|testicular embryonal carcinoma and teratoma|testicular embryonal carcinoma and teratoma
752461|NCT00432094|testicular embryonal carcinoma and yolk sac tumor|testicular embryonal carcinoma and yolk sac tumor
752462|NCT00432094|testicular embryonal carcinoma|testicular embryonal carcinoma
752463|NCT00432094|testicular yolk sac tumor and teratoma|testicular yolk sac tumor and teratoma
752464|NCT00432094|testicular yolk sac tumor|testicular yolk sac tumor
752465|NCT00432094|testicular seminoma|testicular seminoma
752466|NCT00432094|stage IV extragonadal non-seminomatous germ cell tumor|stage iv extragonadal non-seminomatous germ cell tumor
752467|NCT00432094|stage IV extragonadal seminoma|stage iv extragonadal seminoma
752468|NCT00432094|stage I extragonadal non-seminomatous germ cell tumor|stage i extragonadal non-seminomatous germ cell tumor
752469|NCT00432094|stage I extragonadal seminoma|stage i extragonadal seminoma
752470|NCT00432094|stage II extragonadal non-seminomatous germ cell tumor|stage ii extragonadal non-seminomatous germ cell tumor
752471|NCT00432094|stage II extragonadal seminoma|stage ii extragonadal seminoma
752472|NCT00432094|stage III extragonadal non-seminomatous germ cell tumor|stage iii extragonadal non-seminomatous germ cell tumor
752473|NCT00432094|stage III extragonadal seminoma|stage iii extragonadal seminoma
752474|NCT00432094|stage II ovarian germ cell tumor|stage ii ovarian germ cell tumor
752475|NCT00432094|stage I malignant testicular germ cell tumor|stage i malignant testicular germ cell tumor
752476|NCT00432094|stage II malignant testicular germ cell tumor|stage ii malignant testicular germ cell tumor
752477|NCT00432094|adult teratoma|adult teratoma
752478|NCT00432094|childhood teratoma|childhood teratoma
752479|NCT00432094|testicular immature teratoma|testicular immature teratoma
752480|NCT00432094|testicular mature teratoma|testicular mature teratoma
752481|NCT00432094|adult central nervous system germ cell tumor|adult central nervous system germ cell tumor
752482|NCT00432094|childhood central nervous system germ cell tumor|childhood central nervous system germ cell tumor
752483|NCT00432081|Dementia|dementia
752484|NCT00432081|Inflammation|inflammation
752485|NCT00432081|Anti-Inflammatory Agents|anti-inflammatory agents
752486|NCT00432081|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal
752487|NCT00432081|Drug Therapy|drug therapy
752488|NCT00432068|Healthy volunteers|healthy volunteers
752489|NCT00432068|octreotide pamoate|octreotide pamoate
752490|NCT00432068|pharmacokinetics|pharmacokinetics
752492|NCT00432055|Cerebral Palsy|cerebral palsy
752493|NCT00432055|Spastic contractures|spastic contractures
752494|NCT00432055|Botulinum toxin type A|botulinum toxin type a
752495|NCT00432042|Mumps and Rubella|mumps and rubella
752496|NCT00432042|Haemophilus influenzae type b (Infanrix® hexa)|haemophilus influenzae type b (infanrix® hexa)
752497|NCT00432029|Flicker induced vasodilatation|flicker induced vasodilatation
752498|NCT00432029|Flow mediated vasodilatation|flow mediated vasodilatation
752499|NCT00432029|Forearm blood flow|forearm blood flow
752500|NCT00432029|Retinal vessel diameter|retinal vessel diameter
752501|NCT00432029|Endothelial dysfunction|endothelial dysfunction
752502|NCT00432016|HIV|hiv
752503|NCT00432016|pharmacokinetics|pharmacokinetics
752504|NCT00432016|zidovudine|zidovudine
752505|NCT00432016|amdoxovir|amdoxovir
752506|NCT00432016|DAPD|dapd
752507|NCT00432016|AMDX|amdx
752508|NCT00432016|Treatment Naive|treatment naive
752509|NCT00432003|Treatment Experienced|treatment experienced
752510|NCT00432003|HIV|hiv
752511|NCT00432003|Antiretroviral Therapy, Highly Active|antiretroviral therapy, highly active
752512|NCT00431977|Coronary Atherosclerosis|coronary atherosclerosis
752513|NCT00431977|Diabetes Mellitus|diabetes mellitus
752514|NCT00431964|azithromycin, Zithromax|azithromycin, zithromax
752515|NCT00431951|Healthy Volunteers|healthy volunteers
752516|NCT00431925|head and neck cancer|head and neck cancer
752517|NCT00431925|radiation therapy|radiation therapy
752518|NCT00431925|chemotherapy|chemotherapy
752519|NCT00431925|mucositis|mucositis
752520|NCT00431925|cytokines|cytokines
752521|NCT00431925|gastrostomy|gastrostomy
752522|NCT00431925|radiotherapy|radiotherapy
752523|NCT00431912|cutaneous T-cell lymphoma|cutaneous t-cell lymphoma
752524|NCT00431912|mycosis fungoides|mycosis fungoides
752525|NCT00431912|Sézary syndrome|sézary syndrome
752526|NCT00431912|APO866|apo866
752527|NCT00431912|phase II study|phase ii study
752528|NCT00431899|nutrition|nutrition
752529|NCT00431899|omega 3 fatty acids|omega 3 fatty acids
752530|NCT00431899|insulin resistance|insulin resistance
752531|NCT00431886|Chest pains|chest pains
752532|NCT00431886|Computed tomography|computed tomography
752533|NCT00431886|Emergency|emergency
752534|NCT00431873|Lymphocytic Leukemia, Chronic (Refractory)|lymphocytic leukemia, chronic (refractory)
752535|NCT00431873|Phase II|phase ii
752536|NCT00431860|Coronary atherosclerosis, Spiral Computed Tomography|coronary atherosclerosis, spiral computed tomography
752537|NCT00431847|Anesthesia, Regional|anesthesia, regional
752538|NCT00431847|Causalgia|causalgia
752539|NCT00431847|Trauma|trauma
752540|NCT00431847|Complex Regional Pain Syndrome Type II|complex regional pain syndrome type ii
752541|NCT00431847|Neuropathic Pain|neuropathic pain
752542|NCT00431847|PTSD|ptsd
752543|NCT00431847|Combat Stress Disorders|combat stress disorders
752544|NCT00431847|Afghan War, 2001-|afghan war, 2001-
752545|NCT00431847|Iraq War, 2003-|iraq war, 2003-
752546|NCT00431834|Permanent Atrial Fibrillation Surgical RF Ablation|permanent atrial fibrillation surgical rf ablation
752648|NCT00431444|Osteoporosis|osteoporosis
752547|NCT00431834|Permanent Atrial Fibrillation|permanent atrial fibrillation
752548|NCT00431821|Exercise|exercise
752549|NCT00431821|Rehabilitation|rehabilitation
752550|NCT00431821|Stroke|stroke
752551|NCT00431808|Malaria|malaria
752552|NCT00431808|vaccine|vaccine
752553|NCT00431808|Apical Membrane Antigene|apical membrane antigene
752554|NCT00431808|Mali|mali
752555|NCT00431808|Adults|adults
752556|NCT00431795|Advanced breast cancer|advanced breast cancer
752557|NCT00431795|Pegylated liposomal doxorubicin|pegylated liposomal doxorubicin
752558|NCT00431795|Epirubicin|epirubicin
752559|NCT00431782|Atrial fibrillation|atrial fibrillation
752560|NCT00431782|Anticoagulation|anticoagulation
752561|NCT00431769|Multiple myeloma|multiple myeloma
752562|NCT00431769|Bortezomib|bortezomib
752563|NCT00431769|Dexamethasone|dexamethasone
752564|NCT00431769|VELCADE|velcade
752565|NCT00431756|Barrett's esophagus|barrett's esophagus
752566|NCT00431756|gastroesophageal reflux disease (GERD)|gastroesophageal reflux disease (gerd)
752567|NCT00431756|esophageal cancer|esophageal cancer
752568|NCT00431756|DNA methylation|dna methylation
752569|NCT00431743|Fluid Therapy|fluid therapy
752570|NCT00431743|Crystalloid|crystalloid
752571|NCT00431743|Colloid|colloid
752572|NCT00431743|Perioperative|perioperative
752573|NCT00431743|Optimization|optimization
752574|NCT00431743|Goal-directed Therapy|goal-directed therapy
752575|NCT00431717|Coronary Atherosclerosis|coronary atherosclerosis
752576|NCT00431717|Diabetes Mellitus|diabetes mellitus
752577|NCT00431704|advanced|advanced
752578|NCT00431704|her-2 positive|her-2 positive
752579|NCT00431678|Community-acquired Pneumonia|community-acquired pneumonia
752580|NCT00431665|Renal Plasma Flow|renal plasma flow
752581|NCT00431665|Glomerular Filtration Rate|glomerular filtration rate
752582|NCT00431665|Free fatty acids|free fatty acids
752583|NCT00431639|Animal-Assisted Therapy|animal-assisted therapy
752584|NCT00431639|Pain|pain
752585|NCT00431639|Oncology|oncology
752586|NCT00431639|Cancer Pain|cancer pain
752587|NCT00431626|Benign|benign
752588|NCT00431626|Prostatic|prostatic
752589|NCT00431626|Hyperplasia|hyperplasia
752590|NCT00431626|Lower|lower
752591|NCT00431626|Urinary|urinary
752592|NCT00431626|Track|track
752593|NCT00431626|Symptoms|symptoms
752594|NCT00431626|Laser|laser
752595|NCT00431626|Transurethral|transurethral
752596|NCT00431626|Prostate|prostate
752597|NCT00431613|NSCLC|nsclc
752598|NCT00431613|Induction chemotherapy|induction chemotherapy
752599|NCT00431613|Concurrent chemoradiotherapy|concurrent chemoradiotherapy
752600|NCT00431613|Consolidation therapy|consolidation therapy
752601|NCT00431613|Docetaxel|docetaxel
752602|NCT00431613|Gemcitabine|gemcitabine
752603|NCT00431613|Carboplatin|carboplatin
752604|NCT00431600|Regional Blood Flow|regional blood flow
752605|NCT00431600|Color Doppler Optical Coherence Tomography|color doppler optical coherence tomography
752606|NCT00431600|CDOCT|cdoct
752607|NCT00431600|Retinal Blood Flow|retinal blood flow
752608|NCT00431600|Hyperoxia|hyperoxia
752609|NCT00431600|Vasoconstriction|vasoconstriction
752610|NCT00431600|Laser Doppler Velocimetry|laser doppler velocimetry
752611|NCT00431600|Retinal Vessel Analyzer|retinal vessel analyzer
752612|NCT00431587|morbid obesity|morbid obesity
752613|NCT00431587|metabolic syndrome|metabolic syndrome
752614|NCT00431587|visceral fat|visceral fat
752615|NCT00431587|peripheral fat|peripheral fat
752616|NCT00431574|schizophrenia|schizophrenia
752617|NCT00431574|schizoaffective|schizoaffective
752618|NCT00431574|antipsychotic|antipsychotic
752619|NCT00431574|randomized control trial|randomized control trial
752620|NCT00431561|Glioblastoma|glioblastoma
752621|NCT00431561|Anaplastic astrocytoma|anaplastic astrocytoma
752622|NCT00431561|Antisense|antisense
752623|NCT00431561|Cancer|cancer
752624|NCT00431561|Transforming growth factor beta2 (TGF-beta2)|transforming growth factor beta2 (tgf-beta2)
752625|NCT00431561|Targeted therapy|targeted therapy
752626|NCT00431561|Immunotherapy|immunotherapy
752627|NCT00431561|Brain tumor|brain tumor
752628|NCT00431561|Central nervous system (CNS)|central nervous system (cns)
752629|NCT00431561|Convection-enhanced delivery (CED) / microperfusion|convection-enhanced delivery (ced) / microperfusion
752630|NCT00431561|Locoregional application|locoregional application
752631|NCT00431535|Fluid|fluid
752632|NCT00431535|SvO2|svo2
752633|NCT00431535|Mobilisation|mobilisation
752634|NCT00431535|Orthostatic function|orthostatic function
752635|NCT00431509|Osteoarthritis|osteoarthritis
752636|NCT00431509|Arthroplasty|arthroplasty
752637|NCT00431509|Replacement|replacement
752638|NCT00431509|Knee|knee
752639|NCT00431509|Instrumentation|instrumentation
752640|NCT00431496|Anemia|anemia
752641|NCT00431496|Intact Parathyroid Hormone (iPTH)|intact parathyroid hormone (ipth)
752642|NCT00431496|Secondary Hyperparathyroidism (SHPT)|secondary hyperparathyroidism (shpt)
752643|NCT00431483|antibacterial agents|antibacterial agents
752644|NCT00431483|surgery|surgery
752645|NCT00431483|pharmacist|pharmacist
752646|NCT00431483|economics, pharmaceutical|economics, pharmaceutical
752647|NCT00431470|Classroom violence, character, bullying, self esteem|classroom violence, character, bullying, self esteem
752649|NCT00431444|Post-menopausal|post-menopausal
752650|NCT00431444|Bone mineral density|bone mineral density
752651|NCT00431405|rheumatoid arthritis|rheumatoid arthritis
752652|NCT00431405|cardiovascular disease|cardiovascular disease
752653|NCT00431405|coronary disease|coronary disease
752654|NCT00431392|Choroidal blood flow|choroidal blood flow
752655|NCT00431392|NO-synthase|no-synthase
752656|NCT00431392|light/dark transition|light/dark transition
752657|NCT00431366|Fatigue|fatigue
752658|NCT00431366|Repetitive TMS (rTMS)|repetitive tms (rtms)
752659|NCT00431366|Parkinson's Disease|parkinson's disease
752660|NCT00431366|Peg Board Test|peg board test
752661|NCT00431366|Levodopa|levodopa
752662|NCT00431366|Parkinson Disease|parkinson disease
752663|NCT00431366|PD|pd
752664|NCT00431340|Multiple myeloma|multiple myeloma
752665|NCT00431340|myeloma|myeloma
752666|NCT00431340|plasma cell myeloma|plasma cell myeloma
752667|NCT00431340|bone marrow cancer|bone marrow cancer
752668|NCT00431340|myelomatosis|myelomatosis
752669|NCT00431340|Kahler's disease|kahler's disease
752670|NCT00431340|PXD101|pxd101
752671|NCT00431340|belinostat|belinostat
752672|NCT00431340|bortezomib|bortezomib
752673|NCT00431327|patient navigator|patient navigator
752674|NCT00431327|peer support|peer support
752675|NCT00431327|colonoscopy|colonoscopy
752676|NCT00431327|adherence|adherence
752677|NCT00431327|None: have to be scheduled for screening or diagnostic colonoscopy|none: have to be scheduled for screening or diagnostic colonoscopy
752678|NCT00431314|End Stage Renal Disease|end stage renal disease
752679|NCT00431314|Hemodialysis|hemodialysis
752680|NCT00431314|Critical Limb Ischemia|critical limb ischemia
752681|NCT00431314|Autofluorescence|autofluorescence
752682|NCT00431301|Progressive Supranuclear Palsy|progressive supranuclear palsy
752683|NCT00431301|Epidemiology|epidemiology
752684|NCT00431301|Case-Control|case-control
752685|NCT00431301|Genetic|genetic
752686|NCT00431301|Environmental|environmental
752687|NCT00431301|Neurodegenerative Disease|neurodegenerative disease
752688|NCT00431301|Movement Disorders|movement disorders
752689|NCT00431301|Atypical Parkinsonism|atypical parkinsonism
752690|NCT00431301|Parkinson Plus|parkinson plus
752691|NCT00431301|Steele-Richardson-Olszewski|steele-richardson-olszewski
752692|NCT00431301|PSP|psp
752693|NCT00431288|nutrition|nutrition
752694|NCT00431288|adolescent nutrition|adolescent nutrition
752695|NCT00431288|blood pressure|blood pressure
752696|NCT00431288|hypertension|hypertension
752697|NCT00431288|diet therapy|diet therapy
752698|NCT00431288|patient education|patient education
752699|NCT00431262|alcoholism|alcoholism
752700|NCT00431262|antabuse|antabuse
752701|NCT00431262|disulfiram|disulfiram
752702|NCT00431262|abstinence|abstinence
752703|NCT00431262|cognitive behavioural therapy|cognitive behavioural therapy
752704|NCT00431236|cisplatin|cisplatin
752705|NCT00431236|CINV|cinv
752706|NCT00431236|highly emetogenic|highly emetogenic
752707|NCT00431223|fMRI|fmri
752708|NCT00431223|working memory|working memory
752709|NCT00431223|schizophrenia|schizophrenia
752710|NCT00431223|treatment refractory|treatment refractory
752711|NCT00431223|cognitive skills training|cognitive skills training
752712|NCT00431223|dorsolateral prefrontal cortex|dorsolateral prefrontal cortex
752713|NCT00431223|cognitive remediation|cognitive remediation
752714|NCT00431223|treatment refractory schizophrenia of > 5 years duration|treatment refractory schizophrenia of > 5 years duration
752715|NCT00431210|NPC|npc
752716|NCT00431210|EPV|epv
752717|NCT00431184|bipolar disorder|bipolar disorder
752718|NCT00431184|bipolar mania|bipolar mania
752719|NCT00431184|schizoaffective disorder|schizoaffective disorder
752720|NCT00431184|schizoaffective mania|schizoaffective mania
752721|NCT00431184|mania|mania
752722|NCT00431184|kappa opiates|kappa opiates
752723|NCT00431184|opiates|opiates
752724|NCT00431171|spinal cord injuries|spinal cord injuries
752725|NCT00431171|lithium|lithium
752726|NCT00431158|Acute Respiratory Distress Syndrome|acute respiratory distress syndrome
752727|NCT00431158|ARDS|ards
752728|NCT00431158|Respiratory failure|respiratory failure
752729|NCT00431158|Mechanical Ventilation|mechanical ventilation
752730|NCT00431158|Positive end expiratory pressure|positive end expiratory pressure
752731|NCT00431158|Lung recruitment maneuver|lung recruitment maneuver
752732|NCT00431119|bullous autoimmune disease|bullous autoimmune disease
752733|NCT00431119|bullous pemphigoid|bullous pemphigoid
752734|NCT00431119|immunosuppressants|immunosuppressants
752735|NCT00431119|corticosteroids|corticosteroids
752736|NCT00431119|mycophenolate mofetil|mycophenolate mofetil
752737|NCT00431106|Breast cancer|breast cancer
752738|NCT00431106|Chemotherapy|chemotherapy
752739|NCT00431106|Vinorelbine|vinorelbine
752740|NCT00431106|Gemcitabine|gemcitabine
752741|NCT00431106|Capecitabine|capecitabine
752742|NCT00431080|Early breast cancer|early breast cancer
752743|NCT00431080|Axillary node positive|axillary node positive
752744|NCT00431080|Adjuvant chemotherapy|adjuvant chemotherapy
752745|NCT00431080|Dose dense|dose dense
752746|NCT00431080|Docetaxel|docetaxel
752747|NCT00431080|Paclitaxel|paclitaxel
752748|NCT00431080|FEC|fec
752749|NCT00431054|Ovarian Cancer|ovarian cancer
752750|NCT00431054|Fallopian Tube Cancer|fallopian tube cancer
752751|NCT00431054|Peritoneal Cancer|peritoneal cancer
752752|NCT00431054|Perifosine|perifosine
752753|NCT00431054|Docetaxel|docetaxel
752754|NCT00431054|Taxotere|taxotere
752755|NCT00431041|Solifenacin succinate|solifenacin succinate
752756|NCT00431041|Oxybutynin immediate release|oxybutynin immediate release
752757|NCT00431041|Xerostomia|xerostomia
752758|NCT00431041|Overactive bladder|overactive bladder
752759|NCT00431028|Cataract|cataract
752760|NCT00431028|Endophthalmitis|endophthalmitis
752761|NCT00431028|Antibiotics|antibiotics
753435|NCT00428545|Myeloma|myeloma
752762|NCT00431028|Anti-Inflammatory Agents|anti-inflammatory agents
752763|NCT00431028|Drug Delivery Systems|drug delivery systems
752764|NCT00431015|Lung Cancer|lung cancer
752765|NCT00431015|Cancer of the lung|cancer of the lung
752766|NCT00431015|Non-small cell lung cancer|non-small cell lung cancer
752767|NCT00431002|Exercise|exercise
752768|NCT00431002|Resistance training|resistance training
752769|NCT00430989|Anaesthesia|anaesthesia
752770|NCT00430989|Major Surgery|major surgery
752771|NCT00430989|Coronary artery disease|coronary artery disease
752772|NCT00430989|Nitrous oxide|nitrous oxide
752773|NCT00430989|Effects of Nitrous Oxide following Anaesthesia|effects of nitrous oxide following anaesthesia
752774|NCT00430989|Anaesthesia and coronary artery disease|anaesthesia and coronary artery disease
752775|NCT00430976|psychomotor function|psychomotor function
752776|NCT00430976|neuromuscular system|neuromuscular system
752777|NCT00430976|memory|memory
752778|NCT00430976|brain electrical activity|brain electrical activity
752779|NCT00430976|Mental Processes|mental processes
752780|NCT00430950|Moderate-to-Severe Hypertension|moderate-to-severe hypertension
752781|NCT00430950|Essential Hypertension|essential hypertension
752782|NCT00430950|Combination Therapy|combination therapy
752783|NCT00430950|Fixed-Combination Dose|fixed-combination dose
752784|NCT00430937|Complicated Skin and Soft Tissue Infections. Daptomycin, Vancomycin, Teicoplanin|complicated skin and soft tissue infections. daptomycin, vancomycin, teicoplanin
752785|NCT00430937|Complicated skin and soft tissue infections|complicated skin and soft tissue infections
752786|NCT00430924|Kidney Failure, Chronic|kidney failure, chronic
752787|NCT00430924|Proteinuria|proteinuria
752788|NCT00430924|Aldosterone|aldosterone
752789|NCT00430924|Renin-Angiotensin System|renin-angiotensin system
752790|NCT00430911|malignant gliomas|malignant gliomas
752791|NCT00430898|ulcerative colitis basiliximab|ulcerative colitis basiliximab
752792|NCT00430885|Heart failure|heart failure
752793|NCT00430885|Myocardial infarction|myocardial infarction
752794|NCT00430885|Patients with acute myocardial infarction|patients with acute myocardial infarction
752795|NCT00430872|Spinal Cord Tumor|spinal cord tumor
752796|NCT00430872|Intramedullary Spinal Cord Tumor|intramedullary spinal cord tumor
752797|NCT00430872|Extramedullary Spinal Cord Tumor|extramedullary spinal cord tumor
752798|NCT00430872|Symptoms|symptoms
752799|NCT00430872|Survey|survey
752800|NCT00430859|Sepsis|sepsis
752801|NCT00430859|Alkaline|alkaline
752802|NCT00430859|Phosphatase|phosphatase
752803|NCT00430859|Lipopolysaccharide|lipopolysaccharide
752804|NCT00430846|Antigens,CD30|antigens,cd30
752805|NCT00430846|Antibody-Drug Conjugate|antibody-drug conjugate
752806|NCT00430846|Antibodies, Monoclonal|antibodies, monoclonal
752807|NCT00430846|Lymphoma, Non-Hodgkin|lymphoma, non-hodgkin
752808|NCT00430846|Disease, Hodgkin|disease, hodgkin
752809|NCT00430846|Lymphoma, Large-Cell, Anaplastic|lymphoma, large-cell, anaplastic
752810|NCT00430846|Hematologic Diseases|hematologic diseases
752811|NCT00430846|Lymphoma|lymphoma
752812|NCT00430820|Biomarkers|biomarkers
752813|NCT00430820|Proteomics|proteomics
752814|NCT00430820|Mass spectrometry|mass spectrometry
752815|NCT00430820|Atherosclerosis|atherosclerosis
752816|NCT00430820|Acute coronary syndromes|acute coronary syndromes
752817|NCT00430820|Myocardial infarction|myocardial infarction
752818|NCT00430820|Coronary artery disease|coronary artery disease
752819|NCT00430807|giant cell arteritis,|giant cell arteritis,
752820|NCT00430807|hydroxychloroquine,|hydroxychloroquine,
752821|NCT00430807|corticosteroid sparing,|corticosteroid sparing,
752822|NCT00430807|corticodependence|corticodependence
752823|NCT00430794|resistant hypertension|resistant hypertension
752824|NCT00430794|Spironolactone|spironolactone
752825|NCT00430794|double-blind|double-blind
752826|NCT00430794|randomised controlled trial|randomised controlled trial
752827|NCT00430794|ambulatory blood pressure monitoring|ambulatory blood pressure monitoring
752828|NCT00430781|pazopanib|pazopanib
752829|NCT00430781|ErB1/ErB2|erb1/erb2
752830|NCT00430781|lapatinib|lapatinib
752831|NCT00430781|persistent|persistent
752832|NCT00430781|VEGF|vegf
752833|NCT00430781|recurrent|recurrent
752834|NCT00430781|metastatic cervical cancer|metastatic cervical cancer
752835|NCT00430781|advanced|advanced
752836|NCT00430781|FIGO Stage IVB|figo stage ivb
752837|NCT00430768|Gene Transfer Techniques|gene transfer techniques
752838|NCT00430768|Gene Therapy|gene therapy
752839|NCT00430768|AAV|aav
752840|NCT00430768|AAT|aat
752841|NCT00430768|Phase I|phase i
752842|NCT00430768|Intramuscular transfer|intramuscular transfer
752844|NCT00430703|severe traumatic brain injury|severe traumatic brain injury
752845|NCT00430703|body weight support treadmill training|body weight support treadmill training
752846|NCT00430703|Electroencephalogram|electroencephalogram
752847|NCT00430703|Event Related Potentials|event related potentials
752848|NCT00430664|pleurodesis|pleurodesis
752849|NCT00430664|talc|talc
752850|NCT00430664|iodopovidone|iodopovidone
752851|NCT00430651|Non Small Cell Lung Cancer|non small cell lung cancer
752852|NCT00430651|2nd line chemotherapy|2nd line chemotherapy
752853|NCT00430651|Docetaxel|docetaxel
752854|NCT00430638|Hypertension|hypertension
753911|NCT00426933|cSSSI|csssi
752855|NCT00430638|Angiotensin Receptor Blocker|angiotensin receptor blocker
752856|NCT00430638|Calcium Channel Blocker|calcium channel blocker
752857|NCT00430638|Angiotensin Converting Enzyme Inhibitor|angiotensin converting enzyme inhibitor
752858|NCT00430638|Hydrochlorothiazide|hydrochlorothiazide
752859|NCT00430638|Stage I and II Hypertension|stage i and ii hypertension
752860|NCT00430625|VPRIV®|vpriv®
752861|NCT00430625|Enzyme Replacement Therapy|enzyme replacement therapy
752862|NCT00430625|Gaucher disease|gaucher disease
752863|NCT00430625|glucocerebrosidase|glucocerebrosidase
752864|NCT00430625|beta-glucocerebrosidase|beta-glucocerebrosidase
752865|NCT00430625|Acid beta-glucocerebrosidase|acid beta-glucocerebrosidase
752866|NCT00430625|glucosylceramidase|glucosylceramidase
752867|NCT00430625|D-glucosyl-N-acylsphingosine glucohydrolase|d-glucosyl-n-acylsphingosine glucohydrolase
752868|NCT00430625|gene activation|gene activation
752869|NCT00430625|human|human
752870|NCT00430612|Myocardial Infarction|myocardial infarction
752871|NCT00430612|Heart Attack|heart attack
752872|NCT00430612|Beta Blockers|beta blockers
752873|NCT00430612|Survival|survival
752874|NCT00430573|cognitive-behavior therapy|cognitive-behavior therapy
752875|NCT00430573|d-cycloserine|d-cycloserine
752876|NCT00430573|cognitive enhancer|cognitive enhancer
752877|NCT00430573|drug dependence|drug dependence
752878|NCT00430573|opiate dependence|opiate dependence
752879|NCT00430573|exposure|exposure
752880|NCT00430573|isolated doses of d-cycloserine|isolated doses of d-cycloserine
752881|NCT00430573|isolated doses of matching pill placebo|isolated doses of matching pill placebo
752882|NCT00430573|DCS|dcs
752883|NCT00430560|work therapy|work therapy
752884|NCT00430560|cognitive rehabilitation|cognitive rehabilitation
752885|NCT00430560|schizophrenia|schizophrenia
752886|NCT00430560|schizoaffective disorder|schizoaffective disorder
752887|NCT00430560|treatment outcome|treatment outcome
752888|NCT00430534|Epstein Barr Virus|epstein barr virus
752889|NCT00430534|Belgium|belgium
752890|NCT00430534|Infectious mononucleosis|infectious mononucleosis
752891|NCT00430521|Pandemic Flu|pandemic flu
752892|NCT00430521|Pandemic influenza vaccine (GSK1119711A)|pandemic influenza vaccine (gsk1119711a)
752893|NCT00430508|Moderate-to-Severe Hypertension|moderate-to-severe hypertension
752894|NCT00430508|Essential Hypertension|essential hypertension
752895|NCT00430508|Combination Therapy|combination therapy
752896|NCT00430508|Fixed-Combination Dose|fixed-combination dose
752897|NCT00430495|atacicept|atacicept
752898|NCT00430495|arthritis|arthritis
752899|NCT00430482|Substance Dependence|substance dependence
752900|NCT00430482|Cognitive-Behavior Therapy|cognitive-behavior therapy
752901|NCT00430482|Opiate Dependence|opiate dependence
752902|NCT00430482|Treatment Moderators|treatment moderators
752903|NCT00430469|Lactoferrin|lactoferrin
752904|NCT00430469|hLF|hlf
752905|NCT00430469|Neutropenia|neutropenia
752906|NCT00430469|Myeloablative|myeloablative
752907|NCT00430469|Treatment|treatment
752908|NCT00430469|Fungal|fungal
752909|NCT00430469|Bacterial|bacterial
752910|NCT00430469|Infections|infections
752911|NCT00430469|Bone marrow transplant|bone marrow transplant
752912|NCT00430456|Aerobic exercise|aerobic exercise
752913|NCT00430456|Balance, postural|balance, postural
752914|NCT00430456|Cardiovascular deconditioning|cardiovascular deconditioning
752915|NCT00430456|Gait|gait
752916|NCT00430456|MRI, functional|mri, functional
752917|NCT00430456|Physical therapy techniques|physical therapy techniques
752918|NCT00430456|Self Efficacy|self efficacy
752919|NCT00430456|Treadmill test|treadmill test
752920|NCT00430443|Acute Lymphocytic Leukemia|acute lymphocytic leukemia
752921|NCT00430443|Acute Myelogenous Leukemia|acute myelogenous leukemia
752922|NCT00430443|Annamycin|annamycin
752923|NCT00430443|Liposomal Annamycin|liposomal annamycin
752924|NCT00430417|Pregnancy|pregnancy
752925|NCT00430417|Lactation|lactation
752926|NCT00430417|Endocrine System Diseases|endocrine system diseases
752927|NCT00430417|MusculoSkeletal System Disease|musculoskeletal system disease
752928|NCT00430417|Hormone|hormone
752929|NCT00430417|Physiologic Properties|physiologic properties
752930|NCT00430391|DVD|dvd
752931|NCT00430391|Multi-media|multi-media
752932|NCT00430391|Schizophrenia|schizophrenia
752933|NCT00430391|Normal Comparison|normal comparison
752934|NCT00430391|Consent procedures|consent procedures
752935|NCT00430378|Xerostomia|xerostomia
752936|NCT00430378|Dry Mouth|dry mouth
752937|NCT00430378|Mouth Dryness|mouth dryness
752938|NCT00430378|Nasopharyngeal Cancer|nasopharyngeal cancer
752939|NCT00430378|Acupuncture|acupuncture
752942|NCT00430365|Maintenance therapy|maintenance therapy
752943|NCT00430365|Autologous Stem Cell Transplantation|autologous stem cell transplantation
752944|NCT00430313|Nausea|nausea
752945|NCT00430313|Vomiting|vomiting
752946|NCT00430313|Electro-Stimulation|electro-stimulation
752947|NCT00430313|ES|es
752948|NCT00430313|K1 Acupuncture Point|k1 acupuncture point
752949|NCT00430313|Yongquan Acupuncture Point|yongquan acupuncture point
752950|NCT00430313|TAI|tai
752951|NCT00430313|transarterial infusion|transarterial infusion
752952|NCT00430313|liver metastasis|liver metastasis
752953|NCT00430313|chemotherapy induced nausea and vomiting|chemotherapy induced nausea and vomiting
752955|NCT00430313|Cisplatin|cisplatin
752956|NCT00430313|Oxaliplatin|oxaliplatin
752957|NCT00430300|Dry Powder for Inhalation|dry powder for inhalation
752958|NCT00430300|Chronic Obstructive Pulmonary Disease|chronic obstructive pulmonary disease
752959|NCT00430300|Lung Function testing|lung function testing
752960|NCT00430287|primary open angle glaucoma|primary open angle glaucoma
752961|NCT00430287|low tension glaucoma|low tension glaucoma
752962|NCT00430287|pigmentary glaucoma|pigmentary glaucoma
752963|NCT00430287|exfoliative glaucoma|exfoliative glaucoma
752964|NCT00430274|glaucoma|glaucoma
752965|NCT00430274|retinal gliosis-like alterations|retinal gliosis-like alterations
752966|NCT00430274|optical coherence tomography|optical coherence tomography
752967|NCT00430274|automated microperimetry|automated microperimetry
752968|NCT00430261|bronchoalveolar carcinoma|bronchoalveolar carcinoma
752970|NCT00430261|adenocarcinoma|adenocarcinoma
752971|NCT00430261|lung cancer|lung cancer
752972|NCT00430261|oral|oral
752973|NCT00430261|Stage IIIB and IV lung cancer|stage iiib and iv lung cancer
752974|NCT00430261|Any bronchoalveolar carcinoma (BAC)|any bronchoalveolar carcinoma (bac)
752975|NCT00430261|Any adenocarcinoma in a never-smoker|any adenocarcinoma in a never-smoker
752976|NCT00430248|tophi|tophi
752977|NCT00430248|hyperuricemia|hyperuricemia
752978|NCT00430248|uric acid|uric acid
752979|NCT00430248|Drug Therapy|drug therapy
752980|NCT00430235|prostate|prostate
752981|NCT00430235|cancer|cancer
752982|NCT00430235|BAY 43-9006|bay 43-9006
752983|NCT00430183|stage I prostate cancer|stage i prostate cancer
752984|NCT00430183|stage IIB prostate cancer|stage iib prostate cancer
752985|NCT00430183|stage IIA prostate cancer|stage iia prostate cancer
752986|NCT00430183|stage III prostate cancer|stage iii prostate cancer
752987|NCT00430183|adenocarcinoma of the prostate|adenocarcinoma of the prostate
752988|NCT00430170|ischemia-reperfusion injury|ischemia-reperfusion injury
752989|NCT00430170|adenosine|adenosine
752990|NCT00430170|dipyridamole|dipyridamole
752991|NCT00430170|caffeine|caffeine
752992|NCT00430157|Vienna Challenge Chamber|vienna challenge chamber
752993|NCT00430157|Seasonal Allergic Rhinitis|seasonal allergic rhinitis
752994|NCT00430157|Inflammation|inflammation
752995|NCT00430118|T-cell childhood acute lymphoblastic leukemia|t-cell childhood acute lymphoblastic leukemia
752996|NCT00430118|recurrent childhood acute lymphoblastic leukemia|recurrent childhood acute lymphoblastic leukemia
752997|NCT00430118|untreated childhood acute lymphoblastic leukemia|untreated childhood acute lymphoblastic leukemia
752998|NCT00430118|B-cell childhood acute lymphoblastic leukemia|b-cell childhood acute lymphoblastic leukemia
752999|NCT00430105|Vasculitis|vasculitis
753000|NCT00430105|ANCA|anca
753001|NCT00430105|Wegener's granulomatosis|wegener's granulomatosis
753002|NCT00430105|Renal vasculitis|renal vasculitis
753003|NCT00430105|Cyclophosphamide|cyclophosphamide
753004|NCT00430053|stage I cutaneous T-cell non-Hodgkin lymphoma|stage i cutaneous t-cell non-hodgkin lymphoma
753005|NCT00430053|stage II cutaneous T-cell non-Hodgkin lymphoma|stage ii cutaneous t-cell non-hodgkin lymphoma
753006|NCT00430053|stage III cutaneous T-cell non-Hodgkin lymphoma|stage iii cutaneous t-cell non-hodgkin lymphoma
753007|NCT00430053|stage IV cutaneous T-cell non-Hodgkin lymphoma|stage iv cutaneous t-cell non-hodgkin lymphoma
753008|NCT00430053|stage I mycosis fungoides/Sezary syndrome|stage i mycosis fungoides/sezary syndrome
753009|NCT00430053|stage II mycosis fungoides/Sezary syndrome|stage ii mycosis fungoides/sezary syndrome
753010|NCT00430053|stage III mycosis fungoides/Sezary syndrome|stage iii mycosis fungoides/sezary syndrome
753011|NCT00430053|stage IV mycosis fungoides/Sezary syndrome|stage iv mycosis fungoides/sezary syndrome
753012|NCT00430040|Type 2 Diabetes Mellitus|type 2 diabetes mellitus
753013|NCT00430040|Hypertension|hypertension
753014|NCT00430040|Carvedilol CR|carvedilol cr
753015|NCT00430040|Beta-blocker|beta-blocker
753016|NCT00430040|Oxidative stress|oxidative stress
753017|NCT00430040|Inflammation|inflammation
753018|NCT00430040|Vascular benefits|vascular benefits
753019|NCT00430027|Esophageal|esophageal
753020|NCT00430027|Esophagus|esophagus
753021|NCT00430014|Advanced Cancer|advanced cancer
753022|NCT00430014|Relapsed|relapsed
753023|NCT00430014|Atiprimod|atiprimod
753024|NCT00430014|Guanylyl cyclase receptor antagonist|guanylyl cyclase receptor antagonist
753025|NCT00430001|Metastatic breast neoplasm|metastatic breast neoplasm
753026|NCT00429988|breast cancer|breast cancer
753027|NCT00429975|fluorquinolones,|fluorquinolones,
753028|NCT00429975|b-lactams,|b-lactams,
753029|NCT00429975|immunomodulation.|immunomodulation.
753030|NCT00429962|subfoveal choroidal neovascularization (CNV)|subfoveal choroidal neovascularization (cnv)
753031|NCT00429962|age-related macular degeneration|age-related macular degeneration
753032|NCT00429962|ranibizumab monotherapy|ranibizumab monotherapy
753033|NCT00429962|combined verteporfin-therapy|combined verteporfin-therapy
753034|NCT00429962|Lucentis® (ranibizumab)|lucentis® (ranibizumab)
753035|NCT00429962|Visudyne®|visudyne®
753036|NCT00429962|photodynamic therapy|photodynamic therapy
753037|NCT00429949|Dasatinib|dasatinib
753038|NCT00429949|Plateau phase|plateau phase
753039|NCT00429936|Dry Age Related Macular Degeneration|dry age related macular degeneration
753040|NCT00429936|Geographic Atrophy|geographic atrophy
753041|NCT00429910|accelerated phase chronic myelogenous leukemia|accelerated phase chronic myelogenous leukemia
753042|NCT00429910|blastic phase chronic myelogenous leukemia|blastic phase chronic myelogenous leukemia
753043|NCT00429910|chronic phase chronic myelogenous leukemia|chronic phase chronic myelogenous leukemia
753044|NCT00429910|meningeal chronic myelogenous leukemia|meningeal chronic myelogenous leukemia
753045|NCT00429897|Hypertension|hypertension
753046|NCT00429897|Low Renin|low renin
753047|NCT00429884|Atrial fibrillation|atrial fibrillation
753048|NCT00429871|Metastatic breast cancer;|metastatic breast cancer;
753049|NCT00429871|First line chemotherapy;|first line chemotherapy;
753050|NCT00429871|Docetaxel;|docetaxel;
753051|NCT00429871|Epirubicin;|epirubicin;
753052|NCT00429871|Capecitabine|capecitabine
753053|NCT00429858|recurrent pancreatic cancer|recurrent pancreatic cancer
753054|NCT00429858|stage III pancreatic cancer|stage iii pancreatic cancer
753055|NCT00429858|adenocarcinoma of the pancreas|adenocarcinoma of the pancreas
753056|NCT00429858|stage IV pancreatic cancer|stage iv pancreatic cancer
753057|NCT00429845|HIV|hiv
753058|NCT00429845|HAART|haart
753059|NCT00429845|Nutrition|nutrition
753060|NCT00429845|Dyslipidemia|dyslipidemia
753061|NCT00429832|Nausea, vomiting, antiemetic|nausea, vomiting, antiemetic
753062|NCT00429806|Vaginal atrophy|vaginal atrophy
753063|NCT00429806|DHEA|dhea
753064|NCT00429806|Prasterone|prasterone
753065|NCT00429806|Menopause|menopause
753066|NCT00429780|Leishmaniasis vaccine|leishmaniasis vaccine
753067|NCT00429780|Alum-ALM|alum-alm
753068|NCT00429780|First generation vaccine|first generation vaccine
753069|NCT00429780|Leishmanin positive|leishmanin positive
753070|NCT00429780|Healthy Volunteers|healthy volunteers
753071|NCT00429780|Response to Leishmanin (Leishmanin Skin Test>0)|response to leishmanin (leishmanin skin test>0)
753072|NCT00429780|No History of Cutaneous Leishmaniasis|no history of cutaneous leishmaniasis
753073|NCT00429767|Opioid|opioid
753074|NCT00429767|Cocaine|cocaine
753075|NCT00429767|Drug Self Administration|drug self administration
753076|NCT00429754|Nausea and vomiting after using cytostatic drugs|nausea and vomiting after using cytostatic drugs
753077|NCT00429728|Pharmacokinetics,|pharmacokinetics,
753078|NCT00429728|tolerability,|tolerability,
753079|NCT00429728|healthy,|healthy,
753080|NCT00429728|subjects,|subjects,
753081|NCT00429728|smokers,|smokers,
753082|NCT00429728|non-smokers|non-smokers
753083|NCT00429715|Leishmaniasis vaccine|leishmaniasis vaccine
753084|NCT00429715|Alum-ALM|alum-alm
753085|NCT00429715|First generation vaccine|first generation vaccine
753086|NCT00429715|Healthy volunteers|healthy volunteers
753087|NCT00429715|No response to leishmanin|no response to leishmanin
753088|NCT00429715|No history of cutaneous leishmaniasis|no history of cutaneous leishmaniasis
753089|NCT00429702|nausea|nausea
753090|NCT00429702|vomiting|vomiting
753091|NCT00429702|emetic chemotherapy|emetic chemotherapy
753092|NCT00429702|unspecified childhood solid tumor, protocol specific|unspecified childhood solid tumor, protocol specific
753093|NCT00429689|Male, MDD, Testosterone, DHEA-S,Cortisol|male, mdd, testosterone, dhea-s,cortisol
753094|NCT00429689|Male|male
753095|NCT00429689|18-65|18-65
753096|NCT00429689|Major Depression|major depression
753097|NCT00429676|Randomized|randomized
753098|NCT00429676|Controlled|controlled
753099|NCT00429676|Trial|trial
753100|NCT00429676|Delirium|delirium
753101|NCT00429676|Haloperidol|haloperidol
753102|NCT00429663|distal femur|distal femur
753103|NCT00429663|femur fracture|femur fracture
753104|NCT00429650|Weight maintenance|weight maintenance
753105|NCT00429650|Weight loss|weight loss
753106|NCT00429637|EBC pH|ebc ph
753107|NCT00429637|Airway acidification|airway acidification
753108|NCT00429637|Condensimetry|condensimetry
753109|NCT00429637|ARDS|ards
753110|NCT00429637|RSV|rsv
753111|NCT00429637|ALI|ali
753112|NCT00429637|Airway reconstruction|airway reconstruction
753113|NCT00429624|Neck Pain|neck pain
753114|NCT00429624|Chiropractic manipulation|chiropractic manipulation
753115|NCT00429624|Randomized controlled trial|randomized controlled trial
753116|NCT00429611|biphasic defibrillation|biphasic defibrillation
753117|NCT00429611|inhospital|inhospital
753118|NCT00429611|post-resuscitation myocardial function|post-resuscitation myocardial function
753119|NCT00429611|defibrillation efficacy|defibrillation efficacy
753120|NCT00429611|high energy versus low energy|high energy versus low energy
753121|NCT00429611|cardiac arrest patients|cardiac arrest patients
753122|NCT00429585|tibia fracture|tibia fracture
753123|NCT00429585|proximal tibia|proximal tibia
753124|NCT00429572|Breast Cancer|breast cancer
753725|NCT00427557|Lymphoma|lymphoma
753125|NCT00429572|PBPC Transplantation|pbpc transplantation
753126|NCT00429572|Stem Cell Infusion|stem cell infusion
753127|NCT00429572|Fludarabine|fludarabine
753128|NCT00429572|Melphalan|melphalan
753129|NCT00429559|Cancer;|cancer;
753130|NCT00429559|Ovarian cancer;|ovarian cancer;
753131|NCT00429559|Recurrent ovarian cancer platinum-resistant|recurrent ovarian cancer platinum-resistant
753132|NCT00429546|Disclosure|disclosure
753133|NCT00429546|Serostatus|serostatus
753134|NCT00429507|Breast Cancer|breast cancer
753135|NCT00429507|Blood Stem Cell|blood stem cell
753136|NCT00429507|Bone Metastases|bone metastases
753137|NCT00429507|Radiation Therapy|radiation therapy
753138|NCT00429507|Gamma Camera|gamma camera
753139|NCT00429507|Sm-EDTMP|sm-edtmp
753140|NCT00429507|Samarium 153-EDTMP|samarium 153-edtmp
753141|NCT00429507|Stem Cell Transplant|stem cell transplant
753142|NCT00429507|Autologous Peripheral Blood Stem Cell Transplantation|autologous peripheral blood stem cell transplantation
753143|NCT00429507|PBSCT|pbsct
753144|NCT00429507|Questionnaire|questionnaire
753145|NCT00429494|Hematopoietic Stem Cell Transplantation|hematopoietic stem cell transplantation
753146|NCT00429494|GnRH Analogue|gnrh analogue
753147|NCT00429494|Gonadotropin-releasing hormone analogue|gonadotropin-releasing hormone analogue
753148|NCT00429494|GnRH-a|gnrh-a
753149|NCT00429494|Ovarian Function|ovarian function
753150|NCT00429494|Fertility|fertility
753151|NCT00429494|Leuprolide Acetate|leuprolide acetate
753152|NCT00429494|Lupron Depot|lupron depot
753153|NCT00429494|premature ovarian failure|premature ovarian failure
753154|NCT00429494|POF|pof
753155|NCT00429494|Abnormal suppression of menstruation|abnormal suppression of menstruation
753156|NCT00429494|absence of menstruation|absence of menstruation
753157|NCT00429481|Oral live attenuated human rotavirus vaccine|oral live attenuated human rotavirus vaccine
753158|NCT00429481|Gastroenteritis|gastroenteritis
753159|NCT00429481|Vomiting|vomiting
753160|NCT00429455|Fertility|fertility
753161|NCT00429455|Menopause|menopause
753162|NCT00429455|Hematopoietic Stem Cell Transplantation|hematopoietic stem cell transplantation
753163|NCT00429455|Questionnaire|questionnaire
753164|NCT00429455|Survey|survey
753165|NCT00429442|Simvastatin|simvastatin
753166|NCT00429442|CNS Inflammation|cns inflammation
753167|NCT00429442|Copaxone|copaxone
753168|NCT00429429|Peanut allergy|peanut allergy
753169|NCT00429416|Hematologic Malignancies|hematologic malignancies
753170|NCT00429416|GVHD|gvhd
753171|NCT00429416|Graft-Versus-Host-Disease|graft-versus-host-disease
753172|NCT00429416|LLME|llme
753173|NCT00429416|CD34+ stem cell infusions|cd34+ stem cell infusions
753174|NCT00429416|CD34- fraction|cd34- fraction
753175|NCT00429416|Cyclosporine|cyclosporine
753176|NCT00429416|Mycophenolate Mofetil|mycophenolate mofetil
753177|NCT00429416|HSCT|hsct
753178|NCT00429416|Hematopoietic stem cell transplantation|hematopoietic stem cell transplantation
753179|NCT00429403|Breast Cancer|breast cancer
753180|NCT00429403|Chemotherapy|chemotherapy
753181|NCT00429403|Ovarian Function|ovarian function
753182|NCT00429403|Goserelin|goserelin
753183|NCT00429403|Zoladex|zoladex
753184|NCT00429403|Ovary function|ovary function
753185|NCT00429403|Fertility|fertility
753186|NCT00429403|Early Menopause|early menopause
753187|NCT00429390|Metabolic syndrome|metabolic syndrome
753188|NCT00429390|Ramadan Fasting|ramadan fasting
753189|NCT00429390|Insulin sensitivity|insulin sensitivity
753190|NCT00429390|Iran|iran
753191|NCT00429377|tacrolimus|tacrolimus
753192|NCT00429377|FK506|fk506
753193|NCT00429377|lupus nephritis|lupus nephritis
753194|NCT00429364|Aortic Root Dissection|aortic root dissection
753195|NCT00429364|Aortic Root Dilation|aortic root dilation
753196|NCT00429364|Pediatric Heart Network|pediatric heart network
753197|NCT00429338|Genitourinary|genitourinary
753198|NCT00429338|Prostate Cancer|prostate cancer
753199|NCT00429338|Magnetic Resonance Imaging|magnetic resonance imaging
753200|NCT00429338|MRI|mri
753201|NCT00429338|Magnetic Resonance Spectroscopic Imaging|magnetic resonance spectroscopic imaging
753202|NCT00429338|MRSI|mrsi
753203|NCT00429338|Endorectal MRSI|endorectal mrsi
753204|NCT00429338|Endorectal magnetic resonance spectroscopy imaging|endorectal magnetic resonance spectroscopy imaging
753205|NCT00429338|3 Tesla|3 tesla
753206|NCT00429338|3T Scan|3t scan
753207|NCT00429338|Endorectal coil|endorectal coil
753208|NCT00429338|Perfluorocarbon compound|perfluorocarbon compound
753209|NCT00429338|PFC|pfc
753210|NCT00429338|PFC-filled endorectal coil|pfc-filled endorectal coil
753211|NCT00429338|PFC-MRSI|pfc-mrsi
753212|NCT00429338|AIR-MRSI|air-mrsi
753213|NCT00429325|acute infectious diarrhea,|acute infectious diarrhea,
753214|NCT00429325|fecal calprotectin,|fecal calprotectin,
753215|NCT00429325|stool culture,|stool culture,
753216|NCT00429325|hemoccult test,|hemoccult test,
753217|NCT00429325|Guaiac fecal occult blood test (FOBT)|guaiac fecal occult blood test (fobt)
753218|NCT00429325|fecal lactoferrin|fecal lactoferrin
753219|NCT00429312|Melanoma|melanoma
753220|NCT00429312|Oncolytic virus|oncolytic virus
753221|NCT00429312|Pexa-Vec|pexa-vec
753222|NCT00429299|neo-adjuvant trastuzumab early breast cancer lapatinib|neo-adjuvant trastuzumab early breast cancer lapatinib
753223|NCT00429286|Health Services Research|health services research
753224|NCT00429273|ADHD|adhd
753225|NCT00429273|Guanfacine|guanfacine
753226|NCT00429273|Methylphenidate|methylphenidate
753227|NCT00429273|Focalin XR|focalin xr
753228|NCT00429273|Pediatric|pediatric
753229|NCT00429273|Cognitive function|cognitive function
753230|NCT00429273|Combination therapy|combination therapy
753231|NCT00429260|depression|depression
753232|NCT00429260|antidepressive agents|antidepressive agents
753233|NCT00429247|Occult tumor cells|occult tumor cells
753912|NCT00426933|MRSA|mrsa
753234|NCT00429247|Micrometastatic cells|micrometastatic cells
753235|NCT00429247|Cytokeratin-19|cytokeratin-19
753236|NCT00429247|Trastuzumab|trastuzumab
753237|NCT00429247|Completion of Adjuvant Treatment|completion of adjuvant treatment
753238|NCT00429234|Advanced Cancer|advanced cancer
753239|NCT00429234|Solid Tumors|solid tumors
753240|NCT00429234|Dasatinib|dasatinib
753241|NCT00429234|BMS-354825|bms-354825
753242|NCT00429234|Sprycel|sprycel
753243|NCT00429234|Gemcitabine|gemcitabine
753244|NCT00429234|Gemcitabine Hydrochloride|gemcitabine hydrochloride
753245|NCT00429234|Gemzar|gemzar
753246|NCT00429221|ADHD|adhd
753247|NCT00429208|Nicotine Dependence|nicotine dependence
753248|NCT00429208|Smoking|smoking
753249|NCT00429208|Tobacco Use Disorder|tobacco use disorder
753250|NCT00429208|Nicotine Use Disorder|nicotine use disorder
753251|NCT00429195|LIPGENE|lipgene
753252|NCT00429195|Fatty acid|fatty acid
753253|NCT00429195|Dietary intervention|dietary intervention
753254|NCT00429195|Metabolic syndrome|metabolic syndrome
753255|NCT00429195|Insulin resistance|insulin resistance
753256|NCT00429182|Breast Cancer|breast cancer
753257|NCT00429182|breast carcinoma|breast carcinoma
753258|NCT00429182|Carboplatin|carboplatin
753259|NCT00429182|Paraplatin|paraplatin
753260|NCT00429182|Cyclophosphamide|cyclophosphamide
753261|NCT00429182|Neosar|neosar
753262|NCT00429182|Cytoxan|cytoxan
753263|NCT00429182|Thiotepa|thiotepa
753264|NCT00429182|Purged Autologous Stem Cells|purged autologous stem cells
753265|NCT00429182|Circulating Tumor Cells|circulating tumor cells
753266|NCT00429182|CTCs|ctcs
753267|NCT00429169|Major Depressive Disorder|major depressive disorder
753268|NCT00429169|MDD|mdd
753269|NCT00429156|Non-invasive ventilation|non-invasive ventilation
753270|NCT00429156|Non-invasive positive pressure ventilation|non-invasive positive pressure ventilation
753271|NCT00429156|Home ventilation|home ventilation
753272|NCT00429156|Domiciliary ventilation|domiciliary ventilation
753273|NCT00429156|Chronic obstructive pulmonary disease|chronic obstructive pulmonary disease
753274|NCT00429156|COPD|copd
753275|NCT00429156|Respiratory failure|respiratory failure
753276|NCT00429156|Acute hypercapnic respiratory failure|acute hypercapnic respiratory failure
753277|NCT00429156|NIV|niv
753278|NCT00429156|NIPPV|nippv
753279|NCT00429156|Type II respiratory failure|type ii respiratory failure
753280|NCT00429143|Hematologic Malignancies|hematologic malignancies
753281|NCT00429143|Two Step Approach|two step approach
753282|NCT00429143|Haploidentical Transplant|haploidentical transplant
753283|NCT00429117|Spirituality|spirituality
753284|NCT00429117|Work Related Stress|work related stress
753285|NCT00429117|Religious Beliefs|religious beliefs
753286|NCT00429117|Survey|survey
753287|NCT00429104|Breast Cancer|breast cancer
753288|NCT00429104|Carcinoma of the Breast|carcinoma of the breast
753289|NCT00429104|HER-2/neu Overexpression|her-2/neu overexpression
753290|NCT00429104|Herceptin|herceptin
753291|NCT00429104|Trastuzumab|trastuzumab
753292|NCT00429104|GM-CSF|gm-csf
753293|NCT00429104|Sargramostim|sargramostim
753294|NCT00429104|Leukine|leukine
753295|NCT00429078|Gastric Cancer|gastric cancer
753296|NCT00429078|T Cells|t cells
753297|NCT00429078|Gene Transfer|gene transfer
753298|NCT00429065|Non-Hodgkin lymphoma|non-hodgkin lymphoma
753299|NCT00429065|rituximab|rituximab
753300|NCT00429065|immunotherapy|immunotherapy
753301|NCT00429052|Coronary Disease|coronary disease
753302|NCT00429052|Coronary Stenosis|coronary stenosis
753303|NCT00429052|Percutaneous Transluminal Coronary Angioplasty|percutaneous transluminal coronary angioplasty
753304|NCT00429052|Stents|stents
753305|NCT00429052|Sirolimus|sirolimus
753306|NCT00429026|Kidney Cancer|kidney cancer
753307|NCT00429026|Renal Cell Cancer|renal cell cancer
753308|NCT00429026|Stem Cell Transplant|stem cell transplant
753309|NCT00429026|Cyclophosphamide|cyclophosphamide
753310|NCT00429026|Fludarabine|fludarabine
753311|NCT00429026|Melphalan|melphalan
753312|NCT00429026|NST|nst
753313|NCT00429013|Pressure ulcer|pressure ulcer
753314|NCT00429013|Lingual electric stimulation|lingual electric stimulation
753315|NCT00429013|Paraplegic patient|paraplegic patient
753316|NCT00429013|Pressure Ulcer/Prevention & control|pressure ulcer/prevention & control
753317|NCT00429000|Hypothermia|hypothermia
753318|NCT00429000|Infant mortality|infant mortality
753319|NCT00429000|Infant morbidity|infant morbidity
753320|NCT00429000|Intervention|intervention
753321|NCT00429000|Randomisation|randomisation
753322|NCT00429000|Longitudinal research.|longitudinal research.
753323|NCT00429000|Low-income country|low-income country
753324|NCT00428987|Energy Expenditure|energy expenditure
753325|NCT00428987|Neurocognitive Function|neurocognitive function
753326|NCT00428987|Obesity|obesity
753327|NCT00428987|Metabolism|metabolism
753328|NCT00428987|Phenotype|phenotype
753329|NCT00428987|Body Composition|body composition
753330|NCT00428987|Morbid Obesity|morbid obesity
753331|NCT00428987|Overweight|overweight
753332|NCT00428987|Healthy Volunteer|healthy volunteer
753333|NCT00428974|Psoriasis|psoriasis
753334|NCT00428961|diabetes mellitus|diabetes mellitus
753335|NCT00428961|insulin resistance|insulin resistance
753336|NCT00428961|atherosclerosis|atherosclerosis
753337|NCT00428948|ADPKD|adpkd
753338|NCT00428948|Polycystic|polycystic
753339|NCT00428948|kidney|kidney
753340|NCT00428948|ADPKD (Autosomal Dominant Polycystic Kidney Disease)|adpkd (autosomal dominant polycystic kidney disease)
753341|NCT00428935|Duchenne|duchenne
753342|NCT00428935|Muscle|muscle
753343|NCT00428935|Muscular Dystrophy|muscular dystrophy
753344|NCT00428935|Gene Therapy|gene therapy
753345|NCT00428935|Dystrophin|dystrophin
753346|NCT00428935|Adeno-Associated Virus|adeno-associated virus
753347|NCT00428935|AAV|aav
753348|NCT00428922|Metastatic|metastatic
753349|NCT00428922|Breast Cancer|breast cancer
753350|NCT00428922|MBC|mbc
753351|NCT00428909|Pharmacokinetic|pharmacokinetic
753352|NCT00428909|STI571|sti571
753353|NCT00428909|imatinib|imatinib
753354|NCT00428909|CML|cml
753355|NCT00428909|Chronic Myeloid Leukemia|chronic myeloid leukemia
753356|NCT00428909|Philadelphia Chromosome|philadelphia chromosome
753357|NCT00428909|acetaminophen|acetaminophen
753358|NCT00428896|Breast cancer|breast cancer
753359|NCT00428896|iressa circulating tumor cells|iressa circulating tumor cells
753360|NCT00428883|Scleroderma, Systemic|scleroderma, systemic
753361|NCT00428883|Scleroderma, Diffuse|scleroderma, diffuse
753362|NCT00428870|Shoulder|shoulder
753363|NCT00428870|impingement|impingement
753364|NCT00428870|conservative|conservative
753365|NCT00428870|acromioplasty|acromioplasty
753366|NCT00428870|arthroscopy|arthroscopy
753367|NCT00428844|Osteomyelitis|osteomyelitis
753368|NCT00428844|Prosthetic Hip|prosthetic hip
753369|NCT00428844|Prosthetic Knee|prosthetic knee
753370|NCT00428844|MRSA|mrsa
753371|NCT00428844|Osteomyelitis Associated with an Infected Prosthetic Hip or Knee Joint|osteomyelitis associated with an infected prosthetic hip or knee joint
753372|NCT00428844|Staphylococci|staphylococci
753373|NCT00428831|influenza, genomic data, nasopharyngeal aspirate|influenza, genomic data, nasopharyngeal aspirate
753374|NCT00428818|MRSA|mrsa
753375|NCT00428805|body composition|body composition
753376|NCT00428805|physical activity|physical activity
753377|NCT00428805|dietary intake|dietary intake
753378|NCT00428805|children|children
753379|NCT00428792|ADHD|adhd
753380|NCT00428792|methylphenidate|methylphenidate
753381|NCT00428792|children|children
753382|NCT00428792|food effect|food effect
753383|NCT00428792|Attention-Deficit Hyperactivity Disorder (ADHD) in children|attention-deficit hyperactivity disorder (adhd) in children
753384|NCT00428779|Running during 24 hours|running during 24 hours
753385|NCT00428779|Voluntary evoked force on the muscles|voluntary evoked force on the muscles
753386|NCT00428779|Electrically evoked force on the muscles|electrically evoked force on the muscles
753387|NCT00428779|EMG activity|emg activity
753388|NCT00428779|Muscle biopsy|muscle biopsy
753389|NCT00428779|subjects will be recruited among experienced ultra-runners|subjects will be recruited among experienced ultra-runners
753390|NCT00428753|avian influenza, China, H5N1|avian influenza, china, h5n1
753391|NCT00428727|Diabetic foot|diabetic foot
753392|NCT00428727|Ulcer|ulcer
753393|NCT00428727|nitric oxide|nitric oxide
753394|NCT00428727|treatment|treatment
753395|NCT00428727|donor|donor
753396|NCT00428727|controlled trial|controlled trial
753397|NCT00428701|stress ulcer|stress ulcer
753398|NCT00428701|critically ill|critically ill
753399|NCT00428701|gastric acid|gastric acid
753400|NCT00428701|gastric aspirates|gastric aspirates
753401|NCT00428701|esomeprazole|esomeprazole
753402|NCT00428688|Hodgkin's lymphoma|hodgkin's lymphoma
753403|NCT00428688|cardiovascular disease|cardiovascular disease
753404|NCT00428688|radiation therapy|radiation therapy
753405|NCT00428688|Brachial artery flow-mediated dilation (FMD)|brachial artery flow-mediated dilation (fmd)
753406|NCT00428675|screening|screening
753407|NCT00428675|fatigue|fatigue
753408|NCT00428662|coronary stenting|coronary stenting
753409|NCT00428662|drug eluting stents|drug eluting stents
753410|NCT00428662|paclitaxel|paclitaxel
753411|NCT00428662|nanoporous|nanoporous
753412|NCT00428649|Selenium supplements|selenium supplements
753413|NCT00428649|Selenoprotein P|selenoprotein p
753414|NCT00428649|Optimization|optimization
753415|NCT00428636|ileostomy|ileostomy
753416|NCT00428636|rectal resection|rectal resection
753417|NCT00428636|proctectomy|proctectomy
753418|NCT00428636|stoma closure|stoma closure
753419|NCT00428623|Patient comfort|patient comfort
753420|NCT00428623|Wound dressings|wound dressings
753421|NCT00428623|infection|infection
753422|NCT00428623|vascular surgery|vascular surgery
753423|NCT00428571|Type 2 Diabetes|type 2 diabetes
753424|NCT00428571|Bariatric surgery|bariatric surgery
753425|NCT00428571|Obesity|obesity
753426|NCT00428571|Laparoscopic gastric bypass|laparoscopic gastric bypass
753427|NCT00428571|Laparoscopic adjustable gastric banding|laparoscopic adjustable gastric banding
753428|NCT00428558|acute myeloid leukemia|acute myeloid leukemia
753429|NCT00428558|Core Binding Factor|core binding factor
753430|NCT00428558|t(8;21)|t(8;21)
753431|NCT00428558|inv(16)|inv(16)
753432|NCT00428558|timed-sequential induction|timed-sequential induction
753433|NCT00428545|Advanced Malignancy|advanced malignancy
753434|NCT00428545|Lymphoma|lymphoma
753436|NCT00428545|Solid Tumors|solid tumors
753437|NCT00428545|Bevacizumab|bevacizumab
753438|NCT00428545|Avastin|avastin
753439|NCT00428545|Anti-VEGF monoclonal antibody|anti-vegf monoclonal antibody
753440|NCT00428545|rhuMAb-VEGF|rhumab-vegf
753441|NCT00428545|Bortezomib|bortezomib
753442|NCT00428545|Velcade|velcade
753443|NCT00428545|PS-341|ps-341
753444|NCT00428545|LDP-341|ldp-341
753445|NCT00428545|MLN341|mln341
753446|NCT00428519|HIV infection|hiv infection
753447|NCT00428519|Neurokinin-1 receptor antagonist|neurokinin-1 receptor antagonist
753448|NCT00428519|CCR5 expression|ccr5 expression
753449|NCT00428519|Treatment Naive|treatment naive
753450|NCT00428506|ascites|ascites
753451|NCT00428506|cirrhosis|cirrhosis
753452|NCT00428506|post-paracentesis circulatory dysfunction|post-paracentesis circulatory dysfunction
753453|NCT00428506|albumin|albumin
753454|NCT00428506|portal-hypertension|portal-hypertension
753455|NCT00428493|human influenza A, H5N1, bird flu, avian influenza, China|human influenza a, h5n1, bird flu, avian influenza, china
753456|NCT00428467|Heart Failure|heart failure
753457|NCT00428467|LV Geometry|lv geometry
753458|NCT00428467|Heart MRT|heart mrt
753459|NCT00428454|drug-eluting stent|drug-eluting stent
753460|NCT00428454|chronic total occlusion|chronic total occlusion
753461|NCT00428454|sirolimus-eluting stent|sirolimus-eluting stent
753462|NCT00428454|zotarolimus-eluting stent|zotarolimus-eluting stent
753464|NCT00428441|D-dimer|d-dimer
753465|NCT00428441|Recurrence|recurrence
753466|NCT00428441|Venous thromboembolism|venous thromboembolism
753467|NCT00428428|kidney stone|kidney stone
753468|NCT00428428|ureteroscopy|ureteroscopy
753469|NCT00428402|Education|education
753470|NCT00428402|4th-8th Grade Student|4th-8th grade student
753471|NCT00428402|MIDAS Project|midas project
753472|NCT00428402|Focus Group Discussion|focus group discussion
753473|NCT00428402|Bastrop|bastrop
753474|NCT00428389|Dementia, Alzheimer's, Rivastigmine, donepezil|dementia, alzheimer's, rivastigmine, donepezil
753475|NCT00428363|posterior capsule opacification|posterior capsule opacification
753476|NCT00428363|PCO|pco
753477|NCT00428363|after cataract|after cataract
753478|NCT00428363|intraocular lens|intraocular lens
753479|NCT00428363|optic edge design|optic edge design
753480|NCT00428363|sharp optic edge|sharp optic edge
753481|NCT00428337|HIV Seronegativity|hiv seronegativity
753482|NCT00428337|EP1233|ep1233
753483|NCT00428337|MVA-mBN32|mva-mbn32
753484|NCT00428337|HIV Preventive Vaccine|hiv preventive vaccine
753485|NCT00428311|Polycystic ovary syndrome|polycystic ovary syndrome
753486|NCT00428311|Hyperandrogenism|hyperandrogenism
753487|NCT00428311|Hirsutism|hirsutism
753488|NCT00428311|Cardiovascular risk|cardiovascular risk
753489|NCT00428311|Chronic inflammation|chronic inflammation
753490|NCT00428311|Metformin|metformin
753491|NCT00428311|Cyproterone acetate|cyproterone acetate
753492|NCT00428311|Oral contraceptives|oral contraceptives
753493|NCT00428298|Bipolar|bipolar
753494|NCT00428298|Cognitive|cognitive
753495|NCT00428298|Attention|attention
753496|NCT00428298|Memory|memory
753497|NCT00428298|Manic Depression|manic depression
753498|NCT00428298|Bi-polar|bi-polar
753499|NCT00428285|Human Papilloma Virus|human papilloma virus
753500|NCT00428285|HIV infected MSM|hiv infected msm
753501|NCT00428285|Treatment Experienced|treatment experienced
753502|NCT00428285|Treatment Naive|treatment naive
753503|NCT00428285|Anal Intraepithelial Neoplasia|anal intraepithelial neoplasia
753504|NCT00428272|Monoclonal Antibody Lexatumumab|monoclonal antibody lexatumumab
753505|NCT00428272|Interferon Gamma|interferon gamma
753506|NCT00428272|Solid Tumor|solid tumor
753507|NCT00428272|Phase I|phase i
753508|NCT00428272|Malignant Tumor|malignant tumor
753509|NCT00428272|Metastatic Tumor|metastatic tumor
753510|NCT00428272|Pediatric Solid Tumor|pediatric solid tumor
753511|NCT00428272|Ewing Sarcoma|ewing sarcoma
753512|NCT00428272|Osteosarcoma|osteosarcoma
753513|NCT00428272|Neuroblastoma|neuroblastoma
753514|NCT00428272|Rhabdomyosarcoma|rhabdomyosarcoma
753515|NCT00428246|Chronic Kidney Disease|chronic kidney disease
753516|NCT00428246|Endothelial dysfunction|endothelial dysfunction
753517|NCT00428246|Inflammation|inflammation
753518|NCT00428246|Hypertension|hypertension
753519|NCT00428246|paricalcitol|paricalcitol
753520|NCT00428246|Blood pressure|blood pressure
753521|NCT00428246|Vitamin D|vitamin d
753522|NCT00428246|Glomerular filtration rate|glomerular filtration rate
753523|NCT00428233|CLL|cll
753524|NCT00428233|vaccine|vaccine
753525|NCT00428220|Potentially other tumor types in the future|potentially other tumor types in the future
754103|NCT00426296|Boosted|boosted
753526|NCT00428207|type 1 diabetes, insulin pump therapy, glycemic stability|type 1 diabetes, insulin pump therapy, glycemic stability
753527|NCT00428194|stage IIA cervical cancer|stage iia cervical cancer
753528|NCT00428194|stage IB cervical cancer|stage ib cervical cancer
753529|NCT00428194|stage IIB cervical cancer|stage iib cervical cancer
753530|NCT00428194|stage III cervical cancer|stage iii cervical cancer
753531|NCT00428194|stage IVA cervical cancer|stage iva cervical cancer
753532|NCT00428194|cervical squamous cell carcinoma|cervical squamous cell carcinoma
753533|NCT00428181|Brief alcohol intervention|brief alcohol intervention
753534|NCT00428181|Booster session|booster session
753535|NCT00428181|Personalized feedback|personalized feedback
753536|NCT00428181|Motivational interview|motivational interview
753537|NCT00428181|Injury recidivism|injury recidivism
753538|NCT00428181|Psychological Interview|psychological interview
753539|NCT00428181|Risk Reduction Behaviors|risk reduction behaviors
753540|NCT00428168|Betahistine|betahistine
753541|NCT00428168|Weight Gain Control|weight gain control
753542|NCT00428168|Weight Gain due to Olanzapine Treatment|weight gain due to olanzapine treatment
753543|NCT00428168|Obesity|obesity
753544|NCT00428168|Schizophrenic disorder|schizophrenic disorder
753545|NCT00428155|hemostasis|hemostasis
753546|NCT00428155|angioplasty|angioplasty
753547|NCT00428155|stenting|stenting
753548|NCT00428155|closure device|closure device
753549|NCT00428155|angioseal|angioseal
753550|NCT00428155|starclose|starclose
753551|NCT00428142|stage III grade 1 follicular lymphoma|stage iii grade 1 follicular lymphoma
753552|NCT00428142|stage III grade 2 follicular lymphoma|stage iii grade 2 follicular lymphoma
753553|NCT00428142|stage III grade 3 follicular lymphoma|stage iii grade 3 follicular lymphoma
753554|NCT00428142|stage IV grade 1 follicular lymphoma|stage iv grade 1 follicular lymphoma
753555|NCT00428142|stage IV grade 2 follicular lymphoma|stage iv grade 2 follicular lymphoma
753556|NCT00428142|stage IV grade 3 follicular lymphoma|stage iv grade 3 follicular lymphoma
753557|NCT00428129|Acute Iliofemoral Deep Vein Thrombosis|acute iliofemoral deep vein thrombosis
753558|NCT00428116|HIV-1|hiv-1
753559|NCT00428116|Pediatric|pediatric
753560|NCT00428116|HAART|haart
753561|NCT00428116|Treatment Naive|treatment naive
753562|NCT00428103|Mitral valve regurgitation|mitral valve regurgitation
753563|NCT00428090|apolipoprotein E|apolipoprotein e
753564|NCT00428090|monotherapy|monotherapy
753565|NCT00428090|cognition|cognition
753566|NCT00428090|mild|mild
753567|NCT00428090|rosiglitazone|rosiglitazone
753568|NCT00428090|Alzheimer's disease|alzheimer's disease
753569|NCT00428090|moderate|moderate
753570|NCT00428077|Philadelphia chromosome positive (Ph+) chronic myelogenous leukemia|philadelphia chromosome positive (ph+) chronic myelogenous leukemia
753571|NCT00428077|chronic phase chronic myelogenous leukemia|chronic phase chronic myelogenous leukemia
753572|NCT00428064|Renal allograft|renal allograft
753573|NCT00428064|Renal|renal
753574|NCT00428064|Kidney|kidney
753575|NCT00428064|Transplant|transplant
753576|NCT00428051|Epidemiology|epidemiology
753577|NCT00428051|Surveillance|surveillance
753578|NCT00428051|Streptococcal Pneumonia|streptococcal pneumonia
753579|NCT00428038|Infant, Premature|infant, premature
753580|NCT00428038|Bronchopulmonary Dysplasia|bronchopulmonary dysplasia
753581|NCT00428038|Asthma|asthma
753582|NCT00428025|pancreatitis|pancreatitis
753583|NCT00428012|quality of life, kidney transplantation|quality of life, kidney transplantation
753584|NCT00427999|Hormone-refractory|hormone-refractory
753585|NCT00427999|prostate cancer|prostate cancer
753586|NCT00427999|multitargeted|multitargeted
753587|NCT00427999|tyrosinkinase|tyrosinkinase
753588|NCT00427986|Diabetes|diabetes
753589|NCT00427986|Macular oedema|macular oedema
753590|NCT00427986|Osmosis|osmosis
753591|NCT00427986|Galactose|galactose
753592|NCT00427986|Intravenous|intravenous
753593|NCT00427986|Retinal thickness|retinal thickness
753594|NCT00427986|Starling|starling
753595|NCT00427960|cholesterol|cholesterol
753596|NCT00427960|statin|statin
753597|NCT00427960|Asian|asian
753598|NCT00427960|LDL-cholesterol|ldl-cholesterol
753599|NCT00427947|phantom limb pain|phantom limb pain
753600|NCT00427947|amputation|amputation
753601|NCT00427947|anesthetics, local|anesthetics, local
753602|NCT00427947|postoperative analgesia|postoperative analgesia
753603|NCT00427947|ropivacaine|ropivacaine
753604|NCT00427947|analgesia|analgesia
753605|NCT00427908|Meningococcal serogroups A, C, W-135 and/or Y diseases|meningococcal serogroups a, c, w-135 and/or y diseases
753606|NCT00427908|Conjugate vaccine|conjugate vaccine
753607|NCT00427908|Immunogenicity|immunogenicity
753608|NCT00427908|Meningococcal vaccine|meningococcal vaccine
753609|NCT00427908|Persistence|persistence
753610|NCT00427908|Non-inferiority|non-inferiority
753611|NCT00427895|Vaccine|vaccine
753612|NCT00427895|Pneumococcal Infections Prevention and Control|pneumococcal infections prevention and control
753613|NCT00427843|osteoarthritis|osteoarthritis
753614|NCT00427843|knee|knee
753615|NCT00427843|gait|gait
753616|NCT00427843|muscle strength|muscle strength
753617|NCT00427843|hip|hip
753618|NCT00427843|exercise|exercise
753619|NCT00427830|Mycobacterium tuberculosis|mycobacterium tuberculosis
753620|NCT00427830|85A antigen|85a antigen
753621|NCT00427830|Recombinant Modified Vaccinia Ankara|recombinant modified vaccinia ankara
753622|NCT00427830|Phase I study|phase i study
753623|NCT00427830|Immunogenicity|immunogenicity
753624|NCT00427830|BCG|bcg
753625|NCT00427817|Adenoma, Prostatic|adenoma, prostatic
753626|NCT00427817|Prostate|prostate
753627|NCT00427817|Proteomics|proteomics
753628|NCT00427817|Urology|urology
753629|NCT00427804|Calcium absorption|calcium absorption
753630|NCT00427804|Vitamin D|vitamin d
753631|NCT00427791|Acute Lymphoblastic Leukemia|acute lymphoblastic leukemia
753632|NCT00427791|Leukemia|leukemia
753633|NCT00427791|Total Body Irradiation|total body irradiation
753634|NCT00427791|Etoposide|etoposide
753635|NCT00427791|Rituximab|rituximab
753636|NCT00427791|Rituxan|rituxan
753637|NCT00427791|TBI|tbi
753638|NCT00427791|ALL|all
753639|NCT00427778|incontinence ring|incontinence ring
753640|NCT00427778|pessary|pessary
753641|NCT00427778|urinary incontinence|urinary incontinence
753642|NCT00427778|urodynamic study|urodynamic study
753643|NCT00427778|quality of life|quality of life
753644|NCT00427778|crossover trial|crossover trial
753645|NCT00427778|randomised trial|randomised trial
753646|NCT00427765|Multiple Myeloma|multiple myeloma
753647|NCT00427765|Hodgkin's Disease|hodgkin's disease
753648|NCT00427765|Non-Hodgkin's Lymphoma|non-hodgkin's lymphoma
753649|NCT00427765|Leukemia|leukemia
753650|NCT00427765|Lymphoma|lymphoma
753651|NCT00427765|Busulfan|busulfan
753652|NCT00427765|Melphalan|melphalan
753653|NCT00427765|Autologous bone marrow|autologous bone marrow
753654|NCT00427765|BMT|bmt
753655|NCT00427765|Peripheral blood stem cell transplant|peripheral blood stem cell transplant
753656|NCT00427765|PBSCT|pbsct
753657|NCT00427752|Transgastric|transgastric
753658|NCT00427752|Endoluminal|endoluminal
753659|NCT00427752|Peritoneoscopy|peritoneoscopy
753660|NCT00427752|Diagnostic|diagnostic
753661|NCT00427752|Feasibility|feasibility
753662|NCT00427739|Axial Flow Ventricular Assist Device|axial flow ventricular assist device
753663|NCT00427739|Cardiac CT|cardiac ct
753664|NCT00427739|Stage IV heart failure|stage iv heart failure
753665|NCT00427726|Gene Transfer|gene transfer
753666|NCT00427726|Hematopoietic Stem Cells|hematopoietic stem cells
753667|NCT00427726|Follow-Up|follow-up
753668|NCT00427713|adenocarcinoma of the rectum|adenocarcinoma of the rectum
753669|NCT00427713|stage III rectal cancer|stage iii rectal cancer
753670|NCT00427713|stage II rectal cancer|stage ii rectal cancer
753671|NCT00427700|Polycystic Ovary Syndrome|polycystic ovary syndrome
753672|NCT00427700|clomiphene citrate|clomiphene citrate
753673|NCT00427700|Raloxifene|raloxifene
753674|NCT00427674|Parkinson|parkinson
753675|NCT00427674|Imaging|imaging
753676|NCT00427661|Sickle Cell Disease|sickle cell disease
753677|NCT00427661|Thalassemia|thalassemia
753678|NCT00427661|Hemoglobinopathies|hemoglobinopathies
753679|NCT00427648|Administration, Intravesical|administration, intravesical
753680|NCT00427648|Anesthetics, Local|anesthetics, local
753681|NCT00427635|neonates|neonates
753682|NCT00427635|infants|infants
753683|NCT00427635|GERD|gerd
753684|NCT00427635|reflux|reflux
753685|NCT00427622|hot flashes|hot flashes
753686|NCT00427609|Treatment|treatment
753687|NCT00427609|Psoriasis|psoriasis
753688|NCT00427609|efficacy|efficacy
753689|NCT00427609|Bicillin|bicillin
753690|NCT00427596|GW427353 oral tablets,|gw427353 oral tablets,
753691|NCT00427596|healthy adult subjects,|healthy adult subjects,
753692|NCT00427596|food effect|food effect
753693|NCT00427583|Malignant,|malignant,
753694|NCT00427583|peripheral,|peripheral,
753695|NCT00427583|nerve sheath tumors,|nerve sheath tumors,
753697|NCT00427583|neurofibromatosis,|neurofibromatosis,
753698|NCT00427583|NF1,|nf1,
753699|NCT00427583|Imatinib mesylate|imatinib mesylate
753700|NCT00427570|stage II colon cancer|stage ii colon cancer
753701|NCT00427570|stage III colon cancer|stage iii colon cancer
753702|NCT00427557|Multiple Myeloma|multiple myeloma
753703|NCT00427557|Acute Myeloid Leukemia|acute myeloid leukemia
753704|NCT00427557|Myelodysplastic Syndrome|myelodysplastic syndrome
753705|NCT00427557|Acute Lymphoblastic Leukemia|acute lymphoblastic leukemia
753706|NCT00427557|Non-Hodgkin's Lymphoma|non-hodgkin's lymphoma
753707|NCT00427557|Hodgkin's Lymphoma|hodgkin's lymphoma
753708|NCT00427557|Chronic Lymphocytic Leukemia|chronic lymphocytic leukemia
753709|NCT00427557|Cellular Therapy|cellular therapy
753710|NCT00427557|Umbilical Cord Blood Cells|umbilical cord blood cells
753711|NCT00427557|Cord Blood Transplantation|cord blood transplantation
753712|NCT00427557|Stem Cells|stem cells
753713|NCT00427557|Stem Cell Transplantation|stem cell transplantation
753714|NCT00427557|Allogeneic|allogeneic
753715|NCT00427557|Hematopoietic Stem Cell Transplantation|hematopoietic stem cell transplantation
753716|NCT00427557|Graft vs. Host Disease|graft vs. host disease
753717|NCT00427557|GVD|gvd
753718|NCT00427557|Fludarabine|fludarabine
753719|NCT00427557|Fludarabine Phosphate|fludarabine phosphate
753720|NCT00427557|Fludara|fludara
753721|NCT00427557|Melphalan|melphalan
753722|NCT00427557|Rituximab|rituximab
753723|NCT00427557|Rituxan|rituxan
753724|NCT00427557|Leukemia|leukemia
753726|NCT00427544|Uterine leiomyomata (Fibroids)|uterine leiomyomata (fibroids)
753727|NCT00427531|hot flashes|hot flashes
753728|NCT00427505|Interaction|interaction
753729|NCT00427505|healthy volunteers|healthy volunteers
753730|NCT00427505|deferasirox|deferasirox
753731|NCT00427505|midazolam|midazolam
753732|NCT00427479|Allergy|allergy
753733|NCT00427479|Food|food
753734|NCT00427479|Hay fever|hay fever
753735|NCT00427479|Screening|screening
753736|NCT00427453|Mycobacterium tuberculosis|mycobacterium tuberculosis
753737|NCT00427453|85A antigen|85a antigen
753738|NCT00427453|Recombinant Modified Vaccinia Virus Ankara|recombinant modified vaccinia virus ankara
753739|NCT00427453|Phase I study|phase i study
753740|NCT00427453|Immunogenicity|immunogenicity
753741|NCT00427453|BCG|bcg
753742|NCT00427440|Glioma|glioma
753743|NCT00427440|Brain Tumor|brain tumor
753744|NCT00427427|non-metastatic breast cancer|non-metastatic breast cancer
753745|NCT00427427|HER-2 positive breast cancer|her-2 positive breast cancer
753746|NCT00427427|Herceptin (trastuzumab)|herceptin (trastuzumab)
753747|NCT00427427|delayed adjuvant therapy|delayed adjuvant therapy
753748|NCT00427427|acceptability rate|acceptability rate
753749|NCT00427427|non-metastatic, HER-2 positive breast cancer|non-metastatic, her-2 positive breast cancer
753750|NCT00427414|AIDS-related Kaposi sarcoma|aids-related kaposi sarcoma
753751|NCT00427414|recurrent Kaposi sarcoma|recurrent kaposi sarcoma
753752|NCT00427388|Cardiac Surgical Procedures|cardiac surgical procedures
753753|NCT00427388|Cardiopulmonary Bypass|cardiopulmonary bypass
753754|NCT00427388|Systemic inflammatory Response Syndrome|systemic inflammatory response syndrome
753755|NCT00427388|Steroid|steroid
753756|NCT00427388|Myocardial Infarction|myocardial infarction
753757|NCT00427388|Randomized Clinical Trial|randomized clinical trial
753758|NCT00427375|Rectal cancer surgery|rectal cancer surgery
753759|NCT00427375|Neoadjuvant radiochemotherapy|neoadjuvant radiochemotherapy
753760|NCT00427375|Randomized clinical trial|randomized clinical trial
753761|NCT00427375|Multicenter study|multicenter study
753762|NCT00427349|localized gastrointestinal carcinoid tumor|localized gastrointestinal carcinoid tumor
753763|NCT00427349|recurrent gastrointestinal carcinoid tumor|recurrent gastrointestinal carcinoid tumor
753764|NCT00427349|metastatic gastrointestinal carcinoid tumor|metastatic gastrointestinal carcinoid tumor
753765|NCT00427349|regional gastrointestinal carcinoid tumor|regional gastrointestinal carcinoid tumor
753766|NCT00427349|gastrinoma|gastrinoma
753767|NCT00427349|insulinoma|insulinoma
753768|NCT00427349|WDHA syndrome|wdha syndrome
753769|NCT00427349|glucagonoma|glucagonoma
753770|NCT00427349|pancreatic polypeptide tumor|pancreatic polypeptide tumor
753771|NCT00427349|somatostatinoma|somatostatinoma
753772|NCT00427349|recurrent islet cell carcinoma|recurrent islet cell carcinoma
753773|NCT00427349|neuroendocrine tumor|neuroendocrine tumor
753774|NCT00427336|Severe Aplastic Anemia|severe aplastic anemia
753775|NCT00427336|Bone Marrow Failure|bone marrow failure
753776|NCT00427336|Stem Cell Transplantation|stem cell transplantation
753777|NCT00427336|Fludarabine|fludarabine
753778|NCT00427336|Cyclophosphamide|cyclophosphamide
753779|NCT00427336|Antithymocyte Globulin|antithymocyte globulin
753780|NCT00427336|SAA|saa
753781|NCT00427336|ATG|atg
753782|NCT00427336|Cytoxan|cytoxan
753783|NCT00427336|Neosar|neosar
753784|NCT00427336|Fludarabine Phosphate|fludarabine phosphate
753785|NCT00427336|Thymoglobulin|thymoglobulin
753786|NCT00427323|sleep|sleep
753787|NCT00427323|aging|aging
753788|NCT00427323|biological rhythm|biological rhythm
753789|NCT00427323|melatonin|melatonin
753790|NCT00427323|alertness|alertness
753791|NCT00427323|early morning awakening|early morning awakening
753792|NCT00427323|daytime sleepiness|daytime sleepiness
753793|NCT00427323|difficulty maintaining sleep|difficulty maintaining sleep
753794|NCT00427323|sleep maintenance insomnia|sleep maintenance insomnia
753795|NCT00427310|stage I colon cancer|stage i colon cancer
753796|NCT00427310|stage II colon cancer|stage ii colon cancer
753797|NCT00427310|stage III colon cancer|stage iii colon cancer
753798|NCT00427310|adenocarcinoma of the colon|adenocarcinoma of the colon
753799|NCT00427297|HIV-1|hiv-1
753800|NCT00427297|Pediatric|pediatric
753801|NCT00427297|nevirapine|nevirapine
753802|NCT00427297|HAART|haart
753803|NCT00427297|Resistance|resistance
753804|NCT00427297|Treatment Naive|treatment naive
753805|NCT00427284|Eplerenone auf die Endothelfunktion bei Patienten mit stabiler koronarer Herzkrankheit|eplerenone auf die endothelfunktion bei patienten mit stabiler koronarer herzkrankheit
753806|NCT00427271|aspirin|aspirin
753807|NCT00427271|enalapril|enalapril
753808|NCT00427271|microalbuminuria|microalbuminuria
753809|NCT00427271|glomerular filtration rate|glomerular filtration rate
753810|NCT00427258|healthy subjects|healthy subjects
753811|NCT00427245|menopausal symptoms|menopausal symptoms
753812|NCT00427245|infertility|infertility
753813|NCT00427245|stage IA breast cancer|stage ia breast cancer
753814|NCT00427245|stage IB breast cancer|stage ib breast cancer
753815|NCT00427245|stage II breast cancer|stage ii breast cancer
753816|NCT00427245|stage IIIA breast cancer|stage iiia breast cancer
753817|NCT00427245|stage IIIB breast cancer|stage iiib breast cancer
753818|NCT00427245|estrogen receptor-negative breast cancer|estrogen receptor-negative breast cancer
753819|NCT00427245|estrogen receptor-positive breast cancer|estrogen receptor-positive breast cancer
753820|NCT00427245|progesterone receptor-negative breast cancer|progesterone receptor-negative breast cancer
753821|NCT00427232|coronary heart disease|coronary heart disease
753822|NCT00427232|endothelins|endothelins
753823|NCT00427232|coronary angiography|coronary angiography
753824|NCT00427232|blood flow velocity|blood flow velocity
753825|NCT00427232|fractional flow reserve, myocardial|fractional flow reserve, myocardial
753826|NCT00427219|Benign Prostatic Hyperplasia|benign prostatic hyperplasia
753827|NCT00427219|Prostatic Adenoma, Benign|prostatic adenoma, benign
753828|NCT00427219|Prostatic Hypertrophy, Benign|prostatic hypertrophy, benign
753829|NCT00427219|Enlarged Prostate|enlarged prostate
753830|NCT00427219|Prostatism|prostatism
753831|NCT00427219|Adenoma, Prostatic|adenoma, prostatic
753832|NCT00427206|acetaminophen|acetaminophen
753833|NCT00427206|alcohol|alcohol
753834|NCT00427206|liver injury|liver injury
753835|NCT00427193|dietary restriction|dietary restriction
753836|NCT00427193|disease /disorder prevention /control|disease /disorder prevention /control
753837|NCT00427193|nutrition of aging|nutrition of aging
753838|NCT00427193|bioenergetics|bioenergetics
753839|NCT00427193|cardiovascular function|cardiovascular function
753840|NCT00427193|disease /disorder proneness /risk|disease /disorder proneness /risk
753841|NCT00427193|insulin sensitivity / resistance|insulin sensitivity / resistance
753842|NCT00427180|Visual Perception|visual perception
753843|NCT00427180|Retina|retina
753844|NCT00427180|Light|light
753845|NCT00427180|Retinitis Pigmentosa|retinitis pigmentosa
753846|NCT00427180|Visual acuity|visual acuity
753847|NCT00427180|Retinal Implant|retinal implant
753848|NCT00427180|Electrical stimulation|electrical stimulation
753849|NCT00427167|Blood Stage|blood stage
753850|NCT00427167|Investigational|investigational
753851|NCT00427167|Vaccine|vaccine
753852|NCT00427167|Malaria|malaria
753853|NCT00427167|Healthy Volunteer|healthy volunteer
753855|NCT00427141|tolerability,|tolerability,
753856|NCT00427141|pharmacokinetics,|pharmacokinetics,
753857|NCT00427141|first time in human,|first time in human,
753858|NCT00427141|food effect|food effect
753859|NCT00427141|safety,|safety,
753860|NCT00427128|Major Depression|major depression
753861|NCT00427128|"true drug response"|"true drug response"
753862|NCT00427128|"placebo response pattern"|"placebo response pattern"
753863|NCT00427128|continuation treatment outcomes|continuation treatment outcomes
753864|NCT00427115|Patients undergoing allogeneic stem cell transplantations|patients undergoing allogeneic stem cell transplantations
753865|NCT00427102|Oral MRX-1024|oral mrx-1024
753866|NCT00427102|High-Dose Cisplatin Chemotherapy|high-dose cisplatin chemotherapy
753867|NCT00427102|Standard Radiation Therapy|standard radiation therapy
753868|NCT00427089|Colon cleansing|colon cleansing
753869|NCT00427089|Polyethylene Glycol|polyethylene glycol
753870|NCT00427089|Sodium Phosphate|sodium phosphate
753871|NCT00427076|vancomycin|vancomycin
753872|NCT00427076|cotrimoxazole|cotrimoxazole
753873|NCT00427076|trimethoprim/ sulfamethoxazole|trimethoprim/ sulfamethoxazole
753874|NCT00427076|methicillin-resistant Staphylococcus aureus|methicillin-resistant staphylococcus aureus
753875|NCT00427076|Health care association infections|health care association infections
753876|NCT00427076|MRSA bacteremia or other microbiologically documented MRSA infections (defined clinically by CDC criteria)|mrsa bacteremia or other microbiologically documented mrsa infections (defined clinically by cdc criteria)
753877|NCT00427076|Suspected neurosurgical meningitis|suspected neurosurgical meningitis
753878|NCT00427076|Sepsis during hemodialysis, catheter-associated and catheter-related infections|sepsis during hemodialysis, catheter-associated and catheter-related infections
753879|NCT00427076|Ventilator-associated pneumonia|ventilator-associated pneumonia
753880|NCT00427076|Surgical site infection in the presence of a foreign body|surgical site infection in the presence of a foreign body
753881|NCT00427063|retinal vessels|retinal vessels
753882|NCT00427063|tortuosity|tortuosity
753883|NCT00427050|Actinic Keratoses (AK)|actinic keratoses (ak)
753884|NCT00427050|PEP005|pep005
753885|NCT00427050|Topical|topical
753886|NCT00427050|Dermatology|dermatology
753887|NCT00427037|Vitamin D deficiency|vitamin d deficiency
753888|NCT00427037|Chronic Kidney Disease|chronic kidney disease
753889|NCT00427024|renal transplantation|renal transplantation
753890|NCT00427024|acute rejection|acute rejection
753891|NCT00427024|transport|transport
753892|NCT00427024|transporter|transporter
753893|NCT00427024|acute rejection after renal transplantation|acute rejection after renal transplantation
753894|NCT00426998|Choroidal neovascularization due to age-related macular degeneration|choroidal neovascularization due to age-related macular degeneration
753895|NCT00426985|Tendonitis|tendonitis
753896|NCT00426985|Bursitis|bursitis
753897|NCT00426985|Pain|pain
753898|NCT00426985|Shoulder Pain|shoulder pain
753899|NCT00426985|Elbow Pain|elbow pain
753900|NCT00426985|Knee Pain|knee pain
753901|NCT00426985|Tendon Injury|tendon injury
753902|NCT00426985|Muscle, Bone and Cartilage Disorders|muscle, bone and cartilage disorders
753903|NCT00426959|Adenocarcinoma of the prostate|adenocarcinoma of the prostate
753904|NCT00426959|PSA of less than 10 ng/mL|psa of less than 10 ng/ml
753905|NCT00426959|Combined Gleason score 6 or less|combined gleason score 6 or less
754104|NCT00426296|Lipodystrophy|lipodystrophy
753906|NCT00426959|International Prostate Symptom Score (IPSS) must <or= to 18|international prostate symptom score (ipss) must <or= to 18
753907|NCT00426946|Depression Children Reboxetine|depression children reboxetine
753908|NCT00426946|A diagnosis of major depressive disorder or a dysthimic disorder according to DSM-IV-TR.|a diagnosis of major depressive disorder or a dysthimic disorder according to dsm-iv-tr.
753909|NCT00426946|Drug naïve or without chronic medication for at least one month.|drug naïve or without chronic medication for at least one month.
753910|NCT00426946|Only children who agree to participate and whose parents will sign and informed consent form will be included.|only children who agree to participate and whose parents will sign and informed consent form will be included.
753913|NCT00426920|pharmacokinetics|pharmacokinetics
753914|NCT00426920|pharmacodynamics|pharmacodynamics
753915|NCT00426920|inhaled|inhaled
753916|NCT00426920|recombinant human insulin|recombinant human insulin
753917|NCT00426907|Osteoarthritis, Knee|osteoarthritis, knee
753918|NCT00426907|Osteotomy|osteotomy
753919|NCT00426907|Healing|healing
753920|NCT00426907|Rehabilitation|rehabilitation
753921|NCT00426907|Roentgen Stereometric Analysis|roentgen stereometric analysis
753922|NCT00426894|surveillance cultures|surveillance cultures
753923|NCT00426894|children|children
753924|NCT00426894|cardiac surgery|cardiac surgery
753925|NCT00426894|perioperative prophylaxis|perioperative prophylaxis
753926|NCT00426881|Exercise|exercise
753927|NCT00426881|Resistance training|resistance training
753928|NCT00426868|ADRC|adrc
753929|NCT00426868|Stem Cells|stem cells
753930|NCT00426868|chronic ischemia|chronic ischemia
753931|NCT00426868|heart disease|heart disease
753932|NCT00426868|coronary artery disease|coronary artery disease
753933|NCT00426868|inducible reversible ischemia|inducible reversible ischemia
753934|NCT00426855|Lymphoma, Non-Hodgkin, Low-Grade|lymphoma, non-hodgkin, low-grade
753935|NCT00426842|Blood pressure|blood pressure
753936|NCT00426842|Orthostatic hypotension|orthostatic hypotension
753937|NCT00426842|Spinal Cord Injury|spinal cord injury
753938|NCT00426842|Sympathetic vascular control|sympathetic vascular control
753939|NCT00426842|Midodrine|midodrine
753940|NCT00426829|Liver Cancer|liver cancer
753941|NCT00426829|Biliary Tract|biliary tract
753942|NCT00426829|Hepatocellular Carcinoma|hepatocellular carcinoma
753943|NCT00426829|Cholangiocarcinoma|cholangiocarcinoma
753944|NCT00426829|Bevacizumab|bevacizumab
753945|NCT00426829|Proton Therapy|proton therapy
753946|NCT00426829|Radiation Therapy|radiation therapy
753947|NCT00426829|PT|pt
753948|NCT00426829|RT|rt
753949|NCT00426829|Proton RT|proton rt
753950|NCT00426829|Avastin|avastin
753951|NCT00426829|Anti-VEGF monoclonal antibody|anti-vegf monoclonal antibody
753952|NCT00426829|rhuMAb-VEGF|rhumab-vegf
753953|NCT00426816|primary insomnia|primary insomnia
753954|NCT00426816|PSG sleep recordings|psg sleep recordings
753955|NCT00426816|daytime cognitive function|daytime cognitive function
753956|NCT00426816|Insomnia|insomnia
753957|NCT00426816|SB-649868|sb-649868
753958|NCT00426777|prostate cancer|prostate cancer
753959|NCT00426777|prostatic adenoma|prostatic adenoma
753960|NCT00426777|prostatic neoplasm|prostatic neoplasm
753961|NCT00426764|peripheral T-cell lymphoma|peripheral t-cell lymphoma
753962|NCT00426764|T-cell lymphoma|t-cell lymphoma
753963|NCT00426764|romidepsin|romidepsin
753964|NCT00426751|Eptifibatide|eptifibatide
753965|NCT00426751|ST-elevation Myocardial Infarction|st-elevation myocardial infarction
753966|NCT00426751|STEMI|stemi
753967|NCT00426751|Abciximab|abciximab
753968|NCT00426725|labor|labor
753969|NCT00426725|pain|pain
753970|NCT00426725|relief|relief
753971|NCT00426725|labour|labour
753972|NCT00426725|device|device
753973|NCT00426712|Chronic kidney failure|chronic kidney failure
753974|NCT00426712|Chronic kidney disease|chronic kidney disease
753975|NCT00426712|Hemodialysis|hemodialysis
753976|NCT00426712|HBV vaccine|hbv vaccine
753977|NCT00426712|Hepatitis B vaccine|hepatitis b vaccine
753978|NCT00426712|Hepatitis B|hepatitis b
753979|NCT00426712|Hepatitis|hepatitis
753980|NCT00426712|HBV|hbv
753981|NCT00426712|Prevention & Control|prevention & control
753982|NCT00426699|enterovirus|enterovirus
753983|NCT00426699|meningitis|meningitis
753984|NCT00426699|sepsis|sepsis
753985|NCT00426699|myocarditis|myocarditis
753986|NCT00426699|kidney|kidney
753987|NCT00426699|urine|urine
753988|NCT00426699|glomerulonephritis|glomerulonephritis
753989|NCT00426686|thrombotic thrombocytopenic purpura|thrombotic thrombocytopenic purpura
753990|NCT00426686|prognostic factors|prognostic factors
753991|NCT00426686|ADAMTS13|adamts13
753992|NCT00426673|partial onset seizures, phenytoin, dilatin, brivaracetam, interaction|partial onset seizures, phenytoin, dilatin, brivaracetam, interaction
753993|NCT00426660|HIV Infections|hiv infections
753994|NCT00426647|Osteoarthritis|osteoarthritis
753995|NCT00426647|Pain|pain
753996|NCT00426647|Norspan|norspan
753997|NCT00426647|Buprenorphine|buprenorphine
753998|NCT00426647|Tramadol|tramadol
753999|NCT00426634|Asthma|asthma
754000|NCT00426634|Allergens|allergens
754001|NCT00426634|Mold|mold
754002|NCT00426634|Asthma Counselor|asthma counselor
754003|NCT00426634|Environmental Remediation|environmental remediation
754449|NCT00424931|sleepiness|sleepiness
754004|NCT00426621|Knee osteoarthritis, degenerative joint disease, knee pain, joint pain, topical NSAID,|knee osteoarthritis, degenerative joint disease, knee pain, joint pain, topical nsaid,
754005|NCT00426621|diclofenac sodium|diclofenac sodium
754006|NCT00426608|HPA axis,|hpa axis,
754007|NCT00426608|Healthy volunteers|healthy volunteers
754008|NCT00426608|hormones,|hormones,
754009|NCT00426608|GSK561679,|gsk561679,
754010|NCT00426608|cortisol,|cortisol,
754011|NCT00426582|Cancer|cancer
754012|NCT00426582|maximum tolerated dose|maximum tolerated dose
754013|NCT00426582|dose-limiting toxicity|dose-limiting toxicity
754014|NCT00426582|patupilone|patupilone
754015|NCT00426582|carboplatin|carboplatin
754016|NCT00426582|pharmacokinetics|pharmacokinetics
754017|NCT00426556|Breast cancer|breast cancer
754018|NCT00426556|Cancer of the breast|cancer of the breast
754019|NCT00426556|Human mammary carcinoma|human mammary carcinoma
754020|NCT00426556|HER-2|her-2
754021|NCT00426556|Metastatic|metastatic
754022|NCT00426556|everolimus|everolimus
754023|NCT00426556|trastuzumab|trastuzumab
754024|NCT00426556|paclitaxel|paclitaxel
754025|NCT00426543|Clinical trial|clinical trial
754026|NCT00426543|Intervention study|intervention study
754027|NCT00426543|Double-blind randomised controlled study|double-blind randomised controlled study
754028|NCT00426530|HER2-overexpressing metastatic breast cancer|her2-overexpressing metastatic breast cancer
754029|NCT00426530|Breast cancer|breast cancer
754030|NCT00426530|Cancer of the breast|cancer of the breast
754031|NCT00426530|Human mammary carcinoma|human mammary carcinoma
754032|NCT00426530|HER-2|her-2
754033|NCT00426530|metastatic|metastatic
754034|NCT00426530|everolimus|everolimus
754035|NCT00426530|trastuzumab|trastuzumab
754036|NCT00426530|vinorelbine|vinorelbine
754037|NCT00426517|MUD Transplant|mud transplant
754038|NCT00426517|Transplant|transplant
754039|NCT00426517|AlloPBSC|allopbsc
754040|NCT00426517|HLA Matched Transplant|hla matched transplant
754041|NCT00426517|BMT|bmt
754042|NCT00426517|Congenital Immunodeficiency|congenital immunodeficiency
754043|NCT00426517|Bone Marrow Transplant|bone marrow transplant
754044|NCT00426504|Head,|head,
754045|NCT00426504|Neck,|neck,
754046|NCT00426504|Cancer,|cancer,
754047|NCT00426504|Tomotherapy,|tomotherapy,
754048|NCT00426504|IMRT,|imrt,
754049|NCT00426478|AMPM, SBP, DBP, Valsartan plus Hydrochlorothiazide, Amlodipine, high blood pressure|ampm, sbp, dbp, valsartan plus hydrochlorothiazide, amlodipine, high blood pressure
754050|NCT00426465|Motor Practice|motor practice
754051|NCT00426465|Magnetic Stimulation|magnetic stimulation
754052|NCT00426465|Stroke|stroke
754053|NCT00426465|Spacing Effect|spacing effect
754054|NCT00426465|Massed Practice|massed practice
754055|NCT00426465|Healthy Volunteer|healthy volunteer
754056|NCT00426465|HV|hv
754178|NCT00425984|HIV seronegativity|hiv seronegativity
754179|NCT00425984|HPV|hpv
754057|NCT00426452|Vascular endothelial growth factor receptor (VEGF-R) tyrosine kinase inhibitor|vascular endothelial growth factor receptor (vegf-r) tyrosine kinase inhibitor
754058|NCT00426452|Vatalinib|vatalinib
754059|NCT00426452|Proton-pump inhibitors|proton-pump inhibitors
754060|NCT00426452|Omeprazole|omeprazole
754061|NCT00426452|Healthy Postmenopausal Female Volunteers|healthy postmenopausal female volunteers
754062|NCT00426439|malaria|malaria
754063|NCT00426439|Plasmodium falciparum|plasmodium falciparum
754064|NCT00426439|children|children
754065|NCT00426439|Guinea-Bissau|guinea-bissau
754066|NCT00426439|artemether|artemether
754067|NCT00426439|lumefantrine|lumefantrine
754068|NCT00426439|chloroquine|chloroquine
754069|NCT00426439|Coartem|coartem
754070|NCT00426413|ketosis-prone diabetes|ketosis-prone diabetes
754071|NCT00426413|diabetic ketoacidosis|diabetic ketoacidosis
754072|NCT00426413|obesity|obesity
754073|NCT00426413|insulin dependence|insulin dependence
754074|NCT00426413|mechanisms|mechanisms
754076|NCT00426374|AIDS|aids
754077|NCT00426374|Troponin|troponin
754078|NCT00426374|natriuretic peptide|natriuretic peptide
754079|NCT00426374|heart failure|heart failure
754080|NCT00426374|heart disease children|heart disease children
754081|NCT00426374|HIV pediatric|hiv pediatric
754082|NCT00426374|AIDS pediatric|aids pediatric
754083|NCT00426361|Human Papillomavirus|human papillomavirus
754084|NCT00426348|IgA nephropathy|iga nephropathy
754085|NCT00426348|probucol|probucol
754086|NCT00426348|valsartan|valsartan
754087|NCT00426348|treatment|treatment
754088|NCT00426348|antioxidant|antioxidant
754089|NCT00426348|IGA nephropathy：a kind of glomerulonephritis,which IgA is the dominant immunodeposit in mesangial areas|iga nephropathy：a kind of glomerulonephritis,which iga is the dominant immunodeposit in mesangial areas
754090|NCT00426335|breast|breast
754091|NCT00426335|cancer|cancer
754092|NCT00426335|cognitive behaviour therapy|cognitive behaviour therapy
754093|NCT00426335|psychological|psychological
754094|NCT00426322|maxillary sinus augmentation|maxillary sinus augmentation
754095|NCT00426322|bone graft|bone graft
754096|NCT00426322|bovine bone mineral|bovine bone mineral
754097|NCT00426322|dental implants|dental implants
754098|NCT00426296|HIV|hiv
754099|NCT00426296|Reyataz|reyataz
754100|NCT00426296|atazanavir|atazanavir
754101|NCT00426296|Norvir|norvir
754102|NCT00426296|ritonavir|ritonavir
754105|NCT00426296|Treatment Experienced|treatment experienced
754106|NCT00426283|Eosinophilic Esophagitis|eosinophilic esophagitis
754107|NCT00426257|Ovarian Cancer|ovarian cancer
754108|NCT00426257|stage III|stage iii
754109|NCT00426257|hyperthermic intraperitoneal chemotherapy|hyperthermic intraperitoneal chemotherapy
754110|NCT00426257|debulking surgery|debulking surgery
754111|NCT00426257|HIPEC|hipec
754112|NCT00426244|Osteopathic Manipulative Medicine|osteopathic manipulative medicine
754208|NCT00425867|reccurent abortions|reccurent abortions
754113|NCT00426244|Osteopathic Manipulative Treatment|osteopathic manipulative treatment
754114|NCT00426244|Pregnancy|pregnancy
754115|NCT00426244|Physiologic|physiologic
754116|NCT00426244|Gait|gait
754117|NCT00426244|Low back pain|low back pain
754118|NCT00426244|Heart rate variability|heart rate variability
754119|NCT00426231|Randomized Controlled Trials|randomized controlled trials
754120|NCT00426231|Health Education|health education
754121|NCT00426231|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors
754122|NCT00426231|Patient Nonadherence|patient nonadherence
754123|NCT00426218|Systemic Juvenile Idiopathic Arthritis|systemic juvenile idiopathic arthritis
754124|NCT00426218|Immunogenicity|immunogenicity
754125|NCT00426218|Pharmacokinetics|pharmacokinetics
754126|NCT00426218|Anti-IL-1ß Monoclonal Antibody|anti-il-1ß monoclonal antibody
754127|NCT00426218|ACZ885|acz885
754128|NCT00426218|SJIA|sjia
754129|NCT00426218|Pediatrics|pediatrics
754130|NCT00426205|GM-CSF|gm-csf
754131|NCT00426205|GVAX|gvax
754132|NCT00426205|Cancer vaccine|cancer vaccine
754133|NCT00426205|blood stem cell transplantation|blood stem cell transplantation
754134|NCT00426205|MDS|mds
754135|NCT00426205|AML|aml
754136|NCT00426205|CML|cml
754137|NCT00426192|Immunedefense Suppression|immunedefense suppression
754138|NCT00426192|Cardiopulmonary Bypass|cardiopulmonary bypass
754139|NCT00426192|Mannitol|mannitol
754140|NCT00426192|Hemofiltration|hemofiltration
754141|NCT00426192|Cytokines|cytokines
754142|NCT00426192|Receptors, Surface CD14|receptors, surface cd14
754143|NCT00426179|Imatinib, allergic inflammation, out of allergy season, repeated nasal allergen, seasonal allergic rhinitis, sensitive, Timothy grass pollen, c-kit inhibition|imatinib, allergic inflammation, out of allergy season, repeated nasal allergen, seasonal allergic rhinitis, sensitive, timothy grass pollen, c-kit inhibition
754144|NCT00426140|EPO|epo
754145|NCT00426140|Patupilone|patupilone
754146|NCT00426140|Solid Tumors|solid tumors
754147|NCT00426127|Pancreatic|pancreatic
754148|NCT00426127|Docetaxel|docetaxel
754149|NCT00426127|Doxorubicin|doxorubicin
754150|NCT00426127|Enoxaparin|enoxaparin
754151|NCT00426101|Hemophagocytic lymphohistiocytosis|hemophagocytic lymphohistiocytosis
754152|NCT00426075|Deep vein thrombosis of the lower extremities|deep vein thrombosis of the lower extremities
754153|NCT00426062|Squamous Cell Carcinoma of Tongue and mouth floor|squamous cell carcinoma of tongue and mouth floor
754154|NCT00426049|Coronary artery disease|coronary artery disease
754155|NCT00426049|Stents|stents
754156|NCT00426049|Immunosuppressive Agents|immunosuppressive agents
754157|NCT00426049|Coronary restenosis|coronary restenosis
754158|NCT00426049|Safety|safety
754159|NCT00426036|Open-label study, healthy subjects, stable impaired renal function, licarbazepine, pharmacokinetics, metabolism, safety.|open-label study, healthy subjects, stable impaired renal function, licarbazepine, pharmacokinetics, metabolism, safety.
754160|NCT00426023|Vernal keratoconjunctivitis|vernal keratoconjunctivitis
754161|NCT00426023|Cyclosporine|cyclosporine
754162|NCT00426023|Children|children
754163|NCT00426023|Clinical trial|clinical trial
754164|NCT00426010|Placebo effect|placebo effect
754165|NCT00426010|Caffeine|caffeine
754166|NCT00426010|Systolic BP|systolic bp
754167|NCT00426010|VAS|vas
754168|NCT00425997|Hypertension, valsartan/HCTZ, amlodipine and HCTZ|hypertension, valsartan/hctz, amlodipine and hctz
754169|NCT00425984|HIV|hiv
754170|NCT00425984|Male circumcision|male circumcision
754171|NCT00425984|Sexually transmitted infections|sexually transmitted infections
754172|NCT00425984|Sexual risk behaviors|sexual risk behaviors
754173|NCT00425984|Adult males|adult males
754174|NCT00425984|Haemophilus ducreyi|haemophilus ducreyi
754175|NCT00425984|Human papillomavirus|human papillomavirus
754176|NCT00425984|Rakai|rakai
754177|NCT00425984|Uganda|uganda
754181|NCT00425958|year and more after TBI|year and more after tbi
754182|NCT00425958|good vision|good vision
754183|NCT00425958|at least one functinal hand|at least one functinal hand
754184|NCT00425958|cap[able od doing shopping during everyday life|cap[able od doing shopping during everyday life
754185|NCT00425932|Magnetic Resonance Imaging|magnetic resonance imaging
754186|NCT00425932|Rituximab|rituximab
754187|NCT00425932|Low Field MRI|low field mri
754188|NCT00425932|Biomarkers|biomarkers
754189|NCT00425919|Type 2 Diabetes|type 2 diabetes
754190|NCT00425919|Diabetes|diabetes
754191|NCT00425906|psychosocial effects of cancer and its treatment|psychosocial effects of cancer and its treatment
754192|NCT00425906|unspecified adult solid tumor, protocol specific|unspecified adult solid tumor, protocol specific
754193|NCT00425906|constipation, impaction, and bowel obstruction|constipation, impaction, and bowel obstruction
754194|NCT00425906|anorexia|anorexia
754195|NCT00425906|pain|pain
754196|NCT00425893|influenza|influenza
754197|NCT00425893|masks|masks
754198|NCT00425893|transmission|transmission
754199|NCT00425893|hand hygiene|hand hygiene
754200|NCT00425893|non-pharmacologic interventions|non-pharmacologic interventions
754201|NCT00425880|Pregnancy|pregnancy
754202|NCT00425880|Asthma|asthma
754203|NCT00425880|Tobacco Abuse|tobacco abuse
754204|NCT00425880|Exhaled Nitric Oxide|exhaled nitric oxide
754205|NCT00425867|PAR1 gene|par1 gene
754206|NCT00425867|polymorphisms|polymorphisms
754207|NCT00425867|abortions|abortions
754209|NCT00425867|premature delivery|premature delivery
754210|NCT00425841|adenocarcinoma of the pancreas|adenocarcinoma of the pancreas
754211|NCT00425841|stage III pancreatic cancer|stage iii pancreatic cancer
754212|NCT00425841|stage II pancreatic cancer|stage ii pancreatic cancer
754213|NCT00425815|Cognition|cognition
754214|NCT00425815|Ampakines|ampakines
754215|NCT00425815|Schizophrenia|schizophrenia
754216|NCT00425802|noncontiguous stage II adult diffuse large cell lymphoma|noncontiguous stage ii adult diffuse large cell lymphoma
754217|NCT00425802|recurrent adult diffuse large cell lymphoma|recurrent adult diffuse large cell lymphoma
754218|NCT00425802|stage III adult diffuse large cell lymphoma|stage iii adult diffuse large cell lymphoma
754219|NCT00425802|stage IV adult diffuse large cell lymphoma|stage iv adult diffuse large cell lymphoma
754220|NCT00425802|B-cell chronic lymphocytic leukemia|b-cell chronic lymphocytic leukemia
754221|NCT00425802|refractory chronic lymphocytic leukemia|refractory chronic lymphocytic leukemia
754222|NCT00425802|stage III chronic lymphocytic leukemia|stage iii chronic lymphocytic leukemia
754223|NCT00425802|stage IV chronic lymphocytic leukemia|stage iv chronic lymphocytic leukemia
754224|NCT00425802|noncontiguous stage II mantle cell lymphoma|noncontiguous stage ii mantle cell lymphoma
754225|NCT00425802|recurrent mantle cell lymphoma|recurrent mantle cell lymphoma
754226|NCT00425802|stage III mantle cell lymphoma|stage iii mantle cell lymphoma
754227|NCT00425802|stage IV mantle cell lymphoma|stage iv mantle cell lymphoma
754228|NCT00425802|noncontiguous stage II grade 1 follicular lymphoma|noncontiguous stage ii grade 1 follicular lymphoma
754229|NCT00425802|noncontiguous stage II grade 2 follicular lymphoma|noncontiguous stage ii grade 2 follicular lymphoma
754230|NCT00425802|recurrent grade 1 follicular lymphoma|recurrent grade 1 follicular lymphoma
754231|NCT00425802|recurrent grade 2 follicular lymphoma|recurrent grade 2 follicular lymphoma
754232|NCT00425802|stage III grade 1 follicular lymphoma|stage iii grade 1 follicular lymphoma
754233|NCT00425802|stage III grade 2 follicular lymphoma|stage iii grade 2 follicular lymphoma
754234|NCT00425802|stage IV grade 1 follicular lymphoma|stage iv grade 1 follicular lymphoma
754235|NCT00425802|stage IV grade 2 follicular lymphoma|stage iv grade 2 follicular lymphoma
754236|NCT00425802|noncontiguous stage II small lymphocytic lymphoma|noncontiguous stage ii small lymphocytic lymphoma
754237|NCT00425802|recurrent small lymphocytic lymphoma|recurrent small lymphocytic lymphoma
754238|NCT00425802|stage III small lymphocytic lymphoma|stage iii small lymphocytic lymphoma
754239|NCT00425802|stage IV small lymphocytic lymphoma|stage iv small lymphocytic lymphoma
754240|NCT00425802|noncontiguous stage II marginal zone lymphoma|noncontiguous stage ii marginal zone lymphoma
754241|NCT00425802|recurrent marginal zone lymphoma|recurrent marginal zone lymphoma
754242|NCT00425802|splenic marginal zone lymphoma|splenic marginal zone lymphoma
754243|NCT00425802|stage III marginal zone lymphoma|stage iii marginal zone lymphoma
754244|NCT00425802|stage IV marginal zone lymphoma|stage iv marginal zone lymphoma
754245|NCT00425802|noncontiguous stage II adult immunoblastic large cell lymphoma|noncontiguous stage ii adult immunoblastic large cell lymphoma
754246|NCT00425802|stage III adult immunoblastic large cell lymphoma|stage iii adult immunoblastic large cell lymphoma
754247|NCT00425802|stage IV adult immunoblastic large cell lymphoma|stage iv adult immunoblastic large cell lymphoma
754248|NCT00425802|extranodal marginal zone B-cell lymphoma of mucosa-associated lymphoid tissue|extranodal marginal zone b-cell lymphoma of mucosa-associated lymphoid tissue
754249|NCT00425802|nodal marginal zone B-cell lymphoma|nodal marginal zone b-cell lymphoma
754250|NCT00425802|recurrent adult immunoblastic large cell lymphoma|recurrent adult immunoblastic large cell lymphoma
754251|NCT00425789|Deep Chemical Peeling|deep chemical peeling
754252|NCT00425789|Hyperbaric Therapy|hyperbaric therapy
754253|NCT00425789|post-deep peel|post-deep peel
754254|NCT00425776|Breast cancer|breast cancer
754255|NCT00425776|Acupuncture|acupuncture
754256|NCT00425776|Post-menopausal hot flushes|post-menopausal hot flushes
754257|NCT00425776|Se-estradiol|se-estradiol
754258|NCT00425776|Se-endorphine|se-endorphine
754259|NCT00425763|malaria|malaria
754260|NCT00425763|efficacy|efficacy
754261|NCT00425763|intermittent preventive therapy in infants|intermittent preventive therapy in infants
754262|NCT00425763|drug resistance|drug resistance
754263|NCT00425750|stage IV squamous cell carcinoma of the lip and oral cavity|stage iv squamous cell carcinoma of the lip and oral cavity
754264|NCT00425750|recurrent squamous cell carcinoma of the lip and oral cavity|recurrent squamous cell carcinoma of the lip and oral cavity
754265|NCT00425750|stage IV squamous cell carcinoma of the oropharynx|stage iv squamous cell carcinoma of the oropharynx
754266|NCT00425750|recurrent squamous cell carcinoma of the oropharynx|recurrent squamous cell carcinoma of the oropharynx
754267|NCT00425750|stage IV squamous cell carcinoma of the hypopharynx|stage iv squamous cell carcinoma of the hypopharynx
754268|NCT00425750|recurrent squamous cell carcinoma of the hypopharynx|recurrent squamous cell carcinoma of the hypopharynx
754269|NCT00425750|stage IV squamous cell carcinoma of the larynx|stage iv squamous cell carcinoma of the larynx
754270|NCT00425750|recurrent squamous cell carcinoma of the larynx|recurrent squamous cell carcinoma of the larynx
754271|NCT00425737|Oral live attenuated human rotavirus vaccine|oral live attenuated human rotavirus vaccine
754272|NCT00425737|Gastroenteritis|gastroenteritis
754273|NCT00425724|proteinuria|proteinuria
754274|NCT00425724|nephritis|nephritis
754275|NCT00425724|nephrotic syndrome|nephrotic syndrome
754276|NCT00425724|glomerulonephritis|glomerulonephritis
754277|NCT00425711|Acamprosate|acamprosate
754278|NCT00425711|Alcohol Dependence|alcohol dependence
754279|NCT00425711|Driving Under the Influence|driving under the influence
754280|NCT00425711|Drug Court|drug court
754281|NCT00425711|DUI Court|dui court
754282|NCT00425685|cardiopulmonary resuscitation, ECMO, shock, survival, heart failure, transplantation, heart assist device.|cardiopulmonary resuscitation, ecmo, shock, survival, heart failure, transplantation, heart assist device.
754283|NCT00425659|Health utility|health utility
754284|NCT00425659|Home sleep study|home sleep study
754285|NCT00425646|stage IIIB non-small cell lung cancer|stage iiib non-small cell lung cancer
754286|NCT00425646|stage IV non-small cell lung cancer|stage iv non-small cell lung cancer
754287|NCT00425646|adenocarcinoma of the lung|adenocarcinoma of the lung
754288|NCT00425646|bronchoalveolar cell lung cancer|bronchoalveolar cell lung cancer
754289|NCT00425646|large cell lung cancer|large cell lung cancer
754290|NCT00425646|recurrent non-small cell lung cancer|recurrent non-small cell lung cancer
754291|NCT00425633|Homeopathic|homeopathic
754292|NCT00425633|Potassium|potassium
754293|NCT00425633|Dichromate|dichromate
754294|NCT00425633|Kalium|kalium
754295|NCT00425633|Bichromicum|bichromicum
754296|NCT00425633|Mechanical|mechanical
754297|NCT00425633|Ventilation|ventilation
754298|NCT00425633|Secretions|secretions
754299|NCT00425620|Chronic Sinusitis|chronic sinusitis
754300|NCT00425620|Chronic Rhinosinusitis|chronic rhinosinusitis
754301|NCT00425607|Hutchinson-Gilford Progeria Syndrome|hutchinson-gilford progeria syndrome
754302|NCT00425607|HGPS|hgps
754303|NCT00425607|Progeria|progeria
754305|NCT00425607|Farnesyltransferase Inhibitor|farnesyltransferase inhibitor
754306|NCT00425607|Lonafarnib|lonafarnib
754307|NCT00425594|colonoscopy|colonoscopy
754308|NCT00425594|bowel preparation|bowel preparation
754309|NCT00425594|prep|prep
754310|NCT00425581|N-terminal pro-BNP,|n-terminal pro-bnp,
754311|NCT00425581|Cardiac Troponin-T,|cardiac troponin-t,
754312|NCT00425581|Very low birth weight infants|very low birth weight infants
754313|NCT00425581|hemodynamic instability|hemodynamic instability
754314|NCT00425581|myocardial dysfunction|myocardial dysfunction
754315|NCT00425568|hypogonadism|hypogonadism
754316|NCT00425568|low testosterone level|low testosterone level
754317|NCT00425568|gonadal deficiency|gonadal deficiency
754318|NCT00425555|Cutaneous T-Cell Lymphoma, adults|cutaneous t-cell lymphoma, adults
754319|NCT00425555|Mycosis Fungoides|mycosis fungoides
754320|NCT00425555|Sézary Syndrome|sézary syndrome
754321|NCT00425555|CTCL|ctcl
754322|NCT00425542|Pulmonary embolism|pulmonary embolism
754323|NCT00425542|Outpatient care|outpatient care
754324|NCT00425542|Prognosis|prognosis
754325|NCT00425516|neoadjuvant chemotherapy|neoadjuvant chemotherapy
754326|NCT00425516|breast cancer|breast cancer
754327|NCT00425516|sequential treatment|sequential treatment
754328|NCT00425503|Prostate Cancer|prostate cancer
754329|NCT00425503|Bortezomib|bortezomib
754330|NCT00425503|Radical Prostatectomy|radical prostatectomy
754331|NCT00425503|Phase 2 Clinical Trial|phase 2 clinical trial
754332|NCT00425477|refractory anemia with excess blasts|refractory anemia with excess blasts
754333|NCT00425477|recurrent adult acute myeloid leukemia|recurrent adult acute myeloid leukemia
754334|NCT00425477|untreated adult acute myeloid leukemia|untreated adult acute myeloid leukemia
754335|NCT00425477|secondary acute myeloid leukemia|secondary acute myeloid leukemia
754336|NCT00425477|de novo myelodysplastic syndromes|de novo myelodysplastic syndromes
754337|NCT00425477|previously treated myelodysplastic syndromes|previously treated myelodysplastic syndromes
754338|NCT00425477|secondary myelodysplastic syndromes|secondary myelodysplastic syndromes
754339|NCT00425477|myelodysplastic/myeloproliferative disease, unclassifiable|myelodysplastic/myeloproliferative disease, unclassifiable
754340|NCT00425477|refractory anemia with ringed sideroblasts|refractory anemia with ringed sideroblasts
754341|NCT00425477|refractory cytopenia with multilineage dysplasia|refractory cytopenia with multilineage dysplasia
754342|NCT00425477|chronic myelomonocytic leukemia|chronic myelomonocytic leukemia
754343|NCT00425477|adult acute myeloid leukemia with 11q23 (MLL) abnormalities|adult acute myeloid leukemia with 11q23 (mll) abnormalities
754344|NCT00425477|adult acute minimally differentiated myeloid leukemia (M0)|adult acute minimally differentiated myeloid leukemia (m0)
754345|NCT00425477|adult acute myeloblastic leukemia without maturation (M1)|adult acute myeloblastic leukemia without maturation (m1)
754346|NCT00425477|adult acute myeloblastic leukemia with maturation (M2)|adult acute myeloblastic leukemia with maturation (m2)
754347|NCT00425477|adult acute myelomonocytic leukemia (M4)|adult acute myelomonocytic leukemia (m4)
754348|NCT00425477|adult acute monoblastic leukemia (M5a)|adult acute monoblastic leukemia (m5a)
754349|NCT00425477|adult acute monocytic leukemia (M5b)|adult acute monocytic leukemia (m5b)
754350|NCT00425477|adult pure erythroid leukemia (M6b)|adult pure erythroid leukemia (m6b)
754351|NCT00425477|adult erythroleukemia (M6a)|adult erythroleukemia (m6a)
754352|NCT00425477|adult acute megakaryoblastic leukemia (M7)|adult acute megakaryoblastic leukemia (m7)
754353|NCT00425477|adult acute myeloid leukemia with t(16;16)(p13;q22)|adult acute myeloid leukemia with t(16;16)(p13;q22)
754354|NCT00425477|adult acute myeloid leukemia with t(8;21)(q22;q22)|adult acute myeloid leukemia with t(8;21)(q22;q22)
754355|NCT00425477|adult acute myeloid leukemia with inv(16)(p13;q22)|adult acute myeloid leukemia with inv(16)(p13;q22)
754356|NCT00425451|Periodontitis|periodontitis
754357|NCT00425451|Dental Care|dental care
754358|NCT00425451|Efficacy|efficacy
754359|NCT00425451|Safety|safety
754360|NCT00425425|squamous cell carcinoma of the esophagus|squamous cell carcinoma of the esophagus
755207|NCT00422630|Diabetes|diabetes
754361|NCT00425425|stage IIA esophageal cancer|stage iia esophageal cancer
754362|NCT00425425|stage IIB esophageal cancer|stage iib esophageal cancer
754363|NCT00425425|stage IIIA esophageal cancer|stage iiia esophageal cancer
754364|NCT00425425|stage IIIB esophageal cancer|stage iiib esophageal cancer
754365|NCT00425425|stage IIIC esophageal cancer|stage iiic esophageal cancer
754366|NCT00425399|Schizophrenia|schizophrenia
754367|NCT00425399|Shiatsu|shiatsu
754368|NCT00425386|stage III renal cell cancer|stage iii renal cell cancer
754369|NCT00425386|stage IV renal cell cancer|stage iv renal cell cancer
754370|NCT00425386|clear cell renal cell carcinoma|clear cell renal cell carcinoma
754371|NCT00425386|recurrent renal cell cancer|recurrent renal cell cancer
754372|NCT00425373|Hypertension, Valsartan, Amlodipine, high blood pressure|hypertension, valsartan, amlodipine, high blood pressure
754373|NCT00425360|stage III pancreatic cancer|stage iii pancreatic cancer
754374|NCT00425360|stage IV pancreatic cancer|stage iv pancreatic cancer
754375|NCT00425360|duct cell adenocarcinoma of the pancreas|duct cell adenocarcinoma of the pancreas
754376|NCT00425360|recurrent pancreatic cancer|recurrent pancreatic cancer
754377|NCT00425347|Multiple myeloma, MM, plasma cell myeloma, cancer|multiple myeloma, mm, plasma cell myeloma, cancer
754378|NCT00425334|Blood loss|blood loss
754379|NCT00425334|Ischemia|ischemia
754380|NCT00425334|Hemoglobin|hemoglobin
754381|NCT00425334|Blood Substitutes|blood substitutes
754382|NCT00425334|Plasma Expanders|plasma expanders
754383|NCT00425321|Arthritis|arthritis
754384|NCT00425321|Joints|joints
754385|NCT00425321|Auto immune|auto immune
754386|NCT00425308|Everolimus, calcineurine inhibitor, renal transplantation in maintenance, chronic allograft nephropathy|everolimus, calcineurine inhibitor, renal transplantation in maintenance, chronic allograft nephropathy
754387|NCT00425282|RWJ-333369|rwj-333369
754388|NCT00425282|anticonvulsants|anticonvulsants
754389|NCT00425282|antiepileptic drugs|antiepileptic drugs
754390|NCT00425269|lifestyle intervention|lifestyle intervention
754391|NCT00425269|Type 2 Diabetes|type 2 diabetes
754392|NCT00425269|Metabolic syndrome|metabolic syndrome
754393|NCT00425269|Pakistani women|pakistani women
754394|NCT00425269|dietary change|dietary change
754395|NCT00425269|Physical activity|physical activity
754396|NCT00425269|Norway|norway
754397|NCT00425243|primary insomnia|primary insomnia
754398|NCT00425243|chronic insomnia|chronic insomnia
754399|NCT00425178|Chronic wounds|chronic wounds
754400|NCT00425178|Diabetes|diabetes
754401|NCT00425178|Ulcers|ulcers
754402|NCT00425178|Arterial bypass|arterial bypass
754403|NCT00425178|Angioplasty|angioplasty
754404|NCT00425178|Diabetic ulcers|diabetic ulcers
754405|NCT00425152|stage II colon cancer|stage ii colon cancer
754406|NCT00425152|stage III colon cancer|stage iii colon cancer
754407|NCT00425139|Cancer|cancer
754408|NCT00425139|Video game|video game
754409|NCT00425139|Adolescent|adolescent
754410|NCT00425139|Young adult|young adult
754411|NCT00425126|Delayed Graft Function|delayed graft function
754412|NCT00425126|Kidney Transplantation|kidney transplantation
754413|NCT00425113|Mycobacterium Tuberculosis|mycobacterium tuberculosis
754414|NCT00425113|Anaerobic|anaerobic
754415|NCT00425113|FDG-PET-HRCT|fdg-pet-hrct
754416|NCT00425113|HRCT|hrct
754417|NCT00425113|Lesion Matrix|lesion matrix
754418|NCT00425113|Tuberculosis|tuberculosis
754419|NCT00425113|TB|tb
754420|NCT00425074|slow release ASA|slow release asa
754421|NCT00425074|platelet functionalism|platelet functionalism
754422|NCT00425074|secondary cardiovascular prevention|secondary cardiovascular prevention
754423|NCT00425035|Renal Cancer|renal cancer
754424|NCT00425022|lung cancer|lung cancer
754425|NCT00425022|video-assisted thoracic surgery|video-assisted thoracic surgery
754426|NCT00425009|Berberine|berberine
754427|NCT00425009|Type 2 diabetes|type 2 diabetes
754428|NCT00425009|Treatment|treatment
754429|NCT00424983|Multiple myeloma|multiple myeloma
754430|NCT00424983|breast cancer|breast cancer
754431|NCT00424983|zoledronic acid|zoledronic acid
754432|NCT00424983|pharmacokinetics|pharmacokinetics
754433|NCT00424970|high altitude|high altitude
754434|NCT00424970|hypoxia|hypoxia
754435|NCT00424970|pulmonary hypertension|pulmonary hypertension
754436|NCT00424970|polycythemia|polycythemia
754437|NCT00424970|hypoventilation|hypoventilation
754438|NCT00424957|Ammonia|ammonia
754439|NCT00424957|Astrocytes|astrocytes
754440|NCT00424957|Citric acid cycle|citric acid cycle
754441|NCT00424957|Alpha ketoglutarate dehydrogenase|alpha ketoglutarate dehydrogenase
754442|NCT00424944|Malaria|malaria
754443|NCT00424944|Vaccine|vaccine
754444|NCT00424944|GMZ2|gmz2
754445|NCT00424944|Safety|safety
754446|NCT00424944|African|african
754447|NCT00424944|immunogenicity|immunogenicity
754448|NCT00424931|narcolepsy|narcolepsy
754452|NCT00424918|middle school-based|middle school-based
754453|NCT00424918|feasibility|feasibility
754454|NCT00424866|Peripheral Arterial Disease|peripheral arterial disease
754455|NCT00424866|Ischemia|ischemia
754456|NCT00424866|Intermittent Claudication|intermittent claudication
754457|NCT00424840|lung cancer, Carboplatin, bortezomib, Bevacizumab|lung cancer, carboplatin, bortezomib, bevacizumab
754458|NCT00424827|pancreatic cancer, gemcitabine, 5-FU, cetuximab, radiation|pancreatic cancer, gemcitabine, 5-fu, cetuximab, radiation
754459|NCT00424814|HIV mother to child prevention|hiv mother to child prevention
754460|NCT00424814|HIV Infections|hiv infections
754461|NCT00424814|Kaletra|kaletra
754462|NCT00424814|Combivir|combivir
754463|NCT00424814|HIV Seronegativity|hiv seronegativity
754464|NCT00424788|multiple sclerosis (MS)|multiple sclerosis (ms)
754465|NCT00424775|Non-Small Cell Lung Cancer (NSCLC)|non-small cell lung cancer (nsclc)
754466|NCT00424762|Diabetes Mellitus, Type 2|diabetes mellitus, type 2
754467|NCT00424762|Congestive Heart Failure|congestive heart failure
754468|NCT00424762|Cardiopulmonary exercise testing|cardiopulmonary exercise testing
754469|NCT00424762|intracellular cardiomyocyte triglycerides|intracellular cardiomyocyte triglycerides
754470|NCT00424762|thiazolidinedione|thiazolidinedione
754471|NCT00424762|rosiglitazone|rosiglitazone
754472|NCT00424762|nuclear magnetic resonance|nuclear magnetic resonance
754473|NCT00424749|Antineutrophil cytoplasmic antibody associated vasculitis|antineutrophil cytoplasmic antibody associated vasculitis
754474|NCT00424749|Glomerulonephritis|glomerulonephritis
754475|NCT00424749|Rituximab|rituximab
754476|NCT00424736|blunt trauma, pediatric patient, imaging, computer tomography|blunt trauma, pediatric patient, imaging, computer tomography
754477|NCT00424723|pemetrexed|pemetrexed
754478|NCT00424723|neuroendocrine tumors|neuroendocrine tumors
754479|NCT00424723|metastatic neuroendocrine tumors|metastatic neuroendocrine tumors
754480|NCT00424710|choroidal neovascularization|choroidal neovascularization
754481|NCT00424697|Brain imaging,|brain imaging,
754482|NCT00424697|fMRI,|fmri,
754483|NCT00424697|stimulation,|stimulation,
754484|NCT00424697|pharmacodynamics,|pharmacodynamics,
754485|NCT00424697|tolerability,|tolerability,
754486|NCT00424697|healthy subjects|healthy subjects
754487|NCT00424684|TB|tb
754488|NCT00424684|Chronic Liver Disease|chronic liver disease
754489|NCT00424658|breathing disorders|breathing disorders
754490|NCT00424645|Hematologic Malignancy|hematologic malignancy
754491|NCT00424645|Solid Tumor|solid tumor
754492|NCT00424645|Glucarpidase|glucarpidase
754493|NCT00424645|Voraxaze|voraxaze
754494|NCT00424645|Delayed Methotrexate Clearance|delayed methotrexate clearance
754495|NCT00424645|Placebo|placebo
754496|NCT00424619|Vitamin D|vitamin d
754497|NCT00424619|Hip fracture|hip fracture
754498|NCT00424619|Optimal level|optimal level
754499|NCT00424619|Deficiency|deficiency
754500|NCT00424619|Functional muscle strength|functional muscle strength
754501|NCT00424606|High risk node negative|high risk node negative
754502|NCT00424567|Fracture|fracture
754503|NCT00424567|non union fracture|non union fracture
754504|NCT00424567|ununited fracture|ununited fracture
754505|NCT00424567|pseudarthrosis|pseudarthrosis
754506|NCT00424541|Pharmacokinetics, pharmacodynamics, safety, RAS profile, SPP100, aliskiren, Japanese, essential hypertension|pharmacokinetics, pharmacodynamics, safety, ras profile, spp100, aliskiren, japanese, essential hypertension
754507|NCT00424541|Mild to moderate essential hypertension|mild to moderate essential hypertension
754508|NCT00424528|COPD including chronic bronchitis and emphysema|copd including chronic bronchitis and emphysema
754509|NCT00424515|Imatinib|imatinib
754510|NCT00424515|Gleevec|gleevec
754511|NCT00424489|Refractory Myasthenia Gravis|refractory myasthenia gravis
754512|NCT00424489|Autologous Stem Cell Transplantation|autologous stem cell transplantation
754513|NCT00424489|Cyclophosphamide and ATG|cyclophosphamide and atg
754514|NCT00424476|Autoimmune Diseases|autoimmune diseases
754515|NCT00424476|Lupus|lupus
754516|NCT00424476|SLE|sle
754939|NCT00423605|Muscular Pain|muscular pain
754517|NCT00424476|Systemic Lupus Erythematosus|systemic lupus erythematosus
754518|NCT00424476|Belimumab|belimumab
754519|NCT00424476|Antibodies|antibodies
754520|NCT00424463|Amyotrophic lateral sclerosis (ALS)|amyotrophic lateral sclerosis (als)
754521|NCT00424450|contrast ultrasound|contrast ultrasound
754522|NCT00424450|muscle perfusion|muscle perfusion
754523|NCT00424424|Postoperative Dental Pain|postoperative dental pain
754524|NCT00424385|AIPC, Prostate cancer|aipc, prostate cancer
754525|NCT00424385|prostate|prostate
754526|NCT00424359|Mulitple Sclerosis|mulitple sclerosis
754527|NCT00424359|Ambulation|ambulation
754528|NCT00424346|Active Rheumatoid Arthritis|active rheumatoid arthritis
754529|NCT00424346|anti-interleukin-1beta monoclonal antibody|anti-interleukin-1beta monoclonal antibody
754530|NCT00424346|methotrexate|methotrexate
754531|NCT00424320|Acute kidney failure|acute kidney failure
754532|NCT00424320|Contrast-induced nephropathy|contrast-induced nephropathy
754533|NCT00424320|Non-ionic contrast media|non-ionic contrast media
754534|NCT00424320|Ionic contrast media|ionic contrast media
754535|NCT00424320|Iopamidol|iopamidol
754536|NCT00424320|Percutaneous coronary intervention|percutaneous coronary intervention
754537|NCT00424320|Coronariography|coronariography
754606|NCT00424242|recurrent adult diffuse mixed cell lymphoma|recurrent adult diffuse mixed cell lymphoma
754538|NCT00424281|Arixtra, fondaparinux, vasopressor, venous thrombolism|arixtra, fondaparinux, vasopressor, venous thrombolism
754539|NCT00424268|COPD|copd
754540|NCT00424268|Roflumilast|roflumilast
754541|NCT00424255|Cancer of the Head and Neck|cancer of the head and neck
754542|NCT00424255|Neck cancer|neck cancer
754543|NCT00424255|Adjuvant|adjuvant
754544|NCT00424255|Head and neck cancer|head and neck cancer
755208|NCT00422630|Cholesterol|cholesterol
754545|NCT00424255|High-risk head and neck cancer|high-risk head and neck cancer
754546|NCT00424255|Post-surgery|post-surgery
754547|NCT00424255|Head cancer|head cancer
754548|NCT00424242|unspecified adult solid tumor, protocol specific|unspecified adult solid tumor, protocol specific
754549|NCT00424242|tumors metastatic to brain|tumors metastatic to brain
754550|NCT00424242|leptomeningeal metastases|leptomeningeal metastases
754551|NCT00424242|primary central nervous system non-Hodgkin lymphoma|primary central nervous system non-hodgkin lymphoma
754552|NCT00424242|primary central nervous system Hodgkin lymphoma|primary central nervous system hodgkin lymphoma
754553|NCT00424242|meningeal chronic myelogenous leukemia|meningeal chronic myelogenous leukemia
754554|NCT00424242|relapsing chronic myelogenous leukemia|relapsing chronic myelogenous leukemia
754555|NCT00424242|chronic eosinophilic leukemia|chronic eosinophilic leukemia
754556|NCT00424242|primary myelofibrosis|primary myelofibrosis
754557|NCT00424242|chronic neutrophilic leukemia|chronic neutrophilic leukemia
754558|NCT00424242|essential thrombocythemia|essential thrombocythemia
754559|NCT00424242|polycythemia vera|polycythemia vera
754560|NCT00424242|recurrent adult acute lymphoblastic leukemia|recurrent adult acute lymphoblastic leukemia
754561|NCT00424242|adult acute myeloid leukemia with 11q23 (MLL) abnormalities|adult acute myeloid leukemia with 11q23 (mll) abnormalities
754562|NCT00424242|adult acute myeloid leukemia with inv(16)(p13;q22)|adult acute myeloid leukemia with inv(16)(p13;q22)
754563|NCT00424242|adult acute myeloid leukemia with t(15;17)(q22;q12)|adult acute myeloid leukemia with t(15;17)(q22;q12)
754564|NCT00424242|adult acute myeloid leukemia with t(16;16)(p13;q22)|adult acute myeloid leukemia with t(16;16)(p13;q22)
754565|NCT00424242|adult acute myeloid leukemia with t(8;21)(q22;q22)|adult acute myeloid leukemia with t(8;21)(q22;q22)
754566|NCT00424242|recurrent adult acute myeloid leukemia|recurrent adult acute myeloid leukemia
754567|NCT00424242|previously treated myelodysplastic syndromes|previously treated myelodysplastic syndromes
754568|NCT00424242|secondary acute myeloid leukemia|secondary acute myeloid leukemia
754569|NCT00424242|acute undifferentiated leukemia|acute undifferentiated leukemia
754570|NCT00424242|mast cell leukemia|mast cell leukemia
754571|NCT00424242|recurrent adult T-cell leukemia/lymphoma|recurrent adult t-cell leukemia/lymphoma
754572|NCT00424242|stage IV adult T-cell leukemia/lymphoma|stage iv adult t-cell leukemia/lymphoma
754573|NCT00424242|T-cell large granular lymphocyte leukemia|t-cell large granular lymphocyte leukemia
754574|NCT00424242|atypical chronic myeloid leukemia, BCR-ABL negative|atypical chronic myeloid leukemia, bcr-abl negative
754575|NCT00424242|stage IV chronic lymphocytic leukemia|stage iv chronic lymphocytic leukemia
754576|NCT00424242|refractory chronic lymphocytic leukemia|refractory chronic lymphocytic leukemia
754577|NCT00424242|chronic myelomonocytic leukemia|chronic myelomonocytic leukemia
754578|NCT00424242|refractory hairy cell leukemia|refractory hairy cell leukemia
754579|NCT00424242|prolymphocytic leukemia|prolymphocytic leukemia
754580|NCT00424242|stage IV mycosis fungoides/Sezary syndrome|stage iv mycosis fungoides/sezary syndrome
754581|NCT00424242|recurrent mycosis fungoides/Sezary syndrome|recurrent mycosis fungoides/sezary syndrome
754582|NCT00424242|stage IV cutaneous T-cell non-Hodgkin lymphoma|stage iv cutaneous t-cell non-hodgkin lymphoma
754583|NCT00424242|recurrent cutaneous T-cell non-Hodgkin lymphoma|recurrent cutaneous t-cell non-hodgkin lymphoma
754584|NCT00424242|adult grade III lymphomatoid granulomatosis|adult grade iii lymphomatoid granulomatosis
754585|NCT00424242|intraocular lymphoma|intraocular lymphoma
754586|NCT00424242|post-transplant lymphoproliferative disorder|post-transplant lymphoproliferative disorder
754587|NCT00424242|refractory multiple myeloma|refractory multiple myeloma
754588|NCT00424242|stage IV adult Hodgkin lymphoma|stage iv adult hodgkin lymphoma
754589|NCT00424242|recurrent adult Hodgkin lymphoma|recurrent adult hodgkin lymphoma
754590|NCT00424242|anaplastic large cell lymphoma|anaplastic large cell lymphoma
754591|NCT00424242|angioimmunoblastic T-cell lymphoma|angioimmunoblastic t-cell lymphoma
754592|NCT00424242|Waldenstrom macroglobulinemia|waldenstrom macroglobulinemia
754593|NCT00424242|stage IV adult Burkitt lymphoma|stage iv adult burkitt lymphoma
754594|NCT00424242|recurrent adult Burkitt lymphoma|recurrent adult burkitt lymphoma
754595|NCT00424242|stage IV adult diffuse large cell lymphoma|stage iv adult diffuse large cell lymphoma
754596|NCT00424242|stage IV adult diffuse mixed cell lymphoma|stage iv adult diffuse mixed cell lymphoma
754597|NCT00424242|stage IV adult diffuse small cleaved cell lymphoma|stage iv adult diffuse small cleaved cell lymphoma
754598|NCT00424242|stage IV adult immunoblastic large cell lymphoma|stage iv adult immunoblastic large cell lymphoma
754599|NCT00424242|stage IV adult lymphoblastic lymphoma|stage iv adult lymphoblastic lymphoma
754600|NCT00424242|stage IV grade 1 follicular lymphoma|stage iv grade 1 follicular lymphoma
754601|NCT00424242|stage IV grade 2 follicular lymphoma|stage iv grade 2 follicular lymphoma
754602|NCT00424242|stage IV grade 3 follicular lymphoma|stage iv grade 3 follicular lymphoma
754603|NCT00424242|stage IV mantle cell lymphoma|stage iv mantle cell lymphoma
754604|NCT00424242|stage IV marginal zone lymphoma|stage iv marginal zone lymphoma
754605|NCT00424242|recurrent adult diffuse large cell lymphoma|recurrent adult diffuse large cell lymphoma
754687|NCT00424151|Dysthyroid Ophthalmopathy|dysthyroid ophthalmopathy
754607|NCT00424242|recurrent adult diffuse small cleaved cell lymphoma|recurrent adult diffuse small cleaved cell lymphoma
754608|NCT00424242|recurrent adult immunoblastic large cell lymphoma|recurrent adult immunoblastic large cell lymphoma
754609|NCT00424242|recurrent adult lymphoblastic lymphoma|recurrent adult lymphoblastic lymphoma
754610|NCT00424242|recurrent grade 1 follicular lymphoma|recurrent grade 1 follicular lymphoma
754831|NCT00423826|refractory multiple myeloma|refractory multiple myeloma
754611|NCT00424242|recurrent grade 2 follicular lymphoma|recurrent grade 2 follicular lymphoma
754612|NCT00424242|recurrent grade 3 follicular lymphoma|recurrent grade 3 follicular lymphoma
754613|NCT00424242|recurrent mantle cell lymphoma|recurrent mantle cell lymphoma
754614|NCT00424242|recurrent marginal zone lymphoma|recurrent marginal zone lymphoma
754615|NCT00424242|extranodal marginal zone B-cell lymphoma of mucosa-associated lymphoid tissue|extranodal marginal zone b-cell lymphoma of mucosa-associated lymphoid tissue
754616|NCT00424242|nodal marginal zone B-cell lymphoma|nodal marginal zone b-cell lymphoma
754617|NCT00424242|splenic marginal zone lymphoma|splenic marginal zone lymphoma
754618|NCT00424242|stage IV small lymphocytic lymphoma|stage iv small lymphocytic lymphoma
754619|NCT00424242|recurrent small lymphocytic lymphoma|recurrent small lymphocytic lymphoma
754620|NCT00424242|adult nasal type extranodal NK/T-cell lymphoma|adult nasal type extranodal nk/t-cell lymphoma
754621|NCT00424242|accelerated phase chronic myelogenous leukemia|accelerated phase chronic myelogenous leukemia
754622|NCT00424242|blastic phase chronic myelogenous leukemia|blastic phase chronic myelogenous leukemia
754623|NCT00424242|chronic phase chronic myelogenous leukemia|chronic phase chronic myelogenous leukemia
754624|NCT00424242|de novo myelodysplastic syndromes|de novo myelodysplastic syndromes
754625|NCT00424242|secondary myelodysplastic syndromes|secondary myelodysplastic syndromes
754626|NCT00424242|secondary myelofibrosis|secondary myelofibrosis
754627|NCT00424242|AIDS-related peripheral/systemic lymphoma|aids-related peripheral/systemic lymphoma
754628|NCT00424242|AIDS-related primary CNS lymphoma|aids-related primary cns lymphoma
754629|NCT00424242|recurrent adult grade III lymphomatoid granulomatosis|recurrent adult grade iii lymphomatoid granulomatosis
754630|NCT00424242|stage III multiple myeloma|stage iii multiple myeloma
754631|NCT00424242|primary systemic amyloidosis|primary systemic amyloidosis
754632|NCT00424242|extramedullary plasmacytoma|extramedullary plasmacytoma
754633|NCT00424242|monoclonal gammopathy of undetermined significance|monoclonal gammopathy of undetermined significance
754634|NCT00424242|isolated plasmacytoma of bone|isolated plasmacytoma of bone
754635|NCT00424229|MDS INT-2MDS HIGH RISKDELETION 5q[31]Lenalidomide|mds int-2mds high riskdeletion 5q[31]lenalidomide
754636|NCT00424216|Mood|mood
754637|NCT00424216|Emotion|emotion
754638|NCT00424216|Judgment|judgment
754639|NCT00424216|Cortex|cortex
754640|NCT00424216|Brain Stimulation|brain stimulation
754641|NCT00424216|Healthy Volunteer|healthy volunteer
754643|NCT00424203|cognitive/functional effects|cognitive/functional effects
754644|NCT00424203|depression|depression
754645|NCT00424203|malnutrition|malnutrition
754646|NCT00424203|psychosocial effects of cancer and its treatment|psychosocial effects of cancer and its treatment
754647|NCT00424203|stage IA breast cancer|stage ia breast cancer
754648|NCT00424203|stage IB breast cancer|stage ib breast cancer
754649|NCT00424203|stage II breast cancer|stage ii breast cancer
754650|NCT00424203|stage IIIA breast cancer|stage iiia breast cancer
754651|NCT00424203|stage IIIB breast cancer|stage iiib breast cancer
754652|NCT00424203|stage IIIC breast cancer|stage iiic breast cancer
754653|NCT00424203|estrogen receptor-negative breast cancer|estrogen receptor-negative breast cancer
754654|NCT00424203|progesterone receptor-negative breast cancer|progesterone receptor-negative breast cancer
754655|NCT00424190|Abscess|abscess
754656|NCT00424190|Antibacterial|antibacterial
754657|NCT00424190|Antibiotic|antibiotic
754658|NCT00424190|Antimicrobial|antimicrobial
754659|NCT00424190|Bacterial infection, skin|bacterial infection, skin
754660|NCT00424190|Ceftaroline|ceftaroline
754661|NCT00424190|Ceftaroline acetate|ceftaroline acetate
754662|NCT00424190|Cellulitis|cellulitis
754663|NCT00424190|Cephalosporin|cephalosporin
754664|NCT00424190|Complicated skin and skin structure infection|complicated skin and skin structure infection
754665|NCT00424190|cSSSI|csssi
754666|NCT00424190|Intravenous|intravenous
754667|NCT00424190|Methicillin-resistant Staphylococcus Aureus (MRSA)|methicillin-resistant staphylococcus aureus (mrsa)
754668|NCT00424190|PPI-0903|ppi-0903
754669|NCT00424190|Prodrug|prodrug
754670|NCT00424190|Skin disease, bacterial|skin disease, bacterial
754671|NCT00424190|Skin infection|skin infection
754672|NCT00424190|Staphylococcal skin infection|staphylococcal skin infection
754673|NCT00424190|Staphylococcus aureus|staphylococcus aureus
754674|NCT00424190|Streptococcal skin infection|streptococcal skin infection
754675|NCT00424190|Surgical site infection|surgical site infection
754676|NCT00424190|TAK-599|tak-599
754677|NCT00424177|idiopathic thrombocytopenic purpura|idiopathic thrombocytopenic purpura
754678|NCT00424177|ITP|itp
754679|NCT00424177|thrombocytopenia|thrombocytopenia
754680|NCT00424177|platelets|platelets
754681|NCT00424164|male breast cancer|male breast cancer
754682|NCT00424164|stage IIIB breast cancer|stage iiib breast cancer
754683|NCT00424164|stage IIIC breast cancer|stage iiic breast cancer
754684|NCT00424164|stage IV breast cancer|stage iv breast cancer
754685|NCT00424164|recurrent breast cancer|recurrent breast cancer
754686|NCT00424151|Graves' Disease|graves' disease
754688|NCT00424151|Thyroid related orbitopathy|thyroid related orbitopathy
754689|NCT00424138|stage IIIB non-small cell lung cancer|stage iiib non-small cell lung cancer
754690|NCT00424138|stage IV non-small cell lung cancer|stage iv non-small cell lung cancer
754691|NCT00424138|recurrent non-small cell lung cancer|recurrent non-small cell lung cancer
754692|NCT00424138|stage IIIA non-small cell lung cancer|stage iiia non-small cell lung cancer
754693|NCT00424125|Asthma|asthma
754694|NCT00424125|Compliance|compliance
754695|NCT00424125|Randomized clinical trial|randomized clinical trial
754696|NCT00424112|motivation to change|motivation to change
754697|NCT00424112|treatment motivation|treatment motivation
754698|NCT00424112|alcohol use disorders|alcohol use disorders
754699|NCT00424099|Advanced Cancer|advanced cancer
754700|NCT00424099|Fatigue|fatigue
754701|NCT00424099|Nursing Telephone Intervention|nursing telephone intervention
754702|NCT00424099|NTI|nti
754703|NCT00424099|Methylphenidate|methylphenidate
754704|NCT00424099|Placebo|placebo
754705|NCT00424099|Ritalin|ritalin
754706|NCT00424060|adult glioblastoma|adult glioblastoma
754707|NCT00424060|recurrent adult brain tumor|recurrent adult brain tumor
754708|NCT00424060|adult giant cell glioblastoma|adult giant cell glioblastoma
754709|NCT00424060|adult gliosarcoma|adult gliosarcoma
754710|NCT00424047|Multiple Myeloma|multiple myeloma
754711|NCT00424047|Celgene|celgene
754712|NCT00424047|Revlimid|revlimid
754713|NCT00424047|CC-5013|cc-5013
754714|NCT00424034|safety|safety
754715|NCT00424034|Pharmacokinetics|pharmacokinetics
754716|NCT00424034|effect of food on pharmacokinetics|effect of food on pharmacokinetics
754717|NCT00424008|Glucocorticosteroids|glucocorticosteroids
754718|NCT00424008|Dry Powder Inhaler|dry powder inhaler
754719|NCT00424008|Bronchodilator|bronchodilator
754720|NCT00424008|Metered-Dose Inhaler|metered-dose inhaler
754721|NCT00423969|Depression|depression
754722|NCT00423969|Cognitive Impairment|cognitive impairment
754723|NCT00423956|Teeth root resorption, ultrasound, therapy|teeth root resorption, ultrasound, therapy
754724|NCT00423943|cognition|cognition
754725|NCT00423943|memory|memory
754726|NCT00423930|stage II squamous cell carcinoma of the hypopharynx|stage ii squamous cell carcinoma of the hypopharynx
754727|NCT00423930|stage III squamous cell carcinoma of the hypopharynx|stage iii squamous cell carcinoma of the hypopharynx
754728|NCT00423930|stage IV squamous cell carcinoma of the hypopharynx|stage iv squamous cell carcinoma of the hypopharynx
754729|NCT00423930|stage III squamous cell carcinoma of the larynx|stage iii squamous cell carcinoma of the larynx
754730|NCT00423930|stage IV squamous cell carcinoma of the larynx|stage iv squamous cell carcinoma of the larynx
755052|NCT00423189|LUV|luv
754731|NCT00423930|stage III squamous cell carcinoma of the lip and oral cavity|stage iii squamous cell carcinoma of the lip and oral cavity
754732|NCT00423930|stage IV squamous cell carcinoma of the lip and oral cavity|stage iv squamous cell carcinoma of the lip and oral cavity
754733|NCT00423930|stage III squamous cell carcinoma of the oropharynx|stage iii squamous cell carcinoma of the oropharynx
754734|NCT00423930|stage IV squamous cell carcinoma of the oropharynx|stage iv squamous cell carcinoma of the oropharynx
754735|NCT00423930|stage III squamous cell carcinoma of the paranasal sinus and nasal cavity|stage iii squamous cell carcinoma of the paranasal sinus and nasal cavity
754736|NCT00423930|stage IV squamous cell carcinoma of the paranasal sinus and nasal cavity|stage iv squamous cell carcinoma of the paranasal sinus and nasal cavity
754737|NCT00423930|tongue cancer|tongue cancer
754738|NCT00423917|stage IV breast cancer|stage iv breast cancer
754739|NCT00423917|male breast cancer|male breast cancer
754740|NCT00423917|recurrent breast cancer|recurrent breast cancer
754741|NCT00423904|Early intervention|early intervention
754742|NCT00423904|Brief intervention|brief intervention
754743|NCT00423904|alcohol|alcohol
754744|NCT00423904|general hospital|general hospital
754745|NCT00423865|unspecified adult solid tumor, protocol specific|unspecified adult solid tumor, protocol specific
754746|NCT00423865|CISPLATIN|cisplatin
754747|NCT00423865|RAD001 (EVEROLIMUS)|rad001 (everolimus)
754748|NCT00423865|06-129|06-129
754749|NCT00423852|recurrent ovarian germ cell tumor|recurrent ovarian germ cell tumor
754750|NCT00423852|stage III ovarian germ cell tumor|stage iii ovarian germ cell tumor
754751|NCT00423852|stage IV ovarian germ cell tumor|stage iv ovarian germ cell tumor
754752|NCT00423852|recurrent malignant testicular germ cell tumor|recurrent malignant testicular germ cell tumor
754753|NCT00423852|adult central nervous system germ cell tumor|adult central nervous system germ cell tumor
754754|NCT00423852|stage III malignant testicular germ cell tumor|stage iii malignant testicular germ cell tumor
754755|NCT00423852|stage II malignant testicular germ cell tumor|stage ii malignant testicular germ cell tumor
754756|NCT00423852|recurrent extragonadal non-seminomatous germ cell tumor|recurrent extragonadal non-seminomatous germ cell tumor
754757|NCT00423852|recurrent extragonadal seminoma|recurrent extragonadal seminoma
754758|NCT00423852|stage III extragonadal non-seminomatous germ cell tumor|stage iii extragonadal non-seminomatous germ cell tumor
754759|NCT00423852|stage III extragonadal seminoma|stage iii extragonadal seminoma
754760|NCT00423852|stage IV extragonadal non-seminomatous germ cell tumor|stage iv extragonadal non-seminomatous germ cell tumor
754761|NCT00423852|stage IV extragonadal seminoma|stage iv extragonadal seminoma
754762|NCT00423852|recurrent extragonadal germ cell tumor|recurrent extragonadal germ cell tumor
754763|NCT00423852|adult teratoma|adult teratoma
754764|NCT00423852|testicular immature teratoma|testicular immature teratoma
755199|NCT00422656|WM|wm
754765|NCT00423852|testicular mature teratoma|testicular mature teratoma
754766|NCT00423839|Mycobacterium tuberculosis|mycobacterium tuberculosis
754767|NCT00423839|Antigen 85A|antigen 85a
754768|NCT00423839|Modified Vaccinia Virus Ankara (MVA).|modified vaccinia virus ankara (mva).
754769|NCT00423826|accelerated phase chronic myelogenous leukemia|accelerated phase chronic myelogenous leukemia
754770|NCT00423826|blastic phase chronic myelogenous leukemia|blastic phase chronic myelogenous leukemia
754771|NCT00423826|childhood chronic myelogenous leukemia|childhood chronic myelogenous leukemia
754772|NCT00423826|relapsing chronic myelogenous leukemia|relapsing chronic myelogenous leukemia
754773|NCT00423826|adult acute lymphoblastic leukemia in remission|adult acute lymphoblastic leukemia in remission
754774|NCT00423826|recurrent adult acute lymphoblastic leukemia|recurrent adult acute lymphoblastic leukemia
754775|NCT00423826|childhood acute lymphoblastic leukemia in remission|childhood acute lymphoblastic leukemia in remission
754776|NCT00423826|recurrent childhood acute lymphoblastic leukemia|recurrent childhood acute lymphoblastic leukemia
754777|NCT00423826|adult acute myeloid leukemia in remission|adult acute myeloid leukemia in remission
754778|NCT00423826|adult acute myeloid leukemia with 11q23 (MLL) abnormalities|adult acute myeloid leukemia with 11q23 (mll) abnormalities
754779|NCT00423826|adult acute myeloid leukemia with inv(16)(p13;q22)|adult acute myeloid leukemia with inv(16)(p13;q22)
754780|NCT00423826|adult acute myeloid leukemia with t(15;17)(q22;q12)|adult acute myeloid leukemia with t(15;17)(q22;q12)
754781|NCT00423826|adult acute myeloid leukemia with t(16;16)(p13;q22)|adult acute myeloid leukemia with t(16;16)(p13;q22)
754782|NCT00423826|adult acute myeloid leukemia with t(8;21)(q22;q22)|adult acute myeloid leukemia with t(8;21)(q22;q22)
754783|NCT00423826|recurrent adult acute myeloid leukemia|recurrent adult acute myeloid leukemia
754784|NCT00423826|adult acute minimally differentiated myeloid leukemia (M0)|adult acute minimally differentiated myeloid leukemia (m0)
754785|NCT00423826|adult acute myeloblastic leukemia without maturation (M1)|adult acute myeloblastic leukemia without maturation (m1)
754786|NCT00423826|adult acute myeloblastic leukemia with maturation (M2)|adult acute myeloblastic leukemia with maturation (m2)
754787|NCT00423826|adult acute promyelocytic leukemia (M3)|adult acute promyelocytic leukemia (m3)
754788|NCT00423826|adult acute myelomonocytic leukemia (M4)|adult acute myelomonocytic leukemia (m4)
754789|NCT00423826|adult acute monoblastic leukemia (M5a)|adult acute monoblastic leukemia (m5a)
754790|NCT00423826|adult acute monocytic leukemia (M5b)|adult acute monocytic leukemia (m5b)
754791|NCT00423826|adult erythroleukemia (M6a)|adult erythroleukemia (m6a)
754792|NCT00423826|adult pure erythroid leukemia (M6b)|adult pure erythroid leukemia (m6b)
754793|NCT00423826|adult acute megakaryoblastic leukemia (M7)|adult acute megakaryoblastic leukemia (m7)
754794|NCT00423826|childhood acute myeloblastic leukemia without maturation (M1)|childhood acute myeloblastic leukemia without maturation (m1)
754795|NCT00423826|childhood acute myeloblastic leukemia with maturation (M2)|childhood acute myeloblastic leukemia with maturation (m2)
754796|NCT00423826|childhood acute promyelocytic leukemia (M3)|childhood acute promyelocytic leukemia (m3)
754797|NCT00423826|childhood acute myelomonocytic leukemia (M4)|childhood acute myelomonocytic leukemia (m4)
754798|NCT00423826|childhood acute monoblastic leukemia (M5a)|childhood acute monoblastic leukemia (m5a)
754799|NCT00423826|childhood acute monocytic leukemia (M5b)|childhood acute monocytic leukemia (m5b)
754800|NCT00423826|childhood acute erythroleukemia (M6)|childhood acute erythroleukemia (m6)
754801|NCT00423826|childhood acute megakaryocytic leukemia (M7)|childhood acute megakaryocytic leukemia (m7)
754802|NCT00423826|childhood acute myeloid leukemia in remission|childhood acute myeloid leukemia in remission
754803|NCT00423826|secondary myelodysplastic syndromes|secondary myelodysplastic syndromes
754804|NCT00423826|recurrent childhood acute myeloid leukemia|recurrent childhood acute myeloid leukemia
754805|NCT00423826|refractory chronic lymphocytic leukemia|refractory chronic lymphocytic leukemia
754806|NCT00423826|recurrent adult Hodgkin lymphoma|recurrent adult hodgkin lymphoma
754807|NCT00423826|recurrent/refractory childhood Hodgkin lymphoma|recurrent/refractory childhood hodgkin lymphoma
754808|NCT00423826|adult grade III lymphomatoid granulomatosis|adult grade iii lymphomatoid granulomatosis
754809|NCT00423826|adult nasal type extranodal NK/T-cell lymphoma|adult nasal type extranodal nk/t-cell lymphoma
754810|NCT00423826|Waldenstrom macroglobulinemia|waldenstrom macroglobulinemia
754811|NCT00423826|recurrent adult Burkitt lymphoma|recurrent adult burkitt lymphoma
754812|NCT00423826|recurrent adult diffuse large cell lymphoma|recurrent adult diffuse large cell lymphoma
754813|NCT00423826|recurrent adult diffuse mixed cell lymphoma|recurrent adult diffuse mixed cell lymphoma
754814|NCT00423826|recurrent adult diffuse small cleaved cell lymphoma|recurrent adult diffuse small cleaved cell lymphoma
754815|NCT00423826|recurrent adult immunoblastic large cell lymphoma|recurrent adult immunoblastic large cell lymphoma
754816|NCT00423826|recurrent grade 1 follicular lymphoma|recurrent grade 1 follicular lymphoma
754817|NCT00423826|recurrent grade 2 follicular lymphoma|recurrent grade 2 follicular lymphoma
754818|NCT00423826|recurrent grade 3 follicular lymphoma|recurrent grade 3 follicular lymphoma
754819|NCT00423826|recurrent mantle cell lymphoma|recurrent mantle cell lymphoma
754820|NCT00423826|extranodal marginal zone B-cell lymphoma of mucosa-associated lymphoid tissue|extranodal marginal zone b-cell lymphoma of mucosa-associated lymphoid tissue
754821|NCT00423826|nodal marginal zone B-cell lymphoma|nodal marginal zone b-cell lymphoma
754822|NCT00423826|recurrent marginal zone lymphoma|recurrent marginal zone lymphoma
755053|NCT00423189|Lucentis|lucentis
754823|NCT00423826|secondary acute myeloid leukemia|secondary acute myeloid leukemia
754824|NCT00423826|stage I multiple myeloma|stage i multiple myeloma
754825|NCT00423826|stage II multiple myeloma|stage ii multiple myeloma
755200|NCT00422656|perifosine|perifosine
754826|NCT00423826|stage III multiple myeloma|stage iii multiple myeloma
754827|NCT00423826|extramedullary plasmacytoma|extramedullary plasmacytoma
754828|NCT00423826|isolated plasmacytoma of bone|isolated plasmacytoma of bone
754829|NCT00423826|monoclonal gammopathy of undetermined significance|monoclonal gammopathy of undetermined significance
754830|NCT00423826|primary systemic amyloidosis|primary systemic amyloidosis
754832|NCT00423826|de novo myelodysplastic syndromes|de novo myelodysplastic syndromes
754833|NCT00423826|childhood acute minimally differentiated myeloid leukemia (M0)|childhood acute minimally differentiated myeloid leukemia (m0)
754834|NCT00423826|childhood grade III lymphomatoid granulomatosis|childhood grade iii lymphomatoid granulomatosis
754835|NCT00423826|childhood nasal type extranodal NK/T-cell lymphoma|childhood nasal type extranodal nk/t-cell lymphoma
754836|NCT00423826|recurrent adult grade III lymphomatoid granulomatosis|recurrent adult grade iii lymphomatoid granulomatosis
754837|NCT00423826|recurrent childhood large cell lymphoma|recurrent childhood large cell lymphoma
754838|NCT00423826|recurrent childhood lymphoblastic lymphoma|recurrent childhood lymphoblastic lymphoma
754839|NCT00423826|childhood diffuse large cell lymphoma|childhood diffuse large cell lymphoma
754840|NCT00423826|childhood immunoblastic large cell lymphoma|childhood immunoblastic large cell lymphoma
754841|NCT00423826|Burkitt lymphoma|burkitt lymphoma
754842|NCT00423826|recurrent childhood small noncleaved cell lymphoma|recurrent childhood small noncleaved cell lymphoma
754843|NCT00423826|previously treated myelodysplastic syndromes|previously treated myelodysplastic syndromes
754844|NCT00423826|splenic marginal zone lymphoma|splenic marginal zone lymphoma
754845|NCT00423826|recurrent childhood grade III lymphomatoid granulomatosis|recurrent childhood grade iii lymphomatoid granulomatosis
754846|NCT00423826|recurrent adult lymphoblastic lymphoma|recurrent adult lymphoblastic lymphoma
754847|NCT00423826|recurrent small lymphocytic lymphoma|recurrent small lymphocytic lymphoma
754848|NCT00423826|secondary myelofibrosis|secondary myelofibrosis
754849|NCT00423813|FMS|fms
754850|NCT00423813|Fibro|fibro
754851|NCT00423813|pain|pain
754852|NCT00423813|Body pain|body pain
754853|NCT00423813|tenderness|tenderness
754854|NCT00423813|stiffness|stiffness
754855|NCT00423813|muscular pain|muscular pain
754856|NCT00423813|joint pain|joint pain
754857|NCT00423787|Allergy|allergy
754858|NCT00423787|Allergoid|allergoid
754859|NCT00423787|Specific Immunotherapy|specific immunotherapy
754860|NCT00423774|Allogeneic Hematopoietic Stem Cell Transplant|allogeneic hematopoietic stem cell transplant
754861|NCT00423774|Psychological Distress|psychological distress
754862|NCT00423774|Coping|coping
754863|NCT00423774|Cognitive Behavior Therapy|cognitive behavior therapy
754864|NCT00423774|Bone Marrow Transplant|bone marrow transplant
754865|NCT00423774|Coping Skills|coping skills
754866|NCT00423761|Pharmacokinetics,|pharmacokinetics,
754867|NCT00423761|tolerability,|tolerability,
754868|NCT00423761|healthy,|healthy,
754869|NCT00423761|subjects|subjects
754870|NCT00423722|Advanced Cancer|advanced cancer
754871|NCT00423722|Hospice Care|hospice care
754872|NCT00423722|Caregiver|caregiver
754873|NCT00423722|Saline|saline
754874|NCT00423722|Hydration|hydration
754875|NCT00423722|Dehydration|dehydration
754876|NCT00423709|Hodgkin's Disease|hodgkin's disease
754877|NCT00423709|Allogeneic Blood Stem Cell Transplantation|allogeneic blood stem cell transplantation
754878|NCT00423709|Bone Marrow Transplantation|bone marrow transplantation
754879|NCT00423709|Fludarabine|fludarabine
754880|NCT00423709|Melphalan|melphalan
754881|NCT00423696|stage IV colon cancer|stage iv colon cancer
754882|NCT00423696|stage IV rectal cancer|stage iv rectal cancer
754883|NCT00423696|recurrent colon cancer|recurrent colon cancer
754884|NCT00423696|recurrent rectal cancer|recurrent rectal cancer
754885|NCT00423683|Cancer|cancer
754886|NCT00423683|thromboembolism|thromboembolism
754887|NCT00423657|Abscess|abscess
754888|NCT00423657|Antibacterial|antibacterial
754889|NCT00423657|Antibiotic|antibiotic
754890|NCT00423657|Antimicrobial|antimicrobial
754891|NCT00423657|Bacterial infection, skin|bacterial infection, skin
754892|NCT00423657|Ceftaroline|ceftaroline
754893|NCT00423657|Ceftaroline acetate|ceftaroline acetate
754894|NCT00423657|Cellulitis|cellulitis
754895|NCT00423657|Cephalosporin|cephalosporin
754896|NCT00423657|Complicated skin and skin structure infection (cSSSI)|complicated skin and skin structure infection (csssi)
754897|NCT00423657|cSSSI|csssi
754898|NCT00423657|Intravenous|intravenous
754899|NCT00423657|Methicillin-resistant Staphylococcus Aureus (MRSA)|methicillin-resistant staphylococcus aureus (mrsa)
754900|NCT00423657|PPI-0903|ppi-0903
754901|NCT00423657|Prodrug|prodrug
754902|NCT00423657|Skin disease, bacterial|skin disease, bacterial
754903|NCT00423657|Skin infection|skin infection
754904|NCT00423657|Staphylococcal skin infection|staphylococcal skin infection
754905|NCT00423657|Staphylococcus aureus|staphylococcus aureus
754906|NCT00423657|Streptococcal skin infection|streptococcal skin infection
754907|NCT00423657|Surgical site infection|surgical site infection
754908|NCT00423657|TAK-599|tak-599
754909|NCT00423644|Multiple Myeloma|multiple myeloma
754910|NCT00423644|arsenic|arsenic
754911|NCT00423644|cancer study|cancer study
754912|NCT00423644|failed treatment|failed treatment
754913|NCT00423631|Pain|pain
754914|NCT00423631|Fibromyalgia|fibromyalgia
754915|NCT00423631|Internet|internet
754916|NCT00423618|recurrent adult soft tissue sarcoma|recurrent adult soft tissue sarcoma
754917|NCT00423618|stage I adult soft tissue sarcoma|stage i adult soft tissue sarcoma
754918|NCT00423618|stage II adult soft tissue sarcoma|stage ii adult soft tissue sarcoma
754919|NCT00423618|stage III adult soft tissue sarcoma|stage iii adult soft tissue sarcoma
754920|NCT00423618|adult synovial sarcoma|adult synovial sarcoma
754921|NCT00423618|adult angiosarcoma|adult angiosarcoma
754922|NCT00423618|adult epithelioid sarcoma|adult epithelioid sarcoma
754923|NCT00423618|adult extraskeletal chondrosarcoma|adult extraskeletal chondrosarcoma
754924|NCT00423618|adult leiomyosarcoma|adult leiomyosarcoma
754925|NCT00423618|adult liposarcoma|adult liposarcoma
754926|NCT00423618|adult malignant fibrous histiocytoma|adult malignant fibrous histiocytoma
754927|NCT00423618|adult malignant hemangiopericytoma|adult malignant hemangiopericytoma
754928|NCT00423618|adult malignant mesenchymoma|adult malignant mesenchymoma
754929|NCT00423618|adult fibrosarcoma|adult fibrosarcoma
754930|NCT00423618|adult neurofibrosarcoma|adult neurofibrosarcoma
754931|NCT00423618|adult alveolar soft-part sarcoma|adult alveolar soft-part sarcoma
754932|NCT00423605|FMS|fms
754933|NCT00423605|Fibro|fibro
754934|NCT00423605|Pain|pain
754935|NCT00423605|Body Pain|body pain
754936|NCT00423605|Tenderness|tenderness
754937|NCT00423605|Joint pain|joint pain
754938|NCT00423605|Stiffness|stiffness
754940|NCT00423566|Mycobacterium tuberculosis|mycobacterium tuberculosis
754941|NCT00423566|85A antigen|85a antigen
754942|NCT00423566|Recombinant Modified Vaccinia virus Ankara|recombinant modified vaccinia virus ankara
754943|NCT00423566|Phase I study|phase i study
754944|NCT00423566|Immunogenicity|immunogenicity
754945|NCT00423553|Nitrite and Cytoprotection|nitrite and cytoprotection
754946|NCT00423553|Ischemic Preconditioning|ischemic preconditioning
754947|NCT00423553|Atrial Trabeculae Contractile Function|atrial trabeculae contractile function
754948|NCT00423553|Ischemia|ischemia
754949|NCT00423540|magnesium infusion|magnesium infusion
754950|NCT00423540|magnesium sulfate|magnesium sulfate
754951|NCT00423540|rest cramps|rest cramps
754952|NCT00423540|nocturnal leg cramps|nocturnal leg cramps
754953|NCT00423540|muscle cramps|muscle cramps
754954|NCT00423540|fractional urinary excretion|fractional urinary excretion
754955|NCT00423540|urinary excretion|urinary excretion
754956|NCT00423540|24 hour urine|24 hour urine
754957|NCT00423540|serum magnesium|serum magnesium
754958|NCT00423540|magnesium deficiency|magnesium deficiency
754959|NCT00423540|family practice|family practice
754960|NCT00423540|general practice|general practice
754961|NCT00423540|richmond|richmond
754962|NCT00423540|cramp frequency|cramp frequency
754963|NCT00423540|magnesium status|magnesium status
754964|NCT00423540|urinary magnesium|urinary magnesium
754965|NCT00423540|cramp diary|cramp diary
754966|NCT00423540|sf 36|sf 36
754967|NCT00423527|multiple sclerosis|multiple sclerosis
754968|NCT00423527|central pain|central pain
754969|NCT00423527|levetiracetam|levetiracetam
754970|NCT00423514|graft versus host disease|graft versus host disease
754971|NCT00423514|adult acute lymphoblastic leukemia in remission|adult acute lymphoblastic leukemia in remission
754972|NCT00423514|adult acute myeloid leukemia in remission|adult acute myeloid leukemia in remission
754973|NCT00423514|childhood acute lymphoblastic leukemia in remission|childhood acute lymphoblastic leukemia in remission
754974|NCT00423514|childhood chronic myelogenous leukemia|childhood chronic myelogenous leukemia
754975|NCT00423514|recurrent childhood acute myeloid leukemia|recurrent childhood acute myeloid leukemia
754976|NCT00423514|accelerated phase chronic myelogenous leukemia|accelerated phase chronic myelogenous leukemia
754977|NCT00423514|acute undifferentiated leukemia|acute undifferentiated leukemia
754978|NCT00423514|adult acute myeloid leukemia with 11q23 (MLL) abnormalities|adult acute myeloid leukemia with 11q23 (mll) abnormalities
754979|NCT00423514|blastic phase chronic myelogenous leukemia|blastic phase chronic myelogenous leukemia
754980|NCT00423514|juvenile myelomonocytic leukemia|juvenile myelomonocytic leukemia
754981|NCT00423514|previously treated myelodysplastic syndromes|previously treated myelodysplastic syndromes
754982|NCT00423514|recurrent adult acute lymphoblastic leukemia|recurrent adult acute lymphoblastic leukemia
754983|NCT00423514|recurrent adult acute myeloid leukemia|recurrent adult acute myeloid leukemia
754984|NCT00423514|relapsing chronic myelogenous leukemia|relapsing chronic myelogenous leukemia
754985|NCT00423514|secondary acute myeloid leukemia|secondary acute myeloid leukemia
754986|NCT00423514|secondary myelodysplastic syndromes|secondary myelodysplastic syndromes
754987|NCT00423514|childhood acute myeloid leukemia in remission|childhood acute myeloid leukemia in remission
754988|NCT00423514|de novo myelodysplastic syndromes|de novo myelodysplastic syndromes
754989|NCT00423514|recurrent childhood acute lymphoblastic leukemia|recurrent childhood acute lymphoblastic leukemia
754990|NCT00423514|chronic phase chronic myelogenous leukemia|chronic phase chronic myelogenous leukemia
754991|NCT00423514|adult acute myeloid leukemia with inv(16)(p13;q22)|adult acute myeloid leukemia with inv(16)(p13;q22)
754992|NCT00423514|adult acute myeloid leukemia with t(15;17)(q22;q12)|adult acute myeloid leukemia with t(15;17)(q22;q12)
754993|NCT00423514|adult acute myeloid leukemia with t(16;16)(p13;q22)|adult acute myeloid leukemia with t(16;16)(p13;q22)
754994|NCT00423514|adult acute myeloid leukemia with t(8;21)(q22;q22)|adult acute myeloid leukemia with t(8;21)(q22;q22)
754995|NCT00423514|childhood myelodysplastic syndromes|childhood myelodysplastic syndromes
755699|NCT00420433|Radiography|radiography
754996|NCT00423475|adenocarcinoma of the prostate|adenocarcinoma of the prostate
754997|NCT00423475|stage IIB prostate cancer|stage iib prostate cancer
754998|NCT00423475|stage IIA prostate cancer|stage iia prostate cancer
754999|NCT00423475|stage III prostate cancer|stage iii prostate cancer
755000|NCT00423475|recurrent prostate cancer|recurrent prostate cancer
755001|NCT00423475|stage IV prostate cancer|stage iv prostate cancer
755002|NCT00423462|Psychotherapy|psychotherapy
755003|NCT00423462|Long-term effects|long-term effects
755004|NCT00423449|Advanced Stage IIIB/IV Non-Small Cell Lung Cancer|advanced stage iiib/iv non-small cell lung cancer
755005|NCT00423436|Non-Small Cell Lung Cancer|non-small cell lung cancer
755006|NCT00423436|Small Cell Lung Cancer|small cell lung cancer
755007|NCT00423436|Voice Response System|voice response system
755008|NCT00423436|Questionnaire|questionnaire
755010|NCT00423436|NSCLC|nsclc
755011|NCT00423410|Cancer|cancer
755012|NCT00423410|Tumor|tumor
755013|NCT00423410|Lymphoma|lymphoma
755014|NCT00423397|squamous cell carcinoma of the skin|squamous cell carcinoma of the skin
755015|NCT00423397|recurrent skin cancer|recurrent skin cancer
755016|NCT00423384|Ibandronate|ibandronate
755017|NCT00423384|Placebo|placebo
755018|NCT00423384|Doubleblind|doubleblind
755019|NCT00423384|Bone|bone
755020|NCT00423384|loss|loss
755021|NCT00423384|Kidney|kidney
755022|NCT00423384|transplant|transplant
755023|NCT00423371|first Carpometacarpal (CMC) Joint|first carpometacarpal (cmc) joint
755024|NCT00423358|rheumatoid arthritis|rheumatoid arthritis
755025|NCT00423358|hypovitaminosis D|hypovitaminosis d
755026|NCT00423358|bone turnover|bone turnover
755027|NCT00423358|ergocalciferol|ergocalciferol
755028|NCT00423332|cancer|cancer
755029|NCT00423332|tumour|tumour
755030|NCT00423332|advanced cancer|advanced cancer
755031|NCT00423332|Metastatic renal cell carcinoma|metastatic renal cell carcinoma
755032|NCT00423332|kidney cancer|kidney cancer
755033|NCT00423332|RECENTIN|recentin
755034|NCT00423319|Prevention of deep vein thrombosis and|prevention of deep vein thrombosis and
755035|NCT00423319|pulmonary embolism after total hip replacement surgery|pulmonary embolism after total hip replacement surgery
755036|NCT00423293|stage II anal cancer|stage ii anal cancer
755037|NCT00423293|stage IIIA anal cancer|stage iiia anal cancer
755038|NCT00423293|stage IIIB anal cancer|stage iiib anal cancer
755039|NCT00423293|basaloid carcinoma of the anus|basaloid carcinoma of the anus
755040|NCT00423293|cloacogenic carcinoma of the anus|cloacogenic carcinoma of the anus
755041|NCT00423293|squamous cell carcinoma of the anus|squamous cell carcinoma of the anus
755042|NCT00423280|Endothelium|endothelium
755043|NCT00423280|Nitric Oxide|nitric oxide
755044|NCT00423280|Magnetic Resonance Imaging|magnetic resonance imaging
755045|NCT00423280|Tetrahydrobiopterin|tetrahydrobiopterin
755046|NCT00423254|Cancer Vaccine|cancer vaccine
755047|NCT00423228|Alzheimer's disease|alzheimer's disease
755048|NCT00423228|cognitive impairment|cognitive impairment
755049|NCT00423228|cholinesterase inhibitors|cholinesterase inhibitors
755050|NCT00423228|sustained-release implants|sustained-release implants
755051|NCT00423228|long acting treatment|long acting treatment
755054|NCT00423189|Visudyne|visudyne
755055|NCT00423189|PDT|pdt
755056|NCT00423189|AMD|amd
755057|NCT00423189|ARMD|armd
755058|NCT00423189|Age|age
755059|NCT00423189|Related|related
755060|NCT00423189|Macular|macular
755061|NCT00423189|Degeneration|degeneration
755062|NCT00423163|Aspergillosis/blood|aspergillosis/blood
755063|NCT00423163|micafungin|micafungin
755064|NCT00423163|voriconazole|voriconazole
755065|NCT00423163|Aspergillus|aspergillus
755066|NCT00423124|Hematological malignancies|hematological malignancies
755067|NCT00423124|HSV-TK|hsv-tk
755068|NCT00423124|Haploidentical HCT|haploidentical hct
755069|NCT00423124|GvHD|gvhd
755070|NCT00423124|GvL|gvl
755071|NCT00423111|Multiple sclerosis|multiple sclerosis
755072|NCT00423111|Memory|memory
755073|NCT00423111|Cognitive deficits|cognitive deficits
755074|NCT00423111|MRI|mri
755075|NCT00423111|Hippocampus|hippocampus
755076|NCT00423111|Prefrontal cortex|prefrontal cortex
755077|NCT00423098|Lupus Nephritis|lupus nephritis
755078|NCT00423098|enteric-coated mycophenolate sodium|enteric-coated mycophenolate sodium
755079|NCT00423098|EC-MPS|ec-mps
755080|NCT00423098|Myfortic|myfortic
755081|NCT00423085|rivastigmine，Alzheimer's Disease, transdermal patch|rivastigmine，alzheimer's disease, transdermal patch
755082|NCT00423072|cleft palate|cleft palate
755083|NCT00423072|palatoplasty|palatoplasty
755084|NCT00423072|otitis|otitis
755085|NCT00423072|middle ear|middle ear
755086|NCT00423072|Eustachian tube|eustachian tube
755087|NCT00423059|intravitreal bevacizumab|intravitreal bevacizumab
755088|NCT00423059|proliferative diabetic retinopathy|proliferative diabetic retinopathy
755089|NCT00423059|VEGF|vegf
755090|NCT00423059|PEDF|pedf
755091|NCT00423046|Vaccines|vaccines
755092|NCT00423046|Cervical cancer|cervical cancer
755093|NCT00423046|Immunogenicity|immunogenicity
755094|NCT00423046|Humans|humans
755095|NCT00423046|Safety|safety
755096|NCT00423046|Viral infections|viral infections
755097|NCT00423046|Human papillomavirus (HPV)|human papillomavirus (hpv)
755700|NCT00420433|X-Ray|x-ray
755098|NCT00423046|Comparative study|comparative study
755099|NCT00423046|Human papillomavirus vaccine|human papillomavirus vaccine
755100|NCT00423046|Adults|adults
755101|NCT00423020|Acute myocardial infarction|acute myocardial infarction
755102|NCT00423020|Restenosis|restenosis
755103|NCT00423020|erythropoietin|erythropoietin
755104|NCT00423020|EPOC-AMI|epoc-ami
755105|NCT00422994|end stage renal impairment|end stage renal impairment
755106|NCT00422994|tolerability|tolerability
755107|NCT00422994|ropinirole|ropinirole
755108|NCT00422994|pharmacokinetics|pharmacokinetics
755109|NCT00422994|hemodialysis|hemodialysis
755110|NCT00422981|Dementia|dementia
755111|NCT00422981|Memory|memory
755112|NCT00422981|Alzheimers|alzheimers
755113|NCT00422981|Cognition|cognition
755114|NCT00422981|Mind|mind
755115|NCT00422981|Aging|aging
755116|NCT00422968|Coronary artery disease|coronary artery disease
755117|NCT00422968|Stent|stent
755118|NCT00422968|Bypass surgery, coronary artery|bypass surgery, coronary artery
755119|NCT00422955|fluid retention|fluid retention
755120|NCT00422955|Autonomic Neuropathy|autonomic neuropathy
755121|NCT00422929|otitis media|otitis media
755122|NCT00422929|ear|ear
755123|NCT00422929|acute otitis|acute otitis
755124|NCT00422929|middle ear|middle ear
755125|NCT00422929|Eustachian tube|eustachian tube
755126|NCT00422929|recurrent acute otitis media|recurrent acute otitis media
755127|NCT00422929|chronic otitis media with effusion|chronic otitis media with effusion
755128|NCT00422929|no significant history of otitis media|no significant history of otitis media
755129|NCT00422903|neo-adjuvant|neo-adjuvant
755130|NCT00422903|letrozole|letrozole
755131|NCT00422903|lapatinib|lapatinib
755132|NCT00422903|primary breast cancer|primary breast cancer
755133|NCT00422890|Acute myeloid leukaemia or Myelodysplastic syndrome|acute myeloid leukaemia or myelodysplastic syndrome
755134|NCT00422877|Liver Cancer|liver cancer
755135|NCT00422851|otitis|otitis
755136|NCT00422851|gas diffusion|gas diffusion
755137|NCT00422851|Eustachian tube|eustachian tube
755138|NCT00422851|tympanic membrane|tympanic membrane
755139|NCT00422838|Hepatitis C|hepatitis c
755140|NCT00422838|Liver|liver
755141|NCT00422838|immunology|immunology
755142|NCT00422838|regulation|regulation
755143|NCT00422838|Genotype 1,2,3|genotype 1,2,3
755144|NCT00422838|Treatment|treatment
755145|NCT00422838|Chronic|chronic
755146|NCT00422838|Pegylated interferon|pegylated interferon
755147|NCT00422838|Ribavirin|ribavirin
755148|NCT00422825|Food effect|food effect
755149|NCT00422825|bioavailability|bioavailability
755150|NCT00422825|pharmacokinetic|pharmacokinetic
755151|NCT00422825|imatinib|imatinib
755152|NCT00422825|STI571|sti571
755153|NCT00422825|modified release formulation of STI571|modified release formulation of sti571
755154|NCT00422825|CML|cml
755155|NCT00422825|Chronic Myeloid Leukemia|chronic myeloid leukemia
755156|NCT00422825|Philadelphia Chromosome|philadelphia chromosome
755157|NCT00422812|Migraine, Staccato Prochlorperazine|migraine, staccato prochlorperazine
755158|NCT00422812|Migraine headache with or without aura.|migraine headache with or without aura.
755159|NCT00422799|relapsed Waldenstrom's macroglobulinemia|relapsed waldenstrom's macroglobulinemia
755160|NCT00422799|refractory Waldenstrom's macroglobulinemia|refractory waldenstrom's macroglobulinemia
755161|NCT00422799|Velcade|velcade
755162|NCT00422799|WM|wm
755163|NCT00422786|Refractory Clear Cell Renal Cell Carcinoma|refractory clear cell renal cell carcinoma
755164|NCT00422786|Phase II|phase ii
755165|NCT00422786|Thallion|thallion
755166|NCT00422786|TLN-232|tln-232
755167|NCT00422786|CAP-232|cap-232
755168|NCT00422786|M2PK|m2pk
755169|NCT00422773|phase I/II|phase i/ii
755170|NCT00422773|cetuximab|cetuximab
755171|NCT00422773|oxaliplatin|oxaliplatin
755172|NCT00422773|irinotecan|irinotecan
755173|NCT00422773|5-FU|5-fu
755174|NCT00422773|chemotherapy|chemotherapy
755175|NCT00422773|dose escalation|dose escalation
755176|NCT00422773|safety|safety
755177|NCT00422760|esophageal perforation|esophageal perforation
755178|NCT00422760|COPD|copd
755179|NCT00422747|asthma|asthma
755180|NCT00422747|transient wheezing|transient wheezing
755181|NCT00422747|early diagnosis|early diagnosis
755182|NCT00422747|exhaled air|exhaled air
755183|NCT00422747|nitrogen monoxide|nitrogen monoxide
755184|NCT00422747|airway resistance|airway resistance
755185|NCT00422721|early severe retinal dystrophy|early severe retinal dystrophy
755186|NCT00422721|amaurosis of leber|amaurosis of leber
755187|NCT00422695|HIV|hiv
755188|NCT00422695|Quantitative Sensory Testing|quantitative sensory testing
755189|NCT00422695|Neuropathy|neuropathy
755190|NCT00422695|Treatment Experienced|treatment experienced
755191|NCT00422695|Treatment Naive|treatment naive
755192|NCT00422682|Solid tumors|solid tumors
755193|NCT00422669|Pacemaker|pacemaker
755194|NCT00422669|Implantable Pulse Generator (IPG)|implantable pulse generator (ipg)
755195|NCT00422669|AV Conduction Disturbance|av conduction disturbance
755196|NCT00422669|Select Site Pacing|select site pacing
755197|NCT00422656|relapsed Waldenstrom's Macroglobulinemia|relapsed waldenstrom's macroglobulinemia
755198|NCT00422656|refractory Waldenstrom's Macroglobulinemia|refractory waldenstrom's macroglobulinemia
755201|NCT00422643|OA,HA,Intra-articular|oa,ha,intra-articular
755202|NCT00422630|Weight loss|weight loss
755203|NCT00422630|Obesity|obesity
755204|NCT00422630|Metabolic Syndrome|metabolic syndrome
755205|NCT00422630|Diet|diet
755206|NCT00422630|Hypertension|hypertension
755209|NCT00422617|psoriasis|psoriasis
755210|NCT00422617|alefacept|alefacept
755211|NCT00422604|COPD|copd
755212|NCT00422604|plethysmography.|plethysmography.
755213|NCT00422604|muscarinic receptor antagonist|muscarinic receptor antagonist
755214|NCT00422604|anticholinergic|anticholinergic
755215|NCT00422591|Cytarabine, Idarubicin|cytarabine, idarubicin
755216|NCT00422591|Leukemia|leukemia
755217|NCT00422591|Acute Myeloid Leukemia|acute myeloid leukemia
755218|NCT00422591|AML|aml
755219|NCT00422591|Cytarabine|cytarabine
755220|NCT00422591|Idarubicin|idarubicin
755221|NCT00422578|erectile dysfunction|erectile dysfunction
755222|NCT00422578|tadalafil|tadalafil
755223|NCT00422565|Coronary Artery Disease|coronary artery disease
755224|NCT00422565|Stent|stent
755225|NCT00422565|Myocardial Infarction|myocardial infarction
755226|NCT00422552|inspiratory capacity, FEV1, COPD|inspiratory capacity, fev1, copd
755227|NCT00422539|trichloroacetic acid|trichloroacetic acid
755228|NCT00422539|varicella scar|varicella scar
755229|NCT00422526|Preterm delivery, short cervix, progesterone|preterm delivery, short cervix, progesterone
755230|NCT00422500|Lung Cancer|lung cancer
755231|NCT00422500|Advanced Lung Cancer|advanced lung cancer
755232|NCT00422500|Chemotherapy Symptoms|chemotherapy symptoms
755233|NCT00422500|Disease-Related Symptoms|disease-related symptoms
755234|NCT00422500|Treatment-Related Symptoms|treatment-related symptoms
755235|NCT00422500|Symptom Management|symptom management
755236|NCT00422500|Questionnaire|questionnaire
755237|NCT00422500|Telephone Interactive System|telephone interactive system
755238|NCT00422500|IVR Telephone System|ivr telephone system
755239|NCT00422500|DNA Repair Capacity|dna repair capacity
755240|NCT00422500|DRC|drc
755241|NCT00422500|Cognitive Symptoms|cognitive symptoms
755242|NCT00422487|Type 2 Diabetes Mellitus|type 2 diabetes mellitus
755243|NCT00422474|Ischemic stroke|ischemic stroke
755244|NCT00422474|Baroreflex sensitivity|baroreflex sensitivity
755245|NCT00422474|Prognosis|prognosis
755246|NCT00422474|Cardiovascular autonomic regulation|cardiovascular autonomic regulation
755247|NCT00422461|Clinical Trial, Randomized Controlled Trial, Humans, Cyclic Nucleotide Phosphodiesterases Type 5|clinical trial, randomized controlled trial, humans, cyclic nucleotide phosphodiesterases type 5
755248|NCT00422448|Dermoscopy|dermoscopy
755249|NCT00422448|Histopathology|histopathology
755250|NCT00422448|Genetics|genetics
755251|NCT00422448|Nevi|nevi
755252|NCT00422448|Nevogenesis|nevogenesis
755253|NCT00422435|Percutaneous coronary intervention (PCI)|percutaneous coronary intervention (pci)
755254|NCT00422435|Drug eluting stent (DES)|drug eluting stent (des)
755255|NCT00422422|Brivaracetam|brivaracetam
755256|NCT00422422|Epilepsy|epilepsy
755257|NCT00422422|Child|child
755258|NCT00422422|Pharmacokinetics|pharmacokinetics
755259|NCT00422422|Adolescents|adolescents
755260|NCT00422409|SEMS|sems
755261|NCT00422396|Hypertrigliceridemia|hypertrigliceridemia
755262|NCT00422396|Metabolic syndrome|metabolic syndrome
755263|NCT00422396|Obesity|obesity
755264|NCT00422396|Fenofibrate|fenofibrate
755265|NCT00422396|Lipoproteins|lipoproteins
755266|NCT00422396|Cytokines|cytokines
755267|NCT00422357|Type 2 Diabetes Mellitus|type 2 diabetes mellitus
755268|NCT00422357|Urtica Dioica (or stinging nettle)|urtica dioica (or stinging nettle)
755269|NCT00422357|Hypoglycemic agents|hypoglycemic agents
755270|NCT00422344|RAD001|rad001
755271|NCT00422344|Sunitinib|sunitinib
755272|NCT00422344|renal|renal
755273|NCT00422344|kidney|kidney
755274|NCT00422331|Bipolar I Disorder|bipolar i disorder
755275|NCT00422331|Bipolar Disorder|bipolar disorder
755276|NCT00422331|Lithium|lithium
755277|NCT00422318|Heart Failure|heart failure
755278|NCT00422318|Insulin|insulin
755279|NCT00422318|Metabolism|metabolism
755280|NCT00422318|Pharmacology|pharmacology
755281|NCT00422318|Uric Acid|uric acid
755282|NCT00422305|Infant, Premature|infant, premature
755283|NCT00422305|Bronchopulmonary dysplasia|bronchopulmonary dysplasia
755284|NCT00422305|asthma|asthma
755285|NCT00422292|Menactra vaccine|menactra vaccine
755286|NCT00422292|Meningococcal meningitis|meningococcal meningitis
755287|NCT00422292|Measles|measles
755288|NCT00422292|Mumps|mumps
755289|NCT00422292|Rubella|rubella
755290|NCT00422292|Varicella vaccines|varicella vaccines
755291|NCT00422292|Haemophilus influenzae type b|haemophilus influenzae type b
755292|NCT00422292|Pneumococcal conjugate vaccine|pneumococcal conjugate vaccine
755293|NCT00422279|Bone Inductive Implant|bone inductive implant
755294|NCT00422266|Dyslipidemia|dyslipidemia
755295|NCT00422253|insulin resistance|insulin resistance
755296|NCT00422253|insulin secretion|insulin secretion
755297|NCT00422253|advanced glycation end-products|advanced glycation end-products
755298|NCT00422240|Acne vulgaris|acne vulgaris
755299|NCT00422240|Adapalene|adapalene
755300|NCT00422240|Benzoyl Peroxide|benzoyl peroxide
755301|NCT00422214|Bipolar Disorder|bipolar disorder
755302|NCT00422214|Bipolar Depression,|bipolar depression,
755303|NCT00422214|Manic Depression|manic depression
755304|NCT00422214|Seroquel|seroquel
755305|NCT00422214|Seroquel SR|seroquel sr
755306|NCT00422214|quetiapine fumarate|quetiapine fumarate
755307|NCT00422201|Cortisol|cortisol
755308|NCT00422201|Cushing's Syndrome|cushing's syndrome
755309|NCT00422201|Ectopic ACTH Secretion|ectopic acth secretion
755310|NCT00422201|Cushing Syndrome|cushing syndrome
755311|NCT00422175|Safety, tolerability, pharmacokinetics, pharmacodynamics, oral, BAF312, healthy volunteers|safety, tolerability, pharmacokinetics, pharmacodynamics, oral, baf312, healthy volunteers
755312|NCT00422149|Sublingual immunotherapy|sublingual immunotherapy
755313|NCT00422149|Rhinoconjunctivitis|rhinoconjunctivitis
755314|NCT00422136|middle ear|middle ear
755315|NCT00422136|otitis|otitis
755316|NCT00422136|genetics|genetics
755317|NCT00422123|Bipolar Disorder|bipolar disorder
755318|NCT00422123|Bipolar Mania|bipolar mania
755319|NCT00422123|Manic Depression|manic depression
755320|NCT00422123|Seroquel|seroquel
755321|NCT00422123|Seroquel SR|seroquel sr
755322|NCT00422123|quetiapine fumarate|quetiapine fumarate
755323|NCT00422110|Seletracetam|seletracetam
755324|NCT00422110|Epilepsies|epilepsies
755325|NCT00422110|Partial|partial
755326|NCT00422110|Epilepsy|epilepsy
755327|NCT00422110|Focal|focal
755328|NCT00422084|Malaria|malaria
755329|NCT00422084|ACT|act
755330|NCT00422084|P falciparum|p falciparum
755331|NCT00422071|Transcranial Magnetic Stimulation (TMS)|transcranial magnetic stimulation (tms)
755332|NCT00422071|Dopamine|dopamine
755333|NCT00422071|Gambling|gambling
755334|NCT00422071|Healthy Volunteer|healthy volunteer
755335|NCT00422071|HV|hv
755336|NCT00422032|Myelodysplastic Syndrome|myelodysplastic syndrome
755337|NCT00422032|Leukemia|leukemia
755338|NCT00422032|Clofarabine|clofarabine
755339|NCT00422032|MDS|mds
755340|NCT00422019|Renal Cancer|renal cancer
755341|NCT00422019|Kidney Cancer|kidney cancer
755342|NCT00422006|bariatric surgery planned|bariatric surgery planned
755343|NCT00421993|Acne vulgaris|acne vulgaris
755344|NCT00421993|Adapalene|adapalene
755345|NCT00421993|Benzoyl Peroxide|benzoyl peroxide
755346|NCT00421967|Postoperative pain|postoperative pain
755347|NCT00421954|psychosis NOS|psychosis nos
755348|NCT00421954|MDD w/ psychotic features|mdd w/ psychotic features
755349|NCT00421954|bipolar disorder w. psychotic features|bipolar disorder w. psychotic features
755350|NCT00421941|enteral feeding|enteral feeding
755351|NCT00421941|critical care|critical care
755352|NCT00421941|fish oil|fish oil
755353|NCT00421941|surgical|surgical
755354|NCT00421928|Chronic Pain|chronic pain
755355|NCT00421928|Osteoarthritis, Knee|osteoarthritis, knee
755356|NCT00421928|tapentadol|tapentadol
755357|NCT00421928|Pain Assessment|pain assessment
755358|NCT00421902|Hot flashes, prostate cancer, acupuncture|hot flashes, prostate cancer, acupuncture
755359|NCT00421889|Ovarian cancer|ovarian cancer
755360|NCT00421889|Ovarian Neoplasms|ovarian neoplasms
755361|NCT00421889|Primary peritoneal|primary peritoneal
755362|NCT00421889|Epithelial ovarian|epithelial ovarian
755363|NCT00421889|Fallopian tube|fallopian tube
755364|NCT00421889|Bladder cancer|bladder cancer
755365|NCT00421889|belinostat|belinostat
755366|NCT00421889|PXD101|pxd101
755367|NCT00421889|mixed mullerian cancer of ovarian origin|mixed mullerian cancer of ovarian origin
755368|NCT00421876|cardiac rehabilitation|cardiac rehabilitation
755369|NCT00421876|lifestyle management|lifestyle management
755370|NCT00421876|risk factor management|risk factor management
755371|NCT00421876|myocardial infarction|myocardial infarction
755372|NCT00421876|randomized trials|randomized trials
755373|NCT00421863|hypertension|hypertension
755374|NCT00421863|systolic blood pressure|systolic blood pressure
755375|NCT00421837|influenza, flu, genotypic analysis, sub-study|influenza, flu, genotypic analysis, sub-study
755376|NCT00421811|cancer|cancer
755377|NCT00421811|tumors|tumors
755378|NCT00421811|melanoma|melanoma
755379|NCT00421811|anticarcinogenic agents|anticarcinogenic agents
755380|NCT00421811|antineoplastic agents|antineoplastic agents
755381|NCT00421811|cadherins|cadherins
755382|NCT00421811|solid tumors|solid tumors
755383|NCT00421798|tuberculosis, paucibacillary, mycobacteria, Mexico, Colombia|tuberculosis, paucibacillary, mycobacteria, mexico, colombia
755384|NCT00421785|N-acetylcysteine|n-acetylcysteine
755385|NCT00421785|Peritoneal Dialysis|peritoneal dialysis
755386|NCT00421785|ADMA|adma
755387|NCT00421772|cerebral ventriculomegaly|cerebral ventriculomegaly
755388|NCT00421772|prenatal diagnostic|prenatal diagnostic
755389|NCT00421772|neuropsychological outcome|neuropsychological outcome
755390|NCT00421759|Sensory loss|sensory loss
755391|NCT00421759|psychomotor function|psychomotor function
755392|NCT00421759|balance|balance
755393|NCT00421759|gait|gait
755394|NCT00421733|Type 2 Diabetic Nephropathy|type 2 diabetic nephropathy
755395|NCT00421720|remifentanil|remifentanil
755396|NCT00421720|sufentanil|sufentanil
755397|NCT00421720|propofol|propofol
755398|NCT00421720|analgesia|analgesia
755399|NCT00421720|sedation|sedation
755400|NCT00421720|mechanically ventilated|mechanically ventilated
755401|NCT00421720|intensive care|intensive care
755402|NCT00421720|pharmacoeconomic|pharmacoeconomic
755403|NCT00421720|weaning|weaning
755404|NCT00421720|delirium|delirium
755405|NCT00421720|randomized|randomized
755406|NCT00421720|Germany|germany
755803|NCT00419939|Re-learning|re-learning
755407|NCT00421707|Irritable Bowel Syndrome safety|irritable bowel syndrome safety
755408|NCT00421681|Aging|aging
755409|NCT00421681|exercise|exercise
755410|NCT00421681|health behavior|health behavior
755411|NCT00421668|HIV|hiv
755412|NCT00421668|Tanzania|tanzania
755413|NCT00421668|Micronutrients|micronutrients
755414|NCT00421668|Infants/children|infants/children
755415|NCT00421668|Infectious Disease|infectious disease
755416|NCT00421668|Growth faltering|growth faltering
755417|NCT00421629|health insurance|health insurance
755418|NCT00421629|hospitalization insurance|hospitalization insurance
755419|NCT00421629|community based health insurance|community based health insurance
755420|NCT00421629|health care access|health care access
755421|NCT00421629|developing countries|developing countries
755422|NCT00421629|randomized controlled trials|randomized controlled trials
755423|NCT00421616|Calorimetry|calorimetry
755424|NCT00421616|Overweight|overweight
755425|NCT00421616|Weight loss|weight loss
755426|NCT00421616|Appetite|appetite
755427|NCT00421603|Cocaine|cocaine
755428|NCT00421603|Adderall|adderall
755429|NCT00421603|Topiramate|topiramate
755430|NCT00421603|ADHD|adhd
755431|NCT00421590|Randomized, partially blind, placebo controlled, crossover, drug interaction with concomitant antacid, pharmacokinetics, pharmacodynamics, SMC021|randomized, partially blind, placebo controlled, crossover, drug interaction with concomitant antacid, pharmacokinetics, pharmacodynamics, smc021
755432|NCT00421577|Caries Diagnosis|caries diagnosis
755433|NCT00421577|Replica technique|replica technique
755434|NCT00421564|Menopausal|menopausal
755435|NCT00421564|Traditional Chinese Medicine|traditional chinese medicine
755436|NCT00421551|HIV Infections|hiv infections
755437|NCT00421551|darunavir|darunavir
755438|NCT00421551|Ritonavir|ritonavir
755439|NCT00421551|HIV Protease Inhibitors|hiv protease inhibitors
755440|NCT00421551|treatment experienced|treatment experienced
755441|NCT00421538|Deep vein Thrombosis|deep vein thrombosis
755442|NCT00421538|Calf vein thrombosis|calf vein thrombosis
755443|NCT00421538|Low-molecular weight heparin|low-molecular weight heparin
755444|NCT00421538|Placebo|placebo
755445|NCT00421538|Elastic contention|elastic contention
755446|NCT00421538|Compression Ultrasonography|compression ultrasonography
755447|NCT00421525|multiple myeloma|multiple myeloma
755448|NCT00421525|Myeloma, Plasma-Cell|myeloma, plasma-cell
755449|NCT00421525|PLASMACYTOMA|plasmacytoma
755450|NCT00421512|Renal cell carcinoma|renal cell carcinoma
755451|NCT00421512|Metastatic|metastatic
755452|NCT00421512|Kidney Cancer|kidney cancer
755453|NCT00421512|Bevacizumab|bevacizumab
755454|NCT00421512|Sunitinib|sunitinib
755455|NCT00421486|Oral human papillomavirus infection|oral human papillomavirus infection
755456|NCT00421486|HIV-infection|hiv-infection
755457|NCT00421486|High-risk HPV viral load|high-risk hpv viral load
755458|NCT00421486|Oral human papillomavirus infection in HIV-positive men|oral human papillomavirus infection in hiv-positive men
755459|NCT00421486|Treatment Experienced|treatment experienced
755460|NCT00421486|Treatment Naive|treatment naive
755461|NCT00421473|HIV|hiv
755462|NCT00421473|Malaria prophylaxis|malaria prophylaxis
755463|NCT00421473|Treatment Experienced|treatment experienced
755464|NCT00421460|Nebido in hypogonadism with erectile dysfunction|nebido in hypogonadism with erectile dysfunction
755465|NCT00421447|Breast Cancer|breast cancer
755466|NCT00421447|pQCT|pqct
755467|NCT00421447|Anastrozole|anastrozole
755468|NCT00421447|bone geometry|bone geometry
755469|NCT00421434|Hepatitis C|hepatitis c
755470|NCT00421421|Acute Urinary Retention|acute urinary retention
755471|NCT00421421|Benign Prostatic Hyperplasia|benign prostatic hyperplasia
755472|NCT00421421|Trial Without Catheter|trial without catheter
755473|NCT00421408|Dietary protein|dietary protein
755474|NCT00421408|Calcium|calcium
755475|NCT00421408|Parathyroid hormone|parathyroid hormone
755476|NCT00421408|Bone markers|bone markers
755477|NCT00421408|Bone mineral density|bone mineral density
755478|NCT00421408|IGF-1|igf-1
755479|NCT00421408|Urine Calcium|urine calcium
755480|NCT00421395|NHL|nhl
755481|NCT00421395|B-cell NHL|b-cell nhl
755482|NCT00421395|Non-Hodgkins lymphoma|non-hodgkins lymphoma
755483|NCT00421369|Major depressive disorder|major depressive disorder
755484|NCT00421369|Antidepressants|antidepressants
755485|NCT00421369|Triiodothyronine (T3)|triiodothyronine (t3)
755486|NCT00421369|Thyroid Function|thyroid function
755487|NCT00421369|Augmentation|augmentation
755488|NCT00421369|Thyroid pathway genes|thyroid pathway genes
755489|NCT00421356|amputation, transfemoral, lower extremity, prosthetic knee|amputation, transfemoral, lower extremity, prosthetic knee
755490|NCT00421343|disease/disorder proneness/risk|disease/disorder proneness/risk
755491|NCT00421343|osteoporotic fractures|osteoporotic fractures
755492|NCT00421343|accidental falls|accidental falls
755493|NCT00421343|aging|aging
755494|NCT00421330|Abdominal aortic aneurysm|abdominal aortic aneurysm
755495|NCT00421330|AAA|aaa
755496|NCT00421330|randomised controlled trial|randomised controlled trial
755497|NCT00421330|Endovascular repair|endovascular repair
755498|NCT00421330|conventional open repair|conventional open repair
755499|NCT00421317|Ocular, Metastatic melanoma|ocular, metastatic melanoma
755500|NCT00421265|prostate cancer|prostate cancer
755501|NCT00421265|active surveillance|active surveillance
755502|NCT00421265|indolent features|indolent features
755503|NCT00421252|clopidogrel|clopidogrel
755504|NCT00421252|hemorrhagic complication|hemorrhagic complication
755505|NCT00421252|vascular complication|vascular complication
755506|NCT00421252|antiplatelet agent|antiplatelet agent
755507|NCT00421252|stenting|stenting
755508|NCT00421252|percutaneous coronary intervention|percutaneous coronary intervention
755509|NCT00421252|risk|risk
755510|NCT00421252|ischemia|ischemia
755511|NCT00421252|troponin|troponin
755512|NCT00421252|sheath size|sheath size
755513|NCT00421239|hypertensive urgency|hypertensive urgency
755514|NCT00421239|arterial hypertension|arterial hypertension
755515|NCT00421226|Safety, tolerability, pharmacokinetics, pharmacodynamics, ACZ885, Japanese,|safety, tolerability, pharmacokinetics, pharmacodynamics, acz885, japanese,
755516|NCT00421213|APL|apl
755517|NCT00421213|Lymphoma|lymphoma
755518|NCT00421213|T-cell Lymphoma|t-cell lymphoma
755519|NCT00421213|Peripheral T-cell Lymphoma|peripheral t-cell lymphoma
755520|NCT00421200|Hip arthroplasty|hip arthroplasty
755521|NCT00421200|Anesthesia, spinal|anesthesia, spinal
755522|NCT00421200|Hypotension|hypotension
755523|NCT00421200|Ischemia|ischemia
755524|NCT00421200|Blood substitutes|blood substitutes
755525|NCT00421200|Plasma expanders|plasma expanders
755526|NCT00421187|Antibiotic resistant neutropenic fever|antibiotic resistant neutropenic fever
755527|NCT00421187|ARNF|arnf
755528|NCT00421187|Ambisome|ambisome
755529|NCT00421187|Liposomal amphotericin B|liposomal amphotericin b
755530|NCT00421174|Etanercept|etanercept
755531|NCT00421174|IPS|ips
755532|NCT00421161|olive oil|olive oil
755533|NCT00421161|stasis dermatitis|stasis dermatitis
755534|NCT00421161|Patients with stasis dermatitis for at least six months.|patients with stasis dermatitis for at least six months.
755535|NCT00421122|Chinese patients|chinese patients
755536|NCT00421122|COPD|copd
755537|NCT00421109|Urticaria|urticaria
755538|NCT00421109|Hives|hives
755539|NCT00421109|Wheals|wheals
755540|NCT00421109|Flare|flare
755541|NCT00421109|Chronic|chronic
755542|NCT00421109|Idiopathic|idiopathic
755543|NCT00421109|Erythema|erythema
755544|NCT00421109|Skin diseases, vascular|skin diseases, vascular
755545|NCT00421109|Hypersensitivity, Immediate|hypersensitivity, immediate
755546|NCT00421109|Allergic|allergic
755547|NCT00421109|Cutaneous|cutaneous
755548|NCT00421096|uterine cervical cancer|uterine cervical cancer
755549|NCT00421083|Erectile dysfunction as a result of traumatic spinal cord injury|erectile dysfunction as a result of traumatic spinal cord injury
755550|NCT00421070|Aggression|aggression
755551|NCT00421070|Massage|massage
755552|NCT00421070|Stress|stress
755553|NCT00421070|Psychiatric inpatient|psychiatric inpatient
755554|NCT00421057|Breast Cancer|breast cancer
755555|NCT00421057|Cancer-Related Fatigue|cancer-related fatigue
755556|NCT00421057|Fatigue|fatigue
755557|NCT00421057|Exercise|exercise
755558|NCT00421057|Strength Training|strength training
755559|NCT00421057|Endurance Exercise|endurance exercise
755560|NCT00421057|Questionnaire|questionnaire
755561|NCT00421057|Survey|survey
755562|NCT00421044|EPO|epo
755563|NCT00421044|Patupilone|patupilone
755564|NCT00421044|Solid Tumors|solid tumors
755565|NCT00421018|Asthma|asthma
755566|NCT00421018|Allergy|allergy
755567|NCT00421018|Cytokines|cytokines
755568|NCT00421018|Glucocorticoids|glucocorticoids
755569|NCT00421018|Inflammation|inflammation
755570|NCT00421018|Nitric Oxide (NO)|nitric oxide (no)
755571|NCT00421018|Quality of Life|quality of life
755572|NCT00421018|Self-Rated Health|self-rated health
755573|NCT00421018|Stress|stress
755574|NCT00420992|hip|hip
755575|NCT00420992|knee|knee
755576|NCT00420992|pain|pain
755577|NCT00420992|osteoarthritis|osteoarthritis
755578|NCT00420992|OA|oa
755579|NCT00420992|Kadian|kadian
755580|NCT00420992|Alpharma|alpharma
755581|NCT00420992|naltrexone|naltrexone
755582|NCT00420992|Opioid|opioid
755583|NCT00420992|morphine|morphine
755584|NCT00420992|Embeda|embeda
755585|NCT00420992|ALO-01|alo-01
755586|NCT00420966|lower respiratory tract infection|lower respiratory tract infection
755587|NCT00420966|respiratory syncytial virus infections|respiratory syncytial virus infections
755588|NCT00420966|palivizumab|palivizumab
755589|NCT00420966|outcomes|outcomes
755590|NCT00420966|utilization|utilization
755591|NCT00420966|compliance|compliance
755592|NCT00420940|vibration|vibration
755593|NCT00420940|mechanical loading|mechanical loading
755594|NCT00420940|bone mineral density|bone mineral density
755595|NCT00420940|women's health|women's health
755596|NCT00420940|osteoporosis|osteoporosis
755597|NCT00420927|Early Rheumatoid Arthritis|early rheumatoid arthritis
755598|NCT00420927|Tumor Necrosis Factor Optimization|tumor necrosis factor optimization
755599|NCT00420914|Thrombocytopenia|thrombocytopenia
755600|NCT00420914|Platelets|platelets
755601|NCT00420914|Dose|dose
755602|NCT00420914|Bleeding|bleeding
755603|NCT00420901|function|function
755604|NCT00420901|inhibition|inhibition
756106|NCT00418665|Revlimid|revlimid
755605|NCT00420875|plantar fasciitis|plantar fasciitis
755606|NCT00420875|plantar fasciosis|plantar fasciosis
755607|NCT00420875|Achilles tendinosis|achilles tendinosis
755608|NCT00420875|Achilles tendinitis|achilles tendinitis
755609|NCT00420875|heel pain|heel pain
755610|NCT00420875|fasciosis|fasciosis
755611|NCT00420875|fasciitis|fasciitis
755612|NCT00420875|tendinosis|tendinosis
755613|NCT00420875|tendinitis|tendinitis
755614|NCT00420875|conservative treatment|conservative treatment
755615|NCT00420862|Lung neoplasms|lung neoplasms
755616|NCT00420862|Early diagnosis|early diagnosis
755617|NCT00420862|Screening|screening
755618|NCT00420862|Spiral Computed Tomography|spiral computed tomography
755619|NCT00420862|Randomized Controlled Trial|randomized controlled trial
755620|NCT00420836|Cystic fibrosis, tobramycin, PARI eFlow, PARI LC Plus, nebulizer, pharmacokinetic|cystic fibrosis, tobramycin, pari eflow, pari lc plus, nebulizer, pharmacokinetic
755621|NCT00420823|First Episode Psychosis|first episode psychosis
755622|NCT00420797|Faecal seepage|faecal seepage
755623|NCT00420797|ileal pouch anal anastomosis (IPAA)|ileal pouch anal anastomosis (ipaa)
755624|NCT00420797|quality of life|quality of life
755625|NCT00420797|faecal incontinence|faecal incontinence
755626|NCT00420797|ileo-anal pouch construction|ileo-anal pouch construction
755627|NCT00420797|phenylephrine hydrochloride gel|phenylephrine hydrochloride gel
755628|NCT00420797|IPAA-related faecal incontinence|ipaa-related faecal incontinence
755629|NCT00420797|placebo|placebo
755630|NCT00420784|Genotype 1|genotype 1
755631|NCT00420771|Benzodiazepine|benzodiazepine
755632|NCT00420771|Gabapentin|gabapentin
755633|NCT00420771|Methadone|methadone
755634|NCT00420758|Infant|infant
755635|NCT00420758|Malnutrition|malnutrition
755636|NCT00420758|Sub-Saharan Africa|sub-saharan africa
755637|NCT00420758|Treatment|treatment
755638|NCT00420758|Growth|growth
755639|NCT00420758|Haemoglobin|haemoglobin
755640|NCT00420758|Fortified spread|fortified spread
755641|NCT00420758|Food supplement|food supplement
755642|NCT00420719|ALS|als
755643|NCT00420719|Amyotrophic Lateral Sclerosis|amyotrophic lateral sclerosis
755644|NCT00420719|Lou Gehrig's disease|lou gehrig's disease
755645|NCT00420719|Diaphragm for Ventilatory Assist|diaphragm for ventilatory assist
755646|NCT00420719|Diaphragm Pacing|diaphragm pacing
755647|NCT00420667|unfractionated heparin|unfractionated heparin
755648|NCT00420667|enoxaparin|enoxaparin
755649|NCT00420667|low molecular weight heparin|low molecular weight heparin
755650|NCT00420667|bypass surgery|bypass surgery
755651|NCT00420667|bleeding|bleeding
755652|NCT00420654|Turner syndrome|turner syndrome
755653|NCT00420654|growth hormone treatment|growth hormone treatment
755654|NCT00420654|positron emission tomography|positron emission tomography
755655|NCT00420654|heart|heart
755656|NCT00420641|MDD|mdd
755657|NCT00420641|flexible-dose|flexible-dose
755658|NCT00420641|Major Depressive Disorder|major depressive disorder
755659|NCT00420641|paroxetine|paroxetine
755660|NCT00420641|GSK372475|gsk372475
755661|NCT00420615|Cancer|cancer
755662|NCT00420615|EPO906|epo906
755663|NCT00420615|Patupilone|patupilone
755664|NCT00420589|Weight loss|weight loss
755665|NCT00420589|Weight regain|weight regain
755666|NCT00420589|Weight maintenance|weight maintenance
755667|NCT00420576|Post-menopausal|post-menopausal
755668|NCT00420576|Traditional Chinese Medicine|traditional chinese medicine
755669|NCT00420576|Randomized|randomized
755670|NCT00420563|Cancer, palliative treatment|cancer, palliative treatment
755671|NCT00420550|Interstitial Cystitis|interstitial cystitis
755672|NCT00420550|Pelvic pain|pelvic pain
755673|NCT00420550|Guided Imagery|guided imagery
755674|NCT00420537|Kidney|kidney
755675|NCT00420537|Heart Transplantation|heart transplantation
755676|NCT00420537|Creatinine|creatinine
755677|NCT00420537|Glomerular Filtration Rate|glomerular filtration rate
755678|NCT00420524|EPO|epo
755679|NCT00420524|Patupilone|patupilone
755680|NCT00420524|Solid Tumors|solid tumors
755681|NCT00420511|Type 2 diabetes|type 2 diabetes
755682|NCT00420511|beta-cell function|beta-cell function
755683|NCT00420511|sitagliptin|sitagliptin
755684|NCT00420511|intensive insulin therapy|intensive insulin therapy
755685|NCT00420498|Schizophrenia|schizophrenia
755686|NCT00420498|Prefrontal Cortical Function|prefrontal cortical function
755687|NCT00420498|Smoking|smoking
755688|NCT00420498|Cognition|cognition
755689|NCT00420498|Positive and Negative Symptoms|positive and negative symptoms
755690|NCT00420498|Tobacco|tobacco
755691|NCT00420498|Cigarette Smoking|cigarette smoking
755692|NCT00420498|Dopamine|dopamine
755693|NCT00420485|Maximum Tolerated Dose|maximum tolerated dose
755694|NCT00420485|Solid Tumors|solid tumors
755695|NCT00420485|Dose Limiting Toxicity|dose limiting toxicity
755696|NCT00420485|Topoisomerase-1 Inhibitor|topoisomerase-1 inhibitor
755697|NCT00420433|Breast Cancer|breast cancer
755698|NCT00420433|Bone Metastases|bone metastases
755701|NCT00420433|Computed Tomography|computed tomography
755702|NCT00420433|CT Scan|ct scan
755703|NCT00420433|Skeletal Scintigraphy|skeletal scintigraphy
755704|NCT00420394|Neoadjuvant chemotherapy|neoadjuvant chemotherapy
755705|NCT00420394|Adjuvant chemoradiotherapy|adjuvant chemoradiotherapy
755706|NCT00420394|Adenocarcinoma of stomach and gastroesophageal junction|adenocarcinoma of stomach and gastroesophageal junction
755707|NCT00420381|Recurrent Cancer|recurrent cancer
755708|NCT00420368|Infant|infant
755709|NCT00420368|Malnutrition|malnutrition
755710|NCT00420368|Sub-Saharan Africa|sub-saharan africa
755711|NCT00420368|Treatment|treatment
755712|NCT00420368|Growth|growth
755713|NCT00420368|Haemoglobin|haemoglobin
755714|NCT00420368|Fortified spread|fortified spread
755715|NCT00420368|Food supplement|food supplement
755716|NCT00420355|antiretroviral therapy|antiretroviral therapy
755717|NCT00420355|protease inhibitors|protease inhibitors
755718|NCT00420355|drug interactions|drug interactions
755719|NCT00420355|HIV infection|hiv infection
755720|NCT00420355|acquired immunodeficiency syndrome|acquired immunodeficiency syndrome
755721|NCT00420355|Treatment Experienced|treatment experienced
755722|NCT00420342|Pre-Hypertension in Postmenopausal Women|pre-hypertension in postmenopausal women
755723|NCT00420316|Intussusception|intussusception
755724|NCT00420316|Gastroenteritis|gastroenteritis
755725|NCT00420316|Finland|finland
755726|NCT00420303|Refractory Heel Enthesitis in Spondylarthropathy|refractory heel enthesitis in spondylarthropathy
755727|NCT00420303|Spondylarthropathy|spondylarthropathy
755728|NCT00420303|Refractory Heel Enthesitis|refractory heel enthesitis
755729|NCT00420290|inflammation|inflammation
755730|NCT00420290|end stage renal disease|end stage renal disease
755731|NCT00420277|Hip arthroplasty|hip arthroplasty
755732|NCT00420277|Anesthesia, spinal|anesthesia, spinal
755733|NCT00420277|Hypotension|hypotension
755734|NCT00420277|Ischemia|ischemia
755735|NCT00420277|Blood substitutes|blood substitutes
755736|NCT00420277|Plasma expanders|plasma expanders
755737|NCT00420238|Axial Ankylosing Spondylitis|axial ankylosing spondylitis
755738|NCT00420238|Adult|adult
755739|NCT00420225|Cystocele|cystocele
755740|NCT00420225|surgery|surgery
755741|NCT00420225|mesh|mesh
755742|NCT00420225|genital prolapse|genital prolapse
755743|NCT00420212|relapsing|relapsing
755744|NCT00420212|oral|oral
755745|NCT00420212|remitting|remitting
755746|NCT00420212|multiple sclerosis|multiple sclerosis
755747|NCT00420173|cutaneous lupus erythematosus|cutaneous lupus erythematosus
755748|NCT00420173|standardized evaluation|standardized evaluation
755749|NCT00420173|core set questionnaire|core set questionnaire
755750|NCT00420173|epidemiological data|epidemiological data
755751|NCT00420173|laboratory features|laboratory features
755752|NCT00420160|Smoking cessation|smoking cessation
755753|NCT00420160|Exercise|exercise
755754|NCT00420160|Nicotine Patch|nicotine patch
755755|NCT00420160|Disease Prevention|disease prevention
755756|NCT00420147|knee osteoarthritis|knee osteoarthritis
755757|NCT00420147|orthosis|orthosis
755758|NCT00420147|wedge|wedge
755759|NCT00420147|gait|gait
755760|NCT00420134|mesenchymal stem cell|mesenchymal stem cell
755761|NCT00420134|end stage liver disease|end stage liver disease
755762|NCT00420134|Cirrhosis|cirrhosis
755763|NCT00420134|stem cell therapy|stem cell therapy
755764|NCT00420121|standardized evaluation|standardized evaluation
755765|NCT00420121|core set questionnaire|core set questionnaire
755766|NCT00420121|epidemiological data|epidemiological data
755767|NCT00420121|laboratory analysis|laboratory analysis
755768|NCT00420108|Heart Failure, Congestive|heart failure, congestive
755769|NCT00420108|Cardiac Pacemaker, Artificial|cardiac pacemaker, artificial
755770|NCT00420108|Ventricular Pressure|ventricular pressure
755771|NCT00420095|diabetes|diabetes
755772|NCT00420095|type 1|type 1
755773|NCT00420095|type 2|type 2
755774|NCT00420082|Rhinitis|rhinitis
755775|NCT00420082|Seasonal|seasonal
755776|NCT00420082|Allergic|allergic
755777|NCT00420082|Pollen allergy|pollen allergy
755778|NCT00420082|Environmental Exposure Chamber|environmental exposure chamber
755779|NCT00420082|Challenge Chamber|challenge chamber
755780|NCT00420043|Food effect|food effect
755781|NCT00420043|bioavailability|bioavailability
755782|NCT00420043|pharmacokinetic|pharmacokinetic
755783|NCT00420043|STI571|sti571
755784|NCT00420043|modified release formulation of STI571|modified release formulation of sti571
755785|NCT00420043|CML|cml
755786|NCT00420043|Chronic Myeloid Leukemia|chronic myeloid leukemia
755787|NCT00420043|Philadelphia Chromosome|philadelphia chromosome
755788|NCT00420043|imatinib|imatinib
755789|NCT00420030|upfront abciximab|upfront abciximab
755790|NCT00420030|PCI|pci
755791|NCT00420030|cardiogenic shock|cardiogenic shock
755792|NCT00420017|Amiodarone|amiodarone
755793|NCT00420017|Atrial fibrillation|atrial fibrillation
755794|NCT00420017|Surgical procedures, thoracic|surgical procedures, thoracic
755795|NCT00419991|Tigecycline|tigecycline
755796|NCT00419991|Staphylococcal Infections|staphylococcal infections
755797|NCT00419991|Catheter|catheter
755798|NCT00419952|Moderate Asthma|moderate asthma
755799|NCT00419952|Severe Asthma|severe asthma
755800|NCT00419939|Severe traumatic brain injury|severe traumatic brain injury
755801|NCT00419939|Intensive neurorehabilitation|intensive neurorehabilitation
755802|NCT00419939|"Patient Participation[Professional-Patient Relations"|"patient participation[professional-patient relations"
755804|NCT00419939|Daily life activities|daily life activities
755805|NCT00419939|Rehabilitation|rehabilitation
755806|NCT00419926|Renal, Kidney, Intensified, Enteric-coated mycophenolate sodium, Transplant|renal, kidney, intensified, enteric-coated mycophenolate sodium, transplant
755807|NCT00419913|Ovulation Induction|ovulation induction
755808|NCT00419913|In vitro Fertilization|in vitro fertilization
755809|NCT00419913|Pregnancy|pregnancy
755810|NCT00419900|breast cancer|breast cancer
755811|NCT00419900|diagnosis|diagnosis
755812|NCT00419900|x-ray diffraction|x-ray diffraction
755813|NCT00419900|synchrotron|synchrotron
755814|NCT00419900|hair|hair
755815|NCT00419887|Safety, tolerability, pharmacokinetics, pharmacodynamics, LAF237, vildagliptin, Chinese, healthy volunteers|safety, tolerability, pharmacokinetics, pharmacodynamics, laf237, vildagliptin, chinese, healthy volunteers
755816|NCT00419874|Blood-brain barrier|blood-brain barrier
755817|NCT00419874|Post traumatic epilepsy|post traumatic epilepsy
755818|NCT00419874|Seizures|seizures
755819|NCT00419861|Influenza, surveillance, flu, parent protocol|influenza, surveillance, flu, parent protocol
755820|NCT00419848|Acne|acne
755821|NCT00419848|Azithromycin|azithromycin
755822|NCT00419848|Doxycycline|doxycycline
755823|NCT00419835|diabetic nephropathy|diabetic nephropathy
755824|NCT00419835|proteinuria|proteinuria
755825|NCT00419835|CKD progression|ckd progression
755826|NCT00419835|dialysis|dialysis
755827|NCT00419822|Acupuncture|acupuncture
755828|NCT00419822|Range of Motion|range of motion
755829|NCT00419822|Quality of Life|quality of life
755830|NCT00419809|methotrexate,|methotrexate,
755831|NCT00419809|SB-681323,|sb-681323,
755832|NCT00419809|p38 MAP Kinase Inhibitor,|p38 map kinase inhibitor,
755833|NCT00419809|liver function|liver function
755834|NCT00419809|Rheumatoid Arthritis,|rheumatoid arthritis,
755835|NCT00419796|Osteoarthritis, controlled hypertension, lumiracoxib, ibuprofen, high blood pressure|osteoarthritis, controlled hypertension, lumiracoxib, ibuprofen, high blood pressure
755836|NCT00419783|Allergic rhinitis|allergic rhinitis
755837|NCT00419783|Urticaria|urticaria
755838|NCT00419770|zygomycosis|zygomycosis
755839|NCT00419770|Rhizopus|rhizopus
755840|NCT00419770|iron|iron
755841|NCT00419770|iron-chelation|iron-chelation
755842|NCT00419770|adjunctive therapy|adjunctive therapy
755843|NCT00419757|Moderate asthma|moderate asthma
755844|NCT00419757|Severe asthma|severe asthma
755845|NCT00419744|COPD|copd
755846|NCT00419731|nicotine|nicotine
755847|NCT00419731|smoking|smoking
755848|NCT00419731|addiction|addiction
755849|NCT00419705|acute stroke|acute stroke
755850|NCT00419705|infrared laser therapy|infrared laser therapy
755851|NCT00419705|clinical trial|clinical trial
755852|NCT00419705|safety|safety
755853|NCT00419705|effectiveness|effectiveness
755854|NCT00419692|pharmacokinetic,|pharmacokinetic,
755855|NCT00419692|RLS|rls
755856|NCT00419692|formulation,|formulation,
755857|NCT00419692|food effect,|food effect,
755858|NCT00419692|controlled release for RLS,|controlled release for rls,
755859|NCT00419692|SK&F101468,|sk&f101468,
755860|NCT00419679|breast cancer|breast cancer
755861|NCT00419679|hair|hair
755862|NCT00419679|fibre|fibre
755863|NCT00419679|synchrotron|synchrotron
755864|NCT00419679|x-ray diffraction|x-ray diffraction
755865|NCT00419666|Calcitriol|calcitriol
755866|NCT00419666|Psoriasis|psoriasis
755867|NCT00419666|PK|pk
755868|NCT00419666|Adolescents|adolescents
755869|NCT00419653|schizophrenia fMRI drug therapy amisulpride|schizophrenia fmri drug therapy amisulpride
755870|NCT00419640|Sinus node disease|sinus node disease
755871|NCT00419640|AV node disease|av node disease
755872|NCT00419627|proteomics of solid tumors|proteomics of solid tumors
755873|NCT00419601|ventilated newborns (≥ 36 SSW)and infants (≤60 days)|ventilated newborns (≥ 36 ssw)and infants (≤60 days)
755874|NCT00419601|of any medical condition|of any medical condition
755875|NCT00419588|infant, premature|infant, premature
755876|NCT00419588|Bronchopulmonary dysplasia|bronchopulmonary dysplasia
755877|NCT00419588|asthma|asthma
755878|NCT00419575|renal|renal
755879|NCT00419575|transplantation|transplantation
755880|NCT00419575|immunosuppression|immunosuppression
755881|NCT00419575|monitoring|monitoring
755882|NCT00419562|oral insulin|oral insulin
755883|NCT00419562|autoantigen|autoantigen
755884|NCT00419562|self tolerance|self tolerance
755885|NCT00419562|oral tolerance|oral tolerance
755886|NCT00419562|DPT-1|dpt-1
755887|NCT00419562|prevention|prevention
755888|NCT00419562|"at risk for developing type 1 diabetes"|"at risk for developing type 1 diabetes"
755889|NCT00419562|juvenile diabetes|juvenile diabetes
755890|NCT00419562|T1D|t1d
755891|NCT00419562|diabetes mellitus|diabetes mellitus
755892|NCT00419562|Type 1 diabetes TrialNet|type 1 diabetes trialnet
755893|NCT00419562|TrialNet|trialnet
755894|NCT00419549|ERCP|ercp
755895|NCT00419549|Pancreatitis|pancreatitis
755896|NCT00419549|Nitroglycerine|nitroglycerine
755897|NCT00419549|Valdecoxib|valdecoxib
755898|NCT00419536|LBH|lbh
755900|NCT00419536|Prostate Cancer|prostate cancer
755901|NCT00419536|HRPC|hrpc
755902|NCT00419510|Genetic counseling|genetic counseling
755903|NCT00419510|BRCA1 and BRCA2|brca1 and brca2
755904|NCT00419510|African American|african american
755905|NCT00419497|Paleolithic diet|paleolithic diet
755906|NCT00419497|Mediterranean-style diet|mediterranean-style diet
755907|NCT00419497|Glucose tolerance|glucose tolerance
755908|NCT00419497|Diabetes type 2|diabetes type 2
755909|NCT00419497|Weight loss|weight loss
755910|NCT00419497|Waist|waist
755911|NCT00419471|Depression|depression
755912|NCT00419471|Myocardial infarction|myocardial infarction
755913|NCT00419471|Angina, unstable|angina, unstable
755914|NCT00419458|ventilator weaning|ventilator weaning
755915|NCT00419458|weaning|weaning
755916|NCT00419458|respiratory failure|respiratory failure
755917|NCT00419458|inspiratory muscle strength training|inspiratory muscle strength training
755918|NCT00419445|Attention Deficit Hyperactivity Disorder in adults|attention deficit hyperactivity disorder in adults
755919|NCT00419432|Pediatrics|pediatrics
755920|NCT00419432|Cerebral Palsy|cerebral palsy
755921|NCT00419432|Gait Analysis|gait analysis
755922|NCT00419432|Orthopedic Surgery|orthopedic surgery
755923|NCT00419419|Raynaud's|raynaud's
755924|NCT00419406|UVA1|uva1
755925|NCT00419406|N-B UVB|n-b uvb
755926|NCT00419406|phototherapy|phototherapy
755927|NCT00419406|atopic dermatitis|atopic dermatitis
755928|NCT00419406|SCORAD index|scorad index
755929|NCT00419393|Keppra XR|keppra xr
755930|NCT00419393|Levetiracetam XR|levetiracetam xr
755931|NCT00419393|long term|long term
755932|NCT00419393|partial seizures|partial seizures
755933|NCT00419380|clogged ear tubes|clogged ear tubes
755934|NCT00419354|Pacemaker|pacemaker
755935|NCT00419354|Tricuspid regurgitation|tricuspid regurgitation
755936|NCT00419341|Immune globulin subcutaneous|immune globulin subcutaneous
755937|NCT00419341|SCIG|scig
755938|NCT00419341|Primary immunodeficiency|primary immunodeficiency
755940|NCT00419328|solid tumors NGR-hTNF|solid tumors ngr-htnf
755941|NCT00419315|alcoholism|alcoholism
755942|NCT00419315|primary care|primary care
755943|NCT00419315|treatment|treatment
755944|NCT00419289|COPD, rehabilitation, quality of life|copd, rehabilitation, quality of life
755945|NCT00419276|Total knee arthroplasty, postoperative analgesia|total knee arthroplasty, postoperative analgesia
755946|NCT00419276|Primary, unilateral, total knee arthroplasty|primary, unilateral, total knee arthroplasty
755947|NCT00419263|influenza|influenza
755948|NCT00419263|flu|flu
755949|NCT00419250|relapsed|relapsed
755950|NCT00419250|refractory|refractory
755951|NCT00419250|fludarabine|fludarabine
755952|NCT00419250|Revlimid|revlimid
755953|NCT00419250|lenalidomide|lenalidomide
755954|NCT00419250|CLL|cll
755955|NCT00419250|B-cell CLL|b-cell cll
755956|NCT00419250|CC-5013|cc-5013
755957|NCT00419250|Chronic Lymphocytic Leukemia|chronic lymphocytic leukemia
755958|NCT00419237|hepatic impairment pharmacokinetics|hepatic impairment pharmacokinetics
755959|NCT00419224|Peripheral blood stem cell transplantation|peripheral blood stem cell transplantation
755960|NCT00419224|Non-myeloabalative|non-myeloabalative
755961|NCT00419224|Influenza vaccination|influenza vaccination
755962|NCT00419224|Humoral immune response|humoral immune response
755963|NCT00419224|Immunogenicity|immunogenicity
755964|NCT00419211|Pregnancy, Exercise, Depression|pregnancy, exercise, depression
755965|NCT00419198|Ischemia|ischemia
755966|NCT00419198|Reperfusion|reperfusion
755967|NCT00419198|Myocardial infarction|myocardial infarction
755968|NCT00419198|Postconditioning|postconditioning
755969|NCT00419185|macular hole surgery|macular hole surgery
755970|NCT00419185|indocyanine green|indocyanine green
755971|NCT00419185|trypan blue|trypan blue
755972|NCT00419185|internal limiting membrane|internal limiting membrane
755973|NCT00419172|Pharmacokinetics|pharmacokinetics
755974|NCT00419172|Deferasirox|deferasirox
755975|NCT00419172|Exjade|exjade
755976|NCT00419172|ICL670|icl670
755977|NCT00419172|Rifampicin|rifampicin
755978|NCT00419172|Healthy, Volunteers|healthy, volunteers
755979|NCT00419159|Colorectal cancer|colorectal cancer
755980|NCT00419159|metastatic colorectal adenocarcinoma|metastatic colorectal adenocarcinoma
755981|NCT00419159|anti-EGFR antibody|anti-egfr antibody
755982|NCT00419146|Schizophrenia|schizophrenia
755983|NCT00419146|Schizophreniform disorders|schizophreniform disorders
755984|NCT00419146|Schizoaffective disorder|schizoaffective disorder
755985|NCT00419146|Psychotic disorders|psychotic disorders
755986|NCT00419146|Randomized Controlled Trials|randomized controlled trials
755987|NCT00419146|Longitudinal Studies|longitudinal studies
755988|NCT00419146|Fatty Acids, Omega-3|fatty acids, omega-3
755989|NCT00419146|Eicosapentaenoic Acid|eicosapentaenoic acid
755990|NCT00419146|Vitamins|vitamins
755991|NCT00419146|Antioxidants|antioxidants
755992|NCT00419146|Ascorbic Acid|ascorbic acid
755993|NCT00419146|Alpha-Tocopherol|alpha-tocopherol
755994|NCT00419146|Placebos|placebos
755995|NCT00419146|Antipsychotic Agents|antipsychotic agents
755996|NCT00419146|Oxidative Stress|oxidative stress
755997|NCT00419146|Fatty Acids, Unsaturated|fatty acids, unsaturated
755998|NCT00419146|Phospholipases|phospholipases
756000|NCT00419146|Adverse effects|adverse effects
756001|NCT00419146|Delusions|delusions
756002|NCT00419146|Hallucinations|hallucinations
756003|NCT00419146|Neuropsychological Tests|neuropsychological tests
756004|NCT00419146|Attention|attention
756005|NCT00419146|Memory|memory
756006|NCT00419146|Hypertriglyceridemia|hypertriglyceridemia
756007|NCT00419146|Models, Statistical|models, statistical
756008|NCT00419133|Cholera|cholera
756009|NCT00419133|Vaccine|vaccine
756010|NCT00419133|Kolkata|kolkata
756011|NCT00419133|West Bengal|west bengal
756012|NCT00419133|India|india
756013|NCT00419133|Immunogenicity|immunogenicity
756014|NCT00419133|Safety|safety
756015|NCT00419094|Keppra XR|keppra xr
756016|NCT00419094|conversion to monotherapy|conversion to monotherapy
756017|NCT00419094|partial seizures|partial seizures
756018|NCT00419081|leukemia|leukemia
756019|NCT00419081|lymphoma|lymphoma
756020|NCT00419055|percutaneous coronary intervention|percutaneous coronary intervention
756021|NCT00419042|cancer|cancer
756022|NCT00419042|Lung cancer|lung cancer
756023|NCT00419042|None small-cell lung cancer|none small-cell lung cancer
756024|NCT00419029|combat|combat
756025|NCT00419029|depression|depression
756026|NCT00419029|PTSD|ptsd
756027|NCT00419029|substance abuse|substance abuse
756028|NCT00418990|Multivitamin|multivitamin
756029|NCT00418990|Academic performance|academic performance
756030|NCT00418977|Anorexia Nervosa|anorexia nervosa
756031|NCT00418964|Anterior cruciate ligament rupture|anterior cruciate ligament rupture
756032|NCT00418964|Anterior cruciate ligament(A02.513.514.100)|anterior cruciate ligament(a02.513.514.100)
756033|NCT00418951|Voriconazole|voriconazole
756034|NCT00418951|Vfend|vfend
756035|NCT00418951|Liposomal amphotericin B|liposomal amphotericin b
756036|NCT00418951|Ambisome|ambisome
756037|NCT00418951|Acute Myelogenous Leukemia|acute myelogenous leukemia
756038|NCT00418951|Myelodysplastic Syndrome|myelodysplastic syndrome
756039|NCT00418951|AML|aml
756040|NCT00418951|MDS|mds
756041|NCT00418938|EGFR|egfr
756042|NCT00418938|FOLFIRI|folfiri
756043|NCT00418938|2nd Line Therapy|2nd line therapy
756044|NCT00418938|2nd Line mCRC Therapy|2nd line mcrc therapy
756045|NCT00418938|mCRC|mcrc
756046|NCT00418938|Irinotecan|irinotecan
756047|NCT00418938|panitumumab|panitumumab
756048|NCT00418938|bevacizumab|bevacizumab
756049|NCT00418899|Brain Tumor|brain tumor
756050|NCT00418899|Glioma|glioma
756051|NCT00418899|Linkage Study|linkage study
756052|NCT00418899|Survey|survey
756053|NCT00418899|Gliogene|gliogene
756054|NCT00418899|High-risk familial brain tumor pedigrees|high-risk familial brain tumor pedigrees
756055|NCT00418886|NSCLC|nsclc
756056|NCT00418886|Non Small Cell Lung Cancer|non small cell lung cancer
756057|NCT00418873|schizophrenia|schizophrenia
756058|NCT00418873|zotepine|zotepine
756059|NCT00418873|risperidone|risperidone
756060|NCT00418873|second generation antipsychotic|second generation antipsychotic
756061|NCT00418860|Angioplasty, Transluminal, Percutaneous Coronary|angioplasty, transluminal, percutaneous coronary
756062|NCT00418860|Stent thrombosis|stent thrombosis
756063|NCT00418860|Zotarolimus-eluting stent|zotarolimus-eluting stent
756064|NCT00418847|pediatrics|pediatrics
756065|NCT00418847|lysosomal storage diseases|lysosomal storage diseases
756066|NCT00418847|Gangliosidoses GM2|gangliosidoses gm2
756067|NCT00418847|Tay-Sachs disease|tay-sachs disease
756068|NCT00418847|Sandhoff disease|sandhoff disease
756069|NCT00418847|Infantile GM2-activator deficiency|infantile gm2-activator deficiency
756070|NCT00418847|Miglustat|miglustat
756071|NCT00418808|motor|motor
756072|NCT00418808|development|development
756073|NCT00418808|multiple pregnancies|multiple pregnancies
756074|NCT00418808|general movement|general movement
756075|NCT00418808|video recording|video recording
756076|NCT00418795|Acute Intermittent Porphyria|acute intermittent porphyria
756077|NCT00418795|treatment|treatment
756078|NCT00418795|Acute attack|acute attack
756079|NCT00418769|nilotinib|nilotinib
756080|NCT00418769|bioavailability|bioavailability
756081|NCT00418769|tablet|tablet
756082|NCT00418769|capsule|capsule
756083|NCT00418769|PK|pk
756084|NCT00418769|healthy, subject(s),|healthy, subject(s),
756085|NCT00418756|nilotinib|nilotinib
756086|NCT00418756|Rifampin|rifampin
756087|NCT00418756|PK|pk
756088|NCT00418756|healthy subjects|healthy subjects
756089|NCT00418743|cancer|cancer
756090|NCT00418743|Lung cancer|lung cancer
756091|NCT00418743|small-cell lung cancer|small-cell lung cancer
756092|NCT00418730|androgenetic alopecia|androgenetic alopecia
756093|NCT00418730|male pattern hair loss|male pattern hair loss
756094|NCT00418730|male pattern baldness|male pattern baldness
756095|NCT00418730|androgenetic alopecia or male pattern hair loss|androgenetic alopecia or male pattern hair loss
756096|NCT00418704|cancer|cancer
756097|NCT00418704|Lung cancer|lung cancer
756098|NCT00418704|None small-cell lung cancer|none small-cell lung cancer
756099|NCT00418691|Brain Tumor|brain tumor
756100|NCT00418691|Methylphenidate|methylphenidate
756101|NCT00418691|Ritalin|ritalin
756102|NCT00418691|Modafinil|modafinil
756103|NCT00418691|Provigil|provigil
756105|NCT00418691|Concentration|concentration
756107|NCT00418665|Lenalidomide|lenalidomide
756108|NCT00418665|Low Platelet Count|low platelet count
756109|NCT00418665|Low Risk Myelodysplastic Syndrome|low risk myelodysplastic syndrome
756110|NCT00418665|Intermediate 1 Myelodysplastic Syndrome|intermediate 1 myelodysplastic syndrome
756111|NCT00418665|MDS|mds
756112|NCT00418665|Myelodysplastic Syndrome|myelodysplastic syndrome
756113|NCT00418652|Normal Controls|normal controls
756114|NCT00418639|Chronic Hepatitis C|chronic hepatitis c
756115|NCT00418626|nilotinib|nilotinib
756116|NCT00418626|hepatic impairment|hepatic impairment
756117|NCT00418626|Child-Pugh scale|child-pugh scale
756118|NCT00418626|PK|pk
756119|NCT00418626|healthy, subject(s)|healthy, subject(s)
756120|NCT00418626|Subjects with impaired hepatic function and healthy subjects|subjects with impaired hepatic function and healthy subjects
756121|NCT00418600|Secondary Hyperparathyroidism|secondary hyperparathyroidism
756122|NCT00418600|Hectorol® (doxercalciferol capsules)|hectorol® (doxercalciferol capsules)
756123|NCT00418600|Hectorol® (doxercalciferol injection)|hectorol® (doxercalciferol injection)
756124|NCT00418587|Vitamin D|vitamin d
756125|NCT00418587|Lupus|lupus
756126|NCT00418574|Ovarian cancer|ovarian cancer
756127|NCT00418574|Abagovomab|abagovomab
756128|NCT00418561|rhASA|rhasa
756129|NCT00418561|MLD|mld
756130|NCT00418561|Metazym|metazym
756131|NCT00418535|Lymphoma, NK/T-Cell|lymphoma, nk/t-cell
756132|NCT00418522|Insulin Glargine Diabetes HbA1c|insulin glargine diabetes hba1c
756133|NCT00418509|Dose proportionality|dose proportionality
756134|NCT00418509|pharmacokinetics|pharmacokinetics
756135|NCT00418509|mometasone|mometasone
756136|NCT00418509|formoterol|formoterol
756137|NCT00418509|Healthy volunteers study|healthy volunteers study
756138|NCT00418496|Unresectable|unresectable
756139|NCT00418496|Metastatic|metastatic
756140|NCT00418483|thrombolytic|thrombolytic
756141|NCT00418483|thrombolysis|thrombolysis
756142|NCT00418483|acute peripheral arterial occlusion|acute peripheral arterial occlusion
756143|NCT00418483|peripheral vascular disease|peripheral vascular disease
756144|NCT00418483|thrombosis|thrombosis
756145|NCT00418483|endovascular|endovascular
756146|NCT00418470|Cystic fibrosis|cystic fibrosis
756147|NCT00418470|Catheterization, peripheral|catheterization, peripheral
756148|NCT00418470|Phlebitis|phlebitis
756149|NCT00418470|Anti-Bacterial Agents|anti-bacterial agents
756150|NCT00418470|Osmolar Concentration|osmolar concentration
756151|NCT00418457|Breast Cancer|breast cancer
756152|NCT00418457|Anesthesia; regional|anesthesia; regional
756153|NCT00418457|cancer recurrence|cancer recurrence
756154|NCT00418457|Anesthesia; inhalational|anesthesia; inhalational
756155|NCT00418457|Analgesia; opioid|analgesia; opioid
756156|NCT00418444|Breast cancer,group psychotherapy,RCT,women's mental health|breast cancer,group psychotherapy,rct,women's mental health
756157|NCT00418418|Cell transplantation|cell transplantation
756158|NCT00418418|Heart failure|heart failure
756159|NCT00418418|Clinical trials|clinical trials
756160|NCT00418405|Arthritis, Rheumatoid|arthritis, rheumatoid
756161|NCT00418405|Cohort Studies|cohort studies
756162|NCT00418392|pneumothorax, aspiration, minocycline, pleurodesis|pneumothorax, aspiration, minocycline, pleurodesis
756163|NCT00418379|Sublingual immunotherapy|sublingual immunotherapy
756164|NCT00418379|Grass pollen tablet|grass pollen tablet
756165|NCT00418379|Allergic rhinoconjunctivitis|allergic rhinoconjunctivitis
756166|NCT00418366|Mild, moderate, severe renal insufficiency|mild, moderate, severe renal insufficiency
756167|NCT00418366|End stage renal disease|end stage renal disease
756168|NCT00418353|Antenatal corticosteroids|antenatal corticosteroids
756169|NCT00418353|Betamethasone|betamethasone
756170|NCT00418353|Dexamethasone|dexamethasone
756171|NCT00418353|Premature|premature
756172|NCT00418340|Irritable Bowel Syndrome,|irritable bowel syndrome,
756173|NCT00418340|Visceral hypersensitivity,|visceral hypersensitivity,
756174|NCT00418340|probiotic therapy,|probiotic therapy,
756175|NCT00418340|immune response|immune response
756176|NCT00418327|Tarceva|tarceva
756177|NCT00418327|refractory and relapsed malignant brain tumors|refractory and relapsed malignant brain tumors
756178|NCT00418327|newly diagnosed brain stem glioma|newly diagnosed brain stem glioma
756179|NCT00418301|Pain|pain
756180|NCT00418301|Neurostimulation|neurostimulation
756181|NCT00418288|GLP-1|glp-1
756182|NCT00418288|glucose metabolism|glucose metabolism
756183|NCT00418288|Type 2 diabetes|type 2 diabetes
756184|NCT00418288|brain|brain
756185|NCT00418288|PET|pet
756186|NCT00418275|Cerebrovascular Stroke|cerebrovascular stroke
756187|NCT00418262|fetal alcohol syndrome|fetal alcohol syndrome
756188|NCT00418262|attention deficit disorder|attention deficit disorder
756189|NCT00418262|attention deficit disorder with hyperactivity|attention deficit disorder with hyperactivity
756190|NCT00418262|ADD|add
756191|NCT00418262|FAS|fas
756192|NCT00418262|FASD|fasd
756193|NCT00418262|ADHD|adhd
756194|NCT00418249|Androgenetic Alopecia|androgenetic alopecia
756195|NCT00418249|Telogen effluvium|telogen effluvium
756196|NCT00418249|Chronic telogen effluvium|chronic telogen effluvium
756197|NCT00418249|Menopause|menopause
756198|NCT00418249|Female Androgenetic Alopecia (FAGA)|female androgenetic alopecia (faga)
756199|NCT00418223|Urinary retention|urinary retention
756201|NCT00418223|Catheterization|catheterization
756202|NCT00418223|Ultrasound|ultrasound
756203|NCT00418210|Accelerated Partial Breast Irradiation|accelerated partial breast irradiation
756204|NCT00418210|Conformal Radiation Therapy|conformal radiation therapy
756205|NCT00418210|Feasibility|feasibility
756206|NCT00418210|Early breast cancer|early breast cancer
756207|NCT00418197|spinal stenosis|spinal stenosis
756208|NCT00418197|low back pain|low back pain
756209|NCT00418197|spondylolisthesis|spondylolisthesis
756210|NCT00418197|lumbar spinal stenosis|lumbar spinal stenosis
756211|NCT00418197|leg pain|leg pain
756212|NCT00418197|spinal diseases|spinal diseases
756213|NCT00418184|ADHD|adhd
756214|NCT00418184|inattentive|inattentive
756215|NCT00418184|impulsive|impulsive
756216|NCT00418184|hyperactive|hyperactive
756217|NCT00418184|poor academic performance|poor academic performance
756218|NCT00418184|poor self-discipline|poor self-discipline
756219|NCT00418184|low self-esteem|low self-esteem
756220|NCT00418158|Pulmonary complications|pulmonary complications
756221|NCT00418145|Relapsing Forms of Multiple Sclerosis|relapsing forms of multiple sclerosis
756222|NCT00418132|SSc|ssc
756223|NCT00418132|Systemic Sclerosis|systemic sclerosis
756224|NCT00418132|Progressive Systemic Sclerosis|progressive systemic sclerosis
756225|NCT00418106|Premature birth|premature birth
756226|NCT00418106|Pumping breast milk|pumping breast milk
756227|NCT00418106|Kangaroo holding|kangaroo holding
756228|NCT00418093|mullerian carcinoma|mullerian carcinoma
756229|NCT00418067|Coronary Artery Disease|coronary artery disease
756230|NCT00418067|Stent|stent
756231|NCT00418028|capecitabine|capecitabine
756232|NCT00418028|schedule|schedule
756233|NCT00418028|breast cancer|breast cancer
756234|NCT00418015|µ-opioid receptor|µ-opioid receptor
756235|NCT00418015|neuraxial labor analgesia|neuraxial labor analgesia
756236|NCT00418015|pharmacogenetics|pharmacogenetics
756237|NCT00418002|Single-rising dose , multiple rising dose, elderly, cognitive, , pharmacokinetic, impairment.|single-rising dose , multiple rising dose, elderly, cognitive, , pharmacokinetic, impairment.
756238|NCT00418002|Healthy elderly male and female subjects|healthy elderly male and female subjects
756239|NCT00417989|Glycemic control|glycemic control
756240|NCT00417989|Sensor|sensor
756241|NCT00417976|Advanced Pancreatic Cancer|advanced pancreatic cancer
756242|NCT00417963|Carotid|carotid
756243|NCT00417963|Artery|artery
756244|NCT00417963|Stenosis|stenosis
756245|NCT00417950|diabetes|diabetes
756246|NCT00417950|acarbose|acarbose
756247|NCT00417950|alcohol|alcohol
756248|NCT00417950|inflammation|inflammation
756249|NCT00417950|oxidative stress|oxidative stress
756250|NCT00417950|Mild diabetes mellitus|mild diabetes mellitus
756251|NCT00417924|Patient education|patient education
756252|NCT00417924|Patient satisfaction|patient satisfaction
756253|NCT00417924|Eye health|eye health
756254|NCT00417911|multiple myeloma|multiple myeloma
756255|NCT00417911|autologous stem cell transplantation|autologous stem cell transplantation
756256|NCT00417911|high-dose melphalan|high-dose melphalan
756257|NCT00417911|bortezomib|bortezomib
756258|NCT00417911|consolidation|consolidation
756259|NCT00417911|event free survival|event free survival
756260|NCT00417911|phase III|phase iii
756261|NCT00417898|Stroke|stroke
756262|NCT00417898|Cerebral Ischemia|cerebral ischemia
756263|NCT00417898|Tissue Plasminogen Activator|tissue plasminogen activator
756264|NCT00417898|Aspirin|aspirin
756265|NCT00417898|Human|human
756266|NCT00417898|Cerebral Reperfusion|cerebral reperfusion
756267|NCT00417872|Clostridium difficile|clostridium difficile
756268|NCT00417846|Age-Related Macular Degeneration|age-related macular degeneration
756269|NCT00417846|Optical Coherence Tomography, OCT|optical coherence tomography, oct
756270|NCT00417846|Preferential Hyperacuity Perimeter, PHP|preferential hyperacuity perimeter, php
756271|NCT00417846|Amsler Grid|amsler grid
756272|NCT00417820|Safety, tolerability, pharmacodynamics, single administration, BCT194, healthy volunteers, psoriasis|safety, tolerability, pharmacodynamics, single administration, bct194, healthy volunteers, psoriasis
756273|NCT00417807|refractory desmoplastic small round cell tumors|refractory desmoplastic small round cell tumors
756274|NCT00417807|PDGF-R|pdgf-r
756275|NCT00417794|attention deficit hyperactivity disorder|attention deficit hyperactivity disorder
756276|NCT00417794|ADHD|adhd
756277|NCT00417794|fetal alcohol syndrome|fetal alcohol syndrome
756278|NCT00417794|FAS|fas
756279|NCT00417794|FASD|fasd
756280|NCT00417794|atomoxetine hcl|atomoxetine hcl
756281|NCT00417781|ADHD, adolescence, family study, endophenotype, outcome|adhd, adolescence, family study, endophenotype, outcome
756282|NCT00417768|tissue plasminogen activator|tissue plasminogen activator
756283|NCT00417768|intraabdominal|intraabdominal
756284|NCT00417768|abscess|abscess
756285|NCT00417768|percutaneous drainage|percutaneous drainage
756286|NCT00417755|Nutritional intake|nutritional intake
756287|NCT00417755|Mechanical ventilation|mechanical ventilation
756288|NCT00417755|Enteral feeding|enteral feeding
756289|NCT00417742|headache|headache
756290|NCT00417742|migraine headache|migraine headache
756291|NCT00417742|tension headache|tension headache
756292|NCT00417729|Diabetes|diabetes
756293|NCT00417729|Acarobse|acarobse
756294|NCT00417729|Metformin|metformin
756295|NCT00417729|oxidative stress|oxidative stress
756296|NCT00417729|Mean amplitude Glycemic Excursion|mean amplitude glycemic excursion
756297|NCT00417729|Meal test|meal test
756298|NCT00417716|Diffuse Diabetic Macular Edema|diffuse diabetic macular edema
756299|NCT00417716|Intravitreal Bevacizumab|intravitreal bevacizumab
756300|NCT00417716|Anti-VEGF drugs|anti-vegf drugs
756301|NCT00417703|Intraocular Pressure|intraocular pressure
756302|NCT00417703|Intravitreous Injection|intravitreous injection
756303|NCT00417703|Ranibizumab|ranibizumab
756304|NCT00417690|Crohn's Disease|crohn's disease
756305|NCT00417690|Acute Flare|acute flare
756306|NCT00417690|Mild to moderate Crohn's Disease|mild to moderate crohn's disease
756307|NCT00417690|Ileocecal distribution|ileocecal distribution
756308|NCT00417677|Advanced Renal Carcinoma|advanced renal carcinoma
756309|NCT00417664|cardiac surgery|cardiac surgery
756310|NCT00417664|valvular surgery|valvular surgery
756311|NCT00417664|delirium|delirium
756312|NCT00417664|postoperative delirium|postoperative delirium
756313|NCT00417664|cognitive dysfunction|cognitive dysfunction
756314|NCT00417664|altered mental status|altered mental status
756315|NCT00417651|Bacterial|bacterial
756316|NCT00417651|contamination|contamination
756317|NCT00417651|gastrotomy|gastrotomy
756318|NCT00417651|Complications|complications
756319|NCT00417638|myocardial infarction|myocardial infarction
756320|NCT00417638|acute intervention|acute intervention
756321|NCT00417638|percutaneous intervention|percutaneous intervention
756322|NCT00417638|endovascular cooling|endovascular cooling
756323|NCT00417638|endovascular rewarming|endovascular rewarming
756324|NCT00417625|Coronary Artery Perfusion|coronary artery perfusion
756325|NCT00417625|MRI|mri
756326|NCT00417625|Fractional Flow Reserve|fractional flow reserve
756327|NCT00417625|Coronary Flow Reserve|coronary flow reserve
756328|NCT00417625|Collateral Artery Perfusion|collateral artery perfusion
756329|NCT00417625|Cardiovascular Disease|cardiovascular disease
756330|NCT00417625|Coronary Artery Disease|coronary artery disease
756331|NCT00417625|CAD|cad
756332|NCT00417612|Rickets, Hypophosphatemia|rickets, hypophosphatemia
756333|NCT00417612|Rickets, Vitamin D-Resistant|rickets, vitamin d-resistant
756334|NCT00417612|Rickets, X-linked hypophosphatemic|rickets, x-linked hypophosphatemic
756335|NCT00417599|Prevention of overweight|prevention of overweight
756336|NCT00417599|Prevention of obesity|prevention of obesity
756337|NCT00417599|Treatment of overweight|treatment of overweight
756338|NCT00417599|Treatment of obesity|treatment of obesity
756339|NCT00417586|Stroke|stroke
756340|NCT00417573|Immunodeficiency|immunodeficiency
756341|NCT00417573|Gammaglobulin|gammaglobulin
756342|NCT00417573|IgG subclass deficiency with recurrent infections|igg subclass deficiency with recurrent infections
756343|NCT00417560|Influenza A/H5N1|influenza a/h5n1
756344|NCT00417560|vaccine|vaccine
756345|NCT00417560|avian influenza H5N1|avian influenza h5n1
756346|NCT00417560|H5N1|h5n1
756347|NCT00417547|Self Concept|self concept
756348|NCT00417547|Eating Disorder|eating disorder
756349|NCT00417547|Body Mass Index|body mass index
756350|NCT00417547|Dressing|dressing
756351|NCT00417547|Islamic Veil|islamic veil
756352|NCT00417534|Coronary Disease|coronary disease
756353|NCT00417534|Inflammation|inflammation
756354|NCT00417534|Genetics|genetics
756355|NCT00417534|HLA Antigens|hla antigens
756356|NCT00417534|Aortic Valve|aortic valve
756357|NCT00417521|Adolescents|adolescents
756358|NCT00417521|Anorexia|anorexia
756359|NCT00417521|Eating disorder|eating disorder
756360|NCT00417521|Family therapy|family therapy
756361|NCT00417508|function|function
756362|NCT00417508|elderly|elderly
756363|NCT00417508|ADL|adl
756364|NCT00417508|nutritional supplementation|nutritional supplementation
756365|NCT00417508|Quality of life|quality of life
756366|NCT00417508|handgrip strength|handgrip strength
756367|NCT00417508|Body Composition|body composition
756368|NCT00417495|adenocarcinoma, breast, multifocal lesions, surgery|adenocarcinoma, breast, multifocal lesions, surgery
756369|NCT00417482|Risperidone treatment, psychosis, agitation, aggression,|risperidone treatment, psychosis, agitation, aggression,
756370|NCT00417482|discontinuation, placebo|discontinuation, placebo
756371|NCT00417456|Acne|acne
756372|NCT00417456|Telemedicine|telemedicine
756373|NCT00417456|Dermatology|dermatology
756374|NCT00417443|epidural|epidural
756375|NCT00417443|clonidine|clonidine
756376|NCT00417443|hyperalgesia|hyperalgesia
756377|NCT00417443|laparotomy|laparotomy
756378|NCT00417417|Endothelium|endothelium
756379|NCT00417417|Inflammation|inflammation
756380|NCT00417417|Nitric Oxide|nitric oxide
756381|NCT00417417|Rilonacept|rilonacept
756382|NCT00417417|Cytokines|cytokines
756383|NCT00417417|Coronary Artery Disease|coronary artery disease
756384|NCT00417417|CAD|cad
756385|NCT00417417|Atherosclerosis|atherosclerosis
756386|NCT00417404|preterm|preterm
756387|NCT00417404|nutrition|nutrition
756388|NCT00417404|vitamin A|vitamin a
756389|NCT00417404|electroretinogram|electroretinogram
756390|NCT00417404|conjunctiva|conjunctiva
756391|NCT00417404|vitamin A status|vitamin a status
756392|NCT00417404|conjunctival health|conjunctival health
756393|NCT00417378|ACS|acs
756401|NCT00417365|Lactobacilli|lactobacilli
756402|NCT00417365|Nugent|nugent
756403|NCT00417365|Amsel|amsel
756404|NCT00417352|no intervention|no intervention
756405|NCT00417352|bracing restricted forearm and wrist movement|bracing restricted forearm and wrist movement
756406|NCT00417352|bracing with added mass near elbow|bracing with added mass near elbow
756407|NCT00417352|bracing with added mass near wrist|bracing with added mass near wrist
756408|NCT00417339|hemodialysis|hemodialysis
756409|NCT00417339|dialysis adequacy|dialysis adequacy
756410|NCT00417339|uremic retention solute|uremic retention solute
756411|NCT00417326|ONO-5046Na|ono-5046na
756412|NCT00417326|acute respiratory failure|acute respiratory failure
756413|NCT00417326|community-acquired pneumonia|community-acquired pneumonia
756414|NCT00417313|knee pain|knee pain
756415|NCT00417313|acupuncture /acupressure|acupuncture /acupressure
756416|NCT00417313|alternative medicine|alternative medicine
756417|NCT00417313|analgesia|analgesia
756418|NCT00417313|arthritis therapy|arthritis therapy
756419|NCT00417313|chronic pain|chronic pain
756420|NCT00417313|functional ability|functional ability
756421|NCT00417287|Pancreas|pancreas
756422|NCT00417287|Cancer|cancer
756423|NCT00417287|Carcinoma|carcinoma
756424|NCT00417274|Cancer of Prostate|cancer of prostate
756425|NCT00417274|Prostate Cancer|prostate cancer
756426|NCT00417274|Cancer of the Prostate|cancer of the prostate
756427|NCT00417274|Neoplasms, Prostate|neoplasms, prostate
756428|NCT00417274|Neoplasms, Prostatic|neoplasms, prostatic
756429|NCT00417274|Prostate Neoplasms|prostate neoplasms
756430|NCT00417274|Prostatic Cancer|prostatic cancer
756431|NCT00417274|Androgen-Independent Prostate Cancer|androgen-independent prostate cancer
756432|NCT00417261|ATF936, AXT914, healthy subjects, pharmacokinetics, parathyroid hormone, osteoporosis|atf936, axt914, healthy subjects, pharmacokinetics, parathyroid hormone, osteoporosis
756433|NCT00417261|Healthy male and female subjects|healthy male and female subjects
756434|NCT00417235|catheter related infection|catheter related infection
756435|NCT00417235|catheter dressing|catheter dressing
756436|NCT00417235|prevention|prevention
756437|NCT00417235|Chlorhexidine impregnated dressings|chlorhexidine impregnated dressings
756438|NCT00417235|Infection|infection
756439|NCT00417235|catheterization|catheterization
756440|NCT00417209|advanced pancreatic cancer|advanced pancreatic cancer
756441|NCT00417196|pharmacodynamic effects, safety, healthy subjects,|pharmacodynamic effects, safety, healthy subjects,
756442|NCT00417196|Healthy male and female subjects|healthy male and female subjects
756443|NCT00417183|GnRH antagonist|gnrh antagonist
756444|NCT00417183|GnRH agonist|gnrh agonist
756445|NCT00417183|Long protocol|long protocol
756446|NCT00417183|Flexible|flexible
756447|NCT00417170|High Blood pressure|high blood pressure
756448|NCT00417170|Hypertension|hypertension
756449|NCT00417170|metabolic syndrome|metabolic syndrome
756450|NCT00417170|insulin resistance|insulin resistance
756451|NCT00417170|endothelial dysfunction|endothelial dysfunction
756452|NCT00417170|pre-diabetic|pre-diabetic
756453|NCT00417170|amlodipine,|amlodipine,
756454|NCT00417170|aliskiren,|aliskiren,
756455|NCT00417170|IGT,|igt,
756456|NCT00417170|IFG,|ifg,
756457|NCT00417170|MBF|mbf
756458|NCT00417157|GnRH antagonist|gnrh antagonist
756459|NCT00417157|Poor responders|poor responders
756460|NCT00417157|Oocyte donation|oocyte donation
756461|NCT00417157|Modified natural cycle|modified natural cycle
756462|NCT00417144|OHSS|ohss
756463|NCT00417144|PCOS|pcos
756464|NCT00417144|GnRH antagonist|gnrh antagonist
756465|NCT00417144|GnRH agonist|gnrh agonist
756466|NCT00417131|Islet transplantation,|islet transplantation,
756467|NCT00417131|coagulation,|coagulation,
756468|NCT00417131|graft destruction,|graft destruction,
756469|NCT00417131|islet imaging|islet imaging
756470|NCT00417118|Anxiety|anxiety
756471|NCT00417118|clinical trials|clinical trials
756472|NCT00417105|hemodialysis|hemodialysis
756473|NCT00417105|dialysis adequacy|dialysis adequacy
756474|NCT00417105|chronic kidney disease|chronic kidney disease
756475|NCT00417092|coronary artery bypass grafting|coronary artery bypass grafting
756476|NCT00417092|reduced left ventricular function|reduced left ventricular function
756477|NCT00417092|postoperative pacing|postoperative pacing
756478|NCT00417092|cardiac resynchronization|cardiac resynchronization
756479|NCT00417079|Cancer|cancer
756480|NCT00417079|Prostate|prostate
756481|NCT00417066|poor responders|poor responders
756482|NCT00417066|GnRH antagonist|gnrh antagonist
756483|NCT00417066|GnRH agonist|gnrh agonist
756484|NCT00417066|flare up|flare up
756485|NCT00417066|short protocol|short protocol
756486|NCT00417053|disseminated neuroblastoma|disseminated neuroblastoma
756487|NCT00417053|localized resectable neuroblastoma|localized resectable neuroblastoma
756488|NCT00417053|localized unresectable neuroblastoma|localized unresectable neuroblastoma
756489|NCT00417053|regional neuroblastoma|regional neuroblastoma
756490|NCT00417053|stage 4S neuroblastoma|stage 4s neuroblastoma
756491|NCT00417040|adenocarcinoma of the prostate|adenocarcinoma of the prostate
756492|NCT00417040|recurrent prostate cancer|recurrent prostate cancer
756493|NCT00417040|stage IV prostate cancer|stage iv prostate cancer
756494|NCT00417027|Patient controlled epidural analgesia|patient controlled epidural analgesia
756495|NCT00417027|Labor analgesia|labor analgesia
756496|NCT00417027|Epidural analgesia|epidural analgesia
756497|NCT00417014|stage I childhood Hodgkin lymphoma|stage i childhood hodgkin lymphoma
756498|NCT00417014|stage II childhood Hodgkin lymphoma|stage ii childhood hodgkin lymphoma
756499|NCT00417014|stage III childhood Hodgkin lymphoma|stage iii childhood hodgkin lymphoma
756500|NCT00417014|stage IV childhood Hodgkin lymphoma|stage iv childhood hodgkin lymphoma
756501|NCT00417014|recurrent/refractory childhood Hodgkin lymphoma|recurrent/refractory childhood hodgkin lymphoma
756502|NCT00417001|sedation|sedation
756503|NCT00417001|colonoscopy|colonoscopy
756504|NCT00417001|Aroma therapy|aroma therapy
756505|NCT00416988|melanoma|melanoma
756506|NCT00416988|weight changes|weight changes
756507|NCT00416975|breast cancer|breast cancer
756508|NCT00416962|Oseltamivir, amantidine, Symmetrel, Tamiflu|oseltamivir, amantidine, symmetrel, tamiflu
756509|NCT00416949|anaplastic thyroid cancer|anaplastic thyroid cancer
756510|NCT00416949|insular thyroid cancer|insular thyroid cancer
756511|NCT00416949|thyroid gland medullary carcinoma|thyroid gland medullary carcinoma
756512|NCT00416949|recurrent thyroid cancer|recurrent thyroid cancer
756513|NCT00416949|stage I follicular thyroid cancer|stage i follicular thyroid cancer
756514|NCT00416949|stage I papillary thyroid cancer|stage i papillary thyroid cancer
756515|NCT00416949|stage II follicular thyroid cancer|stage ii follicular thyroid cancer
756516|NCT00416949|stage II papillary thyroid cancer|stage ii papillary thyroid cancer
756517|NCT00416949|stage III follicular thyroid cancer|stage iii follicular thyroid cancer
756518|NCT00416949|stage III papillary thyroid cancer|stage iii papillary thyroid cancer
756519|NCT00416949|stage IVA follicular thyroid cancer|stage iva follicular thyroid cancer
756520|NCT00416949|stage IVB follicular thyroid cancer|stage ivb follicular thyroid cancer
756521|NCT00416949|stage IVC follicular thyroid cancer|stage ivc follicular thyroid cancer
756522|NCT00416949|stage IVA papillary thyroid cancer|stage iva papillary thyroid cancer
756523|NCT00416949|stage IVB papillary thyroid cancer|stage ivb papillary thyroid cancer
756524|NCT00416949|stage IVC papillary thyroid cancer|stage ivc papillary thyroid cancer
756525|NCT00416923|recurrent adult Burkitt lymphoma|recurrent adult burkitt lymphoma
756526|NCT00416923|recurrent adult diffuse large cell lymphoma|recurrent adult diffuse large cell lymphoma
756527|NCT00416923|recurrent adult diffuse mixed cell lymphoma|recurrent adult diffuse mixed cell lymphoma
756528|NCT00416923|recurrent adult immunoblastic large cell lymphoma|recurrent adult immunoblastic large cell lymphoma
756529|NCT00416923|recurrent adult lymphoblastic lymphoma|recurrent adult lymphoblastic lymphoma
756530|NCT00416923|recurrent grade 1 follicular lymphoma|recurrent grade 1 follicular lymphoma
756531|NCT00416923|recurrent grade 2 follicular lymphoma|recurrent grade 2 follicular lymphoma
756532|NCT00416923|recurrent grade 3 follicular lymphoma|recurrent grade 3 follicular lymphoma
756533|NCT00416923|recurrent adult diffuse small cleaved cell lymphoma|recurrent adult diffuse small cleaved cell lymphoma
756534|NCT00416923|recurrent mantle cell lymphoma|recurrent mantle cell lymphoma
756535|NCT00416923|recurrent marginal zone lymphoma|recurrent marginal zone lymphoma
756536|NCT00416923|recurrent small lymphocytic lymphoma|recurrent small lymphocytic lymphoma
756537|NCT00416923|stage IV adult Burkitt lymphoma|stage iv adult burkitt lymphoma
756538|NCT00416923|stage IV adult diffuse large cell lymphoma|stage iv adult diffuse large cell lymphoma
756539|NCT00416923|stage IV adult diffuse mixed cell lymphoma|stage iv adult diffuse mixed cell lymphoma
756540|NCT00416923|stage IV adult diffuse small cleaved cell lymphoma|stage iv adult diffuse small cleaved cell lymphoma
756541|NCT00416923|stage IV adult immunoblastic large cell lymphoma|stage iv adult immunoblastic large cell lymphoma
756542|NCT00416923|stage IV adult lymphoblastic lymphoma|stage iv adult lymphoblastic lymphoma
756543|NCT00416923|stage IV grade 1 follicular lymphoma|stage iv grade 1 follicular lymphoma
756544|NCT00416923|stage IV grade 2 follicular lymphoma|stage iv grade 2 follicular lymphoma
756545|NCT00416923|stage IV grade 3 follicular lymphoma|stage iv grade 3 follicular lymphoma
756546|NCT00416923|stage IV mantle cell lymphoma|stage iv mantle cell lymphoma
756547|NCT00416923|stage IV marginal zone lymphoma|stage iv marginal zone lymphoma
756548|NCT00416923|stage IV small lymphocytic lymphoma|stage iv small lymphocytic lymphoma
756549|NCT00416923|primary central nervous system non-Hodgkin lymphoma|primary central nervous system non-hodgkin lymphoma
756550|NCT00416923|leptomeningeal metastases|leptomeningeal metastases
756551|NCT00416923|intraocular lymphoma|intraocular lymphoma
756552|NCT00416923|AIDS-related primary CNS lymphoma|aids-related primary cns lymphoma
756553|NCT00416923|Waldenström macroglobulinemia|waldenström macroglobulinemia
756554|NCT00416923|extranodal marginal zone B-cell lymphoma of mucosa-associated lymphoid tissue|extranodal marginal zone b-cell lymphoma of mucosa-associated lymphoid tissue
756555|NCT00416923|nodal marginal zone B-cell lymphoma|nodal marginal zone b-cell lymphoma
756556|NCT00416923|splenic marginal zone lymphoma|splenic marginal zone lymphoma
756557|NCT00416910|refractory chronic lymphocytic leukemia|refractory chronic lymphocytic leukemia
756558|NCT00416910|stage III chronic lymphocytic leukemia|stage iii chronic lymphocytic leukemia
756559|NCT00416910|stage IV chronic lymphocytic leukemia|stage iv chronic lymphocytic leukemia
756560|NCT00416910|stage I chronic lymphocytic leukemia|stage i chronic lymphocytic leukemia
756982|NCT00416078|internet|internet
756561|NCT00416910|stage II chronic lymphocytic leukemia|stage ii chronic lymphocytic leukemia
756562|NCT00416897|stage I multiple myeloma|stage i multiple myeloma
756563|NCT00416897|stage II multiple myeloma|stage ii multiple myeloma
756564|NCT00416897|stage III multiple myeloma|stage iii multiple myeloma
756565|NCT00416897|renal failure|renal failure
756566|NCT00416884|chronic phase chronic myelogenous leukemia|chronic phase chronic myelogenous leukemia
756567|NCT00416884|childhood chronic myelogenous leukemia|childhood chronic myelogenous leukemia
756568|NCT00416884|relapsing chronic myelogenous leukemia|relapsing chronic myelogenous leukemia
756569|NCT00416871|stage IV renal cell cancer|stage iv renal cell cancer
756570|NCT00416871|recurrent renal cell cancer|recurrent renal cell cancer
756571|NCT00416858|stage III esophageal cancer|stage iii esophageal cancer
756572|NCT00416845|pharmacodynamic effects, cardiac effects, healthy subjects, synthetic sphingosine 1 phosphate (S1P) receptor modulator|pharmacodynamic effects, cardiac effects, healthy subjects, synthetic sphingosine 1 phosphate (s1p) receptor modulator
756573|NCT00416845|Healthy male and female subjects|healthy male and female subjects
756574|NCT00416832|stage II childhood Hodgkin lymphoma|stage ii childhood hodgkin lymphoma
756575|NCT00416832|stage III childhood Hodgkin lymphoma|stage iii childhood hodgkin lymphoma
756576|NCT00416832|stage IV childhood Hodgkin lymphoma|stage iv childhood hodgkin lymphoma
756577|NCT00416832|stage I childhood Hodgkin lymphoma|stage i childhood hodgkin lymphoma
756578|NCT00416819|primary central nervous system non-Hodgkin lymphoma|primary central nervous system non-hodgkin lymphoma
756579|NCT00416819|primary central nervous system Hodgkin lymphoma|primary central nervous system hodgkin lymphoma
756580|NCT00416780|psychosocial effects of cancer and its treatment|psychosocial effects of cancer and its treatment
756581|NCT00416780|recurrent breast cancer|recurrent breast cancer
756582|NCT00416780|stage I breast cancer|stage i breast cancer
756583|NCT00416780|stage II breast cancer|stage ii breast cancer
756584|NCT00416780|stage IV breast cancer|stage iv breast cancer
756585|NCT00416767|metastatic gastrointestinal carcinoid tumor|metastatic gastrointestinal carcinoid tumor
756586|NCT00416767|recurrent gastrointestinal carcinoid tumor|recurrent gastrointestinal carcinoid tumor
756587|NCT00416767|regional gastrointestinal carcinoid tumor|regional gastrointestinal carcinoid tumor
756588|NCT00416767|gastrinoma|gastrinoma
756589|NCT00416767|insulinoma|insulinoma
756590|NCT00416767|WDHA syndrome|wdha syndrome
756591|NCT00416767|glucagonoma|glucagonoma
756592|NCT00416767|pancreatic polypeptide tumor|pancreatic polypeptide tumor
756593|NCT00416767|somatostatinoma|somatostatinoma
756594|NCT00416767|recurrent islet cell carcinoma|recurrent islet cell carcinoma
756595|NCT00416754|breast cancer|breast cancer
756596|NCT00416754|stage I breast cancer|stage i breast cancer
756597|NCT00416754|stage II breast cancer|stage ii breast cancer
756598|NCT00416754|stage IIIA breast cancer|stage iiia breast cancer
756599|NCT00416754|stage IIIB breast cancer|stage iiib breast cancer
756600|NCT00416754|stage IIIC breast cancer|stage iiic breast cancer
756601|NCT00416754|stage IV breast cancer|stage iv breast cancer
756602|NCT00416741|Metabolic Syndrome|metabolic syndrome
756603|NCT00416741|Obesity|obesity
756604|NCT00416741|Hyperlipidemia|hyperlipidemia
756605|NCT00416741|High blood pressure|high blood pressure
756606|NCT00416741|Diabetes|diabetes
756607|NCT00416728|Aliskiren , Valsartan , bioavailability, hypertension|aliskiren , valsartan , bioavailability, hypertension
756608|NCT00416728|Healthy male and female subjects|healthy male and female subjects
756609|NCT00416702|safety study, pharmacokinetic effects, healthy subjects, hepatic impairment, liver|safety study, pharmacokinetic effects, healthy subjects, hepatic impairment, liver
756610|NCT00416702|Subjects with mild and moderate hepatic impairment and healthy subjects|subjects with mild and moderate hepatic impairment and healthy subjects
756611|NCT00416689|nausea and vomiting|nausea and vomiting
756612|NCT00416689|pulmonary carcinoid tumor|pulmonary carcinoid tumor
756613|NCT00416689|recurrent breast cancer|recurrent breast cancer
756614|NCT00416689|stage I breast cancer|stage i breast cancer
756615|NCT00416689|stage II breast cancer|stage ii breast cancer
756616|NCT00416689|stage IIIA breast cancer|stage iiia breast cancer
756617|NCT00416689|stage IIIB breast cancer|stage iiib breast cancer
756618|NCT00416689|stage IIIC breast cancer|stage iiic breast cancer
756619|NCT00416689|stage IV breast cancer|stage iv breast cancer
756620|NCT00416689|recurrent non-small cell lung cancer|recurrent non-small cell lung cancer
756621|NCT00416689|stage I non-small cell lung cancer|stage i non-small cell lung cancer
756622|NCT00416689|stage II non-small cell lung cancer|stage ii non-small cell lung cancer
756623|NCT00416689|stage IIIA non-small cell lung cancer|stage iiia non-small cell lung cancer
756624|NCT00416689|stage IIIB non-small cell lung cancer|stage iiib non-small cell lung cancer
756625|NCT00416689|stage IV non-small cell lung cancer|stage iv non-small cell lung cancer
756626|NCT00416689|extensive stage small cell lung cancer|extensive stage small cell lung cancer
756627|NCT00416689|limited stage small cell lung cancer|limited stage small cell lung cancer
756628|NCT00416689|recurrent small cell lung cancer|recurrent small cell lung cancer
756629|NCT00416676|localized resectable neuroblastoma|localized resectable neuroblastoma
756630|NCT00416676|localized unresectable neuroblastoma|localized unresectable neuroblastoma
756631|NCT00416676|regional neuroblastoma|regional neuroblastoma
756632|NCT00416663|Stem cells|stem cells
756633|NCT00416663|Progenitor cells|progenitor cells
756634|NCT00416663|Angina Pectoris|angina pectoris
756635|NCT00416663|Heart Failure|heart failure
756636|NCT00416663|Angiogenesis|angiogenesis
756637|NCT00416650|stage IIIB non-small cell lung cancer|stage iiib non-small cell lung cancer
756638|NCT00416650|stage IV non-small cell lung cancer|stage iv non-small cell lung cancer
756639|NCT00416650|bronchoalveolar cell lung cancer|bronchoalveolar cell lung cancer
756985|NCT00416052|calciuria|calciuria
756640|NCT00416650|recurrent non-small cell lung cancer|recurrent non-small cell lung cancer
756641|NCT00416637|unspecified adult solid tumor, protocol specific|unspecified adult solid tumor, protocol specific
756642|NCT00416624|unspecified adult solid tumor, protocol specific|unspecified adult solid tumor, protocol specific
756643|NCT00416624|extramedullary plasmacytoma|extramedullary plasmacytoma
756644|NCT00416624|isolated plasmacytoma of bone|isolated plasmacytoma of bone
756645|NCT00416624|refractory multiple myeloma|refractory multiple myeloma
756646|NCT00416624|stage I multiple myeloma|stage i multiple myeloma
756647|NCT00416624|stage II multiple myeloma|stage ii multiple myeloma
756648|NCT00416624|stage III multiple myeloma|stage iii multiple myeloma
756649|NCT00416624|Waldenstrom macroglobulinemia|waldenstrom macroglobulinemia
756650|NCT00416624|post-transplant lymphoproliferative disorder|post-transplant lymphoproliferative disorder
756651|NCT00416624|stage I adult T-cell leukemia/lymphoma|stage i adult t-cell leukemia/lymphoma
756652|NCT00416624|stage II adult T-cell leukemia/lymphoma|stage ii adult t-cell leukemia/lymphoma
756653|NCT00416624|stage III adult T-cell leukemia/lymphoma|stage iii adult t-cell leukemia/lymphoma
756654|NCT00416624|stage IV adult T-cell leukemia/lymphoma|stage iv adult t-cell leukemia/lymphoma
756655|NCT00416624|recurrent adult T-cell leukemia/lymphoma|recurrent adult t-cell leukemia/lymphoma
756656|NCT00416624|AIDS-related peripheral/systemic lymphoma|aids-related peripheral/systemic lymphoma
756657|NCT00416624|AIDS-related primary CNS lymphoma|aids-related primary cns lymphoma
756658|NCT00416624|angioimmunoblastic T-cell lymphoma|angioimmunoblastic t-cell lymphoma
756659|NCT00416624|anaplastic large cell lymphoma|anaplastic large cell lymphoma
756660|NCT00416624|stage I cutaneous T-cell non-Hodgkin lymphoma|stage i cutaneous t-cell non-hodgkin lymphoma
756661|NCT00416624|stage II cutaneous T-cell non-Hodgkin lymphoma|stage ii cutaneous t-cell non-hodgkin lymphoma
756662|NCT00416624|stage III cutaneous T-cell non-Hodgkin lymphoma|stage iii cutaneous t-cell non-hodgkin lymphoma
756663|NCT00416624|stage IV cutaneous T-cell non-Hodgkin lymphoma|stage iv cutaneous t-cell non-hodgkin lymphoma
756664|NCT00416624|recurrent cutaneous T-cell non-Hodgkin lymphoma|recurrent cutaneous t-cell non-hodgkin lymphoma
756665|NCT00416624|stage I mycosis fungoides/Sezary syndrome|stage i mycosis fungoides/sezary syndrome
756666|NCT00416624|stage II mycosis fungoides/Sezary syndrome|stage ii mycosis fungoides/sezary syndrome
756667|NCT00416624|stage III mycosis fungoides/Sezary syndrome|stage iii mycosis fungoides/sezary syndrome
756668|NCT00416624|stage IV mycosis fungoides/Sezary syndrome|stage iv mycosis fungoides/sezary syndrome
756669|NCT00416624|recurrent mycosis fungoides/Sezary syndrome|recurrent mycosis fungoides/sezary syndrome
756670|NCT00416624|stage I adult Hodgkin lymphoma|stage i adult hodgkin lymphoma
756671|NCT00416624|stage II adult Hodgkin lymphoma|stage ii adult hodgkin lymphoma
756672|NCT00416624|stage III adult Hodgkin lymphoma|stage iii adult hodgkin lymphoma
756673|NCT00416624|stage IV adult Hodgkin lymphoma|stage iv adult hodgkin lymphoma
756674|NCT00416624|recurrent adult Hodgkin lymphoma|recurrent adult hodgkin lymphoma
756675|NCT00416624|adult grade III lymphomatoid granulomatosis|adult grade iii lymphomatoid granulomatosis
756676|NCT00416624|stage I adult Burkitt lymphoma|stage i adult burkitt lymphoma
756677|NCT00416624|stage III adult Burkitt lymphoma|stage iii adult burkitt lymphoma
756678|NCT00416624|stage IV adult Burkitt lymphoma|stage iv adult burkitt lymphoma
756679|NCT00416624|noncontiguous stage II adult Burkitt lymphoma|noncontiguous stage ii adult burkitt lymphoma
756680|NCT00416624|noncontiguous stage II adult diffuse large cell lymphoma|noncontiguous stage ii adult diffuse large cell lymphoma
756681|NCT00416624|noncontiguous stage II adult diffuse mixed cell lymphoma|noncontiguous stage ii adult diffuse mixed cell lymphoma
756682|NCT00416624|noncontiguous stage II adult diffuse small cleaved cell lymphoma|noncontiguous stage ii adult diffuse small cleaved cell lymphoma
756683|NCT00416624|noncontiguous stage II adult immunoblastic large cell lymphoma|noncontiguous stage ii adult immunoblastic large cell lymphoma
756684|NCT00416624|noncontiguous stage II adult lymphoblastic lymphoma|noncontiguous stage ii adult lymphoblastic lymphoma
756685|NCT00416624|noncontiguous stage II grade 1 follicular lymphoma|noncontiguous stage ii grade 1 follicular lymphoma
756686|NCT00416624|noncontiguous stage II grade 2 follicular lymphoma|noncontiguous stage ii grade 2 follicular lymphoma
756687|NCT00416624|noncontiguous stage II grade 3 follicular lymphoma|noncontiguous stage ii grade 3 follicular lymphoma
756688|NCT00416624|noncontiguous stage II mantle cell lymphoma|noncontiguous stage ii mantle cell lymphoma
756689|NCT00416624|noncontiguous stage II marginal zone lymphoma|noncontiguous stage ii marginal zone lymphoma
756690|NCT00416624|noncontiguous stage II small lymphocytic lymphoma|noncontiguous stage ii small lymphocytic lymphoma
756691|NCT00416624|contiguous stage II adult Burkitt lymphoma|contiguous stage ii adult burkitt lymphoma
756692|NCT00416624|contiguous stage II adult diffuse large cell lymphoma|contiguous stage ii adult diffuse large cell lymphoma
756693|NCT00416624|contiguous stage II adult diffuse mixed cell lymphoma|contiguous stage ii adult diffuse mixed cell lymphoma
756694|NCT00416624|contiguous stage II adult diffuse small cleaved cell lymphoma|contiguous stage ii adult diffuse small cleaved cell lymphoma
756695|NCT00416624|contiguous stage II adult immunoblastic large cell lymphoma|contiguous stage ii adult immunoblastic large cell lymphoma
756696|NCT00416624|contiguous stage II adult lymphoblastic lymphoma|contiguous stage ii adult lymphoblastic lymphoma
756697|NCT00416624|contiguous stage II grade 1 follicular lymphoma|contiguous stage ii grade 1 follicular lymphoma
756698|NCT00416624|contiguous stage II grade 2 follicular lymphoma|contiguous stage ii grade 2 follicular lymphoma
756699|NCT00416624|contiguous stage II grade 3 follicular lymphoma|contiguous stage ii grade 3 follicular lymphoma
756700|NCT00416624|contiguous stage II mantle cell lymphoma|contiguous stage ii mantle cell lymphoma
757093|NCT00415701|Etomidate|etomidate
756701|NCT00416624|contiguous stage II marginal zone lymphoma|contiguous stage ii marginal zone lymphoma
756702|NCT00416624|contiguous stage II small lymphocytic lymphoma|contiguous stage ii small lymphocytic lymphoma
756703|NCT00416624|stage I adult diffuse large cell lymphoma|stage i adult diffuse large cell lymphoma
756704|NCT00416624|stage I adult diffuse mixed cell lymphoma|stage i adult diffuse mixed cell lymphoma
756705|NCT00416624|stage I adult diffuse small cleaved cell lymphoma|stage i adult diffuse small cleaved cell lymphoma
756706|NCT00416624|stage III adult diffuse large cell lymphoma|stage iii adult diffuse large cell lymphoma
756707|NCT00416624|stage III adult diffuse mixed cell lymphoma|stage iii adult diffuse mixed cell lymphoma
756708|NCT00416624|stage III adult diffuse small cleaved cell lymphoma|stage iii adult diffuse small cleaved cell lymphoma
756709|NCT00416624|stage IV adult diffuse large cell lymphoma|stage iv adult diffuse large cell lymphoma
756710|NCT00416624|stage IV adult diffuse mixed cell lymphoma|stage iv adult diffuse mixed cell lymphoma
756711|NCT00416624|stage IV adult diffuse small cleaved cell lymphoma|stage iv adult diffuse small cleaved cell lymphoma
756712|NCT00416624|stage I adult immunoblastic large cell lymphoma|stage i adult immunoblastic large cell lymphoma
756713|NCT00416624|stage III adult immunoblastic large cell lymphoma|stage iii adult immunoblastic large cell lymphoma
756714|NCT00416624|stage IV adult immunoblastic large cell lymphoma|stage iv adult immunoblastic large cell lymphoma
756715|NCT00416624|stage I adult lymphoblastic lymphoma|stage i adult lymphoblastic lymphoma
756716|NCT00416624|stage III adult lymphoblastic lymphoma|stage iii adult lymphoblastic lymphoma
756717|NCT00416624|stage IV adult lymphoblastic lymphoma|stage iv adult lymphoblastic lymphoma
756718|NCT00416624|stage I grade 1 follicular lymphoma|stage i grade 1 follicular lymphoma
756719|NCT00416624|stage I grade 2 follicular lymphoma|stage i grade 2 follicular lymphoma
756720|NCT00416624|stage I grade 3 follicular lymphoma|stage i grade 3 follicular lymphoma
756721|NCT00416624|stage III grade 1 follicular lymphoma|stage iii grade 1 follicular lymphoma
756722|NCT00416624|stage III grade 2 follicular lymphoma|stage iii grade 2 follicular lymphoma
756723|NCT00416624|stage III grade 3 follicular lymphoma|stage iii grade 3 follicular lymphoma
756724|NCT00416624|stage IV grade 1 follicular lymphoma|stage iv grade 1 follicular lymphoma
756725|NCT00416624|stage IV grade 2 follicular lymphoma|stage iv grade 2 follicular lymphoma
756726|NCT00416624|stage IV grade 3 follicular lymphoma|stage iv grade 3 follicular lymphoma
756727|NCT00416624|stage I mantle cell lymphoma|stage i mantle cell lymphoma
756728|NCT00416624|stage I marginal zone lymphoma|stage i marginal zone lymphoma
756729|NCT00416624|stage III mantle cell lymphoma|stage iii mantle cell lymphoma
756730|NCT00416624|stage III marginal zone lymphoma|stage iii marginal zone lymphoma
756731|NCT00416624|stage IV mantle cell lymphoma|stage iv mantle cell lymphoma
756732|NCT00416624|stage IV marginal zone lymphoma|stage iv marginal zone lymphoma
756733|NCT00416624|stage I small lymphocytic lymphoma|stage i small lymphocytic lymphoma
756734|NCT00416624|stage III small lymphocytic lymphoma|stage iii small lymphocytic lymphoma
756735|NCT00416624|stage IV small lymphocytic lymphoma|stage iv small lymphocytic lymphoma
756736|NCT00416624|extranodal marginal zone B-cell lymphoma of mucosa-associated lymphoid tissue|extranodal marginal zone b-cell lymphoma of mucosa-associated lymphoid tissue
756737|NCT00416624|nodal marginal zone B-cell lymphoma|nodal marginal zone b-cell lymphoma
756738|NCT00416624|splenic marginal zone lymphoma|splenic marginal zone lymphoma
756739|NCT00416624|recurrent adult Burkitt lymphoma|recurrent adult burkitt lymphoma
756740|NCT00416624|recurrent adult diffuse large cell lymphoma|recurrent adult diffuse large cell lymphoma
756741|NCT00416624|recurrent adult diffuse mixed cell lymphoma|recurrent adult diffuse mixed cell lymphoma
756742|NCT00416624|recurrent adult diffuse small cleaved cell lymphoma|recurrent adult diffuse small cleaved cell lymphoma
756743|NCT00416624|recurrent adult grade III lymphomatoid granulomatosis|recurrent adult grade iii lymphomatoid granulomatosis
756744|NCT00416624|recurrent adult immunoblastic large cell lymphoma|recurrent adult immunoblastic large cell lymphoma
756745|NCT00416624|recurrent adult lymphoblastic lymphoma|recurrent adult lymphoblastic lymphoma
756746|NCT00416624|recurrent grade 1 follicular lymphoma|recurrent grade 1 follicular lymphoma
756747|NCT00416624|recurrent grade 2 follicular lymphoma|recurrent grade 2 follicular lymphoma
756748|NCT00416624|recurrent grade 3 follicular lymphoma|recurrent grade 3 follicular lymphoma
756749|NCT00416624|recurrent mantle cell lymphoma|recurrent mantle cell lymphoma
756750|NCT00416624|recurrent marginal zone lymphoma|recurrent marginal zone lymphoma
756751|NCT00416624|recurrent small lymphocytic lymphoma|recurrent small lymphocytic lymphoma
756752|NCT00416624|adult acute lymphoblastic leukemia in remission|adult acute lymphoblastic leukemia in remission
756753|NCT00416624|recurrent adult acute lymphoblastic leukemia|recurrent adult acute lymphoblastic leukemia
756754|NCT00416624|untreated adult acute lymphoblastic leukemia|untreated adult acute lymphoblastic leukemia
756755|NCT00416624|stage I chronic lymphocytic leukemia|stage i chronic lymphocytic leukemia
756756|NCT00416624|stage II chronic lymphocytic leukemia|stage ii chronic lymphocytic leukemia
756757|NCT00416624|stage III chronic lymphocytic leukemia|stage iii chronic lymphocytic leukemia
756758|NCT00416624|stage IV chronic lymphocytic leukemia|stage iv chronic lymphocytic leukemia
756759|NCT00416624|refractory chronic lymphocytic leukemia|refractory chronic lymphocytic leukemia
756760|NCT00416624|refractory hairy cell leukemia|refractory hairy cell leukemia
756761|NCT00416624|progressive hairy cell leukemia, initial treatment|progressive hairy cell leukemia, initial treatment
756984|NCT00416052|calcium|calcium
756762|NCT00416624|prolymphocytic leukemia|prolymphocytic leukemia
756763|NCT00416624|anemia|anemia
756987|NCT00416052|1,25-vitamin D|1,25-vitamin d
756764|NCT00416624|monoclonal gammopathy of undetermined significance|monoclonal gammopathy of undetermined significance
756765|NCT00416624|primary systemic amyloidosis|primary systemic amyloidosis
756766|NCT00416624|T-cell large granular lymphocyte leukemia|t-cell large granular lymphocyte leukemia
756767|NCT00416624|acute undifferentiated leukemia|acute undifferentiated leukemia
756768|NCT00416624|mast cell leukemia|mast cell leukemia
756769|NCT00416624|adult nasal type extranodal NK/T-cell lymphoma|adult nasal type extranodal nk/t-cell lymphoma
756770|NCT00416624|untreated hairy cell leukemia|untreated hairy cell leukemia
756771|NCT00416611|High blood pressure|high blood pressure
756772|NCT00416611|Awareness|awareness
756773|NCT00416611|Treatment|treatment
756774|NCT00416611|Effective Control|effective control
756775|NCT00416611|Coronary heart disease risk reduction|coronary heart disease risk reduction
756776|NCT00416611|Hypertension|hypertension
756777|NCT00416585|acne|acne
756778|NCT00416585|isotretinoin|isotretinoin
756779|NCT00416585|calcium. vitamin D|calcium. vitamin d
756780|NCT00416572|psychosocial effects of cancer and its treatment|psychosocial effects of cancer and its treatment
756781|NCT00416572|stage I breast cancer|stage i breast cancer
756782|NCT00416572|stage II breast cancer|stage ii breast cancer
756783|NCT00416559|long-term effects secondary to cancer therapy in children|long-term effects secondary to cancer therapy in children
756784|NCT00416559|localized resectable neuroblastoma|localized resectable neuroblastoma
756785|NCT00416559|localized unresectable neuroblastoma|localized unresectable neuroblastoma
756786|NCT00416559|regional neuroblastoma|regional neuroblastoma
756787|NCT00416546|Healthy Caucasians|healthy caucasians
756788|NCT00416546|Healthy Japanese subjects|healthy japanese subjects
756789|NCT00416546|Immunosuppressant|immunosuppressant
756790|NCT00416546|early T-cell activation blockers|early t-cell activation blockers
756791|NCT00416546|inhibition of protein kinase C|inhibition of protein kinase c
756792|NCT00416533|recurrent prostate cancer|recurrent prostate cancer
756793|NCT00416533|stage III prostate cancer|stage iii prostate cancer
756794|NCT00416533|stage IV prostate cancer|stage iv prostate cancer
756795|NCT00416533|adenocarcinoma of the prostate|adenocarcinoma of the prostate
756796|NCT00416520|Chronic Kidney Disease|chronic kidney disease
756797|NCT00416520|Dialysis|dialysis
756798|NCT00416520|Hyperphosphatemia|hyperphosphatemia
756799|NCT00416520|Phosphate binder|phosphate binder
756800|NCT00416507|adenocarcinoma of the pancreas|adenocarcinoma of the pancreas
756801|NCT00416507|stage III pancreatic cancer|stage iii pancreatic cancer
756802|NCT00416507|stage II pancreatic cancer|stage ii pancreatic cancer
756803|NCT00416494|adenocarcinoma of the colon|adenocarcinoma of the colon
756804|NCT00416494|recurrent colon cancer|recurrent colon cancer
756805|NCT00416494|stage IV colon cancer|stage iv colon cancer
756806|NCT00416494|adenocarcinoma of the rectum|adenocarcinoma of the rectum
756807|NCT00416494|recurrent rectal cancer|recurrent rectal cancer
756808|NCT00416494|stage IV rectal cancer|stage iv rectal cancer
756809|NCT00416481|unspecified adult solid tumor, protocol specific|unspecified adult solid tumor, protocol specific
756810|NCT00416468|Aliskiren , Valsartan, bioavailability, hypertension|aliskiren , valsartan, bioavailability, hypertension
756811|NCT00416468|Healthy male and female subjects|healthy male and female subjects
756812|NCT00416442|healthy subjects, safety, tolerability, dose escalation, pharmacokinetics, benzodiazepine|healthy subjects, safety, tolerability, dose escalation, pharmacokinetics, benzodiazepine
756813|NCT00416442|Healthy male and female subjects|healthy male and female subjects
756814|NCT00416429|recurrent renal cell cancer|recurrent renal cell cancer
756815|NCT00416429|stage IV renal cell cancer|stage iv renal cell cancer
756816|NCT00416403|breast cancer in situ|breast cancer in situ
756817|NCT00416403|ductal breast carcinoma in situ|ductal breast carcinoma in situ
756818|NCT00416403|stage IA breast cancer|stage ia breast cancer
756819|NCT00416403|stage IB breast cancer|stage ib breast cancer
756820|NCT00416390|benign prostatic hyperplasia|benign prostatic hyperplasia
756821|NCT00416390|stage I prostate cancer|stage i prostate cancer
756822|NCT00416390|stage IIB prostate cancer|stage iib prostate cancer
756823|NCT00416390|stage IIA prostate cancer|stage iia prostate cancer
756824|NCT00416390|stage III prostate cancer|stage iii prostate cancer
756825|NCT00416390|stage IV prostate cancer|stage iv prostate cancer
756826|NCT00416377|stage I childhood Hodgkin lymphoma|stage i childhood hodgkin lymphoma
756827|NCT00416377|stage II childhood Hodgkin lymphoma|stage ii childhood hodgkin lymphoma
756828|NCT00416377|stage III childhood Hodgkin lymphoma|stage iii childhood hodgkin lymphoma
756829|NCT00416377|stage IV childhood Hodgkin lymphoma|stage iv childhood hodgkin lymphoma
756830|NCT00416377|recurrent/refractory childhood Hodgkin lymphoma|recurrent/refractory childhood hodgkin lymphoma
756831|NCT00416364|hernia|hernia
756832|NCT00416364|inguinal|inguinal
756833|NCT00416364|quality of life|quality of life
756834|NCT00416351|anaplastic large cell lymphoma|anaplastic large cell lymphoma
756835|NCT00416351|angioimmunoblastic T-cell lymphoma|angioimmunoblastic t-cell lymphoma
756836|NCT00416351|recurrent adult lymphoblastic lymphoma|recurrent adult lymphoblastic lymphoma
756837|NCT00416351|recurrent adult T-cell leukemia/lymphoma|recurrent adult t-cell leukemia/lymphoma
756838|NCT00416351|recurrent mycosis fungoides/Sezary syndrome|recurrent mycosis fungoides/sezary syndrome
756839|NCT00416351|adult nasal type extranodal NK/T-cell lymphoma|adult nasal type extranodal nk/t-cell lymphoma
756840|NCT00416351|prolymphocytic leukemia|prolymphocytic leukemia
756988|NCT00416052|Calcitriol|calcitriol
756841|NCT00416351|childhood nasal type extranodal NK/T-cell lymphoma|childhood nasal type extranodal nk/t-cell lymphoma
756842|NCT00416351|recurrent childhood lymphoblastic lymphoma|recurrent childhood lymphoblastic lymphoma
756843|NCT00416351|recurrent cutaneous T-cell non-Hodgkin lymphoma|recurrent cutaneous t-cell non-hodgkin lymphoma
756844|NCT00416351|small intestine lymphoma|small intestine lymphoma
756845|NCT00416338|renal failure|renal failure
756846|NCT00416338|infection|infection
756847|NCT00416338|peritonitis|peritonitis
756848|NCT00416325|prostate cancer|prostate cancer
756849|NCT00416312|extranodal marginal zone B-cell lymphoma of mucosa-associated lymphoid tissue|extranodal marginal zone b-cell lymphoma of mucosa-associated lymphoid tissue
756850|NCT00416312|nodal marginal zone B-cell lymphoma|nodal marginal zone b-cell lymphoma
756851|NCT00416312|recurrent adult Burkitt lymphoma|recurrent adult burkitt lymphoma
756852|NCT00416312|recurrent adult diffuse large cell lymphoma|recurrent adult diffuse large cell lymphoma
756853|NCT00416312|recurrent adult diffuse small cleaved cell lymphoma|recurrent adult diffuse small cleaved cell lymphoma
756854|NCT00416312|recurrent adult diffuse mixed cell lymphoma|recurrent adult diffuse mixed cell lymphoma
756855|NCT00416312|recurrent adult immunoblastic large cell lymphoma|recurrent adult immunoblastic large cell lymphoma
756856|NCT00416312|recurrent adult lymphoblastic lymphoma|recurrent adult lymphoblastic lymphoma
756857|NCT00416312|recurrent grade 1 follicular lymphoma|recurrent grade 1 follicular lymphoma
756858|NCT00416312|recurrent grade 2 follicular lymphoma|recurrent grade 2 follicular lymphoma
756859|NCT00416312|recurrent grade 3 follicular lymphoma|recurrent grade 3 follicular lymphoma
756860|NCT00416312|recurrent mantle cell lymphoma|recurrent mantle cell lymphoma
756861|NCT00416312|recurrent marginal zone lymphoma|recurrent marginal zone lymphoma
756862|NCT00416312|recurrent small lymphocytic lymphoma|recurrent small lymphocytic lymphoma
756863|NCT00416312|splenic marginal zone lymphoma|splenic marginal zone lymphoma
756864|NCT00416312|stage III adult Burkitt lymphoma|stage iii adult burkitt lymphoma
756865|NCT00416312|stage III adult diffuse large cell lymphoma|stage iii adult diffuse large cell lymphoma
756866|NCT00416312|stage III adult diffuse mixed cell lymphoma|stage iii adult diffuse mixed cell lymphoma
756867|NCT00416312|stage III adult diffuse small cleaved cell lymphoma|stage iii adult diffuse small cleaved cell lymphoma
756868|NCT00416312|stage III adult immunoblastic large cell lymphoma|stage iii adult immunoblastic large cell lymphoma
756869|NCT00416312|stage III adult lymphoblastic lymphoma|stage iii adult lymphoblastic lymphoma
756870|NCT00416312|stage III grade 1 follicular lymphoma|stage iii grade 1 follicular lymphoma
756871|NCT00416312|stage III grade 2 follicular lymphoma|stage iii grade 2 follicular lymphoma
756872|NCT00416312|stage III grade 3 follicular lymphoma|stage iii grade 3 follicular lymphoma
756873|NCT00416312|stage III mantle cell lymphoma|stage iii mantle cell lymphoma
756874|NCT00416312|stage III marginal zone lymphoma|stage iii marginal zone lymphoma
756875|NCT00416312|stage III small lymphocytic lymphoma|stage iii small lymphocytic lymphoma
756876|NCT00416312|stage IV adult Burkitt lymphoma|stage iv adult burkitt lymphoma
756877|NCT00416312|stage IV adult diffuse large cell lymphoma|stage iv adult diffuse large cell lymphoma
756878|NCT00416312|stage IV adult diffuse small cleaved cell lymphoma|stage iv adult diffuse small cleaved cell lymphoma
756879|NCT00416312|stage IV adult diffuse mixed cell lymphoma|stage iv adult diffuse mixed cell lymphoma
756880|NCT00416312|stage IV adult immunoblastic large cell lymphoma|stage iv adult immunoblastic large cell lymphoma
756881|NCT00416312|stage IV adult lymphoblastic lymphoma|stage iv adult lymphoblastic lymphoma
756882|NCT00416312|stage IV grade 1 follicular lymphoma|stage iv grade 1 follicular lymphoma
756883|NCT00416312|stage IV grade 2 follicular lymphoma|stage iv grade 2 follicular lymphoma
756884|NCT00416312|stage IV grade 3 follicular lymphoma|stage iv grade 3 follicular lymphoma
756885|NCT00416312|stage IV mantle cell lymphoma|stage iv mantle cell lymphoma
756886|NCT00416312|stage IV marginal zone lymphoma|stage iv marginal zone lymphoma
756887|NCT00416312|stage IV small lymphocytic lymphoma|stage iv small lymphocytic lymphoma
756888|NCT00416312|Waldenström macroglobulinemia|waldenström macroglobulinemia
756889|NCT00416312|contiguous stage II adult Burkitt lymphoma|contiguous stage ii adult burkitt lymphoma
756890|NCT00416312|contiguous stage II adult diffuse large cell lymphoma|contiguous stage ii adult diffuse large cell lymphoma
756891|NCT00416312|contiguous stage II adult diffuse mixed cell lymphoma|contiguous stage ii adult diffuse mixed cell lymphoma
756892|NCT00416312|contiguous stage II adult diffuse small cleaved cell lymphoma|contiguous stage ii adult diffuse small cleaved cell lymphoma
756893|NCT00416312|contiguous stage II adult immunoblastic large cell lymphoma|contiguous stage ii adult immunoblastic large cell lymphoma
756894|NCT00416312|contiguous stage II adult lymphoblastic lymphoma|contiguous stage ii adult lymphoblastic lymphoma
756895|NCT00416312|contiguous stage II grade 1 follicular lymphoma|contiguous stage ii grade 1 follicular lymphoma
756896|NCT00416312|contiguous stage II grade 2 follicular lymphoma|contiguous stage ii grade 2 follicular lymphoma
756897|NCT00416312|contiguous stage II grade 3 follicular lymphoma|contiguous stage ii grade 3 follicular lymphoma
756898|NCT00416312|contiguous stage II mantle cell lymphoma|contiguous stage ii mantle cell lymphoma
756899|NCT00416312|contiguous stage II marginal zone lymphoma|contiguous stage ii marginal zone lymphoma
756900|NCT00416312|contiguous stage II small lymphocytic lymphoma|contiguous stage ii small lymphocytic lymphoma
756901|NCT00416312|noncontiguous stage II adult Burkitt lymphoma|noncontiguous stage ii adult burkitt lymphoma
756902|NCT00416312|noncontiguous stage II adult diffuse large cell lymphoma|noncontiguous stage ii adult diffuse large cell lymphoma
756983|NCT00416078|randomized control trial|randomized control trial
756989|NCT00416052|bone mineral density|bone mineral density
756903|NCT00416312|noncontiguous stage II adult diffuse mixed cell lymphoma|noncontiguous stage ii adult diffuse mixed cell lymphoma
756904|NCT00416312|noncontiguous stage II adult diffuse small cleaved cell lymphoma|noncontiguous stage ii adult diffuse small cleaved cell lymphoma
756905|NCT00416312|noncontiguous stage II adult immunoblastic large cell lymphoma|noncontiguous stage ii adult immunoblastic large cell lymphoma
756906|NCT00416312|noncontiguous stage II adult lymphoblastic lymphoma|noncontiguous stage ii adult lymphoblastic lymphoma
756907|NCT00416312|noncontiguous stage II grade 1 follicular lymphoma|noncontiguous stage ii grade 1 follicular lymphoma
756908|NCT00416312|noncontiguous stage II grade 2 follicular lymphoma|noncontiguous stage ii grade 2 follicular lymphoma
756909|NCT00416312|noncontiguous stage II grade 3 follicular lymphoma|noncontiguous stage ii grade 3 follicular lymphoma
756910|NCT00416312|noncontiguous stage II mantle cell lymphoma|noncontiguous stage ii mantle cell lymphoma
756911|NCT00416312|noncontiguous stage II marginal zone lymphoma|noncontiguous stage ii marginal zone lymphoma
756912|NCT00416312|noncontiguous stage II small lymphocytic lymphoma|noncontiguous stage ii small lymphocytic lymphoma
756913|NCT00416312|stage I adult Burkitt lymphoma|stage i adult burkitt lymphoma
756914|NCT00416312|stage I adult diffuse large cell lymphoma|stage i adult diffuse large cell lymphoma
756915|NCT00416312|stage I adult diffuse mixed cell lymphoma|stage i adult diffuse mixed cell lymphoma
756916|NCT00416312|stage I adult diffuse small cleaved cell lymphoma|stage i adult diffuse small cleaved cell lymphoma
756917|NCT00416312|stage I adult immunoblastic large cell lymphoma|stage i adult immunoblastic large cell lymphoma
756918|NCT00416312|stage I adult lymphoblastic lymphoma|stage i adult lymphoblastic lymphoma
756919|NCT00416312|stage I grade 1 follicular lymphoma|stage i grade 1 follicular lymphoma
756920|NCT00416312|stage I grade 2 follicular lymphoma|stage i grade 2 follicular lymphoma
756921|NCT00416312|stage I grade 3 follicular lymphoma|stage i grade 3 follicular lymphoma
756922|NCT00416312|stage I mantle cell lymphoma|stage i mantle cell lymphoma
756923|NCT00416312|stage I marginal zone lymphoma|stage i marginal zone lymphoma
756924|NCT00416312|stage I small lymphocytic lymphoma|stage i small lymphocytic lymphoma
756925|NCT00416312|adult grade III lymphomatoid granulomatosis|adult grade iii lymphomatoid granulomatosis
756926|NCT00416312|recurrent adult grade III lymphomatoid granulomatosis|recurrent adult grade iii lymphomatoid granulomatosis
756927|NCT00416312|primary central nervous system non-Hodgkin lymphoma|primary central nervous system non-hodgkin lymphoma
756928|NCT00416312|adult nasal type extranodal NK/T-cell lymphoma|adult nasal type extranodal nk/t-cell lymphoma
756929|NCT00416299|Cardiac biomarker|cardiac biomarker
756930|NCT00416299|cardiac surgery|cardiac surgery
756931|NCT00416299|elderly|elderly
756932|NCT00416299|postoperative complications|postoperative complications
756933|NCT00416299|Patients aged 75 years or older undergoing cardiac surgery|patients aged 75 years or older undergoing cardiac surgery
756934|NCT00416286|Cetylpyridinium chlorid|cetylpyridinium chlorid
756935|NCT00416286|Sustained release|sustained release
756936|NCT00416286|orthodontic patients|orthodontic patients
756937|NCT00416286|streptococcus mutans|streptococcus mutans
756938|NCT00416286|Lactobacillus|lactobacillus
756939|NCT00416286|Rate of bacterial load in saliva of orthodontic patients|rate of bacterial load in saliva of orthodontic patients
756940|NCT00416273|Multiple Myeloma|multiple myeloma
756941|NCT00416273|Bortezomib|bortezomib
756942|NCT00416273|PS341|ps341
756943|NCT00416273|Proteasome inhibitor|proteasome inhibitor
756944|NCT00416273|Consolidation therapy|consolidation therapy
756945|NCT00416260|Respiratory Distress Syndrome, Adult|respiratory distress syndrome, adult
756946|NCT00416260|High-Frequency Ventilation|high-frequency ventilation
756947|NCT00416260|Respiration, Artificial|respiration, artificial
756948|NCT00416247|Hypnosis|hypnosis
756950|NCT00416247|Cortical excitability|cortical excitability
756951|NCT00416221|Depression|depression
756952|NCT00416221|Lexapro|lexapro
756953|NCT00416208|Multiple Myeloma|multiple myeloma
756954|NCT00416208|Clinical trial|clinical trial
756955|NCT00416208|Bortezomib|bortezomib
756956|NCT00416208|PS341|ps341
756957|NCT00416208|Proteasome inhibitor|proteasome inhibitor
756958|NCT00416208|Consolidation therapy|consolidation therapy
756959|NCT00416182|Cystic fibrosis|cystic fibrosis
756960|NCT00416182|chronic sinusitis|chronic sinusitis
756961|NCT00416182|mucolytic|mucolytic
756962|NCT00416169|Frontotemporal Dementia|frontotemporal dementia
756963|NCT00416169|Pick Complex|pick complex
756964|NCT00416169|galantamine hydrobromide|galantamine hydrobromide
756965|NCT00416156|Obesity|obesity
756966|NCT00416156|Inflammation|inflammation
756967|NCT00416143|Bed rest for idiopathic sudden sensorineural hearing loss|bed rest for idiopathic sudden sensorineural hearing loss
756968|NCT00416130|Phase I/II Clinical Trial|phase i/ii clinical trial
756969|NCT00416130|Vorinostat|vorinostat
756970|NCT00416130|SAHA|saha
756971|NCT00416130|Recurrent Breast Cancer|recurrent breast cancer
756972|NCT00416130|Metastatic Breast Cancer|metastatic breast cancer
756973|NCT00416117|Neck pain|neck pain
756974|NCT00416117|Cervical pain|cervical pain
756975|NCT00416117|Radicular pain|radicular pain
756976|NCT00416117|Manual therapy|manual therapy
756977|NCT00416117|Mobilization|mobilization
756978|NCT00416117|Manipulation|manipulation
756979|NCT00416104|analgesia|analgesia
756980|NCT00416091|Tourette disorder, ADHD, comorbidity, neuropsychological|tourette disorder, adhd, comorbidity, neuropsychological
756981|NCT00416078|technology development and assessment|technology development and assessment
756990|NCT00416052|osteodensitometry|osteodensitometry
756991|NCT00416039|midazolam|midazolam
756992|NCT00416039|sublingual|sublingual
756993|NCT00416039|oral morphine|oral morphine
756994|NCT00416039|children|children
756995|NCT00416039|bone fracture|bone fracture
756996|NCT00416039|bone fracture with a deformed member|bone fracture with a deformed member
756997|NCT00416026|Quality improvement|quality improvement
756998|NCT00416026|Patient-centered care|patient-centered care
756999|NCT00416026|Acute coronary syndrome|acute coronary syndrome
757000|NCT00416026|Telephone counseling|telephone counseling
757001|NCT00416013|Beta Natriuretic Peptide|beta natriuretic peptide
757002|NCT00416013|Troponin|troponin
757003|NCT00416013|Hemodialysis|hemodialysis
757004|NCT00416000|Open/Elective EVAR patients|open/elective evar patients
757005|NCT00415987|Multiple Myeloma|multiple myeloma
757006|NCT00415974|Weight Loss|weight loss
757007|NCT00415974|Obesity|obesity
757008|NCT00415974|Overweight|overweight
757009|NCT00415974|Physical Activity|physical activity
757010|NCT00415974|Nutrition|nutrition
757011|NCT00415974|Primary Care Physicians|primary care physicians
757012|NCT00415974|Primary Care|primary care
757013|NCT00415974|Counseling|counseling
757014|NCT00415974|Adolescent|adolescent
757015|NCT00415961|Percutaneous Coronary Intervention (PCI)|percutaneous coronary intervention (pci)
757016|NCT00415961|Drug-eluting stent (DES)|drug-eluting stent (des)
757017|NCT00415948|Heart|heart
757018|NCT00415948|Cardiac|cardiac
757019|NCT00415948|Acute Coronary Syndrome|acute coronary syndrome
757020|NCT00415948|Sample Procurement|sample procurement
757021|NCT00415922|Bioequivalence|bioequivalence
757022|NCT00415922|bioavailability|bioavailability
757023|NCT00415922|carbidopa|carbidopa
757024|NCT00415922|levodopa|levodopa
757025|NCT00415922|entacapone|entacapone
757026|NCT00415922|fasting condition|fasting condition
757027|NCT00415922|Healthy volunteers study|healthy volunteers study
757028|NCT00415909|Leukemia|leukemia
757029|NCT00415909|Chronic Myelogenous Leukemia|chronic myelogenous leukemia
757030|NCT00415909|CML|cml
757031|NCT00415909|Imatinib|imatinib
757032|NCT00415909|Gleevec|gleevec
757033|NCT00415909|TALL-104|tall-104
757034|NCT00415896|weaning|weaning
757035|NCT00415896|work of breathing|work of breathing
757036|NCT00415896|spontaneous breathing trial|spontaneous breathing trial
757037|NCT00415896|rapid shallow breathing|rapid shallow breathing
757038|NCT00415883|Relative bioavailability, formulation, Japanese, valsartan, healthy subjects|relative bioavailability, formulation, japanese, valsartan, healthy subjects
757039|NCT00415870|Overweight|overweight
757040|NCT00415870|Cell Phone|cell phone
757041|NCT00415870|Technology|technology
757042|NCT00415857|Chronic Myelogenous Leukemia|chronic myelogenous leukemia
757043|NCT00415857|Leukemia|leukemia
757044|NCT00415857|Peptide Vaccine|peptide vaccine
757045|NCT00415857|PR1 Peptide|pr1 peptide
757046|NCT00415857|Imatinib|imatinib
757047|NCT00415857|Gleevec|gleevec
757048|NCT00415857|GM-CSF|gm-csf
757049|NCT00415857|Sargramostim|sargramostim
757050|NCT00415857|Leukine|leukine
757051|NCT00415857|Peginterferon alfa-2b|peginterferon alfa-2b
757052|NCT00415857|Peg-Intron|peg-intron
757053|NCT00415844|Bioequivalence|bioequivalence
757054|NCT00415844|bioavailability|bioavailability
757055|NCT00415844|carbidopa|carbidopa
757056|NCT00415844|levodopa|levodopa
757057|NCT00415844|entacapone|entacapone
757058|NCT00415844|fasting condition|fasting condition
757059|NCT00415844|Healthy volunteers study|healthy volunteers study
757060|NCT00415831|Bioequivalence|bioequivalence
757061|NCT00415831|bioavailability|bioavailability
757062|NCT00415831|carbidopa|carbidopa
757063|NCT00415831|levodopa|levodopa
757064|NCT00415831|entacapone|entacapone
757065|NCT00415831|fed condition|fed condition
757066|NCT00415831|Healthy volunteers study|healthy volunteers study
757067|NCT00415818|Lung Cancer|lung cancer
757068|NCT00415818|NSCLC|nsclc
757069|NCT00415818|Cancer Vaccine|cancer vaccine
757070|NCT00415818|Stage IV Non-Small Cell Lung Cancer|stage iv non-small cell lung cancer
757071|NCT00415818|Stage IIIb Non-Small Cell Lung Cancer with effusion|stage iiib non-small cell lung cancer with effusion
757072|NCT00415792|Ovulation induction|ovulation induction
757073|NCT00415792|hCG|hcg
757074|NCT00415792|GnRH agonist|gnrh agonist
757075|NCT00415792|hyper-responders|hyper-responders
757076|NCT00415779|hormone refractory|hormone refractory
757077|NCT00415779|bone metastasis|bone metastasis
757078|NCT00415779|chemotherapy|chemotherapy
757079|NCT00415779|biphosphonates|biphosphonates
757080|NCT00415766|recombinant hCG|recombinant hcg
757081|NCT00415766|urinary hCG|urinary hcg
757082|NCT00415740|Bioequivalence|bioequivalence
757083|NCT00415740|bioavailability|bioavailability
757084|NCT00415740|carbidopa|carbidopa
757085|NCT00415740|levodopa|levodopa
757086|NCT00415740|entacapone|entacapone
757087|NCT00415740|fasting|fasting
757088|NCT00415740|Healthy volunteers study|healthy volunteers study
757089|NCT00415714|Primary Insomnia|primary insomnia
757090|NCT00415714|Chronic Insomnia|chronic insomnia
757091|NCT00415714|Biofeedback|biofeedback
757092|NCT00415714|Sleeplessness|sleeplessness
757095|NCT00415701|Adrenocortical Insufficiency|adrenocortical insufficiency
757096|NCT00415701|Hemodynamic Process|hemodynamic process
757097|NCT00415701|Vasoactive Agonists|vasoactive agonists
757098|NCT00415701|Coronary Artery Bypass|coronary artery bypass
757099|NCT00415701|Ischemic Coronary Heart Disease|ischemic coronary heart disease
757100|NCT00415701|Mitral valve reconstruction/replacement|mitral valve reconstruction/replacement
757101|NCT00415701|Mitral valve regurgitation|mitral valve regurgitation
757102|NCT00415701|Heart Valve Prosthesis|heart valve prosthesis
757103|NCT00415701|Cardiopulmonary Bypass|cardiopulmonary bypass
757104|NCT00415688|lifestyle modification|lifestyle modification
757105|NCT00415688|weight loss|weight loss
757106|NCT00415688|hyperglycemia|hyperglycemia
757107|NCT00415688|hypoglycemic agents|hypoglycemic agents
757108|NCT00415675|Lung Cancer|lung cancer
757109|NCT00415675|Abdominal Cancer|abdominal cancer
757110|NCT00415675|Tissue Motion|tissue motion
757111|NCT00415675|Breathing|breathing
757112|NCT00415675|Motion CT Scans|motion ct scans
757113|NCT00415649|HIV Preventive Vaccine|hiv preventive vaccine
757114|NCT00415649|HIV Seronegativity|hiv seronegativity
757115|NCT00415610|cerebral hemorrhage|cerebral hemorrhage
757116|NCT00415610|intracerebral hemorrhage|intracerebral hemorrhage
757117|NCT00415610|stroke|stroke
757118|NCT00415610|hypertension|hypertension
757119|NCT00415610|blood pressure|blood pressure
757120|NCT00415610|nicardipine|nicardipine
757121|NCT00415610|antihypertensive agent|antihypertensive agent
757122|NCT00415610|hematoma expansion|hematoma expansion
757123|NCT00415597|chronic pain|chronic pain
757124|NCT00415597|joint pain|joint pain
757125|NCT00415597|back pain|back pain
757126|NCT00415597|diabetic peripheral neuropathy|diabetic peripheral neuropathy
757127|NCT00415597|post herpetic neuralgia|post herpetic neuralgia
757128|NCT00415597|ALO-01|alo-01
757129|NCT00415597|Embeda|embeda
757130|NCT00415597|Chronic Non-Malignant Pain|chronic non-malignant pain
757131|NCT00415584|hypercalcemia|hypercalcemia
757132|NCT00415584|transplant|transplant
757133|NCT00415571|Hypogonadism|hypogonadism
757134|NCT00415571|Erectile Dysfunction|erectile dysfunction
757135|NCT00415558|Atrial Fibrillation|atrial fibrillation
757136|NCT00415545|Heart Failure|heart failure
757137|NCT00415545|Patient Education|patient education
757138|NCT00415532|splenectomy|splenectomy
757139|NCT00415532|platelet|platelet
757140|NCT00415532|AMG 531|amg 531
757141|NCT00415532|thrombopoietin|thrombopoietin
757142|NCT00415532|blood disorder|blood disorder
757143|NCT00415532|bleeding disorder|bleeding disorder
757144|NCT00415532|immune thrombocytopenic purpura|immune thrombocytopenic purpura
757145|NCT00415532|idiopathic thrombocytopenic purpura|idiopathic thrombocytopenic purpura
757146|NCT00415532|immune (idiopathic) thrombocytopenic purpura|immune (idiopathic) thrombocytopenic purpura
757147|NCT00415532|TPO|tpo
757148|NCT00415532|thrombopoietic protein|thrombopoietic protein
757149|NCT00415519|Amyotrophic lateral sclerosis|amyotrophic lateral sclerosis
757150|NCT00415519|free radical scavenger|free radical scavenger
757151|NCT00415493|rhinitis|rhinitis
757152|NCT00415493|non-allergic rhinitis|non-allergic rhinitis
757153|NCT00415493|rhinomanometry|rhinomanometry
757154|NCT00415493|cold air|cold air
757155|NCT00415493|triggers: cold, dry air inhalation|triggers: cold, dry air inhalation
757156|NCT00415493|warm, most air inhalation|warm, most air inhalation
757157|NCT00415493|Nonallergic rhinitis; normal controls|nonallergic rhinitis; normal controls
757158|NCT00415467|Brain Tumor|brain tumor
757159|NCT00415467|Radiation Therapy System|radiation therapy system
757160|NCT00415467|GliaSite RTS|gliasite rts
757161|NCT00415454|Pancreatic Cancer|pancreatic cancer
757162|NCT00415441|physiotherapy|physiotherapy
757163|NCT00415441|exercise|exercise
757164|NCT00415441|manual therapy|manual therapy
757165|NCT00415441|shoulder pain|shoulder pain
757166|NCT00415441|rotator cuff|rotator cuff
757167|NCT00415415|Racial Disparities|racial disparities
757168|NCT00415415|Psychosocial Risk Factors|psychosocial risk factors
757169|NCT00415415|Neighborhood Socioeconomic Status|neighborhood socioeconomic status
757170|NCT00415415|CVD|cvd
757171|NCT00415415|CHD|chd
757172|NCT00415402|Vitamin D3|vitamin d3
757173|NCT00415402|morbidity|morbidity
757174|NCT00415402|mortality|mortality
757175|NCT00415402|low birth weight|low birth weight
757176|NCT00415402|supplementation|supplementation
757177|NCT00415402|TH1|th1
757178|NCT00415402|TH2|th2
757180|NCT00415402|Neopterin|neopterin
757181|NCT00415402|immune response|immune response
757182|NCT00415389|Stroke|stroke
757183|NCT00415389|interactive educational program|interactive educational program
757184|NCT00415389|acute ischemic stroke|acute ischemic stroke
757185|NCT00415376|seizure|seizure
757186|NCT00415376|adult tumors metastatic to brain|adult tumors metastatic to brain
757419|NCT00414583|Fabry Disease|fabry disease
757187|NCT00415376|unspecified adult solid tumor, protocol specific|unspecified adult solid tumor, protocol specific
757188|NCT00415350|Bronchiectasis|bronchiectasis
757189|NCT00415350|Macrolide|macrolide
757190|NCT00415350|Azithromycin|azithromycin
757191|NCT00415350|Antibiotic prophylaxis|antibiotic prophylaxis
757192|NCT00415350|Immunomodulation|immunomodulation
757193|NCT00415350|Inflammation|inflammation
757194|NCT00415350|Lung function|lung function
757196|NCT00415350|Bacterial colonization|bacterial colonization
757197|NCT00415337|lung|lung
757198|NCT00415337|neoplasm|neoplasm
757199|NCT00415337|bronchoscopy|bronchoscopy
757200|NCT00415337|ultrasonography|ultrasonography
757201|NCT00415337|histology|histology
757202|NCT00415311|Liver Transplantation|liver transplantation
757203|NCT00415311|rhMBL|rhmbl
757204|NCT00415298|recurrent squamous cell carcinoma of the hypopharynx|recurrent squamous cell carcinoma of the hypopharynx
757205|NCT00415298|recurrent squamous cell carcinoma of the larynx|recurrent squamous cell carcinoma of the larynx
757206|NCT00415298|recurrent squamous cell carcinoma of the lip and oral cavity|recurrent squamous cell carcinoma of the lip and oral cavity
757207|NCT00415298|recurrent squamous cell carcinoma of the nasopharynx|recurrent squamous cell carcinoma of the nasopharynx
757208|NCT00415298|recurrent squamous cell carcinoma of the oropharynx|recurrent squamous cell carcinoma of the oropharynx
757209|NCT00415298|stage III squamous cell carcinoma of the hypopharynx|stage iii squamous cell carcinoma of the hypopharynx
757210|NCT00415298|stage III squamous cell carcinoma of the larynx|stage iii squamous cell carcinoma of the larynx
757211|NCT00415298|stage III squamous cell carcinoma of the lip and oral cavity|stage iii squamous cell carcinoma of the lip and oral cavity
757212|NCT00415298|stage III squamous cell carcinoma of the nasopharynx|stage iii squamous cell carcinoma of the nasopharynx
757213|NCT00415298|stage III squamous cell carcinoma of the oropharynx|stage iii squamous cell carcinoma of the oropharynx
757214|NCT00415298|stage IV squamous cell carcinoma of the hypopharynx|stage iv squamous cell carcinoma of the hypopharynx
757215|NCT00415298|stage IV squamous cell carcinoma of the larynx|stage iv squamous cell carcinoma of the larynx
757216|NCT00415298|stage IV squamous cell carcinoma of the lip and oral cavity|stage iv squamous cell carcinoma of the lip and oral cavity
757217|NCT00415298|stage IV squamous cell carcinoma of the nasopharynx|stage iv squamous cell carcinoma of the nasopharynx
757218|NCT00415298|stage IV squamous cell carcinoma of the oropharynx|stage iv squamous cell carcinoma of the oropharynx
757219|NCT00415285|Breast|breast
757220|NCT00415285|Cancer|cancer
757221|NCT00415285|Early-Stage|early-stage
757222|NCT00415285|Chemotherapy|chemotherapy
757223|NCT00415233|stage I follicular thyroid cancer|stage i follicular thyroid cancer
757224|NCT00415233|stage I papillary thyroid cancer|stage i papillary thyroid cancer
757225|NCT00415233|stage II follicular thyroid cancer|stage ii follicular thyroid cancer
757226|NCT00415233|stage II papillary thyroid cancer|stage ii papillary thyroid cancer
757227|NCT00415233|stage III follicular thyroid cancer|stage iii follicular thyroid cancer
757228|NCT00415233|stage III papillary thyroid cancer|stage iii papillary thyroid cancer
757229|NCT00415233|stage IV follicular thyroid cancer|stage iv follicular thyroid cancer
757230|NCT00415233|stage IV papillary thyroid cancer|stage iv papillary thyroid cancer
757231|NCT00415220|Chiropractic|chiropractic
757232|NCT00415220|Manipulation|manipulation
757233|NCT00415220|Back surgery|back surgery
757234|NCT00415220|Herniated lumbar disc|herniated lumbar disc
757235|NCT00415220|Sciatica|sciatica
757236|NCT00415220|Lumbar microdiscectomy|lumbar microdiscectomy
757237|NCT00415220|Cost-effectiveness|cost-effectiveness
757238|NCT00415207|CYP2C8|cyp2c8
757239|NCT00415207|MDR1|mdr1
757240|NCT00415207|Pharmacogenetics|pharmacogenetics
757241|NCT00415207|Paclitaxel|paclitaxel
757242|NCT00415181|CYP2C8|cyp2c8
757243|NCT00415181|MDR1|mdr1
757244|NCT00415181|Pharmacogenetics|pharmacogenetics
757245|NCT00415181|Paclitaxel|paclitaxel
757246|NCT00415142|Depression|depression
757247|NCT00415142|Major depressive disorders|major depressive disorders
757248|NCT00415142|Controlled clinical trial|controlled clinical trial
757249|NCT00415129|Influenza|influenza
757250|NCT00415129|Orthomyxoviridae Infections|orthomyxoviridae infections
757251|NCT00415129|Influenza Pandemics|influenza pandemics
757252|NCT00415129|A/H5N1 strain|a/h5n1 strain
757253|NCT00415116|unspecified adult solid tumor, protocol specific|unspecified adult solid tumor, protocol specific
757254|NCT00415103|Emesis|emesis
757255|NCT00415103|Nausea|nausea
757256|NCT00415103|leukemia|leukemia
757257|NCT00415103|lymphoma|lymphoma
757258|NCT00415090|Nevirapine|nevirapine
757259|NCT00415090|Antiretroviral treatment|antiretroviral treatment
757260|NCT00415090|Triple nucleoside therapy|triple nucleoside therapy
757261|NCT00415090|HIV|hiv
757262|NCT00415090|Treatment Experienced|treatment experienced
757263|NCT00415064|Multiple Myeloma|multiple myeloma
757264|NCT00415064|Perifosine|perifosine
757265|NCT00415064|Lenalidomide|lenalidomide
757266|NCT00415064|Dexamethasone|dexamethasone
757267|NCT00415051|Rift Valley Fever, vaccine|rift valley fever, vaccine
757268|NCT00415038|hypertension|hypertension
757269|NCT00415038|pharmacogenomic|pharmacogenomic
757270|NCT00415038|adducin|adducin
757271|NCT00415038|ouabain|ouabain
757272|NCT00415038|rostafuroxin|rostafuroxin
757273|NCT00415025|long-term effects secondary to cancer therapy in adults|long-term effects secondary to cancer therapy in adults
757274|NCT00415025|oral complications of radiation therapy|oral complications of radiation therapy
757275|NCT00415025|radiation toxicity|radiation toxicity
757276|NCT00415025|stage III squamous cell carcinoma of the hypopharynx|stage iii squamous cell carcinoma of the hypopharynx
757277|NCT00415025|stage IV squamous cell carcinoma of the hypopharynx|stage iv squamous cell carcinoma of the hypopharynx
757278|NCT00415025|stage III squamous cell carcinoma of the larynx|stage iii squamous cell carcinoma of the larynx
757279|NCT00415025|stage III verrucous carcinoma of the larynx|stage iii verrucous carcinoma of the larynx
757280|NCT00415025|stage IV squamous cell carcinoma of the larynx|stage iv squamous cell carcinoma of the larynx
757281|NCT00415025|stage IV verrucous carcinoma of the larynx|stage iv verrucous carcinoma of the larynx
757282|NCT00415025|stage III lymphoepithelioma of the oropharynx|stage iii lymphoepithelioma of the oropharynx
757283|NCT00415025|stage III squamous cell carcinoma of the oropharynx|stage iii squamous cell carcinoma of the oropharynx
757284|NCT00415025|stage IV lymphoepithelioma of the oropharynx|stage iv lymphoepithelioma of the oropharynx
757285|NCT00415025|stage IV squamous cell carcinoma of the oropharynx|stage iv squamous cell carcinoma of the oropharynx
757286|NCT00415025|stage III basal cell carcinoma of the lip|stage iii basal cell carcinoma of the lip
757287|NCT00415025|stage III squamous cell carcinoma of the lip and oral cavity|stage iii squamous cell carcinoma of the lip and oral cavity
757288|NCT00415025|stage IV basal cell carcinoma of the lip|stage iv basal cell carcinoma of the lip
757289|NCT00415025|stage IV squamous cell carcinoma of the lip and oral cavity|stage iv squamous cell carcinoma of the lip and oral cavity
757290|NCT00415025|stage III adenoid cystic carcinoma of the oral cavity|stage iii adenoid cystic carcinoma of the oral cavity
757291|NCT00415025|stage III mucoepidermoid carcinoma of the oral cavity|stage iii mucoepidermoid carcinoma of the oral cavity
757292|NCT00415025|stage III verrucous carcinoma of the oral cavity|stage iii verrucous carcinoma of the oral cavity
757293|NCT00415025|stage IV adenoid cystic carcinoma of the oral cavity|stage iv adenoid cystic carcinoma of the oral cavity
757294|NCT00415025|stage IV mucoepidermoid carcinoma of the oral cavity|stage iv mucoepidermoid carcinoma of the oral cavity
757295|NCT00415025|stage IV verrucous carcinoma of the oral cavity|stage iv verrucous carcinoma of the oral cavity
757296|NCT00415025|metastatic squamous neck cancer with occult primary|metastatic squamous neck cancer with occult primary
757297|NCT00415025|stage III lymphoepithelioma of the nasopharynx|stage iii lymphoepithelioma of the nasopharynx
757298|NCT00415025|stage III squamous cell carcinoma of the nasopharynx|stage iii squamous cell carcinoma of the nasopharynx
757299|NCT00415025|stage IV lymphoepithelioma of the nasopharynx|stage iv lymphoepithelioma of the nasopharynx
757300|NCT00415025|stage IV squamous cell carcinoma of the nasopharynx|stage iv squamous cell carcinoma of the nasopharynx
757301|NCT00415025|stage III esthesioneuroblastoma of the paranasal sinus and nasal cavity|stage iii esthesioneuroblastoma of the paranasal sinus and nasal cavity
757302|NCT00415025|stage III inverted papilloma of the paranasal sinus and nasal cavity|stage iii inverted papilloma of the paranasal sinus and nasal cavity
757303|NCT00415025|stage III midline lethal granuloma of the paranasal sinus and nasal cavity|stage iii midline lethal granuloma of the paranasal sinus and nasal cavity
757304|NCT00415025|stage III squamous cell carcinoma of the paranasal sinus and nasal cavity|stage iii squamous cell carcinoma of the paranasal sinus and nasal cavity
757305|NCT00415025|stage IV esthesioneuroblastoma of the paranasal sinus and nasal cavity|stage iv esthesioneuroblastoma of the paranasal sinus and nasal cavity
757306|NCT00415025|stage IV inverted papilloma of the paranasal sinus and nasal cavity|stage iv inverted papilloma of the paranasal sinus and nasal cavity
757307|NCT00415025|stage IV midline lethal granuloma of the paranasal sinus and nasal cavity|stage iv midline lethal granuloma of the paranasal sinus and nasal cavity
757308|NCT00415025|stage IV squamous cell carcinoma of the paranasal sinus and nasal cavity|stage iv squamous cell carcinoma of the paranasal sinus and nasal cavity
757309|NCT00415025|stage III salivary gland cancer|stage iii salivary gland cancer
757310|NCT00415025|stage IV salivary gland cancer|stage iv salivary gland cancer
757311|NCT00415025|recurrent salivary gland cancer|recurrent salivary gland cancer
757312|NCT00415025|recurrent lymphoepithelioma of the nasopharynx|recurrent lymphoepithelioma of the nasopharynx
757313|NCT00415025|recurrent lymphoepithelioma of the oropharynx|recurrent lymphoepithelioma of the oropharynx
757314|NCT00415025|recurrent squamous cell carcinoma of the hypopharynx|recurrent squamous cell carcinoma of the hypopharynx
757315|NCT00415025|recurrent squamous cell carcinoma of the larynx|recurrent squamous cell carcinoma of the larynx
757316|NCT00415025|recurrent squamous cell carcinoma of the nasopharynx|recurrent squamous cell carcinoma of the nasopharynx
757317|NCT00415025|recurrent squamous cell carcinoma of the oropharynx|recurrent squamous cell carcinoma of the oropharynx
757318|NCT00415025|recurrent verrucous carcinoma of the larynx|recurrent verrucous carcinoma of the larynx
757319|NCT00415025|recurrent adenoid cystic carcinoma of the oral cavity|recurrent adenoid cystic carcinoma of the oral cavity
757320|NCT00415025|recurrent mucoepidermoid carcinoma of the oral cavity|recurrent mucoepidermoid carcinoma of the oral cavity
757321|NCT00415025|recurrent verrucous carcinoma of the oral cavity|recurrent verrucous carcinoma of the oral cavity
757322|NCT00415025|recurrent esthesioneuroblastoma of the paranasal sinus and nasal cavity|recurrent esthesioneuroblastoma of the paranasal sinus and nasal cavity
757323|NCT00415025|recurrent inverted papilloma of the paranasal sinus and nasal cavity|recurrent inverted papilloma of the paranasal sinus and nasal cavity
757324|NCT00415025|recurrent midline lethal granuloma of the paranasal sinus and nasal cavity|recurrent midline lethal granuloma of the paranasal sinus and nasal cavity
757325|NCT00415025|recurrent squamous cell carcinoma of the paranasal sinus and nasal cavity|recurrent squamous cell carcinoma of the paranasal sinus and nasal cavity
757326|NCT00415025|recurrent basal cell carcinoma of the lip|recurrent basal cell carcinoma of the lip
757327|NCT00415025|recurrent squamous cell carcinoma of the lip and oral cavity|recurrent squamous cell carcinoma of the lip and oral cavity
757328|NCT00415025|recurrent metastatic squamous neck cancer with occult primary|recurrent metastatic squamous neck cancer with occult primary
757329|NCT00415025|untreated metastatic squamous neck cancer with occult primary|untreated metastatic squamous neck cancer with occult primary
757330|NCT00414999|Macular degeneration|macular degeneration
757331|NCT00414999|Vascular diseases|vascular diseases
757332|NCT00414999|Retinal disorders|retinal disorders
757333|NCT00414999|Macular edema|macular edema
757335|NCT00414960|Prevention|prevention
757336|NCT00414947|Bioequivalence|bioequivalence
757337|NCT00414947|safety|safety
757338|NCT00414947|LAF237|laf237
757339|NCT00414947|vildagliptin|vildagliptin
757340|NCT00414947|Chinese|chinese
757341|NCT00414947|healthy subjects|healthy subjects
757342|NCT00414934|cancer|cancer
757343|NCT00414934|bone scan|bone scan
757344|NCT00414934|NaF bone PET|naf bone pet
757345|NCT00414921|Attention deficit hyperactivity disorder|attention deficit hyperactivity disorder
757346|NCT00414921|ADHD|adhd
757347|NCT00414921|clonidine|clonidine
757348|NCT00414921|methylphenidate|methylphenidate
757349|NCT00414921|MPH|mph
757350|NCT00414908|Chronic Pancreatitis|chronic pancreatitis
757351|NCT00414908|Pancreatectomy|pancreatectomy
757352|NCT00414908|Pancreatic Exocrine Insufficiency|pancreatic exocrine insufficiency
757353|NCT00414882|TB, tuberculosis, Mycobacterium tuberculosis, Brazil|tb, tuberculosis, mycobacterium tuberculosis, brazil
757354|NCT00414869|Liver|liver
757355|NCT00414869|Portal pressure|portal pressure
757356|NCT00414869|Fibrosis|fibrosis
757357|NCT00414869|Nitric oxide|nitric oxide
757358|NCT00414856|GERD|gerd
757359|NCT00414856|gastroesophageal reflux disease|gastroesophageal reflux disease
757360|NCT00414856|meal-induced gastroesophageal reflux events|meal-induced gastroesophageal reflux events
757361|NCT00414843|Storage|storage
757362|NCT00414843|Bile|bile
757363|NCT00414843|Biomarkers|biomarkers
757364|NCT00414843|biliary malignancies|biliary malignancies
757365|NCT00414830|prevention|prevention
757366|NCT00414830|health technology assessment|health technology assessment
757367|NCT00414830|population based|population based
757368|NCT00414830|fracture|fracture
757369|NCT00414817|Inhaled Corticosteroids|inhaled corticosteroids
757370|NCT00414817|ICS|ics
757371|NCT00414817|Adherence|adherence
757372|NCT00414804|Pain|pain
757373|NCT00414804|Neurostimulation|neurostimulation
757374|NCT00414778|Safety, pharmacokinetics, oral, single dose, multiple dose, LHT344, Chinese, healthy subjects|safety, pharmacokinetics, oral, single dose, multiple dose, lht344, chinese, healthy subjects
757375|NCT00414765|Metastatic Renal Cell Carcinoma|metastatic renal cell carcinoma
757376|NCT00414765|Metastatic Melanoma|metastatic melanoma
757377|NCT00414765|Aldesleukin|aldesleukin
757378|NCT00414765|IL-2|il-2
757379|NCT00414752|Smoking, abstinence, craving, smoker, AFQ056, nicotine, placebo|smoking, abstinence, craving, smoker, afq056, nicotine, placebo
757380|NCT00414739|growth of dendritic cells|growth of dendritic cells
757381|NCT00414739|prevention|prevention
757382|NCT00414726|ischemic stroke|ischemic stroke
757383|NCT00414726|normobaric oxygen therapy|normobaric oxygen therapy
757384|NCT00414713|Upper GI bleeding|upper gi bleeding
757385|NCT00414713|Cirrhosis|cirrhosis
757386|NCT00414713|Portal hypertension|portal hypertension
757387|NCT00414713|Non-variceal bleeding|non-variceal bleeding
757388|NCT00414713|Transfusion|transfusion
757389|NCT00414700|Cartilage|cartilage
757390|NCT00414700|Articular|articular
757392|NCT00414700|Knee|knee
757393|NCT00414687|Primary or secondary Pulmonary hypertension|primary or secondary pulmonary hypertension
757394|NCT00414687|Iloprost|iloprost
757395|NCT00414687|Inhaled|inhaled
757396|NCT00414687|Long-term treatment|long-term treatment
757397|NCT00414661|Observational non-interventional long-term safety|observational non-interventional long-term safety
757398|NCT00414648|Lymphangiomyomatosis|lymphangiomyomatosis
757399|NCT00414648|Lung Disease|lung disease
757400|NCT00414635|HIV/AIDS|hiv/aids
757401|NCT00414635|efavirenz|efavirenz
757402|NCT00414635|tenofovir|tenofovir
757403|NCT00414635|emtricitabine|emtricitabine
757404|NCT00414635|FOTO|foto
757405|NCT00414635|treatment interruption|treatment interruption
757406|NCT00414635|Atripla|atripla
757407|NCT00414635|Truvada|truvada
757408|NCT00414635|Treatment Experienced|treatment experienced
757409|NCT00414622|Alzheimer|alzheimer
757410|NCT00414622|Probable Alzheimer disease|probable alzheimer disease
757411|NCT00414609|myocardial infarction, aliskiren, heart failure|myocardial infarction, aliskiren, heart failure
757412|NCT00414609|Post acute myocardial infarction with systolic dysfunction|post acute myocardial infarction with systolic dysfunction
757413|NCT00414583|Cerebrovascular Accident|cerebrovascular accident
757414|NCT00414583|Cerebrovascular Accident, Acute|cerebrovascular accident, acute
757415|NCT00414583|CVA (Cerebrovascular Accident)|cva (cerebrovascular accident)
757416|NCT00414583|Cerebral Stroke|cerebral stroke
757417|NCT00414583|Stroke, Acute|stroke, acute
757418|NCT00414583|Cerebrovascular Stroke|cerebrovascular stroke
757420|NCT00414583|Anderson-Fabry Disease|anderson-fabry disease
757421|NCT00414583|Fabry's Disease|fabry's disease
757422|NCT00414570|Positron Emission Tomography (PET)|positron emission tomography (pet)
757423|NCT00414570|3'-deoxy-3'(18F)fluorothymidine ([18]F-FLT)|3'-deoxy-3'(18f)fluorothymidine ([18]f-flt)
757424|NCT00414557|Musculoskeletal diseases|musculoskeletal diseases
757425|NCT00414557|Joint diseases|joint diseases
757426|NCT00414544|Nasolabial folds|nasolabial folds
757427|NCT00414544|Dermal filler|dermal filler
757428|NCT00414544|Injectable dermal filler|injectable dermal filler
757429|NCT00414544|Soft tissue augmentation|soft tissue augmentation
757430|NCT00414518|Acute Infection|acute infection
757431|NCT00414518|Early HIV Infection|early hiv infection
757432|NCT00414518|Short-Term Antiretroviral Therapy|short-term antiretroviral therapy
757433|NCT00414518|Treatment Interruption|treatment interruption
757434|NCT00414518|Antiretroviral Drug (ARV)|antiretroviral drug (arv)
757435|NCT00414518|ART|art
757436|NCT00414492|metastatic colorectal cancer|metastatic colorectal cancer
757437|NCT00414492|liver metastasis|liver metastasis
757438|NCT00414492|tumor margins|tumor margins
757439|NCT00414492|neoadjuvant therapy|neoadjuvant therapy
757440|NCT00414479|schistosomiasis|schistosomiasis
757441|NCT00414479|anaemia|anaemia
757442|NCT00414479|malaria|malaria
757443|NCT00414479|iron deficiency|iron deficiency
757444|NCT00414453|Neuropathic pain|neuropathic pain
757445|NCT00414453|Chronic pain|chronic pain
757446|NCT00414453|Multiple sclerosis|multiple sclerosis
757447|NCT00414453|Central neuropathic pain|central neuropathic pain
757448|NCT00414453|Peripheral neuropathic pain|peripheral neuropathic pain
757449|NCT00414453|Opioid analgesic|opioid analgesic
757450|NCT00414453|Lidocaine|lidocaine
757451|NCT00414440|end-stage renal disease, ESRD, autosomal dominant polycystic kidney disease, ADPKD, everolimus|end-stage renal disease, esrd, autosomal dominant polycystic kidney disease, adpkd, everolimus
757452|NCT00414427|Knee Osteoarthritis|knee osteoarthritis
757453|NCT00414427|Ultrasonography|ultrasonography
757454|NCT00414427|Corticosteroids|corticosteroids
757455|NCT00414414|TB|tb
757456|NCT00414414|Tuberculosis|tuberculosis
757457|NCT00414414|HIV|hiv
757458|NCT00414414|Co-infection|co-infection
757459|NCT00414414|Steroid|steroid
757460|NCT00414414|Prednisone|prednisone
757461|NCT00414414|oral corticosteroids|oral corticosteroids
757462|NCT00414414|TB Treatment|tb treatment
757463|NCT00414414|South Africa|south africa
757464|NCT00414388|AIPC|aipc
757465|NCT00414375|Perforated Appendicitis|perforated appendicitis
757466|NCT00414375|Abscess|abscess
757467|NCT00414375|Appendectomy|appendectomy
757468|NCT00414362|Bacteremia|bacteremia
757469|NCT00414362|Urinary Tract Infections|urinary tract infections
757470|NCT00414362|Fluoroquinolone|fluoroquinolone
757471|NCT00414349|Topical analgesic|topical analgesic
757472|NCT00414349|Multiple dose|multiple dose
757473|NCT00414336|Blood Stage|blood stage
757474|NCT00414336|Investigational|investigational
757475|NCT00414336|Endemic|endemic
757476|NCT00414336|Malaria|malaria
757477|NCT00414310|Decitabine|decitabine
757478|NCT00414310|Dacogen|dacogen
757479|NCT00414310|5-AZA|5-aza
757480|NCT00414310|Valproic Acid|valproic acid
757481|NCT00414310|Myelodysplastic Syndrome|myelodysplastic syndrome
757482|NCT00414310|Acute Myelogenous Leukemia|acute myelogenous leukemia
757483|NCT00414310|MDS|mds
757484|NCT00414310|AML|aml
757485|NCT00414297|CAD|cad
757486|NCT00414297|ECP|ecp
757487|NCT00414297|CFI|cfi
757488|NCT00414297|CPI|cpi
757489|NCT00414297|MPR|mpr
757490|NCT00414284|HIV/AIDS|hiv/aids
757491|NCT00414284|viremia|viremia
757492|NCT00414284|Kaletra|kaletra
757493|NCT00414284|pharmacokinetics|pharmacokinetics
757494|NCT00414284|viral load|viral load
757495|NCT00414284|LPV/r|lpv/r
757496|NCT00414284|Treatment Experienced|treatment experienced
757497|NCT00414271|gastric cancer, neo-adjuvant chemotherapy|gastric cancer, neo-adjuvant chemotherapy
757498|NCT00414258|Pain Response|pain response
757499|NCT00414232|Rectal Cancer|rectal cancer
757500|NCT00414232|Chemoradiation|chemoradiation
757501|NCT00414232|Rectal Cancer receiving chemoradiation.|rectal cancer receiving chemoradiation.
757502|NCT00414206|AMD|amd
757503|NCT00414206|Wet AMD|wet amd
757504|NCT00414193|AmpC beta-lactamase|ampc beta-lactamase
757505|NCT00414193|Bacteremia|bacteremia
757506|NCT00414193|Piperacillin|piperacillin
757507|NCT00414193|Tazobactam|tazobactam
757508|NCT00414167|Binge eating|binge eating
757509|NCT00414167|Obesity|obesity
757510|NCT00414167|Medication|medication
757511|NCT00414167|Craving|craving
757512|NCT00414167|Emotional eating|emotional eating
757513|NCT00414154|Group based patient education,|group based patient education,
757514|NCT00414154|multidisciplinary,|multidisciplinary,
757515|NCT00414154|physical activity,|physical activity,
757516|NCT00414154|adherence to treatment,|adherence to treatment,
757517|NCT00414154|quality of life|quality of life
757518|NCT00414141|Allergy|allergy
757519|NCT00414141|Allergoid|allergoid
757520|NCT00414141|Specific Immunotherapy|specific immunotherapy
757521|NCT00414128|vasculitis|vasculitis
757522|NCT00414128|ANCA|anca
757813|NCT00413270|nilotinib,|nilotinib,
757523|NCT00414128|mycophenolate mofetil|mycophenolate mofetil
757524|NCT00414128|cyclophosphamide|cyclophosphamide
757525|NCT00414128|Anti neutrophil cytoplasm antibody associated vasculitis|anti neutrophil cytoplasm antibody associated vasculitis
757526|NCT00414115|Observational controlled study|observational controlled study
757527|NCT00414115|Genomic biomarkers|genomic biomarkers
757528|NCT00414115|Adverse drug reaction|adverse drug reaction
757529|NCT00414115|In children OR adults|in children or adults
757530|NCT00414102|Chronic Insomnia|chronic insomnia
757531|NCT00414102|Sleep Initiation and Maintenance Disorder|sleep initiation and maintenance disorder
757532|NCT00414102|Drug Therapy|drug therapy
757533|NCT00414076|Uterine Leiomyosarcoma|uterine leiomyosarcoma
757534|NCT00414076|Uterine Neoplasm|uterine neoplasm
757535|NCT00414076|Uterine Sarcomas|uterine sarcomas
757536|NCT00414076|Uterine Cancer|uterine cancer
757537|NCT00414076|Uterus|uterus
757538|NCT00414076|LMS|lms
757539|NCT00414076|ER Positivity|er positivity
757540|NCT00414076|Femara|femara
757541|NCT00414076|Letrozole|letrozole
757542|NCT00414063|Fecal Energy|fecal energy
757543|NCT00414063|Urine Energy|urine energy
757544|NCT00414063|Bomb Calorimetry|bomb calorimetry
757545|NCT00414063|Gut Maintenance Flora|gut maintenance flora
757546|NCT00414063|Obesity|obesity
757547|NCT00414063|Energy Metabolism|energy metabolism
757548|NCT00414037|insomnia|insomnia
757549|NCT00414037|lunesta|lunesta
757550|NCT00414037|eszopiclone|eszopiclone
757551|NCT00414037|pain|pain
757552|NCT00414037|fMRI|fmri
757553|NCT00414024|Opioid, constipation, tegaserod|opioid, constipation, tegaserod
757554|NCT00414011|Removal of corneal epithelium followed by excimer laser treatment during prk|removal of corneal epithelium followed by excimer laser treatment during prk
757555|NCT00413998|Functional ischaemic mitral regurgitation|functional ischaemic mitral regurgitation
757556|NCT00413985|Low Birth Weight|low birth weight
757557|NCT00413985|Fortified Human Milk|fortified human milk
757558|NCT00413985|breastfeeding|breastfeeding
757559|NCT00413985|infants|infants
757560|NCT00413985|growth|growth
757561|NCT00413959|NHL|nhl
757562|NCT00413946|Premature infant|premature infant
757563|NCT00413946|developmental outcome|developmental outcome
757564|NCT00413933|falls|falls
757565|NCT00413933|prevention|prevention
757566|NCT00413933|elderly|elderly
757567|NCT00413933|multidisciplinary intervention|multidisciplinary intervention
757568|NCT00413933|health care utilization|health care utilization
757569|NCT00413920|Steroids avoidance,|steroids avoidance,
757570|NCT00413920|enteric-coated mycophenolate sodium (EC-MPS),|enteric-coated mycophenolate sodium (ec-mps),
757571|NCT00413920|de novo renal transplantation|de novo renal transplantation
757572|NCT00413881|Residual refractive error left over from initial LASIK correction.|residual refractive error left over from initial lasik correction.
757573|NCT00413881|Higher Order aberrations measured using a wavefront analyzer.|higher order aberrations measured using a wavefront analyzer.
757574|NCT00413868|Myopia with our without astigmatism|myopia with our without astigmatism
757575|NCT00413855|Abdominal pain|abdominal pain
757576|NCT00413855|Appendectomy|appendectomy
757577|NCT00413855|Laparoscopy|laparoscopy
757578|NCT00413855|Chronic appendicitis|chronic appendicitis
757579|NCT00413855|Appendicopathy|appendicopathy
757580|NCT00413842|Transcranial Direct Current Stimulation (tDCS)|transcranial direct current stimulation (tdcs)
757581|NCT00413842|Plasticity|plasticity
757582|NCT00413842|Primary Motor Cortex|primary motor cortex
757583|NCT00413842|Cerebellum|cerebellum
757584|NCT00413842|Transcranial Magnetic Stimulation (TMS)|transcranial magnetic stimulation (tms)
757585|NCT00413842|Healthy Volunteer|healthy volunteer
757586|NCT00413842|HV|hv
757587|NCT00413829|age related macular degeneration|age related macular degeneration
757588|NCT00413829|anti-VEGF therapy|anti-vegf therapy
757589|NCT00413816|Anemia|anemia
757590|NCT00413816|Critically ill|critically ill
757591|NCT00413803|Hemodialysis|hemodialysis
757592|NCT00413803|Nocturnal dialysis|nocturnal dialysis
757593|NCT00413803|Cardiovascular disease|cardiovascular disease
757594|NCT00413803|Quality of Life|quality of life
757595|NCT00413803|left ventricular hypertrophy|left ventricular hypertrophy
757596|NCT00413790|Heart rate, overactive bladder|heart rate, overactive bladder
757597|NCT00413751|Large pupils rendering night vision difficulties such as haloes, glare, and monocular diplopia|large pupils rendering night vision difficulties such as haloes, glare, and monocular diplopia
757598|NCT00413738|Central venous catheter|central venous catheter
757599|NCT00413738|Catheter related bloodstream infection|catheter related bloodstream infection
757600|NCT00413738|Heparin|heparin
757601|NCT00413738|Chlorhexidine|chlorhexidine
757602|NCT00413738|Sulfadiazine|sulfadiazine
757603|NCT00413725|HIV Seronegativity|hiv seronegativity
757604|NCT00413725|HIV Preventive Vaccine|hiv preventive vaccine
757605|NCT00413725|Adenovirus|adenovirus
757606|NCT00413712|Supraventricular Tachycardia|supraventricular tachycardia
757607|NCT00413712|Calcium Channel Blockers|calcium channel blockers
757608|NCT00413712|Verapamil|verapamil
757609|NCT00413712|Diltiazem|diltiazem
757610|NCT00413712|Adenosine|adenosine
757611|NCT00413699|long-term|long-term
757612|NCT00413699|open-label|open-label
757613|NCT00413699|safety|safety
758310|NCT00411385|HepC|hepc
757614|NCT00413686|Mixed solid tumors|mixed solid tumors
757615|NCT00413673|Naturally occurring low to moderate myopia, with or without low levels of astigmatism in U.S. Army personnel|naturally occurring low to moderate myopia, with or without low levels of astigmatism in u.s. army personnel
757616|NCT00413660|DMARD therapy|dmard therapy
757617|NCT00413647|CardioPET|cardiopet
757618|NCT00413647|Coronary Artery Disease|coronary artery disease
757619|NCT00413647|Electrocardiogram|electrocardiogram
757620|NCT00413647|Radiation Dosimetry|radiation dosimetry
757622|NCT00413621|Alzheimer Disease|alzheimer disease
757623|NCT00413621|Amyloid|amyloid
757624|NCT00413621|AD|ad
757625|NCT00413621|Healthy Volunteer|healthy volunteer
757626|NCT00413621|HV|hv
757627|NCT00413608|Human|human
757628|NCT00413608|Adults|adults
757629|NCT00413608|Male|male
757630|NCT00413608|Alleles|alleles
757631|NCT00413608|Genotype|genotype
757632|NCT00413608|Platelet Aggregation/drug effects|platelet aggregation/drug effects
757633|NCT00413608|Platelet Aggregation Inhibitors/*pharmacology|platelet aggregation inhibitors/*pharmacology
757634|NCT00413608|Platelet Function Tests|platelet function tests
757635|NCT00413608|Pharmacogenetics|pharmacogenetics
757636|NCT00413608|*Polymorphism, Genetic|*polymorphism, genetic
757637|NCT00413608|Ticlopidine/*analogs & derivatives/pharmacology|ticlopidine/*analogs & derivatives/pharmacology
757638|NCT00413608|Healthy subjects|healthy subjects
757639|NCT00413595|Cerebrovascular Accident|cerebrovascular accident
757640|NCT00413595|Cerebrovascular Accident, Acute|cerebrovascular accident, acute
757641|NCT00413595|Fabry Disease|fabry disease
757642|NCT00413595|Fabry's Disease|fabry's disease
757643|NCT00413595|Anderson-Fabry Disease|anderson-fabry disease
757644|NCT00413595|CVA (Cerebrovascular Accident)|cva (cerebrovascular accident)
757645|NCT00413595|Stroke, acute|stroke, acute
757646|NCT00413595|Cerebral Stroke|cerebral stroke
757647|NCT00413582|Pectus Excavatum|pectus excavatum
757648|NCT00413582|Bar Repair|bar repair
757649|NCT00413582|Pain Control|pain control
757650|NCT00413582|Pectus Excavatum Repair|pectus excavatum repair
757651|NCT00413556|Rhinitis|rhinitis
757652|NCT00413556|Oral tablets|oral tablets
757654|NCT00413556|grass pollen|grass pollen
757655|NCT00413556|inmunotherapy|inmunotherapy
757656|NCT00413543|COPD|copd
757657|NCT00413543|exacerbation|exacerbation
757658|NCT00413543|pulmonary rehabilitation|pulmonary rehabilitation
757659|NCT00413543|exercise tolerance|exercise tolerance
757660|NCT00413543|exacerbations|exacerbations
757661|NCT00413543|quality of life|quality of life
757662|NCT00413543|readmissions|readmissions
757663|NCT00413517|Naturally occurring myopia with or without astigmatism|naturally occurring myopia with or without astigmatism
757664|NCT00413504|Fondaparinux|fondaparinux
757665|NCT00413504|Monotherapy|monotherapy
757666|NCT00413504|Deep Vein thrombosis|deep vein thrombosis
757667|NCT00413504|Pulmonary Embolism|pulmonary embolism
757668|NCT00413504|Anticoagulation|anticoagulation
757669|NCT00413491|Breast Cancer|breast cancer
757670|NCT00413491|BRCA1 gene|brca1 gene
757671|NCT00413491|BRCA2 gene|brca2 gene
757672|NCT00413491|Magnetic Resonance Imaging|magnetic resonance imaging
757673|NCT00413491|Mammography|mammography
757674|NCT00413491|Ultrasonography|ultrasonography
757675|NCT00413478|5-Aza|5-aza
757676|NCT00413478|Azacytidine|azacytidine
757677|NCT00413478|Vidaza|vidaza
757678|NCT00413478|CLL|cll
757679|NCT00413478|Chronic Lymphocytic Leukemia|chronic lymphocytic leukemia
757680|NCT00413478|Richter's transformation|richter's transformation
757681|NCT00413478|Leukemia|leukemia
757682|NCT00413465|Renal Plasma Flow|renal plasma flow
757683|NCT00413465|Endotoxemia|endotoxemia
757684|NCT00413465|Type 2 diabetes|type 2 diabetes
757685|NCT00413452|Rheumatoid Arthritis|rheumatoid arthritis
757686|NCT00413452|Etanercept|etanercept
757687|NCT00413452|Enbrel|enbrel
757688|NCT00413452|Amgen|amgen
757689|NCT00413439|Isavuconazole|isavuconazole
757690|NCT00413439|BAL8557|bal8557
757691|NCT00413439|ASP9766|asp9766
757692|NCT00413439|chemotherapy|chemotherapy
757693|NCT00413439|prophylaxis|prophylaxis
757694|NCT00413439|systemic fungal infection|systemic fungal infection
757695|NCT00413426|Pharmacokinetics|pharmacokinetics
757696|NCT00413426|oral|oral
757697|NCT00413426|single dose|single dose
757698|NCT00413426|table|table
757699|NCT00413426|suspension|suspension
757700|NCT00413426|release|release
757701|NCT00413426|darifenacin|darifenacin
757702|NCT00413426|healthy subjects|healthy subjects
757703|NCT00413426|Healthy volunteers study|healthy volunteers study
757704|NCT00413413|Hypertension, valsartan, amlodipine, high blood pressure|hypertension, valsartan, amlodipine, high blood pressure
757705|NCT00413400|Inflammation|inflammation
757706|NCT00413400|Visceral adiposity|visceral adiposity
757707|NCT00413400|TNF|tnf
757708|NCT00413400|Adiponectin|adiponectin
757709|NCT00413400|glucose tolerance|glucose tolerance
757710|NCT00413400|endothelial function|endothelial function
757711|NCT00413400|metabolic syndrome|metabolic syndrome
757712|NCT00413387|Asthma|asthma
757713|NCT00413387|Combinations|combinations
757714|NCT00413387|Inhaled therapy|inhaled therapy
757715|NCT00413387|Corticosteroids|corticosteroids
757716|NCT00413387|Long acting bronchodilators|long acting bronchodilators
757717|NCT00413387|Beclomethasone|beclomethasone
757718|NCT00413387|Formoterol|formoterol
757719|NCT00413387|Budesonide|budesonide
757720|NCT00413374|Lovenox|lovenox
757721|NCT00413374|Enoxaparin|enoxaparin
757722|NCT00413374|Prophylaxis|prophylaxis
757723|NCT00413374|Pulmonary Embolism|pulmonary embolism
757724|NCT00413374|Acute Deep Vein Thrombosis|acute deep vein thrombosis
757725|NCT00413374|Venous Thrombosis|venous thrombosis
757726|NCT00413374|Thrombosis|thrombosis
757727|NCT00413374|Anticoagulation|anticoagulation
757728|NCT00413361|Systemic Lupus Erythematosus|systemic lupus erythematosus
757729|NCT00413361|Hydroxychloroquine|hydroxychloroquine
757730|NCT00413348|Type 2 diabetes|type 2 diabetes
757731|NCT00413348|Probiotics|probiotics
757732|NCT00413348|Insulin-resistance|insulin-resistance
757733|NCT00413348|Inflammation|inflammation
757734|NCT00413348|Hyperinsulinemic euglycemic clamp|hyperinsulinemic euglycemic clamp
757735|NCT00413348|Endotoxin|endotoxin
757736|NCT00413335|Childhood and Adolescent Obesity|childhood and adolescent obesity
757737|NCT00413335|Metabolic phenotype|metabolic phenotype
757738|NCT00413335|Impaired Glucose Tolerance|impaired glucose tolerance
757739|NCT00413335|Type 2 Diabetes Mellitus|type 2 diabetes mellitus
757740|NCT00413335|Insulin Sensitivity|insulin sensitivity
757741|NCT00413335|Insulin Resistance|insulin resistance
757742|NCT00413335|Abdominal fat partitioning|abdominal fat partitioning
757743|NCT00413335|Impaired Glucose Tolerance (IGT)|impaired glucose tolerance (igt)
757744|NCT00413335|Type 2 Diabetes Mellitus (T2DM)|type 2 diabetes mellitus (t2dm)
757745|NCT00413322|Advanced Solid tumor|advanced solid tumor
757746|NCT00413322|Adenosarcoma|adenosarcoma
757747|NCT00413322|Androgen-independent prostate cancer|androgen-independent prostate cancer
757748|NCT00413322|belinostat|belinostat
757749|NCT00413322|bladder cancer|bladder cancer
757750|NCT00413322|bladder neoplasms|bladder neoplasms
757751|NCT00413322|Breast cancer|breast cancer
757752|NCT00413322|Carcinoma, Bronchogenic|carcinoma, bronchogenic
757753|NCT00413322|Carcinoma, Non-Small-Cell Lung|carcinoma, non-small-cell lung
757754|NCT00413322|Carcinoma, Small Cell|carcinoma, small cell
757755|NCT00413322|Carcinosarcoma|carcinosarcoma
757756|NCT00413322|Chondrosarcoma|chondrosarcoma
757757|NCT00413322|Coin Lesion, Pulmonary|coin lesion, pulmonary
757758|NCT00413322|colorectal cancer|colorectal cancer
757759|NCT00413322|Esophageal Neoplasms|esophageal neoplasms
757760|NCT00413322|Facial Neoplasms|facial neoplasms
757761|NCT00413322|Fibrosarcoma|fibrosarcoma
757762|NCT00413322|head and neck cancer|head and neck cancer
757763|NCT00413322|Hemangiosarcoma|hemangiosarcoma
757764|NCT00413322|Histiocytoma, Malignant Fibrous|histiocytoma, malignant fibrous
757765|NCT00413322|kidney cancer|kidney cancer
757766|NCT00413322|Leiomyosarcoma|leiomyosarcoma
757767|NCT00413322|Liposarcoma|liposarcoma
757768|NCT00413322|lung cancer|lung cancer
757769|NCT00413322|lung neoplasms|lung neoplasms
757770|NCT00413322|Lymphangiosarcoma|lymphangiosarcoma
757771|NCT00413322|mesothelioma|mesothelioma
757772|NCT00413322|mesothelioma, cystic|mesothelioma, cystic
757773|NCT00413322|Mixed Tumor, Mesodermal|mixed tumor, mesodermal
757774|NCT00413322|Mouth Neoplasms|mouth neoplasms
757775|NCT00413322|Myosarcoma|myosarcoma
757776|NCT00413322|Myxosarcoma|myxosarcoma
757777|NCT00413322|Osteosarcoma|osteosarcoma
757778|NCT00413322|Otorhinolaryngologic Neoplasms|otorhinolaryngologic neoplasms
757779|NCT00413322|Ovarian cancer|ovarian cancer
757780|NCT00413322|Pancoast's Syndrome|pancoast's syndrome
757781|NCT00413322|Parathyroid Neoplasms|parathyroid neoplasms
757782|NCT00413322|Phyllodes Tumor|phyllodes tumor
757783|NCT00413322|Pulmonary Sclerosing Hemangioma|pulmonary sclerosing hemangioma
757784|NCT00413322|sarcoma|sarcoma
757785|NCT00413322|thyroid cancer|thyroid cancer
757786|NCT00413322|Thyroid Neoplasms|thyroid neoplasms
757787|NCT00413322|Tracheal Neoplasms|tracheal neoplasms
757788|NCT00413322|PXD101|pxd101
757789|NCT00413309|Acute Coronary Syndrome|acute coronary syndrome
757790|NCT00413309|Percutaneous Coronary Intervention|percutaneous coronary intervention
757791|NCT00413309|Antiplatelet Therapy|antiplatelet therapy
757792|NCT00413309|PillCam|pillcam
757793|NCT00413309|Endoscopy|endoscopy
757794|NCT00413296|PTSD|ptsd
757795|NCT00413296|Anxiety|anxiety
757796|NCT00413296|Pharmacotherapy|pharmacotherapy
757797|NCT00413296|Levetiracetam|levetiracetam
757798|NCT00413296|Relapse prevention|relapse prevention
757799|NCT00413283|Advanced Non-Small Cell Lung Cancer|advanced non-small cell lung cancer
757800|NCT00413283|Chemotherapy Induced Thrombocytopenia|chemotherapy induced thrombocytopenia
757801|NCT00413283|CIT|cit
757802|NCT00413283|NSCLC|nsclc
757803|NCT00413283|Stage IIIB NSCLC|stage iiib nsclc
757804|NCT00413283|Stage IV NSCLC|stage iv nsclc
757805|NCT00413283|Gemcitabine|gemcitabine
757806|NCT00413283|Carboplatin|carboplatin
757807|NCT00413283|Cisplatin|cisplatin
757808|NCT00413270|Imatinib resistant,|imatinib resistant,
757809|NCT00413270|Imatinib intolerant,|imatinib intolerant,
757810|NCT00413270|CML- blast crisis,|cml- blast crisis,
757811|NCT00413270|CML- Accelerated phase,|cml- accelerated phase,
757812|NCT00413270|CML- chronic phase,|cml- chronic phase,
757814|NCT00413270|Chronic myelogenous leukemia,|chronic myelogenous leukemia,
757815|NCT00413270|blast crisis,|blast crisis,
757816|NCT00413270|accelerated phase,|accelerated phase,
757817|NCT00413270|chronic phase|chronic phase
757818|NCT00413257|Postoperative Hyperalgesia|postoperative hyperalgesia
757819|NCT00413257|cardiac Surgical Procedures|cardiac surgical procedures
757820|NCT00413257|Nefopam|nefopam
757821|NCT00413257|Randomized Controlled Trials|randomized controlled trials
758219|NCT00411814|melbourne,|melbourne,
757822|NCT00413257|Pain and chronic disease|pain and chronic disease
757823|NCT00413244|Hypogonadal|hypogonadal
757824|NCT00413244|coronary artery disease|coronary artery disease
757825|NCT00413244|percutaneous coronary intervention (PCI)|percutaneous coronary intervention (pci)
757826|NCT00413231|Thoracic Aneurysm|thoracic aneurysm
757827|NCT00413231|Endovascular Aortic Repair (EVAR)|endovascular aortic repair (evar)
757828|NCT00413231|Endovascular Stent Graft|endovascular stent graft
757829|NCT00413231|Endograft|endograft
757830|NCT00413231|Thoracic Aortic Aneurysm|thoracic aortic aneurysm
757831|NCT00413231|Endovascular procedure|endovascular procedure
757832|NCT00413231|Descending Thoracic Aneurysm|descending thoracic aneurysm
757833|NCT00413231|Valiant Stent Graft System|valiant stent graft system
757834|NCT00413218|Invasive Candida infections|invasive candida infections
757835|NCT00413218|BAL8557|bal8557
757836|NCT00413218|ASP9766|asp9766
757837|NCT00413218|Isavuconazole|isavuconazole
757838|NCT00413218|Candidemia|candidemia
757839|NCT00413218|Candidemia and other invasive candida infections|candidemia and other invasive candida infections
757840|NCT00413218|Phase III study|phase iii study
757841|NCT00413179|Polycystic Ovarian Syndrome|polycystic ovarian syndrome
757842|NCT00413179|Chronic Anovulation|chronic anovulation
757843|NCT00413179|Chronic Oligoovulation|chronic oligoovulation
757844|NCT00413179|Infertility|infertility
757845|NCT00413179|Hyperandrogenism|hyperandrogenism
757846|NCT00413179|Metformin|metformin
757847|NCT00413179|Ovulation induction|ovulation induction
757848|NCT00413166|Acute Promyelocytic Leukemia|acute promyelocytic leukemia
757849|NCT00413166|APL|apl
757850|NCT00413166|ATRA|atra
757851|NCT00413166|All-Trans Retinoic Acid|all-trans retinoic acid
757852|NCT00413166|Arsenic Trioxide|arsenic trioxide
757853|NCT00413166|Theophylline|theophylline
757854|NCT00413166|Gemtuzumab|gemtuzumab
757855|NCT00413153|HIV|hiv
757856|NCT00413153|Kaletra|kaletra
757857|NCT00413153|Reyataz|reyataz
757858|NCT00413153|Insulin sensitivity|insulin sensitivity
757859|NCT00413153|Lipids|lipids
757860|NCT00413153|Body Composition|body composition
757861|NCT00413153|Receiving Kaletra|receiving kaletra
757862|NCT00413153|Treatment Experienced|treatment experienced
757863|NCT00413140|childhood disease|childhood disease
757864|NCT00413140|cystic fibrosis|cystic fibrosis
757865|NCT00413140|exhaled breath condensate|exhaled breath condensate
757866|NCT00413140|exhaled nitric oxide|exhaled nitric oxide
757867|NCT00413140|airway inflammation|airway inflammation
757868|NCT00413140|non-invasive inflammatory markers|non-invasive inflammatory markers
757869|NCT00413140|controls|controls
757870|NCT00413140|children|children
757871|NCT00413127|Systemic lidocaine|systemic lidocaine
757872|NCT00413127|peridural lidocaine|peridural lidocaine
757873|NCT00413127|perioperative analgesia|perioperative analgesia
757874|NCT00413127|inflammation|inflammation
757875|NCT00413127|Anesthesia|anesthesia
757876|NCT00413088|renal insufficency|renal insufficency
757877|NCT00413088|low molecular weight heparin|low molecular weight heparin
757878|NCT00413088|pharmacokinetics|pharmacokinetics
757879|NCT00413088|elderly|elderly
757880|NCT00413075|Solid tumors|solid tumors
757881|NCT00413075|Adenosarcoma|adenosarcoma
757882|NCT00413075|B-cell lymphoma|b-cell lymphoma
757883|NCT00413075|belinostat|belinostat
757884|NCT00413075|bladder cancer|bladder cancer
757885|NCT00413075|Breast cancer|breast cancer
757886|NCT00413075|Carcinoma, Non-Small-Cell Lung|carcinoma, non-small-cell lung
757887|NCT00413075|Carcinoma, Small Cell|carcinoma, small cell
757888|NCT00413075|Chondrosarcoma|chondrosarcoma
757889|NCT00413075|colorectal cancer|colorectal cancer
757890|NCT00413075|Esophageal Neoplasms|esophageal neoplasms
757891|NCT00413075|Fibrosarcoma|fibrosarcoma
757892|NCT00413075|head and neck cancer|head and neck cancer
757893|NCT00413075|Hemangiosarcoma|hemangiosarcoma
757894|NCT00413075|Hodgkins Disease|hodgkins disease
757895|NCT00413075|kidney cancer|kidney cancer
757896|NCT00413075|Leiomyosarcoma|leiomyosarcoma
757897|NCT00413075|Liposarcoma|liposarcoma
757898|NCT00413075|lung cancer|lung cancer
757899|NCT00413075|lymphoma|lymphoma
757900|NCT00413075|mesothelioma|mesothelioma
757901|NCT00413075|mesothelioma, cystic|mesothelioma, cystic
757902|NCT00413075|Mixed Tumor, Mesodermal|mixed tumor, mesodermal
757903|NCT00413075|Osteosarcoma|osteosarcoma
757904|NCT00413075|Otorhinolaryngologic Neoplasms|otorhinolaryngologic neoplasms
757905|NCT00413075|Ovarian cancer|ovarian cancer
757906|NCT00413075|Parathyroid Neoplasms|parathyroid neoplasms
757907|NCT00413075|Prostate cancer|prostate cancer
757908|NCT00413075|sarcoma|sarcoma
757909|NCT00413075|T-cell lymphoma|t-cell lymphoma
757910|NCT00413075|thyroid cancer|thyroid cancer
757911|NCT00413075|PXD101|pxd101
757912|NCT00413049|Hypertension, valsartan, amlodipine, high blood pressure|hypertension, valsartan, amlodipine, high blood pressure
757913|NCT00413036|Celgene|celgene
757914|NCT00413036|Revlimid|revlimid
757915|NCT00413036|CC-5013|cc-5013
757916|NCT00413036|Non-hodgkin's lymphoma|non-hodgkin's lymphoma
757917|NCT00413036|Lenalidomide|lenalidomide
757918|NCT00413036|CC5013|cc5013
757919|NCT00413036|NHL|nhl
757920|NCT00413023|depression|depression
757921|NCT00413023|major depressive disorder|major depressive disorder
757922|NCT00413023|MDD|mdd
757923|NCT00412997|advanced solid tumor|advanced solid tumor
757924|NCT00412997|Cutaneous T-cell lymphoma|cutaneous t-cell lymphoma
757925|NCT00412997|Phase I|phase i
757926|NCT00412997|HDAC inhibitor|hdac inhibitor
757927|NCT00412997|Adult patients|adult patients
757928|NCT00412971|Recurrence of bladder cancer|recurrence of bladder cancer
757929|NCT00412971|Fluorescence cystoscopy|fluorescence cystoscopy
757930|NCT00412932|Hypertension|hypertension
757931|NCT00412932|Angiotensin Receptor Blocker|angiotensin receptor blocker
757932|NCT00412932|Calcium Channel Blocker|calcium channel blocker
757933|NCT00412932|Angiotensin Converting Enzyme Inhibitor|angiotensin converting enzyme inhibitor
757934|NCT00412932|Hydrochlorothiazide|hydrochlorothiazide
757935|NCT00412932|Stage I and II Hypertension|stage i and ii hypertension
757936|NCT00412919|Myeloma|myeloma
757937|NCT00412919|Relapsed|relapsed
757938|NCT00412919|Refractory|refractory
757939|NCT00412906|Low-grade inflammation|low-grade inflammation
757940|NCT00412906|insulin resistance|insulin resistance
757941|NCT00412906|Metabolism|metabolism
757942|NCT00412906|Type 2 diabetes|type 2 diabetes
757943|NCT00412906|Endotoxemia|endotoxemia
757944|NCT00412906|Fat tissue|fat tissue
757945|NCT00412906|Muscle tissue|muscle tissue
757946|NCT00412906|RT-PCR|rt-pcr
757947|NCT00412893|Invasive fungal disease|invasive fungal disease
757948|NCT00412893|BAL8557|bal8557
757949|NCT00412893|Isavuconazole|isavuconazole
757950|NCT00412893|ASP9766|asp9766
757951|NCT00412893|Filamentous fungi|filamentous fungi
757952|NCT00412893|Phase III|phase iii
757953|NCT00412893|Aspergillus species|aspergillus species
757954|NCT00412867|Cerebral Infarction|cerebral infarction
757955|NCT00412867|acute ischemic stroke|acute ischemic stroke
757956|NCT00412867|Brain ischemia|brain ischemia
757957|NCT00412841|Avascular Necrosis|avascular necrosis
757958|NCT00412841|Lipitor|lipitor
757959|NCT00412841|SLE|sle
757960|NCT00412828|Melanoma|melanoma
757961|NCT00412828|CR011-vcMMAE|cr011-vcmmae
757962|NCT00412815|insulin sensitivity|insulin sensitivity
757963|NCT00412815|coronary artery disease|coronary artery disease
757964|NCT00412815|exercise training|exercise training
757965|NCT00412802|enoxaparine|enoxaparine
757966|NCT00412802|acute coronary syndrome|acute coronary syndrome
757967|NCT00412802|renal failure|renal failure
757968|NCT00412802|dose adaptation|dose adaptation
757969|NCT00412789|Advanced solid tumor|advanced solid tumor
757970|NCT00412789|Patupilone|patupilone
757971|NCT00412763|Acute hepatitis|acute hepatitis
757972|NCT00412763|Acute viral hepatitis|acute viral hepatitis
757973|NCT00412763|Acute nonviral hepatitis|acute nonviral hepatitis
757974|NCT00412763|Silymarin|silymarin
757975|NCT00412763|Milk Thistle|milk thistle
757976|NCT00412750|hepatitis B|hepatitis b
757977|NCT00412750|hepatitis B Virus (HBV)|hepatitis b virus (hbv)
757978|NCT00412750|chronic hepatitis B|chronic hepatitis b
757979|NCT00412750|telbivudine|telbivudine
757980|NCT00412750|peginterferon|peginterferon
757981|NCT00412724|diet|diet
757982|NCT00412724|acceptability|acceptability
757983|NCT00412724|palatability|palatability
757984|NCT00412724|food|food
757985|NCT00412724|questionnaire|questionnaire
757986|NCT00412724|Food habits|food habits
757987|NCT00412672|Myocardial infarction|myocardial infarction
757988|NCT00412672|contrast echocardiography|contrast echocardiography
757989|NCT00412672|collateral circulation|collateral circulation
757990|NCT00412659|Sinus, Pilonidal|sinus, pilonidal
757991|NCT00412659|Pilonidal sinus|pilonidal sinus
757992|NCT00412659|Pilonidal cysts|pilonidal cysts
757993|NCT00412659|Pilonidal disease|pilonidal disease
757994|NCT00412659|midline excision|midline excision
757995|NCT00412659|Karydakis operation|karydakis operation
757996|NCT00412659|expertise based study|expertise based study
757997|NCT00412659|surgery|surgery
757998|NCT00412659|therapy|therapy
757999|NCT00412646|HIV|hiv
758000|NCT00412646|AIDS|aids
758001|NCT00412646|Dose finding study|dose finding study
758002|NCT00412646|TMC125-C203|tmc125-c203
758003|NCT00412646|Treatment Experienced|treatment experienced
758004|NCT00412633|Obesity|obesity
758005|NCT00412633|Men|men
758006|NCT00412633|Overweight|overweight
758007|NCT00412607|Ventricular Tachycardia|ventricular tachycardia
758008|NCT00412607|Heart Diseases|heart diseases
758009|NCT00412607|Arrhythmia|arrhythmia
758010|NCT00412581|Melanoma|melanoma
758011|NCT00412581|Lenalidomide|lenalidomide
758012|NCT00412581|Dacarbazine|dacarbazine
758013|NCT00412581|CC-5013|cc-5013
758014|NCT00412581|Revlimid|revlimid
758015|NCT00412581|DTIC|dtic
758211|NCT00411866|pharmacokinetics,|pharmacokinetics,
758016|NCT00412568|Naturally occuring myopia with or without astigmatism.|naturally occuring myopia with or without astigmatism.
758017|NCT00412542|Glioblastoma Multiforme|glioblastoma multiforme
758018|NCT00412542|Glioma|glioma
758019|NCT00412542|Thalidomide|thalidomide
758020|NCT00412542|Thalomid|thalomid
758021|NCT00412542|CPT-11|cpt-11
758022|NCT00412542|Irinotecan|irinotecan
758023|NCT00412542|malignant glioma|malignant glioma
758220|NCT00411814|healthy|healthy
758024|NCT00412529|HBeAg-positive, chronic hepatitis B|hbeag-positive, chronic hepatitis b
758025|NCT00412529|telbivudine|telbivudine
758026|NCT00412529|entecavir|entecavir
758027|NCT00412529|viral kinetics|viral kinetics
758028|NCT00412516|Japanese Encephalitis|japanese encephalitis
758029|NCT00412516|Japanese B Encephalitis|japanese b encephalitis
758030|NCT00412516|Japanese B Viral Encephalitis|japanese b viral encephalitis
758031|NCT00412516|Viral Encephalitis, Japanese B|viral encephalitis, japanese b
758032|NCT00412490|Oral Cavity Cancer|oral cavity cancer
758033|NCT00412490|Body Image|body image
758034|NCT00412490|Smoking|smoking
758035|NCT00412490|Appearance|appearance
758036|NCT00412490|Questionnaire|questionnaire
758037|NCT00412490|Interview|interview
758039|NCT00412477|Lfn-p24|lfn-p24
758040|NCT00412477|Anthrax|anthrax
758041|NCT00412477|IM|im
758042|NCT00412477|HIV-1|hiv-1
758043|NCT00412477|HIV Preventive Vaccine|hiv preventive vaccine
758044|NCT00412464|fondaparinux|fondaparinux
758045|NCT00412464|thrombosis|thrombosis
758046|NCT00412464|heparin-induced thrombocytopenia|heparin-induced thrombocytopenia
758047|NCT00412464|pediatrics|pediatrics
758048|NCT00412451|Diabetic Macular Edema|diabetic macular edema
758049|NCT00412451|PVD|pvd
758050|NCT00412451|DME|dme
758051|NCT00412451|Diabetic Retinopathy|diabetic retinopathy
758052|NCT00412438|Atrial Fibrillation|atrial fibrillation
758053|NCT00412425|Melanoma|melanoma
758054|NCT00412425|Nausea|nausea
758055|NCT00412425|Vomiting|vomiting
758056|NCT00412425|Palonosetron|palonosetron
758057|NCT00412425|Cisplatin|cisplatin
758058|NCT00412425|Vinblastine|vinblastine
758059|NCT00412425|Loss of Appetite|loss of appetite
758060|NCT00412425|Weight loss|weight loss
758061|NCT00412412|Cancer of Breast|cancer of breast
758062|NCT00412412|Cancer of the Breast|cancer of the breast
758063|NCT00412399|Employment|employment
758064|NCT00412399|Negative workplace events|negative workplace events
758065|NCT00412399|Healthy controls|healthy controls
758066|NCT00412399|Fatigue|fatigue
758067|NCT00412399|Physical activity|physical activity
758068|NCT00412386|Pediatric|pediatric
758069|NCT00412386|Congenital Heart Disease|congenital heart disease
758070|NCT00412386|Imaging|imaging
758071|NCT00412373|Schizoaffective Disorder|schizoaffective disorder
758072|NCT00412373|antipsychotic|antipsychotic
758073|NCT00412373|paliperidone|paliperidone
758074|NCT00412373|placebo|placebo
758075|NCT00412360|Double cord blood|double cord blood
758076|NCT00412347|hyperglycemia|hyperglycemia
758077|NCT00412347|diabetes|diabetes
758078|NCT00412347|insulin drip|insulin drip
758079|NCT00412347|hypoglycemia|hypoglycemia
758080|NCT00412347|general wards|general wards
758081|NCT00412321|Lymphoma, Non-Hodgkin|lymphoma, non-hodgkin
758082|NCT00412321|Multiple Myeloma|multiple myeloma
758083|NCT00412321|Castleman's disease|castleman's disease
758084|NCT00412321|intravenous|intravenous
758085|NCT00412321|IL-6|il-6
758086|NCT00412308|spinal cord injury|spinal cord injury
758087|NCT00412308|ventilator dependency|ventilator dependency
758088|NCT00412308|ventilator weaning|ventilator weaning
758089|NCT00412308|tidal volume|tidal volume
758090|NCT00412295|Naturally occuring myopia with or without astigmatism.|naturally occuring myopia with or without astigmatism.
758091|NCT00412295|Wavefront errors|wavefront errors
758092|NCT00412269|Insulin Sensitivity|insulin sensitivity
758093|NCT00412269|Total abdominal fat|total abdominal fat
758094|NCT00412269|Visceral abdominal fat|visceral abdominal fat
758095|NCT00412269|Reproductive Hormones|reproductive hormones
758096|NCT00412269|Menopause|menopause
758097|NCT00412269|Diabetes|diabetes
758098|NCT00412269|Fat Distribution|fat distribution
758099|NCT00412269|Sex Hormones|sex hormones
758100|NCT00412256|Treatment|treatment
758101|NCT00412256|Disease activity|disease activity
758102|NCT00412256|Clinical trial|clinical trial
758103|NCT00412243|Burkitt's Lymphoma|burkitt's lymphoma
758104|NCT00412243|Lymphoblastic Lymphoma|lymphoblastic lymphoma
758105|NCT00412243|Acute Lymphoblastic Leukemia|acute lymphoblastic leukemia
758106|NCT00412243|Clofarabine|clofarabine
758107|NCT00412243|Clofarex|clofarex
758108|NCT00412243|Clolar|clolar
758109|NCT00412243|Cyclophosphamide|cyclophosphamide
758110|NCT00412243|Neosar|neosar
758111|NCT00412243|Cytoxan|cytoxan
758112|NCT00412230|Pre-eclampsia|pre-eclampsia
758113|NCT00412230|Gestational diabetes|gestational diabetes
758114|NCT00412230|Insulin resistance|insulin resistance
758115|NCT00412230|hypertension in pregnancy|hypertension in pregnancy
758116|NCT00412204|double-blind|double-blind
758117|NCT00412204|placebo-controlled|placebo-controlled
758118|NCT00412204|crossover|crossover
758308|NCT00411385|Hepatitis C|hepatitis c
758119|NCT00412204|effects of tiotropium bromide|effects of tiotropium bromide
758120|NCT00412204|gas exchange|gas exchange
758121|NCT00412204|Chronic Obstructive Pulmonary Disease|chronic obstructive pulmonary disease
758122|NCT00412204|exercise.|exercise.
758123|NCT00412191|healthy volunteers|healthy volunteers
758124|NCT00412191|bioequivalence|bioequivalence
758125|NCT00412191|food effects|food effects
758126|NCT00412178|Internet|internet
758127|NCT00412178|mobile communication|mobile communication
758128|NCT00412178|glucose monitoring|glucose monitoring
758129|NCT00412165|Prevention of Type 2 Diabetes|prevention of type 2 diabetes
758130|NCT00412165|Adolescents|adolescents
758131|NCT00412165|Obesity|obesity
758132|NCT00412165|Overweight|overweight
758133|NCT00412165|Internet Technology|internet technology
758134|NCT00412165|Cell Phone|cell phone
758135|NCT00412152|A randomised|a randomised
758136|NCT00412152|double blind|double blind
758137|NCT00412152|parallel group|parallel group
758138|NCT00412152|multicentre study to demonstrate improvement in symptoms of constipation in subjects with non malignant pain|multicentre study to demonstrate improvement in symptoms of constipation in subjects with non malignant pain
758139|NCT00412152|Moderate to severe chronic non-malignant pain|moderate to severe chronic non-malignant pain
758140|NCT00412139|vascular calcifications|vascular calcifications
758141|NCT00412139|uremic toxins|uremic toxins
758142|NCT00412139|renal osteodystrophy|renal osteodystrophy
758143|NCT00412139|Dialysis|dialysis
758144|NCT00412126|Diabetes Mellitus|diabetes mellitus
758145|NCT00412126|Coronary Restenosis|coronary restenosis
758146|NCT00412126|Insulin|insulin
758147|NCT00412126|Angioplasty|angioplasty
758148|NCT00412100|A randomised|a randomised
758149|NCT00412100|double-blind|double-blind
758150|NCT00412100|double-dummy|double-dummy
758151|NCT00412100|parallel-group multicentre study to demonstrate improvement in symptoms of constipation|parallel-group multicentre study to demonstrate improvement in symptoms of constipation
758152|NCT00412100|Moderate to severe, chronic non-malignant pain|moderate to severe, chronic non-malignant pain
758153|NCT00412087|vitamin D|vitamin d
758154|NCT00412087|cholecalciferol|cholecalciferol
758155|NCT00412087|pregnant women|pregnant women
758156|NCT00412074|Breastfeeding|breastfeeding
758157|NCT00412074|Vitamin D|vitamin d
758158|NCT00412074|Vitamin D deficiency|vitamin d deficiency
758159|NCT00412061|Cancer|cancer
758160|NCT00412061|Carcinoid|carcinoid
758161|NCT00412061|Tumor|tumor
758162|NCT00412061|Neuroendocrine|neuroendocrine
758163|NCT00412061|Carcinoma|carcinoma
758164|NCT00412061|Everolimus|everolimus
758165|NCT00412061|Octreotide|octreotide
758166|NCT00412022|early breast cancer|early breast cancer
758167|NCT00412022|adjuvant therapy|adjuvant therapy
758168|NCT00412022|premenopause|premenopause
758169|NCT00412022|premenopausal|premenopausal
758170|NCT00412022|menopausal status|menopausal status
758171|NCT00412022|postmenopause|postmenopause
758172|NCT00412022|bone mineral density|bone mineral density
758173|NCT00412022|hormone sensitive|hormone sensitive
758174|NCT00412022|aromatase inhibitors|aromatase inhibitors
758175|NCT00412022|letrozole|letrozole
758176|NCT00412022|disease-free survival|disease-free survival
758177|NCT00412009|tuberculosis|tuberculosis
758178|NCT00412009|control|control
758179|NCT00412009|treatment|treatment
758180|NCT00412009|adherence|adherence
758181|NCT00411996|indinavir/ritonavir|indinavir/ritonavir
758182|NCT00411996|HIV/TB|hiv/tb
758183|NCT00411996|rifampicin|rifampicin
758184|NCT00411996|PK and efficacy of IDV/RTV 600/100 mg BID with rifampicin|pk and efficacy of idv/rtv 600/100 mg bid with rifampicin
758185|NCT00411996|Treatment Naive|treatment naive
758186|NCT00411983|chronic HIV infection|chronic hiv infection
758187|NCT00411983|long term cohort of HIV infection|long term cohort of hiv infection
758188|NCT00411970|23 gauge pars plana vitrectomy|23 gauge pars plana vitrectomy
758189|NCT00411970|conjunctival erythema and injection|conjunctival erythema and injection
758190|NCT00411970|20 gauge pars plana vitrectomy|20 gauge pars plana vitrectomy
758191|NCT00411970|vitreous and retinal surgery|vitreous and retinal surgery
758192|NCT00411957|atazanavir/ritonavir|atazanavir/ritonavir
758193|NCT00411957|pharmacokinetic of ATV/r200/100 OD+2NRTIs|pharmacokinetic of atv/r200/100 od+2nrtis
758194|NCT00411944|tacrolimus pharmacokinetics|tacrolimus pharmacokinetics
758195|NCT00411944|CYP3A4 - CYP3A5|cyp3a4 - cyp3a5
758196|NCT00411944|P-glycoprotein|p-glycoprotein
758197|NCT00411944|single nucleotide polymorphisms|single nucleotide polymorphisms
758198|NCT00411944|renal transplantation|renal transplantation
758199|NCT00411944|calcineurin-inhibitor-associated nephrotoxicity|calcineurin-inhibitor-associated nephrotoxicity
758200|NCT00411905|Myelodysplastic syndromes|myelodysplastic syndromes
758201|NCT00411905|IPSS Int-2 and High risk|ipss int-2 and high risk
758202|NCT00411905|Bortezomib|bortezomib
758203|NCT00411905|Low dose Cytarabine|low dose cytarabine
758204|NCT00411905|Bone Marrow diseases|bone marrow diseases
758205|NCT00411879|Heart Arrest|heart arrest
758206|NCT00411879|Cardiopulmonary Resuscitation|cardiopulmonary resuscitation
758207|NCT00411879|Epinephrine|epinephrine
758208|NCT00411879|Vasopressin|vasopressin
758209|NCT00411879|Adrenal Cortex Hormones|adrenal cortex hormones
758210|NCT00411866|safety|safety
758309|NCT00411385|CHC|chc
758212|NCT00411853|Prostate, Hormone Refractory, Cancer|prostate, hormone refractory, cancer
758213|NCT00411840|stem cell therapy|stem cell therapy
758214|NCT00411840|peripheral arterial disease|peripheral arterial disease
758215|NCT00411840|limb ischemia|limb ischemia
758216|NCT00411827|Cytology|cytology
758217|NCT00411827|Keratomileusis, Laser In Situ|keratomileusis, laser in situ
758218|NCT00411827|Keratectomy, Photorefractive, Excimer Laser|keratectomy, photorefractive, excimer laser
758223|NCT00411814|Safety and pharmacokinetic study,|safety and pharmacokinetic study,
758224|NCT00411814|mild asthmatic patients,|mild asthmatic patients,
758225|NCT00411814|australia|australia
758226|NCT00411814|monoclonal|monoclonal
758227|NCT00411814|female,|female,
758228|NCT00411814|volunteers,|volunteers,
758229|NCT00411801|bleeding disorder|bleeding disorder
758230|NCT00411801|universal plasma|universal plasma
758231|NCT00411801|plasma|plasma
758232|NCT00411801|plasma exchange|plasma exchange
758233|NCT00411788|HER-2 positive|her-2 positive
758234|NCT00411788|breast cancer|breast cancer
758235|NCT00411788|HER-2 positive breast cancer|her-2 positive breast cancer
758236|NCT00411762|Pancreatic|pancreatic
758237|NCT00411736|Cystic Fibrosis|cystic fibrosis
758238|NCT00411736|Pseudomonas aeruginosa|pseudomonas aeruginosa
758239|NCT00411736|Azithromycin|azithromycin
758240|NCT00411736|Intermittent pulmonary infection|intermittent pulmonary infection
758241|NCT00411723|multiple sclerosis, chronic-progressive, relapsing-remitting|multiple sclerosis, chronic-progressive, relapsing-remitting
758242|NCT00411671|Lung Cancer|lung cancer
758243|NCT00411671|Non-Small Cell Lung Cancer|non-small cell lung cancer
758244|NCT00411671|NSCLC|nsclc
758245|NCT00411671|Sorafenib|sorafenib
758246|NCT00411671|BAY 43-9006|bay 43-9006
758247|NCT00411671|Battle Program|battle program
758248|NCT00411645|prevention|prevention
758249|NCT00411645|prophylaxis|prophylaxis
758250|NCT00411645|Cytomegalovirus|cytomegalovirus
758251|NCT00411645|CMV|cmv
758252|NCT00411645|allogeneic stem cell transplant|allogeneic stem cell transplant
758253|NCT00411645|SCT|sct
758254|NCT00411632|Lung Cancer|lung cancer
758255|NCT00411632|Non-Small Cell Lung Cancer|non-small cell lung cancer
758256|NCT00411632|NSCLC|nsclc
758257|NCT00411632|Erlotinib|erlotinib
758258|NCT00411632|Tarceva|tarceva
758259|NCT00411632|Bexarotene|bexarotene
758260|NCT00411632|Targretin|targretin
758261|NCT00411632|OSI-774|osi-774
758262|NCT00411632|Battle Program|battle program
758263|NCT00411619|Tuberous Sclerosis Complex (TSC)|tuberous sclerosis complex (tsc)
758264|NCT00411619|Subendymal Giant Cell Astrocytomas (SEGA'S)|subendymal giant cell astrocytomas (sega's)
758265|NCT00411619|Mammalian Target of Rapamycin (mTOR)|mammalian target of rapamycin (mtor)
758266|NCT00411619|Everolimus (RAD001)|everolimus (rad001)
758267|NCT00411619|Tuberous Sclerosis with Subependymal Giant Cell Astrocytomas|tuberous sclerosis with subependymal giant cell astrocytomas
758268|NCT00411606|Healthy|healthy
758269|NCT00411606|Allergy|allergy
758270|NCT00411606|Allergic Rhinoconjunctivitis|allergic rhinoconjunctivitis
758271|NCT00411593|Non-Small Cell Lung Cancer|non-small cell lung cancer
758272|NCT00411593|Lung Cancer|lung cancer
758273|NCT00411593|NSCLC|nsclc
758274|NCT00411593|Bortezomib|bortezomib
758275|NCT00411593|Bevacizumab|bevacizumab
758276|NCT00411580|Mild, moderate Alzheimer's Disease (AD), Aß-specific antibody, CAD106|mild, moderate alzheimer's disease (ad), aß-specific antibody, cad106
758277|NCT00411567|markers, inflammation, optimal, sub-optimal, corticosteroid, bronchial asthma|markers, inflammation, optimal, sub-optimal, corticosteroid, bronchial asthma
758278|NCT00411541|acute lymphoblastic leukemia, maintenance, BFM protocol|acute lymphoblastic leukemia, maintenance, bfm protocol
758279|NCT00411541|intermediate risk childhood acute lymphoblastic leukemia|intermediate risk childhood acute lymphoblastic leukemia
758280|NCT00411528|Prostate Cancer|prostate cancer
758281|NCT00411528|Hormone Refractory|hormone refractory
758282|NCT00411528|patupilone|patupilone
758283|NCT00411528|docetaxel|docetaxel
758284|NCT00411463|Interpersonal Therapy|interpersonal therapy
758285|NCT00411463|Social Rhythm Therapy|social rhythm therapy
758286|NCT00411463|Bipolar Disorder|bipolar disorder
758287|NCT00411463|Depression|depression
758288|NCT00411463|Seroquel|seroquel
758289|NCT00411450|k-ras|k-ras
758290|NCT00411450|biomarker|biomarker
758291|NCT00411450|colorectal|colorectal
758292|NCT00411450|colon|colon
758293|NCT00411450|rectal|rectal
758294|NCT00411450|FOLFOX|folfox
758295|NCT00411450|FOLFIRI|folfiri
758296|NCT00411424|Rheumatoid Arthritis|rheumatoid arthritis
758297|NCT00411424|Randomized Control Trial|randomized control trial
758298|NCT00411424|Treatment outcomes|treatment outcomes
758299|NCT00411424|Monoclonal antibody|monoclonal antibody
758300|NCT00411411|GLP-1|glp-1
758301|NCT00411411|GIP|gip
758302|NCT00411411|Incretin hormones|incretin hormones
758303|NCT00411411|DPP-IV inhibitor|dpp-iv inhibitor
758304|NCT00411411|Hyperglycaemic clamp|hyperglycaemic clamp
758305|NCT00411411|Meal test|meal test
758306|NCT00411398|Anxiety, SNRI, SSRI,GAD,SAD|anxiety, snri, ssri,gad,sad
758307|NCT00411385|Chronic Hepatitis C|chronic hepatitis c
758311|NCT00411385|Genotype 1|genotype 1
758312|NCT00411385|Hepatitis|hepatitis
758313|NCT00411385|HCV|hcv
758314|NCT00411372|Questionnaire|questionnaire
758315|NCT00411372|COPD|copd
758316|NCT00411372|Shortness of Breath|shortness of breath
758317|NCT00411359|Refractory angina|refractory angina
758318|NCT00411359|Cardiac rehabilitation|cardiac rehabilitation
758319|NCT00411359|Symptomology|symptomology
758320|NCT00411359|Physical ability|physical ability
758321|NCT00411359|Exercise|exercise
758322|NCT00411359|Psychology|psychology
758323|NCT00411359|Quality of life|quality of life
758324|NCT00411359|Risk factors|risk factors
758325|NCT00411346|Asthma|asthma
758326|NCT00411346|Self-Monitoring|self-monitoring
758327|NCT00411346|Cost-effectiveness|cost-effectiveness
758328|NCT00411333|diabetic retinopathy|diabetic retinopathy
758329|NCT00411333|fluorescein angiography|fluorescein angiography
758330|NCT00411333|steroid|steroid
758331|NCT00411333|anti-angiogenesis|anti-angiogenesis
758332|NCT00411320|Asthma|asthma
758333|NCT00411320|Smoking|smoking
758334|NCT00411320|Steroid Resistance|steroid resistance
758335|NCT00411320|Corticosteroid insensitivity|corticosteroid insensitivity
758336|NCT00411307|Analgesia|analgesia
758337|NCT00411307|Postoperative pain|postoperative pain
758338|NCT00411294|ergocalciferol|ergocalciferol
758339|NCT00411294|chronic kidney disease|chronic kidney disease
758340|NCT00411294|secondary hyperparathyroidism|secondary hyperparathyroidism
758341|NCT00411294|vitamin D deficiency|vitamin d deficiency
758342|NCT00411281|acute myeloid leukemia/transient myeloproliferative disorder|acute myeloid leukemia/transient myeloproliferative disorder
758343|NCT00411268|Chronic low back pain|chronic low back pain
758344|NCT00411268|OROS hydromorphone slow release tablet|oros hydromorphone slow release tablet
758345|NCT00411268|Quality of Life|quality of life
758346|NCT00411255|Blink Reflex|blink reflex
758347|NCT00411255|Transcranial Magnetic Stimulation (TMS)|transcranial magnetic stimulation (tms)
758348|NCT00411255|Dystonia|dystonia
758349|NCT00411255|Blepharospasm|blepharospasm
758350|NCT00411255|BSP|bsp
758351|NCT00411255|Focal Dystonia|focal dystonia
758352|NCT00411242|agomelatine, major depressive disorder, MDD, depression|agomelatine, major depressive disorder, mdd, depression
758353|NCT00411216|vestibular rehabilitation|vestibular rehabilitation
758354|NCT00411216|vestibular hypofunction|vestibular hypofunction
758355|NCT00411203|Protein kinase C, tamoxifen, acute mania, clinical trial|protein kinase c, tamoxifen, acute mania, clinical trial
758356|NCT00411190|Osteoarthritis|osteoarthritis
758357|NCT00411190|Postmenopausal|postmenopausal
758358|NCT00411190|Osteoporosis|osteoporosis
758359|NCT00411177|end-stage renal disease|end-stage renal disease
758360|NCT00411177|hemodialysis|hemodialysis
758361|NCT00411177|cardiovascular morbidity and mortality|cardiovascular morbidity and mortality
758362|NCT00411177|high flux dialyser|high flux dialyser
758363|NCT00411177|on-line hemodiafiltration|on-line hemodiafiltration
758364|NCT00411177|arterial stiffness|arterial stiffness
758365|NCT00411177|inflammation|inflammation
758366|NCT00411177|life quality|life quality
758367|NCT00411177|left ventricular hypertrophy|left ventricular hypertrophy
758368|NCT00411164|knee pain|knee pain
758369|NCT00411164|hip pain|hip pain
758370|NCT00411164|opioid|opioid
758371|NCT00411151|Adenocarcinoma of esophagogastric junction|adenocarcinoma of esophagogastric junction
758372|NCT00411151|Adenocarcinoma of lower esophagus (Barrett carcinoma)|adenocarcinoma of lower esophagus (barrett carcinoma)
758373|NCT00411138|endometrial clear cell carcinoma|endometrial clear cell carcinoma
758374|NCT00411138|stage II endometrial carcinoma|stage ii endometrial carcinoma
758375|NCT00411138|stage IA grade 3 endometrial carcinoma|stage ia grade 3 endometrial carcinoma
758376|NCT00411138|stage IB endometrial carcinoma|stage ib endometrial carcinoma
758377|NCT00411138|stage IIIA endometrial carcinoma|stage iiia endometrial carcinoma
758378|NCT00411138|stage IIIB endometrial carcinoma|stage iiib endometrial carcinoma
758379|NCT00411138|stage IIIC endometrial carcinoma|stage iiic endometrial carcinoma
758380|NCT00411125|Postmenopausal|postmenopausal
758381|NCT00411125|osteoporosis|osteoporosis
758382|NCT00411125|Pharmacokinetics/dynamics|pharmacokinetics/dynamics
758383|NCT00411125|Calcitonin|calcitonin
758384|NCT00411112|Sentinel node|sentinel node
758385|NCT00411112|Isosulphan blue|isosulphan blue
758386|NCT00411112|Isotopic detection|isotopic detection
758387|NCT00411112|Survival|survival
758388|NCT00411099|agomelatine, major depressive disorder, MDD, depression|agomelatine, major depressive disorder, mdd, depression
758389|NCT00411086|contiguous stage II grade 1 follicular lymphoma|contiguous stage ii grade 1 follicular lymphoma
758390|NCT00411086|contiguous stage II grade 2 follicular lymphoma|contiguous stage ii grade 2 follicular lymphoma
758391|NCT00411086|contiguous stage II grade 3 follicular lymphoma|contiguous stage ii grade 3 follicular lymphoma
758392|NCT00411086|noncontiguous stage II grade 1 follicular lymphoma|noncontiguous stage ii grade 1 follicular lymphoma
758393|NCT00411086|noncontiguous stage II grade 2 follicular lymphoma|noncontiguous stage ii grade 2 follicular lymphoma
758394|NCT00411086|noncontiguous stage II grade 3 follicular lymphoma|noncontiguous stage ii grade 3 follicular lymphoma
758395|NCT00411086|stage I grade 1 follicular lymphoma|stage i grade 1 follicular lymphoma
758396|NCT00411086|stage I grade 2 follicular lymphoma|stage i grade 2 follicular lymphoma
759031|NCT00408967|Ovarian|ovarian
758397|NCT00411086|stage I grade 3 follicular lymphoma|stage i grade 3 follicular lymphoma
758398|NCT00411086|stage III grade 1 follicular lymphoma|stage iii grade 1 follicular lymphoma
758399|NCT00411086|stage III grade 2 follicular lymphoma|stage iii grade 2 follicular lymphoma
758400|NCT00411086|stage III grade 3 follicular lymphoma|stage iii grade 3 follicular lymphoma
758401|NCT00411086|stage IV grade 1 follicular lymphoma|stage iv grade 1 follicular lymphoma
758402|NCT00411086|stage IV grade 2 follicular lymphoma|stage iv grade 2 follicular lymphoma
758403|NCT00411086|stage IV grade 3 follicular lymphoma|stage iv grade 3 follicular lymphoma
758498|NCT00410683|stage IIIA non-small cell lung cancer|stage iiia non-small cell lung cancer
758404|NCT00411086|Granulocyte-Macrophage Colony Stimulating Factor|granulocyte-macrophage colony stimulating factor
758405|NCT00411086|GM-CSF|gm-csf
758406|NCT00411086|Rituximab|rituximab
758407|NCT00411086|Rituxan|rituxan
758408|NCT00411073|darapladib|darapladib
758409|NCT00411073|moxifloxacin|moxifloxacin
758410|NCT00411073|QT study|qt study
758411|NCT00411060|Rotator Cuff Tear|rotator cuff tear
758412|NCT00411047|stage IIIB non-small cell lung cancer|stage iiib non-small cell lung cancer
758413|NCT00411047|stage IV non-small cell lung cancer|stage iv non-small cell lung cancer
758414|NCT00411047|adenocarcinoma of the lung|adenocarcinoma of the lung
758415|NCT00411047|bronchoalveolar cell lung cancer|bronchoalveolar cell lung cancer
758416|NCT00411047|large cell lung cancer|large cell lung cancer
758417|NCT00411034|Opioids|opioids
758418|NCT00411034|Chronic Cancer Pain|chronic cancer pain
758419|NCT00411034|analgesic|analgesic
758420|NCT00410995|Physically fit volunteers|physically fit volunteers
758421|NCT00410982|Lymphoid Malignancies|lymphoid malignancies
758422|NCT00410982|Hodgkin's Disease|hodgkin's disease
758423|NCT00410982|Non-Hodgkin's Lymphoma|non-hodgkin's lymphoma
758424|NCT00410982|Acute Lymphoblastic Leukemia|acute lymphoblastic leukemia
758425|NCT00410982|Chronic Lymphocytic Leukemia|chronic lymphocytic leukemia
758426|NCT00410982|Hematopoietic Cell Transplantation|hematopoietic cell transplantation
758427|NCT00410982|Myeloma|myeloma
758428|NCT00410982|Leukemia|leukemia
758429|NCT00410982|Lymphoma|lymphoma
758430|NCT00410982|Busulfan|busulfan
758431|NCT00410982|Busulfex|busulfex
758432|NCT00410982|Myleran|myleran
758433|NCT00410982|Gemcitabine|gemcitabine
758434|NCT00410982|Gemcitabine Hydrochloride|gemcitabine hydrochloride
758435|NCT00410982|Gemzar|gemzar
758436|NCT00410982|Melphalan|melphalan
758437|NCT00410982|Alkeran|alkeran
758438|NCT00410969|resuscitation|resuscitation
758439|NCT00410969|hypothermia|hypothermia
758440|NCT00410956|adult primary hepatocellular carcinoma|adult primary hepatocellular carcinoma
758441|NCT00410956|localized unresectable adult primary liver cancer|localized unresectable adult primary liver cancer
758442|NCT00410956|advanced adult primary liver cancer|advanced adult primary liver cancer
758443|NCT00410956|recurrent adult primary liver cancer|recurrent adult primary liver cancer
758444|NCT00410956|adult primary cholangiocellular carcinoma|adult primary cholangiocellular carcinoma
758445|NCT00410943|Cancer pain|cancer pain
758446|NCT00410943|Oral analgesic|oral analgesic
758447|NCT00410943|OROS hydromorphone HCI|oros hydromorphone hci
758448|NCT00410930|Immunotherapy, major allergen, birch|immunotherapy, major allergen, birch
758449|NCT00410878|Opioids|opioids
758450|NCT00410878|Chronic cancer pain|chronic cancer pain
758451|NCT00410878|Analgesic|analgesic
758452|NCT00410865|Oral Premalignancies|oral premalignancies
758453|NCT00410865|Mouth Cancer|mouth cancer
758454|NCT00410865|Dysplasia/Carcinoma in Situ (CIS) of the Oral Cavity|dysplasia/carcinoma in situ (cis) of the oral cavity
758455|NCT00410865|Dysplasia/Carcinoma in situ (CIS) of the Oral Pharynx|dysplasia/carcinoma in situ (cis) of the oral pharynx
758456|NCT00410865|Advexin|advexin
758457|NCT00410865|Gene Therapy|gene therapy
758458|NCT00410865|INGN 201|ingn 201
758459|NCT00410865|Wild Type p53 Gene Induction|wild type p53 gene induction
758460|NCT00410852|Insulin|insulin
758461|NCT00410852|Hyperglycemia|hyperglycemia
758462|NCT00410852|Hypoglycemia|hypoglycemia
758463|NCT00410852|Intensive care|intensive care
758464|NCT00410852|Critical care|critical care
758465|NCT00410813|stage IV breast cancer|stage iv breast cancer
758466|NCT00410813|male breast cancer|male breast cancer
758467|NCT00410813|recurrent breast cancer|recurrent breast cancer
758468|NCT00410813|bone metastases|bone metastases
758469|NCT00410800|Insulin Resistance|insulin resistance
758470|NCT00410800|Body Composition|body composition
758471|NCT00410800|Kinetic Modeling|kinetic modeling
758472|NCT00410787|Chronic cancer pain|chronic cancer pain
758473|NCT00410787|OROS hydromorphone HCI (slow release)|oros hydromorphone hci (slow release)
758474|NCT00410787|long-term repeated dosing|long-term repeated dosing
758475|NCT00410774|stage III pancreatic cancer|stage iii pancreatic cancer
758476|NCT00410774|stage I pancreatic cancer|stage i pancreatic cancer
758477|NCT00410774|adenocarcinoma of the pancreas|adenocarcinoma of the pancreas
758478|NCT00410774|stage II pancreatic cancer|stage ii pancreatic cancer
758479|NCT00410761|ZD6474|zd6474
758481|NCT00410761|Hereditary Medullary Thyroid Cancer|hereditary medullary thyroid cancer
758482|NCT00410761|Sporadic Medullary Thyroid Cancer|sporadic medullary thyroid cancer
758483|NCT00410761|Medullary Thyroid Cancer|medullary thyroid cancer
758484|NCT00410748|Chronic cancer pain|chronic cancer pain
758485|NCT00410748|chronic pain|chronic pain
758486|NCT00410735|ONO-1078|ono-1078
758487|NCT00410735|chronic sinusitis|chronic sinusitis
758488|NCT00410722|Nutrition|nutrition
758489|NCT00410722|Type 2 Diabetes|type 2 diabetes
758490|NCT00410709|Pediculosis Capitis|pediculosis capitis
758491|NCT00410709|Head Lice|head lice
758492|NCT00410709|Crawlers|crawlers
758493|NCT00410709|Ova|ova
758494|NCT00410709|Nits|nits
758495|NCT00410696|High-dose chemotherapy|high-dose chemotherapy
758496|NCT00410696|Growth factor|growth factor
758497|NCT00410696|Pegfilgrastim|pegfilgrastim
758746|NCT00410059|Tarceva|tarceva
758499|NCT00410683|stage IIIB non-small cell lung cancer|stage iiib non-small cell lung cancer
758500|NCT00410670|Gene|gene
758501|NCT00410670|Genetics|genetics
758502|NCT00410670|Family History|family history
758503|NCT00410670|Radiation Therapy|radiation therapy
758504|NCT00410670|Children|children
758505|NCT00410657|graft versus host disease|graft versus host disease
758506|NCT00410657|adult acute myeloid leukemia with 11q23 (MLL) abnormalities|adult acute myeloid leukemia with 11q23 (mll) abnormalities
758507|NCT00410657|adult acute myeloid leukemia with inv(16)(p13;q22)|adult acute myeloid leukemia with inv(16)(p13;q22)
758508|NCT00410657|adult acute myeloid leukemia with t(15;17)(q22;q12)|adult acute myeloid leukemia with t(15;17)(q22;q12)
758509|NCT00410657|adult acute myeloid leukemia with t(16;16)(p13;q22)|adult acute myeloid leukemia with t(16;16)(p13;q22)
758510|NCT00410657|adult acute myeloid leukemia with t(8;21)(q22;q22)|adult acute myeloid leukemia with t(8;21)(q22;q22)
758511|NCT00410657|accelerated phase chronic myelogenous leukemia|accelerated phase chronic myelogenous leukemia
758512|NCT00410657|adult acute lymphoblastic leukemia in remission|adult acute lymphoblastic leukemia in remission
758513|NCT00410657|adult acute myeloid leukemia in remission|adult acute myeloid leukemia in remission
758514|NCT00410657|atypical chronic myeloid leukemia|atypical chronic myeloid leukemia
758515|NCT00410657|blastic phase chronic myelogenous leukemia|blastic phase chronic myelogenous leukemia
758516|NCT00410657|childhood chronic myelogenous leukemia|childhood chronic myelogenous leukemia
758517|NCT00410657|chronic phase chronic myelogenous leukemia|chronic phase chronic myelogenous leukemia
758518|NCT00410657|chronic eosinophilic leukemia|chronic eosinophilic leukemia
758519|NCT00410657|chronic idiopathic myelofibrosis|chronic idiopathic myelofibrosis
758520|NCT00410657|chronic myelomonocytic leukemia|chronic myelomonocytic leukemia
758521|NCT00410657|chronic neutrophilic leukemia|chronic neutrophilic leukemia
758522|NCT00410657|de novo myelodysplastic syndromes|de novo myelodysplastic syndromes
758523|NCT00410657|disseminated neuroblastoma|disseminated neuroblastoma
758524|NCT00410657|extranodal marginal zone B-cell lymphoma of mucosa-associated lymphoid tissue|extranodal marginal zone b-cell lymphoma of mucosa-associated lymphoid tissue
758525|NCT00410657|juvenile myelomonocytic leukemia|juvenile myelomonocytic leukemia
758526|NCT00410657|myelodysplastic/myeloproliferative disease, unclassifiable|myelodysplastic/myeloproliferative disease, unclassifiable
758527|NCT00410657|nodal marginal zone B-cell lymphoma|nodal marginal zone b-cell lymphoma
758528|NCT00410657|noncontiguous stage II adult Burkitt lymphoma|noncontiguous stage ii adult burkitt lymphoma
758529|NCT00410657|stage III adult Burkitt lymphoma|stage iii adult burkitt lymphoma
758530|NCT00410657|stage IV adult Burkitt lymphoma|stage iv adult burkitt lymphoma
758531|NCT00410657|noncontiguous stage II adult diffuse large cell lymphoma|noncontiguous stage ii adult diffuse large cell lymphoma
758532|NCT00410657|stage III adult diffuse large cell lymphoma|stage iii adult diffuse large cell lymphoma
758533|NCT00410657|stage IV adult diffuse large cell lymphoma|stage iv adult diffuse large cell lymphoma
758534|NCT00410657|noncontiguous stage II adult diffuse mixed cell lymphoma|noncontiguous stage ii adult diffuse mixed cell lymphoma
758535|NCT00410657|stage III adult diffuse mixed cell lymphoma|stage iii adult diffuse mixed cell lymphoma
758536|NCT00410657|stage IV adult diffuse mixed cell lymphoma|stage iv adult diffuse mixed cell lymphoma
758537|NCT00410657|noncontiguous stage II adult diffuse small cleaved cell lymphoma|noncontiguous stage ii adult diffuse small cleaved cell lymphoma
758538|NCT00410657|stage III adult diffuse small cleaved cell lymphoma|stage iii adult diffuse small cleaved cell lymphoma
758539|NCT00410657|stage IV adult diffuse small cleaved cell lymphoma|stage iv adult diffuse small cleaved cell lymphoma
758540|NCT00410657|noncontiguous stage II adult immunoblastic large cell lymphoma|noncontiguous stage ii adult immunoblastic large cell lymphoma
758541|NCT00410657|stage III adult immunoblastic large cell lymphoma|stage iii adult immunoblastic large cell lymphoma
758542|NCT00410657|stage IV adult immunoblastic large cell lymphoma|stage iv adult immunoblastic large cell lymphoma
758543|NCT00410657|noncontiguous stage II adult lymphoblastic lymphoma|noncontiguous stage ii adult lymphoblastic lymphoma
758544|NCT00410657|stage III adult lymphoblastic lymphoma|stage iii adult lymphoblastic lymphoma
758545|NCT00410657|stage IV adult lymphoblastic lymphoma|stage iv adult lymphoblastic lymphoma
758546|NCT00410657|noncontiguous stage II grade 1 follicular lymphoma|noncontiguous stage ii grade 1 follicular lymphoma
758547|NCT00410657|stage III grade 1 follicular lymphoma|stage iii grade 1 follicular lymphoma
758548|NCT00410657|stage IV grade 1 follicular lymphoma|stage iv grade 1 follicular lymphoma
758549|NCT00410657|noncontiguous stage II grade 2 follicular lymphoma|noncontiguous stage ii grade 2 follicular lymphoma
758550|NCT00410657|stage III grade 2 follicular lymphoma|stage iii grade 2 follicular lymphoma
758551|NCT00410657|stage IV grade 2 follicular lymphoma|stage iv grade 2 follicular lymphoma
758552|NCT00410657|noncontiguous stage II grade 3 follicular lymphoma|noncontiguous stage ii grade 3 follicular lymphoma
758553|NCT00410657|stage III grade 3 follicular lymphoma|stage iii grade 3 follicular lymphoma
758731|NCT00410124|kidney cancer|kidney cancer
758554|NCT00410657|stage IV grade 3 follicular lymphoma|stage iv grade 3 follicular lymphoma
758555|NCT00410657|noncontiguous stage II mantle cell lymphoma|noncontiguous stage ii mantle cell lymphoma
758556|NCT00410657|stage III mantle cell lymphoma|stage iii mantle cell lymphoma
758557|NCT00410657|stage IV mantle cell lymphoma|stage iv mantle cell lymphoma
758558|NCT00410657|noncontiguous stage II marginal zone lymphoma|noncontiguous stage ii marginal zone lymphoma
758559|NCT00410657|splenic marginal zone lymphoma|splenic marginal zone lymphoma
758560|NCT00410657|stage III marginal zone lymphoma|stage iii marginal zone lymphoma
758561|NCT00410657|stage IV marginal zone lymphoma|stage iv marginal zone lymphoma
758562|NCT00410657|noncontiguous stage II small lymphocytic lymphoma|noncontiguous stage ii small lymphocytic lymphoma
758563|NCT00410657|stage III small lymphocytic lymphoma|stage iii small lymphocytic lymphoma
758564|NCT00410657|stage IV small lymphocytic lymphoma|stage iv small lymphocytic lymphoma
758565|NCT00410657|poor prognosis metastatic gestational trophoblastic tumor|poor prognosis metastatic gestational trophoblastic tumor
758566|NCT00410657|stage I multiple myeloma|stage i multiple myeloma
758567|NCT00410657|stage II multiple myeloma|stage ii multiple myeloma
758568|NCT00410657|stage III multiple myeloma|stage iii multiple myeloma
758569|NCT00410657|stage II ovarian epithelial cancer|stage ii ovarian epithelial cancer
758570|NCT00410657|stage III ovarian epithelial cancer|stage iii ovarian epithelial cancer
758571|NCT00410657|stage IV ovarian epithelial cancer|stage iv ovarian epithelial cancer
758572|NCT00410657|aggressive, noncontiguous stage II adult non-Hodgkin lymphoma|aggressive, noncontiguous stage ii adult non-hodgkin lymphoma
758573|NCT00410657|stage III adult Hodgkin lymphoma|stage iii adult hodgkin lymphoma
758574|NCT00410657|stage IV adult Hodgkin lymphoma|stage iv adult hodgkin lymphoma
758575|NCT00410657|stage III chronic lymphocytic leukemia|stage iii chronic lymphocytic leukemia
758576|NCT00410657|stage IV chronic lymphocytic leukemia|stage iv chronic lymphocytic leukemia
758577|NCT00410657|stage III malignant testicular germ cell tumor|stage iii malignant testicular germ cell tumor
758578|NCT00410657|stage IIIA breast cancer|stage iiia breast cancer
758579|NCT00410657|stage IIIB breast cancer|stage iiib breast cancer
758580|NCT00410657|stage IIIC breast cancer|stage iiic breast cancer
758581|NCT00410657|stage IV breast cancer|stage iv breast cancer
758582|NCT00410657|childhood acute lymphoblastic leukemia in remission|childhood acute lymphoblastic leukemia in remission
758583|NCT00410657|childhood acute myeloid leukemia in remission|childhood acute myeloid leukemia in remission
758584|NCT00410657|childhood myelodysplastic syndromes|childhood myelodysplastic syndromes
758585|NCT00410644|Non-malignant chronic pain|non-malignant chronic pain
758586|NCT00410644|pain|pain
758587|NCT00410644|analgesics|analgesics
758588|NCT00410644|opioid|opioid
758589|NCT00410631|localized resectable neuroblastoma|localized resectable neuroblastoma
758590|NCT00410631|localized unresectable neuroblastoma|localized unresectable neuroblastoma
758591|NCT00410631|regional neuroblastoma|regional neuroblastoma
758592|NCT00410631|stage 4S neuroblastoma|stage 4s neuroblastoma
758593|NCT00410631|disseminated neuroblastoma|disseminated neuroblastoma
758594|NCT00410631|recurrent neuroblastoma|recurrent neuroblastoma
758595|NCT00410618|cognitive/functional effects|cognitive/functional effects
758596|NCT00410618|long-term effects secondary to cancer therapy in adults|long-term effects secondary to cancer therapy in adults
758597|NCT00410618|recurrent colon cancer|recurrent colon cancer
758598|NCT00410618|stage I colon cancer|stage i colon cancer
758599|NCT00410618|stage II colon cancer|stage ii colon cancer
758600|NCT00410618|stage III colon cancer|stage iii colon cancer
758601|NCT00410618|stage IV colon cancer|stage iv colon cancer
758602|NCT00410592|GERD|gerd
758603|NCT00410592|acid reflux|acid reflux
758604|NCT00410592|heartburn|heartburn
758605|NCT00410592|PPI|ppi
758606|NCT00410592|Hispanic|hispanic
758607|NCT00410579|pain|pain
758608|NCT00410579|fatigue|fatigue
758609|NCT00410579|long-term effects secondary to cancer therapy in adults|long-term effects secondary to cancer therapy in adults
758610|NCT00410579|psychosocial effects of cancer and its treatment|psychosocial effects of cancer and its treatment
758611|NCT00410579|stage II rectal cancer|stage ii rectal cancer
758612|NCT00410579|stage III rectal cancer|stage iii rectal cancer
758613|NCT00410579|stage II colon cancer|stage ii colon cancer
758614|NCT00410579|stage III colon cancer|stage iii colon cancer
758615|NCT00410579|adenocarcinoma of the colon|adenocarcinoma of the colon
758616|NCT00410566|Acid sphingomyelinase deficiency|acid sphingomyelinase deficiency
758617|NCT00410566|Niemann-Pick disease|niemann-pick disease
758618|NCT00410566|Lysosomal storage disorder|lysosomal storage disorder
758619|NCT00410566|Enzyme replacement therapy|enzyme replacement therapy
758620|NCT00410566|Treatment|treatment
758621|NCT00410540|Cancer pain|cancer pain
758622|NCT00410540|Oral analgesic|oral analgesic
758623|NCT00410540|OROS hydromorphone HCL|oros hydromorphone hcl
758624|NCT00410540|Morphine sulfate|morphine sulfate
758625|NCT00410527|Antibacterials|antibacterials
758626|NCT00410527|Colonization|colonization
758627|NCT00410527|Infection|infection
758628|NCT00410527|Pneumonia|pneumonia
758629|NCT00410527|Resistance|resistance
758630|NCT00410514|Beta-3 Receptor Agonist|beta-3 receptor agonist
758631|NCT00410514|YM178|ym178
758632|NCT00410514|Men|men
758633|NCT00410514|Lower Urinary Tract Symptoms|lower urinary tract symptoms
758634|NCT00410514|Bladder Outlet Obstruction|bladder outlet obstruction
758635|NCT00410501|Pharmacokinetics, interaction, QAB149, indacaterol, ketoconazole, healthy subjects|pharmacokinetics, interaction, qab149, indacaterol, ketoconazole, healthy subjects
758636|NCT00410488|Sarcoma|sarcoma
758637|NCT00410488|Palonosetron|palonosetron
758638|NCT00410488|Aloxi|aloxi
758639|NCT00410488|Nausea|nausea
758640|NCT00410488|Vomiting|vomiting
758641|NCT00410475|Ionizing Radiation|ionizing radiation
758642|NCT00410475|Cohort Study|cohort study
758643|NCT00410475|Radiation-Induced Neoplasms|radiation-induced neoplasms
758644|NCT00410475|Radiologic Technologists|radiologic technologists
758645|NCT00410475|Ultraviolet Radiation|ultraviolet radiation
758646|NCT00410462|recurrent adult soft tissue sarcoma|recurrent adult soft tissue sarcoma
758647|NCT00410462|stage IV adult soft tissue sarcoma|stage iv adult soft tissue sarcoma
758648|NCT00410462|adult liposarcoma|adult liposarcoma
758649|NCT00410462|adult fibrosarcoma|adult fibrosarcoma
758650|NCT00410462|adult malignant fibrous histiocytoma|adult malignant fibrous histiocytoma
758651|NCT00410462|adult leiomyosarcoma|adult leiomyosarcoma
758652|NCT00410462|adult rhabdomyosarcoma|adult rhabdomyosarcoma
758653|NCT00410462|adult alveolar soft-part sarcoma|adult alveolar soft-part sarcoma
758654|NCT00410462|adult malignant mesenchymoma|adult malignant mesenchymoma
758655|NCT00410462|adult angiosarcoma|adult angiosarcoma
758656|NCT00410462|adult epithelioid sarcoma|adult epithelioid sarcoma
758657|NCT00410462|adult neurofibrosarcoma|adult neurofibrosarcoma
758658|NCT00410462|adult synovial sarcoma|adult synovial sarcoma
758659|NCT00410462|recurrent uterine sarcoma|recurrent uterine sarcoma
758660|NCT00410462|stage IV uterine sarcoma|stage iv uterine sarcoma
758661|NCT00410462|ovarian sarcoma|ovarian sarcoma
758662|NCT00410462|small intestine leiomyosarcoma|small intestine leiomyosarcoma
758663|NCT00410462|recurrent small intestine cancer|recurrent small intestine cancer
758664|NCT00410449|End stage renal disease treated by hemodialysis|end stage renal disease treated by hemodialysis
758665|NCT00410449|Hemodialysis vascular access patency|hemodialysis vascular access patency
758666|NCT00410449|Vitamin E|vitamin e
758667|NCT00410449|oxidative markers|oxidative markers
758668|NCT00410449|pentosidine|pentosidine
758669|NCT00410449|hydroxynonenal|hydroxynonenal
758670|NCT00410449|levuglandin|levuglandin
758671|NCT00410436|Type 1 Diabetes|type 1 diabetes
758672|NCT00410436|Resistance Exercise|resistance exercise
758673|NCT00410436|Aerobic Exercise|aerobic exercise
758674|NCT00410423|Leukemia|leukemia
758675|NCT00410423|Acute Myeloid Leukemia|acute myeloid leukemia
758676|NCT00410423|Acute Lymphoid / Lymphoblastic Leukemia|acute lymphoid / lymphoblastic leukemia
758677|NCT00410397|Low back pain|low back pain
758678|NCT00410397|Hip pain|hip pain
758679|NCT00410384|Antibodies|antibodies
758680|NCT00410384|Autoimmune Diseases|autoimmune diseases
758681|NCT00410384|Systemic Lupus Erythematosus|systemic lupus erythematosus
758682|NCT00410384|SLE|sle
758683|NCT00410384|Belimumab|belimumab
758684|NCT00410384|Lupus|lupus
758685|NCT00410371|tolerability|tolerability
758686|NCT00410371|safety|safety
758687|NCT00410371|Pharmacokinetic characteristics|pharmacokinetic characteristics
758688|NCT00410358|Gimatecan|gimatecan
758689|NCT00410358|topoisomerase I inhibitor|topoisomerase i inhibitor
758690|NCT00410358|advanced solid tumors|advanced solid tumors
758691|NCT00410332|tonsillectomy|tonsillectomy
758692|NCT00410332|pain|pain
758693|NCT00410332|homeopathy|homeopathy
758694|NCT00410332|Traumeel|traumeel
758695|NCT00410306|Hypogonadism|hypogonadism
758696|NCT00410306|Nebido|nebido
758697|NCT00410306|Testosterone|testosterone
758698|NCT00410306|Observational Study|observational study
758699|NCT00410293|Heart failure|heart failure
758700|NCT00410293|Diagnostic|diagnostic
758701|NCT00410293|Natriuretic peptide|natriuretic peptide
758702|NCT00410293|NT-pro B-type natriuretic peptide|nt-pro b-type natriuretic peptide
758703|NCT00410293|Length of stay|length of stay
758704|NCT00410293|Costs|costs
758705|NCT00410267|glaucoma|glaucoma
758706|NCT00410267|Post operative from selective laser trabeculoplasty|post operative from selective laser trabeculoplasty
758707|NCT00410241|Genome|genome
758708|NCT00410241|Cardiovascular|cardiovascular
758709|NCT00410241|Volunteers|volunteers
758710|NCT00410241|Genes|genes
758711|NCT00410241|Atherosclerosis|atherosclerosis
758712|NCT00410228|safety, tolerability, pharmacokinetics, pharmacodynamics, AHT956|safety, tolerability, pharmacokinetics, pharmacodynamics, aht956
758713|NCT00410189|Non-Small Cell Lung Cancer|non-small cell lung cancer
758714|NCT00410189|NSCLC|nsclc
758715|NCT00410189|Lung Cancer|lung cancer
758716|NCT00410189|ZD6474|zd6474
758717|NCT00410189|Zactima|zactima
758718|NCT00410189|Vandetanib|vandetanib
758719|NCT00410189|BATTLE Program|battle program
758720|NCT00410163|B-cell|b-cell
758721|NCT00410163|cyclophosphamide|cyclophosphamide
758722|NCT00410163|fludarabine|fludarabine
758723|NCT00410163|Chronic Lymphocytic Leukemia|chronic lymphocytic leukemia
758724|NCT00410163|Ofatumumab|ofatumumab
758725|NCT00410150|Status asthmaticus|status asthmaticus
758726|NCT00410150|Asthma|asthma
758727|NCT00410150|Helium|helium
758728|NCT00410150|Children|children
758729|NCT00410124|advanced kidney cancer|advanced kidney cancer
758730|NCT00410124|everolimus|everolimus
758732|NCT00410124|oral therapy|oral therapy
758733|NCT00410111|sepsis|sepsis
758734|NCT00410111|encephalopathy|encephalopathy
758735|NCT00410111|cerebral perfusion|cerebral perfusion
758736|NCT00410111|electroencephalogram|electroencephalogram
758737|NCT00410098|asthma|asthma
758738|NCT00410098|yoga|yoga
758739|NCT00410098|heat|heat
758740|NCT00410098|humidity|humidity
758741|NCT00410098|bikram|bikram
758742|NCT00410059|Non-Small Cell Lung Cancer|non-small cell lung cancer
758743|NCT00410059|Lung Cancer|lung cancer
758744|NCT00410059|NSCLC|nsclc
758745|NCT00410059|Erlotinib|erlotinib
758748|NCT00410059|Battle Program|battle program
758749|NCT00410020|alpha linolenic acid|alpha linolenic acid
758750|NCT00410020|atrial fibrillation|atrial fibrillation
758751|NCT00410020|omega 3 fatty acids|omega 3 fatty acids
758752|NCT00410020|diet|diet
758753|NCT00410020|rapeseed oil|rapeseed oil
758754|NCT00410020|canola oil|canola oil
758755|NCT00410020|cardiovascular diseases|cardiovascular diseases
758756|NCT00410007|ADPKD|adpkd
758757|NCT00410007|Urinary Aquaporin-2|urinary aquaporin-2
758758|NCT00410007|ENaC|enac
758759|NCT00410007|Fractional sodium excretion|fractional sodium excretion
758760|NCT00410007|High/low sodium diet|high/low sodium diet
758761|NCT00409994|Colorectal cancer|colorectal cancer
758762|NCT00409994|M-tor inhibitor|m-tor inhibitor
758763|NCT00409994|Rapamycin|rapamycin
758764|NCT00409981|in stent restenosis|in stent restenosis
758765|NCT00409981|paclitaxel coated balloon catheter|paclitaxel coated balloon catheter
758766|NCT00409981|paccocath|paccocath
758767|NCT00409981|drug eluting balloon|drug eluting balloon
758768|NCT00409968|Lung Cancer|lung cancer
758769|NCT00409968|Non Small Cell Lung Cancer|non small cell lung cancer
758770|NCT00409968|BATTLE Program|battle program
758771|NCT00409968|Umbrella Trial|umbrella trial
758772|NCT00409968|Tumor Biopsy|tumor biopsy
758773|NCT00409968|NSCLC|nsclc
758774|NCT00409955|Lamellar transplant|lamellar transplant
758775|NCT00409955|Lyophilization|lyophilization
758776|NCT00409955|Corneas storage|corneas storage
758777|NCT00409955|Keratoconus patients|keratoconus patients
758778|NCT00409955|Best corrected visual acuity < 20/60|best corrected visual acuity < 20/60
758779|NCT00409955|Signed the consent inform|signed the consent inform
758780|NCT00409942|Chronic heart failure|chronic heart failure
758781|NCT00409942|Torasemide prolonged release|torasemide prolonged release
758782|NCT00409942|Myocardial fibrosis|myocardial fibrosis
758783|NCT00409942|Loop diuretics|loop diuretics
758784|NCT00409942|Peptide of procollagen type 1|peptide of procollagen type 1
758785|NCT00409929|Safety, tolerability, pharmacokinetics, pharmacodynamics, AEB071, healthy subjects, transplantation|safety, tolerability, pharmacokinetics, pharmacodynamics, aeb071, healthy subjects, transplantation
758786|NCT00409916|chronic heart failure|chronic heart failure
758787|NCT00409916|heart failure|heart failure
758788|NCT00409916|congestive heart failure|congestive heart failure
758789|NCT00409916|impedance cardiography|impedance cardiography
758790|NCT00409916|ICG|icg
758791|NCT00409916|transthoracic electrical bioimpedance|transthoracic electrical bioimpedance
758792|NCT00409916|non-invasive|non-invasive
758793|NCT00409916|TEB|teb
758794|NCT00409890|Buscopan|buscopan
758795|NCT00409890|Hyoscine|hyoscine
758796|NCT00409890|Shortens|shortens
758797|NCT00409890|Labor|labor
758798|NCT00409890|Stage|stage
758799|NCT00409864|Gallbaldder Cancer|gallbaldder cancer
758800|NCT00409864|Endoscopic stenting|endoscopic stenting
758801|NCT00409864|Percutaneous biliary drainage|percutaneous biliary drainage
758802|NCT00409851|HYPERTENSION, VALSARTAN, AMLODIPINE,SAFETY|hypertension, valsartan, amlodipine,safety
758803|NCT00409838|Rheumatoid Arthritis, with inadequate response to methotrexate|rheumatoid arthritis, with inadequate response to methotrexate
758804|NCT00409799|Bone graft substitute|bone graft substitute
758805|NCT00409799|Promotion of bone healing|promotion of bone healing
758806|NCT00409786|Obesity|obesity
758807|NCT00409786|Diabetes|diabetes
758808|NCT00409786|Internet|internet
758809|NCT00409786|Obesity with high cardiovascular risk|obesity with high cardiovascular risk
758810|NCT00409760|HYEPRTENSION, VALSARTAN, AMLODIPINE, high blood pressure|hyeprtension, valsartan, amlodipine, high blood pressure
758811|NCT00409747|Immunology|immunology
758812|NCT00409747|Microglia|microglia
758813|NCT00409747|NF-Kappa-B|nf-kappa-b
758814|NCT00409747|Antibiotic|antibiotic
758815|NCT00409747|Autism|autism
758816|NCT00409747|Minocycline|minocycline
758817|NCT00409747|Regressive Autism|regressive autism
758818|NCT00409734|pyloric|pyloric
758819|NCT00409734|stenosis|stenosis
758820|NCT00409721|Amyotrophic Lateral Sclerosis|amyotrophic lateral sclerosis
758821|NCT00409721|ALS|als
758822|NCT00409721|Motor Neuron Disease|motor neuron disease
758823|NCT00409721|MND|mnd
758824|NCT00409721|Memantine|memantine
758825|NCT00409708|Attention Deficit Hyperactivity Disorder,|attention deficit hyperactivity disorder,
758826|NCT00409708|ADHD|adhd
758827|NCT00409708|Cytogenetic abnormalities,|cytogenetic abnormalities,
758828|NCT00409708|extended-release methylphenidate,|extended-release methylphenidate,
758924|NCT00409279|Caregiving|caregiving
758829|NCT00409695|Acute Graft versus Host Disease|acute graft versus host disease
758830|NCT00409695|aGVHD|agvhd
758831|NCT00409695|Blood And Marrow Transplantation|blood and marrow transplantation
758832|NCT00409695|Thymoglobulin|thymoglobulin
758834|NCT00409682|Crohn's Disease|crohn's disease
758835|NCT00409669|Barraquer tonometer|barraquer tonometer
758836|NCT00409669|Intraocular pressure|intraocular pressure
758837|NCT00409669|Tonometry|tonometry
758838|NCT00409643|HYPERTENSION, VALSARTAN, AMLODIPINE, high blood pressure|hypertension, valsartan, amlodipine, high blood pressure
758839|NCT00409630|Asthma|asthma
758840|NCT00409591|Thailand|thailand
758841|NCT00409591|Developing Countries|developing countries
758843|NCT00409591|Mother-to-child transmission|mother-to-child transmission
758844|NCT00409591|HIV-1|hiv-1
758845|NCT00409591|HIV-1 infection|hiv-1 infection
758846|NCT00409591|HIV Seronegativity|hiv seronegativity
758847|NCT00409578|Post acute coronary syndrome|post acute coronary syndrome
758848|NCT00409578|Acute|acute
758849|NCT00409578|coronary syndrome|coronary syndrome
758850|NCT00409578|B-type natriuretic peptide|b-type natriuretic peptide
758851|NCT00409578|N-terminal|n-terminal
758852|NCT00409578|pro-B-type natriuretic peptide|pro-b-type natriuretic peptide
758853|NCT00409578|myocardial infarctions|myocardial infarctions
758854|NCT00409565|head and neck cancer|head and neck cancer
758855|NCT00409565|cetuximab|cetuximab
758856|NCT00409565|bevacizumab|bevacizumab
758857|NCT00409565|squamous cell carcinoma|squamous cell carcinoma
758858|NCT00409565|SCCHN|scchn
758859|NCT00409565|Squamous Cell Carcinoma of the Head and Neck|squamous cell carcinoma of the head and neck
758860|NCT00409526|Iloprost|iloprost
758861|NCT00409526|PPHN|pphn
758862|NCT00409526|Newborn|newborn
758863|NCT00409526|Pulmonary Hypertension|pulmonary hypertension
758864|NCT00409526|Term|term
758865|NCT00409526|Persistent Pulmonary Hypertension of the Newborn|persistent pulmonary hypertension of the newborn
758866|NCT00409500|Safety, tolerability, pharmacokinetics, AQW051, food, Japanese, healthy male subjects|safety, tolerability, pharmacokinetics, aqw051, food, japanese, healthy male subjects
758867|NCT00409500|Healthy volunteers study|healthy volunteers study
758868|NCT00409487|obstructive sleep apnea|obstructive sleep apnea
758869|NCT00409487|hypertension|hypertension
758870|NCT00409487|ambulatory bloop pressure monitoring|ambulatory bloop pressure monitoring
758871|NCT00409448|TBI|tbi
758872|NCT00409448|intracranial edema|intracranial edema
758873|NCT00409448|brain edema|brain edema
758874|NCT00409448|craniocerebral trauma|craniocerebral trauma
758875|NCT00409448|head injury|head injury
758876|NCT00409448|brain hemorrhage, traumatic|brain hemorrhage, traumatic
758877|NCT00409448|subdural hematoma|subdural hematoma
758878|NCT00409448|brain concussion|brain concussion
758879|NCT00409448|head injuries, closed|head injuries, closed
758880|NCT00409448|epidural hematoma|epidural hematoma
758881|NCT00409448|extra-axial hemorrhage|extra-axial hemorrhage
758882|NCT00409448|cortical contusion|cortical contusion
758883|NCT00409435|Postural tachycardia syndrome (POTS)|postural tachycardia syndrome (pots)
758884|NCT00409422|pediatric obesity|pediatric obesity
758885|NCT00409422|overweight|overweight
758886|NCT00409422|insulin resistance|insulin resistance
758887|NCT00409422|hyperinsulinemia|hyperinsulinemia
758888|NCT00409422|weight management program|weight management program
758889|NCT00409422|family-based|family-based
758890|NCT00409409|Sublingual immunotherapy|sublingual immunotherapy
758891|NCT00409409|Grass pollen tablet|grass pollen tablet
758892|NCT00409409|Allergic rhinoconjunctivitis|allergic rhinoconjunctivitis
758893|NCT00409396|Ulcerative|ulcerative
758894|NCT00409396|Colitis|colitis
758895|NCT00409396|PGE-M|pge-m
758896|NCT00409396|fecal calprotectin|fecal calprotectin
758897|NCT00409396|disease biomarkers|disease biomarkers
758898|NCT00409383|Advanced Melanoma|advanced melanoma
758899|NCT00409383|Normal baseline LDH|normal baseline ldh
758900|NCT00409383|Chemotherapy naive|chemotherapy naive
758901|NCT00409357|urinary tract|urinary tract
758902|NCT00409344|Thoracoabdominal Aortic Aneurysm|thoracoabdominal aortic aneurysm
758903|NCT00409344|Dexmedetomidine|dexmedetomidine
758904|NCT00409344|Mechanical ventilation|mechanical ventilation
758905|NCT00409331|Head and Neck Cancer|head and neck cancer
758906|NCT00409331|HNSCC|hnscc
758907|NCT00409331|Submandibular and Sublingual Salivary Sparing|submandibular and sublingual salivary sparing
758908|NCT00409331|Amifostine|amifostine
758909|NCT00409331|Ethyol|ethyol
758910|NCT00409331|Radiation Therapy|radiation therapy
758911|NCT00409318|Inflammation|inflammation
758912|NCT00409318|Visceral adiposity|visceral adiposity
758913|NCT00409318|TNF|tnf
758914|NCT00409318|CRP|crp
758915|NCT00409318|Adiponectin|adiponectin
758916|NCT00409318|Insulin resistance|insulin resistance
758917|NCT00409318|metabolic syndrome|metabolic syndrome
758918|NCT00409292|RAD001|rad001
758919|NCT00409292|metastatic pancreatic cancer|metastatic pancreatic cancer
758920|NCT00409279|Aging|aging
758921|NCT00409279|Parent / Adult-child interaction|parent / adult-child interaction
758922|NCT00409279|Family caregivers|family caregivers
758923|NCT00409279|Alzheimer's|alzheimer's
758925|NCT00409253|PRE-ECLAMPSIA-URAPIDIL-NICARDIPINE|pre-eclampsia-urapidil-nicardipine
758926|NCT00409240|Group Intervention|group intervention
758927|NCT00409240|Pharmacotherapy|pharmacotherapy
758928|NCT00409240|Behavioral Modification|behavioral modification
758929|NCT00409240|Diabetes|diabetes
758930|NCT00409227|swl|swl
758931|NCT00409227|lithotripsy|lithotripsy
758932|NCT00409227|stone disease|stone disease
758933|NCT00409227|urolithiasis|urolithiasis
758934|NCT00409227|nephrolithiasis|nephrolithiasis
758935|NCT00409214|Glioma|glioma
758936|NCT00409214|Litx™|litx™
758937|NCT00409214|LS11|ls11
758938|NCT00409214|Glioblastoma multiforme|glioblastoma multiforme
758939|NCT00409214|Anaplastic Astrocytoma|anaplastic astrocytoma
758940|NCT00409214|GBM|gbm
758942|NCT00409201|schizophrenia|schizophrenia
758943|NCT00409201|reboxetine|reboxetine
758944|NCT00409201|cognitive|cognitive
758945|NCT00409201|behavior|behavior
758946|NCT00409188|Non-Small Cell Lung Carcinoma;|non-small cell lung carcinoma;
758947|NCT00409188|stage III;|stage iii;
758948|NCT00409188|unresectable;|unresectable;
758949|NCT00409188|vaccine; Tecemotide; L-BLP25;|vaccine; tecemotide; l-blp25;
758950|NCT00409188|Cyclophosphamide;|cyclophosphamide;
758951|NCT00409188|placebo controlled;|placebo controlled;
758952|NCT00409188|randomized;|randomized;
758953|NCT00409188|double blind;|double blind;
758954|NCT00409188|immunotherapy;|immunotherapy;
758955|NCT00409175|FAP|fap
758956|NCT00409175|Fx-1006A|fx-1006a
758957|NCT00409175|transthyretin|transthyretin
758958|NCT00409175|TTR|ttr
758959|NCT00409175|amyloid|amyloid
758960|NCT00409175|polyneuropathy|polyneuropathy
758961|NCT00409175|V30M|v30m
758962|NCT00409175|familial|familial
758963|NCT00409175|hereditary|hereditary
758964|NCT00409175|amyloidosis|amyloidosis
758965|NCT00409175|FoldRx|foldrx
758966|NCT00409162|Tattoo removal|tattoo removal
758967|NCT00409149|Hypertension|hypertension
758968|NCT00409149|Diet|diet
758969|NCT00409149|physical exercise|physical exercise
758970|NCT00409149|naturopathic|naturopathic
758971|NCT00409149|group therapy|group therapy
758972|NCT00409149|Qi Gong|qi gong
758973|NCT00409136|Alert|alert
758974|NCT00409136|Deep Vein Thrombosis|deep vein thrombosis
758975|NCT00409136|Pulmonary Embolism|pulmonary embolism
758976|NCT00409136|Venous Thromboembolism|venous thromboembolism
758977|NCT00409136|Prophylaxis|prophylaxis
758978|NCT00409136|Anticoagulation|anticoagulation
758979|NCT00409123|vasospastic women|vasospastic women
758980|NCT00409123|controls|controls
758981|NCT00409123|core cooling|core cooling
758982|NCT00409123|core warming|core warming
758983|NCT00409123|external cooling|external cooling
758984|NCT00409123|external warming|external warming
758985|NCT00409123|LDF|ldf
758986|NCT00409123|choroidal blood flow|choroidal blood flow
758987|NCT00409123|temperature|temperature
758988|NCT00409123|vasospastic subjects|vasospastic subjects
758989|NCT00409123|normal subjects|normal subjects
758990|NCT00409110|Ocular Pulse Amplitude|ocular pulse amplitude
758991|NCT00409110|Dynamic Contour Tonometry|dynamic contour tonometry
758992|NCT00409110|Pulsatility Index|pulsatility index
758993|NCT00409110|Choroidal Laser Doppler Flowmetry|choroidal laser doppler flowmetry
758994|NCT00409110|Finometer|finometer
758995|NCT00409097|ADMA|adma
758996|NCT00409097|MOF|mof
758997|NCT00409097|Critical illness|critical illness
758998|NCT00409084|varices|varices
758999|NCT00409084|band ligation|band ligation
759000|NCT00409084|portal hypertension|portal hypertension
759001|NCT00409084|primary prophylaxis|primary prophylaxis
759002|NCT00409084|cirrhosis|cirrhosis
759003|NCT00409084|beta blockers|beta blockers
759004|NCT00409071|Non metastatic breast cancer|non metastatic breast cancer
759005|NCT00409071|Adjuvant chemotherapy|adjuvant chemotherapy
759006|NCT00409071|Nausea|nausea
759007|NCT00409071|Vomiting|vomiting
759008|NCT00409071|Quality of life|quality of life
759009|NCT00409071|Homeopathy|homeopathy
759010|NCT00409058|TBI (Traumatic Brain Injury)|tbi (traumatic brain injury)
759011|NCT00409058|Intracranial Edema|intracranial edema
759012|NCT00409058|Brain Edema|brain edema
759013|NCT00409058|Craniocerebral Trauma|craniocerebral trauma
759014|NCT00409058|Head Injury|head injury
759015|NCT00409058|Brain Hemorrhage, Traumatic|brain hemorrhage, traumatic
759016|NCT00409058|Subdural Hematoma|subdural hematoma
759017|NCT00409058|Brain Concussion|brain concussion
759018|NCT00409058|Head Injuries, Closed|head injuries, closed
759019|NCT00409045|Obstructive Sleep Apnea|obstructive sleep apnea
759020|NCT00409045|Pulmonary Embolism|pulmonary embolism
759021|NCT00409045|male and female patients suspected of having a pulmonary embolism.|male and female patients suspected of having a pulmonary embolism.
759022|NCT00409032|osteoporosis|osteoporosis
759023|NCT00409032|BMD|bmd
759024|NCT00409032|CTX|ctx
759025|NCT00409032|Post menopausal|post menopausal
759026|NCT00409032|strontium|strontium
759027|NCT00409032|bone turnover|bone turnover
759028|NCT00409032|clinical development|clinical development
759029|NCT00408980|diet|diet
759030|NCT00408980|breast milk fat|breast milk fat
759033|NCT00408967|Epithelial|epithelial
759034|NCT00408967|Recurrent|recurrent
759035|NCT00408967|Platinum|platinum
759036|NCT00408967|Second-line therapy|second-line therapy
759037|NCT00408967|Maintenance Therapy|maintenance therapy
759038|NCT00408967|Biologic|biologic
759039|NCT00408967|Targeted Therapy|targeted therapy
759040|NCT00408967|Antibody|antibody
759041|NCT00408941|EEG|eeg
759042|NCT00408941|AEP|aep
759043|NCT00408941|Artefacts|artefacts
759044|NCT00408941|Propofol|propofol
759045|NCT00408941|Local Anaesthesia|local anaesthesia
759046|NCT00408928|Graft-versus-Host Disease|graft-versus-host disease
759047|NCT00408928|bortezomib|bortezomib
759048|NCT00408915|Lisuride|lisuride
759143|NCT00408512|adverse events|adverse events
759049|NCT00408915|Continuous Dopaminergic Stimulation|continuous dopaminergic stimulation
759050|NCT00408915|Motor Fluctuations|motor fluctuations
759051|NCT00408915|Off-Times|off-times
759052|NCT00408915|Troublesome Dyskinesia|troublesome dyskinesia
759053|NCT00408915|Parkinson's Disease with motor fluctuations with OFF periods and/or troublesome dyskinesias of more than four hours per day|parkinson's disease with motor fluctuations with off periods and/or troublesome dyskinesias of more than four hours per day
759054|NCT00408889|liver transplantation|liver transplantation
759055|NCT00408889|organ failure|organ failure
759056|NCT00408889|outcome|outcome
759057|NCT00408863|Breast cancer|breast cancer
759058|NCT00408863|Tibolone|tibolone
759059|NCT00408863|Climacteric symptoms|climacteric symptoms
759060|NCT00408850|sympathetic nervous system, pioglitazone, metabolic syndrome|sympathetic nervous system, pioglitazone, metabolic syndrome
759061|NCT00408824|insulin resistance|insulin resistance
759062|NCT00408824|adipocytokine|adipocytokine
759063|NCT00408824|Metabolic syndrome|metabolic syndrome
759064|NCT00408824|Diabetes|diabetes
759065|NCT00408798|Treatment of Alopecia areata with intracutaneous injections of Botulinum Toxin A|treatment of alopecia areata with intracutaneous injections of botulinum toxin a
759066|NCT00408785|Botulinum Toxin Type A|botulinum toxin type a
759067|NCT00408785|safety|safety
759068|NCT00408785|efficacy|efficacy
759069|NCT00408785|glabellar lines|glabellar lines
759070|NCT00408772|liver metastases|liver metastases
759071|NCT00408772|stage IV colon cancer|stage iv colon cancer
759072|NCT00408772|stage IV rectal cancer|stage iv rectal cancer
759073|NCT00408772|adenocarcinoma of the colon|adenocarcinoma of the colon
759074|NCT00408772|adenocarcinoma of the rectum|adenocarcinoma of the rectum
759075|NCT00408772|recurrent colon cancer|recurrent colon cancer
759076|NCT00408772|recurrent rectal cancer|recurrent rectal cancer
759077|NCT00408759|xerostomia|xerostomia
759078|NCT00408759|hypnosis|hypnosis
759079|NCT00408759|dry mouth|dry mouth
759080|NCT00408759|radiotherapy|radiotherapy
759081|NCT00408759|head and neck cancer|head and neck cancer
759082|NCT00408746|stomatognathic system|stomatognathic system
759083|NCT00408746|maxilla|maxilla
759084|NCT00408746|palate|palate
759085|NCT00408746|development|development
759086|NCT00408720|Spectral OCT|spectral oct
759087|NCT00408720|SLO|slo
759088|NCT00408720|Retinal Imagining|retinal imagining
759089|NCT00408707|local infiltration analgesia|local infiltration analgesia
759090|NCT00408707|postoperative pain|postoperative pain
759091|NCT00408707|ropivacaine|ropivacaine
759092|NCT00408668|Malaria Vaccine|malaria vaccine
759093|NCT00408642|adherence|adherence
759094|NCT00408642|treatment|treatment
759095|NCT00408642|antiretroviral|antiretroviral
759096|NCT00408642|HAART|haart
759097|NCT00408642|HIV|hiv
759098|NCT00408642|Treatment Naive|treatment naive
759099|NCT00408629|Ulcerative Colitis|ulcerative colitis
759100|NCT00408629|Adalimumab|adalimumab
759101|NCT00408629|TNF Antagonist|tnf antagonist
759102|NCT00408629|Mayo Score|mayo score
759103|NCT00408603|second line treatment|second line treatment
759104|NCT00408603|platinum resistant|platinum resistant
759105|NCT00408603|ovary|ovary
759106|NCT00408603|ovaries|ovaries
759107|NCT00408603|cancer|cancer
759108|NCT00408603|epithelial|epithelial
759109|NCT00408603|carcinomas|carcinomas
759110|NCT00408603|tumor|tumor
759111|NCT00408590|ovarian clear cell cystadenocarcinoma|ovarian clear cell cystadenocarcinoma
759112|NCT00408590|ovarian endometrioid adenocarcinoma|ovarian endometrioid adenocarcinoma
759113|NCT00408590|primary peritoneal cavity cancer|primary peritoneal cavity cancer
759114|NCT00408590|ovarian mixed epithelial carcinoma|ovarian mixed epithelial carcinoma
759115|NCT00408590|ovarian mucinous cystadenocarcinoma|ovarian mucinous cystadenocarcinoma
759116|NCT00408590|ovarian serous cystadenocarcinoma|ovarian serous cystadenocarcinoma
759117|NCT00408590|ovarian undifferentiated adenocarcinoma|ovarian undifferentiated adenocarcinoma
759118|NCT00408590|recurrent ovarian epithelial cancer|recurrent ovarian epithelial cancer
759119|NCT00408590|Brenner tumor|brenner tumor
759120|NCT00408577|glucose intolerance|glucose intolerance
759121|NCT00408577|cardiovascular disease|cardiovascular disease
759122|NCT00408577|insulin resistance|insulin resistance
759123|NCT00408577|endothelial dysfunction|endothelial dysfunction
759124|NCT00408564|adenocarcinoma of the pancreas|adenocarcinoma of the pancreas
759125|NCT00408564|stage II pancreatic cancer|stage ii pancreatic cancer
759126|NCT00408564|stage III pancreatic cancer|stage iii pancreatic cancer
759127|NCT00408551|stage IV colon cancer|stage iv colon cancer
759128|NCT00408551|stage IV rectal cancer|stage iv rectal cancer
759129|NCT00408551|liver metastases|liver metastases
759130|NCT00408551|recurrent colon cancer|recurrent colon cancer
759131|NCT00408551|recurrent rectal cancer|recurrent rectal cancer
759132|NCT00408538|Microbicide|microbicide
759133|NCT00408538|HIV|hiv
759134|NCT00408538|Prevention|prevention
759135|NCT00408538|Rectal|rectal
759136|NCT00408538|HIV Prevention|hiv prevention
759137|NCT00408525|memory loss|memory loss
759138|NCT00408525|memory problems|memory problems
759139|NCT00408525|alzheimer's|alzheimer's
759140|NCT00408525|forgetfulness|forgetfulness
759141|NCT00408525|forgetting|forgetting
759142|NCT00408512|treatment|treatment
759144|NCT00408512|adherence|adherence
759146|NCT00408512|polymorphism|polymorphism
759147|NCT00408499|unspecified adult solid tumor, protocol specific|unspecified adult solid tumor, protocol specific
759148|NCT00408499|stage IIIA non-small cell lung cancer|stage iiia non-small cell lung cancer
759149|NCT00408499|stage IIIB non-small cell lung cancer|stage iiib non-small cell lung cancer
759150|NCT00408499|stage IV non-small cell lung cancer|stage iv non-small cell lung cancer
759151|NCT00408499|recurrent non-small cell lung cancer|recurrent non-small cell lung cancer
759152|NCT00408447|stem cell transplant|stem cell transplant
759153|NCT00408447|sickle cell disease|sickle cell disease
759154|NCT00408447|thalassemia|thalassemia
759155|NCT00408447|moderately ablative|moderately ablative
759156|NCT00408447|cord blood transplant|cord blood transplant
759157|NCT00408447|matched family donor|matched family donor
759158|NCT00408434|PPARgamma agonist|ppargamma agonist
759159|NCT00408434|advanced or metastatic malignancies|advanced or metastatic malignancies
759160|NCT00408434|Tumor|tumor
759161|NCT00408434|Cancer|cancer
759162|NCT00408408|stage I breast cancer|stage i breast cancer
759163|NCT00408408|stage II breast cancer|stage ii breast cancer
759164|NCT00408408|stage IIIA breast cancer|stage iiia breast cancer
759165|NCT00408395|influenza|influenza
759166|NCT00408395|children|children
759167|NCT00408395|vaccine|vaccine
759168|NCT00408395|influenza disease|influenza disease
759169|NCT00408382|Lipitor|lipitor
759170|NCT00408382|atorvastatin|atorvastatin
759171|NCT00408382|Hypercholesteremia|hypercholesteremia
759172|NCT00408382|yellow coronary plaque|yellow coronary plaque
759173|NCT00408369|prophylactic|prophylactic
759174|NCT00408369|malaria|malaria
759175|NCT00408369|challenge|challenge
759176|NCT00408356|Zinc treatment|zinc treatment
759177|NCT00408356|supplementation|supplementation
759178|NCT00408356|Enterotoxigenic E. coli|enterotoxigenic e. coli
759179|NCT00408356|diarrhoea|diarrhoea
759180|NCT00408317|Cystic Fibrosis|cystic fibrosis
759181|NCT00408317|Exocrine Pancreatic Insufficiency|exocrine pancreatic insufficiency
759182|NCT00408317|Ultrase® MT20|ultrase® mt20
759183|NCT00408304|interferon alpha|interferon alpha
759184|NCT00408304|depression|depression
759185|NCT00408304|omega 3|omega 3
759186|NCT00408291|fracture|fracture
759187|NCT00408291|shoulder|shoulder
759188|NCT00408291|bone density|bone density
759189|NCT00408291|healing|healing
759190|NCT00408278|Acute Promyelocytic Leukemia|acute promyelocytic leukemia
759191|NCT00408265|Nicotine Dependence|nicotine dependence
759192|NCT00408265|Contingency Management|contingency management
759193|NCT00408252|recurrent or locally advanced|recurrent or locally advanced
759194|NCT00408252|cytokine failure|cytokine failure
759195|NCT00408239|Factor Xa inhibitor|factor xa inhibitor
759196|NCT00408239|Thromboembolism|thromboembolism
759197|NCT00408239|Arthroplasty|arthroplasty
759198|NCT00408239|Knee Replacement|knee replacement
759199|NCT00408239|Prevention and Control|prevention and control
759200|NCT00408200|Atrial fibrillation|atrial fibrillation
759201|NCT00408200|Atrial arrhythmia|atrial arrhythmia
759202|NCT00408187|Randomized Controlled Trials|randomized controlled trials
759203|NCT00408187|Immunosuppression|immunosuppression
759204|NCT00408187|Adult|adult
759205|NCT00408187|Chronic Disease|chronic disease
759206|NCT00408187|Dermatologic Agents|dermatologic agents
759207|NCT00408187|Female|female
759208|NCT00408187|Humans|humans
759209|NCT00408187|Male|male
759210|NCT00408187|Middle Aged|middle aged
759211|NCT00408187|Severity of Illness Index|severity of illness index
759212|NCT00408187|Treatment Outcome|treatment outcome
759213|NCT00408187|Quality of Life|quality of life
759214|NCT00408187|Double-Blind Method|double-blind method
759215|NCT00408174|IBD|ibd
759216|NCT00408174|UC|uc
759217|NCT00408174|Ulcerative Colitis|ulcerative colitis
759218|NCT00408174|Inflammatory Bowel Disease|inflammatory bowel disease
759219|NCT00408161|Contingency Management|contingency management
759220|NCT00408161|Alcohol Dependence|alcohol dependence
759221|NCT00408135|Respiratory Tract Infections|respiratory tract infections
759222|NCT00408135|Skin Diseases|skin diseases
759223|NCT00408135|Sinusitis|sinusitis
759224|NCT00408109|Avian Influenza|avian influenza
759225|NCT00408109|Healthy|healthy
759226|NCT00408109|Immunity|immunity
759227|NCT00408109|Preventive|preventive
759228|NCT00408109|Bird Flu|bird flu
759229|NCT00408109|Healthy Volunteer|healthy volunteer
759231|NCT00408096|osteoarthritis|osteoarthritis
759232|NCT00408096|shoulder|shoulder
759233|NCT00408096|resurfacing|resurfacing
759234|NCT00408096|prosthesis|prosthesis
759235|NCT00408070|ovarian cancer|ovarian cancer
759236|NCT00408070|fallopian tube cancer|fallopian tube cancer
759237|NCT00408070|peritoneal cancer|peritoneal cancer
759238|NCT00408057|lipid lowering|lipid lowering
759239|NCT00408057|target achievement|target achievement
759240|NCT00408057|Patients with established cardiovascular disease|patients with established cardiovascular disease
759241|NCT00408031|Major depressive disorder|major depressive disorder
759242|NCT00408031|NMDA receptor|nmda receptor
759243|NCT00408031|Treatment-Resistant|treatment-resistant
759244|NCT00408031|D-cycloserine|d-cycloserine
759245|NCT00407992|Headache|headache
759248|NCT00407940|Claudication|claudication
759249|NCT00407914|wrinkles|wrinkles
759250|NCT00407914|soft tissue filler|soft tissue filler
759251|NCT00407914|Aquamid|aquamid
759252|NCT00407901|Visually Challenged|visually challenged
759253|NCT00407901|Legally Blind|legally blind
759254|NCT00407901|Functional Assessment Questionnaire|functional assessment questionnaire
759255|NCT00407901|Low Functioning|low functioning
759256|NCT00407901|High Functioning|high functioning
759257|NCT00407875|Prostate|prostate
759258|NCT00407875|Cancer|cancer
759259|NCT00407875|Radiation|radiation
759260|NCT00407862|insulin resistance|insulin resistance
759261|NCT00407862|beta cell function|beta cell function
759262|NCT00407862|endothelial dysfunction|endothelial dysfunction
759263|NCT00407836|HIV|hiv
759264|NCT00407836|CD4 T cell level|cd4 t cell level
759265|NCT00407836|CD4 autoimmunity|cd4 autoimmunity
759266|NCT00407836|Viral load|viral load
759267|NCT00407836|T cell vaccination|t cell vaccination
759268|NCT00407836|HIV Therapeutic Vaccine|hiv therapeutic vaccine
759269|NCT00407823|Child|child
759270|NCT00407823|Septic shock|septic shock
759271|NCT00407823|Resuscitation|resuscitation
759272|NCT00407823|Central venous oxygen saturation|central venous oxygen saturation
759273|NCT00407823|Cardiac output|cardiac output
759274|NCT00407823|Goal-directed therapy|goal-directed therapy
759275|NCT00407797|Lyrica|lyrica
759276|NCT00407797|Epilepsies - Partial|epilepsies - partial
759277|NCT00407784|primary aldosteronism|primary aldosteronism
759278|NCT00407784|hypertension|hypertension
759279|NCT00407784|aldosteron-renin ratio|aldosteron-renin ratio
759280|NCT00407784|eplerenone|eplerenone
759281|NCT00407784|aldosteron-receptor antagonist|aldosteron-receptor antagonist
759282|NCT00407784|screening|screening
759283|NCT00407771|platelet function assay|platelet function assay
759284|NCT00407771|Glycoprotein inhibitors|glycoprotein inhibitors
759285|NCT00407771|percutaneous coronary intervention|percutaneous coronary intervention
759286|NCT00407771|Diabetes Mellitus|diabetes mellitus
759287|NCT00407758|recurrent ovarian epithelial cancer|recurrent ovarian epithelial cancer
759288|NCT00407758|primary peritoneal cavity cancer|primary peritoneal cavity cancer
759289|NCT00407745|Pain|pain
759290|NCT00407745|central neuropathic pain|central neuropathic pain
759291|NCT00407732|hepatitis C|hepatitis c
759292|NCT00407732|mental disorder|mental disorder
759293|NCT00407732|substance use|substance use
759294|NCT00407732|psychosocial intervention|psychosocial intervention
759295|NCT00407719|Choroidal Neovascularization|choroidal neovascularization
759296|NCT00407706|Breast Cancer, FACS, SCM, Malignant, Benign, Lymphocytes|breast cancer, facs, scm, malignant, benign, lymphocytes
759297|NCT00407693|Dosimetry|dosimetry
759298|NCT00407693|Effective Dose|effective dose
759299|NCT00407693|Radiation-Absorbed Dose|radiation-absorbed dose
759300|NCT00407680|Type 2 diabetes mellitus|type 2 diabetes mellitus
759301|NCT00407680|Hypertension|hypertension
759302|NCT00407680|Angiotensin II Receptor Blocker|angiotensin ii receptor blocker
759303|NCT00407680|Diabetic nephropathy|diabetic nephropathy
759304|NCT00407667|hemiparesis|hemiparesis
759305|NCT00407667|rehabilitation|rehabilitation
759306|NCT00407667|upper limb rehabilitation|upper limb rehabilitation
759307|NCT00407667|arm therapy|arm therapy
759308|NCT00407641|diabetes mellitus|diabetes mellitus
759309|NCT00407641|chronic hemodialysis|chronic hemodialysis
759310|NCT00407641|anticoagulation|anticoagulation
759311|NCT00407641|outcome|outcome
759312|NCT00407628|Stroke|stroke
759313|NCT00407628|Diffusion spectrum tractography|diffusion spectrum tractography
759314|NCT00407628|Functional MRI (fMRI)|functional mri (fmri)
759315|NCT00407628|Lower extremity|lower extremity
759316|NCT00407602|retinitis pigmentosa|retinitis pigmentosa
759317|NCT00407602|device|device
759318|NCT00407602|retinal implant|retinal implant
759319|NCT00407602|retinal prosthesis|retinal prosthesis
759320|NCT00407602|RP|rp
759321|NCT00407602|outer retinal degeneration|outer retinal degeneration
759322|NCT00407576|Alzheimer's Disease|alzheimer's disease
759323|NCT00407576|Positron Emission Tomography|positron emission tomography
759324|NCT00407576|Brain|brain
759325|NCT00407576|Neurochemistry|neurochemistry
759326|NCT00407576|Beta-Amyloid Plaques|beta-amyloid plaques
759328|NCT00407576|MeS-IMPY|mes-impy
759329|NCT00407576|Alzheimer Disease|alzheimer disease
759330|NCT00407576|AD|ad
759331|NCT00407576|Dementia|dementia
759332|NCT00407576|Healthy Volunteer|healthy volunteer
759333|NCT00407576|HV|hv
759334|NCT00407550|stage IIIB non-small cell lung cancer|stage iiib non-small cell lung cancer
759335|NCT00407550|stage IV non-small cell lung cancer|stage iv non-small cell lung cancer
759336|NCT00407550|recurrent non-small cell lung cancer|recurrent non-small cell lung cancer
759337|NCT00407498|P 276-00|p 276-00
759338|NCT00407498|Advanced Refractory Neoplasm|advanced refractory neoplasm
759339|NCT00407498|Maximum Tolerated Dose|maximum tolerated dose
759340|NCT00407498|Dose Limiting Toxicity|dose limiting toxicity
759341|NCT00407498|Pharmacokinetics|pharmacokinetics
759342|NCT00407472|Bio-equivalence study in healthy volunteers, indication|bio-equivalence study in healthy volunteers, indication
759343|NCT00407472|of product is growth hormone deficiency|of product is growth hormone deficiency
759344|NCT00407446|PDE5 inhibition|pde5 inhibition
759345|NCT00407446|chronic heart failure|chronic heart failure
759346|NCT00407446|endothelial function|endothelial function
759347|NCT00407446|exercise ventilation|exercise ventilation
759348|NCT00407433|Gemcitabine|gemcitabine
759349|NCT00407433|Oxaliplatine|oxaliplatine
759350|NCT00407433|Paediatric solid tumors|paediatric solid tumors
759351|NCT00407433|Other CNS tumors|other cns tumors
759352|NCT00407433|Other miscellaneous solid non-CNS tumours|other miscellaneous solid non-cns tumours
759353|NCT00407420|Childhood|childhood
759354|NCT00407420|Obesity|obesity
759355|NCT00407420|Behavior modification|behavior modification
759356|NCT00407420|Insulin resistance|insulin resistance
759357|NCT00407407|Epithelial ovarian|epithelial ovarian
759358|NCT00407407|Primary peritoneal or fallopian tube carcinoma|primary peritoneal or fallopian tube carcinoma
759359|NCT00407407|Abraxane|abraxane
759360|NCT00407407|Carboplatin|carboplatin
759361|NCT00407394|Pneumonia|pneumonia
759362|NCT00407394|Wheezing|wheezing
759363|NCT00407394|Treatment|treatment
759364|NCT00407394|Children|children
759365|NCT00407394|India|india
759367|NCT00407355|vein occlusion|vein occlusion
759368|NCT00407355|macular edema|macular edema
759369|NCT00407342|Psoriasis|psoriasis
759370|NCT00407342|biologics|biologics
759371|NCT00407342|alefacept|alefacept
759372|NCT00407342|Narrowband UVB|narrowband uvb
759373|NCT00407342|Phototherapy|phototherapy
759374|NCT00407342|Half-side comparison|half-side comparison
759375|NCT00407329|BPH|bph
759376|NCT00407316|Uveitis|uveitis
759377|NCT00407316|Quality of life|quality of life
759378|NCT00407316|Visual function|visual function
759379|NCT00407290|pregnancy|pregnancy
759380|NCT00407290|vaginal delivery|vaginal delivery
759381|NCT00407277|nicotine dependence|nicotine dependence
759382|NCT00407277|smoking|smoking
759383|NCT00407277|nicotine patch|nicotine patch
759384|NCT00407277|double-blind|double-blind
759385|NCT00407277|randomized|randomized
759386|NCT00407277|placebo|placebo
759387|NCT00407277|psychosis|psychosis
759388|NCT00407277|schizophrenia|schizophrenia
759389|NCT00407277|schizophreniform|schizophreniform
759390|NCT00407277|schizoaffective disorder|schizoaffective disorder
759391|NCT00407264|bronchial squamous metaplasia|bronchial squamous metaplasia
759392|NCT00407264|bronchial squamous dysplasia|bronchial squamous dysplasia
759393|NCT00407251|refractory|refractory
759394|NCT00407251|prostate|prostate
759395|NCT00407251|hormone|hormone
759396|NCT00407238|barrier function, multi-purpose solutions, silicone hydrogel contact lenses|barrier function, multi-purpose solutions, silicone hydrogel contact lenses
759397|NCT00407212|early stage idiopathic Parkinson's disease|early stage idiopathic parkinson's disease
759398|NCT00407199|social phobia, anxiety, quetiapine|social phobia, anxiety, quetiapine
759399|NCT00407186|CRITICS|critics
759400|NCT00407186|gastric cancer|gastric cancer
759401|NCT00407186|surgery|surgery
759402|NCT00407186|adjuvant|adjuvant
759403|NCT00407186|chemotherapy|chemotherapy
759404|NCT00407186|chemoradiotherapy|chemoradiotherapy
759405|NCT00407186|capecitabine|capecitabine
759406|NCT00407186|cisplatin|cisplatin
759407|NCT00407186|epirubicin|epirubicin
759408|NCT00407160|Kidney transplant|kidney transplant
759409|NCT00407160|Tolerance induction|tolerance induction
759410|NCT00407160|High Panel Reactive Antibody (PRA) kidney recipients|high panel reactive antibody (pra) kidney recipients
759411|NCT00407147|bacterial infection|bacterial infection
759412|NCT00407147|empiric antibiotic treatment|empiric antibiotic treatment
759413|NCT00407147|duration antibiotic treatment|duration antibiotic treatment
759414|NCT00407147|reduce antibiotic treatment|reduce antibiotic treatment
759415|NCT00407147|procalcitonin|procalcitonin
759416|NCT00407147|PCT Kryptor|pct kryptor
759417|NCT00407147|sepsis|sepsis
759418|NCT00407147|Intensive Care Unit|intensive care unit
759419|NCT00407147|antibiotic treatment|antibiotic treatment
759420|NCT00407121|Neovascular Membrane|neovascular membrane
759421|NCT00407121|Uveitis|uveitis
759422|NCT00407121|Bevacizumab|bevacizumab
759423|NCT00407108|vitreoretinal surgery|vitreoretinal surgery
759424|NCT00407095|Parkinson Disease|parkinson disease
759425|NCT00407043|Dry Eye Disease|dry eye disease
759427|NCT00407043|Restasis|restasis
759428|NCT00407043|Loteprednol|loteprednol
759429|NCT00407043|Cyclosporine|cyclosporine
759430|NCT00407004|acute-on-chronic liver failure, MARS, Prometheus, bilirubin, bile acids, cytokines|acute-on-chronic liver failure, mars, prometheus, bilirubin, bile acids, cytokines
759431|NCT00406991|retinal blood flow|retinal blood flow
759432|NCT00406991|diabetic retinopathy|diabetic retinopathy
759433|NCT00406991|microthrombosis|microthrombosis
759434|NCT00406991|aspirin|aspirin
759435|NCT00406991|clopidogrel|clopidogrel
759436|NCT00406978|MYELOMA|myeloma
759437|NCT00406978|THALIDOMIDE|thalidomide
759438|NCT00406978|DEFIBRODITE|defibrodite
759439|NCT00406939|Gene Therapy|gene therapy
759440|NCT00406939|Immunology|immunology
759441|NCT00406939|Phase I Clinical Trial|phase i clinical trial
759442|NCT00406900|uveal melanoma|uveal melanoma
759443|NCT00406900|metastatic disease|metastatic disease
759444|NCT00406874|infertility|infertility
759853|NCT00405119|tolerance|tolerance
759445|NCT00406874|semen quality|semen quality
759446|NCT00406874|sexual function|sexual function
759447|NCT00406874|blood pressure|blood pressure
759448|NCT00406874|omega 3 fats|omega 3 fats
759449|NCT00406874|folic acid|folic acid
759450|NCT00406861|reaction|reaction
759451|NCT00406861|ENL|enl
759452|NCT00406861|leprosy|leprosy
759453|NCT00406835|Whole Brain Radiation Therapy|whole brain radiation therapy
759454|NCT00406835|Stereotactic Radiosurgery|stereotactic radiosurgery
759455|NCT00406835|Brain metastases|brain metastases
759456|NCT00406822|Glaucoma|glaucoma
759457|NCT00406822|collagen matrix|collagen matrix
759458|NCT00406822|OculusGen|oculusgen
759459|NCT00406822|trabeculectomy|trabeculectomy
759460|NCT00406822|tissue engineering|tissue engineering
759461|NCT00406809|Sezary syndrome|sezary syndrome
759462|NCT00406809|cutaneous T-cell lymphoma|cutaneous t-cell lymphoma
759463|NCT00406809|follicular lymphoma|follicular lymphoma
759464|NCT00406809|marginal zone lymphoma|marginal zone lymphoma
759465|NCT00406809|indolent T-cell lymphoma|indolent t-cell lymphoma
759466|NCT00406809|Navitoclax|navitoclax
759467|NCT00406809|Non-Hodgkin's lymphoma|non-hodgkin's lymphoma
759468|NCT00406809|peripheral T-cell lymphoma|peripheral t-cell lymphoma
759469|NCT00406809|ABT-263|abt-263
759470|NCT00406809|lymphoid malignancies|lymphoid malignancies
759471|NCT00406809|chronic lymphoid leukemia|chronic lymphoid leukemia
759472|NCT00406809|mycosis fungoides|mycosis fungoides
759473|NCT00406809|mantle cell lymphoma|mantle cell lymphoma
759474|NCT00406783|Allergic Rhinitis|allergic rhinitis
759475|NCT00406783|Intermittent Allergic Rhinitis|intermittent allergic rhinitis
759476|NCT00406770|Obesity|obesity
759477|NCT00406770|Light therapy|light therapy
759478|NCT00406770|Hypocaloric diet|hypocaloric diet
759479|NCT00406757|T-cell|t-cell
759480|NCT00406757|T-ALL|t-all
759481|NCT00406757|T-LBL|t-lbl
759482|NCT00406757|506U78|506u78
759483|NCT00406757|ara-G|ara-g
759484|NCT00406757|ara-GTP|ara-gtp
759485|NCT00406757|Lymphoma|lymphoma
759486|NCT00406757|Leukemia|leukemia
759487|NCT00406744|neovascularization|neovascularization
759488|NCT00406731|Endothelin-1|endothelin-1
759489|NCT00406731|L-NG-Monomethyl Arginine|l-ng-monomethyl arginine
759490|NCT00406731|Optic Nerve Head blood flow|optic nerve head blood flow
759491|NCT00406718|Medication Adherence|medication adherence
759492|NCT00406718|Psychosocial Treatment|psychosocial treatment
759493|NCT00406718|Cognitive Adaptation Training|cognitive adaptation training
759494|NCT00406718|Med-e Monitor|med-e monitor
759495|NCT00406718|Adaptive Function|adaptive function
759496|NCT00406705|Exercise Tolerance|exercise tolerance
759497|NCT00406705|Dyspnea|dyspnea
759498|NCT00406705|Rehabilitation|rehabilitation
759499|NCT00406705|Helium|helium
759500|NCT00406692|Zonisamide|zonisamide
759501|NCT00406692|Alcoholism|alcoholism
759502|NCT00406692|Alcohol|alcohol
759503|NCT00406679|pain, postoperative|pain, postoperative
759504|NCT00406679|surgery, oral|surgery, oral
759505|NCT00406679|surgery, dental|surgery, dental
759506|NCT00406640|MDD|mdd
759507|NCT00406640|Major Depressive Disorder|major depressive disorder
759508|NCT00406640|Depression|depression
759509|NCT00406627|filariasis, lymphatic filariasis, Egypt|filariasis, lymphatic filariasis, egypt
759510|NCT00406614|High Blood Pressure|high blood pressure
759511|NCT00406588|Parkinson Disease|parkinson disease
759512|NCT00406575|Congestive heart failure|congestive heart failure
759513|NCT00406575|Relaxin|relaxin
759514|NCT00406575|Hemodynamics|hemodynamics
759515|NCT00406575|Renal function|renal function
759516|NCT00406562|uncontrolled|uncontrolled
759517|NCT00406549|Staphylococcus aureus|staphylococcus aureus
759518|NCT00406549|Nasal colonization|nasal colonization
759519|NCT00406549|pre-surgical patients|pre-surgical patients
759520|NCT00406549|Sensitivity|sensitivity
759521|NCT00406549|Specificity|specificity
759522|NCT00406549|Nasal Staphylococcus aureus in pre-surgical patients|nasal staphylococcus aureus in pre-surgical patients
759523|NCT00406536|Cystic Fibrosis|cystic fibrosis
759524|NCT00406536|Pancreatic Insufficiency|pancreatic insufficiency
759525|NCT00406536|LYM-X-SORB™|lym-x-sorb™
759526|NCT00406536|LXS|lxs
759527|NCT00406484|Methadone|methadone
759528|NCT00406484|Counseling|counseling
759529|NCT00406484|HIV risk reduction|hiv risk reduction
759530|NCT00406484|HIV Seronegativity|hiv seronegativity
759531|NCT00406471|Ischemic|ischemic
759532|NCT00406471|Central|central
759533|NCT00406471|Retinal|retinal
759534|NCT00406471|Vein|vein
759535|NCT00406471|Occlusion|occlusion
759536|NCT00406471|Ranibizumab|ranibizumab
759537|NCT00406471|Lucentis|lucentis
759538|NCT00406471|CRVO|crvo
759539|NCT00406471|ISCRVO|iscrvo
759540|NCT00406458|Diabetic neuropathy|diabetic neuropathy
759541|NCT00406458|Diabetes Type I or II|diabetes type i or ii
759542|NCT00406458|Mild to moderate sensorimotor diabetic polyneuropathy|mild to moderate sensorimotor diabetic polyneuropathy
759543|NCT00406445|p53 Mutation|p53 mutation
759544|NCT00406445|Li-Fraumeni Syndrome|li-fraumeni syndrome
759545|NCT00406445|Aerobic Metabolism|aerobic metabolism
759546|NCT00406445|Magnetic Resonance Spectroscopy|magnetic resonance spectroscopy
759547|NCT00406432|BRL029060/Paroxetine CR|brl029060/paroxetine cr
759548|NCT00406432|pharmacokinetics|pharmacokinetics
759549|NCT00406432|repeat dose|repeat dose
759550|NCT00406419|anti-CD20|anti-cd20
759551|NCT00406419|stage|stage
759552|NCT00406419|CD20|cd20
759553|NCT00406419|RA|ra
759554|NCT00406393|Acute Myelogenous Leukemia|acute myelogenous leukemia
759555|NCT00406393|Acute Lymphoblastic Leukemia|acute lymphoblastic leukemia
759556|NCT00406393|Chronic Myelogenous Leukemia|chronic myelogenous leukemia
759557|NCT00406380|Telangiectasias|telangiectasias
759558|NCT00406380|Leakage|leakage
759559|NCT00406380|Bevacizumab|bevacizumab
759560|NCT00406380|Telangiectasias secondary to Branch Retinal Vein Occlusion (BRVO)|telangiectasias secondary to branch retinal vein occlusion (brvo)
759561|NCT00406380|Idiopathic juxtafoveal retinal telangiectasias|idiopathic juxtafoveal retinal telangiectasias
759562|NCT00406315|ziprasidone, quetiapine (Seroquel) switch, open label, flexible dose, schizophrenia, schizoaffective disorder|ziprasidone, quetiapine (seroquel) switch, open label, flexible dose, schizophrenia, schizoaffective disorder
759563|NCT00406302|NSCLC|nsclc
759564|NCT00406302|non-small-cell lung cancer|non-small-cell lung cancer
759565|NCT00406276|Lung Cancer|lung cancer
759566|NCT00406263|nuclear sclerotic cataract|nuclear sclerotic cataract
759567|NCT00406263|cataract|cataract
759568|NCT00406211|Rubella|rubella
759569|NCT00406211|Varicella|varicella
759570|NCT00406211|Measles|measles
759571|NCT00406211|Mumps|mumps
759572|NCT00406211|Germany|germany
759573|NCT00406211|Austria|austria
759574|NCT00406198|Sepsis syndrom|sepsis syndrom
759575|NCT00406198|severe sepsis|severe sepsis
759576|NCT00406198|septic shock|septic shock
759577|NCT00406198|hemofiltration|hemofiltration
759578|NCT00406198|multiple organ failure|multiple organ failure
759579|NCT00406185|Registry|registry
759580|NCT00406185|cardiac catheterization laboratory|cardiac catheterization laboratory
759581|NCT00406185|coronary heart disease|coronary heart disease
759582|NCT00406185|cardiovascular disease|cardiovascular disease
759583|NCT00406159|Autism|autism
759584|NCT00406159|Hyperbaric Oxygen Therapy|hyperbaric oxygen therapy
759585|NCT00406159|Behavioral assessments|behavioral assessments
759586|NCT00406120|eye|eye
759587|NCT00406120|uvea|uvea
759588|NCT00406120|iris|iris
759589|NCT00406120|choroid|choroid
759590|NCT00406120|ciliary body|ciliary body
759591|NCT00406120|melanoma|melanoma
759592|NCT00406120|iris melanoma|iris melanoma
759593|NCT00406120|choroidal melanoma|choroidal melanoma
759594|NCT00406120|ciliary body melanoma|ciliary body melanoma
759595|NCT00406120|uveal melanoma|uveal melanoma
759596|NCT00406120|posterior uveal melanoma|posterior uveal melanoma
759597|NCT00406120|prognosis|prognosis
759598|NCT00406120|metastasis|metastasis
759599|NCT00406120|genetic testing|genetic testing
759600|NCT00406120|molecular testing|molecular testing
759601|NCT00406120|gene expression profiling|gene expression profiling
759602|NCT00406107|branch retinal vein occlusion|branch retinal vein occlusion
759603|NCT00406107|macular edema|macular edema
759604|NCT00406107|pegaptanib sodium|pegaptanib sodium
759605|NCT00406107|vascular endothelial growth factor|vascular endothelial growth factor
759606|NCT00406094|NARES|nares
759607|NCT00406094|eosinophils|eosinophils
759608|NCT00406094|nasal symptoms|nasal symptoms
759609|NCT00406068|Bladder neoplasm|bladder neoplasm
759610|NCT00406068|Intravesical drug administration|intravesical drug administration
759611|NCT00406068|Neoplasm recurrence, local|neoplasm recurrence, local
759612|NCT00406068|Transitional cell, carcinoma|transitional cell, carcinoma
759613|NCT00406068|Carcinoma in situ|carcinoma in situ
759614|NCT00406068|Mycobacterium|mycobacterium
759615|NCT00406042|glaucoma|glaucoma
759616|NCT00406042|trabeculoplasty|trabeculoplasty
759617|NCT00406042|steroids|steroids
759618|NCT00406016|Acute spinal cord injury;|acute spinal cord injury;
759619|NCT00406003|BRL029060/Paroxetine CR|brl029060/paroxetine cr
759620|NCT00406003|pharmacokinetics|pharmacokinetics
759621|NCT00406003|safety|safety
759622|NCT00405990|HIV|hiv
759623|NCT00405990|MTCT|mtct
760025|NCT00404365|depression|depression
759624|NCT00405990|heterosexual behaviour|heterosexual behaviour
759625|NCT00405990|sexual risk behaviour|sexual risk behaviour
759626|NCT00405990|couple counselling|couple counselling
759627|NCT00405990|Voluntary counselling and testing|voluntary counselling and testing
759628|NCT00405990|HIV Seronegativity|hiv seronegativity
759629|NCT00405977|Neuromuscular block|neuromuscular block
759630|NCT00405977|Magnesium|magnesium
759631|NCT00405977|Rocuronium|rocuronium
759632|NCT00405977|Time course of action|time course of action
759633|NCT00405938|Breast cancer|breast cancer
759634|NCT00405938|Metastatic breast cancer|metastatic breast cancer
759635|NCT00405938|Bevacizumab|bevacizumab
759636|NCT00405938|Anastrozole|anastrozole
759637|NCT00405938|Fulvestrant|fulvestrant
759638|NCT00405925|AIDS|aids
759639|NCT00405925|Treatment Naive|treatment naive
759640|NCT00405899|Allergy|allergy
759641|NCT00405899|Seasonal Allergic Rhinitis|seasonal allergic rhinitis
759642|NCT00405899|Perennial Allergic Rhinitis|perennial allergic rhinitis
759643|NCT00405873|Primary hepatocellular carcinoma|primary hepatocellular carcinoma
759644|NCT00405873|Liver cancer|liver cancer
759645|NCT00405873|Tumour response|tumour response
759646|NCT00405873|Quality of life|quality of life
759647|NCT00405847|Sleep|sleep
759648|NCT00405847|Critical illness|critical illness
759649|NCT00405847|Cytokine|cytokine
759650|NCT00405834|Pressure Ulcers|pressure ulcers
759651|NCT00405821|AIDS|aids
759652|NCT00405821|HIV Disease Progression|hiv disease progression
759653|NCT00405821|Quality of Life|quality of life
759654|NCT00405821|HIV Viral Load|hiv viral load
759655|NCT00405821|Genital Ulcers|genital ulcers
759656|NCT00405821|HIV|hiv
759657|NCT00405821|Treatment Naive|treatment naive
759658|NCT00405795|Pressure Ulcer|pressure ulcer
759659|NCT00405782|metastatic breast cancer|metastatic breast cancer
759660|NCT00405782|exercise intervention|exercise intervention
759661|NCT00405769|statin intolerance|statin intolerance
759662|NCT00405769|hyperlipidemia|hyperlipidemia
759663|NCT00405769|lifestyle changes|lifestyle changes
759664|NCT00405769|red yeast rice|red yeast rice
759665|NCT00405756|Newly Diagnosed Multiple Myeloma|newly diagnosed multiple myeloma
759666|NCT00405756|Celgene|celgene
759667|NCT00405756|CC-5013|cc-5013
759668|NCT00405756|Revlimid|revlimid
759669|NCT00405756|Lenalidomide|lenalidomide
759670|NCT00405756|Melphalan|melphalan
759671|NCT00405756|Prednisone|prednisone
759672|NCT00405756|Elderly|elderly
759673|NCT00405743|CP-4055|cp-4055
759674|NCT00405743|ELACYT™|elacyt™
759675|NCT00405743|Cancer|cancer
759676|NCT00405743|Refractory|refractory
759677|NCT00405743|Relapsed|relapsed
759678|NCT00405743|Hematologic Malignancies|hematologic malignancies
759679|NCT00405743|Leukemia|leukemia
759680|NCT00405743|ALL|all
759681|NCT00405743|AML|aml
759682|NCT00405743|AMM|amm
759683|NCT00405743|CLL|cll
759684|NCT00405743|CML|cml
759685|NCT00405743|CMML|cmml
759686|NCT00405743|MDS|mds
759687|NCT00405730|Cataracts|cataracts
759688|NCT00405717|ischemic heart disease|ischemic heart disease
759689|NCT00405717|acute coronary syndromes|acute coronary syndromes
759690|NCT00405717|percutaneous transluminal coronary angioplasty|percutaneous transluminal coronary angioplasty
759691|NCT00405717|statin|statin
759692|NCT00405717|clopidogrel|clopidogrel
759693|NCT00405704|Vesicoureteral Reflux|vesicoureteral reflux
759694|NCT00405704|Urinary Tract Infections|urinary tract infections
759695|NCT00405704|Renal Scarring|renal scarring
759696|NCT00405704|Antibiotic Resistance|antibiotic resistance
759697|NCT00405704|Controlled Clinical Trial|controlled clinical trial
759698|NCT00405704|Trimethoprim-Sulfamethoxazole|trimethoprim-sulfamethoxazole
759699|NCT00405704|Children|children
759700|NCT00405691|Medical Device|medical device
759701|NCT00405691|Spine|spine
759702|NCT00405691|Lumbar Spinal Stenosis|lumbar spinal stenosis
759703|NCT00405691|Degenerative Spondylolisthesis|degenerative spondylolisthesis
759704|NCT00405691|Facet Arthrosis|facet arthrosis
759705|NCT00405691|Back and Leg Pain|back and leg pain
759706|NCT00405691|Spine Research|spine research
759707|NCT00405691|Medical Device Research|medical device research
759708|NCT00405691|Impliant|impliant
759709|NCT00405691|Lumbar Treatment|lumbar treatment
759710|NCT00405691|Spinal Treatment|spinal treatment
759711|NCT00405691|Spinal Device|spinal device
759712|NCT00405678|Exercise Intervention|exercise intervention
759713|NCT00405678|Breast Cancer|breast cancer
759714|NCT00405678|Neo-Adjuvant Therapy|neo-adjuvant therapy
759715|NCT00405678|Operable Breast Cancer Stage I-II receiving neo-adjuvant chemotherapy|operable breast cancer stage i-ii receiving neo-adjuvant chemotherapy
759716|NCT00405665|Cystic Fibrosis|cystic fibrosis
759717|NCT00405665|L-Arginine|l-arginine
759718|NCT00405665|Pediatrics|pediatrics
759719|NCT00405665|pulmonary function|pulmonary function
759848|NCT00405158|Antibiotic therapy|antibiotic therapy
759720|NCT00405652|Liver transplantation, mycophenolate, GI problems, Quality of Life|liver transplantation, mycophenolate, gi problems, quality of life
759721|NCT00405626|post partum hemmorhage,Arnica montana,Bellis Perenis|post partum hemmorhage,arnica montana,bellis perenis
759722|NCT00405613|Aspirin|aspirin
759723|NCT00405613|Bleeding|bleeding
759724|NCT00405613|Clinical Trial|clinical trial
759725|NCT00405613|Dental Extraction|dental extraction
759726|NCT00405600|Lumbar degenerative disease|lumbar degenerative disease
759727|NCT00405600|spinal stenosis|spinal stenosis
759728|NCT00405600|spondylolisthesis|spondylolisthesis
759729|NCT00405600|non instrumented surgery|non instrumented surgery
759730|NCT00405600|instrumented surgery|instrumented surgery
759732|NCT00405574|prostate|prostate
759733|NCT00405574|PSA|psa
759734|NCT00405574|antiangiogenic|antiangiogenic
759735|NCT00405574|copper|copper
759736|NCT00405574|ATN-224|atn-224
759737|NCT00405561|Advanced Colorectal Carcinoma|advanced colorectal carcinoma
759738|NCT00405535|OCD|ocd
759739|NCT00405535|Obsessive Compulsive Disorder|obsessive compulsive disorder
759740|NCT00405535|Glycine|glycine
759741|NCT00405522|Lumbar Puncture|lumbar puncture
759742|NCT00405522|Pediatrics|pediatrics
759743|NCT00405522|Propofol|propofol
759744|NCT00405522|Remifentanil|remifentanil
759745|NCT00405522|sedation|sedation
759746|NCT00405522|Oncology|oncology
759747|NCT00405509|Upper Respiratory Infection|upper respiratory infection
759748|NCT00405509|Common Cold|common cold
759749|NCT00405483|arthroplasty|arthroplasty
759750|NCT00405483|RSA|rsa
759751|NCT00405483|micromotion|micromotion
759752|NCT00405483|osteoarthritis|osteoarthritis
759753|NCT00405483|minimally invasive|minimally invasive
759754|NCT00405483|ProfemurZ|profemurz
759755|NCT00405470|arthroplasty|arthroplasty
759756|NCT00405470|RSA|rsa
759757|NCT00405470|micromotion|micromotion
759758|NCT00405470|osteoarthritis|osteoarthritis
759759|NCT00405444|Pediatrics|pediatrics
759760|NCT00405444|Pain|pain
759761|NCT00405444|Voiding Cystourethrogram|voiding cystourethrogram
759762|NCT00405444|Catheterization|catheterization
759763|NCT00405444|Fentanyl|fentanyl
759764|NCT00405431|glaucoma filtering surgery|glaucoma filtering surgery
759765|NCT00405431|restasis|restasis
759766|NCT00405431|conjunctival inflammation|conjunctival inflammation
759767|NCT00405405|Head and neck cancer|head and neck cancer
759768|NCT00405405|Parotid gland cancer|parotid gland cancer
759769|NCT00405405|thyroid gland cancer|thyroid gland cancer
759770|NCT00405405|melanoma|melanoma
759771|NCT00405405|Chemoradiotherapy|chemoradiotherapy
759772|NCT00405405|bevacizumab|bevacizumab
759773|NCT00405405|erlotinib|erlotinib
759774|NCT00405392|risedronate|risedronate
759775|NCT00405392|Ibandronate|ibandronate
759776|NCT00405392|preference|preference
759777|NCT00405392|Osteoporosis|osteoporosis
759778|NCT00405379|arthroplasty|arthroplasty
759779|NCT00405379|RSA|rsa
759780|NCT00405379|Osteoarthritis|osteoarthritis
759781|NCT00405379|trabecular metal mesh|trabecular metal mesh
759782|NCT00405366|stage II renal cell cancer|stage ii renal cell cancer
759783|NCT00405366|stage III renal cell cancer|stage iii renal cell cancer
759784|NCT00405366|stage IV renal cell cancer|stage iv renal cell cancer
759785|NCT00405353|multiple sclerosis|multiple sclerosis
759786|NCT00405353|testosterone|testosterone
759787|NCT00405327|tumor vaccine|tumor vaccine
759788|NCT00405327|metastatic solid tumors|metastatic solid tumors
759789|NCT00405327|recurrent tumors|recurrent tumors
759790|NCT00405314|respiratory failure|respiratory failure
759791|NCT00405314|non invasive ventilation|non invasive ventilation
759792|NCT00405314|prehospital|prehospital
759793|NCT00405314|endotracheal intubation|endotracheal intubation
759794|NCT00405314|continuous positive airway pressure|continuous positive airway pressure
759795|NCT00405301|Tuberculosis|tuberculosis
759796|NCT00405301|Drug Induced Hepatotoxicity|drug induced hepatotoxicity
759797|NCT00405301|Anti-tuberculosis drugs|anti-tuberculosis drugs
759798|NCT00405301|India|india
759799|NCT00405288|Hemorrhoids|hemorrhoids
759800|NCT00405288|Pregnancy|pregnancy
759801|NCT00405288|antihemorrhoidal|antihemorrhoidal
759802|NCT00405288|Proctofoam|proctofoam
759803|NCT00405288|infants|infants
759804|NCT00405275|antineoplastic|antineoplastic
759805|NCT00405275|antiparasitics|antiparasitics
759806|NCT00405275|antirheumatics|antirheumatics
759807|NCT00405275|chronic diseases|chronic diseases
759808|NCT00405275|clinical trial|clinical trial
759809|NCT00405275|connective tissue|connective tissue
759810|NCT00405275|double-blind|double-blind
759811|NCT00405275|drug treatment|drug treatment
759812|NCT00405275|gastric medications|gastric medications
759813|NCT00405275|joint|joint
759814|NCT00405275|multi-site trial|multi-site trial
759815|NCT00405275|musculoskeletal|musculoskeletal
759816|NCT00405275|randomized|randomized
759817|NCT00405275|rheumatoid arthritis|rheumatoid arthritis
759818|NCT00405262|Pediatrics|pediatrics
759819|NCT00405262|Postoperative Analgesia|postoperative analgesia
759820|NCT00405262|orthopedic surgery|orthopedic surgery
759821|NCT00405262|Iliac Crest Bone Graft|iliac crest bone graft
759822|NCT00405262|Osteotomy|osteotomy
759823|NCT00405262|cleft palate|cleft palate
759824|NCT00405249|HIV-1|hiv-1
759825|NCT00405249|Treatment Experienced|treatment experienced
759826|NCT00405236|inflammation|inflammation
759827|NCT00405236|exacerbations|exacerbations
759828|NCT00405210|hormone-resistant|hormone-resistant
759829|NCT00405210|metastatic prostatic cancer|metastatic prostatic cancer
759830|NCT00405210|pharmacokinetics|pharmacokinetics
759831|NCT00405210|naïve patient|naïve patient
759832|NCT00405197|MUFA|mufa
759833|NCT00405197|Mediterranean diet|mediterranean diet
759834|NCT00405197|Insulin resistance|insulin resistance
759835|NCT00405197|metabolic syndrome X|metabolic syndrome x
759836|NCT00405184|PID|pid
759837|NCT00405184|IVIg|ivig
759838|NCT00405184|IntragamP|intragamp
759839|NCT00405171|Efavirenz|efavirenz
759840|NCT00405171|Nevirapine|nevirapine
759841|NCT00405171|Dyslipidemia|dyslipidemia
759842|NCT00405171|HIV|hiv
759843|NCT00405158|Lactation mastitis|lactation mastitis
759844|NCT00405158|Breast inflammation|breast inflammation
759845|NCT00405158|Breastfeeding|breastfeeding
759846|NCT00405158|Care interventions|care interventions
759847|NCT00405158|Acupuncture treatment|acupuncture treatment
759849|NCT00405145|Epilepsy|epilepsy
759850|NCT00405145|MRI|mri
759851|NCT00405145|EEG|eeg
759852|NCT00405145|Neuroimaging|neuroimaging
759854|NCT00405119|pharmacodynamics|pharmacodynamics
759855|NCT00405119|ranitidine|ranitidine
759856|NCT00405119|esomeprazole|esomeprazole
759857|NCT00405119|pharmacokinetics|pharmacokinetics
759858|NCT00405119|gastroesophageal reflux disease (GERD)|gastroesophageal reflux disease (gerd)
759859|NCT00405119|AH23844|ah23844
759860|NCT00405106|stress|stress
759861|NCT00405106|anxiety|anxiety
759862|NCT00405106|myopia progression|myopia progression
759863|NCT00405106|accommodation|accommodation
759864|NCT00405106|vergence|vergence
759865|NCT00405093|cardiopulmonary bypass|cardiopulmonary bypass
759866|NCT00405093|circulatory arrest|circulatory arrest
759867|NCT00405093|aprotinin|aprotinin
759868|NCT00405093|thoracic aorta surgery|thoracic aorta surgery
759869|NCT00405080|Rifampin GW679769|rifampin gw679769
759870|NCT00405067|Cholesterol|cholesterol
759871|NCT00405015|rosiglitazone|rosiglitazone
759872|NCT00405015|ischemia-reperfusion injury|ischemia-reperfusion injury
759873|NCT00405015|human|human
759874|NCT00405015|Annexin A5 scintigraphy|annexin a5 scintigraphy
759875|NCT00405015|metabolic syndrome|metabolic syndrome
759876|NCT00405002|Acute respiratory failure|acute respiratory failure
759877|NCT00404989|HIV|hiv
759878|NCT00404989|HBV|hbv
759879|NCT00404989|Hepatitis|hepatitis
759880|NCT00404989|Pregnancy|pregnancy
759881|NCT00404989|Registry|registry
759882|NCT00404976|inflammometry|inflammometry
759883|NCT00404976|exhaled breath condensate|exhaled breath condensate
759884|NCT00404976|fractional exhaled nitric oxide|fractional exhaled nitric oxide
759885|NCT00404976|asthma|asthma
759886|NCT00404976|children|children
759887|NCT00404963|GSK376501,|gsk376501,
759888|NCT00404963|First Time in Human,|first time in human,
759889|NCT00404963|Single Dose,|single dose,
759890|NCT00404963|Dose Escalation,|dose escalation,
759891|NCT00404963|Healthy Overweight/Obese Volunteer|healthy overweight/obese volunteer
759892|NCT00404950|hyperglycemia|hyperglycemia
759893|NCT00404950|cardiopulmonary bypass|cardiopulmonary bypass
759894|NCT00404950|renal injury|renal injury
759895|NCT00404950|diabetes|diabetes
759896|NCT00404924|Non-Small-Cell Lung Carcinoma|non-small-cell lung carcinoma
759897|NCT00404924|Adenocarcinoma|adenocarcinoma
759898|NCT00404924|Squamous Cell Carcinoma|squamous cell carcinoma
759899|NCT00404924|Large Cell Carcinoma|large cell carcinoma
759900|NCT00404911|Oppositional Defiant Disorder|oppositional defiant disorder
759901|NCT00404898|World Trade Center dust|world trade center dust
759902|NCT00404885|uveitis|uveitis
759903|NCT00404885|calcineurin|calcineurin
759904|NCT00404885|inflammation|inflammation
759905|NCT00404872|Stroke|stroke
759906|NCT00404859|inflammometry|inflammometry
759907|NCT00404859|exhaled breath condensate|exhaled breath condensate
759908|NCT00404859|fractional exhaled nitric oxide|fractional exhaled nitric oxide
759909|NCT00404859|asthma|asthma
759910|NCT00404859|cystic fibrosis|cystic fibrosis
759911|NCT00404859|monitoring|monitoring
759912|NCT00404859|exacerbations|exacerbations
759913|NCT00404859|paediatric|paediatric
759914|NCT00404846|Hyperbaric oxygenation therapy|hyperbaric oxygenation therapy
759915|NCT00404846|HBOT|hbot
759916|NCT00404846|Autism|autism
759917|NCT00404833|idiopathic membranous nephropathy or focal segmental glomerulosclerosis|idiopathic membranous nephropathy or focal segmental glomerulosclerosis
759918|NCT00404820|osteoporosis|osteoporosis
759919|NCT00404820|bisphosphonate|bisphosphonate
759920|NCT00404820|biomarker|biomarker
759921|NCT00404820|zoledronic acid|zoledronic acid
759922|NCT00404820|alendronate|alendronate
759923|NCT00404820|postmenopausal|postmenopausal
759924|NCT00404807|Continuous positive airway pressure|continuous positive airway pressure
759925|NCT00404807|cardiovascular diseases|cardiovascular diseases
759926|NCT00404807|sleep apnea syndromes|sleep apnea syndromes
759927|NCT00404807|sleep breathing disorders|sleep breathing disorders
759928|NCT00404807|sham CPAP|sham cpap
759929|NCT00404794|membranous lupus nephritis|membranous lupus nephritis
759930|NCT00404781|ischemic heart disease|ischemic heart disease
759931|NCT00404781|acute coronary syndromes|acute coronary syndromes
759932|NCT00404781|percutaneous transluminal coronary angioplasty|percutaneous transluminal coronary angioplasty
759933|NCT00404781|platelet function|platelet function
759934|NCT00404781|aspirin|aspirin
759935|NCT00404781|clopidogrel|clopidogrel
759936|NCT00404781|cilostazol|cilostazol
759937|NCT00404768|Premature Labor|premature labor
759938|NCT00404768|Pre Term Labor|pre term labor
759939|NCT00404768|intravenous|intravenous
759940|NCT00404768|fetal fibronectin|fetal fibronectin
759941|NCT00404755|Depression|depression
759942|NCT00404742|uveitis|uveitis
759943|NCT00404742|calcineurin|calcineurin
759944|NCT00404729|Glaucoma|glaucoma
759945|NCT00404729|Optic Neuropathy, Ischemic|optic neuropathy, ischemic
759946|NCT00404729|Visual Pathways,|visual pathways,
759947|NCT00404729|Optic nerve|optic nerve
759948|NCT00404729|Neural conduction|neural conduction
759949|NCT00404690|Gastroschisis|gastroschisis
759950|NCT00404690|Silo|silo
759951|NCT00404690|Operative closure|operative closure
759952|NCT00404664|influenza vaccine|influenza vaccine
759953|NCT00404664|influenza immunization|influenza immunization
759954|NCT00404664|reminder letters|reminder letters
759955|NCT00404664|raffle prize|raffle prize
759956|NCT00404651|Diphtheria|diphtheria
759957|NCT00404651|Tetanus|tetanus
759958|NCT00404651|Pertussis|pertussis
759959|NCT00404651|Hepatitis B|hepatitis b
759960|NCT00404651|Poliomyelitis|poliomyelitis
759961|NCT00404651|Invasive Haemophilus influenzae type b.|invasive haemophilus influenzae type b.
759962|NCT00404638|Enuresis Nocturna|enuresis nocturna
759963|NCT00404638|Paula Method|paula method
759964|NCT00404638|Circular muscle exercise|circular muscle exercise
759965|NCT00404638|Sphincter|sphincter
759966|NCT00404625|Bacteremia caused by ESBL-producing Enterobacteriaceae|bacteremia caused by esbl-producing enterobacteriaceae
759967|NCT00404625|Pneumonia caused by ESBL-producing Enterobacteriaceae|pneumonia caused by esbl-producing enterobacteriaceae
759968|NCT00404625|Abdomen infections due to ESBL-producing Enterobacteriaceae|abdomen infections due to esbl-producing enterobacteriaceae
759969|NCT00404625|Skin infections caused by ESBL-producing Enterobacteriaceae|skin infections caused by esbl-producing enterobacteriaceae
759970|NCT00404625|Urinary infections due to ESBL-producing Enterobacteriaceae|urinary infections due to esbl-producing enterobacteriaceae
759971|NCT00404612|uveitis|uveitis
759972|NCT00404612|calcineurin|calcineurin
759973|NCT00404599|simvastatin, atorvastatin, oxidative stress|simvastatin, atorvastatin, oxidative stress
759974|NCT00404586|Environmental Challenge Chamber|environmental challenge chamber
759975|NCT00404586|GW784568X|gw784568x
759976|NCT00404586|Intranasal|intranasal
759977|NCT00404573|Schizophrenia|schizophrenia
759978|NCT00404560|Primary Immune Deficiency|primary immune deficiency
759979|NCT00404560|Autoimmune|autoimmune
759980|NCT00404560|Genetic Defects|genetic defects
759981|NCT00404560|Immune Defects|immune defects
759982|NCT00404560|Infection Susceptibility|infection susceptibility
759983|NCT00404560|Recurrent Infections|recurrent infections
759984|NCT00404560|Immune Disorders|immune disorders
759985|NCT00404560|Immune Defects of Phagocytes|immune defects of phagocytes
759986|NCT00404560|Unusual, Chronic Bacterial, Mycobacterial, and Fungal Infections|unusual, chronic bacterial, mycobacterial, and fungal infections
759987|NCT00404547|Asthma|asthma
759988|NCT00404547|Alvesco®|alvesco®
759989|NCT00404547|Ciclesonide|ciclesonide
759990|NCT00404534|functional dyspepsia|functional dyspepsia
759991|NCT00404534|Helicobacter pylori|helicobacter pylori
759992|NCT00404534|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal
759993|NCT00404534|Gastritis|gastritis
759994|NCT00404521|Tumor|tumor
759995|NCT00404521|PM02734|pm02734
759996|NCT00404521|PharmaMar|pharmamar
759997|NCT00404508|Hydralazine|hydralazine
759998|NCT00404508|Magnesium Valproate|magnesium valproate
759999|NCT00404508|Chemotherapy resistance|chemotherapy resistance
760000|NCT00404508|Epigenetic therapy|epigenetic therapy
760001|NCT00404482|uveitis|uveitis
760002|NCT00404482|jia|jia
760003|NCT00404482|Cyclosporine A|cyclosporine a
760004|NCT00404482|MTX|mtx
760005|NCT00404443|Acupuncture|acupuncture
760006|NCT00404443|Electroacupuncture|electroacupuncture
760007|NCT00404443|Rheumatoid arthritis|rheumatoid arthritis
760008|NCT00404430|Endothelial function|endothelial function
760009|NCT00404430|Peripheral Arterial Tone|peripheral arterial tone
760010|NCT00404430|Systemic Inflammation|systemic inflammation
760011|NCT00404430|Oxidative Stress|oxidative stress
760012|NCT00404430|Respiratory and peripheral muscular function|respiratory and peripheral muscular function
760013|NCT00404430|Cardiovascular risk|cardiovascular risk
760014|NCT00404430|COPD severity|copd severity
760015|NCT00404417|pain|pain
760016|NCT00404417|lumbar|lumbar
760017|NCT00404404|recurrent breast cancer|recurrent breast cancer
760018|NCT00404404|stage IV breast cancer|stage iv breast cancer
760019|NCT00404391|Moderate to severe pain following bunionectomy surgery|moderate to severe pain following bunionectomy surgery
760020|NCT00404378|Healthy subjects|healthy subjects
760021|NCT00404378|Pharmacokinetics|pharmacokinetics
760022|NCT00404378|Drug interaction|drug interaction
760023|NCT00404378|Ketoconazole|ketoconazole
760024|NCT00404378|Casopitant|casopitant
760026|NCT00404365|extensive stage small cell lung cancer|extensive stage small cell lung cancer
760027|NCT00404365|limited stage small cell lung cancer|limited stage small cell lung cancer
760028|NCT00404365|recurrent small cell lung cancer|recurrent small cell lung cancer
760029|NCT00404365|stage I non-small cell lung cancer|stage i non-small cell lung cancer
760030|NCT00404365|stage II non-small cell lung cancer|stage ii non-small cell lung cancer
760031|NCT00404365|stage IIIA non-small cell lung cancer|stage iiia non-small cell lung cancer
760032|NCT00404365|stage IIIB non-small cell lung cancer|stage iiib non-small cell lung cancer
760033|NCT00404365|stage IV non-small cell lung cancer|stage iv non-small cell lung cancer
760034|NCT00404365|recurrent non-small cell lung cancer|recurrent non-small cell lung cancer
760035|NCT00404352|Rebif New Formulation|rebif new formulation
760036|NCT00404352|Clinical Isolated Syndrome|clinical isolated syndrome
760037|NCT00404352|Multiple Sclerosis|multiple sclerosis
760038|NCT00404339|recurrent squamous cell carcinoma of the lip and oral cavity|recurrent squamous cell carcinoma of the lip and oral cavity
760039|NCT00404339|stage I squamous cell carcinoma of the lip and oral cavity|stage i squamous cell carcinoma of the lip and oral cavity
760040|NCT00404339|stage II squamous cell carcinoma of the lip and oral cavity|stage ii squamous cell carcinoma of the lip and oral cavity
760041|NCT00404339|stage III squamous cell carcinoma of the lip and oral cavity|stage iii squamous cell carcinoma of the lip and oral cavity
760042|NCT00404339|metastatic squamous neck cancer with occult primary squamous cell carcinoma|metastatic squamous neck cancer with occult primary squamous cell carcinoma
760043|NCT00404339|recurrent metastatic squamous neck cancer with occult primary|recurrent metastatic squamous neck cancer with occult primary
760044|NCT00404339|recurrent squamous cell carcinoma of the paranasal sinus and nasal cavity|recurrent squamous cell carcinoma of the paranasal sinus and nasal cavity
760045|NCT00404339|stage I squamous cell carcinoma of the paranasal sinus and nasal cavity|stage i squamous cell carcinoma of the paranasal sinus and nasal cavity
760046|NCT00404339|stage II squamous cell carcinoma of the paranasal sinus and nasal cavity|stage ii squamous cell carcinoma of the paranasal sinus and nasal cavity
760047|NCT00404339|stage III squamous cell carcinoma of the paranasal sinus and nasal cavity|stage iii squamous cell carcinoma of the paranasal sinus and nasal cavity
760048|NCT00404339|stage I squamous cell carcinoma of the hypopharynx|stage i squamous cell carcinoma of the hypopharynx
760049|NCT00404339|stage I squamous cell carcinoma of the larynx|stage i squamous cell carcinoma of the larynx
760050|NCT00404339|stage I squamous cell carcinoma of the nasopharynx|stage i squamous cell carcinoma of the nasopharynx
760051|NCT00404339|stage I squamous cell carcinoma of the oropharynx|stage i squamous cell carcinoma of the oropharynx
760052|NCT00404339|stage II squamous cell carcinoma of the hypopharynx|stage ii squamous cell carcinoma of the hypopharynx
760053|NCT00404339|stage II squamous cell carcinoma of the larynx|stage ii squamous cell carcinoma of the larynx
760054|NCT00404339|stage II squamous cell carcinoma of the nasopharynx|stage ii squamous cell carcinoma of the nasopharynx
760055|NCT00404339|stage II squamous cell carcinoma of the oropharynx|stage ii squamous cell carcinoma of the oropharynx
760056|NCT00404339|stage III squamous cell carcinoma of the hypopharynx|stage iii squamous cell carcinoma of the hypopharynx
760057|NCT00404339|stage III squamous cell carcinoma of the larynx|stage iii squamous cell carcinoma of the larynx
760058|NCT00404339|stage III squamous cell carcinoma of the nasopharynx|stage iii squamous cell carcinoma of the nasopharynx
760059|NCT00404339|stage III squamous cell carcinoma of the oropharynx|stage iii squamous cell carcinoma of the oropharynx
760060|NCT00404339|recurrent squamous cell carcinoma of the hypopharynx|recurrent squamous cell carcinoma of the hypopharynx
760061|NCT00404339|recurrent squamous cell carcinoma of the larynx|recurrent squamous cell carcinoma of the larynx
760062|NCT00404339|recurrent squamous cell carcinoma of the nasopharynx|recurrent squamous cell carcinoma of the nasopharynx
760063|NCT00404339|recurrent squamous cell carcinoma of the oropharynx|recurrent squamous cell carcinoma of the oropharynx
760064|NCT00404339|stage IV squamous cell carcinoma of the hypopharynx|stage iv squamous cell carcinoma of the hypopharynx
760065|NCT00404339|stage IV squamous cell carcinoma of the larynx|stage iv squamous cell carcinoma of the larynx
760066|NCT00404339|stage IV squamous cell carcinoma of the lip and oral cavity|stage iv squamous cell carcinoma of the lip and oral cavity
760067|NCT00404339|stage IV squamous cell carcinoma of the nasopharynx|stage iv squamous cell carcinoma of the nasopharynx
760068|NCT00404339|stage IV squamous cell carcinoma of the oropharynx|stage iv squamous cell carcinoma of the oropharynx
760069|NCT00404339|stage IV squamous cell carcinoma of the paranasal sinus and nasal cavity|stage iv squamous cell carcinoma of the paranasal sinus and nasal cavity
760070|NCT00404339|tongue cancer|tongue cancer
760071|NCT00404326|Cervical carcinoma|cervical carcinoma
760072|NCT00404326|Epigenetic therapy|epigenetic therapy
760073|NCT00404326|Hydralazine|hydralazine
760074|NCT00404326|Valproate|valproate
760075|NCT00404326|Microarray analysis|microarray analysis
760076|NCT00404287|C reactive protein|c reactive protein
760077|NCT00404287|Inflammation|inflammation
760078|NCT00404287|Aortic valve stenosis|aortic valve stenosis
760079|NCT00404287|progression|progression
760080|NCT00404274|healthy human volunteer|healthy human volunteer
760081|NCT00404274|GW679769|gw679769
760082|NCT00404274|warfarin|warfarin
760083|NCT00404274|casopitant|casopitant
760084|NCT00404261|Fluticasone Propionate|fluticasone propionate
760085|NCT00404261|healthcare professional satisfaction|healthcare professional satisfaction
760086|NCT00404261|patient satisfaction|patient satisfaction
760087|NCT00404261|metered dose inhaler with counter|metered dose inhaler with counter
760088|NCT00404261|Salmeterol|salmeterol
760189|NCT00403702|Retinal detachment|retinal detachment
760089|NCT00404261|Chronic Obstructive Pulmonary Disease (COPD)|chronic obstructive pulmonary disease (copd)
760090|NCT00404248|adult anaplastic astrocytoma|adult anaplastic astrocytoma
760091|NCT00404248|adult anaplastic oligodendroglioma|adult anaplastic oligodendroglioma
760092|NCT00404248|adult giant cell glioblastoma|adult giant cell glioblastoma
760093|NCT00404248|recurrent adult brain tumor|recurrent adult brain tumor
760094|NCT00404248|adult glioblastoma|adult glioblastoma
760095|NCT00404248|adult gliosarcoma|adult gliosarcoma
760096|NCT00404235|stage IV melanoma|stage iv melanoma
760097|NCT00404235|recurrent melanoma|recurrent melanoma
760098|NCT00404222|Acute Pain following Bunionectomy|acute pain following bunionectomy
760099|NCT00404183|Pain associated with osteoarthritis|pain associated with osteoarthritis
760100|NCT00404170|imaging|imaging
760101|NCT00404170|Parkinson|parkinson
760102|NCT00404170|progression|progression
760103|NCT00404157|Lupus|lupus
760104|NCT00404157|U2970g|u2970g
760105|NCT00404144|small vessel|small vessel
760106|NCT00404144|paclitaxel coated balloon catheter|paclitaxel coated balloon catheter
760107|NCT00404144|pepcad|pepcad
760108|NCT00404144|drug eluting balloon|drug eluting balloon
760109|NCT00404118|long-term care|long-term care
760110|NCT00404118|satisfaction|satisfaction
760111|NCT00404118|cost|cost
760112|NCT00404105|Excimer laser|excimer laser
760113|NCT00404092|aspergillosis|aspergillosis
760114|NCT00404092|caspofungin|caspofungin
760115|NCT00404092|maximum tolerated dose|maximum tolerated dose
760116|NCT00404079|Chronic low back pain|chronic low back pain
760117|NCT00404014|MCI following CABG surgery|mci following cabg surgery
760118|NCT00404001|Microbia|microbia
760119|NCT00404001|MD-0727|md-0727
760120|NCT00404001|Primary Hypercholesterolemia|primary hypercholesterolemia
760121|NCT00404001|Hypercholesterolemia|hypercholesterolemia
760122|NCT00404001|Hyperlipidemia|hyperlipidemia
760123|NCT00404001|Dyslipidemia|dyslipidemia
760124|NCT00404001|Cholesterol|cholesterol
760125|NCT00404001|LDL|ldl
760126|NCT00403962|anxiety|anxiety
760127|NCT00403962|Social Anxiety Disorder|social anxiety disorder
760128|NCT00403962|SAD|sad
760129|NCT00403936|osteopathic manipulation|osteopathic manipulation
760130|NCT00403936|autonomic nervous system|autonomic nervous system
760131|NCT00403923|Lactose intolerance|lactose intolerance
760132|NCT00403923|Ulcerative colitis|ulcerative colitis
760133|NCT00403923|Lactose|lactose
760134|NCT00403923|Threshold|threshold
760135|NCT00403897|Constipation|constipation
760136|NCT00403884|Drusen|drusen
760137|NCT00403884|Geographic atrophy|geographic atrophy
760138|NCT00403884|diabetes|diabetes
760139|NCT00403884|macular edema|macular edema
760140|NCT00403884|laser|laser
760141|NCT00403884|retinal pigment epithelium|retinal pigment epithelium
760142|NCT00403871|Anaesthesia|anaesthesia
760143|NCT00403871|Pregnency|pregnency
760144|NCT00403871|Heart disease|heart disease
760145|NCT00403845|chronic obstructive pulmonary disease|chronic obstructive pulmonary disease
760146|NCT00403845|COPD|copd
760147|NCT00403845|QAB149|qab149
760148|NCT00403845|indacaterol|indacaterol
760149|NCT00403845|long acting β2-agonist|long acting β2-agonist
760150|NCT00403806|Adenotonsillectomy|adenotonsillectomy
760151|NCT00403806|Pediatrics|pediatrics
760152|NCT00403806|Postoperative Nausea and Vomiting|postoperative nausea and vomiting
760153|NCT00403806|Pain|pain
760154|NCT00403806|Oral intake|oral intake
760155|NCT00403806|Dexamethasone|dexamethasone
760156|NCT00403806|Dose finding|dose finding
760157|NCT00403780|Critical limb ischemia|critical limb ischemia
760158|NCT00403780|Pain control|pain control
760159|NCT00403780|Rest pain in lower limb ischemia|rest pain in lower limb ischemia
760160|NCT00403780|pregabalin|pregabalin
760161|NCT00403780|randomized controlled study|randomized controlled study
760162|NCT00403780|Ischemia, therapy|ischemia, therapy
760163|NCT00403780|Lower extremity, blood supply|lower extremity, blood supply
760164|NCT00403780|Pain, prevention & control|pain, prevention & control
760165|NCT00403780|Pain, therapy|pain, therapy
760166|NCT00403767|Atrial Fibrillation|atrial fibrillation
760167|NCT00403767|Stroke|stroke
760168|NCT00403767|Embolism|embolism
760169|NCT00403767|Non-central nervous system systemic embolism|non-central nervous system systemic embolism
760170|NCT00403767|Non-valvular atrial fibrillation|non-valvular atrial fibrillation
760171|NCT00403767|Blood Clot|blood clot
760172|NCT00403767|Rivaroxaban|rivaroxaban
760173|NCT00403767|Warfarin|warfarin
760174|NCT00403767|Anticoagulants|anticoagulants
760175|NCT00403767|Arrhythmias, Cardiac|arrhythmias, cardiac
760176|NCT00403754|asthma|asthma
760177|NCT00403754|QAB149|qab149
760178|NCT00403754|indacaterol|indacaterol
760179|NCT00403754|long acting β2-agonist|long acting β2-agonist
760180|NCT00403754|bronchodilator|bronchodilator
760181|NCT00403741|behavior|behavior
760182|NCT00403741|physical activity|physical activity
760183|NCT00403741|motivation|motivation
760184|NCT00403728|Ischemia|ischemia
760185|NCT00403728|Reperfusion|reperfusion
760186|NCT00403728|Myocardial infarction|myocardial infarction
760187|NCT00403728|ciclosporin A|ciclosporin a
760188|NCT00403728|acute myocardial infarction|acute myocardial infarction
760190|NCT00403702|proliferative vitreoretinopathy|proliferative vitreoretinopathy
760191|NCT00403702|heavier-than-water internal tamponades|heavier-than-water internal tamponades
760192|NCT00403689|Increased non-specific inflammatory markers|increased non-specific inflammatory markers
760193|NCT00403676|nurse practitioner|nurse practitioner
760194|NCT00403676|rheumatology care|rheumatology care
760195|NCT00403676|outpatient clinic|outpatient clinic
760196|NCT00403676|patient satisfaction|patient satisfaction
760197|NCT00403663|Body mass index|body mass index
760198|NCT00403663|Combined Spinal-Epidural Anesthesia|combined spinal-epidural anesthesia
760199|NCT00403663|Cesarean section|cesarean section
760200|NCT00403663|Obesity|obesity
760201|NCT00403650|Sarcoidosis|sarcoidosis
760202|NCT00403650|Dyspnea|dyspnea
760203|NCT00403650|Interstitial lung disease|interstitial lung disease
760204|NCT00403637|Asthma, indacaterol, long acting β2-agonist|asthma, indacaterol, long acting β2-agonist
760205|NCT00403585|Adefovir Dipivoxil(Hepsera)|adefovir dipivoxil(hepsera)
760206|NCT00403585|Chronic Hepatitis B (CHB)|chronic hepatitis b (chb)
760207|NCT00403572|Preeclampsia|preeclampsia
760208|NCT00403572|Trans cranial Doppler|trans cranial doppler
760209|NCT00403572|Cardiac output|cardiac output
760210|NCT00403572|systemic vascular resistance|systemic vascular resistance
760211|NCT00403572|blood pressure|blood pressure
760212|NCT00403559|seborrheic dermatitis|seborrheic dermatitis
760213|NCT00403546|Schizophrenia|schizophrenia
760214|NCT00403533|Hepatitis C|hepatitis c
760215|NCT00403533|viral load|viral load
760216|NCT00403533|antiviral therapy|antiviral therapy
760217|NCT00403533|cholesterol|cholesterol
760218|NCT00403533|atorvastatin|atorvastatin
760219|NCT00403520|Alzheimer's disease|alzheimer's disease
760220|NCT00403520|Mild cognitive impairment|mild cognitive impairment
760221|NCT00403507|Mild Dementia|mild dementia
760222|NCT00403507|Mild Alzheimer|mild alzheimer
760223|NCT00403507|Cognitive Impairment|cognitive impairment
760224|NCT00403507|Cholinesterase Inhibitor|cholinesterase inhibitor
760225|NCT00403507|Exercise|exercise
760226|NCT00403507|Physical activity|physical activity
760227|NCT00403507|Behavior|behavior
760228|NCT00403507|Memory loss|memory loss
760229|NCT00403494|Intermittent Claudication|intermittent claudication
760231|NCT00403494|Symptomatic Peripheral Arterial Disease|symptomatic peripheral arterial disease
760232|NCT00403494|Peripheral Arterial Disease|peripheral arterial disease
760233|NCT00403494|PAD|pad
760234|NCT00403494|6R-BH4|6r-bh4
760235|NCT00403494|BH4|bh4
760236|NCT00403494|sapropterin dihydrochloride|sapropterin dihydrochloride
760237|NCT00403494|endothelial dysfunction|endothelial dysfunction
760238|NCT00403494|Nitric Oxide|nitric oxide
760239|NCT00403494|NO|no
760240|NCT00403481|Hypertension|hypertension
760241|NCT00403481|Angiotensin Receptor Blocker|angiotensin receptor blocker
760242|NCT00403481|Calcium Channel Blocker|calcium channel blocker
760243|NCT00403481|Angiotensin Converting Enzyme Inhibitor|angiotensin converting enzyme inhibitor
760244|NCT00403481|Hydrochlorothiazide|hydrochlorothiazide
760245|NCT00403481|Stage I and II Hypertension|stage i and ii hypertension
760246|NCT00403481|Type II Diabetes|type ii diabetes
760247|NCT00403455|Clinical|clinical
760248|NCT00403455|Genetics|genetics
760249|NCT00403455|Monoamine transporter|monoamine transporter
760250|NCT00403455|Pharmacogenetics|pharmacogenetics
760251|NCT00403455|Post Traumatic Stress Disorder|post traumatic stress disorder
760252|NCT00403442|Macular Degeneration|macular degeneration
760253|NCT00403429|oral chemotherapy|oral chemotherapy
760254|NCT00403429|platinum resistant|platinum resistant
760255|NCT00403429|platinum refractory|platinum refractory
760256|NCT00403429|second line|second line
760257|NCT00403416|AEB071|aeb071
760258|NCT00403416|Tacrolimus|tacrolimus
760259|NCT00403416|Mycophenolic acid|mycophenolic acid
760260|NCT00403416|Basiliximab|basiliximab
760261|NCT00403416|Rejection|rejection
760262|NCT00403416|Kidney function|kidney function
760263|NCT00403416|Immunosuppression|immunosuppression
760264|NCT00403403|SCLC|sclc
760265|NCT00403403|SALUTE|salute
760266|NCT00403403|Lung Cancer|lung cancer
760267|NCT00403403|Avastin|avastin
760268|NCT00403377|melanoma|melanoma
760269|NCT00403377|basal cell carcinoma of the skin|basal cell carcinoma of the skin
760270|NCT00403377|squamous cell carcinoma of the skin|squamous cell carcinoma of the skin
760271|NCT00403364|Helicobacter pylori infection|helicobacter pylori infection
760272|NCT00403364|Treatment|treatment
760273|NCT00403364|Double blind placebo controlled trial|double blind placebo controlled trial
760274|NCT00403351|Risk|risk
760275|NCT00403351|Coronary artery disease|coronary artery disease
760276|NCT00403351|Heart Rate variability|heart rate variability
760277|NCT00403351|Pulse wave analysis|pulse wave analysis
760278|NCT00403351|BNP|bnp
760279|NCT00403351|CRP|crp
760280|NCT00403338|myocardial ischemia|myocardial ischemia
760281|NCT00403338|coronary disease|coronary disease
760282|NCT00403338|heart disease|heart disease
760283|NCT00403338|Coronary Stenosis [MeSH heading: C14.280.647.250.285]|coronary stenosis [mesh heading: c14.280.647.250.285]
760284|NCT00403325|Central Serous Chorioretinopathy|central serous chorioretinopathy
760285|NCT00403312|Physical Activity|physical activity
760286|NCT00403312|Wellness Programs|wellness programs
760287|NCT00403312|Pharmacological Smoking Cessation|pharmacological smoking cessation
760288|NCT00403299|Coronary artery disease|coronary artery disease
760289|NCT00403299|Cardiac transplantation|cardiac transplantation
760290|NCT00403299|Coronary artery disease in heart transplanted patients|coronary artery disease in heart transplanted patients
760291|NCT00403286|Chronic|chronic
760292|NCT00403286|Obstructive|obstructive
760293|NCT00403286|Pulmonary|pulmonary
760294|NCT00403286|Disease|disease
760295|NCT00403286|COPD|copd
760296|NCT00403286|Safety|safety
760297|NCT00403286|Efficacy|efficacy
760298|NCT00403286|Pharmacokinetic|pharmacokinetic
760299|NCT00403286|Dose-finding|dose-finding
760300|NCT00403273|Painful Knee Arthroplasty|painful knee arthroplasty
760301|NCT00403273|Botulinum Toxin A|botulinum toxin a
760302|NCT00403273|Randomized Controlled Trial|randomized controlled trial
760303|NCT00403273|Pain and Function|pain and function
760304|NCT00403260|malaria|malaria
760305|NCT00403260|ACT|act
760306|NCT00403260|P falciparum|p falciparum
760307|NCT00403260|pyronaridine|pyronaridine
760308|NCT00403260|artesunate|artesunate
760309|NCT00403247|Schizophrenia|schizophrenia
760310|NCT00403247|Schizoaffective Disorder|schizoaffective disorder
760311|NCT00403247|Homocysteine|homocysteine
760312|NCT00403247|Vitamins|vitamins
760313|NCT00403234|Postoperative pain|postoperative pain
760314|NCT00403234|opioid|opioid
760315|NCT00403234|transdermal|transdermal
760316|NCT00403234|TKA (total knee arthroplasty)|tka (total knee arthroplasty)
760317|NCT00403221|Gene therapy|gene therapy
760318|NCT00403221|Prostate cancer|prostate cancer
760319|NCT00403221|Immunology, Angiogenesis inhibition|immunology, angiogenesis inhibition
760320|NCT00403221|Phase I clinical trial|phase i clinical trial
760321|NCT00403208|Ventilation, Mechanical|ventilation, mechanical
760322|NCT00403208|Sedation|sedation
760323|NCT00403195|Ocular Ischemic Syndrome|ocular ischemic syndrome
760324|NCT00403182|recurrent breast cancer|recurrent breast cancer
760325|NCT00403182|stage IIIA breast cancer|stage iiia breast cancer
760326|NCT00403182|stage IIIB breast cancer|stage iiib breast cancer
760327|NCT00403182|stage IIIC breast cancer|stage iiic breast cancer
760328|NCT00403182|stage IV breast cancer|stage iv breast cancer
760329|NCT00403169|stage III renal cell cancer|stage iii renal cell cancer
760330|NCT00403169|stage IV renal cell cancer|stage iv renal cell cancer
760331|NCT00403169|recurrent renal cell cancer|recurrent renal cell cancer
760332|NCT00403156|Macular Degeneration|macular degeneration
760333|NCT00403143|intraocular lens, colour vision, blue-light filtering|intraocular lens, colour vision, blue-light filtering
760334|NCT00403117|Naltrexone|naltrexone
760335|NCT00403117|Smoked Marijuana|smoked marijuana
760336|NCT00403104|ONO-2506PO|ono-2506po
760337|NCT00403104|Amyotrophic Lateral Sclerosis|amyotrophic lateral sclerosis
760338|NCT00403104|ALS|als
760339|NCT00403091|Diabetes mellitus|diabetes mellitus
760340|NCT00403091|Internet|internet
760341|NCT00403091|Education, Professional|education, professional
760342|NCT00403091|Quality Indicators, Health Care|quality indicators, health care
760343|NCT00403091|Quality of Health Care|quality of health care
760344|NCT00403091|Hypertension|hypertension
760345|NCT00403091|Hyperlipidemia|hyperlipidemia
760346|NCT00403078|Carotid Artery Stenting (Endovascular)|carotid artery stenting (endovascular)
760347|NCT00403065|recurrent non-small cell lung cancer|recurrent non-small cell lung cancer
760348|NCT00403065|stage IV non-small cell lung cancer|stage iv non-small cell lung cancer
760349|NCT00403065|tumors metastatic to brain|tumors metastatic to brain
760350|NCT00403052|colorectal|colorectal
760351|NCT00403052|cancer|cancer
760352|NCT00403052|carcinoma|carcinoma
760353|NCT00403052|metastatic|metastatic
760354|NCT00403052|colon|colon
760355|NCT00403052|rectal|rectal
760356|NCT00403052|neoplasm|neoplasm
760357|NCT00403052|cetuximab|cetuximab
760358|NCT00403052|irinotecan|irinotecan
760359|NCT00403052|1018 ISS|1018 iss
760360|NCT00403052|combination therapy|combination therapy
760361|NCT00403039|Central Retinal Vein Occlusion|central retinal vein occlusion
760362|NCT00403026|Bevacizumab (Avastin)|bevacizumab (avastin)
760363|NCT00403026|Intravitreal injection|intravitreal injection
760364|NCT00403026|VEGF|vegf
760365|NCT00403026|CRVO|crvo
760366|NCT00403026|BRVO|brvo
760367|NCT00403026|PDR|pdr
760368|NCT00403026|CNVM|cnvm
760369|NCT00403013|nerve block/*methods|nerve block/*methods
760370|NCT00403013|Anesthetics, Local/pharmacokinetics|anesthetics, local/pharmacokinetics
760371|NCT00403013|*Brachial Plexus|*brachial plexus
760372|NCT00403000|recurrent prostate cancer|recurrent prostate cancer
760373|NCT00402987|sore throat|sore throat
760374|NCT00402987|acute pain|acute pain
760375|NCT00402974|osteocalcin|osteocalcin
760376|NCT00402974|vitamin K|vitamin k
760377|NCT00402974|carboxylation|carboxylation
760378|NCT00402974|healthy children|healthy children
760379|NCT00402961|Acupuncture|acupuncture
760380|NCT00402961|Post-Colectomy Ileus|post-colectomy ileus
760381|NCT00402961|Abdominal Surgery|abdominal surgery
760382|NCT00402961|Colon Surgery|colon surgery
760383|NCT00402948|High eosinophils level in sputum|high eosinophils level in sputum
760459|NCT00402779|Placebo|placebo
760384|NCT00402935|long-term effects secondary to cancer therapy in adults|long-term effects secondary to cancer therapy in adults
760385|NCT00402935|long-term effects secondary to cancer therapy in children|long-term effects secondary to cancer therapy in children
760386|NCT00402935|sexual dysfunction and infertility|sexual dysfunction and infertility
760387|NCT00402935|sexuality and reproductive issues|sexuality and reproductive issues
760388|NCT00402935|adult acute lymphoblastic leukemia in remission|adult acute lymphoblastic leukemia in remission
760389|NCT00402935|childhood acute lymphoblastic leukemia in remission|childhood acute lymphoblastic leukemia in remission
760390|NCT00402935|recurrent adult acute lymphoblastic leukemia|recurrent adult acute lymphoblastic leukemia
760391|NCT00402935|recurrent childhood acute lymphoblastic leukemia|recurrent childhood acute lymphoblastic leukemia
760392|NCT00402935|untreated adult acute lymphoblastic leukemia|untreated adult acute lymphoblastic leukemia
760393|NCT00402935|untreated childhood acute lymphoblastic leukemia|untreated childhood acute lymphoblastic leukemia
760394|NCT00402935|adult acute myeloid leukemia in remission|adult acute myeloid leukemia in remission
760395|NCT00402935|recurrent adult acute myeloid leukemia|recurrent adult acute myeloid leukemia
760396|NCT00402935|recurrent childhood acute myeloid leukemia|recurrent childhood acute myeloid leukemia
760397|NCT00402935|untreated adult acute myeloid leukemia|untreated adult acute myeloid leukemia
760398|NCT00402935|untreated childhood acute myeloid leukemia and other myeloid malignancies|untreated childhood acute myeloid leukemia and other myeloid malignancies
760399|NCT00402935|secondary acute myeloid leukemia|secondary acute myeloid leukemia
760400|NCT00402935|stage I adult Hodgkin lymphoma|stage i adult hodgkin lymphoma
760401|NCT00402935|stage I childhood Hodgkin lymphoma|stage i childhood hodgkin lymphoma
760402|NCT00402935|stage II adult Hodgkin lymphoma|stage ii adult hodgkin lymphoma
760403|NCT00402935|stage II childhood Hodgkin lymphoma|stage ii childhood hodgkin lymphoma
760404|NCT00402935|stage III adult Hodgkin lymphoma|stage iii adult hodgkin lymphoma
760405|NCT00402935|stage III childhood Hodgkin lymphoma|stage iii childhood hodgkin lymphoma
760406|NCT00402935|stage IV adult Hodgkin lymphoma|stage iv adult hodgkin lymphoma
760407|NCT00402935|stage IV childhood Hodgkin lymphoma|stage iv childhood hodgkin lymphoma
760408|NCT00402935|recurrent adult Hodgkin lymphoma|recurrent adult hodgkin lymphoma
760409|NCT00402935|recurrent/refractory childhood Hodgkin lymphoma|recurrent/refractory childhood hodgkin lymphoma
760410|NCT00402935|unspecified adult solid tumor, protocol specific|unspecified adult solid tumor, protocol specific
760411|NCT00402935|unspecified childhood solid tumor, protocol specific|unspecified childhood solid tumor, protocol specific
760412|NCT00402935|childhood acute myeloid leukemia in remission|childhood acute myeloid leukemia in remission
760413|NCT00402935|adult acute myeloid leukemia with 11q23 (MLL) abnormalities|adult acute myeloid leukemia with 11q23 (mll) abnormalities
760414|NCT00402935|adult acute myeloid leukemia with inv(16)(p13;q22)|adult acute myeloid leukemia with inv(16)(p13;q22)
760415|NCT00402935|adult acute myeloid leukemia with t(16;16)(p13;q22)|adult acute myeloid leukemia with t(16;16)(p13;q22)
760416|NCT00402935|adult acute myeloid leukemia with t(15;17)(q22;q12)|adult acute myeloid leukemia with t(15;17)(q22;q12)
760417|NCT00402935|adult acute myeloid leukemia with t(8;21)(q22;q22)|adult acute myeloid leukemia with t(8;21)(q22;q22)
760418|NCT00402922|Coronary Heart Disease|coronary heart disease
760419|NCT00402909|Type 2 diabetes,|type 2 diabetes,
760420|NCT00402909|fasting glucose,|fasting glucose,
760421|NCT00402909|postprandial glucose,|postprandial glucose,
760422|NCT00402909|blood sugar,|blood sugar,
760423|NCT00402909|HbA1c,|hba1c,
760424|NCT00402909|insulin,|insulin,
760425|NCT00402909|glargine,|glargine,
760426|NCT00402909|metformin,|metformin,
760427|NCT00402909|thiazolidinedione|thiazolidinedione
760428|NCT00402896|Lung Cancer|lung cancer
760429|NCT00402896|Non-Small Cell Lung Cancer|non-small cell lung cancer
760430|NCT00402896|Pleural Effusion|pleural effusion
760431|NCT00402896|Indwelling Intrapleural Denver Catheter|indwelling intrapleural denver catheter
760432|NCT00402896|ZD6474|zd6474
760433|NCT00402896|Vascular Endothelial Growth Factor Receptor|vascular endothelial growth factor receptor
760435|NCT00402896|Epidermal Growth factor Receptor|epidermal growth factor receptor
760436|NCT00402896|EGFR|egfr
760437|NCT00402896|Tyrosine Kinase Inhibitor|tyrosine kinase inhibitor
760438|NCT00402857|Parenting Education|parenting education
760439|NCT00402857|Child, Preschool|child, preschool
760440|NCT00402857|Preventive Intervention|preventive intervention
760441|NCT00402857|Primary Health Care|primary health care
760442|NCT00402857|Pediatrics|pediatrics
760443|NCT00402857|Attention Deficit Disorders|attention deficit disorders
760444|NCT00402857|Oppositional Defiant Disorder|oppositional defiant disorder
760445|NCT00402857|Disruptive Behavior Disorder|disruptive behavior disorder
760446|NCT00402844|Multicenter|multicenter
760447|NCT00402844|Pelvic organ prolapse|pelvic organ prolapse
760448|NCT00402844|Prospective|prospective
760449|NCT00402844|Transvaginal mesh|transvaginal mesh
760450|NCT00402818|Moderate to severe plaque psoriasis|moderate to severe plaque psoriasis
760451|NCT00402805|Influenza vaccine|influenza vaccine
760452|NCT00402805|Intradermal|intradermal
760453|NCT00402805|Lung transplantation|lung transplantation
760454|NCT00402792|Acute pain following bunionectomy surgery|acute pain following bunionectomy surgery
760455|NCT00402779|Oral Cancer|oral cancer
760456|NCT00402779|Oral IEN Lesion with LOH|oral ien lesion with loh
760457|NCT00402779|Loss of Heterozygosity|loss of heterozygosity
760458|NCT00402779|Intraepithelial Neoplasia|intraepithelial neoplasia
760460|NCT00402779|Erlotinib|erlotinib
760461|NCT00402779|Tarceva|tarceva
760462|NCT00402779|OSI-774|osi-774
760463|NCT00402766|Mesothelioma|mesothelioma
760464|NCT00402766|Pleural Mesothelioma|pleural mesothelioma
760465|NCT00402766|Peritoneal Mesothelioma|peritoneal mesothelioma
760466|NCT00402766|PDGF-R|pdgf-r
760467|NCT00402766|Pemetrexed|pemetrexed
760468|NCT00402766|Alimta|alimta
760469|NCT00402766|Cisplatin|cisplatin
760470|NCT00402766|Imatinib Mesylate|imatinib mesylate
760471|NCT00402766|Gleevec|gleevec
760472|NCT00402766|Platinol|platinol
760473|NCT00402766|Platinol-AQ|platinol-aq
760474|NCT00402766|CDDP|cddp
760475|NCT00402766|Ly231514|ly231514
760476|NCT00402766|Multitargeted Antifolate|multitargeted antifolate
760477|NCT00402766|NSC-698037|nsc-698037
760478|NCT00402766|STI571|sti571
760479|NCT00402766|NSSC-716051|nssc-716051
760480|NCT00402753|Cancer, Exercise, Health Related Quality of Life, PBSCT|cancer, exercise, health related quality of life, pbsct
760481|NCT00402740|Carotid|carotid
760482|NCT00402740|Artery|artery
760483|NCT00402740|Disease|disease
760484|NCT00402740|Stent|stent
760488|NCT00402714|Allogeneic Stem Cell Transplant|allogeneic stem cell transplant
760489|NCT00402701|walking|walking
760490|NCT00402701|motor activity|motor activity
760491|NCT00402701|students|students
760492|NCT00402701|schools|schools
760493|NCT00402701|transportation|transportation
760494|NCT00402701|motor vehicles|motor vehicles
760495|NCT00402688|Chronic Prostatitis|chronic prostatitis
760496|NCT00402688|Prostatitis|prostatitis
760497|NCT00402688|levofloxacin|levofloxacin
760498|NCT00402688|Levaquin|levaquin
760499|NCT00402675|NSTEMI|nstemi
760500|NCT00402675|infarction|infarction
760501|NCT00402675|treatment|treatment
760502|NCT00402675|percutaneous coronary intervention|percutaneous coronary intervention
760503|NCT00402675|non-ST-elevation myocardial infarction|non-st-elevation myocardial infarction
760504|NCT00402662|everolimus|everolimus
760505|NCT00402662|imatinib|imatinib
760506|NCT00402649|influenza, A/H5N1, avian influenza, vaccine|influenza, a/h5n1, avian influenza, vaccine
760507|NCT00402623|sarcoidosis|sarcoidosis
760508|NCT00402623|quercetin|quercetin
760509|NCT00402623|supplementation|supplementation
760510|NCT00402623|oxidative stress|oxidative stress
760511|NCT00402623|inflammation|inflammation
760512|NCT00402610|HIV|hiv
760513|NCT00402610|Tuberculosis|tuberculosis
760514|NCT00402610|Chemoprophylaxis|chemoprophylaxis
760515|NCT00402610|Anergy|anergy
760516|NCT00402610|AIDS|aids
760517|NCT00402597|Acute Coronary Syndrome (ACS)|acute coronary syndrome (acs)
760518|NCT00402597|Myocardial Ischemia|myocardial ischemia
760519|NCT00402597|Rivaroxaban (BAY59-7939)|rivaroxaban (bay59-7939)
760520|NCT00402597|Anti-platelet agents|anti-platelet agents
760521|NCT00402597|Aspirin|aspirin
760522|NCT00402597|Thienopyridine|thienopyridine
760523|NCT00402597|Clopidogrel|clopidogrel
760524|NCT00402571|acetaminophen|acetaminophen
760525|NCT00402571|alcohol|alcohol
760526|NCT00402571|liver injury|liver injury
760527|NCT00402558|Acute Myeloid Leukemia|acute myeloid leukemia
760528|NCT00402558|Chronic Myelogenous Leukemia|chronic myelogenous leukemia
760529|NCT00402558|Myelodysplastic Syndrome|myelodysplastic syndrome
760530|NCT00402558|Leukemia|leukemia
760531|NCT00402558|NK Cells|nk cells
760532|NCT00402558|Natural Killer Cells|natural killer cells
760533|NCT00402558|Fludarabine|fludarabine
760534|NCT00402558|Busulfan|busulfan
760535|NCT00402558|Thymoglobulin|thymoglobulin
760536|NCT00402558|AML|aml
760537|NCT00402558|CML|cml
760538|NCT00402558|MDS|mds
760539|NCT00402558|ATG|atg
760540|NCT00402558|Antithymocyte globulin|antithymocyte globulin
760541|NCT00402558|Busulfex|busulfex
760542|NCT00402558|Myleran®|myleran®
760543|NCT00402558|Fludarabine Phosphate|fludarabine phosphate
760544|NCT00402558|G-CSF|g-csf
760545|NCT00402558|Filgrastim|filgrastim
760546|NCT00402558|Neupogen|neupogen
760547|NCT00402558|Interleukin-2|interleukin-2
760548|NCT00402558|IL-2|il-2
760549|NCT00402558|Aldesleukin|aldesleukin
760550|NCT00402558|Proleukin|proleukin
760551|NCT00402558|Tacrolimus|tacrolimus
760552|NCT00402558|Prograf|prograf
760553|NCT00402558|Methotrexate|methotrexate
760554|NCT00402545|SCCHN|scchn
760555|NCT00402545|C-TPF|c-tpf
760556|NCT00402545|5-FU|5-fu
760557|NCT00402545|squamous cell carcinoma of the head and neck|squamous cell carcinoma of the head and neck
760558|NCT00402532|Lung Transplantation|lung transplantation
760559|NCT00402532|Immunosuppression|immunosuppression
760560|NCT00402532|Mortality|mortality
760561|NCT00402532|Graft rejection|graft rejection
760562|NCT00402532|Bronchiolitis obliterans|bronchiolitis obliterans
760563|NCT00402532|Opportunistic infections|opportunistic infections
760564|NCT00402532|Nephrotoxicity|nephrotoxicity
760565|NCT00402519|accelerated partial breast irradiation|accelerated partial breast irradiation
760566|NCT00402519|multicatheter brachytherapy|multicatheter brachytherapy
760766|NCT00401830|Vimpat|vimpat
760567|NCT00402519|high dose rate brachytherapy|high dose rate brachytherapy
760568|NCT00402519|pulsed dose rate brachytherapy|pulsed dose rate brachytherapy
760569|NCT00402506|coronary|coronary
760571|NCT00402506|ischemia|ischemia
760572|NCT00402506|reperfusion injury|reperfusion injury
760573|NCT00402506|cardiac|cardiac
760574|NCT00402506|heart|heart
760575|NCT00402506|neurological|neurological
760576|NCT00402506|cardiopulmonary bypass|cardiopulmonary bypass
760577|NCT00402506|cardioprotection|cardioprotection
760578|NCT00402506|myocardium|myocardium
760579|NCT00402506|myocardial|myocardial
760580|NCT00402506|myocardial revascularization|myocardial revascularization
760581|NCT00402493|Glaucoma|glaucoma
760582|NCT00402493|Ocular Hypertension|ocular hypertension
760583|NCT00402493|Xalatan|xalatan
760584|NCT00402493|Alpahgan|alpahgan
760585|NCT00402493|Ibuprofen|ibuprofen
760586|NCT00402493|Non-Steroidal Anti-Inflammatory|non-steroidal anti-inflammatory
760587|NCT00402493|Brimonidine|brimonidine
760588|NCT00402493|Latanoprost|latanoprost
760589|NCT00402493|Eye Pressure|eye pressure
760590|NCT00402493|Intra-Ocular Pressure|intra-ocular pressure
760591|NCT00402480|Sickle Cell Anemia with Elevated TCD flow velocity|sickle cell anemia with elevated tcd flow velocity
760592|NCT00402467|Prevention of venous thromboembolism|prevention of venous thromboembolism
760593|NCT00402454|HIV|hiv
760594|NCT00402454|Tuberculosis|tuberculosis
760595|NCT00402454|Prophylaxis|prophylaxis
760596|NCT00402454|AIDS|aids
760597|NCT00402428|Chronic Hepatitis C|chronic hepatitis c
760598|NCT00402428|Hepatitis C|hepatitis c
760599|NCT00402428|CHC|chc
760600|NCT00402428|HepC|hepc
760601|NCT00402428|Genotype 1|genotype 1
760602|NCT00402428|Hepatitis|hepatitis
760603|NCT00402428|HCV|hcv
760604|NCT00402415|metastatic|metastatic
760605|NCT00402415|malignancy|malignancy
760606|NCT00402415|advanced solid tumors|advanced solid tumors
760607|NCT00402415|unresectable|unresectable
760608|NCT00402415|Solid Tumors|solid tumors
760609|NCT00402402|Tuberculin skin test|tuberculin skin test
760610|NCT00402402|Quantiferon-TB Gold assay|quantiferon-tb gold assay
760611|NCT00402402|Chronic liver disease|chronic liver disease
760612|NCT00402402|Liver transplantation|liver transplantation
760613|NCT00402402|Latent tuberculosis infection|latent tuberculosis infection
760614|NCT00402389|Perinatal Depression|perinatal depression
760615|NCT00402389|Postpartum Depression|postpartum depression
760616|NCT00402389|Omega-3 Fatty Acids|omega-3 fatty acids
760617|NCT00402389|Eicosapentaenoic Acid (EPA)|eicosapentaenoic acid (epa)
760618|NCT00402389|Docosahexaenoic Acid (DHA)|docosahexaenoic acid (dha)
760619|NCT00402389|Pregnancy|pregnancy
760620|NCT00402389|Psychotherapy|psychotherapy
760621|NCT00402376|End-stage heart failure|end-stage heart failure
760622|NCT00402376|heart failure;|heart failure;
760623|NCT00402376|ventricular assist device;|ventricular assist device;
760624|NCT00402376|statin;|statin;
760625|NCT00402376|heart transplantation;|heart transplantation;
760626|NCT00402376|myocardial function;|myocardial function;
760627|NCT00402376|mitochondrial respiratory function;|mitochondrial respiratory function;
760628|NCT00402363|Lovaza|lovaza
760629|NCT00402363|Omega-3 fatty acids|omega-3 fatty acids
760630|NCT00402363|Omacor|omacor
760631|NCT00402363|Paroxysmal atrial fibrillation|paroxysmal atrial fibrillation
760632|NCT00402350|Staccato Fentanyl, Pharmacokinetics, Pharmacodynamics, inhaled fentanyl|staccato fentanyl, pharmacokinetics, pharmacodynamics, inhaled fentanyl
760633|NCT00402337|Constipation|constipation
760634|NCT00402337|Chronic Constipation|chronic constipation
760635|NCT00402337|Microbia|microbia
760636|NCT00402337|linaclotide|linaclotide
760637|NCT00402337|linaclotide acetate|linaclotide acetate
760638|NCT00402337|MD-1100|md-1100
760639|NCT00402324|Mixed episode associated with Bipolar I|mixed episode associated with bipolar i
760640|NCT00402311|Health Services for the Aged|health services for the aged
760641|NCT00402311|Geriatric Psychiatry|geriatric psychiatry
760642|NCT00402298|PTSD|ptsd
760643|NCT00402298|MDMA|mdma
760644|NCT00402298|psychotherapy|psychotherapy
760645|NCT00402298|Posttraumatic stress disorder|posttraumatic stress disorder
760646|NCT00402298|Israel|israel
760647|NCT00402285|adenocarcinoma of the prostate|adenocarcinoma of the prostate
760648|NCT00402285|stage I prostate cancer|stage i prostate cancer
760649|NCT00402285|stage IIB prostate cancer|stage iib prostate cancer
760650|NCT00402285|stage IIA prostate cancer|stage iia prostate cancer
760651|NCT00402272|drug eluting stents|drug eluting stents
760652|NCT00402272|stents|stents
760653|NCT00402272|Angioplasty|angioplasty
760654|NCT00402272|coronary artery disease|coronary artery disease
760655|NCT00402272|total coronary occlusion|total coronary occlusion
760656|NCT00402272|coronary artery restenosis|coronary artery restenosis
760657|NCT00402272|stent thrombosis|stent thrombosis
760658|NCT00402272|vascular disease|vascular disease
760659|NCT00402272|myocardial ischemia|myocardial ischemia
760660|NCT00402272|coronary artery stenosis|coronary artery stenosis
760661|NCT00402259|acute non-variceal upper gastrointestinal bleeding|acute non-variceal upper gastrointestinal bleeding
760662|NCT00402246|Randomized Controlled Trials|randomized controlled trials
760663|NCT00402246|Defibrillators|defibrillators
760664|NCT00402246|Remote Consultation|remote consultation
760665|NCT00402207|asthma|asthma
760666|NCT00402207|non-invasive inflammometry|non-invasive inflammometry
760667|NCT00402207|exhaled nitric oxide|exhaled nitric oxide
760668|NCT00402207|exhaled breath condensate|exhaled breath condensate
760669|NCT00402207|paediatric|paediatric
760670|NCT00402207|extrafine HFA-beclomethasone|extrafine hfa-beclomethasone
760671|NCT00402207|HFA-fluticasone|hfa-fluticasone
760672|NCT00402194|Obesity|obesity
760673|NCT00402194|Insulin resistance|insulin resistance
760674|NCT00402194|Impaired glucose tolerance|impaired glucose tolerance
760675|NCT00402194|pre-diabetes|pre-diabetes
760676|NCT00402181|Myeloma|myeloma
760677|NCT00402181|Intravenous|intravenous
760678|NCT00402181|Monoclonal antibody|monoclonal antibody
760679|NCT00402181|Siltuximab|siltuximab
760680|NCT00402181|Dexamethasone|dexamethasone
760681|NCT00402181|CNTO 328|cnto 328
760682|NCT00402155|electroretinogram|electroretinogram
760683|NCT00402155|visual evoked potential|visual evoked potential
760684|NCT00402155|contrast sensitivity|contrast sensitivity
760685|NCT00402142|HIV Infection|hiv infection
760686|NCT00402142|Dendritic cell vaccine|dendritic cell vaccine
760687|NCT00402142|Autologous virus|autologous virus
760688|NCT00402142|Heat inactivated|heat inactivated
760689|NCT00402142|HIV Therapeutic Vaccine|hiv therapeutic vaccine
760690|NCT00402129|Ethnic Skin|ethnic skin
760691|NCT00402129|Laser|laser
760692|NCT00402129|Photobiology|photobiology
760693|NCT00402129|Quality of life|quality of life
760694|NCT00402103|Hypertension, aliskiren, amlodipine, HCTZ, blood pressure|hypertension, aliskiren, amlodipine, hctz, blood pressure
760695|NCT00402090|thiopurines|thiopurines
760696|NCT00402090|thiopurine methyl transferase|thiopurine methyl transferase
760697|NCT00402090|toxicity|toxicity
760698|NCT00402090|pharmacogenomics|pharmacogenomics
760699|NCT00402077|overweight|overweight
760700|NCT00402077|obesity|obesity
760701|NCT00402077|pramlintide|pramlintide
760702|NCT00402077|Symlin|symlin
760703|NCT00402077|sibutramine|sibutramine
760704|NCT00402077|Meridia|meridia
760705|NCT00402077|phentermine|phentermine
760706|NCT00402077|Amylin|amylin
760707|NCT00402064|bisphosphonates|bisphosphonates
760708|NCT00402064|children|children
760709|NCT00402064|dental|dental
760710|NCT00402064|Osteomyelitis|osteomyelitis
760711|NCT00402064|medication|medication
760712|NCT00402025|Metastatic|metastatic
760713|NCT00402025|Pancreas|pancreas
760714|NCT00402025|Adenocarcinoma|adenocarcinoma
760715|NCT00402012|Diabetes Mellitus, Type 2|diabetes mellitus, type 2
760716|NCT00401999|PET|pet
760717|NCT00401999|C-11 Raclopride|c-11 raclopride
760718|NCT00401999|Dopamine|dopamine
760719|NCT00401999|OPRM1|oprm1
760720|NCT00401999|Alcohol|alcohol
760721|NCT00401999|Healthy Volunteer|healthy volunteer
760722|NCT00401999|HV|hv
760723|NCT00401986|Refractory Asthma|refractory asthma
760724|NCT00401986|Bronchial Thermoplasty|bronchial thermoplasty
760725|NCT00401986|Alair System|alair system
760726|NCT00401986|RISA (Research in Severe Asthma)|risa (research in severe asthma)
760727|NCT00401960|Enterococcus|enterococcus
760728|NCT00401960|Daptomycin|daptomycin
760729|NCT00401960|Endocarditis|endocarditis
760730|NCT00401947|HCV|hcv
760731|NCT00401947|Chronic|chronic
760732|NCT00401947|Hepatitis|hepatitis
760733|NCT00401934|cholera, Vibrio cholerae, diarrhea, Bangladesh, children|cholera, vibrio cholerae, diarrhea, bangladesh, children
760734|NCT00401908|Acute gastrointestinal bleeding|acute gastrointestinal bleeding
760735|NCT00401908|Acute coronary syndrome|acute coronary syndrome
760736|NCT00401895|TRANSJUGULAR INTRAHEPATIC PORTOSYSTEMIC SHUNT|transjugular intrahepatic portosystemic shunt
760737|NCT00401895|Covered stents|covered stents
760738|NCT00401895|portal hypertension|portal hypertension
760739|NCT00401895|hepatic encephalopathy|hepatic encephalopathy
760740|NCT00401882|Cardiac arrest|cardiac arrest
760741|NCT00401882|Sudden Cardiac Death|sudden cardiac death
760742|NCT00401882|Ventricular Fibrillation|ventricular fibrillation
760743|NCT00401882|Pulseless Ventricular Tachycardia|pulseless ventricular tachycardia
760744|NCT00401882|Cardiopulmonary resuscitation|cardiopulmonary resuscitation
760745|NCT00401869|vigor|vigor
760746|NCT00401869|function|function
760747|NCT00401869|well-being|well-being
760748|NCT00401869|hand-strength|hand-strength
760749|NCT00401869|surgery|surgery
760750|NCT00401869|anemia|anemia
760751|NCT00401869|transfusion|transfusion
760752|NCT00401869|strength|strength
760753|NCT00401869|quality-of-life|quality-of-life
760754|NCT00401856|Cardiomyopathy|cardiomyopathy
760755|NCT00401856|Fibrosis|fibrosis
760756|NCT00401856|Magnetic-Resonance|magnetic-resonance
760757|NCT00401856|Eplerenone|eplerenone
760758|NCT00401843|multiple myeloma|multiple myeloma
760759|NCT00401843|Monoclonal Antibody|monoclonal antibody
760760|NCT00401843|Intravenous|intravenous
760761|NCT00401843|refractory or relapsed multiple myeloma|refractory or relapsed multiple myeloma
760762|NCT00401843|velcade|velcade
760763|NCT00401843|bortezomib|bortezomib
760764|NCT00401830|Fibromyalgia Syndrome|fibromyalgia syndrome
760765|NCT00401830|Lacosamide|lacosamide
760767|NCT00401830|Harkoseride|harkoseride
760768|NCT00401804|Multiple Myeloma|multiple myeloma
760769|NCT00401804|renal impairment|renal impairment
760770|NCT00401804|Velcade|velcade
760771|NCT00401778|Lung Cancer|lung cancer
760772|NCT00401765|Prostatic neoplasm|prostatic neoplasm
760773|NCT00401765|intravenous|intravenous
760774|NCT00401765|docetaxel|docetaxel
760775|NCT00401765|monoclonal antibody|monoclonal antibody
760776|NCT00401752|NSAID-associated gastric ulcer|nsaid-associated gastric ulcer
760777|NCT00401726|Major Depressive Disorder|major depressive disorder
760778|NCT00401726|Depression|depression
760779|NCT00401726|Anxiety|anxiety
760780|NCT00401713|submacular membrane|submacular membrane
760781|NCT00401713|transplantation of RPE|transplantation of rpe
760782|NCT00401713|translocation of RPE and Choroid|translocation of rpe and choroid
760783|NCT00401700|influenza|influenza
760784|NCT00401700|influenza vaccine|influenza vaccine
760785|NCT00401700|pregnancy|pregnancy
760786|NCT00401687|Reduced Heart Function|reduced heart function
760787|NCT00401674|ovarian cancer|ovarian cancer
760788|NCT00401674|elderly|elderly
760789|NCT00401674|weekly chemotherapy|weekly chemotherapy
760790|NCT00401674|first-line|first-line
760791|NCT00401648|POC|poc
760792|NCT00401648|photosensitive|photosensitive
760794|NCT00401648|brivaracetam|brivaracetam
760795|NCT00401648|PPR|ppr
760796|NCT00401648|AED|aed
760797|NCT00401635|advanced|advanced
760798|NCT00401635|recurrent|recurrent
760799|NCT00401635|chemotherapy|chemotherapy
760800|NCT00401635|first-line|first-line
760801|NCT00401609|elderly|elderly
760802|NCT00401596|ALTO|alto
760803|NCT00401583|GW786034 (pazopanib) cytochrome P450 interaction|gw786034 (pazopanib) cytochrome p450 interaction
760804|NCT00401570|Antibody|antibody
760805|NCT00401570|Pancreas|pancreas
760806|NCT00401570|Carcinoma|carcinoma
760807|NCT00401570|Cancer|cancer
760808|NCT00401570|Pancreatic|pancreatic
760809|NCT00401557|Leishmaniasis, Leishmania (Viannia), Colombia|leishmaniasis, leishmania (viannia), colombia
760810|NCT00401544|anemia|anemia
760811|NCT00401544|chemotherapy induced anemia|chemotherapy induced anemia
760812|NCT00401544|darbepoetin alfa|darbepoetin alfa
760813|NCT00401544|cancer|cancer
760814|NCT00401531|Hepatitis B|hepatitis b
760815|NCT00401531|Polio|polio
760816|NCT00401531|Diphtheria|diphtheria
760817|NCT00401531|Pertussis|pertussis
760818|NCT00401531|H. influenzae type b|h. influenzae type b
760819|NCT00401518|Spinal Stenosis|spinal stenosis
760820|NCT00401518|Lumbar Spinal Stenosis|lumbar spinal stenosis
760821|NCT00401518|Facet Arthroplasty|facet arthroplasty
760822|NCT00401518|Posterior Fusion|posterior fusion
760823|NCT00401518|Facet Arthritis|facet arthritis
760824|NCT00401505|rubella|rubella
760825|NCT00401505|rubella vaccine|rubella vaccine
760826|NCT00401505|postpartum|postpartum
760827|NCT00401505|immunity|immunity
760828|NCT00401492|elderly|elderly
760829|NCT00401492|chemotherapy|chemotherapy
760830|NCT00401492|quality of life|quality of life
760831|NCT00401492|ADL|adl
760832|NCT00401492|toxicity|toxicity
760833|NCT00401479|GW427353|gw427353
760834|NCT00401479|b3-Adrenergic Receptor Agonist|b3-adrenergic receptor agonist
760835|NCT00401479|Irritable Bowel Syndrome (IBS)|irritable bowel syndrome (ibs)
760836|NCT00401479|pharmacokinetics|pharmacokinetics
760837|NCT00401479|tolerability|tolerability
760838|NCT00401479|gastrointestinal transit|gastrointestinal transit
760839|NCT00401466|prophylactic ICD therapy|prophylactic icd therapy
760840|NCT00401466|home monitoring|home monitoring
760841|NCT00401466|follow-up interval|follow-up interval
760842|NCT00401466|remote follow-up|remote follow-up
760843|NCT00401440|Medical termination of pregnancy|medical termination of pregnancy
760844|NCT00401440|Induction of abortion|induction of abortion
760845|NCT00401440|Misoprostol|misoprostol
760846|NCT00401440|MTP in second trimester|mtp in second trimester
760847|NCT00401440|400 microgram vaginal misoprostol|400 microgram vaginal misoprostol
760848|NCT00401427|HER2 overexpression|her2 overexpression
760849|NCT00401427|combination therapy|combination therapy
760850|NCT00401414|Warfarin|warfarin
760851|NCT00401414|Thrombosis|thrombosis
760852|NCT00401414|Genetics|genetics
760853|NCT00401414|Nomogram|nomogram
760854|NCT00401414|Pulmonary Embolism|pulmonary embolism
760855|NCT00401414|Deep Vein Thrombosis|deep vein thrombosis
760856|NCT00401414|Dosing|dosing
760857|NCT00401414|INR|inr
760858|NCT00401414|Anticoagulation|anticoagulation
760859|NCT00401414|Therapy|therapy
760860|NCT00401414|Orthopedic Surgery|orthopedic surgery
760861|NCT00401388|Chemo Insensitive Sarcomas|chemo insensitive sarcomas
760862|NCT00401388|Chondrosarcomas|chondrosarcomas
760863|NCT00401388|Alveolar soft part sarcomas|alveolar soft part sarcomas
760864|NCT00401388|Extra skeletal myxoid chondrosarcomas|extra skeletal myxoid chondrosarcomas
760865|NCT00401388|Perifosine|perifosine
760866|NCT00401349|Leishmania|leishmania
760867|NCT00401349|Mif Alleles|mif alleles
760868|NCT00401349|Colombia|colombia
760869|NCT00401349|children|children
760870|NCT00401336|Magnetic resonance imaging|magnetic resonance imaging
760871|NCT00401336|Hepatic iron|hepatic iron
760872|NCT00401336|Steatosis|steatosis
760873|NCT00401297|Leishmaniasis|leishmaniasis
760874|NCT00401297|L. Viannia|l. viannia
760875|NCT00401297|Leishmania|leishmania
760876|NCT00401297|Colombia|colombia
760877|NCT00401258|IBS|ibs
760878|NCT00401258|irritable bowel syndrome|irritable bowel syndrome
760879|NCT00401258|irritable bowel|irritable bowel
760880|NCT00401206|dexmedetomidine|dexmedetomidine
760881|NCT00401206|sedation|sedation
760882|NCT00401206|bronchoscopy|bronchoscopy
760883|NCT00401206|COPD|copd
760884|NCT00401193|Menorrhagia|menorrhagia
760885|NCT00401193|Heavy Menstrual Bleeding|heavy menstrual bleeding
760886|NCT00401180|unspecified adult solid tumor, protocol specific|unspecified adult solid tumor, protocol specific
760887|NCT00401167|Alzheimer's disease|alzheimer's disease
760888|NCT00401167|behavioral and psychological symptoms of dementia|behavioral and psychological symptoms of dementia
760889|NCT00401167|severe Alzheimer's disease|severe alzheimer's disease
760890|NCT00401167|memantine|memantine
760891|NCT00401167|agitation|agitation
760892|NCT00401167|aggression|aggression
760893|NCT00401154|Spastic Diplegia|spastic diplegia
760894|NCT00401154|Cerebral Palsy|cerebral palsy
760895|NCT00401154|Children|children
760896|NCT00401154|Adolescents|adolescents
760897|NCT00401154|Strengthening|strengthening
760898|NCT00401154|Endurance|endurance
760899|NCT00401141|Systemic lupus|systemic lupus
760900|NCT00401141|B lymphocytes|b lymphocytes
760901|NCT00401141|transcriptomas|transcriptomas
760902|NCT00401128|clear cell renal cell carcinoma|clear cell renal cell carcinoma
760903|NCT00401128|recurrent renal cell cancer|recurrent renal cell cancer
760904|NCT00401128|papillary renal cell carcinoma|papillary renal cell carcinoma
760905|NCT00401128|stage IV renal cell cancer|stage iv renal cell cancer
760906|NCT00401102|self-injurious behavior|self-injurious behavior
760907|NCT00401102|depression|depression
760908|NCT00401102|adolescents|adolescents
760909|NCT00401102|psychotherapy|psychotherapy
760910|NCT00401089|negative symptoms schizophrenia|negative symptoms schizophrenia
760911|NCT00401089|Atypical antipsychotics|atypical antipsychotics
760912|NCT00401089|Neurocognition impairment|neurocognition impairment
760913|NCT00401089|obesity risk factor|obesity risk factor
760914|NCT00401089|Diabetes insulin resistance schizophrenia|diabetes insulin resistance schizophrenia
760915|NCT00401076|SA-001|sa-001
760916|NCT00401076|Pancreatic Exocrine Insufficiency|pancreatic exocrine insufficiency
760917|NCT00401076|Chronic Pancreatitis|chronic pancreatitis
760918|NCT00401076|Pancreatectomy|pancreatectomy
760919|NCT00401063|Cancer|cancer
760920|NCT00401063|Acupuncture|acupuncture
760921|NCT00401063|Cancer Pain|cancer pain
760922|NCT00401063|Quality of life|quality of life
760923|NCT00401050|patellofemoral pain syndrome|patellofemoral pain syndrome
760924|NCT00401050|chiropractic|chiropractic
760925|NCT00401050|knee pain|knee pain
760926|NCT00401050|chiropractic manipulation|chiropractic manipulation
760927|NCT00401050|Graston Instrument Soft Tissue Mobilization(GISTM)|graston instrument soft tissue mobilization(gistm)
760928|NCT00401024|adult anaplastic oligodendroglioma|adult anaplastic oligodendroglioma
760929|NCT00401024|adult oligodendroglioma|adult oligodendroglioma
760930|NCT00401024|adult anaplastic astrocytoma|adult anaplastic astrocytoma
760931|NCT00401024|adult giant cell glioblastoma|adult giant cell glioblastoma
760932|NCT00401024|adult gliosarcoma|adult gliosarcoma
760933|NCT00401024|recurrent adult brain tumor|recurrent adult brain tumor
760934|NCT00401024|adult brain stem glioma|adult brain stem glioma
760935|NCT00401024|adult mixed glioma|adult mixed glioma
760936|NCT00401024|adult glioblastoma|adult glioblastoma
761054|NCT00400608|pediatrics|pediatrics
760937|NCT00401024|adult pilocytic astrocytoma|adult pilocytic astrocytoma
760938|NCT00401024|adult diffuse astrocytoma|adult diffuse astrocytoma
760939|NCT00401024|adult anaplastic ependymoma|adult anaplastic ependymoma
760940|NCT00401024|adult ependymoma|adult ependymoma
760941|NCT00401024|adult myxopapillary ependymoma|adult myxopapillary ependymoma
760942|NCT00401024|adult subependymoma|adult subependymoma
760943|NCT00401024|adult pineal gland astrocytoma|adult pineal gland astrocytoma
760944|NCT00401024|adult subependymal giant cell astrocytoma|adult subependymal giant cell astrocytoma
760945|NCT00401011|Perifosine|perifosine
760946|NCT00401011|Bortezomib|bortezomib
760947|NCT00401011|Dexamethasone|dexamethasone
760948|NCT00401011|Relapsed or Refractory Multiple Myeloma|relapsed or refractory multiple myeloma
760949|NCT00400998|Seasonal Allergic Rhinitis|seasonal allergic rhinitis
760950|NCT00400998|Quality of Life|quality of life
760951|NCT00400998|Efficacy|efficacy
760952|NCT00400998|Validation|validation
760953|NCT00400998|Fluticasone Propionate|fluticasone propionate
760954|NCT00400985|Heart Failure, Congestive|heart failure, congestive
760955|NCT00400985|Diagnostic|diagnostic
760956|NCT00400985|Ambulatory Monitoring|ambulatory monitoring
760957|NCT00400985|Intrathoracic Impedance|intrathoracic impedance
760958|NCT00400972|GlideScope|glidescope
760959|NCT00400972|videolaryngoscopy|videolaryngoscopy
760960|NCT00400972|intubation|intubation
760961|NCT00400972|nasal|nasal
760962|NCT00400972|nasotracheal|nasotracheal
760963|NCT00400972|laryngoscopy|laryngoscopy
760964|NCT00400972|anesthesia|anesthesia
760965|NCT00400959|cell therapy|cell therapy
760966|NCT00400959|acute myocardial infarction|acute myocardial infarction
760967|NCT00400946|drug/agent toxicity by tissue/organ|drug/agent toxicity by tissue/organ
760968|NCT00400946|untreated childhood acute lymphoblastic leukemia|untreated childhood acute lymphoblastic leukemia
760969|NCT00400946|L1 childhood acute lymphoblastic leukemia|l1 childhood acute lymphoblastic leukemia
760970|NCT00400946|L2 childhood acute lymphoblastic leukemia|l2 childhood acute lymphoblastic leukemia
760971|NCT00400946|T-cell childhood acute lymphoblastic leukemia|t-cell childhood acute lymphoblastic leukemia
760972|NCT00400933|Psycho-education|psycho-education
760973|NCT00400933|Eating disorders|eating disorders
760974|NCT00400933|Personality disorders|personality disorders
760975|NCT00400933|Relatives and close friends|relatives and close friends
760976|NCT00400933|Caregiver burden|caregiver burden
760977|NCT00400907|long-term effects secondary to cancer therapy in adults|long-term effects secondary to cancer therapy in adults
760978|NCT00400907|stage I adult diffuse large cell lymphoma|stage i adult diffuse large cell lymphoma
760979|NCT00400907|contiguous stage II adult diffuse large cell lymphoma|contiguous stage ii adult diffuse large cell lymphoma
760980|NCT00400907|noncontiguous stage II adult diffuse large cell lymphoma|noncontiguous stage ii adult diffuse large cell lymphoma
760981|NCT00400907|stage III adult diffuse large cell lymphoma|stage iii adult diffuse large cell lymphoma
761081|NCT00400556|filgrastim|filgrastim
760982|NCT00400907|stage IV adult diffuse large cell lymphoma|stage iv adult diffuse large cell lymphoma
760983|NCT00400894|prostate cancer|prostate cancer
760984|NCT00400894|annexin A3|annexin a3
760985|NCT00400894|early detection|early detection
760986|NCT00400894|exprimate urine|exprimate urine
760987|NCT00400881|mechanical ventilation|mechanical ventilation
760988|NCT00400881|weaning|weaning
760989|NCT00400881|respiratory failure|respiratory failure
760990|NCT00400881|spontaneous breathing trial|spontaneous breathing trial
760991|NCT00400868|rheumatoid arthritis, occupational therapy, joint protection|rheumatoid arthritis, occupational therapy, joint protection
760992|NCT00400855|Asthma|asthma
760993|NCT00400855|AMP challenge|amp challenge
760994|NCT00400842|SA-001|sa-001
760995|NCT00400842|Pancreatic Exocrine Insufficiency|pancreatic exocrine insufficiency
760996|NCT00400842|Pancreatectomy|pancreatectomy
760997|NCT00400816|adult anaplastic oligodendroglioma|adult anaplastic oligodendroglioma
760998|NCT00400816|adult mixed glioma|adult mixed glioma
760999|NCT00400803|Carcinoma, Non-Small-Cell Lung|carcinoma, non-small-cell lung
761000|NCT00400803|Gemcitabine|gemcitabine
761001|NCT00400803|Carboplatin|carboplatin
761002|NCT00400803|Bevacizumab|bevacizumab
761003|NCT00400803|Biological therapy|biological therapy
761004|NCT00400803|Drug therapy|drug therapy
761005|NCT00400790|neurocognitive decline|neurocognitive decline
761006|NCT00400790|coronary artery bypass surgery|coronary artery bypass surgery
761007|NCT00400790|composite morbidity|composite morbidity
761008|NCT00400790|postoperative care cost|postoperative care cost
761009|NCT00400777|Valsartan|valsartan
761010|NCT00400777|hydrochlorothiazide|hydrochlorothiazide
761011|NCT00400777|amlodipine|amlodipine
761012|NCT00400777|hypertension|hypertension
761013|NCT00400777|high blood pressure|high blood pressure
761014|NCT00400764|NHL|nhl
761015|NCT00400764|Follicular NHL|follicular nhl
761016|NCT00400764|Rituxan|rituxan
761017|NCT00400764|Apo2L/TRAIL|apo2l/trail
761018|NCT00400751|Health-compromised smokers, family cessation intervention|health-compromised smokers, family cessation intervention
761019|NCT00400738|HIV-1 infection|hiv-1 infection
761020|NCT00400738|pharmacokinetics|pharmacokinetics
761021|NCT00400738|protease inhibitor|protease inhibitor
761022|NCT00400738|double boosted protease inhibitors|double boosted protease inhibitors
761023|NCT00400738|PIs|pis
761024|NCT00400738|Treatment Naive|treatment naive
761025|NCT00400725|maintenance|maintenance
761026|NCT00400725|scalp psoriasis|scalp psoriasis
761027|NCT00400725|Galderma|galderma
761028|NCT00400712|mobility|mobility
761029|NCT00400712|strength|strength
761030|NCT00400712|balance|balance
761031|NCT00400712|function|function
761032|NCT00400712|reintegration|reintegration
761033|NCT00400712|community|community
761034|NCT00400699|psychosocial effects of cancer and its treatment|psychosocial effects of cancer and its treatment
761035|NCT00400699|unspecified adult solid tumor, protocol specific|unspecified adult solid tumor, protocol specific
761036|NCT00400686|anemia|anemia
761037|NCT00400686|stage I multiple myeloma|stage i multiple myeloma
761038|NCT00400686|stage II multiple myeloma|stage ii multiple myeloma
761039|NCT00400686|stage III multiple myeloma|stage iii multiple myeloma
761040|NCT00400686|refractory multiple myeloma|refractory multiple myeloma
761041|NCT00400673|Acute myelogenous leukemia|acute myelogenous leukemia
761042|NCT00400673|Adult patients|adult patients
761043|NCT00400673|Cytogenetic risk class|cytogenetic risk class
761044|NCT00400673|Clinico-cytogenetic risk model|clinico-cytogenetic risk model
761045|NCT00400673|Risk-oriented therapy|risk-oriented therapy
761046|NCT00400660|GSK615915 asthma surfactant MDI|gsk615915 asthma surfactant mdi
761047|NCT00400647|kidney transplant|kidney transplant
761048|NCT00400647|enteric-coated mycophenolate sodium|enteric-coated mycophenolate sodium
761049|NCT00400647|quality of life|quality of life
761050|NCT00400647|gastrointestinal symptoms|gastrointestinal symptoms
761051|NCT00400621|acetaminophen|acetaminophen
761052|NCT00400621|alcohol|alcohol
761053|NCT00400621|liver injury|liver injury
761055|NCT00400608|ADVAIR Inhaler|advair inhaler
761057|NCT00400608|ADVAIR DISKUS|advair diskus
761058|NCT00400595|peritonitis|peritonitis
761059|NCT00400595|catheter related infection|catheter related infection
761060|NCT00400595|exit site ointments|exit site ointments
761061|NCT00400595|mupirocin|mupirocin
761062|NCT00400595|Polysporin Triple|polysporin triple
761063|NCT00400582|Heart failure|heart failure
761064|NCT00400582|Gene polymorphism|gene polymorphism
761065|NCT00400582|Candesartan|candesartan
761066|NCT00400582|ACE inhibitors|ace inhibitors
761067|NCT00400582|BNP|bnp
761068|NCT00400582|Pharmacogenomics|pharmacogenomics
761069|NCT00400569|Sunitinib malate|sunitinib malate
761070|NCT00400569|SUTENT|sutent
761071|NCT00400569|SU011248|su011248
761072|NCT00400569|Soft tissue sarcoma|soft tissue sarcoma
761073|NCT00400569|Gastrointestinal stromal tumors (GIST)|gastrointestinal stromal tumors (gist)
761074|NCT00400569|MFH|mfh
761075|NCT00400569|Tyrosine kinase inhibitor|tyrosine kinase inhibitor
761076|NCT00400569|Imatinib mesylate|imatinib mesylate
761077|NCT00400569|Phase II|phase ii
761078|NCT00400556|mobilization|mobilization
761079|NCT00400556|ATRA|atra
761080|NCT00400556|G-CSF|g-csf
761083|NCT00400556|stem cell mobilization|stem cell mobilization
761084|NCT00400556|hematopoietic stem and progenitor cells|hematopoietic stem and progenitor cells
761085|NCT00400543|obstructive sleep apnea|obstructive sleep apnea
761086|NCT00400543|arterial stiffness|arterial stiffness
761087|NCT00400543|atherosclerosis|atherosclerosis
761088|NCT00400543|CPAP|cpap
761089|NCT00400543|heart disease|heart disease
761090|NCT00400517|stage III prostate cancer|stage iii prostate cancer
761091|NCT00400517|stage II prostate cancer|stage ii prostate cancer
761092|NCT00400517|adenocarcinoma of the prostate|adenocarcinoma of the prostate
761093|NCT00400517|stage I prostate cancer|stage i prostate cancer
761094|NCT00400517|stage IV prostate cancer|stage iv prostate cancer
761095|NCT00400504|Thrombelastograph|thrombelastograph
761096|NCT00400504|Cancer|cancer
761097|NCT00400504|Thromboembolism|thromboembolism
761098|NCT00400504|Hypercoagulable|hypercoagulable
761099|NCT00400491|diabetes|diabetes
761100|NCT00400491|insulin|insulin
761101|NCT00400491|glycated hemoglobin|glycated hemoglobin
761102|NCT00400491|cholecalciferol|cholecalciferol
761103|NCT00400491|vitamin D|vitamin d
761104|NCT00400478|DLBCL|dlbcl
761105|NCT00400478|NHL 13|nhl 13
761106|NCT00400478|Rituximab|rituximab
761107|NCT00400478|maintenance|maintenance
761108|NCT00400465|thyroid|thyroid
761109|NCT00400465|thyroidectomy|thyroidectomy
761110|NCT00400465|dressing|dressing
761111|NCT00400452|wheelchair|wheelchair
761112|NCT00400452|skills|skills
761113|NCT00400452|long-term-care|long-term-care
761114|NCT00400452|caregivers|caregivers
761115|NCT00400426|Palliative radiotherapy|palliative radiotherapy
761116|NCT00400426|Recurrent|recurrent
761117|NCT00400426|Head and neck Neoplasm|head and neck neoplasm
761118|NCT00400426|Quality of life|quality of life
761119|NCT00400413|Neuropsychology|neuropsychology
761120|NCT00400413|fMRI|fmri
761121|NCT00400413|Reading|reading
761122|NCT00400413|Phonology|phonology
761123|NCT00400413|Deafness|deafness
761124|NCT00400400|RenalTransplantation|renaltransplantation
761125|NCT00400400|KidneyTransplantation|kidneytransplantation
761126|NCT00400400|MPA|mpa
761127|NCT00400400|EC-MPS|ec-mps
761128|NCT00400387|recurrent pregnancy loss|recurrent pregnancy loss
761129|NCT00400374|Head and Neck Cancer|head and neck cancer
761130|NCT00400335|Testosterone|testosterone
761131|NCT00400335|Men|men
761132|NCT00400335|Hypogonadism|hypogonadism
761133|NCT00400335|Dutasteride|dutasteride
761134|NCT00400335|DHT|dht
761135|NCT00400335|Androgen deficiency|androgen deficiency
761136|NCT00400322|glioblastoma multiforme|glioblastoma multiforme
761137|NCT00400322|cytomegalovirus infection|cytomegalovirus infection
761138|NCT00400322|antiviral treatment|antiviral treatment
761139|NCT00400322|valganciclovir|valganciclovir
761140|NCT00400270|Asthma|asthma
761141|NCT00400270|Randomised controlled trial|randomised controlled trial
761142|NCT00400270|Breathing exercises|breathing exercises
761143|NCT00400270|Relaxation exercises|relaxation exercises
761144|NCT00400270|Primary care|primary care
761145|NCT00400257|Heart Failure|heart failure
761146|NCT00400257|BNP|bnp
761147|NCT00400244|wheelchairs|wheelchairs
761148|NCT00400244|skills|skills
761149|NCT00400244|french|french
761150|NCT00400231|metabolic syndrome|metabolic syndrome
761151|NCT00400231|Triglycerides|triglycerides
761152|NCT00400231|Insulin Resistance|insulin resistance
761153|NCT00400231|inflammation|inflammation
761154|NCT00400231|Cardiovascular Disease|cardiovascular disease
761155|NCT00400231|Elevated triglycerides|elevated triglycerides
761156|NCT00400231|without diabetes|without diabetes
761157|NCT00400205|Squamous Cell Carcinoma of the Oral Cavity|squamous cell carcinoma of the oral cavity
761158|NCT00400192|Microchimerism|microchimerism
761159|NCT00400192|Injuries|injuries
761160|NCT00400192|Leukocytes|leukocytes
761161|NCT00400192|Immunologic Techniques|immunologic techniques
761162|NCT00400179|Gastric Cancer|gastric cancer
761163|NCT00400166|Peer support|peer support
761164|NCT00400166|Psychiatric disability|psychiatric disability
761165|NCT00400166|Mutual support|mutual support
761166|NCT00400166|Psychiatric Rehabilitation|psychiatric rehabilitation
761167|NCT00400140|Myopia, defocus|myopia, defocus
761168|NCT00400127|transfemoral amputee|transfemoral amputee
761169|NCT00400127|silicon suspension|silicon suspension
761170|NCT00400127|balance|balance
761171|NCT00400127|gait|gait
761172|NCT00400114|esophageal|esophageal
761173|NCT00400114|esophagus|esophagus
761174|NCT00400114|cancer|cancer
761175|NCT00400114|sutent|sutent
761176|NCT00400114|sunitinib|sunitinib
761177|NCT00400101|Malaria|malaria
761178|NCT00400101|Vaccine|vaccine
761179|NCT00400101|Plasmodium|plasmodium
761180|NCT00400101|falciparum|falciparum
761181|NCT00400101|Phase I|phase i
761182|NCT00400101|Peptide|peptide
761183|NCT00400101|Virosome|virosome
761184|NCT00400101|safety|safety
761185|NCT00400101|immunogenicity|immunogenicity
761310|NCT00399568|Postoperative|postoperative
761186|NCT00400088|Major Depressive Disorder|major depressive disorder
761187|NCT00400088|Depression|depression
761284|NCT00399633|PACAP|pacap
761188|NCT00400088|Bipolar Disorder|bipolar disorder
761189|NCT00400088|Manic Depressive Illness|manic depressive illness
761190|NCT00400088|Randomized Trial|randomized trial
761191|NCT00400088|Antidepressant Treatment|antidepressant treatment
761192|NCT00400088|Lithium Treatment|lithium treatment
761193|NCT00400075|Polyarteritis|polyarteritis
761194|NCT00400075|Vasculitis|vasculitis
761195|NCT00400075|Therapy|therapy
761196|NCT00400075|Cyclophosphamide|cyclophosphamide
761197|NCT00400075|Azathioprine|azathioprine
761198|NCT00400062|Critical care|critical care
761199|NCT00400062|delirium|delirium
761200|NCT00400062|long-term cognitive impairment|long-term cognitive impairment
761201|NCT00400062|mechanical ventilation|mechanical ventilation
761202|NCT00400062|critical illness|critical illness
761203|NCT00400062|dementia|dementia
761204|NCT00400062|aging|aging
761205|NCT00400062|sedatives and analgesics|sedatives and analgesics
761206|NCT00400036|cod protein|cod protein
761207|NCT00400036|insulin sensitivity|insulin sensitivity
761208|NCT00400036|plasma lipids|plasma lipids
761209|NCT00400036|glucose tolerance|glucose tolerance
761210|NCT00400036|plasma inflammatory markers|plasma inflammatory markers
761211|NCT00400036|skeletal muscle insulin signaling|skeletal muscle insulin signaling
761212|NCT00400036|type 2 diabetes|type 2 diabetes
761213|NCT00400036|humans|humans
761214|NCT00400023|Advanced Solid Tumors|advanced solid tumors
761215|NCT00400010|Expert system|expert system
761216|NCT00400010|Transtheoretical Model of Behavior Change|transtheoretical model of behavior change
761217|NCT00400010|Brief intervention|brief intervention
761218|NCT00400010|General hospital|general hospital
761219|NCT00399997|Exercise|exercise
761220|NCT00399997|Exercise referral|exercise referral
761221|NCT00399997|Lifestyle diseases|lifestyle diseases
761222|NCT00399997|Sedentary behavior|sedentary behavior
761223|NCT00399984|Continuing Medical Education|continuing medical education
761224|NCT00399971|Idiopathic Aplastic Anemia|idiopathic aplastic anemia
761225|NCT00399971|Has Failed Conventional Immunosuppressive Therapy|has failed conventional immunosuppressive therapy
761226|NCT00399971|Not Eligible For Bone Marrow Transplantation|not eligible for bone marrow transplantation
761227|NCT00399971|C15.378.071.085|c15.378.071.085
761228|NCT00399945|Cystic fibrosis, tobramycin, PARI eFlow, PARI LC Plus, nebulizer, pharmacoscintigraphy|cystic fibrosis, tobramycin, pari eflow, pari lc plus, nebulizer, pharmacoscintigraphy
761229|NCT00399932|metabolic syndrome|metabolic syndrome
761230|NCT00399932|insulin resistance|insulin resistance
761231|NCT00399932|NASH|nash
761232|NCT00399932|hepatic fibrosis|hepatic fibrosis
761233|NCT00399932|Fibroscan|fibroscan
761234|NCT00399932|elastography by MRI|elastography by mri
761235|NCT00399919|Perhipheral Artery Disease|perhipheral artery disease
761236|NCT00399919|Claudication|claudication
761237|NCT00399919|Exercise|exercise
761238|NCT00399919|Intermittent Claudication due to Peripheral Artery Disease|intermittent claudication due to peripheral artery disease
761239|NCT00399893|Childhood obesity|childhood obesity
761240|NCT00399893|Prader-Willi Syndrome|prader-willi syndrome
761241|NCT00399893|Octreotide|octreotide
761242|NCT00399893|Ghrelin|ghrelin
761243|NCT00399893|Weight loss|weight loss
761244|NCT00399893|Body composition|body composition
761245|NCT00399893|Energy expenditure|energy expenditure
761246|NCT00399880|Clinical Trial|clinical trial
761247|NCT00399880|Behavioral/Social|behavioral/social
761248|NCT00399880|Cardiovascular Disease|cardiovascular disease
761249|NCT00399880|Risk Factors/Analysis|risk factors/analysis
761250|NCT00399867|multiple myeloma|multiple myeloma
761251|NCT00399867|refractory|refractory
761252|NCT00399867|cell adhesion mediated drug resistance|cell adhesion mediated drug resistance
761253|NCT00399841|Pain|pain
761254|NCT00399841|Chronic Pain|chronic pain
761255|NCT00399841|Neurostimulation|neurostimulation
761256|NCT00399815|Chronic viral hepatitis C|chronic viral hepatitis c
761257|NCT00399815|HCV RNA|hcv rna
761258|NCT00399815|Fibroscan|fibroscan
761259|NCT00399815|Fibrotest|fibrotest
761260|NCT00399815|hepatic elastography by MRI|hepatic elastography by mri
761261|NCT00399789|Non-Small-Cell Lung|non-small-cell lung
761262|NCT00399789|Perifosine|perifosine
761263|NCT00399776|bone mineral|bone mineral
761264|NCT00399776|antipsychotic therapy|antipsychotic therapy
761265|NCT00399776|bone mineral accrual|bone mineral accrual
761266|NCT00399776|bone mineral content|bone mineral content
761267|NCT00399763|Adolescent|adolescent
761268|NCT00399763|ADHD|adhd
761269|NCT00399763|SUD|sud
761270|NCT00399737|ACE activity|ace activity
761271|NCT00399737|Fermented milk peptides|fermented milk peptides
761272|NCT00399737|Healthy male volunteers|healthy male volunteers
761273|NCT00399698|Severe conduct problems|severe conduct problems
761274|NCT00399698|Risperidone|risperidone
761275|NCT00399698|Risperdal|risperdal
761276|NCT00399685|HIV|hiv
761277|NCT00399672|HCV|hcv
761278|NCT00399672|injection drug users|injection drug users
761279|NCT00399672|ribavirin|ribavirin
761280|NCT00399672|pegylated interferon|pegylated interferon
761281|NCT00399672|illicit drug users|illicit drug users
761282|NCT00399659|Opioid, constipation, tegaserod|opioid, constipation, tegaserod
761283|NCT00399633|VIP|vip
761287|NCT00399620|Periodontitis|periodontitis
761288|NCT00399620|Diabetes|diabetes
761289|NCT00399620|Gingival crevicular fluid|gingival crevicular fluid
761290|NCT00399620|GCF|gcf
761291|NCT00399620|Saliva|saliva
761292|NCT00399620|Chromogranin|chromogranin
761293|NCT00399620|Electrophorèse|electrophorèse
761294|NCT00399620|Western Blot|western blot
761295|NCT00399620|RT-HPLC|rt-hplc
761296|NCT00399607|colonic neoplasms|colonic neoplasms
761297|NCT00399607|colorectal adenoma|colorectal adenoma
761298|NCT00399607|calcium|calcium
761299|NCT00399607|vitamin D|vitamin d
761300|NCT00399594|Mechanical dyssynchrony|mechanical dyssynchrony
761301|NCT00399594|Biventricular pacing|biventricular pacing
761302|NCT00399594|Cardiac resynchronization therapy|cardiac resynchronization therapy
761303|NCT00399581|Acute Respiratory Distress Syndrome|acute respiratory distress syndrome
761304|NCT00399581|Acute Lung Injury|acute lung injury
761305|NCT00399581|Mechanical Ventilation|mechanical ventilation
761306|NCT00399581|Lung|lung
761307|NCT00399568|Pain|pain
761308|NCT00399568|Gynecologic|gynecologic
761309|NCT00399568|IV Acetaminophen|iv acetaminophen
761311|NCT00399568|Analgesic|analgesic
761312|NCT00399555|Single Ventricle|single ventricle
761313|NCT00399555|Hypoplastic Left Heart|hypoplastic left heart
761314|NCT00399555|Developmental|developmental
761315|NCT00399542|Irritable Bowel Syndrome With Constipation|irritable bowel syndrome with constipation
761316|NCT00399529|Stage IV HER-2/neu overexpressing breast cancer|stage iv her-2/neu overexpressing breast cancer
761317|NCT00399516|Pain|pain
761318|NCT00399516|Neurostimulation|neurostimulation
761319|NCT00399516|Back pain|back pain
761320|NCT00399516|Chronic Pain|chronic pain
761321|NCT00399503|Noninvasive assessment|noninvasive assessment
761322|NCT00399503|Combined parameter|combined parameter
761323|NCT00399503|Holter|holter
761324|NCT00399490|Monoclonal antibody|monoclonal antibody
761325|NCT00399464|Benign Prostatic Hyperplasia|benign prostatic hyperplasia
761326|NCT00399464|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists
761327|NCT00399464|alfuzosin|alfuzosin
761328|NCT00399451|Sleep Apnea,Obstructive|sleep apnea,obstructive
761329|NCT00399451|apnea-hypopnea index (AHI)|apnea-hypopnea index (ahi)
761330|NCT00399451|polidocanol|polidocanol
761331|NCT00399451|sclerotherapy|sclerotherapy
761332|NCT00399451|pharynges|pharynges
761333|NCT00399438|Diarrhea-predominant irritable bowel syndrome|diarrhea-predominant irritable bowel syndrome
761334|NCT00399425|Heparin, Low-Molecular-Weight|heparin, low-molecular-weight
761335|NCT00399425|Bemiparin|bemiparin
761336|NCT00399425|Foot Ulcer, Diabetic|foot ulcer, diabetic
761337|NCT00399425|Diabetic Angiopathies|diabetic angiopathies
761338|NCT00399425|Primary Health Care|primary health care
761339|NCT00399412|S-ICD|s-icd
761340|NCT00399412|ICD|icd
761341|NCT00399412|ECG signals|ecg signals
761342|NCT00399412|Resting|resting
761343|NCT00399399|Churg-Strauss|churg-strauss
761344|NCT00399399|Vasculitis|vasculitis
761345|NCT00399399|Therapy|therapy
761346|NCT00399399|Cyclophosphamide|cyclophosphamide
761347|NCT00399399|Azathioprine|azathioprine
761348|NCT00399386|S ICD|s icd
761349|NCT00399386|ICD|icd
761350|NCT00399386|Ablation|ablation
761351|NCT00399386|EP study|ep study
761352|NCT00399386|Paediatric|paediatric
761353|NCT00399386|ECG|ecg
761354|NCT00399373|disease management|disease management
761355|NCT00399373|substance abuse|substance abuse
761356|NCT00399360|HIV|hiv
761357|NCT00399360|Metabolic Syndrome|metabolic syndrome
761358|NCT00399360|Lifestyle Modification|lifestyle modification
761359|NCT00399360|Metformin|metformin
761360|NCT00399360|Treatment Experienced|treatment experienced
761361|NCT00399347|Diabetes Mellitus, prevalence , Ethiopians Jews, Israel|diabetes mellitus, prevalence , ethiopians jews, israel
761362|NCT00399334|Schizophrenia|schizophrenia
761363|NCT00399334|Schizoaffective|schizoaffective
761364|NCT00399334|relapse|relapse
761365|NCT00399334|risk factors|risk factors
761366|NCT00399334|Observational study|observational study
761367|NCT00399334|Antipsychotic medication|antipsychotic medication
761368|NCT00399321|Post menopause women receiving adjuvant care|post menopause women receiving adjuvant care
761369|NCT00399308|wound|wound
761370|NCT00399308|leg|leg
761371|NCT00399308|venous|venous
761372|NCT00399308|chronic|chronic
761373|NCT00399308|wound healing|wound healing
761374|NCT00399295|Analgesia|analgesia
761375|NCT00399282|Rheumatoid arthritis|rheumatoid arthritis
761376|NCT00399282|Health related quality of life|health related quality of life
761377|NCT00399282|Omega 3 fatty acids|omega 3 fatty acids
761378|NCT00399282|Vitamin E|vitamin e
761379|NCT00399269|Anemia|anemia
761380|NCT00399256|contrast-induced nephropathy|contrast-induced nephropathy
761381|NCT00399256|Acetylcysteine|acetylcysteine
761382|NCT00399256|Zinc|zinc
761383|NCT00399256|Cystatin C|cystatin c
761384|NCT00399256|Creatinine|creatinine
761385|NCT00399243|cluster headache|cluster headache
761386|NCT00399243|sumatriptan|sumatriptan
761387|NCT00399217|subcutaneous ICD|subcutaneous icd
761388|NCT00399217|ICD|icd
761389|NCT00399217|DFT|dft
761390|NCT00399217|Pacing threshold|pacing threshold
761393|NCT00399191|iron deficiency anemia|iron deficiency anemia
761394|NCT00399191|iron deficiency|iron deficiency
761395|NCT00399191|absorption|absorption
761396|NCT00399191|iron absorption|iron absorption
761397|NCT00399191|iron uptake|iron uptake
761398|NCT00399178|Osteoarthritis|osteoarthritis
761399|NCT00399178|Norspan versus Tramadol|norspan versus tramadol
761400|NCT00399178|Randomised|randomised
761401|NCT00399178|Efficacy and safety|efficacy and safety
761402|NCT00399178|OA pain of the hip and/or knee|oa pain of the hip and/or knee
761403|NCT00399165|Oral Contraception for Men|oral contraception for men
761404|NCT00399165|Contraceptive agent|contraceptive agent
761405|NCT00399152|Perifosine|perifosine
761406|NCT00399152|Sunitinib Malate|sunitinib malate
761407|NCT00399152|Renal cancer|renal cancer
761408|NCT00399152|GIST|gist
761409|NCT00399152|advanced cancers|advanced cancers
761410|NCT00399074|Sickle Cell anemia|sickle cell anemia
761411|NCT00399074|Malaria|malaria
761412|NCT00399074|Presumptive treatment|presumptive treatment
761413|NCT00399074|Sulfadoxine- pyrimethamine|sulfadoxine- pyrimethamine
761414|NCT00399074|Children|children
761415|NCT00399074|Uganda|uganda
761416|NCT00399048|Pain|pain
761417|NCT00399048|Osteoarthritis|osteoarthritis
761418|NCT00399048|knee Osteoarthritis|knee osteoarthritis
761419|NCT00399048|hip Osteoarthritis .|hip osteoarthritis .
761420|NCT00399035|Colorectal Cancer|colorectal cancer
761421|NCT00399035|Cediranib|cediranib
761422|NCT00399035|RECENTIN|recentin
761423|NCT00399009|Circular stapling devices|circular stapling devices
761424|NCT00399009|anastomotic leak|anastomotic leak
761425|NCT00399009|anastomotic dehiscence|anastomotic dehiscence
761426|NCT00399009|rectal cancer|rectal cancer
761427|NCT00398996|antiretroviral therapy|antiretroviral therapy
761428|NCT00398996|HIV|hiv
761429|NCT00398996|Opportunistic infections|opportunistic infections
761430|NCT00398996|CD4|cd4
761431|NCT00398996|Viral load|viral load
761432|NCT00398996|TB/HIV co infection|tb/hiv co infection
761433|NCT00398996|Treatment Naive|treatment naive
761434|NCT00398983|Acute Myelogenous Leukemia|acute myelogenous leukemia
761435|NCT00398983|AML|aml
761436|NCT00398983|Remission|remission
761437|NCT00398983|Decitabine|decitabine
761438|NCT00398983|Maintenance Therapy|maintenance therapy
761439|NCT00398970|Endobronchial ultrasonography|endobronchial ultrasonography
761440|NCT00398970|Fluoroscopy|fluoroscopy
761441|NCT00398970|Guide sheath|guide sheath
761442|NCT00398970|Peripheral pulmonary lesion|peripheral pulmonary lesion
761443|NCT00398970|Transbronchial biopsy|transbronchial biopsy
761444|NCT00398957|Analgesia|analgesia
761445|NCT00398944|Guideline based decision support system, Hypertension, Diabetes|guideline based decision support system, hypertension, diabetes
761446|NCT00398905|Prevention of venous thromboembolism|prevention of venous thromboembolism
761447|NCT00398892|Type 2 diabetes mellitus|type 2 diabetes mellitus
761448|NCT00398892|Glycaemic control|glycaemic control
761449|NCT00398892|Lipoic acid|lipoic acid
761450|NCT00398892|Diabetic nephropathy|diabetic nephropathy
761451|NCT00398879|Capecitabine|capecitabine
761452|NCT00398866|Hyaluronan|hyaluronan
761453|NCT00398866|Carpometacarpal|carpometacarpal
761454|NCT00398866|Outcomes|outcomes
761455|NCT00398866|Carpometacarpal Joints|carpometacarpal joints
761456|NCT00398853|insulin|insulin
761457|NCT00398853|glucose|glucose
761458|NCT00398853|chromium|chromium
761459|NCT00398840|Cancer|cancer
761460|NCT00398840|Solid Tumors|solid tumors
761461|NCT00398840|advanced solid tumors|advanced solid tumors
761553|NCT00398424|Impaired Hepatic Function|impaired hepatic function
761462|NCT00398827|American Society of Anesthesiologists (ASA)|american society of anesthesiologists (asa)
761463|NCT00398827|Observer's Assessment of Alertness Scale (OAA/S)|observer's assessment of alertness scale (oaa/s)
761464|NCT00398827|Aldrete Scoring System|aldrete scoring system
761465|NCT00398827|Surgery or procedure using monitored care anesthesia|surgery or procedure using monitored care anesthesia
761466|NCT00398827|Surgery or procedure at least 30 minutes in duration|surgery or procedure at least 30 minutes in duration
761467|NCT00398814|Perifosine|perifosine
761468|NCT00398814|Sorafenib|sorafenib
761469|NCT00398814|Renal cancer|renal cancer
761470|NCT00398814|Hepatocellular cancer|hepatocellular cancer
761471|NCT00398814|other advanced solid tumors|other advanced solid tumors
761472|NCT00398801|gastroparesis|gastroparesis
761473|NCT00398788|Pain|pain
761474|NCT00398775|procalcitonin guided antibiotic discontinuation|procalcitonin guided antibiotic discontinuation
761475|NCT00398775|fever of unknown origin|fever of unknown origin
761476|NCT00398749|Anemia|anemia
761477|NCT00398749|Neoplasms|neoplasms
761478|NCT00398749|Antineoplastic agents|antineoplastic agents
761479|NCT00398749|Chemotherapy|chemotherapy
761480|NCT00398749|Efficacy|efficacy
761481|NCT00398749|Epoetin alfa|epoetin alfa
761482|NCT00398736|Presence of severe sepsis and septic shock, mechanical ventilation|presence of severe sepsis and septic shock, mechanical ventilation
761483|NCT00398723|Narrowband UBV Phototherapy|narrowband ubv phototherapy
761484|NCT00398723|Skin biopsies|skin biopsies
761485|NCT00398710|Waldenström's Macroglobulinemia|waldenström's macroglobulinemia
761486|NCT00398710|Perifosine|perifosine
761487|NCT00398697|perifosine|perifosine
761490|NCT00398684|Developing countries|developing countries
761491|NCT00398684|prophylaxis|prophylaxis
761492|NCT00398684|mother to child transmission|mother to child transmission
761493|NCT00398684|HIV-1|hiv-1
761494|NCT00398684|HIV-1 infection|hiv-1 infection
761495|NCT00398684|HIV Seronegativity|hiv seronegativity
761496|NCT00398671|primary successful cardio-pulmonary resuscitation|primary successful cardio-pulmonary resuscitation
761497|NCT00398671|pre-hospital setting|pre-hospital setting
761498|NCT00398658|Endophthalmitis|endophthalmitis
761499|NCT00398658|Post-traumatic Endophthalmitis|post-traumatic endophthalmitis
761500|NCT00398658|Bacterial Endophthalmitis|bacterial endophthalmitis
761501|NCT00398658|Prophylaxis of Endophthalmitis|prophylaxis of endophthalmitis
761502|NCT00398658|Intra Ocular Injection of antibiotics|intra ocular injection of antibiotics
761503|NCT00398645|GW685698X|gw685698x
761504|NCT00398645|Adults|adults
761505|NCT00398645|Pharmacokinetics|pharmacokinetics
761506|NCT00398645|Pharmacogenetics|pharmacogenetics
761507|NCT00398645|Asthma|asthma
761508|NCT00398645|Adolescents|adolescents
761509|NCT00398593|Adherence with therapy|adherence with therapy
761510|NCT00398593|Adherence enhancing intervention|adherence enhancing intervention
761511|NCT00398593|Nonadherence|nonadherence
761512|NCT00398593|Ulcerative colitis|ulcerative colitis
761514|NCT00398580|Testosterone|testosterone
761515|NCT00398580|Hypogonadism|hypogonadism
761516|NCT00398580|Dutasteride|dutasteride
761517|NCT00398580|Androgen deficiency|androgen deficiency
761518|NCT00398567|HKI-272|hki-272
761519|NCT00398567|neratinib|neratinib
761520|NCT00398567|trastuzumab|trastuzumab
761521|NCT00398567|breast cancer|breast cancer
761522|NCT00398567|Nerlynx|nerlynx
761523|NCT00398567|PB-272|pb-272
761524|NCT00398567|HER2|her2
761525|NCT00398554|stage II childhood Hodgkin lymphoma|stage ii childhood hodgkin lymphoma
761526|NCT00398554|stage III childhood Hodgkin lymphoma|stage iii childhood hodgkin lymphoma
761527|NCT00398554|stage IV childhood Hodgkin lymphoma|stage iv childhood hodgkin lymphoma
761528|NCT00398554|stage I childhood Hodgkin lymphoma|stage i childhood hodgkin lymphoma
761529|NCT00398554|childhood lymphocyte depletion Hodgkin lymphoma|childhood lymphocyte depletion hodgkin lymphoma
761530|NCT00398554|childhood mixed cellularity Hodgkin lymphoma|childhood mixed cellularity hodgkin lymphoma
761531|NCT00398554|childhood nodular sclerosis Hodgkin lymphoma|childhood nodular sclerosis hodgkin lymphoma
761532|NCT00398528|Multiple Sclerosis|multiple sclerosis
761533|NCT00398528|Disease Modifying Therapy|disease modifying therapy
761534|NCT00398489|stage IIIA breast cancer|stage iiia breast cancer
761535|NCT00398489|stage IIIB breast cancer|stage iiib breast cancer
761536|NCT00398489|stage IIIC breast cancer|stage iiic breast cancer
761537|NCT00398489|stage II breast cancer|stage ii breast cancer
761538|NCT00398489|inflammatory breast cancer|inflammatory breast cancer
761539|NCT00398476|taste|taste
761540|NCT00398476|questionnaire|questionnaire
761541|NCT00398476|preference|preference
761542|NCT00398476|attributes|attributes
761543|NCT00398476|odor|odor
761544|NCT00398476|after taste|after taste
761545|NCT00398476|scent|scent
761546|NCT00398463|tirofiban|tirofiban
761547|NCT00398463|aspirin resistance|aspirin resistance
761548|NCT00398463|clopidogrel resistance|clopidogrel resistance
761549|NCT00398450|recurrent melanoma|recurrent melanoma
761550|NCT00398450|stage IV melanoma|stage iv melanoma
761551|NCT00398437|tumors metastatic to brain|tumors metastatic to brain
761552|NCT00398437|stage IV breast cancer|stage iv breast cancer
761554|NCT00398411|prophylaxis|prophylaxis
761555|NCT00398411|bacteremia|bacteremia
761556|NCT00398411|moxifloxacin|moxifloxacin
761557|NCT00398411|stem cell transplantation|stem cell transplantation
761558|NCT00398411|Hodgkin disease|hodgkin disease
761559|NCT00398411|non-Hodgkin lymphoma|non-hodgkin lymphoma
761560|NCT00398411|multiple myeloma|multiple myeloma
761561|NCT00398411|solid tumor|solid tumor
761562|NCT00398411|autologous stem cell transplantation|autologous stem cell transplantation
761563|NCT00398398|gastric cancer|gastric cancer
761564|NCT00398398|chemotherapy|chemotherapy
761565|NCT00398398|cetuximab|cetuximab
761566|NCT00398398|capecitabine|capecitabine
761567|NCT00398398|oxaliplatin|oxaliplatin
761568|NCT00398385|squamous cell lung cancer|squamous cell lung cancer
761569|NCT00398385|adenocarcinoma of the lung|adenocarcinoma of the lung
761570|NCT00398385|adenosquamous cell lung cancer|adenosquamous cell lung cancer
761571|NCT00398385|bronchoalveolar cell lung cancer|bronchoalveolar cell lung cancer
761572|NCT00398385|large cell lung cancer|large cell lung cancer
761573|NCT00398385|stage IB non-small cell lung cancer|stage ib non-small cell lung cancer
761574|NCT00398385|stage IIA non-small cell lung cancer|stage iia non-small cell lung cancer
761575|NCT00398385|stage IIB non-small cell lung cancer|stage iib non-small cell lung cancer
761576|NCT00398359|Obesity|obesity
761577|NCT00398359|Overweight|overweight
761578|NCT00398359|Children|children
761579|NCT00398359|Behavioral|behavioral
761580|NCT00398359|Motivational|motivational
761581|NCT00398359|Family|family
761582|NCT00398359|Primary care|primary care
761583|NCT00398333|Colorectal Neoplasms|colorectal neoplasms
761584|NCT00398333|Eicosapentaenoic Acid|eicosapentaenoic acid
761585|NCT00398333|Quality of Life|quality of life
761586|NCT00398333|Nutritional Status|nutritional status
761587|NCT00398307|Renal Impairment|renal impairment
761588|NCT00398281|prostate cancer|prostate cancer
761589|NCT00398268|Fracture|fracture
761590|NCT00398268|Forearm|forearm
761591|NCT00398268|Distal|distal
761592|NCT00398268|Child|child
761593|NCT00398268|Treatment|treatment
761594|NCT00398255|arthritis|arthritis
761595|NCT00398255|self management|self management
761596|NCT00398255|patient education|patient education
761597|NCT00398242|fracture|fracture
761598|NCT00398242|forearm|forearm
761599|NCT00398242|midshaft|midshaft
761600|NCT00398242|child|child
761601|NCT00398242|treatment|treatment
761602|NCT00398229|In-Vitro Fertilization|in-vitro fertilization
761603|NCT00398229|human chorionic gonadotropin|human chorionic gonadotropin
761604|NCT00398229|frozen-thawed embryo transfer|frozen-thawed embryo transfer
761605|NCT00398229|implantation rate|implantation rate
761606|NCT00398216|Anti-coagulant|anti-coagulant
761607|NCT00398216|hip replacement|hip replacement
761608|NCT00398216|hip replacement surgery|hip replacement surgery
761609|NCT00398216|unilateral hip replacement surgery|unilateral hip replacement surgery
761610|NCT00398216|DeepVein Thrombosis|deepvein thrombosis
761611|NCT00398216|Venous Thromboembolism|venous thromboembolism
761612|NCT00398216|pulmonary embolism|pulmonary embolism
761613|NCT00398216|Prevention of Blood Clots|prevention of blood clots
761614|NCT00398203|NaviAid™ BGE Device|naviaid™ bge device
761615|NCT00398203|Small Intestine|small intestine
761616|NCT00398203|Intestinal Diseases|intestinal diseases
761617|NCT00398190|Smoking|smoking
761618|NCT00398190|Tobacco use disorder|tobacco use disorder
761619|NCT00398138|adult acute myeloid leukemia in remission|adult acute myeloid leukemia in remission
761620|NCT00398138|adult acute myeloid leukemia with 11q23 (MLL) abnormalities|adult acute myeloid leukemia with 11q23 (mll) abnormalities
761621|NCT00398138|adult acute myeloid leukemia with inv(16)(p13;q22)|adult acute myeloid leukemia with inv(16)(p13;q22)
761622|NCT00398138|adult acute myeloid leukemia with t(15;17)(q22;q12)|adult acute myeloid leukemia with t(15;17)(q22;q12)
761623|NCT00398138|adult acute myeloid leukemia with t(16;16)(p13;q22)|adult acute myeloid leukemia with t(16;16)(p13;q22)
761624|NCT00398138|adult acute myeloid leukemia with t(8;21)(q22;q22)|adult acute myeloid leukemia with t(8;21)(q22;q22)
761625|NCT00398138|de novo myelodysplastic syndromes|de novo myelodysplastic syndromes
761626|NCT00398138|previously treated myelodysplastic syndromes|previously treated myelodysplastic syndromes
761627|NCT00398138|secondary myelodysplastic syndromes|secondary myelodysplastic syndromes
761628|NCT00398138|recurrent non-small cell lung cancer|recurrent non-small cell lung cancer
761629|NCT00398138|stage IIIA non-small cell lung cancer|stage iiia non-small cell lung cancer
761630|NCT00398138|stage IIIB non-small cell lung cancer|stage iiib non-small cell lung cancer
761631|NCT00398138|stage IV non-small cell lung cancer|stage iv non-small cell lung cancer
761632|NCT00398138|advanced malignant mesothelioma|advanced malignant mesothelioma
761633|NCT00398138|recurrent malignant mesothelioma|recurrent malignant mesothelioma
761634|NCT00398138|primary peritoneal cavity cancer|primary peritoneal cavity cancer
761635|NCT00398125|GSK364735|gsk364735
761636|NCT00398125|HIV-1|hiv-1
761637|NCT00398125|integrase inhibitor|integrase inhibitor
761638|NCT00398086|Metastatic Pancreatic Cancer, Abraxane, Gemcitabine|metastatic pancreatic cancer, abraxane, gemcitabine
761639|NCT00398073|stage II melanoma|stage ii melanoma
761640|NCT00398073|stage III melanoma|stage iii melanoma
761641|NCT00398073|stage IV melanoma|stage iv melanoma
761642|NCT00398073|recurrent melanoma|recurrent melanoma
761643|NCT00398073|ciliary body and choroid melanoma, medium/large size|ciliary body and choroid melanoma, medium/large size
761644|NCT00398073|ciliary body and choroid melanoma, small size|ciliary body and choroid melanoma, small size
761645|NCT00398073|recurrent intraocular melanoma|recurrent intraocular melanoma
761646|NCT00398073|metastatic intraocular melanoma|metastatic intraocular melanoma
761647|NCT00398060|life-style counseling|life-style counseling
761648|NCT00398060|type 2 diabetes|type 2 diabetes
761649|NCT00398060|prediabetes|prediabetes
761650|NCT00398060|physical activity|physical activity
761651|NCT00398060|diet|diet
761652|NCT00398060|cognitive-behavioral|cognitive-behavioral
761653|NCT00398047|de novo myelodysplastic syndromes|de novo myelodysplastic syndromes
761654|NCT00398047|refractory anemia with ringed sideroblasts|refractory anemia with ringed sideroblasts
761655|NCT00398047|refractory anemia with excess blasts|refractory anemia with excess blasts
761656|NCT00398047|refractory anemia|refractory anemia
761657|NCT00398047|refractory cytopenia with multilineage dysplasia|refractory cytopenia with multilineage dysplasia
761658|NCT00398047|chronic myelomonocytic leukemia|chronic myelomonocytic leukemia
761659|NCT00398047|secondary myelodysplastic syndromes|secondary myelodysplastic syndromes
761660|NCT00398047|childhood myelodysplastic syndromes|childhood myelodysplastic syndromes
761661|NCT00398034|opioids|opioids
761662|NCT00398034|pain|pain
761663|NCT00398034|hypogonadism|hypogonadism
761664|NCT00398034|depression|depression
761665|NCT00398034|fatigue|fatigue
761666|NCT00398034|cognition|cognition
761667|NCT00398034|libido|libido
761668|NCT00398021|constipation|constipation
761669|NCT00398021|bowel habits|bowel habits
761670|NCT00398008|Buprenorphine|buprenorphine
761671|NCT00398008|Naltrexone|naltrexone
761852|NCT00397215|H5N1|h5n1
761672|NCT00398008|HIV risk reduction behavior|hiv risk reduction behavior
761673|NCT00398008|Counseling|counseling
761674|NCT00398008|HIV Seronegativity|hiv seronegativity
761675|NCT00397995|Fracture|fracture
761676|NCT00397995|Forearm|forearm
761677|NCT00397995|Distal|distal
761678|NCT00397995|Child|child
761679|NCT00397995|Treatment|treatment
761680|NCT00397969|colon cancer|colon cancer
761681|NCT00397969|rectal cancer|rectal cancer
761682|NCT00397969|precancerous condition|precancerous condition
761683|NCT00397943|Tuberculosis|tuberculosis
761684|NCT00397930|cancer-related sleep disturbance|cancer-related sleep disturbance
761685|NCT00397930|fatigue|fatigue
761686|NCT00397930|sleep disorders|sleep disorders
761687|NCT00397904|adenocarcinoma of the esophagus|adenocarcinoma of the esophagus
761688|NCT00397904|squamous cell carcinoma of the esophagus|squamous cell carcinoma of the esophagus
761689|NCT00397904|recurrent esophageal cancer|recurrent esophageal cancer
761690|NCT00397904|recurrent gastric cancer|recurrent gastric cancer
761691|NCT00397904|adenocarcinoma of the stomach|adenocarcinoma of the stomach
761692|NCT00397904|stage IV esophageal cancer|stage iv esophageal cancer
761693|NCT00397904|stage IV gastric cancer|stage iv gastric cancer
761694|NCT00397865|Obesity|obesity
761695|NCT00397865|Overweight|overweight
761696|NCT00397852|Fracture|fracture
761697|NCT00397852|Forearm|forearm
761698|NCT00397852|Distal|distal
761699|NCT00397852|Child|child
761700|NCT00397852|Treatment|treatment
761701|NCT00397839|male osteoporosis|male osteoporosis
761702|NCT00397839|osteoporosis|osteoporosis
761703|NCT00397839|bisphonates|bisphonates
761704|NCT00397839|bone|bone
761705|NCT00397800|recurrent grade 1 follicular lymphoma|recurrent grade 1 follicular lymphoma
761706|NCT00397800|recurrent grade 2 follicular lymphoma|recurrent grade 2 follicular lymphoma
761707|NCT00397800|Waldenstrom macroglobulinemia|waldenstrom macroglobulinemia
761708|NCT00397800|recurrent mantle cell lymphoma|recurrent mantle cell lymphoma
761709|NCT00397800|recurrent marginal zone lymphoma|recurrent marginal zone lymphoma
761710|NCT00397800|extranodal marginal zone B-cell lymphoma of mucosa-associated lymphoid tissue|extranodal marginal zone b-cell lymphoma of mucosa-associated lymphoid tissue
761711|NCT00397800|nodal marginal zone B-cell lymphoma|nodal marginal zone b-cell lymphoma
761712|NCT00397800|splenic marginal zone lymphoma|splenic marginal zone lymphoma
761713|NCT00397774|Palliative care|palliative care
761714|NCT00397774|Physical exercise|physical exercise
761715|NCT00397774|Physical function|physical function
761716|NCT00397761|inflammatory breast cancer|inflammatory breast cancer
761717|NCT00397761|stage II breast cancer|stage ii breast cancer
761718|NCT00397761|stage IIIA breast cancer|stage iiia breast cancer
761719|NCT00397761|stage IIIB breast cancer|stage iiib breast cancer
761720|NCT00397748|Phospholipase A2|phospholipase a2
761721|NCT00397748|D2 Receptors|d2 receptors
761722|NCT00397748|Apomorphine|apomorphine
761723|NCT00397748|Trimethobenzamide|trimethobenzamide
761724|NCT00397748|Attention Deficit Hyperactivity Disorder|attention deficit hyperactivity disorder
761725|NCT00397748|ADHD|adhd
761726|NCT00397748|Healthy Volunteer|healthy volunteer
761727|NCT00397748|HV|hv
761728|NCT00397735|pregnancy|pregnancy
761729|NCT00397735|chorioamnionitis|chorioamnionitis
761730|NCT00397735|preterm labor|preterm labor
761731|NCT00397735|preterm premature rupture of the membranes|preterm premature rupture of the membranes
761732|NCT00397735|Intra-amniotic infection|intra-amniotic infection
761733|NCT00397735|Intra-amniotic inflammation|intra-amniotic inflammation
761734|NCT00397722|safety|safety
761735|NCT00397722|outpatients with a diagnosis of Social Anxiety disorder (SocAD).|outpatients with a diagnosis of social anxiety disorder (socad).
761736|NCT00397722|effectiveness|effectiveness
761737|NCT00397709|Latent tuberculosis infection.|latent tuberculosis infection.
761738|NCT00397709|Isoniazid.|isoniazid.
761739|NCT00397709|Rifampin.|rifampin.
761740|NCT00397709|Clinical trial.|clinical trial.
761741|NCT00397709|treatment of latent tuberculosis infection|treatment of latent tuberculosis infection
761742|NCT00397696|Parkinson|parkinson
761743|NCT00397696|imaging|imaging
761744|NCT00397696|nicotinic receptors|nicotinic receptors
761745|NCT00397657|carotid intima media thickness|carotid intima media thickness
761746|NCT00397657|atherosclerosis|atherosclerosis
761747|NCT00397657|niacin|niacin
761748|NCT00397657|coronary heart disease|coronary heart disease
761749|NCT00397657|HDL-C|hdl-c
761750|NCT00397657|LDL-C|ldl-c
761751|NCT00397644|pediatrician|pediatrician
761752|NCT00397644|well-child care visit|well-child care visit
761753|NCT00397644|low-income children|low-income children
761754|NCT00397644|family psychosocial problem|family psychosocial problem
761755|NCT00397605|bipolar|bipolar
761756|NCT00397605|therapeutic potential|therapeutic potential
761757|NCT00397605|neurocognitive performance|neurocognitive performance
761758|NCT00397605|cannabinoids|cannabinoids
761759|NCT00397592|Growth Hormone|growth hormone
761760|NCT00397592|Cardiovascular System|cardiovascular system
761761|NCT00397592|Endothelial Progenitor Cells|endothelial progenitor cells
761762|NCT00397579|adult acute myeloid leukemia with 11q23 (MLL) abnormalities|adult acute myeloid leukemia with 11q23 (mll) abnormalities
761763|NCT00397579|adult acute myeloid leukemia with inv(16)(p13;q22)|adult acute myeloid leukemia with inv(16)(p13;q22)
761764|NCT00397579|adult acute myeloid leukemia with t(15;17)(q22;q12)|adult acute myeloid leukemia with t(15;17)(q22;q12)
761765|NCT00397579|adult acute myeloid leukemia with t(16;16)(p13;q22)|adult acute myeloid leukemia with t(16;16)(p13;q22)
761766|NCT00397579|adult acute myeloid leukemia with t(8;21)(q22;q22)|adult acute myeloid leukemia with t(8;21)(q22;q22)
761767|NCT00397579|recurrent adult acute myeloid leukemia|recurrent adult acute myeloid leukemia
761768|NCT00397579|secondary acute myeloid leukemia|secondary acute myeloid leukemia
761769|NCT00397579|untreated adult acute myeloid leukemia|untreated adult acute myeloid leukemia
761770|NCT00397579|de novo myelodysplastic syndromes|de novo myelodysplastic syndromes
761771|NCT00397579|previously treated myelodysplastic syndromes|previously treated myelodysplastic syndromes
761772|NCT00397579|secondary myelodysplastic syndromes|secondary myelodysplastic syndromes
761773|NCT00397579|blastic plasmacytoid dendritic cell neoplasm|blastic plasmacytoid dendritic cell neoplasm
761774|NCT00397579|plasmacytoid dendritic cell leukemia|plasmacytoid dendritic cell leukemia
761775|NCT00397579|CD123+|cd123+
761777|NCT00397566|Treatment Experienced|treatment experienced
761778|NCT00397540|HBV DNA|hbv dna
761779|NCT00397540|HCC|hcc
761780|NCT00397540|recurrence|recurrence
761781|NCT00397540|PEIT|peit
761782|NCT00397540|RFTA|rfta
761783|NCT00397514|Biventricular pacing|biventricular pacing
761784|NCT00397514|Congenital heart disease|congenital heart disease
761785|NCT00397514|Tissue Doppler echocardiography|tissue doppler echocardiography
761786|NCT00397501|cognitive/functional effects|cognitive/functional effects
761787|NCT00397501|psychosocial effects of cancer and its treatment|psychosocial effects of cancer and its treatment
761788|NCT00397501|drug/agent toxicity by tissue/organ|drug/agent toxicity by tissue/organ
761789|NCT00397501|recurrent breast cancer|recurrent breast cancer
761790|NCT00397501|stage IV breast cancer|stage iv breast cancer
761791|NCT00397501|adult tumors metastatic to brain|adult tumors metastatic to brain
761792|NCT00397488|recurrent bladder cancer|recurrent bladder cancer
761793|NCT00397488|stage IV bladder cancer|stage iv bladder cancer
761794|NCT00397488|transitional cell carcinoma of the bladder|transitional cell carcinoma of the bladder
761795|NCT00397488|anterior urethral cancer|anterior urethral cancer
761796|NCT00397488|posterior urethral cancer|posterior urethral cancer
761797|NCT00397488|recurrent urethral cancer|recurrent urethral cancer
761798|NCT00397488|metastatic transitional cell cancer of the renal pelvis and ureter|metastatic transitional cell cancer of the renal pelvis and ureter
761799|NCT00397488|recurrent transitional cell cancer of the renal pelvis and ureter|recurrent transitional cell cancer of the renal pelvis and ureter
761800|NCT00397488|urethral cancer associated with invasive bladder cancer|urethral cancer associated with invasive bladder cancer
761801|NCT00397462|Osteoporosis|osteoporosis
761802|NCT00397462|Sarcopenia|sarcopenia
761803|NCT00397462|Calf muscle pump|calf muscle pump
761804|NCT00397462|Venous insufficiency|venous insufficiency
761805|NCT00397462|DEXA|dexa
761806|NCT00397462|Soleus muscle|soleus muscle
761807|NCT00397462|APG|apg
761808|NCT00397449|Malaria, malaria vaccine, randomised, safety, immunogenicity|malaria, malaria vaccine, randomised, safety, immunogenicity
761809|NCT00397423|Amyotrophic Lateral Sclerosis|amyotrophic lateral sclerosis
761810|NCT00397423|Granulocyte Colony Stimulating Factor|granulocyte colony stimulating factor
761811|NCT00397423|Randomized Control Trial Study|randomized control trial study
761812|NCT00397410|hip protectors|hip protectors
761813|NCT00397410|uptake and adherence|uptake and adherence
761814|NCT00397410|Nursing home residents|nursing home residents
761815|NCT00397410|efficacy|efficacy
761816|NCT00397410|prevention|prevention
761817|NCT00397397|Urinary Calculi|urinary calculi
761818|NCT00397397|Rowatinex|rowatinex
761819|NCT00397397|Alfuzosin|alfuzosin
761820|NCT00397397|Drug Therapy|drug therapy
761821|NCT00397358|Peritoneal Dialysis|peritoneal dialysis
761822|NCT00397358|Hypertriglyceridemia|hypertriglyceridemia
761823|NCT00397358|Extraneal(7.5% icodextrin)Peritoneal Dialysis Solution|extraneal(7.5% icodextrin)peritoneal dialysis solution
761824|NCT00397345|Renal|renal
761825|NCT00397345|TroVax|trovax
761826|NCT00397345|survival|survival
761827|NCT00397345|metastatic|metastatic
761828|NCT00397345|Kidney|kidney
761829|NCT00397345|cancer|cancer
761830|NCT00397345|immunotherapy|immunotherapy
761831|NCT00397345|Locally advanced or metastatic, measurable, histologically proven clear cell renal carcinoma.|locally advanced or metastatic, measurable, histologically proven clear cell renal carcinoma.
761832|NCT00397332|GVHD|gvhd
761833|NCT00397319|Growth Hormone|growth hormone
761834|NCT00397319|Cardiovascular System|cardiovascular system
761835|NCT00397293|AT101|at101
761836|NCT00397293|AT-101|at-101
761837|NCT00397293|cancer|cancer
761838|NCT00397293|lung|lung
761839|NCT00397293|small-cell|small-cell
761840|NCT00397293|topotecan|topotecan
761841|NCT00397280|Inflammatory Response|inflammatory response
761842|NCT00397280|Lipopolysaccharide|lipopolysaccharide
761843|NCT00397280|Healthy Volunteer|healthy volunteer
761844|NCT00397280|HV|hv
761845|NCT00397267|Dyspnea|dyspnea
761846|NCT00397267|Cough|cough
761847|NCT00397254|Migraine|migraine
761848|NCT00397254|rizatriptan|rizatriptan
761849|NCT00397228|Parkinson|parkinson
761850|NCT00397228|imaging|imaging
761851|NCT00397228|dopamine transporter|dopamine transporter
761855|NCT00397202|Menstruation|menstruation
761856|NCT00397189|Primary insomnia as defined by DSM IV criteria|primary insomnia as defined by dsm iv criteria
761857|NCT00397163|Coronary artery bypass graft surgery|coronary artery bypass graft surgery
761858|NCT00397163|Remote ischemic preconditioning|remote ischemic preconditioning
761859|NCT00397163|Troponin-T|troponin-t
761860|NCT00397150|Infant Nutrition [G06.696.259.750]|infant nutrition [g06.696.259.750]
761861|NCT00397150|Infant Care [N02.421.088.120] +|infant care [n02.421.088.120] +
761862|NCT00397150|Diarrhea, Infantile [C23.888.821.214.500]|diarrhea, infantile [c23.888.821.214.500]
761863|NCT00397150|Child Health Services [N02.421.143.130] +|child health services [n02.421.143.130] +
761864|NCT00397150|Counseling [N02.421.143.303]|counseling [n02.421.143.303]
761865|NCT00397150|Growth [G07.574.249] +|growth [g07.574.249] +
761866|NCT00397150|Micronutrients [D11.430]|micronutrients [d11.430]
761867|NCT00397150|Breast Feeding [G06.696.259.750.500]|breast feeding [g06.696.259.750.500]
761868|NCT00397137|Symptomatic haemorrhoids|symptomatic haemorrhoids
761869|NCT00397137|haemorrhoidectomy|haemorrhoidectomy
761870|NCT00397137|stapled anopexy|stapled anopexy
761871|NCT00397111|Morphometry|morphometry
761872|NCT00397111|BOLD|bold
761873|NCT00397111|fMRI|fmri
761874|NCT00397111|Spectrometry|spectrometry
761875|NCT00397111|Relaxometry|relaxometry
761876|NCT00397111|Healthy Volunteer|healthy volunteer
761877|NCT00397111|HV|hv
761878|NCT00397098|Anxiety disorders, Relapse prevention|anxiety disorders, relapse prevention
761879|NCT00397072|Glioblastoma recurrent,temozolomide, epothilone|glioblastoma recurrent,temozolomide, epothilone
761880|NCT00397059|Escitalopram|escitalopram
761881|NCT00397059|Pharmacokinetics|pharmacokinetics
761882|NCT00397059|Pharmacodynamics|pharmacodynamics
761883|NCT00397059|CYP2C19|cyp2c19
761884|NCT00397059|Pupillometry|pupillometry
761885|NCT00397059|healthy volunteers|healthy volunteers
761886|NCT00397046|Advanced Malignant Solid Tumors|advanced malignant solid tumors
761887|NCT00397046|HKI-272|hki-272
761888|NCT00397046|Neratinib|neratinib
761889|NCT00397046|Nerlynx|nerlynx
761890|NCT00397033|Schizoaffective Disorder|schizoaffective disorder
761891|NCT00397033|antipsychotic|antipsychotic
761892|NCT00397033|paliperidone|paliperidone
761893|NCT00397033|placebo|placebo
761894|NCT00397020|quetiapine|quetiapine
761895|NCT00397020|divalproex|divalproex
761896|NCT00397007|tinnitus|tinnitus
761897|NCT00397007|biofeedback|biofeedback
761898|NCT00397007|psychophysiological reactivity|psychophysiological reactivity
761899|NCT00397007|intervention|intervention
761900|NCT00396994|biomechanics|biomechanics
761901|NCT00396994|osteogenesis|osteogenesis
761902|NCT00396994|osteoporosis|osteoporosis
761903|NCT00396994|bone regeneration|bone regeneration
761904|NCT00396981|Intracranial saccular aneurysms|intracranial saccular aneurysms
761905|NCT00396981|Endovascular coiling therapy|endovascular coiling therapy
761906|NCT00396981|Retreatment|retreatment
761907|NCT00396981|Raymond scale|raymond scale
761908|NCT00396981|Matrix|matrix
761909|NCT00396981|GDC|gdc
761910|NCT00396981|Guglielmi Detachable Coil|guglielmi detachable coil
761911|NCT00396968|AMD3100|amd3100
761912|NCT00396968|Acute Myelogenous Leukemai|acute myelogenous leukemai
761913|NCT00396968|Myelodysplastic Syndromes|myelodysplastic syndromes
762113|NCT00396240|hypercholesterolaemia|hypercholesterolaemia
761914|NCT00396968|Allogeneic stem cell transplantation|allogeneic stem cell transplantation
761915|NCT00396955|osteoarthritis|osteoarthritis
761916|NCT00396955|arthritis|arthritis
761917|NCT00396955|pain|pain
761918|NCT00396942|Electroencephalogram (EEG)|electroencephalogram (eeg)
761919|NCT00396942|Nerve Conduction Study|nerve conduction study
761920|NCT00396942|Transcranial Magnetic Stimulation (TMS)|transcranial magnetic stimulation (tms)
761921|NCT00396942|Motor Evoked Potential|motor evoked potential
761922|NCT00396942|Parkinson Disease|parkinson disease
761923|NCT00396942|PD|pd
761924|NCT00396942|Healthy Volunteer|healthy volunteer
761925|NCT00396942|HV|hv
761926|NCT00396929|Paclitaxel|paclitaxel
761927|NCT00396929|Restenosis|restenosis
761928|NCT00396929|Stent|stent
761929|NCT00396929|Intracoronary Dosis|intracoronary dosis
761930|NCT00396929|Paclitaxel-eluting Stent|paclitaxel-eluting stent
761931|NCT00396916|cancer patients|cancer patients
761932|NCT00396903|Anaesthetic techniques|anaesthetic techniques
761933|NCT00396903|epidural catheters|epidural catheters
761934|NCT00396903|paraesthesia|paraesthesia
761935|NCT00396903|side effects.|side effects.
761936|NCT00396890|Theta Burst Stimulation|theta burst stimulation
761937|NCT00396890|Repetitive TMS (rTMS)|repetitive tms (rtms)
761938|NCT00396890|Transcranial Magnetic Stimulation (TMS)|transcranial magnetic stimulation (tms)
761939|NCT00396890|Primary Motor Cortex|primary motor cortex
761940|NCT00396890|Interhemispheric Disinhibition|interhemispheric disinhibition
761941|NCT00396890|Healthy Volunteer|healthy volunteer
761942|NCT00396890|HV|hv
761943|NCT00396877|cyanotic congenital heart disease|cyanotic congenital heart disease
761944|NCT00396877|shunt palliation|shunt palliation
761945|NCT00396877|thrombosis|thrombosis
761946|NCT00396877|clopidogrel|clopidogrel
761947|NCT00396864|cutaneous lymphoma|cutaneous lymphoma
761948|NCT00396864|marginal zone lymphoma|marginal zone lymphoma
761950|NCT00396825|Alzheimer's Disease|alzheimer's disease
761951|NCT00396825|Stress management|stress management
761952|NCT00396812|Autoimmune disease|autoimmune disease
761953|NCT00396812|Biologic response modifiers|biologic response modifiers
761954|NCT00396812|Disease-modifying antirheumatic drugs (DMARDS)|disease-modifying antirheumatic drugs (dmards)
761955|NCT00396812|Immune system|immune system
761956|NCT00396812|Rheumatoid arthritis (RA)|rheumatoid arthritis (ra)
761957|NCT00396812|Rituximab (anti-CD20 monoclonal antibodies)|rituximab (anti-cd20 monoclonal antibodies)
761958|NCT00396786|Prevention of venous thromboembolism|prevention of venous thromboembolism
761959|NCT00396773|electrocoagulation,pregnancy,brian waves|electrocoagulation,pregnancy,brian waves
761960|NCT00396760|cardiac surgery|cardiac surgery
761961|NCT00396760|blood transfusion|blood transfusion
761962|NCT00396760|antifibrinolytics|antifibrinolytics
761963|NCT00396760|aprotinin|aprotinin
761964|NCT00396760|tranexamic acid|tranexamic acid
761965|NCT00396747|Early rheumatoid arthritis,|early rheumatoid arthritis,
761966|NCT00396747|glucocorticoids,|glucocorticoids,
761967|NCT00396747|pulse therapy,|pulse therapy,
761968|NCT00396747|infliximab,|infliximab,
761969|NCT00396747|TNF blockade|tnf blockade
761970|NCT00396734|Imaging|imaging
761971|NCT00396734|cocaine|cocaine
761972|NCT00396734|methadone|methadone
761973|NCT00396734|craving|craving
761974|NCT00396734|PET|pet
761975|NCT00396734|FDG|fdg
761976|NCT00396734|D2|d2
761977|NCT00396734|Modafinil|modafinil
761978|NCT00396734|Topiramate|topiramate
761979|NCT00396721|Nephropathy, IGA|nephropathy, iga
761980|NCT00396721|Pilot trial|pilot trial
761981|NCT00396721|Sirolimus|sirolimus
761982|NCT00396721|Rapamune|rapamune
761983|NCT00396708|Robotics|robotics
761984|NCT00396708|Rehabilitation|rehabilitation
761985|NCT00396708|Arm|arm
761986|NCT00396708|Stroke|stroke
761987|NCT00396708|Weakness|weakness
761988|NCT00396708|Outpatient|outpatient
761989|NCT00396708|Chronic|chronic
761990|NCT00396695|PTSD, traumatic memory|ptsd, traumatic memory
761991|NCT00396682|HCC|hcc
761992|NCT00396682|T cell|t cell
761993|NCT00396669|Nicotine|nicotine
761994|NCT00396669|Dopamine|dopamine
761995|NCT00396669|Imaging|imaging
761996|NCT00396669|Raclopride|raclopride
761997|NCT00396669|Addiction|addiction
761998|NCT00396669|Genetics|genetics
761999|NCT00396656|hypertension|hypertension
762000|NCT00396656|valsartan|valsartan
762001|NCT00396656|atenolol|atenolol
762002|NCT00396656|hydrochlorothiazide|hydrochlorothiazide
762003|NCT00396656|microcirculation|microcirculation
762004|NCT00396656|arterial compliance|arterial compliance
762005|NCT00396656|pulse wave analysis|pulse wave analysis
762006|NCT00396643|Ultra-High Risk|ultra-high risk
762007|NCT00396643|Psychosis|psychosis
762008|NCT00396643|Schizophrenia|schizophrenia
762009|NCT00396643|Omega-3 fatty acids|omega-3 fatty acids
762010|NCT00396643|RCT|rct
762011|NCT00396630|Transmission|transmission
762012|NCT00396630|Gastroenteritis|gastroenteritis
762013|NCT00396630|Shedding|shedding
762014|NCT00396630|rotavirus|rotavirus
762015|NCT00396630|HRV vaccine|hrv vaccine
762016|NCT00396617|Laryngeal or pharyngo-laryngeal's carcinoma,|laryngeal or pharyngo-laryngeal's carcinoma,
762017|NCT00396617|voice prosthesis tracheooesophageal shunt,|voice prosthesis tracheooesophageal shunt,
762018|NCT00396617|titanium beads,|titanium beads,
762019|NCT00396617|cellular colonization|cellular colonization
762020|NCT00396617|Laryngeal or pharyngo-laryngeal's carcinoma|laryngeal or pharyngo-laryngeal's carcinoma
762021|NCT00396604|indacaterol|indacaterol
762022|NCT00396604|long acting beta agonist|long acting beta agonist
762023|NCT00396591|Ovarian cancer|ovarian cancer
762024|NCT00396591|malignant ascites|malignant ascites
762025|NCT00396591|angiogenesis|angiogenesis
762026|NCT00396591|angiogenesis inhibition|angiogenesis inhibition
762027|NCT00396591|VEGF-Trap fusion recombinant protein|vegf-trap fusion recombinant protein
762028|NCT00396578|aerosolized antibiotics|aerosolized antibiotics
762029|NCT00396578|ventilator associated pneumonia|ventilator associated pneumonia
762030|NCT00396578|clinical pulmonary infection score|clinical pulmonary infection score
762031|NCT00396578|bacterial resistance|bacterial resistance
762032|NCT00396565|Schizophrenia|schizophrenia
762033|NCT00396565|JNS007ER|jns007er
762034|NCT00396565|Positive and Negative Syndrome Scale (PANSS)|positive and negative syndrome scale (panss)
762035|NCT00396565|Paliperidone|paliperidone
762036|NCT00396565|Extended Release Osmotic Controlled-Release Oral Delivery System (OROS) paliperidone|extended release osmotic controlled-release oral delivery system (oros) paliperidone
762037|NCT00396552|refractory transcranial magnetic stimulation|refractory transcranial magnetic stimulation
762038|NCT00396552|obsessive compulsive disorder|obsessive compulsive disorder
762039|NCT00396552|randomized|randomized
762040|NCT00396552|placebo-controlled|placebo-controlled
762041|NCT00396552|double-blind|double-blind
762042|NCT00396526|Nonsevere pneumonia|nonsevere pneumonia
762043|NCT00396526|treatment|treatment
762044|NCT00396526|underfives|underfives
762045|NCT00396526|children|children
762046|NCT00396526|Community|community
762048|NCT00396513|PCOS|pcos
762049|NCT00396513|Statin|statin
762051|NCT00396513|Testosterone|testosterone
762052|NCT00396513|Menstrual cycle|menstrual cycle
762053|NCT00396513|Lipids|lipids
762054|NCT00396500|Deworming|deworming
762055|NCT00396500|Malnutrition|malnutrition
762056|NCT00396500|children|children
762057|NCT00396500|Community|community
762058|NCT00396500|India|india
762059|NCT00396487|Metastatic colorectal cancer|metastatic colorectal cancer
762060|NCT00396487|tailored treatment|tailored treatment
762061|NCT00396487|genetic markers|genetic markers
762062|NCT00396487|gene polymorphism|gene polymorphism
762063|NCT00396487|chemotherapy|chemotherapy
762064|NCT00396474|Small for gestational age, Insulin Sensitivity Index, growth hormone treatment|small for gestational age, insulin sensitivity index, growth hormone treatment
762065|NCT00396461|Critical Illness|critical illness
762066|NCT00396461|Fat Emulsions, Intravenous|fat emulsions, intravenous
762067|NCT00396461|Superinfection|superinfection
762068|NCT00396461|Parenteral Nutrition|parenteral nutrition
762069|NCT00396435|anaemia|anaemia
762070|NCT00396435|renal transplantation|renal transplantation
762071|NCT00396435|kidney failure|kidney failure
762072|NCT00396422|psoriasis|psoriasis
762073|NCT00396422|skin|skin
762074|NCT00396422|auto immune|auto immune
762075|NCT00396396|Creatinine clearance|creatinine clearance
762076|NCT00396396|Acetylcysteine|acetylcysteine
762077|NCT00396383|Multiple Myeloma|multiple myeloma
762078|NCT00396383|Stem cell mobilization|stem cell mobilization
762079|NCT00396383|apheresis|apheresis
762080|NCT00396370|Bacillus Calmette-Guérin|bacillus calmette-guérin
762081|NCT00396370|parent protocol|parent protocol
762082|NCT00396370|tuberculosis|tuberculosis
762083|NCT00396357|Type 2 diabetes|type 2 diabetes
762084|NCT00396357|vildagliptin|vildagliptin
762085|NCT00396357|hemoglobin A1c|hemoglobin a1c
762086|NCT00396357|metformin|metformin
762087|NCT00396344|Systemic sepsis|systemic sepsis
762088|NCT00396331|Multiple Myeloma|multiple myeloma
762089|NCT00396331|Non-Hodgkin's Lymphoma|non-hodgkin's lymphoma
762090|NCT00396331|autologous transplantation|autologous transplantation
762091|NCT00396331|AMD3100|amd3100
762092|NCT00396331|stem cell mobilization|stem cell mobilization
762093|NCT00396331|plerixafor|plerixafor
762094|NCT00396318|TNKase|tnkase
762095|NCT00396318|CVA|cva
762096|NCT00396318|CVAD|cvad
762097|NCT00396318|Central venous access catheter|central venous access catheter
762098|NCT00396305|Influenza, vaccine, efficacy, elderly|influenza, vaccine, efficacy, elderly
762099|NCT00396292|Anemia|anemia
762100|NCT00396292|postpartum|postpartum
762101|NCT00396292|Postpartum anemia|postpartum anemia
762102|NCT00396279|Giant Cell Tumor of Bone|giant cell tumor of bone
762103|NCT00396266|Non-Hodgkin's Lymphoma|non-hodgkin's lymphoma
762104|NCT00396266|Multiple Myeloma|multiple myeloma
762105|NCT00396266|stem cell mobilization|stem cell mobilization
762106|NCT00396266|AMD3100|amd3100
762107|NCT00396266|autologous transplantation|autologous transplantation
762108|NCT00396253|HD|hd
762109|NCT00396253|TNKase|tnkase
762110|NCT00396253|Hemodialysis|hemodialysis
762111|NCT00396253|Catheter clearance|catheter clearance
762112|NCT00396240|rosuvastatin|rosuvastatin
762114|NCT00396240|cholesterol|cholesterol
762115|NCT00396240|LDL-C|ldl-c
762116|NCT00396240|triglyceride|triglyceride
762117|NCT00396240|plasma lipids|plasma lipids
762118|NCT00396240|compliance|compliance
762119|NCT00396227|Type 2 diabetes|type 2 diabetes
762120|NCT00396227|vildagliptin|vildagliptin
762121|NCT00396227|hemoglobin A1c|hemoglobin a1c
762122|NCT00396227|metformin|metformin
762123|NCT00396214|Schizophrenia|schizophrenia
762124|NCT00396214|weight changes|weight changes
762125|NCT00396201|Hodgkin's Disease|hodgkin's disease
762126|NCT00396201|Stem cell mobilization|stem cell mobilization
762127|NCT00396201|apheresis|apheresis
762128|NCT00396188|Keratoconus|keratoconus
762129|NCT00396188|LASIK|lasik
762130|NCT00396188|Orthokeratology|orthokeratology
762131|NCT00396188|Pellucid Marginal Degeneration|pellucid marginal degeneration
762132|NCT00396188|Refractive Surgery|refractive surgery
762133|NCT00396188|normal cornea|normal cornea
762134|NCT00396188|post myopic LASIK|post myopic lasik
762135|NCT00396188|post hyperopic LASIK|post hyperopic lasik
762136|NCT00396188|corneal pathologies (e.g. pellucid marginal degeneration)|corneal pathologies (e.g. pellucid marginal degeneration)
762137|NCT00396149|rBet v 1|rbet v 1
762138|NCT00396149|Birch pollen allergy|birch pollen allergy
762139|NCT00396149|Sublingual Immunotherapy|sublingual immunotherapy
762140|NCT00396136|Congestive Heart Failure|congestive heart failure
762141|NCT00396136|Cardiac Resynchronization Therapy|cardiac resynchronization therapy
762142|NCT00396136|Left Ventricular Lead|left ventricular lead
762143|NCT00396123|Chronic Kidney Disease|chronic kidney disease
762144|NCT00396123|Anemia|anemia
762145|NCT00396110|cholesterol|cholesterol
762146|NCT00396110|coronary heart disease|coronary heart disease
762147|NCT00396110|rosuvastatin|rosuvastatin
762148|NCT00396110|LDL-C goal|ldl-c goal
762149|NCT00396110|hypercholesterolemia|hypercholesterolemia
762150|NCT00396097|ISS|iss
762151|NCT00396097|human growth hormone|human growth hormone
762152|NCT00396084|Brazil|brazil
762153|NCT00396084|gatifloxacin|gatifloxacin
762154|NCT00396084|isoniazid|isoniazid
762155|NCT00396084|levofloxacin|levofloxacin
762156|NCT00396084|linezolid|linezolid
762157|NCT00396084|moxifloxacin|moxifloxacin
762158|NCT00396084|tuberculosis|tuberculosis
762159|NCT00396071|Type 2 diabetes|type 2 diabetes
762160|NCT00396071|vildagliptin|vildagliptin
762161|NCT00396071|incretin effect|incretin effect
762162|NCT00396071|metformin|metformin
762163|NCT00396045|Multiple Myeloma, Lenalidomide, elderly patients|multiple myeloma, lenalidomide, elderly patients
762164|NCT00396032|HD|hd
762165|NCT00396032|Hemodialysis|hemodialysis
762166|NCT00396032|Catheter clearance|catheter clearance
762167|NCT00396032|TNKase|tnkase
762168|NCT00396032|Renal Insufficiency|renal insufficiency
762169|NCT00395993|anemia|anemia
762170|NCT00395993|heavy uterine bleeding|heavy uterine bleeding
762171|NCT00395993|menorrhagia|menorrhagia
762172|NCT00395993|Anemia secondary to heavy uterine bleeding|anemia secondary to heavy uterine bleeding
762173|NCT00395967|Non-Hodgkin's Lymphoma|non-hodgkin's lymphoma
762174|NCT00395967|Multiple Myeloma|multiple myeloma
762175|NCT00395967|stem cell mobilization|stem cell mobilization
762176|NCT00395967|autologous transplantation|autologous transplantation
762177|NCT00395967|AMD3100|amd3100
762178|NCT00395954|Lactose Intolerance|lactose intolerance
762179|NCT00395954|Lactose|lactose
762180|NCT00395954|Threshold|threshold
762181|NCT00395928|heart|heart
762182|NCT00395928|echocardiography|echocardiography
762183|NCT00395928|diastolic function|diastolic function
762184|NCT00395928|left ventricle|left ventricle
762185|NCT00395928|right ventricle|right ventricle
762186|NCT00395928|cigarette smoking|cigarette smoking
762187|NCT00395928|Smoking|smoking
762188|NCT00395928|Heart Ventricles|heart ventricles
762189|NCT00395928|Diastole|diastole
762190|NCT00395928|Doppler Echocardiography|doppler echocardiography
762191|NCT00395915|schizophrenia|schizophrenia
762192|NCT00395915|antipsychotics|antipsychotics
762193|NCT00395915|treatment non response|treatment non response
762194|NCT00395915|pragmatic trial|pragmatic trial
762195|NCT00395902|Sensipar|sensipar
762196|NCT00395902|cinacalcet|cinacalcet
762197|NCT00395902|Mimpara|mimpara
762198|NCT00395889|Lung Transplantation|lung transplantation
762199|NCT00395889|Physical Activities in Daily Life|physical activities in daily life
762200|NCT00395889|Pulmonary Rehabilitation|pulmonary rehabilitation
762201|NCT00395889|Functional Status|functional status
762202|NCT00395876|TNKase|tnkase
762203|NCT00395876|CVA|cva
762204|NCT00395876|CVAD|cvad
762205|NCT00395876|Central venous access catheter|central venous access catheter
762206|NCT00395876|CVA catheter|cva catheter
762207|NCT00395850|cocaine dependence|cocaine dependence
762208|NCT00395850|disulfiram|disulfiram
762209|NCT00395850|clinical trial|clinical trial
762210|NCT00395850|methadone maintenance|methadone maintenance
762211|NCT00395850|pharmacogenetics|pharmacogenetics
762212|NCT00395850|dopamine beta-hydroxylase|dopamine beta-hydroxylase
762213|NCT00395837|Aging|aging
762214|NCT00395837|Wellness|wellness
762215|NCT00395837|Aerobic exercise|aerobic exercise
762216|NCT00395837|Prevention|prevention
762217|NCT00395824|citrate|citrate
762218|NCT00395824|anticoagulation|anticoagulation
762219|NCT00395824|heparin-coated membrane|heparin-coated membrane
762220|NCT00395811|Myocardial Infarction|myocardial infarction
762221|NCT00395811|stem cell therapy|stem cell therapy
762222|NCT00395811|Coronary Artery Bypass Grafting|coronary artery bypass grafting
762223|NCT00395798|cervical intervertebral disc displacement|cervical intervertebral disc displacement
762224|NCT00395798|cervical spondylosis|cervical spondylosis
762225|NCT00395798|radiculopathy|radiculopathy
762226|NCT00395798|neck collar|neck collar
762227|NCT00395798|brace|brace
762228|NCT00395798|physiotherapy|physiotherapy
762229|NCT00395798|treatment|treatment
762230|NCT00395798|rehabilitation|rehabilitation
762231|NCT00395785|Carotid stenosis|carotid stenosis
762232|NCT00395785|Intracranial Embolism|intracranial embolism
762233|NCT00395785|Carotid artery|carotid artery
762234|NCT00395785|Carotid stent|carotid stent
762235|NCT00395785|Embolic protection|embolic protection
762236|NCT00395785|TriActiv ProGuard System|triactiv proguard system
762237|NCT00395785|Carotid angioplasty|carotid angioplasty
762238|NCT00395772|Treatment of venous thromboembolism|treatment of venous thromboembolism
762239|NCT00395759|contrast sensitivity|contrast sensitivity
762240|NCT00395733|Gadovist|gadovist
762241|NCT00395733|Gadavist|gadavist
762242|NCT00395733|MRI Imaging|mri imaging
762243|NCT00395733|vascular diseases|vascular diseases
762244|NCT00395733|Chinese|chinese
762245|NCT00395720|TB|tb
762246|NCT00395720|Tuberculosis|tuberculosis
762247|NCT00395720|HIV|hiv
762248|NCT00395720|Vaccine|vaccine
762249|NCT00395720|MVA85A|mva85a
762250|NCT00395720|HIV Therapeutic Vaccine|hiv therapeutic vaccine
762251|NCT00395707|Macular Degeneration|macular degeneration
762252|NCT00395707|Age Related Macular Degeneration|age related macular degeneration
762253|NCT00395707|Retinal Angiomatous Proliferations|retinal angiomatous proliferations
762254|NCT00395694|epilepsy|epilepsy
762255|NCT00395694|Incidence of rash|incidence of rash
762256|NCT00395694|safety evaluation for initial dose|safety evaluation for initial dose
762257|NCT00395694|patients with Valproic acid|patients with valproic acid
762258|NCT00395681|Obesity|obesity
762259|NCT00395681|Propofol|propofol
762260|NCT00395681|Morbidly obese|morbidly obese
762261|NCT00395681|BMI|bmi
762262|NCT00395668|TETRA|tetra
762263|NCT00395668|EMF|emf
762264|NCT00395668|Human exposure study|human exposure study
762265|NCT00395668|Symptoms|symptoms
762266|NCT00395668|Well-being|well-being
762267|NCT00395668|Cognitive function|cognitive function
762268|NCT00395655|locally advanced breast cancer|locally advanced breast cancer
762269|NCT00395655|hydralazine|hydralazine
762270|NCT00395655|magnesium valproate|magnesium valproate
762271|NCT00395655|epigenetic therapy|epigenetic therapy
762272|NCT00395655|gene expression|gene expression
762273|NCT00395642|Congestive Heart Failure|congestive heart failure
762274|NCT00395642|Cardiac Resynchronization Therapy|cardiac resynchronization therapy
762275|NCT00395642|Home Monitoring|home monitoring
762276|NCT00395642|Telemonitoring|telemonitoring
762277|NCT00395642|Remote Monitoring|remote monitoring
762278|NCT00395629|Deferasirox|deferasirox
762279|NCT00395629|ICL670A|icl670a
762280|NCT00395629|Iron chelators|iron chelators
762281|NCT00395629|Deferiprone|deferiprone
762282|NCT00395629|Transfusional Hemochromatosis|transfusional hemochromatosis
762283|NCT00395590|OSA inflammatory cytokines, metabolic syndrome|osa inflammatory cytokines, metabolic syndrome
762284|NCT00395564|Urologic Surgery|urologic surgery
762285|NCT00395551|choroidal neovascularization|choroidal neovascularization
762286|NCT00395551|Choroidal Neovascularization Not related to Age-Related Macular Degeneration|choroidal neovascularization not related to age-related macular degeneration
762287|NCT00395538|Parathyroid|parathyroid
762288|NCT00395538|Bone Biopsy|bone biopsy
762289|NCT00395538|Calcium-Sensing Receptor|calcium-sensing receptor
762290|NCT00395538|Bone Density|bone density
762291|NCT00395538|Bone Turnover|bone turnover
762292|NCT00395538|Hypoparathyroidism|hypoparathyroidism
762293|NCT00395512|Glucose Metabolism Disorder|glucose metabolism disorder
762294|NCT00395512|Dysmetabolic Syndrome|dysmetabolic syndrome
762295|NCT00395512|Type II Diabetes|type ii diabetes
762296|NCT00395512|Diabetes Mellitus, Lipoatrophic|diabetes mellitus, lipoatrophic
762297|NCT00395512|Dyslipidemia|dyslipidemia
762298|NCT00395512|Drug Therapy|drug therapy
762299|NCT00395499|Risperidone|risperidone
762300|NCT00395499|9-Hydroxyrisperidone|9-hydroxyrisperidone
762301|NCT00395499|Plasma|plasma
762302|NCT00395499|Saliva|saliva
762303|NCT00395499|children|children
762304|NCT00395486|rosuvastatin|rosuvastatin
762305|NCT00395486|lipoprotein|lipoprotein
762306|NCT00395486|metabolic syndrome|metabolic syndrome
762307|NCT00395460|Gadovist|gadovist
762308|NCT00395460|Gadavist|gadavist
762309|NCT00395460|Contrast agent|contrast agent
762310|NCT00395460|Brain|brain
762311|NCT00395460|Spine disease|spine disease
762312|NCT00395460|Magnetic Resonance Imaging|magnetic resonance imaging
762313|NCT00395447|Cardiac Pacemaker|cardiac pacemaker
762314|NCT00395447|Defibrillator|defibrillator
762315|NCT00395447|Replacement|replacement
762316|NCT00395447|Upgrade|upgrade
762317|NCT00395434|Advanced Solid Tumors|advanced solid tumors
762318|NCT00395434|Advanced Solid Tumours|advanced solid tumours
762319|NCT00395434|Advanced Solid Tumor|advanced solid tumor
762320|NCT00395434|Advanced Solid Tumour|advanced solid tumour
762321|NCT00395434|Advanced|advanced
762322|NCT00395434|Malignant|malignant
762323|NCT00395434|Solid|solid
762324|NCT00395434|Tumors|tumors
762325|NCT00395434|Tumours|tumours
762326|NCT00395434|Tumor|tumor
762327|NCT00395434|Tumour|tumour
762328|NCT00395434|Cancer|cancer
762329|NCT00395434|Malignant Solid Tumors|malignant solid tumors
762330|NCT00395434|Malignant Solid Tumours|malignant solid tumours
762331|NCT00395434|Malignant Solid Tumor|malignant solid tumor
762332|NCT00395434|Malignant Solid Tumour|malignant solid tumour
762333|NCT00395434|Metastatic Cancer|metastatic cancer
762334|NCT00395434|Metastatic Disease|metastatic disease
762335|NCT00395434|Advanced Cancer|advanced cancer
762336|NCT00395434|Vascular Disrupting Agent|vascular disrupting agent
762337|NCT00395434|Anti-angiogenesis agent|anti-angiogenesis agent
762338|NCT00395434|Phase 1|phase 1
762339|NCT00395421|treatment-naive|treatment-naive
762340|NCT00395395|Postmenopausal|postmenopausal
762341|NCT00395395|osteoporosis|osteoporosis
762342|NCT00395395|Pharmacokinetics/dynamics|pharmacokinetics/dynamics
762343|NCT00395395|Calcitonin|calcitonin
762344|NCT00395382|Vascular calcification|vascular calcification
762345|NCT00395382|Arterial stiffness|arterial stiffness
762346|NCT00395382|Cardiovascular risk|cardiovascular risk
762347|NCT00395382|Bone mineral metabolism|bone mineral metabolism
762348|NCT00395382|Calcium|calcium
762349|NCT00395369|aprotinin|aprotinin
762350|NCT00395369|cardiac surgery|cardiac surgery
762351|NCT00395369|neurological dysfunction|neurological dysfunction
762352|NCT00395369|optical coherance tomography|optical coherance tomography
762353|NCT00395356|Diet|diet
762354|NCT00395356|Caloric restriction|caloric restriction
762355|NCT00395356|Intermittent diet|intermittent diet
762356|NCT00395356|Obesity|obesity
762357|NCT00395356|Postmenopausal women|postmenopausal women
762358|NCT00395330|Respiratory Function Tests|respiratory function tests
762359|NCT00395330|Oscillometry|oscillometry
762360|NCT00395330|World Trade Center Disaster|world trade center disaster
762361|NCT00395330|Environmental Exposure|environmental exposure
762362|NCT00395330|Distal Airways|distal airways
762363|NCT00395317|magnetic resonance imaging|magnetic resonance imaging
762364|NCT00395317|multiple sclerosis|multiple sclerosis
762365|NCT00395317|SB-683699|sb-683699
762366|NCT00395291|Chronic kidney disease|chronic kidney disease
762367|NCT00395291|End stage renal disease|end stage renal disease
762368|NCT00395278|Antibody|antibody
762369|NCT00395278|KSHV|kshv
762370|NCT00395278|Kaposi's Sarcoma|kaposi's sarcoma
762371|NCT00395278|HIV|hiv
762372|NCT00395278|Kaposi Sarcoma|kaposi sarcoma
762373|NCT00395265|Deep Vein Thrombosis|deep vein thrombosis
762374|NCT00395265|Chronic Venous Insufficiency|chronic venous insufficiency
762375|NCT00395265|Post Thrombotic Syndrome|post thrombotic syndrome
762376|NCT00395265|Blood Coagulation|blood coagulation
762377|NCT00395265|Inflammation|inflammation
762378|NCT00395252|pancreatic cancer|pancreatic cancer
762379|NCT00395252|adjuvant chemotherapy|adjuvant chemotherapy
762380|NCT00395252|phase 2|phase 2
762381|NCT00395252|R0 or R1 resected Adenocarcinoma of the Pancreas|r0 or r1 resected adenocarcinoma of the pancreas
762382|NCT00395239|Asthma|asthma
762383|NCT00395239|Inhaled corticosteroid|inhaled corticosteroid
762384|NCT00395239|ICS|ics
762385|NCT00395239|Metabolites|metabolites
762386|NCT00395239|Induced sputum|induced sputum
762387|NCT00395239|Virtual Asthma Clinic|virtual asthma clinic
762388|NCT00395226|Rosacea|rosacea
762389|NCT00395213|Anxiety|anxiety
762390|NCT00395213|Major Depression|major depression
762391|NCT00395213|Anorexia|anorexia
762392|NCT00395213|Bulimia|bulimia
762393|NCT00395213|OCD|ocd
762394|NCT00395213|Antidepressant|antidepressant
762395|NCT00395213|SSRI|ssri
762396|NCT00395213|SNRI|snri
762397|NCT00395200|Multiple Sclerosis|multiple sclerosis
762398|NCT00395200|Safety|safety
762399|NCT00395200|Therapeutics|therapeutics
762400|NCT00395200|Mesenchymal Stem Cells|mesenchymal stem cells
762401|NCT00395200|Multipotent Mesenchymal Stromal Cells|multipotent mesenchymal stromal cells
762402|NCT00395200|Optic Neuritis|optic neuritis
762403|NCT00395174|Influenza|influenza
762404|NCT00395161|sepsis|sepsis
762405|NCT00395161|prevention|prevention
762406|NCT00395161|mineral supplementation|mineral supplementation
762407|NCT00395135|Obesity|obesity
762408|NCT00395135|Weight loss|weight loss
762409|NCT00395135|lorcaserin|lorcaserin
762410|NCT00395135|APD356|apd356
762411|NCT00395135|BLOOM|bloom
762412|NCT00395135|Hypertension|hypertension
762413|NCT00395135|Dyslipidemia|dyslipidemia
762414|NCT00395135|Sleep apnea|sleep apnea
762415|NCT00395135|glucose tolerance|glucose tolerance
762416|NCT00395135|cardiovascular disease|cardiovascular disease
762417|NCT00395135|Arena|arena
762418|NCT00395122|Band Atrophy|band atrophy
762419|NCT00395122|Optical Coherence Tomography|optical coherence tomography
762420|NCT00395122|Scanning Laser Polarimetry|scanning laser polarimetry
762421|NCT00395122|Chiasmal Lesions|chiasmal lesions
762422|NCT00395109|cancer|cancer
762423|NCT00395109|hypoxia|hypoxia
762424|NCT00395109|PET scan|pet scan
762425|NCT00395109|CT scan|ct scan
762426|NCT00395096|Exhaled Nitric Oxide|exhaled nitric oxide
762427|NCT00395096|Asthma|asthma
762428|NCT00395096|Tobacco Smoke|tobacco smoke
762429|NCT00395096|Allergen|allergen
762430|NCT00395070|Melanoma|melanoma
762431|NCT00395070|DTIC|dtic
762432|NCT00395070|TMZ|tmz
762433|NCT00395070|Stage 3|stage 3
762434|NCT00395070|Stage 4|stage 4
762435|NCT00395070|Metastatic|metastatic
762436|NCT00395070|Metastatic Melanoma (Stage 3, Stage 4 Melanoma)|metastatic melanoma (stage 3, stage 4 melanoma)
762437|NCT00395044|Cannabis treatment|cannabis treatment
762438|NCT00395044|marijuana treatment|marijuana treatment
762439|NCT00395031|schizophrenia|schizophrenia
762440|NCT00395031|Schizoaffective Disorder|schizoaffective disorder
762441|NCT00395031|metabolic markers|metabolic markers
762442|NCT00395031|ziprasidone|ziprasidone
762443|NCT00395031|diabetes|diabetes
762444|NCT00395018|Chronic Hepatitis B Virus, Liver Transplant|chronic hepatitis b virus, liver transplant
762445|NCT00395005|Kallikrein|kallikrein
762446|NCT00395005|Cytokines|cytokines
762447|NCT00395005|Proteinuria|proteinuria
762448|NCT00395005|Renal function|renal function
762449|NCT00395005|Chronic kidney disease|chronic kidney disease
762450|NCT00394992|Colorectal cancer|colorectal cancer
762451|NCT00394992|Liver metastasis|liver metastasis
762452|NCT00394992|Radical resection|radical resection
762453|NCT00394992|Adjuvant therapy|adjuvant therapy
762454|NCT00394992|Bevacizumab|bevacizumab
762455|NCT00394992|Capecitabine|capecitabine
762456|NCT00394992|Oxaliplatin|oxaliplatin
762457|NCT00394992|Hepatica|hepatica
762458|NCT00394940|COPD|copd
762459|NCT00394940|Emphysema|emphysema
762460|NCT00394940|Chronic Bronchitis|chronic bronchitis
762461|NCT00394940|Inflammation|inflammation
762462|NCT00394940|CD14|cd14
762463|NCT00394940|TLR4|tlr4
762464|NCT00394940|Proteomics|proteomics
762465|NCT00394927|Non-Interventional|non-interventional
762466|NCT00394927|Surveillance|surveillance
762467|NCT00394927|Adverse Effects|adverse effects
762468|NCT00394927|AntiEpileptic Drug treatment|antiepileptic drug treatment
762469|NCT00394888|Hemangioma|hemangioma
762470|NCT00394888|PHACE|phace
762471|NCT00394888|Lumbosacral hemangioma|lumbosacral hemangioma
762472|NCT00394888|Occult Spinal Dysraphism|occult spinal dysraphism
762473|NCT00394875|Randomized controlled trial|randomized controlled trial
762474|NCT00394875|Delegation, Professional|delegation, professional
762475|NCT00394875|Nurses|nurses
762476|NCT00394849|Tonsillectomy|tonsillectomy
762477|NCT00394849|Suturing of tonsillar pillars|suturing of tonsillar pillars
762478|NCT00394849|pain|pain
762479|NCT00394849|postoperative hemorrhage, bleeding|postoperative hemorrhage, bleeding
762480|NCT00394836|ofatumumab|ofatumumab
762481|NCT00394836|rituximab|rituximab
762482|NCT00394836|NHL|nhl
762483|NCT00394836|CD20|cd20
762484|NCT00394836|refractory|refractory
762485|NCT00394823|Hypertension, valsartan, compliance|hypertension, valsartan, compliance
762486|NCT00394784|gram negative bacteria|gram negative bacteria
762487|NCT00394784|culture|culture
762488|NCT00394784|infection|infection
762489|NCT00394771|oral contraceptives|oral contraceptives
762490|NCT00394771|breakthrough bleeding|breakthrough bleeding
762491|NCT00394771|spotting|spotting
762492|NCT00394758|ultrasonic surgical aspiration|ultrasonic surgical aspiration
762493|NCT00394758|CO2 laser surgery|co2 laser surgery
762494|NCT00394758|vulvar dysplasia|vulvar dysplasia
762495|NCT00394758|vaginal dysplasia|vaginal dysplasia
762496|NCT00394758|recurrence|recurrence
762497|NCT00394745|Hypertension, Metabolic Syndrome, lipid subfractions|hypertension, metabolic syndrome, lipid subfractions
762498|NCT00394732|chronic low back pain|chronic low back pain
762499|NCT00394732|total disc replacement|total disc replacement
762500|NCT00394732|multidisciplinary rehabilitation|multidisciplinary rehabilitation
762501|NCT00394732|clinical effects|clinical effects
762502|NCT00394732|cost effectiveness|cost effectiveness
762503|NCT00394732|randomized controlled trial|randomized controlled trial
762504|NCT00394732|multicenter study|multicenter study
762505|NCT00394706|cardiac arrest|cardiac arrest
762506|NCT00394706|cardiopulmonary resuscitation|cardiopulmonary resuscitation
762507|NCT00394693|Primary CBCL including (WHO/EORTC classification 2005)|primary cbcl including (who/eortc classification 2005)
762508|NCT00394693|Primary cutaneous marginal zone B-cell lymphoma|primary cutaneous marginal zone b-cell lymphoma
762509|NCT00394693|Primary cutaneous follicle center B-cell lymphoma|primary cutaneous follicle center b-cell lymphoma
762510|NCT00394693|Primary cutaneous diffuse large B-cell other than leg type|primary cutaneous diffuse large b-cell other than leg type
762511|NCT00394693|Histologically consistent with primary CBCL|histologically consistent with primary cbcl
762512|NCT00394693|Relapse or active disease|relapse or active disease
762513|NCT00394680|coronary revascularization|coronary revascularization
762514|NCT00394680|stent inmplantation|stent inmplantation
762515|NCT00394680|coronary bypass|coronary bypass
762516|NCT00394628|Glioblastoma Multiforme|glioblastoma multiforme
762517|NCT00394628|Radiotherapy|radiotherapy
762518|NCT00394628|temozolomide|temozolomide
762519|NCT00394628|adjuvant temozolomide|adjuvant temozolomide
762520|NCT00394602|Gastric Cancer|gastric cancer
762521|NCT00394602|Pancreatic Cancer|pancreatic cancer
762522|NCT00394602|Cervical Cancer|cervical cancer
762523|NCT00394602|Vulvar Cancer|vulvar cancer
762524|NCT00394602|Endometrial Cancer|endometrial cancer
762525|NCT00394602|Anal Cancer|anal cancer
762526|NCT00394602|Quality of Life|quality of life
762527|NCT00394602|Questionnaire|questionnaire
762528|NCT00394602|Interview|interview
762529|NCT00394602|Emesis|emesis
762530|NCT00394602|Nausea|nausea
762531|NCT00394602|Survey|survey
762532|NCT00394576|Kidney School|kidney school
762533|NCT00394576|Short Test of Functional Health Literacy|short test of functional health literacy
762534|NCT00394576|Chronic Kidney Disease Knowledge Assessment Tool of Nutrition|chronic kidney disease knowledge assessment tool of nutrition
762535|NCT00394576|Short Form 12 version 2|short form 12 version 2
762536|NCT00394576|Three Day Dietary Diary|three day dietary diary
762537|NCT00394576|Kidney Disease Self-Management Survey|kidney disease self-management survey
762538|NCT00394563|osteoarthritis monoclonal antibody|osteoarthritis monoclonal antibody
762539|NCT00394550|laryngomalacia|laryngomalacia
762540|NCT00394550|supraglottoplasty|supraglottoplasty
762541|NCT00394550|Tonsillectomy|tonsillectomy
762542|NCT00394550|Adenoidectomy|adenoidectomy
762543|NCT00394550|obstructive sleep apnea|obstructive sleep apnea
762544|NCT00394550|Laser|laser
762545|NCT00394550|Polysomnogram|polysomnogram
762546|NCT00394550|airway obstruction|airway obstruction
762547|NCT00394524|ICU|icu
762548|NCT00394524|hyperglycemia|hyperglycemia
762549|NCT00394524|glucommander|glucommander
762550|NCT00394498|Myocardial Infarction|myocardial infarction
762551|NCT00394498|Stem Cells|stem cells
762552|NCT00394485|Chronic Obstructive Pulmonary Disease|chronic obstructive pulmonary disease
762556|NCT00394472|Patient reported symptoms|patient reported symptoms
762557|NCT00394472|Proton pump inhibitor|proton pump inhibitor
762558|NCT00394459|Anaesthetic techniques|anaesthetic techniques
762559|NCT00394459|epidural|epidural
762560|NCT00394459|catheters|catheters
762561|NCT00394459|paraesthesia|paraesthesia
762562|NCT00394459|side effects|side effects
762563|NCT00394459|Anesthesia, Epidural [E03.155.086.131]|anesthesia, epidural [e03.155.086.131]
762564|NCT00394446|Solid Tumors|solid tumors
762565|NCT00394446|Refractory|refractory
762566|NCT00394446|Brain|brain
762567|NCT00394433|TPCA|tpca
762568|NCT00394433|Taxotere|taxotere
762569|NCT00394433|Platinum|platinum
762570|NCT00394433|Avastin|avastin
762571|NCT00394433|Camptosar|camptosar
762572|NCT00394433|gastric cancer|gastric cancer
762573|NCT00394407|inpatient|inpatient
762574|NCT00394407|diabetes management|diabetes management
762575|NCT00394407|insulin therapy|insulin therapy
762576|NCT00394381|acute myeloid leukemia|acute myeloid leukemia
762577|NCT00394381|myelodysplastic syndrome|myelodysplastic syndrome
762578|NCT00394381|autologous CIK cells|autologous cik cells
762579|NCT00394381|autologous peripheral blood stem cell transplant|autologous peripheral blood stem cell transplant
762580|NCT00394368|asthma|asthma
762581|NCT00394368|combinations|combinations
762582|NCT00394368|inhaled therapy|inhaled therapy
762583|NCT00394368|corticosteroids|corticosteroids
762584|NCT00394368|long acting bronchodilators|long acting bronchodilators
762585|NCT00394368|salmeterol|salmeterol
762586|NCT00394368|beclomethasone|beclomethasone
762587|NCT00394368|formoterol|formoterol
762588|NCT00394368|fluticasone|fluticasone
762589|NCT00394316|CD34 Stem Cells|cd34 stem cells
762590|NCT00394316|Busulfan|busulfan
762591|NCT00394316|Gene Therapy|gene therapy
762592|NCT00394316|Immune Reconstitution|immune reconstitution
762593|NCT00394316|Engraftment|engraftment
762594|NCT00394316|Chronic Granulomatous Disease (CGD)|chronic granulomatous disease (cgd)
762595|NCT00394316|Gp91 Phox Deficiency|gp91 phox deficiency
762596|NCT00394316|Peripheral Blood Stem Cells|peripheral blood stem cells
762597|NCT00394316|Bone Marrow Transplantation|bone marrow transplantation
762598|NCT00394316|Chronic Granulomatous Disease|chronic granulomatous disease
762599|NCT00394316|CGD|cgd
762600|NCT00394303|Open heart surgery|open heart surgery
762601|NCT00394303|Diabetes mellitus|diabetes mellitus
762602|NCT00394303|Hyperglycemia|hyperglycemia
762603|NCT00394303|Surgical site infection|surgical site infection
762604|NCT00394303|Normoglycemia|normoglycemia
762605|NCT00394290|Down Syndrome|down syndrome
762606|NCT00394290|Obstructive Sleep Apnea Syndrome|obstructive sleep apnea syndrome
762607|NCT00394290|Continuous Positive Pressure|continuous positive pressure
762608|NCT00394290|Hypersomnia|hypersomnia
762609|NCT00394264|low back pain|low back pain
762610|NCT00394264|active duty military personnel|active duty military personnel
762611|NCT00394264|manual/manipulative therapy|manual/manipulative therapy
762612|NCT00394264|osteopathic manipulative treatment|osteopathic manipulative treatment
762613|NCT00394264|physical medicine|physical medicine
762614|NCT00394251|Adjuvant therapy|adjuvant therapy
762615|NCT00394251|Bevacizumab|bevacizumab
762616|NCT00394251|Abraxane|abraxane
762617|NCT00394251|Early stage breast cancer|early stage breast cancer
762618|NCT00394225|6-Minute Walk Test|6-minute walk test
762619|NCT00394225|COPD|copd
762620|NCT00394225|Helium-Hyperoxia|helium-hyperoxia
762621|NCT00394225|Exercise|exercise
762622|NCT00394225|Chronic Obstructive Pulmonary Disease (COPD)|chronic obstructive pulmonary disease (copd)
762623|NCT00394212|Weight Loss|weight loss
762624|NCT00394212|Transoral Suturing|transoral suturing
762625|NCT00394212|Dilated gastrojejunostomy|dilated gastrojejunostomy
762626|NCT00394212|Inadequate weight loss following primary RYGB|inadequate weight loss following primary rygb
762627|NCT00394199|Asthma|asthma
762628|NCT00394199|Fluticasone Propionate|fluticasone propionate
762629|NCT00394199|formoterol fumarate|formoterol fumarate
762630|NCT00394199|Pressurized metered dose inhaler|pressurized metered dose inhaler
762631|NCT00394199|Hydrofluoroalkane|hydrofluoroalkane
762632|NCT00394199|Mild to Moderate Asthma|mild to moderate asthma
762633|NCT00394186|GW427353|gw427353
762634|NCT00394186|b3-Adrenergic Receptor Agonist|b3-adrenergic receptor agonist
762635|NCT00394186|Irritable Bowel Syndrome (IBS)|irritable bowel syndrome (ibs)
762636|NCT00394186|efficacy|efficacy
762637|NCT00394186|tolerability|tolerability
762638|NCT00394186|pharmacokinetics|pharmacokinetics
762639|NCT00394173|IBS|ibs
762640|NCT00394173|diarrhea|diarrhea
762641|NCT00394173|gastrointestinal functional disorder|gastrointestinal functional disorder
762642|NCT00394173|IBS-D|ibs-d
762643|NCT00394147|advanced|advanced
762644|NCT00394147|head|head
762645|NCT00394147|neck|neck
762646|NCT00394147|cancer|cancer
762647|NCT00394134|Melanoma|melanoma
762648|NCT00394134|Sun Exposure|sun exposure
762649|NCT00394134|Sun Protection|sun protection
762650|NCT00394134|Interview|interview
762651|NCT00394121|Asthma|asthma
762652|NCT00394121|Fluticasone Propionate|fluticasone propionate
762653|NCT00394121|Formoterol Fumarate|formoterol fumarate
762654|NCT00394121|Pressurized metered does inhaler|pressurized metered does inhaler
762655|NCT00394121|Hydrofluoroalkane|hydrofluoroalkane
762656|NCT00394121|Mild to moderate-severe asthma|mild to moderate-severe asthma
762657|NCT00394095|Bipolar Disorder|bipolar disorder
762658|NCT00394095|Weight Gain|weight gain
762659|NCT00394082|Metastatic breast cancer, Abraxane, Bevacizumab|metastatic breast cancer, abraxane, bevacizumab
762660|NCT00394056|placebo|placebo
762661|NCT00394056|balanced|balanced
762662|NCT00394056|paroxetine|paroxetine
762663|NCT00394056|repeated dose|repeated dose
762664|NCT00394056|Hearing Loss|hearing loss
762665|NCT00394056|loudness|loudness
762666|NCT00394056|combination|combination
762667|NCT00394056|Tinnitus|tinnitus
762668|NCT00394056|vestipitant (GW597599)|vestipitant (gw597599)
762669|NCT00394056|randomised|randomised
762670|NCT00394056|annoyance|annoyance
762671|NCT00394056|crossover|crossover
762672|NCT00394043|Carpal Tunnel Sydrome|carpal tunnel sydrome
762673|NCT00394043|Osteopathic Manipulative Treatment|osteopathic manipulative treatment
762674|NCT00394043|Osteopathic Manipulative Medicine|osteopathic manipulative medicine
762675|NCT00394043|Physical Medicine|physical medicine
762676|NCT00394030|GSK716155 pharmacodynamics pharmacokinetics injection site|gsk716155 pharmacodynamics pharmacokinetics injection site
762677|NCT00394017|Heading Health Plan Implementation|heading health plan implementation
762678|NCT00394017|Computer-Assisted Instruction|computer-assisted instruction
762679|NCT00394017|General Practice|general practice
762680|NCT00394017|Dementia|dementia
762681|NCT00394017|education|education
762682|NCT00394004|Decision Making|decision making
762683|NCT00394004|Health Disparities|health disparities
762684|NCT00394004|Hispanic|hispanic
762685|NCT00394004|African-American|african-american
762686|NCT00394004|Clinical Trials|clinical trials
762687|NCT00394004|HIV Positive|hiv positive
762688|NCT00393991|Asthma|asthma
762689|NCT00393991|Fluticasone Propionate|fluticasone propionate
762690|NCT00393991|Formoterol Fumarate|formoterol fumarate
762691|NCT00393991|Pressurized metered dose inhaler|pressurized metered dose inhaler
762692|NCT00393991|Hydrofluoroalkane|hydrofluoroalkane
762693|NCT00393991|Mild to Moderate Asthma|mild to moderate asthma
762694|NCT00393978|Bipolar mania|bipolar mania
762695|NCT00393978|Cannabis consumption|cannabis consumption
762696|NCT00393965|Metastases|metastases
762697|NCT00393965|Refractory|refractory
762698|NCT00393965|Brain|brain
762699|NCT00393952|Asthma|asthma
762700|NCT00393952|Fluticasone Propionate|fluticasone propionate
762701|NCT00393952|Formoterol Fumarate|formoterol fumarate
762702|NCT00393952|Pressurized metered dose inhaler|pressurized metered dose inhaler
762703|NCT00393952|Hydrofluoroalkane|hydrofluoroalkane
762704|NCT00393952|Moderate-Severe Asthma|moderate-severe asthma
762705|NCT00393939|advanced breast cancer|advanced breast cancer
762706|NCT00393939|sunitinib|sunitinib
762707|NCT00393939|docetaxel|docetaxel
762708|NCT00393939|Phase 3|phase 3
762709|NCT00393926|Robotics|robotics
762710|NCT00393926|Rehabilitation|rehabilitation
762711|NCT00393926|Upper Extremity|upper extremity
762712|NCT00393926|CVA|cva
762713|NCT00393913|Sleep Apnea|sleep apnea
762714|NCT00393913|Sleep-Disordered Breathing|sleep-disordered breathing
762715|NCT00393913|Snoring|snoring
762716|NCT00393900|otitis media|otitis media
762717|NCT00393900|tympanostomy tube|tympanostomy tube
762718|NCT00393900|eustachian tube function|eustachian tube function
762719|NCT00393900|gas exchange|gas exchange
762720|NCT00393900|tympanostomy tubes|tympanostomy tubes
762721|NCT00393887|Inguinal hernia|inguinal hernia
762722|NCT00393887|polypropylene|polypropylene
762723|NCT00393887|Biodesign IHM|biodesign ihm
762724|NCT00393887|lichtenstein|lichtenstein
762725|NCT00393874|Anxiety D/O|anxiety d/o
762726|NCT00393874|Mood D/O|mood d/o
762727|NCT00393861|Germ Cell Tumor|germ cell tumor
762728|NCT00393861|Germ Cell Cancer|germ cell cancer
762729|NCT00393848|Hip Replacement Arthroplasty|hip replacement arthroplasty
762730|NCT00393848|Hip Replacement Surgery|hip replacement surgery
762731|NCT00393848|Hip Surgery|hip surgery
762732|NCT00393848|Hip Rehabilitation|hip rehabilitation
762733|NCT00393848|Avascular Necrosis|avascular necrosis
762734|NCT00393848|Knee replacement surgery|knee replacement surgery
762735|NCT00393848|Total knee arthroplasty|total knee arthroplasty
762736|NCT00393822|KGF|kgf
762737|NCT00393822|Palifermin|palifermin
762738|NCT00393822|Oral Mucositis|oral mucositis
762739|NCT00393822|Clinical Trial|clinical trial
762740|NCT00393822|Amgen|amgen
762741|NCT00393822|Oncology|oncology
762742|NCT00393822|Colon Cancer|colon cancer
762743|NCT00393809|transitional cell carcinoma|transitional cell carcinoma
762744|NCT00393809|H19 gene|h19 gene
762745|NCT00393809|plasmid|plasmid
762746|NCT00393809|diphtheria toxin|diphtheria toxin
762747|NCT00393783|Breast Cancer|breast cancer
762748|NCT00393783|Metastatic|metastatic
762749|NCT00393783|HER2|her2
762750|NCT00393783|04-101|04-101
762751|NCT00393770|Risk of type 2 diabetes|risk of type 2 diabetes
762752|NCT00393757|Malaria, Plasmodium falciparum, Kenya|malaria, plasmodium falciparum, kenya
762753|NCT00393731|labor|labor
762759|NCT00393692|Age-related macular degeneration|age-related macular degeneration
762760|NCT00393692|Geographic atrophy|geographic atrophy
762761|NCT00393692|drusen|drusen
762762|NCT00393679|Children 6-59 months|children 6-59 months
762763|NCT00393679|P.falciparum|p.falciparum
762764|NCT00393679|Haemoglobin|haemoglobin
762765|NCT00393679|Informed consent|informed consent
762766|NCT00393679|ACT|act
762767|NCT00393666|Absence|absence
762768|NCT00393666|Epilepsy|epilepsy
762769|NCT00393666|Seizure|seizure
762770|NCT00393666|Brain|brain
762771|NCT00393653|osteoarthritis|osteoarthritis
762772|NCT00393653|gastroesophageal reflux disease|gastroesophageal reflux disease
762773|NCT00393653|practice-based research|practice-based research
762774|NCT00393653|N-of-1 trial|n-of-1 trial
762775|NCT00393653|prescription|prescription
762776|NCT00393653|single-patient trial|single-patient trial
762777|NCT00393640|Early Initiation of lactogenesis II|early initiation of lactogenesis ii
762778|NCT00393627|Dementia|dementia
762779|NCT00393627|Sleep disturbance|sleep disturbance
762780|NCT00393627|Behavioral strategies|behavioral strategies
762781|NCT00393627|Alzheimer's Disease|alzheimer's disease
762782|NCT00393627|Adult Family Homes|adult family homes
762783|NCT00393614|CSWS, interiktal epileptiform activity|csws, interiktal epileptiform activity
762784|NCT00393601|Cystectomy|cystectomy
762785|NCT00393588|Brain|brain
762786|NCT00393588|Cognitive Deficits|cognitive deficits
762787|NCT00393588|Cognitive Testing|cognitive testing
762788|NCT00393588|MRI|mri
762789|NCT00393588|Multiple Sclerosis|multiple sclerosis
762790|NCT00393588|MS|ms
762791|NCT00393588|Healthy Volunteer|healthy volunteer
762792|NCT00393588|HV|hv
762793|NCT00393575|HIV Prevention|hiv prevention
762794|NCT00393575|HIV positive communities|hiv positive communities
762795|NCT00393562|excessive sleepiness|excessive sleepiness
762796|NCT00393562|hypersomnolence|hypersomnolence
762797|NCT00393562|Parkinson's disease|parkinson's disease
762798|NCT00393549|Median Neuropathy at the wrist (MNW)|median neuropathy at the wrist (mnw)
762799|NCT00393536|Depression|depression
762800|NCT00393536|Guidelines|guidelines
762801|NCT00393536|Educational outreach visiting|educational outreach visiting
762802|NCT00393536|Prescribing|prescribing
762803|NCT00393510|Diabetic Foot Ulcer|diabetic foot ulcer
762804|NCT00393510|Traditional Chinese Medicine|traditional chinese medicine
762805|NCT00393497|Breast Cancer|breast cancer
762806|NCT00393497|lymphedema|lymphedema
762807|NCT00393471|Arthritis|arthritis
762808|NCT00393471|Rheumatoid|rheumatoid
762809|NCT00393471|Safety|safety
762810|NCT00393458|chronic obstructive pulmonary disease|chronic obstructive pulmonary disease
762811|NCT00393458|COPD|copd
762812|NCT00393458|indacaterol|indacaterol
762813|NCT00393458|long-acting β2 agonist|long-acting β2 agonist
762814|NCT00393445|GLP-1|glp-1
762815|NCT00393445|Exendin(9-39)|exendin(9-39)
762816|NCT00393445|Insulin|insulin
762817|NCT00393445|Glucagon|glucagon
762818|NCT00393445|Human physiology|human physiology
762819|NCT00393432|Action Observation|action observation
762820|NCT00393432|Motor Memory|motor memory
762821|NCT00393432|Transcranial Magnetic Stimulation (TMS)|transcranial magnetic stimulation (tms)
762822|NCT00393432|Use-Dependent Plasticity|use-dependent plasticity
762823|NCT00393432|Healthy Volunteer|healthy volunteer
762824|NCT00393432|HV|hv
762825|NCT00393419|hypertension|hypertension
762826|NCT00393419|hyperlipidemia|hyperlipidemia
762827|NCT00393419|adherence|adherence
762828|NCT00393419|pharmacist|pharmacist
762829|NCT00393419|elderly|elderly
762830|NCT00393419|medication|medication
762831|NCT00393406|Objective Risk|objective risk
762832|NCT00393406|Gail Model|gail model
762833|NCT00393406|Subjective Risk|subjective risk
762834|NCT00393406|Medical Risk-Reducing Strategies|medical risk-reducing strategies
762835|NCT00393406|Physical Activity, Diet, Alcohol Use|physical activity, diet, alcohol use
762836|NCT00393406|Breast Cancer Risk|breast cancer risk
762837|NCT00393393|osteoarthritis|osteoarthritis
762838|NCT00393393|knee|knee
762839|NCT00393393|hylan|hylan
762840|NCT00393380|Myelogenous Leukemia, Chronic|myelogenous leukemia, chronic
762841|NCT00393380|Myelodysplasia|myelodysplasia
762842|NCT00393380|Parathyroid Hormone|parathyroid hormone
762843|NCT00393380|Umbilical Cord Blood Stem Cell Transplantation|umbilical cord blood stem cell transplantation
762844|NCT00393367|Asthma|asthma
762845|NCT00393367|Acute|acute
762846|NCT00393367|Treatment|treatment
762847|NCT00393367|Children|children
762848|NCT00393367|Pediatric|pediatric
762849|NCT00393367|Inhaled corticosteroid|inhaled corticosteroid
762850|NCT00393367|Budesonide|budesonide
762851|NCT00393367|Budesonide inhalation suspension|budesonide inhalation suspension
762852|NCT00393367|Asthma score|asthma score
762853|NCT00393367|Emergency|emergency
762854|NCT00393367|Emergency Department|emergency department
762855|NCT00393367|Asthma flare|asthma flare
762856|NCT00393367|Clinical trial|clinical trial
762857|NCT00393367|Randomized clinical trial|randomized clinical trial
762858|NCT00393367|Randomized trial|randomized trial
762859|NCT00393367|Pulmonary index score|pulmonary index score
762860|NCT00393367|Hospitalization|hospitalization
762861|NCT00393367|Moderate asthma|moderate asthma
762862|NCT00393367|Severe asthma|severe asthma
762863|NCT00393367|Mixing budesonide|mixing budesonide
762864|NCT00393367|Budesonide admixture|budesonide admixture
762865|NCT00393367|Albuterol|albuterol
762866|NCT00393367|Continuous albuterol|continuous albuterol
762867|NCT00393367|Ipratropium bromide|ipratropium bromide
762868|NCT00393341|Breast Cancer|breast cancer
762869|NCT00393315|in stent restenosis|in stent restenosis
762870|NCT00393315|paclitaxel coated balloon catheter|paclitaxel coated balloon catheter
762871|NCT00393315|pepcad|pepcad
762872|NCT00393315|drug eluting balloon|drug eluting balloon
762873|NCT00393302|HIV testing in pregnant women|hiv testing in pregnant women
762874|NCT00393289|Calcium absorption|calcium absorption
762875|NCT00393289|D-vitamin status|d-vitamin status
762876|NCT00393289|Whole body calcium retention|whole body calcium retention
762877|NCT00393289|Calcium intake|calcium intake
762878|NCT00393289|PTH status|pth status
762879|NCT00393276|Treatment Experienced|treatment experienced
762880|NCT00393276|Treatment Naive|treatment naive
762881|NCT00393276|Immunizations|immunizations
762882|NCT00393250|Pain Management|pain management
762883|NCT00393250|Sickle Cell|sickle cell
762884|NCT00393250|Sickle Cell Disease|sickle cell disease
762885|NCT00393250|Pain|pain
762886|NCT00393250|Hypnosis|hypnosis
762887|NCT00393224|Epidemiology|epidemiology
762888|NCT00393224|Nasopharyngeal Carcinoma|nasopharyngeal carcinoma
762889|NCT00393224|Genetic|genetic
762890|NCT00393224|Viruses|viruses
762891|NCT00393224|Cancer|cancer
762892|NCT00393224|NPC|npc
762893|NCT00393198|Intrauterine System|intrauterine system
762894|NCT00393198|Contraception|contraception
762895|NCT00393198|Menorrhagia|menorrhagia
762896|NCT00393185|Immunosuppression|immunosuppression
762897|NCT00393185|Primary Biliary Cirrhosis|primary biliary cirrhosis
762898|NCT00393185|Allogeneic Hematopoietic Stem Cell|allogeneic hematopoietic stem cell
762899|NCT00393172|exercise|exercise
762900|NCT00393172|breast cancer|breast cancer
762901|NCT00393172|prevention|prevention
762902|NCT00393172|obesity|obesity
762903|NCT00393172|estrogen metabolism|estrogen metabolism
762904|NCT00393172|oxidative stress|oxidative stress
762905|NCT00393172|IGF-1|igf-1
762906|NCT00393159|Effusion|effusion
762907|NCT00393159|Otitis|otitis
762908|NCT00393159|Media|media
762909|NCT00393159|Ear|ear
762910|NCT00393159|Popper|popper
762911|NCT00393159|Children|children
762912|NCT00393146|Rheumatoid arthritis|rheumatoid arthritis
762913|NCT00393146|MRI|mri
762914|NCT00393120|HIV-infection|hiv-infection
762915|NCT00393120|viral load|viral load
762916|NCT00393120|CCR5|ccr5
762917|NCT00393120|viral tropism|viral tropism
762918|NCT00393120|HIV-1 infection|hiv-1 infection
762919|NCT00393120|Treatment Naive|treatment naive
762920|NCT00393107|follicular lymphoma|follicular lymphoma
762921|NCT00393107|non-Hodgkin lymphoma|non-hodgkin lymphoma
762922|NCT00393107|Fludarabine|fludarabine
762923|NCT00393107|Cyclophosphamide|cyclophosphamide
762924|NCT00393107|Rituximab|rituximab
762925|NCT00393107|combination|combination
762926|NCT00393107|immuno-chemotherapy|immuno-chemotherapy
762927|NCT00393107|relapsed|relapsed
762928|NCT00393094|Brain Tumor|brain tumor
762929|NCT00393094|Chemotherapy|chemotherapy
762930|NCT00393094|Progression|progression
762931|NCT00393094|Radiotherapy|radiotherapy
762932|NCT00393094|Antiangiogenesis|antiangiogenesis
762933|NCT00393094|Glioma|glioma
762934|NCT00393042|Attention Deficit Hyperactivity Disorder|attention deficit hyperactivity disorder
762935|NCT00393042|sleep|sleep
762936|NCT00393042|side effects|side effects
762937|NCT00393042|stimulants|stimulants
762938|NCT00393029|Tumor Regression|tumor regression
762939|NCT00393029|In Vivo Cell Survival|in vivo cell survival
762940|NCT00393029|Toxicity Profile|toxicity profile
762941|NCT00393029|Metastatic Renal Cell Cancer|metastatic renal cell cancer
762942|NCT00393029|Cancer|cancer
762943|NCT00393029|Metastatic Cancer|metastatic cancer
762944|NCT00393003|Anesthesia|anesthesia
762945|NCT00393003|Sedation|sedation
762946|NCT00392990|stage I adult Burkitt lymphoma|stage i adult burkitt lymphoma
762947|NCT00392990|stage III adult Burkitt lymphoma|stage iii adult burkitt lymphoma
762948|NCT00392990|stage IV adult Burkitt lymphoma|stage iv adult burkitt lymphoma
762949|NCT00392990|contiguous stage II adult Burkitt lymphoma|contiguous stage ii adult burkitt lymphoma
762950|NCT00392990|noncontiguous stage II adult Burkitt lymphoma|noncontiguous stage ii adult burkitt lymphoma
762951|NCT00392990|AIDS-related peripheral/systemic lymphoma|aids-related peripheral/systemic lymphoma
762952|NCT00392977|Manganese|manganese
762953|NCT00392977|Neonatal Intensive Care|neonatal intensive care
762954|NCT00392977|MRI|mri
762955|NCT00392977|Parenteral Nutrition|parenteral nutrition
762956|NCT00392977|Prematurity|prematurity
762957|NCT00392964|Antacids|antacids
762958|NCT00392964|Proton pump inhibitors|proton pump inhibitors
762959|NCT00392964|aspirin|aspirin
762960|NCT00392964|ischemic heart disease|ischemic heart disease
762961|NCT00392964|Dyspepsia|dyspepsia
762962|NCT00392951|ALPS|alps
762970|NCT00392951|Hemolytic Anemia|hemolytic anemia
762971|NCT00392951|Immune Thrombocytopenia|immune thrombocytopenia
762972|NCT00392951|Neutropenia|neutropenia
762973|NCT00392951|ITP|itp
762974|NCT00392951|Lupus|lupus
762975|NCT00392938|recurrent prostate cancer|recurrent prostate cancer
762976|NCT00392938|stage IV prostate cancer|stage iv prostate cancer
762977|NCT00392938|bone metastases|bone metastases
762978|NCT00392925|overweight|overweight
762979|NCT00392925|obesity|obesity
762980|NCT00392925|pramlintide|pramlintide
762981|NCT00392925|leptin|leptin
762982|NCT00392925|Amylin|amylin
762983|NCT00392912|testosterone|testosterone
762984|NCT00392912|hypogonadal|hypogonadal
762985|NCT00392912|cerebral glucose metabolism|cerebral glucose metabolism
762986|NCT00392912|PET scan|pet scan
762987|NCT00392912|Alzheimer's disease|alzheimer's disease
762988|NCT00392899|stage II colon cancer|stage ii colon cancer
762989|NCT00392899|stage II rectal cancer|stage ii rectal cancer
762990|NCT00392899|adenocarcinoma of the colon|adenocarcinoma of the colon
762991|NCT00392899|adenocarcinoma of the rectum|adenocarcinoma of the rectum
762992|NCT00392886|untreated childhood medulloblastoma|untreated childhood medulloblastoma
762993|NCT00392886|untreated childhood supratentorial primitive neuroectodermal tumor|untreated childhood supratentorial primitive neuroectodermal tumor
762994|NCT00392886|childhood infratentorial ependymoma|childhood infratentorial ependymoma
762995|NCT00392886|childhood supratentorial ependymoma|childhood supratentorial ependymoma
762996|NCT00392886|newly diagnosed childhood ependymoma|newly diagnosed childhood ependymoma
762997|NCT00392886|childhood high-grade cerebral astrocytoma|childhood high-grade cerebral astrocytoma
762998|NCT00392886|childhood oligodendroglioma|childhood oligodendroglioma
762999|NCT00392886|childhood atypical teratoid/rhabdoid tumor|childhood atypical teratoid/rhabdoid tumor
763000|NCT00392886|childhood choroid plexus tumor|childhood choroid plexus tumor
763001|NCT00392886|untreated childhood cerebellar astrocytoma|untreated childhood cerebellar astrocytoma
763002|NCT00392886|untreated childhood visual pathway and hypothalamic glioma|untreated childhood visual pathway and hypothalamic glioma
763003|NCT00392886|untreated childhood pineoblastoma|untreated childhood pineoblastoma
763004|NCT00392873|Amenorrhea|amenorrhea
763005|NCT00392873|Energy deficiency|energy deficiency
763006|NCT00392873|Resting energy expenditure|resting energy expenditure
763007|NCT00392873|Bone metabolism|bone metabolism
763008|NCT00392873|Bone mineral density|bone mineral density
763009|NCT00392873|Exercise|exercise
763010|NCT00392860|Wheelchair|wheelchair
763011|NCT00392860|Handrims|handrims
763012|NCT00392860|Rehabilitation|rehabilitation
763185|NCT00392314|PET/CT|pet/ct
763013|NCT00392860|Upper extremity|upper extremity
763014|NCT00392847|Child mental disorder|child mental disorder
763015|NCT00392847|Home visit|home visit
763016|NCT00392847|Postnatal depression|postnatal depression
763017|NCT00392847|Social Support|social support
763018|NCT00392847|Random selection|random selection
763019|NCT00392834|stage I adult Burkitt lymphoma|stage i adult burkitt lymphoma
763020|NCT00392834|stage III adult Burkitt lymphoma|stage iii adult burkitt lymphoma
763021|NCT00392834|stage IV adult Burkitt lymphoma|stage iv adult burkitt lymphoma
763022|NCT00392834|contiguous stage II adult Burkitt lymphoma|contiguous stage ii adult burkitt lymphoma
763023|NCT00392834|noncontiguous stage II adult Burkitt lymphoma|noncontiguous stage ii adult burkitt lymphoma
763024|NCT00392834|AIDS-related peripheral/systemic lymphoma|aids-related peripheral/systemic lymphoma
763025|NCT00392808|Meningococcal vaccine|meningococcal vaccine
763026|NCT00392808|Immunization, secondary|immunization, secondary
763027|NCT00392808|vaccines conjugated|vaccines conjugated
763028|NCT00392808|Meningococcal disease|meningococcal disease
763029|NCT00392795|Critical Care|critical care
763030|NCT00392795|Delirium|delirium
763031|NCT00392795|Long-term cognitive impairment|long-term cognitive impairment
763032|NCT00392795|mechanical ventilation|mechanical ventilation
763033|NCT00392795|Critical illness|critical illness
763034|NCT00392795|dementia|dementia
763035|NCT00392795|sedatives and analgesics|sedatives and analgesics
763036|NCT00392795|aging|aging
763037|NCT00392782|adult acute myeloid leukemia with 11q23 (MLL) abnormalities|adult acute myeloid leukemia with 11q23 (mll) abnormalities
763038|NCT00392782|adult acute myeloid leukemia in remission|adult acute myeloid leukemia in remission
763039|NCT00392782|childhood acute myeloid leukemia in remission|childhood acute myeloid leukemia in remission
763040|NCT00392782|de novo myelodysplastic syndromes|de novo myelodysplastic syndromes
763156|NCT00392509|limb salvage|limb salvage
763041|NCT00392782|previously treated myelodysplastic syndromes|previously treated myelodysplastic syndromes
763042|NCT00392782|adult acute myeloid leukemia with inv(16)(p13;q22)|adult acute myeloid leukemia with inv(16)(p13;q22)
763043|NCT00392782|adult acute myeloid leukemia with t(15;17)(q22;q12)|adult acute myeloid leukemia with t(15;17)(q22;q12)
763044|NCT00392782|adult acute myeloid leukemia with t(16;16)(p13;q22)|adult acute myeloid leukemia with t(16;16)(p13;q22)
763045|NCT00392782|adult acute myeloid leukemia with t(8;21)(q22;q22)|adult acute myeloid leukemia with t(8;21)(q22;q22)
763046|NCT00392782|recurrent adult acute myeloid leukemia|recurrent adult acute myeloid leukemia
763047|NCT00392782|recurrent childhood acute myeloid leukemia|recurrent childhood acute myeloid leukemia
763048|NCT00392782|secondary acute myeloid leukemia|secondary acute myeloid leukemia
763049|NCT00392782|accelerated phase chronic myelogenous leukemia|accelerated phase chronic myelogenous leukemia
763050|NCT00392782|blastic phase chronic myelogenous leukemia|blastic phase chronic myelogenous leukemia
763051|NCT00392782|childhood chronic myelogenous leukemia|childhood chronic myelogenous leukemia
763052|NCT00392782|relapsing chronic myelogenous leukemia|relapsing chronic myelogenous leukemia
763053|NCT00392782|secondary myelodysplastic syndromes|secondary myelodysplastic syndromes
763054|NCT00392769|Endometrial Cancer|endometrial cancer
763055|NCT00392769|Progressive or Recurrent Endometrial Cancer|progressive or recurrent endometrial cancer
763056|NCT00392769|Cetuximab|cetuximab
763057|NCT00392769|C225|c225
763058|NCT00392769|Erbitux™|erbitux™
763059|NCT00392769|IMC-C225|imc-c225
763060|NCT00392769|Epidermal growth factor receptor|epidermal growth factor receptor
763061|NCT00392769|EGFR|egfr
763062|NCT00392769|Endometrioid Tumor|endometrioid tumor
763063|NCT00392769|Serous Tumor|serous tumor
763064|NCT00392769|Clear cell Tumor|clear cell tumor
763065|NCT00392769|Mixed malignant Mullerian Tumors|mixed malignant mullerian tumors
763066|NCT00392756|Kallmann Syndrome|kallmann syndrome
763067|NCT00392756|Hypogonadotropic Hypogonadism|hypogonadotropic hypogonadism
763068|NCT00392756|GnRH deficiency|gnrh deficiency
763069|NCT00392756|Pulsatile GnRH|pulsatile gnrh
763070|NCT00392743|Bolus|bolus
763071|NCT00392743|11C-Raclopride|11c-raclopride
763072|NCT00392743|Schizophrenia|schizophrenia
763073|NCT00392743|123I-IBZM|123i-ibzm
763074|NCT00392743|SPECT|spect
763075|NCT00392743|Receptor Occupancy|receptor occupancy
763076|NCT00392743|PET|pet
763077|NCT00392743|MRI|mri
763078|NCT00392743|Antipsychotics|antipsychotics
763079|NCT00392743|Bolus/Infusion|bolus/infusion
763080|NCT00392730|Manganese|manganese
763081|NCT00392730|Neonatal Intensive Care|neonatal intensive care
763082|NCT00392730|MRI|mri
763083|NCT00392730|Parenteral Nutrition|parenteral nutrition
763084|NCT00392730|Prematurity|prematurity
763085|NCT00392717|lipoprotein metabolism|lipoprotein metabolism
763086|NCT00392717|cardiovascular disease|cardiovascular disease
763087|NCT00392717|obesity|obesity
763088|NCT00392691|recurrent adult Burkitt lymphoma|recurrent adult burkitt lymphoma
763089|NCT00392691|recurrent adult diffuse large cell lymphoma|recurrent adult diffuse large cell lymphoma
763090|NCT00392691|recurrent adult diffuse mixed cell lymphoma|recurrent adult diffuse mixed cell lymphoma
763091|NCT00392691|recurrent adult diffuse small cleaved cell lymphoma|recurrent adult diffuse small cleaved cell lymphoma
763092|NCT00392691|recurrent adult immunoblastic large cell lymphoma|recurrent adult immunoblastic large cell lymphoma
763093|NCT00392691|recurrent adult lymphoblastic lymphoma|recurrent adult lymphoblastic lymphoma
763186|NCT00392314|Therapy|therapy
763094|NCT00392691|recurrent grade 1 follicular lymphoma|recurrent grade 1 follicular lymphoma
763095|NCT00392691|recurrent grade 2 follicular lymphoma|recurrent grade 2 follicular lymphoma
763096|NCT00392691|recurrent grade 3 follicular lymphoma|recurrent grade 3 follicular lymphoma
763097|NCT00392691|recurrent mantle cell lymphoma|recurrent mantle cell lymphoma
763098|NCT00392691|recurrent marginal zone lymphoma|recurrent marginal zone lymphoma
763099|NCT00392691|recurrent small lymphocytic lymphoma|recurrent small lymphocytic lymphoma
763100|NCT00392691|extranodal marginal zone B-cell lymphoma of mucosa-associated lymphoid tissue|extranodal marginal zone b-cell lymphoma of mucosa-associated lymphoid tissue
763101|NCT00392691|nodal marginal zone B-cell lymphoma|nodal marginal zone b-cell lymphoma
763102|NCT00392691|splenic marginal zone lymphoma|splenic marginal zone lymphoma
763103|NCT00392691|Waldenström macroglobulinemia|waldenström macroglobulinemia
763104|NCT00392678|Type 2 Diabetes|type 2 diabetes
763105|NCT00392678|Inflammation|inflammation
763106|NCT00392678|Obesity|obesity
763107|NCT00392678|Metabolic Syndrome|metabolic syndrome
763108|NCT00392665|SCCHN|scchn
763109|NCT00392665|erlotinib|erlotinib
763110|NCT00392665|tarceva|tarceva
763111|NCT00392639|Heart arrest|heart arrest
763112|NCT00392639|Cardiopulmonary resuscitation|cardiopulmonary resuscitation
763113|NCT00392639|Humans|humans
763114|NCT00392639|Hypothermia|hypothermia
763115|NCT00392639|Brain diseases|brain diseases
763116|NCT00392639|Hypoxia-ischemia|hypoxia-ischemia
763117|NCT00392639|Cost Benefit Analysis|cost benefit analysis
763118|NCT00392639|Prospective study|prospective study
763119|NCT00392639|Comparative study|comparative study
763120|NCT00392639|Treatment outcome|treatment outcome
763121|NCT00392639|Hypothermia for|hypothermia for
763122|NCT00392639|out-of-hospital cardiac arrest|out-of-hospital cardiac arrest
763123|NCT00392639|from cardiac origin|from cardiac origin
763124|NCT00392639|successfully resuscitated|successfully resuscitated
763125|NCT00392587|Pharmacodynamics|pharmacodynamics
763126|NCT00392587|Pharmacokinetics|pharmacokinetics
763127|NCT00392587|Tolerability|tolerability
763128|NCT00392587|COPD|copd
763129|NCT00392587|Safety|safety
763130|NCT00392574|Gastroenteritis|gastroenteritis
763131|NCT00392548|GBM|gbm
763132|NCT00392548|glioblastoma|glioblastoma
763133|NCT00392548|urine|urine
763134|NCT00392548|VEGF|vegf
763135|NCT00392548|radiation|radiation
763136|NCT00392548|Patients must be enrolled to an RTOG GBM study that prescribes 6000 cGy of radiation therapy.|patients must be enrolled to an rtog gbm study that prescribes 6000 cgy of radiation therapy.
763137|NCT00392535|adenocarcinoma of the prostate|adenocarcinoma of the prostate
763138|NCT00392535|stage IIB prostate cancer|stage iib prostate cancer
763139|NCT00392535|stage IIA prostate cancer|stage iia prostate cancer
763140|NCT00392535|stage III prostate cancer|stage iii prostate cancer
763141|NCT00392522|Anxiety|anxiety
763142|NCT00392522|Cough|cough
763143|NCT00392522|Number of general anaesthesias (due to procedure failure)|number of general anaesthesias (due to procedure failure)
763144|NCT00392522|Patients satisfaction|patients satisfaction
763145|NCT00392522|Chest physician satisfaction|chest physician satisfaction
763146|NCT00392509|critical limb ischemia|critical limb ischemia
763147|NCT00392509|cell therapy for angiogenesis|cell therapy for angiogenesis
763148|NCT00392509|aldehyde dehydrogenase-bright cells|aldehyde dehydrogenase-bright cells
763149|NCT00392509|peripheral artery disease|peripheral artery disease
763150|NCT00392509|peripheral vascular disease|peripheral vascular disease
763151|NCT00392509|leg pain|leg pain
763152|NCT00392509|PVD|pvd
763153|NCT00392509|PAD|pad
763154|NCT00392509|CLI|cli
763155|NCT00392509|amputation|amputation
763157|NCT00392483|Heading Health Plan Implementation|heading health plan implementation
763158|NCT00392483|Computer-Assisted Instruction|computer-assisted instruction
763159|NCT00392483|General Practice|general practice
763160|NCT00392483|Dementia|dementia
763161|NCT00392470|adenocarcinoma of the rectum|adenocarcinoma of the rectum
763162|NCT00392470|stage III rectal cancer|stage iii rectal cancer
763163|NCT00392470|stage IV rectal cancer|stage iv rectal cancer
763164|NCT00392457|Idiopathic Hypogonadotropic Hypogonadism|idiopathic hypogonadotropic hypogonadism
763165|NCT00392457|Kallmann Syndrome|kallmann syndrome
763166|NCT00392457|Agonadal|agonadal
763167|NCT00392418|iron deficiency anemia|iron deficiency anemia
763168|NCT00392418|hematologic disease|hematologic disease
763169|NCT00392418|infancy|infancy
763170|NCT00392418|pediatrics|pediatrics
763171|NCT00392418|Sprinkles®|sprinkles®
763172|NCT00392418|iron|iron
763173|NCT00392418|micronutrient|micronutrient
763174|NCT00392405|Contrast Induced Nephropathy|contrast induced nephropathy
763175|NCT00392392|Breast Cancer|breast cancer
763176|NCT00392379|Tobacco use disorder|tobacco use disorder
763177|NCT00392379|Tobacco cessation|tobacco cessation
763178|NCT00392366|MRI guided Laser Therapy|mri guided laser therapy
763179|NCT00392366|Laser Interstitial Thermal Therapy|laser interstitial thermal therapy
763180|NCT00392366|Magnetic Resonance Thermal Imaging|magnetic resonance thermal imaging
763181|NCT00392366|Liver Metastasis|liver metastasis
763182|NCT00392340|recurrent neuroblastoma|recurrent neuroblastoma
763183|NCT00392340|disseminated neuroblastoma|disseminated neuroblastoma
763184|NCT00392314|hodgkin lymphoma|hodgkin lymphoma
763187|NCT00392301|wound healing|wound healing
763188|NCT00392301|skin|skin
763189|NCT00392301|graft donor site|graft donor site
763190|NCT00392301|donor site|donor site
763191|NCT00392301|transepidermal water loss|transepidermal water loss
763192|NCT00392288|Bronchial Asthma|bronchial asthma
763193|NCT00392275|Cataract|cataract
763194|NCT00392275|Aqueous absorption|aqueous absorption
763195|NCT00392275|Funtioning Filtering Blebs|funtioning filtering blebs
763196|NCT00392262|Moderate essential hypertension (WHO grade II)|moderate essential hypertension (who grade ii)
763197|NCT00392249|Schizophrenia|schizophrenia
763198|NCT00392249|Drug adherence|drug adherence
763199|NCT00392236|Schizoaffective Disorder|schizoaffective disorder
763200|NCT00392197|OPC-14597|opc-14597
763201|NCT00392197|Schizophrenia|schizophrenia
763202|NCT00392184|accelerated partial breast irradiation|accelerated partial breast irradiation
763203|NCT00392184|multicatheter brachytherapy|multicatheter brachytherapy
763204|NCT00392184|high dose rate brachytherapy|high dose rate brachytherapy
763205|NCT00392184|pulsed dose rate brachytherapy|pulsed dose rate brachytherapy
763206|NCT00392145|Pediatrics|pediatrics
763207|NCT00392145|Gastroenteritis|gastroenteritis
763208|NCT00392145|Dehydration|dehydration
763209|NCT00392145|IV Rehydration|iv rehydration
763210|NCT00392132|HIV|hiv
763211|NCT00392119|MR-guided therapy|mr-guided therapy
763212|NCT00392119|Laser interstitial thermal therapy|laser interstitial thermal therapy
763213|NCT00392119|brain metastasis|brain metastasis
763214|NCT00392119|Magnetic Resonance Thermal imaging (MRTI)|magnetic resonance thermal imaging (mrti)
763215|NCT00392106|atrial fibrillation|atrial fibrillation
763216|NCT00392106|arrhythmia|arrhythmia
763217|NCT00392106|AF ablation|af ablation
763218|NCT00392106|antiarrhythmic agent|antiarrhythmic agent
763219|NCT00392106|catheter ablation|catheter ablation
763220|NCT00392106|pulmonary veins|pulmonary veins
763221|NCT00392093|Systemic lupus erythematosus|systemic lupus erythematosus
763222|NCT00392093|Menopause hormonal therapy|menopause hormonal therapy
763223|NCT00392093|Menopausal symptoms|menopausal symptoms
763224|NCT00392093|Bone mineral density|bone mineral density
763225|NCT00392054|Atrial Fibrillation|atrial fibrillation
763226|NCT00392054|Paroxysmal|paroxysmal
763227|NCT00392054|Pulmonary Vein Isolation|pulmonary vein isolation
763228|NCT00392054|Ablation Catheter|ablation catheter
763229|NCT00392054|Anti-arrhythmic Drug Therapy|anti-arrhythmic drug therapy
763230|NCT00392054|First Line Therapy|first line therapy
763231|NCT00392041|Fibromyalgia|fibromyalgia
763232|NCT00392041|Insomnia|insomnia
763233|NCT00392041|Sleep|sleep
763234|NCT00392041|Eszopiclone|eszopiclone
763237|NCT00392028|Bone drug level|bone drug level
763238|NCT00392028|Blood drug level|blood drug level
763239|NCT00392028|Tissue drug level|tissue drug level
763240|NCT00392015|Malaria Vaccine|malaria vaccine
763241|NCT00392015|Adenovirus|adenovirus
763242|NCT00392015|Plasmodium falciparum|plasmodium falciparum
763243|NCT00392002|GERD|gerd
763244|NCT00391989|Ph+ Acute Lymphoblastic Leukaemia|ph+ acute lymphoblastic leukaemia
763245|NCT00391989|Dasatinib|dasatinib
763246|NCT00391989|targeted therapy|targeted therapy
763247|NCT00391989|Patients with Ph positive and or BCR ABL positive ALL|patients with ph positive and or bcr abl positive all
763248|NCT00391976|Cystic fibrosis|cystic fibrosis
763249|NCT00391950|Prostate cancer|prostate cancer
763250|NCT00391950|Cancer treatment induced bone loss (CTIBL)|cancer treatment induced bone loss (ctibl)
763251|NCT00391950|Androgen deprivation therapy (ADT)|androgen deprivation therapy (adt)
763252|NCT00391937|"resurfacing hip [MESH]"|"resurfacing hip [mesh]"
763253|NCT00391937|"conventional position method"|"conventional position method"
763254|NCT00391937|"surgery, computer-assisted [MESH]"|"surgery, computer-assisted [mesh]"
763255|NCT00391924|Dehydroepiandrosterone|dehydroepiandrosterone
763256|NCT00391924|Fatigue|fatigue
763257|NCT00391924|Quality of life|quality of life
763258|NCT00391924|Lupus Erythematosus, Systemic|lupus erythematosus, systemic
763259|NCT00391924|Sjogren's Syndrome|sjogren's syndrome
763260|NCT00391924|Bone mineral density|bone mineral density
763261|NCT00391911|Rhabdomyolysis|rhabdomyolysis
763262|NCT00391911|CRRT|crrt
763263|NCT00391911|N-Acetylcysteine|n-acetylcysteine
763264|NCT00391898|Parkinson's disease, adults, levodopa/carbidopa/entacapone, wearing-off, activities of daily living|parkinson's disease, adults, levodopa/carbidopa/entacapone, wearing-off, activities of daily living
763265|NCT00391872|ACS|acs
763266|NCT00391872|Acute coronary syndrome|acute coronary syndrome
763267|NCT00391872|Heart attack|heart attack
763268|NCT00391872|Unstable angina|unstable angina
763269|NCT00391872|Coronary artery disease|coronary artery disease
763270|NCT00391859|Pharmacist-initiated Intervention Trial in OsteoArthritis|pharmacist-initiated intervention trial in osteoarthritis
763271|NCT00391846|Heart Failure|heart failure
763272|NCT00391846|Ventricular Dysfunction|ventricular dysfunction
763273|NCT00391846|NTproBNP|ntprobnp
763274|NCT00391833|Alzheimer's disease, Ginseng, CD34|alzheimer's disease, ginseng, cd34
763275|NCT00391820|constipation|constipation
763276|NCT00391820|chronic|chronic
763277|NCT00391820|bowel function|bowel function
763278|NCT00391807|Contraception|contraception
763279|NCT00391794|Memory|memory
763280|NCT00391794|Alzheimer's disease|alzheimer's disease
763281|NCT00391794|Dementia|dementia
763282|NCT00391794|Support Group|support group
763283|NCT00391794|Psychosocial|psychosocial
763284|NCT00391781|mechanical infertility|mechanical infertility
763285|NCT00391781|hysterosalpingogram|hysterosalpingogram
763286|NCT00391781|hysterosalpingography|hysterosalpingography
763287|NCT00391768|influenza, oseltamivir, Tamiflu®, antiviral, children, infants|influenza, oseltamivir, tamiflu®, antiviral, children, infants
763288|NCT00391755|Migraine Headache|migraine headache
763289|NCT00391742|Brief intervention|brief intervention
763290|NCT00391742|Motivational Interviewing|motivational interviewing
763291|NCT00391742|Primary care|primary care
763292|NCT00391742|Stepped-care|stepped-care
763293|NCT00391729|ADHD|adhd
763294|NCT00391716|Alcohol|alcohol
763295|NCT00391716|Alcohol treatment|alcohol treatment
763296|NCT00391716|Alcoholism|alcoholism
763297|NCT00391716|Alcohol Dependence|alcohol dependence
763298|NCT00391703|Cystic fibrosis|cystic fibrosis
763299|NCT00391703|mucoviscidosis|mucoviscidosis
763300|NCT00391703|electrostimulation|electrostimulation
763301|NCT00391703|retraining|retraining
763302|NCT00391690|Serum bone marker|serum bone marker
763303|NCT00391690|Prostate cancer|prostate cancer
763304|NCT00391690|Bisphosphonates|bisphosphonates
763305|NCT00391690|Early detection of metastasis|early detection of metastasis
763306|NCT00391677|Cognitive Rehabilitation|cognitive rehabilitation
763307|NCT00391677|Behavior Therapy|behavior therapy
763308|NCT00391664|Endometrial cancer|endometrial cancer
763309|NCT00391664|Ovarian Cancer|ovarian cancer
763310|NCT00391664|Cervical Cancer|cervical cancer
763311|NCT00391664|Genital Cancer|genital cancer
763312|NCT00391664|Vulvar Cancer|vulvar cancer
763313|NCT00391664|Vaginal Cancer|vaginal cancer
763314|NCT00391664|Other Gynecological Cancers|other gynecological cancers
763315|NCT00391651|UTI|uti
763316|NCT00391638|HIV and Hepatitis B coinfection|hiv and hepatitis b coinfection
763317|NCT00391638|Peg interferon|peg interferon
763318|NCT00391638|tenofovir|tenofovir
763319|NCT00391638|emtricitabine|emtricitabine
763320|NCT00391638|Hepatitis B e Antigens|hepatitis b e antigens
763321|NCT00391638|Treatment Experienced|treatment experienced
763322|NCT00391625|Gaucher disease, Enzyme Replacement Therapy|gaucher disease, enzyme replacement therapy
763323|NCT00391612|COPD (Chronic Obstructive Pulmonary Disease)|copd (chronic obstructive pulmonary disease)
763324|NCT00391612|Emphysema|emphysema
763325|NCT00391612|Hyperinflation|hyperinflation
763326|NCT00391612|Minimally Invasive|minimally invasive
763327|NCT00391599|Cesarean Section,|cesarean section,
763328|NCT00391599|Enema|enema
763329|NCT00391586|erlotinib|erlotinib
763330|NCT00391586|NSCLC|nsclc
763331|NCT00391586|chemotherapy|chemotherapy
763332|NCT00391586|platinum|platinum
763333|NCT00391586|lung|lung
763334|NCT00391586|lung cancer|lung cancer
763335|NCT00391560|refractory leukemia|refractory leukemia
763336|NCT00391547|Gingivitis Disease|gingivitis disease
763337|NCT00391534|Epilepsy|epilepsy
763338|NCT00391534|oxcarbazepine|oxcarbazepine
763339|NCT00391521|Oncology. All solid Tumour disease.|oncology. all solid tumour disease.
763340|NCT00391508|Ostomy|ostomy
763341|NCT00391508|Peristomal skin|peristomal skin
763342|NCT00391508|Skin complication|skin complication
763343|NCT00391495|ADHD|adhd
763344|NCT00391495|Cytokines|cytokines
763345|NCT00391495|CR-P|cr-p
763346|NCT00391482|IV Drug Users|iv drug users
763347|NCT00391482|Hepatitis C Virus|hepatitis c virus
763348|NCT00391482|Human Immunodeficiency Virus|human immunodeficiency virus
763349|NCT00391482|Intervention|intervention
763350|NCT00391482|HIV Seronegativity|hiv seronegativity
763351|NCT00391469|cardiac arrest|cardiac arrest
763352|NCT00391469|mild hypothermia|mild hypothermia
763353|NCT00391456|animal-assisted therapy|animal-assisted therapy
763354|NCT00391456|dog hospital visit|dog hospital visit
763355|NCT00391456|heart failure|heart failure
763356|NCT00391443|BUILD 3|build 3
763357|NCT00391443|Idiopathic Pulmonary Fibrosis|idiopathic pulmonary fibrosis
763358|NCT00391443|Tracleer|tracleer
763359|NCT00391443|Interstitial Lung Disease|interstitial lung disease
763360|NCT00391443|bosentan|bosentan
763361|NCT00391443|Actelion|actelion
763362|NCT00391430|PTSD|ptsd
763363|NCT00391430|Trauma|trauma
763364|NCT00391430|Sexual Abuse|sexual abuse
763365|NCT00391430|Sexual Assault|sexual assault
763366|NCT00391417|hot flush|hot flush
763367|NCT00391417|hot flash|hot flash
763368|NCT00391417|estrogen|estrogen
763369|NCT00391417|vaginal atrophy|vaginal atrophy
763370|NCT00391404|Childhood cancer survivors|childhood cancer survivors
763371|NCT00391404|Osteoporosis|osteoporosis
763372|NCT00391404|Bone mineral density|bone mineral density
763373|NCT00391404|Therapy|therapy
763374|NCT00391404|Bisphosphonate|bisphosphonate
763375|NCT00391404|Randomized controlled trial|randomized controlled trial
763376|NCT00391391|Influenza|influenza
763377|NCT00391391|Orthomyxoviruses|orthomyxoviruses
763378|NCT00391391|Inactivated Split-virion influenza vaccine|inactivated split-virion influenza vaccine
763379|NCT00391391|Infants|infants
763380|NCT00391391|children.|children.
763381|NCT00391378|Diffusion-Weighted Magnetic Resonance Imaging|diffusion-weighted magnetic resonance imaging
763382|NCT00391378|MRI (Magnetic Resonance Imaging)|mri (magnetic resonance imaging)
763383|NCT00391378|Stroke|stroke
763384|NCT00391378|Cognition|cognition
763385|NCT00391378|Heart|heart
763386|NCT00391365|ankle osteoarthritis|ankle osteoarthritis
763387|NCT00391365|arthritis|arthritis
763388|NCT00391365|arthrodesis|arthrodesis
763389|NCT00391365|arthroplasty|arthroplasty
763390|NCT00391365|Gait|gait
763391|NCT00391365|step count|step count
763392|NCT00391365|walking|walking
763393|NCT00391352|Multiple Sclerosis|multiple sclerosis
763394|NCT00391352|Disease Modifying Therapy|disease modifying therapy
763395|NCT00391339|Bryophyllum p.|bryophyllum p.
763396|NCT00391339|Nifedipine|nifedipine
763397|NCT00391339|Tocolysis|tocolysis
763398|NCT00391326|Bivalirudin|bivalirudin
763399|NCT00391326|Heparin|heparin
763400|NCT00391326|Bleeding|bleeding
763401|NCT00391326|TIMI flow|timi flow
763402|NCT00391326|STEMI|stemi
763403|NCT00391313|Chikungunya|chikungunya
763404|NCT00391313|Chikungunya disease|chikungunya disease
763405|NCT00391300|melanoma|melanoma
763406|NCT00391300|basal cell carcinoma of the skin|basal cell carcinoma of the skin
763407|NCT00391300|squamous cell carcinoma of the skin|squamous cell carcinoma of the skin
763408|NCT00391287|Red-Cell Aplasia due to Chronic Kidney Failure|red-cell aplasia due to chronic kidney failure
763409|NCT00391287|Aplastic Anemia|aplastic anemia
763410|NCT00391287|Recombinant Erythropoietin|recombinant erythropoietin
763411|NCT00391287|Surveillance Registry|surveillance registry
763412|NCT00391287|Registries|registries
763413|NCT00391261|weight gain|weight gain
763414|NCT00391261|obesity|obesity
763415|NCT00391261|metabolism|metabolism
763416|NCT00391248|non-small cell lung cancer|non-small cell lung cancer
763417|NCT00391248|palliative radiation|palliative radiation
763418|NCT00391248|tarceva|tarceva
763419|NCT00391248|palliative thoracic radiation therapy|palliative thoracic radiation therapy
763420|NCT00391235|bipolar disorder|bipolar disorder
763421|NCT00391235|magnetic resonance imaging|magnetic resonance imaging
763422|NCT00391235|white matter|white matter
763423|NCT00391235|diffusion tensor imaging|diffusion tensor imaging
763424|NCT00391235|children|children
763425|NCT00391235|adolescents|adolescents
763426|NCT00391222|Bipolar I Disorder|bipolar i disorder
763427|NCT00391222|Intramuscular injection|intramuscular injection
763428|NCT00391222|prevention of mood episodes|prevention of mood episodes
763429|NCT00391222|long acting injectable|long acting injectable
763430|NCT00391222|risperidone|risperidone
763431|NCT00391183|Gallbladder cancer|gallbladder cancer
763432|NCT00391183|Quality of life|quality of life
763435|NCT00391183|Performance status|performance status
763436|NCT00391170|Oral Chronic GVHD|oral chronic gvhd
763437|NCT00391170|Topical Dexamethasone|topical dexamethasone
763438|NCT00391170|Tissue Markers|tissue markers
763439|NCT00391170|Salivary Proteomics|salivary proteomics
763440|NCT00391170|Quality of Life|quality of life
763441|NCT00391170|Oral Chronic Graft Versus Host Disease|oral chronic graft versus host disease
763442|NCT00391170|Oral Pain|oral pain
763443|NCT00391170|Mouth Pain|mouth pain
763444|NCT00391157|Múltiple Myeloma|múltiple myeloma
763445|NCT00391157|Transplant|transplant
763446|NCT00391157|Patients <65 years.|patients <65 years.
763447|NCT00391144|Pattern Dystrophy|pattern dystrophy
763448|NCT00391144|Choroidal Neovascularization|choroidal neovascularization
763449|NCT00391144|Intravitreal Avastin Injection|intravitreal avastin injection
763450|NCT00391131|PID|pid
763451|NCT00391131|SCIG|scig
763452|NCT00391131|Ig|ig
763453|NCT00391131|Quality of Life|quality of life
763454|NCT00391131|Serious Bacterial Infections|serious bacterial infections
763455|NCT00391105|intubation|intubation
763456|NCT00391105|Sedation|sedation
763457|NCT00391105|Analgesia|analgesia
763458|NCT00391105|preterm neonate|preterm neonate
763459|NCT00391105|remifentanil|remifentanil
763460|NCT00391105|morphine|morphine
763461|NCT00391105|respiratory distress syndrome|respiratory distress syndrome
763462|NCT00391079|Central Neuropathic Pain|central neuropathic pain
763463|NCT00391066|CD23+/CD20+ B-cell CLL|cd23+/cd20+ b-cell cll
763464|NCT00391066|CLL|cll
763465|NCT00391053|Influenza|influenza
763466|NCT00391053|Orthomyxoviruses|orthomyxoviruses
763467|NCT00391053|Inactivated Split-virion influenza vaccine|inactivated split-virion influenza vaccine
763468|NCT00391053|Adults|adults
763469|NCT00391040|diabetes mellitus, structured treatment and teaching, education,|diabetes mellitus, structured treatment and teaching, education,
763470|NCT00391040|elderly patients, geriatrics|elderly patients, geriatrics
763471|NCT00391027|type 2 diabetes, insulin, glycemic control|type 2 diabetes, insulin, glycemic control
763472|NCT00391014|Acute myeloid Leukemia|acute myeloid leukemia
763473|NCT00391014|Allogeneic haematopoietic progenitor cell transplant|allogeneic haematopoietic progenitor cell transplant
763474|NCT00391014|Acute Invasive Aspergillosis|acute invasive aspergillosis
763475|NCT00391001|mania|mania
763476|NCT00391001|bipolar disorder|bipolar disorder
763477|NCT00391001|taurine|taurine
763478|NCT00391001|adolescents|adolescents
763479|NCT00390988|blood count|blood count
763480|NCT00390988|capillary|capillary
763481|NCT00390988|venous|venous
763482|NCT00390988|Adult|adult
763483|NCT00390988|reference values|reference values
763484|NCT00390975|Tegaserod|tegaserod
763485|NCT00390975|diabetes|diabetes
763486|NCT00390975|diabetic gastroparesis|diabetic gastroparesis
763487|NCT00390975|gastric emptying|gastric emptying
763488|NCT00390975|gastric retention|gastric retention
763489|NCT00390975|electrogastrography|electrogastrography
763490|NCT00390962|copeptin|copeptin
763491|NCT00390962|vasopressin|vasopressin
763492|NCT00390962|Adh|adh
763493|NCT00390962|SIADH|siadh
763494|NCT00390962|diabetes insipidus|diabetes insipidus
763495|NCT00390962|stroke|stroke
763496|NCT00390962|risk factors|risk factors
763497|NCT00390962|Neurological patients with ischemic and hemorrhagic stroke and patients undergoing intracranial surgery.|neurological patients with ischemic and hemorrhagic stroke and patients undergoing intracranial surgery.
763498|NCT00390949|HIV prevention|hiv prevention
763499|NCT00390949|Zimbabwe|zimbabwe
763500|NCT00390949|Core groups|core groups
763501|NCT00390949|Peer education|peer education
763502|NCT00390949|Syndromic management|syndromic management
763503|NCT00390949|Commercial sex workers|commercial sex workers
763504|NCT00390949|Condom distribution|condom distribution
763505|NCT00390949|HIV Seronegativity|hiv seronegativity
763506|NCT00390923|smoking|smoking
763507|NCT00390923|nicotine dependence|nicotine dependence
763508|NCT00390923|double-blind|double-blind
763509|NCT00390923|placebo-controlled|placebo-controlled
763510|NCT00390923|randomized|randomized
763511|NCT00390923|full substitution therapy|full substitution therapy
763512|NCT00390923|selegiline|selegiline
763513|NCT00390910|Pneumococcal vaccine|pneumococcal vaccine
763514|NCT00390910|Preterm|preterm
763515|NCT00390910|Safety|safety
763516|NCT00390910|Pneumococcal disease|pneumococcal disease
763517|NCT00390910|Immunogenicity|immunogenicity
763518|NCT00390897|chronic myeloid leukaemia|chronic myeloid leukaemia
763519|NCT00390897|Glivec|glivec
763520|NCT00390897|Interferon|interferon
763521|NCT00390884|Fluzone®|fluzone®
763522|NCT00390884|Influenza|influenza
763523|NCT00390884|Influenza virus infection|influenza virus infection
763524|NCT00390884|Influenza vaccine|influenza vaccine
763525|NCT00390858|β-thalassemia major|β-thalassemia major
763526|NCT00390858|iron overload|iron overload
763527|NCT00390858|deferasirox|deferasirox
763528|NCT00390858|pediatric rare anemia|pediatric rare anemia
763529|NCT00390845|MAP kinase|map kinase
763530|NCT00390845|SB681323|sb681323
763531|NCT00390845|neuropathic pain|neuropathic pain
763532|NCT00390845|patients|patients
763534|NCT00390845|nerve trauma|nerve trauma
763536|NCT00390819|Community acquired pneumonia|community acquired pneumonia
763537|NCT00390806|Brain metastases from Non-Small Cell Lung Cancer|brain metastases from non-small cell lung cancer
763538|NCT00390806|Brain metastases brain tumor lung cancer oral chemotherapy HYCAMTIN topotecan NSCLC WBRT whole brain radiation|brain metastases brain tumor lung cancer oral chemotherapy hycamtin topotecan nsclc wbrt whole brain radiation
763539|NCT00390780|Miconazole Lauriad|miconazole lauriad
763540|NCT00390780|Oropharyngeal candidiasis|oropharyngeal candidiasis
763541|NCT00390780|HIV patients|hiv patients
763542|NCT00390780|Mycology|mycology
763543|NCT00390780|Clinical picture of Oropharyngeal candidiasis|clinical picture of oropharyngeal candidiasis
763544|NCT00390780|Candida culture positive|candida culture positive
763545|NCT00390780|Treatment Experienced|treatment experienced
763546|NCT00390767|Peripheral arterial disease|peripheral arterial disease
763547|NCT00390767|Peripheral vascular disease|peripheral vascular disease
763548|NCT00390767|Claudication|claudication
763549|NCT00390767|Cell therapy|cell therapy
763550|NCT00390767|Gene therapy|gene therapy
763551|NCT00390767|Endothelial cells|endothelial cells
763552|NCT00390767|Smooth muscle cells|smooth muscle cells
763553|NCT00390767|Angiogenesis|angiogenesis
763554|NCT00390754|pregnancy|pregnancy
763555|NCT00390754|unintended|unintended
763556|NCT00390754|menses|menses
763557|NCT00390741|hip fracture|hip fracture
763558|NCT00390741|bone mineral density|bone mineral density
763559|NCT00390741|exercise|exercise
763560|NCT00390715|Acute Myeloblastic Leukemia|acute myeloblastic leukemia
763561|NCT00390702|Ventricular septal defect|ventricular septal defect
763562|NCT00390702|VSD|vsd
763563|NCT00390676|cancer|cancer
763564|NCT00390676|tumors|tumors
763565|NCT00390676|anticarcinogenic agents|anticarcinogenic agents
763566|NCT00390676|antineoplastic agents|antineoplastic agents
763567|NCT00390676|cadherins|cadherins
763568|NCT00390676|solid tumors|solid tumors
763569|NCT00390663|Paediatric|paediatric
763570|NCT00390663|Epistaxis|epistaxis
763571|NCT00390663|Nose bleed|nose bleed
763572|NCT00390663|Naseptin|naseptin
763573|NCT00390650|Anxiety|anxiety
763574|NCT00390650|clinical trials|clinical trials
763575|NCT00390637|Diogenes|diogenes
763576|NCT00390637|Diet Intervention|diet intervention
763577|NCT00390637|Family|family
763578|NCT00390637|Glycemic Index|glycemic index
763579|NCT00390637|Protein|protein
763580|NCT00390624|Urodilatin|urodilatin
763581|NCT00390624|Mannitol|mannitol
763582|NCT00390624|Acute Kidney Failure|acute kidney failure
763583|NCT00390611|Ovarian Cancer|ovarian cancer
763584|NCT00390598|colonoscopy|colonoscopy
763585|NCT00390598|large bowel preparation|large bowel preparation
763586|NCT00390598|bowel cleansing|bowel cleansing
763587|NCT00390598|randomized controlled trial|randomized controlled trial
763588|NCT00390585|Renal Insufficiency|renal insufficiency
763589|NCT00390585|Angioplasty, Transluminal, Percutaneous Coronary|angioplasty, transluminal, percutaneous coronary
763590|NCT00390585|Contrast media|contrast media
763591|NCT00390572|sleep|sleep
763592|NCT00390572|consultation and referral|consultation and referral
763593|NCT00390572|outcome assessment|outcome assessment
763594|NCT00390572|primary care|primary care
763595|NCT00390559|Nicotine Replacement Therapy|nicotine replacement therapy
763596|NCT00390559|Tobacco Smoking|tobacco smoking
763597|NCT00390559|Smoking stimuli|smoking stimuli
763598|NCT00390559|Gender|gender
763599|NCT00390533|Anxiety|anxiety
763600|NCT00390533|clinical trials|clinical trials
763601|NCT00390520|Type 2 diabetes|type 2 diabetes
763602|NCT00390520|vildagliptin|vildagliptin
763603|NCT00390520|glucagon|glucagon
763604|NCT00390520|hypoglycemia|hypoglycemia
763605|NCT00390507|Acceleromyography|acceleromyography
763606|NCT00390507|TOF-Watch|tof-watch
763607|NCT00390507|Posttetanic count|posttetanic count
763608|NCT00390507|Train of four|train of four
763609|NCT00390507|Neuromuscular blockade|neuromuscular blockade
763610|NCT00390494|Fibroids|fibroids
763611|NCT00390494|Leiomyoma|leiomyoma
763612|NCT00390494|Hysterectomy|hysterectomy
763613|NCT00390494|Myomectomy|myomectomy
763614|NCT00390494|Uterine Fibroid Embolization|uterine fibroid embolization
763615|NCT00390494|Questionnaire|questionnaire
763616|NCT00390481|Carotid Occlusion|carotid occlusion
763617|NCT00390481|Cognition|cognition
763618|NCT00390468|Tandutinib|tandutinib
763619|NCT00390468|MLN518|mln518
763620|NCT00390468|CT53518|ct53518
763621|NCT00390468|pain|pain
763622|NCT00390468|adenocarcinoma of the prostate|adenocarcinoma of the prostate
763623|NCT00390468|recurrent prostate cancer|recurrent prostate cancer
763624|NCT00390468|stage IV prostate cancer|stage iv prostate cancer
763625|NCT00390468|bone metastases|bone metastases
763626|NCT00390468|hormone-based castration|hormone-based castration
763627|NCT00390442|cardiogenic pulmonary edema|cardiogenic pulmonary edema
763628|NCT00390442|non invasive ventilation|non invasive ventilation
763629|NCT00390442|CPAP|cpap
763630|NCT00390429|stage IIIB non-small cell lung cancer|stage iiib non-small cell lung cancer
763631|NCT00390429|stage IV non-small cell lung cancer|stage iv non-small cell lung cancer
763632|NCT00390429|recurrent non-small cell lung cancer|recurrent non-small cell lung cancer
763633|NCT00390429|unspecified adult solid tumor, protocol specific|unspecified adult solid tumor, protocol specific
763634|NCT00390416|Metastatic|metastatic
763635|NCT00390416|Gastroesophageal|gastroesophageal
763636|NCT00390416|Docetaxel|docetaxel
763637|NCT00390416|Cisplatin|cisplatin
763638|NCT00390416|Fluorouracil|fluorouracil
763639|NCT00390416|Bevacizumab|bevacizumab
763640|NCT00390416|Metastatic Gastroesophageal Adenocarcinoma|metastatic gastroesophageal adenocarcinoma
763641|NCT00390416|06-096|06-096
763642|NCT00390403|adult glioblastoma|adult glioblastoma
763643|NCT00390403|adult gliosarcoma|adult gliosarcoma
763644|NCT00390403|adult giant cell glioblastoma|adult giant cell glioblastoma
763645|NCT00390390|Heartburn, frequent heartburn, proton pump inhibitor, lansoprazole|heartburn, frequent heartburn, proton pump inhibitor, lansoprazole
763646|NCT00390377|x-ray diffraction|x-ray diffraction
763647|NCT00390377|hair|hair
763648|NCT00390377|breast cancer|breast cancer
763649|NCT00390377|synchrotron|synchrotron
763650|NCT00390364|adenocarcinoma of the colon|adenocarcinoma of the colon
763651|NCT00390364|adenocarcinoma of the rectum|adenocarcinoma of the rectum
763652|NCT00390364|recurrent colon cancer|recurrent colon cancer
763653|NCT00390364|stage III colon cancer|stage iii colon cancer
763654|NCT00390364|stage IV colon cancer|stage iv colon cancer
763655|NCT00390364|recurrent rectal cancer|recurrent rectal cancer
763656|NCT00390364|stage III rectal cancer|stage iii rectal cancer
763657|NCT00390364|stage IV rectal cancer|stage iv rectal cancer
763658|NCT00390351|Optical coherence tomography|optical coherence tomography
763659|NCT00390338|recurrent melanoma|recurrent melanoma
763660|NCT00390338|stage IV melanoma|stage iv melanoma
763661|NCT00390338|stage IIIA melanoma|stage iiia melanoma
763662|NCT00390338|stage IIIB melanoma|stage iiib melanoma
763663|NCT00390338|stage IIIC melanoma|stage iiic melanoma
763664|NCT00390312|Post operative pain|post operative pain
763665|NCT00390312|Third molar extraction|third molar extraction
763666|NCT00390312|Dental surgery|dental surgery
763667|NCT00390312|Morphine|morphine
763668|NCT00390286|Telemedicine|telemedicine
763669|NCT00390273|diabetes|diabetes
763670|NCT00390273|metformin|metformin
763671|NCT00390273|hyperlactatemia|hyperlactatemia
763672|NCT00390221|MS|ms
763673|NCT00390221|multiple sclerosis|multiple sclerosis
763674|NCT00390208|Macular Degeneration|macular degeneration
764035|NCT00388869|calcium|calcium
763675|NCT00390208|Degenerative changes in the macula lutea of the retina.|degenerative changes in the macula lutea of the retina.
763676|NCT00390208|Maculopathy, Age-Related|maculopathy, age-related
763677|NCT00390208|Age-Related Maculopathies|age-related maculopathies
763678|NCT00390208|Age-Related Maculopathy|age-related maculopathy
763679|NCT00390208|Maculopathies, Age-Related|maculopathies, age-related
763680|NCT00390208|RETINAL DEGENERATION|retinal degeneration
763681|NCT00390208|ARMD|armd
763682|NCT00390208|AMD|amd
763683|NCT00390208|Lucentis|lucentis
763684|NCT00390208|Visudyne|visudyne
763685|NCT00390208|Photodynamic Therapy|photodynamic therapy
763686|NCT00390208|Verteporfin|verteporfin
763687|NCT00390208|Ranibizumab|ranibizumab
763688|NCT00390208|Intravitreal Dexamethasone|intravitreal dexamethasone
763689|NCT00390195|Hepatocellular carcinoma|hepatocellular carcinoma
763690|NCT00390195|RAD001|rad001
763691|NCT00390195|Rapamycin|rapamycin
763692|NCT00390195|Randomize|randomize
763693|NCT00390195|Phase I|phase i
763694|NCT00390195|Phase II|phase ii
763695|NCT00390195|Pharmacokinetics|pharmacokinetics
763696|NCT00390182|GI tumors|gi tumors
763697|NCT00390182|Locally Advanced|locally advanced
763698|NCT00390182|Metastatic|metastatic
763699|NCT00390182|Hepatobiliary|hepatobiliary
763700|NCT00390182|Ovary|ovary
763701|NCT00390169|breast neoplasms|breast neoplasms
763702|NCT00390169|stress|stress
763703|NCT00390169|personality|personality
763704|NCT00390169|psychology|psychology
763705|NCT00390156|refractory|refractory
763706|NCT00390156|prior treatment|prior treatment
763707|NCT00390156|solid tumors|solid tumors
763708|NCT00390156|phase I|phase i
763709|NCT00390156|phase 1|phase 1
763710|NCT00390143|Immunogenicity|immunogenicity
763711|NCT00390143|Meningococcal vaccine|meningococcal vaccine
763712|NCT00390143|Conjugate vaccine|conjugate vaccine
763713|NCT00390143|Persistence|persistence
763714|NCT00390130|Vaccination|vaccination
763715|NCT00390130|Pediatrics|pediatrics
763716|NCT00390130|Pain|pain
763717|NCT00390117|unspecified adult solid tumor, protocol specific|unspecified adult solid tumor, protocol specific
763718|NCT00390117|recurrent adult Burkitt lymphoma|recurrent adult burkitt lymphoma
763719|NCT00390117|recurrent adult diffuse large cell lymphoma|recurrent adult diffuse large cell lymphoma
763720|NCT00390117|recurrent adult diffuse mixed cell lymphoma|recurrent adult diffuse mixed cell lymphoma
763721|NCT00390117|recurrent adult immunoblastic large cell lymphoma|recurrent adult immunoblastic large cell lymphoma
763722|NCT00390117|recurrent adult lymphoblastic lymphoma|recurrent adult lymphoblastic lymphoma
763723|NCT00390117|recurrent adult diffuse small cleaved cell lymphoma|recurrent adult diffuse small cleaved cell lymphoma
763724|NCT00390117|recurrent grade 1 follicular lymphoma|recurrent grade 1 follicular lymphoma
763725|NCT00390117|recurrent grade 2 follicular lymphoma|recurrent grade 2 follicular lymphoma
763726|NCT00390117|recurrent grade 3 follicular lymphoma|recurrent grade 3 follicular lymphoma
763727|NCT00390117|recurrent mantle cell lymphoma|recurrent mantle cell lymphoma
763728|NCT00390117|recurrent marginal zone lymphoma|recurrent marginal zone lymphoma
763729|NCT00390117|recurrent small lymphocytic lymphoma|recurrent small lymphocytic lymphoma
763730|NCT00390117|Waldenstrom macroglobulinemia|waldenstrom macroglobulinemia
763731|NCT00390117|recurrent adult grade III lymphomatoid granulomatosis|recurrent adult grade iii lymphomatoid granulomatosis
763732|NCT00390117|adult nasal type extranodal NK/T-cell lymphoma|adult nasal type extranodal nk/t-cell lymphoma
763733|NCT00390117|extranodal marginal zone B-cell lymphoma of mucosa-associated lymphoid tissue|extranodal marginal zone b-cell lymphoma of mucosa-associated lymphoid tissue
763734|NCT00390117|nodal marginal zone B-cell lymphoma|nodal marginal zone b-cell lymphoma
763735|NCT00390117|splenic marginal zone lymphoma|splenic marginal zone lymphoma
763736|NCT00390104|Neuromuscular Disease|neuromuscular disease
763737|NCT00390104|Muscle weakness|muscle weakness
763738|NCT00390104|Muscle atrophy|muscle atrophy
763739|NCT00390091|Lupus|lupus
763740|NCT00390091|Nephritis|nephritis
763741|NCT00390091|Kidney|kidney
763742|NCT00390091|SLE|sle
763743|NCT00390091|Systemic Lupus Erythematosus|systemic lupus erythematosus
763744|NCT00390091|Nephritis, Lupus|nephritis, lupus
763745|NCT00390078|Vaccine|vaccine
763746|NCT00390078|Safety|safety
763747|NCT00390078|T-cell epitope|t-cell epitope
763748|NCT00390078|Acquired Immune Deficiency Syndrome Virus|acquired immune deficiency syndrome virus
763749|NCT00390078|HIV Therapeutic Vaccine|hiv therapeutic vaccine
763750|NCT00390065|Follow-up|follow-up
763751|NCT00390065|Premature infants|premature infants
763752|NCT00390065|Nitric Oxide|nitric oxide
763753|NCT00390065|Respiratory function testing|respiratory function testing
763754|NCT00390065|Neurodevelopmental outcomes|neurodevelopmental outcomes
763755|NCT00390039|Pain, postoperative|pain, postoperative
763756|NCT00390039|Surgery, orthopedic|surgery, orthopedic
763757|NCT00390039|Morphine|morphine
763758|NCT00390026|Neovascular age-related macular degeneration|neovascular age-related macular degeneration
763759|NCT00390026|Bevacizumab|bevacizumab
763760|NCT00390026|Photodynamic therapy|photodynamic therapy
763761|NCT00390013|Vulvar Pain|vulvar pain
763762|NCT00389948|Heartburn, frequent heartburn, proton pump inhibitor, lansoprazole|heartburn, frequent heartburn, proton pump inhibitor, lansoprazole
763763|NCT00389935|Gastrointestinal Bleeding|gastrointestinal bleeding
763764|NCT00389935|Arteriovenous Malformation|arteriovenous malformation
763765|NCT00389935|Angiodysplasia|angiodysplasia
763766|NCT00389935|Hereditary Hemorrhagic Telangiectasia|hereditary hemorrhagic telangiectasia
763767|NCT00389935|Obscure Bleeding|obscure bleeding
763768|NCT00389922|unspecified adult solid tumor, protocol specific|unspecified adult solid tumor, protocol specific
763769|NCT00389909|Premature infants|premature infants
763770|NCT00389909|Apnea|apnea
763771|NCT00389909|Doxapram|doxapram
763772|NCT00389909|pharmacokinetics|pharmacokinetics
763773|NCT00389883|supratentorial brain tumors|supratentorial brain tumors
763774|NCT00389883|propofol|propofol
763775|NCT00389883|sevoflurane|sevoflurane
763776|NCT00389883|remifentanil|remifentanil
763777|NCT00389883|sufentanil.|sufentanil.
763778|NCT00389870|recurrent colon cancer|recurrent colon cancer
763779|NCT00389870|stage IV colon cancer|stage iv colon cancer
763780|NCT00389870|recurrent rectal cancer|recurrent rectal cancer
763781|NCT00389870|stage IV rectal cancer|stage iv rectal cancer
763782|NCT00389870|adenocarcinoma of the colon|adenocarcinoma of the colon
763783|NCT00389870|adenocarcinoma of the rectum|adenocarcinoma of the rectum
763784|NCT00389857|Influenza|influenza
763785|NCT00389857|Influenza Virus Vaccine|influenza virus vaccine
763786|NCT00389857|Fluzone®|fluzone®
763787|NCT00389844|hip fracture|hip fracture
763788|NCT00389844|exercise|exercise
763789|NCT00389844|motivation|motivation
763790|NCT00389831|Rotigotine|rotigotine
763791|NCT00389831|Rotigotine nasal spray|rotigotine nasal spray
763792|NCT00389831|Efficacy, safety and tolerability|efficacy, safety and tolerability
763793|NCT00389831|Restless Legs Syndrome|restless legs syndrome
763794|NCT00389818|contiguous stage II grade 3 follicular lymphoma|contiguous stage ii grade 3 follicular lymphoma
763795|NCT00389818|noncontiguous stage II grade 3 follicular lymphoma|noncontiguous stage ii grade 3 follicular lymphoma
763796|NCT00389818|stage I grade 3 follicular lymphoma|stage i grade 3 follicular lymphoma
763797|NCT00389818|stage III grade 3 follicular lymphoma|stage iii grade 3 follicular lymphoma
763798|NCT00389818|stage IV grade 3 follicular lymphoma|stage iv grade 3 follicular lymphoma
763799|NCT00389818|AIDS-related diffuse large cell lymphoma|aids-related diffuse large cell lymphoma
763800|NCT00389818|contiguous stage II adult diffuse large cell lymphoma|contiguous stage ii adult diffuse large cell lymphoma
763801|NCT00389818|noncontiguous stage II adult diffuse large cell lymphoma|noncontiguous stage ii adult diffuse large cell lymphoma
763802|NCT00389818|stage I adult diffuse large cell lymphoma|stage i adult diffuse large cell lymphoma
763803|NCT00389818|stage III adult diffuse large cell lymphoma|stage iii adult diffuse large cell lymphoma
763804|NCT00389818|stage IV adult diffuse large cell lymphoma|stage iv adult diffuse large cell lymphoma
763805|NCT00389818|AIDS-related immunoblastic large cell lymphoma|aids-related immunoblastic large cell lymphoma
763806|NCT00389818|contiguous stage II adult immunoblastic large cell lymphoma|contiguous stage ii adult immunoblastic large cell lymphoma
763807|NCT00389818|noncontiguous stage II adult immunoblastic large cell lymphoma|noncontiguous stage ii adult immunoblastic large cell lymphoma
763808|NCT00389818|stage I adult immunoblastic large cell lymphoma|stage i adult immunoblastic large cell lymphoma
763809|NCT00389818|stage III adult immunoblastic large cell lymphoma|stage iii adult immunoblastic large cell lymphoma
763810|NCT00389818|stage IV adult immunoblastic large cell lymphoma|stage iv adult immunoblastic large cell lymphoma
763811|NCT00389818|AIDS-related peripheral/systemic lymphoma|aids-related peripheral/systemic lymphoma
763812|NCT00389805|recurrent non-small cell lung cancer|recurrent non-small cell lung cancer
763813|NCT00389805|stage IIIB non-small cell lung cancer|stage iiib non-small cell lung cancer
763814|NCT00389805|stage IV non-small cell lung cancer|stage iv non-small cell lung cancer
763815|NCT00389805|unspecified adult solid tumor, protocol specific|unspecified adult solid tumor, protocol specific
763816|NCT00389766|localized unresectable neuroblastoma|localized unresectable neuroblastoma
763817|NCT00389766|recurrent neuroblastoma|recurrent neuroblastoma
763818|NCT00389766|regional neuroblastoma|regional neuroblastoma
763819|NCT00389766|localized resectable neuroblastoma|localized resectable neuroblastoma
763820|NCT00389766|disseminated neuroblastoma|disseminated neuroblastoma
763821|NCT00389753|Scars|scars
763822|NCT00389753|Hydratation|hydratation
763823|NCT00389753|After Treatment|after treatment
763824|NCT00389714|pedodontics|pedodontics
763825|NCT00389714|carious|carious
763826|NCT00389714|dental restoration|dental restoration
763827|NCT00389714|antibacterial|antibacterial
763828|NCT00389714|nanoparticles|nanoparticles
763829|NCT00389701|stage I multiple myeloma|stage i multiple myeloma
763830|NCT00389701|stage II multiple myeloma|stage ii multiple myeloma
763831|NCT00389701|stage III multiple myeloma|stage iii multiple myeloma
763832|NCT00389701|refractory multiple myeloma|refractory multiple myeloma
763833|NCT00389688|stage I non-small cell lung cancer|stage i non-small cell lung cancer
763834|NCT00389688|stage II non-small cell lung cancer|stage ii non-small cell lung cancer
763835|NCT00389649|congestive heart failure|congestive heart failure
763836|NCT00389649|pacemaker|pacemaker
763837|NCT00389649|heart rate|heart rate
763838|NCT00389636|Diabetes|diabetes
763839|NCT00389636|Foot|foot
763840|NCT00389636|Extremity|extremity
763841|NCT00389636|Ulcer|ulcer
763842|NCT00389636|Wound|wound
763843|NCT00389636|Gauze|gauze
763844|NCT00389610|stage I pancreatic cancer|stage i pancreatic cancer
764036|NCT00388869|CT|ct
763845|NCT00389610|stage II pancreatic cancer|stage ii pancreatic cancer
763846|NCT00389610|stage III pancreatic cancer|stage iii pancreatic cancer
763847|NCT00389610|adenocarcinoma of the pancreas|adenocarcinoma of the pancreas
763848|NCT00389597|degenerative disc disease|degenerative disc disease
763849|NCT00389597|cervical arthroplasty|cervical arthroplasty
763850|NCT00389597|Mobi C|mobi c
763851|NCT00389597|multilevel|multilevel
763852|NCT00389597|anterior cervical discectomy and fusion|anterior cervical discectomy and fusion
763853|NCT00389584|cognitive/functional effects|cognitive/functional effects
763854|NCT00389584|poor performance status|poor performance status
763855|NCT00389584|long-term effects secondary to cancer therapy in adults|long-term effects secondary to cancer therapy in adults
763856|NCT00389584|long-term effects secondary to cancer therapy in children|long-term effects secondary to cancer therapy in children
763857|NCT00389584|adult tumors metastatic to brain|adult tumors metastatic to brain
763858|NCT00389584|unspecified adult solid tumor, protocol specific|unspecified adult solid tumor, protocol specific
763859|NCT00389584|unspecified childhood solid tumor, protocol specific|unspecified childhood solid tumor, protocol specific
763860|NCT00389558|Skin colonization|skin colonization
763861|NCT00389558|Antiseptic|antiseptic
763862|NCT00389558|Epicutaneocavous catheter dressing|epicutaneocavous catheter dressing
763863|NCT00389558|Infant|infant
763864|NCT00389532|Influenza|influenza
763865|NCT00389532|Influenza Vaccine|influenza vaccine
763866|NCT00389519|Hypertension/*etiology|hypertension/*etiology
763867|NCT00389519|Blood Pressure|blood pressure
763868|NCT00389519|Pediatric|pediatric
763869|NCT00389519|Adolescent|adolescent
763870|NCT00389519|Child|child
763871|NCT00389506|stage II adult Hodgkin lymphoma|stage ii adult hodgkin lymphoma
763872|NCT00389506|stage III adult Hodgkin lymphoma|stage iii adult hodgkin lymphoma
763873|NCT00389506|stage IV adult Hodgkin lymphoma|stage iv adult hodgkin lymphoma
763874|NCT00389506|recurrent adult Hodgkin lymphoma|recurrent adult hodgkin lymphoma
763876|NCT00389493|Augmentation|augmentation
763877|NCT00389493|Antipsychotics|antipsychotics
763878|NCT00389493|Cognitive-Behavioral Therapy|cognitive-behavioral therapy
763879|NCT00389480|Solid Tumors|solid tumors
763880|NCT00389480|Solid Malignancies|solid malignancies
763881|NCT00389480|Phase I|phase i
763882|NCT00389467|stroke|stroke
763883|NCT00389467|ischemic stroke|ischemic stroke
763884|NCT00389467|blood clot|blood clot
763885|NCT00389467|Merci Retriever|merci retriever
763886|NCT00389467|Penumbra System|penumbra system
763887|NCT00389467|embolectomy|embolectomy
763888|NCT00389467|magnetic resonance imaging|magnetic resonance imaging
763890|NCT00389467|CT|ct
763891|NCT00389467|SPOTRIAS|spotrias
763892|NCT00389454|Acetaminophen|acetaminophen
763893|NCT00389454|Fever|fever
763894|NCT00389454|cerebro spinal fluid|cerebro spinal fluid
763895|NCT00389454|Infants|infants
763896|NCT00389441|VEGFR inhibitor|vegfr inhibitor
763897|NCT00389441|tyrosine kinase inhibitor|tyrosine kinase inhibitor
763898|NCT00389441|anti-angiogenic|anti-angiogenic
763899|NCT00389441|carcinoma|carcinoma
763900|NCT00389441|papillary|papillary
763901|NCT00389441|follicular|follicular
763902|NCT00389441|medullary|medullary
763903|NCT00389441|anaplastic|anaplastic
763904|NCT00389428|Hematologic malignancies|hematologic malignancies
763905|NCT00389428|Malignancies, hematologic|malignancies, hematologic
763906|NCT00389428|Hematopoietic malignancies|hematopoietic malignancies
763907|NCT00389415|Type 2 Diabetes|type 2 diabetes
763908|NCT00389415|Vildagliptin|vildagliptin
763909|NCT00389415|HbA1c|hba1c
763910|NCT00389402|lipids|lipids
763911|NCT00389402|lipodystrophy|lipodystrophy
763912|NCT00389402|fat distribution|fat distribution
763913|NCT00389402|hiv-1|hiv-1
763914|NCT00389402|antiretroviral therapy|antiretroviral therapy
763915|NCT00389402|Treatment Naive|treatment naive
763916|NCT00389389|Advanced Solid Malignancies|advanced solid malignancies
763917|NCT00389389|Advanced solid tumors|advanced solid tumors
763918|NCT00389389|Cancer|cancer
763919|NCT00389389|Phase I|phase i
763920|NCT00389389|Solid tumors|solid tumors
763921|NCT00389389|Solid malignancies|solid malignancies
763922|NCT00389337|Sepsis|sepsis
763923|NCT00389337|SIRS|sirs
763924|NCT00389337|Biomarkers|biomarkers
763925|NCT00389337|xMAP|xmap
763926|NCT00389324|Primary immune deficiency|primary immune deficiency
763927|NCT00389311|Microbicide|microbicide
763928|NCT00389311|Safety|safety
763929|NCT00389311|HIV prevention|hiv prevention
763930|NCT00389311|HIV Seronegativity|hiv seronegativity
763931|NCT00389298|Chronic hepatitis C|chronic hepatitis c
763932|NCT00389298|Viral kinetics|viral kinetics
763933|NCT00389298|Phase II|phase ii
763934|NCT00389298|Pharmacokinetics (PK)|pharmacokinetics (pk)
763935|NCT00389298|Safety and tolerability|safety and tolerability
763936|NCT00389285|Carcinoma, renal cell|carcinoma, renal cell
763937|NCT00389285|interleukin-21|interleukin-21
763938|NCT00389285|sorafenib|sorafenib
763939|NCT00389285|Immunotherapy|immunotherapy
763940|NCT00389259|Insecticides|insecticides
763941|NCT00389259|Organophosphate|organophosphate
763942|NCT00389259|Scopolamine|scopolamine
763943|NCT00389259|randomized control study|randomized control study
764140|NCT00388570|adult|adult
763944|NCT00389259|Organophosphate or carbamate intoxication|organophosphate or carbamate intoxication
763945|NCT00389246|obesity|obesity
763946|NCT00389246|genetic consultation|genetic consultation
763947|NCT00389246|randomized controlled trial|randomized controlled trial
763948|NCT00389220|Coronary Disease|coronary disease
763949|NCT00389220|Coronary Stenosis|coronary stenosis
763950|NCT00389220|Angioplasty|angioplasty
763951|NCT00389220|Coronary Restenosis|coronary restenosis
763952|NCT00389220|Drug Eluting Stent|drug eluting stent
763953|NCT00389194|HIV-1 infection|hiv-1 infection
763954|NCT00389194|fat distribution|fat distribution
763955|NCT00389194|lipodystrophy|lipodystrophy
763956|NCT00389194|lipids|lipids
763957|NCT00389194|kidney function|kidney function
763958|NCT00389194|Treatment Experienced|treatment experienced
763959|NCT00389181|Unruptured brain arteriovenous malformation|unruptured brain arteriovenous malformation
763960|NCT00389181|AVM|avm
763961|NCT00389181|BAVM|bavm
763962|NCT00389181|Stroke|stroke
763963|NCT00389181|Intracranial Hemorrhage|intracranial hemorrhage
763964|NCT00389168|Hypertension|hypertension
763965|NCT00389168|Cardiac hypertrophy|cardiac hypertrophy
763966|NCT00389168|Angiotensin|angiotensin
763967|NCT00389168|Human|human
763968|NCT00389155|Advanced or metastatic transitional cell carcinoma of the urothelium|advanced or metastatic transitional cell carcinoma of the urothelium
763969|NCT00389142|pelvic pain|pelvic pain
763970|NCT00389142|urinary frequency|urinary frequency
763971|NCT00389142|painful bladder|painful bladder
763972|NCT00389142|urinary urgency|urinary urgency
763973|NCT00389129|Platelets|platelets
763974|NCT00389129|Aspirin Resistance|aspirin resistance
763975|NCT00389129|Platelet aggregation|platelet aggregation
763976|NCT00389090|temozolomide resistant|temozolomide resistant
763977|NCT00389090|anaplastic glioma|anaplastic glioma
763978|NCT00389090|anaplastic astrocytoma|anaplastic astrocytoma
763979|NCT00389090|anaplastic oligodendroglioma|anaplastic oligodendroglioma
763980|NCT00389090|anaplastic oligoastrocytoma|anaplastic oligoastrocytoma
763981|NCT00389077|perifosine|perifosine
763982|NCT00389077|solid tumors|solid tumors
763983|NCT00389077|lymphomas|lymphomas
763984|NCT00389077|anticancer agent|anticancer agent
763985|NCT00389064|Generalised Anxiety Disorder|generalised anxiety disorder
763986|NCT00389064|GAD|gad
763987|NCT00389051|Non-Hodgkin's Lymphoma|non-hodgkin's lymphoma
763988|NCT00389051|Malignant lymphoma|malignant lymphoma
763989|NCT00389038|headache|headache
763990|NCT00389038|coping skills training|coping skills training
763991|NCT00389038|amitriptyline|amitriptyline
763992|NCT00389038|attention control|attention control
763993|NCT00389025|Subject with clinical history of seasonal allergic conjunctivitis|subject with clinical history of seasonal allergic conjunctivitis
763994|NCT00389012|rehabilitation|rehabilitation
763995|NCT00389012|hemiplegic gait|hemiplegic gait
763996|NCT00389012|exercise therapy|exercise therapy
763997|NCT00389012|physical therapy|physical therapy
763998|NCT00388999|Multiple Myeloma|multiple myeloma
763999|NCT00388999|Stem Cell Transplant|stem cell transplant
764000|NCT00388999|rhMBL|rhmbl
764001|NCT00388973|Major Depressive Disorder|major depressive disorder
764002|NCT00388973|MDD|mdd
764003|NCT00388960|small cell lung cancer|small cell lung cancer
764004|NCT00388960|amrubicin|amrubicin
764005|NCT00388947|vaginal prolapse|vaginal prolapse
764006|NCT00388947|cystocele|cystocele
764007|NCT00388947|rectocele|rectocele
764008|NCT00388947|enterocele|enterocele
764009|NCT00388947|apical prolapse|apical prolapse
764010|NCT00388947|vaginal vault prolapse|vaginal vault prolapse
764011|NCT00388934|Percutaneous coronary intervention|percutaneous coronary intervention
764012|NCT00388934|Angina pectoris|angina pectoris
764013|NCT00388934|Stent|stent
764014|NCT00388921|Vitamin A|vitamin a
764015|NCT00388921|Children|children
764016|NCT00388921|Severe malnutrition|severe malnutrition
764017|NCT00388921|Retinol|retinol
764018|NCT00388921|Retinol binding protein|retinol binding protein
764019|NCT00388921|Diarrhoea|diarrhoea
764020|NCT00388921|ALRI|alri
764021|NCT00388921|Age 6-59 months|age 6-59 months
764022|NCT00388921|Either sex|either sex
764023|NCT00388921|Severe malnutrition as defined by the presence of any of the followings:|severe malnutrition as defined by the presence of any of the followings:
764024|NCT00388921|Bipedal oedema|bipedal oedema
764025|NCT00388921|Weight (measured after correction of dehydration) for height Z score <-3 of the National Center for Health Statistics (NCHS) reference|weight (measured after correction of dehydration) for height z score <-3 of the national center for health statistics (nchs) reference
764026|NCT00388921|Written informed consent of respective parents/ guardians for participation of the children in the study.|written informed consent of respective parents/ guardians for participation of the children in the study.
764027|NCT00388921|Children having diarrhoea (watery or invasive) or cough and cold or both for the last 48 hours.|children having diarrhoea (watery or invasive) or cough and cold or both for the last 48 hours.
764028|NCT00388908|vertebral fractures|vertebral fractures
764029|NCT00388908|osteoporosis|osteoporosis
764030|NCT00388908|prevention|prevention
764031|NCT00388908|case-finding|case-finding
764032|NCT00388908|quality improvement|quality improvement
764033|NCT00388895|Acute lymphoblastic Leukemia|acute lymphoblastic leukemia
764034|NCT00388869|renal artery|renal artery
764037|NCT00388869|hypertension|hypertension
764038|NCT00388856|antioxidant supplementation|antioxidant supplementation
764039|NCT00388856|preeclampsia|preeclampsia
764040|NCT00388856|prevention|prevention
764041|NCT00388843|carotid atherosclerosis|carotid atherosclerosis
764042|NCT00388843|magnetic resonance imaging|magnetic resonance imaging
764043|NCT00388843|atherosclerosis|atherosclerosis
764044|NCT00388843|ultrasound|ultrasound
764045|NCT00388843|inflammation|inflammation
764046|NCT00388843|statins|statins
764047|NCT00388843|vulnerable plaque|vulnerable plaque
764048|NCT00388843|stroke|stroke
764049|NCT00388830|Gallbladder|gallbladder
764050|NCT00388830|Ultrasound|ultrasound
764051|NCT00388830|Emergency Medicine|emergency medicine
764052|NCT00388817|Hypertension|hypertension
764053|NCT00388817|Blood pressure|blood pressure
764054|NCT00388817|Adherence|adherence
764055|NCT00388817|Compliance|compliance
764056|NCT00388817|Pharmacist|pharmacist
764057|NCT00388817|Pharmacy|pharmacy
764058|NCT00388817|Costs|costs
764059|NCT00388804|Prostate Cancer|prostate cancer
764060|NCT00388804|External Beam Radiotherapy|external beam radiotherapy
764061|NCT00388804|Radiation Therapy|radiation therapy
764062|NCT00388804|Hormone Therapy|hormone therapy
764063|NCT00388804|Bicalutamide|bicalutamide
764064|NCT00388804|Casodex|casodex
764065|NCT00388804|Leuprolide|leuprolide
764066|NCT00388804|Lupron|lupron
764067|NCT00388804|Goserelin|goserelin
764068|NCT00388804|Zoladex|zoladex
764069|NCT00388804|Flutamide|flutamide
764070|NCT00388804|EBRT|ebrt
764071|NCT00388791|symptomatology|symptomatology
764072|NCT00388791|Schein questionnaire|schein questionnaire
764073|NCT00388791|fluoresceien staining|fluoresceien staining
764074|NCT00388765|bronchoscopy|bronchoscopy
764075|NCT00388765|sample bank|sample bank
764076|NCT00388765|research study volunteer|research study volunteer
764077|NCT00388752|Acupuncture|acupuncture
764078|NCT00388752|Phantom limb pain|phantom limb pain
764079|NCT00388752|Residual limb pain|residual limb pain
764080|NCT00388752|amputation|amputation
764081|NCT00388752|amputee|amputee
764082|NCT00388752|traumatic|traumatic
764083|NCT00388752|surgical|surgical
764084|NCT00388752|Traumatic amputation upper extremity|traumatic amputation upper extremity
764085|NCT00388752|Traumatic amputation lower extremity|traumatic amputation lower extremity
764086|NCT00388752|Surgical amputation upper extremity|surgical amputation upper extremity
764087|NCT00388752|Surgical amputation lower extremity|surgical amputation lower extremity
764088|NCT00388739|Pediatric Asthma|pediatric asthma
764089|NCT00388739|Pulmicort|pulmicort
764090|NCT00388739|TEDAS ED|tedas ed
764091|NCT00388739|Acute exacerbation of asthma|acute exacerbation of asthma
764092|NCT00388739|Chronic asthma|chronic asthma
764093|NCT00388726|Locally recurrent breast cancer|locally recurrent breast cancer
764094|NCT00388726|metastatic breast cancer|metastatic breast cancer
764095|NCT00388713|Radiation therapy|radiation therapy
764096|NCT00388713|Radiation-Induced Atherosclerosis|radiation-induced atherosclerosis
764097|NCT00388713|Carotid Artery Diseases|carotid artery diseases
764098|NCT00388713|Breast Cancer|breast cancer
764099|NCT00388713|Intima Media thickening Ultrasound|intima media thickening ultrasound
764100|NCT00388700|Colorectal cancer, DAVANAT, colon cancer, 5-FU|colorectal cancer, davanat, colon cancer, 5-fu
764101|NCT00388687|Hypoxia|hypoxia
764102|NCT00388687|FAZA|faza
764103|NCT00388687|PET|pet
764104|NCT00388687|Radiochemotherapy|radiochemotherapy
764105|NCT00388674|Chronic Hepatitis B Virus|chronic hepatitis b virus
764106|NCT00388661|sleep problems|sleep problems
764107|NCT00388661|quality of life|quality of life
764108|NCT00388661|melatonin|melatonin
764109|NCT00388661|sleep apnea|sleep apnea
764110|NCT00388661|medication|medication
764111|NCT00388661|preload|preload
764112|NCT00388661|nutritional status|nutritional status
764113|NCT00388661|ProBNP|probnp
764114|NCT00388648|Dialysis|dialysis
764115|NCT00388648|Vegan Diet|vegan diet
764116|NCT00388648|Mortality|mortality
764117|NCT00388648|Morbidity|morbidity
764118|NCT00388648|Treatment outcome|treatment outcome
764119|NCT00388635|Multiple Myeloma|multiple myeloma
764120|NCT00388635|Patients over 65 years old|patients over 65 years old
764121|NCT00388622|Heart failure|heart failure
764122|NCT00388622|Adherence|adherence
764123|NCT00388622|Compliance|compliance
764124|NCT00388622|Pharmacy|pharmacy
764125|NCT00388622|Pharmacist|pharmacist
764126|NCT00388622|Health-related quality of life|health-related quality of life
764127|NCT00388622|Clinical exacerbation|clinical exacerbation
764128|NCT00388622|Costs|costs
764129|NCT00388596|SB-751689|sb-751689
764130|NCT00388596|osteoporosis|osteoporosis
764131|NCT00388596|drug interaction|drug interaction
764132|NCT00388596|ketoconazole|ketoconazole
764133|NCT00388596|atorvastatin|atorvastatin
764134|NCT00388596|rosuvastatin|rosuvastatin
764135|NCT00388583|Influenza|influenza
764136|NCT00388583|Orthomyxoviruses|orthomyxoviruses
764137|NCT00388583|Inactivated Split-virion influenza vaccine|inactivated split-virion influenza vaccine
764138|NCT00388583|Elderly.|elderly.
764139|NCT00388570|Asthma|asthma
764141|NCT00388570|paediatric|paediatric
764142|NCT00388570|NIOX MINO®|niox mino®
764143|NCT00388570|NIOX®|niox®
764144|NCT00388570|nitric oxide|nitric oxide
764145|NCT00388570|airway inflammation|airway inflammation
764146|NCT00388570|open−label|open−label
764147|NCT00388570|single−cohort|single−cohort
764148|NCT00388531|Acute Lymphoblastic Leucemia|acute lymphoblastic leucemia
764149|NCT00388531|Aggressive Non-Hodgkin-Lymphoma|aggressive non-hodgkin-lymphoma
764150|NCT00388531|CNS relapse|cns relapse
764151|NCT00388531|Cytarabine liposome|cytarabine liposome
764152|NCT00388505|tobramycin|tobramycin
764153|NCT00388492|HIV Infected|hiv infected
764154|NCT00388466|whole body vibration|whole body vibration
764155|NCT00388466|muscle function|muscle function
764156|NCT00388466|cystic fibrosis|cystic fibrosis
764157|NCT00388466|mechanography|mechanography
764158|NCT00388466|chair-rising-test|chair-rising-test
764159|NCT00388453|Healthy volunteers|healthy volunteers
764160|NCT00388440|Mumps|mumps
764161|NCT00388440|Singapore|singapore
764162|NCT00388440|Rubella|rubella
764163|NCT00388440|Measles|measles
764164|NCT00388427|advanced cancer|advanced cancer
764165|NCT00388427|solid tumor|solid tumor
764166|NCT00388427|solid malignancies|solid malignancies
764167|NCT00388427|phase I|phase i
764168|NCT00388401|Postoperative Ileus|postoperative ileus
764169|NCT00388388|Remodeling|remodeling
764170|NCT00388388|Resistance arteries|resistance arteries
764171|NCT00388388|angiotensin receptor blocker|angiotensin receptor blocker
764172|NCT00388388|thiazide diuretic|thiazide diuretic
764173|NCT00388362|GVHD|gvhd
764174|NCT00388336|Anemia|anemia
764175|NCT00388336|Neoplasms, Hemoglobin values|neoplasms, hemoglobin values
764176|NCT00388336|PROCRIT|procrit
764177|NCT00388336|Epoetin alfa|epoetin alfa
764178|NCT00388323|Alcohol|alcohol
764179|NCT00388323|Hepatitis|hepatitis
764180|NCT00388323|Cirrhosis|cirrhosis
764181|NCT00388323|Inflammation|inflammation
764182|NCT00388323|Cytokines|cytokines
764183|NCT00388323|ADIPOKINES|adipokines
764184|NCT00388323|Adipose tissue|adipose tissue
764185|NCT00388310|cellulitis|cellulitis
764186|NCT00388310|furuncles|furuncles
764187|NCT00388310|carbuncles|carbuncles
764188|NCT00388310|abscess|abscess
764189|NCT00388297|Subclinical Hypothyroidism|subclinical hypothyroidism
764190|NCT00388297|Hypothyroxinemia|hypothyroxinemia
764191|NCT00388297|Thyroid|thyroid
764192|NCT00388297|Pregnancy|pregnancy
764193|NCT00388297|Intellectual Development|intellectual development
764194|NCT00388284|hemostasis|hemostasis
764195|NCT00388284|arterial sealing|arterial sealing
764196|NCT00388271|Alpha-blocker|alpha-blocker
764197|NCT00388271|Alfuzosin|alfuzosin
764200|NCT00388258|Postoperative ileus|postoperative ileus
764201|NCT00388245|PCI|pci
764202|NCT00388245|CABG|cabg
764203|NCT00388245|Ejection Fraction|ejection fraction
764204|NCT00388245|Myocardial Revascularization|myocardial revascularization
764205|NCT00388232|COPD|copd
764206|NCT00388232|prevalence|prevalence
764207|NCT00388232|smoke|smoke
764208|NCT00388232|biomass|biomass
764209|NCT00388232|occupational|occupational
764210|NCT00388232|Malatya|malatya
764211|NCT00388232|Turkey|turkey
764212|NCT00388219|Buprenorphine|buprenorphine
764213|NCT00388219|Transdermal patch|transdermal patch
764214|NCT00388219|Centrally acting analgesic|centrally acting analgesic
764215|NCT00388219|Plasma level|plasma level
764216|NCT00388219|Healthy volunteers|healthy volunteers
764217|NCT00388206|NSCLC|nsclc
764218|NCT00388206|Avastin|avastin
764219|NCT00388206|anti-VEGF|anti-vegf
764220|NCT00388206|lung cancer|lung cancer
764221|NCT00388206|colorectal cancer|colorectal cancer
764222|NCT00388206|ARIES|aries
764223|NCT00388206|Colon Cancer|colon cancer
764224|NCT00388193|ALL (L3)|all (l3)
764225|NCT00388193|BURKITT's LYMPHOMA|burkitt's lymphoma
764226|NCT00388193|RITUXIMAB|rituximab
764227|NCT00388180|cholesterol|cholesterol
764228|NCT00388180|inflammation|inflammation
764229|NCT00388180|fat|fat
764230|NCT00388167|Invader fungal infection (IFI)|invader fungal infection (ifi)
764231|NCT00388167|Invasive Aspergillosis (AI)|invasive aspergillosis (ai)
764232|NCT00388167|Invasive Candidiasis (CI)|invasive candidiasis (ci)
764233|NCT00388167|Caspofungin acetate|caspofungin acetate
764234|NCT00388154|Endometrial Cancer|endometrial cancer
764235|NCT00388154|Gemcitabine|gemcitabine
764236|NCT00388154|Gemzar|gemzar
764237|NCT00388154|Gemcitabine Hydrochloride|gemcitabine hydrochloride
764238|NCT00388154|Cisplatin|cisplatin
764239|NCT00388154|Platinol-AQ|platinol-aq
764240|NCT00388154|Platinol|platinol
764241|NCT00388154|CDDP|cddp
764242|NCT00388141|Preterm Infant;|preterm infant;
764243|NCT00388141|NIDCAP;|nidcap;
764244|NCT00388141|Neonatal Care,|neonatal care,
764245|NCT00388141|Intervention Study;|intervention study;
764246|NCT00388141|Growth and Development;|growth and development;
764247|NCT00388141|Maternal Self-esteem.|maternal self-esteem.
764248|NCT00388141|Maternal Social support|maternal social support
764249|NCT00388141|NICU|nicu
764250|NCT00388128|Intermittent Claudication|intermittent claudication
764251|NCT00388128|PAD|pad
764252|NCT00388128|Caffeine|caffeine
764253|NCT00388128|Walking capacity|walking capacity
764254|NCT00388128|ABI|abi
764255|NCT00388128|QoL|qol
764256|NCT00388128|Growth factor|growth factor
764257|NCT00388115|ductal breast carcinoma in situ|ductal breast carcinoma in situ
764258|NCT00388115|stage I breast cancer|stage i breast cancer
764259|NCT00388115|stage II breast cancer|stage ii breast cancer
764260|NCT00388115|breast cancer in situ|breast cancer in situ
764261|NCT00388089|unspecified adult solid tumor, protocol specific|unspecified adult solid tumor, protocol specific
764262|NCT00388089|extensive stage small cell lung cancer|extensive stage small cell lung cancer
764263|NCT00388089|recurrent small cell lung cancer|recurrent small cell lung cancer
764264|NCT00388076|carboplatin|carboplatin
764265|NCT00388076|lapatinib|lapatinib
764266|NCT00388076|TAXOL|taxol
764267|NCT00388076|PARAPLATIN|paraplatin
764268|NCT00388076|paclitaxel|paclitaxel
764269|NCT00388076|TYKERB|tykerb
764270|NCT00388076|Pazopanib|pazopanib
764271|NCT00388063|Neuroendocrine|neuroendocrine
764272|NCT00388063|Carcinoma|carcinoma
764273|NCT00388063|Atiprimod|atiprimod
764274|NCT00388063|Carcinoid|carcinoid
764275|NCT00388050|Decision aid, diabetes, primary care|decision aid, diabetes, primary care
764276|NCT00388024|stage III squamous cell carcinoma of the hypopharynx|stage iii squamous cell carcinoma of the hypopharynx
764277|NCT00388024|stage III squamous cell carcinoma of the larynx|stage iii squamous cell carcinoma of the larynx
764278|NCT00388024|stage III squamous cell carcinoma of the lip and oral cavity|stage iii squamous cell carcinoma of the lip and oral cavity
764279|NCT00388024|stage III squamous cell carcinoma of the nasopharynx|stage iii squamous cell carcinoma of the nasopharynx
764280|NCT00388024|stage III squamous cell carcinoma of the oropharynx|stage iii squamous cell carcinoma of the oropharynx
764281|NCT00388024|stage III lymphoepithelioma of the nasopharynx|stage iii lymphoepithelioma of the nasopharynx
764282|NCT00388024|stage III lymphoepithelioma of the oropharynx|stage iii lymphoepithelioma of the oropharynx
764283|NCT00388024|squamous cell carcinoma of unknown primary|squamous cell carcinoma of unknown primary
764284|NCT00388024|newly diagnosed carcinoma of unknown primary|newly diagnosed carcinoma of unknown primary
764285|NCT00388024|metastatic squamous neck cancer with occult primary squamous cell carcinoma|metastatic squamous neck cancer with occult primary squamous cell carcinoma
764286|NCT00388024|untreated metastatic squamous neck cancer with occult primary|untreated metastatic squamous neck cancer with occult primary
764287|NCT00388024|stage IV squamous cell carcinoma of the hypopharynx|stage iv squamous cell carcinoma of the hypopharynx
764288|NCT00388024|stage IV squamous cell carcinoma of the larynx|stage iv squamous cell carcinoma of the larynx
764289|NCT00388024|stage IV squamous cell carcinoma of the lip and oral cavity|stage iv squamous cell carcinoma of the lip and oral cavity
764290|NCT00388024|stage IV squamous cell carcinoma of the nasopharynx|stage iv squamous cell carcinoma of the nasopharynx
764291|NCT00388024|stage IV squamous cell carcinoma of the oropharynx|stage iv squamous cell carcinoma of the oropharynx
764292|NCT00388024|stage IV lymphoepithelioma of the nasopharynx|stage iv lymphoepithelioma of the nasopharynx
764293|NCT00388024|stage IV lymphoepithelioma of the oropharynx|stage iv lymphoepithelioma of the oropharynx
764294|NCT00388011|Post surgical pain|post surgical pain
764295|NCT00388011|Bunionectomy|bunionectomy
764296|NCT00388011|Hammer Toe Syndrome|hammer toe syndrome
764297|NCT00388011|Morphine|morphine
764298|NCT00387998|unspecified adult solid tumor, protocol specific|unspecified adult solid tumor, protocol specific
764299|NCT00387972|Type 2 diabetes mellitus (T2DM)|type 2 diabetes mellitus (t2dm)
764300|NCT00387972|glycosylated hemoglobin (HbA1c)|glycosylated hemoglobin (hba1c)
764301|NCT00387972|denagliptin|denagliptin
764302|NCT00387972|diabetes treatment|diabetes treatment
764303|NCT00387972|glycemic control|glycemic control
764304|NCT00387959|recurrent mantle cell lymphoma|recurrent mantle cell lymphoma
764305|NCT00387959|stage III mantle cell lymphoma|stage iii mantle cell lymphoma
764306|NCT00387959|stage IV mantle cell lymphoma|stage iv mantle cell lymphoma
764307|NCT00387959|recurrent adult diffuse large cell lymphoma|recurrent adult diffuse large cell lymphoma
764308|NCT00387959|stage III adult diffuse large cell lymphoma|stage iii adult diffuse large cell lymphoma
764309|NCT00387959|stage IV adult diffuse large cell lymphoma|stage iv adult diffuse large cell lymphoma
764310|NCT00387959|B-cell chronic lymphocytic leukemia|b-cell chronic lymphocytic leukemia
764311|NCT00387959|refractory chronic lymphocytic leukemia|refractory chronic lymphocytic leukemia
764312|NCT00387959|stage III chronic lymphocytic leukemia|stage iii chronic lymphocytic leukemia
764313|NCT00387959|stage IV chronic lymphocytic leukemia|stage iv chronic lymphocytic leukemia
764314|NCT00387959|extranodal marginal zone B-cell lymphoma of mucosa-associated lymphoid tissue|extranodal marginal zone b-cell lymphoma of mucosa-associated lymphoid tissue
764315|NCT00387959|nodal marginal zone B-cell lymphoma|nodal marginal zone b-cell lymphoma
764316|NCT00387959|recurrent marginal zone lymphoma|recurrent marginal zone lymphoma
764317|NCT00387959|recurrent adult diffuse small cleaved cell lymphoma|recurrent adult diffuse small cleaved cell lymphoma
764318|NCT00387959|splenic marginal zone lymphoma|splenic marginal zone lymphoma
764319|NCT00387959|recurrent grade 1 follicular lymphoma|recurrent grade 1 follicular lymphoma
764320|NCT00387959|recurrent grade 2 follicular lymphoma|recurrent grade 2 follicular lymphoma
764321|NCT00387959|recurrent grade 3 follicular lymphoma|recurrent grade 3 follicular lymphoma
764409|NCT00387647|myeloid|myeloid
764410|NCT00387647|acute|acute
764322|NCT00387959|noncontiguous stage II grade 1 follicular lymphoma|noncontiguous stage ii grade 1 follicular lymphoma
764323|NCT00387959|noncontiguous stage II grade 2 follicular lymphoma|noncontiguous stage ii grade 2 follicular lymphoma
764324|NCT00387959|noncontiguous stage II grade 3 follicular lymphoma|noncontiguous stage ii grade 3 follicular lymphoma
764325|NCT00387959|stage III grade 1 follicular lymphoma|stage iii grade 1 follicular lymphoma
764326|NCT00387959|stage III grade 2 follicular lymphoma|stage iii grade 2 follicular lymphoma
764327|NCT00387959|stage III grade 3 follicular lymphoma|stage iii grade 3 follicular lymphoma
764328|NCT00387959|stage IV grade 1 follicular lymphoma|stage iv grade 1 follicular lymphoma
764329|NCT00387959|stage IV grade 2 follicular lymphoma|stage iv grade 2 follicular lymphoma
764330|NCT00387959|stage IV grade 3 follicular lymphoma|stage iv grade 3 follicular lymphoma
764331|NCT00387959|noncontiguous stage II marginal zone lymphoma|noncontiguous stage ii marginal zone lymphoma
764332|NCT00387959|stage III marginal zone lymphoma|stage iii marginal zone lymphoma
764333|NCT00387959|stage IV marginal zone lymphoma|stage iv marginal zone lymphoma
764334|NCT00387959|noncontiguous stage II adult diffuse small cleaved cell lymphoma|noncontiguous stage ii adult diffuse small cleaved cell lymphoma
764335|NCT00387959|stage III adult diffuse small cleaved cell lymphoma|stage iii adult diffuse small cleaved cell lymphoma
764336|NCT00387959|stage IV adult diffuse small cleaved cell lymphoma|stage iv adult diffuse small cleaved cell lymphoma
764337|NCT00387959|noncontiguous stage II adult diffuse large cell lymphoma|noncontiguous stage ii adult diffuse large cell lymphoma
764338|NCT00387959|noncontiguous stage II mantle cell lymphoma|noncontiguous stage ii mantle cell lymphoma
764339|NCT00387946|smoking|smoking
764340|NCT00387946|cessation|cessation
764341|NCT00387946|tobacco|tobacco
764342|NCT00387933|recurrent adult brain tumor|recurrent adult brain tumor
764343|NCT00387933|adult glioblastoma|adult glioblastoma
764344|NCT00387933|adult anaplastic astrocytoma|adult anaplastic astrocytoma
764345|NCT00387933|adult anaplastic oligodendroglioma|adult anaplastic oligodendroglioma
764346|NCT00387933|adult gliosarcoma|adult gliosarcoma
764347|NCT00387933|adult giant cell glioblastoma|adult giant cell glioblastoma
764348|NCT00387933|adult anaplastic ependymoma|adult anaplastic ependymoma
764349|NCT00387933|adult brain stem glioma|adult brain stem glioma
764350|NCT00387933|adult mixed glioma|adult mixed glioma
764351|NCT00387933|adult pineal gland astrocytoma|adult pineal gland astrocytoma
764352|NCT00387907|Herceptin|herceptin
764353|NCT00387907|Taxane|taxane
764354|NCT00387907|Breast Cancer|breast cancer
764355|NCT00387894|adult glioblastoma|adult glioblastoma
764356|NCT00387894|adult gliosarcoma|adult gliosarcoma
764357|NCT00387894|recurrent adult brain tumor|recurrent adult brain tumor
764358|NCT00387881|sumatriptan succinate,|sumatriptan succinate,
764359|NCT00387881|naproxen sodium,|naproxen sodium,
764360|NCT00387881|parallel group,|parallel group,
764361|NCT00387881|double-blind,|double-blind,
764362|NCT00387881|placebo-controlled,|placebo-controlled,
764363|NCT00387881|Combination product,|combination product,
764364|NCT00387881|migrainous headache|migrainous headache
764365|NCT00387881|Probable migraine, a sub-type of Migraine|probable migraine, a sub-type of migraine
764366|NCT00387881|probable migraine,|probable migraine,
764367|NCT00387868|Thymoma|thymoma
764368|NCT00387868|Thymic carcinoma|thymic carcinoma
764369|NCT00387868|Preoperative chemotherapy and radiation|preoperative chemotherapy and radiation
764370|NCT00387868|Response rate|response rate
764371|NCT00387855|suicide|suicide
764372|NCT00387855|depression|depression
764373|NCT00387777|Buprenorphine|buprenorphine
764374|NCT00387777|Transdermal patch|transdermal patch
764375|NCT00387777|multidose|multidose
764376|NCT00387777|Centrally acting analgesic|centrally acting analgesic
764377|NCT00387777|Plasma level|plasma level
764378|NCT00387777|Healthy volunteers|healthy volunteers
764379|NCT00387764|renal cell carcinoma|renal cell carcinoma
764380|NCT00387764|pazopanib|pazopanib
764381|NCT00387764|anti-angiogenic therapy|anti-angiogenic therapy
764382|NCT00387764|open label|open label
764383|NCT00387738|Ragweed|ragweed
764384|NCT00387738|Allergy|allergy
764385|NCT00387738|Allergic|allergic
764386|NCT00387738|Rhinitis|rhinitis
764387|NCT00387738|Hay Fever|hay fever
764388|NCT00387738|Seasonal|seasonal
764389|NCT00387738|Treatment|treatment
764390|NCT00387738|Immunotherapy|immunotherapy
764391|NCT00387738|Vaccine|vaccine
764392|NCT00387725|Adolescent|adolescent
764393|NCT00387725|Meningococcal|meningococcal
764394|NCT00387725|Safety|safety
764395|NCT00387712|exercise|exercise
764396|NCT00387712|inflammation|inflammation
764397|NCT00387712|motor performance|motor performance
764398|NCT00387712|skeletal muscle|skeletal muscle
764399|NCT00387712|chronic stroke survivors|chronic stroke survivors
764400|NCT00387712|treadmill exercise|treadmill exercise
764401|NCT00387699|limited stage small cell lung cancer|limited stage small cell lung cancer
764402|NCT00387673|electrical stimulation|electrical stimulation
764403|NCT00387673|hand|hand
764404|NCT00387673|Rehabilitation|rehabilitation
764405|NCT00387673|spinal cord injury|spinal cord injury
764406|NCT00387660|extensive stage small cell lung cancer|extensive stage small cell lung cancer
764407|NCT00387660|limited stage small cell lung cancer|limited stage small cell lung cancer
764408|NCT00387660|recurrent small cell lung cancer|recurrent small cell lung cancer
764411|NCT00387647|monocytic|monocytic
764412|NCT00387634|tick born encephalitis, TBE, adults|tick born encephalitis, tbe, adults
764413|NCT00387621|heart failure|heart failure
764414|NCT00387621|diastolic dysfunction|diastolic dysfunction
764415|NCT00387621|systolic dysfunction|systolic dysfunction
764416|NCT00387621|preclinical|preclinical
764417|NCT00387621|natriuretic peptide|natriuretic peptide
764418|NCT00387621|B-type natriuretic peptide|b-type natriuretic peptide
764419|NCT00387621|cyclic guanosine monophosphate|cyclic guanosine monophosphate
764420|NCT00387608|unspecified adult solid tumor, protocol specific|unspecified adult solid tumor, protocol specific
764421|NCT00387608|refractory chronic lymphocytic leukemia|refractory chronic lymphocytic leukemia
764422|NCT00387608|stage III chronic lymphocytic leukemia|stage iii chronic lymphocytic leukemia
764423|NCT00387608|stage IV chronic lymphocytic leukemia|stage iv chronic lymphocytic leukemia
764424|NCT00387608|stage III grade 1 follicular lymphoma|stage iii grade 1 follicular lymphoma
764425|NCT00387608|stage III grade 2 follicular lymphoma|stage iii grade 2 follicular lymphoma
764426|NCT00387608|stage IV grade 1 follicular lymphoma|stage iv grade 1 follicular lymphoma
764427|NCT00387608|stage IV grade 2 follicular lymphoma|stage iv grade 2 follicular lymphoma
764428|NCT00387608|recurrent grade 1 follicular lymphoma|recurrent grade 1 follicular lymphoma
764429|NCT00387608|recurrent grade 2 follicular lymphoma|recurrent grade 2 follicular lymphoma
764430|NCT00387608|recurrent grade 3 follicular lymphoma|recurrent grade 3 follicular lymphoma
764431|NCT00387608|stage III grade 3 follicular lymphoma|stage iii grade 3 follicular lymphoma
764432|NCT00387608|stage IV grade 3 follicular lymphoma|stage iv grade 3 follicular lymphoma
764433|NCT00387595|Family History|family history
764434|NCT00387595|CAD|cad
764435|NCT00387595|CAC|cac
764436|NCT00387595|cIMT|cimt
764437|NCT00387595|CV Risk Factors|cv risk factors
764438|NCT00387582|Diabetes|diabetes
764439|NCT00387582|Macular Edema|macular edema
764440|NCT00387582|Diabetic Retinopathy|diabetic retinopathy
764441|NCT00387582|Lucentis|lucentis
764442|NCT00387582|Ranibizumab|ranibizumab
764443|NCT00387569|Toddlers|toddlers
764444|NCT00387569|Vaccine|vaccine
764445|NCT00387569|Safety|safety
764446|NCT00387556|ketamine|ketamine
764447|NCT00387556|children|children
764448|NCT00387556|emesis|emesis
764449|NCT00387530|recurrent lymphoepithelioma of the nasopharynx|recurrent lymphoepithelioma of the nasopharynx
764450|NCT00387530|post-transplant lymphoproliferative disorder|post-transplant lymphoproliferative disorder
764451|NCT00387530|adult nasal type extranodal NK/T-cell lymphoma|adult nasal type extranodal nk/t-cell lymphoma
764452|NCT00387530|recurrent adult Hodgkin lymphoma|recurrent adult hodgkin lymphoma
764453|NCT00387530|AIDS-related peripheral/systemic lymphoma|aids-related peripheral/systemic lymphoma
764454|NCT00387530|AIDS-related primary CNS lymphoma|aids-related primary cns lymphoma
764455|NCT00387530|recurrent gastric cancer|recurrent gastric cancer
764458|NCT00387517|hypertension|hypertension
764459|NCT00387517|aliskiren|aliskiren
764460|NCT00387517|blood pressure|blood pressure
764461|NCT00387517|hydrochlorothiazide|hydrochlorothiazide
764462|NCT00387517|HCTZ|hctz
764463|NCT00387504|unspecified adult solid tumor, protocol specific|unspecified adult solid tumor, protocol specific
764464|NCT00387478|Allergy|allergy
764465|NCT00387478|Specific Immunotherapy|specific immunotherapy
764466|NCT00387478|Tree|tree
764467|NCT00387478|Environmental Exposure Chamber|environmental exposure chamber
764468|NCT00387452|Aging|aging
764469|NCT00387452|Type 2 diabetes|type 2 diabetes
764470|NCT00387452|exercise|exercise
764471|NCT00387452|aerobic training|aerobic training
764472|NCT00387452|strength training|strength training
764473|NCT00387452|glucose metabolism arterial baroreceptors|glucose metabolism arterial baroreceptors
764474|NCT00387452|heart rate variability|heart rate variability
764475|NCT00387452|cerebral autoregulation|cerebral autoregulation
764476|NCT00387452|tilt table study|tilt table study
764477|NCT00387452|transcranial Doppler|transcranial doppler
764478|NCT00387452|autonomic nervous system|autonomic nervous system
764479|NCT00387439|Anal incontinence|anal incontinence
764480|NCT00387439|Gastroenterology|gastroenterology
764481|NCT00387439|Anoperineal physiotherapy|anoperineal physiotherapy
764482|NCT00387439|Randomized clinical trial|randomized clinical trial
764483|NCT00387413|Duloxetine|duloxetine
764484|NCT00387413|GSK189254|gsk189254
764485|NCT00387413|Healthy volunteers|healthy volunteers
764486|NCT00387413|Phase I.|phase i.
764487|NCT00387413|Electrical hyperalgesia model|electrical hyperalgesia model
764488|NCT00387400|adult giant cell glioblastoma|adult giant cell glioblastoma
764489|NCT00387400|adult gliosarcoma|adult gliosarcoma
764490|NCT00387400|recurrent adult brain tumor|recurrent adult brain tumor
764491|NCT00387400|adult glioblastoma|adult glioblastoma
764492|NCT00387387|pharmacokinetics|pharmacokinetics
764493|NCT00387387|colorectal cancer|colorectal cancer
764494|NCT00387387|pazopanib|pazopanib
764495|NCT00387387|capecitabine|capecitabine
764496|NCT00387387|CapeOx|capeox
764497|NCT00387387|5-fluorouracil|5-fluorouracil
764498|NCT00387387|oxaliplatin|oxaliplatin
764499|NCT00387387|combination therapy|combination therapy
764500|NCT00387387|FOLFOX 6|folfox 6
764501|NCT00387361|Post-Operative Nausea|post-operative nausea
764502|NCT00387361|Nausea|nausea
764503|NCT00387361|Anesthesia|anesthesia
764504|NCT00387361|Osteopathic Manipulative Treatment|osteopathic manipulative treatment
764505|NCT00387361|Osteopathic Manipulative Medicine|osteopathic manipulative medicine
764506|NCT00387361|Manipulation, Osteopathic|manipulation, osteopathic
764507|NCT00387361|Osteopathy|osteopathy
764508|NCT00387361|Texas College of Osteopathic Medicine|texas college of osteopathic medicine
764509|NCT00387348|fatigue|fatigue
764510|NCT00387348|psychosocial effects of cancer and its treatment|psychosocial effects of cancer and its treatment
764511|NCT00387348|stage IIIB non-small cell lung cancer|stage iiib non-small cell lung cancer
764512|NCT00387348|stage IV non-small cell lung cancer|stage iv non-small cell lung cancer
764513|NCT00387348|extensive stage small cell lung cancer|extensive stage small cell lung cancer
764514|NCT00387348|advanced adult primary liver cancer|advanced adult primary liver cancer
764515|NCT00387348|depression|depression
764516|NCT00387348|stage III pancreatic cancer|stage iii pancreatic cancer
764517|NCT00387348|stage IV pancreatic cancer|stage iv pancreatic cancer
764518|NCT00387348|stage IV esophageal cancer|stage iv esophageal cancer
764519|NCT00387348|stage IV gastric cancer|stage iv gastric cancer
764520|NCT00387348|stage IVA colon cancer|stage iva colon cancer
764521|NCT00387348|stage IVB colon cancer|stage ivb colon cancer
764522|NCT00387348|stage IVA rectal cancer|stage iva rectal cancer
764523|NCT00387348|stage IVB rectal cancer|stage ivb rectal cancer
764524|NCT00387348|unresectable gallbladder cancer|unresectable gallbladder cancer
764525|NCT00387348|unresectable extrahepatic bile duct cancer|unresectable extrahepatic bile duct cancer
764526|NCT00387322|unspecified adult solid tumor, protocol specific|unspecified adult solid tumor, protocol specific
764527|NCT00387322|recurrent non-small cell lung cancer|recurrent non-small cell lung cancer
764528|NCT00387322|stage IIIB non-small cell lung cancer|stage iiib non-small cell lung cancer
764529|NCT00387322|stage IV non-small cell lung cancer|stage iv non-small cell lung cancer
764530|NCT00387309|Bowel|bowel
764531|NCT00387283|WNV|wnv
764532|NCT00387283|West Nile virus|west nile virus
764533|NCT00387283|WNV meningoencephalitis|wnv meningoencephalitis
764534|NCT00387270|Huntington's disease|huntington's disease
764535|NCT00387270|Dimebon|dimebon
764536|NCT00387270|dose-escalation|dose-escalation
764537|NCT00387270|Phase 1-2a|phase 1-2a
764538|NCT00387270|randomized|randomized
764539|NCT00387270|controlled|controlled
764540|NCT00387270|double-blind|double-blind
764541|NCT00387270|Unified Huntington's Disease Rating Scale|unified huntington's disease rating scale
764542|NCT00387257|platelet aggregation|platelet aggregation
764543|NCT00387257|SB-659032|sb-659032
764544|NCT00387257|rilapladib|rilapladib
764545|NCT00387244|Pain;|pain;
764546|NCT00387244|Back Pain;|back pain;
764547|NCT00387244|Neurostimulation|neurostimulation
764548|NCT00387231|Myocardial Ischemia|myocardial ischemia
764549|NCT00387231|Randomized Controlled Trials|randomized controlled trials
764550|NCT00387231|Angioplasty, Transluminal, Percutaneous Coronary|angioplasty, transluminal, percutaneous coronary
764551|NCT00387231|Drug Therapy|drug therapy
764552|NCT00387218|Exercise|exercise
764553|NCT00387218|Physical Functional Ability|physical functional ability
764554|NCT00387218|Spinal Range of Motion|spinal range of motion
764555|NCT00387218|Balance|balance
764556|NCT00387218|Economy of Movement|economy of movement
764557|NCT00387218|Aerobic Conditioning|aerobic conditioning
764558|NCT00387218|Quality of Life|quality of life
764559|NCT00387218|Adherence|adherence
764560|NCT00387205|chronic administration|chronic administration
764561|NCT00387205|monotherapy and combination therapies|monotherapy and combination therapies
764562|NCT00387205|solid|solid
764563|NCT00387205|lapatinib (TYKERB, TYVERB)|lapatinib (tykerb, tyverb)
764564|NCT00387205|malignant tumor|malignant tumor
764565|NCT00387205|Pazopanib|pazopanib
764566|NCT00387205|GW786034|gw786034
764567|NCT00387205|cancer|cancer
764568|NCT00387205|safety|safety
764569|NCT00387192|Von Willebrand Disease|von willebrand disease
764570|NCT00387192|Factor VIII|factor viii
764571|NCT00387192|Von Willebrand Factor|von willebrand factor
764572|NCT00387192|Pharmacokinetics|pharmacokinetics
764573|NCT00387179|Circadian Rhythm Sleep Disorders|circadian rhythm sleep disorders
764574|NCT00387166|Type 2 Diabetes|type 2 diabetes
764575|NCT00387166|Cardiovascular|cardiovascular
764576|NCT00387166|Blood Pressure|blood pressure
764577|NCT00387166|Hispanic|hispanic
764578|NCT00387166|Women|women
764579|NCT00387166|Social Context|social context
764580|NCT00387166|Psychosocial|psychosocial
764581|NCT00387153|Oncology|oncology
764582|NCT00387153|Cancer|cancer
764583|NCT00387153|Blood Cancers|blood cancers
764584|NCT00387140|Dental Pain, Postoperative|dental pain, postoperative
764585|NCT00387127|Neck Cancer|neck cancer
764586|NCT00387127|Locally advanced head and neck cancer|locally advanced head and neck cancer
764587|NCT00387127|locally advanced|locally advanced
764588|NCT00387127|Head and Neck cancer|head and neck cancer
764589|NCT00387127|lapatinib|lapatinib
764590|NCT00387127|EGFR/ErbB2 inhibitor|egfr/erbb2 inhibitor
764591|NCT00387127|Head Cancer|head cancer
764592|NCT00387114|C-reactive protein|c-reactive protein
764593|NCT00387114|nitrotyrosine|nitrotyrosine
764594|NCT00387114|oxidative stress|oxidative stress
764595|NCT00387114|resistin|resistin
764596|NCT00387114|vitamin C|vitamin c
764597|NCT00387101|Diabetic Foot Ulcer|diabetic foot ulcer
764598|NCT00387101|Diabetes Mellitus|diabetes mellitus
764599|NCT00387101|Debridement|debridement
764600|NCT00387101|Dermal-LSR|dermal-lsr
764601|NCT00387101|Standard of Care|standard of care
764602|NCT00387075|Parkinson Disease|parkinson disease
764603|NCT00387075|SPECT imaging|spect imaging
764604|NCT00387062|Breast Cancer|breast cancer
764605|NCT00387062|Cognitive Impairment|cognitive impairment
764606|NCT00387062|Chemofog|chemofog
764607|NCT00387062|Chemobrain|chemobrain
764608|NCT00387062|Post-chemotherapy cognitive impairment|post-chemotherapy cognitive impairment
764609|NCT00387049|Anxiety Sensitivity|anxiety sensitivity
764610|NCT00387023|Non-Hodgkin's Lymphoma|non-hodgkin's lymphoma
764611|NCT00387023|Orbital Lymphoma|orbital lymphoma
764612|NCT00387023|Rituximab|rituximab
764613|NCT00387023|Rituxan|rituxan
764614|NCT00387023|Zevalin|zevalin
764615|NCT00387023|Ibritumomab tiuxetan|ibritumomab tiuxetan
764616|NCT00387023|IDEC-Y2B8|idec-y2b8
764617|NCT00387023|Eye|eye
764618|NCT00386984|hepatocellular carcinoma; Sandostatin-LAR; RCT|hepatocellular carcinoma; sandostatin-lar; rct
764619|NCT00386971|L-carnitine|l-carnitine
764620|NCT00386971|HIV|hiv
764621|NCT00386971|TGRL metabolism|tgrl metabolism
764622|NCT00386971|postprandial|postprandial
764623|NCT00386971|HIV Treatment Experienced|hiv treatment experienced
764624|NCT00386958|corneal ulcers|corneal ulcers
764625|NCT00386958|bacterial keratitis|bacterial keratitis
764626|NCT00386958|childhood blindness|childhood blindness
764627|NCT00386958|povidone-iodine|povidone-iodine
764628|NCT00386945|Tobacco|tobacco
764629|NCT00386945|Cessation.|cessation.
764630|NCT00386945|Chiropractic patients.|chiropractic patients.
764631|NCT00386945|Doctors of Chiropractic.|doctors of chiropractic.
764632|NCT00386945|Health care providers.|health care providers.
764633|NCT00386945|Behavioral intervention.|behavioral intervention.
764634|NCT00386945|Tobacco intervention.|tobacco intervention.
764635|NCT00386945|Cigarettes.|cigarettes.
764636|NCT00386945|Smokeless tobacco.|smokeless tobacco.
764637|NCT00386945|Smoking intervention.|smoking intervention.
764638|NCT00386906|Melanoma|melanoma
764639|NCT00386906|Conjunctival Melanoma|conjunctival melanoma
764640|NCT00386906|Malignant Melanoma of the Conjunctiva|malignant melanoma of the conjunctiva
764641|NCT00386906|Malignant Melanoma of the Eyelid|malignant melanoma of the eyelid
764642|NCT00386906|Sebaceous Cell Carcinoma|sebaceous cell carcinoma
764643|NCT00386906|Sebaceous Cell Carcinoma of the Conjunctiva|sebaceous cell carcinoma of the conjunctiva
764644|NCT00386906|Sebaceous Cell Carcinoma of the Eyelid|sebaceous cell carcinoma of the eyelid
764645|NCT00386906|Sentinel Lymph Node|sentinel lymph node
764646|NCT00386906|Lymphatic Mapping|lymphatic mapping
764647|NCT00386906|Eyelid|eyelid
764648|NCT00386906|Eyelid Lesion|eyelid lesion
764649|NCT00386867|medical abortion|medical abortion
764650|NCT00386867|mifepristone|mifepristone
764651|NCT00386867|misoprostol|misoprostol
764652|NCT00386867|buccal administration|buccal administration
764653|NCT00386854|exercise|exercise
764654|NCT00386854|lipid metabolism|lipid metabolism
764655|NCT00386854|lipoproteins|lipoproteins
764656|NCT00386854|insulin resistance|insulin resistance
764657|NCT00386854|inflammation|inflammation
764658|NCT00386841|Major depression|major depression
764659|NCT00386841|First degree relatives|first degree relatives
764660|NCT00386841|Escitalopram|escitalopram
764661|NCT00386841|Cortisol|cortisol
764662|NCT00386841|Cognition|cognition
764663|NCT00386841|Personality|personality
764664|NCT00386841|Endo-phenotype|endo-phenotype
764665|NCT00386828|colorectal cancer|colorectal cancer
764666|NCT00386828|advanced colorectal cancer|advanced colorectal cancer
764667|NCT00386802|Neutropenia|neutropenia
764668|NCT00386802|Antifungals|antifungals
764669|NCT00386789|Typhoid Fever|typhoid fever
764670|NCT00386789|Serological Survey|serological survey
764671|NCT00386789|Follow-Up|follow-up
764672|NCT00386789|Protection|protection
764673|NCT00386776|computers|computers
764674|NCT00386776|diagnosis|diagnosis
764675|NCT00386776|medical records|medical records
764676|NCT00386776|physician patient relations|physician patient relations
764677|NCT00386776|medical history taking|medical history taking
764678|NCT00386776|medical informatics applications|medical informatics applications
764679|NCT00386763|Marsh fever|marsh fever
764680|NCT00386763|Plasmodium infections|plasmodium infections
764681|NCT00386763|Remittent fever|remittent fever
764682|NCT00386763|Paludism|paludism
764683|NCT00386763|Artemether|artemether
764684|NCT00386763|Artemisinins|artemisinins
764685|NCT00386763|Malaria|malaria
764686|NCT00386763|Benflumetol|benflumetol
764687|NCT00386763|Lumefantrine|lumefantrine
764688|NCT00386750|Malaria|malaria
764689|NCT00386750|hearing|hearing
764690|NCT00386750|co-artemether|co-artemether
764691|NCT00386750|auditory|auditory
764692|NCT00386750|Plasmodium falciparum|plasmodium falciparum
764693|NCT00386750|marsh fever|marsh fever
764694|NCT00386750|Plasmodium infections|plasmodium infections
764695|NCT00386750|remittent fever|remittent fever
764696|NCT00386750|paludism|paludism
764697|NCT00386750|artemether|artemether
764698|NCT00386750|artemisinins|artemisinins
764699|NCT00386750|benflumetol|benflumetol
764700|NCT00386750|lumefantrine|lumefantrine
764701|NCT00386737|Asthma|asthma
764702|NCT00386737|Breath Testing|breath testing
764703|NCT00386737|Laser Spectroscopy|laser spectroscopy
764704|NCT00386737|eNO|eno
764705|NCT00386737|Nitric Oxide|nitric oxide
764706|NCT00386737|Lower Airway Inflammation|lower airway inflammation
764707|NCT00386737|Carbon Dioxide|carbon dioxide
764708|NCT00386737|CO2|co2
764709|NCT00386724|Pain|pain
764710|NCT00386724|Neurostimulation|neurostimulation
764711|NCT00386724|Leg Pain|leg pain
764712|NCT00386724|Back Pain|back pain
764713|NCT00386711|suicide|suicide
764714|NCT00386711|depressed patients|depressed patients
764715|NCT00386711|primary care|primary care
764716|NCT00386698|Influenza,|influenza,
764717|NCT00386698|improved vaccine,|improved vaccine,
764718|NCT00386698|influenza disease|influenza disease
764719|NCT00386698|elderly|elderly
764720|NCT00386685|Cancer|cancer
764721|NCT00386685|Breast|breast
764722|NCT00386685|metastatic breast cancer|metastatic breast cancer
764723|NCT00386672|Calcium|calcium
764724|NCT00386672|Vitamin D|vitamin d
764725|NCT00386672|Weight Loss|weight loss
764726|NCT00386672|Overweight|overweight
764727|NCT00386672|Obesity|obesity
764728|NCT00386672|Lite Orange Juice|lite orange juice
764729|NCT00386646|Dry eye syndromes therapy|dry eye syndromes therapy
764730|NCT00386633|Vaccine|vaccine
764731|NCT00386633|Safety|safety
764732|NCT00386633|T-cell epitope|t-cell epitope
764733|NCT00386633|Acquired Immune Deficiency Syndrome Virus|acquired immune deficiency syndrome virus
764734|NCT00386633|HIV Preventive Vaccine|hiv preventive vaccine
764735|NCT00386620|Breast Cancer|breast cancer
764736|NCT00386620|Cancer Control|cancer control
764737|NCT00386620|Spousal Relationships|spousal relationships
764738|NCT00386620|Questionnaire|questionnaire
764739|NCT00386620|Interview|interview
764740|NCT00386620|Pain|pain
764741|NCT00386607|Hypertension, aliskiren, valsartan, HCTZ, blood pressure|hypertension, aliskiren, valsartan, hctz, blood pressure
764742|NCT00386594|Barrett Esophagus|barrett esophagus
764743|NCT00386594|High grade dysplasia|high grade dysplasia
764744|NCT00386594|Carcinoma in situ|carcinoma in situ
764745|NCT00386594|825A|825a
764746|NCT00386542|vaccination|vaccination
764747|NCT00386542|influenza vaccine|influenza vaccine
764748|NCT00386542|jet injection|jet injection
764749|NCT00386542|intradermal injection|intradermal injection
764750|NCT00386542|infancy|infancy
764751|NCT00386542|children|children
764752|NCT00386542|dose-sparing|dose-sparing
764753|NCT00386542|cutaneous vaccination|cutaneous vaccination
764754|NCT00386542|Dominican Republic|dominican republic
764755|NCT00386542|pandemic preparedness|pandemic preparedness
764756|NCT00386542|jet injector|jet injector
764757|NCT00386542|reduced dosage|reduced dosage
764758|NCT00386542|immunogenicity|immunogenicity
764759|NCT00386542|reactogenicity|reactogenicity
764760|NCT00386542|safety|safety
764761|NCT00386542|needle-free|needle-free
764762|NCT00386542|immune response|immune response
764763|NCT00386542|hemagglutination inhibition|hemagglutination inhibition
764764|NCT00386542|Infant|infant
764765|NCT00386529|low dose aspirin|low dose aspirin
764766|NCT00386529|Hypertension|hypertension
764767|NCT00386529|administration time dependent effect|administration time dependent effect
764768|NCT00386516|cholangiocarcinoma|cholangiocarcinoma
764769|NCT00386516|bile duct|bile duct
764770|NCT00386516|biliary|biliary
764771|NCT00386516|intra-hepatic|intra-hepatic
764772|NCT00386516|extra-hepatic|extra-hepatic
764773|NCT00386516|gall bladder|gall bladder
764774|NCT00386516|cancer|cancer
764775|NCT00386516|carcinoma|carcinoma
764776|NCT00386516|metastatic|metastatic
764777|NCT00386516|metastasis|metastasis
764778|NCT00386516|advanced|advanced
764779|NCT00386516|recurrent|recurrent
764780|NCT00386490|celiac disease|celiac disease
764781|NCT00386490|larazotide acetate|larazotide acetate
764782|NCT00386477|Povidone iodine|povidone iodine
764783|NCT00386477|postoperative infection|postoperative infection
764784|NCT00386477|presurgical cleansing|presurgical cleansing
764785|NCT00386464|bipap|bipap
764786|NCT00386464|lou gehrigs disease|lou gehrigs disease
764787|NCT00386464|motor neuron disease|motor neuron disease
764788|NCT00386464|respiratory muscles|respiratory muscles
764789|NCT00386451|Intravenous chemotherapy|intravenous chemotherapy
764790|NCT00386412|Cytomegalovirus infection|cytomegalovirus infection
764791|NCT00386399|Advanced Pancreatic Cancer|advanced pancreatic cancer
764792|NCT00386399|Mutated BRCA2 Gene|mutated brca2 gene
764793|NCT00386399|Recurrent Pancreatic Cancer|recurrent pancreatic cancer
764794|NCT00386386|hydration|hydration
764795|NCT00386386|prehospital|prehospital
764796|NCT00386386|mass casualty incident|mass casualty incident
764797|NCT00386373|Chronic Myeloid Leukemia|chronic myeloid leukemia
764798|NCT00386373|CML|cml
764799|NCT00386373|ALL|all
764800|NCT00386373|AML|aml
764801|NCT00386373|Leukemia|leukemia
764802|NCT00386373|Imatinib Mesylate|imatinib mesylate
764803|NCT00386373|Gleevec|gleevec
764804|NCT00386373|Philadelphia-Positive|philadelphia-positive
764805|NCT00386373|Bone marrow transplant|bone marrow transplant
764806|NCT00386373|BMT|bmt
764807|NCT00386373|Stem cell transplant|stem cell transplant
764808|NCT00386373|SCT|sct
764809|NCT00386347|HIV|hiv
764810|NCT00386347|repeat dose|repeat dose
764811|NCT00386347|pharmacokinetics|pharmacokinetics
764812|NCT00386347|bioavailability|bioavailability
764813|NCT00386347|single-dose|single-dose
764814|NCT00386347|food effect|food effect
764815|NCT00386334|insomnia|insomnia
764816|NCT00386334|chronic|chronic
764817|NCT00386334|primary|primary
764818|NCT00386321|Zevalin|zevalin
764819|NCT00386321|Zevalin plus CHOP|zevalin plus chop
764820|NCT00386321|Diffuse large B-cell lymphoma|diffuse large b-cell lymphoma
764821|NCT00386321|First line Diffuse large B-cell lymphoma|first line diffuse large b-cell lymphoma
764822|NCT00386308|Heavy Menstrual Bleeding|heavy menstrual bleeding
764823|NCT00386308|Menorrhagia|menorrhagia
764824|NCT00386282|Mifepristone|mifepristone
764825|NCT00386282|Misoprostol|misoprostol
764826|NCT00386282|Buccal administration|buccal administration
764827|NCT00386269|codeine phosphate analgesia|codeine phosphate analgesia
764828|NCT00386256|telehealth|telehealth
764829|NCT00386256|telerehabilitation|telerehabilitation
764830|NCT00386256|deconditioning|deconditioning
764831|NCT00386256|exercise|exercise
764832|NCT00386243|analgesia|analgesia
764833|NCT00386243|analgesics|analgesics
764834|NCT00386243|cognitive behavioral therapy|cognitive behavioral therapy
764835|NCT00386243|Pain|pain
764836|NCT00386243|self-management|self-management
764837|NCT00386243|stepped care|stepped care
764838|NCT00386243|musculoskeletal pain|musculoskeletal pain
764839|NCT00386230|transmission|transmission
764840|NCT00386230|infant|infant
764841|NCT00386230|HIV|hiv
764842|NCT00386230|pregnancy|pregnancy
764843|NCT00386230|HIV-1 infection|hiv-1 infection
764844|NCT00386230|HIV Seronegativity|hiv seronegativity
764845|NCT00386217|Cervical Cancer|cervical cancer
764846|NCT00386217|Breast Cancer|breast cancer
764847|NCT00386217|Hodgkin's Disease|hodgkin's disease
764848|NCT00386217|Non-Hodgkin's Lymphoma|non-hodgkin's lymphoma
764849|NCT00386217|Female Infertility|female infertility
764850|NCT00386217|Telephone Survey|telephone survey
764851|NCT00386204|Q-switched Ruby laser|q-switched ruby laser
764852|NCT00386191|Platelet Aggregation Inhibitors|platelet aggregation inhibitors
764853|NCT00386191|Ischemic cerebrovascular disease|ischemic cerebrovascular disease
764854|NCT00386178|vitamin E|vitamin e
764855|NCT00386178|gamma tocopherol|gamma tocopherol
764856|NCT00386178|moderate to severe asthma|moderate to severe asthma
764857|NCT00386178|healthy subjects|healthy subjects
764858|NCT00386165|larazotide acetate|larazotide acetate
764859|NCT00386152|Anemia|anemia
764860|NCT00386152|Cancer|cancer
764861|NCT00386152|Chemotherapy-Induced Anemia|chemotherapy-induced anemia
764862|NCT00386152|Epoetin alfa|epoetin alfa
764863|NCT00386152|Darbepoetin alfa|darbepoetin alfa
764864|NCT00386139|Diastolic|diastolic
764865|NCT00386139|systolic|systolic
764866|NCT00386139|hypertension|hypertension
764867|NCT00386139|aliskiren|aliskiren
764868|NCT00386139|blood pressure|blood pressure
764869|NCT00386139|hydrochlorothiazide, HCTZ|hydrochlorothiazide, hctz
764870|NCT00386126|Heart Failure|heart failure
764871|NCT00386126|Anemia|anemia
764872|NCT00386126|Treatment|treatment
764873|NCT00386113|Influenza|influenza
764874|NCT00386113|improved vaccine|improved vaccine
764875|NCT00386113|elderly|elderly
764876|NCT00386100|Fasting Plasma Glucose|fasting plasma glucose
764877|NCT00386100|Dual energy X ray absorptiometry (DXA)|dual energy x ray absorptiometry (dxa)
764878|NCT00386100|Drug-naive|drug-naive
764879|NCT00386100|Type 2 diabetes mellitus|type 2 diabetes mellitus
764880|NCT00386100|Bone Mineral Density|bone mineral density
764881|NCT00386100|Hyperglycemia|hyperglycemia
764882|NCT00386100|HbA1c|hba1c
764883|NCT00386087|Breast Cancer|breast cancer
764884|NCT00386087|Cancer of the Breast|cancer of the breast
764885|NCT00386074|NaFeEDTA|nafeedta
764886|NCT00386074|electrolytic iron|electrolytic iron
764887|NCT00386074|efficacy|efficacy
764888|NCT00386074|whole maize flour|whole maize flour
764889|NCT00386074|phytate|phytate
764890|NCT00386074|school-age children|school-age children
764891|NCT00386074|controlled trial|controlled trial
764892|NCT00386074|Africa|africa
764893|NCT00386061|Obesity|obesity
764894|NCT00386061|risk factors|risk factors
764895|NCT00386048|Cognitive Behavioral Therapy|cognitive behavioral therapy
764896|NCT00386048|Pediatric Sickle Cell Disease|pediatric sickle cell disease
764897|NCT00386048|Pain Management|pain management
764898|NCT00386035|Treatment Experienced|treatment experienced
764899|NCT00386022|Gonadotropin-releasing hormone|gonadotropin-releasing hormone
764900|NCT00386022|Estrogens|estrogens
764901|NCT00386022|postmenopausal women|postmenopausal women
764902|NCT00386022|Pituitary hormones|pituitary hormones
764903|NCT00386009|Benign Prostatic Hyperplasia|benign prostatic hyperplasia
764904|NCT00386009|Benign Prostatic Hypertrophy|benign prostatic hypertrophy
764905|NCT00385996|Carcinoma,non-small cell lung|carcinoma,non-small cell lung
764906|NCT00385996|preoperative|preoperative
764907|NCT00385996|Tarceva|tarceva
764908|NCT00385996|Response rate|response rate
764909|NCT00385983|thyroidectomy|thyroidectomy
764910|NCT00385983|thyroid neoplasm|thyroid neoplasm
764911|NCT00385983|postoperative complications|postoperative complications
764912|NCT00385983|cost effectiveness|cost effectiveness
764913|NCT00385957|Treatment Naive|treatment naive
764914|NCT00385931|Hypertension|hypertension
764915|NCT00385931|high cholesterol|high cholesterol
764916|NCT00385931|valsartan|valsartan
764917|NCT00385931|simvastatin|simvastatin
764918|NCT00385918|Cardiovascular Fitness|cardiovascular fitness
764919|NCT00385918|Exercise|exercise
764920|NCT00385918|Gait|gait
764921|NCT00385918|Spinal Cord Injury|spinal cord injury
764922|NCT00385918|Treadmill Training|treadmill training
764923|NCT00385892|Healthy volonteers|healthy volonteers
764924|NCT00385892|Abdominal binder|abdominal binder
764926|NCT00385892|MAP|map
764927|NCT00385892|APP|app
764928|NCT00385866|Patient Navigator|patient navigator
764929|NCT00385866|Community health|community health
764930|NCT00385866|Communication|communication
764931|NCT00385853|PTK|ptk
764932|NCT00385853|temozolomide|temozolomide
764933|NCT00385853|glioblastoma|glioblastoma
764934|NCT00385840|Influenza vaccine|influenza vaccine
764935|NCT00385840|Influenza|influenza
764936|NCT00385827|Cancer|cancer
764937|NCT00385827|Prostate|prostate
764938|NCT00385827|IL-6|il-6
764939|NCT00385827|Mitoxantrone|mitoxantrone
764940|NCT00385827|Metastatic prostate cancer|metastatic prostate cancer
764941|NCT00385801|cocaine|cocaine
764942|NCT00385801|dependence|dependence
764943|NCT00385801|risperidal|risperidal
764944|NCT00385801|MRI|mri
764945|NCT00385788|Hodgkin's Disease|hodgkin's disease
764946|NCT00385788|Stem Cell Transplantation|stem cell transplantation
764947|NCT00385788|Antithymocyte Globulin|antithymocyte globulin
764948|NCT00385788|Gemcitabine|gemcitabine
764949|NCT00385788|Gemzar|gemzar
764950|NCT00385788|Fludarabine|fludarabine
764951|NCT00385788|Fludarabine Phosphate|fludarabine phosphate
764952|NCT00385788|Melphalan|melphalan
764953|NCT00385788|Allogeneic stem cell transplantation|allogeneic stem cell transplantation
764954|NCT00385788|AST|ast
764955|NCT00385788|SCT|sct
764956|NCT00385788|ATG|atg
764957|NCT00385788|Thymoglobulin|thymoglobulin
764958|NCT00385775|Cancer|cancer
764959|NCT00385775|solid tumours|solid tumours
764960|NCT00385775|refractory|refractory
764961|NCT00385775|antisense|antisense
764962|NCT00385775|oligonucleotide|oligonucleotide
764963|NCT00385762|Human volunteers|human volunteers
764964|NCT00385749|Implanted cardioverter defibrillator|implanted cardioverter defibrillator
764965|NCT00385749|congestive heart failure|congestive heart failure
764966|NCT00385749|right ventricular lead placement|right ventricular lead placement
764967|NCT00385749|select site pacing|select site pacing
764968|NCT00385736|Moderate to Severe Ulcerative Colitis|moderate to severe ulcerative colitis
764969|NCT00385736|Double-blind|double-blind
764970|NCT00385736|Adalimumab|adalimumab
764971|NCT00385736|Induction of Clinical Remission|induction of clinical remission
764972|NCT00385723|affect|affect
764973|NCT00385723|inflammation|inflammation
764974|NCT00385710|Progressive supranuclear palsy (PSP)|progressive supranuclear palsy (psp)
764975|NCT00385697|Randomized|randomized
764976|NCT00385697|Double Blind|double blind
764977|NCT00385697|Parallel Group|parallel group
764978|NCT00385697|Controlled Clinical Trial|controlled clinical trial
764979|NCT00385684|Agitation|agitation
764980|NCT00385684|Alzheimer Disease|alzheimer disease
764981|NCT00385684|Analgesics|analgesics
764982|NCT00385684|Dementia|dementia
764983|NCT00385684|Narcotics|narcotics
764984|NCT00385684|Opioid|opioid
764985|NCT00385684|Pain|pain
764986|NCT00385684|Palliative Care|palliative care
764987|NCT00385684|Psychomotor|psychomotor
764988|NCT00385684|Suffering, Physical|suffering, physical
764989|NCT00385658|Dyslipidemia|dyslipidemia
764990|NCT00385658|metabolic syndrome|metabolic syndrome
764991|NCT00385658|fluvastatin|fluvastatin
764992|NCT00385658|fenofibrate|fenofibrate
764993|NCT00385658|simvastatin|simvastatin
764994|NCT00385658|ezetimibe|ezetimibe
764995|NCT00385645|HIV seronegativity|hiv seronegativity
764996|NCT00385632|Treatment Experienced|treatment experienced
764997|NCT00385606|prolonged continuous infusion|prolonged continuous infusion
764998|NCT00385606|Cox-2 inhibitors|cox-2 inhibitors
764999|NCT00385567|AIDS|aids
765000|NCT00385567|Treatment Experienced|treatment experienced
765001|NCT00385554|Microbicide|microbicide
765002|NCT00385554|HIV prevention|hiv prevention
765003|NCT00385554|Botswana|botswana
765004|NCT00385554|Preventing acquisition of HIV infection|preventing acquisition of hiv infection
765005|NCT00385554|HIV Seronegativity|hiv seronegativity
765006|NCT00385541|pain|pain
765007|NCT00385541|morphine|morphine
765008|NCT00385541|hydromorphone|hydromorphone
765009|NCT00385541|nausea|nausea
765010|NCT00385541|vomiting|vomiting
765011|NCT00385541|pruritis|pruritis
765012|NCT00385528|Case complexity|case complexity
765013|NCT00385528|INTERMED|intermed
765014|NCT00385528|Consultation liaison psychiatry|consultation liaison psychiatry
765015|NCT00385528|depression|depression
765016|NCT00385502|toenail|toenail
765017|NCT00385502|fungus|fungus
765018|NCT00385502|onychomycosis|onychomycosis
765019|NCT00385502|antifungal|antifungal
765020|NCT00385502|anti-fungal|anti-fungal
765021|NCT00385502|nail|nail
765022|NCT00385476|Advanced Cancer|advanced cancer
765023|NCT00385476|Medication Knowledge|medication knowledge
765024|NCT00385476|Emergency Center|emergency center
765025|NCT00385476|Questionnaire|questionnaire
765026|NCT00385476|Survey|survey
765027|NCT00385463|Asthma|asthma
765028|NCT00385463|Rhinitis|rhinitis
765029|NCT00385463|Allergic Asthma|allergic asthma
765030|NCT00385437|Driving safety|driving safety
765031|NCT00385437|maintenance of wakefulness test|maintenance of wakefulness test
765032|NCT00385437|major depressive disorder|major depressive disorder
765033|NCT00385437|mirtazapine|mirtazapine
765034|NCT00385398|tumors metastatic to brain|tumors metastatic to brain
765035|NCT00385398|stage IV non-small cell lung cancer|stage iv non-small cell lung cancer
765036|NCT00385372|low pseudoallergen diet|low pseudoallergen diet
765037|NCT00385372|elimination diet|elimination diet
765038|NCT00385372|provocation diet|provocation diet
765039|NCT00385372|oral provocation|oral provocation
765040|NCT00385372|natural food ingredients|natural food ingredients
765041|NCT00385372|food additives|food additives
765042|NCT00385372|flavours|flavours
765043|NCT00385346|Expressive writing|expressive writing
765044|NCT00385346|Male infertility|male infertility
765045|NCT00385333|Mitochondrion|mitochondrion
765046|NCT00385333|Retina|retina
765047|NCT00385333|Mitochondria|mitochondria
765048|NCT00385333|Metabolism|metabolism
765049|NCT00385333|In Vivo Imaging|in vivo imaging
765050|NCT00385333|Age-Related Macular Degeneration|age-related macular degeneration
765051|NCT00385333|AMD|amd
765052|NCT00385333|Diabetic Retinopathy|diabetic retinopathy
765053|NCT00385333|DR|dr
765054|NCT00385333|Hippel-Lindau Disease|hippel-lindau disease
765055|NCT00385333|VHL|vhl
765056|NCT00385307|Depression|depression
765057|NCT00385307|Clinical Trials|clinical trials
765058|NCT00385307|Major Depressive Disorder|major depressive disorder
765059|NCT00385294|Genetic|genetic
765060|NCT00385294|pain|pain
765061|NCT00385294|obstetrical|obstetrical
765062|NCT00385281|proteomic profiling, influenza, vaccine, FluMist|proteomic profiling, influenza, vaccine, flumist
765063|NCT00385268|cocaine|cocaine
765064|NCT00385255|Immunogenicity,|immunogenicity,
765065|NCT00385255|Influenza|influenza
765066|NCT00385255|Co-administration,|co-administration,
765068|NCT00385242|coronary artery disease|coronary artery disease
765069|NCT00385242|left ventricular dysfunction|left ventricular dysfunction
765070|NCT00385242|positron emission tomography|positron emission tomography
765071|NCT00385242|viable myocardium|viable myocardium
765072|NCT00385242|revascularization|revascularization
765073|NCT00385242|cost effectiveness|cost effectiveness
765074|NCT00385229|Asphyxia neonatorum|asphyxia neonatorum
765075|NCT00385229|Birth Injury|birth injury
765076|NCT00385229|Meconium Aspiration Syndrome|meconium aspiration syndrome
765077|NCT00385216|Third Molar|third molar
765078|NCT00385216|Pain|pain
765079|NCT00385203|cancer|cancer
765080|NCT00385203|tumour|tumour
765081|NCT00385203|advanced cancer|advanced cancer
765082|NCT00385203|Metastatic Gastro-Intestinal Stromal Tumours|metastatic gastro-intestinal stromal tumours
765083|NCT00385203|gastro-intestinal cancer|gastro-intestinal cancer
765084|NCT00385203|RECENTIN|recentin
765085|NCT00385190|SAD|sad
765086|NCT00385164|lung neoplasms|lung neoplasms
765087|NCT00385164|positron emissions tomography|positron emissions tomography
765088|NCT00385164|radiotherapy planning|radiotherapy planning
765089|NCT00385151|Post conditioning|post conditioning
765090|NCT00385138|Percutaneous Coronary Intervention (PCI)|percutaneous coronary intervention (pci)
765091|NCT00385138|ACS|acs
765092|NCT00385125|relapsed|relapsed
765093|NCT00385125|refractory|refractory
765094|NCT00385125|CD 20 positive|cd 20 positive
765095|NCT00385112|Cardiology|cardiology
765096|NCT00385112|Echocardiograms|echocardiograms
765097|NCT00385112|Surgery|surgery
765098|NCT00385112|Valve Disease|valve disease
765099|NCT00385112|Heart Valve Disease|heart valve disease
765100|NCT00385099|IBS|ibs
765101|NCT00385099|stress|stress
765102|NCT00385099|CRF1|crf1
765103|NCT00385086|Sciatica|sciatica
765104|NCT00385086|Pain|pain
765105|NCT00385086|TNF-alpha|tnf-alpha
765106|NCT00385086|Discectomy|discectomy
765107|NCT00385086|Fibrosis|fibrosis
765108|NCT00385086|Spine|spine
765109|NCT00385047|malaria|malaria
765110|NCT00385047|vaccine|vaccine
765111|NCT00385047|AMA-1 (apical membrane antigen-1)|ama-1 (apical membrane antigen-1)
765112|NCT00385047|efficacy|efficacy
765113|NCT00385034|randomized controlled trial|randomized controlled trial
765114|NCT00385034|RCT|rct
765115|NCT00385034|partner violence|partner violence
765117|NCT00385034|screening|screening
765118|NCT00385034|family practice|family practice
765119|NCT00385034|computer|computer
765120|NCT00385021|Advanced|advanced
765121|NCT00385021|metastatic|metastatic
765122|NCT00385021|colorectal|colorectal
765123|NCT00385021|cancer|cancer
765124|NCT00385021|Avastin|avastin
765125|NCT00385008|Combination product, sumatriptan succinate, naproxen sodium, absorption, pharmacokinetics, disintegration, gastric transit, gastric scintigraphy|combination product, sumatriptan succinate, naproxen sodium, absorption, pharmacokinetics, disintegration, gastric transit, gastric scintigraphy
765126|NCT00384995|Contrast Induced Nephropathy|contrast induced nephropathy
765127|NCT00384995|Chronic Kidney Disease|chronic kidney disease
765128|NCT00384995|Acute Renal Failure|acute renal failure
765129|NCT00384995|End-stage Renal Disease|end-stage renal disease
765130|NCT00384995|Cardiovascular diseases|cardiovascular diseases
765131|NCT00384995|Coronary catheterization|coronary catheterization
765132|NCT00384995|Percutaneous coronary intervention|percutaneous coronary intervention
765133|NCT00384995|Intra-arterial angiography|intra-arterial angiography
765134|NCT00384995|Bicarbonate|bicarbonate
765135|NCT00384995|Saline|saline
765136|NCT00384982|Bone marrow-derived stem cells|bone marrow-derived stem cells
765137|NCT00384982|Acute myocardial infarction|acute myocardial infarction
765138|NCT00384969|RAD001|rad001
765139|NCT00384969|Sorafenib|sorafenib
765140|NCT00384969|Renal Cell Carcinoma|renal cell carcinoma
765141|NCT00384969|Metastatic|metastatic
765142|NCT00384956|MDS either de novo or secondary, fitting any of the WHO classifications.|mds either de novo or secondary, fitting any of the who classifications.
765143|NCT00384943|postpartum depression|postpartum depression
765144|NCT00384943|exercise|exercise
765145|NCT00384891|Superficial urothelial cell carcinoma of bladder|superficial urothelial cell carcinoma of bladder
765146|NCT00384891|NMIBC|nmibc
765147|NCT00384891|Non Muscle Invasive Bladder Cancer|non muscle invasive bladder cancer
765148|NCT00384891|Hyperthermia|hyperthermia
765149|NCT00384891|Bladder instillation|bladder instillation
765150|NCT00384891|Mitomycin C|mitomycin c
765151|NCT00384891|RITE|rite
765152|NCT00384891|SHTC|shtc
765153|NCT00384891|Intravesical|intravesical
765154|NCT00384865|Pulmonary Arterial Hypertension|pulmonary arterial hypertension
765155|NCT00384852|Fracture|fracture
765156|NCT00384852|Humerus|humerus
765157|NCT00384826|Adenocarcinoma, Bronchiolo-Alveolar|adenocarcinoma, bronchiolo-alveolar
765158|NCT00384787|HIV Seronegativity|hiv seronegativity
765159|NCT00384787|Adenoviral Vector Vaccine|adenoviral vector vaccine
765160|NCT00384787|DNA Plasmid Vaccine|dna plasmid vaccine
765161|NCT00384787|HIV Preventive Vaccine|hiv preventive vaccine
765162|NCT00384774|Migraine|migraine
765163|NCT00384748|Cerebrovascular Accident|cerebrovascular accident
765164|NCT00384748|Rehabilitation|rehabilitation
765165|NCT00384748|Telemedicine|telemedicine
765167|NCT00384735|soft tissue tumor|soft tissue tumor
765168|NCT00384722|Left ventricular lead|left ventricular lead
765169|NCT00384722|Pacing|pacing
765170|NCT00384722|Heart Failure|heart failure
765171|NCT00384709|Elderly|elderly
765172|NCT00384709|Hospitalization|hospitalization
765173|NCT00384709|Geriatrics|geriatrics
765174|NCT00384709|Mortality|mortality
765175|NCT00384709|Readmission|readmission
765176|NCT00384709|Length of Stay|length of stay
765177|NCT00384696|Risk Perception|risk perception
765178|NCT00384696|Smoking Cessation|smoking cessation
765179|NCT00384696|Nicotine Replacement Therapy|nicotine replacement therapy
765180|NCT00384696|Questionnaire|questionnaire
765181|NCT00384696|Nicotine|nicotine
765182|NCT00384683|Endothelial Dysfunction|endothelial dysfunction
765183|NCT00384683|Endothelial Cells|endothelial cells
765184|NCT00384683|Perioperative Outcome|perioperative outcome
765185|NCT00384683|Blood Sample|blood sample
765186|NCT00384670|dengue|dengue
765187|NCT00384670|vaccine|vaccine
765188|NCT00384657|chronic heart failure|chronic heart failure
765189|NCT00384657|chronic kidney disease|chronic kidney disease
765190|NCT00384657|anemia|anemia
765191|NCT00384657|intravenous iron|intravenous iron
765192|NCT00384644|heart failure|heart failure
765193|NCT00384644|sepsis|sepsis
765194|NCT00384644|septic shock|septic shock
765195|NCT00384644|cardiogenic shock|cardiogenic shock
765196|NCT00384631|Neovascular|neovascular
765197|NCT00384631|Glaucoma|glaucoma
765198|NCT00384631|Bevacizumab|bevacizumab
765199|NCT00384631|Avastin|avastin
765200|NCT00384631|Intravitreal|intravitreal
765201|NCT00384631|IOP|iop
765202|NCT00384618|Kidney, Antioxidants, Statin, Carotid IMT|kidney, antioxidants, statin, carotid imt
765203|NCT00384592|heartburn|heartburn
765204|NCT00384592|reflux|reflux
765205|NCT00384592|proton pump inhibitor|proton pump inhibitor
765206|NCT00384592|GERD|gerd
765207|NCT00384592|GORD|gord
765208|NCT00384579|back|back
765209|NCT00384579|pain|pain
765308|NCT00384124|Squamous cell carcinoma in situ of the skin|squamous cell carcinoma in situ of the skin
765210|NCT00384540|-Heart Transplant, Allograft Vasculopathy, Dobutamine Stress Echocardiography, Brain Natriuretic Peptide|-heart transplant, allograft vasculopathy, dobutamine stress echocardiography, brain natriuretic peptide
765211|NCT00384540|Vasculopathy|vasculopathy
765212|NCT00384527|Clostridium difficile|clostridium difficile
765213|NCT00384514|Coronary Artery disease with chronic stable angina|coronary artery disease with chronic stable angina
765214|NCT00384501|keratoconus|keratoconus
765215|NCT00384501|Intacs|intacs
765216|NCT00384488|Diabetes mellitus|diabetes mellitus
765217|NCT00384488|Weight control|weight control
765218|NCT00384488|Healthy eating|healthy eating
765219|NCT00384488|Physical Activity|physical activity
765220|NCT00384475|Seasonal Allergic Rhinitis|seasonal allergic rhinitis
765221|NCT00384475|Ciclesonide|ciclesonide
765222|NCT00384475|Hay Fever|hay fever
765223|NCT00384475|SAR|sar
765224|NCT00384462|Premature infants (32-35 weeks GA) <6 months of age at the start of the RSV season who are not receiving palivizumab and do not have CLD of prematurity|premature infants (32-35 weeks ga) <6 months of age at the start of the rsv season who are not receiving palivizumab and do not have cld of prematurity
765225|NCT00384462|Respiratory Syncytial Viruses|respiratory syncytial viruses
765226|NCT00384449|Eales|eales
765227|NCT00384436|Major Depressive Disorder|major depressive disorder
765228|NCT00384423|Alzheimer's Disease|alzheimer's disease
765229|NCT00384423|AD|ad
765230|NCT00384423|PRX-03140|prx-03140
765231|NCT00384423|Dementia|dementia
765232|NCT00384423|Epix|epix
765233|NCT00384423|Predix|predix
765234|NCT00384423|Cognition enhancing|cognition enhancing
765235|NCT00384410|Pain|pain
765236|NCT00384410|Insomnia|insomnia
765237|NCT00384410|Nabilone|nabilone
765238|NCT00384397|Menactra vaccine|menactra vaccine
765239|NCT00384397|Meningococcal meningitis|meningococcal meningitis
765240|NCT00384397|Measles|measles
765241|NCT00384397|Mumps|mumps
765242|NCT00384397|Rubella|rubella
765243|NCT00384397|Varicella virus|varicella virus
765244|NCT00384397|Haemophilus influenzae type b|haemophilus influenzae type b
765245|NCT00384397|Pneumococcal conjugate vaccine|pneumococcal conjugate vaccine
765246|NCT00384384|Dialysis|dialysis
765247|NCT00384384|Serum potassium|serum potassium
765248|NCT00384384|18b glycyrrhetinic acid|18b glycyrrhetinic acid
765249|NCT00384384|insulin sensitivity|insulin sensitivity
765250|NCT00384371|back|back
765251|NCT00384371|pain|pain
765252|NCT00384358|Fractures|fractures
765253|NCT00384345|bright light treatment|bright light treatment
765254|NCT00384345|exercise|exercise
765255|NCT00384345|body fat index|body fat index
765256|NCT00384345|mood|mood
765257|NCT00384345|sleep|sleep
765258|NCT00384345|fatigue|fatigue
765259|NCT00384332|Bipolar Depression|bipolar depression
765260|NCT00384332|Weight gain bipolar medicine|weight gain bipolar medicine
765261|NCT00384332|side effects olanzapine|side effects olanzapine
765262|NCT00384332|gastrointestinal hormones bipolar medicine|gastrointestinal hormones bipolar medicine
765263|NCT00384319|resuscitation|resuscitation
765264|NCT00384319|hypothermia|hypothermia
765265|NCT00384306|COPD|copd
765266|NCT00384306|prednisolone|prednisolone
765267|NCT00384306|bone biopsy|bone biopsy
765268|NCT00384306|tetracycline labelling|tetracycline labelling
765269|NCT00384267|malaria, infants, preterm babies, neonates, Mali|malaria, infants, preterm babies, neonates, mali
765270|NCT00384254|Tobacco.|tobacco.
765271|NCT00384254|Cessation.|cessation.
765272|NCT00384254|Dental patients.|dental patients.
765273|NCT00384254|Dentists.|dentists.
765274|NCT00384254|Hygienists.|hygienists.
765275|NCT00384254|Dental assistants.|dental assistants.
765276|NCT00384254|Health care providers.|health care providers.
765277|NCT00384254|Behavioral intervention.|behavioral intervention.
765278|NCT00384254|Tobacco intervention.|tobacco intervention.
765279|NCT00384254|Cigarettes.|cigarettes.
765280|NCT00384254|Smokeless tobacco.|smokeless tobacco.
765281|NCT00384254|Smoking intervention.|smoking intervention.
765282|NCT00384241|Blood Pressure, High|blood pressure, high
765283|NCT00384241|Stress|stress
765284|NCT00384241|Inflammation|inflammation
765285|NCT00384228|Chronic Myelogenous Leukemia|chronic myelogenous leukemia
765286|NCT00384228|Acute Lymphoblastic Leukemia|acute lymphoblastic leukemia
765287|NCT00384202|Tacrolimus|tacrolimus
765288|NCT00384202|Liver Transplantation|liver transplantation
765289|NCT00384189|Asthma|asthma
765290|NCT00384189|Ciclesonide|ciclesonide
765291|NCT00384189|children|children
765292|NCT00384176|Metastatic Colorectal Cancer|metastatic colorectal cancer
765293|NCT00384176|RECENTIN|recentin
765294|NCT00384163|cardiac|cardiac
765295|NCT00384163|adult|adult
765296|NCT00384163|PVR|pvr
765297|NCT00384150|galiximab|galiximab
765298|NCT00384150|antibody|antibody
765299|NCT00384150|refractory|refractory
765300|NCT00384150|follicular|follicular
765301|NCT00384150|relapsed|relapsed
765302|NCT00384150|NHL|nhl
765303|NCT00384150|rituximab|rituximab
765304|NCT00384150|retreatment|retreatment
765305|NCT00384137|Tacrolimus|tacrolimus
765306|NCT00384137|Kidney Transplantation|kidney transplantation
765307|NCT00384124|Bowens disease|bowens disease
765309|NCT00384124|imiquimod|imiquimod
765310|NCT00384098|Psoriasis|psoriasis
765311|NCT00384072|postmenopausal|postmenopausal
765312|NCT00384072|women|women
765313|NCT00384072|SERM|serm
765314|NCT00384072|osteoporosis|osteoporosis
765315|NCT00384033|MDD|mdd
765316|NCT00384033|Major Depressive Disorder|major depressive disorder
765317|NCT00384033|Depression|depression
765318|NCT00384020|Major Depression Disorder|major depression disorder
765319|NCT00384020|Antidepressant|antidepressant
765320|NCT00384020|Pharmacogenomics|pharmacogenomics
765321|NCT00384020|Cytochrome P450|cytochrome p450
765322|NCT00384020|Serotonin Transporter|serotonin transporter
765323|NCT00384007|back pain|back pain
765324|NCT00384007|herniated disc|herniated disc
765325|NCT00384007|leg pain|leg pain
765326|NCT00384007|pinched nerves|pinched nerves
765327|NCT00384007|sciatica|sciatica
765328|NCT00384007|radiculopathy|radiculopathy
765329|NCT00383994|Chronic Lymphocytic Leukemia|chronic lymphocytic leukemia
765330|NCT00383994|CLL|cll
765331|NCT00383994|Non-Hodgkin's Lymphoma|non-hodgkin's lymphoma
765332|NCT00383994|B-Cell Lymphoma|b-cell lymphoma
765333|NCT00383994|Lymphoma|lymphoma
765334|NCT00383994|granulocyte-macrophage colony-stimulating factor|granulocyte-macrophage colony-stimulating factor
765335|NCT00383994|Leukemia|leukemia
765336|NCT00383994|NK Cells|nk cells
765337|NCT00383994|Rituximab|rituximab
765338|NCT00383994|GM-CSF|gm-csf
765339|NCT00383994|Non-myeloablative Allogeneic Stem Cell Transplantation|non-myeloablative allogeneic stem cell transplantation
765340|NCT00383994|Stem Cell Transplant|stem cell transplant
765341|NCT00383981|malondialdehyde optoelectronic vitamin complex|malondialdehyde optoelectronic vitamin complex
765342|NCT00383942|Pregnancy|pregnancy
765343|NCT00383942|Extra amniotic saline infusion|extra amniotic saline infusion
765344|NCT00383942|Misoprostol|misoprostol
765345|NCT00383942|Labor induction|labor induction
765346|NCT00383929|Blood pressure reduction|blood pressure reduction
765347|NCT00383929|combination therapy|combination therapy
765348|NCT00383929|candesartan cilexetil|candesartan cilexetil
765349|NCT00383929|hydrochlorothiazide|hydrochlorothiazide
765350|NCT00383916|healthy|healthy
765351|NCT00383890|American Society of Anesthesiologists (ASA)|american society of anesthesiologists (asa)
765352|NCT00383890|Mallampati Score|mallampati score
765353|NCT00383890|Ramsay Sedation Scale (RSS)|ramsay sedation scale (rss)
765354|NCT00383864|liver fibrosis|liver fibrosis
765355|NCT00383864|portal pressure|portal pressure
765356|NCT00383864|antiviral therapy|antiviral therapy
765357|NCT00383851|ATN-224|atn-224
765358|NCT00383851|Temozolomide|temozolomide
765359|NCT00383851|Combination|combination
765360|NCT00383851|Sequential|sequential
765361|NCT00383851|Anti-angiogenic|anti-angiogenic
765362|NCT00383851|Copper|copper
765363|NCT00383838|brief motivational intervention; teens; substance use|brief motivational intervention; teens; substance use
765364|NCT00383825|conjunctival autografts|conjunctival autografts
765365|NCT00383825|amniotic membrane|amniotic membrane
765366|NCT00383825|indocyanine green angiography|indocyanine green angiography
765860|NCT00381927|Anxiety|anxiety
765367|NCT00383825|pterygium surgery|pterygium surgery
765368|NCT00383812|Polypoidal choroidal vasculopathy|polypoidal choroidal vasculopathy
765369|NCT00383812|Intravitreal Bevacizumab|intravitreal bevacizumab
765370|NCT00383799|Ventricular tachycardia|ventricular tachycardia
765371|NCT00383786|PTSD|ptsd
765372|NCT00383786|Substance P|substance p
765373|NCT00383786|Treatment Study|treatment study
765374|NCT00383786|Placebo|placebo
765375|NCT00383786|Controlled|controlled
765376|NCT00383786|Post Traumatic Stress Disorder|post traumatic stress disorder
765377|NCT00383773|retinal vein occlusion|retinal vein occlusion
765378|NCT00383773|rTPA|rtpa
765379|NCT00383747|cognition|cognition
765380|NCT00383747|nicotine|nicotine
765381|NCT00383747|schizophrenia|schizophrenia
765382|NCT00383734|HIV-Associated Lipodystrophy Syndrome|hiv-associated lipodystrophy syndrome
765383|NCT00383734|polylactic acid|polylactic acid
765384|NCT00383734|polyacrylamide gels|polyacrylamide gels
765385|NCT00383695|adenocarcinoma of the rectum|adenocarcinoma of the rectum
765386|NCT00383695|stage I rectal cancer|stage i rectal cancer
765387|NCT00383695|stage II rectal cancer|stage ii rectal cancer
765388|NCT00383695|stage III rectal cancer|stage iii rectal cancer
765389|NCT00383682|postamputation pain|postamputation pain
765390|NCT00383682|phantom pain|phantom pain
765391|NCT00383682|stump pain|stump pain
765392|NCT00383682|neuroma pain|neuroma pain
765393|NCT00383682|opioid|opioid
765394|NCT00383682|mexiletine|mexiletine
765395|NCT00383669|HIV|hiv
765396|NCT00383669|AIDS|aids
765397|NCT00383669|Disease Progression|disease progression
765398|NCT00383669|Multivitamins|multivitamins
765399|NCT00383669|Anti-Retroviral Therapy|anti-retroviral therapy
765400|NCT00383669|HAART|haart
765401|NCT00383669|Tanzania|tanzania
765402|NCT00383669|Africa|africa
765403|NCT00383656|gonadotropin releasing hormone|gonadotropin releasing hormone
765404|NCT00383656|GnRH deficiency|gnrh deficiency
765405|NCT00383656|hypothalamic amenorrhea|hypothalamic amenorrhea
765406|NCT00383656|hypogonadotropic hypogonadism|hypogonadotropic hypogonadism
765407|NCT00383656|Kallman's syndrome|kallman's syndrome
765408|NCT00383656|infertility|infertility
765409|NCT00383630|End Stage Heart Failure|end stage heart failure
765410|NCT00383630|LVAD|lvad
765411|NCT00383630|Bone Marrow Transplantation|bone marrow transplantation
765412|NCT00383630|Stem Cell Transplantation|stem cell transplantation
765413|NCT00383617|pre-radiographic|pre-radiographic
765414|NCT00383617|screening|screening
765415|NCT00383617|early diagnosis|early diagnosis
765416|NCT00383578|Type 2 diabetes|type 2 diabetes
765417|NCT00383578|vildagliptin|vildagliptin
765418|NCT00383578|hemoglobin A1c|hemoglobin a1c
765419|NCT00383578|metformin|metformin
765420|NCT00383539|Influenza|influenza
765421|NCT00383539|Orthomyxoviruses|orthomyxoviruses
765422|NCT00383539|Inactivated Split-virion influenza vaccine|inactivated split-virion influenza vaccine
765423|NCT00383539|Adults|adults
765424|NCT00383526|Influenza|influenza
765425|NCT00383526|Orthomyxoviruses|orthomyxoviruses
765426|NCT00383526|Inactivated Split-virion influenza vaccine|inactivated split-virion influenza vaccine
765427|NCT00383526|elderly|elderly
765428|NCT00383513|Lupus|lupus
765429|NCT00383513|Antibody|antibody
765430|NCT00383513|B-Cell Immunotherapy|b-cell immunotherapy
765431|NCT00383461|tobacco use disorder|tobacco use disorder
765432|NCT00383448|Stem cell transplantation|stem cell transplantation
765433|NCT00383448|Inborn errors of metabolism|inborn errors of metabolism
765434|NCT00383448|Adrenoleukodystrophy (ALD)|adrenoleukodystrophy (ald)
765435|NCT00383448|Metachromatic leukodystrophy (MLD)|metachromatic leukodystrophy (mld)
765436|NCT00383448|Globoid cell leukodystrophy (GLD or Krabbe)|globoid cell leukodystrophy (gld or krabbe)
765437|NCT00383448|Tay Sachs|tay sachs
765438|NCT00383448|Sandhoff|sandhoff
765439|NCT00383448|Sanfilippo syndrome|sanfilippo syndrome
765440|NCT00383448|Mucopolysaccharidosis III (MPS-III)|mucopolysaccharidosis iii (mps-iii)
765441|NCT00383448|GM1 gangliosidosis|gm1 gangliosidosis
765442|NCT00383448|I-cell|i-cell
765443|NCT00383448|mucolipidosis|mucolipidosis
765444|NCT00383409|breast|breast
765445|NCT00383409|cancer|cancer
765446|NCT00383409|fatigue|fatigue
765447|NCT00383409|multivitamins|multivitamins
765448|NCT00383357|Performance|performance
765449|NCT00383357|Gait stability|gait stability
765450|NCT00383357|sedative|sedative
765451|NCT00383357|hypnotic|hypnotic
765452|NCT00383357|quality of life|quality of life
765453|NCT00383357|sleep disorder|sleep disorder
765454|NCT00383357|wakefulness|wakefulness
765455|NCT00383357|sleeping pills|sleeping pills
765456|NCT00383357|Cognitive function|cognitive function
765457|NCT00383344|Crohn Disease|crohn disease
765458|NCT00383344|Positron Emission Tomography|positron emission tomography
765459|NCT00383344|Colonoscopy|colonoscopy
765460|NCT00383318|Neonate|neonate
765461|NCT00383318|Hyperbilirubinemia|hyperbilirubinemia
765462|NCT00383318|Jaundice|jaundice
765463|NCT00383318|G6PD Deficiency|g6pd deficiency
765464|NCT00383318|Gilbert's Syndrome|gilbert's syndrome
765465|NCT00383305|neonatal|neonatal
765466|NCT00383305|hypoxic|hypoxic
765467|NCT00383305|ischemic|ischemic
765963|NCT00381628|cells|cells
765468|NCT00383305|encephalopathy|encephalopathy
765469|NCT00383305|HIE|hie
765470|NCT00383305|birth asphyxia|birth asphyxia
765471|NCT00383305|neonatal encephalopathy|neonatal encephalopathy
765472|NCT00383305|Asphyxia Neonatorum|asphyxia neonatorum
765473|NCT00383305|hypothermia, therapeutic|hypothermia, therapeutic
765474|NCT00383305|brain cooling|brain cooling
765475|NCT00383305|selective head cooling|selective head cooling
765476|NCT00383279|recurrent cervical cancer|recurrent cervical cancer
765477|NCT00383279|stage 0 cervical cancer|stage 0 cervical cancer
765478|NCT00383279|stage IA cervical cancer|stage ia cervical cancer
765479|NCT00383279|stage IB cervical cancer|stage ib cervical cancer
765480|NCT00383279|stage IIA cervical cancer|stage iia cervical cancer
765481|NCT00383279|stage IIB cervical cancer|stage iib cervical cancer
765482|NCT00383279|stage III cervical cancer|stage iii cervical cancer
765483|NCT00383279|stage IVA cervical cancer|stage iva cervical cancer
765484|NCT00383279|stage IVB cervical cancer|stage ivb cervical cancer
765485|NCT00383279|recurrent uterine sarcoma|recurrent uterine sarcoma
765486|NCT00383279|stage I uterine sarcoma|stage i uterine sarcoma
765487|NCT00383279|stage II uterine sarcoma|stage ii uterine sarcoma
765488|NCT00383279|stage III uterine sarcoma|stage iii uterine sarcoma
765865|NCT00381914|Vitamin D|vitamin d
765489|NCT00383279|stage IV uterine sarcoma|stage iv uterine sarcoma
765490|NCT00383279|borderline ovarian surface epithelial-stromal tumor|borderline ovarian surface epithelial-stromal tumor
765491|NCT00383279|ovarian sarcoma|ovarian sarcoma
765492|NCT00383279|ovarian stromal cancer|ovarian stromal cancer
765493|NCT00383279|recurrent ovarian epithelial cancer|recurrent ovarian epithelial cancer
765494|NCT00383279|recurrent ovarian germ cell tumor|recurrent ovarian germ cell tumor
765495|NCT00383279|stage I ovarian epithelial cancer|stage i ovarian epithelial cancer
765496|NCT00383279|stage I ovarian germ cell tumor|stage i ovarian germ cell tumor
765497|NCT00383279|stage II ovarian epithelial cancer|stage ii ovarian epithelial cancer
765498|NCT00383279|stage II ovarian germ cell tumor|stage ii ovarian germ cell tumor
765499|NCT00383279|stage III ovarian epithelial cancer|stage iii ovarian epithelial cancer
765500|NCT00383279|stage III ovarian germ cell tumor|stage iii ovarian germ cell tumor
765501|NCT00383279|stage IV ovarian epithelial cancer|stage iv ovarian epithelial cancer
765502|NCT00383279|stage IV ovarian germ cell tumor|stage iv ovarian germ cell tumor
765503|NCT00383214|Lupus,|lupus,
765504|NCT00383214|antibody,|antibody,
765505|NCT00383214|B-cell immunotherapy|b-cell immunotherapy
765506|NCT00383201|Contact Lens Care|contact lens care
765507|NCT00383188|Arthritis, Rheumatoid|arthritis, rheumatoid
765508|NCT00383175|Ocular Accommodation|ocular accommodation
765509|NCT00383175|Reading|reading
765510|NCT00383162|Combination Product|combination product
765511|NCT00383162|naproxen sodium|naproxen sodium
765512|NCT00383162|sumatriptan succinate|sumatriptan succinate
765513|NCT00383162|short acting triptan|short acting triptan
765514|NCT00383162|migraine, acute|migraine, acute
765515|NCT00383162|Poor response|poor response
765516|NCT00383136|STEMI|stemi
765517|NCT00383136|Primary Angioplasty|primary angioplasty
765518|NCT00383136|Abciximab|abciximab
765519|NCT00383136|Tirofiban|tirofiban
765520|NCT00383123|Fluarix|fluarix
765521|NCT00383123|Influenza|influenza
765522|NCT00383110|Diabetes|diabetes
765523|NCT00383110|Health Outcomes|health outcomes
765524|NCT00383110|Racial Preference|racial preference
765525|NCT00383110|Clinical Trial|clinical trial
765526|NCT00383110|Ethnic Differences|ethnic differences
765527|NCT00383097|CTLs|ctls
765528|NCT00383097|LMP1|lmp1
765529|NCT00383097|LMP2|lmp2
765530|NCT00383097|CYTOTOXIC T-LYMPHOCYTES|cytotoxic t-lymphocytes
765531|NCT00383097|CD45|cd45
765532|NCT00383097|ANTIBODY|antibody
765533|NCT00383097|EBV-POSITIVE HODGKIN'S|ebv-positive hodgkin's
765534|NCT00383097|NON-HODGKIN'S LYMPHOMA|non-hodgkin's lymphoma
765535|NCT00383084|Pain|pain
765536|NCT00383084|Physical Activity|physical activity
765537|NCT00383084|Fatigue|fatigue
765538|NCT00383084|Lifestyle Activity|lifestyle activity
765539|NCT00383071|Apheresis|apheresis
765540|NCT00383071|Avian Flu|avian flu
765541|NCT00383071|Healthy Volunteers|healthy volunteers
765542|NCT00383071|Infectious Diseases|infectious diseases
765543|NCT00383071|IVIG|ivig
765544|NCT00383071|Healthy Volunteer|healthy volunteer
765545|NCT00383071|HV|hv
765546|NCT00383058|obesity|obesity
765547|NCT00383058|green tea|green tea
765548|NCT00383045|Buprenorphine|buprenorphine
765549|NCT00383045|Naltrexone|naltrexone
765550|NCT00383045|HIV risk reduction behavior|hiv risk reduction behavior
765551|NCT00383045|Counseling|counseling
765552|NCT00383006|Psychotherapy, Group|psychotherapy, group
765553|NCT00383006|Stress Disorders, Post-Traumatic|stress disorders, post-traumatic
765554|NCT00383006|Ambulatory Care|ambulatory care
765555|NCT00382993|migraine with or without aura|migraine with or without aura
765556|NCT00382993|naproxen sodium|naproxen sodium
765557|NCT00382993|combination product|combination product
765558|NCT00382993|sumatriptan succinate|sumatriptan succinate
765559|NCT00382993|poor response|poor response
765560|NCT00382993|short acting triptan|short acting triptan
765561|NCT00382993|migraine, acute|migraine, acute
765562|NCT00382980|influenza, vaccine, A/H5N1, aluminum hydroxide, Vero cell|influenza, vaccine, a/h5n1, aluminum hydroxide, vero cell
765563|NCT00382967|Parkinsonian Syndromes, Parkinsonism, DaTSCAN, SPECT, clinical management, quality of life, movement disorder|parkinsonian syndromes, parkinsonism, datscan, spect, clinical management, quality of life, movement disorder
765564|NCT00382967|Clinically uncertain Parkinsonian Syndromes|clinically uncertain parkinsonian syndromes
765565|NCT00382954|Acute Myelogenous Leukemia|acute myelogenous leukemia
765566|NCT00382954|AML|aml
765567|NCT00382954|Relapse|relapse
765568|NCT00382954|Elderly|elderly
765569|NCT00382954|Velcade|velcade
765570|NCT00382954|Idarubicin|idarubicin
765571|NCT00382954|Bortezomib|bortezomib
765572|NCT00382928|Randomized Controlled Trials|randomized controlled trials
765573|NCT00382928|Defibrillators|defibrillators
765574|NCT00382928|Medical Devices|medical devices
765575|NCT00382915|Smoking|smoking
765576|NCT00382915|Topography|topography
765577|NCT00382915|Nicotine|nicotine
765578|NCT00382902|Contact Lens Care|contact lens care
765579|NCT00382889|Anti-Asthmatic Agents|anti-asthmatic agents
765580|NCT00382889|corticosteroids|corticosteroids
765581|NCT00382889|symptom-driven|symptom-driven
765582|NCT00382889|beclomethasone|beclomethasone
765583|NCT00382889|salbutamol|salbutamol
765584|NCT00382876|apnea, hypoxia, car seat, car bed|apnea, hypoxia, car seat, car bed
765585|NCT00382863|heart failure|heart failure
765586|NCT00382863|cardiac support|cardiac support
765587|NCT00382863|Paracor|paracor
765588|NCT00382863|HeartNet|heartnet
765589|NCT00382863|PEERLESS-HF|peerless-hf
765590|NCT00382850|Nissen fundoplication|nissen fundoplication
765591|NCT00382850|gastroesophageal reflux|gastroesophageal reflux
765592|NCT00382837|Lupus,|lupus,
765593|NCT00382837|Antibody,|antibody,
765594|NCT00382837|B-Cell immunotherapy|b-cell immunotherapy
765595|NCT00382824|Progressive Supranuclear Palsy|progressive supranuclear palsy
765596|NCT00382824|CoQ10|coq10
765597|NCT00382824|Coenzyme Q10|coenzyme q10
765598|NCT00382811|Recurrent Ovarian Epithelial Cancer|recurrent ovarian epithelial cancer
765599|NCT00382811|Stage IV Ovarian Epithelial Cancer|stage iv ovarian epithelial cancer
765600|NCT00382811|Peritoneal Cavity Cancer|peritoneal cavity cancer
765703|NCT00382512|Moderate Plaque Psoriasis|moderate plaque psoriasis
765601|NCT00382811|Stage III Ovarian Epithelial Cancer|stage iii ovarian epithelial cancer
765603|NCT00382785|support|support
765604|NCT00382785|breast cancer|breast cancer
765605|NCT00382772|HRV vaccine|hrv vaccine
765606|NCT00382772|Diarrhoea|diarrhoea
765607|NCT00382772|Rotavirus|rotavirus
765608|NCT00382746|Congestive|congestive
765609|NCT00382746|Heart|heart
765610|NCT00382746|Failure|failure
765611|NCT00382746|CHF|chf
765612|NCT00382733|Solid Tumors|solid tumors
765613|NCT00382707|repetitive transcranial magnetic stimulation|repetitive transcranial magnetic stimulation
765614|NCT00382707|low frequency|low frequency
765615|NCT00382707|frontal lobe epilepsy|frontal lobe epilepsy
765616|NCT00382707|brain excitability|brain excitability
765617|NCT00382707|electromyography|electromyography
765618|NCT00382694|Myeloma|myeloma
765619|NCT00382694|Induction therapy|induction therapy
765620|NCT00382694|High-dose melphalan|high-dose melphalan
765621|NCT00382694|Autologous stem cell support|autologous stem cell support
765622|NCT00382694|Fludarabine|fludarabine
765623|NCT00382694|Cyclophosphamide|cyclophosphamide
765624|NCT00382694|Dexamethasone|dexamethasone
765625|NCT00382694|Safety|safety
765626|NCT00382694|Toxicity|toxicity
765627|NCT00382681|Contact Lens Care|contact lens care
765628|NCT00382668|hepatically impaired|hepatically impaired
765629|NCT00382655|Prevention|prevention
765630|NCT00382655|Emergency Medical Services|emergency medical services
765631|NCT00382655|Emergency Medical Technicians|emergency medical technicians
765632|NCT00382642|alcoholism, alcohol disorder, drinking,alcohol|alcoholism, alcohol disorder, drinking,alcohol
765633|NCT00382629|Multiple sclerosis|multiple sclerosis
765634|NCT00382629|MS|ms
765635|NCT00382629|Bayhill|bayhill
765636|NCT00382629|BHT-3009|bht-3009
765637|NCT00382629|immunotherapy|immunotherapy
765638|NCT00382616|behavioral problems|behavioral problems
765639|NCT00382616|learning problems|learning problems
765640|NCT00382616|inattentive|inattentive
765641|NCT00382616|impulsive|impulsive
765642|NCT00382616|hyperactive|hyperactive
765643|NCT00382616|children|children
765644|NCT00382616|phosphatidylserine|phosphatidylserine
765645|NCT00382616|long-chain polyunsaturated fatty acid|long-chain polyunsaturated fatty acid
765646|NCT00382616|eicosapentaenoic acid|eicosapentaenoic acid
765647|NCT00382616|docosahexaenoic acid|docosahexaenoic acid
765648|NCT00382616|omega3:omega6 ratio|omega3:omega6 ratio
765649|NCT00382616|eicosapentaenoic acid:arachidonic acid ratio|eicosapentaenoic acid:arachidonic acid ratio
765650|NCT00382616|Test of Variables of Attention|test of variables of attention
765651|NCT00382616|ADHD index scores|adhd index scores
765652|NCT00382603|Contact Lens Care|contact lens care
765653|NCT00382590|Acute Myelogenous Leukemia|acute myelogenous leukemia
765654|NCT00382590|AML|aml
765655|NCT00382590|Myelodysplastic Syndrome|myelodysplastic syndrome
765656|NCT00382590|Leukemia|leukemia
765657|NCT00382590|MDS|mds
765658|NCT00382590|Azacytidine|azacytidine
765659|NCT00382590|5-Azacytidine|5-azacytidine
765660|NCT00382590|5-aza|5-aza
765661|NCT00382590|Vidaza|vidaza
765662|NCT00382590|5-AZC|5-azc
765663|NCT00382590|AZA-CR|aza-cr
765664|NCT00382590|Ladakamycin|ladakamycin
765665|NCT00382590|Ara-C|ara-c
765666|NCT00382590|Cytarabine|cytarabine
765667|NCT00382590|Cytosar|cytosar
765668|NCT00382590|DepoCyt|depocyt
765669|NCT00382590|Cytosine arabinosine hydrochloride|cytosine arabinosine hydrochloride
765670|NCT00382590|Valproic Acid|valproic acid
765671|NCT00382590|VPA|vpa
765672|NCT00382590|Depakene|depakene
765673|NCT00382564|Imaging|imaging
765674|NCT00382564|Arteriosclerosis|arteriosclerosis
765675|NCT00382564|Hardening of the arteries|hardening of the arteries
765676|NCT00382564|MRA|mra
765677|NCT00382564|Narrowing of Vessels|narrowing of vessels
765678|NCT00382564|Noninvasive Plaque Imaging|noninvasive plaque imaging
765679|NCT00382564|Atherosclerotic Disease|atherosclerotic disease
765680|NCT00382564|Plaque|plaque
765681|NCT00382564|Arteries|arteries
765682|NCT00382564|Diabetes|diabetes
765683|NCT00382564|Hypertension|hypertension
765684|NCT00382551|Alcohol|alcohol
765685|NCT00382551|Red wine|red wine
765686|NCT00382551|Endothelial function|endothelial function
765687|NCT00382551|Flow-mediated vasodilation|flow-mediated vasodilation
765688|NCT00382551|Cardiovascular disease|cardiovascular disease
765689|NCT00382538|mifepristone|mifepristone
765690|NCT00382538|induction|induction
765691|NCT00382538|abortion|abortion
765692|NCT00382538|injection, intra-amniotic|injection, intra-amniotic
765693|NCT00382525|Bradyarrhythmia|bradyarrhythmia
765694|NCT00382525|Atrial Fibrillation|atrial fibrillation
765695|NCT00382525|Ventricular Tachycardia|ventricular tachycardia
765696|NCT00382525|Ventricular Fibrillation|ventricular fibrillation
765697|NCT00382525|Heart Failure|heart failure
765698|NCT00382525|Pacemaker|pacemaker
765699|NCT00382525|Implantable Cardioverter Defibrillator|implantable cardioverter defibrillator
765700|NCT00382525|Cardiac Resynchronization Therapy|cardiac resynchronization therapy
765701|NCT00382525|Loop recorder|loop recorder
765702|NCT00382525|Registry|registry
765704|NCT00382499|Intravenous Lidocaine|intravenous lidocaine
765705|NCT00382499|Lidocaine Infusion|lidocaine infusion
765706|NCT00382499|Total Abdominal Hysterectomy|total abdominal hysterectomy
765707|NCT00382499|Analgesia|analgesia
765708|NCT00382499|Anesthesia|anesthesia
765709|NCT00382499|Adjunct|adjunct
765710|NCT00382486|Intestinal transplant|intestinal transplant
765711|NCT00382486|Bone marrow|bone marrow
765712|NCT00382486|Irradiation of allograft|irradiation of allograft
765713|NCT00382473|Diabetes Mellitus, Type 2|diabetes mellitus, type 2
765714|NCT00382473|Overweight|overweight
765715|NCT00382473|Fatty acid oxidation|fatty acid oxidation
765716|NCT00382473|Mitochondria|mitochondria
765717|NCT00382473|Exercise|exercise
765718|NCT00382447|breath actuated nebulizer|breath actuated nebulizer
765719|NCT00382447|nebulizer|nebulizer
765720|NCT00382434|emergency pharmacist|emergency pharmacist
765721|NCT00382434|emergency medicine|emergency medicine
765722|NCT00382434|emergency department|emergency department
765723|NCT00382434|medical error|medical error
765724|NCT00382434|adverse event|adverse event
765725|NCT00382434|pharmacist|pharmacist
765726|NCT00382434|patient safety|patient safety
765727|NCT00382421|Myocardial Ischemia|myocardial ischemia
765728|NCT00382421|Randomized Controlled Trials|randomized controlled trials
765729|NCT00382421|Drug Therapy|drug therapy
765730|NCT00382408|Acute respiratory disease prevention|acute respiratory disease prevention
765731|NCT00382408|Adenovirus|adenovirus
765732|NCT00382395|Glaucoma shunt|glaucoma shunt
765733|NCT00382395|Ocular implant|ocular implant
765734|NCT00382395|Gold|gold
765735|NCT00382395|trabeculectomy|trabeculectomy
765736|NCT00382382|Autism|autism
765737|NCT00382382|Asperger Syndrome|asperger syndrome
765738|NCT00382382|Restricted repetitive behavior|restricted repetitive behavior
765739|NCT00382382|Stereotyped patterns of behavior|stereotyped patterns of behavior
765740|NCT00382382|Typically Developing children|typically developing children
765741|NCT00382382|Human Volunteers|human volunteers
765742|NCT00382369|familial vocal cord paralysis|familial vocal cord paralysis
765743|NCT00382369|genetic screening|genetic screening
765744|NCT00382356|Benign Prostatic Enlargement|benign prostatic enlargement
765745|NCT00382356|Benign Prostatic Hypertrophy|benign prostatic hypertrophy
765746|NCT00382356|Dutasteride|dutasteride
765747|NCT00382356|5-alpha reductase inhibitors|5-alpha reductase inhibitors
765748|NCT00382356|Hormonal therapy|hormonal therapy
765749|NCT00382343|Prevention|prevention
765750|NCT00382343|Pyelonephritis|pyelonephritis
765751|NCT00382343|Renal scars|renal scars
765752|NCT00382343|Vesico-ureteral reflux|vesico-ureteral reflux
765753|NCT00382343|Dimercaptosuccinic acid renal scan (DMSA)|dimercaptosuccinic acid renal scan (dmsa)
765754|NCT00382330|Vulva|vulva
765755|NCT00382317|MSCT indications|msct indications
765756|NCT00382304|Clostridium difficile-associated diarrhea|clostridium difficile-associated diarrhea
765757|NCT00382304|C. difficile|c. difficile
765758|NCT00382304|CDAD|cdad
766473|NCT00379275|Sarcoidosis|sarcoidosis
765759|NCT00382304|Clostridium difficile|clostridium difficile
765760|NCT00382304|Clostridium difficile Disease|clostridium difficile disease
765761|NCT00382304|Clostridium Enterocolitis|clostridium enterocolitis
765762|NCT00382304|Antibiotic-Associated Colitis|antibiotic-associated colitis
765763|NCT00382304|Infectious diarrhea|infectious diarrhea
765764|NCT00382291|OCD|ocd
765765|NCT00382291|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation
765766|NCT00382291|Placebos|placebos
765767|NCT00382291|Cognitive Behavior Therapy|cognitive behavior therapy
765768|NCT00382291|Child Psychiatry|child psychiatry
765769|NCT00382291|Activation Syndrome|activation syndrome
765770|NCT00382291|Psychometrics|psychometrics
765771|NCT00382278|Stem cell|stem cell
765772|NCT00382278|Liver cirrhosis|liver cirrhosis
765773|NCT00382278|Cellular therapy|cellular therapy
765774|NCT00382278|Autologous|autologous
765775|NCT00382278|Bone marrow|bone marrow
765776|NCT00382265|urolithiasis|urolithiasis
765777|NCT00382265|renal colic|renal colic
765778|NCT00382265|kidney stones|kidney stones
765779|NCT00382265|urinary stone disease|urinary stone disease
765780|NCT00382252|unspecified adult solid tumor, protocol specific|unspecified adult solid tumor, protocol specific
765781|NCT00382252|lung metastases|lung metastases
765782|NCT00382239|diabetes|diabetes
765783|NCT00382239|exenatide|exenatide
765784|NCT00382239|LY2148568|ly2148568
765785|NCT00382239|Lilly|lilly
765786|NCT00382239|Amylin|amylin
765787|NCT00382239|Japan|japan
765788|NCT00382226|Glaucoma|glaucoma
765789|NCT00382200|de novo myelodysplastic syndromes|de novo myelodysplastic syndromes
765790|NCT00382200|previously treated myelodysplastic syndromes|previously treated myelodysplastic syndromes
765791|NCT00382187|influenza|influenza
765792|NCT00382187|pandemic influenza|pandemic influenza
765793|NCT00382187|influenza vaccine|influenza vaccine
765794|NCT00382187|adjuvanted influenza vaccine|adjuvanted influenza vaccine
765795|NCT00382187|H5N1 influenza antigen|h5n1 influenza antigen
765796|NCT00382187|MF59|mf59
765797|NCT00382187|Pandemic influenza disease|pandemic influenza disease
765798|NCT00382174|pressure ulcers|pressure ulcers
765799|NCT00382174|cutaneous wound- healing|cutaneous wound- healing
765800|NCT00382174|chronic wound-healing|chronic wound-healing
765801|NCT00382174|Thymosin Beta 4|thymosin beta 4
765802|NCT00382174|laminin-5|laminin-5
765803|NCT00382161|impotence|impotence
765804|NCT00382161|erectile dysfunction|erectile dysfunction
765805|NCT00382161|cardiovascular risk factor|cardiovascular risk factor
765806|NCT00382161|statin|statin
765807|NCT00382148|TOPS|tops
765808|NCT00382148|Peanut allergy|peanut allergy
765809|NCT00382148|Peanut-induced allergy|peanut-induced allergy
765810|NCT00382148|Allergy|allergy
765811|NCT00382135|Impotence|impotence
765812|NCT00382135|erectile dysfunction|erectile dysfunction
765813|NCT00382135|semen|semen
765814|NCT00382135|sperm|sperm
765815|NCT00382135|Healthy male volunteers|healthy male volunteers
765816|NCT00382135|men with mild erectile dysfunction|men with mild erectile dysfunction
765817|NCT00382122|Glaucoma|glaucoma
765818|NCT00382122|Ocular hypertension|ocular hypertension
765819|NCT00382122|Dry eye|dry eye
765820|NCT00382122|Ocular surface disease|ocular surface disease
765821|NCT00382096|Type 2 diabetes|type 2 diabetes
765822|NCT00382096|vildagliptin|vildagliptin
765823|NCT00382096|metformin|metformin
765824|NCT00382096|hemoglobin A1c|hemoglobin a1c
765825|NCT00382083|Mammogram|mammogram
765826|NCT00382083|Pain|pain
765827|NCT00382083|Discomfort|discomfort
765828|NCT00382083|Breast|breast
765829|NCT00382083|Pre-medication|pre-medication
765830|NCT00382070|stage I breast cancer|stage i breast cancer
765831|NCT00382070|stage II breast cancer|stage ii breast cancer
765832|NCT00382070|stage IIIA breast cancer|stage iiia breast cancer
765833|NCT00382057|Testosterone|testosterone
765834|NCT00382057|Insulin resistance|insulin resistance
765835|NCT00382057|Insulin sensitivity|insulin sensitivity
765836|NCT00382057|Metabolic disorders|metabolic disorders
765837|NCT00382044|Kidney Failure, Chronic|kidney failure, chronic
765838|NCT00382044|Dialysis|dialysis
765839|NCT00382044|Anemia|anemia
765840|NCT00382044|epoetin|epoetin
765841|NCT00382018|recurrent breast cancer|recurrent breast cancer
765842|NCT00382018|stage IV breast cancer|stage iv breast cancer
765843|NCT00381992|sexual risk behavior|sexual risk behavior
765844|NCT00381992|diabetes mellitus|diabetes mellitus
765845|NCT00381992|hypertension|hypertension
765846|NCT00381992|obesity|obesity
765847|NCT00381992|human immunodeficiency virus|human immunodeficiency virus
765848|NCT00381992|hyperlipidemia|hyperlipidemia
765849|NCT00381992|chlamydia|chlamydia
765850|NCT00381979|Depression|depression
765851|NCT00381979|Anxiety|anxiety
765852|NCT00381979|Adolescents|adolescents
765853|NCT00381979|Treatment|treatment
765854|NCT00381979|Supportive Expressive Therapy|supportive expressive therapy
765855|NCT00381966|Prostate Cancer|prostate cancer
765856|NCT00381966|Brachytherapy|brachytherapy
765857|NCT00381927|Breast Cancer Risk|breast cancer risk
765858|NCT00381927|Counseling|counseling
765859|NCT00381927|Prevention|prevention
765861|NCT00381927|BRCA1 mutation|brca1 mutation
765862|NCT00381927|BRCA2 mutation|brca2 mutation
765863|NCT00381927|Tamoxifen|tamoxifen
765864|NCT00381914|Infants|infants
765866|NCT00381914|Dose-response|dose-response
765867|NCT00381901|stage II breast cancer|stage ii breast cancer
765868|NCT00381901|stage IIIA breast cancer|stage iiia breast cancer
765869|NCT00381901|stage IIIB breast cancer|stage iiib breast cancer
765870|NCT00381901|stage IA breast cancer|stage ia breast cancer
765871|NCT00381901|stage IB breast cancer|stage ib breast cancer
765872|NCT00381901|recurrent breast cancer|recurrent breast cancer
765873|NCT00381901|stage IIIC breast cancer|stage iiic breast cancer
765874|NCT00381888|thromboembolism|thromboembolism
765875|NCT00381888|cervical cancer|cervical cancer
765876|NCT00381888|endometrial cancer|endometrial cancer
765877|NCT00381888|ovarian epithelial cancer|ovarian epithelial cancer
765878|NCT00381888|ovarian germ cell tumor|ovarian germ cell tumor
765879|NCT00381888|borderline ovarian surface epithelial-stromal tumor|borderline ovarian surface epithelial-stromal tumor
765880|NCT00381888|ovarian sarcoma|ovarian sarcoma
765881|NCT00381888|ovarian stromal cancer|ovarian stromal cancer
765882|NCT00381888|uterine sarcoma|uterine sarcoma
765883|NCT00381888|vaginal cancer|vaginal cancer
765884|NCT00381888|vulvar cancer|vulvar cancer
765885|NCT00381888|fallopian tube cancer|fallopian tube cancer
765886|NCT00381875|HIV infection|hiv infection
765887|NCT00381862|nausea and vomiting|nausea and vomiting
765888|NCT00381862|recurrent colon cancer|recurrent colon cancer
765889|NCT00381862|stage IV colon cancer|stage iv colon cancer
765890|NCT00381862|recurrent rectal cancer|recurrent rectal cancer
765891|NCT00381862|stage IV rectal cancer|stage iv rectal cancer
765892|NCT00381849|Cystone|cystone
765893|NCT00381849|Uricare|uricare
765894|NCT00381849|Computerized tomography|computerized tomography
765895|NCT00381849|Kidney calculi|kidney calculi
765896|NCT00381849|Supersaturation|supersaturation
765897|NCT00381849|Nephrolithiasis|nephrolithiasis
765898|NCT00381849|Quantitative CT|quantitative ct
765899|NCT00381836|Prostate Cancer|prostate cancer
765900|NCT00381836|Anemia|anemia
765901|NCT00381836|Blood transfusion|blood transfusion
765902|NCT00381836|Cancer|cancer
765903|NCT00381836|Critical illness|critical illness
765904|NCT00381836|Drug efficacy|drug efficacy
765905|NCT00381836|Drug safety|drug safety
765906|NCT00381836|Drug tolerability|drug tolerability
765907|NCT00381836|Erythropoietin|erythropoietin
765908|NCT00381836|Fatigue|fatigue
765909|NCT00381836|Hemoglobin|hemoglobin
765910|NCT00381836|Human|human
765911|NCT00381836|Male|male
765912|NCT00381836|Multicenter study|multicenter study
765913|NCT00381836|Quality of life|quality of life
765914|NCT00381836|Questionnaire|questionnaire
765915|NCT00381836|Randomized controlled trial|randomized controlled trial
765916|NCT00381836|Recombinant erythropoietin|recombinant erythropoietin
765917|NCT00381823|Pregnant women|pregnant women
765918|NCT00381823|Intervention Studies|intervention studies
765919|NCT00381823|African Americans|african americans
765920|NCT00381823|Infant Mortality|infant mortality
765921|NCT00381823|Environmental Tobacco Smoke Pollution|environmental tobacco smoke pollution
765922|NCT00381823|Depression|depression
765923|NCT00381823|Partner Abuse|partner abuse
765924|NCT00381823|Tobacco Smoke|tobacco smoke
765925|NCT00381810|Rituxan|rituxan
765926|NCT00381810|SLE|sle
765927|NCT00381810|Lupus|lupus
765928|NCT00381784|YMSM|ymsm
765929|NCT00381784|HIV/AIDS|hiv/aids
765930|NCT00381784|Condom use|condom use
765931|NCT00381784|Drug users|drug users
765932|NCT00381784|Minority women|minority women
765933|NCT00381771|Globus Pharyngeus|globus pharyngeus
765934|NCT00381771|Xerostomia|xerostomia
765935|NCT00381771|Salivary Hypofunction|salivary hypofunction
765936|NCT00381771|Pharyngoxerosis|pharyngoxerosis
765937|NCT00381758|ADHD|adhd
765938|NCT00381758|Methylphenidate|methylphenidate
765939|NCT00381758|Metadate CD|metadate cd
765940|NCT00381758|Concerta|concerta
765941|NCT00381758|COMACS|comacs
765942|NCT00381758|Attention Deficit Hyperactivity Disorder (ADHD)|attention deficit hyperactivity disorder (adhd)
765943|NCT00381732|Impotence|impotence
765944|NCT00381732|erectile dysfunction|erectile dysfunction
765945|NCT00381706|squamous cell carcinoma of the esophagus|squamous cell carcinoma of the esophagus
765946|NCT00381706|adenocarcinoma of the esophagus|adenocarcinoma of the esophagus
765947|NCT00381706|stage IV esophageal cancer|stage iv esophageal cancer
765948|NCT00381706|recurrent esophageal cancer|recurrent esophageal cancer
765949|NCT00381693|primary myelofibrosis|primary myelofibrosis
765950|NCT00381693|polycythemia vera|polycythemia vera
765951|NCT00381693|essential thrombocythemia|essential thrombocythemia
765952|NCT00381693|secondary myelofibrosis|secondary myelofibrosis
765953|NCT00381667|safety|safety
765954|NCT00381667|GW642444M|gw642444m
765955|NCT00381667|Single Dose|single dose
765956|NCT00381667|pharmacodynamics|pharmacodynamics
765957|NCT00381667|pharmacokinetics|pharmacokinetics
765958|NCT00381667|GW642444H|gw642444h
765959|NCT00381667|tolerability|tolerability
765960|NCT00381654|Solid Tumors|solid tumors
765961|NCT00381654|Tyrosine Kinases|tyrosine kinases
765962|NCT00381628|Anatomy|anatomy
765964|NCT00381628|epithelial cells|epithelial cells
765965|NCT00381628|blood cells|blood cells
765966|NCT00381628|cystic fibrosis|cystic fibrosis
765967|NCT00381628|equipment and supplies|equipment and supplies
765968|NCT00381628|disposable equipment|disposable equipment
765969|NCT00381628|reagent kits|reagent kits
765970|NCT00381615|Meningococcal disease|meningococcal disease
765971|NCT00381615|prevention|prevention
765972|NCT00381615|vaccination|vaccination
765973|NCT00381602|End stage renal disease|end stage renal disease
765974|NCT00381602|Hemodialysis|hemodialysis
765975|NCT00381602|Malnutrition|malnutrition
765976|NCT00381602|End stage renal disease (ESRD)|end stage renal disease (esrd)
765977|NCT00381589|clozapine-induced hypersalivation|clozapine-induced hypersalivation
765978|NCT00381576|Resistance training|resistance training
765979|NCT00381576|Strength training|strength training
765980|NCT00381576|Training adaptations|training adaptations
765981|NCT00381576|CNS|cns
765982|NCT00381563|Bracing|bracing
765983|NCT00381563|Patellofemoral|patellofemoral
765984|NCT00381563|Osteoarthritis|osteoarthritis
765985|NCT00381537|childhood epilepsy|childhood epilepsy
765986|NCT00381537|Active childhood epilepsy|active childhood epilepsy
765987|NCT00381524|human immunodeficiency virus|human immunodeficiency virus
765988|NCT00381524|behavior change|behavior change
765989|NCT00381511|pulmonary embolism,|pulmonary embolism,
765990|NCT00381511|deferred diagnosis,|deferred diagnosis,
765991|NCT00381511|protective anticoagulation|protective anticoagulation
765992|NCT00381511|anticoagulants|anticoagulants
765993|NCT00381472|Parkinson's Disease|parkinson's disease
765994|NCT00381472|Dyskinesia|dyskinesia
765995|NCT00381472|Adjunctive Therapy with L-dopa|adjunctive therapy with l-dopa
765996|NCT00381446|corneal staining|corneal staining
765997|NCT00381446|contact lens care|contact lens care
765998|NCT00381446|multipurpose solution|multipurpose solution
766000|NCT00381433|Hepatitis C virus|hepatitis c virus
766001|NCT00381407|ADHD|adhd
766002|NCT00381407|Organizational Skills|organizational skills
766003|NCT00381407|Contingency Management|contingency management
766004|NCT00381394|amphotericin B|amphotericin b
766005|NCT00381394|safety|safety
766006|NCT00381394|tolerability and pharmacokinetics of oral sitamaquine|tolerability and pharmacokinetics of oral sitamaquine
766007|NCT00381394|Visceral leishmaniasis|visceral leishmaniasis
766008|NCT00381381|Alzheimer's disease|alzheimer's disease
766009|NCT00381368|breast cancer|breast cancer
766010|NCT00381368|skeletal metastases|skeletal metastases
766011|NCT00381368|bisphosphonate therapy|bisphosphonate therapy
766012|NCT00381368|Breast cancer with painful skeletal metastases|breast cancer with painful skeletal metastases
766013|NCT00381355|asthma|asthma
766014|NCT00381355|children|children
766015|NCT00381355|written action plan|written action plan
766016|NCT00381355|education|education
766017|NCT00381355|guided self-management|guided self-management
766018|NCT00381355|efficacy|efficacy
766019|NCT00381355|compliance|compliance
766020|NCT00381355|b2-agonists|b2-agonists
766021|NCT00381355|inhaled corticosteroids|inhaled corticosteroids
766022|NCT00381355|oral steroids|oral steroids
766023|NCT00381355|relapse|relapse
766024|NCT00381355|randomised controlled trial|randomised controlled trial
766025|NCT00381355|emergency department|emergency department
766026|NCT00381342|diabetes|diabetes
766027|NCT00381342|exenatide|exenatide
766028|NCT00381342|Amylin|amylin
766029|NCT00381342|Lilly|lilly
766030|NCT00381342|monotherapy|monotherapy
766031|NCT00381329|Motivational Interviewing|motivational interviewing
766032|NCT00381329|Structured Brief Advice|structured brief advice
766033|NCT00381329|Adolescent Smoking|adolescent smoking
766034|NCT00381329|Behavioral Intervention|behavioral intervention
766035|NCT00381329|Smoking|smoking
766036|NCT00381329|Primary Care|primary care
766037|NCT00381329|Tobacco|tobacco
766039|NCT00381303|AIDS|aids
766040|NCT00381303|Immunodeficiency Virus, Human|immunodeficiency virus, human
766041|NCT00381303|Females|females
766042|NCT00381303|Women|women
766043|NCT00381303|PREZISTA|prezista
766044|NCT00381303|darunavir|darunavir
766045|NCT00381303|TMC114|tmc114
766046|NCT00381303|Protease Inhibitor|protease inhibitor
766047|NCT00381290|Arthritis|arthritis
766048|NCT00381290|Arthritis, Degenerative|arthritis, degenerative
766049|NCT00381290|Knee Health|knee health
766050|NCT00381290|Obesity|obesity
766051|NCT00381290|Overweight|overweight
766052|NCT00381290|Osteoarthritis|osteoarthritis
766053|NCT00381290|Weight Loss|weight loss
766054|NCT00381290|Diet|diet
766055|NCT00381290|Exercise|exercise
766056|NCT00381290|Knee Pain|knee pain
766057|NCT00381277|nephrolithiasis|nephrolithiasis
766058|NCT00381277|citrate|citrate
766059|NCT00381277|oxalate|oxalate
766060|NCT00381251|vaginal atrophy|vaginal atrophy
766061|NCT00381251|postmenopausal osteoporosis|postmenopausal osteoporosis
766062|NCT00381251|menopause|menopause
766063|NCT00381251|hot flashes|hot flashes
766064|NCT00381238|Alzheimer's Disease|alzheimer's disease
766065|NCT00381238|Rosiglitazone|rosiglitazone
766066|NCT00381225|Radio-frequency ablation; Head and Neck neoplasia.|radio-frequency ablation; head and neck neoplasia.
766474|NCT00379275|Uveitis|uveitis
766067|NCT00381212|Immunotherapeutic injection|immunotherapeutic injection
766068|NCT00381199|fibromyalgia|fibromyalgia
766069|NCT00381199|cannabinoid|cannabinoid
766070|NCT00381199|chronic pain|chronic pain
766071|NCT00381199|sleep|sleep
766072|NCT00381199|insomnia|insomnia
766073|NCT00381199|diffuse widespread pain|diffuse widespread pain
766074|NCT00381199|antidepressant|antidepressant
766075|NCT00381186|impaired glucose tolerance|impaired glucose tolerance
766076|NCT00381186|type 2 diabetes|type 2 diabetes
766077|NCT00381173|MGI PHARMA|mgi pharma
766078|NCT00381173|ZYC3-002|zyc3-002
766079|NCT00381173|ZYC300|zyc300
766080|NCT00381173|plasmid DNA|plasmid dna
766081|NCT00381173|cyclophosphamide|cyclophosphamide
766082|NCT00381173|Cytoxan|cytoxan
766083|NCT00381173|advanced breast cancer|advanced breast cancer
766084|NCT00381173|advanced ovarian cancer|advanced ovarian cancer
766085|NCT00381173|hormone refractory prostate cancer|hormone refractory prostate cancer
766086|NCT00381173|advanced colon cancer|advanced colon cancer
766087|NCT00381173|advanced renal cancer|advanced renal cancer
766088|NCT00381173|advanced stage malignancies|advanced stage malignancies
766089|NCT00381173|immune therapy|immune therapy
766090|NCT00381173|gene therapy|gene therapy
766091|NCT00381173|biologic therapy|biologic therapy
766092|NCT00381173|T-regulatory cells|t-regulatory cells
766093|NCT00381173|cancer vaccine|cancer vaccine
766094|NCT00381173|vaccine|vaccine
766095|NCT00381173|Advanced stage malignancies-ovary, breast, colon, prostate|advanced stage malignancies-ovary, breast, colon, prostate
766096|NCT00381160|weight loss|weight loss
766097|NCT00381160|obesity|obesity
766098|NCT00381160|sugar-sweetened beverages|sugar-sweetened beverages
766099|NCT00381160|diet|diet
766100|NCT00381160|adolescence|adolescence
766101|NCT00381134|double-blind|double-blind
766102|NCT00381134|placebo-controlled|placebo-controlled
766103|NCT00381134|nephropathy|nephropathy
766104|NCT00381134|blood pressure|blood pressure
766105|NCT00381134|urine albumin to creatinine ratio|urine albumin to creatinine ratio
766106|NCT00381134|placebo|placebo
766107|NCT00381121|Tissue Biobank|tissue biobank
766108|NCT00381121|molecular markers|molecular markers
766109|NCT00381121|molecular pathways|molecular pathways
766111|NCT00381082|Pediculus|pediculus
766112|NCT00381082|capitis|capitis
766113|NCT00381082|lice|lice
766114|NCT00381069|Recreation Centers|recreation centers
766115|NCT00381069|Families|families
766116|NCT00381069|Obesity Prevention|obesity prevention
766117|NCT00381056|labor and delivery care|labor and delivery care
766118|NCT00381056|teamwork training|teamwork training
766119|NCT00381056|crew resource management|crew resource management
766120|NCT00381056|cluster-randomized trial|cluster-randomized trial
766121|NCT00381043|Alcohol Dependence|alcohol dependence
766122|NCT00381043|Family Medicine Setting|family medicine setting
766123|NCT00381043|University of North Carolina at Chapel Hill|university of north carolina at chapel hill
766124|NCT00381030|beta-Adrenergic Blockers|beta-adrenergic blockers
766125|NCT00381030|Disease Management|disease management
766126|NCT00381004|Chronic Lymphocytic Leukemia|chronic lymphocytic leukemia
766127|NCT00381004|Leukemia|leukemia
766128|NCT00381004|Cyclophosphamide|cyclophosphamide
766129|NCT00381004|Fludarabine|fludarabine
766130|NCT00381004|Sargramostim|sargramostim
766131|NCT00381004|Rituximab|rituximab
766132|NCT00381004|GM-CSF|gm-csf
766133|NCT00381004|FCR|fcr
766134|NCT00380978|labor pain|labor pain
766135|NCT00380978|cesarean section|cesarean section
766136|NCT00380978|epidural analgesia|epidural analgesia
766137|NCT00380978|opioid analgesics|opioid analgesics
766138|NCT00380978|local anesthetics|local anesthetics
766139|NCT00380978|labor induced|labor induced
766140|NCT00380965|Chemotherapy-induced|chemotherapy-induced
766141|NCT00380965|neuropathy|neuropathy
766142|NCT00380965|cancer|cancer
766143|NCT00380952|IDC|idc
766144|NCT00380952|DCIS|dcis
766145|NCT00380952|ILC|ilc
766146|NCT00380926|polyunsatturated fatty acids|polyunsatturated fatty acids
766147|NCT00380926|nutrition|nutrition
766148|NCT00380926|low-dose allergen challenge|low-dose allergen challenge
766149|NCT00380926|exhaled nitric oxide|exhaled nitric oxide
766150|NCT00380887|bioavailability|bioavailability
766151|NCT00380887|bioequivalence|bioequivalence
766152|NCT00380887|marketed product|marketed product
766153|NCT00380887|Premarin|premarin
766154|NCT00380887|Medroxyprogesterone acetate|medroxyprogesterone acetate
766155|NCT00380887|MPA|mpa
766156|NCT00380887|Postmenopausal|postmenopausal
766157|NCT00380887|vasomotor symptoms|vasomotor symptoms
766158|NCT00380874|Pain|pain
766159|NCT00380874|chemotherapy|chemotherapy
766160|NCT00380861|Total Knee Replacement|total knee replacement
766161|NCT00380861|Flexion|flexion
766162|NCT00380861|Range of Motion|range of motion
766163|NCT00380861|Activities of Daily Living|activities of daily living
766164|NCT00380861|Implant design|implant design
766165|NCT00380861|Subject Satisfaction|subject satisfaction
766166|NCT00380861|Non-inflammatory arthritis|non-inflammatory arthritis
766167|NCT00380848|sleep apnea|sleep apnea
766168|NCT00380848|end stage renal disease|end stage renal disease
767148|NCT00377468|CRPS|crps
766169|NCT00380848|hemodiafiltration|hemodiafiltration
766170|NCT00380835|metastatic breast cancer|metastatic breast cancer
766171|NCT00380835|amrubicin|amrubicin
766172|NCT00380822|alpa-glucosidase inhibitor|alpa-glucosidase inhibitor
766173|NCT00380796|Chronic Obstructive Pulmonary Disease|chronic obstructive pulmonary disease
766174|NCT00380796|COPD|copd
766175|NCT00380770|HIV|hiv
766176|NCT00380770|AIDS|aids
766177|NCT00380770|Kaposi's sarcoma|kaposi's sarcoma
766178|NCT00380770|Human herpesvirus 8|human herpesvirus 8
766179|NCT00380757|cardiac arrest|cardiac arrest
766180|NCT00380757|CPR|cpr
766181|NCT00380757|resuscitation|resuscitation
766182|NCT00380757|fatigue|fatigue
766183|NCT00380757|quality|quality
766184|NCT00380731|Social Anxiety Disorder|social anxiety disorder
766185|NCT00380731|Magnetic Resonance Imaging|magnetic resonance imaging
766186|NCT00380731|Cognitive Behavior Therapy|cognitive behavior therapy
766187|NCT00380640|Pediatrics|pediatrics
766188|NCT00380640|Epidermolysis Bullosa|epidermolysis bullosa
766189|NCT00380640|Trimethoprim|trimethoprim
766190|NCT00380640|Wound Healing|wound healing
766191|NCT00380614|Acute Hepatitis B, Lamivudine|acute hepatitis b, lamivudine
766192|NCT00380575|hyponatremia|hyponatremia
766193|NCT00380575|hypervolemic|hypervolemic
766194|NCT00380575|euvolemic|euvolemic
766195|NCT00380575|vasopressins|vasopressins
766196|NCT00380575|YM087|ym087
766197|NCT00380562|Quality of life|quality of life
766198|NCT00380562|Cognitive Functioning|cognitive functioning
766199|NCT00380562|Activities of Daily Living|activities of daily living
766200|NCT00380562|Disability prevention|disability prevention
766201|NCT00380549|osteoarthritis, hip replacement|osteoarthritis, hip replacement
766202|NCT00380536|Peer-led Education|peer-led education
766203|NCT00380510|Family Physicians|family physicians
766204|NCT00380510|Adolescents|adolescents
766205|NCT00380510|Preventive Care|preventive care
766206|NCT00380510|Health Behavior|health behavior
766207|NCT00380497|Pediatrics|pediatrics
766208|NCT00380497|Colonoscopy|colonoscopy
766209|NCT00380497|Bowel cleanout|bowel cleanout
766210|NCT00380497|Poly-Ethylene Glycol|poly-ethylene glycol
766211|NCT00380497|Pico-Salax|pico-salax
766212|NCT00380471|bath PUVA|bath puva
766213|NCT00380458|Obstructive|obstructive
766214|NCT00380458|Sleep|sleep
766215|NCT00380458|Apnea|apnea
766216|NCT00380458|Pain|pain
766217|NCT00380458|UPPP|uppp
766218|NCT00380458|Tonsillectomy|tonsillectomy
766219|NCT00380458|Narcotics|narcotics
766220|NCT00380445|Vildagliptin, Type 2 diabetes|vildagliptin, type 2 diabetes
766221|NCT00380419|Pregnancy|pregnancy
766222|NCT00380419|Postpartum Depression|postpartum depression
766223|NCT00380406|Gonadotropin releasing hormone agonist|gonadotropin releasing hormone agonist
766224|NCT00380406|GnRH|gnrh
766225|NCT00380406|Fertility|fertility
766226|NCT00380406|Fertility preservation|fertility preservation
766227|NCT00380406|Oncology|oncology
766228|NCT00380406|Cancer|cancer
766229|NCT00380406|Chemotherapy|chemotherapy
766230|NCT00380393|Malaria|malaria
766231|NCT00380393|Plasmodium|plasmodium
766232|NCT00380393|RTS|rts
766233|NCT00380393|S/AS01|s/as01
766234|NCT00380393|Falciparum|falciparum
766235|NCT00380380|Vildagliptin, type 2 diabetes, gastric emptying|vildagliptin, type 2 diabetes, gastric emptying
766236|NCT00380354|allergen|allergen
766237|NCT00380354|methacholine|methacholine
766238|NCT00380354|GSK256066|gsk256066
766239|NCT00380354|mild asthmatics|mild asthmatics
766240|NCT00380354|repeat dose|repeat dose
766241|NCT00380354|challenge|challenge
766242|NCT00380354|late asthmatic response|late asthmatic response
766243|NCT00380328|Pharmacokinetic|pharmacokinetic
766244|NCT00380328|healthy subjects|healthy subjects
766245|NCT00380315|Cough|cough
766246|NCT00380315|Chronic bronchitis|chronic bronchitis
766247|NCT00380315|PNDs|pnds
766248|NCT00380315|Post Nasal Drip syndrome|post nasal drip syndrome
766249|NCT00380315|GERD|gerd
766250|NCT00380315|gastroesophageal reflux disease|gastroesophageal reflux disease
766251|NCT00380315|bronchiectasis|bronchiectasis
766252|NCT00380302|Alzheimer's disease|alzheimer's disease
766253|NCT00380302|symptomatic|symptomatic
766254|NCT00380302|cognition|cognition
766255|NCT00380289|Essential hypertension|essential hypertension
766256|NCT00380289|Glucose metabolism|glucose metabolism
766257|NCT00380289|Thiazides|thiazides
766258|NCT00380289|Beta blockers|beta blockers
766259|NCT00380276|Alzheimer's|alzheimer's
766260|NCT00380276|Dementia|dementia
766261|NCT00380276|Dementia of Alzheimer Type|dementia of alzheimer type
766262|NCT00380237|Bird Flu|bird flu
766263|NCT00380237|Avian Flu|avian flu
766264|NCT00380224|schizophrenia|schizophrenia
766265|NCT00380211|Thimerosal reduced content|thimerosal reduced content
766266|NCT00380211|Immunogenicity, safety, reactogenicity|immunogenicity, safety, reactogenicity
766267|NCT00380211|Young and elderly adults|young and elderly adults
766268|NCT00380211|Influenza vaccine|influenza vaccine
766269|NCT00380185|Peripheral Arterial Disease|peripheral arterial disease
766270|NCT00380185|Atherosclerosis|atherosclerosis
766271|NCT00380172|AMD|amd
766272|NCT00380172|Macular Degeneration|macular degeneration
766273|NCT00380172|Retinal Degeneration|retinal degeneration
766274|NCT00380159|Extension study to ACH443-014A|extension study to ach443-014a
766275|NCT00380146|Malaria|malaria
766276|NCT00380146|Intermittent presumptive treatment|intermittent presumptive treatment
766277|NCT00380146|IPT|ipt
766278|NCT00380146|Pharmacokinetic|pharmacokinetic
766279|NCT00380146|Efficacy|efficacy
766280|NCT00380146|Gametocyte|gametocyte
766281|NCT00380146|Molecular markers|molecular markers
766282|NCT00380133|COPD SB-681323 prednisolone biomarkers|copd sb-681323 prednisolone biomarkers
766283|NCT00380107|Minor surgery|minor surgery
766284|NCT00380107|Volume optimization|volume optimization
766285|NCT00380107|Volume deficit|volume deficit
766286|NCT00380107|Epidural anesthesia|epidural anesthesia
766287|NCT00380094|ACS|acs
766288|NCT00380094|NSTEMI|nstemi
766289|NCT00380094|Myeloperoxidase|myeloperoxidase
766290|NCT00380094|nonST segment elevation myocardial infarction|nonst segment elevation myocardial infarction
766291|NCT00380081|Insomnia|insomnia
766292|NCT00380055|Cancer Screening|cancer screening
766293|NCT00380055|Navigators|navigators
766294|NCT00380055|Community Outreach|community outreach
766295|NCT00380055|Behavioral Change|behavioral change
766296|NCT00380055|Access|access
766297|NCT00380042|Cortical Electrical Stimulation|cortical electrical stimulation
766298|NCT00380042|Treatment Resistant Depression|treatment resistant depression
766299|NCT00380042|Major Depressive Disorder|major depressive disorder
766300|NCT00380029|stage II bladder cancer|stage ii bladder cancer
766301|NCT00380029|transitional cell carcinoma of the bladder|transitional cell carcinoma of the bladder
766302|NCT00380016|Angioplasty|angioplasty
766303|NCT00380016|Stent|stent
766304|NCT00380016|Coronary Artery Disease|coronary artery disease
766305|NCT00380016|Peripheral Artery Disease|peripheral artery disease
766306|NCT00380016|Percutaneous Coronary Intervention|percutaneous coronary intervention
766307|NCT00380016|CAD|cad
766308|NCT00380016|PAD|pad
766309|NCT00380016|Cardiovascular Disease|cardiovascular disease
766310|NCT00379990|iNOS|inos
766311|NCT00379990|Exhaled NO|exhaled no
766312|NCT00379990|Rheumatoid arthritis|rheumatoid arthritis
766313|NCT00379938|Parvovirus B-19, Parvoviridae, vaccine|parvovirus b-19, parvoviridae, vaccine
766314|NCT00379925|Physical Activity|physical activity
766315|NCT00379925|Exercise|exercise
766316|NCT00379925|Dietary Habits|dietary habits
766317|NCT00379899|calcification|calcification
766318|NCT00379899|vascular calcification|vascular calcification
766319|NCT00379899|coronary vascular calcification|coronary vascular calcification
766320|NCT00379899|chronic kidney disease|chronic kidney disease
766321|NCT00379899|end stage renal disease|end stage renal disease
766322|NCT00379899|dialysis|dialysis
766323|NCT00379886|ECT|ect
766324|NCT00379886|Depression|depression
766325|NCT00379886|Anesthiticum|anesthiticum
766326|NCT00379886|Propofol|propofol
766327|NCT00379886|Thiopental|thiopental
766328|NCT00379847|hyponatremia|hyponatremia
766329|NCT00379847|hypervolemic|hypervolemic
766330|NCT00379847|euvolemic|euvolemic
766331|NCT00379847|treatment outcomes|treatment outcomes
766332|NCT00379847|YM087|ym087
766333|NCT00379834|glaucoma|glaucoma
766334|NCT00379834|diurnal|diurnal
766335|NCT00379834|intraocular pressure|intraocular pressure
766336|NCT00379821|chloroquine, malaria, Plasmodium falciparum, Malawi, children|chloroquine, malaria, plasmodium falciparum, malawi, children
766337|NCT00379808|coronary heart disease|coronary heart disease
766338|NCT00379808|montelukast|montelukast
766339|NCT00379808|inflammation|inflammation
766340|NCT00379795|CNV|cnv
766341|NCT00379795|Lucentis|lucentis
766342|NCT00379795|AMD|amd
766343|NCT00379795|Age-related macular degeneration|age-related macular degeneration
766344|NCT00379795|RVO|rvo
766345|NCT00379769|diabetes|diabetes
766346|NCT00379769|CV outcomes|cv outcomes
766347|NCT00379769|rosiglitazone|rosiglitazone
766348|NCT00379769|Type II diabetes|type ii diabetes
766349|NCT00379769|sulfonylurea|sulfonylurea
766350|NCT00379769|RECORD|record
766351|NCT00379769|metformin|metformin
766352|NCT00379756|Erectile dysfunction, impotence|erectile dysfunction, impotence
766353|NCT00379730|CT scan|ct scan
766354|NCT00379730|breathing tests|breathing tests
766355|NCT00379730|lung function tests|lung function tests
766356|NCT00379730|biomarkers|biomarkers
766357|NCT00379730|prednisolone|prednisolone
766358|NCT00379730|IOS|ios
766359|NCT00379730|COPD|copd
766360|NCT00379730|clinical outcomes|clinical outcomes
766361|NCT00379717|helical tomotherapy|helical tomotherapy
766362|NCT00379717|dose escalation|dose escalation
766363|NCT00379717|chemotherapy|chemotherapy
766364|NCT00379704|Tissue factor|tissue factor
766365|NCT00379704|Obesity|obesity
766366|NCT00379704|Adipose tissue|adipose tissue
766367|NCT00379704|Microparticles|microparticles
766368|NCT00379691|spinal|spinal
766369|NCT00379691|Cesarean section|cesarean section
766370|NCT00379691|hypotension|hypotension
766371|NCT00379691|nausea|nausea
766372|NCT00379691|vomiting|vomiting
766373|NCT00379691|phenylephrine|phenylephrine
766374|NCT00379678|atopic dermatitis|atopic dermatitis
766375|NCT00379665|Lung|lung
766376|NCT00379665|Chemotherapy|chemotherapy
766377|NCT00379665|Cisplatin|cisplatin
766378|NCT00379665|Intratumoral|intratumoral
766379|NCT00379665|Bronchoscope|bronchoscope
766380|NCT00379665|Brachytherapy|brachytherapy
766381|NCT00379652|Community Health Centers|community health centers
766382|NCT00379652|Diabetes|diabetes
766383|NCT00379652|Blood Pressure, High|blood pressure, high
766384|NCT00379639|Pancreatic cancer|pancreatic cancer
766385|NCT00379639|advanced solid tumors|advanced solid tumors
766386|NCT00379626|Paraphilia|paraphilia
766387|NCT00379626|Hormonal treatment|hormonal treatment
766388|NCT00379626|Cognitive treatment|cognitive treatment
766389|NCT00379600|Anti-inflammatory treatment|anti-inflammatory treatment
766390|NCT00379600|Rheumatoid Arthritis|rheumatoid arthritis
766391|NCT00379587|Rituximab|rituximab
766392|NCT00379587|Chronic GVHD|chronic gvhd
766393|NCT00379574|diffuse large B-cell lymphoma|diffuse large b-cell lymphoma
766394|NCT00379574|Bortezomib|bortezomib
766395|NCT00379574|CHOP|chop
766396|NCT00379574|Lenograstim|lenograstim
766397|NCT00379561|Prostate Cancer|prostate cancer
766398|NCT00379561|Recurrent Prostate Cancer|recurrent prostate cancer
766399|NCT00379561|Non-Metastatic prostate cancer|non-metastatic prostate cancer
766400|NCT00379561|Recurrent Localized Prostate Cancer with Biochemical Failure|recurrent localized prostate cancer with biochemical failure
766401|NCT00379535|pregnancy , lack of iodine|pregnancy , lack of iodine
766402|NCT00379535|lack of iodine during pregnancy|lack of iodine during pregnancy
766403|NCT00379522|hemorrhagic|hemorrhagic
766404|NCT00379522|shock|shock
766405|NCT00379522|traumatic|traumatic
766406|NCT00379522|shock treatment|shock treatment
766407|NCT00379522|vasopressin|vasopressin
766408|NCT00379522|Circulatory Collapse|circulatory collapse
766409|NCT00379522|Hypovolemic Shock|hypovolemic shock
766410|NCT00379509|recurrent breast cancer|recurrent breast cancer
766411|NCT00379509|stage IIIA breast cancer|stage iiia breast cancer
766412|NCT00379509|stage IIIB breast cancer|stage iiib breast cancer
766413|NCT00379509|stage IIIC breast cancer|stage iiic breast cancer
766414|NCT00379509|stage IV breast cancer|stage iv breast cancer
766415|NCT00379509|male breast cancer|male breast cancer
766416|NCT00379496|Fibromyalgia|fibromyalgia
766417|NCT00379496|Acupuncture|acupuncture
766418|NCT00379496|Randomized study|randomized study
766419|NCT00379483|Transfusional iron overload|transfusional iron overload
766420|NCT00379483|Deferasirox|deferasirox
766421|NCT00379470|Brain tumor|brain tumor
766422|NCT00379470|Treatment|treatment
766423|NCT00379470|Minimal toxicity|minimal toxicity
766425|NCT00379470|Glioblastoma|glioblastoma
766426|NCT00379470|Recurrent|recurrent
766427|NCT00379470|TTFields|ttfields
766428|NCT00379457|alveolar childhood rhabdomyosarcoma|alveolar childhood rhabdomyosarcoma
766429|NCT00379457|previously untreated childhood rhabdomyosarcoma|previously untreated childhood rhabdomyosarcoma
766430|NCT00379457|childhood malignant mesenchymoma|childhood malignant mesenchymoma
766431|NCT00379457|nonmetastatic childhood soft tissue sarcoma|nonmetastatic childhood soft tissue sarcoma
766432|NCT00379457|embryonal childhood rhabdomyosarcoma|embryonal childhood rhabdomyosarcoma
766433|NCT00379457|embryonal-botryoid childhood rhabdomyosarcoma|embryonal-botryoid childhood rhabdomyosarcoma
766434|NCT00379444|tobacco, intervention, tobacco cessation, ALaska Natives,|tobacco, intervention, tobacco cessation, alaska natives,
766435|NCT00379444|Native Americans, pregnancy, women|native americans, pregnancy, women
766436|NCT00379405|Saquinavir/ritonavir|saquinavir/ritonavir
766437|NCT00379405|Single therapy|single therapy
766438|NCT00379405|Virological efficacy|virological efficacy
766439|NCT00379405|Safety|safety
766440|NCT00379405|HIV-1|hiv-1
766441|NCT00379392|Stroke|stroke
766442|NCT00379392|Mental Imagery|mental imagery
766443|NCT00379392|Constraint Induced Therapy|constraint induced therapy
766444|NCT00379379|electroacupuncture, plasma glucose, plasma insulin|electroacupuncture, plasma glucose, plasma insulin
766445|NCT00379366|Randomized Controlled Trials|randomized controlled trials
766446|NCT00379366|Renal Dialysis|renal dialysis
766447|NCT00379366|Graft Occlusion, Vascular|graft occlusion, vascular
766448|NCT00379366|Angioplasty|angioplasty
766449|NCT00379366|Vascular Patency|vascular patency
766450|NCT00379366|Radiation, Ionizing|radiation, ionizing
766451|NCT00379353|Advanced Cancers|advanced cancers
766452|NCT00379353|Anorexia|anorexia
766453|NCT00379353|Fatigue|fatigue
766454|NCT00379353|Thalidomide|thalidomide
766455|NCT00379353|Placebo|placebo
766456|NCT00379327|Pregnancy|pregnancy
766457|NCT00379327|Acupuncture|acupuncture
766458|NCT00379327|Pregnancy Outcome|pregnancy outcome
766459|NCT00379327|Randomized Controlled Trial|randomized controlled trial
766460|NCT00379327|Double-Blind Method|double-blind method
766461|NCT00379314|Incontinence|incontinence
766462|NCT00379314|Urinary|urinary
766463|NCT00379314|Female|female
766464|NCT00379314|Surgery|surgery
766465|NCT00379314|Complications|complications
766466|NCT00379301|Atrial Fibrillation|atrial fibrillation
766467|NCT00379301|A-Fib|a-fib
766468|NCT00379301|AF|af
766469|NCT00379301|Persistent|persistent
766470|NCT00379301|Permanent|permanent
766471|NCT00379301|Pulmonary Vein Isolation|pulmonary vein isolation
766472|NCT00379301|Ablation|ablation
766475|NCT00379275|Pulmonary Sarcoidosis|pulmonary sarcoidosis
766476|NCT00379275|HLA-Typing|hla-typing
766477|NCT00379275|Cytokines|cytokines
766478|NCT00379275|Serum Markers|serum markers
766479|NCT00379262|Nasopharyngeal Carcinoma|nasopharyngeal carcinoma
766480|NCT00379262|Chemoradiotherapy|chemoradiotherapy
766481|NCT00379262|Accelerated Fractionation|accelerated fractionation
766482|NCT00379249|hypercholesterolemia|hypercholesterolemia
766483|NCT00379249|statin|statin
766484|NCT00379249|compliance|compliance
766485|NCT00379236|osteoarthritis|osteoarthritis
766486|NCT00379236|knee|knee
766487|NCT00379223|retinal vein occlusion|retinal vein occlusion
766488|NCT00379223|vitrectomy|vitrectomy
766489|NCT00379223|surgery|surgery
766490|NCT00379223|retinal disorders|retinal disorders
766491|NCT00379223|vascular diseases|vascular diseases
766492|NCT00379210|Attention|attention
766493|NCT00379210|ERP|erp
766494|NCT00379210|event-related potentials|event-related potentials
766495|NCT00379210|fMRI|fmri
766496|NCT00379210|functional magnetic resonance imaging|functional magnetic resonance imaging
766497|NCT00379210|MBSR|mbsr
766498|NCT00379210|Mindfulness Based Stress Reduction|mindfulness based stress reduction
766499|NCT00379210|Mindfulness Meditation Training|mindfulness meditation training
766501|NCT00379197|stage IV breast cancer, estrogen receptor positive|stage iv breast cancer, estrogen receptor positive
766502|NCT00379197|recurrent breast cancer|recurrent breast cancer
766503|NCT00379197|hormone-refractory, metastatic breast cancer|hormone-refractory, metastatic breast cancer
766504|NCT00379184|arthritis|arthritis
766505|NCT00379171|Children|children
766506|NCT00379171|Complementary feeding|complementary feeding
766507|NCT00379171|Breast feeding|breast feeding
766508|NCT00379171|Cow's milk|cow's milk
766509|NCT00379171|Formula|formula
766510|NCT00379171|Protein|protein
766511|NCT00379171|LCPUFA|lcpufa
766512|NCT00379171|Fish oil|fish oil
766513|NCT00379171|Lipid profile|lipid profile
766514|NCT00379171|Intestinal inflammation|intestinal inflammation
766515|NCT00379171|Intestinal microbiota|intestinal microbiota
766516|NCT00379158|multiple micronutrient supplements|multiple micronutrient supplements
766517|NCT00379158|home-fortification|home-fortification
766518|NCT00379158|complementary foods|complementary foods
766519|NCT00379158|infants|infants
766520|NCT00379158|Ghana|ghana
766521|NCT00379145|uterine leiomyosarcoma|uterine leiomyosarcoma
766522|NCT00379145|recurrent uterine sarcoma|recurrent uterine sarcoma
766523|NCT00379145|stage III uterine sarcoma|stage iii uterine sarcoma
766524|NCT00379145|stage IV uterine sarcoma|stage iv uterine sarcoma
766525|NCT00379132|Glioma|glioma
766526|NCT00379132|prostatic|prostatic
766527|NCT00379132|breast|breast
766528|NCT00379132|non-small cell lung|non-small cell lung
766529|NCT00379132|melanoma|melanoma
766530|NCT00379132|colorectal|colorectal
766531|NCT00379132|pancreatic|pancreatic
766532|NCT00379119|adenocarcinoma of the prostate|adenocarcinoma of the prostate
766533|NCT00379119|recurrent prostate cancer|recurrent prostate cancer
766534|NCT00379119|stage I prostate cancer|stage i prostate cancer
766535|NCT00379119|stage IIB prostate cancer|stage iib prostate cancer
766536|NCT00379119|stage IIA prostate cancer|stage iia prostate cancer
766537|NCT00379119|stage III prostate cancer|stage iii prostate cancer
766538|NCT00379106|Supportive|supportive
766539|NCT00379106|Mastectomy|mastectomy
766540|NCT00379106|Quality of Life|quality of life
766541|NCT00379106|Arm Function|arm function
766542|NCT00379093|Alcohol|alcohol
766543|NCT00379093|Comorbidity|comorbidity
766544|NCT00379093|Aging|aging
766545|NCT00379093|Brief Advice|brief advice
766546|NCT00379093|Randomized Trial|randomized trial
766547|NCT00379067|Benign Prostatic Hyperplasia|benign prostatic hyperplasia
766548|NCT00379067|Nocturia|nocturia
766549|NCT00379067|Actigraphy|actigraphy
766550|NCT00379067|Tamsulosin|tamsulosin
766551|NCT00379054|social support, smoking, smoking cessation, intervention,|social support, smoking, smoking cessation, intervention,
766552|NCT00379054|telephone counseling|telephone counseling
766553|NCT00379041|stage I adult Hodgkin lymphoma|stage i adult hodgkin lymphoma
766554|NCT00379041|stage II adult Hodgkin lymphoma|stage ii adult hodgkin lymphoma
766555|NCT00379028|COPD|copd
766556|NCT00379015|stage IIIB breast cancer|stage iiib breast cancer
766557|NCT00379015|stage IIIC breast cancer|stage iiic breast cancer
766558|NCT00379015|stage IV breast cancer|stage iv breast cancer
766559|NCT00379002|Interstitial Cystitis|interstitial cystitis
766560|NCT00379002|Sexual Dysfunction|sexual dysfunction
766561|NCT00379002|Vulvodynia|vulvodynia
766562|NCT00379002|Pelvic Pain|pelvic pain
766563|NCT00379002|incontinence|incontinence
766564|NCT00378976|HIV infection|hiv infection
766565|NCT00378976|HIV shedding|hiv shedding
766566|NCT00378976|HSV suppression|hsv suppression
766567|NCT00378976|Co-infected|co-infected
766568|NCT00378976|MSM|msm
766569|NCT00378976|Reactivation|reactivation
766570|NCT00378976|Valacyclovir|valacyclovir
766571|NCT00378950|Congestive Heart Failure|congestive heart failure
766572|NCT00378937|unspecified adult solid tumor, protocol specific|unspecified adult solid tumor, protocol specific
766573|NCT00378937|pain|pain
766574|NCT00378885|HIV-prevention|hiv-prevention
766575|NCT00378885|Internet Prevention intervention|internet prevention intervention
766576|NCT00378885|Online randomized controlled trial|online randomized controlled trial
766577|NCT00378885|Effect evaluation|effect evaluation
766578|NCT00378885|MSM|msm
766579|NCT00378885|Steady relationships|steady relationships
766580|NCT00378859|Children|children
766581|NCT00378859|Milk|milk
766582|NCT00378859|Meat|meat
766583|NCT00378859|Animal Protein|animal protein
766584|NCT00378859|Growth Factors|growth factors
766585|NCT00378859|IGF-I|igf-i
766586|NCT00378859|IGFBP-3|igfbp-3
766587|NCT00378859|Insulin|insulin
766588|NCT00378846|fever, sweats, and hot flashes|fever, sweats, and hot flashes
766589|NCT00378833|Primary Hypercholesterolemia or Mixed Hyperlipidemia|primary hypercholesterolemia or mixed hyperlipidemia
766590|NCT00378820|Children|children
766591|NCT00378820|Whey|whey
766592|NCT00378820|Casein|casein
766593|NCT00378820|Milk minerals|milk minerals
766594|NCT00378820|Growth factors|growth factors
766595|NCT00378820|IGF-I|igf-i
766596|NCT00378820|Insulin|insulin
766597|NCT00378781|infection|infection
766598|NCT00378781|poor vascular access|poor vascular access
766599|NCT00378781|thromboembolism|thromboembolism
766600|NCT00378781|adult acute myeloid leukemia with 11q23 (MLL) abnormalities|adult acute myeloid leukemia with 11q23 (mll) abnormalities
766601|NCT00378781|adult acute myeloid leukemia with inv(16)(p13;q22)|adult acute myeloid leukemia with inv(16)(p13;q22)
766602|NCT00378781|adult acute myeloid leukemia with t(15;17)(q22;q12)|adult acute myeloid leukemia with t(15;17)(q22;q12)
766603|NCT00378781|adult acute myeloid leukemia with t(16;16)(p13;q22)|adult acute myeloid leukemia with t(16;16)(p13;q22)
766604|NCT00378781|adult acute myeloid leukemia with t(8;21)(q22;q22)|adult acute myeloid leukemia with t(8;21)(q22;q22)
766605|NCT00378781|accelerated phase chronic myelogenous leukemia|accelerated phase chronic myelogenous leukemia
766606|NCT00378781|adult acute lymphoblastic leukemia in remission|adult acute lymphoblastic leukemia in remission
766607|NCT00378781|adult acute myeloid leukemia in remission|adult acute myeloid leukemia in remission
766608|NCT00378781|atypical chronic myeloid leukemia, BCR-ABL negative|atypical chronic myeloid leukemia, bcr-abl negative
766609|NCT00378781|blastic phase chronic myelogenous leukemia|blastic phase chronic myelogenous leukemia
766610|NCT00378781|childhood acute lymphoblastic leukemia in remission|childhood acute lymphoblastic leukemia in remission
766611|NCT00378781|childhood acute myeloid leukemia in remission|childhood acute myeloid leukemia in remission
766612|NCT00378781|childhood chronic myelogenous leukemia|childhood chronic myelogenous leukemia
766613|NCT00378781|chronic eosinophilic leukemia|chronic eosinophilic leukemia
766614|NCT00378781|primary myelofibrosis|primary myelofibrosis
766615|NCT00378781|chronic myelomonocytic leukemia|chronic myelomonocytic leukemia
766616|NCT00378781|chronic neutrophilic leukemia|chronic neutrophilic leukemia
766617|NCT00378781|chronic phase chronic myelogenous leukemia|chronic phase chronic myelogenous leukemia
766618|NCT00378781|de novo myelodysplastic syndromes|de novo myelodysplastic syndromes
766619|NCT00378781|disseminated neuroblastoma|disseminated neuroblastoma
766620|NCT00378781|extranodal marginal zone B-cell lymphoma of mucosa-associated lymphoid tissue|extranodal marginal zone b-cell lymphoma of mucosa-associated lymphoid tissue
766621|NCT00378781|juvenile myelomonocytic leukemia|juvenile myelomonocytic leukemia
766622|NCT00378781|myelodysplastic/myeloproliferative neoplasm, unclassifiable|myelodysplastic/myeloproliferative neoplasm, unclassifiable
766623|NCT00378781|nodal marginal zone B-cell lymphoma|nodal marginal zone b-cell lymphoma
766624|NCT00378781|noncontiguous stage II adult Burkitt lymphoma|noncontiguous stage ii adult burkitt lymphoma
766625|NCT00378781|noncontiguous stage II adult diffuse large cell lymphoma|noncontiguous stage ii adult diffuse large cell lymphoma
766626|NCT00378781|noncontiguous stage II adult diffuse mixed cell lymphoma|noncontiguous stage ii adult diffuse mixed cell lymphoma
766627|NCT00378781|noncontiguous stage II adult diffuse small cleaved cell lymphoma|noncontiguous stage ii adult diffuse small cleaved cell lymphoma
766628|NCT00378781|noncontiguous stage II adult immunoblastic large cell lymphoma|noncontiguous stage ii adult immunoblastic large cell lymphoma
766629|NCT00378781|noncontiguous stage II adult lymphoblastic lymphoma|noncontiguous stage ii adult lymphoblastic lymphoma
766630|NCT00378781|noncontiguous stage II grade 1 follicular lymphoma|noncontiguous stage ii grade 1 follicular lymphoma
766631|NCT00378781|noncontiguous stage II grade 2 follicular lymphoma|noncontiguous stage ii grade 2 follicular lymphoma
766632|NCT00378781|noncontiguous stage II grade 3 follicular lymphoma|noncontiguous stage ii grade 3 follicular lymphoma
766633|NCT00378781|noncontiguous stage II mantle cell lymphoma|noncontiguous stage ii mantle cell lymphoma
766634|NCT00378781|noncontiguous stage II marginal zone lymphoma|noncontiguous stage ii marginal zone lymphoma
766635|NCT00378781|noncontiguous stage II small lymphocytic lymphoma|noncontiguous stage ii small lymphocytic lymphoma
766636|NCT00378781|poor prognosis metastatic gestational trophoblastic tumor|poor prognosis metastatic gestational trophoblastic tumor
766637|NCT00378781|previously treated myelodysplastic syndromes|previously treated myelodysplastic syndromes
766638|NCT00378781|recurrent adult acute lymphoblastic leukemia|recurrent adult acute lymphoblastic leukemia
766639|NCT00378781|recurrent adult acute myeloid leukemia|recurrent adult acute myeloid leukemia
766640|NCT00378781|recurrent adult Burkitt lymphoma|recurrent adult burkitt lymphoma
766641|NCT00378781|recurrent adult Hodgkin lymphoma|recurrent adult hodgkin lymphoma
766642|NCT00378781|recurrent adult diffuse large cell lymphoma|recurrent adult diffuse large cell lymphoma
766643|NCT00378781|recurrent adult diffuse mixed cell lymphoma|recurrent adult diffuse mixed cell lymphoma
766644|NCT00378781|recurrent adult diffuse small cleaved cell lymphoma|recurrent adult diffuse small cleaved cell lymphoma
766645|NCT00378781|recurrent adult immunoblastic large cell lymphoma|recurrent adult immunoblastic large cell lymphoma
766646|NCT00378781|recurrent adult lymphoblastic lymphoma|recurrent adult lymphoblastic lymphoma
766647|NCT00378781|recurrent breast cancer|recurrent breast cancer
766648|NCT00378781|recurrent/refractory childhood Hodgkin lymphoma|recurrent/refractory childhood hodgkin lymphoma
766649|NCT00378781|recurrent childhood acute lymphoblastic leukemia|recurrent childhood acute lymphoblastic leukemia
766650|NCT00378781|recurrent childhood acute myeloid leukemia|recurrent childhood acute myeloid leukemia
766651|NCT00378781|recurrent childhood large cell lymphoma|recurrent childhood large cell lymphoma
766652|NCT00378781|recurrent childhood lymphoblastic lymphoma|recurrent childhood lymphoblastic lymphoma
766653|NCT00378781|recurrent childhood small noncleaved cell lymphoma|recurrent childhood small noncleaved cell lymphoma
766654|NCT00378781|recurrent cutaneous T-cell non-Hodgkin lymphoma|recurrent cutaneous t-cell non-hodgkin lymphoma
766655|NCT00378781|recurrent grade 1 follicular lymphoma|recurrent grade 1 follicular lymphoma
766656|NCT00378781|recurrent grade 2 follicular lymphoma|recurrent grade 2 follicular lymphoma
766657|NCT00378781|recurrent grade 3 follicular lymphoma|recurrent grade 3 follicular lymphoma
766658|NCT00378781|recurrent mantle cell lymphoma|recurrent mantle cell lymphoma
766659|NCT00378781|recurrent marginal zone lymphoma|recurrent marginal zone lymphoma
766660|NCT00378781|recurrent mycosis fungoides/Sezary syndrome|recurrent mycosis fungoides/sezary syndrome
766661|NCT00378781|recurrent neuroblastoma|recurrent neuroblastoma
766662|NCT00378781|recurrent ovarian epithelial cancer|recurrent ovarian epithelial cancer
766663|NCT00378781|recurrent ovarian germ cell tumor|recurrent ovarian germ cell tumor
766664|NCT00378781|recurrent small lymphocytic lymphoma|recurrent small lymphocytic lymphoma
766665|NCT00378781|recurrent malignant testicular germ cell tumor|recurrent malignant testicular germ cell tumor
766666|NCT00378781|recurrent Wilms tumor and other childhood kidney tumors|recurrent wilms tumor and other childhood kidney tumors
766667|NCT00378781|refractory chronic lymphocytic leukemia|refractory chronic lymphocytic leukemia
766668|NCT00378781|refractory hairy cell leukemia|refractory hairy cell leukemia
766669|NCT00378781|refractory multiple myeloma|refractory multiple myeloma
766670|NCT00378781|relapsing chronic myelogenous leukemia|relapsing chronic myelogenous leukemia
766671|NCT00378781|secondary acute myeloid leukemia|secondary acute myeloid leukemia
766672|NCT00378781|secondary myelodysplastic syndromes|secondary myelodysplastic syndromes
766673|NCT00378781|splenic marginal zone lymphoma|splenic marginal zone lymphoma
766674|NCT00378781|stage I multiple myeloma|stage i multiple myeloma
766675|NCT00378781|stage II multiple myeloma|stage ii multiple myeloma
766676|NCT00378781|stage II ovarian epithelial cancer|stage ii ovarian epithelial cancer
766677|NCT00378781|stage III adult Burkitt lymphoma|stage iii adult burkitt lymphoma
766678|NCT00378781|stage III adult Hodgkin lymphoma|stage iii adult hodgkin lymphoma
766679|NCT00378781|stage III adult diffuse large cell lymphoma|stage iii adult diffuse large cell lymphoma
766680|NCT00378781|stage III adult diffuse mixed cell lymphoma|stage iii adult diffuse mixed cell lymphoma
766681|NCT00378781|stage III adult diffuse small cleaved cell lymphoma|stage iii adult diffuse small cleaved cell lymphoma
766682|NCT00378781|stage III adult immunoblastic large cell lymphoma|stage iii adult immunoblastic large cell lymphoma
766683|NCT00378781|stage III adult lymphoblastic lymphoma|stage iii adult lymphoblastic lymphoma
766684|NCT00378781|stage III chronic lymphocytic leukemia|stage iii chronic lymphocytic leukemia
766685|NCT00378781|stage III grade 1 follicular lymphoma|stage iii grade 1 follicular lymphoma
766686|NCT00378781|stage III grade 2 follicular lymphoma|stage iii grade 2 follicular lymphoma
766687|NCT00378781|stage III grade 3 follicular lymphoma|stage iii grade 3 follicular lymphoma
766688|NCT00378781|stage III mantle cell lymphoma|stage iii mantle cell lymphoma
766689|NCT00378781|stage III marginal zone lymphoma|stage iii marginal zone lymphoma
766690|NCT00378781|stage III multiple myeloma|stage iii multiple myeloma
766691|NCT00378781|stage III ovarian epithelial cancer|stage iii ovarian epithelial cancer
766692|NCT00378781|stage III small lymphocytic lymphoma|stage iii small lymphocytic lymphoma
766693|NCT00378781|stage III malignant testicular germ cell tumor|stage iii malignant testicular germ cell tumor
766694|NCT00378781|stage IIIA breast cancer|stage iiia breast cancer
766695|NCT00378781|stage IIIB breast cancer|stage iiib breast cancer
766696|NCT00378781|stage IIIC breast cancer|stage iiic breast cancer
766697|NCT00378781|stage IV adult Burkitt lymphoma|stage iv adult burkitt lymphoma
766698|NCT00378781|stage IV adult Hodgkin lymphoma|stage iv adult hodgkin lymphoma
766699|NCT00378781|stage IV adult diffuse large cell lymphoma|stage iv adult diffuse large cell lymphoma
766700|NCT00378781|stage IV adult diffuse mixed cell lymphoma|stage iv adult diffuse mixed cell lymphoma
766701|NCT00378781|stage IV adult diffuse small cleaved cell lymphoma|stage iv adult diffuse small cleaved cell lymphoma
766702|NCT00378781|stage IV adult immunoblastic large cell lymphoma|stage iv adult immunoblastic large cell lymphoma
766703|NCT00378781|stage IV adult lymphoblastic lymphoma|stage iv adult lymphoblastic lymphoma
766704|NCT00378781|stage IV breast cancer|stage iv breast cancer
766705|NCT00378781|stage IV chronic lymphocytic leukemia|stage iv chronic lymphocytic leukemia
766706|NCT00378781|stage IV grade 1 follicular lymphoma|stage iv grade 1 follicular lymphoma
766707|NCT00378781|stage IV grade 2 follicular lymphoma|stage iv grade 2 follicular lymphoma
766708|NCT00378781|stage IV grade 3 follicular lymphoma|stage iv grade 3 follicular lymphoma
766709|NCT00378781|stage IV mantle cell lymphoma|stage iv mantle cell lymphoma
767149|NCT00377468|Pain|pain
766710|NCT00378781|stage IV marginal zone lymphoma|stage iv marginal zone lymphoma
766711|NCT00378781|stage IV ovarian epithelial cancer|stage iv ovarian epithelial cancer
766712|NCT00378781|stage IV small lymphocytic lymphoma|stage iv small lymphocytic lymphoma
766713|NCT00378781|acute undifferentiated leukemia|acute undifferentiated leukemia
766714|NCT00378781|mast cell leukemia|mast cell leukemia
766715|NCT00378781|stage I adult T-cell leukemia/lymphoma|stage i adult t-cell leukemia/lymphoma
766716|NCT00378781|stage II adult T-cell leukemia/lymphoma|stage ii adult t-cell leukemia/lymphoma
766717|NCT00378781|stage III adult T-cell leukemia/lymphoma|stage iii adult t-cell leukemia/lymphoma
766718|NCT00378781|stage IV adult T-cell leukemia/lymphoma|stage iv adult t-cell leukemia/lymphoma
766719|NCT00378781|recurrent adult T-cell leukemia/lymphoma|recurrent adult t-cell leukemia/lymphoma
766720|NCT00378781|T-cell large granular lymphocyte leukemia|t-cell large granular lymphocyte leukemia
766721|NCT00378781|stage I chronic lymphocytic leukemia|stage i chronic lymphocytic leukemia
766722|NCT00378781|stage II chronic lymphocytic leukemia|stage ii chronic lymphocytic leukemia
766723|NCT00378781|meningeal chronic myelogenous leukemia|meningeal chronic myelogenous leukemia
766724|NCT00378781|prolymphocytic leukemia|prolymphocytic leukemia
766725|NCT00378781|stage I adult Hodgkin lymphoma|stage i adult hodgkin lymphoma
766726|NCT00378781|stage II adult Hodgkin lymphoma|stage ii adult hodgkin lymphoma
766727|NCT00378781|stage I childhood Hodgkin lymphoma|stage i childhood hodgkin lymphoma
766728|NCT00378781|stage II childhood Hodgkin lymphoma|stage ii childhood hodgkin lymphoma
766729|NCT00378781|stage III childhood Hodgkin lymphoma|stage iii childhood hodgkin lymphoma
766730|NCT00378781|stage IV childhood Hodgkin lymphoma|stage iv childhood hodgkin lymphoma
766731|NCT00378781|anaplastic large cell lymphoma|anaplastic large cell lymphoma
766732|NCT00378781|angioimmunoblastic T-cell lymphoma|angioimmunoblastic t-cell lymphoma
766733|NCT00378781|stage I mycosis fungoides/Sezary syndrome|stage i mycosis fungoides/sezary syndrome
766734|NCT00378781|stage II mycosis fungoides/Sezary syndrome|stage ii mycosis fungoides/sezary syndrome
766735|NCT00378781|stage III mycosis fungoides/Sezary syndrome|stage iii mycosis fungoides/sezary syndrome
766885|NCT00378534|AML|aml
766736|NCT00378781|stage IV mycosis fungoides/Sezary syndrome|stage iv mycosis fungoides/sezary syndrome
766737|NCT00378781|stage I cutaneous T-cell non-Hodgkin lymphoma|stage i cutaneous t-cell non-hodgkin lymphoma
766738|NCT00378781|stage II cutaneous T-cell non-Hodgkin lymphoma|stage ii cutaneous t-cell non-hodgkin lymphoma
766739|NCT00378781|stage III cutaneous T-cell non-Hodgkin lymphoma|stage iii cutaneous t-cell non-hodgkin lymphoma
766740|NCT00378781|stage IV cutaneous T-cell non-Hodgkin lymphoma|stage iv cutaneous t-cell non-hodgkin lymphoma
766741|NCT00378781|adult grade III lymphomatoid granulomatosis|adult grade iii lymphomatoid granulomatosis
766742|NCT00378781|recurrent adult grade III lymphomatoid granulomatosis|recurrent adult grade iii lymphomatoid granulomatosis
766743|NCT00378781|childhood grade III lymphomatoid granulomatosis|childhood grade iii lymphomatoid granulomatosis
766744|NCT00378781|recurrent childhood grade III lymphomatoid granulomatosis|recurrent childhood grade iii lymphomatoid granulomatosis
766745|NCT00378781|Waldenstrom macroglobulinemia|waldenstrom macroglobulinemia
766746|NCT00378781|stage I adult Burkitt lymphoma|stage i adult burkitt lymphoma
766747|NCT00378781|stage I adult diffuse large cell lymphoma|stage i adult diffuse large cell lymphoma
766748|NCT00378781|stage I adult diffuse mixed cell lymphoma|stage i adult diffuse mixed cell lymphoma
766749|NCT00378781|stage I adult diffuse small cleaved cell lymphoma|stage i adult diffuse small cleaved cell lymphoma
766750|NCT00378781|stage I adult immunoblastic large cell lymphoma|stage i adult immunoblastic large cell lymphoma
766751|NCT00378781|stage I adult lymphoblastic lymphoma|stage i adult lymphoblastic lymphoma
766752|NCT00378781|stage I grade 1 follicular lymphoma|stage i grade 1 follicular lymphoma
766753|NCT00378781|stage I grade 2 follicular lymphoma|stage i grade 2 follicular lymphoma
766754|NCT00378781|stage I grade 3 follicular lymphoma|stage i grade 3 follicular lymphoma
766755|NCT00378781|stage I mantle cell lymphoma|stage i mantle cell lymphoma
766756|NCT00378781|stage I marginal zone lymphoma|stage i marginal zone lymphoma
766757|NCT00378781|stage I small lymphocytic lymphoma|stage i small lymphocytic lymphoma
766758|NCT00378781|contiguous stage II adult Burkitt lymphoma|contiguous stage ii adult burkitt lymphoma
766759|NCT00378781|contiguous stage II adult diffuse large cell lymphoma|contiguous stage ii adult diffuse large cell lymphoma
766760|NCT00378781|contiguous stage II adult diffuse mixed cell lymphoma|contiguous stage ii adult diffuse mixed cell lymphoma
766761|NCT00378781|contiguous stage II adult diffuse small cleaved cell lymphoma|contiguous stage ii adult diffuse small cleaved cell lymphoma
766762|NCT00378781|contiguous stage II adult immunoblastic large cell lymphoma|contiguous stage ii adult immunoblastic large cell lymphoma
766763|NCT00378781|contiguous stage II adult lymphoblastic lymphoma|contiguous stage ii adult lymphoblastic lymphoma
766764|NCT00378781|contiguous stage II grade 1 follicular lymphoma|contiguous stage ii grade 1 follicular lymphoma
766765|NCT00378781|contiguous stage II grade 2 follicular lymphoma|contiguous stage ii grade 2 follicular lymphoma
766766|NCT00378781|contiguous stage II grade 3 follicular lymphoma|contiguous stage ii grade 3 follicular lymphoma
766767|NCT00378781|contiguous stage II mantle cell lymphoma|contiguous stage ii mantle cell lymphoma
766768|NCT00378781|contiguous stage II marginal zone lymphoma|contiguous stage ii marginal zone lymphoma
766769|NCT00378781|contiguous stage II small lymphocytic lymphoma|contiguous stage ii small lymphocytic lymphoma
766770|NCT00378781|stage I childhood large cell lymphoma|stage i childhood large cell lymphoma
766771|NCT00378781|stage II childhood large cell lymphoma|stage ii childhood large cell lymphoma
766772|NCT00378781|stage III childhood large cell lymphoma|stage iii childhood large cell lymphoma
766773|NCT00378781|stage IV childhood large cell lymphoma|stage iv childhood large cell lymphoma
766774|NCT00378781|stage I childhood lymphoblastic lymphoma|stage i childhood lymphoblastic lymphoma
766775|NCT00378781|stage II childhood lymphoblastic lymphoma|stage ii childhood lymphoblastic lymphoma
766776|NCT00378781|stage III childhood lymphoblastic lymphoma|stage iii childhood lymphoblastic lymphoma
766777|NCT00378781|stage IV childhood lymphoblastic lymphoma|stage iv childhood lymphoblastic lymphoma
766778|NCT00378781|stage I childhood small noncleaved cell lymphoma|stage i childhood small noncleaved cell lymphoma
766779|NCT00378781|stage II childhood small noncleaved cell lymphoma|stage ii childhood small noncleaved cell lymphoma
766780|NCT00378781|stage III childhood small noncleaved cell lymphoma|stage iii childhood small noncleaved cell lymphoma
766781|NCT00378781|stage IV childhood small noncleaved cell lymphoma|stage iv childhood small noncleaved cell lymphoma
766782|NCT00378781|primary central nervous system non-Hodgkin lymphoma|primary central nervous system non-hodgkin lymphoma
766783|NCT00378781|post-transplant lymphoproliferative disorder|post-transplant lymphoproliferative disorder
766784|NCT00378781|intraocular lymphoma|intraocular lymphoma
766785|NCT00378781|stage I melanoma|stage i melanoma
766786|NCT00378781|stage II melanoma|stage ii melanoma
766787|NCT00378781|stage III melanoma|stage iii melanoma
766788|NCT00378781|stage IV melanoma|stage iv melanoma
766789|NCT00378781|recurrent melanoma|recurrent melanoma
766790|NCT00378781|unspecified adult solid tumor, protocol specific|unspecified adult solid tumor, protocol specific
766791|NCT00378781|unspecified childhood solid tumor, protocol specific|unspecified childhood solid tumor, protocol specific
766792|NCT00378781|stage I adult soft tissue sarcoma|stage i adult soft tissue sarcoma
766793|NCT00378781|stage II adult soft tissue sarcoma|stage ii adult soft tissue sarcoma
766794|NCT00378781|stage III adult soft tissue sarcoma|stage iii adult soft tissue sarcoma
766795|NCT00378781|stage IV adult soft tissue sarcoma|stage iv adult soft tissue sarcoma
766796|NCT00378781|recurrent adult soft tissue sarcoma|recurrent adult soft tissue sarcoma
766797|NCT00378781|metastatic childhood soft tissue sarcoma|metastatic childhood soft tissue sarcoma
766884|NCT00378534|Acute Myeloid Leukemia|acute myeloid leukemia
766798|NCT00378781|nonmetastatic childhood soft tissue sarcoma|nonmetastatic childhood soft tissue sarcoma
766799|NCT00378781|recurrent childhood soft tissue sarcoma|recurrent childhood soft tissue sarcoma
766800|NCT00378781|localized Ewing sarcoma/peripheral primitive neuroectodermal tumor|localized ewing sarcoma/peripheral primitive neuroectodermal tumor
766801|NCT00378781|metastatic Ewing sarcoma/peripheral primitive neuroectodermal tumor|metastatic ewing sarcoma/peripheral primitive neuroectodermal tumor
766922|NCT00378404|Metastatic|metastatic
766802|NCT00378781|recurrent Ewing sarcoma/peripheral primitive neuroectodermal tumor|recurrent ewing sarcoma/peripheral primitive neuroectodermal tumor
766803|NCT00378781|previously treated childhood rhabdomyosarcoma|previously treated childhood rhabdomyosarcoma
766804|NCT00378781|previously untreated childhood rhabdomyosarcoma|previously untreated childhood rhabdomyosarcoma
766805|NCT00378781|recurrent childhood rhabdomyosarcoma|recurrent childhood rhabdomyosarcoma
766806|NCT00378781|recurrent uterine sarcoma|recurrent uterine sarcoma
766807|NCT00378781|stage I uterine sarcoma|stage i uterine sarcoma
766808|NCT00378781|stage II uterine sarcoma|stage ii uterine sarcoma
766809|NCT00378781|stage III uterine sarcoma|stage iii uterine sarcoma
766810|NCT00378781|stage IV uterine sarcoma|stage iv uterine sarcoma
766811|NCT00378781|localized osteosarcoma|localized osteosarcoma
766812|NCT00378781|metastatic osteosarcoma|metastatic osteosarcoma
766813|NCT00378781|recurrent osteosarcoma|recurrent osteosarcoma
766814|NCT00378781|chondrosarcoma|chondrosarcoma
766815|NCT00378781|small intestine leiomyosarcoma|small intestine leiomyosarcoma
766816|NCT00378781|recurrent small intestine cancer|recurrent small intestine cancer
766817|NCT00378781|childhood myelodysplastic syndromes|childhood myelodysplastic syndromes
766818|NCT00378768|stage I multiple myeloma|stage i multiple myeloma
766819|NCT00378768|stage II multiple myeloma|stage ii multiple myeloma
766820|NCT00378768|stage III multiple myeloma|stage iii multiple myeloma
766821|NCT00378768|refractory multiple myeloma|refractory multiple myeloma
766822|NCT00378755|velcade|velcade
766823|NCT00378755|myeloma|myeloma
766824|NCT00378755|VAD regimen|vad regimen
766825|NCT00378755|Transplantation, Autologous|transplantation, autologous
766826|NCT00378742|Glaucoma|glaucoma
766827|NCT00378742|Gene|gene
766828|NCT00378742|Phenotype-Genotype correlation|phenotype-genotype correlation
766829|NCT00378742|Molecular Diagnosis|molecular diagnosis
766830|NCT00378742|Retinal Degeneration|retinal degeneration
766831|NCT00378742|Inherited Eye Disease|inherited eye disease
766832|NCT00378742|Retinitis Pigmentosa|retinitis pigmentosa
766833|NCT00378742|Macular Dystrophy|macular dystrophy
766834|NCT00378742|Congenital Glaucoma|congenital glaucoma
766835|NCT00378729|PCOS|pcos
766836|NCT00378729|FERTILOSCOPY|fertiloscopy
766837|NCT00378729|Ovarian hyperstimulation|ovarian hyperstimulation
766838|NCT00378729|Multiple pregnancies|multiple pregnancies
766839|NCT00378729|Patient with PCOS (Rotterdam criteria)|patient with pcos (rotterdam criteria)
766840|NCT00378729|Failure of treatment with Clomiphene Citrate|failure of treatment with clomiphene citrate
766841|NCT00378729|Age between 18 and 36 years old|age between 18 and 36 years old
766842|NCT00378729|Spermogram must be normal|spermogram must be normal
766843|NCT00378729|Permeability of Fallopian tubes|permeability of fallopian tubes
766844|NCT00378716|stage II colon cancer|stage ii colon cancer
766845|NCT00378716|stage III colon cancer|stage iii colon cancer
766846|NCT00378716|adenocarcinoma of the colon|adenocarcinoma of the colon
766847|NCT00378690|Prostate Cancer|prostate cancer
766848|NCT00378690|Prostate Specific Antigen|prostate specific antigen
766849|NCT00378677|Powder inhalation|powder inhalation
766850|NCT00378677|Side effects|side effects
766851|NCT00378677|Nephrotoxicity|nephrotoxicity
766852|NCT00378677|Calcineurin inhibitor|calcineurin inhibitor
766853|NCT00378677|Bronchiolitis obliterans syndrome|bronchiolitis obliterans syndrome
766854|NCT00378677|Forced Expiratory Volume|forced expiratory volume
766855|NCT00378664|urinary incontinence|urinary incontinence
766856|NCT00378664|spinal cord injury|spinal cord injury
766857|NCT00378664|spina bifida|spina bifida
766858|NCT00378651|Intubation, Endotracheal|intubation, endotracheal
766859|NCT00378651|Anesthesia, General|anesthesia, general
766860|NCT00378638|lymph|lymph
766861|NCT00378638|node|node
766862|NCT00378638|positive|positive
766863|NCT00378638|breast|breast
766864|NCT00378638|cancer|cancer
766865|NCT00378638|metastases|metastases
766866|NCT00378638|angiogenesis|angiogenesis
766867|NCT00378638|bevacizumab|bevacizumab
766868|NCT00378638|chemotherapy|chemotherapy
766869|NCT00378612|trials|trials
766870|NCT00378612|stents|stents
766871|NCT00378612|coronary occlusions|coronary occlusions
766872|NCT00378547|Tonsillectomy|tonsillectomy
766873|NCT00378547|pregabalin|pregabalin
766874|NCT00378547|dexamethasone|dexamethasone
766875|NCT00378547|multimodal postoperative analgesia|multimodal postoperative analgesia
766876|NCT00378534|Chronic Myelogenous Leukemia (CML)|chronic myelogenous leukemia (cml)
766877|NCT00378534|Acute Myelogenous Leukemia (AML)|acute myelogenous leukemia (aml)
766878|NCT00378534|Chronic Lymphocytic Leukemia (CLL)|chronic lymphocytic leukemia (cll)
766879|NCT00378534|Acute Lymphoblastic Leukemia (ALL)|acute lymphoblastic leukemia (all)
766880|NCT00378534|Myelodysplastic Syndrome (MDS)|myelodysplastic syndrome (mds)
766881|NCT00378534|Leukemia|leukemia
766882|NCT00378534|Chronic Myelogenous Leukemia|chronic myelogenous leukemia
766886|NCT00378534|Chronic Lymphocytic Leukemia|chronic lymphocytic leukemia
766887|NCT00378534|CLL|cll
766888|NCT00378534|Acute Lymphoblastic Leukemia|acute lymphoblastic leukemia
766889|NCT00378534|ALL|all
766890|NCT00378534|Myelodysplasia Syndrome|myelodysplasia syndrome
766891|NCT00378521|Raynaud's|raynaud's
766892|NCT00378521|Nitroglycerin|nitroglycerin
766893|NCT00378521|topical gel|topical gel
766894|NCT00378521|cold hands|cold hands
766895|NCT00378521|painful hands|painful hands
766896|NCT00378521|scleroderma|scleroderma
766897|NCT00378508|immune therapy|immune therapy
766898|NCT00378508|autoimmunity|autoimmunity
766899|NCT00378508|insulin secretion|insulin secretion
766900|NCT00378508|diabetes mellitus|diabetes mellitus
766901|NCT00378495|miltefosine|miltefosine
766902|NCT00378495|kala azar|kala azar
766903|NCT00378495|Brazil|brazil
766904|NCT00378482|Melanoma and other tumors|melanoma and other tumors
766905|NCT00378469|Hepcidin|hepcidin
766906|NCT00378469|Hemojuvelin|hemojuvelin
766907|NCT00378469|Iron|iron
766908|NCT00378469|Healthy volunteers|healthy volunteers
766909|NCT00378417|Otitis Media|otitis media
766910|NCT00378417|Pneumococcal Infections|pneumococcal infections
766911|NCT00378417|Pneumococcal Vaccines|pneumococcal vaccines
766912|NCT00378417|Proportional Hazards Models|proportional hazards models
766913|NCT00378417|Prospective Studies|prospective studies
766914|NCT00378417|Streptococcus pneumoniae|streptococcus pneumoniae
766915|NCT00378417|Vaccines, Conjugate|vaccines, conjugate
766916|NCT00378404|NSCLC|nsclc
766917|NCT00378404|Non-Small Cell Lung Cancer|non-small cell lung cancer
766918|NCT00378404|Non-Small Cell|non-small cell
766919|NCT00378404|Lung Cancer|lung cancer
766920|NCT00378404|Docetaxel|docetaxel
766921|NCT00378404|Radiation|radiation
766923|NCT00378404|Recurrent|recurrent
766924|NCT00378391|ST-Elevation Myocardial Infarction|st-elevation myocardial infarction
766925|NCT00378391|upstream abciximab|upstream abciximab
766926|NCT00378391|guideline adherence|guideline adherence
766927|NCT00378391|hospital networking|hospital networking
766928|NCT00378365|Acute promyelocytic leukaemia|acute promyelocytic leukaemia
766929|NCT00378365|ATRA|atra
766930|NCT00378365|Idarubicin|idarubicin
766931|NCT00378365|Arsenic trioxide|arsenic trioxide
766932|NCT00378365|Patient with a newly acute promyelocytic leukaemia (APL)|patient with a newly acute promyelocytic leukaemia (apl)
766933|NCT00378365|Unmapped MeSH term|unmapped mesh term
766934|NCT00378352|Acute Myocardial Infarction|acute myocardial infarction
766935|NCT00378352|Left Ventricular Remodeling|left ventricular remodeling
766936|NCT00378352|Cardiac Magnetic Resonance Imaging|cardiac magnetic resonance imaging
766937|NCT00378352|Endothelial Progenitor Cells|endothelial progenitor cells
766938|NCT00378352|Infarct Size|infarct size
766939|NCT00378339|arthrosis|arthrosis
766940|NCT00378339|gold|gold
766941|NCT00378326|paraneoplastic syndrome|paraneoplastic syndrome
766942|NCT00378313|NSABP|nsabp
766943|NCT00378313|gemcitabine|gemcitabine
766944|NCT00378313|epirubicin|epirubicin
766945|NCT00378313|paclitaxel|paclitaxel
766946|NCT00378313|Taxol|taxol
766947|NCT00378313|breast cancer|breast cancer
766948|NCT00378313|neoadjuvant chemotherapy|neoadjuvant chemotherapy
766949|NCT00378313|primary chemotherapy|primary chemotherapy
766950|NCT00378300|Atopic Dermatitis|atopic dermatitis
766951|NCT00378300|Probiotics|probiotics
766952|NCT00378300|T Regulatory Cells|t regulatory cells
766953|NCT00378287|Acid Reflux|acid reflux
766954|NCT00378287|Proton Pump Inhibitor|proton pump inhibitor
766955|NCT00378287|GERD|gerd
766956|NCT00378274|Neuropathic pain|neuropathic pain
766957|NCT00378274|Chronic pain|chronic pain
766958|NCT00378274|Depression|depression
766959|NCT00378274|Anxiety|anxiety
766960|NCT00378261|Rheumatoid Arthritis|rheumatoid arthritis
766961|NCT00378248|Personality disorders,|personality disorders,
766962|NCT00378248|Day treatment,|day treatment,
766963|NCT00378248|Group psychotherapy,|group psychotherapy,
766964|NCT00378248|Combined psychotherapy,|combined psychotherapy,
766965|NCT00378248|Outcome,|outcome,
766966|NCT00378248|Attachment pattern|attachment pattern
766967|NCT00378235|neurosurgery, craniotomy|neurosurgery, craniotomy
766968|NCT00378235|convection-enhanced delivery|convection-enhanced delivery
766969|NCT00378235|CNS interstitial infusion|cns interstitial infusion
766970|NCT00378235|recombinant toxins|recombinant toxins
766971|NCT00378235|malignant glioma, recurrent|malignant glioma, recurrent
766972|NCT00378235|catheter,|catheter,
766973|NCT00378235|intratumoral therapy|intratumoral therapy
766974|NCT00378235|positive pressure microinfusion|positive pressure microinfusion
766975|NCT00378222|Myeloma previously untreated|myeloma previously untreated
766976|NCT00378222|Single autologous transplantation|single autologous transplantation
766977|NCT00378222|Double autologous transplantation|double autologous transplantation
766978|NCT00378222|Complete response|complete response
766979|NCT00378209|relapsed multiple myeloma|relapsed multiple myeloma
766980|NCT00378209|refractory multiple myeloma|refractory multiple myeloma
766981|NCT00378196|Idiopathic Parafoveal Telangiectasia (IPT)|idiopathic parafoveal telangiectasia (ipt)
766982|NCT00378196|Also Known As Idiopathic Juxtafoveal Telangiectasia (IJFT)|also known as idiopathic juxtafoveal telangiectasia (ijft)
766983|NCT00378183|weight loss|weight loss
766984|NCT00378183|behavioral therapy|behavioral therapy
766985|NCT00378183|risperidone|risperidone
766986|NCT00378183|switching antipsychotics|switching antipsychotics
766987|NCT00378183|schizoaffective disorder|schizoaffective disorder
766988|NCT00378183|Risperdal|risperdal
766989|NCT00378183|schizophrenia|schizophrenia
766990|NCT00378183|olanzapine|olanzapine
766991|NCT00378183|Zyprexa|zyprexa
766992|NCT00378170|intubation|intubation
766993|NCT00378170|difficulty|difficulty
766994|NCT00378170|Macintosh|macintosh
766995|NCT00378170|dental damage|dental damage
766996|NCT00378170|complications|complications
766997|NCT00378157|autism|autism
766998|NCT00378157|joint attention|joint attention
766999|NCT00378157|intervention|intervention
767000|NCT00378157|joint engagement|joint engagement
767001|NCT00378157|language|language
767002|NCT00378118|HIV-1|hiv-1
767003|NCT00378118|HIV-2|hiv-2
767004|NCT00378105|newly diagnosed multiple myeloma|newly diagnosed multiple myeloma
767005|NCT00378092|Schizophrenia|schizophrenia
767006|NCT00378092|Risperidone|risperidone
767007|NCT00378092|Risperdal consta|risperdal consta
767008|NCT00378053|Radiation|radiation
767009|NCT00378053|Exposure|exposure
767010|NCT00378053|Hand|hand
767011|NCT00378053|Orthopaedic|orthopaedic
767012|NCT00378053|Surgeons|surgeons
767013|NCT00378027|Pulmonary Embolism|pulmonary embolism
767014|NCT00378027|PE|pe
767015|NCT00378027|Outpatient|outpatient
767016|NCT00378027|Anticoagulation|anticoagulation
767017|NCT00378014|Liver transplantation, everolimus, CNI|liver transplantation, everolimus, cni
767018|NCT00378001|Infertility, FSH, IVF, Ovarian stimulation|infertility, fsh, ivf, ovarian stimulation
767019|NCT00377988|Contraception|contraception
767020|NCT00377988|Hormonal contraception|hormonal contraception
767021|NCT00377988|Oral contraception|oral contraception
767022|NCT00377988|Ethinyl estradiol|ethinyl estradiol
767023|NCT00377988|Progestin|progestin
767024|NCT00377988|Transdermal|transdermal
767025|NCT00377988|Thrombosis|thrombosis
767026|NCT00377988|Venous thromboembolism|venous thromboembolism
767027|NCT00377975|UCP-1|ucp-1
767028|NCT00377975|ephedrine|ephedrine
767029|NCT00377975|caffeine|caffeine
767030|NCT00377975|pioglitazone|pioglitazone
767031|NCT00377962|thoracic transplant recipients|thoracic transplant recipients
767032|NCT00377962|everolimus|everolimus
767033|NCT00377962|immunosuppressants|immunosuppressants
767034|NCT00377949|Systemic Sclerosis|systemic sclerosis
767035|NCT00377949|Scleroderma|scleroderma
767036|NCT00377949|Pulmonary Hypertension|pulmonary hypertension
767037|NCT00377949|PHAROS|pharos
767038|NCT00377949|PHROS|phros
767039|NCT00377949|Exercise Echocardiogram|exercise echocardiogram
767040|NCT00377949|Pulmonary Functional Tests|pulmonary functional tests
767041|NCT00377949|Six minute walk tests|six minute walk tests
767042|NCT00377949|6 minute walk tests|6 minute walk tests
767043|NCT00377949|Right heart catheterization|right heart catheterization
767044|NCT00377936|Adenocarcinoma of the pancreas|adenocarcinoma of the pancreas
767045|NCT00377936|Locally advanced|locally advanced
767046|NCT00377936|Metastatic|metastatic
767047|NCT00377923|pharmacodynamic and pharmacokinetic study|pharmacodynamic and pharmacokinetic study
767048|NCT00377923|Progesterone|progesterone
767049|NCT00377923|healthy volunteers|healthy volunteers
767050|NCT00377923|Endometrial decidualisation|endometrial decidualisation
767051|NCT00377910|Chronic Achilles tendinopathy|chronic achilles tendinopathy
767052|NCT00377910|Polidocanol|polidocanol
767053|NCT00377910|Ultrasound|ultrasound
767054|NCT00377910|Efficacy|efficacy
767055|NCT00377910|RCT|rct
767056|NCT00377897|critical leg ischemia|critical leg ischemia
767057|NCT00377897|PAD|pad
767058|NCT00377897|cell therapy|cell therapy
767059|NCT00377884|THA|tha
767060|NCT00377871|Stentless|stentless
767061|NCT00377871|Biological|biological
767062|NCT00377871|aortic|aortic
767063|NCT00377871|heart|heart
767064|NCT00377871|valve|valve
767065|NCT00377871|prosthesis|prosthesis
767066|NCT00377871|artificial|artificial
767067|NCT00377858|diabetes|diabetes
767068|NCT00377858|type 2|type 2
767069|NCT00377845|self test|self test
767070|NCT00377845|PAP smear|pap smear
767071|NCT00377845|tampon test|tampon test
767072|NCT00377845|cervical dysplasia|cervical dysplasia
767073|NCT00377832|Fetal tachycardia|fetal tachycardia
767074|NCT00377832|Fever in labor|fever in labor
767075|NCT00377832|Acetaminophen|acetaminophen
767076|NCT00377832|Non reassuring fetal status|non reassuring fetal status
767077|NCT00377819|RANKL|rankl
767078|NCT00377819|RANK|rank
767079|NCT00377819|denosumab|denosumab
767080|NCT00377819|AMG 162|amg 162
767081|NCT00377819|osteoporosis|osteoporosis
767082|NCT00377819|bone turnover|bone turnover
767083|NCT00377819|bone mineral density|bone mineral density
767084|NCT00377819|clinical trial|clinical trial
767085|NCT00377819|postmenopausal osteoporosis|postmenopausal osteoporosis
767086|NCT00377819|alendronate|alendronate
767087|NCT00377819|total hip bone mineral density|total hip bone mineral density
767280|NCT00376974|video|video
767088|NCT00377806|Superficial thrombophlebitis, diclofenac gel, non steroidal antiinflammatory drugs|superficial thrombophlebitis, diclofenac gel, non steroidal antiinflammatory drugs
767089|NCT00377780|Breast cancer|breast cancer
767090|NCT00377780|metastatic|metastatic
767091|NCT00377780|cardiotoxicity|cardiotoxicity
767092|NCT00377780|liposomal|liposomal
767093|NCT00377780|doxorubicin|doxorubicin
767094|NCT00377780|trastuzumab|trastuzumab
767095|NCT00377780|docetaxel|docetaxel
767096|NCT00377780|HER2/neu positive metastatic breast cancer|her2/neu positive metastatic breast cancer
767097|NCT00377767|Chronic Care Model|chronic care model
767098|NCT00377767|Obesity|obesity
767099|NCT00377767|Overweight|overweight
767100|NCT00377767|Children|children
767101|NCT00377767|Body Mass Index|body mass index
767102|NCT00377767|Primary Care|primary care
767103|NCT00377754|dengue virus, immunity, hemorrhagic fever, Philippines|dengue virus, immunity, hemorrhagic fever, philippines
767104|NCT00377728|Seasonal Allergic Rhinitis Inflammation Vienna CHallenge Chamber|seasonal allergic rhinitis inflammation vienna challenge chamber
767105|NCT00377715|Dimebon, Alzheimer's Disease, Alzheimer's Disease Assessment Scale-cognitive subscale (ADAS-cog)|dimebon, alzheimer's disease, alzheimer's disease assessment scale-cognitive subscale (adas-cog)
767106|NCT00377702|Coronary Heart Disease|coronary heart disease
767107|NCT00377702|Risk Factors|risk factors
767108|NCT00377702|Heart Failure|heart failure
767109|NCT00377689|Accidental falls|accidental falls
767110|NCT00377689|Cerebrovascular accident|cerebrovascular accident
767111|NCT00377689|Balance|balance
767112|NCT00377689|ADL|adl
767113|NCT00377689|Self efficacy|self efficacy
767114|NCT00377689|Quality of Life|quality of life
767115|NCT00377689|Gait parameters|gait parameters
767116|NCT00377676|diabetes|diabetes
767117|NCT00377676|diabetes mellitus|diabetes mellitus
767118|NCT00377611|Influenza vaccine|influenza vaccine
767119|NCT00377598|Herpes Zoster|herpes zoster
767120|NCT00377598|Neuralgia|neuralgia
767121|NCT00377598|Drug Therapy|drug therapy
767122|NCT00377585|Elderly|elderly
767123|NCT00377585|Improved vaccine|improved vaccine
767124|NCT00377585|Influenza|influenza
767125|NCT00377585|Influenza disease|influenza disease
767126|NCT00377572|Immunoglobulins|immunoglobulins
767127|NCT00377572|Immunoglobulin E|immunoglobulin e
767128|NCT00377572|omalizumab|omalizumab
767129|NCT00377572|anti-IgE|anti-ige
767130|NCT00377559|Breast cancer|breast cancer
767131|NCT00377559|metastatic|metastatic
767132|NCT00377559|cardiotoxicity|cardiotoxicity
767133|NCT00377559|liposomal|liposomal
767134|NCT00377559|doxorubicin|doxorubicin
767135|NCT00377559|docetaxel|docetaxel
767136|NCT00377559|HER2/neu negative metastatic breast cancer|her2/neu negative metastatic breast cancer
767137|NCT00377546|Retinal Surgery|retinal surgery
767138|NCT00377533|wheelchairs|wheelchairs
767139|NCT00377533|caregivers|caregivers
767140|NCT00377533|skills|skills
767141|NCT00377507|catechin|catechin
767142|NCT00377507|elderly|elderly
767143|NCT00377507|mouth washing|mouth washing
767144|NCT00377507|disabled|disabled
767145|NCT00377507|colonized|colonized
767146|NCT00377494|malaria, Plasmodium falciparum, vaccine, Ghana|malaria, plasmodium falciparum, vaccine, ghana
767147|NCT00377468|THC|thc
767150|NCT00377468|Complex Regional Pain Syndrome|complex regional pain syndrome
767151|NCT00377468|Neuropathic Pain|neuropathic pain
767152|NCT00377468|Chronic|chronic
767153|NCT00377468|Prevention|prevention
767154|NCT00377455|scleroderma|scleroderma
767155|NCT00377455|systemic sclerosis|systemic sclerosis
767156|NCT00377455|bosentan|bosentan
767157|NCT00377455|pulmonary hypertension|pulmonary hypertension
767158|NCT00377455|PHAROS|pharos
767159|NCT00377455|PHROS|phros
767160|NCT00377455|exercise echocardiogram|exercise echocardiogram
767161|NCT00377429|Epithelial Cancer|epithelial cancer
767162|NCT00377429|Epithelial Carcinoma|epithelial carcinoma
767163|NCT00377429|Epithelial Ovarian Cancer|epithelial ovarian cancer
767164|NCT00377429|Epithelial Ovarian Carcinoma|epithelial ovarian carcinoma
767165|NCT00377429|Fallopian Tube Cancer|fallopian tube cancer
767166|NCT00377429|Fallopian Tube Carcinoma|fallopian tube carcinoma
767167|NCT00377429|Ovarian Cancer|ovarian cancer
767168|NCT00377429|Ovarian Carcinoma|ovarian carcinoma
767169|NCT00377429|Ovarian Epithelial Cancer|ovarian epithelial cancer
767170|NCT00377429|Ovarian Epithelial Carcinoma|ovarian epithelial carcinoma
767171|NCT00377429|Peritoneal Cancer|peritoneal cancer
767172|NCT00377429|Peritoneal Carcinoma|peritoneal carcinoma
767173|NCT00377429|Advanced Epithelial Ovarian Cancer|advanced epithelial ovarian cancer
767174|NCT00377416|Gene Transfer Techniques|gene transfer techniques
767175|NCT00377416|Gene Therapy|gene therapy
767176|NCT00377403|rhinosinusitis, sinusitis, amoxicillin|rhinosinusitis, sinusitis, amoxicillin
767177|NCT00377390|Immunoglobulin|immunoglobulin
767178|NCT00377390|IgE|ige
767179|NCT00377390|Omalizumab|omalizumab
767180|NCT00377377|GH release|gh release
767181|NCT00377377|Pharmacokinetics|pharmacokinetics
767182|NCT00377377|Safety|safety
767183|NCT00377364|Acetaminophen|acetaminophen
767184|NCT00377364|corticosteroids|corticosteroids
767185|NCT00377364|prednisone|prednisone
767186|NCT00377351|Public Health|public health
767187|NCT00377351|Elderly Population|elderly population
767188|NCT00377351|Neurodegenerative Diseases|neurodegenerative diseases
767189|NCT00377351|Exposure|exposure
767190|NCT00377351|Lifestyle|lifestyle
767191|NCT00377338|Bronchoscopy|bronchoscopy
767192|NCT00377338|Diagnostic imaging|diagnostic imaging
767193|NCT00377338|Laser scanning confocal microscopy|laser scanning confocal microscopy
767194|NCT00377338|Pulmonary Alveoli|pulmonary alveoli
767195|NCT00377338|Healthy volunteers|healthy volunteers
767196|NCT00377338|Diffuse peripheral lung disease|diffuse peripheral lung disease
767197|NCT00377338|Focal peripheral lung disease|focal peripheral lung disease
767198|NCT00377312|Endocrine System Diseases|endocrine system diseases
767199|NCT00377312|MusculoSkeletal System Disease|musculoskeletal system disease
767200|NCT00377312|Hormone|hormone
767201|NCT00377312|Physiologic Properties|physiologic properties
767202|NCT00377299|Amphetamine Abuse|amphetamine abuse
767203|NCT00377299|Amphetamine Dependence|amphetamine dependence
767204|NCT00377299|Bipolar Disorder|bipolar disorder
767205|NCT00377299|Major Depressive Disorder|major depressive disorder
767206|NCT00377299|Citicoline|citicoline
767207|NCT00377286|Osteoarthritis|osteoarthritis
767208|NCT00377286|Knee Pain|knee pain
767209|NCT00377286|Glucosamine|glucosamine
767210|NCT00377286|MRI|mri
767211|NCT00377286|CTX-II|ctx-ii
767212|NCT00377286|Biomarkers|biomarkers
767213|NCT00377286|Skin quality|skin quality
767214|NCT00377260|acute otitis media, infants, children|acute otitis media, infants, children
767215|NCT00377247|Carcinoma|carcinoma
767216|NCT00377247|Head|head
767217|NCT00377247|Neck|neck
767218|NCT00377247|Oral Cavity|oral cavity
767219|NCT00377247|Oropharynx|oropharynx
767220|NCT00377247|Mouth|mouth
767221|NCT00377208|Blood Pressure, High|blood pressure, high
767222|NCT00377195|Marginal Zone Lymphoma|marginal zone lymphoma
767223|NCT00377195|Involved field radiotherapy|involved field radiotherapy
767224|NCT00377195|H. pylori|h. pylori
767225|NCT00377169|Treatment Experienced|treatment experienced
767226|NCT00377156|cognitive/functional effects|cognitive/functional effects
767227|NCT00377156|tumors metastatic to brain|tumors metastatic to brain
767228|NCT00377156|stage IV breast cancer|stage iv breast cancer
767229|NCT00377156|stage IV prostate cancer|stage iv prostate cancer
767230|NCT00377156|stage IV non-small cell lung cancer|stage iv non-small cell lung cancer
767231|NCT00377156|male breast cancer|male breast cancer
767232|NCT00377156|recurrent breast cancer|recurrent breast cancer
767233|NCT00377156|recurrent prostate cancer|recurrent prostate cancer
767234|NCT00377156|recurrent non-small cell lung cancer|recurrent non-small cell lung cancer
767235|NCT00377143|warfarin|warfarin
767236|NCT00377143|pharmacogenomic|pharmacogenomic
767237|NCT00377143|CYP2C9|cyp2c9
767238|NCT00377143|VKORC1|vkorc1
767239|NCT00377143|polymorphism, single nucleotide|polymorphism, single nucleotide
767240|NCT00377130|psychosocial effects of cancer and its treatment|psychosocial effects of cancer and its treatment
767241|NCT00377130|unspecified adult solid tumor, protocol specific|unspecified adult solid tumor, protocol specific
767242|NCT00377091|pulmonary embolism|pulmonary embolism
767243|NCT00377091|venous thromboembolism|venous thromboembolism
767244|NCT00377091|pharmacoeconomic|pharmacoeconomic
767246|NCT00377091|unfractionated heparin|unfractionated heparin
767247|NCT00377091|fondaparinux|fondaparinux
767248|NCT00377091|length of stay|length of stay
767249|NCT00377091|costs|costs
767250|NCT00377091|bleeding|bleeding
767251|NCT00377091|thrombosis|thrombosis
767252|NCT00377078|recombinant human lactoferrin|recombinant human lactoferrin
767253|NCT00377052|recurrent mantle cell lymphoma|recurrent mantle cell lymphoma
767254|NCT00377039|ACR 1990 Fibromyalgia|acr 1990 fibromyalgia
767255|NCT00377039|Fibromyalgia Impact Questionnaire|fibromyalgia impact questionnaire
767256|NCT00377026|weight loss|weight loss
767257|NCT00377026|postpartum|postpartum
767258|NCT00377026|weight retention|weight retention
767259|NCT00376987|renal cell carcinoma|renal cell carcinoma
767260|NCT00376987|bladder cancer|bladder cancer
767261|NCT00376987|cervical cancer|cervical cancer
767262|NCT00376987|esophageal cancer|esophageal cancer
767263|NCT00376987|gastric cancer|gastric cancer
767264|NCT00376987|adult acute myeloid leukemia|adult acute myeloid leukemia
767265|NCT00376987|pancreatic cancer|pancreatic cancer
767266|NCT00376987|hypopharyngeal cancer|hypopharyngeal cancer
767267|NCT00376987|lip and oral cavity cancer|lip and oral cavity cancer
767268|NCT00376987|laryngeal cancer|laryngeal cancer
767269|NCT00376987|nasopharyngeal cancer|nasopharyngeal cancer
767270|NCT00376987|oropharyngeal cancer|oropharyngeal cancer
767271|NCT00376987|paranasal sinus and nasal cavity cancer|paranasal sinus and nasal cavity cancer
767272|NCT00376987|non-small cell lung cancer|non-small cell lung cancer
767273|NCT00376987|small cell lung cancer|small cell lung cancer
767274|NCT00376987|adult primary liver cancer|adult primary liver cancer
767275|NCT00376987|tongue cancer|tongue cancer
767276|NCT00376987|tobacco use disorder|tobacco use disorder
767277|NCT00376974|glaucoma|glaucoma
767278|NCT00376974|compliance|compliance
767279|NCT00376974|intraocular pressure|intraocular pressure
767281|NCT00376961|contiguous stage II mantle cell lymphoma|contiguous stage ii mantle cell lymphoma
767282|NCT00376961|noncontiguous stage II mantle cell lymphoma|noncontiguous stage ii mantle cell lymphoma
767283|NCT00376961|stage III mantle cell lymphoma|stage iii mantle cell lymphoma
767284|NCT00376961|stage IV mantle cell lymphoma|stage iv mantle cell lymphoma
767285|NCT00376948|adenocarcinoma of the pancreas|adenocarcinoma of the pancreas
767286|NCT00376948|stage III pancreatic cancer|stage iii pancreatic cancer
767287|NCT00376948|stage IV pancreatic cancer|stage iv pancreatic cancer
767288|NCT00376948|recurrent pancreatic cancer|recurrent pancreatic cancer
767289|NCT00376935|Treatment Experienced|treatment experienced
767290|NCT00376922|pain|pain
767291|NCT00376922|psychosocial effects of cancer and its treatment|psychosocial effects of cancer and its treatment
767292|NCT00376922|accelerated phase chronic myelogenous leukemia|accelerated phase chronic myelogenous leukemia
767293|NCT00376922|acute undifferentiated leukemia|acute undifferentiated leukemia
767294|NCT00376922|adult acute myeloid leukemia with 11q23 (MLL) abnormalities|adult acute myeloid leukemia with 11q23 (mll) abnormalities
767295|NCT00376922|adult acute myeloid leukemia with inv(16)(p13;q22)|adult acute myeloid leukemia with inv(16)(p13;q22)
767296|NCT00376922|adult acute myeloid leukemia with t(15;17)(q22;q12)|adult acute myeloid leukemia with t(15;17)(q22;q12)
767297|NCT00376922|adult acute myeloid leukemia with t(16;16)(p13;q22)|adult acute myeloid leukemia with t(16;16)(p13;q22)
767298|NCT00376922|adult acute myeloid leukemia with t(8;21)(q22;q22)|adult acute myeloid leukemia with t(8;21)(q22;q22)
767299|NCT00376922|atypical chronic myeloid leukemia, BCR-ABL1 negative|atypical chronic myeloid leukemia, bcr-abl1 negative
767300|NCT00376922|blastic phase chronic myelogenous leukemia|blastic phase chronic myelogenous leukemia
767301|NCT00376922|chronic eosinophilic leukemia|chronic eosinophilic leukemia
767302|NCT00376922|primary myelofibrosis|primary myelofibrosis
767303|NCT00376922|chronic myelomonocytic leukemia|chronic myelomonocytic leukemia
767304|NCT00376922|chronic neutrophilic leukemia|chronic neutrophilic leukemia
767305|NCT00376922|chronic phase chronic myelogenous leukemia|chronic phase chronic myelogenous leukemia
767306|NCT00376922|de novo myelodysplastic syndromes|de novo myelodysplastic syndromes
767307|NCT00376922|essential thrombocythemia|essential thrombocythemia
767308|NCT00376922|extramedullary plasmacytoma|extramedullary plasmacytoma
767309|NCT00376922|meningeal chronic myelogenous leukemia|meningeal chronic myelogenous leukemia
767310|NCT00376922|myelodysplastic/myeloproliferative neoplasm, unclassifiable|myelodysplastic/myeloproliferative neoplasm, unclassifiable
767311|NCT00376922|polycythemia vera|polycythemia vera
767312|NCT00376922|previously treated myelodysplastic syndromes|previously treated myelodysplastic syndromes
767313|NCT00376922|primary systemic amyloidosis|primary systemic amyloidosis
767314|NCT00376922|progressive hairy cell leukemia, initial treatment|progressive hairy cell leukemia, initial treatment
767315|NCT00376922|prolymphocytic leukemia|prolymphocytic leukemia
767316|NCT00376922|secondary acute myeloid leukemia|secondary acute myeloid leukemia
767317|NCT00376922|secondary myelodysplastic syndromes|secondary myelodysplastic syndromes
767318|NCT00376922|stage III adult T-cell leukemia/lymphoma|stage iii adult t-cell leukemia/lymphoma
767319|NCT00376922|stage III chronic lymphocytic leukemia|stage iii chronic lymphocytic leukemia
767320|NCT00376922|stage III multiple myeloma|stage iii multiple myeloma
767321|NCT00376922|stage IV adult T-cell leukemia/lymphoma|stage iv adult t-cell leukemia/lymphoma
767322|NCT00376922|stage IV chronic lymphocytic leukemia|stage iv chronic lymphocytic leukemia
767323|NCT00376922|relapsing chronic myelogenous leukemia|relapsing chronic myelogenous leukemia
767324|NCT00376922|adult acute lymphoblastic leukemia in remission|adult acute lymphoblastic leukemia in remission
767325|NCT00376922|recurrent adult acute lymphoblastic leukemia|recurrent adult acute lymphoblastic leukemia
767326|NCT00376922|untreated adult acute lymphoblastic leukemia|untreated adult acute lymphoblastic leukemia
767327|NCT00376922|adult acute myeloid leukemia in remission|adult acute myeloid leukemia in remission
767328|NCT00376922|recurrent adult acute myeloid leukemia|recurrent adult acute myeloid leukemia
767329|NCT00376922|untreated adult acute myeloid leukemia|untreated adult acute myeloid leukemia
767330|NCT00376922|mast cell leukemia|mast cell leukemia
767331|NCT00376922|stage I adult T-cell leukemia/lymphoma|stage i adult t-cell leukemia/lymphoma
767332|NCT00376922|stage II adult T-cell leukemia/lymphoma|stage ii adult t-cell leukemia/lymphoma
767333|NCT00376922|T-cell large granular lymphocyte leukemia|t-cell large granular lymphocyte leukemia
767334|NCT00376922|stage I chronic lymphocytic leukemia|stage i chronic lymphocytic leukemia
767335|NCT00376922|stage II chronic lymphocytic leukemia|stage ii chronic lymphocytic leukemia
767336|NCT00376922|refractory hairy cell leukemia|refractory hairy cell leukemia
767337|NCT00376922|recurrent adult T-cell leukemia/lymphoma|recurrent adult t-cell leukemia/lymphoma
767338|NCT00376922|refractory chronic lymphocytic leukemia|refractory chronic lymphocytic leukemia
767339|NCT00376922|untreated hairy cell leukemia|untreated hairy cell leukemia
767340|NCT00376922|recurrent adult Hodgkin lymphoma|recurrent adult hodgkin lymphoma
767341|NCT00376922|stage I adult Hodgkin lymphoma|stage i adult hodgkin lymphoma
767342|NCT00376922|stage II adult Hodgkin lymphoma|stage ii adult hodgkin lymphoma
767343|NCT00376922|stage III adult Hodgkin lymphoma|stage iii adult hodgkin lymphoma
767344|NCT00376922|stage IV adult Hodgkin lymphoma|stage iv adult hodgkin lymphoma
767345|NCT00376922|anaplastic large cell lymphoma|anaplastic large cell lymphoma
767346|NCT00376922|angioimmunoblastic T-cell lymphoma|angioimmunoblastic t-cell lymphoma
767347|NCT00376922|recurrent mycosis fungoides/Sezary syndrome|recurrent mycosis fungoides/sezary syndrome
767851|NCT00375544|Osteoarthritis|osteoarthritis
767348|NCT00376922|stage I mycosis fungoides/Sezary syndrome|stage i mycosis fungoides/sezary syndrome
767349|NCT00376922|stage II mycosis fungoides/Sezary syndrome|stage ii mycosis fungoides/sezary syndrome
767350|NCT00376922|stage III mycosis fungoides/Sezary syndrome|stage iii mycosis fungoides/sezary syndrome
767351|NCT00376922|stage IV mycosis fungoides/Sezary syndrome|stage iv mycosis fungoides/sezary syndrome
767352|NCT00376922|recurrent cutaneous T-cell non-Hodgkin lymphoma|recurrent cutaneous t-cell non-hodgkin lymphoma
767353|NCT00376922|stage I cutaneous T-cell non-Hodgkin lymphoma|stage i cutaneous t-cell non-hodgkin lymphoma
767354|NCT00376922|stage II cutaneous T-cell non-Hodgkin lymphoma|stage ii cutaneous t-cell non-hodgkin lymphoma
767355|NCT00376922|stage III cutaneous T-cell non-Hodgkin lymphoma|stage iii cutaneous t-cell non-hodgkin lymphoma
767356|NCT00376922|stage IV cutaneous T-cell non-Hodgkin lymphoma|stage iv cutaneous t-cell non-hodgkin lymphoma
767357|NCT00376922|adult grade III lymphomatoid granulomatosis|adult grade iii lymphomatoid granulomatosis
767358|NCT00376922|recurrent adult grade III lymphomatoid granulomatosis|recurrent adult grade iii lymphomatoid granulomatosis
767359|NCT00376922|Waldenström macroglobulinemia|waldenström macroglobulinemia
767360|NCT00376922|contiguous stage II adult Burkitt lymphoma|contiguous stage ii adult burkitt lymphoma
767361|NCT00376922|noncontiguous stage II adult Burkitt lymphoma|noncontiguous stage ii adult burkitt lymphoma
767362|NCT00376922|recurrent adult Burkitt lymphoma|recurrent adult burkitt lymphoma
767363|NCT00376922|stage I adult Burkitt lymphoma|stage i adult burkitt lymphoma
767364|NCT00376922|stage III adult Burkitt lymphoma|stage iii adult burkitt lymphoma
767365|NCT00376922|stage IV adult Burkitt lymphoma|stage iv adult burkitt lymphoma
767366|NCT00376922|contiguous stage II adult diffuse large cell lymphoma|contiguous stage ii adult diffuse large cell lymphoma
767367|NCT00376922|contiguous stage II adult diffuse mixed cell lymphoma|contiguous stage ii adult diffuse mixed cell lymphoma
767368|NCT00376922|contiguous stage II adult diffuse small cleaved cell lymphoma|contiguous stage ii adult diffuse small cleaved cell lymphoma
767369|NCT00376922|noncontiguous stage II adult diffuse large cell lymphoma|noncontiguous stage ii adult diffuse large cell lymphoma
767370|NCT00376922|noncontiguous stage II adult diffuse mixed cell lymphoma|noncontiguous stage ii adult diffuse mixed cell lymphoma
767371|NCT00376922|noncontiguous stage II adult diffuse small cleaved cell lymphoma|noncontiguous stage ii adult diffuse small cleaved cell lymphoma
767372|NCT00376922|recurrent adult diffuse large cell lymphoma|recurrent adult diffuse large cell lymphoma
767373|NCT00376922|recurrent adult diffuse mixed cell lymphoma|recurrent adult diffuse mixed cell lymphoma
767374|NCT00376922|recurrent adult diffuse small cleaved cell lymphoma|recurrent adult diffuse small cleaved cell lymphoma
767375|NCT00376922|stage I adult diffuse large cell lymphoma|stage i adult diffuse large cell lymphoma
767376|NCT00376922|stage I adult diffuse mixed cell lymphoma|stage i adult diffuse mixed cell lymphoma
767377|NCT00376922|stage I adult diffuse small cleaved cell lymphoma|stage i adult diffuse small cleaved cell lymphoma
767378|NCT00376922|stage III adult diffuse large cell lymphoma|stage iii adult diffuse large cell lymphoma
767379|NCT00376922|stage III adult diffuse mixed cell lymphoma|stage iii adult diffuse mixed cell lymphoma
767380|NCT00376922|stage III adult diffuse small cleaved cell lymphoma|stage iii adult diffuse small cleaved cell lymphoma
767381|NCT00376922|stage IV adult diffuse large cell lymphoma|stage iv adult diffuse large cell lymphoma
767382|NCT00376922|stage IV adult diffuse mixed cell lymphoma|stage iv adult diffuse mixed cell lymphoma
767383|NCT00376922|stage IV adult diffuse small cleaved cell lymphoma|stage iv adult diffuse small cleaved cell lymphoma
767384|NCT00376922|contiguous stage II adult immunoblastic large cell lymphoma|contiguous stage ii adult immunoblastic large cell lymphoma
767385|NCT00376922|noncontiguous stage II adult immunoblastic large cell lymphoma|noncontiguous stage ii adult immunoblastic large cell lymphoma
767386|NCT00376922|recurrent adult immunoblastic large cell lymphoma|recurrent adult immunoblastic large cell lymphoma
767387|NCT00376922|stage I adult immunoblastic large cell lymphoma|stage i adult immunoblastic large cell lymphoma
767388|NCT00376922|stage III adult immunoblastic large cell lymphoma|stage iii adult immunoblastic large cell lymphoma
767389|NCT00376922|stage IV adult immunoblastic large cell lymphoma|stage iv adult immunoblastic large cell lymphoma
767390|NCT00376922|contiguous stage II adult lymphoblastic lymphoma|contiguous stage ii adult lymphoblastic lymphoma
767391|NCT00376922|noncontiguous stage II adult lymphoblastic lymphoma|noncontiguous stage ii adult lymphoblastic lymphoma
767392|NCT00376922|recurrent adult lymphoblastic lymphoma|recurrent adult lymphoblastic lymphoma
767393|NCT00376922|stage I adult lymphoblastic lymphoma|stage i adult lymphoblastic lymphoma
767394|NCT00376922|stage III adult lymphoblastic lymphoma|stage iii adult lymphoblastic lymphoma
767395|NCT00376922|stage IV adult lymphoblastic lymphoma|stage iv adult lymphoblastic lymphoma
767396|NCT00376922|contiguous stage II grade 1 follicular lymphoma|contiguous stage ii grade 1 follicular lymphoma
767397|NCT00376922|contiguous stage II grade 2 follicular lymphoma|contiguous stage ii grade 2 follicular lymphoma
767398|NCT00376922|contiguous stage II grade 3 follicular lymphoma|contiguous stage ii grade 3 follicular lymphoma
767399|NCT00376922|noncontiguous stage II grade 1 follicular lymphoma|noncontiguous stage ii grade 1 follicular lymphoma
767400|NCT00376922|noncontiguous stage II grade 2 follicular lymphoma|noncontiguous stage ii grade 2 follicular lymphoma
767401|NCT00376922|noncontiguous stage II grade 3 follicular lymphoma|noncontiguous stage ii grade 3 follicular lymphoma
767402|NCT00376922|recurrent grade 1 follicular lymphoma|recurrent grade 1 follicular lymphoma
767403|NCT00376922|recurrent grade 2 follicular lymphoma|recurrent grade 2 follicular lymphoma
767404|NCT00376922|recurrent grade 3 follicular lymphoma|recurrent grade 3 follicular lymphoma
767405|NCT00376922|stage I grade 1 follicular lymphoma|stage i grade 1 follicular lymphoma
767406|NCT00376922|stage I grade 2 follicular lymphoma|stage i grade 2 follicular lymphoma
767407|NCT00376922|stage I grade 3 follicular lymphoma|stage i grade 3 follicular lymphoma
767408|NCT00376922|stage III grade 1 follicular lymphoma|stage iii grade 1 follicular lymphoma
767409|NCT00376922|stage III grade 2 follicular lymphoma|stage iii grade 2 follicular lymphoma
767410|NCT00376922|stage III grade 3 follicular lymphoma|stage iii grade 3 follicular lymphoma
767411|NCT00376922|stage IV grade 1 follicular lymphoma|stage iv grade 1 follicular lymphoma
767412|NCT00376922|stage IV grade 2 follicular lymphoma|stage iv grade 2 follicular lymphoma
767413|NCT00376922|stage IV grade 3 follicular lymphoma|stage iv grade 3 follicular lymphoma
767414|NCT00376922|contiguous stage II mantle cell lymphoma|contiguous stage ii mantle cell lymphoma
767415|NCT00376922|noncontiguous stage II mantle cell lymphoma|noncontiguous stage ii mantle cell lymphoma
767416|NCT00376922|recurrent mantle cell lymphoma|recurrent mantle cell lymphoma
767417|NCT00376922|stage I mantle cell lymphoma|stage i mantle cell lymphoma
767418|NCT00376922|stage III mantle cell lymphoma|stage iii mantle cell lymphoma
767419|NCT00376922|stage IV mantle cell lymphoma|stage iv mantle cell lymphoma
767420|NCT00376922|contiguous stage II marginal zone lymphoma|contiguous stage ii marginal zone lymphoma
767421|NCT00376922|extranodal marginal zone B-cell lymphoma of mucosa-associated lymphoid tissue|extranodal marginal zone b-cell lymphoma of mucosa-associated lymphoid tissue
767422|NCT00376922|nodal marginal zone B-cell lymphoma|nodal marginal zone b-cell lymphoma
767423|NCT00376922|noncontiguous stage II marginal zone lymphoma|noncontiguous stage ii marginal zone lymphoma
767424|NCT00376922|recurrent marginal zone lymphoma|recurrent marginal zone lymphoma
767425|NCT00376922|splenic marginal zone lymphoma|splenic marginal zone lymphoma
767426|NCT00376922|stage I marginal zone lymphoma|stage i marginal zone lymphoma
767427|NCT00376922|stage III marginal zone lymphoma|stage iii marginal zone lymphoma
767428|NCT00376922|stage IV marginal zone lymphoma|stage iv marginal zone lymphoma
767429|NCT00376922|contiguous stage II small lymphocytic lymphoma|contiguous stage ii small lymphocytic lymphoma
767430|NCT00376922|noncontiguous stage II small lymphocytic lymphoma|noncontiguous stage ii small lymphocytic lymphoma
767431|NCT00376922|recurrent small lymphocytic lymphoma|recurrent small lymphocytic lymphoma
767432|NCT00376922|stage I small lymphocytic lymphoma|stage i small lymphocytic lymphoma
767433|NCT00376922|stage III small lymphocytic lymphoma|stage iii small lymphocytic lymphoma
767434|NCT00376922|stage IV small lymphocytic lymphoma|stage iv small lymphocytic lymphoma
767435|NCT00376922|isolated plasmacytoma of bone|isolated plasmacytoma of bone
767436|NCT00376922|monoclonal gammopathy of undetermined significance|monoclonal gammopathy of undetermined significance
767437|NCT00376922|refractory multiple myeloma|refractory multiple myeloma
767438|NCT00376922|stage I multiple myeloma|stage i multiple myeloma
767439|NCT00376922|stage II multiple myeloma|stage ii multiple myeloma
767440|NCT00376922|post-transplant lymphoproliferative disorder|post-transplant lymphoproliferative disorder
767441|NCT00376922|primary central nervous system non-Hodgkin lymphoma|primary central nervous system non-hodgkin lymphoma
767442|NCT00376909|breast cancer|breast cancer
767443|NCT00376909|cervical cancer|cervical cancer
767444|NCT00376909|colon cancer|colon cancer
767445|NCT00376909|rectal cancer|rectal cancer
767446|NCT00376896|IBS fMRI|ibs fmri
767447|NCT00376883|multiple myeloma|multiple myeloma
767448|NCT00376883|pamidronate prophylaxis|pamidronate prophylaxis
767449|NCT00376883|dose comparison|dose comparison
767450|NCT00376883|quality of life|quality of life
767451|NCT00376883|skeletal event|skeletal event
767457|NCT00376870|Type 2 Diabetes Mellitus|type 2 diabetes mellitus
767458|NCT00376857|Indocyanine green, toxicity, epiretinal membrane, visual field defect|indocyanine green, toxicity, epiretinal membrane, visual field defect
767459|NCT00376844|stage I endometrial carcinoma|stage i endometrial carcinoma
767460|NCT00376831|colonoscopy|colonoscopy
767461|NCT00376831|conscious sedation|conscious sedation
767462|NCT00376831|midazolam|midazolam
767463|NCT00376831|ketamine|ketamine
767464|NCT00376831|fentanyl|fentanyl
767465|NCT00376818|psychosocial effects of cancer and its treatment|psychosocial effects of cancer and its treatment
767466|NCT00376818|adult anaplastic astrocytoma|adult anaplastic astrocytoma
767467|NCT00376818|adult anaplastic ependymoma|adult anaplastic ependymoma
767468|NCT00376818|adult anaplastic oligodendroglioma|adult anaplastic oligodendroglioma
767469|NCT00376818|adult giant cell glioblastoma|adult giant cell glioblastoma
767470|NCT00376818|adult gliosarcoma|adult gliosarcoma
767471|NCT00376818|adult medulloblastoma|adult medulloblastoma
767472|NCT00376818|adult anaplastic meningioma|adult anaplastic meningioma
767473|NCT00376818|adult papillary meningioma|adult papillary meningioma
767474|NCT00376818|adult mixed glioma|adult mixed glioma
767475|NCT00376818|recurrent adult brain tumor|recurrent adult brain tumor
767476|NCT00376818|adult glioblastoma|adult glioblastoma
767477|NCT00376818|adult grade III meningioma|adult grade iii meningioma
767478|NCT00376805|stage IV breast cancer|stage iv breast cancer
767479|NCT00376805|male breast cancer|male breast cancer
767480|NCT00376805|recurrent breast cancer|recurrent breast cancer
767481|NCT00376792|stage IIB prostate cancer|stage iib prostate cancer
767482|NCT00376792|stage IIA prostate cancer|stage iia prostate cancer
767483|NCT00376792|stage III prostate cancer|stage iii prostate cancer
767484|NCT00376792|adenocarcinoma of the prostate|adenocarcinoma of the prostate
767485|NCT00376779|Haemophilus influenzae type b|haemophilus influenzae type b
767486|NCT00376779|Double-blind|double-blind
767487|NCT00376779|Finland|finland
767488|NCT00376779|randomized|randomized
767489|NCT00376779|phase 2|phase 2
767490|NCT00376779|GSK Biologicals|gsk biologicals
767491|NCT00376779|DTPa-HBV-IPV/Hib|dtpa-hbv-ipv/hib
767492|NCT00376766|Cluster seizure|cluster seizure
767493|NCT00376766|seizure clustering|seizure clustering
767494|NCT00376766|repetitive seizure|repetitive seizure
767495|NCT00376766|Drug resistant epilepsy|drug resistant epilepsy
767496|NCT00376766|Levetiracetam|levetiracetam
767497|NCT00376766|keppra|keppra
767498|NCT00376753|Transcranial Magnetic Stimulation (TMS)|transcranial magnetic stimulation (tms)
767499|NCT00376753|Writer's Cramp|writer's cramp
767500|NCT00376753|Electromyogram|electromyogram
767501|NCT00376753|Focal Hand Dystonia|focal hand dystonia
767502|NCT00376753|FHD|fhd
767503|NCT00376753|Healthy Volunteer|healthy volunteer
767504|NCT00376753|HV|hv
767505|NCT00376740|breast cancer, postmenopausal, letrozole, zoledronic acid, adjuvant,bone mineral density|breast cancer, postmenopausal, letrozole, zoledronic acid, adjuvant,bone mineral density
767506|NCT00376727|unspecified adult solid tumor, protocol specific|unspecified adult solid tumor, protocol specific
767507|NCT00376714|plethysmography|plethysmography
767508|NCT00376714|muscarinic receptor antagonist|muscarinic receptor antagonist
767509|NCT00376714|COPD|copd
767510|NCT00376714|repeat dosing|repeat dosing
767511|NCT00376701|Choroidal Neovascularization|choroidal neovascularization
767512|NCT00376701|Photodynamic Therapy|photodynamic therapy
767513|NCT00376701|Age Related Macular Degeneration|age related macular degeneration
767514|NCT00376701|Triamcinolone Acetonide|triamcinolone acetonide
767515|NCT00376701|Avastin|avastin
767516|NCT00376701|Visudyne|visudyne
767517|NCT00376675|fatigue|fatigue
767518|NCT00376675|unspecified adult solid tumor, protocol specific|unspecified adult solid tumor, protocol specific
767519|NCT00376662|HRT|hrt
767520|NCT00376662|Etidronate|etidronate
767521|NCT00376662|Fractures|fractures
767522|NCT00376662|Osteoporosis|osteoporosis
767523|NCT00376662|Asthma|asthma
767524|NCT00376662|Glucocorticoids|glucocorticoids
767525|NCT00376649|crohns|crohns
767526|NCT00376649|quality of life|quality of life
767527|NCT00376649|lifestyle changing|lifestyle changing
767528|NCT00376649|remmision|remmision
767529|NCT00376597|lymphedema|lymphedema
767530|NCT00376597|stage IA breast cancer|stage ia breast cancer
767531|NCT00376597|stage IB breast cancer|stage ib breast cancer
767532|NCT00376597|stage II breast cancer|stage ii breast cancer
767533|NCT00376597|stage IIIA breast cancer|stage iiia breast cancer
767534|NCT00376597|stage IIIB breast cancer|stage iiib breast cancer
767535|NCT00376597|stage IIIC breast cancer|stage iiic breast cancer
767536|NCT00376584|Primary Hypercholesteremia|primary hypercholesteremia
767537|NCT00376584|Mixed Hyperlipidemia|mixed hyperlipidemia
767538|NCT00376571|PCI|pci
767539|NCT00376571|Bifurcation lesion|bifurcation lesion
767540|NCT00376558|cocaine dependence|cocaine dependence
767541|NCT00376545|Functional Magnetic Resonance Imaging (fMRI)|functional magnetic resonance imaging (fmri)
767542|NCT00376545|Visuomotor|visuomotor
767543|NCT00376545|Occipital Cortex|occipital cortex
767544|NCT00376545|Prefrontal Cortex|prefrontal cortex
767545|NCT00376545|Healthy Volunteer|healthy volunteer
767546|NCT00376545|HV|hv
767547|NCT00376532|Cardiac Ischemia|cardiac ischemia
767548|NCT00376532|Cardiac Arrhythmia|cardiac arrhythmia
767549|NCT00376532|Defibrillator|defibrillator
767550|NCT00376532|Matrix Metalloproteinase|matrix metalloproteinase
767551|NCT00376532|Genetic Polymorphism|genetic polymorphism
767552|NCT00376519|graft versus host disease|graft versus host disease
767553|NCT00376519|adult acute lymphoblastic leukemia in remission|adult acute lymphoblastic leukemia in remission
767554|NCT00376519|adult acute myeloid leukemia in remission|adult acute myeloid leukemia in remission
767555|NCT00376519|secondary acute myeloid leukemia|secondary acute myeloid leukemia
767556|NCT00376519|refractory anemia with excess blasts|refractory anemia with excess blasts
767557|NCT00376519|myelodysplastic syndromes|myelodysplastic syndromes
767558|NCT00376519|chronic myelogenous leukemia|chronic myelogenous leukemia
767559|NCT00376519|refractory anemia|refractory anemia
767560|NCT00376519|prolymphocytic leukemia|prolymphocytic leukemia
767561|NCT00376519|stage IV adult lymphoblastic lymphoma|stage iv adult lymphoblastic lymphoma
767562|NCT00376519|recurrent adult Burkitt lymphoma|recurrent adult burkitt lymphoma
767563|NCT00376519|stage I adult Burkitt lymphoma|stage i adult burkitt lymphoma
767564|NCT00376519|stage III adult Burkitt lymphoma|stage iii adult burkitt lymphoma
767565|NCT00376519|stage IV adult Burkitt lymphoma|stage iv adult burkitt lymphoma
767566|NCT00376519|follicular lymphoma|follicular lymphoma
767567|NCT00376519|mantle cell lymphoma|mantle cell lymphoma
767568|NCT00376519|chronic idiopathic myelofibrosis|chronic idiopathic myelofibrosis
767569|NCT00376519|secondary myelofibrosis|secondary myelofibrosis
767570|NCT00376519|refractory chronic lymphocytic leukemia|refractory chronic lymphocytic leukemia
767571|NCT00376519|recurrent small lymphocytic lymphoma|recurrent small lymphocytic lymphoma
767572|NCT00376519|recurrent marginal zone lymphoma|recurrent marginal zone lymphoma
767573|NCT00376519|marginal zone lymphoma|marginal zone lymphoma
767762|NCT00375921|smell|smell
767574|NCT00376519|diffuse large cell lymphoma|diffuse large cell lymphoma
767575|NCT00376519|anaplastic large cell lymphoma|anaplastic large cell lymphoma
767576|NCT00376519|lymphoblastic lymphoma|lymphoblastic lymphoma
767577|NCT00376519|immunoblastic large cell lymphoma|immunoblastic large cell lymphoma
767578|NCT00376519|multiple myeloma|multiple myeloma
767579|NCT00376506|Aspiration|aspiration
767580|NCT00376506|Rehabilitation|rehabilitation
767581|NCT00376506|Swallowing Disorders|swallowing disorders
767583|NCT00376506|Parkinson's Disease|parkinson's disease
767584|NCT00376506|Dysphagia|dysphagia
767585|NCT00376506|Parkinson Disease|parkinson disease
767586|NCT00376506|PD|pd
767587|NCT00376493|Abortion|abortion
767588|NCT00376493|Infection|infection
767589|NCT00376493|Antibiotics|antibiotics
767590|NCT00376493|Treatment|treatment
767591|NCT00376493|Pregnancy complications|pregnancy complications
767592|NCT00376480|refractory anemia with excess blasts in transformation|refractory anemia with excess blasts in transformation
767593|NCT00376480|adult acute lymphoblastic leukemia in remission|adult acute lymphoblastic leukemia in remission
767594|NCT00376480|refractory anemia with excess blasts|refractory anemia with excess blasts
767595|NCT00376480|refractory anemia|refractory anemia
767596|NCT00376480|adult acute myeloid leukemia in remission|adult acute myeloid leukemia in remission
767597|NCT00376480|childhood acute lymphoblastic leukemia in remission|childhood acute lymphoblastic leukemia in remission
767598|NCT00376480|childhood acute myeloid leukemia in remission|childhood acute myeloid leukemia in remission
767599|NCT00376480|de novo myelodysplastic syndromes|de novo myelodysplastic syndromes
767600|NCT00376480|previously treated myelodysplastic syndromes|previously treated myelodysplastic syndromes
767601|NCT00376480|secondary acute myeloid leukemia|secondary acute myeloid leukemia
767602|NCT00376480|adult acute myeloid leukemia with 11q23 (MLL) abnormalities|adult acute myeloid leukemia with 11q23 (mll) abnormalities
767603|NCT00376480|adult acute myeloid leukemia with inv(16)(p13;q22)|adult acute myeloid leukemia with inv(16)(p13;q22)
767604|NCT00376480|adult acute myeloid leukemia with t(15;17)(q22;q12)|adult acute myeloid leukemia with t(15;17)(q22;q12)
767605|NCT00376480|adult acute myeloid leukemia with t(16;16)(p13;q22)|adult acute myeloid leukemia with t(16;16)(p13;q22)
767606|NCT00376480|adult acute myeloid leukemia with t(8;21)(q22;q22)|adult acute myeloid leukemia with t(8;21)(q22;q22)
767607|NCT00376480|secondary myelodysplastic syndromes|secondary myelodysplastic syndromes
767608|NCT00376480|childhood myelodysplastic syndromes|childhood myelodysplastic syndromes
767609|NCT00376467|Acute Lymphoblastic Leukemia|acute lymphoblastic leukemia
767610|NCT00376467|Philadelphia positive|philadelphia positive
767611|NCT00376467|Adult|adult
767612|NCT00376467|Elderly|elderly
767613|NCT00376467|Imatinib|imatinib
767614|NCT00376454|neuropathic pain|neuropathic pain
767615|NCT00376441|vaginal|vaginal
767616|NCT00376441|incontinence|incontinence
767617|NCT00376441|sexual function|sexual function
767618|NCT00376428|Cystic Fibrosis Transmembrane Conductance Regulator|cystic fibrosis transmembrane conductance regulator
767619|NCT00376428|Premature termination codon|premature termination codon
767620|NCT00376428|Gentamicin-induced readthrough|gentamicin-induced readthrough
767621|NCT00376415|Lessertia frutescens|lessertia frutescens
767622|NCT00376415|Sutherlandia frutescens|sutherlandia frutescens
767623|NCT00376415|Phase 1 clinical trial|phase 1 clinical trial
767624|NCT00376415|Human safety study|human safety study
767625|NCT00376402|Pandemic|pandemic
767626|NCT00376402|Influenza|influenza
767627|NCT00376402|Prevention|prevention
767628|NCT00376402|Vaccine|vaccine
768227|NCT00374205|ACT|act
767629|NCT00376402|Prevention of Pandemic Influenza|prevention of pandemic influenza
767630|NCT00376376|levofloxacin|levofloxacin
767631|NCT00376376|pharmacodynamic|pharmacodynamic
767632|NCT00376376|bactericidal|bactericidal
767633|NCT00376363|glaucoma|glaucoma
767634|NCT00376363|Ahmed implant|ahmed implant
767635|NCT00376363|Baerveldt implant|baerveldt implant
767636|NCT00376350|Low Back Pain|low back pain
767637|NCT00376350|Chronic|chronic
767638|NCT00376350|Manipulation|manipulation
767639|NCT00376350|Chiropractic|chiropractic
767640|NCT00376350|Massage|massage
767641|NCT00376337|Invasive Aspergillosis|invasive aspergillosis
767642|NCT00376337|Salvage Therapy|salvage therapy
767643|NCT00376337|Micafungin|micafungin
767644|NCT00376324|pharmacokinetics|pharmacokinetics
767645|NCT00376324|human bone|human bone
767646|NCT00376311|Lequesne's algo-functional score|lequesne's algo-functional score
767647|NCT00376311|Biomarkers of joint metabolism|biomarkers of joint metabolism
767648|NCT00376298|incontinence|incontinence
767649|NCT00376298|prostate cancer|prostate cancer
767650|NCT00376298|interstitial cystitis|interstitial cystitis
767651|NCT00376272|atrial fibrillation,atrial remodeling,dysrhythmias,valsartan|atrial fibrillation,atrial remodeling,dysrhythmias,valsartan
767652|NCT00376259|lamivudine resistance|lamivudine resistance
767653|NCT00376259|Hepatitis B virus|hepatitis b virus
767654|NCT00376233|Schizophrenia,|schizophrenia,
767655|NCT00376233|Cannabinoids,|cannabinoids,
767656|NCT00376233|Arachidonic Acid,|arachidonic acid,
767657|NCT00376233|Niacin,|niacin,
767658|NCT00376233|Prostaglandins|prostaglandins
767659|NCT00376220|Bipolar|bipolar
767660|NCT00376220|Depression|depression
767661|NCT00376207|Cerebral infarct|cerebral infarct
767662|NCT00376207|physical exercise|physical exercise
767663|NCT00376207|insulin sensitivity|insulin sensitivity
767664|NCT00376207|low grade chronic inflammation|low grade chronic inflammation
767665|NCT00376207|intervention|intervention
767666|NCT00376207|HOMA|homa
767667|NCT00376207|PASE|pase
767668|NCT00376194|Pervasive Developmental Disorder|pervasive developmental disorder
767669|NCT00376194|Alternative Therapy|alternative therapy
767670|NCT00376194|Autism|autism
767671|NCT00376194|Asperger's Disorder|asperger's disorder
767672|NCT00376194|Clinical Trial|clinical trial
767673|NCT00376194|Autism Spectrum Disorder|autism spectrum disorder
767674|NCT00376194|ASD|asd
767675|NCT00376194|Asperger Disorder|asperger disorder
767676|NCT00376181|type 2 diabetes|type 2 diabetes
767677|NCT00376181|hypertension|hypertension
767678|NCT00376181|blood pressure|blood pressure
767679|NCT00376181|diastolic blood pressure|diastolic blood pressure
767680|NCT00376155|malaria|malaria
767681|NCT00376155|prevention|prevention
767682|NCT00376155|intermittent|intermittent
767683|NCT00376155|drugs|drugs
767684|NCT00376142|Intention|intention
767685|NCT00376142|Behaviour|behaviour
767686|NCT00376142|Evidence-based practice|evidence-based practice
767687|NCT00376142|Intervention|intervention
767688|NCT00376116|Implantable cardioverter-defibrillator|implantable cardioverter-defibrillator
767689|NCT00376116|Pacemaker|pacemaker
767690|NCT00376116|Cardiac resynchronisation therapy|cardiac resynchronisation therapy
767691|NCT00376116|Heart failure|heart failure
767692|NCT00376116|Predictor|predictor
767693|NCT00376116|Mortality|mortality
767694|NCT00376116|Rehospitalization|rehospitalization
767695|NCT00376116|Telemedicine|telemedicine
767696|NCT00376116|Home Monitoring|home monitoring
767697|NCT00376103|Brain Tumor|brain tumor
767698|NCT00376103|GBM|gbm
767699|NCT00376103|Glioblastoma Multiforme|glioblastoma multiforme
767700|NCT00376103|Glioblastoma|glioblastoma
767701|NCT00376103|Brachytherapy|brachytherapy
767702|NCT00376103|Temozolomide|temozolomide
767703|NCT00376103|Temodar|temodar
767704|NCT00376090|MVA vector|mva vector
767705|NCT00376090|Immunogenicity|immunogenicity
767706|NCT00376090|HIV vaccine|hiv vaccine
767707|NCT00376090|HIV preventative vaccine|hiv preventative vaccine
767708|NCT00376077|Thrombocytopenia|thrombocytopenia
767709|NCT00376077|pediatric|pediatric
767710|NCT00376077|methylprednisolone|methylprednisolone
767711|NCT00376077|intracranial hemorrhage|intracranial hemorrhage
767712|NCT00376077|intravenous immune globulin|intravenous immune globulin
767713|NCT00376064|Growth hormone (GH)|growth hormone (gh)
767714|NCT00376064|IGF-1|igf-1
767715|NCT00376064|Acromegaly|acromegaly
767716|NCT00376064|Pituitary adenoma|pituitary adenoma
767717|NCT00376064|Brain tumor|brain tumor
767718|NCT00376064|Brain cancer|brain cancer
767719|NCT00376064|Octreotide acetate|octreotide acetate
767720|NCT00376051|frontotemporal lobar degeneration|frontotemporal lobar degeneration
767721|NCT00376051|frontotemporal dementia|frontotemporal dementia
767722|NCT00376051|serotonin|serotonin
767723|NCT00376051|dementia|dementia
767724|NCT00376051|behavioural disturbances|behavioural disturbances
767725|NCT00376038|GSK189074|gsk189074
767726|NCT00376038|T2DM|t2dm
767727|NCT00376038|GSK189075|gsk189075
767728|NCT00376038|Glucophage|glucophage
767729|NCT00376038|Obesity|obesity
767730|NCT00376038|Diabetes|diabetes
767731|NCT00376038|Metformin|metformin
767732|NCT00376038|Type 2 Diabetes Mellitus|type 2 diabetes mellitus
767733|NCT00376038|Drug Interaction|drug interaction
767734|NCT00376025|Kashin-Beck Disease|kashin-beck disease
767735|NCT00376025|Kashin-Beck Osteoarthropathy|kashin-beck osteoarthropathy
767736|NCT00376012|Chemotherapy for TB in HIV infection|chemotherapy for tb in hiv infection
767737|NCT00375986|Cesarean delivery|cesarean delivery
767738|NCT00375986|Placental removal|placental removal
767739|NCT00375986|Blood loss|blood loss
767740|NCT00375973|Fatigue|fatigue
767741|NCT00375973|Fatigue syndrome, chronic|fatigue syndrome, chronic
767742|NCT00375973|Chronic fatigue syndrome|chronic fatigue syndrome
767743|NCT00375973|CFS|cfs
767744|NCT00375973|Fibromyalgia|fibromyalgia
767745|NCT00375960|Pain associated with diabetes Type I or Type II|pain associated with diabetes type i or type ii
767746|NCT00375960|Neuropathic Pain due to diabetes|neuropathic pain due to diabetes
767747|NCT00375960|Diabetic peripheral neuropathic pain|diabetic peripheral neuropathic pain
767748|NCT00375960|Pain|pain
767749|NCT00375960|Diabetes with burning sensation in the arms and/or legs|diabetes with burning sensation in the arms and/or legs
767750|NCT00375960|Diabetes with tingling sensation in the arms and/or legs|diabetes with tingling sensation in the arms and/or legs
767751|NCT00375960|Neuropathic Pain Due to Diabetes Type I or Type II|neuropathic pain due to diabetes type i or type ii
767752|NCT00375947|exercise|exercise
767753|NCT00375947|hand disability|hand disability
767754|NCT00375947|arthritis|arthritis
767755|NCT00375947|AUSCAN|auscan
767756|NCT00375934|Bunionectomy|bunionectomy
767757|NCT00375934|Bunion surgery|bunion surgery
767758|NCT00375934|Post-operative pain|post-operative pain
767759|NCT00375921|diet|diet
767760|NCT00375921|food|food
767761|NCT00375921|taste|taste
767763|NCT00375921|head and neck|head and neck
767764|NCT00375921|radiation|radiation
767765|NCT00375921|chemotherapy|chemotherapy
767766|NCT00375908|Neonatal Encephalopathy|neonatal encephalopathy
767767|NCT00375908|Hypoxic-Ischemic Brain Injury|hypoxic-ischemic brain injury
767768|NCT00375908|Umbilical Cord Blood|umbilical cord blood
767769|NCT00375908|Proteomics|proteomics
767770|NCT00375895|Cyclosporin|cyclosporin
767771|NCT00375895|Peginterferon|peginterferon
767772|NCT00375895|Ribavirin|ribavirin
767773|NCT00375895|Chronic hepatitis C|chronic hepatitis c
767774|NCT00375895|Liver transplantation|liver transplantation
767775|NCT00375869|Neuroprotection|neuroprotection
767776|NCT00375869|neuron specific enolase|neuron specific enolase
767777|NCT00375869|CSF glutamate levels|csf glutamate levels
767778|NCT00375869|Darbepoetin Alfa|darbepoetin alfa
767779|NCT00375856|arthroplasty|arthroplasty
767780|NCT00375856|knee|knee
767781|NCT00375856|computer-assist|computer-assist
767782|NCT00375856|gait|gait
767783|NCT00375856|Total knee arthroplasty|total knee arthroplasty
767784|NCT00375856|knee prostheses|knee prostheses
767785|NCT00375804|Endometrial Cancer|endometrial cancer
767786|NCT00375791|Relapsed Multiple Myeloma|relapsed multiple myeloma
767787|NCT00375791|Refractory Multiple Myeloma|refractory multiple myeloma
767788|NCT00375778|Parkinson's Disease|parkinson's disease
767789|NCT00375778|Positron Emission Tomography|positron emission tomography
767790|NCT00375778|Memantine|memantine
767791|NCT00375778|NMDA antagonists|nmda antagonists
767792|NCT00375778|Cerebral Blood Flow|cerebral blood flow
767793|NCT00375778|Cerebral Metabolic Rate of Oxygen|cerebral metabolic rate of oxygen
767794|NCT00375765|Dutasteride|dutasteride
767795|NCT00375765|BPH|bph
767796|NCT00375765|Prostate cancer|prostate cancer
767797|NCT00375765|Gene expression|gene expression
767798|NCT00375765|PSA|psa
767799|NCT00375752|Breast cancer|breast cancer
767800|NCT00375752|Anti tumor potential|anti tumor potential
767801|NCT00375752|Letrozole|letrozole
767802|NCT00375752|Zoledronic acid|zoledronic acid
767803|NCT00375752|Neoadjuvant treatment|neoadjuvant treatment
767804|NCT00375752|Hormone responsive breast cancer|hormone responsive breast cancer
767805|NCT00375739|Actinic Keratosis|actinic keratosis
767806|NCT00375739|Topical|topical
767807|NCT00375739|Solar Keratosis|solar keratosis
767808|NCT00375739|Sun Spots|sun spots
767809|NCT00375739|Dermatology|dermatology
767810|NCT00375726|Dengue Fever|dengue fever
767811|NCT00375726|Dengue Vaccine|dengue vaccine
767812|NCT00375726|Dengue Virus|dengue virus
767813|NCT00375726|Dengue Hemorrhagic Fever|dengue hemorrhagic fever
767814|NCT00375726|Dengue Shock Syndrome|dengue shock syndrome
767815|NCT00375713|Dermatitis|dermatitis
767816|NCT00375713|Eczema|eczema
767817|NCT00375713|Pruritus|pruritus
767818|NCT00375713|Xyzal|xyzal
767819|NCT00375713|Zyrtec|zyrtec
767820|NCT00375713|Levocetirizine|levocetirizine
767821|NCT00375713|Cetirizine|cetirizine
767822|NCT00375700|food|food
767823|NCT00375700|diet|diet
767824|NCT00375700|oral supplement|oral supplement
767825|NCT00375700|head and neck cancer|head and neck cancer
767826|NCT00375700|radiation|radiation
767827|NCT00375687|Prostate cancer|prostate cancer
767828|NCT00375661|hepatocellular carcinoma|hepatocellular carcinoma
767829|NCT00375648|Prostate|prostate
767830|NCT00375648|Cancer|cancer
767831|NCT00375648|Bone metastases|bone metastases
767832|NCT00375648|Zoledronic acid|zoledronic acid
767833|NCT00375648|Bone metastases-related pain|bone metastases-related pain
767834|NCT00375648|Prostate cancer|prostate cancer
767835|NCT00375635|mFPSA|mfpsa
767836|NCT00375635|Uremic toxins|uremic toxins
767837|NCT00375635|Protein bound toxins|protein bound toxins
767838|NCT00375635|Uremia|uremia
767839|NCT00375635|Chronic hemodialysis|chronic hemodialysis
767840|NCT00375622|HHT|hht
767841|NCT00375622|Epistaxis|epistaxis
767842|NCT00375622|Tamoxifen|tamoxifen
767843|NCT00375622|Hemoglobin|hemoglobin
767844|NCT00375609|Prevention of Venous Thromboembolism|prevention of venous thromboembolism
767845|NCT00375583|Lymphatic Filariasis|lymphatic filariasis
767846|NCT00375583|Diethylcarbamazine|diethylcarbamazine
767847|NCT00375583|Microfilariae|microfilariae
767848|NCT00375583|Helminths|helminths
767849|NCT00375583|Nematode|nematode
767850|NCT00375544|Laser Therapy, Low-Level|laser therapy, low-level
767852|NCT00375544|Phototherapy|phototherapy
767853|NCT00375544|Osteoarthritis, knee|osteoarthritis, knee
767854|NCT00375544|Light-emitting diode|light-emitting diode
767855|NCT00375531|Post Traumatic Stress Disorder|post traumatic stress disorder
767856|NCT00375531|Mindfulness Meditation|mindfulness meditation
767857|NCT00375518|Thoracic Surgery|thoracic surgery
767858|NCT00375518|Cardiopulmonary complications|cardiopulmonary complications
767859|NCT00375518|Atorvastatin|atorvastatin
767860|NCT00375505|Breast Cancer|breast cancer
767861|NCT00375505|Premenopausal|premenopausal
767862|NCT00375505|Bone mineral density|bone mineral density
767863|NCT00375505|Cancer therapy induced bone loss|cancer therapy induced bone loss
767864|NCT00375505|zoledronic acid|zoledronic acid
767865|NCT00375492|diabetes|diabetes
767866|NCT00375492|overweight|overweight
767867|NCT00375492|obesity|obesity
767868|NCT00375492|weight loss|weight loss
767869|NCT00375492|exenatide|exenatide
767870|NCT00375492|Amylin|amylin
767871|NCT00375492|Lilly|lilly
767872|NCT00375466|Hemorrhage|hemorrhage
767873|NCT00375466|Transfusion|transfusion
767874|NCT00375466|Blood components|blood components
767875|NCT00375466|Fibrinolysis|fibrinolysis
767876|NCT00375466|Platelet activation|platelet activation
767877|NCT00375453|Paclitaxel|paclitaxel
767878|NCT00375453|Advanced Solid Tumors|advanced solid tumors
767879|NCT00375440|Tranexamic Acid|tranexamic acid
767880|NCT00375440|Revision Total Hip Replacement|revision total hip replacement
767881|NCT00375440|Reduction in Blood Loss|reduction in blood loss
767882|NCT00375427|Breast cancer|breast cancer
767883|NCT00375427|Zoledronic acid|zoledronic acid
767884|NCT00375427|Skeletal related events (SRE)|skeletal related events (sre)
767885|NCT00375414|Enteral tube feeding,|enteral tube feeding,
767886|NCT00375414|endoscopic gastropexy,|endoscopic gastropexy,
767887|NCT00375414|percutaneous endoscopic gastrostomy,|percutaneous endoscopic gastrostomy,
767888|NCT00375414|PEG|peg
767889|NCT00375388|Type 2 diabetes mellitus|type 2 diabetes mellitus
767890|NCT00375388|Metformin on top of insulin therapy|metformin on top of insulin therapy
767891|NCT00375388|Randomized placebo-controlled trial|randomized placebo-controlled trial
767892|NCT00375388|Diabetes regulation|diabetes regulation
767893|NCT00375388|Daily dose of insulin|daily dose of insulin
767894|NCT00375388|Body Weight|body weight
767895|NCT00375388|Patients with type 2 diabetes|patients with type 2 diabetes
767896|NCT00375388|Intensive insulin therapy|intensive insulin therapy
767897|NCT00375388|Age: 30-80 years|age: 30-80 years
767898|NCT00375388|Body mass index|body mass index
767899|NCT00375388|Lipids|lipids
767900|NCT00375388|Blood Pressure|blood pressure
767901|NCT00375388|Endothelial function|endothelial function
767902|NCT00375388|Low grade inflammation|low grade inflammation
767903|NCT00375388|Fibrinolysis|fibrinolysis
767904|NCT00375388|Microvascular complications|microvascular complications
767905|NCT00375388|Macrovascular complications|macrovascular complications
767906|NCT00375375|Minimal hepatic encephalopathy|minimal hepatic encephalopathy
767907|NCT00375375|Hepatic encephalopathy|hepatic encephalopathy
767908|NCT00375375|Subclinical hepatic encephalopathy|subclinical hepatic encephalopathy
767909|NCT00375375|Health related quality of life|health related quality of life
767910|NCT00375362|nitroglycerin|nitroglycerin
767911|NCT00375362|morphine|morphine
767912|NCT00375362|patient controlled analgesia|patient controlled analgesia
767913|NCT00375362|total knee arthroplasty|total knee arthroplasty
767914|NCT00375349|fatty liver|fatty liver
767915|NCT00375349|statin|statin
767916|NCT00375349|non-alcoholic|non-alcoholic
767917|NCT00375336|Aortic valve|aortic valve
767918|NCT00375336|Calcification|calcification
767919|NCT00375336|Endothelial dysfunction|endothelial dysfunction
767920|NCT00375336|Calcium metabolism|calcium metabolism
767921|NCT00375336|Coronary artery disease|coronary artery disease
767922|NCT00375323|factor VIII inhibitor|factor viii inhibitor
767923|NCT00375310|Phase I|phase i
767924|NCT00375310|Pancreas Cancer|pancreas cancer
767925|NCT00375310|Chemo-radiotherapy|chemo-radiotherapy
767926|NCT00375297|antidepressants|antidepressants
767927|NCT00375297|sexual dysfunction|sexual dysfunction
767928|NCT00375297|women|women
767929|NCT00375297|sildenafil|sildenafil
767930|NCT00375297|PDE5 inhibitors|pde5 inhibitors
767931|NCT00375297|serotonin reuptake inhibitor antidepressants|serotonin reuptake inhibitor antidepressants
767932|NCT00375271|Monitoring, Intraoperative|monitoring, intraoperative
767933|NCT00375271|Hemodynamic Processes|hemodynamic processes
767934|NCT00375271|Treatment Protocols|treatment protocols
767935|NCT00375258|Adult trauma patients with ongoing significant haemorrhage or at risk of significant haemorrhage|adult trauma patients with ongoing significant haemorrhage or at risk of significant haemorrhage
767936|NCT00375245|phase I|phase i
767937|NCT00375245|metastatic|metastatic
767938|NCT00375245|advanced cancer|advanced cancer
767939|NCT00375245|lung cancer|lung cancer
767940|NCT00375245|renal cancer|renal cancer
767941|NCT00375245|kidney cancer|kidney cancer
767942|NCT00375245|head and neck cancer|head and neck cancer
767943|NCT00375245|bladder cancer|bladder cancer
767944|NCT00375245|breast cancer|breast cancer
767945|NCT00375245|colorectal cancer|colorectal cancer
767946|NCT00375245|esophagus|esophagus
767947|NCT00375245|GIST|gist
767948|NCT00375245|liver cancer|liver cancer
767949|NCT00375245|melanoma|melanoma
767950|NCT00375245|mesothelioma|mesothelioma
767951|NCT00375245|lymphoma|lymphoma
767952|NCT00375245|ovary cancer|ovary cancer
767953|NCT00375245|ovarian cancer|ovarian cancer
767954|NCT00375245|pancreas cancer|pancreas cancer
767955|NCT00375245|pancreatic cancer|pancreatic cancer
767956|NCT00375245|prostate cancer|prostate cancer
767957|NCT00375245|stomach cancer|stomach cancer
767958|NCT00375245|thyroid cancer|thyroid cancer
767959|NCT00375245|Metastatic solid tumor|metastatic solid tumor
767960|NCT00375232|Exercise-Induced Bronchospasm|exercise-induced bronchospasm
767961|NCT00375232|Asthma|asthma
767962|NCT00375232|Cardiopulmonary Stress Test|cardiopulmonary stress test
767963|NCT00375232|Eucapnic Voluntary Hyperventilation|eucapnic voluntary hyperventilation
767964|NCT00375232|Induced sputum|induced sputum
767965|NCT00375219|Chronic Myeloid Leukemia|chronic myeloid leukemia
767966|NCT00375219|CML|cml
767967|NCT00375219|HHT|hht
767968|NCT00375219|Homoharringtonine|homoharringtonine
767969|NCT00375219|Omacetaxine|omacetaxine
767970|NCT00375219|T315i|t315i
767971|NCT00375219|ChemGenex|chemgenex
767972|NCT00375219|ChemGenex Pharmaceuticals|chemgenex pharmaceuticals
767973|NCT00375206|PowderMed, DNA vaccine, influenza|powdermed, dna vaccine, influenza
767974|NCT00375193|small cell lung cancer|small cell lung cancer
767975|NCT00375193|amrubicin|amrubicin
767976|NCT00375180|food|food
767977|NCT00375180|diet|diet
767978|NCT00375180|mucositis|mucositis
767979|NCT00375180|xerostomia|xerostomia
767980|NCT00375180|dysphagia|dysphagia
767981|NCT00375180|taste|taste
767982|NCT00375180|smell|smell
767983|NCT00375180|head and neck|head and neck
767984|NCT00375180|radiation|radiation
767985|NCT00375180|chemotherapy|chemotherapy
767986|NCT00375167|Recovery, Hope, Empowerment, Randomized Control Trial|recovery, hope, empowerment, randomized control trial
767987|NCT00375154|Acute respiratory failure|acute respiratory failure
767988|NCT00375154|Prehospital care|prehospital care
767989|NCT00375154|Noninvasive ventilation|noninvasive ventilation
767990|NCT00375154|Emergency|emergency
767991|NCT00375128|Malaria|malaria
767992|NCT00375128|Vaccine|vaccine
767993|NCT00375128|Prime-boost|prime-boost
767994|NCT00375128|Challenge|challenge
767995|NCT00375102|acupuncture|acupuncture
767996|NCT00375102|relaxation response|relaxation response
767997|NCT00375102|homeless|homeless
767998|NCT00375102|veterans|veterans
767999|NCT00375102|randomized trials|randomized trials
768000|NCT00375089|Early-onset Morbid Obesity|early-onset morbid obesity
768001|NCT00375063|left main stenosis|left main stenosis
768002|NCT00375063|Percutaneous Coronary Intervention|percutaneous coronary intervention
768003|NCT00375063|Coronary Artery Bypass Grafting|coronary artery bypass grafting
768004|NCT00375037|hand washing|hand washing
768005|NCT00375037|cluster randomized trial|cluster randomized trial
768006|NCT00375037|performance feedback|performance feedback
768007|NCT00375037|healthcare workers|healthcare workers
768008|NCT00375037|Hand hygiene|hand hygiene
768009|NCT00375037|hand washing adherence|hand washing adherence
768010|NCT00375024|Patient navigation|patient navigation
768011|NCT00375024|Breast cancer|breast cancer
768012|NCT00375024|Colon cancer|colon cancer
768013|NCT00375024|Questionnaire|questionnaire
768014|NCT00375011|MELD-Model of End Stage Liver Disease score|meld-model of end stage liver disease score
768015|NCT00375011|CTP-Child-Turcotte-Pugh score|ctp-child-turcotte-pugh score
768016|NCT00375011|MEGX-monoethylglycinexylidide-resultant of metabolism of lidocaine|megx-monoethylglycinexylidide-resultant of metabolism of lidocaine
768017|NCT00375011|HCC-Hepatocellular carcinoma|hcc-hepatocellular carcinoma
768018|NCT00375011|HCV-Hepatitis C virus|hcv-hepatitis c virus
768019|NCT00375011|NASH-Non-alcoholic Steatohepatitis|nash-non-alcoholic steatohepatitis
768020|NCT00374998|Malaria|malaria
768021|NCT00374998|Vaccine|vaccine
768022|NCT00374998|Prime-boost|prime-boost
768023|NCT00374985|chemoradiation|chemoradiation
768024|NCT00374985|docetaxel|docetaxel
768025|NCT00374985|oxaliplatin|oxaliplatin
768026|NCT00374985|gastric|gastric
768027|NCT00374985|neoadjuvant|neoadjuvant
768028|NCT00374985|radiochemotherapy|radiochemotherapy
768029|NCT00374959|Prevention of pneumonia|prevention of pneumonia
768030|NCT00374959|ceftriaxone|ceftriaxone
768031|NCT00374959|continuous aspiration|continuous aspiration
768032|NCT00374959|subglottic secretions|subglottic secretions
768033|NCT00374959|Mechanical ventilation with Endotracheal intubation.|mechanical ventilation with endotracheal intubation.
768034|NCT00374959|Absence of infection|absence of infection
768035|NCT00374933|AML|aml
768036|NCT00374933|ALL|all
768037|NCT00374933|MDS|mds
768038|NCT00374933|Allogeneic transplant|allogeneic transplant
768039|NCT00374933|Acute Myelogenous Leukemia|acute myelogenous leukemia
768040|NCT00374933|Acute Lymphoblastic Leukemia|acute lymphoblastic leukemia
768041|NCT00374933|Myelodysplastic Syndrome|myelodysplastic syndrome
768042|NCT00374933|Adoptive cell therapy|adoptive cell therapy
768043|NCT00374933|Non-myeloablative|non-myeloablative
768044|NCT00374920|bipolar|bipolar
768045|NCT00374920|mania|mania
768046|NCT00374920|mixed|mixed
768047|NCT00374894|2,3-dimercaptosuccinic acid|2,3-dimercaptosuccinic acid
768048|NCT00374894|Blood Lead Levels|blood lead levels
768049|NCT00374894|children|children
768050|NCT00374894|multi-nutrients|multi-nutrients
768051|NCT00374842|Influenza vaccine|influenza vaccine
768052|NCT00374842|Prophylaxis Influenza vaccine|prophylaxis influenza vaccine
768053|NCT00374829|randomised prospective trial|randomised prospective trial
768054|NCT00374829|medication refill compliance|medication refill compliance
768055|NCT00374829|hypertension|hypertension
768056|NCT00374829|ambulatory blood pressure monitoring|ambulatory blood pressure monitoring
768057|NCT00374829|information technology based patient support system|information technology based patient support system
768058|NCT00374829|process of care, quality of life, pharmacoeconomics|process of care, quality of life, pharmacoeconomics
768059|NCT00374829|multidisciplinary patient management|multidisciplinary patient management
768060|NCT00374803|Kidney|kidney
768061|NCT00374803|Transplant|transplant
768062|NCT00374803|Corticosteroid|corticosteroid
768063|NCT00374803|Myfortic|myfortic
768064|NCT00374790|Lead toxicity|lead toxicity
768065|NCT00374777|Insomnia|insomnia
768066|NCT00374777|schizophrenia|schizophrenia
768067|NCT00374777|manic-depressive psychosis|manic-depressive psychosis
768068|NCT00374777|zolpidem|zolpidem
768069|NCT00374764|Autism, Applied Behavioral Analysis, Risperidone|autism, applied behavioral analysis, risperidone
768070|NCT00374751|Samarium|samarium
768071|NCT00374751|Kyphoplasty|kyphoplasty
768072|NCT00374751|Pain management|pain management
768073|NCT00374751|Bone metastases|bone metastases
768074|NCT00374751|Histologically proven malignancy in the primary site|histologically proven malignancy in the primary site
768075|NCT00374751|Radiographic evidence of bone metastasis|radiographic evidence of bone metastasis
768076|NCT00374751|Significant pain equal or more than score 5|significant pain equal or more than score 5
768077|NCT00374751|Karnofsky Performance status >40|karnofsky performance status >40
768078|NCT00374751|The patient must sign a study specific informed consent|the patient must sign a study specific informed consent
768079|NCT00374738|Guided Imagery for Trauma (GIFT)|guided imagery for trauma (gift)
768080|NCT00374738|Posttraumatic Stress Disorder (PTSD)|posttraumatic stress disorder (ptsd)
768081|NCT00374738|Military Sexual Trauma (MST)|military sexual trauma (mst)
768082|NCT00374738|Military Sexual Trauma - related PTSD|military sexual trauma - related ptsd
768083|NCT00374725|Ulcerative Colitis|ulcerative colitis
768084|NCT00374725|Probiotic|probiotic
768085|NCT00374725|Placebo controlled trial|placebo controlled trial
768086|NCT00374725|Lactobacillus rhamnosus|lactobacillus rhamnosus
768087|NCT00374725|Lactobacillus acidophilus|lactobacillus acidophilus
768088|NCT00374712|Phosphate|phosphate
768089|NCT00374712|Dialysis|dialysis
768090|NCT00374712|Klotho|klotho
768091|NCT00374712|Hemodialysis|hemodialysis
768092|NCT00374699|Velcade|velcade
768093|NCT00374699|Bortezomib|bortezomib
768094|NCT00374699|CHOP|chop
768095|NCT00374699|Peripheral T-cell lymphomas(PTCLs)|peripheral t-cell lymphomas(ptcls)
768096|NCT00374699|natural killer (NK)-cell lymphomas|natural killer (nk)-cell lymphomas
768097|NCT00374686|cytomegalovirus|cytomegalovirus
768098|NCT00374686|kidney|kidney
768099|NCT00374686|transplantation|transplantation
768100|NCT00374686|valganciclovir|valganciclovir
768101|NCT00374686|preemptive|preemptive
768103|NCT00374673|chronic pain|chronic pain
768104|NCT00374673|fibromyalgia|fibromyalgia
768105|NCT00374673|IBS|ibs
768106|NCT00374673|burning mouth syndrome|burning mouth syndrome
768107|NCT00374673|predictive factors|predictive factors
768108|NCT00374660|Irofulven|irofulven
768109|NCT00374660|Oxaliplatin|oxaliplatin
768110|NCT00374647|Renal|renal
768111|NCT00374647|Kidney|kidney
768112|NCT00374647|Transplant|transplant
768113|NCT00374608|pediatric|pediatric
768114|NCT00374608|congenital complete heart block|congenital complete heart block
768115|NCT00374608|dual chamber pacemaker|dual chamber pacemaker
768116|NCT00374595|Kidney Transplant|kidney transplant
768117|NCT00374595|Vascular Risk|vascular risk
768118|NCT00374595|inflammation|inflammation
768119|NCT00374595|Diabetes|diabetes
768120|NCT00374595|Insulin resistance|insulin resistance
768121|NCT00374595|Chronic kidney disease|chronic kidney disease
768228|NCT00374205|Coartem|coartem
768122|NCT00374582|Bioelectric impedance analysis|bioelectric impedance analysis
768123|NCT00374582|BIA|bia
768124|NCT00374582|ESLD|esld
768125|NCT00374582|LVP|lvp
768126|NCT00374582|Large volume paracentesis|large volume paracentesis
768127|NCT00374582|Ascites|ascites
768128|NCT00374582|Liver|liver
768129|NCT00374582|Hepatic|hepatic
768130|NCT00374569|Gymnastics, Computerized Dynamic Posturography, Balance|gymnastics, computerized dynamic posturography, balance
768131|NCT00374556|eszopiclone|eszopiclone
768132|NCT00374556|insomnia|insomnia
768133|NCT00374543|Bipolar Disorder|bipolar disorder
768134|NCT00374543|Generalized Anxiety Disorder|generalized anxiety disorder
768135|NCT00374543|Double-blind|double-blind
768136|NCT00374543|Placebo-controlled|placebo-controlled
768137|NCT00374543|Ziprasidone|ziprasidone
768138|NCT00374517|Mycobacterium Tuberculosis|mycobacterium tuberculosis
768139|NCT00374517|Pimonidazole Hydrochloride|pimonidazole hydrochloride
768140|NCT00374517|Recurrent Tuberculosis|recurrent tuberculosis
768141|NCT00374517|Hypoxyprobe|hypoxyprobe
768142|NCT00374517|mRNA Expression|mrna expression
768143|NCT00374517|Pulmonary Tuberculosis|pulmonary tuberculosis
768144|NCT00374491|ACL|acl
768145|NCT00374491|Bone Screw|bone screw
768146|NCT00374491|Knee|knee
768147|NCT00374478|Scopolamine|scopolamine
768148|NCT00374478|Antiemetic|antiemetic
768149|NCT00374478|Task performance and analysis|task performance and analysis
768150|NCT00374478|Psychomotor vigilance test|psychomotor vigilance test
768151|NCT00374465|Dilated Cardiomyopathy|dilated cardiomyopathy
768152|NCT00374465|Heart Failure|heart failure
768153|NCT00374452|hypertension|hypertension
768154|NCT00374452|practice guidelines|practice guidelines
768155|NCT00374452|quality of health care|quality of health care
768156|NCT00374452|decision support systems|decision support systems
768157|NCT00374452|evidence-based medicine|evidence-based medicine
768158|NCT00374452|medical informatics|medical informatics
768159|NCT00374439|depression|depression
768160|NCT00374439|adolescents|adolescents
768161|NCT00374439|prevention|prevention
768162|NCT00374439|schools|schools
768163|NCT00374426|depression|depression
768164|NCT00374426|diabetes mellitus|diabetes mellitus
768165|NCT00374426|depression recurrence|depression recurrence
768166|NCT00374413|DDD|ddd
768167|NCT00374413|artificial disc|artificial disc
768168|NCT00374400|Kidney|kidney
768169|NCT00374400|Transplant|transplant
768170|NCT00374400|Paired donation|paired donation
768171|NCT00374400|Living donor|living donor
768172|NCT00374387|Healthy women|healthy women
768173|NCT00374374|probiotic|probiotic
768174|NCT00374361|insulin sensitivity|insulin sensitivity
768175|NCT00374361|endothelial function|endothelial function
768176|NCT00374361|adolescence|adolescence
768177|NCT00374361|lipids|lipids
768178|NCT00374361|puberty|puberty
768179|NCT00374348|Schizophrenia with OCD|schizophrenia with ocd
768180|NCT00374348|Schizophrenia with-comorbid symptoms of Obsessive Compulsive Disorder(OCD)|schizophrenia with-comorbid symptoms of obsessive compulsive disorder(ocd)
768181|NCT00374335|prospective cohort study|prospective cohort study
768182|NCT00374322|Breast Cancer|breast cancer
768183|NCT00374322|ErbB2-overexpressing|erbb2-overexpressing
768184|NCT00374322|early-stage breast cancer|early-stage breast cancer
768185|NCT00374322|adjuvant|adjuvant
768186|NCT00374309|Hemorrhagic Fever|hemorrhagic fever
768187|NCT00374309|Healthy|healthy
768188|NCT00374309|Immunity|immunity
768189|NCT00374309|T -Cells|t -cells
768190|NCT00374309|Filovirus|filovirus
768191|NCT00374309|Healthy Volunteer|healthy volunteer
768192|NCT00374309|HV|hv
768193|NCT00374296|Leukemia|leukemia
768194|NCT00374296|MDS|mds
768195|NCT00374296|Phase II|phase ii
768196|NCT00374296|Acute Myelogenous Leukemia (AML)|acute myelogenous leukemia (aml)
768197|NCT00374296|High Risk Myelodysplastic Syndromes (MDS)|high risk myelodysplastic syndromes (mds)
768198|NCT00374283|Monitoring|monitoring
768199|NCT00374283|Polyomavirus|polyomavirus
768200|NCT00374283|Kidney|kidney
768201|NCT00374283|Pancreas|pancreas
768202|NCT00374283|Transplant|transplant
768203|NCT00374270|Diabetes (type I and type II)|diabetes (type i and type ii)
768204|NCT00374257|NB-UVB|nb-uvb
768205|NCT00374257|cGVHD|cgvhd
768206|NCT00374244|schizophrenia|schizophrenia
768207|NCT00374244|pimozide|pimozide
768208|NCT00374244|clozapine|clozapine
768209|NCT00374231|Liver|liver
768210|NCT00374231|Transplant|transplant
768211|NCT00374231|Corticosteroid withdrawal|corticosteroid withdrawal
768212|NCT00374231|Tacrolimus|tacrolimus
768213|NCT00374231|CellCept|cellcept
768214|NCT00374231|MMF|mmf
768215|NCT00374231|Mycophenolate mofetil|mycophenolate mofetil
768216|NCT00374218|Carbohydrate|carbohydrate
768217|NCT00374218|Glycemic index|glycemic index
768218|NCT00374218|Randomized|randomized
768219|NCT00374218|Double-blind|double-blind
768220|NCT00374218|Glucose|glucose
768221|NCT00374218|Insulin|insulin
768222|NCT00374218|C-reactive protein|c-reactive protein
768223|NCT00374205|Ghana|ghana
768224|NCT00374205|Effectiveness|effectiveness
768225|NCT00374205|Safety|safety
768226|NCT00374205|Drug-Resistance|drug-resistance
768236|NCT00374192|Quality of Life|quality of life
768237|NCT00374166|Anti-anxiety agents|anti-anxiety agents
768238|NCT00374166|antidepressive agents|antidepressive agents
768239|NCT00374166|controlled clinical trial|controlled clinical trial
768240|NCT00374153|Alcohol|alcohol
768241|NCT00374153|Drinking|drinking
768242|NCT00374153|College|college
768243|NCT00374153|Motivational|motivational
768244|NCT00374153|Feedback|feedback
768245|NCT00374153|Assessment|assessment
768246|NCT00374140|small cell|small cell
768247|NCT00374140|lung|lung
768248|NCT00374127|Marijuana|marijuana
768249|NCT00374127|Comparison between joints and blunts|comparison between joints and blunts
768250|NCT00374127|Pharmacokinetic effects|pharmacokinetic effects
768251|NCT00374114|cervical|cervical
768252|NCT00374114|dysplasia|dysplasia
768253|NCT00374101|PPIs,|ppis,
768254|NCT00374101|endoscopic therapy,|endoscopic therapy,
768255|NCT00374101|peptic ulcers,|peptic ulcers,
768256|NCT00374101|upper gastrointestinal bleeding,|upper gastrointestinal bleeding,
768257|NCT00374101|non-variceal upper gastrointestinal bleeding|non-variceal upper gastrointestinal bleeding
768258|NCT00374088|N-acetylcysteine|n-acetylcysteine
768259|NCT00374088|Myocardial dysfunction|myocardial dysfunction
768260|NCT00374088|Transposition of the Great Arteries|transposition of the great arteries
768261|NCT00374075|Spinal Muscular Atrophy (SMA)|spinal muscular atrophy (sma)
768262|NCT00374075|Valproic Acid|valproic acid
768263|NCT00374062|Mohs Surgery|mohs surgery
768264|NCT00374049|Prostate|prostate
768265|NCT00374049|vaccine|vaccine
768266|NCT00374049|immunosuppression|immunosuppression
768267|NCT00374049|dendritic cells|dendritic cells
768268|NCT00374036|chemotherapy|chemotherapy
768269|NCT00374036|stomach cancer metastatic|stomach cancer metastatic
768270|NCT00374036|Capecitabine|capecitabine
768271|NCT00374036|Irinotecan|irinotecan
768272|NCT00374023|Zinc|zinc
768273|NCT00374023|vitamin A|vitamin a
768274|NCT00374023|immunity|immunity
768275|NCT00374023|morbidity|morbidity
768276|NCT00374023|height gain|height gain
768277|NCT00374023|weight gain|weight gain
768278|NCT00374023|Children aged between 1 and 3 years|children aged between 1 and 3 years
768279|NCT00374023|Weight for age between 70% and 61% of NCHS standard|weight for age between 70% and 61% of nchs standard
768280|NCT00374023|Acute diarrhoeal Patients|acute diarrhoeal patients
768281|NCT00374023|No signs of vitamin A deficiency|no signs of vitamin a deficiency
768282|NCT00374023|Who has not received measles vaccine|who has not received measles vaccine
768283|NCT00374010|end-of-life decision making|end-of-life decision making
768284|NCT00374010|advance care planning|advance care planning
768285|NCT00373984|shoulder|shoulder
768286|NCT00373984|thoracotomy|thoracotomy
768287|NCT00373971|Activities of daily living|activities of daily living
768288|NCT00373971|Elderly|elderly
768289|NCT00373971|Nutrition|nutrition
768290|NCT00373971|Postoperative|postoperative
768291|NCT00373971|Hip fractures|hip fractures
768292|NCT00373971|Hip replacement|hip replacement
768293|NCT00373971|Knee replacement|knee replacement
768294|NCT00373945|HLA-B*5701|hla-b*5701
768295|NCT00373945|pharmacogenetic marker|pharmacogenetic marker
768296|NCT00373945|hypersensitivity to abacavir,|hypersensitivity to abacavir,
768297|NCT00373945|retrospective analysis|retrospective analysis
768298|NCT00373932|Exercise|exercise
768299|NCT00373932|Physical Activity|physical activity
768300|NCT00373932|Adherence|adherence
768301|NCT00373906|MALT Lymphoma, Bortezomib|malt lymphoma, bortezomib
768302|NCT00373893|Pain|pain
768303|NCT00373893|Hyperalgesia|hyperalgesia
768304|NCT00373893|capsaicin|capsaicin
768305|NCT00373880|Aripiprazole|aripiprazole
768306|NCT00373880|Cocaine abuse|cocaine abuse
768307|NCT00373867|Secondary prevention|secondary prevention
768308|NCT00373867|Physical therapy|physical therapy
768309|NCT00373867|Fear-avoidance beliefs|fear-avoidance beliefs
768310|NCT00373867|Disability|disability
768311|NCT00373854|Hypoglycemia|hypoglycemia
768312|NCT00373854|Endothelial function|endothelial function
768313|NCT00373841|Lung|lung
768314|NCT00373841|Fibrosis|fibrosis
768315|NCT00373841|Idiopathic|idiopathic
768316|NCT00373841|Biomarkers|biomarkers
768317|NCT00373841|Genomics|genomics
768318|NCT00373841|Longitudinal|longitudinal
768319|NCT00373828|Chest Pain|chest pain
768320|NCT00373828|Chest Wall|chest wall
768321|NCT00373828|Angina Pectoris|angina pectoris
768322|NCT00373828|Atypical Chest Pain|atypical chest pain
768323|NCT00373828|Physical Examination|physical examination
768324|NCT00373828|Myocardial Perfusion Imaging|myocardial perfusion imaging
768325|NCT00373828|Observational Study|observational study
768326|NCT00373828|Non-Cardiac Chest Pain|non-cardiac chest pain
768327|NCT00373828|Ischemic Heart Disease|ischemic heart disease
768328|NCT00373815|acute GVHD|acute gvhd
768329|NCT00373815|Immunosuppression|immunosuppression
768330|NCT00373789|Botulinum Toxin A|botulinum toxin a
768331|NCT00373789|Urinary Incontinence|urinary incontinence
768332|NCT00373789|Detrusor Overactivity|detrusor overactivity
768333|NCT00373776|mucosal|mucosal
768334|NCT00373776|leishmaniasis|leishmaniasis
768335|NCT00373776|miltefosine|miltefosine
768336|NCT00373763|Congenital diaphragmatic hernia|congenital diaphragmatic hernia
768337|NCT00373763|tracheal occlusion|tracheal occlusion
768338|NCT00373763|fetus|fetus
768339|NCT00373763|fetal surgery|fetal surgery
768340|NCT00373763|fetoscopy|fetoscopy
768341|NCT00373750|Native American health|native american health
768342|NCT00373750|Teen pregnancy|teen pregnancy
768343|NCT00373750|Family strengthening|family strengthening
768344|NCT00373750|Substance abuse prevention|substance abuse prevention
768345|NCT00373750|Injury prevention|injury prevention
768346|NCT00373724|sacroiliac joint|sacroiliac joint
768347|NCT00373724|low back pain|low back pain
768348|NCT00373724|radiofrequency|radiofrequency
768349|NCT00373698|Stress Disorders, Posttraumatic|stress disorders, posttraumatic
768350|NCT00373698|Delivery of Health Care, Integrated|delivery of health care, integrated
768351|NCT00373698|Primary Health Care|primary health care
768352|NCT00373698|Veterans|veterans
768353|NCT00373698|Depression|depression
768354|NCT00373685|GI events in patients with moderate GI risk treated with NSAIDS|gi events in patients with moderate gi risk treated with nsaids
768355|NCT00373672|schizophrenia|schizophrenia
768356|NCT00373672|cognition|cognition
768357|NCT00373659|Neovascularization|neovascularization
768358|NCT00373659|Age-related macular degeneration|age-related macular degeneration
768359|NCT00373659|Ranibizumab (Lucentis)|ranibizumab (lucentis)
768560|NCT00372970|bloating|bloating
768360|NCT00373659|Optical coherence tomography|optical coherence tomography
768361|NCT00373659|Intravitreal injection|intravitreal injection
768362|NCT00373646|MALT Lymphoma|malt lymphoma
768363|NCT00373646|thalidomide|thalidomide
768364|NCT00373646|disseminated MALT Lymphoma or at relapse following HP-eradication|disseminated malt lymphoma or at relapse following hp-eradication
768365|NCT00373646|or chemotherapy or radiation|or chemotherapy or radiation
768366|NCT00373633|THoracic Surgery|thoracic surgery
768367|NCT00373633|thoracic epidural|thoracic epidural
768368|NCT00373633|epidural|epidural
768369|NCT00373633|thoracotomy|thoracotomy
768370|NCT00373633|intercostal nerve block|intercostal nerve block
768371|NCT00373633|intercostal|intercostal
768372|NCT00373633|nerve block|nerve block
768373|NCT00373620|endometrial cancer|endometrial cancer
768374|NCT00373620|high risk|high risk
768375|NCT00373620|weekly paclitaxel|weekly paclitaxel
768376|NCT00373620|Cuncurrent chemoradiation|cuncurrent chemoradiation
768377|NCT00373607|Non complicated malaria|non complicated malaria
768378|NCT00373607|Microscopy|microscopy
768380|NCT00373607|Children|children
768381|NCT00373594|Cold agglutinin disease|cold agglutinin disease
768382|NCT00373594|Hemolytic|hemolytic
768383|NCT00373594|Anemia|anemia
768384|NCT00373594|Lymphoproliferative disease|lymphoproliferative disease
768385|NCT00373594|Monoclonal antibodies|monoclonal antibodies
768386|NCT00373594|Rituximab|rituximab
768387|NCT00373594|Fludarabine|fludarabine
768388|NCT00373581|Vigabatrin|vigabatrin
768389|NCT00373581|GABA levels|gaba levels
768390|NCT00373581|Smoked cocaine|smoked cocaine
768391|NCT00373568|mucosal|mucosal
768392|NCT00373568|miltefosine|miltefosine
768393|NCT00373555|Sarcoidosis|sarcoidosis
768394|NCT00373555|mediastinal adenopathy|mediastinal adenopathy
768395|NCT00373555|bronchoscopy|bronchoscopy
768396|NCT00373555|Transbronchial needle aspiration|transbronchial needle aspiration
768397|NCT00373555|endobronchial ultrasonography|endobronchial ultrasonography
768398|NCT00373542|Restless Legs Syndrome|restless legs syndrome
768399|NCT00373542|ropinirole|ropinirole
768400|NCT00373542|polysomnography|polysomnography
768401|NCT00373542|RLS|rls
768402|NCT00373542|PSG|psg
768403|NCT00373529|Acute myelogenous leukemia|acute myelogenous leukemia
768404|NCT00373529|Acute myeloid leukemia|acute myeloid leukemia
768405|NCT00373529|newly Diagnosed AML|newly diagnosed aml
768406|NCT00373529|Clofarabine|clofarabine
768407|NCT00373529|CLASSIC II|classic ii
768408|NCT00373529|CLO243|clo243
768409|NCT00373516|psoriasis|psoriasis
768410|NCT00373516|topical therapy|topical therapy
768411|NCT00373503|Lofexidine|lofexidine
768412|NCT00373503|Oral THC|oral thc
768413|NCT00373503|Cannabinoids|cannabinoids
768414|NCT00373477|Depression|depression
768415|NCT00373477|Primary Care|primary care
768416|NCT00373477|Care Manager|care manager
768417|NCT00373464|Postoperative pain|postoperative pain
768418|NCT00373464|Opioid|opioid
768419|NCT00373464|Etoricoxib|etoricoxib
768420|NCT00373464|Ketorolac|ketorolac
768421|NCT00373464|Laparoscopic Surgery|laparoscopic surgery
768422|NCT00373464|Surgical Procedures, Gynecologic|surgical procedures, gynecologic
768423|NCT00373451|NSTEMI|nstemi
768424|NCT00373438|Congenital diaphragmatic hernia|congenital diaphragmatic hernia
768425|NCT00373438|tracheal occlusion|tracheal occlusion
768426|NCT00373438|fetus|fetus
768427|NCT00373438|fetal surgery|fetal surgery
768428|NCT00373438|fetoscopy|fetoscopy
768429|NCT00373438|ECMO|ecmo
768430|NCT00373425|Adjuvant Non-small Cell Lung Cancer|adjuvant non-small cell lung cancer
768431|NCT00373425|Tarceva|tarceva
768432|NCT00373425|Early-stage Lung Cancer|early-stage lung cancer
768433|NCT00373425|Adjuvant|adjuvant
768434|NCT00373425|RADIANT|radiant
768435|NCT00373425|NSCLC|nsclc
768436|NCT00373425|EGFR-positive tumor|egfr-positive tumor
768437|NCT00373425|Stage IB Non-small Cell Lung Cancer|stage ib non-small cell lung cancer
768438|NCT00373425|Stage II Non-small Cell Lung Cancer|stage ii non-small cell lung cancer
768439|NCT00373425|Stage IIIA Non-small Cell Lung Cancer|stage iiia non-small cell lung cancer
768440|NCT00373412|cytomegalovirus|cytomegalovirus
768441|NCT00373412|vaccine|vaccine
768442|NCT00373412|T cell|t cell
768443|NCT00373412|antibodies|antibodies
768444|NCT00373399|Cannabinoids|cannabinoids
768445|NCT00373399|Risk taking|risk taking
768446|NCT00373399|Decision making|decision making
768447|NCT00373386|growth hormone|growth hormone
768448|NCT00373386|endothelial function|endothelial function
768449|NCT00373373|Sorafenib|sorafenib
768450|NCT00373373|Acute Myeloid Leukemia|acute myeloid leukemia
768451|NCT00373373|Flt3|flt3
768452|NCT00373373|AML|aml
768453|NCT00373373|Kinase Inhibitor|kinase inhibitor
768454|NCT00373360|pulmonary hypertension|pulmonary hypertension
768455|NCT00373360|PAH|pah
768456|NCT00373360|Remodulin|remodulin
768457|NCT00373360|treprostinil|treprostinil
768458|NCT00373360|Quality of Life|quality of life
768459|NCT00373360|Rapid Switch|rapid switch
768460|NCT00373334|gastroesophageal reflux disease|gastroesophageal reflux disease
768461|NCT00373334|GERD|gerd
768462|NCT00373334|heartburn|heartburn
768463|NCT00373308|Quality of Life|quality of life
768464|NCT00373295|Baclofen|baclofen
768465|NCT00373295|Marijuana Dependence|marijuana dependence
768466|NCT00373295|Marijuana Withdrawal|marijuana withdrawal
768467|NCT00373282|PVR|pvr
768468|NCT00373282|Retinal detachment|retinal detachment
768469|NCT00373282|Silicone oil|silicone oil
768470|NCT00373282|Triamcinolone|triamcinolone
768471|NCT00373269|Acute ischemic stroke|acute ischemic stroke
768472|NCT00373269|Stroke|stroke
768473|NCT00373269|Hyperglycemia|hyperglycemia
768474|NCT00373269|Procoagulation|procoagulation
768475|NCT00373269|Diabetes|diabetes
768476|NCT00373269|Blood coagulation|blood coagulation
768477|NCT00373256|Breast cancer|breast cancer
768478|NCT00373256|advanced|advanced
768479|NCT00373256|sunitinib|sunitinib
768480|NCT00373256|bevacizumab|bevacizumab
768481|NCT00373256|paclitaxel|paclitaxel
768482|NCT00373256|Phase 3|phase 3
768483|NCT00373243|hepatic impairment pharmacokinetics|hepatic impairment pharmacokinetics
768484|NCT00373230|weight loss|weight loss
768485|NCT00373230|telemedicine|telemedicine
768486|NCT00373230|african-american|african-american
768487|NCT00373230|rural|rural
768488|NCT00373217|fallopian tube cancer|fallopian tube cancer
768489|NCT00373217|stage III ovarian epithelial cancer|stage iii ovarian epithelial cancer
768490|NCT00373217|stage IV ovarian epithelial cancer|stage iv ovarian epithelial cancer
768491|NCT00373217|primary peritoneal cavity cancer|primary peritoneal cavity cancer
768492|NCT00373204|Advanced non-small cell lung cancer|advanced non-small cell lung cancer
768493|NCT00373204|Non-small cell lung cancer|non-small cell lung cancer
768494|NCT00373204|Lung cancer|lung cancer
768495|NCT00373204|Metastatic lung cancer|metastatic lung cancer
768496|NCT00373204|Second line treatment for advanced lung cancer|second line treatment for advanced lung cancer
768497|NCT00373204|Cancer|cancer
768498|NCT00373204|Advanced lung cancer|advanced lung cancer
768499|NCT00373191|stage I breast cancer|stage i breast cancer
768500|NCT00373191|stage II breast cancer|stage ii breast cancer
768501|NCT00373191|stage IIIA breast cancer|stage iiia breast cancer
768502|NCT00373191|stage IIIB breast cancer|stage iiib breast cancer
768503|NCT00373191|stage IIIC breast cancer|stage iiic breast cancer
768504|NCT00373191|ductal breast carcinoma in situ|ductal breast carcinoma in situ
768505|NCT00373178|rosiglitazone|rosiglitazone
768506|NCT00373178|metformin|metformin
768507|NCT00373165|Renal Transplantation|renal transplantation
768508|NCT00373165|CMV|cmv
768509|NCT00373165|Ganciclovir|ganciclovir
768510|NCT00373165|Prophylaxis|prophylaxis
768511|NCT00373165|Preemptive Therapy|preemptive therapy
768512|NCT00373165|Graft Survival|graft survival
768513|NCT00373165|Proteomics|proteomics
768514|NCT00373152|stage I breast cancer|stage i breast cancer
768515|NCT00373152|stage II breast cancer|stage ii breast cancer
768516|NCT00373152|stage IIIA breast cancer|stage iiia breast cancer
768517|NCT00373152|stage IIIC breast cancer|stage iiic breast cancer
768518|NCT00373152|stage IV breast cancer|stage iv breast cancer
768519|NCT00373139|Pregnancy,|pregnancy,
768520|NCT00373139|Screening,|screening,
768521|NCT00373139|Whole Blood|whole blood
768522|NCT00373126|nicotine|nicotine
768523|NCT00373126|schizophrenia|schizophrenia
768524|NCT00373126|reward|reward
768525|NCT00373126|withdrawal|withdrawal
768526|NCT00373113|advanced breast cancer|advanced breast cancer
768527|NCT00373113|metastatic breast cancer|metastatic breast cancer
768528|NCT00373113|treatment resistant|treatment resistant
768529|NCT00373113|treatment failure|treatment failure
768530|NCT00373100|Zinc|zinc
768531|NCT00373100|placebo|placebo
768532|NCT00373100|severe pneumonia|severe pneumonia
768533|NCT00373100|children|children
768534|NCT00373087|Parkinson's disease|parkinson's disease
768535|NCT00373087|Catechol O-methyltransferase|catechol o-methyltransferase
768537|NCT00373087|pharmacogenetic|pharmacogenetic
768538|NCT00373074|Spinal Puncture Headache|spinal puncture headache
768539|NCT00373048|HIV-1 malaria Clinical Trial|hiv-1 malaria clinical trial
768540|NCT00373035|prostate cancer|prostate cancer
768541|NCT00373022|depression|depression
768542|NCT00373022|anxiety disorder|anxiety disorder
768543|NCT00373022|psychosocial effects of cancer and its treatment|psychosocial effects of cancer and its treatment
768544|NCT00373022|stage II colon cancer|stage ii colon cancer
768545|NCT00373022|stage III colon cancer|stage iii colon cancer
768546|NCT00373022|stage II rectal cancer|stage ii rectal cancer
768547|NCT00373022|stage III rectal cancer|stage iii rectal cancer
768548|NCT00373009|Low back pain|low back pain
768549|NCT00373009|Primary prevention|primary prevention
768550|NCT00373009|Secondary prevention|secondary prevention
768551|NCT00373009|Lumbar stabilization|lumbar stabilization
768552|NCT00373009|Psychosocial education|psychosocial education
768553|NCT00372983|chronic HCV|chronic hcv
768554|NCT00372983|Failed treatment|failed treatment
768555|NCT00372983|genotype 1|genotype 1
768556|NCT00372983|failed treatment with pegylated interferon plus ribavirin|failed treatment with pegylated interferon plus ribavirin
768557|NCT00372970|gastroparesis|gastroparesis
768558|NCT00372970|vomiting|vomiting
768559|NCT00372970|nausea|nausea
768561|NCT00372970|dyspepsia|dyspepsia
768562|NCT00372957|pharmacodynamics|pharmacodynamics
768563|NCT00372957|Diabetes|diabetes
768564|NCT00372957|pharmacokinetics|pharmacokinetics
768565|NCT00372944|advanced pancreatic cancer|advanced pancreatic cancer
768566|NCT00372944|metastatic pancreatic cancer|metastatic pancreatic cancer
768567|NCT00372944|AZD6244|azd6244
768568|NCT00372905|follicular lymphoma|follicular lymphoma
768569|NCT00372892|Idiopathic Thrombocytopenic Purpura|idiopathic thrombocytopenic purpura
768570|NCT00372892|Rituximab|rituximab
768571|NCT00372892|Feasibility study|feasibility study
768572|NCT00372879|amyotrophic lateral sclerosis|amyotrophic lateral sclerosis
768573|NCT00372879|vitamin E|vitamin e
768574|NCT00372879|muscle cramp|muscle cramp
768575|NCT00372840|psychosocial effects of cancer and its treatment|psychosocial effects of cancer and its treatment
768576|NCT00372840|stage I breast cancer|stage i breast cancer
768577|NCT00372840|stage II breast cancer|stage ii breast cancer
768578|NCT00372840|stage IIIA breast cancer|stage iiia breast cancer
768579|NCT00372840|stage IIIA colon cancer|stage iiia colon cancer
768580|NCT00372840|stage I prostate cancer|stage i prostate cancer
768581|NCT00372840|stage IIB prostate cancer|stage iib prostate cancer
768582|NCT00372840|stage IIA prostate cancer|stage iia prostate cancer
768583|NCT00372840|stage III prostate cancer|stage iii prostate cancer
768584|NCT00372840|stage I non-small cell lung cancer|stage i non-small cell lung cancer
768585|NCT00372840|stage II non-small cell lung cancer|stage ii non-small cell lung cancer
768586|NCT00372840|stage IIIA non-small cell lung cancer|stage iiia non-small cell lung cancer
768587|NCT00372840|limited stage small cell lung cancer|limited stage small cell lung cancer
768588|NCT00372840|stage I rectal cancer|stage i rectal cancer
768589|NCT00372840|stage IIA rectal cancer|stage iia rectal cancer
768590|NCT00372840|stage IIB rectal cancer|stage iib rectal cancer
768591|NCT00372840|stage IIC rectal cancer|stage iic rectal cancer
768592|NCT00372840|stage IIIA rectal cancer|stage iiia rectal cancer
768593|NCT00372840|pulmonary carcinoid tumor|pulmonary carcinoid tumor
768594|NCT00372840|stage I thymoma|stage i thymoma
768595|NCT00372840|stage II thymoma|stage ii thymoma
768596|NCT00372840|stage III thymoma|stage iii thymoma
768597|NCT00372840|stage I colon cancer|stage i colon cancer
768598|NCT00372840|stage IIA colon cancer|stage iia colon cancer
768599|NCT00372840|stage IIB colon cancer|stage iib colon cancer
768600|NCT00372840|stage IIC colon cancer|stage iic colon cancer
768601|NCT00372840|stage IA malignant mesothelioma|stage ia malignant mesothelioma
768602|NCT00372840|stage IB malignant mesothelioma|stage ib malignant mesothelioma
768603|NCT00372840|stage II malignant mesothelioma|stage ii malignant mesothelioma
768604|NCT00372840|stage III malignant mesothelioma|stage iii malignant mesothelioma
768605|NCT00372814|diabetes|diabetes
768606|NCT00372814|regimen adherence|regimen adherence
768607|NCT00372814|metabolic control|metabolic control
768608|NCT00372814|adolescents|adolescents
768609|NCT00372814|family therapy|family therapy
768610|NCT00372801|Osteoarthritis|osteoarthritis
768611|NCT00372801|Ibuprofen|ibuprofen
768612|NCT00372801|COX2|cox2
768613|NCT00372801|VAS|vas
768614|NCT00372801|knee|knee
768615|NCT00372801|single dose|single dose
768616|NCT00372788|NSCLC|nsclc
768617|NCT00372788|Advanced Non-Small Cell Lung Cancer|advanced non-small cell lung cancer
768618|NCT00372788|AZD6244|azd6244
768619|NCT00372775|brain metastases|brain metastases
768620|NCT00372775|Sunitinib|sunitinib
768621|NCT00372775|Phase 2|phase 2
768622|NCT00372762|Insulin resistance|insulin resistance
768623|NCT00372762|heart failure|heart failure
768624|NCT00372762|diuretic therapy|diuretic therapy
768625|NCT00372749|Alcohol dependence|alcohol dependence
768626|NCT00372749|Craving|craving
768627|NCT00372749|Disulfiram|disulfiram
768628|NCT00372749|Cue exposure|cue exposure
768629|NCT00372736|unspecified adult solid tumor, protocol specific|unspecified adult solid tumor, protocol specific
768630|NCT00372723|toxic epidermal necrlysis|toxic epidermal necrlysis
768631|NCT00372723|ten|ten
768632|NCT00372710|Breast cancer|breast cancer
768633|NCT00372710|Palliation|palliation
768634|NCT00372710|Bone metastasis|bone metastasis
768635|NCT00372710|Zoledronic acid|zoledronic acid
768636|NCT00372697|acromegaly|acromegaly
768637|NCT00372697|octreotide acetate|octreotide acetate
768638|NCT00372697|partial responder patients|partial responder patients
768639|NCT00372684|Plasmodium falciparum|plasmodium falciparum
768640|NCT00372684|Malaria|malaria
768641|NCT00372684|Imported malaria|imported malaria
768642|NCT00372684|Severe malaria|severe malaria
768643|NCT00372684|Uncomplicated malaria|uncomplicated malaria
768644|NCT00372684|Intensive Care Units|intensive care units
768645|NCT00372684|Polymorphism, Genetic|polymorphism, genetic
768646|NCT00372684|Parasitic Sensitivity Tests|parasitic sensitivity tests
768647|NCT00372684|Inflammation Mediators|inflammation mediators
768648|NCT00372671|Cardiac Rehabilitation|cardiac rehabilitation
768649|NCT00372671|Improving Cardiac Rehabilitation Participation|improving cardiac rehabilitation participation
768650|NCT00372658|hysterosalpingogram|hysterosalpingogram
768651|NCT00372658|intracervical local anesthesia|intracervical local anesthesia
768652|NCT00372658|pain perception|pain perception
768653|NCT00372658|visual analogue scale|visual analogue scale
768654|NCT00372645|Healthy|healthy
768655|NCT00372632|Pregnancy malaria prevention|pregnancy malaria prevention
768656|NCT00372619|recurrent childhood acute lymphoblastic leukemia|recurrent childhood acute lymphoblastic leukemia
768657|NCT00372619|recurrent childhood acute myeloid leukemia|recurrent childhood acute myeloid leukemia
768658|NCT00372619|acute undifferentiated leukemia|acute undifferentiated leukemia
768659|NCT00372619|adult acute minimally differentiated myeloid leukemia (M0)|adult acute minimally differentiated myeloid leukemia (m0)
768660|NCT00372619|childhood acute minimally differentiated myeloid leukemia (M0)|childhood acute minimally differentiated myeloid leukemia (m0)
768661|NCT00372619|adult acute myeloblastic leukemia without maturation (M1)|adult acute myeloblastic leukemia without maturation (m1)
768662|NCT00372619|childhood acute myeloblastic leukemia without maturation (M1)|childhood acute myeloblastic leukemia without maturation (m1)
768663|NCT00372619|adult acute myeloblastic leukemia with maturation (M2)|adult acute myeloblastic leukemia with maturation (m2)
768664|NCT00372619|childhood acute myeloblastic leukemia with maturation (M2)|childhood acute myeloblastic leukemia with maturation (m2)
768665|NCT00372619|adult acute myelomonocytic leukemia (M4)|adult acute myelomonocytic leukemia (m4)
768666|NCT00372619|childhood acute myelomonocytic leukemia (M4)|childhood acute myelomonocytic leukemia (m4)
768667|NCT00372619|adult acute monoblastic leukemia (M5a)|adult acute monoblastic leukemia (m5a)
768668|NCT00372619|childhood acute monoblastic leukemia (M5a)|childhood acute monoblastic leukemia (m5a)
768669|NCT00372619|adult acute monocytic leukemia (M5b)|adult acute monocytic leukemia (m5b)
768670|NCT00372619|childhood acute monocytic leukemia (M5b)|childhood acute monocytic leukemia (m5b)
768671|NCT00372619|adult erythroleukemia (M6a)|adult erythroleukemia (m6a)
768672|NCT00372619|adult pure erythroid leukemia (M6b)|adult pure erythroid leukemia (m6b)
768673|NCT00372619|childhood acute erythroleukemia (M6)|childhood acute erythroleukemia (m6)
768674|NCT00372619|adult acute megakaryoblastic leukemia (M7)|adult acute megakaryoblastic leukemia (m7)
768675|NCT00372619|childhood acute megakaryocytic leukemia (M7)|childhood acute megakaryocytic leukemia (m7)
768676|NCT00372619|recurrent adult acute lymphoblastic leukemia|recurrent adult acute lymphoblastic leukemia
768677|NCT00372619|recurrent adult acute myeloid leukemia|recurrent adult acute myeloid leukemia
768678|NCT00372606|Obesity|obesity
768679|NCT00372606|Overweight|overweight
768680|NCT00372606|Hispanics|hispanics
768681|NCT00372606|Online|online
768682|NCT00372606|Weight Loss|weight loss
768683|NCT00372593|adult acute myeloid leukemia with 11q23 (MLL) abnormalities|adult acute myeloid leukemia with 11q23 (mll) abnormalities
768684|NCT00372593|adult acute myeloid leukemia with inv(16)(p13;q22)|adult acute myeloid leukemia with inv(16)(p13;q22)
768685|NCT00372593|adult acute myeloid leukemia with t(16;16)(p13;q22)|adult acute myeloid leukemia with t(16;16)(p13;q22)
768686|NCT00372593|adult acute myeloid leukemia with t(8;21)(q22;q22)|adult acute myeloid leukemia with t(8;21)(q22;q22)
768687|NCT00372593|untreated adult acute myeloid leukemia|untreated adult acute myeloid leukemia
768688|NCT00372593|untreated childhood acute myeloid leukemia and other myeloid malignancies|untreated childhood acute myeloid leukemia and other myeloid malignancies
768689|NCT00372593|adult acute basophilic leukemia|adult acute basophilic leukemia
768690|NCT00372593|adult acute eosinophilic leukemia|adult acute eosinophilic leukemia
768691|NCT00372593|adult acute minimally differentiated myeloid leukemia (M0)|adult acute minimally differentiated myeloid leukemia (m0)
768692|NCT00372593|adult acute myeloblastic leukemia without maturation (M1)|adult acute myeloblastic leukemia without maturation (m1)
768693|NCT00372593|adult acute myeloblastic leukemia with maturation (M2)|adult acute myeloblastic leukemia with maturation (m2)
768694|NCT00372593|adult acute myelomonocytic leukemia (M4)|adult acute myelomonocytic leukemia (m4)
768695|NCT00372593|adult acute monoblastic leukemia (M5a)|adult acute monoblastic leukemia (m5a)
768696|NCT00372593|adult acute monocytic leukemia (M5b)|adult acute monocytic leukemia (m5b)
768697|NCT00372593|adult erythroleukemia (M6a)|adult erythroleukemia (m6a)
768698|NCT00372593|adult pure erythroid leukemia (M6b)|adult pure erythroid leukemia (m6b)
768699|NCT00372593|adult acute megakaryoblastic leukemia (M7)|adult acute megakaryoblastic leukemia (m7)
768700|NCT00372593|childhood acute basophilic leukemia|childhood acute basophilic leukemia
768794|NCT00372320|Dry mouth|dry mouth
768701|NCT00372593|childhood acute eosinophilic leukemia|childhood acute eosinophilic leukemia
768702|NCT00372593|childhood acute minimally differentiated myeloid leukemia (M0)|childhood acute minimally differentiated myeloid leukemia (m0)
768703|NCT00372593|childhood acute myeloblastic leukemia without maturation (M1)|childhood acute myeloblastic leukemia without maturation (m1)
768704|NCT00372593|childhood acute myeloblastic leukemia with maturation (M2)|childhood acute myeloblastic leukemia with maturation (m2)
768827|NCT00372190|treatment|treatment
768705|NCT00372593|childhood acute myelomonocytic leukemia (M4)|childhood acute myelomonocytic leukemia (m4)
768706|NCT00372593|childhood acute monocytic leukemia (M5b)|childhood acute monocytic leukemia (m5b)
768707|NCT00372593|childhood acute monoblastic leukemia (M5a)|childhood acute monoblastic leukemia (m5a)
768708|NCT00372593|childhood acute erythroleukemia (M6)|childhood acute erythroleukemia (m6)
768709|NCT00372593|childhood acute megakaryocytic leukemia (M7)|childhood acute megakaryocytic leukemia (m7)
768710|NCT00372541|ceftriaxone|ceftriaxone
768711|NCT00372541|chloramphenicol|chloramphenicol
768712|NCT00372541|severe pneumonia|severe pneumonia
768713|NCT00372541|children|children
768714|NCT00372515|epidermal growth factor|epidermal growth factor
768715|NCT00372515|EGFR|egfr
768716|NCT00372515|lung cancer|lung cancer
768717|NCT00372515|Iressa|iressa
768718|NCT00372515|Gefitinib|gefitinib
768719|NCT00372502|sepsis|sepsis
768720|NCT00372502|shock|shock
768721|NCT00372502|emergency department|emergency department
768722|NCT00372502|resuscitation|resuscitation
768723|NCT00372489|anemia|anemia
768724|NCT00372489|chronic kidney disease|chronic kidney disease
768725|NCT00372489|CKD|ckd
768726|NCT00372489|chronic renal failure|chronic renal failure
768727|NCT00372489|CRF|crf
768728|NCT00372489|dialysis|dialysis
768729|NCT00372489|erythropoietin|erythropoietin
768730|NCT00372489|EPO|epo
768731|NCT00372489|erythropoiesis stimulating agent|erythropoiesis stimulating agent
768732|NCT00372489|ESA|esa
768733|NCT00372489|Hematide™|hematide™
768734|NCT00372489|hemodialysis|hemodialysis
768735|NCT00372489|hemoglobin|hemoglobin
768736|NCT00372489|Hb|hb
768737|NCT00372489|Hgb|hgb
768738|NCT00372489|Omontys|omontys
768739|NCT00372489|peginesatide|peginesatide
768740|NCT00372489|red blood cell|red blood cell
768741|NCT00372489|red blood cell production|red blood cell production
768742|NCT00372476|Breast cancer|breast cancer
768743|NCT00372476|Tyrosine inhibitor|tyrosine inhibitor
768744|NCT00372476|Chemotherapy|chemotherapy
768745|NCT00372476|Imatinib|imatinib
768746|NCT00372463|diabetes|diabetes
768747|NCT00372463|type 2 diabetes|type 2 diabetes
768748|NCT00372463|type II diabetes|type ii diabetes
768749|NCT00372463|diabetes mellitus|diabetes mellitus
768750|NCT00372463|diabetes type 2|diabetes type 2
768751|NCT00372463|diabetes type II|diabetes type ii
768752|NCT00372463|diabetes education|diabetes education
768753|NCT00372463|patient education|patient education
768754|NCT00372463|workshop|workshop
768755|NCT00372463|class|class
768756|NCT00372463|education|education
768757|NCT00372463|online|online
768758|NCT00372463|on-line|on-line
768759|NCT00372463|internet|internet
768760|NCT00372463|web|web
768761|NCT00372450|recurrent esophageal cancer|recurrent esophageal cancer
768762|NCT00372450|stage III esophageal cancer|stage iii esophageal cancer
768763|NCT00372450|stage IV esophageal cancer|stage iv esophageal cancer
768764|NCT00372450|squamous cell carcinoma of the esophagus|squamous cell carcinoma of the esophagus
768765|NCT00372450|adenocarcinoma of the esophagus|adenocarcinoma of the esophagus
768766|NCT00372450|gastrointestinal complications|gastrointestinal complications
768767|NCT00372437|Refractory solid tumors|refractory solid tumors
768768|NCT00372437|Phase I/II|phase i/ii
768769|NCT00372437|Refractory and solid tumors|refractory and solid tumors
768770|NCT00372424|Breast cancer over-expressing HER2. First-line treatment with sunitinib/docetaxel/trastuzumab.|breast cancer over-expressing her2. first-line treatment with sunitinib/docetaxel/trastuzumab.
768771|NCT00372411|Stroke|stroke
768772|NCT00372411|Rehabilitation|rehabilitation
768773|NCT00372411|Single-blind|single-blind
768774|NCT00372411|Clinical Trial|clinical trial
768775|NCT00372411|Randomized controlled trial|randomized controlled trial
768776|NCT00372411|Upper extremity|upper extremity
768777|NCT00372411|Robotics|robotics
768778|NCT00372398|scleroderma|scleroderma
768779|NCT00372398|sclerosis|sclerosis
768780|NCT00372398|atherosclerosis|atherosclerosis
768781|NCT00372372|corticosteroids, bone mineral, risedronate, bisphosphonate|corticosteroids, bone mineral, risedronate, bisphosphonate
768782|NCT00372359|Attention Deficit Disorder|attention deficit disorder
768783|NCT00372359|Hyperactivity|hyperactivity
768784|NCT00372359|Methylphenidate|methylphenidate
768785|NCT00372333|musculoskeletal pain; soft tissue inflammation; IDEA-033|musculoskeletal pain; soft tissue inflammation; idea-033
768786|NCT00372320|Adenovirus|adenovirus
768787|NCT00372320|Aquaporin-1|aquaporin-1
768788|NCT00372320|Gene Transfer|gene transfer
768789|NCT00372320|Radiation-Induced Salivary Hypofunction|radiation-induced salivary hypofunction
768790|NCT00372320|Salivary Gland|salivary gland
768791|NCT00372320|Xerostomia|xerostomia
768792|NCT00372320|Salivary Dysfunction|salivary dysfunction
768793|NCT00372320|Hyposalivation|hyposalivation
768795|NCT00372320|head and neck cancer|head and neck cancer
768796|NCT00372320|side effects radiation damage|side effects radiation damage
768797|NCT00372294|Toxoplasmosis|toxoplasmosis
768798|NCT00372294|Chorioretinitis|chorioretinitis
768799|NCT00372294|Intravitreal Clindamycin|intravitreal clindamycin
768800|NCT00372294|Dexamethasone in chorioretinitis|dexamethasone in chorioretinitis
768801|NCT00372294|Toxoplasmic|toxoplasmic
768802|NCT00372281|MRI, CLIAVIST, MACROPHAGE, INFECTION, SPINE|mri, cliavist, macrophage, infection, spine
768803|NCT00372268|Comparison of four conditionings of the insufflated gas during laparoscopy and their consequences on the core temperature and the post-operative pain.|comparison of four conditionings of the insufflated gas during laparoscopy and their consequences on the core temperature and the post-operative pain.
768804|NCT00372268|Women with womb pathology needing laparoscopic surgery|women with womb pathology needing laparoscopic surgery
768805|NCT00372268|No emergency|no emergency
768806|NCT00372268|Aged over 18 years|aged over 18 years
768807|NCT00372242|Mal-nutrition|mal-nutrition
768808|NCT00372242|Morbidity|morbidity
768809|NCT00372242|Nutrition Education|nutrition education
768810|NCT00372242|Complementary Feeding|complementary feeding
768811|NCT00372242|Weight gain|weight gain
768812|NCT00372242|Height|height
768813|NCT00372216|myocardial infarction|myocardial infarction
768814|NCT00372216|Clopidogrel|clopidogrel
768815|NCT00372216|primary PCI|primary pci
768816|NCT00372216|TIMI-flow|timi-flow
768817|NCT00372216|STEMI within 6 hrs.|stemi within 6 hrs.
768818|NCT00372203|Non-small cell lung cancer|non-small cell lung cancer
768819|NCT00372203|NSCLC|nsclc
768820|NCT00372203|EBUS|ebus
768821|NCT00372203|Endobronchial ultrasound|endobronchial ultrasound
768822|NCT00372203|mediastinoscopy|mediastinoscopy
768823|NCT00372190|Pelvic organ prolapse|pelvic organ prolapse
768824|NCT00372190|recurrence|recurrence
768825|NCT00372190|mesh|mesh
768826|NCT00372190|complications|complications
768828|NCT00372177|monoclonal antibody|monoclonal antibody
768829|NCT00372177|diagnostics|diagnostics
768830|NCT00372177|RA|ra
768831|NCT00372177|Immunoglobulins|immunoglobulins
768832|NCT00372177|molecular target|molecular target
768833|NCT00372177|Tc99m-pertechnetate|tc99m-pertechnetate
768834|NCT00372177|Fab-fragment of Anti-human CD4|fab-fragment of anti-human cd4
768835|NCT00372177|Radiopharmaceutical|radiopharmaceutical
768836|NCT00372177|chronic inflammatory diseases|chronic inflammatory diseases
768837|NCT00372177|active Rheumatoid Arthritis|active rheumatoid arthritis
768838|NCT00372164|ASIPP|asipp
768839|NCT00372164|Guidelines|guidelines
768840|NCT00372151|Schizophrenia|schizophrenia
768841|NCT00372151|Schizoaffective disorders|schizoaffective disorders
768842|NCT00372151|Theonine|theonine
768843|NCT00372151|Augmentation|augmentation
768844|NCT00372138|Abdominal aortic aneurysms|abdominal aortic aneurysms
768845|NCT00372138|Endoleaks|endoleaks
768846|NCT00372138|Prevention|prevention
768847|NCT00372125|Prader-Willi syndrome|prader-willi syndrome
768848|NCT00372125|Growth hormone|growth hormone
768849|NCT00372125|Body composition|body composition
768850|NCT00372112|Chronic Obstructive Pulmonary Disease (COPD)|chronic obstructive pulmonary disease (copd)
768851|NCT00372112|COPD|copd
768852|NCT00372099|Postmenopausal women|postmenopausal women
768853|NCT00372099|bone microarchitecture|bone microarchitecture
768854|NCT00372099|peripheral quantitative micro-CT|peripheral quantitative micro-ct
768855|NCT00372099|salmon calcitonin|salmon calcitonin
768856|NCT00372034|contact lenses|contact lenses
768857|NCT00372034|intolerance|intolerance
768858|NCT00372034|punctal plugs|punctal plugs
768859|NCT00372034|tear volume|tear volume
768860|NCT00372034|Intolerance to contact lens wear due to dryness symptoms|intolerance to contact lens wear due to dryness symptoms
768861|NCT00372021|non arthritic ischemic optic neuropathy|non arthritic ischemic optic neuropathy
768862|NCT00372021|anterior ischemic optic neuropathy|anterior ischemic optic neuropathy
768863|NCT00372021|Optic nerve Neurotomy|optic nerve neurotomy
768864|NCT00371995|Visceral leishmaniasis|visceral leishmaniasis
768865|NCT00371995|kala-azar|kala-azar
768866|NCT00371995|miltefosine|miltefosine
768867|NCT00371995|AmBisome|ambisome
768868|NCT00371982|Fish oil|fish oil
768869|NCT00371982|Type 2 diabetic women|type 2 diabetic women
768870|NCT00371982|adiposity|adiposity
768871|NCT00371982|adipose tissue inflammation|adipose tissue inflammation
768872|NCT00371982|PAI-1|pai-1
768873|NCT00371982|Insulin sensitivity|insulin sensitivity
768874|NCT00371969|Unsafe drinking|unsafe drinking
768875|NCT00371969|Human Immunodeficiency Virus|human immunodeficiency virus
768876|NCT00371969|Motivational Interviewing|motivational interviewing
768877|NCT00371956|raloxifene|raloxifene
768878|NCT00371956|estrogen|estrogen
768879|NCT00371956|receptor|receptor
768880|NCT00371956|modulation|modulation
768881|NCT00371956|osteoporosis|osteoporosis
768882|NCT00371956|steroid|steroid
768883|NCT00371956|Steroids|steroids
768884|NCT00371943|variceal bleeding,band ligation, beta-blocker|variceal bleeding,band ligation, beta-blocker
768885|NCT00371943|had history of esophageal variceal bleeding|had history of esophageal variceal bleeding
768886|NCT00371904|Rituximab|rituximab
768887|NCT00371904|donor|donor
768888|NCT00371904|sensitised|sensitised
768893|NCT00371878|Bronchoalveolar lavage|bronchoalveolar lavage
768894|NCT00371878|Lymphocyte|lymphocyte
768895|NCT00371878|Immunoglobulin|immunoglobulin
768896|NCT00371878|HIV|hiv
768897|NCT00371878|Streptococcus pneumoniae|streptococcus pneumoniae
768898|NCT00371878|Conjugate vaccine|conjugate vaccine
768899|NCT00371865|Behavior therapy|behavior therapy
768900|NCT00371865|Chronic pain|chronic pain
768901|NCT00371865|Cognitive therapy|cognitive therapy
768902|NCT00371865|Meditation|meditation
768903|NCT00371865|Mindfulness|mindfulness
768904|NCT00371865|Psychotherapy|psychotherapy
768905|NCT00371839|Hearing Loss|hearing loss
768906|NCT00371839|Hearing Aids|hearing aids
768907|NCT00371839|Rehabilitation of hearing impaired|rehabilitation of hearing impaired
768908|NCT00371826|Renal transplantation|renal transplantation
768909|NCT00371826|everolimus|everolimus
768910|NCT00371826|Immunosuppressants|immunosuppressants
768911|NCT00371800|Cinnamon|cinnamon
768912|NCT00371800|Type 1 Diabetes|type 1 diabetes
768913|NCT00371800|Adolescent|adolescent
768914|NCT00371800|HbA1c|hba1c
768915|NCT00371774|Psoriasis|psoriasis
769210|NCT00370604|Anaesthesia|anaesthesia
768916|NCT00371774|Plaque Psoriasis|plaque psoriasis
768917|NCT00371774|Amevive®|amevive®
768918|NCT00371774|alefacept|alefacept
768919|NCT00371761|Hepatitis B virus|hepatitis b virus
768920|NCT00371761|Pegylated interferon alfa-2b (PegIntron)|pegylated interferon alfa-2b (pegintron)
768921|NCT00371735|Malaria CDA LAPDAP Africa|malaria cda lapdap africa
768922|NCT00371722|Cesarean section|cesarean section
768923|NCT00371722|Appendectomy|appendectomy
768924|NCT00371683|Prevention of deep vein thrombosis and pulmonary embolism after total knee replacement surgery|prevention of deep vein thrombosis and pulmonary embolism after total knee replacement surgery
768925|NCT00371670|Knee, osteoarthritis, pain, disease modifying|knee, osteoarthritis, pain, disease modifying
768926|NCT00371657|obesity|obesity
768927|NCT00371657|small for gestation age|small for gestation age
768928|NCT00371657|intrauterine growth restriction|intrauterine growth restriction
768929|NCT00371644|Stress Disorders, Post-Traumatic|stress disorders, post-traumatic
768930|NCT00371644|Cognitive Processing Therapy|cognitive processing therapy
768931|NCT00371644|Military sexual trauma|military sexual trauma
768932|NCT00371644|Psychology, Military|psychology, military
768933|NCT00371644|Veterans|veterans
768934|NCT00371644|Rape|rape
768935|NCT00371644|Veterans, psychology|veterans, psychology
768936|NCT00371644|Healthcare utilization|healthcare utilization
768937|NCT00371631|biofilm|biofilm
768938|NCT00371631|clinical trial|clinical trial
768939|NCT00371631|Escherichia coli|escherichia coli
768940|NCT00371631|urinary catheter|urinary catheter
768941|NCT00371618|Fluoroscopy|fluoroscopy
768942|NCT00371618|Interventional Pain Management Procedures|interventional pain management procedures
768943|NCT00371605|Voriconazole|voriconazole
768944|NCT00371605|Liver Transplant|liver transplant
768945|NCT00371605|Fungal Infection|fungal infection
768946|NCT00371592|Treatment Naive|treatment naive
768947|NCT00371579|rosuvastatin|rosuvastatin
768948|NCT00371579|hepatitis C|hepatitis c
768949|NCT00371579|geranylgeranylation|geranylgeranylation
768950|NCT00371579|HCV-RNA load|hcv-rna load
768951|NCT00371566|squamous cell carcinoma of head and neck|squamous cell carcinoma of head and neck
768952|NCT00371566|lapatinib|lapatinib
768953|NCT00371566|ErbB1/ErbB2 inhibitor|erbb1/erbb2 inhibitor
768954|NCT00371566|apoptosis|apoptosis
768955|NCT00371553|relapsed or cisplatin-refractory germ cell cancer|relapsed or cisplatin-refractory germ cell cancer
768956|NCT00371553|germ cell cancer|germ cell cancer
768957|NCT00371553|SU011248 (Sunitinib)|su011248 (sunitinib)
768958|NCT00371540|Africa|africa
768959|NCT00371540|Antiretrovirals|antiretrovirals
768960|NCT00371527|Bronchitis|bronchitis
768961|NCT00371527|Acute bronchitis|acute bronchitis
768962|NCT00371527|Ipratropium|ipratropium
768963|NCT00371527|Cough|cough
768964|NCT00371527|Metered dose inhaler|metered dose inhaler
768965|NCT00371527|Antibiotic prescriptions|antibiotic prescriptions
768966|NCT00371527|Sputum production|sputum production
768967|NCT00371501|lupus|lupus
768968|NCT00371501|atherosclerosis|atherosclerosis
768969|NCT00371501|thrombosis|thrombosis
768970|NCT00371501|statin|statin
768971|NCT00371501|lipid|lipid
768972|NCT00371488|ErbB2|erbb2
768973|NCT00371488|Stage IV breast cancer|stage iv breast cancer
768974|NCT00371488|ErbB1|erbb1
768975|NCT00371488|breast cancer|breast cancer
768976|NCT00371488|lapatinib|lapatinib
768977|NCT00371488|Herceptin|herceptin
768978|NCT00371488|trastuzumab|trastuzumab
768979|NCT00371462|intervention study|intervention study
768980|NCT00371462|technology|technology
768981|NCT00371462|weight loss|weight loss
768982|NCT00371449|hearing loss|hearing loss
768983|NCT00371449|hearing aids|hearing aids
768984|NCT00371436|Counseling|counseling
768985|NCT00371436|Education|education
768986|NCT00371436|Evaluation studies|evaluation studies
768987|NCT00371436|Quality of health care|quality of health care
768988|NCT00371436|Rehabilitation of hearing impaired|rehabilitation of hearing impaired
768989|NCT00371436|Triage|triage
768990|NCT00371410|Vitrectomy|vitrectomy
768991|NCT00371410|Intravitreal triamcinolone acetonide|intravitreal triamcinolone acetonide
768992|NCT00371410|Macular focal laser photocoagulation|macular focal laser photocoagulation
768993|NCT00371410|Best-corrected visual acuity|best-corrected visual acuity
768994|NCT00371410|Central macular thickness|central macular thickness
768995|NCT00371397|yoga|yoga
768996|NCT00371397|immune function|immune function
768997|NCT00371397|stress|stress
768998|NCT00371397|health|health
768999|NCT00371397|mood|mood
769000|NCT00371397|skin barrier repair|skin barrier repair
769001|NCT00371384|massage|massage
769002|NCT00371384|back pain|back pain
769003|NCT00371384|effectiveness|effectiveness
769004|NCT00371371|clinical trial|clinical trial
769005|NCT00371371|chronic critical limb ischemia|chronic critical limb ischemia
769006|NCT00371371|leg pain|leg pain
769007|NCT00371371|cell therapy|cell therapy
769008|NCT00371371|bone marrow|bone marrow
769009|NCT00371371|mononuclear|mononuclear
769010|NCT00371371|progenitor cell|progenitor cell
769011|NCT00371371|stem cell|stem cell
769012|NCT00371371|critical limb ischemia|critical limb ischemia
769013|NCT00371371|nonhealing leg ulcer|nonhealing leg ulcer
769014|NCT00371345|Recurrent, locally-advanced, or metastatic breast cancer|recurrent, locally-advanced, or metastatic breast cancer
769015|NCT00371332|chronic periodontitis, mouth|chronic periodontitis, mouth
769016|NCT00371332|Moderate to advanced chronic periodontitis|moderate to advanced chronic periodontitis
769017|NCT00371319|lupus|lupus
769018|NCT00371319|nephritis|nephritis
769019|NCT00371319|tacrolimus|tacrolimus
769020|NCT00371319|mycophenolate mofetil|mycophenolate mofetil
769021|NCT00371306|Diabetes|diabetes
769022|NCT00371306|Pregnancy|pregnancy
769023|NCT00371293|Sleep Apnea|sleep apnea
769024|NCT00371293|C-Reactive Protein|c-reactive protein
769025|NCT00371293|Obesity|obesity
769026|NCT00371293|Insulin Resistance|insulin resistance
769027|NCT00371293|Arterial stiffness|arterial stiffness
769028|NCT00371280|hydroxyapatite|hydroxyapatite
769029|NCT00371280|peg|peg
769030|NCT00371280|prosthetic motility|prosthetic motility
769031|NCT00371280|orbital implant|orbital implant
769032|NCT00371267|cognitive behavioral therapy|cognitive behavioral therapy
769033|NCT00371267|pain|pain
769034|NCT00371254|Recurrent, locally-advanced, or 'triple negative' metastatic breast cancer|recurrent, locally-advanced, or 'triple negative' metastatic breast cancer
769035|NCT00371241|ECMO|ecmo
769036|NCT00371241|extracorporeal membrane oxygenation|extracorporeal membrane oxygenation
769037|NCT00371241|cytokines|cytokines
769038|NCT00371241|chemokines|chemokines
769039|NCT00371228|cord clamping|cord clamping
769040|NCT00371228|hematocrit|hematocrit
769041|NCT00371228|hemoglobin|hemoglobin
769042|NCT00371228|timing|timing
769043|NCT00371215|hemostasis|hemostasis
769044|NCT00371215|grafting, skin|grafting, skin
769045|NCT00371215|hemostatics|hemostatics
769046|NCT00371215|phase 2|phase 2
769047|NCT00371202|keratoconus, penetrating keratoplasty,|keratoconus, penetrating keratoplasty,
769048|NCT00371202|deep lamellar keratoplasty|deep lamellar keratoplasty
769049|NCT00371202|big bubble technique|big bubble technique
769050|NCT00371189|circumsporozoite, malaria, vaccine|circumsporozoite, malaria, vaccine
769051|NCT00371176|Cognitive Behavior Therapy|cognitive behavior therapy
769052|NCT00371176|Cognitive enhancers|cognitive enhancers
769053|NCT00371176|Combat Disorders|combat disorders
769054|NCT00371176|D-Cycloserine|d-cycloserine
769055|NCT00371176|Stress Disorders, Post-Traumatic|stress disorders, post-traumatic
769056|NCT00371163|Identification of genes by microarray analyses.|identification of genes by microarray analyses.
769057|NCT00371137|FMS|fms
769058|NCT00371137|Fibro|fibro
769059|NCT00371137|pain|pain
769060|NCT00371137|Body pain|body pain
769061|NCT00371137|tenderness|tenderness
769062|NCT00371137|joint pain|joint pain
769063|NCT00371137|stiffness|stiffness
769064|NCT00371137|muscular pain|muscular pain
769065|NCT00371124|Myopia treatment|myopia treatment
769066|NCT00371124|Atropine|atropine
769067|NCT00371111|Resistant uveitic cystoid macular edema|resistant uveitic cystoid macular edema
769068|NCT00371111|intravitreal triamcinolone|intravitreal triamcinolone
769069|NCT00371111|intravitreal bevacizumab|intravitreal bevacizumab
769070|NCT00371098|influenza vaccination|influenza vaccination
769071|NCT00371098|coronary artery disease|coronary artery disease
769072|NCT00371098|prevention|prevention
769073|NCT00371098|acute coronary syndromes|acute coronary syndromes
769074|NCT00371085|heart failure|heart failure
769075|NCT00371085|quality improvement|quality improvement
769076|NCT00371085|patient education|patient education
769077|NCT00371085|health care economics|health care economics
769078|NCT00371072|Aphakic Glaucoma|aphakic glaucoma
769079|NCT00371072|trabeculectomy with mitomycin- C|trabeculectomy with mitomycin- c
769080|NCT00371072|Ahmed glaucoma implant|ahmed glaucoma implant
769081|NCT00371059|Agitation|agitation
769082|NCT00371059|Dementia|dementia
769083|NCT00371059|Alzheimer's|alzheimer's
769084|NCT00371046|preterm labor|preterm labor
769085|NCT00371046|transvaginal ultrasound cervical length|transvaginal ultrasound cervical length
769086|NCT00371046|fetal fibronectin|fetal fibronectin
769087|NCT00371046|preterm birth|preterm birth
769088|NCT00371020|silicone oil|silicone oil
769090|NCT00371020|retinal redetachment|retinal redetachment
769091|NCT00371020|low molecular weight heparin|low molecular weight heparin
769092|NCT00371020|5-FU|5-fu
769093|NCT00370994|post-lumbar surgery syndrome|post-lumbar surgery syndrome
769094|NCT00370994|percutaneous lumbar epidural adhesiolysis|percutaneous lumbar epidural adhesiolysis
769095|NCT00370994|hypertonic saline neurolysis|hypertonic saline neurolysis
769096|NCT00370981|investigational drug|investigational drug
769097|NCT00370981|ejaculation|ejaculation
769098|NCT00370968|Children|children
769099|NCT00370968|India|india
769100|NCT00370968|Hospital|hospital
769101|NCT00370968|Zinc|zinc
769102|NCT00370968|Malnutrition|malnutrition
769103|NCT00370968|Treatment|treatment
769104|NCT00370955|Phacoemulsification|phacoemulsification
769105|NCT00370955|Corneal endothelial cell loss|corneal endothelial cell loss
769106|NCT00370955|Hydrodynamic parameters|hydrodynamic parameters
769107|NCT00370955|Total ultrasound energy|total ultrasound energy
769108|NCT00370955|Total infused fluids|total infused fluids
769109|NCT00370942|GW823093C|gw823093c
769110|NCT00370942|diabetes|diabetes
769111|NCT00370942|type 2 diabetes mellitus|type 2 diabetes mellitus
769112|NCT00370942|DPP-IV inhibitor|dpp-iv inhibitor
769113|NCT00370916|Clinical Decision Support Systems|clinical decision support systems
769114|NCT00370916|Continuity of Patient Care|continuity of patient care
769115|NCT00370916|Medication Errors|medication errors
769116|NCT00370916|Drug Adverse Effects|drug adverse effects
769117|NCT00370903|cesarean|cesarean
769118|NCT00370903|planned|planned
769119|NCT00370903|emergent|emergent
769120|NCT00370903|postpartum depression|postpartum depression
769121|NCT00370890|nasopharyngeal cancer|nasopharyngeal cancer
769122|NCT00370890|adjuvant chemotherapy|adjuvant chemotherapy
769123|NCT00370890|EBV DNA|ebv dna
769124|NCT00370890|PET CT scan|pet ct scan
769125|NCT00370877|Post-partum hemorrhage|post-partum hemorrhage
769126|NCT00370877|Arterial embolization|arterial embolization
769127|NCT00370877|Surgery|surgery
769128|NCT00370877|Hysterectomy|hysterectomy
769129|NCT00370877|Activated recombinant human factor VII|activated recombinant human factor vii
769130|NCT00370864|Pandemic|pandemic
769131|NCT00370864|Influenza|influenza
769132|NCT00370864|Prevention|prevention
769133|NCT00370864|Vaccine|vaccine
769134|NCT00370864|Prevention of Pandemic Influenza|prevention of pandemic influenza
769135|NCT00370851|intravitreal Avastin|intravitreal avastin
769136|NCT00370851|BRVO|brvo
769137|NCT00370851|Macular edema|macular edema
769138|NCT00370838|Tics|tics
769139|NCT00370838|Tourette syndrome|tourette syndrome
769140|NCT00370838|levetiracetam|levetiracetam
769141|NCT00370838|clonidine|clonidine
769142|NCT00370825|Visceral leishmaniasis|visceral leishmaniasis
769143|NCT00370825|miltefosine|miltefosine
769144|NCT00370825|AmBisome|ambisome
769145|NCT00370825|Combination|combination
769146|NCT00370812|amniotic membrane transplantation|amniotic membrane transplantation
769147|NCT00370812|ocular chemical burns|ocular chemical burns
769148|NCT00370799|Caudal Epidural injections|caudal epidural injections
769149|NCT00370799|lumbar disc herniation|lumbar disc herniation
769150|NCT00370799|spinal stenosis|spinal stenosis
769151|NCT00370799|discogenic pain|discogenic pain
769152|NCT00370799|post-lumbar laminectomy syndrome|post-lumbar laminectomy syndrome
769153|NCT00370786|Choroidal neovascularization (CNV)|choroidal neovascularization (cnv)
769154|NCT00370786|Bevacizumab|bevacizumab
769155|NCT00370786|Non AMD|non amd
769156|NCT00370786|High myopia|high myopia
769157|NCT00370786|angioid streaks|angioid streaks
769158|NCT00370786|Ocular histoplasmosis|ocular histoplasmosis
769159|NCT00370786|Idiopathic|idiopathic
769160|NCT00370773|Failed Back Surgery Syndrome|failed back surgery syndrome
769161|NCT00370773|Back Pain|back pain
769162|NCT00370773|Chronic Pain|chronic pain
769163|NCT00370773|Spinal Cord Stimulation|spinal cord stimulation
769164|NCT00370760|PVR|pvr
769165|NCT00370760|Oral colchicine|oral colchicine
769166|NCT00370760|Dexamethasone|dexamethasone
769167|NCT00370760|low molecular weight heparin|low molecular weight heparin
769168|NCT00370760|5-FU|5-fu
769169|NCT00370734|botulinum toxin|botulinum toxin
769170|NCT00370734|thyroid eye disease|thyroid eye disease
769171|NCT00370734|lid retraction|lid retraction
769172|NCT00370721|Proliferative diabetic retinopathy(PDR)|proliferative diabetic retinopathy(pdr)
769173|NCT00370721|Pan retinal photocoagulation (PRP)|pan retinal photocoagulation (prp)
769174|NCT00370721|Vitreous hemorrhage|vitreous hemorrhage
769175|NCT00370721|Traction retinal detachment|traction retinal detachment
769176|NCT00370721|Neovascularization on disc (NVD)|neovascularization on disc (nvd)
769177|NCT00370721|Neovascularization elsewhere (NVE)|neovascularization elsewhere (nve)
769178|NCT00370721|Fibrous proliferation on disc (FPD)|fibrous proliferation on disc (fpd)
769179|NCT00370721|Fibrous proliferaiton elsewhere (FPE)|fibrous proliferaiton elsewhere (fpe)
769180|NCT00370708|Cesarean|cesarean
769181|NCT00370708|Oral|oral
769182|NCT00370708|Intake|intake
769183|NCT00370695|Chronic back pain|chronic back pain
769184|NCT00370695|Intractable neuropathic back pain|intractable neuropathic back pain
769185|NCT00370695|Lumbar radiculopathy|lumbar radiculopathy
769186|NCT00370695|Spinal cord stimulation|spinal cord stimulation
769187|NCT00370669|Bevacizumab|bevacizumab
769188|NCT00370669|CSME|csme
769189|NCT00370669|MPC|mpc
769190|NCT00370669|Triamcinolone acetonide|triamcinolone acetonide
769191|NCT00370656|Diabetic Peripheral Neuropathy|diabetic peripheral neuropathy
769192|NCT00370643|hyperglycaemia|hyperglycaemia
769193|NCT00370643|open heart surgery|open heart surgery
769194|NCT00370643|intensive care unit|intensive care unit
769195|NCT00370630|CRVO|crvo
769196|NCT00370630|Intravitreal Avastin|intravitreal avastin
769197|NCT00370630|Intravitreal triamcinolone|intravitreal triamcinolone
769198|NCT00370617|chronic hepatitis C|chronic hepatitis c
769199|NCT00370617|insulin resistance|insulin resistance
769200|NCT00370617|therapy|therapy
769201|NCT00370604|Parturient|parturient
769202|NCT00370604|Obstetrics|obstetrics
769203|NCT00370604|Pregnancy|pregnancy
769204|NCT00370604|Labour|labour
769205|NCT00370604|Labor|labor
769206|NCT00370604|Headache|headache
769207|NCT00370604|Epidural|epidural
769208|NCT00370604|Analgesia|analgesia
769209|NCT00370604|Anesthesia|anesthesia
769211|NCT00370591|Inhaled corticosteroids|inhaled corticosteroids
769212|NCT00370591|Asthma|asthma
769213|NCT00370578|STEMI, THROMBUS, ASPIRATION DEVICE, NO REFLOW|stemi, thrombus, aspiration device, no reflow
769214|NCT00370539|Photodynamic therapy,|photodynamic therapy,
769215|NCT00370539|Bevacizumab,|bevacizumab,
769216|NCT00370539|Triamcinolone,|triamcinolone,
769217|NCT00370539|Age-related macular degeneration,|age-related macular degeneration,
769218|NCT00370539|Choroidal neovascular membrane|choroidal neovascular membrane
769219|NCT00370526|heart failure|heart failure
769220|NCT00370526|resynchronization|resynchronization
769221|NCT00370526|CRT|crt
769222|NCT00370526|Bi-V pacemaker|bi-v pacemaker
769223|NCT00370526|LV lead placement|lv lead placement
769224|NCT00370526|hemodynamic assessment|hemodynamic assessment
769225|NCT00370526|CRT Outcomes|crt outcomes
769226|NCT00370513|pazopanib|pazopanib
769227|NCT00370513|liver cancer|liver cancer
769228|NCT00370513|hepatocellular cancer|hepatocellular cancer
769229|NCT00370500|Schizophrenia|schizophrenia
769230|NCT00370500|Dopamine transporter gene|dopamine transporter gene
769231|NCT00370500|DNA methylation|dna methylation
769232|NCT00370500|Epigenetics|epigenetics
769233|NCT00370487|Abortion|abortion
769234|NCT00370487|Midlevel providers|midlevel providers
769235|NCT00370487|South Africa|south africa
769236|NCT00370487|Viet Nam|viet nam
769237|NCT00370474|Bi-V lead|bi-v lead
769238|NCT00370474|Magnetic Navigation|magnetic navigation
769239|NCT00370474|Cardiac Resynchronization Therapy|cardiac resynchronization therapy
769240|NCT00370461|Basic Cardiac Life Support|basic cardiac life support
769241|NCT00370461|Termination of Resuscitation|termination of resuscitation
769242|NCT00370461|Emergency Medical Services|emergency medical services
769243|NCT00370461|Primary Care Paramedics|primary care paramedics
769244|NCT00370461|Out of Hospital Cardiac Arrest|out of hospital cardiac arrest
769245|NCT00370435|rheumatoid arthritis|rheumatoid arthritis
769246|NCT00370435|safety|safety
769247|NCT00370435|GW274150|gw274150
769248|NCT00370435|pharmacokinetics|pharmacokinetics
769249|NCT00370435|tolerability|tolerability
769250|NCT00370422|Cystoid macular edema|cystoid macular edema
769251|NCT00370422|Diabetic macular edema|diabetic macular edema
769252|NCT00370422|Hard exudates|hard exudates
769253|NCT00370422|Intravitreal bevacizumab|intravitreal bevacizumab
769254|NCT00370422|Intravitreal triamcinolone|intravitreal triamcinolone
769255|NCT00370422|Macular thickness|macular thickness
769256|NCT00370409|Rebleeding|rebleeding
769257|NCT00370409|Diabetic vitreous hemorrhage|diabetic vitreous hemorrhage
769258|NCT00370409|Cryotherapy|cryotherapy
769259|NCT00370396|Streptococcus pneumonia, pneumococcal conjugate vaccine|streptococcus pneumonia, pneumococcal conjugate vaccine
769260|NCT00370383|Non Small Cell Lung Cancer|non small cell lung cancer
769261|NCT00370383|PATIENTS ≥ 70 YEARS WITH UNRESECTABLE STAGE 3 OR 4 NSCLC|patients ≥ 70 years with unresectable stage 3 or 4 nsclc
769262|NCT00370370|Bevacizumab,|bevacizumab,
769263|NCT00370370|Triamcinolone|triamcinolone
769264|NCT00370370|Age-related macular degeneration|age-related macular degeneration
769265|NCT00370370|Choroidal neovascular membrane|choroidal neovascular membrane
769266|NCT00370357|Microbicide|microbicide
769267|NCT00370357|SPL7013|spl7013
769268|NCT00370357|VivaGel|vivagel
769269|NCT00370344|Gallbladder diseases|gallbladder diseases
769270|NCT00370344|gallstones|gallstones
769271|NCT00370344|cholecystectomy|cholecystectomy
769272|NCT00370344|minilaparotomy|minilaparotomy
769273|NCT00370344|laparoscopy|laparoscopy
769274|NCT00370331|ITP|itp
769275|NCT00370331|idiopathic|idiopathic
769276|NCT00370331|platelets|platelets
769277|NCT00370331|purpura|purpura
769278|NCT00370331|thrombocytopenia|thrombocytopenia
769279|NCT00370331|Idiopathic Thrombocytopenic Purpura|idiopathic thrombocytopenic purpura
769280|NCT00370331|thrombocytopenic|thrombocytopenic
769281|NCT00370318|Pneumococcal Disease|pneumococcal disease
769282|NCT00370305|11ß-hydroxysteroid dehydrogenase|11ß-hydroxysteroid dehydrogenase
769283|NCT00370305|rosiglitazone|rosiglitazone
769284|NCT00370305|insulin sensitivity|insulin sensitivity
769285|NCT00370305|Impaired glucose tolerance|impaired glucose tolerance
769286|NCT00370279|Pseudophakic retinal detachment,|pseudophakic retinal detachment,
769287|NCT00370279|Aphakic retinal detachment,|aphakic retinal detachment,
769288|NCT00370279|Scleral buckling,|scleral buckling,
769289|NCT00370279|Primary vitrectomy,|primary vitrectomy,
769290|NCT00370279|Proliferative vitreoretinopathy|proliferative vitreoretinopathy
769291|NCT00370266|Macular edema|macular edema
769292|NCT00370266|Branch retinal vein occlusion|branch retinal vein occlusion
769293|NCT00370266|Intravitreal triamcinolone|intravitreal triamcinolone
769294|NCT00370266|Macular thickness|macular thickness
769295|NCT00370266|Retinal neovascularization|retinal neovascularization
769296|NCT00370253|hepatorenal syndrome|hepatorenal syndrome
769297|NCT00370253|ascites|ascites
769298|NCT00370253|portal hypertension|portal hypertension
769299|NCT00370253|cirrhosis|cirrhosis
769300|NCT00370240|Female|female
769301|NCT00370240|Anesthetics,local|anesthetics,local
769302|NCT00370227|Streptococcus pneumonia, pneumococcal conjugate vaccine|streptococcus pneumonia, pneumococcal conjugate vaccine
769303|NCT00370214|Pulmonary arterial hypertension|pulmonary arterial hypertension
769304|NCT00370214|Lung diseases|lung diseases
769305|NCT00370214|Heart diseases|heart diseases
769306|NCT00370214|Pulmonary circulation|pulmonary circulation
769307|NCT00370214|Vascular resistance|vascular resistance
769308|NCT00370214|PAH|pah
769309|NCT00370214|Hypertension|hypertension
769310|NCT00370201|retinal detachment|retinal detachment
769311|NCT00370201|proliferative vitreoretinopathy|proliferative vitreoretinopathy
769312|NCT00370188|problem gambling|problem gambling
769313|NCT00370188|topiramate|topiramate
769314|NCT00370123|endometriosis|endometriosis
769315|NCT00370123|apoptosis|apoptosis
769316|NCT00370123|regulatory T cells|regulatory t cells
769317|NCT00370097|Asthma infants FLOVENT spacer|asthma infants flovent spacer
769318|NCT00370071|MS|ms
769319|NCT00370058|ect|ect
769320|NCT00370058|depression|depression
769321|NCT00370058|homocysteine|homocysteine
769322|NCT00370058|mthfr genotype|mthfr genotype
769323|NCT00370032|mucosal blood flow d-IBS|mucosal blood flow d-ibs
769324|NCT00370019|Premature Ovarian Failure|premature ovarian failure
769325|NCT00370019|Ovulation|ovulation
769326|NCT00370019|Fertility|fertility
769327|NCT00370019|Estrogen Replacement|estrogen replacement
769328|NCT00370019|Follicle Function|follicle function
769329|NCT00370019|Premature Menopause|premature menopause
769330|NCT00370019|POF|pof
769331|NCT00370006|cytomegalovirus|cytomegalovirus
769332|NCT00370006|vaccine|vaccine
769333|NCT00370006|T cell|t cell
769334|NCT00370006|antibodies|antibodies
769335|NCT00369993|asthma|asthma
769336|NCT00369993|spacer|spacer
769337|NCT00369967|Contraception|contraception
769338|NCT00369967|Adolescents|adolescents
769339|NCT00369967|Contraceptive vaginal ring|contraceptive vaginal ring
769340|NCT00369967|Quick start|quick start
769341|NCT00369954|recurrent ovarian epithelial cancer|recurrent ovarian epithelial cancer
769342|NCT00369954|fallopian tube cancer|fallopian tube cancer
769343|NCT00369954|peritoneal cavity cancer|peritoneal cavity cancer
769344|NCT00369915|Cholinergic|cholinergic
769345|NCT00369915|Unipolar|unipolar
769346|NCT00369915|Bipolar|bipolar
769347|NCT00369915|Depression|depression
769348|NCT00369915|Muscarinic|muscarinic
769349|NCT00369915|Scopolamine|scopolamine
769350|NCT00369915|Major Depressive Disorder|major depressive disorder
769351|NCT00369915|MDD|mdd
769352|NCT00369915|Bipolar Disorder|bipolar disorder
769353|NCT00369915|BP|bp
769354|NCT00369902|pain|pain
769355|NCT00369902|acupuncture|acupuncture
769356|NCT00369889|Thymoma|thymoma
769357|NCT00369889|Thymic Cancer|thymic cancer
769358|NCT00369876|Burns|burns
769359|NCT00369876|Anorexia|anorexia
769360|NCT00369876|Neuropeptide|neuropeptide
769361|NCT00369876|Leptin|leptin
769362|NCT00369876|Adiponectin|adiponectin
769363|NCT00369876|Gherlin|gherlin
769364|NCT00369863|Cystoid macular edema|cystoid macular edema
769365|NCT00369863|Diabetic macular edema|diabetic macular edema
769366|NCT00369863|Hard exudates|hard exudates
769367|NCT00369863|Intravitreal triamcinolone|intravitreal triamcinolone
769368|NCT00369863|Macular thickness|macular thickness
769369|NCT00369850|osteoporosis|osteoporosis
769370|NCT00369850|stage I breast cancer|stage i breast cancer
769371|NCT00369850|stage II breast cancer|stage ii breast cancer
769372|NCT00369850|stage IIIA breast cancer|stage iiia breast cancer
769373|NCT00369824|HPV|hpv
769374|NCT00369824|HPV, diptheria, pertussis, tetanus, meningitis|hpv, diptheria, pertussis, tetanus, meningitis
769375|NCT00369811|Cholecystectomy, postoperative|cholecystectomy, postoperative
769376|NCT00369798|Unipolar Depression|unipolar depression
769377|NCT00369798|Phosphorylation|phosphorylation
769378|NCT00369798|Affinity States|affinity states
769379|NCT00369798|Compartment Analysis|compartment analysis
769380|NCT00369798|(R)-(11)C Rolipram|(r)-(11)c rolipram
769381|NCT00369798|Depression|depression
769382|NCT00369798|Major Depressive Disorder|major depressive disorder
769383|NCT00369798|MDD|mdd
769384|NCT00369798|Healthy Volunteer|healthy volunteer
769386|NCT00369785|cognitive/functional effects|cognitive/functional effects
769387|NCT00369785|fatigue|fatigue
769388|NCT00369785|psychosocial effects of cancer and its treatment|psychosocial effects of cancer and its treatment
769389|NCT00369785|radiation toxicity|radiation toxicity
769390|NCT00369785|tumors metastatic to brain|tumors metastatic to brain
769391|NCT00369785|adult brain stem glioma|adult brain stem glioma
769392|NCT00369785|adult central nervous system germ cell tumor|adult central nervous system germ cell tumor
769393|NCT00369785|adult choroid plexus tumor|adult choroid plexus tumor
769394|NCT00369785|adult craniopharyngioma|adult craniopharyngioma
769395|NCT00369785|adult mixed glioma|adult mixed glioma
769396|NCT00369785|adult anaplastic meningioma|adult anaplastic meningioma
769397|NCT00369785|meningeal melanocytoma|meningeal melanocytoma
769398|NCT00369785|adult meningeal hemangiopericytoma|adult meningeal hemangiopericytoma
769399|NCT00369785|adult grade I meningioma|adult grade i meningioma
769400|NCT00369785|adult grade II meningioma|adult grade ii meningioma
769401|NCT00369785|adult grade III meningioma|adult grade iii meningioma
769402|NCT00369785|adult papillary meningioma|adult papillary meningioma
769403|NCT00369785|adult anaplastic oligodendroglioma|adult anaplastic oligodendroglioma
769404|NCT00369785|adult oligodendroglioma|adult oligodendroglioma
769405|NCT00369785|adult pineoblastoma|adult pineoblastoma
769406|NCT00369785|adult pineocytoma|adult pineocytoma
769407|NCT00369785|adult anaplastic astrocytoma|adult anaplastic astrocytoma
769408|NCT00369785|adult diffuse astrocytoma|adult diffuse astrocytoma
769409|NCT00369785|adult glioblastoma|adult glioblastoma
769410|NCT00369785|adult giant cell glioblastoma|adult giant cell glioblastoma
769411|NCT00369785|adult gliosarcoma|adult gliosarcoma
769412|NCT00369785|adult pilocytic astrocytoma|adult pilocytic astrocytoma
769413|NCT00369785|adult ependymoblastoma|adult ependymoblastoma
769414|NCT00369785|adult medulloblastoma|adult medulloblastoma
769415|NCT00369785|adult supratentorial primitive neuroectodermal tumor (PNET)|adult supratentorial primitive neuroectodermal tumor (pnet)
769416|NCT00369785|adult anaplastic ependymoma|adult anaplastic ependymoma
769417|NCT00369785|adult ependymoma|adult ependymoma
769418|NCT00369785|adult myxopapillary ependymoma|adult myxopapillary ependymoma
769419|NCT00369785|adult subependymoma|adult subependymoma
769420|NCT00369772|Aranesp|aranesp
769421|NCT00369772|Anemia|anemia
769422|NCT00369772|Kidney Disease|kidney disease
769423|NCT00369772|Hemoglobin|hemoglobin
769424|NCT00369772|darbepoetin alfa|darbepoetin alfa
769425|NCT00369772|QoL|qol
769426|NCT00369759|Acute Lower Respiratory Infection|acute lower respiratory infection
769427|NCT00369759|Retractions|retractions
769428|NCT00369759|Bronchiolitis or pneumonia|bronchiolitis or pneumonia
769429|NCT00369759|Wheezing|wheezing
769430|NCT00369759|Rales|rales
769431|NCT00369759|Crackles|crackles
769432|NCT00369746|Depression|depression
769433|NCT00369746|Alcohol Abuse|alcohol abuse
769434|NCT00369746|Alcohol Dependence|alcohol dependence
769435|NCT00369733|Aranesp|aranesp
769436|NCT00369733|Anemia|anemia
769437|NCT00369733|Kidney Disease|kidney disease
769438|NCT00369733|Hemoglobin|hemoglobin
769439|NCT00369733|darbepoetin alfa|darbepoetin alfa
769440|NCT00369733|QoL|qol
769441|NCT00369720|Prematurity|prematurity
769442|NCT00369720|Resuscitation|resuscitation
769443|NCT00369720|Room Air|room air
769444|NCT00369707|Non-Hodgkin's Lymphoma|non-hodgkin's lymphoma
769445|NCT00369694|Esophageal varices|esophageal varices
769446|NCT00369694|Portal Hypertension|portal hypertension
769447|NCT00369694|Melena|melena
769448|NCT00369694|Hematemesis|hematemesis
769449|NCT00369694|Gastrointestinal Hemorrhage|gastrointestinal hemorrhage
769450|NCT00369694|Terlipressin|terlipressin
769451|NCT00369694|Efficacy|efficacy
769452|NCT00369694|Safety|safety
769453|NCT00369681|stage II adult Hodgkin lymphoma|stage ii adult hodgkin lymphoma
769454|NCT00369681|stage III adult Hodgkin lymphoma|stage iii adult hodgkin lymphoma
769455|NCT00369681|stage IV adult Hodgkin lymphoma|stage iv adult hodgkin lymphoma
769456|NCT00369681|adult lymphocyte depletion Hodgkin lymphoma|adult lymphocyte depletion hodgkin lymphoma
769457|NCT00369681|adult mixed cellularity Hodgkin lymphoma|adult mixed cellularity hodgkin lymphoma
769458|NCT00369681|adult nodular sclerosis Hodgkin lymphoma|adult nodular sclerosis hodgkin lymphoma
769459|NCT00369668|Rehabilitation|rehabilitation
769460|NCT00369668|Physical Therapy Techniques|physical therapy techniques
769461|NCT00369668|Occupational Therapy|occupational therapy
769462|NCT00369668|Upper Extremity; Motor skills|upper extremity; motor skills
769463|NCT00369642|Cognitive-behavioral therapy|cognitive-behavioral therapy
769464|NCT00369642|Children|children
769465|NCT00369642|Obsessive-compulsive disorder|obsessive-compulsive disorder
769466|NCT00369642|Intensive Cognitive-behavioral therapy|intensive cognitive-behavioral therapy
769467|NCT00369642|Weekly Cognitive-behavioral therapy|weekly cognitive-behavioral therapy
769468|NCT00369629|recurrent mycosis fungoides/Sezary syndrome|recurrent mycosis fungoides/sezary syndrome
769469|NCT00369629|stage I mycosis fungoides/Sezary syndrome|stage i mycosis fungoides/sezary syndrome
769470|NCT00369629|stage II mycosis fungoides/Sezary syndrome|stage ii mycosis fungoides/sezary syndrome
769471|NCT00369629|stage III mycosis fungoides/Sezary syndrome|stage iii mycosis fungoides/sezary syndrome
769472|NCT00369629|stage IV mycosis fungoides/Sezary syndrome|stage iv mycosis fungoides/sezary syndrome
770770|NCT00364806|Headache|headache
769473|NCT00369629|stage I cutaneous T-cell non-Hodgkin lymphoma|stage i cutaneous t-cell non-hodgkin lymphoma
769474|NCT00369629|stage II cutaneous T-cell non-Hodgkin lymphoma|stage ii cutaneous t-cell non-hodgkin lymphoma
769475|NCT00369629|stage III cutaneous T-cell non-Hodgkin lymphoma|stage iii cutaneous t-cell non-hodgkin lymphoma
769476|NCT00369629|stage IV cutaneous T-cell non-Hodgkin lymphoma|stage iv cutaneous t-cell non-hodgkin lymphoma
769477|NCT00369629|recurrent cutaneous T-cell non-Hodgkin lymphoma|recurrent cutaneous t-cell non-hodgkin lymphoma
769478|NCT00369603|Alzheimer's Disease|alzheimer's disease
769479|NCT00369603|fMRI|fmri
769480|NCT00369603|Functional Neuroimaging|functional neuroimaging
769481|NCT00369603|Allosteric Nicotinic Receptor Modulation|allosteric nicotinic receptor modulation
769482|NCT00369603|Acetylcholinesterase Inhibition|acetylcholinesterase inhibition
769483|NCT00369603|Head to head|head to head
769484|NCT00369603|Dose escalation|dose escalation
769485|NCT00369603|Biomarker|biomarker
769486|NCT00369577|Agitation|agitation
769487|NCT00369577|Schizophrenia|schizophrenia
769488|NCT00369564|neurotoxicity|neurotoxicity
769489|NCT00369564|peripheral neuropathy|peripheral neuropathy
769490|NCT00369564|stage I Wilms tumor|stage i wilms tumor
769491|NCT00369564|stage II Wilms tumor|stage ii wilms tumor
769492|NCT00369564|stage III Wilms tumor|stage iii wilms tumor
769493|NCT00369564|stage IV Wilms tumor|stage iv wilms tumor
769494|NCT00369564|stage V Wilms tumor|stage v wilms tumor
769495|NCT00369564|previously untreated childhood rhabdomyosarcoma|previously untreated childhood rhabdomyosarcoma
769496|NCT00369564|childhood grade III lymphomatoid granulomatosis|childhood grade iii lymphomatoid granulomatosis
769497|NCT00369564|childhood diffuse large cell lymphoma|childhood diffuse large cell lymphoma
769498|NCT00369564|childhood immunoblastic large cell lymphoma|childhood immunoblastic large cell lymphoma
769499|NCT00369564|stage I childhood large cell lymphoma|stage i childhood large cell lymphoma
769500|NCT00369564|stage II childhood large cell lymphoma|stage ii childhood large cell lymphoma
769501|NCT00369564|stage III childhood large cell lymphoma|stage iii childhood large cell lymphoma
769502|NCT00369564|stage IV childhood large cell lymphoma|stage iv childhood large cell lymphoma
769503|NCT00369564|stage I childhood lymphoblastic lymphoma|stage i childhood lymphoblastic lymphoma
769504|NCT00369564|stage II childhood lymphoblastic lymphoma|stage ii childhood lymphoblastic lymphoma
769505|NCT00369564|stage III childhood lymphoblastic lymphoma|stage iii childhood lymphoblastic lymphoma
769506|NCT00369564|stage IV childhood lymphoblastic lymphoma|stage iv childhood lymphoblastic lymphoma
769507|NCT00369564|childhood Burkitt lymphoma|childhood burkitt lymphoma
769508|NCT00369564|stage I childhood small noncleaved cell lymphoma|stage i childhood small noncleaved cell lymphoma
769509|NCT00369564|stage II childhood small noncleaved cell lymphoma|stage ii childhood small noncleaved cell lymphoma
769510|NCT00369564|stage III childhood small noncleaved cell lymphoma|stage iii childhood small noncleaved cell lymphoma
769511|NCT00369564|stage IV childhood small noncleaved cell lymphoma|stage iv childhood small noncleaved cell lymphoma
769512|NCT00369564|untreated childhood acute lymphoblastic leukemia|untreated childhood acute lymphoblastic leukemia
769513|NCT00369538|Podocyte - podocyturia - microparticles - angiotensin receptor antagonist - glomerulosclerosis|podocyte - podocyturia - microparticles - angiotensin receptor antagonist - glomerulosclerosis
769514|NCT00369538|Patients presenting with stable glomerular nephropathy with proteinuria, normal or slightly altered renal function, with hypertension|patients presenting with stable glomerular nephropathy with proteinuria, normal or slightly altered renal function, with hypertension
769515|NCT00369512|Phase II|phase ii
769516|NCT00369512|Erlotinib|erlotinib
769517|NCT00369512|Radiotherapy|radiotherapy
769518|NCT00369512|Squamous Cell Carcinomas|squamous cell carcinomas
769519|NCT00369512|Cutaneous|cutaneous
769520|NCT00369512|Stage III|stage iii
769521|NCT00369486|diabetic|diabetic
769522|NCT00369486|macular|macular
769523|NCT00369486|edema|edema
769524|NCT00369486|peribulbar|peribulbar
769525|NCT00369486|triamcinolone|triamcinolone
769526|NCT00369486|acetonide|acetonide
769527|NCT00369486|laser|laser
769528|NCT00369486|photocoagulation|photocoagulation
769529|NCT00369486|intraocular|intraocular
769530|NCT00369486|DME|dme
769531|NCT00369473|rheumatoid arthritis|rheumatoid arthritis
769532|NCT00369460|recurrent pancreatic cancer|recurrent pancreatic cancer
769533|NCT00369460|stage III pancreatic cancer|stage iii pancreatic cancer
769534|NCT00369460|adenocarcinoma of the pancreas|adenocarcinoma of the pancreas
769535|NCT00369460|stage IV pancreatic cancer|stage iv pancreatic cancer
769536|NCT00369447|Non small cell lung cancer|non small cell lung cancer
769537|NCT00369447|NSCLC|nsclc
769538|NCT00369447|Nimotuzumab|nimotuzumab
769539|NCT00369447|TheraCIM|theracim
769540|NCT00369447|h-R3|h-r3
769541|NCT00369447|YM BioSciences|ym biosciences
769542|NCT00369447|Radiation|radiation
769543|NCT00369447|Non small cell lung cancer, Stage IIb, III and IV|non small cell lung cancer, stage iib, iii and iv
769544|NCT00369421|Biochemical Diseases|biochemical diseases
769545|NCT00369421|Rare Diseases|rare diseases
769546|NCT00369421|Family Studies|family studies
769547|NCT00369421|Screening|screening
769548|NCT00369421|Next Generation Sequencing|next generation sequencing
769549|NCT00369408|Randomized Trial|randomized trial
769550|NCT00369408|Medication for Heavy Drinking|medication for heavy drinking
769551|NCT00369408|Naltrexone Treatment|naltrexone treatment
769651|NCT00368940|Geriatric Depression|geriatric depression
769552|NCT00369408|Daily vs. Targeted Administration|daily vs. targeted administration
769553|NCT00369395|melanoma|melanoma
769554|NCT00369395|antibody|antibody
769555|NCT00369395|angiogenesis|angiogenesis
769556|NCT00369395|volociximab|volociximab
769557|NCT00369382|Heart Transplant|heart transplant
769558|NCT00369382|Kidney Failure|kidney failure
769559|NCT00369343|Major Depressive Disorder|major depressive disorder
769560|NCT00369343|vasomotor symptoms|vasomotor symptoms
769561|NCT00369343|menopause|menopause
769562|NCT00369343|diabetic neuropathy|diabetic neuropathy
769563|NCT00369343|fibromyalgia|fibromyalgia
769564|NCT00369330|atrial fibrillation|atrial fibrillation
769565|NCT00369330|early cardioversion|early cardioversion
769566|NCT00369330|electrical cardioversion|electrical cardioversion
769567|NCT00369304|Health|health
769568|NCT00369278|Renal transplantation, mycophenolate|renal transplantation, mycophenolate
769569|NCT00369265|Gastroesophageal reflux|gastroesophageal reflux
769570|NCT00369265|Laryngitis|laryngitis
769571|NCT00369265|Hoarseness|hoarseness
769572|NCT00369265|Dysphonia|dysphonia
769573|NCT00369265|Proton pump inhibitor|proton pump inhibitor
769574|NCT00369252|Nimotuzumab|nimotuzumab
769575|NCT00369252|TheraCIM|theracim
769576|NCT00369252|H-R3|h-r3
769577|NCT00369252|Solid tumours|solid tumours
769578|NCT00369252|EGFR|egfr
769579|NCT00369252|Monoclonal antibody|monoclonal antibody
769580|NCT00369239|Early psychosis|early psychosis
769581|NCT00369239|premorbid functioning|premorbid functioning
769582|NCT00369239|Scale for Assessment of Insight|scale for assessment of insight
769583|NCT00369239|Risperdal Consta|risperdal consta
769584|NCT00369239|risperidone long acting injectable|risperidone long acting injectable
769585|NCT00369226|Velcade|velcade
769586|NCT00369226|Bortezomib|bortezomib
769587|NCT00369226|Allogeneic Stem Cell Transplant|allogeneic stem cell transplant
769588|NCT00369226|GVHD|gvhd
769589|NCT00369213|Crossover trial|crossover trial
769590|NCT00369213|condom failure|condom failure
769591|NCT00369213|additional spermicidal lubricant|additional spermicidal lubricant
769592|NCT00369148|glinides|glinides
769593|NCT00369148|premixed insulin|premixed insulin
769594|NCT00369148|combination therapy|combination therapy
769595|NCT00369148|glycemic control|glycemic control
769596|NCT00369135|work|work
769597|NCT00369135|Musculoskeletal Disorders|musculoskeletal disorders
769598|NCT00369109|recurrent colon cancer|recurrent colon cancer
769599|NCT00369109|stage III colon cancer|stage iii colon cancer
769600|NCT00369109|stage IV colon cancer|stage iv colon cancer
769601|NCT00369109|recurrent rectal cancer|recurrent rectal cancer
769602|NCT00369109|stage III rectal cancer|stage iii rectal cancer
769603|NCT00369109|stage IV rectal cancer|stage iv rectal cancer
769604|NCT00369109|recurrent pancreatic cancer|recurrent pancreatic cancer
769605|NCT00369109|stage II pancreatic cancer|stage ii pancreatic cancer
769606|NCT00369109|stage III pancreatic cancer|stage iii pancreatic cancer
769607|NCT00369109|stage IV pancreatic cancer|stage iv pancreatic cancer
769608|NCT00369109|recurrent breast cancer|recurrent breast cancer
769609|NCT00369109|stage IIIA breast cancer|stage iiia breast cancer
769610|NCT00369109|stage IIIB breast cancer|stage iiib breast cancer
769611|NCT00369109|stage IIIC breast cancer|stage iiic breast cancer
769612|NCT00369109|stage IV breast cancer|stage iv breast cancer
769613|NCT00369096|Peritoneal Dialysis|peritoneal dialysis
769614|NCT00369096|Bemiparin|bemiparin
769615|NCT00369096|Icodextrin|icodextrin
769616|NCT00369096|Peritoneal Transport Disorders|peritoneal transport disorders
769617|NCT00369083|Frail elderly|frail elderly
769618|NCT00369083|Hospital at home|hospital at home
769619|NCT00369070|AMG 706|amg 706
769620|NCT00369070|Bevacizumab|bevacizumab
769621|NCT00369070|Paclitaxel and Carboplatin|paclitaxel and carboplatin
769622|NCT00369070|Randomized|randomized
769623|NCT00369070|Non-Small Cell Lung Cancer|non-small cell lung cancer
769624|NCT00369057|Intraocular pressure|intraocular pressure
769625|NCT00369057|Prostatectomy|prostatectomy
769626|NCT00369057|Robotic|robotic
769627|NCT00369057|Glaucoma|glaucoma
769628|NCT00369057|Carbon dioxide|carbon dioxide
769629|NCT00369044|decompensated heart failure|decompensated heart failure
769630|NCT00369044|prednisone|prednisone
769631|NCT00369044|diuretics|diuretics
769632|NCT00369044|diuresis|diuresis
769633|NCT00369031|HIV|hiv
769634|NCT00369031|vaccine|vaccine
769635|NCT00369031|nasal immunization|nasal immunization
769636|NCT00369018|photodynamic therapy|photodynamic therapy
769637|NCT00369018|methyl aminolevulinate|methyl aminolevulinate
769638|NCT00369018|hexaminolevulinate|hexaminolevulinate
769639|NCT00369018|dose-finding|dose-finding
769640|NCT00369018|cervical dysplasia|cervical dysplasia
769641|NCT00369005|Transfusions|transfusions
769642|NCT00369005|Erythrocyte|erythrocyte
769643|NCT00369005|Anemia|anemia
769644|NCT00369005|Brain|brain
769645|NCT00369005|Infant, Premature|infant, premature
769646|NCT00368979|Benign Prostatic Hyperplasia BPH dutasteride|benign prostatic hyperplasia bph dutasteride
769647|NCT00368966|Pneumococcal|pneumococcal
769648|NCT00368966|Pediatric|pediatric
769649|NCT00368966|Vaccine|vaccine
769650|NCT00368940|Memory Deficits|memory deficits
769652|NCT00368940|Cognitive Impairment|cognitive impairment
769653|NCT00368940|Executive Dysfunction|executive dysfunction
769654|NCT00368940|Disability|disability
769655|NCT00368940|Problem Solving Therapy|problem solving therapy
769656|NCT00368914|unspecified adult solid tumor, protocol specific|unspecified adult solid tumor, protocol specific
769657|NCT00368901|Aranesp|aranesp
769658|NCT00368901|Anemia|anemia
769659|NCT00368901|Kidney Disease|kidney disease
769660|NCT00368901|Hemoglobin|hemoglobin
769661|NCT00368901|darbepoetin alfa|darbepoetin alfa
769662|NCT00368901|QoL|qol
769663|NCT00368862|Alcoholism|alcoholism
769664|NCT00368862|Depression|depression
769665|NCT00368862|Efficacy study|efficacy study
769666|NCT00368862|Memantine|memantine
769667|NCT00368862|Escitalopram|escitalopram
769668|NCT00368849|Huntington Disease|huntington disease
769669|NCT00368849|Chorea|chorea
769670|NCT00368849|Attention|attention
769671|NCT00368849|ADHD|adhd
769672|NCT00368849|ADD|add
769673|NCT00368849|Strattera|strattera
769674|NCT00368849|Atomoxetine|atomoxetine
769675|NCT00368836|Capnography|capnography
769676|NCT00368836|Thromboembolism|thromboembolism
769677|NCT00368836|Arthroplasty|arthroplasty
769678|NCT00368836|D-dimer|d-dimer
769679|NCT00368823|point of care|point of care
769680|NCT00368823|evidence based medicine|evidence based medicine
769681|NCT00368810|Children|children
769682|NCT00368810|Cross-Sectional|cross-sectional
769683|NCT00368810|Glycosylphosphatidylinositol|glycosylphosphatidylinositol
769684|NCT00368810|Cytokines|cytokines
769685|NCT00368810|Peripheral Blood Mononuclear Cells|peripheral blood mononuclear cells
769686|NCT00368810|Malaria|malaria
769687|NCT00368797|Gene Therapy|gene therapy
769688|NCT00368797|PAOD|paod
769689|NCT00368797|CLI|cli
769690|NCT00368771|Irritable Bowel Syndrome|irritable bowel syndrome
769691|NCT00368771|Abdominal Pain|abdominal pain
769692|NCT00368771|Abdominal Discomfort|abdominal discomfort
769693|NCT00368771|Diarrhea|diarrhea
769694|NCT00368771|Constipation|constipation
769695|NCT00368771|IBS|ibs
769696|NCT00368758|Meteorism|meteorism
769697|NCT00368758|Bloating|bloating
769698|NCT00368758|Irritable bowel syndrome (IBS)|irritable bowel syndrome (ibs)
769699|NCT00368758|Probiotics|probiotics
769700|NCT00368758|Bowel gas|bowel gas
769701|NCT00368732|Congenital Heart Defects|congenital heart defects
769702|NCT00368706|solifenacin|solifenacin
769703|NCT00368706|Overactive bladder|overactive bladder
769704|NCT00368706|Urinary incontinence|urinary incontinence
769705|NCT00368706|Treatment outcomes|treatment outcomes
769706|NCT00368706|VESIcare|vesicare
769707|NCT00368680|Respiratory Distress Syndrome|respiratory distress syndrome
769708|NCT00368680|Early Bubble CPAP|early bubble cpap
769709|NCT00368680|Mechanical Ventilation|mechanical ventilation
769710|NCT00368680|Surfactant|surfactant
769711|NCT00368667|Anorexia Nervosa|anorexia nervosa
769712|NCT00368667|Body Composition|body composition
769713|NCT00368667|Metabolic Rate|metabolic rate
769714|NCT00368628|acute ischemic stroke|acute ischemic stroke
769715|NCT00368628|sleep apnea|sleep apnea
769716|NCT00368628|continuous positive airway pressure|continuous positive airway pressure
769717|NCT00368615|melanoma|melanoma
769718|NCT00368615|malignant melanoma|malignant melanoma
769719|NCT00368589|atherosclerotic plaque|atherosclerotic plaque
769720|NCT00368589|USPIO|uspio
769721|NCT00368589|Atheroma|atheroma
769722|NCT00368589|thrombo-embolic stroke|thrombo-embolic stroke
769723|NCT00368589|magnetic resonance imaging|magnetic resonance imaging
769724|NCT00368589|Ultra small Super-Paramagnetic Iron Oxide|ultra small super-paramagnetic iron oxide
769725|NCT00368576|SB-480848|sb-480848
769726|NCT00368576|methacholine challenge|methacholine challenge
769727|NCT00368576|asthma|asthma
769728|NCT00368576|inhaled steroid|inhaled steroid
769729|NCT00368550|Alcohol Drinking|alcohol drinking
769730|NCT00368550|Alcohol Dependence|alcohol dependence
769731|NCT00368550|Sertraline Pharmacotherapy|sertraline pharmacotherapy
769732|NCT00368550|Alcoholism Subtypes|alcoholism subtypes
769733|NCT00368550|Early- versus Late-Onset Alcoholism|early- versus late-onset alcoholism
769734|NCT00368537|skin infection|skin infection
769735|NCT00368537|antibiotics|antibiotics
769736|NCT00368524|cocaine dependence|cocaine dependence
769737|NCT00368524|mental disorder|mental disorder
769738|NCT00368524|dual diagnoses|dual diagnoses
769739|NCT00368524|homelessness|homelessness
769740|NCT00368511|Fall Prevention|fall prevention
769741|NCT00368511|Dynamic Posturography|dynamic posturography
769742|NCT00368511|Nolwenn Effect|nolwenn effect
769743|NCT00368511|Music Listening|music listening
769744|NCT00368498|teicoplanin|teicoplanin
769745|NCT00368485|diaphragm electrical activity|diaphragm electrical activity
769746|NCT00368485|non invasive ventilation|non invasive ventilation
769747|NCT00368485|patient ventilator interaction|patient ventilator interaction
769748|NCT00368472|Refractory|refractory
769749|NCT00368472|Partial|partial
769750|NCT00368472|Seizures|seizures
769751|NCT00368459|raloxifene, women|raloxifene, women
769752|NCT00368446|Nontuberculous Mycobacterial Infection|nontuberculous mycobacterial infection
770438|NCT00365599|Tamoxifen|tamoxifen
769753|NCT00368446|Primary Ciliary Dyskinesia|primary ciliary dyskinesia
769754|NCT00368446|Cystic Fibrosis|cystic fibrosis
769755|NCT00368446|Pseudohypoaldosteronism|pseudohypoaldosteronism
769756|NCT00368446|Chronic Granulomatous Disease|chronic granulomatous disease
769757|NCT00368446|Mycobacterial Infection|mycobacterial infection
769758|NCT00368446|PCD|pcd
769759|NCT00368446|CF|cf
769760|NCT00368446|PHA|pha
769761|NCT00368446|Healthy Volunteer|healthy volunteer
769762|NCT00368446|HV|hv
769763|NCT00368433|Sensory Processing|sensory processing
769764|NCT00368433|Electromyogram|electromyogram
769765|NCT00368433|Tic Disorder|tic disorder
769766|NCT00368433|Tourette Syndrome|tourette syndrome
769767|NCT00368433|Tourette's Syndrome|tourette's syndrome
769768|NCT00368433|Healthy Volunteer|healthy volunteer
769769|NCT00368433|HV|hv
769770|NCT00368420|ovarian cancer|ovarian cancer
769771|NCT00368420|recurrence|recurrence
769772|NCT00368420|surgery|surgery
769773|NCT00368407|308-nm excimer laser|308-nm excimer laser
769774|NCT00368407|vitiligo|vitiligo
769775|NCT00368394|Insulin glulisine|insulin glulisine
769776|NCT00368394|Euglycaemic clamp|euglycaemic clamp
769777|NCT00368394|Diabetes mellitus Type 1|diabetes mellitus type 1
769778|NCT00368381|sepsis|sepsis
769779|NCT00368381|septicemia|septicemia
769780|NCT00368381|sepsis syndrome|sepsis syndrome
769781|NCT00368381|adrenal insufficiency|adrenal insufficiency
769782|NCT00368381|adrenal cortex hormones|adrenal cortex hormones
769783|NCT00368381|hydrocortisone|hydrocortisone
769784|NCT00368381|fludrocortisone|fludrocortisone
769785|NCT00368355|haploidenticalstem cell transplant|haploidenticalstem cell transplant
769786|NCT00368355|acute lymphoblastic leukemia|acute lymphoblastic leukemia
769787|NCT00368355|Non Hodgkins Lymphoma|non hodgkins lymphoma
769788|NCT00368355|Myelodysplastic Syndrome|myelodysplastic syndrome
769789|NCT00368355|Acute myeloid leukemia|acute myeloid leukemia
769790|NCT00368355|Chronic myelogenous leukemia|chronic myelogenous leukemia
769791|NCT00368355|Hemophagocytic lymphohistiocytosis (HLH)|hemophagocytic lymphohistiocytosis (hlh)
769792|NCT00368355|Familial hemophagocytic lymphohistiocytosis (FLH)|familial hemophagocytic lymphohistiocytosis (flh)
769793|NCT00368355|Viral-associated hemophagocytic syndrome (VAHS)|viral-associated hemophagocytic syndrome (vahs)
769794|NCT00368355|X-linked lymphoproliferative disease (XLP)|x-linked lymphoproliferative disease (xlp)
769795|NCT00368316|Dysentery|dysentery
769796|NCT00368316|S. sonnei|s. sonnei
769797|NCT00368316|Antibody Response|antibody response
769798|NCT00368316|Protection|protection
769799|NCT00368303|Major Depression|major depression
769800|NCT00368303|paroxetine controlled release (CR)|paroxetine controlled release (cr)
769801|NCT00368303|paroxetine immediate release (IR)|paroxetine immediate release (ir)
769802|NCT00368290|cocaine dependence|cocaine dependence
769803|NCT00368290|hiv prevention|hiv prevention
769804|NCT00368277|Systolic hypertension|systolic hypertension
769805|NCT00368277|hypertension|hypertension
769806|NCT00368277|aliskiren|aliskiren
769807|NCT00368277|blood pressure|blood pressure
769808|NCT00368277|ramipril|ramipril
769809|NCT00368277|HTN|htn
769810|NCT00368264|lupus|lupus
769811|NCT00368264|nephritis|nephritis
769812|NCT00368264|membraneous|membraneous
769813|NCT00368264|proteinuria|proteinuria
769814|NCT00368264|TNF|tnf
769815|NCT00368264|infliximab|infliximab
769816|NCT00368264|azathioprine|azathioprine
769817|NCT00368264|autoantibodies|autoantibodies
769818|NCT00368251|Unverricht-Lundborg Disease|unverricht-lundborg disease
769819|NCT00368251|Baltic Myoclonus|baltic myoclonus
769820|NCT00368251|Progressive Myoclonic Epilepsies|progressive myoclonic epilepsies
769821|NCT00368251|Myoclonus|myoclonus
769822|NCT00368251|Brivaracetam|brivaracetam
769823|NCT00368238|Platelet function tests|platelet function tests
769824|NCT00368238|Erythropoietin|erythropoietin
769825|NCT00368238|Aspirin|aspirin
769826|NCT00368238|Clopidogrel|clopidogrel
769827|NCT00368225|Viral Hepatitis|viral hepatitis
769828|NCT00368225|Hepatitis C|hepatitis c
769829|NCT00368225|HCV|hcv
769830|NCT00368225|Liver Transplant|liver transplant
769831|NCT00368225|Renal Transplant|renal transplant
769832|NCT00368225|Kidney Transplant|kidney transplant
769833|NCT00368212|Somatization|somatization
769834|NCT00368212|Refractory Symptoms|refractory symptoms
769835|NCT00368199|single photon emission computer tomography (SPECT)|single photon emission computer tomography (spect)
769836|NCT00368199|transcranial sonography|transcranial sonography
769837|NCT00368199|transcranial duplex scanning|transcranial duplex scanning
769838|NCT00368199|parkinson's disease|parkinson's disease
769839|NCT00368199|atypical parkinson syndromes|atypical parkinson syndromes
769840|NCT00368199|parkinsonism|parkinsonism
769841|NCT00368199|parkinsonian|parkinsonian
769842|NCT00368199|diagnostic|diagnostic
769843|NCT00368199|progressive supranuclear paralysis|progressive supranuclear paralysis
769844|NCT00368160|Next day driving|next day driving
769845|NCT00368147|Hemodialysis|hemodialysis
769846|NCT00368147|Arteriovenous Fistula|arteriovenous fistula
769847|NCT00368147|Arteriovenous Graft|arteriovenous graft
769848|NCT00368147|Left Ventricular Hypertrophy|left ventricular hypertrophy
769849|NCT00368147|Brain Natriuretic Peptide|brain natriuretic peptide
769850|NCT00368134|Type 2 Diabetes|type 2 diabetes
769851|NCT00368134|Vildagliptin|vildagliptin
769852|NCT00368134|HbA1c|hba1c
769853|NCT00368121|Multiple Myeloma|multiple myeloma
769854|NCT00368121|Cetuximab|cetuximab
769855|NCT00368095|DM|dm
769856|NCT00368095|HT|ht
769857|NCT00368095|Dyslipidemia|dyslipidemia
769858|NCT00368095|Obesity|obesity
769859|NCT00368095|Cardiovascular disease|cardiovascular disease
769860|NCT00368095|Cerebrovascular disease|cerebrovascular disease
769861|NCT00368095|Myocardial infarction|myocardial infarction
769862|NCT00368095|stroke|stroke
769863|NCT00368095|Metabolic syndrome|metabolic syndrome
769864|NCT00368095|CVD-CAD|cvd-cad
769865|NCT00368082|EBV-Positive Lymphoma|ebv-positive lymphoma
769866|NCT00368082|Hodgkin´s Disease (HD)|hodgkin´s disease (hd)
769867|NCT00368082|Non-Hodgkin's lymphoma (NHL)|non-hodgkin's lymphoma (nhl)
769868|NCT00368082|relapsed Hodgkin's disease|relapsed hodgkin's disease
769869|NCT00368082|relapsed non-Hodgkin's disease|relapsed non-hodgkin's disease
769870|NCT00368082|lymphoma|lymphoma
769871|NCT00368082|TGFbeta resistant LMP-specific CTLs|tgfbeta resistant lmp-specific ctls
769872|NCT00368082|cytotoxic T cells|cytotoxic t cells
769873|NCT00368069|Epilepsy|epilepsy
769874|NCT00368069|Keppra® XR|keppra® xr
769875|NCT00368069|Levetiracetam XR|levetiracetam xr
769876|NCT00368069|Extended release|extended release
769877|NCT00368043|Pituitary|pituitary
769878|NCT00368043|Adrenal|adrenal
769879|NCT00368043|Growth|growth
769880|NCT00368043|Cortisol|cortisol
769881|NCT00368043|Stress Response|stress response
769882|NCT00368043|Adoption|adoption
769883|NCT00368043|Thyroid Hormone|thyroid hormone
769884|NCT00368043|Psychosocial Adjustment|psychosocial adjustment
769885|NCT00368043|Healthy Volunteer|healthy volunteer
769886|NCT00368043|HV|hv
769887|NCT00368030|Insomnia related to major depressive disorder.|insomnia related to major depressive disorder.
769888|NCT00368004|Coloboma|coloboma
769889|NCT00368004|Genetics|genetics
769890|NCT00368004|Optic Nerve Coloboma|optic nerve coloboma
769891|NCT00368004|Chorioretinal Coloboma|chorioretinal coloboma
769892|NCT00368004|Iris Coloboma|iris coloboma
769893|NCT00368004|Uveal Coloboma|uveal coloboma
769894|NCT00367991|Platelet function tests|platelet function tests
769895|NCT00367991|Erythropoietin|erythropoietin
769896|NCT00367991|Myocardial infarction|myocardial infarction
769897|NCT00367978|Hypertension, diabetes, African-American, amlodipine/benazepril|hypertension, diabetes, african-american, amlodipine/benazepril
769898|NCT00367965|Insomnia related to rheumatoid arthritis (RA)|insomnia related to rheumatoid arthritis (ra)
769899|NCT00367952|HIV|hiv
769900|NCT00367952|apricitabine|apricitabine
769901|NCT00367952|drug resistance|drug resistance
769902|NCT00367952|reverse transcriptase|reverse transcriptase
769903|NCT00367952|lamivudine|lamivudine
769904|NCT00367939|Hypertension|hypertension
769905|NCT00367926|ginseng|ginseng
769906|NCT00367926|polysaccharides|polysaccharides
769907|NCT00367926|postprandial glycemia|postprandial glycemia
769908|NCT00367926|area under the glucose curve|area under the glucose curve
769909|NCT00367926|peak incremental glucose|peak incremental glucose
769910|NCT00367913|pulmonary disease|pulmonary disease
769911|NCT00367913|Treatment of Opportunist Mycobacteria|treatment of opportunist mycobacteria
769912|NCT00367913|Clarithromycin|clarithromycin
769913|NCT00367913|Ciprofloxacin|ciprofloxacin
769914|NCT00367913|M.vaccae|m.vaccae
769915|NCT00367913|Pulmonary diseases caused by Opportunist Mycobacteria|pulmonary diseases caused by opportunist mycobacteria
769916|NCT00367900|Diet|diet
769917|NCT00367900|Lifestyle|lifestyle
769918|NCT00367900|Neurodegenerative Diseases|neurodegenerative diseases
769919|NCT00367900|Elderly Population|elderly population
769920|NCT00367900|Public Health|public health
769921|NCT00367900|Parkinson Disease|parkinson disease
769922|NCT00367900|Environment|environment
769923|NCT00367887|Hepatitis C|hepatitis c
769924|NCT00367874|Opiate dependence|opiate dependence
769925|NCT00367874|Benzodiazepine dependence|benzodiazepine dependence
769926|NCT00367874|Polydrug Abuse|polydrug abuse
769927|NCT00367874|Detoxification|detoxification
769928|NCT00367874|Withdrawal Treatment|withdrawal treatment
769929|NCT00367861|GIST|gist
769930|NCT00367861|Glivec®|glivec®
769931|NCT00367861|randomized|randomized
769932|NCT00367861|phase III|phase iii
769933|NCT00367848|suspected fractures in the ankle and wrist|suspected fractures in the ankle and wrist
769934|NCT00367822|Restless Legs Syndrome|restless legs syndrome
769935|NCT00367822|dopamine agonist|dopamine agonist
769936|NCT00367822|lisuride|lisuride
769937|NCT00367822|ropinirole|ropinirole
769938|NCT00367809|Meditation|meditation
769939|NCT00367809|Mindfulness|mindfulness
769940|NCT00367809|Organ Transplant|organ transplant
769941|NCT00367809|Transplantation|transplantation
769942|NCT00367809|Minnesota|minnesota
769943|NCT00367809|Immune suppressive therapy|immune suppressive therapy
769944|NCT00367796|Craniosynostosis|craniosynostosis
769945|NCT00367796|Philadelphia Type|philadelphia type
769946|NCT00367770|bosentan|bosentan
769947|NCT00367770|PAH related to Eisenmenger physiology|pah related to eisenmenger physiology
769948|NCT00367770|Tracleer|tracleer
769949|NCT00367757|paroxysmal atrial fibrillation|paroxysmal atrial fibrillation
769950|NCT00367757|persistent atrial fibrillation|persistent atrial fibrillation
769951|NCT00367757|high burden of atrial fibrillation|high burden of atrial fibrillation
769952|NCT00367757|atrial fibrillation ablation|atrial fibrillation ablation
769953|NCT00367757|Pulmonary vein isolation|pulmonary vein isolation
769954|NCT00367757|AF trigger|af trigger
769955|NCT00367757|complex fractionated electrograms|complex fractionated electrograms
769956|NCT00367757|CFE|cfe
769957|NCT00367757|CFAE|cfae
769958|NCT00367757|complex fractionated atrial electrograms|complex fractionated atrial electrograms
769959|NCT00367757|refractory antiarrhythmic medication|refractory antiarrhythmic medication
769960|NCT00367757|PVAI|pvai
769961|NCT00367757|Ensite NavX|ensite navx
769962|NCT00367757|NavX|navx
769963|NCT00367757|CoolPath catheter|coolpath catheter
769964|NCT00367757|irrigated ablation catheter|irrigated ablation catheter
769965|NCT00367757|high burden of paroxysmal or persistent atrial fibrillation|high burden of paroxysmal or persistent atrial fibrillation
769966|NCT00367757|candidates for AF ablation|candidates for af ablation
769967|NCT00367757|symptomatic AF|symptomatic af
770069|NCT00367224|ultraviolet B.|ultraviolet b.
770173|NCT00366626|Genetic|genetic
769968|NCT00367757|AF is refractory to at least one antiarrhythmic medication|af is refractory to at least one antiarrhythmic medication
769969|NCT00367744|mitochondria|mitochondria
769970|NCT00367744|HIV|hiv
769971|NCT00367744|lipoatrophy|lipoatrophy
769972|NCT00367731|HIV|hiv
769973|NCT00367731|AIDS|aids
769974|NCT00367731|Neurological complications|neurological complications
769975|NCT00367731|HAART|haart
769976|NCT00367692|Scleritis|scleritis
769977|NCT00367679|pazopanib|pazopanib
769978|NCT00367679|I-ELCAP|i-elcap
769979|NCT00367679|non-small cell lung cancer|non-small cell lung cancer
769980|NCT00367679|antiangiogenesis|antiangiogenesis
769981|NCT00367679|NSCLC|nsclc
769982|NCT00367679|GW786034|gw786034
769983|NCT00367640|Sublingual immunotherapy|sublingual immunotherapy
769984|NCT00367640|Grass pollen tablet|grass pollen tablet
769985|NCT00367640|Allergic rhinoconjunctivitis|allergic rhinoconjunctivitis
769986|NCT00367627|Children|children
769987|NCT00367627|Malnutrition|malnutrition
769988|NCT00367627|Ascaris Lumbricoides|ascaris lumbricoides
769989|NCT00367627|Trichuris trichiura Morbidity|trichuris trichiura morbidity
769990|NCT00367627|Helminthiasis|helminthiasis
769991|NCT00367627|Children 2-5 years|children 2-5 years
769992|NCT00367627|Stool RME +ve for helminthiasis|stool rme +ve for helminthiasis
769993|NCT00367614|Adolescents|adolescents
769994|NCT00367614|GERD|gerd
769995|NCT00367588|chemotherapy|chemotherapy
769996|NCT00367588|diet|diet
769997|NCT00367588|hematological malignancy|hematological malignancy
769998|NCT00367588|infection prevention|infection prevention
769999|NCT00367588|protective isolation|protective isolation
770000|NCT00367588|Patients with cytopenia due to intensive chemotherapy for hematological malignancy|patients with cytopenia due to intensive chemotherapy for hematological malignancy
770001|NCT00367575|alcoholism|alcoholism
770002|NCT00367575|drinking|drinking
770003|NCT00367575|randomized|randomized
770004|NCT00367575|internet personalized alcohol feedback|internet personalized alcohol feedback
770005|NCT00367562|IGA NEPHROPATHY|iga nephropathy
770006|NCT00367562|STEROIDS|steroids
770007|NCT00367562|ENALAPRIL|enalapril
770008|NCT00367562|VALSARTAN|valsartan
770009|NCT00367562|PROTEINURIA|proteinuria
770010|NCT00367562|IMMUNOGLOBULIN A NEPHROPATHY (IGA NEPHROPATHY)|immunoglobulin a nephropathy (iga nephropathy)
770011|NCT00367549|Labor|labor
770012|NCT00367549|instrumental delivery|instrumental delivery
770013|NCT00367549|nutrition|nutrition
770014|NCT00367549|epidural anesthesia|epidural anesthesia
770015|NCT00367549|oxytocin|oxytocin
770016|NCT00367536|Health|health
770017|NCT00367523|Echocardiogram|echocardiogram
770018|NCT00367523|Nigeria|nigeria
770019|NCT00367523|Screening|screening
770020|NCT00367523|Sickle Cell Disease|sickle cell disease
770021|NCT00367523|Genetics|genetics
770022|NCT00367497|aggressive non-Hodgkin's lymphoma|aggressive non-hodgkin's lymphoma
770023|NCT00367497|salvage chemotherapy|salvage chemotherapy
770024|NCT00367497|rituximab|rituximab
770025|NCT00367471|metastatic|metastatic
770026|NCT00367471|paclitaxel|paclitaxel
770027|NCT00367471|lapatinib|lapatinib
770028|NCT00367471|trastuzumab|trastuzumab
770029|NCT00367471|carboplatin|carboplatin
770030|NCT00367471|breast cancer|breast cancer
770031|NCT00367458|Viremia|viremia
770032|NCT00367458|Statin|statin
770033|NCT00367458|HIV Replication|hiv replication
770034|NCT00367458|Cholesterol|cholesterol
770035|NCT00367458|Lipid Raft|lipid raft
770036|NCT00367458|HIV Infection|hiv infection
770037|NCT00367458|HIV Positive|hiv positive
770038|NCT00367432|Epilepsies|epilepsies
770039|NCT00367432|Partial|partial
770040|NCT00367432|Keppra|keppra
770041|NCT00367432|levetiracetam|levetiracetam
770042|NCT00367393|Pimecrolimus, skin atrophy, dermoscopy, atopic dermatitis, eczema|pimecrolimus, skin atrophy, dermoscopy, atopic dermatitis, eczema
770043|NCT00367380|Malaria|malaria
770044|NCT00367380|Sporozoite|sporozoite
771073|NCT00363506|nutritional|nutritional
770045|NCT00367380|Challenge Model|challenge model
770046|NCT00367380|Plasmodium vivax|plasmodium vivax
770047|NCT00367380|Human Volunteers|human volunteers
770048|NCT00367367|embryo transfer|embryo transfer
770049|NCT00367367|hysteroscopy|hysteroscopy
770050|NCT00367367|curettage|curettage
770051|NCT00367367|iv-vitro fertilization|iv-vitro fertilization
770052|NCT00367367|molecular markers|molecular markers
770053|NCT00367367|endometrial receptivity|endometrial receptivity
770054|NCT00367367|endometrial dating|endometrial dating
770055|NCT00367354|Imaging Technology|imaging technology
770056|NCT00367354|Cardiology|cardiology
770057|NCT00367341|Depression, Treatment, Imaging|depression, treatment, imaging
770058|NCT00367328|Hidradenitis Supperativa|hidradenitis supperativa
770059|NCT00367315|Osteoarthritis, lumiracoxib, celecoxib, cyclooxygenase-2 inhibitors|osteoarthritis, lumiracoxib, celecoxib, cyclooxygenase-2 inhibitors
770060|NCT00367302|addiction|addiction
770061|NCT00367302|jail|jail
770062|NCT00367302|opiates|opiates
770063|NCT00367302|buprenorphine|buprenorphine
770064|NCT00367302|clinical trial|clinical trial
770065|NCT00367276|Females requiring contraceptives|females requiring contraceptives
770066|NCT00367263|Asthma|asthma
770067|NCT00367224|vitiligo|vitiligo
770068|NCT00367224|tolerance|tolerance
770070|NCT00367211|Gastric Ulcers|gastric ulcers
770071|NCT00367211|NSAID|nsaid
770072|NCT00367211|Arthritis|arthritis
770073|NCT00367185|Multiple myeloma|multiple myeloma
770074|NCT00367185|Elderly patients|elderly patients
770075|NCT00367185|Thalidomide|thalidomide
770076|NCT00367185|Autologous transplantation|autologous transplantation
770077|NCT00367172|human immunodeficiency virus|human immunodeficiency virus
770078|NCT00367172|acquired immunodeficiency syndrome|acquired immunodeficiency syndrome
770079|NCT00367172|substance abuse|substance abuse
770080|NCT00367172|directly administered antiretroviral therapy|directly administered antiretroviral therapy
770081|NCT00367172|adherence, directly observed therapy|adherence, directly observed therapy
770082|NCT00367159|Vesico-ureteral reflux, autologous adipocytes, adipocytes graft|vesico-ureteral reflux, autologous adipocytes, adipocytes graft
770083|NCT00367146|liver transplantation|liver transplantation
770084|NCT00367146|children|children
770085|NCT00367146|immunosuppression|immunosuppression
770086|NCT00367146|mycophenolatmofetil|mycophenolatmofetil
770087|NCT00367146|calcineurin inhibitor|calcineurin inhibitor
770088|NCT00367146|kidney disease|kidney disease
770089|NCT00367133|diabetic|diabetic
770090|NCT00367133|macular|macular
770091|NCT00367133|edema|edema
770092|NCT00367133|intravitreal|intravitreal
770093|NCT00367133|triamcinolone|triamcinolone
770094|NCT00367133|laser|laser
770095|NCT00367133|photocoagulation|photocoagulation
770096|NCT00367133|DME|dme
770097|NCT00367107|Autism spectrum disorders|autism spectrum disorders
770098|NCT00367107|long-term outcomes|long-term outcomes
770099|NCT00367107|caregiver burden|caregiver burden
770100|NCT00367107|birth cohort|birth cohort
770101|NCT00367107|nested case-control study|nested case-control study
770102|NCT00367094|Hypertension, benazepril, hydrochlorothiazide, fixed combination|hypertension, benazepril, hydrochlorothiazide, fixed combination
770103|NCT00367081|Toxoplasmic Encephalitis|toxoplasmic encephalitis
770104|NCT00367081|AIDS|aids
770105|NCT00367068|Cerebral palsy|cerebral palsy
770106|NCT00367068|Spasticity|spasticity
770107|NCT00367068|Child|child
770108|NCT00367068|Baclofen|baclofen
770109|NCT00367068|Intrathecal injection|intrathecal injection
770110|NCT00367055|Beta cell function|beta cell function
770111|NCT00367055|Type 2 diabetes|type 2 diabetes
770112|NCT00367055|Combination treatment|combination treatment
770113|NCT00367029|Physical Activity|physical activity
770114|NCT00367003|Depression, Unipolar, Bipolar-II, DBS, Imaging|depression, unipolar, bipolar-ii, dbs, imaging
770115|NCT00366990|Arterial Stiffening|arterial stiffening
770116|NCT00366977|Cessation|cessation
770117|NCT00366977|Smoking|smoking
770118|NCT00366977|Quitline|quitline
770119|NCT00366977|Policies|policies
770120|NCT00366977|Counseling|counseling
770121|NCT00366951|Cervical Ripening|cervical ripening
770122|NCT00366951|Labor, Induced|labor, induced
770123|NCT00366951|Balloon Dilation|balloon dilation
770124|NCT00366951|Oxytocin|oxytocin
770125|NCT00366938|Osteoarthritis, lumiracoxib, celecoxib, Cox-2|osteoarthritis, lumiracoxib, celecoxib, cox-2
770126|NCT00366912|work of breathing|work of breathing
770127|NCT00366912|pressure time product|pressure time product
770128|NCT00366912|muscle pressures|muscle pressures
770129|NCT00366899|Vaccine|vaccine
770130|NCT00366899|Infants|infants
770131|NCT00366886|cardiac|cardiac
770132|NCT00366886|pediatric|pediatric
770133|NCT00366886|surgery|surgery
770134|NCT00366886|blood markers|blood markers
770135|NCT00366873|Infant|infant
770136|NCT00366873|Term|term
770137|NCT00366860|soy|soy
770138|NCT00366860|isoflavones|isoflavones
770139|NCT00366860|bone resorption|bone resorption
770140|NCT00366860|osteogenesis|osteogenesis
770141|NCT00366860|diet|diet
770142|NCT00366860|hyperlipidemia|hyperlipidemia
770143|NCT00366847|cardiac|cardiac
770144|NCT00366847|MRI|mri
770145|NCT00366847|pediatrics|pediatrics
770146|NCT00366834|Anthracycline|anthracycline
770147|NCT00366834|Cyclophosphamide|cyclophosphamide
770148|NCT00366834|Moderately|moderately
770149|NCT00366834|Nausea|nausea
770150|NCT00366834|Emetogenic|emetogenic
770151|NCT00366834|Vomiting|vomiting
770152|NCT00366821|cardiac|cardiac
770153|NCT00366821|pediatric|pediatric
770154|NCT00366821|genetic|genetic
770155|NCT00366782|Respiratory Tract Disease|respiratory tract disease
770156|NCT00366782|Bovine|bovine
770157|NCT00366782|Chimeric Vaccine|chimeric vaccine
770158|NCT00366756|Vision|vision
770159|NCT00366756|Visual Acuity|visual acuity
770160|NCT00366730|Amebiasis|amebiasis
770161|NCT00366730|Entamoeba histolytica|entamoeba histolytica
770162|NCT00366717|Cancer under chemotherapy|cancer under chemotherapy
770163|NCT00366704|Schizophrenia|schizophrenia
770164|NCT00366691|cataract|cataract
770165|NCT00366678|Safety|safety
770166|NCT00366678|Vaccine|vaccine
770167|NCT00366652|Healthy|healthy
770168|NCT00366639|Heart failure, congestive|heart failure, congestive
770169|NCT00366639|Heart decompensation|heart decompensation
770170|NCT00366626|Alcohol dependence|alcohol dependence
770171|NCT00366626|Alcoholism|alcoholism
770172|NCT00366626|Craving|craving
770174|NCT00366613|Cataract|cataract
770175|NCT00366613|Cataract Extraction|cataract extraction
770176|NCT00366600|Breast Cancer|breast cancer
770177|NCT00366600|Health|health
770178|NCT00366600|Pharmacokinetics|pharmacokinetics
770179|NCT00366600|healthy subjects|healthy subjects
770180|NCT00366561|neonates|neonates
770181|NCT00366561|neurological complications|neurological complications
770182|NCT00366561|surgery|surgery
770183|NCT00366548|Vaccine|vaccine
770184|NCT00366548|Infant|infant
770185|NCT00366535|Muscle Pain|muscle pain
770186|NCT00366535|Fibrositis Allodynia|fibrositis allodynia
770187|NCT00366535|Stiffness|stiffness
770188|NCT00366535|Tender Points|tender points
770189|NCT00366535|Fibromyalgia|fibromyalgia
770190|NCT00366522|Safety|safety
770191|NCT00366522|Healthy|healthy
770192|NCT00366522|healthy subjects|healthy subjects
770193|NCT00366509|Vac A Toxin|vac a toxin
770194|NCT00366509|Lung|lung
770195|NCT00366509|Bronchoscopy|bronchoscopy
770196|NCT00366509|Endoscopy|endoscopy
770197|NCT00366509|Cytotoxin|cytotoxin
770198|NCT00366509|Pulmonary Disease|pulmonary disease
770199|NCT00366509|Lung Disease|lung disease
770200|NCT00366509|Genetic Disease|genetic disease
770201|NCT00366509|Oropharyngeal Disease|oropharyngeal disease
770202|NCT00366509|Pulmonary Fibrosis|pulmonary fibrosis
770203|NCT00366509|Asthma|asthma
770204|NCT00366483|healthy young volunteers|healthy young volunteers
770205|NCT00366483|healthy elderly volunteers|healthy elderly volunteers
770206|NCT00366483|Alzheimer's disease|alzheimer's disease
770207|NCT00366483|5HT1A antagonist|5ht1a antagonist
770208|NCT00366483|Health|health
770209|NCT00366483|Pharmacokinetics|pharmacokinetics
770210|NCT00366444|Bunionectomy|bunionectomy
770211|NCT00366444|Bunion surgery|bunion surgery
770212|NCT00366444|Post-operative pain|post-operative pain
770213|NCT00366431|OIBD|oibd
770214|NCT00366431|OIC|oic
770215|NCT00366431|Opioid|opioid
770216|NCT00366431|Constipation|constipation
770217|NCT00366431|Laxative|laxative
770218|NCT00366418|CLL|cll
770219|NCT00366418|Monoclonal Antibody Therapy|monoclonal antibody therapy
770220|NCT00366418|Anti CD20|anti cd20
770221|NCT00366418|Biologic Response Modifier Therapy|biologic response modifier therapy
770222|NCT00366418|Fractionated-Dose|fractionated-dose
770223|NCT00366418|Low-Dose|low-dose
770224|NCT00366418|Chronic Lymphocytic Leukemia|chronic lymphocytic leukemia
770225|NCT00366405|cataract|cataract
770226|NCT00366392|Low Vision|low vision
770227|NCT00366392|Optical Aids|optical aids
770228|NCT00366353|Mechanical Ventilation|mechanical ventilation
770229|NCT00366353|Spontaneous Breathing Trial|spontaneous breathing trial
770230|NCT00366353|Sedation|sedation
770231|NCT00366340|safety|safety
770232|NCT00366340|Vaccine|vaccine
770233|NCT00366327|Schizophrenia|schizophrenia
770234|NCT00366314|Blood samples|blood samples
770235|NCT00366314|Medication administration|medication administration
770236|NCT00366314|CICU|cicu
770237|NCT00366314|PICU|picu
770238|NCT00366314|NICU|nicu
770239|NCT00366301|type 2 diabetes|type 2 diabetes
770240|NCT00366301|insulin|insulin
770241|NCT00366301|insulin injection|insulin injection
770242|NCT00366301|metformin|metformin
770243|NCT00366301|C-reactive protein|c-reactive protein
770244|NCT00366301|insulin sensitivity|insulin sensitivity
770245|NCT00366301|glycemic control|glycemic control
770246|NCT00366301|inflammation|inflammation
770247|NCT00366288|Healthy|healthy
770248|NCT00366288|Safety|safety
770249|NCT00366275|follicular lymphoma|follicular lymphoma
770250|NCT00366275|rituximab|rituximab
770251|NCT00366275|immunochemotherapy|immunochemotherapy
770252|NCT00366275|peripheral blood stem cells (PBSC) mobilization|peripheral blood stem cells (pbsc) mobilization
770253|NCT00366275|in vivo purging|in vivo purging
770254|NCT00366275|autotransplant|autotransplant
770255|NCT00366275|bcl-2 rearrangement|bcl-2 rearrangement
770256|NCT00366275|molecular response|molecular response
770257|NCT00366262|Health|health
770258|NCT00366249|Diabetic foot infection|diabetic foot infection
770259|NCT00366249|Osteomyelitis|osteomyelitis
770260|NCT00366249|Diabetes Complications|diabetes complications
770261|NCT00366249|Foot ulcer|foot ulcer
770262|NCT00366249|Skin infection|skin infection
770263|NCT00366236|Amebiasis|amebiasis
770264|NCT00366236|Entamoeba histolytica|entamoeba histolytica
770265|NCT00366223|infection|infection
770266|NCT00366223|candida|candida
770267|NCT00366210|stroke|stroke
770268|NCT00366210|rehabilitation|rehabilitation
770269|NCT00366210|physical therapy|physical therapy
770270|NCT00366210|occupational therapy|occupational therapy
770271|NCT00366210|arm|arm
770272|NCT00366197|Rapid Shallow Breathing Index|rapid shallow breathing index
770273|NCT00366197|Mechanical Ventilation|mechanical ventilation
770274|NCT00366184|Neuromodulation|neuromodulation
770275|NCT00366184|Stroke|stroke
770276|NCT00366184|Motor Cortex|motor cortex
770277|NCT00366184|Motor Learning|motor learning
770278|NCT00366184|L-Dopa|l-dopa
770279|NCT00366184|Transcranial Magnetic Stimulation|transcranial magnetic stimulation
770280|NCT00366184|Levodopa|levodopa
770281|NCT00366184|Healthy Volunteer|healthy volunteer
770282|NCT00366184|HV|hv
770283|NCT00366171|Schizophrenia|schizophrenia
770284|NCT00366158|Patients with intact AV conduction|patients with intact av conduction
770285|NCT00366145|acute GVHD|acute gvhd
770286|NCT00366145|steroid refractory GVHD|steroid refractory gvhd
770287|NCT00366145|severe steroid refractory acute GVHD|severe steroid refractory acute gvhd
770288|NCT00366145|steroid refractory|steroid refractory
770289|NCT00366145|Steroid Refractory Acute Graft Versus Host Disease|steroid refractory acute graft versus host disease
770290|NCT00366132|Diabetic|diabetic
770291|NCT00366132|Foot Ulcers|foot ulcers
770292|NCT00366132|TRT|trt
770293|NCT00366132|DermaGold|dermagold
770294|NCT00366132|Shockwave|shockwave
770295|NCT00366132|ESWT|eswt
770296|NCT00366132|Diabetes Mellitus|diabetes mellitus
770297|NCT00366119|hypertension|hypertension
770298|NCT00366119|ramipril|ramipril
770299|NCT00366119|blood pressure|blood pressure
770300|NCT00366119|artery stiffness|artery stiffness
770301|NCT00366119|BNP|bnp
770302|NCT00366119|CRP|crp
770303|NCT00366106|Relapsed Multiple Myeloma|relapsed multiple myeloma
770304|NCT00366106|Refractory Multiple Myeloma|refractory multiple myeloma
770305|NCT00366093|Menopause|menopause
770306|NCT00366093|Perimenopause|perimenopause
770307|NCT00366080|GSK189254 H3 Histamine Narcolepsy|gsk189254 h3 histamine narcolepsy
770308|NCT00366067|Bronchial asthma|bronchial asthma
770309|NCT00366067|Phenytoin|phenytoin
770310|NCT00366067|Antiepileptic drugs|antiepileptic drugs
770311|NCT00366067|Efficacy|efficacy
770312|NCT00366028|Organization Innovation|organization innovation
770313|NCT00366028|Diffusion of Innovation|diffusion of innovation
770314|NCT00366028|Evidence-based Medicine|evidence-based medicine
770315|NCT00366028|Infection Control|infection control
770316|NCT00366015|Coronary Artery Disease|coronary artery disease
770317|NCT00366015|PCI|pci
770318|NCT00366015|Drug eluting stents|drug eluting stents
770319|NCT00366015|Coronary Hybrid Revascularization|coronary hybrid revascularization
770320|NCT00366015|Robotic CABG|robotic cabg
770321|NCT00366002|Darifenacin,Overactive Bladder,antimuscarinic,M3 muscarinic receptor antagonist|darifenacin,overactive bladder,antimuscarinic,m3 muscarinic receptor antagonist
770322|NCT00365989|Fibroids|fibroids
770323|NCT00365989|leiomyoma|leiomyoma
770324|NCT00365989|neoplasm|neoplasm
770325|NCT00365989|benign tumors|benign tumors
770326|NCT00365976|Insomnia|insomnia
770327|NCT00365976|Low Back Pain|low back pain
770328|NCT00365976|Hypnotics|hypnotics
770329|NCT00365976|Eszopiclone|eszopiclone
770330|NCT00365976|Pain|pain
770331|NCT00365976|Disability|disability
770332|NCT00365963|lung cancer, caregivers, support, resources, education|lung cancer, caregivers, support, resources, education
770333|NCT00365950|Duration of anticoagulation|duration of anticoagulation
770334|NCT00365950|Deep vein thrombosis and/or pulmonary embolism|deep vein thrombosis and/or pulmonary embolism
770335|NCT00365937|immunotherapy|immunotherapy
770336|NCT00365937|adjuvants|adjuvants
770337|NCT00365937|IMP321|imp321
770338|NCT00365937|Montanide ISA51 VG|montanide isa51 vg
770339|NCT00365937|tumor-specific peptides|tumor-specific peptides
770340|NCT00365924|12 month therapy with postmenopausal women with osteoporosis to examine changes in bone quality parameters|12 month therapy with postmenopausal women with osteoporosis to examine changes in bone quality parameters
770341|NCT00365911|No specific condition|no specific condition
770342|NCT00365898|Chronic non-malignant pain, opioid|chronic non-malignant pain, opioid
770343|NCT00365885|Medical Informatics|medical informatics
770344|NCT00365885|Decision Support Systems, Clinical|decision support systems, clinical
770345|NCT00365885|Community Health Services|community health services
770346|NCT00365885|Costs and Cost analysis|costs and cost analysis
770347|NCT00365872|Sarcoma|sarcoma
770348|NCT00365872|Intratumoral injection|intratumoral injection
770349|NCT00365872|Dendritic cells|dendritic cells
770350|NCT00365872|Neo-adjuvant treatment|neo-adjuvant treatment
770351|NCT00365872|Immunotherapy|immunotherapy
770352|NCT00365872|Pheresis|pheresis
770353|NCT00365872|Radiation|radiation
770354|NCT00365859|Serious behavioral problems in children and adolescents with AD|serious behavioral problems in children and adolescents with ad
770355|NCT00365859|behavioral problems|behavioral problems
770356|NCT00365846|prevent kidney rejection|prevent kidney rejection
770357|NCT00365833|Transplantation|transplantation
770358|NCT00365833|Cardiovascular|cardiovascular
770359|NCT00365833|Renal|renal
770360|NCT00365820|Opioid, constipation, tegaserod|opioid, constipation, tegaserod
770361|NCT00365820|Opioid-induced constipation|opioid-induced constipation
770362|NCT00365807|Obesity|obesity
770363|NCT00365807|Overweight|overweight
770364|NCT00365807|Behavioral treatment|behavioral treatment
770365|NCT00365807|Family involvement|family involvement
770366|NCT00365794|Aging|aging
770367|NCT00365794|Older men|older men
770368|NCT00365794|Abdominal obesity|abdominal obesity
770369|NCT00365794|Central obesity|central obesity
770370|NCT00365794|Insulin resistance|insulin resistance
770371|NCT00365794|Low testosterone|low testosterone
770372|NCT00365781|Injection Site Reaction|injection site reaction
770373|NCT00365781|Subcutaneous administration|subcutaneous administration
770374|NCT00365781|Dermatological effects|dermatological effects
770375|NCT00365781|Antisense|antisense
770376|NCT00365768|stage II childhood lymphoblastic lymphoma|stage ii childhood lymphoblastic lymphoma
770377|NCT00365768|stage III childhood lymphoblastic lymphoma|stage iii childhood lymphoblastic lymphoma
770378|NCT00365768|stage II childhood small noncleaved cell lymphoma|stage ii childhood small noncleaved cell lymphoma
770379|NCT00365768|stage I Wilms tumor|stage i wilms tumor
770380|NCT00365768|stage II Wilms tumor|stage ii wilms tumor
770381|NCT00365768|stage III Wilms tumor|stage iii wilms tumor
770382|NCT00365768|stage IV Wilms tumor|stage iv wilms tumor
770383|NCT00365768|stage V Wilms tumor|stage v wilms tumor
770384|NCT00365768|childhood grade III lymphomatoid granulomatosis|childhood grade iii lymphomatoid granulomatosis
770385|NCT00365768|childhood diffuse large cell lymphoma|childhood diffuse large cell lymphoma
770386|NCT00365768|childhood immunoblastic large cell lymphoma|childhood immunoblastic large cell lymphoma
770387|NCT00365768|stage I childhood large cell lymphoma|stage i childhood large cell lymphoma
770388|NCT00365768|stage I childhood lymphoblastic lymphoma|stage i childhood lymphoblastic lymphoma
770389|NCT00365768|stage I childhood small noncleaved cell lymphoma|stage i childhood small noncleaved cell lymphoma
770390|NCT00365768|stage II childhood large cell lymphoma|stage ii childhood large cell lymphoma
770391|NCT00365768|stage III childhood large cell lymphoma|stage iii childhood large cell lymphoma
770392|NCT00365768|stage IV childhood large cell lymphoma|stage iv childhood large cell lymphoma
770393|NCT00365768|stage IV childhood lymphoblastic lymphoma|stage iv childhood lymphoblastic lymphoma
770394|NCT00365768|stage IV childhood small noncleaved cell lymphoma|stage iv childhood small noncleaved cell lymphoma
770395|NCT00365768|childhood Burkitt lymphoma|childhood burkitt lymphoma
770396|NCT00365768|stage III childhood small noncleaved cell lymphoma|stage iii childhood small noncleaved cell lymphoma
770397|NCT00365768|untreated childhood acute lymphoblastic leukemia|untreated childhood acute lymphoblastic leukemia
770398|NCT00365768|childhood nasal type extranodal NK/T-cell lymphoma|childhood nasal type extranodal nk/t-cell lymphoma
770399|NCT00365768|previously untreated childhood rhabdomyosarcoma|previously untreated childhood rhabdomyosarcoma
770400|NCT00365768|localized Ewing sarcoma/PNET|localized ewing sarcoma/pnet
770401|NCT00365768|metastatic Ewing sarcoma/PNET|metastatic ewing sarcoma/pnet
770402|NCT00365768|neurotoxicity|neurotoxicity
770403|NCT00365768|peripheral neuropathy|peripheral neuropathy
770404|NCT00365755|disseminated neuroblastoma|disseminated neuroblastoma
770405|NCT00365742|red yeast rice|red yeast rice
770406|NCT00365742|pharmaceutical grade fish oil|pharmaceutical grade fish oil
770407|NCT00365742|simvastatin|simvastatin
770408|NCT00365742|primary prevention|primary prevention
770409|NCT00365729|genitoanal HPV infection|genitoanal hpv infection
770410|NCT00365729|HIV infection|hiv infection
770411|NCT00365716|HPV 6/11/16/18 infection and related genital disease|hpv 6/11/16/18 infection and related genital disease
770412|NCT00365703|Infant, Premature|infant, premature
770413|NCT00365703|Tube feeding|tube feeding
770414|NCT00365690|AIDS|aids
770415|NCT00365690|Older Adults|older adults
770416|NCT00365690|Telephone|telephone
770417|NCT00365690|Telemedicine|telemedicine
770418|NCT00365651|obesity|obesity
770419|NCT00365651|overweight|overweight
770420|NCT00365638|PCOS|pcos
770421|NCT00365638|statin|statin
770422|NCT00365638|testosterone|testosterone
770423|NCT00365638|lipids|lipids
770424|NCT00365625|Psoriasis|psoriasis
770425|NCT00365625|JAM3 protein, human|jam3 protein, human
770426|NCT00365625|Cell Adhesion Molecules|cell adhesion molecules
770427|NCT00365625|Skin|skin
770428|NCT00365625|Inflammation|inflammation
770429|NCT00365625|Lymphocytes|lymphocytes
770430|NCT00365612|HIV|hiv
770431|NCT00365612|HIV-1|hiv-1
770432|NCT00365612|AIDS|aids
770433|NCT00365612|Human Immunodeficiency Virus|human immunodeficiency virus
770434|NCT00365612|HIV-1 Infection|hiv-1 infection
770435|NCT00365599|Breast cancer|breast cancer
770436|NCT00365599|Suberoylanilide hydroxamic acid (SAHA)|suberoylanilide hydroxamic acid (saha)
770437|NCT00365599|Vorinostat|vorinostat
770439|NCT00365599|Anti-hormonal therapy|anti-hormonal therapy
770440|NCT00365599|Estrogen receptor positive|estrogen receptor positive
770441|NCT00365599|Progesterone receptor positive|progesterone receptor positive
770442|NCT00365599|Metastatic disease|metastatic disease
770443|NCT00365599|Aromatase inhibitors (Ais)|aromatase inhibitors (ais)
770444|NCT00365599|Histone deacetylase (HDAC) inhibitors|histone deacetylase (hdac) inhibitors
770445|NCT00365599|Selective estrogen receptor modulators(SERMS)|selective estrogen receptor modulators(serms)
770446|NCT00365586|Pain|pain
770447|NCT00365586|Osteoarthritis|osteoarthritis
770448|NCT00365586|Knee|knee
770449|NCT00365586|NSAID|nsaid
770450|NCT00365547|recurrent non-small cell lung cancer|recurrent non-small cell lung cancer
770451|NCT00365547|stage IIIB non-small cell lung cancer|stage iiib non-small cell lung cancer
770452|NCT00365547|stage IV non-small cell lung cancer|stage iv non-small cell lung cancer
770453|NCT00365547|adenocarcinoma of the lung|adenocarcinoma of the lung
770454|NCT00365547|bronchoalveolar cell lung cancer|bronchoalveolar cell lung cancer
770455|NCT00365547|large cell lung cancer|large cell lung cancer
770456|NCT00365534|First colonoscopy examination|first colonoscopy examination
770457|NCT00365521|Organ transplant patients receiving immunosuppressive therapy|organ transplant patients receiving immunosuppressive therapy
770458|NCT00365508|bladder cancer|bladder cancer
770459|NCT00365508|cervical cancer|cervical cancer
770460|NCT00365508|esophageal cancer|esophageal cancer
770461|NCT00365508|gastric cancer|gastric cancer
770462|NCT00365508|renal cell carcinoma|renal cell carcinoma
770463|NCT00365508|adult primary liver cancer|adult primary liver cancer
770464|NCT00365508|non-small cell lung cancer|non-small cell lung cancer
770465|NCT00365508|small cell lung cancer|small cell lung cancer
770466|NCT00365508|pancreatic cancer|pancreatic cancer
770467|NCT00365508|hypopharyngeal cancer|hypopharyngeal cancer
770468|NCT00365508|laryngeal cancer|laryngeal cancer
770469|NCT00365508|lip and oral cavity cancer|lip and oral cavity cancer
770470|NCT00365508|nasopharyngeal cancer|nasopharyngeal cancer
770471|NCT00365508|oropharyngeal cancer|oropharyngeal cancer
770472|NCT00365508|paranasal sinus and nasal cavity cancer|paranasal sinus and nasal cavity cancer
770473|NCT00365508|adult acute myeloid leukemia|adult acute myeloid leukemia
770474|NCT00365508|tongue cancer|tongue cancer
770475|NCT00365508|tobacco use disorder|tobacco use disorder
770476|NCT00365495|Type 2 diabetes|type 2 diabetes
770477|NCT00365495|physical training|physical training
770478|NCT00365495|mitochondrial function|mitochondrial function
770479|NCT00365482|Epilepsy|epilepsy
770480|NCT00365482|Bipolar Disorder|bipolar disorder
770481|NCT00365469|Probiotics|probiotics
770482|NCT00365469|Eczema|eczema
770483|NCT00365469|Asthma|asthma
770484|NCT00365469|Allergic Rhinitis|allergic rhinitis
770485|NCT00365469|Prevention|prevention
770486|NCT00365469|Immunological responses|immunological responses
770487|NCT00365456|Lumbar Spine Bone Mineral Density (BMD)|lumbar spine bone mineral density (bmd)
770488|NCT00365443|anogenital warts|anogenital warts
770489|NCT00365443|premalignancy|premalignancy
770490|NCT00365443|HPV|hpv
770491|NCT00365443|Human papillomavirus|human papillomavirus
770492|NCT00365430|Patient safety|patient safety
770493|NCT00365430|Adverse event|adverse event
770494|NCT00365430|Prevention|prevention
770495|NCT00365430|Knowledge|knowledge
770496|NCT00365430|Inpatient|inpatient
770497|NCT00365430|Hospital|hospital
770498|NCT00365430|Nursing home|nursing home
770499|NCT00365430|Long term care|long term care
770500|NCT00365430|Nurse|nurse
770501|NCT00365417|NSABP|nsabp
770502|NCT00365417|Doxorubicin|doxorubicin
770503|NCT00365417|Cyclophosphamide|cyclophosphamide
770504|NCT00365417|Bevacizumab|bevacizumab
770505|NCT00365417|Capecitabine|capecitabine
770506|NCT00365417|Docetaxel|docetaxel
770507|NCT00365417|Breast cancer|breast cancer
770508|NCT00365417|Locally advanced|locally advanced
770509|NCT00365417|Neoadjuvant|neoadjuvant
770510|NCT00365417|Locally advanced breast cancer|locally advanced breast cancer
770511|NCT00365404|Behavioral change|behavioral change
770512|NCT00365404|Weight management|weight management
770513|NCT00365404|Physical activity|physical activity
770514|NCT00365339|HIV|hiv
770515|NCT00365339|Protease Inhibitor|protease inhibitor
770516|NCT00365326|AC133|ac133
770517|NCT00365326|coronary|coronary
770518|NCT00365326|bone marrow|bone marrow
770519|NCT00365326|autologous|autologous
770520|NCT00365326|coronary artery disease|coronary artery disease
770521|NCT00365313|celecoxib|celecoxib
770522|NCT00365313|oesomeprazole|oesomeprazole
770523|NCT00365313|arthritis|arthritis
770524|NCT00365313|ulcer bleeding|ulcer bleeding
770525|NCT00365300|GERD|gerd
770526|NCT00365300|Infants|infants
770527|NCT00365300|Gastroesophageal Reflux|gastroesophageal reflux
770528|NCT00365287|stage IV breast cancer|stage iv breast cancer
770529|NCT00365287|recurrent renal cell cancer|recurrent renal cell cancer
770530|NCT00365287|stage III renal cell cancer|stage iii renal cell cancer
770531|NCT00365287|stage IV renal cell cancer|stage iv renal cell cancer
770532|NCT00365287|adult acute myeloid leukemia in remission|adult acute myeloid leukemia in remission
770593|NCT00365287|refractory multiple myeloma|refractory multiple myeloma
770533|NCT00365287|adult acute myeloid leukemia with 11q23 (MLL) abnormalities|adult acute myeloid leukemia with 11q23 (mll) abnormalities
770534|NCT00365287|adult acute myeloid leukemia with inv(16)(p13;q22)|adult acute myeloid leukemia with inv(16)(p13;q22)
770535|NCT00365287|adult acute myeloid leukemia with t(15;17)(q22;q12)|adult acute myeloid leukemia with t(15;17)(q22;q12)
770536|NCT00365287|adult acute myeloid leukemia with t(16;16)(p13;q22)|adult acute myeloid leukemia with t(16;16)(p13;q22)
770537|NCT00365287|adult acute myeloid leukemia with t(8;21)(q22;q22)|adult acute myeloid leukemia with t(8;21)(q22;q22)
770538|NCT00365287|recurrent adult acute myeloid leukemia|recurrent adult acute myeloid leukemia
770539|NCT00365287|recurrent childhood acute myeloid leukemia|recurrent childhood acute myeloid leukemia
770540|NCT00365287|accelerated phase chronic myelogenous leukemia|accelerated phase chronic myelogenous leukemia
770541|NCT00365287|chronic phase chronic myelogenous leukemia|chronic phase chronic myelogenous leukemia
770542|NCT00365287|relapsing chronic myelogenous leukemia|relapsing chronic myelogenous leukemia
770543|NCT00365287|recurrent adult Hodgkin lymphoma|recurrent adult hodgkin lymphoma
770544|NCT00365287|recurrent/refractory childhood Hodgkin lymphoma|recurrent/refractory childhood hodgkin lymphoma
770545|NCT00365287|stage III adult Hodgkin lymphoma|stage iii adult hodgkin lymphoma
770546|NCT00365287|stage IV adult Hodgkin lymphoma|stage iv adult hodgkin lymphoma
770547|NCT00365287|stage III chronic lymphocytic leukemia|stage iii chronic lymphocytic leukemia
771000|NCT00363818|Aggregation|aggregation
770548|NCT00365287|stage IV chronic lymphocytic leukemia|stage iv chronic lymphocytic leukemia
770549|NCT00365287|stage I multiple myeloma|stage i multiple myeloma
770550|NCT00365287|stage II multiple myeloma|stage ii multiple myeloma
770551|NCT00365287|stage III multiple myeloma|stage iii multiple myeloma
770552|NCT00365287|de novo myelodysplastic syndromes|de novo myelodysplastic syndromes
770553|NCT00365287|previously treated myelodysplastic syndromes|previously treated myelodysplastic syndromes
770554|NCT00365287|secondary myelodysplastic syndromes|secondary myelodysplastic syndromes
770555|NCT00365287|refractory anemia|refractory anemia
770556|NCT00365287|adult acute lymphoblastic leukemia in remission|adult acute lymphoblastic leukemia in remission
770557|NCT00365287|blastic phase chronic myelogenous leukemia|blastic phase chronic myelogenous leukemia
770558|NCT00365287|childhood acute lymphoblastic leukemia in remission|childhood acute lymphoblastic leukemia in remission
770559|NCT00365287|childhood acute myeloid leukemia in remission|childhood acute myeloid leukemia in remission
770560|NCT00365287|childhood chronic myelogenous leukemia|childhood chronic myelogenous leukemia
770561|NCT00365287|extranodal marginal zone B-cell lymphoma of mucosa-associated lymphoid tissue|extranodal marginal zone b-cell lymphoma of mucosa-associated lymphoid tissue
770562|NCT00365287|nodal marginal zone B-cell lymphoma|nodal marginal zone b-cell lymphoma
770563|NCT00365287|noncontiguous stage II adult Burkitt lymphoma|noncontiguous stage ii adult burkitt lymphoma
770564|NCT00365287|noncontiguous stage II adult diffuse large cell lymphoma|noncontiguous stage ii adult diffuse large cell lymphoma
770565|NCT00365287|noncontiguous stage II adult diffuse mixed cell lymphoma|noncontiguous stage ii adult diffuse mixed cell lymphoma
770566|NCT00365287|noncontiguous stage II adult diffuse small cleaved cell lymphoma|noncontiguous stage ii adult diffuse small cleaved cell lymphoma
770567|NCT00365287|noncontiguous stage II adult immunoblastic large cell lymphoma|noncontiguous stage ii adult immunoblastic large cell lymphoma
770568|NCT00365287|noncontiguous stage II adult lymphoblastic lymphoma|noncontiguous stage ii adult lymphoblastic lymphoma
770569|NCT00365287|noncontiguous stage II grade 1 follicular lymphoma|noncontiguous stage ii grade 1 follicular lymphoma
770570|NCT00365287|noncontiguous stage II grade 2 follicular lymphoma|noncontiguous stage ii grade 2 follicular lymphoma
770571|NCT00365287|noncontiguous stage II grade 3 follicular lymphoma|noncontiguous stage ii grade 3 follicular lymphoma
770572|NCT00365287|noncontiguous stage II mantle cell lymphoma|noncontiguous stage ii mantle cell lymphoma
770573|NCT00365287|noncontiguous stage II marginal zone lymphoma|noncontiguous stage ii marginal zone lymphoma
770574|NCT00365287|noncontiguous stage II small lymphocytic lymphoma|noncontiguous stage ii small lymphocytic lymphoma
770575|NCT00365287|recurrent adult acute lymphoblastic leukemia|recurrent adult acute lymphoblastic leukemia
770576|NCT00365287|recurrent adult Burkitt lymphoma|recurrent adult burkitt lymphoma
770577|NCT00365287|recurrent adult diffuse large cell lymphoma|recurrent adult diffuse large cell lymphoma
770578|NCT00365287|recurrent adult diffuse mixed cell lymphoma|recurrent adult diffuse mixed cell lymphoma
770579|NCT00365287|recurrent adult diffuse small cleaved cell lymphoma|recurrent adult diffuse small cleaved cell lymphoma
770580|NCT00365287|recurrent adult immunoblastic large cell lymphoma|recurrent adult immunoblastic large cell lymphoma
770581|NCT00365287|recurrent adult lymphoblastic lymphoma|recurrent adult lymphoblastic lymphoma
770582|NCT00365287|recurrent childhood acute lymphoblastic leukemia|recurrent childhood acute lymphoblastic leukemia
770583|NCT00365287|recurrent childhood lymphoblastic lymphoma|recurrent childhood lymphoblastic lymphoma
770584|NCT00365287|recurrent childhood large cell lymphoma|recurrent childhood large cell lymphoma
770585|NCT00365287|recurrent childhood small noncleaved cell lymphoma|recurrent childhood small noncleaved cell lymphoma
770586|NCT00365287|recurrent grade 1 follicular lymphoma|recurrent grade 1 follicular lymphoma
770587|NCT00365287|recurrent grade 2 follicular lymphoma|recurrent grade 2 follicular lymphoma
770588|NCT00365287|recurrent grade 3 follicular lymphoma|recurrent grade 3 follicular lymphoma
770589|NCT00365287|recurrent mantle cell lymphoma|recurrent mantle cell lymphoma
770590|NCT00365287|recurrent marginal zone lymphoma|recurrent marginal zone lymphoma
770591|NCT00365287|recurrent small lymphocytic lymphoma|recurrent small lymphocytic lymphoma
770592|NCT00365287|refractory chronic lymphocytic leukemia|refractory chronic lymphocytic leukemia
770594|NCT00365287|secondary acute myeloid leukemia|secondary acute myeloid leukemia
770595|NCT00365287|splenic marginal zone lymphoma|splenic marginal zone lymphoma
770596|NCT00365287|stage III adult Burkitt lymphoma|stage iii adult burkitt lymphoma
770597|NCT00365287|stage III adult diffuse large cell lymphoma|stage iii adult diffuse large cell lymphoma
770598|NCT00365287|stage III adult diffuse mixed cell lymphoma|stage iii adult diffuse mixed cell lymphoma
770599|NCT00365287|stage III adult diffuse small cleaved cell lymphoma|stage iii adult diffuse small cleaved cell lymphoma
770600|NCT00365287|stage III adult immunoblastic large cell lymphoma|stage iii adult immunoblastic large cell lymphoma
770601|NCT00365287|stage III adult lymphoblastic lymphoma|stage iii adult lymphoblastic lymphoma
770602|NCT00365287|stage III grade 1 follicular lymphoma|stage iii grade 1 follicular lymphoma
770603|NCT00365287|stage III grade 2 follicular lymphoma|stage iii grade 2 follicular lymphoma
770604|NCT00365287|stage III grade 3 follicular lymphoma|stage iii grade 3 follicular lymphoma
770605|NCT00365287|stage III mantle cell lymphoma|stage iii mantle cell lymphoma
770606|NCT00365287|stage III marginal zone lymphoma|stage iii marginal zone lymphoma
770607|NCT00365287|stage III small lymphocytic lymphoma|stage iii small lymphocytic lymphoma
770608|NCT00365287|stage IV adult Burkitt lymphoma|stage iv adult burkitt lymphoma
770609|NCT00365287|stage IV adult diffuse large cell lymphoma|stage iv adult diffuse large cell lymphoma
770610|NCT00365287|stage IV adult diffuse mixed cell lymphoma|stage iv adult diffuse mixed cell lymphoma
770611|NCT00365287|stage IV adult diffuse small cleaved cell lymphoma|stage iv adult diffuse small cleaved cell lymphoma
770612|NCT00365287|stage IV adult immunoblastic large cell lymphoma|stage iv adult immunoblastic large cell lymphoma
770613|NCT00365287|stage IV adult lymphoblastic lymphoma|stage iv adult lymphoblastic lymphoma
770614|NCT00365287|stage IV grade 1 follicular lymphoma|stage iv grade 1 follicular lymphoma
770615|NCT00365287|stage IV grade 2 follicular lymphoma|stage iv grade 2 follicular lymphoma
770616|NCT00365287|stage IV grade 3 follicular lymphoma|stage iv grade 3 follicular lymphoma
770617|NCT00365287|stage IV mantle cell lymphoma|stage iv mantle cell lymphoma
770618|NCT00365287|stage IV marginal zone lymphoma|stage iv marginal zone lymphoma
770619|NCT00365287|stage IV small lymphocytic lymphoma|stage iv small lymphocytic lymphoma
770620|NCT00365287|refractory anemia with excess blasts in transformation|refractory anemia with excess blasts in transformation
770621|NCT00365287|refractory anemia with ringed sideroblasts|refractory anemia with ringed sideroblasts
770622|NCT00365287|refractory cytopenia with multilineage dysplasia|refractory cytopenia with multilineage dysplasia
770623|NCT00365287|refractory anemia with excess blasts|refractory anemia with excess blasts
770624|NCT00365287|childhood myelodysplastic syndromes|childhood myelodysplastic syndromes
770625|NCT00365274|non-Hodgkin's lymphoma|non-hodgkin's lymphoma
770626|NCT00365274|NHL|nhl
770627|NCT00365274|murine monoclonal antibody|murine monoclonal antibody
770628|NCT00365274|mAb|mab
770629|NCT00365274|SGN-30|sgn-30
770630|NCT00365274|CHOP|chop
770631|NCT00365274|Cyclophosphamide|cyclophosphamide
770632|NCT00365274|Doxorubicin Hydrochloride|doxorubicin hydrochloride
770633|NCT00365274|Vincristine|vincristine
770634|NCT00365274|Prednisone|prednisone
770635|NCT00365274|anaplastic large cell lymphoma|anaplastic large cell lymphoma
770636|NCT00365274|Lymphoma|lymphoma
770637|NCT00365274|Lymphoma, Large B-Cell, Diffuse|lymphoma, large b-cell, diffuse
770638|NCT00365274|Lymphoma, Non-Hodgkin|lymphoma, non-hodgkin
770639|NCT00365274|Lymphoma, Large-Cell, Anaplastic|lymphoma, large-cell, anaplastic
770640|NCT00365274|Neoplasms by Histologic Type|neoplasms by histologic type
770641|NCT00365274|Neoplasms|neoplasms
770642|NCT00365274|Lymphoproliferative Disorders|lymphoproliferative disorders
770643|NCT00365274|Lymphatic Diseases|lymphatic diseases
770644|NCT00365274|Immunoproliferative Disorders|immunoproliferative disorders
770645|NCT00365274|Immune System Diseases|immune system diseases
770646|NCT00365274|Lymphoma, B-Cell|lymphoma, b-cell
770647|NCT00365274|Lymphoma, T-Cell|lymphoma, t-cell
770648|NCT00365274|Antibodies|antibodies
770649|NCT00365274|Antibodies, Monoclonal|antibodies, monoclonal
770650|NCT00365274|Immunologic Factors|immunologic factors
770651|NCT00365274|Physiological Effects of Drugs|physiological effects of drugs
770652|NCT00365274|Pharmacologic Actions|pharmacologic actions
770653|NCT00365274|Immunosuppressive Agents|immunosuppressive agents
770654|NCT00365274|Antirheumatic Agents|antirheumatic agents
770655|NCT00365274|Therapeutic Uses|therapeutic uses
770656|NCT00365274|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating
770657|NCT00365274|Alkylating Agents|alkylating agents
770658|NCT00365274|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action
770659|NCT00365274|Antineoplastic Agents|antineoplastic agents
770660|NCT00365274|Myeloablative Agonists|myeloablative agonists
770661|NCT00365274|Antibiotics|antibiotics
770662|NCT00365274|Antineoplastic|antineoplastic
770663|NCT00365261|pain|pain
770664|NCT00365261|fatigue|fatigue
770665|NCT00365261|sleep|sleep
770666|NCT00365261|bone marrow transplant|bone marrow transplant
770667|NCT00365261|cancer|cancer
770668|NCT00365248|Surgical resection of the liver with or without segmental transplantation|surgical resection of the liver with or without segmental transplantation
770669|NCT00365222|Temozolomide|temozolomide
770670|NCT00365222|Temodar|temodar
770671|NCT00365222|Glioblastoma|glioblastoma
770672|NCT00365222|Gliosarcoma|gliosarcoma
770673|NCT00365222|Brain Tumor|brain tumor
770674|NCT00365222|Quality of Life|quality of life
770675|NCT00365222|Neurological|neurological
770676|NCT00365196|Autonomic Nervous System|autonomic nervous system
770677|NCT00365183|Non Small Cell Lung Cancer|non small cell lung cancer
770678|NCT00365183|Lung Cancer|lung cancer
770679|NCT00365183|Metastatic Lung Cancer|metastatic lung cancer
770680|NCT00365183|Inoperable Lung Cancer|inoperable lung cancer
770681|NCT00365183|Advanced Lung Cancer|advanced lung cancer
770682|NCT00365183|Large Cell Lung Cancer|large cell lung cancer
770683|NCT00365183|Adenocarcinoma, lung|adenocarcinoma, lung
770684|NCT00365183|Squamous Cell Carcinoma, lung|squamous cell carcinoma, lung
770685|NCT00365183|Squamous Cell Lung Cancer|squamous cell lung cancer
770686|NCT00365183|Large Cell Carcinoma, lung|large cell carcinoma, lung
770687|NCT00365183|Cancer of the Lung|cancer of the lung
770688|NCT00365183|Carcinoma|carcinoma
770689|NCT00365183|Bronchogenic|bronchogenic
770690|NCT00365144|stage IV pancreatic cancer|stage iv pancreatic cancer
770691|NCT00365144|adenocarcinoma of the pancreas|adenocarcinoma of the pancreas
770692|NCT00365144|recurrent pancreatic cancer|recurrent pancreatic cancer
770693|NCT00365131|Type I Gaucher disease|type i gaucher disease
770694|NCT00365131|Glucocerebrosidase Deficiency Disease|glucocerebrosidase deficiency disease
771001|NCT00363805|lung cancer|lung cancer
770695|NCT00365118|Port wine stains|port wine stains
770696|NCT00365118|naevus flammeus|naevus flammeus
770697|NCT00365105|pain|pain
770698|NCT00365105|bone metastases|bone metastases
770699|NCT00365105|extensive stage small cell lung cancer|extensive stage small cell lung cancer
770700|NCT00365105|recurrent breast cancer|recurrent breast cancer
770701|NCT00365105|stage IV breast cancer|stage iv breast cancer
770702|NCT00365105|recurrent non-small cell lung cancer|recurrent non-small cell lung cancer
770703|NCT00365105|stage IV non-small cell lung cancer|stage iv non-small cell lung cancer
770704|NCT00365105|recurrent prostate cancer|recurrent prostate cancer
770705|NCT00365105|stage IV prostate cancer|stage iv prostate cancer
770706|NCT00365092|Insertion of tympanostomy tubes|insertion of tympanostomy tubes
770707|NCT00365092|Otitis media with effusion|otitis media with effusion
770708|NCT00365092|Child development|child development
770709|NCT00365092|Literacy|literacy
770710|NCT00365092|Attention|attention
770711|NCT00365092|Middle-ear effusion|middle-ear effusion
770712|NCT00365092|Educational status|educational status
770713|NCT00365092|Behavior|behavior
770714|NCT00365092|Social behavior|social behavior
770715|NCT00365092|Achievement|achievement
770716|NCT00365040|myopia|myopia
770717|NCT00365040|excimer laser|excimer laser
770718|NCT00365027|GNRH agonist|gnrh agonist
770719|NCT00365027|ovarian hyperstimulation syndrome|ovarian hyperstimulation syndrome
770720|NCT00365027|Embryo cryopreservation|embryo cryopreservation
770721|NCT00365014|aplastic anemia|aplastic anemia
770722|NCT00365014|myelodysplastic syndromes|myelodysplastic syndromes
770723|NCT00365014|cytopenias|cytopenias
770724|NCT00365014|acute myeloid leukemia|acute myeloid leukemia
770725|NCT00365014|myelodysplastic/myeloproliferative diseases|myelodysplastic/myeloproliferative diseases
770726|NCT00365014|benzene poisoning|benzene poisoning
770727|NCT00364988|pioglitazone|pioglitazone
770728|NCT00364988|losartan|losartan
770729|NCT00364988|proteinuria|proteinuria
770730|NCT00364988|end stage renal disease (ESRD)|end stage renal disease (esrd)
770731|NCT00364975|gourmet healthy cooking|gourmet healthy cooking
770732|NCT00364975|quality of life|quality of life
770733|NCT00364975|adjuvant chemotherapy|adjuvant chemotherapy
770734|NCT00364975|weight|weight
770735|NCT00364975|breast cancer|breast cancer
770736|NCT00364962|NPC|npc
770737|NCT00364962|Nasopharyngectomy|nasopharyngectomy
770738|NCT00364962|KTP laser|ktp laser
770739|NCT00364962|recurrence|recurrence
770740|NCT00364949|Polycystic Ovary Syndrome|polycystic ovary syndrome
770741|NCT00364949|PCOS|pcos
770742|NCT00364949|Pregnant|pregnant
770743|NCT00364949|Cord Blood|cord blood
770744|NCT00364936|palliative care|palliative care
770745|NCT00364936|hospice|hospice
770746|NCT00364936|end-of-life|end-of-life
770747|NCT00364936|symptom control|symptom control
770748|NCT00364936|evaluation|evaluation
770749|NCT00364936|effectiveness|effectiveness
770750|NCT00364923|Peripheral T-cell Lymphoma|peripheral t-cell lymphoma
770751|NCT00364923|T-cell Lymphoma|t-cell lymphoma
770752|NCT00364923|Lymphoma|lymphoma
770753|NCT00364923|PDX|pdx
770754|NCT00364923|Pralatrexate|pralatrexate
770755|NCT00364923|Vitamin B12|vitamin b12
770756|NCT00364923|Folic acid|folic acid
770757|NCT00364910|Myocardial Infarction (MI)|myocardial infarction (mi)
770758|NCT00364910|Cognitive Behavioral Therapy (CBT)|cognitive behavioral therapy (cbt)
770759|NCT00364910|Adherence|adherence
770760|NCT00364910|Depression|depression
770761|NCT00364884|chronic kidney disease|chronic kidney disease
770762|NCT00364871|Obesity|obesity
770763|NCT00364858|Type 1 Gaucher Disease|type 1 gaucher disease
770764|NCT00364858|Glucocerebrosidase Deficiency Disease|glucocerebrosidase deficiency disease
770765|NCT00364845|Quality of Life|quality of life
770766|NCT00364845|Chronic Kidney Disease|chronic kidney disease
770767|NCT00364845|Anemia|anemia
770768|NCT00364819|Primary Biliary Cirrhosis|primary biliary cirrhosis
770769|NCT00364806|Migraine|migraine
770771|NCT00364793|HIV, Pediatric|hiv, pediatric
770772|NCT00364767|Moderate alcohol consumption|moderate alcohol consumption
770773|NCT00364767|Fat and carbohydrate oxidative capacity|fat and carbohydrate oxidative capacity
770774|NCT00364767|Postprandial glycemic response|postprandial glycemic response
770775|NCT00364754|Tesmilifene|tesmilifene
770776|NCT00364754|DPPE|dppe
770777|NCT00364754|Breast cancer|breast cancer
770778|NCT00364754|Cyclophosphamide|cyclophosphamide
770779|NCT00364754|Epirubicin|epirubicin
770780|NCT00364754|Pharmacokinetic|pharmacokinetic
770781|NCT00364715|Nuclear localization, annexin A1, oral SCC|nuclear localization, annexin a1, oral scc
770782|NCT00364702|Virtual Reality|virtual reality
770783|NCT00364702|ADHD|adhd
770784|NCT00364702|Methylphenidate|methylphenidate
770785|NCT00364689|Encephalopathy, Hepatic|encephalopathy, hepatic
770786|NCT00364689|Portosystemic Encephalopathy|portosystemic encephalopathy
770787|NCT00364689|Encephalopathy, Hepatocerebral|encephalopathy, hepatocerebral
770788|NCT00364689|Encephalopathy, Portal-Systemic|encephalopathy, portal-systemic
770789|NCT00364689|Encephalopathy, Portosystemic|encephalopathy, portosystemic
770790|NCT00364689|Hepatic Coma|hepatic coma
770791|NCT00364689|Hepatic Stupor|hepatic stupor
771002|NCT00363805|prevention|prevention
770792|NCT00364689|Hepatocerebral Encephalopathy|hepatocerebral encephalopathy
770793|NCT00364689|Portal-Systemic Encephalopathy|portal-systemic encephalopathy
770794|NCT00364676|Vinorelbine|vinorelbine
770795|NCT00364676|solid tumors|solid tumors
770796|NCT00364676|Hodgkins|hodgkins
770797|NCT00364676|Non hodgkins|non hodgkins
770798|NCT00364676|Lymphoma|lymphoma
770799|NCT00364676|Advanced solid tumors|advanced solid tumors
770800|NCT00364663|NSCLC|nsclc
770801|NCT00364663|staging|staging
770802|NCT00364663|18F-FDG PET|18f-fdg pet
770803|NCT00364663|decision tree model|decision tree model
770804|NCT00364663|cost-effectiveness|cost-effectiveness
770805|NCT00364650|Renal transplantation|renal transplantation
770806|NCT00364650|Diarrhea|diarrhea
770807|NCT00364650|Immunosuppression|immunosuppression
770808|NCT00364650|Probiotics|probiotics
770809|NCT00364637|Sevoflurane|sevoflurane
770810|NCT00364637|Anesthesia|anesthesia
770811|NCT00364637|Troponin|troponin
770812|NCT00364637|Myocardial Preconditioning|myocardial preconditioning
770813|NCT00364637|Surgery, Cardiac|surgery, cardiac
770814|NCT00364637|Stents|stents
770815|NCT00364637|Non-cardiac Surgery|non-cardiac surgery
770816|NCT00364637|Surgery|surgery
770817|NCT00364624|lung cancer|lung cancer
770818|NCT00364624|adrenal insufficiency|adrenal insufficiency
770819|NCT00364598|Anginera|anginera
770820|NCT00364598|LVAD|lvad
770821|NCT00364598|Transplant|transplant
770822|NCT00364598|Histology|histology
770823|NCT00364598|LVAD implantation as a bridge to transplant|lvad implantation as a bridge to transplant
770824|NCT00364572|sciatica|sciatica
770825|NCT00364572|low back pain|low back pain
770826|NCT00364572|epidural|epidural
770827|NCT00364572|tumor necrosis factor|tumor necrosis factor
770828|NCT00364559|intracerebral hemorrhage|intracerebral hemorrhage
770829|NCT00364559|statins|statins
770830|NCT00364559|rosuvastatin|rosuvastatin
770831|NCT00364559|stroke|stroke
770832|NCT00364546|Osteoarthritis|osteoarthritis
770833|NCT00364546|Pain|pain
770834|NCT00364546|Low Back Pain|low back pain
770835|NCT00364546|Hip Pain|hip pain
770836|NCT00364546|Knee Pain|knee pain
770837|NCT00364546|Backache|backache
770838|NCT00364546|tapentadol|tapentadol
770839|NCT00364533|Arthralgia|arthralgia
770840|NCT00364533|Pain|pain
770841|NCT00364533|Pain Assessment|pain assessment
770842|NCT00364533|Hip Replacement|hip replacement
770843|NCT00364533|Tapentadol|tapentadol
770844|NCT00364520|Hematologic Diseases|hematologic diseases
770845|NCT00364520|Benzene|benzene
770846|NCT00364520|Genetic Polymorphisms|genetic polymorphisms
770847|NCT00364494|Hematocrit|hematocrit
770848|NCT00364494|Hemodilution|hemodilution
770849|NCT00364494|Blood Transfusion|blood transfusion
770850|NCT00364494|Cardiopulmonary Bypass|cardiopulmonary bypass
770851|NCT00364494|Multiple Organ Failure|multiple organ failure
770852|NCT00364494|Surgery, Cardiac|surgery, cardiac
770853|NCT00364494|Kidney Failure|kidney failure
770854|NCT00364494|Cardiac Surgical Procedures|cardiac surgical procedures
770855|NCT00364481|apnea|apnea
770856|NCT00364481|tongue|tongue
770857|NCT00364481|exercises|exercises
770858|NCT00364481|reflux|reflux
770859|NCT00364481|airway|airway
770860|NCT00364481|upper|upper
770861|NCT00364481|fatigue|fatigue
770862|NCT00364468|pegfilgrastim|pegfilgrastim
770863|NCT00364468|neutropenia|neutropenia
770864|NCT00364468|cancer patients|cancer patients
770865|NCT00364468|lymphoma|lymphoma
770866|NCT00364455|Hormone refractory prostate cancer|hormone refractory prostate cancer
770867|NCT00364455|Anemia|anemia
770868|NCT00364455|Quality-of-life|quality-of-life
770869|NCT00364442|asthma|asthma
770870|NCT00364429|schizophrenic patients|schizophrenic patients
770871|NCT00364429|SPET|spet
770872|NCT00364429|NMDA receptor|nmda receptor
770873|NCT00364429|ligand [123]I-CNS 1261|ligand [123]i-cns 1261
770874|NCT00364416|Heart Failure, congestive|heart failure, congestive
770875|NCT00364416|Heart decompensation|heart decompensation
770876|NCT00364403|Glycemic index|glycemic index
770877|NCT00364403|Glycemic load|glycemic load
770878|NCT00364403|Low fat|low fat
770879|NCT00364403|Impaired glucose tolerance|impaired glucose tolerance
770880|NCT00364403|Large for gestational age infant|large for gestational age infant
770881|NCT00364403|Excessive body weight|excessive body weight
770882|NCT00364390|CABG|cabg
770883|NCT00364390|Anginera|anginera
770884|NCT00364390|CAD|cad
770885|NCT00364351|Non Small Cell Lung Cancer|non small cell lung cancer
770886|NCT00364351|NSCLC|nsclc
770887|NCT00364338|gourmet healthy cooking|gourmet healthy cooking
770888|NCT00364338|quality of life|quality of life
770889|NCT00364338|preimenopause|preimenopause
770890|NCT00364338|weight|weight
770891|NCT00364338|lipids|lipids
770892|NCT00364325|Heart failure, congestive|heart failure, congestive
770893|NCT00364325|Heart decompensation|heart decompensation
770894|NCT00364312|behavior therapy|behavior therapy
770895|NCT00364312|dietary control|dietary control
770896|NCT00364312|exercise|exercise
770897|NCT00364312|diabetes mellitus|diabetes mellitus
771003|NCT00363805|green tea|green tea
770898|NCT00364312|behavior modification|behavior modification
770899|NCT00364312|blood glucose|blood glucose
770900|NCT00364312|clinical trial|clinical trial
770901|NCT00364312|diabetes education|diabetes education
770902|NCT00364312|health behavior|health behavior
770903|NCT00364312|health care service utilization|health care service utilization
770904|NCT00364312|obesity|obesity
770905|NCT00364312|quality of life|quality of life
770906|NCT00364299|Ventilator-associated pneumonia|ventilator-associated pneumonia
770907|NCT00364299|Mechanical ventilation|mechanical ventilation
770908|NCT00364299|Tracheal tube cuff pressure|tracheal tube cuff pressure
770909|NCT00364286|Chronic Lymphocytic Leukemia|chronic lymphocytic leukemia
770910|NCT00364286|Small Lymphocytic Lymphoma|small lymphocytic lymphoma
770911|NCT00364286|Prolymphocytic Leukemia|prolymphocytic leukemia
770912|NCT00364286|Leukemia|leukemia
770913|NCT00364286|Lymphoma|lymphoma
770914|NCT00364286|Dasatinib|dasatinib
770915|NCT00364286|BMS-354825|bms-354825
770916|NCT00364273|Asthma|asthma
770917|NCT00364260|Anemia|anemia
770918|NCT00364260|epoetin alfa|epoetin alfa
770919|NCT00364247|Acute pain|acute pain
770920|NCT00364247|bunionectomy|bunionectomy
770921|NCT00364234|Renal Osteodystrophy|renal osteodystrophy
770922|NCT00364195|Metastatic breast cancer|metastatic breast cancer
770923|NCT00364195|Tesmilifene|tesmilifene
770924|NCT00364195|DPPE|dppe
770925|NCT00364182|Hemophilia B|hemophilia b
770926|NCT00364182|BeneFIX|benefix
770927|NCT00364169|constipation|constipation
770928|NCT00364169|cancer|cancer
770929|NCT00364169|surgery|surgery
770930|NCT00364169|intervention|intervention
770931|NCT00364169|nursing|nursing
770932|NCT00364169|postoperative|postoperative
770933|NCT00364143|Cancer|cancer
770934|NCT00364143|Advanced Solid Tumor|advanced solid tumor
770935|NCT00364143|Oncology|oncology
770936|NCT00364117|150 discharges|150 discharges
770937|NCT00364117|adults|adults
770938|NCT00364117|Internal Medicine|internal medicine
770939|NCT00364104|Iron deficiency|iron deficiency
770940|NCT00364104|Helicobacter infection|helicobacter infection
770941|NCT00364104|Epidemiology|epidemiology
770942|NCT00364091|allergic conjunctivitis, ophthalmology, multicenter, controlled|allergic conjunctivitis, ophthalmology, multicenter, controlled
770943|NCT00364078|Cross-sectional correlational study|cross-sectional correlational study
770944|NCT00364078|Uncertainty|uncertainty
770945|NCT00364078|Locus of Control|locus of control
770946|NCT00364078|Quality of life|quality of life
770947|NCT00364078|Transitoriness|transitoriness
770948|NCT00364078|Cancer care|cancer care
770949|NCT00364052|Valganciclovir, Oral Ganciclovir, Liver transplant|valganciclovir, oral ganciclovir, liver transplant
770950|NCT00364013|Oncology|oncology
770951|NCT00364013|Cancer|cancer
770952|NCT00364013|metastatic colorectal cancer|metastatic colorectal cancer
770953|NCT00364013|EGFr|egfr
770954|NCT00364013|Panitumumab|panitumumab
770955|NCT00364013|Clinical Trail|clinical trail
770956|NCT00364013|Amgen|amgen
770957|NCT00364000|haemodialysis|haemodialysis
770958|NCT00364000|hyperphosphatemia|hyperphosphatemia
770959|NCT00364000|sevelamer|sevelamer
770960|NCT00364000|calcium acetate|calcium acetate
770961|NCT00363987|nephropathy with type 2 diabetes|nephropathy with type 2 diabetes
770963|NCT00363974|leukemia|leukemia
770964|NCT00363974|relapse|relapse
770965|NCT00363974|refractory|refractory
770966|NCT00363974|antisense|antisense
770967|NCT00363974|oligonucleotide|oligonucleotide
770968|NCT00363961|End stage renal disease|end stage renal disease
770969|NCT00363961|Maintenance dialysis|maintenance dialysis
770970|NCT00363961|Resistance exercise|resistance exercise
770971|NCT00363961|Muscle wasting|muscle wasting
770972|NCT00363961|Disability|disability
770973|NCT00363948|MK-0431|mk-0431
770974|NCT00363948|ONO-5435|ono-5435
770975|NCT00363948|Type 2 diabetes mellitus|type 2 diabetes mellitus
770976|NCT00363922|Coronary Artery Bypass [E04.100.376.719.332]|coronary artery bypass [e04.100.376.719.332]
770977|NCT00363909|psychosocial effects of cancer and its treatment|psychosocial effects of cancer and its treatment
770978|NCT00363909|hot flashes|hot flashes
770979|NCT00363909|breast cancer|breast cancer
770980|NCT00363896|COPD|copd
770981|NCT00363896|Lung function|lung function
770982|NCT00363896|Exacerbations|exacerbations
770983|NCT00363896|Quality of Life|quality of life
770984|NCT00363870|Influenza vaccine|influenza vaccine
770985|NCT00363870|Prophylaxis Influenza vaccine|prophylaxis influenza vaccine
770986|NCT00363857|fatigue|fatigue
770987|NCT00363857|sleep|sleep
770988|NCT00363857|sleep disorder|sleep disorder
770989|NCT00363857|Legs|legs
770990|NCT00363857|RLS|rls
770991|NCT00363857|Restless Legs Syndrome|restless legs syndrome
770992|NCT00363857|Ropinirole|ropinirole
770993|NCT00363844|MK-0431|mk-0431
770994|NCT00363844|ONO-5435|ono-5435
770995|NCT00363844|Type 2 diabetes mellitus|type 2 diabetes mellitus
770996|NCT00363818|Endothelial function|endothelial function
770997|NCT00363818|Platelet function|platelet function
770998|NCT00363818|Coronary artery disease|coronary artery disease
770999|NCT00363818|Thrombosis|thrombosis
771004|NCT00363805|former smokers|former smokers
771005|NCT00363792|Healthy subjects|healthy subjects
771006|NCT00363779|Large Granular Lymphocyte (LGL)|large granular lymphocyte (lgl)
771007|NCT00363779|LGL|lgl
771008|NCT00363779|Leukemia|leukemia
771009|NCT00363779|Cyclosporine|cyclosporine
771010|NCT00363779|Microarray|microarray
771011|NCT00363779|Gene Expression|gene expression
771012|NCT00363779|Cyclosporin|cyclosporin
771013|NCT00363779|Large Granular Lymphocyte Leukemia|large granular lymphocyte leukemia
771014|NCT00363779|LGL Leukemia|lgl leukemia
771015|NCT00363753|Transient ischemic attack|transient ischemic attack
771016|NCT00363753|Stroke|stroke
771017|NCT00363753|Aspirin|aspirin
771018|NCT00363753|Clopidogrel|clopidogrel
771019|NCT00363740|GW685698X|gw685698x
771020|NCT00363740|allergic rhinitis|allergic rhinitis
771021|NCT00363740|Seasonal Allergic Rhinitis|seasonal allergic rhinitis
771022|NCT00363727|dyskinesia|dyskinesia
771023|NCT00363727|SINEMET|sinemet
771024|NCT00363727|Parkinson's disease|parkinson's disease
771025|NCT00363727|controlled release ropinirole|controlled release ropinirole
771026|NCT00363701|Protonpumpinhibitors|protonpumpinhibitors
771027|NCT00363701|withdrawal|withdrawal
771028|NCT00363701|longterm treatment|longterm treatment
771029|NCT00363701|dyspepsia|dyspepsia
771030|NCT00363701|functional dyspepsia|functional dyspepsia
771031|NCT00363701|gastrooesophageal reflux|gastrooesophageal reflux
771032|NCT00363701|upper endoscopy|upper endoscopy
771033|NCT00363688|Non life threatening allergic reaction|non life threatening allergic reaction
771034|NCT00363688|oral challenge|oral challenge
771035|NCT00363688|penicillin|penicillin
771036|NCT00363688|skin testing|skin testing
771037|NCT00363675|Hand Burns|hand burns
771038|NCT00363675|Pediatrics|pediatrics
771039|NCT00363649|Philadelphia chromosome positive chronic myelogenous leukemia|philadelphia chromosome positive chronic myelogenous leukemia
771040|NCT00363649|chronic phase chronic myelogenous leukemia|chronic phase chronic myelogenous leukemia
771041|NCT00363636|relapsed|relapsed
771042|NCT00363636|NHL|nhl
771043|NCT00363636|pharmacokinetics|pharmacokinetics
771044|NCT00363636|antibody|antibody
771045|NCT00363636|safety|safety
771046|NCT00363636|galiximab|galiximab
771047|NCT00363636|efficacy|efficacy
771048|NCT00363636|rituximab|rituximab
771049|NCT00363636|refractory|refractory
771050|NCT00363610|Advanced and/or Metastatic Solid Tumors and Lymphoma|advanced and/or metastatic solid tumors and lymphoma
771051|NCT00363597|dyspepsia|dyspepsia
771052|NCT00363597|gastrointestinal disease|gastrointestinal disease
771053|NCT00363597|indigestion|indigestion
771054|NCT00363584|localized resectable adult primary liver cancer|localized resectable adult primary liver cancer
771055|NCT00363584|cholangiocarcinoma of the extrahepatic bile duct|cholangiocarcinoma of the extrahepatic bile duct
771056|NCT00363584|cholangiocarcinoma of the gallbladder|cholangiocarcinoma of the gallbladder
771057|NCT00363584|adenocarcinoma of the gallbladder|adenocarcinoma of the gallbladder
771058|NCT00363584|adenocarcinoma with squamous metaplasia of the gallbladder|adenocarcinoma with squamous metaplasia of the gallbladder
771059|NCT00363584|anaplastic carcinoma of the gallbladder|anaplastic carcinoma of the gallbladder
771060|NCT00363584|localized gallbladder cancer|localized gallbladder cancer
771061|NCT00363584|localized extrahepatic bile duct cancer|localized extrahepatic bile duct cancer
771062|NCT00363584|squamous cell carcinoma of the gallbladder|squamous cell carcinoma of the gallbladder
771063|NCT00363584|adult primary cholangiocellular carcinoma|adult primary cholangiocellular carcinoma
771064|NCT00363558|skin graft|skin graft
771065|NCT00363558|fixation|fixation
771066|NCT00363558|cyanoacrylate glue|cyanoacrylate glue
771067|NCT00363558|skin staples|skin staples
771068|NCT00363545|Prophylaxis against gastroenteritis caused by Rotavirus|prophylaxis against gastroenteritis caused by rotavirus
771069|NCT00363532|migraine with out aura|migraine with out aura
771070|NCT00363519|MK-0431|mk-0431
771071|NCT00363519|ONO-5435|ono-5435
771072|NCT00363519|Type 2 diabetes mellitus|type 2 diabetes mellitus
771074|NCT00363506|C10.228.140.546.399.750|c10.228.140.546.399.750
771075|NCT00363480|Asthma|asthma
771076|NCT00363480|Asthma Control Test|asthma control test
771077|NCT00363480|SERETIDE|seretide
771078|NCT00363467|Busulfan|busulfan
771079|NCT00363467|Acute myeloid leukemia (AML)|acute myeloid leukemia (aml)
771080|NCT00363467|Hematopoietic Stem Cell Transplantation (HSCT)|hematopoietic stem cell transplantation (hsct)
771081|NCT00363467|Dendritic cells|dendritic cells
771082|NCT00363467|Bone marrow transplantation|bone marrow transplantation
771083|NCT00363467|PBSC mobilization|pbsc mobilization
771084|NCT00363467|Autologous stem cells|autologous stem cells
771085|NCT00363454|Phase I|phase i
771086|NCT00363454|Pharmacokinetics|pharmacokinetics
771087|NCT00363454|TCN-PM|tcn-pm
771088|NCT00363454|VD-0002|vd-0002
771089|NCT00363454|Immunohistochemistry|immunohistochemistry
771090|NCT00363454|Serum tumor marker|serum tumor marker
771091|NCT00363454|Akt phosphorylation|akt phosphorylation
771092|NCT00363454|Ex vivo testing|ex vivo testing
771093|NCT00363454|metastatic|metastatic
771094|NCT00363441|head and neck neoplasms|head and neck neoplasms
771095|NCT00363441|squamous cell cancer|squamous cell cancer
771382|NCT00362128|Blood Pressure, High|blood pressure, high
771096|NCT00363441|intensity modulated radiotherapy|intensity modulated radiotherapy
771097|NCT00363428|pulmonary complications|pulmonary complications
771098|NCT00363428|perioperative/postoperative complications|perioperative/postoperative complications
771099|NCT00363428|tobacco use disorder|tobacco use disorder
771100|NCT00363428|non-small cell lung cancer|non-small cell lung cancer
771101|NCT00363428|small cell lung cancer|small cell lung cancer
771102|NCT00363402|Cystic Fibrosis|cystic fibrosis
771103|NCT00363389|Hysteroscopy|hysteroscopy
771104|NCT00363389|Misoprostol|misoprostol
771105|NCT00363389|Uterine hemorrhage|uterine hemorrhage
771106|NCT00363389|Uterine cervix|uterine cervix
771107|NCT00363389|Dilatation|dilatation
771108|NCT00363376|olanzapine|olanzapine
771109|NCT00363376|zonisamide|zonisamide
771110|NCT00363376|weight gain|weight gain
771111|NCT00363376|bipolar disorder|bipolar disorder
771112|NCT00363376|psychotic disorders|psychotic disorders
771113|NCT00363363|Pediatrics|pediatrics
771114|NCT00363363|Fontan Procedure|fontan procedure
771115|NCT00363363|Physical Activity|physical activity
771116|NCT00363363|Physical Fitness|physical fitness
771117|NCT00363363|Congenital Heart Defects|congenital heart defects
771118|NCT00363363|exercise rehabilitation|exercise rehabilitation
771119|NCT00363337|Adults|adults
771120|NCT00363337|Bipolar Depression|bipolar depression
771121|NCT00363337|Bipolar Disorder|bipolar disorder
771122|NCT00363337|Bipolar I|bipolar i
771123|NCT00363337|Bipolar II|bipolar ii
771124|NCT00363337|Depression|depression
771125|NCT00363324|stem cell|stem cell
771126|NCT00363324|acute myocardial infarction|acute myocardial infarction
771127|NCT00363311|Dutasteride Prostate Cancer Expectant management REDEEM|dutasteride prostate cancer expectant management redeem
771128|NCT00363298|D-amphetamine, dextro-amphetamine, stimulant drug|d-amphetamine, dextro-amphetamine, stimulant drug
771129|NCT00363285|adenocarcinoma of the prostate|adenocarcinoma of the prostate
771130|NCT00363285|stage III prostate cancer|stage iii prostate cancer
771131|NCT00363285|stage IV prostate cancer|stage iv prostate cancer
771132|NCT00363246|Elderly|elderly
771133|NCT00363246|Fall risk|fall risk
771134|NCT00363246|Veterans|veterans
771135|NCT00363246|WheelChairs|wheelchairs
771136|NCT00363246|Injury|injury
771137|NCT00363233|type 2 diabetes|type 2 diabetes
771138|NCT00363233|lignans|lignans
771139|NCT00363233|flaxseed|flaxseed
771140|NCT00363233|cholesterol|cholesterol
771141|NCT00363220|Infection|infection
771142|NCT00363220|E coli|e coli
771143|NCT00363220|Klebsiella|klebsiella
771144|NCT00363220|ESBL|esbl
771145|NCT00363207|behavior|behavior
771146|NCT00363207|local anesthesia|local anesthesia
771147|NCT00363207|behavior after dental local anesthesia|behavior after dental local anesthesia
771148|NCT00363194|Pazopanib GW786034 Advanced cancer Metastatic cancer|pazopanib gw786034 advanced cancer metastatic cancer
771149|NCT00363181|Insulin resistance|insulin resistance
771150|NCT00363181|Metabolic problems|metabolic problems
771151|NCT00363181|Weight gain|weight gain
771152|NCT00363181|Mental health problems|mental health problems
771153|NCT00363181|Mental disorders|mental disorders
771154|NCT00363181|Antipsychotic medication|antipsychotic medication
771155|NCT00363181|Olanzapine|olanzapine
771156|NCT00363168|Hemorrhagic Choroidal Neovascularization|hemorrhagic choroidal neovascularization
771157|NCT00363155|chronic|chronic
771158|NCT00363155|hepatitis b|hepatitis b
771159|NCT00363142|HIV-1 LEXIVA Ritonavir Once-daily|hiv-1 lexiva ritonavir once-daily
771160|NCT00363129|neurotoxicity|neurotoxicity
771161|NCT00363129|unspecified adult solid tumor, protocol specific|unspecified adult solid tumor, protocol specific
771162|NCT00363116|Kidney transplant|kidney transplant
771163|NCT00363116|Pancreas transplant|pancreas transplant
771164|NCT00363116|Daclizumab|daclizumab
771165|NCT00363116|Tacrolimus|tacrolimus
771166|NCT00363116|Mycophenolate mofetil|mycophenolate mofetil
771167|NCT00363116|Steroids|steroids
771168|NCT00363116|Immunosuppression|immunosuppression
772307|NCT00358891|Prematurity|prematurity
771169|NCT00363116|Acute allograft rejection|acute allograft rejection
771170|NCT00363090|contiguous stage II adult diffuse large cell lymphoma|contiguous stage ii adult diffuse large cell lymphoma
771171|NCT00363090|contiguous stage II adult diffuse mixed cell lymphoma|contiguous stage ii adult diffuse mixed cell lymphoma
771172|NCT00363090|noncontiguous stage II adult diffuse large cell lymphoma|noncontiguous stage ii adult diffuse large cell lymphoma
771173|NCT00363090|noncontiguous stage II adult diffuse mixed cell lymphoma|noncontiguous stage ii adult diffuse mixed cell lymphoma
771174|NCT00363090|stage III adult diffuse large cell lymphoma|stage iii adult diffuse large cell lymphoma
771175|NCT00363090|stage III adult diffuse mixed cell lymphoma|stage iii adult diffuse mixed cell lymphoma
771176|NCT00363090|stage IV adult diffuse large cell lymphoma|stage iv adult diffuse large cell lymphoma
771177|NCT00363090|stage IV adult diffuse mixed cell lymphoma|stage iv adult diffuse mixed cell lymphoma
771178|NCT00363090|angioimmunoblastic T-cell lymphoma|angioimmunoblastic t-cell lymphoma
771179|NCT00363090|anaplastic large cell lymphoma|anaplastic large cell lymphoma
771180|NCT00363090|stage II adult T-cell leukemia/lymphoma|stage ii adult t-cell leukemia/lymphoma
771181|NCT00363090|stage III adult T-cell leukemia/lymphoma|stage iii adult t-cell leukemia/lymphoma
771182|NCT00363090|stage IV adult T-cell leukemia/lymphoma|stage iv adult t-cell leukemia/lymphoma
771183|NCT00363077|Influenza vaccine|influenza vaccine
771184|NCT00363077|Prophylaxis Influenza vaccine|prophylaxis influenza vaccine
771185|NCT00363051|Pancreatic|pancreatic
771186|NCT00363051|Tumor|tumor
771187|NCT00363051|Islet Cell|islet cell
771188|NCT00363051|Carcinoma|carcinoma
771189|NCT00363051|Neuroendocrine|neuroendocrine
771190|NCT00363051|Endocrine|endocrine
771191|NCT00363051|Atypical Carcinoid|atypical carcinoid
771192|NCT00363051|RADIANT1|radiant1
771193|NCT00363051|RADIANT-1|radiant-1
771194|NCT00363038|Bruising|bruising
771195|NCT00363038|Topical 20% arnica|topical 20% arnica
771196|NCT00363025|Acute myeloid leukemia|acute myeloid leukemia
771197|NCT00363025|Older patients|older patients
771198|NCT00363025|Patient aged 65 years or more|patient aged 65 years or more
771199|NCT00363012|stage IIIA breast cancer|stage iiia breast cancer
771200|NCT00363012|stage IIIB breast cancer|stage iiib breast cancer
771201|NCT00363012|stage IIIC breast cancer|stage iiic breast cancer
771202|NCT00363012|stage IV breast cancer|stage iv breast cancer
771203|NCT00363012|male breast cancer|male breast cancer
771204|NCT00362999|Allergic|allergic
771205|NCT00362999|Rhinitis|rhinitis
771206|NCT00362999|Pharmacogenetics|pharmacogenetics
771207|NCT00362999|Histamine|histamine
771208|NCT00362986|dermatologic complications|dermatologic complications
771209|NCT00362986|unspecified adult solid tumor, protocol specific|unspecified adult solid tumor, protocol specific
771210|NCT00362973|male breast cancer|male breast cancer
771211|NCT00362973|recurrent breast cancer|recurrent breast cancer
771212|NCT00362973|stage I breast cancer|stage i breast cancer
771213|NCT00362973|stage II breast cancer|stage ii breast cancer
771214|NCT00362973|stage IIIA breast cancer|stage iiia breast cancer
771215|NCT00362973|stage IIIB breast cancer|stage iiib breast cancer
771216|NCT00362973|stage IIIC breast cancer|stage iiic breast cancer
771217|NCT00362973|stage IV breast cancer|stage iv breast cancer
771218|NCT00362960|Type 2 Diabetes Mellitus|type 2 diabetes mellitus
771219|NCT00362960|Diabetic Nephropathy|diabetic nephropathy
771220|NCT00362960|Inflammatory Markers|inflammatory markers
771221|NCT00362960|Proteinuria|proteinuria
771222|NCT00362960|Renal Disease|renal disease
771223|NCT00362947|Superficial vein thrombosis|superficial vein thrombosis
771224|NCT00362947|thrombophlebitis|thrombophlebitis
771225|NCT00362947|LMWH|lmwh
771226|NCT00362947|parnaparin|parnaparin
771227|NCT00362934|Hyperlipidemia Combined|hyperlipidemia combined
771228|NCT00362934|efficacy combination fenofibrate simvastatin versus atorvastatin|efficacy combination fenofibrate simvastatin versus atorvastatin
771229|NCT00362921|adult glioblastoma multiforme|adult glioblastoma multiforme
771230|NCT00362921|adult gliosarcoma|adult gliosarcoma
771231|NCT00362921|recurrent adult brain tumor|recurrent adult brain tumor
771232|NCT00362908|Obesity|obesity
771233|NCT00362908|Hypertension|hypertension
771234|NCT00362908|Insulin Resistance|insulin resistance
771235|NCT00362869|Enteroaggregative Escherichia coli, diarrhea, challenge|enteroaggregative escherichia coli, diarrhea, challenge
771236|NCT00362856|larazotide acetate|larazotide acetate
771237|NCT00362843|11C-Leucine|11c-leucine
771238|NCT00362843|Positron Emission Tomography (PET)|positron emission tomography (pet)
771239|NCT00362843|Cerebral Protein Synthesis|cerebral protein synthesis
771240|NCT00362843|Propofol|propofol
771241|NCT00362843|Fragile X|fragile x
771242|NCT00362843|Fragile X Syndrome|fragile x syndrome
771243|NCT00362817|Recurrent|recurrent
771244|NCT00362817|Symptomatic|symptomatic
771245|NCT00362804|tetrabenazine|tetrabenazine
771246|NCT00362804|partial response|partial response
771247|NCT00362804|psychosis|psychosis
771248|NCT00362804|schizophrenia|schizophrenia
771249|NCT00362804|schizoaffective disorder|schizoaffective disorder
771250|NCT00362804|partial response to antipsychotics|partial response to antipsychotics
771251|NCT00362791|voluntary counseling and testing|voluntary counseling and testing
771252|NCT00362791|HIV/STD prevention counseling|hiv/std prevention counseling
771253|NCT00362791|HIV/STD prevention intervention|hiv/std prevention intervention
771254|NCT00362791|counseling efficacy|counseling efficacy
771255|NCT00362765|Type 2 Diabetes|type 2 diabetes
771256|NCT00362765|Dyslipidemia|dyslipidemia
771257|NCT00362765|Hyperinsulinemic|hyperinsulinemic
771258|NCT00362765|Clamp|clamp
771259|NCT00362765|Metformin|metformin
771260|NCT00362765|Fenofibrate|fenofibrate
771261|NCT00362752|norfloxacin|norfloxacin
771262|NCT00362752|hepatopulmonary syndrome|hepatopulmonary syndrome
771263|NCT00362726|HIV|hiv
771264|NCT00362687|HIV, HAART|hiv, haart
771265|NCT00362661|PTSD|ptsd
771266|NCT00362661|cortisol|cortisol
771267|NCT00362661|memory|memory
771268|NCT00362661|treatment|treatment
771269|NCT00362622|Travalert|travalert
771270|NCT00362622|open angle glaucoma|open angle glaucoma
771271|NCT00362609|Safety|safety
771272|NCT00362596|Acyclovir|acyclovir
771273|NCT00362596|HIV|hiv
771274|NCT00362596|HSV|hsv
771275|NCT00362583|Cancer pain with breakthrough pain episodes|cancer pain with breakthrough pain episodes
771276|NCT00362570|Newly diagnosed|newly diagnosed
771277|NCT00362544|antifungal prophylaxis|antifungal prophylaxis
771278|NCT00362544|allogeneic stem-cell transplantation|allogeneic stem-cell transplantation
771279|NCT00362544|acute leukaemia|acute leukaemia
771280|NCT00362544|antifungal prophylaxis treatment of allogeneic stem-cell transplantation and acute leukaemia|antifungal prophylaxis treatment of allogeneic stem-cell transplantation and acute leukaemia
771281|NCT00362518|atherosclerosis|atherosclerosis
771282|NCT00362518|vitamin C|vitamin c
771283|NCT00362518|vitamin E|vitamin e
771284|NCT00362492|TKR|tkr
771285|NCT00362492|Ultrasonography|ultrasonography
771286|NCT00362492|asymptomatic deep venous thrombosis|asymptomatic deep venous thrombosis
771287|NCT00362492|extended duration prophylaxis|extended duration prophylaxis
771288|NCT00362492|short duration prophylaxis|short duration prophylaxis
771289|NCT00362479|pregnancy prevention|pregnancy prevention
771290|NCT00362479|oral contraceptives|oral contraceptives
771291|NCT00362466|Leukemia (chronic myeloid leukemia - chronic phase)|leukemia (chronic myeloid leukemia - chronic phase)
771292|NCT00362440|HIV lipodystrophy|hiv lipodystrophy
771293|NCT00362440|Leptin|leptin
771294|NCT00362440|Fat wasting|fat wasting
771295|NCT00362440|Pioglitazone|pioglitazone
771296|NCT00362440|Insulin resistance|insulin resistance
771297|NCT00362427|Hepatitis B|hepatitis b
771298|NCT00362427|Pertussis|pertussis
771299|NCT00362427|Diphtheria|diphtheria
771300|NCT00362427|Tetanus|tetanus
771301|NCT00362427|H. influenzae type b|h. influenzae type b
771302|NCT00362427|Polio|polio
771303|NCT00362414|Stroke|stroke
771304|NCT00362401|Psychoacoustics|psychoacoustics
771305|NCT00362401|Quality of Life|quality of life
771306|NCT00362401|Heart Valve Prosthesis|heart valve prosthesis
771307|NCT00362388|Coronary artery disease|coronary artery disease
771308|NCT00362388|Ischemic heart disease|ischemic heart disease
771309|NCT00362388|Angiogenesis|angiogenesis
771310|NCT00362388|Cells|cells
771311|NCT00362388|Cardiac surgery|cardiac surgery
771312|NCT00362375|Adult|adult
771313|NCT00362375|*HIV Infections/pc [Prevention & Control]|*hiv infections/pc [prevention & control]
771314|NCT00362375|Female|female
771315|NCT00362375|Humans|humans
771316|NCT00362375|Risk-Taking|risk-taking
771317|NCT00362375|Safe Sex|safe sex
771318|NCT00362375|Sexual Behavior|sexual behavior
771319|NCT00362375|HIV Testing|hiv testing
771320|NCT00362362|Amyotrophic Lateral Sclerosis|amyotrophic lateral sclerosis
771321|NCT00362362|Primary Lateral Sclerosis|primary lateral sclerosis
771322|NCT00362362|Genetics|genetics
771323|NCT00362362|Blood Sample|blood sample
771324|NCT00362362|PLS|pls
771325|NCT00362362|ALS|als
771326|NCT00362349|ITP|itp
771327|NCT00362349|IVIg|ivig
771328|NCT00362349|Platelet count|platelet count
771329|NCT00362349|Bleeding|bleeding
771330|NCT00362336|Hepatitis B|hepatitis b
771331|NCT00362336|Polio|polio
771332|NCT00362336|Diphtheria|diphtheria
771333|NCT00362336|Pertussis|pertussis
771334|NCT00362336|H. influenzae type b|h. influenzae type b
771335|NCT00362323|Treatment of Dyslipidemia and of Type 2 Diabetes Mellitus|treatment of dyslipidemia and of type 2 diabetes mellitus
771336|NCT00362310|classical kaposi's sarcoma|classical kaposi's sarcoma
771337|NCT00362310|treatment|treatment
771338|NCT00362310|HIV protease inhibitor indinavir|hiv protease inhibitor indinavir
771339|NCT00362284|Alzheimer's disease|alzheimer's disease
771340|NCT00362284|coping|coping
771341|NCT00362284|quality of life|quality of life
771342|NCT00362284|caregiving|caregiving
771343|NCT00362271|Healthy Subjects|healthy subjects
771344|NCT00362245|Amikacin|amikacin
771345|NCT00362245|Pharmacokinetics|pharmacokinetics
771346|NCT00362245|Pharmacodynamics|pharmacodynamics
771347|NCT00362245|Intra-Thecal injection|intra-thecal injection
771348|NCT00362232|Prevention of venous thromboembolism|prevention of venous thromboembolism
771349|NCT00362219|topical|topical
771350|NCT00362219|morphine|morphine
771351|NCT00362219|pain|pain
771352|NCT00362219|skin-wound|skin-wound
771353|NCT00362219|skin-graft|skin-graft
771354|NCT00362219|peripheral analgesia|peripheral analgesia
771355|NCT00362219|burn|burn
771454|NCT00361751|Glucose metabolism|glucose metabolism
771356|NCT00362206|Hyperlipidemia Combined, efficacy combination fenofibrate simvastatin versus pravastatin|hyperlipidemia combined, efficacy combination fenofibrate simvastatin versus pravastatin
771357|NCT00362206|Hyperlipidemia Combined|hyperlipidemia combined
771358|NCT00362193|Diabetes|diabetes
771359|NCT00362193|Chronic disease management|chronic disease management
771360|NCT00362193|Relapse|relapse
771361|NCT00362180|LDL-cholesterol|ldl-cholesterol
771362|NCT00362180|apoB-100|apob-100
771363|NCT00362180|apoB-48|apob-48
771364|NCT00362180|triglyceride|triglyceride
771365|NCT00362180|HeFH|hefh
771366|NCT00362180|FHBL|fhbl
771367|NCT00362167|Clinical Experience|clinical experience
771368|NCT00362167|Educational Training|educational training
771369|NCT00362167|Pain Syndromes|pain syndromes
771370|NCT00362167|Analgesia|analgesia
771371|NCT00362167|Pain Medicine|pain medicine
771372|NCT00362167|Therapy|therapy
771373|NCT00362167|Neuropathic|neuropathic
771374|NCT00362167|Chronic Pain|chronic pain
771375|NCT00362167|Acute Pain|acute pain
771376|NCT00362167|Analgesics|analgesics
771377|NCT00362167|Medication|medication
771378|NCT00362167|Evaluation|evaluation
771379|NCT00362141|levetiracetam|levetiracetam
771380|NCT00362141|status|status
771381|NCT00362141|epilepticus|epilepticus
771383|NCT00362128|Obesity|obesity
771384|NCT00362128|Tobacco Use Disorder|tobacco use disorder
771385|NCT00362115|hypertension|hypertension
771386|NCT00362115|blood pressure|blood pressure
771387|NCT00362115|diastolic blood pressure|diastolic blood pressure
771388|NCT00362115|drug therapy|drug therapy
771389|NCT00362102|EGFR-detectable metastatic colorectal carcinoma with documented progressive disease to irinotecan-based chemotherapy and failure|egfr-detectable metastatic colorectal carcinoma with documented progressive disease to irinotecan-based chemotherapy and failure
771390|NCT00362089|n-3 fatty acids|n-3 fatty acids
771391|NCT00362089|n-6 fatty acids|n-6 fatty acids
771392|NCT00362089|long chain polyunsaturated fatty acids|long chain polyunsaturated fatty acids
771393|NCT00362089|pregnancy|pregnancy
771394|NCT00362089|lactation|lactation
771395|NCT00362089|breast feeding|breast feeding
771396|NCT00362089|breast milk|breast milk
771397|NCT00362089|adipose tissue|adipose tissue
771398|NCT00362089|newborn|newborn
771399|NCT00362089|fetal development|fetal development
771400|NCT00362076|Perception|perception
771401|NCT00362076|Development|development
771402|NCT00362076|Cognition|cognition
771403|NCT00362076|Vision|vision
771404|NCT00362076|Infants|infants
771405|NCT00362076|Autonomic Function|autonomic function
771406|NCT00362076|Cardiac Vagal Tone|cardiac vagal tone
771407|NCT00362076|Categorization|categorization
771408|NCT00362076|Habituation|habituation
771409|NCT00362076|Motion-Carried Information|motion-carried information
771410|NCT00362063|growth hormone|growth hormone
771411|NCT00362050|malaria, falciparum|malaria, falciparum
771412|NCT00362050|uncomplicated Plasmodium falciparum malaria|uncomplicated plasmodium falciparum malaria
771413|NCT00361998|Uncomplicated Cystitis|uncomplicated cystitis
771414|NCT00361998|Nitrofurantoin Macrocrystals|nitrofurantoin macrocrystals
771415|NCT00361985|Gastric bypass|gastric bypass
771416|NCT00361985|Anastomotic stricture|anastomotic stricture
771417|NCT00361985|Morbid obesity|morbid obesity
771418|NCT00361985|Bariatric surgery|bariatric surgery
771419|NCT00361985|Omeprazole|omeprazole
771420|NCT00361959|fluticasone propionate/salmeterol combination|fluticasone propionate/salmeterol combination
771421|NCT00361959|tiotropium|tiotropium
771422|NCT00361959|SERETIDE|seretide
771423|NCT00361959|COPD exacerbation|copd exacerbation
771424|NCT00361946|Type 2 diabetes|type 2 diabetes
771425|NCT00361946|Lean|lean
771426|NCT00361946|Obese|obese
771427|NCT00361920|steroid resistant asthma|steroid resistant asthma
771428|NCT00361907|Pulsatile intravenous insulin|pulsatile intravenous insulin
771429|NCT00361907|Oral carbohydrate loading|oral carbohydrate loading
771430|NCT00361907|Respiratory Quotients|respiratory quotients
771431|NCT00361907|Hypoglycemia|hypoglycemia
771432|NCT00361907|Diabetic Complications|diabetic complications
771433|NCT00361907|Circulating vascular and inflammatory markers|circulating vascular and inflammatory markers
771434|NCT00361868|Treatment of Dyslipidemia and of Type 2 Diabetes Mellitus|treatment of dyslipidemia and of type 2 diabetes mellitus
771435|NCT00361855|MI|mi
771436|NCT00361842|Colorectal cancer|colorectal cancer
771437|NCT00361842|Colorectal carcinoma|colorectal carcinoma
771438|NCT00361842|Colonic cancer|colonic cancer
771439|NCT00361842|Rectal cancer|rectal cancer
771440|NCT00361829|Development|development
771441|NCT00361829|Childhood Growth|childhood growth
771442|NCT00361816|Maternal Effect Gene|maternal effect gene
771443|NCT00361816|Embryonic Development|embryonic development
771444|NCT00361816|Infertility|infertility
771445|NCT00361803|chemotherapy|chemotherapy
771446|NCT00361803|recurrent|recurrent
771447|NCT00361803|refractory|refractory
771448|NCT00361803|research|research
771449|NCT00361803|cancer|cancer
771450|NCT00361803|pharmacokinetics|pharmacokinetics
771451|NCT00361790|Healthy Subjects|healthy subjects
771452|NCT00361777|Dexamethasone|dexamethasone
771453|NCT00361777|Cushing Syndrome|cushing syndrome
771890|NCT00360568|levodopa|levodopa
771455|NCT00361751|Fat Metabolism|fat metabolism
771456|NCT00361751|Insulin Resistance|insulin resistance
771457|NCT00361751|Protein Metabolism|protein metabolism
771458|NCT00361751|Tracer Methodology|tracer methodology
771459|NCT00361738|Type 2 Diabetes Mellitus|type 2 diabetes mellitus
771460|NCT00361725|severe sepsis|severe sepsis
771461|NCT00361725|organ failure|organ failure
771462|NCT00361725|activated protein C|activated protein c
771463|NCT00361725|thrombomodulin|thrombomodulin
771464|NCT00361725|EPCR|epcr
771465|NCT00361712|Epidural|epidural
771466|NCT00361712|analgesia|analgesia
771467|NCT00361712|labor|labor
771468|NCT00361712|cytokines|cytokines
771469|NCT00361699|stroke|stroke
771470|NCT00361699|brain ischemia|brain ischemia
771471|NCT00361699|cerebrovascular accident|cerebrovascular accident
771472|NCT00361699|statin|statin
771473|NCT00361699|hydroxymethylglutaryl-CoA reductase inhibitors|hydroxymethylglutaryl-coa reductase inhibitors
771474|NCT00361699|cholesterol|cholesterol
771475|NCT00361699|hypercholesterolemia|hypercholesterolemia
771476|NCT00361699|hyperlipidemia|hyperlipidemia
771477|NCT00361699|multicenter studies|multicenter studies
771478|NCT00361699|prospective studies|prospective studies
771479|NCT00361699|endpoint determination|endpoint determination
771480|NCT00361699|randomized controlled trials|randomized controlled trials
771481|NCT00361699|recurrence|recurrence
771482|NCT00361699|pravastatin|pravastatin
771483|NCT00361699|c-reactive Protein|c-reactive protein
771484|NCT00361686|tramadol|tramadol
771485|NCT00361686|remifentanyl|remifentanyl
771486|NCT00361686|patient controlled analgesia|patient controlled analgesia
771487|NCT00361686|abortion|abortion
771488|NCT00361673|Health Disparities|health disparities
771489|NCT00361673|Built Environments|built environments
771490|NCT00361660|Motor skills|motor skills
771491|NCT00361660|Occupational Therapy|occupational therapy
771492|NCT00361660|Physical Therapy Techniques|physical therapy techniques
771493|NCT00361660|Rehabilitation|rehabilitation
771494|NCT00361660|Upper Extremity|upper extremity
771495|NCT00361660|Stroke|stroke
771496|NCT00361634|Etanercept|etanercept
771497|NCT00361634|Enbrel|enbrel
771498|NCT00361634|DCE-MRI|dce-mri
771499|NCT00361634|RA|ra
771500|NCT00361621|VELCADE|velcade
771501|NCT00361608|diabetes|diabetes
771502|NCT00361608|hypoglycemia|hypoglycemia
771503|NCT00361608|monitor|monitor
771504|NCT00361608|children with Type I Diabetes|children with type i diabetes
771505|NCT00361595|osteoporosis|osteoporosis
771506|NCT00361595|zoledronic acid|zoledronic acid
771507|NCT00361595|forteo|forteo
771508|NCT00361582|Osteoarthritis|osteoarthritis
771509|NCT00361582|tapentadol|tapentadol
771510|NCT00361582|knee-replacement|knee-replacement
771511|NCT00361582|hip replacement|hip replacement
771512|NCT00361582|pain|pain
771513|NCT00361569|vaginal atrophy|vaginal atrophy
771514|NCT00361569|vaginal dryness|vaginal dryness
771515|NCT00361569|vaginal itching|vaginal itching
771516|NCT00361569|vaginal pain|vaginal pain
771517|NCT00361556|low back pain|low back pain
771518|NCT00361556|disability|disability
771519|NCT00361556|health education|health education
771520|NCT00361556|primary care|primary care
771521|NCT00361543|Schizophrenia|schizophrenia
771522|NCT00361543|Mental Illness|mental illness
771523|NCT00361543|SERM|serm
771524|NCT00361543|Raloxifene|raloxifene
771525|NCT00361543|Cognition|cognition
771526|NCT00361530|stroke|stroke
771527|NCT00361530|brain ischemia|brain ischemia
771528|NCT00361530|cerebrovascular accident|cerebrovascular accident
771529|NCT00361530|statin|statin
771530|NCT00361530|hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors
771531|NCT00361530|cholesterol|cholesterol
771532|NCT00361530|hypercholesterolemia|hypercholesterolemia
771533|NCT00361530|hyperlipidemia|hyperlipidemia
771534|NCT00361530|multicenter studies|multicenter studies
771535|NCT00361530|prospective studies|prospective studies
771536|NCT00361530|endpoint determination|endpoint determination
771537|NCT00361530|randomized controlled trials|randomized controlled trials
771538|NCT00361530|recurrence|recurrence
771539|NCT00361530|pravastatin|pravastatin
771540|NCT00361530|plaque|plaque
771541|NCT00361530|tunica intima|tunica intima
771542|NCT00361530|tunica media|tunica media
771543|NCT00361530|ultrasonography|ultrasonography
771544|NCT00361530|carotid arteries|carotid arteries
771545|NCT00361517|GM monitoring|gm monitoring
771546|NCT00361517|Immunocompromised|immunocompromised
771547|NCT00361517|hematological disorder|hematological disorder
771548|NCT00361517|Allogenic HSCT recipients|allogenic hsct recipients
771549|NCT00361517|Aspergillus PCR assay|aspergillus pcr assay
771550|NCT00361504|Osteoarthritis|osteoarthritis
771551|NCT00361504|Pain|pain
771552|NCT00361504|Low Back Pain|low back pain
771553|NCT00361504|Hip Pain|hip pain
771554|NCT00361504|Knee Pain|knee pain
771555|NCT00361504|Backache|backache
771556|NCT00361504|Tapentadol|tapentadol
771557|NCT00361491|Depression|depression
771558|NCT00361491|antidepressive disorders|antidepressive disorders
771891|NCT00360568|efficacy|efficacy
771559|NCT00361491|controlled clinical trial|controlled clinical trial
771560|NCT00361478|exercise|exercise
771561|NCT00361478|postnatal depression|postnatal depression
771562|NCT00361478|psychological health|psychological health
771563|NCT00361478|well-being|well-being
771564|NCT00361426|COPD|copd
771565|NCT00361426|Respiration Rate|respiration rate
771566|NCT00361426|Monitoring|monitoring
771567|NCT00361413|Stem cell transplantation|stem cell transplantation
771568|NCT00361413|GVHD|gvhd
771569|NCT00361413|Graft Versus Host Disease|graft versus host disease
771570|NCT00361400|pregnancy|pregnancy
771571|NCT00361400|hormonal contraception|hormonal contraception
771572|NCT00361387|Sarcoidosis|sarcoidosis
771573|NCT00361387|Sarcoid|sarcoid
771574|NCT00361374|Depression|depression
771575|NCT00361374|Omega-3|omega-3
771576|NCT00361374|Boston|boston
771577|NCT00361348|Palifermin|palifermin
771578|NCT00361348|drug interaction|drug interaction
771579|NCT00361335|Rheumatoid arthritis|rheumatoid arthritis
771580|NCT00361335|Golimumab|golimumab
771581|NCT00361335|Methotrexate|methotrexate
771582|NCT00361335|Tumor Necrosis Factor-alpha|tumor necrosis factor-alpha
771583|NCT00361335|Immunology|immunology
771584|NCT00361309|liver cancer|liver cancer
771585|NCT00361309|HCC|hcc
771586|NCT00361296|refractory anemia with excess blasts|refractory anemia with excess blasts
771587|NCT00361296|refractory anemia with ringed sideroblasts|refractory anemia with ringed sideroblasts
771588|NCT00361296|refractory anemia|refractory anemia
771589|NCT00361296|refractory cytopenia with multilineage dysplasia|refractory cytopenia with multilineage dysplasia
771590|NCT00361296|de novo myelodysplastic syndromes|de novo myelodysplastic syndromes
771591|NCT00361296|previously treated myelodysplastic syndromes|previously treated myelodysplastic syndromes
771592|NCT00361296|secondary myelodysplastic syndromes|secondary myelodysplastic syndromes
771593|NCT00361270|Biofeedback|biofeedback
771594|NCT00361270|Hypnosis|hypnosis
771595|NCT00361270|Low Back Pain, Recurrent|low back pain, recurrent
771596|NCT00361270|Pain beliefs|pain beliefs
771597|NCT00361270|Pain coping strategies|pain coping strategies
771598|NCT00361270|Pain intensity|pain intensity
771599|NCT00361270|Pain interference|pain interference
771600|NCT00361270|Pain quality|pain quality
771601|NCT00361270|Self-help treatment|self-help treatment
771602|NCT00361270|Sleep dysfunction|sleep dysfunction
771603|NCT00361257|Treatment Experienced|treatment experienced
771604|NCT00361244|Sutent|sutent
771605|NCT00361231|Avastin|avastin
771606|NCT00361231|GEMOX|gemox
771607|NCT00361218|depression|depression
771608|NCT00361218|biology|biology
771609|NCT00361205|Parkinson's Disease, pharmacology, compliance, dopaminergic|parkinson's disease, pharmacology, compliance, dopaminergic
771610|NCT00361192|temporal arteritis|temporal arteritis
771611|NCT00361192|duplex of temporal artery|duplex of temporal artery
771612|NCT00361192|biopsy of temporal artery|biopsy of temporal artery
771613|NCT00361179|Observation|observation
771614|NCT00361179|Post-treatment|post-treatment
771615|NCT00361166|Schizophrenia|schizophrenia
771616|NCT00361166|psychosis|psychosis
771617|NCT00361166|delusions|delusions
771618|NCT00361166|hallucination|hallucination
771619|NCT00361140|Busulfan|busulfan
771620|NCT00361140|Fludarabine|fludarabine
771621|NCT00361140|Chimerism|chimerism
771622|NCT00361140|Allogeneic stem cell transplantation (HCT)|allogeneic stem cell transplantation (hct)
771623|NCT00361140|Myelodysplastic Syndromes|myelodysplastic syndromes
771624|NCT00361140|Leukemia Myeloproliferative disorders (MPD)|leukemia myeloproliferative disorders (mpd)
771625|NCT00361140|Leukemia, Lymphocytic|leukemia, lymphocytic
771626|NCT00361140|Myeloma|myeloma
771627|NCT00361140|Lymphoma|lymphoma
771628|NCT00361140|AUC|auc
771629|NCT00361140|Hematologic malignancies|hematologic malignancies
771630|NCT00361127|Heart failure|heart failure
771631|NCT00361127|pulmonary edema|pulmonary edema
771632|NCT00361127|ACE-inhibitors|ace-inhibitors
771633|NCT00361127|lung diffusion|lung diffusion
771634|NCT00361127|exercise capacity|exercise capacity
771635|NCT00361127|Chronic heart failure|chronic heart failure
771636|NCT00361101|HIV|hiv
771637|NCT00361101|X4 tropic virus|x4 tropic virus
771638|NCT00361088|Velcade (PS-341)|velcade (ps-341)
771639|NCT00361088|Bortezomib|bortezomib
771640|NCT00361088|Zarnestra (R115777)|zarnestra (r115777)
771641|NCT00361088|Tipifarnib|tipifarnib
771642|NCT00361075|Perimenopause|perimenopause
771643|NCT00361075|Abdominal adipose tissue|abdominal adipose tissue
771644|NCT00361075|Women's health|women's health
771645|NCT00361075|Cholesterol|cholesterol
771646|NCT00361075|Lipid Metabolism|lipid metabolism
771647|NCT00361062|aggressive|aggressive
771648|NCT00361062|SSRI's|ssri's
771649|NCT00361062|simulation|simulation
771650|NCT00361062|behavioral|behavioral
771651|NCT00361062|Side Effects, Psychological|side effects, psychological
771652|NCT00361062|adverse effects|adverse effects
771653|NCT00361062|Serotonin Reuptake Inhibitors|serotonin reuptake inhibitors
771654|NCT00361062|aggressive behavior|aggressive behavior
771655|NCT00361062|computer simulation|computer simulation
771656|NCT00361049|graft versus host disease|graft versus host disease
772106|NCT00359645|Alcohol|alcohol
771657|NCT00361049|unspecified adult solid tumor, protocol specific|unspecified adult solid tumor, protocol specific
771658|NCT00361049|adult acute myeloid leukemia with 11q23 (MLL) abnormalities|adult acute myeloid leukemia with 11q23 (mll) abnormalities
771659|NCT00361049|adult acute myeloid leukemia with inv(16)(p13;q22)|adult acute myeloid leukemia with inv(16)(p13;q22)
771660|NCT00361049|adult acute myeloid leukemia with t(15;17)(q22;q12)|adult acute myeloid leukemia with t(15;17)(q22;q12)
771661|NCT00361049|adult acute myeloid leukemia with t(16;16)(p13;q22)|adult acute myeloid leukemia with t(16;16)(p13;q22)
771662|NCT00361049|adult acute myeloid leukemia with t(8;21)(q22;q22)|adult acute myeloid leukemia with t(8;21)(q22;q22)
771663|NCT00361049|accelerated phase chronic myelogenous leukemia|accelerated phase chronic myelogenous leukemia
771664|NCT00361049|adult acute lymphoblastic leukemia in remission|adult acute lymphoblastic leukemia in remission
771665|NCT00361049|adult acute myeloid leukemia in remission|adult acute myeloid leukemia in remission
771666|NCT00361049|atypical chronic myeloid leukemia|atypical chronic myeloid leukemia
771667|NCT00361049|blastic phase chronic myelogenous leukemia|blastic phase chronic myelogenous leukemia
771668|NCT00361049|chronic eosinophilic leukemia|chronic eosinophilic leukemia
771669|NCT00361049|primary myelofibrosis|primary myelofibrosis
771670|NCT00361049|chronic myelomonocytic leukemia|chronic myelomonocytic leukemia
771671|NCT00361049|chronic neutrophilic leukemia|chronic neutrophilic leukemia
771672|NCT00361049|chronic phase chronic myelogenous leukemia|chronic phase chronic myelogenous leukemia
771673|NCT00361049|de novo myelodysplastic syndromes|de novo myelodysplastic syndromes
771674|NCT00361049|disseminated neuroblastoma|disseminated neuroblastoma
771675|NCT00361049|extranodal marginal zone B-cell lymphoma of mucosa-associated lymphoid tissue|extranodal marginal zone b-cell lymphoma of mucosa-associated lymphoid tissue
771676|NCT00361049|myelodysplastic/myeloproliferative disease, unclassifiable|myelodysplastic/myeloproliferative disease, unclassifiable
771677|NCT00361049|nodal marginal zone B-cell lymphoma|nodal marginal zone b-cell lymphoma
771678|NCT00361049|noncontiguous stage II adult Burkitt lymphoma|noncontiguous stage ii adult burkitt lymphoma
771679|NCT00361049|noncontiguous stage II adult diffuse large cell lymphoma|noncontiguous stage ii adult diffuse large cell lymphoma
771680|NCT00361049|noncontiguous stage II adult diffuse mixed cell lymphoma|noncontiguous stage ii adult diffuse mixed cell lymphoma
771681|NCT00361049|noncontiguous stage II adult diffuse small cleaved cell lymphoma|noncontiguous stage ii adult diffuse small cleaved cell lymphoma
771682|NCT00361049|noncontiguous stage II adult immunoblastic large cell lymphoma|noncontiguous stage ii adult immunoblastic large cell lymphoma
771683|NCT00361049|noncontiguous stage II adult lymphoblastic lymphoma|noncontiguous stage ii adult lymphoblastic lymphoma
771684|NCT00361049|noncontiguous stage II grade 1 follicular lymphoma|noncontiguous stage ii grade 1 follicular lymphoma
771685|NCT00361049|noncontiguous stage II grade 2 follicular lymphoma|noncontiguous stage ii grade 2 follicular lymphoma
771686|NCT00361049|noncontiguous stage II grade 3 follicular lymphoma|noncontiguous stage ii grade 3 follicular lymphoma
771687|NCT00361049|noncontiguous stage II mantle cell lymphoma|noncontiguous stage ii mantle cell lymphoma
771688|NCT00361049|noncontiguous stage II marginal zone lymphoma|noncontiguous stage ii marginal zone lymphoma
771689|NCT00361049|noncontiguous stage II small lymphocytic lymphoma|noncontiguous stage ii small lymphocytic lymphoma
771690|NCT00361049|poor prognosis metastatic gestational trophoblastic tumor|poor prognosis metastatic gestational trophoblastic tumor
771691|NCT00361049|previously treated myelodysplastic syndromes|previously treated myelodysplastic syndromes
771692|NCT00361049|secondary acute myeloid leukemia|secondary acute myeloid leukemia
771693|NCT00361049|secondary myelodysplastic syndromes|secondary myelodysplastic syndromes
771694|NCT00361049|splenic marginal zone lymphoma|splenic marginal zone lymphoma
771695|NCT00361049|stage I multiple myeloma|stage i multiple myeloma
771696|NCT00361049|stage II multiple myeloma|stage ii multiple myeloma
771697|NCT00361049|stage II ovarian epithelial cancer|stage ii ovarian epithelial cancer
771698|NCT00361049|stage III adult Burkitt lymphoma|stage iii adult burkitt lymphoma
771699|NCT00361049|stage III adult Hodgkin lymphoma|stage iii adult hodgkin lymphoma
771700|NCT00361049|stage III adult diffuse large cell lymphoma|stage iii adult diffuse large cell lymphoma
771701|NCT00361049|stage III adult diffuse mixed cell lymphoma|stage iii adult diffuse mixed cell lymphoma
771702|NCT00361049|stage III adult diffuse small cleaved cell lymphoma|stage iii adult diffuse small cleaved cell lymphoma
771703|NCT00361049|stage III adult immunoblastic large cell lymphoma|stage iii adult immunoblastic large cell lymphoma
771704|NCT00361049|stage III adult lymphoblastic lymphoma|stage iii adult lymphoblastic lymphoma
771705|NCT00361049|stage III chronic lymphocytic leukemia|stage iii chronic lymphocytic leukemia
771706|NCT00361049|stage III grade 1 follicular lymphoma|stage iii grade 1 follicular lymphoma
771707|NCT00361049|stage III grade 2 follicular lymphoma|stage iii grade 2 follicular lymphoma
771708|NCT00361049|stage III grade 3 follicular lymphoma|stage iii grade 3 follicular lymphoma
771709|NCT00361049|stage III mantle cell lymphoma|stage iii mantle cell lymphoma
771710|NCT00361049|stage III marginal zone lymphoma|stage iii marginal zone lymphoma
771711|NCT00361049|stage III multiple myeloma|stage iii multiple myeloma
771712|NCT00361049|stage III ovarian epithelial cancer|stage iii ovarian epithelial cancer
771713|NCT00361049|stage III small lymphocytic lymphoma|stage iii small lymphocytic lymphoma
771714|NCT00361049|stage III malignant testicular germ cell tumor|stage iii malignant testicular germ cell tumor
771715|NCT00361049|stage IIIA breast cancer|stage iiia breast cancer
771716|NCT00361049|stage IIIB breast cancer|stage iiib breast cancer
771717|NCT00361049|stage IIIC breast cancer|stage iiic breast cancer
771718|NCT00361049|stage IV adult Burkitt lymphoma|stage iv adult burkitt lymphoma
771719|NCT00361049|stage IV adult Hodgkin lymphoma|stage iv adult hodgkin lymphoma
771720|NCT00361049|stage IV adult diffuse large cell lymphoma|stage iv adult diffuse large cell lymphoma
771721|NCT00361049|stage IV adult diffuse mixed cell lymphoma|stage iv adult diffuse mixed cell lymphoma
771722|NCT00361049|stage IV adult diffuse small cleaved cell lymphoma|stage iv adult diffuse small cleaved cell lymphoma
771723|NCT00361049|stage IV adult immunoblastic large cell lymphoma|stage iv adult immunoblastic large cell lymphoma
771724|NCT00361049|stage IV adult lymphoblastic lymphoma|stage iv adult lymphoblastic lymphoma
771725|NCT00361049|stage IV breast cancer|stage iv breast cancer
771726|NCT00361049|stage IV chronic lymphocytic leukemia|stage iv chronic lymphocytic leukemia
771727|NCT00361049|stage IV grade 1 follicular lymphoma|stage iv grade 1 follicular lymphoma
771728|NCT00361049|stage IV grade 2 follicular lymphoma|stage iv grade 2 follicular lymphoma
771729|NCT00361049|stage IV grade 3 follicular lymphoma|stage iv grade 3 follicular lymphoma
771730|NCT00361049|stage IV mantle cell lymphoma|stage iv mantle cell lymphoma
771731|NCT00361049|stage IV marginal zone lymphoma|stage iv marginal zone lymphoma
771732|NCT00361049|stage IV ovarian epithelial cancer|stage iv ovarian epithelial cancer
771733|NCT00361049|stage IV small lymphocytic lymphoma|stage iv small lymphocytic lymphoma
771734|NCT00361036|Leiomyoma|leiomyoma
771735|NCT00361036|Leiomyomatosis|leiomyomatosis
771736|NCT00361036|Uterine Neoplasms|uterine neoplasms
771737|NCT00361036|BeadBlock|beadblock
771738|NCT00361036|Embsophere|embsophere
771739|NCT00361036|Embolization|embolization
771740|NCT00361036|Uterine fibroid embolization|uterine fibroid embolization
771741|NCT00361023|Angiotensin type 1 receptor blocker (ARB)|angiotensin type 1 receptor blocker (arb)
771742|NCT00361023|losartan|losartan
771743|NCT00361023|type 2 diabetes|type 2 diabetes
771744|NCT00361023|insulin sensitivity and secretion|insulin sensitivity and secretion
771745|NCT00361023|glucose metabolism|glucose metabolism
771746|NCT00361010|Keppra|keppra
771747|NCT00361010|Epilepsy|epilepsy
771748|NCT00361010|Childhood Absence Epilepsy|childhood absence epilepsy
771749|NCT00361010|Seizures|seizures
771750|NCT00360997|Stroke rehabilitation|stroke rehabilitation
771751|NCT00360997|Physical therapy|physical therapy
771752|NCT00360984|CSII|csii
771753|NCT00360984|insulin analog|insulin analog
771754|NCT00360984|severe hypoglycaemia|severe hypoglycaemia
771755|NCT00360984|altered hypoglycaemia awareness|altered hypoglycaemia awareness
771756|NCT00360984|diabetes quality of life|diabetes quality of life
771757|NCT00360984|CGMS|cgms
771758|NCT00360971|mucositis|mucositis
771759|NCT00360971|pain|pain
771760|NCT00360971|radiation toxicity|radiation toxicity
771761|NCT00360971|stage III squamous cell carcinoma of the hypopharynx|stage iii squamous cell carcinoma of the hypopharynx
771762|NCT00360971|stage IV squamous cell carcinoma of the hypopharynx|stage iv squamous cell carcinoma of the hypopharynx
771763|NCT00360971|stage III squamous cell carcinoma of the larynx|stage iii squamous cell carcinoma of the larynx
771764|NCT00360971|stage IV squamous cell carcinoma of the larynx|stage iv squamous cell carcinoma of the larynx
771765|NCT00360971|stage III squamous cell carcinoma of the lip and oral cavity|stage iii squamous cell carcinoma of the lip and oral cavity
771766|NCT00360971|stage IV squamous cell carcinoma of the lip and oral cavity|stage iv squamous cell carcinoma of the lip and oral cavity
771767|NCT00360971|stage III squamous cell carcinoma of the oropharynx|stage iii squamous cell carcinoma of the oropharynx
771768|NCT00360971|stage IV squamous cell carcinoma of the oropharynx|stage iv squamous cell carcinoma of the oropharynx
771769|NCT00360958|ultrafiltration|ultrafiltration
771770|NCT00360958|heart failure|heart failure
771771|NCT00360958|fluid overload|fluid overload
771772|NCT00360945|childhood oligodendroglioma|childhood oligodendroglioma
771773|NCT00360945|untreated childhood cerebellar astrocytoma|untreated childhood cerebellar astrocytoma
771774|NCT00360945|childhood high-grade cerebral astrocytoma|childhood high-grade cerebral astrocytoma
771775|NCT00360945|childhood low-grade cerebral astrocytoma|childhood low-grade cerebral astrocytoma
771776|NCT00360945|recurrent childhood cerebellar astrocytoma|recurrent childhood cerebellar astrocytoma
771777|NCT00360945|recurrent childhood cerebral astrocytoma|recurrent childhood cerebral astrocytoma
771778|NCT00360945|recurrent childhood brain tumor|recurrent childhood brain tumor
771779|NCT00360932|facial lipoatrophy|facial lipoatrophy
771780|NCT00360932|HIV/AIDs|hiv/aids
771781|NCT00360919|casomorphin|casomorphin
771782|NCT00360919|cheese|cheese
771783|NCT00360919|craving|craving
771784|NCT00360919|casein|casein
771785|NCT00360919|milk|milk
771786|NCT00360906|RRMS|rrms
771787|NCT00360906|Omega-3|omega-3
771788|NCT00360906|Treatment|treatment
771789|NCT00360867|Extension study|extension study
771790|NCT00360867|solid tumors|solid tumors
771791|NCT00360854|untreated childhood brain stem glioma|untreated childhood brain stem glioma
771792|NCT00360854|recurrent childhood cerebellar astrocytoma|recurrent childhood cerebellar astrocytoma
771793|NCT00360854|recurrent childhood cerebral astrocytoma|recurrent childhood cerebral astrocytoma
771794|NCT00360854|recurrent childhood ependymoma|recurrent childhood ependymoma
771795|NCT00360854|recurrent childhood medulloblastoma|recurrent childhood medulloblastoma
771796|NCT00360854|recurrent childhood supratentorial primitive neuroectodermal tumor|recurrent childhood supratentorial primitive neuroectodermal tumor
771797|NCT00360854|recurrent childhood visual pathway and hypothalamic glioma|recurrent childhood visual pathway and hypothalamic glioma
772107|NCT00359645|Tobacco|tobacco
771798|NCT00360854|childhood central nervous system germ cell tumor|childhood central nervous system germ cell tumor
771799|NCT00360854|childhood choroid plexus tumor|childhood choroid plexus tumor
771800|NCT00360854|childhood craniopharyngioma|childhood craniopharyngioma
771801|NCT00360854|childhood grade I meningioma|childhood grade i meningioma
771802|NCT00360854|childhood grade II meningioma|childhood grade ii meningioma
771803|NCT00360854|childhood grade III meningioma|childhood grade iii meningioma
771804|NCT00360854|childhood low-grade cerebral astrocytoma|childhood low-grade cerebral astrocytoma
771805|NCT00360854|childhood infratentorial ependymoma|childhood infratentorial ependymoma
771806|NCT00360854|childhood supratentorial ependymoma|childhood supratentorial ependymoma
771807|NCT00360854|recurrent childhood brain tumor|recurrent childhood brain tumor
771808|NCT00360854|recurrent childhood subependymal giant cell astrocytoma|recurrent childhood subependymal giant cell astrocytoma
771809|NCT00360854|recurrent childhood pineoblastoma|recurrent childhood pineoblastoma
771810|NCT00360841|auricular|auricular
771811|NCT00360841|acupuncture|acupuncture
771812|NCT00360828|Recurrent Anaplastic Astrocytoma|recurrent anaplastic astrocytoma
771813|NCT00360828|Mixed Malignant Glioma|mixed malignant glioma
771814|NCT00360828|Oligodendroglioma|oligodendroglioma
771815|NCT00360828|Irinotecan|irinotecan
771816|NCT00360828|Brain tumor|brain tumor
771817|NCT00360828|Nitrosoureas|nitrosoureas
771818|NCT00360828|Brain and nervous system|brain and nervous system
771819|NCT00360802|chronic low back pain|chronic low back pain
771820|NCT00360802|cognitive-behavioral therapy|cognitive-behavioral therapy
771821|NCT00360802|Mindful Based Stress Reduction|mindful based stress reduction
771822|NCT00360802|pain clinics|pain clinics
771823|NCT00360802|anxiety|anxiety
771824|NCT00360802|quality of life|quality of life
771825|NCT00360802|chronic pain|chronic pain
771826|NCT00360789|STROKE REHABILITATION|stroke rehabilitation
771827|NCT00360789|pHYSICAL THERAPY|physical therapy
771828|NCT00360750|intraocular retinoblastoma|intraocular retinoblastoma
771829|NCT00360750|extraocular retinoblastoma|extraocular retinoblastoma
771830|NCT00360737|Clinical Trials|clinical trials
771831|NCT00360737|Investigational Drug|investigational drug
771832|NCT00360737|Healthy Volunteers|healthy volunteers
771833|NCT00360737|Botulinum Antitoxin|botulinum antitoxin
771834|NCT00360737|Phoenix, Arizona|phoenix, arizona
771835|NCT00360724|dysthymia|dysthymia
771836|NCT00360724|dysthymic disorder|dysthymic disorder
771837|NCT00360724|chronic depression|chronic depression
771838|NCT00360724|chronic low-grade depression|chronic low-grade depression
771839|NCT00360724|atypical depression|atypical depression
771840|NCT00360724|minor depression|minor depression
771841|NCT00360724|depression NOS|depression nos
771842|NCT00360724|depression|depression
771843|NCT00360724|depressive disorder|depressive disorder
771844|NCT00360724|mood disorder|mood disorder
771845|NCT00360724|unipolar depression|unipolar depression
771846|NCT00360724|low-grade depression|low-grade depression
771847|NCT00360711|Moral Distress|moral distress
771848|NCT00360711|Nondirectiveness|nondirectiveness
771849|NCT00360711|Ethical Dilemma|ethical dilemma
771850|NCT00360685|Tacrolimus|tacrolimus
771851|NCT00360685|Methotrexate|methotrexate
771852|NCT00360685|Mycophenolate mofetil|mycophenolate mofetil
771853|NCT00360685|Mucositis|mucositis
771854|NCT00360685|Acute graft-versus-host disease (aGVHD)|acute graft-versus-host disease (agvhd)
771855|NCT00360685|Engraftment|engraftment
771856|NCT00360685|hemolytic/uremic syndrome (HUS)|hemolytic/uremic syndrome (hus)
771857|NCT00360685|Thrombotic thrombocytopenic purpura (TTP)|thrombotic thrombocytopenic purpura (ttp)
771858|NCT00360672|Acute Myelogenous Leukemia|acute myelogenous leukemia
771859|NCT00360672|Myelodysplastic Syndrome|myelodysplastic syndrome
771860|NCT00360659|Obstructive sleep Apnea|obstructive sleep apnea
771861|NCT00360659|Hypertension|hypertension
771862|NCT00360659|Vasoactive hormones|vasoactive hormones
771863|NCT00360646|LIVER DIS|liver dis
771864|NCT00360646|CHEM IND|chem ind
771865|NCT00360646|Drugs|drugs
771866|NCT00360646|Drug induced liver injury|drug induced liver injury
771867|NCT00360646|phenotype|phenotype
771868|NCT00360646|cholestatic liver injury|cholestatic liver injury
771869|NCT00360646|hepatocellular liver injury|hepatocellular liver injury
771870|NCT00360646|mixed liver injury|mixed liver injury
771871|NCT00360646|genotype|genotype
771872|NCT00360633|Parkinson's Disease|parkinson's disease
771873|NCT00360633|Impulse control disorder|impulse control disorder
771874|NCT00360633|Dopamine agonist withdrawal syndrome|dopamine agonist withdrawal syndrome
771875|NCT00360633|Anxiety|anxiety
771876|NCT00360633|Depression|depression
771877|NCT00360633|Healthcare Utilization|healthcare utilization
771878|NCT00360633|Disability|disability
771879|NCT00360633|Quality of life|quality of life
771880|NCT00360633|Cognitive function|cognitive function
771881|NCT00360633|Psychosis|psychosis
771882|NCT00360633|Apathy|apathy
771883|NCT00360633|Dyskinesias|dyskinesias
771884|NCT00360633|Wearing off|wearing off
771885|NCT00360594|alcoholism|alcoholism
771886|NCT00360581|Smoking abstinence|smoking abstinence
771887|NCT00360568|carbidopa|carbidopa
771888|NCT00360568|severe motor fluctuations|severe motor fluctuations
771889|NCT00360568|intestinal gel|intestinal gel
771892|NCT00360568|levodopa carbidopa intestinal gel|levodopa carbidopa intestinal gel
771893|NCT00360568|dyskinesia|dyskinesia
771894|NCT00360568|Parkinson's Disease|parkinson's disease
771895|NCT00360568|Duodopa|duodopa
771896|NCT00360568|levodopa-carbidopa|levodopa-carbidopa
771897|NCT00360568|DUOPA|duopa
771898|NCT00360516|healthy volunteers|healthy volunteers
771899|NCT00360503|Cystic fibrosis|cystic fibrosis
771900|NCT00360503|Antibiotic resistance|antibiotic resistance
771901|NCT00360503|Microbiology|microbiology
771902|NCT00360490|Idiopathic Menorrhagia|idiopathic menorrhagia
771903|NCT00360477|Kidney stone removal surgery|kidney stone removal surgery
771904|NCT00360451|Prevention|prevention
771905|NCT00360451|Child|child
771906|NCT00360451|Adolescent|adolescent
771907|NCT00360451|Parent|parent
771908|NCT00360438|Leukemia|leukemia
771909|NCT00360438|Lymphoma|lymphoma
771910|NCT00360438|Tumor Lysis Syndrome|tumor lysis syndrome
771911|NCT00360438|TLS|tls
771912|NCT00360438|Rasburicase|rasburicase
771913|NCT00360438|Elitek|elitek
771914|NCT00360425|anemia|anemia
771915|NCT00360425|intravenous iron|intravenous iron
771916|NCT00360425|pharmacokinetics|pharmacokinetics
771917|NCT00360425|QTc|qtc
771918|NCT00360399|Escitalopram|escitalopram
771919|NCT00360399|Duloxetine|duloxetine
771920|NCT00360399|Cognitive Behavioral Therapy|cognitive behavioral therapy
771921|NCT00360399|PET|pet
771922|NCT00360399|fMRI|fmri
771923|NCT00360373|bariatric|bariatric
771924|NCT00360373|obesity|obesity
771925|NCT00360373|insulin resistance|insulin resistance
771926|NCT00360373|gastric bypass|gastric bypass
771927|NCT00360373|adolescent|adolescent
771928|NCT00360360|Neoplasm, Unknown Primary|neoplasm, unknown primary
771929|NCT00360334|diabetes|diabetes
771930|NCT00360334|exenatide|exenatide
771931|NCT00360334|insulin glargine|insulin glargine
771932|NCT00360334|Lilly|lilly
771933|NCT00360334|Amylin|amylin
771934|NCT00360282|Migraine|migraine
771935|NCT00360282|Triptans|triptans
771936|NCT00360282|Motion Sickness|motion sickness
771937|NCT00360256|Depression|depression
771938|NCT00360256|Amplichip P450 tests|amplichip p450 tests
771939|NCT00360256|Antidepressants|antidepressants
771940|NCT00360230|Vaccine|vaccine
771941|NCT00360230|Prophylaxis Plasmodium falciparum malaria|prophylaxis plasmodium falciparum malaria
771942|NCT00360230|Plasmodium falciparum|plasmodium falciparum
771943|NCT00360230|Malaria|malaria
771944|NCT00360217|Omega-3|omega-3
771945|NCT00360217|Triglyceride|triglyceride
771946|NCT00360217|Hyperlipidemia|hyperlipidemia
771947|NCT00360217|Coronary Artery Disease|coronary artery disease
771948|NCT00360217|Fatty Acids|fatty acids
771949|NCT00360217|Safety|safety
771950|NCT00360217|Fish Oil|fish oil
771951|NCT00360217|Docosohexanoic Acid|docosohexanoic acid
771952|NCT00360204|Infant health|infant health
771953|NCT00360204|parenting competence|parenting competence
771954|NCT00360204|Home nurse visit|home nurse visit
771955|NCT00360204|maternal post-partum care|maternal post-partum care
771956|NCT00360204|postpartum health utilization|postpartum health utilization
771957|NCT00360204|Breastfeeding|breastfeeding
771958|NCT00360178|hypertension|hypertension
771959|NCT00360178|valsartan|valsartan
771960|NCT00360178|amlodipine|amlodipine
771961|NCT00360178|hydrochlorothiazide|hydrochlorothiazide
771962|NCT00360152|Breast Cancer|breast cancer
771963|NCT00360152|Axilla|axilla
771964|NCT00360152|Ultrasound|ultrasound
771965|NCT00360152|FNA|fna
771966|NCT00360152|Molecular Analysis|molecular analysis
771967|NCT00360139|Sculptra|sculptra
771968|NCT00360139|lipoatrophy|lipoatrophy
771969|NCT00360139|emaciation|emaciation
771970|NCT00360139|facial|facial
771971|NCT00360139|dermal filler|dermal filler
771972|NCT00360139|poly-L-lactic acid|poly-l-lactic acid
771973|NCT00360139|Dermik|dermik
771974|NCT00360139|SpaMD|spamd
771975|NCT00360139|Sanofi|sanofi
771976|NCT00360139|Facial lipoatrophy|facial lipoatrophy
771977|NCT00360139|Facial emaciation|facial emaciation
771978|NCT00360126|Lamictal|lamictal
771979|NCT00360126|lamotrigine|lamotrigine
771980|NCT00360126|Open-Label Extension Study|open-label extension study
771981|NCT00360126|Bipolar Disorder|bipolar disorder
771982|NCT00360087|Treatment Study|treatment study
771983|NCT00360087|Sickle Cell Anemia|sickle cell anemia
771984|NCT00360087|6-Minute Walk|6-minute walk
771985|NCT00360087|Right Heart Catheterization|right heart catheterization
771986|NCT00360087|Tracleer|tracleer
771987|NCT00360087|Sickle Cell|sickle cell
771989|NCT00360074|secondary hypothyroidism|secondary hypothyroidism
771990|NCT00360074|body weight adjusted thyroxin dose|body weight adjusted thyroxin dose
771991|NCT00360074|triiodothyronine supplementation|triiodothyronine supplementation
771992|NCT00360061|Type 1 Diabetes Mellitus|type 1 diabetes mellitus
771993|NCT00360061|Adolescents|adolescents
771994|NCT00360061|Cognitive Behaviour Therapy|cognitive behaviour therapy
771995|NCT00360048|oxytocin|oxytocin
771996|NCT00360048|tnf|tnf
771997|NCT00360048|sepsis|sepsis
771998|NCT00360048|lps|lps
771999|NCT00360009|Parkinson's disease|parkinson's disease
772000|NCT00360009|Parkinson disease|parkinson disease
772001|NCT00360009|PD|pd
772002|NCT00360009|deep brain stimulation|deep brain stimulation
772003|NCT00360009|DBS|dbs
772004|NCT00360009|subthalamic nucleus|subthalamic nucleus
772005|NCT00360009|STN|stn
772006|NCT00360009|globus pallidus interna|globus pallidus interna
772007|NCT00360009|GPi|gpi
772008|NCT00360009|mood|mood
772009|NCT00360009|motor symptoms|motor symptoms
772010|NCT00360009|cognition|cognition
772011|NCT00360009|emotion|emotion
772012|NCT00360009|memory|memory
772013|NCT00360009|attention|attention
772014|NCT00360009|tremor|tremor
772015|NCT00360009|rigidity|rigidity
772016|NCT00360009|bradykinesia|bradykinesia
772017|NCT00359996|diabetes|diabetes
772018|NCT00359996|quality improvement|quality improvement
772019|NCT00359996|community health center|community health center
772020|NCT00359996|health disparities|health disparities
772021|NCT00359983|Humans|humans
772022|NCT00359983|Meningococcal vaccines|meningococcal vaccines
772023|NCT00359983|Immunogenicity|immunogenicity
772024|NCT00359983|Vaccines|vaccines
772025|NCT00359983|H. influenzae type b vaccine|h. influenzae type b vaccine
772026|NCT00359983|Conjugate|conjugate
772027|NCT00359983|Toddlers|toddlers
772028|NCT00359983|Comparative study|comparative study
772029|NCT00359983|Neisseria meningitidis|neisseria meningitidis
772030|NCT00359970|Diarrhea|diarrhea
772031|NCT00359970|Travel|travel
772032|NCT00359970|Travelers' diarrhea|travelers' diarrhea
772033|NCT00359970|Azithromycin|azithromycin
772034|NCT00359970|Loperamide|loperamide
772035|NCT00359970|Treatment|treatment
772036|NCT00359970|Antibiotic|antibiotic
772037|NCT00359957|Pediatric obesity|pediatric obesity
772038|NCT00359957|Physical activity|physical activity
772039|NCT00359957|Visceral fat|visceral fat
772040|NCT00359957|Weight|weight
772041|NCT00359944|Alzheimer|alzheimer
772042|NCT00359944|Dementia|dementia
772043|NCT00359931|Neural Networks|neural networks
772044|NCT00359931|Mathematical Modeling|mathematical modeling
772045|NCT00359931|Auditory Processing|auditory processing
772046|NCT00359931|Tinnitis|tinnitis
772047|NCT00359931|Hearing Loss|hearing loss
772048|NCT00359918|infarction|infarction
772049|NCT00359918|facilitated PCI|facilitated pci
772050|NCT00359918|primary PCI|primary pci
772051|NCT00359918|infarct size|infarct size
772052|NCT00359918|fibrinolysis|fibrinolysis
772053|NCT00359918|ST-elevation myocardial infarction (STEMI)|st-elevation myocardial infarction (stemi)
772054|NCT00359905|Benign prostatic hyperplasia|benign prostatic hyperplasia
772055|NCT00359905|alpha-blockers|alpha-blockers
772056|NCT00359879|diabetes|diabetes
772057|NCT00359879|exenatide|exenatide
772058|NCT00359879|Lilly|lilly
772059|NCT00359879|Amylin|amylin
772060|NCT00359853|Norfloxacin, primary prophylaxis, SBP|norfloxacin, primary prophylaxis, sbp
772061|NCT00359840|darbepoetin alfa|darbepoetin alfa
772062|NCT00359840|anemia|anemia
772063|NCT00359840|cancer patients|cancer patients
772064|NCT00359840|chemotherapy|chemotherapy
772065|NCT00359814|Cyclosporine|cyclosporine
772066|NCT00359814|renal insufficiency, chronic|renal insufficiency, chronic
772067|NCT00359814|long-term care|long-term care
772068|NCT00359801|Large Simple Trial|large simple trial
772069|NCT00359775|Coping|coping
772070|NCT00359775|psychosocial|psychosocial
772071|NCT00359775|Quality of Life|quality of life
772072|NCT00359775|problem solving|problem solving
772073|NCT00359762|exenatide|exenatide
772074|NCT00359762|diabetes|diabetes
772075|NCT00359762|Amylin|amylin
772076|NCT00359762|Lilly|lilly
772077|NCT00359762|glimepiride|glimepiride
772078|NCT00359736|alveolitis, fibrosing|alveolitis, fibrosing
772079|NCT00359736|exercise, aerobic|exercise, aerobic
772080|NCT00359736|fibrosis, pulmonary|fibrosis, pulmonary
772081|NCT00359736|hypertension, pulmonary|hypertension, pulmonary
772082|NCT00359723|Parkinson's disease|parkinson's disease
772083|NCT00359723|PD|pd
772084|NCT00359723|methylphenidate|methylphenidate
772085|NCT00359723|Ritalin|ritalin
772086|NCT00359723|MPD|mpd
772087|NCT00359710|Multiracial Populations|multiracial populations
772088|NCT00359710|Human Genetic Variation|human genetic variation
772089|NCT00359710|Family History|family history
772090|NCT00359710|Admixture|admixture
772091|NCT00359710|Physician-Patient Communication|physician-patient communication
772092|NCT00359710|Ancestry|ancestry
772093|NCT00359710|Self-Identified Multiracial Adults|self-identified multiracial adults
772094|NCT00359710|Interview|interview
772095|NCT00359684|Cystinosis|cystinosis
772096|NCT00359684|Cystine|cystine
772097|NCT00359684|Lysomal Storage Disease|lysomal storage disease
772098|NCT00359684|Mutation Analysis|mutation analysis
772099|NCT00359684|Metabolic Disease|metabolic disease
772100|NCT00359658|Cyclosporine|cyclosporine
772101|NCT00359658|Glucocorticoids|glucocorticoids
772102|NCT00359658|renal insufficiency, chronic|renal insufficiency, chronic
772103|NCT00359658|long-term care|long-term care
772104|NCT00359645|Screening|screening
772105|NCT00359645|Upper aerodigestive tract cancer|upper aerodigestive tract cancer
772108|NCT00359645|Randomized trial|randomized trial
772109|NCT00359632|Optic neuropathy following long-term linezolid use|optic neuropathy following long-term linezolid use
772110|NCT00359619|HPV vaccine|hpv vaccine
772111|NCT00359606|DNA Methylation|dna methylation
772112|NCT00359606|Advanced Cancer|advanced cancer
772113|NCT00359606|Methyltransferase Inhibitor|methyltransferase inhibitor
772114|NCT00359606|Epigenetics|epigenetics
772115|NCT00359606|Gene Re-Expression|gene re-expression
772116|NCT00359593|Stroke|stroke
772117|NCT00359593|Rehabilitation|rehabilitation
772118|NCT00359593|Knowledge translation|knowledge translation
772119|NCT00359593|Evidence based practice|evidence based practice
772120|NCT00359593|Outcomes|outcomes
772121|NCT00359580|Rare Diseases|rare diseases
772122|NCT00359580|Consanguinity|consanguinity
772123|NCT00359567|nausea and vomiting|nausea and vomiting
772124|NCT00359554|Influenza|influenza
772125|NCT00359541|CYP2C9|cyp2c9
772126|NCT00359541|CYP2C19|cyp2c19
772127|NCT00359541|Pharmacology|pharmacology
772128|NCT00359541|Genotype|genotype
772129|NCT00359541|Metabolism|metabolism
772130|NCT00359515|Archived Samples|archived samples
772131|NCT00359515|Mutation Screening|mutation screening
772132|NCT00359515|Genotype-Phenotype Correlation|genotype-phenotype correlation
772133|NCT00359515|Pediatric Developmental Disorder|pediatric developmental disorder
772134|NCT00359515|Cataracts|cataracts
772135|NCT00359515|Mutation Detection|mutation detection
772136|NCT00359515|Lowe Syndrome|lowe syndrome
772137|NCT00359515|Genotype|genotype
772138|NCT00359476|Locally advanced/metastatic gastric adenocarcinoma|locally advanced/metastatic gastric adenocarcinoma
772139|NCT00359476|adenocarcinoma-gastroesophageal junction|adenocarcinoma-gastroesophageal junction
772140|NCT00359476|Gastric Adenocarcinoma|gastric adenocarcinoma
772141|NCT00359463|hepatitis C-associated thrombocytopenia|hepatitis c-associated thrombocytopenia
772142|NCT00359463|chemotherapy induced thrombocytopenia|chemotherapy induced thrombocytopenia
772143|NCT00359463|thrombocytopenia|thrombocytopenia
772144|NCT00359463|hepatic impairment|hepatic impairment
772145|NCT00359463|chronic immune thrombocytopenia purpura|chronic immune thrombocytopenia purpura
772146|NCT00359450|Locally advanced or metastatic non-small cell lung cancer|locally advanced or metastatic non-small cell lung cancer
772147|NCT00359424|acute ischemic stroke|acute ischemic stroke
772148|NCT00359424|rt-PA|rt-pa
772149|NCT00359424|thrombolytic|thrombolytic
772150|NCT00359424|recombinant tissue plasminogen activator|recombinant tissue plasminogen activator
772151|NCT00359424|recanalization|recanalization
772152|NCT00359424|blood clot|blood clot
772153|NCT00359424|stroke|stroke
772154|NCT00359424|clot-dissolving|clot-dissolving
772155|NCT00359424|Activase®|activase®
772156|NCT00359424|Actilyse®|actilyse®
772157|NCT00359424|Concentric Merci® Retriever|concentric merci® retriever
772158|NCT00359424|EKOS® Micro-Infusion catheter (MicroLysus)|ekos® micro-infusion catheter (microlysus)
772159|NCT00359424|The Penumbra System™|the penumbra system™
772160|NCT00359424|Standard microcatheter|standard microcatheter
772161|NCT00359411|Epstein-Barr Virus|epstein-barr virus
772162|NCT00359411|B-Cell Lymphoma|b-cell lymphoma
772163|NCT00359411|Herpes Virus|herpes virus
772164|NCT00359411|Infectious Mononucleosis|infectious mononucleosis
772165|NCT00359398|Cardiopulmonary bypass|cardiopulmonary bypass
772166|NCT00359398|Blood component removal|blood component removal
772167|NCT00359385|primary hyperparathyroidism|primary hyperparathyroidism
772168|NCT00359385|hyperparathyroidism|hyperparathyroidism
772169|NCT00359385|PHPT|phpt
772171|NCT00359385|hypercalcemia|hypercalcemia
772172|NCT00359385|bone density|bone density
772173|NCT00359385|osteoporosis|osteoporosis
772174|NCT00359385|bone turnover|bone turnover
772175|NCT00359385|DXA|dxa
772176|NCT00359385|pQCT|pqct
772177|NCT00359385|cQCT|cqct
772178|NCT00359385|alendronate|alendronate
772179|NCT00359385|Fosamax|fosamax
772180|NCT00359385|parathyroid hormone|parathyroid hormone
772181|NCT00359385|parathyroid surgery|parathyroid surgery
772182|NCT00359385|parathyroidectomy|parathyroidectomy
772183|NCT00359385|Silverberg|silverberg
772184|NCT00359385|Rubin|rubin
772185|NCT00359385|Bilezikian|bilezikian
772186|NCT00359385|treatment|treatment
772187|NCT00359372|Chronic Heart Failure|chronic heart failure
772188|NCT00359372|Cardiac Resynchronization|cardiac resynchronization
772189|NCT00359372|Magnetic Resonance Imaging|magnetic resonance imaging
772190|NCT00359372|Biventricular Pacing|biventricular pacing
772191|NCT00359372|Heart Function|heart function
772192|NCT00359372|CRT|crt
772193|NCT00359359|Small Cell Lung Cancer|small cell lung cancer
772194|NCT00359346|Plasmapheresis|plasmapheresis
772195|NCT00359346|Auto-antibodies|auto-antibodies
772196|NCT00359346|Autonomic Nervous System|autonomic nervous system
772197|NCT00359346|Dysautonomia|dysautonomia
772198|NCT00359346|Sympathetic Nervous System|sympathetic nervous system
772199|NCT00359346|Autonomic Failure|autonomic failure
772200|NCT00359320|Pancreaticoduodenectomy|pancreaticoduodenectomy
772201|NCT00359320|Pancreaticojejunostomy|pancreaticojejunostomy
772202|NCT00359320|Pancreatic Cancer|pancreatic cancer
772203|NCT00359307|Genetic|genetic
772204|NCT00359307|Longitudinal|longitudinal
772205|NCT00359307|Prospective|prospective
772206|NCT00359307|Epidemiology|epidemiology
772207|NCT00359307|Heart Attack|heart attack
772208|NCT00359294|Tumor|tumor
772209|NCT00359294|Lymphoma|lymphoma
772210|NCT00359294|Zalypsis|zalypsis
772211|NCT00359294|PharmaMar|pharmamar
772212|NCT00359294|PM00104|pm00104
772213|NCT00359281|healthy volunteers|healthy volunteers
772214|NCT00359268|Polymerase Chain Reaction|polymerase chain reaction
772215|NCT00359268|Random Priming|random priming
772216|NCT00359268|Nucleic Acid|nucleic acid
772217|NCT00359268|Viral Genome|viral genome
772218|NCT00359255|Exercise|exercise
772219|NCT00359255|rehabilitation|rehabilitation
772220|NCT00359255|upper limb|upper limb
772221|NCT00359255|inpatient|inpatient
772222|NCT00359255|RCT|rct
772223|NCT00359255|activities of daily living|activities of daily living
772224|NCT00359242|Infant Sleep|infant sleep
772225|NCT00359242|Infant Diet|infant diet
772226|NCT00359242|Infant Temperament|infant temperament
772227|NCT00359242|Rapid Infant weight gain|rapid infant weight gain
772228|NCT00359242|Infant Development|infant development
772229|NCT00359242|Parenting Competence|parenting competence
772230|NCT00359242|infant weight gain|infant weight gain
772231|NCT00359216|Hypopnea Syndrome|hypopnea syndrome
772232|NCT00359203|syncope|syncope
772233|NCT00359203|implantable loop recorder|implantable loop recorder
772234|NCT00359190|lapatinib|lapatinib
772235|NCT00359190|breast cancer|breast cancer
772236|NCT00359190|treatment-naive|treatment-naive
772237|NCT00359177|emesis liver problems hepatic impairment GW679769|emesis liver problems hepatic impairment gw679769
772239|NCT00359164|Avastin|avastin
772240|NCT00359164|Visudyne|visudyne
772241|NCT00359164|Medical condition being studied AMD|medical condition being studied amd
772242|NCT00359151|Perioperative care of total arthroplasty assessing opioid consumption|perioperative care of total arthroplasty assessing opioid consumption
772243|NCT00359138|Histamine H1 Antagonists|histamine h1 antagonists
772244|NCT00359138|Anti-Allergic Agents|anti-allergic agents
772245|NCT00359125|bipolar|bipolar
772246|NCT00359125|RU-486|ru-486
772247|NCT00359125|mifepristone|mifepristone
772248|NCT00359125|neurocognition|neurocognition
772249|NCT00359125|mood|mood
772250|NCT00359125|cortisol|cortisol
772251|NCT00359125|HPA axis|hpa axis
772252|NCT00359112|Type 2 diabetes|type 2 diabetes
772253|NCT00359112|overweight|overweight
772254|NCT00359112|AVANDAMET|avandamet
772255|NCT00359112|metformin|metformin
772256|NCT00359112|sulphonylurea|sulphonylurea
772257|NCT00359099|Hepatic Medicine|hepatic medicine
772258|NCT00359099|Surgery|surgery
772259|NCT00359086|Relapsed and Refractory Lymphoma|relapsed and refractory lymphoma
772260|NCT00359086|Phase II|phase ii
772261|NCT00359073|asthma|asthma
772262|NCT00359073|leukotrienes|leukotrienes
772263|NCT00359073|rhinovirus|rhinovirus
772264|NCT00359060|Physical activity|physical activity
772265|NCT00359060|Sex steroid hormones|sex steroid hormones
772266|NCT00359060|Breast cancer risk|breast cancer risk
772267|NCT00359060|Intervention study|intervention study
772268|NCT00359060|Postmenopausal women|postmenopausal women
772269|NCT00359047|Osteoporosis|osteoporosis
772270|NCT00359047|Fragility fracture|fragility fracture
772271|NCT00359047|Women|women
772272|NCT00359047|Randomised control trial|randomised control trial
772273|NCT00359047|Patient education|patient education
772274|NCT00359047|Diagnosis|diagnosis
772275|NCT00359047|Treatment|treatment
772276|NCT00359034|Doppler ultrasound|doppler ultrasound
772277|NCT00359034|pulsewave velocity|pulsewave velocity
772278|NCT00359034|intrauterine growth restriction|intrauterine growth restriction
772279|NCT00359034|Fetal Pulsewave Velocity|fetal pulsewave velocity
772280|NCT00359021|HIV-1|hiv-1
772281|NCT00359021|treatment experienced|treatment experienced
772282|NCT00359021|virologic failure|virologic failure
772283|NCT00359008|AMD|amd
772284|NCT00359008|CNV|cnv
772285|NCT00359008|PHP|php
772286|NCT00358995|Cognitive Behavioral Therapy|cognitive behavioral therapy
772287|NCT00358995|Primary Obsessions|primary obsessions
772288|NCT00358995|Obsessive Compulsive Disorder|obsessive compulsive disorder
772289|NCT00358995|Compulsive Disorder|compulsive disorder
772290|NCT00358982|Relapsed or Refractory Hodgkin's Lymphoma|relapsed or refractory hodgkin's lymphoma
772291|NCT00358982|Phase II|phase ii
772292|NCT00358969|borderline personality disorder|borderline personality disorder
772293|NCT00358969|guanfacine|guanfacine
772294|NCT00358969|impulsivity|impulsivity
772295|NCT00358969|aggression|aggression
772296|NCT00358969|affective instability|affective instability
772297|NCT00358956|medullary thyroid cancer|medullary thyroid cancer
772298|NCT00358956|MTC|mtc
772299|NCT00358956|hereditary medullary thyroid cancer|hereditary medullary thyroid cancer
772300|NCT00358956|thyroid cancer|thyroid cancer
772301|NCT00358943|Gaucher Disease|gaucher disease
772302|NCT00358943|Glucocerebrosidase Deficiency Disease|glucocerebrosidase deficiency disease
772303|NCT00358930|squamous cell carcinoma of the head and neck|squamous cell carcinoma of the head and neck
772304|NCT00358904|Hill Sachs|hill sachs
772305|NCT00358904|Weber osteotomy|weber osteotomy
772306|NCT00358904|shoulder dislocation|shoulder dislocation
772308|NCT00358891|Chronic Lung Disease|chronic lung disease
772309|NCT00358891|Respiratory Health|respiratory health
772310|NCT00358891|Neurodevelopment|neurodevelopment
772311|NCT00358891|Preschool|preschool
772312|NCT00358891|Influencing Factors|influencing factors
772313|NCT00358878|Ascites|ascites
772314|NCT00358878|Liver Cirrhosis|liver cirrhosis
772315|NCT00358865|Virtual Reality|virtual reality
772316|NCT00358865|ABI|abi
772317|NCT00358865|Projected system|projected system
772318|NCT00358852|Schizophrenia|schizophrenia
772319|NCT00358852|Mental disorder|mental disorder
772320|NCT00358852|Schizoaffective disorder|schizoaffective disorder
772321|NCT00358852|Schizophreniform disorder|schizophreniform disorder
772322|NCT00358852|Epidemiological study|epidemiological study
772323|NCT00358852|Scale validation|scale validation
772324|NCT00358852|Relapse|relapse
772325|NCT00358852|Short Term Hospitalization|short term hospitalization
772326|NCT00358852|PRE-COG|pre-cog
772327|NCT00358852|RISSCH4075|rissch4075
772328|NCT00358839|Familial hemiplegic migraine type 1 and 2|familial hemiplegic migraine type 1 and 2
772329|NCT00358839|CGRP|cgrp
772330|NCT00358839|middle cerebral artery|middle cerebral artery
772709|NCT00357435|Cornea|cornea
772331|NCT00358839|superficial temporal artery|superficial temporal artery
772332|NCT00358839|headache|headache
772333|NCT00358839|genotype|genotype
772334|NCT00358839|Healthy Volunteers|healthy volunteers
772335|NCT00358813|emesis|emesis
772336|NCT00358813|renal impairment|renal impairment
772337|NCT00358813|GW679769|gw679769
772338|NCT00358813|kidney problems|kidney problems
772339|NCT00358800|OSAHS and REMStar Auto with C-Flex|osahs and remstar auto with c-flex
772340|NCT00358787|Supracondylar fracture|supracondylar fracture
772341|NCT00358787|humerus|humerus
772342|NCT00358787|ulnar nerve injury|ulnar nerve injury
772343|NCT00358787|Baumann's angle|baumann's angle
772344|NCT00358787|Supracondylar fracture of the humerus|supracondylar fracture of the humerus
772345|NCT00358774|homeopathic|homeopathic
772346|NCT00358774|common cold|common cold
772347|NCT00358774|Research Subjects|research subjects
772348|NCT00358761|Lone Star Tick|lone star tick
772349|NCT00358761|Borrelia|borrelia
772350|NCT00358761|Skin Biopsy|skin biopsy
772351|NCT00358761|Spirochete|spirochete
772352|NCT00358761|Erythema Migrans|erythema migrans
772353|NCT00358761|Southern Tick-Assoicated Rash Illness|southern tick-assoicated rash illness
772354|NCT00358761|STARI|stari
772355|NCT00358748|Preterm|preterm
772356|NCT00358748|hypotension|hypotension
772357|NCT00358748|steroids|steroids
772358|NCT00358748|hydrocortisone|hydrocortisone
772359|NCT00358735|SAFE|safe
772360|NCT00358735|CECT|cect
772362|NCT00358735|ActiveCare|activecare
772363|NCT00358735|ActiveCare+SFT|activecare+sft
772364|NCT00358735|Deep Vein Thrombosis prevention|deep vein thrombosis prevention
772365|NCT00358735|Total Hip Replacement|total hip replacement
772366|NCT00358735|Total Hip Arthroplasty|total hip arthroplasty
772367|NCT00358735|Low Molecular Weight Heparin|low molecular weight heparin
772368|NCT00358735|MCS|mcs
772369|NCT00358709|Cognitive-behavioral therapy|cognitive-behavioral therapy
772370|NCT00358709|symptom management|symptom management
772371|NCT00358709|first psychotic episode|first psychotic episode
772372|NCT00358696|tenofovir|tenofovir
772373|NCT00358696|didanosine|didanosine
772374|NCT00358696|hiv|hiv
772375|NCT00358696|hepatitis c virus infection|hepatitis c virus infection
772376|NCT00358696|treatment|treatment
772377|NCT00358683|certolizunab pegol|certolizunab pegol
772378|NCT00358683|long term safety follow-up|long term safety follow-up
772379|NCT00358683|Chrohn's disease|chrohn's disease
772380|NCT00358683|infliximab failures patients|infliximab failures patients
772381|NCT00358683|Greek population|greek population
772382|NCT00358644|Acute Myeloid Leukemia|acute myeloid leukemia
772383|NCT00358644|AML|aml
772384|NCT00358644|Decitabine|decitabine
772385|NCT00358644|Dacogen|dacogen
772386|NCT00358644|MGI PHARMA, INC.|mgi pharma, inc.
772387|NCT00358631|depression|depression
772388|NCT00358631|antidepressive agents|antidepressive agents
772389|NCT00358631|controlled clinical trial|controlled clinical trial
772390|NCT00358618|Randomized|randomized
772391|NCT00358618|double-blind|double-blind
772392|NCT00358618|3-group clinical interventional study|3-group clinical interventional study
772393|NCT00358605|OSAHS|osahs
772394|NCT00358605|Oral Appliance|oral appliance
772395|NCT00358605|Hypopnoea Syndrome|hypopnoea syndrome
772396|NCT00358592|surgical instruments|surgical instruments
772397|NCT00358592|cesarean section|cesarean section
772398|NCT00358592|obesity|obesity
772399|NCT00358579|Vasopressin|vasopressin
772400|NCT00358579|Adrenaline|adrenaline
772401|NCT00358579|Survival|survival
772402|NCT00358579|Return of spontaneous of circulation|return of spontaneous of circulation
772403|NCT00358566|Advanced|advanced
772404|NCT00358566|Unresesctable|unresesctable
772405|NCT00358566|Adenocarcinoma|adenocarcinoma
772406|NCT00358566|Pancreatic cancer|pancreatic cancer
772407|NCT00358553|Human Volunteers|human volunteers
772408|NCT00358540|sarcoma|sarcoma
772409|NCT00358540|eltrombopag|eltrombopag
772410|NCT00358540|thrombopoiesis|thrombopoiesis
772411|NCT00358540|thrombocytopenia|thrombocytopenia
772412|NCT00358514|Tibia|tibia
772413|NCT00358514|fracture|fracture
772414|NCT00358514|compartment syndrome|compartment syndrome
772415|NCT00358514|fasciotomy|fasciotomy
772416|NCT00358501|Defibrotide|defibrotide
772417|NCT00358501|Severe veno occlusive disease|severe veno occlusive disease
772418|NCT00358501|Multi organ failure|multi organ failure
772419|NCT00358501|Stem cell transplant|stem cell transplant
772420|NCT00358501|Liver|liver
772421|NCT00358501|Regimen related toxicity|regimen related toxicity
772422|NCT00358501|Day 100 survival|day 100 survival
772423|NCT00358488|Safety|safety
772424|NCT00358488|Asthmatic patients|asthmatic patients
772425|NCT00358488|GSK159797|gsk159797
772426|NCT00358488|Efficacy|efficacy
772427|NCT00358475|perennial allergic rhinitis|perennial allergic rhinitis
772428|NCT00358462|NGU, M genitalium, Ureaplasma, azithromycin, doxycycline|ngu, m genitalium, ureaplasma, azithromycin, doxycycline
772429|NCT00358449|eosinophilic|eosinophilic
772430|NCT00358449|mepolizumab|mepolizumab
772431|NCT00358449|esophagitis|esophagitis
772432|NCT00358436|COPD|copd
772433|NCT00358436|Lung function|lung function
772434|NCT00358436|Exacerbations|exacerbations
772435|NCT00358436|Quality of Life|quality of life
772436|NCT00358423|CME|cme
772437|NCT00358423|Pegaptanib|pegaptanib
772438|NCT00358423|Post-Surgical Ocular Inflammation|post-surgical ocular inflammation
772439|NCT00358410|Functional Dyspepsia|functional dyspepsia
772440|NCT00358410|Barostat|barostat
772441|NCT00358410|Stomach|stomach
772442|NCT00358397|Solid Tumor|solid tumor
772443|NCT00358397|Clostridial|clostridial
772444|NCT00358397|Spore-forming bacteria|spore-forming bacteria
772445|NCT00358397|hypoxia|hypoxia
772446|NCT00358397|anaerobes|anaerobes
772447|NCT00358397|Clostridium novyi|clostridium novyi
772448|NCT00358397|Bacteria|bacteria
772449|NCT00358397|Bacteriolytic|bacteriolytic
772450|NCT00358397|Tumor lysis|tumor lysis
772451|NCT00358397|Necrosis|necrosis
772452|NCT00358397|Colon Cancer|colon cancer
772453|NCT00358397|Lung Cancer|lung cancer
772454|NCT00358397|Sarcoma|sarcoma
772455|NCT00358397|Bladder Cancer|bladder cancer
772456|NCT00358397|Rectal Cancer|rectal cancer
772457|NCT00358397|Gastric Cancer|gastric cancer
772458|NCT00358397|Pancreatic Cancer|pancreatic cancer
772459|NCT00358397|Experimental Therapy|experimental therapy
772460|NCT00358397|Solid Tumors|solid tumors
772461|NCT00358384|tolerability|tolerability
772462|NCT00358384|safety|safety
772463|NCT00358384|angiogenesis|angiogenesis
772464|NCT00358384|vascular endothelial growth factor|vascular endothelial growth factor
772465|NCT00358384|pharmacodynamics|pharmacodynamics
772466|NCT00358384|pharmacokinetics|pharmacokinetics
772467|NCT00358384|microplaque|microplaque
772468|NCT00358384|VEGF|vegf
772469|NCT00358384|GW786034|gw786034
772470|NCT00358371|bioavailability flucloxacillin|bioavailability flucloxacillin
772471|NCT00358358|COPD|copd
772472|NCT00358358|Impulse Oscillometry System|impulse oscillometry system
772473|NCT00358358|Computerized Tomography|computerized tomography
772474|NCT00358345|AMD|amd
772475|NCT00358332|malaria, vaccine, Mali, children|malaria, vaccine, mali, children
772476|NCT00358319|Valproic Acid (VPA)|valproic acid (vpa)
772477|NCT00358319|Karenitecin|karenitecin
772478|NCT00358319|Malignant Melanoma|malignant melanoma
772479|NCT00358319|Histone deacetylases (HDAC)inhibitors|histone deacetylases (hdac)inhibitors
772480|NCT00358319|Topoisomerase I inhibitor|topoisomerase i inhibitor
772481|NCT00358319|metastatic|metastatic
772482|NCT00358306|Endothelium|endothelium
772483|NCT00358306|Chronic Kidney Disease|chronic kidney disease
772484|NCT00358306|Acute Kidney Injury|acute kidney injury
772485|NCT00358306|Hemolytic-uremic syndrome (HUS)|hemolytic-uremic syndrome (hus)
772486|NCT00358293|Multiple Sclerosis|multiple sclerosis
772487|NCT00358293|Spasticity|spasticity
772488|NCT00358293|Sublingual Tizanidine|sublingual tizanidine
772489|NCT00358293|Ashworth Scores|ashworth scores
772490|NCT00358293|Spasticity in Multiple Sclerosis Patients|spasticity in multiple sclerosis patients
772491|NCT00358280|Patients ASA category I ～ II|patients asa category i ～ ii
772492|NCT00358280|Unilateral Lower limb surgery|unilateral lower limb surgery
772493|NCT00358280|Spinal Anesthesia|spinal anesthesia
772494|NCT00358267|Inferior Turbinate Reduction|inferior turbinate reduction
772495|NCT00358267|Partial Resection of Inferior Turbinates (PRIT)|partial resection of inferior turbinates (prit)
772496|NCT00358267|Radiofrequency Ablation (RFA)|radiofrequency ablation (rfa)
772497|NCT00358267|NOSE scale|nose scale
772498|NCT00358267|Nasal Obstruction|nasal obstruction
772499|NCT00358241|Nerve block, postoperative pain, analgesia|nerve block, postoperative pain, analgesia
772500|NCT00358228|Smoking cessation|smoking cessation
772501|NCT00358228|Abstinence|abstinence
772502|NCT00358215|Survival study|survival study
772503|NCT00358215|morbidity and mortality|morbidity and mortality
772504|NCT00358215|heart failure hospitalization|heart failure hospitalization
772505|NCT00358215|all-cause death|all-cause death
772506|NCT00358215|patient-reported outcomes|patient-reported outcomes
772605|NCT00357799|Intravenous Access|intravenous access
772507|NCT00358215|Kansas City Cardiomyopathy questionnaire|kansas city cardiomyopathy questionnaire
772508|NCT00358215|anemia treatment|anemia treatment
772509|NCT00358202|intramuscular antibiotics|intramuscular antibiotics
772510|NCT00358202|nursing home acquired pneumonia|nursing home acquired pneumonia
772512|NCT00358202|pharmacoeconomics|pharmacoeconomics
772513|NCT00358202|cefepime|cefepime
772514|NCT00358202|ceftriaxone|ceftriaxone
772515|NCT00358189|deep brain stimulation|deep brain stimulation
772516|NCT00358189|gait|gait
772517|NCT00358189|manual dexterity|manual dexterity
772518|NCT00358189|parkinson's disease|parkinson's disease
772519|NCT00358176|Treatment osteoporosis postmenopausal|treatment osteoporosis postmenopausal
772520|NCT00358163|angiogenesis|angiogenesis
772521|NCT00358163|taxane|taxane
772522|NCT00358163|tyrosine kinase|tyrosine kinase
772523|NCT00358163|pharmacokinetics|pharmacokinetics
772524|NCT00358163|Vatalanib|vatalanib
772525|NCT00358163|Taxol|taxol
772526|NCT00358150|Type 1 Gaucher Disease|type 1 gaucher disease
772527|NCT00358150|Glucocerebrosidase Deficiency Disease|glucocerebrosidase deficiency disease
772528|NCT00358137|Blood Pressure, High|blood pressure, high
772529|NCT00358111|high-grade disease|high-grade disease
772710|NCT00357435|Genetics|genetics
772530|NCT00358111|Cervical examination|cervical examination
772531|NCT00358111|targeting biopsies|targeting biopsies
772532|NCT00358111|dysplasia|dysplasia
772533|NCT00358111|cancer|cancer
772534|NCT00358098|PET|pet
772535|NCT00358098|hormone positive breast cancer|hormone positive breast cancer
772536|NCT00358085|Endovascular|endovascular
772537|NCT00358085|Vascular Surgical Procedures|vascular surgical procedures
772538|NCT00358085|Aneurysm|aneurysm
772539|NCT00358085|Expertise Based Methodology|expertise based methodology
772540|NCT00358072|Acute lymphoblastic leukemia|acute lymphoblastic leukemia
772541|NCT00358072|Adult patients|adult patients
772542|NCT00358072|Minimal residual disease|minimal residual disease
772543|NCT00358072|Risk-oriented therapy|risk-oriented therapy
772544|NCT00358059|diabetes mellitus|diabetes mellitus
772545|NCT00358059|adolescence|adolescence
772546|NCT00358059|adherence|adherence
772547|NCT00358059|glycemic control|glycemic control
772548|NCT00358059|adaptation|adaptation
772549|NCT00358059|communication|communication
772550|NCT00358046|Hyperphosphatemia|hyperphosphatemia
772551|NCT00358046|Chronic kidney disease|chronic kidney disease
772552|NCT00358046|Dialysis|dialysis
772553|NCT00358046|Hyperphosphatemia in CKD patients on dialysis|hyperphosphatemia in ckd patients on dialysis
772554|NCT00358020|MYELOMA, THALIDOMIDE, BORTEZOMIB|myeloma, thalidomide, bortezomib
772555|NCT00358007|Kilovoltage Imaging|kilovoltage imaging
772556|NCT00358007|Cone-beam CT|cone-beam ct
772557|NCT00358007|CBCT|cbct
772558|NCT00358007|radiation therapy|radiation therapy
772559|NCT00358007|head and neck neoplasms|head and neck neoplasms
772560|NCT00357994|carbidopa|carbidopa
772561|NCT00357994|levodopa-carbidopa|levodopa-carbidopa
772562|NCT00357994|levodopa|levodopa
772563|NCT00357994|levodopa/carbidopa suspension|levodopa/carbidopa suspension
772564|NCT00357994|dyskinesia|dyskinesia
772565|NCT00357994|Duodopa|duodopa
772566|NCT00357994|levodopa-carbidopa intestinal gel|levodopa-carbidopa intestinal gel
772567|NCT00357994|Severe Motor Fluctuations|severe motor fluctuations
772568|NCT00357994|DUOPA|duopa
772569|NCT00357981|Contraceptive patch|contraceptive patch
772570|NCT00357981|menstruation|menstruation
772571|NCT00357981|economics|economics
772572|NCT00357942|Morphine|morphine
772573|NCT00357942|Mouthwash|mouthwash
772574|NCT00357942|Mucositis|mucositis
772575|NCT00357942|Pain|pain
772576|NCT00357942|Cancer|cancer
772577|NCT00357942|Child|child
772578|NCT00357942|Adolescent|adolescent
772579|NCT00357929|permissive hypercarbia|permissive hypercarbia
772580|NCT00357929|weaning from mechanical ventilation|weaning from mechanical ventilation
772581|NCT00357916|PEP005|pep005
772582|NCT00357916|Safety|safety
772583|NCT00357903|Rheumatoid Arthritis, Etanercept, Long-term Safety, Enbrel|rheumatoid arthritis, etanercept, long-term safety, enbrel
772584|NCT00357890|type 1 diabetes|type 1 diabetes
772585|NCT00357890|diabetes|diabetes
772586|NCT00357890|new onset|new onset
772587|NCT00357890|CSII|csii
772588|NCT00357890|insulin glargine|insulin glargine
772589|NCT00357890|insulin sensitivity|insulin sensitivity
772590|NCT00357890|beta cell function|beta cell function
772591|NCT00357890|beta cell preservation|beta cell preservation
772592|NCT00357851|pancreatitis, blood loss|pancreatitis, blood loss
772593|NCT00357838|normal healthy women|normal healthy women
772594|NCT00357812|Herpes Simplex Virus Type 1|herpes simplex virus type 1
772595|NCT00357812|Herpes Simplex Keratitis|herpes simplex keratitis
772596|NCT00357812|Cornea|cornea
772597|NCT00357812|Dendretic Ulcer|dendretic ulcer
772598|NCT00357812|In vivo Confocal Microscopy|in vivo confocal microscopy
772599|NCT00357812|Nested Multi-plex PCR|nested multi-plex pcr
772600|NCT00357812|Monoclonal Antibody|monoclonal antibody
772601|NCT00357812|Glycoprotein D|glycoprotein d
772602|NCT00357812|Glycoprotein C|glycoprotein c
772603|NCT00357799|Venipuncture|venipuncture
772604|NCT00357799|Randomized Controlled Trial|randomized controlled trial
772607|NCT00357799|Emergency Department Nursing|emergency department nursing
772608|NCT00357799|VeinViewer|veinviewer
772609|NCT00357799|Pediatrics|pediatrics
772610|NCT00357799|Emergency Nursing|emergency nursing
772611|NCT00357786|Lysosomal Disease|lysosomal disease
772612|NCT00357786|Glycolipid|glycolipid
772613|NCT00357786|Stroke|stroke
772614|NCT00357786|Peripheral Neuropathy|peripheral neuropathy
772615|NCT00357786|Storage Disorder|storage disorder
772616|NCT00357760|Metastatic Renal Cell Carcinoma|metastatic renal cell carcinoma
772617|NCT00357760|VEGF Trap|vegf trap
772618|NCT00357747|unspecified adult solid tumor, protocol specific|unspecified adult solid tumor, protocol specific
772619|NCT00357734|lung cancer|lung cancer
772620|NCT00357734|breast cancer|breast cancer
772621|NCT00357695|Praxis|praxis
772622|NCT00357695|Grasping|grasping
772623|NCT00357695|Premotor Cortex|premotor cortex
772624|NCT00357695|Visuo-Motor Integration|visuo-motor integration
772625|NCT00357695|Motor Imagination|motor imagination
772626|NCT00357682|esophageal cancer|esophageal cancer
772627|NCT00357682|Barrett's esophagus|barrett's esophagus
772711|NCT00357435|Dystrophy|dystrophy
772628|NCT00357669|Unverricht-Lundborg disease|unverricht-lundborg disease
772629|NCT00357669|Baltic myoclonus|baltic myoclonus
772630|NCT00357669|progressive myoclonic epilepsies|progressive myoclonic epilepsies
772631|NCT00357669|myoclonus|myoclonus
772632|NCT00357669|brivaracetam|brivaracetam
772633|NCT00357656|Hemophilia A (severe or moderately severe)|hemophilia a (severe or moderately severe)
772634|NCT00357643|calcium|calcium
772635|NCT00357643|vitamin D|vitamin d
772636|NCT00357643|bone loss|bone loss
772637|NCT00357630|adenocarcinoma of unknown primary|adenocarcinoma of unknown primary
772638|NCT00357630|newly diagnosed carcinoma of unknown primary|newly diagnosed carcinoma of unknown primary
772639|NCT00357630|undifferentiated carcinoma of unknown primary|undifferentiated carcinoma of unknown primary
772640|NCT00357630|pain|pain
772641|NCT00357617|stage I squamous cell carcinoma of the hypopharynx|stage i squamous cell carcinoma of the hypopharynx
772642|NCT00357617|stage II squamous cell carcinoma of the hypopharynx|stage ii squamous cell carcinoma of the hypopharynx
772643|NCT00357617|stage III squamous cell carcinoma of the hypopharynx|stage iii squamous cell carcinoma of the hypopharynx
772644|NCT00357617|stage IV squamous cell carcinoma of the hypopharynx|stage iv squamous cell carcinoma of the hypopharynx
772645|NCT00357617|stage I squamous cell carcinoma of the larynx|stage i squamous cell carcinoma of the larynx
772646|NCT00357617|stage II squamous cell carcinoma of the larynx|stage ii squamous cell carcinoma of the larynx
772647|NCT00357617|stage III squamous cell carcinoma of the larynx|stage iii squamous cell carcinoma of the larynx
772648|NCT00357617|stage IV squamous cell carcinoma of the larynx|stage iv squamous cell carcinoma of the larynx
772649|NCT00357617|stage I squamous cell carcinoma of the lip and oral cavity|stage i squamous cell carcinoma of the lip and oral cavity
772650|NCT00357617|stage II squamous cell carcinoma of the lip and oral cavity|stage ii squamous cell carcinoma of the lip and oral cavity
772651|NCT00357617|stage III squamous cell carcinoma of the lip and oral cavity|stage iii squamous cell carcinoma of the lip and oral cavity
772652|NCT00357617|stage IV squamous cell carcinoma of the lip and oral cavity|stage iv squamous cell carcinoma of the lip and oral cavity
772653|NCT00357617|stage I squamous cell carcinoma of the oropharynx|stage i squamous cell carcinoma of the oropharynx
772654|NCT00357617|stage II squamous cell carcinoma of the oropharynx|stage ii squamous cell carcinoma of the oropharynx
772655|NCT00357617|stage III squamous cell carcinoma of the oropharynx|stage iii squamous cell carcinoma of the oropharynx
772656|NCT00357617|stage IV squamous cell carcinoma of the oropharynx|stage iv squamous cell carcinoma of the oropharynx
772657|NCT00357617|recurrent squamous cell carcinoma of the hypopharynx|recurrent squamous cell carcinoma of the hypopharynx
772658|NCT00357617|recurrent squamous cell carcinoma of the larynx|recurrent squamous cell carcinoma of the larynx
772659|NCT00357617|recurrent squamous cell carcinoma of the lip and oral cavity|recurrent squamous cell carcinoma of the lip and oral cavity
772660|NCT00357617|recurrent squamous cell carcinoma of the oropharynx|recurrent squamous cell carcinoma of the oropharynx
772661|NCT00357604|HIV|hiv
772662|NCT00357604|Protease Inhibitor|protease inhibitor
772663|NCT00357591|Heart Failure|heart failure
772664|NCT00357591|Acute Decompensation|acute decompensation
772665|NCT00357591|Chronic Heart Failure|chronic heart failure
772666|NCT00357578|Macrophages|macrophages
772667|NCT00357578|Biopsy|biopsy
772668|NCT00357578|Genetic Analysis|genetic analysis
772669|NCT00357578|Geographic Atrophy|geographic atrophy
772670|NCT00357578|Choroidal Neovascularization|choroidal neovascularization
772671|NCT00357578|Fibroblast|fibroblast
772672|NCT00357578|Disciform|disciform
772673|NCT00357578|Age-Related Macular Degeneration|age-related macular degeneration
772674|NCT00357565|MDS|mds
772675|NCT00357565|AML|aml
772676|NCT00357552|Treatment Experienced|treatment experienced
772677|NCT00357526|vaginal ring|vaginal ring
772678|NCT00357526|Oral contraceptive pills|oral contraceptive pills
772679|NCT00357526|Teenagers|teenagers
772680|NCT00357526|Young women|young women
772681|NCT00357526|Patient satisfaction|patient satisfaction
772682|NCT00357513|Cerebrovascular Disease|cerebrovascular disease
772683|NCT00357513|Gene Chip|gene chip
772684|NCT00357513|Inflammation|inflammation
772685|NCT00357513|Pathophysiology Stroke|pathophysiology stroke
772686|NCT00357513|Stroke Genomics|stroke genomics
772687|NCT00357513|Stroke Subtypes|stroke subtypes
772688|NCT00357513|Neuroimaging|neuroimaging
772689|NCT00357513|Clinical Outcome Measures|clinical outcome measures
772690|NCT00357513|Stroke|stroke
772691|NCT00357513|CVA|cva
772692|NCT00357513|Healthy Volunteer|healthy volunteer
772693|NCT00357513|HV|hv
772694|NCT00357513|Normal Control|normal control
772695|NCT00357500|Metronomic|metronomic
772696|NCT00357500|antiangiogenic|antiangiogenic
772697|NCT00357487|Sentinel lymph node|sentinel lymph node
772698|NCT00357487|Breast cancer|breast cancer
772699|NCT00357487|Lymphoscintigraphy|lymphoscintigraphy
772700|NCT00357487|Probe|probe
772701|NCT00357487|Operative gamma camera|operative gamma camera
772702|NCT00357487|Breast cancer and sentinel lymph node biopsy|breast cancer and sentinel lymph node biopsy
772703|NCT00357487|Use of lymphoscintigraphy|use of lymphoscintigraphy
772704|NCT00357487|Use of intraoperative gamma camera|use of intraoperative gamma camera
772705|NCT00357487|Use of intraoperative probe|use of intraoperative probe
772706|NCT00357474|HCC, TACE, PEIT|hcc, tace, peit
772707|NCT00357461|stage IV melanoma|stage iv melanoma
772708|NCT00357461|recurrent melanoma|recurrent melanoma
772712|NCT00357435|Gene|gene
772713|NCT00357435|Mapping|mapping
772714|NCT00357435|Molecular|molecular
772715|NCT00357435|Bietti|bietti
772716|NCT00357435|Fleck|fleck
772717|NCT00357435|Positional Cloning|positional cloning
772718|NCT00357435|Linkage|linkage
772719|NCT00357422|HCC, operation, percutaneous ethanol injection|hcc, operation, percutaneous ethanol injection
772720|NCT00357409|GABA|gaba
772721|NCT00357409|Occipital|occipital
772722|NCT00357409|Vision|vision
772723|NCT00357409|Plasticity|plasticity
772724|NCT00357409|MRS|mrs
772725|NCT00357409|Blind|blind
772726|NCT00357396|metastatic Ewing sarcoma/peripheral primitive neuroectodermal tumor|metastatic ewing sarcoma/peripheral primitive neuroectodermal tumor
772727|NCT00357396|recurrent Ewing sarcoma/peripheral primitive neuroectodermal tumor|recurrent ewing sarcoma/peripheral primitive neuroectodermal tumor
772728|NCT00357357|Alzheimer's disease|alzheimer's disease
772729|NCT00357344|Obesity|obesity
772730|NCT00357344|Gray Matter|gray matter
772731|NCT00357344|Eating Behavior|eating behavior
772732|NCT00357344|Brain MRI|brain mri
772733|NCT00357344|Body Weight Regulation|body weight regulation
772734|NCT00357331|postmenopausal osteopenia|postmenopausal osteopenia
772735|NCT00357331|treatment|treatment
772736|NCT00357331|bone loss|bone loss
772737|NCT00357266|Uveitis|uveitis
772738|NCT00357266|Interleukin 2|interleukin 2
772739|NCT00357266|Interleukin 2 Receptor|interleukin 2 receptor
772740|NCT00357266|Microarrays|microarrays
772741|NCT00357266|Genetic Expression|genetic expression
772742|NCT00357266|Daclizumab|daclizumab
772743|NCT00357266|HAT|hat
772744|NCT00357266|Zenapax|zenapax
772745|NCT00357266|Proteins|proteins
772746|NCT00357266|RNA|rna
772747|NCT00357266|Ocular Inflammatory Disease|ocular inflammatory disease
772748|NCT00357253|untreated childhood brain stem glioma|untreated childhood brain stem glioma
772749|NCT00357253|childhood high-grade cerebral astrocytoma|childhood high-grade cerebral astrocytoma
772750|NCT00357253|untreated childhood cerebellar astrocytoma|untreated childhood cerebellar astrocytoma
772751|NCT00357240|Protease inhibitor|protease inhibitor
772752|NCT00357227|Atrial fibrillation|atrial fibrillation
772753|NCT00357227|Stroke|stroke
772754|NCT00357227|Vascular Dementia|vascular dementia
772755|NCT00357227|Mild Cognitive Impairment|mild cognitive impairment
772756|NCT00357214|bone turnover|bone turnover
772757|NCT00357214|calcium excretion|calcium excretion
772758|NCT00357214|nitrogen excretion|nitrogen excretion
772759|NCT00357214|potassium bicarbonate|potassium bicarbonate
772760|NCT00357214|muscle loss|muscle loss
772761|NCT00357214|muscle atrophy|muscle atrophy
772762|NCT00357214|bone loss|bone loss
772763|NCT00357123|abdominal sepsis|abdominal sepsis
772764|NCT00357123|sepsis|sepsis
772765|NCT00357123|rosuvastatin|rosuvastatin
772766|NCT00357110|Breast neoplasms|breast neoplasms
772767|NCT00357110|breast cancer|breast cancer
772768|NCT00357110|early breast cancer|early breast cancer
772769|NCT00357110|oncology|oncology
772770|NCT00357110|cancer|cancer
772771|NCT00357110|breast cancer micrometastasis|breast cancer micrometastasis
772772|NCT00357110|fulvestrant|fulvestrant
772773|NCT00357097|randomised|randomised
772774|NCT00357097|ropinirole|ropinirole
772775|NCT00357097|depression|depression
772776|NCT00357097|RLS|rls
772777|NCT00357097|placebo|placebo
772778|NCT00357097|mood|mood
772779|NCT00357097|double-blind|double-blind
772780|NCT00357097|restless legs syndrome|restless legs syndrome
772781|NCT00357097|germany|germany
772782|NCT00357084|graft versus host disease|graft versus host disease
772783|NCT00357084|adult acute myeloid leukemia with 11q23 (MLL) abnormalities|adult acute myeloid leukemia with 11q23 (mll) abnormalities
772784|NCT00357084|adult acute myeloid leukemia with inv(16)(p13;q22)|adult acute myeloid leukemia with inv(16)(p13;q22)
772785|NCT00357084|adult acute myeloid leukemia with t(15;17)(q22;q12)|adult acute myeloid leukemia with t(15;17)(q22;q12)
772786|NCT00357084|adult acute myeloid leukemia with t(16;16)(p13;q22)|adult acute myeloid leukemia with t(16;16)(p13;q22)
772923|NCT00356941|stage II non-small cell lung cancer|stage ii non-small cell lung cancer
772787|NCT00357084|adult acute myeloid leukemia with t(8;21)(q22;q22)|adult acute myeloid leukemia with t(8;21)(q22;q22)
772788|NCT00357084|accelerated phase chronic myelogenous leukemia|accelerated phase chronic myelogenous leukemia
772789|NCT00357084|adult acute lymphoblastic leukemia in remission|adult acute lymphoblastic leukemia in remission
772790|NCT00357084|adult acute myeloid leukemia in remission|adult acute myeloid leukemia in remission
772791|NCT00357084|atypical chronic myeloid leukemia|atypical chronic myeloid leukemia
772792|NCT00357084|blastic phase chronic myelogenous leukemia|blastic phase chronic myelogenous leukemia
772793|NCT00357084|childhood acute lymphoblastic leukemia in remission|childhood acute lymphoblastic leukemia in remission
772794|NCT00357084|childhood acute myeloid leukemia in remission|childhood acute myeloid leukemia in remission
772795|NCT00357084|childhood chronic myelogenous leukemia|childhood chronic myelogenous leukemia
772796|NCT00357084|chronic eosinophilic leukemia|chronic eosinophilic leukemia
772797|NCT00357084|chronic idiopathic myelofibrosis|chronic idiopathic myelofibrosis
772798|NCT00357084|chronic myelomonocytic leukemia|chronic myelomonocytic leukemia
772799|NCT00357084|chronic neutrophilic leukemia|chronic neutrophilic leukemia
772800|NCT00357084|chronic phase chronic myelogenous leukemia|chronic phase chronic myelogenous leukemia
772801|NCT00357084|de novo myelodysplastic syndromes|de novo myelodysplastic syndromes
772802|NCT00357084|disseminated neuroblastoma|disseminated neuroblastoma
772803|NCT00357084|extranodal marginal zone B-cell lymphoma of mucosa-associated lymphoid tissue|extranodal marginal zone b-cell lymphoma of mucosa-associated lymphoid tissue
772804|NCT00357084|juvenile myelomonocytic leukemia|juvenile myelomonocytic leukemia
772805|NCT00357084|myelodysplastic/myeloproliferative disease, unclassifiable|myelodysplastic/myeloproliferative disease, unclassifiable
772806|NCT00357084|nodal marginal zone B-cell lymphoma|nodal marginal zone b-cell lymphoma
772807|NCT00357084|noncontiguous stage II adult Burkitt lymphoma|noncontiguous stage ii adult burkitt lymphoma
772808|NCT00357084|noncontiguous stage II adult diffuse large cell lymphoma|noncontiguous stage ii adult diffuse large cell lymphoma
772809|NCT00357084|noncontiguous stage II adult diffuse mixed cell lymphoma|noncontiguous stage ii adult diffuse mixed cell lymphoma
772810|NCT00357084|noncontiguous stage II adult diffuse small cleaved cell lymphoma|noncontiguous stage ii adult diffuse small cleaved cell lymphoma
772811|NCT00357084|noncontiguous stage II adult immunoblastic large cell lymphoma|noncontiguous stage ii adult immunoblastic large cell lymphoma
772812|NCT00357084|noncontiguous stage II adult lymphoblastic lymphoma|noncontiguous stage ii adult lymphoblastic lymphoma
772813|NCT00357084|noncontiguous stage II grade 1 follicular lymphoma|noncontiguous stage ii grade 1 follicular lymphoma
772814|NCT00357084|noncontiguous stage II grade 2 follicular lymphoma|noncontiguous stage ii grade 2 follicular lymphoma
772815|NCT00357084|noncontiguous stage II grade 3 follicular lymphoma|noncontiguous stage ii grade 3 follicular lymphoma
772816|NCT00357084|noncontiguous stage II mantle cell lymphoma|noncontiguous stage ii mantle cell lymphoma
772817|NCT00357084|noncontiguous stage II marginal zone lymphoma|noncontiguous stage ii marginal zone lymphoma
772818|NCT00357084|noncontiguous stage II small lymphocytic lymphoma|noncontiguous stage ii small lymphocytic lymphoma
772819|NCT00357084|poor prognosis metastatic gestational trophoblastic tumor|poor prognosis metastatic gestational trophoblastic tumor
772820|NCT00357084|previously treated childhood rhabdomyosarcoma|previously treated childhood rhabdomyosarcoma
773048|NCT00356343|Cerebral Palsy|cerebral palsy
772821|NCT00357084|previously treated myelodysplastic syndromes|previously treated myelodysplastic syndromes
772822|NCT00357084|recurrent adult acute lymphoblastic leukemia|recurrent adult acute lymphoblastic leukemia
772823|NCT00357084|recurrent adult acute myeloid leukemia|recurrent adult acute myeloid leukemia
772824|NCT00357084|recurrent adult Burkitt lymphoma|recurrent adult burkitt lymphoma
772825|NCT00357084|recurrent adult Hodgkin lymphoma|recurrent adult hodgkin lymphoma
772826|NCT00357084|recurrent adult diffuse large cell lymphoma|recurrent adult diffuse large cell lymphoma
772827|NCT00357084|recurrent adult diffuse mixed cell lymphoma|recurrent adult diffuse mixed cell lymphoma
772828|NCT00357084|recurrent adult diffuse small cleaved cell lymphoma|recurrent adult diffuse small cleaved cell lymphoma
772829|NCT00357084|recurrent adult immunoblastic large cell lymphoma|recurrent adult immunoblastic large cell lymphoma
772830|NCT00357084|recurrent adult lymphoblastic lymphoma|recurrent adult lymphoblastic lymphoma
772831|NCT00357084|recurrent/refractory childhood Hodgkin lymphoma|recurrent/refractory childhood hodgkin lymphoma
772832|NCT00357084|recurrent childhood acute lymphoblastic leukemia|recurrent childhood acute lymphoblastic leukemia
772833|NCT00357084|recurrent childhood acute myeloid leukemia|recurrent childhood acute myeloid leukemia
772834|NCT00357084|recurrent childhood large cell lymphoma|recurrent childhood large cell lymphoma
772835|NCT00357084|recurrent childhood lymphoblastic lymphoma|recurrent childhood lymphoblastic lymphoma
772836|NCT00357084|recurrent childhood rhabdomyosarcoma|recurrent childhood rhabdomyosarcoma
772837|NCT00357084|recurrent childhood small noncleaved cell lymphoma|recurrent childhood small noncleaved cell lymphoma
772838|NCT00357084|recurrent cutaneous T-cell non-Hodgkin lymphoma|recurrent cutaneous t-cell non-hodgkin lymphoma
772839|NCT00357084|recurrent grade 1 follicular lymphoma|recurrent grade 1 follicular lymphoma
772840|NCT00357084|recurrent grade 2 follicular lymphoma|recurrent grade 2 follicular lymphoma
772841|NCT00357084|recurrent grade 3 follicular lymphoma|recurrent grade 3 follicular lymphoma
772842|NCT00357084|recurrent mantle cell lymphoma|recurrent mantle cell lymphoma
772843|NCT00357084|recurrent marginal zone lymphoma|recurrent marginal zone lymphoma
772844|NCT00357084|recurrent mycosis fungoides/Sezary syndrome|recurrent mycosis fungoides/sezary syndrome
772845|NCT00357084|recurrent small lymphocytic lymphoma|recurrent small lymphocytic lymphoma
773023|NCT00356473|Statins|statins
772846|NCT00357084|recurrent Wilms tumor and other childhood kidney tumors|recurrent wilms tumor and other childhood kidney tumors
772847|NCT00357084|refractory chronic lymphocytic leukemia|refractory chronic lymphocytic leukemia
772848|NCT00357084|refractory hairy cell leukemia|refractory hairy cell leukemia
772849|NCT00357084|refractory multiple myeloma|refractory multiple myeloma
772850|NCT00357084|relapsing chronic myelogenous leukemia|relapsing chronic myelogenous leukemia
772851|NCT00357084|secondary acute myeloid leukemia|secondary acute myeloid leukemia
772852|NCT00357084|secondary myelodysplastic syndromes|secondary myelodysplastic syndromes
772853|NCT00357084|splenic marginal zone lymphoma|splenic marginal zone lymphoma
772854|NCT00357084|stage I multiple myeloma|stage i multiple myeloma
772855|NCT00357084|stage II multiple myeloma|stage ii multiple myeloma
772856|NCT00357084|stage II ovarian epithelial cancer|stage ii ovarian epithelial cancer
772857|NCT00357084|stage III adult Burkitt lymphoma|stage iii adult burkitt lymphoma
772858|NCT00357084|stage III adult Hodgkin lymphoma|stage iii adult hodgkin lymphoma
772859|NCT00357084|stage III adult diffuse large cell lymphoma|stage iii adult diffuse large cell lymphoma
772860|NCT00357084|stage III adult diffuse mixed cell lymphoma|stage iii adult diffuse mixed cell lymphoma
772861|NCT00357084|stage III adult diffuse small cleaved cell lymphoma|stage iii adult diffuse small cleaved cell lymphoma
773149|NCT00355940|position|position
772862|NCT00357084|stage III adult immunoblastic large cell lymphoma|stage iii adult immunoblastic large cell lymphoma
772863|NCT00357084|stage III adult lymphoblastic lymphoma|stage iii adult lymphoblastic lymphoma
772864|NCT00357084|stage III chronic lymphocytic leukemia|stage iii chronic lymphocytic leukemia
772865|NCT00357084|stage III grade 1 follicular lymphoma|stage iii grade 1 follicular lymphoma
772866|NCT00357084|stage III grade 2 follicular lymphoma|stage iii grade 2 follicular lymphoma
772867|NCT00357084|stage III grade 3 follicular lymphoma|stage iii grade 3 follicular lymphoma
772868|NCT00357084|stage III mantle cell lymphoma|stage iii mantle cell lymphoma
772869|NCT00357084|stage III marginal zone lymphoma|stage iii marginal zone lymphoma
772870|NCT00357084|stage III multiple myeloma|stage iii multiple myeloma
772871|NCT00357084|stage III small lymphocytic lymphoma|stage iii small lymphocytic lymphoma
772872|NCT00357084|stage III malignant testicular germ cell tumor|stage iii malignant testicular germ cell tumor
772873|NCT00357084|stage IV adult Burkitt lymphoma|stage iv adult burkitt lymphoma
772874|NCT00357084|stage IV adult Hodgkin lymphoma|stage iv adult hodgkin lymphoma
772875|NCT00357084|stage IV adult diffuse large cell lymphoma|stage iv adult diffuse large cell lymphoma
772876|NCT00357084|stage IV adult diffuse mixed cell lymphoma|stage iv adult diffuse mixed cell lymphoma
772877|NCT00357084|stage IV adult diffuse small cleaved cell lymphoma|stage iv adult diffuse small cleaved cell lymphoma
772878|NCT00357084|stage IV adult immunoblastic large cell lymphoma|stage iv adult immunoblastic large cell lymphoma
772879|NCT00357084|stage IV adult lymphoblastic lymphoma|stage iv adult lymphoblastic lymphoma
772880|NCT00357084|stage IV chronic lymphocytic leukemia|stage iv chronic lymphocytic leukemia
772881|NCT00357084|stage IV grade 1 follicular lymphoma|stage iv grade 1 follicular lymphoma
772882|NCT00357084|stage IV grade 2 follicular lymphoma|stage iv grade 2 follicular lymphoma
772883|NCT00357084|stage IV grade 3 follicular lymphoma|stage iv grade 3 follicular lymphoma
772884|NCT00357084|stage IV mantle cell lymphoma|stage iv mantle cell lymphoma
772885|NCT00357084|stage IV marginal zone lymphoma|stage iv marginal zone lymphoma
772886|NCT00357084|stage IV small lymphocytic lymphoma|stage iv small lymphocytic lymphoma
772887|NCT00357084|Waldenstrom macroglobulinemia|waldenstrom macroglobulinemia
772888|NCT00357084|childhood myelodysplastic syndromes|childhood myelodysplastic syndromes
772889|NCT00357071|Autoimmunity|autoimmunity
772890|NCT00357071|Cell Mediated Immunity|cell mediated immunity
772891|NCT00357071|S Antigen|s antigen
772892|NCT00357071|Cell Proliferation|cell proliferation
772893|NCT00357071|Uveitis|uveitis
772894|NCT00357071|Cell Proliferation Assays|cell proliferation assays
772895|NCT00357071|Auto-Antibody|auto-antibody
772896|NCT00357071|Auto-Antigens|auto-antigens
772897|NCT00357058|Deafferentiation-Induced Plasticity|deafferentiation-induced plasticity
772898|NCT00357058|fMRI|fmri
772899|NCT00357058|Cortical Reorganization|cortical reorganization
772900|NCT00357058|Tactile Performance|tactile performance
772901|NCT00357058|Transcranial Magnetic Stimulation|transcranial magnetic stimulation
772902|NCT00357058|Tactile Discrimination|tactile discrimination
772903|NCT00357058|Plasticity|plasticity
772904|NCT00357058|Healthy Volunteer|healthy volunteer
772905|NCT00357058|HV|hv
772906|NCT00357058|Normal Control|normal control
772907|NCT00357006|Schizophrenia|schizophrenia
772908|NCT00357006|Estrogen|estrogen
772909|NCT00357006|Psychosis|psychosis
772910|NCT00356993|nicotine replacement therapy|nicotine replacement therapy
772911|NCT00356993|smoking cessation|smoking cessation
772912|NCT00356980|unspecified adult solid tumor, protocol specific|unspecified adult solid tumor, protocol specific
772913|NCT00356967|smoking|smoking
772914|NCT00356967|cessation|cessation
772915|NCT00356967|tobacco|tobacco
772916|NCT00356967|smoking cessation|smoking cessation
772917|NCT00356967|tobacco use cessation|tobacco use cessation
772918|NCT00356954|Kidney failure|kidney failure
772919|NCT00356954|Contrast media|contrast media
772920|NCT00356954|Antioxidant|antioxidant
772921|NCT00356954|Prevention|prevention
772922|NCT00356941|recurrent non-small cell lung cancer|recurrent non-small cell lung cancer
773231|NCT00355680|Retina|retina
772924|NCT00356941|stage IIIA non-small cell lung cancer|stage iiia non-small cell lung cancer
772925|NCT00356941|stage IIIB non-small cell lung cancer|stage iiib non-small cell lung cancer
772926|NCT00356928|previously treated myelodysplastic syndromes|previously treated myelodysplastic syndromes
772927|NCT00356928|secondary myelodysplastic syndromes|secondary myelodysplastic syndromes
772928|NCT00356928|secondary acute myeloid leukemia|secondary acute myeloid leukemia
772929|NCT00356928|chronic myelomonocytic leukemia|chronic myelomonocytic leukemia
772930|NCT00356928|de novo myelodysplastic syndromes|de novo myelodysplastic syndromes
772931|NCT00356915|Nail fungus|nail fungus
772932|NCT00356915|Onychomycosis|onychomycosis
772933|NCT00356915|Itraconazole|itraconazole
772934|NCT00356915|Toenail|toenail
772935|NCT00356863|Intervention|intervention
772936|NCT00356863|Awareness|awareness
772937|NCT00356863|Cardiac Rehabilitation (CR)|cardiac rehabilitation (cr)
772938|NCT00356863|Coronary Artery Patients|coronary artery patients
772939|NCT00356863|Coronary Artery Bypass Grafting Surgery (CABG)|coronary artery bypass grafting surgery (cabg)
772940|NCT00356824|Child|child
772941|NCT00356811|Lapatinib|lapatinib
772942|NCT00356811|Metastatic breast cancer|metastatic breast cancer
772943|NCT00356811|Paclitaxel|paclitaxel
772944|NCT00356811|ErbB2-amplification|erbb2-amplification
772945|NCT00356811|GW572016|gw572016
772946|NCT00356798|pandemic|pandemic
772947|NCT00356798|influenza|influenza
772949|NCT00356798|vaccine|vaccine
772950|NCT00356785|lifestyle|lifestyle
772951|NCT00356785|diet|diet
772952|NCT00356785|exercise|exercise
772953|NCT00356785|physical activity|physical activity
772954|NCT00356785|obesity|obesity
772955|NCT00356759|warfarin|warfarin
772956|NCT00356759|prothrombin time|prothrombin time
772957|NCT00356759|monitoring|monitoring
772958|NCT00356746|Perioperative inflammatory response|perioperative inflammatory response
772959|NCT00356746|General anesthesia|general anesthesia
772960|NCT00356746|Toll-Like Receptors|toll-like receptors
772961|NCT00356733|cardiorenal syndrome|cardiorenal syndrome
772962|NCT00356733|erythropoietin|erythropoietin
772963|NCT00356733|Heart Failure, Congestive|heart failure, congestive
772964|NCT00356733|Renal Insufficiency, Chronic|renal insufficiency, chronic
772965|NCT00356707|Body Mass Index|body mass index
772966|NCT00356681|AMG 706|amg 706
772967|NCT00356681|Paclitaxel|paclitaxel
772968|NCT00356681|Metastatic Breast Cancer|metastatic breast cancer
772969|NCT00356681|Antiangiogenic|antiangiogenic
772970|NCT00356681|Bevacizumab|bevacizumab
772971|NCT00356668|HFNC|hfnc
772972|NCT00356668|NCPAP|ncpap
772973|NCT00356668|nasal continuous positive airway pressure|nasal continuous positive airway pressure
772974|NCT00356668|humidified high flow nasal cannula|humidified high flow nasal cannula
772975|NCT00356668|esophageal pressure|esophageal pressure
772976|NCT00356668|gas flow|gas flow
772977|NCT00356655|Depressive disorder|depressive disorder
772978|NCT00356655|Patient compliance|patient compliance
772979|NCT00356655|Antidepressive Agents|antidepressive agents
772980|NCT00356655|Patient education|patient education
772981|NCT00356655|Community pharmacy services|community pharmacy services
772982|NCT00356655|Counseling|counseling
772983|NCT00356642|PK|pk
772984|NCT00356642|GW842470X|gw842470x
772985|NCT00356642|safety|safety
772986|NCT00356642|tolerability|tolerability
772987|NCT00356642|PD|pd
772988|NCT00356642|Atopic Dermatitis|atopic dermatitis
772989|NCT00356629|bronchopulmonary ignition|bronchopulmonary ignition
772990|NCT00356629|condensate of exhaled air|condensate of exhaled air
772991|NCT00356629|Mucoviscidosis|mucoviscidosis
772992|NCT00356629|Asthma|asthma
772993|NCT00356616|Antiretroviral treatment|antiretroviral treatment
772994|NCT00356616|virological failure|virological failure
772995|NCT00356616|HIV|hiv
772996|NCT00356603|Migraine|migraine
772997|NCT00356603|Sumatriptan Succinate Injection Kit|sumatriptan succinate injection kit
772998|NCT00356603|Cluster Headache|cluster headache
772999|NCT00356603|self-injection|self-injection
773000|NCT00356590|Rheumatoid Arthritis|rheumatoid arthritis
773001|NCT00356590|Etanercept|etanercept
773002|NCT00356590|Long-term Safety|long-term safety
773003|NCT00356590|Enbrel|enbrel
773004|NCT00356564|Prophylaxis for hepatitis B disease|prophylaxis for hepatitis b disease
773005|NCT00356551|Teen pregnancy|teen pregnancy
773006|NCT00356551|Family strengthening|family strengthening
773007|NCT00356551|Substance abuse prevention|substance abuse prevention
773008|NCT00356551|Depression prevention|depression prevention
773009|NCT00356551|Parent involvement|parent involvement
773010|NCT00356512|Phosphate|phosphate
773011|NCT00356512|Vitamin D|vitamin d
773012|NCT00356512|Hypoparathyroidism|hypoparathyroidism
773013|NCT00356512|Phosphatonin|phosphatonin
773014|NCT00356512|Clamp|clamp
773015|NCT00356486|Chronic Hepatitis C|chronic hepatitis c
773016|NCT00356486|Co-infection|co-infection
773017|NCT00356486|Induction dose|induction dose
773018|NCT00356486|HIV|hiv
773019|NCT00356486|HIV Infections|hiv infections
773020|NCT00356473|Rheumatoid arthritis|rheumatoid arthritis
773021|NCT00356473|Atherosclerosis|atherosclerosis
773022|NCT00356473|High density lipoprotein (HDL) cholesterol|high density lipoprotein (hdl) cholesterol
773024|NCT00356473|HDL anti-inflammatory properties|hdl anti-inflammatory properties
773025|NCT00356473|Atorvastatin|atorvastatin
773026|NCT00356434|deep vein thrombosis|deep vein thrombosis
773027|NCT00356434|thrombophilia|thrombophilia
773028|NCT00356434|pregnancy|pregnancy
773029|NCT00356434|thromboprophylaxis|thromboprophylaxis
773030|NCT00356434|decreased mobility|decreased mobility
773031|NCT00356434|hospitalization|hospitalization
773032|NCT00356408|CDP870|cdp870
773033|NCT00356408|certolizumab pegol|certolizumab pegol
773034|NCT00356408|Crohn's Disease|crohn's disease
773035|NCT00356395|endothelial function, insulin resistance, adipocytokines|endothelial function, insulin resistance, adipocytokines
773036|NCT00356382|probiotic|probiotic
773037|NCT00356382|Lactobacillus (L.) casei|lactobacillus (l.) casei
773038|NCT00356382|cultured dairy drink|cultured dairy drink
773039|NCT00356382|Health|health
773040|NCT00356369|Immunogenicity|immunogenicity
773041|NCT00356369|Healthy|healthy
773042|NCT00356369|Persistence|persistence
773043|NCT00356369|Meningococcal vaccine|meningococcal vaccine
773044|NCT00356369|Non-inferiority|non-inferiority
773045|NCT00356369|Meningococcal A C W Y Diseases|meningococcal a c w y diseases
773046|NCT00356369|meningococcal serogroups A, C, W & Y diseases|meningococcal serogroups a, c, w & y diseases
773047|NCT00356343|NMES|nmes
773049|NCT00356343|Spastic Diplegia|spastic diplegia
773050|NCT00356343|Electrical Stimulation|electrical stimulation
773051|NCT00356343|Children|children
773052|NCT00356330|pacemaker|pacemaker
773053|NCT00356330|magnetic resonance imaging|magnetic resonance imaging
773054|NCT00356330|safety|safety
773055|NCT00356317|Culture|culture
773056|NCT00356317|Family|family
773057|NCT00356317|Therapy|therapy
773058|NCT00356304|Dysthymia|dysthymia
773059|NCT00356304|Major Depression|major depression
773060|NCT00356304|Hispanics|hispanics
773061|NCT00356304|Latinos|latinos
773062|NCT00356304|Motivational Interviewing|motivational interviewing
773063|NCT00356304|Adherence|adherence
773065|NCT00356291|AIDS|aids
773066|NCT00356291|Prevention|prevention
773067|NCT00356291|Serious Mental Illness|serious mental illness
773068|NCT00356278|D-Cycloserine|d-cycloserine
773069|NCT00356278|Virtual Reality|virtual reality
773070|NCT00356278|Exposure Therapy|exposure therapy
773071|NCT00356278|Veterans|veterans
773072|NCT00356278|Cognitive Behavior Therapy|cognitive behavior therapy
773073|NCT00356278|Translational Research|translational research
773074|NCT00356265|Blood Pressure Nitric Oxide|blood pressure nitric oxide
773075|NCT00356265|L-NMMA|l-nmma
773076|NCT00356265|Phenylephrine|phenylephrine
773077|NCT00356265|Vasoreactivity|vasoreactivity
773078|NCT00356265|Blood Pressure|blood pressure
773079|NCT00356239|Defibrillators, Implantable|defibrillators, implantable
773080|NCT00356239|Heart Failure, Congestive|heart failure, congestive
773081|NCT00356239|Magnetic Resonance Imaging|magnetic resonance imaging
773082|NCT00356226|norepinephrine|norepinephrine
773083|NCT00356226|renin|renin
773084|NCT00356226|aldosterone|aldosterone
773085|NCT00356226|hemodynamics|hemodynamics
773086|NCT00356226|spironolactone|spironolactone
773087|NCT00356213|morbid obesity|morbid obesity
773088|NCT00356213|bariatric surgery|bariatric surgery
773089|NCT00356213|sleeve-gastrectomy|sleeve-gastrectomy
773090|NCT00356213|Roux-Y-gastric bypass|roux-y-gastric bypass
773091|NCT00356213|outcome|outcome
773092|NCT00356213|weight loss|weight loss
773093|NCT00356174|Food Allergy|food allergy
773094|NCT00356161|colorectal neoplasms|colorectal neoplasms
773095|NCT00356161|hepatocellular carcinoma|hepatocellular carcinoma
773096|NCT00356161|gallbladder cancer|gallbladder cancer
773097|NCT00356161|bile duct cancer|bile duct cancer
773098|NCT00356161|hepatic arterial infusion|hepatic arterial infusion
773099|NCT00356148|breast cancer|breast cancer
773100|NCT00356148|breast surgery|breast surgery
773101|NCT00356148|clean wound|clean wound
773102|NCT00356148|overweight|overweight
773103|NCT00356148|prophylaxis|prophylaxis
773104|NCT00356148|antibiotics|antibiotics
773105|NCT00356122|Lung|lung
773106|NCT00356122|non-small cell|non-small cell
773107|NCT00356122|chemotherapy|chemotherapy
773108|NCT00356122|tumor|tumor
773109|NCT00356122|advanced|advanced
773110|NCT00356122|recurrent|recurrent
773111|NCT00356122|metastatic|metastatic
773112|NCT00356122|Non-Small Cell Lung Cancer (NSCLC)|non-small cell lung cancer (nsclc)
773113|NCT00356070|Attention Deficit Hyperactivity Disorder, treatment,|attention deficit hyperactivity disorder, treatment,
773114|NCT00356070|Strattera,|strattera,
773115|NCT00356070|rehabilitation|rehabilitation
773116|NCT00356057|atrial fibrillation|atrial fibrillation
773117|NCT00356057|AV node ablation|av node ablation
773118|NCT00356057|pacemaker|pacemaker
773119|NCT00356057|congestive heart failure|congestive heart failure
773120|NCT00356044|Transradial access|transradial access
773121|NCT00356044|Femoral access|femoral access
773122|NCT00356044|Femoral vs radial access|femoral vs radial access
773123|NCT00356031|Avastin|avastin
773124|NCT00356018|Epilepsy|epilepsy
773125|NCT00356018|Compliance|compliance
773126|NCT00356005|falciparum malaria|falciparum malaria
773127|NCT00356005|therapy|therapy
773128|NCT00356005|azithromycin|azithromycin
773129|NCT00356005|artesunate|artesunate
773130|NCT00356005|Coartem|coartem
773131|NCT00356005|Bangladesh|bangladesh
773132|NCT00355992|Myocardial Ischemia|myocardial ischemia
773133|NCT00355992|Chest pain|chest pain
773134|NCT00355992|Ischemia Modified Albumin|ischemia modified albumin
773135|NCT00355992|Acute Coronary Syndrome|acute coronary syndrome
773136|NCT00355979|Obesity, intragastric balloon, Pharmacotherapy|obesity, intragastric balloon, pharmacotherapy
773137|NCT00355966|Premature rupture of membranes|premature rupture of membranes
773138|NCT00355966|Induction of labour with Misoprostol|induction of labour with misoprostol
773139|NCT00355966|Induction of labour with PGE2 gel|induction of labour with pge2 gel
773140|NCT00355953|Post-Menopausal Women|post-menopausal women
773141|NCT00355953|Osteoporosis|osteoporosis
773142|NCT00355953|Phytoestrogen|phytoestrogen
773143|NCT00355953|Genistein|genistein
773144|NCT00355940|endovascular|endovascular
773145|NCT00355940|aortic|aortic
773146|NCT00355940|repair|repair
773147|NCT00355940|navigation|navigation
773148|NCT00355940|DynaCT|dynact
773150|NCT00355940|sensor|sensor
773151|NCT00355927|Deep brain stimulation|deep brain stimulation
773152|NCT00355927|Microelectrode recordings|microelectrode recordings
773153|NCT00355927|Basal Ganglia|basal ganglia
773154|NCT00355927|Sedation|sedation
773155|NCT00355927|Propofol|propofol
773156|NCT00355914|Lumbar Facet Joint Nerve Block|lumbar facet joint nerve block
773157|NCT00355901|Ulcerative Colitis|ulcerative colitis
773158|NCT00355901|Colitis|colitis
773159|NCT00355901|Steroid-Refractory|steroid-refractory
773160|NCT00355901|Visilizumab|visilizumab
773161|NCT00355901|Intravenous Steroid-Refractory Ulcerative Colitis (IVSR-UC)|intravenous steroid-refractory ulcerative colitis (ivsr-uc)
773162|NCT00355888|Cancer|cancer
773163|NCT00355888|Advanced or Metastatic Solid Tumor|advanced or metastatic solid tumor
773164|NCT00355875|newborn|newborn
773165|NCT00355875|preterm|preterm
773166|NCT00355875|resuscitation|resuscitation
773167|NCT00355875|oxidative injury|oxidative injury
773168|NCT00355875|protein carbonyl|protein carbonyl
773169|NCT00355862|Sirolimus|sirolimus
773170|NCT00355862|mTOR|mtor
773171|NCT00355862|HCC-recurrence free survival|hcc-recurrence free survival
773172|NCT00355862|Liver transplant recipients|liver transplant recipients
773173|NCT00355862|HCC recurrence free survival|hcc recurrence free survival
773174|NCT00355836|Motor Imagery|motor imagery
773175|NCT00355836|Stroke|stroke
773176|NCT00355836|Neuro-rehabilitation|neuro-rehabilitation
773177|NCT00355836|health psychology|health psychology
773178|NCT00355836|neuroscience|neuroscience
773179|NCT00355836|randomised controlled trial|randomised controlled trial
773180|NCT00355823|electric field|electric field
773181|NCT00355823|wound current|wound current
773182|NCT00355823|wound healing|wound healing
773183|NCT00355823|bioelectric field|bioelectric field
773184|NCT00355823|chronic ulcer|chronic ulcer
773185|NCT00355823|diabetic|diabetic
773186|NCT00355823|Diabetes|diabetes
773187|NCT00355823|aging|aging
773188|NCT00355810|Probiotics|probiotics
773189|NCT00355797|Bradycardia|bradycardia
773190|NCT00355797|Sinus Node Dysfunction|sinus node dysfunction
773191|NCT00355797|Chronotropic incompetence|chronotropic incompetence
773192|NCT00355797|Pacemaker|pacemaker
773193|NCT00355797|Rate adaptive|rate adaptive
773194|NCT00355784|growth hormone|growth hormone
773195|NCT00355784|overfeeding|overfeeding
773196|NCT00355784|energy expenditure|energy expenditure
773197|NCT00355784|protein metabolism|protein metabolism
773198|NCT00355784|lipid metabolism|lipid metabolism
773199|NCT00355771|allergic rhinitis|allergic rhinitis
773200|NCT00355771|histamine antagonist|histamine antagonist
773201|NCT00355771|sleep disorder|sleep disorder
773202|NCT00355758|Prostate Cancer Detection by Serum Proteomic Profiling|prostate cancer detection by serum proteomic profiling
773203|NCT00355745|Breast|breast
773204|NCT00355745|tumor|tumor
773205|NCT00355745|ultrasound|ultrasound
773206|NCT00355745|biopsy|biopsy
773207|NCT00355745|Breast mammographic or ultrasound findings|breast mammographic or ultrasound findings
773208|NCT00355732|Respiration|respiration
773209|NCT00355732|COPD|copd
773210|NCT00355732|Mechanical Ventilation|mechanical ventilation
773211|NCT00355732|Ventilator Weaning|ventilator weaning
773212|NCT00355732|Respiratory Failure|respiratory failure
773213|NCT00355732|ICU|icu
773214|NCT00355732|Pressure Support Ventilation|pressure support ventilation
773215|NCT00355719|Nevirapine|nevirapine
773216|NCT00355719|Atazanavir|atazanavir
773217|NCT00355719|Pharmacokinetics|pharmacokinetics
773218|NCT00355719|Interactions|interactions
773219|NCT00355706|chronic low back pain|chronic low back pain
773220|NCT00355706|thoracic facet joint|thoracic facet joint
773221|NCT00355706|nerve block|nerve block
773222|NCT00355693|Anxiety|anxiety
773223|NCT00355693|Dental|dental
773224|NCT00355693|Oral|oral
773225|NCT00355693|Surgery|surgery
773226|NCT00355693|Colonoscopy|colonoscopy
773227|NCT00355693|Propofol|propofol
773228|NCT00355693|Sedation|sedation
773229|NCT00355693|Effect|effect
773230|NCT00355693|Reaction|reaction
773232|NCT00355680|Retinal Diseases|retinal diseases
773233|NCT00355680|Retinal Vessels|retinal vessels
773234|NCT00355680|Laser Coagulation|laser coagulation
773235|NCT00355667|diuretics|diuretics
773236|NCT00355667|furosemide|furosemide
773237|NCT00355667|azosemide|azosemide
773238|NCT00355667|congestive heart failure|congestive heart failure
773239|NCT00355654|Diphtheria|diphtheria
773240|NCT00355654|Tetanus|tetanus
773241|NCT00355654|Pertussis|pertussis
773242|NCT00355654|Poliomyelitis|poliomyelitis
773243|NCT00355654|Haemophilus influenzae type b|haemophilus influenzae type b
773244|NCT00355654|Hepatitis B|hepatitis b
773245|NCT00355641|Ropinirole|ropinirole
773246|NCT00355641|Restless Legs Syndrome|restless legs syndrome
773247|NCT00355641|RLS|rls
773248|NCT00355628|Pain|pain
773249|NCT00355628|Cancer|cancer
773250|NCT00355628|Neoplasm|neoplasm
773251|NCT00355628|Continual Reassessment Method|continual reassessment method
773252|NCT00355628|Pain Associated with Cancer/Neoplasms|pain associated with cancer/neoplasms
773721|NCT00353977|Vaccine|vaccine
773253|NCT00355615|Heterozygous Familial Hypercholesterolemia|heterozygous familial hypercholesterolemia
773254|NCT00355602|Antibiotics|antibiotics
773255|NCT00355602|Controlled Clinical Trial|controlled clinical trial
773256|NCT00355589|Hypertension|hypertension
773257|NCT00355589|High Blood Pressure|high blood pressure
773258|NCT00355589|Diuretic|diuretic
773259|NCT00355589|Angiotensin converting enzyme inhibitor|angiotensin converting enzyme inhibitor
773260|NCT00355589|Ambulatory blood pressure monitoring|ambulatory blood pressure monitoring
773261|NCT00355576|Amyotrophic Lateral Sclerosis|amyotrophic lateral sclerosis
773262|NCT00355576|Celecoxib|celecoxib
773263|NCT00355576|Creatine|creatine
773264|NCT00355576|Minocycline|minocycline
773265|NCT00355576|Combination|combination
773266|NCT00355576|Selection|selection
773267|NCT00355576|ALS|als
773268|NCT00355576|Motor Neuron Disease|motor neuron disease
773269|NCT00355550|Mild Cognitive Impairment|mild cognitive impairment
773270|NCT00355550|Cognition disorders|cognition disorders
773271|NCT00355550|nutritional supplement|nutritional supplement
773272|NCT00355550|dietary supplement|dietary supplement
773273|NCT00355524|HIV-1|hiv-1
773274|NCT00355524|Darunavir|darunavir
773275|NCT00355524|Ritonavir|ritonavir
773276|NCT00355524|TMC114|tmc114
773277|NCT00355511|heart failure, congestive|heart failure, congestive
773278|NCT00355511|patient care team|patient care team
773279|NCT00355511|randomized controlled trial|randomized controlled trial
773280|NCT00355511|disease management|disease management
773281|NCT00355511|drug therapy|drug therapy
773282|NCT00355511|diet therapy|diet therapy
773283|NCT00355511|hospitalization|hospitalization
773284|NCT00355511|mortality|mortality
773285|NCT00355498|functional magnetic resonance imaging|functional magnetic resonance imaging
773286|NCT00355498|positron emission tomography|positron emission tomography
773287|NCT00355498|beta-amyloid|beta-amyloid
773288|NCT00355498|tau|tau
773289|NCT00355485|Acne|acne
773290|NCT00355485|Microdermabrasion|microdermabrasion
773291|NCT00355472|Adult T-Cell Leukemia|adult t-cell leukemia
773292|NCT00355472|ATL|atl
773293|NCT00355472|Adult Peripheral T-Cell Lymphoma|adult peripheral t-cell lymphoma
773294|NCT00355472|PTCL|ptcl
773295|NCT00355459|Meibomian Gland Dystrophy|meibomian gland dystrophy
773296|NCT00355446|Cataract|cataract
773297|NCT00355446|Human Aqueous|human aqueous
773298|NCT00355433|urinary incontinence|urinary incontinence
773299|NCT00355433|urodynamics|urodynamics
773300|NCT00355433|temperature|temperature
773301|NCT00355407|Aranesp|aranesp
773302|NCT00355407|allogeneic stem cell transplant|allogeneic stem cell transplant
773303|NCT00355381|Information Services|information services
773304|NCT00355381|Randomized Controlled Trials|randomized controlled trials
773305|NCT00355381|Medical Records Systems, Computerized|medical records systems, computerized
773306|NCT00355381|Internet|internet
773307|NCT00355381|Librarians|librarians
773308|NCT00355381|Breast Neoplasms|breast neoplasms
773309|NCT00355381|Patient Satisfaction|patient satisfaction
773310|NCT00355381|Health Personnel|health personnel
773311|NCT00355381|Costs and Cost Analysis|costs and cost analysis
773312|NCT00355381|Premature Birth|premature birth
773313|NCT00355368|intubation|intubation
773314|NCT00355368|intensive care|intensive care
773315|NCT00355368|neuromuscular depolarizing agents|neuromuscular depolarizing agents
773316|NCT00355368|neuromuscular nondepolarizing agents|neuromuscular nondepolarizing agents
773317|NCT00355368|neuromuscular blocking agents|neuromuscular blocking agents
773318|NCT00355355|Hepatocellular carcinoma|hepatocellular carcinoma
773319|NCT00355355|HCC|hcc
773320|NCT00355355|Liver Neoplasms|liver neoplasms
773321|NCT00355355|Talaporfin Sodium (LS11)|talaporfin sodium (ls11)
773322|NCT00355355|Light emitting diodes (LEDs)|light emitting diodes (leds)
773323|NCT00355355|Light activation|light activation
773324|NCT00355342|Osteoporosis|osteoporosis
773325|NCT00355342|Bone Mineral Density|bone mineral density
773326|NCT00355342|Osteopenia|osteopenia
773327|NCT00355342|Chronic Obstructive Pulmonary Disease|chronic obstructive pulmonary disease
773328|NCT00355342|COPD|copd
773329|NCT00355329|Traditional Chinese Medicine (TCM)|traditional chinese medicine (tcm)
773330|NCT00355329|Autism|autism
773331|NCT00355329|Autistic Spectrum Disorder|autistic spectrum disorder
773332|NCT00355329|Tongue Acupuncture (TAC)|tongue acupuncture (tac)
773333|NCT00355329|18F-fluorodeoxyglucose Positron Emission Tomography (PET)|18f-fluorodeoxyglucose positron emission tomography (pet)
773334|NCT00355329|children|children
773335|NCT00355316|Breast Cancer|breast cancer
773336|NCT00355316|Peripheral|peripheral
773337|NCT00355316|Blood|blood
773338|NCT00355303|Premature rupture of membranes at term|premature rupture of membranes at term
773339|NCT00355303|Induction of labour|induction of labour
773340|NCT00355303|Misoprostol|misoprostol
773341|NCT00355303|PGE2 gel|pge2 gel
773342|NCT00355303|Immediate induction with PGE2 gel|immediate induction with pge2 gel
773343|NCT00355303|Immediate induction with Misoprostol|immediate induction with misoprostol
773344|NCT00355290|Chronic Oral Anticoagulation|chronic oral anticoagulation
773345|NCT00355277|Tricyclic antidepressants|tricyclic antidepressants
773346|NCT00355277|Neuropathic pain|neuropathic pain
773347|NCT00355277|Local anaesthesia|local anaesthesia
773348|NCT00355277|Transcutaneous|transcutaneous
773349|NCT00355251|Atorvastatin|atorvastatin
773350|NCT00355251|Viral replication|viral replication
773351|NCT00355251|HIV-1|hiv-1
773352|NCT00355251|plasma cholesterol|plasma cholesterol
773353|NCT00355251|Cell membrane cholesterol|cell membrane cholesterol
773354|NCT00355225|insecticide-treated bednets|insecticide-treated bednets
773355|NCT00355225|malaria|malaria
773356|NCT00355225|africa|africa
773357|NCT00355225|social marketing|social marketing
773358|NCT00355225|ante-natal care|ante-natal care
773359|NCT00355225|ITN coverage|itn coverage
773360|NCT00355225|ITn use|itn use
773361|NCT00355212|percutaneous ethanol injection|percutaneous ethanol injection
773362|NCT00355212|radiofrequency|radiofrequency
773363|NCT00355212|liver cirrhosis|liver cirrhosis
773364|NCT00355212|carcinoma, hepatocellular|carcinoma, hepatocellular
773365|NCT00355199|DLBCL|dlbcl
773366|NCT00355199|R-HDS|r-hds
773367|NCT00355199|R-CHOP14|r-chop14
773368|NCT00355186|acute myocardial infarction|acute myocardial infarction
773369|NCT00355186|MRI|mri
773370|NCT00355186|bone marrow cells|bone marrow cells
773371|NCT00355186|stem cells|stem cells
773372|NCT00355186|remodeling|remodeling
773373|NCT00355160|Headache|headache
773374|NCT00355160|Sinusitis|sinusitis
773375|NCT00355160|Rhinitis|rhinitis
773376|NCT00355160|Facial Pain|facial pain
773377|NCT00355147|Ischemic stroke|ischemic stroke
773378|NCT00355147|Preventive medicine|preventive medicine
773379|NCT00355147|Transient Ischemic Attack|transient ischemic attack
773380|NCT00355147|Neurology|neurology
773381|NCT00355147|Risk management|risk management
773382|NCT00355134|fingolimod|fingolimod
773383|NCT00355134|FTY720|fty720
773384|NCT00355134|relapsing-remitting multiple sclerosis|relapsing-remitting multiple sclerosis
773385|NCT00355134|MS|ms
773386|NCT00355134|RRMS|rrms
773387|NCT00355121|Meningococcal meningitis|meningococcal meningitis
773388|NCT00355121|Tetanus|tetanus
773389|NCT00355121|Diphtheria|diphtheria
773390|NCT00355121|Pertussis|pertussis
773391|NCT00355121|Poliomyelitis|poliomyelitis
773392|NCT00355121|Neisseria meningitidis|neisseria meningitidis
773393|NCT00355108|Rendu Osler syndrome|rendu osler syndrome
773394|NCT00355108|Epistaxis|epistaxis
773395|NCT00355108|Tranexamic acid|tranexamic acid
773396|NCT00355108|clinical trial|clinical trial
773397|NCT00355095|multiple sclerosis|multiple sclerosis
773398|NCT00355095|add-on Therapy|add-on therapy
773399|NCT00355095|erythropoietin|erythropoietin
773400|NCT00355095|methylprednisolone|methylprednisolone
773401|NCT00355095|autoimmune optic neuritis|autoimmune optic neuritis
773402|NCT00355082|epilepsy|epilepsy
773403|NCT00355082|lamotrigine|lamotrigine
773404|NCT00355082|Lamictal|lamictal
773405|NCT00355082|monotherapy|monotherapy
773406|NCT00355069|pediatric|pediatric
773407|NCT00355069|asthma|asthma
773408|NCT00355069|translational research|translational research
773409|NCT00355069|health information technology|health information technology
773410|NCT00355056|Migraine|migraine
773411|NCT00355056|PFO|pfo
773412|NCT00355056|Migraine Headache|migraine headache
773413|NCT00355056|patent foramen ovale|patent foramen ovale
773414|NCT00355043|Zinc treatment|zinc treatment
773415|NCT00355043|Bronchiolitis|bronchiolitis
773416|NCT00355043|Wheezing|wheezing
773417|NCT00355043|Children aged 2 months to 23 months|children aged 2 months to 23 months
773418|NCT00355043|Diagnosed case of acute bronchiolitis|diagnosed case of acute bronchiolitis
773419|NCT00355004|colon cancer|colon cancer
773420|NCT00355004|rectal cancer|rectal cancer
773421|NCT00354978|Colorectal Cancer|colorectal cancer
773422|NCT00354978|FOLFIRI|folfiri
773423|NCT00354978|Irinotecan|irinotecan
773424|NCT00354978|CPT-11|cpt-11
773425|NCT00354978|Leucovorin|leucovorin
773426|NCT00354978|LV|lv
773427|NCT00354978|Folinic Acid|folinic acid
773428|NCT00354978|Fluorouracil|fluorouracil
773429|NCT00354978|5-FU|5-fu
773430|NCT00354978|Adrucil|adrucil
773431|NCT00354978|Efudex|efudex
773434|NCT00354978|Anti-VEGF monoclonal antibody|anti-vegf monoclonal antibody
773435|NCT00354978|rhuMAb-VEGF|rhumab-vegf
773436|NCT00354965|ABS|abs
773437|NCT00354965|Acute Bacterial|acute bacterial
773438|NCT00354965|Sinusitis|sinusitis
773439|NCT00354965|Bacterial Sinusitis|bacterial sinusitis
773440|NCT00354952|Healthy volunteers|healthy volunteers
773441|NCT00354952|Antibiotic exposure|antibiotic exposure
773442|NCT00354952|Resistance selection|resistance selection
773443|NCT00354926|Non-Hodgkin's Lymphoma|non-hodgkin's lymphoma
773444|NCT00354926|rituximab|rituximab
773445|NCT00354926|humanized monoclonal antibody|humanized monoclonal antibody
773446|NCT00354926|anti-CD20 monoclonal antibody|anti-cd20 monoclonal antibody
773447|NCT00354913|adult grade I meningioma|adult grade i meningioma
773448|NCT00354913|adult grade II meningioma|adult grade ii meningioma
773449|NCT00354913|adult grade III meningioma|adult grade iii meningioma
773450|NCT00354913|adult papillary meningioma|adult papillary meningioma
773722|NCT00353977|CMV|cmv
773451|NCT00354913|adult anaplastic meningioma|adult anaplastic meningioma
773452|NCT00354913|recurrent adult brain tumor|recurrent adult brain tumor
773453|NCT00354913|glioblastoma multiforme (GBM)|glioblastoma multiforme (gbm)
773454|NCT00354913|Imatinib|imatinib
773455|NCT00354913|Imatinib mesylate|imatinib mesylate
773456|NCT00354913|Hydroxyurea|hydroxyurea
773457|NCT00354913|Droxia|droxia
773458|NCT00354913|Hydrea|hydrea
773459|NCT00354913|Hydroxycarbamide|hydroxycarbamide
773460|NCT00354913|Gleevec|gleevec
773461|NCT00354913|Meningioma|meningioma
773462|NCT00354900|breast cancer|breast cancer
773463|NCT00354900|fibrinolysis|fibrinolysis
773464|NCT00354900|urokinase-type plasminogen activator|urokinase-type plasminogen activator
773465|NCT00354900|plasminogen activator inhibitor|plasminogen activator inhibitor
773466|NCT00354900|aprotinin|aprotinin
773467|NCT00354900|plasmin/alpha-2-antiplasmin complex|plasmin/alpha-2-antiplasmin complex
773468|NCT00354887|Gastrointestinal Cancer|gastrointestinal cancer
773469|NCT00354887|Small Bowel Cancer|small bowel cancer
773470|NCT00354887|Ampulla of Vater|ampulla of vater
773471|NCT00354887|Capecitabine|capecitabine
773472|NCT00354887|Xeloda|xeloda
773473|NCT00354887|Oxaliplatin|oxaliplatin
773474|NCT00354887|Eloxatin|eloxatin
773475|NCT00354874|GW642444 asthmatic subjects safety tolerability PD and PK|gw642444 asthmatic subjects safety tolerability pd and pk
773476|NCT00354861|Healthy volunteers|healthy volunteers
773477|NCT00354861|IMP321|imp321
773478|NCT00354861|Adjuvant|adjuvant
773479|NCT00354861|Pharmacodynamics|pharmacodynamics
773480|NCT00354822|Zevalin|zevalin
773481|NCT00354822|Lymphoma, Non-Hodgkin|lymphoma, non-hodgkin
773482|NCT00354809|cognition|cognition
773483|NCT00354809|Primary Insomnia|primary insomnia
773484|NCT00354809|sleep|sleep
773485|NCT00354809|polysomnography|polysomnography
773486|NCT00354796|bleeding|bleeding
773487|NCT00354796|anticoagulation|anticoagulation
773488|NCT00354796|LMWH|lmwh
773489|NCT00354796|Enoxaparin|enoxaparin
773490|NCT00354783|Very low birth weight premature infants|very low birth weight premature infants
773491|NCT00354783|Kicking|kicking
773492|NCT00354783|Stepping|stepping
773493|NCT00354783|Walking|walking
773494|NCT00354783|Motor development|motor development
773495|NCT00354783|Kinematics|kinematics
773496|NCT00354770|Trichotillomania|trichotillomania
773497|NCT00354770|Hair-pulling|hair-pulling
773498|NCT00354757|gastroesophageal reflux disease, proton-pump inhibitor test|gastroesophageal reflux disease, proton-pump inhibitor test
773499|NCT00354744|adult rhabdomyosarcoma|adult rhabdomyosarcoma
773500|NCT00354744|previously untreated childhood rhabdomyosarcoma|previously untreated childhood rhabdomyosarcoma
773501|NCT00354744|adult malignant mesenchymoma|adult malignant mesenchymoma
773502|NCT00354744|childhood malignant mesenchymoma|childhood malignant mesenchymoma
773503|NCT00354744|metastatic childhood soft tissue sarcoma|metastatic childhood soft tissue sarcoma
773504|NCT00354744|stage IV adult soft tissue sarcoma|stage iv adult soft tissue sarcoma
773505|NCT00354731|nephrotic syndrome, pentoxifylline, corticosteroid|nephrotic syndrome, pentoxifylline, corticosteroid
773506|NCT00354705|Colon Cancer|colon cancer
773507|NCT00354705|Adenocarcinoma of the Colon|adenocarcinoma of the colon
773508|NCT00354705|Cancer Recurrence|cancer recurrence
773509|NCT00354705|Survey|survey
773510|NCT00354705|Chemotherapy|chemotherapy
773511|NCT00354705|Surgery|surgery
773512|NCT00354679|adenocarcinoma of the esophagus|adenocarcinoma of the esophagus
773513|NCT00354679|recurrent esophageal cancer|recurrent esophageal cancer
773514|NCT00354679|stage III esophageal cancer|stage iii esophageal cancer
773515|NCT00354679|stage II esophageal cancer|stage ii esophageal cancer
773516|NCT00354666|inhaled|inhaled
773517|NCT00354666|asthmatic subjects|asthmatic subjects
773518|NCT00354666|GSK159797|gsk159797
773519|NCT00354666|safety and tolerability|safety and tolerability
773520|NCT00354666|efficacy|efficacy
773521|NCT00354666|dry powder|dry powder
773522|NCT00354653|HBeAg|hbeag
773523|NCT00354653|HBV|hbv
773524|NCT00354653|CHRONIC HEPATITIS|chronic hepatitis
773525|NCT00354653|lamivudine|lamivudine
773526|NCT00354640|breast cancer|breast cancer
773527|NCT00354640|breast cancer in situ|breast cancer in situ
773528|NCT00354640|ductal breast carcinoma in situ|ductal breast carcinoma in situ
773529|NCT00354640|stage I breast cancer|stage i breast cancer
773530|NCT00354640|stage II breast cancer|stage ii breast cancer
773531|NCT00354640|stage IIIA breast cancer|stage iiia breast cancer
773532|NCT00354640|stage IIIB breast cancer|stage iiib breast cancer
773533|NCT00354640|stage IIIC breast cancer|stage iiic breast cancer
773534|NCT00354627|HIV-1|hiv-1
773535|NCT00354627|Early Access Program (EAP)|early access program (eap)
773536|NCT00354627|TMC125|tmc125
773537|NCT00354627|treatment-experienced|treatment-experienced
773538|NCT00354627|failing multiple antiretroviral (ARV) regimens|failing multiple antiretroviral (arv) regimens
773539|NCT00354627|limited to no treatment options|limited to no treatment options
773540|NCT00354601|fallopian tube cancer|fallopian tube cancer
773541|NCT00354601|peritoneal cavity cancer|peritoneal cavity cancer
773542|NCT00354601|recurrent ovarian epithelial cancer|recurrent ovarian epithelial cancer
773543|NCT00354601|ovarian clear cell cystadenocarcinoma|ovarian clear cell cystadenocarcinoma
773821|NCT00353665|memantine|memantine
773544|NCT00354601|ovarian endometrioid adenocarcinoma|ovarian endometrioid adenocarcinoma
773545|NCT00354601|ovarian mucinous cystadenocarcinoma|ovarian mucinous cystadenocarcinoma
773546|NCT00354601|ovarian serous cystadenocarcinoma|ovarian serous cystadenocarcinoma
773547|NCT00354601|ovarian undifferentiated adenocarcinoma|ovarian undifferentiated adenocarcinoma
773548|NCT00354588|chronic renal failure|chronic renal failure
773549|NCT00354588|arterial stiffness|arterial stiffness
773550|NCT00354588|arterial wave reflections|arterial wave reflections
773551|NCT00354575|Constipation;|constipation;
773552|NCT00354575|Chinese herb;|chinese herb;
773553|NCT00354575|Long-term care;|long-term care;
773554|NCT00354575|Integrative Chinese Medicine and Western Medicine;|integrative chinese medicine and western medicine;
773555|NCT00354562|Lung Cancer|lung cancer
773556|NCT00354562|Non-Small Cell Lung Cancer|non-small cell lung cancer
773557|NCT00354562|NSCLC|nsclc
773558|NCT00354562|ABT-751|abt-751
773559|NCT00354562|docetaxel|docetaxel
773560|NCT00354562|Taxotere|taxotere
773561|NCT00354549|recurrent non-small cell lung cancer|recurrent non-small cell lung cancer
773562|NCT00354549|stage IIIB non-small cell lung cancer|stage iiib non-small cell lung cancer
773563|NCT00354549|stage IV non-small cell lung cancer|stage iv non-small cell lung cancer
773564|NCT00354549|adenocarcinoma of the lung|adenocarcinoma of the lung
773565|NCT00354549|bronchoalveolar cell lung cancer|bronchoalveolar cell lung cancer
773566|NCT00354549|large cell lung cancer|large cell lung cancer
773567|NCT00354536|GSK716155|gsk716155
773568|NCT00354536|albiglutide|albiglutide
773569|NCT00354536|pharmacodynamics|pharmacodynamics
773570|NCT00354536|pharmacokinetics|pharmacokinetics
773571|NCT00354523|Solid Tumor|solid tumor
773572|NCT00354523|Thyroid Cancer|thyroid cancer
773573|NCT00354523|Medullary Thyroid Cancer|medullary thyroid cancer
773574|NCT00354523|MTC|mtc
773575|NCT00354523|Advanced Metastatic Medullary Thyroid Carcinoma|advanced metastatic medullary thyroid carcinoma
773576|NCT00354523|Capecitabine|capecitabine
773577|NCT00354523|Dacarbazine|dacarbazine
773578|NCT00354523|Imatinib|imatinib
773579|NCT00354523|Gleevec|gleevec
773580|NCT00354523|Imatinib Mesylate|imatinib mesylate
773581|NCT00354523|DTIC-Dome|dtic-dome
773582|NCT00354523|Xeloda|xeloda
773583|NCT00354510|atopic dermatitis|atopic dermatitis
773584|NCT00354510|GW842470X|gw842470x
773585|NCT00354510|PDE4 inhibitor|pde4 inhibitor
773586|NCT00354497|prostate cancer|prostate cancer
773587|NCT00354484|anemia|anemia
773588|NCT00354484|postpartum|postpartum
773589|NCT00354458|heart failure|heart failure
773590|NCT00354458|diuretic|diuretic
773591|NCT00354458|renal impairment|renal impairment
773592|NCT00354458|renal function|renal function
773593|NCT00354445|Age-Related Macular Degeneration (AMD)|age-related macular degeneration (amd)
773594|NCT00354445|pegaptanib sodium|pegaptanib sodium
773595|NCT00354445|subfoveal CNV|subfoveal cnv
773596|NCT00354445|macugen|macugen
773597|NCT00354432|recurrent prostate cancer|recurrent prostate cancer
773598|NCT00354432|stage I prostate cancer|stage i prostate cancer
773599|NCT00354432|stage IIB prostate cancer|stage iib prostate cancer
773600|NCT00354432|stage IIA prostate cancer|stage iia prostate cancer
773601|NCT00354432|stage III prostate cancer|stage iii prostate cancer
773602|NCT00354432|stage IV prostate cancer|stage iv prostate cancer
773603|NCT00354432|hot flashes|hot flashes
773604|NCT00354406|Abciximab|abciximab
773605|NCT00354406|Magnetic Resonance Imaging|magnetic resonance imaging
773606|NCT00354406|Percutaneous Transluminal Coronary Angioplasty|percutaneous transluminal coronary angioplasty
773607|NCT00354393|localized malignant mesothelioma|localized malignant mesothelioma
773608|NCT00354393|sarcomatous mesothelioma|sarcomatous mesothelioma
773609|NCT00354393|advanced malignant mesothelioma|advanced malignant mesothelioma
773610|NCT00354393|epithelial mesothelioma|epithelial mesothelioma
773611|NCT00354380|Malaria|malaria
773612|NCT00354380|Africa|africa
773613|NCT00354380|Methalyne-blue|methalyne-blue
773614|NCT00354380|Artesunate|artesunate
773615|NCT00354380|Amodiaquine|amodiaquine
773616|NCT00354367|Crohn Disease|crohn disease
773617|NCT00354367|Certolizumab pegol|certolizumab pegol
773618|NCT00354367|Fistula|fistula
773619|NCT00354354|COPD|copd
773620|NCT00354354|Combivent|combivent
773622|NCT00354354|Bronchodilator|bronchodilator
773623|NCT00354354|Kinetics|kinetics
773624|NCT00354328|HCM|hcm
773625|NCT00354328|Echocardiography|echocardiography
773626|NCT00354328|Diastolic Dysfunction|diastolic dysfunction
773627|NCT00354328|Enalapril|enalapril
773628|NCT00354315|Shared decision making|shared decision making
773629|NCT00354315|Optimal drug prescription|optimal drug prescription
773630|NCT00354302|osteoporosis|osteoporosis
773631|NCT00354302|stage I breast cancer|stage i breast cancer
773632|NCT00354302|stage II breast cancer|stage ii breast cancer
773633|NCT00354302|stage IIIA breast cancer|stage iiia breast cancer
773634|NCT00354276|adult acute myeloid leukemia with 11q23 (MLL) abnormalities|adult acute myeloid leukemia with 11q23 (mll) abnormalities
773635|NCT00354276|adult acute myeloid leukemia with t(16;16)(p13;q22)|adult acute myeloid leukemia with t(16;16)(p13;q22)
773636|NCT00354276|untreated adult acute myeloid leukemia|untreated adult acute myeloid leukemia
773927|NCT00353184|Emergency|emergency
773637|NCT00354276|adult acute myelomonocytic leukemia (M4)|adult acute myelomonocytic leukemia (m4)
773638|NCT00354276|adult acute monocytic leukemia (M5b)|adult acute monocytic leukemia (m5b)
773639|NCT00354276|adult erythroleukemia (M6a)|adult erythroleukemia (m6a)
773640|NCT00354276|adult pure erythroid leukemia (M6b)|adult pure erythroid leukemia (m6b)
773641|NCT00354276|adult acute monoblastic leukemia (M5a)|adult acute monoblastic leukemia (m5a)
773642|NCT00354276|adult acute megakaryoblastic leukemia (M7)|adult acute megakaryoblastic leukemia (m7)
773643|NCT00354276|adult acute basophilic leukemia|adult acute basophilic leukemia
773644|NCT00354276|adult acute myeloblastic leukemia without maturation (M1)|adult acute myeloblastic leukemia without maturation (m1)
773645|NCT00354276|adult acute myeloblastic leukemia with maturation (M2)|adult acute myeloblastic leukemia with maturation (m2)
773646|NCT00354276|adult acute eosinophilic leukemia|adult acute eosinophilic leukemia
773647|NCT00354276|adult acute minimally differentiated myeloid leukemia (M0)|adult acute minimally differentiated myeloid leukemia (m0)
773648|NCT00354263|Healthy male volunteers|healthy male volunteers
773649|NCT00354263|IMP321|imp321
773650|NCT00354263|Adjuvant|adjuvant
773651|NCT00354263|Monotherapy|monotherapy
773652|NCT00354263|Pharmacokinetics/Pharmacodynamics|pharmacokinetics/pharmacodynamics
773653|NCT00354237|diabetes mellitus|diabetes mellitus
773654|NCT00354237|cardiac rehabilitation|cardiac rehabilitation
773655|NCT00354237|insulin|insulin
773656|NCT00354224|recurrent gastric cancer|recurrent gastric cancer
773657|NCT00354224|stage III gastric cancer|stage iii gastric cancer
773658|NCT00354224|stage IV gastric cancer|stage iv gastric cancer
773659|NCT00354211|Cardiac Output|cardiac output
773660|NCT00354211|Hemodynamic Phenomena|hemodynamic phenomena
773661|NCT00354198|rapidly progressive glomerulonephritis|rapidly progressive glomerulonephritis
773662|NCT00354198|pentoxifylline|pentoxifylline
773663|NCT00354172|adult acute myeloid leukemia with 11q23 (MLL) abnormalities|adult acute myeloid leukemia with 11q23 (mll) abnormalities
773664|NCT00354172|adult acute myeloid leukemia with inv(16)(p13;q22)|adult acute myeloid leukemia with inv(16)(p13;q22)
773665|NCT00354172|adult acute myeloid leukemia with t(15;17)(q22;q12)|adult acute myeloid leukemia with t(15;17)(q22;q12)
773666|NCT00354172|adult acute myeloid leukemia with t(16;16)(p13;q22)|adult acute myeloid leukemia with t(16;16)(p13;q22)
773667|NCT00354172|adult acute myeloid leukemia with t(8;21)(q22;q22)|adult acute myeloid leukemia with t(8;21)(q22;q22)
773668|NCT00354172|atypical chronic myeloid leukemia|atypical chronic myeloid leukemia
773669|NCT00354172|blastic phase chronic myelogenous leukemia|blastic phase chronic myelogenous leukemia
773670|NCT00354172|childhood chronic myelogenous leukemia|childhood chronic myelogenous leukemia
773671|NCT00354172|previously treated myelodysplastic syndromes|previously treated myelodysplastic syndromes
773672|NCT00354172|recurrent adult acute myeloid leukemia|recurrent adult acute myeloid leukemia
773673|NCT00354172|recurrent childhood acute myeloid leukemia|recurrent childhood acute myeloid leukemia
773674|NCT00354172|relapsing chronic myelogenous leukemia|relapsing chronic myelogenous leukemia
773675|NCT00354172|secondary acute myeloid leukemia|secondary acute myeloid leukemia
773676|NCT00354172|secondary myelodysplastic syndromes|secondary myelodysplastic syndromes
773677|NCT00354172|childhood myelodysplastic syndromes|childhood myelodysplastic syndromes
773678|NCT00354159|Implantable cardioverter defibrillator|implantable cardioverter defibrillator
773679|NCT00354159|Intracardiac pressures|intracardiac pressures
773680|NCT00354146|Farnesyl transferase inhibitor|farnesyl transferase inhibitor
773681|NCT00354146|relapsed or refractory acute myeloid leukemia|relapsed or refractory acute myeloid leukemia
773682|NCT00354133|Parkinson Disease|parkinson disease
773683|NCT00354133|Deep Brain Stimulation|deep brain stimulation
773684|NCT00354133|PDQ-39|pdq-39
773685|NCT00354081|Coronary Artery Disease|coronary artery disease
773686|NCT00354081|Myocardial Infarction|myocardial infarction
773687|NCT00354081|Cerebrovascular Stroke|cerebrovascular stroke
773688|NCT00354081|Homocysteine|homocysteine
773689|NCT00354081|Folic Acid|folic acid
773690|NCT00354081|Vitamin B 12|vitamin b 12
773691|NCT00354081|Vitamin B 6|vitamin b 6
773692|NCT00354068|adult anaplastic oligodendroglioma|adult anaplastic oligodendroglioma
773693|NCT00354068|adult giant cell glioblastoma|adult giant cell glioblastoma
773694|NCT00354068|adult gliosarcoma|adult gliosarcoma
773695|NCT00354068|adult mixed glioma|adult mixed glioma
773696|NCT00354068|adult anaplastic astrocytoma|adult anaplastic astrocytoma
773697|NCT00354068|recurrent adult brain tumor|recurrent adult brain tumor
774119|NCT00352573|Instrument|instrument
773698|NCT00354068|adult glioblastoma|adult glioblastoma
773699|NCT00354042|GW597901X|gw597901x
773700|NCT00354042|Asthma|asthma
773701|NCT00354042|Crossover|crossover
773702|NCT00354042|dose ascending|dose ascending
773703|NCT00354042|repeat dose|repeat dose
773704|NCT00354042|inhaled|inhaled
773705|NCT00354029|hemorrhoids|hemorrhoids
773706|NCT00354029|hemorrhoidectomy|hemorrhoidectomy
773707|NCT00354029|S (+) ketamine|s (+) ketamine
773708|NCT00354029|pain|pain
773709|NCT00354016|influenza|influenza
773710|NCT00354016|vaccine|vaccine
773711|NCT00354003|Parkinson|parkinson
773712|NCT00354003|Imaging|imaging
773713|NCT00353990|insulin|insulin
773714|NCT00353990|bioavailability|bioavailability
773715|NCT00353990|duodenum|duodenum
773716|NCT00353990|infusion|infusion
773717|NCT00353990|healthy|healthy
773718|NCT00353990|diabetes|diabetes
773719|NCT00353990|absorption|absorption
773720|NCT00353977|Cytomegalovirus|cytomegalovirus
773723|NCT00353977|Immunization|immunization
773724|NCT00353977|Peripheral Blood Stem Cell Transplantation|peripheral blood stem cell transplantation
773725|NCT00353977|Stem Cell Allotransplant|stem cell allotransplant
773726|NCT00353951|primary care|primary care
773727|NCT00353951|lower respiratory tract infection|lower respiratory tract infection
773728|NCT00353951|antibiotics|antibiotics
773729|NCT00353951|cough|cough
773730|NCT00353938|PTSD, MDMA, psychotherapy, Switzerland|ptsd, mdma, psychotherapy, switzerland
773731|NCT00353925|Hypertrophy|hypertrophy
773733|NCT00353925|Cardiac|cardiac
773734|NCT00353925|Blood Pressure|blood pressure
773735|NCT00353925|Papillary Muscle|papillary muscle
773736|NCT00353912|Blood|blood
773737|NCT00353912|Venous|venous
773738|NCT00353912|Systolic|systolic
773739|NCT00353912|Diastolic|diastolic
773740|NCT00353912|Pulse|pulse
773741|NCT00353912|Pressure|pressure
773742|NCT00353899|Magnetic Resonance Imaging|magnetic resonance imaging
773743|NCT00353899|Pediatric|pediatric
773744|NCT00353899|Normal Volunteer|normal volunteer
773745|NCT00353899|Electrocardiogram|electrocardiogram
773746|NCT00353899|Cardiac|cardiac
773747|NCT00353899|Healthy Volunteer|healthy volunteer
773748|NCT00353899|HV|hv
773749|NCT00353886|Retrospective|retrospective
773750|NCT00353886|Epilepsy|epilepsy
773751|NCT00353886|Antiepileptic Drugs|antiepileptic drugs
773752|NCT00353886|Behavioral Development|behavioral development
773753|NCT00353886|Intellectual Development|intellectual development
773754|NCT00353873|FLIXOTIDE|flixotide
773755|NCT00353873|asthmatics children 4-11 years|asthmatics children 4-11 years
773756|NCT00353873|SERETIDE|seretide
773757|NCT00353873|asthma-control|asthma-control
773758|NCT00353860|Leukemia|leukemia
773759|NCT00353860|Transplant - Mortality|transplant - mortality
773760|NCT00353860|Immunosuppression|immunosuppression
773761|NCT00353860|Radiation|radiation
773762|NCT00353860|Cure|cure
773763|NCT00353860|Peripheral Blood Stem Cells|peripheral blood stem cells
773764|NCT00353860|Graft-Versus Leukemia/Myeloma|graft-versus leukemia/myeloma
773765|NCT00353860|Graft-Versus-Host Disease|graft-versus-host disease
773766|NCT00353860|Cyclosporine|cyclosporine
773767|NCT00353860|Fludarabine|fludarabine
773768|NCT00353847|acupuncture, RCTs, chronic LBP|acupuncture, rcts, chronic lbp
773769|NCT00353834|endothelial dysfunction|endothelial dysfunction
773770|NCT00353834|subclinical inflammation|subclinical inflammation
773771|NCT00353834|flow mediated brachial artery dilation|flow mediated brachial artery dilation
773772|NCT00353834|pulse wave analysis|pulse wave analysis
773773|NCT00353834|glucagon like polypeptide mimetics|glucagon like polypeptide mimetics
773774|NCT00353834|type 2 diabetes mellitus|type 2 diabetes mellitus
773775|NCT00353821|Tumor Necrosis Factor Alpha (TNF-Alpha)|tumor necrosis factor alpha (tnf-alpha)
773776|NCT00353821|Interferon-Gamma (IFN-Gamma)|interferon-gamma (ifn-gamma)
773777|NCT00353821|Interleukin-10 (IL-10)|interleukin-10 (il-10)
773778|NCT00353821|Interleukin-6 (IL-6)|interleukin-6 (il-6)
773779|NCT00353821|Interleukin-1 (IL-1 Ra)|interleukin-1 (il-1 ra)
773780|NCT00353821|Interleukin-1 Receptor Antagonist (IL-1 Ra)|interleukin-1 receptor antagonist (il-1 ra)
773781|NCT00353821|Vitamin D Receptor (VitD R)|vitamin d receptor (vitd r)
773782|NCT00353795|MESA|mesa
773783|NCT00353795|MRI|mri
773784|NCT00353795|Cardiovascular|cardiovascular
773785|NCT00353795|Cardiac|cardiac
773786|NCT00353795|Coronary|coronary
773787|NCT00353795|Atherosclerosis|atherosclerosis
773788|NCT00353782|Triglyceride|triglyceride
773789|NCT00353782|PHOSPHOLIPIDS|phospholipids
773790|NCT00353782|Free and Esterfied Cholesterol|free and esterfied cholesterol
773791|NCT00353782|Polydisperse|polydisperse
773792|NCT00353782|Lipoprotein Transport System|lipoprotein transport system
773793|NCT00353769|scalp laceration|scalp laceration
773794|NCT00353769|tissue adhesive|tissue adhesive
773795|NCT00353769|wound care|wound care
773796|NCT00353769|cost effectiveness|cost effectiveness
773797|NCT00353743|infected abortion|infected abortion
773798|NCT00353743|treatment period|treatment period
773799|NCT00353743|doxycycline|doxycycline
773800|NCT00353743|metronidazole|metronidazole
773801|NCT00353743|placebo|placebo
774120|NCT00352573|Physicians|physicians
773802|NCT00353730|Serial Analysis of Gene Expression|serial analysis of gene expression
773803|NCT00353730|Carotid Artery Plaque|carotid artery plaque
773804|NCT00353730|Atherosclerosis|atherosclerosis
773805|NCT00353717|breast|breast
773806|NCT00353717|basal like|basal like
773807|NCT00353717|carcinoma|carcinoma
773808|NCT00353717|metastatic|metastatic
773809|NCT00353717|EGFR|egfr
773810|NCT00353704|Intervertebral disk displacement|intervertebral disk displacement
773811|NCT00353704|disk prolapse|disk prolapse
773812|NCT00353704|pregabalin|pregabalin
773813|NCT00353678|Hip replacement|hip replacement
773814|NCT00353678|Arthroplasty|arthroplasty
773815|NCT00353678|Prevention|prevention
773816|NCT00353678|Thromboembolism|thromboembolism
773817|NCT00353678|Treatment outcomes|treatment outcomes
773818|NCT00353678|Arthroplasty, replacement, hip|arthroplasty, replacement, hip
773819|NCT00353665|amyotrophic lateral sclerosis|amyotrophic lateral sclerosis
773820|NCT00353665|motor neuron disease|motor neuron disease
773822|NCT00353665|clinical trial|clinical trial
773823|NCT00353652|Blood Pressure, High|blood pressure, high
773824|NCT00353639|Ulcera|ulcera
773825|NCT00353639|Telomerase|telomerase
773826|NCT00353639|TERT|tert
773827|NCT00353639|TERC|terc
773828|NCT00353639|SBDS|sbds
773829|NCT00353639|DNA Helicase|dna helicase
773830|NCT00353639|Inflammatory Bowel Disease|inflammatory bowel disease
773831|NCT00353639|IBD|ibd
773832|NCT00353626|Amputation|amputation
773833|NCT00353626|trans tibial|trans tibial
773834|NCT00353626|prosthesis|prosthesis
773835|NCT00353626|motion analysis|motion analysis
773836|NCT00353613|Antibiotic prophylaxis|antibiotic prophylaxis
773837|NCT00353600|Proteinuria|proteinuria
773838|NCT00353600|Renal Failure|renal failure
773839|NCT00353600|Angiotension Converting Enzyme Inhibitor|angiotension converting enzyme inhibitor
773840|NCT00353600|Glomerular Filtration Rate|glomerular filtration rate
773841|NCT00353587|insulin sensitizer|insulin sensitizer
773842|NCT00353587|type 2 diabetes|type 2 diabetes
773843|NCT00353587|diabetes|diabetes
773844|NCT00353587|glucose control|glucose control
773845|NCT00353574|Resistant Hypertension|resistant hypertension
773846|NCT00353548|Bulimia Nervosa|bulimia nervosa
773847|NCT00353548|Binge Eating Disorder|binge eating disorder
773848|NCT00353548|Obesity|obesity
773849|NCT00353548|Anorexia Nervosa|anorexia nervosa
773850|NCT00353535|glomerulosclerosis, focal|glomerulosclerosis, focal
773851|NCT00353535|pretransplant immunosuppression|pretransplant immunosuppression
773852|NCT00353535|total lymphoid irradiation|total lymphoid irradiation
773853|NCT00353535|renal transplant|renal transplant
773854|NCT00353535|recurrence|recurrence
773855|NCT00353496|Non functioning entero-pancreatic tumours|non functioning entero-pancreatic tumours
773856|NCT00353483|Breast Cancer|breast cancer
773857|NCT00353483|Neoadjuvant|neoadjuvant
773858|NCT00353470|PD|pd
773859|NCT00353470|CBT|cbt
773860|NCT00353470|PFPP|pfpp
773861|NCT00353457|Adjuvant therapy|adjuvant therapy
773862|NCT00353457|Rectal cancer|rectal cancer
773863|NCT00353457|Capecitabine|capecitabine
773864|NCT00353457|Oxaliplatin|oxaliplatin
773865|NCT00353457|Cetuximab|cetuximab
773866|NCT00353457|Erbitux|erbitux
773867|NCT00353444|head injury|head injury
773868|NCT00353444|transcranial Doppler|transcranial doppler
773869|NCT00353444|pulsatility index|pulsatility index
773870|NCT00353444|vasospasm in head injury|vasospasm in head injury
773871|NCT00353431|Hyperglycaemia|hyperglycaemia
773872|NCT00353431|algorithm|algorithm
773873|NCT00353431|emergency|emergency
773874|NCT00353431|s.c. insulin therapy|s.c. insulin therapy
773875|NCT00353431|Emergency patient|emergency patient
773876|NCT00353405|Adolescents|adolescents
773877|NCT00353405|Sexually Transmitted Infections|sexually transmitted infections
773878|NCT00353405|Gonorrhea|gonorrhea
773879|NCT00353405|Chlamydia Infections|chlamydia infections
773880|NCT00353366|safety|safety
773881|NCT00353366|Post-marketing surveillance (PMS)|post-marketing surveillance (pms)
773882|NCT00353366|Rotarix|rotarix
773883|NCT00353366|oral|oral
773884|NCT00353366|Filipino|filipino
773885|NCT00353366|Rotavirus|rotavirus
773886|NCT00353366|Gastroenteritis|gastroenteritis
773887|NCT00353366|Human Rotavirus (HRV) vaccine|human rotavirus (hrv) vaccine
773888|NCT00353353|no specific conditions|no specific conditions
773889|NCT00353340|sodium bicarbonate,|sodium bicarbonate,
773890|NCT00353340|n-acetylcisteine,|n-acetylcisteine,
773891|NCT00353340|contrast nephropathy,|contrast nephropathy,
773892|NCT00353340|cardiac catheterisation|cardiac catheterisation
773893|NCT00353327|HIV|hiv
773894|NCT00353327|Passive immunotherapy|passive immunotherapy
773895|NCT00353301|Carcinoma, Renal Cell|carcinoma, renal cell
773896|NCT00353301|Receptor, Epidermal Growth Factor|receptor, epidermal growth factor
773897|NCT00353301|mTOR protein|mtor protein
773898|NCT00353301|Sirolimus|sirolimus
773899|NCT00353301|Erlotinib|erlotinib
773900|NCT00353275|Strict glycemic control|strict glycemic control
773901|NCT00353249|Cognitive Behavioral Therapy|cognitive behavioral therapy
773902|NCT00353249|CBT|cbt
773903|NCT00353249|Homeless Women|homeless women
774121|NCT00352573|Resources|resources
773904|NCT00353236|delivery of preterm infant and/or twins|delivery of preterm infant and/or twins
773905|NCT00353223|Heart Failure|heart failure
773906|NCT00353223|Functional Impairment|functional impairment
773907|NCT00353223|Health-Related Quality of Life|health-related quality of life
773908|NCT00353223|Telemedicine|telemedicine
773909|NCT00353210|IVF|ivf
773910|NCT00353210|embryos|embryos
773911|NCT00353210|research|research
773912|NCT00353210|donation|donation
773913|NCT00353210|surplus|surplus
773914|NCT00353210|stem cells|stem cells
773915|NCT00353210|abnormal embryo|abnormal embryo
773916|NCT00353210|screening|screening
773917|NCT00353197|IVF|ivf
773918|NCT00353197|embryos|embryos
773919|NCT00353197|research|research
773920|NCT00353197|donation|donation
773921|NCT00353197|surplus|surplus
773922|NCT00353197|stem cells|stem cells
773923|NCT00353184|Acute|acute
773924|NCT00353184|Asthma|asthma
773925|NCT00353184|Child|child
773926|NCT00353184|Pediatric|pediatric
773928|NCT00353184|Oral|oral
773929|NCT00353184|Montelukast|montelukast
773930|NCT00353184|Forced Expiratory Volume in One Second|forced expiratory volume in one second
773931|NCT00353184|FEV1|fev1
773932|NCT00353171|Smoking|smoking
773933|NCT00353171|PCB|pcb
773934|NCT00353171|DDE|dde
773935|NCT00353171|Menstrual Cycle|menstrual cycle
773936|NCT00353171|NC Infant Feeding Study|nc infant feeding study
773937|NCT00353158|Phototesting|phototesting
773938|NCT00353158|UVR/UVA|uvr/uva
773939|NCT00353158|Sunburn|sunburn
773940|NCT00353158|Doxycycline|doxycycline
773941|NCT00353158|Voriconazole|voriconazole
773942|NCT00353158|Phototoxicity|phototoxicity
773943|NCT00353158|Healthy Volunteer|healthy volunteer
773944|NCT00353158|HV|hv
773945|NCT00353145|Unknown Primary Neoplasms|unknown primary neoplasms
773946|NCT00353145|UPC|upc
773947|NCT00353145|Unknown Primary Cancer|unknown primary cancer
773948|NCT00353145|Questionnaire|questionnaire
773949|NCT00353145|Gemcitabine|gemcitabine
773950|NCT00353145|Gemcitabine Hydrochloride|gemcitabine hydrochloride
773951|NCT00353145|Gemzar|gemzar
773952|NCT00353145|Oxaliplatin|oxaliplatin
773953|NCT00353145|Eloxatin|eloxatin
773954|NCT00353145|Gemox|gemox
773955|NCT00353119|Palmoplantar pustulosis|palmoplantar pustulosis
773956|NCT00353119|Psoriasis|psoriasis
773957|NCT00353119|Etanercept|etanercept
773958|NCT00353106|Graft-Versus-Host Disease|graft-versus-host disease
773959|NCT00353106|GVHD|gvhd
773960|NCT00353106|Chronic Graft-Versus-Host Disease|chronic graft-versus-host disease
773961|NCT00353106|cGVHD|cgvhd
773962|NCT00353106|Interview|interview
773963|NCT00353106|Questionnaire|questionnaire
773964|NCT00353106|Survey|survey
773965|NCT00353106|Caregiver|caregiver
773966|NCT00353093|deep vein thrombosis,D-dimer,ultrasonography|deep vein thrombosis,d-dimer,ultrasonography
773967|NCT00353080|Prevention of postmenopausal osteoporosis|prevention of postmenopausal osteoporosis
773968|NCT00353067|unstable angina|unstable angina
773969|NCT00353067|myocardial infarction|myocardial infarction
773970|NCT00353067|coronary thrombosis|coronary thrombosis
773971|NCT00353067|coronary atherosclerosis|coronary atherosclerosis
773972|NCT00353054|Caltrate|caltrate
773973|NCT00353054|Lipoproteins|lipoproteins
773974|NCT00353054|Glucose|glucose
773975|NCT00353054|Insulin|insulin
773976|NCT00353054|Blood pressure|blood pressure
773977|NCT00353054|Body fat|body fat
773978|NCT00353054|Body weight|body weight
773979|NCT00353054|Women|women
773980|NCT00353054|Diet|diet
773981|NCT00353054|Macronutrients|macronutrients
773982|NCT00353041|topical|topical
773983|NCT00353041|anesthetic|anesthetic
773984|NCT00353041|pain|pain
773985|NCT00353028|Fluvoxamine Maleate|fluvoxamine maleate
773986|NCT00353028|Depression|depression
773987|NCT00353028|Children and Adolescents|children and adolescents
773988|NCT00353015|Gastrointestinal cancer|gastrointestinal cancer
773989|NCT00353015|high grade gastrointestinal neuroendocrine carcinoma|high grade gastrointestinal neuroendocrine carcinoma
773990|NCT00353015|High grade neuroendocrine carcinoma of unknown primary site|high grade neuroendocrine carcinoma of unknown primary site
773991|NCT00353015|Cisplatin|cisplatin
773992|NCT00353015|Platinol-AQ|platinol-aq
773993|NCT00353015|Platinol|platinol
773994|NCT00353015|CDDP|cddp
773995|NCT00353015|CPT-11|cpt-11
773996|NCT00353015|Irinotecan|irinotecan
773997|NCT00353002|Pain|pain
773998|NCT00353002|Ametop|ametop
773999|NCT00353002|Liposomal Lidocaine|liposomal lidocaine
774000|NCT00353002|Venous cannulation|venous cannulation
774001|NCT00352976|Bone Marrow transplant|bone marrow transplant
774002|NCT00352976|stem cell transplant|stem cell transplant
774003|NCT00352976|cord blood transplant|cord blood transplant
774004|NCT00352976|total body irradiation|total body irradiation
774005|NCT00352976|thymic shielding|thymic shielding
774006|NCT00352963|Open, phase 3, Infanrix hexa™, Hib-MenC, co-administered|open, phase 3, infanrix hexa™, hib-menc, co-administered
774007|NCT00352950|NSCLC, Lung cancer|nsclc, lung cancer
774008|NCT00352950|Panitumumab|panitumumab
774009|NCT00352950|Sirolimus|sirolimus
774010|NCT00352950|mTOR|mtor
774011|NCT00352950|Monoclonal antibody|monoclonal antibody
774012|NCT00352937|Coronary Arteriosclerosis|coronary arteriosclerosis
774013|NCT00352937|Tomography, X-Ray Computed|tomography, x-ray computed
774014|NCT00352937|Tomography, Emission-Computed, Single-Photon|tomography, emission-computed, single-photon
774015|NCT00352924|Cancer|cancer
774016|NCT00352924|Pesticides|pesticides
774017|NCT00352924|Agriculture|agriculture
774018|NCT00352911|HIV-1|hiv-1
774019|NCT00352885|Cancer|cancer
774020|NCT00352885|IL-2 therapy|il-2 therapy
774021|NCT00352885|Antidepressant|antidepressant
774022|NCT00352885|Immune system|immune system
774023|NCT00352885|Neuroendocrine response|neuroendocrine response
774024|NCT00352872|Pharmacogenetics|pharmacogenetics
774025|NCT00352872|Toxicity|toxicity
774026|NCT00352872|Pre-Menopausal|pre-menopausal
774027|NCT00352872|Women|women
774028|NCT00352872|Doxorubicin|doxorubicin
774029|NCT00352872|Cyclophosphamide|cyclophosphamide
774030|NCT00352872|Breast Cancer|breast cancer
774031|NCT00352872|Chemotherapy|chemotherapy
774032|NCT00352859|Cancer|cancer
774033|NCT00352859|Renal Cell Cancer|renal cell cancer
774034|NCT00352859|RCC|rcc
774035|NCT00352846|Non-Hodgkin's Lymphoma|non-hodgkin's lymphoma
774036|NCT00352846|Lymphoma|lymphoma
774037|NCT00352846|Zoledronic Acid|zoledronic acid
774038|NCT00352846|Zoledronate|zoledronate
774039|NCT00352846|Zometa|zometa
774040|NCT00352846|Vitamin D|vitamin d
774041|NCT00352846|Calcium Carbonate|calcium carbonate
774042|NCT00352846|Bone Loss|bone loss
774043|NCT00352833|gastric cancer|gastric cancer
774044|NCT00352833|investigational drug|investigational drug
774045|NCT00352833|adjuvant therapy|adjuvant therapy
774046|NCT00352833|intraoperative|intraoperative
774047|NCT00352833|intraperitoneal|intraperitoneal
774048|NCT00352833|EpCAM-positive tumor|epcam-positive tumor
774049|NCT00352820|Caregiver|caregiver
774050|NCT00352820|Brain cancer|brain cancer
774051|NCT00352820|Glioma|glioma
774052|NCT00352820|Questionnaire|questionnaire
774053|NCT00352820|Survey|survey
774054|NCT00352820|Interview|interview
774055|NCT00352807|Cataract|cataract
774056|NCT00352794|Combination chemotherapy|combination chemotherapy
774057|NCT00352794|Myelofibrosis (MF)|myelofibrosis (mf)
774058|NCT00352781|nicotine replacement therapy|nicotine replacement therapy
774059|NCT00352781|smoking cessation|smoking cessation
774060|NCT00352768|Fluvoxamine Maleate|fluvoxamine maleate
774061|NCT00352768|OCD|ocd
774062|NCT00352768|Children and Adolescents|children and adolescents
774063|NCT00352742|Multiple myeloma|multiple myeloma
774064|NCT00352742|bortezomib|bortezomib
774065|NCT00352742|ATN-224|atn-224
774066|NCT00352742|refractory|refractory
774067|NCT00352742|relapsed|relapsed
774068|NCT00352742|antiangiogenic|antiangiogenic
774069|NCT00352729|Burns|burns
774070|NCT00352729|ACell|acell
774071|NCT00352729|Donor Site|donor site
774072|NCT00352703|Oral mucositis|oral mucositis
774073|NCT00352703|Non-Hodgkin's lymphoma (NHL)|non-hodgkin's lymphoma (nhl)
774074|NCT00352703|conditioning chemotherapy|conditioning chemotherapy
774075|NCT00352703|autologous PBSCT|autologous pbsct
774076|NCT00352703|multiple myeloma (MM)|multiple myeloma (mm)
774077|NCT00352703|Melphalan|melphalan
774078|NCT00352664|Advanced Cancer|advanced cancer
774079|NCT00352664|Cancer Pain|cancer pain
774080|NCT00352664|Donepezil|donepezil
774081|NCT00352664|Sedation|sedation
774082|NCT00352664|Placebo|placebo
774083|NCT00352651|Acute Herpes Zoster (AHZ)|acute herpes zoster (ahz)
774084|NCT00352651|Postherpetic Neuralgia (PHN)|postherpetic neuralgia (phn)
774085|NCT00352651|Pregabalin|pregabalin
774086|NCT00352651|Lyrica|lyrica
774087|NCT00352651|Pain|pain
774088|NCT00352638|colon cancer|colon cancer
774089|NCT00352638|rectal cancer|rectal cancer
774090|NCT00352625|Tendonitis|tendonitis
774091|NCT00352625|Bursitis|bursitis
774092|NCT00352625|Pain|pain
774093|NCT00352625|Shoulder Pain|shoulder pain
774094|NCT00352625|Elbow Pain|elbow pain
774095|NCT00352625|Knee Pain|knee pain
774096|NCT00352625|Tendon Injury|tendon injury
774097|NCT00352625|Muscle, Bone and Cartilage Disorders|muscle, bone and cartilage disorders
774098|NCT00352612|clinical trial|clinical trial
774099|NCT00352612|randomized|randomized
774100|NCT00352612|blinded|blinded
774101|NCT00352612|controlled|controlled
774102|NCT00352599|Neurofibromatosis Type 1|neurofibromatosis type 1
774103|NCT00352599|NF1|nf1
774104|NCT00352599|Lovastatin|lovastatin
774105|NCT00352599|statin|statin
774106|NCT00352586|Classical Conditioning|classical conditioning
774107|NCT00352586|Learning|learning
774108|NCT00352586|NMDA|nmda
774109|NCT00352586|Startle|startle
774110|NCT00352586|Eyeblink|eyeblink
774111|NCT00352586|Anxiety|anxiety
774112|NCT00352586|Fear Conditioning|fear conditioning
774113|NCT00352586|Fear Potentiated Startle|fear potentiated startle
774114|NCT00352586|Extinction|extinction
774115|NCT00352586|D-cycloserine|d-cycloserine
774116|NCT00352586|Healthy Volunteer|healthy volunteer
774117|NCT00352586|HV|hv
774118|NCT00352586|Normal Control|normal control
774122|NCT00352573|Microallocation|microallocation
774123|NCT00352573|Ethics|ethics
774124|NCT00352560|Patients with Paroxysmal Atrial Fibrillation (PAF)|patients with paroxysmal atrial fibrillation (paf)
774125|NCT00352547|Immunosuppresant|immunosuppresant
774126|NCT00352547|Genetic Polymorphism|genetic polymorphism
774127|NCT00352547|Drug Metabolism|drug metabolism
774128|NCT00352547|Pharmacogenetics|pharmacogenetics
774129|NCT00352547|Rapamycin|rapamycin
774130|NCT00352521|adult anaplastic astrocytoma|adult anaplastic astrocytoma
774131|NCT00352521|adult mixed glioma|adult mixed glioma
774132|NCT00352521|adult giant cell glioblastoma|adult giant cell glioblastoma
774133|NCT00352521|adult gliosarcoma|adult gliosarcoma
774134|NCT00352521|recurrent adult brain tumor|recurrent adult brain tumor
774135|NCT00352521|adult glioblastoma|adult glioblastoma
774136|NCT00352521|adult anaplastic ependymoma|adult anaplastic ependymoma
774213|NCT00352391|NSCLC|nsclc
774137|NCT00352521|adult anaplastic oligodendroglioma|adult anaplastic oligodendroglioma
774138|NCT00352521|adult pineal gland astrocytoma|adult pineal gland astrocytoma
774139|NCT00352508|Internet, dietary advice, saturated fat|internet, dietary advice, saturated fat
774140|NCT00352495|childhood low-grade cerebral astrocytoma|childhood low-grade cerebral astrocytoma
774141|NCT00352495|recurrent childhood cerebellar astrocytoma|recurrent childhood cerebellar astrocytoma
774142|NCT00352495|recurrent childhood cerebral astrocytoma|recurrent childhood cerebral astrocytoma
774143|NCT00352495|childhood oligodendroglioma|childhood oligodendroglioma
774144|NCT00352495|neurofibromatosis type 1|neurofibromatosis type 1
774145|NCT00352495|recurrent childhood visual pathway and hypothalamic glioma|recurrent childhood visual pathway and hypothalamic glioma
774146|NCT00352495|untreated childhood visual pathway and hypothalamic glioma|untreated childhood visual pathway and hypothalamic glioma
774147|NCT00352482|Pulmonary Hypertension|pulmonary hypertension
774148|NCT00352482|Idiopathic Pulmonary Fibrosis|idiopathic pulmonary fibrosis
774149|NCT00352469|Alcoholism|alcoholism
774150|NCT00352469|Anxiety|anxiety
774151|NCT00352469|GAD|gad
774152|NCT00352469|PTSD|ptsd
774153|NCT00352469|Panic Disorder|panic disorder
774154|NCT00352469|OCD|ocd
774155|NCT00352456|Amygdala|amygdala
774156|NCT00352456|Facial Affect|facial affect
774157|NCT00352456|Instrumental Learning|instrumental learning
774158|NCT00352456|Psychopathy|psychopathy
774159|NCT00352456|Emotion|emotion
774160|NCT00352456|Orbitofrontal Cortex|orbitofrontal cortex
774161|NCT00352456|Healthy Volunteer|healthy volunteer
774162|NCT00352456|HV|hv
774163|NCT00352443|adult grade III lymphomatoid granulomatosis|adult grade iii lymphomatoid granulomatosis
774164|NCT00352443|recurrent adult grade III lymphomatoid granulomatosis|recurrent adult grade iii lymphomatoid granulomatosis
774165|NCT00352443|Waldenstrom macroglobulinemia|waldenstrom macroglobulinemia
774166|NCT00352443|recurrent adult Burkitt lymphoma|recurrent adult burkitt lymphoma
774167|NCT00352443|stage IV adult Burkitt lymphoma|stage iv adult burkitt lymphoma
774168|NCT00352443|recurrent adult diffuse large cell lymphoma|recurrent adult diffuse large cell lymphoma
774398|NCT00351832|Type 2 diabetes|type 2 diabetes
774169|NCT00352443|recurrent adult diffuse mixed cell lymphoma|recurrent adult diffuse mixed cell lymphoma
774170|NCT00352443|recurrent adult diffuse small cleaved cell lymphoma|recurrent adult diffuse small cleaved cell lymphoma
774171|NCT00352443|recurrent adult immunoblastic large cell lymphoma|recurrent adult immunoblastic large cell lymphoma
774172|NCT00352443|recurrent adult lymphoblastic lymphoma|recurrent adult lymphoblastic lymphoma
774173|NCT00352443|recurrent grade 1 follicular lymphoma|recurrent grade 1 follicular lymphoma
774174|NCT00352443|recurrent grade 2 follicular lymphoma|recurrent grade 2 follicular lymphoma
774175|NCT00352443|recurrent grade 3 follicular lymphoma|recurrent grade 3 follicular lymphoma
774176|NCT00352443|recurrent mantle cell lymphoma|recurrent mantle cell lymphoma
774177|NCT00352443|recurrent marginal zone lymphoma|recurrent marginal zone lymphoma
774178|NCT00352443|recurrent small lymphocytic lymphoma|recurrent small lymphocytic lymphoma
774179|NCT00352443|stage IV adult diffuse large cell lymphoma|stage iv adult diffuse large cell lymphoma
774180|NCT00352443|stage IV adult diffuse mixed cell lymphoma|stage iv adult diffuse mixed cell lymphoma
774181|NCT00352443|stage IV adult diffuse small cleaved cell lymphoma|stage iv adult diffuse small cleaved cell lymphoma
774182|NCT00352443|stage IV adult immunoblastic large cell lymphoma|stage iv adult immunoblastic large cell lymphoma
774183|NCT00352443|stage IV adult lymphoblastic lymphoma|stage iv adult lymphoblastic lymphoma
774184|NCT00352443|stage IV grade 1 follicular lymphoma|stage iv grade 1 follicular lymphoma
774185|NCT00352443|stage IV grade 2 follicular lymphoma|stage iv grade 2 follicular lymphoma
774186|NCT00352443|stage IV grade 3 follicular lymphoma|stage iv grade 3 follicular lymphoma
774187|NCT00352443|stage IV mantle cell lymphoma|stage iv mantle cell lymphoma
774188|NCT00352443|stage IV marginal zone lymphoma|stage iv marginal zone lymphoma
774189|NCT00352443|stage IV small lymphocytic lymphoma|stage iv small lymphocytic lymphoma
774190|NCT00352443|extranodal marginal zone B-cell lymphoma of mucosa-associated lymphoid tissue|extranodal marginal zone b-cell lymphoma of mucosa-associated lymphoid tissue
774191|NCT00352443|nodal marginal zone B-cell lymphoma|nodal marginal zone b-cell lymphoma
774192|NCT00352443|splenic marginal zone lymphoma|splenic marginal zone lymphoma
774193|NCT00352443|unspecified adult solid tumor, protocol specific|unspecified adult solid tumor, protocol specific
774194|NCT00352443|anaplastic large cell lymphoma|anaplastic large cell lymphoma
774195|NCT00352443|angioimmunoblastic T-cell lymphoma|angioimmunoblastic t-cell lymphoma
774196|NCT00352443|adult nasal type extranodal NK/T-cell lymphoma|adult nasal type extranodal nk/t-cell lymphoma
774197|NCT00352430|Nitric Oxide|nitric oxide
774198|NCT00352430|PDE Inhibitors|pde inhibitors
774199|NCT00352430|Pulmonary Hypertension|pulmonary hypertension
774200|NCT00352430|Sickle Cell|sickle cell
774201|NCT00352430|Thalassemia|thalassemia
774202|NCT00352430|Sickle Cell Anemia|sickle cell anemia
774203|NCT00352404|Endomicroscopy|endomicroscopy
774204|NCT00352404|Chromoendoscopy|chromoendoscopy
774205|NCT00352404|Chromoscopy|chromoscopy
774206|NCT00352404|Ulcerative Colitis|ulcerative colitis
774207|NCT00352404|Intraepithelial Neoplasia|intraepithelial neoplasia
774208|NCT00352391|Non-Small Cell Lung Cancer|non-small cell lung cancer
774209|NCT00352391|Head And Neck Cancer|head and neck cancer
774210|NCT00352391|Lung Cancer|lung cancer
774211|NCT00352391|Bronchoscopy|bronchoscopy
774212|NCT00352391|Laryngoscopy|laryngoscopy
774214|NCT00352391|Disease Free Survival|disease free survival
774215|NCT00352391|Current Smoker|current smoker
774216|NCT00352391|Former Smoker|former smoker
774217|NCT00352378|Primary|primary
774218|NCT00352352|Traditional Chinese Medicine (TCM)|traditional chinese medicine (tcm)
774219|NCT00352352|Alternative Medicine (AM)|alternative medicine (am)
774220|NCT00352352|Tongue Acupuncture (TAC)|tongue acupuncture (tac)
774221|NCT00352352|Autism Spectrum Disorder (ASD)|autism spectrum disorder (asd)
774222|NCT00352352|Autism|autism
774223|NCT00352352|Children|children
774224|NCT00352339|Schizophrenia|schizophrenia
774225|NCT00352339|Switching|switching
774226|NCT00352339|Early stage|early stage
774227|NCT00352339|Risperidone|risperidone
774228|NCT00352339|Aripirazole|aripirazole
774229|NCT00352313|adult anaplastic oligodendroglioma|adult anaplastic oligodendroglioma
774230|NCT00352313|adult gliosarcoma|adult gliosarcoma
774231|NCT00352313|adult mixed glioma|adult mixed glioma
774232|NCT00352313|adult anaplastic astrocytoma|adult anaplastic astrocytoma
774233|NCT00352313|recurrent adult brain tumor|recurrent adult brain tumor
774234|NCT00352313|adult glioblastoma|adult glioblastoma
774235|NCT00352313|adult giant cell glioblastoma|adult giant cell glioblastoma
774236|NCT00352287|Visceral fat|visceral fat
774237|NCT00352287|Impaired glucose tolerance|impaired glucose tolerance
774238|NCT00352287|Insulin resistance|insulin resistance
774239|NCT00352287|Growth hormone|growth hormone
774240|NCT00352287|Thiazolidinedione|thiazolidinedione
774241|NCT00352261|Barrett's Esophagus|barrett's esophagus
774242|NCT00352248|Alternative Medicine (AM)|alternative medicine (am)
774243|NCT00352248|Traditional Chinese Medicine|traditional chinese medicine
774244|NCT00352248|Tongue Acupuncture|tongue acupuncture
774245|NCT00352248|Autistic Spectrum Disorder|autistic spectrum disorder
774246|NCT00352248|Autism|autism
774247|NCT00352248|Children|children
774248|NCT00352235|Chronic hepatitis C|chronic hepatitis c
774249|NCT00352235|KRN7000|krn7000
774250|NCT00352235|a-GalCer|a-galcer
774251|NCT00352235|immunotherapy|immunotherapy
774252|NCT00352235|Natural Killer T cells|natural killer t cells
774253|NCT00352235|interferon|interferon
774254|NCT00352222|iliac arteries|iliac arteries
774255|NCT00352222|implantation|implantation
774256|NCT00352222|treatment of atherosclerotic disease|treatment of atherosclerotic disease
774257|NCT00352222|stenosed|stenosed
774258|NCT00352222|occlusive|occlusive
774259|NCT00352209|Cyclophosphamide|cyclophosphamide
774260|NCT00352209|Preparative Regimens|preparative regimens
774261|NCT00352209|Risk Factors|risk factors
774262|NCT00352209|Chart Review|chart review
774263|NCT00352209|Incidence|incidence
774264|NCT00352196|Asperger's Disorder|asperger's disorder
774265|NCT00352196|Risperidone|risperidone
774266|NCT00352196|Magnetic Resonance Spectroscopy|magnetic resonance spectroscopy
774267|NCT00352196|Social Skills|social skills
774268|NCT00352183|Hyperlipidemia Combined|hyperlipidemia combined
774269|NCT00352183|Combination of fenofibrate and simvastatin|combination of fenofibrate and simvastatin
774270|NCT00352170|calcium|calcium
774271|NCT00352170|vitamin D|vitamin d
774272|NCT00352170|secondary hyperparathyroidism|secondary hyperparathyroidism
774273|NCT00352170|osteoporotic fractures|osteoporotic fractures
774274|NCT00352157|Soy|soy
774275|NCT00352157|Dermatology|dermatology
774276|NCT00352157|Skin|skin
774277|NCT00352157|Hair|hair
774278|NCT00352157|Finger Nails|finger nails
774279|NCT00352157|Weight Loss|weight loss
774280|NCT00352157|Body Mass Index|body mass index
774281|NCT00352157|Photoaging of Skin|photoaging of skin
774282|NCT00352157|Skin Wrinkling|skin wrinkling
774283|NCT00352131|unspecified adult solid tumor, protocol specific|unspecified adult solid tumor, protocol specific
774284|NCT00352131|stage II pancreatic cancer|stage ii pancreatic cancer
774285|NCT00352131|stage III pancreatic cancer|stage iii pancreatic cancer
774286|NCT00352131|stage IV pancreatic cancer|stage iv pancreatic cancer
774287|NCT00352131|recurrent pancreatic cancer|recurrent pancreatic cancer
774288|NCT00352118|oral complications of radiation therapy|oral complications of radiation therapy
774289|NCT00352118|oral complications of chemotherapy|oral complications of chemotherapy
774290|NCT00352118|mucositis|mucositis
774291|NCT00352118|xerostomia|xerostomia
774375|NCT00351936|Schizophrenia|schizophrenia
774376|NCT00351936|Diabetes|diabetes
774292|NCT00352118|stage III squamous cell carcinoma of the hypopharynx|stage iii squamous cell carcinoma of the hypopharynx
774293|NCT00352118|stage IV squamous cell carcinoma of the hypopharynx|stage iv squamous cell carcinoma of the hypopharynx
774294|NCT00352118|stage III squamous cell carcinoma of the larynx|stage iii squamous cell carcinoma of the larynx
774295|NCT00352118|stage IV squamous cell carcinoma of the larynx|stage iv squamous cell carcinoma of the larynx
774296|NCT00352118|stage III squamous cell carcinoma of the lip and oral cavity|stage iii squamous cell carcinoma of the lip and oral cavity
774297|NCT00352118|stage IV squamous cell carcinoma of the lip and oral cavity|stage iv squamous cell carcinoma of the lip and oral cavity
774298|NCT00352118|stage III squamous cell carcinoma of the oropharynx|stage iii squamous cell carcinoma of the oropharynx
774299|NCT00352118|stage IV squamous cell carcinoma of the oropharynx|stage iv squamous cell carcinoma of the oropharynx
774300|NCT00352105|stage III squamous cell carcinoma of the hypopharynx|stage iii squamous cell carcinoma of the hypopharynx
774301|NCT00352105|stage IV squamous cell carcinoma of the hypopharynx|stage iv squamous cell carcinoma of the hypopharynx
774302|NCT00352105|stage III squamous cell carcinoma of the larynx|stage iii squamous cell carcinoma of the larynx
774303|NCT00352105|stage IV squamous cell carcinoma of the larynx|stage iv squamous cell carcinoma of the larynx
774304|NCT00352105|stage III squamous cell carcinoma of the lip and oral cavity|stage iii squamous cell carcinoma of the lip and oral cavity
774305|NCT00352105|stage IV squamous cell carcinoma of the lip and oral cavity|stage iv squamous cell carcinoma of the lip and oral cavity
774306|NCT00352105|stage III squamous cell carcinoma of the oropharynx|stage iii squamous cell carcinoma of the oropharynx
774307|NCT00352105|stage IV squamous cell carcinoma of the oropharynx|stage iv squamous cell carcinoma of the oropharynx
774308|NCT00352092|Kidney disease|kidney disease
774309|NCT00352092|Renal transplant|renal transplant
774310|NCT00352092|HLA Identical|hla identical
774311|NCT00352092|Living Donor|living donor
774312|NCT00352092|Corticosteroid free|corticosteroid free
774313|NCT00352092|Calcineurin sparing|calcineurin sparing
774314|NCT00352092|Adults|adults
774315|NCT00352079|transitional cell carcinoma of the bladder|transitional cell carcinoma of the bladder
774316|NCT00352079|stage 0 bladder cancer|stage 0 bladder cancer
774317|NCT00352079|stage I bladder cancer|stage i bladder cancer
774318|NCT00352079|recurrent bladder cancer|recurrent bladder cancer
774319|NCT00352066|Human Immunodeficiency Virus|human immunodeficiency virus
774320|NCT00352066|anti-retroviral therapy|anti-retroviral therapy
774321|NCT00352066|nucleoside analogue|nucleoside analogue
774322|NCT00352066|reverse transcriptase|reverse transcriptase
774323|NCT00352066|apricitabine|apricitabine
774324|NCT00352066|tipranavir|tipranavir
774325|NCT00352066|bioequivalence|bioequivalence
774326|NCT00352066|drug-drug interaction|drug-drug interaction
774327|NCT00352066|pharmacokinetics|pharmacokinetics
774328|NCT00352053|Phase 3|phase 3
774329|NCT00352053|Randomized, Double-Blind|randomized, double-blind
774330|NCT00352053|Control|control
774331|NCT00352053|Treatment-Experienced|treatment-experienced
774332|NCT00352053|OBR|obr
774333|NCT00352053|Optimized background regimen|optimized background regimen
774334|NCT00352053|Highly Active Antiretroviral Therapy|highly active antiretroviral therapy
774335|NCT00352053|HAART|haart
774336|NCT00352053|HIV|hiv
774337|NCT00352053|HIV-1|hiv-1
774338|NCT00352053|AIDS Virus|aids virus
774339|NCT00352053|Human Immunodeficiency Virus|human immunodeficiency virus
774340|NCT00352053|Acquired Immune Deficiency Syndrome Virus|acquired immune deficiency syndrome virus
774341|NCT00352053|Virus|virus
774342|NCT00352053|Human Immunodeficiency|human immunodeficiency
774343|NCT00352053|Pediatrics|pediatrics
774344|NCT00352027|Hodgkin's Disease|hodgkin's disease
774345|NCT00352014|Monitoring of antiplatelet therapy|monitoring of antiplatelet therapy
774346|NCT00352014|antiplatelet therapy|antiplatelet therapy
774347|NCT00352014|platelet function assays|platelet function assays
774348|NCT00352014|Aspirin|aspirin
774349|NCT00352014|Clopidogrel|clopidogrel
774350|NCT00352014|elective PCI|elective pci
774351|NCT00352001|refractory anemia with excess blasts|refractory anemia with excess blasts
774352|NCT00352001|previously treated myelodysplastic syndromes|previously treated myelodysplastic syndromes
774353|NCT00352001|chronic myelomonocytic leukemia|chronic myelomonocytic leukemia
774354|NCT00352001|de novo myelodysplastic syndromes|de novo myelodysplastic syndromes
774355|NCT00352001|secondary myelodysplastic syndromes|secondary myelodysplastic syndromes
774356|NCT00351988|Lung Cancer|lung cancer
774357|NCT00351988|Non-Small Cell Lung Cancer|non-small cell lung cancer
774358|NCT00351988|Breast Cancer|breast cancer
774359|NCT00351988|Psychosocial|psychosocial
774360|NCT00351988|Behavioral|behavioral
774361|NCT00351988|Caregiver|caregiver
774362|NCT00351988|Interview|interview
774363|NCT00351988|Questionnaire|questionnaire
774364|NCT00351988|Minority Caregiver|minority caregiver
774365|NCT00351988|Non-Minority Caregiver|non-minority caregiver
774366|NCT00351988|Survey|survey
774367|NCT00351962|lung neoplasms|lung neoplasms
774368|NCT00351962|metastatic lung cancer|metastatic lung cancer
774369|NCT00351962|stereotactic radiation|stereotactic radiation
774370|NCT00351949|Advanced or metastatic renal cell carcinoma|advanced or metastatic renal cell carcinoma
774371|NCT00351949|IMP321|imp321
774372|NCT00351949|Monotherapy|monotherapy
774373|NCT00351949|LAG-3|lag-3
774374|NCT00351949|CD223|cd223
774379|NCT00351936|Insulin Resistance|insulin resistance
774380|NCT00351910|Major Depressive Disorder|major depressive disorder
774381|NCT00351910|MDD|mdd
774382|NCT00351884|Type 2 diabetes|type 2 diabetes
774383|NCT00351884|vildagliptin|vildagliptin
774384|NCT00351884|Hemoglobin A1c|hemoglobin a1c
774385|NCT00351871|HCV|hcv
774386|NCT00351858|Breast Cancer|breast cancer
774387|NCT00351858|investigational drug|investigational drug
774388|NCT00351858|drug therapy|drug therapy
774389|NCT00351858|Antineoplastic Protocols|antineoplastic protocols
774390|NCT00351858|Immunotherapy|immunotherapy
774391|NCT00351858|Metastatic breast cancer|metastatic breast cancer
774392|NCT00351858|Advanced breast cancer|advanced breast cancer
774393|NCT00351858|Stage III to IV breast cancer|stage iii to iv breast cancer
774394|NCT00351858|Hormonal therapy refractory|hormonal therapy refractory
774395|NCT00351858|Failure of hormonal therapy|failure of hormonal therapy
774396|NCT00351858|Her-2/neu expressing breast cancer|her-2/neu expressing breast cancer
774397|NCT00351858|low to moderate Her-2/neu expression|low to moderate her-2/neu expression
774399|NCT00351832|Vildagliptin|vildagliptin
774400|NCT00351832|Hemoglobin A1c|hemoglobin a1c
774401|NCT00351819|Testosterone|testosterone
774402|NCT00351819|Pain|pain
774403|NCT00351819|Opioid|opioid
774404|NCT00351819|Hypogonadism|hypogonadism
774405|NCT00351806|acute intracerebral infarction|acute intracerebral infarction
774406|NCT00351780|fractional flow reserve|fractional flow reserve
774407|NCT00351780|bifurcation|bifurcation
774408|NCT00351780|stent|stent
774409|NCT00351767|Diabetes|diabetes
774410|NCT00351767|Dabetic Feet|dabetic feet
774411|NCT00351741|Burns|burns
774412|NCT00351715|Sublingual Methadone|sublingual methadone
774413|NCT00351715|Cancer related breakthrough pain|cancer related breakthrough pain
774414|NCT00351715|feasibility study|feasibility study
774415|NCT00351715|Phase II/open label|phase ii/open label
774416|NCT00351715|Outpatients|outpatients
774417|NCT00351715|Safety/ efficacy|safety/ efficacy
774418|NCT00351715|previously receiving opioids|previously receiving opioids
774419|NCT00351715|speak English|speak english
774420|NCT00351702|Preventive therapy|preventive therapy
774421|NCT00351689|Probiotic bacteria|probiotic bacteria
774422|NCT00351689|cutaneous immune homeostasis|cutaneous immune homeostasis
774423|NCT00351689|UV radiation|uv radiation
774424|NCT00351689|dietary supplement|dietary supplement
774425|NCT00351676|Drug Therapy|drug therapy
774426|NCT00351676|Hospitals, Teaching|hospitals, teaching
774427|NCT00351676|Hospitals, Community|hospitals, community
774428|NCT00351676|Interprofessional relations|interprofessional relations
774429|NCT00351676|Patient Care Team|patient care team
774430|NCT00351676|Pharmacists|pharmacists
774431|NCT00351676|Pharmacy Service, Hospital|pharmacy service, hospital
774432|NCT00351676|Comparative Study|comparative study
774433|NCT00351676|Hospitalization|hospitalization
774434|NCT00351663|Venous Thrombosis|venous thrombosis
774435|NCT00351663|Critical Illness|critical illness
774436|NCT00351663|Blood Coagulation|blood coagulation
774437|NCT00351663|Factor Xa|factor xa
774438|NCT00351650|Imaging|imaging
774439|NCT00351650|Type 1 Diabetes Mellitus (T1DM)|type 1 diabetes mellitus (t1dm)
774440|NCT00351650|Islet|islet
774441|NCT00351650|B Cell Mass|b cell mass
774442|NCT00351650|Pet Scan|pet scan
774443|NCT00351650|Type 1 Diabetes|type 1 diabetes
774444|NCT00351650|T1DM|t1dm
774445|NCT00351650|Pancreas|pancreas
774446|NCT00351650|Healthy Volunteer|healthy volunteer
774447|NCT00351650|HV|hv
774448|NCT00351637|Sublingual methadone|sublingual methadone
774449|NCT00351637|iatrogenic|iatrogenic
774450|NCT00351637|treatment related incident breakthrough pain|treatment related incident breakthrough pain
774451|NCT00351637|feasibility study|feasibility study
774452|NCT00351637|Phase II/open-label|phase ii/open-label
774453|NCT00351637|inpatients|inpatients
774454|NCT00351637|Safety/efficacy|safety/efficacy
774455|NCT00351637|Cancer related breakthrough pain|cancer related breakthrough pain
774456|NCT00351637|previously receiving opioids|previously receiving opioids
774457|NCT00351637|speak English|speak english
774458|NCT00351624|DHA supplementation|dha supplementation
774459|NCT00351624|Cognitive function|cognitive function
774460|NCT00351624|Preschool children|preschool children
774461|NCT00351624|Attention and behavior|attention and behavior
774462|NCT00351624|Healthy Children|healthy children
774463|NCT00351611|epilepsy partial seizure treatment with pregabalin or placebo|epilepsy partial seizure treatment with pregabalin or placebo
774464|NCT00351611|vision testing|vision testing
774465|NCT00351598|Tumour Volume|tumour volume
774466|NCT00351598|Prognostic value|prognostic value
774467|NCT00351585|Vildagliptin|vildagliptin
774468|NCT00351585|Type 2 diabetes|type 2 diabetes
774469|NCT00351585|Insulin secretion|insulin secretion
774470|NCT00351585|Beta cell|beta cell
774471|NCT00351572|colon cancer|colon cancer
774472|NCT00351559|allograft|allograft
774473|NCT00351559|rejection|rejection
774474|NCT00351559|biopsy|biopsy
774475|NCT00351559|gene|gene
774476|NCT00351559|expression|expression
774477|NCT00351559|cardiac|cardiac
774478|NCT00351559|heart|heart
774480|NCT00351546|Vildagliptin|vildagliptin
774481|NCT00351546|Type 2 diabetes|type 2 diabetes
774482|NCT00351546|Insulin sensitivity|insulin sensitivity
774483|NCT00351546|Insulin action|insulin action
774484|NCT00351533|Respiratory distress syndrome, adult|respiratory distress syndrome, adult
774485|NCT00351533|Acute lung injury|acute lung injury
774486|NCT00351533|Acute respiratory distress syndrome|acute respiratory distress syndrome
774487|NCT00351533|ARDS, human|ards, human
774488|NCT00351533|Fish oils|fish oils
774489|NCT00351533|Fatty Acids, Omega-3|fatty acids, omega-3
774490|NCT00351533|Docosahexaenoic Acids|docosahexaenoic acids
774491|NCT00351533|Eicosapentaenoic Acid|eicosapentaenoic acid
774492|NCT00351520|Anthoponotic Cutaneous leishmaniasis|anthoponotic cutaneous leishmaniasis
774493|NCT00351520|Glucantime|glucantime
774494|NCT00351520|Miltefosine|miltefosine
774495|NCT00351507|Vildagliptin|vildagliptin
774496|NCT00351507|Type 2 diabetes|type 2 diabetes
774497|NCT00351494|embolization|embolization
774498|NCT00351494|contrast enhanced ultrasound|contrast enhanced ultrasound
774499|NCT00351494|myoma|myoma
774500|NCT00351494|uterine artery|uterine artery
774501|NCT00351494|microvascularisation|microvascularisation
774502|NCT00351481|IVF|ivf
774503|NCT00351481|endometrial receptivity|endometrial receptivity
774504|NCT00351481|embryo implantation|embryo implantation
774505|NCT00351481|recurrent implantation failure|recurrent implantation failure
774506|NCT00351468|eltrombopag olamine|eltrombopag olamine
774507|NCT00351468|SB-497115-GR|sb-497115-gr
774508|NCT00351468|idiopathic thrombocytopenic purpura|idiopathic thrombocytopenic purpura
774509|NCT00351468|thrombocytopenia|thrombocytopenia
774510|NCT00351468|ITP|itp
774511|NCT00351468|platelets|platelets
774512|NCT00351455|hernia|hernia
774513|NCT00351455|incisional hernia|incisional hernia
774514|NCT00351455|ventral hernia|ventral hernia
774515|NCT00351455|umbilical hernia|umbilical hernia
774516|NCT00351442|Host Resistance|host resistance
774517|NCT00351429|Glaucoma|glaucoma
774518|NCT00351429|Trabeculectomy|trabeculectomy
774519|NCT00351429|Sutures|sutures
774520|NCT00351416|GnRH deficiency|gnrh deficiency
774521|NCT00351416|GnRH antagonist|gnrh antagonist
774522|NCT00351416|Letrozole|letrozole
774523|NCT00351416|GnRH|gnrh
774524|NCT00351416|FSH|fsh
774525|NCT00351416|LH|lh
774526|NCT00351416|Inhibins|inhibins
774527|NCT00351403|Chronic HCV infection|chronic hcv infection
774528|NCT00351403|Genotype 1|genotype 1
774529|NCT00351403|Individually adapted therapy|individually adapted therapy
774530|NCT00351403|Peginterferon alfa-2b|peginterferon alfa-2b
774531|NCT00351403|Ribavirin|ribavirin
774532|NCT00351403|Sustained viral response (SVR)|sustained viral response (svr)
774533|NCT00351390|congestive heart failure treatment|congestive heart failure treatment
774534|NCT00351390|congestive heart failure, prognosis|congestive heart failure, prognosis
774535|NCT00351390|NT-proBNP testing|nt-probnp testing
774536|NCT00351377|Autoimmune disease, mycophenolate, GI problems|autoimmune disease, mycophenolate, gi problems
774537|NCT00351364|atherosclerosis|atherosclerosis
774538|NCT00351364|inflammation|inflammation
774539|NCT00351364|leukotriene blockade|leukotriene blockade
774540|NCT00351364|endothelial function|endothelial function
774541|NCT00351351|Kidney Stones|kidney stones
774542|NCT00351351|Renal Calculi|renal calculi
774543|NCT00351312|Pressure ulcers|pressure ulcers
774544|NCT00351312|socks|socks
774545|NCT00351312|foot pressure|foot pressure
774546|NCT00351299|Delirium|delirium
774547|NCT00351299|Agitation|agitation
774548|NCT00351299|Sedation|sedation
774549|NCT00351299|Dexmedetomidine|dexmedetomidine
774550|NCT00351299|Surgical|surgical
774551|NCT00351286|peripheral arterial disease|peripheral arterial disease
774552|NCT00351286|peripheral vascular disease|peripheral vascular disease
774553|NCT00351286|claudication|claudication
774554|NCT00351273|Chlamydia|chlamydia
774555|NCT00351260|Bifurcation|bifurcation
774556|NCT00351260|Coronary|coronary
774557|NCT00351260|Stenosis|stenosis
774558|NCT00351260|Stent|stent
774559|NCT00351260|drug elution|drug elution
774560|NCT00351247|Myocardial Infarction|myocardial infarction
774561|NCT00351247|Primary PCI|primary pci
774562|NCT00351247|Postconditioning|postconditioning
774563|NCT00351247|MRI|mri
774564|NCT00351234|Diabetes Mellitus Type I,|diabetes mellitus type i,
774565|NCT00351234|Hypoglycemia,|hypoglycemia,
774566|NCT00351234|Carnitine|carnitine
774567|NCT00351208|Spinal cord stimulation|spinal cord stimulation
774568|NCT00351208|Spinal cord stimulation efficacy|spinal cord stimulation efficacy
774569|NCT00351208|Spinal cord stimulators|spinal cord stimulators
774570|NCT00351208|Stimulation frequencies|stimulation frequencies
774571|NCT00351208|Stimulation pulse-widths|stimulation pulse-widths
774572|NCT00351208|Varying settings|varying settings
774573|NCT00351195|Hepatocellular carcinoma|hepatocellular carcinoma
774574|NCT00351195|Etoposide|etoposide
774575|NCT00351195|Oxaliplatin|oxaliplatin
774576|NCT00351195|Capecitabine|capecitabine
774577|NCT00351182|Scrub typhus|scrub typhus
774578|NCT00351182|Telithromycin|telithromycin
774579|NCT00351182|Doxycycline|doxycycline
774874|NCT00349869|arthritis|arthritis
774580|NCT00351169|Major Depressive Disorder|major depressive disorder
774581|NCT00351169|MDD|mdd
774582|NCT00351156|Gaucher Disease|gaucher disease
774583|NCT00351156|Gaucher Disease, Type 1|gaucher disease, type 1
774584|NCT00351156|Gaucher Disease, Type 2|gaucher disease, type 2
774585|NCT00351156|Gaucher Disease, Type 3|gaucher disease, type 3
774586|NCT00351156|Neuronopathic Gaucher Disease|neuronopathic gaucher disease
774587|NCT00351156|Non-Neuronopathic Gaucher Disease|non-neuronopathic gaucher disease
774588|NCT00351156|Lysosomal Storage Disease|lysosomal storage disease
774589|NCT00351156|Metabolism, Inborn Errors|metabolism, inborn errors
774590|NCT00351156|Metabolic Diseases|metabolic diseases
774591|NCT00351156|Sphingolipidoses|sphingolipidoses
774592|NCT00351156|Genetic Diseases, Inborn|genetic diseases, inborn
774593|NCT00351143|QoL|qol
774594|NCT00351143|Asthma|asthma
774595|NCT00351143|asthma compliance enhancement|asthma compliance enhancement
774596|NCT00351143|Salmeterol/fluticasone|salmeterol/fluticasone
774597|NCT00351143|Total control|total control
774598|NCT00351143|SERETIDE|seretide
774599|NCT00351143|FEV1|fev1
774600|NCT00351130|Hypertension,|hypertension,
774601|NCT00351130|stage 1 hypertension,|stage 1 hypertension,
774602|NCT00351130|stage 2 hypertension,|stage 2 hypertension,
774603|NCT00351130|valsartan,|valsartan,
774604|NCT00351130|amlodipine,|amlodipine,
774605|NCT00351117|St. John's Wort|st. john's wort
774606|NCT00351117|Selective Serotonin Receptor Inhibitor|selective serotonin receptor inhibitor
774607|NCT00351117|Microvasculature|microvasculature
774608|NCT00351117|Natural Health Products|natural health products
774609|NCT00351104|Sprain|sprain
774610|NCT00351104|Strain|strain
774611|NCT00351104|Pain|pain
774612|NCT00351104|Ankle Pain|ankle pain
774613|NCT00351104|Muscle, Bone and Cartilage Disorders|muscle, bone and cartilage disorders
774614|NCT00351078|Cystic fibrosis|cystic fibrosis
774615|NCT00351078|Nonsense mutation|nonsense mutation
774616|NCT00351078|Premature stop codon|premature stop codon
774617|NCT00351078|CF|cf
774618|NCT00351078|PTC124|ptc124
774619|NCT00351065|erectile dysfunction, PDE-5 inhibitor|erectile dysfunction, pde-5 inhibitor
774620|NCT00351052|Pimecrolimus, Atopic Dermatitis, Eczema, Pediatric|pimecrolimus, atopic dermatitis, eczema, pediatric
774621|NCT00351026|opioid dependence|opioid dependence
774622|NCT00351026|methadone|methadone
774623|NCT00351026|HIV|hiv
774624|NCT00351013|malaria|malaria
774625|NCT00351013|Plasmodium falciparum|plasmodium falciparum
774626|NCT00351013|Tropica Nosode|tropica nosode
774627|NCT00351013|Homeopathy|homeopathy
774628|NCT00351000|Schizophrenia|schizophrenia
774629|NCT00351000|Ziprasidone|ziprasidone
774630|NCT00351000|Diabetes|diabetes
774631|NCT00351000|Insulin Resistance|insulin resistance
774632|NCT00350987|Procalcitonin, guidelines, LRTI, non-inferiority|procalcitonin, guidelines, lrti, non-inferiority
774633|NCT00350987|COLD|cold
774634|NCT00350961|Cholangiocarcinoma|cholangiocarcinoma
774635|NCT00350961|Fixed dose rate|fixed dose rate
774636|NCT00350961|Gemcitabine|gemcitabine
774637|NCT00350961|Oxaliplatin|oxaliplatin
774638|NCT00350961|Capecitabine|capecitabine
774639|NCT00350948|Ovary|ovary
774640|NCT00350935|fMRI|fmri
774641|NCT00350935|Visual perception|visual perception
774642|NCT00350935|Attention|attention
774643|NCT00350909|drug abuse|drug abuse
774644|NCT00350896|trapezotrapezoidial|trapezotrapezoidial
774645|NCT00350896|scaphotrapezial|scaphotrapezial
774646|NCT00350896|thumb|thumb
774647|NCT00350896|pain|pain
774648|NCT00350896|orthoses|orthoses
774649|NCT00350896|Osteoarthritis in the BTOA concerns the trapezometacarpal joint|osteoarthritis in the btoa concerns the trapezometacarpal joint
774650|NCT00350883|Cognitive Therapy|cognitive therapy
774651|NCT00350883|Negative Symptoms|negative symptoms
774652|NCT00350883|Functional Outcomes|functional outcomes
774653|NCT00350883|Schizophrenia|schizophrenia
774654|NCT00350883|Schizoaffective Disorder|schizoaffective disorder
774655|NCT00350870|disulfiram|disulfiram
774656|NCT00350870|cognitive behavioral therapy|cognitive behavioral therapy
774657|NCT00350870|contingency management|contingency management
774658|NCT00350870|drug abuse therapy|drug abuse therapy
774659|NCT00350870|educational/resource design/development|educational/resource design/development
774660|NCT00350844|Sickle Cell Disease|sickle cell disease
774661|NCT00350844|Pulmonary Hypertension|pulmonary hypertension
774662|NCT00350831|Solid tumor|solid tumor
774663|NCT00350818|Acute Myelogenous Leukemia|acute myelogenous leukemia
774664|NCT00350818|Myelodysplastic Syndrome|myelodysplastic syndrome
774665|NCT00350818|Allogeneic Transplantation|allogeneic transplantation
774666|NCT00350818|Leukemia|leukemia
774667|NCT00350818|Azacitidine|azacitidine
774668|NCT00350818|Vidaza|vidaza
774669|NCT00350805|Schizophrenia|schizophrenia
774670|NCT00350805|Time perception|time perception
774671|NCT00350805|Cortical synchronization|cortical synchronization
774672|NCT00350805|Electroencephalography|electroencephalography
774673|NCT00350779|Type 2 Diabetes Mellitus|type 2 diabetes mellitus
774674|NCT00350766|Myocardial Infarction|myocardial infarction
774675|NCT00350766|Myocardial Ischemia|myocardial ischemia
774676|NCT00350766|Ventricular Remodeling|ventricular remodeling
774875|NCT00349869|yoga|yoga
774677|NCT00350766|Bone Marrow Cell Transplantation|bone marrow cell transplantation
774678|NCT00350766|Stem cells|stem cells
774679|NCT00350753|Cholangiocarcinoma|cholangiocarcinoma
774680|NCT00350727|relapsed|relapsed
774681|NCT00350727|lapatinib|lapatinib
774682|NCT00350727|Pazopanib|pazopanib
774683|NCT00350727|glioblastoma|glioblastoma
774684|NCT00350714|HCV (Hepatitis C Virus)|hcv (hepatitis c virus)
774685|NCT00350714|MBT (Methacetin Breath Test)|mbt (methacetin breath test)
774686|NCT00350714|Hepatitis C Virus Patients|hepatitis c virus patients
774687|NCT00350701|DM type 2|dm type 2
774688|NCT00350701|Hypogonadism|hypogonadism
774689|NCT00350701|Testosterone|testosterone
774690|NCT00350701|AndroGel|androgel
774691|NCT00350688|Bladder,|bladder,
774692|NCT00350688|Cancer,|cancer,
774693|NCT00350688|Chemoradiation,|chemoradiation,
774694|NCT00350688|IMRT,|imrt,
774695|NCT00350688|tomotherapy|tomotherapy
774696|NCT00350662|Deferiprone|deferiprone
774698|NCT00350662|Desferrioxamine|desferrioxamine
774699|NCT00350662|Hemochromatosis|hemochromatosis
774700|NCT00350662|Iron overload|iron overload
774701|NCT00350662|Thalassemia|thalassemia
774702|NCT00350649|behavior modification|behavior modification
774703|NCT00350649|cognitive behavioral therapy|cognitive behavioral therapy
774704|NCT00350649|combination therapy|combination therapy
774705|NCT00350649|drug abuse therapy|drug abuse therapy
774706|NCT00350649|drug addition|drug addition
774707|NCT00350649|human therapy evaluation|human therapy evaluation
774708|NCT00350649|psychotherapy|psychotherapy
774709|NCT00350649|clinical trial phase II|clinical trial phase ii
774710|NCT00350649|coping|coping
774711|NCT00350649|drug and alcohol abstinence|drug and alcohol abstinence
774712|NCT00350649|longitudinal human study|longitudinal human study
774713|NCT00350649|outcomes research|outcomes research
774714|NCT00350649|outpatient care|outpatient care
774715|NCT00350649|psychological reinforcement|psychological reinforcement
774716|NCT00350649|therapy compliance|therapy compliance
774717|NCT00350649|behavior and social research tag|behavior and social research tag
774718|NCT00350649|human subjects|human subjects
774719|NCT00350649|neuropsychological test|neuropsychological test
774720|NCT00350649|patient oriented research|patient oriented research
774721|NCT00350636|OAB, anticholineric, oxybutynin, urge urinary incontinence|oab, anticholineric, oxybutynin, urge urinary incontinence
774722|NCT00350623|AIDS|aids
774723|NCT00350610|cognitive behavior therapy|cognitive behavior therapy
774724|NCT00350610|computer assisted instruction|computer assisted instruction
774725|NCT00350610|drug abuse therapy|drug abuse therapy
774726|NCT00350610|educational resource design and development|educational resource design and development
774727|NCT00350597|Malignant Melanoma|malignant melanoma
774728|NCT00350597|Adjuvant Therapy|adjuvant therapy
774729|NCT00350597|Cytokine Therapy|cytokine therapy
774730|NCT00350597|Immunologic Testing|immunologic testing
774731|NCT00350584|Mindfulness|mindfulness
774732|NCT00350584|Psychoeducation|psychoeducation
774733|NCT00350584|Telehealth Intervention|telehealth intervention
774734|NCT00350571|behavior therapy|behavior therapy
774735|NCT00350571|counseling|counseling
774736|NCT00350571|drug abuse therapy|drug abuse therapy
774737|NCT00350571|outpatient care|outpatient care
774738|NCT00350571|therapy compliance|therapy compliance
774739|NCT00350571|clinical trial phase I|clinical trial phase i
774740|NCT00350571|coping|coping
774741|NCT00350571|outcomes research|outcomes research
774742|NCT00350571|satisfaction|satisfaction
774743|NCT00350571|social psychology|social psychology
774744|NCT00350571|patient oriented research|patient oriented research
774745|NCT00350532|pain, chronic pain|pain, chronic pain
774746|NCT00350532|acetylcholine|acetylcholine
774747|NCT00350532|clonidine|clonidine
774748|NCT00350532|a2-adrenergic agonists|a2-adrenergic agonists
774749|NCT00350532|alpha2-adrenergic agonists|alpha2-adrenergic agonists
774750|NCT00350519|Hemostasis, Surgical|hemostasis, surgical
774751|NCT00350519|Epoetin alfa|epoetin alfa
774752|NCT00350519|Surgery|surgery
774753|NCT00350519|Abdomen|abdomen
774754|NCT00350519|Pelvis|pelvis
774755|NCT00350519|PROCRIT|procrit
774756|NCT00350519|pRBC|prbc
774757|NCT00350519|Blood transfusion|blood transfusion
774758|NCT00350519|Packed red blood cell transfusion|packed red blood cell transfusion
774759|NCT00350480|acute uterine bleeding|acute uterine bleeding
774760|NCT00350467|Schizophrenia|schizophrenia
774761|NCT00350467|DSM-IV|dsm-iv
774762|NCT00350467|PANSS|panss
774763|NCT00350467|informed consent|informed consent
774764|NCT00350441|Sildenafil Citrate|sildenafil citrate
774765|NCT00350441|Cardiopulmonary bypass|cardiopulmonary bypass
774766|NCT00350441|Open heart surgery|open heart surgery
774767|NCT00350428|Acute primary angle closure|acute primary angle closure
774768|NCT00350428|Laser preipheral iridotomy|laser preipheral iridotomy
774769|NCT00350428|Phacoemulsification|phacoemulsification
774770|NCT00350415|ulcerative colitis, inflammatory bowel disease|ulcerative colitis, inflammatory bowel disease
774771|NCT00350402|Parkinson's disease|parkinson's disease
774772|NCT00350402|PD|pd
774773|NCT00350402|masked faces|masked faces
774774|NCT00350402|diminished facial expressivity|diminished facial expressivity
774775|NCT00350402|diminished facial expression|diminished facial expression
774776|NCT00350402|high intensity respiratory muscle strength training|high intensity respiratory muscle strength training
774777|NCT00350402|MST|mst
774778|NCT00350389|Falls, Older persons|falls, older persons
774779|NCT00350376|asthma|asthma
774780|NCT00350376|allergies|allergies
774781|NCT00350376|Xolair|xolair
774782|NCT00350376|Advair|advair
774783|NCT00350350|XEROSTOMIA|xerostomia
774784|NCT00350350|MOUTH DRYNESS|mouth dryness
774785|NCT00350350|ELDERLY|elderly
774786|NCT00350350|ORAL LUBRICANT|oral lubricant
774787|NCT00350298|Monoclonal antibody,|monoclonal antibody,
774788|NCT00350298|Clostridium difficile Associated Diarrhea|clostridium difficile associated diarrhea
774789|NCT00350285|cannabis|cannabis
774790|NCT00350285|marijuana|marijuana
774791|NCT00350272|HIV-1 treatment naive|hiv-1 treatment naive
774792|NCT00350233|Bone Tumors|bone tumors
774793|NCT00350233|Bone Cancer|bone cancer
774794|NCT00350233|Prostate Cancer|prostate cancer
774795|NCT00350233|lung cancer|lung cancer
774796|NCT00350220|Single ventricle|single ventricle
774797|NCT00350220|Bidirectional Glenn|bidirectional glenn
774798|NCT00350220|Fontan|fontan
774799|NCT00350220|Congenital cardiac disease|congenital cardiac disease
774800|NCT00350220|Red blood cell transfusion|red blood cell transfusion
774801|NCT00350220|oxygen utilization|oxygen utilization
774802|NCT00350220|lactate level|lactate level
774803|NCT00350220|hemoglobin level|hemoglobin level
774804|NCT00350194|Fatty Acids, Omega-3|fatty acids, omega-3
774805|NCT00350168|Blood pressure|blood pressure
774806|NCT00350168|Venous pressure|venous pressure
774807|NCT00350168|Systolic pressure|systolic pressure
774808|NCT00350168|Diastolic pressure|diastolic pressure
774809|NCT00350168|Pulse pressure|pulse pressure
774810|NCT00350155|Video capsule endoscopy, healthy volunteers, naproxen, omeprazole, lumiracoxib, small bowel|video capsule endoscopy, healthy volunteers, naproxen, omeprazole, lumiracoxib, small bowel
774811|NCT00350142|Stereotactic Body Radiotherapy (SBRT)|stereotactic body radiotherapy (sbrt)
774812|NCT00350142|pancreas cancer|pancreas cancer
774813|NCT00350142|locally advanced|locally advanced
774814|NCT00350142|local control|local control
774815|NCT00350142|Gemcitabine|gemcitabine
774816|NCT00350129|glucose|glucose
774817|NCT00350129|vasospasm|vasospasm
774818|NCT00350129|RVA|rva
774819|NCT00350129|LDF|ldf
774820|NCT00350129|vasospastic subjects|vasospastic subjects
774821|NCT00350129|non-vasospastic subjects|non-vasospastic subjects
774822|NCT00350116|plaque psoriasis|plaque psoriasis
774823|NCT00350116|Vitamin B12|vitamin b12
774824|NCT00350090|Anemia|anemia
774825|NCT00350090|Neoplasms|neoplasms
774826|NCT00350090|Hemoglobin values|hemoglobin values
774827|NCT00350077|Burns|burns
774828|NCT00350064|Metabolic Syndrome|metabolic syndrome
774829|NCT00350064|Obesity|obesity
774830|NCT00350064|Exercise|exercise
774831|NCT00350064|Diabetes|diabetes
774832|NCT00350064|Physical Activity|physical activity
774833|NCT00350051|Prostate cancer|prostate cancer
774834|NCT00350051|Metastatic androgen-independent prostate cancer|metastatic androgen-independent prostate cancer
774835|NCT00350025|urothelial|urothelial
774836|NCT00350025|urologic|urologic
774837|NCT00350025|neoplasm|neoplasm
774838|NCT00350025|advanced|advanced
774839|NCT00350025|metastatic|metastatic
774840|NCT00350012|stroke|stroke
774841|NCT00350012|visual|visual
774842|NCT00350012|spatial neglect|spatial neglect
774843|NCT00349999|Vibrio cholerae, Cholera, Bangladesh, esophagogastroduodenoscopy, sub-study|vibrio cholerae, cholera, bangladesh, esophagogastroduodenoscopy, sub-study
774844|NCT00349973|Schizophrenia|schizophrenia
774845|NCT00349973|Positive symptoms|positive symptoms
774846|NCT00349973|Negative symptoms|negative symptoms
774847|NCT00349973|Cognitive deficits|cognitive deficits
774848|NCT00349960|Erythropoiesis stimulating agent|erythropoiesis stimulating agent
774849|NCT00349960|Dosing frequency|dosing frequency
774850|NCT00349960|Hemodialysis|hemodialysis
774851|NCT00349960|Therapeutic equivalence|therapeutic equivalence
774852|NCT00349934|Metastatic breast cancer|metastatic breast cancer
774853|NCT00349934|IMP321|imp321
774854|NCT00349934|hLAG-3Ig|hlag-3ig
774855|NCT00349934|LAG-3|lag-3
774856|NCT00349934|CD223|cd223
774857|NCT00349934|Chemotherapy|chemotherapy
774858|NCT00349934|Paclitaxel|paclitaxel
774859|NCT00349934|Combination therapy|combination therapy
774860|NCT00349921|pain|pain
774861|NCT00349921|chronic pain|chronic pain
774862|NCT00349921|clonidine|clonidine
774863|NCT00349921|adenosine|adenosine
774864|NCT00349921|complex regional pain syndrome|complex regional pain syndrome
774865|NCT00349921|CRPS|crps
774866|NCT00349921|a2-adrenergic agonists|a2-adrenergic agonists
774867|NCT00349921|alpha2-adrenergic agonists|alpha2-adrenergic agonists
774868|NCT00349908|Atherosclerosis,Wide Neck Aneurysm|atherosclerosis,wide neck aneurysm
774869|NCT00349895|Percutaneous Transluminal Coronary Angioplasty|percutaneous transluminal coronary angioplasty
774870|NCT00349895|Stent implantation|stent implantation
774871|NCT00349869|inflammatory arthritis|inflammatory arthritis
774872|NCT00349869|rheumatoid arthritis|rheumatoid arthritis
774873|NCT00349869|knee osteoarthritis|knee osteoarthritis
774877|NCT00349804|Temperature Homeostasis|temperature homeostasis
774878|NCT00349791|Natural Menopause|natural menopause
774879|NCT00349765|cardiovascular disease|cardiovascular disease
774880|NCT00349765|saturated fat|saturated fat
774881|NCT00349765|trans fat|trans fat
774882|NCT00349765|polyunsaturated fat|polyunsaturated fat
774883|NCT00349765|diet|diet
774884|NCT00349765|intramyocellular lipid|intramyocellular lipid
774885|NCT00349752|certolizumab pegol|certolizumab pegol
774886|NCT00349752|Cimzia|cimzia
774887|NCT00349752|Crohn's Disease|crohn's disease
774888|NCT00349752|Inflammatory Bowel Disease|inflammatory bowel disease
775158|NCT00348608|Coronary|coronary
774889|NCT00349739|age related macular degeneration|age related macular degeneration
774890|NCT00349726|NICHD Neonatal Research Network|nichd neonatal research network
774891|NCT00349726|Pharmacokinetics|pharmacokinetics
774892|NCT00349726|Inositol|inositol
774893|NCT00349726|Very Low Birth Weight (VLBW)|very low birth weight (vlbw)
774894|NCT00349726|Extremely Low Birth Weight (ELBW)|extremely low birth weight (elbw)
774895|NCT00349726|Prematurity|prematurity
774896|NCT00349713|Plasmodium falciparum Malaria, Mali, adjuvant|plasmodium falciparum malaria, mali, adjuvant
774897|NCT00349700|healing|healing
774898|NCT00349700|skin|skin
774899|NCT00349700|infection|infection
774900|NCT00349700|wound therapy|wound therapy
774901|NCT00349674|Wegener's granulomatosis,|wegener's granulomatosis,
774902|NCT00349674|microscopic polyangiitis,|microscopic polyangiitis,
774903|NCT00349674|ANCA-associated vasculitis,|anca-associated vasculitis,
774904|NCT00349674|methotrexate,|methotrexate,
774905|NCT00349674|azathioprine|azathioprine
774906|NCT00349661|clopidogrel|clopidogrel
774907|NCT00349661|omeprazole|omeprazole
774908|NCT00349648|subacromial|subacromial
774909|NCT00349648|impingement|impingement
774910|NCT00349648|acromioplasty|acromioplasty
774911|NCT00349648|physiotherapy|physiotherapy
774912|NCT00349635|Weight loss and diet.|weight loss and diet.
774913|NCT00349622|amyotrophic lateral sclerosis|amyotrophic lateral sclerosis
774914|NCT00349622|ALS|als
774915|NCT00349622|ceftriaxone|ceftriaxone
774916|NCT00349622|cephalosporin antibiotic|cephalosporin antibiotic
774917|NCT00349622|motor neurons|motor neurons
774918|NCT00349596|Hypomethylating agent|hypomethylating agent
774919|NCT00349596|Chemotherapy|chemotherapy
774920|NCT00349596|Relapsed or refractory ALL|relapsed or refractory all
774921|NCT00349596|Acute Lymphocytic Leukemia (ALL)|acute lymphocytic leukemia (all)
774922|NCT00349570|thrombus|thrombus
774923|NCT00349570|aspiration catheter|aspiration catheter
774924|NCT00349557|Prostate Cancer|prostate cancer
774925|NCT00349557|High-Risk Prostate Cancer|high-risk prostate cancer
774926|NCT00349557|1st line therapy|1st line therapy
774927|NCT00349544|Neck pain|neck pain
774928|NCT00349544|Cervicalgia|cervicalgia
774929|NCT00349544|Quality of life|quality of life
774930|NCT00349544|Disability|disability
774931|NCT00349518|Chronic and Advanced Phase CML and|chronic and advanced phase cml and
774932|NCT00349518|Philadelphia Chromosome Positive ALL with imatinib intolerance or resistance|philadelphia chromosome positive all with imatinib intolerance or resistance
774933|NCT00349505|previous treatment surgery + 6 cycles of platinum based chemotherapy|previous treatment surgery + 6 cycles of platinum based chemotherapy
774934|NCT00349492|Small Cell Lung Cancer|small cell lung cancer
774935|NCT00349492|Extensive Disease|extensive disease
774936|NCT00349492|Chemotherapy|chemotherapy
774937|NCT00349492|Randomisation|randomisation
774938|NCT00349479|stroke|stroke
774939|NCT00349479|tissue plasminogen activator|tissue plasminogen activator
774940|NCT00349479|t-PA|t-pa
774941|NCT00349479|barrier assessment and interactive educational intervention|barrier assessment and interactive educational intervention
774942|NCT00349479|BA-IEI|ba-iei
774943|NCT00349466|Keratoconjunctivitis Sicca|keratoconjunctivitis sicca
774944|NCT00349466|KCS|kcs
774945|NCT00349466|Dry Eye|dry eye
774946|NCT00349453|Deferiprone|deferiprone
774947|NCT00349453|L1|l1
774948|NCT00349453|Desferrioxamine|desferrioxamine
774949|NCT00349453|Hemochromatosis|hemochromatosis
774950|NCT00349453|Iron overload|iron overload
774951|NCT00349453|Thalassemia|thalassemia
774952|NCT00349440|Dry eye|dry eye
774953|NCT00349427|Insulin|insulin
774954|NCT00349427|BRL49653 /rosiglitazone|brl49653 /rosiglitazone
774955|NCT00349427|Type 2 Diabetes Mellitus|type 2 diabetes mellitus
774956|NCT00349414|Advanced glaucoma|advanced glaucoma
774957|NCT00349414|Refractory glaucoma|refractory glaucoma
774958|NCT00349414|Cyclophotocoagulation|cyclophotocoagulation
774959|NCT00349414|Transscleral cyclophotocoagulation|transscleral cyclophotocoagulation
774960|NCT00349414|Micropulse transscleral cyclophotocoagulation|micropulse transscleral cyclophotocoagulation
774961|NCT00349401|pain|pain
774962|NCT00349401|chronic pain|chronic pain
774963|NCT00349401|morphine|morphine
774964|NCT00349401|ketorolac|ketorolac
774965|NCT00349388|Mesalamine|mesalamine
774966|NCT00349388|Ulcerative Colitis|ulcerative colitis
774967|NCT00349375|Hyperlipidemia Combined, efficacy combination fenofibrate simvastatin|hyperlipidemia combined, efficacy combination fenofibrate simvastatin
774968|NCT00349323|Community directed treatment,|community directed treatment,
774969|NCT00349323|soil-transmitted helminth infections,|soil-transmitted helminth infections,
774970|NCT00349323|treatment coverage,|treatment coverage,
774971|NCT00349323|Zambia|zambia
774972|NCT00349284|Hyperlipidemia Combined and features of the metabolic syndrome, efficacy combination fenofibrate ezetimibe|hyperlipidemia combined and features of the metabolic syndrome, efficacy combination fenofibrate ezetimibe
774973|NCT00349271|Chagas Cardiomyopathy|chagas cardiomyopathy
774974|NCT00349271|Dilated Cardiomyopathy|dilated cardiomyopathy
774975|NCT00349271|stem cells|stem cells
774976|NCT00349271|Therapeutics|therapeutics
774977|NCT00349271|Randomized Controlled Trials|randomized controlled trials
774978|NCT00349258|OHSS|ohss
774979|NCT00349258|PCOS|pcos
774980|NCT00349258|Previous high response|previous high response
774981|NCT00349258|GnRH antagonist|gnrh antagonist
774982|NCT00349258|GnRH agonist|gnrh agonist
774983|NCT00349258|IVF|ivf
774984|NCT00349245|Endotracheal|endotracheal
774985|NCT00349245|Awake fiberoptic intubation|awake fiberoptic intubation
774986|NCT00349245|Dexmedetomidine|dexmedetomidine
774987|NCT00349245|Remifentanil|remifentanil
774988|NCT00349232|childhood obesity|childhood obesity
774989|NCT00349232|lifestyle intervention|lifestyle intervention
774990|NCT00349232|school health program|school health program
774991|NCT00349232|special primary education|special primary education
774992|NCT00349219|first-line|first-line
774993|NCT00349219|second-line|second-line
774994|NCT00349219|targeted therapy|targeted therapy
774995|NCT00349193|Relapsing Remitting Multiple Sclerosis|relapsing remitting multiple sclerosis
774996|NCT00349180|Total Hip Replacement|total hip replacement
774997|NCT00349180|Enoxaparin|enoxaparin
774998|NCT00349167|unspecified adult solid tumor, protocol specific|unspecified adult solid tumor, protocol specific
774999|NCT00349141|Pandemic influenza|pandemic influenza
775000|NCT00349128|Treatment of Dyslipidemia and of Type 2 Diabetes Mellitus|treatment of dyslipidemia and of type 2 diabetes mellitus
775001|NCT00349102|Non-small-cell lung cancer|non-small-cell lung cancer
775002|NCT00349102|Breath-hold|breath-hold
775003|NCT00349102|Radiation pneumonitis|radiation pneumonitis
775004|NCT00349102|Serum cytokines|serum cytokines
775005|NCT00349102|LENT-SOMA scale|lent-soma scale
775006|NCT00349102|Non-metastatic non-small-cell lung cancer|non-metastatic non-small-cell lung cancer
775007|NCT00349089|Non-small cell lung cancer|non-small cell lung cancer
775008|NCT00349089|adjuvant therapy|adjuvant therapy
775009|NCT00349089|clinical feasibility rate|clinical feasibility rate
775010|NCT00349050|trigeminal neuralgia|trigeminal neuralgia
775011|NCT00349050|neuropathic pain|neuropathic pain
775012|NCT00349050|complex regional pain syndrome|complex regional pain syndrome
775013|NCT00349050|reflex sympathetic dystrophy|reflex sympathetic dystrophy
775014|NCT00349050|pain|pain
775015|NCT00349050|chronic pain|chronic pain
775016|NCT00349050|transcranial magnetic stimulation|transcranial magnetic stimulation
775017|NCT00349050|TMS|tms
775018|NCT00349050|laboratory pain assessment|laboratory pain assessment
775019|NCT00349037|DNA vaccine|dna vaccine
775020|NCT00349037|influenza|influenza
775021|NCT00349037|immunogenicity|immunogenicity
775022|NCT00349037|tolerability|tolerability
775023|NCT00349037|PMED|pmed
775024|NCT00349037|efficacy|efficacy
775025|NCT00349037|challenge virus|challenge virus
775026|NCT00349024|unspecified childhood solid tumor, protocol specific|unspecified childhood solid tumor, protocol specific
775027|NCT00349024|pain|pain
775028|NCT00349024|childhood acute lymphoblastic leukemia|childhood acute lymphoblastic leukemia
775029|NCT00349024|childhood Hodgkin lymphoma|childhood hodgkin lymphoma
775030|NCT00349024|chondrosarcoma|chondrosarcoma
775031|NCT00349024|osteosarcoma|osteosarcoma
775032|NCT00349024|childhood soft tissue sarcoma|childhood soft tissue sarcoma
775033|NCT00349024|Wilms tumor and other childhood kidney tumors|wilms tumor and other childhood kidney tumors
775034|NCT00349024|neuroblastoma|neuroblastoma
775035|NCT00349024|childhood acute myeloid leukemia/other myeloid malignancies|childhood acute myeloid leukemia/other myeloid malignancies
775036|NCT00349024|childhood large cell lymphoma|childhood large cell lymphoma
775037|NCT00349024|childhood lymphoblastic lymphoma|childhood lymphoblastic lymphoma
775038|NCT00349024|childhood small noncleaved cell lymphoma|childhood small noncleaved cell lymphoma
775039|NCT00349024|childhood rhabdomyosarcoma|childhood rhabdomyosarcoma
775040|NCT00349024|childhood brain stem glioma|childhood brain stem glioma
775041|NCT00349024|childhood central nervous system germ cell tumor|childhood central nervous system germ cell tumor
775042|NCT00349024|childhood cerebellar astrocytoma|childhood cerebellar astrocytoma
775043|NCT00349024|childhood cerebral astrocytoma/malignant glioma|childhood cerebral astrocytoma/malignant glioma
775044|NCT00349024|childhood choroid plexus tumor|childhood choroid plexus tumor
775045|NCT00349024|childhood craniopharyngioma|childhood craniopharyngioma
775046|NCT00349024|childhood ependymoma|childhood ependymoma
775047|NCT00349024|childhood medulloblastoma|childhood medulloblastoma
775048|NCT00349024|childhood meningioma|childhood meningioma
775049|NCT00349024|childhood oligodendroglioma|childhood oligodendroglioma
775050|NCT00349024|childhood atypical teratoid/rhabdoid tumor|childhood atypical teratoid/rhabdoid tumor
775051|NCT00349024|childhood spinal cord neoplasm|childhood spinal cord neoplasm
775052|NCT00349024|childhood supratentorial primitive neuroectodermal tumor|childhood supratentorial primitive neuroectodermal tumor
775053|NCT00349024|childhood visual pathway and hypothalamic glioma|childhood visual pathway and hypothalamic glioma
775056|NCT00349024|Ewing sarcoma/peripheral primitive neuroectodermal tumor (PNET)|ewing sarcoma/peripheral primitive neuroectodermal tumor (pnet)
775057|NCT00349011|menopause|menopause
775058|NCT00349011|genetic counseling|genetic counseling
775059|NCT00349011|breast cancer|breast cancer
775060|NCT00349011|tamoxifen|tamoxifen
775061|NCT00349011|chemoprevention|chemoprevention
775062|NCT00348998|adenocarcinoma of the prostate|adenocarcinoma of the prostate
775063|NCT00348998|stage IIB prostate cancer|stage iib prostate cancer
775064|NCT00348998|stage IIA prostate cancer|stage iia prostate cancer
775159|NCT00348608|Angiography|angiography
775065|NCT00348998|stage III prostate cancer|stage iii prostate cancer
775066|NCT00348998|stage IV prostate cancer|stage iv prostate cancer
775067|NCT00348972|Glargine|glargine
775068|NCT00348972|prediabetes|prediabetes
775069|NCT00348972|impaired glucose tolerance|impaired glucose tolerance
775070|NCT00348972|impaired fasting glucose|impaired fasting glucose
775071|NCT00348959|Haematological Malignancies|haematological malignancies
775072|NCT00348959|Autologous Stem Cell Transplantation|autologous stem cell transplantation
775073|NCT00348959|Allogeneic Stem Cell Transplantation|allogeneic stem cell transplantation
775074|NCT00348959|Quality of Life|quality of life
775075|NCT00348959|Life Threatening Illness|life threatening illness
775076|NCT00348959|Art in Health Care|art in health care
775077|NCT00348959|Randomised Controlled Trial|randomised controlled trial
775078|NCT00348959|Mixed Methods Research|mixed methods research
775079|NCT00348946|Klinefelter syndrome|klinefelter syndrome
775080|NCT00348946|androgen|androgen
775081|NCT00348946|androgen oxandrolone|androgen oxandrolone
775082|NCT00348933|Developmental Delay|developmental delay
775083|NCT00348933|Mental Retardation|mental retardation
775085|NCT00348933|Microcephaly|microcephaly
775086|NCT00348933|Seizures|seizures
775087|NCT00348920|Aortic Valve|aortic valve
775088|NCT00348920|Aortic Stenosis|aortic stenosis
775089|NCT00348920|High Spinal Anesthesia|high spinal anesthesia
775090|NCT00348920|Total Spinal Anesthesia|total spinal anesthesia
775091|NCT00348920|Stress Response|stress response
775092|NCT00348920|Inflammatory Mediators|inflammatory mediators
775093|NCT00348920|Renal Function|renal function
775094|NCT00348920|Hemodynamic Stability|hemodynamic stability
775095|NCT00348907|doppler|doppler
775096|NCT00348907|CIVIQ quality of life|civiq quality of life
775097|NCT00348907|Hydrotherapy|hydrotherapy
775098|NCT00348907|anticoagulants|anticoagulants
775099|NCT00348881|Diphtheria|diphtheria
775100|NCT00348881|Tetanus|tetanus
775101|NCT00348881|Pertussis|pertussis
775102|NCT00348881|Hepatitis B Hansenula (HB)|hepatitis b hansenula (hb)
775103|NCT00348881|Haemophilus influenzae type b|haemophilus influenzae type b
775104|NCT00348868|HIV Infection|hiv infection
775105|NCT00348868|Opioid dependence|opioid dependence
775106|NCT00348868|DSM-IV criteria for opioid dependence|dsm-iv criteria for opioid dependence
775107|NCT00348855|High Blood Pressure|high blood pressure
775108|NCT00348855|High cardiovascular risk|high cardiovascular risk
775109|NCT00348855|Type 2 diabetes|type 2 diabetes
775110|NCT00348855|Reaching goals|reaching goals
775111|NCT00348842|Immunotherapy|immunotherapy
775112|NCT00348829|CHF|chf
775113|NCT00348829|mitral insufficiency|mitral insufficiency
775114|NCT00348829|conductance catheter|conductance catheter
775115|NCT00348829|mitral valve repair|mitral valve repair
775116|NCT00348816|stage I prostate cancer|stage i prostate cancer
775117|NCT00348816|stage IIB prostate cancer|stage iib prostate cancer
775118|NCT00348816|stage IIA prostate cancer|stage iia prostate cancer
775119|NCT00348816|stage III prostate cancer|stage iii prostate cancer
775120|NCT00348816|stage IV prostate cancer|stage iv prostate cancer
775121|NCT00348790|adult grade I meningioma|adult grade i meningioma
775122|NCT00348790|adult grade II meningioma|adult grade ii meningioma
775123|NCT00348790|adult grade III meningioma|adult grade iii meningioma
775124|NCT00348790|adult malignant hemangiopericytoma|adult malignant hemangiopericytoma
775125|NCT00348790|adult anaplastic meningioma|adult anaplastic meningioma
775126|NCT00348790|adult papillary meningioma|adult papillary meningioma
775127|NCT00348790|adult melanocytic lesion|adult melanocytic lesion
775128|NCT00348790|recurrent adult brain tumor|recurrent adult brain tumor
775129|NCT00348777|Visual analogic Scale of pain|visual analogic scale of pain
775130|NCT00348777|Womac indice|womac indice
775131|NCT00348777|SF-36 quality of life|sf-36 quality of life
775132|NCT00348777|Hydrotherapy|hydrotherapy
775133|NCT00348764|lauromacrogol|lauromacrogol
775134|NCT00348764|Sclerotherapy|sclerotherapy
775135|NCT00348738|radiotherapy|radiotherapy
775136|NCT00348738|clinical trial|clinical trial
775137|NCT00348738|erythropoietin|erythropoietin
775138|NCT00348738|cervix cancer|cervix cancer
775139|NCT00348738|Phase III|phase iii
775140|NCT00348738|2 Arms|2 arms
775141|NCT00348725|Treatment of Dyslipidemia and of Type 2 Diabetes Mellitus|treatment of dyslipidemia and of type 2 diabetes mellitus
775143|NCT00348660|Screening for Hepatitis C in Pregnancy|screening for hepatitis c in pregnancy
775144|NCT00348647|Prevention|prevention
775145|NCT00348647|Exercise|exercise
775146|NCT00348647|Overuse|overuse
775147|NCT00348647|Anterior knee pain syndrome|anterior knee pain syndrome
775148|NCT00348647|Exertional lower leg pain|exertional lower leg pain
775150|NCT00348647|Risk factors|risk factors
775151|NCT00348647|Hip|hip
775152|NCT00348634|Constipation, Tegaserod, orocecal transit, colonic transit, gastric emptying|constipation, tegaserod, orocecal transit, colonic transit, gastric emptying
775153|NCT00348621|cataract surgery|cataract surgery
775154|NCT00348621|refractive correction|refractive correction
775155|NCT00348621|low vision services|low vision services
775156|NCT00348621|nursing home|nursing home
775157|NCT00348621|visual impairment|visual impairment
775161|NCT00348608|CAD|cad
775162|NCT00348595|Prostate Cancer|prostate cancer
775163|NCT00348569|CT|ct
775164|NCT00348569|Coronary|coronary
775165|NCT00348569|Cardiac|cardiac
775166|NCT00348569|Angiography|angiography
775167|NCT00348569|X-ray|x-ray
775168|NCT00348569|CAD|cad
775169|NCT00348569|Chest pain|chest pain
775170|NCT00348543|age-related macula degeneration|age-related macula degeneration
775171|NCT00348543|prophylactic laser treatment|prophylactic laser treatment
775172|NCT00348543|exudative complication|exudative complication
775173|NCT00348530|Systolic heart failure; Therapy; Cardiomyopathy|systolic heart failure; therapy; cardiomyopathy
775174|NCT00348491|Dental surgery|dental surgery
775175|NCT00348491|acute pain|acute pain
775176|NCT00348491|lumiracoxib|lumiracoxib
775177|NCT00348491|celecoxib|celecoxib
775178|NCT00348491|Moderate to severe pain following dental surgery|moderate to severe pain following dental surgery
775179|NCT00348478|trachoma|trachoma
775180|NCT00348478|chlamydia trachomatis|chlamydia trachomatis
775181|NCT00348478|water|water
775182|NCT00348478|health education|health education
775183|NCT00348478|face washing|face washing
775184|NCT00348465|Brachytherapy|brachytherapy
775185|NCT00348465|Prostate volume|prostate volume
775186|NCT00348452|osteoarthritis pain; knee; hip; extended release analgesia; opioid|osteoarthritis pain; knee; hip; extended release analgesia; opioid
775187|NCT00348426|Food Borne Botulism|food borne botulism
775188|NCT00348413|Graves ophthalmopathy/therapy|graves ophthalmopathy/therapy
775189|NCT00348413|Randomized controlled trial|randomized controlled trial
775190|NCT00348413|Methylprednisolone|methylprednisolone
775191|NCT00348413|Methotrexate|methotrexate
775192|NCT00348387|Imovax polio|imovax polio
775193|NCT00348387|poliomyelitis|poliomyelitis
775194|NCT00348374|type two diabetes, insulin, HbA1c|type two diabetes, insulin, hba1c
775195|NCT00348361|Hay fever|hay fever
775196|NCT00348361|biomarkers|biomarkers
775197|NCT00348309|apolipoprotein E|apolipoprotein e
775198|NCT00348309|Alzheimer's disease|alzheimer's disease
775199|NCT00348309|cognition|cognition
775200|NCT00348309|rosiglitazone|rosiglitazone
775201|NCT00348309|adjunctive therapy|adjunctive therapy
775202|NCT00348296|Scleroderma, Systemic|scleroderma, systemic
775203|NCT00348270|Cataract|cataract
775204|NCT00348270|Intraocular lens|intraocular lens
775205|NCT00348270|Aberration|aberration
775206|NCT00348270|Wavefront|wavefront
775207|NCT00348231|diabetes mellitus, biphasic insulin analogue|diabetes mellitus, biphasic insulin analogue
775208|NCT00348218|Neurovision|neurovision
775209|NCT00348218|Myopia Therapy|myopia therapy
775210|NCT00348192|Alzheimer's Disease|alzheimer's disease
775211|NCT00348192|cognition global functioning|cognition global functioning
775212|NCT00348192|symptomatic|symptomatic
775213|NCT00348192|SB-742457|sb-742457
775214|NCT00348179|Vascular abnormalities|vascular abnormalities
775215|NCT00348179|Type 1 diabetes|type 1 diabetes
775216|NCT00348179|Healthy control subjects|healthy control subjects
775217|NCT00348153|Uveitis|uveitis
775218|NCT00348153|Adalimumab|adalimumab
775219|NCT00348153|TNF alpha|tnf alpha
775220|NCT00348140|adjunctive therapy|adjunctive therapy
775221|NCT00348140|moderate|moderate
775222|NCT00348140|Alzheimer's disease|alzheimer's disease
775223|NCT00348140|apolipoprotein E|apolipoprotein e
775224|NCT00348140|mild|mild
775225|NCT00348140|rosiglitazone|rosiglitazone
775226|NCT00348140|cognition|cognition
775227|NCT00348127|Neurovision|neurovision
775228|NCT00348127|Myopia Therapy|myopia therapy
775229|NCT00348114|autologous|autologous
775230|NCT00348114|transplantation ex-vivo expanded limbal epithelium|transplantation ex-vivo expanded limbal epithelium
775231|NCT00348114|limbal deficiency|limbal deficiency
775232|NCT00348101|Patients undergoing major vascular surgery having documented CAD or risk factors for CAD|patients undergoing major vascular surgery having documented cad or risk factors for cad
775233|NCT00348088|Metastatic|metastatic
775234|NCT00348088|Melanoma|melanoma
775235|NCT00348088|Untreated|untreated
775236|NCT00348088|Biomarker|biomarker
775237|NCT00348075|Neurovision|neurovision
775238|NCT00348075|Adult myopia|adult myopia
775239|NCT00348075|Therapy|therapy
775240|NCT00348049|LASIK|lasik
775241|NCT00348049|PRK|prk
775242|NCT00348049|Myopia|myopia
775243|NCT00348036|Major Depression|major depression
775244|NCT00348036|Trauma|trauma
775245|NCT00348036|Primary Care|primary care
775246|NCT00348036|Low-Income Patients|low-income patients
775247|NCT00348010|osteoarthritis|osteoarthritis
775248|NCT00348010|knee pain|knee pain
775249|NCT00348010|extended release analgesia|extended release analgesia
775250|NCT00348010|opioid|opioid
775251|NCT00347971|Lymphoma, Non-Hodgkin|lymphoma, non-hodgkin
775252|NCT00347971|interleukin-21|interleukin-21
775253|NCT00347971|rituximab|rituximab
775254|NCT00347971|Immunotherapy|immunotherapy
775255|NCT00347958|Tetanus,|tetanus,
775256|NCT00347958|Diphtheria,|diphtheria,
775257|NCT00347958|Pertussis|pertussis
775258|NCT00347945|convergence insufficiency, vision therapy, orthoptics|convergence insufficiency, vision therapy, orthoptics
775259|NCT00347919|GW786034|gw786034
775260|NCT00347919|Quality of Life|quality of life
775261|NCT00347919|GW572016|gw572016
775262|NCT00347919|Lapatinib|lapatinib
775263|NCT00347919|Pazopanib|pazopanib
775264|NCT00347919|Metastatic|metastatic
775265|NCT00347919|Breast cancer|breast cancer
775266|NCT00347919|Genetics|genetics
775267|NCT00347919|FISH|fish
775268|NCT00347919|Advanced|advanced
775269|NCT00347893|Primary open angle glaucoma|primary open angle glaucoma
775270|NCT00347893|Ocular hypertension|ocular hypertension
775271|NCT00347893|Pseudo-exfoliative glaucoma|pseudo-exfoliative glaucoma
775272|NCT00347893|Pigment Dispersion glaucoma|pigment dispersion glaucoma
775273|NCT00347893|selective laser trabeculoplasty|selective laser trabeculoplasty
775274|NCT00347893|intraocular pressure|intraocular pressure
775275|NCT00347880|Bronchiolitis|bronchiolitis
775276|NCT00347880|ANP|anp
775277|NCT00347880|BNP|bnp
775278|NCT00347880|Atrial Natriuretic Peptide|atrial natriuretic peptide
775279|NCT00347880|Brain Natriuretic Peptide|brain natriuretic peptide
775280|NCT00347880|Vasopressin|vasopressin
775281|NCT00347880|ADH|adh
775282|NCT00347880|Pediatric|pediatric
775283|NCT00347880|Respiratory Distress|respiratory distress
775284|NCT00347880|Fluid Balance|fluid balance
775285|NCT00347867|IUGR|iugr
775286|NCT00347867|PET|pet
775287|NCT00347867|Pregnancy|pregnancy
775288|NCT00347867|Viagra|viagra
775289|NCT00347867|Sildenafil citrate|sildenafil citrate
775290|NCT00347854|Normal, healthy eyes (other than correction for visual acuity)|normal, healthy eyes (other than correction for visual acuity)
775291|NCT00347828|Antibiotic prophylaxis|antibiotic prophylaxis
775292|NCT00347828|Vigamox|vigamox
775293|NCT00347828|Moxifloxacin|moxifloxacin
775294|NCT00347828|Zymar|zymar
775295|NCT00347828|Gatifloxacin|gatifloxacin
775296|NCT00347828|Preoperative antibiotic|preoperative antibiotic
775297|NCT00347828|Eye infection|eye infection
775298|NCT00347789|glaucoma|glaucoma
775299|NCT00347789|trabeculectomy|trabeculectomy
775300|NCT00347789|filtering bleb revision|filtering bleb revision
775301|NCT00347789|intraocular pressure|intraocular pressure
775302|NCT00347789|needling procedure|needling procedure
775303|NCT00347789|mitomycin C|mitomycin c
775304|NCT00347776|trichiasis|trichiasis
775305|NCT00347776|azithromycin|azithromycin
775306|NCT00347776|trichiasis surgery|trichiasis surgery
775307|NCT00347776|topical tetracycline|topical tetracycline
775308|NCT00347763|trachoma|trachoma
775309|NCT00347763|chlamydia|chlamydia
775310|NCT00347763|flies|flies
775311|NCT00347763|permethrin|permethrin
775312|NCT00347750|Lopinavir|lopinavir
775313|NCT00347750|Pharmacokinetic|pharmacokinetic
775314|NCT00347750|Pharmacodynamic|pharmacodynamic
775315|NCT00347750|Ethiopian population|ethiopian population
775316|NCT00347750|Caucasian population|caucasian population
775317|NCT00347724|chronic low back pain; chronic pain; low back pain; extended-release analgesia; opioid|chronic low back pain; chronic pain; low back pain; extended-release analgesia; opioid
775318|NCT00347698|diabetic retinopathy|diabetic retinopathy
775319|NCT00347698|bevacizumab|bevacizumab
775320|NCT00347698|photocoagulation|photocoagulation
775321|NCT00347685|chronic non-malignant pain; chronic pain; non-malignant|chronic non-malignant pain; chronic pain; non-malignant
775322|NCT00347685|pain; moderate pain; severe pain|pain; moderate pain; severe pain
775323|NCT00347672|Bird Flu|bird flu
775324|NCT00347659|Lung volume reduction|lung volume reduction
775325|NCT00347659|Bronchoscopy|bronchoscopy
775326|NCT00347659|Emphysema|emphysema
775327|NCT00347659|COPD|copd
775328|NCT00347659|NETT|nett
775329|NCT00347659|Lung disease|lung disease
775330|NCT00347659|COLD|cold
775331|NCT00347659|BLVR|blvr
775332|NCT00347607|trachoma|trachoma
775333|NCT00347607|chlamydia trachomatis|chlamydia trachomatis
775334|NCT00347607|surveillance|surveillance
775335|NCT00347607|azithromycin|azithromycin
775336|NCT00347594|Corneal surface topography|corneal surface topography
775337|NCT00347594|Ocular aberrations|ocular aberrations
775338|NCT00347581|convergence insufficiency|convergence insufficiency
775339|NCT00347581|base-in prism|base-in prism
775340|NCT00347581|orthoptics|orthoptics
775341|NCT00347581|vision therapy|vision therapy
775342|NCT00347568|decision aids|decision aids
775343|NCT00347568|high risk|high risk
775344|NCT00347568|breast cancer|breast cancer
775345|NCT00347568|breast cancer prevention|breast cancer prevention
775346|NCT00347555|malaria, falciparum, Plasmodium falciparum malaria, vaccine|malaria, falciparum, plasmodium falciparum malaria, vaccine
775347|NCT00347542|Vitamin D|vitamin d
775348|NCT00347542|Diabetes|diabetes
775349|NCT00347542|Insulin sensitivity|insulin sensitivity
775350|NCT00347542|Obesity|obesity
775448|NCT00347139|Asthmatic patients|asthmatic patients
775351|NCT00347529|DNA vaccine, influenza, immunogenicity, tolerability, PMED, pandemic|dna vaccine, influenza, immunogenicity, tolerability, pmed, pandemic
775352|NCT00347516|IOL formula|iol formula
775353|NCT00347516|High myopia|high myopia
775354|NCT00347516|axial length|axial length
775355|NCT00347477|cardiac arrest|cardiac arrest
775356|NCT00347477|hypothermia|hypothermia
775357|NCT00347477|neurologic outcome|neurologic outcome
775358|NCT00347477|edema|edema
775359|NCT00347464|Kleinfelter|kleinfelter
775360|NCT00347451|myopia|myopia
775361|NCT00347451|optical coherence tomography|optical coherence tomography
775362|NCT00347438|breast cancer|breast cancer
775363|NCT00347438|neoadjuvant|neoadjuvant
775364|NCT00347438|locally advanced|locally advanced
775365|NCT00347425|Switch Study|switch study
775366|NCT00347425|Schizophrenia|schizophrenia
775367|NCT00347425|Atypical Antipsychotics|atypical antipsychotics
775368|NCT00347412|NSCLC|nsclc
775369|NCT00347412|Stage IIIb|stage iiib
775370|NCT00347412|Stage IV|stage iv
775371|NCT00347412|Non Small Cell Lung Cancer (NSCLC)|non small cell lung cancer (nsclc)
775372|NCT00347412|NSCLC Stage IIIb with malignant pleural/pericardial effusion|nsclc stage iiib with malignant pleural/pericardial effusion
775373|NCT00347412|NSCLC Stage IV|nsclc stage iv
775374|NCT00347399|macular degeneration|macular degeneration
775375|NCT00347399|antibodies|antibodies
775376|NCT00347399|angiogenesis inhibitor|angiogenesis inhibitor
775377|NCT00347386|Infants|infants
775378|NCT00347386|India|india
775379|NCT00347386|Zinc|zinc
775380|NCT00347386|Bacterial illness|bacterial illness
775381|NCT00347386|Treatment|treatment
775382|NCT00347373|conjugated linoleic acid|conjugated linoleic acid
775383|NCT00347373|obesity|obesity
775384|NCT00347373|body composition|body composition
775385|NCT00347373|body fat mass|body fat mass
775386|NCT00347373|lean body mass|lean body mass
775387|NCT00347360|carvedilol|carvedilol
775388|NCT00347360|hypertension|hypertension
775389|NCT00347360|lisinopril|lisinopril
775390|NCT00347360|factorial|factorial
775391|NCT00347334|Torticollis|torticollis
775392|NCT00347334|infant home positioning|infant home positioning
775393|NCT00347334|head control|head control
775394|NCT00347321|Percutaneous tracheostomy|percutaneous tracheostomy
775395|NCT00347321|Endotracheal intubation|endotracheal intubation
775396|NCT00347321|Mechanical ventilation|mechanical ventilation
775397|NCT00347321|Cardiac surgery|cardiac surgery
775398|NCT00347321|Ventilator-free days|ventilator-free days
775399|NCT00347308|brow ptosis, facial aesthetics, browlift, facelift|brow ptosis, facial aesthetics, browlift, facelift
775400|NCT00347282|Post enucleation socket syndrome|post enucleation socket syndrome
775401|NCT00347282|Multi-slice computed tomography scan|multi-slice computed tomography scan
775402|NCT00347282|Prospective studies|prospective studies
775403|NCT00347282|Tomography, X Ray Computed|tomography, x ray computed
775404|NCT00347269|Anxiety Disorders|anxiety disorders
775405|NCT00347269|Post-traumatic Stress Disorder|post-traumatic stress disorder
775406|NCT00347269|Generalized Anxiety Disorder|generalized anxiety disorder
775407|NCT00347269|Panic Disorder|panic disorder
775408|NCT00347269|Social Anxiety Disorder|social anxiety disorder
775409|NCT00347269|Stress|stress
775410|NCT00347269|Stress Disorders, Traumatic|stress disorders, traumatic
775411|NCT00347269|Stress Disorders, Post-Traumatic|stress disorders, post-traumatic
775412|NCT00347269|Mental Health Disorders|mental health disorders
775413|NCT00347230|Intacs ring segments|intacs ring segments
775414|NCT00347230|Keratoconus|keratoconus
775415|NCT00347217|Cholesterol|cholesterol
775416|NCT00347217|rosuvastatin|rosuvastatin
775417|NCT00347217|LDL-C goal|ldl-c goal
775418|NCT00347217|observational study|observational study
775419|NCT00347217|primary prevention|primary prevention
775420|NCT00347217|secondary prevention|secondary prevention
775421|NCT00347204|PRK|prk
775422|NCT00347204|laser vision correction|laser vision correction
775423|NCT00347204|surface ablation|surface ablation
775424|NCT00347204|pain|pain
775425|NCT00347204|wound healing|wound healing
775426|NCT00347204|corneal haze|corneal haze
775427|NCT00347191|Corneal thickness|corneal thickness
775428|NCT00347191|Intraocular pressure|intraocular pressure
775429|NCT00347191|Instrumentation|instrumentation
775430|NCT00347191|Glaucoma|glaucoma
775431|NCT00347191|Keratoconus|keratoconus
775432|NCT00347178|Asymptomatic Narrow Angles|asymptomatic narrow angles
775433|NCT00347178|Primary Angle Closure Suspects|primary angle closure suspects
775434|NCT00347178|Laser Peripheral Iridotomy|laser peripheral iridotomy
775435|NCT00347178|Randomised Controlled Trial|randomised controlled trial
775436|NCT00347165|macular degeneration|macular degeneration
775437|NCT00347165|angiogenesis|angiogenesis
775438|NCT00347165|antibodies|antibodies
775439|NCT00347152|Intellectual disabilities|intellectual disabilities
775440|NCT00347152|development disabilities|development disabilities
775441|NCT00347152|behavior disorders|behavior disorders
775442|NCT00347152|stable epilepsy|stable epilepsy
775443|NCT00347139|Tolerability|tolerability
775444|NCT00347139|Pharmacodynamics|pharmacodynamics
775445|NCT00347139|Safety|safety
775446|NCT00347139|Pharmacokinetics|pharmacokinetics
775447|NCT00347139|GW642444|gw642444
775453|NCT00347126|Intraocular pressure|intraocular pressure
775454|NCT00347126|Hyperemia|hyperemia
775455|NCT00347113|P. falciparum|p. falciparum
775456|NCT00347113|malaria|malaria
775457|NCT00347113|schistosome infections|schistosome infections
775458|NCT00347113|soil-transmitted helminths infection|soil-transmitted helminths infection
775459|NCT00347113|anaemia|anaemia
775460|NCT00347113|immune response|immune response
775461|NCT00347113|Tanzania|tanzania
775462|NCT00347087|Insulin sensitivity|insulin sensitivity
775463|NCT00347087|chronic heart failure|chronic heart failure
775464|NCT00347087|metabolism|metabolism
775465|NCT00347074|Keratoconus, corneal topography, ocular aberrometry, visual outcome, contact lens wear, quality of life|keratoconus, corneal topography, ocular aberrometry, visual outcome, contact lens wear, quality of life
775466|NCT00347061|Benign Prostatic Hyperplasiam|benign prostatic hyperplasiam
775467|NCT00347061|Adrenergic alpha-antagonist|adrenergic alpha-antagonist
775468|NCT00347048|Ulcerative colitis|ulcerative colitis
775469|NCT00347048|tacrolimus|tacrolimus
775470|NCT00347048|FK506|fk506
775471|NCT00347048|treatment outcome|treatment outcome
775472|NCT00347022|Multislice computed tomography (MSCT)indications|multislice computed tomography (msct)indications
775473|NCT00347009|Cirrhosis|cirrhosis
775474|NCT00347009|Advanced Fibrosis|advanced fibrosis
775475|NCT00347009|Chronic Hepatitis B|chronic hepatitis b
775476|NCT00347009|Adefovir Dipivoxil|adefovir dipivoxil
775477|NCT00346996|diabetes|diabetes
775478|NCT00346996|insulin|insulin
775479|NCT00346996|insulin analogues|insulin analogues
775480|NCT00346996|hypoglycaemia|hypoglycaemia
775481|NCT00346996|severe hypoglycaemia|severe hypoglycaemia
775482|NCT00346970|Metabolic Syndrome|metabolic syndrome
775483|NCT00346970|High Density Lipoprotein|high density lipoprotein
775484|NCT00346970|Extended-Release Niacin|extended-release niacin
775485|NCT00346970|Endothelial Function|endothelial function
775486|NCT00346970|Endothelial Progenitor Cells|endothelial progenitor cells
775487|NCT00346931|glaucoma|glaucoma
775488|NCT00346931|cataract|cataract
775489|NCT00346931|surgery|surgery
775490|NCT00346931|intraocular pressure|intraocular pressure
775491|NCT00346931|phacoemulsification|phacoemulsification
775492|NCT00346931|trabeculotomy|trabeculotomy
775493|NCT00346918|ADPKD|adpkd
775494|NCT00346918|autosomal dominant polycystic kidney disease|autosomal dominant polycystic kidney disease
775495|NCT00346918|Sirolimus|sirolimus
775496|NCT00346918|volumetry|volumetry
775497|NCT00346905|GERD|gerd
775498|NCT00346905|Gastroesophageal Reflux Disease|gastroesophageal reflux disease
775499|NCT00346905|Reflux|reflux
775500|NCT00346905|Enteryx|enteryx
775501|NCT00346892|Prophylaxis rotavirus|prophylaxis rotavirus
775502|NCT00346879|fondaparinux for prevention of blood clots|fondaparinux for prevention of blood clots
775503|NCT00346853|Dark adaptation inhibition|dark adaptation inhibition
775504|NCT00346853|Stargardt macular dystrophy|stargardt macular dystrophy
775505|NCT00346853|4-Methylpyrazole (4-MP)|4-methylpyrazole (4-mp)
775506|NCT00346853|Antizol|antizol
775507|NCT00346853|Fomepizole|fomepizole
775508|NCT00346840|Labor induction|labor induction
775509|NCT00346840|cervical ripening|cervical ripening
775510|NCT00346840|misoprostol|misoprostol
775511|NCT00346840|vaginal insert|vaginal insert
775512|NCT00346814|Retinopathy of prematurity|retinopathy of prematurity
775513|NCT00346814|antiangiogenic therapy|antiangiogenic therapy
775514|NCT00346801|Non-Small Cell Lung Cancer|non-small cell lung cancer
775515|NCT00346801|Lung Cancer|lung cancer
775516|NCT00346801|Celecoxib|celecoxib
775517|NCT00346801|Cisplatin|cisplatin
775518|NCT00346801|Platinol|platinol
775519|NCT00346801|CPT-11|cpt-11
775520|NCT00346801|Irinotecan|irinotecan
775521|NCT00346801|SC-58635|sc-58635
775522|NCT00346801|Celebrex|celebrex
775523|NCT00346801|Radiation Therapy|radiation therapy
775524|NCT00346775|questionnaire|questionnaire
775525|NCT00346775|nasal spray|nasal spray
775526|NCT00346775|Seasonal allergic rhinitis|seasonal allergic rhinitis
775527|NCT00346775|nasal spray questionnaire|nasal spray questionnaire
775528|NCT00346775|allergic rhinitis|allergic rhinitis
775529|NCT00346762|Former Plasma Donors|former plasma donors
775530|NCT00346762|Commercial Plasma Donors|commercial plasma donors
775531|NCT00346762|Long-Term Nonprogressors|long-term nonprogressors
775532|NCT00346762|Host Factors|host factors
775533|NCT00346762|Viral Factors|viral factors
775535|NCT00346749|Inflammation|inflammation
775536|NCT00346749|FEV1|fev1
775537|NCT00346749|Sputum|sputum
775538|NCT00346736|Alternative medicine|alternative medicine
775539|NCT00346736|Traditional Chinese medicine|traditional chinese medicine
775540|NCT00346736|Acupuncture|acupuncture
775541|NCT00346736|Autistic Spectrum Disorder|autistic spectrum disorder
775542|NCT00346736|Autism|autism
775543|NCT00346736|Children|children
775544|NCT00346723|Influenza, Vaccine, CHMP criteria|influenza, vaccine, chmp criteria
775545|NCT00346710|communication|communication
775546|NCT00346710|patient experience|patient experience
775547|NCT00346710|fellowship training|fellowship training
775548|NCT00346697|AIDS|aids
775549|NCT00346697|HIV|hiv
775550|NCT00346697|HAART|haart
775551|NCT00346697|Lipids|lipids
775552|NCT00346697|Triglycerides|triglycerides
775553|NCT00346697|Cholesterol|cholesterol
775554|NCT00346697|omega-3 fatty acids|omega-3 fatty acids
775555|NCT00346697|bone turnover|bone turnover
775556|NCT00346697|inflammation|inflammation
775557|NCT00346697|insulin resistance|insulin resistance
775558|NCT00346684|Lymphoma|lymphoma
775559|NCT00346684|LPHD|lphd
775560|NCT00346684|Rituximab|rituximab
775561|NCT00346671|Reiki|reiki
775562|NCT00346671|Stress|stress
775563|NCT00346671|CAM|cam
775564|NCT00346658|Osteoporosis|osteoporosis
775565|NCT00346658|bone density|bone density
775566|NCT00346658|magnesium|magnesium
775567|NCT00346658|vitamin D|vitamin d
775568|NCT00346645|NON-SMALL CELL LUNG CANCER METASTATIC|non-small cell lung cancer metastatic
775569|NCT00346632|AML|aml
775570|NCT00346632|ALL|all
775571|NCT00346632|MDS|mds
775572|NCT00346632|CML|cml
775573|NCT00346632|Kinase Inhibitor|kinase inhibitor
775574|NCT00346606|Chronic Idiopathic Urticaria|chronic idiopathic urticaria
775575|NCT00346606|Desloratadine|desloratadine
775576|NCT00346606|Denosin|denosin
775577|NCT00346606|Levocetirizine|levocetirizine
775578|NCT00346567|mother-to-child-transmission|mother-to-child-transmission
775579|NCT00346567|PMTCT|pmtct
775580|NCT00346567|HIV|hiv
775581|NCT00346567|resistance|resistance
775582|NCT00346567|NNRTI|nnrti
775583|NCT00346554|COPD|copd
775584|NCT00346554|Sleep disorders|sleep disorders
775585|NCT00346554|pulmonary rehabilitation|pulmonary rehabilitation
775586|NCT00346541|glaucoma|glaucoma
775587|NCT00346541|polymorphism, genetic|polymorphism, genetic
775588|NCT00346515|carotid artery|carotid artery
775589|NCT00346515|carotid stenosis|carotid stenosis
775590|NCT00346515|carotid stenting|carotid stenting
775591|NCT00346515|embolic protection|embolic protection
775592|NCT00346489|Trabeculectomy|trabeculectomy
775593|NCT00346489|5-fluorouracil|5-fluorouracil
775594|NCT00346489|Mitomycin C|mitomycin c
775595|NCT00346476|TB|tb
775596|NCT00346476|Transmission|transmission
775597|NCT00346476|Genetic Diversity|genetic diversity
775598|NCT00346476|Genetic Testing|genetic testing
775599|NCT00346476|RFLP|rflp
775600|NCT00346463|Allopurinol|allopurinol
775601|NCT00346463|Fetal Growth Retardation|fetal growth retardation
775602|NCT00346463|Oxidative Stress|oxidative stress
775603|NCT00346463|Placental Insufficiency|placental insufficiency
775604|NCT00346450|Culture|culture
775605|NCT00346450|Conjunctiva|conjunctiva
775606|NCT00346450|transplantation|transplantation
775607|NCT00346450|pterygium|pterygium
775608|NCT00346450|ocular surface|ocular surface
775609|NCT00346437|angina|angina
775610|NCT00346437|FGF-4|fgf-4
775611|NCT00346437|angiogenesis|angiogenesis
775612|NCT00346437|adenovector|adenovector
775613|NCT00346437|growth factor|growth factor
775614|NCT00346437|myocardial ischemia|myocardial ischemia
775615|NCT00346437|revascularization|revascularization
775616|NCT00346424|occluded central catheter|occluded central catheter
775617|NCT00346424|central venous access devices dysfunction|central venous access devices dysfunction
775618|NCT00346424|withdrawal occlusion|withdrawal occlusion
775619|NCT00346424|Thrombosis|thrombosis
775620|NCT00346424|Venous thrombosis|venous thrombosis
775621|NCT00346411|rheumatoid arthritis|rheumatoid arthritis
775622|NCT00346411|mood|mood
775623|NCT00346411|adherence|adherence
775624|NCT00346411|medication|medication
775625|NCT00346398|asthma|asthma
775626|NCT00346398|allergen|allergen
775627|NCT00346398|allergic disease|allergic disease
775628|NCT00346398|allergen immunotherapy|allergen immunotherapy
775629|NCT00346398|allergic sensitization|allergic sensitization
775630|NCT00346398|atopic dermatitis|atopic dermatitis
775631|NCT00346398|eczema|eczema
775632|NCT00346398|food allergy|food allergy
775633|NCT00346398|oral mucosal immunoprophylaxis (OMIP)|oral mucosal immunoprophylaxis (omip)
775634|NCT00346385|recurrent small cell lung cancer|recurrent small cell lung cancer
775635|NCT00346385|merkel cell carcinoma|merkel cell carcinoma
775636|NCT00346385|ovarian cancer|ovarian cancer
775637|NCT00346372|Ocular Melanoma|ocular melanoma
775638|NCT00346372|Optical Coherence Tomography|optical coherence tomography
775639|NCT00346372|Eye Tumor|eye tumor
775640|NCT00346372|Choroidal Melanoma|choroidal melanoma
775641|NCT00346372|Uveal Melanoma|uveal melanoma
775642|NCT00346359|graft versus host disease|graft versus host disease
775643|NCT00346359|chronic phase chronic myelogenous leukemia|chronic phase chronic myelogenous leukemia
775644|NCT00346359|childhood chronic myelogenous leukemia|childhood chronic myelogenous leukemia
775645|NCT00346359|blastic phase chronic myelogenous leukemia|blastic phase chronic myelogenous leukemia
775646|NCT00346359|accelerated phase chronic myelogenous leukemia|accelerated phase chronic myelogenous leukemia
775647|NCT00346359|relapsing chronic myelogenous leukemia|relapsing chronic myelogenous leukemia
775648|NCT00346359|adult acute myeloid leukemia in remission|adult acute myeloid leukemia in remission
775649|NCT00346359|recurrent adult acute myeloid leukemia|recurrent adult acute myeloid leukemia
775650|NCT00346359|childhood acute myeloid leukemia in remission|childhood acute myeloid leukemia in remission
775738|NCT00346099|oxaliplatin|oxaliplatin
775651|NCT00346359|recurrent childhood acute myeloid leukemia|recurrent childhood acute myeloid leukemia
775652|NCT00346359|de novo myelodysplastic syndromes|de novo myelodysplastic syndromes
775653|NCT00346359|previously treated myelodysplastic syndromes|previously treated myelodysplastic syndromes
775654|NCT00346359|secondary myelodysplastic syndromes|secondary myelodysplastic syndromes
775655|NCT00346359|atypical chronic myeloid leukemia|atypical chronic myeloid leukemia
775656|NCT00346359|chronic myelomonocytic leukemia|chronic myelomonocytic leukemia
775657|NCT00346359|juvenile myelomonocytic leukemia|juvenile myelomonocytic leukemia
775658|NCT00346359|myelodysplastic/myeloproliferative disease, unclassifiable|myelodysplastic/myeloproliferative disease, unclassifiable
775659|NCT00346359|secondary acute myeloid leukemia|secondary acute myeloid leukemia
775660|NCT00346359|chronic eosinophilic leukemia|chronic eosinophilic leukemia
775661|NCT00346359|chronic idiopathic myelofibrosis|chronic idiopathic myelofibrosis
775662|NCT00346359|chronic neutrophilic leukemia|chronic neutrophilic leukemia
775663|NCT00346359|adult acute myeloid leukemia with 11q23 (MLL) abnormalities|adult acute myeloid leukemia with 11q23 (mll) abnormalities
775664|NCT00346359|adult acute myeloid leukemia with inv(16)(p13;q22)|adult acute myeloid leukemia with inv(16)(p13;q22)
775665|NCT00346359|adult acute myeloid leukemia with t(15;17)(q22;q12)|adult acute myeloid leukemia with t(15;17)(q22;q12)
775666|NCT00346359|adult acute myeloid leukemia with t(16;16)(p13;q22)|adult acute myeloid leukemia with t(16;16)(p13;q22)
775667|NCT00346359|adult acute myeloid leukemia with t(8;21)(q22;q22)|adult acute myeloid leukemia with t(8;21)(q22;q22)
775668|NCT00346359|childhood myelodysplastic syndromes|childhood myelodysplastic syndromes
775669|NCT00346346|Immunity|immunity
775670|NCT00346346|Memory|memory
775671|NCT00346346|ELISPOT|elispot
775672|NCT00346346|Malaria|malaria
775673|NCT00346346|Prospective|prospective
775674|NCT00346333|Retinitis Pigmentosa, Inherited Retinal Degeneration|retinitis pigmentosa, inherited retinal degeneration
775675|NCT00346320|stage I non-small cell lung cancer|stage i non-small cell lung cancer
775676|NCT00346320|stage II non-small cell lung cancer|stage ii non-small cell lung cancer
775677|NCT00346320|adenocarcinoma of the lung|adenocarcinoma of the lung
775678|NCT00346320|adenosquamous cell lung cancer|adenosquamous cell lung cancer
775679|NCT00346320|bronchoalveolar cell lung cancer|bronchoalveolar cell lung cancer
775680|NCT00346320|large cell lung cancer|large cell lung cancer
775681|NCT00346320|squamous cell lung cancer|squamous cell lung cancer
775682|NCT00346294|Rheumatoid Arthritis|rheumatoid arthritis
775683|NCT00346294|Device|device
775684|NCT00346294|Auto-injector|auto-injector
775685|NCT00346294|SureClick|sureclick
775686|NCT00346294|Enbrel|enbrel
775687|NCT00346294|Etanercept|etanercept
775688|NCT00346281|unresectable pancreatic cancer|unresectable pancreatic cancer
775689|NCT00346281|brachytherapy|brachytherapy
775690|NCT00346281|32P|32p
775691|NCT00346281|BioSilicon|biosilicon
775692|NCT00346281|locally advanced|locally advanced
775693|NCT00346281|gemcitabine|gemcitabine
775694|NCT00346281|intratumourally|intratumourally
775695|NCT00346281|unresectable|unresectable
775696|NCT00346255|stage I multiple myeloma|stage i multiple myeloma
775697|NCT00346255|stage II multiple myeloma|stage ii multiple myeloma
775698|NCT00346255|stage III multiple myeloma|stage iii multiple myeloma
775699|NCT00346242|thalassemia|thalassemia
775700|NCT00346242|zoledronic acid|zoledronic acid
775701|NCT00346242|skeletal events|skeletal events
775702|NCT00346229|stage III B breast cancer|stage iii b breast cancer
775703|NCT00346229|stage III C breast cancer|stage iii c breast cancer
775704|NCT00346229|stage IV breast cancer|stage iv breast cancer
775705|NCT00346229|inflammatory breast cancer|inflammatory breast cancer
775706|NCT00346229|recurrent breast cancer|recurrent breast cancer
775707|NCT00346177|heart|heart
775708|NCT00346177|stem Cells|stem cells
775709|NCT00346177|low EF|low ef
775710|NCT00346177|heart attack|heart attack
775711|NCT00346177|cardiomyopathy|cardiomyopathy
775712|NCT00346177|congestive heart failure|congestive heart failure
775713|NCT00346177|cardiovascular disease|cardiovascular disease
775714|NCT00346177|Heart Failure|heart failure
775715|NCT00346177|Low Ejection Fraction|low ejection fraction
775716|NCT00346151|renal transplantation|renal transplantation
775717|NCT00346151|kidney transplantation|kidney transplantation
775718|NCT00346151|renal allograft recipient|renal allograft recipient
775719|NCT00346151|anti-rejection drugs|anti-rejection drugs
775720|NCT00346151|immunosuppression protocol|immunosuppression protocol
775721|NCT00346151|immunosuppression withdrawal|immunosuppression withdrawal
775722|NCT00346125|soft tissue sarcoma|soft tissue sarcoma
775723|NCT00346125|Malignant fibrous histiocytoma|malignant fibrous histiocytoma
775724|NCT00346125|Liposarcoma|liposarcoma
775725|NCT00346125|Fibrosarcoma|fibrosarcoma
775726|NCT00346125|Leiomyosarcoma|leiomyosarcoma
775727|NCT00346125|Synovial sarcoma|synovial sarcoma
775728|NCT00346125|Malignant peripheral nerve sheath tumor (MPNST)|malignant peripheral nerve sheath tumor (mpnst)
775729|NCT00346125|Epithelioid sarcoma|epithelioid sarcoma
775730|NCT00346112|ICD|icd
775731|NCT00346112|distress|distress
775732|NCT00346112|anxiety|anxiety
775733|NCT00346112|quality-of-life|quality-of-life
775734|NCT00346099|NSABP|nsabp
775735|NCT00346099|panitumumab|panitumumab
775736|NCT00346099|rectal cancer|rectal cancer
775737|NCT00346099|colorectal cancer|colorectal cancer
775739|NCT00346099|capecitabine|capecitabine
775740|NCT00346099|combined modality therapy|combined modality therapy
775741|NCT00346099|combined pelvic radiation therapy|combined pelvic radiation therapy
775742|NCT00346099|Rectal cancer with or without metastasis|rectal cancer with or without metastasis
775743|NCT00346086|CpG oligonucleotide vaccine|cpg oligonucleotide vaccine
775744|NCT00346086|ragweed immunotherapy|ragweed immunotherapy
775745|NCT00346073|Prophylaxis for diphtheria, tetanus, pertussis|prophylaxis for diphtheria, tetanus, pertussis
775746|NCT00346073|Immunogenicity, booster, dTpa|immunogenicity, booster, dtpa
775867|NCT00345683|Neisseria meningitidis|neisseria meningitidis
775747|NCT00346060|Dry age related macular degeneration.|dry age related macular degeneration.
775748|NCT00346060|Retinal Transplant|retinal transplant
775749|NCT00346060|Fetal Tissue|fetal tissue
775750|NCT00346060|Early treatment diabetic retinopathy study|early treatment diabetic retinopathy study
775751|NCT00346060|20/200 or worse.|20/200 or worse.
775752|NCT00346021|Children's behavior towards hat use|children's behavior towards hat use
775753|NCT00346008|melanoma|melanoma
775754|NCT00346008|recurrent melanoma|recurrent melanoma
775755|NCT00346008|stage I melanoma|stage i melanoma
775756|NCT00346008|stage II melanoma|stage ii melanoma
775757|NCT00346008|stage III melanoma|stage iii melanoma
775758|NCT00346008|stage IV melanoma|stage iv melanoma
775759|NCT00345982|Schizophrenia|schizophrenia
775760|NCT00345982|Treatment-resistant|treatment-resistant
775761|NCT00345982|sertindole|sertindole
775762|NCT00345982|clozapine|clozapine
775763|NCT00345969|Testosterone Replacement Therapy|testosterone replacement therapy
775764|NCT00345969|Physical Frailty|physical frailty
775765|NCT00345969|Hip Fracture|hip fracture
775766|NCT00345956|Prophylaxis against gastroenteritis caused by Rotavirus|prophylaxis against gastroenteritis caused by rotavirus
775767|NCT00345943|Eating Disorders|eating disorders
775768|NCT00345943|Bulimia Nervosa|bulimia nervosa
775769|NCT00345943|Bulimia|bulimia
775770|NCT00345943|fMRI|fmri
775771|NCT00345943|Magnetic Resonance Imaging|magnetic resonance imaging
775772|NCT00345930|Complementary and alternative medicine|complementary and alternative medicine
775773|NCT00345930|Complementary therapies|complementary therapies
775774|NCT00345930|Alternative therapies|alternative therapies
775775|NCT00345930|Prescription Drugs|prescription drugs
775776|NCT00345930|Non prescription Drugs|non prescription drugs
775777|NCT00345930|Liver Disease|liver disease
775778|NCT00345930|Chemical Ind|chemical ind
775779|NCT00345930|Phenotype|phenotype
775780|NCT00345930|Proteomics|proteomics
775781|NCT00345930|Metabolomics|metabolomics
775782|NCT00345930|Cholestatic Liver Injury|cholestatic liver injury
775783|NCT00345930|Hepatocellular Liver Injury|hepatocellular liver injury
775784|NCT00345930|Mixed Liver Injury|mixed liver injury
775785|NCT00345930|Matched Case Control Studies|matched case control studies
775786|NCT00345930|Genotype|genotype
775787|NCT00345930|Liver Dis|liver dis
775788|NCT00345930|Chem Ind|chem ind
775789|NCT00345917|Retinitis Pigmentosa|retinitis pigmentosa
775790|NCT00345917|Retinal Transplant|retinal transplant
775791|NCT00345917|Fetal Tissue|fetal tissue
775792|NCT00345917|Early treatment diabetic retinopathy study|early treatment diabetic retinopathy study
775793|NCT00345917|20/200 or worse.|20/200 or worse.
775794|NCT00345904|influenza, vaccine|influenza, vaccine
775795|NCT00345904|prophylaxis of influenza|prophylaxis of influenza
775796|NCT00345891|Lung neoplasms|lung neoplasms
775797|NCT00345891|Family|family
775798|NCT00345891|Stress|stress
775799|NCT00345878|HPV-16/18 L1 VLP AS04|hpv-16/18 l1 vlp as04
775800|NCT00345878|Cervical neoplasia|cervical neoplasia
775801|NCT00345878|Cervical cancer|cervical cancer
775802|NCT00345878|Human Papillomavirus (HPV)|human papillomavirus (hpv)
775803|NCT00345878|Double-blind|double-blind
775804|NCT00345878|AS04|as04
775805|NCT00345865|Hodgkin lymphoma|hodgkin lymphoma
775806|NCT00345865|non-Hodgkin lymphoma|non-hodgkin lymphoma
775807|NCT00345865|HIV-associated lymphoma|hiv-associated lymphoma
775808|NCT00345852|twin to twin transfusion syndrome|twin to twin transfusion syndrome
775809|NCT00345852|fetoscopic selective laser photocoagulation|fetoscopic selective laser photocoagulation
775810|NCT00345852|amnioreduction|amnioreduction
775811|NCT00345839|Cinacalcet HCl|cinacalcet hcl
775812|NCT00345839|Cinacalcet|cinacalcet
775813|NCT00345839|AMG 073|amg 073
775814|NCT00345839|Sensipar|sensipar
775815|NCT00345839|Mimpara|mimpara
775816|NCT00345839|Calcimimetic|calcimimetic
775817|NCT00345839|Hemodialysis|hemodialysis
775819|NCT00345839|Secondary hyperparathyroidism (HPT)|secondary hyperparathyroidism (hpt)
775820|NCT00345826|accelerated phase chronic myelogenous leukemia|accelerated phase chronic myelogenous leukemia
775821|NCT00345826|blastic phase chronic myelogenous leukemia|blastic phase chronic myelogenous leukemia
775822|NCT00345826|chronic phase chronic myelogenous leukemia|chronic phase chronic myelogenous leukemia
775823|NCT00345826|relapsing chronic myelogenous leukemia|relapsing chronic myelogenous leukemia
775824|NCT00345826|recurrent adult acute lymphoblastic leukemia|recurrent adult acute lymphoblastic leukemia
775825|NCT00345826|chronic myelogenous leukemia, BCR-ABL1 positive|chronic myelogenous leukemia, bcr-abl1 positive
775826|NCT00345813|adenocarcinoma of the prostate|adenocarcinoma of the prostate
775827|NCT00345813|stage I prostate cancer|stage i prostate cancer
775828|NCT00345813|stage IIB prostate cancer|stage iib prostate cancer
775829|NCT00345813|stage IIA prostate cancer|stage iia prostate cancer
775830|NCT00345813|stage III prostate cancer|stage iii prostate cancer
775831|NCT00345813|stage IV prostate cancer|stage iv prostate cancer
775832|NCT00345800|Endocrine Evaluation cataplexy|endocrine evaluation cataplexy
775833|NCT00345800|sodium oxybate (xyrem)|sodium oxybate (xyrem)
775834|NCT00345787|Osteoarthritic Pain|osteoarthritic pain
775835|NCT00345774|Pulmonary Hypertension|pulmonary hypertension
775836|NCT00345774|PH|ph
775837|NCT00345774|Pulmonary Arterial Hypertension|pulmonary arterial hypertension
775838|NCT00345774|PAH|pah
775839|NCT00345774|Chronic Obstructive Pulmonary Disease|chronic obstructive pulmonary disease
775840|NCT00345774|COPD|copd
775841|NCT00345774|PRX-08066|prx-08066
775842|NCT00345774|Predix|predix
775843|NCT00345761|Advanced and/or metastatic colorectal cancer|advanced and/or metastatic colorectal cancer
775844|NCT00345735|Cancer pain with breakthrough pain episodes|cancer pain with breakthrough pain episodes
775845|NCT00345722|Strawberry|strawberry
775846|NCT00345722|Almond|almond
775847|NCT00345722|Soy protein|soy protein
775848|NCT00345722|viscous dietary fibre|viscous dietary fibre
775849|NCT00345722|plant sterols|plant sterols
775850|NCT00345722|portfolio diet|portfolio diet
775851|NCT00345722|blood lipids|blood lipids
775852|NCT00345722|compliance|compliance
775853|NCT00345722|blood pressure|blood pressure
775854|NCT00345709|Ovarian Cancer|ovarian cancer
775855|NCT00345709|Peritoneal Cancer|peritoneal cancer
775856|NCT00345709|Fallopian Tube Cancer|fallopian tube cancer
775857|NCT00345709|Elizabeth Registry|elizabeth registry
775858|NCT00345709|Questionnaire|questionnaire
775859|NCT00345709|Registry|registry
775860|NCT00345709|Survey|survey
775861|NCT00345696|Capecitabine|capecitabine
775862|NCT00345696|Oxaliplatin|oxaliplatin
775863|NCT00345696|Bevacizumab|bevacizumab
775864|NCT00345696|First line|first line
775865|NCT00345683|H. influenzae type B vaccine|h. influenzae type b vaccine
775866|NCT00345683|Infants|infants
775868|NCT00345683|Vaccines, conjugate|vaccines, conjugate
775869|NCT00345683|Meningococcal vaccines|meningococcal vaccines
775870|NCT00345683|Prophylaxis|prophylaxis
775871|NCT00345683|Comparative study|comparative study
775872|NCT00345683|Safety|safety
775873|NCT00345683|Humans|humans
775874|NCT00345670|Lower respiratory tract illness|lower respiratory tract illness
775875|NCT00345670|RSV and PIV3 infection|rsv and piv3 infection
775876|NCT00345657|Hyperlipidemia|hyperlipidemia
775877|NCT00345657|Dyslipidemia|dyslipidemia
775878|NCT00345657|Niacin|niacin
775879|NCT00345657|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors
775880|NCT00345657|Combination lipid therapy|combination lipid therapy
775881|NCT00345657|Lovastatin|lovastatin
775882|NCT00345644|Postmenopausal|postmenopausal
775883|NCT00345631|Closure Device|closure device
775884|NCT00345631|Angiography|angiography
775885|NCT00345631|Angioplasty|angioplasty
775886|NCT00345631|Hemostasis|hemostasis
775887|NCT00345631|Heart Catheterization|heart catheterization
775888|NCT00345631|Peripheral Angiography|peripheral angiography
775889|NCT00345631|Femoral Closure|femoral closure
775890|NCT00345631|Vascular Closure|vascular closure
775891|NCT00345631|Coronary Angiography|coronary angiography
775892|NCT00345618|Deep venous thrombosis|deep venous thrombosis
775893|NCT00345618|pulmonary embolism|pulmonary embolism
775894|NCT00345618|anticoagulant drugs|anticoagulant drugs
775895|NCT00345605|Argininosuccinic Acid Lyase Deficiency|argininosuccinic acid lyase deficiency
775896|NCT00345605|ASA|asa
775897|NCT00345579|Prophylaxis|prophylaxis
775898|NCT00345579|Neisseria meningitidis Vaccines, conjugate|neisseria meningitidis vaccines, conjugate
775899|NCT00345579|Infants|infants
775900|NCT00345579|Meningococcal vaccines|meningococcal vaccines
775901|NCT00345579|H. influenzae type B vaccine|h. influenzae type b vaccine
775902|NCT00345579|Humans|humans
775903|NCT00345579|Safety|safety
775904|NCT00345566|cerebral palsy|cerebral palsy
775905|NCT00345566|protein composition|protein composition
775906|NCT00345566|gastric emptying rate|gastric emptying rate
775907|NCT00345566|tube feeding|tube feeding
775908|NCT00345553|Biliary Atresia|biliary atresia
775909|NCT00345553|Cholestasis|cholestasis
775910|NCT00345540|Platinum Resistant Tumors of Ovarian Origin|platinum resistant tumors of ovarian origin
775911|NCT00345527|Problem gambling|problem gambling
775912|NCT00345527|Clinically significant anger|clinically significant anger
775913|NCT00345514|Children|children
775914|NCT00345514|Self-efficacy|self-efficacy
775915|NCT00345514|Organization|organization
775916|NCT00345514|Process of care|process of care
775917|NCT00345501|contrast media|contrast media
775918|NCT00345501|contrast nephropathy|contrast nephropathy
775919|NCT00345475|Birth Defects|birth defects
775920|NCT00345475|Epilepsy|epilepsy
775921|NCT00345475|High Risk Pregnancy|high risk pregnancy
775922|NCT00345462|Influenza, Vaccine, CHMP criteria|influenza, vaccine, chmp criteria
775923|NCT00345449|cystic fibrosis,|cystic fibrosis,
775924|NCT00345449|lung disease,|lung disease,
775925|NCT00345449|lung transplantation,|lung transplantation,
775926|NCT00345449|decision aid|decision aid
775927|NCT00345436|Insulin Sensitivity|insulin sensitivity
775928|NCT00345436|Moderate intensity|moderate intensity
775929|NCT00345436|Insulin Resistance|insulin resistance
775930|NCT00345436|Exercise Intervention|exercise intervention
776509|NCT00343031|Infection|infection
775931|NCT00345410|obesity and dyslipidemia|obesity and dyslipidemia
775932|NCT00345397|cecostomy|cecostomy
775933|NCT00345397|colonoscopy|colonoscopy
775934|NCT00345397|colostomy|colostomy
775935|NCT00345397|constipation|constipation
775936|NCT00345397|endoscopy, gastrointestinal|endoscopy, gastrointestinal
775937|NCT00345397|fecal incontinence|fecal incontinence
775938|NCT00345397|percutaneous|percutaneous
775939|NCT00345397|quality of life|quality of life
775940|NCT00345397|spinal cord injury|spinal cord injury
775941|NCT00345384|Dexmedetomidine|dexmedetomidine
775942|NCT00345384|Sedation|sedation
775943|NCT00345384|Opioid|opioid
775944|NCT00345384|Respiratory depression|respiratory depression
775945|NCT00345371|methamphetamine addiction|methamphetamine addiction
775946|NCT00345358|Booster vaccination|booster vaccination
775947|NCT00345358|Catch-up vaccination|catch-up vaccination
775948|NCT00345358|Pneumococcal vaccine|pneumococcal vaccine
775949|NCT00345358|Immunogenicity|immunogenicity
775950|NCT00345358|Safety|safety
775951|NCT00345358|Pneumococcal disease|pneumococcal disease
775952|NCT00345345|Neutropenia|neutropenia
775953|NCT00345345|Monoclonal Antibody Therapy|monoclonal antibody therapy
775954|NCT00345345|Anti-CD52|anti-cd52
775955|NCT00345345|T-LGL Leukemia|t-lgl leukemia
775956|NCT00345345|LGL Leukemia|lgl leukemia
775957|NCT00345345|Leukemia|leukemia
775958|NCT00345319|rabies|rabies
775959|NCT00345319|vaccine|vaccine
775960|NCT00345319|post-exposure prophylaxis|post-exposure prophylaxis
775961|NCT00345306|endometrial preparation|endometrial preparation
775962|NCT00345306|Utrogestan|utrogestan
775963|NCT00345306|Endometrin|endometrin
775964|NCT00345293|Prostate Cancer|prostate cancer
775965|NCT00345280|Cystic fibrosis|cystic fibrosis
775966|NCT00345280|eye|eye
775967|NCT00345280|inflammation|inflammation
775968|NCT00345280|apoptosis|apoptosis
775969|NCT00345280|C11+|c11+
775970|NCT00345267|Asthma|asthma
775971|NCT00345267|Children|children
775972|NCT00345267|Integrated Care Pathway|integrated care pathway
775973|NCT00345267|Evidence based medicine|evidence based medicine
775974|NCT00345267|Prescribing errors|prescribing errors
775975|NCT00345241|Blepharitis|blepharitis
775976|NCT00345228|High myopia|high myopia
775977|NCT00345228|Choroidal neovascularisation|choroidal neovascularisation
775978|NCT00345228|Lacquer crack|lacquer crack
775979|NCT00345228|Fundus fluorescein angiography|fundus fluorescein angiography
775980|NCT00345228|Indocyanine green angiography|indocyanine green angiography
775981|NCT00345228|Axial length|axial length
775982|NCT00345215|Urinary Aquaporin 2|urinary aquaporin 2
775983|NCT00345215|High/low Sodium Diet|high/low sodium diet
775984|NCT00345215|Fractional Sodium Excretion|fractional sodium excretion
775985|NCT00345202|HMG-COA reductase inhibition|hmg-coa reductase inhibition
775986|NCT00345202|GFR|gfr
775987|NCT00345202|RPF|rpf
775988|NCT00345202|FE|fe
775989|NCT00345202|CL|cl
775990|NCT00345189|Hsp90 inhibitor|hsp90 inhibitor
775991|NCT00345189|CNF2024|cnf2024
775992|NCT00345189|Advanced Solid Tumors|advanced solid tumors
775993|NCT00345176|age-related macular degeneration|age-related macular degeneration
775994|NCT00345176|AMD|amd
775996|NCT00345176|zeaxanthin|zeaxanthin
775997|NCT00345176|docosahexaenoic acid|docosahexaenoic acid
775998|NCT00345176|eicosapentaenoic acid|eicosapentaenoic acid
775999|NCT00345163|Glioblastoma Multiforme|glioblastoma multiforme
776000|NCT00345163|Avastin|avastin
776001|NCT00345163|Brain Cancer|brain cancer
776002|NCT00345163|GBM|gbm
776003|NCT00345150|hypertension|hypertension
776004|NCT00345150|nitric oxide|nitric oxide
776005|NCT00345150|renal hemodynamics|renal hemodynamics
776006|NCT00345137|Renal hemodynamics|renal hemodynamics
776007|NCT00345137|Nitric oxide|nitric oxide
776008|NCT00345124|urinary aquaporin-2|urinary aquaporin-2
776009|NCT00345124|ENaC|enac
776010|NCT00345124|fractional sodium excretion|fractional sodium excretion
776011|NCT00345124|High/low sodium diet|high/low sodium diet
776012|NCT00345111|Restor IOL versus Conventional IOL|restor iol versus conventional iol
776013|NCT00345098|Depression, Antidepressive agents|depression, antidepressive agents
776014|NCT00345098|Clinical Trial|clinical trial
776015|NCT00345098|Phase III|phase iii
776016|NCT00345098|Multicenter study|multicenter study
776017|NCT00345072|Menopause|menopause
776018|NCT00345072|Decision aids|decision aids
776019|NCT00345072|Internet|internet
776020|NCT00345072|Hormone Replacement Therapy|hormone replacement therapy
776021|NCT00345072|Breast Cancer|breast cancer
776022|NCT00345072|Cardiovascular Disease|cardiovascular disease
776023|NCT00345072|Osteoporosis|osteoporosis
776024|NCT00345059|second line|second line
776025|NCT00345059|monochemotherapy|monochemotherapy
776026|NCT00345059|combination chemotherapy|combination chemotherapy
776027|NCT00345059|platinum refractory|platinum refractory
776028|NCT00345059|previously treated|previously treated
776031|NCT00345033|Glucose Metabolism|glucose metabolism
776032|NCT00345020|Deep Lamellar Endotheliam Keratoplasty|deep lamellar endotheliam keratoplasty
776033|NCT00345007|Retinal detachment|retinal detachment
776034|NCT00345007|Macular function|macular function
776035|NCT00345007|Multifocal electrophysiology|multifocal electrophysiology
776036|NCT00344994|Restless Legs Syndrome|restless legs syndrome
776037|NCT00344994|Mirapex (pramipexole)|mirapex (pramipexole)
776038|NCT00344994|Requip(Ropinirole)|requip(ropinirole)
776039|NCT00344994|Dopamine Agonist|dopamine agonist
776040|NCT00344981|Cell Cycle Agents|cell cycle agents
776041|NCT00344955|HMG-COA reductase inhibition|hmg-coa reductase inhibition
776042|NCT00344955|GFR|gfr
776043|NCT00344955|RPF|rpf
776044|NCT00344955|FE|fe
776045|NCT00344955|CL|cl
776046|NCT00344916|Renal hemodynamics|renal hemodynamics
776047|NCT00344916|Nitric oxide|nitric oxide
776048|NCT00344903|Atherosclerosis|atherosclerosis
776049|NCT00344903|Heart Failure|heart failure
776050|NCT00344903|Ventricular Hypertrophy|ventricular hypertrophy
776051|NCT00344903|Myocardial Infarction|myocardial infarction
776052|NCT00344903|Screening|screening
776053|NCT00344903|Hypertension|hypertension
776054|NCT00344903|Diabetes|diabetes
776055|NCT00344903|Obesity|obesity
776056|NCT00344903|Metabolic Syndrome|metabolic syndrome
776057|NCT00344890|Cervical fusion|cervical fusion
776058|NCT00344890|Anterior Cervical Discectomy and Fusion|anterior cervical discectomy and fusion
776059|NCT00344890|ACDF|acdf
776060|NCT00344877|Epilepsy|epilepsy
776061|NCT00344877|Temporal Lobe Epilepsy|temporal lobe epilepsy
776062|NCT00344877|Cortical Excitability|cortical excitability
776063|NCT00344877|Transcranial Direct Current Stimulation (tDCS)|transcranial direct current stimulation (tdcs)
776064|NCT00344877|Memory Testing|memory testing
776065|NCT00344877|Seizures|seizures
776066|NCT00344877|Transcranial Magnetic Stimulation (TMS)|transcranial magnetic stimulation (tms)
776067|NCT00344877|Memory|memory
776068|NCT00344877|Plasticity|plasticity
776069|NCT00344864|Contact Lenses Higher Order Aberrations|contact lenses higher order aberrations
776070|NCT00344851|menstrual cyclicity|menstrual cyclicity
776071|NCT00344851|insulin resistance|insulin resistance
776072|NCT00344851|body fat distribution|body fat distribution
776073|NCT00344851|pancreatic ß-cell function|pancreatic ß-cell function
776074|NCT00344851|inflammatory markers|inflammatory markers
776075|NCT00344851|liver function tests|liver function tests
776076|NCT00344838|LADARWave™|ladarwave™
776077|NCT00344838|WaveScan Wavefront™ Systems|wavescan wavefront™ systems
776078|NCT00344825|B- Chronic Lymphocytic Leukemia|b- chronic lymphocytic leukemia
776079|NCT00344799|Choroidal Melanoma|choroidal melanoma
776080|NCT00344799|Choroidal Malignant Melanoma|choroidal malignant melanoma
776081|NCT00344799|Ocular Melanoma|ocular melanoma
776082|NCT00344799|Uveal Melanoma|uveal melanoma
776083|NCT00344786|CLL|cll
776084|NCT00344786|CNF2024|cnf2024
776085|NCT00344786|Hsp90 inhibitor|hsp90 inhibitor
776086|NCT00344773|Locally advanced (IIIB) pulmonary adenocarcinoma with EGFR mutation|locally advanced (iiib) pulmonary adenocarcinoma with egfr mutation
776087|NCT00344773|Metastatic (IV) pulmonary adenocarcinoma with EGFR mutation|metastatic (iv) pulmonary adenocarcinoma with egfr mutation
776088|NCT00344773|Recurrent pulmonary adenocarcinoma with EGFR mutation|recurrent pulmonary adenocarcinoma with egfr mutation
776089|NCT00344747|intervention program|intervention program
776090|NCT00344747|diet|diet
776091|NCT00344747|physical activity|physical activity
776092|NCT00344747|adolescents|adolescents
776093|NCT00344747|obesity|obesity
776094|NCT00344734|Nitric oxide|nitric oxide
776095|NCT00344734|Renal hemodynamics|renal hemodynamics
776096|NCT00344721|Meibomian Gland Syndrome|meibomian gland syndrome
776097|NCT00344721|Blepharitis|blepharitis
776098|NCT00344708|Tissue-Cultured Human Amniotic Epithelial Cells onto damaged corneal surface|tissue-cultured human amniotic epithelial cells onto damaged corneal surface
776099|NCT00344682|memantine|memantine
776100|NCT00344682|Namenda|namenda
776101|NCT00344682|augmentation|augmentation
776102|NCT00344682|add-on|add-on
776103|NCT00344682|depression|depression
776104|NCT00344682|MDD (major depressive disorder)|mdd (major depressive disorder)
776105|NCT00344682|unipolar depression|unipolar depression
776106|NCT00344682|NMDA|nmda
776107|NCT00344682|ketamine|ketamine
776108|NCT00344682|uncompetitive NMDA receptor antagonist|uncompetitive nmda receptor antagonist
776109|NCT00344669|underweight|underweight
776110|NCT00344669|preschool|preschool
776111|NCT00344669|mass deworming|mass deworming
776112|NCT00344656|Eating Disorders|eating disorders
776113|NCT00344656|Anorexia Nervosa|anorexia nervosa
776114|NCT00344643|Comparison of Daily wear versus Extended wear in bacterial binding and corneal epithelial thickness|comparison of daily wear versus extended wear in bacterial binding and corneal epithelial thickness
776115|NCT00344617|Choroidal neovascularisation|choroidal neovascularisation
776116|NCT00344617|Polypoidal choroidal vasculopathy|polypoidal choroidal vasculopathy
776117|NCT00344617|Intravitreal injection|intravitreal injection
776118|NCT00344617|Avastin|avastin
776119|NCT00344604|Patients who have undergone routine LASIK as a primary refractive procedure for myopia, hyperopia, or astigmatism.|patients who have undergone routine lasik as a primary refractive procedure for myopia, hyperopia, or astigmatism.
776120|NCT00344591|HIV|hiv
776122|NCT00344578|Higher Order Abberations|higher order abberations
776123|NCT00344539|asexual blood stage vaccine, Plasmodium falciparum malaria|asexual blood stage vaccine, plasmodium falciparum malaria
776124|NCT00344526|AL amyloidosis|al amyloidosis
776125|NCT00344526|Autologous stem cell transplantation|autologous stem cell transplantation
776126|NCT00344526|Melphalan|melphalan
776127|NCT00344526|Dexamethasone|dexamethasone
776128|NCT00344513|registry|registry
776129|NCT00344513|OPTIMIZE|optimize
776130|NCT00344513|Heart failure|heart failure
776131|NCT00344513|OPTIMIZE-HF|optimize-hf
776132|NCT00344500|Antipsychotic|antipsychotic
776133|NCT00344500|Bipolar|bipolar
776134|NCT00344500|Diabetes|diabetes
776135|NCT00344500|Mental Illness|mental illness
776136|NCT00344500|Nutrition|nutrition
776137|NCT00344500|Obesity|obesity
776138|NCT00344500|Schizoaffective|schizoaffective
776139|NCT00344500|Schizophrenia|schizophrenia
776140|NCT00344500|Weight Gain|weight gain
776141|NCT00344500|Weight Loss|weight loss
776142|NCT00344474|Prevention|prevention
776143|NCT00344474|Addiction|addiction
776144|NCT00344474|Personality|personality
776145|NCT00344474|Adolescents|adolescents
776146|NCT00344474|Binge Drinking|binge drinking
776147|NCT00344474|Alcohol Abuse|alcohol abuse
776148|NCT00344474|Comorbidity|comorbidity
776149|NCT00344474|Depression|depression
776150|NCT00344474|Anxiety|anxiety
776151|NCT00344474|Antisocial Behaviour|antisocial behaviour
776152|NCT00344448|Adhesion Molecule|adhesion molecule
776153|NCT00344448|Interventional Study|interventional study
776154|NCT00344448|Immunomodulation|immunomodulation
776155|NCT00344448|Autoimmunity|autoimmunity
776156|NCT00344448|Sjogren Syndrome|sjogren syndrome
776157|NCT00344448|SS|ss
776158|NCT00344435|Hemophilia|hemophilia
776159|NCT00344435|Antibody|antibody
776160|NCT00344435|Mutations|mutations
776161|NCT00344435|SNP|snp
776162|NCT00344435|clotting|clotting
776163|NCT00344422|Anthracyclines|anthracyclines
776164|NCT00344422|Liposomes|liposomes
776165|NCT00344422|Liposomal|liposomal
776166|NCT00344422|Vincristine|vincristine
776167|NCT00344422|Doxorubicin|doxorubicin
776168|NCT00344422|Dexamethasone|dexamethasone
776169|NCT00344422|Pegylated Liposomal Doxorubicin|pegylated liposomal doxorubicin
776170|NCT00344422|DOXIL|doxil
776171|NCT00344422|drug resistant myeloma|drug resistant myeloma
776172|NCT00344409|darbepoetin alfa|darbepoetin alfa
776173|NCT00344409|anemia|anemia
776174|NCT00344409|cancer patients|cancer patients
776175|NCT00344409|platinum containing chemotherapy|platinum containing chemotherapy
776176|NCT00344383|oral contraceptive|oral contraceptive
776177|NCT00344383|breakthrough bleeding|breakthrough bleeding
776178|NCT00344383|spotting|spotting
776179|NCT00344370|Pitavastatin|pitavastatin
776180|NCT00344370|Type II Diabetes Mellitus|type ii diabetes mellitus
776181|NCT00344370|Combined Dyslipidemia|combined dyslipidemia
776182|NCT00344344|Asthma|asthma
776183|NCT00344344|Cockroach|cockroach
776184|NCT00344344|Dust Mite|dust mite
776185|NCT00344344|Extermination|extermination
776186|NCT00344344|Targeted Cleaning|targeted cleaning
776187|NCT00344344|Allergy|allergy
776188|NCT00344344|Prevention|prevention
776189|NCT00344331|Lysosomal Storage|lysosomal storage
776190|NCT00344331|Biomarkers|biomarkers
776191|NCT00344331|Longitudinal|longitudinal
776192|NCT00344331|Niemann Pick Type C|niemann pick type c
776193|NCT00344331|NPC|npc
776194|NCT00344331|Lysosomal Storage Disorder|lysosomal storage disorder
776195|NCT00344318|Immunogenicity|immunogenicity
776196|NCT00344318|Safety|safety
776197|NCT00344318|Pneumococcal vaccine|pneumococcal vaccine
776198|NCT00344318|Pneumococcal disease|pneumococcal disease
776199|NCT00344305|children, FluMist, shedding,|children, flumist, shedding,
776200|NCT00344292|Polymorphism, Genetic|polymorphism, genetic
776201|NCT00344292|Coronary Artery Disease|coronary artery disease
776202|NCT00344292|Coronary Arteriosclerosis|coronary arteriosclerosis
776203|NCT00344292|Polymorphism, Single Nucleotide|polymorphism, single nucleotide
776204|NCT00344292|SNPs|snps
776205|NCT00344279|Coinfection|coinfection
776206|NCT00344279|AIDS|aids
776207|NCT00344279|Lymphatic Filariasis|lymphatic filariasis
776208|NCT00344279|Diethylcarbamazine (DEC)|diethylcarbamazine (dec)
776209|NCT00344279|Albendazole|albendazole
776210|NCT00344266|Obesity|obesity
776211|NCT00344266|Adipose Tissue|adipose tissue
776212|NCT00344266|Microarrays|microarrays
776213|NCT00344266|Cytokines|cytokines
776214|NCT00344266|Eicosanoids|eicosanoids
776215|NCT00344266|Gene Expression|gene expression
776216|NCT00344266|Adipokines|adipokines
776217|NCT00344266|Inflammation|inflammation
776218|NCT00344266|Weight Loss|weight loss
776219|NCT00344266|Lipid Products|lipid products
776220|NCT00344253|Uveitis|uveitis
776221|NCT00344253|Macular Edema|macular edema
776222|NCT00344253|Interferon|interferon
776223|NCT00344253|Multiple Sclerosis|multiple sclerosis
776224|NCT00344253|Encephalomyelitis disseminata (ED)|encephalomyelitis disseminata (ed)
776225|NCT00344240|type 2 diabetes|type 2 diabetes
776226|NCT00344240|exercise|exercise
776615|NCT00342654|Cancer|cancer
776227|NCT00344240|activity guidance|activity guidance
776228|NCT00344240|health education|health education
776229|NCT00344227|neovascularization|neovascularization
776510|NCT00343031|DDT|ddt
776230|NCT00344227|age-related macular degeneration|age-related macular degeneration
776231|NCT00344227|vascular endothelial growth factor (VEGF)|vascular endothelial growth factor (vegf)
776232|NCT00344227|antigen-binding fragment (Fab)|antigen-binding fragment (fab)
776233|NCT00344227|antiangiogenesis|antiangiogenesis
776234|NCT00344227|optical coherence tomography (OCT)|optical coherence tomography (oct)
776235|NCT00344214|HIV|hiv
776236|NCT00344214|STDs|stds
776237|NCT00344214|Methamphetamine|methamphetamine
776238|NCT00344201|Pterygium|pterygium
776239|NCT00344201|Fibrin adhesive|fibrin adhesive
776240|NCT00344201|Conjunctival graft|conjunctival graft
776241|NCT00344201|Ocular surface reconstruction|ocular surface reconstruction
776242|NCT00344188|Cutaneous|cutaneous
776243|NCT00344188|Visceral|visceral
776244|NCT00344188|Leishmanial Infection|leishmanial infection
776245|NCT00344188|MucocutaneousLeishmaniasis|mucocutaneousleishmaniasis
776246|NCT00344188|Leishmaniasis|leishmaniasis
776247|NCT00344175|hypercholesterolemia|hypercholesterolemia
776248|NCT00344175|dyslipidemia|dyslipidemia
776249|NCT00344175|CHD|chd
776250|NCT00344175|pitavastatin|pitavastatin
776251|NCT00344175|simvastatin|simvastatin
776252|NCT00344175|2 or more risk factors for coronary heart disease|2 or more risk factors for coronary heart disease
776253|NCT00344175|combined dyslipidemia|combined dyslipidemia
776254|NCT00344162|Epidemiology|epidemiology
776255|NCT00344162|Population|population
776256|NCT00344162|Pregnancy|pregnancy
776257|NCT00344162|Preeclampsia|preeclampsia
776258|NCT00344149|Idiopathic Thrombocytopenic Purpura|idiopathic thrombocytopenic purpura
776259|NCT00344149|Rituximab|rituximab
776260|NCT00344149|Splenectomy|splenectomy
776261|NCT00344149|Response|response
776262|NCT00344149|Treatment|treatment
776263|NCT00344149|treatment of Idiopathic Thrombocytopenic Purpura|treatment of idiopathic thrombocytopenic purpura
776264|NCT00344136|Blood Pressure, High|blood pressure, high
776265|NCT00344136|Stroke|stroke
776266|NCT00344136|Hypertension|hypertension
776267|NCT00344136|Diabetes Mellitus|diabetes mellitus
776268|NCT00344136|Obesity|obesity
776269|NCT00344136|Cerebrovascular Accident|cerebrovascular accident
776270|NCT00344136|Atherosclerosis|atherosclerosis
776271|NCT00344123|HIV|hiv
776272|NCT00344110|Hypertension, aliskiren, blood pressure, renin|hypertension, aliskiren, blood pressure, renin
776273|NCT00344097|soy protein|soy protein
776274|NCT00344097|pain|pain
776275|NCT00344097|thoracotomy|thoracotomy
776276|NCT00344084|Leishmania Major|leishmania major
776277|NCT00344084|Phlebotomus Duboscqi|phlebotomus duboscqi
776278|NCT00344084|Dermatology|dermatology
776279|NCT00344084|Vector-Transmitted Disease|vector-transmitted disease
776280|NCT00344084|Africa|africa
776281|NCT00344084|Cutaneous Leishmaniasis|cutaneous leishmaniasis
776282|NCT00344084|CL|cl
776283|NCT00344071|Clinical|clinical
776284|NCT00344071|Tissue|tissue
776285|NCT00344071|Photographs|photographs
776286|NCT00344071|Women|women
776287|NCT00344071|Case-Control|case-control
776288|NCT00344058|pregnancy|pregnancy
776289|NCT00344058|preeclampsia|preeclampsia
776290|NCT00344058|treatment|treatment
776291|NCT00344045|Subjects with postoperative pain after Total Hip Arthroplasty|subjects with postoperative pain after total hip arthroplasty
776292|NCT00344032|Double-blind|double-blind
776293|NCT00344032|Human Papillomavirus|human papillomavirus
776294|NCT00344032|Phase IIIb|phase iiib
776295|NCT00344032|Controlled|controlled
776296|NCT00344032|Randomized|randomized
776297|NCT00344032|India|india
776298|NCT00344019|Acute coronary syndrome|acute coronary syndrome
776299|NCT00344019|Percutaneous coronary intervention|percutaneous coronary intervention
776300|NCT00344019|Peri-procedure myocardial infarction|peri-procedure myocardial infarction
776301|NCT00344006|Malaria CDA COARTEM Africa pediatrics children|malaria cda coartem africa pediatrics children
776302|NCT00343993|noninvasive positive pressure ventilation|noninvasive positive pressure ventilation
776303|NCT00343993|acute lung injury|acute lung injury
776304|NCT00343993|acute respiratory distress syndrome|acute respiratory distress syndrome
776305|NCT00343954|sickle cell disease|sickle cell disease
776306|NCT00343941|HIV-1 infection|hiv-1 infection
776307|NCT00343941|Tucaresol|tucaresol
776308|NCT00343941|Viral suppression|viral suppression
776309|NCT00343915|Persistence|persistence
776310|NCT00343915|Hepatitis B vaccine|hepatitis b vaccine
776311|NCT00343902|Hawthorn|hawthorn
776312|NCT00343902|Crataegus|crataegus
776313|NCT00343902|Herbs|herbs
776314|NCT00343889|Diphtheria|diphtheria
776315|NCT00343889|Tetanus|tetanus
776316|NCT00343889|Pertussis|pertussis
776317|NCT00343889|Hepatitis B Hansenula (HB)|hepatitis b hansenula (hb)
776318|NCT00343889|Haemophilus influenzae type b|haemophilus influenzae type b
776319|NCT00343889|Haemophilus Influenzae|haemophilus influenzae
776320|NCT00343876|hs-CRP|hs-crp
776321|NCT00343876|aspirin|aspirin
776322|NCT00343876|clopidogrel|clopidogrel
776323|NCT00343850|idiopathic chronic inflammatory disease of large intestine|idiopathic chronic inflammatory disease of large intestine
776324|NCT00343850|ulcerative colitis|ulcerative colitis
776325|NCT00343850|inactive ulcerative colitis|inactive ulcerative colitis
776326|NCT00343850|chronic disease of large intestine|chronic disease of large intestine
776327|NCT00343850|medication adherence|medication adherence
776328|NCT00343850|Asacol|asacol
776329|NCT00343850|mesalamine|mesalamine
776330|NCT00343824|Burn wounds - Silver Dressings - Bacterial Control|burn wounds - silver dressings - bacterial control
776331|NCT00343811|Attention-Deficit/Hyper Activity Disorder|attention-deficit/hyper activity disorder
776332|NCT00343811|ADHD|adhd
776333|NCT00343759|Breast cancer|breast cancer
776334|NCT00343759|Tyrosine kinase inhibitors|tyrosine kinase inhibitors
776335|NCT00343759|Lapatinib|lapatinib
776336|NCT00343759|Biologic response modifiers|biologic response modifiers
776337|NCT00343759|Magnetic resonance imaging|magnetic resonance imaging
776338|NCT00343759|Treatment-naive, operable|treatment-naive, operable
776339|NCT00343733|diabetic peripheral neuropathy|diabetic peripheral neuropathy
776340|NCT00343733|postherpetic neuralgia|postherpetic neuralgia
776341|NCT00343733|traumatic injury|traumatic injury
776342|NCT00343733|complex regional pain syndrome|complex regional pain syndrome
776343|NCT00343733|back pain|back pain
776344|NCT00343733|neck pain|neck pain
776345|NCT00343733|fibromyalgia|fibromyalgia
776346|NCT00343733|chronic pancreatitis|chronic pancreatitis
776347|NCT00343733|osteoarthritis|osteoarthritis
776348|NCT00343720|VELCADE|velcade
776349|NCT00343720|Alimta|alimta
776350|NCT00343720|locally advanced|locally advanced
776351|NCT00343720|metastatic|metastatic
776352|NCT00343720|non-small cell lung cancer|non-small cell lung cancer
776353|NCT00343720|complete response|complete response
776354|NCT00343720|partial response|partial response
776355|NCT00343720|Locally Advanced or Metastatic Non-Small Cell Lung Cancer|locally advanced or metastatic non-small cell lung cancer
776356|NCT00343707|Social Anxiety Disorder|social anxiety disorder
776357|NCT00343707|brain imaging|brain imaging
776358|NCT00343707|Positron Emission Tomography|positron emission tomography
776359|NCT00343707|antidepressant|antidepressant
776360|NCT00343681|Influenza|influenza
776361|NCT00343681|Orthomyxoviridae Infections|orthomyxoviridae infections
776362|NCT00343681|Orthomyxoviruses|orthomyxoviruses
776363|NCT00343681|Split-virion influenza vaccine|split-virion influenza vaccine
776364|NCT00343668|advanced gastric cancer|advanced gastric cancer
776365|NCT00343668|First-line therapy|first-line therapy
776366|NCT00343668|S-1|s-1
776367|NCT00343668|irinotecan|irinotecan
776368|NCT00343655|Hypercholesterolemia|hypercholesterolemia
776369|NCT00343642|Crohn's disease|crohn's disease
776370|NCT00343642|Fructooligosaccharide|fructooligosaccharide
776371|NCT00343642|Inulin|inulin
776372|NCT00343642|Diet|diet
776373|NCT00343642|Treatment|treatment
776374|NCT00343642|Bacterial flora|bacterial flora
776375|NCT00343642|Oxidative stress|oxidative stress
776376|NCT00343629|unspecified adult solid tumor, protocol specific|unspecified adult solid tumor, protocol specific
776377|NCT00343616|cognitive/functional effects|cognitive/functional effects
776378|NCT00343616|fatigue|fatigue
776379|NCT00343616|psychosocial effects of cancer and its treatment|psychosocial effects of cancer and its treatment
776380|NCT00343616|stage I breast cancer|stage i breast cancer
776381|NCT00343616|stage II breast cancer|stage ii breast cancer
776382|NCT00343616|stage IIIA breast cancer|stage iiia breast cancer
776383|NCT00343603|maculopathy|maculopathy
776384|NCT00343577|proteinuria|proteinuria
776385|NCT00343577|ARBs|arbs
776386|NCT00343577|agalsidase-beta|agalsidase-beta
776387|NCT00343577|MDRD estimated GFR|mdrd estimated gfr
776388|NCT00343577|Chronic kidney disease|chronic kidney disease
776389|NCT00343551|Hypertension, ambulatory blood pressure, missed dose, aliskiren|hypertension, ambulatory blood pressure, missed dose, aliskiren
776390|NCT00343525|HCV|hcv
776391|NCT00343525|monoclonal antibody|monoclonal antibody
776392|NCT00343525|phase 1|phase 1
776393|NCT00343512|inflammatory breast cancer|inflammatory breast cancer
776394|NCT00343512|stage II breast cancer|stage ii breast cancer
776395|NCT00343512|stage IIIA breast cancer|stage iiia breast cancer
776396|NCT00343512|stage IIIB breast cancer|stage iiib breast cancer
776397|NCT00343512|stage IIIC breast cancer|stage iiic breast cancer
776398|NCT00343499|atrial fibrillation|atrial fibrillation
776399|NCT00343499|valsartan|valsartan
776400|NCT00343499|sinus rhythm|sinus rhythm
776401|NCT00343499|persistent atrial fibrillation undergoing electrical cardioversion to restore normal sinus rhythm|persistent atrial fibrillation undergoing electrical cardioversion to restore normal sinus rhythm
776402|NCT00343486|Overactive Bladder|overactive bladder
776403|NCT00343473|Fuch's dystrophy|fuch's dystrophy
776404|NCT00343473|corneal disorders|corneal disorders
776405|NCT00343473|cornea|cornea
776406|NCT00343473|lasik|lasik
776407|NCT00343473|refractive surgery|refractive surgery
776408|NCT00343460|nausea and vomiting|nausea and vomiting
776409|NCT00343460|unspecified adult solid tumor, protocol specific|unspecified adult solid tumor, protocol specific
776410|NCT00343447|stage I chronic lymphocytic leukemia|stage i chronic lymphocytic leukemia
776411|NCT00343447|stage II chronic lymphocytic leukemia|stage ii chronic lymphocytic leukemia
776412|NCT00343447|stage III chronic lymphocytic leukemia|stage iii chronic lymphocytic leukemia
776616|NCT00342654|Environment|environment
776413|NCT00343447|stage IV chronic lymphocytic leukemia|stage iv chronic lymphocytic leukemia
776414|NCT00343434|stage I breast cancer|stage i breast cancer
776415|NCT00343434|stage II breast cancer|stage ii breast cancer
776511|NCT00343031|Contaminant|contaminant
776416|NCT00343434|stage IIIA breast cancer|stage iiia breast cancer
776417|NCT00343434|stage IIIB breast cancer|stage iiib breast cancer
776418|NCT00343434|stage IIIC breast cancer|stage iiic breast cancer
776419|NCT00343434|obesity|obesity
776420|NCT00343421|Diphtheria|diphtheria
776421|NCT00343421|Tetanus|tetanus
776422|NCT00343421|Pertussis|pertussis
776423|NCT00343421|Poliomyelitis|poliomyelitis
776424|NCT00343421|Haemophilus influenzae type b|haemophilus influenzae type b
776425|NCT00343421|Pneumococcal infections|pneumococcal infections
776426|NCT00343408|recurrent non-small cell lung cancer|recurrent non-small cell lung cancer
776427|NCT00343408|stage IIIB non-small cell lung cancer|stage iiib non-small cell lung cancer
776428|NCT00343408|stage IV non-small cell lung cancer|stage iv non-small cell lung cancer
776429|NCT00343408|recurrent colon cancer|recurrent colon cancer
776430|NCT00343408|stage III colon cancer|stage iii colon cancer
776431|NCT00343408|stage IV colon cancer|stage iv colon cancer
776432|NCT00343408|recurrent rectal cancer|recurrent rectal cancer
776433|NCT00343408|stage III rectal cancer|stage iii rectal cancer
776434|NCT00343408|stage IV rectal cancer|stage iv rectal cancer
776435|NCT00343395|rosiglitazone|rosiglitazone
776436|NCT00343395|metformin|metformin
776437|NCT00343395|hs-CRP|hs-crp
776438|NCT00343395|inflammation|inflammation
776439|NCT00343382|sexuality and reproductive issues|sexuality and reproductive issues
776440|NCT00343382|sexual dysfunction|sexual dysfunction
776441|NCT00343382|recurrent breast cancer|recurrent breast cancer
776442|NCT00343382|stage I breast cancer|stage i breast cancer
776443|NCT00343382|stage II breast cancer|stage ii breast cancer
776444|NCT00343382|stage IIIA breast cancer|stage iiia breast cancer
776445|NCT00343382|stage IIIB breast cancer|stage iiib breast cancer
776446|NCT00343382|stage IIIC breast cancer|stage iiic breast cancer
776447|NCT00343382|stage IV breast cancer|stage iv breast cancer
776448|NCT00343369|B-cell childhood acute lymphoblastic leukemia|b-cell childhood acute lymphoblastic leukemia
776449|NCT00343369|recurrent childhood acute lymphoblastic leukemia|recurrent childhood acute lymphoblastic leukemia
776450|NCT00343369|T-cell childhood acute lymphoblastic leukemia|t-cell childhood acute lymphoblastic leukemia
776451|NCT00343369|untreated childhood acute lymphoblastic leukemia|untreated childhood acute lymphoblastic leukemia
776452|NCT00343356|Bladder neoplasm;|bladder neoplasm;
776453|NCT00343356|Carcinoma;|carcinoma;
776454|NCT00343356|Epirubicin;|epirubicin;
776455|NCT00343356|BCG;|bcg;
776456|NCT00343356|Perfusion|perfusion
776457|NCT00343317|puerperal sepsis|puerperal sepsis
776458|NCT00343317|HIV infection|hiv infection
776459|NCT00343317|prophylactic antibiotics|prophylactic antibiotics
776460|NCT00343304|Stroke.Robot.Ergometer.Group OT|stroke.robot.ergometer.group ot
776461|NCT00343291|Non-Small Cell Lung Cancer|non-small cell lung cancer
776462|NCT00343291|Malignant pleural effusions|malignant pleural effusions
776463|NCT00343278|Valaciclovir Hydrochloride|valaciclovir hydrochloride
776464|NCT00343278|hemodialysis patient|hemodialysis patient
776465|NCT00343278|ALDH|aldh
776466|NCT00343278|pharmacokinetics|pharmacokinetics
776467|NCT00343278|Japanese|japanese
776468|NCT00343265|Preterm birth|preterm birth
776469|NCT00343265|Multiple pregnancy|multiple pregnancy
776470|NCT00343265|Vaginal progesterone|vaginal progesterone
776471|NCT00343265|Preterm birth in multiple pregnancy|preterm birth in multiple pregnancy
776472|NCT00343226|Basiliximab, transplantation, liver, renal function|basiliximab, transplantation, liver, renal function
776473|NCT00343213|Prognostic value of p16INK4a|prognostic value of p16ink4a
776474|NCT00343213|CIN 1|cin 1
776475|NCT00343213|LSIL|lsil
776476|NCT00343213|HPV|hpv
776477|NCT00343187|Tarceva|tarceva
776478|NCT00343187|Rash|rash
776479|NCT00343187|EGFR-1 Rash|egfr-1 rash
776480|NCT00343187|erlotinib|erlotinib
776481|NCT00343187|Aczone|aczone
776482|NCT00343187|Dapsone|dapsone
776483|NCT00343187|Non-small Cell Lung Cancer|non-small cell lung cancer
776484|NCT00343187|subjects treated with Tarceva for non-small cell lung cancer (NSCLC) who subsequently develop a rash suspected to be related to Tarceva|subjects treated with tarceva for non-small cell lung cancer (nsclc) who subsequently develop a rash suspected to be related to tarceva
776485|NCT00343174|stroke|stroke
776486|NCT00343174|vascular diseases|vascular diseases
776487|NCT00343161|Nexium|nexium
776488|NCT00343135|Skin|skin
776489|NCT00343135|AUGMENTIN|augmentin
776490|NCT00343135|1gm|1gm
776491|NCT00343135|Soft|soft
776492|NCT00343135|tissue|tissue
776493|NCT00343135|Infections|infections
776494|NCT00343122|liver|liver
776495|NCT00343122|cirrhosis|cirrhosis
776496|NCT00343122|hepatopulmonary syndrome|hepatopulmonary syndrome
776497|NCT00343096|intranasal|intranasal
776498|NCT00343096|buccal|buccal
776499|NCT00343096|lorazepam|lorazepam
776500|NCT00343096|paediatric|paediatric
776501|NCT00343096|convulsions|convulsions
776502|NCT00343083|Head and Neck Neoplasms|head and neck neoplasms
776503|NCT00343044|platinum resistant ovarian cancer|platinum resistant ovarian cancer
776504|NCT00343044|recurrent ovarian cancer|recurrent ovarian cancer
776505|NCT00343044|platinum resistant cancer|platinum resistant cancer
776506|NCT00343031|Insecticides|insecticides
776507|NCT00343031|Children|children
776508|NCT00343031|Women|women
776512|NCT00343018|Preschoolers|preschoolers
776513|NCT00343018|Young Children|young children
776514|NCT00343018|Eyewitness|eyewitness
776515|NCT00343018|Memory|memory
776516|NCT00343005|Blood-Stage|blood-stage
776517|NCT00343005|Investigational|investigational
776518|NCT00343005|Endemic|endemic
776519|NCT00343005|Malaria|malaria
776520|NCT00343005|Vaccine|vaccine
776521|NCT00342992|Vitamin E|vitamin e
776522|NCT00342992|Micronutrients|micronutrients
776523|NCT00342992|Genetics|genetics
776524|NCT00342992|Smoking|smoking
776525|NCT00342992|Biomarkers|biomarkers
776526|NCT00342966|Metabolism|metabolism
776527|NCT00342966|Tracer Studies|tracer studies
776528|NCT00342966|Chemoprevention|chemoprevention
776529|NCT00342966|Selenomethionine|selenomethionine
776530|NCT00342966|Plasma Selenoproteins|plasma selenoproteins
776531|NCT00342953|saline|saline
776532|NCT00342953|silicone|silicone
776533|NCT00342953|Breast Implants|breast implants
776534|NCT00342953|augmentation mammoplasty|augmentation mammoplasty
776535|NCT00342953|visk|visk
776536|NCT00342940|influenza|influenza
776537|NCT00342940|influenza vaccine|influenza vaccine
776538|NCT00342940|flu|flu
776539|NCT00342940|vaccination|vaccination
776540|NCT00342940|immunogenicity|immunogenicity
776541|NCT00342927|American Indians|american indians
776542|NCT00342927|Complications|complications
776543|NCT00342927|Genetics|genetics
776544|NCT00342927|Linkage|linkage
776545|NCT00342927|Type 2 Diabetes|type 2 diabetes
776546|NCT00342927|Diabetic Kidney Disease|diabetic kidney disease
776547|NCT00342888|Childhood Cancer|childhood cancer
776548|NCT00342888|Pesticides|pesticides
776549|NCT00342888|Polychlorinated Biphenyls|polychlorinated biphenyls
776550|NCT00342888|Organochlorines|organochlorines
776551|NCT00342888|Polybrominated Diphenyl Ethers|polybrominated diphenyl ethers
776552|NCT00342875|Bladder Cancer|bladder cancer
776553|NCT00342875|Exposure|exposure
776554|NCT00342875|Drinking Water|drinking water
776555|NCT00342862|Pregnancy|pregnancy
776556|NCT00342862|Amevive|amevive
776557|NCT00342862|alefacept|alefacept
776558|NCT00342862|Registry|registry
776559|NCT00342862|Psoriasis|psoriasis
776560|NCT00342849|Clinical Trial|clinical trial
776561|NCT00342849|Low-level Lead Poisoning|low-level lead poisoning
776562|NCT00342849|Chelation|chelation
776563|NCT00342849|Developmental Assessment|developmental assessment
776564|NCT00342849|Succimer|succimer
776565|NCT00342836|Akt|akt
776566|NCT00342836|Immunohistochemistry|immunohistochemistry
776567|NCT00342836|Myoinositol|myoinositol
776568|NCT00342836|Bronchial Specimens|bronchial specimens
776569|NCT00342836|Phosphorylation|phosphorylation
776570|NCT00342823|Linkage Analysis|linkage analysis
776571|NCT00342823|Canidate Gene Analysis|canidate gene analysis
776572|NCT00342823|Genome Scan|genome scan
776573|NCT00342823|L. Chagasi|l. chagasi
776574|NCT00342823|Visceral Leishmania|visceral leishmania
776575|NCT00342810|Eye Diseases|eye diseases
776576|NCT00342797|second primary cancer|second primary cancer
776577|NCT00342797|retinoblastoma|retinoblastoma
776578|NCT00342797|RB1 germline mutation|rb1 germline mutation
776579|NCT00342784|Mutation|mutation
776580|NCT00342784|Cancer Genetics|cancer genetics
776581|NCT00342771|Tobacco Use|tobacco use
776582|NCT00342771|Tumor Biology|tumor biology
776583|NCT00342771|Biomarker|biomarker
776584|NCT00342771|Risk Factor|risk factor
776585|NCT00342771|Health Disparity|health disparity
776586|NCT00342758|Asthma|asthma
776587|NCT00342758|Wheeze|wheeze
776588|NCT00342758|Environment|environment
776589|NCT00342758|Diet|diet
776590|NCT00342758|Infection|infection
776591|NCT00342732|Genetics|genetics
776592|NCT00342732|Fat Intake|fat intake
776593|NCT00342732|Pima Indians|pima indians
776594|NCT00342732|Weight Control|weight control
776595|NCT00342732|Appetite Control|appetite control
776596|NCT00342706|Teen Pregnancy|teen pregnancy
776597|NCT00342706|Short Inter-Pregnancy Intervals|short inter-pregnancy intervals
776598|NCT00342693|Radiation|radiation
776599|NCT00342693|Screening|screening
776600|NCT00342693|Cancer|cancer
776601|NCT00342693|Nodules|nodules
776602|NCT00342693|Nuclear|nuclear
776603|NCT00342693|Thyroid Screening|thyroid screening
776604|NCT00342693|Thyroid Gland|thyroid gland
776605|NCT00342667|Pregnancy|pregnancy
776606|NCT00342667|Preterm Birth|preterm birth
776607|NCT00342667|Predictors of Outcome|predictors of outcome
776608|NCT00342667|Neonatal/Infant Complications|neonatal/infant complications
776609|NCT00342667|Neurologic Development|neurologic development
776610|NCT00342667|(SqrRoot) mniotic Fluid|(sqrroot) mniotic fluid
776611|NCT00342667|Cerebral Palsy|cerebral palsy
776612|NCT00342667|Risk Factors|risk factors
776613|NCT00342667|Pregnancy Complications|pregnancy complications
776614|NCT00342654|Epidemiology|epidemiology
776620|NCT00342641|Multiple Myeloma|multiple myeloma
776621|NCT00342641|Thyroiditis|thyroiditis
776622|NCT00342641|Cohort Study|cohort study
776623|NCT00342641|Record linkage study|record linkage study
776624|NCT00342641|Hepatitis C|hepatitis c
776625|NCT00342628|Antibody|antibody
776626|NCT00342628|Reactions|reactions
776627|NCT00342628|Vaccine|vaccine
776628|NCT00342628|Conjugate Vaccine|conjugate vaccine
776629|NCT00342628|Typhoid Fever|typhoid fever
776630|NCT00342628|Trial|trial
776631|NCT00342628|Safety|safety
776632|NCT00342628|Immunogenicity|immunogenicity
776633|NCT00342628|Comparability|comparability
776634|NCT00342628|DTP|dtp
776635|NCT00342602|JC Virus|jc virus
776636|NCT00342602|Opportunistic Infection|opportunistic infection
776637|NCT00342602|Single Nucleotide Polymorphism|single nucleotide polymorphism
776638|NCT00342602|Genotype|genotype
776639|NCT00342602|Sequencing|sequencing
776640|NCT00342589|Pneumocystis|pneumocystis
776641|NCT00342589|HIV|hiv
776642|NCT00342589|Oral Wash|oral wash
776643|NCT00342589|PCR|pcr
776644|NCT00342589|Drug Resistance|drug resistance
776645|NCT00342576|Filarial Parasites|filarial parasites
776646|NCT00342576|Wuchereria Bancrofti|wuchereria bancrofti
776647|NCT00342576|Brugia Malayi|brugia malayi
776648|NCT00342576|Diethylcarbamazine (DEC)|diethylcarbamazine (dec)
776649|NCT00342576|Ivermectin|ivermectin
776650|NCT00342563|mecamylamine|mecamylamine
776651|NCT00342563|treatment|treatment
776652|NCT00342563|alcohol dependence|alcohol dependence
776653|NCT00342563|smoking|smoking
776654|NCT00342550|Pregnancy|pregnancy
776655|NCT00342550|Preterm Birth|preterm birth
776656|NCT00342550|Pregnancy Complications|pregnancy complications
776657|NCT00342537|Pathology|pathology
776658|NCT00342537|Genetics|genetics
776659|NCT00342537|Testicular Cancer|testicular cancer
776660|NCT00342537|Familial|familial
776661|NCT00342537|Cancer Epidemiology|cancer epidemiology
776662|NCT00342524|IVIG|ivig
776663|NCT00342524|Plasmapheresis|plasmapheresis
776664|NCT00342524|Blood Collection|blood collection
776665|NCT00342524|Immune Globulin|immune globulin
776666|NCT00342524|Severe Acute Respiratory Syndrome|severe acute respiratory syndrome
776667|NCT00342524|SARS|sars
776668|NCT00342511|Pap|pap
776669|NCT00342511|Hybrid Capture 2|hybrid capture 2
776670|NCT00342511|HSIL|hsil
776671|NCT00342511|Colposcopy|colposcopy
776672|NCT00342511|CIN|cin
776673|NCT00342511|Specimen Collection|specimen collection
776674|NCT00342498|DNA|dna
776675|NCT00342498|Hormone|hormone
776676|NCT00342498|Resistance|resistance
776677|NCT00342498|Skeleton|skeleton
776678|NCT00342485|Cellular Immunity|cellular immunity
776679|NCT00342485|HIV-infected|hiv-infected
776680|NCT00342485|Immune Deficiency|immune deficiency
776681|NCT00342485|Cancer|cancer
776682|NCT00342485|Transplantation|transplantation
776683|NCT00342472|Esophageal Cancer|esophageal cancer
776684|NCT00342472|Polycyclic Aromatic Hydrocarbons|polycyclic aromatic hydrocarbons
776685|NCT00342446|Gonadotropins|gonadotropins
776686|NCT00342446|CLOMIPHENE|clomiphene
776687|NCT00342446|Ovulation-Stimulating Drugs|ovulation-stimulating drugs
776688|NCT00342433|Androgens|androgens
776689|NCT00342433|Serum|serum
776690|NCT00342433|Tissue|tissue
776691|NCT00342407|Cancer Risk|cancer risk
776692|NCT00342407|Cosmic Radiation|cosmic radiation
776693|NCT00342407|Airlines|airlines
776694|NCT00342407|Flight Attendants|flight attendants
776695|NCT00342407|Circadian Rhythm|circadian rhythm
776696|NCT00342394|Biological Monitoring|biological monitoring
776697|NCT00342394|Exposure Determinants|exposure determinants
776698|NCT00342394|Exposure Validation|exposure validation
776699|NCT00342394|Occupational Exposure|occupational exposure
776700|NCT00342394|Pesticides|pesticides
776701|NCT00342394|Agriculture|agriculture
776702|NCT00342381|Motor fatigue|motor fatigue
776703|NCT00342381|Cognitive fatigue|cognitive fatigue
776704|NCT00342368|CPAP|cpap
776705|NCT00342368|ARDS|ards
776706|NCT00342368|ALI|ali
776707|NCT00342368|Hypoxemia|hypoxemia
776708|NCT00342368|Intubation|intubation
776709|NCT00342355|Protease Inhibitors|protease inhibitors
776710|NCT00342355|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors
776711|NCT00342355|AIDS|aids
776712|NCT00342355|Opportunistic Infections|opportunistic infections
776713|NCT00342355|Resource-Poor|resource-poor
776714|NCT00342342|Association|association
776715|NCT00342342|Linkage Study|linkage study
776716|NCT00342342|Familial Aggregation|familial aggregation
776717|NCT00342342|Linkage Disequilibrium|linkage disequilibrium
776718|NCT00342329|Case-Control|case-control
776719|NCT00342329|Hydrocarbons|hydrocarbons
776720|NCT00342329|Metals|metals
776721|NCT00342329|Silica|silica
776722|NCT00342329|Tobacco Smoke|tobacco smoke
776723|NCT00342329|Lupus Nephritis|lupus nephritis
776724|NCT00342329|Environmental Exposures|environmental exposures
776725|NCT00342329|Occupational Exposures|occupational exposures
776726|NCT00342316|Acute Myeloid Leukemia|acute myeloid leukemia
776727|NCT00342316|Stem Cell Transplantation|stem cell transplantation
776728|NCT00342316|Reduced Intensity Conditioning|reduced intensity conditioning
776729|NCT00342316|Survival|survival
776730|NCT00342316|Relapse|relapse
776731|NCT00342303|Premature Infants|premature infants
776732|NCT00342303|Fatty Acid Metabolism|fatty acid metabolism
776733|NCT00342303|Polyunsaturated Fatty Acids|polyunsaturated fatty acids
776734|NCT00342303|Infant Formula|infant formula
776735|NCT00342303|Gas-chromatography|gas-chromatography
776736|NCT00342303|Mass Spectrometry|mass spectrometry
776737|NCT00342290|Pathophysiological Volume Measurement|pathophysiological volume measurement
776738|NCT00342290|Power Doppler Ultrasound|power doppler ultrasound
776739|NCT00342290|Prediction of Adverse Pregnancy Outcome|prediction of adverse pregnancy outcome
776740|NCT00342290|Subchorionic Hemorrhage|subchorionic hemorrhage
776741|NCT00342277|Premature Rupture of Membranes|premature rupture of membranes
776742|NCT00342277|Genetic Risk Factors|genetic risk factors
776743|NCT00342277|Tissue Specific Expression|tissue specific expression
776744|NCT00342277|Quantitative Real Time PCR|quantitative real time pcr
776745|NCT00342277|Preterm Birth|preterm birth
776746|NCT00342277|Expression Profiling|expression profiling
776747|NCT00342277|Microarrays|microarrays
776748|NCT00342264|Lung Cancer|lung cancer
776749|NCT00342264|Smoking|smoking
776750|NCT00342264|Diesel Exhaust|diesel exhaust
776751|NCT00342251|Macular Degeneration|macular degeneration
776752|NCT00342251|Retinal Images|retinal images
776753|NCT00342251|Risk Factors|risk factors
776754|NCT00342251|Linkage Analysis|linkage analysis
776755|NCT00342251|Gene|gene
776756|NCT00342251|Mutation|mutation
776757|NCT00342225|Observation|observation
776758|NCT00342225|Mothers|mothers
776759|NCT00342225|Description|description
776760|NCT00342212|Walking|walking
776761|NCT00342212|Jogging|jogging
776762|NCT00342212|Bridging Study|bridging study
776763|NCT00342212|Data Comparability|data comparability
776764|NCT00342212|Healthy Adults|healthy adults
776765|NCT00342212|Healthy Volunteer|healthy volunteer
776766|NCT00342212|HV|hv
776767|NCT00342199|Incidence|incidence
776768|NCT00342199|Prevalence|prevalence
776769|NCT00342199|Immunity|immunity
776770|NCT00342199|Bacteriology|bacteriology
776771|NCT00342199|Pathogenesis|pathogenesis
776772|NCT00342186|China|china
776773|NCT00342186|Cancer|cancer
776774|NCT00342186|Hepatitis B|hepatitis b
776775|NCT00342186|Genetics|genetics
776776|NCT00342186|Liver Disease|liver disease
776777|NCT00342186|HBV|hbv
776778|NCT00342173|Cervix|cervix
776779|NCT00342173|Natural History|natural history
776780|NCT00342173|Neoplasia|neoplasia
776781|NCT00342173|HPV|hpv
776782|NCT00342173|Costa Rica|costa rica
776783|NCT00342160|AIDS|aids
776784|NCT00342160|HIV Infectiousness|hiv infectiousness
776785|NCT00342160|Immunity|immunity
776786|NCT00342160|CTL|ctl
776787|NCT00342160|Epidemiology|epidemiology
776788|NCT00342147|EBV|ebv
776789|NCT00342147|NPC|npc
776790|NCT00342134|Demyelination|demyelination
776791|NCT00342134|Inflammation|inflammation
776792|NCT00342134|Immunosuppression|immunosuppression
776793|NCT00342134|Autoimmunity|autoimmunity
776794|NCT00342134|Bone Marrow|bone marrow
776795|NCT00342134|Multiple Sclerosis|multiple sclerosis
776796|NCT00342121|Cancer|cancer
776797|NCT00342121|NHL|nhl
776798|NCT00342121|Pesticides|pesticides
776799|NCT00342121|Atrazine|atrazine
776800|NCT00342121|Organophosphates|organophosphates
776801|NCT00342121|Cancer Risk|cancer risk
776802|NCT00342121|Normal Control|normal control
776803|NCT00342095|Autoimmune Diseases|autoimmune diseases
776804|NCT00342095|Estrogen|estrogen
776805|NCT00342095|Silica|silica
776806|NCT00342095|Pesticides|pesticides
776807|NCT00342095|Major Histocompatibility Complex|major histocompatibility complex
776808|NCT00342095|Genetic Susceptibility|genetic susceptibility
776809|NCT00342082|Zidovudine|zidovudine
776810|NCT00342082|HIV|hiv
776811|NCT00342082|Cord Blood|cord blood
776812|NCT00342069|Decision Making|decision making
776813|NCT00342069|Genetic Counseling|genetic counseling
776814|NCT00342069|Pregnancy Options|pregnancy options
776815|NCT00342069|Attitudes Toward Reproductive Options|attitudes toward reproductive options
776816|NCT00342069|Beliefs About Down Syndrome Risk|beliefs about down syndrome risk
776817|NCT00342069|Down Syndrome Risk|down syndrome risk
776818|NCT00342069|Pregnancy|pregnancy
776819|NCT00342056|Pharmacogenetics|pharmacogenetics
776820|NCT00342056|Transporter Proteins|transporter proteins
776821|NCT00342056|Drug Exposure|drug exposure
776822|NCT00342056|Imatinib|imatinib
776823|NCT00342056|Retrospective|retrospective
776824|NCT00342056|Cancer|cancer
776825|NCT00342043|Sickle Trait|sickle trait
776826|NCT00342043|Fetal Hemoglobin|fetal hemoglobin
776827|NCT00342043|Hemoglobin C|hemoglobin c
776828|NCT00342043|Beta-Thalassemia|beta-thalassemia
776829|NCT00342043|Artesunate-Amodiaquine|artesunate-amodiaquine
776830|NCT00342030|Respiratory|respiratory
776831|NCT00342030|Polymorphism|polymorphism
776832|NCT00342030|Fruit|fruit
776833|NCT00342030|COPD|copd
776834|NCT00342030|Prospective|prospective
776836|NCT00342017|Filarial Infections|filarial infections
776837|NCT00342017|Helminths|helminths
776838|NCT00342017|Tuberculosis|tuberculosis
776839|NCT00342017|Filarial Infection|filarial infection
776840|NCT00342004|Shanghai|shanghai
776841|NCT00342004|Residential History|residential history
776842|NCT00342004|Exposure Assessment|exposure assessment
776843|NCT00342004|Cohort Study|cohort study
776844|NCT00342004|Molecular Epidemiology|molecular epidemiology
776845|NCT00341991|DNA Repair|dna repair
776846|NCT00341991|Genes|genes
776847|NCT00341991|Pigmentation|pigmentation
776848|NCT00341991|Skin Cancer|skin cancer
776849|NCT00341991|Sun Exposure|sun exposure
776850|NCT00341965|DDT|ddt
776851|NCT00341965|DDE|dde
776852|NCT00341965|Androgen Levels|androgen levels
776853|NCT00341965|Farming|farming
776854|NCT00341965|Antiandrogen|antiandrogen
776855|NCT00341952|Case-Control Study|case-control study
776856|NCT00341952|Non-Hodgkin Lymphoma|non-hodgkin lymphoma
776857|NCT00341939|Drug Therapy|drug therapy
776858|NCT00341939|Pharmacogenetics|pharmacogenetics
776859|NCT00341939|Cancer|cancer
776860|NCT00341939|Pharmacodynamics|pharmacodynamics
776861|NCT00341939|Parmacokinetics|parmacokinetics
776862|NCT00341913|Research|research
776863|NCT00341913|Repository|repository
776864|NCT00341913|Registry|registry
776865|NCT00341913|Surveillance|surveillance
776866|NCT00341913|Databases|databases
776867|NCT00341900|Chromosome Translocations|chromosome translocations
776868|NCT00341900|Cosmic Radiation|cosmic radiation
776869|NCT00341900|Airline Flight Crew|airline flight crew
776870|NCT00341900|Airlines|airlines
776871|NCT00341900|Flight Crew|flight crew
776872|NCT00341900|Occupational Exposure|occupational exposure
776873|NCT00341887|Screening|screening
776874|NCT00341887|AIDS|aids
776875|NCT00341887|Antiretrovirals|antiretrovirals
776876|NCT00341887|Military|military
776877|NCT00341887|Force readiness|force readiness
776878|NCT00341874|DNA Mutations|dna mutations
776879|NCT00341874|Genetic Variation|genetic variation
776880|NCT00341874|GENETIC LINKAGE|genetic linkage
776881|NCT00341874|Usher Syndrome|usher syndrome
776882|NCT00341874|BLINDNESS|blindness
776883|NCT00341861|Bladder Cancer|bladder cancer
776884|NCT00341861|Occupational and Environmental Risks|occupational and environmental risks
776885|NCT00341861|Lifestyle Factors|lifestyle factors
776886|NCT00341861|Epidemiology|epidemiology
776887|NCT00341861|Genetic Susceptibility|genetic susceptibility
776888|NCT00341848|Apoptosis|apoptosis
776889|NCT00341848|Environment|environment
776890|NCT00341848|Infection|infection
776891|NCT00341848|Inflammation|inflammation
776892|NCT00341848|Leiomyoma|leiomyoma
776893|NCT00341848|Uterine Leiomyoma|uterine leiomyoma
776894|NCT00341848|Uterus|uterus
776895|NCT00341835|Association|association
776896|NCT00341835|Genetics|genetics
776897|NCT00341835|Linkage|linkage
776898|NCT00341822|Amniocentesis|amniocentesis
776899|NCT00341822|Chorionic Villus Sampling|chorionic villus sampling
776900|NCT00341822|Fertility|fertility
776901|NCT00341822|Genetic Counseling|genetic counseling
776902|NCT00341822|Decisional Conflict|decisional conflict
776903|NCT00341822|Prenatal Testing|prenatal testing
776904|NCT00341822|Questionnaire|questionnaire
776905|NCT00341809|Natural Killer Cells|natural killer cells
776906|NCT00341809|Autoimmune Disease|autoimmune disease
776907|NCT00341809|Chronic Inflammation|chronic inflammation
776908|NCT00341809|Two-Locus Interaction|two-locus interaction
776909|NCT00341809|Allele/Haplotype Analysis|allele/haplotype analysis
776910|NCT00341796|AIDS|aids
776911|NCT00341796|HIV|hiv
776912|NCT00341796|Perinatal|perinatal
776913|NCT00341796|Transmission|transmission
776914|NCT00341796|Antiretroviral|antiretroviral
776915|NCT00341796|Outcomes|outcomes
776916|NCT00341783|Plasmodium|plasmodium
776917|NCT00341783|Falciparum|falciparum
776918|NCT00341783|Screening|screening
776919|NCT00341783|Malaria|malaria
776920|NCT00341757|Family Reports|family reports
776921|NCT00341757|Cancer|cancer
776922|NCT00341757|Questionnaire|questionnaire
776923|NCT00341757|Validity|validity
776924|NCT00341757|Surveillance|surveillance
776925|NCT00341744|Vision|vision
776926|NCT00341744|Aids|aids
776927|NCT00341731|Cystic Ovaries|cystic ovaries
776928|NCT00341731|Environmental Factors|environmental factors
776929|NCT00341731|Heritability|heritability
776930|NCT00341731|Hyperandrogenism|hyperandrogenism
776931|NCT00341731|Twin Study|twin study
776932|NCT00341718|Interview|interview
776933|NCT00341718|Genetics|genetics
776934|NCT00341705|AIDS|aids
776935|NCT00341705|Cancer|cancer
776936|NCT00341705|Hepatitis C Virus|hepatitis c virus
776937|NCT00341705|HIV|hiv
776938|NCT00341705|Natural History|natural history
776939|NCT00341705|Hemophilia|hemophilia
776940|NCT00341705|Hepatitis C|hepatitis c
776941|NCT00341692|Mammary|mammary
776942|NCT00341692|Development|development
776943|NCT00341692|Cancer|cancer
776944|NCT00341692|Risk|risk
776945|NCT00341692|Genes|genes
776946|NCT00341679|Autoimmune Diseases|autoimmune diseases
776947|NCT00341679|Polymyositis|polymyositis
776948|NCT00341679|Dermatomyositis|dermatomyositis
776949|NCT00341679|Idiopathic Inflammatory Myopathies|idiopathic inflammatory myopathies
776950|NCT00341679|CONNECTIVE TISSUE DISEASES|connective tissue diseases
776951|NCT00341679|IIM|iim
776952|NCT00341666|Immune Regulation|immune regulation
776953|NCT00341666|Co-Infection|co-infection
776954|NCT00341666|Filariasis|filariasis
776955|NCT00341666|Immunology|immunology
776956|NCT00341666|Filarial Infection|filarial infection
776957|NCT00341653|Asthma|asthma
776958|NCT00341653|Pulmonary Function|pulmonary function
776959|NCT00341653|Air Pollution|air pollution
776960|NCT00341653|Genetic Polymorphism|genetic polymorphism
776961|NCT00341653|Environmental Tobacco Agents|environmental tobacco agents
776962|NCT00341640|Teen Pregnancy|teen pregnancy
776963|NCT00341627|Bone Tumor|bone tumor
776964|NCT00341627|Familial Chordoma|familial chordoma
776965|NCT00341627|Gene Mapping|gene mapping
776966|NCT00341627|Genetics|genetics
776967|NCT00341627|Sporadic Chordoma|sporadic chordoma
776968|NCT00341614|Exercise|exercise
776969|NCT00341614|Diabetes Mellitus, Type 2|diabetes mellitus, type 2
776970|NCT00341614|Postmenopause|postmenopause
776971|NCT00341614|Diet|diet
776972|NCT00341601|Mycobacterium Tuberculosis|mycobacterium tuberculosis
776973|NCT00341601|TLR-2|tlr-2
776974|NCT00341601|Recurrent Tuberculosis|recurrent tuberculosis
776975|NCT00341601|Phenolic Glycolipid|phenolic glycolipid
776976|NCT00341601|mRNA Expression Profiles|mrna expression profiles
776977|NCT00341588|Testicular Cancer|testicular cancer
776978|NCT00341588|Epidemiology|epidemiology
776979|NCT00341588|Testicular Germ Cell Cancer|testicular germ cell cancer
776980|NCT00341588|TGCT|tgct
776981|NCT00341588|Healthy Volunteer|healthy volunteer
776982|NCT00341575|Family Systems|family systems
776983|NCT00341575|Communication|communication
776984|NCT00341575|Information Diffusion|information diffusion
776985|NCT00341575|Social Networks|social networks
776986|NCT00341575|Family Dynamics|family dynamics
776987|NCT00341562|Gene Expression Profiling|gene expression profiling
776988|NCT00341562|Vascular Disease|vascular disease
776989|NCT00341549|Genetics|genetics
776990|NCT00341549|Mapping|mapping
776991|NCT00341549|Gene|gene
776992|NCT00341549|Myopia|myopia
776993|NCT00341549|Nearsightedness|nearsightedness
776994|NCT00341536|Diet|diet
776995|NCT00341536|Pilot|pilot
776996|NCT00341536|Cohort|cohort
776997|NCT00341536|Environmental|environmental
776998|NCT00341536|Chronic Disease|chronic disease
776999|NCT00341523|Cytology|cytology
777000|NCT00341523|Endoscopy|endoscopy
777001|NCT00341523|Esophageal Cancer|esophageal cancer
777002|NCT00341523|Early Detection|early detection
777003|NCT00341523|Treatment|treatment
777004|NCT00341510|Risk Behavior|risk behavior
777005|NCT00341510|Health Status|health status
777006|NCT00341510|Adolescence|adolescence
777007|NCT00341510|Positive Health Behaviors|positive health behaviors
777008|NCT00341510|Social Support|social support
777009|NCT00341510|Health Behavior|health behavior
777010|NCT00341510|Survey|survey
777011|NCT00341497|Leukoplakia|leukoplakia
777012|NCT00341497|Oral Mucosa|oral mucosa
777013|NCT00341497|Biomarkers|biomarkers
777014|NCT00341484|Genetics|genetics
777015|NCT00341484|Liver Cancer|liver cancer
777017|NCT00341471|School|school
777018|NCT00341471|Sixth Grade|sixth grade
777019|NCT00341471|Curricular|curricular
777020|NCT00341471|Howard University|howard university
777021|NCT00341471|D.C.|d.c.
777022|NCT00341471|Adolescent Pregnancy|adolescent pregnancy
777023|NCT00341471|Intervention|intervention
777024|NCT00341458|Breast Cancer|breast cancer
777025|NCT00341458|Environment|environment
777026|NCT00341458|Genetics|genetics
777027|NCT00341458|Epidemiology|epidemiology
777028|NCT00341445|Environmental Intervention|environmental intervention
777029|NCT00341445|Indoor Allergens|indoor allergens
777030|NCT00341445|Environment|environment
777031|NCT00341432|NRT Study|nrt study
777032|NCT00341432|Smoking Cessation|smoking cessation
777033|NCT00341419|ABC Transporter|abc transporter
777034|NCT00341419|ABCC6|abcc6
777035|NCT00341419|Slkin Laxity|slkin laxity
777036|NCT00341419|Genetic Association|genetic association
777037|NCT00341419|Angiod Streaks|angiod streaks
777038|NCT00341419|Pseudoxanthoma Elasticum|pseudoxanthoma elasticum
777039|NCT00341419|PXE|pxe
777040|NCT00341406|Multisizer 3|multisizer 3
777041|NCT00341406|Signaling|signaling
777042|NCT00341406|Obesity|obesity
777043|NCT00341406|Type 2 Diabetes|type 2 diabetes
777044|NCT00341406|Adipose Cell Turn Over|adipose cell turn over
777045|NCT00341393|HIV Infection|hiv infection
777046|NCT00341393|AIDS|aids
777047|NCT00341393|Viral Load|viral load
777048|NCT00341393|Retroviral Treatment|retroviral treatment
777049|NCT00341393|Uganda|uganda
777050|NCT00341380|Cancer|cancer
777051|NCT00341380|Lung Cancer|lung cancer
777052|NCT00341380|Surgical Resection|surgical resection
777053|NCT00341380|Non-Small Cell Lung Cancer|non-small cell lung cancer
777059|NCT00341367|Radiculopathy|radiculopathy
777060|NCT00341354|Pneumonia|pneumonia
777061|NCT00341354|Bacterial Infection|bacterial infection
777062|NCT00341354|Nosocomial Infection|nosocomial infection
777063|NCT00341354|Trachea|trachea
777064|NCT00341354|Biofilm|biofilm
777065|NCT00341354|Mucus Shaver|mucus shaver
777066|NCT00341341|Smoking|smoking
777067|NCT00341341|Smoking Cessation|smoking cessation
777068|NCT00341341|GSTM1|gstm1
777069|NCT00341341|Glutathione S. Transferase|glutathione s. transferase
777070|NCT00341341|Lung Cancer|lung cancer
777071|NCT00341341|Smokers|smokers
777072|NCT00341341|Genetic Risk Communication|genetic risk communication
777073|NCT00341328|India|india
777074|NCT00341328|Pulmonary Tuberculosis|pulmonary tuberculosis
777075|NCT00341328|Category-I Pulmonary Tuberculosis|category-i pulmonary tuberculosis
777076|NCT00341328|Immunomodulator|immunomodulator
777077|NCT00341328|Mycobacterium w|mycobacterium w
777078|NCT00341315|Epidemiology|epidemiology
777079|NCT00341315|DDT|ddt
777080|NCT00341315|BMI|bmi
777081|NCT00341315|Serum|serum
777082|NCT00341315|Case-Control Study|case-control study
777083|NCT00341302|HIV|hiv
777084|NCT00341302|AIDS|aids
777085|NCT00341302|Perinatal|perinatal
777086|NCT00341302|Transmission|transmission
777087|NCT00341302|Outcomes|outcomes
777088|NCT00341289|Submersion|submersion
777089|NCT00341289|Epidemiology|epidemiology
777090|NCT00341289|Fatal|fatal
777091|NCT00341289|Child|child
777092|NCT00341289|Swim|swim
777093|NCT00341289|Drowning|drowning
777094|NCT00341289|Survey|survey
777095|NCT00341276|Esophageal Cancer|esophageal cancer
777096|NCT00341276|Genetics|genetics
777097|NCT00341276|Polymorphism|polymorphism
777098|NCT00341276|Susceptibility Genes|susceptibility genes
777099|NCT00341276|Tumor|tumor
777100|NCT00341263|Twins|twins
777101|NCT00341263|Clinical Research|clinical research
777102|NCT00341263|Endocrinology|endocrinology
777103|NCT00341263|Breast Cancer|breast cancer
777104|NCT00341263|Biochemical Epidemiology|biochemical epidemiology
777105|NCT00341250|Blood Stage|blood stage
777106|NCT00341250|Investigational|investigational
777107|NCT00341250|Endemic|endemic
777108|NCT00341250|Malaria|malaria
777109|NCT00341237|Genotype|genotype
777110|NCT00341237|Phenotype|phenotype
777111|NCT00341237|Environmental Factor|environmental factor
777112|NCT00341237|Single Nucleotide Polymorphism|single nucleotide polymorphism
777113|NCT00341224|Aggression|aggression
777114|NCT00341224|Violence|violence
777115|NCT00341224|Adolescents|adolescents
777116|NCT00341224|Randomized Trial|randomized trial
777117|NCT00341224|Behavioral Intervention|behavioral intervention
777118|NCT00341211|AIDS|aids
777119|NCT00341211|Cancer|cancer
777120|NCT00341211|Epidemiology|epidemiology
777121|NCT00341211|Immunology|immunology
777122|NCT00341211|Virology|virology
777123|NCT00341198|Rheumatoid Arthritis|rheumatoid arthritis
777124|NCT00341198|Lupus|lupus
777125|NCT00341198|Scleroderma|scleroderma
777126|NCT00341198|Sjogren's Syndrome|sjogren's syndrome
777127|NCT00341198|Farming|farming
777128|NCT00341198|Autoimmune Disease|autoimmune disease
777129|NCT00341198|Exposure|exposure
777130|NCT00341185|Biodosimetry|biodosimetry
777131|NCT00341185|Dose Reconstruction|dose reconstruction
777132|NCT00341185|Radioactive Fallout|radioactive fallout
777133|NCT00341185|Thyroid Screening|thyroid screening
777134|NCT00341185|Ultrasound|ultrasound
777135|NCT00341172|Retinitis|retinitis
777136|NCT00341172|Cytomegalovirus|cytomegalovirus
777137|NCT00341172|HIV-1|hiv-1
777138|NCT00341172|Polymorphisms|polymorphisms
777139|NCT00341172|HAART|haart
777140|NCT00341159|Breast|breast
777141|NCT00341159|BRCA1|brca1
777142|NCT00341159|BRCA2|brca2
777143|NCT00341159|Inherited|inherited
777144|NCT00341159|Association|association
777145|NCT00341159|Breast Cancer|breast cancer
777146|NCT00341159|Population-Based|population-based
777147|NCT00341159|Cancer Susceptibility Alleles|cancer susceptibility alleles
777148|NCT00341146|Cancer|cancer
777149|NCT00341146|Catonese Chinese|catonese chinese
777150|NCT00341146|Genetic Predisposition|genetic predisposition
777151|NCT00341146|Genotyping|genotyping
777152|NCT00341146|Triad analysis|triad analysis
777153|NCT00341146|Nasopharyngeal Cancer|nasopharyngeal cancer
777154|NCT00341146|NPC|npc
777155|NCT00341133|Laterality|laterality
777156|NCT00341133|Heterotaxy|heterotaxy
777157|NCT00341133|Holoprosencephaly|holoprosencephaly
777158|NCT00341133|Genetic Testing|genetic testing
777159|NCT00341133|Congential Cardiac Malformations|congential cardiac malformations
777160|NCT00341133|Disturbed Internal Organ Positioning|disturbed internal organ positioning
777161|NCT00341120|Genotypes|genotypes
777162|NCT00341120|Mutation|mutation
777163|NCT00341120|Folate|folate
777164|NCT00341120|Male Infertility|male infertility
777165|NCT00341120|Nutrition|nutrition
777166|NCT00341107|Cancer|cancer
777167|NCT00341107|Genes|genes
777168|NCT00341107|Screening|screening
777169|NCT00341107|Primary Care|primary care
777170|NCT00341107|Inherited Susceptibility|inherited susceptibility
777171|NCT00341094|Cohort|cohort
777172|NCT00341094|Radiation|radiation
777173|NCT00341094|In Utero|in utero
777174|NCT00341094|Genomic|genomic
777175|NCT00341081|Short Tandem Repeat|short tandem repeat
777176|NCT00341081|Molecular Epidemiology|molecular epidemiology
777177|NCT00341081|Viral Infection|viral infection
777178|NCT00341081|Mixture Detection|mixture detection
777179|NCT00341081|Intervention & Education|intervention & education
777180|NCT00341081|Intervention|intervention
777181|NCT00341081|Education|education
777182|NCT00341068|Birth Defects|birth defects
777183|NCT00341068|Folic Acid|folic acid
777184|NCT00341068|Gene-Environment Interactions|gene-environment interactions
777185|NCT00341068|Neural Tube Defects|neural tube defects
777186|NCT00341068|Cleft Lip|cleft lip
777187|NCT00341055|Anemia|anemia
777188|NCT00341055|Hemoglobin|hemoglobin
777189|NCT00341055|Chemotherapy|chemotherapy
777190|NCT00341055|Epoetin alfa|epoetin alfa
777191|NCT00341042|Normal Values|normal values
777192|NCT00341042|Complete Blood Count|complete blood count
777193|NCT00341042|HIV|hiv
777194|NCT00341042|Tuberculosis|tuberculosis
777195|NCT00341042|Flow Cytometry|flow cytometry
777196|NCT00341029|Longitudinal Study|longitudinal study
777197|NCT00341029|Chromosomal Effects|chromosomal effects
777198|NCT00341029|Sister Chromatid Exchanges|sister chromatid exchanges
777199|NCT00341029|Micronuclei|micronuclei
777200|NCT00341029|Stimulants|stimulants
777201|NCT00341029|Attention Deficit Hyperactivity Disorder|attention deficit hyperactivity disorder
777202|NCT00341029|ADHD|adhd
777203|NCT00341016|Radiation|radiation
777204|NCT00341003|Plasmodium Falciparum|plasmodium falciparum
777205|NCT00341003|Hemoglobin E|hemoglobin e
777206|NCT00341003|Mefloquine|mefloquine
777207|NCT00341003|Artemisinin|artemisinin
777208|NCT00341003|Piperaquine|piperaquine
777209|NCT00341003|Malaria|malaria
777210|NCT00340990|Tuberculosis|tuberculosis
777211|NCT00340990|HIV|hiv
777212|NCT00340990|CD4+ T Cell|cd4+ t cell
777213|NCT00340990|Interferon-Gamma|interferon-gamma
777214|NCT00340990|Lymphocyte Proliferation|lymphocyte proliferation
777215|NCT00340977|Birth Defects|birth defects
777216|NCT00340977|Cleft Lip and Palate|cleft lip and palate
777217|NCT00340977|Genetic Susceptibility|genetic susceptibility
777218|NCT00340964|Photography|photography
777219|NCT00340964|Self-Esteem|self-esteem
777220|NCT00340964|Perceived Social Stigma|perceived social stigma
777221|NCT00340964|Hopefulness|hopefulness
777222|NCT00340964|Cleft Lip and Palate|cleft lip and palate
777223|NCT00340964|Hemifacial Microsomia|hemifacial microsomia
777224|NCT00340964|Treacher Collins Syndrome|treacher collins syndrome
777225|NCT00340964|Mobius Syndrome|mobius syndrome
777226|NCT00340964|Apert Syndrome|apert syndrome
777227|NCT00340964|Videography|videography
777228|NCT00340964|Craniofacial Differences|craniofacial differences
777229|NCT00340964|Self -Esteem|self -esteem
777230|NCT00340951|Regulatory T Cells|regulatory t cells
777231|NCT00340951|Bronchiolitis Obliterans Syndrome|bronchiolitis obliterans syndrome
777232|NCT00340951|Genetic Polymorphism|genetic polymorphism
777233|NCT00340951|Innate Immunity|innate immunity
777234|NCT00340951|Transplantation|transplantation
777235|NCT00340951|Lung Transplantation|lung transplantation
777236|NCT00340938|Adherence|adherence
777237|NCT00340938|Education|education
777238|NCT00340938|Problem Solving|problem solving
777239|NCT00340938|Motivation|motivation
777240|NCT00340938|Locus of Responsibility|locus of responsibility
777241|NCT00340912|Skin Biopsy|skin biopsy
777242|NCT00340899|Perinatal Mortality|perinatal mortality
777243|NCT00340899|Perinatal Morbidity|perinatal morbidity
777244|NCT00340899|Preterm Birth|preterm birth
777245|NCT00340899|Pregnancy Complications|pregnancy complications
777246|NCT00340899|Pregnancy|pregnancy
777247|NCT00340886|Genetic Susceptibility|genetic susceptibility
777248|NCT00340886|Single Nucleotide Polymorphism|single nucleotide polymorphism
777249|NCT00340886|Environmental Risk Factor|environmental risk factor
777250|NCT00340886|Allelic Variants|allelic variants
777251|NCT00340886|Ascertainment by Genotype|ascertainment by genotype
777252|NCT00340873|Molecular Epidemiology|molecular epidemiology
777253|NCT00340873|Cross-Sectional|cross-sectional
777254|NCT00340873|Gene-Enviroment Interaction|gene-enviroment interaction
777255|NCT00340860|Disease Activity|disease activity
777256|NCT00340860|Pregnancy|pregnancy
777257|NCT00340860|Exposure|exposure
777258|NCT00340860|Norway Mother and Child Study|norway mother and child study
777259|NCT00340847|Molecular Profiling|molecular profiling
777260|NCT00340847|In Situ Hybridization|in situ hybridization
777261|NCT00340847|SAGE|sage
777262|NCT00340847|Tumor Markers|tumor markers
777263|NCT00340847|IHC|ihc
777264|NCT00340847|Lung Cancer|lung cancer
777265|NCT00340847|Genetics|genetics
777266|NCT00340834|FTY720|fty720
777267|NCT00340834|Interferon|interferon
777268|NCT00340834|RRMS|rrms
777269|NCT00340834|Multiple Sclerosis|multiple sclerosis
777270|NCT00340834|Efficacy|efficacy
777271|NCT00340821|HTLV-I|htlv-i
777272|NCT00340808|Endometrial Cancer|endometrial cancer
777273|NCT00340808|Epidemiology|epidemiology
777274|NCT00340808|Questionnaire|questionnaire
777275|NCT00340808|Etiology|etiology
777276|NCT00340808|Biomarkers|biomarkers
777277|NCT00340795|Media Analysis|media analysis
777278|NCT00340795|Nutrition|nutrition
777279|NCT00340795|Physical Activity|physical activity
777280|NCT00340795|After-School|after-school
777281|NCT00340795|Exercise|exercise
777282|NCT00340782|Menstrual Cycles|menstrual cycles
777283|NCT00340782|Early Pregnancy|early pregnancy
777284|NCT00340782|Reproductive Hormones|reproductive hormones
777285|NCT00340782|Stress|stress
777286|NCT00340782|Adrenal Function|adrenal function
777287|NCT00340769|Cytokines|cytokines
777288|NCT00340769|Inflammation|inflammation
777289|NCT00340769|mRNA Stability|mrna stability
777290|NCT00340769|Pygmy|pygmy
777291|NCT00340769|Zinc Finger Proteins|zinc finger proteins
777292|NCT00340769|Ethnic Group|ethnic group
777293|NCT00340756|GCMS|gcms
777294|NCT00340756|LCMS-MS|lcms-ms
777295|NCT00340743|Heterocyclic Aminos|heterocyclic aminos
777296|NCT00340743|Cruciferous Vegetables|cruciferous vegetables
777297|NCT00340743|Yogurt|yogurt
777298|NCT00340743|Chlorophyllin|chlorophyllin
777299|NCT00340743|Comet Assay|comet assay
777300|NCT00340743|Diet|diet
777301|NCT00340743|Healthy Volunteer|healthy volunteer
777302|NCT00340730|Health Education|health education
777303|NCT00340730|Mentoring|mentoring
777304|NCT00340730|Parenting|parenting
777305|NCT00340730|Social Skills Training|social skills training
777306|NCT00340730|Violence|violence
777307|NCT00340730|Intervention|intervention
777308|NCT00340730|Youth Injury|youth injury
777309|NCT00340717|Methylation|methylation
777310|NCT00340717|Genes|genes
777311|NCT00340717|Screening|screening
777312|NCT00340717|Prospective|prospective
777313|NCT00340717|Diagnosis|diagnosis
777314|NCT00340704|tamsulosin|tamsulosin
777315|NCT00340704|pediatric|pediatric
777316|NCT00340704|neurogenic bladder|neurogenic bladder
777317|NCT00340691|Parasite|parasite
777318|NCT00340691|Chemotherapy|chemotherapy
777319|NCT00340691|Wuchereria Bancrofti|wuchereria bancrofti
777320|NCT00340678|Angiotensin II Receptor Antagonist|angiotensin ii receptor antagonist
777321|NCT00340678|Therapeutic Trial|therapeutic trial
777322|NCT00340678|Glomerular Filtration Rate|glomerular filtration rate
777323|NCT00340678|Kidney Biopsy|kidney biopsy
777324|NCT00340678|Non-Insulin Dependent Diabetes Mellitus|non-insulin dependent diabetes mellitus
777325|NCT00340665|Soy|soy
777326|NCT00340665|Infant Formula|infant formula
777327|NCT00340665|Sexual Development|sexual development
777328|NCT00340665|Hormone|hormone
777329|NCT00340665|Isoflavones|isoflavones
777330|NCT00340652|Soy|soy
777331|NCT00340652|Isoflavones|isoflavones
777332|NCT00340652|Infant Formula|infant formula
777333|NCT00340652|Sexual Development|sexual development
777334|NCT00340652|Hormone|hormone
777335|NCT00340639|Adherence|adherence
777336|NCT00340639|Chronic Illness|chronic illness
777337|NCT00340639|Adolescent|adolescent
777338|NCT00340639|Family|family
777339|NCT00340639|Self-Regulation|self-regulation
777340|NCT00340626|Linkage Analysis|linkage analysis
777341|NCT00340626|Genotyping|genotyping
777342|NCT00340626|Birth Defects|birth defects
777343|NCT00340626|Family Study|family study
777344|NCT00340626|Positional Cloning|positional cloning
777345|NCT00340613|Type 1 Diabetes|type 1 diabetes
777346|NCT00340613|Poorly controlled glucose|poorly controlled glucose
777347|NCT00340613|adolescents|adolescents
777348|NCT00340600|Cancer|cancer
777349|NCT00340600|DES|des
777350|NCT00340600|Endocrine Disrupting Chemicals|endocrine disrupting chemicals
777351|NCT00340600|In Utero|in utero
777352|NCT00340587|Zona Pellucida|zona pellucida
777353|NCT00340587|Human Eggs|human eggs
777354|NCT00340587|ZP1, ZP2, ZP3|zp1, zp2, zp3
777355|NCT00340587|Fertilization|fertilization
777356|NCT00340574|Human|human
777357|NCT00340574|Clinical Trial|clinical trial
777358|NCT00340574|Mosquito|mosquito
777359|NCT00340574|Healthy Volunteer|healthy volunteer
777360|NCT00340574|HV|hv
777361|NCT00340561|Test Track|test track
777362|NCT00340561|Distraction|distraction
777363|NCT00340561|Motor Vehicle|motor vehicle
777364|NCT00340561|Learning|learning
777365|NCT00340561|Inexperience|inexperience
777366|NCT00340548|Genotyping|genotyping
777367|NCT00340548|Polymorphisms|polymorphisms
777368|NCT00340548|Co-Infection|co-infection
777369|NCT00340548|Chemokines|chemokines
777370|NCT00340548|Associations|associations
777371|NCT00340548|HIV|hiv
777372|NCT00340548|HCV|hcv
777373|NCT00340548|Hepatitis C|hepatitis c
777374|NCT00340548|Hemophilia|hemophilia
777375|NCT00340535|Disinfection byproducts|disinfection byproducts
777376|NCT00340535|Genetic Variation|genetic variation
777377|NCT00340535|Trihalomethanes|trihalomethanes
777378|NCT00340522|Sarcoma|sarcoma
777379|NCT00340522|Brain Tumor|brain tumor
777380|NCT00340522|Embryonal Tumor|embryonal tumor
777381|NCT00340522|Tumor Array|tumor array
777382|NCT00340522|Childhood Cancer|childhood cancer
777383|NCT00340522|Plexiform Neurofibromas|plexiform neurofibromas
777384|NCT00340522|Drug Screening|drug screening
777385|NCT00340522|Immunohistochemistry|immunohistochemistry
777386|NCT00340509|Genetics|genetics
777387|NCT00340509|Population|population
777388|NCT00340509|CHD Risk|chd risk
777389|NCT00340509|Epidemiology|epidemiology
777390|NCT00340509|Gene Mapping|gene mapping
777391|NCT00340496|Schwannoma|schwannoma
777392|NCT00340496|Meningioma|meningioma
777393|NCT00340496|Follow-Up|follow-up
777394|NCT00340496|Radiation Therapy|radiation therapy
777395|NCT00340496|Cohort|cohort
777396|NCT00340483|Smoking Cessation|smoking cessation
777397|NCT00340483|Young Adults|young adults
777398|NCT00340483|Quit Smoking|quit smoking
777399|NCT00340483|Email|email
777400|NCT00340483|Social Marketing|social marketing
777401|NCT00340470|Injury|injury
777402|NCT00340470|Motor Vehicle|motor vehicle
777403|NCT00340470|Parenting|parenting
777404|NCT00340470|Randomized Trial|randomized trial
777405|NCT00340470|Behavioral Intervention|behavioral intervention
777406|NCT00340457|Case-Control Study|case-control study
777407|NCT00340457|Renal Cell Carcinoma|renal cell carcinoma
777408|NCT00340457|Kidney Cancer|kidney cancer
777409|NCT00340457|Diet|diet
777410|NCT00340457|Occupation|occupation
777411|NCT00340444|Linkage|linkage
777412|NCT00340444|Covariates|covariates
777413|NCT00340444|Association|association
777414|NCT00340444|Fine Mapping|fine mapping
777415|NCT00340444|Inflammatory Bowel Disease|inflammatory bowel disease
777416|NCT00340444|Ulcerative Colitis|ulcerative colitis
777417|NCT00340444|Crohn's Disease|crohn's disease
777418|NCT00340431|Human|human
777419|NCT00340431|Clinical Trial|clinical trial
777420|NCT00340431|Mosquito|mosquito
777421|NCT00340418|Bronchoalveolar Lavage|bronchoalveolar lavage
777422|NCT00340418|Acute Rejection|acute rejection
777423|NCT00340418|Chronic Rejection|chronic rejection
777424|NCT00340418|Genetic Polymorphisms|genetic polymorphisms
777425|NCT00340418|Innate Immunity|innate immunity
777426|NCT00340418|Lung Transplantation|lung transplantation
777427|NCT00340418|Lung Allograft Rejection|lung allograft rejection
777428|NCT00340405|Blood|blood
777429|NCT00340405|Lung Cancer|lung cancer
777430|NCT00340405|Occupational Exposure|occupational exposure
777431|NCT00340405|Radon|radon
777432|NCT00340405|Arsenic|arsenic
777433|NCT00340392|Mammary Stem Cells|mammary stem cells
777434|NCT00340392|Breast Cancer|breast cancer
777435|NCT00340392|Cancer Stem Cells|cancer stem cells
777436|NCT00340392|Gene Expression Profiling|gene expression profiling
777437|NCT00340379|Psychotic|psychotic
777438|NCT00340366|Homocysteine|homocysteine
777439|NCT00340366|Vitamin B12|vitamin b12
777440|NCT00340366|Birth Defects|birth defects
777441|NCT00340366|Pregnancy|pregnancy
777442|NCT00340366|Folate|folate
777443|NCT00340366|Irish Individuals|irish individuals
777444|NCT00340353|Gene Expression|gene expression
777445|NCT00340353|Drug Sensitivity|drug sensitivity
777446|NCT00340353|TFE3|tfe3
777447|NCT00340353|ASPL-TFE3|aspl-tfe3
777448|NCT00340353|NOD-SCID Mice|nod-scid mice
777449|NCT00340353|Sarcoma|sarcoma
777450|NCT00340353|Alveolar Soft Part Sarcoma|alveolar soft part sarcoma
777451|NCT00340353|ASPS|asps
777452|NCT00340340|Population-Based Case Control Study|population-based case control study
777453|NCT00340340|Lung Cancer|lung cancer
777454|NCT00340340|Epidemiology|epidemiology
777455|NCT00340340|Smoking|smoking
777456|NCT00340340|Smokers|smokers
777457|NCT00340340|Genetics|genetics
777458|NCT00340327|healthy subjects|healthy subjects
777459|NCT00340314|symptomatic|symptomatic
777460|NCT00340314|paroxysmal|paroxysmal
777461|NCT00340314|atrial fibrillation|atrial fibrillation
777462|NCT00340301|Polymorphism|polymorphism
777463|NCT00340301|Neurodegenerative Diseases|neurodegenerative diseases
777464|NCT00340301|ALS|als
777465|NCT00340288|Neoplasms|neoplasms
777466|NCT00340288|Life Style/Endrocrinology|life style/endrocrinology
777467|NCT00340288|Magnetic Resonance Imaging|magnetic resonance imaging
777468|NCT00340288|Molecular Characterization|molecular characterization
777469|NCT00340288|Leiomyoma|leiomyoma
777470|NCT00340275|Bacterial Vaginosis|bacterial vaginosis
777471|NCT00340275|Vaginal Infection|vaginal infection
777472|NCT00340275|Vaginitis|vaginitis
777473|NCT00340275|Cohort Study|cohort study
777474|NCT00340275|Sexually Transmitted Disease|sexually transmitted disease
777475|NCT00340262|Supplemental Hormone Use|supplemental hormone use
777476|NCT00340262|Osteoporosis|osteoporosis
777477|NCT00340262|Endogenous Sex Hormones|endogenous sex hormones
777478|NCT00340249|Premature Rupture of the Membranes (PROM)|premature rupture of the membranes (prom)
777479|NCT00340249|Preterm Delivery|preterm delivery
777480|NCT00340249|In-Utero Fetal Demise|in-utero fetal demise
777481|NCT00340249|Chorioamnionitis|chorioamnionitis
777482|NCT00340249|Spontaneous Abortion|spontaneous abortion
777483|NCT00340223|Immunity|immunity
777484|NCT00340223|Mutations|mutations
777485|NCT00340223|Viral Selection|viral selection
777486|NCT00340223|Disease Progression|disease progression
777487|NCT00340223|RNA|rna
777489|NCT00340210|Breast Cancer|breast cancer
777490|NCT00340210|Etiology|etiology
777491|NCT00340210|Hormones|hormones
777492|NCT00340210|Prospective Study|prospective study
777493|NCT00340184|concurrent|concurrent
777494|NCT00340184|chemoradiation|chemoradiation
777495|NCT00340184|paclitaxel|paclitaxel
777496|NCT00340184|carboplatin|carboplatin
777497|NCT00340171|Intrauterine Growth Retardation|intrauterine growth retardation
777498|NCT00340158|Mammary|mammary
777499|NCT00340158|Diagnosis|diagnosis
777500|NCT00340158|Aggressive|aggressive
777501|NCT00340158|Pathology|pathology
777502|NCT00340158|Epidemiology|epidemiology
777503|NCT00340132|Insulin Sensitivity|insulin sensitivity
777504|NCT00340132|Insulin Secretion|insulin secretion
777505|NCT00340132|Glucose Tolerance|glucose tolerance
777506|NCT00340132|Adipose Tissue|adipose tissue
777507|NCT00340132|Preadipocytes|preadipocytes
777508|NCT00340119|CHOICE Cohort|choice cohort
777509|NCT00340119|End Stage Renal Disease|end stage renal disease
777510|NCT00340119|Epidemiology|epidemiology
777511|NCT00340119|Prevention|prevention
777512|NCT00340119|Single Nucleotide Polymorphisms|single nucleotide polymorphisms
777513|NCT00340119|ESRD|esrd
777514|NCT00340106|Infant Health Study|infant health study
777515|NCT00340106|Environmental Tobacco Smoke|environmental tobacco smoke
777516|NCT00340106|Infant Health|infant health
777517|NCT00340093|Adherence|adherence
777518|NCT00340093|Behavioral Intervention|behavioral intervention
777519|NCT00340093|Adolescence|adolescence
777520|NCT00340093|Self-Regulation|self-regulation
777521|NCT00340093|Behavioral Medicine|behavioral medicine
777522|NCT00340093|Diabetes|diabetes
777523|NCT00340080|Abacavir|abacavir
777524|NCT00340080|Pharmacogenetics|pharmacogenetics
777525|NCT00340080|hypersensitivity|hypersensitivity
777526|NCT00340080|HLA-B*5701|hla-b*5701
777527|NCT00340054|brain tumor|brain tumor
777528|NCT00340028|Ovulation|ovulation
777529|NCT00340028|Diary Record|diary record
777530|NCT00340028|Urine Collection|urine collection
777531|NCT00340028|Leutinizing Hormone|leutinizing hormone
777532|NCT00340028|Blood Collection|blood collection
777533|NCT00340028|Hormone|hormone
777534|NCT00340028|Pregnancy|pregnancy
777535|NCT00340015|Cancer|cancer
777536|NCT00340015|Mortality|mortality
777537|NCT00340015|Lifestyle Factors|lifestyle factors
777538|NCT00340015|Cohort|cohort
777539|NCT00340002|Fetal Anatomy|fetal anatomy
777540|NCT00340002|Pregnancy|pregnancy
777541|NCT00340002|Prenatal Diagnosis|prenatal diagnosis
777542|NCT00339989|Molecular Markers|molecular markers
777543|NCT00339989|Human Papillomavirus|human papillomavirus
777544|NCT00339989|Cervix|cervix
777545|NCT00339989|Cancer|cancer
777546|NCT00339989|Microarray|microarray
777547|NCT00339976|Case-Control Study|case-control study
777548|NCT00339976|Death Certificates|death certificates
777549|NCT00339976|National Death Index|national death index
777550|NCT00339976|Cause of Death Information|cause of death information
777551|NCT00339976|Lead Exposure|lead exposure
777552|NCT00339976|Amyotrophic Lateral Sclerosis|amyotrophic lateral sclerosis
777553|NCT00339976|ALS|als
777554|NCT00339963|Microarray|microarray
777555|NCT00339963|Lymphoma|lymphoma
777556|NCT00339963|Gene Expression|gene expression
777557|NCT00339963|Molecular Diagnosis|molecular diagnosis
777558|NCT00339963|Prognosis|prognosis
777559|NCT00339963|Leukemia|leukemia
777560|NCT00339963|Myeloma|myeloma
777561|NCT00339963|Lymphoid Malignancy|lymphoid malignancy
777562|NCT00339950|Colorectal adenoma|colorectal adenoma
777563|NCT00339950|Screening|screening
777564|NCT00339950|Diet|diet
777565|NCT00339950|Risk Factors|risk factors
777566|NCT00339937|Human Herpes virus 8 (HHV8)|human herpes virus 8 (hhv8)
777567|NCT00339937|Kaposi sarcoma (KS)|kaposi sarcoma (ks)
777568|NCT00339924|Clinical Decision-Making|clinical decision-making
777569|NCT00339924|Physician Bias|physician bias
777570|NCT00339924|Genetics|genetics
777571|NCT00339924|Race|race
777572|NCT00339924|Ethnicity|ethnicity
777573|NCT00339924|Human Genetic Variation|human genetic variation
777574|NCT00339911|Repository|repository
777575|NCT00339911|Phlebotomy|phlebotomy
777576|NCT00339911|Venipuncture|venipuncture
777577|NCT00339911|Anemia|anemia
777578|NCT00339911|Occupational Health Services|occupational health services
777579|NCT00339898|Minimal Residual Disease|minimal residual disease
777580|NCT00339898|Ewings Sarcoma|ewings sarcoma
777581|NCT00339885|Monogenic Diabetes|monogenic diabetes
777582|NCT00339885|Type 2 Diabetes Mellitus|type 2 diabetes mellitus
777583|NCT00339885|QTL|qtl
777584|NCT00339872|healthy subjects|healthy subjects
777585|NCT00339859|Molecular Epidemiology of Lung Cancer|molecular epidemiology of lung cancer
777586|NCT00339859|Health Disparities|health disparities
777587|NCT00339846|Craniosynostosis|craniosynostosis
777698|NCT00339508|Bug Reports|bug reports
777588|NCT00339846|Craniofrontonasal Syndrome|craniofrontonasal syndrome
777589|NCT00339846|CFNS|cfns
777590|NCT00339833|Salsalate|salsalate
777591|NCT00339833|Insulin Resistance|insulin resistance
777592|NCT00339833|Diabetes Mellitus|diabetes mellitus
777593|NCT00339833|Inflammation|inflammation
777594|NCT00339833|Diabetes|diabetes
777595|NCT00339833|HCV|hcv
777596|NCT00339807|Retrovirus|retrovirus
777597|NCT00339807|Caribbean|caribbean
777598|NCT00339807|Transmission|transmission
777599|NCT00339807|Genetic|genetic
777600|NCT00339807|Viral Markers|viral markers
777601|NCT00339807|HTLV-1|htlv-1
777602|NCT00339794|Racial Profiling|racial profiling
777603|NCT00339794|Genomics|genomics
777604|NCT00339794|Genetic Testing|genetic testing
777605|NCT00339794|Family History|family history
777606|NCT00339794|Family Physician|family physician
777607|NCT00339781|Fetomaternal Microchimerism|fetomaternal microchimerism
777608|NCT00339781|Cell Trafficking|cell trafficking
777609|NCT00339781|Discordant Twins|discordant twins
777610|NCT00339781|Maternofetal Microchimerism|maternofetal microchimerism
777611|NCT00339781|Diabetes Type I|diabetes type i
777612|NCT00339781|Twins|twins
777613|NCT00339768|Helicobacter Pylori|helicobacter pylori
777614|NCT00339768|Gastric Cancer Prevention|gastric cancer prevention
777615|NCT00339768|Precancerous Gastric Lesions|precancerous gastric lesions
777616|NCT00339742|Esophageal Cancer|esophageal cancer
777617|NCT00339742|Case-Control Study|case-control study
777618|NCT00339742|Environmental Risk Factors|environmental risk factors
777619|NCT00339742|Genetic Risk Factors|genetic risk factors
777620|NCT00339729|Children|children
777621|NCT00339729|Behavior|behavior
777622|NCT00339729|Epidemiology|epidemiology
777623|NCT00339729|Lead|lead
777624|NCT00339729|Learning Disorder|learning disorder
777625|NCT00339716|Cohort|cohort
777626|NCT00339716|Radiation|radiation
777627|NCT00339716|In Utero|in utero
777628|NCT00339703|Resistin|resistin
777629|NCT00339703|Asthma|asthma
777630|NCT00339703|CRP|crp
777631|NCT00339703|Diabetes|diabetes
777632|NCT00339703|FIZZ|fizz
777633|NCT00339690|Asthma|asthma
777634|NCT00339690|Allergy|allergy
777635|NCT00339690|Intervention|intervention
777636|NCT00339690|Behaviors|behaviors
777637|NCT00339690|Test-Kit|test-kit
777638|NCT00339690|Dust Mites Allergen|dust mites allergen
777639|NCT00339677|Measurement Error|measurement error
777640|NCT00339677|Dietary Assessment|dietary assessment
777641|NCT00339677|Dietary Intake|dietary intake
777642|NCT00339677|Energy|energy
777643|NCT00339677|Protein|protein
777644|NCT00339664|Pharmacokinetics|pharmacokinetics
777645|NCT00339664|Quantify|quantify
777646|NCT00339664|HPLC|hplc
777647|NCT00339664|LC/MS|lc/ms
777648|NCT00339664|Pharmacodynamics|pharmacodynamics
777649|NCT00339651|Precursors|precursors
777650|NCT00339651|Endometrial Cancer|endometrial cancer
777651|NCT00339651|Hyperplasia|hyperplasia
777652|NCT00339651|Progression|progression
777653|NCT00339638|Epidemiology|epidemiology
777654|NCT00339638|Risk Prediction|risk prediction
777655|NCT00339638|Biomarkers|biomarkers
777656|NCT00339638|Nested Case Control|nested case control
777657|NCT00339625|Intervention|intervention
777658|NCT00339625|Diet|diet
777659|NCT00339625|Colon|colon
777660|NCT00339612|Perinatal|perinatal
777661|NCT00339612|HIV|hiv
777662|NCT00339612|AIDS|aids
777663|NCT00339599|Atherosclerosis|atherosclerosis
777664|NCT00339599|Single Nucleotide Polymorphisms|single nucleotide polymorphisms
777665|NCT00339599|Monocyte Chemotactic Protein-1|monocyte chemotactic protein-1
777666|NCT00339599|Inflammation|inflammation
777667|NCT00339599|Eotaxin|eotaxin
777668|NCT00339586|Non-small cell lung cancer|non-small cell lung cancer
777669|NCT00339586|tyrosine kinase inhibition|tyrosine kinase inhibition
777670|NCT00339586|first-line treatment|first-line treatment
777671|NCT00339586|mutant EGFR-gene|mutant egfr-gene
777672|NCT00339573|Asthma|asthma
777673|NCT00339573|Exposure|exposure
777674|NCT00339573|Home|home
777675|NCT00339573|Indoor|indoor
777676|NCT00339573|Allergy|allergy
777677|NCT00339560|Ampulla of Vater|ampulla of vater
777678|NCT00339560|Gallbaldder|gallbaldder
777679|NCT00339560|Cancer|cancer
777680|NCT00339560|Extrahepatic Bile Duct|extrahepatic bile duct
777681|NCT00339547|Leiomyomas|leiomyomas
777682|NCT00339547|Ultrasound|ultrasound
777683|NCT00339547|Hysterectomy|hysterectomy
777684|NCT00339547|Epidemiology|epidemiology
777685|NCT00339547|Hyperinsulinemia|hyperinsulinemia
777686|NCT00339534|African Men|african men
777687|NCT00339534|Case-Control Study|case-control study
777688|NCT00339534|Prostate Cancer|prostate cancer
777689|NCT00339534|Cancer|cancer
777690|NCT00339521|Asthma|asthma
777691|NCT00339521|Mexico|mexico
777692|NCT00339521|Triads|triads
777693|NCT00339521|Polymorphism|polymorphism
777694|NCT00339521|Genetic Predisposition|genetic predisposition
777695|NCT00339508|Linkage Analysis|linkage analysis
777696|NCT00339508|Cancer Genetics|cancer genetics
777697|NCT00339508|Software|software
777699|NCT00339508|Computer Programs|computer programs
777700|NCT00339508|Data Analysis|data analysis
777701|NCT00339495|Prostate|prostate
777702|NCT00339495|Screening Trail|screening trail
777703|NCT00339495|Ovarian|ovarian
777706|NCT00339482|AMERICAN INDIAN|american indian
777707|NCT00339482|Diabetes|diabetes
777708|NCT00339482|Renal Diseases|renal diseases
777709|NCT00339482|Cardiovascular Disease|cardiovascular disease
777710|NCT00339469|Prevention|prevention
777711|NCT00339469|Colorectal Neoplasms|colorectal neoplasms
777712|NCT00339469|Insulin Resistance|insulin resistance
777713|NCT00339469|Inflammation Obesity|inflammation obesity
777714|NCT00339469|Adenoma|adenoma
777715|NCT00339456|Therapy|therapy
777716|NCT00339456|Africa|africa
777717|NCT00339456|Structured|structured
777718|NCT00339456|Interruption|interruption
777719|NCT00339456|Antiretroviral|antiretroviral
777721|NCT00339443|Buccal Cells|buccal cells
777722|NCT00339443|Concordance|concordance
777723|NCT00339443|DNA Yields|dna yields
777724|NCT00339443|pH Meter|ph meter
777725|NCT00339443|Urine pH|urine ph
777726|NCT00339443|Calibration|calibration
777727|NCT00339430|Genotyping|genotyping
777728|NCT00339430|HIV|hiv
777729|NCT00339430|HPV|hpv
777730|NCT00339430|HCV|hcv
777731|NCT00339430|HBV|hbv
777732|NCT00339417|Lymphatic Filariasis|lymphatic filariasis
777733|NCT00339417|Chemotherapy|chemotherapy
777734|NCT00339404|Genotyping|genotyping
777735|NCT00339404|Linkage Analysis|linkage analysis
777736|NCT00339404|Cancer|cancer
777737|NCT00339404|Hereditary Melanoma|hereditary melanoma
777738|NCT00339391|Adjustment|adjustment
777739|NCT00339391|Environmental Complexity|environmental complexity
777740|NCT00339391|Mental Illness|mental illness
777741|NCT00339391|Non-literate|non-literate
777742|NCT00339391|West Africa|west africa
777743|NCT00339391|Stress|stress
777744|NCT00339391|Knowledge|knowledge
777745|NCT00339391|Mental Health|mental health
777746|NCT00339391|AIDS|aids
777747|NCT00339378|Record Linkage|record linkage
777748|NCT00339378|Retrospective|retrospective
777749|NCT00339378|Cohort|cohort
777750|NCT00339378|Registries|registries
777751|NCT00339378|Agricultural|agricultural
777752|NCT00339365|Infants|infants
777753|NCT00339365|Toddlers|toddlers
777754|NCT00339365|Attachment|attachment
777755|NCT00339365|Maltreatment|maltreatment
777756|NCT00339365|Foster Care|foster care
777757|NCT00339352|Brain|brain
777758|NCT00339352|Exposures|exposures
777759|NCT00339352|Genetics|genetics
777760|NCT00339352|Glioma|glioma
777761|NCT00339352|Occupations|occupations
777762|NCT00339339|Dental Materials|dental materials
777763|NCT00339339|Resins|resins
777764|NCT00339339|BisDMA|bisdma
777765|NCT00339339|Absorption|absorption
777766|NCT00339339|Systemic|systemic
777767|NCT00339326|Human Herpes virus 8 (HHV8)|human herpes virus 8 (hhv8)
777768|NCT00339326|Kaposis sarcoma (KS)|kaposis sarcoma (ks)
777769|NCT00339326|Kaposi Sarcoma|kaposi sarcoma
777770|NCT00339326|Karposi Sarcoma-Associated Herpesvirus|karposi sarcoma-associated herpesvirus
777771|NCT00339326|KSHV|kshv
777772|NCT00339326|KS|ks
777773|NCT00339313|Obesity|obesity
777774|NCT00339313|Etiology|etiology
777775|NCT00339313|Macronutrient Selection|macronutrient selection
777776|NCT00339313|Taste Preference|taste preference
777777|NCT00339313|Mixed Meal Test|mixed meal test
777778|NCT00339300|Etiology|etiology
777779|NCT00339300|Brain Cancer|brain cancer
777780|NCT00339300|Epidemiology|epidemiology
777781|NCT00339300|Brain Tumors|brain tumors
777782|NCT00339300|Glioma|glioma
777783|NCT00339287|Inflammation|inflammation
777784|NCT00339287|Innate Immunity|innate immunity
777785|NCT00339287|Macrophages|macrophages
777786|NCT00339287|Neutrophils|neutrophils
777787|NCT00339287|Pathogenesis|pathogenesis
777788|NCT00339274|Repositories|repositories
777789|NCT00339274|Pathology|pathology
777790|NCT00339274|Belarus|belarus
777791|NCT00339274|Russia|russia
777792|NCT00339274|Ukraine|ukraine
777793|NCT00339261|Cardiovascular|cardiovascular
777794|NCT00339261|Renal|renal
777795|NCT00339261|Autoimmune Disease|autoimmune disease
777796|NCT00339261|Genetics|genetics
777797|NCT00339261|Mortality|mortality
777798|NCT00339248|Hyperplasia|hyperplasia
777799|NCT00339248|Atypia|atypia
777800|NCT00339248|Polymorphism|polymorphism
777801|NCT00339248|Progression|progression
777802|NCT00339248|Epidemiology|epidemiology
777803|NCT00339235|Preterm Birth Prevention|preterm birth prevention
777804|NCT00339235|Preterm Birth|preterm birth
777805|NCT00339235|Pregnancy|pregnancy
777806|NCT00339235|Pregnancy Complications|pregnancy complications
777807|NCT00339222|Genetics|genetics
777808|NCT00339222|Kindreds|kindreds
777809|NCT00339222|Mediterranean Population|mediterranean population
777810|NCT00339222|Nevi|nevi
777811|NCT00339222|Pigmentation|pigmentation
777812|NCT00339222|Melanoma-Prone Families|melanoma-prone families
777813|NCT00339222|Sun Exposure|sun exposure
777814|NCT00339222|Melanoma|melanoma
777815|NCT00339209|Genetic Polymorphisms|genetic polymorphisms
777816|NCT00339209|Acute Rejection|acute rejection
777817|NCT00339209|Bronchiolitis Obliterans Syndrome|bronchiolitis obliterans syndrome
777818|NCT00339209|Transplant Rejection|transplant rejection
777819|NCT00339209|Innate Immunity|innate immunity
777820|NCT00339209|Lung Transplantation Rejection|lung transplantation rejection
777821|NCT00339196|AML|aml
777822|NCT00339196|MDS High risk|mds high risk
777823|NCT00339196|Demethylating agents|demethylating agents
777824|NCT00339196|HDAC Inhibitors|hdac inhibitors
777825|NCT00339183|Oncology|oncology
777826|NCT00339183|Cancer|cancer
777827|NCT00339183|Metastatic Colorectal Cancer|metastatic colorectal cancer
777828|NCT00339183|EGFr|egfr
777829|NCT00339183|Panitumumab|panitumumab
777830|NCT00339183|Clinical Trial|clinical trial
777831|NCT00339183|Amgen|amgen
777832|NCT00339170|Schizoaffective Disorder|schizoaffective disorder
777833|NCT00339170|Schizophrenic Disorders|schizophrenic disorders
777834|NCT00339170|Psychotic Disorders|psychotic disorders
777835|NCT00339170|Cognition|cognition
777836|NCT00339157|IDIOPATHIC JUVENILE ARTHRITIS|idiopathic juvenile arthritis
777837|NCT00339157|PEDIATRICS|pediatrics
777838|NCT00339157|ORPHAN DISEASE|orphan disease
777839|NCT00339157|INTERLEUKIN - 1|interleukin - 1
777840|NCT00339157|RECEPTORS , INTERLEUKINS|receptors , interleukins
777841|NCT00339157|ANTAGONISTS|antagonists
777842|NCT00339144|Solid tumors (including relapsed disease) that are refractory to standard therapies or for which no effective standard therapy exists|solid tumors (including relapsed disease) that are refractory to standard therapies or for which no effective standard therapy exists
777843|NCT00339131|radiopharmaceutical|radiopharmaceutical
777844|NCT00339131|radiation dosimetry|radiation dosimetry
777845|NCT00339131|iodine|iodine
777846|NCT00339131|MIBG|mibg
777847|NCT00339131|iobenguane|iobenguane
777848|NCT00339131|Ultratrace|ultratrace
777849|NCT00339131|neuroendocrine tumors|neuroendocrine tumors
777850|NCT00339105|Acute|acute
777851|NCT00339105|Coronary|coronary
777852|NCT00339105|Syndrome|syndrome
777853|NCT00339105|HyperQ|hyperq
777854|NCT00339105|High|high
777855|NCT00339105|Frequency|frequency
777856|NCT00339105|ECG|ecg
777857|NCT00339105|chest|chest
777858|NCT00339105|pain|pain
777859|NCT00339092|HIV|hiv
777860|NCT00339092|ART|art
777861|NCT00339066|Late-Life Depression|late-life depression
777862|NCT00339053|thoracic aortic aneurysm|thoracic aortic aneurysm
777863|NCT00339053|immunonutrition|immunonutrition
777864|NCT00339053|respiratory failure|respiratory failure
777865|NCT00339053|lenght of stay ICU|lenght of stay icu
777866|NCT00339040|HPV|hpv
777867|NCT00339027|child care centers|child care centers
777868|NCT00339027|community based research|community based research
777869|NCT00339027|behavioral health|behavioral health
777870|NCT00339027|health literacy|health literacy
777871|NCT00339027|unmet healthcare needs|unmet healthcare needs
777872|NCT00339001|Erythropoietin|erythropoietin
777873|NCT00339001|Iron|iron
777874|NCT00339001|Retinopathy of prematurity|retinopathy of prematurity
777875|NCT00338988|Gastrointestinal|gastrointestinal
777876|NCT00338988|Capecitabine|capecitabine
777877|NCT00338988|Oxaliplatin|oxaliplatin
777878|NCT00338988|Carcinoma of the Gallbladder|carcinoma of the gallbladder
777879|NCT00338988|Carcinoma of the Intrahepatic or Extrahepatic Biliary Tract|carcinoma of the intrahepatic or extrahepatic biliary tract
777880|NCT00338988|Xeloda|xeloda
777881|NCT00338988|Eloxatin|eloxatin
777882|NCT00338975|Psychotic Disorders|psychotic disorders
777883|NCT00338975|Schizoaffective Disorder|schizoaffective disorder
777884|NCT00338975|Cognitive Behavioral Therapy|cognitive behavioral therapy
777885|NCT00338975|Social Skills Training|social skills training
777886|NCT00338962|SSRI|ssri
777887|NCT00338962|treatment|treatment
777888|NCT00338962|naltrexone|naltrexone
777889|NCT00338962|alcohol dependence|alcohol dependence
777890|NCT00338962|Desipramine|desipramine
777891|NCT00338962|depression|depression
777892|NCT00338962|PTSD|ptsd
777893|NCT00338949|Ziprasidone|ziprasidone
777894|NCT00338949|Olanzapine|olanzapine
777895|NCT00338949|Risperidone|risperidone
777896|NCT00338949|Schizoaffective Disorder|schizoaffective disorder
777897|NCT00338949|Insulin Sensitivity|insulin sensitivity
777898|NCT00338949|Visceral Adiposity|visceral adiposity
777899|NCT00338949|Metabolic Syndrome|metabolic syndrome
777900|NCT00338936|Hypertension|hypertension
777901|NCT00338936|Valsartan|valsartan
777902|NCT00338936|Hydrochlorothiazide|hydrochlorothiazide
777903|NCT00338910|healthy volunteers|healthy volunteers
777904|NCT00338897|Venous Thromboembolism|venous thromboembolism
777905|NCT00338897|Prevention|prevention
777906|NCT00338897|Arthroplasty|arthroplasty
777907|NCT00338897|Replacement|replacement
777908|NCT00338897|Hip|hip
777909|NCT00338897|orthopedic surgery|orthopedic surgery
777910|NCT00338845|STDs|stds
777911|NCT00338832|Lifestyle Intervention|lifestyle intervention
777912|NCT00338832|Schizoaffective Disorder|schizoaffective disorder
777913|NCT00338819|DVT prevention|dvt prevention
777914|NCT00338819|Hemodynamic study|hemodynamic study
777915|NCT00338819|IPC|ipc
777916|NCT00338819|CECT|cect
777917|NCT00338806|Prevention|prevention
777918|NCT00338806|Mood Disorders|mood disorders
777919|NCT00338806|Unipolar Depression|unipolar depression
777920|NCT00338793|Tuberculosis;|tuberculosis;
777921|NCT00338793|Pleural effusion;|pleural effusion;
777922|NCT00338793|Corticosteroids.|corticosteroids.
777923|NCT00338780|Chronic Hepatitis B|chronic hepatitis b
777924|NCT00338780|Lamivudine|lamivudine
777925|NCT00338780|HBeAg negative|hbeag negative
777926|NCT00338767|AIDS|aids
777927|NCT00338767|DOT|dot
777928|NCT00338767|Directly Observed Therapy|directly observed therapy
777929|NCT00338715|Effectiveness|effectiveness
777930|NCT00338715|Pulmonary Vein Isolation Procedure|pulmonary vein isolation procedure
777931|NCT00338715|Coronary Artery Bypass Surgery|coronary artery bypass surgery
777932|NCT00338715|Atrial Fibrillation|atrial fibrillation
777933|NCT00338702|Diabetic|diabetic
777934|NCT00338702|Foot|foot
777935|NCT00338702|Ulcer|ulcer
777936|NCT00338702|Autologous|autologous
777937|NCT00338702|Platelet|platelet
777938|NCT00338702|Gel|gel
777939|NCT00338689|infant formula|infant formula
777940|NCT00338689|protein content|protein content
777941|NCT00338689|growth|growth
777942|NCT00338689|obesity|obesity
777943|NCT00338689|breast feeding|breast feeding
777944|NCT00338676|Aortic stenosis|aortic stenosis
777945|NCT00338676|Elderly|elderly
777946|NCT00338663|anterior cruciate ligament reconstruction|anterior cruciate ligament reconstruction
777947|NCT00338663|knee immobilization|knee immobilization
777948|NCT00338663|postoperative pain|postoperative pain
777949|NCT00338624|lower urinary tract symptoms|lower urinary tract symptoms
777950|NCT00338624|DITROPAN XL|ditropan xl
777951|NCT00338624|oxybutynin extended release tablets|oxybutynin extended release tablets
777952|NCT00338611|vision therapy|vision therapy
777953|NCT00338611|orthoptics|orthoptics
777954|NCT00338611|pencil push-up therapy|pencil push-up therapy
777955|NCT00338598|glycine|glycine
777956|NCT00338598|treatment|treatment
777957|NCT00338598|alcohol dependence|alcohol dependence
777958|NCT00338598|schizophrenia|schizophrenia
777959|NCT00338585|PAO|pao
777960|NCT00338585|acute peripheral arterial occlusion|acute peripheral arterial occlusion
777961|NCT00338585|thrombolysis|thrombolysis
777962|NCT00338585|blood clot|blood clot
777963|NCT00338585|leg attack|leg attack
777964|NCT00338585|alfimeprase|alfimeprase
777965|NCT00338585|thrombus|thrombus
777966|NCT00338585|embolism|embolism
777967|NCT00338585|thromboembolism|thromboembolism
777968|NCT00338585|claudication|claudication
777969|NCT00338585|thrombolytic|thrombolytic
777970|NCT00338585|thrombosis|thrombosis
777971|NCT00338585|plasminogen activator|plasminogen activator
777972|NCT00338585|arterial flow|arterial flow
777973|NCT00338572|Inflammation|inflammation
777974|NCT00338572|Blood Pressure, High|blood pressure, high
777975|NCT00338559|Strabismus|strabismus
777976|NCT00338559|LMA|lma
777977|NCT00338559|ET Tube|et tube
777978|NCT00338559|POV|pov
777979|NCT00338546|Cocaine|cocaine
777980|NCT00338546|Sympathetic nerve activity|sympathetic nerve activity
777981|NCT00338546|Blood pressure|blood pressure
777982|NCT00338546|Cutaneous vasoconstriction|cutaneous vasoconstriction
777983|NCT00338546|Coronary vasoconstriction|coronary vasoconstriction
777984|NCT00338533|childhood glaucoma|childhood glaucoma
777985|NCT00338520|Cerebral malaria, phenylalanine, Tanzania|cerebral malaria, phenylalanine, tanzania
777986|NCT00338507|Chronic Bronchitis|chronic bronchitis
777987|NCT00338507|Chronic Obstructive Pulmonary Disease|chronic obstructive pulmonary disease
777988|NCT00338468|Anemia|anemia
777989|NCT00338468|Elderly|elderly
777990|NCT00338468|Hemoglobin level|hemoglobin level
777991|NCT00338468|Chronic Kidney Disease|chronic kidney disease
777992|NCT00338455|Congestive heart failure|congestive heart failure
777993|NCT00338455|cardiac transplantation|cardiac transplantation
777994|NCT00338455|renal insufficiency|renal insufficiency
777995|NCT00338455|renal failure|renal failure
777996|NCT00338455|dialysis|dialysis
777997|NCT00338455|ultrafiltration|ultrafiltration
777998|NCT00338455|vasodilator|vasodilator
777999|NCT00338455|Natrecor (nesiritide)|natrecor (nesiritide)
778000|NCT00338442|Immune compromised|immune compromised
778001|NCT00338442|Varicella Zoster Virus ( VZV) Infection|varicella zoster virus ( vzv) infection
778002|NCT00338442|Pediatric|pediatric
778003|NCT00338429|sleep onset latency|sleep onset latency
778004|NCT00338429|bedtime resistance|bedtime resistance
778005|NCT00338416|Chemotherapy Induced Anemia|chemotherapy induced anemia
778006|NCT00338416|PROCRIT (Epoetin alfa)|procrit (epoetin alfa)
778007|NCT00338416|Chemotherapy|chemotherapy
778008|NCT00338416|Epoetin alfa|epoetin alfa
778009|NCT00338403|CPAP pressure of -5cm/water during cold, dry air exposure|cpap pressure of -5cm/water during cold, dry air exposure
778010|NCT00338403|CPAP pressure of 0cm/water during cold, dry air exposure|cpap pressure of 0cm/water during cold, dry air exposure
778011|NCT00338403|CPAP pressure of 5cm/water during cold, dry air exposure|cpap pressure of 5cm/water during cold, dry air exposure
778116|NCT00338039|Gemcitabine|gemcitabine
778117|NCT00338039|Oxaliplatin|oxaliplatin
778012|NCT00338403|CPAP pressure of 10cm/water during cold, dry air exposure|cpap pressure of 10cm/water during cold, dry air exposure
778013|NCT00338390|Antiretrovirals|antiretrovirals
778014|NCT00338390|CD4 cell count|cd4 cell count
778015|NCT00338390|toxicity|toxicity
778016|NCT00338377|Melanoma|melanoma
778125|NCT00338026|ECO-4601|eco-4601
778017|NCT00338377|Regional nodal disease|regional nodal disease
778018|NCT00338377|Dendritic Cell Immunization|dendritic cell immunization
778019|NCT00338377|Lymphodepletion|lymphodepletion
778020|NCT00338377|Adoptive Cell Transfer|adoptive cell transfer
778021|NCT00338377|T Cells|t cells
778022|NCT00338377|Vaccine|vaccine
778023|NCT00338377|Cyclosphosphamide|cyclosphosphamide
778024|NCT00338377|Cytoxan|cytoxan
778025|NCT00338377|Neosar|neosar
778026|NCT00338377|Dendritic Cells|dendritic cells
778027|NCT00338377|Tumor Infiltrating Lymphocytes|tumor infiltrating lymphocytes
778028|NCT00338377|TIL Cells|til cells
778029|NCT00338377|MART Peptide|mart peptide
778030|NCT00338377|Fludarabine|fludarabine
778031|NCT00338377|Fludarabine Phosphate|fludarabine phosphate
778032|NCT00338377|Fludara|fludara
778033|NCT00338377|Proleukin|proleukin
778034|NCT00338377|IL-2|il-2
778035|NCT00338377|Interleukin-2|interleukin-2
778036|NCT00338377|Leptomeningeal disease|leptomeningeal disease
778037|NCT00338364|Pediatric pain|pediatric pain
778038|NCT00338364|Pediatric anxiety|pediatric anxiety
778039|NCT00338364|Painful procedures|painful procedures
778040|NCT00338338|essential hypertension|essential hypertension
778041|NCT00338338|Amlodipine|amlodipine
778042|NCT00338338|blood pressure|blood pressure
778043|NCT00338338|lacidipine|lacidipine
778044|NCT00338325|Pediatric Anxiety|pediatric anxiety
778045|NCT00338325|Pediatric Pain|pediatric pain
778046|NCT00338312|Natural Menopause|natural menopause
778047|NCT00338312|HSDD|hsdd
778048|NCT00338299|Anemia|anemia
778049|NCT00338299|hemoglobin|hemoglobin
778050|NCT00338299|chemotherapy|chemotherapy
778051|NCT00338299|subcutaneous injection|subcutaneous injection
778052|NCT00338299|Epoetin alfa|epoetin alfa
778053|NCT00338286|anemia|anemia
778054|NCT00338286|metastatic breast cancer|metastatic breast cancer
778055|NCT00338286|Hemoglobin|hemoglobin
778056|NCT00338286|progression-free survival (PFS)|progression-free survival (pfs)
778057|NCT00338286|erythropoiesis-stimulating agents (ESA)|erythropoiesis-stimulating agents (esa)
778058|NCT00338273|Bipolar I disorder with major depressive episode|bipolar i disorder with major depressive episode
778059|NCT00338247|advanced|advanced
778060|NCT00338247|TYKERB|tykerb
778061|NCT00338247|HER2 positive|her2 positive
778062|NCT00338247|Stage IIIc|stage iiic
778063|NCT00338247|ErbB2 positive|erbb2 positive
778064|NCT00338247|GW572016|gw572016
778065|NCT00338247|metastatic|metastatic
778066|NCT00338247|Stage IIIb|stage iiib
778067|NCT00338247|breast cancer|breast cancer
778068|NCT00338234|anemia|anemia
778069|NCT00338234|intensive care|intensive care
778070|NCT00338234|cardiac surgery|cardiac surgery
778071|NCT00338234|iron metabolism|iron metabolism
778072|NCT00338234|hepcidin|hepcidin
778073|NCT00338221|Diarrhea, Malnutrition, Brazil|diarrhea, malnutrition, brazil
778074|NCT00338208|low vision|low vision
778075|NCT00338208|glaucoma|glaucoma
778076|NCT00338195|Caffeine dependence|caffeine dependence
778077|NCT00338195|Caffeine withdrawal|caffeine withdrawal
778078|NCT00338182|Solid tumor|solid tumor
778079|NCT00338156|Left Ventricle Remodelling|left ventricle remodelling
778080|NCT00338156|Collagen markers|collagen markers
778081|NCT00338156|Neurohormones|neurohormones
778082|NCT00338156|Cardiac MRI|cardiac mri
778083|NCT00338143|Plaque psoriasis|plaque psoriasis
778084|NCT00338143|Antipsoriatic|antipsoriatic
778085|NCT00338130|Melanoma|melanoma
778086|NCT00338130|Phase II|phase ii
778087|NCT00338130|AZD6244|azd6244
778088|NCT00338130|temozolomide|temozolomide
778089|NCT00338117|Dementia|dementia
778090|NCT00338117|neurodegenerative disorder|neurodegenerative disorder
778091|NCT00338117|impairment of memory|impairment of memory
778092|NCT00338117|galantamine|galantamine
778093|NCT00338117|galanthamine|galanthamine
778094|NCT00338117|acetylcholinesterase inhibitor|acetylcholinesterase inhibitor
778095|NCT00338117|Mini Mental State Examination score|mini mental state examination score
778096|NCT00338104|insulin|insulin
778097|NCT00338104|glargine|glargine
778098|NCT00338104|intravenous|intravenous
778099|NCT00338104|subcutaneous|subcutaneous
778100|NCT00338104|hospital|hospital
778101|NCT00338104|diabetes|diabetes
778102|NCT00338104|glucose|glucose
778103|NCT00338104|inpatient|inpatient
778104|NCT00338091|Renal Insufficiency,Chronic|renal insufficiency,chronic
778105|NCT00338091|Disease Progression|disease progression
778106|NCT00338091|Proteinuria|proteinuria
778107|NCT00338091|Dose-Response Relationship,Drug|dose-response relationship,drug
778108|NCT00338091|Benazepril|benazepril
778109|NCT00338091|Losartan|losartan
778110|NCT00338065|Intraocular Pressure|intraocular pressure
778111|NCT00338052|Contraception|contraception
778112|NCT00338039|Pancreatic Cancer|pancreatic cancer
778113|NCT00338039|Cetuximab|cetuximab
778114|NCT00338039|C225|c225
778115|NCT00338039|Erbitux|erbitux
778118|NCT00338039|Eloxatin|eloxatin
778119|NCT00338039|Capecitabine|capecitabine
778120|NCT00338039|Xeloda|xeloda
778121|NCT00338026|Solid Tumors|solid tumors
778122|NCT00338026|Thallion|thallion
778123|NCT00338026|TLN-4601|tln-4601
778124|NCT00338026|Ecopia|ecopia
778126|NCT00338026|Patients with histologically confirmed solid tumors:|patients with histologically confirmed solid tumors:
778127|NCT00338026|High Grade Glioma|high grade glioma
778128|NCT00338026|Colorectal|colorectal
778129|NCT00338026|Lung|lung
778130|NCT00338026|Breast|breast
778131|NCT00338026|Ovarian|ovarian
778132|NCT00338026|Pancreatic|pancreatic
778133|NCT00338026|Prostate|prostate
778134|NCT00338013|sleep|sleep
778135|NCT00338000|Chronic renal failure|chronic renal failure
778136|NCT00338000|left ventricular hypertrophy|left ventricular hypertrophy
778137|NCT00338000|epoetin alfa|epoetin alfa
778138|NCT00337974|cognitive enhancement|cognitive enhancement
778139|NCT00337974|memory|memory
778140|NCT00337974|auditory memory|auditory memory
778141|NCT00337974|speech|speech
778142|NCT00337974|computerized|computerized
778143|NCT00337961|Optic Nerve Sheath Fenestration|optic nerve sheath fenestration
778144|NCT00337948|Anemia|anemia
778145|NCT00337948|Epoetin Alfa|epoetin alfa
778146|NCT00337948|Chemotherapy|chemotherapy
778147|NCT00337948|Anemia due to Cancer|anemia due to cancer
778148|NCT00337935|Long Term Care Facilities|long term care facilities
778149|NCT00337935|subcutaneous injections|subcutaneous injections
778150|NCT00337935|PROCRIT|procrit
778151|NCT00337935|Epoetin alfa|epoetin alfa
778152|NCT00337935|Anemia|anemia
778153|NCT00337922|EPZICOM|epzicom
778154|NCT00337922|Lamivudine|lamivudine
778155|NCT00337922|Abacavir|abacavir
778156|NCT00337922|pharmacokinetics|pharmacokinetics
778157|NCT00337922|Japanese|japanese
778158|NCT00337909|cognitive enhancement|cognitive enhancement
778159|NCT00337909|memory|memory
778160|NCT00337909|auditory memory|auditory memory
778161|NCT00337909|speech|speech
778162|NCT00337909|computerized|computerized
778163|NCT00337896|vaccine, influenza, A/H5N1, CMI, sub-study|vaccine, influenza, a/h5n1, cmi, sub-study
778164|NCT00337883|Glioblastoma Multiforme|glioblastoma multiforme
778165|NCT00337883|glioma|glioma
778166|NCT00337883|Grade IV glioma|grade iv glioma
778167|NCT00337870|Pediatric Anxiety|pediatric anxiety
778168|NCT00337870|Pediatric Pain|pediatric pain
778169|NCT00337870|Emergency room procedures|emergency room procedures
778170|NCT00337818|Non-inferiority|non-inferiority
778171|NCT00337818|Immunogenicity|immunogenicity
778172|NCT00337818|HPV Vaccine Consistency|hpv vaccine consistency
778173|NCT00337805|colloid|colloid
778174|NCT00337805|crystalloid|crystalloid
778175|NCT00337805|hemodynamics|hemodynamics
778176|NCT00337805|flow-directed|flow-directed
778177|NCT00337805|resuscitation|resuscitation
778178|NCT00337766|Blood Loss|blood loss
778179|NCT00337766|Postoperative Blood loss|postoperative blood loss
778180|NCT00337753|Gambling|gambling
778181|NCT00337714|Central venous catheter,|central venous catheter,
778182|NCT00337714|bloodstream infections,|bloodstream infections,
778183|NCT00337714|intensive care unit|intensive care unit
778184|NCT00337688|Cerebral Palsy|cerebral palsy
778185|NCT00337688|Spasticity|spasticity
778186|NCT00337688|Joystick|joystick
778187|NCT00337688|Wheelchair|wheelchair
778188|NCT00337688|rehabilitation|rehabilitation
778189|NCT00337636|NCL|ncl
778190|NCT00337636|INCL|incl
778191|NCT00337636|LINCL|lincl
778192|NCT00337636|Batten disease|batten disease
778193|NCT00337636|Infantile Neuronal Ceroid Lipofuscinosis (INCL)|infantile neuronal ceroid lipofuscinosis (incl)
778194|NCT00337636|Late Infantile Neuronal Ceroid Lipofuscinosis (LINCL)|late infantile neuronal ceroid lipofuscinosis (lincl)
778195|NCT00337623|Cataracts|cataracts
778196|NCT00337623|Corticosteroids|corticosteroids
778197|NCT00337623|Scheimpflug|scheimpflug
778198|NCT00337623|Lens autofluorescence|lens autofluorescence
778199|NCT00337597|Normal saline|normal saline
778200|NCT00337597|Dextrose 5% in water|dextrose 5% in water
778201|NCT00337597|neurostimulation|neurostimulation
778202|NCT00337597|Continuous regional analgesia after total knee arthroplasty|continuous regional analgesia after total knee arthroplasty
778203|NCT00337584|out patient surgery|out patient surgery
778204|NCT00337584|quality improvement|quality improvement
778205|NCT00337571|Serious behavioral problems in children and adolescents with AD|serious behavioral problems in children and adolescents with ad
778206|NCT00337558|treatment outcomes|treatment outcomes
778207|NCT00337558|Overactive bladder|overactive bladder
778208|NCT00337558|Solifenacin succinate|solifenacin succinate
778209|NCT00337558|urinary incontinence|urinary incontinence
778210|NCT00337558|urge incontinence|urge incontinence
778211|NCT00337558|frequency|frequency
778212|NCT00337545|Metastatic|metastatic
778213|NCT00337545|Refractory|refractory
778214|NCT00337519|chronic lymphocytic leukemia|chronic lymphocytic leukemia
778215|NCT00337519|reduced intensity conditioning|reduced intensity conditioning
778216|NCT00337519|alemtuzumab|alemtuzumab
778217|NCT00337519|allogeneic stem cell transplantation|allogeneic stem cell transplantation
778218|NCT00337506|the efficacy and safety of Velcade plus dexamethasone|the efficacy and safety of velcade plus dexamethasone
778219|NCT00337506|Multiple Myeloma|multiple myeloma
778220|NCT00337480|acute coronary syndrome|acute coronary syndrome
778221|NCT00337480|cardiovascular risk factors|cardiovascular risk factors
778222|NCT00337480|smoking habits|smoking habits
778223|NCT00337480|obesity|obesity
778224|NCT00337480|sedentary lifestyle|sedentary lifestyle
778225|NCT00337480|overweight|overweight
778226|NCT00337480|education|education
778227|NCT00337480|follow up after hospitalization|follow up after hospitalization
778228|NCT00337467|HIV-Infected Patients Evidencing Virologic Suppression|hiv-infected patients evidencing virologic suppression
778229|NCT00337454|Imatinib resistant or intolerant CML|imatinib resistant or intolerant cml
778230|NCT00337454|Treatment resistant or intolerant Ph+ALL|treatment resistant or intolerant ph+all
778231|NCT00337441|Chronic Anemia|chronic anemia
778232|NCT00337441|Anemia|anemia
778233|NCT00337441|Chronic Diseases|chronic diseases
778234|NCT00337441|Elderly|elderly
778235|NCT00337441|Epoetin alfa|epoetin alfa
778236|NCT00337441|Fatigue|fatigue
778237|NCT00337441|Quality of life|quality of life
778238|NCT00337441|Mobility|mobility
778239|NCT00337402|Gastrostomy|gastrostomy
778240|NCT00337402|Quality of life|quality of life
778241|NCT00337389|Metastatic|metastatic
778242|NCT00337389|Colorectal|colorectal
778243|NCT00337389|Cancer|cancer
778244|NCT00337389|CoFactor|cofactor
778245|NCT00337389|Stage IV|stage iv
778246|NCT00337350|Schizophrenia|schizophrenia
778247|NCT00337350|Glucose Metabolism|glucose metabolism
778248|NCT00337350|Insulin Resistance|insulin resistance
778249|NCT00337337|Diabetes|diabetes
778250|NCT00337337|rice|rice
778251|NCT00337337|fiber|fiber
778252|NCT00337324|Diabetic neuropathy|diabetic neuropathy
778253|NCT00337324|Complications of diabetes|complications of diabetes
778254|NCT00337324|Neuropathies|neuropathies
778255|NCT00337324|Electromagnetic stimulation|electromagnetic stimulation
778256|NCT00337324|Neuropathic pain|neuropathic pain
778257|NCT00337298|Diabetes|diabetes
778258|NCT00337298|Retinopathy|retinopathy
778259|NCT00337298|Blood Pressure|blood pressure
778260|NCT00337298|Amlodipine|amlodipine
778261|NCT00337298|Lisinopril|lisinopril
778262|NCT00337285|Attention Deficit Hyperactivity Disorder|attention deficit hyperactivity disorder
778263|NCT00337285|Attention Deficit Disorders with Hyperactivity|attention deficit disorders with hyperactivity
778264|NCT00337285|Attention Deficit Hyperactivity Disorders|attention deficit hyperactivity disorders
778265|NCT00337272|chronic insomnia|chronic insomnia
778266|NCT00337259|marginal zone lymphoma|marginal zone lymphoma
778267|NCT00337259|gemcitabine|gemcitabine
778268|NCT00337246|refractory chronic lymphocytic leukemia|refractory chronic lymphocytic leukemia
778269|NCT00337246|stage I chronic lymphocytic leukemia|stage i chronic lymphocytic leukemia
778270|NCT00337246|stage II chronic lymphocytic leukemia|stage ii chronic lymphocytic leukemia
778271|NCT00337246|stage III chronic lymphocytic leukemia|stage iii chronic lymphocytic leukemia
778272|NCT00337246|stage IV chronic lymphocytic leukemia|stage iv chronic lymphocytic leukemia
778273|NCT00337233|fatigue|fatigue
778274|NCT00337233|psychosocial effects of cancer and its treatment|psychosocial effects of cancer and its treatment
778275|NCT00337233|recurrent breast cancer|recurrent breast cancer
778276|NCT00337233|stage I breast cancer|stage i breast cancer
778277|NCT00337233|stage II breast cancer|stage ii breast cancer
778278|NCT00337233|stage IIIA breast cancer|stage iiia breast cancer
778279|NCT00337233|stage IIIB breast cancer|stage iiib breast cancer
778280|NCT00337233|stage IIIC breast cancer|stage iiic breast cancer
778281|NCT00337233|stage IV breast cancer|stage iv breast cancer
778282|NCT00337233|recurrent ovarian epithelial cancer|recurrent ovarian epithelial cancer
778283|NCT00337233|recurrent ovarian germ cell tumor|recurrent ovarian germ cell tumor
778284|NCT00337233|stage I ovarian epithelial cancer|stage i ovarian epithelial cancer
778285|NCT00337233|stage I ovarian germ cell tumor|stage i ovarian germ cell tumor
778286|NCT00337233|stage II ovarian epithelial cancer|stage ii ovarian epithelial cancer
778287|NCT00337233|stage II ovarian germ cell tumor|stage ii ovarian germ cell tumor
778288|NCT00337233|stage III ovarian epithelial cancer|stage iii ovarian epithelial cancer
778289|NCT00337233|stage III ovarian germ cell tumor|stage iii ovarian germ cell tumor
778290|NCT00337233|stage IV ovarian epithelial cancer|stage iv ovarian epithelial cancer
778291|NCT00337233|stage IV ovarian germ cell tumor|stage iv ovarian germ cell tumor
778292|NCT00337220|allograft|allograft
778293|NCT00337220|graft|graft
778294|NCT00337207|adult glioblastoma|adult glioblastoma
778295|NCT00337207|adult gliosarcoma|adult gliosarcoma
778296|NCT00337207|recurrent adult brain tumor|recurrent adult brain tumor
778297|NCT00337207|adult anaplastic astrocytoma|adult anaplastic astrocytoma
778298|NCT00337207|adult giant cell glioblastoma|adult giant cell glioblastoma
778299|NCT00337181|HIV-1|hiv-1
778300|NCT00337181|Natural History|natural history
778301|NCT00337181|HIV vaccine|hiv vaccine
778302|NCT00337181|Thailand|thailand
778303|NCT00337168|recurrent adult acute lymphoblastic leukemia|recurrent adult acute lymphoblastic leukemia
778304|NCT00337168|L1 adult acute lymphoblastic leukemia|l1 adult acute lymphoblastic leukemia
778305|NCT00337168|L2 adult acute lymphoblastic leukemia|l2 adult acute lymphoblastic leukemia
778306|NCT00337168|B-cell adult acute lymphoblastic leukemia|b-cell adult acute lymphoblastic leukemia
778307|NCT00337168|T-cell adult acute lymphoblastic leukemia|t-cell adult acute lymphoblastic leukemia
778308|NCT00337155|Recurrent Prostate Cancer|recurrent prostate cancer
778309|NCT00337155|metastatic Cancer|metastatic cancer
778310|NCT00337142|gestational diabetes|gestational diabetes
778312|NCT00337142|hypoglycemia|hypoglycemia
778313|NCT00337129|metastatic squamous neck cancer with occult primary squamous cell carcinoma|metastatic squamous neck cancer with occult primary squamous cell carcinoma
778314|NCT00337129|recurrent metastatic squamous neck cancer with occult primary|recurrent metastatic squamous neck cancer with occult primary
778315|NCT00337129|recurrent squamous cell carcinoma of the hypopharynx|recurrent squamous cell carcinoma of the hypopharynx
778316|NCT00337129|recurrent squamous cell carcinoma of the larynx|recurrent squamous cell carcinoma of the larynx
778317|NCT00337129|recurrent squamous cell carcinoma of the lip and oral cavity|recurrent squamous cell carcinoma of the lip and oral cavity
778318|NCT00337129|recurrent squamous cell carcinoma of the oropharynx|recurrent squamous cell carcinoma of the oropharynx
778319|NCT00337129|recurrent squamous cell carcinoma of the paranasal sinus and nasal cavity|recurrent squamous cell carcinoma of the paranasal sinus and nasal cavity
778320|NCT00337129|stage IV squamous cell carcinoma of the hypopharynx|stage iv squamous cell carcinoma of the hypopharynx
778321|NCT00337129|stage IV squamous cell carcinoma of the larynx|stage iv squamous cell carcinoma of the larynx
778322|NCT00337129|stage IV squamous cell carcinoma of the lip and oral cavity|stage iv squamous cell carcinoma of the lip and oral cavity
778323|NCT00337129|stage IV squamous cell carcinoma of the oropharynx|stage iv squamous cell carcinoma of the oropharynx
778324|NCT00337129|stage IV squamous cell carcinoma of the paranasal sinus and nasal cavity|stage iv squamous cell carcinoma of the paranasal sinus and nasal cavity
778325|NCT00337129|untreated metastatic squamous neck cancer with occult primary|untreated metastatic squamous neck cancer with occult primary
778326|NCT00337129|salivary gland squamous cell carcinoma|salivary gland squamous cell carcinoma
778327|NCT00337090|Over Active Bladder|over active bladder
778328|NCT00337090|Urinary incontinence|urinary incontinence
778329|NCT00337090|YM178|ym178
778330|NCT00337090|Symptomatic Over Active Bladder|symptomatic over active bladder
778331|NCT00337077|Eribulin Mesylate|eribulin mesylate
778332|NCT00337077|metastatic hormone refractory prostate cancer|metastatic hormone refractory prostate cancer
778333|NCT00337077|Halichondrin B Analog|halichondrin b analog
778334|NCT00337064|Breast cancer treatment|breast cancer treatment
778335|NCT00337064|Partial breast radiation|partial breast radiation
778336|NCT00337064|Radiation Therapy|radiation therapy
778337|NCT00337064|Adjuvant Treatment|adjuvant treatment
778338|NCT00337051|Renal transplantation|renal transplantation
778339|NCT00337051|renal allograft|renal allograft
778340|NCT00337051|end-stage renal disease|end-stage renal disease
778341|NCT00337051|renal failure|renal failure
778342|NCT00337051|general anaesthesia|general anaesthesia
778343|NCT00337051|inhaled anaesthetic|inhaled anaesthetic
778344|NCT00337051|Sevoflurane|sevoflurane
778345|NCT00337051|ischemia|ischemia
778346|NCT00337051|reperfusion|reperfusion
778347|NCT00337051|ischemic lesions|ischemic lesions
778348|NCT00336973|Plaque Psoriasis|plaque psoriasis
778349|NCT00336973|Raptiva|raptiva
778350|NCT00336973|Anti-TNF|anti-tnf
778351|NCT00336960|stage II rectal cancer|stage ii rectal cancer
778352|NCT00336960|stage III rectal cancer|stage iii rectal cancer
778353|NCT00336960|adenocarcinoma of the rectum|adenocarcinoma of the rectum
778354|NCT00336947|stage III squamous cell carcinoma of the hypopharynx|stage iii squamous cell carcinoma of the hypopharynx
778355|NCT00336947|stage IV squamous cell carcinoma of the hypopharynx|stage iv squamous cell carcinoma of the hypopharynx
778356|NCT00336947|stage III squamous cell carcinoma of the larynx|stage iii squamous cell carcinoma of the larynx
778357|NCT00336947|stage IV squamous cell carcinoma of the larynx|stage iv squamous cell carcinoma of the larynx
778358|NCT00336947|stage III squamous cell carcinoma of the lip and oral cavity|stage iii squamous cell carcinoma of the lip and oral cavity
778359|NCT00336947|stage IV squamous cell carcinoma of the lip and oral cavity|stage iv squamous cell carcinoma of the lip and oral cavity
778360|NCT00336947|stage III squamous cell carcinoma of the oropharynx|stage iii squamous cell carcinoma of the oropharynx
778361|NCT00336947|stage IV squamous cell carcinoma of the oropharynx|stage iv squamous cell carcinoma of the oropharynx
778362|NCT00336947|stage III squamous cell carcinoma of the paranasal sinus and nasal cavity|stage iii squamous cell carcinoma of the paranasal sinus and nasal cavity
778363|NCT00336947|stage IV squamous cell carcinoma of the paranasal sinus and nasal cavity|stage iv squamous cell carcinoma of the paranasal sinus and nasal cavity
778364|NCT00336934|adenocarcinoma of the prostate|adenocarcinoma of the prostate
778365|NCT00336934|recurrent prostate cancer|recurrent prostate cancer
778366|NCT00336934|stage I prostate cancer|stage i prostate cancer
778367|NCT00336934|stage II prostate cancer|stage ii prostate cancer
778368|NCT00336934|stage III prostate cancer|stage iii prostate cancer
778369|NCT00336934|stage IV prostate cancer|stage iv prostate cancer
778370|NCT00336908|Intensive Care,Neonatal|intensive care,neonatal
778371|NCT00336908|Parenteral nutrition|parenteral nutrition
778372|NCT00336908|Fat emulsions,Intravenous|fat emulsions,intravenous
778373|NCT00336895|Liver transplantation|liver transplantation
778374|NCT00336895|mycophenolate mofetil|mycophenolate mofetil
778375|NCT00336895|gastrointestinal|gastrointestinal
778376|NCT00336895|adverse effects|adverse effects
778377|NCT00336882|traumatic brain injury|traumatic brain injury
778378|NCT00336882|propofol|propofol
778379|NCT00336882|oxidative stress|oxidative stress
778380|NCT00336882|microdialysis|microdialysis
778381|NCT00336856|Colon Cancer|colon cancer
778382|NCT00336843|Zevalin|zevalin
778383|NCT00336843|B-cell non-Hodgkin's lymphoma|b-cell non-hodgkin's lymphoma
778671|NCT00335491|non-small cell lung cancer|non-small cell lung cancer
778384|NCT00336843|autologous stem cell transplantation|autologous stem cell transplantation
778385|NCT00336843|BuCyE regimen|bucye regimen
778386|NCT00336830|Cardiac Rehabilitation|cardiac rehabilitation
778387|NCT00336830|Improving Cardiac Rehabilitation Participation|improving cardiac rehabilitation participation
778388|NCT00336830|coronary angioplasty|coronary angioplasty
778389|NCT00336830|coronary artery bypass surgery|coronary artery bypass surgery
778390|NCT00336817|Liver transplantation|liver transplantation
778391|NCT00336817|mycophenolate mofetil|mycophenolate mofetil
778392|NCT00336817|gastrointestinal|gastrointestinal
778393|NCT00336817|adverse effects|adverse effects
778394|NCT00336791|Breast Cancer|breast cancer
778395|NCT00336791|Gene Expression|gene expression
778396|NCT00336791|Fluorouracil|fluorouracil
778397|NCT00336791|Cyclophosphamide|cyclophosphamide
778398|NCT00336791|Doxorubicin|doxorubicin
778399|NCT00336791|Paclitaxel|paclitaxel
778400|NCT00336765|solid tumors|solid tumors
778401|NCT00336752|undisplaced ,unstable wEBER B ankle fractures|undisplaced ,unstable weber b ankle fractures
778402|NCT00336752|operative intervention|operative intervention
778403|NCT00336752|non operative intervention|non operative intervention
778404|NCT00336739|Gastric acidity determination|gastric acidity determination
778405|NCT00336739|Calcium sensing receptor|calcium sensing receptor
778406|NCT00336713|depression|depression
778407|NCT00336713|antidepressive agents|antidepressive agents
778408|NCT00336713|controlled clinical trial|controlled clinical trial
778409|NCT00336700|Pancreas|pancreas
778410|NCT00336700|Cancer|cancer
778411|NCT00336700|Pancreatic|pancreatic
778412|NCT00336687|Thrombopenia|thrombopenia
778413|NCT00336687|Reanimation|reanimation
778414|NCT00336687|Thrombopenia in reanimation|thrombopenia in reanimation
778415|NCT00336674|Type 1 diabetes|type 1 diabetes
778416|NCT00336661|Periodontitis|periodontitis
778417|NCT00336661|Chronic Periodontitis|chronic periodontitis
778418|NCT00336661|Gingivitis|gingivitis
778419|NCT00336661|PERIOWAVE|periowave
778420|NCT00336661|Photodynamic Disinfection|photodynamic disinfection
778421|NCT00336648|Pancreatic Neoplasms|pancreatic neoplasms
778422|NCT00336648|Bevacizumab|bevacizumab
778423|NCT00336648|Gemcitabine|gemcitabine
778424|NCT00336648|Radiation Therapy|radiation therapy
778425|NCT00336648|adenocarcinoma of the pancreatic head|adenocarcinoma of the pancreatic head
778426|NCT00336648|adenocarcinoma of the uncinate process|adenocarcinoma of the uncinate process
778427|NCT00336635|smallpox, vaccine, immunity|smallpox, vaccine, immunity
778428|NCT00336622|Carpal Tunnel Syndrome|carpal tunnel syndrome
778429|NCT00336622|Splints|splints
778430|NCT00336596|middle cerebral artery occlusion|middle cerebral artery occlusion
778431|NCT00336596|intracranial embolism and thrombosis|intracranial embolism and thrombosis
778432|NCT00336596|ultrasound enhanced thrombolysis|ultrasound enhanced thrombolysis
778433|NCT00336596|Patients receiving iv thrombolytic therapy (t-PA)|patients receiving iv thrombolytic therapy (t-pa)
778434|NCT00336583|oxaliplatin|oxaliplatin
778435|NCT00336583|ESHAOX|eshaox
778436|NCT00336583|refractory|refractory
778437|NCT00336583|relapsed|relapsed
778438|NCT00336583|non-hodgkin's lymphoma|non-hodgkin's lymphoma
778439|NCT00336570|Oxidative Stress|oxidative stress
778440|NCT00336570|Endothelial Function|endothelial function
778441|NCT00336570|Flow Mediated Dilation|flow mediated dilation
778442|NCT00336557|High-Dose Interferon|high-dose interferon
778443|NCT00336557|Neutralizing Antibodies|neutralizing antibodies
778444|NCT00336544|Pneumonia|pneumonia
778445|NCT00336544|Respiratory|respiratory
778446|NCT00336544|Infection|infection
778447|NCT00336544|Infectious|infectious
778448|NCT00336544|Advanced|advanced
778449|NCT00336544|Life|life
778450|NCT00336544|Sciences|sciences
778451|NCT00336544|Lung|lung
778452|NCT00336544|Pulmonary|pulmonary
778453|NCT00336544|Cethromycin|cethromycin
778454|NCT00336544|Clarithromycin|clarithromycin
778455|NCT00336544|Biaxin|biaxin
778456|NCT00336531|prophylactic itraconazole|prophylactic itraconazole
778457|NCT00336531|Relapsed pediatric solid tumors|relapsed pediatric solid tumors
778458|NCT00336531|Embryonal brain tumor|embryonal brain tumor
778459|NCT00336505|Pneumonia|pneumonia
778460|NCT00336505|Respiratory|respiratory
778461|NCT00336505|Infection|infection
778462|NCT00336505|Infectious|infectious
778463|NCT00336505|Advanced|advanced
778464|NCT00336505|Life|life
778465|NCT00336505|Sciences|sciences
778466|NCT00336505|Lung|lung
778467|NCT00336505|Pulmonary|pulmonary
778468|NCT00336505|Cethromycin|cethromycin
778469|NCT00336505|Restanza|restanza
778470|NCT00336505|Clarithromycin|clarithromycin
778471|NCT00336505|Biaxin|biaxin
778472|NCT00336492|Ulcerative colitis|ulcerative colitis
778473|NCT00336492|inflammatory bowel disease|inflammatory bowel disease
778474|NCT00336492|children|children
778475|NCT00336466|Cardiac bypass surgery|cardiac bypass surgery
778476|NCT00336453|Influenza|influenza
778477|NCT00336427|MRSA|mrsa
778478|NCT00336427|Colonization|colonization
778479|NCT00336427|Pregnancy|pregnancy
778480|NCT00336427|Neonates|neonates
778481|NCT00336414|Juvenile Systemic Lupus Erythematosus nephritis|juvenile systemic lupus erythematosus nephritis
778482|NCT00336414|randomised actively controlled clinical trial|randomised actively controlled clinical trial
778483|NCT00336414|cyclophosphamide|cyclophosphamide
778484|NCT00336414|prednisone|prednisone
778485|NCT00336414|azathioprine|azathioprine
778486|NCT00336414|methylprednisolone|methylprednisolone
778487|NCT00336401|anesthesia|anesthesia
778488|NCT00336401|non cardiac surgery|non cardiac surgery
778489|NCT00336401|cardiac outcomes|cardiac outcomes
778490|NCT00336388|Malaria|malaria
778491|NCT00336362|Beta Thalassemia Major|beta thalassemia major
778492|NCT00336362|Hematopoietic Stem Cell Mobilization|hematopoietic stem cell mobilization
778493|NCT00336362|Gene Transfer Techniques|gene transfer techniques
778494|NCT00336349|diabetes mellitus|diabetes mellitus
778495|NCT00336349|neuropathic pain|neuropathic pain
778496|NCT00336323|diabetic|diabetic
778497|NCT00336323|macular|macular
778498|NCT00336323|edema|edema
778499|NCT00336323|avastin|avastin
778500|NCT00336323|bevacizumab|bevacizumab
778501|NCT00336323|anti-VEGF|anti-vegf
778502|NCT00336323|retinal thickness|retinal thickness
778503|NCT00336323|visual acuity|visual acuity
778504|NCT00336323|DME|dme
778505|NCT00336310|Diabetes Mellitus|diabetes mellitus
778506|NCT00336310|Treatment|treatment
778507|NCT00336310|Repaglinide|repaglinide
778508|NCT00336297|screening|screening
778509|NCT00336297|screening methods|screening methods
778510|NCT00336297|intimate partner violence|intimate partner violence
778511|NCT00336284|Telemonitoring|telemonitoring
778512|NCT00336284|ICD|icd
778513|NCT00336284|Reduction of office follow-ups|reduction of office follow-ups
778514|NCT00336271|coffee|coffee
778515|NCT00336271|caffeine|caffeine
778516|NCT00336271|healthy subjects|healthy subjects
778517|NCT00336258|Deep Vein Thrombosis|deep vein thrombosis
778518|NCT00336258|Cancer|cancer
778519|NCT00336258|US- Doppler|us- doppler
778520|NCT00336258|Procoagulant Microparticles|procoagulant microparticles
778521|NCT00336258|Asymptomatic|asymptomatic
778522|NCT00336245|Contraception|contraception
778523|NCT00336245|Women|women
778524|NCT00336245|HIV/AIDS|hiv/aids
778525|NCT00336245|IUD|iud
778526|NCT00336245|IUCD|iucd
778527|NCT00336232|Vitamin K metabolism|vitamin k metabolism
778528|NCT00336232|Bone health|bone health
778529|NCT00336232|Metabolism|metabolism
778530|NCT00336219|GERD|gerd
778531|NCT00336219|Pantoprazole|pantoprazole
778532|NCT00336206|Low dose Alemtuzumab|low dose alemtuzumab
778533|NCT00336206|Chronic lymphocytic leukemia|chronic lymphocytic leukemia
778534|NCT00336206|B-Cell|b-cell
778535|NCT00336193|home visitation|home visitation
778536|NCT00336193|family outcomes|family outcomes
778537|NCT00336193|competency training|competency training
778538|NCT00336180|Adolescent|adolescent
778539|NCT00336180|Adolescent behavior|adolescent behavior
778540|NCT00336180|Adolescent development|adolescent development
778541|NCT00336180|Drinking behavior|drinking behavior
778542|NCT00336180|Health behavior|health behavior
778543|NCT00336180|Reproductive Behavior|reproductive behavior
778544|NCT00336180|Sexual Behavior|sexual behavior
778545|NCT00336180|South Africa|south africa
778546|NCT00336167|carnitine palmitoyl transferase 2 deficiency|carnitine palmitoyl transferase 2 deficiency
778547|NCT00336167|Fatty acid oxidation|fatty acid oxidation
778548|NCT00336167|Mitochondria|mitochondria
778549|NCT00336128|infant|infant
778550|NCT00336128|kindergarten|kindergarten
778551|NCT00336128|obesity|obesity
778552|NCT00336128|adiposity|adiposity
778553|NCT00336115|pertussis|pertussis
778554|NCT00336115|bone marrow transplant|bone marrow transplant
778555|NCT00336102|fatigue|fatigue
778556|NCT00336102|hypothyroidism|hypothyroidism
778557|NCT00336102|stage I breast cancer|stage i breast cancer
778558|NCT00336102|stage II breast cancer|stage ii breast cancer
778559|NCT00336102|stage IIIA breast cancer|stage iiia breast cancer
778560|NCT00336102|stage IIIB breast cancer|stage iiib breast cancer
778561|NCT00336089|fatigue|fatigue
778562|NCT00336089|pain|pain
778563|NCT00336089|cancer survivor|cancer survivor
778564|NCT00336089|breast cancer in situ|breast cancer in situ
778565|NCT00336089|inflammatory breast cancer|inflammatory breast cancer
778566|NCT00336089|stage IA breast cancer|stage ia breast cancer
778567|NCT00336089|stage IB breast cancer|stage ib breast cancer
778568|NCT00336089|stage II breast cancer|stage ii breast cancer
778569|NCT00336089|stage IIIA breast cancer|stage iiia breast cancer
778570|NCT00336089|stage IIIB breast cancer|stage iiib breast cancer
778571|NCT00336089|stage IIIC breast cancer|stage iiic breast cancer
778572|NCT00336089|stage IV breast cancer|stage iv breast cancer
778573|NCT00336089|recurrent breast cancer|recurrent breast cancer
778574|NCT00336076|Mast cell disease|mast cell disease
778575|NCT00336076|Anaphylaxis|anaphylaxis
778576|NCT00336076|c-kit|c-kit
778577|NCT00336076|Mutation|mutation
778578|NCT00336076|Mastocytosis (suspected or proven)|mastocytosis (suspected or proven)
778579|NCT00336050|Air Pollution|air pollution
778580|NCT00336050|Pulmonary Function|pulmonary function
778581|NCT00336011|pacemaker|pacemaker
778582|NCT00336011|magnetic resonance imaging|magnetic resonance imaging
778583|NCT00336011|safety|safety
778584|NCT00335985|polymyositis, dermatomyositis|polymyositis, dermatomyositis
778585|NCT00335985|High-dose intravenous immunoglobulin|high-dose intravenous immunoglobulin
778586|NCT00335985|Venoglobulin-IH|venoglobulin-ih
778587|NCT00335985|Steroid-resistant polymyositis(PM) and dermatomyositis(DM)|steroid-resistant polymyositis(pm) and dermatomyositis(dm)
778588|NCT00335972|Carotid Endarterectomy patients|carotid endarterectomy patients
778589|NCT00335959|adenocarcinoma of the stomach|adenocarcinoma of the stomach
778590|NCT00335959|stage I gastric cancer|stage i gastric cancer
778591|NCT00335959|stage II gastric cancer|stage ii gastric cancer
778592|NCT00335959|stage III gastric cancer|stage iii gastric cancer
778593|NCT00335933|Postherpetic Neuralgia (PHN)|postherpetic neuralgia (phn)
778594|NCT00335920|Sudden Hearing Loss|sudden hearing loss
778595|NCT00335920|intratympanic|intratympanic
778596|NCT00335920|steroids|steroids
778597|NCT00335907|Clinical trial|clinical trial
778598|NCT00335907|Controlled clinical trial|controlled clinical trial
778599|NCT00335907|Shock, Septic|shock, septic
778600|NCT00335894|Infertility|infertility
778601|NCT00335894|IVF|ivf
778602|NCT00335894|ART|art
778603|NCT00335894|hMG|hmg
778604|NCT00335881|Prophylaxis for hepatitis B disease|prophylaxis for hepatitis b disease
778605|NCT00335868|accelerated phase chronic myelogenous leukemia|accelerated phase chronic myelogenous leukemia
778606|NCT00335868|blastic phase chronic myelogenous leukemia|blastic phase chronic myelogenous leukemia
778607|NCT00335868|chronic phase chronic myelogenous leukemia|chronic phase chronic myelogenous leukemia
778608|NCT00335868|relapsing chronic myelogenous leukemia|relapsing chronic myelogenous leukemia
778609|NCT00335855|Device, influenza|device, influenza
778610|NCT00335829|localized unresectable adult primary liver cancer|localized unresectable adult primary liver cancer
778611|NCT00335829|adult primary hepatocellular carcinoma|adult primary hepatocellular carcinoma
778612|NCT00335829|advanced adult primary liver cancer|advanced adult primary liver cancer
778613|NCT00335829|recurrent adult primary liver cancer|recurrent adult primary liver cancer
778614|NCT00335816|stage II rectal cancer|stage ii rectal cancer
778615|NCT00335816|stage III rectal cancer|stage iii rectal cancer
778616|NCT00335816|adenocarcinoma of the rectum|adenocarcinoma of the rectum
778617|NCT00335751|recurrent adult soft tissue sarcoma|recurrent adult soft tissue sarcoma
778618|NCT00335751|stage I adult soft tissue sarcoma|stage i adult soft tissue sarcoma
778619|NCT00335751|localized osteosarcoma|localized osteosarcoma
778620|NCT00335751|metastatic osteosarcoma|metastatic osteosarcoma
778621|NCT00335751|recurrent osteosarcoma|recurrent osteosarcoma
778622|NCT00335751|stage II adult soft tissue sarcoma|stage ii adult soft tissue sarcoma
778623|NCT00335751|stage III adult soft tissue sarcoma|stage iii adult soft tissue sarcoma
778624|NCT00335751|stage IV adult soft tissue sarcoma|stage iv adult soft tissue sarcoma
778625|NCT00335725|Ovarian stimulation|ovarian stimulation
778626|NCT00335725|Infertility|infertility
778627|NCT00335725|ICSI|icsi
778628|NCT00335725|FSH|fsh
778629|NCT00335712|ONO-5129|ono-5129
778630|NCT00335712|type 2 diabetes mellitus|type 2 diabetes mellitus
778631|NCT00335699|Hypercholesterolemia with nondiabetic metabolic syndrome|hypercholesterolemia with nondiabetic metabolic syndrome
778632|NCT00335686|Mitochondrial toxicity|mitochondrial toxicity
778633|NCT00335686|Lopinavir-rtv|lopinavir-rtv
778634|NCT00335686|Nevirapine|nevirapine
778635|NCT00335686|DNA mitochondrial/DNA nuclear|dna mitochondrial/dna nuclear
778636|NCT00335660|Idiopathic Detrusor Overactivity|idiopathic detrusor overactivity
778637|NCT00335660|NK-1 Receptor Antagonist|nk-1 receptor antagonist
778638|NCT00335660|Neurokinin|neurokinin
778639|NCT00335660|Urge Incontinence|urge incontinence
778640|NCT00335647|stage III multiple myeloma|stage iii multiple myeloma
778641|NCT00335647|refractory multiple myeloma|refractory multiple myeloma
778642|NCT00335647|stage II multiple myeloma|stage ii multiple myeloma
778643|NCT00335634|Prostate Cancer|prostate cancer
778644|NCT00335634|Radical Prostatectomy|radical prostatectomy
778645|NCT00335634|Sexual Dysfunction|sexual dysfunction
778646|NCT00335634|Intimacy|intimacy
778647|NCT00335634|Adaptation|adaptation
778648|NCT00335634|Psychosocial Oncology|psychosocial oncology
778649|NCT00335621|COPD|copd
778650|NCT00335621|ipratropium|ipratropium
778651|NCT00335621|tiotropium|tiotropium
778652|NCT00335595|colorectal cancer|colorectal cancer
778653|NCT00335595|Bevacizumab|bevacizumab
778654|NCT00335595|capecitabine|capecitabine
778655|NCT00335595|oxaliplatin|oxaliplatin
778656|NCT00335582|alpha 2 agonists|alpha 2 agonists
778657|NCT00335582|cardiac events|cardiac events
778658|NCT00335582|non cardiac surgery|non cardiac surgery
778659|NCT00335569|Infertility, sterility, hCG, IVF|infertility, sterility, hcg, ivf
778660|NCT00335543|adenocarcinoma of the pancreas|adenocarcinoma of the pancreas
778661|NCT00335543|stage I pancreatic cancer|stage i pancreatic cancer
778662|NCT00335543|stage II pancreatic cancer|stage ii pancreatic cancer
778663|NCT00335543|stage III pancreatic cancer|stage iii pancreatic cancer
778664|NCT00335517|Lumbar surgery|lumbar surgery
778933|NCT00334464|DVT|dvt
778665|NCT00335517|Surgery L3-S1|surgery l3-s1
778666|NCT00335517|DepoDur|depodur
778667|NCT00335517|Post-operative pain|post-operative pain
778668|NCT00335517|Pain control|pain control
778669|NCT00335517|Pain relief|pain relief
778670|NCT00335491|small cell lung cancer|small cell lung cancer
778672|NCT00335491|colon cancer|colon cancer
778673|NCT00335491|prostate cancer|prostate cancer
778674|NCT00335491|breast cancer|breast cancer
778675|NCT00335491|male breast cancer|male breast cancer
778676|NCT00335491|fatigue|fatigue
778677|NCT00335491|lymphoma|lymphoma
778678|NCT00335491|ovarian epithelial cancer|ovarian epithelial cancer
778679|NCT00335491|bladder cancer|bladder cancer
778680|NCT00335491|esophageal cancer|esophageal cancer
778681|NCT00335478|neutropenia|neutropenia
778682|NCT00335478|infection|infection
778683|NCT00335478|unspecified adult solid tumor, protocol specific|unspecified adult solid tumor, protocol specific
778684|NCT00335478|fever, sweats, and hot flashes|fever, sweats, and hot flashes
778685|NCT00335452|platelet aggregation inhibitors|platelet aggregation inhibitors
778686|NCT00335452|acute coronary disease|acute coronary disease
778687|NCT00335452|percutaneous coronary|percutaneous coronary
778688|NCT00335413|Renal autoregulation|renal autoregulation
778689|NCT00335413|Glomerular filtration rate|glomerular filtration rate
778690|NCT00335413|Type 1 diabetes|type 1 diabetes
778691|NCT00335374|Parkinson's disease|parkinson's disease
778692|NCT00335361|Male Contraceptive Devices|male contraceptive devices
778693|NCT00335361|Intra Vas Device (IVD)|intra vas device (ivd)
778694|NCT00335361|Male Sterilization|male sterilization
778695|NCT00335361|Vasectomy|vasectomy
778696|NCT00335361|Intra Vas Deferens Occlusion|intra vas deferens occlusion
778697|NCT00335361|Vas Occlusion|vas occlusion
778698|NCT00335348|Multiple Myeloma|multiple myeloma
778699|NCT00335348|Relapse|relapse
778700|NCT00335348|Bortezomib|bortezomib
778701|NCT00335348|Dexamethasone|dexamethasone
778702|NCT00335348|Maintenance|maintenance
778703|NCT00335335|Coronary|coronary
778704|NCT00335335|Angiography|angiography
778705|NCT00335335|X-ray|x-ray
778706|NCT00335335|CAD|cad
778707|NCT00335322|Human Immunodeficiency Virus (HIV)|human immunodeficiency virus (hiv)
778708|NCT00335309|chronic rhinosinusitis|chronic rhinosinusitis
778709|NCT00335309|sinus irrigation|sinus irrigation
778710|NCT00335296|PFO|pfo
778711|NCT00335296|Migraine|migraine
778712|NCT00335296|Stroke|stroke
778713|NCT00335296|TIA (transient ischemic attack)|tia (transient ischemic attack)
778714|NCT00335296|Decompression Illness|decompression illness
778715|NCT00335270|HIV Type 1|hiv type 1
778716|NCT00335257|Drospirenone|drospirenone
778717|NCT00335257|Safety|safety
778718|NCT00335257|INAS|inas
778719|NCT00335231|Post-cataract surgery endophthalmitis|post-cataract surgery endophthalmitis
778720|NCT00335218|Early postmenopausal state|early postmenopausal state
778721|NCT00335218|Climacteric symptoms|climacteric symptoms
778722|NCT00335218|Hormone replacement therapy|hormone replacement therapy
778723|NCT00335205|ropinirole|ropinirole
778724|NCT00335205|dopamine|dopamine
778725|NCT00335205|D2|d2
778726|NCT00335205|depression|depression
778727|NCT00335205|bipolar|bipolar
778728|NCT00335192|Intracellular concentrations|intracellular concentrations
778729|NCT00335192|Plasma concentration|plasma concentration
778730|NCT00335192|Abacavir|abacavir
778731|NCT00335192|Tenofovir|tenofovir
778732|NCT00335192|Lamivudine (3TC)|lamivudine (3tc)
778733|NCT00335192|Pharmacokinetic interactions|pharmacokinetic interactions
778734|NCT00335179|Actinic keratosis|actinic keratosis
778735|NCT00335179|AK|ak
778736|NCT00335179|imiquimod|imiquimod
778737|NCT00335179|confocal microscopy|confocal microscopy
778738|NCT00335179|gene microarray|gene microarray
778739|NCT00335166|Parkinson Disease|parkinson disease
778740|NCT00335153|severe motor fluctuations|severe motor fluctuations
778741|NCT00335153|levodopa|levodopa
778742|NCT00335153|levodopa/carbidopa intestinal gel|levodopa/carbidopa intestinal gel
778743|NCT00335153|efficacy|efficacy
778744|NCT00335153|dyskinesia|dyskinesia
778745|NCT00335153|Parkinson's Disease|parkinson's disease
778746|NCT00335153|carbidopa|carbidopa
778747|NCT00335153|DUOPA|duopa
778748|NCT00335140|primary central nervous system non-Hodgkin lymphoma|primary central nervous system non-hodgkin lymphoma
778749|NCT00335114|cyclosporine, dry eye syndrome, contact lens|cyclosporine, dry eye syndrome, contact lens
778750|NCT00335101|Coronary Artery Disease (CAD), Renal Impairment, Serum creatinine (SCr), Iodixanol, Ioversol, Iopromide, Contrast Induced Nephropathy (CIN)|coronary artery disease (cad), renal impairment, serum creatinine (scr), iodixanol, ioversol, iopromide, contrast induced nephropathy (cin)
778751|NCT00335088|Prophylaxis,|prophylaxis,
778752|NCT00335088|Intraocular surgery|intraocular surgery
778753|NCT00335088|Lacrimal sac|lacrimal sac
778754|NCT00335088|Eye lid|eye lid
778755|NCT00335088|No conditions|no conditions
778756|NCT00335062|Autoimmune thyroid disease|autoimmune thyroid disease
778757|NCT00335062|Children and Adolescents|children and adolescents
778758|NCT00335062|TSH Receptor Antibodies|tsh receptor antibodies
778759|NCT00335049|myopia progression|myopia progression
778760|NCT00335049|bifocal|bifocal
778761|NCT00335036|Implantable Cardioverter Defibrillator|implantable cardioverter defibrillator
778762|NCT00335036|Ventricular Arrhythmia|ventricular arrhythmia
778763|NCT00335036|Sudden Cardiac Death|sudden cardiac death
778764|NCT00335036|Congenital Heart Disease|congenital heart disease
778765|NCT00335036|Pediatric Electrophysiology|pediatric electrophysiology
779036|NCT00334126|quetiapine|quetiapine
778766|NCT00335023|postpartum hemorrhage|postpartum hemorrhage
778767|NCT00335023|red blood cell transfusion|red blood cell transfusion
778768|NCT00335023|health related quality of life|health related quality of life
778769|NCT00335010|Nitroglycerine|nitroglycerine
778770|NCT00335010|gastroesophageal anastomosis|gastroesophageal anastomosis
778771|NCT00335010|microvascular bloodflow|microvascular bloodflow
778772|NCT00335010|microvascular hemoglobinsaturation|microvascular hemoglobinsaturation
778884|NCT00334594|epithelial mesothelioma|epithelial mesothelioma
778773|NCT00334997|stage I squamous cell carcinoma of the larynx|stage i squamous cell carcinoma of the larynx
778774|NCT00334997|stage II squamous cell carcinoma of the larynx|stage ii squamous cell carcinoma of the larynx
778775|NCT00334997|stage 0 laryngeal cancer|stage 0 laryngeal cancer
778776|NCT00334984|childhood fibrosarcoma|childhood fibrosarcoma
778777|NCT00334984|childhood neurofibrosarcoma|childhood neurofibrosarcoma
778778|NCT00334984|childhood synovial sarcoma|childhood synovial sarcoma
778779|NCT00334984|chondrosarcoma|chondrosarcoma
778780|NCT00334984|localized osteosarcoma|localized osteosarcoma
778781|NCT00334984|metastatic osteosarcoma|metastatic osteosarcoma
778782|NCT00334984|metastatic childhood soft tissue sarcoma|metastatic childhood soft tissue sarcoma
778783|NCT00334984|nonmetastatic childhood soft tissue sarcoma|nonmetastatic childhood soft tissue sarcoma
778784|NCT00334984|metastatic Ewing sarcoma/peripheral primitive neuroectodermal tumor|metastatic ewing sarcoma/peripheral primitive neuroectodermal tumor
778785|NCT00334984|localized Ewing sarcoma/peripheral primitive neuroectodermal tumor|localized ewing sarcoma/peripheral primitive neuroectodermal tumor
778786|NCT00334984|previously treated childhood rhabdomyosarcoma|previously treated childhood rhabdomyosarcoma
778787|NCT00334984|previously untreated childhood rhabdomyosarcoma|previously untreated childhood rhabdomyosarcoma
778788|NCT00334984|childhood alveolar soft-part sarcoma|childhood alveolar soft-part sarcoma
778789|NCT00334984|childhood angiosarcoma|childhood angiosarcoma
778790|NCT00334984|childhood epithelioid sarcoma|childhood epithelioid sarcoma
778791|NCT00334984|childhood leiomyosarcoma|childhood leiomyosarcoma
778792|NCT00334984|childhood liposarcoma|childhood liposarcoma
778793|NCT00334984|localized childhood malignant fibrous histiocytoma of bone|localized childhood malignant fibrous histiocytoma of bone
778794|NCT00334984|metastatic childhood malignant fibrous histiocytoma of bone|metastatic childhood malignant fibrous histiocytoma of bone
778795|NCT00334984|childhood malignant mesenchymoma|childhood malignant mesenchymoma
778796|NCT00334984|dermatofibrosarcoma protuberans|dermatofibrosarcoma protuberans
778797|NCT00334984|childhood desmoplastic small round cell tumor|childhood desmoplastic small round cell tumor
778798|NCT00334971|African-American|african-american
778799|NCT00334971|estradiol|estradiol
778800|NCT00334971|luteinizing hormone|luteinizing hormone
778801|NCT00334971|follicle stimulating hormone|follicle stimulating hormone
778802|NCT00334971|androstenedione|androstenedione
778803|NCT00334971|aromatase|aromatase
778804|NCT00334971|inhibins|inhibins
778805|NCT00334971|ovarian|ovarian
778806|NCT00334971|Healthy volunteers|healthy volunteers
778807|NCT00334971|Fragile X|fragile x
778808|NCT00334945|Fibroblast Growth Factors|fibroblast growth factors
778809|NCT00334945|Bone development|bone development
778810|NCT00334932|refractory multiple myeloma|refractory multiple myeloma
778811|NCT00334932|stage I multiple myeloma|stage i multiple myeloma
778812|NCT00334932|stage II multiple myeloma|stage ii multiple myeloma
778813|NCT00334932|stage III multiple myeloma|stage iii multiple myeloma
778814|NCT00334919|Diabetes|diabetes
778815|NCT00334919|Pre-Diabetes|pre-diabetes
778816|NCT00334919|Anti-Inflammatory Diet|anti-inflammatory diet
778817|NCT00334919|Diet Study|diet study
778818|NCT00334919|Inflammation|inflammation
778819|NCT00334919|Diabetic Diet|diabetic diet
778820|NCT00334906|memantine|memantine
778821|NCT00334906|Alzheimer's disease|alzheimer's disease
778822|NCT00334906|MRI|mri
778823|NCT00334906|moderate Alzheimer's disease|moderate alzheimer's disease
778824|NCT00334880|Attention Deficit Hyperactivity Disorder|attention deficit hyperactivity disorder
778825|NCT00334880|Attention Deficit Disorders with Hyperactivity|attention deficit disorders with hyperactivity
778826|NCT00334880|Attention Deficit Hyperactivity Disorders|attention deficit hyperactivity disorders
778827|NCT00334867|localized Ewing sarcoma/peripheral primitive neuroectodermal tumor|localized ewing sarcoma/peripheral primitive neuroectodermal tumor
778828|NCT00334854|childhood synovial sarcoma|childhood synovial sarcoma
778829|NCT00334854|nonmetastatic childhood soft tissue sarcoma|nonmetastatic childhood soft tissue sarcoma
778830|NCT00334854|childhood alveolar soft-part sarcoma|childhood alveolar soft-part sarcoma
778831|NCT00334854|childhood angiosarcoma|childhood angiosarcoma
778832|NCT00334854|childhood epithelioid sarcoma|childhood epithelioid sarcoma
778833|NCT00334854|childhood fibrosarcoma|childhood fibrosarcoma
778834|NCT00334854|childhood leiomyosarcoma|childhood leiomyosarcoma
778835|NCT00334854|childhood liposarcoma|childhood liposarcoma
778836|NCT00334854|childhood neurofibrosarcoma|childhood neurofibrosarcoma
778837|NCT00334854|localized childhood malignant fibrous histiocytoma of bone|localized childhood malignant fibrous histiocytoma of bone
778838|NCT00334854|childhood malignant hemangiopericytoma|childhood malignant hemangiopericytoma
778839|NCT00334854|dermatofibrosarcoma protuberans|dermatofibrosarcoma protuberans
778840|NCT00334854|chondrosarcoma|chondrosarcoma
778841|NCT00334828|Severe sepsis|severe sepsis
778842|NCT00334828|septic shock|septic shock
778843|NCT00334828|sepsis|sepsis
778844|NCT00334776|recurrent melanoma|recurrent melanoma
778845|NCT00334776|stage IV melanoma|stage iv melanoma
778846|NCT00334776|ciliary body and choroid melanoma, medium/large size|ciliary body and choroid melanoma, medium/large size
778847|NCT00334776|iris melanoma|iris melanoma
778848|NCT00334776|recurrent intraocular melanoma|recurrent intraocular melanoma
778849|NCT00334776|extraocular extension melanoma|extraocular extension melanoma
778850|NCT00334763|recurrent non-small cell lung cancer|recurrent non-small cell lung cancer
778851|NCT00334763|stage IIIB non-small cell lung cancer|stage iiib non-small cell lung cancer
778852|NCT00334763|stage IV non-small cell lung cancer|stage iv non-small cell lung cancer
778853|NCT00334763|squamous cell lung cancer|squamous cell lung cancer
778854|NCT00334750|Glaucoma, Open-Angle Ocular Hypertension Risk factors Canadian|glaucoma, open-angle ocular hypertension risk factors canadian
778855|NCT00334737|erythropoietin|erythropoietin
778856|NCT00334737|darbepoetin|darbepoetin
778857|NCT00334737|transfusions|transfusions
778858|NCT00334737|neonates|neonates
778859|NCT00334737|outcomes|outcomes
778860|NCT00334737|neurodevelopment|neurodevelopment
778861|NCT00334724|Cardiovascular disease|cardiovascular disease
778862|NCT00334724|Vascular disease|vascular disease
778863|NCT00334724|Hypertension|hypertension
778864|NCT00334724|Home blood pressure measurement|home blood pressure measurement
778865|NCT00334711|Permanent Neonatal Diabetes|permanent neonatal diabetes
778866|NCT00334711|Kir6.2|kir6.2
778867|NCT00334711|KCNJ11|kcnj11
778868|NCT00334711|Infancy onset diabetes|infancy onset diabetes
778869|NCT00334711|Sulfonylurea|sulfonylurea
778870|NCT00334672|hemophagocytic lymphohistiocytosis|hemophagocytic lymphohistiocytosis
778871|NCT00334659|HIV-1 Infection|hiv-1 infection
778872|NCT00334646|cyclophosphamide|cyclophosphamide
778873|NCT00334646|CINV|cinv
778874|NCT00334646|Chemotherapy induced nausea and vomiting|chemotherapy induced nausea and vomiting
778875|NCT00334633|bacterial vaginosis|bacterial vaginosis
778876|NCT00334633|tinidazole|tinidazole
778877|NCT00334620|randomised double-blinded trial|randomised double-blinded trial
778878|NCT00334620|rehabilitation|rehabilitation
778879|NCT00334620|radon spa therapy|radon spa therapy
778880|NCT00334620|long-term effectiveness|long-term effectiveness
778881|NCT00334607|HRV vaccine|hrv vaccine
778882|NCT00334607|diarrhoea|diarrhoea
778883|NCT00334607|rotavirus|rotavirus
778885|NCT00334594|sarcomatous mesothelioma|sarcomatous mesothelioma
778886|NCT00334594|stage IA malignant mesothelioma|stage ia malignant mesothelioma
778887|NCT00334594|stage IB malignant mesothelioma|stage ib malignant mesothelioma
778888|NCT00334594|stage II malignant mesothelioma|stage ii malignant mesothelioma
778889|NCT00334594|stage III malignant mesothelioma|stage iii malignant mesothelioma
778890|NCT00334568|AVANDIA|avandia
778891|NCT00334568|Alzheimers Disease|alzheimers disease
778892|NCT00334555|trichomoniasis|trichomoniasis
778893|NCT00334555|partner notification|partner notification
778894|NCT00334542|breast cancer|breast cancer
778895|NCT00334542|ductal breast carcinoma in situ|ductal breast carcinoma in situ
778896|NCT00334542|breast cancer in situ|breast cancer in situ
778897|NCT00334542|stage I breast cancer|stage i breast cancer
778898|NCT00334542|stage II breast cancer|stage ii breast cancer
778899|NCT00334542|stage IIIA breast cancer|stage iiia breast cancer
778900|NCT00334542|stage IIIB breast cancer|stage iiib breast cancer
778901|NCT00334542|stage IIIC breast cancer|stage iiic breast cancer
778902|NCT00334529|Tamiflu|tamiflu
778904|NCT00334529|Antiviral|antiviral
778905|NCT00334529|Neuraminidase Inhibitor|neuraminidase inhibitor
778906|NCT00334529|Pharmacokinetic Trial|pharmacokinetic trial
778907|NCT00334529|Healthy Volunteer|healthy volunteer
778908|NCT00334529|HV|hv
778909|NCT00334516|Motor Neuron Disease|motor neuron disease
778910|NCT00334516|Cognitive Testing|cognitive testing
778911|NCT00334516|Movement-Related Potential|movement-related potential
778912|NCT00334516|MRI|mri
778913|NCT00334516|Neuropsychologic Testing|neuropsychologic testing
778914|NCT00334516|Primary Lateral Sclerosis|primary lateral sclerosis
778915|NCT00334516|PLS|pls
778916|NCT00334516|Amyotrophic Lateral Sclerosis|amyotrophic lateral sclerosis
778917|NCT00334516|ALS|als
778918|NCT00334516|Healthy Volunteer|healthy volunteer
778919|NCT00334516|HV|hv
778920|NCT00334503|alpa-glucosidase inhibitor,Biguanide|alpa-glucosidase inhibitor,biguanide
778921|NCT00334490|Pulmonary Hypertension|pulmonary hypertension
778922|NCT00334490|Sildenafil|sildenafil
778923|NCT00334490|Viagra|viagra
778924|NCT00334490|Cardiac Surgery|cardiac surgery
778925|NCT00334490|Cardiopulmonary Bypass|cardiopulmonary bypass
778926|NCT00334477|erectile dysfunction|erectile dysfunction
778927|NCT00334477|chronic renal dysfunction|chronic renal dysfunction
778928|NCT00334477|tadalafil|tadalafil
778929|NCT00334464|warfarin metabolism|warfarin metabolism
778930|NCT00334464|CYP2C0|cyp2c0
778931|NCT00334464|anticoagulation|anticoagulation
778932|NCT00334464|genotyping|genotyping
778934|NCT00334464|PE|pe
778935|NCT00334451|Heart Failure|heart failure
778936|NCT00334451|Remote Monitoring|remote monitoring
778937|NCT00334451|Implantable Device|implantable device
778938|NCT00334438|recurrent grade 1 follicular lymphoma|recurrent grade 1 follicular lymphoma
778939|NCT00334438|recurrent grade 2 follicular lymphoma|recurrent grade 2 follicular lymphoma
778940|NCT00334438|recurrent grade 3 follicular lymphoma|recurrent grade 3 follicular lymphoma
778941|NCT00334438|recurrent mantle cell lymphoma|recurrent mantle cell lymphoma
778942|NCT00334438|recurrent small lymphocytic lymphoma|recurrent small lymphocytic lymphoma
778943|NCT00334399|alpa-glucosidase inhibitor,Biguanide|alpa-glucosidase inhibitor,biguanide
778944|NCT00334386|Hypertension|hypertension
778945|NCT00334386|Anti-hypertensive effect|anti-hypertensive effect
778946|NCT00334386|Diuretic|diuretic
778947|NCT00334373|Myocardial infarction|myocardial infarction
778948|NCT00334373|Magnetic Resonance Imaging|magnetic resonance imaging
778949|NCT00334373|Coronary Angioplasty|coronary angioplasty
778950|NCT00334334|Streptococcus pneumonia, vaccine|streptococcus pneumonia, vaccine
778951|NCT00334321|IMRT|imrt
778952|NCT00334321|Tomotherapy|tomotherapy
778953|NCT00334321|Post-Hysterectomy|post-hysterectomy
778954|NCT00334321|Endometrial Cancer|endometrial cancer
778955|NCT00334295|Recurrent or metastatic endometrial carcinoma|recurrent or metastatic endometrial carcinoma
778956|NCT00334282|Metastatic|metastatic
778957|NCT00334282|Anti-angiogenesis|anti-angiogenesis
778958|NCT00334282|GW786034|gw786034
778959|NCT00334282|Pazopanib|pazopanib
778960|NCT00334269|obesity|obesity
778961|NCT00334269|physical activity|physical activity
778962|NCT00334269|daily energy intake|daily energy intake
778963|NCT00334269|nutrition|nutrition
778964|NCT00334269|healthy lifestyle|healthy lifestyle
778965|NCT00334269|Aboriginal|aboriginal
778966|NCT00334269|body fat|body fat
778967|NCT00334269|exercise|exercise
778968|NCT00334269|education|education
778969|NCT00334269|family|family
778970|NCT00334269|body mass index|body mass index
778971|NCT00334269|knowledge|knowledge
778972|NCT00334269|randomized controlled trial|randomized controlled trial
778973|NCT00334269|community|community
778974|NCT00334269|intervention|intervention
778975|NCT00334269|Six Nations Indian Reserve|six nations indian reserve
778976|NCT00334269|household|household
778977|NCT00334269|health counselling|health counselling
778978|NCT00334256|PMTCT|pmtct
778979|NCT00334256|Resistance|resistance
778980|NCT00334256|HIV infection|hiv infection
778981|NCT00334256|Pregnancy|pregnancy
778982|NCT00334243|in vitro fertilization|in vitro fertilization
778983|NCT00334243|infertile|infertile
778984|NCT00334243|infertility|infertility
778985|NCT00334243|pregnancy|pregnancy
778986|NCT00334243|pregnancy rates|pregnancy rates
778987|NCT00334243|microflare protocol|microflare protocol
778988|NCT00334243|antagonist protocol|antagonist protocol
778989|NCT00334243|demi-halt protocol|demi-halt protocol
778990|NCT00334243|poor responders|poor responders
778991|NCT00334243|low antral follicle count|low antral follicle count
778992|NCT00334243|Infertile Patients undergoing in vitro fertilization (IVF)|infertile patients undergoing in vitro fertilization (ivf)
778993|NCT00334243|Patients with a previous poor response to ovarian stimulation|patients with a previous poor response to ovarian stimulation
778994|NCT00334243|Patients with an antral follicle count of less than 10|patients with an antral follicle count of less than 10
778995|NCT00334230|Functional Magnetic Resonance Imaging (fMRI)|functional magnetic resonance imaging (fmri)
778996|NCT00334230|Transcranial Magnetic Stimulation (TMS)|transcranial magnetic stimulation (tms)
778997|NCT00334230|Locomotion|locomotion
778998|NCT00334230|Cortical Reorganization|cortical reorganization
778999|NCT00334230|Rehabilitation|rehabilitation
779000|NCT00334230|fMRI|fmri
779001|NCT00334230|Stroke|stroke
779002|NCT00334230|Healthy Volunteer|healthy volunteer
779003|NCT00334230|HV|hv
779004|NCT00334217|Psychology: cognitive aspects|psychology: cognitive aspects
779005|NCT00334217|Substance-Related Disorders|substance-related disorders
779006|NCT00334217|treatment efficacy|treatment efficacy
779007|NCT00334204|Platelet Function Analyser-100 (PFA-100)|platelet function analyser-100 (pfa-100)
779008|NCT00334204|renal failure|renal failure
779009|NCT00334204|kidney biopsy|kidney biopsy
779010|NCT00334204|bleeding|bleeding
779011|NCT00334204|hematoma|hematoma
779012|NCT00334191|Cardiac surgery,|cardiac surgery,
779013|NCT00334191|Cardiopulmonary bypass,|cardiopulmonary bypass,
779014|NCT00334191|Oxidative stress,|oxidative stress,
779015|NCT00334191|Acute renal dysfunction,|acute renal dysfunction,
779016|NCT00334191|Sodium Bicarbonate|sodium bicarbonate
779017|NCT00334178|Migraine|migraine
779018|NCT00334178|Migraine prophylaxis|migraine prophylaxis
779019|NCT00334152|NK-1|nk-1
779020|NCT00334152|antiemetics|antiemetics
779021|NCT00334152|casopitant mesylate|casopitant mesylate
779022|NCT00334152|postoperative nausea and vomiting|postoperative nausea and vomiting
779023|NCT00334152|ondansetron hydrochloride|ondansetron hydrochloride
779024|NCT00334152|5HT3|5ht3
779025|NCT00334152|ZOFRAN|zofran
779026|NCT00334152|PONV|ponv
779027|NCT00334139|serum bone markers|serum bone markers
779028|NCT00334139|bone metastasis|bone metastasis
779029|NCT00334139|prostate cancer|prostate cancer
779030|NCT00334139|breast cancer|breast cancer
779031|NCT00334139|quality of life|quality of life
779032|NCT00334139|bisphosphonates|bisphosphonates
779033|NCT00334126|Schizophrenia|schizophrenia
779034|NCT00334126|Antipsychotic|antipsychotic
779035|NCT00334126|paliperidone|paliperidone
779039|NCT00334113|Diabetes Mellitus|diabetes mellitus
779040|NCT00334113|Exercise|exercise
779041|NCT00334113|Obesity|obesity
779042|NCT00334113|Telemedicine|telemedicine
779043|NCT00334100|Exercise|exercise
779044|NCT00334100|multiple sclerosis|multiple sclerosis
779045|NCT00334100|treadmill|treadmill
779046|NCT00334087|primary dental prevention|primary dental prevention
779047|NCT00334087|early childhood caries|early childhood caries
779048|NCT00334087|prenatal oral care|prenatal oral care
779049|NCT00334074|AML|aml
779050|NCT00334074|MDS|mds
779051|NCT00334074|CML|cml
779052|NCT00334074|Relapsed|relapsed
779053|NCT00334074|Refractory|refractory
779054|NCT00334074|Chemo treatment|chemo treatment
779055|NCT00334074|Clofarabine|clofarabine
779056|NCT00334074|Cytarabine|cytarabine
779057|NCT00334074|standard or poor cytogenetic risk AML|standard or poor cytogenetic risk aml
779058|NCT00334074|untreated high-risk (>10% blasts) MDS|untreated high-risk (>10% blasts) mds
779059|NCT00334074|CML in accelerated phase or blast crisis|cml in accelerated phase or blast crisis
779060|NCT00334074|Elderly AML patients with risk of anthracycline toxicity|elderly aml patients with risk of anthracycline toxicity
779061|NCT00334061|Penumbra|penumbra
779062|NCT00334061|Ischemic|ischemic
779063|NCT00334061|Stroke|stroke
779064|NCT00334061|Intervention|intervention
779065|NCT00334061|Neurovascular|neurovascular
779066|NCT00334061|Thrombus|thrombus
779067|NCT00334061|Embolectomy|embolectomy
779068|NCT00334061|Ischemic stroke|ischemic stroke
779069|NCT00334048|Medication-induced sexual dysfunction|medication-induced sexual dysfunction
779070|NCT00334048|SSRI-induced sexual dysfunction|ssri-induced sexual dysfunction
779071|NCT00334048|Anorgasmia|anorgasmia
779072|NCT00334048|Delayed ejaculation|delayed ejaculation
779073|NCT00334048|Sexual dysfunction|sexual dysfunction
779074|NCT00334048|Antidepressant-induced sexual dysfunction|antidepressant-induced sexual dysfunction
779075|NCT00334048|Requip|requip
779076|NCT00334048|Ropinirole|ropinirole
779077|NCT00334048|Dopamine agonist|dopamine agonist
779078|NCT00334048|Serotonin reuptake inhibitor|serotonin reuptake inhibitor
779079|NCT00334048|Sexual dysfunction, physiological, medication-induced|sexual dysfunction, physiological, medication-induced
779080|NCT00334022|Fuzeon|fuzeon
779081|NCT00334022|Viral Decay|viral decay
779082|NCT00334009|Cardiac Surgery|cardiac surgery
779083|NCT00334009|Cardiopulmonary Bypass|cardiopulmonary bypass
779084|NCT00334009|COMT-Polymorphism|comt-polymorphism
779085|NCT00334009|Vasoplegia|vasoplegia
779086|NCT00334009|Catecholamines|catecholamines
779087|NCT00334009|Acute Renal Failure|acute renal failure
779088|NCT00333970|cognition|cognition
779089|NCT00333970|neuropsychology|neuropsychology
779090|NCT00333970|Rehabilitation|rehabilitation
779091|NCT00333970|treatment efficacy|treatment efficacy
779092|NCT00333970|cognitive remediation|cognitive remediation
779093|NCT00333957|capsule endoscopy|capsule endoscopy
779094|NCT00333944|Organophosphorus poisoning|organophosphorus poisoning
779095|NCT00333944|Atropine|atropine
779096|NCT00333944|Pralidoxime|pralidoxime
779097|NCT00333944|Intermediate syndrome.|intermediate syndrome.
779098|NCT00333931|Impulsive Aggression|impulsive aggression
779099|NCT00333931|Posttraumatic Stress Disorder|posttraumatic stress disorder
779100|NCT00333918|Cataract Extraction|cataract extraction
779101|NCT00333918|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal
779102|NCT00333905|Exercise|exercise
779103|NCT00333905|Exercise Therapy|exercise therapy
779104|NCT00333892|primary HIV infection|primary hiv infection
779105|NCT00333892|chronic HIV infection|chronic hiv infection
779106|NCT00333879|Rehabilitation|rehabilitation
779107|NCT00333879|Sensory Aid|sensory aid
779108|NCT00333840|CML|cml
779109|NCT00333840|STI571|sti571
779110|NCT00333840|imatinib|imatinib
779111|NCT00333840|interferon|interferon
779112|NCT00333840|interferon alpha|interferon alpha
779113|NCT00333840|cytosine arabinoside|cytosine arabinoside
779114|NCT00333840|chronic myeloid leukemia|chronic myeloid leukemia
779115|NCT00333840|Philadelphia chromosome positive|philadelphia chromosome positive
779116|NCT00333827|Dilated Cardiomyopathy|dilated cardiomyopathy
779117|NCT00333827|stem cells|stem cells
779118|NCT00333827|Therapeutics|therapeutics
779119|NCT00333827|Randomized Controlled Trials|randomized controlled trials
779120|NCT00333801|Posttraumatic Stress Disorder|posttraumatic stress disorder
779121|NCT00333801|Veterans|veterans
779122|NCT00333801|Vocational Rehabilitation|vocational rehabilitation
779123|NCT00333801|Supported Employment|supported employment
779124|NCT00333801|Individual Placement and Support|individual placement and support
779125|NCT00333788|Crohn's Disease|crohn's disease
779126|NCT00333788|Certolizumab pegol|certolizumab pegol
779127|NCT00333788|CDP870|cdp870
779128|NCT00333788|Cimzia|cimzia
779129|NCT00333762|aging|aging
779130|NCT00333762|blindness|blindness
779131|NCT00333762|wheelchairs|wheelchairs
779132|NCT00333762|spinal cord injury|spinal cord injury
779133|NCT00333749|children|children
779134|NCT00333736|Injection site reactions|injection site reactions
779135|NCT00333736|enfuvirtide administration|enfuvirtide administration
779136|NCT00333723|Rosiglitazone|rosiglitazone
779138|NCT00333723|Type 2 Diabetes Mellitus|type 2 diabetes mellitus
779139|NCT00333723|African American|african american
779140|NCT00333723|Hispanic|hispanic
779141|NCT00333710|Rehabilitation|rehabilitation
779142|NCT00333710|Telecommunication|telecommunication
779143|NCT00333697|Deep vein thrombosis|deep vein thrombosis
779144|NCT00333697|Duplex ultrasound|duplex ultrasound
779145|NCT00333697|Pulmonary embolism|pulmonary embolism
779146|NCT00333671|Macular oedema|macular oedema
779147|NCT00333671|Diabetes|diabetes
779148|NCT00333671|Pathogenesis|pathogenesis
779149|NCT00333671|Osmolality|osmolality
779150|NCT00333671|Retinal thickness|retinal thickness
779151|NCT00333658|psychotherapy, group|psychotherapy, group
779152|NCT00333658|rehabilitation, vocational|rehabilitation, vocational
779153|NCT00333658|treatment outcome|treatment outcome
779154|NCT00333645|Liver transplantation|liver transplantation
779155|NCT00333645|Invasive fungal infection|invasive fungal infection
779156|NCT00333645|Invasive aspergillosis|invasive aspergillosis
779157|NCT00333645|Prophylaxis|prophylaxis
779158|NCT00333645|Caspofungin|caspofungin
779160|NCT00333632|Dexmedetomidine|dexmedetomidine
779161|NCT00333632|Postoperative care|postoperative care
779162|NCT00333632|Sedation|sedation
779163|NCT00333619|sleep disorders|sleep disorders
779164|NCT00333619|rehabilitation|rehabilitation
779165|NCT00333619|rehabilitation outcomes|rehabilitation outcomes
779166|NCT00333593|Dialysis|dialysis
779167|NCT00333593|Large pore dialyser|large pore dialyser
779168|NCT00333593|Cytokines|cytokines
779169|NCT00333593|Noradrenaline|noradrenaline
779170|NCT00333580|Ethnography|ethnography
779171|NCT00333580|Psychometrics|psychometrics
779172|NCT00333580|Qualitative Research|qualitative research
779173|NCT00333567|arthroscopic knee surgery|arthroscopic knee surgery
779174|NCT00333567|cyclooxygenase-2 inhibitors|cyclooxygenase-2 inhibitors
779175|NCT00333567|lumiracoxib|lumiracoxib
779176|NCT00333567|COX189|cox189
779177|NCT00333567|Ambulatory arthroscopic knee surgery|ambulatory arthroscopic knee surgery
779178|NCT00333554|DHA|dha
779179|NCT00333554|docosahexaenoic acid|docosahexaenoic acid
779180|NCT00333554|omega-3 fatty acid|omega-3 fatty acid
779181|NCT00333554|fish oil|fish oil
779182|NCT00333554|pregnancy|pregnancy
779183|NCT00333554|infancy|infancy
779184|NCT00333554|prevention|prevention
779185|NCT00333554|"at risk for developing type 1 diabetes"|"at risk for developing type 1 diabetes"
779186|NCT00333554|juvenile diabetes|juvenile diabetes
779187|NCT00333554|T1D|t1d
779188|NCT00333554|diabetes mellitus|diabetes mellitus
779189|NCT00333554|Type 1 diabetes TrialNet|type 1 diabetes trialnet
779190|NCT00333554|TrialNet|trialnet
779191|NCT00333554|dietary supplementation|dietary supplementation
779192|NCT00333554|nutrition|nutrition
779193|NCT00333541|Contraceptive behavior|contraceptive behavior
779194|NCT00333541|Internet Use|internet use
779195|NCT00333541|Adolescent pregnancy|adolescent pregnancy
779196|NCT00333541|Unintended pregnancy|unintended pregnancy
779197|NCT00333528|Chemical Warfare Agents|chemical warfare agents
779198|NCT00333528|Chemical Nerve Agent Intoxication|chemical nerve agent intoxication
779199|NCT00333528|Chemical Terrorism|chemical terrorism
779200|NCT00333515|Chemical nerve agent intoxication|chemical nerve agent intoxication
779201|NCT00333502|Cancer, Neoplasms, Solid Tumor, Ovarian Cancer, Lung Cancer,|cancer, neoplasms, solid tumor, ovarian cancer, lung cancer,
779202|NCT00333502|Non Small Cell Lung Cancer, Pancreatic Cancer,|non small cell lung cancer, pancreatic cancer,
779203|NCT00333502|Breast Cancer, Colon Cancer, Endometrial Cancer,|breast cancer, colon cancer, endometrial cancer,
779204|NCT00333502|Kidney (Renal Cell) Cancer, Melanoma, Prostate Cancer,|kidney (renal cell) cancer, melanoma, prostate cancer,
779205|NCT00333502|Skin Cancer, Thyroid Cancer,|skin cancer, thyroid cancer,
779206|NCT00333502|Solid Malignancies|solid malignancies
779207|NCT00333489|valsartan|valsartan
779208|NCT00333489|amlodipine|amlodipine
779209|NCT00333489|hypertension|hypertension
779210|NCT00333437|Scleroderma, Systemic|scleroderma, systemic
779211|NCT00333424|HIV|hiv
779212|NCT00333424|Human Immunodeficiency Virus|human immunodeficiency virus
779213|NCT00333424|Prophylactic vaccine|prophylactic vaccine
779214|NCT00333398|CSL Influenza Vaccine, influenza, vaccine, immunogenicity|csl influenza vaccine, influenza, vaccine, immunogenicity
779215|NCT00333385|Ceftazidime|ceftazidime
779216|NCT00333385|Continuous infusion|continuous infusion
779217|NCT00333385|Antibiotic course|antibiotic course
779218|NCT00333333|Thrombocytopenia|thrombocytopenia
779219|NCT00333333|Small for Gestational Age (SGA)|small for gestational age (sga)
779220|NCT00333333|Preeclampsia|preeclampsia
779221|NCT00333320|acute myocardial infarction|acute myocardial infarction
779222|NCT00333320|postconditioning|postconditioning
779223|NCT00333320|coronary reserve|coronary reserve
779224|NCT00333320|ejection fraction|ejection fraction
779225|NCT00333307|relaxin|relaxin
779226|NCT00333307|preeclampsia|preeclampsia
779227|NCT00333281|Healthy Volunteers|healthy volunteers
779228|NCT00333242|Pain|pain
779229|NCT00333242|opioid|opioid
779230|NCT00333242|hyperalgesia|hyperalgesia
779231|NCT00333242|methadone|methadone
779232|NCT00333229|Breast Cancer|breast cancer
779233|NCT00333229|premenopausal|premenopausal
779234|NCT00333229|Bone Mineral density|bone mineral density
779235|NCT00333229|Cancer therapy induced bone loss|cancer therapy induced bone loss
779236|NCT00333229|zoledronic acid|zoledronic acid
779237|NCT00333203|epimacular membrane|epimacular membrane
779238|NCT00333190|stem cell transplant|stem cell transplant
779239|NCT00333190|graft versus host disease|graft versus host disease
779240|NCT00333190|GVHD|gvhd
779241|NCT00333190|CD+8 T cell depletion|cd+8 t cell depletion
779242|NCT00333177|Schizoaffective Disorder, Depressed Type|schizoaffective disorder, depressed type
779243|NCT00333177|Schizophreniform Disorder|schizophreniform disorder
779244|NCT00333177|First-Episode Schizophrenia|first-episode schizophrenia
779245|NCT00333177|Supported Employment|supported employment
779246|NCT00333177|Cognitive Remediation|cognitive remediation
779247|NCT00333177|Health Behavior Training|health behavior training
779248|NCT00333177|Antipsychotic Medication|antipsychotic medication
779249|NCT00333164|intracranial arteriosclerosis|intracranial arteriosclerosis
779250|NCT00333164|cilostazol|cilostazol
779251|NCT00333164|Platelete aggrigation inhibitors dual antiplatelet therapy|platelete aggrigation inhibitors dual antiplatelet therapy
779252|NCT00333164|Drug therapy, combination|drug therapy, combination
779253|NCT00333164|Clinical trials|clinical trials
779254|NCT00333138|FTY720|fty720
779256|NCT00333138|Multiple Sclerosis|multiple sclerosis
779257|NCT00333138|RRMS|rrms
779258|NCT00333112|Treatment Outcome|treatment outcome
779259|NCT00333112|Urology|urology
779260|NCT00333112|Solifenacin succinate|solifenacin succinate
779261|NCT00333112|Urinary Incontinence|urinary incontinence
779262|NCT00333099|Enteral nutrition|enteral nutrition
779263|NCT00333099|immunonutrients|immunonutrients
779264|NCT00333099|head and neck cancer|head and neck cancer
779265|NCT00333099|esophageal cancer|esophageal cancer
779266|NCT00333099|chemoradiotherapy|chemoradiotherapy
779267|NCT00333099|H&N or esophageal cancer patients with a chemoradiotherapy treatment.|h&n or esophageal cancer patients with a chemoradiotherapy treatment.
779268|NCT00333086|Endometrial Cancer|endometrial cancer
779269|NCT00333086|Aromatase inhibitor|aromatase inhibitor
779270|NCT00333086|Letrozole|letrozole
779271|NCT00333073|urinary incontinence|urinary incontinence
779272|NCT00333073|Bulkamid|bulkamid
779273|NCT00333047|Metastatic breast cancer|metastatic breast cancer
779274|NCT00333047|Aromatase inhibitor|aromatase inhibitor
779275|NCT00333047|Letrozole|letrozole
779276|NCT00333034|Psoriasis|psoriasis
779277|NCT00333021|Fondaparinux Abdominal surgery Japanese VTE|fondaparinux abdominal surgery japanese vte
779278|NCT00333008|Diffuse Large B Cell Lymphoma|diffuse large b cell lymphoma
779279|NCT00333008|CDOP|cdop
779280|NCT00333008|Dose Dense|dose dense
779281|NCT00333008|Anne Arbor Stage I-IV|anne arbor stage i-iv
779282|NCT00333008|Any IPI score|any ipi score
779283|NCT00332995|HIV Seronegativity|hiv seronegativity
779284|NCT00332982|best practices, performance improvement, intensive care, measurement|best practices, performance improvement, intensive care, measurement
779285|NCT00332969|Open label|open label
779286|NCT00332969|phase II|phase ii
779287|NCT00332969|disease|disease
779288|NCT00332969|clinical trial|clinical trial
779289|NCT00332969|Octreotide|octreotide
779290|NCT00332969|thymoma|thymoma
779291|NCT00332969|cancer|cancer
779292|NCT00332969|tumor|tumor
779293|NCT00332943|colorectal polyps|colorectal polyps
779294|NCT00332943|colorectal cancer|colorectal cancer
779295|NCT00332943|Virtual colonoscopy|virtual colonoscopy
779296|NCT00332943|Fecal tagging|fecal tagging
779297|NCT00332943|MR colonography|mr colonography
779298|NCT00332930|HIV|hiv
779299|NCT00332930|Therapeutic vaccine|therapeutic vaccine
779300|NCT00332917|Parkinson's disease|parkinson's disease
779301|NCT00332904|betablocker|betablocker
779302|NCT00332904|aldosterone antagonist|aldosterone antagonist
779303|NCT00332904|peripheral haemodynamics|peripheral haemodynamics
779304|NCT00332904|cardiac haemodynamics|cardiac haemodynamics
779305|NCT00332904|oxygenation|oxygenation
779306|NCT00332891|Anxiety|anxiety
779307|NCT00332891|Anti-Anxiety Agents|anti-anxiety agents
779308|NCT00332891|controlled Clinical Trials|controlled clinical trials
779309|NCT00332878|Behavioral Intervention|behavioral intervention
779310|NCT00332878|HIV|hiv
779311|NCT00332878|HSV2|hsv2
779312|NCT00332865|Head and neck cancer|head and neck cancer
779313|NCT00332865|Radiotherapy|radiotherapy
779314|NCT00332865|Dysphagia|dysphagia
779315|NCT00332865|Exercise|exercise
779316|NCT00332865|Deglutition|deglutition
779317|NCT00332865|Randomized controlled trial|randomized controlled trial
779318|NCT00332865|Quality of life|quality of life
779319|NCT00332865|Tube feeding|tube feeding
779320|NCT00332852|Postive breast cancer|postive breast cancer
779321|NCT00332852|postmenopausal|postmenopausal
779322|NCT00332852|disease free survival|disease free survival
779323|NCT00332852|letrozole|letrozole
779324|NCT00332852|early adjuvant treatment|early adjuvant treatment
779325|NCT00332852|primary hormone receptor|primary hormone receptor
779326|NCT00332839|enteric-coated mycophenolate sodium, everolimus, CNI-free regimen|enteric-coated mycophenolate sodium, everolimus, cni-free regimen
779327|NCT00332826|Inhaled insulin|inhaled insulin
779328|NCT00332826|Diabetes Type I and II with Asthma|diabetes type i and ii with asthma
779329|NCT00332813|HIV Risk Behavior|hiv risk behavior
779330|NCT00332813|Pregnancy|pregnancy
779331|NCT00332813|Drug Abuse|drug abuse
779332|NCT00332800|Stroke-Nutritional Supplementation-Functional Recovery|stroke-nutritional supplementation-functional recovery
779333|NCT00332787|Major Depressive Disorder|major depressive disorder
779334|NCT00332735|spinal|spinal
779335|NCT00332735|anesthesia|anesthesia
779336|NCT00332735|articaine|articaine
779337|NCT00332735|bupivacaine|bupivacaine
779338|NCT00332735|outpatient|outpatient
779339|NCT00332735|surgery|surgery
779340|NCT00332735|limbs|limbs
779341|NCT00332709|Breast cancer|breast cancer
779342|NCT00332709|postmenopausal|postmenopausal
779343|NCT00332709|bone mineral density|bone mineral density
779344|NCT00332709|Zoledronic acid|zoledronic acid
779345|NCT00332709|Letrozole|letrozole
779346|NCT00332709|extended adjuvant treatment.|extended adjuvant treatment.
779347|NCT00332709|Postmenopausal women with primary hormone receptor positive breast cancer|postmenopausal women with primary hormone receptor positive breast cancer
779348|NCT00332696|bowel obstruction,|bowel obstruction,
779349|NCT00332696|peritoneal carcinomatosis|peritoneal carcinomatosis
779350|NCT00332696|Octreotide|octreotide
779351|NCT00332696|inoperable|inoperable
779352|NCT00332683|Dysphagia|dysphagia
779353|NCT00332683|spine surgery|spine surgery
779354|NCT00332683|cuff pressure|cuff pressure
779355|NCT00332670|(Non-seasonal) Depression|(non-seasonal) depression
779356|NCT00332670|bright light therapy|bright light therapy
779357|NCT00332670|randomized controlled trial|randomized controlled trial
779358|NCT00332670|suprachiasmatic nucleus|suprachiasmatic nucleus
779359|NCT00332670|HPA-axis|hpa-axis
779360|NCT00332670|DHEA|dhea
779361|NCT00332670|melatonin|melatonin
779362|NCT00332670|actigraphy|actigraphy
779363|NCT00332670|elderly|elderly
779364|NCT00332670|self-efficacy|self-efficacy
779365|NCT00332670|social support|social support
779366|NCT00332631|Cardiac surgery,|cardiac surgery,
779367|NCT00332631|Cardiopulmonary bypass,|cardiopulmonary bypass,
779368|NCT00332631|Oxidative stress,|oxidative stress,
779369|NCT00332631|Acute renal dysfunction,|acute renal dysfunction,
779370|NCT00332631|N-acetylcysteine|n-acetylcysteine
779371|NCT00332618|MULTICENTER|multicenter
779372|NCT00332618|CONTROLLED|controlled
779373|NCT00332618|PARALLEL GROUPS|parallel groups
779374|NCT00332605|Methamphetamine Dependence|methamphetamine dependence
779375|NCT00332592|Necrotizing Enterocolitis|necrotizing enterocolitis
779376|NCT00332592|Intragastric microdialysis|intragastric microdialysis
779377|NCT00332592|Peritoneal microdialysis|peritoneal microdialysis
779378|NCT00332592|Infants|infants
779379|NCT00332579|Compulsive Shoplifting|compulsive shoplifting
779380|NCT00332579|Kleptomania|kleptomania
779381|NCT00332579|Compulsive Stealing|compulsive stealing
779382|NCT00332514|pharmacist intervention|pharmacist intervention
779383|NCT00332514|post-discharge telephone call|post-discharge telephone call
779384|NCT00332514|black hole|black hole
779385|NCT00332462|Liver transplantation, Cyclosporine|liver transplantation, cyclosporine
779386|NCT00332449|early breast feeding|early breast feeding
779387|NCT00332449|hypoglycemia|hypoglycemia
779388|NCT00332449|newborn|newborn
779389|NCT00332410|Voriconazole|voriconazole
779390|NCT00332410|renal transplant|renal transplant
779391|NCT00332410|kidney function|kidney function
779392|NCT00332410|kidneys|kidneys
779393|NCT00332371|Intensive Care|intensive care
779394|NCT00332371|Shock, Septic|shock, septic
779395|NCT00332371|Adsorption|adsorption
779396|NCT00332371|Sorption Detoxification|sorption detoxification
779397|NCT00332332|Phase IV|phase iv
779398|NCT00332332|Psoriasis|psoriasis
779399|NCT00332332|Inflammation|inflammation
779400|NCT00332319|spinal cord injury|spinal cord injury
779401|NCT00332319|urgency|urgency
779402|NCT00332319|Overactive bladder|overactive bladder
779403|NCT00332319|neurogenic|neurogenic
779404|NCT00332319|neurometry|neurometry
779405|NCT00332319|frequency|frequency
779406|NCT00332319|urge incontinence|urge incontinence
779407|NCT00332306|Once daily antiretroviral treatment|once daily antiretroviral treatment
779408|NCT00332306|Concomitant antituberculosis treatment|concomitant antituberculosis treatment
779409|NCT00332306|HIV Infections|hiv infections
779410|NCT00332280|solid tumors|solid tumors
779411|NCT00332280|clinical benefit|clinical benefit
779412|NCT00332280|quality of life|quality of life
779413|NCT00332280|esophageal cancer|esophageal cancer
779414|NCT00332280|colon cancer|colon cancer
779415|NCT00332280|pancreatic cancer|pancreatic cancer
779416|NCT00332280|gastric cancer|gastric cancer
779417|NCT00332280|liver cancer|liver cancer
779418|NCT00332280|gall bladder cancer|gall bladder cancer
779419|NCT00332280|prostate cancer|prostate cancer
779420|NCT00332280|gynecological cancer|gynecological cancer
779421|NCT00332280|lung cancer|lung cancer
779422|NCT00332280|Tumors of GI tract, prostate and gynaecological|tumors of gi tract, prostate and gynaecological
779423|NCT00332267|Sepsis|sepsis
779424|NCT00332267|Hypoxia|hypoxia
779425|NCT00332267|Altitude Sickness|altitude sickness
779426|NCT00332267|Endotoxin|endotoxin
779427|NCT00332267|Cytokines|cytokines
779428|NCT00332267|Cerebral blood flow|cerebral blood flow
779429|NCT00332267|Cerebral metabolism|cerebral metabolism
779430|NCT00332267|Reactive oxygen species|reactive oxygen species
779431|NCT00332254|Anterior cruciate ligament tear|anterior cruciate ligament tear
779432|NCT00332254|Meniscus tear|meniscus tear
779433|NCT00332254|Chondral injury|chondral injury
779434|NCT00332241|Serious behavioral problems in children and adolescents with AD|serious behavioral problems in children and adolescents with ad
779435|NCT00332241|Behavioral Problems|behavioral problems
779436|NCT00332228|opiate dependence|opiate dependence
779437|NCT00332228|heroin dependence|heroin dependence
779438|NCT00332228|naltrexone|naltrexone
779439|NCT00332228|cognitive behavioral therapy|cognitive behavioral therapy
779440|NCT00332215|Cystic Fibrosis|cystic fibrosis
779441|NCT00332215|Antioxidants|antioxidants
779442|NCT00332215|Inhalational therapy|inhalational therapy
779443|NCT00332215|Induced sputum|induced sputum
779444|NCT00332215|Airway inflammation|airway inflammation
779446|NCT00332176|Hepatitis C|hepatitis c
779447|NCT00332176|Celgosivir|celgosivir
779448|NCT00332176|HCV|hcv
779449|NCT00332176|Genotype 1|genotype 1
779450|NCT00332176|Treatment-naive|treatment-naive
779451|NCT00332176|Early viral kinetics|early viral kinetics
779452|NCT00332163|STEPP|stepp
779453|NCT00332163|STEP|step
779454|NCT00332163|STEEP|steep
779455|NCT00332163|mCRC|mcrc
779456|NCT00332163|Skin Toxicities|skin toxicities
779457|NCT00332163|Skin Rash|skin rash
779458|NCT00332163|Metastatic Colorectal Cancer|metastatic colorectal cancer
779459|NCT00332163|Anti-EGFr Skin Rash|anti-egfr skin rash
779460|NCT00332163|colon cancer|colon cancer
779461|NCT00332163|colorectal cancer|colorectal cancer
779462|NCT00332163|rectal cancer|rectal cancer
779463|NCT00332150|parents|parents
779464|NCT00332150|newborn|newborn
779465|NCT00332150|clinical trials|clinical trials
779466|NCT00332111|transplant|transplant
779467|NCT00332111|pancreas|pancreas
779468|NCT00332098|Childhood Mood Disorders|childhood mood disorders
779469|NCT00332098|Family Treatment|family treatment
779470|NCT00332098|Psychoeducation|psychoeducation
779471|NCT00332098|Pharmacotherapy|pharmacotherapy
779472|NCT00332098|Family Functioning|family functioning
779473|NCT00332098|Psychosocial Intervention|psychosocial intervention
779474|NCT00332046|fMRI placebo GW679769 Social Anxiety Disorder SAD|fmri placebo gw679769 social anxiety disorder sad
779475|NCT00332033|Fibroids|fibroids
779476|NCT00332033|Leiomyoma|leiomyoma
779477|NCT00332033|Pirfenidone|pirfenidone
779478|NCT00332033|Misoprostol|misoprostol
779479|NCT00332033|Non-Surgical|non-surgical
779480|NCT00332033|Collagen|collagen
779481|NCT00332033|Uterus|uterus
779482|NCT00332033|Uterine Fibroids|uterine fibroids
779483|NCT00332033|Uterine Leiomyoma|uterine leiomyoma
779484|NCT00331942|Breast|breast
779485|NCT00331942|Cancer|cancer
779486|NCT00331942|Associated|associated
779487|NCT00331942|Antibodies|antibodies
779488|NCT00331929|Asthma|asthma
779489|NCT00331929|Allergy|allergy
779490|NCT00331929|Respiratory|respiratory
779491|NCT00331929|Pollution|pollution
779492|NCT00331929|Children|children
779493|NCT00331929|Air pollution|air pollution
779494|NCT00331890|Neuroprotection|neuroprotection
779495|NCT00331890|Acute ischemic stroke|acute ischemic stroke
779496|NCT00331890|Cerebral infarction|cerebral infarction
779497|NCT00331877|family|family
779498|NCT00331877|end-of-life|end-of-life
779499|NCT00331877|intensive care unit|intensive care unit
779500|NCT00331864|AMD, ranibizumab|amd, ranibizumab
779501|NCT00331838|Prevention|prevention
779502|NCT00331838|Venous Thrombosis|venous thrombosis
779503|NCT00331838|Orthopedic Surgery|orthopedic surgery
779504|NCT00331825|Schizophrenia, EPS, risperidone, olanzapine|schizophrenia, eps, risperidone, olanzapine
779505|NCT00331812|Hypermetabolism|hypermetabolism
779506|NCT00331812|Mitochondrial abnormalities|mitochondrial abnormalities
779507|NCT00331812|Oxidant/antioxidant status|oxidant/antioxidant status
779508|NCT00331799|Depression|depression
779509|NCT00331799|Pharmacotherapy|pharmacotherapy
779510|NCT00331799|Duloxetine|duloxetine
779511|NCT00331786|colon cancer|colon cancer
779512|NCT00331786|rectal cancer|rectal cancer
779513|NCT00331773|adenocarcinoma of the prostate|adenocarcinoma of the prostate
779514|NCT00331773|stage IIB prostate cancer|stage iib prostate cancer
779515|NCT00331773|stage IIA prostate cancer|stage iia prostate cancer
779516|NCT00331760|stage I endometrial carcinoma|stage i endometrial carcinoma
779517|NCT00331760|stage II endometrial carcinoma|stage ii endometrial carcinoma
779518|NCT00331760|stage III endometrial carcinoma|stage iii endometrial carcinoma
779519|NCT00331760|endometrial adenoacanthoma|endometrial adenoacanthoma
779520|NCT00331760|endometrial adenocarcinoma|endometrial adenocarcinoma
779521|NCT00331760|endometrial adenosquamous cell carcinoma|endometrial adenosquamous cell carcinoma
779522|NCT00331760|stage IB cervical cancer|stage ib cervical cancer
779523|NCT00331760|stage IIA cervical cancer|stage iia cervical cancer
779524|NCT00331760|stage IIB cervical cancer|stage iib cervical cancer
779525|NCT00331760|cervical adenocarcinoma|cervical adenocarcinoma
779526|NCT00331760|cervical adenosquamous cell carcinoma|cervical adenosquamous cell carcinoma
779527|NCT00331760|cervical squamous cell carcinoma|cervical squamous cell carcinoma
779528|NCT00331721|Acute Ischemic Stroke|acute ischemic stroke
779529|NCT00331708|Malaria|malaria
779530|NCT00331708|Efficacy|efficacy
779531|NCT00331708|Pharmacokinetic|pharmacokinetic
779532|NCT00331708|Gametocyte|gametocyte
779533|NCT00331708|Molecular markers|molecular markers
779534|NCT00331708|Sulfadoxine-pyrimethamine|sulfadoxine-pyrimethamine
779535|NCT00331708|Artesunate|artesunate
779536|NCT00331708|Artemisinin|artemisinin
779537|NCT00331695|Progesterone|progesterone
779538|NCT00331695|Preterm delivery|preterm delivery
779539|NCT00331695|Preterm labor|preterm labor
779540|NCT00331695|Cervical length|cervical length
779541|NCT00331695|ultrasonography|ultrasonography
779542|NCT00331669|deep brain stimulation|deep brain stimulation
779543|NCT00331669|pallidum|pallidum
779544|NCT00331669|tardive dystonia|tardive dystonia
779545|NCT00331669|randomized|randomized
779546|NCT00331669|double blind|double blind
779547|NCT00331669|multicenter|multicenter
779548|NCT00331656|noninvasive|noninvasive
779549|NCT00331656|positive|positive
779550|NCT00331656|cuirass|cuirass
779551|NCT00331656|ventilation|ventilation
779552|NCT00331656|respiratory|respiratory
779553|NCT00331656|failure|failure
779554|NCT00331630|stage I breast cancer|stage i breast cancer
779555|NCT00331630|stage II breast cancer|stage ii breast cancer
779556|NCT00331630|stage IIIA breast cancer|stage iiia breast cancer
779557|NCT00331630|stage IIIB breast cancer|stage iiib breast cancer
779558|NCT00331630|stage IIIC breast cancer|stage iiic breast cancer
779559|NCT00331565|Bariatric surgery|bariatric surgery
779560|NCT00331565|Bioavailability|bioavailability
779561|NCT00331565|Bioequivalence|bioequivalence
779562|NCT00331565|Atorvastatin|atorvastatin
779563|NCT00331565|CYP's|cyp's
779564|NCT00331565|P-gp|p-gp
779565|NCT00331565|OATP|oatp
779566|NCT00331539|Cochlear implant|cochlear implant
779567|NCT00331539|threshold (T) measurement|threshold (t) measurement
779568|NCT00331539|comfort (C) level|comfort (c) level
779569|NCT00331539|profound hearing loss|profound hearing loss
779570|NCT00331539|auditory stimuli|auditory stimuli
779571|NCT00331539|profound hearing loss patients eligible for the study should be capable of providing reliable|profound hearing loss patients eligible for the study should be capable of providing reliable
779572|NCT00331539|subjective counted thresholds and has good NRT recordings, implanted with|subjective counted thresholds and has good nrt recordings, implanted with
779573|NCT00331539|the Nucleus Freedom system|the nucleus freedom system
779574|NCT00331526|adult glioblastoma|adult glioblastoma
779575|NCT00331526|adult gliosarcoma|adult gliosarcoma
779576|NCT00331526|adult giant cell glioblastoma|adult giant cell glioblastoma
779577|NCT00331487|Glucose Metabolism Disorder|glucose metabolism disorder
779578|NCT00331487|Dysmetabolic Syndrome|dysmetabolic syndrome
779579|NCT00331487|Type II Diabetes|type ii diabetes
779580|NCT00331487|Diabetes Mellitus|diabetes mellitus
779581|NCT00331487|Lipoatrophic|lipoatrophic
779582|NCT00331487|Dyslipidemia|dyslipidemia
779583|NCT00331487|Drug Therapy|drug therapy
779584|NCT00331474|BCG|bcg
779585|NCT00331474|HIV|hiv
779586|NCT00331474|Immune responses|immune responses
779587|NCT00331474|Delayed vaccination|delayed vaccination
779588|NCT00331474|Infant morbidity|infant morbidity
779589|NCT00331474|Nutritional status|nutritional status
779590|NCT00331474|Morbidity|morbidity
779591|NCT00331474|Mortality|mortality
779592|NCT00331448|Treatment Experienced|treatment experienced
779593|NCT00331448|Lipoatrophy|lipoatrophy
779594|NCT00331448|Lipohypertrophy|lipohypertrophy
779595|NCT00331448|Glucose|glucose
779596|NCT00331448|Cholesterol|cholesterol
779597|NCT00331448|Triglycerides|triglycerides
779598|NCT00331448|MRI|mri
779599|NCT00331448|DXA|dxa
779600|NCT00331448|Carotid IMT|carotid imt
779601|NCT00331448|LDL|ldl
779602|NCT00331448|HDL|hdl
779603|NCT00331435|AMD|amd
779604|NCT00331435|PCV|pcv
779605|NCT00331435|PDT|pdt
779606|NCT00331422|ovarian clear cell cystadenocarcinoma|ovarian clear cell cystadenocarcinoma
779607|NCT00331422|ovarian endometrioid adenocarcinoma|ovarian endometrioid adenocarcinoma
779608|NCT00331422|ovarian mixed epithelial carcinoma|ovarian mixed epithelial carcinoma
779609|NCT00331422|ovarian mucinous cystadenocarcinoma|ovarian mucinous cystadenocarcinoma
779610|NCT00331422|ovarian serous cystadenocarcinoma|ovarian serous cystadenocarcinoma
779611|NCT00331422|ovarian undifferentiated adenocarcinoma|ovarian undifferentiated adenocarcinoma
779612|NCT00331422|stage III ovarian epithelial cancer|stage iii ovarian epithelial cancer
779613|NCT00331422|stage IV ovarian epithelial cancer|stage iv ovarian epithelial cancer
779614|NCT00331422|peritoneal cavity cancer|peritoneal cavity cancer
779921|NCT00330200|HbA1c|hba1c
779615|NCT00331422|fallopian tube cancer|fallopian tube cancer
779616|NCT00331422|Brenner tumor|brenner tumor
779617|NCT00331409|stage III renal cell cancer|stage iii renal cell cancer
779618|NCT00331409|stage IV renal cell cancer|stage iv renal cell cancer
779619|NCT00331409|clear cell renal cell carcinoma|clear cell renal cell carcinoma
779620|NCT00331409|recurrent renal cell cancer|recurrent renal cell cancer
779744|NCT00330772|Transfusion|transfusion
779621|NCT00331357|acute idiopathic thrombocytopenic purpura|acute idiopathic thrombocytopenic purpura
779622|NCT00331357|paediatric|paediatric
779623|NCT00331357|quality of life|quality of life
779624|NCT00331331|Uveitis|uveitis
779625|NCT00331331|Intermediate Uveitis|intermediate uveitis
779626|NCT00331331|OCULAR INFLAMMATORY DISEASE|ocular inflammatory disease
779627|NCT00331331|Macular Edema|macular edema
779628|NCT00331331|Vasculitis|vasculitis
779629|NCT00331318|Transcranial Direct Current Stimulation (tDCS)|transcranial direct current stimulation (tdcs)
779630|NCT00331318|Transcranial Magnetic Stimulation (TMS)|transcranial magnetic stimulation (tms)
779631|NCT00331318|Motor Learning|motor learning
779632|NCT00331318|Brain Plasticity|brain plasticity
779633|NCT00331318|Healthy Volunteer|healthy volunteer
779635|NCT00331305|Exercise|exercise
779636|NCT00331292|Asthma bronchoscopy|asthma bronchoscopy
779637|NCT00331279|polycystic ovary syndrome|polycystic ovary syndrome
779638|NCT00331279|insulin resistance|insulin resistance
779639|NCT00331279|cinnamon|cinnamon
779640|NCT00331253|Indocyanine Green-Mediated Photothrombosis|indocyanine green-mediated photothrombosis
779641|NCT00331253|Neovascular|neovascular
779642|NCT00331253|Age-Related Macular Degeneration|age-related macular degeneration
779643|NCT00331227|flavonoids|flavonoids
779644|NCT00331227|food supplements|food supplements
779645|NCT00331227|endothelial function|endothelial function
779646|NCT00331227|no conditions allowed, healthy volunteers only|no conditions allowed, healthy volunteers only
779647|NCT00331214|Surgical menopause|surgical menopause
779648|NCT00331214|HSDD|hsdd
779649|NCT00331201|NEC|nec
779650|NCT00331188|Esophageal Variceal Bleeding|esophageal variceal bleeding
779651|NCT00331188|Portal Hypertension|portal hypertension
779652|NCT00331188|Hepatic Cirrhosis|hepatic cirrhosis
779653|NCT00331188|Cirrhosis|cirrhosis
779654|NCT00331188|Liver Cirrhosis|liver cirrhosis
779655|NCT00331188|Somatostatin Analog|somatostatin analog
779656|NCT00331188|Vapreotide|vapreotide
779657|NCT00331188|Acute Esophageal Variceal Bleeding|acute esophageal variceal bleeding
779658|NCT00331162|Renal Transplantation|renal transplantation
779659|NCT00331162|Pancreas Transplantation|pancreas transplantation
779660|NCT00331162|Graft Rejection|graft rejection
779661|NCT00331162|Immunosuppression|immunosuppression
779662|NCT00331162|Kidney failure, chronic|kidney failure, chronic
779663|NCT00331162|Diabetes Mellitus, Type 1|diabetes mellitus, type 1
779664|NCT00331162|Diabetes Mellitus, Type 2|diabetes mellitus, type 2
779665|NCT00331149|safety|safety
779666|NCT00331149|efficacy|efficacy
779667|NCT00331149|L-dopa|l-dopa
779668|NCT00331149|ropinirole PR|ropinirole pr
779669|NCT00331149|Parkinson's disease|parkinson's disease
779670|NCT00331149|ropinirole IR|ropinirole ir
779671|NCT00331149|adjunctive therapy|adjunctive therapy
779672|NCT00331149|superiority|superiority
779673|NCT00331149|REQUIP|requip
779674|NCT00331149|health outcomes|health outcomes
779675|NCT00331136|malaria|malaria
779676|NCT00331136|pyronaridine|pyronaridine
779677|NCT00331136|artesunate|artesunate
779678|NCT00331136|falciparum|falciparum
779679|NCT00331136|ACT|act
779680|NCT00331123|Surgical menopause|surgical menopause
779681|NCT00331123|HSDD|hsdd
779682|NCT00331097|elderly|elderly
779683|NCT00331097|adjuvant therapy|adjuvant therapy
779684|NCT00331097|intermediate risk|intermediate risk
779685|NCT00331097|high risk|high risk
779686|NCT00331084|prevention of post inflammation in cataract surgery|prevention of post inflammation in cataract surgery
779687|NCT00331071|Contraception|contraception
779688|NCT00331071|Hormonal contraception|hormonal contraception
779689|NCT00331071|Oral contraception|oral contraception
779690|NCT00331071|Ethinyl estradiol, Progestin, Contraception|ethinyl estradiol, progestin, contraception
779691|NCT00331071|Transdermal|transdermal
779692|NCT00331058|Severe Asthma bronchoscopy|severe asthma bronchoscopy
779693|NCT00331045|Opioids|opioids
779694|NCT00331045|cancer|cancer
779695|NCT00331045|constipation|constipation
779696|NCT00331032|VivaGel™, sexually transmitted, microbicide, herpes simplex|vivagel™, sexually transmitted, microbicide, herpes simplex
779697|NCT00331019|Streptococcus Group B|streptococcus group b
779698|NCT00331019|Pregnancy|pregnancy
779699|NCT00331006|Blood Coagulation Factor Inhibitors|blood coagulation factor inhibitors
779700|NCT00330993|mifepristone|mifepristone
779701|NCT00330993|misoprostol|misoprostol
779702|NCT00330993|medical abortion|medical abortion
779703|NCT00330993|buccal administration|buccal administration
779704|NCT00330980|Cognition|cognition
779705|NCT00330980|Statins|statins
779706|NCT00330980|Serotonin|serotonin
779707|NCT00330980|Cholesterol|cholesterol
779708|NCT00330967|Fat Emulsions, Intravenous|fat emulsions, intravenous
779709|NCT00330967|Free Fatty Acids|free fatty acids
779710|NCT00330967|Glucose Clamp Technique|glucose clamp technique
779711|NCT00330967|Inflammation|inflammation
779712|NCT00330967|Insulin Resistance|insulin resistance
779713|NCT00330967|Muscle, Skeletal|muscle, skeletal
779714|NCT00330967|NF-Kappa B|nf-kappa b
779715|NCT00330954|viral response genes|viral response genes
779716|NCT00330902|malaria|malaria
779717|NCT00330902|subpatent parasitaemia|subpatent parasitaemia
779718|NCT00330902|dry season|dry season
779719|NCT00330902|primaquine|primaquine
779720|NCT00330902|Plasmodium falciparum infection detected by PCR|plasmodium falciparum infection detected by pcr
779721|NCT00330889|Rheumatoid Arthritis|rheumatoid arthritis
779722|NCT00330876|pitavastatin|pitavastatin
779723|NCT00330876|hypercholesterolemia|hypercholesterolemia
779724|NCT00330876|combined dyslipidemia|combined dyslipidemia
779725|NCT00330863|Relapse|relapse
779726|NCT00330863|Prevention|prevention
779727|NCT00330863|Schizophrenia|schizophrenia
779728|NCT00330863|Injectable Medication|injectable medication
779729|NCT00330850|Migraine|migraine
779730|NCT00330850|Photophobia|photophobia
779731|NCT00330850|Phonophobia|phonophobia
779732|NCT00330850|Aura|aura
779733|NCT00330824|prevention of post inflammation in LASIK surgery|prevention of post inflammation in lasik surgery
779734|NCT00330811|Pediatrics|pediatrics
779735|NCT00330811|Non-cardiac Illness|non-cardiac illness
779736|NCT00330811|B-type Natriuretic Peptide (BNP)|b-type natriuretic peptide (bnp)
779737|NCT00330798|Photorefractive Keratectomy|photorefractive keratectomy
779738|NCT00330772|Cardiac Surger|cardiac surger
779739|NCT00330772|Coronary Artery Bypass Grafting|coronary artery bypass grafting
779740|NCT00330772|Graft patency|graft patency
779741|NCT00330772|Aspirin|aspirin
779742|NCT00330772|Clopidogrel|clopidogrel
779743|NCT00330772|Hemorrhage|hemorrhage
779745|NCT00330759|Bone metastases|bone metastases
779746|NCT00330759|lytic bone lesions|lytic bone lesions
779747|NCT00330759|advanced cancer|advanced cancer
779748|NCT00330759|multiple myeloma|multiple myeloma
779749|NCT00330759|lymphoma|lymphoma
779750|NCT00330759|solid tumors|solid tumors
779751|NCT00330759|skeletal related events|skeletal related events
779752|NCT00330759|skeletal fractures|skeletal fractures
779753|NCT00330759|spinal cord compressions, radiation to bone|spinal cord compressions, radiation to bone
779754|NCT00330759|surgery to bone, bisphosphonates|surgery to bone, bisphosphonates
779755|NCT00330759|denosumab|denosumab
779756|NCT00330746|elderly|elderly
779757|NCT00330746|chemotherapy|chemotherapy
779758|NCT00330746|targeted therapy|targeted therapy
779759|NCT00330746|combination therapy|combination therapy
779760|NCT00330746|sequential therapy|sequential therapy
779761|NCT00330746|randomized phase II|randomized phase ii
779762|NCT00330746|one year survival|one year survival
779763|NCT00330733|Cardiovascular Disease|cardiovascular disease
779764|NCT00330733|Inflammation|inflammation
779765|NCT00330733|Insulin Resistance|insulin resistance
779766|NCT00330733|Type 2 DM|type 2 dm
779767|NCT00330720|Personal Emergency Response System|personal emergency response system
779768|NCT00330720|Anxiety|anxiety
779769|NCT00330720|Fear of Falling|fear of falling
779770|NCT00330720|RCT|rct
779771|NCT00330707|bladder cancer|bladder cancer
779772|NCT00330707|BCG|bcg
779773|NCT00330707|interferon alpha|interferon alpha
779774|NCT00330694|Physical Therapy|physical therapy
779775|NCT00330694|Organisation of care|organisation of care
779776|NCT00330681|Amyotrophic lateral sclerosis|amyotrophic lateral sclerosis
779777|NCT00330681|free radical scavenger|free radical scavenger
779778|NCT00330668|Insulin-like Growth Factor Deficiency|insulin-like growth factor deficiency
779779|NCT00330668|IGF-1|igf-1
779780|NCT00330668|Short Stature|short stature
779781|NCT00330655|Binge eating|binge eating
779782|NCT00330655|Obesity|obesity
779783|NCT00330655|Eating disorder|eating disorder
779784|NCT00330642|Streptococcus Group B|streptococcus group b
779785|NCT00330642|Pregnancy|pregnancy
779786|NCT00330616|WELLBUTRIN|wellbutrin
779787|NCT00330616|elderly|elderly
779788|NCT00330616|depression|depression
779789|NCT00330616|Pharmacokinetics|pharmacokinetics
779790|NCT00330603|Cough|cough
779791|NCT00330603|Gastroesophageal Reflux|gastroesophageal reflux
779792|NCT00330590|Central Venous|central venous
779793|NCT00330590|Ultrasonography|ultrasonography
779794|NCT00330590|Catheterization|catheterization
779795|NCT00330564|VHL Syndrome|vhl syndrome
779796|NCT00330564|Von Hippel-Lindau Syndrome|von hippel-lindau syndrome
779797|NCT00330564|VHL Disease|vhl disease
779798|NCT00330564|Kidney|kidney
779799|NCT00330564|Retina|retina
779800|NCT00330564|Brain|brain
779801|NCT00330564|Spinal cord|spinal cord
779802|NCT00330564|Pancreas|pancreas
779803|NCT00330564|Inner ear|inner ear
779804|NCT00330564|Cysts|cysts
779805|NCT00330564|Tumors|tumors
779806|NCT00330564|Sunitinib Malate|sunitinib malate
779807|NCT00330564|SU011248|su011248
779808|NCT00330564|Sutent|sutent
779809|NCT00330564|VHL|vhl
779810|NCT00330564|Sunitinib|sunitinib
779811|NCT00330564|Renal cell carcinoma|renal cell carcinoma
779812|NCT00330564|Hemangioblastoma|hemangioblastoma
779813|NCT00330564|Endothelium|endothelium
779920|NCT00330200|Fasting plasma glucose|fasting plasma glucose
779814|NCT00330551|Schizoaffective Disorder, Depressed Type|schizoaffective disorder, depressed type
779815|NCT00330551|Schizophreniform Disorder|schizophreniform disorder
779816|NCT00330551|First-episode Schizophrenia|first-episode schizophrenia
779817|NCT00330551|Injectable Risperidone|injectable risperidone
779818|NCT00330538|Osteoporosis|osteoporosis
779819|NCT00330538|Childhood acute lymphoblastic leukemia|childhood acute lymphoblastic leukemia
779820|NCT00330512|regional anestesia|regional anestesia
779821|NCT00330512|cesarean section|cesarean section
779824|NCT00330499|Locally invasive|locally invasive
779825|NCT00330499|Bladder cancer|bladder cancer
779826|NCT00330499|Chemoradiotherapy|chemoradiotherapy
779827|NCT00330499|Efficacy|efficacy
779828|NCT00330499|Organ conservation|organ conservation
779829|NCT00330486|Acamprosate|acamprosate
779830|NCT00330486|Addiction|addiction
779831|NCT00330486|Alcoholism|alcoholism
779832|NCT00330486|Alcohol dependence|alcohol dependence
779833|NCT00330486|Bipolar disorder|bipolar disorder
779834|NCT00330486|Depression|depression
779835|NCT00330486|Impulsivity|impulsivity
779836|NCT00330486|Mania|mania
779837|NCT00330486|Substance abuse|substance abuse
779838|NCT00330460|Osteoporosis|osteoporosis
779839|NCT00330460|Osteopenia|osteopenia
779840|NCT00330460|AMG 162|amg 162
779841|NCT00330460|Fracture - hip|fracture - hip
779842|NCT00330460|Postmenopausal|postmenopausal
779843|NCT00330447|pregnancy|pregnancy
779844|NCT00330447|in utero|in utero
779845|NCT00330447|chemotherapy|chemotherapy
779846|NCT00330447|radiotherapy|radiotherapy
779847|NCT00330447|cancer|cancer
779848|NCT00330447|offspring|offspring
779849|NCT00330447|neonatal|neonatal
779850|NCT00330447|long term|long term
779851|NCT00330447|follow up|follow up
779852|NCT00330447|cancer during pregnancy|cancer during pregnancy
779853|NCT00330447|chemotherapy and radiotherapy during pregnancy|chemotherapy and radiotherapy during pregnancy
779854|NCT00330447|long term follow up of children|long term follow up of children
779855|NCT00330434|Alcohol|alcohol
779856|NCT00330434|Bupropion|bupropion
779857|NCT00330434|Chlorzoxazone|chlorzoxazone
779858|NCT00330434|Interaction|interaction
779859|NCT00330434|Induction|induction
779860|NCT00330434|Depression|depression
779861|NCT00330434|Smoking|smoking
779862|NCT00330434|Drinking|drinking
779863|NCT00330434|Cytochrome P450 Enzyme|cytochrome p450 enzyme
779864|NCT00330434|CYP2B6|cyp2b6
779865|NCT00330434|CYP2E1|cyp2e1
779866|NCT00330434|Pharmacogenetics|pharmacogenetics
779867|NCT00330434|Pharmacokinetics|pharmacokinetics
779868|NCT00330434|Pharmacodynamics|pharmacodynamics
779869|NCT00330434|Boston|boston
779870|NCT00330434|Tufts University|tufts university
779871|NCT00330408|Adherence|adherence
779872|NCT00330408|GP training|gp training
779873|NCT00330408|Medication Event Monitoring System(MEMS)|medication event monitoring system(mems)
779874|NCT00330408|Antihypertensive Medication|antihypertensive medication
779875|NCT00330408|Hypertension|hypertension
779876|NCT00330356|Dietary Salt|dietary salt
779877|NCT00330356|Blood Pressure|blood pressure
779878|NCT00330356|Normotensives|normotensives
779879|NCT00330343|morphine|morphine
779880|NCT00330343|naloxone|naloxone
779881|NCT00330343|pediatrics|pediatrics
779882|NCT00330343|adverse effects|adverse effects
779883|NCT00330343|pain|pain
779884|NCT00330330|Fasting plasma glucose|fasting plasma glucose
779885|NCT00330330|HbA1c|hba1c
779886|NCT00330317|Letrozole|letrozole
779887|NCT00330317|Breast Conserving Surgery|breast conserving surgery
779888|NCT00330317|NeoAdjuvant|neoadjuvant
779889|NCT00330317|Early Breast Cancer|early breast cancer
779890|NCT00330304|Tuberculosis|tuberculosis
779891|NCT00330304|Child|child
779892|NCT00330304|HIV|hiv
779893|NCT00330304|prophylaxis|prophylaxis
779894|NCT00330304|mortality|mortality
779895|NCT00330291|PTSD|ptsd
779896|NCT00330291|Xyrem|xyrem
779897|NCT00330291|Sleep problems|sleep problems
779898|NCT00330278|Cesarean section|cesarean section
779899|NCT00330278|Antibiotic prophylaxis|antibiotic prophylaxis
779900|NCT00330278|Cefazolin|cefazolin
779901|NCT00330252|Chronic Lymphocytic Leukemia|chronic lymphocytic leukemia
779902|NCT00330252|Relapsed Chronic Lymphocytic Leukemia|relapsed chronic lymphocytic leukemia
779903|NCT00330252|Alemtuzumab|alemtuzumab
779904|NCT00330252|Campath|campath
779905|NCT00330252|Rituximab|rituximab
779906|NCT00330252|Rituxan|rituxan
779907|NCT00330239|Substance Abuse|substance abuse
779908|NCT00330239|Trauma|trauma
779909|NCT00330239|Dependence|dependence
779910|NCT00330226|schizophrenia|schizophrenia
779911|NCT00330226|bipolar disorder|bipolar disorder
779912|NCT00330226|atypical antipsychotics|atypical antipsychotics
779913|NCT00330226|mood stabilizers|mood stabilizers
779914|NCT00330226|biological markers|biological markers
779915|NCT00330213|transthoracic|transthoracic
779916|NCT00330213|echocardiography|echocardiography
779917|NCT00330213|red wine|red wine
779918|NCT00330213|cognac|cognac
779919|NCT00330213|coronary reactivity|coronary reactivity
779922|NCT00330200|Metabolism|metabolism
779923|NCT00330187|nicotine dependence|nicotine dependence
779924|NCT00330187|bupropion SR|bupropion sr
779925|NCT00330187|smoking cessation|smoking cessation
779926|NCT00330187|adolescents|adolescents
779927|NCT00330187|contingency management|contingency management
779928|NCT00330174|Alcoholism|alcoholism
779929|NCT00330174|Mood|mood
779930|NCT00330174|Anxiety|anxiety
779931|NCT00330174|Acamprosate|acamprosate
779932|NCT00330148|trypanosomiasis|trypanosomiasis
779933|NCT00330148|gambiense|gambiense
779934|NCT00330148|combination drug therapy|combination drug therapy
779935|NCT00330148|sleeping sickness|sleeping sickness
779936|NCT00330148|Uganda|uganda
779937|NCT00330135|hip osteoarthritis|hip osteoarthritis
779938|NCT00330135|Hyaluronic acid|hyaluronic acid
779939|NCT00330135|Viscosupplementation|viscosupplementation
779940|NCT00330135|intra-articular injections|intra-articular injections
779941|NCT00330122|radius articular displaced fractures|radius articular displaced fractures
779942|NCT00330122|fore locked plate|fore locked plate
779943|NCT00330122|external radiocarpal fixer|external radiocarpal fixer
779944|NCT00330109|glioma|glioma
779945|NCT00330109|machine learning|machine learning
779946|NCT00330109|advanced diagnostic imaging|advanced diagnostic imaging
779947|NCT00330096|bone loss, osteoporosis, prevention, hesperidin|bone loss, osteoporosis, prevention, hesperidin
779948|NCT00330070|8-week treatment|8-week treatment
779949|NCT00330070|oral tablets|oral tablets
779950|NCT00330070|persistent moderate to severe asthma|persistent moderate to severe asthma
779951|NCT00330070|AQLQ|aqlq
779952|NCT00330070|asthma control|asthma control
779953|NCT00330070|quality of life|quality of life
779954|NCT00330018|BMT|bmt
779955|NCT00330018|CMV|cmv
779956|NCT00330018|GVHD|gvhd
779957|NCT00330005|psychotherapy|psychotherapy
779958|NCT00330005|bipolar disorder|bipolar disorder
779959|NCT00330005|psychodynamic|psychodynamic
779960|NCT00330005|psychoeducation|psychoeducation
779961|NCT00330005|illness management|illness management
779962|NCT00330005|controlled trial|controlled trial
779963|NCT00330005|pilot study|pilot study
779964|NCT00329979|aortic stenosis|aortic stenosis
779965|NCT00329979|radial|radial
779966|NCT00329979|femoral|femoral
779967|NCT00329979|vascular access site|vascular access site
779968|NCT00329979|embolism|embolism
779969|NCT00329979|cerebral|cerebral
779970|NCT00329979|MRI|mri
779971|NCT00329979|stroke|stroke
779972|NCT00329966|Influenza|influenza
779973|NCT00329966|adult|adult
779974|NCT00329966|elderly|elderly
779975|NCT00329966|vaccine|vaccine
779976|NCT00329940|Letrozole|letrozole
779977|NCT00329940|breast cancer|breast cancer
779978|NCT00329940|critical musculoskeletal|critical musculoskeletal
779979|NCT00329940|postmenopausal|postmenopausal
779980|NCT00329940|rheumatologic tolerance|rheumatologic tolerance
779981|NCT00329927|Adjuvanted Influenza Vaccine|adjuvanted influenza vaccine
779982|NCT00329914|Preterm delivery|preterm delivery
779983|NCT00329914|Prevention|prevention
779984|NCT00329914|Twins|twins
779985|NCT00329914|Progesterone|progesterone
779986|NCT00329901|Meningitis|meningitis
779987|NCT00329901|healthy subject|healthy subject
779988|NCT00329901|vaccine|vaccine
779989|NCT00329888|Endoscopic papillary balloon dilatation|endoscopic papillary balloon dilatation
779990|NCT00329888|Endoscopic sphincterotomy|endoscopic sphincterotomy
779991|NCT00329862|Laparoscopic Adjustable Gastric Banding|laparoscopic adjustable gastric banding
779992|NCT00329862|Truncal Vagotomy|truncal vagotomy
779993|NCT00329862|Lap Band|lap band
779994|NCT00329862|Lap Banding|lap banding
779995|NCT00329862|Obesity Surgery|obesity surgery
779996|NCT00329862|Bariatric surgery|bariatric surgery
779997|NCT00329862|Weight Loss Surgery|weight loss surgery
779998|NCT00329849|Meningitis|meningitis
779999|NCT00329849|children|children
780000|NCT00329849|vaccine|vaccine
780001|NCT00329849|safety|safety
780002|NCT00329849|efficacy|efficacy
780003|NCT00329823|Hidradenitis suppurativa, etanercept|hidradenitis suppurativa, etanercept
780004|NCT00329797|osteoporosis|osteoporosis
780005|NCT00329797|adenocarcinoma of the prostate|adenocarcinoma of the prostate
780006|NCT00329797|stage IIB prostate cancer|stage iib prostate cancer
780007|NCT00329797|stage IIA prostate cancer|stage iia prostate cancer
780008|NCT00329797|stage III prostate cancer|stage iii prostate cancer
780009|NCT00329797|stage IV prostate cancer|stage iv prostate cancer
780010|NCT00329784|peanut allergy|peanut allergy
780011|NCT00329784|egg allergy|egg allergy
780012|NCT00329784|eczema|eczema
780013|NCT00329784|peanut|peanut
780014|NCT00329784|allergy|allergy
780015|NCT00329784|allergies|allergies
780016|NCT00329784|allergic reaction|allergic reaction
780017|NCT00329784|anaphylaxis|anaphylaxis
780018|NCT00329784|infants|infants
780019|NCT00329784|children|children
780020|NCT00329758|moderate head injury|moderate head injury
780021|NCT00329758|rosuvastatin|rosuvastatin
780022|NCT00329758|statin|statin
780023|NCT00329758|amnesia|amnesia
780024|NCT00329758|orientation|orientation
780025|NCT00329745|Rotavirus Gastroenteritis|rotavirus gastroenteritis
780026|NCT00329745|Human rotavirus vaccine, efficacy, infants|human rotavirus vaccine, efficacy, infants
780027|NCT00329706|mild cognitive impairment|mild cognitive impairment
780028|NCT00329706|Alzheimer's disease|alzheimer's disease
780029|NCT00329706|dementia|dementia
780030|NCT00329706|FDG|fdg
780031|NCT00329706|PET|pet
780032|NCT00329680|Sepsis|sepsis
780033|NCT00329680|Severe Sepsis|severe sepsis
780034|NCT00329680|Septic Shock|septic shock
780035|NCT00329680|Enteral Nutrition|enteral nutrition
780036|NCT00329680|Antioxidants|antioxidants
780040|NCT00329680|Intensive Care|intensive care
780041|NCT00329680|ICU|icu
780042|NCT00329667|heart valve|heart valve
780043|NCT00329667|mitral|mitral
780044|NCT00329667|aortic|aortic
780045|NCT00329667|valvular disease|valvular disease
780046|NCT00329654|Burn wounds, light therapy|burn wounds, light therapy
780047|NCT00329628|Prevention|prevention
780048|NCT00329628|Thromboembolism|thromboembolism
780049|NCT00329615|Cancer cachexia|cancer cachexia
780050|NCT00329615|Tumor host metabolism|tumor host metabolism
780051|NCT00329602|Moderate|moderate
780052|NCT00329602|Restless Legs Syndrome|restless legs syndrome
780053|NCT00329602|Severe|severe
780054|NCT00329602|ropinirole|ropinirole
780055|NCT00329589|Malignancies of the central nervous system, head and neck area|malignancies of the central nervous system, head and neck area
780056|NCT00329589|and cervix|and cervix
780057|NCT00329563|Cardiac Arrest|cardiac arrest
780058|NCT00329563|Hypothermia|hypothermia
780059|NCT00329550|Certolizumab pegol|certolizumab pegol
780060|NCT00329550|Cimzia|cimzia
780061|NCT00329550|CZP|czp
780062|NCT00329537|Crohn's Disease|crohn's disease
780063|NCT00329537|Sargramostim|sargramostim
780064|NCT00329537|CDAI|cdai
780065|NCT00329537|Moderately to severely active Crohn's Disease|moderately to severely active crohn's disease
780066|NCT00329524|Tinnitus|tinnitus
780067|NCT00329524|TMS|tms
780068|NCT00329524|Transcranial Magnetic Stimulation|transcranial magnetic stimulation
780069|NCT00329511|pregnancy|pregnancy
780070|NCT00329511|hypertension|hypertension
780071|NCT00329511|compliance|compliance
780072|NCT00329511|clonidine patch|clonidine patch
780073|NCT00329511|methyldopa|methyldopa
780074|NCT00329498|ascorbic acid|ascorbic acid
780075|NCT00329485|Elevated BNP Levels in CHF patients|elevated bnp levels in chf patients
780076|NCT00329459|menstrual migraine|menstrual migraine
780077|NCT00329459|headache|headache
780078|NCT00329459|early intervention|early intervention
780079|NCT00329459|dysmenorrhea|dysmenorrhea
780080|NCT00329446|GAD|gad
780081|NCT00329446|anxiety|anxiety
780082|NCT00329433|Deep venous thrombosis|deep venous thrombosis
780083|NCT00329433|DVT|dvt
780084|NCT00329433|Heparin induced thrombocytopenia|heparin induced thrombocytopenia
780085|NCT00329433|HIT|hit
780086|NCT00329433|Direct thrombin inhibitor|direct thrombin inhibitor
780087|NCT00329420|Crohn's Disease|crohn's disease
780088|NCT00329420|CDP870|cdp870
780089|NCT00329420|Certolizumab pegol|certolizumab pegol
780090|NCT00329420|CZP|czp
780091|NCT00329407|Alcoholism|alcoholism
780092|NCT00329407|Heavy Drinking|heavy drinking
780093|NCT00329407|Alcohol Dependence|alcohol dependence
780094|NCT00329394|Ketamine|ketamine
780095|NCT00329394|Analgesia|analgesia
780096|NCT00329394|Alcool-dependent|alcool-dependent
780097|NCT00329394|carcinological surgery|carcinological surgery
780098|NCT00329381|Allergic|allergic
780099|NCT00329381|Asthma|asthma
780100|NCT00329381|Immunotherapy|immunotherapy
780101|NCT00329368|Cancer|cancer
780102|NCT00329368|Vaccine|vaccine
780103|NCT00329368|Phase I|phase i
780104|NCT00329368|FolateImmune|folateimmune
780105|NCT00329368|Recurrent|recurrent
780106|NCT00329368|Refractory|refractory
780107|NCT00329368|Experimental|experimental
780108|NCT00329355|menstrual migraine|menstrual migraine
780109|NCT00329355|headache|headache
780110|NCT00329355|early intervention|early intervention
780111|NCT00329355|dysmenorrhea|dysmenorrhea
780112|NCT00329342|Low back pain;|low back pain;
780113|NCT00329342|Return to work;|return to work;
780114|NCT00329342|Posture|posture
780115|NCT00329329|Advanced solid malignancies|advanced solid malignancies
780116|NCT00329316|Pre-term labor|pre-term labor
780117|NCT00329316|progesterone|progesterone
780118|NCT00329303|Moderate to severe chronic plaque psoriasis|moderate to severe chronic plaque psoriasis
780119|NCT00329303|anti TNF α|anti tnf α
780120|NCT00329303|CDP 870|cdp 870
780121|NCT00329303|Cimzia®|cimzia®
780122|NCT00329303|certolizumab pegol|certolizumab pegol
780123|NCT00329303|retreatment|retreatment
780124|NCT00329290|pregnancy|pregnancy
780125|NCT00329290|anticoagulation|anticoagulation
780126|NCT00329290|enoxaparin|enoxaparin
780127|NCT00329290|prosthetic heart valves|prosthetic heart valves
780128|NCT00329277|age-related macular degeneration|age-related macular degeneration
780129|NCT00329277|preferred retinal locus|preferred retinal locus
780130|NCT00329277|macular perimetry|macular perimetry
780131|NCT00329264|GAD|gad
780132|NCT00329264|anxiety|anxiety
780134|NCT00329251|Viral load|viral load
780135|NCT00329251|Vaccines|vaccines
780136|NCT00329251|Immunotherapy|immunotherapy
780137|NCT00329225|Type 2 Diabetes Mellitus Thiazolidinediones Insulin|type 2 diabetes mellitus thiazolidinediones insulin
780138|NCT00329212|Pharmacokinetics|pharmacokinetics
780139|NCT00329212|Bioavailability|bioavailability
780140|NCT00329212|Therapeutic Equivalency|therapeutic equivalency
780141|NCT00329199|Depression|depression
780142|NCT00329199|Adolescents|adolescents
780143|NCT00329199|Family Therapy|family therapy
780144|NCT00329199|Primary Care|primary care
780145|NCT00329199|Family Conflict|family conflict
780146|NCT00329186|Healthy Subjects|healthy subjects
780147|NCT00329186|Major Depressive Disorder|major depressive disorder
780148|NCT00329186|Depression|depression
780149|NCT00329186|Cytochrome P-450 CYP2D6|cytochrome p-450 cyp2d6
780150|NCT00329186|Pharmacokinetics|pharmacokinetics
780151|NCT00329186|Health|health
780152|NCT00329147|Healthy Subjects|healthy subjects
780153|NCT00329147|Major Depressive Disorder|major depressive disorder
780154|NCT00329147|Depression|depression
780155|NCT00329121|SCCIS|sccis
780156|NCT00329121|Bowens disease|bowens disease
780157|NCT00329121|PEP005|pep005
780158|NCT00329121|Topical|topical
780159|NCT00329121|Dermatology|dermatology
780160|NCT00329121|Cutaneous Squamous Cell Carcinoma in situ|cutaneous squamous cell carcinoma in situ
780161|NCT00329095|Glaucoma|glaucoma
780162|NCT00329095|Compliance|compliance
780163|NCT00329069|statin|statin
780164|NCT00329069|atorvastatin|atorvastatin
780165|NCT00329069|hypercholesterolemia|hypercholesterolemia
780166|NCT00329069|coronary artery disease|coronary artery disease
780167|NCT00329069|monocyte|monocyte
780168|NCT00329069|collateral formation|collateral formation
780169|NCT00329069|arteriogenesis|arteriogenesis
780170|NCT00329069|chemotaxis|chemotaxis
780171|NCT00329069|migration|migration
780172|NCT00329069|growth factors|growth factors
780173|NCT00329069|vascular endothelial growth factor A|vascular endothelial growth factor a
780174|NCT00329069|placenta growth factor 1|placenta growth factor 1
780175|NCT00329069|hepatocyte growth factor|hepatocyte growth factor
780176|NCT00329069|monocyte chemotactic protein 1|monocyte chemotactic protein 1
780177|NCT00329056|Parkinson's disease|parkinson's disease
780178|NCT00329056|MitoQ|mitoq
780179|NCT00329056|UPDRS|updrs
780180|NCT00329043|Prostate Cancer|prostate cancer
780181|NCT00329043|Adenocarcinoma of the Prostate|adenocarcinoma of the prostate
780182|NCT00329043|Ductal Adenocarcinoma of the Prostate|ductal adenocarcinoma of the prostate
780183|NCT00329043|Hormonal Ablation|hormonal ablation
780184|NCT00329043|Radical Prostatectomy|radical prostatectomy
780185|NCT00329043|LHRH Agonist|lhrh agonist
780186|NCT00329043|Lupron|lupron
780187|NCT00329043|Leuprolide|leuprolide
780188|NCT00329043|Sunitinib Malate|sunitinib malate
780189|NCT00329043|SU011248|su011248
780190|NCT00329030|Large B-Cell Lymphoma|large b-cell lymphoma
780191|NCT00329030|Non-Hodgkin's Lymphoma|non-hodgkin's lymphoma
780192|NCT00329017|SNPs|snps
780193|NCT00329017|single nucleotide polymorphism|single nucleotide polymorphism
780194|NCT00329017|breast atypia|breast atypia
780195|NCT00329017|breast epithelial hyperplasia|breast epithelial hyperplasia
780196|NCT00329017|high risk for breast cancer|high risk for breast cancer
780197|NCT00329004|Solid Tumors|solid tumors
780198|NCT00328991|wart|wart
780199|NCT00328991|common wart|common wart
780200|NCT00328991|verruca vulgaris|verruca vulgaris
780201|NCT00328991|verruca plantaris|verruca plantaris
780202|NCT00328991|plantar wart|plantar wart
780203|NCT00328991|duct tape|duct tape
780204|NCT00328991|occlusion therapy|occlusion therapy
780205|NCT00328978|schizophrenia|schizophrenia
780206|NCT00328978|schizoaffective disorders|schizoaffective disorders
780207|NCT00328965|Korean patients|korean patients
780208|NCT00328965|Type 2 diabetes|type 2 diabetes
780209|NCT00328965|Endothelial function|endothelial function
780210|NCT00328965|lacidipine|lacidipine
780211|NCT00328965|Essential hypertension|essential hypertension
780212|NCT00328952|schizophrenia|schizophrenia
780213|NCT00328952|auditory verbal hallucination|auditory verbal hallucination
780214|NCT00328952|antipsychotic treatment|antipsychotic treatment
780215|NCT00328939|ARIXTRA|arixtra
780216|NCT00328939|prevention of DVT|prevention of dvt
780217|NCT00328926|Hypogonadotropic Hypogonadism (LH <1.2 IU/L)|hypogonadotropic hypogonadism (lh <1.2 iu/l)
780218|NCT00328926|Placebo|placebo
780219|NCT00328926|Luveris® 75 IU|luveris® 75 iu
780220|NCT00328926|Luveris® 25 IU|luveris® 25 iu
780221|NCT00328926|Recombinant human chorionic gonadotropin (r-hCG)|recombinant human chorionic gonadotropin (r-hcg)
780222|NCT00328913|satiety|satiety
780223|NCT00328913|food intake|food intake
780224|NCT00328913|mood|mood
780225|NCT00328913|wellness|wellness
780226|NCT00328913|weight management|weight management
780227|NCT00328900|Galvanic skin response|galvanic skin response
780228|NCT00328900|Anesthesia|anesthesia
780229|NCT00328900|Atropine|atropine
780230|NCT00328887|Esophageal Neoplasms|esophageal neoplasms
780231|NCT00328874|Progressive Supranuclear Palsy|progressive supranuclear palsy
780232|NCT00328874|Coenzyme Q10|coenzyme q10
780233|NCT00328861|Adoptive Cell Therapy|adoptive cell therapy
780234|NCT00328861|Cutaneous Melanoma|cutaneous melanoma
780235|NCT00328861|Clinical Response|clinical response
780236|NCT00328861|Rate of Repopulation|rate of repopulation
780237|NCT00328861|Toxicity Profile|toxicity profile
780238|NCT00328861|Metastatic Melanoma|metastatic melanoma
780239|NCT00328861|Metastatic Kidney Cancer|metastatic kidney cancer
780240|NCT00328848|patient care management|patient care management
780241|NCT00328848|chronic disease|chronic disease
780242|NCT00328835|Optic Nerve|optic nerve
780243|NCT00328835|Glaucoma|glaucoma
780244|NCT00328822|Primary insomnia|primary insomnia
780245|NCT00328822|Quetiapine|quetiapine
780246|NCT00328822|Randomized controlled trial|randomized controlled trial
780247|NCT00328822|Double blind|double blind
780248|NCT00328796|Perineal|perineal
780249|NCT00328796|repair|repair
780250|NCT00328796|episiotomies|episiotomies
780251|NCT00328796|midwives|midwives
780252|NCT00328796|pain relief|pain relief
780253|NCT00328796|Episiotomy|episiotomy
780254|NCT00328783|Breast cancer|breast cancer
780255|NCT00328783|Active Breathing Control|active breathing control
780256|NCT00328783|Active Breathing Coordinator|active breathing coordinator
780257|NCT00328783|ABC|abc
780258|NCT00328770|liver transplant|liver transplant
780259|NCT00328770|hepatocellular carcinoma|hepatocellular carcinoma
780260|NCT00328770|sirolimus|sirolimus
780261|NCT00328757|gynecologic cancer|gynecologic cancer
780262|NCT00328757|cervical cancer|cervical cancer
780263|NCT00328757|ovarian cancer|ovarian cancer
780264|NCT00328757|endometrial cancer|endometrial cancer
780265|NCT00328757|radical abdominal hysterectomy|radical abdominal hysterectomy
780266|NCT00328757|pelvic lymphadenectomy|pelvic lymphadenectomy
780267|NCT00328757|surgical staging|surgical staging
780268|NCT00328757|postoperative feeding|postoperative feeding
780269|NCT00328757|Early-stage gynecologic cancer patients|early-stage gynecologic cancer patients
780270|NCT00328744|Weight|weight
780271|NCT00328744|Dietary intake|dietary intake
780272|NCT00328744|Energy|energy
780273|NCT00328744|Hedonics|hedonics
780274|NCT00328744|Behavioral|behavioral
780275|NCT00328744|Sensory-specific satiety|sensory-specific satiety
780276|NCT00328744|Monotony|monotony
780277|NCT00328731|Allergy|allergy
780278|NCT00328731|NAET|naet
780279|NCT00328718|Persistent Asthma|persistent asthma
780280|NCT00328718|pediatric asthmatic|pediatric asthmatic
780281|NCT00328718|asthma control|asthma control
780282|NCT00328705|Sensing|sensing
780283|NCT00328705|Capture Management|capture management
780284|NCT00328705|Heart Failure|heart failure
780285|NCT00328705|ICD Indication|icd indication
780286|NCT00328692|heart failure|heart failure
780287|NCT00328692|diuretic|diuretic
780288|NCT00328692|renal impairment|renal impairment
780289|NCT00328692|renal function|renal function
780290|NCT00328679|abdominal|abdominal
780291|NCT00328679|stomach|stomach
780292|NCT00328679|dyspepsia|dyspepsia
780293|NCT00328679|food allergy|food allergy
780294|NCT00328653|vernal keratoconjunctivitis (VKC), eye, allergy, cyclosporin|vernal keratoconjunctivitis (vkc), eye, allergy, cyclosporin
780296|NCT00328640|Ischemic stroke|ischemic stroke
780297|NCT00328627|Diabetes Mellitus, Type 2|diabetes mellitus, type 2
780298|NCT00328627|Drug Therapy|drug therapy
780299|NCT00328627|Diabetes Mellitus, Non Insulin Dependent|diabetes mellitus, non insulin dependent
780300|NCT00328627|Glucose Intolerance|glucose intolerance
780301|NCT00328627|Hyperglycemia|hyperglycemia
780302|NCT00328614|Locally advanced prostate cancer|locally advanced prostate cancer
780303|NCT00328614|positive lymph nodes|positive lymph nodes
780304|NCT00328588|Treatment Efficacy|treatment efficacy
780305|NCT00328588|Treatment Effectiveness|treatment effectiveness
780306|NCT00328588|Disease Management|disease management
780307|NCT00328588|Treatment|treatment
780308|NCT00328588|Safety|safety
780309|NCT00328575|Brain metastases|brain metastases
780310|NCT00328575|Parenchymal|parenchymal
780311|NCT00328575|Neoplasm|neoplasm
780312|NCT00328575|IMRT|imrt
780313|NCT00328575|Intensity Modulated Radiation Therapy|intensity modulated radiation therapy
780314|NCT00328562|Advanced NSCLC|advanced nsclc
780315|NCT00328562|Non-Small Cell Lung Carcinoma|non-small cell lung carcinoma
780316|NCT00328562|Stage IV NSCLC|stage iv nsclc
780317|NCT00328549|Natural History,|natural history,
780318|NCT00328549|Hepatitis C Infection|hepatitis c infection
780319|NCT00328549|Ribavirin|ribavirin
780320|NCT00328549|Pegylated Interferon|pegylated interferon
780321|NCT00328549|Interferon|interferon
780322|NCT00328536|flow-mediated vasodilatation|flow-mediated vasodilatation
780323|NCT00328536|endothelial dysfunction|endothelial dysfunction
780324|NCT00328536|omega-3 fatty acids|omega-3 fatty acids
780325|NCT00328536|type 2 diabetes mellitus|type 2 diabetes mellitus
780326|NCT00328536|postprandial state|postprandial state
780327|NCT00328510|Stereotactic radiotherapy|stereotactic radiotherapy
780328|NCT00328484|COPD|copd
780329|NCT00328484|Chronic Obstructive Pulmonary Disease|chronic obstructive pulmonary disease
780330|NCT00328484|Exercise|exercise
780331|NCT00328484|Emphysema|emphysema
780332|NCT00328484|Chronic Bronchitis|chronic bronchitis
780333|NCT00328471|patient care management|patient care management
780334|NCT00328471|cerebrovascular accident|cerebrovascular accident
780335|NCT00328458|CNS and head and neck cancers|cns and head and neck cancers
780336|NCT00328458|Histologically confirmed CNS malignancy head and neck|histologically confirmed cns malignancy head and neck
780337|NCT00328458|there is on standard therapy or|there is on standard therapy or
780338|NCT00328458|have failed standard therapy|have failed standard therapy
780339|NCT00328445|Curriculum|curriculum
780340|NCT00328445|Classroom management|classroom management
780341|NCT00328445|School-wide climate|school-wide climate
780342|NCT00328445|Parent involvement|parent involvement
780343|NCT00328432|early breast cancer|early breast cancer
780344|NCT00328432|double-blind randomized placebo-controlled|double-blind randomized placebo-controlled
780345|NCT00328432|RCT|rct
780346|NCT00328432|pre-surgical model|pre-surgical model
780347|NCT00328432|DCIS model|dcis model
780348|NCT00328432|COX-2 inhibitor|cox-2 inhibitor
780349|NCT00328432|celecoxib|celecoxib
780350|NCT00328432|Ki-67 placebo|ki-67 placebo
780351|NCT00328419|Photoprotection,|photoprotection,
780352|NCT00328419|Parenteral nutrition|parenteral nutrition
780353|NCT00328419|Oxidant stress|oxidant stress
780354|NCT00328419|Infant, Premature|infant, premature
780355|NCT00328393|Hypertension|hypertension
780356|NCT00328380|Travelers' Diarrhea|travelers' diarrhea
780357|NCT00328380|Xifaxan|xifaxan
780358|NCT00328380|Rifaximin|rifaximin
780359|NCT00328380|Escherichia coli|escherichia coli
780360|NCT00328380|E coli|e coli
780361|NCT00328380|EAEC|eaec
780362|NCT00328380|Enteroaggregative E coli|enteroaggregative e coli
780363|NCT00328380|ETEC|etec
780364|NCT00328380|Enterotoxigenic E coli|enterotoxigenic e coli
780365|NCT00328367|schizophrenia|schizophrenia
780366|NCT00328367|aripiprazole|aripiprazole
780367|NCT00328367|clozapine|clozapine
780368|NCT00328341|traumatic brain injury|traumatic brain injury
780369|NCT00328341|hemorrhagic shock|hemorrhagic shock
780370|NCT00328341|multisystem trauma|multisystem trauma
780371|NCT00328341|under resuscitation|under resuscitation
780372|NCT00328341|tissue oxygen monitoring|tissue oxygen monitoring
780373|NCT00328315|Myocardial Perfusion SPECT|myocardial perfusion spect
780374|NCT00328302|Diabetes|diabetes
780375|NCT00328302|Kidney function|kidney function
780376|NCT00328302|24 ambulatory blood pressure|24 ambulatory blood pressure
780377|NCT00328302|Kidney biopsy|kidney biopsy
780378|NCT00328289|Dialysis associated hypotension|dialysis associated hypotension
780379|NCT00328289|Urea removal|urea removal
780380|NCT00328263|Bio-K+CL1285|bio-k+cl1285
780381|NCT00328263|Probiotics|probiotics
780382|NCT00328263|Antibiotics-associated diarrhea|antibiotics-associated diarrhea
780383|NCT00328263|Clostridium difficile-associated diarrhea|clostridium difficile-associated diarrhea
780384|NCT00328263|Lactobacillus acidophilus|lactobacillus acidophilus
780385|NCT00328263|Clostridium Difficile|clostridium difficile
780386|NCT00328250|Internet|internet
780387|NCT00328250|CBT|cbt
780388|NCT00328250|Insomnia|insomnia
780389|NCT00328250|Sleep|sleep
780390|NCT00328237|Cord Blood Transplant|cord blood transplant
780391|NCT00328237|Umbilical cord blood transplant|umbilical cord blood transplant
780392|NCT00328237|Transplant|transplant
780393|NCT00328237|Fludarabine|fludarabine
780394|NCT00328237|Total Body Irradiation|total body irradiation
780395|NCT00328237|Cyclophosphamide|cyclophosphamide
780396|NCT00328224|ritalin|ritalin
780397|NCT00328224|ADHA|adha
780398|NCT00328224|dental status|dental status
780399|NCT00328224|periodontal status|periodontal status
780400|NCT00328224|Attention-Deficit Hyperactivity Disorder|attention-deficit hyperactivity disorder
780401|NCT00328224|Dental trauma|dental trauma
780402|NCT00328198|CAMPATH|campath
780403|NCT00328198|Alemtuzumab|alemtuzumab
780404|NCT00328198|Leukemia|leukemia
780405|NCT00328198|MabCampath|mabcampath
780406|NCT00328198|Chronic|chronic
780407|NCT00328198|Subcutaneous|subcutaneous
780408|NCT00328198|CLL|cll
780409|NCT00328198|C-CLL|c-cll
780410|NCT00328198|Relapsed|relapsed
780411|NCT00328198|Refractory|refractory
780412|NCT00328198|Chronic Lymphocytic Leukemia|chronic lymphocytic leukemia
780413|NCT00328185|pediatric|pediatric
780414|NCT00328185|heart disease|heart disease
780415|NCT00328185|orthotopic heart transplantation|orthotopic heart transplantation
780416|NCT00328185|allograft fibrosis|allograft fibrosis
780417|NCT00328159|FAO disorders|fao disorders
780418|NCT00328159|long-chain FAO enzyme defects|long-chain fao enzyme defects
780419|NCT00328159|inborn errors of metabolism|inborn errors of metabolism
780420|NCT00328159|carnitine palmitoyltransferase 1 (CPT1),|carnitine palmitoyltransferase 1 (cpt1),
780421|NCT00328159|carnitine-acylcarnitine translocase (CAT),|carnitine-acylcarnitine translocase (cat),
780422|NCT00328159|carnitine palmitoyltransferase 2 (CPT2),|carnitine palmitoyltransferase 2 (cpt2),
780423|NCT00328159|very-long chain acyl-CoA dehydrogenase (VLCAD),|very-long chain acyl-coa dehydrogenase (vlcad),
780424|NCT00328159|L-3-hydroxy-acyl-CoA dehydrogenase (LCHAD)|l-3-hydroxy-acyl-coa dehydrogenase (lchad)
780425|NCT00328159|or trifunctional protein (MTP).|or trifunctional protein (mtp).
780426|NCT00328146|pediatric|pediatric
780427|NCT00328146|cardiac|cardiac
780428|NCT00328146|re-operative surgery|re-operative surgery
780429|NCT00328133|recombinant Factor VIIa|recombinant factor viia
780430|NCT00328133|traumatic hemorrhage|traumatic hemorrhage
780431|NCT00328133|hemorrhagic shock|hemorrhagic shock
780432|NCT00328133|coagulopathy|coagulopathy
780433|NCT00328120|Advanced breast cancer|advanced breast cancer
780434|NCT00328120|Faslodex|faslodex
780435|NCT00328107|Influenza|influenza
780436|NCT00328094|Tight|tight
780437|NCT00328094|Glycemic|glycemic
780438|NCT00328094|control|control
780439|NCT00328094|outcomes|outcomes
780440|NCT00328094|peripheral vascular disease|peripheral vascular disease
780441|NCT00328094|infection|infection
780442|NCT00328094|cardiovascular|cardiovascular
780443|NCT00328094|morbidity|morbidity
780444|NCT00328094|mortality|mortality
780445|NCT00328081|Obesity|obesity
780446|NCT00328081|Weight gain|weight gain
780447|NCT00328081|Anti-obesity medication|anti-obesity medication
780448|NCT00328081|Anti-obesity management strategies|anti-obesity management strategies
780449|NCT00328081|Body Weight|body weight
780450|NCT00328068|ASAS classification|asas classification
780451|NCT00328068|ASAS diagnostic criteria|asas diagnostic criteria
780452|NCT00328068|spondyloarthritis|spondyloarthritis
780453|NCT00328068|spondyloarthropathy|spondyloarthropathy
780454|NCT00328068|spondylitis, ankylosing|spondylitis, ankylosing
780455|NCT00328068|modified New York criteria for AS|modified new york criteria for as
780456|NCT00328068|ESSG criteria for SpA|essg criteria for spa
780457|NCT00328068|Amor criteria for SpA|amor criteria for spa
780458|NCT00328068|arthritis|arthritis
780459|NCT00328068|enthesitis|enthesitis
780460|NCT00328068|magnetic resonance imaging|magnetic resonance imaging
780461|NCT00328055|functional ability|functional ability
780462|NCT00328055|patient care management|patient care management
780463|NCT00328055|communication|communication
780464|NCT00328055|literacy|literacy
780465|NCT00328042|Self-care|self-care
780466|NCT00328042|Quality of Life|quality of life
780467|NCT00328042|Chronic disease|chronic disease
780468|NCT00328029|Busulfan|busulfan
780469|NCT00328029|pharmacokinetic|pharmacokinetic
780470|NCT00328029|respiratory function assessment|respiratory function assessment
780471|NCT00328029|Busulfan pharmacokinetic and respiratory function tests|busulfan pharmacokinetic and respiratory function tests
780472|NCT00328016|hypertension|hypertension
780473|NCT00328016|high blood pressure|high blood pressure
780474|NCT00328016|meditation|meditation
780475|NCT00327990|ibandronate|ibandronate
780476|NCT00327990|osteoporosis|osteoporosis
780477|NCT00327990|preference|preference
780478|NCT00327990|case-finding|case-finding
780479|NCT00327990|post-menopausal|post-menopausal
780480|NCT00327990|alendronate|alendronate
780481|NCT00327977|hypoxemia|hypoxemia
780482|NCT00327977|palliative neonatal surgery|palliative neonatal surgery
780483|NCT00327964|malaria|malaria
780484|NCT00327964|fever|fever
780485|NCT00327964|Uganda|uganda
780486|NCT00327964|children|children
780487|NCT00327964|rapid diagnostic tests|rapid diagnostic tests
780488|NCT00327964|RDTs|rdts
780489|NCT00327964|Africa|africa
780490|NCT00327951|pediatric|pediatric
780491|NCT00327951|cardiac|cardiac
780492|NCT00327951|weight gain pre-operative|weight gain pre-operative
780493|NCT00327951|trisomy 21|trisomy 21
780494|NCT00327951|complete atrioventricular canal|complete atrioventricular canal
780495|NCT00327938|Remifentanil|remifentanil
780496|NCT00327938|Skin Conductance|skin conductance
780497|NCT00327938|Anesthesia|anesthesia
780498|NCT00327938|Analgesics, Opioid|analgesics, opioid
780499|NCT00327925|Ovarian|ovarian
780500|NCT00327925|Cancer|cancer
780501|NCT00327925|Antibodies|antibodies
780502|NCT00327925|Ovarian Cancer Associated Antibodies|ovarian cancer associated antibodies
780503|NCT00327912|Obesity|obesity
780504|NCT00327912|Surgery|surgery
780505|NCT00327912|Gastric bypass|gastric bypass
780506|NCT00327912|Biliopancreatic diversion with Duodenal switch|biliopancreatic diversion with duodenal switch
780507|NCT00327912|Laparoscopy|laparoscopy
780508|NCT00327899|pediatric|pediatric
780509|NCT00327899|congestive heart failure|congestive heart failure
780510|NCT00327899|inotropes|inotropes
780511|NCT00327886|pediatric|pediatric
780512|NCT00327886|Glenn operation|glenn operation
780513|NCT00327886|Cyanosis|cyanosis
780514|NCT00327873|breathlessness|breathlessness
780515|NCT00327873|shortness of breath|shortness of breath
780516|NCT00327873|end-of-life care|end-of-life care
780517|NCT00327873|hospice|hospice
780518|NCT00327808|Smokers|smokers
780519|NCT00327808|Adults|adults
780520|NCT00327808|Inflammatory markers|inflammatory markers
780521|NCT00327795|congenital heart disease|congenital heart disease
780522|NCT00327795|pediatric|pediatric
780523|NCT00327795|surgical outcomes|surgical outcomes
780524|NCT00327782|pediatric|pediatric
780525|NCT00327782|palliative care|palliative care
780526|NCT00327782|end stage heart failure|end stage heart failure
780527|NCT00327769|Advanced breast cancer|advanced breast cancer
780528|NCT00327769|fulvestrant|fulvestrant
780529|NCT00327769|anastrozole|anastrozole
780530|NCT00327756|Depression|depression
780531|NCT00327756|Magnetic Resonance Spectroscopy|magnetic resonance spectroscopy
780532|NCT00327756|Mitochondrial Enhancer|mitochondrial enhancer
780533|NCT00327756|Manic Depressive|manic depressive
780534|NCT00327756|Bioenergetics|bioenergetics
780535|NCT00327756|Bipolar Disorder|bipolar disorder
780536|NCT00327756|Manic Depression|manic depression
780537|NCT00327743|Cancer Alternative Therapies|cancer alternative therapies
780538|NCT00327743|Metastatic Breast Cancer|metastatic breast cancer
780539|NCT00327730|Muscle|muscle
780540|NCT00327730|Spasm|spasm
780541|NCT00327730|Back|back
780542|NCT00327730|Pain|pain
780543|NCT00327717|Epilepsy|epilepsy
780544|NCT00327717|Partial seizures|partial seizures
780545|NCT00327704|Septic Shock|septic shock
780546|NCT00327691|Major cardiovascular event|major cardiovascular event
780547|NCT00327691|Major Coronary event|major coronary event
780548|NCT00327691|Revascularization|revascularization
780549|NCT00327678|ALL,|all,
780550|NCT00327678|young patients,|young patients,
780551|NCT00327678|chemotherapy,|chemotherapy,
780552|NCT00327678|Mabtera,|mabtera,
780553|NCT00327678|Imatinib,|imatinib,
780554|NCT00327678|allogeneic transplant|allogeneic transplant
780555|NCT00327665|pneumonia|pneumonia
780556|NCT00327665|pneumococcal vaccine|pneumococcal vaccine
780557|NCT00327665|elderly subjects|elderly subjects
780558|NCT00327665|invasive pneumococcal diseases|invasive pneumococcal diseases
780559|NCT00327665|Prophylaxis|prophylaxis
780560|NCT00327652|carcinoma|carcinoma
780561|NCT00327652|liver|liver
780562|NCT00327652|hepatic|hepatic
780563|NCT00327652|metastasis|metastasis
780564|NCT00327652|Listeria|listeria
780565|NCT00327626|Fasting plasma glucose|fasting plasma glucose
780566|NCT00327626|HbA1c|hba1c
780567|NCT00327626|Oral antidiabetic agent(s)|oral antidiabetic agent(s)
780568|NCT00327613|PEX|pex
780569|NCT00327613|glaucoma|glaucoma
780570|NCT00327613|MMP|mmp
780571|NCT00327613|DNA degradation|dna degradation
780572|NCT00327613|POAG|poag
780573|NCT00327613|Healthy subjects|healthy subjects
780574|NCT00327587|hypertension|hypertension
780575|NCT00327587|valsartan|valsartan
780576|NCT00327587|amlodipine|amlodipine
780577|NCT00327587|HCTZ|hctz
780578|NCT00327561|Inflammation|inflammation
780579|NCT00327561|Periodontitis|periodontitis
780580|NCT00327561|Endothelial function|endothelial function
780581|NCT00327561|Atherosclerosis|atherosclerosis
780582|NCT00327561|Controlled trial|controlled trial
780583|NCT00327509|mRNA|mrna
780584|NCT00327509|glaucoma|glaucoma
780585|NCT00327483|Transplant|transplant
780586|NCT00327483|Medication error|medication error
780587|NCT00327483|Patient Safety|patient safety
780588|NCT00327483|Information technology|information technology
780589|NCT00327470|neovascular age related macular degeneration|neovascular age related macular degeneration
780590|NCT00327470|choroidal neovascularization|choroidal neovascularization
780591|NCT00327457|colorectal cancer screening|colorectal cancer screening
780592|NCT00327457|sigmoidoscopy|sigmoidoscopy
780593|NCT00327457|colonoscopy|colonoscopy
780594|NCT00327444|Ovarian neoplasm|ovarian neoplasm
780595|NCT00327444|Ascites|ascites
780596|NCT00327444|Angiogenesis inhibitor|angiogenesis inhibitor
780597|NCT00327444|Vascular Endothelial Growth Factor A|vascular endothelial growth factor a
780598|NCT00327444|Recombinant fusion protein|recombinant fusion protein
780599|NCT00327431|Hypertension|hypertension
780600|NCT00327431|Blood Pressure|blood pressure
780601|NCT00327431|Psychosocial Factors|psychosocial factors
780602|NCT00327405|POAG|poag
780603|NCT00327405|Primary Open Angle Glaucoma|primary open angle glaucoma
780604|NCT00327405|Trabeculectomy|trabeculectomy
780605|NCT00327405|Combined Phacotrabeculectomy|combined phacotrabeculectomy
780606|NCT00327405|Combined Glaucoma Cataract Surgery|combined glaucoma cataract surgery
780607|NCT00327405|Releasable Suture|releasable suture
780608|NCT00327405|Ocular Compresssion|ocular compresssion
780609|NCT00327392|Arthroscopy|arthroscopy
780610|NCT00327392|AV Shunt|av shunt
780611|NCT00327392|Bunion|bunion
780612|NCT00327392|Dilatation and Curettage|dilatation and curettage
780613|NCT00327392|Esophagogastroduodenoscopy|esophagogastroduodenoscopy
780614|NCT00327392|Hysteroscopy|hysteroscopy
780615|NCT00327392|Lithotripsy|lithotripsy
780616|NCT00327392|Rotator Cuff/ Shoulder|rotator cuff/ shoulder
780617|NCT00327392|Transesophageal Echocardiography|transesophageal echocardiography
780618|NCT00327392|Ureteroscopy|ureteroscopy
780619|NCT00327392|AQUAVAN|aquavan
780620|NCT00327392|Sedation|sedation
780621|NCT00327379|Bloodloss|bloodloss
780622|NCT00327379|Transfusion Requirements in Patients Undergoing Elective Spinal Fusion Surgery|transfusion requirements in patients undergoing elective spinal fusion surgery
780623|NCT00327366|Menstrual Cycle|menstrual cycle
780624|NCT00327366|Light Therapy|light therapy
780625|NCT00327366|Sex Hormones|sex hormones
780626|NCT00327366|Ovulation|ovulation
780627|NCT00327353|Asthma|asthma
780628|NCT00327353|Salmeterol|salmeterol
780629|NCT00327353|Formoterol|formoterol
780630|NCT00327353|Airway resistance|airway resistance
780732|NCT00326989|Cell therapy|cell therapy
780631|NCT00327340|Metastatic hormone refractory prostate cancer (HRPC)|metastatic hormone refractory prostate cancer (hrpc)
780632|NCT00327301|POAG|poag
780633|NCT00327301|Parkinson's disease|parkinson's disease
780634|NCT00327301|cellular proteome|cellular proteome
780635|NCT00327301|human leucocytes|human leucocytes
780636|NCT00327301|vasospasm|vasospasm
780637|NCT00327301|POAG patients|poag patients
780638|NCT00327301|Patients with Parkinson's disease|patients with parkinson's disease
780639|NCT00327301|Healthy subjects|healthy subjects
780640|NCT00327288|Hormone refractory prostate cancer|hormone refractory prostate cancer
780641|NCT00327262|chronic myeloid leukemia|chronic myeloid leukemia
780642|NCT00327262|Ph+|ph+
780643|NCT00327262|bcr/abl+|bcr/abl+
780645|NCT00327236|Paraneoplastic Neurologic Syndromes|paraneoplastic neurologic syndromes
780646|NCT00327223|Metastatic cancer|metastatic cancer
780647|NCT00327223|Disseminated malignant disease|disseminated malignant disease
780648|NCT00327210|BGAT|bgat
780649|NCT00327210|Blood Glucose Awareness Training|blood glucose awareness training
780650|NCT00327210|Diabetes|diabetes
780651|NCT00327210|T1DM|t1dm
780652|NCT00327210|Internet|internet
780653|NCT00327210|Web|web
780654|NCT00327210|Intervention|intervention
780655|NCT00327210|Treatment|treatment
780656|NCT00327210|Behavior|behavior
780657|NCT00327210|Education|education
780658|NCT00327210|Awareness|awareness
780659|NCT00327197|bronchoscopy|bronchoscopy
780660|NCT00327197|Sputum induction|sputum induction
780661|NCT00327197|Prednisolone|prednisolone
780662|NCT00327197|Asthma|asthma
780663|NCT00327197|biomarkers|biomarkers
780664|NCT00327171|ovarian cancer|ovarian cancer
780665|NCT00327171|angiogenesis|angiogenesis
780666|NCT00327171|angiogenesis inhibition|angiogenesis inhibition
780667|NCT00327171|VEGF-Trap fusion recombinant protein|vegf-trap fusion recombinant protein
780668|NCT00327171|Cancer and other neoplasms|cancer and other neoplasms
780669|NCT00327158|Reaming|reaming
780670|NCT00327158|fracture|fracture
780671|NCT00327158|emboli|emboli
780672|NCT00327145|HCTZ|hctz
780673|NCT00327145|hypertension|hypertension
780674|NCT00327145|valsartan|valsartan
780675|NCT00327145|amlodipine|amlodipine
780676|NCT00327132|Early-stage Lg/Hg Gastric MALT Lymphoma|early-stage lg/hg gastric malt lymphoma
780677|NCT00327132|Eradication of Helicobacter pylori (Hp)|eradication of helicobacter pylori (hp)
780678|NCT00327119|EGFR|egfr
780679|NCT00327119|Fully human|fully human
780680|NCT00327119|Monoclonal antibody|monoclonal antibody
780681|NCT00327119|Panitumumab|panitumumab
780682|NCT00327119|ABX-EGF|abx-egf
780683|NCT00327119|AMG954|amg954
780684|NCT00327119|Colorectal Cancer|colorectal cancer
780685|NCT00327119|Japan|japan
780686|NCT00327106|hip fracture|hip fracture
780687|NCT00327106|transfusion|transfusion
780688|NCT00327106|tranexamic acid|tranexamic acid
780689|NCT00327106|fondaparinux|fondaparinux
780690|NCT00327093|Colorectal cancer,|colorectal cancer,
780691|NCT00327093|immunohistochemistry,|immunohistochemistry,
780692|NCT00327093|monoclonal antibodies,|monoclonal antibodies,
780693|NCT00327093|predictive model,|predictive model,
780694|NCT00327093|antiangiogenic agents,|antiangiogenic agents,
780695|NCT00327093|medical imaging|medical imaging
780696|NCT00327093|Colorectal cancer with liver metastases|colorectal cancer with liver metastases
780697|NCT00327080|HIV|hiv
780698|NCT00327080|AIDS|aids
780699|NCT00327080|Pulmonary Hypertension|pulmonary hypertension
780700|NCT00327080|Blood Flow Studies|blood flow studies
780701|NCT00327080|Right Heart Catheterization|right heart catheterization
780702|NCT00327080|HIV Infection|hiv infection
780703|NCT00327080|HIV Associated Pulmonary Hypertension|hiv associated pulmonary hypertension
780704|NCT00327080|Healthy Volunteer|healthy volunteer
780705|NCT00327080|HV|hv
780706|NCT00327067|Hemoglobin|hemoglobin
780707|NCT00327067|Iron Supplementation|iron supplementation
780708|NCT00327067|Donor Retention|donor retention
780709|NCT00327067|Iron Stores|iron stores
780710|NCT00327067|Ferritin|ferritin
780711|NCT00327067|Transferrin Saturation|transferrin saturation
780712|NCT00327067|Healthy Volunteer|healthy volunteer
780713|NCT00327067|HV|hv
780714|NCT00327067|Blood Donors|blood donors
780715|NCT00327054|Dyslipidaemia|dyslipidaemia
780716|NCT00327054|Herbal medicine|herbal medicine
780717|NCT00327054|Home remedy|home remedy
780718|NCT00327054|Alternative medicine|alternative medicine
780719|NCT00327054|Metabolic syndrome|metabolic syndrome
780720|NCT00327041|Aspirin|aspirin
780721|NCT00327041|Clopidogrel|clopidogrel
780722|NCT00327041|Balloon Angioplasty|balloon angioplasty
780723|NCT00327041|Coronary Thrombosis|coronary thrombosis
780724|NCT00327028|Bronchial asthma|bronchial asthma
780725|NCT00327028|Phenytoin, Diphenine|phenytoin, diphenine
780726|NCT00327028|Antiepileptic drugs|antiepileptic drugs
780727|NCT00327028|Efficacy|efficacy
780728|NCT00327002|Low HDL|low hdl
780729|NCT00327002|Metabolic syndrome|metabolic syndrome
780730|NCT00327002|low HDL Cholesterol in setting of metabolic syndrome|low hdl cholesterol in setting of metabolic syndrome
780731|NCT00326989|Extracorporal shock wave therapy|extracorporal shock wave therapy
780733|NCT00326976|Angioplasty, Transluminal, Percutaneous Coronary|angioplasty, transluminal, percutaneous coronary
780734|NCT00326976|Myocardial Revascularization|myocardial revascularization
780735|NCT00326950|Cancer|cancer
780736|NCT00326950|Tumors|tumors
780737|NCT00326950|Phase I|phase i
780738|NCT00326950|E7389|e7389
780739|NCT00326924|Transfusion|transfusion
780740|NCT00326885|Ascites|ascites
780741|NCT00326885|Epithelial Cancer|epithelial cancer
780742|NCT00326885|Epithelial Carcinoma|epithelial carcinoma
780743|NCT00326885|Epithelial Ovarian Cancer|epithelial ovarian cancer
780744|NCT00326885|Epithelial Ovarian Carcinoma|epithelial ovarian carcinoma
780745|NCT00326885|Fallopian Tube Cancer|fallopian tube cancer
780746|NCT00326885|Fallopian Tube Carcinoma|fallopian tube carcinoma
780747|NCT00326885|Malignant Ascites|malignant ascites
780748|NCT00326885|Ovarian Cancer|ovarian cancer
780749|NCT00326885|Ovarian Carcinoma|ovarian carcinoma
780750|NCT00326885|Ovarian Epithelial Cancer|ovarian epithelial cancer
780751|NCT00326885|Ovarian Epithelial Carcinoma|ovarian epithelial carcinoma
780752|NCT00326885|Peritoneal Cancer|peritoneal cancer
780753|NCT00326885|Peritoneal Carcinoma|peritoneal carcinoma
780754|NCT00326885|Recurrent Ascites|recurrent ascites
780755|NCT00326885|Recurrent Malignant Ascites|recurrent malignant ascites
780756|NCT00326885|Recurrent Symptomatic Malignant Ascites|recurrent symptomatic malignant ascites
780757|NCT00326885|Symptomatic Malignant Ascites|symptomatic malignant ascites
780758|NCT00326885|Symptomatic Ascites|symptomatic ascites
780759|NCT00326885|Neoplasms, Glandular and Epithelial|neoplasms, glandular and epithelial
780760|NCT00326885|Ovarian Neoplasms|ovarian neoplasms
780884|NCT00326404|Adolescents|adolescents
780761|NCT00326885|Fallopian Tube Neoplasms|fallopian tube neoplasms
780762|NCT00326885|Peritoneal Neoplasms|peritoneal neoplasms
780763|NCT00326859|analgesia strategies|analgesia strategies
780764|NCT00326859|pain|pain
780765|NCT00326859|extensive dressing change|extensive dressing change
780766|NCT00326833|Vitamin B12 deficiency|vitamin b12 deficiency
780767|NCT00326833|Vitamin B12 absorption|vitamin b12 absorption
780768|NCT00326833|Holotranscobalamin|holotranscobalamin
780769|NCT00326820|hypercalcemia of malignancy|hypercalcemia of malignancy
780770|NCT00326820|stage IV breast cancer|stage iv breast cancer
780771|NCT00326820|bone metastases|bone metastases
780772|NCT00326820|recurrent breast cancer|recurrent breast cancer
780773|NCT00326820|male breast cancer|male breast cancer
780774|NCT00326807|naltrexone|naltrexone
780775|NCT00326807|alcohol|alcohol
780776|NCT00326807|gambling|gambling
780777|NCT00326807|concurrent|concurrent
780778|NCT00326794|Nonsurgical proximal humerus fracture|nonsurgical proximal humerus fracture
780779|NCT00326794|Rehabilitation|rehabilitation
780780|NCT00326794|Physiotherapy|physiotherapy
780781|NCT00326794|randomised controlled trial|randomised controlled trial
780782|NCT00326781|Nicotine nasal spray + counseling|nicotine nasal spray + counseling
780783|NCT00326781|Transdermal nicotine + counseling|transdermal nicotine + counseling
780784|NCT00326742|Alcoholism|alcoholism
780785|NCT00326742|Risk factors|risk factors
780786|NCT00326742|Adolescence|adolescence
780787|NCT00326742|Stress test|stress test
780788|NCT00326742|HPA system|hpa system
780789|NCT00326742|Family adversity|family adversity
780790|NCT00326742|Candidate genes|candidate genes
780791|NCT00326742|Cortisol|cortisol
780792|NCT00326742|Adrenocorticotrophin|adrenocorticotrophin
780793|NCT00326729|burns|burns
780794|NCT00326729|thermal injury|thermal injury
780795|NCT00326729|hemodynamics|hemodynamics
780796|NCT00326729|microcirculation|microcirculation
780797|NCT00326716|HIV-1 infected pregnant women, either treatment naive or on ATV/RTV combined with ZDV/3TC|hiv-1 infected pregnant women, either treatment naive or on atv/rtv combined with zdv/3tc
780798|NCT00326703|hypoxia|hypoxia
780799|NCT00326703|hypobaric|hypobaric
780800|NCT00326703|altitude|altitude
780801|NCT00326690|Congestive Heart Failure|congestive heart failure
780802|NCT00326690|Coronary Artery Disease|coronary artery disease
780803|NCT00326690|Ischemic Cardiomyopathy|ischemic cardiomyopathy
780804|NCT00326690|Idiopathic Cardiomyopathy|idiopathic cardiomyopathy
780805|NCT00326677|Depression Prevention|depression prevention
780806|NCT00326677|Prevention of Depression|prevention of depression
780807|NCT00326677|Depression in the Elderly|depression in the elderly
780808|NCT00326677|Late Life Depression|late life depression
780809|NCT00326677|Depression in Old Age|depression in old age
780810|NCT00326677|Treatment of Depression in Primary Care Patients|treatment of depression in primary care patients
780811|NCT00326677|Sub syndromal depression|sub syndromal depression
780812|NCT00326677|Minor Depression|minor depression
780813|NCT00326651|infertility|infertility
780814|NCT00326651|pregnancy|pregnancy
780815|NCT00326651|conception|conception
780816|NCT00326651|conceive|conceive
780817|NCT00326651|conceiving|conceiving
780818|NCT00326651|trying to conceive|trying to conceive
780819|NCT00326651|get pregnant|get pregnant
780820|NCT00326651|conception kit|conception kit
780821|NCT00326651|conception cap|conception cap
780822|NCT00326651|fertility|fertility
780823|NCT00326651|Women who are actively trying to become pregnant|women who are actively trying to become pregnant
780920|NCT00326209|IBD|ibd
780824|NCT00326638|prostate, IMRT, tomotherapy, radiation, cancer|prostate, imrt, tomotherapy, radiation, cancer
780825|NCT00326612|Seizures|seizures
780826|NCT00326599|recurrent non-small cell lung cancer|recurrent non-small cell lung cancer
780827|NCT00326599|stage IIIB non-small cell lung cancer|stage iiib non-small cell lung cancer
780828|NCT00326599|stage IV non-small cell lung cancer|stage iv non-small cell lung cancer
780829|NCT00326599|squamous cell lung cancer|squamous cell lung cancer
780830|NCT00326573|Diabetes|diabetes
780831|NCT00326573|Teenagers|teenagers
780832|NCT00326573|Motivational Interviewing|motivational interviewing
780833|NCT00326560|Pterygium excision|pterygium excision
780834|NCT00326560|Cut and paste|cut and paste
780835|NCT00326560|Tisseel fibrin glue|tisseel fibrin glue
780836|NCT00326560|Conjunctival autograft|conjunctival autograft
780839|NCT00326534|Serological reactions|serological reactions
780840|NCT00326534|Polymerase chain reaction|polymerase chain reaction
780841|NCT00326521|Pregnant Women|pregnant women
780842|NCT00326521|Epidural Anesthesia|epidural anesthesia
780843|NCT00326521|Fever|fever
780844|NCT00326521|Chorioamnionitis|chorioamnionitis
780845|NCT00326521|Intrauterine pressure catheter|intrauterine pressure catheter
780846|NCT00326521|Pregnancy|pregnancy
780847|NCT00326508|T Lymphocytes|t lymphocytes
780848|NCT00326508|IL-2 Conjugate|il-2 conjugate
780849|NCT00326508|CD25|cd25
780850|NCT00326508|T Regulatory Cells|t regulatory cells
780851|NCT00326508|Autoimmunity|autoimmunity
780852|NCT00326508|Uveitis|uveitis
780853|NCT00326508|Daclizumab|daclizumab
780854|NCT00326508|Denileukin Diftitox|denileukin diftitox
780855|NCT00326508|Immune Tolerance|immune tolerance
780856|NCT00326508|T Cell|t cell
780857|NCT00326495|Sorafenib|sorafenib
780858|NCT00326495|Cetuximab|cetuximab
780859|NCT00326495|Advanced Cancer|advanced cancer
780860|NCT00326495|Phase II|phase ii
780861|NCT00326495|Colorectal Cancer|colorectal cancer
780862|NCT00326495|Colon Cancer|colon cancer
780863|NCT00326495|Rectal Cancer|rectal cancer
780864|NCT00326495|CRC|crc
780865|NCT00326495|Metastatic Colorectal Cancer|metastatic colorectal cancer
780866|NCT00326482|Drug Toxicity|drug toxicity
780867|NCT00326482|Steatohepatitis|steatohepatitis
780868|NCT00326482|Hepatotoxicity|hepatotoxicity
780869|NCT00326482|Liver Biopsy|liver biopsy
780870|NCT00326482|Liver Disease|liver disease
780871|NCT00326482|HIV|hiv
780872|NCT00326482|Liver Fibrosis|liver fibrosis
780873|NCT00326456|ovarian cancer|ovarian cancer
780874|NCT00326456|chemotherapy|chemotherapy
780875|NCT00326456|first-line|first-line
780876|NCT00326443|Salmonella, vaccine, typhoid fever, S. Typhi|salmonella, vaccine, typhoid fever, s. typhi
780877|NCT00326430|Social Phobia|social phobia
780878|NCT00326430|Cognitive Therapy|cognitive therapy
780879|NCT00326430|Interpersonal Therapy|interpersonal therapy
780880|NCT00326430|Efficacy|efficacy
780881|NCT00326430|Process-Outcome|process-outcome
780882|NCT00326417|Severe Aplastic Anemia|severe aplastic anemia
780883|NCT00326404|Oral Contraceptives|oral contraceptives
780885|NCT00326404|Compliance|compliance
780886|NCT00326391|Attention Deficit Disorder with Hyperactivity, ADHD, Attention Deficit Disorder Adult|attention deficit disorder with hyperactivity, adhd, attention deficit disorder adult
780887|NCT00326365|mechanical ventilation|mechanical ventilation
780888|NCT00326365|secretions|secretions
780889|NCT00326365|viscosity|viscosity
780890|NCT00326365|homeopathy|homeopathy
780891|NCT00326365|kalium bichromate|kalium bichromate
780892|NCT00326365|extubation|extubation
780893|NCT00326352|Sedation|sedation
780894|NCT00326352|Propofol|propofol
780895|NCT00326352|Remifentanil|remifentanil
780896|NCT00326352|recovery|recovery
780897|NCT00326339|R935788|r935788
780898|NCT00326339|Rheumatoid Arthritis|rheumatoid arthritis
780899|NCT00326339|Syk Kinase|syk kinase
780900|NCT00326313|Group B streptococci|group b streptococci
780901|NCT00326313|virulent|virulent
780902|NCT00326313|morbidity|morbidity
780903|NCT00326313|mortality|mortality
780904|NCT00326300|Attention Deficit Hyperactivity Disorder, ADHD, Attention Deficit Disorder Adult|attention deficit hyperactivity disorder, adhd, attention deficit disorder adult
780905|NCT00326287|Community-Acquired Pneumonia|community-acquired pneumonia
780906|NCT00326287|Cephalosporins|cephalosporins
780907|NCT00326287|Methicillin-Resistant Staphylococcus Aureus|methicillin-resistant staphylococcus aureus
780908|NCT00326248|postoperative nausea and vomiting PONV antiemetics NK-1 5HT3 casopitant mesylate ZOFRAN ondansetron hydrochloride|postoperative nausea and vomiting ponv antiemetics nk-1 5ht3 casopitant mesylate zofran ondansetron hydrochloride
780909|NCT00326235|Opioid withdrawal|opioid withdrawal
780910|NCT00326235|Buspirone|buspirone
780911|NCT00326235|Methadone taper|methadone taper
780912|NCT00326222|Patient Education as a Topic|patient education as a topic
780913|NCT00326222|Self-Management Program|self-management program
780914|NCT00326222|Health promotion|health promotion
780915|NCT00326222|Self Efficacy|self efficacy
780916|NCT00326222|Quality of life|quality of life
780917|NCT00326209|UC|uc
780918|NCT00326209|Ulcerative colitis|ulcerative colitis
780919|NCT00326209|Inflammatory bowel disease|inflammatory bowel disease
780921|NCT00326196|CABG|cabg
780922|NCT00326196|Coronary Disease|coronary disease
780923|NCT00326196|Diabetes|diabetes
780924|NCT00326196|PCI|pci
780925|NCT00326170|Combination Chemotherapy|combination chemotherapy
780926|NCT00326170|MDS|mds
780927|NCT00326170|High-Risk Myelodysplastic Syndrome|high-risk myelodysplastic syndrome
780928|NCT00326170|AML|aml
780929|NCT00326170|Acute myelogenous leukemia|acute myelogenous leukemia
780930|NCT00326170|valproic acid|valproic acid
780931|NCT00326170|VPA|vpa
780932|NCT00326170|Depakene|depakene
780933|NCT00326170|5-azacytidine|5-azacytidine
780934|NCT00326170|5-aza|5-aza
780935|NCT00326170|Azacitidine|azacitidine
780936|NCT00326170|5-AZC|5-azc
780937|NCT00326170|Vidaza|vidaza
780938|NCT00326170|AZA-CR|aza-cr
780939|NCT00326170|Ladakamycin|ladakamycin
780940|NCT00326170|NSC-102816|nsc-102816
780941|NCT00326170|All-trans retinoic acid|all-trans retinoic acid
780942|NCT00326170|ATRA|atra
780943|NCT00326170|Tretinoin|tretinoin
780944|NCT00326170|Vesanoid|vesanoid
780945|NCT00326157|antifungal primary prophylaxis treatment|antifungal primary prophylaxis treatment
780946|NCT00326157|allogeneic stem-cell transplantation|allogeneic stem-cell transplantation
780947|NCT00326157|antifungal primary prophylaxis treatment of high risk patients undergoing allogeneic stem-cell transplantation|antifungal primary prophylaxis treatment of high risk patients undergoing allogeneic stem-cell transplantation
780948|NCT00326144|MDD|mdd
780949|NCT00326144|Depression|depression
780950|NCT00326118|Meningococcal serogroup C diseases|meningococcal serogroup c diseases
780951|NCT00326118|H.influenzae type b diseases|h.influenzae type b diseases
780952|NCT00326105|MDD|mdd
780953|NCT00326105|Depression|depression
780954|NCT00326079|Open angle|open angle
780955|NCT00326079|Glaucoma|glaucoma
780956|NCT00326079|Surgery|surgery
780957|NCT00326066|Open angle|open angle
780958|NCT00326066|Glaucoma|glaucoma
780959|NCT00326066|Surgery|surgery
780960|NCT00326066|Cataract|cataract
780961|NCT00326053|Asthma Reoccurrence|asthma reoccurrence
780962|NCT00326053|Acute Asthma|acute asthma
780963|NCT00326053|Patient Discharge|patient discharge
780964|NCT00326053|Emergency Service, Hospital|emergency service, hospital
780965|NCT00326053|Asthma Exacerbation|asthma exacerbation
780966|NCT00326053|Asthma Relapse|asthma relapse
780967|NCT00326040|Open angle|open angle
780968|NCT00326040|Glaucoma|glaucoma
780969|NCT00326040|Refractory|refractory
780970|NCT00326040|Surgery|surgery
780971|NCT00326027|GERD|gerd
780972|NCT00326027|Pantoprazole|pantoprazole
780973|NCT00326027|NERD|nerd
780974|NCT00326014|Open angle|open angle
780975|NCT00326014|Glaucoma|glaucoma
780976|NCT00326014|Cataract|cataract
780977|NCT00326014|Surgery|surgery
780978|NCT00326001|Transvenous Catheter Ablation|transvenous catheter ablation
780979|NCT00326001|Radiofrequency Catheter Ablation|radiofrequency catheter ablation
780980|NCT00326001|Atrial flutter|atrial flutter
780981|NCT00326001|Catheter Ablation|catheter ablation
780982|NCT00325988|Neuroimmunology|neuroimmunology
780983|NCT00325988|Demyelinating Disease|demyelinating disease
780984|NCT00325988|Genetics|genetics
780985|NCT00325988|Proteins|proteins
780986|NCT00325975|Smallpox|smallpox
780987|NCT00325975|Variola|variola
780988|NCT00325975|Orthopoxvirus|orthopoxvirus
780989|NCT00325975|Virus|virus
780990|NCT00325975|Immunogenicity|immunogenicity
780991|NCT00325975|Smallpox Vaccine|smallpox vaccine
780992|NCT00325962|Hypertension|hypertension
780993|NCT00325962|Type 2 Diabetes|type 2 diabetes
780994|NCT00325962|6R-BH4|6r-bh4
780995|NCT00325962|BH4|bh4
780996|NCT00325962|BH4 deficiency|bh4 deficiency
780997|NCT00325962|sapropterin dihydrochloride|sapropterin dihydrochloride
780998|NCT00325962|endothelial dysfunction|endothelial dysfunction
780999|NCT00325962|NO|no
781000|NCT00325962|Nitric Oxide|nitric oxide
781001|NCT00325936|metabolic syndrome|metabolic syndrome
781002|NCT00325936|Hypertension|hypertension
781003|NCT00325936|CCB|ccb
781004|NCT00325936|cilnidipine|cilnidipine
781005|NCT00325923|Decision making|decision making
781006|NCT00325923|Decision support|decision support
781007|NCT00325923|Decisional conflict|decisional conflict
781008|NCT00325923|Menopause|menopause
781009|NCT00325923|Natural health products|natural health products
781010|NCT00325923|Herbs|herbs
781011|NCT00325923|Complementary medicine|complementary medicine
781012|NCT00325923|Complementary therapies|complementary therapies
781013|NCT00325910|Diabetes|diabetes
781014|NCT00325910|Heart Failure|heart failure
781015|NCT00325910|Mortality|mortality
781016|NCT00325910|Hospitalization|hospitalization
781017|NCT00325910|Feasability|feasability
781018|NCT00325884|coronary artery disease|coronary artery disease
781019|NCT00325884|bifurcation lesions|bifurcation lesions
781020|NCT00325884|percutaneous interventions|percutaneous interventions
781021|NCT00325884|stenting|stenting
781022|NCT00325884|outcomes|outcomes
781023|NCT00325884|death|death
781024|NCT00325884|myocardial infarction|myocardial infarction
781025|NCT00325858|osteoarthritis pain|osteoarthritis pain
781026|NCT00325858|knee|knee
781027|NCT00325858|hip|hip
781028|NCT00325858|extended-release analgesia|extended-release analgesia
781029|NCT00325858|opioid|opioid
781030|NCT00325845|Investigational|investigational
781031|NCT00325845|Therapeutic|therapeutic
781032|NCT00325845|Efficacy|efficacy
781033|NCT00325845|Safety|safety
781034|NCT00325845|Outcomes|outcomes
781035|NCT00325845|Lumbar facet joint arthrosis|lumbar facet joint arthrosis
781036|NCT00325845|Lumbar facet joint arthropathy|lumbar facet joint arthropathy
781037|NCT00325832|Hypertension|hypertension
781038|NCT00325832|Blood Pressure|blood pressure
781039|NCT00325832|Systolic Pressure|systolic pressure
781040|NCT00325832|Diastolic Pressure|diastolic pressure
781041|NCT00325832|Blood Pressure Monitoring, Ambulatory|blood pressure monitoring, ambulatory
781042|NCT00325819|Acetaminophen|acetaminophen
781043|NCT00325819|Vaccination|vaccination
781044|NCT00325819|Immunization|immunization
781046|NCT00325793|hypertension|hypertension
781047|NCT00325793|intracerebral hemorrhage|intracerebral hemorrhage
781048|NCT00325793|ischemic stroke|ischemic stroke
781049|NCT00325780|Kowa|kowa
781050|NCT00325780|Hypercholesterolemia|hypercholesterolemia
781051|NCT00325780|dyslipidemia|dyslipidemia
781052|NCT00325780|pitavastatin|pitavastatin
781053|NCT00325780|NK-104|nk-104
781054|NCT00325780|Hypercholesterolemia or combined dyslipidemia|hypercholesterolemia or combined dyslipidemia
781055|NCT00325767|mucociliary clearance|mucociliary clearance
781056|NCT00325767|beta-adrenergic drugs|beta-adrenergic drugs
781057|NCT00325767|inhalation|inhalation
781058|NCT00325767|aerosol|aerosol
781059|NCT00325754|Chronic Obstructive Pulmonary Disease|chronic obstructive pulmonary disease
781060|NCT00325754|COPD|copd
781061|NCT00325741|Lupus|lupus
781062|NCT00325741|Systemic Lupus Erythematosus|systemic lupus erythematosus
781063|NCT00325741|Blood Stem Cell Transplantation|blood stem cell transplantation
781064|NCT00325728|Chronic Insomnia|chronic insomnia
781065|NCT00325728|Sleep Initiation and Maintenance Disorder|sleep initiation and maintenance disorder
781066|NCT00325728|Drug Therapy|drug therapy
781067|NCT00325728|Alzheimer disease|alzheimer disease
781068|NCT00325702|HIV|hiv
781069|NCT00325702|prevention|prevention
781070|NCT00325676|GERD|gerd
781071|NCT00325676|Pantoprazole|pantoprazole
781072|NCT00325676|Complete Remission|complete remission
781073|NCT00325663|acupuncture|acupuncture
781074|NCT00325663|double-blind|double-blind
781075|NCT00325663|sham control|sham control
781076|NCT00325663|osteoarthritis|osteoarthritis
781077|NCT00325663|pain|pain
781078|NCT00325650|Prediabetic state|prediabetic state
781079|NCT00325650|Impaired fasting glucose|impaired fasting glucose
781080|NCT00325650|Impaired glucose Tolerance|impaired glucose tolerance
781081|NCT00325637|CHERISH|cherish
781082|NCT00325637|Ischemic Stroke|ischemic stroke
781083|NCT00325624|Blood Pressure|blood pressure
781084|NCT00325624|Diabetes mellitus|diabetes mellitus
781085|NCT00325624|Hypertension|hypertension
781086|NCT00325624|Home Care|home care
781087|NCT00325624|Glucometer|glucometer
781088|NCT00325611|Palliative care|palliative care
781089|NCT00325611|End of life care|end of life care
781090|NCT00325585|Human Immunodeficiency Viruses|human immunodeficiency viruses
781091|NCT00325585|Acquired Immunodeficiency Syndrome|acquired immunodeficiency syndrome
781092|NCT00325585|Substance Abuse|substance abuse
781093|NCT00325585|Sexually Transmitted Disease, Viral|sexually transmitted disease, viral
781094|NCT00325585|Intervention Studies|intervention studies
781095|NCT00325585|Women's Health|women's health
781096|NCT00325546|Obesity|obesity
781097|NCT00325533|Blood Pressure, High|blood pressure, high
781098|NCT00325533|Blacks|blacks
781099|NCT00325533|African Americans|african americans
781100|NCT00325507|Renal cell cancer|renal cell cancer
781101|NCT00325507|requiring IL-2 treatment|requiring il-2 treatment
781102|NCT00325507|Locally advanced or metastatic renal cell carcinoma|locally advanced or metastatic renal cell carcinoma
781103|NCT00325494|Pancreatic Cancer|pancreatic cancer
781104|NCT00325494|Mesothelioma|mesothelioma
781105|NCT00325494|Ovarian Cancer|ovarian cancer
781106|NCT00325494|Non-Small Cell Lung Cancer|non-small cell lung cancer
781107|NCT00325494|Mesothelin|mesothelin
781108|NCT00325468|bone loss|bone loss
781109|NCT00325468|osteoporosis|osteoporosis
781110|NCT00325442|Pulmonary Arterial Hypertension|pulmonary arterial hypertension
781111|NCT00325429|Type 2 diabetes|type 2 diabetes
781112|NCT00325429|Vildagliptin|vildagliptin
781113|NCT00325429|HbA1c|hba1c
781114|NCT00325416|melphalan|melphalan
781115|NCT00325416|topotecan|topotecan
781116|NCT00325416|topoisomerase|topoisomerase
781117|NCT00325416|bone marrow transplant|bone marrow transplant
781118|NCT00325416|drug sequence|drug sequence
781119|NCT00325403|Pulmonary Arterial Hypertension|pulmonary arterial hypertension
781120|NCT00325390|SR25990C|sr25990c
781121|NCT00325390|Platelet Aggregation Inhibitors|platelet aggregation inhibitors
781122|NCT00325390|NSTEACS|nsteacs
781123|NCT00325377|low back pain|low back pain
781124|NCT00325377|pain|pain
781125|NCT00325377|magnetism|magnetism
781126|NCT00325377|electromagnetic fields|electromagnetic fields
781127|NCT00325377|visual analogue pain scale|visual analogue pain scale
781128|NCT00325351|Ovarian cancer|ovarian cancer
781129|NCT00325351|Ovarian neoplasms, epithelium|ovarian neoplasms, epithelium
781130|NCT00325338|Allergy|allergy
781131|NCT00325338|Specific Immunotherapy|specific immunotherapy
781132|NCT00325338|Ragweed|ragweed
781133|NCT00325338|Environmental Exposure Chamber|environmental exposure chamber
781134|NCT00325325|Kidney Transplantation|kidney transplantation
781135|NCT00325312|Neck Pain|neck pain
781136|NCT00325312|Complementary Therapies|complementary therapies
781571|NCT00324142|Bacterial vaginosis|bacterial vaginosis
781137|NCT00325312|Subcutaneous Carbon Dioxide Insufflations|subcutaneous carbon dioxide insufflations
781138|NCT00325312|Acute Treatment|acute treatment
781139|NCT00325273|Lactobacillus rhamnosus|lactobacillus rhamnosus
781140|NCT00325273|Atopic dermatitis|atopic dermatitis
781141|NCT00325273|Allergic rhinitis|allergic rhinitis
781143|NCT00325273|Infant|infant
781146|NCT00325260|non-inferiority|non-inferiority
781147|NCT00325260|Influvac|influvac
781148|NCT00325260|Agrippal|agrippal
781149|NCT00325260|healthy subjects|healthy subjects
781150|NCT00325247|ZINC SUPPLEMENTATION|zinc supplementation
781151|NCT00325247|ACUTE DIARRHOEA|acute diarrhoea
781152|NCT00325247|UNDER FIVE CHILDREN|under five children
781153|NCT00325247|RURAL BANGLADESH|rural bangladesh
781154|NCT00325221|implantable cardioverter-defibrillator|implantable cardioverter-defibrillator
781155|NCT00325221|telemedicine|telemedicine
781156|NCT00325221|Home Monitoring|home monitoring
781157|NCT00325221|psychosomatic|psychosomatic
781158|NCT00325221|ventricular tachyarrhythmia|ventricular tachyarrhythmia
781159|NCT00325221|quality of life|quality of life
781160|NCT00325221|Electric Countershock|electric countershock
781161|NCT00325182|Alcoholism|alcoholism
781162|NCT00325169|Cross-over|cross-over
781163|NCT00325169|Tiotropium|tiotropium
781164|NCT00325169|Triple|triple
781165|NCT00325169|COPD|copd
781166|NCT00325169|SERETIDE 50/500|seretide 50/500
781167|NCT00325169|Dyspnoea|dyspnoea
781168|NCT00325169|Impulse oscillometry|impulse oscillometry
781169|NCT00325169|Plethysmography|plethysmography
781170|NCT00325117|Type 2 diabetes|type 2 diabetes
781171|NCT00325117|Vildagliptin|vildagliptin
781172|NCT00325117|HbA1c|hba1c
781173|NCT00325104|Multiple Endocrine Neoplasia|multiple endocrine neoplasia
781174|NCT00325104|Gastrinoma|gastrinoma
781175|NCT00325104|Prolacinoma|prolacinoma
781176|NCT00325104|Medullary Thyroid Cancer|medullary thyroid cancer
781177|NCT00325104|Insulinoma|insulinoma
781178|NCT00325104|MEN1|men1
781179|NCT00325104|MEN2A|men2a
781180|NCT00325104|Familial Primary Hyperparathytoidism|familial primary hyperparathytoidism
781181|NCT00325091|Writer's Cramp|writer's cramp
781182|NCT00325091|Electroencephalogram (EEG)|electroencephalogram (eeg)
781183|NCT00325091|Transcranial Magnetic Stimulation (TMS)|transcranial magnetic stimulation (tms)
781184|NCT00325091|Fine Motor Skills|fine motor skills
781185|NCT00325091|Focal Hand Dystonia|focal hand dystonia
781186|NCT00325091|Writer Cramp|writer cramp
781187|NCT00325091|Healthy Volunteer|healthy volunteer
781188|NCT00325091|HV|hv
781189|NCT00325078|Remicade|remicade
781190|NCT00325078|Crohn's Disease|crohn's disease
781191|NCT00325078|IBD|ibd
781192|NCT00325078|CGD Infection|cgd infection
781193|NCT00325078|Infliximab|infliximab
781194|NCT00325078|Chorionic Granulomatous Disease|chorionic granulomatous disease
781195|NCT00325078|CGD|cgd
781196|NCT00325078|Inflammatory Bowel Disease|inflammatory bowel disease
781197|NCT00325065|Amygdala|amygdala
781198|NCT00325065|Emotion|emotion
781199|NCT00325065|Memory|memory
781200|NCT00325065|Threat|threat
781201|NCT00325065|Peptides|peptides
781202|NCT00325065|Neuropeptides|neuropeptides
781203|NCT00325065|Oxytocin|oxytocin
781204|NCT00325065|Vasopressin|vasopressin
781205|NCT00325065|Mood Disorder|mood disorder
781206|NCT00325039|Urinary Incontinence, Stress|urinary incontinence, stress
781207|NCT00325039|Surgery|surgery
781208|NCT00325026|Preterm gestation|preterm gestation
781209|NCT00325026|Cervical ripening|cervical ripening
781210|NCT00325026|Labor induction|labor induction
781211|NCT00325026|Misoprostol|misoprostol
781212|NCT00325026|Foley bulb|foley bulb
781213|NCT00325013|Primary Sclerosing Cholangitis|primary sclerosing cholangitis
781214|NCT00325013|PSC|psc
781215|NCT00325013|DHA|dha
781216|NCT00325013|Docosahexaenoic Acid|docosahexaenoic acid
781217|NCT00324974|Gastroesophageal Reflux Disease|gastroesophageal reflux disease
781218|NCT00324974|infant|infant
781219|NCT00324974|lansoprazole oral suspension|lansoprazole oral suspension
781220|NCT00324974|PPI|ppi
781221|NCT00324961|adefovir dipivoxil|adefovir dipivoxil
781222|NCT00324961|e Antigen negative|e antigen negative
781223|NCT00324961|chronic hepatitis B|chronic hepatitis b
781224|NCT00324961|Chinese|chinese
781225|NCT00324948|Female sexual arousal disorder|female sexual arousal disorder
781226|NCT00324948|Female sexual dysfunction|female sexual dysfunction
781227|NCT00324922|Vancomycin|vancomycin
781228|NCT00324922|Trimethoprim-Sulfamethoxazole Combination|trimethoprim-sulfamethoxazole combination
781229|NCT00324896|Parkinson's|parkinson's
781230|NCT00324896|insomnia|insomnia
781231|NCT00324896|drug|drug
781232|NCT00324896|eszopiclone|eszopiclone
781233|NCT00324896|placebo|placebo
781234|NCT00324883|sodium intake|sodium intake
781235|NCT00324883|sodium excretion|sodium excretion
781236|NCT00324883|chloride excretion|chloride excretion
781237|NCT00324883|creatinine|creatinine
781238|NCT00324883|hypertension|hypertension
781239|NCT00324857|Osteoarthritis, Knee|osteoarthritis, knee
781240|NCT00324857|race|race
781241|NCT00324857|ethnicity|ethnicity
781242|NCT00324857|knee replacement|knee replacement
781243|NCT00324831|contiguous stage II adult diffuse large cell lymphoma|contiguous stage ii adult diffuse large cell lymphoma
781244|NCT00324831|noncontiguous stage II adult diffuse large cell lymphoma|noncontiguous stage ii adult diffuse large cell lymphoma
781245|NCT00324831|stage III adult diffuse large cell lymphoma|stage iii adult diffuse large cell lymphoma
781246|NCT00324831|stage IV adult diffuse large cell lymphoma|stage iv adult diffuse large cell lymphoma
781247|NCT00324818|bacterial vaginosis|bacterial vaginosis
781248|NCT00324818|treatment|treatment
781249|NCT00324779|B-cell childhood acute lymphoblastic leukemia|b-cell childhood acute lymphoblastic leukemia
781250|NCT00324779|untreated childhood acute lymphoblastic leukemia|untreated childhood acute lymphoblastic leukemia
781251|NCT00324779|stage I childhood large cell lymphoma|stage i childhood large cell lymphoma
781252|NCT00324779|stage II childhood large cell lymphoma|stage ii childhood large cell lymphoma
781253|NCT00324779|stage III childhood large cell lymphoma|stage iii childhood large cell lymphoma
781254|NCT00324779|stage IV childhood large cell lymphoma|stage iv childhood large cell lymphoma
781255|NCT00324779|stage I childhood lymphoblastic lymphoma|stage i childhood lymphoblastic lymphoma
781256|NCT00324779|stage II childhood lymphoblastic lymphoma|stage ii childhood lymphoblastic lymphoma
781257|NCT00324779|stage III childhood lymphoblastic lymphoma|stage iii childhood lymphoblastic lymphoma
781258|NCT00324779|stage IV childhood lymphoblastic lymphoma|stage iv childhood lymphoblastic lymphoma
781259|NCT00324779|stage I childhood small noncleaved cell lymphoma|stage i childhood small noncleaved cell lymphoma
781260|NCT00324779|stage II childhood small noncleaved cell lymphoma|stage ii childhood small noncleaved cell lymphoma
781261|NCT00324779|stage III childhood small noncleaved cell lymphoma|stage iii childhood small noncleaved cell lymphoma
781262|NCT00324779|stage IV childhood small noncleaved cell lymphoma|stage iv childhood small noncleaved cell lymphoma
781264|NCT00324753|screening|screening
781265|NCT00324753|communication|communication
781266|NCT00324753|prevention|prevention
781267|NCT00324727|liver metastases|liver metastases
781268|NCT00324727|extraocular extension melanoma|extraocular extension melanoma
781269|NCT00324727|stage IV melanoma|stage iv melanoma
781270|NCT00324727|recurrent melanoma|recurrent melanoma
781271|NCT00324727|recurrent intraocular melanoma|recurrent intraocular melanoma
781272|NCT00324727|metastatic intraocular melanoma|metastatic intraocular melanoma
781273|NCT00324727|iris melanoma|iris melanoma
781274|NCT00324727|ciliary body and choroid melanoma, medium/large size|ciliary body and choroid melanoma, medium/large size
781275|NCT00324714|osteoporosis|osteoporosis
781276|NCT00324714|ductal breast carcinoma in situ|ductal breast carcinoma in situ
781277|NCT00324714|breast cancer in situ|breast cancer in situ
781278|NCT00324701|Mental Health|mental health
781279|NCT00324701|Geriatric Medicine|geriatric medicine
781280|NCT00324701|Depression|depression
781281|NCT00324701|Health Service Delivery|health service delivery
781282|NCT00324701|Aged|aged
781283|NCT00324688|HIV-1|hiv-1
781284|NCT00324688|Methadone|methadone
781285|NCT00324688|HIV-1 infection|hiv-1 infection
781286|NCT00324675|type 2 diabetes,|type 2 diabetes,
781287|NCT00324675|glomerular filtration rate,|glomerular filtration rate,
781288|NCT00324675|renal plasma flow,|renal plasma flow,
781289|NCT00324675|endothelial dysfunction,|endothelial dysfunction,
781290|NCT00324675|proteinuria,|proteinuria,
781291|NCT00324675|diabetic nephropathy|diabetic nephropathy
781292|NCT00324662|Implantable cardioverter-defibrillator|implantable cardioverter-defibrillator
781293|NCT00324662|Ventricular tachyarrhythmia|ventricular tachyarrhythmia
781294|NCT00324662|Supraventricular tachyarrhythmia|supraventricular tachyarrhythmia
781295|NCT00324662|Electric Countershock|electric countershock
781296|NCT00324649|HIV-1|hiv-1
781297|NCT00324623|stage IV melanoma|stage iv melanoma
781298|NCT00324623|recurrent melanoma|recurrent melanoma
781299|NCT00324610|fluoropyrimidines|fluoropyrimidines
781300|NCT00324610|metastases|metastases
781301|NCT00324610|pharmacokinetics|pharmacokinetics
781302|NCT00324610|phase 1-2 study|phase 1-2 study
781303|NCT00324597|unspecified adult solid tumor, protocol specific|unspecified adult solid tumor, protocol specific
781304|NCT00324597|recurrent adult grade III lymphomatoid granulomatosis|recurrent adult grade iii lymphomatoid granulomatosis
781305|NCT00324597|stage III grade 1 follicular lymphoma|stage iii grade 1 follicular lymphoma
781306|NCT00324597|stage III grade 2 follicular lymphoma|stage iii grade 2 follicular lymphoma
781307|NCT00324597|stage III grade 3 follicular lymphoma|stage iii grade 3 follicular lymphoma
781308|NCT00324597|stage IV grade 1 follicular lymphoma|stage iv grade 1 follicular lymphoma
781309|NCT00324597|stage IV grade 2 follicular lymphoma|stage iv grade 2 follicular lymphoma
781310|NCT00324597|stage IV grade 3 follicular lymphoma|stage iv grade 3 follicular lymphoma
781381|NCT00324519|foley bulb|foley bulb
781311|NCT00324597|stage III mantle cell lymphoma|stage iii mantle cell lymphoma
781312|NCT00324597|stage IV mantle cell lymphoma|stage iv mantle cell lymphoma
781313|NCT00324597|stage III marginal zone lymphoma|stage iii marginal zone lymphoma
781314|NCT00324597|stage IV marginal zone lymphoma|stage iv marginal zone lymphoma
781315|NCT00324597|stage III small lymphocytic lymphoma|stage iii small lymphocytic lymphoma
781316|NCT00324597|stage III cutaneous T-cell non-Hodgkin lymphoma|stage iii cutaneous t-cell non-hodgkin lymphoma
781317|NCT00324597|stage IV cutaneous T-cell non-Hodgkin lymphoma|stage iv cutaneous t-cell non-hodgkin lymphoma
781318|NCT00324597|stage III adult T-cell leukemia/lymphoma|stage iii adult t-cell leukemia/lymphoma
781319|NCT00324597|recurrent adult Hodgkin lymphoma|recurrent adult hodgkin lymphoma
781320|NCT00324597|recurrent adult immunoblastic large cell lymphoma|recurrent adult immunoblastic large cell lymphoma
781321|NCT00324597|recurrent adult lymphoblastic lymphoma|recurrent adult lymphoblastic lymphoma
781322|NCT00324597|recurrent adult T-cell leukemia/lymphoma|recurrent adult t-cell leukemia/lymphoma
781538|NCT00324272|Groin dissection|groin dissection
781323|NCT00324597|recurrent cutaneous T-cell non-Hodgkin lymphoma|recurrent cutaneous t-cell non-hodgkin lymphoma
781324|NCT00324597|recurrent grade 1 follicular lymphoma|recurrent grade 1 follicular lymphoma
781325|NCT00324597|recurrent grade 2 follicular lymphoma|recurrent grade 2 follicular lymphoma
781326|NCT00324597|recurrent grade 3 follicular lymphoma|recurrent grade 3 follicular lymphoma
781327|NCT00324597|recurrent mantle cell lymphoma|recurrent mantle cell lymphoma
781328|NCT00324597|recurrent marginal zone lymphoma|recurrent marginal zone lymphoma
781329|NCT00324597|recurrent small lymphocytic lymphoma|recurrent small lymphocytic lymphoma
781330|NCT00324597|splenic marginal zone lymphoma|splenic marginal zone lymphoma
781331|NCT00324597|stage III adult Burkitt lymphoma|stage iii adult burkitt lymphoma
781332|NCT00324597|stage III adult diffuse large cell lymphoma|stage iii adult diffuse large cell lymphoma
781333|NCT00324597|stage III adult diffuse mixed cell lymphoma|stage iii adult diffuse mixed cell lymphoma
781334|NCT00324597|stage III adult diffuse small cleaved cell lymphoma|stage iii adult diffuse small cleaved cell lymphoma
781335|NCT00324597|stage III adult Hodgkin lymphoma|stage iii adult hodgkin lymphoma
781336|NCT00324597|stage III adult immunoblastic large cell lymphoma|stage iii adult immunoblastic large cell lymphoma
781337|NCT00324597|stage III adult lymphoblastic lymphoma|stage iii adult lymphoblastic lymphoma
781338|NCT00324597|Waldenström macroglobulinemia|waldenström macroglobulinemia
781339|NCT00324597|recurrent mycosis fungoides/Sezary syndrome|recurrent mycosis fungoides/sezary syndrome
781340|NCT00324597|stage III mycosis fungoides/Sezary syndrome|stage iii mycosis fungoides/sezary syndrome
781341|NCT00324597|stage IV mycosis fungoides/Sezary syndrome|stage iv mycosis fungoides/sezary syndrome
781342|NCT00324597|stage IV adult Burkitt lymphoma|stage iv adult burkitt lymphoma
781343|NCT00324597|stage IV adult diffuse large cell lymphoma|stage iv adult diffuse large cell lymphoma
781344|NCT00324597|stage IV adult diffuse mixed cell lymphoma|stage iv adult diffuse mixed cell lymphoma
781345|NCT00324597|stage IV adult diffuse small cleaved cell lymphoma|stage iv adult diffuse small cleaved cell lymphoma
781346|NCT00324597|stage IV adult Hodgkin lymphoma|stage iv adult hodgkin lymphoma
781347|NCT00324597|stage IV adult immunoblastic large cell lymphoma|stage iv adult immunoblastic large cell lymphoma
781348|NCT00324597|stage IV adult lymphoblastic lymphoma|stage iv adult lymphoblastic lymphoma
781349|NCT00324597|stage IV adult T-cell leukemia/lymphoma|stage iv adult t-cell leukemia/lymphoma
781350|NCT00324597|adenocarcinoma of the lung|adenocarcinoma of the lung
781351|NCT00324597|bronchoalveolar cell lung cancer|bronchoalveolar cell lung cancer
781352|NCT00324597|large cell lung cancer|large cell lung cancer
781353|NCT00324597|stage IIIA non-small cell lung cancer|stage iiia non-small cell lung cancer
781354|NCT00324597|stage IIIB non-small cell lung cancer|stage iiib non-small cell lung cancer
781355|NCT00324597|stage IV non-small cell lung cancer|stage iv non-small cell lung cancer
781356|NCT00324597|recurrent adult Burkitt lymphoma|recurrent adult burkitt lymphoma
781357|NCT00324597|recurrent adult diffuse large cell lymphoma|recurrent adult diffuse large cell lymphoma
781358|NCT00324597|recurrent adult diffuse mixed cell lymphoma|recurrent adult diffuse mixed cell lymphoma
781359|NCT00324597|recurrent adult diffuse small cleaved cell lymphoma|recurrent adult diffuse small cleaved cell lymphoma
781360|NCT00324597|stage IV small lymphocytic lymphoma|stage iv small lymphocytic lymphoma
781361|NCT00324597|extranodal marginal zone B-cell lymphoma of mucosa-associated lymphoid tissue|extranodal marginal zone b-cell lymphoma of mucosa-associated lymphoid tissue
781362|NCT00324597|nodal marginal zone B-cell lymphoma|nodal marginal zone b-cell lymphoma
781363|NCT00324597|anaplastic large cell lymphoma|anaplastic large cell lymphoma
781364|NCT00324597|angioimmunoblastic T-cell lymphoma|angioimmunoblastic t-cell lymphoma
781365|NCT00324597|post-transplant lymphoproliferative disorder|post-transplant lymphoproliferative disorder
781366|NCT00324597|recurrent non-small cell lung cancer|recurrent non-small cell lung cancer
781367|NCT00324584|type 1 diabetes mellitus|type 1 diabetes mellitus
781368|NCT00324584|telecare|telecare
781369|NCT00324584|telemedicine|telemedicine
781370|NCT00324584|insulin pump therapy|insulin pump therapy
781371|NCT00324558|Bemiparin|bemiparin
781372|NCT00324558|small cell lung carcinoma|small cell lung carcinoma
781373|NCT00324545|Obesity|obesity
781374|NCT00324545|Diets|diets
781375|NCT00324545|Heart Disease|heart disease
781376|NCT00324545|Randomized controlled trial|randomized controlled trial
781377|NCT00324545|Ischemia.|ischemia.
781378|NCT00324519|second trimester|second trimester
781379|NCT00324519|pregnancy termination|pregnancy termination
781380|NCT00324519|misoprostol|misoprostol
781382|NCT00324493|Severe Hemophilia|severe hemophilia
781383|NCT00324493|Musculoskeletal Function|musculoskeletal function
781384|NCT00324493|Factor Replacement|factor replacement
781385|NCT00324467|NON-HODGKIN'S LYMPHOMA|non-hodgkin's lymphoma
781386|NCT00324467|POSITRON EMISSION TOMOGRAPHY|positron emission tomography
781387|NCT00324467|PET|pet
781388|NCT00324467|DLBCL|dlbcl
781389|NCT00324467|R-CHOP|r-chop
781390|NCT00324467|R-ICE|r-ice
781391|NCT00324454|motor neuron disease|motor neuron disease
781392|NCT00324454|amyotrophic lateral sclerosis primary lateral|amyotrophic lateral sclerosis primary lateral
781393|NCT00324454|sclerosis; progressive muscular atrophy|sclerosis; progressive muscular atrophy
781394|NCT00324454|cramps|cramps
781395|NCT00324454|spasticity|spasticity
781396|NCT00324441|Fibromyalgia|fibromyalgia
781397|NCT00324441|Rehabilitation|rehabilitation
781398|NCT00324441|Physical Medicine|physical medicine
781399|NCT00324441|Whole-Body Hyperthermia|whole-body hyperthermia
781400|NCT00324441|Water-Filtered Near Infrared|water-filtered near infrared
781401|NCT00324428|TMS|tms
781402|NCT00324428|Visceral Pain|visceral pain
781403|NCT00324428|Analgesia|analgesia
781404|NCT00324428|Pancreatic Cancer|pancreatic cancer
781405|NCT00324428|Cancer|cancer
781406|NCT00324428|Electric stimulation therapy|electric stimulation therapy
781407|NCT00324428|Electric stimulation|electric stimulation
781408|NCT00324428|Pain|pain
781409|NCT00324428|Safety|safety
781410|NCT00324415|stage I anal cancer|stage i anal cancer
781411|NCT00324415|stage II anal cancer|stage ii anal cancer
781412|NCT00324415|stage IIIA anal cancer|stage iiia anal cancer
781413|NCT00324415|stage IIIB anal cancer|stage iiib anal cancer
781414|NCT00324415|squamous cell carcinoma of the anus|squamous cell carcinoma of the anus
781415|NCT00324415|basaloid carcinoma of the anus|basaloid carcinoma of the anus
781416|NCT00324415|cloacogenic carcinoma of the anus|cloacogenic carcinoma of the anus
781417|NCT00324402|brain natriuretic peptide|brain natriuretic peptide
781418|NCT00324402|pregnancy|pregnancy
781419|NCT00324402|biomarker|biomarker
781420|NCT00324389|Interferon, Gene Expression in Liver, Lymphocytes, High Density Oligonucleotide Microarray Expression Analysis, African American, Hepatitis C|interferon, gene expression in liver, lymphocytes, high density oligonucleotide microarray expression analysis, african american, hepatitis c
781421|NCT00324363|exenatide|exenatide
781422|NCT00324363|diabetes|diabetes
781423|NCT00324363|Amylin|amylin
781424|NCT00324363|Lilly|lilly
781425|NCT00324363|China|china
781426|NCT00324350|Diabetes Mellitus|diabetes mellitus
781427|NCT00324350|Fracture|fracture
781428|NCT00324350|Falls|falls
781429|NCT00324350|Height Loss|height loss
781430|NCT00324324|infection|infection
781431|NCT00324324|adult acute myeloid leukemia with 11q23 (MLL) abnormalities|adult acute myeloid leukemia with 11q23 (mll) abnormalities
781432|NCT00324324|adult acute myeloid leukemia with inv(16)(p13;q22)|adult acute myeloid leukemia with inv(16)(p13;q22)
781433|NCT00324324|adult acute myeloid leukemia with t(15;17)(q22;q12)|adult acute myeloid leukemia with t(15;17)(q22;q12)
781434|NCT00324324|adult acute myeloid leukemia with t(16;16)(p13;q22)|adult acute myeloid leukemia with t(16;16)(p13;q22)
781435|NCT00324324|adult acute myeloid leukemia with t(8;21)(q22;q22)|adult acute myeloid leukemia with t(8;21)(q22;q22)
781436|NCT00324324|accelerated phase chronic myelogenous leukemia|accelerated phase chronic myelogenous leukemia
781437|NCT00324324|adult acute lymphoblastic leukemia in remission|adult acute lymphoblastic leukemia in remission
781438|NCT00324324|adult acute myeloid leukemia in remission|adult acute myeloid leukemia in remission
781439|NCT00324324|atypical chronic myeloid leukemia, BCR-ABL negative|atypical chronic myeloid leukemia, bcr-abl negative
781440|NCT00324324|blastic phase chronic myelogenous leukemia|blastic phase chronic myelogenous leukemia
781441|NCT00324324|chronic eosinophilic leukemia|chronic eosinophilic leukemia
781442|NCT00324324|primary myelofibrosis|primary myelofibrosis
781443|NCT00324324|chronic myelomonocytic leukemia|chronic myelomonocytic leukemia
781444|NCT00324324|chronic neutrophilic leukemia|chronic neutrophilic leukemia
781445|NCT00324324|chronic phase chronic myelogenous leukemia|chronic phase chronic myelogenous leukemia
781446|NCT00324324|de novo myelodysplastic syndromes|de novo myelodysplastic syndromes
781447|NCT00324324|disseminated neuroblastoma|disseminated neuroblastoma
781448|NCT00324324|extranodal marginal zone B-cell lymphoma of mucosa-associated lymphoid tissue|extranodal marginal zone b-cell lymphoma of mucosa-associated lymphoid tissue
781449|NCT00324324|myelodysplastic/myeloproliferative neoplasm, unclassifiable|myelodysplastic/myeloproliferative neoplasm, unclassifiable
781450|NCT00324324|nodal marginal zone B-cell lymphoma|nodal marginal zone b-cell lymphoma
781451|NCT00324324|noncontiguous stage II adult Burkitt lymphoma|noncontiguous stage ii adult burkitt lymphoma
781452|NCT00324324|noncontiguous stage II adult diffuse large cell lymphoma|noncontiguous stage ii adult diffuse large cell lymphoma
781453|NCT00324324|noncontiguous stage II adult diffuse mixed cell lymphoma|noncontiguous stage ii adult diffuse mixed cell lymphoma
781454|NCT00324324|noncontiguous stage II adult diffuse small cleaved cell lymphoma|noncontiguous stage ii adult diffuse small cleaved cell lymphoma
781455|NCT00324324|noncontiguous stage II adult immunoblastic large cell lymphoma|noncontiguous stage ii adult immunoblastic large cell lymphoma
781456|NCT00324324|noncontiguous stage II adult lymphoblastic lymphoma|noncontiguous stage ii adult lymphoblastic lymphoma
781457|NCT00324324|noncontiguous stage II grade 1 follicular lymphoma|noncontiguous stage ii grade 1 follicular lymphoma
781523|NCT00324324|stage IV breast cancer|stage iv breast cancer
781458|NCT00324324|noncontiguous stage II grade 2 follicular lymphoma|noncontiguous stage ii grade 2 follicular lymphoma
781459|NCT00324324|noncontiguous stage II grade 3 follicular lymphoma|noncontiguous stage ii grade 3 follicular lymphoma
781460|NCT00324324|noncontiguous stage II mantle cell lymphoma|noncontiguous stage ii mantle cell lymphoma
781461|NCT00324324|noncontiguous stage II marginal zone lymphoma|noncontiguous stage ii marginal zone lymphoma
781462|NCT00324324|noncontiguous stage II small lymphocytic lymphoma|noncontiguous stage ii small lymphocytic lymphoma
781463|NCT00324324|poor prognosis metastatic gestational trophoblastic tumor|poor prognosis metastatic gestational trophoblastic tumor
781464|NCT00324324|previously treated myelodysplastic syndromes|previously treated myelodysplastic syndromes
781465|NCT00324324|recurrent adult acute lymphoblastic leukemia|recurrent adult acute lymphoblastic leukemia
781466|NCT00324324|recurrent adult acute myeloid leukemia|recurrent adult acute myeloid leukemia
781467|NCT00324324|recurrent adult Burkitt lymphoma|recurrent adult burkitt lymphoma
781468|NCT00324324|recurrent adult Hodgkin lymphoma|recurrent adult hodgkin lymphoma
781469|NCT00324324|recurrent adult diffuse large cell lymphoma|recurrent adult diffuse large cell lymphoma
781470|NCT00324324|recurrent adult diffuse mixed cell lymphoma|recurrent adult diffuse mixed cell lymphoma
781471|NCT00324324|recurrent adult diffuse small cleaved cell lymphoma|recurrent adult diffuse small cleaved cell lymphoma
781472|NCT00324324|recurrent adult immunoblastic large cell lymphoma|recurrent adult immunoblastic large cell lymphoma
781473|NCT00324324|recurrent adult lymphoblastic lymphoma|recurrent adult lymphoblastic lymphoma
781474|NCT00324324|recurrent cutaneous T-cell non-Hodgkin lymphoma|recurrent cutaneous t-cell non-hodgkin lymphoma
781475|NCT00324324|recurrent grade 1 follicular lymphoma|recurrent grade 1 follicular lymphoma
781476|NCT00324324|recurrent grade 2 follicular lymphoma|recurrent grade 2 follicular lymphoma
781477|NCT00324324|recurrent grade 3 follicular lymphoma|recurrent grade 3 follicular lymphoma
781478|NCT00324324|recurrent mantle cell lymphoma|recurrent mantle cell lymphoma
781479|NCT00324324|recurrent marginal zone lymphoma|recurrent marginal zone lymphoma
781480|NCT00324324|recurrent mycosis fungoides/Sezary syndrome|recurrent mycosis fungoides/sezary syndrome
781481|NCT00324324|recurrent neuroblastoma|recurrent neuroblastoma
781482|NCT00324324|recurrent ovarian epithelial cancer|recurrent ovarian epithelial cancer
781483|NCT00324324|recurrent ovarian germ cell tumor|recurrent ovarian germ cell tumor
781484|NCT00324324|recurrent small lymphocytic lymphoma|recurrent small lymphocytic lymphoma
781485|NCT00324324|recurrent malignant testicular germ cell tumor|recurrent malignant testicular germ cell tumor
781486|NCT00324324|refractory chronic lymphocytic leukemia|refractory chronic lymphocytic leukemia
781487|NCT00324324|refractory hairy cell leukemia|refractory hairy cell leukemia
781488|NCT00324324|refractory multiple myeloma|refractory multiple myeloma
781489|NCT00324324|relapsing chronic myelogenous leukemia|relapsing chronic myelogenous leukemia
781490|NCT00324324|secondary acute myeloid leukemia|secondary acute myeloid leukemia
781491|NCT00324324|secondary myelodysplastic syndromes|secondary myelodysplastic syndromes
781492|NCT00324324|splenic marginal zone lymphoma|splenic marginal zone lymphoma
781493|NCT00324324|stage I multiple myeloma|stage i multiple myeloma
781494|NCT00324324|stage II multiple myeloma|stage ii multiple myeloma
781495|NCT00324324|stage II ovarian epithelial cancer|stage ii ovarian epithelial cancer
781496|NCT00324324|stage III adult Burkitt lymphoma|stage iii adult burkitt lymphoma
781497|NCT00324324|stage III adult Hodgkin lymphoma|stage iii adult hodgkin lymphoma
781498|NCT00324324|stage III adult diffuse large cell lymphoma|stage iii adult diffuse large cell lymphoma
781499|NCT00324324|stage III adult diffuse mixed cell lymphoma|stage iii adult diffuse mixed cell lymphoma
781500|NCT00324324|stage III adult diffuse small cleaved cell lymphoma|stage iii adult diffuse small cleaved cell lymphoma
781501|NCT00324324|stage III adult immunoblastic large cell lymphoma|stage iii adult immunoblastic large cell lymphoma
781502|NCT00324324|stage III adult lymphoblastic lymphoma|stage iii adult lymphoblastic lymphoma
781503|NCT00324324|stage III chronic lymphocytic leukemia|stage iii chronic lymphocytic leukemia
781504|NCT00324324|stage III grade 1 follicular lymphoma|stage iii grade 1 follicular lymphoma
781505|NCT00324324|stage III grade 2 follicular lymphoma|stage iii grade 2 follicular lymphoma
781506|NCT00324324|stage III grade 3 follicular lymphoma|stage iii grade 3 follicular lymphoma
781507|NCT00324324|stage III mantle cell lymphoma|stage iii mantle cell lymphoma
781508|NCT00324324|stage III marginal zone lymphoma|stage iii marginal zone lymphoma
781509|NCT00324324|stage III multiple myeloma|stage iii multiple myeloma
781510|NCT00324324|stage III ovarian epithelial cancer|stage iii ovarian epithelial cancer
781511|NCT00324324|stage III small lymphocytic lymphoma|stage iii small lymphocytic lymphoma
781512|NCT00324324|stage III malignant testicular germ cell tumor|stage iii malignant testicular germ cell tumor
781513|NCT00324324|stage IIIA breast cancer|stage iiia breast cancer
781514|NCT00324324|stage IIIB breast cancer|stage iiib breast cancer
781515|NCT00324324|stage IIIC breast cancer|stage iiic breast cancer
781516|NCT00324324|stage IV adult Burkitt lymphoma|stage iv adult burkitt lymphoma
781517|NCT00324324|stage IV adult Hodgkin lymphoma|stage iv adult hodgkin lymphoma
781518|NCT00324324|stage IV adult diffuse large cell lymphoma|stage iv adult diffuse large cell lymphoma
781519|NCT00324324|stage IV adult diffuse mixed cell lymphoma|stage iv adult diffuse mixed cell lymphoma
781520|NCT00324324|stage IV adult diffuse small cleaved cell lymphoma|stage iv adult diffuse small cleaved cell lymphoma
781521|NCT00324324|stage IV adult immunoblastic large cell lymphoma|stage iv adult immunoblastic large cell lymphoma
781522|NCT00324324|stage IV adult lymphoblastic lymphoma|stage iv adult lymphoblastic lymphoma
782204|NCT00321347|Cancer|cancer
781524|NCT00324324|stage IV chronic lymphocytic leukemia|stage iv chronic lymphocytic leukemia
781525|NCT00324324|stage IV grade 1 follicular lymphoma|stage iv grade 1 follicular lymphoma
781526|NCT00324324|stage IV grade 2 follicular lymphoma|stage iv grade 2 follicular lymphoma
781527|NCT00324324|stage IV grade 3 follicular lymphoma|stage iv grade 3 follicular lymphoma
781528|NCT00324324|stage IV mantle cell lymphoma|stage iv mantle cell lymphoma
781529|NCT00324324|stage IV marginal zone lymphoma|stage iv marginal zone lymphoma
781530|NCT00324324|stage IV ovarian epithelial cancer|stage iv ovarian epithelial cancer
781531|NCT00324324|stage IV small lymphocytic lymphoma|stage iv small lymphocytic lymphoma
781532|NCT00324298|drug/agent toxicity by tissue/organ|drug/agent toxicity by tissue/organ
781533|NCT00324298|stage III malignant testicular germ cell tumor|stage iii malignant testicular germ cell tumor
781534|NCT00324285|Diarrhoea|diarrhoea
781535|NCT00324285|severe malnutrition|severe malnutrition
781536|NCT00324285|amylase resistant starch|amylase resistant starch
781537|NCT00324285|ORS|ors
781539|NCT00324272|Axilla (or axillary) dissection|axilla (or axillary) dissection
781540|NCT00324272|Lymph node dissection|lymph node dissection
781541|NCT00324272|Lymphadenectomy|lymphadenectomy
781542|NCT00324272|Seroma|seroma
781543|NCT00324272|Wound drainage|wound drainage
781544|NCT00324272|Fibrin sealant|fibrin sealant
781545|NCT00324272|Malignant melanoma|malignant melanoma
781546|NCT00324272|Squamous cell carcinoma|squamous cell carcinoma
781547|NCT00324246|vaginal infection|vaginal infection
781548|NCT00324246|color appearance|color appearance
781549|NCT00324246|new developed indicator strips (NEW NORMA-SENSE)|new developed indicator strips (new norma-sense)
781550|NCT00324246|in-vitro|in-vitro
781551|NCT00324246|vaginal secretion|vaginal secretion
781552|NCT00324246|elevated pH|elevated ph
781553|NCT00324233|Residual urine|residual urine
781554|NCT00324233|Hematuria|hematuria
781555|NCT00324233|Ultra sound|ultra sound
781556|NCT00324220|Phase I/II|phase i/ii
781557|NCT00324207|Type 1 diabetes mellitus|type 1 diabetes mellitus
781558|NCT00324207|Insulin mRNA|insulin mrna
781559|NCT00324194|Leukemia|leukemia
781560|NCT00324194|Myelodysplastic Syndromes|myelodysplastic syndromes
781561|NCT00324194|Phase I|phase i
781562|NCT00324181|normal-tension glaucoma|normal-tension glaucoma
781563|NCT00324181|psychopathology|psychopathology
781564|NCT00324181|Hong Kong|hong kong
781565|NCT00324168|Bacterial Infections|bacterial infections
781566|NCT00324168|Eye Diseases|eye diseases
781567|NCT00324168|Bacterial Keratitis|bacterial keratitis
781568|NCT00324168|Visual Acuity|visual acuity
781569|NCT00324155|Stage IIIc N3 (unresectable)|stage iiic n3 (unresectable)
781570|NCT00324155|Stage IV melanoma|stage iv melanoma
781572|NCT00324142|Tinidazole|tinidazole
781573|NCT00324142|Vaginitis|vaginitis
781574|NCT00324129|Leukemia|leukemia
781575|NCT00324129|Myelodysplastic Syndromes|myelodysplastic syndromes
781576|NCT00324129|Phase I|phase i
781577|NCT00324103|HIV|hiv
781578|NCT00324103|Chronic Infection|chronic infection
781579|NCT00324103|Clinical Trial|clinical trial
781580|NCT00324103|Structured Treatment Interruption|structured treatment interruption
781581|NCT00324077|Chronic phase chronic myelogenous leukemia (CML)|chronic phase chronic myelogenous leukemia (cml)
781582|NCT00324064|Growth hormone deficiency|growth hormone deficiency
781583|NCT00324038|OA|oa
781584|NCT00324038|Elderly|elderly
781585|NCT00324038|Pain|pain
781586|NCT00324038|OA of the hips and/or knees|oa of the hips and/or knees
781587|NCT00324025|Cryptococcal meningitis|cryptococcal meningitis
781588|NCT00324012|Adrenocortical Carcinoma|adrenocortical carcinoma
781589|NCT00324012|cisplatin|cisplatin
781590|NCT00324012|taxotere|taxotere
781591|NCT00323999|Hysteroscopic resection|hysteroscopic resection
781592|NCT00323999|Menorrhagia|menorrhagia
781593|NCT00323999|fibroids|fibroids
781594|NCT00323999|polyps|polyps
781595|NCT00323986|COPD|copd
781596|NCT00323986|tracheotomy|tracheotomy
781597|NCT00323986|azithromycin|azithromycin
781598|NCT00323986|exacerbation|exacerbation
781599|NCT00323986|hospitalisation|hospitalisation
781600|NCT00323986|exhaled breath condensate|exhaled breath condensate
781601|NCT00323973|Chagas, Heart failure, Cardiomiopathy|chagas, heart failure, cardiomiopathy
781602|NCT00323960|Juvenile dermatomyositis|juvenile dermatomyositis
781603|NCT00323960|randomised actively controlled clinical trial|randomised actively controlled clinical trial
781604|NCT00323960|prednisone|prednisone
781605|NCT00323960|cyclosporine|cyclosporine
781606|NCT00323960|methotrexate|methotrexate
781607|NCT00323960|effectiveness|effectiveness
781608|NCT00323947|ADHD|adhd
781609|NCT00323947|Seizures|seizures
781610|NCT00323947|Methylphenidate|methylphenidate
781611|NCT00323947|Stimulant|stimulant
781612|NCT00323934|metastatic solid tumor|metastatic solid tumor
781613|NCT00323934|aggressive non Hodgkin's Lymphoma|aggressive non hodgkin's lymphoma
781614|NCT00323934|Phase I|phase i
781615|NCT00323934|Advanced Solid Tumors|advanced solid tumors
781616|NCT00323908|Breast Cancer|breast cancer
781617|NCT00323908|prevention|prevention
781618|NCT00323908|tissue sampling|tissue sampling
781619|NCT00323908|polymorphisms|polymorphisms
782205|NCT00321347|Pain|pain
781620|NCT00323908|steroid and carcinogen metabolism|steroid and carcinogen metabolism
781621|NCT00323882|Prostate Cancer|prostate cancer
781622|NCT00323882|Oncology|oncology
781623|NCT00323882|Prostate|prostate
781624|NCT00323882|Cancer|cancer
781625|NCT00323882|Metastatic|metastatic
781626|NCT00323882|Hormone|hormone
781627|NCT00323882|PSA|psa
781628|NCT00323882|Metastatic Hormone-Refractory Prostate Cancer (HRPC)|metastatic hormone-refractory prostate cancer (hrpc)
781629|NCT00323856|Hemophilia A|hemophilia a
781630|NCT00323856|Plasma-derived treatment|plasma-derived treatment
781631|NCT00323856|Factor VIII|factor viii
781632|NCT00323856|Inhibitor|inhibitor
781633|NCT00323843|Kidney stone|kidney stone
781634|NCT00323843|ureteropyeloscopy|ureteropyeloscopy
781635|NCT00323843|renal pelvic pressure|renal pelvic pressure
781636|NCT00323830|gastric cancer|gastric cancer
781637|NCT00323830|radiotherapy|radiotherapy
781638|NCT00323830|postoperative therapy|postoperative therapy
781639|NCT00323830|chemotherapy|chemotherapy
781640|NCT00323804|Maintenance therapy|maintenance therapy
781641|NCT00323804|Non-responder patients|non-responder patients
781642|NCT00323804|Ribavirin/peginterferon combination therapy|ribavirin/peginterferon combination therapy
781643|NCT00323804|Hepatitis C, Chronic|hepatitis c, chronic
781644|NCT00323791|recurrent renal cell cancer|recurrent renal cell cancer
781645|NCT00323791|clear cell renal cell carcinoma|clear cell renal cell carcinoma
781646|NCT00323791|papillary renal cell carcinoma|papillary renal cell carcinoma
781647|NCT00323791|stage IV renal cell cancer|stage iv renal cell cancer
781648|NCT00323778|hyalgan|hyalgan
781649|NCT00323778|knee|knee
781650|NCT00323778|osteoarthritis|osteoarthritis
781651|NCT00323778|MRI|mri
781652|NCT00323765|Transcranial Magnetic Stimulation (TMS)|transcranial magnetic stimulation (tms)
781653|NCT00323765|Cervical Dystonia|cervical dystonia
781654|NCT00323765|Plasticity|plasticity
781655|NCT00323765|Healthy Volunteer|healthy volunteer
781656|NCT00323765|HV|hv
781657|NCT00323752|Blood loss, Erythropoetin|blood loss, erythropoetin
781658|NCT00323739|kidney cancer|kidney cancer
781659|NCT00323739|bevacizumab|bevacizumab
781660|NCT00323713|Chronic renal insufficiency|chronic renal insufficiency
781661|NCT00323713|CKD stage 4|ckd stage 4
781662|NCT00323713|CKD stage 5|ckd stage 5
781663|NCT00323713|Protein intake|protein intake
781664|NCT00323713|Low protein diet|low protein diet
781665|NCT00323713|Very low protein diet|very low protein diet
781666|NCT00323713|Ketoanalogs|ketoanalogs
781667|NCT00323713|Renal death|renal death
781668|NCT00323700|ADHD|adhd
781669|NCT00323700|Effectiveness|effectiveness
781670|NCT00323700|ODD|odd
781671|NCT00323687|HIV-1 Infection|hiv-1 infection
781672|NCT00323674|Hernia Inguinalis|hernia inguinalis
781673|NCT00323661|Pacing|pacing
781674|NCT00323661|Rate-adaptive|rate-adaptive
781675|NCT00323661|Quality of life|quality of life
781676|NCT00323661|Cognitive performance|cognitive performance
781677|NCT00323661|Atrial fibrillation|atrial fibrillation
781678|NCT00323661|Pacemaker sensor|pacemaker sensor
781679|NCT00323635|nocturia|nocturia
781680|NCT00323635|urinary incontinence|urinary incontinence
781681|NCT00323635|overactive bladder|overactive bladder
781682|NCT00323635|tolterodine|tolterodine
781683|NCT00323635|sleep|sleep
781684|NCT00323635|sleep disorder|sleep disorder
781685|NCT00323635|menopause|menopause
781686|NCT00323635|midlife women|midlife women
781687|NCT00323635|psychological tests|psychological tests
781688|NCT00323609|Kyphoplasty|kyphoplasty
781689|NCT00323609|Vertebroplasty|vertebroplasty
781690|NCT00323609|Balloon Kyphoplasty|balloon kyphoplasty
781691|NCT00323609|Inflatable Bone Tamp|inflatable bone tamp
781692|NCT00323609|Spine|spine
781693|NCT00323609|Back Pain|back pain
781694|NCT00323609|Vertebral Compression Fracture|vertebral compression fracture
781695|NCT00323609|Vertebral Body Compression Fracture|vertebral body compression fracture
781696|NCT00323583|Cancer|cancer
781697|NCT00323583|Pancreatic Cancer|pancreatic cancer
781823|NCT00323063|male breast cancer|male breast cancer
781698|NCT00323583|Cancer Alternative Therapies|cancer alternative therapies
781699|NCT00323583|Living with Cancer|living with cancer
781700|NCT00323557|Chronic Lymphocytic Leukemia|chronic lymphocytic leukemia
781701|NCT00323557|Leukemia|leukemia
781702|NCT00323557|Sargramostim|sargramostim
781703|NCT00323557|Pneumococcal Pneumonia|pneumococcal pneumonia
781704|NCT00323557|Pneumococcal Vaccine|pneumococcal vaccine
781705|NCT00323557|Prevnar|prevnar
781706|NCT00323557|GM-CSF|gm-csf
781707|NCT00323557|CLL|cll
781708|NCT00323544|HIV 1|hiv 1
781709|NCT00323544|HIV 1 infection|hiv 1 infection
781710|NCT00323531|thoracoscopy|thoracoscopy
781711|NCT00323531|fibrinolysis|fibrinolysis
781712|NCT00323531|empyema|empyema
781713|NCT00323531|children|children
781714|NCT00323518|oral mucositis|oral mucositis
781715|NCT00323518|hematologic|hematologic
781716|NCT00323518|autologous stem cell transplant|autologous stem cell transplant
781717|NCT00323518|velafermin|velafermin
781718|NCT00323518|stomatitis|stomatitis
781719|NCT00323518|oncology - supportive care|oncology - supportive care
781720|NCT00323518|mouth diseases|mouth diseases
781721|NCT00323492|HIV 1 Infection|hiv 1 infection
781722|NCT00323479|breast cancer treatment|breast cancer treatment
781723|NCT00323479|joint disorders|joint disorders
781724|NCT00323453|Appendectomy|appendectomy
781726|NCT00323453|Infection|infection
781727|NCT00323440|Familial Mediterranean fever|familial mediterranean fever
781728|NCT00323440|Inflammation|inflammation
781729|NCT00323440|Attacks|attacks
781730|NCT00323440|Remission|remission
781731|NCT00323440|RNA|rna
781732|NCT00323440|Cytokines|cytokines
781733|NCT00323440|Inflammatory proteins|inflammatory proteins
781734|NCT00323440|MEFV|mefv
781735|NCT00323440|mutations|mutations
781736|NCT00323440|Colchicine|colchicine
781737|NCT00323440|Treatment|treatment
781738|NCT00323440|microarray RNA analysis|microarray rna analysis
781739|NCT00323427|Audiology|audiology
781740|NCT00323427|Coping behaviors|coping behaviors
781741|NCT00323427|Counseling|counseling
781742|NCT00323427|Hearing aids|hearing aids
781743|NCT00323427|Hearing impairment|hearing impairment
781744|NCT00323427|Patient-centered care|patient-centered care
781745|NCT00323427|Psychological adaptation|psychological adaptation
781746|NCT00323427|Psychological adjustment|psychological adjustment
781747|NCT00323427|Rehabilitation|rehabilitation
781748|NCT00323427|Social adjustment|social adjustment
781749|NCT00323427|Aural Rehabilitation|aural rehabilitation
781750|NCT00323414|PUFA|pufa
781751|NCT00323414|NASH|nash
781752|NCT00323414|Fatty Liver|fatty liver
781753|NCT00323414|Insulin resistance|insulin resistance
781754|NCT00323414|Metabolic syndrome|metabolic syndrome
781755|NCT00323414|Nonalcoholic fatty liver disease|nonalcoholic fatty liver disease
781756|NCT00323414|Nonalcoholic steatohepatitis|nonalcoholic steatohepatitis
781757|NCT00323414|Type 2 Diabetes Mellitus|type 2 diabetes mellitus
781758|NCT00323401|Pregnancy|pregnancy
781759|NCT00323401|Parturition|parturition
781760|NCT00323401|Depression|depression
781761|NCT00323401|Randomized|randomized
781762|NCT00323401|Antenatal classes|antenatal classes
781763|NCT00323375|Malaria|malaria
781764|NCT00323375|Aminoquinolines|aminoquinolines
781765|NCT00323375|Drug Resistance|drug resistance
781766|NCT00323375|Chloroquine Resistance|chloroquine resistance
781767|NCT00323362|recurrent non-small cell lung cancer|recurrent non-small cell lung cancer
781768|NCT00323362|stage IV non-small cell lung cancer|stage iv non-small cell lung cancer
781769|NCT00323349|Glucose Tolerance Test|glucose tolerance test
781770|NCT00323349|Health Knowledge, Attitudes, Practice|health knowledge, attitudes, practice
781771|NCT00323349|Motivation|motivation
781772|NCT00323349|Communication|communication
781773|NCT00323349|Health Behavior|health behavior
781774|NCT00323323|Untreated|untreated
781775|NCT00323323|CD-20 Negative|cd-20 negative
781776|NCT00323323|Large B-Cell Lymphomas|large b-cell lymphomas
781777|NCT00323310|disease of the central nervous system (brain or spine)|disease of the central nervous system (brain or spine)
781778|NCT00323284|Open angle|open angle
781779|NCT00323284|Glaucoma|glaucoma
781780|NCT00323284|Cataract|cataract
781781|NCT00323284|Surgery|surgery
781782|NCT00323271|Chronic pain|chronic pain
781783|NCT00323271|Cognitive behavioral therapy|cognitive behavioral therapy
781784|NCT00323271|Multiple sclerosis|multiple sclerosis
781785|NCT00323271|Randomized controlled trial|randomized controlled trial
781786|NCT00323258|Heart disease|heart disease
781787|NCT00323258|Coronary disease|coronary disease
781788|NCT00323258|Patient compliance|patient compliance
781789|NCT00323258|Treatment refusal|treatment refusal
781790|NCT00323258|Pharmacists|pharmacists
781791|NCT00323258|Continuity of patient care|continuity of patient care
781792|NCT00323258|Evidence-based medicine|evidence-based medicine
781793|NCT00323258|Patient education|patient education
781794|NCT00323258|Adherence|adherence
781795|NCT00323245|Randomized clinical trial|randomized clinical trial
781796|NCT00323245|osteoporosis|osteoporosis
781797|NCT00323245|urinary incontinence|urinary incontinence
781798|NCT00323245|physiotherapy|physiotherapy
781799|NCT00323245|education|education
781800|NCT00323232|DHS, Intertrochanteric|dhs, intertrochanteric
781801|NCT00323219|Cellulitis, RCT, emergency Department, Double-blind, Equivalence trial, Moxifloxacin, Cefazolin, Probenecid.|cellulitis, rct, emergency department, double-blind, equivalence trial, moxifloxacin, cefazolin, probenecid.
781802|NCT00323206|melanoma|melanoma
781803|NCT00323206|electroporation|electroporation
781804|NCT00323206|IL-12|il-12
781805|NCT00323206|gene therapy|gene therapy
781806|NCT00323206|gene transfer|gene transfer
781807|NCT00323193|Behavioral interventions|behavioral interventions
781808|NCT00323193|Mental Illness|mental illness
781809|NCT00323193|Obesity|obesity
781810|NCT00323193|Psycho-educational interventions|psycho-educational interventions
781811|NCT00323193|Weight management|weight management
781812|NCT00323167|Variant Cystic Fibrosis|variant cystic fibrosis
781813|NCT00323167|Primary Ciliary Dyskinesia|primary ciliary dyskinesia
781814|NCT00323154|Morphine, analgesia|morphine, analgesia
781815|NCT00323141|Hernia umbilicalis|hernia umbilicalis
781816|NCT00323115|immunotherapy|immunotherapy
781817|NCT00323115|cancer vaccine|cancer vaccine
781818|NCT00323115|glioblastoma multiforme|glioblastoma multiforme
781819|NCT00323089|microcoil|microcoil
781820|NCT00323089|subcentimetre nodules|subcentimetre nodules
781821|NCT00323063|recurrent breast cancer|recurrent breast cancer
781822|NCT00323063|stage IV breast cancer|stage iv breast cancer
781824|NCT00323063|stage IIIA breast cancer|stage iiia breast cancer
781825|NCT00323063|stage IIIB breast cancer|stage iiib breast cancer
781826|NCT00323063|stage IIIC breast cancer|stage iiic breast cancer
781827|NCT00323037|heart failure|heart failure
781828|NCT00323024|Pulmonary Arterial Hypertension|pulmonary arterial hypertension
781829|NCT00323024|Pulmonary Hypertension|pulmonary hypertension
781830|NCT00323024|Idiopathic PAH|idiopathic pah
781831|NCT00323024|PH associated with connective tissue disease (CTD)|ph associated with connective tissue disease (ctd)
781832|NCT00323024|PH associated with interstitial lung disease (ILD)|ph associated with interstitial lung disease (ild)
781833|NCT00323024|PH associated with congestive heart failure (CHF)|ph associated with congestive heart failure (chf)
781927|NCT00322439|TNF-inhibitor naïve|tnf-inhibitor naïve
781834|NCT00323024|PH associated with chronic obstructive pulmonary disease (COPD)|ph associated with chronic obstructive pulmonary disease (copd)
781835|NCT00322985|T-cell lymphoma|t-cell lymphoma
781836|NCT00322985|lenalidomide|lenalidomide
781837|NCT00322972|Bacterial Infections|bacterial infections
781838|NCT00322972|Chlamydia Infections|chlamydia infections
781839|NCT00322972|Eye Diseases|eye diseases
781840|NCT00322959|dendritic cells|dendritic cells
781841|NCT00322959|Tai-Chi-Chuan|tai-chi-chuan
781842|NCT00322946|Dengue Fever|dengue fever
781843|NCT00322946|Dengue Vaccine|dengue vaccine
781844|NCT00322946|Dengue Virus|dengue virus
781845|NCT00322946|Dengue Hemorrhagic Fever|dengue hemorrhagic fever
781846|NCT00322946|Dengue Shock Syndrome|dengue shock syndrome
781847|NCT00322933|intermittent renal replacement therapy|intermittent renal replacement therapy
781848|NCT00322933|continuous renal replacement therapy|continuous renal replacement therapy
781849|NCT00322933|acute renal failure|acute renal failure
781850|NCT00322933|renal recovery|renal recovery
781851|NCT00322933|mortality|mortality
781852|NCT00322920|cervical cancer|cervical cancer
781853|NCT00322920|topotecan|topotecan
781854|NCT00322920|Stage IVB cervical cancer|stage ivb cervical cancer
781855|NCT00322920|Persistent or recurrent cervical cancer|persistent or recurrent cervical cancer
781856|NCT00322907|malaria|malaria
781857|NCT00322907|treatment|treatment
781858|NCT00322907|cotrifazid|cotrifazid
781859|NCT00322907|clinical trial|clinical trial
781860|NCT00322907|efficacy|efficacy
781861|NCT00322894|Breast cancer|breast cancer
781862|NCT00322894|Risk factors|risk factors
781863|NCT00322894|Treatment|treatment
781864|NCT00322894|Clinico-pathologic|clinico-pathologic
781865|NCT00322894|Outcomes|outcomes
781866|NCT00322894|Tissue repository|tissue repository
781867|NCT00322894|Registry|registry
781868|NCT00322881|carboplatin|carboplatin
781869|NCT00322881|paclitaxel|paclitaxel
781870|NCT00322881|elderly women|elderly women
781871|NCT00322868|Prescription drugs|prescription drugs
781872|NCT00322868|Administration, oral|administration, oral
781873|NCT00322868|Durable medical equipment|durable medical equipment
781874|NCT00322868|Kinetics|kinetics
781875|NCT00322842|Non-Hodgkin's lymphoma|non-hodgkin's lymphoma
781876|NCT00322842|Multiple Myeloma|multiple myeloma
781877|NCT00322842|Stem cell mobilization|stem cell mobilization
781878|NCT00322829|Group B Streptococcus, Strepotococcus agalactiae, detection|group b streptococcus, strepotococcus agalactiae, detection
781879|NCT00322816|Malaria, Plasmodium falciparum, Gambia, larvicides|malaria, plasmodium falciparum, gambia, larvicides
781880|NCT00322803|panic disorder|panic disorder
781881|NCT00322803|proof of concept|proof of concept
781882|NCT00322777|Major depression|major depression
781883|NCT00322777|Spirituality|spirituality
781884|NCT00322777|Randomized clinical trial|randomized clinical trial
781885|NCT00322764|manic depression|manic depression
781886|NCT00322764|bipolar disorder|bipolar disorder
781887|NCT00322764|depression|depression
781888|NCT00322764|uridine|uridine
781889|NCT00322764|RG2417|rg2417
781890|NCT00322738|malaria, Plasmodium falciparum, Gambia, larvicides, vector|malaria, plasmodium falciparum, gambia, larvicides, vector
781891|NCT00322699|Bladder Cancer|bladder cancer
781892|NCT00322699|Photodynamic Therapy|photodynamic therapy
781893|NCT00322699|Photofrin|photofrin
781894|NCT00322699|Photosensitization|photosensitization
781895|NCT00322699|Photoradiation|photoradiation
781896|NCT00322686|oglemilast|oglemilast
781897|NCT00322686|asthma|asthma
781898|NCT00322686|allergen|allergen
781899|NCT00322686|prevention|prevention
781900|NCT00322686|prophylaxis|prophylaxis
781901|NCT00322686|Allergen-Induced Asthma|allergen-induced asthma
781902|NCT00322673|acute myeloid leukemia|acute myeloid leukemia
781903|NCT00322673|AML|aml
781904|NCT00322608|Solid Tumors|solid tumors
781905|NCT00322608|Lymphomas|lymphomas
781906|NCT00322595|Anxiety|anxiety
781907|NCT00322595|GAD|gad
781908|NCT00322582|familial cardiomyopathy|familial cardiomyopathy
781909|NCT00322582|genetics analysis|genetics analysis
781910|NCT00322569|Percutaneous coronary intervention (PCI)|percutaneous coronary intervention (pci)
781911|NCT00322569|Drug eluting stent (DES)|drug eluting stent (des)
782206|NCT00321347|Lidocaine|lidocaine
781912|NCT00322556|Immunoglobulin Intravenous|immunoglobulin intravenous
781913|NCT00322556|Agammaglobulinemia|agammaglobulinemia
781914|NCT00322556|Hypogammaglobulinemia|hypogammaglobulinemia
781915|NCT00322556|Common variable immunodeficiency|common variable immunodeficiency
781916|NCT00322556|Immunoglobulin G|immunoglobulin g
781917|NCT00322556|Children|children
781918|NCT00322543|Percutaneous coronary intervention (PCI)|percutaneous coronary intervention (pci)
781919|NCT00322543|Drug eluting stent (DES)|drug eluting stent (des)
781920|NCT00322491|Non-Hodgkin's Lymphoma|non-hodgkin's lymphoma
781921|NCT00322491|Multiple Myeloma|multiple myeloma
781922|NCT00322491|Stem cell mobilization|stem cell mobilization
781923|NCT00322465|non-gonococcal urethritis, doxycycline, azithromycin, sexually transmitted, tinidazole|non-gonococcal urethritis, doxycycline, azithromycin, sexually transmitted, tinidazole
781924|NCT00322452|NSCLC|nsclc
781925|NCT00322452|Gefitinib|gefitinib
781926|NCT00322439|plaque Psoriasis patients|plaque psoriasis patients
781928|NCT00322426|Freezing of Gait|freezing of gait
781929|NCT00322426|Parkinson's Disease|parkinson's disease
781930|NCT00322426|Sensory Cues|sensory cues
781931|NCT00322413|Epoetin alfa|epoetin alfa
781932|NCT00322413|Epoetin omega|epoetin omega
781933|NCT00322413|Comparative efficacy trial|comparative efficacy trial
781934|NCT00322413|Renal anemia|renal anemia
781935|NCT00322400|Clinical trial|clinical trial
781936|NCT00322400|AMG 706|amg 706
781937|NCT00322400|Anti-angiogenesis|anti-angiogenesis
781938|NCT00322400|Locally Recurrent|locally recurrent
781939|NCT00322400|Metastatic|metastatic
781940|NCT00322400|Breast Cancer|breast cancer
781941|NCT00322400|VEGF|vegf
781942|NCT00322400|Angiogenesis Inhibitor|angiogenesis inhibitor
781943|NCT00322400|Oral|oral
781944|NCT00322400|Multi-kinase Inhibitor|multi-kinase inhibitor
781945|NCT00322400|Anti-tumor|anti-tumor
781946|NCT00322400|PDGF receptor|pdgf receptor
781947|NCT00322400|Paclitaxel|paclitaxel
781948|NCT00322400|Docetaxel|docetaxel
781949|NCT00322400|Targeted Therapy|targeted therapy
781950|NCT00322400|Oncology|oncology
781951|NCT00322400|Amgen|amgen
781952|NCT00322400|c-Kit|c-kit
781953|NCT00322387|Non-Hodgkin's Lymphoma|non-hodgkin's lymphoma
781954|NCT00322387|Multiple Myeloma|multiple myeloma
781955|NCT00322387|Stem cell mobilization|stem cell mobilization
781956|NCT00322348|oncology|oncology
781957|NCT00322348|cancer|cancer
781958|NCT00322348|breast cancer|breast cancer
781959|NCT00322335|H.influenzae type b Disease|h.influenzae type b disease
781960|NCT00322322|L-carnitine supplementation|l-carnitine supplementation
781961|NCT00322322|Hemodialysis|hemodialysis
781962|NCT00322322|Anaemia|anaemia
781963|NCT00322322|Erythropoietin responsiveness|erythropoietin responsiveness
781964|NCT00322309|Cocaine|cocaine
781965|NCT00322309|Substance Abuse|substance abuse
781966|NCT00322296|Parapsoriasis|parapsoriasis
781967|NCT00322296|Cutaneous T-cell lymphoma|cutaneous t-cell lymphoma
781968|NCT00322296|Mycosis fungoides|mycosis fungoides
781969|NCT00322296|Bexarotene|bexarotene
781970|NCT00322296|Retinoids|retinoids
781971|NCT00322283|oglemilast|oglemilast
781972|NCT00322283|asthma|asthma
781973|NCT00322283|exercise|exercise
781974|NCT00322283|prevention|prevention
781975|NCT00322283|prophylaxis|prophylaxis
781976|NCT00322270|Occluded Central Venous Access Devices|occluded central venous access devices
781977|NCT00322270|Occluded Catheters|occluded catheters
781978|NCT00322270|Thrombosis|thrombosis
781979|NCT00322270|thrombosis, catheter|thrombosis, catheter
781980|NCT00322270|alfimeprase|alfimeprase
781981|NCT00322270|thrombotic occlusion|thrombotic occlusion
781982|NCT00322270|thrombosis, CVAD|thrombosis, cvad
781983|NCT00322270|thrombosis, catheters|thrombosis, catheters
781984|NCT00322244|Osteoarthritis|osteoarthritis
781985|NCT00322244|Massage therapy|massage therapy
781986|NCT00322192|Stroke rehabilitation|stroke rehabilitation
781987|NCT00322192|Physical Therapy|physical therapy
781988|NCT00322179|Microarray Analysis|microarray analysis
781989|NCT00322179|Obesity|obesity
781990|NCT00322179|Chronic Hepatitis C|chronic hepatitis c
781991|NCT00322166|accidental falls|accidental falls
781992|NCT00322166|vitamin D|vitamin d
781993|NCT00322166|parathyroid hormone|parathyroid hormone
781994|NCT00322166|osteoporosis|osteoporosis
781995|NCT00322153|memantine|memantine
781996|NCT00322153|Alzheimer's disease|alzheimer's disease
781997|NCT00322153|moderate to severe Alzheimer's disease|moderate to severe alzheimer's disease
781998|NCT00322140|Metastatic|metastatic
781999|NCT00322140|Triterpenoids|triterpenoids
782000|NCT00322140|2-Cyano-3,12-Dioxooleana-1,9(11)Dien-28oic Acid|2-cyano-3,12-dioxooleana-1,9(11)dien-28oic acid
782001|NCT00322140|Dose-Limiting|dose-limiting
782002|NCT00322140|Pharmacokinetic|pharmacokinetic
782003|NCT00322140|Solid Tumor|solid tumor
782004|NCT00322140|Lymphoma|lymphoma
782005|NCT00322127|Hematopoietic Stem Cells|hematopoietic stem cells
782006|NCT00322127|Mobilization|mobilization
782007|NCT00322127|CXCR4|cxcr4
782008|NCT00322127|SDF-1|sdf-1
782009|NCT00322127|Mozobil|mozobil
782010|NCT00322127|Healthy Volunteer|healthy volunteer
782011|NCT00322127|HV|hv
782012|NCT00322114|prostate cancer|prostate cancer
782013|NCT00322062|Colon cleansing|colon cleansing
782014|NCT00322049|Dengue, Vaccine, Thailand|dengue, vaccine, thailand
782015|NCT00322036|Alzheimer Disease|alzheimer disease
782016|NCT00322036|Dementia|dementia
782017|NCT00322023|Negative symptoms|negative symptoms
782018|NCT00322023|NMDA|nmda
782019|NCT00322023|Glutamate|glutamate
782020|NCT00322023|Glycine|glycine
782021|NCT00322010|mechanical ventilation|mechanical ventilation
782022|NCT00322010|physical therapy|physical therapy
782023|NCT00322010|occupational therapy|occupational therapy
782024|NCT00322010|mobilization|mobilization
782025|NCT00322010|clinical protocols|clinical protocols
782026|NCT00322010|ICU acquired weakness|icu acquired weakness
782027|NCT00322010|critical illness myopathy|critical illness myopathy
782028|NCT00322010|muscle atrophy|muscle atrophy
782029|NCT00322010|intensive care unit|intensive care unit
782030|NCT00322010|randomized controlled trial|randomized controlled trial
782032|NCT00321997|Age-Related Macular Degeneration|age-related macular degeneration
782033|NCT00321997|Macular Degeneration|macular degeneration
782034|NCT00321997|Macugen|macugen
782035|NCT00321997|pegaptanib sodium|pegaptanib sodium
782036|NCT00321984|Gastroesophageal Reflux Disease(GERD)|gastroesophageal reflux disease(gerd)
782037|NCT00321984|Heartburn|heartburn
782038|NCT00321971|Anxiety|anxiety
782039|NCT00321971|Mild Cognitive Impairment|mild cognitive impairment
782040|NCT00321971|MCI|mci
782041|NCT00321971|Cognitive Impairment|cognitive impairment
782042|NCT00321971|Alzheimer's Disease|alzheimer's disease
782043|NCT00321971|Caregiver Burden|caregiver burden
782044|NCT00321971|Caregiver Stress|caregiver stress
782045|NCT00321971|Family Dementia Caregiving|family dementia caregiving
782046|NCT00321971|Spousal Dementia Caregiving|spousal dementia caregiving
782047|NCT00321958|Barrett Esophagus|barrett esophagus
782048|NCT00321958|Esophageal Neoplasm|esophageal neoplasm
782049|NCT00321958|Deglutition disorders|deglutition disorders
782050|NCT00321958|Cryotherapy|cryotherapy
782051|NCT00321958|Cryosurgery|cryosurgery
782052|NCT00321958|GERD|gerd
782053|NCT00321958|Neoplasm|neoplasm
782054|NCT00321958|Esophagus|esophagus
782055|NCT00321958|Endoscopy, Digestive System|endoscopy, digestive system
782056|NCT00321945|Atrial Fibrillation|atrial fibrillation
782057|NCT00321945|Atrial Flutter|atrial flutter
782058|NCT00321945|Angiotensin Converting Enzyme Inhibitor|angiotensin converting enzyme inhibitor
782059|NCT00321945|Angiotensin Receptor Blocker|angiotensin receptor blocker
782060|NCT00321906|Rejection in lung transplant|rejection in lung transplant
782061|NCT00321893|Small cell lung cancer|small cell lung cancer
782062|NCT00321893|Non-small cell lung cancer|non-small cell lung cancer
782063|NCT00321893|Budesonide|budesonide
782064|NCT00321893|Entocort EC|entocort ec
782065|NCT00321893|Pulmicort Respules|pulmicort respules
782066|NCT00321893|Rhinocort aqua|rhinocort aqua
782067|NCT00321893|Aerosol budesonide treatment|aerosol budesonide treatment
782068|NCT00321893|Smoking|smoking
782069|NCT00321880|fatigue|fatigue
782070|NCT00321880|psychosocial effects of cancer and its treatment|psychosocial effects of cancer and its treatment
782071|NCT00321880|adult acute myeloid leukemia with 11q23 (MLL) abnormalities|adult acute myeloid leukemia with 11q23 (mll) abnormalities
782072|NCT00321880|adult acute myeloid leukemia with inv(16)(p13;q22)|adult acute myeloid leukemia with inv(16)(p13;q22)
782073|NCT00321880|adult acute myeloid leukemia with t(15;17)(q22;q12)|adult acute myeloid leukemia with t(15;17)(q22;q12)
782074|NCT00321880|adult acute myeloid leukemia with t(16;16)(p13;q22)|adult acute myeloid leukemia with t(16;16)(p13;q22)
782075|NCT00321880|adult acute myeloid leukemia with t(8;21)(q22;q22)|adult acute myeloid leukemia with t(8;21)(q22;q22)
782076|NCT00321880|recurrent adult acute lymphoblastic leukemia|recurrent adult acute lymphoblastic leukemia
782077|NCT00321880|recurrent adult acute myeloid leukemia|recurrent adult acute myeloid leukemia
782078|NCT00321880|untreated adult acute lymphoblastic leukemia|untreated adult acute lymphoblastic leukemia
782079|NCT00321880|untreated adult acute myeloid leukemia|untreated adult acute myeloid leukemia
782080|NCT00321867|rectocele|rectocele
782081|NCT00321867|pelvic prolapse|pelvic prolapse
782082|NCT00321867|graft|graft
782083|NCT00321867|surgical repair|surgical repair
782084|NCT00321828|adenocarcinoma of the colon|adenocarcinoma of the colon
782085|NCT00321828|stage IV colon cancer|stage iv colon cancer
782086|NCT00321815|advanced carcinoma non-small cell lung EGFR positive Erlotinib Tarceva PF-3512676 Phase II immunotherapy immune modulator|advanced carcinoma non-small cell lung egfr positive erlotinib tarceva pf-3512676 phase ii immunotherapy immune modulator
782087|NCT00321802|atrial fibrillation|atrial fibrillation
782088|NCT00321802|statin therapy|statin therapy
782089|NCT00321802|CRP levels|crp levels
782090|NCT00321802|Paroxysmal Atrial Fibrillation|paroxysmal atrial fibrillation
782091|NCT00321789|self care|self care
782092|NCT00321789|social support|social support
782093|NCT00321763|Influenza|influenza
782094|NCT00321763|Influenza vaccine|influenza vaccine
782095|NCT00321750|Oral erosive lichen planus|oral erosive lichen planus
782096|NCT00321750|pimecrolimus cream|pimecrolimus cream
782097|NCT00321737|Erosive Esophagitis|erosive esophagitis
782098|NCT00321711|MDS|mds
782099|NCT00321711|Myelodysplastic Syndromes|myelodysplastic syndromes
782100|NCT00321711|Refractory Cytopenias|refractory cytopenias
782101|NCT00321711|Thrombocytopenia|thrombocytopenia
782102|NCT00321698|adenocarcinoma of the prostate|adenocarcinoma of the prostate
782103|NCT00321698|stage II prostate cancer|stage ii prostate cancer
782104|NCT00321698|stage III prostate cancer|stage iii prostate cancer
782105|NCT00321672|Analgesics|analgesics
782106|NCT00321672|Capsaicin|capsaicin
782107|NCT00321672|Neuropathic pain|neuropathic pain
782108|NCT00321672|Neuropathy|neuropathy
782109|NCT00321672|Distal sensory polyneuropathy|distal sensory polyneuropathy
782110|NCT00321672|Peripheral neuropathy|peripheral neuropathy
782111|NCT00321672|Dermal assessment|dermal assessment
782112|NCT00321672|Pain measurement|pain measurement
782113|NCT00321659|fibromyalgia|fibromyalgia
782114|NCT00321659|self-management|self-management
782115|NCT00321659|exercise|exercise
782116|NCT00321659|patient education|patient education
782117|NCT00321646|prostate cancer|prostate cancer
782118|NCT00321646|bevacizumab|bevacizumab
782119|NCT00321646|docetaxel|docetaxel
782120|NCT00321646|radical prostatectomy|radical prostatectomy
782121|NCT00321633|stage IV breast cancer|stage iv breast cancer
782122|NCT00321633|recurrent breast cancer|recurrent breast cancer
782123|NCT00321633|hereditary breast/ovarian cancer (BRCA1, BRCA2)|hereditary breast/ovarian cancer (brca1, brca2)
782124|NCT00321633|BRCA1 mutation carrier|brca1 mutation carrier
782125|NCT00321633|BRCA2 mutation carrier|brca2 mutation carrier
782126|NCT00321620|Bone metastases|bone metastases
782127|NCT00321620|Hormone-refractory prostate cancer|hormone-refractory prostate cancer
782128|NCT00321620|Skeletal|skeletal
782129|NCT00321620|Fractures|fractures
782130|NCT00321620|Compressions|compressions
782131|NCT00321620|Bisphosphonates|bisphosphonates
782132|NCT00321581|VEGFR2|vegfr2
782133|NCT00321581|Tyrosine Kinase Inhibitor|tyrosine kinase inhibitor
782134|NCT00321581|Antiangiogenesis|antiangiogenesis
782135|NCT00321581|Solid Tumors|solid tumors
782136|NCT00321581|Childhood Cancer|childhood cancer
782137|NCT00321581|Solid Tumor|solid tumor
782138|NCT00321581|Recurrent Solid Tumor|recurrent solid tumor
782139|NCT00321581|Treatment Resistant Solid Tumor|treatment resistant solid tumor
782140|NCT00321581|Acute Myelogenous Leukemia|acute myelogenous leukemia
782142|NCT00321568|Multiple Sclerosis|multiple sclerosis
782143|NCT00321568|Magnetic Resonance|magnetic resonance
782144|NCT00321568|MRI|mri
782145|NCT00321568|Magnetic Field|magnetic field
782146|NCT00321568|MS|ms
782147|NCT00321555|Biologic Therapy|biologic therapy
782148|NCT00321555|Monoclonal Antibody|monoclonal antibody
782149|NCT00321555|Immunotherapy|immunotherapy
782150|NCT00321555|Pseudomonas Exotoxin|pseudomonas exotoxin
782151|NCT00321555|Targeted Therapy|targeted therapy
782152|NCT00321555|Hairy Cell Leukemia|hairy cell leukemia
782153|NCT00321555|HCL|hcl
782154|NCT00321542|Computed tomography|computed tomography
782155|NCT00321542|Diabetes mellitus|diabetes mellitus
782156|NCT00321542|Coronary atherosclerosis|coronary atherosclerosis
782157|NCT00321542|Non-invasive imaging|non-invasive imaging
782158|NCT00321529|Cervical spine instability|cervical spine instability
782159|NCT00321529|Penning Study|penning study
782160|NCT00321516|Bipolar type I Disorder|bipolar type i disorder
782161|NCT00321503|acid reflux|acid reflux
782162|NCT00321503|LPR|lpr
782163|NCT00321503|gastroesophageal reflux|gastroesophageal reflux
782164|NCT00321503|GERD|gerd
782165|NCT00321503|pH probe|ph probe
782166|NCT00321503|proton pump inhibitor|proton pump inhibitor
782167|NCT00321503|PPI|ppi
782168|NCT00321490|MDD|mdd
782169|NCT00321490|Quetiapine fumarate, sustained release|quetiapine fumarate, sustained release
782170|NCT00321490|Depression|depression
782171|NCT00321477|Overactive Bladder|overactive bladder
782172|NCT00321464|Fractures|fractures
782173|NCT00321464|Compressions|compressions
782174|NCT00321464|Bisphosphonates|bisphosphonates
782175|NCT00321464|Bone metastases|bone metastases
782176|NCT00321464|Breast cancer|breast cancer
782177|NCT00321464|Skeletal|skeletal
782178|NCT00321464|Radiation|radiation
782179|NCT00321464|Surgery to Bone|surgery to bone
782180|NCT00321451|insomnia|insomnia
782181|NCT00321451|cognitive behavior therapy|cognitive behavior therapy
782182|NCT00321438|HIV-1|hiv-1
782183|NCT00321438|GW873140|gw873140
782184|NCT00321438|CCR5 antagonist|ccr5 antagonist
782185|NCT00321438|experienced|experienced
782186|NCT00321438|treatment experienced|treatment experienced
782187|NCT00321412|Crohn's disease|crohn's disease
782188|NCT00321412|IBD|ibd
782189|NCT00321412|Inflammatory Bowel Disease|inflammatory bowel disease
782190|NCT00321412|Fistula|fistula
782191|NCT00321399|CORONARY ANATOMY|coronary anatomy
782192|NCT00321399|Coronary Artery Disease|coronary artery disease
782193|NCT00321399|SPECT|spect
782194|NCT00321399|PET|pet
782195|NCT00321399|PET/CT|pet/ct
782196|NCT00321399|CTA|cta
782197|NCT00321386|Glaucoma|glaucoma
782198|NCT00321386|Open Angle|open angle
782199|NCT00321386|Normal Tension|normal tension
782200|NCT00321373|Influenza|influenza
782201|NCT00321373|Influenza vaccine|influenza vaccine
782202|NCT00321360|propofol|propofol
782203|NCT00321360|sedation|sedation
782207|NCT00321334|non-small cell lung cancer|non-small cell lung cancer
782208|NCT00321334|Chemotherapy|chemotherapy
782209|NCT00321334|surgery|surgery
782210|NCT00321334|neo-adjuvant|neo-adjuvant
782211|NCT00321334|adjuvant|adjuvant
782212|NCT00321334|RCT|rct
782213|NCT00321321|Type 2 diabetes mellitus|type 2 diabetes mellitus
782214|NCT00321321|Glucose dependent insulinotropic polypeptide|glucose dependent insulinotropic polypeptide
782215|NCT00321321|Sulfonylurea compounds|sulfonylurea compounds
782216|NCT00321321|insulin secretion|insulin secretion
782217|NCT00321321|Sulfonylurea receptor subunit-SUR1|sulfonylurea receptor subunit-sur1
782218|NCT00321321|Impaired incretin effect|impaired incretin effect
782219|NCT00321308|advanced carcinoma, non-small cell lung cancer, phase II, pemetrexed, Alimta, PF-3512676, immunotherapy, immunomodulator|advanced carcinoma, non-small cell lung cancer, phase ii, pemetrexed, alimta, pf-3512676, immunotherapy, immunomodulator
782220|NCT00321295|Bi-ventricular pacing|bi-ventricular pacing
782221|NCT00321295|Cardiac Surgery|cardiac surgery
782222|NCT00321295|Cardiomyopahty|cardiomyopahty
782327|NCT00320931|PET CT scan|pet ct scan
782223|NCT00321295|Heart Failure|heart failure
782224|NCT00321282|Atrial Fibrillation|atrial fibrillation
782225|NCT00321282|Coronary Artery Bypass Graft|coronary artery bypass graft
782226|NCT00321282|Risk Stratification|risk stratification
782227|NCT00321269|Home Monitoring|home monitoring
782228|NCT00321269|Heart Failure|heart failure
782229|NCT00321269|Depression|depression
782230|NCT00321256|islet transplantation|islet transplantation
782231|NCT00321256|brittle diabetes|brittle diabetes
782232|NCT00321256|severe hypoglycemia|severe hypoglycemia
782233|NCT00321256|type 1 diabetes mellitus|type 1 diabetes mellitus
782234|NCT00321243|triage|triage
782235|NCT00321230|Colon cleansing|colon cleansing
782236|NCT00321217|rheumatoid arthritis|rheumatoid arthritis
782237|NCT00321217|pharmacogenetics|pharmacogenetics
782238|NCT00321217|anti-TNF|anti-tnf
782239|NCT00321217|high throughput genotyping|high throughput genotyping
782240|NCT00321204|Atrial Fibrillation|atrial fibrillation
782241|NCT00321204|Atrial Flutter|atrial flutter
782242|NCT00321204|Cardiac Surgery|cardiac surgery
782243|NCT00321204|Thiazolidinediones|thiazolidinediones
782244|NCT00321178|Mycobacterium ulcerans|mycobacterium ulcerans
782245|NCT00321178|Buruli ulcer|buruli ulcer
782246|NCT00321178|Ghana|ghana
782247|NCT00321178|randomized comparison|randomized comparison
782248|NCT00321178|streptomycin|streptomycin
782249|NCT00321178|rifampicin|rifampicin
782250|NCT00321178|clarithromycin|clarithromycin
782251|NCT00321165|nutrition|nutrition
782252|NCT00321165|parenteral|parenteral
782253|NCT00321165|infection|infection
782254|NCT00321165|katheter|katheter
782255|NCT00321165|taurolidine|taurolidine
782256|NCT00321165|acridine orange|acridine orange
782257|NCT00321165|prevention|prevention
782258|NCT00321139|biomarkers|biomarkers
782259|NCT00321139|oxidative stress|oxidative stress
782260|NCT00321139|intravascular ultrasound|intravascular ultrasound
782261|NCT00321126|Zinc|zinc
782262|NCT00321126|Shigella|shigella
782263|NCT00321126|Children|children
782264|NCT00321126|Bangladesh|bangladesh
782265|NCT00321113|MARGINAL KIDNEY|marginal kidney
782266|NCT00321113|TACROLIMUS|tacrolimus
782267|NCT00321113|IMMUNOSUPPRESSION|immunosuppression
782268|NCT00321113|ELDERLY RECEPIENTS|elderly recepients
782269|NCT00321100|metastatic|metastatic
782270|NCT00321100|colorectal|colorectal
782271|NCT00321100|cancer|cancer
782272|NCT00321100|initial therapy|initial therapy
782273|NCT00321087|Movement Disorder|movement disorder
782274|NCT00321074|IMMUNOSUPPRESSION|immunosuppression
782275|NCT00321074|TACROLIMUS|tacrolimus
782276|NCT00321074|MARGINAL LIVERS|marginal livers
782277|NCT00321074|PHARMACOKINETICS|pharmacokinetics
782278|NCT00321061|HIV Negative|hiv negative
782279|NCT00321061|Healthy|healthy
782280|NCT00321061|Immunity|immunity
782281|NCT00321061|Preventive|preventive
782282|NCT00321061|Virus|virus
782283|NCT00321061|Healthy Volunteer|healthy volunteer
782284|NCT00321061|HV|hv
782285|NCT00321048|breast cancer|breast cancer
782286|NCT00321048|SPECT|spect
782287|NCT00321048|ABC device|abc device
782288|NCT00321048|Invasive adenocarcinoma of the left breast|invasive adenocarcinoma of the left breast
782289|NCT00321048|Ductal Carcinoma In Situ of the left breast|ductal carcinoma in situ of the left breast
782290|NCT00321035|Glaucoma|glaucoma
782291|NCT00321035|Pterygium|pterygium
782292|NCT00321035|collagen matrix|collagen matrix
782293|NCT00321035|oculusgen|oculusgen
782294|NCT00321035|ologen|ologen
782295|NCT00321035|trabeculectomy|trabeculectomy
782296|NCT00321035|anti scarring|anti scarring
782297|NCT00321035|prevent recurrence|prevent recurrence
782298|NCT00321035|tissue engineering|tissue engineering
782299|NCT00321035|Aeon Astron|aeon astron
782300|NCT00321022|Transient Ischemic Attack (TIA)|transient ischemic attack (tia)
782301|NCT00321022|Diagnostic Protocol|diagnostic protocol
782302|NCT00321022|Observational Medicine|observational medicine
782303|NCT00321022|Emergency Department Observational Unit|emergency department observational unit
782304|NCT00321009|Myocardial Infarction|myocardial infarction
782305|NCT00321009|Left Ventricular Mural Thrombus|left ventricular mural thrombus
782306|NCT00321009|Low Molecular Weight Heparin|low molecular weight heparin
782307|NCT00321009|Enoxaparin|enoxaparin
782308|NCT00321009|Warfarin|warfarin
782309|NCT00321009|Echocardiograms|echocardiograms
782310|NCT00320996|Pelvic mass|pelvic mass
782311|NCT00320983|Cancer|cancer
782312|NCT00320983|Cervix|cervix
782313|NCT00320970|TGF-Beta 1|tgf-beta 1
782314|NCT00320970|Angiotensin II|angiotensin ii
782315|NCT00320970|Advanced glycation end products|advanced glycation end products
782316|NCT00320957|Glaucoma|glaucoma
782317|NCT00320957|Pterygium|pterygium
782318|NCT00320957|collagen matrix|collagen matrix
782319|NCT00320957|OculusGen|oculusgen
782320|NCT00320957|trabeculectomy|trabeculectomy
782321|NCT00320957|Anti scarring|anti scarring
782322|NCT00320957|pterygium recurrence|pterygium recurrence
782323|NCT00320957|tissue engineering|tissue engineering
782324|NCT00320957|Aeon Astron|aeon astron
782325|NCT00320957|ologen|ologen
782326|NCT00320931|Coronary artery disease|coronary artery disease
782330|NCT00320918|Unresectable/metastatic cholangiocarcinoma|unresectable/metastatic cholangiocarcinoma
782331|NCT00320918|Cancer|cancer
782332|NCT00320918|Chart Review|chart review
782333|NCT00320905|Cardiac Rehabilitation|cardiac rehabilitation
782334|NCT00320905|Cognitive functioning|cognitive functioning
782335|NCT00320905|Cardiovascular disease|cardiovascular disease
782336|NCT00320892|Death Rattle|death rattle
782337|NCT00320892|Noise level|noise level
782338|NCT00320892|Primary Care|primary care
782339|NCT00320879|diabetes|diabetes
782340|NCT00320879|microalbuminuria|microalbuminuria
782341|NCT00320879|angiotensin II receptor blockade|angiotensin ii receptor blockade
782342|NCT00320879|irbesartan|irbesartan
782343|NCT00320879|dose-response|dose-response
782344|NCT00320879|randomized|randomized
782345|NCT00320879|double-blind|double-blind
782346|NCT00320879|renin-angiotensin-aldosterone system|renin-angiotensin-aldosterone system
782347|NCT00320879|clinical|clinical
782348|NCT00320879|hypertension|hypertension
782349|NCT00320866|Hypodermoclysis|hypodermoclysis
782350|NCT00320866|Evaluation of Symptoms|evaluation of symptoms
782351|NCT00320853|Diabetes|diabetes
782352|NCT00320853|Vitamin D|vitamin d
782353|NCT00320853|Insulin sensitivity|insulin sensitivity
782354|NCT00320853|Insulin secretion|insulin secretion
782355|NCT00320840|preterm infants|preterm infants
782356|NCT00320840|twins|twins
782357|NCT00320840|motherhood|motherhood
782358|NCT00320840|internal resources|internal resources
782359|NCT00320840|familial resources|familial resources
782360|NCT00320827|Apoptosis|apoptosis
782361|NCT00320827|Death receptor 5|death receptor 5
782362|NCT00320827|Cancer|cancer
782363|NCT00320827|Advanced solid malignancies and lymphomas (without leukemic component)|advanced solid malignancies and lymphomas (without leukemic component)
782364|NCT00320801|Chronic pain|chronic pain
782365|NCT00320801|osteoarthritis|osteoarthritis
782366|NCT00320801|transdermal|transdermal
782367|NCT00320788|Neovascular Age-Related Macular Degeneration|neovascular age-related macular degeneration
782368|NCT00320775|Neovascular Age-Related Macular Degeneration|neovascular age-related macular degeneration
782369|NCT00320762|Glaucoma|glaucoma
782370|NCT00320762|Pterygium|pterygium
782371|NCT00320762|collagen matrix|collagen matrix
782372|NCT00320762|OculusGen|oculusgen
782373|NCT00320762|trabeculectomy|trabeculectomy
782374|NCT00320762|Anti scarring|anti scarring
782375|NCT00320762|pterygium recurrence|pterygium recurrence
782376|NCT00320762|tissue engineering|tissue engineering
782377|NCT00320762|Aeon Astron|aeon astron
782378|NCT00320749|Advanced Pancreatic Cancer|advanced pancreatic cancer
782379|NCT00320736|schizophrenia|schizophrenia
782380|NCT00320736|cognitive function|cognitive function
782381|NCT00320736|cholinergic medication|cholinergic medication
782382|NCT00320736|nicotinic receptor agonist|nicotinic receptor agonist
782383|NCT00320723|schizophrenia|schizophrenia
782384|NCT00320723|smoking cessation|smoking cessation
782385|NCT00320723|nicotine|nicotine
782386|NCT00320723|patch|patch
782387|NCT00320723|bupropion|bupropion
782388|NCT00320723|nicotine replacement therapy|nicotine replacement therapy
782389|NCT00320723|cognitive behavioral therapy|cognitive behavioral therapy
782390|NCT00320710|Breast cancer|breast cancer
782391|NCT00320710|zoledronic acid|zoledronic acid
782392|NCT00320710|bone metastases|bone metastases
782393|NCT00320697|schizophrenia|schizophrenia
782394|NCT00320697|smoking cessation|smoking cessation
782395|NCT00320697|relapse prevention|relapse prevention
782396|NCT00320697|nicotine|nicotine
782397|NCT00320697|bupropion|bupropion
782398|NCT00320697|cognitive behavioral therapy|cognitive behavioral therapy
782399|NCT00320697|nicotine replacement therapy|nicotine replacement therapy
782400|NCT00320684|Serotonin Transporter|serotonin transporter
782401|NCT00320684|Positron-Emission Tomography|positron-emission tomography
782402|NCT00320671|First-episode|first-episode
782403|NCT00320671|Schizoaffective Disorder|schizoaffective disorder
782404|NCT00320671|Schizophreniform Disorder|schizophreniform disorder
782405|NCT00320671|Psychotic Disorder Not Otherwise Specified NOS|psychotic disorder not otherwise specified nos
782406|NCT00320671|Aripiprazole|aripiprazole
782407|NCT00320671|Clozapine|clozapine
782408|NCT00320671|Risperidone|risperidone
782409|NCT00320658|Plasmodium falciparum|plasmodium falciparum
782410|NCT00320632|Major Depressive Disorder|major depressive disorder
782411|NCT00320632|MDD|mdd
782412|NCT00320619|Aminocaproic Acids|aminocaproic acids
782413|NCT00320619|Blood Transfusion|blood transfusion
782414|NCT00320606|immunosuppression withdrawal (IS)|immunosuppression withdrawal (is)
782415|NCT00320606|anti-rejection drugs|anti-rejection drugs
782416|NCT00320606|tolerance|tolerance
782417|NCT00320606|allograft function|allograft function
782418|NCT00320593|Myopia|myopia
782419|NCT00320593|Progressive Addition Lenses (PALs)|progressive addition lenses (pals)
782420|NCT00320593|Single Vision Lenses (SVLs)|single vision lenses (svls)
782421|NCT00320593|Accommodative lags|accommodative lags
782422|NCT00320593|Near esophoria|near esophoria
782423|NCT00320593|Refractive error|refractive error
782424|NCT00320580|Metrorrhagia|metrorrhagia
782425|NCT00320580|oral contraception|oral contraception
782426|NCT00320580|breakthrough bleeding|breakthrough bleeding
782427|NCT00320580|spotting|spotting
782428|NCT00320567|osteoporosis|osteoporosis
782429|NCT00320567|anorexia nervosa|anorexia nervosa
782430|NCT00320567|pediatric|pediatric
782431|NCT00320541|Breast Cancer|breast cancer
782432|NCT00320541|Cancer of Breast|cancer of breast
782433|NCT00320541|Cancer of the breast|cancer of the breast
782434|NCT00320541|Breast Neoplasms|breast neoplasms
782435|NCT00320476|Multiple myeloma|multiple myeloma
782436|NCT00320450|SB-681323|sb-681323
782437|NCT00320450|CRP|crp
782438|NCT00320450|Rheumatoid Arthritis SB-681323 CRP RA|rheumatoid arthritis sb-681323 crp ra
782439|NCT00320450|Rheumatoid Arthritis|rheumatoid arthritis
782440|NCT00320450|RA|ra
782441|NCT00320437|trauma|trauma
782442|NCT00320437|anxiety|anxiety
782443|NCT00320437|antenatal|antenatal
782444|NCT00320437|mothers|mothers
782445|NCT00320437|children|children
782446|NCT00320437|Gene x Environment Interaction|gene x environment interaction
782447|NCT00320424|Xa factor|xa factor
782448|NCT00320424|VTE|vte
782449|NCT00320424|MOSLL|mosll
782450|NCT00320424|pentasaccharide|pentasaccharide
782451|NCT00320411|Stage IV breast cancer|stage iv breast cancer
782452|NCT00320411|Herceptin|herceptin
782453|NCT00320411|metastatic breast cancer|metastatic breast cancer
782454|NCT00320411|ErbB1|erbb1
782455|NCT00320411|ErbB2|erbb2
782456|NCT00320411|trastuzumab|trastuzumab
782457|NCT00320411|lapatinib|lapatinib
782458|NCT00320398|Fondaparinux|fondaparinux
782459|NCT00320398|Hip Replacement Arthroplasty|hip replacement arthroplasty
782460|NCT00320398|VTE|vte
782461|NCT00320398|THR|thr
782462|NCT00320398|MOSLL|mosll
782463|NCT00320398|pentasaccharide|pentasaccharide
782464|NCT00320398|Xa factor|xa factor
782465|NCT00320385|lapatinib|lapatinib
782466|NCT00320385|GW572016|gw572016
782467|NCT00320385|ErbB2|erbb2
782468|NCT00320385|EGFR|egfr
782469|NCT00320385|ErbB1|erbb1
782470|NCT00320385|MBC|mbc
782471|NCT00320385|FISH amplification|fish amplification
782472|NCT00320385|Metastatic Breast Cancer|metastatic breast cancer
782473|NCT00320385|dual tyrosine kinase inhibitor|dual tyrosine kinase inhibitor
782474|NCT00320385|Her-2/neu|her-2/neu
782475|NCT00320372|Major Depressive Disorder|major depressive disorder
782476|NCT00320372|Treatment-resistant Depression|treatment-resistant depression
782477|NCT00320359|First-line Cisplatin|first-line cisplatin
782478|NCT00320359|Small Cell Lung Cancer|small cell lung cancer
782479|NCT00320359|topotecan|topotecan
782480|NCT00320359|etoposide|etoposide
782481|NCT00320359|Extensive Disease|extensive disease
782482|NCT00320346|Pandemic|pandemic
782483|NCT00320346|Influenza|influenza
782484|NCT00320346|Prevention|prevention
782485|NCT00320346|Vaccine|vaccine
782486|NCT00320346|Prevention of Pandemic Influenza|prevention of pandemic influenza
782487|NCT00320333|COPD|copd
782488|NCT00320333|rehabilitation|rehabilitation
782489|NCT00320333|health services research|health services research
782490|NCT00320320|No prior chemotherapy|no prior chemotherapy
782491|NCT00320307|Human Immunodeficiency Virus|human immunodeficiency virus
782492|NCT00320307|HIV|hiv
782493|NCT00320307|Abacavir regime|abacavir regime
782494|NCT00320307|ABC|abc
782495|NCT00320281|Botox|botox
782496|NCT00320268|MDD|mdd
782497|NCT00320268|Quetiapine fumarate, sustained release|quetiapine fumarate, sustained release
782498|NCT00320268|Depression|depression
782499|NCT00320255|anticoagulant|anticoagulant
782500|NCT00320242|Parkinson's disease|parkinson's disease
782501|NCT00320242|laser cane|laser cane
782502|NCT00320242|freezing of gait|freezing of gait
782503|NCT00320242|visual cues|visual cues
782504|NCT00320229|angioplasty|angioplasty
782505|NCT00320229|stent|stent
782506|NCT00320229|abciximab|abciximab
782507|NCT00320229|Platelet Glycoprotein GPIIb-IIIa Complex|platelet glycoprotein gpiib-iiia complex
782508|NCT00320229|myocardial infarction|myocardial infarction
782509|NCT00320216|Psoriasis|psoriasis
782510|NCT00320216|CNTO 1275|cnto 1275
782511|NCT00320216|Ustekinumab|ustekinumab
782512|NCT00320216|Stelara|stelara
782513|NCT00320216|Interleukin-12|interleukin-12
782514|NCT00320216|IL-12|il-12
782515|NCT00320216|Interleukin-23|interleukin-23
782516|NCT00320216|IL-23|il-23
782517|NCT00320203|open-angle|open-angle
782518|NCT00320203|glaucoma|glaucoma
782519|NCT00320190|Chronic phase CML, with a suboptimal response after treatment with imatinib|chronic phase cml, with a suboptimal response after treatment with imatinib
782520|NCT00320177|Binge Eating|binge eating
782521|NCT00320177|Food Intake|food intake
782522|NCT00320177|Obesity|obesity
782523|NCT00320177|Melanocortin-4 Receptor Gene|melanocortin-4 receptor gene
782524|NCT00320177|Child|child
782525|NCT00320177|Macronutrient Composition|macronutrient composition
782526|NCT00320164|Healthy Volunteers|healthy volunteers
782527|NCT00320151|chronic lung disease|chronic lung disease
782528|NCT00320138|PTSD|ptsd
782529|NCT00320138|Posttraumatic Stress|posttraumatic stress
782530|NCT00320138|Acupuncture|acupuncture
782531|NCT00320138|Randomized Controlled Trial|randomized controlled trial
782532|NCT00320138|Complementary medicine|complementary medicine
782533|NCT00320138|Alternative medicine|alternative medicine
782534|NCT00320138|Chinese medicine|chinese medicine
782535|NCT00320138|military healthcare|military healthcare
782536|NCT00320125|Dairy|dairy
782537|NCT00320125|Calcium|calcium
782538|NCT00320125|Pregnancy|pregnancy
782539|NCT00320125|Fetus|fetus
782540|NCT00320125|Bone mineralization|bone mineralization
782541|NCT00320112|telemedicine|telemedicine
782542|NCT00320112|case management|case management
782543|NCT00320112|insulin|insulin
782544|NCT00320112|self-care|self-care
782545|NCT00320099|septic shock|septic shock
782546|NCT00320099|adrenal insufficiency|adrenal insufficiency
782547|NCT00320099|glucose control|glucose control
782548|NCT00320099|mineralocorticoids|mineralocorticoids
782549|NCT00320073|unspecified adult solid tumor, protocol specific|unspecified adult solid tumor, protocol specific
782550|NCT00320060|Diabetic nephropathy|diabetic nephropathy
782551|NCT00320060|Advanced Glycation Endproduct Inhibitor|advanced glycation endproduct inhibitor
782552|NCT00320060|Pyridorin|pyridorin
782553|NCT00320060|Pyridoxamine|pyridoxamine
782554|NCT00320047|Binge Eating Disorder|binge eating disorder
782555|NCT00320034|levalbuterol|levalbuterol
782556|NCT00320034|asthma|asthma
782557|NCT00320034|allergen provocation|allergen provocation
782558|NCT00320034|airway inflammation|airway inflammation
782559|NCT00320034|clinical trial|clinical trial
782560|NCT00320021|Diabetic nephropathy|diabetic nephropathy
782561|NCT00320021|Advanced Glycation Endproduct Inhibitor|advanced glycation endproduct inhibitor
782562|NCT00320021|Pyridorin|pyridorin
782563|NCT00320021|Pyridoxamine|pyridoxamine
782564|NCT00319982|Hypertrophic Cardiomyopathy|hypertrophic cardiomyopathy
782565|NCT00319982|Left ventricular hypertrophy|left ventricular hypertrophy
782566|NCT00319982|Diltiazem|diltiazem
782567|NCT00319969|small cell lung cancer|small cell lung cancer
782568|NCT00319969|amrubicin|amrubicin
782569|NCT00319956|premature infant|premature infant
782570|NCT00319956|respiratory distress syndrome|respiratory distress syndrome
782571|NCT00319956|mechanical ventilation|mechanical ventilation
782572|NCT00319943|Cognitive remediation|cognitive remediation
782573|NCT00319943|Cognitive impairment|cognitive impairment
782574|NCT00319943|computer|computer
782575|NCT00319943|training|training
782576|NCT00319930|Chronic lymphocytic leukemia|chronic lymphocytic leukemia
782578|NCT00319930|ZAP-70|zap-70
782579|NCT00319930|Hsp90 inhibitor|hsp90 inhibitor
782580|NCT00319917|Tacrolimus|tacrolimus
782581|NCT00319917|Rheumatoid Arthritis|rheumatoid arthritis
782582|NCT00319917|Tacrolimus anhydrous|tacrolimus anhydrous
782583|NCT00319904|Schizophrenia|schizophrenia
782584|NCT00319904|DNA|dna
782585|NCT00319891|Alzheimer's|alzheimer's
782586|NCT00319891|AD|ad
782587|NCT00319891|Mild Cognitive Impairment|mild cognitive impairment
782588|NCT00319891|Dementia|dementia
782589|NCT00319891|Cognitive remediation|cognitive remediation
782590|NCT00319891|computer-based training|computer-based training
782591|NCT00319865|Multiple Myeloma Relapsed|multiple myeloma relapsed
782592|NCT00319852|Diphteria;|diphteria;
782593|NCT00319852|Tetanus;|tetanus;
782594|NCT00319852|Pertussis;|pertussis;
782595|NCT00319852|Poliomyelitis;|poliomyelitis;
782596|NCT00319852|acellular|acellular
782597|NCT00319839|Head cancer|head cancer
782598|NCT00319839|Neck cancer|neck cancer
782599|NCT00319839|cetuximab|cetuximab
782600|NCT00319839|abraxane|abraxane
782601|NCT00319839|erbitux|erbitux
782602|NCT00319839|IMC-225|imc-225
782603|NCT00319839|NSC-714692|nsc-714692
782604|NCT00319826|Staphylococcus aureus, S. aureus, bacteremia, sepsis|staphylococcus aureus, s. aureus, bacteremia, sepsis
782605|NCT00319774|End-stage renal disease|end-stage renal disease
782606|NCT00319774|Hemodialysis|hemodialysis
782607|NCT00319774|Hypertension|hypertension
782608|NCT00319774|Hypotension|hypotension
782609|NCT00319774|Blood volume|blood volume
782610|NCT00319774|Hypervolemia|hypervolemia
782611|NCT00319774|Quality of life|quality of life
782612|NCT00319774|Biofeedback system|biofeedback system
782613|NCT00319761|glomerulonephritis|glomerulonephritis
782614|NCT00319761|proteinuria|proteinuria
782615|NCT00319761|chronic kidney diseases|chronic kidney diseases
782616|NCT00319748|Breast|breast
782617|NCT00319748|Ovarian|ovarian
782618|NCT00319748|Endometrial|endometrial
782619|NCT00319748|Cervical|cervical
782620|NCT00319748|Metastatic|metastatic
782621|NCT00319748|852A|852a
782622|NCT00319748|IRM|irm
782623|NCT00319748|Oncology|oncology
782624|NCT00319748|Metastatic Cervical Cancer|metastatic cervical cancer
782625|NCT00319748|Metastatic Ovarian Cancer|metastatic ovarian cancer
782626|NCT00319748|Metastatic Breast Cancer|metastatic breast cancer
782627|NCT00319748|Metastatic Endometrial Cancer|metastatic endometrial cancer
782628|NCT00319722|autism|autism
782629|NCT00319722|pervasive developmental disorder|pervasive developmental disorder
782630|NCT00319722|evoked potentials|evoked potentials
782631|NCT00319722|EEG|eeg
782632|NCT00319722|Coherence|coherence
782633|NCT00319709|depression|depression
782634|NCT00319709|antidepressive agents|antidepressive agents
782635|NCT00319709|controlled clinical trial|controlled clinical trial
782636|NCT00319696|digital ulcers|digital ulcers
782637|NCT00319696|systemic sclerosis|systemic sclerosis
782638|NCT00319696|finger ulcers|finger ulcers
782639|NCT00319696|bosentan|bosentan
782640|NCT00319696|open label|open label
782641|NCT00319683|Cancer|cancer
782642|NCT00319683|Tumors|tumors
782643|NCT00319683|Neoplasms|neoplasms
782644|NCT00319683|Anticarcinogenic Agents|anticarcinogenic agents
782645|NCT00319683|Antineoplastic Agents|antineoplastic agents
782646|NCT00319683|Dihydrouracil Dehydrogenase (NADP)|dihydrouracil dehydrogenase (nadp)
782647|NCT00319670|constipation|constipation
782648|NCT00319670|pediatric|pediatric
782649|NCT00319657|Kidney Transplantation|kidney transplantation
782650|NCT00319657|Blood Stem Cell Transplantation|blood stem cell transplantation
782651|NCT00319631|Respiratory Distress Syndrome, Adult|respiratory distress syndrome, adult
782652|NCT00319605|Cross sectional study|cross sectional study
782653|NCT00319605|acceptability|acceptability
782654|NCT00319605|levetiracetam|levetiracetam
782655|NCT00319605|oral solution|oral solution
782656|NCT00319605|Keppra|keppra
782657|NCT00319592|Japanese encephalitis|japanese encephalitis
782658|NCT00319592|ChimeriVax™-JE|chimerivax™-je
782659|NCT00319592|JE-VAX®|je-vax®
782660|NCT00319579|living kidney donors|living kidney donors
782661|NCT00319579|prospective|prospective
782662|NCT00319579|medical|medical
782663|NCT00319579|psychosocial|psychosocial
782664|NCT00319566|Coronary Heart Disease|coronary heart disease
782665|NCT00319566|Hormone replacement therapy|hormone replacement therapy
782666|NCT00319566|Estrogen|estrogen
782667|NCT00319566|Postmenopausal women|postmenopausal women
782668|NCT00319553|Tetanus|tetanus
782669|NCT00319553|diphtheria|diphtheria
782670|NCT00319553|acellular pertussis|acellular pertussis
782671|NCT00319540|Depression|depression
782672|NCT00319540|psychoeducation|psychoeducation
782673|NCT00319540|RCT|rct
782674|NCT00319540|primary health services|primary health services
782675|NCT00319527|long term outcome|long term outcome
782676|NCT00319527|living kidney donor|living kidney donor
782677|NCT00319501|Acute Repetitive Seizures|acute repetitive seizures
782678|NCT00319501|ARS|ars
782679|NCT00319501|Diazepam|diazepam
782680|NCT00319501|Cluster Seizures|cluster seizures
782681|NCT00319488|Wheezing|wheezing
782682|NCT00319488|Respiratory Tract Illness|respiratory tract illness
782683|NCT00319462|point A, cervical cancer, radiotherapy|point a, cervical cancer, radiotherapy
782684|NCT00319436|parenting intervention|parenting intervention
782685|NCT00319436|family intervention|family intervention
782686|NCT00319436|maternal substance abuse|maternal substance abuse
782687|NCT00319436|mother-child relations|mother-child relations
782688|NCT00319436|parent-child relations|parent-child relations
782689|NCT00319423|Hip Osteoarthritis, Exercise therapy, Patient Education|hip osteoarthritis, exercise therapy, patient education
782690|NCT00319410|Menorrhagia|menorrhagia
782691|NCT00319410|intrauterine diagnosis|intrauterine diagnosis
782692|NCT00319410|visual analogue scale|visual analogue scale
782693|NCT00319397|vascular resistance|vascular resistance
782694|NCT00319397|vasomotion|vasomotion
782695|NCT00319397|coronary disorder|coronary disorder
782696|NCT00319397|hemodynamics|hemodynamics
782697|NCT00319397|physical fitness|physical fitness
782698|NCT00319384|congestive heart failure|congestive heart failure
782699|NCT00319384|heart failure|heart failure
782700|NCT00319384|ultrafiltration therapy|ultrafiltration therapy
782701|NCT00319384|fluid overload|fluid overload
782702|NCT00319371|vasospasm|vasospasm
782703|NCT00319371|circadian|circadian
782704|NCT00319371|sleep-disorders|sleep-disorders
782705|NCT00319358|chronic pancreatitis|chronic pancreatitis
782706|NCT00319358|antioxidant supplementation|antioxidant supplementation
782707|NCT00319358|oxidative stress|oxidative stress
782708|NCT00319345|Traumatic brain injury|traumatic brain injury
782802|NCT00318981|Concerta|concerta
782709|NCT00319345|Intracranial pressure|intracranial pressure
782710|NCT00319345|Osmotherapy|osmotherapy
782711|NCT00319345|Glasgow outcome score|glasgow outcome score
782712|NCT00319345|Mannitol|mannitol
782713|NCT00319345|Sodium-Lactate|sodium-lactate
782714|NCT00319332|non-Hodgkin's Lymphoma|non-hodgkin's lymphoma
782715|NCT00319332|follicular lymphoma|follicular lymphoma
782716|NCT00319332|BEXXAR|bexxar
782717|NCT00319332|ZEVALIN|zevalin
782718|NCT00319332|Iodine I 131 Tositumomab|iodine i 131 tositumomab
782719|NCT00319332|Ibritumomab Tiuxetan|ibritumomab tiuxetan
782720|NCT00319332|Follicular, mixed small-cleaved and large-cell|follicular, mixed small-cleaved and large-cell
782721|NCT00319332|Diffuse large cell non-Hodgkin's lymphoma following or concurrent with a diagnosis of follicular lymphoma|diffuse large cell non-hodgkin's lymphoma following or concurrent with a diagnosis of follicular lymphoma
782722|NCT00319319|major depressive disorder,|major depressive disorder,
782723|NCT00319319|serotonin selective reuptake inhibitor,|serotonin selective reuptake inhibitor,
782724|NCT00319319|mecamylamine,|mecamylamine,
782725|NCT00319319|controlled trial,|controlled trial,
782726|NCT00319319|cigarette smoking|cigarette smoking
782727|NCT00319306|Respiratory Tract Diseases|respiratory tract diseases
782728|NCT00319306|Bronchial Diseases|bronchial diseases
782729|NCT00319306|Anti-asthmatic agents|anti-asthmatic agents
782730|NCT00319306|Anti-asthmatic drugs|anti-asthmatic drugs
782731|NCT00319306|Bronchodilators|bronchodilators
782732|NCT00319280|Osteoarthritis, Knee|osteoarthritis, knee
782733|NCT00319280|Osteotomy|osteotomy
782734|NCT00319280|Healing|healing
782735|NCT00319280|Roentgen Stereometric Analysis|roentgen stereometric analysis
782736|NCT00319267|bosentan|bosentan
782737|NCT00319267|children|children
782738|NCT00319267|pharmacokinetics|pharmacokinetics
782739|NCT00319267|pulmonary arterial hypertension|pulmonary arterial hypertension
782740|NCT00319254|Advanced Breast Cancer|advanced breast cancer
782741|NCT00319241|parenting intervention|parenting intervention
782742|NCT00319241|substance abuse treatment|substance abuse treatment
782743|NCT00319241|mother-child relations|mother-child relations
782744|NCT00319241|parent-child relations|parent-child relations
782745|NCT00319241|child abuse and neglect|child abuse and neglect
782746|NCT00319228|AT-III deficiency|at-iii deficiency
782747|NCT00319228|AT-III concentrate|at-iii concentrate
782748|NCT00319228|Bleeding disorders|bleeding disorders
782749|NCT00319228|Blood disorders|blood disorders
782750|NCT00319215|ramelteon|ramelteon
782751|NCT00319215|zopiclone|zopiclone
782752|NCT00319215|driving|driving
782753|NCT00319215|memory|memory
782754|NCT00319215|balance|balance
782755|NCT00319215|psychomotor|psychomotor
782756|NCT00319202|Impaired fasting glucose|impaired fasting glucose
782757|NCT00319202|Abdominal obesity|abdominal obesity
782758|NCT00319202|HOMA|homa
782759|NCT00319202|Angiotensin-receptor blocker|angiotensin-receptor blocker
782760|NCT00319189|Nateglinide|nateglinide
782761|NCT00319189|Renal|renal
782762|NCT00319189|Kidney|kidney
782763|NCT00319189|Transplantation|transplantation
782764|NCT00319189|Diabets|diabets
782765|NCT00319189|Glucose|glucose
782766|NCT00319176|Pregnancy|pregnancy
782767|NCT00319176|Enoxaparin|enoxaparin
782768|NCT00319176|Anticoagulation|anticoagulation
782769|NCT00319163|oral contraceptive|oral contraceptive
782770|NCT00319163|therapeutic equivalency|therapeutic equivalency
782771|NCT00319163|contraceptives, oral, combined|contraceptives, oral, combined
782772|NCT00319150|Erythropoetin resistance|erythropoetin resistance
782773|NCT00319150|End Stage Renal Disease on hemodialysis|end stage renal disease on hemodialysis
782774|NCT00319137|GW274150|gw274150
782775|NCT00319137|Nitric Oxide|nitric oxide
782776|NCT00319137|acute migraine|acute migraine
782777|NCT00319124|Hip Osteoarthritis, muscle strength, range of motion, aerobic capacity, functional capacity, health-related quality of life|hip osteoarthritis, muscle strength, range of motion, aerobic capacity, functional capacity, health-related quality of life
782778|NCT00319111|pulmonary hypertension|pulmonary hypertension
782779|NCT00319111|bosentan|bosentan
782780|NCT00319111|BENEFIT|benefit
782781|NCT00319111|CTEPH|cteph
782782|NCT00319111|inoperable chronic thromboembolic pulmonary hypertension (CTEPH)|inoperable chronic thromboembolic pulmonary hypertension (cteph)
782783|NCT00319098|Adjuvanted pandemic influenza candidate vaccine|adjuvanted pandemic influenza candidate vaccine
782784|NCT00319098|Influenza|influenza
782785|NCT00319085|Arthroplasty,|arthroplasty,
782786|NCT00319085|Hip,|hip,
782787|NCT00319085|Pre-heating,|pre-heating,
782788|NCT00319085|Radiostereometric analysis,|radiostereometric analysis,
782789|NCT00319085|Dual-Energy Radiographic Absorptiometry,|dual-energy radiographic absorptiometry,
782790|NCT00319046|enzyme replacement therapy|enzyme replacement therapy
782791|NCT00319046|Type 1 Gaucher Disease|type 1 gaucher disease
782792|NCT00319046|miglustat|miglustat
782793|NCT00319033|interstitial lung disease|interstitial lung disease
782794|NCT00319033|scleroderma|scleroderma
782795|NCT00319033|bosentan|bosentan
782796|NCT00319020|bosentan|bosentan
782797|NCT00319020|pulmonary arterial hypertension|pulmonary arterial hypertension
782798|NCT00319020|children|children
782799|NCT00319020|FUTURE 1|future 1
782800|NCT00318981|Medication trial|medication trial
782801|NCT00318981|ADHD|adhd
782803|NCT00318981|Efficacy trial|efficacy trial
782804|NCT00318968|Acid Reflux|acid reflux
782805|NCT00318968|Nexium|nexium
782806|NCT00318968|Esomeprazole|esomeprazole
782807|NCT00318955|Dexmedetomidine, Sedation, Extubation, Phase 4|dexmedetomidine, sedation, extubation, phase 4
782808|NCT00318942|Sepsis|sepsis
782809|NCT00318942|Multiple Trauma|multiple trauma
782810|NCT00318942|Hypovolemic Shock|hypovolemic shock
782811|NCT00318929|Treatment Efficacy|treatment efficacy
782812|NCT00318929|pharmacokinetics|pharmacokinetics
782813|NCT00318903|Chemotherapy for cancer of the esophagus|chemotherapy for cancer of the esophagus
782814|NCT00318903|Radiotherapy for cancer of the esophagus|radiotherapy for cancer of the esophagus
782815|NCT00318903|Surgery for cancer of the esophagus|surgery for cancer of the esophagus
782816|NCT00318903|Chemotherapy, radiotherapy, surgery for esophageal cancer|chemotherapy, radiotherapy, surgery for esophageal cancer
782817|NCT00318890|Chemotherapy and Radiotherapy for Head and Neck Cancer|chemotherapy and radiotherapy for head and neck cancer
782818|NCT00318890|Chemotherapy, Radiotherapy Squamous Cell Carcinoma Head Neck|chemotherapy, radiotherapy squamous cell carcinoma head neck
782819|NCT00318877|Obesity|obesity
782820|NCT00318877|Physical activity|physical activity
782821|NCT00318864|depression|depression
782822|NCT00318864|cardiovascular risk|cardiovascular risk
782823|NCT00318864|mechanisms|mechanisms
782824|NCT00318851|Carotid Artery stenting|carotid artery stenting
782825|NCT00318851|Stroke|stroke
782826|NCT00318825|Pain|pain
782827|NCT00318825|Colonoscopy|colonoscopy
782828|NCT00318825|Sedation|sedation
782829|NCT00318812|Randomized controlled trial (RCT)|randomized controlled trial (rct)
782830|NCT00318812|Prospective Studies|prospective studies
782831|NCT00318812|ferric oxide, saccharated|ferric oxide, saccharated
782832|NCT00318812|Peptides|peptides
782833|NCT00318812|Heme|heme
782834|NCT00318812|Iron|iron
782835|NCT00318812|Erythropoietin,|erythropoietin,
782836|NCT00318812|Recombinant|recombinant
782837|NCT00318812|Ferritin|ferritin
782838|NCT00318812|Transferrin|transferrin
782839|NCT00318812|Treatment Outcome|treatment outcome
782840|NCT00318799|prevention of unintended pregnancies|prevention of unintended pregnancies
782841|NCT00318773|PMS|pms
782842|NCT00318773|PMDD|pmdd
782843|NCT00318773|sertraline|sertraline
782844|NCT00318773|antidepressant|antidepressant
782845|NCT00318773|extended treatment|extended treatment
782846|NCT00318773|relapse|relapse
782847|NCT00318760|Drug Cue|drug cue
782848|NCT00318760|Relapse|relapse
782849|NCT00318760|Stress|stress
782850|NCT00318760|Craving|craving
782851|NCT00318747|Amb a 1-Immunostimulatory Oligodeoxyribonucleotide Conjugate|amb a 1-immunostimulatory oligodeoxyribonucleotide conjugate
782852|NCT00318747|AIC|aic
782853|NCT00318747|Amb a I Protein|amb a i protein
782854|NCT00318747|Ragweed Allergy|ragweed allergy
782855|NCT00318747|Hay Fever|hay fever
782856|NCT00318747|Wheeze|wheeze
782857|NCT00318747|Immunotherapy|immunotherapy
782858|NCT00318747|Tolerance|tolerance
782859|NCT00318747|Immunostimulatory|immunostimulatory
782860|NCT00318747|Ragweed Season|ragweed season
782861|NCT00318747|Asthma|asthma
782862|NCT00318747|Asthmatics|asthmatics
782863|NCT00318747|Asthmatic|asthmatic
782864|NCT00318721|Leishmania donovani|leishmania donovani
782865|NCT00318721|cluster-randomised control trial|cluster-randomised control trial
782866|NCT00318721|Long Lasting Impregnated Nets|long lasting impregnated nets
782867|NCT00318721|Bednets|bednets
782868|NCT00318721|Sandflies|sandflies
782869|NCT00318695|Probiotics|probiotics
782870|NCT00318695|Eczema|eczema
782871|NCT00318695|Asthma|asthma
782872|NCT00318695|Allergic Rhinitis|allergic rhinitis
782873|NCT00318695|Prevention|prevention
782874|NCT00318695|Immunological responses|immunological responses
782875|NCT00318682|biopsy|biopsy
782876|NCT00318682|FIBROSCAN|fibroscan
782877|NCT00318669|Anxiety|anxiety
782878|NCT00318669|SAD|sad
782879|NCT00318669|Social|social
782880|NCT00318669|Disorder|disorder
782881|NCT00318656|type 2 diabetes|type 2 diabetes
782882|NCT00318656|rosiglitazone|rosiglitazone
782883|NCT00318656|metformin|metformin
782884|NCT00318656|glimepiride|glimepiride
782885|NCT00318656|glycemia|glycemia
782886|NCT00318643|Non-invasive bladder cancer|non-invasive bladder cancer
782887|NCT00318643|Chemophase|chemophase
782888|NCT00318643|Intravesical administration|intravesical administration
782889|NCT00318643|Superficial Bladder Cancer|superficial bladder cancer
782890|NCT00318630|Asthma AVANDIA Inflammation|asthma avandia inflammation
782891|NCT00318617|peroxisome proliferator activated receptors,|peroxisome proliferator activated receptors,
782892|NCT00318617|PPARs,|ppars,
782893|NCT00318617|Heart Failure,|heart failure,
782894|NCT00318617|cardiac energetics,|cardiac energetics,
782895|NCT00318617|MRI,|mri,
782896|NCT00318617|GW501516X|gw501516x
782897|NCT00318617|fatty acid metabolism,|fatty acid metabolism,
782898|NCT00318604|plasma circulating DNA|plasma circulating dna
782899|NCT00318604|hean and neck cancers|hean and neck cancers
782900|NCT00318604|esophageal cancer|esophageal cancer
782901|NCT00318604|localized head and neck cancers|localized head and neck cancers
782902|NCT00318604|localized esophageal cancer|localized esophageal cancer
782903|NCT00318578|convulsive status epilepticus|convulsive status epilepticus
782904|NCT00318578|outcome|outcome
782905|NCT00318578|prognosis factors|prognosis factors
782906|NCT00318578|seizure duration|seizure duration
782907|NCT00318578|adult|adult
782908|NCT00318578|electroencephalogram|electroencephalogram
782909|NCT00318578|intensive care unit|intensive care unit
782910|NCT00318565|Heart Disease|heart disease
782911|NCT00318565|Atrial Flutter|atrial flutter
782912|NCT00318565|Typical Atrial Flutter|typical atrial flutter
782913|NCT00318552|Antibiotic Therapy|antibiotic therapy
782914|NCT00318552|sepsis treatment|sepsis treatment
782915|NCT00318552|Meropenem|meropenem
782916|NCT00318539|Obsessive Compulsive Disorder|obsessive compulsive disorder
782917|NCT00318513|breast cancer|breast cancer
782918|NCT00318513|lymphedema|lymphedema
782919|NCT00318513|extremity|extremity
782920|NCT00318513|women|women
782921|NCT00318500|Endometriosis|endometriosis
782922|NCT00318500|Dysmenorrhea|dysmenorrhea
782923|NCT00318500|Pelvic pain|pelvic pain
782924|NCT00318500|Dyspareunia|dyspareunia
782925|NCT00318487|Dental implants|dental implants
782926|NCT00318474|Proteinuria|proteinuria
782927|NCT00318474|Immunoglobulin A|immunoglobulin a
782928|NCT00318448|Child Psychology|child psychology
782929|NCT00318448|Pediatric Psychology|pediatric psychology
782930|NCT00318448|Insomnia|insomnia
782931|NCT00318448|Sleeplessness|sleeplessness
782932|NCT00318409|Methamphetamine|methamphetamine
782933|NCT00318409|HIV|hiv
782934|NCT00318396|THA|tha
782935|NCT00318383|Vaccine|vaccine
782936|NCT00318383|Immunogenicity|immunogenicity
782937|NCT00318383|Randomized Controlled Trial|randomized controlled trial
782938|NCT00318370|Ovarian Cancer|ovarian cancer
782939|NCT00318370|Primary Fallopian Tube Cancer|primary fallopian tube cancer
782940|NCT00318370|Peritoneal Cancer|peritoneal cancer
782941|NCT00318357|Cardiac Resynchronization therapy (CRT)|cardiac resynchronization therapy (crt)
782942|NCT00318357|All-cause mortality|all-cause mortality
782943|NCT00318357|Long-term follow-up|long-term follow-up
782944|NCT00318331|Glutamine|glutamine
782945|NCT00318331|Critical Illness|critical illness
782946|NCT00318331|Enteral Feeding|enteral feeding
782947|NCT00318331|Blood Volume Analysis|blood volume analysis
782948|NCT00318318|Premarin,|premarin,
782949|NCT00318318|HRT,|hrt,
782950|NCT00318318|RNA,|rna,
782951|NCT00318318|Gene Expression.|gene expression.
782952|NCT00318318|Postmenopausal Women|postmenopausal women
782953|NCT00318292|preemptive analgesia|preemptive analgesia
782954|NCT00318292|paracervical block|paracervical block
782955|NCT00318292|vaginal hysterectomy|vaginal hysterectomy
782956|NCT00318279|Surgical education|surgical education
782957|NCT00318279|Vascular anastomosis|vascular anastomosis
782958|NCT00318279|Simulator|simulator
782959|NCT00318279|Randomized controlled trial|randomized controlled trial
782960|NCT00318266|Detection of Bladder Cancer using NMP22 Urine Test Kit|detection of bladder cancer using nmp22 urine test kit
782961|NCT00318253|Cranberry juice|cranberry juice
782962|NCT00318253|Antiadhesion|antiadhesion
782963|NCT00318253|Urinary tract infection|urinary tract infection
782964|NCT00318253|vaginosis|vaginosis
782965|NCT00318240|High Intensity Focused Ultrasound|high intensity focused ultrasound
782966|NCT00318240|Men|men
782967|NCT00318240|Locally recurrent prostate cancer.|locally recurrent prostate cancer.
782968|NCT00318227|Postoperative care|postoperative care
782969|NCT00318227|Cardiac Surgery|cardiac surgery
782970|NCT00318227|Blood Transfusion|blood transfusion
782971|NCT00318214|toe ulcer|toe ulcer
782972|NCT00318214|heel ulcer|heel ulcer
782973|NCT00318214|foot ulcer|foot ulcer
782974|NCT00318214|diabetic feet|diabetic feet
782975|NCT00318214|diabetic foot|diabetic foot
782976|NCT00318214|complications of diabetes|complications of diabetes
782977|NCT00318201|Healthy Subjects|healthy subjects
782978|NCT00318188|scleroderma|scleroderma
782979|NCT00318188|HAQ|haq
782980|NCT00318188|Intensive care reeducation, readaptation|intensive care reeducation, readaptation
782981|NCT00318175|Systemic Scleroderma|systemic scleroderma
782982|NCT00318175|Dermal Sclerosis|dermal sclerosis
782983|NCT00318175|Bosentan|bosentan
782984|NCT00318175|Endothelin Receptor Antagonist|endothelin receptor antagonist
782985|NCT00318175|Rodnan Skin Score|rodnan skin score
782986|NCT00318162|autism|autism
782987|NCT00318162|PDD|pdd
782988|NCT00318162|LDN|ldn
782989|NCT00318162|naltrexone|naltrexone
782990|NCT00318136|BRIDGE|bridge
782991|NCT00318136|NSCLC|nsclc
782992|NCT00318136|Lung Cancer|lung cancer
782993|NCT00318136|Avastin|avastin
782994|NCT00318123|Simplification therapy|simplification therapy
782995|NCT00318123|Efficacy|efficacy
782996|NCT00318123|Safety|safety
782997|NCT00318123|Virological effectiveness|virological effectiveness
782998|NCT00318123|Immunological effectiveness|immunological effectiveness
782999|NCT00318123|HIV|hiv
783000|NCT00318110|Metastatic|metastatic
783001|NCT00318110|Renal|renal
783002|NCT00318110|Cell|cell
783003|NCT00318110|Carcinoma|carcinoma
783004|NCT00318110|Unrelated|unrelated
783005|NCT00318110|Donor|donor
783006|NCT00318110|Transplant|transplant
783007|NCT00318110|stage IV|stage iv
783008|NCT00318110|clear cell|clear cell
783009|NCT00318097|McCune Albright Syndrome|mccune albright syndrome
783010|NCT00318097|Histamine regulation|histamine regulation
783011|NCT00318084|Gastroesophageal reflux disease|gastroesophageal reflux disease
783012|NCT00318084|Heartburn|heartburn
783013|NCT00318084|Acid-related diseases|acid-related diseases
783014|NCT00318084|Acid reflux disease|acid reflux disease
783015|NCT00318084|Nexium|nexium
783016|NCT00318071|Stroke|stroke
783017|NCT00318071|Ischemic|ischemic
783018|NCT00318071|Thrombus|thrombus
783019|NCT00318071|Embolectomy|embolectomy
783020|NCT00318071|Thrombectomy|thrombectomy
783021|NCT00318071|Merci|merci
783022|NCT00318071|Concentric|concentric
783023|NCT00318071|Embolus|embolus
783024|NCT00318071|Embolism|embolism
783025|NCT00318071|Mechanical|mechanical
783026|NCT00318045|Refractive error|refractive error
783027|NCT00318045|Asthenopia|asthenopia
783028|NCT00318032|Randomised control trial|randomised control trial
783029|NCT00318032|Screening|screening
783030|NCT00318032|Intensive management|intensive management
783031|NCT00318032|Diabetes mellitus|diabetes mellitus
783032|NCT00318032|Type 2 diabetes|type 2 diabetes
783033|NCT00318019|Energy|energy
783034|NCT00318019|Energy Level|energy level
783035|NCT00318006|chronic|chronic
783036|NCT00318006|nasal|nasal
783037|NCT00318006|sinus|sinus
783038|NCT00318006|symptoms|symptoms
783039|NCT00317980|Cutaneous leishmaniasis|cutaneous leishmaniasis
783040|NCT00317980|Leishmania braziliensis|leishmania braziliensis
783041|NCT00317980|Pentavalent antimony|pentavalent antimony
783042|NCT00317980|Meglumine antimoniate|meglumine antimoniate
783043|NCT00317967|Hypertrophic cardiomyopathy|hypertrophic cardiomyopathy
783044|NCT00317967|Statin therapy|statin therapy
783045|NCT00317967|Regression|regression
783046|NCT00317967|Heart failure|heart failure
783047|NCT00317967|Arrhythmias|arrhythmias
783048|NCT00317967|Sudden cardiac death|sudden cardiac death
783049|NCT00317954|Diabetic nephropathy|diabetic nephropathy
783050|NCT00317954|Spironolactone|spironolactone
783051|NCT00317954|Aldosterone antagonism|aldosterone antagonism
783052|NCT00317954|Renoprotection|renoprotection
783053|NCT00317941|Multiple Sclerosis|multiple sclerosis
783054|NCT00317941|RRMS|rrms
783055|NCT00317928|Polycystic Ovary Syndrome|polycystic ovary syndrome
783056|NCT00317928|Metformin|metformin
783057|NCT00317928|Metabolic Syndrome|metabolic syndrome
783058|NCT00317928|Hyperandrogenism|hyperandrogenism
783059|NCT00317928|Ovulation|ovulation
783060|NCT00317902|Anemia|anemia
783061|NCT00317902|erythropoetin|erythropoetin
783062|NCT00317902|Epoetin alfa|epoetin alfa
783063|NCT00317902|erythropoetin recombinant|erythropoetin recombinant
783064|NCT00317902|HIV, AIDS|hiv, aids
783065|NCT00317889|THA|tha
783066|NCT00317876|Fanconi anemia|fanconi anemia
783067|NCT00317837|Fracture of Femoral Neck|fracture of femoral neck
783068|NCT00317811|stage I multiple myeloma|stage i multiple myeloma
783069|NCT00317811|stage II multiple myeloma|stage ii multiple myeloma
783070|NCT00317811|stage III multiple myeloma|stage iii multiple myeloma
783071|NCT00317798|drug/agent toxicity by tissue/organ|drug/agent toxicity by tissue/organ
783072|NCT00317798|stage I multiple myeloma|stage i multiple myeloma
783073|NCT00317798|stage II multiple myeloma|stage ii multiple myeloma
783074|NCT00317798|stage III multiple myeloma|stage iii multiple myeloma
783075|NCT00317798|refractory multiple myeloma|refractory multiple myeloma
783076|NCT00317785|adult acute myeloid leukemia with 11q23 (MLL) abnormalities|adult acute myeloid leukemia with 11q23 (mll) abnormalities
783077|NCT00317785|adult acute myeloid leukemia with inv(16)(p13;q22)|adult acute myeloid leukemia with inv(16)(p13;q22)
783078|NCT00317785|adult acute myeloid leukemia with t(15;17)(q22;q12)|adult acute myeloid leukemia with t(15;17)(q22;q12)
783079|NCT00317785|adult acute myeloid leukemia with t(16;16)(p13;q22)|adult acute myeloid leukemia with t(16;16)(p13;q22)
783080|NCT00317785|adult acute myeloid leukemia with t(8;21)(q22;q22)|adult acute myeloid leukemia with t(8;21)(q22;q22)
783081|NCT00317785|accelerated phase chronic myelogenous leukemia|accelerated phase chronic myelogenous leukemia
783082|NCT00317785|adult acute lymphoblastic leukemia in remission|adult acute lymphoblastic leukemia in remission
783083|NCT00317785|adult acute myeloid leukemia in remission|adult acute myeloid leukemia in remission
783084|NCT00317785|blastic phase chronic myelogenous leukemia|blastic phase chronic myelogenous leukemia
783085|NCT00317785|chronic phase chronic myelogenous leukemia|chronic phase chronic myelogenous leukemia
783086|NCT00317785|de novo myelodysplastic syndromes|de novo myelodysplastic syndromes
783087|NCT00317785|extranodal marginal zone B-cell lymphoma of mucosa-associated lymphoid tissue|extranodal marginal zone b-cell lymphoma of mucosa-associated lymphoid tissue
783088|NCT00317785|nodal marginal zone B-cell lymphoma|nodal marginal zone b-cell lymphoma
783089|NCT00317785|noncontiguous stage II adult Burkitt lymphoma|noncontiguous stage ii adult burkitt lymphoma
783090|NCT00317785|noncontiguous stage II adult diffuse large cell lymphoma|noncontiguous stage ii adult diffuse large cell lymphoma
783091|NCT00317785|noncontiguous stage II adult diffuse mixed cell lymphoma|noncontiguous stage ii adult diffuse mixed cell lymphoma
783092|NCT00317785|noncontiguous stage II adult diffuse small cleaved cell lymphoma|noncontiguous stage ii adult diffuse small cleaved cell lymphoma
783161|NCT00317746|HIV/HCV Co-infection|hiv/hcv co-infection
783093|NCT00317785|noncontiguous stage II adult immunoblastic large cell lymphoma|noncontiguous stage ii adult immunoblastic large cell lymphoma
783094|NCT00317785|noncontiguous stage II adult lymphoblastic lymphoma|noncontiguous stage ii adult lymphoblastic lymphoma
783095|NCT00317785|noncontiguous stage II grade 1 follicular lymphoma|noncontiguous stage ii grade 1 follicular lymphoma
783096|NCT00317785|noncontiguous stage II grade 2 follicular lymphoma|noncontiguous stage ii grade 2 follicular lymphoma
783097|NCT00317785|noncontiguous stage II grade 3 follicular lymphoma|noncontiguous stage ii grade 3 follicular lymphoma
783098|NCT00317785|noncontiguous stage II mantle cell lymphoma|noncontiguous stage ii mantle cell lymphoma
783099|NCT00317785|noncontiguous stage II marginal zone lymphoma|noncontiguous stage ii marginal zone lymphoma
783100|NCT00317785|noncontiguous stage II small lymphocytic lymphoma|noncontiguous stage ii small lymphocytic lymphoma
783101|NCT00317785|previously treated myelodysplastic syndromes|previously treated myelodysplastic syndromes
783102|NCT00317785|recurrent adult acute lymphoblastic leukemia|recurrent adult acute lymphoblastic leukemia
783103|NCT00317785|recurrent adult acute myeloid leukemia|recurrent adult acute myeloid leukemia
783104|NCT00317785|recurrent adult Burkitt lymphoma|recurrent adult burkitt lymphoma
783105|NCT00317785|recurrent adult Hodgkin lymphoma|recurrent adult hodgkin lymphoma
783106|NCT00317785|recurrent adult diffuse large cell lymphoma|recurrent adult diffuse large cell lymphoma
783107|NCT00317785|recurrent adult diffuse mixed cell lymphoma|recurrent adult diffuse mixed cell lymphoma
783108|NCT00317785|recurrent adult diffuse small cleaved cell lymphoma|recurrent adult diffuse small cleaved cell lymphoma
783109|NCT00317785|recurrent adult immunoblastic large cell lymphoma|recurrent adult immunoblastic large cell lymphoma
783110|NCT00317785|recurrent adult lymphoblastic lymphoma|recurrent adult lymphoblastic lymphoma
783111|NCT00317785|recurrent cutaneous T-cell non-Hodgkin lymphoma|recurrent cutaneous t-cell non-hodgkin lymphoma
783112|NCT00317785|recurrent grade 1 follicular lymphoma|recurrent grade 1 follicular lymphoma
783113|NCT00317785|recurrent grade 2 follicular lymphoma|recurrent grade 2 follicular lymphoma
783114|NCT00317785|recurrent grade 3 follicular lymphoma|recurrent grade 3 follicular lymphoma
783115|NCT00317785|recurrent mantle cell lymphoma|recurrent mantle cell lymphoma
783116|NCT00317785|recurrent marginal zone lymphoma|recurrent marginal zone lymphoma
783117|NCT00317785|recurrent mycosis fungoides/Sezary syndrome|recurrent mycosis fungoides/sezary syndrome
783118|NCT00317785|recurrent small lymphocytic lymphoma|recurrent small lymphocytic lymphoma
783119|NCT00317785|relapsing chronic myelogenous leukemia|relapsing chronic myelogenous leukemia
783120|NCT00317785|secondary acute myeloid leukemia|secondary acute myeloid leukemia
783121|NCT00317785|secondary myelodysplastic syndromes|secondary myelodysplastic syndromes
783122|NCT00317785|splenic marginal zone lymphoma|splenic marginal zone lymphoma
783123|NCT00317785|stage III adult Burkitt lymphoma|stage iii adult burkitt lymphoma
783124|NCT00317785|stage III adult Hodgkin lymphoma|stage iii adult hodgkin lymphoma
783125|NCT00317785|stage III adult diffuse large cell lymphoma|stage iii adult diffuse large cell lymphoma
783126|NCT00317785|stage III adult diffuse mixed cell lymphoma|stage iii adult diffuse mixed cell lymphoma
783127|NCT00317785|stage III adult diffuse small cleaved cell lymphoma|stage iii adult diffuse small cleaved cell lymphoma
783128|NCT00317785|stage III adult immunoblastic large cell lymphoma|stage iii adult immunoblastic large cell lymphoma
783129|NCT00317785|stage III adult lymphoblastic lymphoma|stage iii adult lymphoblastic lymphoma
783130|NCT00317785|stage III grade 1 follicular lymphoma|stage iii grade 1 follicular lymphoma
783131|NCT00317785|stage III grade 2 follicular lymphoma|stage iii grade 2 follicular lymphoma
783132|NCT00317785|stage III grade 3 follicular lymphoma|stage iii grade 3 follicular lymphoma
783133|NCT00317785|stage III mantle cell lymphoma|stage iii mantle cell lymphoma
783134|NCT00317785|stage III marginal zone lymphoma|stage iii marginal zone lymphoma
783135|NCT00317785|stage III small lymphocytic lymphoma|stage iii small lymphocytic lymphoma
783136|NCT00317785|stage IV adult Burkitt lymphoma|stage iv adult burkitt lymphoma
783137|NCT00317785|stage IV adult Hodgkin lymphoma|stage iv adult hodgkin lymphoma
783138|NCT00317785|stage IV adult diffuse large cell lymphoma|stage iv adult diffuse large cell lymphoma
783139|NCT00317785|stage IV adult diffuse mixed cell lymphoma|stage iv adult diffuse mixed cell lymphoma
783140|NCT00317785|stage IV adult diffuse small cleaved cell lymphoma|stage iv adult diffuse small cleaved cell lymphoma
783141|NCT00317785|stage IV adult immunoblastic large cell lymphoma|stage iv adult immunoblastic large cell lymphoma
783142|NCT00317785|stage IV adult lymphoblastic lymphoma|stage iv adult lymphoblastic lymphoma
783143|NCT00317785|stage IV grade 1 follicular lymphoma|stage iv grade 1 follicular lymphoma
783144|NCT00317785|stage IV grade 2 follicular lymphoma|stage iv grade 2 follicular lymphoma
783145|NCT00317785|stage IV grade 3 follicular lymphoma|stage iv grade 3 follicular lymphoma
783146|NCT00317785|stage IV mantle cell lymphoma|stage iv mantle cell lymphoma
783147|NCT00317785|stage IV marginal zone lymphoma|stage iv marginal zone lymphoma
783148|NCT00317785|stage IV small lymphocytic lymphoma|stage iv small lymphocytic lymphoma
783149|NCT00317772|Epithelial Ovarian Cancer|epithelial ovarian cancer
783150|NCT00317772|Peritoneal Cancer|peritoneal cancer
783151|NCT00317772|Fallopian Tube Cancer|fallopian tube cancer
783152|NCT00317772|Epidermal Growth Factor|epidermal growth factor
783153|NCT00317772|Platinum Hypersensitivity|platinum hypersensitivity
783154|NCT00317772|Hycamtin|hycamtin
783155|NCT00317772|Gefitinib|gefitinib
783156|NCT00317772|Iressa|iressa
783157|NCT00317772|Topotecan|topotecan
783158|NCT00317772|EGFR|egfr
783159|NCT00317759|stage IV melanoma|stage iv melanoma
783160|NCT00317759|recurrent melanoma|recurrent melanoma
783162|NCT00317746|Depression|depression
783163|NCT00317746|Citalopram|citalopram
783164|NCT00317733|Ketoprofen|ketoprofen
783165|NCT00317733|Transfersome|transfersome
783166|NCT00317733|Osteoarthritis, Knee|osteoarthritis, knee
783167|NCT00317720|Breast Cancer|breast cancer
783168|NCT00317720|Metastatic Breast Cancer|metastatic breast cancer
783169|NCT00317720|Trastuzumab|trastuzumab
783171|NCT00317720|Herceptin|herceptin
783172|NCT00317707|cardiovascular risk|cardiovascular risk
783173|NCT00317707|cardiovascular diseases|cardiovascular diseases
783174|NCT00317707|cardiovascular prevention|cardiovascular prevention
783175|NCT00317707|polyunsaturated fatty acids|polyunsaturated fatty acids
783176|NCT00317707|diabetes|diabetes
783177|NCT00317707|hypertension|hypertension
783178|NCT00317707|hypercholesterolemia|hypercholesterolemia
783179|NCT00317707|obesity|obesity
783180|NCT00317694|Hyperphosphatemia|hyperphosphatemia
783181|NCT00317694|Phosphate binder|phosphate binder
783182|NCT00317681|Cutaneous lupus erythematosus|cutaneous lupus erythematosus
783183|NCT00317681|Tacrolimus ointment|tacrolimus ointment
783184|NCT00317681|Topical treatment|topical treatment
783185|NCT00317681|Skin lesions|skin lesions
783186|NCT00317655|back pain|back pain
783187|NCT00317642|acute myelogenous leukemia|acute myelogenous leukemia
783188|NCT00317642|acute myeloid leukemia|acute myeloid leukemia
783189|NCT00317642|relapsed AML|relapsed aml
783190|NCT00317642|refractory AML|refractory aml
783191|NCT00317642|clofarabine|clofarabine
783192|NCT00317642|cytarabine|cytarabine
783193|NCT00317642|CLO341|clo341
783194|NCT00317642|clolar|clolar
783195|NCT00317629|leishmaniasis|leishmaniasis
783196|NCT00317629|nitric oxide|nitric oxide
783197|NCT00317629|treatment|treatment
783198|NCT00317629|donor|donor
783199|NCT00317629|controlled trial|controlled trial
783200|NCT00317616|FALS|fals
783201|NCT00317616|SOD1|sod1
783202|NCT00317616|familial|familial
783203|NCT00317616|genetic testing|genetic testing
783204|NCT00317616|genetic counseling|genetic counseling
783205|NCT00317616|ALS|als
783206|NCT00317616|C9ORF72|c9orf72
783207|NCT00317616|TARDBP|tardbp
783208|NCT00317616|VCP|vcp
783209|NCT00317616|FUS|fus
783210|NCT00317616|PFN1|pfn1
783211|NCT00317603|autologous vaccination|autologous vaccination
783212|NCT00317603|GM-CSF|gm-csf
783213|NCT00317603|adenoviral mediated gene transfer|adenoviral mediated gene transfer
783214|NCT00317603|Stage IV breast cancer|stage iv breast cancer
783215|NCT00317590|Diagnosis|diagnosis
783216|NCT00317590|Rapid Diagnostic Test|rapid diagnostic test
783217|NCT00317590|Management|management
783218|NCT00317590|Attributable Fraction|attributable fraction
783219|NCT00317590|Threshold|threshold
783220|NCT00317577|Low-pressure glaucoma|low-pressure glaucoma
783221|NCT00317577|Normal tension glaucoma|normal tension glaucoma
783222|NCT00317577|Neuroprotection|neuroprotection
783223|NCT00317577|Brimonidine|brimonidine
783224|NCT00317577|Visual field progression|visual field progression
783225|NCT00317564|Birth Defects|birth defects
783226|NCT00317564|High Risk Pregnancy|high risk pregnancy
783227|NCT00317564|Multiple Sclerosis|multiple sclerosis
783228|NCT00317551|Aberration control|aberration control
783229|NCT00317551|Accommodative facility|accommodative facility
783230|NCT00317551|Accommodative response|accommodative response
783231|NCT00317551|Peripheral refraction|peripheral refraction
783232|NCT00317551|Accommodative convergence to accommodation ratio|accommodative convergence to accommodation ratio
783233|NCT00317538|Rheumatoid Arthritis|rheumatoid arthritis
783234|NCT00317538|Switching|switching
783235|NCT00317538|Structural Damage|structural damage
783236|NCT00317538|MRI|mri
783237|NCT00317525|Refractive error|refractive error
783238|NCT00317525|Asthenopia|asthenopia
783239|NCT00317512|Hemoglobin Based Oxygen carrier|hemoglobin based oxygen carrier
783240|NCT00317512|HBOC 201|hboc 201
783241|NCT00317512|Percutaneous Revascularization|percutaneous revascularization
783242|NCT00317512|Percutaneous Coronary Intervention|percutaneous coronary intervention
783243|NCT00317512|Non ST-segment Elevation Myocardial Infarction|non st-segment elevation myocardial infarction
783244|NCT00317512|Tissue Oxygenation|tissue oxygenation
783245|NCT00317512|Transluminal Percutaneous Coronary Angioplasty|transluminal percutaneous coronary angioplasty
783246|NCT00317486|pulmonary arterial hypertension|pulmonary arterial hypertension
783247|NCT00317486|Eisenmenger physiology|eisenmenger physiology
783248|NCT00317486|bosentan|bosentan
783249|NCT00317473|Vaccine|vaccine
783250|NCT00317473|Phase 1|phase 1
783251|NCT00317473|Plasmodium falciparum|plasmodium falciparum
783252|NCT00317473|Malaria|malaria
783253|NCT00317473|Merozoite surface protein-1|merozoite surface protein-1
783254|NCT00317473|MSP-1|msp-1
783255|NCT00317473|Falciparum malaria protein 1|falciparum malaria protein 1
783256|NCT00317473|FMP-1|fmp-1
783257|NCT00317473|AS02A|as02a
783258|NCT00317460|Drug Abuse|drug abuse
783259|NCT00317460|Drug Addiction|drug addiction
783260|NCT00317460|Drug Dependence|drug dependence
783261|NCT00317460|Drug Use Disorders|drug use disorders
783262|NCT00317460|Drug Use Disorder|drug use disorder
783263|NCT00317460|Substance Abuse|substance abuse
783264|NCT00317460|Substance Use Disorder|substance use disorder
783265|NCT00317460|Buprenorphine|buprenorphine
783266|NCT00317460|Opiate Addiction|opiate addiction
783267|NCT00317447|Sciatica|sciatica
783268|NCT00317447|Lower back pain|lower back pain
783269|NCT00317447|Prednisone|prednisone
783270|NCT00317447|Randomized, controlled clinical trial|randomized, controlled clinical trial
783271|NCT00317434|ovarian cancer|ovarian cancer
783272|NCT00317421|Phosphodiesterase 5|phosphodiesterase 5
783273|NCT00317421|Sildenafil|sildenafil
783274|NCT00317421|Hypertension|hypertension
783275|NCT00317421|Blood pressure|blood pressure
783276|NCT00317421|Arterial stiffness|arterial stiffness
783277|NCT00317421|Endothelial function|endothelial function
783278|NCT00317408|anaplastic large cell lymphoma|anaplastic large cell lymphoma
783279|NCT00317408|recurrent childhood anaplastic large cell lymphoma|recurrent childhood anaplastic large cell lymphoma
783280|NCT00317408|stage III childhood anaplastic large cell lymphoma|stage iii childhood anaplastic large cell lymphoma
783281|NCT00317408|stage IV childhood anaplastic large cell lymphoma|stage iv childhood anaplastic large cell lymphoma
783282|NCT00317395|Non ST elevation Acute Coronary Syndrome|non st elevation acute coronary syndrome
783283|NCT00317395|Early invasive strategy|early invasive strategy
783284|NCT00317395|Percutaneous Coronary Intervention|percutaneous coronary intervention
783285|NCT00317382|lumbar puncture|lumbar puncture
783286|NCT00317382|headache|headache
783287|NCT00317382|traumatic tap|traumatic tap
783288|NCT00317369|OPC-6535|opc-6535
783289|NCT00317369|Crohn's disease|crohn's disease
783290|NCT00317356|OPC-6535|opc-6535
783291|NCT00317356|ulcerative colitis|ulcerative colitis
783413|NCT00316875|recurrent breast cancer|recurrent breast cancer
783292|NCT00317343|Patients candidate to a PCI with a planned anticoagulation regime other than unfractionated heparin in monotherapy|patients candidate to a pci with a planned anticoagulation regime other than unfractionated heparin in monotherapy
783293|NCT00317317|IVF|ivf
783294|NCT00317317|Acupuncture|acupuncture
783295|NCT00317317|Pregnant|pregnant
783296|NCT00317304|Hot flashes|hot flashes
783297|NCT00317304|vasomotor symptoms|vasomotor symptoms
783298|NCT00317304|menopause|menopause
783299|NCT00317304|mindfulness based stress reduction|mindfulness based stress reduction
783300|NCT00317304|meditation|meditation
783301|NCT00317291|Acupuncture|acupuncture
783302|NCT00317291|HIV|hiv
783303|NCT00317291|AIDS|aids
783304|NCT00317291|Symptom management|symptom management
783305|NCT00317291|Non-invasive|non-invasive
783306|NCT00317291|Complementary Therapies|complementary therapies
783307|NCT00317291|Treatment Experienced|treatment experienced
783308|NCT00317278|Massage|massage
783309|NCT00317278|immune system|immune system
783310|NCT00317278|preterm infants|preterm infants
783311|NCT00317265|coronary artery disease|coronary artery disease
783312|NCT00317265|coronary bypass surgery|coronary bypass surgery
783313|NCT00317265|complete arterial coronary surgery|complete arterial coronary surgery
783314|NCT00317265|internal mammary artery|internal mammary artery
783315|NCT00317252|contrast induced nephropathy|contrast induced nephropathy
783316|NCT00317252|contrast nephropathy|contrast nephropathy
783317|NCT00317252|contrast media|contrast media
783318|NCT00317252|kidney diseases|kidney diseases
783319|NCT00317252|angiotensin converting enzyme inhibitors|angiotensin converting enzyme inhibitors
783320|NCT00317239|Anemia|anemia
783321|NCT00317239|Chronic Kidney Disease|chronic kidney disease
783322|NCT00317239|Iron|iron
783323|NCT00317226|Anemia|anemia
783324|NCT00317226|CKD|ckd
783325|NCT00317226|Chronic Kidney Disease|chronic kidney disease
783326|NCT00317226|Iron|iron
783327|NCT00317226|Maintenance Dose|maintenance dose
783328|NCT00317213|Smoking|smoking
783329|NCT00317213|Nicotine|nicotine
783330|NCT00317213|Withdrawal|withdrawal
783331|NCT00317213|Phospholipids|phospholipids
783332|NCT00317213|Cell membrane fluidity|cell membrane fluidity
783333|NCT00317213|Smoking cessation|smoking cessation
783334|NCT00317148|Hot Flashes|hot flashes
783335|NCT00317148|Menopause|menopause
783336|NCT00317148|Quality of Life|quality of life
783337|NCT00317148|Hot flushes|hot flushes
783338|NCT00317109|meningococcal serogroups A and C diseases|meningococcal serogroups a and c diseases
783339|NCT00317109|tetanus|tetanus
783340|NCT00317109|hepatitis B|hepatitis b
783341|NCT00317109|pertussis|pertussis
783342|NCT00317109|Haemophilus influenzae type b|haemophilus influenzae type b
783343|NCT00317109|meningococcal vaccine|meningococcal vaccine
783344|NCT00317109|Prophylaxis diphtheria|prophylaxis diphtheria
783345|NCT00317096|Drug Therapy|drug therapy
783346|NCT00317096|Maintenance|maintenance
783347|NCT00317096|rituximab|rituximab
783348|NCT00317083|Cough Reflex|cough reflex
783349|NCT00317083|Citric acid|citric acid
783350|NCT00317083|Obesity|obesity
783351|NCT00317083|Sleep apnea syndrome|sleep apnea syndrome
783352|NCT00317070|PBS/IC|pbs/ic
783353|NCT00317070|Painful bladder syndrome including Interstitial cystitis|painful bladder syndrome including interstitial cystitis
783354|NCT00317057|chronic obstructive pulmonary disease|chronic obstructive pulmonary disease
783355|NCT00317057|Outpatient management|outpatient management
783356|NCT00317057|nurse-lead patient education|nurse-lead patient education
783550|NCT00316186|chemonaive|chemonaive
783357|NCT00317044|Moderate to severe Asthma|moderate to severe asthma
783358|NCT00317044|Gastroesophageal Reflux Disease|gastroesophageal reflux disease
783359|NCT00317044|esomeprazole|esomeprazole
783360|NCT00317044|GERD|gerd
783361|NCT00317031|Alcoholism|alcoholism
783362|NCT00317031|Drug Therapy|drug therapy
783363|NCT00317018|depression|depression
783364|NCT00317018|quality improvement|quality improvement
783365|NCT00317018|implementation|implementation
783366|NCT00317018|translation|translation
783367|NCT00317018|evidence-based practice|evidence-based practice
783368|NCT00317018|collaborative care|collaborative care
783369|NCT00317018|adoption|adoption
783370|NCT00317018|sustainability|sustainability
783371|NCT00317018|cost-effectiveness|cost-effectiveness
783372|NCT00317018|rural|rural
783373|NCT00317005|hemodialysis|hemodialysis
783374|NCT00317005|chronic uremia|chronic uremia
783375|NCT00317005|hyperhomocysteinemia|hyperhomocysteinemia
783376|NCT00317005|folate|folate
783377|NCT00316992|Insomnia|insomnia
783378|NCT00316992|Chronic Obstructive Pulmonary Disease|chronic obstructive pulmonary disease
783379|NCT00316992|Drug Therapy|drug therapy
783381|NCT00316979|transcranial magnetic stimulation|transcranial magnetic stimulation
783382|NCT00316979|repetitive transcranial magnetic stimulation|repetitive transcranial magnetic stimulation
783383|NCT00316979|rTMS|rtms
783384|NCT00316966|Nutritional status, dietary intervention, health care use, costs|nutritional status, dietary intervention, health care use, costs
783385|NCT00316940|stage I multiple myeloma|stage i multiple myeloma
783386|NCT00316940|stage II multiple myeloma|stage ii multiple myeloma
783387|NCT00316940|stage III multiple myeloma|stage iii multiple myeloma
783388|NCT00316940|refractory multiple myeloma|refractory multiple myeloma
783389|NCT00316927|adenocarcinoma of the prostate|adenocarcinoma of the prostate
783390|NCT00316927|stage III prostate cancer|stage iii prostate cancer
783391|NCT00316927|stage IV prostate cancer|stage iv prostate cancer
783392|NCT00316914|neurotoxicity|neurotoxicity
783393|NCT00316914|stage II colon cancer|stage ii colon cancer
783394|NCT00316914|stage III colon cancer|stage iii colon cancer
783395|NCT00316914|adenocarcinoma of the colon|adenocarcinoma of the colon
783396|NCT00316914|stage II rectal cancer|stage ii rectal cancer
783397|NCT00316914|stage III rectal cancer|stage iii rectal cancer
783398|NCT00316914|stage IV rectal cancer|stage iv rectal cancer
783399|NCT00316914|stage IV colon cancer|stage iv colon cancer
783400|NCT00316914|adenocarcinoma of the rectum|adenocarcinoma of the rectum
783401|NCT00316901|stage IV renal cell cancer|stage iv renal cell cancer
783402|NCT00316901|stage IV melanoma|stage iv melanoma
783403|NCT00316901|recurrent melanoma|recurrent melanoma
783404|NCT00316901|recurrent renal cell cancer|recurrent renal cell cancer
783405|NCT00316888|squamous cell carcinoma of the anus|squamous cell carcinoma of the anus
783406|NCT00316888|stage I anal cancer|stage i anal cancer
783407|NCT00316888|stage II anal cancer|stage ii anal cancer
783408|NCT00316888|stage IIIA anal cancer|stage iiia anal cancer
783409|NCT00316888|stage IIIB anal cancer|stage iiib anal cancer
783410|NCT00316888|basaloid carcinoma of the anus|basaloid carcinoma of the anus
783411|NCT00316888|cloacogenic carcinoma of the anus|cloacogenic carcinoma of the anus
783412|NCT00316875|stage IV breast cancer|stage iv breast cancer
783414|NCT00316875|male breast cancer|male breast cancer
783415|NCT00316862|adenocarcinoma of the esophagus|adenocarcinoma of the esophagus
783416|NCT00316862|stage II esophageal cancer|stage ii esophageal cancer
783417|NCT00316862|stage III esophageal cancer|stage iii esophageal cancer
783418|NCT00316836|stage I breast cancer|stage i breast cancer
783419|NCT00316836|stage II breast cancer|stage ii breast cancer
783420|NCT00316836|stage IIIA breast cancer|stage iiia breast cancer
783421|NCT00316823|thyroid cancer|thyroid cancer
783422|NCT00316810|Campath 1H|campath 1h
783423|NCT00316810|Alemtuzumab|alemtuzumab
783424|NCT00316810|Tacrolimus|tacrolimus
783425|NCT00316810|Pancreas-kidney transplantation|pancreas-kidney transplantation
783426|NCT00316810|immunosuppression|immunosuppression
783427|NCT00316810|prevention of acute rejection|prevention of acute rejection
783428|NCT00316797|SPECT|spect
783429|NCT00316797|Nuclear Medicine|nuclear medicine
783430|NCT00316784|osteoarthritis; knee; IDEA-033|osteoarthritis; knee; idea-033
783431|NCT00316745|irinotecan|irinotecan
783433|NCT00316745|Oxaliplatin|oxaliplatin
783434|NCT00316745|l-leucovorin|l-leucovorin
783435|NCT00316745|Fluorouracil|fluorouracil
783436|NCT00316745|Metastatic colorectal cancer|metastatic colorectal cancer
783437|NCT00316745|phase III|phase iii
783438|NCT00316732|Avodart|avodart
783439|NCT00316732|IPSS|ipss
783440|NCT00316732|BPH|bph
783441|NCT00316732|dutasteride|dutasteride
783442|NCT00316732|EQ-5D|eq-5d
783443|NCT00316732|Observational|observational
783444|NCT00316719|treatment naive|treatment naive
783445|NCT00316719|CHB|chb
783446|NCT00316719|adefovir|adefovir
783447|NCT00316719|monotherapy|monotherapy
783448|NCT00316706|Prophylaxis HPV-16/18 infections and cervical neoplasia|prophylaxis hpv-16/18 infections and cervical neoplasia
783449|NCT00316693|HPV Vaccine Efficacy|hpv vaccine efficacy
783450|NCT00316667|epidemiology|epidemiology
783451|NCT00316667|risk factors|risk factors
783758|NCT00315575|memory|memory
783452|NCT00316654|Prevention of Meningococcal Meningitis|prevention of meningococcal meningitis
783453|NCT00316654|vaccines, conjugate|vaccines, conjugate
783454|NCT00316654|immunology|immunology
783455|NCT00316654|child|child
783456|NCT00316654|antibody persistence|antibody persistence
783457|NCT00316628|influenza|influenza
783458|NCT00316628|elderly|elderly
783459|NCT00316628|vaccine|vaccine
783460|NCT00316615|influenza|influenza
783461|NCT00316615|non elderly adult and elderly|non elderly adult and elderly
783462|NCT00316615|vaccine|vaccine
783463|NCT00316602|Atopic dermatitis|atopic dermatitis
783464|NCT00316602|Smallpox|smallpox
783465|NCT00316602|Vaccination|vaccination
783466|NCT00316589|HIV|hiv
783467|NCT00316589|treatment experienced|treatment experienced
783468|NCT00316589|treatment vaccinia naive|treatment vaccinia naive
783469|NCT00316576|Kidney failure, Acute|kidney failure, acute
783470|NCT00316576|Genetic Polymorphism|genetic polymorphism
783471|NCT00316576|Angiotensin-converting enzyme|angiotensin-converting enzyme
783472|NCT00316563|cannabinoids|cannabinoids
783473|NCT00316563|taste disorders|taste disorders
783474|NCT00316563|olfaction disorders|olfaction disorders
783476|NCT00316563|palliative medicine|palliative medicine
783477|NCT00316563|caloric intake|caloric intake
783478|NCT00316563|appetite|appetite
783479|NCT00316563|reward|reward
783480|NCT00316563|tetrahydrocannabinol/therapeutic use|tetrahydrocannabinol/therapeutic use
783481|NCT00316563|anorexia/drug therapy|anorexia/drug therapy
783482|NCT00316563|quality of life|quality of life
783483|NCT00316563|chemosensory changes/drug therapy|chemosensory changes/drug therapy
783484|NCT00316550|Irritable Bowel Syndrome (IBS)|irritable bowel syndrome (ibs)
783485|NCT00316537|diabetes|diabetes
783486|NCT00316537|foot ulcers|foot ulcers
783487|NCT00316537|nicotine gel|nicotine gel
783488|NCT00316537|wound healing|wound healing
783489|NCT00316524|Smallpox|smallpox
783490|NCT00316524|Vaccination|vaccination
783491|NCT00316524|Prevention|prevention
783492|NCT00316511|advanced solid malignancies|advanced solid malignancies
783493|NCT00316511|B-cell lymphoma|b-cell lymphoma
783494|NCT00316511|Aroplatin|aroplatin
783495|NCT00316511|L-NDDP|l-nddp
783496|NCT00316511|MTD|mtd
783497|NCT00316511|advanced solid malignancies or B-cell lymphoma|advanced solid malignancies or b-cell lymphoma
783498|NCT00316498|Eye Movement|eye movement
783499|NCT00316498|Niemann Pick C|niemann pick c
783500|NCT00316485|Bone|bone
783501|NCT00316485|Microbiology|microbiology
783502|NCT00316485|Dental Pulp Stem Cell|dental pulp stem cell
783503|NCT00316485|Wisdom Teeth|wisdom teeth
783504|NCT00316485|Biopsy|biopsy
783505|NCT00316485|Third Molar Extraction|third molar extraction
783506|NCT00316472|Hyperphosphatemia|hyperphosphatemia
783507|NCT00316472|End Stage Renal Disease|end stage renal disease
783508|NCT00316472|Renal Osteodystrophy|renal osteodystrophy
783509|NCT00316459|Healthy|healthy
783510|NCT00316459|Cardiac|cardiac
783511|NCT00316459|Pharmacokinetics|pharmacokinetics
783512|NCT00316394|Preventive Health Care|preventive health care
783513|NCT00316394|Annual Health Check-up|annual health check-up
783514|NCT00316394|Primary Care|primary care
783515|NCT00316394|Reminders|reminders
783516|NCT00316381|stem cells|stem cells
783517|NCT00316381|acute myocardial infarction|acute myocardial infarction
783518|NCT00316381|regeneration|regeneration
783519|NCT00316381|left ventricular ejection fraction|left ventricular ejection fraction
783520|NCT00316368|Bi-Ventricular pacing post coronary artery bypass graft|bi-ventricular pacing post coronary artery bypass graft
783521|NCT00316368|coronary artery bypass graft|coronary artery bypass graft
783522|NCT00316355|Anxiety|anxiety
783523|NCT00316355|Behavior therapy|behavior therapy
783524|NCT00316355|Cognitive-behavioral therapy|cognitive-behavioral therapy
783525|NCT00316355|Stepped care|stepped care
783526|NCT00316355|Cost-effectiveness|cost-effectiveness
783527|NCT00316342|Low back pain|low back pain
783528|NCT00316342|Industrial workers|industrial workers
783529|NCT00316342|Recurrent back pain|recurrent back pain
783530|NCT00316342|Back supports|back supports
783531|NCT00316342|Back health education|back health education
783532|NCT00316342|Rehabilitation|rehabilitation
783533|NCT00316316|OCD|ocd
783534|NCT00316303|Serious Mental Illness|serious mental illness
783535|NCT00316303|Dual Diagnosis|dual diagnosis
783536|NCT00316303|Mental Disorders|mental disorders
783537|NCT00316303|Substance-Related Disorders|substance-related disorders
783538|NCT00316290|ADHD|adhd
783539|NCT00316290|Cognitive Behavioral Therapy|cognitive behavioral therapy
783540|NCT00316290|Parent Training|parent training
783541|NCT00316277|Opiate Analgesic Dependence|opiate analgesic dependence
783542|NCT00316264|Respiratory Syncytial Virus|respiratory syncytial virus
783543|NCT00316264|Premature and under 6 mos. of age|premature and under 6 mos. of age
783544|NCT00316264|Chronic Lung Disease over 6 mos. of age|chronic lung disease over 6 mos. of age
783545|NCT00316264|palivizumab|palivizumab
783546|NCT00316264|motavizumab|motavizumab
783548|NCT00316251|Somatosensory dysfunction|somatosensory dysfunction
783549|NCT00316212|Coronary Artery Bypass Graft Surgery involving Cardiopulmonary Bypass|coronary artery bypass graft surgery involving cardiopulmonary bypass
783551|NCT00316186|small cell lung cancer|small cell lung cancer
783552|NCT00316186|untreated|untreated
783553|NCT00316186|Lung cancer|lung cancer
783554|NCT00316186|HYCAMTIN|hycamtin
783555|NCT00316186|first-line|first-line
783556|NCT00316186|extensive disease|extensive disease
783557|NCT00316173|HYCAMTIN|hycamtin
783558|NCT00316173|ovarian cancer|ovarian cancer
783559|NCT00316173|recurrent|recurrent
783560|NCT00316173|relapsed|relapsed
783561|NCT00316173|carboplatin|carboplatin
783562|NCT00316173|topotecan|topotecan
783563|NCT00316173|potentially platinum-sensitive|potentially platinum-sensitive
783564|NCT00316160|sexual dysfunction|sexual dysfunction
783565|NCT00316160|Depression|depression
783566|NCT00316160|MDD|mdd
783567|NCT00316147|diphtheria|diphtheria
783568|NCT00316147|tetanus|tetanus
783569|NCT00316147|poliomyelitis|poliomyelitis
783570|NCT00316147|pertussis|pertussis
783571|NCT00316147|hepatitis B|hepatitis b
783572|NCT00316147|Prophylaxis|prophylaxis
783573|NCT00316147|Haemophilus influenza type b diseases|haemophilus influenza type b diseases
783574|NCT00316134|Pleural Diseases|pleural diseases
783575|NCT00316134|Pleural Effusion|pleural effusion
783576|NCT00316134|Pleural Effusion, Malignant|pleural effusion, malignant
783577|NCT00316134|Pleural Neoplasms|pleural neoplasms
783578|NCT00316134|Neoplasms, Pleural|neoplasms, pleural
783579|NCT00316121|One or Two Level Degenerative Disc Disease|one or two level degenerative disc disease
783580|NCT00316108|Carotid|carotid
783581|NCT00316108|Carotid Artery Stenting|carotid artery stenting
783582|NCT00316108|Stent|stent
783583|NCT00316108|Carotid Endarterectomy|carotid endarterectomy
783584|NCT00316108|Stroke|stroke
783585|NCT00316108|Transient Ischemic Attack|transient ischemic attack
783586|NCT00316108|Stenosis|stenosis
783587|NCT00316108|Atherosclerotic Disease|atherosclerotic disease
783588|NCT00001675|Brain Imaging|brain imaging
783589|NCT00001675|Affect|affect
783590|NCT00001675|Limbic System|limbic system
783591|NCT00001675|Cerebral Blood Volume|cerebral blood volume
783592|NCT00001675|Alcoholism|alcoholism
783593|NCT00001675|Emotion|emotion
783594|NCT00001675|Brain|brain
783595|NCT00001675|Operant|operant
783596|NCT00001675|Autonomic|autonomic
783597|NCT00001675|Relapse|relapse
783598|NCT00001675|Normal Volunteer|normal volunteer
783599|NCT00001673|Alcoholics|alcoholics
783600|NCT00001673|Screening|screening
783601|NCT00001673|Healthy Volunteers|healthy volunteers
783602|NCT00001673|Violent Abusers|violent abusers
783603|NCT00001673|Illicit Drug Testing|illicit drug testing
783604|NCT00001673|Blood Tests|blood tests
783605|NCT00001673|Normal Volunteer|normal volunteer
783606|NCT00316069|Erythropoiesis|erythropoiesis
783607|NCT00316069|Leukapheresis|leukapheresis
783608|NCT00316069|G-CSF|g-csf
783609|NCT00316069|Mobilization|mobilization
783610|NCT00316069|Stem Cells|stem cells
783611|NCT00316069|Apheresis|apheresis
783612|NCT00316069|Blood Donation|blood donation
783613|NCT00316069|Healthy Volunteer|healthy volunteer
783614|NCT00316069|HV|hv
783615|NCT00316056|Genetic Literacy|genetic literacy
783616|NCT00316056|Learning|learning
783617|NCT00316056|Genetic Knowledge|genetic knowledge
783618|NCT00316056|Public Understanding of Science|public understanding of science
783619|NCT00316056|Science Education|science education
783620|NCT00316056|Healthy Volunteer|healthy volunteer
783621|NCT00316056|HV|hv
783622|NCT00316043|Urinary tract infections|urinary tract infections
783623|NCT00316043|Renal failure|renal failure
783624|NCT00316043|Renal scarring|renal scarring
783625|NCT00316043|Prevention|prevention
783626|NCT00316043|Primary Care|primary care
783627|NCT00316043|General Practice|general practice
783628|NCT00316043|Intervention Studies|intervention studies
783629|NCT00316043|Children|children
783630|NCT00316030|AML|aml
783631|NCT00316030|Acute Myeloid Leukemia|acute myeloid leukemia
783632|NCT00316030|Bexarotene|bexarotene
783633|NCT00316030|Leukemia|leukemia
783634|NCT00316017|Trauma|trauma
783635|NCT00316017|Shock|shock
783636|NCT00316004|Traumatic|traumatic
783637|NCT00316004|Brain injury|brain injury
783638|NCT00315991|BG perception|bg perception
783639|NCT00315991|hypoglycemic awareness|hypoglycemic awareness
783640|NCT00315991|pediatric T1DM|pediatric t1dm
783641|NCT00315978|Risk Assessment|risk assessment
783642|NCT00315978|Decision Support Technique|decision support technique
783643|NCT00315978|Physician-Patient Relations|physician-patient relations
783644|NCT00315978|Prevention and Control|prevention and control
783645|NCT00315965|Diffusion|diffusion
783646|NCT00315965|Membrane diffusing capacity|membrane diffusing capacity
783647|NCT00315965|Alveolar capillary gas diffusion|alveolar capillary gas diffusion
783648|NCT00315965|Transfer factor|transfer factor
783649|NCT00315965|Nitric oxide diffusion|nitric oxide diffusion
783650|NCT00315952|type 1 diabetes mellitus|type 1 diabetes mellitus
783651|NCT00315952|inhaled insulin|inhaled insulin
783652|NCT00315952|Positron Emission Tomography|positron emission tomography
783653|NCT00315939|Diabetes|diabetes
783654|NCT00315939|hypoglycemic episodes|hypoglycemic episodes
783860|NCT00315133|Stem cells|stem cells
783655|NCT00315926|Cardiac morbidity|cardiac morbidity
783656|NCT00315926|Melatonin|melatonin
783657|NCT00315926|Surgery|surgery
783658|NCT00315926|Postoperative|postoperative
783659|NCT00315913|Labor|labor
783660|NCT00315913|Dysfunctional Labor|dysfunctional labor
783661|NCT00315913|Labor Arrest|labor arrest
783662|NCT00315913|Primary Cesarean Section Prevention|primary cesarean section prevention
783663|NCT00315900|Seroquel|seroquel
783664|NCT00315900|Depakote ER|depakote er
783665|NCT00315900|Nursing Home|nursing home
783666|NCT00315900|Quetiapine|quetiapine
783667|NCT00315900|Divalproex ER|divalproex er
783668|NCT00315900|Agitation|agitation
783669|NCT00315887|low back pain|low back pain
783670|NCT00315887|opioid|opioid
783671|NCT00315887|transdermal|transdermal
783672|NCT00315874|chronic back pain|chronic back pain
783673|NCT00315874|opioid|opioid
783674|NCT00315874|transdermal|transdermal
783675|NCT00315861|ovarian carcinoma|ovarian carcinoma
783676|NCT00315861|endometrial carcinoma|endometrial carcinoma
783677|NCT00315861|cervical carcinoma|cervical carcinoma
783678|NCT00315861|lung carcinoma|lung carcinoma
783679|NCT00315848|chronic pain|chronic pain
783680|NCT00315848|osteoarthritis|osteoarthritis
783681|NCT00315848|opioid|opioid
783682|NCT00315848|transdermal|transdermal
783683|NCT00315835|postoperative pain|postoperative pain
783684|NCT00315835|opioid|opioid
783685|NCT00315835|transdermal|transdermal
783686|NCT00315822|Surgery|surgery
783687|NCT00315822|colon|colon
783688|NCT00315809|leprosy, Philippines|leprosy, philippines
783689|NCT00315796|Mind-Body Intervention|mind-body intervention
783690|NCT00315796|Distraction|distraction
783691|NCT00315796|Biophilic|biophilic
783692|NCT00315796|Cancer|cancer
783693|NCT00315796|pain|pain
783694|NCT00315796|Bedscapes|bedscapes
783695|NCT00315796|procedures|procedures
783696|NCT00315796|bone marrow aspirate|bone marrow aspirate
783697|NCT00315796|bone marrow biopsy|bone marrow biopsy
783698|NCT00315783|hypertrophic cardiomyopathy|hypertrophic cardiomyopathy
783699|NCT00315783|echocardiography|echocardiography
783700|NCT00315783|magnetic resonance imaging|magnetic resonance imaging
783701|NCT00315770|overweight|overweight
783702|NCT00315770|Metabolic syndrome|metabolic syndrome
783703|NCT00315744|moderate asthma|moderate asthma
783704|NCT00315744|fluticasone|fluticasone
783705|NCT00315744|children|children
783706|NCT00315744|salmeterol|salmeterol
783707|NCT00315744|steroid-sparing|steroid-sparing
783708|NCT00315744|Asthma|asthma
783709|NCT00315731|Bexxar|bexxar
783710|NCT00315731|tositumomab and iodine I 131 tositumomab therapeutic regiment|tositumomab and iodine i 131 tositumomab therapeutic regiment
783711|NCT00315731|fission|fission
783712|NCT00315731|Non-Hodgkin's lymphoma|non-hodgkin's lymphoma
783713|NCT00315731|Iodine I 131 Tositumomab|iodine i 131 tositumomab
783714|NCT00315731|pharmacokinetics|pharmacokinetics
783715|NCT00315731|tellurium|tellurium
783716|NCT00315718|Hintonia latiflora extract|hintonia latiflora extract
783717|NCT00315718|Diabetes mellitus type 2|diabetes mellitus type 2
783718|NCT00315718|HbA1c|hba1c
783719|NCT00315718|Safety|safety
783720|NCT00315718|Liver function tests|liver function tests
783721|NCT00315705|clofarabine|clofarabine
783722|NCT00315705|acute leukemia|acute leukemia
783723|NCT00315705|ALL|all
783724|NCT00315705|AML|aml
783725|NCT00315705|clolar|clolar
783726|NCT00315705|CLO218|clo218
783727|NCT00315692|Ovarian Neoplasms|ovarian neoplasms
783728|NCT00315679|recurrent aphthous stomatitis|recurrent aphthous stomatitis
783729|NCT00315679|recurrent mouth ulcers|recurrent mouth ulcers
783730|NCT00315679|pentoxifylline|pentoxifylline
783731|NCT00315679|clinical trial|clinical trial
783732|NCT00315679|double blind|double blind
783733|NCT00315679|placebo controlled|placebo controlled
783734|NCT00315679|randomized|randomized
783735|NCT00315666|Chronic tension-type headache|chronic tension-type headache
783736|NCT00315653|Bladder Cancer|bladder cancer
783737|NCT00315653|Cancer of Bladder|cancer of bladder
783738|NCT00315653|Bladder Tumors|bladder tumors
783739|NCT00315653|Cancer of the Bladder|cancer of the bladder
783740|NCT00315653|Neoplasms, Bladder|neoplasms, bladder
783741|NCT00315640|Elevated IOP due to intravitreal triamcinolone therapy|elevated iop due to intravitreal triamcinolone therapy
783742|NCT00315627|Islet Transplantation|islet transplantation
783743|NCT00315614|Islet Transplantation|islet transplantation
783744|NCT00315601|Telithromycin (drug)|telithromycin (drug)
783745|NCT00315601|Azithromycin (drug)|azithromycin (drug)
783746|NCT00315601|Bronchoalveolar lavage (procedure)|bronchoalveolar lavage (procedure)
783747|NCT00315601|Pharmacokinetics|pharmacokinetics
783748|NCT00315588|Islet Transplantation|islet transplantation
783749|NCT00315575|Dementia|dementia
783750|NCT00315575|brain circulation|brain circulation
783751|NCT00315575|disease /disorder proneness /risk|disease /disorder proneness /risk
783752|NCT00315575|neuropathology|neuropathology
783753|NCT00315575|neurophysiology|neurophysiology
783754|NCT00315575|aging|aging
783755|NCT00315575|apolipoprotein E|apolipoprotein e
783756|NCT00315575|genotype|genotype
783757|NCT00315575|hemodynamics|hemodynamics
783759|NCT00315575|temporal lobe /cortex|temporal lobe /cortex
783760|NCT00315562|stroke|stroke
783761|NCT00315562|carotid stenosis|carotid stenosis
783762|NCT00315562|carotid endarterectomy|carotid endarterectomy
783763|NCT00315562|timing|timing
783764|NCT00315549|Tonsillitis|tonsillitis
783765|NCT00315549|pharyngitis|pharyngitis
783766|NCT00315549|penicillin|penicillin
783767|NCT00315549|telithromycin|telithromycin
783768|NCT00315549|ketolides|ketolides
783769|NCT00315549|clinical trials|clinical trials
783770|NCT00315523|Levocetirizine|levocetirizine
783771|NCT00315523|Xyzal|xyzal
783772|NCT00315523|Rhinitis|rhinitis
783773|NCT00315523|Allergic|allergic
783774|NCT00315523|Seasonal|seasonal
783775|NCT00315523|Ragweed|ragweed
783776|NCT00315510|Ischemia-reperfusion|ischemia-reperfusion
783777|NCT00315510|Annexin A5|annexin a5
783778|NCT00315497|Giant Cell Arteritis|giant cell arteritis
783779|NCT00315484|Anemia|anemia
783780|NCT00315484|chemotherapy|chemotherapy
783781|NCT00315484|hemoglobin level|hemoglobin level
783782|NCT00315484|recombinant human erythropoietin|recombinant human erythropoietin
783783|NCT00315484|epoetin alfa|epoetin alfa
783784|NCT00315484|darbepoetin alfa|darbepoetin alfa
783785|NCT00315471|Vasculitis|vasculitis
783786|NCT00315458|osteoarthritis|osteoarthritis
783787|NCT00315458|opioid|opioid
783788|NCT00315458|transdermal|transdermal
783789|NCT00315445|chronic back pain|chronic back pain
783790|NCT00315445|opioid|opioid
783791|NCT00315445|transdermal|transdermal
783792|NCT00315432|Natural History, Hepatitis C Infection, HIV Infection, HCV/HIV co-infection Ribavirin, Pegylated Interferon, Interferon|natural history, hepatitis c infection, hiv infection, hcv/hiv co-infection ribavirin, pegylated interferon, interferon
783793|NCT00315419|Large Granular Lymphocyte Leukemia|large granular lymphocyte leukemia
783920|NCT00314925|carcinoid|carcinoid
783794|NCT00315419|Amegakaryocytic Thrombocytopenic Purpura|amegakaryocytic thrombocytopenic purpura
783795|NCT00315419|Idiopathic Pure Red Cell Aplasia|idiopathic pure red cell aplasia
783796|NCT00315419|Paroxysmal Nocturnal Hemoglobinuria|paroxysmal nocturnal hemoglobinuria
783797|NCT00315406|PAN|pan
783798|NCT00315406|Periarteritis Nodosa|periarteritis nodosa
783799|NCT00315393|GPA|gpa
783800|NCT00315393|MPA|mpa
783801|NCT00315393|WG|wg
783802|NCT00315380|EGPA|egpa
783803|NCT00315380|CSS|css
783804|NCT00315367|Multiple Sclerosis|multiple sclerosis
783805|NCT00315367|Memory impairment|memory impairment
783806|NCT00315354|obesity|obesity
783807|NCT00315354|nutrition|nutrition
783808|NCT00315328|Amblyopia|amblyopia
783809|NCT00315328|Atropine|atropine
783810|NCT00315328|Patching|patching
783811|NCT00315315|Nasolacrimal duct obstruction|nasolacrimal duct obstruction
783812|NCT00315315|Balloon catheter nasolacrimal duct dilation|balloon catheter nasolacrimal duct dilation
783813|NCT00315315|Nasolacrimal intubation|nasolacrimal intubation
783814|NCT00315315|Simple Nasolacrimal duct probing|simple nasolacrimal duct probing
783815|NCT00315302|Amblyopia|amblyopia
783816|NCT00315302|Atropine|atropine
783817|NCT00315302|Plano lens|plano lens
783818|NCT00315289|Nasolacrimal duct obstruction|nasolacrimal duct obstruction
783819|NCT00315289|Simple probing|simple probing
783820|NCT00315289|Balloon catheter dilation|balloon catheter dilation
783821|NCT00315289|Nasolacrimal intubation|nasolacrimal intubation
783822|NCT00315276|ADHD|adhd
783823|NCT00315263|DNA|dna
783824|NCT00315263|Genomics|genomics
783825|NCT00315263|SNPs|snps
783826|NCT00315263|Neonatology|neonatology
783827|NCT00315263|Chronic Lung Disease|chronic lung disease
783828|NCT00315263|Periventricular Brain Injury|periventricular brain injury
783829|NCT00315263|Hypoxic Respiratory Failure|hypoxic respiratory failure
783830|NCT00315250|Parkinson|parkinson
783831|NCT00315224|Isolated systolic Hypertension|isolated systolic hypertension
783832|NCT00315224|exercise|exercise
783833|NCT00315224|pulse pressure|pulse pressure
783834|NCT00315224|endothelium|endothelium
783835|NCT00315211|Small Cell Lung Cancer Recurrent|small cell lung cancer recurrent
783836|NCT00315198|amblyopia|amblyopia
783837|NCT00315198|patching|patching
783838|NCT00315198|visual activities|visual activities
783839|NCT00315185|Advanced Non-small Cell Lung Cancer|advanced non-small cell lung cancer
783840|NCT00315185|First Line Treatment|first line treatment
783841|NCT00315172|Adipose Tissue|adipose tissue
783842|NCT00315172|Weight Gain|weight gain
783843|NCT00315172|Pediatric|pediatric
783844|NCT00315172|Body Composition|body composition
783845|NCT00315172|Thermogenesis|thermogenesis
783846|NCT00315172|Exercise|exercise
783847|NCT00315172|Healthy Volunteer|healthy volunteer
783848|NCT00315172|HV|hv
783849|NCT00315159|Squamous|squamous
783850|NCT00315159|Cell|cell
783851|NCT00315159|Carcinoma|carcinoma
783852|NCT00315159|Vulva|vulva
783853|NCT00315159|Sentinel Node|sentinel node
783854|NCT00315146|Body Composition|body composition
783855|NCT00315146|Sarcopenia|sarcopenia
783856|NCT00315146|Weight loss trials|weight loss trials
783857|NCT00315146|Intervention studies|intervention studies
783858|NCT00315146|Elderly|elderly
783859|NCT00315133|Diabetes mellitus|diabetes mellitus
783861|NCT00315133|Autologous stem cell transplantation|autologous stem cell transplantation
783862|NCT00315133|Autoimmune diseases|autoimmune diseases
783863|NCT00315120|Randomized controlled trial|randomized controlled trial
783864|NCT00315120|Low back pain|low back pain
783865|NCT00315120|Spinal manipulative therapy|spinal manipulative therapy
783866|NCT00315120|Spinal manipulation|spinal manipulation
783867|NCT00315120|Osteopathic manipulation|osteopathic manipulation
783868|NCT00315120|Osteopathic medicine|osteopathic medicine
783869|NCT00315120|Physical therapy modalities|physical therapy modalities
783870|NCT00315094|home parenteral nutrition|home parenteral nutrition
783871|NCT00315081|Schizophrenia|schizophrenia
783872|NCT00315081|Hyperprolactinemia|hyperprolactinemia
783873|NCT00315081|Risperidone|risperidone
783874|NCT00315081|Bromocriptin|bromocriptin
783875|NCT00315068|arrythmia|arrythmia
783876|NCT00315068|atrial fibrillation|atrial fibrillation
783877|NCT00315068|proteins|proteins
783878|NCT00315055|Hepatitis B|hepatitis b
783879|NCT00315055|Polio|polio
783880|NCT00315055|Diphtheria|diphtheria
783881|NCT00315055|Pertussis|pertussis
783882|NCT00315055|H influenzae type b|h influenzae type b
783883|NCT00315042|Tonsillitis|tonsillitis
783886|NCT00315042|telithromycin|telithromycin
783887|NCT00315042|ketolides|ketolides
783888|NCT00315042|clinical trials|clinical trials
783889|NCT00315029|Implementation|implementation
783890|NCT00315029|Single embryo transfer|single embryo transfer
783891|NCT00315029|ICSI|icsi
783892|NCT00315029|IVF|ivf
783893|NCT00315029|prevention|prevention
783894|NCT00315016|albuminuria|albuminuria
783895|NCT00315016|eplerenone|eplerenone
783896|NCT00315016|ACE inhibition|ace inhibition
783897|NCT00315016|renal function|renal function
783898|NCT00315016|endothelial function|endothelial function
783899|NCT00315003|Otitis Media|otitis media
783900|NCT00315003|Suppurative|suppurative
783901|NCT00315003|Purulent|purulent
783902|NCT00315003|Ketolide|ketolide
783903|NCT00315003|Azithromycin|azithromycin
783904|NCT00315003|Telithromycin|telithromycin
783905|NCT00315003|Controlled Clinical Trials|controlled clinical trials
783906|NCT00314990|Venous thrombosis|venous thrombosis
783907|NCT00314990|Deep-vein thrombosis|deep-vein thrombosis
783908|NCT00314990|Pulmonary embolism|pulmonary embolism
783909|NCT00314990|Homocysteine|homocysteine
783910|NCT00314990|B-vitamins|b-vitamins
783911|NCT00314990|Folate|folate
783912|NCT00314990|Vitamin B12|vitamin b12
783913|NCT00314990|Vitamin B6|vitamin b6
783914|NCT00314977|Large resectable breast cancer|large resectable breast cancer
783915|NCT00314977|Locally advanced breast cancer|locally advanced breast cancer
783916|NCT00314977|Neoadjuvant therapy|neoadjuvant therapy
783917|NCT00314951|CDAD, Clostridium difficile, diarrhea|cdad, clostridium difficile, diarrhea
783918|NCT00314951|Clostridium difficile-Associated Diarrhea|clostridium difficile-associated diarrhea
783919|NCT00314925|advanced carcinoma|advanced carcinoma
783921|NCT00314925|neuroendocrine features|neuroendocrine features
783922|NCT00314925|oncolytic virus|oncolytic virus
783923|NCT00314925|phase I study|phase i study
783924|NCT00314925|dose escalation study|dose escalation study
783925|NCT00314925|rhabdomyosarcoma|rhabdomyosarcoma
783926|NCT00314925|alveolar rhabdomyosarcoma|alveolar rhabdomyosarcoma
783927|NCT00314925|medulloblastoma|medulloblastoma
783928|NCT00314925|rhabdoid|rhabdoid
783929|NCT00314925|glioblastoma|glioblastoma
783930|NCT00314925|ewing's sarcoma|ewing's sarcoma
783931|NCT00314925|pediatric oncologies|pediatric oncologies
783932|NCT00314925|neuroblastoma|neuroblastoma
783933|NCT00314925|wilms' tumor|wilms' tumor
783934|NCT00314925|retinoblastoma|retinoblastoma
783935|NCT00314925|Large cell lung cancer|large cell lung cancer
783936|NCT00314899|Malaria, Plasmodium falciparum, Kenya, immunity|malaria, plasmodium falciparum, kenya, immunity
783937|NCT00314886|Diet|diet
783938|NCT00314886|Fiber|fiber
783939|NCT00314886|Irritable Bowel Syndrome|irritable bowel syndrome
783940|NCT00314886|Colonic Flora|colonic flora
783941|NCT00314873|Thymic malignancy|thymic malignancy
783942|NCT00314873|Thymic Carcinoma|thymic carcinoma
783943|NCT00314860|Restless Legs Syndrome|restless legs syndrome
783944|NCT00314847|Myocardial infarction|myocardial infarction
783945|NCT00314847|Cardiogenic shock|cardiogenic shock
783946|NCT00314847|Extracorporeal Life Support-Impella|extracorporeal life support-impella
783947|NCT00314834|hemodialysis|hemodialysis
783948|NCT00314834|intradialytic parenteral nutrition|intradialytic parenteral nutrition
783949|NCT00314834|oral supplementation|oral supplementation
783950|NCT00314834|survival|survival
783951|NCT00314834|hospitalization|hospitalization
783952|NCT00314834|serum albumin|serum albumin
783953|NCT00314834|prealbumin|prealbumin
783954|NCT00314834|transthyretin|transthyretin
783955|NCT00314821|bipolar disorder, ropinirole, depression|bipolar disorder, ropinirole, depression
783956|NCT00314808|primary gliomas|primary gliomas
783957|NCT00314808|brain tumors|brain tumors
783958|NCT00314808|vomiting|vomiting
783959|NCT00314808|appetite suppression|appetite suppression
783960|NCT00314808|appetite|appetite
783961|NCT00314795|Drug Therapy|drug therapy
783962|NCT00314795|pure red cell aplasia|pure red cell aplasia
783963|NCT00314795|PRCA|prca
783964|NCT00314795|chronic kidney disease|chronic kidney disease
783966|NCT00314795|chronic renal failure|chronic renal failure
783967|NCT00314795|CRF|crf
783968|NCT00314795|anemia|anemia
783969|NCT00314795|erythropoietin|erythropoietin
783970|NCT00314795|EPO|epo
783971|NCT00314795|erythropoiesis stimulating agent|erythropoiesis stimulating agent
783972|NCT00314795|ESA|esa
783973|NCT00314795|hemoglobin|hemoglobin
783974|NCT00314795|Hb|hb
783975|NCT00314795|Hgb|hgb
783976|NCT00314795|red blood cell|red blood cell
783977|NCT00314795|red blood cell production|red blood cell production
783978|NCT00314782|metastatic hormone-refractory prostate cancer (HRPC)|metastatic hormone-refractory prostate cancer (hrpc)
783979|NCT00314769|Transcranial Direct Current Stimulation (TDCS)|transcranial direct current stimulation (tdcs)
783980|NCT00314769|Motor Learning|motor learning
783981|NCT00314769|Transcranial Magnetic Stimulation (TMS)|transcranial magnetic stimulation (tms)
783982|NCT00314769|Cortical Re-Organization|cortical re-organization
783983|NCT00314769|Neuroplasticity|neuroplasticity
783984|NCT00314769|Neurorehabilitation|neurorehabilitation
783985|NCT00314769|TBI|tbi
783986|NCT00314769|Stroke|stroke
783987|NCT00314769|Healthy Volunteer|healthy volunteer
783988|NCT00314769|HV|hv
783989|NCT00314756|imiquimod cream|imiquimod cream
783990|NCT00314756|nodular basal cell carcinoma|nodular basal cell carcinoma
783991|NCT00314756|curettage|curettage
783992|NCT00314743|Patients with Non-Hodgkins Lymphoma or Multiple Myeloma|patients with non-hodgkins lymphoma or multiple myeloma
783993|NCT00314704|shock|shock
783994|NCT00314704|hypotension|hypotension
783995|NCT00314704|circulatory failure|circulatory failure
783996|NCT00314704|septic shock|septic shock
783997|NCT00314704|cardiogenic shock|cardiogenic shock
783998|NCT00314691|fetal DNA|fetal dna
783999|NCT00314691|prenatal diagnosis|prenatal diagnosis
784000|NCT00314691|maternal plasma|maternal plasma
784001|NCT00314691|Diagnostic potential of cell-free fetal DNA circulating in maternal blood|diagnostic potential of cell-free fetal dna circulating in maternal blood
784002|NCT00314678|Ovarian|ovarian
784003|NCT00314678|Peritoneal|peritoneal
784004|NCT00314665|Sarcoidosis|sarcoidosis
784005|NCT00314665|Chronic Uveitis|chronic uveitis
784006|NCT00314665|Uveitis|uveitis
784007|NCT00314665|Thalidomide|thalidomide
784008|NCT00314652|Osteoarthritis|osteoarthritis
784009|NCT00314652|chronic pain|chronic pain
784010|NCT00314652|opioid|opioid
784011|NCT00314652|transdermal|transdermal
784012|NCT00314626|Antiviral efficacy|antiviral efficacy
784013|NCT00314626|Tolerability|tolerability
784014|NCT00314626|Immunologic response|immunologic response
784015|NCT00314626|Virologic response|virologic response
784016|NCT00314626|HIV|hiv
784017|NCT00314613|Schizophreniform; Schizophrenia; Schizoaffective Disorders|schizophreniform; schizophrenia; schizoaffective disorders
784018|NCT00314600|Fracture|fracture
784019|NCT00314600|Forearm|forearm
784020|NCT00314600|Midshaft|midshaft
784021|NCT00314600|Child|child
784022|NCT00314600|Cast|cast
784023|NCT00314587|fracture|fracture
784024|NCT00314587|forearm|forearm
784025|NCT00314587|midshaft|midshaft
784026|NCT00314587|child|child
784027|NCT00314587|treatment|treatment
784028|NCT00314574|Persistent Asthma|persistent asthma
784029|NCT00314574|EXTRA|extra
784030|NCT00314574|Xolair|xolair
784031|NCT00314574|Difficult Breathing|difficult breathing
784032|NCT00314561|Rosiglitazone|rosiglitazone
784033|NCT00314561|Pioglitazone|pioglitazone
784034|NCT00314561|FMD|fmd
784035|NCT00314561|PWV|pwv
784036|NCT00314561|atherosclerosis|atherosclerosis
784037|NCT00314548|ARDS|ards
784038|NCT00314548|pulmonary hypertension|pulmonary hypertension
784039|NCT00314548|prostacyclins|prostacyclins
784040|NCT00314509|Asthma|asthma
784041|NCT00314509|Ciclesonide|ciclesonide
784042|NCT00314509|Formoterol Fumarate|formoterol fumarate
784043|NCT00314509|Long-acting beta2-agonists|long-acting beta2-agonists
784044|NCT00314509|LABA|laba
784045|NCT00314509|Steroids|steroids
784046|NCT00314483|Mesenchymal stem cells|mesenchymal stem cells
784047|NCT00314483|GVHD|gvhd
784048|NCT00314483|Treatment|treatment
784049|NCT00314483|Steroid refractory GVHD|steroid refractory gvhd
784050|NCT00314457|pain control|pain control
784051|NCT00314457|intra-articular pain control device|intra-articular pain control device
784052|NCT00314457|ACL repair|acl repair
784053|NCT00314457|Bankart Repair|bankart repair
784054|NCT00314444|Psychogenic|psychogenic
784055|NCT00314444|Psychogenic Movement Disorders|psychogenic movement disorders
784056|NCT00314431|neonatal chronic lung disease|neonatal chronic lung disease
784057|NCT00314431|bronchopulmonary dysplasia|bronchopulmonary dysplasia
784058|NCT00314431|prematurity|prematurity
784059|NCT00314431|telephone follow up|telephone follow up
784060|NCT00314431|care coordination|care coordination
784061|NCT00314431|children with special health care needs|children with special health care needs
784062|NCT00314418|Colonoscopy|colonoscopy
784063|NCT00314418|technique|technique
784065|NCT00314418|duration|duration
784066|NCT00314418|position|position
784067|NCT00314418|abdominal pressure|abdominal pressure
784068|NCT00314405|sentinel lymph node|sentinel lymph node
784069|NCT00314405|SLN|sln
784070|NCT00314405|probe|probe
784071|NCT00314405|breast cancer|breast cancer
784072|NCT00314405|lymphoscintigraphy|lymphoscintigraphy
784073|NCT00314405|methylene blue dye|methylene blue dye
784074|NCT00314392|Experimental pain|experimental pain
784075|NCT00314392|Placebo analgesia|placebo analgesia
784076|NCT00314392|Heart rate variability|heart rate variability
784077|NCT00314392|Skin conductance|skin conductance
784078|NCT00314379|Diabetes|diabetes
784079|NCT00314379|Endothelial Function|endothelial function
784080|NCT00314379|Haptoglobin|haptoglobin
784081|NCT00314366|stem cell|stem cell
784082|NCT00314366|autologous|autologous
784083|NCT00314366|ischemia|ischemia
784084|NCT00314353|NSABP|nsabp
784085|NCT00314353|bevacizumab|bevacizumab
784086|NCT00314353|capecitabine|capecitabine
784087|NCT00314353|oxaliplatin|oxaliplatin
784088|NCT00314353|irinotecan|irinotecan
784089|NCT00314353|rectal cancer|rectal cancer
784090|NCT00314353|colon cancer|colon cancer
784091|NCT00314353|colorectal cancer|colorectal cancer
784092|NCT00314340|Chronic Pain|chronic pain
784094|NCT00314327|first episode|first episode
784095|NCT00314327|schizophrenia|schizophrenia
784096|NCT00314327|risperidone|risperidone
784097|NCT00314314|Bipolar Disorder, memory, executive functioning|bipolar disorder, memory, executive functioning
784098|NCT00314301|cerebral palsy|cerebral palsy
784099|NCT00314301|resistance|resistance
784100|NCT00314301|movement|movement
784101|NCT00314301|biomechanics|biomechanics
784102|NCT00314288|Parkinson's Disease|parkinson's disease
784103|NCT00314288|Dyskinesia|dyskinesia
784104|NCT00314288|L-dopa-induced dyskinesia|l-dopa-induced dyskinesia
784105|NCT00314275|Pharmacokinetics|pharmacokinetics
784106|NCT00314275|Coronary Artery Disease|coronary artery disease
784107|NCT00314275|PCI|pci
784108|NCT00314275|Drug Eluting Stent|drug eluting stent
784109|NCT00314262|Skin Lesions|skin lesions
784110|NCT00314262|Premalignant Lesion|premalignant lesion
784111|NCT00314249|Fibromyalgia|fibromyalgia
784112|NCT00314236|Cartilage repair|cartilage repair
784113|NCT00314236|Cartilage|cartilage
784114|NCT00314236|Knee|knee
784115|NCT00314236|Knee Pain|knee pain
784116|NCT00314236|Microfracture|microfracture
784117|NCT00314236|arthroscopy|arthroscopy
784118|NCT00314236|bone marrow stimulation|bone marrow stimulation
784119|NCT00314236|Chondrogenesis|chondrogenesis
784120|NCT00314236|Scaffold|scaffold
784121|NCT00314236|Chitosan|chitosan
784122|NCT00314236|A02.165.165|a02.165.165
784123|NCT00314236|A10.165.382.332|a10.165.382.332
784124|NCT00314236|G07.574.500.325.377.625.180|g07.574.500.325.377.625.180
784125|NCT00314236|A10.165.382.400|a10.165.382.400
784126|NCT00314236|Articular Cartilage Repair|articular cartilage repair
784127|NCT00314210|Generalised Anxiety Disorder|generalised anxiety disorder
784128|NCT00314197|automated counseling system|automated counseling system
784129|NCT00314197|telephone-based intervention|telephone-based intervention
784130|NCT00314197|behavior change|behavior change
784131|NCT00314184|Bipolar I disorder.|bipolar i disorder.
784132|NCT00314171|open-angle glaucoma|open-angle glaucoma
784133|NCT00314171|ocular hypertension|ocular hypertension
784134|NCT00314132|Japanese Encephalitis|japanese encephalitis
784135|NCT00314132|Encephalitis virus|encephalitis virus
784136|NCT00314132|ChimeriVax™-JE Vaccine|chimerivax™-je vaccine
784137|NCT00314119|Tumor Imaging|tumor imaging
784138|NCT00314119|NF1|nf1
784139|NCT00314119|Neurofibromatosis|neurofibromatosis
784140|NCT00314106|Clinical Response|clinical response
784141|NCT00314106|Stage IV Melanoma|stage iv melanoma
784142|NCT00314106|Adoptive Cell Therapy|adoptive cell therapy
784143|NCT00314106|Tumor Infiltrating Lymphocytes|tumor infiltrating lymphocytes
784144|NCT00314106|Immunologic Response|immunologic response
784145|NCT00314106|Metastatic Melanoma|metastatic melanoma
784146|NCT00314093|Clinical Response|clinical response
784147|NCT00314093|Stage IV Melanoma|stage iv melanoma
784148|NCT00314093|Immunotoxin|immunotoxin
784149|NCT00314093|T Regulatory Cells|t regulatory cells
784150|NCT00314093|CD25+ Cells|cd25+ cells
784151|NCT00314093|Metastatic Melanoma|metastatic melanoma
784152|NCT00314080|Botulism|botulism
784153|NCT00314080|Botulinum anti-toxin|botulinum anti-toxin
784154|NCT00314080|Repetitive nerve stimulation|repetitive nerve stimulation
784155|NCT00314080|Respiratory failure|respiratory failure
784156|NCT00314067|Quality of Health Care|quality of health care
784157|NCT00314067|Primary Health Care|primary health care
784158|NCT00314067|Education|education
784159|NCT00314067|E-Learning|e-learning
784160|NCT00314067|Alcohol-related Disorders|alcohol-related disorders
784161|NCT00314054|Hepatitis C|hepatitis c
784162|NCT00314054|Hepatic Impairment|hepatic impairment
784163|NCT00314054|Healthy Volunteer|healthy volunteer
784164|NCT00314054|Phase 1|phase 1
784165|NCT00314054|Hepacivirus|hepacivirus
784166|NCT00314041|Infant|infant
784167|NCT00314041|Conjugate vaccine|conjugate vaccine
784168|NCT00314041|Meningococcal|meningococcal
784169|NCT00314041|Antibody|antibody
784170|NCT00314041|Immune memory|immune memory
784171|NCT00314041|Health|health
784172|NCT00314041|Meningococcal Vaccines|meningococcal vaccines
784173|NCT00314028|African American|african american
784174|NCT00314028|Men|men
784175|NCT00314028|Sexually Transmitted Diseases|sexually transmitted diseases
784176|NCT00314028|Condoms|condoms
784177|NCT00314002|Massive pulmonary embolism|massive pulmonary embolism
784178|NCT00314002|Catheter thrombectomy|catheter thrombectomy
784179|NCT00313976|Multiple Sclerosis|multiple sclerosis
784180|NCT00313976|Early secondary progressive Multiple Sclerosis|early secondary progressive multiple sclerosis
784181|NCT00313963|Anemia, Sickle Cell|anemia, sickle cell
784182|NCT00313963|Magnesium Sulfate|magnesium sulfate
784183|NCT00313963|pediatric|pediatric
784184|NCT00313950|measles|measles
784185|NCT00313950|rubella|rubella
784186|NCT00313950|mumps|mumps
784187|NCT00313950|hepatitis A|hepatitis a
784188|NCT00313924|URGENCY FREQUENCY SYNDROME|urgency frequency syndrome
784189|NCT00313924|URGE INCONTINENCE|urge incontinence
784190|NCT00313911|Diphtheria|diphtheria
784191|NCT00313911|Tetanus|tetanus
784192|NCT00313911|Pertussis|pertussis
784193|NCT00313911|Recombinant Hepatitis B|recombinant hepatitis b
784194|NCT00313911|Poliomyelitis|poliomyelitis
784195|NCT00313911|Haemophilus influenzae type b|haemophilus influenzae type b
784196|NCT00313911|Tetanus protein|tetanus protein
784197|NCT00313898|quality of sexual life, Mild erectile dysfunction|quality of sexual life, mild erectile dysfunction
784198|NCT00313872|gastric cancer|gastric cancer
784199|NCT00313872|chemotherapy|chemotherapy
784200|NCT00313872|irinotecan|irinotecan
784201|NCT00313872|docetaxel|docetaxel
784202|NCT00313859|colorectal cancer|colorectal cancer
784203|NCT00313859|metastatic|metastatic
784204|NCT00313846|Chronic pain|chronic pain
784205|NCT00313846|opioid|opioid
784206|NCT00313846|transdermal|transdermal
784207|NCT00313846|osteoarthritis|osteoarthritis
784208|NCT00313833|Chronic pain|chronic pain
784209|NCT00313833|elderly|elderly
784210|NCT00313833|supervised living|supervised living
784211|NCT00313833|opioid|opioid
784212|NCT00313833|transdermal|transdermal
784213|NCT00313820|Post-stroke pain, pregabalin|post-stroke pain, pregabalin
784214|NCT00313807|contrast nephropathy|contrast nephropathy
784215|NCT00313807|renal failure|renal failure
784216|NCT00313807|Travasol|travasol
784217|NCT00313781|randomized|randomized
784218|NCT00313781|non-comparative|non-comparative
784219|NCT00313781|efficacy|efficacy
784220|NCT00313768|advanced carcinoma, non-small cell lung, Phase II, paclitaxel, Taxol, carboplatin, Paraplatin, bevacizumab, Avastin, PF-3512676, immunotherapy, immunomodulator|advanced carcinoma, non-small cell lung, phase ii, paclitaxel, taxol, carboplatin, paraplatin, bevacizumab, avastin, pf-3512676, immunotherapy, immunomodulator
784221|NCT00313755|colonoscopy, narrow band imaging,|colonoscopy, narrow band imaging,
784222|NCT00313755|high definition endoscopy|high definition endoscopy
784223|NCT00313755|colorectal cancer|colorectal cancer
784224|NCT00313755|dysplasia|dysplasia
784225|NCT00313755|hereditary non-polyposis colorectal cancer|hereditary non-polyposis colorectal cancer
784226|NCT00313755|Lynch Syndrome|lynch syndrome
784227|NCT00313755|HNPCC|hnpcc
784228|NCT00313729|adult oligodendroglioma|adult oligodendroglioma
784229|NCT00313729|adult mixed glioma|adult mixed glioma
784230|NCT00313729|adult diffuse astrocytoma|adult diffuse astrocytoma
784231|NCT00313729|adult pilocytic astrocytoma|adult pilocytic astrocytoma
784232|NCT00313729|adult pineal gland astrocytoma|adult pineal gland astrocytoma
784233|NCT00313716|anemia|anemia
784234|NCT00313716|traumatic brain injury|traumatic brain injury
784235|NCT00313716|recombinant human erythropoietin|recombinant human erythropoietin
784236|NCT00313716|rhEpo|rhepo
784237|NCT00313716|erythropoietin|erythropoietin
784238|NCT00313716|TBI|tbi
784239|NCT00313716|Epo|epo
784240|NCT00313703|headache|headache
784241|NCT00313703|emergency department|emergency department
784242|NCT00313703|migraine|migraine
784243|NCT00313703|recurrent headache|recurrent headache
784244|NCT00313690|Lung Cancer|lung cancer
784245|NCT00313677|muscular dystrophy|muscular dystrophy
784246|NCT00313677|MD|md
784247|NCT00313677|fukutin-related protein gene|fukutin-related protein gene
784248|NCT00313677|limb girdle|limb girdle
784249|NCT00313677|FKRP gene|fkrp gene
784250|NCT00313677|congenital muscular dystrophy|congenital muscular dystrophy
784251|NCT00313677|childhood onset LGMD|childhood onset lgmd
784252|NCT00313677|adult onset LGMD|adult onset lgmd
784253|NCT00313677|POMT1|pomt1
784254|NCT00313677|POMT2|pomt2
784255|NCT00313677|POMGnT|pomgnt
784256|NCT00313677|LARGE|large
784257|NCT00313677|alpha dystroglycan|alpha dystroglycan
784258|NCT00313677|dystroglycanopathy|dystroglycanopathy
784259|NCT00313677|ISPD|ispd
784260|NCT00313677|DPM|dpm
784261|NCT00313677|GMPPB|gmppb
784262|NCT00313677|B3GNT1|b3gnt1
784263|NCT00313677|B3GALNT2|b3galnt2
784264|NCT00313677|GTDC2|gtdc2
784265|NCT00313677|TMEM5|tmem5
784266|NCT00313677|Fukutin|fukutin
784267|NCT00313677|DAG1|dag1
784268|NCT00313677|POMK|pomk
784269|NCT00313625|stage I multiple myeloma|stage i multiple myeloma
784270|NCT00313625|stage II multiple myeloma|stage ii multiple myeloma
784271|NCT00313625|stage III multiple myeloma|stage iii multiple myeloma
784272|NCT00313625|refractory multiple myeloma|refractory multiple myeloma
784273|NCT00313599|recurrent breast cancer|recurrent breast cancer
784274|NCT00313599|stage IV breast cancer|stage iv breast cancer
784275|NCT00313599|recurrent non-small cell lung cancer|recurrent non-small cell lung cancer
784276|NCT00313599|stage IV non-small cell lung cancer|stage iv non-small cell lung cancer
784277|NCT00313599|recurrent prostate cancer|recurrent prostate cancer
784278|NCT00313599|stage IV prostate cancer|stage iv prostate cancer
784279|NCT00313599|recurrent bladder cancer|recurrent bladder cancer
784280|NCT00313599|stage IV bladder cancer|stage iv bladder cancer
784281|NCT00313599|recurrent gastric cancer|recurrent gastric cancer
784282|NCT00313599|stage IV gastric cancer|stage iv gastric cancer
784283|NCT00313599|recurrent esophageal cancer|recurrent esophageal cancer
784284|NCT00313599|stage IV esophageal cancer|stage iv esophageal cancer
784285|NCT00313599|recurrent ovarian germ cell tumor|recurrent ovarian germ cell tumor
784286|NCT00313599|stage IV ovarian germ cell tumor|stage iv ovarian germ cell tumor
784287|NCT00313599|adult central nervous system germ cell tumor|adult central nervous system germ cell tumor
784288|NCT00313599|ovarian choriocarcinoma|ovarian choriocarcinoma
784377|NCT00313196|bosentan|bosentan
784289|NCT00313599|ovarian dysgerminoma|ovarian dysgerminoma
784290|NCT00313599|ovarian embryonal carcinoma|ovarian embryonal carcinoma
784291|NCT00313599|ovarian yolk sac tumor|ovarian yolk sac tumor
784292|NCT00313599|ovarian mixed germ cell tumor|ovarian mixed germ cell tumor
784293|NCT00313599|recurrent ovarian epithelial cancer|recurrent ovarian epithelial cancer
784294|NCT00313599|stage IV ovarian epithelial cancer|stage iv ovarian epithelial cancer
784295|NCT00313599|recurrent extragonadal non-seminomatous germ cell tumor|recurrent extragonadal non-seminomatous germ cell tumor
784296|NCT00313599|recurrent extragonadal seminoma|recurrent extragonadal seminoma
784297|NCT00313599|stage IV extragonadal non-seminomatous germ cell tumor|stage iv extragonadal non-seminomatous germ cell tumor
784298|NCT00313599|stage IV extragonadal seminoma|stage iv extragonadal seminoma
784299|NCT00313599|recurrent extragonadal germ cell tumor|recurrent extragonadal germ cell tumor
784300|NCT00313573|unspecified adult solid tumor, protocol specific|unspecified adult solid tumor, protocol specific
784302|NCT00313573|depression|depression
784303|NCT00313560|adenocarcinoma of the pancreas|adenocarcinoma of the pancreas
784304|NCT00313560|stage I pancreatic cancer|stage i pancreatic cancer
784305|NCT00313560|stage II pancreatic cancer|stage ii pancreatic cancer
784306|NCT00313547|Blood pressure|blood pressure
784307|NCT00313547|Hypertension|hypertension
784308|NCT00313547|Renin|renin
784309|NCT00313547|Aldosterone|aldosterone
784310|NCT00313547|Heart rate variability|heart rate variability
784311|NCT00313534|recurrent prostate cancer|recurrent prostate cancer
784312|NCT00313534|stage IIB prostate cancer|stage iib prostate cancer
784313|NCT00313534|stage IIA prostate cancer|stage iia prostate cancer
784314|NCT00313534|stage III prostate cancer|stage iii prostate cancer
784315|NCT00313534|stage I prostate cancer|stage i prostate cancer
784316|NCT00313521|untreated childhood cerebellar astrocytoma|untreated childhood cerebellar astrocytoma
784317|NCT00313521|childhood high-grade cerebral astrocytoma|childhood high-grade cerebral astrocytoma
784318|NCT00313508|stage IV melanoma|stage iv melanoma
784319|NCT00313508|recurrent melanoma|recurrent melanoma
784320|NCT00313508|ciliary body and choroid melanoma, medium/large size|ciliary body and choroid melanoma, medium/large size
784321|NCT00313508|recurrent intraocular melanoma|recurrent intraocular melanoma
784322|NCT00313508|metastatic intraocular melanoma|metastatic intraocular melanoma
784323|NCT00313508|extraocular extension melanoma|extraocular extension melanoma
784324|NCT00313508|iris melanoma|iris melanoma
784325|NCT00313495|Huntington disease, observational, family members, biomarker|huntington disease, observational, family members, biomarker
784326|NCT00313469|Pharmacokinetics/Pharmacodynamics|pharmacokinetics/pharmacodynamics
784327|NCT00313469|Elderly|elderly
784328|NCT00313469|Anticoagulants|anticoagulants
784329|NCT00313443|Anti-Arrhythmia Agents|anti-arrhythmia agents
784330|NCT00313443|Amiodarone, chronic treatment|amiodarone, chronic treatment
784331|NCT00313443|Amiodarone, adverse effects|amiodarone, adverse effects
784332|NCT00313443|Biopsy, Fine-Needle, Adipose tissue|biopsy, fine-needle, adipose tissue
784333|NCT00313443|Drug concentrations in tissues|drug concentrations in tissues
784334|NCT00313443|Drug accumulation in tissues|drug accumulation in tissues
784335|NCT00313430|Urine concentration ability|urine concentration ability
784336|NCT00313430|chronic renal insufficiency|chronic renal insufficiency
784337|NCT00313430|hypertension|hypertension
784338|NCT00313430|aquaporin2|aquaporin2
784339|NCT00313430|Patients with chronic renal insufficiency|patients with chronic renal insufficiency
784340|NCT00313430|Patients with hypertension|patients with hypertension
784341|NCT00313430|Healthy volunteers|healthy volunteers
784342|NCT00313417|Creatine|creatine
784343|NCT00313417|major depressive disorders|major depressive disorders
784344|NCT00313404|Norovirus|norovirus
784345|NCT00313404|Gastroenteritis|gastroenteritis
784346|NCT00313404|Clinical Trial|clinical trial
784347|NCT00313404|Stomach flu|stomach flu
784348|NCT00313378|Thoracotomy|thoracotomy
784349|NCT00313378|Neuropathic pain|neuropathic pain
784350|NCT00313378|Nerve trauma|nerve trauma
784351|NCT00313378|Ketamine|ketamine
784352|NCT00313378|NMDA receptors|nmda receptors
784353|NCT00313352|adult|adult
784354|NCT00313352|cardiac|cardiac
784355|NCT00313352|transposition of great arteries|transposition of great arteries
784356|NCT00313352|beta-adrenergic blockers|beta-adrenergic blockers
784357|NCT00313339|myocardial infarction|myocardial infarction
784358|NCT00313339|bone marrow|bone marrow
784359|NCT00313339|cd34+|cd34+
784360|NCT00313339|stem cells|stem cells
784361|NCT00313326|Adaptive Support ventilation|adaptive support ventilation
784362|NCT00313326|Weaning|weaning
784363|NCT00313248|Breast Cancer|breast cancer
784364|NCT00313248|Metastatic Breast Cancer|metastatic breast cancer
784365|NCT00313235|Dendritic Vaccine|dendritic vaccine
784366|NCT00313235|Melanoma|melanoma
784367|NCT00313235|Cyclophosphamide (CPA)|cyclophosphamide (cpa)
784368|NCT00313222|CTEPH|cteph
784369|NCT00313222|bosentan|bosentan
784370|NCT00313209|Roflumilast|roflumilast
784371|NCT00313209|Salmeterol|salmeterol
784372|NCT00313209|COPD|copd
784373|NCT00313209|Chronic obstructive pulmonary disease|chronic obstructive pulmonary disease
784374|NCT00313196|Pulmonary Hypertension|pulmonary hypertension
784375|NCT00313196|Sickle Cell Disease|sickle cell disease
784376|NCT00313196|Sickle cell anemia|sickle cell anemia
784380|NCT00313183|Type 1 Diabetes|type 1 diabetes
784381|NCT00313183|pediatric|pediatric
784382|NCT00313183|pramlintide|pramlintide
784383|NCT00313183|Symlin|symlin
784384|NCT00313183|Amylin|amylin
784385|NCT00313170|oncology|oncology
784386|NCT00313170|cancer|cancer
784387|NCT00313170|breast cancer|breast cancer
784388|NCT00313157|Atrial fibrillation|atrial fibrillation
784389|NCT00313131|bacterial vaginosis|bacterial vaginosis
784390|NCT00313131|vaginal candidiasis|vaginal candidiasis
784391|NCT00313131|trichomoniasis|trichomoniasis
784392|NCT00313131|vaginitis|vaginitis
784393|NCT00313131|Ghana|ghana
784394|NCT00313131|Togo|togo
784395|NCT00313131|Mali|mali
784396|NCT00313131|Guinea|guinea
784397|NCT00313118|oxidative stress parameters|oxidative stress parameters
784398|NCT00313105|smoking cessation|smoking cessation
784399|NCT00313105|smokeless tobacco|smokeless tobacco
784400|NCT00313105|nicotine patch|nicotine patch
784401|NCT00313105|nicotine buccal tablets|nicotine buccal tablets
784402|NCT00313105|retreatment|retreatment
784403|NCT00313105|adherence|adherence
784404|NCT00313092|OSAS|osas
784405|NCT00313092|glaucoma|glaucoma
784406|NCT00313092|MMP|mmp
784407|NCT00313066|CTGF|ctgf
784408|NCT00313066|fibrogenic cytokine|fibrogenic cytokine
784409|NCT00313066|FGF|fgf
784410|NCT00313066|pleural fibrosis|pleural fibrosis
784411|NCT00313040|physical activity|physical activity
784412|NCT00313040|sedentary|sedentary
784413|NCT00313040|behavioral medicine|behavioral medicine
784414|NCT00313040|motivational interviewing|motivational interviewing
784415|NCT00313014|Low back pain|low back pain
784416|NCT00313014|opioid|opioid
784417|NCT00313014|transdermal|transdermal
784418|NCT00313014|Butrans|butrans
784419|NCT00312988|Ovarian cancer|ovarian cancer
784420|NCT00312962|Schizoaffective Disorder|schizoaffective disorder
784421|NCT00312962|Cognitive Remediation|cognitive remediation
784422|NCT00312962|fMRI|fmri
784423|NCT00312949|Patient participation|patient participation
784424|NCT00312949|Patient education|patient education
784425|NCT00312949|Consumer involvement|consumer involvement
784426|NCT00312936|Medication adherence|medication adherence
784427|NCT00312936|Medication compliance|medication compliance
784428|NCT00312936|Quality of Life|quality of life
784429|NCT00312936|Stress reduction|stress reduction
784430|NCT00312936|mindfulness based stress reduction|mindfulness based stress reduction
784431|NCT00312936|HIV/AIDS|hiv/aids
784432|NCT00312936|treatment experienced|treatment experienced
784433|NCT00312923|HIV|hiv
784434|NCT00312923|lipids|lipids
784435|NCT00312923|dyslipidemia|dyslipidemia
784436|NCT00312923|policosanol|policosanol
784437|NCT00312923|treatment experienced|treatment experienced
784438|NCT00312910|Cirrhosis|cirrhosis
784439|NCT00312910|Probiotics|probiotics
784440|NCT00312910|Hepatic encephalopathy|hepatic encephalopathy
784441|NCT00312910|Ammonia|ammonia
784442|NCT00312897|Adolescents|adolescents
784443|NCT00312897|Depression|depression
784444|NCT00312897|Fish Oil|fish oil
784445|NCT00312897|Omega-3 Fatty Acids|omega-3 fatty acids
784446|NCT00312897|Psychiatry|psychiatry
784447|NCT00312884|telemonitoring|telemonitoring
784448|NCT00312884|heart failure|heart failure
784449|NCT00312884|randomised|randomised
784450|NCT00312884|hospitalisation|hospitalisation
784451|NCT00312884|HomMed|hommed
784452|NCT00312871|Chronic renal failure|chronic renal failure
784453|NCT00312871|Anemia|anemia
784454|NCT00312871|Renal replacement therapy|renal replacement therapy
784455|NCT00312871|Epoetin|epoetin
784456|NCT00312871|Epoetin alfa|epoetin alfa
784457|NCT00312871|erythropoietin|erythropoietin
784458|NCT00312871|Chronic kidney failure|chronic kidney failure
784459|NCT00312871|end-stage renal disease|end-stage renal disease
784460|NCT00312858|Hepatitis A Virus|hepatitis a virus
784461|NCT00312845|B-cell Non-Hodgkin's Lymphoma|b-cell non-hodgkin's lymphoma
784462|NCT00312832|HIV|hiv
784463|NCT00312832|d4T|d4t
784464|NCT00312832|TDF|tdf
784465|NCT00312832|lipoatrophy|lipoatrophy
784466|NCT00312832|treatment experienced|treatment experienced
784467|NCT00312832|HIV-infection|hiv-infection
784468|NCT00312819|Non-small cel lung cancer|non-small cel lung cancer
784469|NCT00312819|chemotherapy|chemotherapy
784470|NCT00312819|randomized phaseII|randomized phaseii
784471|NCT00312819|disulfiram|disulfiram
784472|NCT00312819|antiangiogenesis|antiangiogenesis
784473|NCT00312819|placebo|placebo
784474|NCT00312806|Gastroesophageal Reflux Disease|gastroesophageal reflux disease
784475|NCT00312806|GERD|gerd
784476|NCT00312806|Pantoprazole|pantoprazole
784477|NCT00312806|ReQuestTM|requesttm
784478|NCT00312793|Anterior Cruciate Ligament reconstruction surgery|anterior cruciate ligament reconstruction surgery
784479|NCT00312780|albuminuria|albuminuria
784480|NCT00312780|diabetic nephropathy|diabetic nephropathy
784481|NCT00312780|diabetes|diabetes
784482|NCT00312767|Agalsidase beta|agalsidase beta
784483|NCT00312767|alpha Galactosidase A|alpha galactosidase a
784484|NCT00312767|aGAL|agal
784485|NCT00312767|rh aGAL|rh agal
784486|NCT00312767|Fabry|fabry
784487|NCT00312767|GL3|gl3
784490|NCT00312767|hemodialysis|hemodialysis
784491|NCT00312741|community-acquired pneumonia|community-acquired pneumonia
784492|NCT00312741|microbiological tests|microbiological tests
784493|NCT00312741|urinary antigen|urinary antigen
784494|NCT00312741|selection of antibiotic treatment|selection of antibiotic treatment
784495|NCT00312728|Brain Cancer|brain cancer
784496|NCT00312728|Brain Metastases|brain metastases
784497|NCT00312728|Avastin|avastin
784498|NCT00312728|NSCLC|nsclc
784499|NCT00312728|Lung Cancer|lung cancer
784500|NCT00312728|PASSPORT|passport
784501|NCT00312715|Deiodinase|deiodinase
784502|NCT00312715|Levothyroxine|levothyroxine
784503|NCT00312715|Liothyronine|liothyronine
784504|NCT00312715|Lipid Metabolism|lipid metabolism
784505|NCT00312715|Healthy Volunteer|healthy volunteer
784506|NCT00312715|HV|hv
784507|NCT00312702|Vaccine|vaccine
784508|NCT00312702|Malaria|malaria
784509|NCT00312702|Liver Stage Antigen-1|liver stage antigen-1
784510|NCT00312702|Falciparum Malaria Protein-11|falciparum malaria protein-11
784511|NCT00312702|AS02A|as02a
784512|NCT00312702|adjuvant|adjuvant
784513|NCT00312689|congenital|congenital
784514|NCT00312689|lacrimal|lacrimal
784515|NCT00312689|stenosis|stenosis
784516|NCT00312689|bacteria|bacteria
784517|NCT00312689|microbiological|microbiological
784518|NCT00312676|Tolerability|tolerability
784519|NCT00312676|Depakote DR|depakote dr
784520|NCT00312676|Depakote ER|depakote er
784521|NCT00312676|Elderly|elderly
784522|NCT00312676|Conversion|conversion
784523|NCT00312663|Vaccine|vaccine
784524|NCT00312663|Phase I/II|phase i/ii
784525|NCT00312663|Malaria|malaria
784526|NCT00312663|Liver Stage Antigen -1|liver stage antigen -1
784527|NCT00312663|Falciparum Malaria Protein -11|falciparum malaria protein -11
784528|NCT00312663|AS01B|as01b
784529|NCT00312663|adjuvant|adjuvant
784530|NCT00312650|ovarian cancer|ovarian cancer
784531|NCT00312650|recurrent|recurrent
784532|NCT00312650|progressive|progressive
784533|NCT00312637|Breast Cancer Staging|breast cancer staging
784534|NCT00312624|ICD implantation|icd implantation
784535|NCT00312624|cardiac MRI|cardiac mri
784536|NCT00312624|cardiomyopathy|cardiomyopathy
784537|NCT00312624|ventricular arrhythmias|ventricular arrhythmias
784538|NCT00312624|LVEF 35% or less|lvef 35% or less
784539|NCT00312624|indication for ICD implantation as part of standard of care|indication for icd implantation as part of standard of care
784540|NCT00312611|Gastric pacing device|gastric pacing device
784541|NCT00312611|Obesity|obesity
784542|NCT00312598|schizophrenia|schizophrenia
784543|NCT00312598|BMI|bmi
784544|NCT00312598|weight|weight
784545|NCT00312598|aripiprazole|aripiprazole
784546|NCT00312598|antipsychotic|antipsychotic
784547|NCT00312598|Mood Disorders with psychotic features|mood disorders with psychotic features
784548|NCT00312585|pregnancy|pregnancy
784549|NCT00312585|acupuncture|acupuncture
784550|NCT00312572|Osteoarthritis, opioid, transdermal|osteoarthritis, opioid, transdermal
784551|NCT00312559|Parkinson's Disease|parkinson's disease
784552|NCT00312546|Virus Latency|virus latency
784553|NCT00312546|Valproic Acid|valproic acid
784554|NCT00312546|Histone Deacetylase|histone deacetylase
784555|NCT00312533|knee|knee
784556|NCT00312533|injection|injection
784557|NCT00312533|function|function
784558|NCT00312533|osteoarthritis|osteoarthritis
784559|NCT00312507|Meconium Aspiration Syndrome|meconium aspiration syndrome
784560|NCT00312507|Surfactant|surfactant
784561|NCT00312507|Bronchoalveolar Lavage|bronchoalveolar lavage
784562|NCT00312507|newborns|newborns
784563|NCT00312468|AIDS|aids
784564|NCT00312455|Substance abuse|substance abuse
784565|NCT00312455|Depression|depression
784566|NCT00312455|Aggression|aggression
784567|NCT00312442|Prostate cancer after radiation therapy|prostate cancer after radiation therapy
784568|NCT00312429|Hematological Malignancies|hematological malignancies
784569|NCT00312429|Leukemia|leukemia
784570|NCT00312429|Lymphoma|lymphoma
784571|NCT00312429|Myelodysplasia|myelodysplasia
784572|NCT00312429|Multiple Myeloma|multiple myeloma
784573|NCT00312416|Choroidal blood flow|choroidal blood flow
784574|NCT00312416|Clonidin|clonidin
784575|NCT00312416|Brimonidin|brimonidin
784576|NCT00312403|Glaucoma|glaucoma
784577|NCT00312403|Gene Polymorphism|gene polymorphism
784578|NCT00312403|Metalloproteinase|metalloproteinase
784579|NCT00312390|Amblyopia|amblyopia
784580|NCT00312390|Retinal vessel diameters|retinal vessel diameters
784581|NCT00312390|Retinal blood flow|retinal blood flow
784582|NCT00312390|Flicker|flicker
784583|NCT00312377|Non-small cell lung cancer|non-small cell lung cancer
784584|NCT00312377|NSCLC|nsclc
784585|NCT00312364|toe ulcer|toe ulcer
784586|NCT00312364|heel ulcer|heel ulcer
784587|NCT00312364|foot ulcer|foot ulcer
784588|NCT00312364|diabetic feet|diabetic feet
784589|NCT00312364|diabetic foot|diabetic foot
784590|NCT00312364|complications of diabetes|complications of diabetes
784591|NCT00312351|AMD|amd
784592|NCT00312351|Age-Related Macular Degeneration|age-related macular degeneration
784593|NCT00312351|Macular Degeneration|macular degeneration
784594|NCT00312351|Macugen|macugen
784595|NCT00312351|pegaptanib sodium|pegaptanib sodium
784596|NCT00312351|ERG|erg
784597|NCT00312351|specular microscopy|specular microscopy
784598|NCT00312351|Age-Related Mcular Degeneration (AMD)|age-related mcular degeneration (amd)
784599|NCT00312325|Optic nerve head blood flow|optic nerve head blood flow
784600|NCT00312325|Choroidal blood flow|choroidal blood flow
784601|NCT00312325|Prednisolone|prednisolone
784602|NCT00312325|Graves´ Ophthalmopathy|graves´ ophthalmopathy
784603|NCT00312325|optic neuritis|optic neuritis
784604|NCT00312312|Asthma|asthma
784605|NCT00312312|Allergic rhinitis|allergic rhinitis
784606|NCT00312312|Atopy|atopy
784607|NCT00312312|Exhaled nitric oxide|exhaled nitric oxide
784608|NCT00312312|Specific immunotherapy|specific immunotherapy
784609|NCT00312312|Atopic diseases|atopic diseases
784610|NCT00312299|Double-Blind Method|double-blind method
784611|NCT00312299|Clinical Trials, Randomized|clinical trials, randomized
784612|NCT00312299|Lenses, Intraocular|lenses, intraocular
784613|NCT00312299|Prospective Studies|prospective studies
784614|NCT00312299|PMMA|pmma
784615|NCT00312299|Visual acuity|visual acuity
784616|NCT00312286|Cervical Neoplasms|cervical neoplasms
784617|NCT00312286|Drug Therapy|drug therapy
784618|NCT00312286|Human Papillomavirus|human papillomavirus
784619|NCT00312286|Cervical Human Papillomavirus|cervical human papillomavirus
784620|NCT00312286|Cervical Dysplasia|cervical dysplasia
784621|NCT00312286|Chemoprevention|chemoprevention
784622|NCT00312286|High Risk Cervical Human Papillomavirus|high risk cervical human papillomavirus
784623|NCT00312286|Atypical Squamous Cells of Undetermined Significance|atypical squamous cells of undetermined significance
784624|NCT00312286|Low Grade Intraepithelial Lesions|low grade intraepithelial lesions
784625|NCT00312273|Heart Arrest|heart arrest
784626|NCT00312273|Cardiopulmonary Resuscitation|cardiopulmonary resuscitation
784627|NCT00312273|Aminophylline|aminophylline
784628|NCT00312273|Bradycardia|bradycardia
784629|NCT00312273|Humans|humans
784630|NCT00312273|Emergency Medical Services|emergency medical services
784631|NCT00312260|Pain|pain
784632|NCT00312260|Analgesia|analgesia
784633|NCT00312260|Gabapentin|gabapentin
784634|NCT00312260|Amitriptyline|amitriptyline
784635|NCT00312260|Pediatrics|pediatrics
784636|NCT00312247|Walking|walking
784637|NCT00312247|Muscle Strength|muscle strength
784638|NCT00312247|Energy Cost|energy cost
784639|NCT00312247|Quality of Life|quality of life
784640|NCT00312234|Muscular Disease|muscular disease
784641|NCT00312234|Fibromyalgia|fibromyalgia
784642|NCT00312234|Exercise Therapy|exercise therapy
784643|NCT00312234|Qigong|qigong
784644|NCT00312234|Aerobic Exercise|aerobic exercise
784645|NCT00312234|pediatrics|pediatrics
784646|NCT00312221|Osteoarthritis, opioid, transdermal|osteoarthritis, opioid, transdermal
784647|NCT00312195|Chronic pain|chronic pain
784648|NCT00312195|opioid|opioid
784649|NCT00312195|transdermal|transdermal
784650|NCT00312195|Butrans™ [BTDS]|butrans™ [btds]
784651|NCT00312169|HIV|hiv
784652|NCT00312169|NNRTI|nnrti
784653|NCT00312169|Incomplete virologic suppression|incomplete virologic suppression
784654|NCT00312169|treatment experienced|treatment experienced
784655|NCT00312143|De novo Kidney Transplant recipients, enteric-coated mycophenolate sodium|de novo kidney transplant recipients, enteric-coated mycophenolate sodium
784656|NCT00312130|Vildaglptin|vildaglptin
784657|NCT00312130|Pre-diabetes|pre-diabetes
784658|NCT00312117|contrast induced nephropathy|contrast induced nephropathy
784659|NCT00312117|sodium bicarbonate|sodium bicarbonate
784660|NCT00312117|cardiac catheterization|cardiac catheterization
784661|NCT00312091|Pharmacokinetics|pharmacokinetics
785300|NCT00309751|NK-104|nk-104
784662|NCT00312091|Treatment Experienced|treatment experienced
784663|NCT00312078|Minimal Hepatic Encephalopathy|minimal hepatic encephalopathy
784664|NCT00312078|Cirrhosis|cirrhosis
784665|NCT00312065|servocontrolled|servocontrolled
784666|NCT00312065|radiant warmer|radiant warmer
784667|NCT00312065|thermistor|thermistor
784668|NCT00312065|heat shield|heat shield
784669|NCT00312052|Coronary Artery Disease|coronary artery disease
784670|NCT00312039|HIV-1|hiv-1
784671|NCT00312039|treatment experienced|treatment experienced
784672|NCT00312026|Plaque Psoriasis|plaque psoriasis
784673|NCT00312026|Hands|hands
784674|NCT00312026|Feet|feet
784675|NCT00312026|Hand|hand
784676|NCT00312013|low molecular weight heparin|low molecular weight heparin
784677|NCT00312013|nadroparin|nadroparin
784678|NCT00312013|non-small cell lung cancer|non-small cell lung cancer
784679|NCT00312013|cancer survival|cancer survival
784680|NCT00312013|prostate cancer|prostate cancer
784681|NCT00312013|pancreatic cancer|pancreatic cancer
784682|NCT00312000|colorectal|colorectal
784683|NCT00312000|cancer|cancer
784684|NCT00312000|capecitabine|capecitabine
784685|NCT00312000|irinotecan|irinotecan
784686|NCT00312000|oxaliplatin|oxaliplatin
784687|NCT00311987|Hypercholesterolemia|hypercholesterolemia
784688|NCT00311987|Thyroid hormone|thyroid hormone
784689|NCT00311987|Diiodothyropropionic acid|diiodothyropropionic acid
784690|NCT00311987|Therapy|therapy
784691|NCT00311974|Dihydralazine|dihydralazine
784692|NCT00311974|Sympathetic activation|sympathetic activation
784693|NCT00311974|Fractional sodium excretion|fractional sodium excretion
784694|NCT00311961|COPD|copd
784695|NCT00311961|Exacerbations|exacerbations
784696|NCT00311961|Corticosteroids|corticosteroids
784697|NCT00311961|Oral|oral
784698|NCT00311961|Intravenous|intravenous
784699|NCT00311961|Chronic Obstructive Pulmonary Disease (COPD)|chronic obstructive pulmonary disease (copd)
784700|NCT00311948|Teen smokers|teen smokers
784701|NCT00311948|Quithelper|quithelper
784702|NCT00311948|Tobacco|tobacco
784703|NCT00311948|Tobacco Website|tobacco website
784704|NCT00311948|Website Intervention|website intervention
784705|NCT00311948|Tobacco counseling|tobacco counseling
784706|NCT00311948|Tobacco abstinence|tobacco abstinence
784707|NCT00311935|Hernia|hernia
784708|NCT00311935|Inguinal|inguinal
784709|NCT00311935|Groin|groin
784710|NCT00311935|Laparoscopic|laparoscopic
784711|NCT00311935|Open|open
784712|NCT00311935|Abdominal wall|abdominal wall
784713|NCT00311922|Diabetes|diabetes
784714|NCT00311922|Education|education
784715|NCT00311922|Health Literacy|health literacy
784716|NCT00311909|Tourette Syndrome|tourette syndrome
784717|NCT00311909|Deep Brain Stimulation|deep brain stimulation
784718|NCT00311909|Video assessment|video assessment
784719|NCT00311909|YGTSS|ygtss
784720|NCT00311909|TSSL|tssl
784721|NCT00311896|Cancer|cancer
784722|NCT00311896|Thrombosis|thrombosis
784723|NCT00311896|Catheter|catheter
784724|NCT00311896|Bemiparin|bemiparin
784725|NCT00311896|Prophylaxis|prophylaxis
784726|NCT00311883|Cystic Fibrosis|cystic fibrosis
784727|NCT00311883|Induced sputum|induced sputum
784728|NCT00311883|Lung inflammation|lung inflammation
784729|NCT00311857|Cetuximab|cetuximab
784730|NCT00311831|Pediatrics|pediatrics
784731|NCT00311831|Gastroenteritis|gastroenteritis
784732|NCT00311831|Education|education
784733|NCT00311792|training|training
784734|NCT00311792|teaching|teaching
784735|NCT00311792|curriculum|curriculum
784736|NCT00311779|Pediculosis capitis|pediculosis capitis
784737|NCT00311779|Head Lice|head lice
784738|NCT00311779|Crawlers|crawlers
784739|NCT00311779|Ova|ova
784740|NCT00311766|Epidermolysis Bullosa|epidermolysis bullosa
784741|NCT00311766|cutaneous wound-healing|cutaneous wound-healing
784742|NCT00311766|chronic wound-healing|chronic wound-healing
784743|NCT00311766|Thymosin Beta 4|thymosin beta 4
784744|NCT00311766|laminin-5|laminin-5
784745|NCT00311753|heparin, thromboprophylaxis, medical patients, acutely ill|heparin, thromboprophylaxis, medical patients, acutely ill
784746|NCT00311753|Acutely ill non surgical patients|acutely ill non surgical patients
784747|NCT00311753|Immobilization|immobilization
784748|NCT00311740|Hypertension,|hypertension,
784749|NCT00311740|Valsartan,|valsartan,
784750|NCT00311740|Hydrochlorothiazide|hydrochlorothiazide
784751|NCT00311727|Cell-Mediated Immune Responses, Influenza, A/H5N1, Vaccine, sub-study|cell-mediated immune responses, influenza, a/h5n1, vaccine, sub-study
784752|NCT00311714|Influenza, United Kingdom|influenza, united kingdom
784753|NCT00311701|Influenza, pediatric|influenza, pediatric
784754|NCT00311688|IL-2|il-2
784755|NCT00311688|Immunomodulatory Therapies|immunomodulatory therapies
784756|NCT00311675|influenza, A/H5N1, vaccine|influenza, a/h5n1, vaccine
784757|NCT00311649|H5N1, Influenza|h5n1, influenza
784758|NCT00311636|stage I breast cancer|stage i breast cancer
784759|NCT00311636|stage II breast cancer|stage ii breast cancer
784760|NCT00311636|stage IIIA breast cancer|stage iiia breast cancer
784761|NCT00311636|stage IIIB breast cancer|stage iiib breast cancer
784762|NCT00311636|stage IIIC breast cancer|stage iiic breast cancer
784763|NCT00311623|stage III prostate cancer|stage iii prostate cancer
784764|NCT00311623|stage I prostate cancer|stage i prostate cancer
784765|NCT00311623|stage IIB prostate cancer|stage iib prostate cancer
784766|NCT00311623|stage IIA prostate cancer|stage iia prostate cancer
784767|NCT00311623|adenocarcinoma of the prostate|adenocarcinoma of the prostate
784768|NCT00311610|recurrent colon cancer|recurrent colon cancer
784769|NCT00311610|stage IV colon cancer|stage iv colon cancer
784770|NCT00311610|recurrent rectal cancer|recurrent rectal cancer
784771|NCT00311610|stage IV rectal cancer|stage iv rectal cancer
784772|NCT00311597|unspecified adult solid tumor, protocol specific|unspecified adult solid tumor, protocol specific
784773|NCT00311584|recurrent neuroblastoma|recurrent neuroblastoma
784774|NCT00311571|bedrest|bedrest
784775|NCT00311571|spaceflight|spaceflight
784776|NCT00311571|Weightlessness|weightlessness
784777|NCT00311571|Countermeasure|countermeasure
784778|NCT00311558|stage IV melanoma|stage iv melanoma
784779|NCT00311558|stage IV adult soft tissue sarcoma|stage iv adult soft tissue sarcoma
784780|NCT00311558|recurrent melanoma|recurrent melanoma
784781|NCT00311545|recurrent renal cell cancer|recurrent renal cell cancer
784782|NCT00311545|stage IV renal cell cancer|stage iv renal cell cancer
784783|NCT00311545|stage III renal cell cancer|stage iii renal cell cancer
784784|NCT00311519|Subcutaneous hydration|subcutaneous hydration
784785|NCT00311519|Hylenex|hylenex
784786|NCT00311519|Hyaluronidase|hyaluronidase
784787|NCT00311506|Pulmozyme|pulmozyme
784788|NCT00311493|TBE|tbe
784789|NCT00311493|vaccine|vaccine
784790|NCT00311493|adults|adults
784791|NCT00311480|influenza|influenza
784792|NCT00311480|pandemic influenza|pandemic influenza
784793|NCT00311480|influenza vaccine|influenza vaccine
784794|NCT00311480|adjuvanted influenza vaccine|adjuvanted influenza vaccine
784795|NCT00311467|renal cell cancer|renal cell cancer
784796|NCT00311441|TBE, children, vaccine|tbe, children, vaccine
784797|NCT00311428|Influenza|influenza
784798|NCT00311428|Children|children
784799|NCT00311428|Vaccine|vaccine
784800|NCT00311415|Prevention of Meningococcal Meningitis|prevention of meningococcal meningitis
784801|NCT00311415|meningococcal vaccines|meningococcal vaccines
784802|NCT00311415|conjugate|conjugate
784803|NCT00311415|immunology|immunology
784805|NCT00311415|antibody persistence|antibody persistence
784806|NCT00311389|Glaucoma|glaucoma
784807|NCT00311389|POAG|poag
784808|NCT00311389|OAG|oag
784809|NCT00311389|OHT|oht
784810|NCT00311350|Safety|safety
784811|NCT00311350|Health|health
784812|NCT00311350|Pharmacokinetics|pharmacokinetics
784813|NCT00311350|ileus|ileus
784814|NCT00311337|VELCADE|velcade
784815|NCT00311337|bortezomib|bortezomib
784816|NCT00311337|maintenance treatment|maintenance treatment
784817|NCT00311337|multiple myeloma|multiple myeloma
784818|NCT00311337|primary disease|primary disease
784819|NCT00311324|behavioral intervention|behavioral intervention
784820|NCT00311311|Kidney transplant|kidney transplant
784821|NCT00311311|Renal transplant|renal transplant
784822|NCT00311311|Immunosuppression|immunosuppression
784823|NCT00311311|Atherosclerosis|atherosclerosis
784824|NCT00311311|Graft Rejection|graft rejection
784825|NCT00311298|tuberculosis|tuberculosis
784826|NCT00311298|hiv|hiv
784827|NCT00311298|diabetes|diabetes
784828|NCT00311298|protein-energy|protein-energy
784829|NCT00311298|micronutrients|micronutrients
784830|NCT00311285|Electromyography|electromyography
784831|NCT00311285|Glucocorticoids|glucocorticoids
784832|NCT00311285|Heart Rate|heart rate
784833|NCT00311285|Physical workload|physical workload
784834|NCT00311285|Mental workload|mental workload
784835|NCT00311285|Ergonomics|ergonomics
784836|NCT00311285|Laparoscopy|laparoscopy
784837|NCT00311285|Workload|workload
784838|NCT00311285|Biomechanics|biomechanics
784839|NCT00311272|dendritic cells|dendritic cells
784840|NCT00311272|antigens, neoplasm|antigens, neoplasm
784841|NCT00311246|Sarcoidosis|sarcoidosis
784842|NCT00311246|Humira|humira
784843|NCT00311246|Adalimumab|adalimumab
784844|NCT00311246|Tumor Necrosis Factor Inhibitors|tumor necrosis factor inhibitors
784845|NCT00311233|child|child
784846|NCT00311233|psychosocial|psychosocial
784847|NCT00311233|predictors|predictors
784848|NCT00311233|cohort|cohort
784849|NCT00311233|recurrent|recurrent
784850|NCT00311220|tuberculosis|tuberculosis
784851|NCT00311220|latent tuberculosis|latent tuberculosis
784852|NCT00311220|tuberculin skin test|tuberculin skin test
784853|NCT00311220|quantiferon TB-RD1|quantiferon tb-rd1
784854|NCT00311220|contact screening|contact screening
784855|NCT00311220|elderly|elderly
784856|NCT00311207|diagnostic kit|diagnostic kit
784857|NCT00311207|immunochromatography test|immunochromatography test
784858|NCT00311207|PCR detection kit|pcr detection kit
784859|NCT00311207|luminex|luminex
784860|NCT00311194|Heart failure|heart failure
784861|NCT00311194|Education|education
784862|NCT00311194|CD-ROM|cd-rom
784863|NCT00311194|Randomization|randomization
784864|NCT00311194|Hospitalization|hospitalization
784865|NCT00311194|Readmission|readmission
784866|NCT00311194|Death|death
784867|NCT00311194|Knowledge|knowledge
784868|NCT00311181|ICD|icd
786413|NCT00305487|Nasal spray|nasal spray
784869|NCT00311181|Defibrillation|defibrillation
784870|NCT00311181|ULV|ulv
784871|NCT00311181|Tuned|tuned
784872|NCT00311155|Olmesartan medoxomil|olmesartan medoxomil
784873|NCT00311155|Hypertension|hypertension
784874|NCT00311142|Sleep pattern|sleep pattern
784875|NCT00311142|newborn|newborn
784876|NCT00311142|actigraphy|actigraphy
784877|NCT00311142|delivery mode|delivery mode
784878|NCT00311142|Parents' approval|parents' approval
784879|NCT00311116|Vitamin E|vitamin e
784880|NCT00311116|Cancer|cancer
784881|NCT00311116|pediatrics|pediatrics
784882|NCT00311116|supportive care|supportive care
784883|NCT00311116|oral mucositis|oral mucositis
784884|NCT00311116|Bayesian analysis|bayesian analysis
784885|NCT00311116|N-of-1 trial|n-of-1 trial
784886|NCT00311116|prophylaxis|prophylaxis
784887|NCT00311103|Elderly|elderly
784888|NCT00311103|Disability|disability
784889|NCT00311103|Musculoskeletal diseases|musculoskeletal diseases
784890|NCT00311090|Deep Venous Thrombosis|deep venous thrombosis
784891|NCT00311051|Asthma|asthma
784892|NCT00311051|Allergens|allergens
784893|NCT00311051|house dust mites|house dust mites
784894|NCT00311051|Ramatroban|ramatroban
784895|NCT00311051|Montelukast|montelukast
784896|NCT00311051|Bronchial Provocation Tests|bronchial provocation tests
784897|NCT00311038|ONO-1101|ono-1101
784898|NCT00311038|Landiolol Hydrochloride|landiolol hydrochloride
784899|NCT00311038|Multi-slice CT|multi-slice ct
784900|NCT00311038|Coronary Artery Disease|coronary artery disease
784902|NCT00311025|physical therapy|physical therapy
784903|NCT00311025|rehabilitation|rehabilitation
784904|NCT00311025|exercise|exercise
784905|NCT00311025|longterm follow-up|longterm follow-up
784906|NCT00311012|Hypertension, Aliskiren|hypertension, aliskiren
784907|NCT00310999|Cervical Vertebrae|cervical vertebrae
784908|NCT00310999|Intubation, Intratracheal|intubation, intratracheal
784909|NCT00310999|Laryngoscopes|laryngoscopes
784910|NCT00310999|Fluoroscopy|fluoroscopy
784911|NCT00310986|Attention Deficit Disorder with Hyperactivity|attention deficit disorder with hyperactivity
784912|NCT00310986|meditation|meditation
784913|NCT00310986|breathing meditation|breathing meditation
784914|NCT00310986|Anapanasathi|anapanasathi
784915|NCT00310986|randomized controlled trial|randomized controlled trial
784916|NCT00310986|nonpharmacologic treatment|nonpharmacologic treatment
784917|NCT00310986|complementary and alternative medicine|complementary and alternative medicine
784918|NCT00310973|HIV|hiv
784919|NCT00310973|Prevention|prevention
784920|NCT00310973|Risk Behavior Reduction|risk behavior reduction
784921|NCT00310973|Roma|roma
784922|NCT00310973|Bulgaria|bulgaria
784923|NCT00310973|HIV seronegativity|hiv seronegativity
784924|NCT00310960|infantile esotropia|infantile esotropia
784925|NCT00310960|acquired non-accommodative esotropia|acquired non-accommodative esotropia
784926|NCT00310960|acquired partially accommodative esotropia|acquired partially accommodative esotropia
784927|NCT00310947|Coronary artery disease|coronary artery disease
784928|NCT00310947|Coronary flow reserve|coronary flow reserve
784929|NCT00310947|Heart failure|heart failure
784930|NCT00310947|prospective randomised|prospective randomised
784931|NCT00310934|heroin dependence|heroin dependence
784932|NCT00310934|methadone|methadone
784933|NCT00310934|buprenorphine|buprenorphine
784934|NCT00310934|contingency management|contingency management
784935|NCT00310934|relapse prevention|relapse prevention
784936|NCT00310908|Renal|renal
784937|NCT00310908|Colic|colic
784938|NCT00310908|Calculi|calculi
784939|NCT00310908|Treatment|treatment
784940|NCT00310895|Refractory|refractory
784941|NCT00310895|Relapsed|relapsed
784942|NCT00310882|breast cancer|breast cancer
784943|NCT00310882|digitalis like compounds|digitalis like compounds
784944|NCT00310882|prognostic factor|prognostic factor
784945|NCT00310869|Preterm Birth|preterm birth
784946|NCT00310869|Prematurity|prematurity
784947|NCT00310869|NIDCAP|nidcap
784948|NCT00310869|Adolescence|adolescence
784949|NCT00310869|Developmental Care|developmental care
784950|NCT00310869|Follow-up|follow-up
784951|NCT00310869|Neurobehavior|neurobehavior
784952|NCT00310856|meningitis|meningitis
784953|NCT00310856|children|children
784954|NCT00310856|vaccine|vaccine
784955|NCT00310830|Pulmonary Arterial Hypertension|pulmonary arterial hypertension
784956|NCT00310830|Pulmonary hypertension|pulmonary hypertension
784957|NCT00310830|Sickle Cell Disease|sickle cell disease
784958|NCT00310830|Sickle cell anemia|sickle cell anemia
784959|NCT00310830|ASSET|asset
784960|NCT00310830|ASSET-1|asset-1
784961|NCT00310817|meningitis|meningitis
784962|NCT00310817|children|children
784963|NCT00310817|vaccine|vaccine
784964|NCT00310804|Influenza|influenza
784966|NCT00310804|Cell-Derived|cell-derived
784967|NCT00310804|Egg-Derived|egg-derived
784968|NCT00310804|Healthy Adults|healthy adults
784969|NCT00310804|Safety|safety
784970|NCT00310804|Immunogenicity|immunogenicity
784971|NCT00310804|Vaccination|vaccination
784972|NCT00310791|anorexia nervosa|anorexia nervosa
784973|NCT00310791|adolescents|adolescents
786414|NCT00305487|Ciclesonide|ciclesonide
784974|NCT00310791|dual-energy x-ray absorptiometry|dual-energy x-ray absorptiometry
784975|NCT00310791|dehydroepiandrosterone (DHEA)|dehydroepiandrosterone (dhea)
784976|NCT00310791|osteoporosis|osteoporosis
784977|NCT00310778|High sodium diet|high sodium diet
784978|NCT00310778|Low sodium diet|low sodium diet
784979|NCT00310778|Renin-angiotensin system blockers|renin-angiotensin system blockers
784980|NCT00310778|AT1 receptor (AT1R) antagonist|at1 receptor (at1r) antagonist
784981|NCT00310778|ACE inhibition|ace inhibition
784982|NCT00310765|abdominal pain|abdominal pain
784983|NCT00310765|surgical adhesions|surgical adhesions
784984|NCT00310726|Mother to Child Transmission of HIV|mother to child transmission of hiv
784985|NCT00310726|Postnatal HIV transmission|postnatal hiv transmission
784986|NCT00310726|HIV|hiv
784987|NCT00310726|Breastfeeding|breastfeeding
784988|NCT00310726|Perinatal HIV Transmission|perinatal hiv transmission
784989|NCT00310726|HIV Seronegativity|hiv seronegativity
784990|NCT00310713|Prevention of Meningococcal Meningitis|prevention of meningococcal meningitis
784991|NCT00310713|vaccines|vaccines
784992|NCT00310713|conjugate|conjugate
784993|NCT00310713|immunology|immunology
784994|NCT00310713|children|children
784995|NCT00310713|antibody persistence|antibody persistence
784996|NCT00310700|Prevention of Meningococcal Meningitis|prevention of meningococcal meningitis
784997|NCT00310700|vaccines, conjugate|vaccines, conjugate
784998|NCT00310700|immunology|immunology
784999|NCT00310700|infant|infant
785000|NCT00310700|antibody persistence|antibody persistence
785104|NCT00310245|Prognostic factors|prognostic factors
785001|NCT00310687|Prevention of Meningococcal Meningitis|prevention of meningococcal meningitis
785002|NCT00310687|vaccines|vaccines
785003|NCT00310687|conjugate|conjugate
785004|NCT00310687|immunology|immunology
785005|NCT00310687|antibody persistence|antibody persistence
785006|NCT00310674|Prevention of Meningococcal Meningitis|prevention of meningococcal meningitis
785007|NCT00310674|meningococcal vaccines|meningococcal vaccines
785008|NCT00310674|conjugate|conjugate
785009|NCT00310674|Immunology|immunology
785010|NCT00310674|infant|infant
785011|NCT00310661|sarizotan|sarizotan
785012|NCT00310661|neuroleptic-induced tardive dyskinesia|neuroleptic-induced tardive dyskinesia
785013|NCT00310648|Influenza, elderly, vaccine|influenza, elderly, vaccine
785014|NCT00310635|Prevention of meningococcal infection|prevention of meningococcal infection
785015|NCT00310622|HyperQ|hyperq
785016|NCT00310622|Ischemia|ischemia
785017|NCT00310622|dobutamine|dobutamine
785018|NCT00310609|Structural abnormalities of the aortic arch and cerebral branches|structural abnormalities of the aortic arch and cerebral branches
785019|NCT00310596|ECG safety|ecg safety
785020|NCT00310583|tactile hyperalgesia|tactile hyperalgesia
785021|NCT00310583|neuropathic pain|neuropathic pain
785022|NCT00310583|enriched design|enriched design
785023|NCT00310583|peripheral nerve lesion|peripheral nerve lesion
785024|NCT00310583|plexus lesion|plexus lesion
785025|NCT00310583|radicular lesion|radicular lesion
785026|NCT00310583|spinal lesion|spinal lesion
785027|NCT00310583|polyneuropathy|polyneuropathy
785028|NCT00310583|postzosteric neuralgia|postzosteric neuralgia
785029|NCT00310570|distal|distal
785030|NCT00310570|interphalangeal|interphalangeal
785031|NCT00310570|extensor tendon|extensor tendon
785032|NCT00310570|avulsion|avulsion
785033|NCT00310505|visceral leishmaniasis|visceral leishmaniasis
785034|NCT00310505|amphotericin B|amphotericin b
785035|NCT00310505|Kala-azar|kala-azar
785036|NCT00310479|Magnetic Resonance Imaging|magnetic resonance imaging
785037|NCT00310479|prostate cancer imaging|prostate cancer imaging
785038|NCT00310479|3T MRS|3t mrs
785039|NCT00310479|functional imaging|functional imaging
785040|NCT00310440|Degenerative disc disease|degenerative disc disease
785041|NCT00310440|P-15 Bone Putty|p-15 bone putty
785042|NCT00310440|Bone graft|bone graft
785043|NCT00310440|Cervical discectomy|cervical discectomy
785044|NCT00310440|Cervical spine|cervical spine
785045|NCT00310427|Anxiety|anxiety
785046|NCT00310427|Alcohol Dependence|alcohol dependence
785047|NCT00310427|Alcoholism|alcoholism
785048|NCT00310414|Imaging Studies|imaging studies
785049|NCT00310414|Botulinum Toxin|botulinum toxin
785050|NCT00310414|Writer's Cramp|writer's cramp
785051|NCT00310414|Focal Hand Dystonia|focal hand dystonia
785052|NCT00310414|FHD|fhd
785053|NCT00310414|Writer Cramp|writer cramp
785054|NCT00310414|Healthy Volunteer|healthy volunteer
785055|NCT00310414|HV|hv
785056|NCT00310401|brain death|brain death
785057|NCT00310401|organ donor|organ donor
785058|NCT00310401|pulmonary edema|pulmonary edema
785059|NCT00310401|albuterol|albuterol
785061|NCT00310401|lung transplantation|lung transplantation
785062|NCT00310401|infiltrates|infiltrates
785063|NCT00310388|Partial Seizures|partial seizures
785064|NCT00310388|Epilepsy|epilepsy
785065|NCT00310388|RTG115097|rtg115097
785066|NCT00310388|Complex Partial Seizures|complex partial seizures
785067|NCT00310388|Anticonvulsant|anticonvulsant
785068|NCT00310388|Potassium Channels|potassium channels
785069|NCT00310388|Epilepsies, Partial|epilepsies, partial
785070|NCT00310375|Epilepsy|epilepsy
785071|NCT00310375|Partial Seizures|partial seizures
785072|NCT00310375|Potassium Channels|potassium channels
785073|NCT00310375|Anticonvulsant|anticonvulsant
785074|NCT00310375|Complex Partial Seizures|complex partial seizures
785075|NCT00310375|Epilepsies, Partial|epilepsies, partial
785076|NCT00310375|RTG115098|rtg115098
785077|NCT00310362|telephone|telephone
785078|NCT00310362|telemedicine|telemedicine
785079|NCT00310362|mass screening|mass screening
785080|NCT00310362|patient education|patient education
785081|NCT00310362|Patient compliance|patient compliance
785082|NCT00310349|pneumococcal vaccine|pneumococcal vaccine
785083|NCT00310349|clinical trial|clinical trial
785084|NCT00310349|Indigenous|indigenous
785085|NCT00310349|Maternal|maternal
785086|NCT00310349|Streptococcus pneumoniae|streptococcus pneumoniae
785087|NCT00310323|sleep apnea|sleep apnea
785088|NCT00310323|phenotyping|phenotyping
785089|NCT00310323|cytochrome P450|cytochrome p450
785090|NCT00310323|drug metabolism|drug metabolism
785091|NCT00310323|child|child
785092|NCT00310310|Continuous positive airway pressure|continuous positive airway pressure
785093|NCT00310310|Patient compliance|patient compliance
785094|NCT00310310|Self-care|self-care
785095|NCT00310284|Insomnia|insomnia
785096|NCT00310284|Sleep|sleep
785097|NCT00310271|DNA vaccine, immunotherapy, HSV-2, PMED|dna vaccine, immunotherapy, hsv-2, pmed
785098|NCT00310245|CD4-guided STI|cd4-guided sti
785099|NCT00310245|Keywords:|keywords:
785100|NCT00310245|HAART|haart
785101|NCT00310245|Clinical outcome|clinical outcome
785102|NCT00310245|Resistance|resistance
785103|NCT00310245|Costs|costs
785105|NCT00310245|pulse therapy|pulse therapy
785106|NCT00310245|treatment experienced|treatment experienced
785107|NCT00310245|treatment interruption|treatment interruption
785108|NCT00310232|Quality of Life|quality of life
785109|NCT00310232|Blood transfusion|blood transfusion
785110|NCT00310219|stage II non-small cell lung cancer|stage ii non-small cell lung cancer
785111|NCT00310219|stage IIIA non-small cell lung cancer|stage iiia non-small cell lung cancer
785112|NCT00310219|stage IIIB non-small cell lung cancer|stage iiib non-small cell lung cancer
785113|NCT00310219|recurrent non-small cell lung cancer|recurrent non-small cell lung cancer
785114|NCT00310206|Influenza, pandemic, H5N1, vaccine|influenza, pandemic, h5n1, vaccine
785115|NCT00310167|stage I grade 1 follicular lymphoma|stage i grade 1 follicular lymphoma
785116|NCT00310167|stage I grade 2 follicular lymphoma|stage i grade 2 follicular lymphoma
785117|NCT00310167|stage I grade 3 follicular lymphoma|stage i grade 3 follicular lymphoma
785118|NCT00310167|contiguous stage II grade 1 follicular lymphoma|contiguous stage ii grade 1 follicular lymphoma
785119|NCT00310167|noncontiguous stage II grade 1 follicular lymphoma|noncontiguous stage ii grade 1 follicular lymphoma
785120|NCT00310167|contiguous stage II grade 2 follicular lymphoma|contiguous stage ii grade 2 follicular lymphoma
785121|NCT00310167|noncontiguous stage II grade 2 follicular lymphoma|noncontiguous stage ii grade 2 follicular lymphoma
785122|NCT00310167|contiguous stage II grade 3 follicular lymphoma|contiguous stage ii grade 3 follicular lymphoma
785123|NCT00310167|noncontiguous stage II grade 3 follicular lymphoma|noncontiguous stage ii grade 3 follicular lymphoma
785124|NCT00310167|stage III grade 1 follicular lymphoma|stage iii grade 1 follicular lymphoma
785125|NCT00310167|stage III grade 2 follicular lymphoma|stage iii grade 2 follicular lymphoma
785126|NCT00310167|stage III grade 3 follicular lymphoma|stage iii grade 3 follicular lymphoma
785127|NCT00310167|stage IV grade 1 follicular lymphoma|stage iv grade 1 follicular lymphoma
785128|NCT00310167|stage IV grade 2 follicular lymphoma|stage iv grade 2 follicular lymphoma
785129|NCT00310167|stage IV grade 3 follicular lymphoma|stage iv grade 3 follicular lymphoma
785130|NCT00310167|recurrent grade 1 follicular lymphoma|recurrent grade 1 follicular lymphoma
785131|NCT00310167|recurrent grade 2 follicular lymphoma|recurrent grade 2 follicular lymphoma
785132|NCT00310167|recurrent grade 3 follicular lymphoma|recurrent grade 3 follicular lymphoma
785133|NCT00310167|Marginal zone lymphoma|marginal zone lymphoma
785134|NCT00310154|stage IIIA non-small cell lung cancer|stage iiia non-small cell lung cancer
785135|NCT00310154|stage IIIB non-small cell lung cancer|stage iiib non-small cell lung cancer
785136|NCT00310154|adenosquamous cell lung cancer|adenosquamous cell lung cancer
785137|NCT00310154|bronchoalveolar cell lung cancer|bronchoalveolar cell lung cancer
785138|NCT00310154|large cell lung cancer|large cell lung cancer
785139|NCT00310154|squamous cell lung cancer|squamous cell lung cancer
785140|NCT00310154|adenocarcinoma of the lung|adenocarcinoma of the lung
785141|NCT00310141|non-small cell lung cancer|non-small cell lung cancer
785142|NCT00310141|small cell lung cancer|small cell lung cancer
785143|NCT00310128|AIDS-related diffuse large cell lymphoma|aids-related diffuse large cell lymphoma
785144|NCT00310128|AIDS-related peripheral/systemic lymphoma|aids-related peripheral/systemic lymphoma
785145|NCT00310128|AIDS-related small noncleaved cell lymphoma|aids-related small noncleaved cell lymphoma
785146|NCT00310128|AIDS-related diffuse mixed cell lymphoma|aids-related diffuse mixed cell lymphoma
785147|NCT00310128|AIDS-related immunoblastic large cell lymphoma|aids-related immunoblastic large cell lymphoma
785148|NCT00310128|contiguous stage II grade 2 follicular lymphoma|contiguous stage ii grade 2 follicular lymphoma
785149|NCT00310128|contiguous stage II grade 3 follicular lymphoma|contiguous stage ii grade 3 follicular lymphoma
785150|NCT00310128|noncontiguous stage II grade 2 follicular lymphoma|noncontiguous stage ii grade 2 follicular lymphoma
785151|NCT00310128|noncontiguous stage II grade 3 follicular lymphoma|noncontiguous stage ii grade 3 follicular lymphoma
785299|NCT00309751|pitavastatin|pitavastatin
785152|NCT00310128|recurrent grade 2 follicular lymphoma|recurrent grade 2 follicular lymphoma
785153|NCT00310128|recurrent grade 3 follicular lymphoma|recurrent grade 3 follicular lymphoma
785154|NCT00310128|stage I grade 2 follicular lymphoma|stage i grade 2 follicular lymphoma
785155|NCT00310128|stage I grade 3 follicular lymphoma|stage i grade 3 follicular lymphoma
785156|NCT00310128|stage III grade 2 follicular lymphoma|stage iii grade 2 follicular lymphoma
785157|NCT00310128|stage III grade 3 follicular lymphoma|stage iii grade 3 follicular lymphoma
785158|NCT00310128|stage IV grade 2 follicular lymphoma|stage iv grade 2 follicular lymphoma
785159|NCT00310128|stage IV grade 3 follicular lymphoma|stage iv grade 3 follicular lymphoma
785160|NCT00310128|contiguous stage II adult Burkitt's lymphoma|contiguous stage ii adult burkitt's lymphoma
785161|NCT00310128|noncontiguous stage II adult Burkitt's lymphoma|noncontiguous stage ii adult burkitt's lymphoma
785162|NCT00310128|recurrent adult Burkitt's lymphoma|recurrent adult burkitt's lymphoma
785163|NCT00310128|stage I adult Burkitt's lymphoma|stage i adult burkitt's lymphoma
785164|NCT00310128|stage III adult Burkitt's lymphoma|stage iii adult burkitt's lymphoma
785165|NCT00310128|stage IV adult Burkitt's lymphoma|stage iv adult burkitt's lymphoma
785166|NCT00310128|anaplastic large cell lymphoma|anaplastic large cell lymphoma
785167|NCT00310128|contiguous stage II adult diffuse large cell lymphoma|contiguous stage ii adult diffuse large cell lymphoma
785168|NCT00310128|noncontiguous stage II adult diffuse large cell lymphoma|noncontiguous stage ii adult diffuse large cell lymphoma
785169|NCT00310128|recurrent adult diffuse large cell lymphoma|recurrent adult diffuse large cell lymphoma
785170|NCT00310128|stage I adult diffuse large cell lymphoma|stage i adult diffuse large cell lymphoma
785171|NCT00310128|stage III adult diffuse large cell lymphoma|stage iii adult diffuse large cell lymphoma
785172|NCT00310128|stage IV adult diffuse large cell lymphoma|stage iv adult diffuse large cell lymphoma
785173|NCT00310128|contiguous stage II adult diffuse mixed cell lymphoma|contiguous stage ii adult diffuse mixed cell lymphoma
785174|NCT00310128|noncontiguous stage II adult diffuse mixed cell lymphoma|noncontiguous stage ii adult diffuse mixed cell lymphoma
785175|NCT00310128|recurrent adult diffuse mixed cell lymphoma|recurrent adult diffuse mixed cell lymphoma
785176|NCT00310128|stage I adult diffuse mixed cell lymphoma|stage i adult diffuse mixed cell lymphoma
785177|NCT00310128|stage III adult diffuse mixed cell lymphoma|stage iii adult diffuse mixed cell lymphoma
785178|NCT00310128|stage IV adult diffuse mixed cell lymphoma|stage iv adult diffuse mixed cell lymphoma
785179|NCT00310128|contiguous stage II adult immunoblastic large cell lymphoma|contiguous stage ii adult immunoblastic large cell lymphoma
785180|NCT00310128|noncontiguous stage II adult immunoblastic large cell lymphoma|noncontiguous stage ii adult immunoblastic large cell lymphoma
785181|NCT00310128|recurrent adult immunoblastic large cell lymphoma|recurrent adult immunoblastic large cell lymphoma
785182|NCT00310128|stage I adult immunoblastic large cell lymphoma|stage i adult immunoblastic large cell lymphoma
785183|NCT00310128|stage III adult immunoblastic large cell lymphoma|stage iii adult immunoblastic large cell lymphoma
785184|NCT00310128|stage IV adult immunoblastic large cell lymphoma|stage iv adult immunoblastic large cell lymphoma
785185|NCT00310115|non-small cell lung cancer|non-small cell lung cancer
785186|NCT00310115|small cell lung cancer|small cell lung cancer
785187|NCT00310115|bladder cancer|bladder cancer
785188|NCT00310115|cervical cancer|cervical cancer
785189|NCT00310115|esophageal cancer|esophageal cancer
785190|NCT00310115|gastric cancer|gastric cancer
785191|NCT00310115|renal cell carcinoma|renal cell carcinoma
785192|NCT00310115|adult primary liver cancer|adult primary liver cancer
785193|NCT00310115|pancreatic cancer|pancreatic cancer
785194|NCT00310115|hypopharyngeal cancer|hypopharyngeal cancer
785195|NCT00310115|lip and oral cavity cancer|lip and oral cavity cancer
785196|NCT00310115|laryngeal cancer|laryngeal cancer
785197|NCT00310115|nasopharyngeal cancer|nasopharyngeal cancer
785198|NCT00310115|oropharyngeal cancer|oropharyngeal cancer
785199|NCT00310115|paranasal sinus and nasal cavity cancer|paranasal sinus and nasal cavity cancer
785200|NCT00310115|adult acute myeloid leukemia|adult acute myeloid leukemia
785201|NCT00310115|tobacco use disorder|tobacco use disorder
785202|NCT00310089|stage IIIA breast cancer|stage iiia breast cancer
785203|NCT00310089|stage IIIB breast cancer|stage iiib breast cancer
785204|NCT00310089|stage IIIC breast cancer|stage iiic breast cancer
785205|NCT00310089|inflammatory breast cancer|inflammatory breast cancer
785206|NCT00310076|carcinoma of the appendix|carcinoma of the appendix
785207|NCT00310076|stage II colon cancer|stage ii colon cancer
785208|NCT00310076|stage III colon cancer|stage iii colon cancer
785209|NCT00310076|stage IV colon cancer|stage iv colon cancer
785210|NCT00310076|recurrent colon cancer|recurrent colon cancer
785211|NCT00310076|stage II rectal cancer|stage ii rectal cancer
785212|NCT00310076|stage III rectal cancer|stage iii rectal cancer
785213|NCT00310076|stage IV rectal cancer|stage iv rectal cancer
785214|NCT00310076|recurrent rectal cancer|recurrent rectal cancer
785215|NCT00310063|nausea and vomiting|nausea and vomiting
785216|NCT00310063|unspecified childhood solid tumor, protocol specific|unspecified childhood solid tumor, protocol specific
785217|NCT00310050|stage II pancreatic cancer|stage ii pancreatic cancer
785218|NCT00310050|stage III pancreatic cancer|stage iii pancreatic cancer
785219|NCT00310050|stage IV pancreatic cancer|stage iv pancreatic cancer
785220|NCT00310011|metastatic transitional cell cancer of the renal pelvis and ureter|metastatic transitional cell cancer of the renal pelvis and ureter
785221|NCT00310011|recurrent transitional cell cancer of the renal pelvis and ureter|recurrent transitional cell cancer of the renal pelvis and ureter
785222|NCT00310011|transitional cell carcinoma of the bladder|transitional cell carcinoma of the bladder
785223|NCT00310011|regional transitional cell cancer of the renal pelvis and ureter|regional transitional cell cancer of the renal pelvis and ureter
785224|NCT00310011|stage IV bladder cancer|stage iv bladder cancer
785225|NCT00310011|recurrent bladder cancer|recurrent bladder cancer
785226|NCT00309998|stage IIIB non-small cell lung cancer|stage iiib non-small cell lung cancer
785227|NCT00309998|stage IV non-small cell lung cancer|stage iv non-small cell lung cancer
785228|NCT00309998|adenocarcinoma of the lung|adenocarcinoma of the lung
785229|NCT00309998|bronchoalveolar cell lung cancer|bronchoalveolar cell lung cancer
785230|NCT00309998|large cell lung cancer|large cell lung cancer
785231|NCT00309998|recurrent non-small cell lung cancer|recurrent non-small cell lung cancer
785232|NCT00309985|metastatic hormone-sensitive prostate cancer|metastatic hormone-sensitive prostate cancer
785233|NCT00309985|docetaxel|docetaxel
785234|NCT00309972|stage IIIA non-small cell lung cancer|stage iiia non-small cell lung cancer
785235|NCT00309972|stage IIIB non-small cell lung cancer|stage iiib non-small cell lung cancer
785236|NCT00309933|cognitive/functional effects|cognitive/functional effects
785237|NCT00309933|spiritual concerns|spiritual concerns
785238|NCT00309933|sexuality and reproductive issues|sexuality and reproductive issues
785239|NCT00309933|psychosocial effects of cancer and its treatment|psychosocial effects of cancer and its treatment
785240|NCT00309933|cancer survivor|cancer survivor
785241|NCT00309933|stage I breast cancer|stage i breast cancer
785242|NCT00309933|stage II breast cancer|stage ii breast cancer
785332|NCT00309686|manic state|manic state
785243|NCT00309933|stage IIIA breast cancer|stage iiia breast cancer
785244|NCT00309933|stage IIIB breast cancer|stage iiib breast cancer
785245|NCT00309933|stage IIIC breast cancer|stage iiic breast cancer
785246|NCT00309920|stage IIIA breast cancer|stage iiia breast cancer
785247|NCT00309920|stage IIIC breast cancer|stage iiic breast cancer
785248|NCT00309894|adenocarcinoma of the prostate|adenocarcinoma of the prostate
785249|NCT00309894|recurrent prostate cancer|recurrent prostate cancer
785250|NCT00309881|refractory chronic lymphocytic leukemia|refractory chronic lymphocytic leukemia
785251|NCT00309881|stage I chronic lymphocytic leukemia|stage i chronic lymphocytic leukemia
785252|NCT00309881|stage II chronic lymphocytic leukemia|stage ii chronic lymphocytic leukemia
785253|NCT00309881|stage III chronic lymphocytic leukemia|stage iii chronic lymphocytic leukemia
785254|NCT00309881|stage IV chronic lymphocytic leukemia|stage iv chronic lymphocytic leukemia
785255|NCT00309868|heart catheterization|heart catheterization
785256|NCT00309868|echocardiogram|echocardiogram
785257|NCT00309868|nesiritide|nesiritide
785258|NCT00309842|blastic phase chronic myelogenous leukemia|blastic phase chronic myelogenous leukemia
785259|NCT00309842|primary myelofibrosis|primary myelofibrosis
785260|NCT00309842|chronic myelomonocytic leukemia|chronic myelomonocytic leukemia
785261|NCT00309842|myelodysplastic syndromes|myelodysplastic syndromes
785262|NCT00309842|juvenile myelomonocytic leukemia|juvenile myelomonocytic leukemia
785263|NCT00309842|recurrent adult Burkitt lymphoma|recurrent adult burkitt lymphoma
785264|NCT00309842|recurrent adult immunoblastic large cell lymphoma|recurrent adult immunoblastic large cell lymphoma
785265|NCT00309842|recurrent lymphoblastic lymphoma|recurrent lymphoblastic lymphoma
785266|NCT00309842|recurrent childhood acute myeloid leukemia|recurrent childhood acute myeloid leukemia
785267|NCT00309842|recurrent childhood large cell lymphoma|recurrent childhood large cell lymphoma
785268|NCT00309842|recurrent follicular lymphoma|recurrent follicular lymphoma
785269|NCT00309842|recurrent marginal zone lymphoma|recurrent marginal zone lymphoma
785270|NCT00309842|recurrent small lymphocytic lymphoma|recurrent small lymphocytic lymphoma
785271|NCT00309842|refractory chronic lymphocytic leukemia|refractory chronic lymphocytic leukemia
785272|NCT00309842|refractory multiple myeloma|refractory multiple myeloma
785273|NCT00309842|chronic myelogenous leukemia|chronic myelogenous leukemia
785274|NCT00309842|secondary acute myeloid leukemia|secondary acute myeloid leukemia
785275|NCT00309842|secondary myelodysplastic syndromes|secondary myelodysplastic syndromes
785276|NCT00309842|multiple myeloma|multiple myeloma
785277|NCT00309842|adult lymphoblastic lymphoma|adult lymphoblastic lymphoma
785278|NCT00309842|refractory anemia with excess blasts|refractory anemia with excess blasts
785279|NCT00309842|refractory anemia|refractory anemia
785280|NCT00309842|Burkitt lymphoma|burkitt lymphoma
785281|NCT00309842|childhood large cell lymphoma|childhood large cell lymphoma
785282|NCT00309842|adult Burkitt lymphoma|adult burkitt lymphoma
785283|NCT00309842|mantle cell lymphoma|mantle cell lymphoma
785284|NCT00309842|childhood lymphoblastic lymphoma|childhood lymphoblastic lymphoma
785285|NCT00309842|childhood myelodysplastic syndromes|childhood myelodysplastic syndromes
785286|NCT00309816|Exercise stress test|exercise stress test
785287|NCT00309803|Carotid artery|carotid artery
785288|NCT00309803|distal protection device|distal protection device
785289|NCT00309790|exercise stress test|exercise stress test
785290|NCT00309777|hypercholesterolemia|hypercholesterolemia
785291|NCT00309777|kowa|kowa
785292|NCT00309777|dyslipidemia|dyslipidemia
785293|NCT00309777|pitavastatin|pitavastatin
785294|NCT00309777|NK-104|nk-104
785295|NCT00309777|Primary Hypercholesterolemia or Combined Dyslipidemia|primary hypercholesterolemia or combined dyslipidemia
785296|NCT00309751|Kowa|kowa
785297|NCT00309751|Type II Diabetes Mellitus|type ii diabetes mellitus
785298|NCT00309751|Combined Dyslipidemia|combined dyslipidemia
785301|NCT00309751|Atorvastatin|atorvastatin
785302|NCT00309738|Kowa|kowa
785304|NCT00309738|Hypercholesterolemia|hypercholesterolemia
785305|NCT00309738|combined dyslipidemia|combined dyslipidemia
785306|NCT00309738|dyslipidemia|dyslipidemia
785307|NCT00309738|pitavastatin|pitavastatin
785308|NCT00309738|NK-104|nk-104
785309|NCT00309738|simvastatin|simvastatin
785310|NCT00309725|Alzheimer's Disease|alzheimer's disease
785311|NCT00309725|cardiac arrhythmias|cardiac arrhythmias
785312|NCT00309712|diabetes|diabetes
785313|NCT00309712|combination lipid treatment|combination lipid treatment
785314|NCT00309712|statin|statin
785315|NCT00309712|fibrate|fibrate
785316|NCT00309712|hypercholesteremia|hypercholesteremia
785317|NCT00309712|mixed dyslipidemia|mixed dyslipidemia
785318|NCT00309699|Affective psychosis|affective psychosis
785319|NCT00309699|mixed-state|mixed-state
785320|NCT00309699|bipolar disorder|bipolar disorder
785321|NCT00309699|manic disorder|manic disorder
785322|NCT00309699|manic-depressive psychosis|manic-depressive psychosis
785323|NCT00309699|mania|mania
785324|NCT00309699|manic state|manic state
785325|NCT00309699|paliperidone|paliperidone
785326|NCT00309699|paliperidone ER.|paliperidone er.
785327|NCT00309686|Affective psychosis|affective psychosis
785328|NCT00309686|bipolar disorder|bipolar disorder
785329|NCT00309686|manic disorder|manic disorder
785330|NCT00309686|manic-depressive psychosis|manic-depressive psychosis
785331|NCT00309686|mania|mania
785333|NCT00309686|paliperidone|paliperidone
785334|NCT00309686|paliperidone ER|paliperidone er
785335|NCT00309686|adjunctive therapy|adjunctive therapy
785336|NCT00309673|tuberculosis, tuberculin, childhood, pain|tuberculosis, tuberculin, childhood, pain
785337|NCT00309660|PPARgamma ligand|ppargamma ligand
785338|NCT00309660|Rosiglitazone|rosiglitazone
785339|NCT00309660|Enema|enema
785340|NCT00309647|prophylaxis of pandemic influenza|prophylaxis of pandemic influenza
785341|NCT00309634|prophylaxis of pandemic influenza|prophylaxis of pandemic influenza
785342|NCT00309621|Hand Dermatoses,|hand dermatoses,
785343|NCT00309621|hand dermatitis|hand dermatitis
785344|NCT00309621|hand eczema|hand eczema
785345|NCT00309621|chronic hand dermatitis|chronic hand dermatitis
785346|NCT00309621|retinoid|retinoid
785347|NCT00309569|Cyclophosphamide|cyclophosphamide
785348|NCT00309569|Methotrexate|methotrexate
785349|NCT00309569|Fluorouracil|fluorouracil
785350|NCT00309569|Epirubicine|epirubicine
785351|NCT00309569|Breast Cancer|breast cancer
785352|NCT00309556|Epirubicin|epirubicin
785353|NCT00309556|Docetaxel|docetaxel
785354|NCT00309556|Capecitabine|capecitabine
785355|NCT00309556|Herceptin|herceptin
785356|NCT00309556|Breast cancer|breast cancer
785357|NCT00309543|Fluorouracil|fluorouracil
785358|NCT00309543|Leucovorin|leucovorin
785359|NCT00309543|Colon cancer|colon cancer
785360|NCT00309530|Fluorouracil|fluorouracil
785361|NCT00309530|Levamisol|levamisol
785362|NCT00309530|Interferon|interferon
785363|NCT00309530|Colon cancer|colon cancer
785364|NCT00309517|Fluorouracil|fluorouracil
785365|NCT00309517|Leucovorin|leucovorin
785366|NCT00309517|MAb 17-1A|mab 17-1a
785367|NCT00309517|Rectal cancer|rectal cancer
785368|NCT00309504|magnetic resonance imaging|magnetic resonance imaging
785369|NCT00309504|magnetic resonance spectroscopy|magnetic resonance spectroscopy
785370|NCT00309491|Tamoxifen|tamoxifen
785371|NCT00309491|Aminoglutethimide|aminoglutethimide
785372|NCT00309491|Breast cancer|breast cancer
785373|NCT00309478|Cyclophosphamide|cyclophosphamide
785374|NCT00309478|Methotrexate|methotrexate
785375|NCT00309478|Fluorouracil|fluorouracil
785376|NCT00309478|Goserelin|goserelin
785377|NCT00309478|Tamoxifen|tamoxifen
785378|NCT00309478|Breast cancer|breast cancer
785379|NCT00309465|Diabetes|diabetes
785380|NCT00309465|Insulin Glargine|insulin glargine
785381|NCT00309465|Surgery|surgery
785382|NCT00309452|First episode psychosis|first episode psychosis
785383|NCT00309452|Specialized care|specialized care
785384|NCT00309452|Phase-specific treatment|phase-specific treatment
785385|NCT00309452|Schizophrenia|schizophrenia
785386|NCT00309452|Disorders with psychotic features|disorders with psychotic features
785387|NCT00309426|atherosclerosis|atherosclerosis
785388|NCT00309413|Schizophrenia and Disorders with Psychotic Features|schizophrenia and disorders with psychotic features
785389|NCT00309400|History|history
785390|NCT00309400|Phenylketonuria|phenylketonuria
785391|NCT00309400|Galactosemia|galactosemia
785392|NCT00309400|Screening|screening
785393|NCT00309400|Treatment|treatment
785394|NCT00309387|Cataract|cataract
785395|NCT00309387|Nutritional supplements|nutritional supplements
785396|NCT00309374|LPS|lps
785397|NCT00309374|Statins|statins
785398|NCT00309374|leukocyte mRNA expression profiles|leukocyte mrna expression profiles
785399|NCT00309361|Soft Tissue Anesthesia (Numbness)|soft tissue anesthesia (numbness)
785400|NCT00309335|Soft Tissue Anesthesia (Numbness)|soft tissue anesthesia (numbness)
785401|NCT00309322|Soft Tissue Anesthesia (Numbness)|soft tissue anesthesia (numbness)
785402|NCT00309296|smoking cessation|smoking cessation
786712|NCT00304421|Gastric pH|gastric ph
785403|NCT00309296|smoking reduction|smoking reduction
785404|NCT00309296|nicotine replacement therapy|nicotine replacement therapy
785405|NCT00309270|Campath-1H, low-dose immunosuppression, T regulatives cells|campath-1h, low-dose immunosuppression, t regulatives cells
785406|NCT00309231|diabetes mellitus|diabetes mellitus
785407|NCT00309231|islet transplantation|islet transplantation
785408|NCT00309218|Pediatric renal transplantation|pediatric renal transplantation
785409|NCT00309218|Steroid withdrawal|steroid withdrawal
785410|NCT00309218|Mycophenolate Mofetil|mycophenolate mofetil
785411|NCT00309218|Cyclosporine A|cyclosporine a
785412|NCT00309218|Stable graft function|stable graft function
785413|NCT00309218|children|children
785414|NCT00309218|renal transplantation|renal transplantation
785415|NCT00309205|HIV seronegativity|hiv seronegativity
785416|NCT00309192|Diabetes, Macular Edema, Triamcinolone|diabetes, macular edema, triamcinolone
785417|NCT00309179|Advanced colorectal cancer|advanced colorectal cancer
785418|NCT00309127|Type 2 Diabetes Mellitus|type 2 diabetes mellitus
785419|NCT00309127|DM Nephropathy|dm nephropathy
785420|NCT00309127|Structured care|structured care
785421|NCT00309114|UTI|uti
785422|NCT00309114|SCI|sci
785423|NCT00309114|E coli|e coli
785424|NCT00309114|Prevention|prevention
785425|NCT00309101|Tacrolimus|tacrolimus
785426|NCT00309101|Myasthenia Gravis|myasthenia gravis
785427|NCT00309088|Tacrolimus|tacrolimus
785428|NCT00309088|Myasthenia Gravis|myasthenia gravis
785429|NCT00309075|Stenosis of the calf and/or pedal arteries|stenosis of the calf and/or pedal arteries
785431|NCT00309062|Birch pollen|birch pollen
785432|NCT00309062|Recombinant|recombinant
785433|NCT00309036|Allergy|allergy
785434|NCT00309036|Grass pollen|grass pollen
785435|NCT00309036|Recombinant|recombinant
785436|NCT00309023|Advanced Solid Tumors|advanced solid tumors
785437|NCT00309010|Focal Hand Dystonia|focal hand dystonia
785438|NCT00309010|Motor Planning|motor planning
785439|NCT00309010|Transcranial Magnetic Stimulation (TMS)|transcranial magnetic stimulation (tms)
785440|NCT00309010|MRI (Magnetic Resonance Imaging)|mri (magnetic resonance imaging)
785441|NCT00309010|FHD|fhd
785442|NCT00309010|Writer's Cramp|writer's cramp
785443|NCT00309010|Healthy Volunteer|healthy volunteer
785444|NCT00309010|HV|hv
785445|NCT00308997|Auditory Hallucinations|auditory hallucinations
785446|NCT00308997|Schizophrenia|schizophrenia
785447|NCT00308997|Schizoaffective Disorder|schizoaffective disorder
785448|NCT00308997|Repetitive Transcranial Magnetic Stimulation|repetitive transcranial magnetic stimulation
785449|NCT00308997|Wernicke's Area|wernicke's area
785450|NCT00308997|Superior Temporal Gyrus|superior temporal gyrus
785451|NCT00308984|Pediatrics|pediatrics
785452|NCT00308984|Intraoperative Awareness|intraoperative awareness
785453|NCT00308984|Pediatric Anesthesia|pediatric anesthesia
785454|NCT00308958|cystic fibrosis|cystic fibrosis
785455|NCT00308958|chest physiotherapy|chest physiotherapy
785456|NCT00308958|airway clearance|airway clearance
785457|NCT00308958|bronchiectasis|bronchiectasis
785458|NCT00308945|Glaucoma|glaucoma
785459|NCT00308945|Blood flow|blood flow
785460|NCT00308945|Choroid|choroid
785461|NCT00308945|Retina|retina
785462|NCT00308945|Prostaglandin analogues|prostaglandin analogues
785463|NCT00308932|fluticasone|fluticasone
785464|NCT00308932|asthma therapy|asthma therapy
785465|NCT00308932|spacer inhaler|spacer inhaler
785466|NCT00308932|HFA-134a|hfa-134a
785467|NCT00308906|infection|infection
785468|NCT00308906|renal dysfunction|renal dysfunction
785469|NCT00308906|aminoglycoside|aminoglycoside
785470|NCT00308906|protein|protein
785471|NCT00308906|child|child
785472|NCT00308893|Antidepressants|antidepressants
785473|NCT00308893|escitalopram|escitalopram
785474|NCT00308893|Genetic polymorphism|genetic polymorphism
785475|NCT00308880|Tranexamic acid|tranexamic acid
785476|NCT00308880|head neck surgery|head neck surgery
785477|NCT00308867|PDT|pdt
785478|NCT00308867|AK|ak
785479|NCT00308867|Cryosurgery|cryosurgery
785480|NCT00308854|AK|ak
785481|NCT00308854|PDT|pdt
785482|NCT00308841|"Objective: To evaluate the efficacy of intrauterine lidocaine instillation in reducing patient discomfort during the removal of a lost IUD"|"objective: to evaluate the efficacy of intrauterine lidocaine instillation in reducing patient discomfort during the removal of a lost iud"
785483|NCT00308815|Resuscitation|resuscitation
785484|NCT00308815|Out-of-hospital cardiac arrest|out-of-hospital cardiac arrest
785485|NCT00308815|cardiac arrest|cardiac arrest
785486|NCT00308815|CPR|cpr
785487|NCT00308802|Kidney|kidney
785488|NCT00308802|Transplant|transplant
785489|NCT00308802|Rejection|rejection
785490|NCT00308802|Kidney Disease|kidney disease
785491|NCT00308802|Kidney Failure|kidney failure
785492|NCT00308802|End Stage Renal Disease|end stage renal disease
785493|NCT00308789|Continuous Positive Airway Pressure|continuous positive airway pressure
785494|NCT00308789|Infant,newborn|infant,newborn
785495|NCT00308789|Artificial respiration|artificial respiration
785496|NCT00308763|Smoking Cessation|smoking cessation
785497|NCT00308763|Nicotine Dependence|nicotine dependence
785498|NCT00308724|Generalized Anxiety Disorder|generalized anxiety disorder
785499|NCT00308724|Geriatric|geriatric
785500|NCT00308711|Cervical ripening|cervical ripening
785501|NCT00308711|Induction of labor|induction of labor
785502|NCT00308711|Dinoprostone vaginal insert|dinoprostone vaginal insert
785503|NCT00308711|Cervidil|cervidil
785504|NCT00308711|Misoprostol vaginal insert|misoprostol vaginal insert
785505|NCT00308711|Modified Bishop's Score|modified bishop's score
785507|NCT00308711|PGE1|pge1
785508|NCT00308711|Uterine Hyperstimulation|uterine hyperstimulation
785509|NCT00308711|Cesarean section|cesarean section
785510|NCT00308698|recombinant human erythropoietin|recombinant human erythropoietin
785511|NCT00308698|adiponectin|adiponectin
785512|NCT00308698|mortality|mortality
785513|NCT00308685|Asthma|asthma
785514|NCT00308685|Pediatric asthma|pediatric asthma
785515|NCT00308633|Cardiac Rehabilitation|cardiac rehabilitation
785516|NCT00308633|Apoptosis|apoptosis
785517|NCT00308633|Gene Expression|gene expression
785518|NCT00308633|Nitric Oxide|nitric oxide
785519|NCT00308633|Reactive Oxygen Species|reactive oxygen species
785520|NCT00308633|Coronary Artery Disease|coronary artery disease
785522|NCT00308620|HIV|hiv
785523|NCT00308620|chloroquine|chloroquine
785524|NCT00308620|disease progression|disease progression
785525|NCT00308620|inflammation|inflammation
785526|NCT00308620|treatment naive|treatment naive
785527|NCT00308607|melanoma|melanoma
785528|NCT00308607|metastatic|metastatic
785529|NCT00308607|bevacizumab|bevacizumab
785530|NCT00308594|cervical radiculopathy|cervical radiculopathy
785531|NCT00308594|dexamethasone|dexamethasone
785532|NCT00308594|corticosteroid|corticosteroid
785533|NCT00308594|oral|oral
785534|NCT00308581|Crohn's Disease|crohn's disease
785535|NCT00308581|Certolizumab pegol|certolizumab pegol
785536|NCT00308568|screening colonoscopy|screening colonoscopy
785537|NCT00308568|adherence|adherence
785538|NCT00308555|Cannabis|cannabis
785539|NCT00308555|Morphine|morphine
785540|NCT00308555|Oxycodone|oxycodone
785541|NCT00308555|Marijuana|marijuana
785542|NCT00308555|chronic pain|chronic pain
785543|NCT00308542|eye diseases|eye diseases
785544|NCT00308542|diabetic eye problems|diabetic eye problems
785545|NCT00308529|Carcinoma Small Cell Lung|carcinoma small cell lung
785546|NCT00308529|Lung Cancer|lung cancer
785547|NCT00308516|Rectal Cancer|rectal cancer
785548|NCT00308516|Cancer of the Rectum|cancer of the rectum
785549|NCT00308516|Colorectal Cancer|colorectal cancer
785550|NCT00308516|Bevacizumab|bevacizumab
785551|NCT00308503|Primary Insomnia|primary insomnia
785552|NCT00308503|Sleep Maintenance Insomnia|sleep maintenance insomnia
785553|NCT00308503|Awakening|awakening
785554|NCT00308477|eye diseases|eye diseases
785555|NCT00308451|chromium|chromium
785556|NCT00308451|chromium picolinate|chromium picolinate
785557|NCT00308451|type 2 diabetes mellitus|type 2 diabetes mellitus
785558|NCT00308451|fructosamine|fructosamine
785559|NCT00308451|glycemic control|glycemic control
785560|NCT00308451|OGTT|ogtt
785561|NCT00308438|Crohn Disease|crohn disease
785562|NCT00308438|Crohn's Disease|crohn's disease
785563|NCT00308425|Renal transplantation, EC-MPS|renal transplantation, ec-mps
785564|NCT00308412|Respiratory Tract Infection|respiratory tract infection
785565|NCT00308386|Nurse Case Management|nurse case management
785566|NCT00308386|Diabetes|diabetes
785567|NCT00308386|Hypertension|hypertension
785568|NCT00308386|Hyperlipidemia|hyperlipidemia
785569|NCT00308386|Behavior therapy|behavior therapy
785570|NCT00308386|Motivational interviewing|motivational interviewing
785571|NCT00308360|Hostility|hostility
785572|NCT00308360|Impulsivity|impulsivity
785573|NCT00308360|Aggression|aggression
785574|NCT00308334|Domperidone|domperidone
785575|NCT00308334|breast milk|breast milk
785576|NCT00308334|breast milk composition|breast milk composition
785577|NCT00308334|preterm infant|preterm infant
785578|NCT00308334|neonate|neonate
785579|NCT00308334|nutrition|nutrition
785580|NCT00308269|Cancer|cancer
785581|NCT00308269|Phase I|phase i
785582|NCT00308269|EC145|ec145
785583|NCT00308269|Recurrent|recurrent
785584|NCT00308269|Refractory|refractory
785585|NCT00308269|Solid Tumors|solid tumors
785586|NCT00308269|Experimental|experimental
785587|NCT00308256|Type1 diabetes;|type1 diabetes;
785588|NCT00308256|nurse-counselling;|nurse-counselling;
785589|NCT00308256|adolescent|adolescent
785590|NCT00308243|Cystic Fibrosis|cystic fibrosis
785591|NCT00308243|Sodium Pyruvate|sodium pyruvate
785592|NCT00308243|Reactive Oxygen Species|reactive oxygen species
785593|NCT00308243|Inflammation of Lung|inflammation of lung
785594|NCT00308230|Congenital, BNP|congenital, bnp
785595|NCT00308217|Heart Disease, Congenital|heart disease, congenital
785596|NCT00308217|Single Ventricle|single ventricle
785597|NCT00308217|Hypoplastic Left Heart Syndrome|hypoplastic left heart syndrome
785598|NCT00308204|discoid lupus|discoid lupus
785599|NCT00308204|lupus|lupus
785600|NCT00308204|discoid lupus erythematosus|discoid lupus erythematosus
785601|NCT00308204|lupus of the scalp|lupus of the scalp
785602|NCT00308191|COPD|copd
785603|NCT00308191|Formoterol|formoterol
785604|NCT00308191|Tiotropium|tiotropium
785605|NCT00308178|Abraxane|abraxane
785606|NCT00308178|dose-dense chemotherapy|dose-dense chemotherapy
785607|NCT00308178|taxol|taxol
785608|NCT00308165|Recurrent Primary Malignant Brain Tumors|recurrent primary malignant brain tumors
785609|NCT00308165|Brain Tumors|brain tumors
785610|NCT00308165|Neoplasms, Brain|neoplasms, brain
785611|NCT00308165|Brain Cancer|brain cancer
785612|NCT00308165|Brain cancer treatment|brain cancer treatment
785613|NCT00308165|Topotecan|topotecan
785614|NCT00308152|Colonoscopy|colonoscopy
785615|NCT00308152|Rehydration|rehydration
785616|NCT00308152|Sedation|sedation
785617|NCT00308139|diabetes|diabetes
785618|NCT00308139|exenatide|exenatide
785619|NCT00308139|long acting release|long acting release
785620|NCT00308139|LAR|lar
785621|NCT00308139|Amylin|amylin
785622|NCT00308139|Lilly|lilly
785623|NCT00308126|Abdominal operation|abdominal operation
785624|NCT00308113|Muscular dystrophy|muscular dystrophy
785625|NCT00308113|Duchenne|duchenne
785626|NCT00308113|CoQ10|coq10
785627|NCT00308113|prednisone|prednisone
785628|NCT00308100|Liver Transplantation|liver transplantation
785629|NCT00308087|Sargramostim|sargramostim
785630|NCT00308087|Leukine|leukine
785631|NCT00308087|NHL|nhl
785632|NCT00308074|behavioral problems|behavioral problems
785633|NCT00308074|aggression|aggression
785634|NCT00308074|autism|autism
785635|NCT00308074|aripiprazole|aripiprazole
785636|NCT00308061|Plasmodium falciparum|plasmodium falciparum
785637|NCT00308061|malaria|malaria
785638|NCT00308061|merozoite surface protein-1|merozoite surface protein-1
785639|NCT00308048|Interferon|interferon
785640|NCT00308048|Pegylated interferon|pegylated interferon
785641|NCT00308048|Pegylated interferon alfa 2b|pegylated interferon alfa 2b
785642|NCT00308048|Hepatitis C|hepatitis c
785643|NCT00308048|Genotype 2|genotype 2
785644|NCT00308048|Genotype 3|genotype 3
785645|NCT00308048|Rapid virological response|rapid virological response
785646|NCT00308048|Short treatment|short treatment
785647|NCT00308048|14 weeks treatment|14 weeks treatment
785648|NCT00308048|health related quality of life|health related quality of life
785649|NCT00308048|sick leave|sick leave
785650|NCT00308048|Injecting drug use|injecting drug use
785651|NCT00308022|Acute Lung Injury|acute lung injury
785652|NCT00308022|Acute Respiratory Distress Syndrome|acute respiratory distress syndrome
785653|NCT00308022|High Frequency Percussive Ventilation|high frequency percussive ventilation
785654|NCT00308022|Ventilator Associated Pneumonia|ventilator associated pneumonia
785655|NCT00308009|Pelvic Organ Prolapse|pelvic organ prolapse
785656|NCT00308009|Urinary stress incontinence|urinary stress incontinence
785658|NCT00307996|CoQ10|coq10
785659|NCT00307996|hemodialysis|hemodialysis
785660|NCT00307996|oxidative marker|oxidative marker
785661|NCT00307996|antioxidant|antioxidant
785662|NCT00307970|fluticasone|fluticasone
785663|NCT00307970|asthma therapy|asthma therapy
785664|NCT00307970|spacer inhaler|spacer inhaler
785665|NCT00307970|HFA-134a|hfa-134a
785666|NCT00307957|Obstructive Sleep Apnea|obstructive sleep apnea
785667|NCT00307957|Daytime Sleepiness|daytime sleepiness
785668|NCT00307957|Pillar Palatal Implants|pillar palatal implants
785669|NCT00307944|Acid Reflux|acid reflux
785670|NCT00307944|Obstructive Sleep Apnea|obstructive sleep apnea
785671|NCT00307944|Daytime Sleepiness|daytime sleepiness
785672|NCT00307931|Certolizumab pegol|certolizumab pegol
785673|NCT00307931|Cimzia|cimzia
785674|NCT00307931|Crohn's disease|crohn's disease
785675|NCT00307931|Greek patients|greek patients
785676|NCT00307918|acupuncture, intraocular pressure, glaucoma|acupuncture, intraocular pressure, glaucoma
785677|NCT00307905|homeopathy|homeopathy
785678|NCT00307905|pain|pain
785679|NCT00307905|traumeel s|traumeel s
785680|NCT00307905|Fracture of neck of femur|fracture of neck of femur
785681|NCT00307905|Surgical correction of fracture of neck of hip|surgical correction of fracture of neck of hip
785682|NCT00307892|Homeopathy|homeopathy
785683|NCT00307892|Traumeel S|traumeel s
785684|NCT00307892|Arthroscopy|arthroscopy
785685|NCT00307892|Pain management|pain management
785686|NCT00307892|Post-operative pain following arthroscopy|post-operative pain following arthroscopy
785687|NCT00307879|Myocardial infarction|myocardial infarction
785688|NCT00307879|revascularization|revascularization
785689|NCT00307879|granulocyte colony stimulating factor (G-CSF)|granulocyte colony stimulating factor (g-csf)
785690|NCT00307866|Known or suspected focal liver lesions detected by spiral CT|known or suspected focal liver lesions detected by spiral ct
785691|NCT00307853|homeopathy|homeopathy
785692|NCT00307853|pain|pain
785693|NCT00307853|traumeel s|traumeel s
785694|NCT00307853|total knee arthroplasty|total knee arthroplasty
785695|NCT00307853|total hip arthroplasty|total hip arthroplasty
785696|NCT00307840|hemodialysis; secondary hyperparathyroidism; hypercalcemia; hyperphosphatemia; vitamin D|hemodialysis; secondary hyperparathyroidism; hypercalcemia; hyperphosphatemia; vitamin d
785697|NCT00307827|Steroid-Refractory|steroid-refractory
785698|NCT00307827|IVSR-UC|ivsr-uc
785699|NCT00307827|Ulcerative Colitis|ulcerative colitis
785700|NCT00307814|Anemia|anemia
785701|NCT00307814|Low Blood Count|low blood count
785702|NCT00307814|Chronic Kidney Failure|chronic kidney failure
785703|NCT00307814|Chronic Kidney Disease|chronic kidney disease
785704|NCT00307814|epoetin alfa|epoetin alfa
785705|NCT00307814|recombinant human erythropoietin|recombinant human erythropoietin
785706|NCT00307801|Dysfunctional uterine bleeding|dysfunctional uterine bleeding
785707|NCT00307788|Psychiatric Comorbidity|psychiatric comorbidity
785708|NCT00307788|Acupuncture|acupuncture
785709|NCT00307788|expectancy|expectancy
785710|NCT00307775|oestradiol, faecal incontinence, post menopausal|oestradiol, faecal incontinence, post menopausal
785711|NCT00307775|post menopausal women with faecal incontinence|post menopausal women with faecal incontinence
785712|NCT00307762|Stroke|stroke
785713|NCT00307762|Physiotherapy|physiotherapy
785714|NCT00307762|Effectiveness|effectiveness
785715|NCT00307762|Gait trainer|gait trainer
785716|NCT00307749|Neuropathy|neuropathy
785717|NCT00307749|Nerve Conduction|nerve conduction
785718|NCT00307736|Fluorouracil|fluorouracil
785719|NCT00307736|bevacizumab|bevacizumab
785720|NCT00307736|erlotinib|erlotinib
785721|NCT00307736|external beam radiation therapy|external beam radiation therapy
785722|NCT00307736|EBRT|ebrt
785723|NCT00307723|EBRT|ebrt
785724|NCT00307723|advanced pancreatic cancer|advanced pancreatic cancer
785725|NCT00307710|Non-Hodgkin's Lymphoma|non-hodgkin's lymphoma
785726|NCT00307710|Influenza Vaccination|influenza vaccination
785727|NCT00307710|Trivalent Baculovirus-Expressed Influenza HA vaccine|trivalent baculovirus-expressed influenza ha vaccine
785728|NCT00307710|Antineoplastic Therapy|antineoplastic therapy
785729|NCT00307697|Letter intervention|letter intervention
785730|NCT00307697|Depression|depression
785731|NCT00307697|Anxiety|anxiety
785732|NCT00307697|Primary health care|primary health care
785829|NCT00307320|pregnancy|pregnancy
785733|NCT00307684|Attention Deficit Hyperactivity Disorder|attention deficit hyperactivity disorder
785734|NCT00307684|Adult|adult
785735|NCT00307684|Long term safety|long term safety
785736|NCT00307684|Efficacy|efficacy
785737|NCT00307684|Quality of life|quality of life
785738|NCT00307671|Systemic necrotizing vasculitides|systemic necrotizing vasculitides
785739|NCT00307671|corticosteroids; azathioprine; mycophenolate mofetil;|corticosteroids; azathioprine; mycophenolate mofetil;
785740|NCT00307671|cyclophosphamide|cyclophosphamide
785741|NCT00307671|Elderly patients|elderly patients
785742|NCT00307671|Randomized controlled trial|randomized controlled trial
785743|NCT00307658|ANCA associated Vasculitides|anca associated vasculitides
785744|NCT00307658|Relapse|relapse
785745|NCT00307658|intravenous Immunoglobulins|intravenous immunoglobulins
785746|NCT00307658|Corticosteroid|corticosteroid
785747|NCT00307658|Immunosuppressant|immunosuppressant
785748|NCT00307645|ANCA associated systemic vasculitis|anca associated systemic vasculitis
785749|NCT00307645|Maintenance therapy|maintenance therapy
785750|NCT00307645|Azathioprine|azathioprine
785751|NCT00307645|Mycophenolate mofetil|mycophenolate mofetil
785752|NCT00307632|Contraception|contraception
785753|NCT00307632|Hormonal patch|hormonal patch
785754|NCT00307632|Norelgestromine|norelgestromine
785755|NCT00307632|Ethinyl estradiol|ethinyl estradiol
785756|NCT00307619|Binge-Eating Disorder|binge-eating disorder
785757|NCT00307606|Mastectomy|mastectomy
785758|NCT00307606|Seroma|seroma
785759|NCT00307606|Breast cancer|breast cancer
785760|NCT00307606|Glucocorticoid|glucocorticoid
785761|NCT00307593|Systemic ANCA+ vascularizes|systemic anca+ vascularizes
785762|NCT00307593|Relapse|relapse
785763|NCT00307593|Corticosteroids|corticosteroids
785764|NCT00307593|Immunosuppressant|immunosuppressant
785765|NCT00307593|Infliximab/rituximab|infliximab/rituximab
785766|NCT00307593|Patients with relapsing or refractory forms of ANCA|patients with relapsing or refractory forms of anca
785767|NCT00307593|associated vasculitides Microscopic polyangiitis|associated vasculitides microscopic polyangiitis
785768|NCT00307580|CVADS|cvads
785769|NCT00307502|protease inhibitors|protease inhibitors
785770|NCT00307502|non-nucleoside analog reverse transcriptase inhibitors|non-nucleoside analog reverse transcriptase inhibitors
785771|NCT00307502|pharmacokinetic models|pharmacokinetic models
785772|NCT00307502|treatment experienced|treatment experienced
785773|NCT00307502|HIV|hiv
785774|NCT00307476|Fecal Incontinence|fecal incontinence
785775|NCT00307476|Fecal Containment Devices|fecal containment devices
785776|NCT00307476|Skin Integrity|skin integrity
785777|NCT00307463|end-stage renal disease|end-stage renal disease
785778|NCT00307463|hemodialysis|hemodialysis
785779|NCT00307463|volume control|volume control
785780|NCT00307463|ultrafiltration|ultrafiltration
785781|NCT00307463|inflammation|inflammation
785782|NCT00307463|cardiovascular disease|cardiovascular disease
785783|NCT00307463|left ventricular hypertrophy|left ventricular hypertrophy
785784|NCT00307463|dietary salt restriction|dietary salt restriction
785785|NCT00307450|Dyskinesias|dyskinesias
785786|NCT00307450|Parkinson's disease|parkinson's disease
785787|NCT00307450|Levetiracetam|levetiracetam
785788|NCT00307450|Treatment|treatment
785789|NCT00307437|Moderate to Severe Plaque-Type Psoriasis|moderate to severe plaque-type psoriasis
785790|NCT00307437|interleukin 23|interleukin 23
785791|NCT00307437|IL-12|il-12
785792|NCT00307437|interleukin-12|interleukin-12
785793|NCT00307437|interleukin-23|interleukin-23
785794|NCT00307437|CNTO1275|cnto1275
785795|NCT00307437|biologic|biologic
785796|NCT00307437|Psoriasis|psoriasis
785797|NCT00307437|CNTO 1275|cnto 1275
785798|NCT00307437|IL23|il23
785799|NCT00307437|interleukin 12|interleukin 12
785800|NCT00307437|IL-23|il-23
785801|NCT00307437|IL12|il12
785802|NCT00307437|ustekinumab|ustekinumab
785803|NCT00307411|Metabolic syndrome|metabolic syndrome
785804|NCT00307398|AMD|amd
785805|NCT00307398|Dry AMD|dry amd
785806|NCT00307398|Drusen|drusen
785807|NCT00307398|CNV|cnv
785808|NCT00307385|Motor Recovery|motor recovery
785809|NCT00307385|Transcranial Direct Current Stimulation (tDCS)|transcranial direct current stimulation (tdcs)
785810|NCT00307385|Homeostatic Plasticity|homeostatic plasticity
785811|NCT00307385|Ipsilesional Primary Motor Cortex|ipsilesional primary motor cortex
785812|NCT00307385|Paretic Fingers Motor Sequence|paretic fingers motor sequence
785813|NCT00307385|Motor Cortex|motor cortex
785814|NCT00307385|Motor Function|motor function
785815|NCT00307385|Motor Learning|motor learning
785816|NCT00307385|Premotor Cortex|premotor cortex
785817|NCT00307385|Primary Motor Cortex|primary motor cortex
785818|NCT00307385|Stroke|stroke
785819|NCT00307385|Healthy Volunteer|healthy volunteer
785820|NCT00307385|HV|hv
785821|NCT00307346|Movement-Related Potential|movement-related potential
785822|NCT00307346|Electroencephalogram|electroencephalogram
785823|NCT00307346|Psychogenic Movement Disorders|psychogenic movement disorders
785824|NCT00307346|Psychogenic Movement Disorder|psychogenic movement disorder
785825|NCT00307346|Healthy Volunteer|healthy volunteer
785826|NCT00307346|HV|hv
785827|NCT00307333|very low birth weight infants|very low birth weight infants
785828|NCT00307333|heart rate characteristics|heart rate characteristics
785832|NCT00307307|atherosclerosis|atherosclerosis
785833|NCT00307307|HDL cholesterol|hdl cholesterol
785834|NCT00307307|niacin|niacin
785835|NCT00307307|MR imaging|mr imaging
785836|NCT00307294|Prostate|prostate
785837|NCT00307294|Androgen|androgen
785838|NCT00307294|AIPC|aipc
785839|NCT00307294|Doxil|doxil
785840|NCT00307268|ADHD Effectiveness|adhd effectiveness
785841|NCT00307255|unspecified adult solid tumor|unspecified adult solid tumor
785842|NCT00307255|protocol specific|protocol specific
785843|NCT00307255|Paclitaxel|paclitaxel
785844|NCT00307255|Abraxane|abraxane
785845|NCT00307255|Gemcitabine|gemcitabine
785846|NCT00307255|Gemzar|gemzar
785847|NCT00307255|Phase I|phase i
785848|NCT00307255|Lineberger|lineberger
785849|NCT00307242|Adefovir Dipivoxil|adefovir dipivoxil
785850|NCT00307242|Lamivudine|lamivudine
785851|NCT00307242|Hepatitis B|hepatitis b
785852|NCT00307229|metastatic breast cancer|metastatic breast cancer
785853|NCT00307229|recurrent breast cancer|recurrent breast cancer
785854|NCT00307216|First Episode Psychosis|first episode psychosis
785855|NCT00307216|Early Psychosis|early psychosis
785856|NCT00307216|Psychosocial Intervention|psychosocial intervention
785857|NCT00307203|Bupropion|bupropion
785858|NCT00307203|Zyban|zyban
785859|NCT00307203|Wellbutrin|wellbutrin
785860|NCT00307203|Smoking cessation|smoking cessation
785861|NCT00307203|Schizophrenia|schizophrenia
785862|NCT00307203|Schizoaffective disorder|schizoaffective disorder
785863|NCT00307203|Cognitive Behavioral Therapy|cognitive behavioral therapy
785864|NCT00307190|BED|bed
785865|NCT00307177|influenza vaccine, baculovirus, immunogenicity, lymphoma|influenza vaccine, baculovirus, immunogenicity, lymphoma
785866|NCT00307164|Treatment Experienced|treatment experienced
785867|NCT00307164|Uridine|uridine
785868|NCT00307151|Treatment Naive|treatment naive
785869|NCT00307151|Mother-To-Child Transmission|mother-to-child transmission
785870|NCT00307151|MTCT|mtct
785871|NCT00307151|Pediatrics|pediatrics
785872|NCT00307151|Viral resistance|viral resistance
785873|NCT00307138|Coronary artery bypass, Off-pump|coronary artery bypass, off-pump
785874|NCT00307138|Hetastarch|hetastarch
785875|NCT00307138|Plasma substitutes|plasma substitutes
785876|NCT00307138|Equivalence|equivalence
785877|NCT00307125|Organ Transplantation|organ transplantation
785878|NCT00307125|Graft function/survival|graft function/survival
785879|NCT00307125|Immunosuppression|immunosuppression
785880|NCT00307125|anti-CD20 (rituximab)|anti-cd20 (rituximab)
785881|NCT00307112|Group A streptococcus, Nicaragua, Rheumatic Heart Disease|group a streptococcus, nicaragua, rheumatic heart disease
785882|NCT00307099|bacterial diseases|bacterial diseases
785883|NCT00307073|Pacemaker|pacemaker
785884|NCT00307073|Managed Ventricular Pacing|managed ventricular pacing
785885|NCT00307073|Ventricular Pacing|ventricular pacing
785886|NCT00307047|Stents|stents
785887|NCT00307047|Angioplasty|angioplasty
785888|NCT00307047|Total coronary occlusion|total coronary occlusion
785889|NCT00307047|coronary restenosis|coronary restenosis
785890|NCT00307047|stent thrombosis|stent thrombosis
785891|NCT00307034|Primary vaccination|primary vaccination
785892|NCT00307034|Pneumococcal disease|pneumococcal disease
785893|NCT00307034|Safety|safety
785894|NCT00307034|Booster vaccination|booster vaccination
785895|NCT00307034|Immunogenicity|immunogenicity
785896|NCT00307034|Pneumococcal vaccine|pneumococcal vaccine
785897|NCT00307034|Dose comparison|dose comparison
785898|NCT00307021|Parasitic Diseases|parasitic diseases
787241|NCT00302679|Screening|screening
785899|NCT00307021|Malaria, Falciparum|malaria, falciparum
785901|NCT00307021|Coccidiosis|coccidiosis
785902|NCT00307008|Prophylaxis Invasive pneumococcal diseases and pneumonia|prophylaxis invasive pneumococcal diseases and pneumonia
785903|NCT00306995|prophylaxis of pandemic influenza|prophylaxis of pandemic influenza
785904|NCT00306982|Prophylaxis Influenza vaccine|prophylaxis influenza vaccine
785905|NCT00306969|mycosis fungoides, Sézary Syndrome|mycosis fungoides, sézary syndrome
785906|NCT00306956|Infant|infant
785907|NCT00306956|Newborn|newborn
785908|NCT00306956|pacifier|pacifier
785909|NCT00306956|dummies|dummies
785910|NCT00306956|breastfeeding|breastfeeding
785911|NCT00306956|Sudden Infant Death|sudden infant death
785912|NCT00306956|SIDS|sids
785913|NCT00306956|Pacifiers|pacifiers
785914|NCT00306930|Total Hip Replacement|total hip replacement
785915|NCT00306930|post-traumatic arthritis|post-traumatic arthritis
785916|NCT00306917|Total Hip Replacement|total hip replacement
785917|NCT00306904|Macular|macular
785918|NCT00306904|Edema|edema
785919|NCT00306904|Diabetic|diabetic
785920|NCT00306904|Retinopathy|retinopathy
785921|NCT00306891|Advanced solid tumours|advanced solid tumours
785922|NCT00306891|Advanced cancer|advanced cancer
785923|NCT00306891|tumor|tumor
785924|NCT00306891|tumour|tumour
785925|NCT00306891|RECENTIN|recentin
785926|NCT00306865|Neurotransmitter|neurotransmitter
785927|NCT00306865|Neuroimaging|neuroimaging
785928|NCT00306865|Movement Disorder|movement disorder
785929|NCT00306865|Focal Hand Dystonia|focal hand dystonia
785930|NCT00306865|FHD|fhd
785931|NCT00306865|HV|hv
785932|NCT00306852|Glaucoma|glaucoma
785933|NCT00306852|Trabeculectomy|trabeculectomy
785934|NCT00306852|Tube shunt surgery|tube shunt surgery
785935|NCT00306839|Tissucol|tissucol
785936|NCT00306839|Tisseel|tisseel
785937|NCT00306839|Lichtenstein|lichtenstein
785938|NCT00306839|hernia|hernia
785939|NCT00306839|inguinal|inguinal
785940|NCT00306826|Impaired glucose tolerance|impaired glucose tolerance
785941|NCT00306813|refractory or relapsed multiple myeloma|refractory or relapsed multiple myeloma
785942|NCT00306813|CC-5013|cc-5013
785943|NCT00306813|Revlimid|revlimid
785944|NCT00306813|lenalidomide|lenalidomide
785945|NCT00306813|RAD|rad
785946|NCT00306800|Methyl aminolevulinate|methyl aminolevulinate
785947|NCT00306800|Photodynamic therapy|photodynamic therapy
785948|NCT00306800|Aktilite CL128 LED light source|aktilite cl128 led light source
785949|NCT00306800|Multiple Actinic Keratosis|multiple actinic keratosis
785950|NCT00306787|Herpes simplex|herpes simplex
785951|NCT00306787|genital herpes|genital herpes
785952|NCT00306787|famciclovir|famciclovir
785953|NCT00306787|valacyclovir|valacyclovir
785954|NCT00306787|Recurrent genital herpes|recurrent genital herpes
785955|NCT00306774|osteoarthritis|osteoarthritis
785956|NCT00306774|vitamin D|vitamin d
785957|NCT00306774|knee pain|knee pain
785958|NCT00306774|cartilage loss|cartilage loss
785959|NCT00306774|WOMAC|womac
785960|NCT00306774|MRI|mri
785961|NCT00306774|cartilage volume|cartilage volume
785962|NCT00306774|OA|oa
785963|NCT00306774|physical function|physical function
785964|NCT00306774|web-based|web-based
785965|NCT00306774|internet-based|internet-based
785966|NCT00306748|Chronic Constipation|chronic constipation
785967|NCT00306748|Chronic Idiopathic Constipation|chronic idiopathic constipation
785968|NCT00306748|Constipation|constipation
785969|NCT00306748|CIC|cic
785970|NCT00306748|CC|cc
785971|NCT00306748|MD-1100|md-1100
785972|NCT00306748|MD-1100 Acetate|md-1100 acetate
785973|NCT00306748|Microbia|microbia
785974|NCT00306748|Microbia, Inc.|microbia, inc.
785975|NCT00306748|linaclotide|linaclotide
785976|NCT00306748|linaclotide acetate|linaclotide acetate
785977|NCT00306735|Multiple Myeloma|multiple myeloma
785978|NCT00306735|Stem Cell Transplantation|stem cell transplantation
785979|NCT00306735|CINV|cinv
785980|NCT00306722|Bronchoscopy|bronchoscopy
785981|NCT00306722|Sedation|sedation
785982|NCT00306722|AQUAVAN|aquavan
785983|NCT00306722|fospropofol disodium|fospropofol disodium
785984|NCT00306722|Flexible bronchoscopy|flexible bronchoscopy
785985|NCT00306709|obesity|obesity
785986|NCT00306709|behavior change|behavior change
785987|NCT00306709|cultural adaptations|cultural adaptations
785988|NCT00306709|weight loss|weight loss
785989|NCT00306696|rosiglitazone|rosiglitazone
785990|NCT00306696|fluid retention|fluid retention
785991|NCT00306696|Type 2 diabetes|type 2 diabetes
785992|NCT00306696|diuretics|diuretics
785993|NCT00306683|Hypothalamic-pituitary lesions|hypothalamic-pituitary lesions
785994|NCT00306683|Craniopharyngioma|craniopharyngioma
785995|NCT00306683|Obesity|obesity
785996|NCT00306683|Diazoxide|diazoxide
785997|NCT00306683|Hyperinsulinemia|hyperinsulinemia
785998|NCT00306683|Pediatric neurosurgery|pediatric neurosurgery
785999|NCT00306683|Oncology|oncology
786000|NCT00306683|Pituitary|pituitary
786001|NCT00306683|Hypothalamus|hypothalamus
786002|NCT00306670|Acquired Hemophilia A|acquired hemophilia a
786003|NCT00306670|Anti-Factor VIII antibodies|anti-factor viii antibodies
786004|NCT00306670|Anti-Factor VIII inhibitors|anti-factor viii inhibitors
786005|NCT00306670|Hemophilia A|hemophilia a
786006|NCT00306670|Factor VIII inhibitors|factor viii inhibitors
786007|NCT00306657|Glaucoma Open-Angle|glaucoma open-angle
786008|NCT00306657|Normal tension glaucoma progressive|normal tension glaucoma progressive
786009|NCT00306657|chronic open angle glaucoma progressive|chronic open angle glaucoma progressive
786010|NCT00306657|optic nerve sheath fenestration|optic nerve sheath fenestration
786011|NCT00306657|cerebrospinal fluid|cerebrospinal fluid
786012|NCT00306657|Beta-Trace Protein|beta-trace protein
786013|NCT00306644|rosiglitazone|rosiglitazone
786014|NCT00306644|Type 2 diabetes|type 2 diabetes
786015|NCT00306644|intima media thickness|intima media thickness
786016|NCT00306644|Insulin resistance|insulin resistance
786017|NCT00306631|Advanced and Metastatic Breast Cancer|advanced and metastatic breast cancer
786018|NCT00306605|Emotional experiences|emotional experiences
786020|NCT00306605|stress|stress
786021|NCT00306605|depressive symptomatology|depressive symptomatology
786022|NCT00306605|NICU|nicu
786023|NCT00306605|preterm birth|preterm birth
786024|NCT00306592|Multiple Sclerosis|multiple sclerosis
786025|NCT00306592|MS|ms
786026|NCT00306579|Ischemic Stroke|ischemic stroke
786027|NCT00306579|Myocardial ischemia|myocardial ischemia
786028|NCT00306579|Myocardial necrosis|myocardial necrosis
786029|NCT00306527|Influenza|influenza
786030|NCT00306527|adult/elderly|adult/elderly
786031|NCT00306527|flu cell culture|flu cell culture
786032|NCT00306527|vaccine|vaccine
786033|NCT00306514|metastatic malignant melanoma of the skin|metastatic malignant melanoma of the skin
786034|NCT00306501|Training|training
786035|NCT00306501|Cortical Stimulation|cortical stimulation
786036|NCT00306501|Sensory Stimulation|sensory stimulation
786037|NCT00306501|Brain Imaging|brain imaging
786038|NCT00306501|Transcranial Magnetic Stimulation (TMS)|transcranial magnetic stimulation (tms)
786039|NCT00306501|Swallowing|swallowing
786040|NCT00306501|Dysphagia|dysphagia
786041|NCT00306501|Stroke|stroke
786042|NCT00306501|CVA|cva
786043|NCT00306501|Cerebral Vascular Accident|cerebral vascular accident
786044|NCT00306501|Healthy Volunteer|healthy volunteer
786045|NCT00306501|HV|hv
786046|NCT00306488|Retinal Pigment Epithelium|retinal pigment epithelium
786047|NCT00306488|Dynamic Light Scattering (DLS)|dynamic light scattering (dls)
786048|NCT00306488|Visual Acuity Decrease|visual acuity decrease
786049|NCT00306488|Intra-ocular Pressure|intra-ocular pressure
786050|NCT00306488|Autofluorescence of Retina|autofluorescence of retina
786051|NCT00306488|Age-Related Macular Degeneration|age-related macular degeneration
786052|NCT00306488|AMD|amd
786053|NCT00306475|schizophrenia, cognition, mood stabilizer|schizophrenia, cognition, mood stabilizer
786054|NCT00306462|Premature Labor|premature labor
786055|NCT00306462|Premature Birth|premature birth
786056|NCT00306462|Magnesium sulfate|magnesium sulfate
786057|NCT00306462|Nifedipine|nifedipine
786058|NCT00306449|Weight gain|weight gain
786059|NCT00306449|obesity|obesity
786060|NCT00306449|overweight|overweight
786061|NCT00306449|young adults|young adults
786062|NCT00306449|lipid disorders|lipid disorders
786063|NCT00306449|insulin resistance|insulin resistance
786064|NCT00306449|randomized controled study|randomized controled study
786065|NCT00306436|Diabetes|diabetes
786066|NCT00306436|renal deficiency|renal deficiency
786067|NCT00306436|hypertension|hypertension
786068|NCT00306423|exercise|exercise
786069|NCT00306410|Vitamin D deficiency|vitamin d deficiency
786070|NCT00306410|HIV/AIDS|hiv/aids
786071|NCT00306410|HAART|haart
786072|NCT00306410|T-Lymphocytes, Regulatory|t-lymphocytes, regulatory
786073|NCT00306410|insulin resistance|insulin resistance
786074|NCT00306410|bone density|bone density
786075|NCT00306397|Kidney transplantation|kidney transplantation
786076|NCT00306397|Steroid free|steroid free
786077|NCT00306397|Calcineurin inhibitor free|calcineurin inhibitor free
786078|NCT00306397|Tacrolimus|tacrolimus
786079|NCT00306397|Sirolimus|sirolimus
786080|NCT00306384|Glucose Metabolism Disorder|glucose metabolism disorder
786081|NCT00306384|Dysmetabolic Syndrome|dysmetabolic syndrome
786082|NCT00306384|Type II Diabetes|type ii diabetes
786083|NCT00306384|Diabetes Mellitus,|diabetes mellitus,
786084|NCT00306384|Lipoatrophic|lipoatrophic
786085|NCT00306384|Dyslipidemia|dyslipidemia
786086|NCT00306384|Drug Therapy|drug therapy
786087|NCT00306371|diode|diode
786088|NCT00306371|laser|laser
786089|NCT00306371|acne|acne
786090|NCT00306371|acne scar|acne scar
786091|NCT00306358|absorption test|absorption test
786092|NCT00306358|cobalamin|cobalamin
786093|NCT00306358|holotranscobalamin|holotranscobalamin
786094|NCT00306358|vitamin B12|vitamin b12
786095|NCT00306345|Outreach|outreach
786096|NCT00306345|Major general surgery|major general surgery
786097|NCT00306345|Intensive care|intensive care
786098|NCT00306345|Serious adverse events|serious adverse events
786099|NCT00306332|Allogeneic Stem cell transplantation|allogeneic stem cell transplantation
786100|NCT00306332|T-cell depletion|t-cell depletion
786101|NCT00306332|B-cell depletion|b-cell depletion
786102|NCT00306332|Immunomagnetic selection|immunomagnetic selection
787919|NCT00300196|Stroke|stroke
786103|NCT00306319|Tuberculosis|tuberculosis
786104|NCT00306293|Recurrent Genital Herpes|recurrent genital herpes
786105|NCT00306280|Helicobacter pylori|helicobacter pylori
786106|NCT00306280|phototherapy|phototherapy
786107|NCT00306280|peptic ulcer|peptic ulcer
786108|NCT00306280|gastric cancer|gastric cancer
786109|NCT00306267|Anemia|anemia
786110|NCT00306267|non-chemotherapy-induced|non-chemotherapy-induced
786111|NCT00306267|non-radiation therapy-induced|non-radiation therapy-induced
786112|NCT00306267|cancer|cancer
786113|NCT00306267|non-myeloid|non-myeloid
786114|NCT00306241|Cervical neoplasia|cervical neoplasia
786115|NCT00306241|Cervical cancer|cervical cancer
786116|NCT00306241|Double-blind|double-blind
786117|NCT00306241|HPV-16/18 L1 VLP AS04|hpv-16/18 l1 vlp as04
786118|NCT00306241|HPV|hpv
786119|NCT00306241|AS04|as04
786120|NCT00306228|ST elevation acute myocardial infarction|st elevation acute myocardial infarction
786121|NCT00306228|Thrombolysis|thrombolysis
786122|NCT00306228|Early routine percutaneous coronary intervention|early routine percutaneous coronary intervention
786123|NCT00306228|tirofiban|tirofiban
786124|NCT00306228|paclitaxel|paclitaxel
786125|NCT00306215|double-blind|double-blind
786126|NCT00306215|placebo-controlled|placebo-controlled
786127|NCT00306215|multicenter|multicenter
786128|NCT00306215|efficacy|efficacy
786129|NCT00306215|safety|safety
786130|NCT00306202|Relapsed and Refractory Leukemia|relapsed and refractory leukemia
786131|NCT00306189|RANKL|rankl
786132|NCT00306189|RANK|rank
786133|NCT00306189|denosumab|denosumab
786134|NCT00306189|AMG 162|amg 162
786135|NCT00306189|osteoporosis|osteoporosis
788657|NCT00297375|Pain|pain
786136|NCT00306189|bone turnover|bone turnover
786137|NCT00306189|bone mineral density|bone mineral density
786138|NCT00306189|Japanese|japanese
786139|NCT00306176|rosiglitazone,exercise,cardiovascular risk factors|rosiglitazone,exercise,cardiovascular risk factors
786140|NCT00306163|Asthma|asthma
786141|NCT00306163|AMP|amp
786142|NCT00306163|Ciclesonide|ciclesonide
786143|NCT00306163|Fluticasone propionate|fluticasone propionate
786144|NCT00306150|Prevention of blood loss|prevention of blood loss
786145|NCT00306150|Blood Loss, Surgical|blood loss, surgical
786146|NCT00306150|Blood Loss, Postoperative|blood loss, postoperative
786147|NCT00306124|Dementia|dementia
786148|NCT00306124|Mild Cognitive Impairment|mild cognitive impairment
786150|NCT00306124|levodopa|levodopa
786151|NCT00306124|learning|learning
786152|NCT00306124|enhancement|enhancement
786153|NCT00306111|stem cell transplantation|stem cell transplantation
786154|NCT00306111|stem cell mobilization|stem cell mobilization
786155|NCT00306111|high-dose therapy|high-dose therapy
786156|NCT00306098|Transplantation, Islets of Langerhans|transplantation, islets of langerhans
786157|NCT00306085|Peripheral arterial disease,|peripheral arterial disease,
786158|NCT00306085|blood marrow cells,|blood marrow cells,
786159|NCT00306085|therapeutic angiogenesis.|therapeutic angiogenesis.
786160|NCT00306046|PETScan|petscan
786161|NCT00306046|Positron-Emission Tomography|positron-emission tomography
786162|NCT00306046|Bisphosphonate|bisphosphonate
786163|NCT00306046|Biochemical Markers|biochemical markers
786164|NCT00306046|Paget's Disease of Bone (monostotic and polyostotic)|paget's disease of bone (monostotic and polyostotic)
786165|NCT00306033|myasthenia gravis|myasthenia gravis
786166|NCT00306033|immunoglobulin|immunoglobulin
786167|NCT00306033|intravenous immunoglobulin|intravenous immunoglobulin
786168|NCT00306033|treatment|treatment
786169|NCT00306020|Skin ulcers|skin ulcers
786170|NCT00306020|Topical morphine|topical morphine
786171|NCT00306020|Chronic pain|chronic pain
786172|NCT00306020|Cancer|cancer
786173|NCT00306007|Pregnancy|pregnancy
786174|NCT00306007|Unplanned pregnancy|unplanned pregnancy
786175|NCT00306007|Psychosocial|psychosocial
786176|NCT00306007|Measure|measure
786177|NCT00305968|Quality of life|quality of life
786178|NCT00305968|Gastrointestinal symptoms|gastrointestinal symptoms
786179|NCT00305968|Health related costs|health related costs
786180|NCT00305955|amblyopia|amblyopia
786181|NCT00305955|bilateral amblyopia|bilateral amblyopia
786182|NCT00305955|refractive error|refractive error
786183|NCT00305942|Lung Cancer|lung cancer
786184|NCT00305942|Carcinoma, Small Cell|carcinoma, small cell
786185|NCT00305929|Treatment of localized prostate cancer|treatment of localized prostate cancer
786186|NCT00305929|Localized prostate cancer|localized prostate cancer
786187|NCT00305916|MSCT|msct
786188|NCT00305916|Idiopathic Cardiomyopathy|idiopathic cardiomyopathy
786189|NCT00305916|Sinus rhythm|sinus rhythm
786190|NCT00305903|Dementia,|dementia,
786191|NCT00305903|Alzheimer's,|alzheimer's,
786192|NCT00305903|Rivastigmine,|rivastigmine,
786193|NCT00305903|Memantine|memantine
786194|NCT00305851|fatigue|fatigue
786195|NCT00305851|pain|pain
786196|NCT00305851|psychosocial effects of cancer and its treatment|psychosocial effects of cancer and its treatment
786197|NCT00305851|adult acute myeloid leukemia with 11q23 (MLL) abnormalities|adult acute myeloid leukemia with 11q23 (mll) abnormalities
786198|NCT00305851|adult acute myeloid leukemia with inv(16)(p13;q22)|adult acute myeloid leukemia with inv(16)(p13;q22)
786199|NCT00305851|adult acute myeloid leukemia with t(15;17)(q22;q12)|adult acute myeloid leukemia with t(15;17)(q22;q12)
786200|NCT00305851|adult acute myeloid leukemia with t(16;16)(p13;q22)|adult acute myeloid leukemia with t(16;16)(p13;q22)
786201|NCT00305851|adult acute myeloid leukemia with t(8;21)(q22;q22)|adult acute myeloid leukemia with t(8;21)(q22;q22)
786202|NCT00305851|accelerated phase chronic myelogenous leukemia|accelerated phase chronic myelogenous leukemia
786203|NCT00305851|adult acute lymphoblastic leukemia in remission|adult acute lymphoblastic leukemia in remission
786204|NCT00305851|adult acute myeloid leukemia in remission|adult acute myeloid leukemia in remission
786205|NCT00305851|atypical chronic myeloid leukemia, BCR-ABL1 negative|atypical chronic myeloid leukemia, bcr-abl1 negative
786206|NCT00305851|blastic phase chronic myelogenous leukemia|blastic phase chronic myelogenous leukemia
786207|NCT00305851|childhood acute lymphoblastic leukemia in remission|childhood acute lymphoblastic leukemia in remission
786208|NCT00305851|childhood acute myeloid leukemia in remission|childhood acute myeloid leukemia in remission
786209|NCT00305851|childhood chronic myelogenous leukemia|childhood chronic myelogenous leukemia
786210|NCT00305851|chronic eosinophilic leukemia|chronic eosinophilic leukemia
786211|NCT00305851|primary myelofibrosis|primary myelofibrosis
786212|NCT00305851|chronic myelomonocytic leukemia|chronic myelomonocytic leukemia
786213|NCT00305851|chronic neutrophilic leukemia|chronic neutrophilic leukemia
786214|NCT00305851|chronic phase chronic myelogenous leukemia|chronic phase chronic myelogenous leukemia
786215|NCT00305851|de novo myelodysplastic syndromes|de novo myelodysplastic syndromes
786216|NCT00305851|disseminated neuroblastoma|disseminated neuroblastoma
786217|NCT00305851|extranodal marginal zone B-cell lymphoma of mucosa-associated lymphoid tissue|extranodal marginal zone b-cell lymphoma of mucosa-associated lymphoid tissue
786218|NCT00305851|juvenile myelomonocytic leukemia|juvenile myelomonocytic leukemia
786280|NCT00305851|stage III grade 2 follicular lymphoma|stage iii grade 2 follicular lymphoma
786219|NCT00305851|myelodysplastic/myeloproliferative neoplasm, unclassifiable|myelodysplastic/myeloproliferative neoplasm, unclassifiable
786220|NCT00305851|nodal marginal zone B-cell lymphoma|nodal marginal zone b-cell lymphoma
786221|NCT00305851|noncontiguous stage II adult Burkitt lymphoma|noncontiguous stage ii adult burkitt lymphoma
786222|NCT00305851|noncontiguous stage II adult diffuse large cell lymphoma|noncontiguous stage ii adult diffuse large cell lymphoma
786223|NCT00305851|noncontiguous stage II adult diffuse mixed cell lymphoma|noncontiguous stage ii adult diffuse mixed cell lymphoma
786224|NCT00305851|noncontiguous stage II adult diffuse small cleaved cell lymphoma|noncontiguous stage ii adult diffuse small cleaved cell lymphoma
786225|NCT00305851|noncontiguous stage II adult immunoblastic large cell lymphoma|noncontiguous stage ii adult immunoblastic large cell lymphoma
786226|NCT00305851|noncontiguous stage II adult lymphoblastic lymphoma|noncontiguous stage ii adult lymphoblastic lymphoma
786227|NCT00305851|noncontiguous stage II grade 1 follicular lymphoma|noncontiguous stage ii grade 1 follicular lymphoma
786228|NCT00305851|noncontiguous stage II grade 2 follicular lymphoma|noncontiguous stage ii grade 2 follicular lymphoma
786229|NCT00305851|noncontiguous stage II grade 3 follicular lymphoma|noncontiguous stage ii grade 3 follicular lymphoma
786230|NCT00305851|noncontiguous stage II mantle cell lymphoma|noncontiguous stage ii mantle cell lymphoma
786231|NCT00305851|noncontiguous stage II marginal zone lymphoma|noncontiguous stage ii marginal zone lymphoma
786232|NCT00305851|noncontiguous stage II small lymphocytic lymphoma|noncontiguous stage ii small lymphocytic lymphoma
786233|NCT00305851|high risk metastatic gestational trophoblastic tumor|high risk metastatic gestational trophoblastic tumor
786234|NCT00305851|previously treated childhood rhabdomyosarcoma|previously treated childhood rhabdomyosarcoma
786235|NCT00305851|previously treated myelodysplastic syndromes|previously treated myelodysplastic syndromes
786236|NCT00305851|recurrent adult acute lymphoblastic leukemia|recurrent adult acute lymphoblastic leukemia
786237|NCT00305851|recurrent adult acute myeloid leukemia|recurrent adult acute myeloid leukemia
786238|NCT00305851|recurrent adult Burkitt lymphoma|recurrent adult burkitt lymphoma
786239|NCT00305851|recurrent adult Hodgkin lymphoma|recurrent adult hodgkin lymphoma
786240|NCT00305851|recurrent adult diffuse large cell lymphoma|recurrent adult diffuse large cell lymphoma
786241|NCT00305851|recurrent adult diffuse mixed cell lymphoma|recurrent adult diffuse mixed cell lymphoma
786242|NCT00305851|recurrent adult diffuse small cleaved cell lymphoma|recurrent adult diffuse small cleaved cell lymphoma
786243|NCT00305851|recurrent adult immunoblastic large cell lymphoma|recurrent adult immunoblastic large cell lymphoma
786244|NCT00305851|recurrent adult lymphoblastic lymphoma|recurrent adult lymphoblastic lymphoma
786245|NCT00305851|recurrent/refractory childhood Hodgkin lymphoma|recurrent/refractory childhood hodgkin lymphoma
786246|NCT00305851|recurrent childhood acute lymphoblastic leukemia|recurrent childhood acute lymphoblastic leukemia
786247|NCT00305851|recurrent childhood acute myeloid leukemia|recurrent childhood acute myeloid leukemia
786248|NCT00305851|recurrent childhood large cell lymphoma|recurrent childhood large cell lymphoma
786249|NCT00305851|recurrent childhood lymphoblastic lymphoma|recurrent childhood lymphoblastic lymphoma
786250|NCT00305851|recurrent childhood rhabdomyosarcoma|recurrent childhood rhabdomyosarcoma
786251|NCT00305851|recurrent childhood small noncleaved cell lymphoma|recurrent childhood small noncleaved cell lymphoma
786252|NCT00305851|recurrent cutaneous T-cell non-Hodgkin lymphoma|recurrent cutaneous t-cell non-hodgkin lymphoma
786253|NCT00305851|recurrent grade 1 follicular lymphoma|recurrent grade 1 follicular lymphoma
786254|NCT00305851|recurrent grade 2 follicular lymphoma|recurrent grade 2 follicular lymphoma
786255|NCT00305851|recurrent grade 3 follicular lymphoma|recurrent grade 3 follicular lymphoma
786256|NCT00305851|recurrent mantle cell lymphoma|recurrent mantle cell lymphoma
786257|NCT00305851|recurrent marginal zone lymphoma|recurrent marginal zone lymphoma
786258|NCT00305851|recurrent mycosis fungoides/Sezary syndrome|recurrent mycosis fungoides/sezary syndrome
786259|NCT00305851|recurrent neuroblastoma|recurrent neuroblastoma
786260|NCT00305851|recurrent ovarian epithelial cancer|recurrent ovarian epithelial cancer
786261|NCT00305851|recurrent ovarian germ cell tumor|recurrent ovarian germ cell tumor
786262|NCT00305851|recurrent small lymphocytic lymphoma|recurrent small lymphocytic lymphoma
786263|NCT00305851|recurrent malignant testicular germ cell tumor|recurrent malignant testicular germ cell tumor
786264|NCT00305851|recurrent Wilms tumor and other childhood kidney tumors|recurrent wilms tumor and other childhood kidney tumors
786265|NCT00305851|refractory chronic lymphocytic leukemia|refractory chronic lymphocytic leukemia
786266|NCT00305851|refractory hairy cell leukemia|refractory hairy cell leukemia
786267|NCT00305851|relapsing chronic myelogenous leukemia|relapsing chronic myelogenous leukemia
786268|NCT00305851|secondary acute myeloid leukemia|secondary acute myeloid leukemia
786269|NCT00305851|secondary myelodysplastic syndromes|secondary myelodysplastic syndromes
786270|NCT00305851|splenic marginal zone lymphoma|splenic marginal zone lymphoma
786271|NCT00305851|stage III adult Burkitt lymphoma|stage iii adult burkitt lymphoma
786272|NCT00305851|stage III adult Hodgkin lymphoma|stage iii adult hodgkin lymphoma
786273|NCT00305851|stage III adult diffuse large cell lymphoma|stage iii adult diffuse large cell lymphoma
786274|NCT00305851|stage III adult diffuse mixed cell lymphoma|stage iii adult diffuse mixed cell lymphoma
786275|NCT00305851|stage III adult diffuse small cleaved cell lymphoma|stage iii adult diffuse small cleaved cell lymphoma
786276|NCT00305851|stage III adult immunoblastic large cell lymphoma|stage iii adult immunoblastic large cell lymphoma
786277|NCT00305851|stage III adult lymphoblastic lymphoma|stage iii adult lymphoblastic lymphoma
786278|NCT00305851|stage III chronic lymphocytic leukemia|stage iii chronic lymphocytic leukemia
786279|NCT00305851|stage III grade 1 follicular lymphoma|stage iii grade 1 follicular lymphoma
786281|NCT00305851|stage III grade 3 follicular lymphoma|stage iii grade 3 follicular lymphoma
786282|NCT00305851|stage III mantle cell lymphoma|stage iii mantle cell lymphoma
786283|NCT00305851|stage III marginal zone lymphoma|stage iii marginal zone lymphoma
786284|NCT00305851|stage III small lymphocytic lymphoma|stage iii small lymphocytic lymphoma
786285|NCT00305851|stage III malignant testicular germ cell tumor|stage iii malignant testicular germ cell tumor
786286|NCT00305851|stage IV adult Burkitt lymphoma|stage iv adult burkitt lymphoma
786287|NCT00305851|stage IV adult Hodgkin lymphoma|stage iv adult hodgkin lymphoma
786288|NCT00305851|stage IV adult diffuse large cell lymphoma|stage iv adult diffuse large cell lymphoma
786289|NCT00305851|stage IV adult diffuse mixed cell lymphoma|stage iv adult diffuse mixed cell lymphoma
786290|NCT00305851|stage IV adult diffuse small cleaved cell lymphoma|stage iv adult diffuse small cleaved cell lymphoma
786291|NCT00305851|stage IV adult immunoblastic large cell lymphoma|stage iv adult immunoblastic large cell lymphoma
786292|NCT00305851|stage IV adult lymphoblastic lymphoma|stage iv adult lymphoblastic lymphoma
786293|NCT00305851|stage IV chronic lymphocytic leukemia|stage iv chronic lymphocytic leukemia
786294|NCT00305851|stage IV grade 1 follicular lymphoma|stage iv grade 1 follicular lymphoma
786295|NCT00305851|stage IV grade 2 follicular lymphoma|stage iv grade 2 follicular lymphoma
786296|NCT00305851|stage IV grade 3 follicular lymphoma|stage iv grade 3 follicular lymphoma
786297|NCT00305851|stage IV mantle cell lymphoma|stage iv mantle cell lymphoma
786298|NCT00305851|stage IV marginal zone lymphoma|stage iv marginal zone lymphoma
786299|NCT00305851|stage IV ovarian epithelial cancer|stage iv ovarian epithelial cancer
786300|NCT00305851|stage IV small lymphocytic lymphoma|stage iv small lymphocytic lymphoma
786301|NCT00305851|stage II ovarian epithelial cancer|stage ii ovarian epithelial cancer
786302|NCT00305851|stage III ovarian epithelial cancer|stage iii ovarian epithelial cancer
786303|NCT00305851|childhood myelodysplastic syndromes|childhood myelodysplastic syndromes
786304|NCT00305851|Ewing sarcoma|ewing sarcoma
786305|NCT00305851|childhood brain tumor|childhood brain tumor
786306|NCT00305851|adult brain tumor|adult brain tumor
786307|NCT00305851|osteosarcoma|osteosarcoma
786308|NCT00305838|stage IV ovarian epithelial cancer|stage iv ovarian epithelial cancer
786309|NCT00305838|recurrent ovarian epithelial cancer|recurrent ovarian epithelial cancer
786310|NCT00305838|stage IIIA ovarian epithelial cancer|stage iiia ovarian epithelial cancer
786311|NCT00305838|stage IIIB ovarian epithelial cancer|stage iiib ovarian epithelial cancer
786312|NCT00305838|stage IIIC ovarian epithelial cancer|stage iiic ovarian epithelial cancer
786313|NCT00305838|recurrent fallopian tube cancer|recurrent fallopian tube cancer
786314|NCT00305838|stage IIIA fallopian tube cancer|stage iiia fallopian tube cancer
786315|NCT00305838|stage IIIB fallopian tube cancer|stage iiib fallopian tube cancer
786316|NCT00305838|stage IIIC fallopian tube cancer|stage iiic fallopian tube cancer
786317|NCT00305838|stage IV fallopian tube cancer|stage iv fallopian tube cancer
786318|NCT00305838|recurrent primary peritoneal cavity cancer|recurrent primary peritoneal cavity cancer
786319|NCT00305838|stage IIIA primary peritoneal cavity cancer|stage iiia primary peritoneal cavity cancer
786320|NCT00305838|stage IIIB primary peritoneal cavity cancer|stage iiib primary peritoneal cavity cancer
786321|NCT00305838|stage IIIC primary peritoneal cavity cancer|stage iiic primary peritoneal cavity cancer
786322|NCT00305838|stage IV primary peritoneal cavity cancer|stage iv primary peritoneal cavity cancer
786323|NCT00305825|recurrent breast cancer|recurrent breast cancer
786324|NCT00305825|stage IIIA breast cancer|stage iiia breast cancer
786325|NCT00305825|stage IIIB breast cancer|stage iiib breast cancer
786326|NCT00305825|stage IIIC breast cancer|stage iiic breast cancer
786327|NCT00305825|stage IV breast cancer|stage iv breast cancer
787920|NCT00300196|Fibrinogen|fibrinogen
786328|NCT00305812|stage I multiple myeloma|stage i multiple myeloma
786329|NCT00305812|stage II multiple myeloma|stage ii multiple myeloma
786330|NCT00305812|stage III multiple myeloma|stage iii multiple myeloma
786331|NCT00305799|neurotoxicity|neurotoxicity
786332|NCT00305799|unspecified adult solid tumor, protocol specific|unspecified adult solid tumor, protocol specific
786333|NCT00305786|recurrent non-small cell lung cancer|recurrent non-small cell lung cancer
786334|NCT00305786|stage IIIB non-small cell lung cancer|stage iiib non-small cell lung cancer
786335|NCT00305786|stage IV non-small cell lung cancer|stage iv non-small cell lung cancer
786336|NCT00305760|stage III pancreatic cancer|stage iii pancreatic cancer
786337|NCT00305760|recurrent pancreatic cancer|recurrent pancreatic cancer
786338|NCT00305760|duct cell adenocarcinoma of the pancreas|duct cell adenocarcinoma of the pancreas
786339|NCT00305760|adenocarcinoma of the pancreas|adenocarcinoma of the pancreas
786340|NCT00305760|stage IV pancreatic cancer|stage iv pancreatic cancer
786341|NCT00305747|recurrent prostate cancer|recurrent prostate cancer
786342|NCT00305747|stage I prostate cancer|stage i prostate cancer
786343|NCT00305747|stage II prostate cancer|stage ii prostate cancer
786344|NCT00305747|stage III prostate cancer|stage iii prostate cancer
786345|NCT00305747|adenocarcinoma of the prostate|adenocarcinoma of the prostate
786346|NCT00305747|stage IV prostate cancer|stage iv prostate cancer
786347|NCT00305708|thrombocytopenia|thrombocytopenia
786348|NCT00305708|childhood acute myeloid leukemia in remission|childhood acute myeloid leukemia in remission
786349|NCT00305708|childhood chronic myelogenous leukemia|childhood chronic myelogenous leukemia
786350|NCT00305708|Diamond-Blackfan anemia|diamond-blackfan anemia
786351|NCT00305708|congenital amegakaryocytic thrombocytopenia|congenital amegakaryocytic thrombocytopenia
786352|NCT00305708|Fanconi anemia|fanconi anemia
786353|NCT00305708|severe congenital neutropenia|severe congenital neutropenia
786354|NCT00305708|chronic phase chronic myelogenous leukemia|chronic phase chronic myelogenous leukemia
786355|NCT00305669|adenocarcinoma of the prostate|adenocarcinoma of the prostate
786356|NCT00305669|stage I prostate cancer|stage i prostate cancer
786357|NCT00305669|stage IIB prostate cancer|stage iib prostate cancer
786358|NCT00305669|stage IIA prostate cancer|stage iia prostate cancer
786359|NCT00305669|stage III prostate cancer|stage iii prostate cancer
786360|NCT00305643|Hand-Foot Syndrome|hand-foot syndrome
786361|NCT00305643|cancer-related problem/condition|cancer-related problem/condition
786362|NCT00305643|drug/agent toxicity by tissue/organ|drug/agent toxicity by tissue/organ
786363|NCT00305643|pain|pain
786364|NCT00305643|palmar-plantar erythrodysesthesia|palmar-plantar erythrodysesthesia
786365|NCT00305643|stage IV breast cancer|stage iv breast cancer
786366|NCT00305643|male breast cancer|male breast cancer
786367|NCT00305643|recurrent breast cancer|recurrent breast cancer
786368|NCT00305643|stage IV colon cancer|stage iv colon cancer
786369|NCT00305643|stage IV rectal cancer|stage iv rectal cancer
786370|NCT00305643|recurrent colon cancer|recurrent colon cancer
786371|NCT00305643|recurrent rectal cancer|recurrent rectal cancer
786372|NCT00305643|Celecoxib|celecoxib
786373|NCT00305643|Celebrex|celebrex
786374|NCT00305643|Capecitabine|capecitabine
786375|NCT00305643|Xeloda|xeloda
786376|NCT00305630|Corticosteroids|corticosteroids
786377|NCT00305630|Triamcinolone|triamcinolone
786378|NCT00305630|Photodynamic therapy|photodynamic therapy
786379|NCT00305630|Choroidal neovascularization|choroidal neovascularization
786380|NCT00305630|Age-related macular degeneration|age-related macular degeneration
786381|NCT00305617|stage IIIA non-small cell lung cancer|stage iiia non-small cell lung cancer
786382|NCT00305617|stage IIIB non-small cell lung cancer|stage iiib non-small cell lung cancer
786383|NCT00305591|magnetic resonance imaging|magnetic resonance imaging
786384|NCT00305591|magnetic resonance spectroscopy|magnetic resonance spectroscopy
786385|NCT00305591|functional magnetic resonance imaging|functional magnetic resonance imaging
786386|NCT00305591|cirrhosis|cirrhosis
786387|NCT00305591|hepatic encephalopathy|hepatic encephalopathy
786388|NCT00305591|l-ornithine l-aspartate|l-ornithine l-aspartate
786389|NCT00305578|Bipolar|bipolar
786390|NCT00305578|Depression|depression
786391|NCT00305578|Incomplete Response|incomplete response
786392|NCT00305565|Depression|depression
786393|NCT00305565|Chronic Depression|chronic depression
786394|NCT00305565|Bipolar Disorder|bipolar disorder
786395|NCT00305552|Randomized controlled trial|randomized controlled trial
786396|NCT00305552|Thalidomide vs placebo|thalidomide vs placebo
786397|NCT00305552|skin sarcoidosis|skin sarcoidosis
786398|NCT00305552|Thalidomide|thalidomide
786399|NCT00305539|Giant Cell Arteritis|giant cell arteritis
786400|NCT00305539|Placebo|placebo
786401|NCT00305539|Anti-TNF|anti-tnf
786402|NCT00305539|Multicenter-randomized-trial|multicenter-randomized-trial
786403|NCT00305539|Proved GCA according to ACR criteria (HUNDER et al 1990)|proved gca according to acr criteria (hunder et al 1990)
786404|NCT00305513|right hemispheric CVA|right hemispheric cva
786405|NCT00305513|neglect|neglect
786406|NCT00305513|phasic alert treatment|phasic alert treatment
786407|NCT00305513|PET scan|pet scan
786408|NCT00305513|patients post right hemispheric CVA (stroke)|patients post right hemispheric cva (stroke)
786409|NCT00305500|OCD|ocd
786410|NCT00305500|Escitalopram|escitalopram
786411|NCT00305487|Hay Fever|hay fever
786412|NCT00305487|Seasonal Allergic Rhinitis|seasonal allergic rhinitis
786415|NCT00305487|Allergic Rhinitis|allergic rhinitis
786416|NCT00305474|Negative symptoms|negative symptoms
786417|NCT00305474|neuropsychological deficits|neuropsychological deficits
786418|NCT00305474|Cognitive function|cognitive function
786419|NCT00305474|diagnostic|diagnostic
786420|NCT00305474|prevention|prevention
786421|NCT00305461|Asthma|asthma
786422|NCT00305461|Quality of Life|quality of life
786423|NCT00305461|Ciclesonide|ciclesonide
786424|NCT00305448|oncology|oncology
786425|NCT00305448|cancer|cancer
786426|NCT00305448|breast cancer|breast cancer
786427|NCT00305435|AMG 531, ITP, Phase 2, Japanese|amg 531, itp, phase 2, japanese
786428|NCT00305409|Crohn's|crohn's
786429|NCT00305409|TNF-alpha|tnf-alpha
786430|NCT00305409|Synbiotic|synbiotic
786431|NCT00305409|Probiotic|probiotic
786432|NCT00305396|Kidney transplantation|kidney transplantation
786433|NCT00305396|immunosuppression|immunosuppression
786434|NCT00305396|sirolimus|sirolimus
786435|NCT00305396|Thymoglobulin|thymoglobulin
786436|NCT00305383|Viramidine|viramidine
786437|NCT00305383|Peginterferon alfa-2b|peginterferon alfa-2b
786438|NCT00305383|Valeant|valeant
786439|NCT00305383|Hepatitis C|hepatitis c
786440|NCT00305383|Rapid virologic response|rapid virologic response
786441|NCT00305383|HCV RNA|hcv rna
786442|NCT00305370|clinical trial|clinical trial
786443|NCT00305370|aripiprazole|aripiprazole
786444|NCT00305370|methylphenidate|methylphenidate
786445|NCT00305370|Bipolar Disorder|bipolar disorder
786446|NCT00305370|Attention-Deficit Hyperactivity Disorder|attention-deficit hyperactivity disorder
786447|NCT00305370|ADHD|adhd
786745|NCT00304213|aging|aging
786448|NCT00305357|Post-Herpetic Neuralgia|post-herpetic neuralgia
786449|NCT00305357|Acute Herpes Zoster|acute herpes zoster
786450|NCT00305344|Type 1 Diabetes Mellitus|type 1 diabetes mellitus
786451|NCT00305344|Umbilical Cord|umbilical cord
786452|NCT00305344|Regeneration|regeneration
786453|NCT00305344|Insulin|insulin
786454|NCT00305344|Islets of Langerhans|islets of langerhans
786455|NCT00305331|Parkinson's disease|parkinson's disease
786456|NCT00305331|Domperidone|domperidone
786457|NCT00305331|Peripheral edema|peripheral edema
786458|NCT00305331|Pramipexole|pramipexole
786459|NCT00305331|Ropinirole|ropinirole
786460|NCT00305305|Agenesis Corpus Callosum|agenesis corpus callosum
786461|NCT00305305|Polymicrogyria|polymicrogyria
786462|NCT00305305|Dandy-Walker|dandy-walker
786463|NCT00305305|Brain Malformation|brain malformation
786464|NCT00305305|Autism|autism
786465|NCT00305305|Epilepsy|epilepsy
786466|NCT00305305|Mental Retardation|mental retardation
786467|NCT00305305|MRI|mri
786468|NCT00305305|Agenesis of the Corpus Callosum (complete or partial)|agenesis of the corpus callosum (complete or partial)
786469|NCT00305305|Confirmed by a brain MRI.|confirmed by a brain mri.
786470|NCT00305305|Aicardi Syndrome.|aicardi syndrome.
786471|NCT00305266|CIDP|cidp
786472|NCT00305266|IVIG|ivig
786473|NCT00305266|gammaglobulin|gammaglobulin
786474|NCT00305266|Chronic Inflammatory Demyelinating Polyradiculoneuropathy|chronic inflammatory demyelinating polyradiculoneuropathy
786475|NCT00305253|maternal mortality|maternal mortality
786476|NCT00305253|obstetric hemorrhage|obstetric hemorrhage
786477|NCT00305240|Myocardial Infarction|myocardial infarction
786478|NCT00305240|Microvolt T Wave Alternans Test|microvolt t wave alternans test
786479|NCT00305240|Implantable Cardioverter Defibrillator (ICD)|implantable cardioverter defibrillator (icd)
786480|NCT00305240|Ventricular Arrythmias|ventricular arrythmias
786481|NCT00305227|urinary tract infection|urinary tract infection
786482|NCT00305227|cystitis|cystitis
786483|NCT00305227|Lactobacillus|lactobacillus
786484|NCT00305227|probiotic|probiotic
786485|NCT00305227|prevention|prevention
786486|NCT00305214|Myocardial Infarction|myocardial infarction
786487|NCT00305214|Microvolt T Wave Alternans Test|microvolt t wave alternans test
786488|NCT00305214|Implantable Cardioverter Defibrillator (ICD)|implantable cardioverter defibrillator (icd)
786489|NCT00305214|Ventricular Arrhythmia|ventricular arrhythmia
786490|NCT00305201|Mucocutaneous Lymph Node Syndrome|mucocutaneous lymph node syndrome
786491|NCT00305201|Kawasaki disease|kawasaki disease
786492|NCT00305201|Endothelial dysfunction|endothelial dysfunction
786493|NCT00305201|Pravastatin|pravastatin
786494|NCT00305201|Statin therapy|statin therapy
786495|NCT00305188|Neurotoxicity syndromes|neurotoxicity syndromes
786496|NCT00305188|Paresthesia|paresthesia
786497|NCT00305188|Oxaliplatin|oxaliplatin
786498|NCT00305188|Xaliproden|xaliproden
786499|NCT00305175|Hydroxyurea|hydroxyurea
786500|NCT00305175|Sickle Cell Anemia|sickle cell anemia
786501|NCT00305162|Acute Coronary Syndrome (ACS)|acute coronary syndrome (acs)
786502|NCT00305162|Percutaneous Coronary Intervention (PCI)|percutaneous coronary intervention (pci)
786503|NCT00305162|non-ST-segment elevation myocardial infarction (NSTEMI)|non-st-segment elevation myocardial infarction (nstemi)
786504|NCT00305162|ST-segment elevation myocardial infarction (STEMI)|st-segment elevation myocardial infarction (stemi)
786505|NCT00305149|Hodgkin Lymphoma|hodgkin lymphoma
786506|NCT00305149|BEACOPP|beacopp
786507|NCT00305149|PET|pet
786508|NCT00305149|Gallium|gallium
786509|NCT00305149|Tailored therapy|tailored therapy
786510|NCT00305136|thoracotomy|thoracotomy
786511|NCT00305136|post-operative pain|post-operative pain
786512|NCT00305136|chronic pain|chronic pain
786513|NCT00305136|endogenous analgesia|endogenous analgesia
786514|NCT00305136|temporal summation|temporal summation
786515|NCT00305136|central sensitization|central sensitization
786516|NCT00305136|prediction|prediction
786517|NCT00305136|Patients Who Should Undergo Thoracotomy|patients who should undergo thoracotomy
786518|NCT00305123|Pharyngitis, Mali, Group A Streptococcus, Children|pharyngitis, mali, group a streptococcus, children
786519|NCT00305110|Pain|pain
786520|NCT00305110|Acute|acute
786521|NCT00305110|Emergency Department|emergency department
786522|NCT00305110|Severe|severe
786523|NCT00305110|Hydromorphone|hydromorphone
786524|NCT00305110|Dilaudid|dilaudid
786525|NCT00305110|Adult|adult
786526|NCT00305097|coffee|coffee
786527|NCT00305097|caffeine|caffeine
786528|NCT00305097|glucose tolerance|glucose tolerance
786529|NCT00305097|body weight|body weight
786530|NCT00305097|insulin sensitivity|insulin sensitivity
786531|NCT00305097|randomized controlled trial|randomized controlled trial
786532|NCT00305084|NGR-hTNF|ngr-htnf
786533|NCT00305084|doxorubicin|doxorubicin
786534|NCT00305084|solid tumors|solid tumors
786535|NCT00305071|pyuria|pyuria
786536|NCT00305071|urinary tract infections|urinary tract infections
786537|NCT00305071|Vaccinium macrocarpon|vaccinium macrocarpon
786538|NCT00305058|Elderly|elderly
786539|NCT00305058|Hydromorphone|hydromorphone
786540|NCT00305058|Morphine|morphine
786541|NCT00305058|Pain|pain
786542|NCT00305058|Acute|acute
786543|NCT00305058|Emergency Department|emergency department
787166|NCT00302991|epilepsy|epilepsy
786544|NCT00305045|Major Depressive Disorder|major depressive disorder
786545|NCT00305045|Repetitive Transcranial Magnetic Stimulation|repetitive transcranial magnetic stimulation
786546|NCT00305045|Treatment resistance|treatment resistance
786547|NCT00305006|cerebral palsy|cerebral palsy
786548|NCT00305006|constraint-induced therapy|constraint-induced therapy
786549|NCT00305006|constraint-induced movement therapy|constraint-induced movement therapy
786550|NCT00305006|CP|cp
786551|NCT00305006|hemiplegia|hemiplegia
786552|NCT00305006|hand|hand
786553|NCT00305006|forced use|forced use
786554|NCT00305006|motor control|motor control
786555|NCT00305006|children|children
786556|NCT00305006|HABIT|habit
786557|NCT00305006|Hand-arm bimanual intensive therapy|hand-arm bimanual intensive therapy
786558|NCT00305006|Bilateral training|bilateral training
786559|NCT00305006|Bimanual training|bimanual training
786560|NCT00305006|functional therapy|functional therapy
786561|NCT00305006|physical therapy|physical therapy
786562|NCT00305006|occupational therapy|occupational therapy
786563|NCT00305006|intensive|intensive
786564|NCT00305006|pediatric|pediatric
786565|NCT00305006|development|development
786566|NCT00305006|upper extremity|upper extremity
786567|NCT00305006|hemiplegic|hemiplegic
786568|NCT00304993|fenofibrate|fenofibrate
786569|NCT00304993|niacin|niacin
786570|NCT00304993|rosiglitazone|rosiglitazone
786571|NCT00304993|LDL phenotype pattern B|ldl phenotype pattern b
786572|NCT00304993|small, dense LDL|small, dense ldl
786573|NCT00304993|insulin resistance|insulin resistance
786574|NCT00304993|Metabolic Syndrome|metabolic syndrome
786575|NCT00304967|Cataract|cataract
786576|NCT00304967|Normal Lenses|normal lenses
786577|NCT00304967|Lens Crystallines|lens crystallines
786578|NCT00304967|Dynamic or Quasielastic Light Scattering (DLS)|dynamic or quasielastic light scattering (dls)
786579|NCT00304967|Eye Examinations|eye examinations
786580|NCT00304967|Healthy Volunteer|healthy volunteer
786581|NCT00304967|HV|hv
786582|NCT00304967|Eye Examination|eye examination
786583|NCT00304954|Age-Related Macular Degeneration|age-related macular degeneration
786584|NCT00304954|Rapamycin|rapamycin
786585|NCT00304954|Remicade|remicade
786586|NCT00304954|Daclizumab|daclizumab
786587|NCT00304954|Immunosuppression|immunosuppression
786588|NCT00304954|Infliximab|infliximab
786589|NCT00304954|Choroidal Neovascularization|choroidal neovascularization
786590|NCT00304954|Sirolimus|sirolimus
786591|NCT00304954|AMD|amd
786592|NCT00304954|Ocular Inflammation|ocular inflammation
786593|NCT00304941|Breast Cancer|breast cancer
786594|NCT00304941|Family History|family history
786595|NCT00304941|Pre/Post Menopausal|pre/post menopausal
786596|NCT00304941|Prevention|prevention
786597|NCT00304941|Risk-Factor|risk-factor
786598|NCT00304941|Body-Mass-Index|body-mass-index
786599|NCT00304941|BRCA1|brca1
786600|NCT00304941|Insulin|insulin
786601|NCT00304941|Genetic Counseling|genetic counseling
786602|NCT00304941|Penetrance|penetrance
786603|NCT00304941|Risk Assessment|risk assessment
786604|NCT00304941|Healthy Volunteer|healthy volunteer
786605|NCT00304941|HV|hv
786606|NCT00304915|HIV, depression|hiv, depression
786607|NCT00304915|patient care management|patient care management
786608|NCT00304915|patient care team|patient care team
786609|NCT00304902|MRSA|mrsa
786610|NCT00304902|Methicillin Resistant Staphylococcus aureus|methicillin resistant staphylococcus aureus
786611|NCT00304902|Staphylococcus aureus Bacteremia|staphylococcus aureus bacteremia
786612|NCT00304889|Clostridium difficile|clostridium difficile
786713|NCT00304421|Gastric Acid Secretion|gastric acid secretion
786613|NCT00304876|Clostridium difficile associated diarrhea|clostridium difficile associated diarrhea
786614|NCT00304863|CDAD|cdad
786615|NCT00304863|Clostridium difficile Associated Diarrhea|clostridium difficile associated diarrhea
786616|NCT00304850|polyamines|polyamines
786617|NCT00304850|pain|pain
786618|NCT00304850|breast cancer|breast cancer
786619|NCT00304850|mastectomy|mastectomy
786620|NCT00304850|post operative pain|post operative pain
786621|NCT00304837|Nonhealing leg ulcers|nonhealing leg ulcers
786622|NCT00304837|Ischemic rest pain|ischemic rest pain
786623|NCT00304824|Glaucoma|glaucoma
786624|NCT00304824|Olfactory functions|olfactory functions
786625|NCT00304824|Sniffing Sticks Test|sniffing sticks test
786626|NCT00304811|MRSA|mrsa
786627|NCT00304811|Methicillin Resistant Staphylococcus aureus|methicillin resistant staphylococcus aureus
786628|NCT00304798|Transient Ischemic Attack (TIA).|transient ischemic attack (tia).
786629|NCT00304798|Stroke.|stroke.
786630|NCT00304798|Hospital admission.|hospital admission.
786631|NCT00304772|Candida|candida
786632|NCT00304772|bloodstream infection|bloodstream infection
786633|NCT00304772|fluconazole|fluconazole
786634|NCT00304772|micafungin|micafungin
786635|NCT00304772|randomized controlled trial|randomized controlled trial
786636|NCT00304759|prostate cancer|prostate cancer
786637|NCT00304759|localized prostate cancer|localized prostate cancer
786638|NCT00304759|intermediate risk|intermediate risk
786639|NCT00304759|prostate specific antigen|prostate specific antigen
786640|NCT00304759|PSA|psa
786641|NCT00304759|radiation fractionation|radiation fractionation
786642|NCT00304759|shorter schedule|shorter schedule
786643|NCT00304759|quality of life|quality of life
786644|NCT00304733|neuropathic foot ulcerations - total contact cast - custom -made footwear - off-loading|neuropathic foot ulcerations - total contact cast - custom -made footwear - off-loading
786645|NCT00304720|Lymphoma|lymphoma
786646|NCT00304720|Leukemia|leukemia
786647|NCT00304694|NPC|npc
786648|NCT00304694|Induction chemotherapy|induction chemotherapy
786649|NCT00304694|Therapeutic response|therapeutic response
786650|NCT00304694|18F-FDG PET|18f-fdg pet
786651|NCT00304681|Attention Deficit Hyperactivity Disorder|attention deficit hyperactivity disorder
786652|NCT00304681|OROS* Methylphenidate|oros* methylphenidate
786653|NCT00304668|HIV-1|hiv-1
786654|NCT00304668|HIV Seronegativity|hiv seronegativity
786655|NCT00304655|Schizophrenia|schizophrenia
786656|NCT00304655|Schizoaffective disorder|schizoaffective disorder
786657|NCT00304655|Aripiprazole|aripiprazole
786658|NCT00304642|HIV-1|hiv-1
786659|NCT00304642|HIV Seronegativity|hiv seronegativity
786660|NCT00304629|Alzheimer's disease|alzheimer's disease
786661|NCT00304629|cholinesterase inhibitors|cholinesterase inhibitors
786662|NCT00304629|galantamine|galantamine
786663|NCT00304616|Schizophrenia|schizophrenia
786664|NCT00304616|Aripiprazole|aripiprazole
786665|NCT00304603|Obesity|obesity
786666|NCT00304603|Type 2 Diabetes Mellitus|type 2 diabetes mellitus
786667|NCT00304603|Topiramate|topiramate
786668|NCT00304603|Pharmacogenomics|pharmacogenomics
786669|NCT00304603|DNA Polymorphism|dna polymorphism
786670|NCT00304577|Strabismus|strabismus
786671|NCT00304577|Esotropia|esotropia
786672|NCT00304577|Surgical techniques|surgical techniques
786673|NCT00304564|Posturography, Fall Prevention, Geriatrics, Nolwenn Effect|posturography, fall prevention, geriatrics, nolwenn effect
786674|NCT00304551|CHC with compensated LC|chc with compensated lc
786675|NCT00304538|diabetes|diabetes
786676|NCT00304525|Anti-angiogenesis therapy|anti-angiogenesis therapy
786677|NCT00304525|Kinase inhibitor therapy|kinase inhibitor therapy
786678|NCT00304525|Raf inhibitor|raf inhibitor
786679|NCT00304525|Locally Advanced Melanoma|locally advanced melanoma
786680|NCT00304512|Amicus Therapeutics|amicus therapeutics
786681|NCT00304512|AT1001|at1001
786682|NCT00304512|Galafold|galafold
786683|NCT00304512|Migalastat|migalastat
786684|NCT00304512|Substrate|substrate
786685|NCT00304499|OROS®|oros®
786686|NCT00304499|middle age|middle age
786687|NCT00304499|elderly|elderly
786688|NCT00304499|oxybutynin|oxybutynin
786689|NCT00304499|urinary incontinenence|urinary incontinenence
786690|NCT00304499|women|women
786691|NCT00304473|Schizophrenia|schizophrenia
786692|NCT00304460|Serum Protein Levels|serum protein levels
786693|NCT00304460|Lymphocyte Phenotypes|lymphocyte phenotypes
786694|NCT00304460|Predictive Analysis|predictive analysis
786695|NCT00304460|Serum Cytokines|serum cytokines
786696|NCT00304460|Kidney Cancer|kidney cancer
786697|NCT00304460|Renal Cell Cancer|renal cell cancer
786698|NCT00304460|Melanoma|melanoma
786699|NCT00304460|Metastatic Melanoma|metastatic melanoma
786700|NCT00304447|Leukemia|leukemia
786701|NCT00304447|Mylotarg|mylotarg
786702|NCT00304447|Safety|safety
786703|NCT00304447|Adverse Events|adverse events
786704|NCT00304434|Adverse effects|adverse effects
786705|NCT00304434|Antiviral|antiviral
786706|NCT00304434|Clinical trial|clinical trial
786707|NCT00304434|Oseltamivir|oseltamivir
786708|NCT00304434|Pharmacokinetics|pharmacokinetics
786709|NCT00304434|Probenecid|probenecid
786710|NCT00304421|Gastroesophageal Reflux Disease|gastroesophageal reflux disease
786711|NCT00304421|Proton Pump Inhibitors|proton pump inhibitors
786714|NCT00304408|Clostridium difficile|clostridium difficile
786715|NCT00304395|Community Acquired Pneumonia|community acquired pneumonia
786716|NCT00304395|CAP|cap
786717|NCT00304382|Pneumococcus|pneumococcus
786718|NCT00304382|Pneumococcal pneumonia|pneumococcal pneumonia
786719|NCT00304369|Clostridium difficile|clostridium difficile
786720|NCT00304356|Clostridium difficile Associated Diarrhea|clostridium difficile associated diarrhea
786721|NCT00304330|gram negative infection|gram negative infection
786722|NCT00304317|calculi|calculi
786723|NCT00304317|ureteral calculi|ureteral calculi
786724|NCT00304317|ureter|ureter
786725|NCT00304304|child care centers|child care centers
786726|NCT00304304|asthma triggers|asthma triggers
786727|NCT00304304|community-based research|community-based research
786728|NCT00304291|Novantrone|novantrone
786729|NCT00304278|Head and Neck Cancer|head and neck cancer
786730|NCT00304278|Erlotinib|erlotinib
786731|NCT00304278|RADPLAT|radplat
786732|NCT00304265|Pertussis,|pertussis,
786733|NCT00304265|Diphtheria,|diphtheria,
786734|NCT00304265|Tetanus,|tetanus,
786735|NCT00304265|Poliomyelitis|poliomyelitis
786736|NCT00304239|Methyl aminolevulinate|methyl aminolevulinate
786737|NCT00304239|Photodynamic therapy|photodynamic therapy
786738|NCT00304239|Aktilite CL128 LED light source|aktilite cl128 led light source
786739|NCT00304239|Multiple Actinic Keratosis|multiple actinic keratosis
786740|NCT00304226|Valsartan,|valsartan,
786741|NCT00304226|amlodipine,|amlodipine,
786742|NCT00304226|hydrochlorothiazide|hydrochlorothiazide
786743|NCT00304213|hypogonadism|hypogonadism
786744|NCT00304213|testosterone|testosterone
786746|NCT00304213|Total testosterone < 300 ng/dL|total testosterone < 300 ng/dl
786747|NCT00304213|Bioavailable testosterone < 70 ng/dL|bioavailable testosterone < 70 ng/dl
786748|NCT00304200|Metastatic Malignant Melanoma|metastatic malignant melanoma
786749|NCT00304187|Binge-Eating Disorder|binge-eating disorder
786750|NCT00304161|Depression|depression
786751|NCT00304161|Parkinson's Disease|parkinson's disease
786752|NCT00304161|Atomoxetine|atomoxetine
786753|NCT00304148|Renal Insufficiency Chronic|renal insufficiency chronic
786754|NCT00304135|localized unresectable adult primary liver cancer|localized unresectable adult primary liver cancer
786755|NCT00304135|unresectable extrahepatic bile duct cancer|unresectable extrahepatic bile duct cancer
786756|NCT00304135|unresectable gallbladder cancer|unresectable gallbladder cancer
786757|NCT00304096|recurrent breast cancer|recurrent breast cancer
786758|NCT00304096|stage IIIA breast cancer|stage iiia breast cancer
786759|NCT00304096|stage IIIB breast cancer|stage iiib breast cancer
786760|NCT00304096|stage IIIC breast cancer|stage iiic breast cancer
786761|NCT00304096|stage IV breast cancer|stage iv breast cancer
786762|NCT00304096|male breast cancer|male breast cancer
786763|NCT00304096|invasive lobular breast carcinoma|invasive lobular breast carcinoma
786764|NCT00304083|adult neurofibrosarcoma|adult neurofibrosarcoma
786765|NCT00304083|childhood neurofibrosarcoma|childhood neurofibrosarcoma
786766|NCT00304083|metastatic childhood soft tissue sarcoma|metastatic childhood soft tissue sarcoma
786767|NCT00304083|nonmetastatic childhood soft tissue sarcoma|nonmetastatic childhood soft tissue sarcoma
786768|NCT00304083|stage IV adult soft tissue sarcoma|stage iv adult soft tissue sarcoma
786769|NCT00304083|neurofibromatosis type 1|neurofibromatosis type 1
786770|NCT00304031|adult glioblastoma|adult glioblastoma
786771|NCT00304031|adult giant cell glioblastoma|adult giant cell glioblastoma
786772|NCT00304031|adult gliosarcoma|adult gliosarcoma
786773|NCT00304018|adult acute myeloid leukemia with 11q23 (MLL) abnormalities|adult acute myeloid leukemia with 11q23 (mll) abnormalities
786774|NCT00304018|recurrent adult acute myeloid leukemia|recurrent adult acute myeloid leukemia
786775|NCT00304018|secondary acute myeloid leukemia|secondary acute myeloid leukemia
786776|NCT00304018|adult acute myeloid leukemia in remission|adult acute myeloid leukemia in remission
786777|NCT00304018|adult acute erythroid leukemia (M6)|adult acute erythroid leukemia (m6)
786778|NCT00304018|adult acute megakaryoblastic leukemia (M7)|adult acute megakaryoblastic leukemia (m7)
786779|NCT00304018|adult acute monoblastic leukemia (M5a)|adult acute monoblastic leukemia (m5a)
786780|NCT00304018|adult acute monocytic leukemia (M5b)|adult acute monocytic leukemia (m5b)
786781|NCT00304018|refractory multiple myeloma|refractory multiple myeloma
786782|NCT00304018|adult acute lymphoblastic leukemia in remission|adult acute lymphoblastic leukemia in remission
786783|NCT00304018|accelerated phase chronic myelogenous leukemia|accelerated phase chronic myelogenous leukemia
786784|NCT00304018|blastic phase chronic myelogenous leukemia|blastic phase chronic myelogenous leukemia
786785|NCT00304018|relapsing chronic myelogenous leukemia|relapsing chronic myelogenous leukemia
786786|NCT00304018|chronic phase chronic myelogenous leukemia|chronic phase chronic myelogenous leukemia
786787|NCT00304018|stage II multiple myeloma|stage ii multiple myeloma
786788|NCT00304018|stage III multiple myeloma|stage iii multiple myeloma
786789|NCT00304018|recurrent adult acute lymphoblastic leukemia|recurrent adult acute lymphoblastic leukemia
786790|NCT00304018|recurrent adult diffuse large cell lymphoma|recurrent adult diffuse large cell lymphoma
786791|NCT00304018|stage III adult diffuse large cell lymphoma|stage iii adult diffuse large cell lymphoma
786792|NCT00304018|recurrent mantle cell lymphoma|recurrent mantle cell lymphoma
786793|NCT00304018|stage III mantle cell lymphoma|stage iii mantle cell lymphoma
786794|NCT00304018|recurrent adult Hodgkin lymphoma|recurrent adult hodgkin lymphoma
787135|NCT00303134|transplant|transplant
786795|NCT00304018|stage III adult Hodgkin lymphoma|stage iii adult hodgkin lymphoma
786796|NCT00304018|adult acute myeloid leukemia with inv(16)(p13;q22)|adult acute myeloid leukemia with inv(16)(p13;q22)
786797|NCT00304018|adult acute myeloid leukemia with t(15;17)(q22;q12)|adult acute myeloid leukemia with t(15;17)(q22;q12)
786798|NCT00304018|adult acute myeloid leukemia with t(16;16)(p13;q22)|adult acute myeloid leukemia with t(16;16)(p13;q22)
786799|NCT00304018|adult acute myeloid leukemia with t(8;21)(q22;q22)|adult acute myeloid leukemia with t(8;21)(q22;q22)
786800|NCT00304018|de novo myelodysplastic syndromes|de novo myelodysplastic syndromes
786801|NCT00304018|previously treated myelodysplastic syndromes|previously treated myelodysplastic syndromes
786802|NCT00304018|secondary myelodysplastic syndromes|secondary myelodysplastic syndromes
786803|NCT00304018|recurrent adult T-cell leukemia/lymphoma|recurrent adult t-cell leukemia/lymphoma
786804|NCT00304018|stage IV adult diffuse large cell lymphoma|stage iv adult diffuse large cell lymphoma
786805|NCT00304018|stage IV adult Hodgkin lymphoma|stage iv adult hodgkin lymphoma
786806|NCT00304018|stage IV adult T-cell leukemia/lymphoma|stage iv adult t-cell leukemia/lymphoma
786807|NCT00304018|stage IV mantle cell lymphoma|stage iv mantle cell lymphoma
786808|NCT00304018|stage III adult T-cell leukemia/lymphoma|stage iii adult t-cell leukemia/lymphoma
786809|NCT00304018|stage I multiple myeloma|stage i multiple myeloma
786810|NCT00304005|refractory chronic lymphocytic leukemia|refractory chronic lymphocytic leukemia
786811|NCT00304005|recurrent adult diffuse large cell lymphoma|recurrent adult diffuse large cell lymphoma
786812|NCT00304005|recurrent adult Hodgkin lymphoma|recurrent adult hodgkin lymphoma
786813|NCT00303992|stage IV breast cancer|stage iv breast cancer
786814|NCT00303992|recurrent breast cancer|recurrent breast cancer
786815|NCT00303979|Systolic Heart Failure|systolic heart failure
786816|NCT00303979|Quality of Care|quality of care
786817|NCT00303979|Outcomes|outcomes
786818|NCT00303979|Evidence-based Guidelines|evidence-based guidelines
786819|NCT00303979|Recommended Therapies|recommended therapies
786820|NCT00303940|unspecified childhood solid tumor, protocol specific|unspecified childhood solid tumor, protocol specific
786821|NCT00303940|recurrent childhood rhabdomyosarcoma|recurrent childhood rhabdomyosarcoma
786822|NCT00303940|recurrent childhood soft tissue sarcoma|recurrent childhood soft tissue sarcoma
786823|NCT00303940|recurrent Ewing sarcoma/peripheral primitive neuroectodermal tumor|recurrent ewing sarcoma/peripheral primitive neuroectodermal tumor
786824|NCT00303940|recurrent osteosarcoma|recurrent osteosarcoma
786825|NCT00303940|recurrent neuroblastoma|recurrent neuroblastoma
786826|NCT00303940|recurrent Wilms tumor and other childhood kidney tumors|recurrent wilms tumor and other childhood kidney tumors
786827|NCT00303940|recurrent childhood malignant germ cell tumor|recurrent childhood malignant germ cell tumor
786828|NCT00303940|recurrent childhood liver cancer|recurrent childhood liver cancer
786829|NCT00303940|recurrent childhood brain stem glioma|recurrent childhood brain stem glioma
786830|NCT00303940|recurrent childhood cerebellar astrocytoma|recurrent childhood cerebellar astrocytoma
786831|NCT00303940|recurrent childhood cerebral astrocytoma|recurrent childhood cerebral astrocytoma
786832|NCT00303940|recurrent childhood ependymoma|recurrent childhood ependymoma
786833|NCT00303940|recurrent childhood medulloblastoma|recurrent childhood medulloblastoma
786834|NCT00303940|recurrent childhood supratentorial primitive neuroectodermal tumor|recurrent childhood supratentorial primitive neuroectodermal tumor
786835|NCT00303940|childhood atypical teratoid/rhabdoid tumor|childhood atypical teratoid/rhabdoid tumor
786836|NCT00303940|childhood low-grade cerebral astrocytoma|childhood low-grade cerebral astrocytoma
786837|NCT00303940|childhood high-grade cerebral astrocytoma|childhood high-grade cerebral astrocytoma
786838|NCT00303940|childhood choroid plexus tumor|childhood choroid plexus tumor
786839|NCT00303940|childhood craniopharyngioma|childhood craniopharyngioma
786840|NCT00303940|childhood infratentorial ependymoma|childhood infratentorial ependymoma
786841|NCT00303940|childhood supratentorial ependymoma|childhood supratentorial ependymoma
786842|NCT00303940|childhood oligodendroglioma|childhood oligodendroglioma
786843|NCT00303940|recurrent childhood visual pathway and hypothalamic glioma|recurrent childhood visual pathway and hypothalamic glioma
786844|NCT00303940|recurrent childhood brain tumor|recurrent childhood brain tumor
786845|NCT00303940|childhood central nervous system germ cell tumor|childhood central nervous system germ cell tumor
786846|NCT00303940|childhood grade I meningioma|childhood grade i meningioma
786847|NCT00303940|childhood grade II meningioma|childhood grade ii meningioma
786848|NCT00303940|childhood grade III meningioma|childhood grade iii meningioma
786849|NCT00303940|childhood malignant ovarian germ cell tumor|childhood malignant ovarian germ cell tumor
786850|NCT00303940|childhood malignant testicular germ cell tumor|childhood malignant testicular germ cell tumor
786851|NCT00303940|childhood teratoma|childhood teratoma
786852|NCT00303927|recurrent pancreatic cancer|recurrent pancreatic cancer
786853|NCT00303927|stage IV pancreatic cancer|stage iv pancreatic cancer
786854|NCT00303914|pain|pain
786855|NCT00303914|psychosocial effects of cancer and its treatment|psychosocial effects of cancer and its treatment
786856|NCT00303914|cognitive/functional effects|cognitive/functional effects
786857|NCT00303914|recurrent breast cancer|recurrent breast cancer
786858|NCT00303914|stage I breast cancer|stage i breast cancer
786859|NCT00303914|stage II breast cancer|stage ii breast cancer
786860|NCT00303914|stage IIIA breast cancer|stage iiia breast cancer
786861|NCT00303914|stage IIIB breast cancer|stage iiib breast cancer
786862|NCT00303914|stage IIIC breast cancer|stage iiic breast cancer
786863|NCT00303914|stage IV breast cancer|stage iv breast cancer
787240|NCT00302679|Pain|pain
786864|NCT00303914|recurrent colon cancer|recurrent colon cancer
786865|NCT00303914|stage I colon cancer|stage i colon cancer
786866|NCT00303914|stage II colon cancer|stage ii colon cancer
786867|NCT00303914|stage III colon cancer|stage iii colon cancer
786868|NCT00303914|stage IV colon cancer|stage iv colon cancer
786869|NCT00303914|recurrent rectal cancer|recurrent rectal cancer
786870|NCT00303914|stage I rectal cancer|stage i rectal cancer
786871|NCT00303914|stage II rectal cancer|stage ii rectal cancer
786872|NCT00303914|stage III rectal cancer|stage iii rectal cancer
786873|NCT00303914|stage IV rectal cancer|stage iv rectal cancer
786874|NCT00303914|extensive stage small cell lung cancer|extensive stage small cell lung cancer
786875|NCT00303914|limited stage small cell lung cancer|limited stage small cell lung cancer
786876|NCT00303914|recurrent small cell lung cancer|recurrent small cell lung cancer
786877|NCT00303914|recurrent non-small cell lung cancer|recurrent non-small cell lung cancer
786878|NCT00303914|stage I non-small cell lung cancer|stage i non-small cell lung cancer
786879|NCT00303914|stage II non-small cell lung cancer|stage ii non-small cell lung cancer
786880|NCT00303914|stage IIIA non-small cell lung cancer|stage iiia non-small cell lung cancer
786881|NCT00303914|stage IIIB non-small cell lung cancer|stage iiib non-small cell lung cancer
786882|NCT00303914|stage IV non-small cell lung cancer|stage iv non-small cell lung cancer
786883|NCT00303914|recurrent prostate cancer|recurrent prostate cancer
786884|NCT00303914|stage I prostate cancer|stage i prostate cancer
786885|NCT00303914|stage IIB prostate cancer|stage iib prostate cancer
786886|NCT00303914|stage IIA prostate cancer|stage iia prostate cancer
786887|NCT00303914|stage III prostate cancer|stage iii prostate cancer
788149|NCT00299481|Tissue Bank|tissue bank
786888|NCT00303914|stage IV prostate cancer|stage iv prostate cancer
786889|NCT00303914|male breast cancer|male breast cancer
786890|NCT00303914|pulmonary carcinoid tumor|pulmonary carcinoid tumor
786891|NCT00303901|lung metastases|lung metastases
786892|NCT00303901|recurrent non-small cell lung cancer|recurrent non-small cell lung cancer
786893|NCT00303901|recurrent small cell lung cancer|recurrent small cell lung cancer
786894|NCT00303901|stage I non-small cell lung cancer|stage i non-small cell lung cancer
786895|NCT00303901|stage II non-small cell lung cancer|stage ii non-small cell lung cancer
786896|NCT00303901|stage IIIA non-small cell lung cancer|stage iiia non-small cell lung cancer
786897|NCT00303901|stage IIIB non-small cell lung cancer|stage iiib non-small cell lung cancer
786898|NCT00303901|stage IV non-small cell lung cancer|stage iv non-small cell lung cancer
786899|NCT00303901|extensive stage small cell lung cancer|extensive stage small cell lung cancer
786900|NCT00303901|limited stage small cell lung cancer|limited stage small cell lung cancer
786901|NCT00303901|pulmonary carcinoid tumor|pulmonary carcinoid tumor
786902|NCT00303888|recurrent ovarian epithelial cancer|recurrent ovarian epithelial cancer
786903|NCT00303888|stage IV ovarian epithelial cancer|stage iv ovarian epithelial cancer
786904|NCT00303888|stage IIIA ovarian epithelial cancer|stage iiia ovarian epithelial cancer
786905|NCT00303888|stage IIIB ovarian epithelial cancer|stage iiib ovarian epithelial cancer
786906|NCT00303888|stage IIIC ovarian epithelial cancer|stage iiic ovarian epithelial cancer
786907|NCT00303888|recurrent primary peritoneal cavity cancer|recurrent primary peritoneal cavity cancer
786908|NCT00303888|stage IIIA primary peritoneal cavity cancer|stage iiia primary peritoneal cavity cancer
786909|NCT00303888|stage IIIB primary peritoneal cavity cancer|stage iiib primary peritoneal cavity cancer
786910|NCT00303888|stage IIIC primary peritoneal cavity cancer|stage iiic primary peritoneal cavity cancer
786911|NCT00303888|stage IV primary peritoneal cavity cancer|stage iv primary peritoneal cavity cancer
786912|NCT00303888|recurrent fallopian tube cancer|recurrent fallopian tube cancer
786913|NCT00303888|stage IIIA fallopian tube cancer|stage iiia fallopian tube cancer
786914|NCT00303888|stage IIIB fallopian tube cancer|stage iiib fallopian tube cancer
786915|NCT00303888|stage IIIC fallopian tube cancer|stage iiic fallopian tube cancer
786916|NCT00303888|stage IV fallopian tube cancer|stage iv fallopian tube cancer
786917|NCT00303875|recurrent prostate cancer|recurrent prostate cancer
786918|NCT00303875|stage I prostate cancer|stage i prostate cancer
786919|NCT00303875|stage IIB prostate cancer|stage iib prostate cancer
786920|NCT00303875|stage IIA prostate cancer|stage iia prostate cancer
786921|NCT00303875|stage III prostate cancer|stage iii prostate cancer
786922|NCT00303875|stage IV prostate cancer|stage iv prostate cancer
786923|NCT00303875|recurrent breast cancer|recurrent breast cancer
786924|NCT00303875|stage I breast cancer|stage i breast cancer
786925|NCT00303875|stage II breast cancer|stage ii breast cancer
786926|NCT00303875|stage IIIA breast cancer|stage iiia breast cancer
786927|NCT00303875|stage IIIB breast cancer|stage iiib breast cancer
786928|NCT00303875|stage IIIC breast cancer|stage iiic breast cancer
786929|NCT00303875|stage IV breast cancer|stage iv breast cancer
786930|NCT00303875|recurrent colon cancer|recurrent colon cancer
786931|NCT00303875|stage I colon cancer|stage i colon cancer
786932|NCT00303875|stage II colon cancer|stage ii colon cancer
786933|NCT00303875|stage III colon cancer|stage iii colon cancer
786934|NCT00303875|stage IV colon cancer|stage iv colon cancer
786935|NCT00303875|recurrent rectal cancer|recurrent rectal cancer
786936|NCT00303875|stage I rectal cancer|stage i rectal cancer
786937|NCT00303875|stage II rectal cancer|stage ii rectal cancer
786938|NCT00303875|stage III rectal cancer|stage iii rectal cancer
786939|NCT00303875|stage IV rectal cancer|stage iv rectal cancer
786940|NCT00303810|childhood infratentorial ependymoma|childhood infratentorial ependymoma
786941|NCT00303810|childhood supratentorial ependymoma|childhood supratentorial ependymoma
786942|NCT00303810|untreated childhood medulloblastoma|untreated childhood medulloblastoma
786943|NCT00303810|newly diagnosed childhood ependymoma|newly diagnosed childhood ependymoma
786944|NCT00303810|untreated childhood supratentorial primitive neuroectodermal tumor|untreated childhood supratentorial primitive neuroectodermal tumor
786945|NCT00303784|hot flashes|hot flashes
786946|NCT00303784|anemia|anemia
786947|NCT00303784|osteoporosis|osteoporosis
786948|NCT00303784|cardiovascular complications|cardiovascular complications
786949|NCT00303784|recurrent prostate cancer|recurrent prostate cancer
786950|NCT00303784|stage III prostate cancer|stage iii prostate cancer
786951|NCT00303784|stage IV prostate cancer|stage iv prostate cancer
786952|NCT00303784|adenocarcinoma of the prostate|adenocarcinoma of the prostate
786953|NCT00303771|adenocarcinoma of the rectum|adenocarcinoma of the rectum
786954|NCT00303771|stage IV rectal cancer|stage iv rectal cancer
786955|NCT00303771|stage IV colon cancer|stage iv colon cancer
786956|NCT00303771|adenocarcinoma of the colon|adenocarcinoma of the colon
786957|NCT00303771|recurrent colon cancer|recurrent colon cancer
786958|NCT00303771|recurrent rectal cancer|recurrent rectal cancer
786959|NCT00303758|adenocarcinoma of the pancreas|adenocarcinoma of the pancreas
786960|NCT00303758|recurrent pancreatic cancer|recurrent pancreatic cancer
786961|NCT00303758|stage IV pancreatic cancer|stage iv pancreatic cancer
786962|NCT00303745|adenocarcinoma of the colon|adenocarcinoma of the colon
786963|NCT00303745|recurrent colon cancer|recurrent colon cancer
786964|NCT00303745|stage IV colon cancer|stage iv colon cancer
788257|NCT00299182|Vincristine|vincristine
786965|NCT00303745|adenocarcinoma of the rectum|adenocarcinoma of the rectum
786966|NCT00303745|recurrent rectal cancer|recurrent rectal cancer
786967|NCT00303745|stage IV rectal cancer|stage iv rectal cancer
786968|NCT00303732|unspecified adult solid tumor, protocol specific|unspecified adult solid tumor, protocol specific
786969|NCT00303732|recurrent renal cell cancer|recurrent renal cell cancer
786970|NCT00303732|stage IV renal cell cancer|stage iv renal cell cancer
786971|NCT00303719|leukemia|leukemia
786972|NCT00303719|lymphoma|lymphoma
786973|NCT00303719|myeloma|myeloma
786974|NCT00303706|CABG, Endoscopic, Radial Artery|cabg, endoscopic, radial artery
786975|NCT00303706|Radial Artery Conduit|radial artery conduit
786976|NCT00303706|Coronary Artery Bypass Surgery|coronary artery bypass surgery
786977|NCT00303706|Endoscopic technique|endoscopic technique
786978|NCT00303667|NK cells|nk cells
786979|NCT00303667|natural killer cells|natural killer cells
786980|NCT00303667|immunotherapy|immunotherapy
786981|NCT00303667|hematopoietic cell transplant|hematopoietic cell transplant
786982|NCT00303667|acute myelogenous leukemia|acute myelogenous leukemia
786983|NCT00303654|recurrent bladder cancer|recurrent bladder cancer
786984|NCT00303654|stage I bladder cancer|stage i bladder cancer
786985|NCT00303654|stage II bladder cancer|stage ii bladder cancer
786986|NCT00303654|stage III bladder cancer|stage iii bladder cancer
786987|NCT00303654|stage IV bladder cancer|stage iv bladder cancer
786988|NCT00303641|Cardiopulmonary bypass|cardiopulmonary bypass
786989|NCT00303641|Inflammatory reaction|inflammatory reaction
786990|NCT00303628|Rectal cancer|rectal cancer
786991|NCT00303628|Bevacizumab|bevacizumab
786992|NCT00303615|ER (-) and PR (-)|er (-) and pr (-)
786993|NCT00303576|HIV-1|hiv-1
786994|NCT00303576|HIV Seronegativity|hiv seronegativity
786995|NCT00303550|skin infection|skin infection
786996|NCT00303550|complicated skin infection|complicated skin infection
786997|NCT00303550|skin structure infection|skin structure infection
786998|NCT00303550|Complicated Skin and Skin Structure Infection|complicated skin and skin structure infection
786999|NCT00303537|hepatitis|hepatitis
787000|NCT00303537|metformin|metformin
787001|NCT00303537|non-alcoholic fatty liver (NAFLD)|non-alcoholic fatty liver (nafld)
787002|NCT00303537|non-alcoholic steatohepatitis (NASH)|non-alcoholic steatohepatitis (nash)
787003|NCT00303537|Nonalcoholic fatty liver disease|nonalcoholic fatty liver disease
787004|NCT00303511|adult|adult
787005|NCT00303511|pacemaker|pacemaker
787006|NCT00303511|bradycardia|bradycardia
787007|NCT00303511|tachycardia|tachycardia
787008|NCT00303511|heart failure|heart failure
787009|NCT00303472|MDS|mds
787010|NCT00303472|Myelodysplastic Syndromes|myelodysplastic syndromes
787011|NCT00303472|Refractory Cytopenias|refractory cytopenias
787012|NCT00303472|Thrombocytopenia|thrombocytopenia
787013|NCT00303459|sildenafil|sildenafil
787014|NCT00303459|Combination Drug Therapy|combination drug therapy
787015|NCT00303459|bosentan|bosentan
787016|NCT00303459|Pulmonary Hypertension|pulmonary hypertension
787017|NCT00303459|Pulmonary Arterial Hypertension|pulmonary arterial hypertension
787018|NCT00303459|Multicenter Study|multicenter study
787019|NCT00303459|Antihypertensive Agents|antihypertensive agents
787020|NCT00303459|Tracleer|tracleer
787021|NCT00303459|endothelin receptor antagonist|endothelin receptor antagonist
787022|NCT00303459|Randomized Controlled Trial|randomized controlled trial
787023|NCT00303459|Phosphodiesterase type 5 inhibitor (PDE5i)|phosphodiesterase type 5 inhibitor (pde5i)
787024|NCT00303459|Outcome Assessment|outcome assessment
787025|NCT00303446|Motor Neuron|motor neuron
787026|NCT00303446|Androgen Receptor|androgen receptor
787027|NCT00303446|Polyglutamine|polyglutamine
787028|NCT00303446|X-Linked|x-linked
787029|NCT00303446|Ligand Dependency|ligand dependency
787030|NCT00303446|Spinal and Bulbar Muscular Atrophy|spinal and bulbar muscular atrophy
787031|NCT00303446|SBMA|sbma
787032|NCT00303446|Kennedy Disease|kennedy disease
787033|NCT00303433|Prevention|prevention
787034|NCT00303433|Post-Operative tates|post-operative tates
787035|NCT00303433|Delirium|delirium
787037|NCT00303420|catheter|catheter
787038|NCT00303420|hemodialysis|hemodialysis
787039|NCT00303420|dysfunction|dysfunction
787040|NCT00303420|thrombolytic|thrombolytic
787041|NCT00303420|alteplase|alteplase
787042|NCT00303394|Type 2 Diabetes, IL-1, inflammation, glucotoxicity, insulin|type 2 diabetes, il-1, inflammation, glucotoxicity, insulin
787043|NCT00303368|Neurofibromatosis (NF1)|neurofibromatosis (nf1)
787044|NCT00303368|Tibial Dysplasia (TD)|tibial dysplasia (td)
787045|NCT00303355|jugular venous pulse|jugular venous pulse
787046|NCT00303342|sleep|sleep
787047|NCT00303342|arousal|arousal
787048|NCT00303342|stress|stress
787049|NCT00303342|cortisol|cortisol
787050|NCT00303342|catecholamines|catecholamines
787051|NCT00303329|β-thalassemia|β-thalassemia
787052|NCT00303329|rare chronic anemia|rare chronic anemia
787053|NCT00303329|iron overload|iron overload
787054|NCT00303329|deferasirox|deferasirox
787055|NCT00303329|chronic anemias|chronic anemias
787056|NCT00303329|transfusional hemosiderosis|transfusional hemosiderosis
787057|NCT00303316|Diphtheria|diphtheria
787058|NCT00303316|Tetanus|tetanus
787059|NCT00303316|Pertussis|pertussis
787060|NCT00303316|whooping cough|whooping cough
787061|NCT00303316|Haemophilus influenzae type b|haemophilus influenzae type b
787062|NCT00303316|Hepatitis B|hepatitis b
787063|NCT00303316|Poliomyelitis|poliomyelitis
787064|NCT00303303|Snake envenomation|snake envenomation
787065|NCT00303303|Antivenins|antivenins
787066|NCT00303303|Disability evaluation|disability evaluation
787067|NCT00303303|Activities of daily living|activities of daily living
787068|NCT00303290|Early Chronic Phase CML|early chronic phase cml
787069|NCT00303290|Peg Interferon Alpha 2b|peg interferon alpha 2b
787070|NCT00303290|Peg Intron|peg intron
787071|NCT00303290|Ara-C|ara-c
787072|NCT00303290|Cytosine Arabinoside|cytosine arabinoside
787073|NCT00303277|Alzheimer's disease|alzheimer's disease
787074|NCT00303277|beta-amyloid|beta-amyloid
787075|NCT00303277|statins|statins
787076|NCT00303264|functional dyspepsia|functional dyspepsia
787077|NCT00303264|cholecystokinin|cholecystokinin
787078|NCT00303264|CCK|cck
787079|NCT00303264|gastrointestinal|gastrointestinal
787080|NCT00303264|intestinal transit|intestinal transit
787081|NCT00303264|GI motility|gi motility
787082|NCT00303264|bloating|bloating
787083|NCT00303264|upper GI discomfort|upper gi discomfort
787084|NCT00303264|upper GI|upper gi
787085|NCT00303264|early satiety|early satiety
787086|NCT00303264|nausea|nausea
787087|NCT00303264|belching|belching
787088|NCT00303264|retching|retching
787089|NCT00303264|vomiting|vomiting
787090|NCT00303264|GERD|gerd
787091|NCT00303251|Locally Advanced or Metastatic Melanoma|locally advanced or metastatic melanoma
787092|NCT00303238|Inflammation|inflammation
787093|NCT00303238|Interleukin-1|interleukin-1
787094|NCT00303238|C-reactive protein|c-reactive protein
787095|NCT00303238|Genotype|genotype
787096|NCT00303238|Rose Hips|rose hips
787097|NCT00303238|Blueberry|blueberry
787098|NCT00303238|Blackberry|blackberry
787099|NCT00303238|Aframomum melegueta|aframomum melegueta
787100|NCT00303238|Resveravine|resveravine
787101|NCT00303225|Biodefense|biodefense
787102|NCT00303225|Smallpox|smallpox
787103|NCT00303225|Monkeypox|monkeypox
787104|NCT00303225|Vaccinia|vaccinia
787105|NCT00303225|Prophylaxis|prophylaxis
787106|NCT00303225|Healthy Volunteer|healthy volunteer
787107|NCT00303225|HV|hv
787108|NCT00303212|heart failure|heart failure
787109|NCT00303212|CHF|chf
787110|NCT00303212|telemedicine|telemedicine
787111|NCT00303212|disease management|disease management
787112|NCT00303199|Multiple Myeloma|multiple myeloma
787113|NCT00303199|Arsenic|arsenic
787114|NCT00303199|Cancer study|cancer study
787115|NCT00303199|Failed treatment|failed treatment
787116|NCT00303186|Rheumatoid Arthritis|rheumatoid arthritis
787117|NCT00303173|Pre-eclampsia|pre-eclampsia
787118|NCT00303173|hypertension|hypertension
787119|NCT00303173|blood pressure|blood pressure
787120|NCT00303173|pregnancy|pregnancy
787121|NCT00303173|randomized clinical trial|randomized clinical trial
787122|NCT00303173|guided imagery|guided imagery
787123|NCT00303173|relaxation|relaxation
787124|NCT00303173|psychophysiology|psychophysiology
787125|NCT00303173|mind-body|mind-body
787126|NCT00303160|heliobacter pylori infection|heliobacter pylori infection
787127|NCT00303160|reactive oxygen species|reactive oxygen species
787128|NCT00303160|antioxidants|antioxidants
787129|NCT00303147|Expressive Writing|expressive writing
787130|NCT00303147|Written Emotional Expression|written emotional expression
787131|NCT00303147|Caregiver Stress|caregiver stress
787132|NCT00303147|Cognition|cognition
787133|NCT00303134|islet cell|islet cell
787134|NCT00303134|diabetes|diabetes
787136|NCT00303134|immunosuppression|immunosuppression
787137|NCT00303134|autoimmunity|autoimmunity
787138|NCT00303134|alloimmunity|alloimmunity
787139|NCT00303121|Glaucoma|glaucoma
787140|NCT00303121|Compliance|compliance
787141|NCT00303121|Therapy|therapy
787142|NCT00303121|Administration technique|administration technique
787143|NCT00303082|Probiotics|probiotics
787144|NCT00303082|Bacterial Vaginosis|bacterial vaginosis
787145|NCT00303082|Premature birth|premature birth
787146|NCT00303082|Intra-uterine Infection|intra-uterine infection
787147|NCT00303082|Periventricular leukomalacia|periventricular leukomalacia
787148|NCT00303069|S. aureus;|s. aureus;
787149|NCT00303069|Vaccine|vaccine
787150|NCT00303069|FIM|fim
787151|NCT00303056|Osteoarthritis|osteoarthritis
787152|NCT00303056|knee|knee
787153|NCT00303043|Hemodynamic monitoring|hemodynamic monitoring
787154|NCT00303043|Mixed venous saturation|mixed venous saturation
787155|NCT00303043|Critically ill patients|critically ill patients
787156|NCT00303030|Fecal incontinence|fecal incontinence
787157|NCT00303030|Biofeedback|biofeedback
787158|NCT00303030|Patient Satisfaction|patient satisfaction
787159|NCT00303030|Quality of LifeTreatment Outcome|quality of lifetreatment outcome
787160|NCT00303030|Injections|injections
787161|NCT00302991|Observational|observational
787162|NCT00302991|cross-sectional|cross-sectional
787163|NCT00302991|health-related quality of life|health-related quality of life
787164|NCT00302991|adverse effects|adverse effects
787165|NCT00302991|Baker´s AEP scale validation|baker´s aep scale validation
787167|NCT00302978|Height phobia|height phobia
787168|NCT00302978|fear of heights|fear of heights
787169|NCT00302978|specific phobia|specific phobia
787170|NCT00302965|Plasma|plasma
787171|NCT00302965|Trauma|trauma
787172|NCT00302965|Critical Care|critical care
787173|NCT00302952|Arthritis, Rheumatoid|arthritis, rheumatoid
787174|NCT00302939|Aging|aging
787175|NCT00302926|Weight loss|weight loss
787176|NCT00302926|obesity|obesity
787177|NCT00302926|energy restriction|energy restriction
787178|NCT00302913|Clopidogrel|clopidogrel
787179|NCT00302913|Coronary Artery Disease|coronary artery disease
787180|NCT00302913|Dose-Response Relationship, Drug|dose-response relationship, drug
787181|NCT00302913|Drug Resistance|drug resistance
787182|NCT00302913|PCI|pci
787183|NCT00302900|Blood Donation|blood donation
787184|NCT00302900|Syncope|syncope
787185|NCT00302900|Vasovagal Reactions|vasovagal reactions
787186|NCT00302887|fibromyalgia|fibromyalgia
787187|NCT00302887|connective tissue manipulation|connective tissue manipulation
787188|NCT00302887|ultrasound therapy|ultrasound therapy
787189|NCT00302887|high voltage pulsed galvanic stimulation|high voltage pulsed galvanic stimulation
787190|NCT00302874|diabetes|diabetes
787191|NCT00302874|hyperglycemia|hyperglycemia
787192|NCT00302874|hospital|hospital
787193|NCT00302874|medicine ward|medicine ward
787194|NCT00302861|B-Cll|b-cll
787195|NCT00302848|Venous thromboembolism|venous thromboembolism
787196|NCT00302848|Drospirenone|drospirenone
787197|NCT00302835|Analgesics|analgesics
787198|NCT00302835|Chronic Kidney Failure|chronic kidney failure
787199|NCT00302822|HIV infections|hiv infections
787200|NCT00302822|Fuzeon|fuzeon
787201|NCT00302822|Truvada|truvada
787202|NCT00302822|AIDS|aids
787203|NCT00302822|Treatment Naive|treatment naive
787204|NCT00302809|Flavonoids|flavonoids
787205|NCT00302809|Arterial stiffness|arterial stiffness
787206|NCT00302809|Blood pressure|blood pressure
787207|NCT00302809|Endothelium|endothelium
787208|NCT00302809|Inflammation|inflammation
787209|NCT00302796|Low Back Pain,|low back pain,
787210|NCT00302783|Education, Medical|education, medical
787211|NCT00302783|Education, Competency-Based|education, competency-based
787212|NCT00302783|Multi-Source Feedback|multi-source feedback
787213|NCT00302783|Communication|communication
787214|NCT00302783|Professionalism|professionalism
787215|NCT00302770|Patients with SAD|patients with sad
787216|NCT00302757|NHL|nhl
787217|NCT00302757|low and high grade non-Hodgkin lymphoma|low and high grade non-hodgkin lymphoma
787218|NCT00302744|Anxiety|anxiety
787219|NCT00302744|Depression|depression
787220|NCT00302744|Mood|mood
787221|NCT00302744|Cancer|cancer
787222|NCT00302744|Quality of Life|quality of life
787223|NCT00302744|Psychiatric|psychiatric
787224|NCT00302744|Psilocybin|psilocybin
787225|NCT00302744|Alternative|alternative
787226|NCT00302744|Los Angeles|los angeles
787227|NCT00302718|Physician Incentive Plan|physician incentive plan
787228|NCT00302718|Quality of Health Care|quality of health care
787229|NCT00302718|Reimbursement, Incentive|reimbursement, incentive
787230|NCT00302718|Randomized Controlled Trial|randomized controlled trial
787231|NCT00302718|Physicians|physicians
787232|NCT00302718|Reward|reward
787233|NCT00302705|Ambulatory blood pressure monitoring|ambulatory blood pressure monitoring
787234|NCT00302705|Valsartan|valsartan
787235|NCT00302705|Enalapril|enalapril
787236|NCT00302705|Missing dose|missing dose
787237|NCT00302679|Colonoscopy|colonoscopy
787238|NCT00302679|Sigmoidoscopy|sigmoidoscopy
787239|NCT00302679|Colon cancer screening|colon cancer screening
787242|NCT00302666|Contraception, Bleeding pattern|contraception, bleeding pattern
787243|NCT00302627|bisphosphonates|bisphosphonates
787244|NCT00302627|vitamin D|vitamin d
787245|NCT00302627|calcium supplement|calcium supplement
787246|NCT00302627|corticosteroid therapy|corticosteroid therapy
787247|NCT00302627|fractures|fractures
787248|NCT00302614|obstructive sleep apnea|obstructive sleep apnea
787249|NCT00302614|snoring|snoring
787250|NCT00302614|collapsibility|collapsibility
787251|NCT00302614|upper airway|upper airway
787252|NCT00302601|Pulmonary embolism|pulmonary embolism
787253|NCT00302601|Right heart strain|right heart strain
787254|NCT00302601|Lung scintigraphy|lung scintigraphy
787255|NCT00302601|Pulmonary angiography|pulmonary angiography
787256|NCT00302588|metastatic carcinoma|metastatic carcinoma
787257|NCT00302588|cervical lymph nodes|cervical lymph nodes
787258|NCT00302588|unknown primary|unknown primary
787259|NCT00302588|diagnosis|diagnosis
787260|NCT00302588|result|result
787261|NCT00302575|Substance-Related Disorders|substance-related disorders
787262|NCT00302575|Prisoners|prisoners
787263|NCT00302562|laryngeal cancer|laryngeal cancer
787264|NCT00302562|hypopharyngeal cancer|hypopharyngeal cancer
787265|NCT00302562|CXCR4|cxcr4
787266|NCT00302562|CXCL12|cxcl12
787267|NCT00302562|matrix metalloproteinases(MMPs)|matrix metalloproteinases(mmps)
787268|NCT00302562|metastasis|metastasis
787269|NCT00302549|Tacrolimus|tacrolimus
787270|NCT00302549|Cyclophosphamide|cyclophosphamide
787271|NCT00302549|Treatment|treatment
787272|NCT00302549|Lupus Nephritis|lupus nephritis
787273|NCT00302536|Idiopathic Focal Segmental Glomerulosclerosis|idiopathic focal segmental glomerulosclerosis
787274|NCT00302536|Treatment|treatment
787275|NCT00302536|Steroids|steroids
787276|NCT00302523|Idiopathic Membranous Nephropathy|idiopathic membranous nephropathy
787277|NCT00302523|Treatment|treatment
787278|NCT00302523|Tacrolimus|tacrolimus
787279|NCT00302523|Cyclophosphamide|cyclophosphamide
787280|NCT00302510|lipoprotein glomerulopathy|lipoprotein glomerulopathy
787281|NCT00302510|treatment|treatment
787282|NCT00302510|immunoadsorption|immunoadsorption
787283|NCT00302510|apolipoprotein E|apolipoprotein e
787284|NCT00302458|healthy volunteers|healthy volunteers
787285|NCT00302432|smoking reduction|smoking reduction
787286|NCT00302432|group therapy|group therapy
787287|NCT00302432|cigarette holders|cigarette holders
787288|NCT00302432|"Flowers Menthol"|"flowers menthol"
787289|NCT00302419|Acute myocardial infarction|acute myocardial infarction
787290|NCT00302419|primary angioplasty|primary angioplasty
787291|NCT00302419|streptokinase|streptokinase
787292|NCT00302419|microvasculature|microvasculature
787293|NCT00302393|healthy volunteers|healthy volunteers
787294|NCT00302341|Pulmonary disease|pulmonary disease
787296|NCT00302341|Hypoxemia|hypoxemia
787297|NCT00302341|AIDS|aids
787298|NCT00302341|Pneumocystis jiroveci|pneumocystis jiroveci
787299|NCT00302315|postcesarean physiotherapy|postcesarean physiotherapy
787300|NCT00302315|incisional pain|incisional pain
787301|NCT00302315|functional activity|functional activity
787302|NCT00302315|connective tissue manipulation|connective tissue manipulation
787303|NCT00302315|transcutaneous electrical nerve stimulation|transcutaneous electrical nerve stimulation
787304|NCT00302302|Blood glucose|blood glucose
787305|NCT00302302|Insulin|insulin
787306|NCT00302302|Triglyceride|triglyceride
787308|NCT00302302|GLP-1|glp-1
787309|NCT00302302|L-arabinose|l-arabinose
787310|NCT00302302|Appetite|appetite
787311|NCT00302302|Energy intake|energy intake
787312|NCT00302289|green tea|green tea
787313|NCT00302289|caffeine|caffeine
787314|NCT00302289|tyrosine|tyrosine
787315|NCT00302289|energy expenditure|energy expenditure
787316|NCT00302289|energy intake|energy intake
787317|NCT00302276|Body fat loss|body fat loss
787318|NCT00302276|energy expenditure|energy expenditure
787319|NCT00302276|capsaicin|capsaicin
787320|NCT00302276|caffeine|caffeine
787321|NCT00302276|green tea|green tea
787322|NCT00302276|calcium|calcium
787323|NCT00302276|fecal fat|fecal fat
787324|NCT00302276|fecal energy|fecal energy
787325|NCT00302263|Green tea|green tea
787326|NCT00302263|capsaicin|capsaicin
787327|NCT00302263|tyrosine|tyrosine
787328|NCT00302263|caffeine|caffeine
787329|NCT00302263|energy expenditure|energy expenditure
787330|NCT00302263|catecholamines|catecholamines
787331|NCT00302250|Cardiovascular|cardiovascular
787332|NCT00302250|Flow-mediated vasodilation (FMD)|flow-mediated vasodilation (fmd)
787333|NCT00302250|Pulse perfusion-mediated vasodilation (PPMV)|pulse perfusion-mediated vasodilation (ppmv)
787334|NCT00302250|Endothelial function|endothelial function
787335|NCT00302250|Heart failure|heart failure
787336|NCT00302237|carotid, stenting, angioplasty|carotid, stenting, angioplasty
787337|NCT00302224|safety|safety
787338|NCT00302224|type 2 diabetes|type 2 diabetes
787339|NCT00302211|PAH|pah
787340|NCT00302211|Pulmonary Arterial Hypertension|pulmonary arterial hypertension
787341|NCT00302198|Amyotrophic Lateral Sclerosis|amyotrophic lateral sclerosis
787342|NCT00302185|Palliative Care|palliative care
787343|NCT00302185|Acupuncture|acupuncture
787344|NCT00302185|Symptom Management|symptom management
787345|NCT00302185|Quality of Life|quality of life
787346|NCT00302172|Cancer|cancer
787347|NCT00302172|solid tumor|solid tumor
787348|NCT00302172|metastatic|metastatic
787349|NCT00302172|primary tumor|primary tumor
787350|NCT00302159|Chemotherapy|chemotherapy
787351|NCT00302159|Radiation|radiation
787352|NCT00302159|Brain Tumor|brain tumor
787353|NCT00302159|GBM|gbm
787354|NCT00302159|Radiosensitizer|radiosensitizer
787355|NCT00302159|Glioblastoma|glioblastoma
787356|NCT00302159|Glioblastoma Multiforme|glioblastoma multiforme
787357|NCT00302146|Lysosomal Storage Disorder|lysosomal storage disorder
787358|NCT00302146|Carrier|carrier
787359|NCT00302146|L-Dopa Uptake|l-dopa uptake
787360|NCT00302146|Glucocerebrosidase|glucocerebrosidase
787361|NCT00302146|Pathogenesis|pathogenesis
787362|NCT00302146|Gaucher Disease|gaucher disease
787363|NCT00302146|Healthy Volunteer|healthy volunteer
787364|NCT00302146|HV|hv
787365|NCT00302133|Alcoholism Bipolar Disorder Pharmacotherapy Naltrexone|alcoholism bipolar disorder pharmacotherapy naltrexone
787366|NCT00302120|Magnetic Resonance Imaging|magnetic resonance imaging
787367|NCT00302120|Breast Neoplasms|breast neoplasms
787368|NCT00302120|Diagnostic Trial|diagnostic trial
787369|NCT00302107|Mirtazapine|mirtazapine
787370|NCT00302107|PTSD|ptsd
787371|NCT00302107|Veterans|veterans
787372|NCT00302107|antidepressant|antidepressant
787373|NCT00302081|Hepatitis C, Chronic|hepatitis c, chronic
787374|NCT00302081|Genotype 2 and Genotype 3|genotype 2 and genotype 3
787375|NCT00302068|Exercise|exercise
788258|NCT00299182|Decadron|decadron
787376|NCT00302029|Cytomegalovirus, risk factors, seroprevalence|cytomegalovirus, risk factors, seroprevalence
787377|NCT00302016|Chronic myeloid leukemia|chronic myeloid leukemia
787378|NCT00302016|AMN 107|amn 107
787379|NCT00302016|Imatinib resistant or intolerant|imatinib resistant or intolerant
787380|NCT00302016|nilotinib|nilotinib
787381|NCT00302016|enact|enact
787382|NCT00301990|stage IV renal cell cancer|stage iv renal cell cancer
787383|NCT00301990|recurrent renal cell cancer|recurrent renal cell cancer
787384|NCT00301990|clear cell renal cell carcinoma|clear cell renal cell carcinoma
787385|NCT00301951|adult acute myeloid leukemia with 11q23 (MLL) abnormalities|adult acute myeloid leukemia with 11q23 (mll) abnormalities
787386|NCT00301951|adult acute myeloid leukemia with inv(16)(p13;q22)|adult acute myeloid leukemia with inv(16)(p13;q22)
787387|NCT00301951|adult acute myeloid leukemia with t(15;17)(q22;q12)|adult acute myeloid leukemia with t(15;17)(q22;q12)
787388|NCT00301951|adult acute myeloid leukemia with t(16;16)(p13;q22)|adult acute myeloid leukemia with t(16;16)(p13;q22)
787389|NCT00301951|adult acute myeloid leukemia with t(8;21)(q22;q22)|adult acute myeloid leukemia with t(8;21)(q22;q22)
787390|NCT00301951|accelerated phase chronic myelogenous leukemia|accelerated phase chronic myelogenous leukemia
787391|NCT00301951|adult acute lymphoblastic leukemia in remission|adult acute lymphoblastic leukemia in remission
787392|NCT00301951|adult acute myeloid leukemia in remission|adult acute myeloid leukemia in remission
787393|NCT00301951|angioimmunoblastic T-cell lymphoma|angioimmunoblastic t-cell lymphoma
787394|NCT00301951|blastic phase chronic myelogenous leukemia|blastic phase chronic myelogenous leukemia
787395|NCT00301951|chronic myelomonocytic leukemia|chronic myelomonocytic leukemia
787396|NCT00301951|chronic phase chronic myelogenous leukemia|chronic phase chronic myelogenous leukemia
787397|NCT00301951|de novo myelodysplastic syndromes|de novo myelodysplastic syndromes
787398|NCT00301951|extranodal marginal zone B-cell lymphoma of mucosa-associated lymphoid tissue|extranodal marginal zone b-cell lymphoma of mucosa-associated lymphoid tissue
787399|NCT00301951|anaplastic large cell lymphoma|anaplastic large cell lymphoma
787400|NCT00301951|nodal marginal zone B-cell lymphoma|nodal marginal zone b-cell lymphoma
787401|NCT00301951|previously treated myelodysplastic syndromes|previously treated myelodysplastic syndromes
787402|NCT00301951|recurrent adult acute lymphoblastic leukemia|recurrent adult acute lymphoblastic leukemia
787403|NCT00301951|recurrent adult acute myeloid leukemia|recurrent adult acute myeloid leukemia
787404|NCT00301951|recurrent adult T-cell leukemia/lymphoma|recurrent adult t-cell leukemia/lymphoma
787405|NCT00301951|recurrent adult Hodgkin lymphoma|recurrent adult hodgkin lymphoma
787406|NCT00301951|recurrent adult diffuse large cell lymphoma|recurrent adult diffuse large cell lymphoma
787407|NCT00301951|recurrent cutaneous T-cell non-Hodgkin lymphoma|recurrent cutaneous t-cell non-hodgkin lymphoma
787408|NCT00301951|recurrent grade 1 follicular lymphoma|recurrent grade 1 follicular lymphoma
787409|NCT00301951|recurrent grade 2 follicular lymphoma|recurrent grade 2 follicular lymphoma
787410|NCT00301951|recurrent grade 3 follicular lymphoma|recurrent grade 3 follicular lymphoma
787411|NCT00301951|recurrent mantle cell lymphoma|recurrent mantle cell lymphoma
787412|NCT00301951|recurrent marginal zone lymphoma|recurrent marginal zone lymphoma
787413|NCT00301951|recurrent mycosis fungoides/Sezary syndrome|recurrent mycosis fungoides/sezary syndrome
787414|NCT00301951|recurrent small lymphocytic lymphoma|recurrent small lymphocytic lymphoma
787415|NCT00301951|refractory chronic lymphocytic leukemia|refractory chronic lymphocytic leukemia
787416|NCT00301951|stage III adult T-cell leukemia/lymphoma|stage iii adult t-cell leukemia/lymphoma
787417|NCT00301951|refractory multiple myeloma|refractory multiple myeloma
787418|NCT00301951|relapsing chronic myelogenous leukemia|relapsing chronic myelogenous leukemia
787419|NCT00301951|secondary acute myeloid leukemia|secondary acute myeloid leukemia
787420|NCT00301951|secondary myelodysplastic syndromes|secondary myelodysplastic syndromes
787421|NCT00301951|splenic marginal zone lymphoma|splenic marginal zone lymphoma
787422|NCT00301951|stage I multiple myeloma|stage i multiple myeloma
787423|NCT00301951|stage II multiple myeloma|stage ii multiple myeloma
787424|NCT00301951|stage IV adult T-cell leukemia/lymphoma|stage iv adult t-cell leukemia/lymphoma
787425|NCT00301951|stage III adult Hodgkin lymphoma|stage iii adult hodgkin lymphoma
787426|NCT00301951|stage III adult diffuse large cell lymphoma|stage iii adult diffuse large cell lymphoma
787427|NCT00301951|stage III chronic lymphocytic leukemia|stage iii chronic lymphocytic leukemia
787428|NCT00301951|stage III grade 1 follicular lymphoma|stage iii grade 1 follicular lymphoma
787429|NCT00301951|stage III grade 2 follicular lymphoma|stage iii grade 2 follicular lymphoma
787430|NCT00301951|stage III grade 3 follicular lymphoma|stage iii grade 3 follicular lymphoma
787431|NCT00301951|stage III mantle cell lymphoma|stage iii mantle cell lymphoma
787432|NCT00301951|stage III marginal zone lymphoma|stage iii marginal zone lymphoma
787433|NCT00301951|stage III multiple myeloma|stage iii multiple myeloma
787434|NCT00301951|stage III small lymphocytic lymphoma|stage iii small lymphocytic lymphoma
787435|NCT00301951|stage IV adult Hodgkin lymphoma|stage iv adult hodgkin lymphoma
787436|NCT00301951|stage IV adult diffuse large cell lymphoma|stage iv adult diffuse large cell lymphoma
787437|NCT00301951|stage IV chronic lymphocytic leukemia|stage iv chronic lymphocytic leukemia
787438|NCT00301951|stage IV grade 1 follicular lymphoma|stage iv grade 1 follicular lymphoma
787439|NCT00301951|stage IV grade 2 follicular lymphoma|stage iv grade 2 follicular lymphoma
787440|NCT00301951|stage IV grade 3 follicular lymphoma|stage iv grade 3 follicular lymphoma
787441|NCT00301951|stage IV mantle cell lymphoma|stage iv mantle cell lymphoma
787442|NCT00301951|stage IV marginal zone lymphoma|stage iv marginal zone lymphoma
787443|NCT00301951|stage IV small lymphocytic lymphoma|stage iv small lymphocytic lymphoma
787444|NCT00301925|stage I breast cancer|stage i breast cancer
787445|NCT00301925|stage II breast cancer|stage ii breast cancer
787446|NCT00301925|stage IIIA breast cancer|stage iiia breast cancer
787447|NCT00301925|male breast cancer|male breast cancer
787448|NCT00301912|chronic phase chronic myelogenous leukemia|chronic phase chronic myelogenous leukemia
787449|NCT00301912|accelerated phase chronic myelogenous leukemia|accelerated phase chronic myelogenous leukemia
787450|NCT00301912|blastic phase chronic myelogenous leukemia|blastic phase chronic myelogenous leukemia
787451|NCT00301912|adult acute myeloid leukemia in remission|adult acute myeloid leukemia in remission
787452|NCT00301912|adult acute myeloid leukemia with 11q23 (MLL) abnormalities|adult acute myeloid leukemia with 11q23 (mll) abnormalities
787453|NCT00301912|adult acute myeloid leukemia with inv(16)(p13;q22)|adult acute myeloid leukemia with inv(16)(p13;q22)
787454|NCT00301912|adult acute myeloid leukemia with t(15;17)(q22;q12)|adult acute myeloid leukemia with t(15;17)(q22;q12)
787455|NCT00301912|adult acute myeloid leukemia with t(16;16)(p13;q22)|adult acute myeloid leukemia with t(16;16)(p13;q22)
787456|NCT00301912|adult acute myeloid leukemia with t(8;21)(q22;q22)|adult acute myeloid leukemia with t(8;21)(q22;q22)
787457|NCT00301912|recurrent adult acute myeloid leukemia|recurrent adult acute myeloid leukemia
787458|NCT00301912|secondary acute myeloid leukemia|secondary acute myeloid leukemia
787459|NCT00301912|de novo myelodysplastic syndromes|de novo myelodysplastic syndromes
787460|NCT00301912|previously treated myelodysplastic syndromes|previously treated myelodysplastic syndromes
787461|NCT00301912|secondary myelodysplastic syndromes|secondary myelodysplastic syndromes
787462|NCT00301912|atypical chronic myeloid leukemia|atypical chronic myeloid leukemia
787463|NCT00301912|myelodysplastic/myeloproliferative disease, unclassifiable|myelodysplastic/myeloproliferative disease, unclassifiable
787464|NCT00301912|adult acute lymphoblastic leukemia in remission|adult acute lymphoblastic leukemia in remission
787465|NCT00301912|recurrent adult lymphoblastic lymphoma|recurrent adult lymphoblastic lymphoma
787466|NCT00301912|anemia|anemia
787467|NCT00301912|refractory chronic lymphocytic leukemia|refractory chronic lymphocytic leukemia
787468|NCT00301912|stage III chronic lymphocytic leukemia|stage iii chronic lymphocytic leukemia
787469|NCT00301912|stage IV chronic lymphocytic leukemia|stage iv chronic lymphocytic leukemia
787470|NCT00301912|Waldenstrom macroglobulinemia|waldenstrom macroglobulinemia
787471|NCT00301912|stage II multiple myeloma|stage ii multiple myeloma
787472|NCT00301912|stage III multiple myeloma|stage iii multiple myeloma
787473|NCT00301912|refractory multiple myeloma|refractory multiple myeloma
787474|NCT00301912|polycythemia vera|polycythemia vera
787475|NCT00301912|essential thrombocythemia|essential thrombocythemia
787476|NCT00301912|extranodal marginal zone B-cell lymphoma of mucosa-associated lymphoid tissue|extranodal marginal zone b-cell lymphoma of mucosa-associated lymphoid tissue
787477|NCT00301912|nodal marginal zone B-cell lymphoma|nodal marginal zone b-cell lymphoma
787478|NCT00301912|splenic marginal zone lymphoma|splenic marginal zone lymphoma
787479|NCT00301912|recurrent adult Burkitt lymphoma|recurrent adult burkitt lymphoma
787480|NCT00301912|recurrent adult diffuse large cell lymphoma|recurrent adult diffuse large cell lymphoma
787481|NCT00301912|recurrent adult diffuse mixed cell lymphoma|recurrent adult diffuse mixed cell lymphoma
787482|NCT00301912|recurrent adult immunoblastic large cell lymphoma|recurrent adult immunoblastic large cell lymphoma
787483|NCT00301912|recurrent grade 3 follicular lymphoma|recurrent grade 3 follicular lymphoma
787484|NCT00301912|recurrent mantle cell lymphoma|recurrent mantle cell lymphoma
787485|NCT00301912|recurrent adult diffuse small cleaved cell lymphoma|recurrent adult diffuse small cleaved cell lymphoma
787486|NCT00301912|recurrent grade 1 follicular lymphoma|recurrent grade 1 follicular lymphoma
787487|NCT00301912|recurrent grade 2 follicular lymphoma|recurrent grade 2 follicular lymphoma
787488|NCT00301912|recurrent marginal zone lymphoma|recurrent marginal zone lymphoma
787489|NCT00301912|recurrent small lymphocytic lymphoma|recurrent small lymphocytic lymphoma
787490|NCT00301912|relapsing chronic myelogenous leukemia|relapsing chronic myelogenous leukemia
787491|NCT00301912|chronic eosinophilic leukemia|chronic eosinophilic leukemia
787492|NCT00301912|chronic idiopathic myelofibrosis|chronic idiopathic myelofibrosis
787493|NCT00301912|chronic myelomonocytic leukemia|chronic myelomonocytic leukemia
787494|NCT00301912|chronic neutrophilic leukemia|chronic neutrophilic leukemia
787495|NCT00301912|noncontiguous stage II adult Burkitt lymphoma|noncontiguous stage ii adult burkitt lymphoma
787496|NCT00301912|noncontiguous stage II adult diffuse large cell lymphoma|noncontiguous stage ii adult diffuse large cell lymphoma
787497|NCT00301912|noncontiguous stage II adult diffuse mixed cell lymphoma|noncontiguous stage ii adult diffuse mixed cell lymphoma
787498|NCT00301912|noncontiguous stage II adult diffuse small cleaved cell lymphoma|noncontiguous stage ii adult diffuse small cleaved cell lymphoma
787499|NCT00301912|noncontiguous stage II adult immunoblastic large cell lymphoma|noncontiguous stage ii adult immunoblastic large cell lymphoma
787500|NCT00301912|noncontiguous stage II adult lymphoblastic lymphoma|noncontiguous stage ii adult lymphoblastic lymphoma
787501|NCT00301912|noncontiguous stage II grade 1 follicular lymphoma|noncontiguous stage ii grade 1 follicular lymphoma
787502|NCT00301912|noncontiguous stage II grade 2 follicular lymphoma|noncontiguous stage ii grade 2 follicular lymphoma
787842|NCT00300560|Colistin|colistin
787503|NCT00301912|noncontiguous stage II grade 3 follicular lymphoma|noncontiguous stage ii grade 3 follicular lymphoma
787504|NCT00301912|noncontiguous stage II mantle cell lymphoma|noncontiguous stage ii mantle cell lymphoma
787505|NCT00301912|noncontiguous stage II marginal zone lymphoma|noncontiguous stage ii marginal zone lymphoma
788259|NCT00299182|Neosar|neosar
787506|NCT00301912|noncontiguous stage II small lymphocytic lymphoma|noncontiguous stage ii small lymphocytic lymphoma
787507|NCT00301912|stage III adult Burkitt lymphoma|stage iii adult burkitt lymphoma
787508|NCT00301912|stage III adult diffuse large cell lymphoma|stage iii adult diffuse large cell lymphoma
787509|NCT00301912|stage III adult diffuse mixed cell lymphoma|stage iii adult diffuse mixed cell lymphoma
787510|NCT00301912|stage III adult diffuse small cleaved cell lymphoma|stage iii adult diffuse small cleaved cell lymphoma
787511|NCT00301912|stage III adult immunoblastic large cell lymphoma|stage iii adult immunoblastic large cell lymphoma
787512|NCT00301912|stage III adult lymphoblastic lymphoma|stage iii adult lymphoblastic lymphoma
787513|NCT00301912|stage III grade 1 follicular lymphoma|stage iii grade 1 follicular lymphoma
787514|NCT00301912|stage III grade 2 follicular lymphoma|stage iii grade 2 follicular lymphoma
787515|NCT00301912|stage III grade 3 follicular lymphoma|stage iii grade 3 follicular lymphoma
787516|NCT00301912|stage III mantle cell lymphoma|stage iii mantle cell lymphoma
787517|NCT00301912|stage III marginal zone lymphoma|stage iii marginal zone lymphoma
787518|NCT00301912|stage III small lymphocytic lymphoma|stage iii small lymphocytic lymphoma
787519|NCT00301912|stage IV adult Burkitt lymphoma|stage iv adult burkitt lymphoma
787520|NCT00301912|stage IV adult diffuse large cell lymphoma|stage iv adult diffuse large cell lymphoma
787521|NCT00301912|stage IV adult diffuse mixed cell lymphoma|stage iv adult diffuse mixed cell lymphoma
787522|NCT00301912|stage IV adult diffuse small cleaved cell lymphoma|stage iv adult diffuse small cleaved cell lymphoma
787523|NCT00301912|stage IV adult immunoblastic large cell lymphoma|stage iv adult immunoblastic large cell lymphoma
787524|NCT00301912|stage IV adult lymphoblastic lymphoma|stage iv adult lymphoblastic lymphoma
787525|NCT00301912|stage IV grade 1 follicular lymphoma|stage iv grade 1 follicular lymphoma
787526|NCT00301912|stage IV grade 2 follicular lymphoma|stage iv grade 2 follicular lymphoma
787527|NCT00301912|stage IV grade 3 follicular lymphoma|stage iv grade 3 follicular lymphoma
787528|NCT00301912|stage IV mantle cell lymphoma|stage iv mantle cell lymphoma
787529|NCT00301912|stage IV marginal zone lymphoma|stage iv marginal zone lymphoma
787530|NCT00301912|stage IV small lymphocytic lymphoma|stage iv small lymphocytic lymphoma
787531|NCT00301912|recurrent adult acute lymphoblastic leukemia|recurrent adult acute lymphoblastic leukemia
787532|NCT00301912|stage I multiple myeloma|stage i multiple myeloma
787533|NCT00301912|childhood myelodysplastic syndromes|childhood myelodysplastic syndromes
787534|NCT00301899|recurrent breast cancer|recurrent breast cancer
787535|NCT00301899|male breast cancer|male breast cancer
787536|NCT00301899|stage IIIA breast cancer|stage iiia breast cancer
787537|NCT00301899|stage IIIB breast cancer|stage iiib breast cancer
787538|NCT00301899|stage IIIC breast cancer|stage iiic breast cancer
787539|NCT00301899|stage IV breast cancer|stage iv breast cancer
787541|NCT00301886|hypercalcemia of malignancy|hypercalcemia of malignancy
787542|NCT00301886|stage IV breast cancer|stage iv breast cancer
787543|NCT00301886|bone metastases|bone metastases
787544|NCT00301886|recurrent breast cancer|recurrent breast cancer
787545|NCT00301873|osteoporosis|osteoporosis
787546|NCT00301873|adult anaplastic astrocytoma|adult anaplastic astrocytoma
787547|NCT00301873|adult giant cell glioblastoma|adult giant cell glioblastoma
787548|NCT00301873|adult anaplastic oligodendroglioma|adult anaplastic oligodendroglioma
787549|NCT00301873|adult gliosarcoma|adult gliosarcoma
787550|NCT00301873|adult mixed glioma|adult mixed glioma
787551|NCT00301873|recurrent adult brain tumor|recurrent adult brain tumor
787552|NCT00301873|adult glioblastoma|adult glioblastoma
787553|NCT00301860|childhood acute lymphoblastic leukemia in remission|childhood acute lymphoblastic leukemia in remission
787554|NCT00301860|childhood acute myeloid leukemia in remission|childhood acute myeloid leukemia in remission
787555|NCT00301860|recurrent childhood acute lymphoblastic leukemia|recurrent childhood acute lymphoblastic leukemia
787921|NCT00300196|Reperfusion|reperfusion
787556|NCT00301860|recurrent childhood acute myeloid leukemia|recurrent childhood acute myeloid leukemia
787557|NCT00301860|recurrent childhood small noncleaved cell lymphoma|recurrent childhood small noncleaved cell lymphoma
787558|NCT00301860|juvenile myelomonocytic leukemia|juvenile myelomonocytic leukemia
787559|NCT00301860|chronic phase chronic myelogenous leukemia|chronic phase chronic myelogenous leukemia
787560|NCT00301860|accelerated phase chronic myelogenous leukemia|accelerated phase chronic myelogenous leukemia
787561|NCT00301860|relapsing chronic myelogenous leukemia|relapsing chronic myelogenous leukemia
787562|NCT00301860|recurrent childhood large cell lymphoma|recurrent childhood large cell lymphoma
787563|NCT00301860|recurrent childhood lymphoblastic lymphoma|recurrent childhood lymphoblastic lymphoma
787564|NCT00301860|recurrent/refractory childhood Hodgkin lymphoma|recurrent/refractory childhood hodgkin lymphoma
787565|NCT00301860|childhood chronic myelogenous leukemia|childhood chronic myelogenous leukemia
787566|NCT00301847|tumors metastatic to brain|tumors metastatic to brain
787567|NCT00301847|recurrent renal cell cancer|recurrent renal cell cancer
787568|NCT00301847|stage IV renal cell cancer|stage iv renal cell cancer
787569|NCT00301834|de novo myelodysplastic syndromes|de novo myelodysplastic syndromes
787570|NCT00301834|previously treated myelodysplastic syndromes|previously treated myelodysplastic syndromes
787571|NCT00301834|secondary myelodysplastic syndromes|secondary myelodysplastic syndromes
787572|NCT00301834|childhood acute myeloid leukemia in remission|childhood acute myeloid leukemia in remission
787573|NCT00301834|childhood chronic myelogenous leukemia|childhood chronic myelogenous leukemia
787574|NCT00301834|congenital amegakaryocytic thrombocytopenia|congenital amegakaryocytic thrombocytopenia
788260|NCT00299182|AD|ad
787575|NCT00301834|Diamond-Blackfan anemia|diamond-blackfan anemia
787576|NCT00301834|severe congenital neutropenia|severe congenital neutropenia
787577|NCT00301834|secondary acute myeloid leukemia|secondary acute myeloid leukemia
787578|NCT00301834|chronic phase chronic myelogenous leukemia|chronic phase chronic myelogenous leukemia
787579|NCT00301834|childhood myelodysplastic syndromes|childhood myelodysplastic syndromes
787580|NCT00301821|contiguous stage II adult diffuse large cell lymphoma|contiguous stage ii adult diffuse large cell lymphoma
787581|NCT00301821|noncontiguous stage II adult diffuse large cell lymphoma|noncontiguous stage ii adult diffuse large cell lymphoma
787582|NCT00301821|stage III adult diffuse large cell lymphoma|stage iii adult diffuse large cell lymphoma
787583|NCT00301821|stage IV adult diffuse large cell lymphoma|stage iv adult diffuse large cell lymphoma
787584|NCT00301808|stage IIIA non-small cell lung cancer|stage iiia non-small cell lung cancer
787585|NCT00301808|stage IIIB non-small cell lung cancer|stage iiib non-small cell lung cancer
787586|NCT00301782|testicular choriocarcinoma and embryonal carcinoma|testicular choriocarcinoma and embryonal carcinoma
787587|NCT00301782|testicular choriocarcinoma and teratoma|testicular choriocarcinoma and teratoma
787588|NCT00301782|testicular choriocarcinoma and yolk sac tumor|testicular choriocarcinoma and yolk sac tumor
787589|NCT00301782|testicular choriocarcinoma|testicular choriocarcinoma
787590|NCT00301782|testicular embryonal carcinoma and teratoma|testicular embryonal carcinoma and teratoma
787591|NCT00301782|testicular embryonal carcinoma and yolk sac tumor|testicular embryonal carcinoma and yolk sac tumor
787592|NCT00301782|testicular embryonal carcinoma|testicular embryonal carcinoma
787593|NCT00301782|testicular yolk sac tumor|testicular yolk sac tumor
787594|NCT00301782|testicular yolk sac tumor and teratoma|testicular yolk sac tumor and teratoma
787595|NCT00301782|stage I malignant testicular germ cell tumor|stage i malignant testicular germ cell tumor
787596|NCT00301782|stage II malignant testicular germ cell tumor|stage ii malignant testicular germ cell tumor
787597|NCT00301782|stage III malignant testicular germ cell tumor|stage iii malignant testicular germ cell tumor
787598|NCT00301782|recurrent malignant testicular germ cell tumor|recurrent malignant testicular germ cell tumor
787599|NCT00301782|recurrent extragonadal non-seminomatous germ cell tumor|recurrent extragonadal non-seminomatous germ cell tumor
787600|NCT00301782|stage I extragonadal non-seminomatous germ cell tumor|stage i extragonadal non-seminomatous germ cell tumor
787601|NCT00301782|stage II extragonadal non-seminomatous germ cell tumor|stage ii extragonadal non-seminomatous germ cell tumor
787602|NCT00301782|stage III extragonadal non-seminomatous germ cell tumor|stage iii extragonadal non-seminomatous germ cell tumor
787603|NCT00301782|stage IV extragonadal non-seminomatous germ cell tumor|stage iv extragonadal non-seminomatous germ cell tumor
787604|NCT00301782|recurrent extragonadal germ cell tumor|recurrent extragonadal germ cell tumor
787605|NCT00301782|testicular immature teratoma|testicular immature teratoma
787606|NCT00301782|testicular mature teratoma|testicular mature teratoma
787607|NCT00301782|adult teratoma|adult teratoma
787608|NCT00301730|lung metastases|lung metastases
787609|NCT00301730|stage IV breast cancer|stage iv breast cancer
787610|NCT00301730|recurrent breast cancer|recurrent breast cancer
787611|NCT00301691|unspecified adult solid tumor, protocol specific|unspecified adult solid tumor, protocol specific
787612|NCT00301678|unspecified adult solid tumor, protocol specific|unspecified adult solid tumor, protocol specific
787614|NCT00301652|vasculitis|vasculitis
787615|NCT00301652|mycophenolate mofetil|mycophenolate mofetil
787616|NCT00301652|cyclophosphamide|cyclophosphamide
787617|NCT00301652|treatment|treatment
787618|NCT00301626|tobacco|tobacco
787619|NCT00301626|nicotine|nicotine
787620|NCT00301626|smoking reduction|smoking reduction
787621|NCT00301613|Henoch-Schonlein purpura nephritis Mycophenolate mofetil|henoch-schonlein purpura nephritis mycophenolate mofetil
787622|NCT00301613|Cyclophosphamide|cyclophosphamide
787623|NCT00301613|treatment|treatment
787624|NCT00301600|Crescentic IgA nephropathy|crescentic iga nephropathy
787625|NCT00301600|Mycophenolate mofetil|mycophenolate mofetil
787626|NCT00301600|Cyclophosphamide|cyclophosphamide
787627|NCT00301600|treatment|treatment
787628|NCT00301587|spina bifida|spina bifida
787629|NCT00301587|birth defects|birth defects
787630|NCT00301587|folic acid|folic acid
787631|NCT00301587|nervous system diseases|nervous system diseases
787632|NCT00301587|folate|folate
787633|NCT00301587|Vitamin B|vitamin b
787634|NCT00301574|Alzheimer's disease|alzheimer's disease
787635|NCT00301574|Cognitive dysfunction|cognitive dysfunction
787636|NCT00301561|Antiretroviral treatment|antiretroviral treatment
787637|NCT00301561|Expanded access|expanded access
787638|NCT00301561|Africa|africa
787639|NCT00301561|Treatment Naive|treatment naive
787640|NCT00301548|antineoplastic protocols|antineoplastic protocols
787641|NCT00301548|neoadjuvant therapy|neoadjuvant therapy
787642|NCT00301548|perioperative chemotherapy|perioperative chemotherapy
787643|NCT00301548|fluorouracil|fluorouracil
787644|NCT00301535|Coronary Artery Bypass Graft|coronary artery bypass graft
787645|NCT00301535|memory loss after cardiac surgery|memory loss after cardiac surgery
787646|NCT00301535|side effects of bypass|side effects of bypass
787647|NCT00301522|Coronary|coronary
787648|NCT00301522|Artery|artery
787649|NCT00301522|Stenosis|stenosis
787650|NCT00301522|Drug-eluting|drug-eluting
787651|NCT00301522|stent|stent
787652|NCT00301522|restenosis|restenosis
787653|NCT00301522|revascularization|revascularization
788656|NCT00297375|treatment|treatment
787654|NCT00301483|multiple trauma|multiple trauma
787655|NCT00301483|bleeding injuries|bleeding injuries
787656|NCT00301483|gunshot wounds|gunshot wounds
787657|NCT00301483|stab wounds|stab wounds
787658|NCT00301483|penetrating injuries|penetrating injuries
787659|NCT00301483|blunt trauma|blunt trauma
787660|NCT00301483|multiple wounds|multiple wounds
787661|NCT00301470|Ureter, obstruction|ureter, obstruction
787662|NCT00301470|Diagnostic techniques, urological|diagnostic techniques, urological
787663|NCT00301470|MRI, functional|mri, functional
787664|NCT00301457|Hormone Sensitive Primary Breast Cancer|hormone sensitive primary breast cancer
787665|NCT00301457|Adjuvant Treatment|adjuvant treatment
787666|NCT00301457|Aromatase Inhibitor|aromatase inhibitor
787667|NCT00301444|phantom limb pain|phantom limb pain
787668|NCT00301444|limb amputation|limb amputation
787669|NCT00301431|Fibromyalgia|fibromyalgia
787670|NCT00301431|Adults|adults
787671|NCT00301431|Outpatients|outpatients
787672|NCT00301431|Adult|adult
787673|NCT00301431|Double-Blind Method|double-blind method
787674|NCT00301418|Glioblastoma Multiforme|glioblastoma multiforme
787675|NCT00301418|Anaplastic Astrocytoma|anaplastic astrocytoma
787676|NCT00301418|High Grade Glial Neoplasms|high grade glial neoplasms
787677|NCT00301418|Brain Tumor|brain tumor
787678|NCT00301405|prostatitis|prostatitis
787679|NCT00301405|pelvic pain|pelvic pain
787680|NCT00301392|Glucose intolerance|glucose intolerance
787681|NCT00301392|Diabetes mellitus|diabetes mellitus
787682|NCT00301392|Statins,HMG-CoA|statins,hmg-coa
787683|NCT00301379|Cholangiocarcinoma|cholangiocarcinoma
787684|NCT00301379|Observational|observational
787685|NCT00301366|alpha 1-Antitrypsin Deficiency|alpha 1-antitrypsin deficiency
787686|NCT00301366|alpha 1-Antitrypsin|alpha 1-antitrypsin
787687|NCT00301366|pulmonary emphysema|pulmonary emphysema
787688|NCT00301353|early menopause|early menopause
787689|NCT00301353|isoflavones/phyto-estrogens|isoflavones/phyto-estrogens
787690|NCT00301353|bone metabolism|bone metabolism
787691|NCT00301353|bone mineral density|bone mineral density
787692|NCT00301353|hormones|hormones
787693|NCT00301249|Diabetes|diabetes
787694|NCT00301249|Nephropathy|nephropathy
787695|NCT00301249|Diabetic Nephropathy|diabetic nephropathy
787696|NCT00301249|Genome Scan|genome scan
787697|NCT00301249|Genetic Research|genetic research
787698|NCT00301236|ADHD, children, CADS-T, Dexmethylphenidate-HCl, extended release|adhd, children, cads-t, dexmethylphenidate-hcl, extended release
787699|NCT00301197|Childhood obesity|childhood obesity
787700|NCT00301197|intervention|intervention
787701|NCT00301197|obesity|obesity
787702|NCT00301197|weight loss|weight loss
787703|NCT00301197|behavior therapy|behavior therapy
787704|NCT00301197|peer group|peer group
787705|NCT00301197|social support network|social support network
787706|NCT00301197|child|child
787707|NCT00301197|clinical research|clinical research
787708|NCT00301197|human subject|human subject
787709|NCT00301184|HIV Seronegativity|hiv seronegativity
787710|NCT00301184|HIV Preventive Vaccine|hiv preventive vaccine
787711|NCT00301184|HIV DNA Vaccine|hiv dna vaccine
787712|NCT00301184|Modified Vaccinia Ankara Vaccine|modified vaccinia ankara vaccine
787713|NCT00301171|Wheezing|wheezing
787714|NCT00301158|unspecified adult solid tumor, protocol specific|unspecified adult solid tumor, protocol specific
787715|NCT00301145|unspecified adult solid tumor, protocol specific|unspecified adult solid tumor, protocol specific
787716|NCT00301119|small cell lung cancer|small cell lung cancer
787717|NCT00301119|non-small cell lung cancer|non-small cell lung cancer
787718|NCT00301119|smoker lung cancer screening|smoker lung cancer screening
787719|NCT00301119|low dose spiral CT screening|low dose spiral ct screening
788227|NCT00299273|Weight Loss|weight loss
787720|NCT00301106|stage IV breast cancer|stage iv breast cancer
787721|NCT00301106|liver metastases|liver metastases
787722|NCT00301093|chronic phase chronic myelogenous leukemia|chronic phase chronic myelogenous leukemia
787723|NCT00301093|Philadelphia chromosome positive chronic myelogenous leukemia|philadelphia chromosome positive chronic myelogenous leukemia
787724|NCT00301080|pain|pain
787725|NCT00301080|neurotoxicity|neurotoxicity
787726|NCT00301080|breast cancer|breast cancer
787727|NCT00301067|stage IV melanoma|stage iv melanoma
787728|NCT00301067|recurrent melanoma|recurrent melanoma
787729|NCT00301054|Anaemia|anaemia
787730|NCT00301054|Malaria|malaria
787731|NCT00301054|Rural Area in Ghana|rural area in ghana
787732|NCT00301041|invasive ductal breast carcinoma|invasive ductal breast carcinoma
787733|NCT00301041|invasive lobular breast carcinoma|invasive lobular breast carcinoma
787734|NCT00301041|stage I breast cancer|stage i breast cancer
787735|NCT00301041|stage II breast cancer|stage ii breast cancer
787736|NCT00301041|stage IIIA breast cancer|stage iiia breast cancer
787737|NCT00301028|stage IV squamous cell carcinoma of the oropharynx|stage iv squamous cell carcinoma of the oropharynx
787738|NCT00301028|stage IV squamous cell carcinoma of the hypopharynx|stage iv squamous cell carcinoma of the hypopharynx
787739|NCT00301028|stage IV squamous cell carcinoma of the larynx|stage iv squamous cell carcinoma of the larynx
787740|NCT00301028|stage IV squamous cell carcinoma of the nasopharynx|stage iv squamous cell carcinoma of the nasopharynx
787741|NCT00301028|stage IV squamous cell carcinoma of the lip and oral cavity|stage iv squamous cell carcinoma of the lip and oral cavity
787742|NCT00301002|safety|safety
787743|NCT00301002|effectiveness|effectiveness
787744|NCT00301002|Alefacept|alefacept
787745|NCT00301002|Palmar|palmar
787746|NCT00301002|Plantar|plantar
787747|NCT00301002|Pustulosis|pustulosis
787748|NCT00300976|Blood glucose|blood glucose
787749|NCT00300976|Blood pressure|blood pressure
787750|NCT00300976|Lipids|lipids
787751|NCT00300963|psychosis|psychosis
787752|NCT00300963|cognition|cognition
787753|NCT00300950|Pancreas Cancer|pancreas cancer
787754|NCT00300950|resected pancreas cancer|resected pancreas cancer
787755|NCT00300950|non-metastatic pancreas cancer|non-metastatic pancreas cancer
787756|NCT00300911|Natriuretic Peptide, Brain|natriuretic peptide, brain
787757|NCT00300911|Heart Failure, Congestive|heart failure, congestive
787758|NCT00300898|contained lumbar herniated disc|contained lumbar herniated disc
787759|NCT00300898|nucleoplasty|nucleoplasty
787760|NCT00300898|percutaneous decompression|percutaneous decompression
787761|NCT00300898|Dekompressor|dekompressor
787762|NCT00300898|intervertebral electrothermal disc decompression|intervertebral electrothermal disc decompression
787763|NCT00300898|IDET|idet
787764|NCT00300885|Non-Small Cell Lung Cancer|non-small cell lung cancer
787765|NCT00300885|NSCLC|nsclc
787766|NCT00300820|Bipolar Disorder|bipolar disorder
787767|NCT00300820|Affected Adults and Adult Siblings|affected adults and adult siblings
787768|NCT00300820|Interest in Genetic Counseling|interest in genetic counseling
787769|NCT00300820|Bipolar|bipolar
787770|NCT00300820|Genes|genes
787771|NCT00300820|Familial|familial
787772|NCT00300820|Education|education
787773|NCT00300820|Testing|testing
787774|NCT00300820|BP|bp
787775|NCT00300820|Adult Siblings|adult siblings
787776|NCT00300807|Hepatitis C|hepatitis c
787777|NCT00300807|Monoclonal Antibody|monoclonal antibody
787778|NCT00300807|failed IFN/RBV treatment|failed ifn/rbv treatment
787779|NCT00300781|phase 2|phase 2
787780|NCT00300781|HER2+ breast cancer|her2+ breast cancer
787781|NCT00300781|monotherapy neratinib|monotherapy neratinib
787782|NCT00300781|HKI-272|hki-272
787783|NCT00300781|Neratinib|neratinib
787784|NCT00300781|Nerlynx|nerlynx
787785|NCT00300781|PB-272|pb-272
787786|NCT00300768|onchocerciasis|onchocerciasis
787787|NCT00300768|onchocerca volvulus|onchocerca volvulus
787788|NCT00300768|river blindness|river blindness
787789|NCT00300768|ivermectin|ivermectin
787790|NCT00300768|moxidectin|moxidectin
787791|NCT00300755|GERD|gerd
787792|NCT00300755|Children|children
787793|NCT00300755|Child|child
787794|NCT00300755|Child, Preschool|child, preschool
787795|NCT00300742|drinking|drinking
787796|NCT00300742|eating|eating
787797|NCT00300742|obesity|obesity
787798|NCT00300742|alcohol|alcohol
787799|NCT00300742|binge eating|binge eating
787800|NCT00300729|Cyclooxygenase-2 inhibitors|cyclooxygenase-2 inhibitors
787801|NCT00300729|Celecoxib|celecoxib
787802|NCT00300729|Carcinoma, non-small-cell lung|carcinoma, non-small-cell lung
787803|NCT00300729|Antineoplastic agents|antineoplastic agents
787804|NCT00300729|Therapy, palliative|therapy, palliative
787805|NCT00300729|Survival|survival
787806|NCT00300716|Multiple Sclerosis|multiple sclerosis
787807|NCT00300716|Cognitive impairment|cognitive impairment
787808|NCT00300716|Memantine|memantine
787809|NCT00300716|Placebo|placebo
787810|NCT00300716|Neuropsychological tests|neuropsychological tests
787811|NCT00300716|Quality of life|quality of life
787812|NCT00300716|Fatigue|fatigue
787813|NCT00300703|Cardiac Arrest|cardiac arrest
787814|NCT00300690|Lower extremity bypass surgery|lower extremity bypass surgery
787815|NCT00300690|femoro-popliteal bypass|femoro-popliteal bypass
787816|NCT00300690|Dacron material|dacron material
787817|NCT00300690|PTFE material|ptfe material
787818|NCT00300677|Pharmacokinetics|pharmacokinetics
787819|NCT00300677|Voriconazole|voriconazole
787820|NCT00300677|Magnetic Resonance Spectroscopy|magnetic resonance spectroscopy
787821|NCT00300651|Cognitive Behavioral Therapy|cognitive behavioral therapy
787822|NCT00300651|Schizophrenia|schizophrenia
787823|NCT00300651|Cognitive Biases|cognitive biases
787824|NCT00300651|Efficacy|efficacy
787825|NCT00300638|Alcoholism|alcoholism
787826|NCT00300638|Emotion|emotion
787827|NCT00300638|Cognition|cognition
787828|NCT00300638|Brain scans|brain scans
787829|NCT00300625|Syncope|syncope
787830|NCT00300625|Near syncope|near syncope
787831|NCT00300625|San Francisco Syncope rule|san francisco syncope rule
787832|NCT00300586|Non-small cell lung cancer ;|non-small cell lung cancer ;
787833|NCT00300586|metastatic ;|metastatic ;
787834|NCT00300586|chemotherapy ;|chemotherapy ;
787835|NCT00300586|erlotinib|erlotinib
787836|NCT00300573|dexelvucitabine|dexelvucitabine
787837|NCT00300573|DFC|dfc
787838|NCT00300573|Treatment Experienced|treatment experienced
787839|NCT00300573|HIV-1|hiv-1
787840|NCT00300560|ESBL-producing E.coli Infections|esbl-producing e.coli infections
787841|NCT00300560|ESBL-producing Klebsiella pneumoniae Infections|esbl-producing klebsiella pneumoniae infections
787843|NCT00300547|colorectal cancer|colorectal cancer
787844|NCT00300547|polyps|polyps
787845|NCT00300547|Virtual colonoscopy|virtual colonoscopy
787846|NCT00300547|synchronous carcinoma|synchronous carcinoma
787847|NCT00300547|MR colonography|mr colonography
787848|NCT00300534|Diagnosis|diagnosis
787849|NCT00300521|hepatocellular carcinoma|hepatocellular carcinoma
787850|NCT00300521|liver transplantation|liver transplantation
787851|NCT00300521|adenovirus-thymidine kinase enzyme|adenovirus-thymidine kinase enzyme
787852|NCT00300521|gene therapy|gene therapy
787853|NCT00300521|immunosuppression|immunosuppression
787854|NCT00300508|Hormone receptor positive breast cancer|hormone receptor positive breast cancer
787855|NCT00300495|Atrial fibrillation|atrial fibrillation
787856|NCT00300495|Lung cancer|lung cancer
787857|NCT00300495|Pulmonary resection|pulmonary resection
787858|NCT00300495|Post-operative complications|post-operative complications
787859|NCT00300482|Dyslipidemia|dyslipidemia
787860|NCT00300482|Coronary Heart Disease|coronary heart disease
787861|NCT00300482|Mixed Dyslipidemia|mixed dyslipidemia
787862|NCT00300469|Mixed Dyslipidemia|mixed dyslipidemia
787863|NCT00300469|Coronary Heart Disease|coronary heart disease
787864|NCT00300469|Dyslipidemia|dyslipidemia
787865|NCT00300456|Dyslipidemia|dyslipidemia
787866|NCT00300456|Coronary Heart Disease|coronary heart disease
787867|NCT00300456|Mixed Dyslipidemia|mixed dyslipidemia
787868|NCT00300417|Flavivirus|flavivirus
787869|NCT00300417|Mosquito|mosquito
787870|NCT00300417|Immunity|immunity
787871|NCT00300417|Preventive|preventive
787872|NCT00300417|West Nile Fever|west nile fever
787873|NCT00300417|West Nile Virus|west nile virus
787874|NCT00300417|Vaccine|vaccine
787875|NCT00300417|Healthy Volunteer|healthy volunteer
787876|NCT00300417|HV|hv
787877|NCT00300404|Schizophrenia|schizophrenia
787878|NCT00300404|Psychosis|psychosis
787879|NCT00300404|Depression|depression
787880|NCT00300404|Affective Disorder|affective disorder
787881|NCT00300391|Delirium|delirium
787882|NCT00300391|Mechanical ventilation|mechanical ventilation
787883|NCT00300391|Intensive care|intensive care
787884|NCT00300391|Haloperidol|haloperidol
787885|NCT00300378|Depression|depression
787886|NCT00300378|Adult|adult
787887|NCT00300378|Outpatients|outpatients
787888|NCT00300365|HDL cholesterol|hdl cholesterol
787889|NCT00300365|Metabolic syndrome|metabolic syndrome
787890|NCT00300352|Coronary artery disease|coronary artery disease
787891|NCT00300352|Folic acid|folic acid
787892|NCT00300352|Endothelial function|endothelial function
787893|NCT00300300|ACL computer-assisted surgery graft|acl computer-assisted surgery graft
787894|NCT00300287|Type 2 diabetes|type 2 diabetes
787895|NCT00300287|Vildagliptin|vildagliptin
787896|NCT00300274|Everolimus|everolimus
787897|NCT00300274|heart transplant|heart transplant
787898|NCT00300274|heart disease|heart disease
787899|NCT00300274|transplantation|transplantation
787900|NCT00300274|heart IVUS assessment at 12 months|heart ivus assessment at 12 months
787901|NCT00300274|rate of graft loss|rate of graft loss
787902|NCT00300274|acute rejection episodes|acute rejection episodes
787903|NCT00300274|survival|survival
787904|NCT00300261|Heart Failure|heart failure
787905|NCT00300248|Acute Respiratory Distress Syndrome|acute respiratory distress syndrome
787906|NCT00300248|Acute Lung Injury|acute lung injury
787907|NCT00300248|Respiratory Failure|respiratory failure
787908|NCT00300248|ARDS, Human|ards, human
787909|NCT00300235|Sickle Cell Anemia|sickle cell anemia
787910|NCT00300222|dermal assessment|dermal assessment
787911|NCT00300222|pain measurement|pain measurement
787912|NCT00300222|diary|diary
787913|NCT00300222|PHN|phn
787914|NCT00300222|shingles|shingles
787915|NCT00300222|neuropathy|neuropathy
787916|NCT00300222|analgesics|analgesics
787917|NCT00300222|capsaicin|capsaicin
787918|NCT00300222|postherpetic neuralgia|postherpetic neuralgia
787922|NCT00300196|Thrombolysis|thrombolysis
787923|NCT00300183|HIV|hiv
787924|NCT00300183|health services accessibility|health services accessibility
787925|NCT00300183|health services research|health services research
787926|NCT00300183|homeless|homeless
787927|NCT00300183|social support|social support
787928|NCT00300183|AIDS|aids
787929|NCT00300183|substance abuse|substance abuse
787930|NCT00300183|mental health|mental health
787931|NCT00300183|quality of life|quality of life
787932|NCT00300183|outreach|outreach
787933|NCT00300183|harm reduction|harm reduction
787934|NCT00300170|HIV|hiv
787935|NCT00300170|race|race
787936|NCT00300170|unstable housing|unstable housing
787937|NCT00300170|health services accessibility|health services accessibility
787938|NCT00300170|health services utilization|health services utilization
787939|NCT00300170|substance abuse|substance abuse
787940|NCT00300170|AIDS|aids
787941|NCT00300170|health services research|health services research
787942|NCT00300170|social support|social support
787943|NCT00300170|depression|depression
787944|NCT00300170|trust|trust
787945|NCT00300170|discrimination|discrimination
787946|NCT00300157|Left main coronary artery stenosis, stent, Taxus|left main coronary artery stenosis, stent, taxus
787947|NCT00300157|Unprotected left main coronary artery disease|unprotected left main coronary artery disease
787948|NCT00300157|Percutaneous coronary intervention with Taxus stent|percutaneous coronary intervention with taxus stent
787949|NCT00300131|Bioabsorbable|bioabsorbable
787950|NCT00300131|Coronary Stent|coronary stent
787951|NCT00300131|Everolimus|everolimus
787952|NCT00300131|drug eluting stents|drug eluting stents
787953|NCT00300131|stents|stents
787954|NCT00300131|angioplasty|angioplasty
787955|NCT00300131|coronary artery disease|coronary artery disease
787956|NCT00300131|total coronary occlusion|total coronary occlusion
787957|NCT00300131|coronary artery restenosis|coronary artery restenosis
787958|NCT00300131|stent thrombosis|stent thrombosis
787959|NCT00300131|vascular disease|vascular disease
787960|NCT00300131|myocardial ischemia|myocardial ischemia
787961|NCT00300131|coronary artery stenosis|coronary artery stenosis
787962|NCT00300105|Patients diagnosed with type 2 diabetes who have participated in and completed the randomized, double-blind, parallel-group, multi-center study GALLANT 4|patients diagnosed with type 2 diabetes who have participated in and completed the randomized, double-blind, parallel-group, multi-center study gallant 4
787963|NCT00300079|Ocular Hypertension Patients|ocular hypertension patients
787964|NCT00300066|Glomerular Filtration Rate|glomerular filtration rate
787965|NCT00300066|Serum Cystatin C|serum cystatin c
787966|NCT00300066|Body Composition|body composition
787967|NCT00300066|bioelectrical impedance spectroscopy|bioelectrical impedance spectroscopy
787968|NCT00300053|angina|angina
787969|NCT00300040|Amputation|amputation
787970|NCT00300040|Lower limb|lower limb
787971|NCT00300040|Critical Limb Ischemia|critical limb ischemia
787972|NCT00300040|residual limb|residual limb
787973|NCT00300040|Peripheral Vascular Disease|peripheral vascular disease
787974|NCT00300040|re-amputation|re-amputation
787975|NCT00300040|Lower Limb Ischemia|lower limb ischemia
787976|NCT00300040|PVD|pvd
787977|NCT00300027|Advanced Gastrointestinal Malignancies|advanced gastrointestinal malignancies
787978|NCT00300014|Post vitrectomy|post vitrectomy
787979|NCT00300014|Recurrent diabetic vitreous hemorrhage|recurrent diabetic vitreous hemorrhage
787980|NCT00300014|Intravitreal triamcinolone injection|intravitreal triamcinolone injection
787981|NCT00300001|Cancer|cancer
787982|NCT00300001|Symptom Management|symptom management
787983|NCT00300001|Supportive Symptom Interventions|supportive symptom interventions
787984|NCT00300001|Symptom Severity|symptom severity
787985|NCT00300001|quality of life|quality of life
787986|NCT00300001|Home-based symptom monitoring|home-based symptom monitoring
787987|NCT00299988|Immunotherapy|immunotherapy
787988|NCT00299988|Amyloid beta protein|amyloid beta protein
787989|NCT00299988|Antibodies|antibodies
787990|NCT00299988|Alzheimer's|alzheimer's
787991|NCT00299988|Dementia|dementia
787992|NCT00299975|Randomized Controlled Trials|randomized controlled trials
787993|NCT00299975|Medicine, Chinese Traditional|medicine, chinese traditional
787994|NCT00299975|Medicine, Herbal|medicine, herbal
787995|NCT00299975|Constipation|constipation
787996|NCT00299962|gene therapy|gene therapy
787997|NCT00299962|immunotherapy|immunotherapy
787998|NCT00299936|hepatitis C|hepatitis c
787999|NCT00299936|chronic hepatitis C|chronic hepatitis c
788000|NCT00299936|ribavirin|ribavirin
788001|NCT00299936|WIN-R|win-r
788002|NCT00299923|drug therapy|drug therapy
788003|NCT00299923|Interferon|interferon
788004|NCT00299897|HIV|hiv
788005|NCT00299897|AIDS|aids
788006|NCT00299897|Treatment Resistance|treatment resistance
788007|NCT00299897|Treatment Failure|treatment failure
788008|NCT00299897|Mutations|mutations
788009|NCT00299897|GP120|gp120
788010|NCT00299897|Entry Inhibitors|entry inhibitors
788011|NCT00299897|HAART|haart
788012|NCT00299897|antiretroviral|antiretroviral
788013|NCT00299897|antiviral|antiviral
788014|NCT00299897|ARV|arv
788015|NCT00299897|CCR5|ccr5
788016|NCT00299897|CXCR4|cxcr4
788017|NCT00299897|receptors|receptors
788018|NCT00299897|intracellular fluid|intracellular fluid
788019|NCT00299897|lipid rafts|lipid rafts
788020|NCT00299897|cholesterol|cholesterol
788021|NCT00299897|chemokine|chemokine
788022|NCT00299897|Treatment Experienced|treatment experienced
788023|NCT00299884|Randomized|randomized
788024|NCT00299884|non-blinded|non-blinded
788025|NCT00299884|prospective|prospective
788026|NCT00299884|open-label|open-label
788027|NCT00299884|LDL-C|ldl-c
788028|NCT00299884|HDL-C|hdl-c
788029|NCT00299871|Type 2 diabetes|type 2 diabetes
788030|NCT00299858|Chronic Obstructive Pulmonary Disease|chronic obstructive pulmonary disease
788031|NCT00299858|Theophylline|theophylline
788032|NCT00299858|Exercise testing|exercise testing
788033|NCT00299845|gastroesophageal reflux|gastroesophageal reflux
788034|NCT00299845|children|children
788035|NCT00299845|lansoprazole|lansoprazole
788036|NCT00299845|cytochrome P450 2C19 (CYP2C19)|cytochrome p450 2c19 (cyp2c19)
788037|NCT00299845|pharmacogenomics|pharmacogenomics
788038|NCT00299845|genetic polymorphisms|genetic polymorphisms
788039|NCT00299845|individualized medicine|individualized medicine
788040|NCT00299845|pharmacokinetics/dynamics|pharmacokinetics/dynamics
788041|NCT00299832|Hypertension, aliskiren, blood pressure, rennin|hypertension, aliskiren, blood pressure, rennin
788042|NCT00299819|Lupus|lupus
788043|NCT00299806|Hypertension, aliskiren, blood pressure, rennin|hypertension, aliskiren, blood pressure, rennin
788044|NCT00299793|Epilepsy|epilepsy
788045|NCT00299793|Quality of life|quality of life
788046|NCT00299780|Mobilization|mobilization
788047|NCT00299780|Stem Cell|stem cell
788048|NCT00299780|Parathyroid Hormone|parathyroid hormone
788049|NCT00299754|Low dose misoprostol|low dose misoprostol
788050|NCT00299754|dinoprostone|dinoprostone
788051|NCT00299754|cervical priming|cervical priming
788052|NCT00299741|Sutent|sutent
788053|NCT00299741|Sunitinib|sunitinib
788054|NCT00299741|Bone|bone
788055|NCT00299741|Metastatic|metastatic
788056|NCT00299741|Hormone-refractory|hormone-refractory
788057|NCT00299741|Biomarkers|biomarkers
788058|NCT00299728|NY-ESO-1|ny-eso-1
788059|NCT00299728|Vaccine|vaccine
788060|NCT00299728|Adjuvant or metastatic setting|adjuvant or metastatic setting
788061|NCT00299728|Several tumor types eligible|several tumor types eligible
788062|NCT00299715|Affective psychosis|affective psychosis
788063|NCT00299715|mixed-state|mixed-state
788064|NCT00299715|bipolar disorder|bipolar disorder
788065|NCT00299715|manic disorder|manic disorder
788066|NCT00299715|manic-depressive|manic-depressive
788067|NCT00299715|psychosis|psychosis
788068|NCT00299715|mania|mania
788069|NCT00299715|manic state|manic state
788070|NCT00299715|paliperidone|paliperidone
788071|NCT00299715|paliperidone ER.|paliperidone er.
788072|NCT00299702|Schizophrenia|schizophrenia
788073|NCT00299702|Relapse|relapse
788074|NCT00299702|Remission|remission
788075|NCT00299702|Treatment Outcome|treatment outcome
788076|NCT00299702|long-acting injectable|long-acting injectable
788077|NCT00299689|Melanoma|melanoma
788078|NCT00299689|Metastatic|metastatic
788079|NCT00299689|Stage IV|stage iv
788080|NCT00299689|Ontak|ontak
788081|NCT00299676|Alzheimer's Disease|alzheimer's disease
788082|NCT00299676|Dementia|dementia
788083|NCT00299676|Post Marketing|post marketing
788084|NCT00299676|Prospective Studies|prospective studies
788085|NCT00299676|Longitudinal Studies|longitudinal studies
788086|NCT00299676|New Zealand|new zealand
788087|NCT00299676|Cholinesterase Inhibitors|cholinesterase inhibitors
788088|NCT00299676|Observational|observational
788089|NCT00299676|Outcomes|outcomes
788090|NCT00299663|group A streptococcal infection|group a streptococcal infection
788091|NCT00299663|genital tract|genital tract
788092|NCT00299663|CARRIER|carrier
788093|NCT00299663|patients with GAS isolation|patients with gas isolation
788094|NCT00299663|Streptococcus Group A|streptococcus group a
788095|NCT00299650|ARDS|ards
788096|NCT00299650|mortality|mortality
788097|NCT00299650|mechanical ventilation|mechanical ventilation
788098|NCT00299650|pneumonia|pneumonia
788099|NCT00299650|muscle relaxants|muscle relaxants
788100|NCT00299624|venous thromboembolism risk,|venous thromboembolism risk,
788101|NCT00299624|elderly,|elderly,
788102|NCT00299624|hypercoagulability|hypercoagulability
788103|NCT00299624|fibrinolysis|fibrinolysis
788104|NCT00299624|microparticles|microparticles
788105|NCT00299611|OCD|ocd
788106|NCT00299611|Anxiety|anxiety
788107|NCT00299611|Pharmacotherapy|pharmacotherapy
788108|NCT00299611|Sertraline|sertraline
788109|NCT00299611|Levetiracetam|levetiracetam
788110|NCT00299598|antibacterial|antibacterial
788111|NCT00299598|composite|composite
788112|NCT00299598|polyethylenimine|polyethylenimine
788113|NCT00299598|nanoparticle|nanoparticle
788114|NCT00299585|dental implant|dental implant
788115|NCT00299585|dental implantation|dental implantation
788116|NCT00299585|osseointegration|osseointegration
788117|NCT00299585|bone cement|bone cement
788118|NCT00299585|osteoconductivity|osteoconductivity
788119|NCT00299585|brushite|brushite
788120|NCT00299585|calcium phosphate|calcium phosphate
788121|NCT00299585|bone augmentation|bone augmentation
788122|NCT00299585|primary stability|primary stability
788123|NCT00299585|immediate implantation|immediate implantation
788124|NCT00299585|Mandibular Ridge Augmentation|mandibular ridge augmentation
788125|NCT00299585|Maxillary Ridge Augmentation|maxillary ridge augmentation
788126|NCT00299585|synthetic implants for rebuilding the alveolar ridge|synthetic implants for rebuilding the alveolar ridge
788127|NCT00299572|alendronate|alendronate
788128|NCT00299572|peritoneal dialysis|peritoneal dialysis
788129|NCT00299572|vascular calcification|vascular calcification
788130|NCT00299572|bone mineral density|bone mineral density
788131|NCT00299559|common cold|common cold
788132|NCT00299559|organic chemicals|organic chemicals
788133|NCT00299559|menthol|menthol
788134|NCT00299559|cineole|cineole
788135|NCT00299559|camphor|camphor
788136|NCT00299559|etheric oils|etheric oils
788137|NCT00299559|alternative medicine|alternative medicine
788138|NCT00299559|smart textiles|smart textiles
788139|NCT00299546|Rheumatoid Arthritis|rheumatoid arthritis
788140|NCT00299546|Anti-TNFa agents|anti-tnfa agents
788141|NCT00299546|subcutaneous injection|subcutaneous injection
788142|NCT00299520|skin infection|skin infection
788143|NCT00299520|complicated skin infection|complicated skin infection
788144|NCT00299520|skin structure infection|skin structure infection
788145|NCT00299507|exudative AMD|exudative amd
788146|NCT00299507|age-related macular degeneration (AMD)|age-related macular degeneration (amd)
788147|NCT00299494|Lymphoma|lymphoma
788148|NCT00299494|NHL|nhl
788150|NCT00299481|Endometrial neoplasm|endometrial neoplasm
788151|NCT00299481|uterine cervical neoplasm|uterine cervical neoplasm
788152|NCT00299481|ovarian neoplasm|ovarian neoplasm
788153|NCT00299481|leiomyoma|leiomyoma
788154|NCT00299481|DNA|dna
788155|NCT00299481|RNA|rna
788156|NCT00299481|Protein|protein
788157|NCT00299481|Serum|serum
788158|NCT00299468|hypertension|hypertension
788159|NCT00299468|home care|home care
788160|NCT00299468|patient activation|patient activation
788161|NCT00299468|stages-of-change|stages-of-change
788162|NCT00299442|behavior|behavior
788163|NCT00299442|conduct|conduct
788164|NCT00299442|child|child
788165|NCT00299442|parenting|parenting
788166|NCT00299442|self-help|self-help
788167|NCT00299442|media-based|media-based
788168|NCT00299429|Stent|stent
788169|NCT00299429|drug-eluting stent|drug-eluting stent
788170|NCT00299429|Minimally invasive bypass surgery|minimally invasive bypass surgery
788171|NCT00299429|left anterior descending|left anterior descending
788172|NCT00299416|Stroke|stroke
788173|NCT00299416|Nonhemorrhagic|nonhemorrhagic
788174|NCT00299416|hypothermia|hypothermia
788175|NCT00299403|Depressive disorder,|depressive disorder,
788176|NCT00299403|Antidepressant effect,|antidepressant effect,
788177|NCT00299403|rTMS,|rtms,
788178|NCT00299403|ECT,|ect,
788179|NCT00299403|cognition,|cognition,
788180|NCT00299403|Saliva cortisol|saliva cortisol
788181|NCT00299403|noninferiority trial|noninferiority trial
788182|NCT00299390|Sagopilone|sagopilone
788183|NCT00299390|Epothilone|epothilone
788184|NCT00299390|SCLC|sclc
788185|NCT00299390|Small Cell Lung Cancer|small cell lung cancer
788186|NCT00299390|Lung Cancer|lung cancer
788187|NCT00299377|STEMI|stemi
788188|NCT00299377|infarct size|infarct size
788189|NCT00299377|primary PCI|primary pci
788190|NCT00299377|no-reflow|no-reflow
788191|NCT00299377|ST-elevation myocardial infarction|st-elevation myocardial infarction
788192|NCT00299364|Climacteric symptoms|climacteric symptoms
788193|NCT00299364|Black Cohosh|black cohosh
788194|NCT00299364|Efficacy|efficacy
788195|NCT00299364|Safety|safety
788196|NCT00299338|HIV|hiv
788197|NCT00299338|AIDS|aids
788198|NCT00299338|CD4|cd4
788199|NCT00299338|HAART|haart
788200|NCT00299338|antiretroviral|antiretroviral
788201|NCT00299338|treatment failure|treatment failure
788202|NCT00299338|resistance|resistance
788203|NCT00299338|CCR4|ccr4
788204|NCT00299338|CXCR5|cxcr5
788205|NCT00299338|gp120|gp120
788206|NCT00299338|gp41|gp41
788207|NCT00299338|cholesterol|cholesterol
788208|NCT00299338|lipid rafts|lipid rafts
788209|NCT00299338|intracellular fluid|intracellular fluid
788210|NCT00299338|receptors|receptors
788211|NCT00299338|chemokine|chemokine
788212|NCT00299338|antigens|antigens
788213|NCT00299338|Treatment Experienced|treatment experienced
788214|NCT00299312|Loss of Purposeful Hand Use Syndrome|loss of purposeful hand use syndrome
788215|NCT00299312|Loss of Communication|loss of communication
788216|NCT00299312|Stereotypic Hand Movements|stereotypic hand movements
788217|NCT00299312|MECP2 mutation|mecp2 mutation
788218|NCT00299312|MECP2 duplication|mecp2 duplication
788219|NCT00299312|CDKL5 mutation|cdkl5 mutation
788220|NCT00299312|FOXG1 mutation|foxg1 mutation
788221|NCT00299286|Ki67|ki67
788222|NCT00299286|Molecular|molecular
788223|NCT00299286|antiproliferative|antiproliferative
788224|NCT00299273|Obesity;|obesity;
788225|NCT00299273|Low calorie high fat/protein diet;|low calorie high fat/protein diet;
788226|NCT00299273|Low-carbohydrate diet|low-carbohydrate diet
788228|NCT00299260|cytomegalovirus, glycoprotein B vaccine, allograft|cytomegalovirus, glycoprotein b vaccine, allograft
788229|NCT00299247|Malaria, Plasmodium falciparum, drug resistance, Colombia|malaria, plasmodium falciparum, drug resistance, colombia
788230|NCT00299234|Attention Deficit Hyperactivity Disorder|attention deficit hyperactivity disorder
788231|NCT00299221|immunosuppression|immunosuppression
788232|NCT00299221|steroid withdrawal|steroid withdrawal
788233|NCT00299221|rejection|rejection
788234|NCT00299221|coronary disease|coronary disease
788235|NCT00299221|cytomegalovirus infection|cytomegalovirus infection
788237|NCT00299195|Oral Leukoplakia|oral leukoplakia
788238|NCT00299195|Benign Neoplasms|benign neoplasms
788239|NCT00299195|Chemoprevention|chemoprevention
788240|NCT00299195|Pan-cyclooxygenase (COX) inhibitor|pan-cyclooxygenase (cox) inhibitor
788241|NCT00299195|sulindac|sulindac
788242|NCT00299195|04-099|04-099
788243|NCT00299182|Non-Hodgkin's Lymphoma|non-hodgkin's lymphoma
788244|NCT00299182|Lymphoma|lymphoma
788245|NCT00299182|Mantle Cell Lymphoma|mantle cell lymphoma
788246|NCT00299182|AMG 531|amg 531
788247|NCT00299182|Romiplostim|romiplostim
788248|NCT00299182|Placebo|placebo
788249|NCT00299182|R-HyperCVAD|r-hypercvad
788250|NCT00299182|R-Ara-C/MTX|r-ara-c/mtx
788251|NCT00299182|Cyclophosphamide|cyclophosphamide
788252|NCT00299182|Cytarabine|cytarabine
788253|NCT00299182|Dexamethasone|dexamethasone
788254|NCT00299182|Doxorubicin|doxorubicin
788255|NCT00299182|Methotrexate|methotrexate
788256|NCT00299182|Rituximab|rituximab
788261|NCT00299182|Hydroxydaunomycin hydrocholoride|hydroxydaunomycin hydrocholoride
788262|NCT00299182|Ara-C|ara-c
788263|NCT00299182|Cytosar|cytosar
788264|NCT00299182|DepoCyt|depocyt
788265|NCT00299182|Cytosine arabinosine hydrochloride|cytosine arabinosine hydrochloride
788266|NCT00299169|N of 1 trial|n of 1 trial
788267|NCT00299169|diabetes mellitus|diabetes mellitus
788268|NCT00299169|HMG CoA Reductase Inhibitors|hmg coa reductase inhibitors
788269|NCT00299169|cardiovascular disease|cardiovascular disease
788270|NCT00299156|Myelodysplastic Syndrome|myelodysplastic syndrome
788271|NCT00299156|MDS|mds
788272|NCT00299156|Chronic Myelomonocytic Leukemia|chronic myelomonocytic leukemia
788273|NCT00299156|CMML|cmml
788274|NCT00299156|Clofarabine|clofarabine
788275|NCT00299156|Clofarex|clofarex
788276|NCT00299156|Clolar|clolar
788277|NCT00299156|Chemotherapy|chemotherapy
788278|NCT00299143|SIPA|sipa
788279|NCT00299143|acute coronary syndrome|acute coronary syndrome
788280|NCT00299130|RA|ra
788281|NCT00299130|Rituxan|rituxan
788282|NCT00299130|SERENE|serene
788283|NCT00299117|Smoking cessation|smoking cessation
788284|NCT00299117|Stress|stress
788285|NCT00299117|Nicotine dependence|nicotine dependence
788286|NCT00299117|Complication, postoperative|complication, postoperative
788287|NCT00299104|Rituxan|rituxan
788288|NCT00299104|MTX|mtx
788289|NCT00299104|RA|ra
788290|NCT00299104|IMAGE|image
788291|NCT00299104|WA17047|wa17047
788292|NCT00299091|Therapeutic drug monitoring|therapeutic drug monitoring
788293|NCT00299091|Treatment Naive|treatment naive
788294|NCT00299091|Treatment Experienced|treatment experienced
788295|NCT00299091|HIV|hiv
788296|NCT00299065|Asthma, bronchial|asthma, bronchial
788297|NCT00299065|Asthma, exercise-induced|asthma, exercise-induced
788298|NCT00299065|Anti-asthmatic agents|anti-asthmatic agents
788299|NCT00299052|Tibia|tibia
788300|NCT00299052|Fracture|fracture
788301|NCT00299052|DBM|dbm
788302|NCT00299039|Randomized controlled trial|randomized controlled trial
788303|NCT00299039|Clinical trial|clinical trial
788304|NCT00299039|Breast tumor surgery|breast tumor surgery
788305|NCT00299039|Outpatient surgery|outpatient surgery
788306|NCT00299039|Analgesia|analgesia
788307|NCT00299039|Outpatient analgesia|outpatient analgesia
788308|NCT00299039|Post surgical analgesia|post surgical analgesia
788309|NCT00299039|≥ 18 and ≤ 70 years of age|≥ 18 and ≤ 70 years of age
788310|NCT00299039|Elective outpatient breast surgery for:|elective outpatient breast surgery for:
788311|NCT00299039|lumpectomy/quadrantectomy +/- Sentinel Lymph Node Biopsy|lumpectomy/quadrantectomy +/- sentinel lymph node biopsy
788312|NCT00299039|lumpectomy/quadrantectomy with Axillary Node Dissection|lumpectomy/quadrantectomy with axillary node dissection
788313|NCT00299039|simple mastectomy +/- Sentinel Lymph Node Biopsy|simple mastectomy +/- sentinel lymph node biopsy
788314|NCT00299039|Modified Radical mastectomy|modified radical mastectomy
788315|NCT00299026|Coronary Artery Disease|coronary artery disease
788316|NCT00299026|Percutaneous Coronary Intervention|percutaneous coronary intervention
788317|NCT00299026|Stent Implant|stent implant
788318|NCT00299026|Drug-coated Stent|drug-coated stent
788319|NCT00299013|Ulcerative colitis|ulcerative colitis
788320|NCT00298987|Chronic Myeloid Leukemia Accelerated and Blast Phase|chronic myeloid leukemia accelerated and blast phase
788321|NCT00298987|Leukemia, Acute, Philadelphia-Positive|leukemia, acute, philadelphia-positive
788322|NCT00298974|Osteoarthritis of the hip or knee|osteoarthritis of the hip or knee
788323|NCT00298935|Randomized Controlled Trial|randomized controlled trial
788324|NCT00298935|Pregnant Women|pregnant women
788325|NCT00298922|Cystic Fibrosis|cystic fibrosis
788326|NCT00298922|Burkholderia cepacia complex|burkholderia cepacia complex
788327|NCT00298896|Lung|lung
788328|NCT00298896|Squamous Cell|squamous cell
788329|NCT00298896|Small Cell|small cell
788330|NCT00298896|Carcinoma|carcinoma
788331|NCT00298896|Cancer|cancer
788332|NCT00298896|Small Cell Lung Cancer|small cell lung cancer
788333|NCT00298883|Renal|renal
788334|NCT00298883|Transplant|transplant
788335|NCT00298883|PRA|pra
788336|NCT00298870|pulmonary tuberculosis|pulmonary tuberculosis
788337|NCT00298870|isoniazid|isoniazid
788338|NCT00298870|arylamine N-acetyltransferase 2|arylamine n-acetyltransferase 2
788339|NCT00298870|pharmacogenomics|pharmacogenomics
788340|NCT00298870|genetic polymorphisms|genetic polymorphisms
788341|NCT00298870|individualized medicine|individualized medicine
788342|NCT00298870|drug-induced hepatotoxity|drug-induced hepatotoxity
788343|NCT00298857|Healthy|healthy
788344|NCT00298857|Obesity|obesity
788345|NCT00298857|Pharmacokinetics|pharmacokinetics
788346|NCT00298844|Type 2 diabetes mellitus|type 2 diabetes mellitus
788347|NCT00298844|Macrovascular disease|macrovascular disease
788348|NCT00298844|Diastolic dysfunction|diastolic dysfunction
788349|NCT00298844|Intima media thickness|intima media thickness
788350|NCT00298844|Single- photon emission computed tomography (SPECT)|single- photon emission computed tomography (spect)
788351|NCT00298818|Epilepsy|epilepsy
788352|NCT00298818|Mental Retardation|mental retardation
788353|NCT00298818|Developmental Disabilities|developmental disabilities
788354|NCT00298805|Migraine|migraine
788355|NCT00298805|Headache|headache
788356|NCT00298805|Depression|depression
788357|NCT00298805|Quality of Life|quality of life
788358|NCT00298792|Cognitive Behavioral Treatment|cognitive behavioral treatment
788359|NCT00298792|Alcohol Dependence|alcohol dependence
788360|NCT00298792|Functional Analysis|functional analysis
788361|NCT00298792|Experience Sampling|experience sampling
788362|NCT00298792|Interactive Voice Response|interactive voice response
788363|NCT00298779|patients with advanced solid tumors or Non-Hodgkins's Lymphoma|patients with advanced solid tumors or non-hodgkins's lymphoma
788364|NCT00298727|Knowledge transfer|knowledge transfer
788365|NCT00298727|Clinical decision-making|clinical decision-making
788366|NCT00298727|Outcome measures|outcome measures
788367|NCT00298714|Hepatitis C, Chronic|hepatitis c, chronic
788368|NCT00298701|Allergy|allergy
788369|NCT00298662|Multiple Sclerosis|multiple sclerosis
788370|NCT00298662|Betaseron-Prograf|betaseron-prograf
788371|NCT00298662|patients of Multiple Sclerosis|patients of multiple sclerosis
788372|NCT00298662|Secondary Progressive type|secondary progressive type
788373|NCT00298662|Relapsing-Remitting type|relapsing-remitting type
788374|NCT00298649|pesticide safety|pesticide safety
788375|NCT00298649|migrant and seasonal farmworkers|migrant and seasonal farmworkers
788376|NCT00298649|Latino/Hispanic|latino/hispanic
788377|NCT00298649|agricultural health|agricultural health
788378|NCT00298649|occupational health|occupational health
788379|NCT00298610|Uncomplicated Malaria|uncomplicated malaria
788380|NCT00298610|GMP artesunate|gmp artesunate
788381|NCT00298584|Diagnostic techniques, urological|diagnostic techniques, urological
788382|NCT00298584|urinary catheterization|urinary catheterization
788383|NCT00298584|Aspiration|aspiration
788384|NCT00298584|Neonates|neonates
788385|NCT00298584|Neonatal Intensive Care Unit|neonatal intensive care unit
788386|NCT00298584|Infant, Newborn|infant, newborn
788387|NCT00298584|Infant, Premature|infant, premature
788388|NCT00298584|Infant, Low-birth weight|infant, low-birth weight
788389|NCT00298571|Cesarean Delivery|cesarean delivery
788390|NCT00298571|Post-operative|post-operative
788391|NCT00298571|Pain|pain
788392|NCT00298571|Local Anesthetic|local anesthetic
788393|NCT00298558|cognition disorder|cognition disorder
788394|NCT00298558|cognitive behavior therapy|cognitive behavior therapy
788395|NCT00298558|functional ability|functional ability
788396|NCT00298532|Pediatrics|pediatrics
788397|NCT00298532|Seizure|seizure
788398|NCT00298532|Trauma|trauma
788399|NCT00298532|Respiratory|respiratory
788400|NCT00298532|Cardiac|cardiac
788401|NCT00298532|Arrest|arrest
788402|NCT00298506|Tacrolimus|tacrolimus
788403|NCT00298506|Mycophenolate mofetil|mycophenolate mofetil
788404|NCT00298506|Cyclophosphamide|cyclophosphamide
788405|NCT00298506|Lupus nephritis|lupus nephritis
788406|NCT00298506|Treatment|treatment
788407|NCT00298493|ICU|icu
788408|NCT00298493|Sedation strategies|sedation strategies
788409|NCT00298493|Daily sedative interruption|daily sedative interruption
788410|NCT00298493|Sedation protocols|sedation protocols
788411|NCT00298480|preterm labor|preterm labor
788412|NCT00298480|transvaginal ultrasound|transvaginal ultrasound
788413|NCT00298480|dynamic cervical change|dynamic cervical change
788414|NCT00298467|ALCL|alcl
788415|NCT00298467|csALCL|csalcl
788416|NCT00298467|pcALCL|pcalcl
788417|NCT00298467|Lymphoma|lymphoma
788418|NCT00298467|Non-Hodgkin's Lymphoma|non-hodgkin's lymphoma
788419|NCT00298467|Anaplastic Large Cell Lymphoma|anaplastic large cell lymphoma
788420|NCT00298467|classic systemci Anaplastic Large Cell Lymphoma (csALCL)|classic systemci anaplastic large cell lymphoma (csalcl)
788421|NCT00298467|primary cutaneous Anaplastic Large Cell Lymphoma (pcALCL)|primary cutaneous anaplastic large cell lymphoma (pcalcl)
788422|NCT00298454|renal failure|renal failure
788423|NCT00298454|oliguric|oliguric
788424|NCT00298454|critically ill|critically ill
788425|NCT00298454|furosemide|furosemide
788426|NCT00298441|intravenous iron administration|intravenous iron administration
788427|NCT00298428|stent|stent
788428|NCT00298428|percutaneous coronary intervention|percutaneous coronary intervention
788429|NCT00298428|platelet aggregation|platelet aggregation
788430|NCT00298428|clopidogrel|clopidogrel
788431|NCT00298428|shear|shear
788432|NCT00298428|metabolic syndrome|metabolic syndrome
788433|NCT00298415|2-years survival|2-years survival
788434|NCT00298402|macrophage|macrophage
788435|NCT00298402|MMP|mmp
788436|NCT00298402|CT scan|ct scan
788437|NCT00298389|macrophage|macrophage
788438|NCT00298389|phagocytosis|phagocytosis
788439|NCT00298389|exacerbation|exacerbation
788440|NCT00298376|Cow’s milk allergy,|cow’s milk allergy,
788441|NCT00298376|food allergy|food allergy
788442|NCT00298376|oral tolerance,|oral tolerance,
788443|NCT00298376|infant,|infant,
788444|NCT00298376|regulatory T cells,|regulatory t cells,
788445|NCT00298376|intestinal microflora|intestinal microflora
788446|NCT00298363|Hepatitis; Hepatitis B virus; Tenofovir|hepatitis; hepatitis b virus; tenofovir
788447|NCT00298350|Phase 2|phase 2
788448|NCT00298350|Phase II|phase ii
788449|NCT00298350|Randomized|randomized
788450|NCT00298350|Controlled|controlled
788451|NCT00298350|Comparator|comparator
788452|NCT00298350|Partially Blind|partially blind
788453|NCT00298350|Protease Inhibitors|protease inhibitors
788454|NCT00298350|Integrase Inhibitors|integrase inhibitors
788455|NCT00298350|Antiviral Agents|antiviral agents
788456|NCT00298350|Antiretroviral Agents|antiretroviral agents
788457|NCT00298350|ART|art
788458|NCT00298350|ARV|arv
788459|NCT00298350|Highly Activity Antiretroviral Therapy|highly activity antiretroviral therapy
788460|NCT00298350|HAART|haart
788461|NCT00298350|Treatment Experienced|treatment experienced
788462|NCT00298324|GvHD|gvhd
788463|NCT00298324|graft versus host disease|graft versus host disease
788464|NCT00298324|extensive|extensive
788465|NCT00298324|myfortic|myfortic
788466|NCT00298298|lung cancer|lung cancer
788467|NCT00298298|non-small cell lung cancere|non-small cell lung cancere
788468|NCT00298298|vaccine|vaccine
788469|NCT00298298|immunotherapy|immunotherapy
788470|NCT00298285|mechanical valve replacement|mechanical valve replacement
788471|NCT00298285|warfarin|warfarin
788472|NCT00298246|Neurodevelopmental Disorders|neurodevelopmental disorders
788473|NCT00298246|Neurological Disorder|neurological disorder
788474|NCT00298246|Children- Onset|children- onset
788475|NCT00298246|Children|children
788476|NCT00298246|Pervasive Developmental Disorder|pervasive developmental disorder
788477|NCT00298246|PDD|pdd
788478|NCT00298246|Autism|autism
788479|NCT00298246|Healthy Volunteer|healthy volunteer
788480|NCT00298246|HV|hv
788481|NCT00298233|Antibody Response|antibody response
788482|NCT00298233|Antiviral Efficacy|antiviral efficacy
788483|NCT00298233|Bird Flu|bird flu
788484|NCT00298233|Severe Respiratory Distress|severe respiratory distress
788485|NCT00298233|Viral Replication and Shedding|viral replication and shedding
788486|NCT00298220|Family Practice|family practice
788487|NCT00298220|Intervention Studies|intervention studies
788488|NCT00298220|Prevention and Control|prevention and control
788489|NCT00298207|high blood pressure|high blood pressure
788490|NCT00298207|hypertension|hypertension
788491|NCT00298207|adult|adult
788492|NCT00298207|African Americans|african americans
788493|NCT00298207|Walking|walking
788494|NCT00298168|Delayed Graft Function|delayed graft function
788495|NCT00298142|Cervicogenic Headache|cervicogenic headache
788496|NCT00298142|Migraine|migraine
788497|NCT00298142|Tension Type Headache|tension type headache
788498|NCT00298103|Antibiotic resistant|antibiotic resistant
788499|NCT00298103|Infection|infection
788500|NCT00298090|Oxygenation|oxygenation
788501|NCT00298077|Infection|infection
788502|NCT00298077|transplant recipients|transplant recipients
788503|NCT00298064|Cervical cancer|cervical cancer
788504|NCT00298064|EGFR|egfr
788505|NCT00298064|cervical|cervical
788506|NCT00298064|genomic|genomic
788507|NCT00298064|DNA|dna
788508|NCT00298064|markers|markers
788509|NCT00298064|prognostic|prognostic
788510|NCT00298064|gene|gene
788511|NCT00298064|epidermal growth factor|epidermal growth factor
788512|NCT00298051|Iron-deficiency anemia|iron-deficiency anemia
788513|NCT00298051|Umbilical cord clamping|umbilical cord clamping
788514|NCT00298051|Infant|infant
788515|NCT00298025|Infertility|infertility
788516|NCT00298025|Cetrotide|cetrotide
788517|NCT00298025|Antagon|antagon
788518|NCT00298025|Recombinant human follicle stimulating hormone (r-hFSH)|recombinant human follicle stimulating hormone (r-hfsh)
788519|NCT00298025|Human Menopausal Gonadotropin (hMG)|human menopausal gonadotropin (hmg)
788520|NCT00298025|Recombinant Human Choriogonadotropin (r-hCG)|recombinant human choriogonadotropin (r-hcg)
788521|NCT00298012|Methotrexate|methotrexate
788622|NCT00297531|Periowave|periowave
788522|NCT00298012|Magnetic Resonance Imaging|magnetic resonance imaging
788523|NCT00298012|Anterior uveitis|anterior uveitis
788524|NCT00297947|schizophrenia|schizophrenia
788525|NCT00297947|quetiapine|quetiapine
788526|NCT00297947|schizoaffective disorder|schizoaffective disorder
788527|NCT00297934|dual-task|dual-task
788528|NCT00297934|postural control|postural control
788529|NCT00297934|cognitive|cognitive
788530|NCT00297908|Ethanol levels|ethanol levels
788531|NCT00297908|Dermal absorbtion|dermal absorbtion
788532|NCT00297895|sentinel lymph node dissection|sentinel lymph node dissection
788533|NCT00297895|complete lymph node dissection|complete lymph node dissection
788534|NCT00297895|surgical|surgical
788535|NCT00297882|Efficacy|efficacy
788536|NCT00297882|Safety|safety
788537|NCT00297882|Children|children
788538|NCT00297882|Cameroon|cameroon
788539|NCT00297856|Boostrix|boostrix
788540|NCT00297830|Heart Transplantation|heart transplantation
788541|NCT00297830|Liver Transplantation|liver transplantation
788542|NCT00297830|Immunosuppression|immunosuppression
788543|NCT00297830|Bone Density/drug effects|bone density/drug effects
788544|NCT00297830|Alendronate|alendronate
788545|NCT00297830|Zoledronic acid|zoledronic acid
788546|NCT00297830|Comparative study|comparative study
788547|NCT00297830|Humans|humans
788548|NCT00297817|Meningococcal Disease; Meningococcal Meningitis; Vaccine|meningococcal disease; meningococcal meningitis; vaccine
788549|NCT00297804|Coronary Artery Disease|coronary artery disease
788550|NCT00297804|Percutaneous Coronary Intervention|percutaneous coronary intervention
788551|NCT00297804|Stent Implant|stent implant
788552|NCT00297804|Drug-coated Stent|drug-coated stent
788553|NCT00297791|rectal cancer|rectal cancer
788554|NCT00297791|laparoscopic technique|laparoscopic technique
788555|NCT00297791|open technique|open technique
788556|NCT00297791|clinical trial|clinical trial
788557|NCT00297791|multicenter study|multicenter study
788558|NCT00297791|randomized controlled trial|randomized controlled trial
788559|NCT00297791|Tumor Below 15cm|tumor below 15cm
788560|NCT00297791|curative surgical resection|curative surgical resection
788561|NCT00297791|no evidence for distant metastases|no evidence for distant metastases
788562|NCT00297765|Renal Transplantation|renal transplantation
788563|NCT00297765|Therapeutics|therapeutics
788564|NCT00297765|Treatment Outcome|treatment outcome
788565|NCT00297765|Safety|safety
788566|NCT00297752|facial burns|facial burns
788567|NCT00297752|cerium flammazine|cerium flammazine
788568|NCT00297752|quality of life|quality of life
788569|NCT00297752|randomised clinical trial|randomised clinical trial
788570|NCT00297739|Aggression|aggression
788571|NCT00297739|ADHD|adhd
788572|NCT00297739|Antipsychotic|antipsychotic
788573|NCT00297726|Osteoarthritis, Knee|osteoarthritis, knee
788574|NCT00297726|Osteoarthritis, Hip|osteoarthritis, hip
788575|NCT00297726|Osteoarthritis, Ankle|osteoarthritis, ankle
788576|NCT00297726|Arthritis|arthritis
788577|NCT00297726|Self-Management|self-management
788578|NCT00297700|Smoking|smoking
788579|NCT00297700|Dental|dental
788580|NCT00297700|Cessation|cessation
788581|NCT00297700|Prevention|prevention
788582|NCT00297700|Control|control
788583|NCT00297700|Quitline|quitline
788584|NCT00297700|5A-Model|5a-model
788585|NCT00297700|Cost-effective|cost-effective
788586|NCT00297687|Vaccines|vaccines
788587|NCT00297687|Healthy Adults|healthy adults
788588|NCT00297687|Health|health
788589|NCT00297687|Adult|adult
788590|NCT00297687|Meningococcal Vaccines|meningococcal vaccines
788591|NCT00297674|clarithromycin|clarithromycin
788592|NCT00297674|sepsis|sepsis
788593|NCT00297674|immunomodulation|immunomodulation
788594|NCT00297661|Coronary Revascularization|coronary revascularization
788595|NCT00297661|Sirolimus-eluting stents|sirolimus-eluting stents
788596|NCT00297661|Paclitaxel-eluting stents|paclitaxel-eluting stents
788597|NCT00297648|Certolizumab pegol|certolizumab pegol
788598|NCT00297648|Crohn's disease|crohn's disease
788599|NCT00297648|Mucosal healing|mucosal healing
788600|NCT00297635|Hyperglycemia|hyperglycemia
788601|NCT00297635|Insulin Infusion Systems|insulin infusion systems
788602|NCT00297635|Blood Glucose Self-Monitoring|blood glucose self-monitoring
788603|NCT00297609|Resuscitation medication errors|resuscitation medication errors
788604|NCT00297609|critical care|critical care
788605|NCT00297609|pediatrics|pediatrics
788606|NCT00297609|clinical decision support systems|clinical decision support systems
788607|NCT00297609|computerized physician order entry|computerized physician order entry
788608|NCT00297596|Metastatic|metastatic
788609|NCT00297596|HER2/neu+|her2/neu+
788610|NCT00297570|CML|cml
788611|NCT00297570|Imatinib|imatinib
788612|NCT00297570|Pegylated Interferon|pegylated interferon
788613|NCT00297570|Philadelphia Positive CML|philadelphia positive cml
788614|NCT00297544|impotence|impotence
788615|NCT00297544|endothelial function|endothelial function
788616|NCT00297544|autonomic nervous system|autonomic nervous system
788617|NCT00297531|Chronic Periodontitis|chronic periodontitis
788618|NCT00297531|Periodontitis|periodontitis
788619|NCT00297531|Photodynamic disinfection|photodynamic disinfection
788620|NCT00297531|PDD|pdd
788621|NCT00297531|PDT|pdt
788623|NCT00297531|Scaling and Root Planing|scaling and root planing
788624|NCT00297531|SRP|srp
788625|NCT00297518|Adult Periodontitis|adult periodontitis
788626|NCT00297518|Chronic Periodontitis|chronic periodontitis
788627|NCT00297518|PDD|pdd
788628|NCT00297518|PDT|pdt
788629|NCT00297518|Photodynamic Disinfection|photodynamic disinfection
788630|NCT00297518|SRP|srp
788631|NCT00297518|Scaling and Root Planing|scaling and root planing
788632|NCT00297505|Cocaine; citalopram; impulsivity; serotonin|cocaine; citalopram; impulsivity; serotonin
788633|NCT00297492|Smoking Cessation|smoking cessation
788634|NCT00297492|Tobacco|tobacco
788635|NCT00297479|Tobacco Cessation|tobacco cessation
788636|NCT00297479|Smoking Cessation|smoking cessation
788637|NCT00297466|tobacco use|tobacco use
788638|NCT00297466|smoking cessation|smoking cessation
788639|NCT00297466|emergency department|emergency department
788640|NCT00297440|Smoking|smoking
788641|NCT00297440|Exercise|exercise
788642|NCT00297440|Adolescent|adolescent
788643|NCT00297440|Girls|girls
788644|NCT00297427|urinary incontinence|urinary incontinence
788645|NCT00297414|Mild Cognitive Impairment|mild cognitive impairment
788646|NCT00297414|Dementia|dementia
788647|NCT00297414|Galantamine|galantamine
788648|NCT00297414|Memory disorders|memory disorders
788649|NCT00297414|Isolated memory impairment|isolated memory impairment
788650|NCT00297414|Alzheimer's disease|alzheimer's disease
788651|NCT00297388|schizophrenia|schizophrenia
788652|NCT00297388|schizoaffective disorder|schizoaffective disorder
788653|NCT00297388|long-acting risperidone|long-acting risperidone
788654|NCT00297388|intramuscular injection risperidone|intramuscular injection risperidone
788655|NCT00297388|risperidone|risperidone
788661|NCT00297362|Alzheimer Disease|alzheimer disease
788662|NCT00297362|Dementia|dementia
788663|NCT00297362|Brain Disease|brain disease
788664|NCT00297362|Memory Loss|memory loss
788665|NCT00297362|Caregiver|caregiver
788666|NCT00297362|Galantamine hydrobromide|galantamine hydrobromide
788667|NCT00297362|Nervous System Diseases|nervous system diseases
788668|NCT00297362|Mental Disorders|mental disorders
788669|NCT00297349|Seizures|seizures
788670|NCT00297349|Epilepsy|epilepsy
788671|NCT00297349|Tonic-clonic|tonic-clonic
788672|NCT00297349|Lennox-Gastaut Syndrome|lennox-gastaut syndrome
788673|NCT00297349|Focal Epilepsy|focal epilepsy
788674|NCT00297349|Topiramate|topiramate
788675|NCT00297349|Epilepsy in Children|epilepsy in children
788676|NCT00297336|Topiramate|topiramate
788677|NCT00297336|Migraine|migraine
788678|NCT00297336|Headache|headache
788679|NCT00297336|Chronic headache|chronic headache
788680|NCT00297336|Chronic migraine|chronic migraine
788681|NCT00297323|Seizures|seizures
788682|NCT00297323|Epilepsy|epilepsy
788683|NCT00297323|Topiramate|topiramate
788684|NCT00297323|Epilepsy in Children|epilepsy in children
788685|NCT00297310|Tacrolimus|tacrolimus
788686|NCT00297310|Kidney transplantation|kidney transplantation
788687|NCT00297310|Transplantation|transplantation
788688|NCT00297310|Kidney failure|kidney failure
788689|NCT00297310|chronic|chronic
788690|NCT00297310|P-Glycoprotein|p-glycoprotein
788691|NCT00297297|Solitary solid and scintigraphically cold thyroid nodules|solitary solid and scintigraphically cold thyroid nodules
788692|NCT00297284|systemic lupus erythematosus|systemic lupus erythematosus
788693|NCT00297284|cognitive efficiency|cognitive efficiency
788694|NCT00297284|cognitive dysfunction|cognitive dysfunction
788695|NCT00297284|cognition|cognition
788696|NCT00297284|memory|memory
788697|NCT00297284|attention|attention
788698|NCT00297284|modafinil|modafinil
788699|NCT00297284|provigil|provigil
788700|NCT00297271|Dementia|dementia
788701|NCT00297271|Mild Cognitive Impairment|mild cognitive impairment
788702|NCT00297271|Patient Registries|patient registries
788703|NCT00297271|Prospective Studies|prospective studies
788704|NCT00297271|Longitudinal Studies|longitudinal studies
788705|NCT00297271|Australia|australia
788706|NCT00297271|Cholinesterase Inhibitors|cholinesterase inhibitors
788707|NCT00297271|Observational|observational
788708|NCT00297271|Non-randomized|non-randomized
788709|NCT00297258|Sarcoma|sarcoma
788710|NCT00297258|Synovial sarcoma|synovial sarcoma
788711|NCT00297258|Pazopanib(GW786034)|pazopanib(gw786034)
788712|NCT00297258|Adipocytic tumors|adipocytic tumors
788713|NCT00297258|Leiomyosarcoma|leiomyosarcoma
788714|NCT00297258|Phase II|phase ii
788715|NCT00297245|gastrodin|gastrodin
788716|NCT00297232|Multiple Sclerosis|multiple sclerosis
788717|NCT00297232|MS|ms
788718|NCT00297219|Hemodialysis|hemodialysis
788719|NCT00297219|Coronary artery calcification|coronary artery calcification
788720|NCT00297219|Adynamic bone disease|adynamic bone disease
788721|NCT00297219|Dialysate calcium|dialysate calcium
788722|NCT00297219|Bone mineral density|bone mineral density
788723|NCT00297219|Bone histomorphometry|bone histomorphometry
788833|NCT00296881|Scaling and Root Planing|scaling and root planing
788724|NCT00297206|pharmacokinetics herpes varicella herpes labialis Epstein-Barr virus|pharmacokinetics herpes varicella herpes labialis epstein-barr virus
788725|NCT00297193|Crohn's Disease|crohn's disease
788726|NCT00297193|HSCT|hsct
788727|NCT00297193|Autologous|autologous
788728|NCT00297193|EBMT|ebmt
788729|NCT00297193|ECCO|ecco
788730|NCT00297180|hunger|hunger
788731|NCT00297180|obesity|obesity
788732|NCT00297180|sodium-dependent glucose transporter|sodium-dependent glucose transporter
788733|NCT00297180|GW869682|gw869682
788734|NCT00297180|body composition|body composition
788735|NCT00297180|SGLT2 inhibitor|sglt2 inhibitor
788736|NCT00297180|weight loss|weight loss
788737|NCT00297167|CF|cf
788738|NCT00297167|Cystic Fibrosis|cystic fibrosis
788739|NCT00297167|EPI|epi
788740|NCT00297167|Exocrine Pancreatic Insufficiency|exocrine pancreatic insufficiency
788741|NCT00297167|Pancreatic|pancreatic
788742|NCT00297167|Enzyme|enzyme
788743|NCT00297167|PEP|pep
788744|NCT00297154|Heart failure, congestive|heart failure, congestive
788745|NCT00297154|Metabolic Syndrome X|metabolic syndrome x
788746|NCT00297154|Obesity|obesity
788747|NCT00297141|Preoperative|preoperative
788748|NCT00297141|Radiochemotherapy|radiochemotherapy
788749|NCT00297141|Newly Diagnosed|newly diagnosed
788750|NCT00297141|Primary Operable|primary operable
788751|NCT00297141|Locally Advanced|locally advanced
788752|NCT00297141|Rectal Carcinoma|rectal carcinoma
788753|NCT00297141|T3|t3
788754|NCT00297141|Lower Rectum|lower rectum
788755|NCT00297141|Middle Rectum|middle rectum
788756|NCT00297141|ABCSG|abcsg
788757|NCT00297141|TAKO|tako
788758|NCT00297141|95|95
788759|NCT00297141|05|05
788760|NCT00297128|pilot study|pilot study
788761|NCT00297128|rectal|rectal
788762|NCT00297128|cancer|cancer
788763|NCT00297128|phase II|phase ii
788764|NCT00297128|preoperative|preoperative
788765|NCT00297128|chemoradiation|chemoradiation
788766|NCT00297128|capecitabine|capecitabine
788767|NCT00297128|cetuximab|cetuximab
788768|NCT00297128|operable|operable
788769|NCT00297128|T4|t4
788770|NCT00297128|ABCSG|abcsg
788771|NCT00297128|TAKO|tako
788772|NCT00297128|R03|r03
788773|NCT00297128|96|96
788774|NCT00297128|06|06
788775|NCT00297115|Roflumilast|roflumilast
788776|NCT00297115|COPD|copd
788777|NCT00297115|Chronic obstructive pulmonary disease|chronic obstructive pulmonary disease
788778|NCT00297102|Roflumilast|roflumilast
788779|NCT00297102|COPD|copd
788780|NCT00297102|Chronic obstructive pulmonary disease|chronic obstructive pulmonary disease
788781|NCT00297089|Lung Cancer|lung cancer
788782|NCT00297089|ABT-751|abt-751
788783|NCT00297089|NSCLC|nsclc
788784|NCT00297089|Alimta|alimta
788785|NCT00297089|Non-Small-Cell Lung Cancer|non-small-cell lung cancer
788786|NCT00297089|pemetrexed|pemetrexed
788787|NCT00297076|HIV-1|hiv-1
788788|NCT00297076|GW873140|gw873140
788789|NCT00297076|CCR5 antagonist|ccr5 antagonist
788790|NCT00297076|experienced|experienced
788791|NCT00297076|Treatment Experienced|treatment experienced
788792|NCT00297063|rosiglitazone|rosiglitazone
788793|NCT00297063|vandia|vandia
788794|NCT00297063|Type 2 diabetes mellitus|type 2 diabetes mellitus
788795|NCT00297063|diabetes;|diabetes;
788796|NCT00297050|Influenza Virus|influenza virus
788797|NCT00297050|Avian Influenza|avian influenza
788798|NCT00297050|Normal Volunteers|normal volunteers
788799|NCT00297050|Neuraminidase Inhibitor|neuraminidase inhibitor
788800|NCT00297050|Viral Disease|viral disease
788801|NCT00297050|Healthy Volunteer|healthy volunteer
788802|NCT00297050|HV|hv
788803|NCT00297037|oral lichen planus, pimecrolimus 1% cream|oral lichen planus, pimecrolimus 1% cream
788804|NCT00296985|Cardiac surgery|cardiac surgery
788805|NCT00296985|Cellsaver|cellsaver
788806|NCT00296985|Neurocognitive Function|neurocognitive function
788807|NCT00296985|Neuronal Protection|neuronal protection
788808|NCT00296985|Quality of Life|quality of life
788809|NCT00296972|peg interferon|peg interferon
788810|NCT00296972|ribavirin|ribavirin
788811|NCT00296972|HAART|haart
788812|NCT00296972|HIV|hiv
788813|NCT00296972|Chronic Hepatitis C|chronic hepatitis c
788814|NCT00296972|Treatment Experienced|treatment experienced
788815|NCT00296959|Dyskinesia|dyskinesia
788816|NCT00296959|AMPA receptor antagonists|ampa receptor antagonists
788817|NCT00296946|Sialorrhoea|sialorrhoea
788818|NCT00296933|Major Depression|major depression
788819|NCT00296933|Antidepressant|antidepressant
788820|NCT00296933|Pharmacotherapy|pharmacotherapy
788821|NCT00296933|Memory functioning|memory functioning
788822|NCT00296933|Memory Impairment|memory impairment
788823|NCT00296920|Deep Brain Stimulation|deep brain stimulation
788824|NCT00296920|Treatment failure|treatment failure
788825|NCT00296907|cancer|cancer
788826|NCT00296907|siblings|siblings
788827|NCT00296907|behavior|behavior
788828|NCT00296907|psychological adaptation|psychological adaptation
788829|NCT00296907|intervention|intervention
788830|NCT00296881|Periodontitis|periodontitis
788831|NCT00296881|Photodynamic Disinfection|photodynamic disinfection
788832|NCT00296881|PERIOWAVE|periowave
788834|NCT00296881|SRP|srp
788835|NCT00296868|reflex sympathetic dystrophy|reflex sympathetic dystrophy
788836|NCT00296868|ascorbic acid|ascorbic acid
788837|NCT00296868|primary prevention|primary prevention
788838|NCT00296868|radius fractures|radius fractures
788839|NCT00296855|Peripheral artery disease|peripheral artery disease
788840|NCT00296842|posttraumatic stress disorder|posttraumatic stress disorder
788841|NCT00296842|children|children
788842|NCT00296842|injury|injury
788843|NCT00296842|road traffic accident|road traffic accident
788844|NCT00296829|Influenza;|influenza;
788845|NCT00296829|Orthomyxoviruses;|orthomyxoviruses;
788846|NCT00296829|Inactivated Split-virion influenza vaccine;|inactivated split-virion influenza vaccine;
788847|NCT00296829|Elderly.|elderly.
788848|NCT00296803|metabolic syndrome|metabolic syndrome
788849|NCT00296777|Major Depression|major depression
788850|NCT00296777|Dysthymia|dysthymia
788851|NCT00296777|f-MRI|f-mri
788852|NCT00296777|Escitalopram|escitalopram
788853|NCT00296777|Bupropion|bupropion
788854|NCT00296777|Imipramine|imipramine
788855|NCT00296777|Neuropsychologic test|neuropsychologic test
788856|NCT00296777|Dichotic listening|dichotic listening
788857|NCT00296777|EEG|eeg
788858|NCT00296777|ERP|erp
788859|NCT00296764|Happy Puppet Syndrome|happy puppet syndrome
788860|NCT00296764|Developmental Disorders|developmental disorders
788861|NCT00296725|Major Depression|major depression
788862|NCT00296725|Dysthymia|dysthymia
788863|NCT00296725|Depression Not Otherwise Specified|depression not otherwise specified
788864|NCT00296725|Dichotic Listening|dichotic listening
788865|NCT00296725|Fluoxetine|fluoxetine
788866|NCT00296725|Imipramine|imipramine
788867|NCT00296725|Predictors|predictors
788868|NCT00296712|Major Depression|major depression
788869|NCT00296712|Dysthymia|dysthymia
788870|NCT00296712|Depression NOS|depression nos
788871|NCT00296712|Escitalopram|escitalopram
788873|NCT00296712|Dual Therapy|dual therapy
788874|NCT00296712|Combination Therapy|combination therapy
788875|NCT00296699|Atypical Depression|atypical depression
788876|NCT00296699|Major Depressive Disorder|major depressive disorder
788877|NCT00296699|Dysthymic Disorder|dysthymic disorder
788878|NCT00296699|Atypical Features|atypical features
788879|NCT00296699|Duloxetine|duloxetine
788880|NCT00296686|Major Depression|major depression
788881|NCT00296686|Refractory Depression|refractory depression
788882|NCT00296686|Tranylcypromine|tranylcypromine
788883|NCT00296686|Dextroamphetamine|dextroamphetamine
788884|NCT00296686|Triiodothyronine|triiodothyronine
788885|NCT00296673|Rehabilitation, Side Bridge test, Muscular endurance|rehabilitation, side bridge test, muscular endurance
788886|NCT00296660|Acute Infection|acute infection
788887|NCT00296634|H5N1, Influenza, vaccine|h5n1, influenza, vaccine
788888|NCT00296621|glutamine|glutamine
788889|NCT00296621|nutrition|nutrition
788890|NCT00296621|children|children
788891|NCT00296621|pediatrics|pediatrics
788892|NCT00296621|randomized controlled clinical trial|randomized controlled clinical trial
788893|NCT00296621|therapy|therapy
788894|NCT00296621|supplement|supplement
788895|NCT00296621|oral administration|oral administration
788896|NCT00296621|handicap|handicap
788897|NCT00296608|stage II rectal cancer|stage ii rectal cancer
788898|NCT00296608|stage III rectal cancer|stage iii rectal cancer
788899|NCT00296608|adenocarcinoma of the rectum|adenocarcinoma of the rectum
788900|NCT00296556|Ulcerative colitis|ulcerative colitis
788901|NCT00296556|EP4 agonist|ep4 agonist
788902|NCT00296556|PGE2|pge2
788903|NCT00296543|hemodialysis|hemodialysis
788904|NCT00296543|sudden cardiac death|sudden cardiac death
788905|NCT00296530|Asthma|asthma
788906|NCT00296530|Allergic Rhinitis|allergic rhinitis
788907|NCT00296517|depression|depression
788908|NCT00296517|double-blind|double-blind
788909|NCT00296517|placebo-controlled|placebo-controlled
788910|NCT00296517|bupropion hydrochloride|bupropion hydrochloride
788911|NCT00296517|SSRI|ssri
788912|NCT00296517|comparative study|comparative study
788913|NCT00296517|non-responder|non-responder
788914|NCT00296504|antiretroviral therapy naive subjects|antiretroviral therapy naive subjects
788915|NCT00296504|fosamprenavir|fosamprenavir
788916|NCT00296504|HIV-1|hiv-1
788917|NCT00296504|protease inhibitor|protease inhibitor
788918|NCT00296504|pro-drug|pro-drug
788919|NCT00296504|antiretroviral therapy|antiretroviral therapy
788920|NCT00296504|LEXIVA|lexiva
788921|NCT00296504|AGENERASE|agenerase
788922|NCT00296504|GW433908|gw433908
788923|NCT00296504|amprenavir|amprenavir
788924|NCT00296491|Allergic Rhinitis|allergic rhinitis
788925|NCT00296491|Asthma|asthma
788926|NCT00296452|cancer|cancer
788927|NCT00296452|nutrition|nutrition
788928|NCT00296426|Adverse Drug Event|adverse drug event
788929|NCT00296426|Inpatients|inpatients
788930|NCT00296426|Outcome assessment|outcome assessment
788931|NCT00296413|epilepsy|epilepsy
788932|NCT00296413|menstrual cycle|menstrual cycle
788933|NCT00296413|valproate|valproate
788934|NCT00296413|lamotrigine|lamotrigine
788935|NCT00296413|oral contraceptive|oral contraceptive
788936|NCT00296400|Hyperlipidemia|hyperlipidemia
788937|NCT00296400|Proteinuria|proteinuria
788938|NCT00296400|Diabetes Mellitus|diabetes mellitus
788939|NCT00296374|Hyperlipidemia|hyperlipidemia
788940|NCT00296374|Proteinuria|proteinuria
788941|NCT00296374|Diabetes Mellitus|diabetes mellitus
788942|NCT00296361|Tacrolimus|tacrolimus
788943|NCT00296361|Kidney Transplantation|kidney transplantation
788944|NCT00296361|Immunosuppression|immunosuppression
788945|NCT00296361|Adult|adult
788946|NCT00296361|Treatment Outcomes|treatment outcomes
788947|NCT00296348|Tacrolimus|tacrolimus
788948|NCT00296348|Kidney Transplantation|kidney transplantation
788949|NCT00296348|Child|child
788950|NCT00296348|Treatment Outcome|treatment outcome
788951|NCT00296348|Immunosuppression|immunosuppression
788952|NCT00296335|Stomach cancer|stomach cancer
788953|NCT00296335|Adjuvant chemotherapy|adjuvant chemotherapy
788954|NCT00296335|Mitomycin|mitomycin
788955|NCT00296335|Cisplatin|cisplatin
788956|NCT00296335|Doxifluridine|doxifluridine
788957|NCT00296322|stomach cancer|stomach cancer
788958|NCT00296322|adjuvant chemotherapy|adjuvant chemotherapy
788959|NCT00296322|mitomycin|mitomycin
788960|NCT00296322|cisplatin|cisplatin
788961|NCT00296322|doxifluridine|doxifluridine
788962|NCT00296309|Tacrolimus|tacrolimus
788963|NCT00296309|Kidney Transplantation|kidney transplantation
788964|NCT00296309|Immunosuppression|immunosuppression
788965|NCT00296309|Adult|adult
788966|NCT00296309|Treatment Outcomes|treatment outcomes
788967|NCT00296296|kidney Transplant|kidney transplant
788968|NCT00296296|Type II Diabetes|type ii diabetes
788969|NCT00296296|Diabetic Nephropathy|diabetic nephropathy
788970|NCT00296296|Immunosuppression|immunosuppression
788971|NCT00296296|Cyclosporin|cyclosporin
788972|NCT00296296|Tacrolimus|tacrolimus
788973|NCT00296283|Relatives|relatives
788974|NCT00296283|Bipolar Disorder|bipolar disorder
788975|NCT00296283|Psychoeducation|psychoeducation
789523|NCT00295048|treatment|treatment
788976|NCT00296244|steroid-free immunosuppression|steroid-free immunosuppression
788977|NCT00296244|liver transplantation|liver transplantation
788978|NCT00296231|premature infants|premature infants
788979|NCT00296231|very low birthweight infants|very low birthweight infants
788980|NCT00296231|high frequency ventilation|high frequency ventilation
788981|NCT00296231|nasal ventilation|nasal ventilation
788982|NCT00296205|Multiple Sclerosis|multiple sclerosis
788983|NCT00296205|Cyclophosphamide|cyclophosphamide
788984|NCT00296205|autoimmune|autoimmune
788985|NCT00296192|Rotigotine|rotigotine
788986|NCT00296192|Rotigotine nasal spray|rotigotine nasal spray
788987|NCT00296192|Efficacy, safety and tolerability|efficacy, safety and tolerability
788988|NCT00296192|Parkinson's disease|parkinson's disease
788989|NCT00296166|Atrial fibrillation|atrial fibrillation
788990|NCT00296166|Permanent Atrial fibrillation|permanent atrial fibrillation
788991|NCT00296166|catheter ablation|catheter ablation
788992|NCT00296166|thoracoscopy|thoracoscopy
788993|NCT00296166|Arrhythmia|arrhythmia
788994|NCT00296166|Heart|heart
788995|NCT00296153|Human immunodeficiency Virus (HIV)|human immunodeficiency virus (hiv)
788996|NCT00296153|Highly Active Antiviral Therapy (HAART)|highly active antiviral therapy (haart)
788997|NCT00296153|Ischemic Heart Disease|ischemic heart disease
788998|NCT00296153|OMACOR|omacor
788999|NCT00296153|Triglycerides|triglycerides
789000|NCT00296153|Endothelial function|endothelial function
789001|NCT00296153|Treatment Experienced|treatment experienced
789002|NCT00296140|post-stroke depression|post-stroke depression
789003|NCT00296140|clinical reminder|clinical reminder
789004|NCT00296140|self-management|self-management
789005|NCT00296114|Cancer|cancer
789006|NCT00296114|Pancreas|pancreas
789007|NCT00296101|Physical Inactivity|physical inactivity
789008|NCT00296088|Mechanical Ventilation|mechanical ventilation
789009|NCT00296088|Critical Care|critical care
789010|NCT00296088|Respiratory Failure|respiratory failure
789011|NCT00296062|unspecified adult solid tumor, protocol specific|unspecified adult solid tumor, protocol specific
789012|NCT00296062|stage III colon cancer|stage iii colon cancer
789013|NCT00296062|stage IV colon cancer|stage iv colon cancer
789014|NCT00296062|stage III rectal cancer|stage iii rectal cancer
789015|NCT00296062|stage IV rectal cancer|stage iv rectal cancer
789016|NCT00296062|recurrent colon cancer|recurrent colon cancer
789017|NCT00296062|recurrent rectal cancer|recurrent rectal cancer
789018|NCT00296049|unspecified adult solid tumor, protocol specific|unspecified adult solid tumor, protocol specific
789019|NCT00296049|infection|infection
789020|NCT00296049|neutropenia|neutropenia
789021|NCT00296049|unspecified childhood solid tumor, protocol specific|unspecified childhood solid tumor, protocol specific
789022|NCT00296036|drug/agent toxicity by tissue/organ|drug/agent toxicity by tissue/organ
789023|NCT00296036|stage I breast cancer|stage i breast cancer
789024|NCT00296036|stage II breast cancer|stage ii breast cancer
789025|NCT00296036|stage IIIA breast cancer|stage iiia breast cancer
789026|NCT00296036|stage IIIB breast cancer|stage iiib breast cancer
789027|NCT00296036|stage IIIC breast cancer|stage iiic breast cancer
789028|NCT00296036|stage IV breast cancer|stage iv breast cancer
789029|NCT00296036|unspecified adult solid tumor, protocol specific|unspecified adult solid tumor, protocol specific
789030|NCT00296023|stage III chronic lymphocytic leukemia|stage iii chronic lymphocytic leukemia
789031|NCT00296023|stage IV chronic lymphocytic leukemia|stage iv chronic lymphocytic leukemia
789032|NCT00296023|stage III adult diffuse small cleaved cell lymphoma|stage iii adult diffuse small cleaved cell lymphoma
789033|NCT00296023|stage IV adult diffuse small cleaved cell lymphoma|stage iv adult diffuse small cleaved cell lymphoma
789034|NCT00296023|noncontiguous stage II grade 1 follicular lymphoma|noncontiguous stage ii grade 1 follicular lymphoma
789035|NCT00296023|noncontiguous stage II grade 2 follicular lymphoma|noncontiguous stage ii grade 2 follicular lymphoma
789036|NCT00296023|noncontiguous stage II grade 3 follicular lymphoma|noncontiguous stage ii grade 3 follicular lymphoma
789037|NCT00296023|stage III grade 1 follicular lymphoma|stage iii grade 1 follicular lymphoma
789038|NCT00296023|stage III grade 2 follicular lymphoma|stage iii grade 2 follicular lymphoma
789039|NCT00296023|stage III grade 3 follicular lymphoma|stage iii grade 3 follicular lymphoma
789040|NCT00296023|stage IV grade 1 follicular lymphoma|stage iv grade 1 follicular lymphoma
789041|NCT00296023|stage IV grade 2 follicular lymphoma|stage iv grade 2 follicular lymphoma
789042|NCT00296023|stage IV grade 3 follicular lymphoma|stage iv grade 3 follicular lymphoma
789043|NCT00296023|noncontiguous stage II marginal zone lymphoma|noncontiguous stage ii marginal zone lymphoma
789044|NCT00296023|stage III marginal zone lymphoma|stage iii marginal zone lymphoma
789045|NCT00296023|stage IV marginal zone lymphoma|stage iv marginal zone lymphoma
789046|NCT00296023|noncontiguous stage II small lymphocytic lymphoma|noncontiguous stage ii small lymphocytic lymphoma
789047|NCT00296023|stage III small lymphocytic lymphoma|stage iii small lymphocytic lymphoma
789048|NCT00296023|stage IV small lymphocytic lymphoma|stage iv small lymphocytic lymphoma
789049|NCT00296023|noncontiguous stage II adult Burkitt lymphoma|noncontiguous stage ii adult burkitt lymphoma
789050|NCT00296023|stage III adult Burkitt lymphoma|stage iii adult burkitt lymphoma
789051|NCT00296023|stage IV adult Burkitt lymphoma|stage iv adult burkitt lymphoma
789052|NCT00296023|stage III adult diffuse large cell lymphoma|stage iii adult diffuse large cell lymphoma
789053|NCT00296023|stage IV adult diffuse large cell lymphoma|stage iv adult diffuse large cell lymphoma
789054|NCT00296023|noncontiguous stage II adult diffuse mixed cell lymphoma|noncontiguous stage ii adult diffuse mixed cell lymphoma
789055|NCT00296023|stage III adult diffuse mixed cell lymphoma|stage iii adult diffuse mixed cell lymphoma
789056|NCT00296023|stage IV adult diffuse mixed cell lymphoma|stage iv adult diffuse mixed cell lymphoma
789057|NCT00296023|noncontiguous stage II adult immunoblastic large cell lymphoma|noncontiguous stage ii adult immunoblastic large cell lymphoma
789058|NCT00296023|stage III adult immunoblastic large cell lymphoma|stage iii adult immunoblastic large cell lymphoma
789059|NCT00296023|stage IV adult immunoblastic large cell lymphoma|stage iv adult immunoblastic large cell lymphoma
789060|NCT00296023|noncontiguous stage II adult lymphoblastic lymphoma|noncontiguous stage ii adult lymphoblastic lymphoma
789061|NCT00296023|stage III adult lymphoblastic lymphoma|stage iii adult lymphoblastic lymphoma
789062|NCT00296023|stage IV adult lymphoblastic lymphoma|stage iv adult lymphoblastic lymphoma
789063|NCT00296023|noncontiguous stage II mantle cell lymphoma|noncontiguous stage ii mantle cell lymphoma
789064|NCT00296023|stage III mantle cell lymphoma|stage iii mantle cell lymphoma
789065|NCT00296023|stage IV mantle cell lymphoma|stage iv mantle cell lymphoma
789066|NCT00296023|extranodal marginal zone B-cell lymphoma of mucosa-associated lymphoid tissue|extranodal marginal zone b-cell lymphoma of mucosa-associated lymphoid tissue
789067|NCT00296023|nodal marginal zone B-cell lymphoma|nodal marginal zone b-cell lymphoma
789068|NCT00296023|splenic marginal zone lymphoma|splenic marginal zone lymphoma
789069|NCT00296023|stage II multiple myeloma|stage ii multiple myeloma
789070|NCT00296023|stage III multiple myeloma|stage iii multiple myeloma
789071|NCT00296023|chronic phase chronic myelogenous leukemia|chronic phase chronic myelogenous leukemia
789072|NCT00296023|primary myelofibrosis|primary myelofibrosis
789073|NCT00296023|polycythemia vera|polycythemia vera
789074|NCT00296023|prolymphocytic leukemia|prolymphocytic leukemia
789075|NCT00296023|stage II adult Hodgkin lymphoma|stage ii adult hodgkin lymphoma
789076|NCT00296023|stage III adult Hodgkin lymphoma|stage iii adult hodgkin lymphoma
789077|NCT00296023|stage IV adult Hodgkin lymphoma|stage iv adult hodgkin lymphoma
789078|NCT00296023|de novo myelodysplastic syndromes|de novo myelodysplastic syndromes
789079|NCT00296023|previously treated myelodysplastic syndromes|previously treated myelodysplastic syndromes
789080|NCT00296023|secondary myelodysplastic syndromes|secondary myelodysplastic syndromes
789081|NCT00296023|refractory anemia with excess blasts in transformation|refractory anemia with excess blasts in transformation
789082|NCT00296023|refractory anemia with excess blasts|refractory anemia with excess blasts
789083|NCT00296023|chronic myelomonocytic leukemia|chronic myelomonocytic leukemia
789388|NCT00295607|Immunosuppression|immunosuppression
789084|NCT00296023|adult acute myeloid leukemia in remission|adult acute myeloid leukemia in remission
789085|NCT00296023|secondary acute myeloid leukemia|secondary acute myeloid leukemia
789086|NCT00296023|Waldenström macroglobulinemia|waldenström macroglobulinemia
789087|NCT00296023|essential thrombocythemia|essential thrombocythemia
789088|NCT00296023|adult acute myeloid leukemia with 11q23 (MLL) abnormalities|adult acute myeloid leukemia with 11q23 (mll) abnormalities
789089|NCT00296023|adult acute myeloid leukemia with inv(16)(p13;q22)|adult acute myeloid leukemia with inv(16)(p13;q22)
789090|NCT00296023|adult acute myeloid leukemia with t(15;17)(q22;q12)|adult acute myeloid leukemia with t(15;17)(q22;q12)
789091|NCT00296023|adult acute myeloid leukemia with t(16;16)(p13;q22)|adult acute myeloid leukemia with t(16;16)(p13;q22)
789092|NCT00296023|adult acute myeloid leukemia with t(8;21)(q22;q22)|adult acute myeloid leukemia with t(8;21)(q22;q22)
789158|NCT00295984|classic Kaposi sarcoma|classic kaposi sarcoma
789093|NCT00296023|noncontiguous stage II adult diffuse large cell lymphoma|noncontiguous stage ii adult diffuse large cell lymphoma
789094|NCT00296023|noncontiguous stage II adult diffuse small cleaved cell lymphoma|noncontiguous stage ii adult diffuse small cleaved cell lymphoma
789095|NCT00296023|stage I multiple myeloma|stage i multiple myeloma
789096|NCT00296010|stage I breast cancer|stage i breast cancer
789097|NCT00296010|stage II breast cancer|stage ii breast cancer
789098|NCT00296010|stage IIIA breast cancer|stage iiia breast cancer
789099|NCT00295997|adult acute myeloid leukemia with 11q23 (MLL) abnormalities|adult acute myeloid leukemia with 11q23 (mll) abnormalities
789100|NCT00295997|adult acute myeloid leukemia with inv(16)(p13;q22)|adult acute myeloid leukemia with inv(16)(p13;q22)
789101|NCT00295997|adult acute myeloid leukemia with t(15;17)(q22;q12)|adult acute myeloid leukemia with t(15;17)(q22;q12)
789102|NCT00295997|adult acute myeloid leukemia with t(16;16)(p13;q22)|adult acute myeloid leukemia with t(16;16)(p13;q22)
789103|NCT00295997|accelerated phase chronic myelogenous leukemia|accelerated phase chronic myelogenous leukemia
789104|NCT00295997|adult acute lymphoblastic leukemia in remission|adult acute lymphoblastic leukemia in remission
789105|NCT00295997|adult acute myeloid leukemia in remission|adult acute myeloid leukemia in remission
789106|NCT00295997|atypical chronic myeloid leukemia, BCR-ABL1 negative|atypical chronic myeloid leukemia, bcr-abl1 negative
789107|NCT00295997|blastic phase chronic myelogenous leukemia|blastic phase chronic myelogenous leukemia
789108|NCT00295997|childhood acute lymphoblastic leukemia in remission|childhood acute lymphoblastic leukemia in remission
789109|NCT00295997|childhood acute myeloid leukemia in remission|childhood acute myeloid leukemia in remission
789110|NCT00295997|childhood chronic myelogenous leukemia|childhood chronic myelogenous leukemia
789111|NCT00295997|chronic eosinophilic leukemia|chronic eosinophilic leukemia
789112|NCT00295997|primary myelofibrosis|primary myelofibrosis
789113|NCT00295997|chronic myelomonocytic leukemia|chronic myelomonocytic leukemia
789114|NCT00295997|chronic neutrophilic leukemia|chronic neutrophilic leukemia
789115|NCT00295997|chronic phase chronic myelogenous leukemia|chronic phase chronic myelogenous leukemia
789116|NCT00295997|de novo myelodysplastic syndromes|de novo myelodysplastic syndromes
789117|NCT00295997|essential thrombocythemia|essential thrombocythemia
789118|NCT00295997|juvenile myelomonocytic leukemia|juvenile myelomonocytic leukemia
789119|NCT00295997|myelodysplastic/myeloproliferative neoplasm, unclassifiable|myelodysplastic/myeloproliferative neoplasm, unclassifiable
789120|NCT00295997|polycythemia vera|polycythemia vera
789121|NCT00295997|previously treated myelodysplastic syndromes|previously treated myelodysplastic syndromes
789122|NCT00295997|recurrent adult acute myeloid leukemia|recurrent adult acute myeloid leukemia
789123|NCT00295997|prolymphocytic leukemia|prolymphocytic leukemia
789124|NCT00295997|recurrent adult Hodgkin lymphoma|recurrent adult hodgkin lymphoma
789125|NCT00295997|recurrent adult diffuse large cell lymphoma|recurrent adult diffuse large cell lymphoma
789126|NCT00295997|recurrent adult immunoblastic large cell lymphoma|recurrent adult immunoblastic large cell lymphoma
789127|NCT00295997|recurrent adult lymphoblastic lymphoma|recurrent adult lymphoblastic lymphoma
789128|NCT00295997|recurrent/refractory childhood Hodgkin lymphoma|recurrent/refractory childhood hodgkin lymphoma
789129|NCT00295997|recurrent childhood acute lymphoblastic leukemia|recurrent childhood acute lymphoblastic leukemia
789130|NCT00295997|recurrent childhood acute myeloid leukemia|recurrent childhood acute myeloid leukemia
789131|NCT00295997|recurrent childhood large cell lymphoma|recurrent childhood large cell lymphoma
789132|NCT00295997|recurrent grade 1 follicular lymphoma|recurrent grade 1 follicular lymphoma
789133|NCT00295997|recurrent grade 2 follicular lymphoma|recurrent grade 2 follicular lymphoma
789134|NCT00295997|recurrent grade 3 follicular lymphoma|recurrent grade 3 follicular lymphoma
789135|NCT00295997|recurrent mantle cell lymphoma|recurrent mantle cell lymphoma
789136|NCT00295997|refractory chronic lymphocytic leukemia|refractory chronic lymphocytic leukemia
789137|NCT00295997|refractory multiple myeloma|refractory multiple myeloma
789138|NCT00295997|relapsing chronic myelogenous leukemia|relapsing chronic myelogenous leukemia
789139|NCT00295997|secondary acute myeloid leukemia|secondary acute myeloid leukemia
789140|NCT00295997|secondary myelodysplastic syndromes|secondary myelodysplastic syndromes
789141|NCT00295997|stage II multiple myeloma|stage ii multiple myeloma
789142|NCT00295997|stage III chronic lymphocytic leukemia|stage iii chronic lymphocytic leukemia
789143|NCT00295997|stage III grade 1 follicular lymphoma|stage iii grade 1 follicular lymphoma
789144|NCT00295997|stage III grade 2 follicular lymphoma|stage iii grade 2 follicular lymphoma
789145|NCT00295997|stage III grade 3 follicular lymphoma|stage iii grade 3 follicular lymphoma
789146|NCT00295997|stage III multiple myeloma|stage iii multiple myeloma
789147|NCT00295997|stage IV chronic lymphocytic leukemia|stage iv chronic lymphocytic leukemia
789148|NCT00295997|stage IV grade 1 follicular lymphoma|stage iv grade 1 follicular lymphoma
789149|NCT00295997|stage IV grade 2 follicular lymphoma|stage iv grade 2 follicular lymphoma
789150|NCT00295997|stage IV grade 3 follicular lymphoma|stage iv grade 3 follicular lymphoma
789151|NCT00295997|recurrent renal cell cancer|recurrent renal cell cancer
789152|NCT00295997|stage IV renal cell cancer|stage iv renal cell cancer
789153|NCT00295997|noncontiguous stage II grade 1 follicular lymphoma|noncontiguous stage ii grade 1 follicular lymphoma
789154|NCT00295997|noncontiguous stage II grade 2 follicular lymphoma|noncontiguous stage ii grade 2 follicular lymphoma
789155|NCT00295997|noncontiguous stage II grade 3 follicular lymphoma|noncontiguous stage ii grade 3 follicular lymphoma
789156|NCT00295997|recurrent adult acute lymphoblastic leukemia|recurrent adult acute lymphoblastic leukemia
789157|NCT00295997|childhood myelodysplastic syndromes|childhood myelodysplastic syndromes
789159|NCT00295984|recurrent Kaposi sarcoma|recurrent kaposi sarcoma
789160|NCT00295971|childhood acute lymphoblastic leukemia in remission|childhood acute lymphoblastic leukemia in remission
789161|NCT00295971|childhood acute myeloid leukemia in remission|childhood acute myeloid leukemia in remission
789162|NCT00295971|de novo myelodysplastic syndromes|de novo myelodysplastic syndromes
789163|NCT00295971|previously treated myelodysplastic syndromes|previously treated myelodysplastic syndromes
789164|NCT00295971|secondary myelodysplastic syndromes|secondary myelodysplastic syndromes
789165|NCT00295971|secondary acute myeloid leukemia|secondary acute myeloid leukemia
789166|NCT00295971|juvenile myelomonocytic leukemia|juvenile myelomonocytic leukemia
789167|NCT00295971|chronic phase chronic myelogenous leukemia|chronic phase chronic myelogenous leukemia
789168|NCT00295971|refractory anemia with excess blasts in transformation|refractory anemia with excess blasts in transformation
789169|NCT00295971|refractory anemia with excess blasts|refractory anemia with excess blasts
789170|NCT00295971|severe congenital neutropenia|severe congenital neutropenia
789171|NCT00295971|congenital amegakaryocytic thrombocytopenia|congenital amegakaryocytic thrombocytopenia
789172|NCT00295971|childhood chronic myelogenous leukemia|childhood chronic myelogenous leukemia
789173|NCT00295971|childhood myelodysplastic syndromes|childhood myelodysplastic syndromes
789174|NCT00295958|recurrent melanoma|recurrent melanoma
789175|NCT00295958|stage IV melanoma|stage iv melanoma
789176|NCT00295958|skin cancer|skin cancer
789177|NCT00295945|pain|pain
789389|NCT00295607|Adult|adult
789178|NCT00295945|perioperative/postoperative complications|perioperative/postoperative complications
789179|NCT00295945|stage III cervical cancer|stage iii cervical cancer
789180|NCT00295945|recurrent cervical cancer|recurrent cervical cancer
789181|NCT00295945|stage IB cervical cancer|stage ib cervical cancer
789182|NCT00295945|stage IIB cervical cancer|stage iib cervical cancer
789183|NCT00295945|stage IVB cervical cancer|stage ivb cervical cancer
789184|NCT00295945|stage IA cervical cancer|stage ia cervical cancer
789185|NCT00295945|stage IIA cervical cancer|stage iia cervical cancer
789186|NCT00295945|stage IVA cervical cancer|stage iva cervical cancer
789187|NCT00295945|stage I endometrial carcinoma|stage i endometrial carcinoma
789188|NCT00295945|stage II endometrial carcinoma|stage ii endometrial carcinoma
789189|NCT00295945|stage III endometrial carcinoma|stage iii endometrial carcinoma
789190|NCT00295945|stage IV endometrial carcinoma|stage iv endometrial carcinoma
789191|NCT00295945|recurrent endometrial carcinoma|recurrent endometrial carcinoma
789192|NCT00295945|stage I uterine sarcoma|stage i uterine sarcoma
789193|NCT00295945|stage II uterine sarcoma|stage ii uterine sarcoma
789194|NCT00295945|stage III uterine sarcoma|stage iii uterine sarcoma
789195|NCT00295945|stage IV uterine sarcoma|stage iv uterine sarcoma
789196|NCT00295945|recurrent uterine sarcoma|recurrent uterine sarcoma
789197|NCT00295945|ovarian sarcoma|ovarian sarcoma
789198|NCT00295945|recurrent ovarian epithelial cancer|recurrent ovarian epithelial cancer
789199|NCT00295945|recurrent ovarian germ cell tumor|recurrent ovarian germ cell tumor
789200|NCT00295945|stage IV ovarian epithelial cancer|stage iv ovarian epithelial cancer
789201|NCT00295945|stage IV ovarian germ cell tumor|stage iv ovarian germ cell tumor
789202|NCT00295945|ovarian stromal cancer|ovarian stromal cancer
789203|NCT00295945|recurrent fallopian tube cancer|recurrent fallopian tube cancer
789204|NCT00295945|stage IA fallopian tube cancer|stage ia fallopian tube cancer
789205|NCT00295945|stage IB fallopian tube cancer|stage ib fallopian tube cancer
789206|NCT00295945|stage IC fallopian tube cancer|stage ic fallopian tube cancer
789207|NCT00295945|stage IIA fallopian tube cancer|stage iia fallopian tube cancer
789208|NCT00295945|stage IIB fallopian tube cancer|stage iib fallopian tube cancer
789209|NCT00295945|stage IIC fallopian tube cancer|stage iic fallopian tube cancer
789210|NCT00295945|stage IIIA fallopian tube cancer|stage iiia fallopian tube cancer
789211|NCT00295945|stage IIIB fallopian tube cancer|stage iiib fallopian tube cancer
789212|NCT00295945|stage IIIC fallopian tube cancer|stage iiic fallopian tube cancer
789213|NCT00295945|stage IV fallopian tube cancer|stage iv fallopian tube cancer
789214|NCT00295945|stage IA ovarian epithelial cancer|stage ia ovarian epithelial cancer
789215|NCT00295945|stage IB ovarian epithelial cancer|stage ib ovarian epithelial cancer
789216|NCT00295945|stage IC ovarian epithelial cancer|stage ic ovarian epithelial cancer
789217|NCT00295945|stage IIA ovarian epithelial cancer|stage iia ovarian epithelial cancer
789218|NCT00295945|stage IIB ovarian epithelial cancer|stage iib ovarian epithelial cancer
789219|NCT00295945|stage IIC ovarian epithelial cancer|stage iic ovarian epithelial cancer
789220|NCT00295945|stage IIIA ovarian epithelial cancer|stage iiia ovarian epithelial cancer
789221|NCT00295945|stage IIIB ovarian epithelial cancer|stage iiib ovarian epithelial cancer
789222|NCT00295945|stage IIIC ovarian epithelial cancer|stage iiic ovarian epithelial cancer
789223|NCT00295945|stage IA ovarian germ cell tumor|stage ia ovarian germ cell tumor
789224|NCT00295945|stage IB ovarian germ cell tumor|stage ib ovarian germ cell tumor
789225|NCT00295945|stage IC ovarian germ cell tumor|stage ic ovarian germ cell tumor
789226|NCT00295945|stage IIA ovarian germ cell tumor|stage iia ovarian germ cell tumor
789227|NCT00295945|stage IIB ovarian germ cell tumor|stage iib ovarian germ cell tumor
789228|NCT00295945|stage IIC ovarian germ cell tumor|stage iic ovarian germ cell tumor
789229|NCT00295945|stage IIIA ovarian germ cell tumor|stage iiia ovarian germ cell tumor
789230|NCT00295945|stage IIIB ovarian germ cell tumor|stage iiib ovarian germ cell tumor
789231|NCT00295945|stage IIIC ovarian germ cell tumor|stage iiic ovarian germ cell tumor
789232|NCT00295932|recurrent grade 1 follicular lymphoma|recurrent grade 1 follicular lymphoma
789233|NCT00295932|recurrent grade 2 follicular lymphoma|recurrent grade 2 follicular lymphoma
789234|NCT00295932|recurrent grade 3 follicular lymphoma|recurrent grade 3 follicular lymphoma
789235|NCT00295932|recurrent small lymphocytic lymphoma|recurrent small lymphocytic lymphoma
789236|NCT00295932|recurrent marginal zone lymphoma|recurrent marginal zone lymphoma
789237|NCT00295932|Waldenstrom macroglobulinemia|waldenstrom macroglobulinemia
789238|NCT00295932|recurrent mantle cell lymphoma|recurrent mantle cell lymphoma
789239|NCT00295932|refractory chronic lymphocytic leukemia|refractory chronic lymphocytic leukemia
789240|NCT00295932|B-cell chronic lymphocytic leukemia|b-cell chronic lymphocytic leukemia
789241|NCT00295932|extranodal marginal zone B-cell lymphoma of mucosa-associated lymphoid tissue|extranodal marginal zone b-cell lymphoma of mucosa-associated lymphoid tissue
789242|NCT00295932|nodal marginal zone B-cell lymphoma|nodal marginal zone b-cell lymphoma
789243|NCT00295932|splenic marginal zone lymphoma|splenic marginal zone lymphoma
789244|NCT00295919|recurrent neuroblastoma|recurrent neuroblastoma
789245|NCT00295906|melanoma|melanoma
789246|NCT00295906|skin cancer|skin cancer
789247|NCT00295893|inflammatory breast cancer|inflammatory breast cancer
789248|NCT00295893|stage II breast cancer|stage ii breast cancer
789249|NCT00295893|stage IIIA breast cancer|stage iiia breast cancer
789250|NCT00295893|stage IIIB breast cancer|stage iiib breast cancer
789251|NCT00295893|stage IIIC breast cancer|stage iiic breast cancer
789252|NCT00295893|male breast cancer|male breast cancer
789253|NCT00295893|Paget disease of the breast with invasive ductal carcinoma|paget disease of the breast with invasive ductal carcinoma
789254|NCT00295893|invasive ductal breast carcinoma with predominant intraductal component|invasive ductal breast carcinoma with predominant intraductal component
789255|NCT00295893|invasive ductal breast carcinoma|invasive ductal breast carcinoma
789256|NCT00295893|medullary ductal breast carcinoma with lymphocytic infiltrate|medullary ductal breast carcinoma with lymphocytic infiltrate
789257|NCT00295893|comedo ductal breast carcinoma|comedo ductal breast carcinoma
789258|NCT00295893|invasive lobular breast carcinoma with predominant in situ component|invasive lobular breast carcinoma with predominant in situ component
789259|NCT00295893|invasive lobular breast carcinoma|invasive lobular breast carcinoma
789260|NCT00295893|mucinous ductal breast carcinoma|mucinous ductal breast carcinoma
789261|NCT00295893|papillary ductal breast carcinoma|papillary ductal breast carcinoma
789262|NCT00295893|tubular ductal breast carcinoma|tubular ductal breast carcinoma
789263|NCT00295880|adult acute myeloid leukemia in remission|adult acute myeloid leukemia in remission
789264|NCT00295880|adult acute myeloid leukemia|adult acute myeloid leukemia
789265|NCT00295880|childhood acute myeloid leukemia in remission|childhood acute myeloid leukemia in remission
789266|NCT00295880|secondary acute myeloid leukemia|secondary acute myeloid leukemia
789267|NCT00295880|accelerated phase chronic myelogenous leukemia|accelerated phase chronic myelogenous leukemia
789268|NCT00295880|childhood chronic myelogenous leukemia|childhood chronic myelogenous leukemia
789269|NCT00295880|chronic phase chronic myelogenous leukemia|chronic phase chronic myelogenous leukemia
789270|NCT00295880|relapsing chronic myelogenous leukemia|relapsing chronic myelogenous leukemia
789271|NCT00295880|refractory anemia with excess blasts|refractory anemia with excess blasts
789272|NCT00295880|de novo myelodysplastic syndromes|de novo myelodysplastic syndromes
789273|NCT00295880|myelodysplastic syndromes|myelodysplastic syndromes
789274|NCT00295880|adult diffuse large cell lymphoma|adult diffuse large cell lymphoma
789275|NCT00295880|adult diffuse mixed cell lymphoma|adult diffuse mixed cell lymphoma
789276|NCT00295880|adult diffuse small cleaved cell lymphoma|adult diffuse small cleaved cell lymphoma
789277|NCT00295880|adult lymphoblastic lymphoma|adult lymphoblastic lymphoma
789278|NCT00295880|grade 3 follicular lymphoma|grade 3 follicular lymphoma
789279|NCT00295880|mantle cell lymphoma|mantle cell lymphoma
789280|NCT00295880|childhood large cell lymphoma|childhood large cell lymphoma
789281|NCT00295880|childhood lymphoblastic lymphoma|childhood lymphoblastic lymphoma
789282|NCT00295880|adult acute lymphoblastic leukemia|adult acute lymphoblastic leukemia
789283|NCT00295880|acute lymphoblastic leukemia|acute lymphoblastic leukemia
789284|NCT00295880|refractory anemia|refractory anemia
789285|NCT00295880|refractory cytopenia|refractory cytopenia
789286|NCT00295880|childhood acute myeloid leukemia|childhood acute myeloid leukemia
789287|NCT00295880|adult immunoblastic large cell lymphoma|adult immunoblastic large cell lymphoma
789288|NCT00295880|blastic phase chronic myelogenous leukemia|blastic phase chronic myelogenous leukemia
789289|NCT00295880|chronic eosinophilic leukemia|chronic eosinophilic leukemia
789290|NCT00295880|chronic neutrophilic leukemia|chronic neutrophilic leukemia
789291|NCT00295880|childhood small noncleaved cell lymphoma|childhood small noncleaved cell lymphoma
789292|NCT00295880|childhood myelodysplastic syndromes|childhood myelodysplastic syndromes
789293|NCT00295867|stage I breast cancer|stage i breast cancer
789294|NCT00295867|stage II breast cancer|stage ii breast cancer
789295|NCT00295867|stage IIIA breast cancer|stage iiia breast cancer
789296|NCT00295867|stage IIIB breast cancer|stage iiib breast cancer
789297|NCT00295867|stage IIIC breast cancer|stage iiic breast cancer
789298|NCT00295854|Interstitial Cystitis|interstitial cystitis
789299|NCT00295854|urgency|urgency
789300|NCT00295854|frequency|frequency
789301|NCT00295854|MN-001|mn-001
789302|NCT00295854|Global Response Assessment|global response assessment
789303|NCT00295854|bladder pain/urgency|bladder pain/urgency
789304|NCT00295854|O'Leary Sant IC Symptom and Problem Index|o'leary sant ic symptom and problem index
789305|NCT00295841|recurrent adult acute lymphoblastic leukemia|recurrent adult acute lymphoblastic leukemia
789306|NCT00295841|recurrent adult acute myeloid leukemia|recurrent adult acute myeloid leukemia
789307|NCT00295841|adult acute myeloid leukemia with 11q23 (MLL) abnormalities|adult acute myeloid leukemia with 11q23 (mll) abnormalities
789308|NCT00295841|adult acute myeloid leukemia with inv(16)(p13;q22)|adult acute myeloid leukemia with inv(16)(p13;q22)
789309|NCT00295841|adult acute myeloid leukemia with t(16;16)(p13;q22)|adult acute myeloid leukemia with t(16;16)(p13;q22)
789310|NCT00295841|adult acute myeloid leukemia with t(8;21)(q22;q22)|adult acute myeloid leukemia with t(8;21)(q22;q22)
789311|NCT00295841|adult acute basophilic leukemia|adult acute basophilic leukemia
789312|NCT00295841|adult acute eosinophilic leukemia|adult acute eosinophilic leukemia
789313|NCT00295841|adult erythroleukemia (M6a)|adult erythroleukemia (m6a)
789314|NCT00295841|adult pure erythroid leukemia (M6b)|adult pure erythroid leukemia (m6b)
789315|NCT00295841|adult acute megakaryoblastic leukemia (M7)|adult acute megakaryoblastic leukemia (m7)
789316|NCT00295841|adult acute minimally differentiated myeloid leukemia (M0)|adult acute minimally differentiated myeloid leukemia (m0)
789317|NCT00295841|adult acute monoblastic leukemia (M5a)|adult acute monoblastic leukemia (m5a)
789318|NCT00295841|adult acute monocytic leukemia (M5b)|adult acute monocytic leukemia (m5b)
789319|NCT00295841|adult acute myeloblastic leukemia with maturation (M2)|adult acute myeloblastic leukemia with maturation (m2)
789320|NCT00295841|adult acute myeloblastic leukemia without maturation (M1)|adult acute myeloblastic leukemia without maturation (m1)
789321|NCT00295841|adult acute myelomonocytic leukemia (M4)|adult acute myelomonocytic leukemia (m4)
789322|NCT00295828|VEGF|vegf
789323|NCT00295828|iris neovascularization|iris neovascularization
789324|NCT00295828|diabetic retinopathy|diabetic retinopathy
789325|NCT00295828|Macugen|macugen
789326|NCT00295802|Prostate Cancer|prostate cancer
789327|NCT00295802|HIFU|hifu
789328|NCT00295802|EDAP|edap
789329|NCT00295802|Low Risk, Localized Prostate Cancer|low risk, localized prostate cancer
789330|NCT00295789|cervical cancer|cervical cancer
789331|NCT00295789|palliative chemotherapy|palliative chemotherapy
789332|NCT00295789|recurrent|recurrent
789333|NCT00295789|persistent|persistent
789334|NCT00295789|stageⅣb|stageⅳb
789335|NCT00295789|cisplatin|cisplatin
789336|NCT00295789|carboplatin|carboplatin
789337|NCT00295789|paclitaxel|paclitaxel
789338|NCT00295776|Inclusion Criteria:Minimum of 4 on the Likert Pain Scale.If currently taking TCA and/or Gabapentin, need to have been on stable dose for minimum of 4 weeks.|inclusion criteria:minimum of 4 on the likert pain scale.if currently taking tca and/or gabapentin, need to have been on stable dose for minimum of 4 weeks.
789339|NCT00295776|Exclusion Criteria:|exclusion criteria:
789340|NCT00295776|Currently on any antiepilepic drugs (AED), except for Gabapentin.|currently on any antiepilepic drugs (aed), except for gabapentin.
789341|NCT00295776|Currently taking opioid or unwilling to washout prior to the study,|currently taking opioid or unwilling to washout prior to the study,
789342|NCT00295776|Pregnant and lactating,|pregnant and lactating,
789343|NCT00295776|Have active severe systemic disease,|have active severe systemic disease,
789344|NCT00295776|History of Stevens-Johnson syndrome or TEN,|history of stevens-johnson syndrome or ten,
789345|NCT00295763|papillary thyroid cancer|papillary thyroid cancer
789346|NCT00295763|follicular thyroid cancer|follicular thyroid cancer
789347|NCT00295763|recombinant human TSH|recombinant human tsh
789348|NCT00295763|Thyrogen|thyrogen
789349|NCT00295763|thyroid stimulating hormone|thyroid stimulating hormone
789350|NCT00295763|thyroid remnant ablation|thyroid remnant ablation
789351|NCT00295763|radioiodine|radioiodine
789352|NCT00295750|Prostate Cancer|prostate cancer
789353|NCT00295737|allergic rhinitis|allergic rhinitis
789354|NCT00295724|bicifadine|bicifadine
789355|NCT00295724|chronic low back pain|chronic low back pain
789356|NCT00295711|bicifadine|bicifadine
789357|NCT00295711|chronic low back pain|chronic low back pain
789358|NCT00295698|HIV|hiv
789359|NCT00295698|Lymphatic filariasis|lymphatic filariasis
789360|NCT00295698|Diethylcarbamazine|diethylcarbamazine
789361|NCT00295698|Interaction|interaction
789362|NCT00295698|Tanzania|tanzania
789363|NCT00295685|Reflux|reflux
789364|NCT00295685|GERD|gerd
789365|NCT00295672|Non-Small-Cell Lung,radiotherapy, Chemotherapy, vinorelbine|non-small-cell lung,radiotherapy, chemotherapy, vinorelbine
789366|NCT00295659|Gestational Diabetes|gestational diabetes
789367|NCT00295659|Screening|screening
789368|NCT00295659|Cost-effectiveness|cost-effectiveness
789369|NCT00295659|obstetrical outcomes|obstetrical outcomes
789370|NCT00295646|Austrian Breast & Colorectal Cancer Study Group (ABCSG)|austrian breast & colorectal cancer study group (abcsg)
789371|NCT00295646|12|12
789372|NCT00295646|Phase 3|phase 3
789373|NCT00295646|breast cancer|breast cancer
789374|NCT00295646|anastrozole|anastrozole
789375|NCT00295646|tamoxifen|tamoxifen
789376|NCT00295646|zoledronic acid|zoledronic acid
789377|NCT00295646|premenopausal|premenopausal
789378|NCT00295646|hormone receptor-positive|hormone receptor-positive
789379|NCT00295646|Stage I|stage i
789380|NCT00295646|Stage II|stage ii
789381|NCT00295646|bone mineral density|bone mineral density
789382|NCT00295646|BMD|bmd
789383|NCT00295646|bisphosphonate|bisphosphonate
789384|NCT00295646|zoledronate|zoledronate
789385|NCT00295620|Hormone receptor positive breast cancer|hormone receptor positive breast cancer
789386|NCT00295607|Tacrolimus|tacrolimus
789387|NCT00295607|Liver Transplantation|liver transplantation
789390|NCT00295607|Treatment Outcome|treatment outcome
789391|NCT00295594|Tacrolimus|tacrolimus
789392|NCT00295594|Liver Transplantation|liver transplantation
789393|NCT00295594|Treatment Outcome|treatment outcome
789394|NCT00295594|Immunosuppression|immunosuppression
789395|NCT00295581|Human|human
789396|NCT00295581|Clinical Trial|clinical trial
789397|NCT00295581|Mosquito|mosquito
789398|NCT00295581|Healthy Volunteer|healthy volunteer
789399|NCT00295581|HV|hv
789400|NCT00295568|Transcranial Magnetic Stimulation (TMS)|transcranial magnetic stimulation (tms)
789401|NCT00295568|Motor Learning|motor learning
789402|NCT00295568|Accuracy|accuracy
789403|NCT00295568|Tracking Motor Task|tracking motor task
789404|NCT00295568|Healthy Volunteer|healthy volunteer
789405|NCT00295568|HV|hv
789406|NCT00295555|ambulatory blood pressure monitoring|ambulatory blood pressure monitoring
789407|NCT00295555|doxazosin|doxazosin
789408|NCT00295555|alpha1-adrenergic antagonists|alpha1-adrenergic antagonists
789409|NCT00295555|sympathetic nervous activity|sympathetic nervous activity
789410|NCT00295555|diabetic nephropathy|diabetic nephropathy
789411|NCT00295555|essential hypertension|essential hypertension
789412|NCT00295555|power spectral analysis|power spectral analysis
789413|NCT00295555|morning surge|morning surge
789414|NCT00295542|ambulatory blood pressure monitoring|ambulatory blood pressure monitoring
789415|NCT00295542|cardiovascular risk|cardiovascular risk
789416|NCT00295542|chronotherapy|chronotherapy
789417|NCT00295542|circadian pattern|circadian pattern
789418|NCT00295529|Primary health care|primary health care
789419|NCT00295529|Breast neoplasm|breast neoplasm
789420|NCT00295529|Education|education
789421|NCT00295516|Rhesus|rhesus
789422|NCT00295516|Isoimmunization|isoimmunization
789423|NCT00295516|Red Cell Alloimmunization|red cell alloimmunization
789424|NCT00295516|Fetal Hemolytic Anemia|fetal hemolytic anemia
789425|NCT00295516|Erythroblastosis fetalis|erythroblastosis fetalis
789426|NCT00295503|mesothelioma|mesothelioma
789427|NCT00295503|bevacizumab|bevacizumab
789428|NCT00295503|chemotherapy|chemotherapy
789429|NCT00295490|double blind randomised controlled trial|double blind randomised controlled trial
789430|NCT00295490|phase II|phase ii
789431|NCT00295490|Devil's Claw|devil's claw
789432|NCT00295490|osteoarthritis of the knee|osteoarthritis of the knee
789433|NCT00295490|osteoarthritis of the hip|osteoarthritis of the hip
789434|NCT00295477|HIV|hiv
789435|NCT00295477|Treatment Experienced|treatment experienced
789436|NCT00295464|Antenatal glucocorticoid|antenatal glucocorticoid
789437|NCT00295464|Premature birth|premature birth
789438|NCT00295438|robot-based tele-echography|robot-based tele-echography
789439|NCT00295438|tele-medicine|tele-medicine
789440|NCT00295425|psoriasis|psoriasis
789441|NCT00295425|randomized clinical trial|randomized clinical trial
789442|NCT00295425|cyclosporine A|cyclosporine a
789443|NCT00295425|mycophenolate mofetil|mycophenolate mofetil
789444|NCT00295425|immunosuppression|immunosuppression
789445|NCT00295399|cerebrovascular accident|cerebrovascular accident
789446|NCT00295399|traumatic brain injury|traumatic brain injury
789447|NCT00295399|stroke|stroke
789448|NCT00295399|telerehabilitation|telerehabilitation
789449|NCT00295373|Hypercholesterolemia|hypercholesterolemia
789450|NCT00295373|Exercise|exercise
789451|NCT00295373|Statin|statin
789452|NCT00295373|Rosuvastatin|rosuvastatin
789453|NCT00295373|TLR4|tlr4
789454|NCT00295373|Inflammation|inflammation
789455|NCT00295360|cholestasis|cholestasis
789456|NCT00295360|BCRP|bcrp
789457|NCT00295360|multidrug resistance|multidrug resistance
789458|NCT00295360|duodenum|duodenum
789459|NCT00295360|bile acids|bile acids
789460|NCT00295360|ABCG2|abcg2
789461|NCT00295334|adherence|adherence
789462|NCT00295334|glycemic control|glycemic control
789463|NCT00295308|Opioid Dependence|opioid dependence
789464|NCT00295308|Clonidine|clonidine
789465|NCT00295308|Buprenorphine|buprenorphine
789466|NCT00295308|Opioid Abstinence|opioid abstinence
789467|NCT00295308|Relapse|relapse
789468|NCT00295295|vibration|vibration
789469|NCT00295295|bone density|bone density
789470|NCT00295282|Ulcerative Colitis|ulcerative colitis
789471|NCT00295282|UC|uc
789472|NCT00295282|Colitis|colitis
789473|NCT00295256|randomized trial|randomized trial
789474|NCT00295256|diabetes|diabetes
789475|NCT00295256|pregnancy|pregnancy
789476|NCT00295230|respiratory distress syndrome|respiratory distress syndrome
789477|NCT00295230|very low birth weight infant|very low birth weight infant
789478|NCT00295230|mechanical ventilation|mechanical ventilation
789479|NCT00295217|Fibroids|fibroids
789480|NCT00295217|Uterine Leiomyomas|uterine leiomyomas
789481|NCT00295217|ExAblate|exablate
789482|NCT00295217|MrgFUS|mrgfus
789483|NCT00295204|Syncope|syncope
789484|NCT00295204|pre-syncope|pre-syncope
789485|NCT00295204|palpitations|palpitations
789486|NCT00295191|end-stage renal disease|end-stage renal disease
789487|NCT00295191|hemodialysis|hemodialysis
789488|NCT00295191|cardiovascular morbidity and mortality|cardiovascular morbidity and mortality
789489|NCT00295191|high flux dialyser|high flux dialyser
789490|NCT00295191|ultrapure dialysate|ultrapure dialysate
789491|NCT00295191|coronary vascular calcifications|coronary vascular calcifications
789492|NCT00295191|carotid intima-media thickness|carotid intima-media thickness
789493|NCT00295191|atherosclerosis|atherosclerosis
789494|NCT00295152|elderly/aged|elderly/aged
789495|NCT00295152|occupational therapy|occupational therapy
789496|NCT00295152|daily activities|daily activities
789497|NCT00295152|caregivers|caregivers
789498|NCT00295152|sense of competence|sense of competence
789499|NCT00295139|treatment|treatment
789500|NCT00295139|dual diagnosis|dual diagnosis
789501|NCT00295126|Edentulous|edentulous
789502|NCT00295126|Tooth Loss|tooth loss
789503|NCT00295126|APC|apc
789504|NCT00295126|Autologous platelet concentrate|autologous platelet concentrate
789505|NCT00295113|Pulmonary arterial pressure|pulmonary arterial pressure
789506|NCT00295113|COPD|copd
789507|NCT00295113|Cardiac output|cardiac output
789508|NCT00295113|pulmonary and cardiac functions|pulmonary and cardiac functions
789509|NCT00295113|pulmonary arterial pressure measurements|pulmonary arterial pressure measurements
789510|NCT00295100|Tamoxifen|tamoxifen
789511|NCT00295100|Prevention|prevention
789512|NCT00295100|Breast Cancer|breast cancer
789513|NCT00295100|MRI|mri
789514|NCT00295087|Premature Ovarian Failure|premature ovarian failure
789515|NCT00295087|X-Chromosome Inactivation|x-chromosome inactivation
789516|NCT00295074|traumatic brain injury|traumatic brain injury
789517|NCT00295074|head injury|head injury
789518|NCT00295074|concussion|concussion
789519|NCT00295074|neuropsychologic test|neuropsychologic test
789520|NCT00295061|alpha 1-Antitrypsin Deficiency|alpha 1-antitrypsin deficiency
789521|NCT00295061|alpha 1-Antitrypsin|alpha 1-antitrypsin
789522|NCT00295061|pulmonary emphysema|pulmonary emphysema
789525|NCT00295048|schizophrenia|schizophrenia
789526|NCT00295022|Levocetirizine|levocetirizine
789527|NCT00295022|Xyzal|xyzal
789528|NCT00295022|Rhinitis|rhinitis
789529|NCT00295022|Allergic|allergic
789530|NCT00295022|Seasonal|seasonal
789531|NCT00295022|Ragweed|ragweed
789532|NCT00294996|Metastatic Her2+ Breast cancer|metastatic her2+ breast cancer
789533|NCT00294996|Myocet|myocet
789534|NCT00294996|liposomal doxorubicin|liposomal doxorubicin
789535|NCT00294996|trastuzumab|trastuzumab
789536|NCT00294931|Lung Cancer, Small Cell|lung cancer, small cell
789537|NCT00294931|Extensive|extensive
789538|NCT00294918|Human Immunodeficiency Virus-associated Adipose Redistribution Syndrome (HARS)|human immunodeficiency virus-associated adipose redistribution syndrome (hars)
789539|NCT00294918|Human Immunodeficiency Virus Infections|human immunodeficiency virus infections
789540|NCT00294918|Serostim®|serostim®
789541|NCT00294918|recombinant human growth hormone (r-hGH)|recombinant human growth hormone (r-hgh)
789542|NCT00294905|COPD|copd
789543|NCT00294905|smoking cessation|smoking cessation
789544|NCT00294905|implementation|implementation
789545|NCT00294905|patient counseling|patient counseling
789546|NCT00294905|general practice|general practice
789547|NCT00294892|HIV|hiv
789548|NCT00294892|mother to child transmission; MTCT|mother to child transmission; mtct
789549|NCT00294892|nevirapine resistance|nevirapine resistance
789550|NCT00294892|pharmacokinetics|pharmacokinetics
789551|NCT00294892|Treatment Naive|treatment naive
789552|NCT00294866|End Stage Renal Disease|end stage renal disease
789553|NCT00294866|Inflammation|inflammation
789554|NCT00294853|Coronary calcium score|coronary calcium score
789555|NCT00294853|Coronary artery disease|coronary artery disease
789556|NCT00294853|Cardiac transplantation|cardiac transplantation
789557|NCT00294853|Coronary calcium score in heart transplanted patients|coronary calcium score in heart transplanted patients
789558|NCT00294853|Coronary artery disease in heart transplanted patients|coronary artery disease in heart transplanted patients
789559|NCT00294827|Liver transplantation|liver transplantation
789560|NCT00294814|Cardiac Surgery|cardiac surgery
789561|NCT00294814|CABG|cabg
789562|NCT00294814|Microemboli|microemboli
789563|NCT00294814|Transcranial Doppler|transcranial doppler
789564|NCT00294814|Cognitive Decline|cognitive decline
789565|NCT00294814|Anastomotic Device|anastomotic device
789566|NCT00294814|Proximal Anastomosis|proximal anastomosis
789567|NCT00294814|Coronary Artery Bypass Graft (CABG)|coronary artery bypass graft (cabg)
789568|NCT00294801|knee osteoarthritis|knee osteoarthritis
789569|NCT00294788|Influenza|influenza
789570|NCT00294788|bioadjuvant|bioadjuvant
789571|NCT00294788|probiotic|probiotic
789572|NCT00294788|HAI|hai
789573|NCT00294788|immunity|immunity
789574|NCT00294788|vaccine|vaccine
789575|NCT00294788|Immune response to influenza vaccine|immune response to influenza vaccine
789576|NCT00294775|diastolic dysfunction|diastolic dysfunction
789577|NCT00294775|Reverse Remodelling|reverse remodelling
789578|NCT00294762|NSCLC|nsclc
789579|NCT00294762|Erlotinib|erlotinib
789580|NCT00294762|Tarceva|tarceva
789581|NCT00294762|Lung Cancer|lung cancer
789582|NCT00294749|Prostate,|prostate,
789583|NCT00294749|Infection,|infection,
789584|NCT00294749|Biopsy,|biopsy,
789585|NCT00294749|Antibiotic,|antibiotic,
789586|NCT00294749|Prophylaxis|prophylaxis
789587|NCT00294736|lung cancer|lung cancer
789588|NCT00294736|erlotinib|erlotinib
789589|NCT00294736|NSCLC|nsclc
789590|NCT00294736|smokers|smokers
789591|NCT00294710|Hypertension, aliskiren, hydrochlorothiazide, amlodipine|hypertension, aliskiren, hydrochlorothiazide, amlodipine
789592|NCT00294697|polymorphisms|polymorphisms
789593|NCT00294697|innate immune response|innate immune response
789594|NCT00294697|immunomonitoring|immunomonitoring
789595|NCT00294697|immuno paralysis|immuno paralysis
789596|NCT00294684|biliary atresia|biliary atresia
789597|NCT00294684|hepatoportoenterostomy|hepatoportoenterostomy
789598|NCT00294684|corticosteroids|corticosteroids
789599|NCT00294671|familial amyloid polyneuropathy|familial amyloid polyneuropathy
789600|NCT00294671|familial amyloidosis|familial amyloidosis
789601|NCT00294671|diflunisal|diflunisal
789602|NCT00294671|amyloidosis|amyloidosis
789603|NCT00294671|transthyretin|transthyretin
789604|NCT00294671|peripheral neuropathy|peripheral neuropathy
789605|NCT00294671|autonomic neuropathy|autonomic neuropathy
789606|NCT00294671|amyloid cardiomyopathy|amyloid cardiomyopathy
789607|NCT00294658|myasthenia gravis|myasthenia gravis
789608|NCT00294658|thymectomy|thymectomy
789609|NCT00294658|prednisone|prednisone
789610|NCT00294658|corticosteroid|corticosteroid
789611|NCT00294658|extended transsternal thymectomy|extended transsternal thymectomy
789612|NCT00294658|ETTX|ettx
789613|NCT00294658|MG|mg
789614|NCT00294658|thymus|thymus
789615|NCT00294658|thymoma|thymoma
789616|NCT00294645|Remote Follow Up|remote follow up
789617|NCT00294645|Diagnostic|diagnostic
789618|NCT00294645|Bradycardia|bradycardia
789619|NCT00294632|Mantle Cell Lymphoma|mantle cell lymphoma
789620|NCT00294632|B-Cell Non-Hodgkin's Lymphoma|b-cell non-hodgkin's lymphoma
789621|NCT00294632|Transformed Large Cell Lymphoma|transformed large cell lymphoma
789622|NCT00294632|Follicular Lymphoma|follicular lymphoma
789625|NCT00294632|Lenalidomide|lenalidomide
789626|NCT00294632|CC-5013|cc-5013
789627|NCT00294632|Revlimid™|revlimid™
789628|NCT00294632|Rituximab|rituximab
789629|NCT00294632|Rituxan|rituxan
789630|NCT00294619|Growth hormone deficiency|growth hormone deficiency
789631|NCT00294606|vasopressor agents|vasopressor agents
789632|NCT00294606|carotid endarterectomy|carotid endarterectomy
789633|NCT00294606|cardiac function|cardiac function
789634|NCT00294606|transesophageal echocardiography|transesophageal echocardiography
789635|NCT00294606|wall motion abnormalities|wall motion abnormalities
789636|NCT00294593|Down syndrome|down syndrome
789637|NCT00294593|folinic acid therapy|folinic acid therapy
789638|NCT00294593|cognitive functions|cognitive functions
789639|NCT00294580|Malaria|malaria
789640|NCT00294580|Cognition|cognition
789641|NCT00294580|Prevention & control|prevention & control
789642|NCT00294580|Anemia|anemia
789643|NCT00294580|Chemoprophylaxis|chemoprophylaxis
789644|NCT00294580|Mortality|mortality
789645|NCT00294580|Children|children
789646|NCT00294580|Randomized controlled trial|randomized controlled trial
789647|NCT00294580|Education|education
789648|NCT00294580|Long-term effects|long-term effects
789649|NCT00294580|The Gambia|the gambia
789650|NCT00294580|Africa, West|africa, west
789651|NCT00294567|Hypertension|hypertension
789652|NCT00294567|PCI|pci
789653|NCT00294567|Calcium Channel Blockers|calcium channel blockers
789654|NCT00294567|IVUS|ivus
789655|NCT00294567|Plaque|plaque
789656|NCT00294554|Parkinson's Disease|parkinson's disease
789657|NCT00294554|Cognitive Impairment|cognitive impairment
789658|NCT00294554|Dementia|dementia
789659|NCT00294554|Memory|memory
789660|NCT00294541|sickle cell disease|sickle cell disease
789661|NCT00294541|sickle cell anemia|sickle cell anemia
789662|NCT00294528|osteoarthritis, knee|osteoarthritis, knee
789663|NCT00294528|total knee arthroplasty|total knee arthroplasty
789664|NCT00294528|range of motion|range of motion
789665|NCT00294528|satisfaction|satisfaction
789666|NCT00294489|HCV|hcv
789667|NCT00294489|Fibrosis|fibrosis
789668|NCT00294489|Breath test|breath test
789669|NCT00294476|IVIg|ivig
789670|NCT00294476|Cancer|cancer
789671|NCT00294476|Melanoma|melanoma
789672|NCT00294463|postmenopause|postmenopause
789673|NCT00294463|endometrium|endometrium
789674|NCT00294463|Gene Expression Profiling|gene expression profiling
789675|NCT00294463|Histology, Comparative|histology, comparative
789676|NCT00294463|Hormone Replacement Therapy|hormone replacement therapy
789677|NCT00294463|Hormones|hormones
789678|NCT00294437|Prostate Cancer|prostate cancer
789679|NCT00294437|Zometa|zometa
789680|NCT00294424|Waiting time|waiting time
789681|NCT00294424|Total hip replacement|total hip replacement
789682|NCT00294424|Total knee replacement|total knee replacement
789683|NCT00294424|Quality of life|quality of life
789684|NCT00294424|The15D|the15d
789685|NCT00294424|Harris Hip Score|harris hip score
789686|NCT00294424|Knee Score|knee score
789687|NCT00294424|Pain measurement|pain measurement
789688|NCT00294424|Cost-effectiveness|cost-effectiveness
789689|NCT00294424|Medication|medication
789690|NCT00294424|Health services|health services
789691|NCT00294424|Social services|social services
789692|NCT00294424|Randomized Controlled Trial|randomized controlled trial
789693|NCT00294398|Asthma, Controller Medications|asthma, controller medications
789694|NCT00294385|Breast Cancer|breast cancer
789695|NCT00294385|Docetaxel|docetaxel
789696|NCT00294359|colorectal neoplasm|colorectal neoplasm
789697|NCT00294346|Social Anxiety Disorder|social anxiety disorder
789698|NCT00294346|Social Phobia|social phobia
789699|NCT00294320|Aldara|aldara
789700|NCT00294320|Actinic Keratosis|actinic keratosis
789701|NCT00294307|Nursing Models of Care|nursing models of care
789702|NCT00294307|Collaborative Care|collaborative care
789703|NCT00294307|Care Management|care management
789704|NCT00294307|Transitional Care|transitional care
789705|NCT00294307|Advanced Practice Nurse Care Interventions|advanced practice nurse care interventions
789706|NCT00294307|Cognitive Impairment|cognitive impairment
789707|NCT00294307|Dementia|dementia
789708|NCT00294307|Delirium|delirium
789709|NCT00294294|vaccine|vaccine
789710|NCT00294294|infant|infant
789711|NCT00294281|Pain|pain
789712|NCT00294281|Tenderness|tenderness
789713|NCT00294281|Depression|depression
789714|NCT00294281|Work Disability|work disability
789715|NCT00294281|Physical Function|physical function
789716|NCT00294281|Quality of Life|quality of life
789717|NCT00294281|Chronic Pain|chronic pain
789718|NCT00294268|obesity|obesity
789719|NCT00294268|CBT|cbt
789720|NCT00294268|motivational enhancement therapy|motivational enhancement therapy
789721|NCT00294268|weight loss maintenance|weight loss maintenance
789722|NCT00294255|mixed mania|mixed mania
789723|NCT00294255|depression|depression
789724|NCT00294255|irritability|irritability
789725|NCT00294242|pregnancy|pregnancy
789726|NCT00294242|membranes sweeping|membranes sweeping
789727|NCT00294242|prelabor rupture of membranes|prelabor rupture of membranes
789728|NCT00294229|Low back pain|low back pain
789729|NCT00294229|Spinal manipulative therapy|spinal manipulative therapy
789730|NCT00294229|Randomised controlled trial|randomised controlled trial
789731|NCT00294216|Omacor|omacor
789732|NCT00294216|Omega-3 PUFA|omega-3 pufa
789733|NCT00294216|Endarterectomy|endarterectomy
789734|NCT00294216|Carotid Plaque stability|carotid plaque stability
789735|NCT00294216|Structural changes|structural changes
789736|NCT00294216|inflammation|inflammation
789737|NCT00294203|Digestive System Surgical Procedures|digestive system surgical procedures
789738|NCT00294203|Post-Operative Care|post-operative care
789739|NCT00294203|Fatigue|fatigue
789740|NCT00294203|Quality of Life|quality of life
789741|NCT00294203|Erythrocyte Transfusion|erythrocyte transfusion
789742|NCT00294203|Esophagectomy|esophagectomy
789743|NCT00294203|Gastric Cancer|gastric cancer
789744|NCT00294203|Hepatectomy|hepatectomy
789745|NCT00294203|Pancreatic Cancer|pancreatic cancer
789746|NCT00294203|Rectum|rectum
789747|NCT00294190|Lung Cancer|lung cancer
789748|NCT00294190|Extensive stage|extensive stage
789749|NCT00294190|Small Cell Lung Cancer|small cell lung cancer
789750|NCT00294177|Trophoblastic Neoplasms|trophoblastic neoplasms
789751|NCT00294177|Chorionic Gonadotropin|chorionic gonadotropin
789752|NCT00294177|Molecular Conformation|molecular conformation
789753|NCT00294164|Human Immunodeficiency Virus-associated Adipose Redistribution Syndrome (HARS)|human immunodeficiency virus-associated adipose redistribution syndrome (hars)
789754|NCT00294164|Human Immunodeficiency Virus Infections|human immunodeficiency virus infections
789755|NCT00294164|recombinant human growth hormone (r-hGH)|recombinant human growth hormone (r-hgh)
789756|NCT00294164|Serostim®|serostim®
789757|NCT00294164|Placebo|placebo
789758|NCT00294151|breast cancer|breast cancer
789759|NCT00294151|prostate cancer|prostate cancer
789760|NCT00294151|vertebral metastasis|vertebral metastasis
789761|NCT00294151|vertebroplasty|vertebroplasty
789762|NCT00294151|vertebral metastasis from breast cancer|vertebral metastasis from breast cancer
789763|NCT00294151|vertebral metastasis from prostate cancer|vertebral metastasis from prostate cancer
789764|NCT00294125|Medical Food|medical food
789765|NCT00294125|Botanicals|botanicals
789766|NCT00294125|Phytochemicals|phytochemicals
789767|NCT00294112|mesenchymal stem cells|mesenchymal stem cells
789768|NCT00294099|A/H5N1, Influenza, Vaccine|a/h5n1, influenza, vaccine
789769|NCT00294086|valsartan,|valsartan,
789770|NCT00294086|chronic heart failure,|chronic heart failure,
789771|NCT00294073|femoral block|femoral block
789772|NCT00294073|fascia iliaca block|fascia iliaca block
789773|NCT00294073|ACL repair|acl repair
789774|NCT00294073|post-operative analgesia|post-operative analgesia
789775|NCT00294073|knee surgery|knee surgery
789776|NCT00294073|ACL damage|acl damage
789777|NCT00294073|knee damage|knee damage
789778|NCT00294060|Pacemaker|pacemaker
789779|NCT00294060|Bradycardia|bradycardia
789780|NCT00294047|Vaccine|vaccine
789781|NCT00294047|Human papillomavirus|human papillomavirus
789782|NCT00294047|Cervical Cancer|cervical cancer
789783|NCT00294047|Cervical Infection|cervical infection
789784|NCT00294034|Registry|registry
789785|NCT00294034|Pacemaker|pacemaker
789786|NCT00294034|Diagnostics|diagnostics
789787|NCT00294008|Schizophrenia|schizophrenia
789788|NCT00294008|Treatment adherence|treatment adherence
790152|NCT00293228|biomarkers|biomarkers
789789|NCT00294008|Antipsychotic agents|antipsychotic agents
789790|NCT00294008|Risperidone|risperidone
789791|NCT00294008|Long-acting injectable|long-acting injectable
789792|NCT00294008|Risperdal tablet|risperdal tablet
789793|NCT00294008|Risperidal Consta|risperidal consta
789794|NCT00293982|Patient satisfaction|patient satisfaction
789795|NCT00293982|Patient expectations|patient expectations
789796|NCT00293982|Pediatric emergency department|pediatric emergency department
789797|NCT00293969|Pain|pain
789798|NCT00293969|Morphine|morphine
789799|NCT00293956|hypothyroxinemia|hypothyroxinemia
789800|NCT00293956|full term infants|full term infants
789801|NCT00293956|near term infants|near term infants
789802|NCT00293956|respiratory distress|respiratory distress
789803|NCT00293956|thyroid disease|thyroid disease
789804|NCT00293943|Atrial fibrillation|atrial fibrillation
789805|NCT00293943|Pulmonary vein ablation|pulmonary vein ablation
789806|NCT00293943|Linear lesions|linear lesions
789807|NCT00293930|Treatment Outcome|treatment outcome
789808|NCT00293930|Tacrolimus|tacrolimus
789809|NCT00293930|Safety|safety
789810|NCT00293930|Psoriasis|psoriasis
789811|NCT00293917|Treatment Outcome|treatment outcome
789812|NCT00293917|Tacrolimus|tacrolimus
789813|NCT00293917|Safety|safety
789814|NCT00293917|Psoriasis|psoriasis
789815|NCT00293904|Allergy|allergy
789816|NCT00293904|Grass Pollen|grass pollen
789817|NCT00293904|Systemic Immunotherapy|systemic immunotherapy
789818|NCT00293891|Treatment Outcome|treatment outcome
789819|NCT00293891|Tacrolimus|tacrolimus
789820|NCT00293891|Safety|safety
789821|NCT00293891|Psoriasis|psoriasis
789822|NCT00293865|Breast infiltrative cancer|breast infiltrative cancer
789823|NCT00293852|Heart failure, Congestive|heart failure, congestive
789824|NCT00293852|Metabolic Syndrome X|metabolic syndrome x
789825|NCT00293852|Ambulatory Care|ambulatory care
789826|NCT00293852|Health behavior|health behavior
789829|NCT00293826|ACR criteria|acr criteria
789830|NCT00293826|methotrexate|methotrexate
789831|NCT00293826|DMARDs|dmards
789832|NCT00293826|patient reported outcomes|patient reported outcomes
789833|NCT00293826|joint assessment|joint assessment
789834|NCT00293813|Post Menopausal|post menopausal
789835|NCT00293813|Osteoporosis|osteoporosis
789836|NCT00293813|MicroCT|microct
789837|NCT00293813|Amgen|amgen
789838|NCT00293813|denosumab|denosumab
789839|NCT00293813|Extreme CT|extreme ct
789840|NCT00293813|XCT|xct
789841|NCT00293813|Fosamax|fosamax
789842|NCT00293813|Alendronate|alendronate
789843|NCT00293800|Open-angle|open-angle
789844|NCT00293800|glaucoma|glaucoma
789845|NCT00293800|ocular|ocular
789846|NCT00293800|hypertension|hypertension
789847|NCT00293787|Open-angle|open-angle
789848|NCT00293787|glaucoma|glaucoma
789849|NCT00293787|ocular|ocular
789850|NCT00293787|hypertension|hypertension
789851|NCT00293774|Prospective|prospective
789852|NCT00293774|Conventional therapy|conventional therapy
789853|NCT00293774|Registry|registry
789854|NCT00293774|Metal-on-metal|metal-on-metal
789855|NCT00293774|Ceramic-on-ceramic|ceramic-on-ceramic
789856|NCT00293774|Hip Arthroplasty|hip arthroplasty
789857|NCT00293761|open-angle|open-angle
789858|NCT00293761|glaucoma|glaucoma
789859|NCT00293761|ocular|ocular
789860|NCT00293761|hypertension|hypertension
789861|NCT00293748|Genomics|genomics
789862|NCT00293748|Statins|statins
789863|NCT00293748|Coronary Heart Disease|coronary heart disease
789864|NCT00293748|Stroke|stroke
789865|NCT00293748|Inflammation|inflammation
789866|NCT00293748|Gene Expression|gene expression
789867|NCT00293748|Vascular Risk|vascular risk
789868|NCT00293748|Peripheral Blood Mononuclear Cells|peripheral blood mononuclear cells
789869|NCT00293748|Atorvastatin|atorvastatin
789870|NCT00293748|Vascular Disease|vascular disease
789871|NCT00293748|Vascular Disease Risk|vascular disease risk
789872|NCT00293735|Preeclampsia|preeclampsia
789873|NCT00293735|Pregnancy|pregnancy
789874|NCT00293735|Hypertension|hypertension
789875|NCT00293735|Eclampsia|eclampsia
789876|NCT00293735|HELLP Syndrome|hellp syndrome
789877|NCT00293735|Seizures|seizures
789878|NCT00293735|Prevention|prevention
789879|NCT00293722|Arthritis|arthritis
789880|NCT00293709|Arthritis|arthritis
789881|NCT00293696|biomarker study|biomarker study
789882|NCT00293696|Patients with clinically localised prostate cancer|patients with clinically localised prostate cancer
789883|NCT00293683|cesarean|cesarean
789884|NCT00293683|closure|closure
789885|NCT00293683|skin|skin
789886|NCT00293683|staple|staple
789887|NCT00293683|absorbable|absorbable
789888|NCT00293683|metal|metal
789889|NCT00293644|Pregnancy Complications|pregnancy complications
789890|NCT00293644|Hyperemesis Gravidarum|hyperemesis gravidarum
789891|NCT00293644|Diclectin|diclectin
789892|NCT00293644|doxylamine succinate|doxylamine succinate
789893|NCT00293644|pyridoxine hydrochloride|pyridoxine hydrochloride
789894|NCT00293618|Implementation of prediction rules|implementation of prediction rules
790153|NCT00293228|isoniazid|isoniazid
789895|NCT00293618|Decision Support Systems, Clinical|decision support systems, clinical
789896|NCT00293618|PONV|ponv
789897|NCT00293618|Emesis|emesis
789898|NCT00293618|Nausea|nausea
789899|NCT00293618|Vomiting|vomiting
789900|NCT00293618|Postoperative|postoperative
789901|NCT00293618|Implementation|implementation
789902|NCT00293618|prediction rule|prediction rule
789903|NCT00293618|impact study|impact study
789904|NCT00293618|decision support|decision support
789905|NCT00293618|clinical decision support|clinical decision support
789906|NCT00293605|aseptic loosening|aseptic loosening
789907|NCT00293605|femoral stem design|femoral stem design
789908|NCT00293592|Heart surgery|heart surgery
789909|NCT00293592|Cardiopulmonary bypass|cardiopulmonary bypass
789910|NCT00293592|Systemic Inflammatory Response Syndrome (SIRS)|systemic inflammatory response syndrome (sirs)
789911|NCT00293579|head and neck cancer|head and neck cancer
789912|NCT00293540|metastatic|metastatic
789913|NCT00293540|secondary|secondary
789914|NCT00293540|Hormone Receptor-Positive Breast Cancer|hormone receptor-positive breast cancer
789915|NCT00293527|Metastatic|metastatic
789916|NCT00293514|standard surgical treatment for air leakage in pulmonary lobectomy|standard surgical treatment for air leakage in pulmonary lobectomy
789917|NCT00293501|clear cell renal cell carcinoma|clear cell renal cell carcinoma
789918|NCT00293501|stage IV renal cell cancer|stage iv renal cell cancer
789919|NCT00293501|recurrent renal cell cancer|recurrent renal cell cancer
789920|NCT00293488|anaplastic large cell lymphoma|anaplastic large cell lymphoma
789921|NCT00293488|angioimmunoblastic T-cell lymphoma|angioimmunoblastic t-cell lymphoma
789922|NCT00293488|extranodal marginal zone B-cell lymphoma of mucosa-associated lymphoid tissue|extranodal marginal zone b-cell lymphoma of mucosa-associated lymphoid tissue
789923|NCT00293488|nodal marginal zone B-cell lymphoma|nodal marginal zone b-cell lymphoma
789924|NCT00293488|recurrent adult Burkitt lymphoma|recurrent adult burkitt lymphoma
789925|NCT00293488|recurrent adult diffuse large cell lymphoma|recurrent adult diffuse large cell lymphoma
789926|NCT00293488|recurrent adult Hodgkin lymphoma|recurrent adult hodgkin lymphoma
789927|NCT00293488|recurrent adult T-cell leukemia/lymphoma|recurrent adult t-cell leukemia/lymphoma
789928|NCT00293488|recurrent cutaneous T-cell non-Hodgkin lymphoma|recurrent cutaneous t-cell non-hodgkin lymphoma
789929|NCT00293488|recurrent grade 1 follicular lymphoma|recurrent grade 1 follicular lymphoma
789930|NCT00293488|recurrent grade 2 follicular lymphoma|recurrent grade 2 follicular lymphoma
789931|NCT00293488|recurrent grade 3 follicular lymphoma|recurrent grade 3 follicular lymphoma
789932|NCT00293488|recurrent mantle cell lymphoma|recurrent mantle cell lymphoma
789933|NCT00293488|recurrent marginal zone lymphoma|recurrent marginal zone lymphoma
789934|NCT00293488|recurrent mycosis fungoides/Sezary syndrome|recurrent mycosis fungoides/sezary syndrome
789935|NCT00293488|splenic marginal zone lymphoma|splenic marginal zone lymphoma
789936|NCT00293462|mucositis|mucositis
789937|NCT00293462|radiation toxicity|radiation toxicity
789938|NCT00293462|recurrent squamous and basal cell carcinoma of the hypopharynx,larynx,lip,nasopharynx|recurrent squamous and basal cell carcinoma of the hypopharynx,larynx,lip,nasopharynx
789939|NCT00293462|oropharynx, paranasal sinus and nasal cavity|oropharynx, paranasal sinus and nasal cavity
789940|NCT00293462|stage I-IV lymphoepithelioma of the nasopharynx|stage i-iv lymphoepithelioma of the nasopharynx
789941|NCT00293462|stage I-IV lymphoepithelioma of the oropharynx|stage i-iv lymphoepithelioma of the oropharynx
789942|NCT00293462|Recurrent and stage I-IV esthesioneuroblastoma of the paranasal sinus and nasal cavity|recurrent and stage i-iv esthesioneuroblastoma of the paranasal sinus and nasal cavity
789943|NCT00293462|Recurrent and stage I-IV inverted papilloma of the paranasal sinus and nasal cavity|recurrent and stage i-iv inverted papilloma of the paranasal sinus and nasal cavity
789944|NCT00293462|Recurrent and stage I-IV midline lethal granuloma of the paranasal sinus and nasal cavity|recurrent and stage i-iv midline lethal granuloma of the paranasal sinus and nasal cavity
789945|NCT00293462|untreated, current,metastatic squamous neck cancer with occult primary|untreated, current,metastatic squamous neck cancer with occult primary
789946|NCT00293462|recurrent verrucous carcinoma of the larynx|recurrent verrucous carcinoma of the larynx
789947|NCT00293462|recurrent lymphoepithelioma of the oropharynx|recurrent lymphoepithelioma of the oropharynx
789948|NCT00293462|stage I verrucous carcinoma of the larynx|stage i verrucous carcinoma of the larynx
789949|NCT00293462|recurrent verrucous carcinoma of the oral cavity|recurrent verrucous carcinoma of the oral cavity
789950|NCT00293462|stage I verrucous carcinoma of the oral cavity|stage i verrucous carcinoma of the oral cavity
789951|NCT00293462|stage II verrucous carcinoma of the larynx|stage ii verrucous carcinoma of the larynx
789952|NCT00293462|stage II verrucous carcinoma of the oral cavity|stage ii verrucous carcinoma of the oral cavity
789953|NCT00293462|stage III verrucous carcinoma of the larynx|stage iii verrucous carcinoma of the larynx
789954|NCT00293462|stage III verrucous carcinoma of the oral cavity|stage iii verrucous carcinoma of the oral cavity
789955|NCT00293462|stage IV verrucous carcinoma of the larynx|stage iv verrucous carcinoma of the larynx
789956|NCT00293462|stage IV verrucous carcinoma of the oral cavity|stage iv verrucous carcinoma of the oral cavity
789957|NCT00293462|recurrent adenoid cystic carcinoma of the oral cavity|recurrent adenoid cystic carcinoma of the oral cavity
789958|NCT00293462|stage I adenoid cystic carcinoma of the oral cavity|stage i adenoid cystic carcinoma of the oral cavity
789959|NCT00293462|stage II adenoid cystic carcinoma of the oral cavity|stage ii adenoid cystic carcinoma of the oral cavity
789960|NCT00293462|stage III adenoid cystic carcinoma of the oral cavity|stage iii adenoid cystic carcinoma of the oral cavity
790081|NCT00293384|secondary acute myeloid leukemia|secondary acute myeloid leukemia
789961|NCT00293462|stage IV adenoid cystic carcinoma of the oral cavity|stage iv adenoid cystic carcinoma of the oral cavity
789962|NCT00293462|recurrent mucoepidermoid carcinoma of the oral cavity|recurrent mucoepidermoid carcinoma of the oral cavity
789963|NCT00293462|stage I mucoepidermoid carcinoma of the oral cavity|stage i mucoepidermoid carcinoma of the oral cavity
789964|NCT00293462|stage II mucoepidermoid carcinoma of the oral cavity|stage ii mucoepidermoid carcinoma of the oral cavity
789965|NCT00293462|stage III mucoepidermoid carcinoma of the oral cavity|stage iii mucoepidermoid carcinoma of the oral cavity
789966|NCT00293462|stage IV mucoepidermoid carcinoma of the oral cavity|stage iv mucoepidermoid carcinoma of the oral cavity
789967|NCT00293462|recurrent squamous cell carcinoma of the lip and oral cavity|recurrent squamous cell carcinoma of the lip and oral cavity
789968|NCT00293462|stage I squamous cell carcinoma of the lip and oral cavity|stage i squamous cell carcinoma of the lip and oral cavity
789969|NCT00293462|stage II squamous cell carcinoma of the lip and oral cavity|stage ii squamous cell carcinoma of the lip and oral cavity
789970|NCT00293462|stage III squamous cell carcinoma of the lip and oral cavity|stage iii squamous cell carcinoma of the lip and oral cavity
789971|NCT00293462|stage IV squamous cell carcinoma of the lip and oral cavity|stage iv squamous cell carcinoma of the lip and oral cavity
789972|NCT00293462|tongue cancer|tongue cancer
789973|NCT00293436|adult primary hepatocellular carcinoma|adult primary hepatocellular carcinoma
789974|NCT00293436|advanced adult primary liver cancer|advanced adult primary liver cancer
789975|NCT00293436|localized resectable adult primary liver cancer|localized resectable adult primary liver cancer
789976|NCT00293423|adult glioblastoma|adult glioblastoma
789977|NCT00293423|recurrent adult brain tumor|recurrent adult brain tumor
789978|NCT00293410|adult acute myeloid leukemia with 11q23 (MLL) abnormalities|adult acute myeloid leukemia with 11q23 (mll) abnormalities
789979|NCT00293410|adult acute myeloid leukemia with inv(16)(p13;q22)|adult acute myeloid leukemia with inv(16)(p13;q22)
789980|NCT00293410|adult acute myeloid leukemia with t(15;17)(q22;q12)|adult acute myeloid leukemia with t(15;17)(q22;q12)
789981|NCT00293410|adult acute myeloid leukemia with t(16;16)(p13;q22)|adult acute myeloid leukemia with t(16;16)(p13;q22)
789982|NCT00293410|adult acute myeloid leukemia with t(8;21)(q22;q22)|adult acute myeloid leukemia with t(8;21)(q22;q22)
789983|NCT00293410|recurrent adult acute myeloid leukemia|recurrent adult acute myeloid leukemia
789984|NCT00293410|recurrent childhood acute myeloid leukemia|recurrent childhood acute myeloid leukemia
789985|NCT00293410|secondary acute myeloid leukemia|secondary acute myeloid leukemia
789986|NCT00293410|myelodysplastic/myeloproliferative disease, unclassifiable|myelodysplastic/myeloproliferative disease, unclassifiable
789987|NCT00293410|accelerated phase chronic myelogenous leukemia|accelerated phase chronic myelogenous leukemia
789988|NCT00293410|chronic idiopathic myelofibrosis|chronic idiopathic myelofibrosis
789989|NCT00293410|chronic myelomonocytic leukemia|chronic myelomonocytic leukemia
789990|NCT00293410|juvenile myelomonocytic leukemia|juvenile myelomonocytic leukemia
789991|NCT00293410|recurrent adult acute lymphoblastic leukemia|recurrent adult acute lymphoblastic leukemia
789992|NCT00293410|recurrent childhood acute lymphoblastic leukemia|recurrent childhood acute lymphoblastic leukemia
789993|NCT00293410|acute undifferentiated leukemia|acute undifferentiated leukemia
789994|NCT00293410|blastic phase chronic myelogenous leukemia|blastic phase chronic myelogenous leukemia
789995|NCT00293410|childhood chronic myelogenous leukemia|childhood chronic myelogenous leukemia
789996|NCT00293410|adult acute basophilic leukemia|adult acute basophilic leukemia
789997|NCT00293410|adult acute eosinophilic leukemia|adult acute eosinophilic leukemia
789998|NCT00293410|adult acute megakaryoblastic leukemia (M7)|adult acute megakaryoblastic leukemia (m7)
789999|NCT00293410|adult acute minimally differentiated myeloid leukemia (M0)|adult acute minimally differentiated myeloid leukemia (m0)
790000|NCT00293410|adult acute monoblastic leukemia (M5a)|adult acute monoblastic leukemia (m5a)
790001|NCT00293410|adult acute monocytic leukemia (M5b)|adult acute monocytic leukemia (m5b)
790002|NCT00293410|adult acute myeloblastic leukemia with maturation (M2)|adult acute myeloblastic leukemia with maturation (m2)
790003|NCT00293410|adult acute myeloblastic leukemia without maturation (M1)|adult acute myeloblastic leukemia without maturation (m1)
790004|NCT00293410|adult acute myelomonocytic leukemia (M4)|adult acute myelomonocytic leukemia (m4)
790005|NCT00293410|adult acute promyelocytic leukemia (M3)|adult acute promyelocytic leukemia (m3)
790006|NCT00293410|adult erythroleukemia (M6a)|adult erythroleukemia (m6a)
790007|NCT00293410|adult pure erythroid leukemia (M6b)|adult pure erythroid leukemia (m6b)
790008|NCT00293410|childhood acute basophilic leukemia|childhood acute basophilic leukemia
790009|NCT00293410|childhood acute monocytic leukemia (M5b)|childhood acute monocytic leukemia (m5b)
790010|NCT00293410|childhood acute eosinophilic leukemia|childhood acute eosinophilic leukemia
790011|NCT00293410|childhood acute erythroleukemia (M6)|childhood acute erythroleukemia (m6)
790012|NCT00293410|childhood acute megakaryocytic leukemia (M7)|childhood acute megakaryocytic leukemia (m7)
790013|NCT00293410|childhood acute minimally differentiated myeloid leukemia (M0)|childhood acute minimally differentiated myeloid leukemia (m0)
790014|NCT00293410|childhood acute myeloblastic leukemia with maturation (M2)|childhood acute myeloblastic leukemia with maturation (m2)
790015|NCT00293410|childhood acute myeloblastic leukemia without maturation (M1)|childhood acute myeloblastic leukemia without maturation (m1)
790016|NCT00293410|childhood acute myelomonocytic leukemia (M4)|childhood acute myelomonocytic leukemia (m4)
790017|NCT00293410|childhood acute monoblastic leukemia (M5a)|childhood acute monoblastic leukemia (m5a)
790018|NCT00293410|childhood acute promyelocytic leukemia (M3)|childhood acute promyelocytic leukemia (m3)
790019|NCT00293397|adult primary hepatocellular carcinoma|adult primary hepatocellular carcinoma
790151|NCT00293228|Latent tuberculosis|latent tuberculosis
790020|NCT00293397|localized unresectable adult primary liver cancer|localized unresectable adult primary liver cancer
790021|NCT00293384|nausea and vomiting|nausea and vomiting
790022|NCT00293384|adult acute myeloid leukemia with 11q23 (MLL) abnormalities|adult acute myeloid leukemia with 11q23 (mll) abnormalities
790023|NCT00293384|adult acute myeloid leukemia with inv(16)(p13;q22)|adult acute myeloid leukemia with inv(16)(p13;q22)
790024|NCT00293384|adult acute myeloid leukemia with t(15;17)(q22;q12)|adult acute myeloid leukemia with t(15;17)(q22;q12)
790025|NCT00293384|adult acute myeloid leukemia with t(16;16)(p13;q22)|adult acute myeloid leukemia with t(16;16)(p13;q22)
790026|NCT00293384|adult acute myeloid leukemia with t(8;21)(q22;q22)|adult acute myeloid leukemia with t(8;21)(q22;q22)
790027|NCT00293384|accelerated phase chronic myelogenous leukemia|accelerated phase chronic myelogenous leukemia
790028|NCT00293384|adult acute lymphoblastic leukemia in remission|adult acute lymphoblastic leukemia in remission
790029|NCT00293384|adult acute myeloid leukemia in remission|adult acute myeloid leukemia in remission
790030|NCT00293384|atypical chronic myeloid leukemia, BCR-ABL negative|atypical chronic myeloid leukemia, bcr-abl negative
790031|NCT00293384|blastic phase chronic myelogenous leukemia|blastic phase chronic myelogenous leukemia
790032|NCT00293384|chronic eosinophilic leukemia|chronic eosinophilic leukemia
790033|NCT00293384|primary myelofibrosis|primary myelofibrosis
790034|NCT00293384|chronic myelomonocytic leukemia|chronic myelomonocytic leukemia
790035|NCT00293384|chronic neutrophilic leukemia|chronic neutrophilic leukemia
790036|NCT00293384|chronic phase chronic myelogenous leukemia|chronic phase chronic myelogenous leukemia
790037|NCT00293384|de novo myelodysplastic syndromes|de novo myelodysplastic syndromes
790038|NCT00293384|disseminated neuroblastoma|disseminated neuroblastoma
790039|NCT00293384|extranodal marginal zone B-cell lymphoma of mucosa-associated lymphoid tissue|extranodal marginal zone b-cell lymphoma of mucosa-associated lymphoid tissue
790040|NCT00293384|myelodysplastic/myeloproliferative neoplasm, unclassifiable|myelodysplastic/myeloproliferative neoplasm, unclassifiable
790041|NCT00293384|nodal marginal zone B-cell lymphoma|nodal marginal zone b-cell lymphoma
790042|NCT00293384|noncontiguous stage II adult Burkitt lymphoma|noncontiguous stage ii adult burkitt lymphoma
790191|NCT00292994|Weight loss|weight loss
790043|NCT00293384|noncontiguous stage II adult diffuse large cell lymphoma|noncontiguous stage ii adult diffuse large cell lymphoma
790044|NCT00293384|noncontiguous stage II adult diffuse mixed cell lymphoma|noncontiguous stage ii adult diffuse mixed cell lymphoma
790045|NCT00293384|noncontiguous stage II adult diffuse small cleaved cell lymphoma|noncontiguous stage ii adult diffuse small cleaved cell lymphoma
790046|NCT00293384|noncontiguous stage II adult immunoblastic large cell lymphoma|noncontiguous stage ii adult immunoblastic large cell lymphoma
790047|NCT00293384|noncontiguous stage II adult lymphoblastic lymphoma|noncontiguous stage ii adult lymphoblastic lymphoma
790048|NCT00293384|noncontiguous stage II grade 1 follicular lymphoma|noncontiguous stage ii grade 1 follicular lymphoma
790049|NCT00293384|noncontiguous stage II grade 2 follicular lymphoma|noncontiguous stage ii grade 2 follicular lymphoma
790050|NCT00293384|noncontiguous stage II grade 3 follicular lymphoma|noncontiguous stage ii grade 3 follicular lymphoma
790051|NCT00293384|noncontiguous stage II mantle cell lymphoma|noncontiguous stage ii mantle cell lymphoma
790052|NCT00293384|noncontiguous stage II marginal zone lymphoma|noncontiguous stage ii marginal zone lymphoma
790053|NCT00293384|noncontiguous stage II small lymphocytic lymphoma|noncontiguous stage ii small lymphocytic lymphoma
790054|NCT00293384|poor prognosis metastatic gestational trophoblastic tumor|poor prognosis metastatic gestational trophoblastic tumor
790055|NCT00293384|previously treated myelodysplastic syndromes|previously treated myelodysplastic syndromes
790056|NCT00293384|recurrent adult acute lymphoblastic leukemia|recurrent adult acute lymphoblastic leukemia
790057|NCT00293384|recurrent adult acute myeloid leukemia|recurrent adult acute myeloid leukemia
790058|NCT00293384|recurrent adult Burkitt lymphoma|recurrent adult burkitt lymphoma
790059|NCT00293384|recurrent adult Hodgkin lymphoma|recurrent adult hodgkin lymphoma
790060|NCT00293384|recurrent adult diffuse large cell lymphoma|recurrent adult diffuse large cell lymphoma
790061|NCT00293384|recurrent adult diffuse mixed cell lymphoma|recurrent adult diffuse mixed cell lymphoma
790062|NCT00293384|recurrent adult diffuse small cleaved cell lymphoma|recurrent adult diffuse small cleaved cell lymphoma
790063|NCT00293384|recurrent adult immunoblastic large cell lymphoma|recurrent adult immunoblastic large cell lymphoma
790064|NCT00293384|recurrent adult lymphoblastic lymphoma|recurrent adult lymphoblastic lymphoma
790065|NCT00293384|recurrent cutaneous T-cell non-Hodgkin lymphoma|recurrent cutaneous t-cell non-hodgkin lymphoma
790066|NCT00293384|recurrent grade 1 follicular lymphoma|recurrent grade 1 follicular lymphoma
790067|NCT00293384|recurrent grade 2 follicular lymphoma|recurrent grade 2 follicular lymphoma
790068|NCT00293384|recurrent grade 3 follicular lymphoma|recurrent grade 3 follicular lymphoma
790069|NCT00293384|recurrent mantle cell lymphoma|recurrent mantle cell lymphoma
790070|NCT00293384|recurrent marginal zone lymphoma|recurrent marginal zone lymphoma
790071|NCT00293384|recurrent mycosis fungoides/Sezary syndrome|recurrent mycosis fungoides/sezary syndrome
790072|NCT00293384|recurrent neuroblastoma|recurrent neuroblastoma
790073|NCT00293384|recurrent ovarian epithelial cancer|recurrent ovarian epithelial cancer
790074|NCT00293384|recurrent ovarian germ cell tumor|recurrent ovarian germ cell tumor
790075|NCT00293384|recurrent small lymphocytic lymphoma|recurrent small lymphocytic lymphoma
790076|NCT00293384|recurrent malignant testicular germ cell tumor|recurrent malignant testicular germ cell tumor
790077|NCT00293384|refractory chronic lymphocytic leukemia|refractory chronic lymphocytic leukemia
790078|NCT00293384|refractory hairy cell leukemia|refractory hairy cell leukemia
790079|NCT00293384|refractory multiple myeloma|refractory multiple myeloma
790080|NCT00293384|relapsing chronic myelogenous leukemia|relapsing chronic myelogenous leukemia
790082|NCT00293384|secondary myelodysplastic syndromes|secondary myelodysplastic syndromes
790083|NCT00293384|splenic marginal zone lymphoma|splenic marginal zone lymphoma
790084|NCT00293384|stage I multiple myeloma|stage i multiple myeloma
790085|NCT00293384|stage II multiple myeloma|stage ii multiple myeloma
790086|NCT00293384|stage II ovarian epithelial cancer|stage ii ovarian epithelial cancer
790087|NCT00293384|stage III adult Burkitt lymphoma|stage iii adult burkitt lymphoma
790088|NCT00293384|stage III adult Hodgkin lymphoma|stage iii adult hodgkin lymphoma
790089|NCT00293384|stage III adult diffuse large cell lymphoma|stage iii adult diffuse large cell lymphoma
790090|NCT00293384|stage III adult diffuse mixed cell lymphoma|stage iii adult diffuse mixed cell lymphoma
790091|NCT00293384|stage III adult diffuse small cleaved cell lymphoma|stage iii adult diffuse small cleaved cell lymphoma
790092|NCT00293384|stage III adult immunoblastic large cell lymphoma|stage iii adult immunoblastic large cell lymphoma
790093|NCT00293384|stage III adult lymphoblastic lymphoma|stage iii adult lymphoblastic lymphoma
790094|NCT00293384|stage III chronic lymphocytic leukemia|stage iii chronic lymphocytic leukemia
790095|NCT00293384|stage III grade 1 follicular lymphoma|stage iii grade 1 follicular lymphoma
790096|NCT00293384|stage III grade 2 follicular lymphoma|stage iii grade 2 follicular lymphoma
790097|NCT00293384|stage III grade 3 follicular lymphoma|stage iii grade 3 follicular lymphoma
790098|NCT00293384|stage III mantle cell lymphoma|stage iii mantle cell lymphoma
790099|NCT00293384|stage III marginal zone lymphoma|stage iii marginal zone lymphoma
790100|NCT00293384|stage III multiple myeloma|stage iii multiple myeloma
790101|NCT00293384|stage III ovarian epithelial cancer|stage iii ovarian epithelial cancer
790102|NCT00293384|stage III small lymphocytic lymphoma|stage iii small lymphocytic lymphoma
790103|NCT00293384|stage III malignant testicular germ cell tumor|stage iii malignant testicular germ cell tumor
790104|NCT00293384|stage IIIA breast cancer|stage iiia breast cancer
790105|NCT00293384|stage IIIB breast cancer|stage iiib breast cancer
790106|NCT00293384|stage IIIC breast cancer|stage iiic breast cancer
790107|NCT00293384|stage IV adult Burkitt lymphoma|stage iv adult burkitt lymphoma
790108|NCT00293384|stage IV adult Hodgkin lymphoma|stage iv adult hodgkin lymphoma
790109|NCT00293384|stage IV adult diffuse large cell lymphoma|stage iv adult diffuse large cell lymphoma
790110|NCT00293384|stage IV adult diffuse mixed cell lymphoma|stage iv adult diffuse mixed cell lymphoma
790111|NCT00293384|stage IV adult diffuse small cleaved cell lymphoma|stage iv adult diffuse small cleaved cell lymphoma
790112|NCT00293384|stage IV adult immunoblastic large cell lymphoma|stage iv adult immunoblastic large cell lymphoma
790113|NCT00293384|stage IV adult lymphoblastic lymphoma|stage iv adult lymphoblastic lymphoma
790114|NCT00293384|stage IV breast cancer|stage iv breast cancer
790115|NCT00293384|stage IV chronic lymphocytic leukemia|stage iv chronic lymphocytic leukemia
790116|NCT00293384|stage IV grade 1 follicular lymphoma|stage iv grade 1 follicular lymphoma
790117|NCT00293384|stage IV grade 2 follicular lymphoma|stage iv grade 2 follicular lymphoma
790118|NCT00293384|stage IV grade 3 follicular lymphoma|stage iv grade 3 follicular lymphoma
790119|NCT00293384|stage IV mantle cell lymphoma|stage iv mantle cell lymphoma
790120|NCT00293384|stage IV marginal zone lymphoma|stage iv marginal zone lymphoma
790121|NCT00293384|stage IV ovarian epithelial cancer|stage iv ovarian epithelial cancer
790122|NCT00293384|stage IV small lymphocytic lymphoma|stage iv small lymphocytic lymphoma
790123|NCT00293371|adenocarcinoma of the prostate|adenocarcinoma of the prostate
790124|NCT00293371|recurrent prostate cancer|recurrent prostate cancer
790125|NCT00293371|stage IV prostate cancer|stage iv prostate cancer
790126|NCT00293358|childhood central nervous system germ cell tumor|childhood central nervous system germ cell tumor
790127|NCT00293358|adult central nervous system germ cell tumor|adult central nervous system germ cell tumor
790128|NCT00293358|childhood central nervous system choriocarcinoma|childhood central nervous system choriocarcinoma
790129|NCT00293358|childhood central nervous system embryonal tumor|childhood central nervous system embryonal tumor
790130|NCT00293358|childhood central nervous system yolk sac tumor|childhood central nervous system yolk sac tumor
790131|NCT00293332|stage I non-small cell lung cancer|stage i non-small cell lung cancer
790132|NCT00293332|stage II non-small cell lung cancer|stage ii non-small cell lung cancer
790133|NCT00293332|stage IIIA non-small cell lung cancer|stage iiia non-small cell lung cancer
790134|NCT00293319|recurrent neuroblastoma|recurrent neuroblastoma
790135|NCT00293293|stage I ovarian epithelial cancer|stage i ovarian epithelial cancer
790136|NCT00293293|stage II ovarian epithelial cancer|stage ii ovarian epithelial cancer
790137|NCT00293293|stage III ovarian epithelial cancer|stage iii ovarian epithelial cancer
790138|NCT00293293|stage IV ovarian epithelial cancer|stage iv ovarian epithelial cancer
790139|NCT00293293|peritoneal cavity cancer|peritoneal cavity cancer
790140|NCT00293280|stage IIIB non-small cell lung cancer|stage iiib non-small cell lung cancer
790141|NCT00293280|stage IV non-small cell lung cancer|stage iv non-small cell lung cancer
790142|NCT00293280|adenocarcinoma of the lung|adenocarcinoma of the lung
790143|NCT00293280|adenosquamous cell lung cancer|adenosquamous cell lung cancer
790144|NCT00293280|bronchoalveolar cell lung cancer|bronchoalveolar cell lung cancer
790145|NCT00293280|large cell lung cancer|large cell lung cancer
790146|NCT00293280|recurrent non-small cell lung cancer|recurrent non-small cell lung cancer
790147|NCT00293280|squamous cell lung cancer|squamous cell lung cancer
790148|NCT00293267|Treatment Experienced|treatment experienced
790149|NCT00293254|Treatment Experienced|treatment experienced
790150|NCT00293241|Pacemaker or ICD replacement|pacemaker or icd replacement
790154|NCT00293228|ELISPOT|elispot
790155|NCT00293228|PPD positive individuals|ppd positive individuals
790156|NCT00293202|etanercept|etanercept
790157|NCT00293202|malnutrition|malnutrition
790158|NCT00293202|inflammation|inflammation
790159|NCT00293202|hemodialysis|hemodialysis
790160|NCT00293189|hip fracture|hip fracture
790161|NCT00293189|epidemiology|epidemiology
790162|NCT00293189|genetics|genetics
790163|NCT00293189|p2x7|p2x7
790164|NCT00293176|Cognitive impairment|cognitive impairment
790165|NCT00293176|Memory Loss|memory loss
790166|NCT00293150|diastolic heart failure|diastolic heart failure
790167|NCT00293150|heart failure|heart failure
790168|NCT00293137|Chronic systolic heart failure|chronic systolic heart failure
790169|NCT00293137|Heart Failure|heart failure
790170|NCT00293124|Gastrointestinal Stromal Tumors|gastrointestinal stromal tumors
790171|NCT00293124|Glivec|glivec
790172|NCT00293111|Multiple Myeloma|multiple myeloma
790173|NCT00293111|Relapsed Multiple Myeloma|relapsed multiple myeloma
790174|NCT00293111|Refractory Multiple Myeloma|refractory multiple myeloma
790175|NCT00293098|Iron overload|iron overload
790176|NCT00293098|Thalassemia|thalassemia
790177|NCT00293098|Iron induced heart disease|iron induced heart disease
790178|NCT00293098|deferoxamine (Desferal)|deferoxamine (desferal)
790179|NCT00293098|Deferiprone|deferiprone
790180|NCT00293085|NSCLC|nsclc
790181|NCT00293085|Docetaxel|docetaxel
790182|NCT00293072|Rituximab, ANCA, vasculitis, lupus,|rituximab, anca, vasculitis, lupus,
790183|NCT00293059|Dysfunctional Uterine Bleeding|dysfunctional uterine bleeding
790184|NCT00293046|Allergy|allergy
790185|NCT00293033|Breakthrough Pain in Patients with Cancer|breakthrough pain in patients with cancer
790186|NCT00293020|Breakthrough Pain in Cancer Patients|breakthrough pain in cancer patients
790187|NCT00292994|Metabolic Syndrome|metabolic syndrome
790188|NCT00292994|Hyperlipidemia|hyperlipidemia
790189|NCT00292994|Type 2 diabetes mellitus|type 2 diabetes mellitus
790190|NCT00292994|Insulin resistance|insulin resistance
790194|NCT00292994|Hypertension|hypertension
790195|NCT00292981|C1 Inhibitor|c1 inhibitor
790196|NCT00292981|Hereditary angioedema|hereditary angioedema
790197|NCT00292981|Acute HAE attack|acute hae attack
790198|NCT00292968|Health Behavior|health behavior
790199|NCT00292968|Prevention|prevention
790200|NCT00292968|Informatics|informatics
790201|NCT00292968|Electronic Health Record|electronic health record
790202|NCT00292955|Cervical Cancer, Cetuximab, Phase II Clinical Trials|cervical cancer, cetuximab, phase ii clinical trials
790203|NCT00292955|Stage IB2-IVB Carcinoma of the Cervix|stage ib2-ivb carcinoma of the cervix
790204|NCT00292942|artesunate|artesunate
790205|NCT00292942|artemisinin|artemisinin
790206|NCT00292942|falciparum|falciparum
790207|NCT00292929|artesunate|artesunate
790208|NCT00292929|artemisinin|artemisinin
790209|NCT00292929|falciparum|falciparum
790210|NCT00292916|whole body vibration|whole body vibration
790211|NCT00292916|exercise|exercise
790212|NCT00292916|elderly woman|elderly woman
790213|NCT00292916|Bone Mineral Density|bone mineral density
790214|NCT00292916|falls|falls
790215|NCT00292916|higher age|higher age
790216|NCT00292903|Perinatal Depression|perinatal depression
790217|NCT00292903|Interpersonal Psychotherapy|interpersonal psychotherapy
790218|NCT00292890|injection devices|injection devices
790219|NCT00292890|injection technique|injection technique
790220|NCT00292890|insulin needles|insulin needles
790221|NCT00292890|insulin administration|insulin administration
790222|NCT00292877|1. Eosinophilic bronchitis, 2. Asthma, 3. Steroid dependent asthma, 4. Sputum eosinophils, 5. SB-240563 (Mepolizumab)|1. eosinophilic bronchitis, 2. asthma, 3. steroid dependent asthma, 4. sputum eosinophils, 5. sb-240563 (mepolizumab)
790223|NCT00292864|Cancer|cancer
790224|NCT00292864|Carcinoma|carcinoma
790225|NCT00292864|Adenocarcinoma|adenocarcinoma
790226|NCT00292864|Tumor|tumor
790227|NCT00292864|Advanced solid tumors|advanced solid tumors
790228|NCT00292838|Eosinophilic bronchitis with asthma|eosinophilic bronchitis with asthma
790229|NCT00292838|Eosinophilic bronchitis without asthma|eosinophilic bronchitis without asthma
790230|NCT00292825|vasovagal syncope|vasovagal syncope
790231|NCT00292825|syncope|syncope
790232|NCT00292825|cardioinhibitory syncope|cardioinhibitory syncope
790233|NCT00292825|neurocardiogenic syncope|neurocardiogenic syncope
790234|NCT00292825|pacing|pacing
790235|NCT00292825|closed loop pacing|closed loop pacing
790236|NCT00292825|tilt table|tilt table
790237|NCT00292812|Infant nutrition|infant nutrition
790238|NCT00292812|Nucleotides|nucleotides
790239|NCT00292812|Infant formula|infant formula
790240|NCT00292799|Polycystic ovary syndrome|polycystic ovary syndrome
790241|NCT00292799|Obesity|obesity
790242|NCT00292799|metformin|metformin
790243|NCT00292799|orlistat|orlistat
790244|NCT00292786|Functional Electrical Stimulation|functional electrical stimulation
790245|NCT00292786|FES|fes
790246|NCT00292786|Walking|walking
790247|NCT00292786|Practice|practice
790248|NCT00292786|Coordination|coordination
790249|NCT00292786|Posture|posture
790250|NCT00292773|Anovulation|anovulation
790251|NCT00292773|Obesity|obesity
790252|NCT00292773|bariatric surgery|bariatric surgery
790253|NCT00292708|Antibiotics|antibiotics
790254|NCT00292708|Prophylaxis|prophylaxis
790255|NCT00292708|Surgical wound infection|surgical wound infection
790256|NCT00292656|Allergy|allergy
790257|NCT00292591|vitamin D|vitamin d
790258|NCT00292591|cholecalciferol|cholecalciferol
790259|NCT00292591|pregnancy|pregnancy
790260|NCT00292591|bone mineral density|bone mineral density
790261|NCT00292578|Allergy|allergy
790262|NCT00292578|Sugar Intolerance|sugar intolerance
790263|NCT00292578|Fatigue|fatigue
790264|NCT00292552|Chronic Obstructive Pulmonary Disease (COPD)|chronic obstructive pulmonary disease (copd)
790265|NCT00292552|longitudinal|longitudinal
790266|NCT00292552|eclipse|eclipse
790267|NCT00292539|Pacemaker|pacemaker
790268|NCT00292539|NYHA class|nyha class
790269|NCT00292539|Ejection fraction|ejection fraction
790270|NCT00292539|Heart Failure|heart failure
790271|NCT00292526|Chemotherapy induced cardiotoxicity|chemotherapy induced cardiotoxicity
790272|NCT00292526|Troponin|troponin
790273|NCT00292526|Heart failure|heart failure
790274|NCT00292500|CABG, anastomotic device; myocardial revascularization|cabg, anastomotic device; myocardial revascularization
790275|NCT00292474|coronary artery disease|coronary artery disease
790276|NCT00292474|percutaneous coronary interventions|percutaneous coronary interventions
790277|NCT00292474|stent implant|stent implant
790278|NCT00292474|drug-coated stent|drug-coated stent
790279|NCT00292461|Epilepsy|epilepsy
790280|NCT00292461|seizures|seizures
790281|NCT00292422|Arthritis, Rheumatoid|arthritis, rheumatoid
790282|NCT00292422|Methotrexate|methotrexate
790283|NCT00292422|Antirheumatic Agents|antirheumatic agents
790284|NCT00292383|Cardiac Pacing, artificial|cardiac pacing, artificial
790285|NCT00292383|Atrial Fibrillation|atrial fibrillation
790286|NCT00292383|Heart failure|heart failure
790287|NCT00292383|Pacemaker leads|pacemaker leads
790288|NCT00292383|Lead position|lead position
790289|NCT00292383|Higher degree AV-Block|higher degree av-block
790290|NCT00292370|Atypical Antipsychotics|atypical antipsychotics
790291|NCT00292370|Controlled Trial|controlled trial
790294|NCT00292370|Stress Disorders, Post-Traumatic|stress disorders, post-traumatic
790295|NCT00292370|Treatment refractory|treatment refractory
790296|NCT00292370|Treatment resistant|treatment resistant
790297|NCT00292344|Travelers' diarrhea|travelers' diarrhea
790298|NCT00292344|rifaximin|rifaximin
790299|NCT00292344|loperamide|loperamide
790300|NCT00292344|enterotoxigenic E. coli|enterotoxigenic e. coli
790301|NCT00292331|gastric varices|gastric varices
790302|NCT00292331|liver cirrhosis|liver cirrhosis
790303|NCT00292331|hepatocelluar carcinoma|hepatocelluar carcinoma
790304|NCT00292331|rebleeding|rebleeding
790305|NCT00292331|long-term|long-term
790306|NCT00292318|adequate relief|adequate relief
790307|NCT00292318|anorectal manometry|anorectal manometry
790308|NCT00292318|biofeedback therapy|biofeedback therapy
790309|NCT00292318|fecal incontinence|fecal incontinence
790310|NCT00292305|PCI|pci
790311|NCT00292305|Bifurcation lesion|bifurcation lesion
790312|NCT00292279|Impact of Omega 3 fatty acid on outcome|impact of omega 3 fatty acid on outcome
790313|NCT00292279|Omega-3 fatty acid|omega-3 fatty acid
790314|NCT00292279|Carcinoma surgery|carcinoma surgery
790315|NCT00292279|Digestive System|digestive system
790316|NCT00292279|Parenteral Nutrition|parenteral nutrition
790317|NCT00292279|Fat Emulsions, Intravenous|fat emulsions, intravenous
790318|NCT00292279|Clinical outcome|clinical outcome
790319|NCT00292279|SIRS|sirs
790320|NCT00292279|Infectious complication|infectious complication
790321|NCT00292279|Postoperative hospital stay|postoperative hospital stay
790322|NCT00292279|Cost of postoperative period|cost of postoperative period
790323|NCT00292279|Post-operative nutritional cost & total treatment cost|post-operative nutritional cost & total treatment cost
790324|NCT00292266|Relapsing-remitting Multiple Sclerosis|relapsing-remitting multiple sclerosis
790325|NCT00292266|Rebif®|rebif®
790326|NCT00292266|Avonex®|avonex®
790327|NCT00292266|interferon-beta-1a|interferon-beta-1a
790328|NCT00292253|MS|ms
790329|NCT00292240|brief motivational intervention; teens; substance use|brief motivational intervention; teens; substance use
790330|NCT00292227|advanced-stage idiopathic Parkinson's disease|advanced-stage idiopathic parkinson's disease
790331|NCT00292214|paracetamol|paracetamol
790332|NCT00292214|acetaminophen|acetaminophen
790333|NCT00292214|pharmacokinetic|pharmacokinetic
790334|NCT00292214|intravenous|intravenous
790335|NCT00292214|oral|oral
790336|NCT00292214|analgesia|analgesia
790337|NCT00292214|pain|pain
790338|NCT00292214|opioid|opioid
790339|NCT00292201|Asthma|asthma
790340|NCT00292201|Statin|statin
790341|NCT00292188|Phase 4, post-traumatic neuropathic pain, neuropathic pain, Nep, post surgical pain, nerve injury, phantom limb pain, international|phase 4, post-traumatic neuropathic pain, neuropathic pain, nep, post surgical pain, nerve injury, phantom limb pain, international
790342|NCT00292175|colonoscopy, narrow band imaging (NBI), ulcerative colitis|colonoscopy, narrow band imaging (nbi), ulcerative colitis
790343|NCT00292162|Chronic Heart Failure|chronic heart failure
790344|NCT00292162|Atrial Fibrillation|atrial fibrillation
790345|NCT00292162|Radiofrequency Ablation|radiofrequency ablation
790346|NCT00292136|Cocaine Dependence|cocaine dependence
790347|NCT00292136|Drug Relapse|drug relapse
790348|NCT00292136|Pharmacokinetics|pharmacokinetics
790349|NCT00292136|EMA|ema
790350|NCT00292136|Polydrug Abuse|polydrug abuse
790351|NCT00292110|HIV|hiv
790352|NCT00292110|Opiate Substitution|opiate substitution
790353|NCT00292110|Pharmacokinetics|pharmacokinetics
790354|NCT00292110|ECG|ecg
790355|NCT00292110|Polydrug Abuse|polydrug abuse
790356|NCT00292097|Respiratory failure|respiratory failure
790357|NCT00292097|Tracheostomy|tracheostomy
790358|NCT00292097|Percutaneous dilatation tracheostomy|percutaneous dilatation tracheostomy
790359|NCT00292097|Endotracheal Conversion|endotracheal conversion
790360|NCT00292097|Traumatic brain injury|traumatic brain injury
790361|NCT00292084|Hepatitis C|hepatitis c
790362|NCT00292084|Celgosivir|celgosivir
790363|NCT00292084|HCV|hcv
790364|NCT00292084|Genotype 1|genotype 1
790365|NCT00292084|Non-responders|non-responders
790366|NCT00292084|End of Treatment Response|end of treatment response
790367|NCT00292084|Sustained Viral Response|sustained viral response
790368|NCT00292058|Telepsychiatry|telepsychiatry
790369|NCT00292058|Videoconference|videoconference
790370|NCT00292058|Psychiatric consultation|psychiatric consultation
790371|NCT00292058|Equivalence trial|equivalence trial
790372|NCT00292045|NY-ESO-1 protein, immunization, advanced prostate cancer|ny-eso-1 protein, immunization, advanced prostate cancer
790373|NCT00292032|cardiac arrest|cardiac arrest
790374|NCT00292032|diagnosis|diagnosis
790375|NCT00292032|genetics|genetics
790376|NCT00292032|testing|testing
790377|NCT00292006|clinical scaphoid fracture|clinical scaphoid fracture
790378|NCT00292006|pediatric|pediatric
790379|NCT00291993|Obstructive sleep apnea|obstructive sleep apnea
790380|NCT00291993|Vasoactive hormones|vasoactive hormones
790381|NCT00291993|Blood pressure|blood pressure
790382|NCT00291980|Dialysis|dialysis
790383|NCT00291980|Pre-dialysis|pre-dialysis
790384|NCT00291980|Hepatitis B vaccine|hepatitis b vaccine
790385|NCT00291980|Prophylaxis hepatitis B infection|prophylaxis hepatitis b infection
790386|NCT00291954|Dialysis|dialysis
790387|NCT00291954|Pre-dialysis|pre-dialysis
790388|NCT00291954|Hepatitis B vaccine|hepatitis b vaccine
790389|NCT00291954|Prophylaxis hepatitis B infection|prophylaxis hepatitis b infection
790390|NCT00291941|Dialysis|dialysis
790391|NCT00291941|Pre-dialysis|pre-dialysis
790392|NCT00291941|Hepatitis B vaccine|hepatitis b vaccine
790393|NCT00291941|Prophylaxis|prophylaxis
790394|NCT00291915|early arthritis, methotrexate, adalimumab|early arthritis, methotrexate, adalimumab
790395|NCT00291902|CHD|chd
790396|NCT00291902|coronary heart disease|coronary heart disease
790397|NCT00291902|atherosclerosis|atherosclerosis
790398|NCT00291902|inflammation|inflammation
790399|NCT00291876|HAVRIX™|havrix™
790400|NCT00291876|Hepatitis A|hepatitis a
790401|NCT00291863|end stage renal failure|end stage renal failure
790402|NCT00291863|peritoneal dialysis|peritoneal dialysis
790403|NCT00291863|simvastatin|simvastatin
790404|NCT00291863|endothelium|endothelium
790405|NCT00291863|vasodilation|vasodilation
790406|NCT00291850|NSCLC|nsclc
790407|NCT00291837|ovarian|ovarian
790408|NCT00291837|CT-2106|ct-2106
790409|NCT00291824|Cardiovascular risks|cardiovascular risks
790410|NCT00291824|Motivational interviewing|motivational interviewing
790411|NCT00291824|Behavior change|behavior change
790412|NCT00291824|Primary care setting|primary care setting
790413|NCT00291811|AMD3100|amd3100
790414|NCT00291811|G-CSF|g-csf
790415|NCT00291798|pilot study|pilot study
790416|NCT00291798|exemestane|exemestane
790417|NCT00291798|endocrinotherapy|endocrinotherapy
790418|NCT00291798|mamma carcinoma|mamma carcinoma
790419|NCT00291798|neoadjuvant|neoadjuvant
790420|NCT00291798|ABCSG|abcsg
790421|NCT00291798|17|17
790422|NCT00291785|colorectal cancer|colorectal cancer
790423|NCT00291785|camptothecin|camptothecin
790424|NCT00291772|Type 1 Diabetes|type 1 diabetes
790425|NCT00291772|hypoglycemia|hypoglycemia
790426|NCT00291772|hyperglycemia|hyperglycemia
790427|NCT00291746|GERD|gerd
790428|NCT00291733|Levetiracetam|levetiracetam
790429|NCT00291733|Levodopa-induced dyskinesias|levodopa-induced dyskinesias
790430|NCT00291733|Parkinson's|parkinson's
790431|NCT00291720|Aldosterone|aldosterone
790432|NCT00291720|Spironolactone|spironolactone
790433|NCT00291720|Chronic Kidney Disease|chronic kidney disease
790434|NCT00291720|Arterial Stiffness|arterial stiffness
790435|NCT00291707|head|head
790436|NCT00291707|neck|neck
790437|NCT00291707|Cetuximab|cetuximab
790438|NCT00291707|Pemetrexed|pemetrexed
790439|NCT00291694|breast atypia|breast atypia
790440|NCT00291694|double-blind randomized clinical trial|double-blind randomized clinical trial
790441|NCT00291694|RCT|rct
790442|NCT00291694|celecoxib|celecoxib
790443|NCT00291694|COX-2 inhibitor|cox-2 inhibitor
790444|NCT00291694|placebo|placebo
790445|NCT00291694|high risk for breast cancer|high risk for breast cancer
790446|NCT00291694|breast epithelial hyperplasia|breast epithelial hyperplasia
790447|NCT00291694|ki-67|ki-67
790448|NCT00291694|chemoprevention|chemoprevention
790449|NCT00291681|Inflammatory Bowel Disease|inflammatory bowel disease
790450|NCT00291681|B cell selection|b cell selection
790451|NCT00291668|Crohn's Disease|crohn's disease
790452|NCT00291668|CDP870, Certolizumab pegol|cdp870, certolizumab pegol
790453|NCT00291655|NEWLY DIAGNOSED EPILEPSY|newly diagnosed epilepsy
790454|NCT00291655|LEVETIRACETAM|levetiracetam
790455|NCT00291655|KEPPRA|keppra
790456|NCT00291655|N01175 (NCT00175903)|n01175 (nct00175903)
790457|NCT00291642|Levocetirizine|levocetirizine
790458|NCT00291642|Xyzal|xyzal
790459|NCT00291642|Rhinitis|rhinitis
790460|NCT00291642|Allergic|allergic
790461|NCT00291642|Seasonal|seasonal
790462|NCT00291642|Ragweed|ragweed
790463|NCT00291629|Myocardial infarction|myocardial infarction
790464|NCT00291629|revascularization|revascularization
790465|NCT00291629|drug eluting stents|drug eluting stents
790466|NCT00291616|chronic hepatitis B, pegylated interferon, thymosin alpha|chronic hepatitis b, pegylated interferon, thymosin alpha
790467|NCT00291603|dialysis|dialysis
790468|NCT00291603|Renal Dialysis|renal dialysis
790469|NCT00291603|inflammation|inflammation
790470|NCT00291603|quality of life|quality of life
790471|NCT00291603|End Stage Kidney Failure|end stage kidney failure
790472|NCT00291590|diabetes|diabetes
790473|NCT00291590|behavioral change|behavioral change
790474|NCT00291590|chronic care model|chronic care model
790475|NCT00291590|stage of change|stage of change
790476|NCT00291590|Medicaid|medicaid
790477|NCT00291590|Dual eligible|dual eligible
790478|NCT00291590|ethnic|ethnic
790479|NCT00291590|self-care|self-care
790480|NCT00291577|advanced|advanced
790481|NCT00291577|sunitinib (Sutent)|sunitinib (sutent)
790482|NCT00291577|docetaxel|docetaxel
790483|NCT00291577|Phase 1B|phase 1b
790484|NCT00291564|Observational|observational
790485|NCT00291564|Heart Failure|heart failure
790486|NCT00291564|Continuous Cardiac Resynchronization Therapy|continuous cardiac resynchronization therapy
790487|NCT00291525|valve|valve
790488|NCT00291525|prosthesis|prosthesis
790489|NCT00291525|antithrombotics|antithrombotics
790490|NCT00291525|randomized|randomized
790491|NCT00291512|HIV|hiv
790492|NCT00291512|STDs|stds
790493|NCT00291512|Methamphetamine abuse|methamphetamine abuse
790494|NCT00291512|MSM|msm
790495|NCT00291499|symptomatic OA of the hand|symptomatic oa of the hand
790496|NCT00291460|COPD|copd
790497|NCT00291460|respiratory failure|respiratory failure
790498|NCT00291460|inspiratory muscle training|inspiratory muscle training
790499|NCT00291434|Head and neck cancer|head and neck cancer
790500|NCT00291434|Fractionation|fractionation
790501|NCT00291434|Radiotherapy|radiotherapy
790502|NCT00291434|Conventional fractionation|conventional fractionation
790503|NCT00291434|Hyperfractionation|hyperfractionation
790504|NCT00291434|Accelerated fractionation|accelerated fractionation
790505|NCT00291421|Alzheimer's Disease|alzheimer's disease
790506|NCT00291421|Dementia|dementia
790507|NCT00291421|Brain Disease|brain disease
790508|NCT00291421|Memory Loss|memory loss
790509|NCT00291421|Caregiver|caregiver
790510|NCT00291421|Primary Caregiver|primary caregiver
790511|NCT00291421|Observation|observation
790512|NCT00291421|galantamine|galantamine
790513|NCT00291421|donepezil|donepezil
790514|NCT00291421|rivastigmine|rivastigmine
790515|NCT00291421|Quality of life|quality of life
790516|NCT00291382|Total asthma control|total asthma control
790517|NCT00291382|airway hyper-responsiveness|airway hyper-responsiveness
790518|NCT00291382|adult|adult
790519|NCT00291382|Asthma|asthma
790520|NCT00291369|Metastatic renal cell carcinoma|metastatic renal cell carcinoma
790521|NCT00291369|Interleukin-2|interleukin-2
790522|NCT00291369|Interferon alfa|interferon alfa
790523|NCT00291369|Cytokines|cytokines
790524|NCT00291369|Survival|survival
790525|NCT00291356|Diabetes|diabetes
790526|NCT00291356|sodium dependent glucose transporter|sodium dependent glucose transporter
790527|NCT00291356|SGLT2|sglt2
790528|NCT00291356|GSK189075|gsk189075
790529|NCT00291356|GSK189074|gsk189074
790530|NCT00291356|SGLT1|sglt1
790531|NCT00291356|GW869683|gw869683
790532|NCT00291343|hepatitis B|hepatitis b
790533|NCT00291343|meningococcal vaccine|meningococcal vaccine
790534|NCT00291343|pertussis|pertussis
790535|NCT00291343|Prophylaxis diphtheria|prophylaxis diphtheria
790536|NCT00291343|meningococcal serogroups A and C diseases|meningococcal serogroups a and c diseases
790537|NCT00291343|tetanus|tetanus
790538|NCT00291343|Haemophilus influenzae type b|haemophilus influenzae type b
790539|NCT00291317|pediatric spinal cord injury|pediatric spinal cord injury
790540|NCT00291317|FES cycling|fes cycling
790541|NCT00291317|bone mineral density|bone mineral density
790542|NCT00291317|quality of life|quality of life
790543|NCT00291304|Magnetic Resonance Imaging|magnetic resonance imaging
790544|NCT00291304|Pathology|pathology
790545|NCT00291278|Endometriosis|endometriosis
790546|NCT00291278|Bone Mineral Density|bone mineral density
790547|NCT00291278|Osteopenia|osteopenia
790548|NCT00291278|Osteoporosis|osteoporosis
790549|NCT00291278|DEXA Scan|dexa scan
790550|NCT00291278|Menopause|menopause
790551|NCT00291278|Screening|screening
790552|NCT00291278|Healthy Volunteer|healthy volunteer
790554|NCT00291265|Bradykinesia|bradykinesia
790555|NCT00291265|Tremor|tremor
790556|NCT00291265|Speech|speech
790557|NCT00291265|Rigidity|rigidity
790558|NCT00291265|Neurodegeneration|neurodegeneration
790559|NCT00291265|Parkinson Disease|parkinson disease
790560|NCT00291265|PD|pd
790561|NCT00291226|schizophrenia prodrome|schizophrenia prodrome
790562|NCT00291200|Psychosis|psychosis
790563|NCT00291200|Basic Symptoms|basic symptoms
790564|NCT00291174|Ventricular Arrhythmia|ventricular arrhythmia
790565|NCT00291174|Myocardial Infarction|myocardial infarction
790566|NCT00291174|Ventricular Dysfunction|ventricular dysfunction
790567|NCT00291174|Coronary Artery Disease|coronary artery disease
790568|NCT00291174|Structural Heart Disease|structural heart disease
790569|NCT00291174|Arrhythmia|arrhythmia
790570|NCT00291174|Cardiomyopathies|cardiomyopathies
790571|NCT00291161|Delivery of Health Care, Integrated|delivery of health care, integrated
790572|NCT00291161|United States Department of Veterans Affairs|united states department of veterans affairs
790573|NCT00291161|Dementia|dementia
790574|NCT00291161|Patient Care Management|patient care management
790575|NCT00291148|Neuropathic pain|neuropathic pain
790576|NCT00291148|Multiple Sclerosis|multiple sclerosis
790577|NCT00291148|pregabalin|pregabalin
790578|NCT00291148|paroxetine|paroxetine
790579|NCT00291135|breast atypia|breast atypia
790580|NCT00291135|open label pilot study|open label pilot study
790581|NCT00291135|letrozole|letrozole
790582|NCT00291135|fine needle aspiration|fine needle aspiration
790583|NCT00291135|high risk for breast cancer|high risk for breast cancer
790584|NCT00291135|breast epithelial hyperplasia|breast epithelial hyperplasia
790585|NCT00291135|Ki-67|ki-67
790586|NCT00291135|hormones plus chemoprevention|hormones plus chemoprevention
790587|NCT00291135|chemoprevention|chemoprevention
790588|NCT00291122|breast atypia|breast atypia
790589|NCT00291122|breast epithelial hyperplasia|breast epithelial hyperplasia
790590|NCT00291122|ki-67|ki-67
790591|NCT00291122|RTPCR|rtpcr
790592|NCT00291122|microdissection|microdissection
790593|NCT00291109|breast atypia|breast atypia
791330|NCT00289016|GM-CSF|gm-csf
790594|NCT00291109|breast epithelial hyperplasia|breast epithelial hyperplasia
790595|NCT00291109|Ki-67|ki-67
790596|NCT00291109|RTPCR|rtpcr
790597|NCT00291109|microdissection|microdissection
790598|NCT00291096|breast atypia|breast atypia
790599|NCT00291096|fine needle aspiration|fine needle aspiration
790600|NCT00291096|high risk for breast cancer|high risk for breast cancer
790601|NCT00291096|breast epithelial hyperplasia|breast epithelial hyperplasia
790602|NCT00291083|NAF|naf
790603|NCT00291083|nipple aspirate fluid|nipple aspirate fluid
790604|NCT00291083|breast atypia|breast atypia
790605|NCT00291083|high risk for breast cancer|high risk for breast cancer
790606|NCT00291083|breast epithelial hyperplasia|breast epithelial hyperplasia
790607|NCT00291083|Ki-67|ki-67
790608|NCT00291083|hormones plus chemoprevention|hormones plus chemoprevention
790609|NCT00291083|chemoprevention|chemoprevention
790610|NCT00291070|ADHD|adhd
790611|NCT00291070|attention|attention
790612|NCT00291070|insomnia|insomnia
790613|NCT00291070|hyperactivity|hyperactivity
790614|NCT00291070|anxiety|anxiety
790615|NCT00291057|Pediculosis|pediculosis
790616|NCT00291057|Head Lice|head lice
790617|NCT00291044|pregnancy, genital herpes|pregnancy, genital herpes
790618|NCT00291031|nightmare|nightmare
790619|NCT00291031|sleep disorder|sleep disorder
790620|NCT00291031|sleep|sleep
790621|NCT00291031|imagery rehearsal|imagery rehearsal
790622|NCT00291031|anxiety disorders|anxiety disorders
790623|NCT00291031|mood disorders|mood disorders
790624|NCT00291031|personality disorders|personality disorders
790625|NCT00291018|ProDisc|prodisc
790626|NCT00291018|ProDisc-C|prodisc-c
790627|NCT00291018|Spinal Fusion|spinal fusion
790628|NCT00291018|Anterior cervical diskectomy|anterior cervical diskectomy
790629|NCT00291018|Cervical spine|cervical spine
790630|NCT00291018|Disc disease|disc disease
790631|NCT00291018|Implant|implant
790632|NCT00291018|Degenerative disc disease|degenerative disc disease
790633|NCT00291018|Intervertebral disc|intervertebral disc
790634|NCT00291005|Prostate cancer|prostate cancer
790635|NCT00291005|HRPC|hrpc
790636|NCT00291005|AIPC|aipc
790637|NCT00291005|Hormone refractory|hormone refractory
790638|NCT00291005|Androgen independent|androgen independent
790639|NCT00291005|Docetaxel|docetaxel
790640|NCT00291005|Taxotere|taxotere
790641|NCT00291005|prednisolone|prednisolone
790642|NCT00290992|urate oxidase, hyperuricemia, lymphoma, leukemia|urate oxidase, hyperuricemia, lymphoma, leukemia
790643|NCT00290979|HMR1964, insulin glulisine, Diabetes Mellitus, Type 1|hmr1964, insulin glulisine, diabetes mellitus, type 1
790644|NCT00290966|docetaxel|docetaxel
790645|NCT00290966|stomach neoplasm|stomach neoplasm
790646|NCT00290953|Metastases|metastases
790647|NCT00290940|Diabetes mellitus, Type 2|diabetes mellitus, type 2
790648|NCT00290940|High blood sugar|high blood sugar
790649|NCT00290940|Hyperglycemia|hyperglycemia
790650|NCT00290940|Antihyperglycemic agents|antihyperglycemic agents
790651|NCT00290940|CS-917|cs-917
791098|NCT00290121|Weight gain|weight gain
790652|NCT00290927|HMR1964, insulin glulisine, Diabetes Mellitus, Type 2|hmr1964, insulin glulisine, diabetes mellitus, type 2
790653|NCT00290888|Rotator Cuff Tear|rotator cuff tear
790654|NCT00290888|Tendon Repair|tendon repair
790655|NCT00290888|Acromioplasty|acromioplasty
790656|NCT00290888|Arthroscopy|arthroscopy
790657|NCT00290888|Orthopedic Surgery|orthopedic surgery
790658|NCT00290875|cspine injury|cspine injury
790659|NCT00290875|radiography|radiography
790660|NCT00290875|clinical impact|clinical impact
790661|NCT00290875|dissemination|dissemination
790662|NCT00290862|Osteoporosis|osteoporosis
790663|NCT00290862|Spine fracture|spine fracture
790664|NCT00290862|Back Pain|back pain
790665|NCT00290862|Vertebroplasty|vertebroplasty
790666|NCT00290862|Vertebral compression fractures related to osteoporosis|vertebral compression fractures related to osteoporosis
790667|NCT00290823|Taenia|taenia
790668|NCT00290823|Seizures|seizures
790669|NCT00290823|Tapeworm|tapeworm
790670|NCT00290823|Parasite|parasite
790671|NCT00290771|imatinib mesylate|imatinib mesylate
790672|NCT00290771|hydroxyurea|hydroxyurea
790673|NCT00290771|protein tyrosine kinases|protein tyrosine kinases
790674|NCT00290771|glioma|glioma
790675|NCT00290771|glioblastoma multiforme|glioblastoma multiforme
790676|NCT00290771|recurrent glioblastoma multiforme|recurrent glioblastoma multiforme
790677|NCT00290771|GBM|gbm
790678|NCT00290771|MacDonald criteria|macdonald criteria
790679|NCT00290745|breast cancer in situ|breast cancer in situ
790680|NCT00290745|ductal breast carcinoma in situ|ductal breast carcinoma in situ
790681|NCT00290732|stage I breast cancer|stage i breast cancer
790682|NCT00290732|stage II breast cancer|stage ii breast cancer
790683|NCT00290732|stage IIIA breast cancer|stage iiia breast cancer
790684|NCT00290732|stage IIIC breast cancer|stage iiic breast cancer
790685|NCT00290732|stage IV breast cancer|stage iv breast cancer
790686|NCT00290732|breast cancer in situ|breast cancer in situ
790965|NCT00290511|Fludarabine|fludarabine
790687|NCT00290732|ductal breast carcinoma in situ|ductal breast carcinoma in situ
790688|NCT00290719|adenocarcinoma of the esophagus|adenocarcinoma of the esophagus
790689|NCT00290719|squamous cell carcinoma of the esophagus|squamous cell carcinoma of the esophagus
790690|NCT00290719|stage II esophageal cancer|stage ii esophageal cancer
790691|NCT00290719|stage III esophageal cancer|stage iii esophageal cancer
790692|NCT00290706|recurrent adult diffuse large cell lymphoma|recurrent adult diffuse large cell lymphoma
790693|NCT00290706|recurrent adult diffuse mixed cell lymphoma|recurrent adult diffuse mixed cell lymphoma
790694|NCT00290706|recurrent adult immunoblastic large cell lymphoma|recurrent adult immunoblastic large cell lymphoma
790695|NCT00290706|recurrent adult lymphoblastic lymphoma|recurrent adult lymphoblastic lymphoma
790696|NCT00290706|recurrent grade 3 follicular lymphoma|recurrent grade 3 follicular lymphoma
790697|NCT00290706|recurrent cutaneous T-cell non-Hodgkin lymphoma|recurrent cutaneous t-cell non-hodgkin lymphoma
790698|NCT00290706|recurrent mycosis fungoides/Sezary syndrome|recurrent mycosis fungoides/sezary syndrome
790699|NCT00290693|recurrent pancreatic cancer|recurrent pancreatic cancer
790700|NCT00290693|adenocarcinoma of the pancreas|adenocarcinoma of the pancreas
790701|NCT00290693|stage IV pancreatic cancer|stage iv pancreatic cancer
790702|NCT00290680|unspecified adult solid tumor, protocol specific|unspecified adult solid tumor, protocol specific
790703|NCT00290667|contiguous stage II adult diffuse large cell lymphoma|contiguous stage ii adult diffuse large cell lymphoma
790704|NCT00290667|noncontiguous stage II adult diffuse large cell lymphoma|noncontiguous stage ii adult diffuse large cell lymphoma
790705|NCT00290667|stage I adult diffuse large cell lymphoma|stage i adult diffuse large cell lymphoma
790706|NCT00290667|stage III adult diffuse large cell lymphoma|stage iii adult diffuse large cell lymphoma
790707|NCT00290667|stage IV adult diffuse large cell lymphoma|stage iv adult diffuse large cell lymphoma
790708|NCT00290667|contiguous stage II adult immunoblastic large cell lymphoma|contiguous stage ii adult immunoblastic large cell lymphoma
790709|NCT00290667|noncontiguous stage II adult immunoblastic large cell lymphoma|noncontiguous stage ii adult immunoblastic large cell lymphoma
790710|NCT00290667|stage I adult immunoblastic large cell lymphoma|stage i adult immunoblastic large cell lymphoma
790711|NCT00290667|stage III adult immunoblastic large cell lymphoma|stage iii adult immunoblastic large cell lymphoma
790712|NCT00290667|stage IV adult immunoblastic large cell lymphoma|stage iv adult immunoblastic large cell lymphoma
790713|NCT00290667|contiguous stage II adult Burkitt lymphoma|contiguous stage ii adult burkitt lymphoma
790714|NCT00290667|noncontiguous stage II adult Burkitt lymphoma|noncontiguous stage ii adult burkitt lymphoma
790715|NCT00290667|stage I adult Burkitt lymphoma|stage i adult burkitt lymphoma
790716|NCT00290667|stage III adult Burkitt lymphoma|stage iii adult burkitt lymphoma
790717|NCT00290667|stage IV adult Burkitt lymphoma|stage iv adult burkitt lymphoma
790718|NCT00290667|contiguous stage II adult diffuse mixed cell lymphoma|contiguous stage ii adult diffuse mixed cell lymphoma
790719|NCT00290667|noncontiguous stage II adult diffuse mixed cell lymphoma|noncontiguous stage ii adult diffuse mixed cell lymphoma
790720|NCT00290667|stage I adult diffuse mixed cell lymphoma|stage i adult diffuse mixed cell lymphoma
790721|NCT00290667|stage III adult diffuse mixed cell lymphoma|stage iii adult diffuse mixed cell lymphoma
790722|NCT00290667|stage IV adult diffuse mixed cell lymphoma|stage iv adult diffuse mixed cell lymphoma
790723|NCT00290667|contiguous stage II adult diffuse small cleaved cell lymphoma|contiguous stage ii adult diffuse small cleaved cell lymphoma
790724|NCT00290667|noncontiguous stage II adult diffuse small cleaved cell lymphoma|noncontiguous stage ii adult diffuse small cleaved cell lymphoma
790725|NCT00290667|stage I adult diffuse small cleaved cell lymphoma|stage i adult diffuse small cleaved cell lymphoma
790726|NCT00290667|stage III adult diffuse small cleaved cell lymphoma|stage iii adult diffuse small cleaved cell lymphoma
790727|NCT00290667|stage IV adult diffuse small cleaved cell lymphoma|stage iv adult diffuse small cleaved cell lymphoma
790728|NCT00290667|contiguous stage II grade 1 follicular lymphoma|contiguous stage ii grade 1 follicular lymphoma
790729|NCT00290667|contiguous stage II grade 2 follicular lymphoma|contiguous stage ii grade 2 follicular lymphoma
790730|NCT00290667|contiguous stage II grade 3 follicular lymphoma|contiguous stage ii grade 3 follicular lymphoma
790731|NCT00290667|noncontiguous stage II grade 1 follicular lymphoma|noncontiguous stage ii grade 1 follicular lymphoma
790732|NCT00290667|noncontiguous stage II grade 2 follicular lymphoma|noncontiguous stage ii grade 2 follicular lymphoma
790733|NCT00290667|noncontiguous stage II grade 3 follicular lymphoma|noncontiguous stage ii grade 3 follicular lymphoma
790734|NCT00290667|stage I grade 1 follicular lymphoma|stage i grade 1 follicular lymphoma
790735|NCT00290667|stage I grade 2 follicular lymphoma|stage i grade 2 follicular lymphoma
790736|NCT00290667|stage I grade 3 follicular lymphoma|stage i grade 3 follicular lymphoma
790737|NCT00290667|stage III grade 1 follicular lymphoma|stage iii grade 1 follicular lymphoma
790738|NCT00290667|stage III grade 2 follicular lymphoma|stage iii grade 2 follicular lymphoma
790739|NCT00290667|stage III grade 3 follicular lymphoma|stage iii grade 3 follicular lymphoma
790740|NCT00290667|stage IV grade 1 follicular lymphoma|stage iv grade 1 follicular lymphoma
790741|NCT00290667|stage IV grade 2 follicular lymphoma|stage iv grade 2 follicular lymphoma
790742|NCT00290667|stage IV grade 3 follicular lymphoma|stage iv grade 3 follicular lymphoma
790743|NCT00290654|ductal breast carcinoma in situ|ductal breast carcinoma in situ
790744|NCT00290654|breast cancer in situ|breast cancer in situ
790745|NCT00290641|adult acute myeloid leukemia in remission|adult acute myeloid leukemia in remission
790746|NCT00290641|adult acute myeloid leukemia with 11q23 (MLL) abnormalities|adult acute myeloid leukemia with 11q23 (mll) abnormalities
790747|NCT00290641|adult acute myeloid leukemia with inv(16)(p13;q22)|adult acute myeloid leukemia with inv(16)(p13;q22)
790748|NCT00290641|adult acute myeloid leukemia with t(15;17)(q22;q12)|adult acute myeloid leukemia with t(15;17)(q22;q12)
790749|NCT00290641|adult acute myeloid leukemia with t(16;16)(p13;q22)|adult acute myeloid leukemia with t(16;16)(p13;q22)
791331|NCT00289016|melanoma|melanoma
790750|NCT00290641|adult acute myeloid leukemia with t(8;21)(q22;q22)|adult acute myeloid leukemia with t(8;21)(q22;q22)
790751|NCT00290641|childhood acute myeloid leukemia in remission|childhood acute myeloid leukemia in remission
790752|NCT00290641|secondary acute myeloid leukemia|secondary acute myeloid leukemia
790753|NCT00290641|accelerated phase chronic myelogenous leukemia|accelerated phase chronic myelogenous leukemia
790754|NCT00290641|childhood chronic myelogenous leukemia|childhood chronic myelogenous leukemia
790755|NCT00290641|chronic phase chronic myelogenous leukemia|chronic phase chronic myelogenous leukemia
790756|NCT00290641|relapsing chronic myelogenous leukemia|relapsing chronic myelogenous leukemia
790757|NCT00290641|refractory anemia with excess blasts|refractory anemia with excess blasts
790758|NCT00290641|de novo myelodysplastic syndromes|de novo myelodysplastic syndromes
790759|NCT00290641|previously treated myelodysplastic syndromes|previously treated myelodysplastic syndromes
790760|NCT00290641|secondary myelodysplastic syndromes|secondary myelodysplastic syndromes
790761|NCT00290641|noncontiguous stage II adult Burkitt lymphoma|noncontiguous stage ii adult burkitt lymphoma
790762|NCT00290641|recurrent adult Burkitt lymphoma|recurrent adult burkitt lymphoma
790763|NCT00290641|stage III adult Burkitt lymphoma|stage iii adult burkitt lymphoma
790764|NCT00290641|stage IV adult Burkitt lymphoma|stage iv adult burkitt lymphoma
790765|NCT00290641|noncontiguous stage II adult diffuse large cell lymphoma|noncontiguous stage ii adult diffuse large cell lymphoma
790766|NCT00290641|recurrent adult diffuse large cell lymphoma|recurrent adult diffuse large cell lymphoma
790767|NCT00290641|stage III adult diffuse large cell lymphoma|stage iii adult diffuse large cell lymphoma
790768|NCT00290641|stage IV adult diffuse large cell lymphoma|stage iv adult diffuse large cell lymphoma
790769|NCT00290641|noncontiguous stage II adult diffuse mixed cell lymphoma|noncontiguous stage ii adult diffuse mixed cell lymphoma
790770|NCT00290641|recurrent adult diffuse mixed cell lymphoma|recurrent adult diffuse mixed cell lymphoma
790771|NCT00290641|stage III adult diffuse mixed cell lymphoma|stage iii adult diffuse mixed cell lymphoma
790772|NCT00290641|stage IV adult diffuse mixed cell lymphoma|stage iv adult diffuse mixed cell lymphoma
790773|NCT00290641|noncontiguous stage II adult diffuse small cleaved cell lymphoma|noncontiguous stage ii adult diffuse small cleaved cell lymphoma
790774|NCT00290641|recurrent adult diffuse small cleaved cell lymphoma|recurrent adult diffuse small cleaved cell lymphoma
790775|NCT00290641|stage III adult diffuse small cleaved cell lymphoma|stage iii adult diffuse small cleaved cell lymphoma
790776|NCT00290641|stage IV adult diffuse small cleaved cell lymphoma|stage iv adult diffuse small cleaved cell lymphoma
790777|NCT00290641|contiguous stage II adult lymphoblastic lymphoma|contiguous stage ii adult lymphoblastic lymphoma
790778|NCT00290641|noncontiguous stage II adult lymphoblastic lymphoma|noncontiguous stage ii adult lymphoblastic lymphoma
790779|NCT00290641|stage III adult lymphoblastic lymphoma|stage iii adult lymphoblastic lymphoma
790780|NCT00290641|stage IV adult lymphoblastic lymphoma|stage iv adult lymphoblastic lymphoma
790781|NCT00290641|noncontiguous stage II grade 3 follicular lymphoma|noncontiguous stage ii grade 3 follicular lymphoma
790782|NCT00290641|recurrent grade 3 follicular lymphoma|recurrent grade 3 follicular lymphoma
790783|NCT00290641|stage III grade 3 follicular lymphoma|stage iii grade 3 follicular lymphoma
790784|NCT00290641|stage IV grade 3 follicular lymphoma|stage iv grade 3 follicular lymphoma
791099|NCT00290121|Appetite|appetite
790785|NCT00290641|noncontiguous stage II mantle cell lymphoma|noncontiguous stage ii mantle cell lymphoma
790786|NCT00290641|recurrent mantle cell lymphoma|recurrent mantle cell lymphoma
790787|NCT00290641|stage III mantle cell lymphoma|stage iii mantle cell lymphoma
790788|NCT00290641|stage IV mantle cell lymphoma|stage iv mantle cell lymphoma
790789|NCT00290641|recurrent childhood large cell lymphoma|recurrent childhood large cell lymphoma
790790|NCT00290641|recurrent childhood lymphoblastic lymphoma|recurrent childhood lymphoblastic lymphoma
790791|NCT00290641|recurrent childhood small noncleaved cell lymphoma|recurrent childhood small noncleaved cell lymphoma
790792|NCT00290641|adult acute lymphoblastic leukemia in remission|adult acute lymphoblastic leukemia in remission
790793|NCT00290641|childhood acute lymphoblastic leukemia in remission|childhood acute lymphoblastic leukemia in remission
790794|NCT00290641|refractory anemia with excess blasts in transformation|refractory anemia with excess blasts in transformation
790795|NCT00290641|refractory cytopenia with multilineage dysplasia|refractory cytopenia with multilineage dysplasia
790796|NCT00290641|recurrent adult acute myeloid leukemia|recurrent adult acute myeloid leukemia
790797|NCT00290641|recurrent childhood acute myeloid leukemia|recurrent childhood acute myeloid leukemia
790798|NCT00290641|noncontiguous stage II adult immunoblastic large cell lymphoma|noncontiguous stage ii adult immunoblastic large cell lymphoma
790799|NCT00290641|recurrent adult immunoblastic large cell lymphoma|recurrent adult immunoblastic large cell lymphoma
790800|NCT00290641|stage III adult immunoblastic large cell lymphoma|stage iii adult immunoblastic large cell lymphoma
790801|NCT00290641|stage IV adult immunoblastic large cell lymphoma|stage iv adult immunoblastic large cell lymphoma
790802|NCT00290641|blastic phase chronic myelogenous leukemia|blastic phase chronic myelogenous leukemia
790803|NCT00290641|chronic idiopathic myelofibrosis|chronic idiopathic myelofibrosis
790804|NCT00290641|chronic eosinophilic leukemia|chronic eosinophilic leukemia
790805|NCT00290641|chronic neutrophilic leukemia|chronic neutrophilic leukemia
790806|NCT00290641|contiguous stage II adult Burkitt lymphoma|contiguous stage ii adult burkitt lymphoma
790807|NCT00290641|stage I adult Burkitt lymphoma|stage i adult burkitt lymphoma
790808|NCT00290641|contiguous stage II adult diffuse large cell lymphoma|contiguous stage ii adult diffuse large cell lymphoma
790809|NCT00290641|stage I adult diffuse large cell lymphoma|stage i adult diffuse large cell lymphoma
791332|NCT00288990|MS|ms
790810|NCT00290641|contiguous stage II adult diffuse mixed cell lymphoma|contiguous stage ii adult diffuse mixed cell lymphoma
790811|NCT00290641|stage I adult diffuse mixed cell lymphoma|stage i adult diffuse mixed cell lymphoma
790812|NCT00290641|contiguous stage II adult diffuse small cleaved cell lymphoma|contiguous stage ii adult diffuse small cleaved cell lymphoma
790813|NCT00290641|stage I adult diffuse small cleaved cell lymphoma|stage i adult diffuse small cleaved cell lymphoma
790814|NCT00290641|contiguous stage II adult immunoblastic large cell lymphoma|contiguous stage ii adult immunoblastic large cell lymphoma
790815|NCT00290641|stage I adult immunoblastic large cell lymphoma|stage i adult immunoblastic large cell lymphoma
790816|NCT00290641|stage I adult lymphoblastic lymphoma|stage i adult lymphoblastic lymphoma
790817|NCT00290641|stage I childhood lymphoblastic lymphoma|stage i childhood lymphoblastic lymphoma
790818|NCT00290641|stage II childhood lymphoblastic lymphoma|stage ii childhood lymphoblastic lymphoma
790819|NCT00290641|stage I childhood small noncleaved cell lymphoma|stage i childhood small noncleaved cell lymphoma
790820|NCT00290641|stage II childhood small noncleaved cell lymphoma|stage ii childhood small noncleaved cell lymphoma
790821|NCT00290641|stage III childhood small noncleaved cell lymphoma|stage iii childhood small noncleaved cell lymphoma
790822|NCT00290641|stage IV childhood small noncleaved cell lymphoma|stage iv childhood small noncleaved cell lymphoma
790823|NCT00290641|contiguous stage II grade 3 follicular lymphoma|contiguous stage ii grade 3 follicular lymphoma
790824|NCT00290641|stage I grade 3 follicular lymphoma|stage i grade 3 follicular lymphoma
790825|NCT00290641|contiguous stage II mantle cell lymphoma|contiguous stage ii mantle cell lymphoma
790826|NCT00290641|stage I mantle cell lymphoma|stage i mantle cell lymphoma
790827|NCT00290641|stage I childhood large cell lymphoma|stage i childhood large cell lymphoma
790828|NCT00290641|stage II childhood large cell lymphoma|stage ii childhood large cell lymphoma
790829|NCT00290641|stage III childhood large cell lymphoma|stage iii childhood large cell lymphoma
790830|NCT00290641|stage IV childhood large cell lymphoma|stage iv childhood large cell lymphoma
790831|NCT00290641|stage III childhood lymphoblastic lymphoma|stage iii childhood lymphoblastic lymphoma
790832|NCT00290641|stage IV childhood lymphoblastic lymphoma|stage iv childhood lymphoblastic lymphoma
790833|NCT00290641|recurrent adult lymphoblastic lymphoma|recurrent adult lymphoblastic lymphoma
790834|NCT00290641|childhood myelodysplastic syndromes|childhood myelodysplastic syndromes
790835|NCT00290628|graft versus host disease|graft versus host disease
790836|NCT00290628|adult acute myeloid leukemia with 11q23 (MLL) abnormalities|adult acute myeloid leukemia with 11q23 (mll) abnormalities
790837|NCT00290628|adult acute myeloid leukemia with inv(16)(p13;q22)|adult acute myeloid leukemia with inv(16)(p13;q22)
790838|NCT00290628|adult acute myeloid leukemia with t(15;17)(q22;q12)|adult acute myeloid leukemia with t(15;17)(q22;q12)
790839|NCT00290628|adult acute myeloid leukemia with t(16;16)(p13;q22)|adult acute myeloid leukemia with t(16;16)(p13;q22)
790840|NCT00290628|adult acute myeloid leukemia with t(8;21)(q22;q22)|adult acute myeloid leukemia with t(8;21)(q22;q22)
790841|NCT00290628|accelerated phase chronic myelogenous leukemia|accelerated phase chronic myelogenous leukemia
790842|NCT00290628|adult acute lymphoblastic leukemia in remission|adult acute lymphoblastic leukemia in remission
790843|NCT00290628|adult acute myeloid leukemia in remission|adult acute myeloid leukemia in remission
790844|NCT00290628|atypical chronic myeloid leukemia|atypical chronic myeloid leukemia
791100|NCT00290121|fMRI|fmri
790845|NCT00290628|blastic phase chronic myelogenous leukemia|blastic phase chronic myelogenous leukemia
790846|NCT00290628|childhood acute lymphoblastic leukemia in remission|childhood acute lymphoblastic leukemia in remission
790847|NCT00290628|childhood acute myeloid leukemia in remission|childhood acute myeloid leukemia in remission
790848|NCT00290628|childhood chronic myelogenous leukemia|childhood chronic myelogenous leukemia
790849|NCT00290628|chronic eosinophilic leukemia|chronic eosinophilic leukemia
790850|NCT00290628|chronic idiopathic myelofibrosis|chronic idiopathic myelofibrosis
790851|NCT00290628|chronic myelomonocytic leukemia|chronic myelomonocytic leukemia
790852|NCT00290628|chronic neutrophilic leukemia|chronic neutrophilic leukemia
790853|NCT00290628|chronic phase chronic myelogenous leukemia|chronic phase chronic myelogenous leukemia
790854|NCT00290628|de novo myelodysplastic syndromes|de novo myelodysplastic syndromes
790855|NCT00290628|extranodal marginal zone B-cell lymphoma of mucosa-associated lymphoid tissue|extranodal marginal zone b-cell lymphoma of mucosa-associated lymphoid tissue
790856|NCT00290628|juvenile myelomonocytic leukemia|juvenile myelomonocytic leukemia
790857|NCT00290628|myelodysplastic/myeloproliferative disease, unclassifiable|myelodysplastic/myeloproliferative disease, unclassifiable
790858|NCT00290628|nodal marginal zone B-cell lymphoma|nodal marginal zone b-cell lymphoma
790859|NCT00290628|noncontiguous stage II adult Burkitt lymphoma|noncontiguous stage ii adult burkitt lymphoma
790860|NCT00290628|noncontiguous stage II adult diffuse large cell lymphoma|noncontiguous stage ii adult diffuse large cell lymphoma
790861|NCT00290628|noncontiguous stage II adult diffuse mixed cell lymphoma|noncontiguous stage ii adult diffuse mixed cell lymphoma
790862|NCT00290628|noncontiguous stage II adult diffuse small cleaved cell lymphoma|noncontiguous stage ii adult diffuse small cleaved cell lymphoma
790863|NCT00290628|noncontiguous stage II adult immunoblastic large cell lymphoma|noncontiguous stage ii adult immunoblastic large cell lymphoma
790864|NCT00290628|noncontiguous stage II adult lymphoblastic lymphoma|noncontiguous stage ii adult lymphoblastic lymphoma
790865|NCT00290628|noncontiguous stage II grade 1 follicular lymphoma|noncontiguous stage ii grade 1 follicular lymphoma
790866|NCT00290628|noncontiguous stage II grade 2 follicular lymphoma|noncontiguous stage ii grade 2 follicular lymphoma
790867|NCT00290628|noncontiguous stage II grade 3 follicular lymphoma|noncontiguous stage ii grade 3 follicular lymphoma
791333|NCT00288977|Diabetes|diabetes
790868|NCT00290628|noncontiguous stage II mantle cell lymphoma|noncontiguous stage ii mantle cell lymphoma
790869|NCT00290628|noncontiguous stage II marginal zone lymphoma|noncontiguous stage ii marginal zone lymphoma
790870|NCT00290628|noncontiguous stage II small lymphocytic lymphoma|noncontiguous stage ii small lymphocytic lymphoma
790871|NCT00290628|previously treated myelodysplastic syndromes|previously treated myelodysplastic syndromes
790872|NCT00290628|recurrent adult acute lymphoblastic leukemia|recurrent adult acute lymphoblastic leukemia
790873|NCT00290628|recurrent adult acute myeloid leukemia|recurrent adult acute myeloid leukemia
790874|NCT00290628|recurrent adult Burkitt lymphoma|recurrent adult burkitt lymphoma
790875|NCT00290628|recurrent adult Hodgkin lymphoma|recurrent adult hodgkin lymphoma
790876|NCT00290628|recurrent adult diffuse large cell lymphoma|recurrent adult diffuse large cell lymphoma
790877|NCT00290628|recurrent adult diffuse mixed cell lymphoma|recurrent adult diffuse mixed cell lymphoma
790878|NCT00290628|recurrent adult diffuse small cleaved cell lymphoma|recurrent adult diffuse small cleaved cell lymphoma
790879|NCT00290628|recurrent adult immunoblastic large cell lymphoma|recurrent adult immunoblastic large cell lymphoma
790880|NCT00290628|recurrent adult lymphoblastic lymphoma|recurrent adult lymphoblastic lymphoma
790881|NCT00290628|recurrent/refractory childhood Hodgkin lymphoma|recurrent/refractory childhood hodgkin lymphoma
790882|NCT00290628|recurrent childhood acute lymphoblastic leukemia|recurrent childhood acute lymphoblastic leukemia
790883|NCT00290628|recurrent childhood acute myeloid leukemia|recurrent childhood acute myeloid leukemia
790884|NCT00290628|recurrent childhood large cell lymphoma|recurrent childhood large cell lymphoma
790885|NCT00290628|recurrent childhood lymphoblastic lymphoma|recurrent childhood lymphoblastic lymphoma
790886|NCT00290628|recurrent childhood small noncleaved cell lymphoma|recurrent childhood small noncleaved cell lymphoma
790887|NCT00290628|recurrent cutaneous T-cell non-Hodgkin lymphoma|recurrent cutaneous t-cell non-hodgkin lymphoma
790888|NCT00290628|recurrent grade 1 follicular lymphoma|recurrent grade 1 follicular lymphoma
790889|NCT00290628|recurrent grade 2 follicular lymphoma|recurrent grade 2 follicular lymphoma
790890|NCT00290628|recurrent grade 3 follicular lymphoma|recurrent grade 3 follicular lymphoma
790891|NCT00290628|recurrent mantle cell lymphoma|recurrent mantle cell lymphoma
790892|NCT00290628|recurrent marginal zone lymphoma|recurrent marginal zone lymphoma
790893|NCT00290628|recurrent mycosis fungoides/Sezary syndrome|recurrent mycosis fungoides/sezary syndrome
790894|NCT00290628|recurrent small lymphocytic lymphoma|recurrent small lymphocytic lymphoma
790895|NCT00290628|refractory chronic lymphocytic leukemia|refractory chronic lymphocytic leukemia
790896|NCT00290628|refractory hairy cell leukemia|refractory hairy cell leukemia
790897|NCT00290628|refractory multiple myeloma|refractory multiple myeloma
790898|NCT00290628|relapsing chronic myelogenous leukemia|relapsing chronic myelogenous leukemia
790899|NCT00290628|secondary acute myeloid leukemia|secondary acute myeloid leukemia
790900|NCT00290628|secondary myelodysplastic syndromes|secondary myelodysplastic syndromes
790901|NCT00290628|splenic marginal zone lymphoma|splenic marginal zone lymphoma
790902|NCT00290628|stage III adult Burkitt lymphoma|stage iii adult burkitt lymphoma
790903|NCT00290628|stage III adult Hodgkin lymphoma|stage iii adult hodgkin lymphoma
790904|NCT00290628|stage III adult diffuse large cell lymphoma|stage iii adult diffuse large cell lymphoma
790905|NCT00290628|stage III adult diffuse mixed cell lymphoma|stage iii adult diffuse mixed cell lymphoma
791102|NCT00290108|Propofol|propofol
790906|NCT00290628|stage III adult diffuse small cleaved cell lymphoma|stage iii adult diffuse small cleaved cell lymphoma
790907|NCT00290628|stage III adult immunoblastic large cell lymphoma|stage iii adult immunoblastic large cell lymphoma
790908|NCT00290628|stage III adult lymphoblastic lymphoma|stage iii adult lymphoblastic lymphoma
790909|NCT00290628|stage III chronic lymphocytic leukemia|stage iii chronic lymphocytic leukemia
790910|NCT00290628|stage III grade 1 follicular lymphoma|stage iii grade 1 follicular lymphoma
790911|NCT00290628|stage III grade 2 follicular lymphoma|stage iii grade 2 follicular lymphoma
790912|NCT00290628|stage III grade 3 follicular lymphoma|stage iii grade 3 follicular lymphoma
790913|NCT00290628|stage III mantle cell lymphoma|stage iii mantle cell lymphoma
790914|NCT00290628|stage III marginal zone lymphoma|stage iii marginal zone lymphoma
790915|NCT00290628|stage III small lymphocytic lymphoma|stage iii small lymphocytic lymphoma
790916|NCT00290628|stage IV adult Burkitt lymphoma|stage iv adult burkitt lymphoma
790917|NCT00290628|stage IV adult Hodgkin lymphoma|stage iv adult hodgkin lymphoma
790918|NCT00290628|stage IV adult diffuse large cell lymphoma|stage iv adult diffuse large cell lymphoma
790919|NCT00290628|stage IV adult diffuse mixed cell lymphoma|stage iv adult diffuse mixed cell lymphoma
790920|NCT00290628|stage IV adult diffuse small cleaved cell lymphoma|stage iv adult diffuse small cleaved cell lymphoma
790921|NCT00290628|stage IV adult immunoblastic large cell lymphoma|stage iv adult immunoblastic large cell lymphoma
790922|NCT00290628|stage IV adult lymphoblastic lymphoma|stage iv adult lymphoblastic lymphoma
790923|NCT00290628|stage IV chronic lymphocytic leukemia|stage iv chronic lymphocytic leukemia
790924|NCT00290628|stage IV grade 1 follicular lymphoma|stage iv grade 1 follicular lymphoma
790925|NCT00290628|stage IV grade 2 follicular lymphoma|stage iv grade 2 follicular lymphoma
790926|NCT00290628|stage IV grade 3 follicular lymphoma|stage iv grade 3 follicular lymphoma
790927|NCT00290628|stage IV mantle cell lymphoma|stage iv mantle cell lymphoma
790928|NCT00290628|stage IV marginal zone lymphoma|stage iv marginal zone lymphoma
790929|NCT00290628|stage IV small lymphocytic lymphoma|stage iv small lymphocytic lymphoma
790930|NCT00290628|Diamond-Blackfan anemia|diamond-blackfan anemia
790931|NCT00290628|Fanconi anemia|fanconi anemia
792395|NCT00284154|Relapsed|relapsed
790932|NCT00290628|childhood myelodysplastic syndromes|childhood myelodysplastic syndromes
790933|NCT00290615|adenocarcinoma of the colon|adenocarcinoma of the colon
790934|NCT00290615|recurrent colon cancer|recurrent colon cancer
790935|NCT00290615|stage IV colon cancer|stage iv colon cancer
790936|NCT00290615|adenocarcinoma of the rectum|adenocarcinoma of the rectum
790937|NCT00290615|recurrent rectal cancer|recurrent rectal cancer
790938|NCT00290615|stage IV rectal cancer|stage iv rectal cancer
790939|NCT00290602|Acute respiratory distress syndrome|acute respiratory distress syndrome
790940|NCT00290602|corticosteroids|corticosteroids
790941|NCT00290602|postoperative complications|postoperative complications
790942|NCT00290602|cytokines|cytokines
790943|NCT00290589|low back pain|low back pain
790944|NCT00290589|emergency department|emergency department
790945|NCT00290589|corticosteroids|corticosteroids
790946|NCT00290576|Digestive and Nutritional Effects|digestive and nutritional effects
790947|NCT00290576|Safety and Growth|safety and growth
790948|NCT00290576|Feeding Tolerance|feeding tolerance
790949|NCT00290550|Advanced Non-Small Cell Lung Cancer|advanced non-small cell lung cancer
790950|NCT00290550|NSCLC|nsclc
790951|NCT00290537|Non-Small Cell Lung Cancer|non-small cell lung cancer
790952|NCT00290537|Lung Cancer|lung cancer
790953|NCT00290537|Carboplatin|carboplatin
790954|NCT00290537|Paclitaxel|paclitaxel
790955|NCT00290537|ZD6474|zd6474
790956|NCT00290537|NSCLC|nsclc
790957|NCT00290524|Oral alimentation following colorectal surgery|oral alimentation following colorectal surgery
790958|NCT00290524|anastomosis|anastomosis
790959|NCT00290524|laparoscopy|laparoscopy
790960|NCT00290524|hospitalization stay|hospitalization stay
790961|NCT00290511|Follicular Lymphoma|follicular lymphoma
790962|NCT00290511|Zevalin|zevalin
790963|NCT00290511|Ibritumomab Tiuxetan|ibritumomab tiuxetan
790964|NCT00290511|IDEC-Y2B8|idec-y2b8
790966|NCT00290511|Fludara|fludara
790967|NCT00290511|Dexamethasone|dexamethasone
790968|NCT00290511|Mitoxantrone|mitoxantrone
790969|NCT00290511|Rituximab|rituximab
790970|NCT00290511|Rituxan|rituxan
790971|NCT00290511|R-FND|r-fnd
790972|NCT00290511|Fludarabine Phosphate|fludarabine phosphate
790973|NCT00290511|Decadron|decadron
790974|NCT00290498|Non-Hodgkin's Lymphoma|non-hodgkin's lymphoma
790975|NCT00290498|B-Cell Non-Hodgkin's Lymphoma|b-cell non-hodgkin's lymphoma
790976|NCT00290498|Lymphoma|lymphoma
790977|NCT00290498|Cyclophosphamide|cyclophosphamide
790978|NCT00290498|Cytarabine|cytarabine
790979|NCT00290498|Doxorubicin|doxorubicin
790980|NCT00290498|Hyper-CVAD|hyper-cvad
790981|NCT00290498|Methotrexate|methotrexate
790982|NCT00290498|Prednisone|prednisone
790983|NCT00290498|Rituximab|rituximab
790984|NCT00290498|Vincristine|vincristine
790985|NCT00290498|R-CHOP|r-chop
790986|NCT00290498|R-HCVAD|r-hcvad
790987|NCT00290498|Dexamethasone|dexamethasone
790988|NCT00290498|Decadron|decadron
790989|NCT00290498|Leucovorin|leucovorin
790990|NCT00290498|Ara-C|ara-c
790991|NCT00290498|Cytosar|cytosar
790992|NCT00290498|Cytoxan|cytoxan
790993|NCT00290498|DepoCyt|depocyt
790994|NCT00290498|Cytosine arabinosine hydrochloride|cytosine arabinosine hydrochloride
790995|NCT00290498|AD|ad
790996|NCT00290498|Hydroxydaunomycin hydrochloride|hydroxydaunomycin hydrochloride
790997|NCT00290498|Neosar|neosar
790998|NCT00290485|non-resectable tumor|non-resectable tumor
790999|NCT00290485|high-risk tumor|high-risk tumor
791000|NCT00290485|metastasis|metastasis
791001|NCT00290485|Response Evaluation Criteria in Solid Tumors (RECIST)|response evaluation criteria in solid tumors (recist)
791002|NCT00290485|Gleevec|gleevec
791003|NCT00290485|Imatinib mesylate|imatinib mesylate
791004|NCT00290459|Gynecologic Disease|gynecologic disease
791005|NCT00290459|Gynecologic Cancer|gynecologic cancer
791006|NCT00290459|Prognostic Markers|prognostic markers
791007|NCT00290433|Lymphoma|lymphoma
791008|NCT00290433|Peripheral T Cell|peripheral t cell
791009|NCT00290433|HCVIDDOXIL Regimen|hcviddoxil regimen
791010|NCT00290433|ARA-C|ara-c
791011|NCT00290433|Cytosar|cytosar
791012|NCT00290433|DepoCyt|depocyt
791013|NCT00290433|Cytosine arabinosine hydrochloride|cytosine arabinosine hydrochloride
791014|NCT00290433|Pegylated Liposomal Doxorubicin|pegylated liposomal doxorubicin
791015|NCT00290433|Doxorubicin hydrochloride|doxorubicin hydrochloride
791016|NCT00290433|Doxil|doxil
791017|NCT00290433|Cyclophosphamide|cyclophosphamide
791018|NCT00290433|Cytoxan|cytoxan
791019|NCT00290433|Neosar|neosar
791020|NCT00290433|Dexamethasone|dexamethasone
791021|NCT00290433|Decadron|decadron
791022|NCT00290433|Mesna|mesna
791023|NCT00290433|Methotrexate|methotrexate
791024|NCT00290433|Vincristine|vincristine
791025|NCT00290433|G-CSF|g-csf
791026|NCT00290433|Filgrastim|filgrastim
791027|NCT00290433|Neupogen|neupogen
791028|NCT00290420|malaria|malaria
791029|NCT00290420|Plasmodium vivax|plasmodium vivax
791030|NCT00290420|pregnancy|pregnancy
791031|NCT00290420|chemoprophylaxis|chemoprophylaxis
791032|NCT00290407|chronic lymphocytic leukemia|chronic lymphocytic leukemia
791033|NCT00290407|small lymphocytic lymphoma|small lymphocytic lymphoma
791034|NCT00290407|rituximab|rituximab
791035|NCT00290407|beta-glucan|beta-glucan
791036|NCT00290394|Blood Pressure,|blood pressure,
791037|NCT00290394|rosiglitazone,Diabetes Mellitus, Type 2,|rosiglitazone,diabetes mellitus, type 2,
791038|NCT00290381|Allergic rhinitis|allergic rhinitis
791039|NCT00290368|Nasal allergen challenge|nasal allergen challenge
791040|NCT00290368|Allergic rhinitis|allergic rhinitis
791041|NCT00290368|Timothy grass pollen|timothy grass pollen
791042|NCT00290368|inflammatory mediators|inflammatory mediators
791043|NCT00290329|Safety|safety
791044|NCT00290329|Meningococcal disease|meningococcal disease
791045|NCT00290329|Meningitidis serogroups A, C,W & Y diseases|meningitidis serogroups a, c,w & y diseases
791046|NCT00290329|Meningococcal vaccine|meningococcal vaccine
791047|NCT00290316|Hepatocellular carcinoma|hepatocellular carcinoma
791048|NCT00290316|Cholangiocarcinoma|cholangiocarcinoma
791049|NCT00290316|Metastasis|metastasis
791050|NCT00290316|Liver neoplasm|liver neoplasm
791051|NCT00290290|Prevention|prevention
791052|NCT00290290|Antiseptic Preoperative Scrub|antiseptic preoperative scrub
791053|NCT00290290|Postoperative Wound Infection|postoperative wound infection
791054|NCT00290251|Endometrium|endometrium
791055|NCT00290251|Progesterone|progesterone
791056|NCT00290251|Estrogen|estrogen
791057|NCT00290251|Fibroid|fibroid
791058|NCT00290251|Hysterectomy|hysterectomy
791059|NCT00290251|Leiomyoma|leiomyoma
791060|NCT00290251|Uterine Fibroids|uterine fibroids
791061|NCT00290251|Fibroids|fibroids
791062|NCT00290238|Chronic Low Back Pain|chronic low back pain
791063|NCT00290238|Lower Extremity Pain|lower extremity pain
791064|NCT00290238|Central Sensitization|central sensitization
791065|NCT00290238|Percutaneous Neuromodulation Therapy|percutaneous neuromodulation therapy
791066|NCT00290225|Posttraumatic stress disorder|posttraumatic stress disorder
791067|NCT00290225|depression|depression
791068|NCT00290225|disaster mental health|disaster mental health
791069|NCT00290225|yoga|yoga
791070|NCT00290225|Breathwork|breathwork
791071|NCT00290225|exposure treatments|exposure treatments
791072|NCT00290212|Women|women
791073|NCT00290212|Bone density|bone density
791074|NCT00290212|Menopause|menopause
791075|NCT00290212|Dietary Supplements|dietary supplements
791076|NCT00290212|Vitamin K2|vitamin k2
791077|NCT00290199|Fetal Membranes, Premature Rupture|fetal membranes, premature rupture
791078|NCT00290199|Labor, Induced|labor, induced
791079|NCT00290199|Foley Catheter|foley catheter
791080|NCT00290186|Cerebral Palsy|cerebral palsy
791081|NCT00290186|Spastic Cerebral Palsy|spastic cerebral palsy
791082|NCT00290186|CP|cp
791083|NCT00290186|Hyperbaric|hyperbaric
791084|NCT00290186|HBOT|hbot
791085|NCT00290173|pre term labor|pre term labor
791086|NCT00290173|therapy|therapy
791087|NCT00290173|maintenance|maintenance
791088|NCT00290160|Hyperkalemia|hyperkalemia
791089|NCT00290160|Protein|protein
791090|NCT00290160|Hyperglycemia|hyperglycemia
791091|NCT00290160|ELBW|elbw
791092|NCT00290147|Dengue|dengue
791093|NCT00290147|DNA vaccine|dna vaccine
791094|NCT00290134|Hypogonadism|hypogonadism
791095|NCT00290134|Testosterone|testosterone
791096|NCT00290121|Schizophrenia|schizophrenia
791097|NCT00290121|Atypical antipsychotics|atypical antipsychotics
791103|NCT00290108|hemodynamic|hemodynamic
791104|NCT00290108|pharmacokinetic|pharmacokinetic
791105|NCT00290095|Multiple Myeloma|multiple myeloma
791106|NCT00290095|Quality of Life|quality of life
791107|NCT00290095|Response Shift|response shift
791108|NCT00290095|Clinically Important Difference|clinically important difference
791109|NCT00290082|sedation|sedation
791110|NCT00290082|midazolam|midazolam
791111|NCT00290082|loxapine|loxapine
791112|NCT00290082|agitation|agitation
791113|NCT00290082|emergency department|emergency department
791114|NCT00290082|toxicological analysis|toxicological analysis
791115|NCT00290069|Renal function|renal function
791116|NCT00290069|Serum creatinine|serum creatinine
791117|NCT00290069|Immunosuppression|immunosuppression
791118|NCT00290069|Rejection|rejection
791119|NCT00290056|CHD|chd
791120|NCT00290056|Arrhythmia|arrhythmia
791121|NCT00290056|ICD|icd
791122|NCT00290056|Omega-3 PUFA|omega-3 pufa
791123|NCT00290056|Nutrition|nutrition
791124|NCT00290043|Insulin glulisine|insulin glulisine
791125|NCT00290043|Diabetes mellitus Type 1|diabetes mellitus type 1
791126|NCT00290043|Postprandial Period|postprandial period
791127|NCT00290043|Pharmacokinetics|pharmacokinetics
791128|NCT00290043|Glucodynamics|glucodynamics
791129|NCT00290030|acute urinary retention|acute urinary retention
791130|NCT00290030|International Prostate Symptom Score (IPSS)|international prostate symptom score (ipss)
791131|NCT00290004|Chronic Lymphocytic Leukemia|chronic lymphocytic leukemia
791132|NCT00290004|Small Lymphocytic Lymphoma|small lymphocytic lymphoma
791133|NCT00290004|Leukemia|leukemia
791134|NCT00290004|Lymphoma|lymphoma
791135|NCT00290004|Motexafin Gadolinium|motexafin gadolinium
791136|NCT00290004|Relapsed Chronic Lymphocytic Leukemia|relapsed chronic lymphocytic leukemia
791137|NCT00290004|Relapsed Small Lymphocytic Lymphoma|relapsed small lymphocytic lymphoma
791138|NCT00290004|Refractory Chronic Lymphocytic Leukemia|refractory chronic lymphocytic leukemia
791139|NCT00290004|Refractory Small Lymphocytic Lymphoma|refractory small lymphocytic lymphoma
791140|NCT00289978|Multiple Sclerosis|multiple sclerosis
791141|NCT00289978|FTY720|fty720
791142|NCT00289978|Fingolimod|fingolimod
791143|NCT00289965|Alcohol Abuse|alcohol abuse
791144|NCT00289965|Alcohol Drinking|alcohol drinking
791145|NCT00289965|Intervention Studies|intervention studies
791146|NCT00289965|Computer-Assisted Instruction|computer-assisted instruction
791147|NCT00289965|College Students|college students
791148|NCT00289952|HIV infections|hiv infections
791149|NCT00289952|Histone deacetylase Inhibitor|histone deacetylase inhibitor
791150|NCT00289952|HIV Reservoirs|hiv reservoirs
791151|NCT00289952|Peripheral Blood Mononuclear Cells|peripheral blood mononuclear cells
791152|NCT00289952|Valproic Acid|valproic acid
791153|NCT00289952|Treatment Experienced|treatment experienced
791154|NCT00289939|women|women
791155|NCT00289939|women's health|women's health
791156|NCT00289939|HIV|hiv
791157|NCT00289939|risk factors|risk factors
791158|NCT00289939|risk behaviors|risk behaviors
791159|NCT00289939|prevention|prevention
791160|NCT00289939|motivational interviewing|motivational interviewing
791161|NCT00289939|domestic violence|domestic violence
791162|NCT00289939|partner violence|partner violence
791163|NCT00289939|behavioral trial|behavioral trial
791164|NCT00289939|community justice|community justice
791165|NCT00289939|criminal justice|criminal justice
791166|NCT00289926|low libido|low libido
791167|NCT00289926|lack of wellbeing|lack of wellbeing
791168|NCT00289913|Hepatitis A virus|hepatitis a virus
791169|NCT00289861|Schizophrenia|schizophrenia
791170|NCT00289861|risperidone|risperidone
791171|NCT00289861|prolactin|prolactin
791172|NCT00289861|clozapine|clozapine
791173|NCT00289835|Coronary Artery Bypass Grafting|coronary artery bypass grafting
791174|NCT00289835|Drug Eluting Stent|drug eluting stent
791175|NCT00289835|Saphenous Vein Graft|saphenous vein graft
791176|NCT00289822|chronic heart failure|chronic heart failure
791177|NCT00289822|myocardial infarction|myocardial infarction
791178|NCT00289783|Primary and booster vaccination|primary and booster vaccination
791179|NCT00289783|Neisseria meningitidis|neisseria meningitidis
791180|NCT00289783|Hib disease|hib disease
791181|NCT00289783|Meningococcal vaccine|meningococcal vaccine
791182|NCT00289783|Meningococcal disease|meningococcal disease
791183|NCT00289783|Children|children
791184|NCT00289783|Immunogenicity|immunogenicity
791185|NCT00289783|Safety|safety
791186|NCT00289783|Infants|infants
791187|NCT00289770|TWINRIX™ ADULT|twinrix™ adult
791188|NCT00289770|Hepatitis A|hepatitis a
791189|NCT00289770|Hepatitis B|hepatitis b
791190|NCT00289757|Havrix™|havrix™
791191|NCT00289757|Hepatitis A|hepatitis a
791192|NCT00289744|Hepatitis A|hepatitis a
791193|NCT00289744|Hepatitis B|hepatitis b
791194|NCT00289744|TWINRIX™ ADULT|twinrix™ adult
791195|NCT00289731|Combined hepatitis A and hepatitis B vaccine|combined hepatitis a and hepatitis b vaccine
791196|NCT00289731|Hepatitis B|hepatitis b
791197|NCT00289731|Hepatitis A|hepatitis a
791198|NCT00289731|Monovalent hepatitis A and hepatitis B vaccines|monovalent hepatitis a and hepatitis b vaccines
791199|NCT00289718|Combined Hepatitis A and B vaccine|combined hepatitis a and b vaccine
791200|NCT00289718|Hepatitis A|hepatitis a
791201|NCT00289718|Hepatitis B|hepatitis b
791202|NCT00289705|Obesity|obesity
791203|NCT00289705|Surgery|surgery
791204|NCT00289705|Adolescent|adolescent
791205|NCT00289705|Roux-en-Y gastric bypass|roux-en-y gastric bypass
791206|NCT00289705|Laparoscopic|laparoscopic
791207|NCT00289666|Sleep Disorder|sleep disorder
791208|NCT00289666|CPAP|cpap
791209|NCT00289653|nicotine dependence,|nicotine dependence,
791210|NCT00289653|transdermal nicotine patch,|transdermal nicotine patch,
791211|NCT00289653|smoking while receiving nicotine replacement,|smoking while receiving nicotine replacement,
791212|NCT00289653|comorbidities|comorbidities
791213|NCT00289640|Stage III (unresectable)|stage iii (unresectable)
791214|NCT00289640|Stage IV melanoma|stage iv melanoma
791215|NCT00289627|Previously treated melanoma|previously treated melanoma
791216|NCT00289627|Unresectable Stage III|unresectable stage iii
791217|NCT00289627|Stage IV|stage iv
791218|NCT00289614|contrast induced nephropathy|contrast induced nephropathy
791219|NCT00289601|aspirin|aspirin
791220|NCT00289601|clopidogrel|clopidogrel
791221|NCT00289601|resistance|resistance
791222|NCT00289601|angioplasty|angioplasty
791223|NCT00289601|percutaneous coronary intervention|percutaneous coronary intervention
791224|NCT00289601|myocardial infarction|myocardial infarction
791225|NCT00289588|Methicillin-resistant Staphylococcus aureus|methicillin-resistant staphylococcus aureus
791226|NCT00289588|Staphylococcus aureus|staphylococcus aureus
791227|NCT00289588|MRSA|mrsa
791228|NCT00289588|CA-MRSA|ca-mrsa
791229|NCT00289575|Femur head aseptic osteonecrosis|femur head aseptic osteonecrosis
791230|NCT00289575|Bone reconstruction|bone reconstruction
791231|NCT00289575|Macroporous biphasic calcium phosphate granules|macroporous biphasic calcium phosphate granules
791232|NCT00289562|B-cell|b-cell
791233|NCT00289562|leukemia|leukemia
791234|NCT00289562|B-lymphoblastic leukemia|b-lymphoblastic leukemia
791235|NCT00289562|lymphoma|lymphoma
791236|NCT00289562|B-All|b-all
791237|NCT00289549|CLL|cll
792396|NCT00284141|lung|lung
791238|NCT00289549|Chronic lymphocytic leukemia|chronic lymphocytic leukemia
791239|NCT00289549|leukemia|leukemia
791240|NCT00289549|Advanced, fludarabine-refractory CLL|advanced, fludarabine-refractory cll
791241|NCT00289523|Major Depressive Disorder, Depressive Disorder, Unipolar Depression, Antidepressants, Electroencephalography|major depressive disorder, depressive disorder, unipolar depression, antidepressants, electroencephalography
791242|NCT00289497|Charcot|charcot
791243|NCT00289497|foot|foot
791244|NCT00289497|ulceration|ulceration
791245|NCT00289497|neuropathy|neuropathy
791246|NCT00289484|Mood disorder|mood disorder
791247|NCT00289471|Sensitivity and specificity|sensitivity and specificity
791248|NCT00289471|Physician's practice patterns|physician's practice patterns
791249|NCT00289471|Health Care costs|health care costs
791250|NCT00289471|Quality of Health Care|quality of health care
791251|NCT00289458|older adults, falls, arthritis, aquatic, exercise|older adults, falls, arthritis, aquatic, exercise
791252|NCT00289419|Arthroplasty, Replacement, Hip|arthroplasty, replacement, hip
791253|NCT00289419|Anesthetics, Local|anesthetics, local
791254|NCT00289419|Pain, Postoperative|pain, postoperative
791255|NCT00289406|hypertension|hypertension
791256|NCT00289380|Nutritional Risk Screening(NRS)|nutritional risk screening(nrs)
791257|NCT00289380|Malnutrition|malnutrition
791258|NCT00289380|Overweight|overweight
791259|NCT00289380|Obesity|obesity
791260|NCT00289380|Clinical nutritional support|clinical nutritional support
791261|NCT00289380|Clinical outcome|clinical outcome
791262|NCT00289380|Cost effectiveness|cost effectiveness
791263|NCT00289380|Complication|complication
791264|NCT00289380|Infective complications|infective complications
791265|NCT00289354|chromium|chromium
791266|NCT00289354|chromium picolinate|chromium picolinate
791267|NCT00289354|type 2 diabetes mellitus|type 2 diabetes mellitus
791268|NCT00289354|HbA1c|hba1c
791269|NCT00289354|hyperglycemia|hyperglycemia
791270|NCT00289354|cholesterol|cholesterol
791271|NCT00289302|Heart Failure|heart failure
791272|NCT00289302|Cardiac pacing|cardiac pacing
791273|NCT00289302|Cardiac resynchronization therapy|cardiac resynchronization therapy
791274|NCT00289302|Implantable Cardioverter Defibrillator|implantable cardioverter defibrillator
791275|NCT00289289|Atrial Fibrillation|atrial fibrillation
791276|NCT00289289|Atrial Tachyarrhythmia|atrial tachyarrhythmia
791277|NCT00289289|Arrhythmia|arrhythmia
791278|NCT00289289|Bradycardia|bradycardia
791279|NCT00289289|Cardiac Pacemaker|cardiac pacemaker
791280|NCT00289289|IPG Indication|ipg indication
791281|NCT00289289|Pacing|pacing
791282|NCT00289276|Cardiomyopathy|cardiomyopathy
791283|NCT00289276|Ventricular Ejection Fraction|ventricular ejection fraction
791284|NCT00289276|Congestive Heart Failure|congestive heart failure
791285|NCT00289276|Impedance|impedance
791286|NCT00289263|metastatic breast cancer|metastatic breast cancer
791287|NCT00289263|maintenance chemotherapy|maintenance chemotherapy
791288|NCT00289250|Malaria|malaria
791289|NCT00289250|Gametocytes|gametocytes
791290|NCT00289250|Asymptomatic carriers|asymptomatic carriers
791291|NCT00289237|Lifestyle intervention|lifestyle intervention
791292|NCT00289237|Behavioural changes|behavioural changes
791293|NCT00289237|CHD|chd
791294|NCT00289237|Type 2 diabetes|type 2 diabetes
791490|NCT00288262|sleep|sleep
791295|NCT00289224|bivalent killed whole cell oral cholera vaccine|bivalent killed whole cell oral cholera vaccine
791296|NCT00289224|double blind randomized clinical trial|double blind randomized clinical trial
791297|NCT00289211|Hereditary angioedema|hereditary angioedema
791298|NCT00289211|HAE|hae
791299|NCT00289211|C1 esterase inhibitor (human)|c1 esterase inhibitor (human)
791300|NCT00289211|C1INH-nf|c1inh-nf
791301|NCT00289198|GW685698X|gw685698x
791302|NCT00289198|perennial allergic rhinitis|perennial allergic rhinitis
791303|NCT00289198|allergic rhinitis|allergic rhinitis
791304|NCT00289185|Coccidiosis|coccidiosis
791305|NCT00289185|Parasitic Diseases|parasitic diseases
791306|NCT00289185|Malaria, Falciparum|malaria, falciparum
791307|NCT00289185|Malaria|malaria
791308|NCT00289159|aged 18-50|aged 18-50
791309|NCT00289159|remitting evolution|remitting evolution
791310|NCT00289159|less than two years of evolution|less than two years of evolution
791311|NCT00289159|MS patients|ms patients
791312|NCT00289146|kidney cancer, immunology|kidney cancer, immunology
791313|NCT00289133|Arthroplasty, Replacement, Knee|arthroplasty, replacement, knee
791314|NCT00289120|urolithiasis, cola|urolithiasis, cola
791315|NCT00289107|Total Knee Replacement|total knee replacement
791316|NCT00289107|Knee Prosthesis|knee prosthesis
791317|NCT00289081|Total Knee Replacement|total knee replacement
791318|NCT00289068|cataract surgery|cataract surgery
791319|NCT00289068|phacoemulsification sleeve|phacoemulsification sleeve
791320|NCT00289055|Peripheral Artery Occlusive Disease|peripheral artery occlusive disease
791321|NCT00289042|atrial fibrillation|atrial fibrillation
791322|NCT00289042|atrial thrombus|atrial thrombus
791323|NCT00289042|cardioversion|cardioversion
791324|NCT00289042|enoxaparin|enoxaparin
791325|NCT00289042|low molecular weight heparin|low molecular weight heparin
791326|NCT00289042|transesophageal echocardiography|transesophageal echocardiography
791327|NCT00289016|gene transfer|gene transfer
791328|NCT00289016|gene therapy|gene therapy
791329|NCT00289016|oncolytic virus|oncolytic virus
791334|NCT00288977|Islet Transplantation|islet transplantation
791335|NCT00288964|balloon|balloon
791336|NCT00288964|fiber|fiber
791337|NCT00288964|respiratory|respiratory
791338|NCT00288964|oxygenator|oxygenator
791339|NCT00288964|Heart Failure|heart failure
791340|NCT00288964|ARDS|ards
791341|NCT00288964|COPD|copd
791342|NCT00288938|Suspicious mole|suspicious mole
791343|NCT00288938|Congenital Nevus|congenital nevus
791344|NCT00288938|Skin Cancer|skin cancer
791345|NCT00288938|Moles|moles
791346|NCT00288938|Pigmented lesion|pigmented lesion
791347|NCT00288938|LCMN|lcmn
791348|NCT00288912|Self-Care|self-care
791349|NCT00288912|Telemedicine|telemedicine
791350|NCT00288912|Pain|pain
791351|NCT00288912|Veterans|veterans
791352|NCT00288899|Informed Consent|informed consent
791353|NCT00288899|Medical Record Systems, computerized|medical record systems, computerized
791354|NCT00288899|Comprehension|comprehension
791355|NCT00288899|Anxiety|anxiety
791356|NCT00288899|Personal Satisfactin|personal satisfactin
791357|NCT00288886|Compliance|compliance
791358|NCT00288886|Aftercare|aftercare
791359|NCT00288886|Reinforcement, social|reinforcement, social
791360|NCT00288886|Alcoholics Anonymous|alcoholics anonymous
791361|NCT00288886|Support Groups|support groups
791362|NCT00288886|Treatment Outcome|treatment outcome
791363|NCT00288873|Vitamin D deficiency|vitamin d deficiency
791364|NCT00288873|Secondary hyperparathyroidism|secondary hyperparathyroidism
791365|NCT00288873|Obesity|obesity
791366|NCT00288860|telemedicine|telemedicine
791367|NCT00288860|treatment compliance|treatment compliance
791368|NCT00288860|mental health|mental health
791369|NCT00288847|Patella Dislocation|patella dislocation
791370|NCT00288847|Surface EMG|surface emg
791371|NCT00288847|Gender difference|gender difference
791372|NCT00288834|stroke|stroke
791373|NCT00288834|dysphagia|dysphagia
791374|NCT00288834|rehabilitation|rehabilitation
791375|NCT00288834|biofeedback|biofeedback
791376|NCT00288821|Gynaecological malignancy|gynaecological malignancy
791377|NCT00288821|Diagnostic Accuracy|diagnostic accuracy
791378|NCT00288821|DWIBS|dwibs
791379|NCT00288821|Lymph Nodes|lymph nodes
791380|NCT00288821|Metastasis|metastasis
791381|NCT00288808|Blood|blood
791382|NCT00288808|Coagulation|coagulation
791383|NCT00288808|PT/InR|pt/inr
791384|NCT00288808|Warfarin|warfarin
791385|NCT00288808|Mechanical Valve|mechanical valve
791386|NCT00288795|Fatigue|fatigue
791387|NCT00288795|Polarity|polarity
791388|NCT00288795|Massage|massage
791389|NCT00288782|Mirtazapine|mirtazapine
791390|NCT00288782|Antidepressant|antidepressant
791391|NCT00288782|Positron Emission Tomography|positron emission tomography
791392|NCT00288769|Recurrent aphthous stomatitis|recurrent aphthous stomatitis
791393|NCT00288769|vitamin B12|vitamin b12
791394|NCT00288756|arrythmias|arrythmias
791395|NCT00288730|Heart Failure|heart failure
791396|NCT00288730|Renal Dysfunction|renal dysfunction
791397|NCT00288730|Cardiomyopathy|cardiomyopathy
791398|NCT00288730|Heart Decompensation|heart decompensation
791399|NCT00288730|Dyspnea Paroxysmal|dyspnea paroxysmal
791400|NCT00288704|Familial Cold Autoinflammatory Syndrome (FCAS)|familial cold autoinflammatory syndrome (fcas)
791401|NCT00288704|Muckle-Wells Syndrome (MWS)|muckle-wells syndrome (mws)
791402|NCT00288704|CIAS1|cias1
791403|NCT00288704|NLRP-3|nlrp-3
791404|NCT00288704|PYPAF1|pypaf1
791405|NCT00288704|Cryopyrin|cryopyrin
791406|NCT00288704|CAPS|caps
791407|NCT00288704|Interleukin-1|interleukin-1
791408|NCT00288691|Treatment-resistant menorrhagia|treatment-resistant menorrhagia
791409|NCT00288678|Diabetic shared care|diabetic shared care
791410|NCT00288678|Health manager|health manager
791411|NCT00288678|Prospective Study|prospective study
791412|NCT00288678|Health Care Quality, Access, and Evaluation|health care quality, access, and evaluation
791413|NCT00288665|Myocardial infarction|myocardial infarction
791414|NCT00288665|aspiration|aspiration
791415|NCT00288665|thrombectomy|thrombectomy
791416|NCT00288665|ventricular remodeling|ventricular remodeling
791417|NCT00288639|Pregabalin for partial seizures|pregabalin for partial seizures
791418|NCT00288626|hematopoietic stem cell transplantation|hematopoietic stem cell transplantation
791419|NCT00288626|HCT- autologous hematopoietic cell transplant|hct- autologous hematopoietic cell transplant
791420|NCT00288626|HDIT-high-dose immunosuppressive therapy|hdit-high-dose immunosuppressive therapy
791421|NCT00288626|BEAM -Carmustine (BCNU), Etoposide (VP-16), Cytarabine (ara-C), and Melphalan|beam -carmustine (bcnu), etoposide (vp-16), cytarabine (ara-c), and melphalan
791422|NCT00288613|ESRD|esrd
791423|NCT00288613|Daily Hemodialysis|daily hemodialysis
791424|NCT00288613|Hemodialysis|hemodialysis
791425|NCT00288613|Kidney Failure|kidney failure
791426|NCT00288613|Kidney Disease|kidney disease
791427|NCT00288600|Immunoglobulins, Intravenous|immunoglobulins, intravenous
791428|NCT00288600|Hyperbilirubinemia|hyperbilirubinemia
791429|NCT00288600|Erythroblastosis, Fetal|erythroblastosis, fetal
791430|NCT00288600|Exchange Transfusion, Whole Blood|exchange transfusion, whole blood
791431|NCT00288587|Heart Failure|heart failure
791432|NCT00288587|Congestive Heart Failure|congestive heart failure
791434|NCT00288574|Depression|depression
791435|NCT00288561|ARMD, ranibizumab, verteporfin|armd, ranibizumab, verteporfin
791436|NCT00288535|coronary bifurcation ; PCI; modified T-Stenting; sirolimus stent|coronary bifurcation ; pci; modified t-stenting; sirolimus stent
791437|NCT00288496|mechanical bowel preparation, colorectal surgery, anastomotic dehiscence|mechanical bowel preparation, colorectal surgery, anastomotic dehiscence
791438|NCT00288444|Advanced malignancies.|advanced malignancies.
791439|NCT00288431|cancer|cancer
791440|NCT00288431|sarcoma|sarcoma
791441|NCT00288418|Colonization of the catheter|colonization of the catheter
791442|NCT00288418|Catheter related bloodstream infection|catheter related bloodstream infection
791443|NCT00288405|Intracranial|intracranial
791444|NCT00288405|Wide-neck|wide-neck
791445|NCT00288405|Saccular|saccular
791446|NCT00288405|Aneurysms|aneurysms
791447|NCT00288379|Asthma|asthma
791448|NCT00288379|allergen challenge|allergen challenge
791449|NCT00288379|airway responsiveness|airway responsiveness
791450|NCT00288379|airway inflammation|airway inflammation
791451|NCT00288379|Symbicort®|symbicort®
791452|NCT00288366|schizophrenia|schizophrenia
791453|NCT00288366|schizoaffective disorder|schizoaffective disorder
791454|NCT00288366|bipolar disorder|bipolar disorder
791455|NCT00288366|metabolic syndrome|metabolic syndrome
791456|NCT00288353|schizophrenia|schizophrenia
791457|NCT00288353|schizoaffective disorder|schizoaffective disorder
791458|NCT00288353|bipolar disorder|bipolar disorder
791459|NCT00288353|metabolic syndrome|metabolic syndrome
791460|NCT00288340|psychotic disorders|psychotic disorders
791461|NCT00288340|auditory hallucinations|auditory hallucinations
791462|NCT00288340|brain structure|brain structure
791463|NCT00288340|psychiatric disorder with auditory hallucinations (at least one every 20 minutes)|psychiatric disorder with auditory hallucinations (at least one every 20 minutes)
791464|NCT00288340|schizophrenia/schizoaffective disorder without auditory hallucinations|schizophrenia/schizoaffective disorder without auditory hallucinations
791465|NCT00288327|diet|diet
791466|NCT00288327|physical activity|physical activity
791467|NCT00288327|smoking cessation|smoking cessation
791468|NCT00288314|PTSD|ptsd
791469|NCT00288314|MRI, Functional|mri, functional
791470|NCT00288314|Anxiety|anxiety
791471|NCT00288314|Working Memory|working memory
791472|NCT00288314|Processing speed|processing speed
791473|NCT00288301|diet|diet
791474|NCT00288301|physical activity|physical activity
791475|NCT00288301|weight management|weight management
791476|NCT00288275|Ovarian Cancer|ovarian cancer
791477|NCT00288275|Fallopian Tube Cancer|fallopian tube cancer
791478|NCT00288275|Peritoneal Cancer|peritoneal cancer
791479|NCT00288275|Assay|assay
791480|NCT00288275|Chemotherapy|chemotherapy
791481|NCT00288275|Recurrent|recurrent
791482|NCT00288275|Refractory|refractory
791483|NCT00288275|Persistent|persistent
791484|NCT00288275|Chemoresponse|chemoresponse
791485|NCT00288275|Sensitivity|sensitivity
791486|NCT00288275|Precision Therapeutics|precision therapeutics
791487|NCT00288262|hot flashes|hot flashes
791488|NCT00288262|melatonin|melatonin
791489|NCT00288262|depression|depression
791491|NCT00288262|luteinizing hormone|luteinizing hormone
791492|NCT00288262|postmenopause|postmenopause
791493|NCT00288249|Breast Cancer|breast cancer
791494|NCT00288249|Breast Neoplasms|breast neoplasms
791495|NCT00288236|Type 2 diabetes mellitus|type 2 diabetes mellitus
791496|NCT00288210|Myocardial Infarction|myocardial infarction
791497|NCT00288210|Stents|stents
791498|NCT00288210|Sirolimus|sirolimus
791499|NCT00288210|abciximab|abciximab
791500|NCT00288145|worksite|worksite
791501|NCT00288145|weight gain prevention (among adults)|weight gain prevention (among adults)
791502|NCT00288145|obesity (among adults)|obesity (among adults)
791503|NCT00288145|physical activity|physical activity
791504|NCT00288145|nutrition|nutrition
791505|NCT00288132|Diabetes|diabetes
791506|NCT00288132|self-management|self-management
791507|NCT00288132|telemedicine|telemedicine
791508|NCT00288132|retinal|retinal
791509|NCT00288132|screening|screening
791510|NCT00288119|Barrett's Esophagus|barrett's esophagus
791511|NCT00288106|recurrent prostate cancer|recurrent prostate cancer
791512|NCT00288106|stage I prostate cancer|stage i prostate cancer
791513|NCT00288106|stage II prostate cancer|stage ii prostate cancer
791514|NCT00288106|stage III prostate cancer|stage iii prostate cancer
791515|NCT00288106|stage IV prostate cancer|stage iv prostate cancer
791516|NCT00288080|stage III prostate cancer|stage iii prostate cancer
791517|NCT00288080|stage IIB prostate cancer|stage iib prostate cancer
791518|NCT00288080|stage IIA prostate cancer|stage iia prostate cancer
791519|NCT00288080|stage IV prostate cancer|stage iv prostate cancer
791520|NCT00288054|stage IIIA non-small cell lung cancer|stage iiia non-small cell lung cancer
791521|NCT00288054|stage IIIB non-small cell lung cancer|stage iiib non-small cell lung cancer
791522|NCT00288054|adenocarcinoma of the lung|adenocarcinoma of the lung
791523|NCT00288054|large cell lung cancer|large cell lung cancer
791524|NCT00288054|squamous cell lung cancer|squamous cell lung cancer
791525|NCT00288028|stage I multiple myeloma|stage i multiple myeloma
791526|NCT00288028|stage II multiple myeloma|stage ii multiple myeloma
791527|NCT00288028|stage III multiple myeloma|stage iii multiple myeloma
792397|NCT00284141|cancer|cancer
791528|NCT00288028|refractory multiple myeloma|refractory multiple myeloma
791529|NCT00288015|adult angiosarcoma|adult angiosarcoma
791530|NCT00288015|recurrent adult soft tissue sarcoma|recurrent adult soft tissue sarcoma
791531|NCT00288015|stage I adult soft tissue sarcoma|stage i adult soft tissue sarcoma
791532|NCT00288015|stage II adult soft tissue sarcoma|stage ii adult soft tissue sarcoma
791533|NCT00288015|stage III adult soft tissue sarcoma|stage iii adult soft tissue sarcoma
791534|NCT00288015|stage IV adult soft tissue sarcoma|stage iv adult soft tissue sarcoma
791535|NCT00288002|inflammatory breast cancer|inflammatory breast cancer
791536|NCT00288002|stage II breast cancer|stage ii breast cancer
791537|NCT00288002|stage IIIA breast cancer|stage iiia breast cancer
791538|NCT00288002|stage IIIB breast cancer|stage iiib breast cancer
791539|NCT00288002|stage IIIC breast cancer|stage iiic breast cancer
791540|NCT00288002|stage IA breast cancer|stage ia breast cancer
791541|NCT00288002|stage IB breast cancer|stage ib breast cancer
791542|NCT00288002|estrogen receptor-negative breast cancer|estrogen receptor-negative breast cancer
791543|NCT00288002|estrogen receptor-positive breast cancer|estrogen receptor-positive breast cancer
791544|NCT00288002|HER2-negative breast cancer|her2-negative breast cancer
791545|NCT00288002|HER2-positive breast cancer|her2-positive breast cancer
791546|NCT00287989|recurrent non-small cell lung cancer|recurrent non-small cell lung cancer
791547|NCT00287989|stage IIIB non-small cell lung cancer|stage iiib non-small cell lung cancer
791548|NCT00287989|stage IV non-small cell lung cancer|stage iv non-small cell lung cancer
791549|NCT00287976|childhood hepatoblastoma|childhood hepatoblastoma
791550|NCT00287976|recurrent childhood liver cancer|recurrent childhood liver cancer
791551|NCT00287963|adenocarcinoma of the lung|adenocarcinoma of the lung
791552|NCT00287963|adenosquamous cell lung cancer|adenosquamous cell lung cancer
791553|NCT00287963|bronchoalveolar cell lung cancer|bronchoalveolar cell lung cancer
791554|NCT00287963|combined type small cell lung cancer|combined type small cell lung cancer
791555|NCT00287963|intermediate type small cell lung cancer|intermediate type small cell lung cancer
791556|NCT00287963|large cell lung cancer|large cell lung cancer
791557|NCT00287963|lymphocyte-like type small cell lung cancer|lymphocyte-like type small cell lung cancer
791558|NCT00287963|recurrent non-small cell lung cancer|recurrent non-small cell lung cancer
791559|NCT00287963|recurrent small cell lung cancer|recurrent small cell lung cancer
791560|NCT00287963|squamous cell lung cancer|squamous cell lung cancer
791561|NCT00287950|disseminated neuroblastoma|disseminated neuroblastoma
791562|NCT00287950|localized resectable neuroblastoma|localized resectable neuroblastoma
791563|NCT00287950|localized unresectable neuroblastoma|localized unresectable neuroblastoma
791564|NCT00287950|regional neuroblastoma|regional neuroblastoma
791565|NCT00287950|stage 4S neuroblastoma|stage 4s neuroblastoma
791566|NCT00287924|childhood infratentorial ependymoma|childhood infratentorial ependymoma
791567|NCT00287924|childhood supratentorial ependymoma|childhood supratentorial ependymoma
791568|NCT00287924|newly diagnosed childhood ependymoma|newly diagnosed childhood ependymoma
791569|NCT00287911|cervical adenocarcinoma|cervical adenocarcinoma
791570|NCT00287911|cervical adenosquamous cell carcinoma|cervical adenosquamous cell carcinoma
791571|NCT00287911|cervical squamous cell carcinoma|cervical squamous cell carcinoma
791572|NCT00287911|stage IB cervical cancer|stage ib cervical cancer
791573|NCT00287911|stage IIA cervical cancer|stage iia cervical cancer
791574|NCT00287911|stage IIB cervical cancer|stage iib cervical cancer
791575|NCT00287911|stage III cervical cancer|stage iii cervical cancer
791576|NCT00287911|stage IVA cervical cancer|stage iva cervical cancer
791577|NCT00287898|breast cancer|breast cancer
791578|NCT00287885|recurrent cervical cancer|recurrent cervical cancer
791579|NCT00287885|stage III cervical cancer|stage iii cervical cancer
791580|NCT00287885|stage IVA cervical cancer|stage iva cervical cancer
791581|NCT00287885|stage IVB cervical cancer|stage ivb cervical cancer
791582|NCT00287885|stage III endometrial carcinoma|stage iii endometrial carcinoma
791583|NCT00287885|recurrent endometrial carcinoma|recurrent endometrial carcinoma
791584|NCT00287885|stage IV endometrial carcinoma|stage iv endometrial carcinoma
791585|NCT00287885|fallopian tube cancer|fallopian tube cancer
791586|NCT00287885|stage III ovarian epithelial cancer|stage iii ovarian epithelial cancer
791587|NCT00287885|stage IV ovarian epithelial cancer|stage iv ovarian epithelial cancer
791588|NCT00287885|stage III ovarian germ cell tumor|stage iii ovarian germ cell tumor
791589|NCT00287885|recurrent ovarian germ cell tumor|recurrent ovarian germ cell tumor
791590|NCT00287885|stage IV ovarian germ cell tumor|stage iv ovarian germ cell tumor
791591|NCT00287885|recurrent ovarian epithelial cancer|recurrent ovarian epithelial cancer
791592|NCT00287885|recurrent uterine sarcoma|recurrent uterine sarcoma
791593|NCT00287885|stage III uterine sarcoma|stage iii uterine sarcoma
791594|NCT00287885|stage IV uterine sarcoma|stage iv uterine sarcoma
791595|NCT00287885|stage III vaginal cancer|stage iii vaginal cancer
791596|NCT00287885|recurrent vaginal cancer|recurrent vaginal cancer
791597|NCT00287885|stage IVA vaginal cancer|stage iva vaginal cancer
791598|NCT00287885|stage IVB vaginal cancer|stage ivb vaginal cancer
791599|NCT00287885|stage III vulvar cancer|stage iii vulvar cancer
791600|NCT00287885|recurrent vulvar cancer|recurrent vulvar cancer
791601|NCT00287885|stage IV vulvar cancer|stage iv vulvar cancer
791602|NCT00287885|ovarian sarcoma|ovarian sarcoma
791603|NCT00287885|ovarian stromal cancer|ovarian stromal cancer
792603|NCT00283465|epoetin|epoetin
791604|NCT00287885|peritoneal cavity cancer|peritoneal cavity cancer
791605|NCT00287872|stage II multiple myeloma|stage ii multiple myeloma
791606|NCT00287872|stage III multiple myeloma|stage iii multiple myeloma
791607|NCT00287859|fallopian tube cancer|fallopian tube cancer
791608|NCT00287859|peritoneal cavity cancer|peritoneal cavity cancer
791609|NCT00287859|recurrent ovarian epithelial cancer|recurrent ovarian epithelial cancer
791610|NCT00287846|desmoid tumor|desmoid tumor
791611|NCT00287820|schizophrenia|schizophrenia
791612|NCT00287820|diabetes|diabetes
791613|NCT00287820|metabolic syndrome|metabolic syndrome
791614|NCT00287820|hyperglycemia|hyperglycemia
791616|NCT00287820|insulin|insulin
791617|NCT00287820|lipids|lipids
791618|NCT00287820|IL-6|il-6
791619|NCT00287820|prolactin|prolactin
791620|NCT00287807|Diabetes mellitus, type 2|diabetes mellitus, type 2
791621|NCT00287807|Blood Glucose Self-Monitoring|blood glucose self-monitoring
791622|NCT00287807|life style|life style
791623|NCT00287794|rheumatoid arthritis|rheumatoid arthritis
791624|NCT00287794|sleep disturbance|sleep disturbance
791625|NCT00287781|Migraine|migraine
791626|NCT00287781|Lidocaine|lidocaine
791627|NCT00287781|Headache|headache
791628|NCT00287768|gastric cancer|gastric cancer
791629|NCT00287768|advanced gastric cancer|advanced gastric cancer
791630|NCT00287768|S-1|s-1
791631|NCT00287768|docetaxel|docetaxel
791632|NCT00287768|phase III study|phase iii study
791633|NCT00287755|gastric cancer|gastric cancer
791634|NCT00287755|S-1|s-1
791635|NCT00287755|chemosensitivity|chemosensitivity
791636|NCT00287755|adjuvant|adjuvant
791637|NCT00287742|risperidone|risperidone
791638|NCT00287742|antipsychotic agents|antipsychotic agents
791639|NCT00287742|Alzheimer's disease|alzheimer's disease
791640|NCT00287742|dementia|dementia
791641|NCT00287742|psychosis|psychosis
791642|NCT00287729|Idiopathic|idiopathic
791643|NCT00287729|Pulmonary|pulmonary
791644|NCT00287729|Fibrosis|fibrosis
791645|NCT00287729|Lung|lung
791646|NCT00287729|Pirfenidone|pirfenidone
791647|NCT00287729|InterMune|intermune
791648|NCT00287716|Idiopathic|idiopathic
791649|NCT00287716|Pulmonary|pulmonary
791650|NCT00287716|Fibrosis|fibrosis
791651|NCT00287716|Lung|lung
791652|NCT00287716|Pirfenidone|pirfenidone
791653|NCT00287716|InterMune|intermune
791654|NCT00287703|Major depression|major depression
791655|NCT00287703|Treatment resistant|treatment resistant
791656|NCT00287703|PEMF|pemf
791657|NCT00287703|AQT|aqt
791658|NCT00287703|Hamilton|hamilton
791659|NCT00287690|arteries|arteries
791660|NCT00287690|blood flow|blood flow
791661|NCT00287690|coronary artery disease|coronary artery disease
791662|NCT00287690|diet|diet
791663|NCT00287677|Growth Hormone|growth hormone
791664|NCT00287677|HIV-1|hiv-1
791665|NCT00287677|Vaccination|vaccination
791666|NCT00287677|Thymopoiesis|thymopoiesis
791667|NCT00287677|HIV-specific responses|hiv-specific responses
791668|NCT00287677|Treatment Experienced|treatment experienced
791669|NCT00287664|hepatorenal syndrome|hepatorenal syndrome
791670|NCT00287664|terlipressin|terlipressin
791671|NCT00287664|albumin|albumin
791672|NCT00287664|cirrhosis|cirrhosis
791673|NCT00287651|Pulsatile intravenous insulin|pulsatile intravenous insulin
791674|NCT00287651|Oral carbohydrate loading|oral carbohydrate loading
791675|NCT00287651|Respiratory Quotients|respiratory quotients
791676|NCT00287651|Hypoglycemia|hypoglycemia
791677|NCT00287638|Obstructive sleep apnea|obstructive sleep apnea
791678|NCT00287625|Chronic obstructive pulmonary disease|chronic obstructive pulmonary disease
791679|NCT00287625|Pulmonary rehabilitation|pulmonary rehabilitation
791680|NCT00287612|GERD|gerd
791681|NCT00287612|Hiatal Hernia|hiatal hernia
791682|NCT00287612|Recurrence|recurrence
791683|NCT00287599|Surgical wound infections|surgical wound infections
791684|NCT00287599|Real-time PCR|real-time pcr
791685|NCT00287599|Rapid identification of bacteria|rapid identification of bacteria
791686|NCT00287599|Cloning|cloning
791687|NCT00287599|16S rRNA sequencing|16s rrna sequencing
791688|NCT00287586|Testosterone Replacement|testosterone replacement
791689|NCT00287586|Heart Disease|heart disease
791690|NCT00287586|Vascular Disease|vascular disease
791691|NCT00287586|Risk Factors for Cardiovascular Disease|risk factors for cardiovascular disease
791692|NCT00287586|Cholesterol|cholesterol
791693|NCT00287586|Obesity|obesity
791694|NCT00287586|Blood pressure|blood pressure
791695|NCT00287586|Quality of Life|quality of life
791696|NCT00287534|Early Breast Cancer|early breast cancer
791697|NCT00287521|open|open
791698|NCT00287521|angle|angle
791699|NCT00287521|glaucoma|glaucoma
791700|NCT00287521|ocular|ocular
791701|NCT00287521|hypertension|hypertension
791702|NCT00287508|Carotid stenting|carotid stenting
791703|NCT00287508|Carotid endarterectomy|carotid endarterectomy
791704|NCT00287508|Carotid artery disease with severe narrowing of the artery|carotid artery disease with severe narrowing of the artery
791705|NCT00287508|Stroke prevention|stroke prevention
791706|NCT00287508|cerebral infarction|cerebral infarction
791707|NCT00287495|AIDS|aids
791708|NCT00287495|HIV|hiv
791709|NCT00287495|Antiangiogenesis|antiangiogenesis
791710|NCT00287495|VEGF|vegf
791711|NCT00287495|AIDS Malignancy|aids malignancy
791712|NCT00287495|Kaposi Sarcoma|kaposi sarcoma
791713|NCT00287495|KS|ks
791714|NCT00287482|Treatment side effects|treatment side effects
791715|NCT00287482|Quality of Life|quality of life
791716|NCT00287482|Transition|transition
791717|NCT00287482|Survivorship|survivorship
791718|NCT00287469|Hepatitis E|hepatitis e
791719|NCT00287469|clinical hepatitis|clinical hepatitis
791720|NCT00287469|vaccine|vaccine
791721|NCT00287469|efficacy|efficacy
791722|NCT00287469|Nepal|nepal
791723|NCT00287417|Nucal translucency|nucal translucency
791724|NCT00287417|Down syndrome|down syndrome
791725|NCT00287417|MSS|mss
791726|NCT00287417|Risk assessment|risk assessment
791727|NCT00287404|type 2 diabetes|type 2 diabetes
791728|NCT00287404|hyperlipidemia|hyperlipidemia
791729|NCT00287404|dyslipidemia|dyslipidemia
791730|NCT00287404|fasting lipids|fasting lipids
791731|NCT00287404|postprandial lipids|postprandial lipids
791732|NCT00287404|Non-HDL cholesterol|non-hdl cholesterol
791733|NCT00287404|NMR lipoanalysis|nmr lipoanalysis
791734|NCT00287404|ATP III guidelines|atp iii guidelines
791735|NCT00287391|Insomnia|insomnia
791736|NCT00287391|Gastroesophageal Reflux Disease (GERD)|gastroesophageal reflux disease (gerd)
791737|NCT00287391|Sleep Disturbance|sleep disturbance
791738|NCT00287352|First episode psychosis|first episode psychosis
791739|NCT00287339|Cough|cough
791740|NCT00287339|GERD|gerd
791741|NCT00287326|Epidural|epidural
791742|NCT00287326|Bupivacaine|bupivacaine
791743|NCT00287326|Clonidine|clonidine
791744|NCT00287313|Unstable INRs|unstable inrs
791745|NCT00287313|Warfarin|warfarin
791746|NCT00287313|Vitamin K|vitamin k
791747|NCT00287300|Malaria|malaria
791748|NCT00287300|Pregnancy|pregnancy
791749|NCT00287300|Efficacy|efficacy
791750|NCT00287300|Azithromycin|azithromycin
791751|NCT00287300|Artesunate|artesunate
791752|NCT00287287|Lenalidomide|lenalidomide
791753|NCT00287287|Clinical Trials phase II|clinical trials phase ii
791754|NCT00287287|Carcinomas, thyroid|carcinomas, thyroid
791755|NCT00287287|Radioiodine-Unresponsive Papillary & Follicular Thyroid Carcinomas|radioiodine-unresponsive papillary & follicular thyroid carcinomas
791756|NCT00287261|myelofibrosis|myelofibrosis
791757|NCT00287261|D009191|d009191
791758|NCT00287248|Alzheimer|alzheimer
791759|NCT00287248|Alzheimer disease|alzheimer disease
791760|NCT00287248|Alzheimer disease (AD)|alzheimer disease (ad)
791761|NCT00287235|Hepatic Encephalopathy|hepatic encephalopathy
791762|NCT00287235|End Stage Liver Disease|end stage liver disease
791763|NCT00287235|Cirrhosis|cirrhosis
791764|NCT00287235|MARS|mars
791765|NCT00287235|Albumin Dialysis|albumin dialysis
791766|NCT00287222|Inoperable and Metastatic Hepatocellular Carcinoma|inoperable and metastatic hepatocellular carcinoma
791767|NCT00287209|RASCABG 1 - study|rascabg 1 - study
791768|NCT00287209|Postoperative atrial fibrillation|postoperative atrial fibrillation
791769|NCT00287209|Randomized, controlled trial|randomized, controlled trial
791770|NCT00287209|Amiodarone|amiodarone
791771|NCT00287196|Melanoma|melanoma
791772|NCT00287196|Lymph node disease|lymph node disease
791773|NCT00287196|Adjuvant radiotherapy|adjuvant radiotherapy
791774|NCT00287196|Lymphoedema|lymphoedema
791775|NCT00287170|Crohn's Disease|crohn's disease
791776|NCT00287170|Local Ileal Delivery|local ileal delivery
791777|NCT00287170|Delayed-Release Formulations|delayed-release formulations
791778|NCT00287170|6-Mercaptopurine|6-mercaptopurine
791779|NCT00287170|Calcitriol|calcitriol
791780|NCT00287157|Traumatic Brain Injury|traumatic brain injury
791781|NCT00287157|Actigraphy|actigraphy
791782|NCT00287157|Spasticity, Cognition and Functioning|spasticity, cognition and functioning
791783|NCT00287144|Hypothyroidism|hypothyroidism
791784|NCT00287131|melanoma|melanoma
791785|NCT00287131|metastatic melanoma|metastatic melanoma
791786|NCT00287131|adoptive immunotherapy|adoptive immunotherapy
791787|NCT00287131|IL-2|il-2
791788|NCT00287105|Chemotherapy|chemotherapy
791789|NCT00287105|Leukemia|leukemia
791790|NCT00287105|Children|children
791791|NCT00287105|Philadelphia chromosome|philadelphia chromosome
791792|NCT00287105|Protein-tyrosine kinase inhibitor|protein-tyrosine kinase inhibitor
791793|NCT00287092|Haemophilus influenzae type b;|haemophilus influenzae type b;
791794|NCT00287092|Corynebacterium diphtheriae;|corynebacterium diphtheriae;
791795|NCT00287092|Clostridium tetani;|clostridium tetani;
791796|NCT00287092|Bordetella pertussis;|bordetella pertussis;
791797|NCT00287092|poliovirus types 1, 2 and 3;|poliovirus types 1, 2 and 3;
791798|NCT00287092|Vero cell;|vero cell;
791799|NCT00287092|Influenza;|influenza;
791800|NCT00287092|Diphtheria|diphtheria
791801|NCT00287053|divalproex sodium|divalproex sodium
791802|NCT00287053|valproic acid|valproic acid
791803|NCT00287053|food intake|food intake
791804|NCT00287053|energy expenditure|energy expenditure
791805|NCT00287053|posture allocation|posture allocation
791806|NCT00287053|None, the population of study is healthy|none, the population of study is healthy
791807|NCT00287040|Breast Cancer|breast cancer
791808|NCT00287040|Mammography|mammography
791809|NCT00287027|psychotic disorders|psychotic disorders
791810|NCT00287027|family burden|family burden
791811|NCT00287027|long acting injectible antipsychotic medication|long acting injectible antipsychotic medication
791812|NCT00287014|Rift valley fever, Kenya|rift valley fever, kenya
791813|NCT00287001|Acquired bilateral nevus of Ota-like macules|acquired bilateral nevus of ota-like macules
791814|NCT00287001|Postinflammatory hyperpigmentation|postinflammatory hyperpigmentation
791815|NCT00287001|Cold air cooling|cold air cooling
791816|NCT00286988|Preventative|preventative
791817|NCT00286988|Open-Label|open-label
791818|NCT00286988|Safety/Efficacy|safety/efficacy
791819|NCT00286975|Leadership skills|leadership skills
791820|NCT00286975|Management skills|management skills
791821|NCT00286975|Postgraduate medical education|postgraduate medical education
791822|NCT00286962|Diabetes mellitus, type 1|diabetes mellitus, type 1
791823|NCT00286962|insulin infusion systems|insulin infusion systems
791950|NCT00286455|Lipoatrophic|lipoatrophic
791824|NCT00286962|continuous intraperitoneal insulin infusion|continuous intraperitoneal insulin infusion
791825|NCT00286962|cross-over studies|cross-over studies
791826|NCT00286949|Parkinson's disease|parkinson's disease
791827|NCT00286949|executive dysfunction|executive dysfunction
791828|NCT00286949|impairment|impairment
791829|NCT00286949|motor skills|motor skills
791830|NCT00286949|cognitive|cognitive
791831|NCT00286936|Hip fracture|hip fracture
791832|NCT00286936|delirium|delirium
791833|NCT00286936|sleep disturbance|sleep disturbance
791834|NCT00286936|hypnotic|hypnotic
791835|NCT00286923|migraine|migraine
791836|NCT00286923|chronic headache|chronic headache
791837|NCT00286923|hyperexcitability|hyperexcitability
791838|NCT00286923|Magnetic stimulation|magnetic stimulation
791839|NCT00286910|AQP-2|aqp-2
791840|NCT00286910|NPHS2-gene|nphs2-gene
791841|NCT00286845|Chemosensitivity|chemosensitivity
791842|NCT00286845|Acute Myeloid Leukemia|acute myeloid leukemia
791843|NCT00286845|Apoptosis|apoptosis
791844|NCT00286845|MiCK Assay|mick assay
791845|NCT00286832|Non-Hodgkin's lymphoma|non-hodgkin's lymphoma
791846|NCT00286832|Diffuse large B-cell lymphoma|diffuse large b-cell lymphoma
791847|NCT00286832|PET|pet
791848|NCT00286832|Prognosis|prognosis
791849|NCT00286819|early breast cancer,|early breast cancer,
791850|NCT00286819|Fluorouracil|fluorouracil
791851|NCT00286793|at-101|at-101
791852|NCT00286793|at101|at101
791853|NCT00286793|cancer|cancer
791854|NCT00286793|hormone refractory|hormone refractory
791855|NCT00286793|prostate|prostate
791856|NCT00286793|docetaxel|docetaxel
791857|NCT00286793|prednisone|prednisone
791858|NCT00286780|AT101|at101
791859|NCT00286780|AT-101|at-101
791860|NCT00286780|cancer|cancer
791861|NCT00286780|lymphoctic|lymphoctic
791862|NCT00286780|lukemia|lukemia
791863|NCT00286780|Rituximab|rituximab
791864|NCT00286767|Opportunistic Infections|opportunistic infections
791865|NCT00286767|Immune Restoration Disease|immune restoration disease
791866|NCT00286767|Mycobacterial Infections|mycobacterial infections
791867|NCT00286767|HIV-1 Infection|hiv-1 infection
791868|NCT00286767|HIV|hiv
791869|NCT00286767|ART Naive|art naive
791870|NCT00286754|Hypertension|hypertension
791871|NCT00286754|Behavior modification|behavior modification
791872|NCT00286754|Randomized controlled trial|randomized controlled trial
791873|NCT00286754|Treatment effectiveness|treatment effectiveness
791874|NCT00286754|Telemedicine|telemedicine
791875|NCT00286754|Prevention|prevention
791876|NCT00286741|Diabetes|diabetes
791877|NCT00286741|Hypertension|hypertension
791878|NCT00286741|Randomized controlled trials|randomized controlled trials
791879|NCT00286741|cost-effectiveness|cost-effectiveness
791880|NCT00286741|health services|health services
791881|NCT00286728|self-help groups|self-help groups
791882|NCT00286728|referral and consultation|referral and consultation
791883|NCT00286702|splints|splints
791884|NCT00286702|Occupational Therapy|occupational therapy
791885|NCT00286663|AIH, Autoimmune Hepatitis|aih, autoimmune hepatitis
791886|NCT00286650|Paracetamol|paracetamol
791887|NCT00286637|OCT|oct
791888|NCT00286637|CSLO|cslo
791889|NCT00286637|SLP|slp
791890|NCT00286637|Perimetry|perimetry
791891|NCT00286637|electrophysiology|electrophysiology
791892|NCT00286637|glaucoma|glaucoma
791893|NCT00286637|macular degeneration|macular degeneration
791894|NCT00286637|retinopathy|retinopathy
791895|NCT00286637|diabetes|diabetes
791896|NCT00286637|macular hole|macular hole
791897|NCT00286611|Amifostine|amifostine
791898|NCT00286598|foot ulcer|foot ulcer
791899|NCT00286598|diabetes mellitus|diabetes mellitus
791900|NCT00286598|motor activity|motor activity
791901|NCT00286598|randomized controlled trial|randomized controlled trial
791902|NCT00286598|prevention|prevention
791903|NCT00286585|preconditioning|preconditioning
791904|NCT00286585|cardiac protection|cardiac protection
791905|NCT00286585|morbidity|morbidity
791906|NCT00286585|mortality|mortality
791907|NCT00286585|major non-cardiac surgery|major non-cardiac surgery
791908|NCT00286585|cardiac mortality and morbidity|cardiac mortality and morbidity
792801|NCT00282568|Adult|adult
791909|NCT00286585|high cardiac perioperative risk|high cardiac perioperative risk
791910|NCT00286572|insulin-dependent diabetes mellitus|insulin-dependent diabetes mellitus
791911|NCT00286572|non-insulin-dependent diabetes mellitus|non-insulin-dependent diabetes mellitus
791912|NCT00286572|coronary artery disease|coronary artery disease
791913|NCT00286572|long-term mortality|long-term mortality
791914|NCT00286559|Coronary artery disease|coronary artery disease
791915|NCT00286559|Coronary artery bypass graft surgery|coronary artery bypass graft surgery
791916|NCT00286559|SPECT|spect
791917|NCT00286559|Adenosin|adenosin
791918|NCT00286546|Testosterone|testosterone
791919|NCT00286546|Major Depression|major depression
791920|NCT00286546|Men|men
791921|NCT00286533|Implant|implant
791922|NCT00286520|Constipation|constipation
791923|NCT00286520|Fecal incontinence|fecal incontinence
791924|NCT00286520|Spinal cord injury|spinal cord injury
791925|NCT00286520|transanal irrigation|transanal irrigation
791926|NCT00286520|quality of life|quality of life
791927|NCT00286507|Full thickness macular hole|full thickness macular hole
791928|NCT00286507|Internal limiting membrane (ILM)|internal limiting membrane (ilm)
791929|NCT00286507|Vitreo retinal surgery|vitreo retinal surgery
791930|NCT00286507|Vitrectomy|vitrectomy
791931|NCT00286494|Glucose Metabolism Disorder|glucose metabolism disorder
791932|NCT00286494|Dysmetabolic Syndrome|dysmetabolic syndrome
791933|NCT00286494|Type II Diabetes|type ii diabetes
791934|NCT00286494|Diabetes Mellitus|diabetes mellitus
791935|NCT00286494|Lipoatrophic|lipoatrophic
791936|NCT00286494|Dyslipidemia|dyslipidemia
791937|NCT00286494|Drug Therapy|drug therapy
791938|NCT00286481|Hyperlipidemia|hyperlipidemia
791939|NCT00286481|Drug Therapy|drug therapy
791940|NCT00286468|Glucose Metabolism Disorder|glucose metabolism disorder
791941|NCT00286468|Dysmetabolic Syndrome|dysmetabolic syndrome
791942|NCT00286468|Type II Diabetes|type ii diabetes
791943|NCT00286468|Diabetes Mellitus|diabetes mellitus
791944|NCT00286468|Lipoatrophic|lipoatrophic
791945|NCT00286468|Dyslipidemia|dyslipidemia
791946|NCT00286468|Drug Therapy|drug therapy
791947|NCT00286455|Glucose Metabolism Disorder|glucose metabolism disorder
791948|NCT00286455|Dysmetabolic Syndrome|dysmetabolic syndrome
791949|NCT00286455|Type II Diabetes; Diabetes Mellitus|type ii diabetes; diabetes mellitus
791951|NCT00286455|Dyslipidemia|dyslipidemia
791952|NCT00286455|Drug Therapy|drug therapy
791953|NCT00286442|Glucose Metabolism Disorder|glucose metabolism disorder
791954|NCT00286442|Dysmetabolic Syndrome|dysmetabolic syndrome
791955|NCT00286442|Type II Diabetes|type ii diabetes
791956|NCT00286442|Diabetes Mellitus|diabetes mellitus
791957|NCT00286442|Lipoatrophic|lipoatrophic
791958|NCT00286442|Dyslipidemia|dyslipidemia
791959|NCT00286442|Drug Therapy|drug therapy
791960|NCT00286429|Glucose Metabolism Disorder|glucose metabolism disorder
791961|NCT00286429|Dysmetabolic Syndrome|dysmetabolic syndrome
791962|NCT00286429|Type II Diabetes|type ii diabetes
791963|NCT00286429|Diabetes Mellitus|diabetes mellitus
791964|NCT00286429|Lipoatrophic|lipoatrophic
791965|NCT00286429|Dyslipidemia|dyslipidemia
791966|NCT00286429|Drug Therapy|drug therapy
791967|NCT00286416|AERD|aerd
791968|NCT00286416|aspirin|aspirin
791969|NCT00286416|allergy|allergy
791970|NCT00286416|omalizumab|omalizumab
791971|NCT00286403|Acute Tubular Necrosis|acute tubular necrosis
791972|NCT00286403|antioxidants|antioxidants
791973|NCT00286403|Fenoldopam|fenoldopam
791974|NCT00286338|Fluid therapy|fluid therapy
791975|NCT00286338|Monitoring|monitoring
791976|NCT00286312|Acute myocardial infarction|acute myocardial infarction
791977|NCT00286312|Primary angioplasty|primary angioplasty
791978|NCT00286312|Reperfusion damage|reperfusion damage
791979|NCT00286312|Atorvastatin|atorvastatin
791980|NCT00286312|Placebo|placebo
791981|NCT00286312|Early left ventricular remodelling|early left ventricular remodelling
791982|NCT00286312|Late left ventricular remodelling|late left ventricular remodelling
791983|NCT00286312|Cardiac MRI|cardiac mri
791984|NCT00286312|Statin|statin
791985|NCT00286312|Transluminal, Percutaneous Coronary|transluminal, percutaneous coronary
791986|NCT00286312|Angioplasty|angioplasty
791987|NCT00286299|Schizophrenia|schizophrenia
791988|NCT00286299|Cardiovascular disease|cardiovascular disease
791989|NCT00286299|Aerobic capacity|aerobic capacity
791990|NCT00286299|Mortality|mortality
791991|NCT00286299|Exercise|exercise
791992|NCT00286286|Laparoscopy|laparoscopy
791993|NCT00286286|Laparoscopic Surgical Procedures|laparoscopic surgical procedures
791994|NCT00286286|Laparoscopic Surgery|laparoscopic surgery
791995|NCT00286286|Gastric Bypass|gastric bypass
791996|NCT00286286|Drug Delivery Systems|drug delivery systems
791997|NCT00286286|Pain Measurement|pain measurement
791998|NCT00286273|kidney failure, acute|kidney failure, acute
791999|NCT00286273|venovenous hemofiltration|venovenous hemofiltration
792000|NCT00286273|hemorrhage|hemorrhage
792001|NCT00286273|heparin, low-molecular-weight|heparin, low-molecular-weight
792002|NCT00286273|nadroparin|nadroparin
792003|NCT00286273|citrates|citrates
792004|NCT00286260|polyneuropathy|polyneuropathy
792005|NCT00286260|neuropathic pain|neuropathic pain
792006|NCT00286260|levetiracetam|levetiracetam
792007|NCT00286234|triglycerides|triglycerides
792008|NCT00286234|HDL-cholesterol|hdl-cholesterol
792009|NCT00286234|insulin resistance|insulin resistance
792010|NCT00286234|omega-3 fatty acids|omega-3 fatty acids
792011|NCT00286234|niacin|niacin
792012|NCT00286208|Medical abortion|medical abortion
792013|NCT00286208|mifepristone|mifepristone
792014|NCT00286208|misoprostol|misoprostol
792015|NCT00286182|Heart Failure|heart failure
792016|NCT00286182|Elderly|elderly
792017|NCT00286182|Diastolic Dysfunction|diastolic dysfunction
792018|NCT00286182|Anemia|anemia
792019|NCT00286182|Ventricular End Diastolic Volume|ventricular end diastolic volume
792020|NCT00286182|Aged|aged
792021|NCT00286169|Extensive-disease small-cell lung cancer (ED-SCLC)|extensive-disease small-cell lung cancer (ed-sclc)
792022|NCT00286156|ADPKD|adpkd
792023|NCT00286130|metastatic colorectal cancer|metastatic colorectal cancer
792024|NCT00286130|FOLFOX 6|folfox 6
792025|NCT00286130|FOLFIRI|folfiri
792026|NCT00286117|Breast Cancer|breast cancer
792027|NCT00286104|Ventriculitis|ventriculitis
792028|NCT00286104|External ventricular catheter|external ventricular catheter
792029|NCT00286104|Antibiotic-impregnated|antibiotic-impregnated
792030|NCT00286091|Hormone refractory prostate cancer|hormone refractory prostate cancer
792031|NCT00286091|androgen independent|androgen independent
792032|NCT00286091|ADT|adt
792033|NCT00286091|bone metastasis|bone metastasis
792034|NCT00286078|Headache|headache
792035|NCT00286078|Migraine|migraine
792036|NCT00286078|Refractory|refractory
792037|NCT00286078|Chronic|chronic
792038|NCT00286078|Pain|pain
792039|NCT00286065|Pain|pain
792040|NCT00286065|Fentanyl|fentanyl
792041|NCT00286065|Analgesics|analgesics
792042|NCT00286065|Opioid|opioid
792043|NCT00286065|Inhalation|inhalation
792044|NCT00286026|Chlamydia trachomatis|chlamydia trachomatis
792045|NCT00285961|Fractures of the wrist, forearm, elbow, ankle, foot|fractures of the wrist, forearm, elbow, ankle, foot
792046|NCT00285961|Distortions of the wrist, elbow, ankle|distortions of the wrist, elbow, ankle
792047|NCT00285961|Wounds without tendon injuries|wounds without tendon injuries
792048|NCT00285935|Major Depressive Disorder|major depressive disorder
792049|NCT00285935|MDD|mdd
792050|NCT00285935|Neurobiology|neurobiology
792051|NCT00285935|Selective Serotonin Reuptake Inhibitor|selective serotonin reuptake inhibitor
792052|NCT00285935|SSRI|ssri
792053|NCT00285935|Depression|depression
792054|NCT00285922|myocardial infarction|myocardial infarction
792055|NCT00285922|electrocardiography|electrocardiography
792056|NCT00285922|myocardial ischemia|myocardial ischemia
792057|NCT00285922|emergency medicine|emergency medicine
792058|NCT00285922|monitoring, physiologic|monitoring, physiologic
792059|NCT00285909|Moderate alcohol consumption|moderate alcohol consumption
792060|NCT00285909|Alcohol dehydrogenase 1c polymorphism|alcohol dehydrogenase 1c polymorphism
792061|NCT00285909|PPAR-gamma activated gene expression|ppar-gamma activated gene expression
792062|NCT00285896|GLP-1|glp-1
792063|NCT00285896|fasting|fasting
792064|NCT00285896|hypoglycaemia|hypoglycaemia
792065|NCT00285883|Invirase|invirase
792066|NCT00285883|HIV|hiv
792067|NCT00285883|DOT|dot
792068|NCT00285883|Treatment Experienced|treatment experienced
792069|NCT00285857|duct cytology|duct cytology
792070|NCT00285844|obesity|obesity
792071|NCT00285844|insulin resistance|insulin resistance
792072|NCT00285844|thiazolidinedione|thiazolidinedione
792073|NCT00285844|weight loss|weight loss
792074|NCT00285844|adipose tissue|adipose tissue
792075|NCT00285844|metabolic syndrome|metabolic syndrome
792076|NCT00285844|diabetes prevention|diabetes prevention
792077|NCT00285844|cardiovascular disease prevention|cardiovascular disease prevention
792078|NCT00285805|Rosiglitazone|rosiglitazone
792079|NCT00285805|Furosemide|furosemide
792080|NCT00285805|Amiloride|amiloride
792081|NCT00285805|Epithelial sodium channel|epithelial sodium channel
792082|NCT00285805|Sodium excretion|sodium excretion
792083|NCT00285792|Preschool, Physical Activity|preschool, physical activity
792084|NCT00285766|Depression|depression
792085|NCT00285753|psychosocial intervention|psychosocial intervention
792086|NCT00285753|mild cognitive impairment|mild cognitive impairment
792087|NCT00285753|support group|support group
792088|NCT00285753|caregivers|caregivers
792089|NCT00285753|Mild Cognitive Impairment (MCI)|mild cognitive impairment (mci)
792090|NCT00285753|Cognitive Impairment No Dementia (CIND)|cognitive impairment no dementia (cind)
792091|NCT00285714|3D computer assisted imaging|3d computer assisted imaging
792092|NCT00285714|maxillofacial surgery|maxillofacial surgery
792093|NCT00285714|cephalometry|cephalometry
792094|NCT00285714|normative value|normative value
792095|NCT00285688|H. Pylori, Clarithromycin resistant, gene|h. pylori, clarithromycin resistant, gene
792096|NCT00285675|Calcitriol, DN-101, Androgen Independent Prostate Cancer (AIPC), Prostate Cancer, Non Small Cell Lung Cancer (NSCLC)|calcitriol, dn-101, androgen independent prostate cancer (aipc), prostate cancer, non small cell lung cancer (nsclc)
792097|NCT00285662|IPTi|ipti
792098|NCT00285662|Malaria|malaria
792099|NCT00285662|Anemia|anemia
792100|NCT00285662|Prevention|prevention
792101|NCT00285662|Infant|infant
792102|NCT00285662|Artesunate|artesunate
792104|NCT00285662|Amodiaquine|amodiaquine
792105|NCT00285662|Papua New Guinea|papua new guinea
792106|NCT00285649|Spinal Manipulation|spinal manipulation
792107|NCT00285636|Long Term Follow-Up|long term follow-up
792108|NCT00285623|Collection of all thromboembolic events,|collection of all thromboembolic events,
792109|NCT00285623|immunological events and drug interactions leading to thromboembolic events or major|immunological events and drug interactions leading to thromboembolic events or major
792110|NCT00285623|bleeding after exposure to TachoSil®.|bleeding after exposure to tachosil®.
792111|NCT00285584|HIV infection|hiv infection
792112|NCT00285584|Depression|depression
792113|NCT00285584|Men who have sex with men|men who have sex with men
792114|NCT00285584|Drug abuse|drug abuse
792115|NCT00285558|obesity|obesity
792116|NCT00285558|adolescent|adolescent
792117|NCT00285558|weight loss|weight loss
792118|NCT00285558|body mass index|body mass index
792119|NCT00285558|evaluation studies|evaluation studies
792120|NCT00285558|peer group|peer group
792121|NCT00285558|behavior therapy|behavior therapy
792122|NCT00285558|diet|diet
792123|NCT00285558|exercise|exercise
792124|NCT00285558|self efficacy|self efficacy
792125|NCT00285558|parents|parents
792126|NCT00285545|Blood Supply|blood supply
792127|NCT00285545|Mesentery|mesentery
792128|NCT00285532|Blood Lead|blood lead
792129|NCT00285532|Pesticides|pesticides
792130|NCT00285532|Community-based|community-based
792131|NCT00285532|Sampling Kits|sampling kits
792132|NCT00285519|Morning hypertension|morning hypertension
792133|NCT00285506|Healthy Volunteers|healthy volunteers
792134|NCT00285493|low back pain|low back pain
792135|NCT00285467|kidney, parathyroid hormone, vitamin d|kidney, parathyroid hormone, vitamin d
792136|NCT00285441|HIV|hiv
792137|NCT00285428|treatment|treatment
792138|NCT00285428|NHL|nhl
792139|NCT00285428|CD20+ B-cell NHL|cd20+ b-cell nhl
792140|NCT00285428|Lymphoma|lymphoma
792141|NCT00285415|Advanced endometrial adenocarcinoma, stage III A, B, C|advanced endometrial adenocarcinoma, stage iii a, b, c
792142|NCT00285402|Migraine|migraine
792143|NCT00285402|Migraine prophylaxis|migraine prophylaxis
792144|NCT00285402|Migraine prevention|migraine prevention
792145|NCT00285402|Chronic migraine treatment|chronic migraine treatment
792146|NCT00285389|Mantle cell lymphoma|mantle cell lymphoma
792147|NCT00285389|Chemotherapy|chemotherapy
792148|NCT00285389|Autologous PBSCT|autologous pbsct
792149|NCT00285389|Molecular evaluation|molecular evaluation
792150|NCT00285376|Depression. Genetics, Pharmacogenetics|depression. genetics, pharmacogenetics
792151|NCT00285363|cancer|cancer
792152|NCT00285363|quality of life|quality of life
792153|NCT00285363|adolescents|adolescents
792154|NCT00285350|myasthenia gravis|myasthenia gravis
792155|NCT00285337|Myelopathy|myelopathy
792156|NCT00285337|Laminectomy|laminectomy
792157|NCT00285337|Laminoplasty|laminoplasty
792158|NCT00285337|Decompression of Spinal Cord|decompression of spinal cord
792159|NCT00285337|Cervical Spondylosis|cervical spondylosis
792160|NCT00285324|Glioma|glioma
792161|NCT00285324|Glioblastoma Multiforme|glioblastoma multiforme
792162|NCT00285324|Brain Cancer|brain cancer
792163|NCT00285324|Diffusion-Weighted Magnetic Resonance Imaging|diffusion-weighted magnetic resonance imaging
792164|NCT00285324|Brain Tumor|brain tumor
792165|NCT00285298|proteinuria|proteinuria
792166|NCT00285298|Kidney failure, chronic|kidney failure, chronic
792167|NCT00285285|Point-of-care Testing|point-of-care testing
792168|NCT00285285|Pediatric Emergency Department|pediatric emergency department
792169|NCT00285285|Length of Stay|length of stay
792170|NCT00285285|Efficiency|efficiency
792171|NCT00285259|cytomegalovirus infection|cytomegalovirus infection
792172|NCT00285259|infectious disease|infectious disease
792173|NCT00285259|viremia|viremia
792174|NCT00285259|cytomegalovirus disease|cytomegalovirus disease
792175|NCT00285259|stem cell transplant|stem cell transplant
792176|NCT00285259|allogeneic|allogeneic
792177|NCT00285259|bone marrow transplant|bone marrow transplant
792178|NCT00285259|hematopoietic cell transplant|hematopoietic cell transplant
792179|NCT00285259|Acute Lymphoblastic Leukemia|acute lymphoblastic leukemia
792180|NCT00285259|Chronic Myelogenous Leukemia|chronic myelogenous leukemia
792181|NCT00285259|Acute Myelogenous Leukemia|acute myelogenous leukemia
792182|NCT00285259|Hodgkin's Lymphoma|hodgkin's lymphoma
792183|NCT00285259|Non-Hodgkin's Lymphoma|non-hodgkin's lymphoma
792184|NCT00285259|Myelodysplastic Syndrome|myelodysplastic syndrome
792185|NCT00285246|combat disorders|combat disorders
792186|NCT00285246|stress, psychological|stress, psychological
792187|NCT00285246|somatoform disorders|somatoform disorders
792188|NCT00285246|life change events|life change events
792189|NCT00285246|utilization|utilization
792190|NCT00285207|Cervical Intraepithelial Neoplasia (CIN)|cervical intraepithelial neoplasia (cin)
792191|NCT00285207|High-grade Cervical Intraepithelial Neoplasia|high-grade cervical intraepithelial neoplasia
792192|NCT00285207|High-grade Squamous Intraepithelial Lesions (HSIL)|high-grade squamous intraepithelial lesions (hsil)
792193|NCT00285207|Human Papilloma Virus (HPV)|human papilloma virus (hpv)
792194|NCT00285207|High-Grade Cervical Intraepithelial Lesions (CIN 2/3)|high-grade cervical intraepithelial lesions (cin 2/3)
792195|NCT00285181|persons|persons
792196|NCT00285168|Osteoporosis|osteoporosis
792197|NCT00285168|Fractures, Bone|fractures, bone
792198|NCT00285168|Bone Mineral Density|bone mineral density
792199|NCT00285155|bupropion|bupropion
792200|NCT00285155|repeated dose|repeated dose
792201|NCT00285155|healthy volunteers|healthy volunteers
792202|NCT00285155|cognitive function|cognitive function
792203|NCT00285155|behaviour|behaviour
792204|NCT00285155|tolerance|tolerance
792205|NCT00285155|Persons|persons
792206|NCT00285142|rosiglitazone|rosiglitazone
792207|NCT00285142|insulin secretion|insulin secretion
792208|NCT00285142|clinical trial|clinical trial
792209|NCT00285142|healthy|healthy
792210|NCT00285142|persons|persons
792211|NCT00285103|Antisense, mRNA antagonist, Bcl-2, CLL|antisense, mrna antagonist, bcl-2, cll
792212|NCT00285090|Burn Injury|burn injury
792213|NCT00285090|Calcium|calcium
792214|NCT00285090|Vitamin D|vitamin d
792215|NCT00285090|Bone Mineral Density|bone mineral density
792216|NCT00285077|Alzheimer disease|alzheimer disease
792217|NCT00285077|nerve growth factors|nerve growth factors
792218|NCT00285077|Clinical Trial|clinical trial
792219|NCT00285064|MDCT|mdct
792220|NCT00285064|viability|viability
792221|NCT00285051|emesis, nausea,|emesis, nausea,
792222|NCT00285038|Deep vein thrombosis|deep vein thrombosis
792223|NCT00285038|Gynecological cancer|gynecological cancer
792224|NCT00285025|Alzheimer disease|alzheimer disease
792225|NCT00285025|nerve growth factors|nerve growth factors
792226|NCT00285025|Clinical Trial|clinical trial
792227|NCT00285012|smoking cessation|smoking cessation
792228|NCT00285012|smoking cessation in COPD|smoking cessation in copd
792229|NCT00284986|GVHD|gvhd
792230|NCT00284986|Graft vs Host Disease|graft vs host disease
792231|NCT00284986|Graft versus Host Disease|graft versus host disease
792232|NCT00284973|malaria|malaria
792233|NCT00284960|erectile dysfunction|erectile dysfunction
792234|NCT00284960|metabolic syndrome|metabolic syndrome
792235|NCT00284960|insulin resistance|insulin resistance
792236|NCT00284960|etiology|etiology
792237|NCT00284947|Side effects|side effects
792238|NCT00284947|calcineurin inhibitors|calcineurin inhibitors
792239|NCT00284947|maintenance|maintenance
792240|NCT00284947|basiliximab|basiliximab
792241|NCT00284947|Kidney maintenance transplant|kidney maintenance transplant
792242|NCT00284934|Dose optimization|dose optimization
792243|NCT00284934|immune suppressive regimen|immune suppressive regimen
792244|NCT00284934|enteric-coated mycophenolate sodium|enteric-coated mycophenolate sodium
792245|NCT00284934|EC-MPS|ec-mps
792246|NCT00284934|renal transplantation|renal transplantation
792247|NCT00284934|kidney|kidney
792248|NCT00284934|transplant|transplant
792249|NCT00284934|maintenance patients|maintenance patients
792250|NCT00284934|Renal transplantation in maintenance|renal transplantation in maintenance
792251|NCT00284921|kidney transplant, hepatitis C, enteric-coated mycophenolate sodium|kidney transplant, hepatitis c, enteric-coated mycophenolate sodium
792252|NCT00284908|S-Tenatoprazole-Na|s-tenatoprazole-na
792253|NCT00284908|Pharmacokinetic|pharmacokinetic
792254|NCT00284908|intragastric pH recording|intragastric ph recording
792255|NCT00284908|dose-response|dose-response
792256|NCT00284895|Obesity|obesity
792257|NCT00284895|Bariatric Surgery|bariatric surgery
792258|NCT00284895|Weight Loss Surgery|weight loss surgery
792259|NCT00284895|Asthma|asthma
792260|NCT00284882|Streptococcus, Fiji, pyoderma, pharyngitis, scabies|streptococcus, fiji, pyoderma, pharyngitis, scabies
792261|NCT00284869|LPS|lps
792262|NCT00284869|ethnicity|ethnicity
792263|NCT00284869|neutrophils|neutrophils
792264|NCT00284869|TNF|tnf
792265|NCT00284843|Streptococcus, Fiji, pyoderma, scabies, rheumatic disease|streptococcus, fiji, pyoderma, scabies, rheumatic disease
792266|NCT00284830|Right Ventricular Pacing|right ventricular pacing
792267|NCT00284830|Persistent Atrial Fibrillation|persistent atrial fibrillation
792268|NCT00284830|Atrioventricular Conduction|atrioventricular conduction
792269|NCT00284830|Heart Failure Hospitalization|heart failure hospitalization
792270|NCT00284830|Cardiovascular Health Care Utilization|cardiovascular health care utilization
792271|NCT00284830|Sinus-node Disease|sinus-node disease
792272|NCT00284830|Minimized Ventricular Pacing|minimized ventricular pacing
792273|NCT00284804|relapsed or refractory Hodgkin's Disease|relapsed or refractory hodgkin's disease
792274|NCT00284778|lung cancer|lung cancer
792275|NCT00284778|second line treatment|second line treatment
792276|NCT00284778|cost-minimization trial|cost-minimization trial
792277|NCT00284778|Pharmaco-economic study|pharmaco-economic study
792278|NCT00284778|docetaxel|docetaxel
792279|NCT00284778|pemetrexed|pemetrexed
792280|NCT00284752|Prostate|prostate
792281|NCT00284752|Cancer|cancer
792282|NCT00284752|Metastatic|metastatic
792283|NCT00284726|Cytokines in lung transplantation|cytokines in lung transplantation
792284|NCT00284726|Cold storage solutions|cold storage solutions
792285|NCT00284726|Ischemic reperfusion injury|ischemic reperfusion injury
792286|NCT00284700|Helicobacter pylori|helicobacter pylori
792287|NCT00284700|Iron deficiency anemia|iron deficiency anemia
792288|NCT00284700|children|children
792289|NCT00284687|bone marrow transplantation|bone marrow transplantation
792290|NCT00284687|CMV disease|cmv disease
792291|NCT00284661|Meniscal repair|meniscal repair
792292|NCT00284661|Meniscal suturing|meniscal suturing
792293|NCT00284661|Meniscal tear|meniscal tear
792294|NCT00284648|Achilles tendon|achilles tendon
792295|NCT00284648|Rupture|rupture
792296|NCT00284648|Non-operative|non-operative
792297|NCT00284648|Operative|operative
792298|NCT00284622|HTO|hto
792299|NCT00284622|Arthroscopy|arthroscopy
792300|NCT00284622|Osteoarthritis|osteoarthritis
792301|NCT00284622|Alignement|alignement
792302|NCT00284622|Varus gonarthrosis|varus gonarthrosis
792303|NCT00284609|Type 2 diabetes,|type 2 diabetes,
792304|NCT00284609|rehabilitation,|rehabilitation,
792305|NCT00284609|quality of life,|quality of life,
792306|NCT00284609|glycaemic control,|glycaemic control,
792307|NCT00284609|lifestyle intervention,|lifestyle intervention,
792308|NCT00284609|patient education,|patient education,
792309|NCT00284609|physical training,|physical training,
792310|NCT00284609|group visits,|group visits,
792311|NCT00284609|reminders|reminders
792312|NCT00284596|Opening wedge high tibial osteotomy|opening wedge high tibial osteotomy
792313|NCT00284596|Radio Sterometric Analysis|radio sterometric analysis
792314|NCT00284596|Locking screw fixation|locking screw fixation
792315|NCT00284583|Morton's Neuroma|morton's neuroma
792316|NCT00284583|Alcohol|alcohol
792317|NCT00284583|Steroid|steroid
792318|NCT00284570|pediatrics|pediatrics
792319|NCT00284570|congenital heart disease|congenital heart disease
792320|NCT00284570|cardiac|cardiac
792321|NCT00284570|cardiopulmonary bypass|cardiopulmonary bypass
792322|NCT00284570|infection|infection
792323|NCT00284570|sepsis|sepsis
792324|NCT00284570|postoperative|postoperative
792325|NCT00284570|marker for infection|marker for infection
792326|NCT00284570|inflammation|inflammation
792327|NCT00284570|cardiac surgery|cardiac surgery
792328|NCT00284557|Behavioral/Social|behavioral/social
792329|NCT00284557|Obesity|obesity
792330|NCT00284557|Pediatrics|pediatrics
792331|NCT00284557|Preventive Medicine|preventive medicine
792332|NCT00284531|cardiac transplantation|cardiac transplantation
792333|NCT00284531|allograft rejection|allograft rejection
792334|NCT00284531|anti-CD25|anti-cd25
792335|NCT00284505|cytokine|cytokine
792336|NCT00284505|arachnoiditis|arachnoiditis
792337|NCT00284505|neuropathic pain|neuropathic pain
792338|NCT00284505|tumor necrosis factor|tumor necrosis factor
792339|NCT00284492|Women|women
792340|NCT00284492|Acupuncture|acupuncture
792341|NCT00284492|Menopause|menopause
792342|NCT00284492|Hot flashes|hot flashes
792343|NCT00284492|Health related quality of life|health related quality of life
792344|NCT00284479|walking intervention|walking intervention
792345|NCT00284479|cardiovascular risk|cardiovascular risk
792346|NCT00284479|inflammatory markers|inflammatory markers
792347|NCT00284479|aerobic fitness|aerobic fitness
792348|NCT00284479|fatness|fatness
792349|NCT00284466|coronary artery disease|coronary artery disease
792350|NCT00284466|cardiac catheterization|cardiac catheterization
792351|NCT00284466|CT coronary angiography|ct coronary angiography
792352|NCT00284466|coronary angiography|coronary angiography
792353|NCT00284453|ventricular|ventricular
792354|NCT00284453|arrhythmias|arrhythmias
792355|NCT00284453|ICD|icd
792356|NCT00284453|VT storm|vt storm
792558|NCT00283621|Ifosfamide|ifosfamide
792357|NCT00284453|ICD patients with VT storm|icd patients with vt storm
792358|NCT00284440|Visual field progression|visual field progression
792359|NCT00284440|Choroidal blood flow|choroidal blood flow
792360|NCT00284401|Reversed prosthesis|reversed prosthesis
792361|NCT00284336|breast cancer|breast cancer
792362|NCT00284336|elderly|elderly
792363|NCT00284336|adjuvant chemotherapy|adjuvant chemotherapy
792364|NCT00284336|Caelyx|caelyx
792365|NCT00284323|Acute Myocardial Infarction|acute myocardial infarction
792366|NCT00284323|PCI|pci
792367|NCT00284323|Adenosine|adenosine
792368|NCT00284323|Postconditioning|postconditioning
792369|NCT00284310|Wrist surgery: 4-corner arthrodesis or proximal row carpectomy|wrist surgery: 4-corner arthrodesis or proximal row carpectomy
792370|NCT00284271|Hodgkin´s Lymphoma|hodgkin´s lymphoma
792371|NCT00284271|eldery patients|eldery patients
792372|NCT00284271|primary diagnosis|primary diagnosis
792373|NCT00284258|Colorectal Cancer|colorectal cancer
792374|NCT00284245|Chronic Pain|chronic pain
792375|NCT00284245|Pain|pain
792376|NCT00284245|Computer Analysis|computer analysis
792377|NCT00284245|Pain Diagrams|pain diagrams
792378|NCT00284232|HbA1c|hba1c
792379|NCT00284232|Self-monitoring blood glucose (SMBG)|self-monitoring blood glucose (smbg)
792380|NCT00284232|Diabetes treatment|diabetes treatment
792381|NCT00284232|quality of care|quality of care
792382|NCT00284219|rTMS, smoking, dopamine, acotinine|rtms, smoking, dopamine, acotinine
792383|NCT00284206|methamphetamine, cognition, outpatient, risperidone|methamphetamine, cognition, outpatient, risperidone
792384|NCT00284180|Breast Neoplasms|breast neoplasms
792385|NCT00284180|Breast Cancer|breast cancer
792386|NCT00284180|Vinflunine|vinflunine
792387|NCT00284180|Vinca Alkaloid|vinca alkaloid
792388|NCT00284180|Javlor|javlor
792389|NCT00284167|tailored|tailored
792390|NCT00284167|web-based|web-based
792391|NCT00284167|weight management|weight management
792392|NCT00284167|obesity|obesity
792393|NCT00284167|efficacy|efficacy
792394|NCT00284154|Extensive stage|extensive stage
792398|NCT00284141|non-small-cell lung cancer|non-small-cell lung cancer
792399|NCT00284141|metastatic|metastatic
792400|NCT00284141|carcinoma|carcinoma
792401|NCT00284141|lung neoplasm|lung neoplasm
792402|NCT00284141|lung diseases|lung diseases
792403|NCT00284141|angiogenesis|angiogenesis
792404|NCT00284141|anti-angiogenesis|anti-angiogenesis
792405|NCT00284141|anti-angiogenesis inhibitors|anti-angiogenesis inhibitors
792406|NCT00284141|cancer and other neoplasms|cancer and other neoplasms
792407|NCT00284141|respiratory tract|respiratory tract
792408|NCT00284141|(lung and bronchial) diseases|(lung and bronchial) diseases
792409|NCT00284128|Cardiovascular Disease C14|cardiovascular disease c14
792410|NCT00284128|vascular disease C14.907|vascular disease c14.907
792411|NCT00284128|hypertension C14.907.489|hypertension c14.907.489
792412|NCT00284115|Gait trainer|gait trainer
792413|NCT00284115|Hemiplegia|hemiplegia
792414|NCT00284115|Rehabilitation|rehabilitation
792415|NCT00284115|Stroke|stroke
792416|NCT00284102|gas exchange|gas exchange
792417|NCT00284102|dead space|dead space
792418|NCT00284102|respiratory failure|respiratory failure
792419|NCT00284102|ALI/ARDS patients|ali/ards patients
792420|NCT00284089|Subfoveal CNV, AMD, ranibizumab|subfoveal cnv, amd, ranibizumab
792421|NCT00284063|spinal manipulation, zygapophysial joints|spinal manipulation, zygapophysial joints
792422|NCT00284050|DME|dme
792423|NCT00284050|Diabetic macular edema|diabetic macular edema
792424|NCT00284050|ranibizumab|ranibizumab
792425|NCT00284050|Diabetic macular edema with center involvement|diabetic macular edema with center involvement
792426|NCT00284037|obstructive sleep apnea,|obstructive sleep apnea,
792427|NCT00284037|baroreceptors|baroreceptors
792428|NCT00284024|breastfeeding|breastfeeding
792429|NCT00284024|domperidone|domperidone
792430|NCT00284024|efficacy|efficacy
792431|NCT00284024|randomized controlled trial|randomized controlled trial
792432|NCT00284024|compliance|compliance
792433|NCT00284011|SAMe|same
792434|NCT00284011|AdoMet|adomet
792435|NCT00284011|Methylation|methylation
792436|NCT00284011|Homocysteine|homocysteine
792437|NCT00284011|Dietary Supplement|dietary supplement
792438|NCT00284011|S-Adenosyl-L-Methionine|s-adenosyl-l-methionine
792439|NCT00283998|Odontoid|odontoid
792440|NCT00283998|Type II fractures|type ii fractures
792441|NCT00283998|Elderly patients|elderly patients
792442|NCT00283998|Surgical vs. conservative treatment|surgical vs. conservative treatment
792443|NCT00283985|NK/T-cell lymphoma|nk/t-cell lymphoma
792444|NCT00283985|Lymphoma|lymphoma
792445|NCT00283985|L-asparaginase|l-asparaginase
792446|NCT00283985|Nasal NK-cell lymphoma|nasal nk-cell lymphoma
792447|NCT00283985|Nasal-type NK-cell Lymphoma|nasal-type nk-cell lymphoma
792448|NCT00283972|Health Outcome Study|health outcome study
792449|NCT00283959|Amicus Therapeutics|amicus therapeutics
792450|NCT00283959|AT1001|at1001
792451|NCT00283959|Galafold|galafold
792452|NCT00283959|Migalastat|migalastat
792453|NCT00283959|Substrate|substrate
792454|NCT00283946|zolpidem|zolpidem
792559|NCT00283608|stage I breast cancer|stage i breast cancer
792455|NCT00283946|sleep initiation and maintenance disorders Hypnotics and sedatives|sleep initiation and maintenance disorders hypnotics and sedatives
792456|NCT00283946|double-blind study|double-blind study
792457|NCT00283946|comparative study|comparative study
792458|NCT00283933|Amicus Therapeutics|amicus therapeutics
792459|NCT00283933|AT1001|at1001
792460|NCT00283933|Galafold|galafold
792461|NCT00283933|Migalastat|migalastat
792462|NCT00283933|Substrate|substrate
792463|NCT00283920|Pharmacokinetics|pharmacokinetics
792464|NCT00283920|Compartmental Analysis|compartmental analysis
792465|NCT00283920|Distribution Volume|distribution volume
792466|NCT00283920|Identitiability|identitiability
792467|NCT00283920|Healthy Volunteer|healthy volunteer
792468|NCT00283920|HV|hv
792469|NCT00283907|Electroencephalogram (EEG)|electroencephalogram (eeg)
792470|NCT00283907|Sense of Agency|sense of agency
792471|NCT00283907|Coherence|coherence
792472|NCT00283907|Voluntary Movement|voluntary movement
792473|NCT00283907|Self-Agency|self-agency
792474|NCT00283907|Healthy Volunteer|healthy volunteer
792475|NCT00283907|HV|hv
792476|NCT00283894|Obesity|obesity
792477|NCT00283894|Leptin|leptin
792478|NCT00283894|Sleep Attacks|sleep attacks
792479|NCT00283894|Energy Metabolism|energy metabolism
792480|NCT00283894|Healthy Control|healthy control
792481|NCT00283894|Narcolepsy|narcolepsy
792482|NCT00283894|Healthy Volunteer|healthy volunteer
792483|NCT00283894|HV|hv
792484|NCT00283881|Haptic Skills|haptic skills
792485|NCT00283881|Implicit Tactile Learning|implicit tactile learning
792486|NCT00283881|Functional Magnetic Resonance Imaging (fMRI)|functional magnetic resonance imaging (fmri)
792487|NCT00283881|Transcranial Magnetic Stimulation (TMS)|transcranial magnetic stimulation (tms)
792488|NCT00283881|Transcranial Direct Current Stimulation (tDCS)|transcranial direct current stimulation (tdcs)
792489|NCT00283881|Stroke|stroke
792490|NCT00283881|Healthy Volunteer|healthy volunteer
792491|NCT00283881|HV|hv
792492|NCT00283868|stroke|stroke
792493|NCT00283868|digital video|digital video
792494|NCT00283868|SPOTRIAS|spotrias
792495|NCT00283855|Rheumatoid Arthritis|rheumatoid arthritis
792496|NCT00283855|Self-Management|self-management
792497|NCT00283855|Internet|internet
792498|NCT00283842|neuropathic pain|neuropathic pain
792499|NCT00283842|diabetic peripheral neuropathy|diabetic peripheral neuropathy
792500|NCT00283829|Immunotherapy|immunotherapy
792501|NCT00283816|Polycystic Ovary Syndrome|polycystic ovary syndrome
792502|NCT00283816|Overweight Adolescent Girls|overweight adolescent girls
792503|NCT00283816|Irregular Menstrual Cycles|irregular menstrual cycles
792504|NCT00283777|insulin|insulin
792505|NCT00283777|glucose|glucose
792506|NCT00283777|body weight|body weight
792507|NCT00283777|chromium|chromium
792508|NCT00283738|migraine|migraine
792509|NCT00283738|aura|aura
792510|NCT00283738|Patent Foramen Ovale (PFO)|patent foramen ovale (pfo)
792511|NCT00283738|cardiac defects|cardiac defects
792512|NCT00283738|Heart Septal Defects, Atrial|heart septal defects, atrial
792513|NCT00283738|Cephalalgia|cephalalgia
792514|NCT00283725|Dementia|dementia
792515|NCT00283725|Alzheimer's Disease|alzheimer's disease
792516|NCT00283725|Acetylcholinesterase inhibitor|acetylcholinesterase inhibitor
792517|NCT00283725|Galantamine|galantamine
792518|NCT00283725|Nursing Home Admission|nursing home admission
792519|NCT00283712|Skin Diseases|skin diseases
792520|NCT00283712|Autoimmune Diseases|autoimmune diseases
792521|NCT00283699|neurocysticercosis|neurocysticercosis
792522|NCT00283699|albendazole|albendazole
792523|NCT00283699|tape worm|tape worm
792524|NCT00283686|polycystic kidney disease|polycystic kidney disease
792525|NCT00283686|polycystic|polycystic
792526|NCT00283686|kidney|kidney
792527|NCT00283686|disease|disease
792528|NCT00283686|adpkd|adpkd
792529|NCT00283686|halt|halt
792530|NCT00283686|pkd|pkd
792531|NCT00283686|blood pressure|blood pressure
792532|NCT00283686|bp|bp
792533|NCT00283686|hypertension|hypertension
792534|NCT00283686|renal|renal
792535|NCT00283686|renin-angiotensin-aldosterone-system|renin-angiotensin-aldosterone-system
792536|NCT00283686|RAAS|raas
792537|NCT00283660|Zinc|zinc
792538|NCT00283660|Dietary Supplements|dietary supplements
792539|NCT00283660|Nutritional Supplements|nutritional supplements
792540|NCT00283660|Child|child
792541|NCT00283660|Mental Health|mental health
792542|NCT00283660|School|school
792543|NCT00283660|Guatemala|guatemala
792544|NCT00283647|lead exposure|lead exposure
792545|NCT00283647|magnetic resonance imaging|magnetic resonance imaging
792546|NCT00283647|magnetic resonance spectroscopy|magnetic resonance spectroscopy
792547|NCT00283647|functional magnetic resonance|functional magnetic resonance
792548|NCT00283647|brain development|brain development
792549|NCT00283621|Aranesp|aranesp
792550|NCT00283621|Darbepoetin Alfa|darbepoetin alfa
792551|NCT00283621|Pegfilgrastim|pegfilgrastim
792552|NCT00283621|Neulasta|neulasta
792553|NCT00283621|Sarcoma|sarcoma
792554|NCT00283621|Adriamycin|adriamycin
792555|NCT00283621|Doxorubicin Hydrocholoride|doxorubicin hydrocholoride
792556|NCT00283621|Adriamycin PFS|adriamycin pfs
792557|NCT00283621|Adriamycin RDF|adriamycin rdf
792560|NCT00283608|stage II breast cancer|stage ii breast cancer
792561|NCT00283608|stage IIIA breast cancer|stage iiia breast cancer
792562|NCT00283608|stage IIIB breast cancer|stage iiib breast cancer
792563|NCT00283608|stage IIIC breast cancer|stage iiic breast cancer
792564|NCT00283595|Anorexia Nervosa|anorexia nervosa
792565|NCT00283595|Eating disorder|eating disorder
792566|NCT00283595|Bone|bone
792567|NCT00283595|Growth hormone|growth hormone
792568|NCT00283595|Osteopenia|osteopenia
792569|NCT00283595|Osteoporosis|osteoporosis
792570|NCT00283569|Glioma|glioma
792571|NCT00283556|High Dose Irinotecan|high dose irinotecan
792572|NCT00283556|CPT-11|cpt-11
792573|NCT00283556|Camptosar|camptosar
792574|NCT00283556|Malignant Glioma|malignant glioma
792575|NCT00283556|Unresectable|unresectable
792576|NCT00283543|Glioma|glioma
792577|NCT00283543|Gliadel Wafer|gliadel wafer
792578|NCT00283530|Cancer|cancer
792579|NCT00283530|Cancer receiving chemotherapy|cancer receiving chemotherapy
792580|NCT00283530|Tumor biopsy|tumor biopsy
792581|NCT00283517|Risperidone long-acting injection|risperidone long-acting injection
792582|NCT00283517|Antipsychotic medication|antipsychotic medication
792583|NCT00283517|Schizophrenia|schizophrenia
792584|NCT00283517|Treatment retention|treatment retention
792585|NCT00283517|Observational study|observational study
792586|NCT00283491|Iron absorption|iron absorption
792587|NCT00283491|Organic acids|organic acids
792588|NCT00283491|Lactobacillus|lactobacillus
792589|NCT00283491|Probiotic|probiotic
792590|NCT00283478|Advanced stage|advanced stage
792591|NCT00283478|Lung cancer|lung cancer
792592|NCT00283465|Anemia|anemia
792593|NCT00283465|cancer|cancer
792594|NCT00283465|neoplasm|neoplasm
792595|NCT00283465|transfusion|transfusion
792596|NCT00283465|quality of life|quality of life
792597|NCT00283465|tumor response|tumor response
792598|NCT00283465|survival|survival
792599|NCT00283465|chemotherapy|chemotherapy
792600|NCT00283465|hemoglobin|hemoglobin
792601|NCT00283465|standard care|standard care
792602|NCT00283465|epoetin alfa|epoetin alfa
792604|NCT00283465|erythropoietin|erythropoietin
792605|NCT00283452|Physical activity maintenance|physical activity maintenance
792606|NCT00283452|Interactive phone and mail-based intervention|interactive phone and mail-based intervention
792607|NCT00283452|Older adults|older adults
792608|NCT00283439|NHL|nhl
792609|NCT00283439|chemotherapy induced thrombocytopenia|chemotherapy induced thrombocytopenia
792610|NCT00283439|CIT|cit
792611|NCT00283439|ICE|ice
792612|NCT00283439|RICE|rice
792613|NCT00283439|Hodgkin's Lymphoma|hodgkin's lymphoma
792614|NCT00283439|Non-Hodgkin's Lymphoma|non-hodgkin's lymphoma
792615|NCT00283439|CHOP|chop
792616|NCT00283439|ESHAP|eshap
792617|NCT00283439|DHAP|dhap
792618|NCT00283439|R-CHOP|r-chop
792619|NCT00283439|R-ESHAP|r-eshap
792620|NCT00283439|R-DHAP|r-dhap
792621|NCT00283413|Covered Stent System|covered stent system
792622|NCT00283413|Saphenous Vein Graft|saphenous vein graft
792623|NCT00283413|Coronary Artery Bypass[MeSH]|coronary artery bypass[mesh]
792624|NCT00283413|Stents[MeSH]|stents[mesh]
792625|NCT00283400|subarachnoid hemorrhage|subarachnoid hemorrhage
792626|NCT00283400|SAH|sah
792627|NCT00283400|human albumin|human albumin
792628|NCT00283400|HA|ha
792629|NCT00283400|cerebral vasospasm|cerebral vasospasm
792630|NCT00283400|aneurysm|aneurysm
792631|NCT00283400|neuroprotective|neuroprotective
792632|NCT00283387|Primary Hyperoxaluria|primary hyperoxaluria
792633|NCT00283374|Metabolic Syndrome|metabolic syndrome
792634|NCT00283374|Obesity|obesity
792635|NCT00283374|Nonalcoholic fatty liver disease|nonalcoholic fatty liver disease
792636|NCT00283374|Nonalcoholic steatohepatitis|nonalcoholic steatohepatitis
792637|NCT00283374|Bariatric Surgery|bariatric surgery
792638|NCT00283348|Renal Transplantation|renal transplantation
792639|NCT00283348|Immunosuppression|immunosuppression
792640|NCT00283348|Chronic Rejection|chronic rejection
792641|NCT00283322|Heparin Induced Thrombocytopenia|heparin induced thrombocytopenia
792642|NCT00283322|HIT|hit
792643|NCT00283322|HITT|hitt
792644|NCT00283322|Thrombosis|thrombosis
792645|NCT00283322|Thromboembolism|thromboembolism
792646|NCT00283309|Corticosteroids|corticosteroids
792647|NCT00283309|Riluzole|riluzole
792648|NCT00283309|Memantine|memantine
792649|NCT00283309|Memory|memory
792650|NCT00283296|manual wheelchair|manual wheelchair
792651|NCT00283296|assistive technology|assistive technology
792652|NCT00283296|travel wheelchair|travel wheelchair
792653|NCT00283283|Influenza|influenza
792654|NCT00283270|Mental health|mental health
792655|NCT00283270|Screening|screening
792656|NCT00283270|Elderly|elderly
792657|NCT00283270|Chinese|chinese
792658|NCT00283270|Problem-solving counselling|problem-solving counselling
792659|NCT00283257|Problem solving|problem solving
792660|NCT00283257|psychosocial support|psychosocial support
792661|NCT00283244|stage IIIB non-small cell lung cancer|stage iiib non-small cell lung cancer
792662|NCT00283244|stage IV non-small cell lung cancer|stage iv non-small cell lung cancer
792663|NCT00283231|Hot Flashes|hot flashes
792664|NCT00283231|Menopausal Symptoms|menopausal symptoms
792665|NCT00283231|Paced respiration|paced respiration
792666|NCT00283231|RESPeRATE|resperate
792667|NCT00283205|Menopausal Symptoms|menopausal symptoms
792668|NCT00283205|Hot Flashes|hot flashes
792669|NCT00283205|Yoga|yoga
792670|NCT00283192|Menopausal Symptoms|menopausal symptoms
792671|NCT00283192|Hot flashes|hot flashes
792672|NCT00283179|Aripiprazole|aripiprazole
792673|NCT00283179|Risperidone|risperidone
792674|NCT00283179|Schizophrenia|schizophrenia
792675|NCT00283179|Schizoaffective disorder|schizoaffective disorder
792676|NCT00283166|Palliative Care|palliative care
792677|NCT00283153|Traumatic Brain Injury|traumatic brain injury
792678|NCT00283153|Stroke|stroke
792679|NCT00283153|Emotion Recognition|emotion recognition
792680|NCT00283153|Affect|affect
792681|NCT00283153|Interventions|interventions
792682|NCT00283127|Chlamydia trachomatis|chlamydia trachomatis
792683|NCT00283127|Mass screening|mass screening
792684|NCT00283127|Home sampling|home sampling
792685|NCT00283127|Urine test|urine test
792686|NCT00283114|Lintuzumab|lintuzumab
792687|NCT00283114|Antigens, CD33|antigens, cd33
792688|NCT00283114|Antibodies, Monoclonal|antibodies, monoclonal
792689|NCT00283114|Leukemia, Myeloid, Acute|leukemia, myeloid, acute
792690|NCT00283114|Myelodysplastic Syndromes|myelodysplastic syndromes
792691|NCT00283114|Hematologic Diseases|hematologic diseases
792692|NCT00283114|Myeloproliferative Disorders|myeloproliferative disorders
792693|NCT00283114|Leukemia|leukemia
792694|NCT00283101|Antigens, CD40|antigens, cd40
792695|NCT00283101|Antibody, Monoclonal|antibody, monoclonal
792696|NCT00283101|Leukemia, Lymphocytic, Chronic, B-Cell|leukemia, lymphocytic, chronic, b-cell
792697|NCT00283101|Hematologic Diseases|hematologic diseases
792698|NCT00283101|Immunoproliferatic Disorders|immunoproliferatic disorders
792699|NCT00283101|Lymphatic Diseases|lymphatic diseases
792700|NCT00283101|Lymphoproliferative Disorders|lymphoproliferative disorders
792701|NCT00283101|Leukemia|leukemia
792702|NCT00283088|stroke|stroke
792703|NCT00283088|hypothermia|hypothermia
792704|NCT00283088|cooling|cooling
793286|NCT00281697|Ribbon 2|ribbon 2
792705|NCT00283088|tissue plasminogen activator|tissue plasminogen activator
792706|NCT00283088|tPA|tpa
792707|NCT00283088|thrombolysis|thrombolysis
792708|NCT00283075|intraabdominal cancer (carcinomas)|intraabdominal cancer (carcinomas)
792709|NCT00283075|agarose macrobeads|agarose macrobeads
792710|NCT00283075|mouse kidney cancer cells|mouse kidney cancer cells
792711|NCT00283075|cancer cell growth inhibition|cancer cell growth inhibition
792712|NCT00283023|All selective craniotomy|all selective craniotomy
792713|NCT00283010|cognitive enhancement|cognitive enhancement
792714|NCT00283010|memory|memory
792715|NCT00283010|auditory memory|auditory memory
792716|NCT00283010|speech|speech
792717|NCT00283010|computerized|computerized
792718|NCT00283010|cognitive decline|cognitive decline
792719|NCT00282971|Type 2 diabetes melllitus|type 2 diabetes melllitus
792720|NCT00282893|aneurysm|aneurysm
792721|NCT00282893|vasospasm|vasospasm
792722|NCT00282893|subarachnoid hemorrhage|subarachnoid hemorrhage
792723|NCT00282893|transluminal ballooning|transluminal ballooning
792724|NCT00282867|stroke|stroke
792725|NCT00282867|acute ischemic stroke|acute ischemic stroke
792726|NCT00282867|hyperglycemia|hyperglycemia
792727|NCT00282867|glucose|glucose
792728|NCT00282867|insulin|insulin
792729|NCT00282867|insulin and potassium therapy|insulin and potassium therapy
792730|NCT00282867|GIK|gik
792731|NCT00282854|epilepsy|epilepsy
792732|NCT00282854|Rolandic epilepsy|rolandic epilepsy
792733|NCT00282841|stroke|stroke
792734|NCT00282841|ultrasound|ultrasound
792735|NCT00282841|occlusion|occlusion
792736|NCT00282841|blockage|blockage
792737|NCT00282841|contrast solution|contrast solution
792738|NCT00282828|Social Anxiety Disorder|social anxiety disorder
792739|NCT00282828|Pharmacotherapy|pharmacotherapy
792740|NCT00282828|Genetics|genetics
792741|NCT00282828|Treatment Refractory|treatment refractory
792742|NCT00282815|obstructive sleep apnea|obstructive sleep apnea
792743|NCT00282815|stroke|stroke
792744|NCT00282815|OSA|osa
792745|NCT00282815|CPAP|cpap
792746|NCT00282815|continuous positive airway pressure|continuous positive airway pressure
792747|NCT00282802|Parkinson's Disease|parkinson's disease
792748|NCT00282802|twins|twins
792749|NCT00282802|SPECT|spect
792750|NCT00282802|National Academy of Sciences/National Resource Council (NAS/NRC) World War II Veteran Twins Cohort Registry|national academy of sciences/national resource council (nas/nrc) world war ii veteran twins cohort registry
792751|NCT00282802|NAS/NRC|nas/nrc
792752|NCT00282802|World War II Veteran Twins|world war ii veteran twins
792753|NCT00282776|Postpartum Depression|postpartum depression
792754|NCT00282776|Telephone Care Management|telephone care management
792755|NCT00282776|Screening for Postpartum Depression|screening for postpartum depression
792756|NCT00282750|"Surgery[MeSH]"|"surgery[mesh]"
792757|NCT00282750|"Surgical Sponges[MeSH]"|"surgical sponges[mesh]"
792758|NCT00282750|"Automatic Data Processing[MeSH]"|"automatic data processing[mesh]"
792759|NCT00282724|Lamellar ichthyosis|lamellar ichthyosis
792760|NCT00282724|Liarozole|liarozole
792761|NCT00282724|Investigator's Global Assessment|investigator's global assessment
792762|NCT00282724|Scaling|scaling
792763|NCT00282711|Diagnostic Techniques, Radioisotope|diagnostic techniques, radioisotope
792764|NCT00282711|Radionuclide Imaging|radionuclide imaging
792765|NCT00282711|Diagnostic Techniques, Cardiovascular|diagnostic techniques, cardiovascular
792766|NCT00282711|Heart Function tests|heart function tests
792767|NCT00282685|Patients with symmetric peripheral diabetic neuropathy|patients with symmetric peripheral diabetic neuropathy
792768|NCT00282672|Barrett's Esophagus|barrett's esophagus
792769|NCT00282672|Dysplasia|dysplasia
792770|NCT00282672|Radiofrequency Ablation|radiofrequency ablation
792771|NCT00282659|Hemodynamics|hemodynamics
792772|NCT00282659|Hypertension|hypertension
792773|NCT00282659|Dyslipidemia|dyslipidemia
792774|NCT00282659|Diabetes|diabetes
792775|NCT00282659|Implantable Cardioverter Defibrillator|implantable cardioverter defibrillator
792776|NCT00282659|Blood Pressure|blood pressure
792777|NCT00282646|critical limb ischemia|critical limb ischemia
792778|NCT00282646|peripheral arterial occlusive disease|peripheral arterial occlusive disease
792779|NCT00282646|[C14.907.137]|[c14.907.137]
792780|NCT00282633|Cesarean Delivery|cesarean delivery
792781|NCT00282633|Wound closure|wound closure
792782|NCT00282633|Suture|suture
792783|NCT00282633|Alternative therapy|alternative therapy
792784|NCT00282633|Surgery|surgery
792785|NCT00282620|Implantable Cardioverter Defibrillator|implantable cardioverter defibrillator
792786|NCT00282620|Magnesium|magnesium
792787|NCT00282620|Electrocardiogram|electrocardiogram
792788|NCT00282620|Ventricular Arrhythmia|ventricular arrhythmia
792789|NCT00282607|Erectile Dysfunction|erectile dysfunction
792790|NCT00282594|Intensive Insulin Therapy|intensive insulin therapy
792791|NCT00282594|General Surgical|general surgical
792792|NCT00282594|Vascular Surgical|vascular surgical
792793|NCT00282594|Tight Glycemic Control|tight glycemic control
792794|NCT00282581|HIV|hiv
792795|NCT00282581|Smallpox|smallpox
792796|NCT00282581|MVA|mva
792797|NCT00282568|Pharmacokinetics|pharmacokinetics
792798|NCT00282568|Therapy|therapy
792799|NCT00282568|Immunosuppression|immunosuppression
792800|NCT00282568|Drugs, Investigational|drugs, investigational
792802|NCT00282555|Esophagitis, Reflux|esophagitis, reflux
792803|NCT00282555|S-Tenatoprazole-Na|s-tenatoprazole-na
792804|NCT00282555|Heartburn|heartburn
792805|NCT00282555|Esophageal endoscopy|esophageal endoscopy
792806|NCT00282542|Hepatocytes|hepatocytes
792807|NCT00282529|lymphedema, screening, treatment|lymphedema, screening, treatment
792808|NCT00282516|asthma|asthma
792809|NCT00282516|telemedicine|telemedicine
792810|NCT00282516|case management|case management
792811|NCT00282516|clinic|clinic
792812|NCT00282516|children|children
792813|NCT00282516|pediatric|pediatric
792814|NCT00282503|aGvHD|agvhd
792815|NCT00282490|Overactive bladder|overactive bladder
792816|NCT00282490|Children|children
792817|NCT00282490|Nerve stimulation|nerve stimulation
792818|NCT00282490|TENS|tens
792819|NCT00282477|cyclist|cyclist
792820|NCT00282464|Bipolar I Depression|bipolar i depression
792821|NCT00282399|Myelodysplastic Syndrome|myelodysplastic syndrome
792822|NCT00282399|MGI Pharma|mgi pharma
792823|NCT00282399|Decitabine|decitabine
792824|NCT00282399|Dacogen|dacogen
792825|NCT00282360|coronary artery disease|coronary artery disease
792826|NCT00282360|diabetes mellitus|diabetes mellitus
792827|NCT00282347|Class IV LN|class iv ln
792828|NCT00282347|Lupus|lupus
792829|NCT00282347|LUNAR|lunar
792830|NCT00282347|LN|ln
792831|NCT00282334|Telemedicine|telemedicine
792832|NCT00282334|Blood pressure|blood pressure
792833|NCT00282334|Quality of life|quality of life
792834|NCT00282334|Cost-effectiveness|cost-effectiveness
792835|NCT00282308|RA|ra
792836|NCT00282308|Rituxan|rituxan
792837|NCT00282308|SIERRA|sierra
792838|NCT00282295|tetanus|tetanus
792839|NCT00282295|pertussis|pertussis
792840|NCT00282295|Prophylaxis|prophylaxis
792841|NCT00282295|meningococcus|meningococcus
792842|NCT00282295|diptheria|diptheria
792843|NCT00282282|non-myeloablative peripheral blood stem cell|non-myeloablative peripheral blood stem cell
792844|NCT00282282|PBSCT|pbsct
792845|NCT00282282|tacrolimus|tacrolimus
792846|NCT00282282|sirolimus|sirolimus
792847|NCT00282269|Traumatic Brain Injury|traumatic brain injury
792848|NCT00282269|Children|children
792849|NCT00282269|Hypothermia|hypothermia
792850|NCT00282269|Outcome|outcome
792851|NCT00282269|Intensive Care|intensive care
792852|NCT00282269|Magnetic resonance Imaging|magnetic resonance imaging
792853|NCT00282256|Child|child
792854|NCT00282256|Pharmacokinetics|pharmacokinetics
792855|NCT00282256|Immunosuppression Drugs|immunosuppression drugs
792856|NCT00282256|Hepatic transplant|hepatic transplant
792857|NCT00282256|Liver Transplantation|liver transplantation
792858|NCT00282243|Pharmacokinetics|pharmacokinetics
792859|NCT00282243|Therapy|therapy
792860|NCT00282243|Immunosuppression|immunosuppression
792861|NCT00282243|Drugs, Investigational|drugs, investigational
792862|NCT00282243|Adult|adult
792863|NCT00282230|Malononitrilamide|malononitrilamide
792864|NCT00282230|immunosuppression|immunosuppression
792865|NCT00282230|treatment efficacy|treatment efficacy
792866|NCT00282230|treatment outcome|treatment outcome
792867|NCT00282217|Kidney Failure|kidney failure
792868|NCT00282217|Kidney Transplant|kidney transplant
792869|NCT00282217|Graft Rejection|graft rejection
792870|NCT00282217|Kidney Transplantation|kidney transplantation
792871|NCT00282204|Hypnosis|hypnosis
792872|NCT00282204|Hypnotherapy|hypnotherapy
792873|NCT00282204|Childbirth|childbirth
792874|NCT00282204|Analgesia|analgesia
792875|NCT00282191|spasticity|spasticity
792876|NCT00282191|mental retardation|mental retardation
792877|NCT00282178|Metabolic|metabolic
792878|NCT00282178|Hypertension|hypertension
792879|NCT00282178|Abdominal obesity|abdominal obesity
792880|NCT00282178|Insulin sensitivity|insulin sensitivity
792881|NCT00282178|Hyperinsulinemic euglycemic clamp|hyperinsulinemic euglycemic clamp
792882|NCT00282152|Early Stage Parkinson's Disease|early stage parkinson's disease
792883|NCT00282152|Parkinson's Disease|parkinson's disease
792884|NCT00282152|Deep Brain Stimulation|deep brain stimulation
792885|NCT00282152|PD|pd
792886|NCT00282152|DBS|dbs
792887|NCT00282126|Calcium balance|calcium balance
792888|NCT00282113|Probiotic|probiotic
792889|NCT00282113|Prebiotic|prebiotic
792890|NCT00282113|NEC|nec
792891|NCT00282113|Premature infants|premature infants
792892|NCT00282113|commensal flora|commensal flora
792893|NCT00282087|early stage|early stage
792894|NCT00282087|high grade|high grade
792895|NCT00282087|uterine leiomyosarcoma|uterine leiomyosarcoma
792896|NCT00282087|adjuvant treatment|adjuvant treatment
792897|NCT00282061|3 conditions in a within-subject design:|3 conditions in a within-subject design:
792898|NCT00282061|1-ad-lib sleep wake|1-ad-lib sleep wake
792899|NCT00282061|2-forced morning wake-up|2-forced morning wake-up
792900|NCT00282061|3- ad-lib sleep wake after treatment with melatonin|3- ad-lib sleep wake after treatment with melatonin
792901|NCT00282035|breast cancer|breast cancer
792902|NCT00282035|breast tumour|breast tumour
792903|NCT00282035|DCIS|dcis
792904|NCT00282035|female|female
792905|NCT00282035|breast conserving surgery|breast conserving surgery
792906|NCT00282035|irradiation|irradiation
792907|NCT00282035|whole breast irradiation|whole breast irradiation
792908|NCT00282035|3D CRT accelerated partial breast irradiation|3d crt accelerated partial breast irradiation
792909|NCT00282035|cosmetic outcome|cosmetic outcome
792910|NCT00282035|quality of life|quality of life
792911|NCT00282022|recurrent small cell lung cancer|recurrent small cell lung cancer
792912|NCT00282022|extensive stage small cell lung cancer|extensive stage small cell lung cancer
792913|NCT00282022|limited stage small cell lung cancer|limited stage small cell lung cancer
792914|NCT00282009|unspecified adult solid tumor, protocol specific|unspecified adult solid tumor, protocol specific
792915|NCT00281996|recurrent pancreatic cancer|recurrent pancreatic cancer
792916|NCT00281996|stage III pancreatic cancer|stage iii pancreatic cancer
792917|NCT00281996|stage IV pancreatic cancer|stage iv pancreatic cancer
792918|NCT00281983|B-cell chronic lymphocytic leukemia|b-cell chronic lymphocytic leukemia
792919|NCT00281983|refractory chronic lymphocytic leukemia|refractory chronic lymphocytic leukemia
792920|NCT00281983|stage III chronic lymphocytic leukemia|stage iii chronic lymphocytic leukemia
792921|NCT00281983|stage IV chronic lymphocytic leukemia|stage iv chronic lymphocytic leukemia
792922|NCT00281983|Waldenström macroglobulinemia|waldenström macroglobulinemia
792923|NCT00281970|stage I non-small cell lung cancer|stage i non-small cell lung cancer
792924|NCT00281970|stage II non-small cell lung cancer|stage ii non-small cell lung cancer
792925|NCT00281970|stage IIIA non-small cell lung cancer|stage iiia non-small cell lung cancer
792926|NCT00281970|stage IIIB non-small cell lung cancer|stage iiib non-small cell lung cancer
792927|NCT00281931|prolymphocytic leukemia|prolymphocytic leukemia
792928|NCT00281918|B-cell chronic lymphocytic leukemia|b-cell chronic lymphocytic leukemia
792929|NCT00281918|stage I chronic lymphocytic leukemia|stage i chronic lymphocytic leukemia
792930|NCT00281918|stage II chronic lymphocytic leukemia|stage ii chronic lymphocytic leukemia
792931|NCT00281918|stage III chronic lymphocytic leukemia|stage iii chronic lymphocytic leukemia
792932|NCT00281918|stage IV chronic lymphocytic leukemia|stage iv chronic lymphocytic leukemia
792933|NCT00281905|untreated childhood brain stem glioma|untreated childhood brain stem glioma
792934|NCT00281905|childhood high-grade cerebral astrocytoma|childhood high-grade cerebral astrocytoma
792935|NCT00281905|childhood low-grade cerebral astrocytoma|childhood low-grade cerebral astrocytoma
792936|NCT00281905|untreated childhood cerebellar astrocytoma|untreated childhood cerebellar astrocytoma
792937|NCT00281905|childhood choroid plexus tumor|childhood choroid plexus tumor
792938|NCT00281905|childhood infratentorial ependymoma|childhood infratentorial ependymoma
792939|NCT00281905|childhood supratentorial ependymoma|childhood supratentorial ependymoma
792940|NCT00281905|newly diagnosed childhood ependymoma|newly diagnosed childhood ependymoma
792941|NCT00281905|untreated childhood medulloblastoma|untreated childhood medulloblastoma
792942|NCT00281905|childhood oligodendroglioma|childhood oligodendroglioma
792943|NCT00281905|untreated childhood supratentorial primitive neuroectodermal tumor|untreated childhood supratentorial primitive neuroectodermal tumor
792944|NCT00281905|disseminated neuroblastoma|disseminated neuroblastoma
792945|NCT00281905|localized resectable neuroblastoma|localized resectable neuroblastoma
792946|NCT00281905|localized unresectable neuroblastoma|localized unresectable neuroblastoma
793352|NCT00281437|autonomy|autonomy
792947|NCT00281905|regional neuroblastoma|regional neuroblastoma
792948|NCT00281905|stage 4S neuroblastoma|stage 4s neuroblastoma
792949|NCT00281892|anemia|anemia
792950|NCT00281892|refractory chronic lymphocytic leukemia|refractory chronic lymphocytic leukemia
792951|NCT00281892|stage 0 chronic lymphocytic leukemia|stage 0 chronic lymphocytic leukemia
792952|NCT00281892|stage I chronic lymphocytic leukemia|stage i chronic lymphocytic leukemia
792953|NCT00281892|stage II chronic lymphocytic leukemia|stage ii chronic lymphocytic leukemia
792954|NCT00281892|stage III chronic lymphocytic leukemia|stage iii chronic lymphocytic leukemia
792955|NCT00281892|stage IV chronic lymphocytic leukemia|stage iv chronic lymphocytic leukemia
792956|NCT00281879|adult acute lymphoblastic leukemia in remission|adult acute lymphoblastic leukemia in remission
792957|NCT00281879|L1 adult acute lymphoblastic leukemia|l1 adult acute lymphoblastic leukemia
792958|NCT00281879|L2 adult acute lymphoblastic leukemia|l2 adult acute lymphoblastic leukemia
792959|NCT00281879|L3 adult acute lymphoblastic leukemia|l3 adult acute lymphoblastic leukemia
792960|NCT00281879|recurrent adult acute lymphoblastic leukemia|recurrent adult acute lymphoblastic leukemia
792961|NCT00281879|accelerated phase chronic myelogenous leukemia|accelerated phase chronic myelogenous leukemia
792962|NCT00281879|blastic phase chronic myelogenous leukemia|blastic phase chronic myelogenous leukemia
792963|NCT00281879|chronic phase chronic myelogenous leukemia|chronic phase chronic myelogenous leukemia
792964|NCT00281879|relapsing chronic myelogenous leukemia|relapsing chronic myelogenous leukemia
792965|NCT00281879|childhood acute lymphoblastic leukemia in remission|childhood acute lymphoblastic leukemia in remission
792966|NCT00281879|L1 childhood acute lymphoblastic leukemia|l1 childhood acute lymphoblastic leukemia
792967|NCT00281879|L2 childhood acute lymphoblastic leukemia|l2 childhood acute lymphoblastic leukemia
792968|NCT00281879|L3 childhood acute lymphoblastic leukemia|l3 childhood acute lymphoblastic leukemia
792969|NCT00281879|recurrent childhood acute lymphoblastic leukemia|recurrent childhood acute lymphoblastic leukemia
792970|NCT00281879|recurrent adult Hodgkin lymphoma|recurrent adult hodgkin lymphoma
792971|NCT00281879|recurrent/refractory childhood Hodgkin lymphoma|recurrent/refractory childhood hodgkin lymphoma
792972|NCT00281879|stage IV adult Hodgkin lymphoma|stage iv adult hodgkin lymphoma
792973|NCT00281879|stage IV childhood Hodgkin lymphoma|stage iv childhood hodgkin lymphoma
792974|NCT00281879|adult acute myeloid leukemia in remission|adult acute myeloid leukemia in remission
792975|NCT00281879|adult acute myeloid leukemia with 11q23 (MLL) abnormalities|adult acute myeloid leukemia with 11q23 (mll) abnormalities
792976|NCT00281879|adult acute myeloid leukemia with t(15;17)(q22;q12)|adult acute myeloid leukemia with t(15;17)(q22;q12)
792977|NCT00281879|adult acute myeloid leukemia with t(16;16)(p13;q22)|adult acute myeloid leukemia with t(16;16)(p13;q22)
792978|NCT00281879|childhood acute myeloid leukemia in remission|childhood acute myeloid leukemia in remission
792979|NCT00281879|recurrent adult acute myeloid leukemia|recurrent adult acute myeloid leukemia
792980|NCT00281879|recurrent childhood acute myeloid leukemia|recurrent childhood acute myeloid leukemia
792981|NCT00281879|myelodysplastic/myeloproliferative neoplasm, unclassifiable|myelodysplastic/myeloproliferative neoplasm, unclassifiable
792982|NCT00281879|previously treated myelodysplastic syndromes|previously treated myelodysplastic syndromes
792983|NCT00281879|secondary myelodysplastic syndromes|secondary myelodysplastic syndromes
792984|NCT00281879|secondary acute myeloid leukemia|secondary acute myeloid leukemia
792985|NCT00281879|refractory anemia with excess blasts in transformation|refractory anemia with excess blasts in transformation
792986|NCT00281879|refractory anemia with excess blasts|refractory anemia with excess blasts
792987|NCT00281879|refractory anemia|refractory anemia
792988|NCT00281879|chronic myelomonocytic leukemia|chronic myelomonocytic leukemia
792989|NCT00281879|childhood chronic myelogenous leukemia|childhood chronic myelogenous leukemia
792990|NCT00281879|chronic eosinophilic leukemia|chronic eosinophilic leukemia
792991|NCT00281879|primary myelofibrosis|primary myelofibrosis
792992|NCT00281879|chronic neutrophilic leukemia|chronic neutrophilic leukemia
792993|NCT00281879|de novo myelodysplastic syndromes|de novo myelodysplastic syndromes
792994|NCT00281879|atypical chronic myeloid leukemia, BCR-ABL negative|atypical chronic myeloid leukemia, bcr-abl negative
792995|NCT00281879|extranodal marginal zone B-cell lymphoma of mucosa-associated lymphoid tissue|extranodal marginal zone b-cell lymphoma of mucosa-associated lymphoid tissue
792996|NCT00281879|juvenile myelomonocytic leukemia|juvenile myelomonocytic leukemia
792997|NCT00281879|nodal marginal zone B-cell lymphoma|nodal marginal zone b-cell lymphoma
792998|NCT00281879|noncontiguous stage II adult Burkitt lymphoma|noncontiguous stage ii adult burkitt lymphoma
792999|NCT00281879|noncontiguous stage II adult diffuse large cell lymphoma|noncontiguous stage ii adult diffuse large cell lymphoma
793000|NCT00281879|noncontiguous stage II adult diffuse mixed cell lymphoma|noncontiguous stage ii adult diffuse mixed cell lymphoma
793001|NCT00281879|noncontiguous stage II adult diffuse small cleaved cell lymphoma|noncontiguous stage ii adult diffuse small cleaved cell lymphoma
793002|NCT00281879|noncontiguous stage II adult immunoblastic large cell lymphoma|noncontiguous stage ii adult immunoblastic large cell lymphoma
793003|NCT00281879|noncontiguous stage II adult lymphoblastic lymphoma|noncontiguous stage ii adult lymphoblastic lymphoma
793004|NCT00281879|noncontiguous stage II grade 1 follicular lymphoma|noncontiguous stage ii grade 1 follicular lymphoma
793005|NCT00281879|noncontiguous stage II grade 2 follicular lymphoma|noncontiguous stage ii grade 2 follicular lymphoma
793006|NCT00281879|noncontiguous stage II grade 3 follicular lymphoma|noncontiguous stage ii grade 3 follicular lymphoma
793007|NCT00281879|noncontiguous stage II mantle cell lymphoma|noncontiguous stage ii mantle cell lymphoma
793008|NCT00281879|noncontiguous stage II marginal zone lymphoma|noncontiguous stage ii marginal zone lymphoma
793009|NCT00281879|noncontiguous stage II small lymphocytic lymphoma|noncontiguous stage ii small lymphocytic lymphoma
793010|NCT00281879|recurrent adult Burkitt lymphoma|recurrent adult burkitt lymphoma
793011|NCT00281879|recurrent adult diffuse large cell lymphoma|recurrent adult diffuse large cell lymphoma
793012|NCT00281879|recurrent adult diffuse mixed cell lymphoma|recurrent adult diffuse mixed cell lymphoma
793013|NCT00281879|recurrent adult diffuse small cleaved cell lymphoma|recurrent adult diffuse small cleaved cell lymphoma
793014|NCT00281879|recurrent adult immunoblastic large cell lymphoma|recurrent adult immunoblastic large cell lymphoma
793015|NCT00281879|recurrent adult lymphoblastic lymphoma|recurrent adult lymphoblastic lymphoma
793016|NCT00281879|recurrent childhood large cell lymphoma|recurrent childhood large cell lymphoma
793017|NCT00281879|recurrent childhood lymphoblastic lymphoma|recurrent childhood lymphoblastic lymphoma
793018|NCT00281879|recurrent childhood small noncleaved cell lymphoma|recurrent childhood small noncleaved cell lymphoma
793019|NCT00281879|recurrent grade 1 follicular lymphoma|recurrent grade 1 follicular lymphoma
793020|NCT00281879|recurrent grade 2 follicular lymphoma|recurrent grade 2 follicular lymphoma
793021|NCT00281879|recurrent grade 3 follicular lymphoma|recurrent grade 3 follicular lymphoma
793022|NCT00281879|recurrent mantle cell lymphoma|recurrent mantle cell lymphoma
793023|NCT00281879|recurrent marginal zone lymphoma|recurrent marginal zone lymphoma
793024|NCT00281879|recurrent small lymphocytic lymphoma|recurrent small lymphocytic lymphoma
793025|NCT00281879|refractory chronic lymphocytic leukemia|refractory chronic lymphocytic leukemia
793026|NCT00281879|refractory hairy cell leukemia|refractory hairy cell leukemia
793027|NCT00281879|refractory multiple myeloma|refractory multiple myeloma
793028|NCT00281879|splenic marginal zone lymphoma|splenic marginal zone lymphoma
793029|NCT00281879|stage I multiple myeloma|stage i multiple myeloma
793030|NCT00281879|stage II multiple myeloma|stage ii multiple myeloma
793031|NCT00281879|stage III adult Burkitt lymphoma|stage iii adult burkitt lymphoma
793032|NCT00281879|stage III adult Hodgkin lymphoma|stage iii adult hodgkin lymphoma
793033|NCT00281879|stage III adult diffuse large cell lymphoma|stage iii adult diffuse large cell lymphoma
793034|NCT00281879|stage III adult diffuse mixed cell lymphoma|stage iii adult diffuse mixed cell lymphoma
793035|NCT00281879|stage III adult diffuse small cleaved cell lymphoma|stage iii adult diffuse small cleaved cell lymphoma
793036|NCT00281879|stage III adult immunoblastic large cell lymphoma|stage iii adult immunoblastic large cell lymphoma
793037|NCT00281879|stage III adult lymphoblastic lymphoma|stage iii adult lymphoblastic lymphoma
793038|NCT00281879|stage III chronic lymphocytic leukemia|stage iii chronic lymphocytic leukemia
793039|NCT00281879|stage III grade 1 follicular lymphoma|stage iii grade 1 follicular lymphoma
793040|NCT00281879|stage III grade 2 follicular lymphoma|stage iii grade 2 follicular lymphoma
793041|NCT00281879|stage III grade 3 follicular lymphoma|stage iii grade 3 follicular lymphoma
793042|NCT00281879|stage III mantle cell lymphoma|stage iii mantle cell lymphoma
793043|NCT00281879|stage III marginal zone lymphoma|stage iii marginal zone lymphoma
793044|NCT00281879|stage III multiple myeloma|stage iii multiple myeloma
793045|NCT00281879|stage III small lymphocytic lymphoma|stage iii small lymphocytic lymphoma
793046|NCT00281879|stage IV adult Burkitt lymphoma|stage iv adult burkitt lymphoma
793047|NCT00281879|stage IV adult diffuse large cell lymphoma|stage iv adult diffuse large cell lymphoma
793048|NCT00281879|stage IV adult diffuse mixed cell lymphoma|stage iv adult diffuse mixed cell lymphoma
793049|NCT00281879|stage IV adult diffuse small cleaved cell lymphoma|stage iv adult diffuse small cleaved cell lymphoma
793050|NCT00281879|stage IV adult immunoblastic large cell lymphoma|stage iv adult immunoblastic large cell lymphoma
793051|NCT00281879|stage IV adult lymphoblastic lymphoma|stage iv adult lymphoblastic lymphoma
793052|NCT00281879|stage IV chronic lymphocytic leukemia|stage iv chronic lymphocytic leukemia
793053|NCT00281879|stage IV grade 1 follicular lymphoma|stage iv grade 1 follicular lymphoma
793054|NCT00281879|stage IV grade 2 follicular lymphoma|stage iv grade 2 follicular lymphoma
793055|NCT00281879|stage IV grade 3 follicular lymphoma|stage iv grade 3 follicular lymphoma
793056|NCT00281879|stage IV mantle cell lymphoma|stage iv mantle cell lymphoma
793057|NCT00281879|stage IV marginal zone lymphoma|stage iv marginal zone lymphoma
793058|NCT00281879|stage IV small lymphocytic lymphoma|stage iv small lymphocytic lymphoma
793059|NCT00281879|stage III childhood Hodgkin lymphoma|stage iii childhood hodgkin lymphoma
793060|NCT00281879|stage III childhood large cell lymphoma|stage iii childhood large cell lymphoma
793061|NCT00281879|stage III childhood lymphoblastic lymphoma|stage iii childhood lymphoblastic lymphoma
793062|NCT00281879|stage III childhood small noncleaved cell lymphoma|stage iii childhood small noncleaved cell lymphoma
793063|NCT00281879|stage IV childhood large cell lymphoma|stage iv childhood large cell lymphoma
793064|NCT00281879|stage IV childhood lymphoblastic lymphoma|stage iv childhood lymphoblastic lymphoma
793065|NCT00281879|stage IV childhood small noncleaved cell lymphoma|stage iv childhood small noncleaved cell lymphoma
793066|NCT00281879|unusual cancers of childhood|unusual cancers of childhood
793067|NCT00281879|childhood myelodysplastic syndromes|childhood myelodysplastic syndromes
793068|NCT00281866|stage IV squamous cell carcinoma of the hypopharynx|stage iv squamous cell carcinoma of the hypopharynx
793069|NCT00281866|stage IV squamous cell carcinoma of the larynx|stage iv squamous cell carcinoma of the larynx
793070|NCT00281866|stage IV squamous cell carcinoma of the lip and oral cavity|stage iv squamous cell carcinoma of the lip and oral cavity
793071|NCT00281866|stage IV squamous cell carcinoma of the nasopharynx|stage iv squamous cell carcinoma of the nasopharynx
793072|NCT00281866|stage IV squamous cell carcinoma of the oropharynx|stage iv squamous cell carcinoma of the oropharynx
793836|NCT00279149|TELESTROKE|telestroke
793073|NCT00281866|stage IV squamous cell carcinoma of the paranasal sinus and nasal cavity|stage iv squamous cell carcinoma of the paranasal sinus and nasal cavity
793074|NCT00281866|recurrent squamous cell carcinoma of the hypopharynx|recurrent squamous cell carcinoma of the hypopharynx
793075|NCT00281866|recurrent squamous cell carcinoma of the larynx|recurrent squamous cell carcinoma of the larynx
793076|NCT00281866|recurrent squamous cell carcinoma of the lip and oral cavity|recurrent squamous cell carcinoma of the lip and oral cavity
793077|NCT00281866|recurrent squamous cell carcinoma of the nasopharynx|recurrent squamous cell carcinoma of the nasopharynx
793078|NCT00281866|recurrent squamous cell carcinoma of the oropharynx|recurrent squamous cell carcinoma of the oropharynx
793079|NCT00281866|recurrent squamous cell carcinoma of the paranasal sinus and nasal cavity|recurrent squamous cell carcinoma of the paranasal sinus and nasal cavity
793080|NCT00281866|recurrent metastatic squamous neck cancer with occult primary|recurrent metastatic squamous neck cancer with occult primary
793081|NCT00281866|metastatic squamous neck cancer with occult primary squamous cell carcinoma|metastatic squamous neck cancer with occult primary squamous cell carcinoma
793082|NCT00281853|neurotoxicity|neurotoxicity
793083|NCT00281853|unspecified adult solid tumor, protocol specific|unspecified adult solid tumor, protocol specific
793084|NCT00281840|stage III squamous cell carcinoma of the hypopharynx|stage iii squamous cell carcinoma of the hypopharynx
793085|NCT00281840|stage IV squamous cell carcinoma of the hypopharynx|stage iv squamous cell carcinoma of the hypopharynx
793086|NCT00281840|stage III squamous cell carcinoma of the larynx|stage iii squamous cell carcinoma of the larynx
793087|NCT00281840|stage IV squamous cell carcinoma of the larynx|stage iv squamous cell carcinoma of the larynx
793088|NCT00281840|stage III squamous cell carcinoma of the lip and oral cavity|stage iii squamous cell carcinoma of the lip and oral cavity
793089|NCT00281840|stage IV squamous cell carcinoma of the lip and oral cavity|stage iv squamous cell carcinoma of the lip and oral cavity
793090|NCT00281840|stage III squamous cell carcinoma of the nasopharynx|stage iii squamous cell carcinoma of the nasopharynx
793091|NCT00281840|stage IV squamous cell carcinoma of the nasopharynx|stage iv squamous cell carcinoma of the nasopharynx
793092|NCT00281840|stage III squamous cell carcinoma of the oropharynx|stage iii squamous cell carcinoma of the oropharynx
793093|NCT00281840|stage IV squamous cell carcinoma of the oropharynx|stage iv squamous cell carcinoma of the oropharynx
793287|NCT00281697|Avastin|avastin
793094|NCT00281827|adenocarcinoma of the lung|adenocarcinoma of the lung
793095|NCT00281827|squamous cell lung cancer|squamous cell lung cancer
793096|NCT00281827|large cell lung cancer|large cell lung cancer
793097|NCT00281827|stage II non-small cell lung cancer|stage ii non-small cell lung cancer
793098|NCT00281827|stage IIIA non-small cell lung cancer|stage iiia non-small cell lung cancer
793099|NCT00281814|psychosocial effects of cancer and its treatment|psychosocial effects of cancer and its treatment
793100|NCT00281814|adult acute myeloid leukemia with 11q23 (MLL) abnormalities|adult acute myeloid leukemia with 11q23 (mll) abnormalities
793101|NCT00281814|adult acute myeloid leukemia with inv(16)(p13;q22)|adult acute myeloid leukemia with inv(16)(p13;q22)
793102|NCT00281814|adult acute myeloid leukemia with t(15;17)(q22;q12)|adult acute myeloid leukemia with t(15;17)(q22;q12)
793103|NCT00281814|adult acute myeloid leukemia with t(16;16)(p13;q22)|adult acute myeloid leukemia with t(16;16)(p13;q22)
793104|NCT00281814|adult acute myeloid leukemia with t(8;21)(q22;q22)|adult acute myeloid leukemia with t(8;21)(q22;q22)
793105|NCT00281814|accelerated phase chronic myelogenous leukemia|accelerated phase chronic myelogenous leukemia
793106|NCT00281814|adult acute lymphoblastic leukemia in remission|adult acute lymphoblastic leukemia in remission
793107|NCT00281814|adult acute myeloid leukemia in remission|adult acute myeloid leukemia in remission
793108|NCT00281814|atypical chronic myeloid leukemia|atypical chronic myeloid leukemia
793109|NCT00281814|blastic phase chronic myelogenous leukemia|blastic phase chronic myelogenous leukemia
793110|NCT00281814|chronic idiopathic myelofibrosis|chronic idiopathic myelofibrosis
793111|NCT00281814|chronic myelomonocytic leukemia|chronic myelomonocytic leukemia
793112|NCT00281814|chronic phase chronic myelogenous leukemia|chronic phase chronic myelogenous leukemia
793113|NCT00281814|de novo myelodysplastic syndromes|de novo myelodysplastic syndromes
793114|NCT00281814|extranodal marginal zone B-cell lymphoma of mucosa-associated lymphoid tissue|extranodal marginal zone b-cell lymphoma of mucosa-associated lymphoid tissue
793115|NCT00281814|myelodysplastic/myeloproliferative disease, unclassifiable|myelodysplastic/myeloproliferative disease, unclassifiable
793116|NCT00281814|nodal marginal zone B-cell lymphoma|nodal marginal zone b-cell lymphoma
793117|NCT00281814|noncontiguous stage II adult Burkitt lymphoma|noncontiguous stage ii adult burkitt lymphoma
793118|NCT00281814|noncontiguous stage II adult diffuse large cell lymphoma|noncontiguous stage ii adult diffuse large cell lymphoma
793119|NCT00281814|noncontiguous stage II adult diffuse mixed cell lymphoma|noncontiguous stage ii adult diffuse mixed cell lymphoma
793120|NCT00281814|noncontiguous stage II adult diffuse small cleaved cell lymphoma|noncontiguous stage ii adult diffuse small cleaved cell lymphoma
793121|NCT00281814|noncontiguous stage II adult immunoblastic large cell lymphoma|noncontiguous stage ii adult immunoblastic large cell lymphoma
793122|NCT00281814|noncontiguous stage II adult lymphoblastic lymphoma|noncontiguous stage ii adult lymphoblastic lymphoma
793123|NCT00281814|noncontiguous stage II grade 1 follicular lymphoma|noncontiguous stage ii grade 1 follicular lymphoma
793124|NCT00281814|noncontiguous stage II grade 2 follicular lymphoma|noncontiguous stage ii grade 2 follicular lymphoma
793125|NCT00281814|noncontiguous stage II grade 3 follicular lymphoma|noncontiguous stage ii grade 3 follicular lymphoma
793126|NCT00281814|noncontiguous stage II mantle cell lymphoma|noncontiguous stage ii mantle cell lymphoma
793127|NCT00281814|noncontiguous stage II marginal zone lymphoma|noncontiguous stage ii marginal zone lymphoma
793128|NCT00281814|noncontiguous stage II small lymphocytic lymphoma|noncontiguous stage ii small lymphocytic lymphoma
793129|NCT00281814|previously treated myelodysplastic syndromes|previously treated myelodysplastic syndromes
793130|NCT00281814|recurrent adult acute lymphoblastic leukemia|recurrent adult acute lymphoblastic leukemia
793131|NCT00281814|recurrent adult acute myeloid leukemia|recurrent adult acute myeloid leukemia
793132|NCT00281814|recurrent adult Burkitt lymphoma|recurrent adult burkitt lymphoma
793133|NCT00281814|recurrent adult Hodgkin lymphoma|recurrent adult hodgkin lymphoma
793134|NCT00281814|recurrent adult diffuse large cell lymphoma|recurrent adult diffuse large cell lymphoma
793135|NCT00281814|recurrent adult diffuse mixed cell lymphoma|recurrent adult diffuse mixed cell lymphoma
793136|NCT00281814|recurrent adult diffuse small cleaved cell lymphoma|recurrent adult diffuse small cleaved cell lymphoma
793137|NCT00281814|recurrent adult immunoblastic large cell lymphoma|recurrent adult immunoblastic large cell lymphoma
793138|NCT00281814|recurrent adult lymphoblastic lymphoma|recurrent adult lymphoblastic lymphoma
793139|NCT00281814|recurrent cutaneous T-cell non-Hodgkin lymphoma|recurrent cutaneous t-cell non-hodgkin lymphoma
793140|NCT00281814|recurrent grade 1 follicular lymphoma|recurrent grade 1 follicular lymphoma
793141|NCT00281814|recurrent grade 2 follicular lymphoma|recurrent grade 2 follicular lymphoma
793142|NCT00281814|recurrent grade 3 follicular lymphoma|recurrent grade 3 follicular lymphoma
793143|NCT00281814|recurrent mantle cell lymphoma|recurrent mantle cell lymphoma
793144|NCT00281814|recurrent marginal zone lymphoma|recurrent marginal zone lymphoma
793145|NCT00281814|recurrent small lymphocytic lymphoma|recurrent small lymphocytic lymphoma
793146|NCT00281814|refractory chronic lymphocytic leukemia|refractory chronic lymphocytic leukemia
793147|NCT00281814|refractory hairy cell leukemia|refractory hairy cell leukemia
793148|NCT00281814|relapsing chronic myelogenous leukemia|relapsing chronic myelogenous leukemia
793149|NCT00281814|secondary acute myeloid leukemia|secondary acute myeloid leukemia
793150|NCT00281814|secondary myelodysplastic syndromes|secondary myelodysplastic syndromes
793151|NCT00281814|splenic marginal zone lymphoma|splenic marginal zone lymphoma
793152|NCT00281814|stage I multiple myeloma|stage i multiple myeloma
793153|NCT00281814|stage II multiple myeloma|stage ii multiple myeloma
793154|NCT00281814|stage III adult Burkitt lymphoma|stage iii adult burkitt lymphoma
793288|NCT00281697|MBC|mbc
793155|NCT00281814|stage III adult Hodgkin lymphoma|stage iii adult hodgkin lymphoma
793156|NCT00281814|stage III adult diffuse large cell lymphoma|stage iii adult diffuse large cell lymphoma
793157|NCT00281814|stage III adult diffuse mixed cell lymphoma|stage iii adult diffuse mixed cell lymphoma
793158|NCT00281814|stage III adult diffuse small cleaved cell lymphoma|stage iii adult diffuse small cleaved cell lymphoma
793159|NCT00281814|stage III adult immunoblastic large cell lymphoma|stage iii adult immunoblastic large cell lymphoma
793160|NCT00281814|stage III adult lymphoblastic lymphoma|stage iii adult lymphoblastic lymphoma
793161|NCT00281814|stage III chronic lymphocytic leukemia|stage iii chronic lymphocytic leukemia
793162|NCT00281814|stage III grade 1 follicular lymphoma|stage iii grade 1 follicular lymphoma
793163|NCT00281814|stage III grade 2 follicular lymphoma|stage iii grade 2 follicular lymphoma
793164|NCT00281814|stage III grade 3 follicular lymphoma|stage iii grade 3 follicular lymphoma
793165|NCT00281814|stage III mantle cell lymphoma|stage iii mantle cell lymphoma
793166|NCT00281814|stage III marginal zone lymphoma|stage iii marginal zone lymphoma
793167|NCT00281814|stage III multiple myeloma|stage iii multiple myeloma
793168|NCT00281814|stage III small lymphocytic lymphoma|stage iii small lymphocytic lymphoma
793169|NCT00281814|stage IV adult Burkitt lymphoma|stage iv adult burkitt lymphoma
793170|NCT00281814|stage IV adult Hodgkin lymphoma|stage iv adult hodgkin lymphoma
793171|NCT00281814|stage IV adult diffuse large cell lymphoma|stage iv adult diffuse large cell lymphoma
793172|NCT00281814|stage IV adult diffuse mixed cell lymphoma|stage iv adult diffuse mixed cell lymphoma
793173|NCT00281814|stage IV adult diffuse small cleaved cell lymphoma|stage iv adult diffuse small cleaved cell lymphoma
793174|NCT00281814|stage IV adult immunoblastic large cell lymphoma|stage iv adult immunoblastic large cell lymphoma
793175|NCT00281814|stage IV adult lymphoblastic lymphoma|stage iv adult lymphoblastic lymphoma
793176|NCT00281814|stage IV chronic lymphocytic leukemia|stage iv chronic lymphocytic leukemia
793177|NCT00281814|stage IV grade 1 follicular lymphoma|stage iv grade 1 follicular lymphoma
793178|NCT00281814|stage IV grade 2 follicular lymphoma|stage iv grade 2 follicular lymphoma
793179|NCT00281814|stage IV grade 3 follicular lymphoma|stage iv grade 3 follicular lymphoma
793180|NCT00281814|stage IV mantle cell lymphoma|stage iv mantle cell lymphoma
793181|NCT00281814|stage IV marginal zone lymphoma|stage iv marginal zone lymphoma
793182|NCT00281814|stage IV small lymphocytic lymphoma|stage iv small lymphocytic lymphoma
793183|NCT00281801|psychosocial effects of cancer and its treatment|psychosocial effects of cancer and its treatment
793184|NCT00281801|adult acute myeloid leukemia with 11q23 (MLL) abnormalities|adult acute myeloid leukemia with 11q23 (mll) abnormalities
793185|NCT00281801|adult acute myeloid leukemia with inv(16)(p13;q22)|adult acute myeloid leukemia with inv(16)(p13;q22)
793186|NCT00281801|adult acute myeloid leukemia with t(15;17)(q22;q12)|adult acute myeloid leukemia with t(15;17)(q22;q12)
793187|NCT00281801|adult acute myeloid leukemia with t(16;16)(p13;q22)|adult acute myeloid leukemia with t(16;16)(p13;q22)
793188|NCT00281801|adult acute myeloid leukemia with t(8;21)(q22;q22)|adult acute myeloid leukemia with t(8;21)(q22;q22)
793189|NCT00281801|accelerated phase chronic myelogenous leukemia|accelerated phase chronic myelogenous leukemia
793190|NCT00281801|adult acute lymphoblastic leukemia in remission|adult acute lymphoblastic leukemia in remission
793191|NCT00281801|adult acute myeloid leukemia in remission|adult acute myeloid leukemia in remission
793192|NCT00281801|atypical chronic myeloid leukemia|atypical chronic myeloid leukemia
794143|NCT00278135|Cognition|cognition
793193|NCT00281801|blastic phase chronic myelogenous leukemia|blastic phase chronic myelogenous leukemia
793194|NCT00281801|chronic idiopathic myelofibrosis|chronic idiopathic myelofibrosis
793195|NCT00281801|chronic myelomonocytic leukemia|chronic myelomonocytic leukemia
793196|NCT00281801|chronic phase chronic myelogenous leukemia|chronic phase chronic myelogenous leukemia
793197|NCT00281801|de novo myelodysplastic syndromes|de novo myelodysplastic syndromes
793198|NCT00281801|extranodal marginal zone B-cell lymphoma of mucosa-associated lymphoid tissue|extranodal marginal zone b-cell lymphoma of mucosa-associated lymphoid tissue
793199|NCT00281801|myelodysplastic/myeloproliferative disease, unclassifiable|myelodysplastic/myeloproliferative disease, unclassifiable
793200|NCT00281801|nodal marginal zone B-cell lymphoma|nodal marginal zone b-cell lymphoma
793201|NCT00281801|noncontiguous stage II adult Burkitt lymphoma|noncontiguous stage ii adult burkitt lymphoma
793202|NCT00281801|noncontiguous stage II adult diffuse large cell lymphoma|noncontiguous stage ii adult diffuse large cell lymphoma
793203|NCT00281801|noncontiguous stage II adult diffuse mixed cell lymphoma|noncontiguous stage ii adult diffuse mixed cell lymphoma
793204|NCT00281801|noncontiguous stage II adult diffuse small cleaved cell lymphoma|noncontiguous stage ii adult diffuse small cleaved cell lymphoma
793205|NCT00281801|noncontiguous stage II adult immunoblastic large cell lymphoma|noncontiguous stage ii adult immunoblastic large cell lymphoma
793206|NCT00281801|noncontiguous stage II adult lymphoblastic lymphoma|noncontiguous stage ii adult lymphoblastic lymphoma
793207|NCT00281801|noncontiguous stage II grade 1 follicular lymphoma|noncontiguous stage ii grade 1 follicular lymphoma
793208|NCT00281801|noncontiguous stage II grade 2 follicular lymphoma|noncontiguous stage ii grade 2 follicular lymphoma
793209|NCT00281801|noncontiguous stage II grade 3 follicular lymphoma|noncontiguous stage ii grade 3 follicular lymphoma
793210|NCT00281801|noncontiguous stage II mantle cell lymphoma|noncontiguous stage ii mantle cell lymphoma
793211|NCT00281801|noncontiguous stage II marginal zone lymphoma|noncontiguous stage ii marginal zone lymphoma
793212|NCT00281801|noncontiguous stage II small lymphocytic lymphoma|noncontiguous stage ii small lymphocytic lymphoma
793213|NCT00281801|previously treated myelodysplastic syndromes|previously treated myelodysplastic syndromes
793285|NCT00281710|Urinary concentrating ability|urinary concentrating ability
793214|NCT00281801|recurrent adult acute lymphoblastic leukemia|recurrent adult acute lymphoblastic leukemia
793215|NCT00281801|recurrent adult acute myeloid leukemia|recurrent adult acute myeloid leukemia
793216|NCT00281801|recurrent adult Burkitt lymphoma|recurrent adult burkitt lymphoma
793217|NCT00281801|recurrent adult Hodgkin lymphoma|recurrent adult hodgkin lymphoma
793218|NCT00281801|recurrent adult diffuse large cell lymphoma|recurrent adult diffuse large cell lymphoma
793219|NCT00281801|recurrent adult diffuse mixed cell lymphoma|recurrent adult diffuse mixed cell lymphoma
793220|NCT00281801|recurrent adult diffuse small cleaved cell lymphoma|recurrent adult diffuse small cleaved cell lymphoma
793221|NCT00281801|recurrent adult immunoblastic large cell lymphoma|recurrent adult immunoblastic large cell lymphoma
793222|NCT00281801|recurrent adult lymphoblastic lymphoma|recurrent adult lymphoblastic lymphoma
793223|NCT00281801|recurrent cutaneous T-cell non-Hodgkin lymphoma|recurrent cutaneous t-cell non-hodgkin lymphoma
793224|NCT00281801|recurrent grade 1 follicular lymphoma|recurrent grade 1 follicular lymphoma
793225|NCT00281801|recurrent grade 2 follicular lymphoma|recurrent grade 2 follicular lymphoma
793226|NCT00281801|recurrent grade 3 follicular lymphoma|recurrent grade 3 follicular lymphoma
793227|NCT00281801|recurrent mantle cell lymphoma|recurrent mantle cell lymphoma
793228|NCT00281801|recurrent marginal zone lymphoma|recurrent marginal zone lymphoma
793229|NCT00281801|recurrent small lymphocytic lymphoma|recurrent small lymphocytic lymphoma
793230|NCT00281801|refractory chronic lymphocytic leukemia|refractory chronic lymphocytic leukemia
793231|NCT00281801|refractory hairy cell leukemia|refractory hairy cell leukemia
793232|NCT00281801|relapsing chronic myelogenous leukemia|relapsing chronic myelogenous leukemia
793233|NCT00281801|secondary acute myeloid leukemia|secondary acute myeloid leukemia
793234|NCT00281801|secondary myelodysplastic syndromes|secondary myelodysplastic syndromes
793235|NCT00281801|splenic marginal zone lymphoma|splenic marginal zone lymphoma
793236|NCT00281801|stage I multiple myeloma|stage i multiple myeloma
793237|NCT00281801|stage II multiple myeloma|stage ii multiple myeloma
793238|NCT00281801|stage III adult Burkitt lymphoma|stage iii adult burkitt lymphoma
793239|NCT00281801|stage III adult Hodgkin lymphoma|stage iii adult hodgkin lymphoma
793240|NCT00281801|stage III adult diffuse large cell lymphoma|stage iii adult diffuse large cell lymphoma
793241|NCT00281801|stage III adult diffuse mixed cell lymphoma|stage iii adult diffuse mixed cell lymphoma
793242|NCT00281801|stage III adult diffuse small cleaved cell lymphoma|stage iii adult diffuse small cleaved cell lymphoma
793243|NCT00281801|stage III adult immunoblastic large cell lymphoma|stage iii adult immunoblastic large cell lymphoma
793244|NCT00281801|stage III adult lymphoblastic lymphoma|stage iii adult lymphoblastic lymphoma
793245|NCT00281801|stage III chronic lymphocytic leukemia|stage iii chronic lymphocytic leukemia
793246|NCT00281801|stage III grade 1 follicular lymphoma|stage iii grade 1 follicular lymphoma
793247|NCT00281801|stage III grade 2 follicular lymphoma|stage iii grade 2 follicular lymphoma
793248|NCT00281801|stage III grade 3 follicular lymphoma|stage iii grade 3 follicular lymphoma
793249|NCT00281801|stage III mantle cell lymphoma|stage iii mantle cell lymphoma
793250|NCT00281801|stage III marginal zone lymphoma|stage iii marginal zone lymphoma
793251|NCT00281801|stage III multiple myeloma|stage iii multiple myeloma
793252|NCT00281801|stage III small lymphocytic lymphoma|stage iii small lymphocytic lymphoma
793253|NCT00281801|stage IV adult Burkitt lymphoma|stage iv adult burkitt lymphoma
793254|NCT00281801|stage IV adult Hodgkin lymphoma|stage iv adult hodgkin lymphoma
794144|NCT00278135|Memory|memory
793255|NCT00281801|stage IV adult diffuse large cell lymphoma|stage iv adult diffuse large cell lymphoma
793256|NCT00281801|stage IV adult diffuse mixed cell lymphoma|stage iv adult diffuse mixed cell lymphoma
793257|NCT00281801|stage IV adult diffuse small cleaved cell lymphoma|stage iv adult diffuse small cleaved cell lymphoma
793258|NCT00281801|stage IV adult immunoblastic large cell lymphoma|stage iv adult immunoblastic large cell lymphoma
793259|NCT00281801|stage IV adult lymphoblastic lymphoma|stage iv adult lymphoblastic lymphoma
793260|NCT00281801|stage IV chronic lymphocytic leukemia|stage iv chronic lymphocytic leukemia
793261|NCT00281801|stage IV grade 1 follicular lymphoma|stage iv grade 1 follicular lymphoma
793262|NCT00281801|stage IV grade 2 follicular lymphoma|stage iv grade 2 follicular lymphoma
793263|NCT00281801|stage IV grade 3 follicular lymphoma|stage iv grade 3 follicular lymphoma
793264|NCT00281801|stage IV mantle cell lymphoma|stage iv mantle cell lymphoma
793265|NCT00281801|stage IV marginal zone lymphoma|stage iv marginal zone lymphoma
793266|NCT00281801|stage IV small lymphocytic lymphoma|stage iv small lymphocytic lymphoma
793267|NCT00281788|stage I esophageal cancer|stage i esophageal cancer
793268|NCT00281788|stage II esophageal cancer|stage ii esophageal cancer
793269|NCT00281788|stage III esophageal cancer|stage iii esophageal cancer
793270|NCT00281762|AQP-2|aqp-2
793271|NCT00281762|NSAID|nsaid
793272|NCT00281762|Urinary concentrating ability|urinary concentrating ability
793273|NCT00281749|ALZHEIMER'S D-SE|alzheimer's d-se
793274|NCT00281749|PARKINSON'S D-SE|parkinson's d-se
793275|NCT00281749|FRAILTY|frailty
793276|NCT00281736|adenocarcinoma of the esophagus|adenocarcinoma of the esophagus
793277|NCT00281736|recurrent esophageal cancer|recurrent esophageal cancer
793278|NCT00281736|stage 0 esophageal cancer|stage 0 esophageal cancer
793279|NCT00281736|stage I esophageal cancer|stage i esophageal cancer
793280|NCT00281736|precancerous condition|precancerous condition
793281|NCT00281723|Aphthous|aphthous
793282|NCT00281723|oral|oral
793283|NCT00281710|AQP-2|aqp-2
793284|NCT00281710|Methylprednisolone|methylprednisolone
793289|NCT00281697|Breast cancer|breast cancer
793290|NCT00281684|Acute Pain|acute pain
793291|NCT00281684|Dental Pain|dental pain
793292|NCT00281684|Vanilloid|vanilloid
793293|NCT00281684|VR1|vr1
793294|NCT00281684|TRPV1|trpv1
793295|NCT00281684|Inflammation|inflammation
793296|NCT00281671|Nesiritide|nesiritide
793297|NCT00281671|Natriuretic Peptide, Brain|natriuretic peptide, brain
793298|NCT00281671|Heart Defects, Congenital|heart defects, congenital
793299|NCT00281671|Cardiopulmonary Bypass|cardiopulmonary bypass
793300|NCT00281671|Diuretics|diuretics
793301|NCT00281658|ErbB2 positive|erbb2 positive
793302|NCT00281658|Her2+|her2+
793303|NCT00281658|metastatic breast cancer|metastatic breast cancer
793304|NCT00281658|FISH positive|fish positive
793305|NCT00281658|Stage IV|stage iv
793306|NCT00281632|Pazopanib|pazopanib
793307|NCT00281632|Fallopian tube cancer|fallopian tube cancer
793308|NCT00281632|Ovarian epithelial cancer|ovarian epithelial cancer
793309|NCT00281632|Peritoneal cancer|peritoneal cancer
793310|NCT00281619|Pediatric Kidney Transplant|pediatric kidney transplant
793311|NCT00281619|Kidney Transplant|kidney transplant
793312|NCT00281619|CellCept|cellcept
793313|NCT00281619|Mycophenolate mofetil|mycophenolate mofetil
793314|NCT00281619|Mycophenolic Acid|mycophenolic acid
793315|NCT00281619|MPA|mpa
793316|NCT00281606|Lopinavir|lopinavir
793317|NCT00281606|antiretroviral therapy|antiretroviral therapy
793318|NCT00281606|cross-over|cross-over
793319|NCT00281606|tolerability|tolerability
793320|NCT00281554|Investigational Therapies|investigational therapies
793321|NCT00281554|Atrial Fibrillation|atrial fibrillation
793322|NCT00281554|Treatment Efficacy|treatment efficacy
793323|NCT00281554|Treatment Effectiveness|treatment effectiveness
793324|NCT00281554|Safety|safety
793325|NCT00281554|RSD1235|rsd1235
793326|NCT00281541|Treatment Efficacy|treatment efficacy
793327|NCT00281541|Treatment Effectiveness|treatment effectiveness
793328|NCT00281541|Disease Management|disease management
793329|NCT00281541|Treatment|treatment
793330|NCT00281541|Safety|safety
793331|NCT00281541|Malignant Melanoma|malignant melanoma
793332|NCT00281528|First Line Metastatic Breast Cancer|first line metastatic breast cancer
793333|NCT00281502|Hepatic Encephalopathy|hepatic encephalopathy
793334|NCT00281502|Hepatitis C|hepatitis c
793335|NCT00281502|Liver Cirrhosis|liver cirrhosis
793336|NCT00281502|Bacterial Overgrowth|bacterial overgrowth
793337|NCT00281489|Recall|recall
793338|NCT00281489|Awareness|awareness
793339|NCT00281489|BIS|bis
793340|NCT00281489|Anesthesia|anesthesia
793341|NCT00281489|Explicit Recall|explicit recall
793342|NCT00281476|multiple myeloma|multiple myeloma
793343|NCT00281476|statins|statins
793344|NCT00281476|bone|bone
793345|NCT00281463|wheelchair|wheelchair
793346|NCT00281463|spinal cord injury|spinal cord injury
793347|NCT00281463|rehabilitation|rehabilitation
793348|NCT00281437|exercise|exercise
793349|NCT00281437|adherence|adherence
793350|NCT00281437|lifestyle|lifestyle
793351|NCT00281437|choice|choice
793353|NCT00281424|exercise adherence|exercise adherence
793354|NCT00281424|cardiac patients|cardiac patients
793355|NCT00281424|walking|walking
793356|NCT00281411|Blood Vessel Prosthesis Implantation|blood vessel prosthesis implantation
793357|NCT00281411|Endovascular aneurysm repair|endovascular aneurysm repair
793358|NCT00281411|Magnetic Resonance Angiography|magnetic resonance angiography
793359|NCT00281411|Computed Tomography Angiography|computed tomography angiography
793360|NCT00281411|Endoleak|endoleak
793361|NCT00281398|homelessness|homelessness
793362|NCT00281398|Attitudes of medical trainees towards the homeless|attitudes of medical trainees towards the homeless
793363|NCT00281385|adherence|adherence
793364|NCT00281385|lifestyle|lifestyle
793365|NCT00281385|exercise|exercise
793366|NCT00281385|pedometer|pedometer
793367|NCT00281385|training|training
793368|NCT00281372|sexual dysfunction|sexual dysfunction
793369|NCT00281372|male|male
793370|NCT00281372|female|female
793371|NCT00281372|dental care|dental care
793372|NCT00281372|need of control|need of control
793373|NCT00281359|cerebral palsy|cerebral palsy
793374|NCT00281359|dynamic splinting|dynamic splinting
793375|NCT00281359|contractures|contractures
793376|NCT00281359|heat therapy|heat therapy
793377|NCT00281346|Doppler echocardiography|doppler echocardiography
793378|NCT00281346|coronary stenosis|coronary stenosis
793379|NCT00281346|Coronary angiography|coronary angiography
793380|NCT00281307|Rhinitis|rhinitis
793381|NCT00281307|Vitamin E|vitamin e
793382|NCT00281307|Intranasal|intranasal
793383|NCT00281294|Arthritis, Rheumatoid|arthritis, rheumatoid
793384|NCT00281281|Extracorporeal Membrane Oxygenation|extracorporeal membrane oxygenation
793385|NCT00281281|vancomycin|vancomycin
793386|NCT00281242|Chronic Obstructive Pulmonary Disease|chronic obstructive pulmonary disease
793387|NCT00281242|COPD|copd
793388|NCT00281229|Chronic Obstructive Pulmonary Disease|chronic obstructive pulmonary disease
793389|NCT00281229|COPD|copd
793390|NCT00281216|Chronic Obstructive Pulmonary Disease|chronic obstructive pulmonary disease
793391|NCT00281216|COPD|copd
793593|NCT00280241|Lymphocytic|lymphocytic
793392|NCT00281203|Chronic Obstructive Pulmonary Disease|chronic obstructive pulmonary disease
793393|NCT00281203|COPD|copd
793394|NCT00281190|Chronic Obstructive Pulmonary Disease|chronic obstructive pulmonary disease
793395|NCT00281190|COPD|copd
793396|NCT00281125|Non-Small Cell Lung Cancer|non-small cell lung cancer
793397|NCT00281125|Pleural Mesothelioma|pleural mesothelioma
793398|NCT00281099|ICD|icd
793399|NCT00281099|Pacing|pacing
793400|NCT00281099|Heart Failure|heart failure
793401|NCT00281073|Intra-Cardiac Echocardiography|intra-cardiac echocardiography
793402|NCT00281073|Cardioversion|cardioversion
793403|NCT00281060|endovascular|endovascular
793404|NCT00281060|balloon angioplasty|balloon angioplasty
793405|NCT00281060|stents|stents
793406|NCT00281047|Helicobacter pylori (H. pylori)|helicobacter pylori (h. pylori)
793407|NCT00281047|FP-10|fp-10
793408|NCT00281047|amoxicillin|amoxicillin
793409|NCT00281047|clarithromycin|clarithromycin
793410|NCT00281047|lansoprazole|lansoprazole
793411|NCT00281034|brain infarction|brain infarction
793412|NCT00281034|SF-36|sf-36
793413|NCT00281034|HRQOL|hrqol
793414|NCT00281034|Japan|japan
793415|NCT00281034|Post-stroke syndrome|post-stroke syndrome
793416|NCT00281021|non-small cell lung cancer|non-small cell lung cancer
793417|NCT00281021|Erlotinib|erlotinib
793418|NCT00281021|Digoxin|digoxin
793419|NCT00281008|LDL-cholesterol|ldl-cholesterol
793420|NCT00281008|apoB-100|apob-100
793421|NCT00281008|Heterozygous Familial Hypercholesterolemia|heterozygous familial hypercholesterolemia
793422|NCT00280995|LDL-cholesterol|ldl-cholesterol
793423|NCT00280995|apoB-100|apob-100
793424|NCT00280995|Homozygous Familial Hypercholesterolemia|homozygous familial hypercholesterolemia
793425|NCT00280982|dendritic cells, immunotherapy, vaccination, mesothelioma|dendritic cells, immunotherapy, vaccination, mesothelioma
793426|NCT00280969|HIV infection|hiv infection
793427|NCT00280969|treatment|treatment
793428|NCT00280969|efavirenz|efavirenz
793429|NCT00280969|atazanavir|atazanavir
793430|NCT00280969|ritonavir|ritonavir
793431|NCT00280943|All NC LTC facilities having ten residents with a hip fracture or osteoporosis on the MDS will be invited to participate in the trial|all nc ltc facilities having ten residents with a hip fracture or osteoporosis on the mds will be invited to participate in the trial
793432|NCT00280930|letrozole|letrozole
793433|NCT00280930|breast cancer|breast cancer
793434|NCT00280930|menopause|menopause
793435|NCT00280917|Rheumatoid Arthritis|rheumatoid arthritis
793436|NCT00280917|RA|ra
793437|NCT00280904|Hydrocephalus|hydrocephalus
793438|NCT00280904|Shunt|shunt
793439|NCT00280891|head and neck|head and neck
793440|NCT00280891|cancer|cancer
793441|NCT00280891|palliation|palliation
793442|NCT00280891|radiotherapy|radiotherapy
793443|NCT00280878|Lymphoma|lymphoma
793444|NCT00280878|CD20+|cd20+
793445|NCT00280865|Tesaglitazar|tesaglitazar
793446|NCT00280865|type 2 diabetes|type 2 diabetes
793447|NCT00280852|anaplastic thyroid cancer|anaplastic thyroid cancer
793448|NCT00280852|chemotherapy|chemotherapy
793449|NCT00280852|radiotherapy|radiotherapy
793450|NCT00280826|OCT|oct
793451|NCT00280826|Retinal Disease|retinal disease
793452|NCT00280826|Adhesion Molecule|adhesion molecule
793453|NCT00280826|Ocular Inflammation|ocular inflammation
793454|NCT00280826|Raptiva|raptiva
793455|NCT00280826|Macular Edema|macular edema
793456|NCT00280826|Uveitis|uveitis
793457|NCT00280826|Immunosuppression|immunosuppression
793458|NCT00280813|treatment|treatment
793459|NCT00280813|dual diagnosis|dual diagnosis
793460|NCT00280800|randomized|randomized
793461|NCT00280800|controlled|controlled
793462|NCT00280800|double blind|double blind
793463|NCT00280800|effectiveness|effectiveness
793464|NCT00280800|auto CPAP|auto cpap
793465|NCT00280800|treatment|treatment
793466|NCT00280800|sleep apnea|sleep apnea
793467|NCT00280787|unresectable|unresectable
793468|NCT00280787|induction|induction
793469|NCT00280787|radiotherapy|radiotherapy
793470|NCT00280787|ZD1839|zd1839
793471|NCT00280774|corticosteroid|corticosteroid
793472|NCT00280774|prednisone|prednisone
793473|NCT00280774|memantine|memantine
793474|NCT00280774|Patients who are taking a corticosteroid for a|patients who are taking a corticosteroid for a
793475|NCT00280774|pulmonary illness|pulmonary illness
793476|NCT00280774|rheumatic illness|rheumatic illness
793477|NCT00280774|kidney transplant|kidney transplant
793478|NCT00280761|adenocarcinoma of the rectum|adenocarcinoma of the rectum
793479|NCT00280761|recurrent rectal cancer|recurrent rectal cancer
793480|NCT00280761|stage II rectal cancer|stage ii rectal cancer
793481|NCT00280761|stage III rectal cancer|stage iii rectal cancer
793482|NCT00280761|stage IV rectal cancer|stage iv rectal cancer
793483|NCT00280748|recurrent non-small cell lung cancer|recurrent non-small cell lung cancer
793484|NCT00280748|stage IV non-small cell lung cancer|stage iv non-small cell lung cancer
793485|NCT00280748|tumors metastatic to brain|tumors metastatic to brain
793486|NCT00280735|stage I non-small cell lung cancer|stage i non-small cell lung cancer
793487|NCT00280735|stage II non-small cell lung cancer|stage ii non-small cell lung cancer
793488|NCT00280735|stage IIIA non-small cell lung cancer|stage iiia non-small cell lung cancer
793489|NCT00280722|Randomised|randomised
793490|NCT00280722|Intervention|intervention
793491|NCT00280722|Leaflet|leaflet
793492|NCT00280722|Information|information
793493|NCT00280722|Awareness|awareness
793494|NCT00280722|Behaviour|behaviour
793495|NCT00280722|Research|research
793496|NCT00280709|Bile duct|bile duct
793497|NCT00280709|Bile duct obstruction|bile duct obstruction
793498|NCT00280709|Biliary stent|biliary stent
793499|NCT00280709|Metal stent|metal stent
793500|NCT00280709|ERCP|ercp
793501|NCT00280709|Patency|patency
793502|NCT00280709|Complication|complication
793503|NCT00280709|Stent occlusion|stent occlusion
793504|NCT00280696|Epilepsies, Partial,|epilepsies, partial,
793505|NCT00280696|Keppra, levetiracetam|keppra, levetiracetam
793506|NCT00280683|Airway Inflammation|airway inflammation
793507|NCT00280683|Moderate persistent asthma|moderate persistent asthma
793508|NCT00280683|Severe Persistent Asthma|severe persistent asthma
793509|NCT00280657|Acne papulopustulosa|acne papulopustulosa
793510|NCT00280592|Prophylaxis|prophylaxis
793511|NCT00280592|Cranberry|cranberry
793512|NCT00280592|Neurogenic bladder|neurogenic bladder
793513|NCT00280553|analgesia|analgesia
793514|NCT00280553|laparoscopic surgical procedures|laparoscopic surgical procedures
793515|NCT00280553|length of stay|length of stay
793516|NCT00280540|Hypertension|hypertension
793517|NCT00280540|High blood pressure|high blood pressure
793518|NCT00280540|Blood pressure control|blood pressure control
793519|NCT00280540|Blood pressure reduction|blood pressure reduction
793520|NCT00280540|Valsartan|valsartan
793521|NCT00280527|NAFLD|nafld
793522|NCT00280527|NASH|nash
793523|NCT00280527|Obesity|obesity
793524|NCT00280527|Bariatric Surgery|bariatric surgery
793525|NCT00280527|Weight Reduction|weight reduction
793526|NCT00280514|abscess|abscess
793527|NCT00280514|penetration|penetration
793528|NCT00280514|antibiotics|antibiotics
793529|NCT00280514|cefpirome|cefpirome
793530|NCT00280514|moxifloxacin|moxifloxacin
793531|NCT00280514|abdominal cyst|abdominal cyst
793532|NCT00280501|Sulpiride|sulpiride
793533|NCT00280501|Quetiapine|quetiapine
793534|NCT00280501|Light/dark transition|light/dark transition
793535|NCT00280501|Choroidal blood flow|choroidal blood flow
793536|NCT00280488|Motivational Interviewing|motivational interviewing
793537|NCT00280488|Alcohol Abuse|alcohol abuse
793538|NCT00280488|Alcohol Dependence|alcohol dependence
793539|NCT00280488|Emergency Care Setting|emergency care setting
793540|NCT00280475|Randomized Controlled Trials|randomized controlled trials
793541|NCT00280475|Brain Neoplasms/Secondary|brain neoplasms/secondary
793542|NCT00280475|Brain Neoplasms/Radiotherapy|brain neoplasms/radiotherapy
793543|NCT00280475|Radiosurgery|radiosurgery
793544|NCT00280462|Nifedipine|nifedipine
793545|NCT00280462|Choroidal blood flow|choroidal blood flow
793546|NCT00280462|Choroidal autoregulation|choroidal autoregulation
793547|NCT00280462|Isometric exercise|isometric exercise
793548|NCT00280449|people living with HIV|people living with hiv
793549|NCT00280449|quality of life|quality of life
793550|NCT00280436|Polysomnography|polysomnography
793551|NCT00280436|Electroencephalography|electroencephalography
793552|NCT00280436|Primary Insomnia|primary insomnia
793553|NCT00280436|Cognition|cognition
793554|NCT00280436|Sleep|sleep
793555|NCT00280423|Cognition|cognition
793556|NCT00280423|Polysomnography|polysomnography
793557|NCT00280423|Primary Insomnia|primary insomnia
793558|NCT00280423|Electroencephalography|electroencephalography
793559|NCT00280423|Sleep|sleep
793560|NCT00280397|Cancer, solid tumors|cancer, solid tumors
793561|NCT00280371|COPD|copd
793562|NCT00280371|Chronic Obstructive Pulmonary Disease|chronic obstructive pulmonary disease
793563|NCT00280371|formoterol|formoterol
793564|NCT00280358|Fluticasone|fluticasone
793565|NCT00280358|Formoterol|formoterol
793566|NCT00280358|PK Study|pk study
793567|NCT00280358|Pharmacokinetics|pharmacokinetics
793568|NCT00280345|pigmentary glaucoma|pigmentary glaucoma
793569|NCT00280345|primary open angle glaucoma|primary open angle glaucoma
793570|NCT00280345|cataract|cataract
793571|NCT00280345|trabeculectomy|trabeculectomy
793572|NCT00280345|cataract surgery|cataract surgery
793573|NCT00280332|colonic adenoma, colonic advanced neoplasm|colonic adenoma, colonic advanced neoplasm
793574|NCT00280319|randomized controlled trial|randomized controlled trial
793575|NCT00280319|depression|depression
793576|NCT00280319|Uganda|uganda
793577|NCT00280319|adolescents|adolescents
793578|NCT00280293|Bipolar Disorder|bipolar disorder
793579|NCT00280293|Cocaine Dependence|cocaine dependence
793580|NCT00280293|Dual Diagnosis|dual diagnosis
793581|NCT00280280|spasticity|spasticity
793582|NCT00280280|Botox|botox
793583|NCT00280280|baclofen|baclofen
793584|NCT00280267|hip fracture|hip fracture
793585|NCT00280267|testosterone|testosterone
793586|NCT00280267|muscle weakness|muscle weakness
793587|NCT00280267|frail elderly|frail elderly
793588|NCT00280267|aging|aging
793589|NCT00280254|Heart Failure|heart failure
793590|NCT00280254|Hemodynamics|hemodynamics
793591|NCT00280254|Echocardiography|echocardiography
793592|NCT00280241|Chronic|chronic
793596|NCT00280241|Cyclophosphamide|cyclophosphamide
793597|NCT00280241|Rituximab|rituximab
793598|NCT00280228|ADHD|adhd
793599|NCT00280228|Oppositional Defiant Disorder|oppositional defiant disorder
793600|NCT00280228|Conduct Disorder|conduct disorder
793601|NCT00280228|Substance Use|substance use
793602|NCT00280228|Drug and Alcohol Use|drug and alcohol use
793603|NCT00280215|Primary Hyperoxaluria|primary hyperoxaluria
793604|NCT00280202|Non-small cell lung cancer|non-small cell lung cancer
793605|NCT00280202|Carcinogenesis|carcinogenesis
793606|NCT00280202|Genomic changes leading to malignant phenotypes in NSCLC.|genomic changes leading to malignant phenotypes in nsclc.
793607|NCT00280202|Simultaneous mutagenesis of epithelial cells.|simultaneous mutagenesis of epithelial cells.
793608|NCT00280202|Chromosomal abnormalities/mutations in bronchial tissues.|chromosomal abnormalities/mutations in bronchial tissues.
793609|NCT00280202|Detect micrometastases in histologically neg. lymph nodes|detect micrometastases in histologically neg. lymph nodes
793610|NCT00280189|Radiofrequency ablation|radiofrequency ablation
793611|NCT00280189|Pulmonary malignancies|pulmonary malignancies
793612|NCT00280189|Primary lung cancer|primary lung cancer
793613|NCT00280189|Pulmonary metastasis|pulmonary metastasis
793614|NCT00280189|Primary lung tumors|primary lung tumors
793615|NCT00280189|Secondary lung tumors|secondary lung tumors
793616|NCT00280189|Coagulation necrosis of soft tissue tumors|coagulation necrosis of soft tissue tumors
793617|NCT00280176|recurrent rectal cancer|recurrent rectal cancer
793618|NCT00280176|stage II rectal cancer|stage ii rectal cancer
793619|NCT00280176|stage III rectal cancer|stage iii rectal cancer
793620|NCT00280176|stage IV rectal cancer|stage iv rectal cancer
793621|NCT00280176|adenocarcinoma of the rectum|adenocarcinoma of the rectum
793622|NCT00280163|Genomics, cardiac surgery|genomics, cardiac surgery
793623|NCT00280150|stage IIIA non-small cell lung cancer|stage iiia non-small cell lung cancer
793624|NCT00280150|stage IIIB non-small cell lung cancer|stage iiib non-small cell lung cancer
793625|NCT00280150|recurrent non-small cell lung cancer|recurrent non-small cell lung cancer
793626|NCT00280150|squamous cell lung cancer|squamous cell lung cancer
793627|NCT00280137|Quality of Life|quality of life
793628|NCT00280137|Pediatric Systemic Lupus Erythematosus|pediatric systemic lupus erythematosus
793629|NCT00280111|rotavirus|rotavirus
793630|NCT00280111|vaccine|vaccine
793631|NCT00280111|safety|safety
793632|NCT00280111|immunogenicity|immunogenicity
793633|NCT00280111|infants|infants
793634|NCT00280072|Renal Failure, Acute|renal failure, acute
793635|NCT00280072|Acute Kidney Failure|acute kidney failure
793636|NCT00280072|Acute Renal Failure|acute renal failure
793637|NCT00280072|Acute Tubular Necrosis|acute tubular necrosis
793638|NCT00280072|Anuria|anuria
793639|NCT00280072|Renal Dialysis|renal dialysis
793640|NCT00280072|Acute Kidney Injury|acute kidney injury
793641|NCT00280059|Epilepsy|epilepsy
793642|NCT00280059|partial seizures|partial seizures
793643|NCT00280059|pregabalin monotherapy|pregabalin monotherapy
793644|NCT00280059|lamotrigine comparator|lamotrigine comparator
794145|NCT00278135|Nutrition|nutrition
793645|NCT00280059|double-blind and randomized trial|double-blind and randomized trial
793646|NCT00280033|H5N1, Influenza, vaccine, parent protocol|h5n1, influenza, vaccine, parent protocol
793647|NCT00280020|sleep disorders|sleep disorders
793648|NCT00280020|meditation|meditation
793649|NCT00280020|cognitive behavior therapy|cognitive behavior therapy
793650|NCT00280007|hepatocellular carcinoma|hepatocellular carcinoma
793651|NCT00280007|TACE|tace
793652|NCT00280007|transarterial chemoembolisation|transarterial chemoembolisation
793653|NCT00280007|portal hypertension|portal hypertension
793654|NCT00280007|angiogenesis|angiogenesis
793655|NCT00280007|VEGF|vegf
793656|NCT00280007|bevacizumab|bevacizumab
793657|NCT00279994|Intermittent claudication|intermittent claudication
793658|NCT00279994|Exercise therapy|exercise therapy
793659|NCT00279994|Therapy feedback|therapy feedback
793660|NCT00279994|Accelerometer|accelerometer
793661|NCT00279994|Physiotherapy|physiotherapy
793662|NCT00279994|PAD;|pad;
793663|NCT00279994|peripheral arterial disease according to Fontaine stage II)|peripheral arterial disease according to fontaine stage ii)
793664|NCT00279981|Atrial fibrillation|atrial fibrillation
793665|NCT00279981|Stroke|stroke
793666|NCT00279981|Pacemaker|pacemaker
793667|NCT00279981|Implantable Cardiac Defibrillator|implantable cardiac defibrillator
793668|NCT00279981|Resynchronization systems|resynchronization systems
793669|NCT00279968|ICD|icd
793670|NCT00279968|Registry|registry
793671|NCT00279968|Ventricular tachycardia|ventricular tachycardia
793672|NCT00279968|Ventricular Fibrillation|ventricular fibrillation
793673|NCT00279955|Heart Failure, Congestive|heart failure, congestive
793674|NCT00279955|Implantable Cardioverter-Defibrillators|implantable cardioverter-defibrillators
793675|NCT00279942|Fibromyalgia|fibromyalgia
793676|NCT00279942|Dietary Supplements|dietary supplements
793677|NCT00279942|Rheumatologic Diseases|rheumatologic diseases
793678|NCT00279942|Complementary and Alternative Medicine|complementary and alternative medicine
793679|NCT00279851|idiopathic seizure|idiopathic seizure
793680|NCT00279851|hypoglycemia|hypoglycemia
793681|NCT00279851|hyperammonemia/hyperinsulinism syndrome|hyperammonemia/hyperinsulinism syndrome
793682|NCT00279812|Immune response|immune response
793877|NCT00278967|preparation|preparation
793683|NCT00279812|Selenomethionine|selenomethionine
793684|NCT00279812|Selenium enriched foods|selenium enriched foods
793685|NCT00279812|Selenium status|selenium status
793686|NCT00279812|Selenium biomarkers|selenium biomarkers
793687|NCT00279799|Sexually Transmitted Diseases, HIV, condom use, adolescents|sexually transmitted diseases, hiv, condom use, adolescents
793688|NCT00279786|pediatric|pediatric
793689|NCT00279773|Acute|acute
793690|NCT00279773|Myeloid|myeloid
793691|NCT00279773|Leukemia|leukemia
793692|NCT00279734|Rheumatoid Arthritis|rheumatoid arthritis
793693|NCT00279721|thyroid neoplasms|thyroid neoplasms
793694|NCT00279721|intensity modulated radiation|intensity modulated radiation
793695|NCT00279721|radiotherapy|radiotherapy
793696|NCT00279708|Granulomatous Inflammation|granulomatous inflammation
793697|NCT00279708|Steroid-Sparing|steroid-sparing
793698|NCT00279708|Pulmonary Function|pulmonary function
793699|NCT00279708|Sarcoidosis, Pulmonary|sarcoidosis, pulmonary
793700|NCT00279708|Statins (Atorvastatin)|statins (atorvastatin)
793701|NCT00279708|Biomarkers|biomarkers
793702|NCT00279708|Nitric Oxide|nitric oxide
793703|NCT00279708|Disease Activity|disease activity
793704|NCT00279708|Quality of Life|quality of life
793705|NCT00279708|Corticosteroids|corticosteroids
793706|NCT00279708|Pulmonary Sarcoidosis|pulmonary sarcoidosis
793707|NCT00279708|Sarcoidosis|sarcoidosis
793708|NCT00279695|Glaucoma|glaucoma
793709|NCT00279695|Accommodation|accommodation
793710|NCT00279695|Ocular Tumors|ocular tumors
793711|NCT00279695|Age-Related Macular Degeneration|age-related macular degeneration
793712|NCT00279695|Ultrasound|ultrasound
793713|NCT00279695|Eye|eye
793714|NCT00279682|depression|depression
793715|NCT00279682|suicide|suicide
793716|NCT00279682|geriatric|geriatric
793717|NCT00279682|elderly|elderly
793718|NCT00279682|primary care|primary care
793719|NCT00279669|Retinopathy of Prematurity|retinopathy of prematurity
793720|NCT00279669|Ultrasound|ultrasound
793721|NCT00279669|Eye|eye
793722|NCT00279656|Frail elderly|frail elderly
793723|NCT00279656|Pharmaceutical services|pharmaceutical services
793724|NCT00279656|Drug therapy|drug therapy
793725|NCT00279656|Geriatrics|geriatrics
793726|NCT00279656|Randomized controlled trial|randomized controlled trial
793727|NCT00279656|Hospitals, teaching|hospitals, teaching
793728|NCT00279643|Laser|laser
793729|NCT00279643|immunohistochemical staining|immunohistochemical staining
793730|NCT00279643|Laser Hair Removal|laser hair removal
793731|NCT00279643|follicular stem cells|follicular stem cells
793732|NCT00279643|keratin 15|keratin 15
793733|NCT00279630|Tibialis Posterior Tendinopathy|tibialis posterior tendinopathy
793734|NCT00279578|haemophilia A|haemophilia a
793735|NCT00279578|thrombelastography|thrombelastography
793736|NCT00279578|recombinant factor VIII|recombinant factor viii
793737|NCT00279578|thrombin generation|thrombin generation
793738|NCT00279565|buprenorphine|buprenorphine
793739|NCT00279565|methadone|methadone
793740|NCT00279565|Peg-Intron|peg-intron
793741|NCT00279565|Rebetol|rebetol
793742|NCT00279552|Vitamin B12 deficiency|vitamin b12 deficiency
793743|NCT00279552|Vitamin B12 malabsorption|vitamin b12 malabsorption
793744|NCT00279552|Intrinsic factor|intrinsic factor
793745|NCT00279552|Holotranscobalamin|holotranscobalamin
793746|NCT00279539|Cardiovascular|cardiovascular
793747|NCT00279539|Gene Therapy|gene therapy
793749|NCT00279539|Stem Cells|stem cells
793750|NCT00279539|Congestive Heart Failure|congestive heart failure
793751|NCT00279539|Coronary Artery Disease|coronary artery disease
793752|NCT00279539|CHF|chf
793753|NCT00279539|Cardiomyopathy|cardiomyopathy
793754|NCT00279526|Depression|depression
793755|NCT00279526|Health services utilization|health services utilization
793756|NCT00279526|Elderly|elderly
793757|NCT00279526|Primary Care|primary care
793758|NCT00279513|homeopathy|homeopathy
793759|NCT00279513|hallux valgus|hallux valgus
793760|NCT00279513|pain|pain
793761|NCT00279513|traumeel s|traumeel s
793762|NCT00279487|Patients undergoing total knee replacement who received pain management by the following modality:|patients undergoing total knee replacement who received pain management by the following modality:
793763|NCT00279487|IV PCA opioid|iv pca opioid
793764|NCT00279487|Local femoral nerve block with 1.5% Mepivacaine & 0.5% Ropivacaine|local femoral nerve block with 1.5% mepivacaine & 0.5% ropivacaine
793765|NCT00279474|cancer patients|cancer patients
793766|NCT00279474|family|family
793767|NCT00279474|cognitive behavior|cognitive behavior
793768|NCT00279474|distress|distress
793769|NCT00279461|Rheumatoid Arthritis|rheumatoid arthritis
793770|NCT00279461|Vitamin D|vitamin d
793771|NCT00279435|Intravenous, Steroid-Refractory, Ulcerative Colitis|intravenous, steroid-refractory, ulcerative colitis
793772|NCT00279422|Intravenous, Steroid-Refractory, Ulcerative Colitis|intravenous, steroid-refractory, ulcerative colitis
793773|NCT00279409|Attention Deficit Hyperactivity Disorder|attention deficit hyperactivity disorder
793774|NCT00279409|ADHD|adhd
793775|NCT00279409|Treatment resistant|treatment resistant
793776|NCT00279409|Partial responder|partial responder
793777|NCT00279409|Non-responder|non-responder
793778|NCT00279409|Atypical Antipsychotic|atypical antipsychotic
793878|NCT00278954|Primary Antibody Deficiency|primary antibody deficiency
793977|NCT00278447|Comorbidity|comorbidity
793779|NCT00279383|Intra-operatively treated patients with hemostatic supporting agents/techniques in addition to the standard surgical procedures|intra-operatively treated patients with hemostatic supporting agents/techniques in addition to the standard surgical procedures
793780|NCT00279370|SSRI Exposure|ssri exposure
793781|NCT00279370|Pregnancy|pregnancy
793782|NCT00279370|Infant Development|infant development
793783|NCT00279357|NBI|nbi
793784|NCT00279357|high risk group for adenomas|high risk group for adenomas
793785|NCT00279331|HIV Seronegativity|hiv seronegativity
793786|NCT00279331|Men who have Sex with Men|men who have sex with men
793787|NCT00279331|MSM|msm
793788|NCT00279331|Peru|peru
793789|NCT00279331|Ecuador|ecuador
793790|NCT00279331|Incidence|incidence
793791|NCT00279331|Prevalence|prevalence
793792|NCT00279331|Drug resistance, viral|drug resistance, viral
793793|NCT00279318|Environment|environment
793794|NCT00279318|Exposures|exposures
793795|NCT00279318|Diet|diet
793796|NCT00279318|Toxins|toxins
793797|NCT00279318|Psychosocial|psychosocial
793798|NCT00279318|Infectious Agents|infectious agents
793799|NCT00279318|Bacterial|bacterial
793800|NCT00279318|Viral|viral
793801|NCT00279318|Immunizations|immunizations
793802|NCT00279318|Autoantibody|autoantibody
793803|NCT00279305|Newly diagnosed type 1 diabetes|newly diagnosed type 1 diabetes
793804|NCT00279305|New Onset type 1 diabetes|new onset type 1 diabetes
793805|NCT00279305|Preservation of insulin secretion|preservation of insulin secretion
793806|NCT00279305|Type 1 diabetes|type 1 diabetes
793807|NCT00279305|Juvenile Onset Diabetes|juvenile onset diabetes
793808|NCT00279305|Insulin Dependent Diabetes|insulin dependent diabetes
793809|NCT00279305|T1D|t1d
793810|NCT00279292|Pancreatic neoplasm|pancreatic neoplasm
793811|NCT00279279|Implantable cardioverter defibrillator (ICD)|implantable cardioverter defibrillator (icd)
793812|NCT00279279|Sudden Cardiac Death|sudden cardiac death
793813|NCT00279279|Primary Prevention|primary prevention
793814|NCT00279266|Diabetic Peripheral Neuropathy|diabetic peripheral neuropathy
793815|NCT00279266|Peripheral Neuropathy|peripheral neuropathy
793816|NCT00279266|Diabetes Mellitus|diabetes mellitus
793817|NCT00279253|clonidine|clonidine
793818|NCT00279253|glaucoma|glaucoma
793819|NCT00279240|Impaired glucose tolerance|impaired glucose tolerance
793820|NCT00279240|Intervention|intervention
793821|NCT00279240|Prevention|prevention
793822|NCT00279227|coronary artery disease|coronary artery disease
793823|NCT00279227|epicardial adipose tissue|epicardial adipose tissue
793824|NCT00279227|epicardial fat|epicardial fat
793825|NCT00279227|obesity|obesity
793826|NCT00279201|diabetes|diabetes
793827|NCT00279201|type 2|type 2
793828|NCT00279188|Bronchial hyperresponsiveness|bronchial hyperresponsiveness
793829|NCT00279188|Atopy|atopy
793830|NCT00279188|Inhaled steroids|inhaled steroids
793831|NCT00279188|Exacerbations|exacerbations
793832|NCT00279188|Lung function decline|lung function decline
793833|NCT00279188|Prognosis|prognosis
793834|NCT00279175|Acute myocardial infarction|acute myocardial infarction
793835|NCT00279149|Telemedicine|telemedicine
793837|NCT00279149|symptoms of ischemic stroke since less than 3 hours|symptoms of ischemic stroke since less than 3 hours
793838|NCT00279136|Bronchial hyperresponsiveness,|bronchial hyperresponsiveness,
793839|NCT00279136|lung function,|lung function,
793840|NCT00279136|airway inflammation,|airway inflammation,
793841|NCT00279136|deep inspiration,|deep inspiration,
793842|NCT00279136|bronchial biopsies|bronchial biopsies
793843|NCT00279136|airway smooth muscle|airway smooth muscle
793845|NCT00279110|Antiretroviral therapy|antiretroviral therapy
793846|NCT00279110|Heroin dependence|heroin dependence
793847|NCT00279110|Methadone|methadone
793848|NCT00279110|Buprenorphine|buprenorphine
793849|NCT00279097|Intracranial pressure|intracranial pressure
793850|NCT00279097|High Frequency Chest Wall Oscillation|high frequency chest wall oscillation
793851|NCT00279097|Neurosurgery|neurosurgery
793852|NCT00279084|Anaemia|anaemia
793853|NCT00279084|Chronic kidney disease|chronic kidney disease
793854|NCT00279084|Type 2 diabetes|type 2 diabetes
793855|NCT00279084|Randomized trial|randomized trial
793856|NCT00279071|dystocia|dystocia
793857|NCT00279071|stimulation|stimulation
793858|NCT00279071|acupuncture|acupuncture
793859|NCT00279071|oxytocin|oxytocin
793860|NCT00279045|type 2 diabetes monotherapy treatment naive|type 2 diabetes monotherapy treatment naive
793861|NCT00279032|GW406381|gw406381
793862|NCT00279032|peripheral nerve injury|peripheral nerve injury
793863|NCT00279032|patients|patients
793864|NCT00279032|allodynia|allodynia
793865|NCT00279032|hyperalgesia|hyperalgesia
793866|NCT00279032|randomised|randomised
793867|NCT00279032|placebo-controlled|placebo-controlled
793868|NCT00279019|GSK233705|gsk233705
793869|NCT00279019|Chronic Obstructive Pulmonary Disease (COPD)|chronic obstructive pulmonary disease (copd)
793870|NCT00279019|COPD|copd
793871|NCT00279006|DES (drug eluting stents)|des (drug eluting stents)
793872|NCT00279006|CAD (cornary artery disease)|cad (cornary artery disease)
793873|NCT00279006|stent retrieval|stent retrieval
793874|NCT00278993|Prostate cancer|prostate cancer
793875|NCT00278993|metastatic disease|metastatic disease
793876|NCT00278967|colonoscopy|colonoscopy
793879|NCT00278954|Common variable hypogammaglobulinemia|common variable hypogammaglobulinemia
793880|NCT00278954|X-linked hypogammaglobulinemia|x-linked hypogammaglobulinemia
793881|NCT00278954|Hypogammaglobulinemia|hypogammaglobulinemia
793882|NCT00278954|Immunodeficiency with hyper-IgM|immunodeficiency with hyper-igm
793883|NCT00278954|Wiskott-Aldrich Syndrome|wiskott-aldrich syndrome
793884|NCT00278941|Seroquel SR™|seroquel sr™
793885|NCT00278941|Major Depressive Disorder|major depressive disorder
793886|NCT00278928|Hypertriglyceridemia|hypertriglyceridemia
793887|NCT00278928|Infant, Premature|infant, premature
793888|NCT00278915|Progressive Precocious Puberty|progressive precocious puberty
793889|NCT00278915|PPP|ppp
793890|NCT00278915|McCune-Albright Syndrome|mccune-albright syndrome
793891|NCT00278915|MAS|mas
793892|NCT00278902|ErbB2+ Breast Cancer|erbb2+ breast cancer
793893|NCT00278902|HER2+ Breast Cancer|her2+ breast cancer
793894|NCT00278889|Colorectal Cancer|colorectal cancer
793895|NCT00278889|phase II|phase ii
793896|NCT00278889|metastatic colorectal cancer|metastatic colorectal cancer
793897|NCT00278889|AZD2171|azd2171
793898|NCT00278889|RECENTIN|recentin
793899|NCT00278876|GIST|gist
793900|NCT00278876|Imatinib|imatinib
793901|NCT00278876|Adjuvant therapy|adjuvant therapy
793902|NCT00278876|Kit mutation|kit mutation
793903|NCT00278863|Stomach cancer|stomach cancer
793904|NCT00278863|Palliative chemotherapy|palliative chemotherapy
793905|NCT00278863|Capecitabine|capecitabine
793906|NCT00278863|S-1|s-1
793907|NCT00278850|Vulvar vestibulitis|vulvar vestibulitis
793908|NCT00278850|Treatment|treatment
793909|NCT00278850|Education|education
793910|NCT00278837|Meditation|meditation
793911|NCT00278837|Stress-reduction|stress-reduction
793912|NCT00278837|Cognitive-affective behavior learning|cognitive-affective behavior learning
793913|NCT00278824|Chronic Pain|chronic pain
793914|NCT00278824|Pain|pain
793915|NCT00278811|Mental Health Services|mental health services
793916|NCT00278811|Suicide|suicide
793917|NCT00278811|Suicide ideation|suicide ideation
793918|NCT00278798|tracehelectomy|tracehelectomy
793919|NCT00278798|radical hysterectomy|radical hysterectomy
793920|NCT00278785|interviews|interviews
793921|NCT00278785|brief intervention|brief intervention
793922|NCT00278785|drinking|drinking
793923|NCT00278785|alcohol|alcohol
793924|NCT00278785|injuries|injuries
793925|NCT00278785|wounds|wounds
793926|NCT00278785|intervention studies|intervention studies
793927|NCT00278759|rapid viral diagnosis|rapid viral diagnosis
793928|NCT00278759|respiratory infection|respiratory infection
793929|NCT00278759|pediatric emergency department|pediatric emergency department
793930|NCT00278759|febrile respiratory infection|febrile respiratory infection
793931|NCT00278746|zinc|zinc
793932|NCT00278746|diarrhea|diarrhea
793933|NCT00278746|cluster randomization|cluster randomization
793934|NCT00278746|hospitalization|hospitalization
793935|NCT00278733|Randomized controlled trial|randomized controlled trial
793936|NCT00278733|brief intervention|brief intervention
793937|NCT00278733|university students|university students
793938|NCT00278733|physician advice|physician advice
793939|NCT00278733|high risk drinking|high risk drinking
793940|NCT00278707|Canavan Disease|canavan disease
793941|NCT00278707|Aspartoacylase Deficiency|aspartoacylase deficiency
793942|NCT00278707|NAA|naa
793943|NCT00278707|Acetate|acetate
793944|NCT00278707|Glyceryltriacetate|glyceryltriacetate
793945|NCT00278694|Oxaliplatin, radiation|oxaliplatin, radiation
793946|NCT00278681|zinc|zinc
793947|NCT00278681|diarrhea|diarrhea
793948|NCT00278681|hospitalization|hospitalization
793949|NCT00278681|programme|programme
793950|NCT00278538|Stem cell, Autoimmune disease, Systemic Lupus Erythematosus|stem cell, autoimmune disease, systemic lupus erythematosus
793951|NCT00278473|Primarily Inattentive|primarily inattentive
793952|NCT00278473|Hyperactive Impulsive Type|hyperactive impulsive type
793953|NCT00278473|Combined Type|combined type
793954|NCT00278473|ADHD|adhd
793955|NCT00278473|Adults|adults
793956|NCT00278473|Psychological|psychological
793957|NCT00278473|Cognitive Behavioral Therapy|cognitive behavioral therapy
793958|NCT00278473|CBT|cbt
793959|NCT00278460|stage IIIB non-small cell lung cancer|stage iiib non-small cell lung cancer
793960|NCT00278460|stage IV non-small cell lung cancer|stage iv non-small cell lung cancer
793961|NCT00278460|adenocarcinoma of the lung|adenocarcinoma of the lung
793962|NCT00278460|bronchoalveolar cell lung cancer|bronchoalveolar cell lung cancer
793963|NCT00278460|large cell lung cancer|large cell lung cancer
793964|NCT00278460|recurrent non-small cell lung cancer|recurrent non-small cell lung cancer
793965|NCT00278460|squamous cell lung cancer|squamous cell lung cancer
793966|NCT00278447|Alcohol|alcohol
793967|NCT00278447|Alcohol use|alcohol use
793968|NCT00278447|Alcohol dependence|alcohol dependence
793969|NCT00278447|Drug|drug
793970|NCT00278447|Drug use|drug use
793971|NCT00278447|Drug dependence|drug dependence
793972|NCT00278447|Utilization|utilization
793973|NCT00278447|Hospitalization|hospitalization
793974|NCT00278447|Primary care|primary care
793975|NCT00278447|Chronic disease management|chronic disease management
793976|NCT00278447|Care management|care management
793978|NCT00278434|cervical cancer|cervical cancer
793979|NCT00278434|cervical intraepithelial neoplasia grade 2|cervical intraepithelial neoplasia grade 2
793980|NCT00278434|cervical intraepithelial neoplasia grade 3|cervical intraepithelial neoplasia grade 3
793981|NCT00278421|contiguous stage II grade 3 follicular lymphoma|contiguous stage ii grade 3 follicular lymphoma
793982|NCT00278421|noncontiguous stage II grade 3 follicular lymphoma|noncontiguous stage ii grade 3 follicular lymphoma
793983|NCT00278421|stage I grade 3 follicular lymphoma|stage i grade 3 follicular lymphoma
793984|NCT00278421|contiguous stage II adult diffuse large cell lymphoma|contiguous stage ii adult diffuse large cell lymphoma
793985|NCT00278421|contiguous stage II adult diffuse mixed cell lymphoma|contiguous stage ii adult diffuse mixed cell lymphoma
793986|NCT00278421|noncontiguous stage II adult diffuse large cell lymphoma|noncontiguous stage ii adult diffuse large cell lymphoma
793987|NCT00278421|noncontiguous stage II adult diffuse mixed cell lymphoma|noncontiguous stage ii adult diffuse mixed cell lymphoma
793988|NCT00278421|stage I adult diffuse large cell lymphoma|stage i adult diffuse large cell lymphoma
793989|NCT00278421|stage I adult diffuse mixed cell lymphoma|stage i adult diffuse mixed cell lymphoma
793990|NCT00278421|nodal marginal zone B-cell lymphoma|nodal marginal zone b-cell lymphoma
793991|NCT00278421|anaplastic large cell lymphoma|anaplastic large cell lymphoma
793992|NCT00278421|contiguous stage II adult immunoblastic large cell lymphoma|contiguous stage ii adult immunoblastic large cell lymphoma
793993|NCT00278421|noncontiguous stage II adult immunoblastic large cell lymphoma|noncontiguous stage ii adult immunoblastic large cell lymphoma
793994|NCT00278421|stage I adult immunoblastic large cell lymphoma|stage i adult immunoblastic large cell lymphoma
793995|NCT00278421|contiguous stage II adult Burkitt lymphoma|contiguous stage ii adult burkitt lymphoma
793996|NCT00278421|contiguous stage II mantle cell lymphoma|contiguous stage ii mantle cell lymphoma
793997|NCT00278421|noncontiguous stage II adult Burkitt lymphoma|noncontiguous stage ii adult burkitt lymphoma
793998|NCT00278421|noncontiguous stage II mantle cell lymphoma|noncontiguous stage ii mantle cell lymphoma
793999|NCT00278421|stage I adult Burkitt lymphoma|stage i adult burkitt lymphoma
794000|NCT00278421|stage I mantle cell lymphoma|stage i mantle cell lymphoma
794001|NCT00278421|contiguous stage II marginal zone lymphoma|contiguous stage ii marginal zone lymphoma
794002|NCT00278421|noncontiguous stage II marginal zone lymphoma|noncontiguous stage ii marginal zone lymphoma
794003|NCT00278421|stage I marginal zone lymphoma|stage i marginal zone lymphoma
794004|NCT00278421|stage III marginal zone lymphoma|stage iii marginal zone lymphoma
794005|NCT00278421|stage IV marginal zone lymphoma|stage iv marginal zone lymphoma
794006|NCT00278421|stage III adult Burkitt lymphoma|stage iii adult burkitt lymphoma
794007|NCT00278421|stage III adult diffuse large cell lymphoma|stage iii adult diffuse large cell lymphoma
794008|NCT00278421|stage III adult diffuse mixed cell lymphoma|stage iii adult diffuse mixed cell lymphoma
794009|NCT00278421|stage III adult immunoblastic large cell lymphoma|stage iii adult immunoblastic large cell lymphoma
794010|NCT00278421|stage III grade 3 follicular lymphoma|stage iii grade 3 follicular lymphoma
794011|NCT00278421|stage III mantle cell lymphoma|stage iii mantle cell lymphoma
794146|NCT00278135|Omega-3|omega-3
794012|NCT00278421|stage IV adult Burkitt lymphoma|stage iv adult burkitt lymphoma
794013|NCT00278421|stage IV adult diffuse large cell lymphoma|stage iv adult diffuse large cell lymphoma
794014|NCT00278421|stage IV adult diffuse mixed cell lymphoma|stage iv adult diffuse mixed cell lymphoma
794015|NCT00278421|stage IV adult immunoblastic large cell lymphoma|stage iv adult immunoblastic large cell lymphoma
794016|NCT00278421|stage IV grade 3 follicular lymphoma|stage iv grade 3 follicular lymphoma
794017|NCT00278421|stage IV mantle cell lymphoma|stage iv mantle cell lymphoma
794018|NCT00278408|contiguous stage II grade 3 follicular lymphoma|contiguous stage ii grade 3 follicular lymphoma
794019|NCT00278408|noncontiguous stage II grade 3 follicular lymphoma|noncontiguous stage ii grade 3 follicular lymphoma
794020|NCT00278408|stage I grade 3 follicular lymphoma|stage i grade 3 follicular lymphoma
794021|NCT00278408|stage III grade 3 follicular lymphoma|stage iii grade 3 follicular lymphoma
794022|NCT00278408|stage IV grade 3 follicular lymphoma|stage iv grade 3 follicular lymphoma
794023|NCT00278408|contiguous stage II adult diffuse large cell lymphoma|contiguous stage ii adult diffuse large cell lymphoma
794024|NCT00278408|contiguous stage II adult diffuse mixed cell lymphoma|contiguous stage ii adult diffuse mixed cell lymphoma
794025|NCT00278408|noncontiguous stage II adult diffuse large cell lymphoma|noncontiguous stage ii adult diffuse large cell lymphoma
794026|NCT00278408|noncontiguous stage II adult diffuse mixed cell lymphoma|noncontiguous stage ii adult diffuse mixed cell lymphoma
794027|NCT00278408|stage I adult diffuse large cell lymphoma|stage i adult diffuse large cell lymphoma
794028|NCT00278408|stage I adult diffuse mixed cell lymphoma|stage i adult diffuse mixed cell lymphoma
794029|NCT00278408|stage III adult diffuse large cell lymphoma|stage iii adult diffuse large cell lymphoma
794030|NCT00278408|stage III adult diffuse mixed cell lymphoma|stage iii adult diffuse mixed cell lymphoma
794031|NCT00278408|stage IV adult diffuse large cell lymphoma|stage iv adult diffuse large cell lymphoma
794032|NCT00278408|stage IV adult diffuse mixed cell lymphoma|stage iv adult diffuse mixed cell lymphoma
794033|NCT00278408|nodal marginal zone B-cell lymphoma|nodal marginal zone b-cell lymphoma
794034|NCT00278408|anaplastic large cell lymphoma|anaplastic large cell lymphoma
794035|NCT00278408|contiguous stage II adult immunoblastic large cell lymphoma|contiguous stage ii adult immunoblastic large cell lymphoma
794036|NCT00278408|noncontiguous stage II adult immunoblastic large cell lymphoma|noncontiguous stage ii adult immunoblastic large cell lymphoma
794037|NCT00278408|stage I adult immunoblastic large cell lymphoma|stage i adult immunoblastic large cell lymphoma
794190|NCT00277966|Fluoroscopy time|fluoroscopy time
794038|NCT00278408|stage III adult immunoblastic large cell lymphoma|stage iii adult immunoblastic large cell lymphoma
794039|NCT00278408|stage IV adult immunoblastic large cell lymphoma|stage iv adult immunoblastic large cell lymphoma
794040|NCT00278408|contiguous stage II adult Burkitt lymphoma|contiguous stage ii adult burkitt lymphoma
794041|NCT00278408|contiguous stage II mantle cell lymphoma|contiguous stage ii mantle cell lymphoma
794042|NCT00278408|noncontiguous stage II adult Burkitt lymphoma|noncontiguous stage ii adult burkitt lymphoma
794043|NCT00278408|noncontiguous stage II mantle cell lymphoma|noncontiguous stage ii mantle cell lymphoma
794044|NCT00278408|stage I adult Burkitt lymphoma|stage i adult burkitt lymphoma
794045|NCT00278408|stage I mantle cell lymphoma|stage i mantle cell lymphoma
794046|NCT00278408|stage III adult Burkitt lymphoma|stage iii adult burkitt lymphoma
794047|NCT00278408|stage III mantle cell lymphoma|stage iii mantle cell lymphoma
794048|NCT00278408|stage IV adult Burkitt lymphoma|stage iv adult burkitt lymphoma
794049|NCT00278408|stage IV mantle cell lymphoma|stage iv mantle cell lymphoma
794050|NCT00278408|contiguous stage II marginal zone lymphoma|contiguous stage ii marginal zone lymphoma
794051|NCT00278408|noncontiguous stage II marginal zone lymphoma|noncontiguous stage ii marginal zone lymphoma
794052|NCT00278408|stage I marginal zone lymphoma|stage i marginal zone lymphoma
794053|NCT00278408|stage III marginal zone lymphoma|stage iii marginal zone lymphoma
794054|NCT00278408|stage IV marginal zone lymphoma|stage iv marginal zone lymphoma
794055|NCT00278369|recurrent renal cell cancer|recurrent renal cell cancer
794056|NCT00278369|stage IV renal cell cancer|stage iv renal cell cancer
794057|NCT00278369|clear cell renal cell carcinoma|clear cell renal cell carcinoma
794058|NCT00278304|cervical adenocarcinoma|cervical adenocarcinoma
794059|NCT00278304|cervical adenosquamous cell carcinoma|cervical adenosquamous cell carcinoma
794060|NCT00278304|cervical squamous cell carcinoma|cervical squamous cell carcinoma
794061|NCT00278304|stage IB cervical cancer|stage ib cervical cancer
794062|NCT00278304|stage IIA cervical cancer|stage iia cervical cancer
794063|NCT00278304|stage IIB cervical cancer|stage iib cervical cancer
794064|NCT00278304|stage III cervical cancer|stage iii cervical cancer
794065|NCT00278304|stage IVA cervical cancer|stage iva cervical cancer
794066|NCT00278304|stage IVB cervical cancer|stage ivb cervical cancer
794067|NCT00278278|untreated childhood brain stem glioma|untreated childhood brain stem glioma
794068|NCT00278278|untreated childhood cerebellar astrocytoma|untreated childhood cerebellar astrocytoma
794069|NCT00278278|childhood high-grade cerebral astrocytoma|childhood high-grade cerebral astrocytoma
794070|NCT00278278|childhood spinal cord neoplasm|childhood spinal cord neoplasm
794071|NCT00278265|T-cell large granular lymphocyte leukemia|t-cell large granular lymphocyte leukemia
794072|NCT00278265|anemia|anemia
794073|NCT00278265|neutropenia|neutropenia
794074|NCT00278252|recurrent childhood ependymoma|recurrent childhood ependymoma
794075|NCT00278252|childhood infratentorial ependymoma|childhood infratentorial ependymoma
794076|NCT00278252|childhood supratentorial ependymoma|childhood supratentorial ependymoma
794077|NCT00278239|long-term effects secondary to cancer therapy in children|long-term effects secondary to cancer therapy in children
794078|NCT00278239|psychosocial effects of cancer and its treatment|psychosocial effects of cancer and its treatment
794079|NCT00278239|cognitive/functional effects|cognitive/functional effects
794080|NCT00278239|childhood supratentorial primitive neuroectodermal tumor|childhood supratentorial primitive neuroectodermal tumor
794081|NCT00278226|unspecified adult solid tumor, protocol specific|unspecified adult solid tumor, protocol specific
794082|NCT00278213|prolymphocytic leukemia|prolymphocytic leukemia
794083|NCT00278213|refractory chronic lymphocytic leukemia|refractory chronic lymphocytic leukemia
794084|NCT00278213|stage I chronic lymphocytic leukemia|stage i chronic lymphocytic leukemia
794085|NCT00278213|stage II chronic lymphocytic leukemia|stage ii chronic lymphocytic leukemia
794086|NCT00278213|stage III chronic lymphocytic leukemia|stage iii chronic lymphocytic leukemia
794087|NCT00278213|stage IV chronic lymphocytic leukemia|stage iv chronic lymphocytic leukemia
794088|NCT00278213|T-cell large granular lymphocyte leukemia|t-cell large granular lymphocyte leukemia
794089|NCT00278200|post-transplant lymphoproliferative disorder|post-transplant lymphoproliferative disorder
794090|NCT00278187|stage IIIB non-small cell lung cancer|stage iiib non-small cell lung cancer
794091|NCT00278187|stage IV non-small cell lung cancer|stage iv non-small cell lung cancer
794092|NCT00278187|recurrent non-small cell lung cancer|recurrent non-small cell lung cancer
794093|NCT00278174|stage IV renal cell cancer|stage iv renal cell cancer
794094|NCT00278174|recurrent renal cell cancer|recurrent renal cell cancer
794095|NCT00278174|clear cell renal cell carcinoma|clear cell renal cell carcinoma
794096|NCT00278161|stage 0 chronic lymphocytic leukemia|stage 0 chronic lymphocytic leukemia
794097|NCT00278161|stage I chronic lymphocytic leukemia|stage i chronic lymphocytic leukemia
794098|NCT00278161|stage II chronic lymphocytic leukemia|stage ii chronic lymphocytic leukemia
794099|NCT00278161|stage III chronic lymphocytic leukemia|stage iii chronic lymphocytic leukemia
794100|NCT00278161|stage IV chronic lymphocytic leukemia|stage iv chronic lymphocytic leukemia
794101|NCT00278161|small lymphocytic lymphoma|small lymphocytic lymphoma
794102|NCT00278161|stage I small lymphocytic lymphoma|stage i small lymphocytic lymphoma
794103|NCT00278161|stage III small lymphocytic lymphoma|stage iii small lymphocytic lymphoma
794104|NCT00278161|stage IV small lymphocytic lymphoma|stage iv small lymphocytic lymphoma
794105|NCT00278161|B-cell chronic lymphocytic leukemia|b-cell chronic lymphocytic leukemia
794106|NCT00278161|splenic marginal zone lymphoma|splenic marginal zone lymphoma
794107|NCT00278161|extranodal marginal zone B-cell lymphoma of mucosa-associated lymphoid tissue|extranodal marginal zone b-cell lymphoma of mucosa-associated lymphoid tissue
794108|NCT00278161|nodal marginal zone B-cell lymphoma|nodal marginal zone b-cell lymphoma
794109|NCT00278161|stage I grade 1 follicular lymphoma|stage i grade 1 follicular lymphoma
794110|NCT00278161|stage I grade 2 follicular lymphoma|stage i grade 2 follicular lymphoma
794111|NCT00278161|stage III grade 1 follicular lymphoma|stage iii grade 1 follicular lymphoma
794112|NCT00278161|stage III grade 2 follicular lymphoma|stage iii grade 2 follicular lymphoma
794113|NCT00278161|stage IV grade 1 follicular lymphoma|stage iv grade 1 follicular lymphoma
794114|NCT00278161|stage IV grade 2 follicular lymphoma|stage iv grade 2 follicular lymphoma
794115|NCT00278161|stage I mantle cell lymphoma|stage i mantle cell lymphoma
794116|NCT00278161|stage III mantle cell lymphoma|stage iii mantle cell lymphoma
794117|NCT00278161|stage IV mantle cell lymphoma|stage iv mantle cell lymphoma
794118|NCT00278161|Waldenstrom macroglobulinemia|waldenstrom macroglobulinemia
794119|NCT00278161|prolymphocytic leukemia|prolymphocytic leukemia
794120|NCT00278161|stage I marginal zone lymphoma|stage i marginal zone lymphoma
794121|NCT00278161|contiguous stage II adult diffuse small cleaved cell lymphoma|contiguous stage ii adult diffuse small cleaved cell lymphoma
794122|NCT00278161|contiguous stage II grade 1 follicular lymphoma|contiguous stage ii grade 1 follicular lymphoma
794123|NCT00278161|contiguous stage II grade 2 follicular lymphoma|contiguous stage ii grade 2 follicular lymphoma
794124|NCT00278161|contiguous stage II mantle cell lymphoma|contiguous stage ii mantle cell lymphoma
794125|NCT00278161|contiguous stage II marginal zone lymphoma|contiguous stage ii marginal zone lymphoma
794126|NCT00278161|contiguous stage II small lymphocytic lymphoma|contiguous stage ii small lymphocytic lymphoma
794127|NCT00278161|noncontiguous stage II adult diffuse small cleaved cell lymphoma|noncontiguous stage ii adult diffuse small cleaved cell lymphoma
794128|NCT00278161|noncontiguous stage II grade 1 follicular lymphoma|noncontiguous stage ii grade 1 follicular lymphoma
794129|NCT00278161|noncontiguous stage II grade 2 follicular lymphoma|noncontiguous stage ii grade 2 follicular lymphoma
794130|NCT00278161|noncontiguous stage II mantle cell lymphoma|noncontiguous stage ii mantle cell lymphoma
794131|NCT00278161|noncontiguous stage II marginal zone lymphoma|noncontiguous stage ii marginal zone lymphoma
794132|NCT00278161|noncontiguous stage II small lymphocytic lymphoma|noncontiguous stage ii small lymphocytic lymphoma
794133|NCT00278161|stage III marginal zone lymphoma|stage iii marginal zone lymphoma
794134|NCT00278161|recurrent grade 1 follicular lymphoma|recurrent grade 1 follicular lymphoma
794135|NCT00278161|recurrent grade 2 follicular lymphoma|recurrent grade 2 follicular lymphoma
794136|NCT00278161|recurrent mantle cell lymphoma|recurrent mantle cell lymphoma
794137|NCT00278161|recurrent marginal zone lymphoma|recurrent marginal zone lymphoma
794138|NCT00278161|recurrent small lymphocytic lymphoma|recurrent small lymphocytic lymphoma
794139|NCT00278161|refractory chronic lymphocytic leukemia|refractory chronic lymphocytic leukemia
794140|NCT00278161|stage IV marginal zone lymphoma|stage iv marginal zone lymphoma
794141|NCT00278148|stage IIIA non-small cell lung cancer|stage iiia non-small cell lung cancer
794142|NCT00278148|stage IIIB non-small cell lung cancer|stage iiib non-small cell lung cancer
794147|NCT00278135|DHA|dha
794148|NCT00278122|stage III melanoma|stage iii melanoma
794149|NCT00278122|stage IV melanoma|stage iv melanoma
794150|NCT00278122|recurrent melanoma|recurrent melanoma
794151|NCT00278109|stage I breast cancer|stage i breast cancer
794152|NCT00278109|stage II breast cancer|stage ii breast cancer
794153|NCT00278096|disability|disability
794154|NCT00278096|occupational therapy|occupational therapy
794155|NCT00278083|Pharmacology|pharmacology
794156|NCT00278083|Asthma|asthma
794157|NCT00278083|TNF-alpha|tnf-alpha
794158|NCT00278070|Metronomic-therapy|metronomic-therapy
794159|NCT00278070|vinorelbine|vinorelbine
794160|NCT00278070|Recurrent Breast Cancer|recurrent breast cancer
794161|NCT00278070|Recurrent Non Small Cell Lung Cancer|recurrent non small cell lung cancer
794162|NCT00278070|Metastatic prostate cancer|metastatic prostate cancer
794163|NCT00278057|Blood pressure;|blood pressure;
794164|NCT00278057|chronic renal failure;|chronic renal failure;
794165|NCT00278057|diabetes mellitus;|diabetes mellitus;
794166|NCT00278057|dialysis fluid; glucose;|dialysis fluid; glucose;
794167|NCT00278057|hemodialysis;|hemodialysis;
794168|NCT00278057|hypertension;|hypertension;
794169|NCT00278057|uremia.|uremia.
794170|NCT00278044|Search as text words in Annotation & Scope Note|search as text words in annotation & scope note
794171|NCT00278031|Retinoblastoma|retinoblastoma
794172|NCT00278031|Quality of life|quality of life
794173|NCT00278005|pediatric|pediatric
794174|NCT00278005|DiGeorge Syndrome|digeorge syndrome
794175|NCT00278005|Congenital heart defects|congenital heart defects
794176|NCT00278005|Infections|infections
794177|NCT00278005|Cardiac surgery|cardiac surgery
794178|NCT00277992|Pediatric|pediatric
794179|NCT00277992|Cardiac|cardiac
794180|NCT00277992|Norwood operation modification|norwood operation modification
794181|NCT00277992|GT/Nissen operation|gt/nissen operation
794182|NCT00277992|Po feed|po feed
794183|NCT00277992|GT fed|gt fed
794184|NCT00277979|pediatric|pediatric
794185|NCT00277979|cardiac|cardiac
794186|NCT00277979|Infantile Pompe's Disease|infantile pompe's disease
794187|NCT00277979|3D Echocardiography|3d echocardiography
794188|NCT00277966|Pediatric|pediatric
794189|NCT00277966|Cardiac Catheterization|cardiac catheterization
794193|NCT00277953|Tracheal Dimensions|tracheal dimensions
794194|NCT00277953|MRI|mri
794195|NCT00277940|Pediatric|pediatric
794196|NCT00277940|Cardiac|cardiac
794197|NCT00277940|Neoaortic Elastic Properties|neoaortic elastic properties
794198|NCT00277940|Aortic Arch Reconstruction|aortic arch reconstruction
794199|NCT00277927|Pediatric|pediatric
794200|NCT00277927|Cardiac|cardiac
794201|NCT00277927|Valvar Pulmonary Stenosis|valvar pulmonary stenosis
794202|NCT00277901|cardiac|cardiac
794203|NCT00277901|pediatric|pediatric
794204|NCT00277901|MRI|mri
794205|NCT00277901|Tetralogy of Fallot TOF|tetralogy of fallot tof
794206|NCT00277901|Aortic Coarctation|aortic coarctation
794207|NCT00277888|Dialysis|dialysis
794208|NCT00277888|Hemodialysis|hemodialysis
794209|NCT00277888|Catheterization|catheterization
794210|NCT00277875|Cardiovascular|cardiovascular
794211|NCT00277875|Flow-Mediated Vasodilation (FMD)|flow-mediated vasodilation (fmd)
794212|NCT00277875|Pulse Perfusion-Mediated Vasodilation (PPMV)|pulse perfusion-mediated vasodilation (ppmv)
794213|NCT00277875|Endothelial Function|endothelial function
794214|NCT00277875|Heart Failure|heart failure
794215|NCT00277875|Local Distensibility|local distensibility
794216|NCT00277875|Arterial Stiffening|arterial stiffening
794217|NCT00277875|Augmentation Index (AI)|augmentation index (ai)
794218|NCT00277875|Aging|aging
794219|NCT00277875|Isolated Systolic Hypertension|isolated systolic hypertension
794220|NCT00277875|Advanced Glycation Endproducts|advanced glycation endproducts
794221|NCT00277875|Vascular Stiffness|vascular stiffness
794222|NCT00277862|chronic hepatitis C;|chronic hepatitis c;
794223|NCT00277862|peg-interferon alfa-2b;|peg-interferon alfa-2b;
794224|NCT00277862|ribavirin,|ribavirin,
794225|NCT00277862|rapid virologic response,|rapid virologic response,
794226|NCT00277862|sustained virological response|sustained virological response
794227|NCT00277849|Sickle|sickle
794228|NCT00277849|Hemoglobinopathy|hemoglobinopathy
794229|NCT00277849|Thalassemia|thalassemia
794230|NCT00277849|G6PD|g6pd
794231|NCT00277849|Plasmodium|plasmodium
794232|NCT00277849|Erythrocyte Variant|erythrocyte variant
794233|NCT00277849|Hemoglobin Variant|hemoglobin variant
794234|NCT00277849|Healthy Volunteer|healthy volunteer
794235|NCT00277849|HV|hv
794236|NCT00277836|malignant tumor|malignant tumor
794237|NCT00277823|Depression|depression
794238|NCT00277823|Adult|adult
794239|NCT00277823|Outpatients|outpatients
794240|NCT00277810|Alzheimer's Disease|alzheimer's disease
794241|NCT00277810|Cholinesterase Inhibitors|cholinesterase inhibitors
794242|NCT00277810|Outpatients|outpatients
794243|NCT00277797|Low Back Pain|low back pain
794244|NCT00277784|Age Related Macular Degeneration|age related macular degeneration
794245|NCT00277784|Ultrasound|ultrasound
794246|NCT00277784|OCT|oct
794247|NCT00277784|Eye|eye
795281|NCT00273078|transducer,|transducer,
794248|NCT00277771|technology in weight loss|technology in weight loss
794249|NCT00277771|standard behavioral therapy for obesity|standard behavioral therapy for obesity
794250|NCT00277758|Interleukin-2|interleukin-2
794251|NCT00277745|periodontitis|periodontitis
794252|NCT00277745|microfluidics|microfluidics
794253|NCT00277745|saliva diagnostics|saliva diagnostics
794254|NCT00277706|periodontitis|periodontitis
794255|NCT00277706|bone regeneration|bone regeneration
794256|NCT00277706|Parathyroid Hormone|parathyroid hormone
794257|NCT00277706|moderate to advanced periodontitis|moderate to advanced periodontitis
794258|NCT00277693|hemodialysis|hemodialysis
794259|NCT00277693|aldosterone|aldosterone
794260|NCT00277693|heart failure|heart failure
794261|NCT00277693|spironolactone|spironolactone
794262|NCT00277680|uterine fibroids|uterine fibroids
794263|NCT00277680|leiomyoma|leiomyoma
794264|NCT00277680|laparoscopy|laparoscopy
794265|NCT00277680|menorrhagia|menorrhagia
794266|NCT00277667|currently experiencing hypomania or mild mania|currently experiencing hypomania or mild mania
794267|NCT00277654|Bipolar Disorder with Concurrent Moderately Severe Anxiety and Lifetime Panic or Generalized Anxiety Disorder|bipolar disorder with concurrent moderately severe anxiety and lifetime panic or generalized anxiety disorder
794268|NCT00277641|Binge Eating Disorder Associated with Obesity|binge eating disorder associated with obesity
794269|NCT00277615|Children|children
794270|NCT00277615|Bladder volume|bladder volume
794271|NCT00277615|Ultrasound|ultrasound
794272|NCT00277576|DNA vaccine|dna vaccine
794273|NCT00277576|immunotherapy|immunotherapy
794274|NCT00277576|Hepatitis B Virus|hepatitis b virus
794275|NCT00277576|Particle Mediated Epidermal Delivery|particle mediated epidermal delivery
794276|NCT00277563|Carpal Tunnel Syndrome|carpal tunnel syndrome
794277|NCT00277563|Neuropathic Pain|neuropathic pain
794278|NCT00277563|Neuromodulation|neuromodulation
794279|NCT00277563|PEMF|pemf
794280|NCT00277563|Magnetic Field Therapy|magnetic field therapy
794281|NCT00277563|Magnetotherapy|magnetotherapy
794282|NCT00277550|Constipation, Tegaserod, Dyspepsia|constipation, tegaserod, dyspepsia
794283|NCT00277537|Mannitol|mannitol
794284|NCT00277524|Pacemaker|pacemaker
794285|NCT00277524|Defibrillator|defibrillator
794286|NCT00277524|Cardiac Resynchronization|cardiac resynchronization
794287|NCT00277524|Dysynchrony|dysynchrony
794288|NCT00277524|Heart failure|heart failure
794292|NCT00277472|Hypertension|hypertension
794293|NCT00277472|High blood pressure|high blood pressure
794294|NCT00277472|diuretics|diuretics
794295|NCT00277472|valsartan|valsartan
794296|NCT00277446|Asthma|asthma
794297|NCT00277446|Soy isoflavones|soy isoflavones
794298|NCT00277446|Eosinophils|eosinophils
794299|NCT00277446|Exhaled nitric oxide|exhaled nitric oxide
794300|NCT00277433|Atopic Dermatitis|atopic dermatitis
794301|NCT00277433|Eczema|eczema
794302|NCT00277433|Genetics|genetics
794303|NCT00277433|Histamine|histamine
794304|NCT00277407|NAET|naet
794305|NCT00277407|Chiropractic procedures|chiropractic procedures
794306|NCT00277407|Acupuncture/acupressure|acupuncture/acupressure
794307|NCT00277407|Treatment of Autism by holistic procedures|treatment of autism by holistic procedures
794308|NCT00277407|Food and Vaccination allergy|food and vaccination allergy
794309|NCT00277394|Acute, symptomatic and objectively confirmed DVT|acute, symptomatic and objectively confirmed dvt
794310|NCT00277381|Adherence|adherence
794311|NCT00277381|Hypertension|hypertension
794312|NCT00277381|Telemedicine|telemedicine
794313|NCT00277368|Epilepsy|epilepsy
794314|NCT00277368|Headache|headache
794315|NCT00277368|Seizure|seizure
794316|NCT00277355|Study of Minocycline in Huntington's Disease|study of minocycline in huntington's disease
794317|NCT00277342|lipid induced hepatic insulin resistance|lipid induced hepatic insulin resistance
794318|NCT00277342|polymorphisms liver fatty-acid-binding-protein|polymorphisms liver fatty-acid-binding-protein
794319|NCT00277342|gluconeogenesis|gluconeogenesis
794320|NCT00277342|glycogenolysis|glycogenolysis
794321|NCT00277342|endogenous glucose production|endogenous glucose production
794322|NCT00277316|Kidney cancer|kidney cancer
794323|NCT00277316|Metastatic|metastatic
794324|NCT00277303|Colon Cancer|colon cancer
794325|NCT00277290|Cancer|cancer
794326|NCT00277290|Recurrent|recurrent
794327|NCT00277290|Platinum-resistant|platinum-resistant
794328|NCT00277290|Platinum-sensitive|platinum-sensitive
794329|NCT00277277|Telemedicine|telemedicine
794330|NCT00277277|Biobehavioral weight loss program|biobehavioral weight loss program
794331|NCT00277277|Body Mass Index|body mass index
794332|NCT00277277|Blood Glucose|blood glucose
794333|NCT00277277|Diabetes Management|diabetes management
794334|NCT00277251|Crohn's disease|crohn's disease
794335|NCT00277251|systemic-onset juvenile rheumatoid arthritis|systemic-onset juvenile rheumatoid arthritis
794336|NCT00277251|juvenile dermatomyositis|juvenile dermatomyositis
794337|NCT00277251|systemic lupus erythematosus (SLE)|systemic lupus erythematosus (sle)
794338|NCT00277251|Mixed connective tissue disease (MCTD)|mixed connective tissue disease (mctd)
794339|NCT00277251|vasculitis|vasculitis
794340|NCT00277238|HCV|hcv
794341|NCT00277238|Hepatitis c virus|hepatitis c virus
794342|NCT00277238|Virus diseases|virus diseases
794343|NCT00277238|Interferon-alpha|interferon-alpha
794344|NCT00277238|Interferons|interferons
794345|NCT00277238|Liver diseases|liver diseases
794346|NCT00277212|Bipolar I Disorder with a recent manic or mixed episode|bipolar i disorder with a recent manic or mixed episode
794347|NCT00277186|Arthroplasty|arthroplasty
794348|NCT00277186|Health services research|health services research
794349|NCT00277186|Intent to treat|intent to treat
794350|NCT00277186|Randomized|randomized
794351|NCT00277186|Controlled|controlled
794352|NCT00277173|Medication Safety|medication safety
794353|NCT00277173|Adverse Drug Events|adverse drug events
794354|NCT00277173|Preventable Adverse Drug Events|preventable adverse drug events
794355|NCT00277173|Culture of Safety|culture of safety
794356|NCT00277173|Failure Modes and Effects Analysis|failure modes and effects analysis
794357|NCT00277173|Teambuilding|teambuilding
794358|NCT00277147|Typhoid Fever|typhoid fever
794359|NCT00277147|Immunogenicity|immunogenicity
794360|NCT00277147|Safety|safety
794361|NCT00277147|Vaccine|vaccine
794362|NCT00277147|Conjugate|conjugate
794363|NCT00277147|Healthy Volunteer|healthy volunteer
794364|NCT00277121|Lipid disorder|lipid disorder
794365|NCT00277121|Gene mutation|gene mutation
794366|NCT00277108|postpartum depression|postpartum depression
794367|NCT00277108|postnatal depression|postnatal depression
794368|NCT00277108|PPD|ppd
794369|NCT00277095|Urinary Incontinence|urinary incontinence
794370|NCT00277082|Metastatic or Recurrent Cancer of the Endometrium or the Lung (NSCLC)|metastatic or recurrent cancer of the endometrium or the lung (nsclc)
794371|NCT00277082|Aerosolized Liposomal 9-Nitro 20|aerosolized liposomal 9-nitro 20
794372|NCT00277082|Camptothecin (L9NC)|camptothecin (l9nc)
794373|NCT00277069|Breast metastatic|breast metastatic
794374|NCT00277056|leukemia|leukemia
794375|NCT00277043|Taxane|taxane
794376|NCT00277043|Test Dose|test dose
794377|NCT00277030|Respiratory Distress Syndrome|respiratory distress syndrome
794378|NCT00277030|Surfactant|surfactant
794379|NCT00277030|Nasal CPAP|nasal cpap
794380|NCT00277017|Combination Therapy|combination therapy
794381|NCT00277017|5-Fluorouracil|5-fluorouracil
794382|NCT00277017|Interferon-a Interleukin-2|interferon-a interleukin-2
794383|NCT00277017|Thalidomide|thalidomide
794384|NCT00277017|Renal Cell Carcinoma|renal cell carcinoma
794385|NCT00276991|Prolonged Viral Suppression|prolonged viral suppression
794386|NCT00276991|HIV Infections|hiv infections
794387|NCT00276978|Therapy-resistant Depression|therapy-resistant depression
794388|NCT00276978|add-on therapy depression|add-on therapy depression
794389|NCT00276965|Bipolar II Depression|bipolar ii depression
794390|NCT00276952|Gonyautoxins|gonyautoxins
794391|NCT00276952|Tension-type Headache|tension-type headache
794392|NCT00276952|Human Treatment|human treatment
794393|NCT00276939|Diabetes Mellitus, Type 2|diabetes mellitus, type 2
794394|NCT00276939|Diet, Vegetarian|diet, vegetarian
794395|NCT00276939|Diet, Fat-Restricted|diet, fat-restricted
794396|NCT00276939|Glycemic Index|glycemic index
794397|NCT00276926|Hypereosinophilic Syndrome|hypereosinophilic syndrome
794398|NCT00276926|Eosinophilic leukemias|eosinophilic leukemias
794399|NCT00276926|STI571 (Gleevec)|sti571 (gleevec)
794400|NCT00276926|PDGF receptor alpha|pdgf receptor alpha
794401|NCT00276926|Familiar hypereosinophilia|familiar hypereosinophilia
794402|NCT00276926|Myeloproliferative disorder (MPD) with eosinophilia|myeloproliferative disorder (mpd) with eosinophilia
794403|NCT00276926|myeloproliferative disorders/myelodysplastic syndromes|myeloproliferative disorders/myelodysplastic syndromes
794404|NCT00276900|Postpartum Depression|postpartum depression
794405|NCT00276900|Recurrent Depression|recurrent depression
794406|NCT00276887|Somatization Disorder|somatization disorder
794407|NCT00276887|Multiple Medically Unexplained Symptoms|multiple medically unexplained symptoms
794408|NCT00276887|Cognitive Behavior Therapy|cognitive behavior therapy
794409|NCT00276887|Mental Health|mental health
794410|NCT00276874|Cocaine Addiction|cocaine addiction
794411|NCT00276874|Cocaine Dependence|cocaine dependence
794412|NCT00276861|adenocarcinoma of the colon|adenocarcinoma of the colon
794413|NCT00276861|recurrent colon cancer|recurrent colon cancer
794414|NCT00276861|stage IV colon cancer|stage iv colon cancer
794415|NCT00276848|stage III chronic lymphocytic leukemia|stage iii chronic lymphocytic leukemia
794416|NCT00276848|stage IV chronic lymphocytic leukemia|stage iv chronic lymphocytic leukemia
794417|NCT00276835|recurrent renal cell cancer|recurrent renal cell cancer
794418|NCT00276835|clear cell renal cell carcinoma|clear cell renal cell carcinoma
794419|NCT00276835|stage IV renal cell cancer|stage iv renal cell cancer
794420|NCT00276835|recurrent melanoma|recurrent melanoma
794421|NCT00276835|stage IV melanoma|stage iv melanoma
794422|NCT00276822|stage I breast cancer|stage i breast cancer
794423|NCT00276822|stage II breast cancer|stage ii breast cancer
794424|NCT00276822|stage IIIA breast cancer|stage iiia breast cancer
794425|NCT00276822|stage IIIB breast cancer|stage iiib breast cancer
794426|NCT00276822|stage IIIC breast cancer|stage iiic breast cancer
794427|NCT00276822|stage IV breast cancer|stage iv breast cancer
794428|NCT00276809|stage 0 chronic lymphocytic leukemia|stage 0 chronic lymphocytic leukemia
794429|NCT00276809|stage I chronic lymphocytic leukemia|stage i chronic lymphocytic leukemia
794582|NCT00276146|red blood cells|red blood cells
794430|NCT00276809|stage II chronic lymphocytic leukemia|stage ii chronic lymphocytic leukemia
794431|NCT00276809|stage III chronic lymphocytic leukemia|stage iii chronic lymphocytic leukemia
794432|NCT00276809|stage IV chronic lymphocytic leukemia|stage iv chronic lymphocytic leukemia
794433|NCT00276796|cervical squamous cell carcinoma|cervical squamous cell carcinoma
794434|NCT00276796|stage III cervical cancer|stage iii cervical cancer
794435|NCT00276796|recurrent cervical cancer|recurrent cervical cancer
794436|NCT00276796|cervical adenocarcinoma|cervical adenocarcinoma
794437|NCT00276796|cervical adenosquamous cell carcinoma|cervical adenosquamous cell carcinoma
794438|NCT00276796|cervical small cell carcinoma|cervical small cell carcinoma
794439|NCT00276796|stage IVA cervical cancer|stage iva cervical cancer
794440|NCT00276796|stage IVB cervical cancer|stage ivb cervical cancer
794441|NCT00276783|primary central nervous system lymphoma|primary central nervous system lymphoma
794442|NCT00276783|tumors metastatic to brain|tumors metastatic to brain
794443|NCT00276783|recurrent adult brain tumor|recurrent adult brain tumor
794444|NCT00276783|adult giant cell glioblastoma|adult giant cell glioblastoma
794445|NCT00276783|adult gliosarcoma|adult gliosarcoma
794446|NCT00276783|adult mixed glioma|adult mixed glioma
794447|NCT00276783|adult anaplastic astrocytoma|adult anaplastic astrocytoma
794448|NCT00276783|adult anaplastic oligodendroglioma|adult anaplastic oligodendroglioma
794449|NCT00276783|adult glioblastoma|adult glioblastoma
794450|NCT00276770|adult anaplastic astrocytoma|adult anaplastic astrocytoma
794451|NCT00276770|adult anaplastic ependymoma|adult anaplastic ependymoma
794452|NCT00276770|adult anaplastic oligodendroglioma|adult anaplastic oligodendroglioma
794453|NCT00276770|adult diffuse astrocytoma|adult diffuse astrocytoma
794454|NCT00276770|adult glioblastoma|adult glioblastoma
794455|NCT00276770|adult giant cell glioblastoma|adult giant cell glioblastoma
794456|NCT00276770|adult gliosarcoma|adult gliosarcoma
794457|NCT00276770|adult ependymoma|adult ependymoma
794458|NCT00276770|adult oligodendroglioma|adult oligodendroglioma
794459|NCT00276770|recurrent adult brain tumor|recurrent adult brain tumor
794460|NCT00276770|adult mixed glioma|adult mixed glioma
794461|NCT00276757|childhood Langerhans cell histiocytosis|childhood langerhans cell histiocytosis
794462|NCT00276744|recurrent pancreatic cancer|recurrent pancreatic cancer
794463|NCT00276744|stage III pancreatic cancer|stage iii pancreatic cancer
794464|NCT00276744|adenocarcinoma of the pancreas|adenocarcinoma of the pancreas
794465|NCT00276744|stage I pancreatic cancer|stage i pancreatic cancer
794466|NCT00276744|stage II pancreatic cancer|stage ii pancreatic cancer
794467|NCT00276731|localized resectable neuroblastoma|localized resectable neuroblastoma
794468|NCT00276731|localized unresectable neuroblastoma|localized unresectable neuroblastoma
794469|NCT00276731|regional neuroblastoma|regional neuroblastoma
794470|NCT00276718|childhood malignant ovarian germ cell tumor|childhood malignant ovarian germ cell tumor
794471|NCT00276718|childhood malignant testicular germ cell tumor|childhood malignant testicular germ cell tumor
794472|NCT00276718|childhood central nervous system germ cell tumor|childhood central nervous system germ cell tumor
794473|NCT00276718|childhood extragonadal germ cell tumor|childhood extragonadal germ cell tumor
794474|NCT00276718|childhood teratoma|childhood teratoma
794475|NCT00276705|adult primary hepatocellular carcinoma|adult primary hepatocellular carcinoma
794476|NCT00276705|childhood hepatocellular carcinoma|childhood hepatocellular carcinoma
794477|NCT00276705|advanced adult primary liver cancer|advanced adult primary liver cancer
794478|NCT00276705|localized resectable adult primary liver cancer|localized resectable adult primary liver cancer
794479|NCT00276705|localized unresectable adult primary liver cancer|localized unresectable adult primary liver cancer
794480|NCT00276705|stage I childhood liver cancer|stage i childhood liver cancer
794481|NCT00276705|stage II childhood liver cancer|stage ii childhood liver cancer
794482|NCT00276705|stage III childhood liver cancer|stage iii childhood liver cancer
794483|NCT00276705|stage IV childhood liver cancer|stage iv childhood liver cancer
794484|NCT00276692|metastatic Ewing sarcoma/peripheral primitive neuroectodermal tumor|metastatic ewing sarcoma/peripheral primitive neuroectodermal tumor
794485|NCT00276679|recurrent neuroblastoma|recurrent neuroblastoma
794486|NCT00276679|disseminated neuroblastoma|disseminated neuroblastoma
794487|NCT00276679|localized unresectable neuroblastoma|localized unresectable neuroblastoma
794488|NCT00276666|untreated childhood medulloblastoma|untreated childhood medulloblastoma
794489|NCT00276640|recurrent childhood brain stem glioma|recurrent childhood brain stem glioma
794490|NCT00276640|untreated childhood brain stem glioma|untreated childhood brain stem glioma
794491|NCT00276640|recurrent childhood cerebellar astrocytoma|recurrent childhood cerebellar astrocytoma
794492|NCT00276640|untreated childhood cerebellar astrocytoma|untreated childhood cerebellar astrocytoma
794493|NCT00276640|childhood low-grade cerebral astrocytoma|childhood low-grade cerebral astrocytoma
794494|NCT00276640|recurrent childhood cerebral astrocytoma|recurrent childhood cerebral astrocytoma
794495|NCT00276640|childhood oligodendroglioma|childhood oligodendroglioma
794496|NCT00276640|recurrent childhood visual pathway and hypothalamic glioma|recurrent childhood visual pathway and hypothalamic glioma
794497|NCT00276640|untreated childhood visual pathway and hypothalamic glioma|untreated childhood visual pathway and hypothalamic glioma
794498|NCT00276640|childhood spinal cord neoplasm|childhood spinal cord neoplasm
794499|NCT00276627|unspecified adult solid tumor, protocol specific|unspecified adult solid tumor, protocol specific
794500|NCT00276614|stage IV renal cell cancer|stage iv renal cell cancer
794501|NCT00276614|recurrent renal cell cancer|recurrent renal cell cancer
794502|NCT00276614|papillary renal cell carcinoma|papillary renal cell carcinoma
794503|NCT00276601|untreated adult acute myeloid leukemia|untreated adult acute myeloid leukemia
794504|NCT00276601|untreated childhood acute myeloid leukemia and other myeloid malignancies|untreated childhood acute myeloid leukemia and other myeloid malignancies
794505|NCT00276601|adult acute promyelocytic leukemia (M3)|adult acute promyelocytic leukemia (m3)
794506|NCT00276601|childhood acute promyelocytic leukemia (M3)|childhood acute promyelocytic leukemia (m3)
794507|NCT00276601|adult acute myeloid leukemia with t(15;17)(q22;q12)|adult acute myeloid leukemia with t(15;17)(q22;q12)
794508|NCT00276588|adenocarcinoma of the lung|adenocarcinoma of the lung
794509|NCT00276588|adenosquamous cell lung cancer|adenosquamous cell lung cancer
794510|NCT00276588|large cell lung cancer|large cell lung cancer
794511|NCT00276588|recurrent non-small cell lung cancer|recurrent non-small cell lung cancer
794512|NCT00276588|squamous cell lung cancer|squamous cell lung cancer
794513|NCT00276588|stage IIIB non-small cell lung cancer|stage iiib non-small cell lung cancer
794514|NCT00276588|stage IV non-small cell lung cancer|stage iv non-small cell lung cancer
794515|NCT00276575|unspecified adult solid tumor, protocol specific|unspecified adult solid tumor, protocol specific
794516|NCT00276549|adenocarcinoma of the prostate|adenocarcinoma of the prostate
794517|NCT00276549|stage IV prostate cancer|stage iv prostate cancer
794518|NCT00276536|stage IV melanoma|stage iv melanoma
794519|NCT00276536|unspecified adult solid tumor, protocol specific|unspecified adult solid tumor, protocol specific
794520|NCT00276523|stage II squamous cell carcinoma of the lip and oral cavity|stage ii squamous cell carcinoma of the lip and oral cavity
794521|NCT00276523|stage III squamous cell carcinoma of the lip and oral cavity|stage iii squamous cell carcinoma of the lip and oral cavity
794522|NCT00276523|stage IV squamous cell carcinoma of the lip and oral cavity|stage iv squamous cell carcinoma of the lip and oral cavity
794523|NCT00276523|stage II squamous cell carcinoma of the oropharynx|stage ii squamous cell carcinoma of the oropharynx
794524|NCT00276523|stage III squamous cell carcinoma of the oropharynx|stage iii squamous cell carcinoma of the oropharynx
794525|NCT00276523|stage IV squamous cell carcinoma of the oropharynx|stage iv squamous cell carcinoma of the oropharynx
794526|NCT00276523|stage II squamous cell carcinoma of the hypopharynx|stage ii squamous cell carcinoma of the hypopharynx
794527|NCT00276523|stage III squamous cell carcinoma of the hypopharynx|stage iii squamous cell carcinoma of the hypopharynx
794528|NCT00276523|stage IV squamous cell carcinoma of the hypopharynx|stage iv squamous cell carcinoma of the hypopharynx
794529|NCT00276523|stage II squamous cell carcinoma of the larynx|stage ii squamous cell carcinoma of the larynx
794631|NCT00275925|partial epilepsy, oxcarbazepine, adults|partial epilepsy, oxcarbazepine, adults
794530|NCT00276523|stage III squamous cell carcinoma of the larynx|stage iii squamous cell carcinoma of the larynx
794531|NCT00276523|stage IV squamous cell carcinoma of the larynx|stage iv squamous cell carcinoma of the larynx
794532|NCT00276523|recurrent squamous cell carcinoma of the hypopharynx|recurrent squamous cell carcinoma of the hypopharynx
794533|NCT00276523|recurrent squamous cell carcinoma of the larynx|recurrent squamous cell carcinoma of the larynx
794534|NCT00276523|recurrent squamous cell carcinoma of the lip and oral cavity|recurrent squamous cell carcinoma of the lip and oral cavity
794535|NCT00276523|recurrent squamous cell carcinoma of the oropharynx|recurrent squamous cell carcinoma of the oropharynx
794536|NCT00276497|Impaired glucose tolerance|impaired glucose tolerance
794537|NCT00276497|Intervention|intervention
794538|NCT00276497|Prevention|prevention
794539|NCT00276445|allergy|allergy
794540|NCT00276445|Allergy conjunctivitis|allergy conjunctivitis
794541|NCT00276445|beta-1-3glucan|beta-1-3glucan
794542|NCT00276445|Th1/Th2|th1/th2
794543|NCT00276341|cognitive impairment|cognitive impairment
794544|NCT00276289|nephrolithiasis|nephrolithiasis
794545|NCT00276289|hypercalciuria|hypercalciuria
794546|NCT00276289|hypokalemia|hypokalemia
794547|NCT00276289|thiazide diuretics|thiazide diuretics
794548|NCT00276276|relapsed|relapsed
794549|NCT00276276|lung cancer|lung cancer
794550|NCT00276276|resistant|resistant
794551|NCT00276276|small cel|small cel
794552|NCT00276276|topotecan (HYCAMTIN)|topotecan (hycamtin)
794553|NCT00276263|Schizophrenia prodrome|schizophrenia prodrome
794554|NCT00276263|Sarcosine|sarcosine
794555|NCT00276263|Psychosis|psychosis
794556|NCT00276263|NMDA receptor|nmda receptor
794557|NCT00276263|Prevention|prevention
794558|NCT00276237|Congenital Heart Disease|congenital heart disease
794559|NCT00276237|Pulmonary Valve Replacement|pulmonary valve replacement
794560|NCT00276224|iron deficiency schistosomiasis soil transmitted helminths|iron deficiency schistosomiasis soil transmitted helminths
794561|NCT00276211|MRI diffusion mamma cancer|mri diffusion mamma cancer
794562|NCT00276198|Clinical trial, controlled|clinical trial, controlled
794563|NCT00276198|Micronutrients|micronutrients
794564|NCT00276198|Dietary Supplementation|dietary supplementation
794565|NCT00276198|Infants|infants
794566|NCT00276185|spasticity ;|spasticity ;
794567|NCT00276185|Botulinum toxin ;|botulinum toxin ;
794568|NCT00276185|Upper limb ;|upper limb ;
794569|NCT00276185|motor function.|motor function.
794570|NCT00276185|spastic hemiplegia after stoke|spastic hemiplegia after stoke
794571|NCT00276159|Leukemia|leukemia
794572|NCT00276159|Lymphoma|lymphoma
794573|NCT00276159|Myeloma|myeloma
794574|NCT00276159|Hematology|hematology
794575|NCT00276159|852A|852a
794577|NCT00276159|Oncology|oncology
794578|NCT00276146|dipyridamole|dipyridamole
794579|NCT00276146|magnesium|magnesium
794580|NCT00276146|sickle cell|sickle cell
794581|NCT00276146|anemia|anemia
794583|NCT00276133|small dense LDL|small dense ldl
794585|NCT00276120|Cancer|cancer
794586|NCT00276120|Young|young
794587|NCT00276120|Women|women
794588|NCT00276107|Vaccine|vaccine
794589|NCT00276107|Healthy Infants|healthy infants
794590|NCT00276094|Urogenital atrophy|urogenital atrophy
794591|NCT00276094|Vaginal atrophy|vaginal atrophy
794592|NCT00276094|Vulvar and vaginal atrophy in postmenopausal women|vulvar and vaginal atrophy in postmenopausal women
794593|NCT00276094|Menopausal symptoms|menopausal symptoms
794594|NCT00276081|Hot flashes|hot flashes
794595|NCT00276081|postmenopausal|postmenopausal
794596|NCT00276081|climacteric symptoms|climacteric symptoms
794597|NCT00276081|hormone replacement therapy|hormone replacement therapy
794598|NCT00276081|gabapentin|gabapentin
794599|NCT00276068|Vulvar vestibulitis|vulvar vestibulitis
794600|NCT00276068|Vulvodynia|vulvodynia
794601|NCT00276068|Desipramine|desipramine
794602|NCT00276068|Lidocaine|lidocaine
794603|NCT00276068|Genetics|genetics
794604|NCT00276055|Soft Tissue Sarcoma|soft tissue sarcoma
794605|NCT00276055|Phase I|phase i
794606|NCT00276055|Gemcitabine|gemcitabine
794607|NCT00276055|Docetaxel|docetaxel
794608|NCT00276055|Bevacizumab|bevacizumab
794609|NCT00276055|vascular endothelial growth factor|vascular endothelial growth factor
794610|NCT00276042|AOM|aom
794611|NCT00276029|Asthma|asthma
794612|NCT00276029|Refractory|refractory
794613|NCT00276003|Lymphoma-Non Hodgkins|lymphoma-non hodgkins
794614|NCT00276003|Phase II|phase ii
794615|NCT00276003|Gemcitabine|gemcitabine
794616|NCT00276003|Irinotecan|irinotecan
794617|NCT00275990|coronary thrombectomy|coronary thrombectomy
794618|NCT00275990|thrombectomy for acute myocardial infarction|thrombectomy for acute myocardial infarction
794619|NCT00275990|C14.280.647.500|c14.280.647.500
794620|NCT00275990|C14.907.553.355.500|c14.907.553.355.500
794621|NCT00275977|"Stem cell"|"stem cell"
794622|NCT00275977|"autologous bone marrow transplantation"|"autologous bone marrow transplantation"
794623|NCT00275977|"Myocardial infarction"|"myocardial infarction"
794624|NCT00275951|Combination|combination
794625|NCT00275951|Chemotherapy|chemotherapy
794626|NCT00275951|Gastric cancer|gastric cancer
794627|NCT00275938|hepatitis B virus|hepatitis b virus
794628|NCT00275938|e antigen|e antigen
794629|NCT00275938|interferon|interferon
794630|NCT00275938|ribavirin|ribavirin
794632|NCT00275834|obesity treatment|obesity treatment
794633|NCT00275834|weight loss|weight loss
794634|NCT00275834|antiobesity drugs|antiobesity drugs
794635|NCT00275834|zonisamide|zonisamide
794636|NCT00275821|Age-related macular degeneration, ranibizumab|age-related macular degeneration, ranibizumab
794637|NCT00275795|NST-NAET testing|nst-naet testing
794638|NCT00275795|Food Ssensitivities|food ssensitivities
794639|NCT00275795|Eczema|eczema
794640|NCT00275795|Acne|acne
794641|NCT00275795|Indigestion|indigestion
794642|NCT00275769|Arrhythmia|arrhythmia
794643|NCT00275769|Bradycardia|bradycardia
794644|NCT00275769|Cardiac Pacemaker Artificial|cardiac pacemaker artificial
794645|NCT00275756|Ocular Physiology|ocular physiology
794646|NCT00275756|Brimonidine|brimonidine
794647|NCT00275756|Timoptic|timoptic
794648|NCT00275756|Dorzolamide|dorzolamide
794649|NCT00275756|ocular blood flow|ocular blood flow
794650|NCT00275756|Regional Blood Flow|regional blood flow
794651|NCT00275730|indometacine|indometacine
794652|NCT00275730|retinal blood flow|retinal blood flow
794653|NCT00275730|choroidal blood flow|choroidal blood flow
794654|NCT00275561|Eosinophilic Esophagitis|eosinophilic esophagitis
794655|NCT00275561|Fluticasone|fluticasone
794656|NCT00275561|Dysphagia|dysphagia
794657|NCT00275535|kidney transplantation|kidney transplantation
794658|NCT00275535|immunosuppression|immunosuppression
794659|NCT00275535|calcineurin inhibitor|calcineurin inhibitor
794660|NCT00275535|sirolimus|sirolimus
794661|NCT00275535|chronic allograft nephropathy|chronic allograft nephropathy
794662|NCT00275509|kidney|kidney
794663|NCT00275509|transplantation|transplantation
794664|NCT00275509|positive crossmatch|positive crossmatch
794665|NCT00275509|antibody mediated rejection|antibody mediated rejection
794666|NCT00275509|rejection|rejection
794667|NCT00275509|induction|induction
794668|NCT00275509|therapy|therapy
794669|NCT00275509|trial|trial
794670|NCT00275496|SLND|slnd
794671|NCT00275496|Sentinel|sentinel
794672|NCT00275496|Melanoma|melanoma
794673|NCT00275496|Surgical|surgical
794674|NCT00275431|cancer|cancer
794675|NCT00275431|AT-101|at-101
794676|NCT00275431|AT101|at101
794677|NCT00275431|B-cell malignancies|b-cell malignancies
794678|NCT00275431|Non-Hodgkin|non-hodgkin
794679|NCT00275431|lymphoma|lymphoma
794680|NCT00275431|lukemia|lukemia
794681|NCT00275418|Crohn's disease|crohn's disease
794682|NCT00275418|remission|remission
794683|NCT00275418|beta carotene|beta carotene
794684|NCT00275405|Effects of Garlic|effects of garlic
794685|NCT00275392|Dizziness|dizziness
794686|NCT00275392|Geriatrics|geriatrics
794687|NCT00275392|Rehabilitation|rehabilitation
794688|NCT00275392|Vestibular rehabilitation|vestibular rehabilitation
794689|NCT00275379|Cystitis|cystitis
794690|NCT00275366|cuff, rotator|cuff, rotator
794691|NCT00275366|Rotator cuff|rotator cuff
794692|NCT00275340|Pain|pain
794693|NCT00275340|Depressive Symptoms|depressive symptoms
794694|NCT00275340|Coronary Artery Bypass|coronary artery bypass
794695|NCT00275340|Convalescence|convalescence
794696|NCT00275340|Quality of Life|quality of life
794697|NCT00275340|Human Activities|human activities
794698|NCT00275327|antibiotics|antibiotics
794699|NCT00275314|transplantation|transplantation
794700|NCT00275301|Borderline Personality Disorder|borderline personality disorder
794701|NCT00275301|BPD|bpd
794702|NCT00275301|PET|pet
794703|NCT00275301|olanzapine|olanzapine
794704|NCT00275301|brain|brain
794705|NCT00275288|Borderline Personality Disorder|borderline personality disorder
794706|NCT00275288|BPD|bpd
794707|NCT00275288|amygdala|amygdala
794708|NCT00275288|facial expression response|facial expression response
794709|NCT00275288|MRI|mri
794710|NCT00275275|PD|pd
794711|NCT00275275|Parkinson's|parkinson's
794712|NCT00275262|Bone marrow transplantation|bone marrow transplantation
794713|NCT00275262|Hematopoietic stem cell transplantation|hematopoietic stem cell transplantation
794714|NCT00275262|Hodgkin's disease|hodgkin's disease
794715|NCT00275262|non-Hodgkin's lymphoma|non-hodgkin's lymphoma
794716|NCT00275262|multiple myeloma|multiple myeloma
794717|NCT00275249|Chronic Pain|chronic pain
794718|NCT00275236|Idiopthic Restless Legs Syndrome|idiopthic restless legs syndrome
794719|NCT00275223|adipose tissue|adipose tissue
794720|NCT00275223|adipocytokines|adipocytokines
794721|NCT00275210|Oxaliplatin|oxaliplatin
794722|NCT00275210|Chemotherapy,adjuvant|chemotherapy,adjuvant
794723|NCT00275210|Colonic Neoplasms|colonic neoplasms
794724|NCT00275184|Bowel preparation|bowel preparation
794725|NCT00275184|capsule endoscopy|capsule endoscopy
794726|NCT00275184|randomised|randomised
794727|NCT00275184|Citramag|citramag
794728|NCT00275184|Senna|senna
794729|NCT00275184|Metoclopramide|metoclopramide
794730|NCT00275184|Patients referred for Capsule endoscopy|patients referred for capsule endoscopy
794731|NCT00275184|occult/overt gastrointestinal bleeding|occult/overt gastrointestinal bleeding
794732|NCT00275184|other suspected small bowel pathology|other suspected small bowel pathology
794733|NCT00275171|Nontoxic nodular goiter|nontoxic nodular goiter
794734|NCT00275171|131I therapy|131i therapy
795428|NCT00272519|Adolescent|adolescent
794735|NCT00275171|thyroid radioiodine uptake|thyroid radioiodine uptake
794736|NCT00275171|optimal time-interval|optimal time-interval
794737|NCT00275171|reduced 131I activity|reduced 131i activity
794738|NCT00275171|goiter reduction|goiter reduction
794739|NCT00275158|Pre-Eclampsia|pre-eclampsia
794740|NCT00275158|Glomerular Filtration Rate (GFR)|glomerular filtration rate (gfr)
794741|NCT00275158|Inulin clearance|inulin clearance
794742|NCT00275158|Hypertension|hypertension
794743|NCT00275158|L-Arginine|l-arginine
794744|NCT00275158|Nitric Oxide|nitric oxide
794746|NCT00275158|Endothelin|endothelin
794747|NCT00275158|ADMA|adma
794748|NCT00275132|stage IIIB non-small cell lung cancer|stage iiib non-small cell lung cancer
794749|NCT00275132|stage IV non-small cell lung cancer|stage iv non-small cell lung cancer
794750|NCT00275119|adenocarcinoma of the pancreas|adenocarcinoma of the pancreas
794751|NCT00275119|stage II pancreatic cancer|stage ii pancreatic cancer
794752|NCT00275119|stage III pancreatic cancer|stage iii pancreatic cancer
794753|NCT00275119|recurrent pancreatic cancer|recurrent pancreatic cancer
794754|NCT00275106|stage I childhood lymphoblastic lymphoma|stage i childhood lymphoblastic lymphoma
794755|NCT00275106|stage II childhood lymphoblastic lymphoma|stage ii childhood lymphoblastic lymphoma
794756|NCT00275106|stage III childhood lymphoblastic lymphoma|stage iii childhood lymphoblastic lymphoma
794757|NCT00275106|stage IV childhood lymphoblastic lymphoma|stage iv childhood lymphoblastic lymphoma
794758|NCT00275067|adult anaplastic astrocytoma|adult anaplastic astrocytoma
794759|NCT00275067|adult gliosarcoma|adult gliosarcoma
794760|NCT00275067|adult anaplastic oligodendroglioma|adult anaplastic oligodendroglioma
794761|NCT00275067|adult mixed glioma|adult mixed glioma
794762|NCT00275067|adult glioblastoma|adult glioblastoma
794763|NCT00275067|adult giant cell glioblastoma|adult giant cell glioblastoma
794764|NCT00275067|recurrent adult brain tumor|recurrent adult brain tumor
794765|NCT00275054|stage 0 chronic lymphocytic leukemia|stage 0 chronic lymphocytic leukemia
794766|NCT00275054|B-cell chronic lymphocytic leukemia|b-cell chronic lymphocytic leukemia
794767|NCT00275054|stage I chronic lymphocytic leukemia|stage i chronic lymphocytic leukemia
794768|NCT00275054|stage II chronic lymphocytic leukemia|stage ii chronic lymphocytic leukemia
794769|NCT00275041|recurrent breast cancer|recurrent breast cancer
794770|NCT00275041|stage IV breast cancer|stage iv breast cancer
794771|NCT00275041|male breast cancer|male breast cancer
794772|NCT00275015|stage 0 chronic lymphocytic leukemia|stage 0 chronic lymphocytic leukemia
794773|NCT00275015|stage I chronic lymphocytic leukemia|stage i chronic lymphocytic leukemia
794774|NCT00275015|stage II chronic lymphocytic leukemia|stage ii chronic lymphocytic leukemia
794775|NCT00275015|stage III chronic lymphocytic leukemia|stage iii chronic lymphocytic leukemia
794776|NCT00275015|stage IV chronic lymphocytic leukemia|stage iv chronic lymphocytic leukemia
794847|NCT00274885|stage IIIB gastric cancer|stage iiib gastric cancer
794777|NCT00275015|refractory chronic lymphocytic leukemia|refractory chronic lymphocytic leukemia
794778|NCT00275002|recurrent childhood brain stem glioma|recurrent childhood brain stem glioma
794779|NCT00275002|recurrent childhood brain tumor|recurrent childhood brain tumor
794780|NCT00274989|B-cell chronic lymphocytic leukemia|b-cell chronic lymphocytic leukemia
794781|NCT00274989|relapsed refractory chronic lymphocytic leukemia|relapsed refractory chronic lymphocytic leukemia
794782|NCT00274989|previously untreated chronic lymphocytic leukemia|previously untreated chronic lymphocytic leukemia
794783|NCT00274976|refractory chronic lymphocytic leukemia|refractory chronic lymphocytic leukemia
794784|NCT00274976|stage III chronic lymphocytic leukemia|stage iii chronic lymphocytic leukemia
794785|NCT00274976|stage IV chronic lymphocytic leukemia|stage iv chronic lymphocytic leukemia
794786|NCT00274963|B-cell chronic lymphocytic leukemia|b-cell chronic lymphocytic leukemia
794787|NCT00274963|refractory chronic lymphocytic leukemia|refractory chronic lymphocytic leukemia
794788|NCT00274950|childhood extragonadal germ cell tumor|childhood extragonadal germ cell tumor
794789|NCT00274950|childhood malignant ovarian germ cell tumor|childhood malignant ovarian germ cell tumor
794790|NCT00274950|childhood malignant testicular germ cell tumor|childhood malignant testicular germ cell tumor
794791|NCT00274950|recurrent childhood malignant germ cell tumor|recurrent childhood malignant germ cell tumor
794792|NCT00274950|childhood teratoma|childhood teratoma
794793|NCT00274950|childhood extracranial germ cell tumor|childhood extracranial germ cell tumor
794794|NCT00274924|contiguous stage II adult diffuse large cell lymphoma|contiguous stage ii adult diffuse large cell lymphoma
794795|NCT00274924|noncontiguous stage II adult diffuse large cell lymphoma|noncontiguous stage ii adult diffuse large cell lymphoma
794796|NCT00274924|stage III adult diffuse large cell lymphoma|stage iii adult diffuse large cell lymphoma
794797|NCT00274924|stage IV adult diffuse large cell lymphoma|stage iv adult diffuse large cell lymphoma
794798|NCT00274911|untreated childhood supratentorial primitive neuroectodermal tumor|untreated childhood supratentorial primitive neuroectodermal tumor
794799|NCT00274898|stage II non-small cell lung cancer|stage ii non-small cell lung cancer
794800|NCT00274898|stage IIIA non-small cell lung cancer|stage iiia non-small cell lung cancer
794801|NCT00274898|stage IIIB non-small cell lung cancer|stage iiib non-small cell lung cancer
794802|NCT00274898|recurrent non-small cell lung cancer|recurrent non-small cell lung cancer
794803|NCT00274885|neurotoxicity|neurotoxicity
794804|NCT00274885|carcinoma of the appendix|carcinoma of the appendix
794805|NCT00274885|recurrent anal cancer|recurrent anal cancer
794806|NCT00274885|stage I anal cancer|stage i anal cancer
794807|NCT00274885|stage II anal cancer|stage ii anal cancer
794808|NCT00274885|stage IIIA anal cancer|stage iiia anal cancer
794809|NCT00274885|stage IIIB anal cancer|stage iiib anal cancer
794810|NCT00274885|stage IV anal cancer|stage iv anal cancer
794811|NCT00274885|localized extrahepatic bile duct cancer|localized extrahepatic bile duct cancer
794812|NCT00274885|recurrent extrahepatic bile duct cancer|recurrent extrahepatic bile duct cancer
794813|NCT00274885|unresectable extrahepatic bile duct cancer|unresectable extrahepatic bile duct cancer
794814|NCT00274885|localized gallbladder cancer|localized gallbladder cancer
794815|NCT00274885|recurrent gallbladder cancer|recurrent gallbladder cancer
794816|NCT00274885|unresectable gallbladder cancer|unresectable gallbladder cancer
794817|NCT00274885|recurrent gastric cancer|recurrent gastric cancer
794818|NCT00274885|stage IV gastric cancer|stage iv gastric cancer
794819|NCT00274885|recurrent colon cancer|recurrent colon cancer
794820|NCT00274885|recurrent rectal cancer|recurrent rectal cancer
794821|NCT00274885|recurrent esophageal cancer|recurrent esophageal cancer
794822|NCT00274885|localized gastrointestinal carcinoid tumor|localized gastrointestinal carcinoid tumor
794823|NCT00274885|metastatic gastrointestinal carcinoid tumor|metastatic gastrointestinal carcinoid tumor
794824|NCT00274885|recurrent gastrointestinal carcinoid tumor|recurrent gastrointestinal carcinoid tumor
794825|NCT00274885|regional gastrointestinal carcinoid tumor|regional gastrointestinal carcinoid tumor
794826|NCT00274885|gastrointestinal stromal tumor|gastrointestinal stromal tumor
794827|NCT00274885|advanced adult primary liver cancer|advanced adult primary liver cancer
794828|NCT00274885|localized resectable adult primary liver cancer|localized resectable adult primary liver cancer
794829|NCT00274885|localized unresectable adult primary liver cancer|localized unresectable adult primary liver cancer
794830|NCT00274885|recurrent adult primary liver cancer|recurrent adult primary liver cancer
794831|NCT00274885|recurrent pancreatic cancer|recurrent pancreatic cancer
794832|NCT00274885|stage I pancreatic cancer|stage i pancreatic cancer
794833|NCT00274885|stage II pancreatic cancer|stage ii pancreatic cancer
794834|NCT00274885|stage III pancreatic cancer|stage iii pancreatic cancer
794835|NCT00274885|recurrent small intestine cancer|recurrent small intestine cancer
794836|NCT00274885|small intestine adenocarcinoma|small intestine adenocarcinoma
794837|NCT00274885|small intestine leiomyosarcoma|small intestine leiomyosarcoma
794838|NCT00274885|small intestine lymphoma|small intestine lymphoma
794839|NCT00274885|stage IV pancreatic cancer|stage iv pancreatic cancer
794840|NCT00274885|metastatic extrahepatic bile duct cancer|metastatic extrahepatic bile duct cancer
794841|NCT00274885|metastatic gallbladder cancer|metastatic gallbladder cancer
794842|NCT00274885|stage IA gastric cancer|stage ia gastric cancer
794843|NCT00274885|stage IB gastric cancer|stage ib gastric cancer
794844|NCT00274885|stage IIA gastric cancer|stage iia gastric cancer
794845|NCT00274885|stage IIB gastric cancer|stage iib gastric cancer
794846|NCT00274885|stage IIIA gastric cancer|stage iiia gastric cancer
795280|NCT00273078|pressure,|pressure,
794848|NCT00274885|stage IIIC gastric cancer|stage iiic gastric cancer
794849|NCT00274885|stage I colon cancer|stage i colon cancer
794850|NCT00274885|stage IIA colon cancer|stage iia colon cancer
794851|NCT00274885|stage IIB colon cancer|stage iib colon cancer
794852|NCT00274885|stage IIIA colon cancer|stage iiia colon cancer
794853|NCT00274885|stage IIIB colon cancer|stage iiib colon cancer
794854|NCT00274885|stage IIIC colon cancer|stage iiic colon cancer
794855|NCT00274885|stage IVA colon cancer|stage iva colon cancer
794856|NCT00274885|stage IVB colon cancer|stage ivb colon cancer
794857|NCT00274885|stage I rectal cancer|stage i rectal cancer
794858|NCT00274885|stage IIA rectal cancer|stage iia rectal cancer
794859|NCT00274885|stage IIB rectal cancer|stage iib rectal cancer
794860|NCT00274885|stage IIC rectal cancer|stage iic rectal cancer
794861|NCT00274885|stage IIIA rectal cancer|stage iiia rectal cancer
794862|NCT00274885|stage IIIB rectal cancer|stage iiib rectal cancer
794863|NCT00274885|stage IIIC rectal cancer|stage iiic rectal cancer
794864|NCT00274885|stage IVA rectal cancer|stage iva rectal cancer
794865|NCT00274885|stage IVB rectal cancer|stage ivb rectal cancer
794866|NCT00274885|stage IA esophageal cancer|stage ia esophageal cancer
794867|NCT00274885|stage IB esophageal cancer|stage ib esophageal cancer
794868|NCT00274885|stage IIA esophageal cancer|stage iia esophageal cancer
794869|NCT00274885|stage IIB esophageal cancer|stage iib esophageal cancer
794870|NCT00274885|stage IIIA esophageal cancer|stage iiia esophageal cancer
794871|NCT00274885|stage IIIB esophageal cancer|stage iiib esophageal cancer
794872|NCT00274885|stage IIIC esophageal cancer|stage iiic esophageal cancer
794873|NCT00274885|stage IV esophageal cancer|stage iv esophageal cancer
794874|NCT00274872|recurrent rectal cancer|recurrent rectal cancer
794875|NCT00274872|stage IV rectal cancer|stage iv rectal cancer
794876|NCT00274872|recurrent colon cancer|recurrent colon cancer
794877|NCT00274872|stage IV colon cancer|stage iv colon cancer
794878|NCT00274872|adenocarcinoma of the colon|adenocarcinoma of the colon
794879|NCT00274872|adenocarcinoma of the rectum|adenocarcinoma of the rectum
794880|NCT00274859|unspecified adult solid tumor, protocol specific|unspecified adult solid tumor, protocol specific
794881|NCT00274846|recurrent adult acute myeloid leukemia|recurrent adult acute myeloid leukemia
794882|NCT00274846|recurrent childhood acute myeloid leukemia|recurrent childhood acute myeloid leukemia
794883|NCT00274846|secondary acute myeloid leukemia|secondary acute myeloid leukemia
794884|NCT00274846|adult acute myeloid leukemia with 11q23 (MLL) abnormalities|adult acute myeloid leukemia with 11q23 (mll) abnormalities
794885|NCT00274846|adult acute myeloid leukemia with inv(16)(p13;q22)|adult acute myeloid leukemia with inv(16)(p13;q22)
794886|NCT00274846|adult acute myeloid leukemia with t(15;17)(q22;q12)|adult acute myeloid leukemia with t(15;17)(q22;q12)
794887|NCT00274846|adult acute myeloid leukemia with t(16;16)(p13;q22)|adult acute myeloid leukemia with t(16;16)(p13;q22)
794888|NCT00274846|adult acute myeloid leukemia with t(8;21)(q22;q22)|adult acute myeloid leukemia with t(8;21)(q22;q22)
794889|NCT00274833|adult glioblastoma|adult glioblastoma
794890|NCT00274833|adult giant cell glioblastoma|adult giant cell glioblastoma
794891|NCT00274833|adult gliosarcoma|adult gliosarcoma
794892|NCT00274820|chronic idiopathic myelofibrosis|chronic idiopathic myelofibrosis
794893|NCT00274820|chronic myelomonocytic leukemia|chronic myelomonocytic leukemia
794894|NCT00274820|atypical chronic myeloid leukemia|atypical chronic myeloid leukemia
794895|NCT00274820|myelodysplastic/myeloproliferative disease, unclassifiable|myelodysplastic/myeloproliferative disease, unclassifiable
794896|NCT00274820|de novo myelodysplastic syndromes|de novo myelodysplastic syndromes
794897|NCT00274820|previously treated myelodysplastic syndromes|previously treated myelodysplastic syndromes
794898|NCT00274820|secondary myelodysplastic syndromes|secondary myelodysplastic syndromes
794899|NCT00274807|untreated adult acute myeloid leukemia|untreated adult acute myeloid leukemia
794900|NCT00274807|adult acute myeloid leukemia with 11q23 (MLL) abnormalities|adult acute myeloid leukemia with 11q23 (mll) abnormalities
794901|NCT00274807|adult acute myeloid leukemia with inv(16)(p13;q22)|adult acute myeloid leukemia with inv(16)(p13;q22)
794902|NCT00274807|adult acute myeloid leukemia with t(15;17)(q22;q12)|adult acute myeloid leukemia with t(15;17)(q22;q12)
794903|NCT00274807|adult acute myeloid leukemia with t(16;16)(p13;q22)|adult acute myeloid leukemia with t(16;16)(p13;q22)
794904|NCT00274807|adult acute myeloid leukemia with t(8;21)(q22;q22)|adult acute myeloid leukemia with t(8;21)(q22;q22)
794905|NCT00274794|noncontiguous stage II adult Burkitt lymphoma|noncontiguous stage ii adult burkitt lymphoma
794906|NCT00274794|extranodal marginal zone B-cell lymphoma of mucosa-associated lymphoid tissue|extranodal marginal zone b-cell lymphoma of mucosa-associated lymphoid tissue
794907|NCT00274794|nodal marginal zone B-cell lymphoma|nodal marginal zone b-cell lymphoma
794908|NCT00274794|stage III adult Burkitt lymphoma|stage iii adult burkitt lymphoma
794909|NCT00274794|stage IV adult Burkitt lymphoma|stage iv adult burkitt lymphoma
794910|NCT00274794|noncontiguous stage II adult diffuse large cell lymphoma|noncontiguous stage ii adult diffuse large cell lymphoma
794911|NCT00274794|noncontiguous stage II adult diffuse mixed cell lymphoma|noncontiguous stage ii adult diffuse mixed cell lymphoma
794912|NCT00274794|noncontiguous stage II adult diffuse small cleaved cell lymphoma|noncontiguous stage ii adult diffuse small cleaved cell lymphoma
794913|NCT00274794|recurrent adult diffuse large cell lymphoma|recurrent adult diffuse large cell lymphoma
794914|NCT00274794|recurrent adult diffuse mixed cell lymphoma|recurrent adult diffuse mixed cell lymphoma
794915|NCT00274794|recurrent adult diffuse small cleaved cell lymphoma|recurrent adult diffuse small cleaved cell lymphoma
794916|NCT00274794|stage III adult diffuse large cell lymphoma|stage iii adult diffuse large cell lymphoma
794917|NCT00274794|stage III adult diffuse mixed cell lymphoma|stage iii adult diffuse mixed cell lymphoma
794918|NCT00274794|stage III adult diffuse small cleaved cell lymphoma|stage iii adult diffuse small cleaved cell lymphoma
794919|NCT00274794|stage IV adult diffuse large cell lymphoma|stage iv adult diffuse large cell lymphoma
794920|NCT00274794|stage IV adult diffuse mixed cell lymphoma|stage iv adult diffuse mixed cell lymphoma
794921|NCT00274794|stage IV adult diffuse small cleaved cell lymphoma|stage iv adult diffuse small cleaved cell lymphoma
794922|NCT00274794|noncontiguous stage II adult immunoblastic large cell lymphoma|noncontiguous stage ii adult immunoblastic large cell lymphoma
794923|NCT00274794|recurrent adult immunoblastic large cell lymphoma|recurrent adult immunoblastic large cell lymphoma
794924|NCT00274794|stage III adult immunoblastic large cell lymphoma|stage iii adult immunoblastic large cell lymphoma
794925|NCT00274794|stage IV adult immunoblastic large cell lymphoma|stage iv adult immunoblastic large cell lymphoma
794926|NCT00274794|noncontiguous stage II adult lymphoblastic lymphoma|noncontiguous stage ii adult lymphoblastic lymphoma
794927|NCT00274794|recurrent adult lymphoblastic lymphoma|recurrent adult lymphoblastic lymphoma
794928|NCT00274794|stage III adult lymphoblastic lymphoma|stage iii adult lymphoblastic lymphoma
794929|NCT00274794|stage IV adult lymphoblastic lymphoma|stage iv adult lymphoblastic lymphoma
794930|NCT00274794|noncontiguous stage II grade 1 follicular lymphoma|noncontiguous stage ii grade 1 follicular lymphoma
794931|NCT00274794|noncontiguous stage II grade 2 follicular lymphoma|noncontiguous stage ii grade 2 follicular lymphoma
794932|NCT00274794|noncontiguous stage II grade 3 follicular lymphoma|noncontiguous stage ii grade 3 follicular lymphoma
794933|NCT00274794|recurrent grade 1 follicular lymphoma|recurrent grade 1 follicular lymphoma
794934|NCT00274794|recurrent grade 2 follicular lymphoma|recurrent grade 2 follicular lymphoma
794935|NCT00274794|recurrent grade 3 follicular lymphoma|recurrent grade 3 follicular lymphoma
794936|NCT00274794|stage III grade 1 follicular lymphoma|stage iii grade 1 follicular lymphoma
794937|NCT00274794|stage III grade 2 follicular lymphoma|stage iii grade 2 follicular lymphoma
794938|NCT00274794|stage III grade 3 follicular lymphoma|stage iii grade 3 follicular lymphoma
794939|NCT00274794|stage IV grade 1 follicular lymphoma|stage iv grade 1 follicular lymphoma
794940|NCT00274794|stage IV grade 2 follicular lymphoma|stage iv grade 2 follicular lymphoma
794941|NCT00274794|stage IV grade 3 follicular lymphoma|stage iv grade 3 follicular lymphoma
794942|NCT00274794|noncontiguous stage II mantle cell lymphoma|noncontiguous stage ii mantle cell lymphoma
794943|NCT00274794|recurrent mantle cell lymphoma|recurrent mantle cell lymphoma
794944|NCT00274794|stage III mantle cell lymphoma|stage iii mantle cell lymphoma
795629|NCT00271596|Focus|focus
794945|NCT00274794|stage IV mantle cell lymphoma|stage iv mantle cell lymphoma
794946|NCT00274794|noncontiguous stage II marginal zone lymphoma|noncontiguous stage ii marginal zone lymphoma
794947|NCT00274794|recurrent marginal zone lymphoma|recurrent marginal zone lymphoma
794948|NCT00274794|splenic marginal zone lymphoma|splenic marginal zone lymphoma
794949|NCT00274794|stage III marginal zone lymphoma|stage iii marginal zone lymphoma
794950|NCT00274794|stage IV marginal zone lymphoma|stage iv marginal zone lymphoma
794951|NCT00274794|noncontiguous stage II small lymphocytic lymphoma|noncontiguous stage ii small lymphocytic lymphoma
794952|NCT00274794|recurrent small lymphocytic lymphoma|recurrent small lymphocytic lymphoma
794953|NCT00274794|stage III small lymphocytic lymphoma|stage iii small lymphocytic lymphoma
794954|NCT00274794|stage IV small lymphocytic lymphoma|stage iv small lymphocytic lymphoma
794955|NCT00274781|refractory anemia with excess blasts in transformation|refractory anemia with excess blasts in transformation
794956|NCT00274781|refractory anemia with excess blasts|refractory anemia with excess blasts
794957|NCT00274781|chronic myelomonocytic leukemia|chronic myelomonocytic leukemia
794958|NCT00274781|secondary acute myeloid leukemia|secondary acute myeloid leukemia
794959|NCT00274781|previously treated myelodysplastic syndromes|previously treated myelodysplastic syndromes
794960|NCT00274781|secondary myelodysplastic syndromes|secondary myelodysplastic syndromes
794961|NCT00274781|de novo myelodysplastic syndromes|de novo myelodysplastic syndromes
794962|NCT00274768|stage IV breast cancer|stage iv breast cancer
794963|NCT00274768|male breast cancer|male breast cancer
794964|NCT00274768|recurrent breast cancer|recurrent breast cancer
794965|NCT00274755|adult anaplastic astrocytoma|adult anaplastic astrocytoma
794966|NCT00274755|adult diffuse astrocytoma|adult diffuse astrocytoma
794967|NCT00274755|adult glioblastoma|adult glioblastoma
794968|NCT00274755|adult giant cell glioblastoma|adult giant cell glioblastoma
794969|NCT00274755|adult gliosarcoma|adult gliosarcoma
794970|NCT00274755|adult pilocytic astrocytoma|adult pilocytic astrocytoma
794971|NCT00274755|adult anaplastic ependymoma|adult anaplastic ependymoma
794972|NCT00274755|adult ependymoma|adult ependymoma
794973|NCT00274755|adult myxopapillary ependymoma|adult myxopapillary ependymoma
794974|NCT00274755|adult subependymoma|adult subependymoma
794975|NCT00274755|adult anaplastic oligodendroglioma|adult anaplastic oligodendroglioma
794976|NCT00274755|adult oligodendroglioma|adult oligodendroglioma
794977|NCT00274755|adult mixed glioma|adult mixed glioma
794978|NCT00274742|Non-Hodgkin's Lymphoma|non-hodgkin's lymphoma
794979|NCT00274742|Cancer immunotherapy|cancer immunotherapy
794980|NCT00274742|Monoclonal antibody|monoclonal antibody
794981|NCT00274742|anti-CD19|anti-cd19
794982|NCT00274742|anti-CD3|anti-cd3
794983|NCT00274742|BiTE|bite
794984|NCT00274742|Blinatumomab|blinatumomab
794985|NCT00274729|Dietary intervention|dietary intervention
794986|NCT00274729|High-carbohydrate diet|high-carbohydrate diet
794987|NCT00274729|High-fat diet|high-fat diet
794988|NCT00274729|Moderate-fat diet|moderate-fat diet
794990|NCT00274729|Weight maintenance|weight maintenance
794991|NCT00274729|Body composition|body composition
794992|NCT00274729|Glucose metabolism|glucose metabolism
794993|NCT00274729|Cardiovascular disease|cardiovascular disease
794994|NCT00274729|Appetite regulation|appetite regulation
794995|NCT00274729|Energy expenditure|energy expenditure
794996|NCT00274703|anti IL-5|anti il-5
794997|NCT00274703|oesophagitis|oesophagitis
794998|NCT00274703|eosinophils|eosinophils
794999|NCT00274703|mepolizumab|mepolizumab
795000|NCT00274703|adults|adults
795001|NCT00274690|Neurokinin-1 Receptor Antagonist|neurokinin-1 receptor antagonist
795002|NCT00274690|GW679769|gw679769
795003|NCT00274690|Post-operative Nausea|post-operative nausea
795004|NCT00274690|NK-1 Receptor Antagonist|nk-1 receptor antagonist
795005|NCT00274690|PONV|ponv
795006|NCT00274690|Post-discharge Nausea and Vomiting|post-discharge nausea and vomiting
795007|NCT00274690|PDNV|pdnv
795008|NCT00274690|Vomiting|vomiting
795009|NCT00274677|Bipolar Disorder|bipolar disorder
795010|NCT00274664|Amblyopia|amblyopia
795011|NCT00274664|Occlusion dose monitoring|occlusion dose monitoring
795012|NCT00274664|Refractive adaptation|refractive adaptation
795013|NCT00274664|Dose-response|dose-response
795014|NCT00274651|CTCL|ctcl
795015|NCT00274651|PTCL|ptcl
795016|NCT00274651|lymphoma|lymphoma
795017|NCT00274651|Non-Hodgkin's Lymphoma|non-hodgkin's lymphoma
795018|NCT00274651|Cutaneous T-Cell Lymphomas (CTCL)|cutaneous t-cell lymphomas (ctcl)
795019|NCT00274651|Peripheral T-Cell Lymphomas (PTCL)|peripheral t-cell lymphomas (ptcl)
795020|NCT00274651|Other Types of Non-Hodgkin's Lymphoma|other types of non-hodgkin's lymphoma
795021|NCT00274651|belinostat|belinostat
795022|NCT00274625|Biomaterials|biomaterials
795023|NCT00274625|Bariatric Surgery|bariatric surgery
795024|NCT00274625|Hernia, Prevention of|hernia, prevention of
795025|NCT00274625|Obesity|obesity
795026|NCT00274625|Bypass Surgery|bypass surgery
795027|NCT00274625|Incisional Hernia|incisional hernia
795028|NCT00274625|Ventral Hernia|ventral hernia
795029|NCT00274495|Genotype 1|genotype 1
795030|NCT00274495|Metabolic syndrome|metabolic syndrome
795031|NCT00274495|Insulin resistance|insulin resistance
795032|NCT00274469|oncology|oncology
795033|NCT00274469|cancer|cancer
795034|NCT00274469|breast cancer|breast cancer
795035|NCT00274456|Metastatic breast cancer, nab paclitaxel, docetaxel,|metastatic breast cancer, nab paclitaxel, docetaxel,
795036|NCT00274404|infectious mononucleosis|infectious mononucleosis
795037|NCT00274404|Epstein-Barr virus|epstein-barr virus
795038|NCT00274404|valacyclovir|valacyclovir
795039|NCT00274404|quantitative PCR|quantitative pcr
795040|NCT00274378|radius fracture|radius fracture
795041|NCT00274378|fracture fixation|fracture fixation
795042|NCT00274378|homologous bone transplantation|homologous bone transplantation
795043|NCT00274365|general practitioners, psychiatry, videoconference|general practitioners, psychiatry, videoconference
795044|NCT00274352|sarcoidosis|sarcoidosis
795045|NCT00274352|adalimumab|adalimumab
795046|NCT00274352|skin diseases|skin diseases
795047|NCT00274339|Laryngopharyngeal Reflux|laryngopharyngeal reflux
795048|NCT00274339|Prevacid|prevacid
795049|NCT00274339|Lifestyle changes|lifestyle changes
795050|NCT00274339|Reflux Finding Score|reflux finding score
795051|NCT00274339|Reflux Symptom Index|reflux symptom index
795052|NCT00274339|Laryngoscopy|laryngoscopy
795053|NCT00274326|Hyponatremia|hyponatremia
795054|NCT00274313|Cystic Fibrosis|cystic fibrosis
795055|NCT00274300|DNA vaccine|dna vaccine
795056|NCT00274300|immunotherapy|immunotherapy
795057|NCT00274300|Herpes Simplex Virus Type 2 (HSV2)|herpes simplex virus type 2 (hsv2)
795058|NCT00274300|Particle Mediated Epidermal Delivery|particle mediated epidermal delivery
795059|NCT00274261|contraception|contraception
795060|NCT00274235|Malaria|malaria
795061|NCT00274235|Prevention|prevention
795062|NCT00274235|Pregnancy|pregnancy
795063|NCT00274235|Low birthweight|low birthweight
795064|NCT00274235|Anemia|anemia
795065|NCT00274235|Africa|africa
795066|NCT00274222|COPD, nebulized budesonide, systemic corticosteroids|copd, nebulized budesonide, systemic corticosteroids
795067|NCT00274209|Ulcerative colitis|ulcerative colitis
795068|NCT00274209|Crohn's disease|crohn's disease
795069|NCT00274209|Chromoendoscopy|chromoendoscopy
795070|NCT00274209|Dysplasia|dysplasia
795071|NCT00274209|Neoplasia|neoplasia
795072|NCT00274196|fractures, occult|fractures, occult
795073|NCT00274196|hip|hip
795074|NCT00274196|ultrasound examination|ultrasound examination
795075|NCT00274196|MRI|mri
795076|NCT00274196|sensitivity|sensitivity
795077|NCT00274196|specificity|specificity
795078|NCT00274170|Migraine|migraine
795079|NCT00274170|Octreotide|octreotide
795080|NCT00274170|Prochlorperazine|prochlorperazine
795081|NCT00274157|Peripheral Vascular Disease|peripheral vascular disease
795082|NCT00274157|Intermittent Claudication|intermittent claudication
795083|NCT00274157|Catheter-based Arterial Revascularization|catheter-based arterial revascularization
795084|NCT00274157|Peripheral angioplasty|peripheral angioplasty
795085|NCT00274157|Peripheral stenting|peripheral stenting
795086|NCT00274157|Functional capacity|functional capacity
795087|NCT00274157|Quality of life|quality of life
795088|NCT00273949|Lactulose|lactulose
795089|NCT00273949|Prebiotics|prebiotics
795090|NCT00273949|Nosocomial infection|nosocomial infection
795091|NCT00273949|children|children
795092|NCT00273949|infants|infants
795093|NCT00273910|Disease Free Survival|disease free survival
795094|NCT00273910|gp 100:209-217 (210m)|gp 100:209-217 (210m)
795095|NCT00273910|Immunologic Response|immunologic response
795096|NCT00273910|Adjuvant Therapy|adjuvant therapy
795097|NCT00273910|Cutaneous Melanoma|cutaneous melanoma
795098|NCT00273910|Melanoma|melanoma
795099|NCT00273897|Dementia Treatment|dementia treatment
795100|NCT00273897|Hand Function|hand function
795101|NCT00273897|Clinical Trials|clinical trials
795102|NCT00273897|Dementia|dementia
795103|NCT00273897|Cortical Syndrome|cortical syndrome
795104|NCT00273897|CBS|cbs
795105|NCT00273897|Apraxia|apraxia
795106|NCT00273884|AML|aml
795107|NCT00273884|Secondary AML|secondary aml
795108|NCT00273884|Leukemia|leukemia
795109|NCT00273871|kidney transplant|kidney transplant
795110|NCT00273858|Rheumatoid Arthritis|rheumatoid arthritis
795111|NCT00273858|Ankylosing Spondylitis|ankylosing spondylitis
795112|NCT00273858|Psoriatic Arthritis|psoriatic arthritis
795113|NCT00273845|case management|case management
795114|NCT00273845|substance abuse treatment|substance abuse treatment
795115|NCT00273845|linkage|linkage
795116|NCT00273832|Chest pain|chest pain
795117|NCT00273832|Angina pectoris|angina pectoris
795118|NCT00273832|Emergency medicine|emergency medicine
795119|NCT00273832|Spiral computed tomography|spiral computed tomography
795120|NCT00273832|Length of stay|length of stay
795121|NCT00273832|Cost analysis|cost analysis
795122|NCT00273819|Congestive heart failure, LV dysfunction|congestive heart failure, lv dysfunction
795123|NCT00273806|Behavioral risk factors|behavioral risk factors
795124|NCT00273806|Primary Care|primary care
795125|NCT00273806|Health services research|health services research
795126|NCT00273780|Patient compliance|patient compliance
795127|NCT00273767|troponin T|troponin t
795128|NCT00273767|CK-MB|ck-mb
795129|NCT00273767|protein S-100|protein s-100
795130|NCT00273767|Cardiopulmonary Bypass|cardiopulmonary bypass
795131|NCT00273767|Erythropoietin|erythropoietin
795132|NCT00273754|Obstructive Sleep Apnea (OSA)|obstructive sleep apnea (osa)
795630|NCT00271596|ADD|add
795133|NCT00273754|Tonsillectomy and Adenoidectomy (T&A)|tonsillectomy and adenoidectomy (t&a)
795134|NCT00273754|Postoperative Complications|postoperative complications
795135|NCT00273754|Recovery|recovery
795136|NCT00273741|palliative care|palliative care
795137|NCT00273741|methylphenidate|methylphenidate
795138|NCT00273728|Hydroxyethyl Starch|hydroxyethyl starch
795139|NCT00273728|shock, septic|shock, septic
795140|NCT00273728|infusion, intravenous|infusion, intravenous
795141|NCT00273728|mortality|mortality
795142|NCT00273715|Comparative|comparative
795143|NCT00273715|Randomized|randomized
795144|NCT00273715|Suture|suture
795145|NCT00273715|Staples, surgical|staples, surgical
795146|NCT00273715|Skin|skin
795147|NCT00273715|Surgical procedures, operative|surgical procedures, operative
795148|NCT00273715|Orthopedics|orthopedics
795149|NCT00273715|Joint, hip|joint, hip
795150|NCT00273715|Surgical procedures of Hip, Operative|surgical procedures of hip, operative
795151|NCT00273702|Gambling|gambling
795152|NCT00273702|Gambler|gambler
795153|NCT00273702|Gamble|gamble
795154|NCT00273702|Pathological|pathological
795155|NCT00273676|Community-acquired pneumonia|community-acquired pneumonia
795156|NCT00273676|Treatment|treatment
795157|NCT00273676|Antibiotics|antibiotics
795158|NCT00273663|cerebral blood flow|cerebral blood flow
795159|NCT00273663|electrical stimulation|electrical stimulation
795160|NCT00273663|Computed Tomography Scanner, X-Ray|computed tomography scanner, x-ray
795161|NCT00273663|Brain Mapping|brain mapping
795162|NCT00273650|Autism|autism
795163|NCT00273650|Placebo|placebo
795164|NCT00273650|B12|b12
795165|NCT00273650|Controlled|controlled
795166|NCT00273650|Complementary Alternative Medicine|complementary alternative medicine
795167|NCT00273650|Vitamin Supplement|vitamin supplement
795168|NCT00273637|heart failure|heart failure
795169|NCT00273637|peripartum cardiomyopathy|peripartum cardiomyopathy
795170|NCT00273637|pregnancy-associated cardiomyopathy|pregnancy-associated cardiomyopathy
795171|NCT00273637|pregnancy complications|pregnancy complications
795172|NCT00273637|nonischemic cardiomyopathy|nonischemic cardiomyopathy
795173|NCT00273624|Therapy-resistant depression|therapy-resistant depression
795174|NCT00273624|add-on therapy depression|add-on therapy depression
795175|NCT00273611|vitamin D deficiency|vitamin d deficiency
795176|NCT00273611|geriatric patients|geriatric patients
795177|NCT00273598|Scoliosis|scoliosis
795178|NCT00273598|spinal disease|spinal disease
795179|NCT00273598|pediatrics|pediatrics
795180|NCT00273598|Adolescents|adolescents
795181|NCT00273598|Universal Spinal Instrumentation System|universal spinal instrumentation system
795182|NCT00273598|Moss Miami Spinal Instrumentation System|moss miami spinal instrumentation system
795183|NCT00273598|Orthopedic Surgery|orthopedic surgery
795184|NCT00273585|Fecal occult blood testing|fecal occult blood testing
795185|NCT00273585|Flexible sigmoidoscopy|flexible sigmoidoscopy
795186|NCT00273585|Colonoscopy|colonoscopy
795187|NCT00273585|Self-efficacy|self-efficacy
795188|NCT00273572|Obesity|obesity
795189|NCT00273572|Women|women
795190|NCT00273572|Arab|arab
795191|NCT00273572|Metabolic syndrome|metabolic syndrome
795192|NCT00273572|Lifestyle intervention|lifestyle intervention
795193|NCT00273572|Quality of life|quality of life
795194|NCT00273559|Renal Transplantation|renal transplantation
795195|NCT00273546|Head and Neck Cancer|head and neck cancer
795196|NCT00273546|Induction|induction
795197|NCT00273546|Chemotherapy|chemotherapy
795198|NCT00273546|Chemoradiotherapy|chemoradiotherapy
795199|NCT00273507|Non-small cell lung cancer|non-small cell lung cancer
795200|NCT00273507|neoadjuvant|neoadjuvant
795201|NCT00273507|resection|resection
795202|NCT00273494|N2 disease|n2 disease
795203|NCT00273494|Non-small cell lung cancer|non-small cell lung cancer
795204|NCT00273494|Surgery|surgery
795205|NCT00273494|Neoadjuvant chemotherapy|neoadjuvant chemotherapy
795207|NCT00273403|Minority Groups|minority groups
795208|NCT00273403|Health Services Accessibility|health services accessibility
795209|NCT00273403|Quality of Life|quality of life
795210|NCT00273377|Anesthesia|anesthesia
795211|NCT00273377|Oxygen|oxygen
795212|NCT00273377|Carbon dioxide|carbon dioxide
795213|NCT00273377|Hypercapnia|hypercapnia
795214|NCT00273377|Hypercarbia|hypercarbia
795215|NCT00273377|Dexamethasone|dexamethasone
795216|NCT00273377|Steroid|steroid
795217|NCT00273377|Postoperative nausea and vomiting (PONV)|postoperative nausea and vomiting (ponv)
795218|NCT00273364|stem cell, autoimmune disease, multiple sclerosis|stem cell, autoimmune disease, multiple sclerosis
795219|NCT00273351|Parkinson|parkinson
795220|NCT00273351|family history|family history
795221|NCT00273351|diagnosis|diagnosis
795222|NCT00273338|Androgen-independent Prostate Cancer (AIPC)|androgen-independent prostate cancer (aipc)
795223|NCT00273338|Prostate Cancer|prostate cancer
795224|NCT00273338|DN-101|dn-101
795225|NCT00273338|calcitriol|calcitriol
795226|NCT00273338|Taxotere|taxotere
795227|NCT00273338|docetaxel|docetaxel
795228|NCT00273325|NICHD Neonatal Research Network|nichd neonatal research network
795229|NCT00273325|Very Low Birth Weight (VLBW)|very low birth weight (vlbw)
795230|NCT00273325|Extremely Low Birth Weight (ELBW)|extremely low birth weight (elbw)
795231|NCT00273325|Prematurity|prematurity
795232|NCT00273325|Pneumococcal Vaccines|pneumococcal vaccines
795233|NCT00273325|Vaccines, Conjugate|vaccines, conjugate
795234|NCT00273325|Immunogenicity|immunogenicity
795235|NCT00273325|Vaccine Response|vaccine response
795236|NCT00273325|Heptavalent pneumococcal conjugate vaccine (PCV-7)|heptavalent pneumococcal conjugate vaccine (pcv-7)
795237|NCT00273325|pneumococcal polysaccharide, type 6B|pneumococcal polysaccharide, type 6b
795238|NCT00273325|Pneumococcal polysaccharide, type 14|pneumococcal polysaccharide, type 14
795239|NCT00273325|Pneumococcal polysaccharide, type 19F,|pneumococcal polysaccharide, type 19f,
795240|NCT00273325|Pneumococcal polysaccharide, 23F|pneumococcal polysaccharide, 23f
795241|NCT00273325|Pneumococcal polysaccharide, 18C|pneumococcal polysaccharide, 18c
795242|NCT00273325|Pneumococcal polysaccharide, 4|pneumococcal polysaccharide, 4
795243|NCT00273325|Pneumococcal polysaccharide, 9V|pneumococcal polysaccharide, 9v
795244|NCT00273312|Advanced unresectable metastatic hepatocellular carcinoma|advanced unresectable metastatic hepatocellular carcinoma
795245|NCT00273312|Liver cancer|liver cancer
795246|NCT00273299|hypertension|hypertension
795247|NCT00273299|high blood pressure|high blood pressure
795248|NCT00273299|valsartan/hydrochlorozide|valsartan/hydrochlorozide
795249|NCT00273299|severe hypertension|severe hypertension
795250|NCT00273286|Diabetes Mellitus, Insulin-Dependent|diabetes mellitus, insulin-dependent
795251|NCT00273286|Diabetes Mellitus, Juvenile-Onset|diabetes mellitus, juvenile-onset
795252|NCT00273286|IDDM|iddm
795253|NCT00273286|Type 1 Diabetes Mellitus|type 1 diabetes mellitus
795254|NCT00273273|HIV|hiv
795255|NCT00273273|Atazanavir|atazanavir
795256|NCT00273273|ritonavir|ritonavir
795257|NCT00273273|tenofovir|tenofovir
795258|NCT00273273|Adolescent|adolescent
795259|NCT00273273|Treatment Experienced|treatment experienced
795260|NCT00273234|Venous|venous
795261|NCT00273234|Ulcer|ulcer
795262|NCT00273234|autologous|autologous
795263|NCT00273234|platelet|platelet
795264|NCT00273234|healing|healing
795265|NCT00273221|Glaucoma|glaucoma
795266|NCT00273221|Cataract|cataract
795267|NCT00273208|breast cancer|breast cancer
795268|NCT00273208|fatigue|fatigue
795269|NCT00273195|Implantable Cardioverter Defibrillator, Anti-tachycardia pacing (ATP)|implantable cardioverter defibrillator, anti-tachycardia pacing (atp)
795270|NCT00273182|Heart Failure|heart failure
795271|NCT00273182|Cardiomyopathy|cardiomyopathy
795272|NCT00273182|Cardiac pacing|cardiac pacing
795273|NCT00273182|Cardiac resynchronization therapy|cardiac resynchronization therapy
795274|NCT00273130|transnasal gastroscopy, stress response, ischaemia|transnasal gastroscopy, stress response, ischaemia
795275|NCT00273117|transnasal gastroscopy|transnasal gastroscopy
795276|NCT00273117|tachycardia|tachycardia
795277|NCT00273117|hypoxemia|hypoxemia
795278|NCT00273078|Speech,|speech,
795279|NCT00273078|tongue,|tongue,
795282|NCT00273078|complete denture|complete denture
795283|NCT00273065|Local Anesthetic|local anesthetic
795284|NCT00273065|Neosaxitoxin|neosaxitoxin
795285|NCT00273052|hypertension|hypertension
795286|NCT00273039|Social Anxiety Disorder|social anxiety disorder
795287|NCT00273039|Anxiety|anxiety
795288|NCT00273039|Psychiatry|psychiatry
795289|NCT00273026|Asthma Advair|asthma advair
795290|NCT00273013|asthma|asthma
795291|NCT00273013|allergen challenge|allergen challenge
795292|NCT00272987|trastuzumab|trastuzumab
795293|NCT00272987|ErbB2|erbb2
795294|NCT00272987|paclitaxel|paclitaxel
795295|NCT00272987|Herceptin|herceptin
795296|NCT00272987|Taxol|taxol
795297|NCT00272987|ErbB1|erbb1
795298|NCT00272987|metastatic breast cancer|metastatic breast cancer
795299|NCT00272987|Stage IV breast cancer|stage iv breast cancer
795300|NCT00272987|lapatinib|lapatinib
795301|NCT00272974|AE adverse event|ae adverse event
795302|NCT00272974|DCF data collection forms|dcf data collection forms
795303|NCT00272974|IRB Institutional Review Board|irb institutional review board
795304|NCT00272974|SAE serious adverse event|sae serious adverse event
795305|NCT00272948|Venoocclusive disease|venoocclusive disease
795306|NCT00272948|Pediatric|pediatric
795307|NCT00272948|myeloablative conditioning|myeloablative conditioning
795308|NCT00272948|stem cell transplant|stem cell transplant
795309|NCT00272935|menopause|menopause
795310|NCT00272935|vasomotor symptoms|vasomotor symptoms
795311|NCT00272922|Biomaterials|biomaterials
795312|NCT00272922|Paraesophageal Hernia|paraesophageal hernia
795313|NCT00272922|Laparoscopy|laparoscopy
795314|NCT00272909|Acute Ischemic Stroke|acute ischemic stroke
795315|NCT00272909|9-Hour window MRI|9-hour window mri
795316|NCT00272909|Serotonin receptor agonist|serotonin receptor agonist
795317|NCT00272896|Migraine|migraine
795318|NCT00272896|VIP|vip
795319|NCT00272896|Transcranial Doppler|transcranial doppler
795320|NCT00272896|Headache|headache
795321|NCT00272883|central core|central core
795322|NCT00272883|centronuclear|centronuclear
795323|NCT00272883|multiminicore|multiminicore
795324|NCT00272883|multicore|multicore
795325|NCT00272883|minicore|minicore
795326|NCT00272883|congenital fiber type disproportion|congenital fiber type disproportion
795327|NCT00272883|myotubular|myotubular
795328|NCT00272883|nemaline|nemaline
795329|NCT00272883|congenital myopathy|congenital myopathy
795330|NCT00272883|neuromuscular|neuromuscular
795331|NCT00272883|rigid spine|rigid spine
795332|NCT00272844|cholesterol|cholesterol
795333|NCT00272844|Smith-Lemli-Opitz syndrome|smith-lemli-opitz syndrome
795334|NCT00272844|mental retardation|mental retardation
795335|NCT00272844|sterols|sterols
795336|NCT00272844|congenital anomalies|congenital anomalies
795337|NCT00272831|Diabetic nephropathy|diabetic nephropathy
795338|NCT00272831|Macroalbuminuria|macroalbuminuria
795339|NCT00272831|Pletaal|pletaal
795340|NCT00272818|Colitis|colitis
795341|NCT00272818|Esophagitis|esophagitis
795342|NCT00272818|CD23|cd23
795343|NCT00272805|chronic heart failure|chronic heart failure
795344|NCT00272805|left ventricular systolic dysfunction|left ventricular systolic dysfunction
795345|NCT00272779|HIV|hiv
795346|NCT00272779|Treatment Naive|treatment naive
795347|NCT00272766|Ocular histoplasmosis|ocular histoplasmosis
795348|NCT00272766|Macugen|macugen
795349|NCT00272766|Photodynamic therapy with Visudyne|photodynamic therapy with visudyne
795350|NCT00272766|Best-corrected visual acuity scores between 20/40-20/200|best-corrected visual acuity scores between 20/40-20/200
795351|NCT00272766|classic or occult choroidal neovascularization|classic or occult choroidal neovascularization
795352|NCT00272740|breast cancer|breast cancer
795353|NCT00272740|fulvestrant|fulvestrant
795354|NCT00272740|Faslodex|faslodex
795355|NCT00272740|hormonotherapy|hormonotherapy
795356|NCT00272740|aromatase inhibitor failure|aromatase inhibitor failure
795357|NCT00272740|Advanced breast cancer|advanced breast cancer
795358|NCT00272727|Asthma|asthma
795359|NCT00272727|dialog tool|dialog tool
795360|NCT00272727|compliance|compliance
795361|NCT00272714|breast pain, tenderness, benign breast conditions|breast pain, tenderness, benign breast conditions
795362|NCT00272675|Nosocomial infection,|nosocomial infection,
795363|NCT00272675|Decontamination,|decontamination,
795364|NCT00272675|Randomized placebo-controlled trial,|randomized placebo-controlled trial,
795365|NCT00272675|Cardiac surgery,|cardiac surgery,
795366|NCT00272675|Chlorhexidine,|chlorhexidine,
795367|NCT00272675|Prevention|prevention
795368|NCT00272662|anemia|anemia
795369|NCT00272662|cancer|cancer
795370|NCT00272662|chemotherapy|chemotherapy
795371|NCT00272662|chemotherapy induced anemia|chemotherapy induced anemia
795372|NCT00272662|CIA|cia
795373|NCT00272662|hemoglobin|hemoglobin
795374|NCT00272662|Hb|hb
795375|NCT00272662|Hgb|hgb
795376|NCT00272662|erythropoietin|erythropoietin
795377|NCT00272662|EPO|epo
795378|NCT00272662|erythropoiesis stimulating agent|erythropoiesis stimulating agent
795379|NCT00272662|ESA|esa
795380|NCT00272662|Hematide|hematide
795381|NCT00272662|Omontys|omontys
795382|NCT00272662|peginesatide|peginesatide
795383|NCT00272662|red blood cell|red blood cell
795384|NCT00272662|red blood cell production|red blood cell production
795385|NCT00272649|Kidney cancer|kidney cancer
795386|NCT00272649|Renal cancer|renal cancer
795387|NCT00272636|atrial fibrillation|atrial fibrillation
795388|NCT00272636|catheter ablation|catheter ablation
795389|NCT00272636|amiodarone|amiodarone
795390|NCT00272636|cardioversion|cardioversion
795391|NCT00272623|Catheter, Indwelling|catheter, indwelling
795392|NCT00272623|Indwelling Catheter|indwelling catheter
795393|NCT00272623|Indwelling Catheters|indwelling catheters
795394|NCT00272623|Implantable Catheters|implantable catheters
795395|NCT00272623|Catheter, Implantable|catheter, implantable
795396|NCT00272623|Catheters, Implantable|catheters, implantable
795397|NCT00272623|Implantable Catheter|implantable catheter
795398|NCT00272623|In-Dwelling Catheters|in-dwelling catheters
795399|NCT00272623|Catheter, In-Dwelling|catheter, in-dwelling
795400|NCT00272623|Catheters, In-Dwelling|catheters, in-dwelling
795401|NCT00272623|In Dwelling Catheters|in dwelling catheters
795402|NCT00272623|In-Dwelling Catheter|in-dwelling catheter
795403|NCT00272623|Venous Reservoirs|venous reservoirs
795404|NCT00272623|Reservoir, Venous|reservoir, venous
795405|NCT00272623|Reservoirs, Venous|reservoirs, venous
795406|NCT00272623|Venous Reservoir|venous reservoir
795407|NCT00272623|Vascular Access Ports|vascular access ports
795408|NCT00272623|Access Port, Vascular|access port, vascular
795409|NCT00272623|Access Ports, Vascular|access ports, vascular
795410|NCT00272623|Port, Vascular Access|port, vascular access
795411|NCT00272623|Ports, Vascular Access|ports, vascular access
795412|NCT00272623|Vascular Access Port|vascular access port
795413|NCT00272610|Skin Aging|skin aging
795414|NCT00272610|Bateman's Purpura|bateman's purpura
795415|NCT00272597|Psychosis|psychosis
795416|NCT00272597|schizophrenia|schizophrenia
795417|NCT00272597|schizoaffective|schizoaffective
795418|NCT00272597|risperidone|risperidone
795419|NCT00272584|Psychosis, schizophrenia, schizoaffective, clozapine, risperidone|psychosis, schizophrenia, schizoaffective, clozapine, risperidone
795420|NCT00272571|ECPT, endothelial progenitor cells|ecpt, endothelial progenitor cells
795421|NCT00272558|Malignant Pleural Mesothelioma|malignant pleural mesothelioma
795422|NCT00272558|Chemotherapy|chemotherapy
795423|NCT00272545|Anorexia Nervosa|anorexia nervosa
795424|NCT00272545|Bulimia Nervosa|bulimia nervosa
795425|NCT00272545|Cognitive Behavioral Therapy|cognitive behavioral therapy
795427|NCT00272519|AIDS|aids
795429|NCT00272519|HIV Positive|hiv positive
795430|NCT00272493|Treatment Experienced|treatment experienced
795431|NCT00272493|Treatment Naive|treatment naive
795432|NCT00272480|HAM/TSP|ham/tsp
795433|NCT00272480|HTLV-I-associated myelopathy|htlv-i-associated myelopathy
795434|NCT00272480|zidovudine|zidovudine
795435|NCT00272480|lamivudine|lamivudine
795436|NCT00272480|antiretroviral therapy|antiretroviral therapy
795437|NCT00272467|Helicobacter pylori|helicobacter pylori
795438|NCT00272467|Stomach ulcer|stomach ulcer
795439|NCT00272467|Rebamipide|rebamipide
795440|NCT00272467|Omeprazole|omeprazole
795441|NCT00272454|cilostazol|cilostazol
795442|NCT00272454|aspirin|aspirin
795443|NCT00272454|cerebral infarction|cerebral infarction
795444|NCT00272428|Prevention trial|prevention trial
795445|NCT00272428|Antioxydant vitamins and minerals|antioxydant vitamins and minerals
795446|NCT00272428|Cancer|cancer
795447|NCT00272428|Ischemic disease|ischemic disease
795448|NCT00272428|Mortality|mortality
795449|NCT00272428|Health related quality of life|health related quality of life
795450|NCT00272415|INO4136g|ino4136g
795451|NCT00272415|inotek|inotek
795452|NCT00272415|Parp|parp
795453|NCT00272415|Temodar|temodar
795454|NCT00272402|physician decision support|physician decision support
795455|NCT00272402|diabetes mellitus|diabetes mellitus
795456|NCT00272402|electronic medical records|electronic medical records
795457|NCT00272402|office systems redesign|office systems redesign
795458|NCT00272376|Myopia|myopia
795459|NCT00272376|Nearsightedness|nearsightedness
795460|NCT00272363|Glaucoma|glaucoma
795461|NCT00272350|Brain|brain
795462|NCT00272350|Tumor|tumor
795463|NCT00272350|Therapy|therapy
795464|NCT00272350|Progression|progression
795465|NCT00272350|Antiangiogenesis|antiangiogenesis
795466|NCT00272350|Brain Tumor|brain tumor
795467|NCT00272350|Malignant Glioma|malignant glioma
795468|NCT00272337|Cardiovascular diseases|cardiovascular diseases
795469|NCT00272337|Aspirin|aspirin
795470|NCT00272337|Atherosclerosis|atherosclerosis
795471|NCT00272337|Myocardial Infarction|myocardial infarction
795472|NCT00272324|Colorectal neoplasms|colorectal neoplasms
795473|NCT00272324|Adenomatous polyps|adenomatous polyps
795474|NCT00272311|Primary prevention|primary prevention
795475|NCT00272311|Cardiovascular diseases|cardiovascular diseases
795476|NCT00272311|Aspirin|aspirin
795477|NCT00272311|Metabolic Syndrome X|metabolic syndrome x
795478|NCT00272311|Atherosclerosis|atherosclerosis
795479|NCT00272285|Serotonin antagonists|serotonin antagonists
795480|NCT00272285|Randomized controlled trial|randomized controlled trial
795481|NCT00272285|Combination drug therapy|combination drug therapy
795482|NCT00272285|Double-blind method|double-blind method
795483|NCT00272272|Fall Prevention, Music Therapy, Geriatric, Nursing Home|fall prevention, music therapy, geriatric, nursing home
795484|NCT00272246|dystonia|dystonia
795485|NCT00272233|Inflammation Mediators [D23.469]|inflammation mediators [d23.469]
795486|NCT00272233|Cardiovascular Physiologic Phenomena [G09.330.553]|cardiovascular physiologic phenomena [g09.330.553]
795487|NCT00272220|Acquired Immunodeficiency Syndrome|acquired immunodeficiency syndrome
795488|NCT00272220|Antiretroviral Therapy, Highly Active|antiretroviral therapy, highly active
795489|NCT00272220|Randomized Controlled Trials|randomized controlled trials
795490|NCT00272220|Africa|africa
795491|NCT00272220|Adherence|adherence
795492|NCT00272220|Treatment Naive|treatment naive
795493|NCT00272207|Fibromyalgia|fibromyalgia
795494|NCT00272207|Cannabinoids|cannabinoids
795495|NCT00272207|Nabilone|nabilone
795496|NCT00272207|Cesamet|cesamet
795497|NCT00272207|Pain|pain
795498|NCT00272194|Endotracheal Intubation|endotracheal intubation
795499|NCT00272194|Supraglottic Airway|supraglottic airway
795500|NCT00272168|Cognitive behavioral therapy|cognitive behavioral therapy
795501|NCT00272168|Social Skills training|social skills training
795502|NCT00272168|Vocational Rehabilitation|vocational rehabilitation
795503|NCT00272142|mortality|mortality
795504|NCT00272142|hospitalization|hospitalization
795505|NCT00272142|diarrhea|diarrhea
795506|NCT00272142|respiratory infection|respiratory infection
795507|NCT00272142|low birth weight|low birth weight
795508|NCT00272142|morbidity|morbidity
795509|NCT00272116|zinc|zinc
795510|NCT00272116|diarrhea|diarrhea
795511|NCT00272116|severe diarrhea|severe diarrhea
795512|NCT00272116|recurrent diarrhea|recurrent diarrhea
795513|NCT00272116|acute lower respiratory infection|acute lower respiratory infection
795514|NCT00272116|pneumonia|pneumonia
795515|NCT00272103|functional dyspepsia|functional dyspepsia
795516|NCT00272103|non ulcer dyspepsia|non ulcer dyspepsia
795517|NCT00272103|drug treatment|drug treatment
795518|NCT00272051|Neurotoxicity syndromes|neurotoxicity syndromes
795519|NCT00272051|Paresthesia|paresthesia
795520|NCT00272051|Oxaliplatin|oxaliplatin
795521|NCT00272051|Xaliproden|xaliproden
795522|NCT00272025|Bipolar Depression|bipolar depression
795523|NCT00272025|Escitalopram|escitalopram
795524|NCT00272025|Mood Stabilizer|mood stabilizer
795525|NCT00272025|Atypical Antipsychotic|atypical antipsychotic
795526|NCT00271999|randomized controlled clinical trial|randomized controlled clinical trial
795527|NCT00271999|hemodialysis|hemodialysis
795528|NCT00271999|End Stage Renal Disease|end stage renal disease
795529|NCT00271986|Peritoneal microdialysis|peritoneal microdialysis
795530|NCT00271986|Low anterior resection|low anterior resection
795531|NCT00271986|Recto-sigmoid cancer|recto-sigmoid cancer
795532|NCT00271986|Anastomotic leakage|anastomotic leakage
795533|NCT00271960|Pregnancy|pregnancy
795534|NCT00271960|Birth Weight|birth weight
795535|NCT00271960|Gestational Age|gestational age
795536|NCT00271960|Preterm Delivery|preterm delivery
795537|NCT00271960|HIV Seronegativity|hiv seronegativity
795538|NCT00271921|eating disorders|eating disorders
795539|NCT00271921|anorexia nervosa|anorexia nervosa
795540|NCT00271921|body fat distribution|body fat distribution
795541|NCT00271921|metabolic syndrome|metabolic syndrome
795542|NCT00271921|visceral adipose tissue|visceral adipose tissue
795543|NCT00271908|HIV|hiv
795544|NCT00271908|AIDS|aids
795545|NCT00271908|Adolescent|adolescent
795546|NCT00271908|Community|community
795547|NCT00271908|Structural Changes|structural changes
795548|NCT00271908|HIV Seronegativity|hiv seronegativity
795549|NCT00271882|Adolescent Females|adolescent females
795550|NCT00271882|HIV positive|hiv positive
795551|NCT00271882|PTSD|ptsd
795552|NCT00271882|Sexual Abuse|sexual abuse
795553|NCT00271869|hematopoietic stem cell transplantation|hematopoietic stem cell transplantation
795554|NCT00271869|graft-versus-host disease|graft-versus-host disease
795555|NCT00271869|treatment|treatment
795556|NCT00271856|HIV|hiv
795557|NCT00271856|Meditation|meditation
795558|NCT00271856|Stress|stress
795559|NCT00271856|Randomized Controlled Trial|randomized controlled trial
795560|NCT00271856|Complementary Therapies|complementary therapies
795561|NCT00271856|MBSR|mbsr
795562|NCT00271856|Not on ART medications|not on art medications
795563|NCT00271830|renal|renal
795564|NCT00271830|transplant|transplant
795565|NCT00271830|sexual dysfunction|sexual dysfunction
795566|NCT00271830|male|male
795567|NCT00271830|dialysis free|dialysis free
795568|NCT00271804|Myelodysplastic syndrome|myelodysplastic syndrome
795569|NCT00271804|Myelodysplasia|myelodysplasia
795570|NCT00271804|MDS|mds
795571|NCT00271804|Velcade|velcade
795572|NCT00271804|Thalidomide|thalidomide
795573|NCT00271804|Bortezomib|bortezomib
795574|NCT00271791|Vestibular Neuronitis|vestibular neuronitis
795575|NCT00271791|Vestibular Function Tests|vestibular function tests
795576|NCT00271791|Vestibular Adaptation|vestibular adaptation
795577|NCT00271791|Steroids|steroids
795578|NCT00271778|Otitis media suppurative|otitis media suppurative
795579|NCT00271778|surgery ear|surgery ear
795580|NCT00271765|Myocardial infarction|myocardial infarction
795581|NCT00271765|Coronary angioplasty|coronary angioplasty
795582|NCT00271765|PARP inhibitor|parp inhibitor
795583|NCT00271765|PARP inhibition|parp inhibition
795584|NCT00271765|Heart Attack|heart attack
795585|NCT00271752|Procalcitonin|procalcitonin
795586|NCT00271752|Sepsis|sepsis
795587|NCT00271752|Intensive Care Unit|intensive care unit
795588|NCT00271752|Sepsis and Complications|sepsis and complications
795589|NCT00271752|Organ Failure|organ failure
795590|NCT00271739|Telemedicine|telemedicine
795591|NCT00271739|Diabetes Mellitus|diabetes mellitus
795592|NCT00271726|distal radius fracture|distal radius fracture
795593|NCT00271726|extraarticular Colles fracture|extraarticular colles fracture
795594|NCT00271713|bone structure|bone structure
795595|NCT00271713|ibandronate|ibandronate
795596|NCT00271700|Diabetes Mellitus|diabetes mellitus
795597|NCT00271700|Outcome Assessment (Healthcare)|outcome assessment (healthcare)
795598|NCT00271700|Inpatients|inpatients
795599|NCT00271700|Hospital Information Systems|hospital information systems
795600|NCT00271700|Education|education
795601|NCT00271687|exercise|exercise
795602|NCT00271687|exercise therapy|exercise therapy
795603|NCT00271687|activities of daily living|activities of daily living
795604|NCT00271687|quality of life|quality of life
795605|NCT00271661|presbyopia; breast cancer survivors|presbyopia; breast cancer survivors
795606|NCT00271635|Charcot-Marie-Tooth Disease|charcot-marie-tooth disease
795607|NCT00271635|Hereditary Motor and Sensory Neuropathies|hereditary motor and sensory neuropathies
795608|NCT00271635|Ascorbic Acid|ascorbic acid
795609|NCT00271635|Vitamin C|vitamin c
795610|NCT00271622|Developmental Delay|developmental delay
795611|NCT00271622|Pediatric|pediatric
795612|NCT00271622|Pervasive Developmental Disorder|pervasive developmental disorder
795613|NCT00271622|Early Development|early development
795614|NCT00271622|Healthy Control Subjects|healthy control subjects
795615|NCT00271622|Autism Spectrum Disorders|autism spectrum disorders
795616|NCT00271622|Healthy Volunteer|healthy volunteer
795617|NCT00271622|HV|hv
795618|NCT00271609|AVASTIN|avastin
795619|NCT00271609|Recurrence|recurrence
795620|NCT00271609|Chemotherapy|chemotherapy
795621|NCT00271609|Anti-Angiogenesis|anti-angiogenesis
795622|NCT00271609|Radiotherapy|radiotherapy
795623|NCT00271609|Brain Tumor|brain tumor
795624|NCT00271609|Malignant Glioma|malignant glioma
795625|NCT00271596|Huntington Disease|huntington disease
795626|NCT00271596|Citalopram|citalopram
795627|NCT00271596|Celexa|celexa
795628|NCT00271596|Chorea|chorea
795634|NCT00271583|emergency contraception|emergency contraception
795635|NCT00271583|antiprogestin|antiprogestin
795636|NCT00271557|Heart Failure|heart failure
795637|NCT00271557|Renal Dysfunction|renal dysfunction
795638|NCT00271557|Cardiomyopathy|cardiomyopathy
795639|NCT00271557|Heart Decompensation|heart decompensation
795640|NCT00271557|Dyspnea Paroxysmal.|dyspnea paroxysmal.
795641|NCT00271544|heart failure|heart failure
795642|NCT00271544|cardiac pacing|cardiac pacing
795643|NCT00271544|left ventricular lead|left ventricular lead
795644|NCT00271544|cardiac resynchronization therapy|cardiac resynchronization therapy
795645|NCT00271531|bacterial infection, pneumonia, ventilation, children|bacterial infection, pneumonia, ventilation, children
795646|NCT00271505|Non-Small Cell Lung Cancer|non-small cell lung cancer
795647|NCT00271505|Lung Cancer|lung cancer
795648|NCT00271505|Bevacizumab|bevacizumab
795649|NCT00271505|Carboplatin|carboplatin
795650|NCT00271505|Docetaxel|docetaxel
795651|NCT00271505|Avastin|avastin
795652|NCT00271505|NSCLC|nsclc
795653|NCT00271505|Anti-VEGF monoclonal antibody|anti-vegf monoclonal antibody
795654|NCT00271505|rhuMAb-VEGF|rhumab-vegf
795655|NCT00271505|Paraplatin®|paraplatin®
795656|NCT00271505|Taxotere|taxotere
795657|NCT00271479|Meningitis|meningitis
795658|NCT00271479|Dose-Response Relationship, Immunologic|dose-response relationship, immunologic
795659|NCT00271479|Neisseria meningitidis|neisseria meningitidis
795660|NCT00271479|Outbreaks|outbreaks
795661|NCT00271479|Vaccine|vaccine
795662|NCT00271479|Africa|africa
795663|NCT00271479|Uganda|uganda
795664|NCT00271479|Prevention of Neisseria meningitidis infections|prevention of neisseria meningitidis infections
795665|NCT00271479|In outbreak contexts in developing countries|in outbreak contexts in developing countries
795666|NCT00271466|opioid|opioid
795667|NCT00271466|fentanyl|fentanyl
795668|NCT00271466|Duragesic|duragesic
795669|NCT00271466|transdermal|transdermal
795670|NCT00271466|chronic pain|chronic pain
795671|NCT00271466|morphine|morphine
795672|NCT00271453|chronic pain|chronic pain
795673|NCT00271453|opioid|opioid
795674|NCT00271453|fentanyl|fentanyl
795675|NCT00271453|transdermal|transdermal
795676|NCT00271453|Durogesic|durogesic
795677|NCT00271453|morphine|morphine
795678|NCT00271440|chlorhexidine|chlorhexidine
795679|NCT00271440|neonatal|neonatal
795680|NCT00271440|skin flora|skin flora
795681|NCT00271440|skin cleansing|skin cleansing
795682|NCT00271440|bacterial colonization|bacterial colonization
795683|NCT00271427|Thyroiditis|thyroiditis
795684|NCT00271427|Autoimmune|autoimmune
795685|NCT00271427|Hashimoto's|hashimoto's
795686|NCT00271427|TPOAb|tpoab
795687|NCT00271427|Selenium|selenium
795688|NCT00271414|chronic pain|chronic pain
795689|NCT00271414|opioid|opioid
795690|NCT00271414|fentanyl|fentanyl
795691|NCT00271414|transdermal|transdermal
795692|NCT00271414|Duragesic|duragesic
795693|NCT00271414|morphine|morphine
795694|NCT00271401|Stents|stents
795695|NCT00271401|Angioplasty, Transluminal, Percutaneous Coronary|angioplasty, transluminal, percutaneous coronary
795696|NCT00271388|Galvanic Vestibular Stimulation|galvanic vestibular stimulation
795697|NCT00271388|Hemispatial Neglect|hemispatial neglect
795698|NCT00271388|Stroke|stroke
795699|NCT00271375|Age|age
795700|NCT00271375|Caregivers|caregivers
795701|NCT00271375|Family|family
795702|NCT00271375|Intervention Studies|intervention studies
795703|NCT00271362|Exercise|exercise
795704|NCT00271362|Physical function|physical function
795705|NCT00271362|Prosthetic mobility|prosthetic mobility
795706|NCT00271362|Rehabilitation|rehabilitation
795707|NCT00271349|Eosinophilic Esophagitis|eosinophilic esophagitis
795708|NCT00271349|Budesonide|budesonide
795709|NCT00271336|NEC|nec
795710|NCT00271336|Premature Infants|premature infants
795711|NCT00271336|TNF|tnf
795712|NCT00271336|Pentoxifylline|pentoxifylline
795713|NCT00271297|pelvic floor|pelvic floor
795714|NCT00271297|exercise therapy|exercise therapy
795715|NCT00271297|prevention|prevention
795716|NCT00271297|ultrasonography|ultrasonography
795717|NCT00271297|risk factors|risk factors
795718|NCT00271245|cirrhosis|cirrhosis
795719|NCT00271245|liver disease|liver disease
795720|NCT00271245|selenium|selenium
795721|NCT00271245|selenoproteins|selenoproteins
795722|NCT00271245|selenoprotein P|selenoprotein p
795723|NCT00271245|biomarkers|biomarkers
795724|NCT00271232|Heart Failure, Cardiac Resynchronization|heart failure, cardiac resynchronization
795725|NCT00271219|opiate addiction|opiate addiction
795726|NCT00271219|opiate dependence|opiate dependence
795727|NCT00271219|substance abuse|substance abuse
795728|NCT00271219|addiction|addiction
795729|NCT00271219|substance addiction|substance addiction
795730|NCT00271219|pregnancy|pregnancy
795731|NCT00271219|buprenorphine|buprenorphine
795732|NCT00271219|methadone|methadone
795733|NCT00271219|fetal|fetal
795734|NCT00271219|neonatal|neonatal
795735|NCT00271219|post-partum|post-partum
795736|NCT00271206|Nicotine Dependence|nicotine dependence
795737|NCT00271206|Tobacco Dependence|tobacco dependence
795738|NCT00271180|Cardiac Pacing|cardiac pacing
795739|NCT00271180|Implantable Cardioverter Defibrillator|implantable cardioverter defibrillator
795740|NCT00271180|pacemaker|pacemaker
795741|NCT00271180|Sinus Bradycardia|sinus bradycardia
795742|NCT00271167|Cardiac surgery|cardiac surgery
795743|NCT00271167|PARP inhibitor|parp inhibitor
795744|NCT00271167|PARP inhibition|parp inhibition
795745|NCT00271167|Bypass surgery|bypass surgery
795746|NCT00271167|CPB surgery|cpb surgery
795747|NCT00271167|Cardiopulmonary bypass|cardiopulmonary bypass
795748|NCT00271167|Coronary revascularization|coronary revascularization
795749|NCT00271167|Cardiac valve replacement|cardiac valve replacement
795750|NCT00271154|Heart Failure|heart failure
795751|NCT00271154|Implantable Cardioverter Defibrillator|implantable cardioverter defibrillator
795752|NCT00271154|Cardiac Resynchronization Therapy|cardiac resynchronization therapy
795753|NCT00271141|Parkinson's disease|parkinson's disease
795754|NCT00271141|Oxidative stress|oxidative stress
795755|NCT00271141|Marker|marker
795756|NCT00271128|NT-proBNP|nt-probnp
795757|NCT00271128|Heart failure|heart failure
795758|NCT00271128|Dyspnea|dyspnea
795759|NCT00271115|Kangaroo holding|kangaroo holding
795760|NCT00271115|Kangaroo care|kangaroo care
795761|NCT00271115|Maternal stress levels|maternal stress levels
795762|NCT00271115|Premature birth|premature birth
795763|NCT00271102|Cystocele, prolapse, anterior repair, colporrhaphy|cystocele, prolapse, anterior repair, colporrhaphy
795764|NCT00271076|CAD|cad
795765|NCT00271076|CEA|cea
795766|NCT00271076|CAS|cas
795767|NCT00271076|IVUS|ivus
795768|NCT00271076|symptomatic|symptomatic
795769|NCT00271076|asymptomatic|asymptomatic
795770|NCT00271076|Cerebral Protection Device|cerebral protection device
795771|NCT00271076|TIA|tia
795772|NCT00271076|Stroke|stroke
795773|NCT00271076|plaque morphology|plaque morphology
795774|NCT00271063|Refractory or Relapsed Acute Lymphocytic Leukemia|refractory or relapsed acute lymphocytic leukemia
795775|NCT00271050|non-Hodgkin's lymphoma|non-hodgkin's lymphoma
795776|NCT00271050|external beam radiotherapy (EBRT)|external beam radiotherapy (ebrt)
795777|NCT00271050|radio-immunotherapy (RIT)|radio-immunotherapy (rit)
795778|NCT00271050|Zevalin|zevalin
795779|NCT00271037|Pelvic organ prolapse|pelvic organ prolapse
795780|NCT00271037|Stress urinary incontinence|stress urinary incontinence
795781|NCT00271037|Surgery|surgery
795782|NCT00271037|Colpocleisis|colpocleisis
795783|NCT00271037|Urinary retention|urinary retention
795784|NCT00271024|Smoking|smoking
795785|NCT00271024|Smoking Cessation|smoking cessation
795786|NCT00270998|Stress urinary incontinence|stress urinary incontinence
795787|NCT00270985|almonds|almonds
795788|NCT00270985|pre-diabetes|pre-diabetes
795789|NCT00270985|inflammatory|inflammatory
795790|NCT00270985|CRP|crp
795791|NCT00270972|Venous leg ulcer|venous leg ulcer
795792|NCT00270972|Venous insufficiency|venous insufficiency
795793|NCT00270972|OrCel|orcel
795794|NCT00270959|PTSD|ptsd
795795|NCT00270946|Venous leg ulcer|venous leg ulcer
795796|NCT00270946|OrCel|orcel
795797|NCT00270946|Compression therapy|compression therapy
795798|NCT00270933|defibrillators|defibrillators
795799|NCT00270933|LLECG|llecg
795800|NCT00270933|ventricular tachycardia|ventricular tachycardia
795801|NCT00270933|ventricular fibrillation|ventricular fibrillation
795802|NCT00270920|Initiation, Maintenance, Breastfeeding|initiation, maintenance, breastfeeding
795803|NCT00270907|Metastatic Breast Cancer|metastatic breast cancer
795804|NCT00270907|Breast Cancer|breast cancer
795805|NCT00270907|CT-2103|ct-2103
795806|NCT00270907|Gemcitabine|gemcitabine
795807|NCT00270907|Xyotax|xyotax
795808|NCT00270907|Gemzar|gemzar
795809|NCT00270894|neoadjuvant chemotherapy|neoadjuvant chemotherapy
795810|NCT00270894|HER2 positive breast cancer|her2 positive breast cancer
795811|NCT00270894|stage II - III breast cancer|stage ii - iii breast cancer
795812|NCT00270881|cord blood transplantation|cord blood transplantation
795813|NCT00270881|myeloablative regimen|myeloablative regimen
795814|NCT00270881|hematologic malignancies|hematologic malignancies
795815|NCT00270868|Double guide wire technique|double guide wire technique
795816|NCT00270868|Difficult selective biliary cannulation|difficult selective biliary cannulation
795817|NCT00270868|ERCP|ercp
795818|NCT00270868|Attempts of cannulation|attempts of cannulation
795819|NCT00270868|Post-ERCP complications.|post-ercp complications.
795820|NCT00270855|Body Composition|body composition
795821|NCT00270855|Exercise|exercise
795822|NCT00270855|Glucose Tolerance|glucose tolerance
795823|NCT00270855|Insulin Sensitivity|insulin sensitivity
795824|NCT00270855|Functional Electric Stimulation|functional electric stimulation
795825|NCT00270842|Education|education
795826|NCT00270842|Exercise|exercise
795827|NCT00270842|Gait|gait
795828|NCT00270842|Peripheral Nervous System|peripheral nervous system
795829|NCT00270842|Postural Balance|postural balance
795830|NCT00270842|Self Efficacy|self efficacy
795831|NCT00270842|Tai Chi Chuan|tai chi chuan
795832|NCT00270829|renal function|renal function
795833|NCT00270816|Multiple Sclerosis|multiple sclerosis
795834|NCT00270816|Interferon-ß-1b|interferon-ß-1b
795835|NCT00270816|Therapy|therapy
795836|NCT00270803|Marijuana, FDG, PET, maze, THC, motor coordination.|marijuana, fdg, pet, maze, thc, motor coordination.
795837|NCT00270790|Head and Neck cancer|head and neck cancer
795838|NCT00270777|Controlled trial|controlled trial
795839|NCT00270777|Snake bite|snake bite
795840|NCT00270777|Safety|safety
795841|NCT00270777|Antivenom|antivenom
795842|NCT00270764|HIV/AIDS|hiv/aids
795843|NCT00270764|Antiretroviral therapy|antiretroviral therapy
795844|NCT00270764|Quality of life|quality of life
795845|NCT00270764|South Africa|south africa
795846|NCT00270764|Treatment Naive|treatment naive
795847|NCT00270751|Video-Assisted Thoracoscopic Surgery|video-assisted thoracoscopic surgery
795848|NCT00270751|Spontaneous pneumothorax|spontaneous pneumothorax
795849|NCT00270751|Pleurectomy|pleurectomy
795850|NCT00270751|Pleural abrasion|pleural abrasion
795851|NCT00270751|Minocycline|minocycline
795852|NCT00270738|urinary incontinence|urinary incontinence
795853|NCT00270738|transversus abdominis|transversus abdominis
795854|NCT00270738|pelvic floor muscles|pelvic floor muscles
795855|NCT00270738|randomized controlled trial|randomized controlled trial
795856|NCT00270725|HIV|hiv
795857|NCT00270725|AIDS|aids
795858|NCT00270725|Labor productivity|labor productivity
795859|NCT00270725|Antiretroviral therapy|antiretroviral therapy
795860|NCT00270725|South Africa|south africa
795861|NCT00270712|kidney|kidney
795862|NCT00270712|transplant|transplant
795863|NCT00270712|dysfunction|dysfunction
795864|NCT00270712|chronic|chronic
795865|NCT00270712|deterioration|deterioration
795866|NCT00270712|loss of function|loss of function
795867|NCT00270699|Dengue Vaccine|dengue vaccine
795868|NCT00270699|Dengue Virus|dengue virus
795869|NCT00270699|Dengue Hemorrhagic Fever|dengue hemorrhagic fever
795870|NCT00270699|Dengue Shock Syndrome|dengue shock syndrome
795871|NCT00270686|Ehlers-Danlos Syndrome|ehlers-danlos syndrome
795872|NCT00270686|Stickler Syndrome|stickler syndrome
795873|NCT00270686|Marfan Syndrome|marfan syndrome
795874|NCT00270686|Genetics|genetics
795875|NCT00270686|Aneurysm|aneurysm
795876|NCT00270673|Lactate|lactate
795877|NCT00270673|Tissue hypoxia|tissue hypoxia
795878|NCT00270673|Intensive care|intensive care
795879|NCT00270673|Goal- directed therapy|goal- directed therapy
795880|NCT00270660|retraction pockets ear|retraction pockets ear
795881|NCT00270660|unsafe otitis media|unsafe otitis media
795882|NCT00270660|otitis media complications|otitis media complications
795883|NCT00270647|cancer|cancer
795884|NCT00270647|prostate cancer|prostate cancer
795885|NCT00270647|colorectal cancer|colorectal cancer
795886|NCT00270647|cardiovascular disease|cardiovascular disease
795887|NCT00270647|eye disease|eye disease
795888|NCT00270647|cognitive decline|cognitive decline
795889|NCT00270634|Randomized Controlled Trials|randomized controlled trials
795890|NCT00270634|Immunosuppression|immunosuppression
795892|NCT00270634|Kidney Transplantation|kidney transplantation
795893|NCT00270634|Treatment Outcome|treatment outcome
795894|NCT00270608|Hypertension|hypertension
795895|NCT00270608|Peripheral vascular disease|peripheral vascular disease
795896|NCT00270608|Diabetes|diabetes
795897|NCT00270608|Total body fat percentage|total body fat percentage
795898|NCT00270556|Treatment Experienced|treatment experienced
795899|NCT00270543|Stomach Neoplasms|stomach neoplasms
795900|NCT00270530|Malaria|malaria
795901|NCT00270530|Placental diseases|placental diseases
795902|NCT00270530|Birth complications|birth complications
795903|NCT00270530|Plasmodium falciparum|plasmodium falciparum
795904|NCT00270530|Zambia|zambia
795905|NCT00270530|HIV-seropositive|hiv-seropositive
795906|NCT00270530|HIV|hiv
795907|NCT00270504|Memokath|memokath
795908|NCT00270504|Urethral stricture|urethral stricture
795909|NCT00270504|urethral stent|urethral stent
795910|NCT00270504|Bulbar urethral stricture|bulbar urethral stricture
795911|NCT00270478|Erythropoietin Therapy|erythropoietin therapy
795912|NCT00270478|Fetal Hemoglobin Induction|fetal hemoglobin induction
795913|NCT00270478|Sickle Cell Disease|sickle cell disease
795914|NCT00270478|Pulmonary Hypertension|pulmonary hypertension
795915|NCT00270478|Chronic Kidney Disease|chronic kidney disease
795916|NCT00270478|SCD|scd
795917|NCT00270465|HIV-positive|hiv-positive
795918|NCT00270465|Treatment Interruption|treatment interruption
795919|NCT00270465|Therapeutic Vaccine|therapeutic vaccine
795920|NCT00270465|HIV/AIDS|hiv/aids
795921|NCT00270465|Virologic Response|virologic response
795922|NCT00270465|HIV Positive|hiv positive
795923|NCT00270452|Myelodyplastic Syndrome (MDS)|myelodyplastic syndrome (mds)
795924|NCT00270452|Wilm's tumor-1|wilm's tumor-1
795925|NCT00270452|Proteinase-3|proteinase-3
795926|NCT00270452|Vaccine Therapy|vaccine therapy
795927|NCT00270452|Acute Myeloid Leukemia|acute myeloid leukemia
795928|NCT00270452|Chronic Myeloid Leukemias|chronic myeloid leukemias
795929|NCT00270452|Myelodysplastic Syndrome|myelodysplastic syndrome
795930|NCT00270452|MDS|mds
795931|NCT00270439|Obesity|obesity
795932|NCT00270439|Omentectomy|omentectomy
795933|NCT00270439|Diabetes Mellitus Type 2|diabetes mellitus type 2
795934|NCT00270439|Laparoscopic|laparoscopic
795935|NCT00270439|Dyslipidemia|dyslipidemia
795936|NCT00270426|Advanced Chronic Renal Insufficiency|advanced chronic renal insufficiency
795937|NCT00270426|Benazepril|benazepril
795938|NCT00270413|breast cancer|breast cancer
795939|NCT00270413|metastatic|metastatic
795940|NCT00270413|taxanes|taxanes
795941|NCT00270413|SU11248|su11248
795942|NCT00270400|Heart Failure|heart failure
795943|NCT00270400|Renal Dysfunction|renal dysfunction
795944|NCT00270400|Cardiomyopathy|cardiomyopathy
795945|NCT00270400|Heart Decompensation|heart decompensation
795946|NCT00270400|Dyspnea Paroxsymal.|dyspnea paroxsymal.
795947|NCT00270387|Acutely Decompensated Congestive Heart Failure|acutely decompensated congestive heart failure
795948|NCT00270387|Heart Failure|heart failure
795949|NCT00270387|Renal Impairment|renal impairment
795950|NCT00270387|Kidney Failure|kidney failure
795951|NCT00270387|Myocardial Infarction.|myocardial infarction.
795952|NCT00270374|Congestive heart failure|congestive heart failure
795953|NCT00270374|CHF|chf
795954|NCT00270374|Left-sided heart failure|left-sided heart failure
795955|NCT00270374|Right-sided heart failure|right-sided heart failure
795956|NCT00270374|Systolic Heart Failure|systolic heart failure
795957|NCT00270361|Heart Failure|heart failure
795958|NCT00270361|Renal Dysfunction|renal dysfunction
795959|NCT00270361|Cardiomyopathy|cardiomyopathy
795960|NCT00270361|Heart Decompensation|heart decompensation
795961|NCT00270361|Dyspnea Paroxsymal|dyspnea paroxsymal
795962|NCT00270361|Outpatient Therapy.|outpatient therapy.
795963|NCT00270348|Asthma|asthma
795964|NCT00270348|Safety|safety
795965|NCT00270348|Pediatrics|pediatrics
795966|NCT00270322|total knee replacement|total knee replacement
795967|NCT00270322|orthopedic surgery|orthopedic surgery
795968|NCT00270322|post operative analgesia|post operative analgesia
795969|NCT00270322|continuous epidural|continuous epidural
795970|NCT00270322|patients controlled analgesia|patients controlled analgesia
795971|NCT00270322|morphine|morphine
795972|NCT00270322|combined spinal epidural anesthesia|combined spinal epidural anesthesia
795973|NCT00270322|anesthesia|anesthesia
795974|NCT00270322|analgesia|analgesia
795975|NCT00270322|epidural marcaine|epidural marcaine
795976|NCT00270322|epidural fentanyl|epidural fentanyl
795977|NCT00270322|pain|pain
795978|NCT00270309|lower urinary tract symptoms, self-management|lower urinary tract symptoms, self-management
795979|NCT00270296|Treatment Naive|treatment naive
795980|NCT00270296|MTCT|mtct
795981|NCT00270296|HIV Seronegativity|hiv seronegativity
795982|NCT00270283|Anemia|anemia
795983|NCT00270283|AIDS|aids
795984|NCT00270283|erythropoietin|erythropoietin
795985|NCT00270283|epoetin alfa|epoetin alfa
795986|NCT00270283|Quality of Life|quality of life
795987|NCT00270283|Zidovudine|zidovudine
795989|NCT00270270|erythropoietin|erythropoietin
795990|NCT00270270|Anemia|anemia
795991|NCT00270270|Quality of Life|quality of life
795992|NCT00270270|epoetin alfa|epoetin alfa
795993|NCT00270270|HIV|hiv
795994|NCT00270270|Zidovudine|zidovudine
795995|NCT00270270|AIDS|aids
795996|NCT00270257|HIV Seronegativity|hiv seronegativity
795997|NCT00270257|Opiate Addiction|opiate addiction
795998|NCT00270257|Opiate Dependence|opiate dependence
795999|NCT00270244|Major Depression|major depression
796000|NCT00270244|Dysthymic Disorder|dysthymic disorder
796001|NCT00270244|Adjustment Disorder With Depressed Mood|adjustment disorder with depressed mood
796002|NCT00270244|Depressive Disorder Not Otherwise Specified|depressive disorder not otherwise specified
796003|NCT00270244|Adolescent|adolescent
796004|NCT00270244|Psychotherapy|psychotherapy
796005|NCT00270231|within-subjects, crossover, laboratory study|within-subjects, crossover, laboratory study
796006|NCT00270231|Naltrexone vs. Placebo|naltrexone vs. placebo
796007|NCT00270218|HIV Seronegativity|hiv seronegativity
796008|NCT00270218|Adenoviral Vector Vaccine|adenoviral vector vaccine
796009|NCT00270218|DNA Plasmid Vaccine|dna plasmid vaccine
796010|NCT00270205|Treatment Experienced|treatment experienced
796011|NCT00270205|HIV Therapeutic Vaccine|hiv therapeutic vaccine
796012|NCT00270192|Breastfeeding|breastfeeding
796013|NCT00270192|exclusive|exclusive
796014|NCT00270192|education|education
796015|NCT00270192|counseling|counseling
796016|NCT00270179|Anemia|anemia
796017|NCT00270179|blood transfusion|blood transfusion
796018|NCT00270179|epoetin alfa|epoetin alfa
796019|NCT00270179|erythropoietin|erythropoietin
796020|NCT00270179|surgery|surgery
796021|NCT00270179|self-blood donation|self-blood donation
796022|NCT00270166|cancer|cancer
796023|NCT00270166|malignancy|malignancy
796024|NCT00270166|red cell transfusion|red cell transfusion
796025|NCT00270166|epoetin alfa|epoetin alfa
796026|NCT00270166|epoetin|epoetin
796027|NCT00270166|erythropoietin|erythropoietin
796028|NCT00270166|red blood cells|red blood cells
796029|NCT00270153|renal transplant, ACE inhibitor|renal transplant, ace inhibitor
796030|NCT00270140|anemia|anemia
796031|NCT00270140|blood transfusion|blood transfusion
796032|NCT00270140|epoetin alfa|epoetin alfa
796033|NCT00270140|erythropoietin|erythropoietin
796034|NCT00270140|surgery|surgery
796035|NCT00270140|blood donation|blood donation
796036|NCT00270140|blood|blood
796037|NCT00270127|Anemia|anemia
796038|NCT00270127|cancer|cancer
796039|NCT00270127|quality of life|quality of life
796040|NCT00270127|chemotherapy|chemotherapy
796043|NCT00270127|epoetin alfa|epoetin alfa
796044|NCT00270127|epoetin|epoetin
796045|NCT00270127|erythropoietin|erythropoietin
796046|NCT00270114|Anemia|anemia
796047|NCT00270114|blood transfusion, autologous|blood transfusion, autologous
796048|NCT00270114|epoetin alfa|epoetin alfa
796049|NCT00270114|epogen|epogen
796050|NCT00270114|erythropoietin|erythropoietin
796051|NCT00270114|orthopedic procedures|orthopedic procedures
796052|NCT00270114|orthopedic surgery|orthopedic surgery
796053|NCT00270101|anemia|anemia
796054|NCT00270101|cancer|cancer
796055|NCT00270101|quality of life|quality of life
796056|NCT00270101|chemotherapy|chemotherapy
796057|NCT00270101|hemoglobin|hemoglobin
796058|NCT00270101|multiple myeloma|multiple myeloma
796059|NCT00270101|transfusion|transfusion
796060|NCT00270101|epoetin alfa|epoetin alfa
796061|NCT00270101|epoetin|epoetin
796062|NCT00270101|erythropoietin|erythropoietin
796063|NCT00270088|Anemia|anemia
796064|NCT00270088|blood transfusion|blood transfusion
796065|NCT00270088|epoetin alfa|epoetin alfa
796066|NCT00270088|epogen|epogen
796067|NCT00270088|erythropoietin|erythropoietin
796068|NCT00270088|orthopedic procedures|orthopedic procedures
796069|NCT00270088|orthopedic surgery|orthopedic surgery
796070|NCT00270075|epogen|epogen
796071|NCT00270075|erythropoietin|erythropoietin
796072|NCT00270075|orthopedic procedures|orthopedic procedures
796073|NCT00270075|orthopedic surgery|orthopedic surgery
796074|NCT00270075|cardiovascular surgical procedures|cardiovascular surgical procedures
796075|NCT00270075|Blood transfusion|blood transfusion
796076|NCT00270075|epoetin alfa|epoetin alfa
796077|NCT00270062|anemia|anemia
796078|NCT00270062|blood transfusion|blood transfusion
796079|NCT00270062|epoetin alfa|epoetin alfa
796080|NCT00270062|erythropoietin|erythropoietin
796081|NCT00270062|surgery|surgery
796082|NCT00270062|blood donation|blood donation
796083|NCT00270062|blood|blood
796084|NCT00270049|Anemia|anemia
796085|NCT00270049|cancer|cancer
796086|NCT00270049|leukemia|leukemia
796087|NCT00270049|chronic lymphocytic leukemia|chronic lymphocytic leukemia
796088|NCT00270049|lymphocytic leukemia|lymphocytic leukemia
796089|NCT00270049|epoetin alfa|epoetin alfa
796090|NCT00270049|erythropoietin|erythropoietin
796091|NCT00270049|red blood cells|red blood cells
796092|NCT00270049|transfusions|transfusions
796093|NCT00270049|quality of life|quality of life
796094|NCT00270036|Blood transfusion|blood transfusion
796095|NCT00270036|epoetin alfa|epoetin alfa
796096|NCT00270036|epogen|epogen
796097|NCT00270036|erythropoietin|erythropoietin
796098|NCT00270036|orthopedic procedures|orthopedic procedures
796099|NCT00270036|orthopedic surgery|orthopedic surgery
796100|NCT00270023|Blood transfusion|blood transfusion
796101|NCT00270023|epoetin alfa|epoetin alfa
796102|NCT00270023|epogen|epogen
796103|NCT00270023|erythropoietin|erythropoietin
796104|NCT00270023|orthopedic procedures|orthopedic procedures
796105|NCT00270023|orthopedic surgery|orthopedic surgery
796106|NCT00270023|cardiovascular surgical procedures|cardiovascular surgical procedures
796107|NCT00270023|breast reduction|breast reduction
796108|NCT00270010|Anemia|anemia
796109|NCT00270010|AIDS|aids
796110|NCT00270010|HIV|hiv
796111|NCT00270010|Zidovudine|zidovudine
796112|NCT00270010|Quality of Life|quality of life
796113|NCT00270010|erythropoietin|erythropoietin
796114|NCT00270010|epoetin alfa|epoetin alfa
796115|NCT00269997|Anemia|anemia
796116|NCT00269997|chemotherapy|chemotherapy
796117|NCT00269997|epoetin alfa|epoetin alfa
796118|NCT00269997|epogen|epogen
796119|NCT00269997|erythropoietin|erythropoietin
796120|NCT00269997|neoplasms|neoplasms
796121|NCT00269997|cancer|cancer
796122|NCT00269984|Anemia|anemia
796123|NCT00269984|Blood transfusion|blood transfusion
796124|NCT00269984|Epoetin alfa|epoetin alfa
796125|NCT00269984|Erythropoietin|erythropoietin
796126|NCT00269984|Neoplasm|neoplasm
796127|NCT00269984|Epogen|epogen
796128|NCT00269984|Cancer|cancer
796129|NCT00269971|hip replacement|hip replacement
796130|NCT00269971|hip replacement surgery|hip replacement surgery
796131|NCT00269971|surgery|surgery
796132|NCT00269971|anemia|anemia
796133|NCT00269971|transfusions|transfusions
796134|NCT00269971|blood|blood
796135|NCT00269971|blood transfusions|blood transfusions
796136|NCT00269958|hip replacement|hip replacement
796137|NCT00269958|hip replacement surgery|hip replacement surgery
796138|NCT00269958|surgery|surgery
796139|NCT00269958|anemia|anemia
796140|NCT00269958|transfusions|transfusions
796141|NCT00269958|blood transfusions|blood transfusions
796142|NCT00269945|Anemia|anemia
796143|NCT00269945|AIDS|aids
796144|NCT00269945|HIV|hiv
796145|NCT00269945|Zidovudine|zidovudine
796146|NCT00269945|Quality of Life|quality of life
796147|NCT00269945|erythropoietin|erythropoietin
796148|NCT00269945|epoetin alfa|epoetin alfa
796149|NCT00269932|Bronchitis|bronchitis
796150|NCT00269932|chronic bronchitis|chronic bronchitis
796151|NCT00269932|lung diseases|lung diseases
796356|NCT00268996|palpography|palpography
796152|NCT00269932|respiratory tract infections|respiratory tract infections
796153|NCT00269932|bronchial diseases|bronchial diseases
796154|NCT00269932|antibacterial agents|antibacterial agents
796155|NCT00269932|quinolones|quinolones
796156|NCT00269932|levofloxacin|levofloxacin
796157|NCT00269919|Schizophrenia|schizophrenia
796158|NCT00269919|Risperidone|risperidone
796159|NCT00269919|Risperidal Consta|risperidal consta
796160|NCT00269906|Angina, unstable|angina, unstable
796161|NCT00269906|Angioplasty, transluminal, percutaneous coronary|angioplasty, transluminal, percutaneous coronary
796162|NCT00269906|Abciximab|abciximab
796163|NCT00269893|Abciximab|abciximab
796164|NCT00269893|Angina, unstable|angina, unstable
796165|NCT00269893|Angioplasty, transluminal, Percutaneous coronary|angioplasty, transluminal, percutaneous coronary
796166|NCT00269880|Angioplasty, Transluminal, Percutaneous coronary|angioplasty, transluminal, percutaneous coronary
796167|NCT00269867|Rheumatoid Arthritis|rheumatoid arthritis
796168|NCT00269867|infliximab|infliximab
796169|NCT00269867|methotrexate|methotrexate
796170|NCT00269854|Crohn's Disease|crohn's disease
796171|NCT00269841|fistulae|fistulae
796172|NCT00269841|Crohn's Disease|crohn's disease
796173|NCT00269828|Non-small cell lung cancer|non-small cell lung cancer
796174|NCT00269828|NSCLC|nsclc
796175|NCT00269828|PS 2|ps 2
796176|NCT00269828|female|female
796177|NCT00269828|chemotherapy|chemotherapy
796178|NCT00269815|ADHD|adhd
796179|NCT00269815|Attention Deficit Hyperactivity Disorder|attention deficit hyperactivity disorder
796180|NCT00269815|OROS®|oros®
796181|NCT00269815|children|children
796182|NCT00269815|methylphenidate|methylphenidate
796183|NCT00269802|ADHD|adhd
796184|NCT00269802|Attention Deficit Hyperactivity Disorder|attention deficit hyperactivity disorder
796185|NCT00269802|OROS®|oros®
796186|NCT00269802|Ritalin®|ritalin®
796187|NCT00269802|children|children
796188|NCT00269802|methylphenidate|methylphenidate
796189|NCT00269789|Attention Deficit Hyperactivity Disorder|attention deficit hyperactivity disorder
796190|NCT00269789|OROS®|oros®
796191|NCT00269789|Ritalin®|ritalin®
796192|NCT00269789|children|children
796193|NCT00269789|methylphenidate|methylphenidate
796194|NCT00269789|ADHD|adhd
796195|NCT00269776|ADHD|adhd
796196|NCT00269776|Attention Deficit Hyperactivity Disorder|attention deficit hyperactivity disorder
796197|NCT00269776|OROS|oros
796198|NCT00269776|children|children
796199|NCT00269776|methylphenidate|methylphenidate
796200|NCT00269776|Ritalin|ritalin
796201|NCT00269763|patch|patch
796202|NCT00269763|pain|pain
796203|NCT00269763|fentanyl|fentanyl
796204|NCT00269763|narcotic|narcotic
796205|NCT00269763|Cancer|cancer
796206|NCT00269750|Ditropan®|ditropan®
796207|NCT00269750|OROS®|oros®
796208|NCT00269750|urge|urge
796209|NCT00269750|oxybutynin|oxybutynin
796210|NCT00269750|mixed urinary incontinence|mixed urinary incontinence
796211|NCT00269737|fentanyl|fentanyl
796212|NCT00269737|pain|pain
796213|NCT00269737|Cancer|cancer
796214|NCT00269737|patch|patch
796215|NCT00269724|urinary incontinence|urinary incontinence
796216|NCT00269724|oxybutynin|oxybutynin
796217|NCT00269724|OROS®|oros®
796218|NCT00269685|Septic shock|septic shock
796219|NCT00269685|catecholamine|catecholamine
796220|NCT00269685|vasopressin|vasopressin
796221|NCT00269685|tonometria|tonometria
796222|NCT00269685|lactate|lactate
796223|NCT00269672|vaccine|vaccine
796224|NCT00269659|Left Bundle Branch Block|left bundle branch block
796225|NCT00269659|Regional cardiac function|regional cardiac function
796226|NCT00269659|Global cardiac function|global cardiac function
796227|NCT00269659|Mechanical asynchrony|mechanical asynchrony
796228|NCT00269659|Echocardiography|echocardiography
796229|NCT00269659|2D echocardiography|2d echocardiography
796230|NCT00269659|Tissue Doppler Imaging|tissue doppler imaging
796231|NCT00269659|Real-time 3D echocardiography|real-time 3d echocardiography
796232|NCT00269659|Cardiovascular Magnetic Resonance Imaging-tagging|cardiovascular magnetic resonance imaging-tagging
796233|NCT00269646|Diet|diet
796234|NCT00269646|Low-carbohydrate|low-carbohydrate
796235|NCT00269646|Insulin|insulin
796236|NCT00269646|Dietary fiber|dietary fiber
796237|NCT00269646|Diabetes|diabetes
796238|NCT00269646|Cardiovascular disease|cardiovascular disease
796239|NCT00269633|Seasonal Affective Disorder|seasonal affective disorder
796240|NCT00269620|contraceptive vaginal ring|contraceptive vaginal ring
796241|NCT00269620|contraceptive patch|contraceptive patch
796242|NCT00269620|oral contraceptives|oral contraceptives
796243|NCT00269620|acceptability|acceptability
796244|NCT00269607|Substance abuse|substance abuse
796245|NCT00269607|Treatment|treatment
796246|NCT00269607|Relapse prevention|relapse prevention
796247|NCT00269607|opioid antagonist|opioid antagonist
796248|NCT00269594|Skin|skin
796249|NCT00269594|Picking|picking
796250|NCT00269594|Pick|pick
796251|NCT00269594|Neurotic Excoriation|neurotic excoriation
796252|NCT00269581|migraine|migraine
796253|NCT00269581|tension headaches|tension headaches
796254|NCT00269581|chronic daily headaches|chronic daily headaches
796255|NCT00269568|medical abortion|medical abortion
796256|NCT00269568|mifepristone|mifepristone
796257|NCT00269568|misoprostol|misoprostol
796258|NCT00269555|Prostate|prostate
796259|NCT00269555|Cancer|cancer
796260|NCT00269555|Prostate Specific Antigen|prostate specific antigen
796261|NCT00269555|C04.588.945.440.770|c04.588.945.440.770
796262|NCT00269542|zinc supplementation|zinc supplementation
796263|NCT00269542|hospitalisations|hospitalisations
796264|NCT00269542|children|children
796265|NCT00269542|mortality|mortality
796266|NCT00269542|iron folic acid|iron folic acid
796267|NCT00269529|postoperative pain|postoperative pain
796268|NCT00269529|knee arthroplasty|knee arthroplasty
796269|NCT00269529|analgesia|analgesia
796270|NCT00269529|infiltration|infiltration
796271|NCT00269529|femoral nerve block|femoral nerve block
796272|NCT00269516|Parkinson's disease|parkinson's disease
796273|NCT00269490|Post-Traumatic Stress Disorder|post-traumatic stress disorder
796274|NCT00269490|Yoga Nidra|yoga nidra
796275|NCT00269477|Meningitis|meningitis
796276|NCT00269477|Meningococcal infection|meningococcal infection
796277|NCT00269477|Neisseria meningitidis|neisseria meningitidis
796278|NCT00269477|Menactra®|menactra®
796279|NCT00269477|Menomune®|menomune®
796280|NCT00269425|Cardiovascular disease|cardiovascular disease
796281|NCT00269425|Nutrition|nutrition
796282|NCT00269425|Mediterranean diet|mediterranean diet
796283|NCT00269425|Low fat diet|low fat diet
796284|NCT00269425|American Heart Association diet|american heart association diet
796285|NCT00269425|Monounsaturated fats|monounsaturated fats
796286|NCT00269425|Omega-3 fats|omega-3 fats
796287|NCT00269425|Outcomes|outcomes
796288|NCT00269412|Irritable bowel syndrome|irritable bowel syndrome
796289|NCT00269399|Clostridium difficile-associated Diarrhea (CDAD)|clostridium difficile-associated diarrhea (cdad)
796290|NCT00269399|CDAD|cdad
796291|NCT00269399|C diff|c diff
796292|NCT00269386|Clarithromycin|clarithromycin
796293|NCT00269386|Crohn's|crohn's
796294|NCT00269373|Unknown primary tumor|unknown primary tumor
796295|NCT00269373|PET-CT|pet-ct
796296|NCT00269360|Chiropractic|chiropractic
796297|NCT00269360|Manual Therapies|manual therapies
796298|NCT00269360|Exercise|exercise
796299|NCT00269360|Randomized|randomized
796300|NCT00269360|Clinical Trial|clinical trial
796301|NCT00269360|Neck Pain|neck pain
796566|NCT00268112|cardiac|cardiac
796302|NCT00269347|Chiropractic|chiropractic
796303|NCT00269347|Manual Therapy|manual therapy
796304|NCT00269347|Exercise|exercise
796305|NCT00269347|Randomized|randomized
796306|NCT00269347|Clinical Trial|clinical trial
796307|NCT00269347|Back Pain|back pain
796308|NCT00269334|antidepressant,major depression,CYP2D6,CYP2C19,SSRI|antidepressant,major depression,cyp2d6,cyp2c19,ssri
796309|NCT00269321|Randomized|randomized
796310|NCT00269321|Clinical Trial|clinical trial
796311|NCT00269321|Low Back Pain|low back pain
796312|NCT00269321|Chiropractic|chiropractic
796313|NCT00269321|Manual Therapies|manual therapies
796314|NCT00269321|Exercise|exercise
796315|NCT00269308|Randomized|randomized
796316|NCT00269308|Clinical Trial|clinical trial
796317|NCT00269308|Neck Pain|neck pain
796318|NCT00269308|Chiropractic|chiropractic
796319|NCT00269308|Manual Therapies|manual therapies
796320|NCT00269308|Exercise|exercise
796321|NCT00269295|Typhoid fever, S typhi, vaccine|typhoid fever, s typhi, vaccine
796322|NCT00269230|cardiac resynchronization therapy, left ventricular Lead, Heart Failure|cardiac resynchronization therapy, left ventricular lead, heart failure
796324|NCT00269178|malaria|malaria
796325|NCT00269178|knowledge attitudes and practice (KAP)|knowledge attitudes and practice (kap)
796326|NCT00269178|bednets|bednets
796327|NCT00269178|peer health education|peer health education
796328|NCT00269139|Behavioral crisis|behavioral crisis
796329|NCT00269139|Perception of social crisis|perception of social crisis
796330|NCT00269139|Repetition compulsion|repetition compulsion
796331|NCT00269139|Intrusive mental events|intrusive mental events
796332|NCT00269139|Uncontrollable urges|uncontrollable urges
796333|NCT00269126|COPD|copd
796334|NCT00269126|Chronic Bronchitis|chronic bronchitis
796335|NCT00269126|Emphysema|emphysema
796336|NCT00269100|Debridement|debridement
796337|NCT00269087|Chronic Bronchitis|chronic bronchitis
796338|NCT00269087|COPD|copd
796339|NCT00269087|Emphysema|emphysema
796340|NCT00269061|pioglitazone|pioglitazone
796341|NCT00269061|diabetes|diabetes
796342|NCT00269061|fluid|fluid
796344|NCT00269048|Lp-PLA2|lp-pla2
796345|NCT00269048|SB-480848|sb-480848
796346|NCT00269035|SB-773812|sb-773812
796347|NCT00269035|SPECT|spect
796348|NCT00269035|D2 RO|d2 ro
796349|NCT00269035|pharmacokinetics|pharmacokinetics
796350|NCT00269035|schizophrenic patients|schizophrenic patients
796351|NCT00269035|5HT2A RO|5ht2a ro
796352|NCT00269022|SB-705498 acute migraine single dose TRPV1 combination inpatient outpatient study|sb-705498 acute migraine single dose trpv1 combination inpatient outpatient study
796353|NCT00269009|Tobacco use|tobacco use
796354|NCT00268996|Coronary artery disease|coronary artery disease
796355|NCT00268996|Lipoprotein-associated Phospholipase A2|lipoprotein-associated phospholipase a2
796358|NCT00268996|endothelial function|endothelial function
796359|NCT00268996|intravascular ultrasound|intravascular ultrasound
796360|NCT00268983|rituximab|rituximab
796361|NCT00268983|tositumomab and iodine I 131 tositumomab|tositumomab and iodine i 131 tositumomab
796362|NCT00268983|non-Hodgkins lymphoma|non-hodgkins lymphoma
796363|NCT00268983|radioimmunotherapy|radioimmunotherapy
796364|NCT00268983|anti-B1 antibody|anti-b1 antibody
796365|NCT00268983|Bexxar|bexxar
796366|NCT00268983|NHL|nhl
796367|NCT00268983|Tositumomab|tositumomab
796368|NCT00268970|Advanced non-small cell lung cancer (NSCLC)|advanced non-small cell lung cancer (nsclc)
796369|NCT00268957|Chronic|chronic
796370|NCT00268957|Hemodialysis|hemodialysis
796371|NCT00268957|Kidney|kidney
796372|NCT00268957|Hyperphosphatemia|hyperphosphatemia
796373|NCT00268957|Chronic kidney disease|chronic kidney disease
796374|NCT00268957|Chronic Renal Insufficiency|chronic renal insufficiency
796375|NCT00268944|Glycogen Storage Disease Type II|glycogen storage disease type ii
796376|NCT00268944|GSD-II|gsd-ii
796377|NCT00268944|Pompe Disease|pompe disease
796378|NCT00268931|premature birth|premature birth
796379|NCT00268931|motor skills|motor skills
796380|NCT00268931|learning|learning
796381|NCT00268931|reaching|reaching
796382|NCT00268918|PTK787|ptk787
796383|NCT00268918|Metastatic breast cancer|metastatic breast cancer
796384|NCT00268918|Refractory gynecological cancer|refractory gynecological cancer
796385|NCT00268892|Prostate Cancer|prostate cancer
796386|NCT00268892|Androgen ablation therapy|androgen ablation therapy
796387|NCT00268879|Irritable bowel syndrome|irritable bowel syndrome
796388|NCT00268879|Constipation-predominant irritable bowel syndrome|constipation-predominant irritable bowel syndrome
796389|NCT00268853|lymphoma|lymphoma
796390|NCT00268853|NHL|nhl
796391|NCT00268853|large cell|large cell
796392|NCT00268853|phase II|phase ii
796393|NCT00268853|CHOP R|chop r
796394|NCT00268853|CPOP R|cpop r
796395|NCT00268853|non Hodgkins|non hodgkins
796396|NCT00268840|Pancreas or biliary cancer|pancreas or biliary cancer
796397|NCT00268827|Kaletra|kaletra
796398|NCT00268827|Comparison|comparison
796399|NCT00268827|Quality of Life|quality of life
796400|NCT00268827|African American|african american
796401|NCT00268788|multifocal motor neuropathy|multifocal motor neuropathy
796402|NCT00268788|subcutaneous|subcutaneous
796403|NCT00268788|IVIG|ivig
796404|NCT00268788|gammaglobulin|gammaglobulin
796405|NCT00268775|community pharmacy services|community pharmacy services
796406|NCT00268775|patient care|patient care
796407|NCT00268775|outcome assessment|outcome assessment
796408|NCT00268775|benzodiazepines therapeutic use|benzodiazepines therapeutic use
796409|NCT00268762|stroke|stroke
796410|NCT00268762|thrombin inhibition|thrombin inhibition
796411|NCT00268762|thrombolysis|thrombolysis
796412|NCT00268762|bleeding|bleeding
796413|NCT00268762|outcome|outcome
796414|NCT00268697|Hyperlipidemia|hyperlipidemia
796415|NCT00268697|Drug Therapy|drug therapy
796416|NCT00268658|Arthroplasty, Replacement, Hip|arthroplasty, replacement, hip
796417|NCT00268658|Arthroplasty, Replacement, Knee|arthroplasty, replacement, knee
796418|NCT00268658|Arthroscopy|arthroscopy
796419|NCT00268606|fibromyalgia|fibromyalgia
796420|NCT00268606|cognitive-behavioral therapy|cognitive-behavioral therapy
796421|NCT00268606|tailored treatment|tailored treatment
796422|NCT00268593|heparanase|heparanase
796423|NCT00268593|angiogenesis|angiogenesis
796424|NCT00268580|Asthma|asthma
796425|NCT00268580|Care map|care map
796426|NCT00268580|Clinical pathway|clinical pathway
796427|NCT00268580|Education|education
796428|NCT00268580|Emergency department|emergency department
796429|NCT00268554|adenosine|adenosine
796430|NCT00268554|caffeine|caffeine
796431|NCT00268554|dipyridamole|dipyridamole
796432|NCT00268541|exercise|exercise
796433|NCT00268541|physical activity|physical activity
796434|NCT00268541|insulin resistance|insulin resistance
796435|NCT00268541|adipose tissue|adipose tissue
796436|NCT00268541|gene expression|gene expression
796437|NCT00268502|fatigue|fatigue
796438|NCT00268502|depression|depression
796439|NCT00268502|spiritual concerns|spiritual concerns
796440|NCT00268502|sexual dysfunction|sexual dysfunction
796441|NCT00268502|sleep disorders|sleep disorders
796442|NCT00268502|cancer survivor|cancer survivor
796443|NCT00268502|stage IA breast cancer|stage ia breast cancer
796444|NCT00268502|stage IB breast cancer|stage ib breast cancer
796445|NCT00268502|stage II breast cancer|stage ii breast cancer
796446|NCT00268502|stage IIIA breast cancer|stage iiia breast cancer
796447|NCT00268502|stage IIIB breast cancer|stage iiib breast cancer
796448|NCT00268502|stage IIIC breast cancer|stage iiic breast cancer
796449|NCT00268489|recurrent non-small cell lung cancer|recurrent non-small cell lung cancer
796450|NCT00268489|squamous cell lung cancer|squamous cell lung cancer
796451|NCT00268489|stage IIIB non-small cell lung cancer|stage iiib non-small cell lung cancer
796452|NCT00268489|stage IV non-small cell lung cancer|stage iv non-small cell lung cancer
796453|NCT00268476|Stage III Prostate Cancer|stage iii prostate cancer
796454|NCT00268476|Stage IV Prostate Cancer|stage iv prostate cancer
796455|NCT00268476|Recurrent Prostate Cancer|recurrent prostate cancer
796456|NCT00268476|Adenocarcinoma of the prostate|adenocarcinoma of the prostate
796457|NCT00268463|liver metastases|liver metastases
796458|NCT00268463|stage IV colon cancer|stage iv colon cancer
796459|NCT00268463|stage IV rectal cancer|stage iv rectal cancer
796460|NCT00268463|adenocarcinoma of the colon|adenocarcinoma of the colon
796461|NCT00268463|adenocarcinoma of the rectum|adenocarcinoma of the rectum
796462|NCT00268450|transitional cell carcinoma of the bladder|transitional cell carcinoma of the bladder
796463|NCT00268450|stage III bladder cancer|stage iii bladder cancer
796464|NCT00268450|stage II bladder cancer|stage ii bladder cancer
796465|NCT00268450|recurrent bladder cancer|recurrent bladder cancer
796466|NCT00268437|adenocarcinoma of the esophagus|adenocarcinoma of the esophagus
796467|NCT00268437|squamous cell carcinoma of the esophagus|squamous cell carcinoma of the esophagus
796468|NCT00268437|stage III esophageal cancer|stage iii esophageal cancer
796469|NCT00268437|stage II esophageal cancer|stage ii esophageal cancer
796470|NCT00268411|adenocarcinoma of the pancreas|adenocarcinoma of the pancreas
796471|NCT00268411|stage IV pancreatic cancer|stage iv pancreatic cancer
796472|NCT00268398|adenocarcinoma of the colon|adenocarcinoma of the colon
796473|NCT00268398|stage IV colon cancer|stage iv colon cancer
796474|NCT00268398|adenocarcinoma of the rectum|adenocarcinoma of the rectum
796475|NCT00268398|stage IV rectal cancer|stage iv rectal cancer
796476|NCT00268398|resectable metastases|resectable metastases
796477|NCT00268372|stage III squamous cell carcinoma of the oropharynx|stage iii squamous cell carcinoma of the oropharynx
796478|NCT00268372|stage IV squamous cell carcinoma of the oropharynx|stage iv squamous cell carcinoma of the oropharynx
796479|NCT00268359|adult anaplastic astrocytoma|adult anaplastic astrocytoma
796480|NCT00268359|adult anaplastic oligodendroglioma|adult anaplastic oligodendroglioma
796481|NCT00268359|adult glioblastoma|adult glioblastoma
796482|NCT00268359|adult gliosarcoma|adult gliosarcoma
796483|NCT00268359|recurrent adult brain tumor|recurrent adult brain tumor
796484|NCT00268359|adult giant cell glioblastoma|adult giant cell glioblastoma
796485|NCT00268346|adenocarcinoma of the esophagus|adenocarcinoma of the esophagus
796486|NCT00268346|recurrent esophageal cancer|recurrent esophageal cancer
796487|NCT00268346|squamous cell carcinoma of the esophagus|squamous cell carcinoma of the esophagus
796488|NCT00268346|stage IV esophageal cancer|stage iv esophageal cancer
796489|NCT00268333|adenocarcinoma of the colon|adenocarcinoma of the colon
796490|NCT00268333|adenocarcinoma of the rectum|adenocarcinoma of the rectum
796491|NCT00268333|stage IV colon cancer|stage iv colon cancer
796492|NCT00268333|stage III colon cancer|stage iii colon cancer
796493|NCT00268333|stage III rectal cancer|stage iii rectal cancer
796494|NCT00268333|stage IV rectal cancer|stage iv rectal cancer
796495|NCT00268320|congestive heart failure, atrial arrhythmia, cardiac resynchronization therapy, implantable cardioverter defibrillator|congestive heart failure, atrial arrhythmia, cardiac resynchronization therapy, implantable cardioverter defibrillator
796496|NCT00268307|Cell therapy|cell therapy
796497|NCT00268294|cardiac resynchronization therapy, atrial arrhythmia|cardiac resynchronization therapy, atrial arrhythmia
796498|NCT00268281|cardiac resynchronization therapy|cardiac resynchronization therapy
796499|NCT00268255|stage I non-small cell lung cancer|stage i non-small cell lung cancer
796500|NCT00268255|stage II non-small cell lung cancer|stage ii non-small cell lung cancer
796501|NCT00268255|adenosquamous cell lung cancer|adenosquamous cell lung cancer
796502|NCT00268255|bronchoalveolar cell lung cancer|bronchoalveolar cell lung cancer
796503|NCT00268255|large cell lung cancer|large cell lung cancer
796504|NCT00268255|squamous cell lung cancer|squamous cell lung cancer
796505|NCT00268255|adenocarcinoma of the lung|adenocarcinoma of the lung
796506|NCT00268242|adult acute myeloid leukemia with 11q23 (MLL) abnormalities|adult acute myeloid leukemia with 11q23 (mll) abnormalities
796507|NCT00268242|adult acute myeloid leukemia with inv(16)(p13;q22)|adult acute myeloid leukemia with inv(16)(p13;q22)
796508|NCT00268242|adult acute myeloid leukemia with t(16;16)(p13;q22)|adult acute myeloid leukemia with t(16;16)(p13;q22)
796509|NCT00268242|adult acute myeloid leukemia with t(8;21)(q22;q22)|adult acute myeloid leukemia with t(8;21)(q22;q22)
796510|NCT00268242|recurrent adult acute myeloid leukemia|recurrent adult acute myeloid leukemia
796511|NCT00268242|adult acute minimally differentiated myeloid leukemia (M0)|adult acute minimally differentiated myeloid leukemia (m0)
796512|NCT00268242|adult acute myeloblastic leukemia without maturation (M1)|adult acute myeloblastic leukemia without maturation (m1)
796513|NCT00268242|adult acute myeloblastic leukemia with maturation (M2)|adult acute myeloblastic leukemia with maturation (m2)
796514|NCT00268242|adult acute myelomonocytic leukemia (M4)|adult acute myelomonocytic leukemia (m4)
796515|NCT00268242|adult acute monoblastic leukemia (M5a)|adult acute monoblastic leukemia (m5a)
796516|NCT00268242|adult acute monocytic leukemia (M5b)|adult acute monocytic leukemia (m5b)
796517|NCT00268242|adult erythroleukemia (M6a)|adult erythroleukemia (m6a)
796518|NCT00268242|adult pure erythroid leukemia (M6b)|adult pure erythroid leukemia (m6b)
796519|NCT00268242|adult acute megakaryoblastic leukemia (M7)|adult acute megakaryoblastic leukemia (m7)
796520|NCT00268229|recurrent adult acute myeloid leukemia|recurrent adult acute myeloid leukemia
796521|NCT00268229|adult acute myeloid leukemia with 11q23 (MLL) abnormalities|adult acute myeloid leukemia with 11q23 (mll) abnormalities
796522|NCT00268229|adult acute myeloid leukemia with inv(16)(p13;q22)|adult acute myeloid leukemia with inv(16)(p13;q22)
796523|NCT00268229|adult acute myeloid leukemia with t(16;16)(p13;q22)|adult acute myeloid leukemia with t(16;16)(p13;q22)
796524|NCT00268229|adult acute myeloid leukemia with t(8;21)(q22;q22)|adult acute myeloid leukemia with t(8;21)(q22;q22)
796525|NCT00268229|adult acute minimally differentiated myeloid leukemia (M0)|adult acute minimally differentiated myeloid leukemia (m0)
796526|NCT00268229|adult acute megakaryoblastic leukemia (M7)|adult acute megakaryoblastic leukemia (m7)
796527|NCT00268229|adult acute monoblastic leukemia (M5a)|adult acute monoblastic leukemia (m5a)
796528|NCT00268229|adult acute monocytic leukemia (M5b)|adult acute monocytic leukemia (m5b)
796529|NCT00268229|adult acute myeloblastic leukemia with maturation (M2)|adult acute myeloblastic leukemia with maturation (m2)
796530|NCT00268229|adult acute myeloblastic leukemia without maturation (M1)|adult acute myeloblastic leukemia without maturation (m1)
796531|NCT00268229|adult acute myelomonocytic leukemia (M4)|adult acute myelomonocytic leukemia (m4)
796532|NCT00268229|adult erythroleukemia (M6a)|adult erythroleukemia (m6a)
796533|NCT00268229|adult pure erythroid leukemia (M6b)|adult pure erythroid leukemia (m6b)
796534|NCT00268216|mortality|mortality
796535|NCT00268216|TORCH|torch
796536|NCT00268216|SERETIDE|seretide
796537|NCT00268216|ADVAIR|advair
796538|NCT00268216|COPD|copd
796539|NCT00268203|expanded access study|expanded access study
796540|NCT00268203|refractory low-grade non-Hodgkin's Lymphoma|refractory low-grade non-hodgkin's lymphoma
796541|NCT00268203|Bexxar®|bexxar®
796542|NCT00268203|Iodine I 131 Tositumomab|iodine i 131 tositumomab
796543|NCT00268203|EAP|eap
796544|NCT00268203|relapsed low-grade non-Hodgkin's lymphoma|relapsed low-grade non-hodgkin's lymphoma
796545|NCT00268177|Airways|airways
796546|NCT00268177|Pulmonary|pulmonary
796547|NCT00268177|Obstructive|obstructive
796548|NCT00268177|Chronic|chronic
796549|NCT00268177|inflammation|inflammation
796550|NCT00268177|salmeterol/fluticasone propionate|salmeterol/fluticasone propionate
796551|NCT00268151|non-small cell lung cancer|non-small cell lung cancer
796552|NCT00268151|oxaliplatin|oxaliplatin
796553|NCT00268151|capecitabine|capecitabine
796554|NCT00268151|XELOX-RT|xelox-rt
796555|NCT00268138|amine fluoride|amine fluoride
796556|NCT00268138|white spot lesions|white spot lesions
796557|NCT00268138|qlf|qlf
796558|NCT00268125|Breast Neoplasm|breast neoplasm
796559|NCT00268125|FEC100|fec100
796560|NCT00268125|Chemotherapy|chemotherapy
796561|NCT00268125|acupression|acupression
796562|NCT00268125|bracelet|bracelet
796563|NCT00268125|nausea|nausea
796564|NCT00268125|vomiting|vomiting
796565|NCT00268112|pediatric|pediatric
796567|NCT00268112|ALCAPA|alcapa
796568|NCT00268112|Tissue Doppler Imaging|tissue doppler imaging
796569|NCT00268099|pediatric|pediatric
796570|NCT00268099|cardiac|cardiac
796571|NCT00268099|repair of right to left shunt lesions|repair of right to left shunt lesions
796572|NCT00268099|Tetralogy of Fallot defects|tetralogy of fallot defects
796573|NCT00268086|constrictive pericarditis|constrictive pericarditis
796574|NCT00268086|adult congenital patients|adult congenital patients
796575|NCT00268086|pulmonary insufficiency|pulmonary insufficiency
796576|NCT00268073|Pediatric|pediatric
796577|NCT00268073|cardiac|cardiac
796578|NCT00268073|neo-aortic insufficience|neo-aortic insufficience
796579|NCT00268073|Norwood standard Stage I procedure|norwood standard stage i procedure
796580|NCT00268073|Norwood Sano procedure|norwood sano procedure
796581|NCT00268060|pediatric|pediatric
796582|NCT00268060|cardiac|cardiac
796583|NCT00268060|Long QT Syndrome|long qt syndrome
796584|NCT00268060|Pacemaker|pacemaker
796585|NCT00268060|Herg mutation|herg mutation
796586|NCT00268047|pediatric|pediatric
796587|NCT00268047|cardiac|cardiac
796588|NCT00268047|surgery|surgery
796589|NCT00268047|transplantation|transplantation
796590|NCT00268047|pulmonary vascular resistance in Fontan patients|pulmonary vascular resistance in fontan patients
796591|NCT00268034|pediatric|pediatric
796592|NCT00268034|cardiac|cardiac
796593|NCT00268034|aneurysms|aneurysms
796594|NCT00268034|left ventricular aneurysms|left ventricular aneurysms
796595|NCT00268034|surgical repair for LV aneurysms|surgical repair for lv aneurysms
796596|NCT00268021|pediatric|pediatric
796597|NCT00268021|biventricular pacemaker|biventricular pacemaker
796598|NCT00268021|automated implantable cardioverter defibrillator|automated implantable cardioverter defibrillator
796599|NCT00268021|AICD|aicd
796600|NCT00268008|aortic valve replacement|aortic valve replacement
796601|NCT00268008|mitral valve replacement|mitral valve replacement
796602|NCT00268008|valvular stenosis|valvular stenosis
796603|NCT00268008|Ross procedure|ross procedure
796604|NCT00268008|Homograft valves|homograft valves
796605|NCT00268008|Bio-prosthetic valves|bio-prosthetic valves
796606|NCT00268008|Mechanical valves|mechanical valves
796607|NCT00267995|Pediatric|pediatric
796608|NCT00267995|cardiac|cardiac
796609|NCT00267995|Ross procedure|ross procedure
796610|NCT00267995|Aortic valve replacement|aortic valve replacement
796611|NCT00267995|Proximal buttressing technique|proximal buttressing technique
796612|NCT00267982|pediatric|pediatric
796613|NCT00267982|cardiac|cardiac
796614|NCT00267982|Radiofrequency Ablation|radiofrequency ablation
796615|NCT00267982|Ectopic Atrial Tachycardia|ectopic atrial tachycardia
796616|NCT00267969|Ustekinumab|ustekinumab
796617|NCT00267969|CNTO1275|cnto1275
796618|NCT00267969|Plaque type Psoriasis|plaque type psoriasis
796619|NCT00267969|Interleukin-23|interleukin-23
796620|NCT00267969|IL-23|il-23
796622|NCT00267969|Interleukin 12|interleukin 12
796623|NCT00267969|IL-12|il-12
796624|NCT00267956|Psoriatic arthritis|psoriatic arthritis
796625|NCT00267956|CNTO 1275|cnto 1275
796626|NCT00267956|Ustekinumab|ustekinumab
796627|NCT00267956|Interleukin-23, IL-12, IL-23|interleukin-23, il-12, il-23
796628|NCT00267956|Monoclonal antibodies|monoclonal antibodies
796629|NCT00267930|AFib|afib
796630|NCT00267930|AF|af
796631|NCT00267904|Adrenaline|adrenaline
796632|NCT00267904|Normal Physiology|normal physiology
796633|NCT00267904|Catecholamines|catecholamines
796634|NCT00267904|Catechols|catechols
796635|NCT00267904|Sympathetic Nervous System|sympathetic nervous system
796636|NCT00267904|Healthy Volunteer|healthy volunteer
796637|NCT00267904|HV|hv
796638|NCT00267891|Healthy Control Subjects|healthy control subjects
796639|NCT00267891|Aggression|aggression
796640|NCT00267891|Prefrontal Cortex Function|prefrontal cortex function
796641|NCT00267891|Children and Adolescents|children and adolescents
796642|NCT00267891|Healthy Volunteer|healthy volunteer
796643|NCT00267891|HV|hv
796644|NCT00267865|HIV|hiv
796645|NCT00267865|AIDS-Related-Primary Central Nervous System Lymphoma|aids-related-primary central nervous system lymphoma
796646|NCT00267865|High Dose Methotrexate|high dose methotrexate
796647|NCT00267865|Rituximab|rituximab
796648|NCT00267865|CNS Lymphoma|cns lymphoma
796649|NCT00267865|AIDS Related-Primary Central Nervous System Lymphoma|aids related-primary central nervous system lymphoma
796650|NCT00267865|AR-PCNSL|ar-pcnsl
796651|NCT00267852|Arthritis|arthritis
796652|NCT00267839|exercise|exercise
796653|NCT00267839|intervention|intervention
796654|NCT00267839|elderly woman|elderly woman
796655|NCT00267839|risk factors|risk factors
796656|NCT00267839|health costs|health costs
796657|NCT00267839|Osteoporosis|osteoporosis
796658|NCT00267839|cardiovascular diseases|cardiovascular diseases
796659|NCT00267839|diabetes|diabetes
796660|NCT00267839|Higher Age|higher age
796661|NCT00267826|Anti-CD20 antibody treatment|anti-cd20 antibody treatment
796662|NCT00267826|Atopic dermatitis|atopic dermatitis
796663|NCT00267826|B cells|b cells
796664|NCT00267826|Cytokines|cytokines
796665|NCT00267826|Immunopathology|immunopathology
796666|NCT00267813|craving|craving
796667|NCT00267813|nicotine|nicotine
796668|NCT00267813|imaging|imaging
796669|NCT00267813|FDG|fdg
796670|NCT00267813|PET|pet
796671|NCT00267813|smoking|smoking
796672|NCT00267813|Bupropion|bupropion
796673|NCT00267800|Lung disease, Interstitial|lung disease, interstitial
796674|NCT00267800|Sarcoidosis|sarcoidosis
796675|NCT00267800|Pulmonary fibrosis|pulmonary fibrosis
796676|NCT00267735|pregnancy|pregnancy
796677|NCT00267735|repeat cesarean|repeat cesarean
796678|NCT00267735|vaginal birth after cesarean|vaginal birth after cesarean
796679|NCT00267696|ovarian cancer|ovarian cancer
796680|NCT00267696|platinum sensitive cancer|platinum sensitive cancer
796681|NCT00267696|fallopian tube cancer|fallopian tube cancer
796682|NCT00267696|peritoneal cancer|peritoneal cancer
796683|NCT00267670|Fatty Liver Disease|fatty liver disease
796684|NCT00267670|Liver|liver
796685|NCT00267670|NASH|nash
796686|NCT00267670|Nonalcoholic Steatohepatitis|nonalcoholic steatohepatitis
796687|NCT00267670|Nonalcoholic Fatty Liver Disease (NAFLD)|nonalcoholic fatty liver disease (nafld)
796688|NCT00267670|Pentoxifylline|pentoxifylline
796689|NCT00267644|Children, dehydration, Ultrasound|children, dehydration, ultrasound
796690|NCT00267631|children, obesity, emergency medicine|children, obesity, emergency medicine
796691|NCT00267553|Atamestane|atamestane
796692|NCT00267553|Breast neoplasms|breast neoplasms
796693|NCT00267553|Combined hormonal therapy|combined hormonal therapy
796694|NCT00267553|Complete estrogen blockade|complete estrogen blockade
796695|NCT00267553|Ductal breast carcinoma|ductal breast carcinoma
796696|NCT00267553|Estrogen blocker|estrogen blocker
796697|NCT00267553|Fareston®|fareston®
796698|NCT00267553|Femara®|femara®
796699|NCT00267553|First line therapy|first line therapy
796700|NCT00267553|Letrozole|letrozole
796701|NCT00267553|Lobular breast carcinoma|lobular breast carcinoma
796702|NCT00267553|Locally advanced breast cancer|locally advanced breast cancer
796703|NCT00267553|Locally recurrent breast cancer|locally recurrent breast cancer
796704|NCT00267553|Maximal estrogen inhibition|maximal estrogen inhibition
796705|NCT00267553|Metastatic breast cancer|metastatic breast cancer
796706|NCT00267553|Neoplasms, Hormone-dependent|neoplasms, hormone-dependent
796707|NCT00267553|Receptor-positive|receptor-positive
796708|NCT00267553|Stage IIIA breast cancer|stage iiia breast cancer
796709|NCT00267553|Stage IIIB breast cancer|stage iiib breast cancer
796710|NCT00267553|Stage IV breast cancer|stage iv breast cancer
796711|NCT00267553|Toremifene|toremifene
796712|NCT00267540|Vitamin D|vitamin d
796713|NCT00267540|adolescent girls|adolescent girls
796714|NCT00267540|bone accretion|bone accretion
796715|NCT00267540|bone turn over|bone turn over
796716|NCT00267540|vitamin D status|vitamin d status
796717|NCT00267540|Vitamin D insufficiency in young girls|vitamin d insufficiency in young girls
796718|NCT00267527|Treatment Experienced|treatment experienced
796719|NCT00267527|HIV Visceral Obesity|hiv visceral obesity
796720|NCT00267514|Hemodialysis|hemodialysis
796721|NCT00267501|Eosinophilic Disorders|eosinophilic disorders
796722|NCT00267488|Hycamtin|hycamtin
796723|NCT00267488|endometrial cancer|endometrial cancer
796724|NCT00267488|topotecan|topotecan
796725|NCT00267475|eosinophilic esophagitis|eosinophilic esophagitis
796726|NCT00267475|eosinophilic gastritis|eosinophilic gastritis
796727|NCT00267475|eosinophilic enteritis|eosinophilic enteritis
796728|NCT00267475|eosinophilic colitis|eosinophilic colitis
796729|NCT00267475|eosinophilic gastroenteritis|eosinophilic gastroenteritis
796730|NCT00267462|pediatric|pediatric
796731|NCT00267462|cardiac|cardiac
796732|NCT00267462|hypertrophic Myopathy|hypertrophic myopathy
796733|NCT00267449|Spectroscopy, Near-Infrared|spectroscopy, near-infrared
796734|NCT00267449|Mammography|mammography
796735|NCT00267449|Breast Cancer|breast cancer
796736|NCT00267436|adaptation|adaptation
796737|NCT00267436|HIV prevention|hiv prevention
796738|NCT00267436|HIV positive|hiv positive
796739|NCT00267436|evidence based interventions|evidence based interventions
796740|NCT00267436|HIV Seronegativity|hiv seronegativity
796741|NCT00267423|pediatric|pediatric
796742|NCT00267423|cardiac|cardiac
796743|NCT00267423|electrophysiology|electrophysiology
796744|NCT00267423|epicardial biventricular pacing|epicardial biventricular pacing
796745|NCT00267410|HIV|hiv
796746|NCT00267410|Adaptation|adaptation
796747|NCT00267410|Behavioral interventions|behavioral interventions
796748|NCT00267410|Seropositive|seropositive
796749|NCT00267410|MSM|msm
796750|NCT00267410|HIV Seronegativity|hiv seronegativity
796751|NCT00267397|infant|infant
796752|NCT00267397|prenatal|prenatal
796753|NCT00267397|birth defects|birth defects
796754|NCT00267397|22Q11 deletion|22q11 deletion
796755|NCT00267384|Aminoglycosides|aminoglycosides
796756|NCT00267371|Migraine headache|migraine headache
796757|NCT00267371|Patent Foramen Ovale|patent foramen ovale
796758|NCT00267371|Patent Foramen Ovale Closure|patent foramen ovale closure
796759|NCT00267332|Sedation|sedation
796760|NCT00267332|Pain|pain
796761|NCT00267332|modafinil|modafinil
796762|NCT00267332|opioids|opioids
796763|NCT00267293|fever treatment|fever treatment
796764|NCT00267293|children|children
796765|NCT00267241|ARDS|ards
796767|NCT00267241|respiratory mechanics|respiratory mechanics
796768|NCT00267241|gas exchange|gas exchange
796769|NCT00267241|assisted ventilation|assisted ventilation
796770|NCT00267228|Anorexia Nervosa|anorexia nervosa
796771|NCT00267228|Eating disorder|eating disorder
796772|NCT00267228|Quality of life|quality of life
796773|NCT00267215|Lumiracoxib|lumiracoxib
796774|NCT00267215|osteoarthritis|osteoarthritis
796775|NCT00267202|Allergic Asthma, IgE, immunotherapy, omalizumab|allergic asthma, ige, immunotherapy, omalizumab
796776|NCT00267189|Liver transplantation, everolimus, calcineurin inhibitor, renal function|liver transplantation, everolimus, calcineurin inhibitor, renal function
796777|NCT00267176|Osteoarthritis,|osteoarthritis,
796778|NCT00267176|hypertension,|hypertension,
796779|NCT00267176|lumiracoxib,|lumiracoxib,
796780|NCT00267176|ibuprofen,|ibuprofen,
796781|NCT00267176|24-hour blood pressure profile|24-hour blood pressure profile
796782|NCT00267163|Alzheimer's disease|alzheimer's disease
796783|NCT00267163|Mild Cognitive Impairment|mild cognitive impairment
796784|NCT00267150|Simultaneous Pancreas-Kidney Transplantation|simultaneous pancreas-kidney transplantation
796785|NCT00267150|mycophenolate|mycophenolate
796786|NCT00267150|GI problems|gi problems
796787|NCT00267137|Pacemaker, Atrial Fibrillation/Therapy|pacemaker, atrial fibrillation/therapy
796788|NCT00267124|cognitive decline|cognitive decline
796789|NCT00267124|dementia|dementia
796790|NCT00267124|neuroimaging|neuroimaging
796791|NCT00267111|Infant,newborn|infant,newborn
796792|NCT00267111|Topical anesthesia|topical anesthesia
796793|NCT00267111|Intramuscular injection|intramuscular injection
796794|NCT00267098|Atrioventricular block|atrioventricular block
796795|NCT00267098|Cardiac Resynchronization Therapy|cardiac resynchronization therapy
796796|NCT00267098|Pacemaker|pacemaker
796797|NCT00267098|Defibrillator|defibrillator
796798|NCT00267098|NYHA Class I, II or III Heart failure|nyha class i, ii or iii heart failure
796799|NCT00267085|Chronic Myeloid Leukemia|chronic myeloid leukemia
796800|NCT00267085|Minimal Residual Disease|minimal residual disease
796801|NCT00267085|Peptide Vaccine|peptide vaccine
796802|NCT00267072|Ovarian Cancer|ovarian cancer
796803|NCT00267059|Chronic Lymphocytic Leukemia|chronic lymphocytic leukemia
796804|NCT00267059|Lenalidomide|lenalidomide
796805|NCT00267059|Revlimid|revlimid
796806|NCT00267059|CLL|cll
796807|NCT00267046|Sarcoma|sarcoma
796808|NCT00267046|Soft Tissue Sarcoma|soft tissue sarcoma
796809|NCT00267046|Oral Mucositis|oral mucositis
796810|NCT00267046|Doxorubicin|doxorubicin
796811|NCT00267046|Adriamycin|adriamycin
796812|NCT00267046|Ifosfamide|ifosfamide
796813|NCT00267046|Palifermin|palifermin
796814|NCT00267046|Vincristine|vincristine
796815|NCT00267046|Cisplatin|cisplatin
796816|NCT00267046|Placebo|placebo
796817|NCT00267033|Neoplasm Metastasis|neoplasm metastasis
796818|NCT00267033|Bone Neoplasms|bone neoplasms
796819|NCT00267033|Pain|pain
796820|NCT00267033|Radiotherapy|radiotherapy
796821|NCT00267033|Vertebroplasty|vertebroplasty
796822|NCT00267033|Combined modality therapy|combined modality therapy
796823|NCT00267007|Peripheral neuropathy|peripheral neuropathy
796824|NCT00267007|Chemotherapy-induced|chemotherapy-induced
796825|NCT00267007|Hemoglobin level|hemoglobin level
796826|NCT00267007|Cancer|cancer
796827|NCT00267007|Taxane|taxane
796828|NCT00267007|Platinum-based chemotherapy|platinum-based chemotherapy
796829|NCT00266994|Thrombosis|thrombosis
796830|NCT00266968|pediatric|pediatric
796831|NCT00266968|cardiac|cardiac
796832|NCT00266968|single ventricle|single ventricle
796833|NCT00266955|pediatric|pediatric
796834|NCT00266955|cardiac|cardiac
796835|NCT00266955|ADHD|adhd
796836|NCT00266955|Adderall|adderall
796837|NCT00266955|Straterra|straterra
796838|NCT00266942|Fontan procedure|fontan procedure
796839|NCT00266942|single ventricle physiology|single ventricle physiology
796840|NCT00266942|intra-atrial|intra-atrial
796841|NCT00266942|extracardiac technique|extracardiac technique
796842|NCT00266929|odontoid fx|odontoid fx
796843|NCT00266929|surgical intervention|surgical intervention
796844|NCT00266929|conservative treatment|conservative treatment
796845|NCT00266929|nonunion|nonunion
796846|NCT00266929|odontoid fractures|odontoid fractures
796847|NCT00266929|surgical treatment|surgical treatment
796848|NCT00266916|adult|adult
796849|NCT00266916|congenital heart disease|congenital heart disease
796850|NCT00266916|percutaneous occlusion|percutaneous occlusion
796851|NCT00266916|percutaneous balloon valvotomy|percutaneous balloon valvotomy
796852|NCT00266916|balloon angioplasty|balloon angioplasty
796853|NCT00266916|complex cyanotic congenital heart defects (CCHD)|complex cyanotic congenital heart defects (cchd)
796854|NCT00266903|adult|adult
796855|NCT00266903|congenital heart disease|congenital heart disease
796856|NCT00266903|Eisenmenger's Syndrome|eisenmenger's syndrome
796857|NCT00266903|Bosentan|bosentan
796858|NCT00266903|Sitaxsetan|sitaxsetan
796859|NCT00266903|Sildenafil|sildenafil
796860|NCT00266877|Lung Cancer|lung cancer
796861|NCT00266877|HKI-272|hki-272
796862|NCT00266877|Neratinib|neratinib
796863|NCT00266877|Nerlynx|nerlynx
796864|NCT00266864|Spinal Cord Injury|spinal cord injury
796865|NCT00266864|Testosterone Replacement Therapy|testosterone replacement therapy
796866|NCT00266864|Dual Energy X ray Absorptiometry|dual energy x ray absorptiometry
796867|NCT00266864|Lean Tissue Mass|lean tissue mass
796868|NCT00266851|Randomized clinical trial|randomized clinical trial
796869|NCT00266851|Asthma|asthma
796870|NCT00266851|Adults|adults
796871|NCT00266851|Azithromycin|azithromycin
796872|NCT00266838|Lacrimal Obstruction|lacrimal obstruction
796873|NCT00266838|Epiphora|epiphora
796874|NCT00266812|temozolomide|temozolomide
796875|NCT00266812|radiotherapy|radiotherapy
796876|NCT00266773|Chronic Pain|chronic pain
796877|NCT00266773|Cognitive Therapy|cognitive therapy
796878|NCT00266773|Cognitive Behavioral Therapy|cognitive behavioral therapy
796879|NCT00266773|Recurrence|recurrence
796880|NCT00266773|Relapse Prevention|relapse prevention
796881|NCT00266773|Educational Technology|educational technology
796882|NCT00266773|CBT|cbt
796883|NCT00266773|CST|cst
796884|NCT00266773|IVR|ivr
796885|NCT00266773|TIVR|tivr
796886|NCT00266747|Anxiety|anxiety
796887|NCT00266747|Anti-Anxiety Agents|anti-anxiety agents
796888|NCT00266747|Controlled Clinical Trial|controlled clinical trial
796889|NCT00266734|Adenoviral conjunctivitis|adenoviral conjunctivitis
796890|NCT00266734|Viral conjunctivitis|viral conjunctivitis
796891|NCT00266734|conjunctivitis|conjunctivitis
796892|NCT00266721|Pancrelipase|pancrelipase
796893|NCT00266721|Abdominal bloating|abdominal bloating
796894|NCT00266721|Abdominal pain|abdominal pain
796895|NCT00266721|Eructation|eructation
796896|NCT00266708|renal transplant|renal transplant
796897|NCT00266708|post-transplant osteoporosis|post-transplant osteoporosis
796898|NCT00266682|Bradycardia|bradycardia
796899|NCT00266669|Raynaud's Phenomenon|raynaud's phenomenon
796900|NCT00266669|Raynaud's Disease|raynaud's disease
796901|NCT00266669|Scleroderma|scleroderma
796902|NCT00266669|Raynaud's Disease Secondary to Scleroderma|raynaud's disease secondary to scleroderma
796903|NCT00266669|Raynaud's Disease Secondary to Other Autoimmune Disease|raynaud's disease secondary to other autoimmune disease
796904|NCT00266617|Anemia|anemia
796905|NCT00266617|chemotherapy|chemotherapy
796906|NCT00266617|epoetin alfa|epoetin alfa
796907|NCT00266617|epogen|epogen
796908|NCT00266617|erythropoietin|erythropoietin
796909|NCT00266617|neoplasms|neoplasms
796910|NCT00266617|cancer|cancer
796911|NCT00266604|Epilepsy|epilepsy
796912|NCT00266604|seizures|seizures
796913|NCT00266604|new-onset epilepsy|new-onset epilepsy
796914|NCT00266604|epilepsy relapse|epilepsy relapse
796915|NCT00266604|epilepsy monotherapy|epilepsy monotherapy
796916|NCT00266591|Epilepsy|epilepsy
796917|NCT00266591|Seizures|seizures
796918|NCT00266591|Topiramate|topiramate
796919|NCT00266591|Prophylaxis|prophylaxis
796920|NCT00266591|Antiepileptic|antiepileptic
796921|NCT00266591|Epileptic seizures|epileptic seizures
796922|NCT00266591|Partial seizure disorder|partial seizure disorder
796923|NCT00266591|Brain disease|brain disease
796924|NCT00266578|Eosinophilic Esophagitis|eosinophilic esophagitis
796925|NCT00266552|conduct disorder|conduct disorder
796926|NCT00266552|oppositional defiant disorder|oppositional defiant disorder
796927|NCT00266552|disruptive behavior disorder not otherwise specified|disruptive behavior disorder not otherwise specified
796928|NCT00266552|ADHD|adhd
796929|NCT00266552|risperidone|risperidone
796930|NCT00266552|antipsychotropic agents|antipsychotropic agents
796931|NCT00266552|children|children
796932|NCT00266539|Postoperative pain|postoperative pain
796933|NCT00266539|patient-controlled analgesia|patient-controlled analgesia
796934|NCT00266526|Allergy|allergy
796935|NCT00266526|Birch pollen|birch pollen
796936|NCT00266526|Recombinant|recombinant
796937|NCT00266513|CD40 Ligand|cd40 ligand
796938|NCT00266513|Nemo|nemo
796939|NCT00266513|Genetics|genetics
796940|NCT00266513|Hyper-IGM|hyper-igm
796941|NCT00266513|Ectodermal Dysplasia|ectodermal dysplasia
796942|NCT00266513|CVID|cvid
796943|NCT00266513|Hyper-IgM Syndrome|hyper-igm syndrome
796944|NCT00266513|Primary Immune Deficiency Disorders|primary immune deficiency disorders
796945|NCT00266513|Common Variable Immune Deficiency|common variable immune deficiency
796946|NCT00266500|Adipose Tissue|adipose tissue
796947|NCT00266500|Weight Gain|weight gain
796948|NCT00266500|Overweight|overweight
796949|NCT00266500|Thermogenesis|thermogenesis
796950|NCT00266500|Deep Body Temperature|deep body temperature
796951|NCT00266500|Adult|adult
796952|NCT00266500|Exercise|exercise
796953|NCT00266487|Homocysteine|homocysteine
796954|NCT00266487|B vitamins|b vitamins
796955|NCT00266487|Folic acid|folic acid
796956|NCT00266487|Randomized trial|randomized trial
796957|NCT00266487|Secondary prevention|secondary prevention
796958|NCT00266474|Cystic Fibrosis with Chronic Rhinosinusitis|cystic fibrosis with chronic rhinosinusitis
796959|NCT00266461|Postoperative Ileus|postoperative ileus
796960|NCT00266448|MRSA|mrsa
796961|NCT00266448|eradication|eradication
796962|NCT00266448|chlorhexidine|chlorhexidine
796963|NCT00266435|Asymptomatic subjects|asymptomatic subjects
796964|NCT00266435|Moderate to high risk for cardiovascular event|moderate to high risk for cardiovascular event
796965|NCT00266396|Total Hip Arthroplasty|total hip arthroplasty
796966|NCT00266396|THA|tha
796967|NCT00266396|Total Knee Arthroplasty|total knee arthroplasty
796968|NCT00266396|TKA|tka
796969|NCT00266396|Total Hip Replacement|total hip replacement
796970|NCT00266396|THR|thr
796971|NCT00266396|Total Knee Replacement|total knee replacement
796972|NCT00266396|TKR|tkr
796973|NCT00266331|Breast cancer|breast cancer
796974|NCT00266331|Radiation skin protection|radiation skin protection
796975|NCT00266318|Hepatitis C Nonresponder|hepatitis c nonresponder
796976|NCT00266318|Genotype 1|genotype 1
796977|NCT00266318|Interferon Alfacon-1|interferon alfacon-1
796978|NCT00266318|Consensus Interferon|consensus interferon
796979|NCT00266318|CIFN|cifn
796980|NCT00266318|Infergen|infergen
796981|NCT00266318|Ribavirin|ribavirin
796982|NCT00266305|n-3 LCPUFA|n-3 lcpufa
796983|NCT00266305|Infant development|infant development
796984|NCT00266305|Visual acuity|visual acuity
796985|NCT00266305|Immune function|immune function
796986|NCT00266305|Breast milk|breast milk
796987|NCT00266292|Fish oil|fish oil
796988|NCT00266292|Polyunsaturated fatty acid|polyunsaturated fatty acid
796989|NCT00266292|Immune function|immune function
796990|NCT00266292|Endothelial function|endothelial function
796991|NCT00266292|Cardiovascular risk factors|cardiovascular risk factors
796992|NCT00266266|Human Papilloma Virus|human papilloma virus
796993|NCT00266214|lidocaine patch 5%|lidocaine patch 5%
796994|NCT00266214|Lidoderm|lidoderm
796995|NCT00266214|carpal tunnel syndrome|carpal tunnel syndrome
796996|NCT00266214|pain|pain
796997|NCT00266214|nerve compression injury|nerve compression injury
796998|NCT00266214|topical analgesic|topical analgesic
796999|NCT00266201|Heart Defects, Congenital|heart defects, congenital
797000|NCT00266201|Right Ventricular Dysfunction|right ventricular dysfunction
797001|NCT00266201|Low Cardiac Output|low cardiac output
797002|NCT00266201|Biochemical markers|biochemical markers
797003|NCT00266201|Neurohumoral activity|neurohumoral activity
797004|NCT00266188|Heart Defects, Congenital|heart defects, congenital
797005|NCT00266188|Tetralogy of Fallot|tetralogy of fallot
797006|NCT00266188|Heart Septal Defects, Ventricular|heart septal defects, ventricular
797007|NCT00266188|Pulmonary Valve Diseases|pulmonary valve diseases
797008|NCT00266188|Magnetic Resonance Imaging|magnetic resonance imaging
797009|NCT00266188|Heart Catheterization|heart catheterization
797010|NCT00266188|Echocardiography|echocardiography
797011|NCT00266175|Pulmonary heart disease|pulmonary heart disease
797012|NCT00266175|Pulmonary hypertension|pulmonary hypertension
797013|NCT00266175|Stent implantation|stent implantation
797014|NCT00266175|Balloon dilatation|balloon dilatation
797015|NCT00266175|Surgery|surgery
797016|NCT00266162|Heart Defects, Congenital|heart defects, congenital
797017|NCT00266162|Eisenmenger Complex|eisenmenger complex
797018|NCT00266162|Hypertension, Pulmonary|hypertension, pulmonary
797019|NCT00266162|Pulmonary Heart Disease|pulmonary heart disease
797341|NCT00265200|lung cancer|lung cancer
797020|NCT00266162|Pulmonary Circulation|pulmonary circulation
797021|NCT00266162|Vascular Resistance|vascular resistance
797022|NCT00266149|Pharmacokinetics|pharmacokinetics
797023|NCT00266149|Lamotrigine|lamotrigine
797024|NCT00266149|Oral Contraceptives|oral contraceptives
797025|NCT00266149|UGT|ugt
797026|NCT00266149|Glucuronidation.|glucuronidation.
797027|NCT00266136|AML treatment, de-novo, secondary, high-risk MDS, chemotherapy, autologous SCT, adult|aml treatment, de-novo, secondary, high-risk mds, chemotherapy, autologous sct, adult
797028|NCT00266123|Kidney Failure|kidney failure
797029|NCT00266123|Kidney Transplant|kidney transplant
797030|NCT00266110|stage IV breast cancer|stage iv breast cancer
797031|NCT00266110|recurrent breast cancer|recurrent breast cancer
797032|NCT00266097|stage III pancreatic cancer|stage iii pancreatic cancer
797033|NCT00266097|stage IV pancreatic cancer|stage iv pancreatic cancer
797034|NCT00266097|unresectable extrahepatic bile duct cancer|unresectable extrahepatic bile duct cancer
797035|NCT00266097|unresectable gallbladder cancer|unresectable gallbladder cancer
797036|NCT00266097|adenocarcinoma of the extrahepatic bile duct|adenocarcinoma of the extrahepatic bile duct
797037|NCT00266097|adenocarcinoma of the gallbladder|adenocarcinoma of the gallbladder
797038|NCT00266097|adenocarcinoma of the pancreas|adenocarcinoma of the pancreas
797039|NCT00266097|recurrent pancreatic cancer|recurrent pancreatic cancer
797040|NCT00266097|recurrent extrahepatic bile duct cancer|recurrent extrahepatic bile duct cancer
797041|NCT00266097|recurrent gallbladder cancer|recurrent gallbladder cancer
797042|NCT00266084|Cervix|cervix
797043|NCT00266084|Uterus|uterus
797044|NCT00266084|Dysplasia|dysplasia
797045|NCT00266084|Cancer|cancer
797046|NCT00266084|Collector|collector
797047|NCT00266071|skin|skin
797048|NCT00266071|pressure|pressure
797049|NCT00266071|age|age
797050|NCT00266058|healthy|healthy
797051|NCT00266058|controls|controls
797052|NCT00266058|research|research
797053|NCT00266058|clinical|clinical
797054|NCT00266058|study|study
797055|NCT00266058|pharmacokinetic|pharmacokinetic
797056|NCT00266058|PK|pk
797057|NCT00266058|HIV|hiv
797058|NCT00266058|malaria|malaria
797059|NCT00266045|Deep Vein Thrombosis|deep vein thrombosis
797060|NCT00266045|Pulmonary Embolism|pulmonary embolism
797061|NCT00266045|D-dimer|d-dimer
797062|NCT00266045|Recurrence|recurrence
797063|NCT00266045|Duration of Anticoagulation|duration of anticoagulation
797064|NCT00266045|Vitamin K Antagonists|vitamin k antagonists
797065|NCT00266019|nonalcoholic steatohepatitis|nonalcoholic steatohepatitis
797066|NCT00266019|nonalcoholic fatty liver disease|nonalcoholic fatty liver disease
797067|NCT00266019|Fatty liver|fatty liver
797068|NCT00266019|Cirrhosis|cirrhosis
797069|NCT00266019|Obesity|obesity
797070|NCT00266019|Weight Reduction|weight reduction
797071|NCT00266019|Weight Management|weight management
797072|NCT00265980|Leptin|leptin
797073|NCT00265980|Obesity|obesity
797074|NCT00265980|Energy|energy
797075|NCT00265980|Autonomics|autonomics
797076|NCT00265980|Neuroendocrine|neuroendocrine
797077|NCT00265941|stage III squamous cell carcinoma of the hypopharynx|stage iii squamous cell carcinoma of the hypopharynx
797078|NCT00265941|stage IV squamous cell carcinoma of the hypopharynx|stage iv squamous cell carcinoma of the hypopharynx
797079|NCT00265941|stage III squamous cell carcinoma of the larynx|stage iii squamous cell carcinoma of the larynx
797080|NCT00265941|stage IV squamous cell carcinoma of the larynx|stage iv squamous cell carcinoma of the larynx
797081|NCT00265941|stage III squamous cell carcinoma of the oropharynx|stage iii squamous cell carcinoma of the oropharynx
797082|NCT00265941|stage IV squamous cell carcinoma of the oropharynx|stage iv squamous cell carcinoma of the oropharynx
797083|NCT00265928|extranodal marginal zone B-cell lymphoma of mucosa-associated lymphoid tissue|extranodal marginal zone b-cell lymphoma of mucosa-associated lymphoid tissue
797084|NCT00265928|recurrent grade 1 follicular lymphoma|recurrent grade 1 follicular lymphoma
797085|NCT00265928|recurrent grade 2 follicular lymphoma|recurrent grade 2 follicular lymphoma
797086|NCT00265928|recurrent grade 3 follicular lymphoma|recurrent grade 3 follicular lymphoma
797087|NCT00265928|recurrent mantle cell lymphoma|recurrent mantle cell lymphoma
797088|NCT00265928|recurrent marginal zone lymphoma|recurrent marginal zone lymphoma
797089|NCT00265928|recurrent small lymphocytic lymphoma|recurrent small lymphocytic lymphoma
797090|NCT00265928|splenic marginal zone lymphoma|splenic marginal zone lymphoma
797091|NCT00265928|recurrent adult diffuse small cleaved cell lymphoma|recurrent adult diffuse small cleaved cell lymphoma
797092|NCT00265928|nodal marginal zone B-cell lymphoma|nodal marginal zone b-cell lymphoma
797093|NCT00265928|Waldenstrom's macroglobulinemia|waldenstrom's macroglobulinemia
797094|NCT00265915|B-cell chronic lymphocytic leukemia|b-cell chronic lymphocytic leukemia
797095|NCT00265915|refractory chronic lymphocytic leukemia|refractory chronic lymphocytic leukemia
797096|NCT00265915|stage 0 chronic lymphocytic leukemia|stage 0 chronic lymphocytic leukemia
797097|NCT00265915|stage I chronic lymphocytic leukemia|stage i chronic lymphocytic leukemia
797098|NCT00265915|stage II chronic lymphocytic leukemia|stage ii chronic lymphocytic leukemia
797099|NCT00265915|stage III chronic lymphocytic leukemia|stage iii chronic lymphocytic leukemia
797100|NCT00265915|stage IV chronic lymphocytic leukemia|stage iv chronic lymphocytic leukemia
797101|NCT00265902|Kaposi sarcoma|kaposi sarcoma
797102|NCT00265889|recurrent adult Hodgkin lymphoma|recurrent adult hodgkin lymphoma
797103|NCT00265889|stage III adult Hodgkin lymphoma|stage iii adult hodgkin lymphoma
797104|NCT00265889|stage IV adult Hodgkin lymphoma|stage iv adult hodgkin lymphoma
797105|NCT00265876|adenocarcinoma of the pancreas|adenocarcinoma of the pancreas
797106|NCT00265876|stage III pancreatic cancer|stage iii pancreatic cancer
797107|NCT00265876|recurrent pancreatic cancer|recurrent pancreatic cancer
797108|NCT00265876|stage IV pancreatic cancer|stage iv pancreatic cancer
797109|NCT00265863|malignant ascites|malignant ascites
797110|NCT00265850|recurrent colon cancer|recurrent colon cancer
797111|NCT00265850|stage III colon cancer|stage iii colon cancer
797112|NCT00265850|stage III rectal cancer|stage iii rectal cancer
797113|NCT00265850|stage IV colon cancer|stage iv colon cancer
797114|NCT00265850|recurrent rectal cancer|recurrent rectal cancer
797115|NCT00265850|stage IV rectal cancer|stage iv rectal cancer
797116|NCT00265850|adenocarcinoma of the colon|adenocarcinoma of the colon
797117|NCT00265850|adenocarcinoma of the rectum|adenocarcinoma of the rectum
797118|NCT00265837|graft versus host disease|graft versus host disease
797119|NCT00265837|adult acute myeloid leukemia in remission|adult acute myeloid leukemia in remission
797120|NCT00265837|adult acute myeloid leukemia with 11q23 (MLL) abnormalities|adult acute myeloid leukemia with 11q23 (mll) abnormalities
797121|NCT00265837|adult acute myeloid leukemia with inv(16)(p13;q22)|adult acute myeloid leukemia with inv(16)(p13;q22)
797122|NCT00265837|adult acute myeloid leukemia with t(15;17)(q22;q12)|adult acute myeloid leukemia with t(15;17)(q22;q12)
797123|NCT00265837|adult acute myeloid leukemia with t(16;16)(p13;q22)|adult acute myeloid leukemia with t(16;16)(p13;q22)
797124|NCT00265837|adult acute myeloid leukemia with t(8;21)(q22;q22)|adult acute myeloid leukemia with t(8;21)(q22;q22)
797125|NCT00265837|recurrent adult acute myeloid leukemia|recurrent adult acute myeloid leukemia
797126|NCT00265837|recurrent childhood acute myeloid leukemia|recurrent childhood acute myeloid leukemia
797127|NCT00265837|childhood acute myeloid leukemia in remission|childhood acute myeloid leukemia in remission
797128|NCT00265837|adult acute lymphoblastic leukemia in remission|adult acute lymphoblastic leukemia in remission
797129|NCT00265837|recurrent adult acute lymphoblastic leukemia|recurrent adult acute lymphoblastic leukemia
797130|NCT00265837|childhood acute lymphoblastic leukemia in remission|childhood acute lymphoblastic leukemia in remission
797131|NCT00265837|recurrent childhood acute lymphoblastic leukemia|recurrent childhood acute lymphoblastic leukemia
797132|NCT00265837|accelerated phase chronic myelogenous leukemia|accelerated phase chronic myelogenous leukemia
797287|NCT00265486|Dive|dive
797133|NCT00265837|blastic phase chronic myelogenous leukemia|blastic phase chronic myelogenous leukemia
797134|NCT00265837|childhood chronic myelogenous leukemia|childhood chronic myelogenous leukemia
797135|NCT00265837|chronic phase chronic myelogenous leukemia|chronic phase chronic myelogenous leukemia
797136|NCT00265837|relapsing chronic myelogenous leukemia|relapsing chronic myelogenous leukemia
797137|NCT00265837|secondary acute myeloid leukemia|secondary acute myeloid leukemia
797138|NCT00265837|de novo myelodysplastic syndromes|de novo myelodysplastic syndromes
797139|NCT00265837|previously treated myelodysplastic syndromes|previously treated myelodysplastic syndromes
797140|NCT00265837|secondary myelodysplastic syndromes|secondary myelodysplastic syndromes
797141|NCT00265837|chronic myelomonocytic leukemia|chronic myelomonocytic leukemia
797142|NCT00265837|juvenile myelomonocytic leukemia|juvenile myelomonocytic leukemia
797143|NCT00265837|atypical chronic myeloid leukemia|atypical chronic myeloid leukemia
797144|NCT00265837|myelodysplastic/myeloproliferative disease, unclassifiable|myelodysplastic/myeloproliferative disease, unclassifiable
797145|NCT00265837|Philadelphia chromosome negative chronic myelogenous leukemia|philadelphia chromosome negative chronic myelogenous leukemia
797146|NCT00265837|stage I multiple myeloma|stage i multiple myeloma
797147|NCT00265837|stage II multiple myeloma|stage ii multiple myeloma
797148|NCT00265837|stage III multiple myeloma|stage iii multiple myeloma
797149|NCT00265837|refractory multiple myeloma|refractory multiple myeloma
797150|NCT00265837|stage III adult Hodgkin lymphoma|stage iii adult hodgkin lymphoma
797151|NCT00265837|stage IV adult Hodgkin lymphoma|stage iv adult hodgkin lymphoma
797152|NCT00265837|extranodal marginal zone B-cell lymphoma of mucosa-associated lymphoid tissue|extranodal marginal zone b-cell lymphoma of mucosa-associated lymphoid tissue
797153|NCT00265837|nodal marginal zone B-cell lymphoma|nodal marginal zone b-cell lymphoma
797154|NCT00265837|noncontiguous stage II adult Burkitt lymphoma|noncontiguous stage ii adult burkitt lymphoma
797155|NCT00265837|noncontiguous stage II adult diffuse large cell lymphoma|noncontiguous stage ii adult diffuse large cell lymphoma
797156|NCT00265837|noncontiguous stage II adult diffuse mixed cell lymphoma|noncontiguous stage ii adult diffuse mixed cell lymphoma
797157|NCT00265837|noncontiguous stage II adult diffuse small cleaved cell lymphoma|noncontiguous stage ii adult diffuse small cleaved cell lymphoma
797158|NCT00265837|noncontiguous stage II adult immunoblastic large cell lymphoma|noncontiguous stage ii adult immunoblastic large cell lymphoma
797159|NCT00265837|noncontiguous stage II adult lymphoblastic lymphoma|noncontiguous stage ii adult lymphoblastic lymphoma
797160|NCT00265837|noncontiguous stage II grade 1 follicular lymphoma|noncontiguous stage ii grade 1 follicular lymphoma
797161|NCT00265837|noncontiguous stage II grade 2 follicular lymphoma|noncontiguous stage ii grade 2 follicular lymphoma
797162|NCT00265837|noncontiguous stage II grade 3 follicular lymphoma|noncontiguous stage ii grade 3 follicular lymphoma
797163|NCT00265837|noncontiguous stage II mantle cell lymphoma|noncontiguous stage ii mantle cell lymphoma
797164|NCT00265837|noncontiguous stage II marginal zone lymphoma|noncontiguous stage ii marginal zone lymphoma
797165|NCT00265837|recurrent adult Hodgkin lymphoma|recurrent adult hodgkin lymphoma
797166|NCT00265837|recurrent adult Burkitt lymphoma|recurrent adult burkitt lymphoma
797240|NCT00265681|chewing tobacco|chewing tobacco
797167|NCT00265837|recurrent adult diffuse large cell lymphoma|recurrent adult diffuse large cell lymphoma
797168|NCT00265837|recurrent adult diffuse mixed cell lymphoma|recurrent adult diffuse mixed cell lymphoma
797169|NCT00265837|recurrent adult diffuse small cleaved cell lymphoma|recurrent adult diffuse small cleaved cell lymphoma
797170|NCT00265837|recurrent adult immunoblastic large cell lymphoma|recurrent adult immunoblastic large cell lymphoma
797171|NCT00265837|recurrent adult lymphoblastic lymphoma|recurrent adult lymphoblastic lymphoma
797172|NCT00265837|recurrent/refractory childhood Hodgkin lymphoma|recurrent/refractory childhood hodgkin lymphoma
797173|NCT00265837|recurrent childhood large cell lymphoma|recurrent childhood large cell lymphoma
797174|NCT00265837|recurrent childhood lymphoblastic lymphoma|recurrent childhood lymphoblastic lymphoma
797175|NCT00265837|recurrent childhood small noncleaved cell lymphoma|recurrent childhood small noncleaved cell lymphoma
797176|NCT00265837|recurrent grade 1 follicular lymphoma|recurrent grade 1 follicular lymphoma
797177|NCT00265837|recurrent grade 2 follicular lymphoma|recurrent grade 2 follicular lymphoma
797178|NCT00265837|recurrent grade 3 follicular lymphoma|recurrent grade 3 follicular lymphoma
797179|NCT00265837|recurrent mantle cell lymphoma|recurrent mantle cell lymphoma
797180|NCT00265837|recurrent marginal zone lymphoma|recurrent marginal zone lymphoma
797181|NCT00265837|recurrent small lymphocytic lymphoma|recurrent small lymphocytic lymphoma
797182|NCT00265837|splenic marginal zone lymphoma|splenic marginal zone lymphoma
797183|NCT00265837|stage III adult Burkitt lymphoma|stage iii adult burkitt lymphoma
797184|NCT00265837|stage III adult diffuse large cell lymphoma|stage iii adult diffuse large cell lymphoma
797185|NCT00265837|stage III adult diffuse mixed cell lymphoma|stage iii adult diffuse mixed cell lymphoma
797186|NCT00265837|stage III adult diffuse small cleaved cell lymphoma|stage iii adult diffuse small cleaved cell lymphoma
797187|NCT00265837|stage IV adult diffuse large cell lymphoma|stage iv adult diffuse large cell lymphoma
797188|NCT00265837|stage IV adult diffuse mixed cell lymphoma|stage iv adult diffuse mixed cell lymphoma
797189|NCT00265837|stage IV adult diffuse small cleaved cell lymphoma|stage iv adult diffuse small cleaved cell lymphoma
797190|NCT00265837|stage III adult lymphoblastic lymphoma|stage iii adult lymphoblastic lymphoma
797191|NCT00265837|stage IV adult lymphoblastic lymphoma|stage iv adult lymphoblastic lymphoma
797192|NCT00265837|stage III grade 1 follicular lymphoma|stage iii grade 1 follicular lymphoma
797193|NCT00265837|stage III grade 2 follicular lymphoma|stage iii grade 2 follicular lymphoma
797194|NCT00265837|stage III grade 3 follicular lymphoma|stage iii grade 3 follicular lymphoma
797195|NCT00265837|stage IV grade 1 follicular lymphoma|stage iv grade 1 follicular lymphoma
797196|NCT00265837|stage IV grade 2 follicular lymphoma|stage iv grade 2 follicular lymphoma
797197|NCT00265837|stage IV grade 3 follicular lymphoma|stage iv grade 3 follicular lymphoma
797198|NCT00265837|stage III mantle cell lymphoma|stage iii mantle cell lymphoma
797199|NCT00265837|stage III marginal zone lymphoma|stage iii marginal zone lymphoma
797200|NCT00265837|stage IV mantle cell lymphoma|stage iv mantle cell lymphoma
797201|NCT00265837|stage IV marginal zone lymphoma|stage iv marginal zone lymphoma
797202|NCT00265837|stage III small lymphocytic lymphoma|stage iii small lymphocytic lymphoma
797203|NCT00265837|stage IV small lymphocytic lymphoma|stage iv small lymphocytic lymphoma
797204|NCT00265837|stage IV adult Burkitt lymphoma|stage iv adult burkitt lymphoma
797205|NCT00265837|stage IV adult immunoblastic large cell lymphoma|stage iv adult immunoblastic large cell lymphoma
797206|NCT00265837|childhood myelodysplastic syndromes|childhood myelodysplastic syndromes
797207|NCT00265824|stage IV colon cancer|stage iv colon cancer
797208|NCT00265824|stage IV rectal cancer|stage iv rectal cancer
797209|NCT00265824|adenocarcinoma of the colon|adenocarcinoma of the colon
797210|NCT00265824|adenocarcinoma of the rectum|adenocarcinoma of the rectum
797211|NCT00265824|chemotherapy|chemotherapy
797212|NCT00265811|stage III colon cancer|stage iii colon cancer
797213|NCT00265811|adenocarcinoma of the colon|adenocarcinoma of the colon
797214|NCT00265785|bronchoalveolar cell lung cancer|bronchoalveolar cell lung cancer
797215|NCT00265785|stage IIIB non-small cell lung cancer|stage iiib non-small cell lung cancer
797216|NCT00265785|stage IV non-small cell lung cancer|stage iv non-small cell lung cancer
797217|NCT00265785|recurrent non-small cell lung cancer|recurrent non-small cell lung cancer
797218|NCT00265772|enteral nutrition|enteral nutrition
797219|NCT00265772|steroids|steroids
797220|NCT00265772|mucosal healing|mucosal healing
797221|NCT00265759|stage II breast cancer|stage ii breast cancer
797222|NCT00265759|stage IIIA breast cancer|stage iiia breast cancer
797223|NCT00265759|stage IIIB breast cancer|stage iiib breast cancer
797224|NCT00265759|stage IIIC breast cancer|stage iiic breast cancer
797225|NCT00265759|estrogen receptor-positive breast cancer|estrogen receptor-positive breast cancer
797226|NCT00265746|metformin|metformin
797227|NCT00265746|gestational diabetes|gestational diabetes
797228|NCT00265746|lifestyle|lifestyle
797229|NCT00265733|male breast cancer|male breast cancer
797230|NCT00265733|recurrent breast cancer|recurrent breast cancer
797231|NCT00265733|stage IV breast cancer|stage iv breast cancer
797232|NCT00265720|African Americans|african americans
797233|NCT00265720|Colorectal Cancer Screening|colorectal cancer screening
797234|NCT00265720|Colorectal Cancer|colorectal cancer
797235|NCT00265720|Colorectal Cancer and African Americans|colorectal cancer and african americans
797236|NCT00265720|Cancer Disparities|cancer disparities
797237|NCT00265707|Hypertension|hypertension
797238|NCT00265707|Hypotension|hypotension
797239|NCT00265681|smokeless tobacco cessation|smokeless tobacco cessation
797241|NCT00265681|oral tobacco|oral tobacco
797242|NCT00265681|smokeless tobacco|smokeless tobacco
797243|NCT00265681|telephone|telephone
797244|NCT00265681|counseling|counseling
797245|NCT00265642|Hepatitis C, Chronic|hepatitis c, chronic
797246|NCT00265642|irbesartan|irbesartan
797247|NCT00265629|Atrial fibrillation|atrial fibrillation
797248|NCT00265616|Refractory status epilepticus,|refractory status epilepticus,
797249|NCT00265616|coma-induction,|coma-induction,
797250|NCT00265616|treatment,|treatment,
797251|NCT00265616|propofol,|propofol,
797252|NCT00265616|barbiturates,|barbiturates,
797253|NCT00265616|efficacy,|efficacy,
797254|NCT00265616|safety.|safety.
797255|NCT00265590|Aniridia|aniridia
797256|NCT00265590|PAX6|pax6
797257|NCT00265590|Keratopathy|keratopathy
797258|NCT00265590|Limbal Stem Cell Deficiency|limbal stem cell deficiency
797259|NCT00265590|Molecular Genetics|molecular genetics
797260|NCT00265564|outcomes assessment|outcomes assessment
797261|NCT00265564|substance use disorders|substance use disorders
797262|NCT00265564|stress disorders, post-traumatic|stress disorders, post-traumatic
797263|NCT00265564|screening|screening
797264|NCT00265551|Schizophrenia|schizophrenia
797265|NCT00265538|Hypertension|hypertension
797266|NCT00265538|Diuretics|diuretics
797267|NCT00265538|Drug Therapy|drug therapy
797268|NCT00265538|Anti-Hypertensive Agents|anti-hypertensive agents
797269|NCT00265538|Patient Intervention|patient intervention
797270|NCT00265525|Randomized Control Trial|randomized control trial
797271|NCT00265525|Exercise Intervention|exercise intervention
797272|NCT00265525|Prevention|prevention
797273|NCT00265525|Rehabilitation|rehabilitation
797274|NCT00265512|Telemedicine|telemedicine
797275|NCT00265512|Aftercare|aftercare
797276|NCT00265499|Coronary Artery Bypass|coronary artery bypass
797277|NCT00265499|Skeletonization|skeletonization
797278|NCT00265499|Internal Thoracic Artery|internal thoracic artery
797279|NCT00265499|Flow|flow
797280|NCT00265499|Length|length
797281|NCT00265499|Pain|pain
797282|NCT00265486|Divers|divers
797283|NCT00265486|Brain|brain
797284|NCT00265486|Flow|flow
797285|NCT00265486|Blood|blood
797286|NCT00265486|EPO|epo
797288|NCT00265486|reflex|reflex
797289|NCT00265460|smoking cessation,|smoking cessation,
797290|NCT00265460|nicotine,|nicotine,
797291|NCT00265460|smokeless tobacco,|smokeless tobacco,
797292|NCT00265460|cigarettes|cigarettes
797293|NCT00265447|knee osteoarthritis|knee osteoarthritis
797294|NCT00265447|exercise|exercise
797295|NCT00265447|aerobic exercise|aerobic exercise
797296|NCT00265447|strengthening exercise|strengthening exercise
797297|NCT00265447|exercise prescription|exercise prescription
797298|NCT00265447|rehabilitation|rehabilitation
797299|NCT00265447|physical disability|physical disability
797300|NCT00265447|physical function|physical function
797301|NCT00265447|physical activity|physical activity
797302|NCT00265447|physical fitness|physical fitness
797303|NCT00265421|Suture Techniques|suture techniques
797304|NCT00265408|Cervicocephalic Arterial Dissection|cervicocephalic arterial dissection
797305|NCT00265382|Adolescent Subjects|adolescent subjects
797306|NCT00265356|Positron Emission Tomography (PET)|positron emission tomography (pet)
797307|NCT00265356|Diagnostic Investigation|diagnostic investigation
797308|NCT00265356|Colorectal cancer|colorectal cancer
797309|NCT00265356|Liver metastases|liver metastases
797310|NCT00265356|Liver surgery|liver surgery
797311|NCT00265330|Children And Adolescents With Bipolar I Disorder (Manic Or Mixed)|children and adolescents with bipolar i disorder (manic or mixed)
797312|NCT00265317|Non-small cell lung cancer|non-small cell lung cancer
797313|NCT00265317|sunitinib|sunitinib
797314|NCT00265317|erlotinib|erlotinib
797315|NCT00265317|Phase 2|phase 2
797316|NCT00265304|Osteoarthritis|osteoarthritis
797317|NCT00265291|Depression|depression
797318|NCT00265291|mood disorders|mood disorders
797319|NCT00265291|affective disorders|affective disorders
797320|NCT00265291|pharmacogenetics|pharmacogenetics
797321|NCT00265291|pharmacogenomics|pharmacogenomics
797322|NCT00265265|Cocaine Dependence|cocaine dependence
797323|NCT00265252|osteonecrosis|osteonecrosis
797324|NCT00265252|total hip replacement|total hip replacement
797325|NCT00265239|Edaravone|edaravone
797326|NCT00265239|Randomized Control Trial|randomized control trial
797327|NCT00265239|ST-Elevation Myocardial Infarction|st-elevation myocardial infarction
797328|NCT00265239|Coronary Angioplasty|coronary angioplasty
797329|NCT00265226|India|india
797330|NCT00265226|Pulmonary Tuberculosis|pulmonary tuberculosis
797331|NCT00265226|Category-II tuberculosis|category-ii tuberculosis
797332|NCT00265226|Immunomodulator|immunomodulator
797333|NCT00265226|Mycobacterium w|mycobacterium w
797334|NCT00265226|Revised National Tuberculosis Control Programme|revised national tuberculosis control programme
797335|NCT00265226|Category-II Pulmonary Tuberculosis|category-ii pulmonary tuberculosis
797336|NCT00265213|breast conservative surgery|breast conservative surgery
797337|NCT00265213|shoulder functional outcome questionnaire|shoulder functional outcome questionnaire
797338|NCT00265213|disability questionnaire|disability questionnaire
797339|NCT00265200|Zometa|zometa
797340|NCT00265200|bone metastasis|bone metastasis
797342|NCT00265200|non-small cell lung cancer|non-small cell lung cancer
797343|NCT00265200|small cell lung cancer|small cell lung cancer
797344|NCT00265200|bone metabolic markers|bone metabolic markers
797345|NCT00265200|tartrate resistant acid phosphatase|tartrate resistant acid phosphatase
797346|NCT00265187|child, bronchiolitis,|child, bronchiolitis,
797347|NCT00265174|SERUM DNA|serum dna
797348|NCT00265174|LOH|loh
797349|NCT00265174|METHYLATION|methylation
797350|NCT00265174|GLIOMA|glioma
797351|NCT00265174|MGMT|mgmt
797352|NCT00265161|influenza vaccine|influenza vaccine
797353|NCT00265161|effectiveness|effectiveness
797354|NCT00265161|health care worker|health care worker
797355|NCT00265161|OBSERVATIONAL STUDY|observational study
797356|NCT00265148|rosiglitazone|rosiglitazone
797357|NCT00265148|cognition|cognition
797358|NCT00265148|cerebral glucose metabolism|cerebral glucose metabolism
797359|NCT00265148|positron emission tomography (PET)|positron emission tomography (pet)
797360|NCT00265148|Alzheimer's Disease|alzheimer's disease
797361|NCT00265135|Renal cell carcinoma|renal cell carcinoma
797362|NCT00265135|CNTO 328|cnto 328
797363|NCT00265135|Infusions|infusions
797364|NCT00265135|Renal cell cancer|renal cell cancer
797365|NCT00265122|Crohn Disease|crohn disease
797366|NCT00265122|Biologic|biologic
797367|NCT00265122|Infusion|infusion
797368|NCT00265122|Injection|injection
797369|NCT00265122|CNTO 1275|cnto 1275
797370|NCT00265122|Ustekinumab|ustekinumab
797371|NCT00265122|C01275|c01275
797372|NCT00265122|IL-12p40|il-12p40
797373|NCT00265109|body dysmorphic disorder|body dysmorphic disorder
797374|NCT00265109|levetiracetam|levetiracetam
797375|NCT00265096|Psoriatic Arthritis|psoriatic arthritis
797376|NCT00265096|Spondyloarthritis|spondyloarthritis
797377|NCT00265096|Spondyloarthropathy|spondyloarthropathy
797378|NCT00265096|subcutaneous injection|subcutaneous injection
797379|NCT00265083|Spondylitis|spondylitis
797380|NCT00265083|subcutaneous injection|subcutaneous injection
797381|NCT00265083|Bechterew's Disease|bechterew's disease
797382|NCT00265083|Spondyloarthritis|spondyloarthritis
797383|NCT00265083|Spondyloarthropathy|spondyloarthropathy
797384|NCT00265057|Cancer;|cancer;
797385|NCT00265057|Tumors;|tumors;
797386|NCT00265057|Neoplasms;|neoplasms;
797387|NCT00265057|Anticarcinogenic Agents;|anticarcinogenic agents;
797388|NCT00265057|Antineoplastic Agents;|antineoplastic agents;
797389|NCT00265057|Cadherins;|cadherins;
797390|NCT00265057|Non-Small-Cell Lung Carcinoma;|non-small-cell lung carcinoma;
797391|NCT00265057|Ovarian Cancer|ovarian cancer
797392|NCT00265044|Behavior Change|behavior change
797393|NCT00265044|patient Education|patient education
797394|NCT00265031|Hodgkin´s Lymphoma|hodgkin´s lymphoma
797395|NCT00265031|advanced stages|advanced stages
797396|NCT00265018|Hodgkin´s lymphoma|hodgkin´s lymphoma
797397|NCT00265018|early stages|early stages
797398|NCT00265005|alteplase|alteplase
797399|NCT00265005|occluded central venous catheter|occluded central venous catheter
797400|NCT00265005|occluded arterial catheter|occluded arterial catheter
797401|NCT00265005|occluded PICC|occluded picc
797402|NCT00265005|neonates|neonates
797403|NCT00265005|infants|infants
797404|NCT00264992|embryo implantation, in vitro fertilization,|embryo implantation, in vitro fertilization,
797405|NCT00264992|cytokine expression|cytokine expression
797406|NCT00264979|Colorectal cancer|colorectal cancer
797407|NCT00264979|Sequential or simultaneous surgery|sequential or simultaneous surgery
797408|NCT00264979|Synchronous hepatic metastases|synchronous hepatic metastases
797409|NCT00264966|Mild asthma|mild asthma
797410|NCT00264953|Hodgkin´s lymphoma|hodgkin´s lymphoma
797411|NCT00264953|intermediate stages|intermediate stages
797412|NCT00264927|Inappropriate ADH Syndrome|inappropriate adh syndrome
797413|NCT00264927|Hyponatremia|hyponatremia
797414|NCT00264914|Inappropriate ADH Syndrome|inappropriate adh syndrome
797415|NCT00264914|Hyponatremia|hyponatremia
797416|NCT00264888|Duchenne muscular dystrophy|duchenne muscular dystrophy
797417|NCT00264888|Nonsense mutation|nonsense mutation
797418|NCT00264888|Premature stop codon|premature stop codon
797419|NCT00264849|Asthma|asthma
797420|NCT00264849|omalizumab|omalizumab
797421|NCT00264849|Severe persistent allergic asthma|severe persistent allergic asthma
797422|NCT00264823|HIV|hiv
797423|NCT00264823|Mental Illness|mental illness
797424|NCT00264810|Responsive Stimulation|responsive stimulation
797425|NCT00264810|Brain Stimulator|brain stimulator
797426|NCT00264810|Epilepsy|epilepsy
797427|NCT00264810|Seizures|seizures
797428|NCT00264784|Streptococcus, Group A, Fiji, epidemiology|streptococcus, group a, fiji, epidemiology
797429|NCT00264771|Fiji, Group A streptococcus, rheumatic, glomerulonephritis|fiji, group a streptococcus, rheumatic, glomerulonephritis
797430|NCT00264758|randomized controlled clinical trial|randomized controlled clinical trial
797431|NCT00264758|hemodialysis|hemodialysis
797432|NCT00264758|end stage renal disease|end stage renal disease
797433|NCT00264745|Caregiver|caregiver
797434|NCT00264745|Stroke|stroke
797435|NCT00264732|cervical lesions|cervical lesions
797436|NCT00264732|cervical dysplasia|cervical dysplasia
797437|NCT00264732|Human papilloma virus|human papilloma virus
797438|NCT00264732|abnormal Pap|abnormal pap
797531|NCT00264381|Fragmin|fragmin
797439|NCT00264732|High-grade cervical intraepithelial lesions (CIN 2/3)|high-grade cervical intraepithelial lesions (cin 2/3)
797440|NCT00264719|A drug is administered to initiate breastfeeding|a drug is administered to initiate breastfeeding
797441|NCT00264680|quality of life|quality of life
797442|NCT00264680|qolie-10|qolie-10
797443|NCT00264680|epilepsy|epilepsy
797444|NCT00264680|lamotrigine|lamotrigine
797445|NCT00264680|Validation of questionnaire|validation of questionnaire
797446|NCT00264667|Dyslipidaemia|dyslipidaemia
797447|NCT00264654|Social|social
797448|NCT00264654|(SAD)|(sad)
797449|NCT00264654|Anxiety|anxiety
797450|NCT00264654|Disorder|disorder
797451|NCT00264641|Hypoglycemia|hypoglycemia
797452|NCT00264641|Cognitive impairment|cognitive impairment
797453|NCT00264641|PET|pet
797454|NCT00264641|CalCAP|calcap
797455|NCT00264628|NK1-antagonist|nk1-antagonist
797456|NCT00264628|Depression|depression
797457|NCT00264628|Fibromyalgia|fibromyalgia
797458|NCT00264628|GW679769|gw679769
797459|NCT00264628|Outpatient|outpatient
797460|NCT00264615|once daily dosing|once daily dosing
797461|NCT00264615|seizure|seizure
797462|NCT00264615|pharmacokinetics|pharmacokinetics
797463|NCT00264615|epilepsy|epilepsy
797464|NCT00264602|Lymphatic mapping|lymphatic mapping
797465|NCT00264602|nodal targeting|nodal targeting
797466|NCT00264602|indocyanine green|indocyanine green
797467|NCT00264602|near infrared imaging|near infrared imaging
797468|NCT00264589|vascular function|vascular function
797469|NCT00264589|cardiac function|cardiac function
797470|NCT00264589|individualized training|individualized training
797471|NCT00264589|ultrasonography|ultrasonography
797472|NCT00264589|body composition|body composition
797473|NCT00264576|influenza|influenza
797474|NCT00264576|flu|flu
797475|NCT00264550|Rheumatoid Arthritis|rheumatoid arthritis
797476|NCT00264550|Golimumab|golimumab
797477|NCT00264550|Methotrexate|methotrexate
797478|NCT00264550|Fully Human anti-TNFa monoclonal antibody|fully human anti-tnfa monoclonal antibody
797479|NCT00264550|Simpony|simpony
797480|NCT00264537|Rheumatoid Arthritis|rheumatoid arthritis
797481|NCT00264537|Methotrexate Naïve|methotrexate naïve
797575|NCT00264160|Bcr Abl|bcr abl
797482|NCT00264537|subcutaneous injection|subcutaneous injection
797483|NCT00264524|Rheumatic heart disease, HLA, Genetics, Taiwan|rheumatic heart disease, hla, genetics, taiwan
797484|NCT00264511|Hyperbaric oxygen|hyperbaric oxygen
797485|NCT00264511|Crush injury|crush injury
797486|NCT00264511|Tibial fracture|tibial fracture
797487|NCT00264511|Gustillo 3|gustillo 3
797488|NCT00264511|soft tissue injury|soft tissue injury
797489|NCT00264511|complications|complications
797490|NCT00264511|outcomes|outcomes
797491|NCT00264511|randomised controlled trial|randomised controlled trial
797492|NCT00264498|Non-Small-Cell Lung Cancer|non-small-cell lung cancer
797493|NCT00264498|NSCLC|nsclc
797494|NCT00264498|Lung Cancer|lung cancer
797495|NCT00264485|Postoperative pain|postoperative pain
797496|NCT00264485|patient-controlled analgesia|patient-controlled analgesia
797497|NCT00264472|Cancer|cancer
797498|NCT00264472|Tumors|tumors
797499|NCT00264472|Neoplasms|neoplasms
797500|NCT00264472|Anticarcinogenic Agents|anticarcinogenic agents
797501|NCT00264472|Antineoplastic Agents|antineoplastic agents
797502|NCT00264472|Dihydrouracil Dehydrogenase (NADP)|dihydrouracil dehydrogenase (nadp)
797503|NCT00264459|Sublingual immunotherapy|sublingual immunotherapy
797504|NCT00264459|Rhinoconjunctivitis|rhinoconjunctivitis
797505|NCT00264459|Rhinitis|rhinitis
797506|NCT00264459|Asthma|asthma
797507|NCT00264446|Cancer; Tumors; Neoplasms; Anticarcinogenic Agents; Antineoplastic Agents;|cancer; tumors; neoplasms; anticarcinogenic agents; antineoplastic agents;
797508|NCT00264446|Dihydrouracil dehydrogenase (NADP); Colorectal Carcinoma; Liver Cancer|dihydrouracil dehydrogenase (nadp); colorectal carcinoma; liver cancer
797509|NCT00264433|Cancer; Tumors; Neoplasms; Anticarcinogenic Agents; Antineoplastic Agents|cancer; tumors; neoplasms; anticarcinogenic agents; antineoplastic agents
797510|NCT00264433|Cadherins; Non-Small-Cell Lung Carcinoma; Esophageal Cancer; Gastric Cancer; Renal Cell Carcinoma; Hepatocellular Carcinoma; Adrenocortical Carcinoma|cadherins; non-small-cell lung carcinoma; esophageal cancer; gastric cancer; renal cell carcinoma; hepatocellular carcinoma; adrenocortical carcinoma
797511|NCT00264420|bone metastases|bone metastases
797512|NCT00264420|breast cancer|breast cancer
797513|NCT00264420|lung cancer|lung cancer
797514|NCT00264420|prostate cancer|prostate cancer
797515|NCT00264420|zoledronic acid|zoledronic acid
797516|NCT00264420|radiation therapy|radiation therapy
797517|NCT00264407|Hearing Loss, Central|hearing loss, central
797518|NCT00264407|Presbycusis|presbycusis
797519|NCT00264407|Hearing Loss, Sensorineural|hearing loss, sensorineural
797520|NCT00264407|Hearing Loss, Cochlear|hearing loss, cochlear
797521|NCT00264407|Hearing Loss, Bilateral|hearing loss, bilateral
797522|NCT00264407|Sex Steroid Hormones|sex steroid hormones
797523|NCT00264407|Estradiol|estradiol
797524|NCT00264394|Computer generated reminder system|computer generated reminder system
797525|NCT00264394|quality control|quality control
797526|NCT00264394|dyslipidemia|dyslipidemia
797527|NCT00264394|antiretroviral therapy|antiretroviral therapy
797528|NCT00264394|HIV infection|hiv infection
797529|NCT00264381|Superficial Thrombophlebitis|superficial thrombophlebitis
797530|NCT00264381|STP|stp
797533|NCT00264381|Superficial Thrombus|superficial thrombus
797534|NCT00264381|Superficial Phlebitis|superficial phlebitis
797535|NCT00264381|phlebitis|phlebitis
797536|NCT00264368|Renal replacement therapy|renal replacement therapy
797537|NCT00264368|CMV disease|cmv disease
797538|NCT00264355|cyclosporine|cyclosporine
797539|NCT00264355|metabolites|metabolites
797540|NCT00264355|metabolic pattern|metabolic pattern
797541|NCT00264355|genotypes|genotypes
797542|NCT00264342|Smoking|smoking
797543|NCT00264342|Tobacco|tobacco
797544|NCT00264342|Nicotine|nicotine
797545|NCT00264316|bone marrow cell transfer|bone marrow cell transfer
797546|NCT00264316|acute myocardial infarction|acute myocardial infarction
797547|NCT00264316|left ventricular function|left ventricular function
797548|NCT00264303|Chronic Idiopathic Urticaria|chronic idiopathic urticaria
797549|NCT00264303|CUTE Levocetirizine Xyzal®|cute levocetirizine xyzal®
797550|NCT00264290|HIV|hiv
797551|NCT00264290|CMV|cmv
797552|NCT00264290|T Cell activation|t cell activation
797553|NCT00264290|Valganciclovir|valganciclovir
797554|NCT00264277|D-dimer|d-dimer
797555|NCT00264277|Recurrence|recurrence
797556|NCT00264277|Venous Thromboembolism|venous thromboembolism
797557|NCT00264277|Anticoagulation|anticoagulation
797558|NCT00264277|Duration|duration
797559|NCT00264264|Closure device|closure device
797560|NCT00264264|Stenting|stenting
797561|NCT00264264|Percutaneous coronary intervention|percutaneous coronary intervention
797562|NCT00264251|HIV|hiv
797563|NCT00264251|Body composition|body composition
797564|NCT00264251|Weight reduction|weight reduction
797565|NCT00264251|Insulin resistance/sensitivity|insulin resistance/sensitivity
797566|NCT00264251|Exercise|exercise
797567|NCT00264251|Diet|diet
797568|NCT00264251|Visceral adiposity|visceral adiposity
797569|NCT00264225|osteoarthritis, pain|osteoarthritis, pain
797570|NCT00264199|Chronic Congestive heart failure|chronic congestive heart failure
797571|NCT00264199|Ischemic heart disease|ischemic heart disease
797572|NCT00264199|insulin resistance|insulin resistance
797573|NCT00264160|AMN107|amn107
797574|NCT00264160|CML|cml
797576|NCT00264160|cytogenetic response|cytogenetic response
797577|NCT00264160|Chronic Myelogenous Leukemia (CML)|chronic myelogenous leukemia (cml)
797578|NCT00264160|imatinib mesylate|imatinib mesylate
797579|NCT00264147|Arcoxia|arcoxia
797580|NCT00264134|Non-Small Cell Lung Cancer|non-small cell lung cancer
797581|NCT00264121|congenital, high scrotal|congenital, high scrotal
797582|NCT00264108|Antineoplastic agents|antineoplastic agents
797583|NCT00264108|Chemotherapy|chemotherapy
797584|NCT00264108|Cost-effectiveness|cost-effectiveness
797585|NCT00264108|Epoetin alfa|epoetin alfa
797586|NCT00264108|Darbepoetin alfa|darbepoetin alfa
797587|NCT00264095|Anemia|anemia
797588|NCT00264095|Blood loss|blood loss
797589|NCT00264095|Transfusion|transfusion
797590|NCT00264095|Blood transfusion|blood transfusion
797591|NCT00264095|Erythropoietin|erythropoietin
797592|NCT00264095|Surgery|surgery
797593|NCT00264095|Surgical blood loss|surgical blood loss
797594|NCT00264095|Tumor|tumor
797595|NCT00264095|Cancer|cancer
797596|NCT00264095|Surgical resection|surgical resection
797597|NCT00264095|Tumor resection|tumor resection
797598|NCT00264069|Adherence|adherence
797599|NCT00264069|Compliance|compliance
797600|NCT00264069|Schizophrenia|schizophrenia
797601|NCT00264069|Bipolar Disorder|bipolar disorder
797602|NCT00264069|Depression|depression
797603|NCT00264069|Personality Disorders|personality disorders
797604|NCT00264069|Registry|registry
797605|NCT00264056|malignant melanoma|malignant melanoma
797606|NCT00264056|hyperthermia|hyperthermia
797607|NCT00264056|chemotherapy|chemotherapy
797608|NCT00264004|Advanced Solid Tumours|advanced solid tumours
797609|NCT00264004|phase II|phase ii
797610|NCT00264004|Hypertension|hypertension
797611|NCT00264004|RECENTIN|recentin
797612|NCT00263978|Venous occlusive disease|venous occlusive disease
797613|NCT00263978|VOD|vod
797614|NCT00263952|Bee venom allergy|bee venom allergy
797615|NCT00263952|Specific immunotherapy|specific immunotherapy
797616|NCT00263939|chronic disease|chronic disease
797617|NCT00263939|patient education|patient education
797618|NCT00263939|self-efficacy|self-efficacy
797619|NCT00263939|self-management|self-management
797620|NCT00263926|Wasp venom allergy,|wasp venom allergy,
797621|NCT00263926|specific immunotherapy|specific immunotherapy
797622|NCT00263900|Influenza A|influenza a
797623|NCT00263900|Influenza B|influenza b
797624|NCT00263900|RSV|rsv
797625|NCT00263887|alpha 1 proteinase inhibitor|alpha 1 proteinase inhibitor
797626|NCT00263887|alpha1 proteinase inhibitor|alpha1 proteinase inhibitor
797627|NCT00263887|congenital emphysema|congenital emphysema
797628|NCT00263887|replacement therapy|replacement therapy
797629|NCT00263861|neurotoxicity|neurotoxicity
797630|NCT00263861|unspecified adult solid tumor, protocol specific|unspecified adult solid tumor, protocol specific
797631|NCT00263822|stage I ovarian epithelial cancer|stage i ovarian epithelial cancer
797632|NCT00263822|stage II ovarian epithelial cancer|stage ii ovarian epithelial cancer
797633|NCT00263822|stage III ovarian epithelial cancer|stage iii ovarian epithelial cancer
797634|NCT00263822|stage IV ovarian epithelial cancer|stage iv ovarian epithelial cancer
797635|NCT00263822|primary peritoneal cavity cancer|primary peritoneal cavity cancer
797636|NCT00263822|fallopian tube cancer|fallopian tube cancer
797637|NCT00263731|lung cancer|lung cancer
797638|NCT00263731|non-small cell lung cancer|non-small cell lung cancer
797639|NCT00263731|small cell lung cancer|small cell lung cancer
797640|NCT00263731|cancer metabolism|cancer metabolism
797641|NCT00263640|House dust mite|house dust mite
797642|NCT00263640|Bronchial Asthma|bronchial asthma
797643|NCT00263640|Allergy|allergy
797644|NCT00263640|House Dust Mite Allergy|house dust mite allergy
797645|NCT00263627|specific immunotherapy|specific immunotherapy
797646|NCT00263627|birch pollen allergy|birch pollen allergy
797647|NCT00263627|Allergovit|allergovit
797648|NCT00263601|Allergovit|allergovit
797649|NCT00263601|Grass pollen allergy|grass pollen allergy
797650|NCT00263588|breast cancer brain metastases ErbB2 positive HER2 positive|breast cancer brain metastases erbb2 positive her2 positive
797651|NCT00263575|EN3267|en3267
797652|NCT00263575|Breakthrough Pain|breakthrough pain
797653|NCT00263575|Safety Study|safety study
797654|NCT00263575|Fentanyl Tablets|fentanyl tablets
797655|NCT00263562|Sickle cell disease|sickle cell disease
797656|NCT00263562|vaso-occlusive crisis|vaso-occlusive crisis
797657|NCT00263562|steroid treatment|steroid treatment
797658|NCT00263549|House dust mite,|house dust mite,
797659|NCT00263549|Allergy|allergy
797660|NCT00263536|Obesity|obesity
797661|NCT00263536|Adiposity|adiposity
797662|NCT00263536|Binge Eating|binge eating
797663|NCT00263536|Social Functioning|social functioning
797664|NCT00263536|Eating Disorders|eating disorders
797665|NCT00263536|Prevention|prevention
797666|NCT00263536|Adolescence|adolescence
797667|NCT00263536|Adolescent Weight Gain|adolescent weight gain
797668|NCT00263536|Overweight|overweight
797669|NCT00263523|Serotonin|serotonin
797670|NCT00263523|Positron Emission Tomograhy|positron emission tomograhy
797671|NCT00263523|Brain|brain
797672|NCT00263523|Neurochemistry|neurochemistry
797673|NCT00263523|Neurotransmitter|neurotransmitter
798156|NCT00261131|spasticity|spasticity
797674|NCT00263523|Healthy Volunteer|healthy volunteer
797675|NCT00263523|HV|hv
797676|NCT00263497|Postinjury chronic pain|postinjury chronic pain
797677|NCT00263497|Transtibial amputation|transtibial amputation
797678|NCT00263497|Physical rehabilitation|physical rehabilitation
797679|NCT00263497|Immediate temporary prosthesis|immediate temporary prosthesis
797680|NCT00263484|Steroids, Fluorinated|steroids, fluorinated
797681|NCT00263484|Thalidomide|thalidomide
797682|NCT00263484|Bisphosphonates|bisphosphonates
797683|NCT00263458|HIV|hiv
797684|NCT00263458|acquired immunodeficiency syndrome|acquired immunodeficiency syndrome
797685|NCT00263458|buprenorphine|buprenorphine
797686|NCT00263458|opioid dependence|opioid dependence
797687|NCT00263458|opioid-related disorders|opioid-related disorders
797688|NCT00263458|integrated care|integrated care
797689|NCT00263458|primary care|primary care
797690|NCT00263445|Growth hormone dosing|growth hormone dosing
797691|NCT00263445|IGF-I|igf-i
797692|NCT00263419|Diabetes Type 2|diabetes type 2
797693|NCT00263419|Late Complications|late complications
797694|NCT00263419|Stress relief management|stress relief management
797695|NCT00263419|psychosocial stress|psychosocial stress
797696|NCT00263393|Myocardial Infarction|myocardial infarction
797697|NCT00263393|Angina Pectoris|angina pectoris
797698|NCT00263393|Cerebrovascular Accident|cerebrovascular accident
797699|NCT00263393|Diabetes Mellitus|diabetes mellitus
797700|NCT00263393|Cluster randomized design|cluster randomized design
797701|NCT00263393|Community-based intervention trial|community-based intervention trial
797702|NCT00263393|Primary Healthcare intervention|primary healthcare intervention
797703|NCT00263393|Lifestyle advice|lifestyle advice
797704|NCT00263380|COPD|copd
797705|NCT00263380|cytokines|cytokines
797706|NCT00263380|corticosteroids|corticosteroids
797707|NCT00263380|beta agonists|beta agonists
797708|NCT00263380|synergistic effect|synergistic effect
797709|NCT00263367|Autism|autism
797710|NCT00263367|Oxidative Stress|oxidative stress
797711|NCT00263367|Hyperbaric Oxygen|hyperbaric oxygen
797712|NCT00263367|Reduced Glutathione|reduced glutathione
797713|NCT00263367|Lipid Peroxides|lipid peroxides
797714|NCT00263341|Contraceptive agents|contraceptive agents
797715|NCT00263341|Female contraception|female contraception
797716|NCT00263341|Progestins|progestins
797717|NCT00263328|immunosuppression|immunosuppression
797718|NCT00263328|JAK3 inhibitor|jak3 inhibitor
797719|NCT00263328|kidney transplant|kidney transplant
797720|NCT00263328|tofacitinib|tofacitinib
797721|NCT00263328|Xeljanz|xeljanz
797722|NCT00263328|CP-690|cp-690
797723|NCT00263328|550|550
797724|NCT00263328|tacromilus|tacromilus
797725|NCT00263328|mycophenolate mofetil|mycophenolate mofetil
797726|NCT00263315|aspergillosis|aspergillosis
797727|NCT00263315|mycosis|mycosis
797728|NCT00263315|neutropenia|neutropenia
797729|NCT00263315|primary prevention|primary prevention
797730|NCT00263315|hematologic diseases|hematologic diseases
797731|NCT00263315|amphotericin B|amphotericin b
797732|NCT00263315|AmBisome|ambisome
797733|NCT00263315|liposomal amphotericin B|liposomal amphotericin b
797734|NCT00263302|dexamethasone, diuretic, congestive heart failure|dexamethasone, diuretic, congestive heart failure
797735|NCT00263250|inguinal hernia|inguinal hernia
797736|NCT00263250|asymptomatic|asymptomatic
797737|NCT00263250|watchful waiting|watchful waiting
797738|NCT00263250|tension-free hernia repair|tension-free hernia repair
797739|NCT00263237|T Cell|t cell
797740|NCT00263237|Lymphocyte|lymphocyte
797741|NCT00263237|Lamina Propria|lamina propria
797742|NCT00263237|Malabsorption|malabsorption
797743|NCT00263237|Colonoscopy|colonoscopy
797744|NCT00263237|Common Variable Immunodeficiency|common variable immunodeficiency
797745|NCT00263237|CVID|cvid
797746|NCT00263237|Gastrointestinal Inflammation|gastrointestinal inflammation
797747|NCT00263211|Breast Cancer|breast cancer
797748|NCT00263211|Metastatic|metastatic
797749|NCT00263211|Platelet|platelet
797750|NCT00263172|internet|internet
797751|NCT00263172|weight management|weight management
797752|NCT00263172|behavior therapy|behavior therapy
797753|NCT00263172|self-help|self-help
797754|NCT00263172|commercial program|commercial program
797755|NCT00263172|obesity|obesity
797756|NCT00263133|Depression|depression
797757|NCT00263133|SSRI|ssri
797758|NCT00263133|Sertraline|sertraline
797759|NCT00263133|synaptic plasticity|synaptic plasticity
797760|NCT00263133|visually evoked potentials|visually evoked potentials
797761|NCT00263107|telerounding|telerounding
797762|NCT00263107|minimally invasive surgery|minimally invasive surgery
797763|NCT00263094|Fasting|fasting
797764|NCT00263094|Headache|headache
797765|NCT00263094|Cox 2 Inhibitors|cox 2 inhibitors
797766|NCT00263094|Pain|pain
797767|NCT00263094|Prophylaxis|prophylaxis
797768|NCT00263081|Hyperlipidemia|hyperlipidemia
797769|NCT00263081|Dyslipidemia|dyslipidemia
797770|NCT00263081|Drug Therapy|drug therapy
797771|NCT00263068|IDIOPATHIC RESTLESS LEGS SYNDROME|idiopathic restless legs syndrome
797772|NCT00263042|Myocardial infarction|myocardial infarction
797773|NCT00263042|cerebrovascular accident|cerebrovascular accident
797774|NCT00263042|obesity|obesity
797775|NCT00262990|Epithelial ovarian cancer|epithelial ovarian cancer
797776|NCT00262990|fallopian tube cancer|fallopian tube cancer
797777|NCT00262990|peritoneal cancer|peritoneal cancer
797778|NCT00262990|primary cancer|primary cancer
797779|NCT00262990|recurrent cancer|recurrent cancer
797780|NCT00262990|doxorubicin|doxorubicin
797781|NCT00262990|taxane chemotherapy|taxane chemotherapy
797782|NCT00262990|platinum chemotherapy|platinum chemotherapy
797783|NCT00262990|Patupilone|patupilone
797784|NCT00262990|taxane platinum resistant|taxane platinum resistant
797785|NCT00262977|diabetes mellitus|diabetes mellitus
797786|NCT00262977|cardiovascular diseases|cardiovascular diseases
797787|NCT00262977|aspirin|aspirin
797788|NCT00262977|quality of healthcare|quality of healthcare
797789|NCT00262964|non-alcoholic fatty liver disease|non-alcoholic fatty liver disease
797790|NCT00262964|obesity|obesity
797791|NCT00262964|fatty liver disease|fatty liver disease
797792|NCT00262951|stage I pancreatic cancer|stage i pancreatic cancer
797793|NCT00262951|stage II pancreatic cancer|stage ii pancreatic cancer
797794|NCT00262951|stage III pancreatic cancer|stage iii pancreatic cancer
797795|NCT00262951|adenocarcinoma of the pancreas|adenocarcinoma of the pancreas
797796|NCT00262938|stage I endometrial carcinoma|stage i endometrial carcinoma
797797|NCT00262938|stage II endometrial carcinoma|stage ii endometrial carcinoma
797798|NCT00262938|weight changes|weight changes
797799|NCT00262925|MOAD|moad
797800|NCT00262925|Methotrexate|methotrexate
797801|NCT00262925|Vincristine|vincristine
797802|NCT00262925|L-asparaginase|l-asparaginase
797803|NCT00262925|Dexamethasone|dexamethasone
797804|NCT00262925|Subcutaneous Campath|subcutaneous campath
797805|NCT00262899|psychosocial effects of cancer and its treatment|psychosocial effects of cancer and its treatment
797806|NCT00262899|ductal breast carcinoma in situ|ductal breast carcinoma in situ
797807|NCT00262899|breast cancer in situ|breast cancer in situ
797808|NCT00262899|stage IA breast cancer|stage ia breast cancer
797809|NCT00262899|stage IB breast cancer|stage ib breast cancer
797810|NCT00262899|stage II breast cancer|stage ii breast cancer
797811|NCT00262899|stage IIIA breast cancer|stage iiia breast cancer
797812|NCT00262886|recurrent renal cell cancer|recurrent renal cell cancer
797813|NCT00262886|stage IV renal cell cancer|stage iv renal cell cancer
797814|NCT00262873|previously treated myelodysplastic syndromes|previously treated myelodysplastic syndromes
797815|NCT00262873|refractory anemia with excess blasts|refractory anemia with excess blasts
797816|NCT00262873|refractory anemia with ringed sideroblasts|refractory anemia with ringed sideroblasts
797817|NCT00262873|refractory anemia|refractory anemia
797818|NCT00262873|secondary myelodysplastic syndromes|secondary myelodysplastic syndromes
797819|NCT00262873|de novo myelodysplastic syndromes|de novo myelodysplastic syndromes
797820|NCT00262860|recurrent adult Hodgkin lymphoma|recurrent adult hodgkin lymphoma
797821|NCT00262808|stage II colon cancer|stage ii colon cancer
797822|NCT00262808|stage III colon cancer|stage iii colon cancer
797823|NCT00262808|adenocarcinoma of the colon|adenocarcinoma of the colon
797824|NCT00262795|stage 0 chronic lymphocytic leukemia|stage 0 chronic lymphocytic leukemia
797825|NCT00262795|stage I chronic lymphocytic leukemia|stage i chronic lymphocytic leukemia
797826|NCT00262795|stage II chronic lymphocytic leukemia|stage ii chronic lymphocytic leukemia
797827|NCT00262795|stage III chronic lymphocytic leukemia|stage iii chronic lymphocytic leukemia
797828|NCT00262795|stage IV chronic lymphocytic leukemia|stage iv chronic lymphocytic leukemia
797829|NCT00262782|B-cell chronic lymphocytic leukemia|b-cell chronic lymphocytic leukemia
797830|NCT00262782|stage 0 chronic lymphocytic leukemia|stage 0 chronic lymphocytic leukemia
797831|NCT00262782|stage I chronic lymphocytic leukemia|stage i chronic lymphocytic leukemia
797832|NCT00262782|stage II chronic lymphocytic leukemia|stage ii chronic lymphocytic leukemia
797833|NCT00262769|cholangiocarcinoma of the extrahepatic bile duct|cholangiocarcinoma of the extrahepatic bile duct
797834|NCT00262769|recurrent extrahepatic bile duct cancer|recurrent extrahepatic bile duct cancer
797835|NCT00262769|unresectable extrahepatic bile duct cancer|unresectable extrahepatic bile duct cancer
797836|NCT00262769|cholangiocarcinoma of the gallbladder|cholangiocarcinoma of the gallbladder
797837|NCT00262769|recurrent gallbladder cancer|recurrent gallbladder cancer
797838|NCT00262769|unresectable gallbladder cancer|unresectable gallbladder cancer
797839|NCT00262769|metastatic extrahepatic bile duct cancer|metastatic extrahepatic bile duct cancer
797840|NCT00262769|metastatic gallbladder cancer|metastatic gallbladder cancer
797841|NCT00262743|B-cell chronic lymphocytic leukemia|b-cell chronic lymphocytic leukemia
797842|NCT00262743|stage 0 chronic lymphocytic leukemia|stage 0 chronic lymphocytic leukemia
797843|NCT00262743|stage I chronic lymphocytic leukemia|stage i chronic lymphocytic leukemia
797844|NCT00262743|stage II chronic lymphocytic leukemia|stage ii chronic lymphocytic leukemia
797845|NCT00262730|adult glioblastoma|adult glioblastoma
797846|NCT00262730|adult giant cell glioblastoma|adult giant cell glioblastoma
797847|NCT00262730|adult gliosarcoma|adult gliosarcoma
797848|NCT00262717|HIV drug resistance testing|hiv drug resistance testing
797849|NCT00262717|Treatment Experienced|treatment experienced
797850|NCT00262704|physician intervention|physician intervention
797851|NCT00262704|diabetes mellitus|diabetes mellitus
797852|NCT00262704|primary care|primary care
797853|NCT00262704|quality improvement|quality improvement
797854|NCT00262704|disease management|disease management
797855|NCT00262652|sodium pyruvate|sodium pyruvate
797856|NCT00262652|anti-inflammatory|anti-inflammatory
797857|NCT00262652|bronchodilation|bronchodilation
797858|NCT00262652|asthma|asthma
797859|NCT00262652|asthmatics|asthmatics
797860|NCT00262639|Alcoholism|alcoholism
797861|NCT00262639|Alcohol Dependence|alcohol dependence
797862|NCT00262639|Alcohol Withdrawal|alcohol withdrawal
797863|NCT00262639|Treatment|treatment
797864|NCT00262639|Pharmacotherapy|pharmacotherapy
797865|NCT00262613|Sodium Pyruvate|sodium pyruvate
797866|NCT00262613|COPD|copd
797867|NCT00262613|Chronic Obstructive Pulmonary Disease|chronic obstructive pulmonary disease
797868|NCT00262587|Sport|sport
797869|NCT00262587|Asthma|asthma
797870|NCT00262587|Treatment|treatment
797871|NCT00262587|Airway inflammation|airway inflammation
797872|NCT00262574|endothelial disfunction|endothelial disfunction
797873|NCT00262574|BNP|bnp
797874|NCT00262574|PCI|pci
797875|NCT00262574|coronary artery disease|coronary artery disease
797876|NCT00262561|Intermittent Claudication|intermittent claudication
797877|NCT00262561|Aspirin resistance|aspirin resistance
797878|NCT00262561|Clopidogrel resistance|clopidogrel resistance
797879|NCT00262548|Obesity|obesity
797880|NCT00262548|Menopause|menopause
797881|NCT00262522|Human Immunodeficiency Virus Infections|human immunodeficiency virus infections
797882|NCT00262509|Rehabilitation|rehabilitation
797883|NCT00262509|Sensory Aid|sensory aid
797884|NCT00262496|Botox|botox
797885|NCT00262496|Overactive bladder|overactive bladder
797886|NCT00262496|Incontinence|incontinence
797887|NCT00262496|Spinal Cord Injury|spinal cord injury
797888|NCT00262470|tachycardia|tachycardia
797889|NCT00262470|sinus tachycardia|sinus tachycardia
797890|NCT00262470|postural tachycardia syndrome (POTS)|postural tachycardia syndrome (pots)
797891|NCT00262457|electrical stimulation|electrical stimulation
797892|NCT00262457|Pressure Ulcers|pressure ulcers
797893|NCT00262457|Spinal Cord Injury|spinal cord injury
797894|NCT00262431|Tracheostomy|tracheostomy
797895|NCT00262431|Tracheostomy timing|tracheostomy timing
797896|NCT00262431|Ventilator associated pneumonia|ventilator associated pneumonia
797897|NCT00262431|Mechanical ventilation|mechanical ventilation
797898|NCT00262392|heterotopic ossification,|heterotopic ossification,
797899|NCT00262392|prevention,|prevention,
797900|NCT00262392|high risk,|high risk,
797901|NCT00262392|bisphosphonates,|bisphosphonates,
797902|NCT00262392|radiotherapy|radiotherapy
797903|NCT00262379|Chronic hepatitis C|chronic hepatitis c
797904|NCT00262379|peginterferon|peginterferon
797905|NCT00262379|ribavirin|ribavirin
797906|NCT00262379|epoetin beta|epoetin beta
797907|NCT00262340|Asthma|asthma
797908|NCT00262340|Pediatrics|pediatrics
797909|NCT00262340|Airway|airway
797910|NCT00262340|Inflammation|inflammation
797911|NCT00262327|antiangiogenesis|antiangiogenesis
797912|NCT00262327|endostatin|endostatin
797913|NCT00262327|adenovirus|adenovirus
797914|NCT00262327|gene therapy|gene therapy
797915|NCT00262327|cancer|cancer
798504|NCT00259870|PANSS|panss
797916|NCT00262236|Hypertension, Aliskiren, Atenolol, Blood Pressure|hypertension, aliskiren, atenolol, blood pressure
797917|NCT00262223|Co-morbid alcohol dependence and PTSD|co-morbid alcohol dependence and ptsd
797918|NCT00262223|Alcohol and other drug use disorders|alcohol and other drug use disorders
797919|NCT00262223|Treatment outcome|treatment outcome
797920|NCT00262197|Diabetes mellitus|diabetes mellitus
797921|NCT00262197|Medical error rates|medical error rates
797922|NCT00262197|Pharmacotherapy|pharmacotherapy
797923|NCT00262184|Post-Menopausal osteopenia|post-menopausal osteopenia
797924|NCT00262158|smoking status|smoking status
797925|NCT00262158|cigarette consumption|cigarette consumption
797926|NCT00262145|glucose|glucose
797927|NCT00262145|lipid|lipid
797928|NCT00262145|diabetes|diabetes
797929|NCT00262145|overweight|overweight
797930|NCT00262119|Physiological pacing|physiological pacing
797931|NCT00262119|Antitachycardia pacing therapies|antitachycardia pacing therapies
797932|NCT00262106|Administration, intravaginal|administration, intravaginal
797933|NCT00262106|Anti-infective agents|anti-infective agents
797934|NCT00262106|Double blind method|double blind method
797935|NCT00262106|Drug evaluation|drug evaluation
797936|NCT00262106|Female|female
797937|NCT00262106|Gels|gels
797938|NCT00262106|HIV infections/prevention and control|hiv infections/prevention and control
797939|NCT00262106|Microbicide|microbicide
797940|NCT00262106|Naphthalenesulfonates/administration and dosage|naphthalenesulfonates/administration and dosage
797941|NCT00262106|Polymers/administration and dosage|polymers/administration and dosage
797942|NCT00262106|Sexual behavior|sexual behavior
797943|NCT00262106|Vaginal creams, foams and jellies|vaginal creams, foams and jellies
797944|NCT00262106|HIV Seronegativity|hiv seronegativity
797945|NCT00262106|Genital Herpes Infections|genital herpes infections
797946|NCT00262093|preeclampsia|preeclampsia
797947|NCT00262093|sFlt1|sflt1
797948|NCT00262093|PlGF|plgf
797949|NCT00262093|parity|parity
797950|NCT00262093|angiogenesis|angiogenesis
797951|NCT00262054|coronary disease|coronary disease
797952|NCT00261989|pulse oximetry readings|pulse oximetry readings
797953|NCT00261989|pediatrics|pediatrics
797954|NCT00261989|cardiac|cardiac
797955|NCT00261989|congenital heart disease|congenital heart disease
797956|NCT00261976|Rheumatoid arthritis|rheumatoid arthritis
797957|NCT00261976|Crohn's disease|crohn's disease
797958|NCT00261976|Psoriasis|psoriasis
797959|NCT00261950|Cinacalcet HCl, Cinacalcet, Amgen (AMG) 073, Sensipar, Mimpara, Calcimimetic|cinacalcet hcl, cinacalcet, amgen (amg) 073, sensipar, mimpara, calcimimetic
797960|NCT00261924|Thrombocytopenic patients|thrombocytopenic patients
797961|NCT00261911|Meridia|meridia
797962|NCT00261911|Sibutramine|sibutramine
797963|NCT00261911|Obesity|obesity
797964|NCT00261911|Adolescent|adolescent
797965|NCT00261911|BMI|bmi
797966|NCT00261898|Sleep Deprivation|sleep deprivation
797967|NCT00261898|Obesity|obesity
797968|NCT00261898|Metabolic Syndrome|metabolic syndrome
797969|NCT00261898|Hormones|hormones
797970|NCT00261898|Public Health|public health
797971|NCT00261898|Overweight|overweight
797972|NCT00261898|Sleep|sleep
797973|NCT00261872|Alcoholism|alcoholism
797974|NCT00261872|Attention Deficit Disorder|attention deficit disorder
797975|NCT00261872|ADHD|adhd
797976|NCT00261859|hazardous drinking|hazardous drinking
797977|NCT00261846|Leukemia|leukemia
797978|NCT00261846|tyrosine kinase inhibitor|tyrosine kinase inhibitor
797979|NCT00261846|philadelphia chromosome|philadelphia chromosome
797980|NCT00261846|Myeloid|myeloid
797981|NCT00261846|Philadelphia Positive|philadelphia positive
797982|NCT00261833|Alpha1-proteinase inhibitor deficiency|alpha1-proteinase inhibitor deficiency
797983|NCT00261833|Emphysema|emphysema
797984|NCT00261833|Chronic augmentation and maintenance therapy|chronic augmentation and maintenance therapy
797985|NCT00261820|Kidney Transplant|kidney transplant
797986|NCT00261807|severe|severe
797987|NCT00261807|skin|skin
797988|NCT00261807|infections|infections
797989|NCT00261794|cognition|cognition
797990|NCT00261794|schizophrenia|schizophrenia
797991|NCT00261794|treatment|treatment
797992|NCT00261781|Treadmill|treadmill
797993|NCT00261781|Walking|walking
797994|NCT00261781|Exercise|exercise
797995|NCT00261781|Automaticity|automaticity
797996|NCT00261781|Quality of Life|quality of life
797997|NCT00261768|Aging|aging
797998|NCT00261768|hearing aids|hearing aids
797999|NCT00261768|hearing loss, sensorineural|hearing loss, sensorineural
798000|NCT00261768|speech recognition|speech recognition
798001|NCT00261755|Acupuncture|acupuncture
798002|NCT00261755|pain relief|pain relief
798003|NCT00261755|labour|labour
798004|NCT00261755|randomized controlled trial|randomized controlled trial
798005|NCT00261755|TENS|tens
798006|NCT00261742|perianal|perianal
798007|NCT00261742|dermatitis|dermatitis
798008|NCT00261742|streptococcus pyogenes|streptococcus pyogenes
798009|NCT00261729|Paroxetine|paroxetine
798010|NCT00261729|Prazosin|prazosin
798011|NCT00261729|Sleep Disorders|sleep disorders
798012|NCT00261729|Stress Disorders, Post-Traumatic|stress disorders, post-traumatic
798013|NCT00261716|clinical trial|clinical trial
798014|NCT00261716|employment|employment
798015|NCT00261716|schizoaffective disorder|schizoaffective disorder
798016|NCT00261716|schizophrenia|schizophrenia
798017|NCT00261690|Virtual Reality Distraction|virtual reality distraction
798018|NCT00261677|Anemia|anemia
798019|NCT00261677|cancer|cancer
798020|NCT00261677|solid tumor|solid tumor
798021|NCT00261677|Hodgkin's Disease|hodgkin's disease
798022|NCT00261677|Acute Lymphocytic Leukemia (ALL)|acute lymphocytic leukemia (all)
798023|NCT00261677|Non-Hodgkin's Lymphoma (NHL)|non-hodgkin's lymphoma (nhl)
798024|NCT00261677|Quality of Life|quality of life
798025|NCT00261677|hemoglobin|hemoglobin
798026|NCT00261677|Epoetin alfa|epoetin alfa
798027|NCT00261638|Mental Health Promotion|mental health promotion
798028|NCT00261638|Mental Health Index|mental health index
798029|NCT00261638|Taiwan Mental Health Index scale|taiwan mental health index scale
798030|NCT00261638|psychophysical health|psychophysical health
798031|NCT00261638|education years over 9 years|education years over 9 years
798032|NCT00261638|normal people, especially joining Mental Health Foundation Promotions|normal people, especially joining mental health foundation promotions
798033|NCT00261625|peritoneal dialysis|peritoneal dialysis
798034|NCT00261625|artery calcification|artery calcification
798035|NCT00261625|bone mineral density|bone mineral density
798036|NCT00261612|relapsed or chemotherapy-refractory disease|relapsed or chemotherapy-refractory disease
798037|NCT00261599|Colonoscopy|colonoscopy
798038|NCT00261599|Sedation|sedation
798039|NCT00261599|AQUAVAN|aquavan
798040|NCT00261599|Fospropofol disodium|fospropofol disodium
798041|NCT00261599|Colon polyps|colon polyps
798042|NCT00261599|Endoscopic outcomes|endoscopic outcomes
798043|NCT00261599|Endoscopic sedation|endoscopic sedation
798044|NCT00261599|Endoscopy|endoscopy
798045|NCT00261586|aspirin|aspirin
798046|NCT00261586|analgesics|analgesics
798047|NCT00261586|cyclooxygenase activity|cyclooxygenase activity
798048|NCT00261586|non-steroidal antiinflammatory drugs|non-steroidal antiinflammatory drugs
798049|NCT00261573|"Alzheimer's disease with cerebrovascular disease (mixed dementia)"|"alzheimer's disease with cerebrovascular disease (mixed dementia)"
798050|NCT00261573|probable vascular dementia|probable vascular dementia
798051|NCT00261573|galantamine|galantamine
798052|NCT00261560|ankle sprain|ankle sprain
798155|NCT00261131|cerebral palsy|cerebral palsy
798053|NCT00261560|acetaminophen extended release, ibuprofen|acetaminophen extended release, ibuprofen
798054|NCT00261547|Kidney transplantation|kidney transplantation
798055|NCT00261547|HLA|hla
798056|NCT00261534|Chemotherapy|chemotherapy
798057|NCT00261521|Kidney failure, Chronic|kidney failure, chronic
798058|NCT00261521|End-stage renal disease|end-stage renal disease
798059|NCT00261521|Kidney failure|kidney failure
798060|NCT00261521|Anemia|anemia
798061|NCT00261521|Dialysis|dialysis
798062|NCT00261521|Epoetin|epoetin
798063|NCT00261521|Erythropoetin|erythropoetin
798064|NCT00261521|Epoetin alfa|epoetin alfa
798065|NCT00261508|Risperidone|risperidone
798066|NCT00261508|child development disorders|child development disorders
798067|NCT00261508|pervasive development disorders|pervasive development disorders
798068|NCT00261508|autistic disorder|autistic disorder
798069|NCT00261508|autism|autism
798070|NCT00261508|developmental disabilities|developmental disabilities
798071|NCT00261508|antipsychotropic agents|antipsychotropic agents
798072|NCT00261495|chronic noncancer pain|chronic noncancer pain
798073|NCT00261495|pain|pain
798074|NCT00261495|analgesia|analgesia
798075|NCT00261495|analgesic opioid|analgesic opioid
798076|NCT00261495|oxycodone|oxycodone
798077|NCT00261495|hydromorphone|hydromorphone
798078|NCT00261482|contraception|contraception
798079|NCT00261482|female contraception|female contraception
798080|NCT00261482|hormonal contraception|hormonal contraception
798081|NCT00261482|transdermal contraception|transdermal contraception
798082|NCT00261482|EVRA|evra
798083|NCT00261482|estrogen|estrogen
798084|NCT00261482|progestin|progestin
798085|NCT00261482|ethinyl estradiol|ethinyl estradiol
798086|NCT00261482|norelgestromin|norelgestromin
798087|NCT00261469|Migraine|migraine
798088|NCT00261469|Headache|headache
798089|NCT00261456|Prostate cancer|prostate cancer
798090|NCT00261456|BRCA1|brca1
798091|NCT00261456|BRCA2|brca2
798092|NCT00261456|prostate screening|prostate screening
798093|NCT00261456|PSA|psa
798094|NCT00261456|prostate biopsy|prostate biopsy
798095|NCT00261443|Bipolar I Disorder with a recent manic or mixed episode|bipolar i disorder with a recent manic or mixed episode
798096|NCT00261430|Schizophrenia|schizophrenia
798097|NCT00261430|acceptance|acceptance
798098|NCT00261430|motivational enhancement therapy|motivational enhancement therapy
798099|NCT00261430|long-acting risperidone|long-acting risperidone
798100|NCT00261430|intramuscular injection|intramuscular injection
798101|NCT00261430|Treatment Guidebook|treatment guidebook
798102|NCT00261430|GAIN Acceptance Approach|gain acceptance approach
798103|NCT00261391|Arteriovenous Malformation|arteriovenous malformation
798104|NCT00261391|Lymphatic Malformation|lymphatic malformation
798105|NCT00261391|Gorham|gorham
798106|NCT00261378|Hepatocellular Carcinoma (HCC)|hepatocellular carcinoma (hcc)
798107|NCT00261339|Gastroesophageal Reflux|gastroesophageal reflux
798108|NCT00261339|Gastroesophageal Reflux Disease|gastroesophageal reflux disease
798109|NCT00261339|Pantoprazole|pantoprazole
798110|NCT00261326|Simvastatin|simvastatin
798111|NCT00261326|Optic Neuritis|optic neuritis
798112|NCT00261326|Multiple Sclerosis|multiple sclerosis
798113|NCT00261313|Breast cancer|breast cancer
798114|NCT00261313|Doses dense chemotherapy|doses dense chemotherapy
798115|NCT00261313|Growth factor support|growth factor support
798116|NCT00261313|Adjuvant Breast Cancer|adjuvant breast cancer
798117|NCT00261300|Gastric acid|gastric acid
798118|NCT00261300|GERD|gerd
798119|NCT00261300|Gastroesophageal reflux disease|gastroesophageal reflux disease
798120|NCT00261300|Pantoprazole|pantoprazole
798121|NCT00261300|Proton pump inhibitor|proton pump inhibitor
798122|NCT00261287|Hay Fever|hay fever
798123|NCT00261287|Allergic Rhinitis|allergic rhinitis
798124|NCT00261287|Perennial Allergic Rhinitis|perennial allergic rhinitis
798125|NCT00261287|Ciclesonide|ciclesonide
798126|NCT00261274|transfusion; red blood cells|transfusion; red blood cells
798127|NCT00261261|children|children
798128|NCT00261261|anxiety|anxiety
798129|NCT00261261|behavioral preparation|behavioral preparation
798130|NCT00261261|family|family
798131|NCT00261261|surgery|surgery
798132|NCT00261261|parents|parents
798133|NCT00261248|Phase 2|phase 2
798134|NCT00261248|Vaccine|vaccine
798135|NCT00261248|Urinary Tract Infection|urinary tract infection
798136|NCT00261248|Vaginal Mucosal|vaginal mucosal
798137|NCT00261235|Rehabilitation, Vocational|rehabilitation, vocational
798138|NCT00261235|Virtues|virtues
798139|NCT00261235|Employment, supported|employment, supported
798140|NCT00261235|veterans|veterans
798141|NCT00261235|Mentally Ill Persons|mentally ill persons
798142|NCT00261222|Amodiaquine|amodiaquine
798143|NCT00261222|Efficacy|efficacy
798144|NCT00261222|Malaria|malaria
798145|NCT00261222|Burkina Faso|burkina faso
798146|NCT00261209|Flexor Tendon Adhesions|flexor tendon adhesions
798147|NCT00261209|Zone II of the Hand|zone ii of the hand
798148|NCT00261196|Frozen Shoulder|frozen shoulder
798149|NCT00261170|smoking|smoking
798150|NCT00261157|nephrectomy|nephrectomy
798151|NCT00261157|Safety|safety
798152|NCT00261157|Laparoscopy|laparoscopy
798153|NCT00261157|telerounding|telerounding
798154|NCT00261157|prostatectomy|prostatectomy
798157|NCT00261131|diplegia|diplegia
798158|NCT00261118|colitis|colitis
798159|NCT00261118|rituximab|rituximab
798160|NCT00261066|Functional outcome|functional outcome
798161|NCT00261066|Orthopaedic surgery|orthopaedic surgery
798162|NCT00261040|Osteoarthritis|osteoarthritis
798163|NCT00261040|Total Hip Arthroplasty|total hip arthroplasty
798164|NCT00261040|Minimally Invasive Surgery|minimally invasive surgery
798165|NCT00261027|ovarian cancer|ovarian cancer
798166|NCT00261014|Recurrent|recurrent
798167|NCT00261014|Idiopathic|idiopathic
798168|NCT00261014|Deep Vein Thrombosis|deep vein thrombosis
798169|NCT00261014|Pulmonary Embolism|pulmonary embolism
798170|NCT00261014|Clinical Prediction Rule|clinical prediction rule
798171|NCT00261014|Venous Thromboembolism|venous thromboembolism
798172|NCT00261014|Risk Factors|risk factors
798173|NCT00261001|Transcutaneous|transcutaneous
798174|NCT00261001|Vaccination|vaccination
798175|NCT00261001|Safety|safety
798176|NCT00261001|Immunogenicity|immunogenicity
798177|NCT00261001|HIV|hiv
798178|NCT00261001|Treatment Experienced|treatment experienced
798179|NCT00260988|Prophylaxis|prophylaxis
798180|NCT00260988|Thromboembolic disease|thromboembolic disease
798181|NCT00260988|End stage renal disease|end stage renal disease
798182|NCT00260988|Hemodialysis|hemodialysis
798183|NCT00260988|Pharmacokinetics|pharmacokinetics
798184|NCT00260988|Low Molecular Weight Heparin|low molecular weight heparin
798185|NCT00260988|Innohep|innohep
798186|NCT00260988|Tinzaparin|tinzaparin
798187|NCT00260988|Fragmin|fragmin
798188|NCT00260988|Dalteparin|dalteparin
798189|NCT00260988|Anti Xa|anti xa
798190|NCT00260988|INR|inr
798191|NCT00260988|Oral anticoagulation|oral anticoagulation
798192|NCT00260988|warfarin|warfarin
798193|NCT00260988|Coumadin|coumadin
798194|NCT00260975|breast cancer|breast cancer
798195|NCT00260975|chemotherapy|chemotherapy
798196|NCT00260975|hormonal therapy|hormonal therapy
798197|NCT00260975|cognitive function|cognitive function
798198|NCT00260975|chemo fog|chemo fog
798199|NCT00260962|Pilot Project,|pilot project,
798200|NCT00260962|Clinical Trial,|clinical trial,
798201|NCT00260962|Treatment Outcome,|treatment outcome,
798202|NCT00260962|Psychopharmacology|psychopharmacology
798203|NCT00260949|rotator cuff tear|rotator cuff tear
798204|NCT00260949|arthroscopic repair|arthroscopic repair
798205|NCT00260936|HIV|hiv
798206|NCT00260936|AIDS|aids
798207|NCT00260936|Adolescent Males|adolescent males
798208|NCT00260936|HIV positive|hiv positive
798209|NCT00260936|Treatment Naive|treatment naive
798210|NCT00260936|Treatment Experienced|treatment experienced
798211|NCT00260923|hypertension|hypertension
798212|NCT00260923|aliskiren|aliskiren
798213|NCT00260923|blood pressure|blood pressure
798214|NCT00260897|avascular necrosis of the femoral head|avascular necrosis of the femoral head
798215|NCT00260897|genotyping|genotyping
798505|NCT00259870|Acute|acute
798216|NCT00260897|linkage analysis|linkage analysis
798217|NCT00260897|pathogenesis|pathogenesis
798218|NCT00260897|therapy|therapy
798219|NCT00260871|lung adenocarcinoma|lung adenocarcinoma
798220|NCT00260871|genetic epidemiology|genetic epidemiology
798221|NCT00260871|environmental factors|environmental factors
798222|NCT00260871|genetic map|genetic map
798223|NCT00260871|coordination center|coordination center
798224|NCT00260858|Glycemic index|glycemic index
798225|NCT00260858|Nutrition|nutrition
798226|NCT00260858|Carbohydrates|carbohydrates
798227|NCT00260858|Glycemic responses|glycemic responses
798228|NCT00260858|Methodology|methodology
798229|NCT00260858|Healthy human subjects|healthy human subjects
798230|NCT00260832|Acute Myeloid Leukemia|acute myeloid leukemia
798231|NCT00260832|Dacogen|dacogen
798232|NCT00260832|Decitabine|decitabine
798233|NCT00260832|Poor or intermediate-risk cytogenetics|poor or intermediate-risk cytogenetics
798234|NCT00260819|Hypoxia-induced pulmonary artery hypertension|hypoxia-induced pulmonary artery hypertension
798235|NCT00260819|High-altitude pulmonary oedema|high-altitude pulmonary oedema
798236|NCT00260819|ETA receptor antagonist|eta receptor antagonist
798237|NCT00260793|Ropinirole|ropinirole
798238|NCT00260793|Parkinson's disease|parkinson's disease
798239|NCT00260793|dopamine agonist|dopamine agonist
798240|NCT00260780|sexually transmitted diseases|sexually transmitted diseases
798241|NCT00260780|Risk Behavior|risk behavior
798242|NCT00260754|Risk behavior|risk behavior
798243|NCT00260754|Sexually transmitted diseases|sexually transmitted diseases
798244|NCT00260741|cannabis|cannabis
798245|NCT00260741|marijuana|marijuana
798246|NCT00260741|Multiple Sclerosis|multiple sclerosis
798247|NCT00260741|Spasticity|spasticity
798248|NCT00260728|vascular access|vascular access
798249|NCT00260728|hemodialysis|hemodialysis
798250|NCT00260715|Risk behavior|risk behavior
798251|NCT00260715|Sexually Transmitted Diseases|sexually transmitted diseases
798252|NCT00260702|Phenotype|phenotype
798253|NCT00260702|Monoclonal|monoclonal
798254|NCT00260702|Immunoglobulin|immunoglobulin
798255|NCT00260702|Immunodeficiency|immunodeficiency
798256|NCT00260702|Dermatitis|dermatitis
798257|NCT00260702|Job's Syndrome|job's syndrome
798258|NCT00260702|Hyper-IgE Syndrome|hyper-ige syndrome
798259|NCT00260702|HIES|hies
798260|NCT00260689|Immunosuppression|immunosuppression
798261|NCT00260689|T-cells|t-cells
798262|NCT00260689|Hematopoiesis|hematopoiesis
798263|NCT00260689|Autoimmunity|autoimmunity
798264|NCT00260689|Thrombocytopenia|thrombocytopenia
798265|NCT00260689|Severe Aplastic Anemia|severe aplastic anemia
798266|NCT00260689|SAA|saa
798267|NCT00260676|brain death|brain death
798268|NCT00260676|lung transplantation|lung transplantation
798269|NCT00260676|organ donors|organ donors
798270|NCT00260676|potential organ donors|potential organ donors
798271|NCT00260663|Hearing Impaired Rehabilitation|hearing impaired rehabilitation
798272|NCT00260663|Hearing Aids|hearing aids
798273|NCT00260663|Randomized Controlled Trials|randomized controlled trials
798274|NCT00260663|Cost Effectiveness|cost effectiveness
798275|NCT00260663|Quality of life|quality of life
798276|NCT00260663|Patient Compliance|patient compliance
798277|NCT00260650|heart failure, congestive|heart failure, congestive
798278|NCT00260650|self-care|self-care
798279|NCT00260650|quality of life|quality of life
798280|NCT00260650|health behavior|health behavior
798281|NCT00260637|Prostatitis|prostatitis
798282|NCT00260624|agitation|agitation
798283|NCT00260624|dementia|dementia
798284|NCT00260624|Alzheimer's Disease|alzheimer's disease
798285|NCT00260611|prostate|prostate
798286|NCT00260598|Non-small cell lung cancer|non-small cell lung cancer
798287|NCT00260598|Head and neck squamous cell cancer|head and neck squamous cell cancer
798288|NCT00260598|White light bronchoscopy|white light bronchoscopy
798289|NCT00260598|Imaging Elastic Scattering Spectroscopy (IESS)|imaging elastic scattering spectroscopy (iess)
798290|NCT00260598|Fluorescence Bronchoscopy|fluorescence bronchoscopy
798291|NCT00260598|COPD|copd
798292|NCT00260598|Helium-Cadmium Laser Bronchoscopy|helium-cadmium laser bronchoscopy
798293|NCT00260598|Autofluorescence spectra of dysplasia & cancer in situ (CIS)|autofluorescence spectra of dysplasia & cancer in situ (cis)
798294|NCT00260598|Severe Chronic Obstructive Pulmonary Disorders(COPD)|severe chronic obstructive pulmonary disorders(copd)
798295|NCT00260585|gastroesophageal reflux disease|gastroesophageal reflux disease
798296|NCT00260585|GERD|gerd
798297|NCT00260585|hiatal hernia|hiatal hernia
798298|NCT00260585|achalasia|achalasia
798299|NCT00260585|Barrett's metaplasia|barrett's metaplasia
798300|NCT00260585|Anti-Reflux Surgery|anti-reflux surgery
798301|NCT00260585|Known/suspected esophageal/gastroesophageal junction tumor|known/suspected esophageal/gastroesophageal junction tumor
798302|NCT00260585|Esophageal disorders such as Barrett's metaplasia|esophageal disorders such as barrett's metaplasia
798303|NCT00260585|Symptomatic gastroesophageal reflux disease|symptomatic gastroesophageal reflux disease
798304|NCT00260572|GERD|gerd
798305|NCT00260572|nissen|nissen
798306|NCT00260572|fundoplication|fundoplication
798307|NCT00260572|reflux|reflux
798308|NCT00260572|toupet|toupet
798309|NCT00260572|QOL|qol
798310|NCT00260572|dyspepsia|dyspepsia
798311|NCT00260572|heartburn|heartburn
798312|NCT00260572|Patients with reflux symptoms for at least 6 months|patients with reflux symptoms for at least 6 months
798313|NCT00260572|Patients scheduled for lap nissen or toupet fundoplication|patients scheduled for lap nissen or toupet fundoplication
798314|NCT00260572|Reflux diagnosed by either endoscopy, upper GI, or 24hr. pH (numeric scale used to specify the acidity of gastric contents)|reflux diagnosed by either endoscopy, upper gi, or 24hr. ph (numeric scale used to specify the acidity of gastric contents)
798315|NCT00260572|On or starting treatment with PPI or pro-motility agents|on or starting treatment with ppi or pro-motility agents
798316|NCT00260559|Esophagectomy|esophagectomy
798317|NCT00260559|Esophageal Cancer|esophageal cancer
798318|NCT00260559|Quality of Life|quality of life
798319|NCT00260559|Minimally Invasive Esophagectomy|minimally invasive esophagectomy
798320|NCT00260559|Laparoscopic Transhiatal Esophagectomy|laparoscopic transhiatal esophagectomy
798321|NCT00260559|Open Esophagectomy|open esophagectomy
798322|NCT00260559|Karnofsky Score|karnofsky score
798323|NCT00260559|Dysphagia score|dysphagia score
798324|NCT00260559|Heartburn Scale|heartburn scale
798325|NCT00260559|Nutrition Score|nutrition score
798326|NCT00260546|Ventricular dyssynchrony|ventricular dyssynchrony
798327|NCT00260520|Low molecular weight heparin|low molecular weight heparin
798328|NCT00260520|Preeclampsia|preeclampsia
798329|NCT00260520|Fetal Growth Restriction|fetal growth restriction
798330|NCT00260520|Thrombophilia|thrombophilia
798331|NCT00260520|Factor V Leiden|factor v leiden
798332|NCT00260520|G20210A prothrombin gene mutation|g20210a prothrombin gene mutation
798333|NCT00260494|Cardiac Surgical Procedures|cardiac surgical procedures
798334|NCT00260494|open saphenous vein graft harvest wounds|open saphenous vein graft harvest wounds
798335|NCT00260494|Postoperative Complications|postoperative complications
798336|NCT00260494|Surgical Wound Infection|surgical wound infection
798337|NCT00260494|Surgical Wound Dehiscence|surgical wound dehiscence
798338|NCT00260481|Methamphetamine Dependence|methamphetamine dependence
798339|NCT00260481|Pharmacotherapy|pharmacotherapy
798340|NCT00260468|Major depression|major depression
798341|NCT00260468|Magnetic resonance imaging|magnetic resonance imaging
798342|NCT00260468|White matter lesions|white matter lesions
798343|NCT00260468|Perfusion|perfusion
798344|NCT00260468|Diffusion|diffusion
798345|NCT00260468|Magnetization transfer|magnetization transfer
798346|NCT00260468|Vascular risk factors|vascular risk factors
798347|NCT00260442|sarcopenia|sarcopenia
798348|NCT00260442|resistance training|resistance training
798349|NCT00260442|strength training|strength training
798350|NCT00260442|skeletal muscle|skeletal muscle
798351|NCT00260442|elderly|elderly
798352|NCT00260442|cholesterol|cholesterol
798353|NCT00260442|aging|aging
798354|NCT00260442|cardiovascular disease|cardiovascular disease
798355|NCT00260442|nutrition|nutrition
798356|NCT00260442|inflammation|inflammation
798357|NCT00260442|lipids|lipids
798358|NCT00260429|Dupuytren's contracture|dupuytren's contracture
798359|NCT00260429|fixed flexion contracture|fixed flexion contracture
798360|NCT00260416|Acute myocardial infarction|acute myocardial infarction
798361|NCT00260416|Symptom duration|symptom duration
798362|NCT00260416|Primary angioplasty|primary angioplasty
798363|NCT00260416|Infarct size|infarct size
798364|NCT00260416|Myocardial scintigraphy|myocardial scintigraphy
798365|NCT00260390|Dysthymic Disorder|dysthymic disorder
798366|NCT00260390|HPG hypofunctioning|hpg hypofunctioning
798367|NCT00260390|Testosterone replacement|testosterone replacement
798368|NCT00260377|Aspirin treatment|aspirin treatment
798369|NCT00260377|Aspirin resistance|aspirin resistance
798370|NCT00260377|Coronary bypass surgery|coronary bypass surgery
798371|NCT00260364|Recurrent carcinoma of the pancreas|recurrent carcinoma of the pancreas
798372|NCT00260364|Adenocarcinoma of the pancreas|adenocarcinoma of the pancreas
798373|NCT00260364|Stage II carcinoma of the pancreas|stage ii carcinoma of the pancreas
798374|NCT00260364|Stage III carcinoma of the pancreas|stage iii carcinoma of the pancreas
798375|NCT00260364|Stage IVA carcinoma of the pancreas|stage iva carcinoma of the pancreas
798376|NCT00260364|Stage IVB carcinoma of the pancreas|stage ivb carcinoma of the pancreas
798377|NCT00260351|rabies;|rabies;
798378|NCT00260351|rabies post-exposure;|rabies post-exposure;
798379|NCT00260351|category III|category iii
798380|NCT00260338|myocardial ischemia|myocardial ischemia
798381|NCT00260338|stem cell|stem cell
798382|NCT00260338|mesenchymal|mesenchymal
798383|NCT00260338|myocardial perfusion|myocardial perfusion
798384|NCT00260325|pretreatment|pretreatment
798385|NCT00260325|healthy volunteers|healthy volunteers
798386|NCT00260312|inactived|inactived
798387|NCT00260312|polio|polio
798388|NCT00260312|vaccine|vaccine
798389|NCT00260312|cuba|cuba
798390|NCT00260312|trial|trial
798391|NCT00260312|randomized|randomized
798392|NCT00260312|eradication|eradication
798393|NCT00260299|cholesterol defects|cholesterol defects
798394|NCT00260299|Mevalonic Aciduria|mevalonic aciduria
798395|NCT00260299|Mevalonate Kinase Deficiency|mevalonate kinase deficiency
798396|NCT00260299|HIDS|hids
798397|NCT00260299|Hyperimmunoglobulinemia with periodic fever syndrome|hyperimmunoglobulinemia with periodic fever syndrome
798398|NCT00260299|MKD|mkd
798399|NCT00260299|Lipid Metabolism, Inborn Errors|lipid metabolism, inborn errors
798400|NCT00260299|Periodic Fever Syndromes, hereditary|periodic fever syndromes, hereditary
798401|NCT00260299|mevalonic acid|mevalonic acid
798402|NCT00260299|mevalonate kinase|mevalonate kinase
798403|NCT00260299|cholesterol, dietary|cholesterol, dietary
798404|NCT00260299|Hyper IgD|hyper igd
798405|NCT00260299|Multiple malformations|multiple malformations
798406|NCT00260299|Fever|fever
798407|NCT00260286|LH pulsatility|lh pulsatility
798408|NCT00260286|energy availability|energy availability
798409|NCT00260286|exercise|exercise
798410|NCT00260286|diet|diet
798411|NCT00260286|gynecological age|gynecological age
798412|NCT00260273|Preventive Therapy|preventive therapy
798413|NCT00260273|Psychoses|psychoses
798414|NCT00260273|Cognitive Behaviour Therapy|cognitive behaviour therapy
798415|NCT00260247|CYP3A4|cyp3a4
798416|NCT00260247|Induction|induction
798417|NCT00260247|Oxcarbazepine|oxcarbazepine
798418|NCT00260247|Carbamazepine|carbamazepine
798419|NCT00260247|Quinidine|quinidine
798420|NCT00260247|Human|human
798421|NCT00260247|In vivo|in vivo
798422|NCT00260234|Transplantation, Pancreatic Islets|transplantation, pancreatic islets
798423|NCT00260234|Diabetes Mellitus, Type 1|diabetes mellitus, type 1
798424|NCT00260234|Insulin Dependent|insulin dependent
798425|NCT00260234|Islet Transplant|islet transplant
798426|NCT00260221|Virtual Reality Hypnosis|virtual reality hypnosis
798427|NCT00260208|Liver transplant, adults, hepatitis C, liver fibrosis, cyclosporine microemulsion, tacrolimus|liver transplant, adults, hepatitis c, liver fibrosis, cyclosporine microemulsion, tacrolimus
798428|NCT00260195|Trauma|trauma
798429|NCT00260195|Violence|violence
798430|NCT00260195|Adolescent|adolescent
798431|NCT00260195|Schools|schools
798432|NCT00260195|Cognitive behavioral therapy|cognitive behavioral therapy
798433|NCT00260182|Depressive Disorder|depressive disorder
798434|NCT00260182|Family|family
798435|NCT00260182|Genetics|genetics
798436|NCT00260169|Treatment Preferences|treatment preferences
798437|NCT00260169|Public sector|public sector
798438|NCT00260169|Latino|latino
798439|NCT00260156|Type 2 diabetes|type 2 diabetes
798440|NCT00260156|vildagliptin|vildagliptin
798441|NCT00260143|HIV+ men|hiv+ men
798442|NCT00260143|Treatment Experienced|treatment experienced
798443|NCT00260130|obesity|obesity
798444|NCT00260130|food intake|food intake
798445|NCT00260130|human|human
798446|NCT00260130|energy balance|energy balance
798447|NCT00260130|beverage|beverage
798448|NCT00260117|Exercise|exercise
798449|NCT00260117|Physical activity|physical activity
798451|NCT00260117|running|running
798452|NCT00260091|Infertility|infertility
798453|NCT00260091|Advanced maternal age|advanced maternal age
798454|NCT00260091|Pregnancy|pregnancy
798455|NCT00260091|Reproductive health|reproductive health
798456|NCT00260091|Fertility treatment|fertility treatment
798457|NCT00260091|Reproduction|reproduction
798458|NCT00260078|Treatment Experienced|treatment experienced
798459|NCT00260078|Pharmacokinetics|pharmacokinetics
798460|NCT00260078|PK|pk
798461|NCT00260065|Myelodysplastic Syndrome|myelodysplastic syndrome
798462|NCT00260065|Decitabine|decitabine
798463|NCT00260065|Dacogen|dacogen
798464|NCT00260065|MGI Pharma|mgi pharma
798465|NCT00260052|traumatic brain injury|traumatic brain injury
798466|NCT00260026|Lung Cancer|lung cancer
798467|NCT00260013|chronic mental illness|chronic mental illness
798468|NCT00260000|mild PKU|mild pku
798469|NCT00260000|Y414C|y414c
798470|NCT00260000|5,6,7,8-tetrahydrobiopterin, BH4|5,6,7,8-tetrahydrobiopterin, bh4
798471|NCT00260000|treatment without protein restriction|treatment without protein restriction
798472|NCT00259987|relapsed adenocarcinoma|relapsed adenocarcinoma
798473|NCT00259987|esophagus|esophagus
798474|NCT00259987|tumors|tumors
798475|NCT00259987|GE junction|ge junction
798476|NCT00259987|cancer|cancer
798477|NCT00259987|lapatinib|lapatinib
798478|NCT00259987|gastric cardia|gastric cardia
798479|NCT00259974|Anti-MAG monoclonal gammopathy|anti-mag monoclonal gammopathy
798480|NCT00259974|Polyneuropathy|polyneuropathy
798481|NCT00259974|Rituximab|rituximab
798482|NCT00259948|HR variability, CVA, Myocardial infarction, aerobic exercise training|hr variability, cva, myocardial infarction, aerobic exercise training
798483|NCT00259935|Any Solid Tumor|any solid tumor
798484|NCT00259922|constipation|constipation
798485|NCT00259922|gastrointestinal|gastrointestinal
798486|NCT00259922|opioids|opioids
798487|NCT00259922|pain|pain
798488|NCT00259922|non-cancer pain|non-cancer pain
798489|NCT00259922|opioid-induced|opioid-induced
798490|NCT00259922|bowel dysfunction|bowel dysfunction
798491|NCT00259909|Patient reported outcomes|patient reported outcomes
798492|NCT00259909|COPD|copd
798493|NCT00259909|acute exacerbation of chronic obstructive pulmonary disease (AECOPD)|acute exacerbation of chronic obstructive pulmonary disease (aecopd)
798494|NCT00259896|exenatide|exenatide
798495|NCT00259896|pharmacokinetics|pharmacokinetics
798496|NCT00259896|pharmacodynamics|pharmacodynamics
798497|NCT00259883|depressive episodes|depressive episodes
798498|NCT00259883|paroxetine|paroxetine
798499|NCT00259883|PAXIL|paxil
798500|NCT00259883|depression|depression
798501|NCT00259883|benzodiazepine|benzodiazepine
798502|NCT00259883|combination|combination
798503|NCT00259870|Schizophrenia|schizophrenia
798508|NCT00259857|Bone Mineral Density|bone mineral density
798509|NCT00259857|DXA|dxa
798510|NCT00259844|Colorectal|colorectal
798511|NCT00259844|Liver Metastases|liver metastases
798512|NCT00259844|Vaccine|vaccine
798513|NCT00259844|Colorectal Liver Metastases|colorectal liver metastases
798514|NCT00259831|cold|cold
798515|NCT00259831|influenza|influenza
798516|NCT00259818|Refractory|refractory
798517|NCT00259818|Solid Tumors|solid tumors
798518|NCT00259805|encephalitis|encephalitis
798519|NCT00259805|epilepsy|epilepsy
798520|NCT00259805|Rasmussens|rasmussens
798521|NCT00259805|rituximab|rituximab
798522|NCT00259805|autoimmune|autoimmune
798523|NCT00259779|COPD|copd
798524|NCT00259753|Wet Age-Related Macular Degeneration|wet age-related macular degeneration
798525|NCT00259740|Multiple Myeloma, Relapsed, Plateau-Phase|multiple myeloma, relapsed, plateau-phase
798526|NCT00259727|Amprenavir|amprenavir
798527|NCT00259727|Glucagon|glucagon
798528|NCT00259727|HIV Protease inhibitors|hiv protease inhibitors
798529|NCT00259727|Indinavir|indinavir
798530|NCT00259727|Lopinavir|lopinavir
798531|NCT00259727|Ritonavir|ritonavir
798532|NCT00259714|hypertension|hypertension
798533|NCT00259714|hemodialysis|hemodialysis
798534|NCT00259714|sodium|sodium
798535|NCT00259714|dialysate|dialysate
798536|NCT00259714|hemodynamics|hemodynamics
798537|NCT00259701|endothelium|endothelium
798538|NCT00259701|iontophoresis|iontophoresis
798539|NCT00259701|acetylcholine|acetylcholine
798540|NCT00259701|nitroglycerin|nitroglycerin
798541|NCT00259701|vasodilation|vasodilation
798542|NCT00259688|Preeclampsia|preeclampsia
798543|NCT00259688|Sleep Apnea|sleep apnea
798544|NCT00259688|CPAP|cpap
798545|NCT00259662|cancer--ovarian|cancer--ovarian
798546|NCT00259662|cancer--endometria|cancer--endometria
798547|NCT00259662|deep vein thrombosis|deep vein thrombosis
798548|NCT00259662|statin therapy in perioperative period|statin therapy in perioperative period
798549|NCT00259623|Cardiac surgery|cardiac surgery
798550|NCT00259623|Radiofrequency ablation|radiofrequency ablation
798551|NCT00259623|Atrial fibrillation|atrial fibrillation
798552|NCT00259610|RA|ra
798553|NCT00259610|painful joints|painful joints
798554|NCT00259610|swollen joints|swollen joints
798555|NCT00259597|nuclear morphology|nuclear morphology
798556|NCT00259597|image analysis|image analysis
798557|NCT00259597|lipid peroxidation|lipid peroxidation
798558|NCT00259597|diet|diet
798559|NCT00259597|proliferative breast disease|proliferative breast disease
798560|NCT00259571|remission|remission
798561|NCT00259571|mesalazin|mesalazin
798562|NCT00259571|non-inferiority study|non-inferiority study
798563|NCT00259571|relapse|relapse
798564|NCT00259558|Ulcerative Colitis|ulcerative colitis
798565|NCT00259558|Dose Finding|dose finding
798566|NCT00259558|Phosphatidylcholine|phosphatidylcholine
798567|NCT00259545|retarded phosphatidylcholine|retarded phosphatidylcholine
798568|NCT00259545|chronic active|chronic active
798569|NCT00259545|steroid|steroid
798570|NCT00259519|premature or preterm birth|premature or preterm birth
798571|NCT00259519|chorioamnionitis|chorioamnionitis
798572|NCT00259519|neonatal sepsis|neonatal sepsis
798573|NCT00259519|labour|labour
798574|NCT00259519|Cesarean Section|cesarean section
798575|NCT00259519|delivery|delivery
798576|NCT00259519|length of stay|length of stay
798577|NCT00259519|pregnancy|pregnancy
798578|NCT00259506|Recurrent depression|recurrent depression
798579|NCT00259506|Mental Health|mental health
798580|NCT00259493|Coronary Artery Disease|coronary artery disease
798581|NCT00259493|Coronary Artery Bypass Graft Surgery|coronary artery bypass graft surgery
798582|NCT00259493|Off-pump CABG|off-pump cabg
798583|NCT00259493|Cardiac CT|cardiac ct
798584|NCT00259493|Bypass Graft CT angiography|bypass graft ct angiography
798585|NCT00259467|Activity, Dementia, Caregiving|activity, dementia, caregiving
798586|NCT00259454|Caregivers|caregivers
798587|NCT00259454|in-home care occupational therapy|in-home care occupational therapy
798588|NCT00259441|Kidney failure|kidney failure
798589|NCT00259441|Contrast media|contrast media
798590|NCT00259441|Prevention|prevention
798591|NCT00259441|Simvastatin|simvastatin
798592|NCT00259428|Atrial Fibrillation|atrial fibrillation
798593|NCT00259428|Atrial Flutter|atrial flutter
798594|NCT00259428|Arrhythmia|arrhythmia
798595|NCT00259428|Anti-Arrhythmia agents|anti-arrhythmia agents
798596|NCT00259415|Support groups|support groups
798597|NCT00259415|Alzheimer's Disease|alzheimer's disease
798598|NCT00259389|Treatment Experienced|treatment experienced
798599|NCT00259389|Adherence|adherence
798600|NCT00259389|Compliance|compliance
798601|NCT00259389|Directly Observed Therapy|directly observed therapy
798602|NCT00259389|DOT|dot
798603|NCT00259389|Treatment Naive|treatment naive
798604|NCT00259376|Atrial Fibrillation|atrial fibrillation
798605|NCT00259376|Atrial Flutter|atrial flutter
798606|NCT00259376|Arrhythmia|arrhythmia
798607|NCT00259376|Anti-Arrhythmia agents|anti-arrhythmia agents
798608|NCT00259350|Central venous catheter|central venous catheter
798609|NCT00259350|Skin disinfection|skin disinfection
798610|NCT00259350|Antisepsis|antisepsis
799066|NCT00257673|Alzheimer's|alzheimer's
798611|NCT00259350|Nosocomial infection|nosocomial infection
798612|NCT00259350|Catheter infection|catheter infection
798613|NCT00259337|Diphteria|diphteria
798614|NCT00259337|Tetanus|tetanus
798615|NCT00259337|Polio|polio
798616|NCT00259337|Acellular Pertussis|acellular pertussis
798617|NCT00259337|Hib|hib
798618|NCT00259337|Haemophilus influenzae type B|haemophilus influenzae type b
798619|NCT00259259|Appetite regulation|appetite regulation
798620|NCT00259259|Hormones|hormones
798621|NCT00259259|Energy intake|energy intake
798622|NCT00259220|Bleeding|bleeding
798623|NCT00259220|Endoscopy|endoscopy
798624|NCT00259220|Gastric tube|gastric tube
798625|NCT00259220|Erythromycin|erythromycin
798626|NCT00259220|Randomized|randomized
798627|NCT00259207|Pulmonary valve regurgitation|pulmonary valve regurgitation
798628|NCT00259207|Valve replacement|valve replacement
798629|NCT00259207|Hybrid procedure|hybrid procedure
798630|NCT00259194|Coronary angiography|coronary angiography
798631|NCT00259194|Complications|complications
798632|NCT00259194|Observation|observation
798633|NCT00259181|chlorhexidine gluconate|chlorhexidine gluconate
798634|NCT00259181|polymethylmethacrylate|polymethylmethacrylate
798635|NCT00259181|Anti-Bacterial Agents|anti-bacterial agents
798636|NCT00259168|Postprandial endothelial function|postprandial endothelial function
798637|NCT00259155|Irritable bowel syndrome, Bacterial overgrowth|irritable bowel syndrome, bacterial overgrowth
798638|NCT00259142|home management of fever, malaria, Uganda|home management of fever, malaria, uganda
798639|NCT00259116|Congestive heart failure|congestive heart failure
798640|NCT00259116|Relaxin|relaxin
798641|NCT00259116|Cardiac hemodynamics|cardiac hemodynamics
798642|NCT00259103|relaxin|relaxin
798643|NCT00259103|pregnancy|pregnancy
798644|NCT00259103|cervical ripening|cervical ripening
798645|NCT00259103|normal pregnancy at least at 40 weeks of gestation|normal pregnancy at least at 40 weeks of gestation
798646|NCT00259038|Carperitide|carperitide
798647|NCT00259038|Atrial Natriuretic Peptide|atrial natriuretic peptide
798648|NCT00259038|Treatment efficacy|treatment efficacy
798649|NCT00259038|Safety|safety
798650|NCT00259038|Heart failure, Congestive|heart failure, congestive
798651|NCT00259038|Pulmonary Artery Catheterization|pulmonary artery catheterization
798652|NCT00259025|Renal failure, chronic|renal failure, chronic
798653|NCT00259025|Death, sudden, cardiac|death, sudden, cardiac
798654|NCT00259025|Heart rate variability|heart rate variability
798655|NCT00259025|Tachycardia, ventricular|tachycardia, ventricular
798656|NCT00259025|Ventricular premature complexes|ventricular premature complexes
798657|NCT00259025|Ventricular repolarization|ventricular repolarization
798658|NCT00259025|Eicosapentaenoic acid|eicosapentaenoic acid
798659|NCT00259025|Docosahexaenoic acid|docosahexaenoic acid
798660|NCT00259012|GERD|gerd
798661|NCT00259012|Infant|infant
798662|NCT00258999|Skin Cholesterol|skin cholesterol
798663|NCT00258999|Carotid Plaque|carotid plaque
798664|NCT00258999|Carotid Intima-Media Thickness|carotid intima-media thickness
798665|NCT00258986|Living donors|living donors
798666|NCT00258986|Nephrectomy|nephrectomy
798667|NCT00258986|Kidney transplantation|kidney transplantation
798668|NCT00258986|Randomized Controlled Trial|randomized controlled trial
798669|NCT00258986|Laparoscopy|laparoscopy
798670|NCT00258973|Hand held Ultrasound|hand held ultrasound
798671|NCT00258973|Office practice|office practice
798672|NCT00258973|Atherosclerosis prevention|atherosclerosis prevention
798673|NCT00258973|Ultrasound training|ultrasound training
798674|NCT00258960|HER2 positive breast cancer|her2 positive breast cancer
798675|NCT00258960|Metastatic breast cancer|metastatic breast cancer
798676|NCT00258947|Smallpox|smallpox
798677|NCT00258947|Orthopoxvirus|orthopoxvirus
798678|NCT00258947|Poxvirus|poxvirus
798679|NCT00258947|Vaccina Virus|vaccina virus
798680|NCT00258947|LISTER Strain|lister strain
798681|NCT00258947|Bioterrorism|bioterrorism
798682|NCT00258934|Influenza|influenza
798683|NCT00258934|Orthomyxoviruses|orthomyxoviruses
798684|NCT00258934|Inactivated|inactivated
798685|NCT00258934|Split-virion influenza vaccine|split-virion influenza vaccine
798686|NCT00258934|adults|adults
798687|NCT00258934|Myxovirus Infection|myxovirus infection
798688|NCT00258934|Orthomyxovirus Infection|orthomyxovirus infection
798689|NCT00258908|ADACEL™|adacel™
798690|NCT00258908|Tetanus|tetanus
798691|NCT00258908|Diphteria|diphteria
798692|NCT00258908|Acellular pertussis|acellular pertussis
798693|NCT00258895|DAPTACEL®|daptacel®
798694|NCT00258895|Pentacel™|pentacel™
798695|NCT00258895|Diphtheria|diphtheria
798696|NCT00258895|Tetanus|tetanus
798697|NCT00258895|Pertussis|pertussis
798698|NCT00258895|Whooping cough|whooping cough
798699|NCT00258895|Acellular Pertussis Vaccine Adsorbed|acellular pertussis vaccine adsorbed
798700|NCT00258882|Tetanus Toxoid,|tetanus toxoid,
798701|NCT00258882|acellular pertussis,|acellular pertussis,
798702|NCT00258882|diphtheria toxoid|diphtheria toxoid
798703|NCT00258869|prospective studies|prospective studies
798704|NCT00258869|biological assay|biological assay
798705|NCT00258869|body weights and measures|body weights and measures
798706|NCT00258869|chemistry, analytical|chemistry, analytical
798707|NCT00258869|microchip analytical procedures|microchip analytical procedures
798708|NCT00258869|spectrum analysis, mass|spectrum analysis, mass
798709|NCT00258869|molecular diagnostic techniques|molecular diagnostic techniques
798710|NCT00258869|microbiological techniques|microbiological techniques
798711|NCT00258869|drug administration schedule|drug administration schedule
798712|NCT00258869|data collection|data collection
798713|NCT00258869|statistics|statistics
798714|NCT00258869|gene expression profiling|gene expression profiling
798715|NCT00258869|sequence analysis|sequence analysis
798716|NCT00258869|human experimentation|human experimentation
798717|NCT00258869|immunoassay|immunoassay
798718|NCT00258869|Trauma severity indices|trauma severity indices
798719|NCT00258869|Glasgow Coma score|glasgow coma score
798720|NCT00258869|Outcome assessment|outcome assessment
798721|NCT00258869|mortality|mortality
798722|NCT00258869|computer models|computer models
798723|NCT00258869|decision modeling|decision modeling
798724|NCT00258869|linear models|linear models
798725|NCT00258869|logistic models|logistic models
798726|NCT00258869|immunologic model|immunologic model
798727|NCT00258869|mathematical model|mathematical model
798728|NCT00258869|non-linear models|non-linear models
798729|NCT00258869|early diagnosis|early diagnosis
798730|NCT00258869|diagnosis, computer assisted|diagnosis, computer assisted
798731|NCT00258869|medical informatics|medical informatics
798732|NCT00258869|prognosis|prognosis
798733|NCT00258869|registries|registries
798734|NCT00258869|computational biology|computational biology
798735|NCT00258869|systems biology|systems biology
798736|NCT00258856|Meningitis|meningitis
798737|NCT00258856|Meningococcal infection|meningococcal infection
798738|NCT00258856|Neisseria meningitidis|neisseria meningitidis
798739|NCT00258856|Menactra®|menactra®
798740|NCT00258856|Menomune®|menomune®
798741|NCT00258843|IMOVAX;|imovax;
798742|NCT00258843|poliomyelitis|poliomyelitis
798743|NCT00258830|Influenza vaccine|influenza vaccine
798744|NCT00258817|Fluzone®|fluzone®
798745|NCT00258817|Influenza Virus Vaccine|influenza virus vaccine
798746|NCT00258791|Psychiatric disorders|psychiatric disorders
798748|NCT00258791|Headache|headache
798749|NCT00258791|Ibuprofen|ibuprofen
798750|NCT00258765|zoledronic acid|zoledronic acid
798751|NCT00258765|prostate cancer|prostate cancer
798752|NCT00258765|high risk|high risk
798753|NCT00258765|PSA|psa
798754|NCT00258765|docetaxel|docetaxel
798755|NCT00258752|Prevention|prevention
798756|NCT00258752|Adolescent|adolescent
798757|NCT00258726|Measels, Mumps, Varicella, Rubella, vaccine, children|measels, mumps, varicella, rubella, vaccine, children
798758|NCT00258713|Randomized Controlled Trials|randomized controlled trials
798759|NCT00258713|Immunosuppression|immunosuppression
798760|NCT00258713|Adult|adult
798761|NCT00258713|Chronic Disease|chronic disease
798762|NCT00258713|Dermatologic Agents|dermatologic agents
798763|NCT00258713|Female|female
798764|NCT00258713|Humans|humans
798765|NCT00258713|Male|male
798766|NCT00258713|Middle Aged|middle aged
798767|NCT00258713|Severity of Illness Index|severity of illness index
798768|NCT00258713|Treatment Outcome|treatment outcome
798769|NCT00258713|Quality of Life|quality of life
798770|NCT00258713|Double-Blind Method|double-blind method
798771|NCT00258687|GVAX|gvax
798772|NCT00258687|GM-CSF|gm-csf
798773|NCT00258687|Adenoviral mediated gene transfer|adenoviral mediated gene transfer
798774|NCT00258687|Pediatric Melanoma|pediatric melanoma
798775|NCT00258674|Diabetes|diabetes
798776|NCT00258674|Care coordination|care coordination
798777|NCT00258674|Case management|case management
798778|NCT00258674|Physician profiling|physician profiling
798779|NCT00258661|Pneumonia|pneumonia
798780|NCT00258661|Osteopathic|osteopathic
798781|NCT00258661|Manipulation|manipulation
798782|NCT00258661|Multi-center|multi-center
798783|NCT00258661|Elderly|elderly
798784|NCT00258635|Allergy|allergy
798785|NCT00258635|Specific Immunotherapy|specific immunotherapy
798786|NCT00258622|Peripheral neuropathic pain|peripheral neuropathic pain
798787|NCT00258622|Neuropathic pain|neuropathic pain
798788|NCT00258622|Chronic pain|chronic pain
798789|NCT00258609|Botulinum toxin type A,|botulinum toxin type a,
798790|NCT00258609|Dysport®,Dysport|dysport®,dysport
798791|NCT00258609|Migraine without aura,|migraine without aura,
798792|NCT00258609|Migraine prophylaxis.|migraine prophylaxis.
798793|NCT00258596|drug-eluting stent|drug-eluting stent
798794|NCT00258596|chronic total occlusion|chronic total occlusion
798795|NCT00258596|sirolimus-eluting stent|sirolimus-eluting stent
798796|NCT00258596|zotarolimus-eluting stent|zotarolimus-eluting stent
798797|NCT00258596|QCA|qca
798798|NCT00258583|"Lung[A04.400]"|"lung[a04.400]"
798799|NCT00258570|"Lung[A04.400]"|"lung[a04.400]"
798800|NCT00258557|HIV|hiv
798801|NCT00258557|Anti-Retroviral agents|anti-retroviral agents
798802|NCT00258557|HIV-1|hiv-1
798803|NCT00258557|TMC114/r|tmc114/r
798804|NCT00258557|Treatment naïve patients|treatment naïve patients
798805|NCT00258544|Lung|lung
798806|NCT00258544|Fibrosis|fibrosis
798807|NCT00258544|Idiopathic|idiopathic
798808|NCT00258544|Microarray|microarray
798809|NCT00258544|Tissue|tissue
798810|NCT00258544|Biopsy|biopsy
798811|NCT00258518|Critically ill patients|critically ill patients
798812|NCT00258505|Spreading depression|spreading depression
798813|NCT00258505|Seizures|seizures
798814|NCT00258505|Blood-brain barrier|blood-brain barrier
798815|NCT00258492|Restless legs syndrome|restless legs syndrome
798816|NCT00258492|Insomnia|insomnia
798817|NCT00258492|Daytime sleepiness|daytime sleepiness
798818|NCT00258492|Exercise|exercise
798819|NCT00258479|Nicotine Dependence|nicotine dependence
798820|NCT00258479|Nicotine Use Disorder|nicotine use disorder
798821|NCT00258479|Tobacco Dependence|tobacco dependence
798822|NCT00258466|adenocarcinoma of the prostate|adenocarcinoma of the prostate
798823|NCT00258466|stage I prostate cancer|stage i prostate cancer
798824|NCT00258466|stage II prostate cancer|stage ii prostate cancer
798825|NCT00258466|stage III prostate cancer|stage iii prostate cancer
798826|NCT00258453|psychosocial effects of cancer and its treatment|psychosocial effects of cancer and its treatment
798827|NCT00258453|long-term effects secondary to cancer therapy in children|long-term effects secondary to cancer therapy in children
798828|NCT00258453|perioperative/postoperative complications|perioperative/postoperative complications
798829|NCT00258453|weight changes|weight changes
798830|NCT00258453|childhood craniopharyngioma|childhood craniopharyngioma
798831|NCT00258440|fatigue|fatigue
798832|NCT00258440|anemia|anemia
798833|NCT00258440|unspecified adult solid tumor, protocol specific|unspecified adult solid tumor, protocol specific
798834|NCT00258427|Fanconi anemia|fanconi anemia
798835|NCT00258401|diarrhea|diarrhea
798836|NCT00258401|radiation toxicity|radiation toxicity
798837|NCT00258401|recurrent uterine sarcoma|recurrent uterine sarcoma
798838|NCT00258401|stage I uterine sarcoma|stage i uterine sarcoma
798839|NCT00258401|stage II uterine sarcoma|stage ii uterine sarcoma
798840|NCT00258401|stage III uterine sarcoma|stage iii uterine sarcoma
798841|NCT00258401|stage IV uterine sarcoma|stage iv uterine sarcoma
798842|NCT00258401|recurrent prostate cancer|recurrent prostate cancer
798843|NCT00258401|stage I prostate cancer|stage i prostate cancer
798844|NCT00258401|stage II prostate cancer|stage ii prostate cancer
798845|NCT00258401|stage III prostate cancer|stage iii prostate cancer
798846|NCT00258401|stage IV prostate cancer|stage iv prostate cancer
798847|NCT00258401|recurrent cervical cancer|recurrent cervical cancer
798848|NCT00258401|stage 0 cervical cancer|stage 0 cervical cancer
798849|NCT00258401|stage IA cervical cancer|stage ia cervical cancer
798850|NCT00258401|stage IB cervical cancer|stage ib cervical cancer
798851|NCT00258401|stage IIA cervical cancer|stage iia cervical cancer
798852|NCT00258401|stage IIB cervical cancer|stage iib cervical cancer
798853|NCT00258401|stage III cervical cancer|stage iii cervical cancer
798854|NCT00258401|stage IVA cervical cancer|stage iva cervical cancer
798855|NCT00258401|stage IVB cervical cancer|stage ivb cervical cancer
798856|NCT00258388|adenocarcinoma of the prostate|adenocarcinoma of the prostate
798857|NCT00258388|recurrent prostate cancer|recurrent prostate cancer
798858|NCT00258388|stage IV prostate cancer|stage iv prostate cancer
798859|NCT00258375|stage IIIA breast cancer|stage iiia breast cancer
798860|NCT00258375|stage IIIB breast cancer|stage iiib breast cancer
798861|NCT00258375|stage IIIC breast cancer|stage iiic breast cancer
798862|NCT00258375|stage IV breast cancer|stage iv breast cancer
798863|NCT00258375|recurrent breast cancer|recurrent breast cancer
798864|NCT00258362|recurrent endometrial carcinoma|recurrent endometrial carcinoma
798865|NCT00258362|stage III endometrial carcinoma|stage iii endometrial carcinoma
798866|NCT00258362|stage IV endometrial carcinoma|stage iv endometrial carcinoma
798867|NCT00258336|recurrent grade 1 follicular lymphoma|recurrent grade 1 follicular lymphoma
798868|NCT00258336|recurrent grade 2 follicular lymphoma|recurrent grade 2 follicular lymphoma
798869|NCT00258336|stage III grade 1 follicular lymphoma|stage iii grade 1 follicular lymphoma
798870|NCT00258336|stage III grade 2 follicular lymphoma|stage iii grade 2 follicular lymphoma
798871|NCT00258336|stage IV grade 1 follicular lymphoma|stage iv grade 1 follicular lymphoma
798872|NCT00258336|stage IV grade 2 follicular lymphoma|stage iv grade 2 follicular lymphoma
798873|NCT00258336|contiguous stage II grade 1 follicular lymphoma|contiguous stage ii grade 1 follicular lymphoma
798874|NCT00258336|contiguous stage II grade 2 follicular lymphoma|contiguous stage ii grade 2 follicular lymphoma
798875|NCT00258336|noncontiguous stage II grade 1 follicular lymphoma|noncontiguous stage ii grade 1 follicular lymphoma
798876|NCT00258336|noncontiguous stage II grade 2 follicular lymphoma|noncontiguous stage ii grade 2 follicular lymphoma
798877|NCT00258336|stage I grade 1 follicular lymphoma|stage i grade 1 follicular lymphoma
798878|NCT00258336|stage I grade 2 follicular lymphoma|stage i grade 2 follicular lymphoma
798879|NCT00258323|adenocarcinoma of the esophagus|adenocarcinoma of the esophagus
798880|NCT00258323|squamous cell carcinoma of the esophagus|squamous cell carcinoma of the esophagus
798881|NCT00258323|stage II esophageal cancer|stage ii esophageal cancer
798882|NCT00258323|stage III esophageal cancer|stage iii esophageal cancer
798883|NCT00258323|stage IV esophageal cancer|stage iv esophageal cancer
798884|NCT00258310|stage I squamous cell carcinoma of the hypopharynx|stage i squamous cell carcinoma of the hypopharynx
798885|NCT00258310|stage I squamous cell carcinoma of the larynx|stage i squamous cell carcinoma of the larynx
798886|NCT00258310|stage I squamous cell carcinoma of the lip and oral cavity|stage i squamous cell carcinoma of the lip and oral cavity
798887|NCT00258310|stage I squamous cell carcinoma of the nasopharynx|stage i squamous cell carcinoma of the nasopharynx
798888|NCT00258310|stage I squamous cell carcinoma of the oropharynx|stage i squamous cell carcinoma of the oropharynx
798889|NCT00258310|stage II squamous cell carcinoma of the hypopharynx|stage ii squamous cell carcinoma of the hypopharynx
798890|NCT00258310|stage II squamous cell carcinoma of the larynx|stage ii squamous cell carcinoma of the larynx
798891|NCT00258310|stage II squamous cell carcinoma of the lip and oral cavity|stage ii squamous cell carcinoma of the lip and oral cavity
798892|NCT00258310|stage II squamous cell carcinoma of the nasopharynx|stage ii squamous cell carcinoma of the nasopharynx
798893|NCT00258310|stage II squamous cell carcinoma of the oropharynx|stage ii squamous cell carcinoma of the oropharynx
798894|NCT00258310|stage III squamous cell carcinoma of the hypopharynx|stage iii squamous cell carcinoma of the hypopharynx
798895|NCT00258310|stage III squamous cell carcinoma of the larynx|stage iii squamous cell carcinoma of the larynx
798896|NCT00258310|stage III squamous cell carcinoma of the lip and oral cavity|stage iii squamous cell carcinoma of the lip and oral cavity
798897|NCT00258310|stage III squamous cell carcinoma of the nasopharynx|stage iii squamous cell carcinoma of the nasopharynx
798898|NCT00258310|stage III squamous cell carcinoma of the oropharynx|stage iii squamous cell carcinoma of the oropharynx
798899|NCT00258310|stage IV squamous cell carcinoma of the hypopharynx|stage iv squamous cell carcinoma of the hypopharynx
798900|NCT00258310|stage IV squamous cell carcinoma of the larynx|stage iv squamous cell carcinoma of the larynx
798901|NCT00258310|stage IV squamous cell carcinoma of the lip and oral cavity|stage iv squamous cell carcinoma of the lip and oral cavity
798902|NCT00258310|stage IV squamous cell carcinoma of the nasopharynx|stage iv squamous cell carcinoma of the nasopharynx
798903|NCT00258310|stage IV squamous cell carcinoma of the oropharynx|stage iv squamous cell carcinoma of the oropharynx
798904|NCT00258297|stage I esophageal cancer|stage i esophageal cancer
798905|NCT00258297|stage II esophageal cancer|stage ii esophageal cancer
798906|NCT00258297|stage III esophageal cancer|stage iii esophageal cancer
798907|NCT00258297|adenocarcinoma of the esophagus|adenocarcinoma of the esophagus
798908|NCT00258297|squamous cell carcinoma of the esophagus|squamous cell carcinoma of the esophagus
798909|NCT00258284|recurrent prostate cancer|recurrent prostate cancer
798910|NCT00258284|stage IV prostate cancer|stage iv prostate cancer
798911|NCT00258284|adenocarcinoma of the prostate|adenocarcinoma of the prostate
798912|NCT00258271|recurrent adult acute myeloid leukemia|recurrent adult acute myeloid leukemia
798913|NCT00258271|adult acute basophilic leukemia|adult acute basophilic leukemia
798914|NCT00258271|adult acute eosinophilic leukemia|adult acute eosinophilic leukemia
798915|NCT00258271|adult acute megakaryoblastic leukemia (M7)|adult acute megakaryoblastic leukemia (m7)
798916|NCT00258271|adult acute myeloblastic leukemia with maturation (M2)|adult acute myeloblastic leukemia with maturation (m2)
798917|NCT00258271|adult acute myelomonocytic leukemia (M4)|adult acute myelomonocytic leukemia (m4)
798918|NCT00258271|adult acute monoblastic leukemia (M5a)|adult acute monoblastic leukemia (m5a)
798919|NCT00258271|adult acute monocytic leukemia (M5b)|adult acute monocytic leukemia (m5b)
798920|NCT00258271|adult acute myeloblastic leukemia without maturation (M1)|adult acute myeloblastic leukemia without maturation (m1)
798921|NCT00258271|adult erythroleukemia (M6a)|adult erythroleukemia (m6a)
798922|NCT00258271|adult pure erythroid leukemia (M6b)|adult pure erythroid leukemia (m6b)
798923|NCT00258271|blastic phase chronic myelogenous leukemia|blastic phase chronic myelogenous leukemia
798924|NCT00258271|relapsing chronic myelogenous leukemia|relapsing chronic myelogenous leukemia
798925|NCT00258258|refractory multiple myeloma|refractory multiple myeloma
798926|NCT00258245|stage II multiple myeloma|stage ii multiple myeloma
798927|NCT00258245|stage III multiple myeloma|stage iii multiple myeloma
798928|NCT00258245|refractory multiple myeloma|refractory multiple myeloma
798929|NCT00258245|stage I multiple myeloma|stage i multiple myeloma
798930|NCT00258232|adenocarcinoma of the colon|adenocarcinoma of the colon
798931|NCT00258232|adenocarcinoma of the rectum|adenocarcinoma of the rectum
798932|NCT00258232|recurrent colon cancer|recurrent colon cancer
798933|NCT00258232|recurrent rectal cancer|recurrent rectal cancer
798934|NCT00258232|stage IV colon cancer|stage iv colon cancer
798935|NCT00258232|stage IV rectal cancer|stage iv rectal cancer
798936|NCT00258206|stage I multiple myeloma|stage i multiple myeloma
798937|NCT00258206|stage II multiple myeloma|stage ii multiple myeloma
798938|NCT00258206|stage III multiple myeloma|stage iii multiple myeloma
798939|NCT00258206|refractory multiple myeloma|refractory multiple myeloma
798940|NCT00258193|C-IBS|c-ibs
798941|NCT00258193|IBS-C|ibs-c
798942|NCT00258193|Constipation-predominant Irritable Bowel Syndrome|constipation-predominant irritable bowel syndrome
798943|NCT00258193|Constipation Predominant Irritable Bowel Syndrome|constipation predominant irritable bowel syndrome
798944|NCT00258193|Irritable Bowel Syndrome|irritable bowel syndrome
798945|NCT00258193|IBS|ibs
798946|NCT00258193|Transit|transit
798947|NCT00258193|Scintigraphy|scintigraphy
798948|NCT00258193|Gastroenterology|gastroenterology
798949|NCT00258193|Gastrointestinal|gastrointestinal
798950|NCT00258193|GC|gc
798951|NCT00258193|MD-1100 Acetate|md-1100 acetate
798952|NCT00258193|MD-1100|md-1100
798953|NCT00258193|linaclotide|linaclotide
798954|NCT00258193|linaclotide acetate|linaclotide acetate
798955|NCT00258180|unspecified childhood solid tumor, protocol specific|unspecified childhood solid tumor, protocol specific
798956|NCT00258180|gastrointestinal complications|gastrointestinal complications
798957|NCT00258180|diarrhea|diarrhea
798958|NCT00258167|Family members|family members
798959|NCT00258167|Illness burden|illness burden
798960|NCT00258167|Mental Disorders|mental disorders
798961|NCT00258167|Family intervention|family intervention
798962|NCT00258115|Obesity|obesity
798963|NCT00258115|Metabolic Syndrome|metabolic syndrome
798964|NCT00258115|Diabetes|diabetes
798965|NCT00258115|Inflammation|inflammation
798966|NCT00258102|levofloxacin|levofloxacin
798967|NCT00258102|urinary tract infections|urinary tract infections
798968|NCT00258102|bacterial infections|bacterial infections
798969|NCT00258102|bacteriuria|bacteriuria
798970|NCT00258102|urinary anti-infective agents|urinary anti-infective agents
798971|NCT00258102|urinary infections|urinary infections
798972|NCT00258102|quinolones|quinolones
798973|NCT00258089|levofloxacin|levofloxacin
798974|NCT00258089|urinary tract infections|urinary tract infections
798975|NCT00258089|bacterial infections|bacterial infections
798976|NCT00258089|bacteriuria|bacteriuria
798977|NCT00258089|urinary anti-infective agents|urinary anti-infective agents
798978|NCT00258089|urinary infections|urinary infections
798979|NCT00258089|quinolones|quinolones
798980|NCT00258076|Transdermal contraception|transdermal contraception
798981|NCT00258076|contraceptive|contraceptive
798982|NCT00258076|hormonal, steroid contraception|hormonal, steroid contraception
798983|NCT00258076|ethinyl estradiol|ethinyl estradiol
798984|NCT00258076|progesterone|progesterone
798985|NCT00258076|EVRA|evra
798986|NCT00258063|Transdermal contraception|transdermal contraception
798987|NCT00258063|contraceptive|contraceptive
798988|NCT00258063|hormonal, steroid contraception|hormonal, steroid contraception
798989|NCT00258063|ethinyl estradiol|ethinyl estradiol
798990|NCT00258063|progesterone|progesterone
798991|NCT00258063|EVRA|evra
798992|NCT00258063|CILEST|cilest
798993|NCT00258063|ORTHO EVRA|ortho evra
798994|NCT00258050|midazolam|midazolam
798995|NCT00258050|pharmacokinetics|pharmacokinetics
798996|NCT00258050|lapatinib|lapatinib
798997|NCT00258037|Physiotherapy|physiotherapy
798998|NCT00258037|Stroke|stroke
798999|NCT00258037|Urinary Incontinence|urinary incontinence
799000|NCT00258037|quality of Life|quality of life
799001|NCT00258024|IPT-SP, pregnancy, malaria,Ghana|ipt-sp, pregnancy, malaria,ghana
799002|NCT00258011|MPS I Disease|mps i disease
799003|NCT00257985|Familial hemiplegic migraine type 1 and 2|familial hemiplegic migraine type 1 and 2
799004|NCT00257985|GTN|gtn
799005|NCT00257985|middle cerebral artery|middle cerebral artery
799006|NCT00257985|superficial temporal artery|superficial temporal artery
799007|NCT00257985|headache|headache
799008|NCT00257985|genotype|genotype
799009|NCT00257972|Bipolar Mania|bipolar mania
799010|NCT00257946|Diaphragm|diaphragm
799011|NCT00257946|Hernia|hernia
799012|NCT00257946|Congenital|congenital
799013|NCT00257933|Corticosteroids|corticosteroids
799014|NCT00257933|Treatment|treatment
799015|NCT00257933|Pediatric|pediatric
799016|NCT00257920|Stage 5 Chronic Kidney Disease (CKD)|stage 5 chronic kidney disease (ckd)
799017|NCT00257907|Latent Tuberculosis|latent tuberculosis
799018|NCT00257907|PPD|ppd
799019|NCT00257907|Antigen Specific T-Cells|antigen specific t-cells
799020|NCT00257907|Lymphocyte Proliferation Assay|lymphocyte proliferation assay
799021|NCT00257907|HIV|hiv
799022|NCT00257907|LPA|lpa
799023|NCT00257894|Baclofen|baclofen
799024|NCT00257894|Conditioning, Classical|conditioning, classical
799025|NCT00257894|Nicotine|nicotine
799026|NCT00257894|Smoking|smoking
799027|NCT00257881|Tumor|tumor
799028|NCT00257855|Secondary Progressive Multiple Sclerosis|secondary progressive multiple sclerosis
799029|NCT00257855|Neuroprotection|neuroprotection
799030|NCT00257855|Axonal loss|axonal loss
799031|NCT00257855|Brain atrophy|brain atrophy
799032|NCT00257855|MRI|mri
799033|NCT00257855|Lamotrigine|lamotrigine
799034|NCT00257855|Sodium Channel Blockers|sodium channel blockers
799035|NCT00257829|Cervical Cancer|cervical cancer
799036|NCT00257816|Cervical Cancer|cervical cancer
799037|NCT00257816|Topotecan|topotecan
799038|NCT00257816|Cisplatin|cisplatin
799039|NCT00257803|Oxytocin, bolus, postpartum hemorrhage|oxytocin, bolus, postpartum hemorrhage
799040|NCT00257790|Fever|fever
799041|NCT00257790|Neutropenia|neutropenia
799042|NCT00257790|Tobramycin|tobramycin
799043|NCT00257790|Aminoglycoside|aminoglycoside
799044|NCT00257790|Penicillin|penicillin
799045|NCT00257764|Swallowing disorder|swallowing disorder
799046|NCT00257764|Stroke|stroke
799047|NCT00257764|Standardized swallowing therapy|standardized swallowing therapy
799048|NCT00257764|Randomized controlled trial|randomized controlled trial
799049|NCT00257725|ADHD|adhd
799050|NCT00257725|Attention-deficit/hyperactivity disorder (ADHD)|attention-deficit/hyperactivity disorder (adhd)
799051|NCT00257712|Alzheimer's disease|alzheimer's disease
799052|NCT00257712|cognition disorders|cognition disorders
799053|NCT00257699|Crohn's Disease|crohn's disease
799054|NCT00257699|Randomized|randomized
799055|NCT00257699|Ciprofloxacin|ciprofloxacin
799056|NCT00257699|Metronidazole|metronidazole
799057|NCT00257699|Antibiotic|antibiotic
799058|NCT00257686|Kowa|kowa
799059|NCT00257686|Hypercholesterolemia|hypercholesterolemia
799060|NCT00257686|combined|combined
799061|NCT00257686|dyslipidemia|dyslipidemia
799062|NCT00257686|elderly|elderly
799063|NCT00257686|pitavastatin|pitavastatin
799064|NCT00257686|NK-104|nk-104
799065|NCT00257673|Cognition|cognition
799067|NCT00257673|Cognitive impairment|cognitive impairment
799068|NCT00257634|lateral epicondylitis|lateral epicondylitis
799069|NCT00257634|iontophoresis|iontophoresis
799070|NCT00257634|dexamethasone|dexamethasone
799071|NCT00257621|HIV-1 protease inhibitor GW640385 ritonavir RTV|hiv-1 protease inhibitor gw640385 ritonavir rtv
799072|NCT00257608|NSCLC|nsclc
799073|NCT00257608|Lung Cancer|lung cancer
799074|NCT00257608|ATLAS|atlas
799075|NCT00257608|Avastin|avastin
799076|NCT00257608|Tarceva|tarceva
799077|NCT00257595|Perennial Allergic Rhinitis pediatric|perennial allergic rhinitis pediatric
799078|NCT00257582|cetirizine|cetirizine
799079|NCT00257582|various type of cutaneous disease accompanied with Pruritus|various type of cutaneous disease accompanied with pruritus
799080|NCT00257582|pediatrics|pediatrics
799081|NCT00257569|Atopic|atopic
799082|NCT00257569|Pediatric|pediatric
799083|NCT00257569|Dermatitis|dermatitis
799084|NCT00257543|sickle cell disease|sickle cell disease
799085|NCT00257543|bone marrow transplant|bone marrow transplant
799086|NCT00257517|Congenital heart disease|congenital heart disease
799087|NCT00257517|Single ventricle|single ventricle
799088|NCT00257517|Infant feeding|infant feeding
799089|NCT00257478|Treatment Efficacy|treatment efficacy
799090|NCT00257478|Treatment Effectiveness|treatment effectiveness
799091|NCT00257478|Disease Management|disease management
799092|NCT00257478|Treatment|treatment
799093|NCT00257478|Safety|safety
799094|NCT00257465|melanoma|melanoma
799095|NCT00257465|metastatic|metastatic
799096|NCT00257465|vaccine|vaccine
799097|NCT00257465|immunotherapy|immunotherapy
799098|NCT00257465|autologous|autologous
799099|NCT00257439|Vitamin B12|vitamin b12
799100|NCT00257439|Folic Acid|folic acid
799101|NCT00257426|adult primary hepatocellular carcinoma|adult primary hepatocellular carcinoma
799102|NCT00257426|advanced adult primary liver cancer|advanced adult primary liver cancer
799825|NCT00255138|Attention|attention
799103|NCT00257426|localized unresectable adult primary liver cancer|localized unresectable adult primary liver cancer
799104|NCT00257426|recurrent adult primary liver cancer|recurrent adult primary liver cancer
799105|NCT00257400|major depressive disorder|major depressive disorder
799106|NCT00257400|psychotherapy|psychotherapy
799107|NCT00257400|childhood sexual abuse|childhood sexual abuse
799108|NCT00257400|trauma|trauma
799109|NCT00257387|Kidney|kidney
799110|NCT00257387|Kidney Transplant|kidney transplant
799111|NCT00257348|Advanced Cervical Carcinoma|advanced cervical carcinoma
799112|NCT00257348|Recurrent Cervical Carcinoma|recurrent cervical carcinoma
799113|NCT00257335|Carcinoma of the head and neck|carcinoma of the head and neck
799114|NCT00257322|Metastatic colon cancer|metastatic colon cancer
799115|NCT00257322|Metastatic rectal cancer|metastatic rectal cancer
799116|NCT00257309|Acute myocardial infarction|acute myocardial infarction
799117|NCT00257309|Elderly|elderly
799118|NCT00257309|Thrombolysis|thrombolysis
799119|NCT00257309|Primary angioplasty|primary angioplasty
799120|NCT00257309|Randomized trial|randomized trial
799121|NCT00257309|Efficacy|efficacy
799122|NCT00257309|Safety|safety
799123|NCT00257283|Chronic renal failure|chronic renal failure
799124|NCT00257283|Hemodialysis|hemodialysis
799125|NCT00257283|OMACOR (omega-3-acid ethyl ester 90)|omacor (omega-3-acid ethyl ester 90)
799126|NCT00257283|intervention study|intervention study
799127|NCT00257283|cardiovascular events|cardiovascular events
799128|NCT00257283|mortality|mortality
799129|NCT00257270|Chronic|chronic
799130|NCT00257270|Tinnitus|tinnitus
799131|NCT00257270|Acoustic trauma|acoustic trauma
799132|NCT00257270|Psychophysics|psychophysics
799133|NCT00257270|Loudness match|loudness match
799134|NCT00257270|gabapentin|gabapentin
799135|NCT00257257|Type 2 diabetes mellitus|type 2 diabetes mellitus
799136|NCT00257244|Immunity, innate|immunity, innate
799137|NCT00257244|Inflammation|inflammation
799138|NCT00257244|Genomics|genomics
799139|NCT00257244|Proteomics|proteomics
799140|NCT00257231|Immunity, innate|immunity, innate
799141|NCT00257231|Inflammation|inflammation
799142|NCT00257231|Genomics|genomics
799143|NCT00257231|Proteomics|proteomics
799144|NCT00257192|Adolescent Subjects With Schizophrenia|adolescent subjects with schizophrenia
799145|NCT00257179|Tissue factor|tissue factor
799146|NCT00257179|Lung cancer|lung cancer
799147|NCT00257179|Tissue factor protein inhibitor|tissue factor protein inhibitor
799148|NCT00257179|Factor VII|factor vii
799149|NCT00257179|Factor X|factor x
799150|NCT00257153|Acute myocardial infarction|acute myocardial infarction
799151|NCT00257153|primary angioplasty|primary angioplasty
799152|NCT00257153|myocardial reperfusion|myocardial reperfusion
799153|NCT00257153|thrombus aspiration|thrombus aspiration
799154|NCT00257140|Bronchitis|bronchitis
799155|NCT00257140|chronic bronchitis|chronic bronchitis
799156|NCT00257140|lung diseases|lung diseases
799157|NCT00257140|respiratory tract infections|respiratory tract infections
799158|NCT00257140|bronchial diseases|bronchial diseases
799159|NCT00257140|antibacterial agents|antibacterial agents
799160|NCT00257140|quinolones|quinolones
799161|NCT00257140|levofloxacin|levofloxacin
799162|NCT00257127|Vaccination|vaccination
799163|NCT00257114|Multiple Myeloma|multiple myeloma
799167|NCT00257088|epidemiology|epidemiology
799168|NCT00257088|risk factors|risk factors
799169|NCT00257088|randomized field trials|randomized field trials
799170|NCT00257075|risperidone|risperidone
799171|NCT00257075|antipsychotic agents|antipsychotic agents
799172|NCT00257075|bipolar disorders|bipolar disorders
799173|NCT00257075|manic episode|manic episode
799174|NCT00257062|Infectious skin diseases|infectious skin diseases
799175|NCT00257062|skin diseases|skin diseases
799176|NCT00257062|bacterial skin diseases|bacterial skin diseases
799177|NCT00257062|antibacterial agents|antibacterial agents
799178|NCT00257062|quinolones|quinolones
799179|NCT00257062|levofloxacin|levofloxacin
799180|NCT00257049|Pneumonia|pneumonia
799181|NCT00257049|lung inflammation|lung inflammation
799182|NCT00257049|bacterial pneumonia|bacterial pneumonia
799183|NCT00257049|lung diseases|lung diseases
799184|NCT00257049|respiratory tract infections|respiratory tract infections
799185|NCT00257049|antibacterial agents|antibacterial agents
799186|NCT00257049|quinolones|quinolones
799187|NCT00257049|levofloxacin|levofloxacin
799188|NCT00257036|Infectious skin diseases|infectious skin diseases
799189|NCT00257036|skin diseases|skin diseases
799190|NCT00257036|bacterial skin diseases|bacterial skin diseases
799191|NCT00257036|cellulitis|cellulitis
799192|NCT00257036|quinolones|quinolones
799193|NCT00257036|levofloxacin|levofloxacin
799194|NCT00257023|Schizophrenia|schizophrenia
799195|NCT00257023|Risperidone|risperidone
799196|NCT00257023|Positive and Negative Syndrome Scale (PANSS)|positive and negative syndrome scale (panss)
799197|NCT00257023|Clinical Global Impression (CGI)|clinical global impression (cgi)
799198|NCT00257023|Positron Emission Tomography (PET)|positron emission tomography (pet)
799199|NCT00257010|Migraine|migraine
799826|NCT00255138|Children|children
799200|NCT00257010|Almotriptan Malate|almotriptan malate
799201|NCT00257010|Headache|headache
799202|NCT00257010|Triptan|triptan
799203|NCT00256997|Schizophrenia|schizophrenia
799204|NCT00256997|Risperidone|risperidone
799205|NCT00256997|Risperdal Consta|risperdal consta
799206|NCT00256984|Obstructive Defecation Syndrome|obstructive defecation syndrome
799207|NCT00256984|Colorectal Surgery|colorectal surgery
799208|NCT00256984|Defecography|defecography
799209|NCT00256984|Constipation|constipation
799210|NCT00256984|Rectocele|rectocele
799211|NCT00256984|Intussusception|intussusception
799212|NCT00256984|Quality of Life|quality of life
799213|NCT00256945|biofilm formation|biofilm formation
799214|NCT00256945|dental plaque|dental plaque
799215|NCT00256945|surface roughness|surface roughness
799216|NCT00256945|dental restoration|dental restoration
799217|NCT00256945|dental materials|dental materials
799218|NCT00256932|bowel dysfunction|bowel dysfunction
799219|NCT00256932|constipation|constipation
799220|NCT00256932|gastrointestinal|gastrointestinal
799221|NCT00256932|opioids|opioids
799222|NCT00256932|pain|pain
799223|NCT00256932|non-cancer pain|non-cancer pain
799224|NCT00256932|Opioid-induced|opioid-induced
799225|NCT00256919|GW856553|gw856553
799226|NCT00256919|biomarkers|biomarkers
799227|NCT00256919|CRP|crp
799228|NCT00256919|rheumatoid arthritis|rheumatoid arthritis
799229|NCT00256906|lateral ventricles|lateral ventricles
799230|NCT00256906|fetal ventriculomegaly|fetal ventriculomegaly
799231|NCT00256893|pain intensity|pain intensity
799232|NCT00256893|numerical rating scale|numerical rating scale
799233|NCT00256893|fibromyalgia|fibromyalgia
799234|NCT00256880|Pazopanib(GW786034)|pazopanib(gw786034)
799235|NCT00256880|Solid Tumors|solid tumors
799236|NCT00256880|Myeloma|myeloma
799237|NCT00256867|Type 2 diabetes Type II|type 2 diabetes type ii
799238|NCT00256854|RLS|rls
799239|NCT00256854|Ropinirole|ropinirole
799240|NCT00256854|Restless Legs Syndrome|restless legs syndrome
799241|NCT00256841|Hypofractionated Chest Radiation|hypofractionated chest radiation
799242|NCT00256841|Taxotere|taxotere
799243|NCT00256841|5-FU|5-fu
799244|NCT00256828|HIV infection|hiv infection
799245|NCT00256828|Highly active antiretroviral therapy|highly active antiretroviral therapy
799246|NCT00256828|Treatment Naive|treatment naive
799247|NCT00256815|Hypofractionated chest radiation|hypofractionated chest radiation
799248|NCT00256815|Oral Navelbine|oral navelbine
799249|NCT00256802|Headache|headache
799250|NCT00256802|migraine|migraine
799251|NCT00256802|MR-angiography|mr-angiography
799252|NCT00256802|healthy volunteers|healthy volunteers
799253|NCT00256802|GTN|gtn
799254|NCT00256802|Middle cerebral artery|middle cerebral artery
799255|NCT00256789|NSCLC, Non-Small Cell Lung Cancer,Weekly Radiation, Taxotere|nsclc, non-small cell lung cancer,weekly radiation, taxotere
799256|NCT00256776|Multiple Myeloma|multiple myeloma
799257|NCT00256776|Velcade|velcade
799258|NCT00256776|Autologous transplantation|autologous transplantation
799259|NCT00256776|Relapse|relapse
799260|NCT00256776|Disease progress|disease progress
799261|NCT00256737|Maintenance of healed erosive esophagitis|maintenance of healed erosive esophagitis
799262|NCT00256724|hypotension|hypotension
799263|NCT00256724|hypovolemia|hypovolemia
799264|NCT00256724|dehydration|dehydration
799265|NCT00256724|sepsis|sepsis
799267|NCT00256711|Locally advanced or metastatic NSCLC.|locally advanced or metastatic nsclc.
799268|NCT00256711|Stage IIIb or Stage IV lung cancer|stage iiib or stage iv lung cancer
799269|NCT00256698|Hormone|hormone
799270|NCT00256698|receptor|receptor
799271|NCT00256698|positive|positive
799272|NCT00256698|breast|breast
799273|NCT00256698|cancer|cancer
799274|NCT00256698|first|first
799275|NCT00256698|relapse|relapse
799276|NCT00256685|Menopause|menopause
799277|NCT00256672|Spinal Cord Injury|spinal cord injury
799278|NCT00256672|TLSO brace|tlso brace
799279|NCT00256672|Spine curvature|spine curvature
799280|NCT00256672|Child|child
799281|NCT00256672|Effectiveness of bracing|effectiveness of bracing
799282|NCT00256659|Medical inpatients|medical inpatients
799283|NCT00256659|Social Work|social work
799284|NCT00256659|Physical therapy|physical therapy
799285|NCT00256659|Occupational therapy|occupational therapy
799286|NCT00256659|Psychiatry|psychiatry
799287|NCT00256659|Early intervention|early intervention
799288|NCT00256659|Iatrogenic complications|iatrogenic complications
799289|NCT00256620|Cardiopulmonary bypass|cardiopulmonary bypass
799290|NCT00256620|Coronary artery disease|coronary artery disease
799291|NCT00256620|Cardiac morbidity|cardiac morbidity
799292|NCT00256620|Neurologic morbidity|neurologic morbidity
799293|NCT00256620|Neurocognitive function|neurocognitive function
799294|NCT00256620|Autoregulation|autoregulation
799295|NCT00256594|Medical Errors|medical errors
799296|NCT00256594|Medication Errors|medication errors
799297|NCT00256594|Prescriptions, Drug|prescriptions, drug
799298|NCT00256581|myocardial perfusion|myocardial perfusion
799299|NCT00256581|Imaging|imaging
799300|NCT00256568|Medical Errors|medical errors
799301|NCT00256568|Medication Errors|medication errors
799302|NCT00256568|Prescriptions, Drug|prescriptions, drug
799303|NCT00256568|Pharmacies|pharmacies
799304|NCT00256568|Ambulatory Care Facilities|ambulatory care facilities
799305|NCT00256542|interstitial cystitis|interstitial cystitis
799306|NCT00256542|pelvic pain|pelvic pain
799307|NCT00256542|urgency|urgency
799308|NCT00256542|frequency|frequency
799309|NCT00256542|Pelvic Pain and/or Urgency of Bladder Origin|pelvic pain and/or urgency of bladder origin
799310|NCT00256529|dysphagia|dysphagia
799311|NCT00256529|eosinophilic esophagitis|eosinophilic esophagitis
799312|NCT00256516|Diet Therapy|diet therapy
799313|NCT00256503|Primary Insomnia|primary insomnia
799314|NCT00256503|Insomnia|insomnia
799315|NCT00256503|Sleep|sleep
799316|NCT00256490|Diffuse large B cells lymphoma|diffuse large b cells lymphoma
799317|NCT00256490|PET/CT|pet/ct
799318|NCT00256490|FDG|fdg
799319|NCT00256464|PTSD|ptsd
799320|NCT00256451|Naltrexone|naltrexone
799321|NCT00256451|Alcohol|alcohol
799322|NCT00256438|Depression|depression
799323|NCT00256438|Transcranial Direct Current Stimulation|transcranial direct current stimulation
799324|NCT00256425|glioma|glioma
799325|NCT00256425|brain tumor|brain tumor
799326|NCT00256425|cognit|cognit
799327|NCT00256425|neuropsycholog|neuropsycholog
799328|NCT00256425|attention|attention
799329|NCT00256425|memory|memory
799330|NCT00256425|executive function|executive function
799331|NCT00256425|rehabilitation|rehabilitation
799332|NCT00256425|remediation|remediation
799333|NCT00256425|training|training
799334|NCT00256386|Baseline|baseline
799335|NCT00256386|Laboratory|laboratory
799336|NCT00256386|Drug|drug
799337|NCT00256373|Low Back Pain|low back pain
799338|NCT00256373|Dynamic Back-Muscle exercise Treatment|dynamic back-muscle exercise treatment
799339|NCT00256373|Interdisciplinary Treatment|interdisciplinary treatment
799340|NCT00256373|Roland Morris Disability Questionnaire|roland morris disability questionnaire
799341|NCT00256373|SF-36|sf-36
799342|NCT00256373|Low Back Pain Rating Scale|low back pain rating scale
799343|NCT00256360|breast cancer|breast cancer
799344|NCT00256360|adjuvant|adjuvant
799345|NCT00256360|dose dense|dose dense
799346|NCT00256360|docetaxel|docetaxel
799347|NCT00256360|pegfilgrastim|pegfilgrastim
799348|NCT00256334|Colon Cancer|colon cancer
799349|NCT00256334|Resveratrol|resveratrol
799350|NCT00256334|Clinical Trial|clinical trial
799351|NCT00256334|WnT signaling|wnt signaling
799352|NCT00256334|Grapes|grapes
799353|NCT00256334|Cancer prevention|cancer prevention
799354|NCT00256321|Gastric Carcinoma|gastric carcinoma
799355|NCT00256321|Gastroesophageal junction Carcinoma|gastroesophageal junction carcinoma
799356|NCT00256308|Head and Neck Cancer|head and neck cancer
799357|NCT00256308|oxaliplatin|oxaliplatin
799358|NCT00256308|resected squamous cell carcinoma|resected squamous cell carcinoma
799359|NCT00256308|Eloxatin™|eloxatin™
799360|NCT00256295|Cancer of the Head and Neck|cancer of the head and neck
799361|NCT00256282|Metastatic Melanoma|metastatic melanoma
799362|NCT00256269|Esophageal Cancer|esophageal cancer
799363|NCT00256269|Gastroesophageal junction cancer|gastroesophageal junction cancer
799364|NCT00256269|Oxaliplatin|oxaliplatin
799365|NCT00256269|Irinotecan|irinotecan
799366|NCT00256256|type 2 diabetes|type 2 diabetes
799367|NCT00256256|GLP-1|glp-1
799368|NCT00256256|PET|pet
799369|NCT00256256|brain|brain
799370|NCT00256256|heart|heart
799372|NCT00256204|Rasagiline Mesylate|rasagiline mesylate
799373|NCT00256191|taxanes|taxanes
799374|NCT00256191|multidrug resistance|multidrug resistance
799375|NCT00256191|mutant tubulin binding|mutant tubulin binding
799376|NCT00256191|Hodgkin's or Non-Hodgkin's Lymphoma|hodgkin's or non-hodgkin's lymphoma
799377|NCT00256178|Hyperlipidemia|hyperlipidemia
799378|NCT00256178|Drug Therapy|drug therapy
799379|NCT00256165|Aortic valve replacement|aortic valve replacement
799380|NCT00256152|Atrial fibrillation|atrial fibrillation
799381|NCT00256152|Pacemaker|pacemaker
799382|NCT00256152|AF suppression pacing|af suppression pacing
799383|NCT00256152|Indications for Pacemaker Implantation due to sinus node or atrio-ventricular node disease|indications for pacemaker implantation due to sinus node or atrio-ventricular node disease
799384|NCT00256113|depression|depression
799385|NCT00256113|antidepressive agents|antidepressive agents
799386|NCT00256113|controlled clinical trial|controlled clinical trial
799387|NCT00256087|Nosocomial rates in critically ill patients|nosocomial rates in critically ill patients
799388|NCT00256009|Late abortion|late abortion
799389|NCT00255983|bronchitis|bronchitis
799390|NCT00255983|AECB|aecb
799391|NCT00255970|Periodontal Treatment of Intraosseous Vertical Defects|periodontal treatment of intraosseous vertical defects
799392|NCT00255957|Stroke, HES, Coagulation, Kinetics, Hemorehology|stroke, hes, coagulation, kinetics, hemorehology
799393|NCT00255944|HIV Prevention|hiv prevention
799394|NCT00255944|Internet Intervention|internet intervention
799395|NCT00255944|STDs|stds
799396|NCT00255931|Heart Failure|heart failure
799397|NCT00255931|Biofeedback-Relaxation|biofeedback-relaxation
799398|NCT00255931|Cognitive Behavioral Therapy|cognitive behavioral therapy
799399|NCT00255918|Evoked Potentials|evoked potentials
800124|NCT00253786|nephropathy|nephropathy
799400|NCT00255918|3-(2,4-dimethoxybenzylidene)anabaseine|3-(2,4-dimethoxybenzylidene)anabaseine
799401|NCT00255918|DMXB-A|dmxb-a
799402|NCT00255918|Receptors, Nicotinic|receptors, nicotinic
799403|NCT00255905|Depression|depression
799404|NCT00255905|Insomnia|insomnia
799405|NCT00255892|HIV|hiv
799406|NCT00255879|Schizophrenia|schizophrenia
799407|NCT00255879|Neuroleptic|neuroleptic
799408|NCT00255879|Tardive dyskinesia|tardive dyskinesia
799409|NCT00255866|Assisted Living Facilities|assisted living facilities
799410|NCT00255866|Aged|aged
799411|NCT00255866|Elderly|elderly
799412|NCT00255866|Caregivers|caregivers
799413|NCT00255840|Treatment Naive|treatment naive
799414|NCT00255814|liver metastases|liver metastases
799415|NCT00255801|stage I cutaneous T-cell non-Hodgkin lymphoma|stage i cutaneous t-cell non-hodgkin lymphoma
799416|NCT00255801|stage II cutaneous T-cell non-Hodgkin lymphoma|stage ii cutaneous t-cell non-hodgkin lymphoma
799417|NCT00255801|stage III cutaneous T-cell non-Hodgkin lymphoma|stage iii cutaneous t-cell non-hodgkin lymphoma
799418|NCT00255801|stage IV cutaneous T-cell non-Hodgkin lymphoma|stage iv cutaneous t-cell non-hodgkin lymphoma
799419|NCT00255801|recurrent cutaneous T-cell non-Hodgkin lymphoma|recurrent cutaneous t-cell non-hodgkin lymphoma
799420|NCT00255801|stage I mycosis fungoides/Sezary syndrome|stage i mycosis fungoides/sezary syndrome
799421|NCT00255801|stage II mycosis fungoides/Sezary syndrome|stage ii mycosis fungoides/sezary syndrome
799422|NCT00255801|stage III mycosis fungoides/Sezary syndrome|stage iii mycosis fungoides/sezary syndrome
799423|NCT00255801|stage IV mycosis fungoides/Sezary syndrome|stage iv mycosis fungoides/sezary syndrome
799424|NCT00255801|recurrent mycosis fungoides/Sezary syndrome|recurrent mycosis fungoides/sezary syndrome
799425|NCT00255788|recurrent breast cancer|recurrent breast cancer
799426|NCT00255788|stage IV breast cancer|stage iv breast cancer
799427|NCT00255788|male breast cancer|male breast cancer
799428|NCT00255775|non-small cell lung cancer|non-small cell lung cancer
799429|NCT00255775|small cell lung cancer|small cell lung cancer
799430|NCT00255749|adult acute lymphoblastic leukemia in remission|adult acute lymphoblastic leukemia in remission
799431|NCT00255749|progressive hairy cell leukemia, initial treatment|progressive hairy cell leukemia, initial treatment
799432|NCT00255749|stage 0 chronic lymphocytic leukemia|stage 0 chronic lymphocytic leukemia
799433|NCT00255749|anemia|anemia
799434|NCT00255749|extramedullary plasmacytoma|extramedullary plasmacytoma
799435|NCT00255749|isolated plasmacytoma of bone|isolated plasmacytoma of bone
799436|NCT00255749|refractory multiple myeloma|refractory multiple myeloma
799437|NCT00255749|monoclonal gammopathy of undetermined significance|monoclonal gammopathy of undetermined significance
799438|NCT00255749|primary systemic amyloidosis|primary systemic amyloidosis
799439|NCT00255749|stage I multiple myeloma|stage i multiple myeloma
799440|NCT00255749|stage II multiple myeloma|stage ii multiple myeloma
799441|NCT00255749|stage III multiple myeloma|stage iii multiple myeloma
799442|NCT00255749|AIDS-related peripheral/systemic lymphoma|aids-related peripheral/systemic lymphoma
799443|NCT00255749|AIDS-related primary CNS lymphoma|aids-related primary cns lymphoma
799444|NCT00255749|anaplastic large cell lymphoma|anaplastic large cell lymphoma
799445|NCT00255749|angioimmunoblastic T-cell lymphoma|angioimmunoblastic t-cell lymphoma
799446|NCT00255749|extranodal marginal zone B-cell lymphoma of mucosa-associated lymphoid tissue|extranodal marginal zone b-cell lymphoma of mucosa-associated lymphoid tissue
799447|NCT00255749|nodal marginal zone B-cell lymphoma|nodal marginal zone b-cell lymphoma
799448|NCT00255749|recurrent adult Burkitt lymphoma|recurrent adult burkitt lymphoma
799449|NCT00255749|recurrent adult diffuse large cell lymphoma|recurrent adult diffuse large cell lymphoma
799790|NCT00255385|Child health|child health
799450|NCT00255749|recurrent adult diffuse mixed cell lymphoma|recurrent adult diffuse mixed cell lymphoma
799451|NCT00255749|recurrent adult diffuse small cleaved cell lymphoma|recurrent adult diffuse small cleaved cell lymphoma
799452|NCT00255749|recurrent adult Hodgkin lymphoma|recurrent adult hodgkin lymphoma
799453|NCT00255749|recurrent adult immunoblastic large cell lymphoma|recurrent adult immunoblastic large cell lymphoma
799454|NCT00255749|recurrent adult lymphoblastic lymphoma|recurrent adult lymphoblastic lymphoma
799455|NCT00255749|recurrent adult T-cell leukemia/lymphoma|recurrent adult t-cell leukemia/lymphoma
799456|NCT00255749|recurrent cutaneous T-cell non-Hodgkin lymphoma|recurrent cutaneous t-cell non-hodgkin lymphoma
799457|NCT00255749|recurrent grade 1 follicular lymphoma|recurrent grade 1 follicular lymphoma
799458|NCT00255749|recurrent grade 2 follicular lymphoma|recurrent grade 2 follicular lymphoma
799459|NCT00255749|recurrent grade 3 follicular lymphoma|recurrent grade 3 follicular lymphoma
799460|NCT00255749|recurrent mantle cell lymphoma|recurrent mantle cell lymphoma
799461|NCT00255749|recurrent marginal zone lymphoma|recurrent marginal zone lymphoma
799462|NCT00255749|recurrent mycosis fungoides/Sezary syndrome|recurrent mycosis fungoides/sezary syndrome
799463|NCT00255749|recurrent small lymphocytic lymphoma|recurrent small lymphocytic lymphoma
799464|NCT00255749|splenic marginal zone lymphoma|splenic marginal zone lymphoma
799465|NCT00255749|stage III adult Burkitt lymphoma|stage iii adult burkitt lymphoma
799466|NCT00255749|stage III adult diffuse large cell lymphoma|stage iii adult diffuse large cell lymphoma
799467|NCT00255749|stage III adult diffuse mixed cell lymphoma|stage iii adult diffuse mixed cell lymphoma
799468|NCT00255749|stage III adult diffuse small cleaved cell lymphoma|stage iii adult diffuse small cleaved cell lymphoma
799469|NCT00255749|stage III adult Hodgkin lymphoma|stage iii adult hodgkin lymphoma
799470|NCT00255749|stage III adult immunoblastic large cell lymphoma|stage iii adult immunoblastic large cell lymphoma
799471|NCT00255749|stage III adult lymphoblastic lymphoma|stage iii adult lymphoblastic lymphoma
799472|NCT00255749|stage III adult T-cell leukemia/lymphoma|stage iii adult t-cell leukemia/lymphoma
799473|NCT00255749|stage III cutaneous T-cell non-Hodgkin lymphoma|stage iii cutaneous t-cell non-hodgkin lymphoma
799474|NCT00255749|stage III grade 1 follicular lymphoma|stage iii grade 1 follicular lymphoma
799475|NCT00255749|stage III grade 2 follicular lymphoma|stage iii grade 2 follicular lymphoma
799476|NCT00255749|stage III grade 3 follicular lymphoma|stage iii grade 3 follicular lymphoma
799477|NCT00255749|stage III mantle cell lymphoma|stage iii mantle cell lymphoma
799478|NCT00255749|stage III marginal zone lymphoma|stage iii marginal zone lymphoma
799479|NCT00255749|stage III mycosis fungoides/Sezary syndrome|stage iii mycosis fungoides/sezary syndrome
799480|NCT00255749|stage III small lymphocytic lymphoma|stage iii small lymphocytic lymphoma
799481|NCT00255749|stage IV adult Burkitt lymphoma|stage iv adult burkitt lymphoma
799482|NCT00255749|stage IV adult diffuse large cell lymphoma|stage iv adult diffuse large cell lymphoma
799483|NCT00255749|stage IV adult diffuse mixed cell lymphoma|stage iv adult diffuse mixed cell lymphoma
799484|NCT00255749|stage IV adult diffuse small cleaved cell lymphoma|stage iv adult diffuse small cleaved cell lymphoma
799485|NCT00255749|stage IV adult Hodgkin lymphoma|stage iv adult hodgkin lymphoma
799486|NCT00255749|stage IV adult immunoblastic large cell lymphoma|stage iv adult immunoblastic large cell lymphoma
799487|NCT00255749|stage IV adult lymphoblastic lymphoma|stage iv adult lymphoblastic lymphoma
799488|NCT00255749|stage IV adult T-cell leukemia/lymphoma|stage iv adult t-cell leukemia/lymphoma
799489|NCT00255749|stage IV cutaneous T-cell non-Hodgkin lymphoma|stage iv cutaneous t-cell non-hodgkin lymphoma
799490|NCT00255749|stage IV grade 1 follicular lymphoma|stage iv grade 1 follicular lymphoma
799491|NCT00255749|stage IV grade 2 follicular lymphoma|stage iv grade 2 follicular lymphoma
799492|NCT00255749|stage IV grade 3 follicular lymphoma|stage iv grade 3 follicular lymphoma
799493|NCT00255749|stage IV mantle cell lymphoma|stage iv mantle cell lymphoma
799494|NCT00255749|stage IV marginal zone lymphoma|stage iv marginal zone lymphoma
799495|NCT00255749|stage IV mycosis fungoides/Sezary syndrome|stage iv mycosis fungoides/sezary syndrome
799496|NCT00255749|stage IV small lymphocytic lymphoma|stage iv small lymphocytic lymphoma
799497|NCT00255749|Waldenström macroglobulinemia|waldenström macroglobulinemia
799498|NCT00255749|contiguous stage II adult Burkitt lymphoma|contiguous stage ii adult burkitt lymphoma
799499|NCT00255749|contiguous stage II adult diffuse large cell lymphoma|contiguous stage ii adult diffuse large cell lymphoma
799500|NCT00255749|contiguous stage II adult diffuse mixed cell lymphoma|contiguous stage ii adult diffuse mixed cell lymphoma
799501|NCT00255749|contiguous stage II adult diffuse small cleaved cell lymphoma|contiguous stage ii adult diffuse small cleaved cell lymphoma
799502|NCT00255749|contiguous stage II adult immunoblastic large cell lymphoma|contiguous stage ii adult immunoblastic large cell lymphoma
799503|NCT00255749|contiguous stage II adult lymphoblastic lymphoma|contiguous stage ii adult lymphoblastic lymphoma
799504|NCT00255749|contiguous stage II grade 1 follicular lymphoma|contiguous stage ii grade 1 follicular lymphoma
799505|NCT00255749|contiguous stage II grade 2 follicular lymphoma|contiguous stage ii grade 2 follicular lymphoma
799506|NCT00255749|contiguous stage II grade 3 follicular lymphoma|contiguous stage ii grade 3 follicular lymphoma
799507|NCT00255749|contiguous stage II mantle cell lymphoma|contiguous stage ii mantle cell lymphoma
799508|NCT00255749|contiguous stage II marginal zone lymphoma|contiguous stage ii marginal zone lymphoma
799509|NCT00255749|contiguous stage II small lymphocytic lymphoma|contiguous stage ii small lymphocytic lymphoma
799510|NCT00255749|noncontiguous stage II adult Burkitt lymphoma|noncontiguous stage ii adult burkitt lymphoma
799511|NCT00255749|noncontiguous stage II adult diffuse large cell lymphoma|noncontiguous stage ii adult diffuse large cell lymphoma
799512|NCT00255749|noncontiguous stage II adult diffuse mixed cell lymphoma|noncontiguous stage ii adult diffuse mixed cell lymphoma
799513|NCT00255749|noncontiguous stage II adult diffuse small cleaved cell lymphoma|noncontiguous stage ii adult diffuse small cleaved cell lymphoma
799514|NCT00255749|noncontiguous stage II adult immunoblastic large cell lymphoma|noncontiguous stage ii adult immunoblastic large cell lymphoma
799515|NCT00255749|noncontiguous stage II adult lymphoblastic lymphoma|noncontiguous stage ii adult lymphoblastic lymphoma
799516|NCT00255749|noncontiguous stage II grade 1 follicular lymphoma|noncontiguous stage ii grade 1 follicular lymphoma
799517|NCT00255749|noncontiguous stage II grade 2 follicular lymphoma|noncontiguous stage ii grade 2 follicular lymphoma
799518|NCT00255749|noncontiguous stage II grade 3 follicular lymphoma|noncontiguous stage ii grade 3 follicular lymphoma
799519|NCT00255749|noncontiguous stage II mantle cell lymphoma|noncontiguous stage ii mantle cell lymphoma
799520|NCT00255749|noncontiguous stage II marginal zone lymphoma|noncontiguous stage ii marginal zone lymphoma
799521|NCT00255749|noncontiguous stage II small lymphocytic lymphoma|noncontiguous stage ii small lymphocytic lymphoma
799522|NCT00255749|post-transplant lymphoproliferative disorder|post-transplant lymphoproliferative disorder
799523|NCT00255749|stage I adult Burkitt lymphoma|stage i adult burkitt lymphoma
799524|NCT00255749|stage I adult diffuse large cell lymphoma|stage i adult diffuse large cell lymphoma
799525|NCT00255749|stage I adult diffuse mixed cell lymphoma|stage i adult diffuse mixed cell lymphoma
799526|NCT00255749|stage I adult diffuse small cleaved cell lymphoma|stage i adult diffuse small cleaved cell lymphoma
799527|NCT00255749|stage I adult Hodgkin lymphoma|stage i adult hodgkin lymphoma
799528|NCT00255749|stage I adult immunoblastic large cell lymphoma|stage i adult immunoblastic large cell lymphoma
799529|NCT00255749|stage I adult lymphoblastic lymphoma|stage i adult lymphoblastic lymphoma
799530|NCT00255749|stage I adult T-cell leukemia/lymphoma|stage i adult t-cell leukemia/lymphoma
799531|NCT00255749|stage I cutaneous T-cell non-Hodgkin lymphoma|stage i cutaneous t-cell non-hodgkin lymphoma
799532|NCT00255749|stage I grade 1 follicular lymphoma|stage i grade 1 follicular lymphoma
799533|NCT00255749|stage I grade 2 follicular lymphoma|stage i grade 2 follicular lymphoma
799534|NCT00255749|stage I grade 3 follicular lymphoma|stage i grade 3 follicular lymphoma
799535|NCT00255749|stage I mantle cell lymphoma|stage i mantle cell lymphoma
799536|NCT00255749|stage I marginal zone lymphoma|stage i marginal zone lymphoma
799537|NCT00255749|stage I small lymphocytic lymphoma|stage i small lymphocytic lymphoma
799538|NCT00255749|stage II adult Hodgkin lymphoma|stage ii adult hodgkin lymphoma
799539|NCT00255749|stage II adult T-cell leukemia/lymphoma|stage ii adult t-cell leukemia/lymphoma
799540|NCT00255749|stage II cutaneous T-cell non-Hodgkin lymphoma|stage ii cutaneous t-cell non-hodgkin lymphoma
799541|NCT00255749|stage I mycosis fungoides/Sezary syndrome|stage i mycosis fungoides/sezary syndrome
799542|NCT00255749|stage II mycosis fungoides/Sezary syndrome|stage ii mycosis fungoides/sezary syndrome
799543|NCT00255749|recurrent adult acute lymphoblastic leukemia|recurrent adult acute lymphoblastic leukemia
799544|NCT00255749|refractory chronic lymphocytic leukemia|refractory chronic lymphocytic leukemia
799545|NCT00255749|stage I chronic lymphocytic leukemia|stage i chronic lymphocytic leukemia
799546|NCT00255749|stage II chronic lymphocytic leukemia|stage ii chronic lymphocytic leukemia
799547|NCT00255749|stage III chronic lymphocytic leukemia|stage iii chronic lymphocytic leukemia
799548|NCT00255749|stage IV chronic lymphocytic leukemia|stage iv chronic lymphocytic leukemia
799549|NCT00255749|refractory hairy cell leukemia|refractory hairy cell leukemia
799550|NCT00255749|prolymphocytic leukemia|prolymphocytic leukemia
799551|NCT00255749|unspecified adult solid tumor, protocol specific|unspecified adult solid tumor, protocol specific
799552|NCT00255749|T-cell large granular lymphocyte leukemia|t-cell large granular lymphocyte leukemia
799553|NCT00255723|adult lymphocyte depletion Hodgkin lymphoma|adult lymphocyte depletion hodgkin lymphoma
799554|NCT00255723|adult mixed cellularity Hodgkin lymphoma|adult mixed cellularity hodgkin lymphoma
799555|NCT00255723|adult nodular sclerosis Hodgkin lymphoma|adult nodular sclerosis hodgkin lymphoma
799556|NCT00255723|recurrent adult Hodgkin lymphoma|recurrent adult hodgkin lymphoma
799557|NCT00255710|graft versus host disease|graft versus host disease
799558|NCT00255710|adult acute myeloid leukemia with 11q23 (MLL) abnormalities|adult acute myeloid leukemia with 11q23 (mll) abnormalities
799559|NCT00255710|adult acute myeloid leukemia with inv(16)(p13;q22)|adult acute myeloid leukemia with inv(16)(p13;q22)
799560|NCT00255710|adult acute myeloid leukemia with t(15;17)(q22;q12)|adult acute myeloid leukemia with t(15;17)(q22;q12)
799561|NCT00255710|adult acute myeloid leukemia with t(16;16)(p13;q22)|adult acute myeloid leukemia with t(16;16)(p13;q22)
799562|NCT00255710|adult acute myeloid leukemia with t(8;21)(q22;q22)|adult acute myeloid leukemia with t(8;21)(q22;q22)
799563|NCT00255710|adult acute lymphoblastic leukemia in remission|adult acute lymphoblastic leukemia in remission
799564|NCT00255710|adult acute myeloid leukemia in remission|adult acute myeloid leukemia in remission
799565|NCT00255710|chronic idiopathic myelofibrosis|chronic idiopathic myelofibrosis
799566|NCT00255710|chronic myelomonocytic leukemia|chronic myelomonocytic leukemia
799567|NCT00255710|chronic phase chronic myelogenous leukemia|chronic phase chronic myelogenous leukemia
799568|NCT00255710|myelodysplastic/myeloproliferative disease, unclassifiable|myelodysplastic/myeloproliferative disease, unclassifiable
799569|NCT00255710|previously treated myelodysplastic syndromes|previously treated myelodysplastic syndromes
799570|NCT00255710|recurrent adult Burkitt lymphoma|recurrent adult burkitt lymphoma
799571|NCT00255710|recurrent adult diffuse large cell lymphoma|recurrent adult diffuse large cell lymphoma
799572|NCT00255710|recurrent adult diffuse mixed cell lymphoma|recurrent adult diffuse mixed cell lymphoma
799791|NCT00255385|Milk fortification|milk fortification
799573|NCT00255710|recurrent adult immunoblastic large cell lymphoma|recurrent adult immunoblastic large cell lymphoma
799574|NCT00255710|recurrent adult lymphoblastic lymphoma|recurrent adult lymphoblastic lymphoma
799575|NCT00255710|recurrent grade 3 follicular lymphoma|recurrent grade 3 follicular lymphoma
799576|NCT00255710|recurrent mantle cell lymphoma|recurrent mantle cell lymphoma
799577|NCT00255710|stage II multiple myeloma|stage ii multiple myeloma
799578|NCT00255710|stage III adult Hodgkin lymphoma|stage iii adult hodgkin lymphoma
799579|NCT00255710|stage III chronic lymphocytic leukemia|stage iii chronic lymphocytic leukemia
799580|NCT00255710|stage III grade 1 follicular lymphoma|stage iii grade 1 follicular lymphoma
799581|NCT00255710|stage III grade 2 follicular lymphoma|stage iii grade 2 follicular lymphoma
799582|NCT00255710|stage III multiple myeloma|stage iii multiple myeloma
799583|NCT00255710|stage III small lymphocytic lymphoma|stage iii small lymphocytic lymphoma
799584|NCT00255710|stage IV adult Hodgkin lymphoma|stage iv adult hodgkin lymphoma
799585|NCT00255710|stage IV chronic lymphocytic leukemia|stage iv chronic lymphocytic leukemia
799586|NCT00255710|stage IV grade 1 follicular lymphoma|stage iv grade 1 follicular lymphoma
799587|NCT00255710|stage IV grade 2 follicular lymphoma|stage iv grade 2 follicular lymphoma
799588|NCT00255710|stage IV small lymphocytic lymphoma|stage iv small lymphocytic lymphoma
799589|NCT00255710|stage II mycosis fungoides/Sezary syndrome|stage ii mycosis fungoides/sezary syndrome
799590|NCT00255710|stage III mycosis fungoides/Sezary syndrome|stage iii mycosis fungoides/sezary syndrome
799591|NCT00255710|stage IV mycosis fungoides/Sezary syndrome|stage iv mycosis fungoides/sezary syndrome
799592|NCT00255710|refractory anemia with excess blasts in transformation|refractory anemia with excess blasts in transformation
799593|NCT00255710|refractory anemia with excess blasts|refractory anemia with excess blasts
799594|NCT00255710|refractory cytopenia with multilineage dysplasia|refractory cytopenia with multilineage dysplasia
799595|NCT00255710|primary systemic amyloidosis|primary systemic amyloidosis
800521|NCT00252954|Spasms|spasms
799596|NCT00255710|de novo myelodysplastic syndromes|de novo myelodysplastic syndromes
799597|NCT00255710|secondary acute myeloid leukemia|secondary acute myeloid leukemia
799598|NCT00255710|secondary myelodysplastic syndromes|secondary myelodysplastic syndromes
799599|NCT00255710|atypical chronic myeloid leukemia|atypical chronic myeloid leukemia
799600|NCT00255697|psychosocial effects of cancer and its treatment|psychosocial effects of cancer and its treatment
799601|NCT00255697|unspecified adult solid tumor, protocol specific|unspecified adult solid tumor, protocol specific
799602|NCT00255684|graft versus host disease|graft versus host disease
799603|NCT00255684|adult acute myeloid leukemia in remission|adult acute myeloid leukemia in remission
799604|NCT00255684|adult acute myeloid leukemia with 11q23 (MLL) abnormalities|adult acute myeloid leukemia with 11q23 (mll) abnormalities
799605|NCT00255684|adult acute myeloid leukemia with t(16;16)(p13;q22)|adult acute myeloid leukemia with t(16;16)(p13;q22)
799606|NCT00255684|adult acute myeloid leukemia with t(8;21)(q22;q22)|adult acute myeloid leukemia with t(8;21)(q22;q22)
799607|NCT00255684|recurrent adult acute myeloid leukemia|recurrent adult acute myeloid leukemia
799608|NCT00255684|childhood acute myeloid leukemia in remission|childhood acute myeloid leukemia in remission
799609|NCT00255684|recurrent childhood acute myeloid leukemia|recurrent childhood acute myeloid leukemia
799610|NCT00255684|adult acute lymphoblastic leukemia in remission|adult acute lymphoblastic leukemia in remission
799611|NCT00255684|recurrent adult acute lymphoblastic leukemia|recurrent adult acute lymphoblastic leukemia
799612|NCT00255684|childhood acute lymphoblastic leukemia in remission|childhood acute lymphoblastic leukemia in remission
799613|NCT00255684|recurrent childhood acute lymphoblastic leukemia|recurrent childhood acute lymphoblastic leukemia
799614|NCT00255684|acute undifferentiated leukemia|acute undifferentiated leukemia
799615|NCT00255684|accelerated phase chronic myelogenous leukemia|accelerated phase chronic myelogenous leukemia
799616|NCT00255684|chronic phase chronic myelogenous leukemia|chronic phase chronic myelogenous leukemia
799617|NCT00255684|childhood chronic myelogenous leukemia|childhood chronic myelogenous leukemia
799618|NCT00255684|refractory anemia with excess blasts|refractory anemia with excess blasts
799619|NCT00255684|refractory anemia|refractory anemia
799620|NCT00255684|chronic myelomonocytic leukemia|chronic myelomonocytic leukemia
799621|NCT00255684|atypical chronic myeloid leukemia, BCR-ABL1 negative|atypical chronic myeloid leukemia, bcr-abl1 negative
799622|NCT00255684|juvenile myelomonocytic leukemia|juvenile myelomonocytic leukemia
799623|NCT00255684|primary myelofibrosis|primary myelofibrosis
799624|NCT00255684|refractory hairy cell leukemia|refractory hairy cell leukemia
799625|NCT00255684|stage I multiple myeloma|stage i multiple myeloma
799626|NCT00255684|stage II multiple myeloma|stage ii multiple myeloma
799627|NCT00255684|stage III multiple myeloma|stage iii multiple myeloma
799628|NCT00255684|refractory multiple myeloma|refractory multiple myeloma
799629|NCT00255684|refractory chronic lymphocytic leukemia|refractory chronic lymphocytic leukemia
799630|NCT00255684|stage III adult Hodgkin lymphoma|stage iii adult hodgkin lymphoma
799631|NCT00255684|stage IV adult Hodgkin lymphoma|stage iv adult hodgkin lymphoma
799632|NCT00255684|recurrent/refractory childhood Hodgkin lymphoma|recurrent/refractory childhood hodgkin lymphoma
799633|NCT00255684|stage III adult Burkitt lymphoma|stage iii adult burkitt lymphoma
799634|NCT00255684|stage IV adult Burkitt lymphoma|stage iv adult burkitt lymphoma
799635|NCT00255684|stage III adult diffuse large cell lymphoma|stage iii adult diffuse large cell lymphoma
799636|NCT00255684|stage III adult diffuse mixed cell lymphoma|stage iii adult diffuse mixed cell lymphoma
799637|NCT00255684|stage III adult diffuse small cleaved cell lymphoma|stage iii adult diffuse small cleaved cell lymphoma
799638|NCT00255684|stage IV adult diffuse large cell lymphoma|stage iv adult diffuse large cell lymphoma
799639|NCT00255684|stage IV adult diffuse mixed cell lymphoma|stage iv adult diffuse mixed cell lymphoma
799640|NCT00255684|stage IV adult diffuse small cleaved cell lymphoma|stage iv adult diffuse small cleaved cell lymphoma
799641|NCT00255684|stage III adult immunoblastic large cell lymphoma|stage iii adult immunoblastic large cell lymphoma
799642|NCT00255684|stage IV adult immunoblastic large cell lymphoma|stage iv adult immunoblastic large cell lymphoma
799643|NCT00255684|stage III adult lymphoblastic lymphoma|stage iii adult lymphoblastic lymphoma
799644|NCT00255684|stage IV adult lymphoblastic lymphoma|stage iv adult lymphoblastic lymphoma
799645|NCT00255684|stage III grade 1 follicular lymphoma|stage iii grade 1 follicular lymphoma
799646|NCT00255684|stage III grade 2 follicular lymphoma|stage iii grade 2 follicular lymphoma
799647|NCT00255684|stage III grade 3 follicular lymphoma|stage iii grade 3 follicular lymphoma
799648|NCT00255684|stage IV grade 1 follicular lymphoma|stage iv grade 1 follicular lymphoma
799649|NCT00255684|stage IV grade 2 follicular lymphoma|stage iv grade 2 follicular lymphoma
799650|NCT00255684|stage IV grade 3 follicular lymphoma|stage iv grade 3 follicular lymphoma
799651|NCT00255684|stage III mantle cell lymphoma|stage iii mantle cell lymphoma
799652|NCT00255684|stage III marginal zone lymphoma|stage iii marginal zone lymphoma
799653|NCT00255684|stage IV mantle cell lymphoma|stage iv mantle cell lymphoma
799654|NCT00255684|stage IV marginal zone lymphoma|stage iv marginal zone lymphoma
799655|NCT00255684|stage III small lymphocytic lymphoma|stage iii small lymphocytic lymphoma
799656|NCT00255684|stage IV small lymphocytic lymphoma|stage iv small lymphocytic lymphoma
799657|NCT00255684|extranodal marginal zone B-cell lymphoma of mucosa-associated lymphoid tissue|extranodal marginal zone b-cell lymphoma of mucosa-associated lymphoid tissue
799658|NCT00255684|nodal marginal zone B-cell lymphoma|nodal marginal zone b-cell lymphoma
799659|NCT00255684|splenic marginal zone lymphoma|splenic marginal zone lymphoma
799727|NCT00255671|adult grade III meningioma|adult grade iii meningioma
799660|NCT00255684|adult acute myeloid leukemia with inv(16)(p13;q22)|adult acute myeloid leukemia with inv(16)(p13;q22)
799661|NCT00255684|adult acute myeloid leukemia with t(15;17)(q22;q12)|adult acute myeloid leukemia with t(15;17)(q22;q12)
799662|NCT00255684|de novo myelodysplastic syndromes|de novo myelodysplastic syndromes
799663|NCT00255684|recurrent mycosis fungoides/Sezary syndrome|recurrent mycosis fungoides/sezary syndrome
799664|NCT00255684|recurrent cutaneous T-cell non-Hodgkin lymphoma|recurrent cutaneous t-cell non-hodgkin lymphoma
799665|NCT00255684|recurrent childhood large cell lymphoma|recurrent childhood large cell lymphoma
799666|NCT00255684|recurrent childhood lymphoblastic lymphoma|recurrent childhood lymphoblastic lymphoma
799667|NCT00255684|recurrent childhood small noncleaved cell lymphoma|recurrent childhood small noncleaved cell lymphoma
799668|NCT00255684|recurrent adult diffuse large cell lymphoma|recurrent adult diffuse large cell lymphoma
799669|NCT00255684|recurrent adult diffuse mixed cell lymphoma|recurrent adult diffuse mixed cell lymphoma
799670|NCT00255684|recurrent adult diffuse small cleaved cell lymphoma|recurrent adult diffuse small cleaved cell lymphoma
799671|NCT00255684|recurrent grade 1 follicular lymphoma|recurrent grade 1 follicular lymphoma
799672|NCT00255684|recurrent grade 2 follicular lymphoma|recurrent grade 2 follicular lymphoma
799673|NCT00255684|recurrent grade 3 follicular lymphoma|recurrent grade 3 follicular lymphoma
799674|NCT00255684|recurrent marginal zone lymphoma|recurrent marginal zone lymphoma
799675|NCT00255684|recurrent small lymphocytic lymphoma|recurrent small lymphocytic lymphoma
799676|NCT00255684|recurrent adult Burkitt lymphoma|recurrent adult burkitt lymphoma
799677|NCT00255684|recurrent adult immunoblastic large cell lymphoma|recurrent adult immunoblastic large cell lymphoma
799678|NCT00255684|recurrent adult lymphoblastic lymphoma|recurrent adult lymphoblastic lymphoma
799679|NCT00255684|recurrent mantle cell lymphoma|recurrent mantle cell lymphoma
799680|NCT00255684|relapsing chronic myelogenous leukemia|relapsing chronic myelogenous leukemia
799681|NCT00255684|myelodysplastic/myeloproliferative neoplasm, unclassifiable|myelodysplastic/myeloproliferative neoplasm, unclassifiable
799682|NCT00255684|previously treated myelodysplastic syndromes|previously treated myelodysplastic syndromes
799683|NCT00255684|recurrent adult Hodgkin lymphoma|recurrent adult hodgkin lymphoma
799684|NCT00255684|secondary acute myeloid leukemia|secondary acute myeloid leukemia
799685|NCT00255684|secondary myelodysplastic syndromes|secondary myelodysplastic syndromes
799686|NCT00255684|noncontiguous stage II adult Burkitt lymphoma|noncontiguous stage ii adult burkitt lymphoma
799687|NCT00255684|noncontiguous stage II adult diffuse large cell lymphoma|noncontiguous stage ii adult diffuse large cell lymphoma
799688|NCT00255684|noncontiguous stage II adult diffuse mixed cell lymphoma|noncontiguous stage ii adult diffuse mixed cell lymphoma
799689|NCT00255684|noncontiguous stage II adult diffuse small cleaved cell lymphoma|noncontiguous stage ii adult diffuse small cleaved cell lymphoma
799690|NCT00255684|noncontiguous stage II adult immunoblastic large cell lymphoma|noncontiguous stage ii adult immunoblastic large cell lymphoma
799691|NCT00255684|noncontiguous stage II adult lymphoblastic lymphoma|noncontiguous stage ii adult lymphoblastic lymphoma
799692|NCT00255684|noncontiguous stage II grade 1 follicular lymphoma|noncontiguous stage ii grade 1 follicular lymphoma
799693|NCT00255684|noncontiguous stage II grade 2 follicular lymphoma|noncontiguous stage ii grade 2 follicular lymphoma
799694|NCT00255684|noncontiguous stage II grade 3 follicular lymphoma|noncontiguous stage ii grade 3 follicular lymphoma
799695|NCT00255684|noncontiguous stage II mantle cell lymphoma|noncontiguous stage ii mantle cell lymphoma
799696|NCT00255684|noncontiguous stage II marginal zone lymphoma|noncontiguous stage ii marginal zone lymphoma
799697|NCT00255684|noncontiguous stage II small lymphocytic lymphoma|noncontiguous stage ii small lymphocytic lymphoma
799698|NCT00255684|childhood myelodysplastic syndromes|childhood myelodysplastic syndromes
799699|NCT00255671|radiation toxicity|radiation toxicity
799700|NCT00255671|tumors metastatic to brain|tumors metastatic to brain
799701|NCT00255671|adult anaplastic astrocytoma|adult anaplastic astrocytoma
799702|NCT00255671|adult anaplastic ependymoma|adult anaplastic ependymoma
799703|NCT00255671|adult anaplastic meningioma|adult anaplastic meningioma
799704|NCT00255671|adult anaplastic oligodendroglioma|adult anaplastic oligodendroglioma
799705|NCT00255671|adult brain stem glioma|adult brain stem glioma
799706|NCT00255671|adult central nervous system germ cell tumor|adult central nervous system germ cell tumor
799707|NCT00255671|adult choroid plexus tumor|adult choroid plexus tumor
799708|NCT00255671|adult craniopharyngioma|adult craniopharyngioma
799709|NCT00255671|adult diffuse astrocytoma|adult diffuse astrocytoma
799710|NCT00255671|adult ependymoblastoma|adult ependymoblastoma
799711|NCT00255671|adult ependymoma|adult ependymoma
799712|NCT00255671|adult giant cell glioblastoma|adult giant cell glioblastoma
799713|NCT00255671|adult gliosarcoma|adult gliosarcoma
799714|NCT00255671|adult medulloblastoma|adult medulloblastoma
799715|NCT00255671|adult melanocytic lesion|adult melanocytic lesion
799716|NCT00255671|adult meningeal hemangiopericytoma|adult meningeal hemangiopericytoma
799717|NCT00255671|adult meningioma|adult meningioma
799718|NCT00255671|adult myxopapillary ependymoma|adult myxopapillary ependymoma
799719|NCT00255671|adult oligodendroglioma|adult oligodendroglioma
799720|NCT00255671|adult papillary meningioma|adult papillary meningioma
799721|NCT00255671|adult pineoblastoma|adult pineoblastoma
799722|NCT00255671|adult pineocytoma|adult pineocytoma
799723|NCT00255671|adult subependymoma|adult subependymoma
799724|NCT00255671|adult supratentorial primitive neuroectodermal tumor (PNET)|adult supratentorial primitive neuroectodermal tumor (pnet)
799725|NCT00255671|adult grade I meningioma|adult grade i meningioma
799726|NCT00255671|adult grade II meningioma|adult grade ii meningioma
799728|NCT00255671|adult mixed glioma|adult mixed glioma
799729|NCT00255671|recurrent adult brain tumor|recurrent adult brain tumor
799730|NCT00255671|adult pilocytic astrocytoma|adult pilocytic astrocytoma
799731|NCT00255671|adult glioblastoma|adult glioblastoma
799732|NCT00255671|ACTH-producing pituitary tumor|acth-producing pituitary tumor
799733|NCT00255671|growth hormone-producing pituitary tumor|growth hormone-producing pituitary tumor
799734|NCT00255671|nonfunctioning pituitary tumor|nonfunctioning pituitary tumor
799735|NCT00255671|prolactin-producing pituitary tumor|prolactin-producing pituitary tumor
799736|NCT00255671|recurrent pituitary tumor|recurrent pituitary tumor
799737|NCT00255671|TSH producing pituitary tumor|tsh producing pituitary tumor
799738|NCT00255619|Continuous ambulatory peritoneal dialysis (CAPD)|continuous ambulatory peritoneal dialysis (capd)
799739|NCT00255619|Peritonitis|peritonitis
799740|NCT00255619|ANDY-disc® (Fresenius Medical care)|andy-disc® (fresenius medical care)
799741|NCT00255619|Ultra® (Baxter)|ultra® (baxter)
799742|NCT00255619|Twin bag System|twin bag system
799743|NCT00255606|adenocarcinoma of the prostate|adenocarcinoma of the prostate
799744|NCT00255606|stage IV prostate cancer|stage iv prostate cancer
799745|NCT00255606|recurrent prostate cancer|recurrent prostate cancer
799746|NCT00255593|Kidney|kidney
799747|NCT00255593|Transplantation|transplantation
799748|NCT00255593|Immunosuppression|immunosuppression
799749|NCT00255593|Rituximab|rituximab
799750|NCT00255580|neuropathy|neuropathy
799751|NCT00255580|cannabis|cannabis
799752|NCT00255580|marijuana|marijuana
799753|NCT00255580|HIV|hiv
799754|NCT00255580|DSPN|dspn
799755|NCT00255567|Visceral Leishmaniasis|visceral leishmaniasis
799756|NCT00255567|Combination|combination
799757|NCT00255554|Borderline Personality Disorder|borderline personality disorder
799758|NCT00255554|BPD|bpd
799759|NCT00255554|Dialectical Behavior Therapy|dialectical behavior therapy
799760|NCT00255554|DBT|dbt
799761|NCT00255554|Escitalopram|escitalopram
799762|NCT00255554|Lexapro|lexapro
799763|NCT00255528|Pediatric hypertension|pediatric hypertension
799764|NCT00255502|Pediatric hypertension|pediatric hypertension
799765|NCT00255450|anemia|anemia
799766|NCT00255411|Conversion Disorder|conversion disorder
799767|NCT00255411|Somatoform Disorder|somatoform disorder
799768|NCT00255411|Involuntary Movement|involuntary movement
799769|NCT00255411|Childhood Abuse|childhood abuse
799770|NCT00255411|Depression|depression
799771|NCT00255411|Psychogenic Movement Disorder|psychogenic movement disorder
799772|NCT00255411|PMD|pmd
799773|NCT00255411|Non-Epileptic Seizure|non-epileptic seizure
799774|NCT00255411|NES|nes
799775|NCT00255411|Healthy Volunteer|healthy volunteer
799776|NCT00255411|HV|hv
799777|NCT00255398|Focal Segmental Glomerulosclerosis|focal segmental glomerulosclerosis
799778|NCT00255398|Minimal Change Disease|minimal change disease
799779|NCT00255398|Diabetic Nephropathy|diabetic nephropathy
799780|NCT00255398|Mass Spectrometry|mass spectrometry
799781|NCT00255398|Proteinuria|proteinuria
799782|NCT00255398|Idiopathic Nephrotic Syndrome|idiopathic nephrotic syndrome
799783|NCT00255398|Glomerular Disease|glomerular disease
799784|NCT00255398|FSG|fsg
799785|NCT00255398|Kidney Disease|kidney disease
799786|NCT00255385|Zinc|zinc
799787|NCT00255385|Iron|iron
799788|NCT00255385|Probiotics|probiotics
799789|NCT00255385|Prebiotics|prebiotics
799792|NCT00255385|Randomized controlled trial|randomized controlled trial
799793|NCT00255346|targeted therapy|targeted therapy
799794|NCT00255346|leukemia|leukemia
799795|NCT00255346|Acute myeloid leukemia (AML)|acute myeloid leukemia (aml)
799796|NCT00255346|Myelodysplastic syndrome (MDS)|myelodysplastic syndrome (mds)
799797|NCT00255346|Agnogenic myeloid metaplasia - myelofibrosis (MMM)|agnogenic myeloid metaplasia - myelofibrosis (mmm)
799798|NCT00255346|Hypereosinophilic syndrome (HES)|hypereosinophilic syndrome (hes)
799799|NCT00255346|Polycythemia vera (PV)|polycythemia vera (pv)
799800|NCT00255346|Mastocytosis|mastocytosis
799801|NCT00255346|CMML|cmml
799802|NCT00255320|healthy volunteers, headache, migraine, hemodynamics, VIP, SPECT, ultrasound|healthy volunteers, headache, migraine, hemodynamics, vip, spect, ultrasound
799803|NCT00255307|cold|cold
799804|NCT00255307|flu|flu
799805|NCT00255307|respiratory tract infection|respiratory tract infection
799806|NCT00255255|Asthma|asthma
799807|NCT00255242|Cystic Fibrosis|cystic fibrosis
799808|NCT00255242|Airway Inflammation|airway inflammation
799809|NCT00255242|Cytokines|cytokines
799810|NCT00255242|Simvastatin|simvastatin
799811|NCT00255242|HMG-CoA reductase inhibitors|hmg-coa reductase inhibitors
799812|NCT00255242|Rho GTP-ase|rho gtp-ase
799813|NCT00255229|irinotecan|irinotecan
799814|NCT00255229|5FU|5fu
799815|NCT00255229|amino acids|amino acids
799816|NCT00255229|heat shock protein|heat shock protein
799817|NCT00255190|Gastroesophageal Reflux Disease|gastroesophageal reflux disease
799818|NCT00255177|Hepatitis C|hepatitis c
799819|NCT00255164|Erosive Esophagitis|erosive esophagitis
799820|NCT00255151|Erosive Esophagitis|erosive esophagitis
799821|NCT00255138|Cancer|cancer
799822|NCT00255138|Cognitive Late Effects|cognitive late effects
799823|NCT00255138|Stimulants|stimulants
799824|NCT00255138|Atomoxetine|atomoxetine
799827|NCT00255125|Estrogen Receptor|estrogen receptor
799828|NCT00255125|Isoflavones|isoflavones
799829|NCT00255125|Prostate Neoplasm|prostate neoplasm
799830|NCT00255125|Soy Supplementation|soy supplementation
799832|NCT00255112|treatment|treatment
799833|NCT00255112|cognitive behavior therapy|cognitive behavior therapy
799834|NCT00255112|family|family
799835|NCT00255112|children|children
799836|NCT00255112|anxiety|anxiety
799837|NCT00255099|HIV|hiv
799838|NCT00255099|HIV-1|hiv-1
799839|NCT00255099|TMC125|tmc125
799840|NCT00255047|Pertussis|pertussis
799841|NCT00255047|Whooping cough|whooping cough
799842|NCT00255047|Filamentous Haemagglutinin|filamentous haemagglutinin
799843|NCT00255047|Fimbriae Types 2 and 3;|fimbriae types 2 and 3;
799844|NCT00255047|Pertactin|pertactin
799845|NCT00255047|Diphtheria|diphtheria
799846|NCT00255047|Tetanus|tetanus
799847|NCT00255047|Poliovirus Types 1, 2, and 3.|poliovirus types 1, 2, and 3.
799848|NCT00255034|chronic hepatitis C|chronic hepatitis c
799849|NCT00255034|pegylated interferon alfa-2b|pegylated interferon alfa-2b
799850|NCT00255034|ribavirin|ribavirin
799851|NCT00255034|Australia|australia
799852|NCT00255021|Diphteria|diphteria
799853|NCT00255021|Tetanus|tetanus
799854|NCT00255021|Pertussis|pertussis
799855|NCT00255021|Poliomyelitis|poliomyelitis
799856|NCT00255021|Haemophilus influenzae type b|haemophilus influenzae type b
799857|NCT00255021|acellular|acellular
799858|NCT00255008|chronic hepatitis C|chronic hepatitis c
799859|NCT00255008|pegylated interferon alfa-2b|pegylated interferon alfa-2b
799860|NCT00255008|ribavirin|ribavirin
799861|NCT00255008|Asia|asia
799862|NCT00254995|Meningitis|meningitis
799863|NCT00254995|Meningococcal disease|meningococcal disease
799864|NCT00254995|Menactra vaccine|menactra vaccine
799865|NCT00254969|Diphteria|diphteria
799866|NCT00254969|tetanus|tetanus
799867|NCT00254969|haemophilus influenzae type b|haemophilus influenzae type b
799868|NCT00254969|poliomyelitis|poliomyelitis
799869|NCT00254969|pertussis|pertussis
799870|NCT00254956|Diseases|diseases
799871|NCT00254956|respiratory tract diseases|respiratory tract diseases
799872|NCT00254956|respiratory hypersensitivity|respiratory hypersensitivity
799873|NCT00254956|asthma|asthma
799874|NCT00254930|learning disorder|learning disorder
799875|NCT00254930|children|children
799876|NCT00254930|behaviour disorder|behaviour disorder
799877|NCT00254930|risperidone|risperidone
799878|NCT00254917|Pentaxim|pentaxim
799879|NCT00254904|advanced carcinoma, non-small cell lung, Phase III, Gemcitabine, Gemzar, Cisplatin, Platinol, PF-3512676, immunotherapy, immune modulator|advanced carcinoma, non-small cell lung, phase iii, gemcitabine, gemzar, cisplatin, platinol, pf-3512676, immunotherapy, immune modulator
799880|NCT00254891|advanced carcinoma, non-small cell lung, Phase III, Paclitaxel, Taxol, Carboplatin, Paraplatin, PF-3512676, immunotherapy, immune modulator|advanced carcinoma, non-small cell lung, phase iii, paclitaxel, taxol, carboplatin, paraplatin, pf-3512676, immunotherapy, immune modulator
799881|NCT00254878|ADHD, Methylphenidate hydrochloride, modified-release|adhd, methylphenidate hydrochloride, modified-release
799882|NCT00254865|Transdermal contraception|transdermal contraception
799883|NCT00254865|contraceptive|contraceptive
799884|NCT00254865|hormonal, steroid contraception|hormonal, steroid contraception
799885|NCT00254865|ethinyl estradiol|ethinyl estradiol
799886|NCT00254865|progesterone|progesterone
799887|NCT00254865|EVRA|evra
799888|NCT00254865|CILEST|cilest
799889|NCT00254852|Primary lumbar fusion|primary lumbar fusion
799890|NCT00254852|Demineralized Bone Matrix|demineralized bone matrix
799891|NCT00254852|DBM|dbm
799892|NCT00254852|Optecure|optecure
799893|NCT00254852|Allograft|allograft
799894|NCT00254852|Autograft|autograft
799895|NCT00254852|Lumbar fusion|lumbar fusion
799896|NCT00254852|Interbody fusion|interbody fusion
799897|NCT00254852|Instrumented fusion|instrumented fusion
799898|NCT00254852|Non-instrumented fusion|non-instrumented fusion
799899|NCT00254852|Exactech|exactech
799900|NCT00254852|Spinal fusion|spinal fusion
799901|NCT00254839|Oral malodor|oral malodor
799902|NCT00254839|Dental implants|dental implants
799903|NCT00254826|Yellow Fever Virus Vaccination|yellow fever virus vaccination
799904|NCT00254813|Schizophrenia|schizophrenia
799905|NCT00254813|Schizoaffective disorder|schizoaffective disorder
799906|NCT00254800|diabetes|diabetes
799907|NCT00254800|exenatide|exenatide
799908|NCT00254800|Amylin|amylin
799909|NCT00254800|Lilly|lilly
799910|NCT00254787|Schizophrenia|schizophrenia
799911|NCT00254774|Bipolar Disorder I or II with Rapid Cycling|bipolar disorder i or ii with rapid cycling
799912|NCT00254761|cannabis|cannabis
799913|NCT00254761|marijuana|marijuana
799914|NCT00254761|neuropathy|neuropathy
799915|NCT00254761|antinociception|antinociception
799916|NCT00254761|mood|mood
799917|NCT00254761|cognition|cognition
799918|NCT00254748|Borderline personality disorder|borderline personality disorder
799919|NCT00254735|Obsessive Compulsive Disorder (OCD)|obsessive compulsive disorder (ocd)
799920|NCT00254722|Traumatic Brain Injury|traumatic brain injury
799921|NCT00254722|Stem Cell|stem cell
799922|NCT00254709|kidney transplant|kidney transplant
799923|NCT00254709|elderly|elderly
799924|NCT00254696|bacterial infection|bacterial infection
799925|NCT00254683|Rectal Cancer|rectal cancer
799926|NCT00254683|Positron Emission Tomography|positron emission tomography
799927|NCT00254683|Fluorodeoxyglucose F18|fluorodeoxyglucose f18
799928|NCT00254683|Computed Tomography|computed tomography
799929|NCT00254683|Neoadjuvant Therapy|neoadjuvant therapy
799930|NCT00254683|Chemotherapy|chemotherapy
799931|NCT00254683|Radiotherapy|radiotherapy
799932|NCT00254670|Alcohol|alcohol
799933|NCT00254670|Naltrexone|naltrexone
799934|NCT00254657|Fibromyalgia|fibromyalgia
799935|NCT00254657|Fibro|fibro
799936|NCT00254657|Keppra|keppra
799937|NCT00254657|Levetiracetam|levetiracetam
799938|NCT00254644|phonological treatment|phonological treatment
799939|NCT00254644|language|language
799940|NCT00254644|fMRI|fmri
799941|NCT00254631|long bone fracture|long bone fracture
799942|NCT00254631|open fractures|open fractures
799943|NCT00254631|closed fractures|closed fractures
799944|NCT00254631|trauma|trauma
799945|NCT00254618|ulcerative colitis; pharmacokinetics; pediatrics|ulcerative colitis; pharmacokinetics; pediatrics
799946|NCT00254605|imaging|imaging
799947|NCT00254605|adaptive optics scanning laser ophthalmoscope|adaptive optics scanning laser ophthalmoscope
799948|NCT00254605|optical coherence tomography|optical coherence tomography
799949|NCT00254605|electroretinography|electroretinography
799950|NCT00254592|Inflammatory|inflammatory
799951|NCT00254592|Breast Cancer|breast cancer
799952|NCT00254592|Female|female
799953|NCT00254592|Neo-adjuvant|neo-adjuvant
799954|NCT00254592|HER-2 positive|her-2 positive
799955|NCT00254592|Hormone receptor|hormone receptor
799956|NCT00254579|refractory melanoma|refractory melanoma
799957|NCT00254579|malignant melanoma|malignant melanoma
799958|NCT00254566|Azithromycin SR; Moxifloxacin; Acute exacerbation of chronic bronchitis (AECB)|azithromycin sr; moxifloxacin; acute exacerbation of chronic bronchitis (aecb)
799959|NCT00254540|Ph2, RCC, SU011248, SUNITINIB|ph2, rcc, su011248, sunitinib
799960|NCT00254527|Methicillin Resistant Staphylococcus aureus|methicillin resistant staphylococcus aureus
799961|NCT00254527|Children|children
799962|NCT00254527|Colonization|colonization
799963|NCT00254527|Risk Factor|risk factor
799964|NCT00254501|diabetes|diabetes
799965|NCT00254475|Valsartan|valsartan
799966|NCT00254475|simvastatin|simvastatin
799967|NCT00254475|hypertension|hypertension
799968|NCT00254475|hypercholesterolemia|hypercholesterolemia
799969|NCT00254475|angiotensin II receptor blocker|angiotensin ii receptor blocker
799970|NCT00254462|ADHD|adhd
799971|NCT00254462|Atomoxetine|atomoxetine
799972|NCT00254436|Epoetin Alfa|epoetin alfa
799973|NCT00254436|Epogen|epogen
799974|NCT00254436|Erythropoietin|erythropoietin
799975|NCT00254410|Chronic Lymphocytic Leukemia|chronic lymphocytic leukemia
799976|NCT00254410|Untreated|untreated
799977|NCT00254410|Fludarabine|fludarabine
799978|NCT00254410|Fludara|fludara
799979|NCT00254410|Cyclophosphamide|cyclophosphamide
799980|NCT00254410|Cytoxan|cytoxan
799981|NCT00254410|Mitoxantrone|mitoxantrone
799982|NCT00254410|Novantrone|novantrone
799983|NCT00254410|Rituximab|rituximab
799984|NCT00254410|Rituxan|rituxan
799985|NCT00254410|Pegylated Filgrastim|pegylated filgrastim
799986|NCT00254410|Neupogen|neupogen
799987|NCT00254397|Melanoma|melanoma
799988|NCT00254397|Uveal Melanoma|uveal melanoma
799989|NCT00254397|Peptide Vaccine|peptide vaccine
800885|NCT00251147|mini-open|mini-open
799990|NCT00254397|LHRH-agonist|lhrh-agonist
799991|NCT00254397|Leuprolide|leuprolide
799992|NCT00254397|Lupron|lupron
799993|NCT00254397|MAGE-3 Peptide|mage-3 peptide
799994|NCT00254397|MAGE-3|mage-3
799995|NCT00254397|GP100 Peptide|gp100 peptide
799996|NCT00254397|Melanoma vaccines|melanoma vaccines
799997|NCT00254397|Tumor fighting immune cells|tumor fighting immune cells
799998|NCT00254397|T cells|t cells
799999|NCT00254397|Skin Cancer|skin cancer
800000|NCT00254397|Eye Cancer|eye cancer
800001|NCT00254358|Nicotine|nicotine
800002|NCT00254358|Dopamine|dopamine
800003|NCT00254358|IBZM|ibzm
800004|NCT00254345|biofilm|biofilm
800005|NCT00254345|adhesion|adhesion
800006|NCT00254345|liquid polish|liquid polish
800007|NCT00254345|bonding resin|bonding resin
800008|NCT00254345|PMMA Polymethylmetacrylate|pmma polymethylmetacrylate
800009|NCT00254345|provisional crown|provisional crown
800010|NCT00254345|no antibiotics treatment three months prior to experiment|no antibiotics treatment three months prior to experiment
800011|NCT00254345|no mouth rinse with oral solutions one month prior to experiment|no mouth rinse with oral solutions one month prior to experiment
800012|NCT00254332|Cutaneous T-cell Lymphoma|cutaneous t-cell lymphoma
800013|NCT00254332|Sezary Syndrome|sezary syndrome
800014|NCT00254332|Mycosis Fungoides|mycosis fungoides
800015|NCT00254332|Denileukin Diftitox|denileukin diftitox
800016|NCT00254306|Ecstasy|ecstasy
800017|NCT00254306|D2 Dopamine Receptor|d2 dopamine receptor
800018|NCT00254306|IBZM|ibzm
800019|NCT00254306|MDMA|mdma
800020|NCT00254280|Warts|warts
800021|NCT00254280|Intense pulsed light|intense pulsed light
800022|NCT00254280|RCT|rct
800023|NCT00254280|Recalcitrant hand and foot warts|recalcitrant hand and foot warts
800821|NCT00251329|pCR|pcr
800024|NCT00254267|Gastrointestinal Stromal Tumor, Imatinib Mesylate Resistance, Phase2 study, AMG 706|gastrointestinal stromal tumor, imatinib mesylate resistance, phase2 study, amg 706
800025|NCT00254254|diabetes|diabetes
800026|NCT00254254|adolescents|adolescents
800027|NCT00254254|exenatide|exenatide
800028|NCT00254254|Amylin|amylin
800029|NCT00254254|Lilly|lilly
800030|NCT00254241|Schizophrenia|schizophrenia
800031|NCT00254228|Balance|balance
800032|NCT00254228|Vestibular|vestibular
800033|NCT00254228|Electrotactile|electrotactile
800034|NCT00254228|BrainPort|brainport
800035|NCT00254228|Sensory substitution|sensory substitution
800036|NCT00254228|Tongue|tongue
800037|NCT00254215|overweight|overweight
800038|NCT00254215|obesity|obesity
800039|NCT00254215|glycemic index|glycemic index
800040|NCT00254215|glycemic load|glycemic load
800041|NCT00254215|high protein diet|high protein diet
800042|NCT00254215|blood cholesterol|blood cholesterol
800043|NCT00254202|Schizophrenia|schizophrenia
800044|NCT00254202|Atypical antipsychotic|atypical antipsychotic
800045|NCT00254202|psychosis|psychosis
800046|NCT00254189|Ovulation|ovulation
800047|NCT00254189|Oral Contraceptive|oral contraceptive
800048|NCT00254176|Neonate|neonate
800049|NCT00254176|Glutathione|glutathione
800050|NCT00254176|Cysteine|cysteine
800051|NCT00254176|Sepsis|sepsis
800052|NCT00254176|Stable Isotope|stable isotope
800053|NCT00254137|capecitabine|capecitabine
800054|NCT00254137|irinotecan|irinotecan
800055|NCT00254137|cetuximab|cetuximab
800056|NCT00254137|oxaliplatin|oxaliplatin
800057|NCT00254137|colorectal cancer|colorectal cancer
800058|NCT00254124|obesity|obesity
800059|NCT00254124|type 2 diabetes mellitus|type 2 diabetes mellitus
800060|NCT00254124|portion control|portion control
800061|NCT00254111|osteoarthritis|osteoarthritis
800062|NCT00254111|hand|hand
800063|NCT00254111|laser|laser
800064|NCT00254111|device|device
800065|NCT00254111|hand pain|hand pain
800066|NCT00254111|stiffness|stiffness
800067|NCT00254085|Type 2 diabtes|type 2 diabtes
800068|NCT00254085|Postprandial hyperglycemia|postprandial hyperglycemia
800069|NCT00254085|Insulin treatment|insulin treatment
800070|NCT00254072|Morbid Obesity|morbid obesity
800071|NCT00254072|Laparoscopic Gastric Bypass|laparoscopic gastric bypass
800072|NCT00254072|Staple Line Hemorrhage|staple line hemorrhage
800073|NCT00254059|OSAHS, OSA, CPAP, polysomnography, overnight oximetry, Obstructive sleep apnea, apnea hypopnea index, AHI, Obstructive Sleep Apnea Hypopnea Syndrome|osahs, osa, cpap, polysomnography, overnight oximetry, obstructive sleep apnea, apnea hypopnea index, ahi, obstructive sleep apnea hypopnea syndrome
800074|NCT00254046|HIV|hiv
800075|NCT00254046|HIV-1|hiv-1
800076|NCT00254046|TMC125|tmc125
800077|NCT00254033|Alzheimer's Disease|alzheimer's disease
800078|NCT00254033|Apathy|apathy
800079|NCT00254033|Brain Reward System|brain reward system
800080|NCT00254033|Dopamine|dopamine
800081|NCT00254033|Dextroamphetamine Challenge|dextroamphetamine challenge
800082|NCT00254033|Methylphenidate|methylphenidate
800083|NCT00254020|stroke|stroke
800084|NCT00254020|depression|depression
800085|NCT00254020|cytokines|cytokines
800086|NCT00254020|serotonin|serotonin
800087|NCT00254020|citalopram|citalopram
800088|NCT00254007|depression|depression
800089|NCT00254007|traumatic brain injury|traumatic brain injury
800090|NCT00254007|serotonin transporter|serotonin transporter
801970|NCT00247130|Omeprazole|omeprazole
800091|NCT00254007|genetic polymorphisms|genetic polymorphisms
800092|NCT00254007|citalopram|citalopram
800093|NCT00253981|Pain, Intractable|pain, intractable
800094|NCT00253981|Infrared Rays|infrared rays
800095|NCT00253981|Leg|leg
800096|NCT00253968|Primary Insomnia|primary insomnia
800097|NCT00253968|Sleeplessness|sleeplessness
800098|NCT00253968|Early Awakening|early awakening
800099|NCT00253968|Chronic Insomnia|chronic insomnia
800100|NCT00253929|adenosine|adenosine
800101|NCT00253929|polymorphisms|polymorphisms
800102|NCT00253929|blood flow|blood flow
800103|NCT00253929|adenosine A2a receptor|adenosine a2a receptor
800104|NCT00253929|AMP deaminase|amp deaminase
800105|NCT00253903|Primary Insomnia|primary insomnia
800106|NCT00253903|Sleeplessness|sleeplessness
800107|NCT00253903|Early Awakening|early awakening
800108|NCT00253903|Chronic Insomnia|chronic insomnia
800109|NCT00253890|sleep quality|sleep quality
800110|NCT00253890|methadone|methadone
800111|NCT00253890|substance use|substance use
800112|NCT00253877|Osteoarthritis|osteoarthritis
800113|NCT00253877|Hip Resurfacing|hip resurfacing
800114|NCT00253864|shoulder surgery|shoulder surgery
800115|NCT00253864|prospective database|prospective database
800116|NCT00253864|long term outcome|long term outcome
800117|NCT00253851|DVT|dvt
800118|NCT00253851|Osteoarthritis|osteoarthritis
800119|NCT00253851|Total Knee Arthroplasty|total knee arthroplasty
800120|NCT00253838|revision hip arthroplasty|revision hip arthroplasty
800121|NCT00253838|bone mineral density|bone mineral density
800122|NCT00253812|colonoscopy, sigmoidoscopy, chromoendoscopy, autofluorescence, narrow band imaging, colorectal cancer, polyp, adenoma,rectal remnant, FAP|colonoscopy, sigmoidoscopy, chromoendoscopy, autofluorescence, narrow band imaging, colorectal cancer, polyp, adenoma,rectal remnant, fap
800123|NCT00253786|diabetes|diabetes
800125|NCT00253773|sulfer amino acids|sulfer amino acids
800126|NCT00253773|redox status|redox status
800127|NCT00253760|redox|redox
800128|NCT00253760|sulfur amino acids|sulfur amino acids
800129|NCT00253760|glutathione|glutathione
800130|NCT00253760|aging|aging
800131|NCT00253734|Influenza|influenza
800132|NCT00253721|adult anaplastic astrocytoma|adult anaplastic astrocytoma
800133|NCT00253721|adult brain stem glioma|adult brain stem glioma
800134|NCT00253721|adult diffuse astrocytoma|adult diffuse astrocytoma
800135|NCT00253721|adult central nervous system germ cell tumor|adult central nervous system germ cell tumor
800136|NCT00253721|adult medulloblastoma|adult medulloblastoma
800137|NCT00253721|adult supratentorial primitive neuroectodermal tumor (PNET)|adult supratentorial primitive neuroectodermal tumor (pnet)
800138|NCT00253721|adult anaplastic oligodendroglioma|adult anaplastic oligodendroglioma
800139|NCT00253721|adult oligodendroglioma|adult oligodendroglioma
800140|NCT00253721|adult pineoblastoma|adult pineoblastoma
800141|NCT00253721|tumors metastatic to brain|tumors metastatic to brain
800142|NCT00253721|adult mixed glioma|adult mixed glioma
800143|NCT00253721|recurrent adult brain tumor|recurrent adult brain tumor
800144|NCT00253721|primary central nervous system non-Hodgkin lymphoma|primary central nervous system non-hodgkin lymphoma
800145|NCT00253708|depression|depression
800146|NCT00253708|nausea and vomiting|nausea and vomiting
800147|NCT00253708|pain|pain
800148|NCT00253708|psychosocial effects of cancer and its treatment|psychosocial effects of cancer and its treatment
800149|NCT00253708|stage IIIA non-small cell lung cancer|stage iiia non-small cell lung cancer
800150|NCT00253708|stage IIIB non-small cell lung cancer|stage iiib non-small cell lung cancer
800151|NCT00253708|stage IV non-small cell lung cancer|stage iv non-small cell lung cancer
800152|NCT00253708|extensive stage small cell lung cancer|extensive stage small cell lung cancer
800153|NCT00253708|stage III gastric cancer|stage iii gastric cancer
800154|NCT00253708|stage III esophageal cancer|stage iii esophageal cancer
800155|NCT00253708|localized unresectable adult primary liver cancer|localized unresectable adult primary liver cancer
800156|NCT00253708|stage III colon cancer|stage iii colon cancer
800157|NCT00253708|stage IV renal cell cancer|stage iv renal cell cancer
800158|NCT00253708|stage IV bladder cancer|stage iv bladder cancer
800159|NCT00253708|stage IV prostate cancer|stage iv prostate cancer
800160|NCT00253708|stage IV breast cancer|stage iv breast cancer
800161|NCT00253708|stage IV ovarian epithelial cancer|stage iv ovarian epithelial cancer
800162|NCT00253708|advanced adult primary liver cancer|advanced adult primary liver cancer
800163|NCT00253708|stage IV melanoma|stage iv melanoma
800164|NCT00253708|stage IV ovarian germ cell tumor|stage iv ovarian germ cell tumor
800165|NCT00253708|ovarian sarcoma|ovarian sarcoma
800166|NCT00253708|ovarian stromal cancer|ovarian stromal cancer
800167|NCT00253708|recurrent small cell lung cancer|recurrent small cell lung cancer
800168|NCT00253708|recurrent adult primary liver cancer|recurrent adult primary liver cancer
800169|NCT00253708|recurrent colon cancer|recurrent colon cancer
800170|NCT00253708|recurrent esophageal cancer|recurrent esophageal cancer
800171|NCT00253708|recurrent gastric cancer|recurrent gastric cancer
800172|NCT00253708|recurrent non-small cell lung cancer|recurrent non-small cell lung cancer
800173|NCT00253708|recurrent bladder cancer|recurrent bladder cancer
800174|NCT00253708|recurrent breast cancer|recurrent breast cancer
800175|NCT00253708|recurrent ovarian epithelial cancer|recurrent ovarian epithelial cancer
800176|NCT00253708|recurrent ovarian germ cell tumor|recurrent ovarian germ cell tumor
800177|NCT00253708|recurrent prostate cancer|recurrent prostate cancer
800178|NCT00253708|recurrent renal cell cancer|recurrent renal cell cancer
800179|NCT00253708|recurrent melanoma|recurrent melanoma
800180|NCT00253669|thromboembolism|thromboembolism
800181|NCT00253669|adult anaplastic astrocytoma|adult anaplastic astrocytoma
800182|NCT00253669|adult anaplastic oligodendroglioma|adult anaplastic oligodendroglioma
800183|NCT00253669|adult glioblastoma|adult glioblastoma
800184|NCT00253669|adult giant cell glioblastoma|adult giant cell glioblastoma
800185|NCT00253669|adult gliosarcoma|adult gliosarcoma
800186|NCT00253643|prostate cancer|prostate cancer
800187|NCT00253643|precancerous condition|precancerous condition
800188|NCT00253591|stage I non-small cell lung cancer|stage i non-small cell lung cancer
800189|NCT00253591|stage II non-small cell lung cancer|stage ii non-small cell lung cancer
800190|NCT00253591|stage IIIA non-small cell lung cancer|stage iiia non-small cell lung cancer
800191|NCT00253591|stage IIIB non-small cell lung cancer|stage iiib non-small cell lung cancer
800192|NCT00253565|unspecified adult solid tumor, protocol specific|unspecified adult solid tumor, protocol specific
800193|NCT00253552|graft versus host disease|graft versus host disease
800194|NCT00253552|adult acute myeloid leukemia with 11q23 (MLL) abnormalities|adult acute myeloid leukemia with 11q23 (mll) abnormalities
800195|NCT00253552|adult acute myeloid leukemia with inv(16)(p13;q22)|adult acute myeloid leukemia with inv(16)(p13;q22)
800196|NCT00253552|adult acute myeloid leukemia with t(15;17)(q22;q12)|adult acute myeloid leukemia with t(15;17)(q22;q12)
800197|NCT00253552|adult acute myeloid leukemia with t(16;16)(p13;q22)|adult acute myeloid leukemia with t(16;16)(p13;q22)
800198|NCT00253552|adult acute myeloid leukemia with t(8;21)(q22;q22)|adult acute myeloid leukemia with t(8;21)(q22;q22)
800199|NCT00253552|accelerated phase chronic myelogenous leukemia|accelerated phase chronic myelogenous leukemia
800200|NCT00253552|adult acute lymphoblastic leukemia in remission|adult acute lymphoblastic leukemia in remission
800417|NCT00253266|Augmentation|augmentation
800201|NCT00253552|adult acute myeloid leukemia in remission|adult acute myeloid leukemia in remission
800202|NCT00253552|atypical chronic myeloid leukemia|atypical chronic myeloid leukemia
800203|NCT00253552|blastic phase chronic myelogenous leukemia|blastic phase chronic myelogenous leukemia
800204|NCT00253552|childhood acute lymphoblastic leukemia in remission|childhood acute lymphoblastic leukemia in remission
800205|NCT00253552|childhood acute myeloid leukemia in remission|childhood acute myeloid leukemia in remission
800206|NCT00253552|childhood chronic myelogenous leukemia|childhood chronic myelogenous leukemia
800207|NCT00253552|chronic eosinophilic leukemia|chronic eosinophilic leukemia
800208|NCT00253552|chronic idiopathic myelofibrosis|chronic idiopathic myelofibrosis
800209|NCT00253552|chronic myelomonocytic leukemia|chronic myelomonocytic leukemia
800210|NCT00253552|chronic neutrophilic leukemia|chronic neutrophilic leukemia
800211|NCT00253552|chronic phase chronic myelogenous leukemia|chronic phase chronic myelogenous leukemia
800212|NCT00253552|de novo myelodysplastic syndromes|de novo myelodysplastic syndromes
800213|NCT00253552|extranodal marginal zone B-cell lymphoma of mucosa-associated lymphoid tissue|extranodal marginal zone b-cell lymphoma of mucosa-associated lymphoid tissue
800214|NCT00253552|juvenile myelomonocytic leukemia|juvenile myelomonocytic leukemia
800215|NCT00253552|myelodysplastic/myeloproliferative disease, unclassifiable|myelodysplastic/myeloproliferative disease, unclassifiable
800216|NCT00253552|nodal marginal zone B-cell lymphoma|nodal marginal zone b-cell lymphoma
800217|NCT00253552|noncontiguous stage II adult Burkitt lymphoma|noncontiguous stage ii adult burkitt lymphoma
800218|NCT00253552|noncontiguous stage II adult diffuse large cell lymphoma|noncontiguous stage ii adult diffuse large cell lymphoma
800219|NCT00253552|noncontiguous stage II adult diffuse mixed cell lymphoma|noncontiguous stage ii adult diffuse mixed cell lymphoma
800220|NCT00253552|noncontiguous stage II adult diffuse small cleaved cell lymphoma|noncontiguous stage ii adult diffuse small cleaved cell lymphoma
800221|NCT00253552|noncontiguous stage II adult immunoblastic large cell lymphoma|noncontiguous stage ii adult immunoblastic large cell lymphoma
800222|NCT00253552|noncontiguous stage II adult lymphoblastic lymphoma|noncontiguous stage ii adult lymphoblastic lymphoma
800223|NCT00253552|noncontiguous stage II grade 1 follicular lymphoma|noncontiguous stage ii grade 1 follicular lymphoma
800224|NCT00253552|noncontiguous stage II grade 2 follicular lymphoma|noncontiguous stage ii grade 2 follicular lymphoma
800225|NCT00253552|noncontiguous stage II grade 3 follicular lymphoma|noncontiguous stage ii grade 3 follicular lymphoma
800226|NCT00253552|noncontiguous stage II mantle cell lymphoma|noncontiguous stage ii mantle cell lymphoma
800227|NCT00253552|noncontiguous stage II marginal zone lymphoma|noncontiguous stage ii marginal zone lymphoma
800228|NCT00253552|noncontiguous stage II small lymphocytic lymphoma|noncontiguous stage ii small lymphocytic lymphoma
800229|NCT00253552|previously treated myelodysplastic syndromes|previously treated myelodysplastic syndromes
800230|NCT00253552|recurrent adult acute lymphoblastic leukemia|recurrent adult acute lymphoblastic leukemia
800231|NCT00253552|recurrent adult acute myeloid leukemia|recurrent adult acute myeloid leukemia
800232|NCT00253552|recurrent adult Burkitt lymphoma|recurrent adult burkitt lymphoma
800233|NCT00253552|recurrent adult Hodgkin lymphoma|recurrent adult hodgkin lymphoma
800234|NCT00253552|recurrent adult diffuse large cell lymphoma|recurrent adult diffuse large cell lymphoma
800235|NCT00253552|recurrent adult diffuse mixed cell lymphoma|recurrent adult diffuse mixed cell lymphoma
800236|NCT00253552|recurrent adult diffuse small cleaved cell lymphoma|recurrent adult diffuse small cleaved cell lymphoma
800237|NCT00253552|recurrent adult immunoblastic large cell lymphoma|recurrent adult immunoblastic large cell lymphoma
800238|NCT00253552|recurrent adult lymphoblastic lymphoma|recurrent adult lymphoblastic lymphoma
801971|NCT00247130|Ranitidine|ranitidine
800239|NCT00253552|recurrent/refractory childhood Hodgkin lymphoma|recurrent/refractory childhood hodgkin lymphoma
800240|NCT00253552|recurrent childhood acute lymphoblastic leukemia|recurrent childhood acute lymphoblastic leukemia
800241|NCT00253552|recurrent childhood acute myeloid leukemia|recurrent childhood acute myeloid leukemia
800242|NCT00253552|recurrent childhood large cell lymphoma|recurrent childhood large cell lymphoma
800243|NCT00253552|recurrent childhood lymphoblastic lymphoma|recurrent childhood lymphoblastic lymphoma
800244|NCT00253552|recurrent childhood rhabdomyosarcoma|recurrent childhood rhabdomyosarcoma
800245|NCT00253552|recurrent childhood small noncleaved cell lymphoma|recurrent childhood small noncleaved cell lymphoma
800246|NCT00253552|recurrent cutaneous T-cell non-Hodgkin lymphoma|recurrent cutaneous t-cell non-hodgkin lymphoma
800247|NCT00253552|recurrent grade 1 follicular lymphoma|recurrent grade 1 follicular lymphoma
800248|NCT00253552|recurrent grade 2 follicular lymphoma|recurrent grade 2 follicular lymphoma
800249|NCT00253552|recurrent grade 3 follicular lymphoma|recurrent grade 3 follicular lymphoma
800250|NCT00253552|recurrent mantle cell lymphoma|recurrent mantle cell lymphoma
800251|NCT00253552|recurrent marginal zone lymphoma|recurrent marginal zone lymphoma
800252|NCT00253552|recurrent mycosis fungoides/Sezary syndrome|recurrent mycosis fungoides/sezary syndrome
800253|NCT00253552|recurrent small lymphocytic lymphoma|recurrent small lymphocytic lymphoma
800254|NCT00253552|refractory chronic lymphocytic leukemia|refractory chronic lymphocytic leukemia
800255|NCT00253552|refractory hairy cell leukemia|refractory hairy cell leukemia
800256|NCT00253552|refractory multiple myeloma|refractory multiple myeloma
800257|NCT00253552|relapsing chronic myelogenous leukemia|relapsing chronic myelogenous leukemia
800258|NCT00253552|secondary acute myeloid leukemia|secondary acute myeloid leukemia
800259|NCT00253552|secondary myelodysplastic syndromes|secondary myelodysplastic syndromes
800260|NCT00253552|splenic marginal zone lymphoma|splenic marginal zone lymphoma
800261|NCT00253552|stage I multiple myeloma|stage i multiple myeloma
800262|NCT00253552|stage II multiple myeloma|stage ii multiple myeloma
800263|NCT00253552|stage III adult Burkitt lymphoma|stage iii adult burkitt lymphoma
800264|NCT00253552|stage III adult Hodgkin lymphoma|stage iii adult hodgkin lymphoma
800265|NCT00253552|stage III adult diffuse large cell lymphoma|stage iii adult diffuse large cell lymphoma
800266|NCT00253552|stage III adult diffuse mixed cell lymphoma|stage iii adult diffuse mixed cell lymphoma
800267|NCT00253552|stage III adult diffuse small cleaved cell lymphoma|stage iii adult diffuse small cleaved cell lymphoma
800268|NCT00253552|stage III adult immunoblastic large cell lymphoma|stage iii adult immunoblastic large cell lymphoma
800269|NCT00253552|stage III adult lymphoblastic lymphoma|stage iii adult lymphoblastic lymphoma
800270|NCT00253552|stage III chronic lymphocytic leukemia|stage iii chronic lymphocytic leukemia
800271|NCT00253552|stage III grade 1 follicular lymphoma|stage iii grade 1 follicular lymphoma
800272|NCT00253552|stage III grade 2 follicular lymphoma|stage iii grade 2 follicular lymphoma
800273|NCT00253552|stage III grade 3 follicular lymphoma|stage iii grade 3 follicular lymphoma
800274|NCT00253552|stage III mantle cell lymphoma|stage iii mantle cell lymphoma
800275|NCT00253552|stage III marginal zone lymphoma|stage iii marginal zone lymphoma
800276|NCT00253552|stage III multiple myeloma|stage iii multiple myeloma
800277|NCT00253552|stage III small lymphocytic lymphoma|stage iii small lymphocytic lymphoma
800278|NCT00253552|stage IV adult Burkitt lymphoma|stage iv adult burkitt lymphoma
800279|NCT00253552|stage IV adult Hodgkin lymphoma|stage iv adult hodgkin lymphoma
800280|NCT00253552|stage IV adult diffuse large cell lymphoma|stage iv adult diffuse large cell lymphoma
800281|NCT00253552|stage IV adult diffuse mixed cell lymphoma|stage iv adult diffuse mixed cell lymphoma
800282|NCT00253552|stage IV adult diffuse small cleaved cell lymphoma|stage iv adult diffuse small cleaved cell lymphoma
800283|NCT00253552|stage IV adult immunoblastic large cell lymphoma|stage iv adult immunoblastic large cell lymphoma
800284|NCT00253552|stage IV adult lymphoblastic lymphoma|stage iv adult lymphoblastic lymphoma
800285|NCT00253552|stage IV chronic lymphocytic leukemia|stage iv chronic lymphocytic leukemia
800286|NCT00253552|stage IV grade 1 follicular lymphoma|stage iv grade 1 follicular lymphoma
800287|NCT00253552|stage IV grade 2 follicular lymphoma|stage iv grade 2 follicular lymphoma
800288|NCT00253552|stage IV grade 3 follicular lymphoma|stage iv grade 3 follicular lymphoma
800289|NCT00253552|stage IV mantle cell lymphoma|stage iv mantle cell lymphoma
800290|NCT00253552|stage IV marginal zone lymphoma|stage iv marginal zone lymphoma
800291|NCT00253552|stage IV small lymphocytic lymphoma|stage iv small lymphocytic lymphoma
800292|NCT00253552|childhood myelodysplastic syndromes|childhood myelodysplastic syndromes
800293|NCT00253539|hereditary breast/ovarian cancer (BRCA1, BRCA2)|hereditary breast/ovarian cancer (brca1, brca2)
800294|NCT00253539|breast cancer|breast cancer
800295|NCT00253513|adult acute lymphoblastic leukemia in remission|adult acute lymphoblastic leukemia in remission
800296|NCT00253513|adult acute myeloid leukemia in remission|adult acute myeloid leukemia in remission
800297|NCT00253513|childhood acute lymphoblastic leukemia in remission|childhood acute lymphoblastic leukemia in remission
800298|NCT00253513|recurrent adult acute lymphoblastic leukemia|recurrent adult acute lymphoblastic leukemia
800299|NCT00253513|recurrent adult acute myeloid leukemia|recurrent adult acute myeloid leukemia
800300|NCT00253513|recurrent childhood acute lymphoblastic leukemia|recurrent childhood acute lymphoblastic leukemia
800301|NCT00253513|recurrent childhood acute myeloid leukemia|recurrent childhood acute myeloid leukemia
800302|NCT00253513|secondary acute myeloid leukemia|secondary acute myeloid leukemia
800303|NCT00253513|myelodysplastic syndromes|myelodysplastic syndromes
800304|NCT00253513|childhood myelodysplastic syndromes|childhood myelodysplastic syndromes
800305|NCT00253500|stage II breast cancer|stage ii breast cancer
800306|NCT00253500|stage I breast cancer|stage i breast cancer
800307|NCT00253500|stage IIIA breast cancer|stage iiia breast cancer
800308|NCT00253500|stage IIIB breast cancer|stage iiib breast cancer
800309|NCT00253487|adult glioblastoma|adult glioblastoma
800310|NCT00253487|adult anaplastic astrocytoma|adult anaplastic astrocytoma
800311|NCT00253487|childhood high-grade cerebral astrocytoma|childhood high-grade cerebral astrocytoma
800312|NCT00253487|adult giant cell glioblastoma|adult giant cell glioblastoma
800313|NCT00253487|adult gliosarcoma|adult gliosarcoma
800314|NCT00253474|neoplasm of uncertain malignant potential|neoplasm of uncertain malignant potential
800315|NCT00253474|unspecified childhood solid tumor, protocol specific|unspecified childhood solid tumor, protocol specific
800316|NCT00253461|stage IV ovarian epithelial cancer|stage iv ovarian epithelial cancer
800317|NCT00253461|stage IV ovarian germ cell tumor|stage iv ovarian germ cell tumor
800318|NCT00253461|extensive stage small cell lung cancer|extensive stage small cell lung cancer
800319|NCT00253461|recurrent small cell lung cancer|recurrent small cell lung cancer
800320|NCT00253461|unspecified adult solid tumor, protocol specific|unspecified adult solid tumor, protocol specific
800321|NCT00253461|recurrent ovarian epithelial cancer|recurrent ovarian epithelial cancer
800322|NCT00253461|recurrent ovarian germ cell tumor|recurrent ovarian germ cell tumor
800323|NCT00253461|tumors metastatic to brain|tumors metastatic to brain
800324|NCT00253448|adult glioblastoma|adult glioblastoma
800325|NCT00253448|adult giant cell glioblastoma|adult giant cell glioblastoma
800326|NCT00253448|adult gliosarcoma|adult gliosarcoma
800327|NCT00253435|recurrent neuroblastoma|recurrent neuroblastoma
800328|NCT00253422|recurrent breast cancer|recurrent breast cancer
800329|NCT00253422|stage IV breast cancer|stage iv breast cancer
800330|NCT00253422|stage IIIB breast cancer|stage iiib breast cancer
800331|NCT00253422|stage IIIC breast cancer|stage iiic breast cancer
800332|NCT00253409|localized malignant mesothelioma|localized malignant mesothelioma
800333|NCT00253396|warfarin|warfarin
800334|NCT00253396|clinical trial|clinical trial
800335|NCT00253396|pain measurement|pain measurement
800336|NCT00253396|heparin|heparin
800337|NCT00253396|heparin, low-molecular-weight|heparin, low-molecular-weight
800338|NCT00253396|Anticoagulants|anticoagulants
800339|NCT00253383|transitional care planning|transitional care planning
800340|NCT00253383|stage IIIB non-small cell lung cancer|stage iiib non-small cell lung cancer
800341|NCT00253383|stage IV non-small cell lung cancer|stage iv non-small cell lung cancer
800342|NCT00253383|extensive stage small cell lung cancer|extensive stage small cell lung cancer
800343|NCT00253383|stage IV breast cancer|stage iv breast cancer
800344|NCT00253383|recurrent breast cancer|recurrent breast cancer
800345|NCT00253383|male breast cancer|male breast cancer
800346|NCT00253383|stage IIIB anal cancer|stage iiib anal cancer
800347|NCT00253383|stage IV anal cancer|stage iv anal cancer
800348|NCT00253383|carcinoma of the appendix|carcinoma of the appendix
800349|NCT00253383|stage III colon cancer|stage iii colon cancer
800350|NCT00253383|stage IV colon cancer|stage iv colon cancer
800351|NCT00253383|stage III rectal cancer|stage iii rectal cancer
800352|NCT00253383|stage IV rectal cancer|stage iv rectal cancer
800353|NCT00253383|stage III esophageal cancer|stage iii esophageal cancer
800354|NCT00253383|stage IV esophageal cancer|stage iv esophageal cancer
800355|NCT00253383|unresectable extrahepatic bile duct cancer|unresectable extrahepatic bile duct cancer
800356|NCT00253383|unresectable gallbladder cancer|unresectable gallbladder cancer
800357|NCT00253383|stage III gastric cancer|stage iii gastric cancer
800358|NCT00253383|stage IV gastric cancer|stage iv gastric cancer
800359|NCT00253383|metastatic gastrointestinal carcinoid tumor|metastatic gastrointestinal carcinoid tumor
800360|NCT00253383|regional gastrointestinal carcinoid tumor|regional gastrointestinal carcinoid tumor
800361|NCT00253383|gastrointestinal stromal tumor|gastrointestinal stromal tumor
800362|NCT00253383|advanced adult primary liver cancer|advanced adult primary liver cancer
800363|NCT00253383|localized unresectable adult primary liver cancer|localized unresectable adult primary liver cancer
800364|NCT00253383|stage III pancreatic cancer|stage iii pancreatic cancer
800365|NCT00253383|recurrent small intestine cancer|recurrent small intestine cancer
800366|NCT00253383|small intestine adenocarcinoma|small intestine adenocarcinoma
800367|NCT00253383|small intestine leiomyosarcoma|small intestine leiomyosarcoma
800368|NCT00253383|small intestine lymphoma|small intestine lymphoma
800369|NCT00253383|stage IV bladder cancer|stage iv bladder cancer
800370|NCT00253383|stage IV renal cell cancer|stage iv renal cell cancer
800371|NCT00253383|clear cell sarcoma of the kidney|clear cell sarcoma of the kidney
800372|NCT00253383|peripheral primitive neuroectodermal tumor of the kidney|peripheral primitive neuroectodermal tumor of the kidney
800373|NCT00253383|rhabdoid tumor of the kidney|rhabdoid tumor of the kidney
800374|NCT00253383|metastatic transitional cell cancer of the renal pelvis and ureter|metastatic transitional cell cancer of the renal pelvis and ureter
800375|NCT00253383|anterior urethral cancer|anterior urethral cancer
800376|NCT00253383|posterior urethral cancer|posterior urethral cancer
800377|NCT00253383|urethral cancer associated with invasive bladder cancer|urethral cancer associated with invasive bladder cancer
800378|NCT00253383|stage IV penile cancer|stage iv penile cancer
800379|NCT00253383|stage IV prostate cancer|stage iv prostate cancer
800380|NCT00253383|stage III malignant testicular germ cell tumor|stage iii malignant testicular germ cell tumor
800381|NCT00253383|stage IV endometrial carcinoma|stage iv endometrial carcinoma
800382|NCT00253383|fallopian tube cancer|fallopian tube cancer
800383|NCT00253383|ovarian sarcoma|ovarian sarcoma
800384|NCT00253383|ovarian stromal cancer|ovarian stromal cancer
800385|NCT00253383|stage IV pancreatic cancer|stage iv pancreatic cancer
800386|NCT00253370|Sorafenib|sorafenib
800387|NCT00253370|Docetaxel|docetaxel
800388|NCT00253370|Cisplatin|cisplatin
800389|NCT00253370|gastric cancer|gastric cancer
800390|NCT00253370|gastroesophageal junction adenocarcinoma|gastroesophageal junction adenocarcinoma
800391|NCT00253357|Heart Failure|heart failure
800392|NCT00253357|Congestive Heart Failure|congestive heart failure
800393|NCT00253357|Fluid overload|fluid overload
800394|NCT00253357|Left sided heart failure|left sided heart failure
800395|NCT00253357|Pacemaker|pacemaker
800396|NCT00253357|Defibrillator|defibrillator
800397|NCT00253344|unspecified adult solid tumor, protocol specific|unspecified adult solid tumor, protocol specific
800398|NCT00253331|Raynaud's|raynaud's
800399|NCT00253331|sclerderma|sclerderma
800400|NCT00253331|systemic sclerosis|systemic sclerosis
800401|NCT00253331|autoimmune disease|autoimmune disease
800402|NCT00253318|Neoplasm Metastasis|neoplasm metastasis
800403|NCT00253318|Breast Cancer|breast cancer
800404|NCT00253318|Docetaxel|docetaxel
800405|NCT00253318|RAD001|rad001
800406|NCT00253318|Taxotere|taxotere
800407|NCT00253305|tinea unguium|tinea unguium
800408|NCT00253305|onychomycosis|onychomycosis
800409|NCT00253292|Burns|burns
800410|NCT00253292|Trauma|trauma
800411|NCT00253292|Outcomes|outcomes
800412|NCT00253292|Quality of Life|quality of life
800413|NCT00253279|Protein Synthesis Rate|protein synthesis rate
800414|NCT00253279|Burn Injury|burn injury
800415|NCT00253279|PET Scan|pet scan
800416|NCT00253266|Treatment resistant depression|treatment resistant depression
800418|NCT00253266|Pharmacogenetics|pharmacogenetics
800419|NCT00253253|orchidopexy, long-term outcome, congenital|orchidopexy, long-term outcome, congenital
800420|NCT00253227|Alzheimer's disease|alzheimer's disease
800421|NCT00253227|dementia|dementia
800422|NCT00253227|brain disease|brain disease
800423|NCT00253227|memory loss|memory loss
800424|NCT00253227|galantamine|galantamine
800425|NCT00253227|placebo|placebo
800426|NCT00253214|Alzheimer's disease|alzheimer's disease
800427|NCT00253214|dementia|dementia
800428|NCT00253214|galantamine hydrobromide|galantamine hydrobromide
800429|NCT00253214|controlled-release|controlled-release
800430|NCT00253214|once-daily dosing|once-daily dosing
800431|NCT00253201|Alzheimer's disease|alzheimer's disease
800432|NCT00253201|dementia|dementia
800433|NCT00253201|brain disease|brain disease
800434|NCT00253201|memory loss|memory loss
800435|NCT00253201|galantamine|galantamine
800436|NCT00253201|placebo|placebo
800437|NCT00253201|caregiver|caregiver
800438|NCT00253201|quality of life|quality of life
800439|NCT00253201|resource utilization|resource utilization
800440|NCT00253188|Alzheimer's disease|alzheimer's disease
800441|NCT00253188|dementia|dementia
800442|NCT00253188|brain disease|brain disease
800443|NCT00253188|memory loss|memory loss
800444|NCT00253188|galantamine|galantamine
800445|NCT00253188|placebo|placebo
800446|NCT00253188|caregiver|caregiver
800447|NCT00253188|quality of life|quality of life
800448|NCT00253188|resource utilization|resource utilization
800449|NCT00253175|topiramate|topiramate
800450|NCT00253175|migraine headache|migraine headache
800451|NCT00253175|migraine prevention|migraine prevention
800452|NCT00253175|migraine|migraine
800453|NCT00253162|risperidone|risperidone
800454|NCT00253162|antipsychotic agents|antipsychotic agents
800455|NCT00253162|bipolar disorders|bipolar disorders
800456|NCT00253162|manic episode|manic episode
800457|NCT00253149|risperidone|risperidone
800458|NCT00253149|antipsychotic agents|antipsychotic agents
800459|NCT00253149|bipolar disorders|bipolar disorders
800460|NCT00253149|manic episode|manic episode
800461|NCT00253136|schizophrenia|schizophrenia
800462|NCT00253136|schizoaffective disorder|schizoaffective disorder
800463|NCT00253136|psychotic disorder|psychotic disorder
800464|NCT00253136|risperidone|risperidone
800465|NCT00253136|long-acting injectable|long-acting injectable
800466|NCT00253136|intramuscular injection|intramuscular injection
800467|NCT00253136|antipsychotic agents|antipsychotic agents
800468|NCT00253123|Dementia|dementia
800469|NCT00253123|Alzheimer's disease|alzheimer's disease
800470|NCT00253123|vascular dementia|vascular dementia
800471|NCT00253123|mixed dementia|mixed dementia
800472|NCT00253123|risperidone|risperidone
800473|NCT00253123|nursing home|nursing home
800474|NCT00253110|Schizophrenia, Psychotic Disorders|schizophrenia, psychotic disorders
800475|NCT00253110|Haloperidol|haloperidol
800476|NCT00253110|Risperidone|risperidone
800477|NCT00253110|Schizoaffective disorder|schizoaffective disorder
800478|NCT00253097|stroke recurrence|stroke recurrence
800479|NCT00253097|risk factors|risk factors
800480|NCT00253097|health behavior|health behavior
800481|NCT00253097|intervention|intervention
800482|NCT00253097|tertiary prevention|tertiary prevention
800483|NCT00253071|Prophylactic treatment|prophylactic treatment
800484|NCT00253071|Pharmacological treatment|pharmacological treatment
800485|NCT00253071|Psychological treatment|psychological treatment
800486|NCT00253058|Allergic|allergic
800487|NCT00253058|pediatric|pediatric
800488|NCT00253058|Rhinitis|rhinitis
800489|NCT00253058|Perennial|perennial
800490|NCT00253045|Motivational Interviewing|motivational interviewing
800491|NCT00253045|antiretroviral therapy|antiretroviral therapy
800492|NCT00253045|medication adherence|medication adherence
800493|NCT00253045|risk reduction behaviors|risk reduction behaviors
800494|NCT00253045|women|women
800496|NCT00253045|AIDS|aids
800497|NCT00253019|birth control|birth control
800498|NCT00253019|continuation|continuation
800499|NCT00253019|abortion|abortion
800500|NCT00253019|contraception|contraception
800501|NCT00253006|NO|no
800502|NCT00253006|mRNA-expression|mrna-expression
800503|NCT00253006|pathophysiology|pathophysiology
800504|NCT00253006|painful bladder syndrome|painful bladder syndrome
800505|NCT00252993|Nausea|nausea
800506|NCT00252993|Vomiting|vomiting
800507|NCT00252993|Chronic Functional Vomiting|chronic functional vomiting
800508|NCT00252993|Functional Vomiting|functional vomiting
800509|NCT00252993|Cyclic Vomiting|cyclic vomiting
800510|NCT00252980|Cannabis|cannabis
800511|NCT00252980|Dependence|dependence
800512|NCT00252980|Marijuana|marijuana
800513|NCT00252980|Substance Abuse Treatment|substance abuse treatment
800514|NCT00252980|Psychotherapy,|psychotherapy,
800515|NCT00252967|Reactive Oxgen Speers|reactive oxgen speers
800516|NCT00252967|Atrial Fibrillation|atrial fibrillation
800517|NCT00252967|Oxidative Stress|oxidative stress
800518|NCT00252967|Inflammation|inflammation
800519|NCT00252954|Spinal cord injury|spinal cord injury
800520|NCT00252954|Neuropathic pain|neuropathic pain
800522|NCT00252941|prostate cancer|prostate cancer
800523|NCT00252941|brachytherapy|brachytherapy
800524|NCT00252941|urethral stenting|urethral stenting
800525|NCT00252928|sodium dichloroisocyanurate|sodium dichloroisocyanurate
800526|NCT00252928|water purification|water purification
800527|NCT00252928|disinfection|disinfection
800528|NCT00252928|Ghana|ghana
800529|NCT00252902|tobacco; emergency department; motivation; counseling|tobacco; emergency department; motivation; counseling
800530|NCT00252889|Metastatic cancer|metastatic cancer
800531|NCT00252889|Metastatic gastric and esophagus adenocarcinoma|metastatic gastric and esophagus adenocarcinoma
800532|NCT00252889|Unresectable pancreatic cancer|unresectable pancreatic cancer
800533|NCT00252889|Unresectable head and neck cancer|unresectable head and neck cancer
800534|NCT00252889|Cancer of undetermined primary|cancer of undetermined primary
800535|NCT00252850|Parkinson's Disease|parkinson's disease
800536|NCT00252850|Gene Transfer|gene transfer
800537|NCT00252798|Non Small Cell Lung Cancer|non small cell lung cancer
800538|NCT00252785|Asthma|asthma
800539|NCT00252746|NSCLC|nsclc
800540|NCT00252746|Non Small Cell Lung Cancer|non small cell lung cancer
800541|NCT00252733|Diabetes Mellitus, Insulin-Dependent|diabetes mellitus, insulin-dependent
800542|NCT00252720|Diabetes mellitus type 1|diabetes mellitus type 1
800543|NCT00252694|Diabetes mellitus type 2|diabetes mellitus type 2
800544|NCT00252681|randomized|randomized
800545|NCT00252681|controlled|controlled
800546|NCT00252681|trial|trial
800547|NCT00252681|necrotizing|necrotizing
800548|NCT00252681|enterocolitis|enterocolitis
800549|NCT00252681|premature|premature
800550|NCT00252681|infants|infants
800551|NCT00252681|laparotomy|laparotomy
800552|NCT00252681|peritoneal|peritoneal
800553|NCT00252681|drainage|drainage
800554|NCT00252668|Rheumatoid Arthritis|rheumatoid arthritis
800555|NCT00252642|Hepatitis C|hepatitis c
800556|NCT00252642|Interferon|interferon
800557|NCT00252642|Cirrhosis|cirrhosis
800558|NCT00252642|Liver Disease|liver disease
800559|NCT00252642|Portal Hypertension|portal hypertension
800560|NCT00252642|Portal Pressure|portal pressure
800561|NCT00252629|Fatigue|fatigue
800562|NCT00252629|Functional Somatic Syndrome|functional somatic syndrome
800563|NCT00252629|Gulf War Syndrome|gulf war syndrome
800564|NCT00252629|Sleep apnea|sleep apnea
800565|NCT00252629|Upper Airway Resistance Syndrome|upper airway resistance syndrome
800566|NCT00252616|Mechanical ventilation|mechanical ventilation
800567|NCT00252616|acute respiratory failure|acute respiratory failure
800568|NCT00252616|early nutrition|early nutrition
800569|NCT00252603|Autism|autism
800570|NCT00252603|Childhood Autism|childhood autism
800571|NCT00252590|Psychotherapy motivational intervention|psychotherapy motivational intervention
800572|NCT00252577|Lithium|lithium
800573|NCT00252577|Pharmacogenetics|pharmacogenetics
800574|NCT00252551|spondylolisthesis, decompressive surgery, osteosynthesis|spondylolisthesis, decompressive surgery, osteosynthesis
800575|NCT00252538|Cortisol|cortisol
800576|NCT00252538|Depression|depression
800577|NCT00252538|Hepatitis C|hepatitis c
800578|NCT00252538|Interferon|interferon
800579|NCT00252538|Polymorphism|polymorphism
800580|NCT00252538|Serotonin|serotonin
800581|NCT00252538|Tryptophan|tryptophan
800582|NCT00252512|Contingency management interventions|contingency management interventions
800583|NCT00252512|Substance use disorders treatment|substance use disorders treatment
800584|NCT00252512|Treatment effectiveness|treatment effectiveness
800585|NCT00252512|Randomized clinical trial|randomized clinical trial
800586|NCT00252512|Behavioral research|behavioral research
800587|NCT00252499|beta cell function|beta cell function
800588|NCT00252499|fenofibrate|fenofibrate
800589|NCT00252499|non-alcoholic steatohepatitis|non-alcoholic steatohepatitis
800590|NCT00252499|rosiglitazone|rosiglitazone
800591|NCT00252499|insulin sensitivity|insulin sensitivity
800592|NCT00252486|Bipolar|bipolar
800593|NCT00252486|Omega-3 Fatty acids|omega-3 fatty acids
800594|NCT00252434|high-risk sexual behavior|high-risk sexual behavior
800595|NCT00252434|methamphetamine use|methamphetamine use
800596|NCT00252434|drug craving|drug craving
800597|NCT00252434|addiction behaviors|addiction behaviors
800598|NCT00252421|osteoporosis|osteoporosis
800599|NCT00252421|bone mineral density|bone mineral density
800600|NCT00252421|nitrates|nitrates
800601|NCT00252408|Fracture|fracture
800602|NCT00252408|Osteoporosis|osteoporosis
800603|NCT00252408|Bone mineral density|bone mineral density
800604|NCT00252408|Hormone replacement therapy|hormone replacement therapy
800605|NCT00252408|Estrogen|estrogen
800606|NCT00252408|Breast cancer|breast cancer
800607|NCT00252395|medication error|medication error
800608|NCT00252395|electronic prescribing|electronic prescribing
800609|NCT00252395|patient safety|patient safety
800610|NCT00252382|Lung|lung
800611|NCT00252382|Squamous Cell|squamous cell
800612|NCT00252382|Large Cell|large cell
800613|NCT00252382|Adenocarcinoma|adenocarcinoma
800614|NCT00252382|Carcinoma|carcinoma
800615|NCT00252382|Cancer|cancer
800616|NCT00252356|major depressive disorder|major depressive disorder
800617|NCT00252356|depression|depression
800618|NCT00252356|major depressive episode|major depressive episode
800917|NCT00250991|rt-PA|rt-pa
800619|NCT00252356|antidepressive agents|antidepressive agents
800620|NCT00252343|anxiety disorder|anxiety disorder
800621|NCT00252330|major depressive disorder|major depressive disorder
800622|NCT00252330|depression|depression
800623|NCT00252330|major depressive episode|major depressive episode
800624|NCT00252330|antidepressive agents|antidepressive agents
800625|NCT00252317|Aortic stenosis|aortic stenosis
800626|NCT00252317|ACE-inhibitores|ace-inhibitores
800627|NCT00252304|Child, severe pneumonia, Zinc, Nepal, therapeutic|child, severe pneumonia, zinc, nepal, therapeutic
800628|NCT00252291|bronchial|bronchial
800629|NCT00252291|hyperresponsiveness|hyperresponsiveness
800630|NCT00252239|stroke|stroke
800631|NCT00252239|tenecteplase|tenecteplase
800632|NCT00252239|TNK|tnk
800633|NCT00252239|ischemic|ischemic
800634|NCT00252239|tissue plasminogen activator|tissue plasminogen activator
800635|NCT00252239|tPA|tpa
800636|NCT00252226|Quetiapine|quetiapine
800637|NCT00252226|bipolar spectrum disorders|bipolar spectrum disorders
800638|NCT00252187|Heart failure|heart failure
800639|NCT00252187|Natriuretic peptides|natriuretic peptides
800640|NCT00252187|B-type natriuretic peptide|b-type natriuretic peptide
800641|NCT00252187|Kidney|kidney
800642|NCT00252187|Nesiritide|nesiritide
800643|NCT00252187|Natrecor|natrecor
800644|NCT00252187|CHF|chf
800645|NCT00252174|MDMA|mdma
800646|NCT00252174|cancer|cancer
800647|NCT00252174|anxiety|anxiety
800648|NCT00252174|psychotherapy|psychotherapy
800649|NCT00252174|quality of life|quality of life
800650|NCT00252161|Neoadjuvant Therapy|neoadjuvant therapy
800651|NCT00252161|Stomach Neoplasms|stomach neoplasms
800652|NCT00252161|Cisplatin|cisplatin
800653|NCT00252161|S-1(combination)|s-1(combination)
800654|NCT00252148|HIV Preventive Vaccine|hiv preventive vaccine
800655|NCT00252135|Moderate to severe asthma|moderate to severe asthma
800656|NCT00252109|HIV|hiv
800657|NCT00252109|Seropositive|seropositive
800658|NCT00252109|MSM|msm
800659|NCT00252109|African American|african american
800660|NCT00252109|Popular Opinion Leader|popular opinion leader
800661|NCT00252096|Diagnosis|diagnosis
800662|NCT00252096|Chlamydia trachomatis|chlamydia trachomatis
800663|NCT00252096|Neisseria gonorrhoeae|neisseria gonorrhoeae
800664|NCT00252096|Nucleic acid amplification test|nucleic acid amplification test
800665|NCT00252096|Rectum|rectum
800666|NCT00252096|Pharynx|pharynx
800667|NCT00252083|Seropositive|seropositive
800668|NCT00252083|MSM|msm
800669|NCT00252083|Hispanic|hispanic
800670|NCT00252083|Popular Opinion Leader|popular opinion leader
800671|NCT00252083|HIV|hiv
800672|NCT00252070|arthritis|arthritis
800673|NCT00252070|exercise|exercise
800674|NCT00252070|function|function
800675|NCT00252070|pain|pain
800676|NCT00252057|rehospitalization|rehospitalization
800677|NCT00252057|readmission|readmission
800678|NCT00252057|adverse events|adverse events
800679|NCT00252057|discharge|discharge
800680|NCT00252031|Borderline Personality Disorder|borderline personality disorder
800681|NCT00252031|BPD|bpd
800682|NCT00252031|Dialectical Behavior Therapy|dialectical behavior therapy
800683|NCT00252031|DBT|dbt
800684|NCT00252018|Nutritional supplement|nutritional supplement
800685|NCT00252018|Prevention|prevention
800686|NCT00252018|Endothelial function|endothelial function
800687|NCT00252018|Flow mediated dilation|flow mediated dilation
800688|NCT00251966|Prevention of gastroduodenal lesions|prevention of gastroduodenal lesions
800689|NCT00251966|erosive oesophagitis|erosive oesophagitis
800690|NCT00251966|upper GI symptoms|upper gi symptoms
800691|NCT00251927|Acid reflux disease|acid reflux disease
800692|NCT00251927|Gastroesophageal Reflux Disease|gastroesophageal reflux disease
800693|NCT00251901|Gastroesophageal reflux disease|gastroesophageal reflux disease
800694|NCT00251901|GERD|gerd
800695|NCT00251888|cervix cancer|cervix cancer
800696|NCT00251888|advanced cervix cancer|advanced cervix cancer
800697|NCT00251888|radiochemotherapy|radiochemotherapy
800698|NCT00251888|pelvic radiotherapy|pelvic radiotherapy
800699|NCT00251888|campto|campto
800700|NCT00251888|cisplatin|cisplatin
800701|NCT00251888|irinotecan|irinotecan
800702|NCT00251888|cisplatyl|cisplatyl
800703|NCT00251888|maximum dose search|maximum dose search
800704|NCT00251875|patient portals|patient portals
800705|NCT00251875|electronic health records|electronic health records
800706|NCT00251875|family history|family history
800707|NCT00251875|health maintenance|health maintenance
800708|NCT00251875|medications|medications
800709|NCT00251875|diabetes|diabetes
800710|NCT00251862|Colorectal cancer screening|colorectal cancer screening
800711|NCT00251862|Shared decision-making|shared decision-making
800712|NCT00251862|Decision aid|decision aid
800713|NCT00251849|Intermittent Claudication|intermittent claudication
800714|NCT00251836|Kidney donation|kidney donation
800715|NCT00251836|Organ Donation|organ donation
800716|NCT00251836|Vascular anatomy|vascular anatomy
800717|NCT00251836|Adrenal Insufficiency|adrenal insufficiency
800718|NCT00251823|ST-Elevation Myocardial Infarction|st-elevation myocardial infarction
800719|NCT00251810|general anaesthesia|general anaesthesia
800720|NCT00251810|depth of hypnosis|depth of hypnosis
800721|NCT00251810|Cerebral State Monitor|cerebral state monitor
800722|NCT00251810|CSM|csm
800723|NCT00251810|Bispectral Index|bispectral index
800724|NCT00251810|BIS|bis
800725|NCT00251797|Phase I|phase i
800726|NCT00251797|Brain cancer|brain cancer
800727|NCT00251797|Recurrent CNS tumors|recurrent cns tumors
800728|NCT00251771|Thrombolytic therapy|thrombolytic therapy
800729|NCT00251771|Postphlebitic syndrome|postphlebitic syndrome
800730|NCT00251771|Venous thrombosis|venous thrombosis
800731|NCT00251758|Non-Erosive Gastroesophageal Reflux Disease(GERD),heartburn|non-erosive gastroesophageal reflux disease(gerd),heartburn
800732|NCT00251745|Non-Erosive Gastroesophageal Reflux Disease (GERD)|non-erosive gastroesophageal reflux disease (gerd)
800733|NCT00251745|Heartburn|heartburn
800734|NCT00251732|acid reflux studies|acid reflux studies
800735|NCT00251732|efficacy of PPI therapy|efficacy of ppi therapy
800736|NCT00251732|failing PPI therapy|failing ppi therapy
800737|NCT00251732|GERD|gerd
800738|NCT00251732|Acid Reflux Disease|acid reflux disease
800739|NCT00251719|Erosive Esophagitis|erosive esophagitis
800740|NCT00251706|atrial fibrillation|atrial fibrillation
800741|NCT00251706|atrial flutter|atrial flutter
800742|NCT00251706|amiodarone|amiodarone
800743|NCT00251706|post-operative|post-operative
800744|NCT00251706|coronary artery bypass surgery|coronary artery bypass surgery
800745|NCT00251706|valve replacement or repair|valve replacement or repair
800746|NCT00251693|Erosive Esophagitis|erosive esophagitis
800747|NCT00251680|Hyperlipidemia|hyperlipidemia
800748|NCT00251680|Drug Therapy|drug therapy
800749|NCT00251654|complications|complications
800750|NCT00251654|adverse events|adverse events
800751|NCT00251654|regional anesthesia|regional anesthesia
800752|NCT00251654|adverse effects|adverse effects
800753|NCT00251628|Tonsils|tonsils
800754|NCT00251628|Tonsillectomy|tonsillectomy
800755|NCT00251615|vascular surgery|vascular surgery
800756|NCT00251615|vascular aging|vascular aging
800757|NCT00251615|arterial aging|arterial aging
800758|NCT00251615|surgical tissue|surgical tissue
800759|NCT00251615|Aging|aging
800760|NCT00251602|heart rate variability|heart rate variability
800761|NCT00251602|gene response|gene response
800762|NCT00251589|Relapsed Non-Small-Cell Lung Cancer|relapsed non-small-cell lung cancer
800763|NCT00251589|Refractory Non-Small-Cell Lung Cancer|refractory non-small-cell lung cancer
800764|NCT00251563|Cancer,Risk factors|cancer,risk factors
800765|NCT00251537|Pilot study|pilot study
800766|NCT00251537|Randomized|randomized
800767|NCT00251537|Placebo-controlled|placebo-controlled
800768|NCT00251537|Double-blind|double-blind
800769|NCT00251537|Effect on viral load|effect on viral load
800770|NCT00251537|LTB4|ltb4
800771|NCT00251537|HIV-1 infection|hiv-1 infection
800772|NCT00251498|Metastatic 1st line NSCLC|metastatic 1st line nsclc
800773|NCT00251485|Metastatic 1st line colorectal cancer|metastatic 1st line colorectal cancer
800774|NCT00251459|SAILOR|sailor
800775|NCT00251459|CNV|cnv
800776|NCT00251459|AMD|amd
800777|NCT00251459|CNV secondary to AMD|cnv secondary to amd
800778|NCT00251433|ErbB1|erbb1
800779|NCT00251433|ErbB2|erbb2
800780|NCT00251433|trastuzumab (Herceptin)|trastuzumab (herceptin)
800781|NCT00251433|lapatinib|lapatinib
800782|NCT00251433|Stage IV breast cancer|stage iv breast cancer
800783|NCT00251433|metastatic breast cancer|metastatic breast cancer
800886|NCT00251147|acromioplasty|acromioplasty
800784|NCT00251433|overexpression of ErbB2 receptors|overexpression of erbb2 receptors
800785|NCT00251433|docetaxel (Taxotere)|docetaxel (taxotere)
800786|NCT00251420|copd|copd
800787|NCT00251420|asthma|asthma
800788|NCT00251420|QoL|qol
800789|NCT00251420|Perceived health status|perceived health status
800790|NCT00251420|Trait anxiety|trait anxiety
800791|NCT00251407|Advanced solid tumor malignancy|advanced solid tumor malignancy
800792|NCT00251407|cisplatin|cisplatin
800793|NCT00251407|CPT-11|cpt-11
800794|NCT00251407|taxotere|taxotere
800795|NCT00251394|B-Cell follicular non-Hodgkin's lymphoma|b-cell follicular non-hodgkin's lymphoma
800796|NCT00251394|Rituxan|rituxan
800797|NCT00251394|Rituximab|rituximab
800798|NCT00251394|1018 ISS|1018 iss
800799|NCT00251394|CD 20 +|cd 20 +
800800|NCT00251381|Oropharyngeal Neoplasms|oropharyngeal neoplasms
800801|NCT00251381|Cetuximab|cetuximab
800802|NCT00251381|Concomitant-boost accelerated radiotherapy|concomitant-boost accelerated radiotherapy
800803|NCT00251368|leukemia|leukemia
800804|NCT00251368|9-Aminocamptothecin|9-aminocamptothecin
800805|NCT00251368|AML|aml
800806|NCT00251368|ALL|all
800807|NCT00251368|refractory leukemia|refractory leukemia
800808|NCT00251368|relapsed leukemia|relapsed leukemia
800809|NCT00251355|gemcitabine|gemcitabine
800810|NCT00251355|5-fluorouracil|5-fluorouracil
800811|NCT00251355|5-FU|5-fu
800812|NCT00251355|unresectable pancreatic cancer|unresectable pancreatic cancer
800813|NCT00251355|non-metastatic pancreatic cancer|non-metastatic pancreatic cancer
800814|NCT00251342|Postnatal depression|postnatal depression
800815|NCT00251342|Randomized controlled trial|randomized controlled trial
800816|NCT00251342|Screening|screening
800817|NCT00251342|Outcome|outcome
800818|NCT00251342|Edinburgh Postnatal Depression Scale|edinburgh postnatal depression scale
800819|NCT00251329|Neoadjuvant|neoadjuvant
800820|NCT00251329|Breast Cancer|breast cancer
800822|NCT00251329|Capecitabine|capecitabine
800823|NCT00251329|Carboplatin|carboplatin
800824|NCT00251329|Docetaxel|docetaxel
800825|NCT00251316|Thyroid Neoplasm|thyroid neoplasm
800826|NCT00251316|I-131|i-131
800827|NCT00251316|Radiation Dose|radiation dose
800828|NCT00251316|Radiation Effect|radiation effect
800829|NCT00251316|Pharmaceutical Adjuvant|pharmaceutical adjuvant
800830|NCT00251316|Thyroid Cancer|thyroid cancer
800831|NCT00251303|Clinical Trial|clinical trial
800832|NCT00251303|Glutamate Antagonist|glutamate antagonist
800833|NCT00251303|Pediatrics|pediatrics
800834|NCT00251303|Basal Ganglia|basal ganglia
800835|NCT00251303|Neuropsychological|neuropsychological
800836|NCT00251303|Obsessive Compulsive Disorder|obsessive compulsive disorder
800837|NCT00251303|OCD|ocd
800838|NCT00251303|Riluzole|riluzole
800839|NCT00251303|Rilutek|rilutek
800840|NCT00251290|transient ischemic attack|transient ischemic attack
800841|NCT00251290|sleep apnea|sleep apnea
800842|NCT00251277|Thrombotic Thrombocytopenic Purpura|thrombotic thrombocytopenic purpura
800843|NCT00251277|TTP|ttp
800844|NCT00251277|Hematology|hematology
800845|NCT00251264|Shoulder instability|shoulder instability
800846|NCT00251264|Traumatic|traumatic
800847|NCT00251264|Anterior|anterior
800848|NCT00251264|Unidirectional|unidirectional
800849|NCT00251264|Open stabilization|open stabilization
800850|NCT00251264|Arthroscopic|arthroscopic
800851|NCT00251264|Bankart repair|bankart repair
800852|NCT00251264|Shoulder instability, traumatic|shoulder instability, traumatic
800853|NCT00251264|Anterior, unidirectional instability|anterior, unidirectional instability
800854|NCT00251264|Bankart|bankart
800855|NCT00251251|Congestive heart failure|congestive heart failure
800856|NCT00251251|Multicentre randomized controlled trial|multicentre randomized controlled trial
800857|NCT00251251|Defibrillator|defibrillator
800858|NCT00251251|Cardiac resynchronization|cardiac resynchronization
800859|NCT00251251|Sudden death/mortality|sudden death/mortality
800860|NCT00251251|Hospitalization|hospitalization
800861|NCT00251251|ICD indication|icd indication
800862|NCT00251251|NYHA Class II|nyha class ii
800863|NCT00251251|LVEF </equal to 30%|lvef </equal to 30%
800864|NCT00251251|QRS >/equal to 120 ms|qrs >/equal to 120 ms
800865|NCT00251238|Raynaud´s phenomenon|raynaud´s phenomenon
800866|NCT00251238|Vasospastic attacks|vasospastic attacks
800867|NCT00251238|Ginkgo biloba|ginkgo biloba
800868|NCT00251225|prostate|prostate
800869|NCT00251212|Alcohol|alcohol
800870|NCT00251212|Violence|violence
800871|NCT00251212|Alcohol consumption|alcohol consumption
800872|NCT00251212|Alcohol, drinking|alcohol, drinking
800873|NCT00251160|Multi-directional instability|multi-directional instability
800874|NCT00251160|MDI|mdi
800875|NCT00251160|Ligamentous laxity|ligamentous laxity
800876|NCT00251160|Multi-directional laxity|multi-directional laxity
800877|NCT00251160|MDL-AII|mdl-aii
800878|NCT00251160|Shoulder instability|shoulder instability
800879|NCT00251160|electrothermal capsulorrhaphy, ETAC|electrothermal capsulorrhaphy, etac
800880|NCT00251160|inferior capsular shift, ICS|inferior capsular shift, ics
800881|NCT00251160|capsular redundancy|capsular redundancy
800882|NCT00251147|rotator cuff|rotator cuff
800883|NCT00251147|open|open
800884|NCT00251147|arthroscopic|arthroscopic
800887|NCT00251147|quality of life|quality of life
800888|NCT00251147|shoulder|shoulder
800889|NCT00251134|myocardial infarction|myocardial infarction
800890|NCT00251134|omega 3-fatty acids|omega 3-fatty acids
800891|NCT00251121|Electrophysiological study|electrophysiological study
800892|NCT00251121|paroxysmal tachycardia|paroxysmal tachycardia
800893|NCT00251108|'traumatic brain injury'|'traumatic brain injury'
800894|NCT00251108|'head injury'|'head injury'
800895|NCT00251108|'brain injuries'|'brain injuries'
800896|NCT00251108|'exercise therapy'|'exercise therapy'
800897|NCT00251108|'physical fitness'|'physical fitness'
800898|NCT00251095|Metastatic Breast Cancer|metastatic breast cancer
800899|NCT00251082|hormone replacement|hormone replacement
800900|NCT00251082|vasomotoric symptoms|vasomotoric symptoms
800901|NCT00251082|bleeding pattern|bleeding pattern
800902|NCT00251069|glucosamine sulphate, osteoarthritis, cholesterol,|glucosamine sulphate, osteoarthritis, cholesterol,
800903|NCT00251043|Pregnancy|pregnancy
800904|NCT00251043|Antepartum Depression|antepartum depression
800905|NCT00251043|Major Depression|major depression
800906|NCT00251017|single nucleotide polymorphisms (SNPs)|single nucleotide polymorphisms (snps)
800907|NCT00251017|personalized medicines|personalized medicines
800908|NCT00251017|Subjects 16 years of age or older, of either sex.|subjects 16 years of age or older, of either sex.
800909|NCT00251017|Subjects have a medication including vancomycin|subjects have a medication including vancomycin
800910|NCT00251004|Renal transplantation, kidney, and organ transplant|renal transplantation, kidney, and organ transplant
800911|NCT00251004|Renal transplant rejection|renal transplant rejection
800912|NCT00250991|stroke|stroke
800913|NCT00250991|integrilin|integrilin
800914|NCT00250991|eptifibatide|eptifibatide
800915|NCT00250991|activase|activase
800916|NCT00250991|recombinant tissue plasminogen activator|recombinant tissue plasminogen activator
800918|NCT00250991|recombinant t-PA|recombinant t-pa
800919|NCT00250991|SPOTRIAS|spotrias
800920|NCT00250978|Advanced Non Small Cell Lung Cancer|advanced non small cell lung cancer
800921|NCT00250952|Clinical Practice Variations|clinical practice variations
800922|NCT00250939|Glycogen Storage Disease Type II|glycogen storage disease type ii
800923|NCT00250939|GSD-II|gsd-ii
800924|NCT00250939|Pompe Disease|pompe disease
800925|NCT00250926|bortezomib|bortezomib
800926|NCT00250926|dexamethasone|dexamethasone
800927|NCT00250926|rituximab|rituximab
800928|NCT00250913|motor activity|motor activity
800929|NCT00250913|determinants|determinants
800930|NCT00250913|psychology|psychology
800931|NCT00250913|health care costs|health care costs
800932|NCT00250913|quality of life|quality of life
800933|NCT00250913|Angioplasty|angioplasty
800934|NCT00250900|Otitis|otitis
800935|NCT00250900|Antibiotic|antibiotic
800936|NCT00250900|Prescription|prescription
800937|NCT00250887|recurrent Glioblastoma, Gefitinib|recurrent glioblastoma, gefitinib
800938|NCT00250848|Lung Diseases|lung diseases
800939|NCT00250848|Cancer|cancer
800940|NCT00250835|Resectable Rectal Cancer|resectable rectal cancer
800941|NCT00250835|Radiation|radiation
800942|NCT00250835|Neoadjuvant|neoadjuvant
800943|NCT00250835|Rectum|rectum
800944|NCT00250835|GI - Colorectal Neoadjuvant|gi - colorectal neoadjuvant
800945|NCT00250835|Cancer|cancer
800946|NCT00250822|Liver|liver
800947|NCT00250822|hepatocellular|hepatocellular
800948|NCT00250822|Gem-Ox|gem-ox
800949|NCT00250822|Cancer|cancer
800950|NCT00250796|Phase II|phase ii
800951|NCT00250796|Hepatocellular carcinoma|hepatocellular carcinoma
800952|NCT00250783|Corpus Uteri|corpus uteri
800953|NCT00250783|Endometrium|endometrium
800954|NCT00250783|Cancer|cancer
800955|NCT00250770|Corpus Uteri|corpus uteri
800956|NCT00250770|Endometrium|endometrium
800957|NCT00250770|Cancer|cancer
800958|NCT00250757|prostate|prostate
800959|NCT00250757|NMR Spectroscopy|nmr spectroscopy
800960|NCT00250744|delayed nausea and vomiting|delayed nausea and vomiting
800961|NCT00250744|Emetogenic Chemotherapy|emetogenic chemotherapy
800962|NCT00250744|Pilot Trial|pilot trial
800963|NCT00250731|diabetes|diabetes
800964|NCT00250731|relationship|relationship
800965|NCT00250731|social support|social support
800966|NCT00250731|behavior change|behavior change
800967|NCT00250731|telemedicine|telemedicine
800968|NCT00250718|Non Hodgkin's Lymphoma|non hodgkin's lymphoma
800969|NCT00250718|Phase II|phase ii
800970|NCT00250718|Lymphoid malignancies|lymphoid malignancies
800971|NCT00250705|Aripiprazole|aripiprazole
800972|NCT00250679|COPD|copd
800973|NCT00250679|chronic bronchitis|chronic bronchitis
800974|NCT00250679|emphysema|emphysema
800975|NCT00250666|Biological Markers|biological markers
800976|NCT00250666|Procalcitonin|procalcitonin
800977|NCT00250666|Critical Care|critical care
800978|NCT00250666|Diagnosis, Differential|diagnosis, differential
800979|NCT00250666|Prospective Study|prospective study
800980|NCT00250666|Sepsis|sepsis
800981|NCT00250666|Antibiotic stewardship|antibiotic stewardship
800982|NCT00250666|Antimicrobial resistance|antimicrobial resistance
800983|NCT00250653|depression|depression
800984|NCT00250653|antidepressive agents|antidepressive agents
800985|NCT00250653|clinical trial|clinical trial
800986|NCT00250640|Primary Pulmonary hypertension|primary pulmonary hypertension
800987|NCT00250627|depression|depression
800988|NCT00250627|antidepressive agents|antidepressive agents
800989|NCT00250627|controlled clinical trial|controlled clinical trial
800990|NCT00250614|depression|depression
800991|NCT00250614|antidepressive agents|antidepressive agents
800992|NCT00250614|controlled clinical trial|controlled clinical trial
800993|NCT00250601|depression|depression
800994|NCT00250601|antidepressive agents|antidepressive agents
800995|NCT00250601|controlled clinical trial|controlled clinical trial
800996|NCT00250588|Asthma|asthma
800997|NCT00250588|Child|child
800998|NCT00250588|Problem-solving|problem-solving
800999|NCT00250588|Quality of Life|quality of life
801000|NCT00250588|Barriers to Care|barriers to care
801001|NCT00250575|Schizophrenia, treatment-resistant, clozapine|schizophrenia, treatment-resistant, clozapine
801002|NCT00250562|Hypertension|hypertension
801003|NCT00250562|Angiotensin II receptor blocker|angiotensin ii receptor blocker
801004|NCT00250562|fixed combination|fixed combination
801005|NCT00250562|diuretics|diuretics
801006|NCT00250549|HIV|hiv
801007|NCT00250549|Prevention|prevention
801008|NCT00250549|Rapid HIV testing|rapid hiv testing
801009|NCT00250523|trauma|trauma
801010|NCT00250523|critical illness|critical illness
801011|NCT00250523|injury|injury
801012|NCT00250510|Obesity treatment|obesity treatment
801013|NCT00250510|Insurance reimbursement|insurance reimbursement
801014|NCT00250510|Health care utilization|health care utilization
801015|NCT00250510|Health care costs|health care costs
801016|NCT00250497|Adolescent|adolescent
801017|NCT00250497|Girls|girls
801018|NCT00250497|Physical Activity|physical activity
801019|NCT00250497|Exercise|exercise
801020|NCT00250497|Diet|diet
801021|NCT00250497|Body image|body image
801022|NCT00250484|analgesia|analgesia
801023|NCT00250484|electric stimulation therapy|electric stimulation therapy
801024|NCT00250484|electric stimulation|electric stimulation
801025|NCT00250484|pain|pain
801026|NCT00250484|safety|safety
801027|NCT00250471|GP IIb/IIIa inhibitors|gp iib/iiia inhibitors
801028|NCT00250471|eptifibatide|eptifibatide
801029|NCT00250471|Anti-thrombotic agents|anti-thrombotic agents
801030|NCT00250445|Arcoxia|arcoxia
801031|NCT00250406|urolithiasis|urolithiasis
801032|NCT00250406|ureteral stent|ureteral stent
801033|NCT00250406|triclosan|triclosan
801034|NCT00250406|drug eluting|drug eluting
801035|NCT00250393|Parkinson's disease|parkinson's disease
801036|NCT00250393|monotherapy|monotherapy
801037|NCT00250380|Aspirin|aspirin
801038|NCT00250380|Platelet Aggregation Inhibitors|platelet aggregation inhibitors
801039|NCT00250367|risperidone|risperidone
801040|NCT00250367|antipsychotic agents|antipsychotic agents
801041|NCT00250367|bipolar disorders|bipolar disorders
801042|NCT00250367|manic episode|manic episode
801043|NCT00250354|conduct disorder|conduct disorder
801044|NCT00250354|oppositional deficit disorder|oppositional deficit disorder
801045|NCT00250354|disruptive behavior disorder not otherwise specified|disruptive behavior disorder not otherwise specified
801046|NCT00250354|ADHD|adhd
801047|NCT00250354|risperidone|risperidone
801048|NCT00250354|antipsychotropic agents|antipsychotropic agents
801049|NCT00250354|children|children
801050|NCT00250289|malodor|malodor
801051|NCT00250289|halitosis|halitosis
801052|NCT00250289|herbal formulation|herbal formulation
801053|NCT00250289|natural medicinals|natural medicinals
801054|NCT00250289|slow release delivery system|slow release delivery system
801055|NCT00250263|rhinitis|rhinitis
801056|NCT00250263|asthma|asthma
801057|NCT00250263|atopy|atopy
801058|NCT00250263|house dust mite|house dust mite
801059|NCT00250263|immunotherapy|immunotherapy
801060|NCT00250263|SLIT|slit
801061|NCT00250237|Post-operative delirium|post-operative delirium
801062|NCT00250237|hip fracture|hip fracture
801063|NCT00250224|Radiotherapy|radiotherapy
801064|NCT00250224|image guided|image guided
801065|NCT00250224|marker|marker
801066|NCT00250211|magnetic resonance imaging, functional|magnetic resonance imaging, functional
801067|NCT00250211|radiation therapy|radiation therapy
801068|NCT00250211|temozolomide|temozolomide
801069|NCT00250211|functional imaging|functional imaging
801070|NCT00250211|concurrent chemoradiation|concurrent chemoradiation
801071|NCT00250198|T Cell|t cell
801072|NCT00250198|Lymphocyte|lymphocyte
801073|NCT00250198|Lamina Propria|lamina propria
801074|NCT00250198|Colonoscopy|colonoscopy
801075|NCT00250198|Placebo|placebo
801076|NCT00250198|Crohn's Disease|crohn's disease
801077|NCT00250198|Crohns Disease|crohns disease
801078|NCT00250185|Ischemia Tolerance|ischemia tolerance
801079|NCT00250185|Endothelial Function|endothelial function
801080|NCT00250185|Forearm Blood Flow|forearm blood flow
801081|NCT00250185|Muscle Recovery|muscle recovery
801082|NCT00250185|Inflammation|inflammation
801083|NCT00250185|Healthy Volunteer|healthy volunteer
801085|NCT00250172|Dosimetry|dosimetry
801086|NCT00250172|Pharmacokinetics|pharmacokinetics
801087|NCT00250172|Compartment Analysis|compartment analysis
801088|NCT00250172|Reproducibility|reproducibility
801089|NCT00250172|Healthy Volunteer|healthy volunteer
801090|NCT00250172|HV|hv
801091|NCT00250159|Congenital Adrenal Hyperplasia (CAH)|congenital adrenal hyperplasia (cah)
801092|NCT00250159|Familial Male Precocious Puberty (FMPP)|familial male precocious puberty (fmpp)
801093|NCT00250159|21-hydroxylast deficiency|21-hydroxylast deficiency
801094|NCT00250159|Adrenal Insufficiency|adrenal insufficiency
801095|NCT00250159|Congenital Adrenal Hyperplasia|congenital adrenal hyperplasia
801096|NCT00250159|CAH|cah
801097|NCT00250159|Familial Male Precocious Puberty|familial male precocious puberty
801098|NCT00250159|FMPP|fmpp
801099|NCT00250146|Celiac Disease|celiac disease
801100|NCT00250146|Gluten|gluten
801101|NCT00250146|Toxicity|toxicity
801102|NCT00250146|Small bowel morphometry|small bowel morphometry
801103|NCT00250133|selective decontamination of the digestive tract|selective decontamination of the digestive tract
801104|NCT00250120|NSCLC|nsclc
801105|NCT00250120|L9NC|l9nc
801106|NCT00250120|Aerosolized Liposomal 9-Nitro-20 (S)-Camptothecin|aerosolized liposomal 9-nitro-20 (s)-camptothecin
801107|NCT00250094|Phase I|phase i
801108|NCT00250094|Ovarian Cancer|ovarian cancer
801109|NCT00250094|Ovary|ovary
801110|NCT00250094|Cancer|cancer
801111|NCT00250081|Cerebral Palsy|cerebral palsy
801112|NCT00250081|Tendon Transfer|tendon transfer
801113|NCT00250081|Botulinum Toxin Type A|botulinum toxin type a
801114|NCT00250081|Occupational Therapy|occupational therapy
801115|NCT00250081|Child|child
801116|NCT00250068|Phase II|phase ii
801117|NCT00250068|Aerosol Delivery|aerosol delivery
801118|NCT00250068|NSCLC|nsclc
801119|NCT00250068|9-Nitrocamptothecin|9-nitrocamptothecin
801120|NCT00250055|NIH|nih
801121|NCT00250055|Non-Invasive diagnosis of cervical tissue|non-invasive diagnosis of cervical tissue
801122|NCT00250055|Los Alamos/NIH|los alamos/nih
801123|NCT00250029|Colorectal Cancer|colorectal cancer
801124|NCT00250029|Pilot Study|pilot study
801125|NCT00250029|Oxaliplatin|oxaliplatin
801126|NCT00250016|Endometrium|endometrium
801127|NCT00250016|Tissue|tissue
801128|NCT00250016|L9NC|l9nc
801129|NCT00250003|Elderly|elderly
801130|NCT00250003|Preventive home visits|preventive home visits
801131|NCT00249990|Uterus|uterus
801132|NCT00249990|Recurrent disease|recurrent disease
801133|NCT00249990|Treatment|treatment
801134|NCT00249990|9-Nitrocamptothecin|9-nitrocamptothecin
801135|NCT00249990|Endometrium|endometrium
801136|NCT00249977|Phase I|phase i
801137|NCT00249977|solid tumors|solid tumors
801138|NCT00249977|DNA repair|dna repair
801139|NCT00249964|Extensive or recurrent small cell lung cancer Phase I|extensive or recurrent small cell lung cancer phase i
801140|NCT00249964|Paclitaxel, Carboplatin, Temozolomide|paclitaxel, carboplatin, temozolomide
801141|NCT00249951|nephrocalcinosis|nephrocalcinosis
801142|NCT00249951|premature infants|premature infants
801143|NCT00249951|hypocitraturia|hypocitraturia
801144|NCT00249951|alcaline citrate therapy|alcaline citrate therapy
801145|NCT00249951|Nephrocalcinosis in premature infants|nephrocalcinosis in premature infants
801146|NCT00249938|Antilipemic agents|antilipemic agents
801147|NCT00249938|hyperlipidemia|hyperlipidemia
801148|NCT00249925|Home modification|home modification
801149|NCT00249925|Occupational Therapy|occupational therapy
801150|NCT00249925|Physical Therapy|physical therapy
801151|NCT00249925|Home care|home care
801152|NCT00249912|Hyperlipidemia|hyperlipidemia
801153|NCT00249912|Drug Therapy|drug therapy
801154|NCT00249899|Hyperlipidemia|hyperlipidemia
801155|NCT00249899|Drug Therapy|drug therapy
801156|NCT00249873|Atrial fibrillation|atrial fibrillation
801157|NCT00249873|Anticoagulant therapy|anticoagulant therapy
801158|NCT00249873|Thromboembolic prevention|thromboembolic prevention
801403|NCT00248807|Hypotension, Postural|hypotension, postural
801159|NCT00249860|Subjects with chronic hepatitis C who have never previously received interferon therapy.|subjects with chronic hepatitis c who have never previously received interferon therapy.
801160|NCT00249847|Hot flashes, vasomotor symptoms, estrogen, paroxetine|hot flashes, vasomotor symptoms, estrogen, paroxetine
801161|NCT00249834|Assisted Reproductive Technology (ART)|assisted reproductive technology (art)
801162|NCT00249834|Infertility|infertility
801163|NCT00249834|Ovarian stimulation|ovarian stimulation
801164|NCT00249808|Candidates for systemic therapy for psoriasis|candidates for systemic therapy for psoriasis
801165|NCT00249795|Atrial fibrillation|atrial fibrillation
801166|NCT00249795|Cardiovascular disease|cardiovascular disease
801167|NCT00249795|angiotensin II blocker|angiotensin ii blocker
801168|NCT00249782|rosacea, Papulopustular Rosacea,erythema, dapsone|rosacea, papulopustular rosacea,erythema, dapsone
801169|NCT00249769|Japanese Encephalitis|japanese encephalitis
801170|NCT00249769|Japanese B Encephalitis|japanese b encephalitis
801171|NCT00249769|Japanese B Viral Encephalitis|japanese b viral encephalitis
801172|NCT00249769|Viral Encephalitis, Japanese B|viral encephalitis, japanese b
801173|NCT00249756|Criminal Justice|criminal justice
801174|NCT00249743|fall prevention|fall prevention
801175|NCT00249743|fall risk management|fall risk management
801177|NCT00249743|cost|cost
801178|NCT00249717|Contingency management|contingency management
801179|NCT00249717|Substance abuse treatment|substance abuse treatment
801180|NCT00249691|cocaine addiction|cocaine addiction
801181|NCT00249691|cocaine dependence|cocaine dependence
801182|NCT00249678|Behavior Therapy|behavior therapy
801183|NCT00249678|methamphetamine|methamphetamine
801184|NCT00249652|End stage liver disease|end stage liver disease
801185|NCT00249652|End stage renal disease|end stage renal disease
801186|NCT00249652|Substance-Related Disorders|substance-related disorders
801187|NCT00249639|Contingency Management|contingency management
801188|NCT00249639|Substance Abuse Treatment|substance abuse treatment
801189|NCT00249626|Contingency management|contingency management
801190|NCT00249626|substance abuse treatment|substance abuse treatment
801191|NCT00249613|gender-responsive substance abuse treatment|gender-responsive substance abuse treatment
801192|NCT00249600|contingency management|contingency management
801193|NCT00249600|substance abuse|substance abuse
801194|NCT00249574|heroin addiction|heroin addiction
801195|NCT00249548|contingency management|contingency management
801196|NCT00249548|substance abuse|substance abuse
801197|NCT00249535|Substance Abuse|substance abuse
801198|NCT00249535|Contingency Management|contingency management
801199|NCT00249522|contingency management|contingency management
801200|NCT00249522|substance abuse treatment|substance abuse treatment
801201|NCT00249509|marijuana dependence|marijuana dependence
801202|NCT00249496|cocaine|cocaine
801203|NCT00249496|opioids|opioids
801204|NCT00249496|contingency management|contingency management
801205|NCT00249496|sexual risk|sexual risk
801206|NCT00249496|HIV|hiv
801207|NCT00249483|Cocaine Addiction|cocaine addiction
801208|NCT00249483|Cocaine Dependence|cocaine dependence
801209|NCT00249470|HIV|hiv
801210|NCT00249470|HIV risk behaviors|hiv risk behaviors
801211|NCT00249470|Heroin|heroin
801212|NCT00249470|Cocaine|cocaine
801213|NCT00249470|Methadone|methadone
801214|NCT00249470|Opioid Dependence|opioid dependence
801215|NCT00249470|Cocaine Abuse|cocaine abuse
801216|NCT00249470|Contingency management|contingency management
801217|NCT00249470|alcohol & drug use|alcohol & drug use
801218|NCT00249470|sexual risk behaviors|sexual risk behaviors
801219|NCT00249457|Behavior Therapy|behavior therapy
801220|NCT00249457|Cocaine Abuse|cocaine abuse
801221|NCT00249457|Cocaine Dependence|cocaine dependence
801222|NCT00249457|Contingency Management|contingency management
801223|NCT00249457|Heroin Dependence|heroin dependence
801224|NCT00249457|Methadone|methadone
801225|NCT00249457|Opioid Dependence|opioid dependence
801226|NCT00249444|cocaine dependence|cocaine dependence
801227|NCT00249444|mirtazipine|mirtazipine
801228|NCT00249431|Gambling|gambling
801229|NCT00249431|Alcohol|alcohol
801230|NCT00249418|Contingency Management|contingency management
801231|NCT00249418|Substance Abuse Treatment|substance abuse treatment
801232|NCT00249405|Clinical trial|clinical trial
801233|NCT00249405|Alcoholism|alcoholism
801234|NCT00249405|Alcohol|alcohol
801235|NCT00249405|Pharmacogenetics|pharmacogenetics
801236|NCT00249405|Citalopram|citalopram
801237|NCT00249405|Genotype|genotype
801238|NCT00249405|Therapy compliance|therapy compliance
801239|NCT00249405|Serotonin inhibitor|serotonin inhibitor
801240|NCT00249405|Alcoholism/alcohol abuse therapy|alcoholism/alcohol abuse therapy
801241|NCT00249392|ocular diseases|ocular diseases
801242|NCT00249392|risk factors|risk factors
801243|NCT00249392|genetic factors|genetic factors
801244|NCT00249379|Alcohol dependence|alcohol dependence
801245|NCT00249379|Acamprosate(drug)|acamprosate(drug)
801246|NCT00249379|Drug Court|drug court
801247|NCT00249379|Probation|probation
801248|NCT00249379|Parole|parole
801249|NCT00249379|Criminal justice|criminal justice
801250|NCT00249366|Alcohol withdrawal|alcohol withdrawal
801251|NCT00249366|Symptom-triggered therapy|symptom-triggered therapy
801252|NCT00249366|Fixed-schedule therapy|fixed-schedule therapy
801253|NCT00249366|CIWA-Ar|ciwa-ar
801254|NCT00249366|Lorazepam (drug)|lorazepam (drug)
801255|NCT00249353|Attention Deficit Hyperactivity Disorder|attention deficit hyperactivity disorder
801256|NCT00249353|ADHD|adhd
801257|NCT00249353|Concerta|concerta
801258|NCT00249340|behavioral weight loss treatment|behavioral weight loss treatment
801259|NCT00249340|brief behavioral treatment|brief behavioral treatment
801260|NCT00249340|commercial weight loss programs|commercial weight loss programs
801261|NCT00249340|Weight Watchers|weight watchers
801262|NCT00249327|HIV testing|hiv testing
801263|NCT00249327|HIV disclosure|hiv disclosure
801264|NCT00249327|HIV Seronegativity|hiv seronegativity
801265|NCT00249314|South Asians|south asians
801266|NCT00249314|European Caucasians|european caucasians
801267|NCT00249314|ethnic differences|ethnic differences
801268|NCT00249314|body composition|body composition
801269|NCT00249314|body fat distribution|body fat distribution
801270|NCT00249314|adipose tissue|adipose tissue
801271|NCT00249314|visceral fat|visceral fat
801272|NCT00249314|myocellular lipids|myocellular lipids
801273|NCT00249314|skeletal muscle|skeletal muscle
801274|NCT00249301|Breast Cancer|breast cancer
801275|NCT00249301|Colon Cancer|colon cancer
801276|NCT00249301|Pancreatic Cancer|pancreatic cancer
801277|NCT00249301|Bladder Cancer|bladder cancer
801278|NCT00249288|Schizophrenia|schizophrenia
801279|NCT00249288|Negative Symptoms|negative symptoms
801280|NCT00249288|Folate|folate
802170|NCT00246350|Massage|massage
801281|NCT00249275|significant refractive errors|significant refractive errors
801282|NCT00249275|children|children
801283|NCT00249275|spectacles|spectacles
801284|NCT00249275|Africa|africa
801285|NCT00249249|hypercholesterolemia|hypercholesterolemia
801286|NCT00249249|dyslipidemia|dyslipidemia
801287|NCT00249249|kowa|kowa
801288|NCT00249249|KRE|kre
801289|NCT00249249|pitavastatin|pitavastatin
801290|NCT00249249|NK-104|nk-104
801291|NCT00249236|risperidone|risperidone
801292|NCT00249236|antipsychotic agents|antipsychotic agents
801293|NCT00249236|bipolar disorders|bipolar disorders
801294|NCT00249236|manic episode|manic episode
801295|NCT00249223|chronic schizophrenia, psychotic disorder, risperidone, long-acting injectable, intramuscular injection, antipsychotic agents|chronic schizophrenia, psychotic disorder, risperidone, long-acting injectable, intramuscular injection, antipsychotic agents
801296|NCT00249210|Sinusitis|sinusitis
801297|NCT00249210|respiratory tract diseases|respiratory tract diseases
801298|NCT00249210|nose diseases|nose diseases
801299|NCT00249210|respiratory tract infections|respiratory tract infections
801300|NCT00249210|paranasal sinus diseases|paranasal sinus diseases
801301|NCT00249210|antibacterial agents|antibacterial agents
801302|NCT00249210|quinolones|quinolones
801303|NCT00249210|levofloxacin|levofloxacin
801304|NCT00249197|skin infection|skin infection
801305|NCT00249197|bacterial infection|bacterial infection
801306|NCT00249197|levofloxacin|levofloxacin
801307|NCT00249197|quinolones|quinolones
801308|NCT00249197|skin|skin
801309|NCT00249197|infection|infection
801310|NCT00249171|acute schizophrenia|acute schizophrenia
801311|NCT00249171|psychosis|psychosis
801312|NCT00249171|risperidone|risperidone
801313|NCT00249171|lorazepam, antipsychotic agents|lorazepam, antipsychotic agents
801314|NCT00249171|emergency treatment|emergency treatment
801315|NCT00249158|Dementia|dementia
801316|NCT00249158|Alzheimer's Disease|alzheimer's disease
801317|NCT00249158|vascular dementia|vascular dementia
801318|NCT00249158|mixed dementia|mixed dementia
801319|NCT00249158|risperidone|risperidone
801320|NCT00249158|nursing home|nursing home
801321|NCT00249145|Dementia|dementia
801322|NCT00249145|Alzheimer's Disease|alzheimer's disease
801323|NCT00249145|vascular dementia|vascular dementia
801324|NCT00249145|mixed dementia, risperidone|mixed dementia, risperidone
801325|NCT00249145|nursing home|nursing home
801326|NCT00249132|chronic schizophrenia|chronic schizophrenia
801327|NCT00249132|psychotic disorder|psychotic disorder
801328|NCT00249132|risperidone|risperidone
801329|NCT00249132|antipsychotic agents|antipsychotic agents
801330|NCT00249119|chronic schizophrenia|chronic schizophrenia
801331|NCT00249119|psychotic disorders|psychotic disorders
801332|NCT00249119|risperidone|risperidone
801333|NCT00249119|antipsychotic agents|antipsychotic agents
801334|NCT00249080|3T MRI|3t mri
801335|NCT00249080|neurodegenerative disease|neurodegenerative disease
801336|NCT00249080|Alzheimer's disease|alzheimer's disease
801337|NCT00249080|spectroscopy|spectroscopy
801338|NCT00249080|Normal, healthy subject without memory complaint|normal, healthy subject without memory complaint
801339|NCT00249080|Not pregnant|not pregnant
801340|NCT00249080|MR compatible|mr compatible
801341|NCT00249067|Congestive Heart Failure, Left-to-Right Shunt|congestive heart failure, left-to-right shunt
801342|NCT00249041|Rheumatoid Arthritis, Enbrel liquid, antibodies|rheumatoid arthritis, enbrel liquid, antibodies
801343|NCT00249015|aerobic exercise|aerobic exercise
801344|NCT00249015|resistance exercise|resistance exercise
801345|NCT00249015|physical fitness|physical fitness
801346|NCT00249015|body composition|body composition
801347|NCT00249015|quality of life|quality of life
801348|NCT00249015|rehabilitation|rehabilitation
801349|NCT00249015|psychosocial oncology|psychosocial oncology
801350|NCT00249015|adherence|adherence
801351|NCT00249002|Vascular Access Graft Failure|vascular access graft failure
801352|NCT00249002|Venous Neointimal Hyperplasia(VNH)|venous neointimal hyperplasia(vnh)
801353|NCT00249002|Hemodialysis|hemodialysis
801354|NCT00248989|Skin aging|skin aging
801355|NCT00248989|Menopausal symptoms|menopausal symptoms
801356|NCT00248976|Angioplasty|angioplasty
801357|NCT00248976|Motivating behavior change|motivating behavior change
801358|NCT00248976|Reducing risk factors|reducing risk factors
801359|NCT00248976|Enhancing quality of life|enhancing quality of life
801360|NCT00248976|Improving treatment outcomes|improving treatment outcomes
801361|NCT00248963|Oral Contraceptive|oral contraceptive
801362|NCT00248950|Angioplasty|angioplasty
801363|NCT00248950|Behavior Change|behavior change
801364|NCT00248937|African-American|african-american
801365|NCT00248937|Hypertension|hypertension
801366|NCT00248937|Medication adherence|medication adherence
801367|NCT00248937|Risk reduction|risk reduction
801368|NCT00248924|Social service intervention|social service intervention
801369|NCT00248924|Social support|social support
801370|NCT00248924|Elderly|elderly
801371|NCT00248924|Homebound|homebound
801372|NCT00248924|Quality of life|quality of life
801373|NCT00248911|Breast cancer|breast cancer
801374|NCT00248911|Gynecologic cancers|gynecologic cancers
801375|NCT00248911|Meditation|meditation
801376|NCT00248911|Stress-reduction|stress-reduction
801377|NCT00248911|Cognitive-affective behavioral learning|cognitive-affective behavioral learning
801378|NCT00248898|nonagenarians|nonagenarians
801379|NCT00248898|quality of life|quality of life
801380|NCT00248898|cardiothoracic surgery|cardiothoracic surgery
801381|NCT00248898|long term survival|long term survival
801382|NCT00248885|Coronary artery bypass graft surgery|coronary artery bypass graft surgery
801383|NCT00248885|Perioperative complications|perioperative complications
801384|NCT00248885|Neurocognitive function|neurocognitive function
801385|NCT00248885|Quality of life|quality of life
801386|NCT00248885|Blood pressure|blood pressure
801387|NCT00248872|African-American|african-american
801388|NCT00248872|Hypertension|hypertension
801389|NCT00248872|Medication adherence|medication adherence
801390|NCT00248872|Risk reduction|risk reduction
801391|NCT00248859|Coronary artery disease|coronary artery disease
801392|NCT00248859|Depressive symptoms|depressive symptoms
801393|NCT00248859|Latino American|latino american
801394|NCT00248846|Angioplasty patients|angioplasty patients
801395|NCT00248846|Behavior change|behavior change
801396|NCT00248846|Physical activity|physical activity
801397|NCT00248846|Risk reduction|risk reduction
801398|NCT00248820|Contrast-enhanced Ultrasound|contrast-enhanced ultrasound
801399|NCT00248820|Ultrasound Contrast agent, microbubbles|ultrasound contrast agent, microbubbles
801400|NCT00248820|Ovarian tumor|ovarian tumor
801401|NCT00248820|vascularization|vascularization
801402|NCT00248807|Blood Pressure, Low|blood pressure, low
801404|NCT00248807|Injuries, Spinal Cord|injuries, spinal cord
801405|NCT00248807|Spinal Cord Transection|spinal cord transection
801406|NCT00248807|Spinal Cord Trauma|spinal cord trauma
801407|NCT00248794|Cognitive Impairment|cognitive impairment
801408|NCT00248794|Rehabilitation|rehabilitation
801714|NCT00247988|Ovarian|ovarian
801409|NCT00248781|Activities of daily living|activities of daily living
801411|NCT00248781|Exercise|exercise
801412|NCT00248781|Weight lifting|weight lifting
801413|NCT00248768|Depression|depression
801414|NCT00248768|Parkinson Disease|parkinson disease
801415|NCT00248768|Transcranial Magnetic Stimulation|transcranial magnetic stimulation
801416|NCT00248755|cystic fibrosis|cystic fibrosis
801417|NCT00248755|mucociliary clearance|mucociliary clearance
801418|NCT00248755|nuclear medicine|nuclear medicine
801419|NCT00248742|IBD, psychological, stress management|ibd, psychological, stress management
801420|NCT00248703|Disseminating tumor cells,breast cancer,docetaxel,adjuvant|disseminating tumor cells,breast cancer,docetaxel,adjuvant
801421|NCT00248690|Subarachnoid hemorrhage|subarachnoid hemorrhage
801422|NCT00248690|Intracranial hypertension|intracranial hypertension
801423|NCT00248690|Intracranial pressure|intracranial pressure
801424|NCT00248690|Diagnostic techniques and procedures|diagnostic techniques and procedures
801425|NCT00248690|Compliance|compliance
801426|NCT00248690|Treatment outcome|treatment outcome
801427|NCT00248690|Intensive care, surgical|intensive care, surgical
801428|NCT00248664|Cystitis, Interstitial|cystitis, interstitial
801429|NCT00248664|Case-Control Studies|case-control studies
801430|NCT00248664|Risk Factors|risk factors
801431|NCT00248651|Bloating|bloating
801432|NCT00248651|Early Fullness|early fullness
801433|NCT00248651|Nausea|nausea
801434|NCT00248651|Upper Abdominal Discomfort|upper abdominal discomfort
801435|NCT00248651|dyspepsia|dyspepsia
801436|NCT00248651|stomach pain|stomach pain
801437|NCT00248651|stomach discomfort|stomach discomfort
801438|NCT00248625|acute liver failure|acute liver failure
801439|NCT00248625|hepatic encephalopathy|hepatic encephalopathy
801440|NCT00248625|acetaminophen toxicity|acetaminophen toxicity
801441|NCT00248625|N-acetylcysteine|n-acetylcysteine
801442|NCT00248612|Venlafaxine|venlafaxine
801443|NCT00248612|Alcoholism|alcoholism
801444|NCT00248612|Anxiety Disorders|anxiety disorders
801445|NCT00248612|Alcohol-Use Disorders|alcohol-use disorders
801446|NCT00248612|Alcohol Abuse|alcohol abuse
801447|NCT00248612|Alcohol Dependence|alcohol dependence
801448|NCT00248612|Cognitive Behavioral Treatment|cognitive behavioral treatment
801449|NCT00248560|recurrent squamous cell carcinoma of the hypopharynx|recurrent squamous cell carcinoma of the hypopharynx
801450|NCT00248560|stage IV squamous cell carcinoma of the hypopharynx|stage iv squamous cell carcinoma of the hypopharynx
801451|NCT00248560|recurrent squamous cell carcinoma of the larynx|recurrent squamous cell carcinoma of the larynx
801452|NCT00248560|stage IV squamous cell carcinoma of the larynx|stage iv squamous cell carcinoma of the larynx
801453|NCT00248560|recurrent squamous cell carcinoma of the lip and oral cavity|recurrent squamous cell carcinoma of the lip and oral cavity
801454|NCT00248560|stage IV squamous cell carcinoma of the lip and oral cavity|stage iv squamous cell carcinoma of the lip and oral cavity
801455|NCT00248560|metastatic squamous neck cancer with occult primary squamous cell carcinoma|metastatic squamous neck cancer with occult primary squamous cell carcinoma
801456|NCT00248560|recurrent metastatic squamous neck cancer with occult primary|recurrent metastatic squamous neck cancer with occult primary
801457|NCT00248560|recurrent squamous cell carcinoma of the nasopharynx|recurrent squamous cell carcinoma of the nasopharynx
801458|NCT00248560|stage IV squamous cell carcinoma of the nasopharynx|stage iv squamous cell carcinoma of the nasopharynx
801459|NCT00248560|recurrent squamous cell carcinoma of the oropharynx|recurrent squamous cell carcinoma of the oropharynx
801460|NCT00248560|stage IV squamous cell carcinoma of the oropharynx|stage iv squamous cell carcinoma of the oropharynx
801461|NCT00248560|recurrent squamous cell carcinoma of the paranasal sinus and nasal cavity|recurrent squamous cell carcinoma of the paranasal sinus and nasal cavity
801462|NCT00248560|stage IV squamous cell carcinoma of the paranasal sinus and nasal cavity|stage iv squamous cell carcinoma of the paranasal sinus and nasal cavity
801463|NCT00248547|nausea and vomiting|nausea and vomiting
801464|NCT00248547|adult acute myeloid leukemia with 11q23 (MLL) abnormalities|adult acute myeloid leukemia with 11q23 (mll) abnormalities
801465|NCT00248547|adult acute myeloid leukemia with inv(16)(p13;q22)|adult acute myeloid leukemia with inv(16)(p13;q22)
801466|NCT00248547|adult acute myeloid leukemia with t(15;17)(q22;q12)|adult acute myeloid leukemia with t(15;17)(q22;q12)
801467|NCT00248547|adult acute myeloid leukemia with t(16;16)(p13;q22)|adult acute myeloid leukemia with t(16;16)(p13;q22)
801468|NCT00248547|adult acute myeloid leukemia with t(8;21)(q22;q22)|adult acute myeloid leukemia with t(8;21)(q22;q22)
801469|NCT00248547|accelerated phase chronic myelogenous leukemia|accelerated phase chronic myelogenous leukemia
801470|NCT00248547|adult acute lymphoblastic leukemia in remission|adult acute lymphoblastic leukemia in remission
801471|NCT00248547|adult acute myeloid leukemia in remission|adult acute myeloid leukemia in remission
801472|NCT00248547|atypical chronic myeloid leukemia|atypical chronic myeloid leukemia
801473|NCT00248547|blastic phase chronic myelogenous leukemia|blastic phase chronic myelogenous leukemia
801474|NCT00248547|chronic eosinophilic leukemia|chronic eosinophilic leukemia
801475|NCT00248547|chronic idiopathic myelofibrosis|chronic idiopathic myelofibrosis
801476|NCT00248547|chronic myelomonocytic leukemia|chronic myelomonocytic leukemia
801477|NCT00248547|chronic neutrophilic leukemia|chronic neutrophilic leukemia
801478|NCT00248547|chronic phase chronic myelogenous leukemia|chronic phase chronic myelogenous leukemia
801479|NCT00248547|de novo myelodysplastic syndromes|de novo myelodysplastic syndromes
801480|NCT00248547|disseminated neuroblastoma|disseminated neuroblastoma
801543|NCT00248547|stage III ovarian epithelial cancer|stage iii ovarian epithelial cancer
801481|NCT00248547|extranodal marginal zone B-cell lymphoma of mucosa-associated lymphoid tissue|extranodal marginal zone b-cell lymphoma of mucosa-associated lymphoid tissue
801482|NCT00248547|myelodysplastic/myeloproliferative disease, unclassifiable|myelodysplastic/myeloproliferative disease, unclassifiable
801483|NCT00248547|nodal marginal zone B-cell lymphoma|nodal marginal zone b-cell lymphoma
801484|NCT00248547|noncontiguous stage II adult Burkitt lymphoma|noncontiguous stage ii adult burkitt lymphoma
801485|NCT00248547|noncontiguous stage II adult diffuse large cell lymphoma|noncontiguous stage ii adult diffuse large cell lymphoma
801486|NCT00248547|noncontiguous stage II adult diffuse mixed cell lymphoma|noncontiguous stage ii adult diffuse mixed cell lymphoma
801487|NCT00248547|noncontiguous stage II adult diffuse small cleaved cell lymphoma|noncontiguous stage ii adult diffuse small cleaved cell lymphoma
801488|NCT00248547|noncontiguous stage II adult immunoblastic large cell lymphoma|noncontiguous stage ii adult immunoblastic large cell lymphoma
801489|NCT00248547|noncontiguous stage II adult lymphoblastic lymphoma|noncontiguous stage ii adult lymphoblastic lymphoma
801490|NCT00248547|noncontiguous stage II grade 1 follicular lymphoma|noncontiguous stage ii grade 1 follicular lymphoma
801491|NCT00248547|noncontiguous stage II grade 2 follicular lymphoma|noncontiguous stage ii grade 2 follicular lymphoma
801492|NCT00248547|noncontiguous stage II grade 3 follicular lymphoma|noncontiguous stage ii grade 3 follicular lymphoma
801493|NCT00248547|noncontiguous stage II mantle cell lymphoma|noncontiguous stage ii mantle cell lymphoma
801494|NCT00248547|noncontiguous stage II marginal zone lymphoma|noncontiguous stage ii marginal zone lymphoma
801495|NCT00248547|noncontiguous stage II small lymphocytic lymphoma|noncontiguous stage ii small lymphocytic lymphoma
801496|NCT00248547|poor prognosis metastatic gestational trophoblastic tumor|poor prognosis metastatic gestational trophoblastic tumor
801497|NCT00248547|previously treated myelodysplastic syndromes|previously treated myelodysplastic syndromes
801498|NCT00248547|recurrent adult acute lymphoblastic leukemia|recurrent adult acute lymphoblastic leukemia
801499|NCT00248547|recurrent adult acute myeloid leukemia|recurrent adult acute myeloid leukemia
801500|NCT00248547|recurrent adult Burkitt lymphoma|recurrent adult burkitt lymphoma
801501|NCT00248547|recurrent adult Hodgkin lymphoma|recurrent adult hodgkin lymphoma
801502|NCT00248547|recurrent adult diffuse large cell lymphoma|recurrent adult diffuse large cell lymphoma
801503|NCT00248547|recurrent adult diffuse mixed cell lymphoma|recurrent adult diffuse mixed cell lymphoma
801504|NCT00248547|recurrent adult diffuse small cleaved cell lymphoma|recurrent adult diffuse small cleaved cell lymphoma
801505|NCT00248547|recurrent adult immunoblastic large cell lymphoma|recurrent adult immunoblastic large cell lymphoma
801506|NCT00248547|recurrent adult lymphoblastic lymphoma|recurrent adult lymphoblastic lymphoma
801507|NCT00248547|recurrent cutaneous T-cell non-Hodgkin lymphoma|recurrent cutaneous t-cell non-hodgkin lymphoma
801508|NCT00248547|recurrent grade 1 follicular lymphoma|recurrent grade 1 follicular lymphoma
801509|NCT00248547|recurrent grade 2 follicular lymphoma|recurrent grade 2 follicular lymphoma
801510|NCT00248547|recurrent grade 3 follicular lymphoma|recurrent grade 3 follicular lymphoma
801511|NCT00248547|recurrent mantle cell lymphoma|recurrent mantle cell lymphoma
801512|NCT00248547|recurrent marginal zone lymphoma|recurrent marginal zone lymphoma
801513|NCT00248547|recurrent mycosis fungoides/Sezary syndrome|recurrent mycosis fungoides/sezary syndrome
801514|NCT00248547|recurrent neuroblastoma|recurrent neuroblastoma
801515|NCT00248547|recurrent ovarian epithelial cancer|recurrent ovarian epithelial cancer
801516|NCT00248547|recurrent ovarian germ cell tumor|recurrent ovarian germ cell tumor
801517|NCT00248547|recurrent small lymphocytic lymphoma|recurrent small lymphocytic lymphoma
801518|NCT00248547|recurrent malignant testicular germ cell tumor|recurrent malignant testicular germ cell tumor
801592|NCT00248430|stage III multiple myeloma|stage iii multiple myeloma
801519|NCT00248547|refractory chronic lymphocytic leukemia|refractory chronic lymphocytic leukemia
801520|NCT00248547|refractory hairy cell leukemia|refractory hairy cell leukemia
801521|NCT00248547|refractory multiple myeloma|refractory multiple myeloma
801522|NCT00248547|relapsing chronic myelogenous leukemia|relapsing chronic myelogenous leukemia
801523|NCT00248547|secondary acute myeloid leukemia|secondary acute myeloid leukemia
801524|NCT00248547|secondary myelodysplastic syndromes|secondary myelodysplastic syndromes
801525|NCT00248547|splenic marginal zone lymphoma|splenic marginal zone lymphoma
801526|NCT00248547|stage I multiple myeloma|stage i multiple myeloma
801527|NCT00248547|stage II multiple myeloma|stage ii multiple myeloma
801528|NCT00248547|stage II ovarian epithelial cancer|stage ii ovarian epithelial cancer
801529|NCT00248547|stage III adult Burkitt lymphoma|stage iii adult burkitt lymphoma
801530|NCT00248547|stage III adult Hodgkin lymphoma|stage iii adult hodgkin lymphoma
801531|NCT00248547|stage III adult diffuse large cell lymphoma|stage iii adult diffuse large cell lymphoma
801532|NCT00248547|stage III adult diffuse mixed cell lymphoma|stage iii adult diffuse mixed cell lymphoma
801533|NCT00248547|stage III adult diffuse small cleaved cell lymphoma|stage iii adult diffuse small cleaved cell lymphoma
801534|NCT00248547|stage III adult immunoblastic large cell lymphoma|stage iii adult immunoblastic large cell lymphoma
801535|NCT00248547|stage III adult lymphoblastic lymphoma|stage iii adult lymphoblastic lymphoma
801536|NCT00248547|stage III chronic lymphocytic leukemia|stage iii chronic lymphocytic leukemia
801537|NCT00248547|stage III grade 1 follicular lymphoma|stage iii grade 1 follicular lymphoma
801538|NCT00248547|stage III grade 2 follicular lymphoma|stage iii grade 2 follicular lymphoma
801539|NCT00248547|stage III grade 3 follicular lymphoma|stage iii grade 3 follicular lymphoma
801540|NCT00248547|stage III mantle cell lymphoma|stage iii mantle cell lymphoma
801541|NCT00248547|stage III marginal zone lymphoma|stage iii marginal zone lymphoma
801542|NCT00248547|stage III multiple myeloma|stage iii multiple myeloma
801544|NCT00248547|stage III small lymphocytic lymphoma|stage iii small lymphocytic lymphoma
801545|NCT00248547|stage III malignant testicular germ cell tumor|stage iii malignant testicular germ cell tumor
801546|NCT00248547|stage IIIA breast cancer|stage iiia breast cancer
801547|NCT00248547|stage IIIB breast cancer|stage iiib breast cancer
801548|NCT00248547|stage IIIC breast cancer|stage iiic breast cancer
801549|NCT00248547|stage IV adult Burkitt lymphoma|stage iv adult burkitt lymphoma
801550|NCT00248547|stage IV adult Hodgkin lymphoma|stage iv adult hodgkin lymphoma
801551|NCT00248547|stage IV adult diffuse large cell lymphoma|stage iv adult diffuse large cell lymphoma
801552|NCT00248547|stage IV adult diffuse mixed cell lymphoma|stage iv adult diffuse mixed cell lymphoma
801553|NCT00248547|stage IV adult diffuse small cleaved cell lymphoma|stage iv adult diffuse small cleaved cell lymphoma
801554|NCT00248547|stage IV adult immunoblastic large cell lymphoma|stage iv adult immunoblastic large cell lymphoma
801555|NCT00248547|stage IV adult lymphoblastic lymphoma|stage iv adult lymphoblastic lymphoma
801556|NCT00248547|stage IV breast cancer|stage iv breast cancer
801557|NCT00248547|stage IV chronic lymphocytic leukemia|stage iv chronic lymphocytic leukemia
801558|NCT00248547|stage IV grade 1 follicular lymphoma|stage iv grade 1 follicular lymphoma
801559|NCT00248547|stage IV grade 2 follicular lymphoma|stage iv grade 2 follicular lymphoma
801560|NCT00248547|stage IV grade 3 follicular lymphoma|stage iv grade 3 follicular lymphoma
801561|NCT00248547|stage IV mantle cell lymphoma|stage iv mantle cell lymphoma
801562|NCT00248547|stage IV marginal zone lymphoma|stage iv marginal zone lymphoma
801563|NCT00248547|stage IV ovarian epithelial cancer|stage iv ovarian epithelial cancer
801564|NCT00248547|stage IV small lymphocytic lymphoma|stage iv small lymphocytic lymphoma
801565|NCT00248547|unspecified adult solid tumor, protocol specific|unspecified adult solid tumor, protocol specific
801566|NCT00248534|primary central nervous system non-Hodgkin lymphoma|primary central nervous system non-hodgkin lymphoma
801567|NCT00248521|unspecified adult solid tumor, protocol specific|unspecified adult solid tumor, protocol specific
801568|NCT00248495|stage IIIA non-small cell lung cancer|stage iiia non-small cell lung cancer
801569|NCT00248495|stage IIIB non-small cell lung cancer|stage iiib non-small cell lung cancer
801570|NCT00248495|stage II non-small cell lung cancer|stage ii non-small cell lung cancer
801571|NCT00248495|stage I non-small cell lung cancer|stage i non-small cell lung cancer
801572|NCT00248482|extensive stage small cell lung cancer|extensive stage small cell lung cancer
801573|NCT00248482|recurrent small cell lung cancer|recurrent small cell lung cancer
801574|NCT00248469|Community randomised trial|community randomised trial
801575|NCT00248469|Sexual behavior|sexual behavior
801576|NCT00248469|Intervention|intervention
801577|NCT00248469|Evaluation|evaluation
801578|NCT00248469|Sexual health education|sexual health education
801579|NCT00248469|Youth-friendly health services|youth-friendly health services
801580|NCT00248469|Adolescents|adolescents
801581|NCT00248469|Behavior change|behavior change
801582|NCT00248469|HIV Seronegativity|hiv seronegativity
801583|NCT00248469|HIV|hiv
801584|NCT00248443|Haematology and cancer patients|haematology and cancer patients
801585|NCT00248443|Acute respiratory failure|acute respiratory failure
801586|NCT00248443|Bronchoalveolar lavage|bronchoalveolar lavage
801587|NCT00248443|Non invasive diagnostic tools|non invasive diagnostic tools
801588|NCT00248443|Mechanical ventilation|mechanical ventilation
801589|NCT00248443|Intensive Care|intensive care
801590|NCT00248430|graft versus host disease|graft versus host disease
801591|NCT00248430|stage II multiple myeloma|stage ii multiple myeloma
801771|NCT00247741|intrathecal|intrathecal
801593|NCT00248430|refractory multiple myeloma|refractory multiple myeloma
801594|NCT00248430|refractory chronic lymphocytic leukemia|refractory chronic lymphocytic leukemia
801595|NCT00248430|stage III chronic lymphocytic leukemia|stage iii chronic lymphocytic leukemia
801596|NCT00248430|stage IV chronic lymphocytic leukemia|stage iv chronic lymphocytic leukemia
801597|NCT00248430|recurrent small lymphocytic lymphoma|recurrent small lymphocytic lymphoma
801598|NCT00248430|stage III small lymphocytic lymphoma|stage iii small lymphocytic lymphoma
801599|NCT00248430|stage IV small lymphocytic lymphoma|stage iv small lymphocytic lymphoma
801600|NCT00248430|recurrent mantle cell lymphoma|recurrent mantle cell lymphoma
801601|NCT00248430|stage III mantle cell lymphoma|stage iii mantle cell lymphoma
801602|NCT00248430|stage IV mantle cell lymphoma|stage iv mantle cell lymphoma
801603|NCT00248430|recurrent grade 1 follicular lymphoma|recurrent grade 1 follicular lymphoma
801604|NCT00248430|recurrent grade 2 follicular lymphoma|recurrent grade 2 follicular lymphoma
801605|NCT00248430|recurrent grade 3 follicular lymphoma|recurrent grade 3 follicular lymphoma
801606|NCT00248430|stage III grade 1 follicular lymphoma|stage iii grade 1 follicular lymphoma
801607|NCT00248430|stage III grade 2 follicular lymphoma|stage iii grade 2 follicular lymphoma
801608|NCT00248430|stage III grade 3 follicular lymphoma|stage iii grade 3 follicular lymphoma
801609|NCT00248430|stage IV grade 1 follicular lymphoma|stage iv grade 1 follicular lymphoma
801610|NCT00248430|stage IV grade 2 follicular lymphoma|stage iv grade 2 follicular lymphoma
801611|NCT00248430|stage IV grade 3 follicular lymphoma|stage iv grade 3 follicular lymphoma
801612|NCT00248404|colorectal cancer|colorectal cancer
801613|NCT00248404|ovarian cancer|ovarian cancer
801614|NCT00248404|lung cancer|lung cancer
801615|NCT00248404|breast cancer|breast cancer
801616|NCT00248404|small bowel cancer|small bowel cancer
801617|NCT00248404|Advanced, recurrent, or metastatic solid tumors of any type|advanced, recurrent, or metastatic solid tumors of any type
801618|NCT00248404|TS overexpression confirmed by fresh biopsy (RTPCR)|ts overexpression confirmed by fresh biopsy (rtpcr)
801619|NCT00248404|Suitable for experimental monotherapy|suitable for experimental monotherapy
801620|NCT00248391|adenoid hypertrophy|adenoid hypertrophy
801621|NCT00248391|feeding position|feeding position
801623|NCT00248391|upright|upright
801624|NCT00248391|pneumonia|pneumonia
801625|NCT00248391|wheezing|wheezing
801626|NCT00248391|otitis|otitis
801627|NCT00248391|adenoid|adenoid
801628|NCT00248391|tonsil|tonsil
801629|NCT00248391|caries|caries
801630|NCT00248378|Multiple Sclerosis|multiple sclerosis
801631|NCT00248378|Cannabis|cannabis
801632|NCT00248378|Spasticity|spasticity
801633|NCT00248378|Tolerability|tolerability
801634|NCT00248365|Chronic GvHD|chronic gvhd
801635|NCT00248365|Extensive chronic GvHD|extensive chronic gvhd
801636|NCT00248365|Resistant chronic GvHD|resistant chronic gvhd
801637|NCT00248352|Coronary Artery Disease|coronary artery disease
801638|NCT00248352|Diabetes Mellitus|diabetes mellitus
801639|NCT00248352|Type 2|type 2
801640|NCT00248352|Chronic Disease|chronic disease
801641|NCT00248339|Hepatitis C|hepatitis c
801642|NCT00248339|Peginterferon|peginterferon
801643|NCT00248339|Ribavirin|ribavirin
801644|NCT00248339|Procrit|procrit
801645|NCT00248339|Epoetin-alpha|epoetin-alpha
801646|NCT00248326|atrial fibrillation|atrial fibrillation
801647|NCT00248326|genetics|genetics
801648|NCT00248326|genetic polymorphisms|genetic polymorphisms
801649|NCT00248313|Kidney Disease|kidney disease
801650|NCT00248300|ventilator-associated pneumonia|ventilator-associated pneumonia
801651|NCT00248300|hospital acquired pneumonia|hospital acquired pneumonia
801652|NCT00248274|atrial fibrillation|atrial fibrillation
801653|NCT00248274|genetics|genetics
801654|NCT00248261|ziprasidone, sertraline, PTSD|ziprasidone, sertraline, ptsd
801655|NCT00248248|Consolidation|consolidation
801656|NCT00248248|Ovarian cancer|ovarian cancer
801657|NCT00248248|DOXIL|doxil
801658|NCT00248248|Hand-foot syndrome|hand-foot syndrome
801659|NCT00248235|exercise|exercise
801660|NCT00248235|rehabilitation|rehabilitation
801661|NCT00248235|head and neck neoplasms|head and neck neoplasms
801662|NCT00248222|Exercise|exercise
801663|NCT00248222|Rehabilitation|rehabilitation
801664|NCT00248222|Aerobic training|aerobic training
801665|NCT00248209|Female Orgasmic Disorder|female orgasmic disorder
801666|NCT00248209|Female Sexual Dysfunction|female sexual dysfunction
801667|NCT00248170|Breast cancer|breast cancer
801668|NCT00248170|letrozole|letrozole
801669|NCT00248170|anastrozole|anastrozole
801670|NCT00248170|adjuvant|adjuvant
801671|NCT00248170|postmenopausal|postmenopausal
801672|NCT00248170|FACE|face
801673|NCT00248157|Diabetic retinopathy|diabetic retinopathy
801674|NCT00248157|Octreotide acetate in microspheres|octreotide acetate in microspheres
801675|NCT00248144|Herpes labialis|herpes labialis
801676|NCT00248131|Diabetic retinopathy, octreotide acetate in microspheres|diabetic retinopathy, octreotide acetate in microspheres
801677|NCT00248118|Randomized|randomized
801678|NCT00248118|Double-blind|double-blind
801679|NCT00248118|Placebo-controlled|placebo-controlled
801680|NCT00248105|Arthritis|arthritis
801681|NCT00248105|Physical Activity|physical activity
801682|NCT00248092|d-Amphetamine|d-amphetamine
801683|NCT00248092|Diethylpropion|diethylpropion
801772|NCT00247728|PI-88|pi-88
801684|NCT00248092|Diethylpropion Hydrochloride|diethylpropion hydrochloride
801685|NCT00248092|Attention Deficit Hyperactivity Disorder|attention deficit hyperactivity disorder
801686|NCT00248092|Attention Deficit Disorders with Hyperactivity|attention deficit disorders with hyperactivity
801687|NCT00248092|Attention Deficit Hyperactivity Disorders|attention deficit hyperactivity disorders
801688|NCT00248092|Amphetamine Abuse|amphetamine abuse
801689|NCT00248092|Amphetamine Dependence|amphetamine dependence
801690|NCT00248092|Amphetamine Addiction|amphetamine addiction
801691|NCT00248092|Amphetamine Users|amphetamine users
801692|NCT00248092|Drug Abuse|drug abuse
801693|NCT00248092|Drug Addiction|drug addiction
801694|NCT00248092|Drug Dependence|drug dependence
801695|NCT00248092|Drug Habituation|drug habituation
801696|NCT00248092|Drug Use Disorders|drug use disorders
801697|NCT00248092|Substance Abuse|substance abuse
801698|NCT00248092|Substance Dependence|substance dependence
801699|NCT00248092|Substance Use Disorders|substance use disorders
801700|NCT00248092|Drug Usage|drug usage
801701|NCT00248092|Substance Addiction|substance addiction
801702|NCT00248079|Coronary Disease|coronary disease
801703|NCT00248066|Coronary artery disease|coronary artery disease
801704|NCT00248066|Restenosis|restenosis
801705|NCT00248066|Coronary stent restenosis|coronary stent restenosis
801706|NCT00248053|Familial adenomatous polyposis patient with 5 or more adenomatous polyps in the colon or ileoanal pouch|familial adenomatous polyposis patient with 5 or more adenomatous polyps in the colon or ileoanal pouch
801707|NCT00248040|Kidney transplantation|kidney transplantation
801708|NCT00248040|Reperfusion Injury|reperfusion injury
801709|NCT00248040|Survival|survival
801710|NCT00248027|early intervention,program evaluation|early intervention,program evaluation
801711|NCT00248014|CLASS II|class ii
801712|NCT00248014|FUNCTIONAL APPLIANCE|functional appliance
801713|NCT00248014|MANDIBULAR ADVANCEMENT STABILITY|mandibular advancement stability
801715|NCT00247988|Relapsed|relapsed
801716|NCT00247975|L-carnitine|l-carnitine
801717|NCT00247975|Breast cancer|breast cancer
801718|NCT00247975|Anthracycline Cardiotoxicity|anthracycline cardiotoxicity
801719|NCT00247975|Primary prevention|primary prevention
801720|NCT00247975|Anthracycline induced cardiotoxicity|anthracycline induced cardiotoxicity
801721|NCT00247975|Left Ventricular Ejection Fraction|left ventricular ejection fraction
801722|NCT00247962|Ankylosing Spondylitis (AS)|ankylosing spondylitis (as)
801723|NCT00247949|carbon dioxide|carbon dioxide
801724|NCT00247949|monitoring|monitoring
801725|NCT00247949|major surgery|major surgery
801726|NCT00247949|repeated blood gas testing|repeated blood gas testing
801727|NCT00247949|carbon dioxide monitoring|carbon dioxide monitoring
801728|NCT00247936|Adenocarcinoma, Esophagectomy|adenocarcinoma, esophagectomy
801729|NCT00247923|Endometrial polyps.|endometrial polyps.
801730|NCT00247923|Angiogenesis.|angiogenesis.
801731|NCT00247923|Asymptomatic.|asymptomatic.
801732|NCT00247923|Symptoms.|symptoms.
801733|NCT00247923|Malignancy.|malignancy.
801734|NCT00247923|Treatment efficiency.|treatment efficiency.
801735|NCT00247923|Vaginal bleeding.|vaginal bleeding.
801736|NCT00247910|hypertension, ambulatory BP, office resting BP, hydrochlorothiazide, stress reduction, self-help, psychotherapy, efficacy|hypertension, ambulatory bp, office resting bp, hydrochlorothiazide, stress reduction, self-help, psychotherapy, efficacy
801737|NCT00247884|Injection drug users|injection drug users
801738|NCT00247884|pegylated interferon|pegylated interferon
801739|NCT00247884|ribavirin,|ribavirin,
801740|NCT00247884|HCV|hcv
801741|NCT00247871|MRSA, USA300, CMRSA-10, CMRSA-6, soft tissue abscesses|mrsa, usa300, cmrsa-10, cmrsa-6, soft tissue abscesses
801742|NCT00247858|MRSA, USA300, CMRSA-10, CMRSA-6, soft tissue abscesses|mrsa, usa300, cmrsa-10, cmrsa-6, soft tissue abscesses
801743|NCT00247845|HIV|hiv
801744|NCT00247845|Atazanavir|atazanavir
801745|NCT00247845|quality of life|quality of life
801746|NCT00247845|Treatment Experienced|treatment experienced
801747|NCT00247832|Monitoring, early mobilization, motivation modality, visitation rate, step rates, anxiety, pain|monitoring, early mobilization, motivation modality, visitation rate, step rates, anxiety, pain
801748|NCT00247832|Elective lobectomy|elective lobectomy
801749|NCT00247819|Substance abuse|substance abuse
801750|NCT00247806|Pilot, pediatric, stem cell transplant, lactose intolerance|pilot, pediatric, stem cell transplant, lactose intolerance
801751|NCT00247793|immunonutrition|immunonutrition
801752|NCT00247793|preoperative optimization|preoperative optimization
801753|NCT00247793|preoperative enteral nutritional supplement|preoperative enteral nutritional supplement
801754|NCT00247793|high risk|high risk
801755|NCT00247793|cardiac surgery|cardiac surgery
801756|NCT00247793|arginine|arginine
801757|NCT00247793|omega-3 polyunsaturated fatty acids|omega-3 polyunsaturated fatty acids
801758|NCT00247793|nucleotides|nucleotides
801759|NCT00247793|glycine|glycine
801760|NCT00247793|immune enhancing nutritional supplement|immune enhancing nutritional supplement
801761|NCT00247793|immune enhancing formula|immune enhancing formula
801762|NCT00247780|Atrial fibrillation|atrial fibrillation
801763|NCT00247780|Pulmonary vein isolation|pulmonary vein isolation
801764|NCT00247780|Tissue Doppler echocardiography|tissue doppler echocardiography
801765|NCT00247754|Anxiety|anxiety
801766|NCT00247754|Therapy|therapy
801767|NCT00247754|Behaviour|behaviour
801768|NCT00247741|spinal anesthesia|spinal anesthesia
801769|NCT00247741|lidocaine|lidocaine
801770|NCT00247741|articaine|articaine
801773|NCT00247728|post resection hepatoma|post resection hepatoma
801774|NCT00247728|adjuvant therapy|adjuvant therapy
801775|NCT00247728|hepatectomy|hepatectomy
801776|NCT00247728|hepatoma|hepatoma
801777|NCT00247715|uninvestigated dyspepsia|uninvestigated dyspepsia
801778|NCT00247715|cost effectiveness|cost effectiveness
801779|NCT00247715|acid suppressive medicine|acid suppressive medicine
801780|NCT00247715|primary care|primary care
801781|NCT00247715|gastrointestinal complaints|gastrointestinal complaints
801782|NCT00247715|Gastrointestinal drugs|gastrointestinal drugs
801783|NCT00247702|CYP2C9|cyp2c9
801784|NCT00247702|VKORC1|vkorc1
801785|NCT00247702|polymorphism|polymorphism
801786|NCT00247702|warfarin|warfarin
801787|NCT00247689|Ritalin|ritalin
801788|NCT00247689|Substance Abuse|substance abuse
801789|NCT00247689|Allelic Variants|allelic variants
801790|NCT00247689|Genotype|genotype
801791|NCT00247689|Addiction-Associated Human Gene Variants|addiction-associated human gene variants
801792|NCT00247689|Methylphenidate|methylphenidate
801793|NCT00247676|Liver neoplasms, sunitinib, Phase 2|liver neoplasms, sunitinib, phase 2
801794|NCT00247663|Aromatase inhibitor|aromatase inhibitor
801795|NCT00247663|letrozole|letrozole
801796|NCT00247663|breast cancer|breast cancer
801797|NCT00247650|neoadjuvant, postmenopausal women, breast cancer, hormonal therapy, bisphosphonate|neoadjuvant, postmenopausal women, breast cancer, hormonal therapy, bisphosphonate
801798|NCT00247637|Mental Health|mental health
801799|NCT00247637|Psychosis|psychosis
801800|NCT00247637|Genetics|genetics
801801|NCT00247637|Heredity|heredity
801802|NCT00247624|Depression|depression
801803|NCT00247624|Hypnotics|hypnotics
801804|NCT00247624|Sleep|sleep
801805|NCT00247624|Quality of Life|quality of life
801806|NCT00247624|Insomnia|insomnia
801807|NCT00247624|Suicide|suicide
801808|NCT00247611|HIV|hiv
801809|NCT00247611|AIDS|aids
801810|NCT00247611|Antiretroviral Medication Adherence|antiretroviral medication adherence
801811|NCT00247585|Alcohol|alcohol
801812|NCT00247585|Alcohol abuse|alcohol abuse
801813|NCT00247585|Alcohol consumption|alcohol consumption
801814|NCT00247585|Unhealthy alcohol use|unhealthy alcohol use
801815|NCT00247585|Residual effects|residual effects
801816|NCT00247585|Sleep Stages|sleep stages
801817|NCT00247585|Respiratory Physiology|respiratory physiology
801818|NCT00247572|d-Amphetamine|d-amphetamine
801819|NCT00247572|Attention Deficit Hyperactivity Disorder|attention deficit hyperactivity disorder
801820|NCT00247572|Attention Deficit Disorders with Hyperactivity|attention deficit disorders with hyperactivity
801821|NCT00247572|Attention Deficit Hyperactivity Disorders|attention deficit hyperactivity disorders
801822|NCT00247572|Amphetamine Abuse|amphetamine abuse
801823|NCT00247572|Amphetamine Dependence|amphetamine dependence
801824|NCT00247572|Amphetamine Addiction|amphetamine addiction
801825|NCT00247572|Amphetamine Users|amphetamine users
801826|NCT00247572|Drug Abuse|drug abuse
801827|NCT00247572|Drug Addiction|drug addiction
801828|NCT00247572|Drug Dependence|drug dependence
801829|NCT00247572|Drug Habituation|drug habituation
801830|NCT00247572|Drug Use Disorders|drug use disorders
801831|NCT00247572|Substance Abuse|substance abuse
801832|NCT00247572|Substance Dependence|substance dependence
801833|NCT00247572|Substance Use Disorders|substance use disorders
801834|NCT00247572|Drug Usage|drug usage
801835|NCT00247572|Substance Addiction|substance addiction
801836|NCT00247572|Drug Abuse, Intravenous|drug abuse, intravenous
801837|NCT00247572|Intravenous Drug Abuse|intravenous drug abuse
801838|NCT00247559|crow's feet|crow's feet
801839|NCT00247559|cosmesis|cosmesis
801840|NCT00247559|ageing|ageing
801841|NCT00247546|Falls|falls
801842|NCT00247546|Accidental falls|accidental falls
801843|NCT00247546|Prevention|prevention
801844|NCT00247546|Aged|aged
801845|NCT00247546|Multifactorial trial|multifactorial trial
801846|NCT00247533|coronary disease|coronary disease
801847|NCT00247533|cerebrovascular disorders|cerebrovascular disorders
801848|NCT00247533|angiography|angiography
801849|NCT00247533|cerebral ischemia|cerebral ischemia
801850|NCT00247533|intracranial atherosclerosis|intracranial atherosclerosis
801851|NCT00247533|Coronary artery disease|coronary artery disease
801852|NCT00247533|cerebral artery stenosis|cerebral artery stenosis
801853|NCT00247533|percutaneous coronary balloon angioplasty|percutaneous coronary balloon angioplasty
801854|NCT00247533|coronary artery bypass surgery|coronary artery bypass surgery
801855|NCT00247533|ischemic stroke|ischemic stroke
801856|NCT00247533|electrocardiograph|electrocardiograph
801857|NCT00247533|electroencephalograph|electroencephalograph
801858|NCT00247533|Nuclear brain scan|nuclear brain scan
801859|NCT00247533|cognition decline|cognition decline
801860|NCT00247533|atrial fibrillation|atrial fibrillation
801861|NCT00247533|undetermined ischemic stroke|undetermined ischemic stroke
801862|NCT00247520|Seasonal allergic rhinitis (SAR), rhinoconjunctivitis, allergy|seasonal allergic rhinitis (sar), rhinoconjunctivitis, allergy
801863|NCT00247507|Anemia|anemia
801864|NCT00247507|atherosclerosis|atherosclerosis
801865|NCT00247507|End-stage renal disease|end-stage renal disease
801866|NCT00247507|Erythropoietin|erythropoietin
801867|NCT00247507|Hemodialysis|hemodialysis
801868|NCT00247507|Oxidative stress|oxidative stress
801869|NCT00247507|Pro-inflammation|pro-inflammation
801870|NCT00247494|HIV-1|hiv-1
801871|NCT00247494|atherosclerosis|atherosclerosis
801872|NCT00247494|immunomodulation|immunomodulation
801873|NCT00247481|Metastatic Breast Cancer|metastatic breast cancer
801874|NCT00247455|Human nutrition|human nutrition
801875|NCT00247455|Dietary fibre|dietary fibre
801876|NCT00247455|Insulin resistance|insulin resistance
801877|NCT00247455|Obesity|obesity
801878|NCT00247455|Glucose|glucose
801879|NCT00247455|Colonic fermentation|colonic fermentation
801880|NCT00247455|Short chain fatty acids|short chain fatty acids
801881|NCT00247455|GLP-1|glp-1
801882|NCT00247455|Appetite|appetite
801883|NCT00247455|Abdominal fat|abdominal fat
801884|NCT00247442|Mammography screening|mammography screening
801885|NCT00247442|Breast cancer screening|breast cancer screening
801886|NCT00247442|Screening outcomes|screening outcomes
801887|NCT00247442|Decision aid|decision aid
801888|NCT00247442|Decision support tool|decision support tool
801889|NCT00247442|Informed choice|informed choice
801890|NCT00247429|depression|depression
801891|NCT00247429|anxiety|anxiety
801892|NCT00247429|elderly|elderly
801893|NCT00247416|Untreated|untreated
801894|NCT00247416|Lung|lung
801895|NCT00247416|Cancer|cancer
801896|NCT00247416|non-small cell|non-small cell
801897|NCT00247416|gemcitabine|gemcitabine
801898|NCT00247416|gemzar|gemzar
801899|NCT00247416|carboplatin|carboplatin
801900|NCT00247416|dexamethasone|dexamethasone
801901|NCT00247403|Intracranial cancer|intracranial cancer
801902|NCT00247403|Cancer|cancer
801903|NCT00247403|2DG|2dg
801904|NCT00247403|2-deoxyglucose|2-deoxyglucose
802102|NCT00246701|Lovaza|lovaza
801905|NCT00247403|Intracranial metastatic cancer|intracranial metastatic cancer
801906|NCT00247390|Chronic Insomnia|chronic insomnia
801907|NCT00247390|Sleep Initiation and Maintenance Disorder|sleep initiation and maintenance disorder
801908|NCT00247390|Drug Therapy|drug therapy
801909|NCT00247377|Morbid Obesity|morbid obesity
801910|NCT00247377|Laparoscopic Gastric Bypass|laparoscopic gastric bypass
801911|NCT00247377|Laparoscopic Gastric Banding|laparoscopic gastric banding
801912|NCT00247364|RLS|rls
801913|NCT00247338|parenteral nutrition|parenteral nutrition
801914|NCT00247338|low calorie|low calorie
801915|NCT00247338|low nitrogen|low nitrogen
801916|NCT00247338|gastrointestinal neoplasms|gastrointestinal neoplasms
801917|NCT00247338|gastrointestinal diseases|gastrointestinal diseases
801918|NCT00247338|gastrectomy|gastrectomy
801919|NCT00247338|colectomy|colectomy
801920|NCT00247338|rectectomy|rectectomy
801921|NCT00247338|operations|operations
801922|NCT00247325|Kidney failure|kidney failure
801923|NCT00247325|Contrast media|contrast media
801924|NCT00247325|Iodixanol|iodixanol
801925|NCT00247325|Ioxaglate|ioxaglate
801926|NCT00247312|Prostate cancer|prostate cancer
801927|NCT00247312|brachytherapy|brachytherapy
801928|NCT00247312|palladium 103|palladium 103
801929|NCT00247312|I-125|i-125
801930|NCT00247299|Vascular lesions|vascular lesions
801931|NCT00247299|Intense pulse light|intense pulse light
801932|NCT00247299|phototermolysis|phototermolysis
801933|NCT00247299|wavelength|wavelength
801934|NCT00247299|filters|filters
801935|NCT00247299|non coherent|non coherent
801936|NCT00247286|urodynamic stress incontinence|urodynamic stress incontinence
801937|NCT00247286|weighted vaginal cones|weighted vaginal cones
801938|NCT00247286|pelvic floor biofeedback|pelvic floor biofeedback
801939|NCT00247286|randomized controlled trial|randomized controlled trial
801940|NCT00247273|randomized controlled trial, osteoporosis, risedronate|randomized controlled trial, osteoporosis, risedronate
801941|NCT00247260|HCC|hcc
801942|NCT00247260|Primary Liver Cancer|primary liver cancer
801943|NCT00247221|Alcohol|alcohol
801944|NCT00247221|Substance abuse|substance abuse
801945|NCT00247221|Adolescent|adolescent
801946|NCT00247221|Family functioning|family functioning
801947|NCT00247208|Coronary artery bypass|coronary artery bypass
801948|NCT00247208|Stents|stents
801949|NCT00247208|Angioplasty, Transluminal, Percutaneous Coronary|angioplasty, transluminal, percutaneous coronary
801950|NCT00247208|Coronary Restenosis|coronary restenosis
801951|NCT00247208|Paclitaxel|paclitaxel
801952|NCT00247195|Major Depression|major depression
801953|NCT00247195|MDD|mdd
801954|NCT00247195|Hispanic|hispanic
801955|NCT00247195|Primary Care|primary care
801956|NCT00247195|Cultural Congruence|cultural congruence
801957|NCT00247182|Stepped Care|stepped care
801958|NCT00247182|Brief Motivational Intervention|brief motivational intervention
801959|NCT00247182|Minimal Intervention|minimal intervention
801960|NCT00247182|Treatment response|treatment response
801961|NCT00247182|College Students|college students
801962|NCT00247169|cervical intraepithelial neoplasia (CIN)|cervical intraepithelial neoplasia (cin)
801963|NCT00247169|progesterone|progesterone
801964|NCT00247156|Autism|autism
801965|NCT00247156|eye contact|eye contact
801966|NCT00247156|Noncommunicable|noncommunicable
801967|NCT00247143|Protease Inhibitor|protease inhibitor
801968|NCT00247143|Antiretroviral Agents|antiretroviral agents
801969|NCT00247143|Treatment Experienced|treatment experienced
801972|NCT00247130|Endoscopic treatment|endoscopic treatment
801973|NCT00247130|Hemostasis|hemostasis
801974|NCT00247130|Peptic ulcer|peptic ulcer
801975|NCT00247117|non-alcoholic fatty liver disease|non-alcoholic fatty liver disease
801976|NCT00247117|insulin resistance|insulin resistance
801977|NCT00247117|metformin|metformin
801978|NCT00247104|Urinary tract infection|urinary tract infection
801979|NCT00247104|Endometritis|endometritis
801980|NCT00247104|Respiratory Distress Syndrome|respiratory distress syndrome
801981|NCT00247104|Necrotizing enterocolitis|necrotizing enterocolitis
801982|NCT00247104|Intraventricular hemorrhage|intraventricular hemorrhage
801983|NCT00247104|Latent period|latent period
801984|NCT00247104|Neonatal infection|neonatal infection
801985|NCT00247091|HIV|hiv
801986|NCT00247091|measles|measles
801987|NCT00247091|measles vaccine|measles vaccine
801988|NCT00247091|children|children
801989|NCT00247091|Zambia|zambia
801990|NCT00247078|black|black
801991|NCT00247078|widow|widow
801992|NCT00247078|spider|spider
801993|NCT00247078|antivenom|antivenom
801994|NCT00247052|post operative pericardial effusion|post operative pericardial effusion
801995|NCT00247052|NSAID|nsaid
801996|NCT00247039|neutropenia|neutropenia
801997|NCT00247039|fever|fever
801998|NCT00247039|garlic|garlic
801999|NCT00247039|infection|infection
802000|NCT00247026|myelodysplasia|myelodysplasia
802001|NCT00247026|curcumin|curcumin
802002|NCT00247026|coenzyme Q10|coenzyme q10
802003|NCT00247026|cytopenia|cytopenia
802004|NCT00247013|automated telephone system|automated telephone system
802005|NCT00247013|breast cancer|breast cancer
802006|NCT00247013|cancer prevention|cancer prevention
802007|NCT00247013|intervention|intervention
802008|NCT00247013|mammography|mammography
802009|NCT00247013|screening|screening
802010|NCT00247000|Cardiovascular Diseases|cardiovascular diseases
802011|NCT00247000|Heart Disease|heart disease
802012|NCT00247000|Heart Failure,Congestive|heart failure,congestive
802013|NCT00247000|Health Outcomes|health outcomes
802014|NCT00247000|Disease Management|disease management
802015|NCT00247000|Telehomecare|telehomecare
802016|NCT00247000|Home Telehealth|home telehealth
802017|NCT00246974|bladder cancer|bladder cancer
802018|NCT00246974|Transitionel cell cancer of the urothelium|transitionel cell cancer of the urothelium
802019|NCT00246961|Adjuvant|adjuvant
802020|NCT00246948|Physical therapy|physical therapy
802021|NCT00246935|COPD|copd
802022|NCT00246935|Phosphodiesterase 4 inhibitor|phosphodiesterase 4 inhibitor
802023|NCT00246935|Roflumilast|roflumilast
802024|NCT00246922|Asthma|asthma
802025|NCT00246922|Roflumilast|roflumilast
802026|NCT00246922|phosphodiesterase 4 inhibitor|phosphodiesterase 4 inhibitor
802027|NCT00246909|Gastroesophageal Reflux|gastroesophageal reflux
802028|NCT00246909|Gastroesophageal Reflux Disease|gastroesophageal reflux disease
802029|NCT00246909|Pantoprazole|pantoprazole
802030|NCT00246883|Endothelial Progenitor Cells|endothelial progenitor cells
802031|NCT00246883|Nitric Oxide|nitric oxide
802032|NCT00246883|Brachial Artery Reactivity|brachial artery reactivity
802033|NCT00246883|Physical Fitness|physical fitness
802034|NCT00246883|C-reactive Protein|c-reactive protein
802035|NCT00246883|Exercise|exercise
802036|NCT00246883|Vascular Function|vascular function
802037|NCT00246870|Seizures|seizures
802038|NCT00246870|Development|development
802039|NCT00246870|Pediatric|pediatric
802040|NCT00246870|Benzodiazepine Receptors|benzodiazepine receptors
802041|NCT00246870|Neurotransmission|neurotransmission
802042|NCT00246870|Succinic Semialdehyde Dehydrogenase|succinic semialdehyde dehydrogenase
802043|NCT00246870|Deficiency|deficiency
802044|NCT00246870|SSADH Deficiency|ssadh deficiency
802045|NCT00246870|Healthy Volunteer|healthy volunteer
802046|NCT00246870|HV|hv
802047|NCT00246857|Apoptosis|apoptosis
802048|NCT00246857|T-cell|t-cell
802049|NCT00246857|Autoimmunity|autoimmunity
802050|NCT00246857|Lymphoproliferation|lymphoproliferation
802051|NCT00246857|B-Cell|b-cell
802052|NCT00246857|Inherited Lymphhocyte Homeostasis|inherited lymphhocyte homeostasis
802053|NCT00246857|Genetic Disease|genetic disease
802054|NCT00246844|Transplant|transplant
802055|NCT00246844|Diabetes|diabetes
802056|NCT00246844|C-Peptide|c-peptide
802057|NCT00246844|B Cell|b cell
802058|NCT00246844|Immunosuppression|immunosuppression
802059|NCT00246844|Type 1 Diabetes|type 1 diabetes
802060|NCT00246844|Pancreas Transplant|pancreas transplant
802061|NCT00246831|fMRI|fmri
802062|NCT00246831|Self-Agency|self-agency
802063|NCT00246831|Functional Magnetic Resonance Imaging (fMRI)|functional magnetic resonance imaging (fmri)
802064|NCT00246831|Voluntary Movement|voluntary movement
802065|NCT00246831|Healthy Volunteer|healthy volunteer
802066|NCT00246831|HV|hv
802067|NCT00246818|Mind-Body|mind-body
802068|NCT00246818|Stress Reduction|stress reduction
802069|NCT00246818|Complementary Medicine|complementary medicine
802070|NCT00246818|Quality of Life|quality of life
802071|NCT00246818|Well-being|well-being
802072|NCT00246818|Psychoneuroimmunology|psychoneuroimmunology
802073|NCT00246818|Tai Chi|tai chi
802074|NCT00246818|Aerobic Exercise|aerobic exercise
802075|NCT00246818|Cancer Survivor|cancer survivor
802076|NCT00246805|Permanent atrial fibrillation|permanent atrial fibrillation
802077|NCT00246805|VVI(R) pacing|vvi(r) pacing
802078|NCT00246805|rate regularization|rate regularization
802079|NCT00246792|School-based intervention|school-based intervention
802080|NCT00246792|Learning disabilities|learning disabilities
802081|NCT00246792|ecological intervention|ecological intervention
802082|NCT00246779|transfusion|transfusion
802083|NCT00246779|cardiac surgery|cardiac surgery
802084|NCT00246779|modified ultrafiltration|modified ultrafiltration
802085|NCT00246779|Cardiopulmonary bypass|cardiopulmonary bypass
802086|NCT00246766|Maternal's movements recorded by a specific sensor|maternal's movements recorded by a specific sensor
802087|NCT00246766|Parameters of fetal distress (umbilical and cerebral Doppler) and new-born parameters.|parameters of fetal distress (umbilical and cerebral doppler) and new-born parameters.
802088|NCT00246753|adenocarcinoma of the prostate|adenocarcinoma of the prostate
802089|NCT00246753|recurrent prostate cancer|recurrent prostate cancer
802090|NCT00246753|stage I prostate cancer|stage i prostate cancer
802091|NCT00246753|stage II prostate cancer|stage ii prostate cancer
802092|NCT00246753|stage III prostate cancer|stage iii prostate cancer
802093|NCT00246753|stage IV prostate cancer|stage iv prostate cancer
802094|NCT00246740|Doxycycline|doxycycline
802095|NCT00246740|coronary artery bypass grafting|coronary artery bypass grafting
802096|NCT00246714|endotoxin tolerance|endotoxin tolerance
802097|NCT00246714|humans|humans
802098|NCT00246714|cross-tolerance|cross-tolerance
802099|NCT00246714|pro and anti-inflammatory cytokines|pro and anti-inflammatory cytokines
802100|NCT00246701|omega-3-acid ethyl esters|omega-3-acid ethyl esters
802101|NCT00246701|simvastatin|simvastatin
802103|NCT00246701|High triglycerides|high triglycerides
802104|NCT00246662|Leukemia|leukemia
802105|NCT00246662|Hematologic|hematologic
802106|NCT00246662|Blood|blood
802107|NCT00246662|Cancer|cancer
802108|NCT00246662|Malignancy|malignancy
802109|NCT00246662|Myelodysplastic Syndromes|myelodysplastic syndromes
802110|NCT00246636|Very high triglycerides|very high triglycerides
802111|NCT00246636|omega-3-acid ethyl esters|omega-3-acid ethyl esters
802112|NCT00246636|fenofibrate|fenofibrate
802113|NCT00246636|Lovaza|lovaza
802114|NCT00246610|Non-randomized open-label single-arm study of Nelfinavir plus Combivir in pregnant females infected with HIV-1 virus.|non-randomized open-label single-arm study of nelfinavir plus combivir in pregnant females infected with hiv-1 virus.
802115|NCT00246597|Anemia|anemia
802116|NCT00246597|Breast cancer|breast cancer
802117|NCT00246597|Hemoglobin|hemoglobin
802118|NCT00246597|Quality of Life|quality of life
802119|NCT00246597|Adjuvant Chemotherapy|adjuvant chemotherapy
802120|NCT00246597|Pure red cell aplasia (PRCA)|pure red cell aplasia (prca)
802121|NCT00246597|Cognitive and executive function|cognitive and executive function
802122|NCT00246584|Hypertension|hypertension
802123|NCT00246584|angiotensin|angiotensin
802124|NCT00246584|renin|renin
802125|NCT00246584|aliskiren|aliskiren
802126|NCT00246558|Tight Achilles Tendon|tight achilles tendon
802127|NCT00246558|Hyperpronation of the foot|hyperpronation of the foot
802128|NCT00246519|hypertension|hypertension
802129|NCT00246519|pharmacogenetics|pharmacogenetics
802130|NCT00246519|pharmacogenomics|pharmacogenomics
802131|NCT00246519|beta-blocker|beta-blocker
802132|NCT00246519|atenolol|atenolol
802133|NCT00246519|diuretic|diuretic
802134|NCT00246519|hydrochlorothiazide|hydrochlorothiazide
802135|NCT00246519|blood pressure|blood pressure
802136|NCT00246519|metabolic adverse effects|metabolic adverse effects
802137|NCT00246506|Infertility|infertility
802138|NCT00246506|Fertility|fertility
802139|NCT00246506|Reproduction|reproduction
802140|NCT00246506|Advanced Maternal Age|advanced maternal age
802141|NCT00246506|Reproductive Medicine|reproductive medicine
802142|NCT00246506|Reproductive Techniques|reproductive techniques
802143|NCT00246506|Pregnancy|pregnancy
802144|NCT00246493|Coronary|coronary
802145|NCT00246493|Endothelial|endothelial
802146|NCT00246493|Vascular|vascular
802147|NCT00246493|Atherosclerosis|atherosclerosis
802148|NCT00246493|Arterial|arterial
802149|NCT00246480|Respiratory Syncytial Virus Infections, RSV, elderly|respiratory syncytial virus infections, rsv, elderly
802150|NCT00246467|plague|plague
802151|NCT00246454|circadian|circadian
802152|NCT00246454|advanced sleep phase|advanced sleep phase
802153|NCT00246454|delayed sleep phase|delayed sleep phase
802154|NCT00246441|Pharmacotherapy|pharmacotherapy
802155|NCT00246441|Self medication|self medication
802156|NCT00246428|Motivational Interviewing|motivational interviewing
802157|NCT00246428|Alcohol Abuse|alcohol abuse
802158|NCT00246428|Alcohol Dependence|alcohol dependence
802159|NCT00246428|Emergency Care Setting|emergency care setting
802160|NCT00246415|Alcohol Dependence|alcohol dependence
802161|NCT00246415|Alcohol Abuse|alcohol abuse
802162|NCT00246415|Memantine|memantine
802163|NCT00246415|Alcohol Treatment|alcohol treatment
802164|NCT00246389|muscle spasm|muscle spasm
802165|NCT00246389|cyclobenzaprine hydrochloride|cyclobenzaprine hydrochloride
802166|NCT00246363|HIV|hiv
802167|NCT00246363|Hepatitis C|hepatitis c
802168|NCT00246350|Headaches|headaches
802169|NCT00246350|Spinal manipulation|spinal manipulation
802171|NCT00246350|chiropractic|chiropractic
802172|NCT00246298|Anemia|anemia
802173|NCT00246298|erythropoetin|erythropoetin
802174|NCT00246298|Epoetin alfa|epoetin alfa
802175|NCT00246298|erythropoietin recombinant|erythropoietin recombinant
802176|NCT00246298|HIV infection|hiv infection
802177|NCT00246298|HIV|hiv
802178|NCT00246298|AIDS|aids
802179|NCT00246285|schizophrenia|schizophrenia
802180|NCT00246285|antipsychotic agents|antipsychotic agents
802181|NCT00246285|risperidone|risperidone
802182|NCT00246285|adolescents|adolescents
802183|NCT00246272|risperidone|risperidone
802184|NCT00246272|schizophrenia|schizophrenia
802185|NCT00246272|rapidly-dissolving|rapidly-dissolving
802186|NCT00246259|Schizophrenia|schizophrenia
802187|NCT00246259|Schizoaffective disorder|schizoaffective disorder
802188|NCT00246259|Schizophreniform disorder|schizophreniform disorder
802189|NCT00246259|Risperidone|risperidone
802190|NCT00246259|Risperdal Consta|risperdal consta
802191|NCT00246246|risperidone|risperidone
802192|NCT00246246|long-acting injectable|long-acting injectable
802193|NCT00246246|bipolar disorder|bipolar disorder
802194|NCT00246246|intramuscular injection|intramuscular injection
802195|NCT00246233|methylphenidate hydrochloride|methylphenidate hydrochloride
802196|NCT00246233|oral tablets|oral tablets
802197|NCT00246233|Major Depressive Disorder|major depressive disorder
802198|NCT00246220|Attention deficit/hyperactivity disorder|attention deficit/hyperactivity disorder
802199|NCT00246220|methylphenidate|methylphenidate
802200|NCT00246220|central nervous system stimulants|central nervous system stimulants
802405|NCT00245193|Major Depression|major depression
802201|NCT00246207|Attention Deficit Hyperactivity Disorder|attention deficit hyperactivity disorder
802202|NCT00246207|once-day oral tablets|once-day oral tablets
802203|NCT00246194|Schizophrenia|schizophrenia
802204|NCT00246194|Mental disorder|mental disorder
802205|NCT00246194|DSM-IV|dsm-iv
802206|NCT00246194|RISPERDAL CONSTA|risperdal consta
802207|NCT00246194|Risperidone|risperidone
802208|NCT00246194|Long-acting risperidone|long-acting risperidone
802209|NCT00246194|Disorganized|disorganized
802210|NCT00246194|Catatonic|catatonic
802211|NCT00246194|Paranoid|paranoid
802212|NCT00246181|Lung cancer|lung cancer
802213|NCT00246181|stereotactic body radiotherapy|stereotactic body radiotherapy
802214|NCT00246168|Rheumatoid arthritis|rheumatoid arthritis
802215|NCT00246168|NSAID add-on therapy|nsaid add-on therapy
802216|NCT00246168|tramadol|tramadol
802217|NCT00246168|acetaminophen|acetaminophen
802218|NCT00246155|chronic|chronic
802219|NCT00246155|muscular|muscular
802220|NCT00246129|Kidney Transplantation|kidney transplantation
802221|NCT00246129|Kidney Disease|kidney disease
802222|NCT00246129|Kidney Failure|kidney failure
802223|NCT00246129|Graft Rejection|graft rejection
802224|NCT00246116|Lung Cancer|lung cancer
802225|NCT00246116|Radiation Oncology|radiation oncology
802226|NCT00246116|Treated with Stereostatic Body Radiation|treated with stereostatic body radiation
802227|NCT00246103|Valproic Acid|valproic acid
802228|NCT00246103|Epirubicin|epirubicin
802229|NCT00246103|Solid Tumor|solid tumor
802230|NCT00246103|Malignancies|malignancies
802231|NCT00246077|chronic transfusion therapy|chronic transfusion therapy
802232|NCT00246077|quality of life|quality of life
802233|NCT00246064|Rheumatoid Arthritis|rheumatoid arthritis
802234|NCT00246064|Infliximab infusions|infliximab infusions
802235|NCT00246064|Methotrexate|methotrexate
802236|NCT00246064|Remicade|remicade
802237|NCT00246051|Police|police
802238|NCT00246051|Sleep|sleep
802239|NCT00246051|Fatigue|fatigue
802240|NCT00246051|Work Hours|work hours
802241|NCT00246051|Sleep disorder|sleep disorder
802242|NCT00246051|Performance|performance
802243|NCT00246038|Abdominal Aortic Aneurysm|abdominal aortic aneurysm
802244|NCT00246038|Aortic Aneurysm|aortic aneurysm
802245|NCT00246038|AAA|aaa
802246|NCT00246038|Endovascular|endovascular
802247|NCT00246038|Stent Graft|stent graft
802248|NCT00246038|Endograft|endograft
802249|NCT00246038|Vascular Prostheses|vascular prostheses
802250|NCT00246012|Melanoma|melanoma
802251|NCT00246012|Neoplasm|neoplasm
802252|NCT00246012|CNTO 95|cnto 95
802253|NCT00246012|Dacarbazine|dacarbazine
802254|NCT00246012|Intetumumab|intetumumab
802255|NCT00245986|Pharmacokinetics|pharmacokinetics
802256|NCT00245986|Cytochrome P450|cytochrome p450
802257|NCT00245986|HIV Resistance|hiv resistance
802258|NCT00245986|Drug Interaction|drug interaction
802259|NCT00245986|Non-Nucleoside Reverse Transcriptase Inhibitors|non-nucleoside reverse transcriptase inhibitors
802260|NCT00245986|HIV Positive|hiv positive
802261|NCT00245986|Healthy Volunteer|healthy volunteer
802262|NCT00245986|HV|hv
802263|NCT00245960|Psoriatic Arthritis|psoriatic arthritis
802264|NCT00245960|Skin Disease|skin disease
802265|NCT00245960|Joint Disease|joint disease
802266|NCT00245947|Crohn's Disease|crohn's disease
802267|NCT00245947|Inflammation|inflammation
802268|NCT00245934|Rheumatoid Arthritis|rheumatoid arthritis
802269|NCT00245921|contraception|contraception
802270|NCT00245908|Asthma|asthma
802271|NCT00245908|Chlamydia pneumoniae|chlamydia pneumoniae
802272|NCT00245908|Chlamydophila pneumoniae|chlamydophila pneumoniae
802273|NCT00245908|Azithromycin|azithromycin
802274|NCT00245895|Anemia,|anemia,
802275|NCT00245895|Prostate Cancer|prostate cancer
802276|NCT00245882|Telehealth|telehealth
802277|NCT00245882|Veterans|veterans
802278|NCT00245882|Glycemic control|glycemic control
802279|NCT00245882|Active care management|active care management
802280|NCT00245882|Care coordination|care coordination
802281|NCT00245869|Contrast-enhanced Ultrasound|contrast-enhanced ultrasound
802282|NCT00245869|Ultrasound Contrast agents, microbubbles|ultrasound contrast agents, microbubbles
802283|NCT00245869|breast cancer|breast cancer
802284|NCT00245869|chemotherapy|chemotherapy
802285|NCT00245869|vascularization|vascularization
802286|NCT00245856|Upper Extremity Deep-Vein Thrombosis|upper extremity deep-vein thrombosis
802287|NCT00245856|DVT|dvt
802288|NCT00245856|Fragmin|fragmin
802289|NCT00245856|Deep-Vein Thrombosis|deep-vein thrombosis
802290|NCT00245856|Thrombosis|thrombosis
802291|NCT00245843|Premature birth|premature birth
802292|NCT00245843|moderate preterm|moderate preterm
802293|NCT00245843|late preterm|late preterm
802294|NCT00245843|Joint attention|joint attention
802295|NCT00245843|Social interaction|social interaction
802296|NCT00245843|Child development|child development
802297|NCT00245843|Parent|parent
802298|NCT00245843|infant|infant
802299|NCT00245830|Ischemia/reperfusion of the liver|ischemia/reperfusion of the liver
802300|NCT00245830|Ischemic Preconditioning|ischemic preconditioning
802301|NCT00245830|Cadaver organ donor|cadaver organ donor
802406|NCT00245154|stage IIIB non-small cell lung cancer|stage iiib non-small cell lung cancer
802302|NCT00245817|Anxiety. Depression. HRQOL. Psycho-educative intervention|anxiety. depression. hrqol. psycho-educative intervention
802303|NCT00245791|Complicated Urinary Infection|complicated urinary infection
802304|NCT00245765|chronic plaque psoriasis, anti TNFα|chronic plaque psoriasis, anti tnfα
802305|NCT00245765|CDP870, Cimzia|cdp870, cimzia
802306|NCT00245752|post term pregnancy|post term pregnancy
802307|NCT00245752|acupuncture|acupuncture
802308|NCT00245752|induction|induction
802309|NCT00245739|HIV infections|hiv infections
802310|NCT00245739|HIV-1|hiv-1
802311|NCT00245739|TMC114|tmc114
802312|NCT00245739|Early access|early access
802313|NCT00245739|Highly antiretroviral treatment experienced patients|highly antiretroviral treatment experienced patients
802314|NCT00245739|Anti-retroviral agents|anti-retroviral agents
802315|NCT00245713|Levetiracetam, adult, partial-onset epilepsy, antiepileptic|levetiracetam, adult, partial-onset epilepsy, antiepileptic
802316|NCT00245687|feeding tube, nutrition, gastric, jejunal|feeding tube, nutrition, gastric, jejunal
802317|NCT00245661|COPD|copd
802318|NCT00245661|respiratory|respiratory
802319|NCT00245661|sleep quality|sleep quality
802320|NCT00245661|temazepam|temazepam
802321|NCT00245661|dyspnea|dyspnea
802322|NCT00245635|Body Dysmorphic Disorder|body dysmorphic disorder
802323|NCT00245635|BDD|bdd
802324|NCT00245635|BDD treatment|bdd treatment
802325|NCT00245635|delusionality variant|delusionality variant
802326|NCT00245635|OCD|ocd
802327|NCT00245622|Phase 2b Tovaxin|phase 2b tovaxin
802328|NCT00245622|Clinically Isolated Syndrome (CIS)|clinically isolated syndrome (cis)
802329|NCT00245622|Relapse-Remitting Multiple Sclerosis (RR-MS)|relapse-remitting multiple sclerosis (rr-ms)
802330|NCT00245583|Pathological Gambling|pathological gambling
802331|NCT00245583|Compulsive Gambling|compulsive gambling
802332|NCT00245583|Gambling|gambling
802333|NCT00245583|topiramate|topiramate
802334|NCT00245557|Depression|depression
802335|NCT00245557|Geriatric|geriatric
802336|NCT00245557|MRI|mri
802337|NCT00245557|Sertraline|sertraline
802338|NCT00245531|endocrine abnormalities|endocrine abnormalities
802339|NCT00245531|cognitive performance|cognitive performance
802340|NCT00245518|prostate cancer|prostate cancer
802342|NCT00245518|androgen deprivation|androgen deprivation
802343|NCT00245518|quality of life|quality of life
802344|NCT00245518|isoflavones|isoflavones
802345|NCT00245492|Colonoscopy|colonoscopy
802346|NCT00245492|Chromoscopy|chromoscopy
802347|NCT00245492|Prevention|prevention
802348|NCT00245479|Primary nocturnal enuresis|primary nocturnal enuresis
802349|NCT00245466|Prostate Cancer|prostate cancer
802350|NCT00245466|Androgen ablation therapy|androgen ablation therapy
802351|NCT00245453|pneumonia|pneumonia
802352|NCT00245453|Spneumoniae|spneumoniae
802353|NCT00245453|bronchitis|bronchitis
802354|NCT00245453|telithromycin|telithromycin
802355|NCT00245453|azithromycin|azithromycin
802356|NCT00245440|S.pneumonia|s.pneumonia
802357|NCT00245440|sinusitis|sinusitis
802358|NCT00245440|ams|ams
802359|NCT00245440|azithromycin|azithromycin
802360|NCT00245427|beta-lactam|beta-lactam
802361|NCT00245427|macrolide|macrolide
802362|NCT00245427|antibiotics|antibiotics
802363|NCT00245388|Mixed Dyslipidemia|mixed dyslipidemia
802364|NCT00245375|Outpatient Surgery for:|outpatient surgery for:
802365|NCT00245375|inguinal hernia repair|inguinal hernia repair
802366|NCT00245375|abdominal hernia repair|abdominal hernia repair
802367|NCT00245375|umbilical hernia repair|umbilical hernia repair
802368|NCT00245362|cancer vaccine|cancer vaccine
802369|NCT00245362|pancreatic cancer|pancreatic cancer
802370|NCT00245362|metastatic pancreatic cancer|metastatic pancreatic cancer
802371|NCT00245362|unresectable pancreatic cancer|unresectable pancreatic cancer
802372|NCT00245362|immunotherapy|immunotherapy
802373|NCT00245349|Head and Neck cancer|head and neck cancer
802374|NCT00245349|Squamous cell carcinoma|squamous cell carcinoma
802375|NCT00245349|FLT|flt
802376|NCT00245349|Fluorothymidine|fluorothymidine
802377|NCT00245349|F-18|f-18
802378|NCT00245336|hemostasis|hemostasis
802379|NCT00245336|surgery|surgery
802380|NCT00245336|hemostatics|hemostatics
802381|NCT00245336|randomized controlled trial|randomized controlled trial
802382|NCT00245336|phase 3|phase 3
802383|NCT00245323|smoking|smoking
802384|NCT00245310|ICG clearance|icg clearance
802385|NCT00245310|liver cirrhosis|liver cirrhosis
802386|NCT00245310|acute liver failure|acute liver failure
802387|NCT00245310|prognosis|prognosis
802388|NCT00245297|Bleeding disorder|bleeding disorder
802389|NCT00245297|severe Haemophilia A|severe haemophilia a
802390|NCT00245297|Prophylaxis|prophylaxis
802391|NCT00245271|Knee|knee
802392|NCT00245271|Musculoskeletal System|musculoskeletal system
802393|NCT00245271|Ligament|ligament
802394|NCT00245271|ACL reconstruction|acl reconstruction
802395|NCT00245245|hemophilia A|hemophilia a
802396|NCT00245245|inhibitor|inhibitor
802397|NCT00245245|treatment|treatment
802398|NCT00245232|PTSD|ptsd
802399|NCT00245232|Cognitive therapy|cognitive therapy
802400|NCT00245232|Rape|rape
802401|NCT00245206|Antipsychotic|antipsychotic
802402|NCT00245206|Diabetes|diabetes
802403|NCT00245206|Hyperlipidemia|hyperlipidemia
802404|NCT00245206|Stroke|stroke
802407|NCT00245154|stage IV non-small cell lung cancer|stage iv non-small cell lung cancer
802408|NCT00245141|embryonal childhood rhabdomyosarcoma|embryonal childhood rhabdomyosarcoma
802409|NCT00245141|embryonal-botryoid childhood rhabdomyosarcoma|embryonal-botryoid childhood rhabdomyosarcoma
802410|NCT00245141|previously untreated childhood rhabdomyosarcoma|previously untreated childhood rhabdomyosarcoma
802411|NCT00245128|chronic idiopathic myelofibrosis|chronic idiopathic myelofibrosis
802412|NCT00245128|polycythemia vera|polycythemia vera
802413|NCT00245128|essential thrombocythemia|essential thrombocythemia
802414|NCT00245115|adult acute myeloblastic leukemia without maturation (M1)|adult acute myeloblastic leukemia without maturation (m1)
802415|NCT00245115|childhood acute myeloblastic leukemia without maturation (M1)|childhood acute myeloblastic leukemia without maturation (m1)
802416|NCT00245115|adult acute myeloblastic leukemia with maturation (M2)|adult acute myeloblastic leukemia with maturation (m2)
802417|NCT00245115|childhood acute myeloblastic leukemia with maturation (M2)|childhood acute myeloblastic leukemia with maturation (m2)
802418|NCT00245115|adult acute promyelocytic leukemia (M3)|adult acute promyelocytic leukemia (m3)
802419|NCT00245115|childhood acute promyelocytic leukemia (M3)|childhood acute promyelocytic leukemia (m3)
802420|NCT00245115|adult acute myelomonocytic leukemia (M4)|adult acute myelomonocytic leukemia (m4)
802421|NCT00245115|childhood acute myelomonocytic leukemia (M4)|childhood acute myelomonocytic leukemia (m4)
802422|NCT00245115|adult acute monoblastic leukemia (M5a)|adult acute monoblastic leukemia (m5a)
802423|NCT00245115|adult acute monocytic leukemia (M5b)|adult acute monocytic leukemia (m5b)
802424|NCT00245115|childhood acute monoblastic leukemia (M5a)|childhood acute monoblastic leukemia (m5a)
802425|NCT00245115|childhood acute monocytic leukemia (M5b)|childhood acute monocytic leukemia (m5b)
802426|NCT00245115|adult erythroleukemia (M6a)|adult erythroleukemia (m6a)
802427|NCT00245115|adult pure erythroid leukemia (M6b)|adult pure erythroid leukemia (m6b)
802428|NCT00245115|childhood acute erythroleukemia (M6)|childhood acute erythroleukemia (m6)
802429|NCT00245115|adult acute megakaryoblastic leukemia (M7)|adult acute megakaryoblastic leukemia (m7)
802430|NCT00245115|childhood acute megakaryocytic leukemia (M7)|childhood acute megakaryocytic leukemia (m7)
802431|NCT00245115|adult acute lymphoblastic leukemia in remission|adult acute lymphoblastic leukemia in remission
802432|NCT00245115|adult acute myeloid leukemia in remission|adult acute myeloid leukemia in remission
802433|NCT00245115|childhood acute lymphoblastic leukemia in remission|childhood acute lymphoblastic leukemia in remission
802434|NCT00245115|childhood acute myeloid leukemia in remission|childhood acute myeloid leukemia in remission
802435|NCT00245115|adult acute myeloid leukemia with 11q23 (MLL) abnormalities|adult acute myeloid leukemia with 11q23 (mll) abnormalities
802436|NCT00245115|adult acute myeloid leukemia with inv(16)(p13;q22)|adult acute myeloid leukemia with inv(16)(p13;q22)
802437|NCT00245115|adult acute myeloid leukemia with t(15;17)(q22;q12)|adult acute myeloid leukemia with t(15;17)(q22;q12)
802438|NCT00245115|adult acute myeloid leukemia with t(16;16)(p13;q22)|adult acute myeloid leukemia with t(16;16)(p13;q22)
802439|NCT00245115|adult acute myeloid leukemia with t(8;21)(q22;q22)|adult acute myeloid leukemia with t(8;21)(q22;q22)
802440|NCT00245115|secondary acute myeloid leukemia|secondary acute myeloid leukemia
802441|NCT00245089|embryonal childhood rhabdomyosarcoma|embryonal childhood rhabdomyosarcoma
802442|NCT00245089|embryonal-botryoid childhood rhabdomyosarcoma|embryonal-botryoid childhood rhabdomyosarcoma
802443|NCT00245089|previously untreated childhood rhabdomyosarcoma|previously untreated childhood rhabdomyosarcoma
802444|NCT00245076|unspecified adult solid tumor, protocol specific|unspecified adult solid tumor, protocol specific
802445|NCT00245050|drug/agent toxicity by tissue/organ|drug/agent toxicity by tissue/organ
802446|NCT00245050|fallopian tube cancer|fallopian tube cancer
802447|NCT00245050|peritoneal cavity cancer|peritoneal cavity cancer
802448|NCT00245050|recurrent ovarian epithelial cancer|recurrent ovarian epithelial cancer
802449|NCT00245050|recurrent endometrial carcinoma|recurrent endometrial carcinoma
802450|NCT00245050|stage III endometrial carcinoma|stage iii endometrial carcinoma
802451|NCT00245050|stage IV endometrial carcinoma|stage iv endometrial carcinoma
802452|NCT00245050|stage IV breast cancer|stage iv breast cancer
802453|NCT00245050|male breast cancer|male breast cancer
802454|NCT00245050|recurrent breast cancer|recurrent breast cancer
802455|NCT00245037|recurrent adult acute lymphoblastic leukemia|recurrent adult acute lymphoblastic leukemia
802456|NCT00245037|recurrent adult acute myeloid leukemia|recurrent adult acute myeloid leukemia
802457|NCT00245037|de novo myelodysplastic syndromes|de novo myelodysplastic syndromes
802458|NCT00245037|previously treated myelodysplastic syndromes|previously treated myelodysplastic syndromes
802459|NCT00245037|secondary myelodysplastic syndromes|secondary myelodysplastic syndromes
802460|NCT00245037|atypical chronic myeloid leukemia, breakpoint cluster region-Abelson (BCR-ABL) negative|atypical chronic myeloid leukemia, breakpoint cluster region-abelson (bcr-abl) negative
802461|NCT00245037|refractory chronic lymphocytic leukemia|refractory chronic lymphocytic leukemia
802462|NCT00245037|stage III chronic lymphocytic leukemia|stage iii chronic lymphocytic leukemia
802463|NCT00245037|stage IV chronic lymphocytic leukemia|stage iv chronic lymphocytic leukemia
802464|NCT00245037|accelerated phase chronic myelogenous leukemia|accelerated phase chronic myelogenous leukemia
802465|NCT00245037|blastic phase chronic myelogenous leukemia|blastic phase chronic myelogenous leukemia
802466|NCT00245037|chronic phase chronic myelogenous leukemia|chronic phase chronic myelogenous leukemia
802467|NCT00245037|relapsing chronic myelogenous leukemia|relapsing chronic myelogenous leukemia
802468|NCT00245037|stage II multiple myeloma|stage ii multiple myeloma
802469|NCT00245037|stage III multiple myeloma|stage iii multiple myeloma
802782|NCT00244283|sevoflurane|sevoflurane
802470|NCT00245037|primary systemic amyloidosis|primary systemic amyloidosis
802471|NCT00245037|refractory multiple myeloma|refractory multiple myeloma
802472|NCT00245037|myelodysplastic/myeloproliferative neoplasm, unclassifiable|myelodysplastic/myeloproliferative neoplasm, unclassifiable
802473|NCT00245037|chronic eosinophilic leukemia|chronic eosinophilic leukemia
802474|NCT00245037|primary myelofibrosis|primary myelofibrosis
802475|NCT00245037|chronic neutrophilic leukemia|chronic neutrophilic leukemia
802476|NCT00245037|essential thrombocythemia|essential thrombocythemia
802477|NCT00245037|polycythemia vera|polycythemia vera
802478|NCT00245037|chronic myelomonocytic leukemia|chronic myelomonocytic leukemia
802479|NCT00245037|acute undifferentiated leukemia|acute undifferentiated leukemia
802480|NCT00245037|extramedullary plasmacytoma|extramedullary plasmacytoma
802481|NCT00245037|isolated plasmacytoma of bone|isolated plasmacytoma of bone
802482|NCT00245037|monoclonal gammopathy of undetermined significance|monoclonal gammopathy of undetermined significance
802483|NCT00245037|stage I multiple myeloma|stage i multiple myeloma
802484|NCT00245037|secondary acute myeloid leukemia|secondary acute myeloid leukemia
802485|NCT00245037|adult acute myeloid leukemia with 11q23 (MLL) abnormalities|adult acute myeloid leukemia with 11q23 (mll) abnormalities
802486|NCT00245037|adult acute myeloid leukemia with inv(16)(p13;q22)|adult acute myeloid leukemia with inv(16)(p13;q22)
802487|NCT00245037|adult acute myeloid leukemia with t(15;17)(q22;q12)|adult acute myeloid leukemia with t(15;17)(q22;q12)
802488|NCT00245037|adult acute myeloid leukemia with t(16;16)(p13;q22)|adult acute myeloid leukemia with t(16;16)(p13;q22)
802489|NCT00245037|adult acute myeloid leukemia with t(8;21)(q22;q22)|adult acute myeloid leukemia with t(8;21)(q22;q22)
802490|NCT00245037|nodal marginal zone B-cell lymphoma|nodal marginal zone b-cell lymphoma
802491|NCT00245037|noncontiguous stage II adult Burkitt lymphoma|noncontiguous stage ii adult burkitt lymphoma
802492|NCT00245037|noncontiguous stage II adult diffuse large cell lymphoma|noncontiguous stage ii adult diffuse large cell lymphoma
802493|NCT00245037|noncontiguous stage II adult diffuse mixed cell lymphoma|noncontiguous stage ii adult diffuse mixed cell lymphoma
802494|NCT00245037|noncontiguous stage II adult diffuse small cleaved cell lymphoma|noncontiguous stage ii adult diffuse small cleaved cell lymphoma
802495|NCT00245037|noncontiguous stage II adult immunoblastic large cell lymphoma|noncontiguous stage ii adult immunoblastic large cell lymphoma
802496|NCT00245037|noncontiguous stage II adult lymphoblastic lymphoma|noncontiguous stage ii adult lymphoblastic lymphoma
802497|NCT00245037|noncontiguous stage II grade 1 follicular lymphoma|noncontiguous stage ii grade 1 follicular lymphoma
802498|NCT00245037|noncontiguous stage II grade 2 follicular lymphoma|noncontiguous stage ii grade 2 follicular lymphoma
802499|NCT00245037|noncontiguous stage II grade 3 follicular lymphoma|noncontiguous stage ii grade 3 follicular lymphoma
802500|NCT00245037|noncontiguous stage II mantle cell lymphoma|noncontiguous stage ii mantle cell lymphoma
802501|NCT00245037|noncontiguous stage II marginal zone lymphoma|noncontiguous stage ii marginal zone lymphoma
802502|NCT00245037|noncontiguous stage II small lymphocytic lymphoma|noncontiguous stage ii small lymphocytic lymphoma
802503|NCT00245037|recurrent adult Burkitt lymphoma|recurrent adult burkitt lymphoma
802504|NCT00245037|recurrent adult Hodgkin lymphoma|recurrent adult hodgkin lymphoma
802505|NCT00245037|recurrent adult diffuse large cell lymphoma|recurrent adult diffuse large cell lymphoma
802506|NCT00245037|recurrent adult diffuse mixed cell lymphoma|recurrent adult diffuse mixed cell lymphoma
802507|NCT00245037|recurrent adult diffuse small cleaved cell lymphoma|recurrent adult diffuse small cleaved cell lymphoma
802508|NCT00245037|recurrent adult immunoblastic large cell lymphoma|recurrent adult immunoblastic large cell lymphoma
802509|NCT00245037|recurrent adult lymphoblastic lymphoma|recurrent adult lymphoblastic lymphoma
802510|NCT00245037|recurrent cutaneous T-cell non-Hodgkin lymphoma|recurrent cutaneous t-cell non-hodgkin lymphoma
802511|NCT00245037|recurrent grade 1 follicular lymphoma|recurrent grade 1 follicular lymphoma
802512|NCT00245037|recurrent grade 2 follicular lymphoma|recurrent grade 2 follicular lymphoma
802513|NCT00245037|recurrent grade 3 follicular lymphoma|recurrent grade 3 follicular lymphoma
802514|NCT00245037|recurrent mantle cell lymphoma|recurrent mantle cell lymphoma
802515|NCT00245037|recurrent marginal zone lymphoma|recurrent marginal zone lymphoma
802516|NCT00245037|recurrent small lymphocytic lymphoma|recurrent small lymphocytic lymphoma
802517|NCT00245037|splenic marginal zone lymphoma|splenic marginal zone lymphoma
802518|NCT00245037|stage III adult Burkitt lymphoma|stage iii adult burkitt lymphoma
802519|NCT00245037|stage III adult Hodgkin lymphoma|stage iii adult hodgkin lymphoma
802520|NCT00245037|stage III adult diffuse large cell lymphoma|stage iii adult diffuse large cell lymphoma
802521|NCT00245037|stage III adult diffuse mixed cell lymphoma|stage iii adult diffuse mixed cell lymphoma
802522|NCT00245037|stage III adult diffuse small cleaved cell lymphoma|stage iii adult diffuse small cleaved cell lymphoma
802523|NCT00245037|stage III adult immunoblastic large cell lymphoma|stage iii adult immunoblastic large cell lymphoma
802524|NCT00245037|stage III adult lymphoblastic lymphoma|stage iii adult lymphoblastic lymphoma
802525|NCT00245037|stage III grade 1 follicular lymphoma|stage iii grade 1 follicular lymphoma
802526|NCT00245037|stage III grade 2 follicular lymphoma|stage iii grade 2 follicular lymphoma
802527|NCT00245037|stage III grade 3 follicular lymphoma|stage iii grade 3 follicular lymphoma
802528|NCT00245037|stage III mantle cell lymphoma|stage iii mantle cell lymphoma
802529|NCT00245037|stage III marginal zone lymphoma|stage iii marginal zone lymphoma
802530|NCT00245037|stage III small lymphocytic lymphoma|stage iii small lymphocytic lymphoma
802531|NCT00245037|stage IV adult Burkitt lymphoma|stage iv adult burkitt lymphoma
802532|NCT00245037|stage IV adult Hodgkin lymphoma|stage iv adult hodgkin lymphoma
802783|NCT00244283|NT proBNP|nt probnp
802533|NCT00245037|stage IV adult diffuse large cell lymphoma|stage iv adult diffuse large cell lymphoma
802534|NCT00245037|stage IV adult diffuse mixed cell lymphoma|stage iv adult diffuse mixed cell lymphoma
802535|NCT00245037|stage IV adult diffuse small cleaved cell lymphoma|stage iv adult diffuse small cleaved cell lymphoma
802536|NCT00245037|stage IV adult immunoblastic large cell lymphoma|stage iv adult immunoblastic large cell lymphoma
802537|NCT00245037|stage IV adult lymphoblastic lymphoma|stage iv adult lymphoblastic lymphoma
802538|NCT00245037|stage IV grade 1 follicular lymphoma|stage iv grade 1 follicular lymphoma
802539|NCT00245037|stage IV grade 2 follicular lymphoma|stage iv grade 2 follicular lymphoma
802540|NCT00245037|stage IV grade 3 follicular lymphoma|stage iv grade 3 follicular lymphoma
802541|NCT00245037|stage IV mantle cell lymphoma|stage iv mantle cell lymphoma
802542|NCT00245037|stage IV marginal zone lymphoma|stage iv marginal zone lymphoma
802543|NCT00245037|stage IV small lymphocytic lymphoma|stage iv small lymphocytic lymphoma
802544|NCT00245037|extranodal marginal zone B-cell lymphoma of mucosa-associated lymphoid tissue|extranodal marginal zone b-cell lymphoma of mucosa-associated lymphoid tissue
802545|NCT00245024|breast cancer|breast cancer
802546|NCT00245024|ductal breast carcinoma in situ|ductal breast carcinoma in situ
802547|NCT00245024|lobular breast carcinoma in situ|lobular breast carcinoma in situ
802548|NCT00245024|breast cancer in situ|breast cancer in situ
802549|NCT00245011|recurrent osteosarcoma|recurrent osteosarcoma
802550|NCT00245011|metastatic osteosarcoma|metastatic osteosarcoma
802551|NCT00245011|localized osteosarcoma|localized osteosarcoma
802552|NCT00244998|adenocarcinoma of the prostate|adenocarcinoma of the prostate
802553|NCT00244998|stage III prostate cancer|stage iii prostate cancer
802554|NCT00244998|stage IV prostate cancer|stage iv prostate cancer
802555|NCT00244985|recurrent grade 1 follicular lymphoma|recurrent grade 1 follicular lymphoma
802556|NCT00244985|recurrent grade 2 follicular lymphoma|recurrent grade 2 follicular lymphoma
802557|NCT00244985|recurrent grade 3 follicular lymphoma|recurrent grade 3 follicular lymphoma
802558|NCT00244985|recurrent mantle cell lymphoma|recurrent mantle cell lymphoma
802559|NCT00244985|recurrent small lymphocytic lymphoma|recurrent small lymphocytic lymphoma
802560|NCT00244985|recurrent adult diffuse large cell lymphoma|recurrent adult diffuse large cell lymphoma
802561|NCT00244985|recurrent adult diffuse mixed cell lymphoma|recurrent adult diffuse mixed cell lymphoma
802562|NCT00244985|recurrent marginal zone lymphoma|recurrent marginal zone lymphoma
802563|NCT00244985|extranodal marginal zone B-cell lymphoma of mucosa-associated lymphoid tissue|extranodal marginal zone b-cell lymphoma of mucosa-associated lymphoid tissue
802564|NCT00244985|nodal marginal zone B-cell lymphoma|nodal marginal zone b-cell lymphoma
802565|NCT00244985|splenic marginal zone lymphoma|splenic marginal zone lymphoma
802566|NCT00244959|stage I breast cancer|stage i breast cancer
802567|NCT00244959|stage II breast cancer|stage ii breast cancer
802568|NCT00244959|stage IIIA breast cancer|stage iiia breast cancer
802569|NCT00244959|stage IIIB breast cancer|stage iiib breast cancer
802570|NCT00244959|stage IIIC breast cancer|stage iiic breast cancer
802571|NCT00244959|ductal breast carcinoma in situ|ductal breast carcinoma in situ
802572|NCT00244959|breast cancer in situ|breast cancer in situ
802573|NCT00244946|nodal marginal zone B-cell lymphoma|nodal marginal zone b-cell lymphoma
802574|NCT00244946|recurrent adult Burkitt lymphoma|recurrent adult burkitt lymphoma
802575|NCT00244946|recurrent adult diffuse large cell lymphoma|recurrent adult diffuse large cell lymphoma
802576|NCT00244946|recurrent adult diffuse mixed cell lymphoma|recurrent adult diffuse mixed cell lymphoma
802577|NCT00244946|recurrent adult diffuse small cleaved cell lymphoma|recurrent adult diffuse small cleaved cell lymphoma
802578|NCT00244946|recurrent adult immunoblastic large cell lymphoma|recurrent adult immunoblastic large cell lymphoma
802748|NCT00244465|Xyrem|xyrem
802579|NCT00244946|recurrent adult lymphoblastic lymphoma|recurrent adult lymphoblastic lymphoma
802580|NCT00244946|recurrent grade 1 follicular lymphoma|recurrent grade 1 follicular lymphoma
802581|NCT00244946|recurrent grade 2 follicular lymphoma|recurrent grade 2 follicular lymphoma
802582|NCT00244946|recurrent grade 3 follicular lymphoma|recurrent grade 3 follicular lymphoma
802583|NCT00244946|recurrent mantle cell lymphoma|recurrent mantle cell lymphoma
802584|NCT00244946|recurrent marginal zone lymphoma|recurrent marginal zone lymphoma
802585|NCT00244946|splenic marginal zone lymphoma|splenic marginal zone lymphoma
802586|NCT00244946|stage III adult Burkitt lymphoma|stage iii adult burkitt lymphoma
802587|NCT00244946|stage III adult diffuse large cell lymphoma|stage iii adult diffuse large cell lymphoma
802588|NCT00244946|stage III adult diffuse mixed cell lymphoma|stage iii adult diffuse mixed cell lymphoma
802589|NCT00244946|stage III adult diffuse small cleaved cell lymphoma|stage iii adult diffuse small cleaved cell lymphoma
802590|NCT00244946|stage III adult immunoblastic large cell lymphoma|stage iii adult immunoblastic large cell lymphoma
802591|NCT00244946|stage III adult lymphoblastic lymphoma|stage iii adult lymphoblastic lymphoma
802592|NCT00244946|stage III grade 1 follicular lymphoma|stage iii grade 1 follicular lymphoma
802593|NCT00244946|stage III grade 2 follicular lymphoma|stage iii grade 2 follicular lymphoma
802594|NCT00244946|stage III grade 3 follicular lymphoma|stage iii grade 3 follicular lymphoma
802595|NCT00244946|stage III mantle cell lymphoma|stage iii mantle cell lymphoma
802596|NCT00244946|stage III marginal zone lymphoma|stage iii marginal zone lymphoma
802597|NCT00244946|stage IV adult Burkitt lymphoma|stage iv adult burkitt lymphoma
802598|NCT00244946|stage IV adult diffuse large cell lymphoma|stage iv adult diffuse large cell lymphoma
802599|NCT00244946|stage IV adult diffuse mixed cell lymphoma|stage iv adult diffuse mixed cell lymphoma
802678|NCT00244725|deep vein thrombosis|deep vein thrombosis
802600|NCT00244946|stage IV adult diffuse small cleaved cell lymphoma|stage iv adult diffuse small cleaved cell lymphoma
802601|NCT00244946|stage IV adult immunoblastic large cell lymphoma|stage iv adult immunoblastic large cell lymphoma
802602|NCT00244946|stage IV adult lymphoblastic lymphoma|stage iv adult lymphoblastic lymphoma
802603|NCT00244946|stage IV grade 1 follicular lymphoma|stage iv grade 1 follicular lymphoma
802604|NCT00244946|stage IV grade 2 follicular lymphoma|stage iv grade 2 follicular lymphoma
802605|NCT00244946|stage IV grade 3 follicular lymphoma|stage iv grade 3 follicular lymphoma
802606|NCT00244946|stage IV mantle cell lymphoma|stage iv mantle cell lymphoma
802607|NCT00244946|stage IV marginal zone lymphoma|stage iv marginal zone lymphoma
802608|NCT00244946|recurrent small lymphocytic lymphoma|recurrent small lymphocytic lymphoma
802609|NCT00244946|stage III small lymphocytic lymphoma|stage iii small lymphocytic lymphoma
802610|NCT00244946|stage IV small lymphocytic lymphoma|stage iv small lymphocytic lymphoma
802611|NCT00244946|noncontiguous stage II adult Burkitt lymphoma|noncontiguous stage ii adult burkitt lymphoma
802612|NCT00244946|noncontiguous stage II adult diffuse large cell lymphoma|noncontiguous stage ii adult diffuse large cell lymphoma
802613|NCT00244946|noncontiguous stage II adult diffuse mixed cell lymphoma|noncontiguous stage ii adult diffuse mixed cell lymphoma
802614|NCT00244946|noncontiguous stage II adult diffuse small cleaved cell lymphoma|noncontiguous stage ii adult diffuse small cleaved cell lymphoma
802615|NCT00244946|noncontiguous stage II adult immunoblastic large cell lymphoma|noncontiguous stage ii adult immunoblastic large cell lymphoma
802616|NCT00244946|noncontiguous stage II adult lymphoblastic lymphoma|noncontiguous stage ii adult lymphoblastic lymphoma
802617|NCT00244946|noncontiguous stage II grade 1 follicular lymphoma|noncontiguous stage ii grade 1 follicular lymphoma
802618|NCT00244946|noncontiguous stage II grade 2 follicular lymphoma|noncontiguous stage ii grade 2 follicular lymphoma
802619|NCT00244946|noncontiguous stage II grade 3 follicular lymphoma|noncontiguous stage ii grade 3 follicular lymphoma
802620|NCT00244946|noncontiguous stage II mantle cell lymphoma|noncontiguous stage ii mantle cell lymphoma
802621|NCT00244946|noncontiguous stage II marginal zone lymphoma|noncontiguous stage ii marginal zone lymphoma
802622|NCT00244946|noncontiguous stage II small lymphocytic lymphoma|noncontiguous stage ii small lymphocytic lymphoma
802623|NCT00244933|stage IV breast cancer|stage iv breast cancer
802624|NCT00244933|recurrent breast cancer|recurrent breast cancer
802625|NCT00244920|adenocarcinoma of the prostate|adenocarcinoma of the prostate
802626|NCT00244920|stage III prostate cancer|stage iii prostate cancer
802627|NCT00244907|Bone Resorption|bone resorption
802628|NCT00244907|Phytoestrogens|phytoestrogens
802629|NCT00244907|Calcium|calcium
802630|NCT00244907|Genistein|genistein
802631|NCT00244907|Equol|equol
802632|NCT00244894|fatigue|fatigue
802633|NCT00244894|recurrent prostate cancer|recurrent prostate cancer
802634|NCT00244894|stage II prostate cancer|stage ii prostate cancer
802635|NCT00244894|stage III prostate cancer|stage iii prostate cancer
802636|NCT00244894|stage IV prostate cancer|stage iv prostate cancer
802637|NCT00244894|hot flashes|hot flashes
802638|NCT00244868|unspecified adult solid tumor, protocol specific|unspecified adult solid tumor, protocol specific
802639|NCT00244868|metastatic cancer|metastatic cancer
802640|NCT00244842|Randomized Controlled Trials|randomized controlled trials
802641|NCT00244842|Immunosuppression|immunosuppression
802642|NCT00244842|Adult|adult
802643|NCT00244842|Chronic Disease|chronic disease
802644|NCT00244842|Dermatologic Agents|dermatologic agents
802645|NCT00244842|Female|female
802646|NCT00244842|Humans|humans
802647|NCT00244842|Male|male
802648|NCT00244842|Middle Aged|middle aged
802649|NCT00244842|Severity of Illness Index|severity of illness index
802650|NCT00244842|Treatment Outcome|treatment outcome
802651|NCT00244842|Quality of Life|quality of life
802652|NCT00244842|Double-Blind Method|double-blind method
802653|NCT00244829|accelerated phase chronic myelogenous leukemia|accelerated phase chronic myelogenous leukemia
802654|NCT00244829|blastic phase chronic myelogenous leukemia|blastic phase chronic myelogenous leukemia
802655|NCT00244829|childhood chronic myelogenous leukemia|childhood chronic myelogenous leukemia
802656|NCT00244829|chronic phase chronic myelogenous leukemia|chronic phase chronic myelogenous leukemia
802657|NCT00244829|Philadelphia chromosome positive chronic myelogenous leukemia|philadelphia chromosome positive chronic myelogenous leukemia
802658|NCT00244829|adult acute lymphoblastic leukemia in remission|adult acute lymphoblastic leukemia in remission
802659|NCT00244829|childhood acute lymphoblastic leukemia in remission|childhood acute lymphoblastic leukemia in remission
802660|NCT00244803|Human Immunodeficiency Virus|human immunodeficiency virus
802661|NCT00244803|FRAM 1|fram 1
802662|NCT00244790|glomerular hyperfiltration|glomerular hyperfiltration
802663|NCT00244790|proteinuria|proteinuria
802664|NCT00244777|Seizure|seizure
802665|NCT00244777|Altered consciousness|altered consciousness
802666|NCT00244777|Hyponatraemia|hyponatraemia
802667|NCT00244777|Diarrhoea|diarrhoea
802668|NCT00244777|Hypo osmolar ORS|hypo osmolar ors
802669|NCT00244764|Angiogenesis|angiogenesis
802670|NCT00244764|Renal Cell Carcinoma|renal cell carcinoma
802671|NCT00244764|Solid tumors|solid tumors
802672|NCT00244764|Pazopanib(GW786034)|pazopanib(gw786034)
802673|NCT00244751|Hepatitis C liver fibrosis|hepatitis c liver fibrosis
802674|NCT00244738|pregnancy|pregnancy
802675|NCT00244738|post-date|post-date
802676|NCT00244738|induction of labor|induction of labor
802677|NCT00244738|castor oil|castor oil
802679|NCT00244725|total knee replacement|total knee replacement
802680|NCT00244725|PE|pe
802681|NCT00244725|Venous thromboembolism|venous thromboembolism
802682|NCT00244725|DVT|dvt
802683|NCT00244725|pulmonary embolism|pulmonary embolism
802684|NCT00244725|VTE|vte
802685|NCT00244712|HEAT|heat
802686|NCT00244712|Antiretroviral-naive|antiretroviral-naive
802687|NCT00244712|HIV|hiv
802688|NCT00244712|EPZICOM|epzicom
802689|NCT00244712|TRUVADA|truvada
802690|NCT00244712|KALETRA|kaletra
802691|NCT00244712|once-daily|once-daily
802692|NCT00244699|youth|youth
802693|NCT00244699|drug addiction|drug addiction
802694|NCT00244699|substance abuse|substance abuse
802695|NCT00244699|mindfulness|mindfulness
802696|NCT00244699|motivational interviewing|motivational interviewing
802697|NCT00244699|brief treatment|brief treatment
802698|NCT00244699|skills training|skills training
802699|NCT00244699|group therapy|group therapy
802700|NCT00244699|emotion regulation|emotion regulation
802701|NCT00244686|Hypereosinophilic Syndrome|hypereosinophilic syndrome
802702|NCT00244686|Mepo|mepo
802703|NCT00244686|HES|hes
802704|NCT00244686|Compassionate Use|compassionate use
802705|NCT00244686|Mepolizumab|mepolizumab
802706|NCT00244673|Vaccination|vaccination
802707|NCT00244673|DTP|dtp
802708|NCT00244673|Child mortality|child mortality
802709|NCT00244673|Sex|sex
802710|NCT00244673|Non-specific effects|non-specific effects
802711|NCT00244647|restenosis|restenosis
802712|NCT00244647|in-stent restenosis|in-stent restenosis
802713|NCT00244621|Pediatric hypertension|pediatric hypertension
802714|NCT00244595|Pediatric hypertension|pediatric hypertension
802715|NCT00244595|Hypertension in children|hypertension in children
802716|NCT00244582|Central Nervous System|central nervous system
802717|NCT00244582|Enzyme Replacement Therapy|enzyme replacement therapy
802718|NCT00244582|Convection|convection
802719|NCT00244582|Gaucher Disease|gaucher disease
802720|NCT00244582|Neuronopathic Gaucher Disease|neuronopathic gaucher disease
802721|NCT00244582|Type 2 Gaucher Disease|type 2 gaucher disease
802722|NCT00244569|Nonalcoholic Fatty Liver Disease|nonalcoholic fatty liver disease
802723|NCT00244569|Nonalcoholic Steatohepatitis|nonalcoholic steatohepatitis
802724|NCT00244569|Liver Function|liver function
802725|NCT00244569|Metabolism|metabolism
802726|NCT00244569|Cirrhosis|cirrhosis
802727|NCT00244569|Fibrosis|fibrosis
802728|NCT00244569|Liver|liver
802729|NCT00244556|Rheumatoid Arthritis|rheumatoid arthritis
802730|NCT00244543|ocular, allergic conjunctivitis, ophthalmic|ocular, allergic conjunctivitis, ophthalmic
802731|NCT00244530|Preventive Therapy|preventive therapy
802732|NCT00244530|Calcium Channel Blockers|calcium channel blockers
802733|NCT00244530|Kidney Failure, Chronic|kidney failure, chronic
802734|NCT00244530|Coronary Artery Bypass|coronary artery bypass
802735|NCT00244530|Heart Valve Prosthesis Implantation|heart valve prosthesis implantation
802736|NCT00244517|ventricular function|ventricular function
802737|NCT00244517|diastolic function|diastolic function
802738|NCT00244517|inhalative anaesthetics|inhalative anaesthetics
802739|NCT00244491|care transitions|care transitions
802740|NCT00244491|geriatric|geriatric
802741|NCT00244491|care coordination|care coordination
802742|NCT00244491|self-management|self-management
802743|NCT00244491|chronic illness|chronic illness
802744|NCT00244491|patient-centered care|patient-centered care
802745|NCT00244465|Narcolepsy|narcolepsy
802746|NCT00244465|Cataplexy|cataplexy
802747|NCT00244465|Oxybate|oxybate
802751|NCT00244452|Endometriosis|endometriosis
802752|NCT00244452|Cetrorelix|cetrorelix
802753|NCT00244452|Hormone|hormone
802754|NCT00244452|Symptoms relief|symptoms relief
802755|NCT00244452|Safety|safety
802756|NCT00244452|Tolerability|tolerability
802757|NCT00244452|Pharmacodynamic|pharmacodynamic
802758|NCT00244452|Pharmacokinetic|pharmacokinetic
802759|NCT00244439|Head Lice|head lice
802760|NCT00244439|Pediculosis capitis|pediculosis capitis
802761|NCT00244426|Prevention of thromboembolic events in patients with non valvular atrial fibrillation|prevention of thromboembolic events in patients with non valvular atrial fibrillation
802762|NCT00244413|Myotonia|myotonia
802763|NCT00244413|Paramyotonia Congenita|paramyotonia congenita
802764|NCT00244413|Thomsen's Disease|thomsen's disease
802765|NCT00244400|Femur Head Necrosis|femur head necrosis
802766|NCT00244400|CYP3A|cyp3a
802767|NCT00244387|advanced stage idiopathic Parkinson's disease|advanced stage idiopathic parkinson's disease
802768|NCT00244361|opsoclonus|opsoclonus
802769|NCT00244361|myoclonus|myoclonus
802770|NCT00244348|hepatic artery infusion|hepatic artery infusion
802771|NCT00244348|colorectal cancer|colorectal cancer
802772|NCT00244348|liver metastasis|liver metastasis
802773|NCT00244348|oxaliplatin|oxaliplatin
802774|NCT00244348|5 fluorouracil|5 fluorouracil
802775|NCT00244335|Post-Traumatic Stress Disorders|post-traumatic stress disorders
802777|NCT00244309|brachytherapy|brachytherapy
802778|NCT00244309|urinary symptoms|urinary symptoms
802779|NCT00244283|Myocardial preconditioning|myocardial preconditioning
802780|NCT00244283|anesthetics|anesthetics
802781|NCT00244283|epidural anesthesia|epidural anesthesia
802784|NCT00244270|totally implantable vascular access devices|totally implantable vascular access devices
802785|NCT00244270|thromboembolism|thromboembolism
802786|NCT00244270|genetic susceptibility to venous thrombosis.|genetic susceptibility to venous thrombosis.
802787|NCT00244257|idiopathic thrombocytopenia purpura|idiopathic thrombocytopenia purpura
802788|NCT00244231|Niacin|niacin
802789|NCT00244231|Hyperlipidemia|hyperlipidemia
802790|NCT00244218|phenylketonuria|phenylketonuria
802791|NCT00244218|hyperphenylalaninemia|hyperphenylalaninemia
802792|NCT00244192|COPD|copd
802793|NCT00244192|infliximab|infliximab
802794|NCT00244192|Remicade|remicade
802795|NCT00244192|inflammation|inflammation
802796|NCT00244192|cachexia|cachexia
802797|NCT00244192|fat-free mass|fat-free mass
802798|NCT00244192|health status|health status
802799|NCT00244192|exercise capacity|exercise capacity
802800|NCT00244179|reactive arthritis|reactive arthritis
802801|NCT00244179|trial|trial
802802|NCT00244179|interferon-gamma|interferon-gamma
802803|NCT00244179|infliximab|infliximab
802804|NCT00244179|chronic|chronic
802805|NCT00244179|tnf-blocker|tnf-blocker
802806|NCT00244166|treatment|treatment
802807|NCT00244166|ankylosing spondylitis|ankylosing spondylitis
802808|NCT00244166|prednisolone|prednisolone
802809|NCT00244166|trial|trial
802810|NCT00244166|steroid|steroid
802811|NCT00244153|intraarticular morphine, steroids, arthroscopy|intraarticular morphine, steroids, arthroscopy
802812|NCT00244140|Ultravist 370|ultravist 370
802813|NCT00244140|CECT|cect
802814|NCT00244140|CT Scan|ct scan
802815|NCT00244114|Hemophilia B|hemophilia b
802816|NCT00244114|Allergic Reaction|allergic reaction
802817|NCT00244101|Prematurity|prematurity
802818|NCT00244101|respiratory distress syndrome|respiratory distress syndrome
802819|NCT00244101|surfactant|surfactant
802820|NCT00244101|nasal continuous positive airway pressure|nasal continuous positive airway pressure
802821|NCT00244088|Abdominal infection|abdominal infection
802822|NCT00244023|Erectile Dysfunction|erectile dysfunction
802823|NCT00244023|Testosterone|testosterone
802824|NCT00244023|Testosterone Therapy|testosterone therapy
802825|NCT00244023|PDE V Inhibitor|pde v inhibitor
802826|NCT00244023|Tadalafil|tadalafil
802827|NCT00244010|Aplastic anemia|aplastic anemia
802828|NCT00244010|Amegakaryocytic thrombocytopenia|amegakaryocytic thrombocytopenia
802829|NCT00244010|Diamond-Blackfan Anemia|diamond-blackfan anemia
802830|NCT00244010|Kostmann syndrome|kostmann syndrome
802831|NCT00244010|Allogeneic stem cell transplantation|allogeneic stem cell transplantation
802832|NCT00244010|Haploidentical stem cell transplant|haploidentical stem cell transplant
802833|NCT00244010|T-cell depletion|t-cell depletion
802834|NCT00244010|Partially matched family member donor transplant|partially matched family member donor transplant
802835|NCT00244010|Refractory cytopenia|refractory cytopenia
802836|NCT00243997|parents|parents
802837|NCT00243997|fathers|fathers
802838|NCT00243997|mothers|mothers
802839|NCT00243984|metabolic syndrome|metabolic syndrome
802840|NCT00243984|type 2 diabetes|type 2 diabetes
802841|NCT00243984|topiramate|topiramate
802842|NCT00243984|weight loss|weight loss
802843|NCT00243971|EARLY-STAGE, IDIOPATHIC PARKINSON'S DISEASE|early-stage, idiopathic parkinson's disease
802844|NCT00243932|amyotrophic lateral sclerosis|amyotrophic lateral sclerosis
802845|NCT00243932|ALS|als
802846|NCT00243932|Lou Gehrig's disease|lou gehrig's disease
802847|NCT00243932|CoQ10|coq10
802848|NCT00243932|coenzyme Q10|coenzyme q10
802849|NCT00243932|antioxidants|antioxidants
802850|NCT00243932|free radicals|free radicals
803225|NCT00242424|safety|safety
802851|NCT00243932|mitochondrial dysfunction|mitochondrial dysfunction
802852|NCT00243919|stroke|stroke
802853|NCT00243919|locomotor|locomotor
802854|NCT00243919|exercise|exercise
802855|NCT00243919|walking|walking
802856|NCT00243919|training program|training program
802857|NCT00243919|body weight support training|body weight support training
802858|NCT00243919|physical therapy|physical therapy
802859|NCT00243906|acute ischemic stroke|acute ischemic stroke
802860|NCT00243906|stroke|stroke
802861|NCT00243906|rt-PA|rt-pa
802862|NCT00243906|thrombolytic|thrombolytic
802863|NCT00243906|recombinant tissue plasminogen activator|recombinant tissue plasminogen activator
802864|NCT00243893|giant aneurysms|giant aneurysms
802865|NCT00243893|arteriovenous malformations|arteriovenous malformations
802866|NCT00243893|minocycline|minocycline
802867|NCT00243893|doxycycline|doxycycline
802868|NCT00243893|BAVM|bavm
802869|NCT00243880|acute ischemic stroke|acute ischemic stroke
802870|NCT00243880|lovastatin|lovastatin
802871|NCT00243880|statin|statin
802872|NCT00243880|neuroprotection|neuroprotection
802873|NCT00243880|SPOTRIAS|spotrias
802874|NCT00243867|Advanced Non-Small Cell Lung Cancer|advanced non-small cell lung cancer
802875|NCT00243854|Pancreatic Cancer|pancreatic cancer
802876|NCT00243854|Resectable Pancreatic Cancer|resectable pancreatic cancer
802877|NCT00243854|adenocarcinoma of the pancreas|adenocarcinoma of the pancreas
802878|NCT00243828|Noninvasive Mechanical Ventilation|noninvasive mechanical ventilation
802879|NCT00243828|Acute Respiratory Failure|acute respiratory failure
802880|NCT00243828|Intubation|intubation
802881|NCT00243815|randomized controlled trial|randomized controlled trial
802882|NCT00243815|prophylactic nonsteroidal antiflammatory drug|prophylactic nonsteroidal antiflammatory drug
802883|NCT00243815|IUD removal|iud removal
802884|NCT00243802|Atrial Fibrillation|atrial fibrillation
802885|NCT00243802|Oxidative Stress|oxidative stress
802886|NCT00243802|Atrial Flutter|atrial flutter
802887|NCT00243789|Duchenne|duchenne
802888|NCT00243789|Genetic|genetic
802889|NCT00243789|Muscular Dystrophy|muscular dystrophy
802890|NCT00243789|DMD|dmd
802891|NCT00243763|Refractory Multiple Myeloma or|refractory multiple myeloma or
802892|NCT00243763|Relapsed Multiple Myeloma|relapsed multiple myeloma
802893|NCT00243750|ankylosing spondylitis|ankylosing spondylitis
802894|NCT00243750|trial|trial
802895|NCT00243750|methotrexate|methotrexate
802896|NCT00243737|Malaria|malaria
802897|NCT00243737|falciparum|falciparum
802898|NCT00243737|Mefloquine|mefloquine
802899|NCT00243737|Artesunate|artesunate
802900|NCT00243737|Artemisinin|artemisinin
802901|NCT00243724|immunohistochemical|immunohistochemical
802902|NCT00243724|erosive esophagitis|erosive esophagitis
802903|NCT00243724|Acid reflux disease|acid reflux disease
802904|NCT00243698|Contrast-enhanced Ultrasound Sonography|contrast-enhanced ultrasound sonography
802905|NCT00243698|Ultrasound Contrast agents, microbubbles|ultrasound contrast agents, microbubbles
802906|NCT00243698|Breast tumors|breast tumors
802907|NCT00243685|Chemosensitivity|chemosensitivity
802908|NCT00243685|Chemotherapy|chemotherapy
802909|NCT00243685|Lung cancer|lung cancer
802910|NCT00243685|Ovarian Cancer|ovarian cancer
802911|NCT00243685|Breast Cancer|breast cancer
802912|NCT00243685|Sarcoma|sarcoma
802913|NCT00243685|Apoptosis|apoptosis
802914|NCT00243685|MiCK Assay|mick assay
802915|NCT00243685|New Technology|new technology
802916|NCT00243685|Patients with pathological diagnoses of breast, lung, and ovarian adenocarcinomas and soft tissue sarcoma|patients with pathological diagnoses of breast, lung, and ovarian adenocarcinomas and soft tissue sarcoma
802917|NCT00243659|Hemophilia A|hemophilia a
802918|NCT00243659|bleeding disorder|bleeding disorder
802919|NCT00243646|Radiation therapy|radiation therapy
802920|NCT00243646|Brachytherapy|brachytherapy
802921|NCT00243646|Prostatic neoplasm|prostatic neoplasm
802922|NCT00243633|focal liver lesions|focal liver lesions
802923|NCT00243633|contrast-enhanced ultrasound sonography|contrast-enhanced ultrasound sonography
802924|NCT00243633|cirrhosis|cirrhosis
802925|NCT00243633|suspected liver metastases|suspected liver metastases
802926|NCT00243633|suspected liver cirrhosis|suspected liver cirrhosis
802927|NCT00243620|Chronic leg ulcers; wound healing; wound care; Vacuum Assisted Closure; topical negative Pressure|chronic leg ulcers; wound healing; wound care; vacuum assisted closure; topical negative pressure
802928|NCT00243607|climacteric symptoms|climacteric symptoms
802929|NCT00243607|breast cancer|breast cancer
802930|NCT00243607|hydrotherapy|hydrotherapy
802931|NCT00243594|Dendritic cells|dendritic cells
802932|NCT00243594|Immunotherapy|immunotherapy
802933|NCT00243594|Vaccination|vaccination
802934|NCT00243594|Melanoma|melanoma
802935|NCT00243594|Peptides|peptides
802936|NCT00243594|MRI|mri
802937|NCT00243594|Scintigraphy|scintigraphy
802938|NCT00243594|Immune response|immune response
802939|NCT00243568|HIV Infections|hiv infections
802940|NCT00243568|Acquired Immunodeficiency Syndrome|acquired immunodeficiency syndrome
802941|NCT00243568|CCR5/CXCR4 mixed tropism|ccr5/cxcr4 mixed tropism
802942|NCT00243568|R5/X4 mixed tropism|r5/x4 mixed tropism
802943|NCT00243568|CCR5 inhibitor|ccr5 inhibitor
802944|NCT00243568|vicriviroc|vicriviroc
802945|NCT00243568|treatment-experienced|treatment-experienced
802946|NCT00243555|peanut hypersensitivity|peanut hypersensitivity
802947|NCT00243555|chemokines|chemokines
802948|NCT00243555|cytokines|cytokines
802949|NCT00243555|RNA,messenger|rna,messenger
802950|NCT00243555|monocytes|monocytes
802951|NCT00243542|Acne, G6PD deficiency, Dapsone|acne, g6pd deficiency, dapsone
802952|NCT00243529|Dendritic cells|dendritic cells
802953|NCT00243529|Melanoma|melanoma
802954|NCT00243529|Vaccine|vaccine
802955|NCT00243529|Immunotherapy|immunotherapy
802956|NCT00243529|RNA|rna
802957|NCT00243529|Peptides|peptides
802958|NCT00243516|Acute Coronary Syndrome|acute coronary syndrome
802959|NCT00243516|Emergency Department|emergency department
802960|NCT00243516|Chest Pain Evaluation Unit|chest pain evaluation unit
802961|NCT00243516|Overtesting|overtesting
802962|NCT00243516|Chest Pain Protocol|chest pain protocol
802963|NCT00243516|Myocardial Infarction|myocardial infarction
802964|NCT00243516|Medical Malpractice|medical malpractice
802965|NCT00243503|Breast Cancer Metastatic|breast cancer metastatic
802966|NCT00243490|Photodynamic therapy|photodynamic therapy
802967|NCT00243490|Malignant glioma|malignant glioma
802968|NCT00243490|Photosan|photosan
802969|NCT00243477|Coronary Artery Bypass|coronary artery bypass
802970|NCT00243477|Surgery|surgery
802971|NCT00243425|Major Depressive Disorder;|major depressive disorder;
802972|NCT00243425|African Americans;|african americans;
802973|NCT00243425|Disparities;|disparities;
802974|NCT00243425|Quality Improvement;|quality improvement;
802975|NCT00243425|Patient Centered Care;|patient centered care;
802976|NCT00243425|Primary Care;|primary care;
802977|NCT00243425|Patient-Physician Relationship;|patient-physician relationship;
802978|NCT00243412|Rituxan|rituxan
802979|NCT00243412|RA|ra
802980|NCT00243399|Fanconi anemia|fanconi anemia
802981|NCT00243399|FA|fa
802982|NCT00243373|Patient safety|patient safety
802983|NCT00243373|Medication safety|medication safety
802984|NCT00243373|Barcode technology|barcode technology
802985|NCT00243360|Urinary tract infections,|urinary tract infections,
802986|NCT00243360|antibiotic use,|antibiotic use,
802987|NCT00243360|long term care facilities|long term care facilities
802988|NCT00243347|RECENTIN|recentin
802989|NCT00243334|Ambulatory Care Information Systems|ambulatory care information systems
802990|NCT00243334|Clinical Decision Support Systems|clinical decision support systems
802991|NCT00243334|Medication Systems|medication systems
802992|NCT00243334|Medication Errors|medication errors
802993|NCT00243334|Reminder Systems|reminder systems
802994|NCT00243334|Drug Monitoring|drug monitoring
802995|NCT00243334|Preventive Health Services|preventive health services
802996|NCT00243334|Time and Motion Studies|time and motion studies
802997|NCT00243334|Efficiency|efficiency
802998|NCT00243334|Cost-Benefit Analysis|cost-benefit analysis
802999|NCT00243321|brachytherapy|brachytherapy
803000|NCT00243321|intensity-modulated radiation therapy|intensity-modulated radiation therapy
803001|NCT00243321|prostate specific antigen|prostate specific antigen
803002|NCT00243308|Anti-inflammatory agents|anti-inflammatory agents
803003|NCT00243308|unstable plaque|unstable plaque
803004|NCT00243308|acute coronary syndrome|acute coronary syndrome
803005|NCT00243295|osteoarthritis|osteoarthritis
803006|NCT00243295|deformity of knee|deformity of knee
803007|NCT00243282|Complementary Therapies|complementary therapies
803008|NCT00243282|Dyspnea|dyspnea
803009|NCT00243282|Palliative Care|palliative care
803010|NCT00243282|Meditation|meditation
803011|NCT00243282|Quality of Life|quality of life
803012|NCT00243269|nausea, acupressure bands, relaxation|nausea, acupressure bands, relaxation
803013|NCT00243243|Burns|burns
803014|NCT00243204|Stage IIIb/IV non-small cell lung cancer|stage iiib/iv non-small cell lung cancer
803015|NCT00243204|NSCLC|nsclc
803016|NCT00243204|Lung Cancer|lung cancer
803017|NCT00243191|newly diagnosed or recurrent|newly diagnosed or recurrent
803018|NCT00243178|Atrial fibrillation|atrial fibrillation
803019|NCT00243178|Anticoagulant therapy|anticoagulant therapy
803020|NCT00243178|Thromboembolic prevention|thromboembolic prevention
803021|NCT00243165|breast cancer|breast cancer
803022|NCT00243165|honey|honey
803023|NCT00243165|myelosuppression|myelosuppression
803024|NCT00243165|chemotherapy|chemotherapy
803025|NCT00243152|pain|pain
803026|NCT00243152|neuropathic|neuropathic
803027|NCT00243152|face|face
803028|NCT00243152|trigeminal|trigeminal
803029|NCT00243139|Oral appliances|oral appliances
803030|NCT00243139|Obstructive sleep apnea|obstructive sleep apnea
803031|NCT00243139|Epworth Sleepiness Scale|epworth sleepiness scale
803032|NCT00243139|SF-36|sf-36
803033|NCT00243126|HIV prevention|hiv prevention
803034|NCT00243126|HIV Seronegativity|hiv seronegativity
803035|NCT00243126|HIV negative|hiv negative
803036|NCT00243113|stage II squamous cell carcinoma of the hypopharynx|stage ii squamous cell carcinoma of the hypopharynx
803037|NCT00243113|stage II squamous cell carcinoma of the larynx|stage ii squamous cell carcinoma of the larynx
803038|NCT00243113|stage III squamous cell carcinoma of the hypopharynx|stage iii squamous cell carcinoma of the hypopharynx
803039|NCT00243113|stage III squamous cell carcinoma of the larynx|stage iii squamous cell carcinoma of the larynx
803040|NCT00243087|stage IV adult diffuse large cell lymphoma|stage iv adult diffuse large cell lymphoma
803041|NCT00243087|recurrent adult diffuse large cell lymphoma|recurrent adult diffuse large cell lymphoma
803042|NCT00243087|recurrent adult Burkitt lymphoma|recurrent adult burkitt lymphoma
803043|NCT00243087|stage IV adult Burkitt lymphoma|stage iv adult burkitt lymphoma
803044|NCT00243087|stage IV grade 3 follicular lymphoma|stage iv grade 3 follicular lymphoma
803045|NCT00243087|recurrent grade 3 follicular lymphoma|recurrent grade 3 follicular lymphoma
803046|NCT00243087|stage IV mantle cell lymphoma|stage iv mantle cell lymphoma
803047|NCT00243087|recurrent mantle cell lymphoma|recurrent mantle cell lymphoma
803048|NCT00243087|recurrent adult immunoblastic large cell lymphoma|recurrent adult immunoblastic large cell lymphoma
803049|NCT00243087|stage IV adult immunoblastic large cell lymphoma|stage iv adult immunoblastic large cell lymphoma
803050|NCT00243087|anaplastic large cell lymphoma|anaplastic large cell lymphoma
803051|NCT00243087|recurrent adult T-cell leukemia/lymphoma|recurrent adult t-cell leukemia/lymphoma
803052|NCT00243087|stage IV adult T-cell leukemia/lymphoma|stage iv adult t-cell leukemia/lymphoma
803053|NCT00243087|stage III adult Burkitt lymphoma|stage iii adult burkitt lymphoma
803054|NCT00243087|stage III adult diffuse large cell lymphoma|stage iii adult diffuse large cell lymphoma
803055|NCT00243087|stage III adult immunoblastic large cell lymphoma|stage iii adult immunoblastic large cell lymphoma
803056|NCT00243087|stage III adult T-cell leukemia/lymphoma|stage iii adult t-cell leukemia/lymphoma
803057|NCT00243087|stage III grade 3 follicular lymphoma|stage iii grade 3 follicular lymphoma
803058|NCT00243087|stage III mantle cell lymphoma|stage iii mantle cell lymphoma
803059|NCT00243048|stage I prostate cancer|stage i prostate cancer
803060|NCT00243048|stage II prostate cancer|stage ii prostate cancer
803061|NCT00243022|cerebral edema|cerebral edema
803062|NCT00243022|adult glioblastoma|adult glioblastoma
803258|NCT00242242|Stroke|stroke
803063|NCT00243022|adult giant cell glioblastoma|adult giant cell glioblastoma
803064|NCT00243022|adult gliosarcoma|adult gliosarcoma
803065|NCT00243022|adult anaplastic astrocytoma|adult anaplastic astrocytoma
803066|NCT00243022|adult anaplastic oligodendroglioma|adult anaplastic oligodendroglioma
803067|NCT00243009|recurrent renal cell cancer|recurrent renal cell cancer
803068|NCT00243009|stage IV renal cell cancer|stage iv renal cell cancer
803069|NCT00243009|clear cell renal cell carcinoma|clear cell renal cell carcinoma
803070|NCT00242996|recurrent adult diffuse large cell lymphoma|recurrent adult diffuse large cell lymphoma
803071|NCT00242983|adenocarcinoma of the lung|adenocarcinoma of the lung
803072|NCT00242983|large cell lung cancer|large cell lung cancer
803073|NCT00242983|recurrent non-small cell lung cancer|recurrent non-small cell lung cancer
803074|NCT00242983|squamous cell lung cancer|squamous cell lung cancer
803075|NCT00242983|stage IIIB non-small cell lung cancer|stage iiib non-small cell lung cancer
803076|NCT00242983|stage IV non-small cell lung cancer|stage iv non-small cell lung cancer
803077|NCT00242957|HIV/AIDS|hiv/aids
803078|NCT00242957|Gender Based Violence|gender based violence
803079|NCT00242957|Structural Interventions|structural interventions
803080|NCT00242957|South Africa|south africa
803081|NCT00242957|HIV Seronegativity|hiv seronegativity
803082|NCT00242944|Acute coronary syndrome|acute coronary syndrome
803083|NCT00242944|Hypercholesterolemia|hypercholesterolemia
803084|NCT00242944|Primary coronary intervention|primary coronary intervention
803085|NCT00242944|Hydroxymethylglutaryl-CoA reductase inhibitors|hydroxymethylglutaryl-coa reductase inhibitors
803086|NCT00242944|coronary plaque|coronary plaque
803087|NCT00242944|Angioplasty, Transluminal, Percutaneous Coronary|angioplasty, transluminal, percutaneous coronary
803088|NCT00242944|Ultrasonography, Interventional|ultrasonography, interventional
803089|NCT00242931|adenocarcinoma of the prostate|adenocarcinoma of the prostate
803090|NCT00242931|recurrent prostate cancer|recurrent prostate cancer
803091|NCT00242931|stage IV prostate cancer|stage iv prostate cancer
803092|NCT00242918|High risk|high risk
803093|NCT00242918|adenocarcinoma|adenocarcinoma
803094|NCT00242918|prostate cancer|prostate cancer
803095|NCT00242918|neoadjuvant|neoadjuvant
803096|NCT00242905|Memory|memory
803097|NCT00242905|Epilepsy|epilepsy
803098|NCT00242905|Children|children
803099|NCT00242905|Magnetic resonance imaging|magnetic resonance imaging
803100|NCT00242905|Functional magnetic resonance imaging|functional magnetic resonance imaging
803101|NCT00242892|Deployment stent optimisation|deployment stent optimisation
803102|NCT00242892|Fractional Flow Reserve|fractional flow reserve
803103|NCT00242892|Stent|stent
803104|NCT00242892|Restenosis|restenosis
803105|NCT00242892|Coronary|coronary
803106|NCT00242879|treatment-experienced|treatment-experienced
803107|NCT00242879|RTV|rtv
803108|NCT00242879|protease inhibitor|protease inhibitor
803109|NCT00242879|ritonavir|ritonavir
803110|NCT00242879|GW640385|gw640385
803111|NCT00242879|HIV-1|hiv-1
803112|NCT00242866|Productivity|productivity
803113|NCT00242866|Efficacy|efficacy
803114|NCT00242866|without aura|without aura
803115|NCT00242866|iNOS|inos
803116|NCT00242866|Safety|safety
803117|NCT00242866|Nitric Oxide|nitric oxide
803118|NCT00242866|Pharmacokinetics|pharmacokinetics
803119|NCT00242866|GW274150|gw274150
803120|NCT00242866|with aura|with aura
803121|NCT00242866|Migraine|migraine
803122|NCT00242866|Prophylaxis|prophylaxis
803123|NCT00242866|Quality of Life|quality of life
803124|NCT00242853|iNOS|inos
803329|NCT00241618|Prospective|prospective
803125|NCT00242853|Rheumatoid arthritis|rheumatoid arthritis
803126|NCT00242853|Exhaled NO|exhaled no
803127|NCT00242840|protease inhibitor|protease inhibitor
803128|NCT00242840|ritonavir|ritonavir
803129|NCT00242840|GW433908|gw433908
803130|NCT00242840|HIV-1|hiv-1
803131|NCT00242840|fosamprenavir|fosamprenavir
803132|NCT00242788|Colorectal Cancer|colorectal cancer
803133|NCT00242775|Asthma|asthma
803134|NCT00242762|Head and Neck Neoplasms|head and neck neoplasms
803135|NCT00242762|Cancer of Head and Neck|cancer of head and neck
803136|NCT00242762|Head and Neck Cancer|head and neck cancer
803137|NCT00242762|Head Cancer|head cancer
803138|NCT00242762|Neck Cancer|neck cancer
803139|NCT00242749|Head and Neck Cancer Disease|head and neck cancer disease
803140|NCT00242749|Head Cancer|head cancer
803141|NCT00242749|Neck Cancer|neck cancer
803142|NCT00242749|Cancer of Head|cancer of head
803143|NCT00242749|Cancer of Neck|cancer of neck
803144|NCT00242749|Cancer of the Head|cancer of the head
803145|NCT00242749|Cancer of the Head and Neck|cancer of the head and neck
803146|NCT00242749|Cancer of the Neck|cancer of the neck
803147|NCT00242749|Neoplasms, Head and Neck|neoplasms, head and neck
803148|NCT00242723|Biopsy|biopsy
803149|NCT00242723|Staging Studies|staging studies
803150|NCT00242723|Screening|screening
803151|NCT00242723|Potentially Malignant or Suspicious Legions|potentially malignant or suspicious legions
803152|NCT00242723|Cancer Primary Evaluation|cancer primary evaluation
803153|NCT00242723|Lung Cancer|lung cancer
803154|NCT00242723|Esophageal Cancer|esophageal cancer
803155|NCT00242723|Malignant Pleural Mesothelioma|malignant pleural mesothelioma
803156|NCT00242710|Endometrium|endometrium
803157|NCT00242710|Uterus|uterus
803158|NCT00242710|Menopause|menopause
803159|NCT00242697|coronary artery bypass surgery|coronary artery bypass surgery
803160|NCT00242697|anesthesia, general|anesthesia, general
803161|NCT00242697|anesthesia, spinal|anesthesia, spinal
803162|NCT00242697|heart-lung machine|heart-lung machine
803163|NCT00242684|Aging|aging
803164|NCT00242684|Undernutrition|undernutrition
803165|NCT00242684|Inflammation|inflammation
803166|NCT00242684|Frail Elderly|frail elderly
803167|NCT00242671|general anesthesia, hyperventilation, carbon dioxide, isocapnic hyperponea|general anesthesia, hyperventilation, carbon dioxide, isocapnic hyperponea
803168|NCT00242658|Physical Activity|physical activity
803169|NCT00242658|Wellness Programs|wellness programs
803170|NCT00242658|Health Promotion|health promotion
803171|NCT00242658|Blood Pressure, High|blood pressure, high
803172|NCT00242645|Doctor-Patient relation|doctor-patient relation
803173|NCT00242645|Physician-Patient relation|physician-patient relation
803174|NCT00242645|Diabetes|diabetes
803175|NCT00242645|Office visits|office visits
803176|NCT00242645|Comparative Study|comparative study
803177|NCT00242645|Health behavior|health behavior
803178|NCT00242645|Randomized controlled trials|randomized controlled trials
803179|NCT00242645|Health Promotion|health promotion
803180|NCT00242645|Health Education|health education
803181|NCT00242645|Computer-tailor information|computer-tailor information
803182|NCT00242606|Newly diagnosed epilepsy|newly diagnosed epilepsy
803183|NCT00242606|Initial monotherapy|initial monotherapy
803184|NCT00242606|Levetiracetam|levetiracetam
803185|NCT00242606|Lamotrigine|lamotrigine
803186|NCT00242593|cognition disorders|cognition disorders
803187|NCT00242593|Alzheimer's disease|alzheimer's disease
803188|NCT00242593|memory|memory
803190|NCT00242580|age-related macular degeneration|age-related macular degeneration
803191|NCT00242580|choroidal neovascularization|choroidal neovascularization
803192|NCT00242567|zoledronic acid|zoledronic acid
803193|NCT00242567|bone metastases|bone metastases
803194|NCT00242567|prostate cancer|prostate cancer
803195|NCT00242567|hormone-sensitive|hormone-sensitive
803196|NCT00242554|Prostate Cancer|prostate cancer
803197|NCT00242554|Bone Metastases|bone metastases
803198|NCT00242554|Zoledronic acid|zoledronic acid
803199|NCT00242541|microadenoma|microadenoma
803200|NCT00242541|macroadenoma|macroadenoma
803201|NCT00242528|Bone Lesions|bone lesions
803202|NCT00242528|Multiple Myeloma|multiple myeloma
803203|NCT00242528|zoledronic acid|zoledronic acid
803204|NCT00242515|High risk Myelodysplastic Syndrome (MDS)|high risk myelodysplastic syndrome (mds)
803205|NCT00242502|Hepatocellular Carcinoma|hepatocellular carcinoma
803206|NCT00242502|Liver Cancer|liver cancer
803207|NCT00242502|Bevacizumab|bevacizumab
803208|NCT00242502|Anti-VEGF monoclonal antibody|anti-vegf monoclonal antibody
803209|NCT00242502|rhuMAb-VEGF|rhumab-vegf
803210|NCT00242502|Erlotinib Hydrochloride|erlotinib hydrochloride
803211|NCT00242502|OSI-774|osi-774
803212|NCT00242502|Tarceva|tarceva
803213|NCT00242502|Erlotinib|erlotinib
803214|NCT00242502|Avastin|avastin
803215|NCT00242489|Arcoxia|arcoxia
803216|NCT00242463|malnutrition|malnutrition
803217|NCT00242463|anabolic steroids|anabolic steroids
803218|NCT00242463|intensive care unit|intensive care unit
803219|NCT00242463|rehabilitation|rehabilitation
803220|NCT00242450|metoclopramide|metoclopramide
803221|NCT00242450|feeding|feeding
803222|NCT00242450|very low birthweightnewborn|very low birthweightnewborn
803223|NCT00242424|influenza vaccine|influenza vaccine
803224|NCT00242424|infants|infants
803226|NCT00242424|immunogenicity|immunogenicity
803227|NCT00242398|Intensive care unit|intensive care unit
803228|NCT00242398|Patients with bleeding high risk|patients with bleeding high risk
803229|NCT00242398|Intermittent hemodialysis without anticoagulation|intermittent hemodialysis without anticoagulation
803230|NCT00242398|Blood lost|blood lost
803231|NCT00242385|Severe congenital Alpha1-Proteinase Inhibitor (Alpha1-PI) deficiency|severe congenital alpha1-proteinase inhibitor (alpha1-pi) deficiency
803232|NCT00242372|Insulin dependent Type 2 diabetes|insulin dependent type 2 diabetes
803233|NCT00242346|Hypertension|hypertension
803234|NCT00242333|COPD|copd
803235|NCT00242333|COAD|coad
803236|NCT00242333|Chronic obstructive pulmonary disease|chronic obstructive pulmonary disease
803237|NCT00242333|emphysema|emphysema
803238|NCT00242333|chronic bronchitis|chronic bronchitis
803239|NCT00242320|COPD|copd
803240|NCT00242320|chronic obstructive pulmonary disease|chronic obstructive pulmonary disease
803241|NCT00242320|Roflumilast|roflumilast
803242|NCT00242307|Asthma|asthma
803243|NCT00242307|Roflumilast|roflumilast
803244|NCT00242307|phosphodiesterase 4 inhibitor|phosphodiesterase 4 inhibitor
803245|NCT00242294|COPD|copd
803246|NCT00242294|Phosphodiesterase 4 inhibitor|phosphodiesterase 4 inhibitor
803247|NCT00242294|Roflumilast|roflumilast
803248|NCT00242281|Sore Throat|sore throat
803249|NCT00242281|Pharyngitis|pharyngitis
803250|NCT00242281|Tonsillitis|tonsillitis
803251|NCT00242255|Histone|histone
803252|NCT00242255|Chromatin|chromatin
803253|NCT00242255|Epigenome|epigenome
803254|NCT00242255|Senescence|senescence
803255|NCT00242255|Acetylation|acetylation
803256|NCT00242255|Aging|aging
803257|NCT00242255|Tissue Sample|tissue sample
803259|NCT00242242|BCI|bci
803260|NCT00242242|Healthy Volunteer|healthy volunteer
803261|NCT00242242|HV|hv
803262|NCT00242229|Depression|depression
803263|NCT00242216|HIV-1 infected people|hiv-1 infected people
803264|NCT00242216|Antiretroviral treatment-naïve|antiretroviral treatment-naïve
803265|NCT00242216|Atazanavir|atazanavir
803266|NCT00242216|Fosamprenavir|fosamprenavir
803267|NCT00242216|ARV Treatment Naive|arv treatment naive
803268|NCT00242203|Breast Cancer|breast cancer
803269|NCT00242203|Neoadjuvant|neoadjuvant
803270|NCT00242203|Micrometastasis|micrometastasis
803271|NCT00242190|drug therapy|drug therapy
803272|NCT00242190|radiotherapy|radiotherapy
803273|NCT00242190|clinical trial|clinical trial
803274|NCT00242177|Multiple Sclerosis|multiple sclerosis
803275|NCT00242177|Relapsing, Remitting|relapsing, remitting
803276|NCT00242177|Autoimmune disease|autoimmune disease
803277|NCT00242164|Hemodialysis|hemodialysis
803278|NCT00242164|Magnesium|magnesium
803279|NCT00242164|Arrhythmia|arrhythmia
803280|NCT00242164|QTc interval|qtc interval
803281|NCT00242164|QT dispersion|qt dispersion
803282|NCT00242151|Delirium, Confusion, Cardiac Surgery, Organic Brain Injury, Diffusion Weighted Magnetic Resonance Imaging (DW-MRI)|delirium, confusion, cardiac surgery, organic brain injury, diffusion weighted magnetic resonance imaging (dw-mri)
803283|NCT00242125|Primary biliary Cirrhosis|primary biliary cirrhosis
803284|NCT00242125|genes|genes
803285|NCT00242125|DNA|dna
803286|NCT00242099|liver transplant|liver transplant
803287|NCT00242099|HHV-6|hhv-6
803288|NCT00242099|HHV-7|hhv-7
803289|NCT00242099|Human Herpesvirus-6|human herpesvirus-6
803290|NCT00242099|Human Herpesvirus-7|human herpesvirus-7
803291|NCT00242047|Tuberculosis.|tuberculosis.
803292|NCT00242047|Children.|children.
803293|NCT00242047|Vaccine.|vaccine.
803294|NCT00242047|BCG.|bcg.
803295|NCT00242021|Satiety, ad libitum food intake, fatty acids, hormones|satiety, ad libitum food intake, fatty acids, hormones
803296|NCT00242008|IDIOPATHIC PARKINSON'S DISEASE|idiopathic parkinson's disease
803297|NCT00241982|rheumatoid arthritis|rheumatoid arthritis
803298|NCT00241982|long circulating liposomes|long circulating liposomes
803299|NCT00241969|nutrition therapy|nutrition therapy
803300|NCT00241969|preschool children|preschool children
803301|NCT00241969|cystic fibrosis|cystic fibrosis
803302|NCT00241943|Hepatitis C|hepatitis c
803303|NCT00241943|Heroin|heroin
803304|NCT00241943|Populations at risk|populations at risk
803305|NCT00241943|testing|testing
803306|NCT00241943|vaccination|vaccination
803307|NCT00241930|Heroin|heroin
803308|NCT00241930|HIV|hiv
803309|NCT00241930|buprenorphine|buprenorphine
803310|NCT00241930|integration|integration
803311|NCT00241930|drug treatment|drug treatment
803312|NCT00241917|hepatitis C|hepatitis c
803313|NCT00241917|heroin|heroin
803314|NCT00241917|populations at risk|populations at risk
803315|NCT00241917|testing|testing
803316|NCT00241917|vaccination|vaccination
803317|NCT00241722|bowel dysfunction|bowel dysfunction
803318|NCT00241722|constipation|constipation
803319|NCT00241722|gastrointestinal|gastrointestinal
803320|NCT00241722|opioids|opioids
803321|NCT00241722|pain|pain
803322|NCT00241722|non-cancer pain|non-cancer pain
803323|NCT00241722|opioid-induced|opioid-induced
803324|NCT00241644|Rotavirus gastroenteritis|rotavirus gastroenteritis
803325|NCT00241644|HRV vaccine|hrv vaccine
803326|NCT00241618|Clinical trial|clinical trial
803327|NCT00241618|Randomized|randomized
803328|NCT00241618|Treatment|treatment
803330|NCT00241618|Parallel Assignment|parallel assignment
803331|NCT00241618|Efficacy Safety Study|efficacy safety study
803332|NCT00241605|Metformin|metformin
803333|NCT00241605|AVANDAMET|avandamet
803334|NCT00241605|Type 2 diabetes|type 2 diabetes
803335|NCT00241592|Cannabis|cannabis
803336|NCT00241592|Marijuana|marijuana
803337|NCT00241592|Vaporization|vaporization
803338|NCT00241592|Volcano|volcano
803339|NCT00241592|THC|thc
803340|NCT00241579|Pain|pain
803341|NCT00241579|Cannabis|cannabis
803342|NCT00241579|Analgesic|analgesic
803343|NCT00241566|Neuropathic pain|neuropathic pain
803344|NCT00241566|Electric cortical stimulation|electric cortical stimulation
803345|NCT00241566|Economic Medical evaluation|economic medical evaluation
803346|NCT00241540|NSAIDs|nsaids
803347|NCT00241540|Upper GI symptoms|upper gi symptoms
803348|NCT00241514|NSAIDs|nsaids
803349|NCT00241514|Upper GI symptoms|upper gi symptoms
803350|NCT00241475|Cancer of the Prostate|cancer of the prostate
803351|NCT00241462|Advanced Breast Cancer|advanced breast cancer
803352|NCT00241449|Locally advanced breast cancer or metastatic breast cancer|locally advanced breast cancer or metastatic breast cancer
803353|NCT00241423|exenatide|exenatide
803354|NCT00241423|diabetes|diabetes
803355|NCT00241423|Amylin|amylin
803356|NCT00241423|Lilly|lilly
803357|NCT00241410|Allergy|allergy
803358|NCT00241410|Specific Immunotherapy|specific immunotherapy
803359|NCT00241410|Sublingual Immunotherapy|sublingual immunotherapy
803360|NCT00241397|pain|pain
803361|NCT00241397|depression|depression
803362|NCT00241397|anxiety disorder|anxiety disorder
803363|NCT00241384|Prostatic Cancer|prostatic cancer
803364|NCT00241384|Brachytherapy|brachytherapy
803365|NCT00241384|Prostatic neoplasm|prostatic neoplasm
803366|NCT00241384|Radiation therapy|radiation therapy
803367|NCT00241371|Multiple Myeloma|multiple myeloma
803368|NCT00241358|Plerixafor|plerixafor
803369|NCT00241358|Stem cell transplantation|stem cell transplantation
803370|NCT00241358|Stem cells|stem cells
803371|NCT00241358|Mobilization|mobilization
803372|NCT00241345|post transplant|post transplant
803373|NCT00241345|Any patient receiving an allogeneic bone marrow or peripheral blood stem cell transplant at Washington University Medical Center|any patient receiving an allogeneic bone marrow or peripheral blood stem cell transplant at washington university medical center
803374|NCT00241332|pain|pain
803375|NCT00241332|hyperalgesia|hyperalgesia
803376|NCT00241332|drug tolerance|drug tolerance
803377|NCT00241332|remifentanil|remifentanil
803378|NCT00241332|fentanyl|fentanyl
803379|NCT00241332|Anterior Cruciate Ligament|anterior cruciate ligament
803380|NCT00241332|Posterior Cruciate Ligament|posterior cruciate ligament
803381|NCT00241332|Medial Collateral Ligament, Knee|medial collateral ligament, knee
803382|NCT00241319|ocular, allergic conjunctivitis, ophthalmic|ocular, allergic conjunctivitis, ophthalmic
803383|NCT00241306|aging|aging
803384|NCT00241306|language|language
803385|NCT00241306|gender|gender
803386|NCT00241293|language|language
803387|NCT00241267|Pulmonary|pulmonary
803388|NCT00241267|Neoplasms|neoplasms
803389|NCT00241267|Endobronchial|endobronchial
803390|NCT00241267|Ultrasonography|ultrasonography
803391|NCT00241267|Primary|primary
803392|NCT00241254|Multiple Sclerosis, Chronic Progressive|multiple sclerosis, chronic progressive
803393|NCT00241254|Cyclophosphamide|cyclophosphamide
803394|NCT00241254|Methylprednisolone|methylprednisolone
803395|NCT00241254|Randomized Controlled Trials|randomized controlled trials
803396|NCT00241254|Double-Blind Study|double-blind study
803397|NCT00241241|myeloproliferative disorder|myeloproliferative disorder
803398|NCT00241241|polycythemia vera|polycythemia vera
803399|NCT00241241|interferon|interferon
803400|NCT00241228|Shock, Septic|shock, septic
803401|NCT00241228|Renal Failure, Acute|renal failure, acute
803402|NCT00241228|Venovenous Hemofiltration|venovenous hemofiltration
803403|NCT00241228|Randomized Controlled Trial|randomized controlled trial
803404|NCT00241228|Multicenter Study|multicenter study
803405|NCT00241228|Mortality|mortality
803406|NCT00241215|Botulinum toxin serotype A|botulinum toxin serotype a
803407|NCT00241215|Cervicobrachial syndrome|cervicobrachial syndrome
803408|NCT00241215|Myofascial pain|myofascial pain
803409|NCT00241215|Cervicothoracic myofascial pain|cervicothoracic myofascial pain
803410|NCT00241215|Propulsion|propulsion
803411|NCT00241215|Postural abnormality|postural abnormality
803412|NCT00241202|signs and symptoms|signs and symptoms
803413|NCT00241202|self care|self care
803414|NCT00241202|patient compliance|patient compliance
803415|NCT00241202|quality of life|quality of life
803416|NCT00241189|Systemic sclerosis|systemic sclerosis
803417|NCT00241189|Scleroderma|scleroderma
803418|NCT00241189|Rapamycin|rapamycin
803419|NCT00241189|Methotrexate|methotrexate
803420|NCT00241176|Psychiatric|psychiatric
803421|NCT00241176|Clinical Trial|clinical trial
803422|NCT00241176|Pediatrics|pediatrics
803423|NCT00241176|Tourette's Disorder|tourette's disorder
803424|NCT00241176|Tic Disorder|tic disorder
803425|NCT00241150|valsartan|valsartan
803426|NCT00241150|hypertension|hypertension
803427|NCT00241150|metabolic syndrome|metabolic syndrome
803530|NCT00240695|galantamine|galantamine
803428|NCT00241150|endothelial function|endothelial function
803429|NCT00241137|hypertension|hypertension
803430|NCT00241137|valsartan|valsartan
803431|NCT00241124|hypertension|hypertension
803432|NCT00241124|valsartan|valsartan
803433|NCT00241124|morning/evening dosing|morning/evening dosing
803434|NCT00241124|lisinopril|lisinopril
803435|NCT00241111|Prostate|prostate
803436|NCT00241111|cancer|cancer
803437|NCT00241111|bone metastasis|bone metastasis
803438|NCT00241111|zoledronic acid|zoledronic acid
803439|NCT00241098|HYPERTENSION|hypertension
803440|NCT00241098|HEART FAILURE|heart failure
803441|NCT00241098|PEPTIDE|peptide
803442|NCT00241098|valsartan|valsartan
803443|NCT00241085|proteinuria|proteinuria
803444|NCT00241085|hypertension|hypertension
803445|NCT00241085|valsartan|valsartan
803446|NCT00241085|type 2 diabetes|type 2 diabetes
803447|NCT00241059|Renal transplantation, maintenance patients, tolerability, EC-MPS|renal transplantation, maintenance patients, tolerability, ec-mps
803448|NCT00241046|Breast cancer|breast cancer
803449|NCT00241046|Machine learning techniques|machine learning techniques
803450|NCT00241046|Aromatase inhibitors|aromatase inhibitors
803451|NCT00241046|1st line treatment|1st line treatment
803452|NCT00241046|2nd line treatment|2nd line treatment
803453|NCT00241020|hepatocellular carcinoma|hepatocellular carcinoma
803454|NCT00241020|Octreotide|octreotide
803455|NCT00241007|HYPERTENSION, VALSARTAN|hypertension, valsartan
803456|NCT00240994|End stage renal disease|end stage renal disease
803457|NCT00240994|Kidney transplantation|kidney transplantation
803458|NCT00240994|Renal transplantation|renal transplantation
803459|NCT00240994|Kidney failure|kidney failure
803460|NCT00240994|Pediatric renal transplant recipients|pediatric renal transplant recipients
803461|NCT00240994|Alemtuzumab|alemtuzumab
803462|NCT00240994|Campath|campath
803463|NCT00240994|Mycophenolate mofetil|mycophenolate mofetil
803464|NCT00240994|MMF|mmf
803465|NCT00240994|CellCept|cellcept
803466|NCT00240994|Tacrolimus|tacrolimus
803467|NCT00240994|Prograf|prograf
803468|NCT00240994|Sirolimus|sirolimus
803469|NCT00240994|Rapamycin|rapamycin
803470|NCT00240981|Andropause|andropause
803471|NCT00240981|frailty|frailty
803472|NCT00240981|hormone replacement therapy|hormone replacement therapy
803473|NCT00240981|Aging|aging
803474|NCT00240968|Avian influenza, vaccine, A/H5N1, sub-study|avian influenza, vaccine, a/h5n1, sub-study
803475|NCT00240955|Renal/Kidney, Transplantation, steroids, EC-MPS|renal/kidney, transplantation, steroids, ec-mps
803476|NCT00240942|Endometriosis|endometriosis
803477|NCT00240942|GnRH analog|gnrh analog
803478|NCT00240942|Aromataseinhibitor|aromataseinhibitor
803479|NCT00240942|Letrozole|letrozole
803480|NCT00240903|revaccination, vaccination, influenza, H5N1 vaccine|revaccination, vaccination, influenza, h5n1 vaccine
803481|NCT00240864|postoperative dental pain|postoperative dental pain
803482|NCT00240864|acetaminophen|acetaminophen
803483|NCT00240864|ibuprofen|ibuprofen
803484|NCT00240851|muscle ache|muscle ache
803485|NCT00240851|pain|pain
803486|NCT00240851|soreness|soreness
803487|NCT00240851|acetaminophen|acetaminophen
803488|NCT00240838|muscle soreness|muscle soreness
803489|NCT00240838|pain, acetaminophen|pain, acetaminophen
803490|NCT00240838|ibuprofen|ibuprofen
803491|NCT00240825|postoperative dental pain|postoperative dental pain
803492|NCT00240825|acetaminophen|acetaminophen
803493|NCT00240825|ibuprofen|ibuprofen
803494|NCT00240812|nocturnal enuresis|nocturnal enuresis
803495|NCT00240812|bedwetting|bedwetting
803496|NCT00240812|ibuprofen|ibuprofen
803497|NCT00240799|osteoarthritis hip|osteoarthritis hip
803498|NCT00240799|osteoarthritis knee|osteoarthritis knee
803499|NCT00240799|acetaminophen|acetaminophen
803500|NCT00240786|osteoarthritis hip|osteoarthritis hip
803501|NCT00240786|osteoarthritis knee|osteoarthritis knee
803502|NCT00240786|acetaminophen|acetaminophen
803503|NCT00240773|osteoarthritis hip|osteoarthritis hip
803504|NCT00240773|osteoarthritis knee|osteoarthritis knee
803505|NCT00240773|acetaminophen, naproxen|acetaminophen, naproxen
803506|NCT00240760|Memantine|memantine
803507|NCT00240760|Down syndrome|down syndrome
803508|NCT00240760|Dementia|dementia
803509|NCT00240760|learning Disability|learning disability
803510|NCT00240760|Treatment of Dementia|treatment of dementia
803511|NCT00240734|Anemia|anemia
803512|NCT00240734|Chronic renal failure|chronic renal failure
803513|NCT00240734|pre-dialysis|pre-dialysis
803514|NCT00240734|diabetic|diabetic
803515|NCT00240721|topiramate|topiramate
803516|NCT00240721|bipolar disorders|bipolar disorders
803517|NCT00240721|mood disorders|mood disorders
803518|NCT00240721|manic state|manic state
803519|NCT00240721|depression|depression
803520|NCT00240721|manic-depressive psychoses|manic-depressive psychoses
803521|NCT00240708|Schizophrenia|schizophrenia
803522|NCT00240708|intramuscular injection|intramuscular injection
803523|NCT00240708|antipsychotic agents|antipsychotic agents
803524|NCT00240708|risperidone|risperidone
803525|NCT00240708|long-acting injectable|long-acting injectable
803526|NCT00240695|Alzheimer's disease|alzheimer's disease
803527|NCT00240695|Dementia|dementia
803528|NCT00240695|Brain Disease|brain disease
803529|NCT00240695|Memory Loss|memory loss
803531|NCT00240695|Nervous System Diseases|nervous system diseases
803532|NCT00240695|open-label|open-label
803533|NCT00240695|elderly|elderly
803534|NCT00240682|Carcinoma, Squamous Cell|carcinoma, squamous cell
803535|NCT00240682|Skin|skin
803536|NCT00240682|cetuximab|cetuximab
803537|NCT00240682|epidermal growth factor receptor|epidermal growth factor receptor
803538|NCT00240669|Maxillo facial surgery,|maxillo facial surgery,
803539|NCT00240669|osteosynthesis,|osteosynthesis,
803540|NCT00240669|resorbable device|resorbable device
803541|NCT00240656|aldosterone antagonists, spironolactone, captopril carvedilol|aldosterone antagonists, spironolactone, captopril carvedilol
803542|NCT00240643|non valvular atrial fibrillation|non valvular atrial fibrillation
803543|NCT00240643|stroke|stroke
803544|NCT00240643|aspirin|aspirin
803545|NCT00240630|acute migraine|acute migraine
803546|NCT00240630|consistency of response|consistency of response
803547|NCT00240630|satisfaction|satisfaction
803548|NCT00240630|migraine|migraine
803549|NCT00240630|early intervention|early intervention
803550|NCT00240617|consistency of response|consistency of response
803551|NCT00240617|migraine|migraine
803552|NCT00240617|satisfaction|satisfaction
803553|NCT00240617|early intervention|early intervention
803554|NCT00240604|corticosteroid treatment|corticosteroid treatment
803555|NCT00240604|inflammatory diseases|inflammatory diseases
803556|NCT00240591|BEXXAR|bexxar
803557|NCT00240591|Tositumomab|tositumomab
803558|NCT00240591|Iodine I 131 Tositumomab|iodine i 131 tositumomab
803559|NCT00240591|low-grade follicular lymphomas|low-grade follicular lymphomas
804429|NCT00236860|topiramate|topiramate
803560|NCT00240578|Long-Term Follow-up|long-term follow-up
803561|NCT00240578|BEXXAR|bexxar
803562|NCT00240578|Iodine I 131 Tositumomab|iodine i 131 tositumomab
803563|NCT00240578|Low-grade lymphoma|low-grade lymphoma
803564|NCT00240565|BEXXAR|bexxar
803565|NCT00240565|non-Hodgkin's Lymphoma|non-hodgkin's lymphoma
803566|NCT00240565|tositumomab|tositumomab
803567|NCT00240565|I-131|i-131
803568|NCT00240552|protease inhibitor|protease inhibitor
803569|NCT00240552|Treatment Experienced|treatment experienced
803570|NCT00240552|amprenavir|amprenavir
803571|NCT00240552|fosamprenavir|fosamprenavir
803572|NCT00240552|GW433908|gw433908
803573|NCT00240552|HIV|hiv
803574|NCT00240552|pro drug|pro drug
803575|NCT00240539|Hepatitis B|hepatitis b
803576|NCT00240526|Hepatitis B immunoglobulin|hepatitis b immunoglobulin
803577|NCT00240526|Hepatitis B antibody persistence|hepatitis b antibody persistence
803578|NCT00240513|Acne|acne
803579|NCT00240500|Long-term follow-up|long-term follow-up
803580|NCT00240500|Hepatitis B antibody persistence|hepatitis b antibody persistence
803581|NCT00240487|Acute Respiratory Distress Syndrome|acute respiratory distress syndrome
803582|NCT00240487|ARDS|ards
803583|NCT00240487|Nitric Oxide|nitric oxide
803584|NCT00240461|respiratory|respiratory
803585|NCT00240461|infection|infection
803586|NCT00240461|influenza|influenza
803587|NCT00240396|fracture|fracture
803588|NCT00240396|Tibia|tibia
803589|NCT00240396|femur|femur
803590|NCT00240396|humerus|humerus
803591|NCT00240396|narcotics|narcotics
803592|NCT00240396|bimodal|bimodal
803593|NCT00240396|analgesia|analgesia
803594|NCT00240396|long-bone|long-bone
803595|NCT00240396|NSAIDS|nsaids
803596|NCT00240344|High risk patients|high risk patients
803597|NCT00240344|Crestor|crestor
803598|NCT00240344|Rosuvastatin|rosuvastatin
803599|NCT00240344|LDL cholesterol|ldl cholesterol
803600|NCT00240344|observational|observational
803601|NCT00240331|End Stage Renal Failure|end stage renal failure
803602|NCT00240318|Coronary Artery Disease|coronary artery disease
803603|NCT00240305|Metabolic Syndrome|metabolic syndrome
803604|NCT00240305|Dyslipidaemia|dyslipidaemia
803605|NCT00240292|Ischaemic or non-ischaemic systolic congestive heart failure|ischaemic or non-ischaemic systolic congestive heart failure
803606|NCT00240279|high blood cholesterol levels|high blood cholesterol levels
803607|NCT00240266|Metabolic Syndrome|metabolic syndrome
803608|NCT00240266|Dyslipaemia|dyslipaemia
803609|NCT00240253|diabetes|diabetes
803610|NCT00240253|Amylin|amylin
803611|NCT00240253|Symlin|symlin
803612|NCT00240253|pramlintide|pramlintide
803613|NCT00240253|insulin glargine|insulin glargine
803614|NCT00240227|Alcoholism|alcoholism
803615|NCT00240227|Cocaine Dependence|cocaine dependence
803616|NCT00240227|Prazosin|prazosin
803617|NCT00240227|Substance use disorders|substance use disorders
803618|NCT00240214|Kidney transplants|kidney transplants
803619|NCT00240188|Hernia|hernia
803620|NCT00240188|Incisional|incisional
803621|NCT00240188|Laparoscopic|laparoscopic
803622|NCT00240188|Mesh|mesh
803623|NCT00240188|Repair|repair
803624|NCT00240188|Ventral|ventral
803625|NCT00240162|Myeloma|myeloma
803626|NCT00240162|PTK|ptk
803627|NCT00240136|Early, severe|early, severe
803628|NCT00240123|ERCP|ercp
803629|NCT00240123|EUS|eus
803630|NCT00240110|Bipolar|bipolar
803631|NCT00240110|Cocaine|cocaine
803632|NCT00240110|Comorbidity|comorbidity
803633|NCT00240071|Breast cancer|breast cancer
803760|NCT00239239|Aranesp|aranesp
803634|NCT00240071|Metastatic breast cancer|metastatic breast cancer
803635|NCT00240071|Hormonal therapy|hormonal therapy
803636|NCT00240071|Bevacizumab|bevacizumab
803637|NCT00240058|Blood Pressure|blood pressure
803638|NCT00240058|Nitric Oxide|nitric oxide
803639|NCT00240058|L-NMMA|l-nmma
803640|NCT00240058|Phenylephrine|phenylephrine
803641|NCT00240058|Nitroprusside|nitroprusside
803642|NCT00240058|Vasoreactivity|vasoreactivity
803643|NCT00240045|Hepatorenal syndrome|hepatorenal syndrome
803644|NCT00240045|Refractory ascites|refractory ascites
803645|NCT00240045|Midodrine|midodrine
803646|NCT00240045|Octreotide|octreotide
803647|NCT00240045|Albumin|albumin
803648|NCT00240045|Cirrhosis|cirrhosis
803649|NCT00240006|Multiple Sclerosis|multiple sclerosis
803650|NCT00240006|Copaxone®|copaxone®
803651|NCT00240006|Shared Solutions®|shared solutions®
803652|NCT00239980|antineoplastic agent|antineoplastic agent
803653|NCT00239980|ovarian cancer|ovarian cancer
803654|NCT00239980|fragmin|fragmin
803655|NCT00239980|dalteparin|dalteparin
803656|NCT00239967|dyslipidemia|dyslipidemia
803657|NCT00239967|obesity|obesity
803658|NCT00239928|Long-Term Study For Pegaptanib Sodium In Patients With Subfoveal Choroidal Neovascularization Secondary To Age-Related Macular Degeneration|long-term study for pegaptanib sodium in patients with subfoveal choroidal neovascularization secondary to age-related macular degeneration
803659|NCT00239902|Transplantation, kidney, and organ transplantation|transplantation, kidney, and organ transplantation
803660|NCT00239889|Forearm fracture|forearm fracture
803661|NCT00239889|Postmenopausal women|postmenopausal women
803662|NCT00239889|Pain|pain
804430|NCT00236860|epilepsy|epilepsy
803663|NCT00239889|Grip strength|grip strength
803664|NCT00239889|Salmon calcitonin|salmon calcitonin
803665|NCT00239876|Transplantation, kidney, and organ transplant|transplantation, kidney, and organ transplant
803666|NCT00239863|Transplantation, kidney,organ transplant|transplantation, kidney,organ transplant
803667|NCT00239850|obesity|obesity
803668|NCT00239850|lifestyle|lifestyle
803669|NCT00239850|treatment|treatment
803670|NCT00239850|Complications|complications
803671|NCT00239850|endocrine changes|endocrine changes
803672|NCT00239850|Lipids|lipids
803673|NCT00239850|C18.654.726.500.495|c18.654.726.500.495
803674|NCT00239837|Adolescent|adolescent
803675|NCT00239837|Foster Care|foster care
803676|NCT00239837|Female|female
803677|NCT00239824|urinary incontinence|urinary incontinence
803678|NCT00239824|pelvic floor muscle training|pelvic floor muscle training
803679|NCT00239824|radical prostatectomy|radical prostatectomy
803680|NCT00239824|physiotherapy|physiotherapy
803681|NCT00239811|Transplantation, kidney, and organ transplant.|transplantation, kidney, and organ transplant.
803682|NCT00239798|Transplantation, kidney, organ transplant|transplantation, kidney, organ transplant
803683|NCT00239785|Transplantation, kidney, and organ transplant.|transplantation, kidney, and organ transplant.
803684|NCT00239772|Cognitive Therapy|cognitive therapy
803685|NCT00239772|PTSD|ptsd
803686|NCT00239772|Females|females
803687|NCT00239772|Rape|rape
803688|NCT00239772|Trauma|trauma
803689|NCT00239759|Epidemiological study|epidemiological study
803690|NCT00239746|Nonsteroidal Anti-inflammatories|nonsteroidal anti-inflammatories
803691|NCT00239746|NSAIDS|nsaids
803692|NCT00239733|HIV|hiv
803693|NCT00239733|HCV|hcv
803694|NCT00239733|Hepatitis C|hepatitis c
803695|NCT00239733|Thrombocytopenia|thrombocytopenia
803696|NCT00239720|Psoriatic Arthritis|psoriatic arthritis
803697|NCT00239720|Arthritis|arthritis
803698|NCT00239720|Psoriasis|psoriasis
803699|NCT00239720|Psoriatic|psoriatic
803700|NCT00239720|PsA|psa
803701|NCT00239707|insulin sensitivity|insulin sensitivity
803702|NCT00239707|blood sugar|blood sugar
803703|NCT00239694|Immune response|immune response
803704|NCT00239694|Antibody response|antibody response
803705|NCT00239681|Primary prevention|primary prevention
803706|NCT00239681|Cardiovascular disease|cardiovascular disease
803707|NCT00239681|Statin therapy|statin therapy
803708|NCT00239681|C-reactive protein|c-reactive protein
803709|NCT00239668|Burns|burns
803710|NCT00239668|Functional|functional
803711|NCT00239668|Psychosocial|psychosocial
803712|NCT00239668|Recovery|recovery
803713|NCT00239668|Long-term|long-term
803714|NCT00239668|Pediatric|pediatric
803715|NCT00239668|Surgical|surgical
803716|NCT00239668|Outcomes|outcomes
803717|NCT00239668|Benchmarking|benchmarking
803718|NCT00239642|Iron|iron
803719|NCT00239642|Anemia|anemia
803720|NCT00239642|CKD|ckd
803721|NCT00239616|Anemia|anemia
803722|NCT00239616|Pharmacokinetics|pharmacokinetics
803723|NCT00239603|OV-Watch|ov-watch
803724|NCT00239603|fertility monitor|fertility monitor
803725|NCT00239603|ovulation induction|ovulation induction
803726|NCT00239603|clomiphene citrate|clomiphene citrate
803727|NCT00239603|anovulation|anovulation
803728|NCT00239603|infertility|infertility
803729|NCT00239577|Dengue infection|dengue infection
803730|NCT00239564|IPX054|ipx054
803731|NCT00239564|Parkinson disease|parkinson disease
803732|NCT00239564|Levodopa|levodopa
803733|NCT00239551|gastric stress ulcer|gastric stress ulcer
803735|NCT00239551|Prostaglandin|prostaglandin
803736|NCT00239525|Cerebrovascular Accident|cerebrovascular accident
803737|NCT00239525|Intracranial Hypertension|intracranial hypertension
803738|NCT00239512|PDA|pda
803739|NCT00239512|VLBW infants|vlbw infants
803740|NCT00239512|Indomethacin|indomethacin
803741|NCT00239512|Ibuprofen|ibuprofen
803742|NCT00239330|high blood cholesterol levels|high blood cholesterol levels
803743|NCT00239317|tamsulosin|tamsulosin
803744|NCT00239317|urinary tract diseases|urinary tract diseases
803745|NCT00239317|male|male
803746|NCT00239304|Stage III Head and Neck Cancer|stage iii head and neck cancer
803747|NCT00239304|Stage IV Head and Neck Cancer|stage iv head and neck cancer
803748|NCT00239265|tamsulosin|tamsulosin
803749|NCT00239265|urinary tract diseases|urinary tract diseases
803750|NCT00239265|female|female
803751|NCT00239252|Interferon alfacon-1|interferon alfacon-1
803752|NCT00239252|Virus disease|virus disease
803753|NCT00239252|Hepatitis C|hepatitis c
803754|NCT00239239|Non-myeloid malignancy|non-myeloid malignancy
803755|NCT00239239|Chemotherapy-induced anemia|chemotherapy-induced anemia
803756|NCT00239239|Oncology|oncology
803757|NCT00239239|Clinical Trials|clinical trials
803758|NCT00239239|Pharmacokinetics|pharmacokinetics
803759|NCT00239239|Darbepoetin alfa|darbepoetin alfa
803761|NCT00239239|Amgen|amgen
803762|NCT00239226|atrial fibrillation|atrial fibrillation
803763|NCT00239226|interatrial septum|interatrial septum
803764|NCT00239226|atrial pacing|atrial pacing
803765|NCT00239226|symptomatic sinus node dysfunction,|symptomatic sinus node dysfunction,
803854|NCT00238706|Randomized trial|randomized trial
803766|NCT00239226|pacemaker indication class I|pacemaker indication class i
803767|NCT00239213|catechins|catechins
803768|NCT00239213|gargling|gargling
803769|NCT00239213|healthy volunteers|healthy volunteers
803770|NCT00239187|Type 2 diabetes|type 2 diabetes
803771|NCT00239174|obesity|obesity
803772|NCT00239161|Pyelonephritis|pyelonephritis
803773|NCT00239148|Type 1 diabetes|type 1 diabetes
803774|NCT00239135|Actinic Keratosis|actinic keratosis
803775|NCT00239135|Topical|topical
803776|NCT00239135|Maximum Tolerated Dose|maximum tolerated dose
803777|NCT00239135|Solar Keratosis|solar keratosis
803778|NCT00239135|Sun Spots|sun spots
803779|NCT00239135|Dermatology|dermatology
803780|NCT00239122|Cognitive Therapy|cognitive therapy
803781|NCT00239122|Psychotic Disorders|psychotic disorders
803782|NCT00239122|Treatment Outcome|treatment outcome
803783|NCT00239096|alcoholic liver cirrhosis|alcoholic liver cirrhosis
803784|NCT00239096|ascites|ascites
803785|NCT00239096|sodium retention|sodium retention
803786|NCT00239083|MYFORMS, Kidney Transplantation, Enteric-Coated Mycophenolate Sodium (EC-MPS), Cyclosporine microemulsion (CsA-ME)|myforms, kidney transplantation, enteric-coated mycophenolate sodium (ec-mps), cyclosporine microemulsion (csa-me)
803787|NCT00239070|EC-MPS, renal transplantation, de novo patients|ec-mps, renal transplantation, de novo patients
803788|NCT00239057|Renal transplantation, EC-MPS|renal transplantation, ec-mps
803789|NCT00239044|Kidney transplant recipients; Enteric-coated Mycophenolate sodium (EC-MPS)|kidney transplant recipients; enteric-coated mycophenolate sodium (ec-mps)
803790|NCT00239031|Renal transplantation, EC-MPS|renal transplantation, ec-mps
803791|NCT00239018|Enteric-Coated Mycophenolate Sodium (EC-MPS), de novo, kidney transplantation, long-term safety.|enteric-coated mycophenolate sodium (ec-mps), de novo, kidney transplantation, long-term safety.
803792|NCT00239005|QoL|qol
803793|NCT00239005|GI Side Effects|gi side effects
803794|NCT00239005|MPA|mpa
803795|NCT00238992|Kidney, de novo transplant, steroid withdrawal, adults, EC-MPS and cyclosporine|kidney, de novo transplant, steroid withdrawal, adults, ec-mps and cyclosporine
803796|NCT00238979|Renal transplantation, Enteric-coated mycophenolate sodium|renal transplantation, enteric-coated mycophenolate sodium
803797|NCT00238966|Renal transplantation, Enteric-Coated Mycophenolate Sodium (EC-MPS)|renal transplantation, enteric-coated mycophenolate sodium (ec-mps)
803798|NCT00238953|Kidney transplantation|kidney transplantation
803799|NCT00238953|enteric-coated mycophenolate sodium|enteric-coated mycophenolate sodium
803800|NCT00238940|Renal transplantation, Enteric-Coated Mycophenolate Sodium (EC-MPS)|renal transplantation, enteric-coated mycophenolate sodium (ec-mps)
803801|NCT00238927|asthma|asthma
803802|NCT00238927|preschool|preschool
803803|NCT00238927|viral|viral
803804|NCT00238927|upper respiratory track infection|upper respiratory track infection
803805|NCT00238927|fluticasone|fluticasone
803806|NCT00238927|inhaled corticosteroids|inhaled corticosteroids
803807|NCT00238927|placebo|placebo
803808|NCT00238927|exacerbations|exacerbations
803809|NCT00238927|severity|severity
803810|NCT00238927|safety|safety
803811|NCT00238927|growth|growth
803812|NCT00238927|bone mineral density|bone mineral density
803813|NCT00238927|adrenal function|adrenal function
803814|NCT00238927|rescue beta2-agonists|rescue beta2-agonists
803815|NCT00238901|Liver transplant, HCV+, steroid free|liver transplant, hcv+, steroid free
803816|NCT00238888|asthma|asthma
803817|NCT00238888|children|children
803818|NCT00238888|adolescent|adolescent
803819|NCT00238888|education|education
803820|NCT00238888|medical review|medical review
803821|NCT00238888|asthma control|asthma control
803822|NCT00238888|questionnaire|questionnaire
803823|NCT00238888|quality of life|quality of life
803824|NCT00238888|emergency department visit|emergency department visit
803825|NCT00238888|use of medication|use of medication
803826|NCT00238888|adherence to treatment|adherence to treatment
803827|NCT00238875|stereotactic body radiation therapy|stereotactic body radiation therapy
803828|NCT00238875|T1N0M0 non-small cell lung cancer|t1n0m0 non-small cell lung cancer
803829|NCT00238875|radiotherapy|radiotherapy
803830|NCT00238862|Diabetes|diabetes
803831|NCT00238862|Corneal transplant|corneal transplant
803832|NCT00238862|Neurotrophic keratitis|neurotrophic keratitis
803833|NCT00238862|Post-bacterial keratitis|post-bacterial keratitis
803834|NCT00238862|Metaherpetic keratitis|metaherpetic keratitis
803835|NCT00238849|Non-small cell lung cancer|non-small cell lung cancer
803836|NCT00238823|cryoablation|cryoablation
803837|NCT00238823|radiofrequency ablation|radiofrequency ablation
803838|NCT00238823|pediatrics|pediatrics
803839|NCT00238823|cardiology|cardiology
803840|NCT00238810|BNP|bnp
803841|NCT00238810|Pediatrics|pediatrics
803842|NCT00238810|Congenital heart disease|congenital heart disease
803843|NCT00238810|b-type natriuretic peptide|b-type natriuretic peptide
803844|NCT00238797|Glioblastoma multiforme|glioblastoma multiforme
803845|NCT00238797|Brain tumour|brain tumour
803846|NCT00238758|Mood Disorder|mood disorder
803847|NCT00238745|Postmenopausal Osteoporosis|postmenopausal osteoporosis
803848|NCT00238732|Vaginal Atrophy|vaginal atrophy
803849|NCT00238732|Postmenopause|postmenopause
803850|NCT00238719|Social Anxiety|social anxiety
803851|NCT00238719|Children Disorders|children disorders
803852|NCT00238706|Radiofrequency catheter ablation|radiofrequency catheter ablation
803853|NCT00238706|Atrial fibrillation|atrial fibrillation
803855|NCT00238693|transplant|transplant
803856|NCT00238693|transplantation of liver, kidney, pancreas|transplantation of liver, kidney, pancreas
803857|NCT00238680|Overactive bladder|overactive bladder
803858|NCT00238680|Children|children
803859|NCT00238680|Bladder rehabilitation|bladder rehabilitation
803860|NCT00238667|Extracranial carotid artery dissection|extracranial carotid artery dissection
803861|NCT00238667|Dissection and stroke|dissection and stroke
803862|NCT00238550|Diabetes|diabetes
803863|NCT00238550|Pain|pain
803864|NCT00238550|Peripheral neuropathy|peripheral neuropathy
803865|NCT00238537|Stroke|stroke
803866|NCT00238537|Thrombolysis|thrombolysis
803868|NCT00238537|Echoplanar|echoplanar
803869|NCT00238537|Penumbra|penumbra
803870|NCT00238524|painful distal diabetic neuropathy|painful distal diabetic neuropathy
803871|NCT00238498|Type 2 diabetes|type 2 diabetes
803872|NCT00238498|vildagliptin|vildagliptin
803873|NCT00238498|HbA1c|hba1c
803874|NCT00238485|Bipolar I Disorder|bipolar i disorder
803875|NCT00238472|Type 2 diabetes|type 2 diabetes
803876|NCT00238472|nateglinide|nateglinide
803877|NCT00238459|Immunity to HIV|immunity to hiv
803878|NCT00238459|Acute Infection|acute infection
803879|NCT00238459|Treatment Naive|treatment naive
803880|NCT00238459|Treatment Interruption|treatment interruption
803881|NCT00238459|Structured Treatment Interruption|structured treatment interruption
803882|NCT00238459|STI|sti
803883|NCT00238446|Enteric-coated mycophenolate sodium, heart transplant recipients, long term safety|enteric-coated mycophenolate sodium, heart transplant recipients, long term safety
803884|NCT00238433|recurrent adult Hodgkin lymphoma|recurrent adult hodgkin lymphoma
803885|NCT00238433|recurrent adult diffuse small cleaved cell lymphoma|recurrent adult diffuse small cleaved cell lymphoma
803886|NCT00238433|stage III adult diffuse small cleaved cell lymphoma|stage iii adult diffuse small cleaved cell lymphoma
803887|NCT00238433|stage IV adult diffuse small cleaved cell lymphoma|stage iv adult diffuse small cleaved cell lymphoma
803888|NCT00238433|recurrent grade 3 follicular lymphoma|recurrent grade 3 follicular lymphoma
803889|NCT00238433|stage III grade 3 follicular lymphoma|stage iii grade 3 follicular lymphoma
803890|NCT00238433|stage IV grade 3 follicular lymphoma|stage iv grade 3 follicular lymphoma
803891|NCT00238433|recurrent adult diffuse mixed cell lymphoma|recurrent adult diffuse mixed cell lymphoma
803892|NCT00238433|stage III adult diffuse mixed cell lymphoma|stage iii adult diffuse mixed cell lymphoma
803893|NCT00238433|stage IV adult diffuse mixed cell lymphoma|stage iv adult diffuse mixed cell lymphoma
803894|NCT00238433|recurrent adult diffuse large cell lymphoma|recurrent adult diffuse large cell lymphoma
803895|NCT00238433|stage III adult diffuse large cell lymphoma|stage iii adult diffuse large cell lymphoma
803896|NCT00238433|stage IV adult diffuse large cell lymphoma|stage iv adult diffuse large cell lymphoma
803897|NCT00238433|recurrent adult immunoblastic large cell lymphoma|recurrent adult immunoblastic large cell lymphoma
803898|NCT00238433|stage III adult immunoblastic large cell lymphoma|stage iii adult immunoblastic large cell lymphoma
803899|NCT00238433|stage IV adult immunoblastic large cell lymphoma|stage iv adult immunoblastic large cell lymphoma
803900|NCT00238433|recurrent adult lymphoblastic lymphoma|recurrent adult lymphoblastic lymphoma
803901|NCT00238433|stage III adult lymphoblastic lymphoma|stage iii adult lymphoblastic lymphoma
803902|NCT00238433|stage IV adult lymphoblastic lymphoma|stage iv adult lymphoblastic lymphoma
803903|NCT00238433|recurrent adult Burkitt lymphoma|recurrent adult burkitt lymphoma
803904|NCT00238433|stage III adult Burkitt lymphoma|stage iii adult burkitt lymphoma
803905|NCT00238433|stage IV adult Burkitt lymphoma|stage iv adult burkitt lymphoma
803906|NCT00238433|recurrent mantle cell lymphoma|recurrent mantle cell lymphoma
803907|NCT00238433|stage III mantle cell lymphoma|stage iii mantle cell lymphoma
803908|NCT00238433|stage IV mantle cell lymphoma|stage iv mantle cell lymphoma
803909|NCT00238433|extranodal marginal zone B-cell lymphoma of mucosa-associated lymphoid tissue|extranodal marginal zone b-cell lymphoma of mucosa-associated lymphoid tissue
803910|NCT00238433|nodal marginal zone B-cell lymphoma|nodal marginal zone b-cell lymphoma
803911|NCT00238433|recurrent marginal zone lymphoma|recurrent marginal zone lymphoma
803912|NCT00238433|splenic marginal zone lymphoma|splenic marginal zone lymphoma
803913|NCT00238433|recurrent small lymphocytic lymphoma|recurrent small lymphocytic lymphoma
803914|NCT00238433|recurrent grade 1 follicular lymphoma|recurrent grade 1 follicular lymphoma
803915|NCT00238433|recurrent grade 2 follicular lymphoma|recurrent grade 2 follicular lymphoma
803916|NCT00238433|recurrent/refractory childhood Hodgkin lymphoma|recurrent/refractory childhood hodgkin lymphoma
803917|NCT00238433|stage III childhood Hodgkin lymphoma|stage iii childhood hodgkin lymphoma
803918|NCT00238433|stage IV childhood Hodgkin lymphoma|stage iv childhood hodgkin lymphoma
803919|NCT00238433|recurrent childhood anaplastic large cell lymphoma|recurrent childhood anaplastic large cell lymphoma
803920|NCT00238433|stage III childhood anaplastic large cell lymphoma|stage iii childhood anaplastic large cell lymphoma
803921|NCT00238433|stage IV childhood anaplastic large cell lymphoma|stage iv childhood anaplastic large cell lymphoma
803922|NCT00238433|childhood grade III lymphomatoid granulomatosis|childhood grade iii lymphomatoid granulomatosis
803923|NCT00238433|recurrent childhood large cell lymphoma|recurrent childhood large cell lymphoma
803924|NCT00238433|stage III childhood large cell lymphoma|stage iii childhood large cell lymphoma
803925|NCT00238433|stage IV childhood large cell lymphoma|stage iv childhood large cell lymphoma
803926|NCT00238433|recurrent childhood lymphoblastic lymphoma|recurrent childhood lymphoblastic lymphoma
803927|NCT00238433|stage III childhood lymphoblastic lymphoma|stage iii childhood lymphoblastic lymphoma
803928|NCT00238433|stage IV childhood lymphoblastic lymphoma|stage iv childhood lymphoblastic lymphoma
803929|NCT00238433|recurrent childhood small noncleaved cell lymphoma|recurrent childhood small noncleaved cell lymphoma
803930|NCT00238433|stage III childhood small noncleaved cell lymphoma|stage iii childhood small noncleaved cell lymphoma
803931|NCT00238433|stage IV childhood small noncleaved cell lymphoma|stage iv childhood small noncleaved cell lymphoma
803932|NCT00238433|recurrent cutaneous T-cell non-Hodgkin lymphoma|recurrent cutaneous t-cell non-hodgkin lymphoma
803933|NCT00238433|stage III cutaneous T-cell non-Hodgkin lymphoma|stage iii cutaneous t-cell non-hodgkin lymphoma
803934|NCT00238433|stage IV cutaneous T-cell non-Hodgkin lymphoma|stage iv cutaneous t-cell non-hodgkin lymphoma
803935|NCT00238407|adenocarcinoma of the esophagus|adenocarcinoma of the esophagus
803936|NCT00238407|squamous cell carcinoma of the esophagus|squamous cell carcinoma of the esophagus
803937|NCT00238407|stage III esophageal cancer|stage iii esophageal cancer
803938|NCT00238407|stage IV esophageal cancer|stage iv esophageal cancer
803939|NCT00238381|adenocarcinoma of the rectum|adenocarcinoma of the rectum
803940|NCT00238381|stage 0 rectal cancer|stage 0 rectal cancer
803941|NCT00238381|stage I rectal cancer|stage i rectal cancer
803942|NCT00238381|stage II rectal cancer|stage ii rectal cancer
803943|NCT00238381|stage III rectal cancer|stage iii rectal cancer
803944|NCT00238381|stage IV rectal cancer|stage iv rectal cancer
803945|NCT00238381|recurrent rectal cancer|recurrent rectal cancer
803946|NCT00238368|contiguous stage II adult diffuse large cell lymphoma|contiguous stage ii adult diffuse large cell lymphoma
803947|NCT00238368|noncontiguous stage II adult diffuse large cell lymphoma|noncontiguous stage ii adult diffuse large cell lymphoma
803948|NCT00238368|stage I adult diffuse large cell lymphoma|stage i adult diffuse large cell lymphoma
803949|NCT00238368|stage III adult diffuse large cell lymphoma|stage iii adult diffuse large cell lymphoma
803950|NCT00238368|stage IV adult diffuse large cell lymphoma|stage iv adult diffuse large cell lymphoma
803951|NCT00238368|contiguous stage II grade 3 follicular lymphoma|contiguous stage ii grade 3 follicular lymphoma
803952|NCT00238368|noncontiguous stage II grade 3 follicular lymphoma|noncontiguous stage ii grade 3 follicular lymphoma
803953|NCT00238368|stage I grade 3 follicular lymphoma|stage i grade 3 follicular lymphoma
803954|NCT00238368|stage III grade 3 follicular lymphoma|stage iii grade 3 follicular lymphoma
803955|NCT00238368|stage IV grade 3 follicular lymphoma|stage iv grade 3 follicular lymphoma
803956|NCT00238368|anaplastic large cell lymphoma|anaplastic large cell lymphoma
803957|NCT00238368|stage I adult T-cell leukemia/lymphoma|stage i adult t-cell leukemia/lymphoma
803958|NCT00238368|stage II adult T-cell leukemia/lymphoma|stage ii adult t-cell leukemia/lymphoma
803959|NCT00238368|stage III adult T-cell leukemia/lymphoma|stage iii adult t-cell leukemia/lymphoma
803960|NCT00238368|stage IV adult T-cell leukemia/lymphoma|stage iv adult t-cell leukemia/lymphoma
803961|NCT00238355|infection|infection
803962|NCT00238355|unspecified adult solid tumor, protocol specific|unspecified adult solid tumor, protocol specific
803963|NCT00238342|stage I ovarian epithelial cancer|stage i ovarian epithelial cancer
803964|NCT00238342|stage II ovarian epithelial cancer|stage ii ovarian epithelial cancer
803965|NCT00238342|stage III ovarian epithelial cancer|stage iii ovarian epithelial cancer
803966|NCT00238342|stage IV ovarian epithelial cancer|stage iv ovarian epithelial cancer
803967|NCT00238342|fallopian tube cancer|fallopian tube cancer
803968|NCT00238342|ovarian clear cell cystadenocarcinoma|ovarian clear cell cystadenocarcinoma
803969|NCT00238342|ovarian endometrioid adenocarcinoma|ovarian endometrioid adenocarcinoma
803970|NCT00238342|ovarian mucinous cystadenocarcinoma|ovarian mucinous cystadenocarcinoma
803971|NCT00238342|ovarian serous cystadenocarcinoma|ovarian serous cystadenocarcinoma
803972|NCT00238342|ovarian undifferentiated adenocarcinoma|ovarian undifferentiated adenocarcinoma
803973|NCT00238329|recurrent melanoma|recurrent melanoma
803974|NCT00238329|stage IV melanoma|stage iv melanoma
803975|NCT00238329|ciliary body and choroid melanoma, medium/large size|ciliary body and choroid melanoma, medium/large size
803976|NCT00238329|extraocular extension melanoma|extraocular extension melanoma
803977|NCT00238329|iris melanoma|iris melanoma
803978|NCT00238329|recurrent intraocular melanoma|recurrent intraocular melanoma
803979|NCT00238316|breast cancer|breast cancer
803980|NCT00238290|recurrent breast cancer|recurrent breast cancer
803981|NCT00238290|stage IIIA breast cancer|stage iiia breast cancer
803982|NCT00238290|stage IIIB breast cancer|stage iiib breast cancer
803983|NCT00238290|stage IIIC breast cancer|stage iiic breast cancer
803984|NCT00238290|stage IV breast cancer|stage iv breast cancer
803985|NCT00238277|adult glioblastoma|adult glioblastoma
803986|NCT00238277|adult giant cell glioblastoma|adult giant cell glioblastoma
803987|NCT00238277|adult gliosarcoma|adult gliosarcoma
803988|NCT00238264|childhood oligodendroglioma|childhood oligodendroglioma
803989|NCT00238264|recurrent childhood cerebellar astrocytoma|recurrent childhood cerebellar astrocytoma
803990|NCT00238264|recurrent childhood cerebral astrocytoma|recurrent childhood cerebral astrocytoma
803991|NCT00238264|childhood low-grade cerebral astrocytoma|childhood low-grade cerebral astrocytoma
803992|NCT00238264|recurrent childhood visual pathway and hypothalamic glioma|recurrent childhood visual pathway and hypothalamic glioma
803993|NCT00238264|untreated childhood cerebellar astrocytoma|untreated childhood cerebellar astrocytoma
803994|NCT00238264|untreated childhood visual pathway and hypothalamic glioma|untreated childhood visual pathway and hypothalamic glioma
803995|NCT00238251|stage IV non-small cell lung cancer|stage iv non-small cell lung cancer
803996|NCT00238251|recurrent non-small cell lung cancer|recurrent non-small cell lung cancer
804080|NCT00237783|Hypotension|hypotension
803997|NCT00238251|tumors metastatic to brain|tumors metastatic to brain
803998|NCT00238238|recurrent grade 1 follicular lymphoma|recurrent grade 1 follicular lymphoma
803999|NCT00238238|recurrent grade 2 follicular lymphoma|recurrent grade 2 follicular lymphoma
804000|NCT00238238|recurrent grade 3 follicular lymphoma|recurrent grade 3 follicular lymphoma
804001|NCT00238225|unspecified adult solid tumor, protocol specific|unspecified adult solid tumor, protocol specific
804002|NCT00238199|stage III pancreatic cancer|stage iii pancreatic cancer
804003|NCT00238199|stage IV pancreatic cancer|stage iv pancreatic cancer
804004|NCT00238173|drug/agent toxicity by tissue/organ|drug/agent toxicity by tissue/organ
804005|NCT00238173|bone marrow suppression|bone marrow suppression
804006|NCT00238173|long-term effects secondary to cancer therapy in children|long-term effects secondary to cancer therapy in children
804007|NCT00238173|recurrent childhood brain stem glioma|recurrent childhood brain stem glioma
804008|NCT00238173|untreated childhood brain stem glioma|untreated childhood brain stem glioma
804009|NCT00238173|childhood central nervous system germ cell tumor|childhood central nervous system germ cell tumor
804010|NCT00238173|recurrent childhood supratentorial primitive neuroectodermal tumor|recurrent childhood supratentorial primitive neuroectodermal tumor
804011|NCT00238173|recurrent childhood visual pathway and hypothalamic glioma|recurrent childhood visual pathway and hypothalamic glioma
804012|NCT00238173|recurrent childhood brain tumor|recurrent childhood brain tumor
804013|NCT00238173|recurrent childhood cerebellar astrocytoma|recurrent childhood cerebellar astrocytoma
804014|NCT00238173|childhood high-grade cerebral astrocytoma|childhood high-grade cerebral astrocytoma
804015|NCT00238173|childhood low-grade cerebral astrocytoma|childhood low-grade cerebral astrocytoma
804016|NCT00238173|recurrent childhood cerebral astrocytoma|recurrent childhood cerebral astrocytoma
804017|NCT00238173|recurrent childhood medulloblastoma|recurrent childhood medulloblastoma
804018|NCT00238173|childhood oligodendroglioma|childhood oligodendroglioma
804019|NCT00238173|childhood infratentorial ependymoma|childhood infratentorial ependymoma
804020|NCT00238173|childhood supratentorial ependymoma|childhood supratentorial ependymoma
804021|NCT00238173|recurrent childhood ependymoma|recurrent childhood ependymoma
804022|NCT00238173|childhood central nervous system choriocarcinoma|childhood central nervous system choriocarcinoma
804023|NCT00238173|childhood central nervous system embryonal tumor|childhood central nervous system embryonal tumor
804024|NCT00238173|childhood central nervous system germinoma|childhood central nervous system germinoma
804025|NCT00238173|childhood central nervous system mixed germ cell tumor|childhood central nervous system mixed germ cell tumor
804026|NCT00238173|childhood central nervous system teratoma|childhood central nervous system teratoma
804027|NCT00238173|childhood central nervous system yolk sac tumor|childhood central nervous system yolk sac tumor
804028|NCT00238173|recurrent childhood central nervous system embryonal tumor|recurrent childhood central nervous system embryonal tumor
804029|NCT00238147|stage II esophageal cancer|stage ii esophageal cancer
804030|NCT00238147|stage III esophageal cancer|stage iii esophageal cancer
804031|NCT00238108|Sleep disorders|sleep disorders
804032|NCT00238108|High blood pressure|high blood pressure
804033|NCT00238082|COPD|copd
804034|NCT00238082|Chronic Obstructive Pulmonary Disease|chronic obstructive pulmonary disease
804035|NCT00238082|Emphysema|emphysema
804036|NCT00238082|Chronic Bronchitis|chronic bronchitis
804037|NCT00238069|Asthma|asthma
804038|NCT00238069|Sleep Apnea|sleep apnea
804039|NCT00238069|Obesity|obesity
804040|NCT00238069|CPAP|cpap
804041|NCT00238056|Domperidone, QT, prematurity|domperidone, qt, prematurity
804042|NCT00238043|Biogeneric Epoetin treatment|biogeneric epoetin treatment
804043|NCT00238043|Renal anaemia|renal anaemia
804044|NCT00238043|Chronic Kidney Disease|chronic kidney disease
804045|NCT00238043|Pure Red Blood Cell Aplasia|pure red blood cell aplasia
804046|NCT00238043|Hemodialysis|hemodialysis
804047|NCT00238030|organ donation|organ donation
804048|NCT00238030|thyroid replacement|thyroid replacement
804049|NCT00238017|malaria, amodiaquine, artesunate, safety, efficacy|malaria, amodiaquine, artesunate, safety, efficacy
804050|NCT00238004|Niacin|niacin
804051|NCT00237965|Skin Self Examination|skin self examination
804052|NCT00237965|Mole Mapping Diagram|mole mapping diagram
804053|NCT00237965|Melanoma|melanoma
804054|NCT00237926|Sleep|sleep
804055|NCT00237926|Fatigue|fatigue
804056|NCT00237926|Exercise tolerance|exercise tolerance
804057|NCT00237926|Quality of life|quality of life
804058|NCT00237926|Health status|health status
804059|NCT00237887|Psoriasis|psoriasis
804060|NCT00237887|adalimumab|adalimumab
804061|NCT00237874|prodrome|prodrome
804062|NCT00237874|ultra high risk|ultra high risk
804063|NCT00237874|aripiprazole|aripiprazole
804064|NCT00237822|Treatment Adherence|treatment adherence
804065|NCT00237822|Co-Occurring Disorders|co-occurring disorders
804066|NCT00237822|Motivational Enhancement Therapy|motivational enhancement therapy
804067|NCT00237822|Contingency Management|contingency management
804068|NCT00237822|MEMS Caps|mems caps
804069|NCT00237796|Behavioral|behavioral
804070|NCT00237796|Cognitive|cognitive
804071|NCT00237796|Functioning|functioning
804072|NCT00237796|Older|older
804074|NCT00237796|Rehabilitation|rehabilitation
804075|NCT00237796|Schizophrenia|schizophrenia
804076|NCT00237796|Skills|skills
804077|NCT00237796|Social|social
804078|NCT00237796|Training|training
804079|NCT00237783|Renal dialysis|renal dialysis
804081|NCT00237783|Dialysis solutions|dialysis solutions
804082|NCT00237770|Blood Pressure|blood pressure
804083|NCT00237770|Cardiovascular Autonomic Control|cardiovascular autonomic control
804084|NCT00237770|Nitric Oxide|nitric oxide
804085|NCT00237770|NOS Inhibitor|nos inhibitor
804086|NCT00237770|Orthostatic Hypotension|orthostatic hypotension
804087|NCT00237770|Spinal Cord Injury|spinal cord injury
804088|NCT00237770|Tetraplegia|tetraplegia
804089|NCT00237757|Patient Care Team|patient care team
804090|NCT00237757|Rehabilitation outcomes|rehabilitation outcomes
804091|NCT00237757|Treatment outcomes|treatment outcomes
804092|NCT00237744|Motor Learning|motor learning
804093|NCT00237744|Rehabilitation|rehabilitation
804094|NCT00237744|Robotics|robotics
804095|NCT00237744|Therapeutic Electric Stimulation|therapeutic electric stimulation
804096|NCT00237731|Acute pain|acute pain
804097|NCT00237731|Morphine titration|morphine titration
804098|NCT00237731|Analgesia|analgesia
804099|NCT00237731|Pre-hospital care|pre-hospital care
804100|NCT00237705|Headache|headache
804101|NCT00237705|Concussion|concussion
804102|NCT00237705|Post concussive syndrome|post concussive syndrome
804103|NCT00237705|Head trauma|head trauma
804104|NCT00237692|Telemedicine|telemedicine
804105|NCT00237692|Adherence|adherence
804106|NCT00237692|Tailored Nurse Intervention|tailored nurse intervention
804107|NCT00237692|Home Blood Pressure Monitoring|home blood pressure monitoring
804108|NCT00237692|cardiovascular disease|cardiovascular disease
804109|NCT00237679|behavior therapy|behavior therapy
804110|NCT00237679|combination therapy|combination therapy
804111|NCT00237679|gastrointestinal disorder chemotherapy|gastrointestinal disorder chemotherapy
804112|NCT00237679|human therapy evaluation|human therapy evaluation
804113|NCT00237679|larynx disorder|larynx disorder
804114|NCT00237679|middle childhood (6-11)|middle childhood (6-11)
804115|NCT00237679|lansoprazole|lansoprazole
804116|NCT00237679|reflux esophagitis|reflux esophagitis
804117|NCT00237679|quality of life|quality of life
804118|NCT00237679|clinical research|clinical research
804119|NCT00237679|human subject|human subject
804120|NCT00237679|laryngoscopy|laryngoscopy
804121|NCT00237679|patient oriented research|patient oriented research
804122|NCT00237679|questionnaire|questionnaire
804123|NCT00237666|Bipolar II Disorder|bipolar ii disorder
804124|NCT00237666|Major Depressive Episode|major depressive episode
804125|NCT00237653|Valganciclovir|valganciclovir
804126|NCT00237653|Cytomegalovirus|cytomegalovirus
804127|NCT00237653|Cryptogenic inflammatory bowel diseases|cryptogenic inflammatory bowel diseases
804128|NCT00237653|Crohn Disease|crohn disease
804129|NCT00237653|colitis, ulcerative|colitis, ulcerative
804130|NCT00237640|Cinnamon|cinnamon
804131|NCT00237640|Diabetes mellitus|diabetes mellitus
804132|NCT00237640|Hyperlipidemia|hyperlipidemia
804133|NCT00237640|Insulin Resistance|insulin resistance
804134|NCT00237627|stage IIIA breast cancer|stage iiia breast cancer
804135|NCT00237627|stage IIIB breast cancer|stage iiib breast cancer
804136|NCT00237627|stage IIIC breast cancer|stage iiic breast cancer
804137|NCT00237627|stage IV breast cancer|stage iv breast cancer
804138|NCT00237627|male breast cancer|male breast cancer
804139|NCT00237627|recurrent ovarian epithelial cancer|recurrent ovarian epithelial cancer
804140|NCT00237627|stage III ovarian epithelial cancer|stage iii ovarian epithelial cancer
804141|NCT00237627|stage IV ovarian epithelial cancer|stage iv ovarian epithelial cancer
804142|NCT00237627|recurrent adult acute lymphoblastic leukemia|recurrent adult acute lymphoblastic leukemia
804143|NCT00237627|recurrent adult acute myeloid leukemia|recurrent adult acute myeloid leukemia
804295|NCT00237393|PTSD|ptsd
804144|NCT00237627|adult acute myeloid leukemia with 11q23 (MLL) abnormalities|adult acute myeloid leukemia with 11q23 (mll) abnormalities
804145|NCT00237627|adult acute myeloid leukemia with inv(16)(p13;q22)|adult acute myeloid leukemia with inv(16)(p13;q22)
804146|NCT00237627|adult acute myeloid leukemia with t(15;17)(q22;q12)|adult acute myeloid leukemia with t(15;17)(q22;q12)
804147|NCT00237627|adult acute myeloid leukemia with t(16;16)(p13;q22)|adult acute myeloid leukemia with t(16;16)(p13;q22)
804148|NCT00237627|adult acute myeloid leukemia with t(8;21)(q22;q22)|adult acute myeloid leukemia with t(8;21)(q22;q22)
804149|NCT00237627|secondary acute myeloid leukemia|secondary acute myeloid leukemia
804150|NCT00237627|mast cell leukemia|mast cell leukemia
804151|NCT00237627|stage III chronic lymphocytic leukemia|stage iii chronic lymphocytic leukemia
804152|NCT00237627|stage IV chronic lymphocytic leukemia|stage iv chronic lymphocytic leukemia
804153|NCT00237627|refractory chronic lymphocytic leukemia|refractory chronic lymphocytic leukemia
804154|NCT00237627|T-cell large granular lymphocyte leukemia|t-cell large granular lymphocyte leukemia
804155|NCT00237627|atypical chronic myeloid leukemia|atypical chronic myeloid leukemia
804156|NCT00237627|accelerated phase chronic myelogenous leukemia|accelerated phase chronic myelogenous leukemia
804157|NCT00237627|blastic phase chronic myelogenous leukemia|blastic phase chronic myelogenous leukemia
804158|NCT00237627|chronic phase chronic myelogenous leukemia|chronic phase chronic myelogenous leukemia
804159|NCT00237627|meningeal chronic myelogenous leukemia|meningeal chronic myelogenous leukemia
804160|NCT00237627|relapsing chronic myelogenous leukemia|relapsing chronic myelogenous leukemia
804161|NCT00237627|chronic myelomonocytic leukemia|chronic myelomonocytic leukemia
804162|NCT00237627|refractory hairy cell leukemia|refractory hairy cell leukemia
804163|NCT00237627|progressive hairy cell leukemia, initial treatment|progressive hairy cell leukemia, initial treatment
804164|NCT00237627|stage III adult T-cell leukemia/lymphoma|stage iii adult t-cell leukemia/lymphoma
804165|NCT00237627|stage IV adult T-cell leukemia/lymphoma|stage iv adult t-cell leukemia/lymphoma
804166|NCT00237627|recurrent adult T-cell leukemia/lymphoma|recurrent adult t-cell leukemia/lymphoma
804167|NCT00237627|stage III adult Hodgkin lymphoma|stage iii adult hodgkin lymphoma
804168|NCT00237627|stage IV adult Hodgkin lymphoma|stage iv adult hodgkin lymphoma
804169|NCT00237627|recurrent adult Hodgkin lymphoma|recurrent adult hodgkin lymphoma
804170|NCT00237627|anaplastic large cell lymphoma|anaplastic large cell lymphoma
804171|NCT00237627|angioimmunoblastic T-cell lymphoma|angioimmunoblastic t-cell lymphoma
804172|NCT00237627|stage III cutaneous T-cell non-Hodgkin lymphoma|stage iii cutaneous t-cell non-hodgkin lymphoma
804173|NCT00237627|stage IV cutaneous T-cell non-Hodgkin lymphoma|stage iv cutaneous t-cell non-hodgkin lymphoma
804174|NCT00237627|stage III mycosis fungoides/Sezary syndrome|stage iii mycosis fungoides/sezary syndrome
804175|NCT00237627|stage IV mycosis fungoides/Sezary syndrome|stage iv mycosis fungoides/sezary syndrome
804176|NCT00237627|recurrent cutaneous T-cell non-Hodgkin lymphoma|recurrent cutaneous t-cell non-hodgkin lymphoma
804177|NCT00237627|recurrent mycosis fungoides/Sezary syndrome|recurrent mycosis fungoides/sezary syndrome
804178|NCT00237627|adult grade III lymphomatoid granulomatosis|adult grade iii lymphomatoid granulomatosis
804179|NCT00237627|adult nasal type extranodal NK/T-cell lymphoma|adult nasal type extranodal nk/t-cell lymphoma
804180|NCT00237627|Waldenstrom macroglobulinemia|waldenstrom macroglobulinemia
804181|NCT00237627|extranodal marginal zone B-cell lymphoma of mucosa-associated lymphoid tissue|extranodal marginal zone b-cell lymphoma of mucosa-associated lymphoid tissue
804182|NCT00237627|splenic marginal zone lymphoma|splenic marginal zone lymphoma
804183|NCT00237627|stage III adult Burkitt lymphoma|stage iii adult burkitt lymphoma
804184|NCT00237627|stage III adult diffuse large cell lymphoma|stage iii adult diffuse large cell lymphoma
804185|NCT00237627|stage III adult diffuse mixed cell lymphoma|stage iii adult diffuse mixed cell lymphoma
804186|NCT00237627|stage III adult diffuse small cleaved cell lymphoma|stage iii adult diffuse small cleaved cell lymphoma
804187|NCT00237627|stage III adult immunoblastic large cell lymphoma|stage iii adult immunoblastic large cell lymphoma
804188|NCT00237627|stage III adult lymphoblastic lymphoma|stage iii adult lymphoblastic lymphoma
804189|NCT00237627|stage III grade 1 follicular lymphoma|stage iii grade 1 follicular lymphoma
804190|NCT00237627|stage III grade 2 follicular lymphoma|stage iii grade 2 follicular lymphoma
804191|NCT00237627|stage III grade 3 follicular lymphoma|stage iii grade 3 follicular lymphoma
804192|NCT00237627|stage III mantle cell lymphoma|stage iii mantle cell lymphoma
804193|NCT00237627|stage III marginal zone lymphoma|stage iii marginal zone lymphoma
804194|NCT00237627|stage III small lymphocytic lymphoma|stage iii small lymphocytic lymphoma
804195|NCT00237627|stage IV adult Burkitt lymphoma|stage iv adult burkitt lymphoma
804196|NCT00237627|stage IV adult diffuse large cell lymphoma|stage iv adult diffuse large cell lymphoma
804197|NCT00237627|stage IV adult diffuse mixed cell lymphoma|stage iv adult diffuse mixed cell lymphoma
804198|NCT00237627|stage IV adult diffuse small cleaved cell lymphoma|stage iv adult diffuse small cleaved cell lymphoma
804199|NCT00237627|stage IV adult immunoblastic large cell lymphoma|stage iv adult immunoblastic large cell lymphoma
804200|NCT00237627|stage IV adult lymphoblastic lymphoma|stage iv adult lymphoblastic lymphoma
804201|NCT00237627|stage IV grade 1 follicular lymphoma|stage iv grade 1 follicular lymphoma
804202|NCT00237627|stage IV grade 2 follicular lymphoma|stage iv grade 2 follicular lymphoma
804203|NCT00237627|stage IV grade 3 follicular lymphoma|stage iv grade 3 follicular lymphoma
804204|NCT00237627|stage IV mantle cell lymphoma|stage iv mantle cell lymphoma
804205|NCT00237627|stage IV marginal zone lymphoma|stage iv marginal zone lymphoma
804206|NCT00237627|stage IV small lymphocytic lymphoma|stage iv small lymphocytic lymphoma
804397|NCT00236964|Chronic Kidney Disease|chronic kidney disease
804207|NCT00237627|recurrent adult Burkitt lymphoma|recurrent adult burkitt lymphoma
804208|NCT00237627|recurrent adult diffuse large cell lymphoma|recurrent adult diffuse large cell lymphoma
804209|NCT00237627|recurrent adult diffuse mixed cell lymphoma|recurrent adult diffuse mixed cell lymphoma
804210|NCT00237627|recurrent adult diffuse small cleaved cell lymphoma|recurrent adult diffuse small cleaved cell lymphoma
804211|NCT00237627|recurrent adult grade III lymphomatoid granulomatosis|recurrent adult grade iii lymphomatoid granulomatosis
804212|NCT00237627|recurrent adult immunoblastic large cell lymphoma|recurrent adult immunoblastic large cell lymphoma
804213|NCT00237627|recurrent adult lymphoblastic lymphoma|recurrent adult lymphoblastic lymphoma
804214|NCT00237627|recurrent grade 1 follicular lymphoma|recurrent grade 1 follicular lymphoma
804215|NCT00237627|recurrent grade 2 follicular lymphoma|recurrent grade 2 follicular lymphoma
804216|NCT00237627|recurrent grade 3 follicular lymphoma|recurrent grade 3 follicular lymphoma
804217|NCT00237627|recurrent mantle cell lymphoma|recurrent mantle cell lymphoma
804218|NCT00237627|recurrent marginal zone lymphoma|recurrent marginal zone lymphoma
804219|NCT00237627|recurrent small lymphocytic lymphoma|recurrent small lymphocytic lymphoma
804220|NCT00237627|intraocular lymphoma|intraocular lymphoma
804221|NCT00237627|primary central nervous system lymphoma|primary central nervous system lymphoma
804222|NCT00237627|stage III multiple myeloma|stage iii multiple myeloma
804223|NCT00237627|stage II multiple myeloma|stage ii multiple myeloma
804224|NCT00237627|refractory multiple myeloma|refractory multiple myeloma
804225|NCT00237627|cutaneous B-cell non-Hodgkin lymphoma|cutaneous b-cell non-hodgkin lymphoma
804226|NCT00237627|recurrent ovarian germ cell tumor|recurrent ovarian germ cell tumor
804227|NCT00237627|stage III ovarian germ cell tumor|stage iii ovarian germ cell tumor
804228|NCT00237627|stage IV ovarian germ cell tumor|stage iv ovarian germ cell tumor
804229|NCT00237627|unspecified adult solid tumor, protocol specific|unspecified adult solid tumor, protocol specific
804230|NCT00237627|recurrent breast cancer|recurrent breast cancer
804231|NCT00237627|nodal marginal zone B-cell lymphoma|nodal marginal zone b-cell lymphoma
804232|NCT00237614|Contrast-induced nephropathy|contrast-induced nephropathy
804233|NCT00237614|Acute myocardial infarction|acute myocardial infarction
804234|NCT00237614|Primary coronary angioplasty|primary coronary angioplasty
804235|NCT00237601|Home birth|home birth
804236|NCT00237601|Hospital birth|hospital birth
804237|NCT00237601|Midwifery|midwifery
804238|NCT00237601|Effectivity|effectivity
804239|NCT00237601|Efficiency|efficiency
804240|NCT00237588|Angiotensin II Type I Receptor Blockers|angiotensin ii type i receptor blockers
804241|NCT00237588|Amlodipine|amlodipine
804242|NCT00237588|Calcium Channel Blockers|calcium channel blockers
804243|NCT00237588|Diabetes Mellitus|diabetes mellitus
804244|NCT00237588|Hypertension|hypertension
804245|NCT00237588|Insulin Resistance|insulin resistance
804246|NCT00237588|Losartan|losartan
804247|NCT00237575|urothelial|urothelial
804248|NCT00237575|bladder|bladder
804249|NCT00237575|gemcitabine|gemcitabine
804250|NCT00237575|cisplatin|cisplatin
804251|NCT00237575|leukine|leukine
804252|NCT00237575|neupogen|neupogen
804253|NCT00237575|filgrastim|filgrastim
804254|NCT00237575|sargramostim|sargramostim
804255|NCT00237575|metastatic|metastatic
804256|NCT00237575|Regionally Advanced|regionally advanced
804257|NCT00237575|Advanced|advanced
804258|NCT00237549|Type 2 diabetes|type 2 diabetes
804259|NCT00237549|Screening|screening
804260|NCT00237549|Intensive treatment|intensive treatment
804261|NCT00237549|Polypharmacy|polypharmacy
804262|NCT00237549|Primary care|primary care
804263|NCT00237536|Benign Prostatic Hyperplasia|benign prostatic hyperplasia
804264|NCT00237536|BPH|bph
804265|NCT00237536|Enlarged Prostate|enlarged prostate
804266|NCT00237523|Breast pain|breast pain
804267|NCT00237523|Mastalgia|mastalgia
804268|NCT00237523|Cyclic mastalgia|cyclic mastalgia
804269|NCT00237523|Periodic mastalgia|periodic mastalgia
804270|NCT00237523|Non-cyclic mastalgia|non-cyclic mastalgia
804271|NCT00237523|Fibrosis|fibrosis
804272|NCT00237523|Nodularity|nodularity
804273|NCT00237523|Cysts|cysts
804274|NCT00237523|Fibrocystic breast disease|fibrocystic breast disease
804275|NCT00237523|Fibrocystic breast condition|fibrocystic breast condition
804276|NCT00237523|Fibocystic breast syndrome|fibocystic breast syndrome
804277|NCT00237510|Antidepressant induced excessive sweating|antidepressant induced excessive sweating
804278|NCT00237497|Insomnia|insomnia
804279|NCT00237497|Center of Pressure|center of pressure
804280|NCT00237497|Postural Sway|postural sway
804281|NCT00237497|Drug Therapy|drug therapy
804282|NCT00237497|Balance and Stability|balance and stability
804283|NCT00237484|pegylated interferon alfa-2b|pegylated interferon alfa-2b
804284|NCT00237484|ribavirin|ribavirin
804285|NCT00237484|infliximab|infliximab
804286|NCT00237484|chronic hepatitis C|chronic hepatitis c
804287|NCT00237471|Acute Myocardial Infarction|acute myocardial infarction
804288|NCT00237471|Hyperglycaemia|hyperglycaemia
804289|NCT00237471|Insulin Infusion|insulin infusion
804290|NCT00237419|Ankylosing spondylitis|ankylosing spondylitis
804291|NCT00237419|Long-term therapy with infliximab|long-term therapy with infliximab
804292|NCT00237419|Radiographic progression|radiographic progression
804293|NCT00237406|IVR, methadone|ivr, methadone
804294|NCT00237406|methadone maintenance|methadone maintenance
804296|NCT00237393|Posttraumatic stress disorder|posttraumatic stress disorder
804297|NCT00237393|Treatment|treatment
804298|NCT00237393|Quetiapine|quetiapine
804299|NCT00237380|Cystic fibrosis|cystic fibrosis
804300|NCT00237380|Nonsense mutation|nonsense mutation
804301|NCT00237380|Premature stop codon|premature stop codon
804302|NCT00237367|Gastroesophageal Reflux|gastroesophageal reflux
804303|NCT00237367|GERD|gerd
804304|NCT00237367|Nighttime heartburn|nighttime heartburn
804305|NCT00237367|heartburn|heartburn
804306|NCT00237367|esophagus|esophagus
804307|NCT00237367|esophageal acid exposure|esophageal acid exposure
804308|NCT00237367|EAE|eae
804309|NCT00237367|Aciphex|aciphex
804310|NCT00237367|Pariet|pariet
804311|NCT00237367|rabeprazole|rabeprazole
804312|NCT00237367|Protonix|protonix
804313|NCT00237367|pantoprazole|pantoprazole
804314|NCT00237354|Recurrent soft tissue breast carcinoma|recurrent soft tissue breast carcinoma
804315|NCT00237341|chronic low back pain|chronic low back pain
804316|NCT00237341|opioid|opioid
804317|NCT00237341|fentanyl|fentanyl
804318|NCT00237328|Heparin resistance|heparin resistance
804319|NCT00237328|Blood clotting|blood clotting
804320|NCT00237328|Heart surgery|heart surgery
804321|NCT00237328|Cardiopulmonary bypass|cardiopulmonary bypass
804322|NCT00237315|Urea|urea
804323|NCT00237315|Inherited metabolic disorders|inherited metabolic disorders
804324|NCT00237302|pediatric migraine|pediatric migraine
804325|NCT00237302|migraine headache|migraine headache
804326|NCT00237302|migraine prophylaxis|migraine prophylaxis
804327|NCT00237302|migraine prevention|migraine prevention
804328|NCT00237302|migraine|migraine
804329|NCT00237289|Manic depression|manic depression
804331|NCT00237289|Depression|depression
804332|NCT00237289|Bipolar disorder|bipolar disorder
804333|NCT00237289|Psychosis|psychosis
804334|NCT00237276|colonoscopy, chromoendoscopy, autoflurescence, narrow band imaging, high definition endoscopy, colorectal cancer, colitis, polyp, DALM, adenoma, video|colonoscopy, chromoendoscopy, autoflurescence, narrow band imaging, high definition endoscopy, colorectal cancer, colitis, polyp, dalm, adenoma, video
804335|NCT00237263|Parkinson's disease, end-of -dose wearing-off, entacapone|parkinson's disease, end-of -dose wearing-off, entacapone
804336|NCT00237250|Pre-diabetes|pre-diabetes
804337|NCT00237250|vildagliptin|vildagliptin
804338|NCT00237250|IGT|igt
804339|NCT00237237|Type 2 diabetes|type 2 diabetes
804340|NCT00237237|vildagliptin|vildagliptin
804341|NCT00237224|Breast Cancer, ER and/or PgR positive, Letrozole|breast cancer, er and/or pgr positive, letrozole
804342|NCT00237211|Aromatase inhibitor|aromatase inhibitor
804343|NCT00237211|letrozole|letrozole
804344|NCT00237211|breast cancer|breast cancer
804345|NCT00237198|Aromatase inhibitor|aromatase inhibitor
804346|NCT00237198|letrozole|letrozole
804347|NCT00237198|breast cancer|breast cancer
804348|NCT00237185|GIST|gist
804349|NCT00237185|c-kit|c-kit
804350|NCT00237185|imatinib mesylate|imatinib mesylate
804351|NCT00237172|GIST|gist
804352|NCT00237172|Imatinib|imatinib
804353|NCT00237172|STI571|sti571
804354|NCT00237172|Gastrointestinal Stromal Tumors|gastrointestinal stromal tumors
804355|NCT00237159|Prostate cancer|prostate cancer
804356|NCT00237159|Bone metastasis|bone metastasis
804357|NCT00237159|Skeletal related event|skeletal related event
804358|NCT00237146|Prostate cancer|prostate cancer
804359|NCT00237146|Zoledronic acid|zoledronic acid
804360|NCT00237146|Bone metastasis|bone metastasis
804361|NCT00237133|Breast cancer,|breast cancer,
804362|NCT00237133|Letrozole,|letrozole,
804363|NCT00237133|Hormonal receptors|hormonal receptors
804364|NCT00237120|Chronic Myelogenous Leukemia|chronic myelogenous leukemia
804365|NCT00237120|Imatinib|imatinib
804366|NCT00237120|CML|cml
804367|NCT00237107|Cytoreduction Surgical Procedures|cytoreduction surgical procedures
804368|NCT00237107|Curretage|curretage
804369|NCT00237107|Photochemotherapy|photochemotherapy
804370|NCT00237094|Diabetes|diabetes
804371|NCT00237094|Self Management|self management
804372|NCT00237094|Interdisciplinary team|interdisciplinary team
804373|NCT00237081|Interstitial Cystitis|interstitial cystitis
804374|NCT00237081|Painful Bladder Syndrome|painful bladder syndrome
804375|NCT00237081|Genetics|genetics
804376|NCT00237081|Risk factors|risk factors
804377|NCT00237081|Family history|family history
804378|NCT00237068|Gastroesophageal Reflux|gastroesophageal reflux
804379|NCT00237055|Children|children
804380|NCT00237055|Crohn's disease|crohn's disease
804381|NCT00237055|Inflammatory bowel disease|inflammatory bowel disease
804382|NCT00237055|Infectious agents|infectious agents
804383|NCT00237055|Colonoscopy|colonoscopy
804384|NCT00237042|Temporomandibular Disorders|temporomandibular disorders
804385|NCT00237042|TMJ Disorders|tmj disorders
804386|NCT00237003|women|women
804387|NCT00237003|incarceration|incarceration
804388|NCT00237003|alcohol use|alcohol use
804389|NCT00237003|motivational interviewing|motivational interviewing
804390|NCT00236990|prostatitis|prostatitis
804391|NCT00236990|Elmiron|elmiron
804392|NCT00236990|pentosan polysulfate sodium|pentosan polysulfate sodium
804393|NCT00236977|CKD|ckd
804394|NCT00236977|iron|iron
804395|NCT00236977|anemia|anemia
804396|NCT00236964|Anemia|anemia
804400|NCT00236951|Chemotherapy|chemotherapy
804401|NCT00236938|iron|iron
804402|NCT00236938|peritoneal dialysis|peritoneal dialysis
804403|NCT00236938|anemia|anemia
804404|NCT00236925|Fibromyalgia|fibromyalgia
804405|NCT00236925|Cortisol|cortisol
804406|NCT00236925|Hydrocortisone|hydrocortisone
804407|NCT00236925|Stress|stress
804408|NCT00236912|complicated appendicitis|complicated appendicitis
804409|NCT00236912|antibiotics|antibiotics
804410|NCT00236912|appendicitis|appendicitis
804411|NCT00236912|infection|infection
804412|NCT00236886|Epilepsy|epilepsy
804413|NCT00236886|Partial Epilepsy|partial epilepsy
804414|NCT00236886|Secondary Generalized Epilepsy|secondary generalized epilepsy
804415|NCT00236886|Primary Generalized Epilepsy|primary generalized epilepsy
804416|NCT00236886|Tonic-Clonic Seizures|tonic-clonic seizures
804417|NCT00236886|Topiramate|topiramate
804418|NCT00236886|Weight Loss|weight loss
804419|NCT00236873|topiramate|topiramate
804420|NCT00236873|epilepsy|epilepsy
804421|NCT00236873|partial epilepsies|partial epilepsies
804422|NCT00236873|partial epilepsy|partial epilepsy
804423|NCT00236873|seizures|seizures
804424|NCT00236873|epileptic seizures|epileptic seizures
804425|NCT00236873|partial seizure disorder|partial seizure disorder
804426|NCT00236873|brain diseases|brain diseases
804427|NCT00236860|partial seizure disorder|partial seizure disorder
804428|NCT00236860|brain diseases|brain diseases
804431|NCT00236860|partial epilepsies|partial epilepsies
804432|NCT00236860|partial epilepsy|partial epilepsy
804433|NCT00236860|seizures|seizures
804434|NCT00236860|epileptic seizures|epileptic seizures
804435|NCT00236847|topiramate|topiramate
804436|NCT00236847|epilepsy|epilepsy
804437|NCT00236847|partial epilepsy|partial epilepsy
804438|NCT00236847|seizures|seizures
804439|NCT00236847|epileptic seizures|epileptic seizures
804440|NCT00236847|partial seizure disorder|partial seizure disorder
804441|NCT00236847|brain diseases|brain diseases
804442|NCT00236834|respiratory tract diseases|respiratory tract diseases
804443|NCT00236834|levofloxacin|levofloxacin
804444|NCT00236834|pneumonia|pneumonia
804445|NCT00236834|quinolones, hospital-acquired pneumonia|quinolones, hospital-acquired pneumonia
804446|NCT00236834|lung diseases|lung diseases
804447|NCT00236821|respiratory tract diseases|respiratory tract diseases
804448|NCT00236821|pneumonia|pneumonia
804449|NCT00236821|levofloxacin|levofloxacin
804450|NCT00236821|community-acquired pneumonia|community-acquired pneumonia
804451|NCT00236821|lung diseases|lung diseases
804452|NCT00236821|quinolones|quinolones
804453|NCT00236808|quinolones, ciprofloxacin|quinolones, ciprofloxacin
804454|NCT00236808|levofloxacin|levofloxacin
804455|NCT00236808|chronic bacterial prostatitis|chronic bacterial prostatitis
804456|NCT00236808|inflammation|inflammation
804457|NCT00236808|chronic prostatitis|chronic prostatitis
804458|NCT00236808|prostatitis|prostatitis
804459|NCT00236808|prostate|prostate
804460|NCT00236808|antibiotic|antibiotic
804461|NCT00236795|contraception|contraception
804462|NCT00236795|hormonal contraception|hormonal contraception
804463|NCT00236795|oral contraception|oral contraception
804464|NCT00236795|steroid, ethinyl estradiol, horgestimate, levonorgestrel contraception|steroid, ethinyl estradiol, horgestimate, levonorgestrel contraception
804465|NCT00236795|transdermal.|transdermal.
804466|NCT00236782|contraception|contraception
804467|NCT00236782|hormonal contraception|hormonal contraception
804468|NCT00236782|oral contraception|oral contraception
804469|NCT00236782|steroid, ethinyl estradiol, progestin contraception|steroid, ethinyl estradiol, progestin contraception
804470|NCT00236782|transdermal.|transdermal.
804471|NCT00236769|contraception|contraception
804472|NCT00236769|transdermal contraception|transdermal contraception
804473|NCT00236769|hormonal, steroidal contraception|hormonal, steroidal contraception
804474|NCT00236769|ethinyl estradiol|ethinyl estradiol
804475|NCT00236769|progesterone|progesterone
804476|NCT00236756|Epilepsy|epilepsy
804477|NCT00236756|Seizures|seizures
804478|NCT00236756|Topiramate|topiramate
804479|NCT00236756|Prophylaxis|prophylaxis
804480|NCT00236756|Antiepileptic|antiepileptic
804481|NCT00236756|Lennox-Gastaut syndrome|lennox-gastaut syndrome
804482|NCT00236756|Seizures, tonic|seizures, tonic
804483|NCT00236743|topiramate|topiramate
804484|NCT00236743|epilepsy|epilepsy
804485|NCT00236743|partial epilepsies|partial epilepsies
804486|NCT00236743|partial epilepsy|partial epilepsy
804487|NCT00236743|seizures|seizures
804488|NCT00236743|epileptic seizures|epileptic seizures
804489|NCT00236743|partial seizure disorder|partial seizure disorder
804490|NCT00236743|children|children
804491|NCT00236743|pediatric|pediatric
804492|NCT00236730|topiramate|topiramate
804493|NCT00236730|epilepsy|epilepsy
804494|NCT00236730|partial epilepsies|partial epilepsies
804495|NCT00236730|partial epilepsy|partial epilepsy
804496|NCT00236730|seizures|seizures
804497|NCT00236730|epileptic seizures|epileptic seizures
804498|NCT00236730|partial seizure disorder|partial seizure disorder
804499|NCT00236730|brain diseases|brain diseases
804500|NCT00236717|Epilepsy|epilepsy
804501|NCT00236717|Seizures|seizures
804504|NCT00236717|Antiepileptic|antiepileptic
804505|NCT00236704|Epilepsy|epilepsy
804506|NCT00236704|Seizures|seizures
804507|NCT00236704|Topiramate|topiramate
804508|NCT00236704|Prophylaxis|prophylaxis
804509|NCT00236704|Antiepileptic|antiepileptic
804510|NCT00236704|Tonic-clonic seizures|tonic-clonic seizures
804511|NCT00236704|Grand mal seizures|grand mal seizures
804512|NCT00236691|topiramate|topiramate
804513|NCT00236691|epilepsy|epilepsy
804514|NCT00236691|partial epilepsies|partial epilepsies
804515|NCT00236691|partial epilepsy|partial epilepsy
804516|NCT00236691|seizures|seizures
804517|NCT00236691|epileptic seizures|epileptic seizures
804518|NCT00236691|partial seizure disorder|partial seizure disorder
804519|NCT00236691|brain diseases|brain diseases
804521|NCT00236678|Rheumatoid arthritis|rheumatoid arthritis
804522|NCT00236678|Hemoglobin level|hemoglobin level
804523|NCT00236665|Obesity|obesity
804524|NCT00236665|Essential Hypertension|essential hypertension
804525|NCT00236665|Mild Hypertension|mild hypertension
804526|NCT00236665|Moderate Hypertension|moderate hypertension
804527|NCT00236665|High Blood Pressure|high blood pressure
804528|NCT00236652|Maxillary Sinusitis|maxillary sinusitis
804529|NCT00236652|Infection|infection
804530|NCT00236639|Obesity|obesity
804531|NCT00236639|Hypertension|hypertension
804532|NCT00236639|Hyperlipidemia|hyperlipidemia
804533|NCT00236639|Type 2 Diabetes Mellitus|type 2 diabetes mellitus
804534|NCT00236639|Body Mass Index|body mass index
804535|NCT00236626|Type 2 Diabetes|type 2 diabetes
804536|NCT00236626|Obesity|obesity
804537|NCT00236626|Insulin Resistance|insulin resistance
804538|NCT00236626|Body Mass Index|body mass index
804539|NCT00236626|Hypertension|hypertension
804540|NCT00236626|Hyperlipidemia|hyperlipidemia
804541|NCT00236626|Sulfonylurea|sulfonylurea
804542|NCT00236626|Topiramate|topiramate
804543|NCT00236626|Adult-Onset Diabetes Mellitus|adult-onset diabetes mellitus
804544|NCT00236626|Metabolic Syndrome|metabolic syndrome
804545|NCT00236613|Obesity|obesity
804546|NCT00236613|Hypertension|hypertension
804547|NCT00236613|Hyperlipidemia|hyperlipidemia
804548|NCT00236613|Body Mass Index|body mass index
804549|NCT00236600|Obesity|obesity
804550|NCT00236600|Hypertension|hypertension
804551|NCT00236600|Hyperlipidemia|hyperlipidemia
804552|NCT00236600|Type 2 Diabetes|type 2 diabetes
804553|NCT00236600|Life style modification|life style modification
804554|NCT00236587|Schizophrenia|schizophrenia
804555|NCT00236587|Intramuscular injection|intramuscular injection
804556|NCT00236587|Antipsychotic agents|antipsychotic agents
804557|NCT00236587|Long-acting risperidone|long-acting risperidone
804558|NCT00236574|Dementia|dementia
804559|NCT00236574|Alzheimer disease|alzheimer disease
804560|NCT00236574|Mild cognitive impairment|mild cognitive impairment
804561|NCT00236574|Galantamine hydrobromide|galantamine hydrobromide
804562|NCT00236574|Memory disorder|memory disorder
804563|NCT00236561|Migraine|migraine
804564|NCT00236561|Common Migraine|common migraine
804565|NCT00236561|Classic Migraine|classic migraine
804566|NCT00236561|Headache|headache
804567|NCT00236561|Topiramate|topiramate
804568|NCT00236561|Propranolol|propranolol
804569|NCT00236561|Prophylaxis|prophylaxis
804570|NCT00236561|Prevention|prevention
804571|NCT00236548|Schizophrenia|schizophrenia
804572|NCT00236548|schizoaffective disorder|schizoaffective disorder
804573|NCT00236548|patient compliance|patient compliance
804574|NCT00236548|long-acting risperidone|long-acting risperidone
804575|NCT00236548|intramuscular injection|intramuscular injection
804576|NCT00236548|Treatment Guidebook|treatment guidebook
804577|NCT00236535|musculoskeletal|musculoskeletal
804578|NCT00236535|Pain|pain
804579|NCT00236535|sprained ankle|sprained ankle
804580|NCT00236535|ligament|ligament
804581|NCT00236535|sprain|sprain
804582|NCT00236535|ankle|ankle
804583|NCT00236522|sinus infection|sinus infection
804584|NCT00236522|acute bacterial sinusitis|acute bacterial sinusitis
804585|NCT00236522|sinusitis|sinusitis
804586|NCT00236522|bacterial sinus infection|bacterial sinus infection
804587|NCT00236509|Migraine|migraine
804588|NCT00236509|Common Migraine|common migraine
804589|NCT00236509|Classic Migraine|classic migraine
804590|NCT00236509|Headache|headache
804591|NCT00236509|Topiramate|topiramate
804592|NCT00236509|Prophylaxis|prophylaxis
804593|NCT00236496|tremor|tremor
804594|NCT00236496|essential tremor|essential tremor
804595|NCT00236483|Oral Surgery|oral surgery
804596|NCT00236483|Analgesics|analgesics
804597|NCT00236483|Postoperative Pain|postoperative pain
804598|NCT00236483|dental|dental
804599|NCT00236470|Disruptive behavior disorder|disruptive behavior disorder
804600|NCT00236470|risperidone|risperidone
804601|NCT00236470|antipsychotropic agents|antipsychotropic agents
804602|NCT00236470|child|child
804603|NCT00236470|adolescent|adolescent
804604|NCT00236457|Schizophrenia|schizophrenia
804605|NCT00236457|Intramuscular injection|intramuscular injection
804606|NCT00236457|Antipsychotic agents|antipsychotic agents
804607|NCT00236457|Long-acting risperidone|long-acting risperidone
804608|NCT00236457|Olanzapine|olanzapine
804611|NCT00236444|disruptive behavior disorders|disruptive behavior disorders
804612|NCT00236444|risperidone|risperidone
804613|NCT00236444|antipsychotropic agents|antipsychotropic agents
804614|NCT00236431|Mild cognitive impairment|mild cognitive impairment
804615|NCT00236431|Galantamine hydrobromide|galantamine hydrobromide
804616|NCT00236431|Memory disorders|memory disorders
804617|NCT00236418|Epilepsy|epilepsy
804618|NCT00236418|Seizures|seizures
804619|NCT00236418|Topiramate|topiramate
804620|NCT00236418|Prophylaxis|prophylaxis
804621|NCT00236418|Antiepileptic|antiepileptic
804622|NCT00236418|Tonic-clonic seizures|tonic-clonic seizures
804623|NCT00236418|Grand mal seizures|grand mal seizures
804624|NCT00236405|Anemia|anemia
804625|NCT00236405|erythropoetin|erythropoetin
804626|NCT00236405|quality-of-life outcomes|quality-of-life outcomes
804627|NCT00236392|Gastroesophageal reflux|gastroesophageal reflux
804628|NCT00236392|Heartburn|heartburn
804629|NCT00236392|Rabeprazole|rabeprazole
804630|NCT00236392|Anti-ulcer agents|anti-ulcer agents
804631|NCT00236392|GERD|gerd
804632|NCT00236392|Proton pump inhibitor|proton pump inhibitor
804633|NCT00236392|GORD|gord
804634|NCT00236392|Non-Erosive Reflux Disease|non-erosive reflux disease
804635|NCT00236392|NERD|nerd
804636|NCT00236379|schizophrenia|schizophrenia
804637|NCT00236379|blood glucose|blood glucose
804638|NCT00236379|glucose metabolism|glucose metabolism
804639|NCT00236379|diabetes mellitus|diabetes mellitus
804640|NCT00236379|risperidone|risperidone
804641|NCT00236379|olanzapine|olanzapine
804642|NCT00236366|Fentanyl|fentanyl
804643|NCT00236366|opioid analgesics|opioid analgesics
804644|NCT00236366|osteoarthritis|osteoarthritis
804645|NCT00236366|arthritis|arthritis
804646|NCT00236366|transdermal administration|transdermal administration
804647|NCT00236353|schizophrenia|schizophrenia
804648|NCT00236353|schizoaffective disorder|schizoaffective disorder
804649|NCT00236353|long-acting risperidone|long-acting risperidone
804650|NCT00236353|intramuscular injection|intramuscular injection
804651|NCT00236340|Amniodrainage|amniodrainage
804652|NCT00236340|Pregnancy|pregnancy
804653|NCT00236340|Amniocentesis|amniocentesis
804654|NCT00236327|Fentanyl|fentanyl
804655|NCT00236327|Analgesia|analgesia
804656|NCT00236327|Pain|pain
804657|NCT00236327|Cancer pain|cancer pain
804658|NCT00236327|Opioid analgesia|opioid analgesia
804659|NCT00236327|Transdermal fentanyl|transdermal fentanyl
804660|NCT00236327|Patient-controlled analgesia|patient-controlled analgesia
804661|NCT00236301|Hormone|hormone
804662|NCT00236301|Menopause|menopause
804663|NCT00236301|Inflammation|inflammation
804664|NCT00236301|Dose effects|dose effects
804665|NCT00236301|Apoptosis|apoptosis
804666|NCT00236288|Cancer treatment and tobacco abuse|cancer treatment and tobacco abuse
804667|NCT00236275|Comparison of imaging modalities|comparison of imaging modalities
804668|NCT00236275|predict the effectiveness of neoadjuvant chemotherapy|predict the effectiveness of neoadjuvant chemotherapy
804669|NCT00236262|SDRA|sdra
804670|NCT00236262|Distress|distress
804671|NCT00236262|Expiratory|expiratory
804672|NCT00236262|Pressure|pressure
804673|NCT00236262|Ventilatory|ventilatory
804674|NCT00236249|Double blind method|double blind method
804675|NCT00236249|Prospective study|prospective study
804676|NCT00236249|Lidocaine/administration and dosage/therapeutic use|lidocaine/administration and dosage/therapeutic use
804677|NCT00236249|Anaesthetics local/administration and dosage|anaesthetics local/administration and dosage
804678|NCT00236249|Opioids/administration and dosage|opioids/administration and dosage
804679|NCT00236249|Pain, postoperative|pain, postoperative
804680|NCT00236249|Perioperative care|perioperative care
804681|NCT00236249|Postoperative care|postoperative care
804682|NCT00236249|Analgesia, Patient-controlled|analgesia, patient-controlled
804683|NCT00236249|Length of stay|length of stay
804684|NCT00236249|Survival analysis|survival analysis
804685|NCT00236249|Patient satisfaction|patient satisfaction
804686|NCT00236249|Surgery|surgery
804687|NCT00236249|Middle age|middle age
804688|NCT00236249|Adult|adult
804689|NCT00236249|Aged|aged
804690|NCT00236223|Primary hip replacement|primary hip replacement
804691|NCT00236223|Gabapentin|gabapentin
804692|NCT00236223|Dexamethasone|dexamethasone
804693|NCT00236223|Ketamine|ketamine
804694|NCT00236223|Multimodal postoperative analgesia.|multimodal postoperative analgesia.
804695|NCT00236210|Vascular Intervention Program|vascular intervention program
804696|NCT00236210|Vascular Disease|vascular disease
804697|NCT00236210|Coronary Artery Disease|coronary artery disease
804698|NCT00236210|Diabetes|diabetes
804699|NCT00236210|Lifestyle Modification|lifestyle modification
804700|NCT00236210|Modifiable Risk Factors|modifiable risk factors
804701|NCT00236197|Heartburn|heartburn
804702|NCT00236197|Rabeprazole|rabeprazole
804703|NCT00236171|topical therapy|topical therapy
804704|NCT00236171|Psoriasis Plaque Test|psoriasis plaque test
804705|NCT00236145|BTP|btp
804706|NCT00236145|Break through pain|break through pain
804707|NCT00236145|breakthrough pain|breakthrough pain
804708|NCT00236093|Sickle Cell|sickle cell
804709|NCT00236041|Breakthrough Pain|breakthrough pain
804710|NCT00236041|Cancer|cancer
804712|NCT00236041|Severe Burns|severe burns
804713|NCT00236041|Children|children
804714|NCT00236041|Adolescents|adolescents
804715|NCT00236041|Analgesia|analgesia
804716|NCT00236041|Sickle Cell Disease|sickle cell disease
804717|NCT00236041|Non-Cancer|non-cancer
804718|NCT00236028|Early Rheumatoid Arthritis|early rheumatoid arthritis
804719|NCT00235989|Relapsing multiple sclerosis|relapsing multiple sclerosis
804720|NCT00235989|interferon beta 1b|interferon beta 1b
804721|NCT00235989|Betaferon|betaferon
804722|NCT00235989|Betaseron|betaseron
804723|NCT00235976|Neuromuscular Blocking Agent|neuromuscular blocking agent
804724|NCT00235976|Anesthesia|anesthesia
804725|NCT00235976|Succinylcholine|succinylcholine
804726|NCT00235976|Tracheal Intubation|tracheal intubation
804727|NCT00235976|Adjunct for tracheal intubation|adjunct for tracheal intubation
804728|NCT00235950|Coronary Heart Disease|coronary heart disease
804729|NCT00235950|Percutaeous Coronary Intervention (PCI)|percutaeous coronary intervention (pci)
804730|NCT00235937|Premenopausal|premenopausal
804731|NCT00235937|Advanced Breast Cancer|advanced breast cancer
804732|NCT00235937|Metastatic Breast Cancer|metastatic breast cancer
804733|NCT00235924|menopause|menopause
804734|NCT00235924|isoflavone|isoflavone
804735|NCT00235924|endometrial safety|endometrial safety
804736|NCT00235924|breast innocuity assessment|breast innocuity assessment
804737|NCT00235924|hot flushes|hot flushes
804738|NCT00235885|Psoriatic Arthritis|psoriatic arthritis
804739|NCT00235885|adalimumab|adalimumab
804740|NCT00235872|Rheumatoid arthritis|rheumatoid arthritis
804741|NCT00235859|Rheumatoid Arthritis|rheumatoid arthritis
804742|NCT00235859|adalimumab|adalimumab
804743|NCT00235846|Endoscopic vein harvesting|endoscopic vein harvesting
804744|NCT00235846|Saphenous vein|saphenous vein
804745|NCT00235833|Rheumatoid Arthritis|rheumatoid arthritis
804746|NCT00235820|Psoriasis|psoriasis
804747|NCT00235820|adalimumab|adalimumab
804748|NCT00235807|Audiology|audiology
804749|NCT00235807|Rehabilitation|rehabilitation
804750|NCT00235807|Tinnitus|tinnitus
804751|NCT00235781|Kidney Transplantation|kidney transplantation
804752|NCT00235781|Antilymphocyte Serum|antilymphocyte serum
804753|NCT00235781|Induction|induction
804754|NCT00235781|Graft Rejection|graft rejection
804755|NCT00235768|Ecstasy|ecstasy
804756|NCT00235768|MDMA|mdma
804757|NCT00235768|Cognition|cognition
804758|NCT00235768|Brain function|brain function
804759|NCT00235768|Neuroimaging|neuroimaging
804760|NCT00235755|Partial Seizures|partial seizures
804761|NCT00235755|Complex Partial Seizures|complex partial seizures
804762|NCT00235755|Epilepsy|epilepsy
804763|NCT00235755|Potassium Channels|potassium channels
804764|NCT00235755|Anticonvulsant|anticonvulsant
804765|NCT00235729|Opiate addiction|opiate addiction
804766|NCT00235729|Opiate dependence|opiate dependence
804767|NCT00235729|Withdrawal symptoms|withdrawal symptoms
804768|NCT00235716|Alzheimer's Disease|alzheimer's disease
804769|NCT00235716|clinical trial|clinical trial
804770|NCT00235716|randomized controlled trial|randomized controlled trial
804771|NCT00235716|alpha-tocopherol|alpha-tocopherol
804772|NCT00235716|vitamin E|vitamin e
804773|NCT00235716|Namenda|namenda
804774|NCT00235716|memantine|memantine
804775|NCT00235677|Endoscopic antireflux treatment|endoscopic antireflux treatment
804776|NCT00235677|GERD|gerd
804777|NCT00235677|Sham-controlled|sham-controlled
804778|NCT00235677|Endocinch|endocinch
804779|NCT00235664|liver transplant recipients|liver transplant recipients
804780|NCT00235664|intestinal transplant recipients|intestinal transplant recipients
804781|NCT00235664|multivisceral transplant recipients|multivisceral transplant recipients
804782|NCT00235651|Lung transplant recipient|lung transplant recipient
804783|NCT00235625|Alternative Medicine|alternative medicine
804784|NCT00235625|Psoriasis|psoriasis
804785|NCT00235625|Turmeric|turmeric
804786|NCT00235625|Curcumin|curcumin
804787|NCT00235625|Dermatology|dermatology
804788|NCT00235599|Growth|growth
804789|NCT00235599|Hormone|hormone
804790|NCT00235599|Deficiency|deficiency
804791|NCT00235586|vitamin D deficiency postmenopausal women|vitamin d deficiency postmenopausal women
804792|NCT00235573|Vitamin B12 absorption|vitamin b12 absorption
804793|NCT00235573|Holo-transcobalamin|holo-transcobalamin
804794|NCT00235560|AML|aml
804795|NCT00235560|Rapamycin|rapamycin
804796|NCT00235560|Elderly|elderly
804797|NCT00235560|Elderly patients not eligible for intensive chemotherapy|elderly patients not eligible for intensive chemotherapy
804798|NCT00235547|abortion|abortion
804799|NCT00235547|randomized|randomized
804800|NCT00235547|contraception|contraception
804801|NCT00235547|pregnancy|pregnancy
804802|NCT00235547|compliance|compliance
804803|NCT00235547|continuation|continuation
804804|NCT00235547|contraceptive patch|contraceptive patch
804805|NCT00235547|transdermal hormonal contraception|transdermal hormonal contraception
804806|NCT00235534|abortion|abortion
804807|NCT00235534|randomized|randomized
804808|NCT00235534|contraception|contraception
804809|NCT00235534|pregnancy|pregnancy
804810|NCT00235534|compliance|compliance
804811|NCT00235534|continuation|continuation
804812|NCT00235534|oral contraceptive pills|oral contraceptive pills
804813|NCT00235521|Pulmonary hypertension|pulmonary hypertension
804814|NCT00235521|Cardiac Surgery|cardiac surgery
804815|NCT00235521|Children|children
804816|NCT00235521|Pediatric Patients|pediatric patients
804817|NCT00235521|Iloprost|iloprost
804819|NCT00235521|nitric oxide|nitric oxide
804820|NCT00235521|Pulmonary hypertension after cardiac surgery in pediatric patients, 0 - 2 years old|pulmonary hypertension after cardiac surgery in pediatric patients, 0 - 2 years old
804821|NCT00235508|Insomnia|insomnia
804822|NCT00235508|Anxiety|anxiety
804823|NCT00235508|Generalized Anxiety Disorder|generalized anxiety disorder
804824|NCT00235495|stroke|stroke
804825|NCT00235469|PAINFUL DISTAL DIABETIC NEUROPATHY|painful distal diabetic neuropathy
804826|NCT00235456|oxygen|oxygen
804827|NCT00235456|surgical complications|surgical complications
804828|NCT00235456|colo-rectal resections|colo-rectal resections
804829|NCT00235443|Painful Distal Diabetic Neuropathy|painful distal diabetic neuropathy
804830|NCT00235417|Bone Marrow Transplantation|bone marrow transplantation
804831|NCT00235404|Treatment of elderly.|treatment of elderly.
804832|NCT00235404|Nursing home.|nursing home.
804833|NCT00235404|Rehabilitation.|rehabilitation.
804934|NCT00234923|Ritonavir|ritonavir
804834|NCT00235404|Readmissions.|readmissions.
804835|NCT00235391|Deferasirox|deferasirox
804836|NCT00235391|Congenital Anemias|congenital anemias
804837|NCT00235391|Anemias|anemias
804838|NCT00235391|Red Blood Cell Disorders|red blood cell disorders
804839|NCT00235391|Chronic Iron Overload|chronic iron overload
804840|NCT00235391|Transfusional Iron Overload|transfusional iron overload
804841|NCT00235391|Iron Chelators|iron chelators
804842|NCT00235391|Oral Iron Chelators|oral iron chelators
804843|NCT00235391|Thalassemia|thalassemia
804844|NCT00235391|Sickle Cell Disease|sickle cell disease
804845|NCT00235391|Diamond Blackfan Anemia|diamond blackfan anemia
804846|NCT00235391|Myelofibrosis|myelofibrosis
804847|NCT00235391|ICL670A|icl670a
804848|NCT00235378|Lupus|lupus
804849|NCT00235378|SLE|sle
804850|NCT00235352|Schizphrenia|schizphrenia
804851|NCT00235352|Cognition|cognition
804852|NCT00235352|Negative Symptoms|negative symptoms
804853|NCT00235339|Oxygen Consumption|oxygen consumption
804854|NCT00235339|Exercise|exercise
804855|NCT00235339|Rehabilitation|rehabilitation
804856|NCT00235326|residents of Walkerton ontario at outbreak|residents of walkerton ontario at outbreak
804857|NCT00235313|Nicotine replacement therapies|nicotine replacement therapies
804858|NCT00235313|Smoking|smoking
804859|NCT00235313|Smoking related diseases|smoking related diseases
804860|NCT00235313|Saliva cotinine|saliva cotinine
804861|NCT00235313|Dose adjustment|dose adjustment
804862|NCT00235313|Smoker; patients with smoking related disease conditions|smoker; patients with smoking related disease conditions
804863|NCT00235300|Anti-T cells antibodies|anti-t cells antibodies
804864|NCT00235300|Cadaveric Donor Renal Transplantation|cadaveric donor renal transplantation
804865|NCT00235300|Acute Renal Allograft Rejection|acute renal allograft rejection
804866|NCT00235300|Induction Therapy|induction therapy
804867|NCT00235287|Angiotensin-Converting Enzyme Inhibitors|angiotensin-converting enzyme inhibitors
804868|NCT00235287|type 1 angiotensin receptor antagonists|type 1 angiotensin receptor antagonists
804869|NCT00235287|blood pressure|blood pressure
804870|NCT00235274|Schizophrenia|schizophrenia
804871|NCT00235274|Secretin|secretin
804872|NCT00235261|Total hip replacement|total hip replacement
804873|NCT00235261|Pregablin|pregablin
804874|NCT00235261|Dexamethasone|dexamethasone
804875|NCT00235261|Multimodal postoperative analgesia.|multimodal postoperative analgesia.
804876|NCT00235248|TIA/Brain infarct|tia/brain infarct
804877|NCT00235248|and plaque>4mm in the aortic arch|and plaque>4mm in the aortic arch
804878|NCT00235248|Or peripheral embolism|or peripheral embolism
804879|NCT00235248|and plaque>4 mm in the thoracic aorta|and plaque>4 mm in the thoracic aorta
804880|NCT00235222|Stavudine|stavudine
804881|NCT00235222|Reduced dose of stavudine|reduced dose of stavudine
804882|NCT00235222|Viral load|viral load
804883|NCT00235222|Peripheral neuropathy|peripheral neuropathy
804884|NCT00235222|Treatment Experienced|treatment experienced
804885|NCT00235183|plasma|plasma
804886|NCT00235183|bleeding|bleeding
804887|NCT00235183|liver transplantation|liver transplantation
804888|NCT00235131|Peripheral Artery Occlusive Disease|peripheral artery occlusive disease
804889|NCT00235105|early ankylosing spondylitis|early ankylosing spondylitis
804890|NCT00235105|spondyloarthritis|spondyloarthritis
804891|NCT00235105|trial|trial
804892|NCT00235105|adalimumab|adalimumab
804893|NCT00235079|Pericarditis|pericarditis
804894|NCT00235079|Recurrence|recurrence
804895|NCT00235079|Therapeutics|therapeutics
804896|NCT00235079|Prevention|prevention
804897|NCT00235079|Colchicine|colchicine
804898|NCT00235053|asthma|asthma
804899|NCT00235053|candidiasis, oral|candidiasis, oral
804900|NCT00235053|voice disorders|voice disorders
804901|NCT00235040|Upper Respiratory Infections|upper respiratory infections
804902|NCT00235040|Respiratory Tract Infections|respiratory tract infections
804903|NCT00235040|Tree Number C01.539.739|tree number c01.539.739
804904|NCT00235040|Tree Number C08.730|tree number c08.730
804905|NCT00235040|Unique ID D012141|unique id d012141
804906|NCT00235014|hypertension|hypertension
804908|NCT00235014|trandolapril|trandolapril
804909|NCT00235014|verapamil|verapamil
804910|NCT00235014|albuminuria|albuminuria
804911|NCT00235001|Hypertension|hypertension
804912|NCT00235001|Tarka|tarka
804913|NCT00234988|Sibutramine|sibutramine
804914|NCT00234988|Obesity|obesity
804915|NCT00234975|Lopinavir|lopinavir
804916|NCT00234975|Ritonavir|ritonavir
804917|NCT00234975|Phase 4|phase 4
804918|NCT00234975|HIV|hiv
804919|NCT00234962|HIV Infection|hiv infection
804920|NCT00234962|HAART|haart
804921|NCT00234962|Lopinavir|lopinavir
804922|NCT00234962|Ritonavir|ritonavir
804923|NCT00234962|Treatment Experienced|treatment experienced
804924|NCT00234962|Treatment Naive|treatment naive
804925|NCT00234949|Cefdinir|cefdinir
804926|NCT00234949|Cephalexin|cephalexin
804927|NCT00234949|Skin Infection|skin infection
804928|NCT00234936|rheumatoid arthritis|rheumatoid arthritis
804929|NCT00234936|adalimumab|adalimumab
804930|NCT00234936|quality of life|quality of life
804931|NCT00234923|HIV Infection|hiv infection
804932|NCT00234923|Kaletra|kaletra
804933|NCT00234923|Lopinavir|lopinavir
804935|NCT00234923|Treatment Naive|treatment naive
804936|NCT00234910|Lopinavir|lopinavir
804937|NCT00234910|Ritonavir|ritonavir
804938|NCT00234910|Kaletra|kaletra
804939|NCT00234910|Tenofovir|tenofovir
804940|NCT00234910|HIV infection|hiv infection
804941|NCT00234910|Treatment Naive|treatment naive
804942|NCT00234897|adalimumab|adalimumab
804943|NCT00234897|rheumatoid arthritis|rheumatoid arthritis
804944|NCT00234884|rheumatoid arthritis|rheumatoid arthritis
804945|NCT00234884|adalimumab|adalimumab
804946|NCT00234871|Hypertension|hypertension
804947|NCT00234871|Diabetes|diabetes
804948|NCT00234871|Proteinuria|proteinuria
804949|NCT00234871|Tarka|tarka
804950|NCT00234871|Lotrel|lotrel
804951|NCT00234858|Hypertension|hypertension
804952|NCT00234858|Metabolic Syndrome|metabolic syndrome
804953|NCT00234858|Tarka|tarka
804954|NCT00234858|Hyzaar|hyzaar
804955|NCT00234832|Obesity|obesity
804956|NCT00234832|Sibutramine|sibutramine
804957|NCT00234819|Menopause|menopause
804958|NCT00234806|telehealth|telehealth
804959|NCT00234806|telemedicine|telemedicine
804960|NCT00234793|childhood cancer|childhood cancer
804961|NCT00234793|intervention|intervention
804962|NCT00234793|maternal coping|maternal coping
804963|NCT00234793|problem solving skills|problem solving skills
804964|NCT00234793|anxiety|anxiety
804965|NCT00234793|cope|cope
804966|NCT00234793|problem solving|problem solving
804967|NCT00234780|acute home care|acute home care
804968|NCT00234767|Acute Respiratory Distress Syndrome|acute respiratory distress syndrome
804969|NCT00234767|ARDS|ards
804970|NCT00234767|Acute Lung Injury|acute lung injury
804971|NCT00234767|ALI|ali
804972|NCT00234767|Cost-effectiveness|cost-effectiveness
804973|NCT00234767|Pharmacoeconomics|pharmacoeconomics
804974|NCT00234767|Long-term follow-up|long-term follow-up
804975|NCT00234754|Incontinence|incontinence
804976|NCT00234754|Surgery|surgery
804977|NCT00234754|Trans-vaginal tape|trans-vaginal tape
804978|NCT00234754|Trans-obturator tape|trans-obturator tape
804979|NCT00234728|psoriasis|psoriasis
804980|NCT00234728|hydrogel|hydrogel
804981|NCT00234728|occlusive dressing|occlusive dressing
804982|NCT00234728|occlusion|occlusion
804983|NCT00234728|hydrocortisone|hydrocortisone
804984|NCT00234728|tacrolimus|tacrolimus
804985|NCT00234728|Protopic|protopic
804986|NCT00234728|triamcinolone|triamcinolone
804987|NCT00234728|calcipotriene|calcipotriene
804988|NCT00234728|Dovonex|dovonex
804989|NCT00234728|halobetasol|halobetasol
804990|NCT00234728|Ultravate|ultravate
804991|NCT00234715|Breast Cancer|breast cancer
804992|NCT00234715|Breast Cancer Risk|breast cancer risk
804993|NCT00234715|Breast Cancer Risk Assessment|breast cancer risk assessment
804994|NCT00234715|Psychosocial|psychosocial
804995|NCT00234715|Acceptance|acceptance
804996|NCT00234676|Parkinson disease|parkinson disease
804997|NCT00234676|women|women
804998|NCT00234676|postmenopause|postmenopause
804999|NCT00234676|estrogen replacement therapy|estrogen replacement therapy
805000|NCT00234676|clinical trials|clinical trials
805001|NCT00234663|Cystic fibrosis|cystic fibrosis
805002|NCT00234663|Nonsense mutation|nonsense mutation
805003|NCT00234663|Premature stop codon|premature stop codon
805004|NCT00234650|position change|position change
805005|NCT00234650|adenoma|adenoma
805006|NCT00234650|colonoscopy|colonoscopy
805007|NCT00234637|Alzheimer's disease,|alzheimer's disease,
805008|NCT00234637|switch,|switch,
805009|NCT00234637|rivastigmine,|rivastigmine,
805010|NCT00234637|memantine|memantine
805011|NCT00234598|Pneumonia|pneumonia
805012|NCT00234598|Dental Health|dental health
805013|NCT00234598|Critical Care|critical care
805014|NCT00234559|Angiogenesis|angiogenesis
805015|NCT00234559|Post surgical dehisced wounds of the lower extremity|post surgical dehisced wounds of the lower extremity
805016|NCT00234533|growth|growth
805017|NCT00234533|child development|child development
805018|NCT00234533|growth hormone|growth hormone
805019|NCT00234533|inadequate growth hormone secretion|inadequate growth hormone secretion
805020|NCT00234533|growth failure|growth failure
805021|NCT00234468|Locally Advanced Non Small Cell Lung Cancer (Stage IIIA and IIIB)|locally advanced non small cell lung cancer (stage iiia and iiib)
805022|NCT00234442|Non symptomatic brain metastases|non symptomatic brain metastases
805023|NCT00234442|Iressa|iressa
805024|NCT00234429|Colorectal carcinoma advanced disease|colorectal carcinoma advanced disease
805025|NCT00234416|Pancreatic Cancer|pancreatic cancer
805026|NCT00234416|EGF-R|egf-r
805027|NCT00234403|Advanced breast cancer|advanced breast cancer
805028|NCT00234403|Metastatic breast cancer|metastatic breast cancer
805029|NCT00234403|ER positive breast cancer|er positive breast cancer
805030|NCT00234403|PR positive breast cancer|pr positive breast cancer
805031|NCT00234377|Schizophrenia|schizophrenia
805032|NCT00234364|Pergolide|pergolide
805033|NCT00234364|Ergotamine derivates|ergotamine derivates
805034|NCT00234364|Valvular heart disease|valvular heart disease
805035|NCT00234338|Children|children
805036|NCT00234338|Vaccine|vaccine
805037|NCT00234338|Prevenar|prevenar
805038|NCT00234312|Depressive Disorders|depressive disorders
805040|NCT00234299|Prostate|prostate
805041|NCT00234299|Preventive Therapy|preventive therapy
805042|NCT00234286|Palliative Care|palliative care
805043|NCT00234286|Terminal Care|terminal care
805044|NCT00234286|Hospice Care|hospice care
805045|NCT00234286|Patient Care Planning|patient care planning
805046|NCT00234286|Nursing Care Plans|nursing care plans
805047|NCT00234286|Quality of Health Care|quality of health care
805048|NCT00234286|Inpatients|inpatients
805049|NCT00234286|Professional education|professional education
805050|NCT00234286|Resuscitation orders|resuscitation orders
805051|NCT00234286|Pastoral Care|pastoral care
805052|NCT00234273|Adapted Physical Activity|adapted physical activity
805053|NCT00234273|Quality of life|quality of life
805054|NCT00234273|cardiovascular risk|cardiovascular risk
805055|NCT00234273|teaching|teaching
805056|NCT00234273|Directly Observed Therapy|directly observed therapy
805057|NCT00234273|Physical activity|physical activity
805058|NCT00234260|Genetics|genetics
805059|NCT00234234|Biologics|biologics
805060|NCT00234208|Complicated parapneumonic effusion|complicated parapneumonic effusion
805061|NCT00234208|Pleural empyema|pleural empyema
805062|NCT00234208|Intervention|intervention
805063|NCT00234208|Medical thoracoscopy|medical thoracoscopy
805064|NCT00234208|Chest tube drainage|chest tube drainage
805065|NCT00234195|Breast Cancer|breast cancer
805066|NCT00234195|Major Depressive Disorder|major depressive disorder
805067|NCT00234182|liver cancer|liver cancer
805068|NCT00234182|hepatectomy|hepatectomy
805069|NCT00234182|survival|survival
805070|NCT00234182|recurrence|recurrence
805071|NCT00234169|Multiple Myeloma|multiple myeloma
805072|NCT00234169|Lymphoma|lymphoma
805073|NCT00234156|Fructose|fructose
805074|NCT00234156|Lipogenesis|lipogenesis
805075|NCT00234156|Triglycerides|triglycerides
805076|NCT00234156|Dialysis|dialysis
805077|NCT00234143|MDS|mds
805078|NCT00234143|EPO|epo
805079|NCT00234143|G-CSF|g-csf
805080|NCT00234143|REGiM|regim
805081|NCT00234130|Dialysis|dialysis
805082|NCT00234130|Cytokines|cytokines
805083|NCT00234130|Triglycerides|triglycerides
805084|NCT00234130|Insulin|insulin
805085|NCT00234104|OPC-41061|opc-41061
805086|NCT00234104|Tolvaptan|tolvaptan
805087|NCT00234104|Heart Failure|heart failure
805088|NCT00234104|Edema|edema
805089|NCT00234104|Extracellular volume expansion|extracellular volume expansion
805090|NCT00234091|Treatment Naive|treatment naive
805091|NCT00234091|Treatment Initiation|treatment initiation
805092|NCT00234091|Infant|infant
805093|NCT00234091|Preschool Child|preschool child
805094|NCT00234091|Child|child
805095|NCT00234091|Zidovudine|zidovudine
805096|NCT00234091|AZT|azt
805097|NCT00234091|Retrovir|retrovir
805098|NCT00234091|3TC|3tc
805099|NCT00234091|Lamivudine|lamivudine
805100|NCT00234091|Epivir|epivir
805101|NCT00234091|Nevirapine|nevirapine
805102|NCT00234091|NVP|nvp
805103|NCT00234091|Viramune|viramune
805104|NCT00234091|Efavirenz|efavirenz
805105|NCT00234091|EFV|efv
805106|NCT00234091|Sustiva|sustiva
805107|NCT00234091|Lopinavir/Ritonavir|lopinavir/ritonavir
805108|NCT00234091|LPV/r|lpv/r
805109|NCT00234091|Kaletra|kaletra
805110|NCT00234091|Nelfinavir|nelfinavir
805111|NCT00234091|NFV|nfv
805112|NCT00234091|Viracept|viracept
805113|NCT00234091|ABC|abc
805114|NCT00234091|Abacavir|abacavir
805115|NCT00234091|Ziagen|ziagen
805116|NCT00234078|OPC-12759|opc-12759
805117|NCT00234078|Dry eye syndromes|dry eye syndromes
805118|NCT00234052|recurrent non-small cell lung cancer|recurrent non-small cell lung cancer
805119|NCT00234052|stage IIIB non-small cell lung cancer|stage iiib non-small cell lung cancer
805120|NCT00234052|stage IV non-small cell lung cancer|stage iv non-small cell lung cancer
805121|NCT00234052|adenocarcinoma of the lung|adenocarcinoma of the lung
805122|NCT00234052|bronchoalveolar cell lung cancer|bronchoalveolar cell lung cancer
805123|NCT00234052|large cell lung cancer|large cell lung cancer
805124|NCT00234039|recurrent bladder cancer|recurrent bladder cancer
805125|NCT00234039|stage 0 bladder cancer|stage 0 bladder cancer
805126|NCT00234039|stage I bladder cancer|stage i bladder cancer
805127|NCT00234039|transitional cell carcinoma of the bladder|transitional cell carcinoma of the bladder
805128|NCT00234026|recurrent mantle cell lymphoma|recurrent mantle cell lymphoma
805129|NCT00234026|stage I mantle cell lymphoma|stage i mantle cell lymphoma
805130|NCT00234026|contiguous stage II mantle cell lymphoma|contiguous stage ii mantle cell lymphoma
805131|NCT00234026|noncontiguous stage II mantle cell lymphoma|noncontiguous stage ii mantle cell lymphoma
805132|NCT00234026|stage III mantle cell lymphoma|stage iii mantle cell lymphoma
805133|NCT00234026|stage IV mantle cell lymphoma|stage iv mantle cell lymphoma
805134|NCT00234000|refractory anemia with excess blasts in transformation|refractory anemia with excess blasts in transformation
805135|NCT00234000|refractory anemia with excess blasts|refractory anemia with excess blasts
805136|NCT00234000|refractory anemia with ringed sideroblasts|refractory anemia with ringed sideroblasts
805137|NCT00234000|refractory anemia|refractory anemia
805138|NCT00234000|chronic myelomonocytic leukemia|chronic myelomonocytic leukemia
805139|NCT00234000|de novo myelodysplastic syndromes|de novo myelodysplastic syndromes
805140|NCT00234000|previously treated myelodysplastic syndromes|previously treated myelodysplastic syndromes
805141|NCT00234000|secondary myelodysplastic syndromes|secondary myelodysplastic syndromes
805142|NCT00233987|recurrent adult Hodgkin lymphoma|recurrent adult hodgkin lymphoma
805143|NCT00233974|stage IIIA breast cancer|stage iiia breast cancer
805144|NCT00233974|stage IIIB breast cancer|stage iiib breast cancer
805145|NCT00233974|stage IIIC breast cancer|stage iiic breast cancer
805146|NCT00233974|stage IV breast cancer|stage iv breast cancer
805147|NCT00233961|chronic phase chronic myelogenous leukemia|chronic phase chronic myelogenous leukemia
805148|NCT00233922|orbit|orbit
805149|NCT00233922|orbital|orbital
805150|NCT00233922|trauma|trauma
805151|NCT00233922|fractures|fractures
805152|NCT00233922|facial|facial
805153|NCT00233909|Leukemia, Myeloid|leukemia, myeloid
805154|NCT00233909|Relapse|relapse
805155|NCT00233909|Chemotherapy|chemotherapy
805156|NCT00233909|Zosuquidar|zosuquidar
805157|NCT00233909|gemtuzumab ozogamicin (GO)|gemtuzumab ozogamicin (go)
805158|NCT00233896|Hematopoietic cell transplant|hematopoietic cell transplant
805159|NCT00233896|Acute graft-vs.-host disease|acute graft-vs.-host disease
805160|NCT00233896|Gastrointestinal tract|gastrointestinal tract
805161|NCT00233896|Randomized trial|randomized trial
805162|NCT00233896|Topical corticosteroid|topical corticosteroid
805163|NCT00233896|Beclomethasone dipropionate|beclomethasone dipropionate
805164|NCT00233896|Prednisone|prednisone
805165|NCT00233896|Survival|survival
805166|NCT00233857|Acute pain|acute pain
805167|NCT00233857|postoperative pain|postoperative pain
805168|NCT00233857|auricular acupuncture|auricular acupuncture
805169|NCT00233844|Acute pain|acute pain
805170|NCT00233844|pain on venipuncture|pain on venipuncture
805171|NCT00233844|"cough-trick"|"cough-trick"
805172|NCT00233844|distraction|distraction
805173|NCT00233831|Postoperative pain|postoperative pain
805174|NCT00233831|analgesia|analgesia
805175|NCT00233831|total knee arthroplasty|total knee arthroplasty
805176|NCT00233753|Intracranial|intracranial
805177|NCT00233753|Wide-neck|wide-neck
805178|NCT00233753|Saccular|saccular
805179|NCT00233753|Aneurysms|aneurysms
805180|NCT00233727|cervical cancer|cervical cancer
805181|NCT00233727|cervical intraepithelial neoplasia|cervical intraepithelial neoplasia
805182|NCT00233727|prevention|prevention
805183|NCT00233727|cryotherapy|cryotherapy
805184|NCT00233727|HPV testing|hpv testing
805185|NCT00233727|cytology|cytology
805186|NCT00233701|NPH|nph
805187|NCT00233701|Hydrocephalus|hydrocephalus
805188|NCT00233636|Squamous Cell Carcinoma of Head and Neck|squamous cell carcinoma of head and neck
805189|NCT00233636|Inoperable locally advanced Squamous Cell Carcinoma of Head and Neck|inoperable locally advanced squamous cell carcinoma of head and neck
805190|NCT00233623|Metastatic Colorectal Cancer|metastatic colorectal cancer
805191|NCT00233610|Casodex monotherapy|casodex monotherapy
805192|NCT00233597|anemia|anemia
805193|NCT00233597|iron|iron
805194|NCT00233584|Children of asthmatic mothers|children of asthmatic mothers
805195|NCT00233545|cutaneous|cutaneous
805196|NCT00233545|leishmaniasis|leishmaniasis
805197|NCT00233545|drug|drug
805198|NCT00233545|miltefosine|miltefosine
805199|NCT00233532|Hypertension|hypertension
805200|NCT00233532|Trandolapril|trandolapril
805201|NCT00233506|CpG 7909|cpg 7909
805202|NCT00233506|CLL|cll
805203|NCT00233493|dermatophytes|dermatophytes
805204|NCT00233480|Randomized Controlled Trial|randomized controlled trial
805205|NCT00233480|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors
805206|NCT00233480|Sympathetic Nervous System|sympathetic nervous system
805207|NCT00233480|Ventricular Remodeling|ventricular remodeling
805208|NCT00233480|Chemokines|chemokines
805209|NCT00233467|antipsychotics|antipsychotics
805210|NCT00233467|PTSD|ptsd
805211|NCT00233467|posttraumatic stress disorder|posttraumatic stress disorder
805212|NCT00233441|Atrial Fibrillation|atrial fibrillation
805213|NCT00233441|Atrial Flutter|atrial flutter
805214|NCT00233441|Arrhythmia|arrhythmia
805215|NCT00233441|Anti-Arrhythmia Agents|anti-arrhythmia agents
805216|NCT00233428|Healthy volunteers|healthy volunteers
805217|NCT00233402|Bladder Cancer|bladder cancer
805218|NCT00233402|Hexvix|hexvix
805219|NCT00233402|Fluorescence|fluorescence
805220|NCT00233402|Cystoscopy|cystoscopy
805221|NCT00233376|Decision support system|decision support system
805222|NCT00233376|Causal probabilistic network|causal probabilistic network
805223|NCT00233376|Antibiotics|antibiotics
805224|NCT00233376|Antibiotic resistance|antibiotic resistance
805225|NCT00233376|Community-acquired infections|community-acquired infections
805226|NCT00233376|Cross-infections|cross-infections
805227|NCT00233350|Neuronavigation|neuronavigation
805228|NCT00233350|Ultrasound|ultrasound
805229|NCT00233350|Brain tumour surgery|brain tumour surgery
805230|NCT00233350|Biopsy|biopsy
805231|NCT00233350|Histopathology|histopathology
805232|NCT00233350|Intraoperative imaging|intraoperative imaging
805233|NCT00233350|3D ultrasound imaging|3d ultrasound imaging
805234|NCT00233337|Malaria, non-immune travelers|malaria, non-immune travelers
805531|NCT00231660|Obesity|obesity
805235|NCT00233324|NICHD Neonatal Research Network|nichd neonatal research network
805236|NCT00233324|Extremely Low Birth Weight (ELBW)|extremely low birth weight (elbw)
805237|NCT00233324|Very Low Birth Weight (VLBW)|very low birth weight (vlbw)
805238|NCT00233324|Prematurity|prematurity
805239|NCT00233324|Mechanical ventilation|mechanical ventilation
805240|NCT00233324|Surfactant|surfactant
805241|NCT00233324|Intubation|intubation
805242|NCT00233324|Neurodevelopmental impairment|neurodevelopmental impairment
805243|NCT00233324|Pulse oximetry|pulse oximetry
805244|NCT00233324|Oxygen saturation|oxygen saturation
805245|NCT00233324|Positive-Pressure Respiration|positive-pressure respiration
805246|NCT00233311|high fat diet|high fat diet
805247|NCT00233311|inflammation|inflammation
805248|NCT00233311|inflammatory markers|inflammatory markers
805249|NCT00233311|C-reactive protein|c-reactive protein
805250|NCT00233311|Aging|aging
805251|NCT00233298|Hypoglycemia|hypoglycemia
805252|NCT00233298|Blood Sugar|blood sugar
805253|NCT00233298|Blood Glucose Level|blood glucose level
805254|NCT00233298|Insulin Sensitivity|insulin sensitivity
805255|NCT00233298|Metabolism|metabolism
805256|NCT00233298|Type 2 Diabetes|type 2 diabetes
805257|NCT00233298|Healthy|healthy
805258|NCT00233272|Frailty|frailty
805259|NCT00233272|Disease Processes|disease processes
805260|NCT00233155|Analgesics|analgesics
805261|NCT00233155|Capsaicin|capsaicin
805262|NCT00233155|Neuropathic pain|neuropathic pain
805263|NCT00233155|Neuropathy|neuropathy
805264|NCT00233155|PHN|phn
805265|NCT00233155|Shingles|shingles
805266|NCT00233142|Diabetes|diabetes
805267|NCT00233142|Emotions|emotions
805268|NCT00233142|Blood glucose|blood glucose
805269|NCT00233142|Expressive Writing|expressive writing
805270|NCT00233129|Day treatment|day treatment
805271|NCT00233129|executive function|executive function
805272|NCT00233129|problem solving|problem solving
805273|NCT00233129|attention|attention
805274|NCT00233129|participation|participation
805275|NCT00233129|TBI|tbi
805276|NCT00233129|brain injury|brain injury
805277|NCT00233129|traumatic brain injury|traumatic brain injury
805278|NCT00233103|Sertraline|sertraline
805279|NCT00233103|TBI|tbi
805280|NCT00233103|depression|depression
805281|NCT00233103|SSRI|ssri
805282|NCT00233103|brain injury|brain injury
805283|NCT00233090|Fatigue|fatigue
805284|NCT00233090|TBI|tbi
805285|NCT00233090|brain injury|brain injury
805286|NCT00233090|Modafinil|modafinil
805287|NCT00233090|traumatic brain injury|traumatic brain injury
805288|NCT00233077|breast cancer|breast cancer
805289|NCT00233077|adjuvant treatment|adjuvant treatment
805290|NCT00233077|racial disparities|racial disparities
805291|NCT00233051|Chronic Obstructive Pulmonary Disease (COPD)|chronic obstructive pulmonary disease (copd)
805292|NCT00233051|Emphysema|emphysema
805293|NCT00233051|Chronic Bronchitis|chronic bronchitis
805294|NCT00233051|Inhaled Steroid|inhaled steroid
805295|NCT00233051|Salmeterol|salmeterol
805296|NCT00233038|Pancreatic cancer|pancreatic cancer
805297|NCT00233038|Pancreatic adenoma|pancreatic adenoma
805298|NCT00233038|Ethanol|ethanol
805299|NCT00233038|Endoscopic ultrasound|endoscopic ultrasound
805300|NCT00233038|Cyst ablation|cyst ablation
805301|NCT00233012|Refractory partial-onset seizures|refractory partial-onset seizures
805302|NCT00233012|Infants aged 1-24 months|infants aged 1-24 months
805303|NCT00233012|Pharmacokinetics|pharmacokinetics
805304|NCT00233012|Topiramate|topiramate
805305|NCT00232999|Allergic asthma|allergic asthma
805306|NCT00232999|Allergen challenge|allergen challenge
805307|NCT00232999|Bronchial hyperresponsiveness|bronchial hyperresponsiveness
805308|NCT00232960|oral and oropharynx carcinoma|oral and oropharynx carcinoma
805309|NCT00232960|surgery|surgery
805310|NCT00232960|postoperative radiotherapy|postoperative radiotherapy
805311|NCT00232960|molecular analysis|molecular analysis
805312|NCT00232960|microsatellite instability|microsatellite instability
805313|NCT00232947|vaccine|vaccine
805314|NCT00232947|elderly|elderly
805315|NCT00232947|immunogenicity|immunogenicity
805320|NCT00232934|Elderly patients|elderly patients
805321|NCT00232882|Hypertension|hypertension
805322|NCT00232882|Blood pressure|blood pressure
805323|NCT00232882|Antihypertensive drugs|antihypertensive drugs
805324|NCT00232882|Clinical Pharmacology|clinical pharmacology
805325|NCT00232882|Autonomic nervous system|autonomic nervous system
805326|NCT00232882|Renin angiotensin system|renin angiotensin system
805327|NCT00232882|Oxidative stress|oxidative stress
805328|NCT00232882|Inflammatory markers|inflammatory markers
805329|NCT00232843|Peripheral Artery Occlusive Disease|peripheral artery occlusive disease
805330|NCT00232817|Postoperative pain|postoperative pain
805331|NCT00232726|Malignant melanoma|malignant melanoma
805332|NCT00232726|CP-4055|cp-4055
805333|NCT00232726|Chemotherapy-naïve patients|chemotherapy-naïve patients
805334|NCT00232726|Phase II|phase ii
805335|NCT00232726|Chemotherapy-naive patients|chemotherapy-naive patients
805336|NCT00232726|Metastatic malignant melanoma|metastatic malignant melanoma
805337|NCT00232713|Birth Defects|birth defects
805338|NCT00232713|Pregnancy|pregnancy
805339|NCT00232713|Uterine Fibroids|uterine fibroids
805340|NCT00232713|Fibroids|fibroids
805341|NCT00232700|Major depressive disorder|major depressive disorder
805342|NCT00232700|Repetitive transcranial magnetic stimulation|repetitive transcranial magnetic stimulation
805343|NCT00232674|Chronic Obstructive Pulmonary Disease|chronic obstructive pulmonary disease
805344|NCT00232635|RSV|rsv
805345|NCT00232635|HSCT|hsct
805346|NCT00232635|HEMATOPOIETIC STEM CELL TRANSPL|hematopoietic stem cell transpl
805347|NCT00232622|Prosthetic valve thrombosis|prosthetic valve thrombosis
805348|NCT00232622|Fibrinolysis|fibrinolysis
805349|NCT00232622|Streptokinase|streptokinase
805350|NCT00232609|Wheelchair|wheelchair
805351|NCT00232609|Exercise|exercise
805352|NCT00232609|Cardiovascular Disease|cardiovascular disease
805353|NCT00232596|Partial Seizures|partial seizures
805354|NCT00232596|Anticonvulsant|anticonvulsant
805355|NCT00232596|Complex Partial Seizures|complex partial seizures
805356|NCT00232596|Potassium Channels|potassium channels
805357|NCT00232596|Epilepsy|epilepsy
805358|NCT00232583|TYpe 2 diabetes mellitus|type 2 diabetes mellitus
805359|NCT00232583|Newly diagnosed|newly diagnosed
805360|NCT00232583|Beta-cell function|beta-cell function
805361|NCT00232570|sleep disturbance|sleep disturbance
805362|NCT00232570|dementia|dementia
805363|NCT00232557|Asthma|asthma
805364|NCT00232557|Disease Management|disease management
805365|NCT00232557|Telecommunications|telecommunications
805366|NCT00232557|Health Services|health services
805367|NCT00232557|Quality of Life|quality of life
805368|NCT00232557|Patient Compliance|patient compliance
805369|NCT00232544|sleep apnea, obstructive|sleep apnea, obstructive
805370|NCT00232544|Quality of Life|quality of life
805371|NCT00232544|Depression|depression
805372|NCT00232544|Patient Compliance|patient compliance
805373|NCT00232518|immune system|immune system
805374|NCT00232518|infection|infection
805375|NCT00232518|allergic rhinitis|allergic rhinitis
805376|NCT00232505|recurrent breast cancer|recurrent breast cancer
805377|NCT00232505|stage IV breast cancer|stage iv breast cancer
805378|NCT00232492|Wisdom|wisdom
805379|NCT00232492|Tooth|tooth
805380|NCT00232492|Teeth|teeth
805381|NCT00232492|Third|third
805382|NCT00232492|Molar|molar
805383|NCT00232466|Vertebroplasty|vertebroplasty
805384|NCT00232466|Vertebral fracture|vertebral fracture
805385|NCT00232466|Actonel|actonel
805386|NCT00232466|Osteoporotic|osteoporotic
805387|NCT00232466|vertebral|vertebral
805388|NCT00232466|fractures|fractures
805389|NCT00232427|Liver cirrhosis|liver cirrhosis
805390|NCT00232427|Hemodynamics|hemodynamics
805391|NCT00232427|Fluid balance|fluid balance
805392|NCT00232414|bipolar|bipolar
805393|NCT00232414|with acute depressive episode|with acute depressive episode
805394|NCT00232401|urine|urine
805395|NCT00232401|circadian rhythm|circadian rhythm
805396|NCT00232388|Ejection Fraction <35%|ejection fraction <35%
805397|NCT00232375|SPIDDM|spiddm
805398|NCT00232375|LADA|lada
805399|NCT00232375|GAD antibody|gad antibody
805400|NCT00232375|Beta cell function|beta cell function
805401|NCT00232375|Insulin|insulin
805402|NCT00232349|schizophrenia|schizophrenia
805403|NCT00232349|galantamine|galantamine
805404|NCT00232349|cholinesterase inhibitors|cholinesterase inhibitors
805405|NCT00232349|quality of life|quality of life
805406|NCT00232349|cognition|cognition
805407|NCT00232336|cocaine|cocaine
805408|NCT00232336|drug|drug
805409|NCT00232336|substance|substance
805410|NCT00232336|abuse|abuse
805411|NCT00232336|addiction|addiction
805412|NCT00232336|dependence|dependence
805413|NCT00232336|quetiapine|quetiapine
805414|NCT00232336|antipsychotic|antipsychotic
805415|NCT00232336|treatment|treatment
805416|NCT00232323|intensive care|intensive care
805417|NCT00232323|stress|stress
805418|NCT00232323|education|education
805419|NCT00232323|simulation|simulation
805420|NCT00232310|Atrial Fibrillation|atrial fibrillation
805421|NCT00232310|Atrial Flutter|atrial flutter
805422|NCT00232310|Electric Countershock|electric countershock
805423|NCT00232297|Tachycardia, Ventricular|tachycardia, ventricular
805424|NCT00232297|Ventricular Fibrillation|ventricular fibrillation
805425|NCT00232297|Defibrillators Implantable|defibrillators implantable
805426|NCT00232297|Arrhythmia|arrhythmia
805427|NCT00232297|Anti-arrhythmia agents|anti-arrhythmia agents
805428|NCT00232258|NK1 Antagonist|nk1 antagonist
805429|NCT00232258|Inflammatory Bowel Disease|inflammatory bowel disease
805430|NCT00232258|Mesalamine|mesalamine
805431|NCT00232232|Atrial mechanical stunning and|atrial mechanical stunning and
805432|NCT00232232|atrial electrical remodeling|atrial electrical remodeling
805433|NCT00232206|NSCLC|nsclc
805434|NCT00232206|Lung|lung
805435|NCT00232206|Cancer|cancer
805436|NCT00232206|Metastatic|metastatic
805437|NCT00232206|Neoadjuvant|neoadjuvant
805438|NCT00232206|Stage IB Non-Small Cell Lung Cancer (NSCLC)|stage ib non-small cell lung cancer (nsclc)
805439|NCT00232206|IIA Non-Small Cell Lung Cancer (NSCLC)|iia non-small cell lung cancer (nsclc)
805532|NCT00231660|Metformin|metformin
805440|NCT00232206|IIB Non-Small Cell Lung Cancer (NSCLC)|iib non-small cell lung cancer (nsclc)
805441|NCT00232206|Some IIIA Non-Small Cell Lung Cancer (NSCLC)|some iiia non-small cell lung cancer (nsclc)
805442|NCT00232193|Multiple Sclerosis|multiple sclerosis
805443|NCT00232193|Interferon Beta 1-a|interferon beta 1-a
805444|NCT00232193|Pulsed steroids|pulsed steroids
805445|NCT00232180|Open-label|open-label
805446|NCT00232180|single arm mortality/morbidity trial eplerenone chronic systolic heart failure|single arm mortality/morbidity trial eplerenone chronic systolic heart failure
805447|NCT00232115|Perioral Dermatitis, pimecrolimus cream|perioral dermatitis, pimecrolimus cream
805448|NCT00232102|Dyspepsia, gastrointestinal, tegaserod|dyspepsia, gastrointestinal, tegaserod
805449|NCT00232089|Dyspepsia, gastrointestinal, tegaserod|dyspepsia, gastrointestinal, tegaserod
805450|NCT00232076|Atopic Dermatitis, Ciclosporin,|atopic dermatitis, ciclosporin,
805451|NCT00232063|Atopic Dermatitis, Ciclosporin,|atopic dermatitis, ciclosporin,
805452|NCT00232050|Asthma, IgE, Omalizumab|asthma, ige, omalizumab
805453|NCT00232037|Dyspepsia, gastrointestinal, tegaserod|dyspepsia, gastrointestinal, tegaserod
805454|NCT00232024|Dyspepsia, gastrointestinal, tegaserod|dyspepsia, gastrointestinal, tegaserod
805455|NCT00232011|Atopic dermatitis, ASM981, pimecrolimus|atopic dermatitis, asm981, pimecrolimus
805456|NCT00231998|Atopic dermatitis, ASM981, pimecrolimus|atopic dermatitis, asm981, pimecrolimus
805457|NCT00231985|Habit-reversal Therapy|habit-reversal therapy
805458|NCT00231985|Behavior Therapy|behavior therapy
805459|NCT00231985|Supportive Therapy|supportive therapy
805461|NCT00231972|MSM|msm
805462|NCT00231959|Depression, Treatment-Resistant|depression, treatment-resistant
805463|NCT00231946|gonadotropins|gonadotropins
805464|NCT00231946|hormone therapy|hormone therapy
805465|NCT00231946|HRT|hrt
805466|NCT00231946|Antigonadotropin|antigonadotropin
805467|NCT00231946|Leuprolide|leuprolide
805468|NCT00231933|Person-centered Care|person-centered care
805469|NCT00231933|Recovery|recovery
805470|NCT00231933|Disparities|disparities
805471|NCT00231933|Culturally Responsive Care|culturally responsive care
805472|NCT00231933|Psychosis|psychosis
805473|NCT00231920|Influenza, Vaccine, Infants|influenza, vaccine, infants
805474|NCT00231907|influenza, vaccine, TIV, LAIV, booster, children|influenza, vaccine, tiv, laiv, booster, children
805475|NCT00231894|atypical antipsychotics|atypical antipsychotics
805476|NCT00231894|hyperglycemia|hyperglycemia
805477|NCT00231894|triglycerides|triglycerides
805478|NCT00231894|HDL|hdl
805479|NCT00231894|cholesterol|cholesterol
805480|NCT00231894|insulin resistance|insulin resistance
805481|NCT00231894|schizophrenia|schizophrenia
805482|NCT00231894|verbal memory|verbal memory
805483|NCT00231881|GORD – Oesophageal sensitivity- Oesophageal permeability|gord – oesophageal sensitivity- oesophageal permeability
805484|NCT00231868|Uterine Papillary Serous Carcinoma|uterine papillary serous carcinoma
805485|NCT00231868|UPSC|upsc
805486|NCT00231868|Radiation Therapy|radiation therapy
805487|NCT00231868|Chemotherapy|chemotherapy
805488|NCT00231855|Epithelial Ovarian Cancer|epithelial ovarian cancer
805489|NCT00231855|Uterine Cancer|uterine cancer
805490|NCT00231855|Prior Therapy|prior therapy
805491|NCT00231855|Chemotherapy|chemotherapy
805492|NCT00231855|Recurrence|recurrence
805493|NCT00231842|Mixed Mesodermal Tumor|mixed mesodermal tumor
805494|NCT00231842|MMT|mmt
805495|NCT00231842|Uterine Cancer|uterine cancer
805496|NCT00231842|Radiation Therapy|radiation therapy
805497|NCT00231842|Chemotherapy|chemotherapy
805498|NCT00231829|Treatment|treatment
805499|NCT00231829|Uterine Papillary Serous Carcinoma|uterine papillary serous carcinoma
805500|NCT00231829|Clear Cell Carcinoma|clear cell carcinoma
805501|NCT00231829|COX-2 Inhibitors|cox-2 inhibitors
805502|NCT00231816|Prevention of Herpes Zoster|prevention of herpes zoster
805503|NCT00231764|Renal transplantation|renal transplantation
805504|NCT00231764|Immunosuppression|immunosuppression
805505|NCT00231764|Daclizumab|daclizumab
805506|NCT00231764|GFR|gfr
805507|NCT00231751|Hemophilia A|hemophilia a
805508|NCT00231751|Inhibitors|inhibitors
805509|NCT00231738|Eicosapentaenoic acid|eicosapentaenoic acid
805510|NCT00231738|Coronary artery disease|coronary artery disease
805511|NCT00231712|prospective analysis of immune function,|prospective analysis of immune function,
805512|NCT00231712|spectratype|spectratype
805513|NCT00231712|immunoscope|immunoscope
805514|NCT00231712|TREC analysis|trec analysis
805515|NCT00231712|solid tumor|solid tumor
805516|NCT00231699|Prevention of Hypothermia|prevention of hypothermia
805517|NCT00231699|Pediatric Patient|pediatric patient
805518|NCT00231699|Cotton|cotton
805519|NCT00231699|Plastic wrap|plastic wrap
805520|NCT00231686|Lung function test|lung function test
805521|NCT00231686|Physical conditioning, human|physical conditioning, human
805522|NCT00231686|Physical fitness|physical fitness
805523|NCT00231686|Quality of life|quality of life
805524|NCT00231673|Diabetic peripheral polyneuropathy|diabetic peripheral polyneuropathy
805525|NCT00231673|Electrophysiology|electrophysiology
805526|NCT00231673|Nerve Conduction Study|nerve conduction study
805527|NCT00231673|Neurological Examination|neurological examination
805528|NCT00231673|Quantitative Sensory Testing|quantitative sensory testing
805529|NCT00231673|Topiramate|topiramate
805530|NCT00231660|Type 2 Diabetes|type 2 diabetes
805533|NCT00231660|Hemoglobin A1c|hemoglobin a1c
805534|NCT00231660|Adult-Onset Diabetes Mellitus (AODM)|adult-onset diabetes mellitus (aodm)
805535|NCT00231647|Obesity|obesity
805536|NCT00231647|Type 2 Diabetes Mellitus|type 2 diabetes mellitus
805537|NCT00231647|Metformin|metformin
805538|NCT00231647|Diabetic Diet|diabetic diet
805539|NCT00231647|Topiramate|topiramate
805540|NCT00231647|Adult-Onset Diabetes Mellitus (AODM)|adult-onset diabetes mellitus (aodm)
805541|NCT00231634|Obesity|obesity
805542|NCT00231634|Type 2 Diabetes Mellitus|type 2 diabetes mellitus
805543|NCT00231634|HbA1c|hba1c
805544|NCT00231634|Sulfonylurea|sulfonylurea
805545|NCT00231634|Topiramate|topiramate
805546|NCT00231634|Adult-Onset Diabetes Mellitus (AODM)|adult-onset diabetes mellitus (aodm)
805547|NCT00231621|Obesity|obesity
805548|NCT00231621|Dyslipidemia|dyslipidemia
805549|NCT00231621|Hyperlipidemia|hyperlipidemia
805550|NCT00231621|Triglyceride|triglyceride
805551|NCT00231621|HDL|hdl
805552|NCT00231621|LDL|ldl
805553|NCT00231621|Diabetes|diabetes
805554|NCT00231608|Obesity|obesity
805555|NCT00231608|Abdominal Obesity|abdominal obesity
805556|NCT00231608|Visceral Fat|visceral fat
805557|NCT00231608|Subcutaneous Fat|subcutaneous fat
805558|NCT00231608|Dislipidemia|dislipidemia
805559|NCT00231608|Hypertension|hypertension
805560|NCT00231608|Type 2 Diabetes Mellitus|type 2 diabetes mellitus
805561|NCT00231595|Migraine|migraine
805562|NCT00231595|Common Migraine|common migraine
805563|NCT00231595|Classic Migraine|classic migraine
805564|NCT00231595|Headache|headache
805565|NCT00231595|Topiramate|topiramate
805566|NCT00231595|Prophylaxis|prophylaxis
805567|NCT00231595|Prevention|prevention
805568|NCT00231582|High-dose with autologous germ-cell tumors|high-dose with autologous germ-cell tumors
805569|NCT00231569|LDL-cholesterol|ldl-cholesterol
805570|NCT00231569|apoB-100|apob-100
805571|NCT00231569|apoB-48|apob-48
805572|NCT00231556|Epilepsy|epilepsy
805573|NCT00231556|Seizures|seizures
805574|NCT00231556|Parital Epilepsies|parital epilepsies
805575|NCT00231556|Generalized Epilepsy|generalized epilepsy
805576|NCT00231556|Tonic-Clonic Epilepsy|tonic-clonic epilepsy
805577|NCT00231556|Topiramate|topiramate
805578|NCT00231530|Type 2 Diabetes Mellitus|type 2 diabetes mellitus
805579|NCT00231530|Obesity|obesity
805580|NCT00231530|Diabetic Diet|diabetic diet
805581|NCT00231530|Hypertension|hypertension
805582|NCT00231530|Hyperlipidemia|hyperlipidemia
805583|NCT00231530|Adult-Onset Diabetes Mellitus(AODM)|adult-onset diabetes mellitus(aodm)
805584|NCT00231504|Polymorphism P1|polymorphism p1
805585|NCT00231504|Polymorphism P2|polymorphism p2
805586|NCT00231504|FSH Receptor|fsh receptor
805587|NCT00231504|Antral follicle count|antral follicle count
805588|NCT00231504|FSH receptor polymorphism|fsh receptor polymorphism
805589|NCT00231491|Overactive bladder|overactive bladder
805590|NCT00231491|Urgency|urgency
805591|NCT00231491|Urge incontinence|urge incontinence
805592|NCT00231491|Botulinum toxin A|botulinum toxin a
805593|NCT00231491|Quality of life|quality of life
805594|NCT00231465|elderly|elderly
805595|NCT00231465|malignant pleural effusion|malignant pleural effusion
805596|NCT00231452|natural acquired immunity,|natural acquired immunity,
805597|NCT00231452|clinical malaria,|clinical malaria,
805598|NCT00231452|P. falciparum,|p. falciparum,
805599|NCT00231452|age,|age,
805600|NCT00231452|exposure,|exposure,
805601|NCT00231452|neonatal immunology,|neonatal immunology,
805602|NCT00231452|infants|infants
805603|NCT00231439|Post-polio syndrome|post-polio syndrome
805604|NCT00231439|IvIg|ivig
805605|NCT00231400|Glycogen Storage Disease Type II (GSD-II)|glycogen storage disease type ii (gsd-ii)
805606|NCT00231400|GSD-II|gsd-ii
805607|NCT00231400|Pompe Disease|pompe disease
805608|NCT00231400|Pompe Disease (late-onset)|pompe disease (late-onset)
805609|NCT00231400|Acid Maltase Deficiency Disease|acid maltase deficiency disease
805610|NCT00231400|Glycogenosis II|glycogenosis ii
805611|NCT00231387|diabetes rosiglitazone plaque|diabetes rosiglitazone plaque
805612|NCT00231374|cerebrospinal fluid|cerebrospinal fluid
805613|NCT00231374|pain in cervical spine|pain in cervical spine
805614|NCT00231374|pain in lumbar spine|pain in lumbar spine
805615|NCT00231374|myelogram|myelogram
805616|NCT00231348|Social anxiety disorder|social anxiety disorder
805617|NCT00231348|social phobia|social phobia
805618|NCT00231348|positron emission tomography (PET|positron emission tomography (pet
805619|NCT00231348|regional cerebral blood flow (rCBF)|regional cerebral blood flow (rcbf)
805620|NCT00231348|nefazodone|nefazodone
805621|NCT00231348|amygdala|amygdala
805622|NCT00231335|schizophrenia|schizophrenia
805623|NCT00231335|depression|depression
805624|NCT00231335|anxiety|anxiety
805625|NCT00231335|negative symptoms|negative symptoms
805626|NCT00231322|Schistosoma haematobium|schistosoma haematobium
805627|NCT00231322|haematuria|haematuria
805628|NCT00231322|ultrasonography|ultrasonography
805629|NCT00231322|Uganda|uganda
805630|NCT00231322|Vesical polyps|vesical polyps
805631|NCT00231309|G-CSF|g-csf
805632|NCT00231309|Bone Marrow|bone marrow
805633|NCT00231309|Hematologic malignancies|hematologic malignancies
805634|NCT00231309|Non-malignancies|non-malignancies
805635|NCT00231309|Matched sibling donor|matched sibling donor
805636|NCT00231309|Allogeneic BMT|allogeneic bmt
805637|NCT00231296|cryoablation|cryoablation
805638|NCT00231296|atrial fibrillation|atrial fibrillation
805639|NCT00231218|vitamin c|vitamin c
805640|NCT00231218|echinacea|echinacea
805641|NCT00231218|propolis|propolis
805642|NCT00231218|upper respiratory tract infection|upper respiratory tract infection
805643|NCT00231218|common cold|common cold
805644|NCT00231218|gastroenteritis|gastroenteritis
805645|NCT00231218|dietary supplement|dietary supplement
805646|NCT00231218|herbal remedy|herbal remedy
805647|NCT00231205|viability|viability
805648|NCT00231205|myocardium|myocardium
805649|NCT00231205|preejection velocity|preejection velocity
805650|NCT00231205|CAD|cad
805651|NCT00231205|echocardiography|echocardiography
805652|NCT00231205|tissue Doppler|tissue doppler
805653|NCT00231192|Diabetes|diabetes
805654|NCT00231192|Adolescents|adolescents
805655|NCT00231192|Cystic Fibrosis|cystic fibrosis
805656|NCT00231192|Insulin|insulin
805657|NCT00231192|Repaglinide|repaglinide
805658|NCT00231179|child, preschool|child, preschool
805659|NCT00231179|intelligence|intelligence
805660|NCT00231179|environment|environment
805661|NCT00231179|home visiting|home visiting
805662|NCT00231166|dose-finding|dose-finding
805663|NCT00231166|monoclonal antibody|monoclonal antibody
805664|NCT00231166|Multiple Myeloma|multiple myeloma
805665|NCT00231153|catheter site infection|catheter site infection
805666|NCT00231153|catheter colonization|catheter colonization
805667|NCT00231153|catheter related blood stream infection|catheter related blood stream infection
805668|NCT00231153|patients with central venous catheters|patients with central venous catheters
805669|NCT00231140|ALS, motor neuron disease|als, motor neuron disease
805670|NCT00231127|COPD|copd
805671|NCT00231127|Osteoporosis|osteoporosis
805672|NCT00231127|Osteopenia|osteopenia
805673|NCT00231127|Glucocorticoids|glucocorticoids
805674|NCT00231127|GOLD|gold
805675|NCT00231127|BODE|bode
805676|NCT00231114|Asthma|asthma
805677|NCT00231101|Smoking|smoking
805678|NCT00231101|Schizophrenia|schizophrenia
805679|NCT00231075|Epithelial ovary cancer F.I.G.O. stages III or IV|epithelial ovary cancer f.i.g.o. stages iii or iv
805680|NCT00231075|70 years or older|70 years or older
805681|NCT00231062|sinusitis|sinusitis
805682|NCT00231062|rhinitis|rhinitis
805683|NCT00231062|sinus surgery|sinus surgery
805684|NCT00231062|maxillary|maxillary
805685|NCT00231062|ethmoid|ethmoid
805686|NCT00231062|sphenoid|sphenoid
805687|NCT00231062|frontal|frontal
805688|NCT00231062|FESS|fess
805689|NCT00231062|sinuplasty|sinuplasty
805690|NCT00231049|Genital Herpes|genital herpes
805691|NCT00231049|HSV-2 Seropositive|hsv-2 seropositive
805692|NCT00231049|Vaccine|vaccine
805693|NCT00231023|Anterior Subtenon|anterior subtenon
805694|NCT00231023|Posterior Peribulbar|posterior peribulbar
805695|NCT00231023|Laser Photocoagulation|laser photocoagulation
805696|NCT00231023|Diabetes|diabetes
805697|NCT00231023|Diabetic Retinopathy|diabetic retinopathy
805698|NCT00231023|Diabetic Macular Edema|diabetic macular edema
805699|NCT00231023|DME|dme
805700|NCT00231010|Retnitis Pigmentosa|retnitis pigmentosa
805701|NCT00231010|Retinal Degeneration|retinal degeneration
805702|NCT00231010|Retinitis Pigmentosa|retinitis pigmentosa
805703|NCT00231010|RP|rp
805704|NCT00231010|Usher Syndrome|usher syndrome
805705|NCT00231010|USH|ush
805706|NCT00231010|Bietti Crystalline Dystrophy|bietti crystalline dystrophy
805707|NCT00231010|BCD|bcd
805708|NCT00230997|Galantamine|galantamine
805709|NCT00230997|Dementia with Lewy Bodies|dementia with lewy bodies
805710|NCT00230997|Treatment|treatment
805711|NCT00230984|Chronic Respiratory Failure|chronic respiratory failure
805712|NCT00230984|Pulmonary Rehabilitation|pulmonary rehabilitation
805713|NCT00230984|Nutritional Depletion|nutritional depletion
805714|NCT00230984|Home|home
805715|NCT00230984|COPD|copd
805716|NCT00230984|Oral Dietary Supplements|oral dietary supplements
805717|NCT00230984|Therapeutic Education|therapeutic education
805718|NCT00230984|Androgens|androgens
805719|NCT00230984|Exacerbation|exacerbation
805721|NCT00230971|Intra-Abdominal Infections|intra-abdominal infections
805722|NCT00230971|Abscess|abscess
805723|NCT00230958|Viramidine|viramidine
805724|NCT00230958|Ribavirin|ribavirin
805725|NCT00230958|Valeant|valeant
805726|NCT00230958|Hepatitis C|hepatitis c
805727|NCT00230958|Pegylated interferon alfa-2b|pegylated interferon alfa-2b
805728|NCT00230932|Veterans|veterans
805729|NCT00230932|Pain|pain
805730|NCT00230932|Palliative Care|palliative care
805731|NCT00230932|Cardiology|cardiology
805732|NCT00230932|Reproducibility of Results|reproducibility of results
805733|NCT00230932|Health Personnel|health personnel
805734|NCT00230932|Heart Failure, Congestive|heart failure, congestive
805735|NCT00230919|Obesity,|obesity,
805736|NCT00230919|weight loss,|weight loss,
805737|NCT00230919|diet counseling|diet counseling
805738|NCT00230919|low-glycemic load|low-glycemic load
805739|NCT00230893|Antipsychotics|antipsychotics
805740|NCT00230893|PTSD|ptsd
805741|NCT00230893|Post Traumatic Stress Disorder|post traumatic stress disorder
805742|NCT00230893|monotherapy|monotherapy
805743|NCT00230893|adjunct therapy|adjunct therapy
805744|NCT00230880|Contraception behavior|contraception behavior
805745|NCT00230880|Condoms|condoms
805746|NCT00230880|Unsafe sex|unsafe sex
805747|NCT00230880|Pregnancy unwanted|pregnancy unwanted
805748|NCT00230880|Adolescent pregnancy|adolescent pregnancy
805749|NCT00230880|Condom use|condom use
805750|NCT00230880|Unprotected sex|unprotected sex
805751|NCT00230880|Unintended pregnancy|unintended pregnancy
805752|NCT00230867|herpes labialis|herpes labialis
805753|NCT00230867|cold sore|cold sore
805754|NCT00230867|acyclovir|acyclovir
805755|NCT00230867|iontophoresis|iontophoresis
805756|NCT00230867|topical|topical
805757|NCT00230854|hepatitis C|hepatitis c
805758|NCT00230854|genotype 1|genotype 1
805759|NCT00230854|non-responders|non-responders
805760|NCT00230854|viral hepatitis|viral hepatitis
805761|NCT00230841|croup|croup
805762|NCT00230841|humidity therapy|humidity therapy
805763|NCT00230841|pediatrics|pediatrics
805764|NCT00230815|Oligoanovulatory infertility|oligoanovulatory infertility
805765|NCT00230815|Follitropin alfa|follitropin alfa
805766|NCT00230815|Pen device|pen device
805767|NCT00230815|Gonal-f®|gonal-f®
805768|NCT00230815|Recombinant Human Choriogonadotropin (r-hCG)|recombinant human choriogonadotropin (r-hcg)
805769|NCT00230815|Ovidrel®|ovidrel®
805770|NCT00230802|pregnancy|pregnancy
805771|NCT00230802|hypothyroidism|hypothyroidism
805772|NCT00230802|levothyroxine|levothyroxine
805773|NCT00230750|influenza, elderly, vaccine, H5N1, parent protocol|influenza, elderly, vaccine, h5n1, parent protocol
805774|NCT00230737|Aged|aged
805775|NCT00230737|Sleep|sleep
805776|NCT00230737|Insomnia|insomnia
805777|NCT00230737|Melatonin|melatonin
805778|NCT00230737|Neurobehavioral Manifestations|neurobehavioral manifestations
805779|NCT00230737|Circadian Rhythms|circadian rhythms
805780|NCT00230737|Human|human
805781|NCT00230737|Polysomnography|polysomnography
805782|NCT00230737|Elderly|elderly
805783|NCT00230724|Exercise maintenance|exercise maintenance
805784|NCT00230711|Physical activity|physical activity
805785|NCT00230711|Cancer follow-up care|cancer follow-up care
805786|NCT00230698|Epilepsy|epilepsy
805787|NCT00230698|Partial Epilepsies|partial epilepsies
805788|NCT00230698|Seizures|seizures
805789|NCT00230698|Topiramate|topiramate
805790|NCT00230685|Pulmonary arteriovenous malformations|pulmonary arteriovenous malformations
805791|NCT00230646|cancer recovery|cancer recovery
805792|NCT00230646|physical activity|physical activity
805793|NCT00230633|Telangiectasia|telangiectasia
805794|NCT00230607|alpha Galactosidase A|alpha galactosidase a
805795|NCT00230607|aGAL|agal
805796|NCT00230607|rh aGAL|rh agal
805797|NCT00230607|Fabry|fabry
805798|NCT00230607|GL3|gl3
805799|NCT00230607|Fabrazyme|fabrazyme
805800|NCT00230607|Lysosomal Storage Disorder|lysosomal storage disorder
805801|NCT00230607|Enzyme Replacement Therapy (ERT)|enzyme replacement therapy (ert)
805802|NCT00230581|IBS-d, IBS|ibs-d, ibs
805803|NCT00230568|Mild to Moderate Alzheimer's Disease|mild to moderate alzheimer's disease
805804|NCT00230568|Hispanic|hispanic
805805|NCT00230568|Latino|latino
805806|NCT00230568|Spanish-speaking|spanish-speaking
805807|NCT00230555|child, preschool|child, preschool
805808|NCT00230555|environment|environment
805809|NCT00230555|intelligence|intelligence
805810|NCT00230542|platinum-sensitive recurrence|platinum-sensitive recurrence
805811|NCT00230542|carboplatin|carboplatin
805812|NCT00230542|pemetrexed|pemetrexed
805813|NCT00230529|Plaque-type Psoriasis|plaque-type psoriasis
805814|NCT00230529|infliximab|infliximab
805815|NCT00230529|Remicade|remicade
805816|NCT00230529|biologics|biologics
805817|NCT00230516|N/A this study is being conducted with healthy volunteers|n/a this study is being conducted with healthy volunteers
805818|NCT00230503|Hepatitis B, Chronic|hepatitis b, chronic
805819|NCT00230503|Hepatitis B Virus|hepatitis b virus
805820|NCT00230503|Pradefovir Mesylate|pradefovir mesylate
805821|NCT00230503|Adefovir Dipivoxyl|adefovir dipivoxyl
805822|NCT00230490|Hepatitis B, Chronic|hepatitis b, chronic
805823|NCT00230490|Hepatitis B Virus|hepatitis b virus
805824|NCT00230490|Pradefovir Mesylate|pradefovir mesylate
805825|NCT00230490|Adefovir Dipivoxyl|adefovir dipivoxyl
805826|NCT00230477|Hepatitis B|hepatitis b
805827|NCT00230464|diabetes|diabetes
805828|NCT00230464|rate of appearance of glucose|rate of appearance of glucose
805829|NCT00230464|insulin secretion|insulin secretion
805830|NCT00230464|glucagon|glucagon
805831|NCT00230425|Alcohol Abuse|alcohol abuse
805832|NCT00230425|Anxiety Disorders|anxiety disorders
805833|NCT00230425|Mood Disorders|mood disorders
805834|NCT00230412|Kidney Failure, Acute|kidney failure, acute
805835|NCT00230412|Acute Renal Failure|acute renal failure
805836|NCT00230412|Kidney Failure|kidney failure
805837|NCT00230412|Heat-Shock Proteins|heat-shock proteins
805838|NCT00230412|Children|children
805839|NCT00230373|Localized scleroderma|localized scleroderma
805840|NCT00230360|constipation|constipation
805942|NCT00229853|pediatric|pediatric
805841|NCT00230360|fecal incontinence|fecal incontinence
805842|NCT00230360|diagnosis|diagnosis
805843|NCT00230360|children|children
805844|NCT00230308|Head and Neck Cancer|head and neck cancer
805845|NCT00230243|Aspergillosis|aspergillosis
805846|NCT00230243|CandidiasisMucormycosis|candidiasismucormycosis
805847|NCT00230243|FusariosisCryptococcosis|fusariosiscryptococcosis
805848|NCT00230243|Endemic Fungal infections|endemic fungal infections
805849|NCT00230243|Phaeohyphomycosis|phaeohyphomycosis
805850|NCT00230217|Relapse|relapse
805851|NCT00230217|Refracturing|refracturing
805852|NCT00230217|Leukemia|leukemia
805853|NCT00230217|Lymphoma|lymphoma
805854|NCT00230217|Solid Tumor|solid tumor
805855|NCT00230204|Multiple sclerosis|multiple sclerosis
805856|NCT00230204|Antibodies|antibodies
805857|NCT00230204|Serum|serum
805858|NCT00230204|Infectious agents|infectious agents
805859|NCT00230204|Immunoglobulin G|immunoglobulin g
805860|NCT00230204|Immunoglobulin M|immunoglobulin m
805861|NCT00230191|Oral|oral
805862|NCT00230191|Mucositis|mucositis
805863|NCT00230191|Stomatitis|stomatitis
805864|NCT00230191|Head and Neck Cancer|head and neck cancer
805865|NCT00230178|Hyperuricemia|hyperuricemia
805866|NCT00230178|Tumor lysis syndrome|tumor lysis syndrome
805867|NCT00230178|Leukemia|leukemia
805868|NCT00230178|Lymphoma|lymphoma
805869|NCT00230178|Myelodysplastic Syndromes|myelodysplastic syndromes
805870|NCT00230178|Solid tumor cancers|solid tumor cancers
805871|NCT00230178|Solid Tumor cancers with hyperuricemia Hyperuricemia (cancer patients only)|solid tumor cancers with hyperuricemia hyperuricemia (cancer patients only)
805872|NCT00230178|Tumor lysis syndrome (cancer patients only)|tumor lysis syndrome (cancer patients only)
805873|NCT00230165|Platelets|platelets
805874|NCT00230165|Erythrocytes|erythrocytes
805875|NCT00230165|Leukocytes|leukocytes
805876|NCT00230165|Coagulation|coagulation
805877|NCT00230165|Thrombosis|thrombosis
805878|NCT00230126|African Americans|african americans
805879|NCT00230113|NAFLD|nafld
805880|NCT00230113|NASH|nash
805881|NCT00230113|Fatty Liver Disease|fatty liver disease
805882|NCT00230113|Omega-3 Fatty Acid|omega-3 fatty acid
805883|NCT00230113|Fish oil|fish oil
805884|NCT00230100|Gender differences|gender differences
805885|NCT00230100|Women|women
805886|NCT00230100|Substance use disorders|substance use disorders
805887|NCT00230100|Alcohol use disorders|alcohol use disorders
805888|NCT00230100|Treatment outcomes|treatment outcomes
805889|NCT00230100|Group therapy|group therapy
805890|NCT00230087|diabetes|diabetes
805891|NCT00230087|nafld|nafld
805892|NCT00230087|nash|nash
805893|NCT00230087|phlebotomy|phlebotomy
805894|NCT00230074|Amyotrophic Lateral Sclerosis; ALS|amyotrophic lateral sclerosis; als
805895|NCT00230061|HIV|hiv
805896|NCT00230009|child abuse, child neglect, substance use, violence exposure, brief intervention|child abuse, child neglect, substance use, violence exposure, brief intervention
805897|NCT00229996|endometriosis|endometriosis
805898|NCT00229996|pelvic pain|pelvic pain
805899|NCT00229996|treatment|treatment
805900|NCT00229983|Substance use disorders|substance use disorders
805901|NCT00229983|Substance abuse|substance abuse
805902|NCT00229983|Alcohol abuse|alcohol abuse
805903|NCT00229983|Drug abuse|drug abuse
805904|NCT00229957|Occupational therapy|occupational therapy
805905|NCT00229957|Physical therapy techniques|physical therapy techniques
805906|NCT00229957|Primary health care|primary health care
805907|NCT00229957|Chronic disease|chronic disease
805908|NCT00229957|Rehabilitation|rehabilitation
805909|NCT00229957|Disease management|disease management
805910|NCT00229957|Self care|self care
805911|NCT00229944|Azithromycin|azithromycin
805912|NCT00229944|V. cholerae O1 / O139|v. cholerae o1 / o139
805913|NCT00229944|adults|adults
805914|NCT00229944|Bangladesh|bangladesh
805915|NCT00229944|Clinical trial|clinical trial
805916|NCT00229931|CATARACT EXTRACTION|cataract extraction
805917|NCT00229931|MACULAR EDEMA|macular edema
805918|NCT00229931|DIABETES|diabetes
805919|NCT00229931|FOCAL LASER|focal laser
805920|NCT00229931|TRIAMCINOLONE|triamcinolone
805921|NCT00229918|Diabetic macular edema|diabetic macular edema
806022|NCT00229567|acute postoperative pain|acute postoperative pain
805922|NCT00229918|Clinically significant macular edema|clinically significant macular edema
805923|NCT00229905|pediatric health|pediatric health
805924|NCT00229905|children|children
805925|NCT00229905|single case study|single case study
805926|NCT00229892|pediatric health|pediatric health
805927|NCT00229892|cardiac|cardiac
805928|NCT00229892|small incisions|small incisions
805929|NCT00229892|operations|operations
805930|NCT00229892|minimally invasive|minimally invasive
805931|NCT00229879|pediatric health|pediatric health
805932|NCT00229879|rare tumor|rare tumor
805933|NCT00229879|children|children
805934|NCT00229879|cardiac|cardiac
805935|NCT00229866|newborn|newborn
805936|NCT00229866|pediatric health|pediatric health
805937|NCT00229866|Feeding difficulty|feeding difficulty
805938|NCT00229866|discharge with a NG tube|discharge with a ng tube
805939|NCT00229866|G-tube placement|g-tube placement
805940|NCT00229866|Nissen fundoplication|nissen fundoplication
805941|NCT00229853|Children's Healthcare of Atlanta|children's healthcare of atlanta
805943|NCT00229853|Thoracoscopic Vascular ring|thoracoscopic vascular ring
805944|NCT00229853|diverticulopexy|diverticulopexy
805945|NCT00229853|Vascular Ring Division|vascular ring division
805946|NCT00229840|MRI, fMRI, Epilepsy, Pediatric|mri, fmri, epilepsy, pediatric
805947|NCT00229827|pediatric health|pediatric health
805948|NCT00229827|cardiac|cardiac
805949|NCT00229827|pediatric population|pediatric population
805950|NCT00229827|congenital heart surgery|congenital heart surgery
805951|NCT00229827|left to right shunt lesions|left to right shunt lesions
805952|NCT00229827|heart surgery|heart surgery
805953|NCT00229827|Atrioventricular canal defects|atrioventricular canal defects
805954|NCT00229814|Tectal Plate Glioma|tectal plate glioma
805955|NCT00229814|Tumor|tumor
805956|NCT00229814|Brain|brain
805957|NCT00229814|MRI|mri
805958|NCT00229814|Spectroscopy|spectroscopy
805959|NCT00229801|Renal Function, MRI|renal function, mri
805960|NCT00229788|orthotopic heart transplantation|orthotopic heart transplantation
805961|NCT00229775|Plasmodium falciparum malaria|plasmodium falciparum malaria
805962|NCT00229775|malaria|malaria
805963|NCT00229775|artemether lumafantrine|artemether lumafantrine
805964|NCT00229775|chloroquine|chloroquine
805965|NCT00229775|sulfadoxine pyrimethamine|sulfadoxine pyrimethamine
805966|NCT00229775|Coartem|coartem
805967|NCT00229762|pneumococcal vaccination coverage with no disease or efficacy outcomes recorded|pneumococcal vaccination coverage with no disease or efficacy outcomes recorded
805968|NCT00229749|HCV|hcv
805969|NCT00229723|Head and Neck Squamous Cell Carcinoma|head and neck squamous cell carcinoma
805970|NCT00229723|Head and Neck Squamous Cell Cancer|head and neck squamous cell cancer
805971|NCT00229723|Squamous Cell Carcinoma|squamous cell carcinoma
805972|NCT00229723|Squamous Cell Cancer|squamous cell cancer
805973|NCT00229710|Diabetes Mellitus, Type II|diabetes mellitus, type ii
805974|NCT00229710|Type 2 Diabetes Mellitus|type 2 diabetes mellitus
805975|NCT00229697|Breast cancer|breast cancer
805976|NCT00229697|metastatic breast cancer|metastatic breast cancer
805977|NCT00229684|Type 2 Diabetes|type 2 diabetes
805978|NCT00229658|diabetes|diabetes
805979|NCT00229658|pramlintide|pramlintide
805980|NCT00229658|Symlin|symlin
805981|NCT00229658|Amylin|amylin
805982|NCT00229658|phase 4|phase 4
805983|NCT00229645|Major Depression|major depression
805984|NCT00229645|Anxiety|anxiety
805985|NCT00229632|Friedreich's Ataxia|friedreich's ataxia
805986|NCT00229632|Idebenone|idebenone
805987|NCT00229632|Ataxia|ataxia
805988|NCT00229632|Drug Trial|drug trial
805989|NCT00229632|Randomized Trial|randomized trial
805990|NCT00229632|Friedreich Ataxia|friedreich ataxia
805991|NCT00229632|FA|fa
805992|NCT00229619|rituxan|rituxan
805993|NCT00229619|Immunosuppression|immunosuppression
805994|NCT00229619|Bone Marrow Failure|bone marrow failure
805995|NCT00229619|Monoclonal Antibody Therapy|monoclonal antibody therapy
805996|NCT00229619|Diamond Blackfan Anemia (DBA)|diamond blackfan anemia (dba)
805997|NCT00229619|T -Cells|t -cells
805998|NCT00229619|B-Cells|b-cells
805999|NCT00229619|Hematopoiesis|hematopoiesis
806000|NCT00229619|Moderate Aplastic Anemia (MAA)|moderate aplastic anemia (maa)
806001|NCT00229619|Diamond-Blackfan Anemia|diamond-blackfan anemia
806002|NCT00229619|DBA|dba
806003|NCT00229619|Pure Red Cell Aplasia|pure red cell aplasia
806004|NCT00229619|PRCA|prca
806005|NCT00229593|Male contraception|male contraception
806006|NCT00229593|Androgen|androgen
806007|NCT00229593|Progestin|progestin
806008|NCT00229593|Spermatogenesis|spermatogenesis
806009|NCT00229593|Gonadotropin suppression|gonadotropin suppression
806010|NCT00229593|Testosterone|testosterone
806011|NCT00229593|Nestorone|nestorone
806012|NCT00229580|Brief Intervention|brief intervention
806013|NCT00229580|Motivational Interviewing|motivational interviewing
806014|NCT00229580|Health Psychology|health psychology
806015|NCT00229580|Alcohol|alcohol
806016|NCT00229580|Hepatitis C|hepatitis c
806017|NCT00229580|Patient Education|patient education
806018|NCT00229567|ketamine|ketamine
806019|NCT00229567|lidocaine|lidocaine
806020|NCT00229567|postoperative ileus|postoperative ileus
806021|NCT00229567|randomized controlled trial|randomized controlled trial
806023|NCT00229554|health surveys|health surveys
806024|NCT00229554|questionnaires|questionnaires
806025|NCT00229541|Medical in-patient rehabilitation|medical in-patient rehabilitation
806026|NCT00229541|Gainfully employed|gainfully employed
806027|NCT00229541|Work incapacity|work incapacity
806028|NCT00229515|Myocardial infarction|myocardial infarction
806029|NCT00229515|Revascularization|revascularization
806030|NCT00229515|Stent|stent
806031|NCT00229515|ST segment elevation|st segment elevation
806032|NCT00229476|Depression|depression
806033|NCT00229476|EEG|eeg
806034|NCT00229476|QEEG|qeeg
806035|NCT00229476|cordance|cordance
806036|NCT00229476|Zoloft|zoloft
806037|NCT00229476|sertraline|sertraline
806038|NCT00229476|placebo|placebo
806039|NCT00229476|electroencephalogram|electroencephalogram
806040|NCT00229476|brain|brain
806041|NCT00229476|antidepressants|antidepressants
806042|NCT00229463|Depression|depression
806043|NCT00229463|genetic|genetic
806044|NCT00229463|gene|gene
806045|NCT00229463|antidepressant|antidepressant
806046|NCT00229463|research|research
806047|NCT00229450|depression|depression
806048|NCT00229450|menopause|menopause
806049|NCT00229450|perimenopause|perimenopause
806050|NCT00229450|mood|mood
806051|NCT00229450|memory|memory
806052|NCT00229450|perimenopausal|perimenopausal
806053|NCT00229450|antidepressant|antidepressant
806054|NCT00229450|estrogen|estrogen
806055|NCT00229437|Diabetic Mononeuropathy|diabetic mononeuropathy
806056|NCT00229437|Diabetic Neuralgia|diabetic neuralgia
806057|NCT00229437|Mononeuropathy, Diabetic|mononeuropathy, diabetic
806058|NCT00229437|Neuralgia, Diabetic|neuralgia, diabetic
806059|NCT00229437|Diabetic Polyneuropathy|diabetic polyneuropathy
806060|NCT00229437|Drug Therapy|drug therapy
806061|NCT00229424|lafutidine|lafutidine
806062|NCT00229424|reflux oesophagitis|reflux oesophagitis
806063|NCT00229424|Gastroesophageal Reflux|gastroesophageal reflux
806064|NCT00229424|famotidine|famotidine
806065|NCT00229424|Double Blind|double blind
806066|NCT00229424|Controlled Study|controlled study
806067|NCT00229424|H2 receptor antagonist|h2 receptor antagonist
806068|NCT00229424|H2-blocker|h2-blocker
806069|NCT00229411|intensive care|intensive care
806070|NCT00229411|teamwork|teamwork
806071|NCT00229411|medical errors|medical errors
806072|NCT00229411|education|education
806073|NCT00229411|simulation|simulation
806074|NCT00229333|Escitalopram|escitalopram
806075|NCT00229333|Depression|depression
806076|NCT00229333|Dementia|dementia
806077|NCT00229333|Treatment|treatment
806078|NCT00229333|Depressive Syndrome in Alzheimer’s Disease|depressive syndrome in alzheimer’s disease
806079|NCT00229333|Depressive Syndrome in Vascular Dementia|depressive syndrome in vascular dementia
806080|NCT00229333|Depressive Syndrome in Mixed Vascular and Alzheimer’s Dementia|depressive syndrome in mixed vascular and alzheimer’s dementia
806081|NCT00229307|Post traumatic stress disorder|post traumatic stress disorder
806082|NCT00229268|Healthy Volunteers|healthy volunteers
806083|NCT00229255|Non-Alcoholic hepatic steatosis|non-alcoholic hepatic steatosis
806084|NCT00229242|Ambulatory blood pressure monitoring|ambulatory blood pressure monitoring
806085|NCT00229242|Echocardiography|echocardiography
806086|NCT00229242|Diastolic function|diastolic function
806087|NCT00229242|Left ventricular mass regression|left ventricular mass regression
806088|NCT00229229|Obesity|obesity
806089|NCT00229229|Cardiovascular Disease|cardiovascular disease
806090|NCT00229229|Metabolic Syndrome|metabolic syndrome
806091|NCT00229229|Canada Food Guide|canada food guide
806092|NCT00229229|Glycemic Index|glycemic index
806093|NCT00229229|Glycemic Load|glycemic load
806094|NCT00229203|Myeloma|myeloma
806095|NCT00229203|Aplidin|aplidin
806096|NCT00229203|Plitidepsin|plitidepsin
806097|NCT00229203|PharmaMar|pharmamar
806098|NCT00229190|Nasal lavage fluid|nasal lavage fluid
806099|NCT00229190|Eosinophils|eosinophils
806100|NCT00229190|Reproducibility of results|reproducibility of results
806101|NCT00229177|ONO-2506|ono-2506
806102|NCT00229177|stroke|stroke
806103|NCT00229177|Acute ischemic stroke|acute ischemic stroke
806104|NCT00229164|Primary Dysmenorrhea,|primary dysmenorrhea,
806105|NCT00229164|Transcutaneous Electric Nerve Stimulation|transcutaneous electric nerve stimulation
806106|NCT00229138|De novo kidney recipients,|de novo kidney recipients,
806107|NCT00229138|EC-MPS,|ec-mps,
806108|NCT00229138|tacrolimus,|tacrolimus,
806109|NCT00229138|efficacy,|efficacy,
806110|NCT00229138|safety,|safety,
806111|NCT00229138|glomerular filtration rate|glomerular filtration rate
806112|NCT00229138|Treatment in de novo kidney recipients|treatment in de novo kidney recipients
806113|NCT00229125|Alcohol Withdrawal Syndrome|alcohol withdrawal syndrome
806114|NCT00229125|CIWA-Ar|ciwa-ar
806115|NCT00229125|Acoustic Startle Procedure|acoustic startle procedure
806116|NCT00229125|Rebound Effect|rebound effect
806117|NCT00229073|dapoxetine|dapoxetine
806118|NCT00229073|premature ejaculation|premature ejaculation
806119|NCT00229073|ejaculation|ejaculation
806120|NCT00229073|sexual dysfunction|sexual dysfunction
806121|NCT00229073|orgasmic disorder|orgasmic disorder
806122|NCT00229073|sexual intercourse|sexual intercourse
806796|NCT00225667|Arrhythmia|arrhythmia
806123|NCT00229060|Complicated Intra-Abdominal Infections|complicated intra-abdominal infections
806124|NCT00229060|Appendicitis|appendicitis
806125|NCT00229060|Cholecystitis|cholecystitis
806126|NCT00229060|Peritonitis|peritonitis
806127|NCT00229047|Ischemic Preconditioning|ischemic preconditioning
806128|NCT00229047|Microvascular Perfusion|microvascular perfusion
806129|NCT00229047|Inflammation|inflammation
806130|NCT00229047|Ischemia and Reperfusion|ischemia and reperfusion
806131|NCT00229047|Chronic Limb Ischemia|chronic limb ischemia
806132|NCT00229034|Systemic Inflammation|systemic inflammation
806133|NCT00229034|Microvascular Perfusion|microvascular perfusion
806134|NCT00229034|Septic Shock|septic shock
806135|NCT00229021|Complicated Urinary Tract Infection|complicated urinary tract infection
806136|NCT00229021|Pyelonephritis|pyelonephritis
806137|NCT00229008|Ceftobiprole medocaril|ceftobiprole medocaril
806138|NCT00229008|Nosocomial Pneumonia|nosocomial pneumonia
806139|NCT00229008|Ventilator-Associated Pneumonia|ventilator-associated pneumonia
806140|NCT00229008|Cephalosporins|cephalosporins
806141|NCT00229008|Methicillin-Resistant Staphylococcus Aureus|methicillin-resistant staphylococcus aureus
806142|NCT00228995|Anemia|anemia
806143|NCT00228995|Subcutaneous injection|subcutaneous injection
806144|NCT00228995|PROCRIT|procrit
806145|NCT00228995|Erythropoietin|erythropoietin
806146|NCT00228995|Epoetin Alfa|epoetin alfa
806147|NCT00228995|Hemoglobin Level|hemoglobin level
806148|NCT00228995|Elderly|elderly
806149|NCT00228982|Complicated Skin Infections|complicated skin infections
806150|NCT00228982|Infectious Skin Diseases|infectious skin diseases
806151|NCT00228982|Bacterial Skin Diseases|bacterial skin diseases
806152|NCT00228982|Staphylococcal Skin Infections|staphylococcal skin infections
806153|NCT00228982|Cephalosporin|cephalosporin
806154|NCT00228956|Breast Cancer|breast cancer
806155|NCT00228956|Aromatase Inhibitor|aromatase inhibitor
806156|NCT00228956|Letrozole|letrozole
806157|NCT00228956|Exemestane|exemestane
806158|NCT00228943|Breast cancer survivorship|breast cancer survivorship
806159|NCT00228943|Hot Flashes|hot flashes
806160|NCT00228943|Serotonin|serotonin
806161|NCT00228930|Breast Cancer|breast cancer
806162|NCT00228930|Tamoxifen|tamoxifen
806163|NCT00228930|Prevention|prevention
806164|NCT00228917|Hib & Neisseria meningitidis serogroups A & C diseases|hib & neisseria meningitidis serogroups a & c diseases
806165|NCT00228904|Pulsatile intravenous insulin|pulsatile intravenous insulin
806166|NCT00228904|Oral carbohydrate loading|oral carbohydrate loading
806167|NCT00228904|Respiratory Quotients|respiratory quotients
806168|NCT00228904|Hypoglycemia|hypoglycemia
806169|NCT00228904|Diabetic Neuropathy|diabetic neuropathy
806170|NCT00228904|Diabetes Mellitus, with complications|diabetes mellitus, with complications
806171|NCT00228891|Pulsatile intravenous insulin|pulsatile intravenous insulin
806172|NCT00228891|Oral carbohydrate loading|oral carbohydrate loading
806173|NCT00228891|Respiratory Quotients|respiratory quotients
806174|NCT00228891|Hypoglycemia|hypoglycemia
806175|NCT00228891|Diabetic Neuropathy|diabetic neuropathy
806176|NCT00228878|Diabetes|diabetes
806177|NCT00228878|Pulsatile intravenous insulin|pulsatile intravenous insulin
806178|NCT00228878|Oral carbohydrate loading|oral carbohydrate loading
806179|NCT00228878|Respiratory Quotients|respiratory quotients
806180|NCT00228878|Hypoglycemia|hypoglycemia
806181|NCT00228878|Diabetes Mellitus, with complications|diabetes mellitus, with complications
806182|NCT00228865|Pulsatile intravenous insulin|pulsatile intravenous insulin
806183|NCT00228865|Oral carbohydrate loading|oral carbohydrate loading
806184|NCT00228865|Mindstream testing|mindstream testing
806185|NCT00228865|Wechsler Memory Scale II|wechsler memory scale ii
806186|NCT00228865|Respiratory Quotients|respiratory quotients
806187|NCT00228865|Hypoglycemia|hypoglycemia
806188|NCT00228865|Diabetes Mellitus with cognitive impairment|diabetes mellitus with cognitive impairment
806189|NCT00228865|Diabetes Mellitus with complications|diabetes mellitus with complications
806190|NCT00228852|Patients with severe T-cell immune deficiency diseases|patients with severe t-cell immune deficiency diseases
806191|NCT00228839|Recipients of an allogeneic hematopoietic stem cell transplant who have acute GVHD|recipients of an allogeneic hematopoietic stem cell transplant who have acute gvhd
806192|NCT00228696|late effects|late effects
806193|NCT00228670|Idiopathic Pulmonary Fibrosis|idiopathic pulmonary fibrosis
806194|NCT00228670|herpesvirus|herpesvirus
806195|NCT00228670|lung biopsy|lung biopsy
806196|NCT00228670|Having diagnosed lung disease|having diagnosed lung disease
806197|NCT00228670|Scheduled to have a lung biopsy as part of the evaluation for your lung disease|scheduled to have a lung biopsy as part of the evaluation for your lung disease
806198|NCT00228644|oxidative stress|oxidative stress
806199|NCT00228644|amino acids|amino acids
806200|NCT00228644|acetaminophen|acetaminophen
806201|NCT00228644|dietary requirements|dietary requirements
806202|NCT00228631|sickle|sickle
806203|NCT00228631|cell|cell
806204|NCT00228618|oxidative stress|oxidative stress
806205|NCT00228618|amino acids|amino acids
806206|NCT00228618|dietary requirements|dietary requirements
806207|NCT00228605|Pain|pain
806208|NCT00228605|Sudden Pain|sudden pain
806209|NCT00228605|Flares|flares
806210|NCT00228605|noncancer|noncancer
806211|NCT00228605|low back pain|low back pain
806212|NCT00228605|neuropathic pain|neuropathic pain
806213|NCT00228605|osteoarthritis pain|osteoarthritis pain
806214|NCT00228605|migraine|migraine
806215|NCT00228605|chronic headache|chronic headache
806216|NCT00228605|diabetic peripheral neuropathy|diabetic peripheral neuropathy
806217|NCT00228579|diabetes|diabetes
806218|NCT00228579|insulin resistance|insulin resistance
806219|NCT00228488|advanced non-nasopharyngeal head and neck carcinoma|advanced non-nasopharyngeal head and neck carcinoma
806220|NCT00228462|Schizophrenia|schizophrenia
806221|NCT00228449|anemia|anemia
806222|NCT00228449|chronic kidney disease|chronic kidney disease
806223|NCT00228449|CKD|ckd
806224|NCT00228449|chronic renal failure|chronic renal failure
806225|NCT00228449|CRF|crf
806226|NCT00228449|dialysis|dialysis
806227|NCT00228449|erythropoietin|erythropoietin
806228|NCT00228449|EPO|epo
806229|NCT00228449|erythropoiesis stimulating agent|erythropoiesis stimulating agent
806230|NCT00228449|ESA|esa
806231|NCT00228449|Hematide™|hematide™
806232|NCT00228449|hemodialysis|hemodialysis
806233|NCT00228449|hemoglobin|hemoglobin
806234|NCT00228449|Hb|hb
806235|NCT00228449|Hgb|hgb
806236|NCT00228449|Omontys|omontys
806237|NCT00228449|peginesatide|peginesatide
806238|NCT00228449|red blood cell|red blood cell
806239|NCT00228449|red blood cell production|red blood cell production
806240|NCT00228436|anemia|anemia
806241|NCT00228436|chronic kidney disease|chronic kidney disease
806242|NCT00228436|CKD|ckd
806243|NCT00228436|chronic renal failure|chronic renal failure
806244|NCT00228436|CRF|crf
806245|NCT00228436|dialysis|dialysis
806246|NCT00228436|erythropoietin|erythropoietin
806247|NCT00228436|EPO|epo
806248|NCT00228436|erythropoiesis stimulating agent|erythropoiesis stimulating agent
806249|NCT00228436|ESA|esa
806250|NCT00228436|Hematide™|hematide™
806251|NCT00228436|hemoglobin|hemoglobin
806252|NCT00228436|Hb|hb
806253|NCT00228436|Hgb|hgb
806254|NCT00228436|Omontys|omontys
806255|NCT00228436|peginesatide|peginesatide
806256|NCT00228436|red blood cell|red blood cell
806257|NCT00228436|red blood cell production|red blood cell production
806258|NCT00228423|Saphenous vein|saphenous vein
806259|NCT00228423|Intimal hyperplasia|intimal hyperplasia
806260|NCT00228423|Coronary artery bypass graft surgery|coronary artery bypass graft surgery
806261|NCT00228423|Antiplatelet therapy|antiplatelet therapy
806262|NCT00228423|Clopidogrel|clopidogrel
806263|NCT00228423|Saphenous vein graft disease|saphenous vein graft disease
806264|NCT00228410|Skin Infections|skin infections
806265|NCT00228410|Skin Disease|skin disease
806266|NCT00228397|Multiple Sclerosis|multiple sclerosis
806267|NCT00228371|Epilepsy|epilepsy
806268|NCT00228371|deep brain stimulation|deep brain stimulation
806269|NCT00228371|Subthalamic nucleus|subthalamic nucleus
806270|NCT00228371|Drug resistant epilepsy|drug resistant epilepsy
806271|NCT00228345|Idiopathic Axonal Polyneuropathy|idiopathic axonal polyneuropathy
806272|NCT00228345|abnormal OGTT|abnormal ogtt
806273|NCT00228293|cardiac arrest|cardiac arrest
806274|NCT00228293|CPR|cpr
806275|NCT00228280|Apicoectomy|apicoectomy
806276|NCT00228280|Retrograde|retrograde
806277|NCT00228280|MTA|mta
806278|NCT00228267|Chronic Headache|chronic headache
806279|NCT00228267|Analgesic Rebound Headache|analgesic rebound headache
806280|NCT00228267|Chronic Daily Headache|chronic daily headache
806281|NCT00228267|Headache, Intractable|headache, intractable
806282|NCT00228267|Randomised controlled trial|randomised controlled trial
806283|NCT00228267|Propofol|propofol
806284|NCT00228254|acute respiratory infection|acute respiratory infection
806285|NCT00228254|acute lower respiratory infection|acute lower respiratory infection
806286|NCT00228254|diarrhea|diarrhea
806287|NCT00228241|Sick sinus syndrome|sick sinus syndrome
806288|NCT00228241|AV-block|av-block
806289|NCT00228228|Multiple Sclerosis|multiple sclerosis
806290|NCT00228228|T-cell vaccination|t-cell vaccination
806291|NCT00228228|Autoreactive T cells|autoreactive t cells
806292|NCT00228215|sleep|sleep
806293|NCT00228215|neonates|neonates
806294|NCT00228215|mothers|mothers
806295|NCT00228215|behavioural intervention|behavioural intervention
806296|NCT00228202|cytomegalovirus|cytomegalovirus
806297|NCT00228202|CMV|cmv
806298|NCT00228202|pregnancy|pregnancy
806299|NCT00228202|amniotic fluid|amniotic fluid
806300|NCT00228202|bone marrow|bone marrow
806301|NCT00228202|transplantation|transplantation
806302|NCT00228202|viral load|viral load
806303|NCT00228202|glycoprotein B|glycoprotein b
806304|NCT00228202|genotyping|genotyping
806305|NCT00228202|PCR|pcr
806306|NCT00228202|real-time PCR|real-time pcr
806307|NCT00228202|CMV disease|cmv disease
806308|NCT00228202|Congenital CMV infection|congenital cmv infection
806309|NCT00228189|Dendritic cells|dendritic cells
806310|NCT00228189|Colorectal cancer|colorectal cancer
806311|NCT00228189|Carcinoembryonic antigen|carcinoembryonic antigen
806312|NCT00228189|Vaccine|vaccine
806313|NCT00228189|Immunotherapy|immunotherapy
806314|NCT00228176|Metabolic syndrome|metabolic syndrome
806315|NCT00228176|Carotid Atherosclerosis|carotid atherosclerosis
806316|NCT00228163|Multiple Sclerosis Relapsing Remitting|multiple sclerosis relapsing remitting
807098|NCT00224341|Pacemaker|pacemaker
806317|NCT00228163|Secondary Progressive|secondary progressive
806318|NCT00228163|Progressive Relapsing|progressive relapsing
806319|NCT00228150|Parkinson Disease|parkinson disease
806320|NCT00228150|levodopa|levodopa
806321|NCT00228150|dopamine agonists|dopamine agonists
806322|NCT00228124|Prostate cancer|prostate cancer
806323|NCT00228124|Continuous androgen suppression|continuous androgen suppression
806324|NCT00228124|Intermittent androgen suppression|intermittent androgen suppression
806325|NCT00228124|Bone loss|bone loss
806326|NCT00228124|Osteoporosis|osteoporosis
806327|NCT00228111|Computed tomography|computed tomography
806328|NCT00228111|wounds and injuries,non penetrating|wounds and injuries,non penetrating
806329|NCT00228111|algorithms|algorithms
806330|NCT00228111|Blunt trauma of the thorax and abdomen|blunt trauma of the thorax and abdomen
806331|NCT00228072|Hyperhidrosis|hyperhidrosis
806332|NCT00228072|Axillary|axillary
806333|NCT00228072|Excision|excision
806334|NCT00228072|Suction-curettage|suction-curettage
806335|NCT00228072|Outcome|outcome
806336|NCT00228059|Bipolar disorder, manic episode/treatment/licarbazepine|bipolar disorder, manic episode/treatment/licarbazepine
806337|NCT00228046|ADHD|adhd
806338|NCT00228046|ODD|odd
806339|NCT00228046|Conduct Disorder|conduct disorder
806340|NCT00228046|CD|cd
806341|NCT00228033|Calcium|calcium
806342|NCT00228033|Pregnancy|pregnancy
806343|NCT00228033|Postpartum Depression|postpartum depression
806344|NCT00228033|Depression|depression
806345|NCT00228020|pediatric, kidney transplantation, basiliximab|pediatric, kidney transplantation, basiliximab
806346|NCT00228007|Injection Drug Use|injection drug use
806347|NCT00228007|HIV Risk Behavior|hiv risk behavior
806348|NCT00228007|HIV Seronegativity|hiv seronegativity
806349|NCT00227994|Cholinesterase Inhibitors|cholinesterase inhibitors
806350|NCT00227994|Elderly|elderly
806351|NCT00227994|Stroke|stroke
806352|NCT00227994|Cognition|cognition
806353|NCT00227981|Depression Relapse|depression relapse
806354|NCT00227981|Maintenance Therapy|maintenance therapy
806355|NCT00227968|Manic-depressive psychosis|manic-depressive psychosis
806356|NCT00227968|Depression, bipolar|depression, bipolar
806357|NCT00227955|Major depression|major depression
806358|NCT00227942|Women|women
806359|NCT00227942|Menopause|menopause
806360|NCT00227942|Depression|depression
806361|NCT00227942|Hot flash|hot flash
806362|NCT00227942|Insomnia|insomnia
806363|NCT00227942|Sleep Disruption|sleep disruption
806364|NCT00227942|Estrogen Replacement Therapy|estrogen replacement therapy
806365|NCT00227929|Major Depressive Disorder|major depressive disorder
806366|NCT00227929|MDD|mdd
806367|NCT00227916|alcohol, marijuana|alcohol, marijuana
806368|NCT00227890|substance abuse|substance abuse
806369|NCT00227877|alcohol abuse|alcohol abuse
806370|NCT00227877|substance abuse|substance abuse
806371|NCT00227877|substance related disorders|substance related disorders
806372|NCT00227864|marijuana|marijuana
806373|NCT00227864|sexual risk|sexual risk
806374|NCT00227838|substance abuse|substance abuse
806375|NCT00227825|Behavioral Intervention|behavioral intervention
806376|NCT00227812|cocaine dependence|cocaine dependence
806377|NCT00227786|unspecified adult solid tumor, protocol specific|unspecified adult solid tumor, protocol specific
806378|NCT00227786|tobacco use disorder|tobacco use disorder
806379|NCT00227773|localized gastrointestinal carcinoid tumor|localized gastrointestinal carcinoid tumor
806380|NCT00227773|metastatic gastrointestinal carcinoid tumor|metastatic gastrointestinal carcinoid tumor
806381|NCT00227773|recurrent gastrointestinal carcinoid tumor|recurrent gastrointestinal carcinoid tumor
806382|NCT00227773|regional gastrointestinal carcinoid tumor|regional gastrointestinal carcinoid tumor
806383|NCT00227773|recurrent islet cell carcinoma|recurrent islet cell carcinoma
806384|NCT00227773|gastrinoma|gastrinoma
806385|NCT00227773|insulinoma|insulinoma
806386|NCT00227773|WDHA syndrome|wdha syndrome
806387|NCT00227773|glucagonoma|glucagonoma
806388|NCT00227773|pancreatic polypeptide tumor|pancreatic polypeptide tumor
806389|NCT00227773|somatostatinoma|somatostatinoma
806390|NCT00227747|adenocarcinoma of the rectum|adenocarcinoma of the rectum
806391|NCT00227747|stage II rectal cancer|stage ii rectal cancer
806392|NCT00227747|stage III rectal cancer|stage iii rectal cancer
806393|NCT00227734|stage IV colon cancer|stage iv colon cancer
806394|NCT00227734|stage IV rectal cancer|stage iv rectal cancer
806395|NCT00227734|recurrent colon cancer|recurrent colon cancer
806396|NCT00227734|recurrent rectal cancer|recurrent rectal cancer
806397|NCT00227721|recurrent ovarian epithelial cancer|recurrent ovarian epithelial cancer
806398|NCT00227721|peritoneal cavity cancer|peritoneal cavity cancer
806399|NCT00227708|adenocarcinoma of the lung|adenocarcinoma of the lung
806400|NCT00227708|adenosquamous cell lung cancer|adenosquamous cell lung cancer
806401|NCT00227708|large cell lung cancer|large cell lung cancer
806402|NCT00227708|squamous cell lung cancer|squamous cell lung cancer
806403|NCT00227708|stage IIIB non-small cell lung cancer|stage iiib non-small cell lung cancer
806404|NCT00227708|stage IV non-small cell lung cancer|stage iv non-small cell lung cancer
806405|NCT00227708|recurrent non-small cell lung cancer|recurrent non-small cell lung cancer
806406|NCT00227695|stage I grade 1 follicular lymphoma|stage i grade 1 follicular lymphoma
806407|NCT00227695|stage I grade 2 follicular lymphoma|stage i grade 2 follicular lymphoma
806408|NCT00227695|stage I grade 3 follicular lymphoma|stage i grade 3 follicular lymphoma
806409|NCT00227695|stage III grade 1 follicular lymphoma|stage iii grade 1 follicular lymphoma
806410|NCT00227695|stage III grade 2 follicular lymphoma|stage iii grade 2 follicular lymphoma
806411|NCT00227695|stage III grade 3 follicular lymphoma|stage iii grade 3 follicular lymphoma
806412|NCT00227695|stage IV grade 1 follicular lymphoma|stage iv grade 1 follicular lymphoma
806413|NCT00227695|stage IV grade 2 follicular lymphoma|stage iv grade 2 follicular lymphoma
806414|NCT00227695|stage IV grade 3 follicular lymphoma|stage iv grade 3 follicular lymphoma
806415|NCT00227695|contiguous stage II grade 1 follicular lymphoma|contiguous stage ii grade 1 follicular lymphoma
806416|NCT00227695|contiguous stage II grade 2 follicular lymphoma|contiguous stage ii grade 2 follicular lymphoma
806417|NCT00227695|contiguous stage II grade 3 follicular lymphoma|contiguous stage ii grade 3 follicular lymphoma
806418|NCT00227695|noncontiguous stage II grade 1 follicular lymphoma|noncontiguous stage ii grade 1 follicular lymphoma
806419|NCT00227695|noncontiguous stage II grade 2 follicular lymphoma|noncontiguous stage ii grade 2 follicular lymphoma
806711|NCT00226109|Na,K-pumps|na,k-pumps
806420|NCT00227695|noncontiguous stage II grade 3 follicular lymphoma|noncontiguous stage ii grade 3 follicular lymphoma
806421|NCT00227695|recurrent grade 1 follicular lymphoma|recurrent grade 1 follicular lymphoma
806422|NCT00227695|recurrent grade 2 follicular lymphoma|recurrent grade 2 follicular lymphoma
806423|NCT00227695|recurrent grade 3 follicular lymphoma|recurrent grade 3 follicular lymphoma
806424|NCT00227682|refractory multiple myeloma|refractory multiple myeloma
806425|NCT00227669|uterine leiomyosarcoma|uterine leiomyosarcoma
806426|NCT00227669|stage III adult soft tissue sarcoma|stage iii adult soft tissue sarcoma
806427|NCT00227669|stage IV adult soft tissue sarcoma|stage iv adult soft tissue sarcoma
806428|NCT00227669|recurrent adult soft tissue sarcoma|recurrent adult soft tissue sarcoma
806429|NCT00227669|stage III uterine sarcoma|stage iii uterine sarcoma
806430|NCT00227669|stage IV uterine sarcoma|stage iv uterine sarcoma
806431|NCT00227669|recurrent uterine sarcoma|recurrent uterine sarcoma
806432|NCT00227669|adult leiomyosarcoma|adult leiomyosarcoma
806433|NCT00227656|stage IV breast cancer|stage iv breast cancer
806434|NCT00227656|recurrent breast cancer|recurrent breast cancer
806435|NCT00227656|male breast cancer|male breast cancer
806436|NCT00227656|tumors metastatic to brain|tumors metastatic to brain
806437|NCT00227630|epithelial mesothelioma|epithelial mesothelioma
806438|NCT00227630|sarcomatous mesothelioma|sarcomatous mesothelioma
806439|NCT00227630|localized malignant mesothelioma|localized malignant mesothelioma
806440|NCT00227630|recurrent malignant mesothelioma|recurrent malignant mesothelioma
806441|NCT00227617|recurrent gastrointestinal carcinoid tumor|recurrent gastrointestinal carcinoid tumor
806442|NCT00227617|regional gastrointestinal carcinoid tumor|regional gastrointestinal carcinoid tumor
806443|NCT00227617|pulmonary carcinoid tumor|pulmonary carcinoid tumor
806444|NCT00227617|gastrinoma|gastrinoma
806445|NCT00227617|insulinoma|insulinoma
806446|NCT00227617|WDHA syndrome|wdha syndrome
806447|NCT00227617|glucagonoma|glucagonoma
806448|NCT00227617|pancreatic polypeptide tumor|pancreatic polypeptide tumor
806449|NCT00227617|somatostatinoma|somatostatinoma
806450|NCT00227617|recurrent islet cell carcinoma|recurrent islet cell carcinoma
806451|NCT00227617|metastatic gastrointestinal carcinoid tumor|metastatic gastrointestinal carcinoid tumor
806452|NCT00227565|extensive stage small cell lung cancer|extensive stage small cell lung cancer
806453|NCT00227539|stage I non-small cell lung cancer|stage i non-small cell lung cancer
806454|NCT00227539|stage II non-small cell lung cancer|stage ii non-small cell lung cancer
806455|NCT00227539|stage IIIA non-small cell lung cancer|stage iiia non-small cell lung cancer
806456|NCT00227539|stage IIIB non-small cell lung cancer|stage iiib non-small cell lung cancer
806457|NCT00227526|Colon|colon
806458|NCT00227526|Surgery|surgery
806459|NCT00227526|Prehabilitation|prehabilitation
806460|NCT00227526|Exercise|exercise
806461|NCT00227500|Hyperlipidaemia|hyperlipidaemia
806462|NCT00227500|Lipid metabolism|lipid metabolism
806463|NCT00227500|Glucose metabolism|glucose metabolism
806464|NCT00227500|HMG CoA reductase inhibitors|hmg coa reductase inhibitors
806465|NCT00227500|Lipodystrophy|lipodystrophy
806466|NCT00227500|Cardiovascular disease|cardiovascular disease
806467|NCT00227500|Treatment Experienced|treatment experienced
806468|NCT00227500|HIV|hiv
806469|NCT00227487|autism|autism
806470|NCT00227487|intestine|intestine
806471|NCT00227487|disaccharidases|disaccharidases
806472|NCT00227487|inflammation|inflammation
806473|NCT00227487|permeability|permeability
806474|NCT00227474|stage IIIB breast cancer|stage iiib breast cancer
806475|NCT00227474|stage IIIC breast cancer|stage iiic breast cancer
806476|NCT00227474|stage IV breast cancer|stage iv breast cancer
806477|NCT00227461|Aphasia|aphasia
806478|NCT00227461|Stroke|stroke
806479|NCT00227448|Ischemic|ischemic
806480|NCT00227448|Stroke|stroke
806481|NCT00227422|Neisseria meningitidis serogroups A & C diseases|neisseria meningitidis serogroups a & c diseases
806482|NCT00227422|Hib diseases|hib diseases
806483|NCT00227409|Repeated chelation therapy|repeated chelation therapy
806484|NCT00227409|Progressive renal insufficiency|progressive renal insufficiency
806485|NCT00227409|Body lead burden|body lead burden
806486|NCT00227409|Long-term outcome|long-term outcome
806487|NCT00227409|Glomerular filtration rate|glomerular filtration rate
806488|NCT00227383|Diabetes|diabetes
806489|NCT00227383|gastroparesis|gastroparesis
806490|NCT00227383|electroacupuncture|electroacupuncture
806491|NCT00227370|Acute rejection|acute rejection
806492|NCT00227370|Non-CMV infections|non-cmv infections
806493|NCT00227370|Resistance|resistance
806494|NCT00227357|HIV|hiv
806495|NCT00227357|AIDS|aids
806496|NCT00227357|Buprenorphine|buprenorphine
806497|NCT00227357|Methadone|methadone
806498|NCT00227357|Primary care|primary care
806499|NCT00227357|dual diagnosis|dual diagnosis
806500|NCT00227357|ptsd|ptsd
806501|NCT00227331|Pneumonia|pneumonia
806502|NCT00227305|Schizophrenia|schizophrenia
806503|NCT00227305|Bipolar I Disorder|bipolar i disorder
806504|NCT00227292|Low back pain|low back pain
806505|NCT00227292|Depression|depression
806506|NCT00227279|Grass pollen allergy|grass pollen allergy
806507|NCT00227279|Hayfever|hayfever
806508|NCT00227279|Allergen immunotherapy|allergen immunotherapy
806509|NCT00227279|Specific immunotherapy|specific immunotherapy
806712|NCT00226109|Magnesium|magnesium
806510|NCT00227266|Spinal Muscular Atrophy (SMA)|spinal muscular atrophy (sma)
806511|NCT00227266|SMA Type 2|sma type 2
806512|NCT00227266|SMA Type 3|sma type 3
806513|NCT00227253|Phenotype|phenotype
806514|NCT00227253|Growth|growth
806515|NCT00227253|Genotype|genotype
806516|NCT00227253|Chromosome 18|chromosome 18
806517|NCT00227201|African-American|african-american
806518|NCT00227201|Hypertension|hypertension
806519|NCT00227201|Complementary medicine|complementary medicine
806520|NCT00227201|Medication adherence|medication adherence
806521|NCT00227175|African American|african american
806522|NCT00227175|Hypertension|hypertension
806523|NCT00227175|Medication adherence|medication adherence
806524|NCT00227175|Risk reduction|risk reduction
806525|NCT00227162|Asthma|asthma
806526|NCT00227162|Behavior change|behavior change
806527|NCT00227162|Physical activity|physical activity
806528|NCT00227162|Risk reduction|risk reduction
806529|NCT00227149|C06.552.380.705.440|c06.552.380.705.440
806530|NCT00227136|5Hydroxytryptamine|5hydroxytryptamine
806531|NCT00227136|Chromogranin A|chromogranin a
806532|NCT00227136|5HIAA|5hiaa
806533|NCT00227136|carcinoid|carcinoid
806534|NCT00227123|Bipolar, cocaine, methamphetamine,quetiapine,risperidone|bipolar, cocaine, methamphetamine,quetiapine,risperidone
806535|NCT00227110|NASH, IGT, T2DM|nash, igt, t2dm
806536|NCT00227097|therapeutic education|therapeutic education
806537|NCT00227097|thrombi embolic disease|thrombi embolic disease
806538|NCT00227084|Mammary glands|mammary glands
806539|NCT00227084|hemostasis|hemostasis
806540|NCT00227084|Mammaplasty|mammaplasty
806541|NCT00227071|accidental falls|accidental falls
806542|NCT00227071|osteoporosis|osteoporosis
806543|NCT00227071|risk factors|risk factors
806544|NCT00227058|allergic rhinitis|allergic rhinitis
806545|NCT00227045|Kidney Transplantation|kidney transplantation
806546|NCT00227032|adult giant cell glioblastoma|adult giant cell glioblastoma
806547|NCT00227032|adult gliosarcoma|adult gliosarcoma
806548|NCT00227032|adult glioblastoma|adult glioblastoma
806549|NCT00227032|recurrent adult brain tumor|recurrent adult brain tumor
806550|NCT00226915|ovarian neoplasms|ovarian neoplasms
806551|NCT00226915|randomized controlled trial|randomized controlled trial
806552|NCT00226915|paclitaxel|paclitaxel
806553|NCT00226915|carboplatin|carboplatin
806554|NCT00226902|Diabetes|diabetes
806555|NCT00226902|Hemoglobin|hemoglobin
806556|NCT00226902|Dialysis|dialysis
806557|NCT00226902|Vascular reactivity|vascular reactivity
806558|NCT00226889|Scleroderma|scleroderma
806559|NCT00226889|Fibrosis|fibrosis
806561|NCT00226889|Bosentan|bosentan
806562|NCT00226889|Endothelin-1|endothelin-1
806563|NCT00226876|dreaming|dreaming
806564|NCT00226876|anaesthesia|anaesthesia
806565|NCT00226876|electroencephalography|electroencephalography
806566|NCT00226876|bispectral index|bispectral index
806567|NCT00226876|awareness|awareness
806568|NCT00226824|Tourette's disorder|tourette's disorder
806569|NCT00226824|tic|tic
806570|NCT00226772|Anterior cruciate ligament reconstruction|anterior cruciate ligament reconstruction
806571|NCT00226772|ACL reconstruction|acl reconstruction
806572|NCT00226759|Anterior cruciate ligament reconstruction|anterior cruciate ligament reconstruction
806573|NCT00226759|ACL reconstruction|acl reconstruction
806574|NCT00226746|Pancreatic Cancer|pancreatic cancer
806575|NCT00226746|Hyperfractionated Radiation Therapy|hyperfractionated radiation therapy
806576|NCT00226746|Gemcitabine|gemcitabine
806577|NCT00226746|Paclitaxel|paclitaxel
806578|NCT00226746|Carcinoma, Pancreatic Ductal|carcinoma, pancreatic ductal
806579|NCT00226733|Coronary Artery Bypass (E04.928.220.520.220)|coronary artery bypass (e04.928.220.520.220)
806580|NCT00226733|Exercise Test [E01.370.370.380.250]|exercise test [e01.370.370.380.250]
806581|NCT00226733|Echocardiography [E01.370.370.380.220]|echocardiography [e01.370.370.380.220]
806582|NCT00226733|Quality of Life [K01.752.400.750]|quality of life [k01.752.400.750]
806583|NCT00226720|alcoholism|alcoholism
806584|NCT00226720|Alcohol dependence|alcohol dependence
806585|NCT00226720|Detoxification|detoxification
806586|NCT00226720|Abstinence maintain|abstinence maintain
806587|NCT00226720|Efficacy|efficacy
807584|NCT00222326|Bladder,|bladder,
806588|NCT00226720|Ambulatory detoxification|ambulatory detoxification
806589|NCT00226707|Chronic hand dermatitis, pimecrolimus, dermatitis|chronic hand dermatitis, pimecrolimus, dermatitis
806590|NCT00226694|Alcoholism|alcoholism
806591|NCT00226694|Stress|stress
806592|NCT00226694|Gender Differences|gender differences
806593|NCT00226694|Addiction|addiction
806594|NCT00226694|Alcohol Dependence|alcohol dependence
806595|NCT00226668|peritumoral brain edema|peritumoral brain edema
806596|NCT00226668|edema|edema
806597|NCT00226668|malignant brain tumor|malignant brain tumor
806598|NCT00226668|astrocytoma|astrocytoma
806599|NCT00226668|brain tumor|brain tumor
806600|NCT00226668|dexamethasone|dexamethasone
806601|NCT00226668|Decadron|decadron
806602|NCT00226655|peritumoral brain edema|peritumoral brain edema
806603|NCT00226655|edema|edema
806604|NCT00226655|malignant brain tumor|malignant brain tumor
806605|NCT00226655|astrocytoma|astrocytoma
806606|NCT00226655|brain tumor|brain tumor
806607|NCT00226655|dexamethasone|dexamethasone
806608|NCT00226655|Decadron|decadron
806609|NCT00226642|depression|depression
806610|NCT00226642|primary care|primary care
806611|NCT00226616|Zinc|zinc
806612|NCT00226616|cholera|cholera
806613|NCT00226616|children|children
806614|NCT00226616|Bangladesh|bangladesh
806615|NCT00226603|groin injury|groin injury
806616|NCT00226603|football|football
806617|NCT00226603|prevention|prevention
806618|NCT00226603|traing programme|traing programme
806619|NCT00226603|cluster randomized study|cluster randomized study
806620|NCT00226590|non-small cell lung cancer|non-small cell lung cancer
806621|NCT00226590|carcinoma|carcinoma
806622|NCT00226590|unresectable|unresectable
806623|NCT00226590|Stage IIIA|stage iiia
806624|NCT00226590|Stage IIIB|stage iiib
806625|NCT00226590|thoracic radiation|thoracic radiation
806626|NCT00226577|Non-Small-Cell Lung Cancer|non-small-cell lung cancer
806627|NCT00226577|resectable|resectable
806628|NCT00226577|NSCLC|nsclc
806629|NCT00226525|Restenosis, skin metal allergy|restenosis, skin metal allergy
806630|NCT00226473|malignant Melanoma|malignant melanoma
806631|NCT00226473|Chemotherapy|chemotherapy
806632|NCT00226473|Metastasis|metastasis
806633|NCT00226473|standard palliative care|standard palliative care
806634|NCT00226473|best supportive care|best supportive care
806635|NCT00226447|Chronic Hepatitis B|chronic hepatitis b
806636|NCT00226447|Pegylated Interferon|pegylated interferon
806637|NCT00226447|Lamivudine|lamivudine
806638|NCT00226434|HIV infection|hiv infection
806639|NCT00226434|Tuberculosis|tuberculosis
806640|NCT00226434|Paradoxical reaction|paradoxical reaction
806641|NCT00226434|Treatment Naive|treatment naive
806642|NCT00226421|opioid|opioid
806643|NCT00226421|oxymorphone|oxymorphone
806644|NCT00226421|chronic pain|chronic pain
806645|NCT00226421|randomized, double-blind trial|randomized, double-blind trial
806646|NCT00226421|low back pain|low back pain
806647|NCT00226408|melanoma,adjuvant therapy,stageIII Interferon|melanoma,adjuvant therapy,stageiii interferon
806648|NCT00226408|high dose|high dose
806649|NCT00226395|oxymorphone|oxymorphone
806650|NCT00226395|acute pain|acute pain
806651|NCT00226395|abdominal surgery|abdominal surgery
806652|NCT00226395|opioids|opioids
806653|NCT00226382|Chronic Hepatitis B|chronic hepatitis b
806654|NCT00226382|Pegylated Interferon-alfa-2a|pegylated interferon-alfa-2a
806655|NCT00226382|Pegasys|pegasys
806656|NCT00226369|Pediatric|pediatric
806657|NCT00226369|Cardiopulmonary bypass|cardiopulmonary bypass
806658|NCT00226369|Congenital heart disease|congenital heart disease
806659|NCT00226369|Reperfusion injury|reperfusion injury
806660|NCT00226330|Patients diagnosed with type 2 diabetes who have participated in and completed the randomized, double-blind, parallel-group, multi-center study GALLANT 6.|patients diagnosed with type 2 diabetes who have participated in and completed the randomized, double-blind, parallel-group, multi-center study gallant 6.
806661|NCT00226304|Focal Brain Lesions|focal brain lesions
806662|NCT00226304|AIDS|aids
806663|NCT00226304|Lymphoma|lymphoma
806664|NCT00226304|EBV|ebv
806665|NCT00226304|FDG-PET|fdg-pet
806666|NCT00226304|HIV Infection|hiv infection
806667|NCT00226304|Brain Lesion|brain lesion
806668|NCT00226291|EBM|ebm
806669|NCT00226291|evidence based medicine|evidence based medicine
806670|NCT00226291|informationist|informationist
806671|NCT00226291|clinical medical librarian|clinical medical librarian
806672|NCT00226265|Cardiac surgery patients|cardiac surgery patients
806673|NCT00226265|Quality of Life|quality of life
806674|NCT00226265|Recall bias|recall bias
806675|NCT00226265|Aortic valve replacement|aortic valve replacement
806676|NCT00226265|Mitral valve replacement|mitral valve replacement
806677|NCT00226265|Tricuspid valve replacement|tricuspid valve replacement
806678|NCT00226265|Coronary artery bypass graft surgery|coronary artery bypass graft surgery
806679|NCT00226252|Wheelchair|wheelchair
806680|NCT00226252|Propulsion|propulsion
806681|NCT00226252|Biomechanics|biomechanics
806682|NCT00226239|head|head
806683|NCT00226239|neck|neck
806684|NCT00226200|Allergic|allergic
806685|NCT00226200|Non allergic|non allergic
806686|NCT00226187|Fatty acids|fatty acids
806687|NCT00226187|Human milk|human milk
806688|NCT00226187|Infant development|infant development
806689|NCT00226187|Very low birthweight infants|very low birthweight infants
806690|NCT00226174|Curcuminoids|curcuminoids
806691|NCT00226174|Oral Lichen Planus|oral lichen planus
806692|NCT00226148|Implant|implant
806693|NCT00226148|Immediate placement|immediate placement
806694|NCT00226148|Molar tooth|molar tooth
806695|NCT00226135|Bipolar disorder|bipolar disorder
806696|NCT00226135|Treatment|treatment
806697|NCT00226135|Long-term|long-term
806698|NCT00226135|Lithium|lithium
806699|NCT00226135|Lamotrigine|lamotrigine
806700|NCT00226135|Randomised Clinical Trial|randomised clinical trial
806701|NCT00226122|Enuresis|enuresis
806702|NCT00226122|Nocturnal|nocturnal
806703|NCT00226122|Monosymptomatic|monosymptomatic
806704|NCT00226122|DDAVP|ddavp
806705|NCT00226122|Indomethacin|indomethacin
806706|NCT00226122|Randomized|randomized
806707|NCT00226109|Alcoholism|alcoholism
806708|NCT00226109|cardiomyopathy|cardiomyopathy
806709|NCT00226109|skeletal muscle|skeletal muscle
806710|NCT00226109|spironolactone|spironolactone
806713|NCT00226096|Clinical Trial|clinical trial
806714|NCT00226096|Blood Pressure|blood pressure
806715|NCT00226096|CVA (Cerebrovascular Accident)|cva (cerebrovascular accident)
806716|NCT00226070|selfrated health,|selfrated health,
806717|NCT00226070|SF-36,|sf-36,
806718|NCT00226070|rehabilitation,|rehabilitation,
806719|NCT00226070|total hip replacement,|total hip replacement,
806720|NCT00226070|patients above 65|patients above 65
806721|NCT00226057|Atopic dermatitis|atopic dermatitis
806722|NCT00226057|Raptiva|raptiva
806723|NCT00226044|Omeprazole, suppository, infants|omeprazole, suppository, infants
806724|NCT00226031|Osteoporosis|osteoporosis
806725|NCT00226031|Wrist fractures|wrist fractures
806726|NCT00226031|Knowledge translation|knowledge translation
806727|NCT00226031|Implementation|implementation
806728|NCT00226031|Educational reminder|educational reminder
806729|NCT00226005|pancreas|pancreas
806730|NCT00226005|adenocarcinoma|adenocarcinoma
806731|NCT00226005|cancer|cancer
806732|NCT00226005|metastatic|metastatic
806733|NCT00226005|advanced cancer|advanced cancer
806734|NCT00226005|Phase II|phase ii
806735|NCT00226005|growth factor|growth factor
806736|NCT00226005|VEGF|vegf
806737|NCT00226005|angiogenesis|angiogenesis
806738|NCT00225979|Acromegaly|acromegaly
806739|NCT00225979|Untreated|untreated
806740|NCT00225979|Newly diagnosed|newly diagnosed
806741|NCT00225979|Octreotide LAR|octreotide lar
806742|NCT00225979|Pituitary surgery|pituitary surgery
806743|NCT00225966|Urinary urgency-frequency|urinary urgency-frequency
806744|NCT00225927|invasive breast cancer|invasive breast cancer
806745|NCT00225927|in situ breast cancer|in situ breast cancer
806746|NCT00225927|radioguided seed localization|radioguided seed localization
806747|NCT00225927|nonpalpable tumour|nonpalpable tumour
806748|NCT00225927|needle localization|needle localization
806749|NCT00225927|margin status|margin status
806750|NCT00225914|Menopause|menopause
806751|NCT00225914|Hormone Therapy|hormone therapy
806752|NCT00225914|Paxil|paxil
806753|NCT00225914|Hot Flash|hot flash
806754|NCT00225914|Sleep Disturbance|sleep disturbance
806755|NCT00225914|Night Sweats|night sweats
806756|NCT00225914|Antidepressants|antidepressants
806757|NCT00225888|Diabetes|diabetes
806758|NCT00225888|Nutrition|nutrition
806759|NCT00225888|Digital photography|digital photography
806760|NCT00225888|Self-management|self-management
806761|NCT00225875|Autoimmune thrombocytopenic purpura|autoimmune thrombocytopenic purpura
806762|NCT00225875|Rituximab|rituximab
806764|NCT00225862|Restless Legs Syndrome|restless legs syndrome
806765|NCT00225849|Aspirin|aspirin
806766|NCT00225849|Primary prevention|primary prevention
806767|NCT00225836|Dysmenorrhoea|dysmenorrhoea
806768|NCT00225836|Women|women
806769|NCT00225836|Pain|pain
806770|NCT00225836|TENS|tens
806771|NCT00225823|Seasonal Allergic Rhinitis Intranasal Corticosteroid|seasonal allergic rhinitis intranasal corticosteroid
806772|NCT00225797|chronic pain|chronic pain
806773|NCT00225797|lower back|lower back
806774|NCT00225797|opioid|opioid
806775|NCT00225797|efficacy|efficacy
806776|NCT00225797|safety|safety
806777|NCT00225784|Stage I, II, III pancreatic adenocarcinoma|stage i, ii, iii pancreatic adenocarcinoma
806778|NCT00225784|Radiographically measurable disease|radiographically measurable disease
806779|NCT00225758|breast cancer|breast cancer
806780|NCT00225758|endocrine therapy|endocrine therapy
806781|NCT00225758|drug resistance|drug resistance
806782|NCT00225758|lapatinib|lapatinib
806783|NCT00225758|epidermal growth factor receptor|epidermal growth factor receptor
806784|NCT00225745|Ghrelin|ghrelin
806785|NCT00225693|coronary artery|coronary artery
806786|NCT00225693|restenosis|restenosis
806787|NCT00225693|patency|patency
806788|NCT00225693|drug eluting|drug eluting
806789|NCT00225693|stent|stent
806790|NCT00225680|coronary artery|coronary artery
806791|NCT00225680|stent|stent
806792|NCT00225680|drug eluting|drug eluting
806793|NCT00225680|patency|patency
806794|NCT00225680|restenosis|restenosis
806795|NCT00225667|Atrial Fibrillation|atrial fibrillation
806797|NCT00225667|Pacemaker, Artificial|pacemaker, artificial
806798|NCT00225667|Atrial High Rate Episodes|atrial high rate episodes
806799|NCT00225667|Electrophysiology|electrophysiology
806800|NCT00225667|Renin-Angiotensin System|renin-angiotensin system
806801|NCT00225667|Hypertension|hypertension
806802|NCT00225667|Cardiac Remodeling|cardiac remodeling
806803|NCT00225654|coronary artery|coronary artery
806805|NCT00225654|drug eluting|drug eluting
806806|NCT00225654|patency|patency
806807|NCT00225654|restenosis|restenosis
806808|NCT00225641|Follow-up|follow-up
806809|NCT00225628|Computerized clinical decision support|computerized clinical decision support
806810|NCT00225628|Patient Safety|patient safety
806811|NCT00225628|Quality of Care|quality of care
806812|NCT00225628|Electronic Medical Records|electronic medical records
806813|NCT00225628|Chronic Disease Management|chronic disease management
806814|NCT00225628|Drug Monitoring|drug monitoring
806815|NCT00225628|Guideline Adherence|guideline adherence
806816|NCT00225628|Reminder Systems|reminder systems
806917|NCT00225251|Dysthymia|dysthymia
806817|NCT00225615|Phenylalanine Hydroxylase|phenylalanine hydroxylase
806818|NCT00225602|Schizophrenia|schizophrenia
806819|NCT00225602|Assertive community treatment|assertive community treatment
806820|NCT00225589|Hypercholesteremia|hypercholesteremia
806821|NCT00225576|medication errors|medication errors
806822|NCT00225576|adverse drug events|adverse drug events
806823|NCT00225576|electronic health records|electronic health records
806824|NCT00225563|Electronic medical records|electronic medical records
806825|NCT00225563|Electronic prescribing|electronic prescribing
806826|NCT00225563|Quality measures|quality measures
806827|NCT00225550|Cancer;|cancer;
806828|NCT00225550|Tumors;|tumors;
806829|NCT00225550|Neoplasms;|neoplasms;
806830|NCT00225550|Anticarcinogenic Agents;|anticarcinogenic agents;
806831|NCT00225550|Antineoplastic Agents;|antineoplastic agents;
806832|NCT00225550|Cadherins|cadherins
806833|NCT00225537|hcv|hcv
806834|NCT00225537|hbv|hbv
806835|NCT00225537|methylumbelliferone|methylumbelliferone
806836|NCT00225537|liver|liver
806837|NCT00225537|hepatitis|hepatitis
806838|NCT00225537|viral|viral
806839|NCT00225537|heparvit|heparvit
806840|NCT00225537|hiv|hiv
806841|NCT00225537|aids|aids
806842|NCT00225524|Depression|depression
806843|NCT00225511|Depression|depression
806844|NCT00225485|Depression|depression
806845|NCT00225459|Religious psychology|religious psychology
806846|NCT00225459|Anxiety disorder|anxiety disorder
806847|NCT00225459|Mood disorder|mood disorder
806848|NCT00225459|Suicide|suicide
806849|NCT00225446|Orthognathic surgery.|orthognathic surgery.
806850|NCT00225446|optic repositioning system.|optic repositioning system.
806851|NCT00225433|infertility|infertility
806852|NCT00225433|in vitro fertilization|in vitro fertilization
806853|NCT00225420|adenocarcinoma of the prostate|adenocarcinoma of the prostate
806854|NCT00225420|stage I prostate cancer|stage i prostate cancer
806855|NCT00225420|stage II prostate cancer|stage ii prostate cancer
806856|NCT00225420|stage III prostate cancer|stage iii prostate cancer
806857|NCT00225420|stage IV prostate cancer|stage iv prostate cancer
806858|NCT00225407|Cannabis|cannabis
806859|NCT00225407|Tetrahydrocannabinol|tetrahydrocannabinol
806860|NCT00225407|Pharmacokinetics|pharmacokinetics
806861|NCT00225407|Psychomotor tests|psychomotor tests
806862|NCT00225407|Event related potentials|event related potentials
806863|NCT00225394|CMV|cmv
806864|NCT00225394|Kidney Transplant|kidney transplant
806865|NCT00225394|Pancreas Transplant|pancreas transplant
806866|NCT00225394|Ganciclovir-resistance|ganciclovir-resistance
806867|NCT00225394|Valganciclovir|valganciclovir
806868|NCT00225394|CMV Disease|cmv disease
806869|NCT00225381|Oxygen consumption|oxygen consumption
806870|NCT00225381|CO2 production|co2 production
806871|NCT00225381|Indirect calorimetry|indirect calorimetry
806872|NCT00225381|Non steady state|non steady state
806873|NCT00225381|Anesthesia monitoring|anesthesia monitoring
806874|NCT00225381|Critical events during anesthesia|critical events during anesthesia
806875|NCT00225381|Acid base balance|acid base balance
806876|NCT00225381|Metabolism during anesthesia|metabolism during anesthesia
806877|NCT00225368|Malaria|malaria
806878|NCT00225368|All-cause mortality|all-cause mortality
806879|NCT00225368|Africa|africa
806880|NCT00225368|Burkina Faso|burkina faso
806881|NCT00225355|Angina pectoris|angina pectoris
806882|NCT00225355|Metabolic syndrome|metabolic syndrome
806883|NCT00225355|Ischaemic heart disease|ischaemic heart disease
806884|NCT00225342|Angina|angina
806885|NCT00225342|Ischaemic heart disease|ischaemic heart disease
806886|NCT00225342|Diabetes|diabetes
806887|NCT00225329|RCT|rct
806888|NCT00225329|intervention study|intervention study
806889|NCT00225329|labour management|labour management
806890|NCT00225329|assessment|assessment
806891|NCT00225316|RCT|rct
806892|NCT00225316|intervention study|intervention study
806893|NCT00225316|addiction|addiction
806894|NCT00225316|substance use|substance use
806895|NCT00225316|pregnancy|pregnancy
806896|NCT00225303|HIV infection|hiv infection
806897|NCT00225303|TMC125|tmc125
807585|NCT00222326|Bowel.|bowel.
806898|NCT00225303|Non-Nucleoside reverse transcriptase inhibitor|non-nucleoside reverse transcriptase inhibitor
806899|NCT00225303|Protease inhibitor|protease inhibitor
806900|NCT00225303|TMC125-C227|tmc125-c227
806901|NCT00225290|Phase III|phase iii
806902|NCT00225290|Hepatocellular Carcinoma|hepatocellular carcinoma
806903|NCT00225277|Glucose Metabolism Disorder|glucose metabolism disorder
806904|NCT00225277|Dysmetabolic Syndrome|dysmetabolic syndrome
806905|NCT00225277|Type II Diabetes|type ii diabetes
806906|NCT00225277|Diabetes Mellitus, Lipoatrophic|diabetes mellitus, lipoatrophic
806907|NCT00225277|Dyslipidemia|dyslipidemia
806908|NCT00225277|Drug Therapy|drug therapy
806909|NCT00225277|Atherosclerosis|atherosclerosis
806910|NCT00225264|Glucose Metabolism Disorder|glucose metabolism disorder
806911|NCT00225264|Dysmetabolic Syndrome|dysmetabolic syndrome
806912|NCT00225264|Type II Diabetes|type ii diabetes
806913|NCT00225264|Diabetes Mellitus, Lipoatrophic|diabetes mellitus, lipoatrophic
806914|NCT00225264|Dyslipidemia|dyslipidemia
806915|NCT00225264|Drug Therapy|drug therapy
806916|NCT00225251|Dysthymic Disorder|dysthymic disorder
806918|NCT00225251|Depression|depression
806919|NCT00225251|Chronic Depression|chronic depression
806920|NCT00225251|Wellbutrin XL|wellbutrin xl
806921|NCT00225238|colonoscopy prep|colonoscopy prep
806922|NCT00225212|non-Hodgkin's lymphoma|non-hodgkin's lymphoma
806923|NCT00225212|diffuse large cell lymphoma|diffuse large cell lymphoma
806924|NCT00225212|mantle cell lymphoma|mantle cell lymphoma
806925|NCT00225212|transformed lymphoma|transformed lymphoma
806926|NCT00225212|other subtypes of B cell lymphoma|other subtypes of b cell lymphoma
806927|NCT00225212|recurrent lymphoma|recurrent lymphoma
806928|NCT00225173|nodular sclerosis|nodular sclerosis
806929|NCT00225173|lymphocyte rich|lymphocyte rich
806930|NCT00225173|lymphocyte depleted|lymphocyte depleted
806931|NCT00225173|mixed cellularity|mixed cellularity
806932|NCT00225160|HIV|hiv
806933|NCT00225160|poly neuropathy|poly neuropathy
806934|NCT00225160|acetyl L-carnitine|acetyl l-carnitine
806935|NCT00225160|treatment naïve|treatment naïve
806936|NCT00225160|combination antiretroviral therapy|combination antiretroviral therapy
806937|NCT00225160|Lipid abnormalities|lipid abnormalities
806938|NCT00225108|Deep vein thrombosis|deep vein thrombosis
806939|NCT00225108|bleeding|bleeding
806940|NCT00225095|meniscectomy|meniscectomy
806941|NCT00225095|Chondrogen|chondrogen
806942|NCT00225095|Mesenchymal Stem Cells|mesenchymal stem cells
806943|NCT00225095|Osiris|osiris
806944|NCT00225082|Lipoatrophy|lipoatrophy
806945|NCT00225082|Mitochondrial function|mitochondrial function
806946|NCT00225082|Nucleoside analogue switch|nucleoside analogue switch
806947|NCT00225082|Treatment Experienced|treatment experienced
806948|NCT00225069|Facial blushing|facial blushing
806949|NCT00225069|Sympathectomy|sympathectomy
806950|NCT00225017|Atazanavir|atazanavir
806951|NCT00225017|Endothelial function|endothelial function
806952|NCT00225017|Treatment Experienced|treatment experienced
806953|NCT00225004|Colles Fracture|colles fracture
806954|NCT00225004|Osteoporosis|osteoporosis
806955|NCT00225004|BMD|bmd
806956|NCT00225004|Quality assurance|quality assurance
806957|NCT00224991|osteoporosis|osteoporosis
806958|NCT00224991|fall frequency|fall frequency
806959|NCT00224991|medical treatment|medical treatment
806960|NCT00224991|compliance|compliance
806961|NCT00224991|quality of life|quality of life
806962|NCT00224991|systematic education|systematic education
806963|NCT00224965|nicotine dependence|nicotine dependence
806964|NCT00224952|seizures|seizures
806965|NCT00224952|Epilepsy|epilepsy
806966|NCT00224926|Tinea Capitis|tinea capitis
806967|NCT00224913|osteoarthritis|osteoarthritis
806968|NCT00224913|quadriceps|quadriceps
806969|NCT00224913|inhibition|inhibition
806970|NCT00224913|functional outcome|functional outcome
806971|NCT00224913|electrical stimulation|electrical stimulation
806972|NCT00224900|Perinatally-acquired HIV infection|perinatally-acquired hiv infection
806973|NCT00224900|Life Skills|life skills
806974|NCT00224900|Focus Group|focus group
806975|NCT00224900|Young adolescents|young adolescents
806976|NCT00224900|Caregivers|caregivers
806977|NCT00224874|Acute Graft vs Host Disease|acute graft vs host disease
806978|NCT00224874|GVHD|gvhd
806979|NCT00224822|Psychiatry|psychiatry
806980|NCT00224822|Antipsychotic|antipsychotic
806981|NCT00224822|Psychopharmacology|psychopharmacology
806982|NCT00224822|Clinical Trial|clinical trial
806983|NCT00224822|Open Label|open label
806984|NCT00224822|Schizophrenia|schizophrenia
806985|NCT00224822|Schizoaffective Disorder|schizoaffective disorder
806986|NCT00224822|Bipolar Disorder|bipolar disorder
806987|NCT00224822|Metabolic Syndrome|metabolic syndrome
806988|NCT00224796|Wound closure|wound closure
806989|NCT00224796|Foot salvage|foot salvage
806990|NCT00224796|Accelerated healing|accelerated healing
806991|NCT00224796|Amputation Wounds of the Diabetic Foot|amputation wounds of the diabetic foot
806992|NCT00224757|Echocardiography|echocardiography
806993|NCT00224744|Vulvar Neoplasms|vulvar neoplasms
806994|NCT00224744|Skin Neoplasms|skin neoplasms
806995|NCT00224744|Ultracision|ultracision
806996|NCT00224744|Lymphadenectomy|lymphadenectomy
807683|NCT00221845|Biomarkers|biomarkers
806997|NCT00224731|Attention disorder with hyperactivity|attention disorder with hyperactivity
806998|NCT00224731|sleep|sleep
806999|NCT00224731|stimulants|stimulants
807000|NCT00224731|actigraphy|actigraphy
807001|NCT00224718|Abdominal aortic aneurysm|abdominal aortic aneurysm
807002|NCT00224718|Endograft|endograft
807003|NCT00224718|Open repair|open repair
807004|NCT00224718|Endovascular repair|endovascular repair
807005|NCT00224718|AAA|aaa
807006|NCT00224705|Albumin dialysis|albumin dialysis
807007|NCT00224705|MARS system|mars system
807008|NCT00224705|Extracorporeal artificial liver support|extracorporeal artificial liver support
807009|NCT00224705|Fulminant hepatitis|fulminant hepatitis
807010|NCT00224705|Subfulminant hepatitis|subfulminant hepatitis
807011|NCT00224705|Acute liver failure|acute liver failure
807012|NCT00224692|Mucositis|mucositis
807013|NCT00224692|Pain|pain
807014|NCT00224692|Morphine|morphine
807015|NCT00224692|Ketamine|ketamine
807016|NCT00224679|Colon cancer|colon cancer
807017|NCT00224679|Aspirin|aspirin
807018|NCT00224679|Adenomas|adenomas
807019|NCT00224679|Prevention|prevention
807020|NCT00224666|Cortex stimulation ,Rebel neuropathic pains|cortex stimulation ,rebel neuropathic pains
807021|NCT00224653|Obesity.|obesity.
807022|NCT00224653|Respiration. Respiration, artificial.|respiration. respiration, artificial.
807023|NCT00224653|Ventilation. Pressure controlled. Volume controlled.|ventilation. pressure controlled. volume controlled.
807024|NCT00224640|Iron-chelating treatment|iron-chelating treatment
807025|NCT00224627|Randomized study|randomized study
807026|NCT00224627|Capsule endoscopy|capsule endoscopy
807027|NCT00224627|Push enteroscopy|push enteroscopy
807028|NCT00224627|Occult gastrointestinal bleeding|occult gastrointestinal bleeding
807029|NCT00224627|Endoscopy|endoscopy
807030|NCT00224614|stem cell transplantation|stem cell transplantation
807031|NCT00224614|reduced-intensity conditioning regimen|reduced-intensity conditioning regimen
807032|NCT00224614|acute myeloid leukemia|acute myeloid leukemia
807033|NCT00224601|Colorectal cancer|colorectal cancer
807034|NCT00224601|HNPCC|hnpcc
807035|NCT00224601|Diagnosis|diagnosis
807036|NCT00224601|Coloscopy|coloscopy
807037|NCT00224601|Chromoscopy|chromoscopy
807038|NCT00224601|Indigo carmine|indigo carmine
807039|NCT00224601|Colorectal Neoplasms|colorectal neoplasms
807040|NCT00224601|Hereditary Nonpolyposis|hereditary nonpolyposis
807041|NCT00224588|Ketamine|ketamine
807042|NCT00224588|Chronic post thoracotomy pain|chronic post thoracotomy pain
807043|NCT00224588|NMDA|nmda
807044|NCT00224588|Post operative|post operative
807045|NCT00224575|Veterans|veterans
807046|NCT00224562|TNF alpha antagonists|tnf alpha antagonists
807047|NCT00224562|infections|infections
807048|NCT00224562|lymphoma|lymphoma
807049|NCT00224562|safety|safety
807050|NCT00224549|Resistant hypertension|resistant hypertension
807051|NCT00224549|Combined diuretic therapy|combined diuretic therapy
807052|NCT00224549|Combined RAS blockers|combined ras blockers
807053|NCT00224536|Myocardial infarction|myocardial infarction
807054|NCT00224536|Bone marrow cells|bone marrow cells
807055|NCT00224536|Intracoronary|intracoronary
807056|NCT00224523|perennial allergic rhinitis|perennial allergic rhinitis
807057|NCT00224523|nasal biopsy|nasal biopsy
807058|NCT00224523|GW685698X|gw685698x
807059|NCT00224510|bipolar disorder bipolar depression lamotrigine|bipolar disorder bipolar depression lamotrigine
807060|NCT00224497|Alzheimer's disease|alzheimer's disease
807061|NCT00224497|cognition global functioning|cognition global functioning
807062|NCT00224497|symptomatic|symptomatic
807063|NCT00224497|B-742457|b-742457
807064|NCT00224484|Herpes Simplex vaccine|herpes simplex vaccine
807065|NCT00224484|Safety|safety
807066|NCT00224484|Adolescents|adolescents
807067|NCT00224484|Immunogenicity|immunogenicity
807068|NCT00224471|Adolescents|adolescents
807069|NCT00224471|Immunogenicity|immunogenicity
807070|NCT00224471|Safety|safety
807071|NCT00224471|Herpes Simplex vaccine|herpes simplex vaccine
807072|NCT00224458|Treatment Experienced|treatment experienced
807073|NCT00224458|HIV-1|hiv-1
807074|NCT00224445|Treatment Naive|treatment naive
807075|NCT00224445|HIV-1|hiv-1
807076|NCT00224432|Atopic Dermatitis|atopic dermatitis
807077|NCT00224432|SCORAD|scorad
807078|NCT00224432|probiotics|probiotics
807079|NCT00224432|cytokines|cytokines
807080|NCT00224432|Infant|infant
807081|NCT00224419|Smoking cessation|smoking cessation
807082|NCT00224419|Pregnancy|pregnancy
807083|NCT00224419|Nicotine replacement therapy|nicotine replacement therapy
807084|NCT00224419|Motivational interviewing|motivational interviewing
807085|NCT00224406|Lung transplantation|lung transplantation
807086|NCT00224406|Reperfusion Injury|reperfusion injury
807087|NCT00224406|Survival|survival
807088|NCT00224393|Amyloidosis|amyloidosis
807089|NCT00224393|Enbrel|enbrel
807090|NCT00224380|Serious mental illness|serious mental illness
807091|NCT00224380|medication adherence|medication adherence
807092|NCT00224367|fracture|fracture
807093|NCT00224367|hip|hip
807094|NCT00224367|ambulation|ambulation
807095|NCT00224354|LYMPHOCYTIC|lymphocytic
807096|NCT00224354|B-LEUKEMIA|b-leukemia
807097|NCT00224354|B-CLL|b-cll
807099|NCT00224341|Atrial Fibrillation|atrial fibrillation
807100|NCT00224341|Prevention pacing|prevention pacing
807101|NCT00224341|Algorithms|algorithms
807102|NCT00224341|Sick sinus syndrome + Atrial Fibrillation|sick sinus syndrome + atrial fibrillation
807103|NCT00224328|Tissue Oxygen Saturation|tissue oxygen saturation
807104|NCT00224328|Peripheral Arterial Disease|peripheral arterial disease
807105|NCT00224328|Critical Limb Ischemia|critical limb ischemia
807106|NCT00224328|Near-infrared Spectroscopy|near-infrared spectroscopy
807107|NCT00224315|Schizophrenia,|schizophrenia,
807108|NCT00224315|schizoaffective disorder,|schizoaffective disorder,
807109|NCT00224315|treatment resistancy|treatment resistancy
807110|NCT00224315|clozapine,|clozapine,
807111|NCT00224315|ziprasidone|ziprasidone
807112|NCT00224315|risperidone|risperidone
807113|NCT00224315|combination|combination
807114|NCT00224302|Schizophrenia,|schizophrenia,
807115|NCT00224302|schizoaffective disorder,|schizoaffective disorder,
807116|NCT00224302|major depressive episode,|major depressive episode,
807117|NCT00224302|combination,|combination,
807118|NCT00224302|duloxetine|duloxetine
807119|NCT00224289|Latanoprost|latanoprost
807120|NCT00224289|Glaucoma|glaucoma
807121|NCT00224289|Intraocular pressure|intraocular pressure
807122|NCT00224263|Traditional Chinese Medicine|traditional chinese medicine
807123|NCT00224263|Lingzhi|lingzhi
807124|NCT00224237|Latino patients|latino patients
807125|NCT00224237|Health practices|health practices
807126|NCT00224237|Culture influences|culture influences
807127|NCT00224224|Clinical performance|clinical performance
807128|NCT00224224|Continuity of care|continuity of care
807129|NCT00224224|Utilization of resources|utilization of resources
807130|NCT00224185|Healthy individuals|healthy individuals
807131|NCT00224185|smokers|smokers
807132|NCT00224185|ex-smokers|ex-smokers
807133|NCT00224185|non-smokers|non-smokers
807134|NCT00224172|Pre-hospitalization characteristics|pre-hospitalization characteristics
807135|NCT00224172|Post-hospitalization characteristics|post-hospitalization characteristics
807136|NCT00224172|Psychosocial measures|psychosocial measures
807137|NCT00224172|Predict re-hospitalization|predict re-hospitalization
807138|NCT00224159|Statin therapy|statin therapy
807139|NCT00224159|Dietary behavior|dietary behavior
807140|NCT00224159|Attitudes and beliefs|attitudes and beliefs
807141|NCT00224159|Self efficacy|self efficacy
807142|NCT00224146|Oxytrol(r)|oxytrol(r)
807143|NCT00224146|transdermal oxybutynin|transdermal oxybutynin
807144|NCT00224146|overactive bladder|overactive bladder
807145|NCT00224133|benign prostatic hyperplasia, alpha blocker|benign prostatic hyperplasia, alpha blocker
807146|NCT00224120|Benign prostatic hyperplasia, alpha blocker|benign prostatic hyperplasia, alpha blocker
807147|NCT00224107|Benign prostatic hyperplasia, BPH, alpha blocker|benign prostatic hyperplasia, bph, alpha blocker
807148|NCT00224094|Menopause|menopause
807149|NCT00224094|Testosterone|testosterone
807150|NCT00224094|Androgens|androgens
807151|NCT00224094|Sex Hormone Binding Globulin|sex hormone binding globulin
807152|NCT00224094|Thyroid function|thyroid function
807153|NCT00224094|Cortisol|cortisol
807154|NCT00224081|iron deficiency anemia|iron deficiency anemia
807155|NCT00224081|ferritin|ferritin
807156|NCT00224081|hemodialysis|hemodialysis
807157|NCT00224081|sodium ferric gluconate|sodium ferric gluconate
807158|NCT00224081|epoetin alfa|epoetin alfa
807159|NCT00224068|Iron deficiency|iron deficiency
807160|NCT00224068|Sodium ferric gluconate|sodium ferric gluconate
807161|NCT00224068|anemia|anemia
807162|NCT00224068|cancer chemotherapy|cancer chemotherapy
807163|NCT00224068|epoetin alfa|epoetin alfa
807164|NCT00224068|Anemia/drug therapy|anemia/drug therapy
807165|NCT00224068|Anemia, Iron-Deficiency/drug therapy/etiology|anemia, iron-deficiency/drug therapy/etiology
807166|NCT00224068|Hematinics/administration & dosage/pharmacology|hematinics/administration & dosage/pharmacology
807167|NCT00224068|Antineoplastic Agents/adverse effects|antineoplastic agents/adverse effects
807168|NCT00224068|Erythropoietin, Recombinant/therapeutic use/adverse effects|erythropoietin, recombinant/therapeutic use/adverse effects
807169|NCT00224055|Iron deficiency|iron deficiency
807170|NCT00224055|Anemia|anemia
807171|NCT00224055|Chronic kidney disease|chronic kidney disease
807172|NCT00224055|Sodium Ferric Gluconate|sodium ferric gluconate
807294|NCT00223626|Cocaine Dependence|cocaine dependence
807173|NCT00224055|Anemia, Iron-Deficiency/drug therapy/etiology|anemia, iron-deficiency/drug therapy/etiology
807174|NCT00224055|Kidney Failure, Chronic/blood/complications/therapy|kidney failure, chronic/blood/complications/therapy
807175|NCT00224042|Iron deficiency|iron deficiency
807176|NCT00224042|Anemia|anemia
807177|NCT00224042|Chronic kidney disease|chronic kidney disease
807178|NCT00224042|Erythropoietic agents|erythropoietic agents
807179|NCT00224042|Sodium Ferric Gluconate|sodium ferric gluconate
807180|NCT00224042|Anemia, Iron-Deficiency/drug therapy/etiology|anemia, iron-deficiency/drug therapy/etiology
807181|NCT00224042|Kidney Failure, Chronic/blood/complications/therapy|kidney failure, chronic/blood/complications/therapy
807182|NCT00224042|Erythropoietin, Recombinant/adverse effects/therapeutic use|erythropoietin, recombinant/adverse effects/therapeutic use
807183|NCT00224003|Anemia|anemia
807184|NCT00223990|Plasmodium|plasmodium
807185|NCT00223990|falciparum|falciparum
807186|NCT00223990|malaria|malaria
807187|NCT00223990|vaccine|vaccine
807188|NCT00223990|AS02A adjuvant|as02a adjuvant
807189|NCT00223990|FMP1|fmp1
807190|NCT00223990|Merozoite surface protein-1|merozoite surface protein-1
807191|NCT00223977|Anemia.|anemia.
807192|NCT00223964|Iron Deficiency|iron deficiency
807193|NCT00223964|Anemia in Pediatric Hemodialysis|anemia in pediatric hemodialysis
807194|NCT00223951|Healthy volunteers, safety, ocular, allergic conjunctivitis, ophthalmic|healthy volunteers, safety, ocular, allergic conjunctivitis, ophthalmic
807195|NCT00223925|Stem cell transplantation|stem cell transplantation
807196|NCT00223925|Allogeneic transplantation|allogeneic transplantation
807197|NCT00223912|Cardiovascular Disease|cardiovascular disease
807198|NCT00223912|Exercise|exercise
807199|NCT00223912|Functional electrical stimulation|functional electrical stimulation
807200|NCT00223912|hemostasis|hemostasis
807201|NCT00223912|Spinal cord injury|spinal cord injury
807202|NCT00223899|Melanoma|melanoma
807203|NCT00223899|Electroporation|electroporation
807204|NCT00223899|IL-2|il-2
807205|NCT00223873|Penile Vibratory Stimulation|penile vibratory stimulation
807206|NCT00223873|Muscles Spasticity|muscles spasticity
807207|NCT00223873|Spasms|spasms
807208|NCT00223873|Ferti Care Vibrator|ferti care vibrator
807209|NCT00223873|Antispasmotic treatment|antispasmotic treatment
807210|NCT00223860|Hypogonadal|hypogonadal
807211|NCT00223860|Hypothalamus|hypothalamus
807212|NCT00223860|Pituitary|pituitary
807213|NCT00223860|Spinal Cord Injury|spinal cord injury
807214|NCT00223860|Testes|testes
807215|NCT00223860|Testosterone|testosterone
807216|NCT00223847|Aphasia rehabilitation|aphasia rehabilitation
807217|NCT00223847|Aphasia therapy|aphasia therapy
807218|NCT00223847|Constraint therapy|constraint therapy
807219|NCT00223847|Language therapy|language therapy
807220|NCT00223834|Counseling|counseling
807221|NCT00223834|Motivation|motivation
807222|NCT00223834|Psychotherapy, brief|psychotherapy, brief
807223|NCT00223821|Behavior Therapy|behavior therapy
807224|NCT00223821|Behavioral Medicine|behavioral medicine
807225|NCT00223821|Behavioral Research|behavioral research
807226|NCT00223821|Behavioral Sciences|behavioral sciences
807227|NCT00223821|Combined Modality Therapy|combined modality therapy
807228|NCT00223821|Drug Therapy|drug therapy
807229|NCT00223821|Overactive bladder|overactive bladder
807230|NCT00223821|Treatment Outcome|treatment outcome
807231|NCT00223821|Urge incontinence|urge incontinence
807232|NCT00223821|Urinary incontinence|urinary incontinence
807233|NCT00223808|Rehabilitation|rehabilitation
807234|NCT00223808|Robotics|robotics
807235|NCT00223795|Cane|cane
807236|NCT00223795|Gait|gait
807237|NCT00223795|Obesity|obesity
807238|NCT00223795|Osteoarthritis|osteoarthritis
807239|NCT00223795|Walking Aids|walking aids
807240|NCT00223782|Diabetes|diabetes
807241|NCT00223782|Peripheral Neuropathy|peripheral neuropathy
807242|NCT00223782|Walking|walking
807243|NCT00223769|oxandrolone|oxandrolone
807244|NCT00223769|oxandrin|oxandrin
807245|NCT00223769|lean body mass|lean body mass
807246|NCT00223769|functional recovery|functional recovery
807247|NCT00223769|resistance training|resistance training
807248|NCT00223756|Vision, Low|vision, low
807249|NCT00223743|essential tremor|essential tremor
807250|NCT00223743|zonisamide|zonisamide
807251|NCT00223743|clinical trial|clinical trial
807252|NCT00223730|Peripheral Blood Stem Cell Transplant|peripheral blood stem cell transplant
807253|NCT00223730|Bone Marrow Transplant|bone marrow transplant
807254|NCT00223730|Citrulline|citrulline
807255|NCT00223730|Urea Cycle|urea cycle
807256|NCT00223730|Hepatic Injury|hepatic injury
807257|NCT00223730|Allogeneic PBSCT|allogeneic pbsct
807258|NCT00223730|Matched-Unrelated PBSCT|matched-unrelated pbsct
807259|NCT00223717|Supine Hypertension|supine hypertension
807260|NCT00223717|Hypertension|hypertension
807261|NCT00223717|Treatment|treatment
807262|NCT00223717|Autonomic failure|autonomic failure
807263|NCT00223717|Pure autonomic failure|pure autonomic failure
807264|NCT00223717|Multiple System Atrophy|multiple system atrophy
807265|NCT00223717|Shy-Drager Syndrome|shy-drager syndrome
807266|NCT00223704|Coronary Artery Bypass|coronary artery bypass
807267|NCT00223704|Blood Transfusion|blood transfusion
807268|NCT00223704|Bradykinin Receptor Antagonism|bradykinin receptor antagonism
807269|NCT00223704|Anti-Inflammatory Agents|anti-inflammatory agents
807270|NCT00223704|Antifibrinolytic Agents|antifibrinolytic agents
807271|NCT00223691|orthostatic hypotension|orthostatic hypotension
807272|NCT00223691|autonomic failure|autonomic failure
807273|NCT00223665|Intermittent Hormone Therapy|intermittent hormone therapy
807274|NCT00223665|Intermittent Androgen Suppression|intermittent androgen suppression
807275|NCT00223665|Biochemical Relapsed Prostate Cancer|biochemical relapsed prostate cancer
807276|NCT00223665|Androgen Deprivation Therapy|androgen deprivation therapy
807277|NCT00223665|Localized Prostate Cancer|localized prostate cancer
807278|NCT00223652|Cognitive-Behavioral Therapy|cognitive-behavioral therapy
807279|NCT00223652|Telephone psychotherapy|telephone psychotherapy
807280|NCT00223652|Clinical Trial|clinical trial
807281|NCT00223652|Primary Care Clinic|primary care clinic
807282|NCT00223652|Treatment for Depression|treatment for depression
807283|NCT00223639|alcoholism /alcohol abuse|alcoholism /alcohol abuse
807284|NCT00223639|alcoholism antagonist|alcoholism antagonist
807285|NCT00223639|anticonvulsant|anticonvulsant
807286|NCT00223639|cognition|cognition
807287|NCT00223639|neuropharmacology|neuropharmacology
807288|NCT00223639|substance abuse related behavior|substance abuse related behavior
807289|NCT00223639|craving|craving
807290|NCT00223639|euphoria|euphoria
807291|NCT00223639|relapse /recurrence|relapse /recurrence
807292|NCT00223639|patient oriented research|patient oriented research
807293|NCT00223626|Cocaine Addiction|cocaine addiction
807295|NCT00223613|diabetes|diabetes
807296|NCT00223613|juvenile diabetes|juvenile diabetes
807297|NCT00223613|insulin deficiency|insulin deficiency
807298|NCT00223600|lipids|lipids
807299|NCT00223600|lipoproproteins|lipoproproteins
807300|NCT00223600|growth|growth
807301|NCT00223600|neurological development|neurological development
807302|NCT00223600|vascular wall|vascular wall
807303|NCT00223600|blood pressure|blood pressure
807304|NCT00223600|nutrient intake|nutrient intake
807305|NCT00223587|driving|driving
807306|NCT00223587|memory|memory
807307|NCT00223561|adult|adult
807308|NCT00223548|prophylaxis|prophylaxis
807309|NCT00223548|contrast-induced nephropathy|contrast-induced nephropathy
807310|NCT00223548|mesna|mesna
807311|NCT00223548|acute renal failure|acute renal failure
807312|NCT00223535|Schizophrenia|schizophrenia
807313|NCT00223535|Cognitive Remediation|cognitive remediation
807314|NCT00223535|Social Skills Training|social skills training
807315|NCT00223535|Psychosocial|psychosocial
807316|NCT00223522|Schizophrenia|schizophrenia
807317|NCT00223522|Schizoaffective|schizoaffective
807318|NCT00223522|MEMS|mems
807319|NCT00223522|adherence to antipsychotic medication|adherence to antipsychotic medication
807320|NCT00223509|mixed mania|mixed mania
807321|NCT00223509|lamotrigine|lamotrigine
807322|NCT00223496|Bipolar Depression|bipolar depression
807323|NCT00223496|Refractory|refractory
807324|NCT00223483|Hematologic Diseases|hematologic diseases
807325|NCT00223483|Genomics|genomics
807326|NCT00223483|Cytokines|cytokines
807327|NCT00223483|Chemokines|chemokines
807328|NCT00223483|Receptors|receptors
807329|NCT00223470|pain|pain
807330|NCT00223457|multiple sclerosis|multiple sclerosis
807331|NCT00223457|compliance|compliance
807332|NCT00223457|adherence|adherence
807333|NCT00223457|disease modifying therapy|disease modifying therapy
807334|NCT00223457|depression|depression
807335|NCT00223457|hope|hope
807336|NCT00223457|quality of life|quality of life
807337|NCT00223444|alcohol|alcohol
807338|NCT00223444|GABA|gaba
807339|NCT00223444|genetic variation|genetic variation
807340|NCT00223418|aripiprazole|aripiprazole
807341|NCT00223418|olanzapine|olanzapine
807342|NCT00223418|vocational|vocational
807343|NCT00223418|learning|learning
807344|NCT00223418|cognition|cognition
807345|NCT00223418|cognitive|cognitive
807346|NCT00223405|enamel wear against ceramic crowns|enamel wear against ceramic crowns
807347|NCT00223379|Apical Periodontitis, Root Canal Therapy, Apical Preparation|apical periodontitis, root canal therapy, apical preparation
807348|NCT00223366|Pain in teeth|pain in teeth
807349|NCT00223353|Biomechanics|biomechanics
807350|NCT00223353|Gait|gait
807351|NCT00223353|Balance|balance
807352|NCT00223340|patient activation|patient activation
807353|NCT00223340|primary care|primary care
807354|NCT00223340|diabetes|diabetes
807355|NCT00223340|cardiovascular risk|cardiovascular risk
807356|NCT00223327|pain|pain
807357|NCT00223327|Normal pulp and normal periodontal status|normal pulp and normal periodontal status
807358|NCT00223327|Chronic apical periodontitis of pulpal origin|chronic apical periodontitis of pulpal origin
807359|NCT00223314|HIV|hiv
807360|NCT00223314|Sexually Transmitted Diseases|sexually transmitted diseases
807361|NCT00223314|Pregnancy|pregnancy
807362|NCT00223314|HIV Seronegativity|hiv seronegativity
807363|NCT00223275|Bipolar Disorder|bipolar disorder
807364|NCT00223275|Alcohol Dependence|alcohol dependence
807365|NCT00223275|Dual Diagnosis|dual diagnosis
807366|NCT00223275|Naltrexone|naltrexone
807367|NCT00223210|bipolar disorder|bipolar disorder
807368|NCT00223210|cocaine dependence|cocaine dependence
807369|NCT00223210|quetiapine|quetiapine
807370|NCT00223197|Bipolar with depression|bipolar with depression
807371|NCT00223197|Recurrent major depressive disorder|recurrent major depressive disorder
807372|NCT00223197|substance abuse dependence|substance abuse dependence
807373|NCT00223171|Stage T3 T4|stage t3 t4
807374|NCT00223171|PSA > 20|psa > 20
807375|NCT00223171|Gleason Score > 7|gleason score > 7
807376|NCT00223158|Thyroid cancer|thyroid cancer
807377|NCT00223158|Hypothyroidism|hypothyroidism
807378|NCT00223158|Whole Body Scintigraphy|whole body scintigraphy
807379|NCT00223158|Liothyronine|liothyronine
807380|NCT00223158|TSH elevation|tsh elevation
807381|NCT00223145|Prostate adenocarcinoma|prostate adenocarcinoma
807382|NCT00223145|Gleason score <= 6 and PSA 10-20|gleason score <= 6 and psa 10-20
807383|NCT00223145|Gleason score = 7 and PSA <=20|gleason score = 7 and psa <=20
807384|NCT00223132|bariatric surgery|bariatric surgery
807385|NCT00223132|body contouring|body contouring
807386|NCT00223132|skin laxity|skin laxity
807387|NCT00223132|plastic surgery|plastic surgery
807388|NCT00223132|suture granuloma|suture granuloma
807389|NCT00223132|absorbable sutures|absorbable sutures
807390|NCT00223119|perineal trauma|perineal trauma
807391|NCT00223119|perineal laceration|perineal laceration
807392|NCT00223119|persistent perineal pain|persistent perineal pain
807393|NCT00223106|urge incontinence|urge incontinence
807394|NCT00223106|urinary incontinence|urinary incontinence
807395|NCT00223106|vault prolapse|vault prolapse
807396|NCT00223106|stess incontinence|stess incontinence
807397|NCT00223106|mixed incontinence|mixed incontinence
807398|NCT00223106|urine leakage|urine leakage
807399|NCT00223106|enterocele|enterocele
807400|NCT00223106|rectocele|rectocele
807401|NCT00223106|cystocele|cystocele
807402|NCT00223093|renal transplantation, TAIZ-moncytes|renal transplantation, taiz-moncytes
807403|NCT00223080|HIV Seronegativity|hiv seronegativity
807404|NCT00223067|renal transplantation|renal transplantation
807405|NCT00223067|TAIZ|taiz
807406|NCT00223054|cyclosporin A|cyclosporin a
807407|NCT00223054|Tacrolimus|tacrolimus
807408|NCT00223054|Everolimus|everolimus
807409|NCT00223054|Sirolimus|sirolimus
807410|NCT00223054|Fluvastatin|fluvastatin
807411|NCT00223041|renal transplantation|renal transplantation
807412|NCT00223041|cardiovasculary disease|cardiovasculary disease
807413|NCT00223041|statin|statin
807414|NCT00223028|fluvastain|fluvastain
807415|NCT00223028|sirolimus|sirolimus
807416|NCT00223028|mycophenolat mofetil|mycophenolat mofetil
807417|NCT00223028|renal transplantation|renal transplantation
807418|NCT00223015|renal transplantation|renal transplantation
807419|NCT00223015|pharmacokinetics|pharmacokinetics
807420|NCT00223015|Fluvastatin|fluvastatin
807421|NCT00223015|Mycophenolat mofetil|mycophenolat mofetil
807422|NCT00223015|tacrolimus|tacrolimus
807423|NCT00222989|GERD|gerd
807424|NCT00222989|PPI|ppi
807425|NCT00222989|Functional heartburn|functional heartburn
807426|NCT00222963|Obesity|obesity
807427|NCT00222963|Obstructive Sleep Apnea Syndrome|obstructive sleep apnea syndrome
807428|NCT00222963|Children|children
807429|NCT00222963|Adolescents|adolescents
807430|NCT00222963|Adenotonsillectomy|adenotonsillectomy
807431|NCT00222950|plant sterols, serum, aortic valve cusps|plant sterols, serum, aortic valve cusps
807432|NCT00222937|Voice Problems|voice problems
807433|NCT00222937|Voice Disorders|voice disorders
807434|NCT00222924|Mitochondria|mitochondria
807435|NCT00222911|plantar fasciitis|plantar fasciitis
807436|NCT00222911|heel pain|heel pain
807437|NCT00222911|heel spur|heel spur
807438|NCT00222911|night splint|night splint
807439|NCT00222911|arch support|arch support
807440|NCT00222911|foot orthosis|foot orthosis
807441|NCT00222911|physical therapy|physical therapy
807442|NCT00222898|Pancreatic Cyst|pancreatic cyst
807443|NCT00222898|PANDA Study|panda study
807444|NCT00222885|PET imaging|pet imaging
807445|NCT00222885|Skeletal muscle|skeletal muscle
807446|NCT00222885|In vivo insulin-stimulated tissue perfusion|in vivo insulin-stimulated tissue perfusion
807447|NCT00222885|Glucose transport|glucose transport
807448|NCT00222885|Glucose phosphorylation|glucose phosphorylation
807449|NCT00222872|Endocrine System Diseases|endocrine system diseases
807450|NCT00222872|MusculoSkeletal System Diseases|musculoskeletal system diseases
807451|NCT00222872|Hormone|hormone
807452|NCT00222872|Postmenopausal Women|postmenopausal women
807453|NCT00222859|HIV|hiv
807454|NCT00222859|HCV|hcv
807455|NCT00222846|Clinical trial|clinical trial
807456|NCT00222846|Behavioral research|behavioral research
807457|NCT00222846|Patient compliance|patient compliance
807458|NCT00222833|Schizophrenia|schizophrenia
807459|NCT00222833|Schizoaffective disorder|schizoaffective disorder
807460|NCT00222833|Aripiprazole|aripiprazole
807461|NCT00222833|Obese|obese
807462|NCT00222833|Overweight|overweight
807463|NCT00222833|Heart Health|heart health
807464|NCT00222833|Antipsychotic|antipsychotic
807465|NCT00222833|Heart Health Factors|heart health factors
807466|NCT00222833|Cardiovascular Health Indices|cardiovascular health indices
807467|NCT00222833|Cardiovascular health|cardiovascular health
807468|NCT00222807|schizophrenia, psychosis, type 2 diabetes mellitus|schizophrenia, psychosis, type 2 diabetes mellitus
807469|NCT00222794|Schizophrenia|schizophrenia
807470|NCT00222794|Schizo-Affective Disorder|schizo-affective disorder
807471|NCT00222794|Negative Symptoms|negative symptoms
807472|NCT00222794|Atomoxetine|atomoxetine
807473|NCT00222794|Strattera|strattera
807474|NCT00222781|Skeletal muscle|skeletal muscle
807475|NCT00222781|Triple-tracer PET imaging|triple-tracer pet imaging
807476|NCT00222768|Adipose tissue|adipose tissue
807477|NCT00222768|PET imaging|pet imaging
807478|NCT00222755|Mood disorders-bipolar|mood disorders-bipolar
807479|NCT00222755|Disease management|disease management
807480|NCT00222755|Quality of care|quality of care
807481|NCT00222742|hypothermia|hypothermia
807482|NCT00222742|pediatric TBI|pediatric tbi
807483|NCT00222729|head|head
807484|NCT00222729|neck|neck
807485|NCT00222716|Treatment adherence|treatment adherence
807486|NCT00222716|HIV|hiv
807487|NCT00222716|Self-efficacy|self-efficacy
807974|NCT00220688|acupressure|acupressure
807488|NCT00222716|Treatment Experienced|treatment experienced
807489|NCT00222703|nicotine addiction|nicotine addiction
807490|NCT00222703|relapse|relapse
807491|NCT00222703|smoking|smoking
807492|NCT00222703|chronic disorders|chronic disorders
807493|NCT00222703|randomized controlled trial|randomized controlled trial
807494|NCT00222703|intervention|intervention
807495|NCT00222690|qualitative interview|qualitative interview
807496|NCT00222690|symptom triggers|symptom triggers
807497|NCT00222690|activity and participation|activity and participation
807498|NCT00222677|venous thromboembolism|venous thromboembolism
807499|NCT00222677|deep vein thrombosis|deep vein thrombosis
807500|NCT00222677|pulmonary embolism|pulmonary embolism
807501|NCT00222677|antithrombotic agents|antithrombotic agents
807502|NCT00222664|hepatitis B|hepatitis b
807503|NCT00222664|hepatocellular carcinoma|hepatocellular carcinoma
807504|NCT00222664|prevention|prevention
807505|NCT00222664|vaccination|vaccination
807506|NCT00222651|pulmonary embolism|pulmonary embolism
807507|NCT00222651|right ventricular dysfunction|right ventricular dysfunction
807508|NCT00222651|thrombolysis|thrombolysis
807509|NCT00222651|echocardiography|echocardiography
807510|NCT00222638|Oral anticoagulants|oral anticoagulants
807511|NCT00222638|Influenza virus|influenza virus
807512|NCT00222638|Influenza vaccine|influenza vaccine
807513|NCT00222638|Pharmacological interference|pharmacological interference
807514|NCT00222625|Intracerebral Hemorrhage|intracerebral hemorrhage
807515|NCT00222625|Oral Anticoagulants|oral anticoagulants
807516|NCT00222625|Antiplatelet Agents|antiplatelet agents
807517|NCT00222625|Recombinant Activated Factor VII|recombinant activated factor vii
807518|NCT00222573|clopidogrel|clopidogrel
807519|NCT00222573|metoprolol|metoprolol
807520|NCT00222573|myocardial infarction|myocardial infarction
807521|NCT00222573|randomised trial|randomised trial
807522|NCT00222560|physical activity counselling|physical activity counselling
807523|NCT00222560|physical activity behavior change intervention|physical activity behavior change intervention
807524|NCT00222560|prevention|prevention
807525|NCT00222560|collaborative health care|collaborative health care
807526|NCT00222560|physical inactivity|physical inactivity
807527|NCT00222560|motivation|motivation
807528|NCT00222560|fitness|fitness
807529|NCT00222560|randomized controlled trial|randomized controlled trial
807530|NCT00222534|Respiratory Insufficiency|respiratory insufficiency
807531|NCT00222534|Alkalosis|alkalosis
807532|NCT00222521|Cystic Fibrosis|cystic fibrosis
807533|NCT00222521|Diabetes|diabetes
807534|NCT00222508|Cystic Fibrosis|cystic fibrosis
807535|NCT00222508|Diabetes|diabetes
807536|NCT00222508|Complications|complications
807537|NCT00222495|Psychotic Disorders in adolescents|psychotic disorders in adolescents
807538|NCT00222495|Schizophrenia in adolescents|schizophrenia in adolescents
807539|NCT00222495|Schizophreniform Disorders in adolescents|schizophreniform disorders in adolescents
807540|NCT00222495|Schizoaffective Disorders in adolescents|schizoaffective disorders in adolescents
807541|NCT00222482|Borderline Personality Disorder|borderline personality disorder
807542|NCT00222469|pancreatic cancer|pancreatic cancer
807543|NCT00222469|unresectable pancreatic cancer|unresectable pancreatic cancer
807544|NCT00222469|metastatic pancreatic cancer|metastatic pancreatic cancer
807545|NCT00222469|bevacizumab|bevacizumab
807546|NCT00222469|oxaliplatin|oxaliplatin
807547|NCT00222469|gemcitabine|gemcitabine
807548|NCT00222469|1st line treatment|1st line treatment
807549|NCT00222469|first line treatment|first line treatment
807550|NCT00222469|locally advanced (unresectable) pancreatic cancer|locally advanced (unresectable) pancreatic cancer
807551|NCT00222456|preterm infants|preterm infants
807552|NCT00222456|early intervention|early intervention
807554|NCT00222456|behavioral problems|behavioral problems
807555|NCT00222456|parenting stress|parenting stress
807556|NCT00222443|Recurrent solid tumors|recurrent solid tumors
807557|NCT00222443|recurrent lymphomas|recurrent lymphomas
807558|NCT00222443|Pediatrics|pediatrics
807559|NCT00222443|Adolescents|adolescents
807560|NCT00222430|Fluoroscopy|fluoroscopy
807561|NCT00222430|Femoral Artery|femoral artery
807562|NCT00222430|Arterial Vascular Access|arterial vascular access
807563|NCT00222404|Carcinoma, Non-Small-Cell Lung|carcinoma, non-small-cell lung
807564|NCT00222404|Pharmacogenomic|pharmacogenomic
807565|NCT00222378|Crohn's disease|crohn's disease
807566|NCT00222378|ulcerative colitis|ulcerative colitis
807567|NCT00222378|cytomegalovirus|cytomegalovirus
807568|NCT00222378|Epstein Bar Virus|epstein bar virus
807569|NCT00222378|Human Herpes virus 6|human herpes virus 6
807570|NCT00222365|homeopathy|homeopathy
807571|NCT00222365|assessment|assessment
807572|NCT00222365|pain|pain
807573|NCT00222365|ligamentoplasty|ligamentoplasty
807574|NCT00222352|Unstable Angina|unstable angina
807575|NCT00222352|Non-ST-segment Myocardial Infarction|non-st-segment myocardial infarction
807576|NCT00222352|Myocardial Necrosis|myocardial necrosis
807577|NCT00222352|Troponin I|troponin i
807578|NCT00222339|Stroke|stroke
807579|NCT00222339|Hand function|hand function
807580|NCT00222339|Task-specific training|task-specific training
807581|NCT00222326|Hysterectomy,|hysterectomy,
807582|NCT00222326|Prolapse,|prolapse,
807583|NCT00222326|Pelvic floor muscles,|pelvic floor muscles,
807586|NCT00222300|Total hip replacement|total hip replacement
807587|NCT00222300|Strength training|strength training
807588|NCT00222300|Gait analysis|gait analysis
807589|NCT00222287|Feldenkrais Method|feldenkrais method
807590|NCT00222287|movement class|movement class
807591|NCT00222287|balance|balance
807592|NCT00222287|Four square step test|four square step test
807593|NCT00222287|Activities Specific Balance Confidence Scale|activities specific balance confidence scale
807594|NCT00222287|systems theory|systems theory
807595|NCT00222274|fibromyalgia|fibromyalgia
807596|NCT00222274|pain|pain
807597|NCT00222274|biofeedback|biofeedback
807598|NCT00222274|heart rate variability|heart rate variability
807599|NCT00222261|antiplatelet therapy|antiplatelet therapy
807600|NCT00222261|aspirin non-responders|aspirin non-responders
807601|NCT00222261|aspirin resistance|aspirin resistance
807602|NCT00222261|clopidogrel|clopidogrel
807603|NCT00222261|coronary heart disease|coronary heart disease
807604|NCT00222261|stable angina pectoris|stable angina pectoris
807605|NCT00222248|Stress urinary incontinence|stress urinary incontinence
807606|NCT00222248|Pelvic floor muscle training|pelvic floor muscle training
807607|NCT00222248|Bladder training|bladder training
807608|NCT00222248|Older women|older women
807609|NCT00222235|schizophrenia|schizophrenia
807610|NCT00222235|schizoaffective disorder|schizoaffective disorder
807611|NCT00222235|negative symptoms|negative symptoms
807612|NCT00222235|cognitive impairments|cognitive impairments
807613|NCT00222222|severe sepsis|severe sepsis
807614|NCT00222222|prognostic markers|prognostic markers
807615|NCT00222222|polymorphisms|polymorphisms
807616|NCT00222222|SIRS|sirs
807617|NCT00222209|Experimental study|experimental study
807618|NCT00222209|chronic pain|chronic pain
807619|NCT00222209|operant learning|operant learning
807620|NCT00222209|comorbidity|comorbidity
807621|NCT00222209|stress|stress
807622|NCT00222209|Fibromyalgia w visceral hypersensitivity|fibromyalgia w visceral hypersensitivity
807623|NCT00222209|Fibromyalgia w/o visceral hypersensitivity|fibromyalgia w/o visceral hypersensitivity
807624|NCT00222196|atherosclerosis|atherosclerosis
807625|NCT00222196|quality of life|quality of life
807626|NCT00222196|pain-score|pain-score
807627|NCT00222196|biomarkers|biomarkers
807628|NCT00222183|Lupus erythematodes|lupus erythematodes
807629|NCT00222183|Elidel|elidel
807630|NCT00222183|Pimecrolimus|pimecrolimus
807631|NCT00222183|Chronic discoid lupus erythematosus (dLE)|chronic discoid lupus erythematosus (dle)
807632|NCT00222183|subacute cutaneous lupus erythematosus (scLE)|subacute cutaneous lupus erythematosus (scle)
807633|NCT00222131|Epigastric Pain|epigastric pain
807634|NCT00222131|Non-Ulcer Dyspepsia (NUD)|non-ulcer dyspepsia (nud)
807635|NCT00222092|post-ERCP pancreatitis|post-ercp pancreatitis
807636|NCT00222092|prophylaxis|prophylaxis
807637|NCT00222092|prognosis|prognosis
807638|NCT00222092|natural course|natural course
807639|NCT00222092|molecular markers|molecular markers
807640|NCT00222066|Aspiration|aspiration
807641|NCT00222066|Fetal ovarian cyst|fetal ovarian cyst
807642|NCT00222066|Ovarian torsion|ovarian torsion
807643|NCT00222053|Myeloma|myeloma
807644|NCT00222053|Autologous transplantation|autologous transplantation
807645|NCT00222053|Maintenance therapy|maintenance therapy
807646|NCT00222053|Thalidomide|thalidomide
807647|NCT00222040|Stroke|stroke
807648|NCT00222040|thrombolysis|thrombolysis
807649|NCT00222040|ultrasound|ultrasound
807650|NCT00222040|microbubbles|microbubbles
807651|NCT00222040|alteplase|alteplase
807652|NCT00222027|Acute lymphoblastic leukemia|acute lymphoblastic leukemia
807653|NCT00222027|adult patient|adult patient
807654|NCT00222027|chemotherapy|chemotherapy
807655|NCT00222027|stem cell transplantation|stem cell transplantation
807656|NCT00222027|Young adult patients|young adult patients
807657|NCT00222014|Refractory ascites|refractory ascites
807658|NCT00222014|Cirrhosis|cirrhosis
807659|NCT00222014|Paracentesesis|paracentesesis
807660|NCT00221988|Elderly|elderly
807661|NCT00221988|Epilepsy|epilepsy
807662|NCT00221988|Cognition|cognition
807663|NCT00221988|Health Outcome|health outcome
807664|NCT00221962|ADHD|adhd
807665|NCT00221923|Primary open angle glaucoma|primary open angle glaucoma
807666|NCT00221923|African American|african american
807667|NCT00221923|Glaucoma/pathology|glaucoma/pathology
807668|NCT00221923|Glaucoma/ physiopathology|glaucoma/ physiopathology
807669|NCT00221923|Nerve Fibers/pathology|nerve fibers/pathology
807670|NCT00221923|Risk factor glaucoma|risk factor glaucoma
807671|NCT00221897|Primary open angle glaucoma|primary open angle glaucoma
807672|NCT00221897|Glaucoma/pathology|glaucoma/pathology
807673|NCT00221897|Glaucoma/physiopathology|glaucoma/physiopathology
807674|NCT00221897|Nerve Fibers/pathology|nerve fibers/pathology
807675|NCT00221897|Risk factors glaucoma|risk factors glaucoma
807676|NCT00221845|Ramipril|ramipril
807677|NCT00221845|Hypertension|hypertension
807678|NCT00221845|Chronic renal failure|chronic renal failure
807679|NCT00221845|Disease progression|disease progression
807680|NCT00221845|Left ventricular hypertrophy|left ventricular hypertrophy
807681|NCT00221845|Intima media thickness|intima media thickness
807682|NCT00221845|Cardiovascular disease|cardiovascular disease
807684|NCT00221845|Gene polymorphisms|gene polymorphisms
807685|NCT00221832|Long QT Syndrome|long qt syndrome
807686|NCT00221832|Hypertrophic cardiomyopathy|hypertrophic cardiomyopathy
807687|NCT00221832|arrhythmogenic right ventricular dysplasia|arrhythmogenic right ventricular dysplasia
807688|NCT00221832|Short QT Syndrome|short qt syndrome
807689|NCT00221832|Brugada Syndrome|brugada syndrome
807690|NCT00221819|Humidification|humidification
807691|NCT00221819|Heat and moisture exchanger|heat and moisture exchanger
807692|NCT00221819|Heated humidifier, non invasive ventilation|heated humidifier, non invasive ventilation
807693|NCT00221806|Arteritis, femoro popliteal bypass, endothelialised prosthesis, saphenous vein graft, permeability, Doppler echography|arteritis, femoro popliteal bypass, endothelialised prosthesis, saphenous vein graft, permeability, doppler echography
807694|NCT00221793|Parkinson|parkinson
807695|NCT00221793|deep subthalamic stimulation|deep subthalamic stimulation
807696|NCT00221793|pharmacological treatment|pharmacological treatment
807697|NCT00221780|Heart failure|heart failure
807698|NCT00221780|Cardiomyopathy, dilated|cardiomyopathy, dilated
808380|NCT00218361|Opioid|opioid
807699|NCT00221780|Coronary disease|coronary disease
807700|NCT00221780|Cardiac Pacing, Artificial|cardiac pacing, artificial
807701|NCT00221780|Hemodynamics|hemodynamics
807702|NCT00221780|Randomized Controlled Trials|randomized controlled trials
807703|NCT00221780|Single-Blind Study|single-blind study
807704|NCT00221767|Neurogenic bladder|neurogenic bladder
807705|NCT00221767|electric stimulation therapy|electric stimulation therapy
807706|NCT00221767|urinary tract infection|urinary tract infection
807707|NCT00221767|urinary incontinence|urinary incontinence
807708|NCT00221767|spinal cord injuries|spinal cord injuries
807709|NCT00221767|spinal nerve roots|spinal nerve roots
807710|NCT00221767|nonRandomized Controlled Trials|nonrandomized controlled trials
807711|NCT00221767|open Study|open study
807712|NCT00221754|HIV,|hiv,
807713|NCT00221754|protease inhibitors|protease inhibitors
807714|NCT00221754|pravastatin|pravastatin
807715|NCT00221754|Treatment Experienced|treatment experienced
807716|NCT00221741|Heart surgery|heart surgery
807717|NCT00221741|Blood Loss, Surgical|blood loss, surgical
807718|NCT00221741|Mortality|mortality
807719|NCT00221741|Blood Transfusion|blood transfusion
807720|NCT00221741|Cohort Studies|cohort studies
807721|NCT00221728|Kidney Neoplasms|kidney neoplasms
807722|NCT00221728|Surgery|surgery
807723|NCT00221728|Catheter Ablation|catheter ablation
807724|NCT00221728|Randomized controlled trials|randomized controlled trials
807725|NCT00221728|Kidney Failure, Chronic|kidney failure, chronic
807726|NCT00221715|arteritis|arteritis
807727|NCT00221715|lower limb ischemia|lower limb ischemia
807728|NCT00221715|femoropopliteal artery bypass|femoropopliteal artery bypass
807729|NCT00221715|blood vessel prothesis implantation|blood vessel prothesis implantation
807730|NCT00221715|saphenous vein|saphenous vein
807731|NCT00221715|vascular permeability|vascular permeability
807732|NCT00221715|doppler ultrasonography|doppler ultrasonography
807733|NCT00221715|randomized clinical trials|randomized clinical trials
807734|NCT00221715|efficacy study|efficacy study
807735|NCT00221702|Melanoma|melanoma
807736|NCT00221702|Neoplasm metastasis|neoplasm metastasis
807737|NCT00221702|Interferon alfa-2b|interferon alfa-2b
807738|NCT00221702|Adjuvants|adjuvants
807739|NCT00221702|Randomized clinical trial|randomized clinical trial
807740|NCT00221702|Disease-free survival time|disease-free survival time
807741|NCT00221702|Safety|safety
807742|NCT00221702|Drug toxicity|drug toxicity
807743|NCT00221702|Quality of life|quality of life
807744|NCT00221689|Severe brain injury|severe brain injury
807745|NCT00221689|Coma|coma
807746|NCT00221689|Hypertonia|hypertonia
807747|NCT00221689|Dysautonomia|dysautonomia
807748|NCT00221689|Baclofen|baclofen
807749|NCT00221689|Randomized Controlled Trials|randomized controlled trials
807750|NCT00221676|influenza vaccine|influenza vaccine
807751|NCT00221676|general practitioner|general practitioner
807752|NCT00221663|Cardiac surgery|cardiac surgery
807753|NCT00221663|Aortic valve replacement|aortic valve replacement
807754|NCT00221663|Minimally invasive surgery|minimally invasive surgery
807755|NCT00221663|Perioperative course|perioperative course
807756|NCT00221650|Hepatitis C, Chronic|hepatitis c, chronic
807757|NCT00221650|HCV infection|hcv infection
807758|NCT00221650|HIV infection|hiv infection
807759|NCT00221650|Treatment Failure|treatment failure
807760|NCT00221650|PEG interferon|peg interferon
807761|NCT00221650|Interferons/therapeutic use|interferons/therapeutic use
807762|NCT00221650|Interferon Alfa-2a/adverse effects|interferon alfa-2a/adverse effects
807763|NCT00221650|Ribavirin/therapeutic use|ribavirin/therapeutic use
807764|NCT00221650|Ribavirin/adverse effects|ribavirin/adverse effects
807765|NCT00221650|Drug Therapy, Combination|drug therapy, combination
807766|NCT00221650|Treatment Experienced|treatment experienced
807767|NCT00221650|Treatment Naive|treatment naive
807768|NCT00221637|Neuralgia|neuralgia
807769|NCT00221637|Valproate|valproate
807770|NCT00221637|Anticonvulsant Drugs|anticonvulsant drugs
807771|NCT00221637|Pain Measurement|pain measurement
807772|NCT00221637|Randomized Controlled Trials|randomized controlled trials
807773|NCT00221624|Hepatitis C, chronic|hepatitis c, chronic
807774|NCT00221624|HCV infection|hcv infection
807775|NCT00221624|Treatment failure|treatment failure
807776|NCT00221624|PEG Interferon|peg interferon
807777|NCT00221624|(Interferons/therapeutic use|(interferons/therapeutic use
807778|NCT00221624|Interferon Alfa-2a/adverse effects)|interferon alfa-2a/adverse effects)
807779|NCT00221624|ribavirin|ribavirin
807780|NCT00221624|(Ribavirin/therapeutic use|(ribavirin/therapeutic use
807781|NCT00221624|Ribavirin/adverse effects)|ribavirin/adverse effects)
807782|NCT00221624|Amantadine|amantadine
807783|NCT00221624|Drug Therapy, Combination|drug therapy, combination
807784|NCT00221520|Sedation, mechanical ventilation|sedation, mechanical ventilation
807785|NCT00221507|Vaccination|vaccination
807786|NCT00221507|Prevention & Control|prevention & control
807787|NCT00221494|depression|depression
807788|NCT00221481|Bipolar|bipolar
807789|NCT00221481|Alcohol|alcohol
807790|NCT00221468|Adolescents|adolescents
807791|NCT00221455|Diabetes Mellitus|diabetes mellitus
807792|NCT00221455|Chronic disease management|chronic disease management
807793|NCT00221455|Patient portal|patient portal
807794|NCT00221455|Patient empowerment|patient empowerment
807795|NCT00221442|Adults|adults
807796|NCT00221442|Binge eating disorder|binge eating disorder
807797|NCT00221442|Blood draw|blood draw
807798|NCT00221442|E.Coli enterprotoxin|e.coli enterprotoxin
807799|NCT00221442|Eating disorders|eating disorders
807800|NCT00221442|Electrocardiogram|electrocardiogram
807801|NCT00221442|Females|females
807802|NCT00221442|Males|males
807803|NCT00221442|Physical exam|physical exam
807804|NCT00221442|Psychiatric evaluation|psychiatric evaluation
807805|NCT00221442|Questionnaire|questionnaire
807806|NCT00221429|child|child
807807|NCT00221429|adolescent|adolescent
807808|NCT00221416|child|child
807809|NCT00221416|adolescent|adolescent
807810|NCT00221403|child|child
807811|NCT00221403|adolescent|adolescent
807812|NCT00221403|bipolar disorder|bipolar disorder
807813|NCT00221390|stroke|stroke
807814|NCT00221390|Chronic stroke with hemiparesis|chronic stroke with hemiparesis
807815|NCT00221377|intubation|intubation
807816|NCT00221377|trachea|trachea
807817|NCT00221377|tube|tube
807818|NCT00221377|cuff|cuff
807819|NCT00221377|children|children
807820|NCT00221364|Trachoma|trachoma
807821|NCT00221364|Chlamydia|chlamydia
807822|NCT00221364|Azithromycin|azithromycin
807823|NCT00221351|cough|cough
807824|NCT00221351|acute bronchitis|acute bronchitis
807825|NCT00221351|upper respiratory tract infection|upper respiratory tract infection
807826|NCT00221351|pneumonia|pneumonia
807827|NCT00221351|lower respiratory tract infection|lower respiratory tract infection
807828|NCT00221338|gabapentin|gabapentin
807829|NCT00221338|pain|pain
807830|NCT00221338|surgery|surgery
807831|NCT00221338|delirium|delirium
807832|NCT00221338|cognitive decline|cognitive decline
807833|NCT00221325|Phase I Clinical Trial|phase i clinical trial
807834|NCT00221325|Pharmacokinetics|pharmacokinetics
807835|NCT00221325|Pharmacodynamics|pharmacodynamics
807836|NCT00221325|CNS Lymphoma|cns lymphoma
807837|NCT00221325|Ocular Lymphoma|ocular lymphoma
807838|NCT00221312|Perimenopausal bone loss|perimenopausal bone loss
807839|NCT00221299|Osteoporosis|osteoporosis
807840|NCT00221299|Steroids|steroids
807841|NCT00221299|Prednisone|prednisone
807842|NCT00221286|chronic hepatitis B|chronic hepatitis b
807843|NCT00221286|human immunodeficiency virus|human immunodeficiency virus
807844|NCT00221286|pegylated interferon|pegylated interferon
807845|NCT00221286|tenofovir DF|tenofovir df
807846|NCT00221286|emtricitabine|emtricitabine
807847|NCT00221260|Analgesia|analgesia
807848|NCT00221260|anesthesia|anesthesia
807849|NCT00221247|cerebral palsy; acupuncture|cerebral palsy; acupuncture
807850|NCT00221234|Diabetes|diabetes
807851|NCT00221234|Physical Activity|physical activity
807852|NCT00221221|breast cancer survivors|breast cancer survivors
807853|NCT00221221|physical activity|physical activity
807854|NCT00221221|health promotion|health promotion
807855|NCT00221208|Diabetes|diabetes
807856|NCT00221208|Resistance Training|resistance training
807857|NCT00221182|Angina|angina
807858|NCT00221182|Heart diseases|heart diseases
807859|NCT00221182|Pain|pain
807860|NCT00221182|Vascular diseases|vascular diseases
807861|NCT00221169|Non-small cell lung cancer|non-small cell lung cancer
807862|NCT00221169|Positron emission tomography|positron emission tomography
807863|NCT00221169|Gross tumor volume|gross tumor volume
807864|NCT00221169|Radiation therapy|radiation therapy
807865|NCT00221156|Abnormal Glucose Tolerance|abnormal glucose tolerance
807866|NCT00221156|coronary artery disease|coronary artery disease
807867|NCT00221156|diabetes mellitus|diabetes mellitus
807868|NCT00221156|clinical outcome|clinical outcome
807869|NCT00221143|Ulcer/ gangrene|ulcer/ gangrene
807870|NCT00221143|Leg diseases|leg diseases
807871|NCT00221143|Pain|pain
807872|NCT00221143|Vascular diseases|vascular diseases
807873|NCT00221143|Chronic limb ischemia|chronic limb ischemia
807874|NCT00221143|Peripheral artery disease|peripheral artery disease
807875|NCT00221130|Regenerative medicine|regenerative medicine
807876|NCT00221130|Periodontal tissue|periodontal tissue
807877|NCT00221117|Spinal Cord Injuries|spinal cord injuries
807878|NCT00221104|stroke|stroke
807879|NCT00221104|brain ischemia|brain ischemia
807880|NCT00221104|cerebrovascular accident|cerebrovascular accident
807881|NCT00221104|statin|statin
807882|NCT00221104|hydroxymethylglutaryl-CoA reductase inhibitors|hydroxymethylglutaryl-coa reductase inhibitors
807883|NCT00221104|cholesterol|cholesterol
807884|NCT00221104|hypercholesterolemia|hypercholesterolemia
807885|NCT00221104|hyperlipidemia|hyperlipidemia
807886|NCT00221104|multicenter studies|multicenter studies
807887|NCT00221104|prospective studies|prospective studies
807888|NCT00221104|endpoint determination|endpoint determination
807889|NCT00221104|randomized controlled trials|randomized controlled trials
807890|NCT00221104|recurrence|recurrence
807891|NCT00221104|pravastatin|pravastatin
807892|NCT00221091|idiopathic normal pressure hydrocephalus|idiopathic normal pressure hydrocephalus
807893|NCT00221091|shunt|shunt
807894|NCT00221078|Cerebrovascular Accident|cerebrovascular accident
807895|NCT00221078|Stroke|stroke
807896|NCT00221065|Sleep Apnea Syndromes|sleep apnea syndromes
807897|NCT00221065|Cerebrovascular Accident|cerebrovascular accident
807899|NCT00221039|Photopheresis|photopheresis
807900|NCT00221039|CTCL|ctcl
807901|NCT00221039|Cutaneous T Cell Lymphoma|cutaneous t cell lymphoma
807902|NCT00221039|Mycosis Fungoides|mycosis fungoides
807903|NCT00221013|Acute Renal Failure|acute renal failure
807904|NCT00221013|Continuous Renal Replacement Therapy|continuous renal replacement therapy
807905|NCT00221013|Continuous Veno-Venous Haemofiltration|continuous veno-venous haemofiltration
807906|NCT00221013|Continuous Veno-Venous Haemodiafiltration|continuous veno-venous haemodiafiltration
807907|NCT00221013|Renal Replacement Therapy|renal replacement therapy
807908|NCT00221000|Rheumatoid Arthritis|rheumatoid arthritis
807909|NCT00220987|Hyperglycemia in the critically ill patient|hyperglycemia in the critically ill patient
807910|NCT00220987|Intensive Insulin Therapy|intensive insulin therapy
807911|NCT00220987|Conventional insulin therapy|conventional insulin therapy
807912|NCT00220987|Hypoglycaemia|hypoglycaemia
807913|NCT00220961|Impaired Glucose Tolerance|impaired glucose tolerance
807914|NCT00220961|Type 2 Diabetes|type 2 diabetes
807915|NCT00220961|Prevention|prevention
807916|NCT00220961|Pioglitazone|pioglitazone
807917|NCT00220948|discogenic pain|discogenic pain
807918|NCT00220948|myoelectric activity|myoelectric activity
807919|NCT00220935|Randomized controlled clinical trial|randomized controlled clinical trial
807920|NCT00220922|Copaxone|copaxone
807921|NCT00220909|Gastric erosions|gastric erosions
807922|NCT00220909|Proton pump inhibitors|proton pump inhibitors
807923|NCT00220896|Delirium|delirium
807924|NCT00220896|Prevention|prevention
807925|NCT00220896|Donepezil|donepezil
807926|NCT00220883|Functional Dyspepsia|functional dyspepsia
807927|NCT00220883|Electrogastrography|electrogastrography
807928|NCT00220870|schizophrenia|schizophrenia
807929|NCT00220870|shared decision making|shared decision making
807930|NCT00220870|compliance|compliance
807931|NCT00220870|maintenance therapy|maintenance therapy
807932|NCT00220857|Rabeprazole|rabeprazole
807933|NCT00220857|Nonsteroidal Antiinflammatory Drugs|nonsteroidal antiinflammatory drugs
807934|NCT00220857|Gastric erosions|gastric erosions
807935|NCT00220831|Diabetes|diabetes
807936|NCT00220831|MI|mi
807937|NCT00220831|CVD disease|cvd disease
807938|NCT00220818|Pediatric GERD|pediatric gerd
807939|NCT00220818|Pediatric Gastroesophageal Reflux Disease|pediatric gastroesophageal reflux disease
807940|NCT00220818|lansoprazole|lansoprazole
807941|NCT00220792|Primary breast cancer|primary breast cancer
807942|NCT00220792|support groups|support groups
807943|NCT00220792|mood disturbance|mood disturbance
807944|NCT00220766|Primary Immune Deficiency|primary immune deficiency
807945|NCT00220766|IGIV|igiv
807946|NCT00220766|Immunoglobulin G|immunoglobulin g
807947|NCT00220753|Dog allergy|dog allergy
807948|NCT00220753|Pet allergy|pet allergy
807949|NCT00220753|Air cleaners|air cleaners
807950|NCT00220753|HEPA filters|hepa filters
807951|NCT00220753|Air filtration|air filtration
807952|NCT00220753|Can f1|can f1
807953|NCT00220753|Asthma|asthma
807954|NCT00220753|Children|children
807955|NCT00220753|Adolescents|adolescents
807956|NCT00220753|Indoor environment|indoor environment
807957|NCT00220753|Indoor allergy|indoor allergy
807958|NCT00220753|Perennial allergy|perennial allergy
807959|NCT00220740|Immunoglobulin G|immunoglobulin g
807960|NCT00220727|Idiopathic (Immune) Thrombocytopenic Purpura|idiopathic (immune) thrombocytopenic purpura
807961|NCT00220727|Immunoglobulin G|immunoglobulin g
807962|NCT00220714|schizophrenia|schizophrenia
807963|NCT00220714|first-episode|first-episode
807964|NCT00220714|patient compliance|patient compliance
807965|NCT00220714|long-acting risperidone|long-acting risperidone
807966|NCT00220714|relapse|relapse
807967|NCT00220701|Dysthymic Disorder|dysthymic disorder
807968|NCT00220701|Depression|depression
807969|NCT00220701|Chronic Depression|chronic depression
807970|NCT00220701|Escitalopram|escitalopram
807971|NCT00220688|nausea|nausea
807972|NCT00220688|vomiting|vomiting
807973|NCT00220688|palliative|palliative
807975|NCT00220675|Malignant extradural spinal cord compression|malignant extradural spinal cord compression
807976|NCT00220675|Erythropoietin|erythropoietin
807977|NCT00220675|Neuroprotectant|neuroprotectant
807978|NCT00220675|Radiotherapy|radiotherapy
807979|NCT00220675|Palliation|palliation
807980|NCT00220662|anorexia nervosa|anorexia nervosa
807981|NCT00220662|bulimia nervosa|bulimia nervosa
807982|NCT00220662|readiness and motivation|readiness and motivation
807983|NCT00220649|solid tumors or adenocarcinoma of the exocrine pancreas|solid tumors or adenocarcinoma of the exocrine pancreas
807984|NCT00220636|Major Depression|major depression
807985|NCT00220636|Depression|depression
807986|NCT00220636|Unipolar Depression|unipolar depression
807987|NCT00220636|Treatment Resistant Depression|treatment resistant depression
807988|NCT00220636|Adjunctive treatment|adjunctive treatment
807989|NCT00220623|major depression|major depression
807990|NCT00220623|psychotherapy|psychotherapy
807991|NCT00220623|antidepressant medications|antidepressant medications
807992|NCT00220623|clincial trial|clincial trial
807993|NCT00220597|group therapy|group therapy
807994|NCT00220597|sexual revictimization|sexual revictimization
807995|NCT00220597|risky sex|risky sex
807996|NCT00220597|addiction|addiction
807997|NCT00220571|AMI|ami
807998|NCT00220571|stent|stent
807999|NCT00220571|PTCA|ptca
808000|NCT00220571|abciximab|abciximab
808001|NCT00220571|reteplase|reteplase
808002|NCT00220571|combo therapy|combo therapy
808003|NCT00220558|Percutaneous Transluminal Coronary Angioplasty|percutaneous transluminal coronary angioplasty
808004|NCT00220558|Bare metal stents|bare metal stents
808005|NCT00220558|drug eluting stents|drug eluting stents
808006|NCT00220545|Polycystic ovarY|polycystic ovary
808007|NCT00220545|Laparoscopic ovarian diathermy|laparoscopic ovarian diathermy
808008|NCT00220545|Induction of ovulation|induction of ovulation
808009|NCT00220545|Clomiphene citrate|clomiphene citrate
808010|NCT00220532|Randomised placebo controlled intervention trial|randomised placebo controlled intervention trial
808011|NCT00220532|Folic acid|folic acid
808012|NCT00220532|Riboflavin|riboflavin
808013|NCT00220532|cervical cancer|cervical cancer
808014|NCT00220506|provigil|provigil
808015|NCT00220506|fatigue|fatigue
808016|NCT00220506|Multiple Sclerosis|multiple sclerosis
808017|NCT00220506|cognition|cognition
808018|NCT00220493|MS|ms
808019|NCT00220493|RITALIN|ritalin
808020|NCT00220493|PASAT|pasat
808021|NCT00220493|COGNITION|cognition
808022|NCT00220493|ATTENTION|attention
808023|NCT00220493|Relapsing remitting|relapsing remitting
808024|NCT00220493|Secondary progressive|secondary progressive
808025|NCT00220493|Primary progressive|primary progressive
808026|NCT00220467|MCI|mci
808027|NCT00220467|aging|aging
808028|NCT00220467|cognition|cognition
808029|NCT00220467|exercise|exercise
808030|NCT00220467|aerobic|aerobic
808031|NCT00220467|insulin|insulin
808032|NCT00220454|cognition|cognition
808033|NCT00220454|estradiol|estradiol
808034|NCT00220454|cortisol|cortisol
808035|NCT00220454|postmenopause|postmenopause
808036|NCT00220441|IGT|igt
808037|NCT00220441|exercise|exercise
808038|NCT00220441|cognition|cognition
808039|NCT00220441|insulin|insulin
808040|NCT00220441|aging|aging
808041|NCT00220441|aerobic|aerobic
808043|NCT00220350|arousal|arousal
808044|NCT00220350|sex offender|sex offender
808045|NCT00220350|suppression of arousal|suppression of arousal
808046|NCT00220350|pedohilia|pedohilia
808047|NCT00220350|leuprolide acetate|leuprolide acetate
808048|NCT00220324|Contraception|contraception
808049|NCT00220285|Antigen|antigen
808050|NCT00220285|CD20|cd20
808051|NCT00220272|Parkinson Disease|parkinson disease
808052|NCT00220272|5-fluorodopa|5-fluorodopa
808053|NCT00220259|Cystic Fibrosis, inhaled corticosteroids|cystic fibrosis, inhaled corticosteroids
808054|NCT00220246|Hereditary colorectal cancer|hereditary colorectal cancer
808055|NCT00220246|Microsatellite instability|microsatellite instability
808056|NCT00220246|Chromosomal instability|chromosomal instability
808057|NCT00220207|Diabetes|diabetes
808058|NCT00220207|Health Education|health education
808059|NCT00220207|Information Technology|information technology
808060|NCT00220207|African Americans|african americans
808061|NCT00220207|Disease Management|disease management
808062|NCT00220207|Internet|internet
808063|NCT00220207|Patient Education|patient education
808064|NCT00220181|Nutritional status|nutritional status
808065|NCT00220181|Bowel symptoms|bowel symptoms
808066|NCT00220181|Radical radiotherapy to pelvis|radical radiotherapy to pelvis
808067|NCT00220181|Gynaecological, urological or rectal cancer|gynaecological, urological or rectal cancer
808068|NCT00220090|Irritable Bowel Syndrome|irritable bowel syndrome
808069|NCT00220090|Cholecystokinin|cholecystokinin
808070|NCT00220090|Dexloxiglumide|dexloxiglumide
808071|NCT00220090|Randomized/withdrawal|randomized/withdrawal
808072|NCT00219999|Hepatitis|hepatitis
808073|NCT00219999|Hepacivirus|hepacivirus
808074|NCT00219999|B Lymphocytes|b lymphocytes
808075|NCT00219999|Chemokines|chemokines
808076|NCT00219999|Antibodies|antibodies
808077|NCT00219986|Treatment Experienced|treatment experienced
808079|NCT00219973|venous thromboembolism|venous thromboembolism
808080|NCT00219973|deep vein thrombosis|deep vein thrombosis
808081|NCT00219973|pulmonary embolism|pulmonary embolism
808082|NCT00219973|bleeding|bleeding
808083|NCT00219973|low-molecular-weight heparin|low-molecular-weight heparin
808084|NCT00219973|cancer|cancer
808085|NCT00219973|surgery|surgery
808086|NCT00219960|Hypertension|hypertension
808087|NCT00219960|Blood Pressure|blood pressure
808088|NCT00219960|Ambulatory Blood Pressure Monitoring|ambulatory blood pressure monitoring
808089|NCT00219960|Complementary and Alternative Medicine|complementary and alternative medicine
808090|NCT00219960|Herbal|herbal
808091|NCT00219960|North American Ginseng|north american ginseng
808092|NCT00219960|Panax Quinquefolius|panax quinquefolius
808093|NCT00219947|HIV Infection|hiv infection
808094|NCT00219947|Acute HIV Infection|acute hiv infection
808095|NCT00219947|Primary HIV Infection|primary hiv infection
809460|NCT00212576|Parenting|parenting
808096|NCT00219947|Acute Seroconversion Syndrome|acute seroconversion syndrome
808097|NCT00219934|New HIV Infection|new hiv infection
808098|NCT00219934|Acute HIV Infection|acute hiv infection
808099|NCT00219934|Primary HIV Infection|primary hiv infection
808100|NCT00219934|Acute Seroconversion Syndrome|acute seroconversion syndrome
808101|NCT00219921|total hip replacement|total hip replacement
808102|NCT00219921|pain treatment|pain treatment
808103|NCT00219908|Multiple sclerosis|multiple sclerosis
808104|NCT00219908|Mitoxantrone|mitoxantrone
808105|NCT00219908|Methylprednisolone|methylprednisolone
808106|NCT00219908|Interferon beta1b|interferon beta1b
808107|NCT00219908|Relapse|relapse
808108|NCT00219908|MRI|mri
808109|NCT00219908|EDSS|edss
808110|NCT00219895|Cystic Fibrosis|cystic fibrosis
808111|NCT00219895|Anti-inflammatory Agents|anti-inflammatory agents
808112|NCT00219895|Ibuprofen|ibuprofen
808113|NCT00219882|Cystic Fibrosis|cystic fibrosis
808114|NCT00219882|curcuminoids|curcuminoids
808115|NCT00219882|turmeric root extract|turmeric root extract
808116|NCT00219882|nasal potential difference (NPD)|nasal potential difference (npd)
808117|NCT00219882|sweat chloride|sweat chloride
808118|NCT00219869|Post|post
808119|NCT00219869|Traumatic|traumatic
808120|NCT00219869|Headache|headache
808121|NCT00219869|Cognitive|cognitive
808122|NCT00219856|Propofol|propofol
808123|NCT00219856|Hepatectomy|hepatectomy
808124|NCT00219856|Oxidative stress|oxidative stress
808125|NCT00219843|Stage III and IV melanoma|stage iii and iv melanoma
808126|NCT00219830|Cardiac Rehabilitation|cardiac rehabilitation
808127|NCT00219830|Walking|walking
808128|NCT00219830|Acute Myocardial Infarction|acute myocardial infarction
808129|NCT00219830|Secondary Prevention|secondary prevention
808130|NCT00219817|Anorexia|anorexia
808131|NCT00219817|Cachexia|cachexia
808132|NCT00219791|methotrexate|methotrexate
808133|NCT00219791|delayed elimination|delayed elimination
808134|NCT00219791|renal insufficiency|renal insufficiency
808135|NCT00219791|CPG2|cpg2
808136|NCT00219791|Voraxaze|voraxaze
808137|NCT00219765|CML|cml
808138|NCT00219765|Acute Phase|acute phase
808139|NCT00219765|Imatinib mesylate|imatinib mesylate
808140|NCT00219765|Cytarabine|cytarabine
808141|NCT00219765|Daunorubicine|daunorubicine
808142|NCT00219752|CML - ederly patients - Imatinib mesylate|cml - ederly patients - imatinib mesylate
808143|NCT00219739|CML|cml
808144|NCT00219739|Imatinib|imatinib
808145|NCT00219739|Interferon|interferon
808146|NCT00219739|Cytarabine|cytarabine
808147|NCT00219726|CML|cml
808148|NCT00219726|Imatinib mesylate|imatinib mesylate
808149|NCT00219726|Stem cell transplantation|stem cell transplantation
808150|NCT00219713|Nitrous oxide and oxygen|nitrous oxide and oxygen
808151|NCT00219713|Pain|pain
808152|NCT00219713|Bone marrow biopsy|bone marrow biopsy
808153|NCT00219713|Bone marrow aspiration|bone marrow aspiration
808154|NCT00219700|NSAID-PC|nsaid-pc
808155|NCT00219700|IBU-PC|ibu-pc
808156|NCT00219687|Heart arrest|heart arrest
808157|NCT00219687|Cardiopulmonary resuscitation|cardiopulmonary resuscitation
808158|NCT00219687|Dispatcher|dispatcher
808159|NCT00219674|education|education
808160|NCT00219674|training, defibrillators|training, defibrillators
808161|NCT00219674|home defibrillators|home defibrillators
808162|NCT00219674|automated external defibrillators|automated external defibrillators
808163|NCT00219674|psychological adjustment|psychological adjustment
808164|NCT00219661|randomised control trial|randomised control trial
808165|NCT00219661|intensive care unit|intensive care unit
808166|NCT00219661|mechanical ventilation|mechanical ventilation
808167|NCT00219661|ventilator-associated pneumonia|ventilator-associated pneumonia
808168|NCT00219661|drainage of subglottic secretions|drainage of subglottic secretions
808169|NCT00219557|Randomized Phase 2 Study of AG-013736 in Combination with Gemcitabine versus Gemcitabine Alone in Advanced Pancreatic Cancer|randomized phase 2 study of ag-013736 in combination with gemcitabine versus gemcitabine alone in advanced pancreatic cancer
808170|NCT00219531|functional MRI|functional mri
808171|NCT00219531|pain perception|pain perception
808172|NCT00219531|anxiety|anxiety
808173|NCT00219531|brain-gut axis|brain-gut axis
808174|NCT00219518|Defecography|defecography
809051|NCT00214682|Cognition|cognition
808175|NCT00219518|Pelvic floor dyssynergia|pelvic floor dyssynergia
808176|NCT00219518|Anismus|anismus
808177|NCT00219505|Diarrhea-predominant irritable bowel syndrome|diarrhea-predominant irritable bowel syndrome
808178|NCT00219505|Acupuncture|acupuncture
808179|NCT00219505|abdominal pain|abdominal pain
808180|NCT00219492|NCCP, mast cell, esophagus|nccp, mast cell, esophagus
808181|NCT00219479|seizure prophylaxis|seizure prophylaxis
808182|NCT00219479|enteral nutrition|enteral nutrition
808183|NCT00219453|Pilot Projects|pilot projects
808184|NCT00219453|Injections, Jet|injections, jet
808185|NCT00219453|Injections, Jet/instrumentation|injections, jet/instrumentation
808186|NCT00219453|Equipment Contamination/prevention and control|equipment contamination/prevention and control
808187|NCT00219453|Blood-Borne Pathogens|blood-borne pathogens
808188|NCT00219453|Disease Transmission, Horizontal|disease transmission, horizontal
808189|NCT00219427|Low vision|low vision
808190|NCT00219401|Pneumococcal vaccine|pneumococcal vaccine
808191|NCT00219401|Antibody responses|antibody responses
808192|NCT00219401|Cellular immunology|cellular immunology
808193|NCT00219401|Th1/Th2 immune responses|th1/th2 immune responses
808194|NCT00219401|Paediatric|paediatric
808195|NCT00219401|Neonatal|neonatal
808196|NCT00219401|Infectious diseases|infectious diseases
808197|NCT00219401|Papua New Guinea|papua new guinea
808198|NCT00219388|Safety|safety
808199|NCT00219388|Efficacy|efficacy
808200|NCT00219388|Levosimendan|levosimendan
808201|NCT00219388|Dobutamine|dobutamine
808202|NCT00219388|Intravenous|intravenous
808203|NCT00219388|Invasive hemodynamics|invasive hemodynamics
808204|NCT00219388|Decompensated Heart Failure|decompensated heart failure
808205|NCT00219375|sivelestat sodium hydrate|sivelestat sodium hydrate
808206|NCT00219375|acute lung injury|acute lung injury
808207|NCT00219375|systemic inflammatory response syndrome|systemic inflammatory response syndrome
808208|NCT00219375|Elaspol|elaspol
808209|NCT00219375|Acute Lung Injury (ALI) Associated With Systemic Inflammatory Response Syndrome (SIRS)|acute lung injury (ali) associated with systemic inflammatory response syndrome (sirs)
808210|NCT00219362|HIV-1 infection|hiv-1 infection
808211|NCT00219362|therapeutic vaccine|therapeutic vaccine
808212|NCT00219362|Treatment Experienced|treatment experienced
808213|NCT00219349|Anxiety Disorders|anxiety disorders
808214|NCT00219349|Anxiety Neuroses|anxiety neuroses
808215|NCT00219349|Behavior Therapy, Cognitive|behavior therapy, cognitive
808216|NCT00219349|Escitalopram|escitalopram
808217|NCT00219336|Prevent Alcohol Exposed Pregnancies|prevent alcohol exposed pregnancies
808218|NCT00219336|Reduced Alcohol Used|reduced alcohol used
808219|NCT00219336|Self-Guided Motivational Intervention|self-guided motivational intervention
808220|NCT00219336|Effective Contraception|effective contraception
808221|NCT00219336|Contraception|contraception
808222|NCT00219336|College Students|college students
808223|NCT00219323|Asthma, IgE, Omalizumab|asthma, ige, omalizumab
808224|NCT00219310|Recurrent Genital Herpes (RGH), famciclovir, episodic treatment, suppressive treatment, Polymerase Chain Reaction (PCR).|recurrent genital herpes (rgh), famciclovir, episodic treatment, suppressive treatment, polymerase chain reaction (pcr).
808225|NCT00219297|EPO|epo
808226|NCT00219297|EPO906|epo906
808227|NCT00219297|Brain cancer|brain cancer
808228|NCT00219297|Brain metastasis|brain metastasis
808229|NCT00219297|Lung cancer|lung cancer
808230|NCT00219297|Lung metastasis|lung metastasis
808231|NCT00219297|Brain metastasis from non-small cell lung cancer|brain metastasis from non-small cell lung cancer
808232|NCT00219284|Parkinson's disease, tremor|parkinson's disease, tremor
808233|NCT00219271|Prostate cancer|prostate cancer
808234|NCT00219271|molecular staging|molecular staging
808235|NCT00219271|antitumor potential|antitumor potential
808236|NCT00219245|Traumatic brain injury, head trauma, rivastigmine, cognitive deficits|traumatic brain injury, head trauma, rivastigmine, cognitive deficits
808237|NCT00219232|Alzheimer's disease|alzheimer's disease
808238|NCT00219232|Dementia|dementia
808239|NCT00219219|zoledronic acid|zoledronic acid
808240|NCT00219219|prostate cancer|prostate cancer
808241|NCT00219219|SRE|sre
808242|NCT00219193|Hypertension, aliskiren, blood pressure, valsartan, HCTZ|hypertension, aliskiren, blood pressure, valsartan, hctz
808243|NCT00219180|Hypertension, Aliskiren|hypertension, aliskiren
808244|NCT00219167|hypertension|hypertension
808245|NCT00219167|aliskiren|aliskiren
808246|NCT00219167|age|age
808247|NCT00219128|Hypertension, aliskiren, blood pressure, placebo|hypertension, aliskiren, blood pressure, placebo
808248|NCT00219115|Hypertension, aliskiren, blood pressure, irbesartan, amlodipine, hydrochlorothiazide|hypertension, aliskiren, blood pressure, irbesartan, amlodipine, hydrochlorothiazide
808249|NCT00219102|Hypertension,|hypertension,
808250|NCT00219102|diabetes,|diabetes,
808251|NCT00219102|aliskiren,|aliskiren,
808252|NCT00219102|blood pressure,|blood pressure,
808253|NCT00219102|valsartan,|valsartan,
808254|NCT00219102|hydrochlorothiazide|hydrochlorothiazide
808255|NCT00219089|Hypertension, aliskiren, blood pressure, diabetes mellitus, ramipril|hypertension, aliskiren, blood pressure, diabetes mellitus, ramipril
808256|NCT00219076|Hypertension, aliskiren, blood pressure, amlodipine|hypertension, aliskiren, blood pressure, amlodipine
808257|NCT00219063|Hypertension, aliskiren, blood pressure, Ramipril, hydrochlorothiazide|hypertension, aliskiren, blood pressure, ramipril, hydrochlorothiazide
808258|NCT00219037|Hypertension, blood pressure, aliskiren|hypertension, blood pressure, aliskiren
809342|NCT00213083|STDs|stds
808259|NCT00219024|Hypertension, aliskiren, blood pressure, hydrochlorothiazide (HCTZ).|hypertension, aliskiren, blood pressure, hydrochlorothiazide (hctz).
808260|NCT00219011|Aliskiren, heart failure,hypertension|aliskiren, heart failure,hypertension
808261|NCT00218998|Exercise|exercise
808262|NCT00218998|Exercise therapy|exercise therapy
808263|NCT00218985|Aerobic capacity|aerobic capacity
808264|NCT00218985|Exercise training|exercise training
808265|NCT00218985|CABG|cabg
808266|NCT00218985|Endothelial function|endothelial function
808267|NCT00218972|Hypertension|hypertension
808268|NCT00218972|endurance training|endurance training
808269|NCT00218972|endothelial function|endothelial function
808270|NCT00218972|left ventricular function|left ventricular function
808271|NCT00218972|Echocardiography|echocardiography
808272|NCT00218972|Quality of life|quality of life
808273|NCT00218972|Essential hypertension grade 1 - 2|essential hypertension grade 1 - 2
808274|NCT00218959|PTSD|ptsd
808275|NCT00218959|trauma treatment|trauma treatment
808276|NCT00218959|refugees|refugees
808277|NCT00218959|randomized controlled|randomized controlled
808278|NCT00218946|pain|pain
808279|NCT00218946|infant, premature|infant, premature
808280|NCT00218946|intubation, gastrointestinal|intubation, gastrointestinal
808281|NCT00218946|Neonatal nursing|neonatal nursing
808282|NCT00218933|Interval training|interval training
808283|NCT00218933|Endothelial dysfunction|endothelial dysfunction
808284|NCT00218933|Aerobic capacity|aerobic capacity
808285|NCT00218933|Exercise|exercise
808286|NCT00218920|aerobic capacity|aerobic capacity
808287|NCT00218920|endothelial function|endothelial function
808288|NCT00218920|exercise|exercise
808289|NCT00218907|HIV prevention|hiv prevention
808290|NCT00218907|HIV counseling|hiv counseling
808291|NCT00218907|HIV testing|hiv testing
808292|NCT00218907|Emergency Medicine|emergency medicine
808293|NCT00218907|HIV Seronegativity|hiv seronegativity
808294|NCT00218894|Effect|effect
808295|NCT00218894|Balance|balance
808296|NCT00218894|Gait|gait
808297|NCT00218894|Falls|falls
808298|NCT00218881|HIV prevention|hiv prevention
808299|NCT00218881|HIV screening|hiv screening
808300|NCT00218881|Emergency Medicine|emergency medicine
808301|NCT00218881|HIV counseling and Testing|hiv counseling and testing
808302|NCT00218881|HIV Seronegativity|hiv seronegativity
808303|NCT00218868|Cytodiagnosis|cytodiagnosis
808304|NCT00218868|Skin Scrape|skin scrape
808305|NCT00218868|Touch Imprint|touch imprint
808306|NCT00218868|Papanicolaou|papanicolaou
808307|NCT00218868|May-Grunvald-Giemsa|may-grunvald-giemsa
808308|NCT00218855|Multiple Myeloma|multiple myeloma
808309|NCT00218855|Phase 3, randomised, double blind study|phase 3, randomised, double blind study
808310|NCT00218855|thalidomide|thalidomide
808311|NCT00218842|exercise|exercise
808312|NCT00218842|functioning|functioning
808313|NCT00218842|frail elderly|frail elderly
808314|NCT00218829|Photodynamic treatment|photodynamic treatment
808315|NCT00218829|Basal cell carcinoma|basal cell carcinoma
808316|NCT00218829|DMSO|dmso
808317|NCT00218790|Sleep|sleep
808318|NCT00218790|Renal failure|renal failure
808319|NCT00218790|Dialysis|dialysis
808320|NCT00218777|Chronic tic disorder|chronic tic disorder
808321|NCT00218777|Motor tics|motor tics
808322|NCT00218777|Vocal tics|vocal tics
808323|NCT00218751|Child abuse|child abuse
808324|NCT00218751|Neglect|neglect
808325|NCT00218751|Home Visitation|home visitation
808326|NCT00218751|Program Evaluation|program evaluation
808327|NCT00218725|Cognitive Therapy|cognitive therapy
808328|NCT00218725|Suicide|suicide
808329|NCT00218725|Addictions|addictions
808330|NCT00218725|Substance Abuse|substance abuse
808331|NCT00218712|HIV|hiv
808332|NCT00218712|AIDS|aids
808333|NCT00218712|MSM|msm
808334|NCT00218712|Cognitive-Behavioral|cognitive-behavioral
808335|NCT00218712|HIV Seronegativity|hiv seronegativity
808336|NCT00218699|HIV|hiv
808337|NCT00218699|MSM Men Who Have Sex with Men|msm men who have sex with men
808338|NCT00218699|Men Who Have Sex With Men|men who have sex with men
808339|NCT00218699|Cognitive-Behavioral|cognitive-behavioral
808340|NCT00218699|HIV Counseling and Testing|hiv counseling and testing
808341|NCT00218699|HIV Seronegativity|hiv seronegativity
808342|NCT00218686|HIV|hiv
808343|NCT00218686|injection drug use|injection drug use
808344|NCT00218686|social networks|social networks
808345|NCT00218673|HIV|hiv
808346|NCT00218673|injection drug use|injection drug use
808347|NCT00218673|social networks|social networks
808348|NCT00218621|Buprenorphine|buprenorphine
808349|NCT00218621|Methadone|methadone
808350|NCT00218608|Cocaine Abuse|cocaine abuse
808351|NCT00218582|12 step groups|12 step groups
808352|NCT00218582|self help|self help
808353|NCT00218582|psychiatric day treatment|psychiatric day treatment
808354|NCT00218582|co-occurring disorders|co-occurring disorders
808355|NCT00218582|dual diagnosis|dual diagnosis
808356|NCT00218569|Alcohol Dependence|alcohol dependence
808357|NCT00218569|Cocaine Dependence|cocaine dependence
808358|NCT00218556|Hepatitis C, Depressive Symptoms|hepatitis c, depressive symptoms
808359|NCT00218543|ADHD|adhd
808360|NCT00218543|Cocaine Abuse|cocaine abuse
808361|NCT00218517|cannabis use disorder|cannabis use disorder
808362|NCT00218491|Cocaine Dependence|cocaine dependence
808363|NCT00218465|Drugs, Investigational|drugs, investigational
808364|NCT00218465|Therapies for Relapse to Nicotine|therapies for relapse to nicotine
808365|NCT00218465|Relapse Prevention|relapse prevention
808366|NCT00218465|Nicotine Cessation Therapies|nicotine cessation therapies
808367|NCT00218465|Smoking Cessation|smoking cessation
808368|NCT00218465|Nicotine Dependence|nicotine dependence
808369|NCT00218452|Tobacco use cessation|tobacco use cessation
808370|NCT00218439|Smoking|smoking
808371|NCT00218413|Vaccine|vaccine
808372|NCT00218413|Immunogenicity|immunogenicity
808373|NCT00218413|Randomized Controlled Trial|randomized controlled trial
808374|NCT00218413|Addiction|addiction
808375|NCT00218387|Cocaine Dependence|cocaine dependence
808376|NCT00218374|Opiate Addiction|opiate addiction
808377|NCT00218374|Opiate Dependence|opiate dependence
808378|NCT00218361|Behavioral economics|behavioral economics
808379|NCT00218361|Drug self administration|drug self administration
808381|NCT00218348|Cocaine Abuse|cocaine abuse
808382|NCT00218348|Dextro-Amphetamine Sulfate|dextro-amphetamine sulfate
808383|NCT00218335|HIV prevention Intervention, injection drug user,peer-oriented, randomized controlled trial, social network|hiv prevention intervention, injection drug user,peer-oriented, randomized controlled trial, social network
808384|NCT00218309|opiate dependence|opiate dependence
808385|NCT00218296|Nicotine Dependence|nicotine dependence
808386|NCT00218296|Tobacco Dependence|tobacco dependence
808387|NCT00218283|Nicotine Dependence|nicotine dependence
808388|NCT00218283|Tobacco Dependence|tobacco dependence
808389|NCT00218270|Smokeless tobacco, harm reduction|smokeless tobacco, harm reduction
808390|NCT00218257|Cocaine|cocaine
808391|NCT00218244|Brand Switching, smokeless tobacco use|brand switching, smokeless tobacco use
808392|NCT00218231|schizophrenia|schizophrenia
808393|NCT00218231|tobacco dependence|tobacco dependence
808394|NCT00218231|nicotine|nicotine
808395|NCT00218218|Nicotine Dependence|nicotine dependence
808396|NCT00218218|Tobacco Dependence|tobacco dependence
808397|NCT00218205|Epirubicin|epirubicin
808398|NCT00218205|Estramustine Phosphate|estramustine phosphate
808399|NCT00218205|Celecoxib|celecoxib
808400|NCT00218205|Hormone Refractory Prostate Cancer|hormone refractory prostate cancer
808401|NCT00218192|hepatitis c|hepatitis c
808402|NCT00218192|injection drug use|injection drug use
808403|NCT00218179|Lung Cancer|lung cancer
808404|NCT00218179|Cotinine|cotinine
808405|NCT00218179|NNAL|nnal
808406|NCT00218179|Carcinogens|carcinogens
808407|NCT00218179|Case-control|case-control
808408|NCT00218179|SNPs|snps
808409|NCT00218166|cocaine|cocaine
808410|NCT00218166|tiagabine|tiagabine
808411|NCT00218166|baclofen|baclofen
808412|NCT00218153|nicotine dependence|nicotine dependence
808413|NCT00218140|tobacco|tobacco
808414|NCT00218127|Heroin dependence|heroin dependence
808415|NCT00218114|ADHD, disruptive behavior disorder, marijuana abuse|adhd, disruptive behavior disorder, marijuana abuse
808416|NCT00218101|opioid dependence|opioid dependence
808417|NCT00218075|Cocaine addiction|cocaine addiction
808418|NCT00218075|cocaine treatment|cocaine treatment
808419|NCT00218036|Cocaine Abuse|cocaine abuse
808420|NCT00218036|Opiate Abuse|opiate abuse
808421|NCT00218023|cocaine|cocaine
808422|NCT00218023|cocaine addiction|cocaine addiction
808423|NCT00218023|cocaine abuse|cocaine abuse
808424|NCT00218023|relapse prevention|relapse prevention
808425|NCT00218010|methadone|methadone
808426|NCT00218010|lactation|lactation
808427|NCT00218010|breastfeeding|breastfeeding
808428|NCT00218010|maternal opioid dependency|maternal opioid dependency
808429|NCT00217997|cocaine abuse|cocaine abuse
808430|NCT00217997|Cocaine-Related Disorders|cocaine-related disorders
808431|NCT00217984|Tobacco use disorder|tobacco use disorder
808432|NCT00217984|Alcohol dependence|alcohol dependence
808433|NCT00217971|cannabis dependence|cannabis dependence
808434|NCT00217971|dronabinol|dronabinol
808435|NCT00217971|treatment|treatment
808436|NCT00217932|Behavioral Disorders|behavioral disorders
808437|NCT00217854|asthma, corticosteroids|asthma, corticosteroids
808438|NCT00217841|MRSA|mrsa
808439|NCT00217763|Dementia|dementia
808440|NCT00217763|Alzheimer's disease|alzheimer's disease
808441|NCT00217724|unspecified adult solid tumor, protocol specific|unspecified adult solid tumor, protocol specific
808442|NCT00217724|pain|pain
808443|NCT00217711|stage III colon cancer|stage iii colon cancer
808444|NCT00217711|stage IV colon cancer|stage iv colon cancer
808445|NCT00217711|stage III rectal cancer|stage iii rectal cancer
808446|NCT00217711|stage IV rectal cancer|stage iv rectal cancer
808447|NCT00217698|recurrent non-small cell lung cancer|recurrent non-small cell lung cancer
808448|NCT00217698|stage IIIB non-small cell lung cancer|stage iiib non-small cell lung cancer
808449|NCT00217698|stage IV non-small cell lung cancer|stage iv non-small cell lung cancer
808450|NCT00217698|adenocarcinoma of the lung|adenocarcinoma of the lung
808451|NCT00217698|large cell lung cancer|large cell lung cancer
808452|NCT00217698|squamous cell lung cancer|squamous cell lung cancer
808453|NCT00217672|stage IV breast cancer|stage iv breast cancer
808454|NCT00217672|recurrent breast cancer|recurrent breast cancer
808455|NCT00217659|male breast cancer|male breast cancer
808456|NCT00217659|recurrent breast cancer|recurrent breast cancer
808457|NCT00217659|stage IV breast cancer|stage iv breast cancer
808458|NCT00217620|adult angiosarcoma|adult angiosarcoma
808459|NCT00217620|adult leiomyosarcoma|adult leiomyosarcoma
808460|NCT00217620|adult liposarcoma|adult liposarcoma
808461|NCT00217620|adult malignant hemangiopericytoma|adult malignant hemangiopericytoma
808462|NCT00217620|recurrent adult soft tissue sarcoma|recurrent adult soft tissue sarcoma
808463|NCT00217620|stage III adult soft tissue sarcoma|stage iii adult soft tissue sarcoma
808464|NCT00217620|stage IV adult soft tissue sarcoma|stage iv adult soft tissue sarcoma
808465|NCT00217607|adult angiosarcoma|adult angiosarcoma
808466|NCT00217607|recurrent adult soft tissue sarcoma|recurrent adult soft tissue sarcoma
808467|NCT00217607|stage III adult soft tissue sarcoma|stage iii adult soft tissue sarcoma
808468|NCT00217607|stage IV adult soft tissue sarcoma|stage iv adult soft tissue sarcoma
808469|NCT00217594|Immunosuppression|immunosuppression
808470|NCT00217594|T Cells|t cells
808471|NCT00217594|Hematopoiesis|hematopoiesis
808472|NCT00217594|Anti-CD52|anti-cd52
808473|NCT00217594|Monoclonal Antibody Therapy|monoclonal antibody therapy
808474|NCT00217581|recurrent gastric cancer|recurrent gastric cancer
808475|NCT00217581|stage III gastric cancer|stage iii gastric cancer
808476|NCT00217581|stage IV gastric cancer|stage iv gastric cancer
808477|NCT00217581|recurrent esophageal cancer|recurrent esophageal cancer
808478|NCT00217581|stage III esophageal cancer|stage iii esophageal cancer
808479|NCT00217581|stage IV esophageal cancer|stage iv esophageal cancer
808480|NCT00217581|adenocarcinoma of the stomach|adenocarcinoma of the stomach
808481|NCT00217568|recurrent ovarian epithelial cancer|recurrent ovarian epithelial cancer
808482|NCT00217568|stage III ovarian epithelial cancer|stage iii ovarian epithelial cancer
808483|NCT00217568|stage IV ovarian epithelial cancer|stage iv ovarian epithelial cancer
808484|NCT00217568|peritoneal cavity cancer|peritoneal cavity cancer
808485|NCT00217555|recurrent ovarian epithelial cancer|recurrent ovarian epithelial cancer
808486|NCT00217555|fallopian tube cancer|fallopian tube cancer
808487|NCT00217555|peritoneal cavity cancer|peritoneal cavity cancer
808488|NCT00217529|stage III ovarian epithelial cancer|stage iii ovarian epithelial cancer
808489|NCT00217529|stage IV ovarian epithelial cancer|stage iv ovarian epithelial cancer
808490|NCT00217529|peritoneal cavity cancer|peritoneal cavity cancer
808491|NCT00217529|ovarian clear cell cystadenocarcinoma|ovarian clear cell cystadenocarcinoma
808492|NCT00217529|ovarian endometrioid adenocarcinoma|ovarian endometrioid adenocarcinoma
808493|NCT00217529|ovarian undifferentiated adenocarcinoma|ovarian undifferentiated adenocarcinoma
808494|NCT00217529|ovarian mucinous cystadenocarcinoma|ovarian mucinous cystadenocarcinoma
808495|NCT00217529|ovarian serous cystadenocarcinoma|ovarian serous cystadenocarcinoma
808496|NCT00217529|Brenner tumor|brenner tumor
808497|NCT00217529|fallopian tube cancer|fallopian tube cancer
808498|NCT00217529|ovarian mixed epithelial carcinoma|ovarian mixed epithelial carcinoma
808499|NCT00217516|adenocarcinoma of the prostate|adenocarcinoma of the prostate
808500|NCT00217516|stage I prostate cancer|stage i prostate cancer
808501|NCT00217516|stage II prostate cancer|stage ii prostate cancer
808502|NCT00217503|AIDS-related peripheral/systemic lymphoma|aids-related peripheral/systemic lymphoma
808503|NCT00217490|unspecified adult solid tumor, protocol specific|unspecified adult solid tumor, protocol specific
808504|NCT00217477|unspecified adult solid tumor, protocol specific|unspecified adult solid tumor, protocol specific
808505|NCT00217464|adenocarcinoma of the prostate|adenocarcinoma of the prostate
808506|NCT00217464|recurrent prostate cancer|recurrent prostate cancer
808507|NCT00217451|Malaria|malaria
808508|NCT00217451|Fosmidomycin|fosmidomycin
808509|NCT00217451|Clindamycin|clindamycin
808510|NCT00217451|Gabon|gabon
808511|NCT00217425|anaplastic large cell lymphoma|anaplastic large cell lymphoma
808512|NCT00217425|stage I adult T-cell leukemia/lymphoma|stage i adult t-cell leukemia/lymphoma
808513|NCT00217425|stage II adult T-cell leukemia/lymphoma|stage ii adult t-cell leukemia/lymphoma
808514|NCT00217425|stage III adult T-cell leukemia/lymphoma|stage iii adult t-cell leukemia/lymphoma
808515|NCT00217425|stage IV adult T-cell leukemia/lymphoma|stage iv adult t-cell leukemia/lymphoma
808516|NCT00217425|peripheral T-cell lymphoma|peripheral t-cell lymphoma
808517|NCT00217386|de novo myelodysplastic syndromes|de novo myelodysplastic syndromes
808518|NCT00217386|previously treated myelodysplastic syndromes|previously treated myelodysplastic syndromes
808519|NCT00217386|secondary myelodysplastic syndromes|secondary myelodysplastic syndromes
808520|NCT00217386|myelodysplastic/myeloproliferative disease, unclassifiable|myelodysplastic/myeloproliferative disease, unclassifiable
808521|NCT00217386|atypical chronic myeloid leukemia|atypical chronic myeloid leukemia
808522|NCT00217347|Gastroesophageal reflux|gastroesophageal reflux
808523|NCT00217347|Dyspepsia|dyspepsia
808524|NCT00217347|Esophageal Capsule Endoscopy|esophageal capsule endoscopy
808525|NCT00217334|Hypertension|hypertension
808526|NCT00217334|Cardiovascular diseases|cardiovascular diseases
808527|NCT00217334|Randomized controlled trial|randomized controlled trial
808528|NCT00217334|Cluster randomization|cluster randomization
808529|NCT00217334|Primary care|primary care
808530|NCT00217321|Parkinson's disease|parkinson's disease
808531|NCT00217321|Parkinson disease|parkinson disease
808532|NCT00217321|Registry|registry
808533|NCT00217321|quality of life|quality of life
808534|NCT00217321|database|database
808535|NCT00217295|Relapsing-remitting multiple sclerosis|relapsing-remitting multiple sclerosis
808536|NCT00217295|Brain atrophy|brain atrophy
808537|NCT00217295|Disease progression|disease progression
808538|NCT00217269|Restenosis|restenosis
808539|NCT00217256|Restenosis|restenosis
808540|NCT00217243|Pain|pain
808541|NCT00217243|Magnetoencephalography|magnetoencephalography
808542|NCT00217243|Median|median
808543|NCT00217243|Ulnar|ulnar
808544|NCT00217243|Causalgia|causalgia
808545|NCT00217243|Complex regional pain syndrome|complex regional pain syndrome
808546|NCT00217243|Evoked fields|evoked fields
808547|NCT00217243|Nerve injury|nerve injury
808548|NCT00217243|Neuropathic pain|neuropathic pain
808549|NCT00217217|non-pharmaceutical|non-pharmaceutical
808550|NCT00217217|alternative|alternative
808551|NCT00217217|imaging|imaging
808552|NCT00217217|magnetic resonance imaging|magnetic resonance imaging
808553|NCT00217217|low field magnetic stimulation|low field magnetic stimulation
808554|NCT00217217|bipolar disorder|bipolar disorder
808555|NCT00217217|depression|depression
809855|NCT00210912|Migraine|migraine
808556|NCT00217217|bipolar depression|bipolar depression
808557|NCT00217204|Cystic fibrosis|cystic fibrosis
808558|NCT00217204|Pancreatic insufficiency|pancreatic insufficiency
808559|NCT00217204|Steatorrhea|steatorrhea
808560|NCT00217204|Fat malabsorption|fat malabsorption
808561|NCT00217204|Pancrelipase|pancrelipase
808562|NCT00217191|Premature Infants|premature infants
808563|NCT00217191|Patent ductus arteriosus|patent ductus arteriosus
808564|NCT00217191|Renal function|renal function
808565|NCT00217191|Ibuprofen|ibuprofen
808566|NCT00217178|Atherosclerosis|atherosclerosis
808567|NCT00217178|CV Risk Factors|cv risk factors
808568|NCT00217178|Homocysteine|homocysteine
808569|NCT00217178|CV disease|cv disease
808570|NCT00217178|Cardiovascular disease|cardiovascular disease
808571|NCT00217165|bipolar|bipolar
808572|NCT00217165|mania|mania
808573|NCT00217165|depression|depression
808574|NCT00217165|taurine|taurine
808575|NCT00217165|alternative|alternative
808576|NCT00217152|Kidney Transplant|kidney transplant
808577|NCT00217139|Hepatitis C|hepatitis c
808578|NCT00217139|Celgosivir|celgosivir
808579|NCT00217139|HCV|hcv
808580|NCT00217139|Genotype 1|genotype 1
808581|NCT00217139|Non-responders|non-responders
808582|NCT00217139|Early Viral Response|early viral response
808583|NCT00217139|EVR|evr
808584|NCT00217035|parenteral nutrition|parenteral nutrition
808585|NCT00217035|burn injury|burn injury
808586|NCT00217035|stable isotopes|stable isotopes
808587|NCT00217035|Proline Metabolic Kinetics|proline metabolic kinetics
808588|NCT00217035|Ornithine Metabolic Kinetics|ornithine metabolic kinetics
808589|NCT00217035|Glutamate Metabolic Kinetics|glutamate metabolic kinetics
808590|NCT00217035|Glutamine Metabolic Kinetics|glutamine metabolic kinetics
808591|NCT00217022|Lymphocytic Colitis|lymphocytic colitis
808592|NCT00217022|diarrhea|diarrhea
808593|NCT00217022|budesonide|budesonide
808594|NCT00216996|parenteral nutrition|parenteral nutrition
808595|NCT00216996|burn injury|burn injury
808596|NCT00216996|stable isotopes|stable isotopes
808597|NCT00216996|Glutamate Metabolic Kinetics|glutamate metabolic kinetics
808598|NCT00216996|Glutamine Metabolic Kinetics|glutamine metabolic kinetics
808599|NCT00216983|parenteral nutrition|parenteral nutrition
808600|NCT00216983|burn injury|burn injury
808601|NCT00216983|stable isotopes|stable isotopes
808602|NCT00216983|Proline Metabolic Kinetics|proline metabolic kinetics
808603|NCT00216983|Ornithine Metabolic Kinetics|ornithine metabolic kinetics
808604|NCT00216983|Glutamate Metabolic Kinetics|glutamate metabolic kinetics
808605|NCT00216983|Glutamine Metabolic Kinetics|glutamine metabolic kinetics
808606|NCT00216970|parenteral nutrition|parenteral nutrition
808607|NCT00216970|burn injury|burn injury
808608|NCT00216970|stable isotopes|stable isotopes
808609|NCT00216970|Arginine Metabolic Kinetics|arginine metabolic kinetics
808610|NCT00216970|Nitric Oxide Formation|nitric oxide formation
808611|NCT00216970|Glutamine Metabolic Kinetics|glutamine metabolic kinetics
808612|NCT00216944|Intubation|intubation
808613|NCT00216944|premedication|premedication
808614|NCT00216905|Patients with alcoholism according to ICD-10 after detoxification|patients with alcoholism according to icd-10 after detoxification
808615|NCT00216866|Embolism|embolism
808616|NCT00216866|Thrombosis|thrombosis
808617|NCT00216814|antiangiogenic effects of bcg treatment and prognosis|antiangiogenic effects of bcg treatment and prognosis
808618|NCT00216801|Upper Tract Transitional Cell (TCC)|upper tract transitional cell (tcc)
808619|NCT00216788|Sucrose|sucrose
808620|NCT00216788|Barrett's esophagus|barrett's esophagus
808621|NCT00216788|Esophagitis|esophagitis
808622|NCT00216788|GERD|gerd
808623|NCT00216788|Reflux|reflux
808624|NCT00216788|Esophagus|esophagus
808625|NCT00216788|Esomeprazole|esomeprazole
808626|NCT00216762|Urticaria|urticaria
808627|NCT00216762|Hives|hives
808628|NCT00216749|Cerebral Infarction Prevention|cerebral infarction prevention
808629|NCT00216749|Cilostazol|cilostazol
808630|NCT00216736|Migraine|migraine
808631|NCT00216736|Headache|headache
808632|NCT00216736|Rebound headache|rebound headache
808633|NCT00216723|Aripiprazole|aripiprazole
808634|NCT00216723|Schizophrenia|schizophrenia
808635|NCT00216723|Bipolar Disorder|bipolar disorder
808636|NCT00216710|Child abuse|child abuse
808637|NCT00216710|Neglect|neglect
808638|NCT00216710|Home visitation|home visitation
808639|NCT00216710|Program evaluation|program evaluation
808640|NCT00216697|Multiple myeloma|multiple myeloma
808641|NCT00216697|Proteasome inhibitor|proteasome inhibitor
808642|NCT00216697|Ubiquitin|ubiquitin
808643|NCT00216697|Boronic acids|boronic acids
808644|NCT00216697|Bortezomib|bortezomib
808645|NCT00216684|Fentanyl, Chronic intractable pain, Japanese patients|fentanyl, chronic intractable pain, japanese patients
808646|NCT00216671|Schizophrenia|schizophrenia
808647|NCT00216671|intramuscular injection|intramuscular injection
808648|NCT00216671|antipsychotic agents|antipsychotic agents
808649|NCT00216671|long-acting risperidone|long-acting risperidone
808650|NCT00216658|Fentanyl|fentanyl
808651|NCT00216658|Cancer pain|cancer pain
808652|NCT00216658|Japanese patients|japanese patients
808653|NCT00216645|Müllerian Carcinoma|müllerian carcinoma
808654|NCT00216645|Doxil|doxil
808655|NCT00216645|Japanese Patients|japanese patients
808656|NCT00216632|Schizophrenia, Schizoaffective disorder|schizophrenia, schizoaffective disorder
808657|NCT00216632|antipsychotic agents|antipsychotic agents
808658|NCT00216632|long-acting risperidone|long-acting risperidone
808659|NCT00216632|intramuscular injection|intramuscular injection
808660|NCT00216619|chronic migraine|chronic migraine
808661|NCT00216619|Topiramate|topiramate
808662|NCT00216619|migraine|migraine
808663|NCT00216619|headache|headache
808664|NCT00216619|chronic headache|chronic headache
808665|NCT00216606|Chronic migraine|chronic migraine
808666|NCT00216606|Migraine|migraine
808667|NCT00216606|Headache|headache
808668|NCT00216606|Migraine headache|migraine headache
808669|NCT00216606|Topiramate|topiramate
808670|NCT00216593|dementia|dementia
808671|NCT00216593|cognition function|cognition function
808672|NCT00216593|Alzheimer disease|alzheimer disease
808673|NCT00216593|behavioral symptoms|behavioral symptoms
808674|NCT00216593|galantamine hydrobromide|galantamine hydrobromide
808675|NCT00216580|Schizophrenia|schizophrenia
808676|NCT00216580|Intramuscular injection|intramuscular injection
808677|NCT00216580|Antipsychotic agents|antipsychotic agents
808678|NCT00216580|Long-acting risperidone|long-acting risperidone
808679|NCT00216580|Schizophreniform disorders|schizophreniform disorders
808680|NCT00216580|Schizoaffective disorder|schizoaffective disorder
808681|NCT00216567|Benign rolandic epilepsy|benign rolandic epilepsy
808682|NCT00216567|Topiramate|topiramate
808683|NCT00216554|Bipolar|bipolar
808684|NCT00216554|risperidone|risperidone
808685|NCT00216554|Adjunctive therapy|adjunctive therapy
808686|NCT00216541|Anemia|anemia
808687|NCT00216541|cancer|cancer
808688|NCT00216541|transfusion|transfusion
808689|NCT00216541|chemotherapy|chemotherapy
808690|NCT00216541|hemoglobin|hemoglobin
808691|NCT00216541|standard care|standard care
808692|NCT00216541|epoetin alfa|epoetin alfa
808693|NCT00216541|epoetin|epoetin
808694|NCT00216541|erythropoietin|erythropoietin
808695|NCT00216528|Schizophrenia|schizophrenia
808696|NCT00216528|risperidone|risperidone
808697|NCT00216528|Intramuscular injection, long-acting risperidone|intramuscular injection, long-acting risperidone
808698|NCT00216515|Alzheimer's disease|alzheimer's disease
808699|NCT00216515|galantamine|galantamine
808700|NCT00216515|attention|attention
808701|NCT00216515|executive function|executive function
808702|NCT00216502|Alzheimer's disease|alzheimer's disease
808703|NCT00216502|Dementia|dementia
808704|NCT00216502|galantamine|galantamine
808705|NCT00216502|placebo|placebo
808706|NCT00216502|Caregiver|caregiver
808707|NCT00216502|Brain disease|brain disease
808708|NCT00216502|Memory loss|memory loss
808709|NCT00216489|gastroesophageal reflux|gastroesophageal reflux
808710|NCT00216489|heartburn|heartburn
808711|NCT00216489|rabeprazole|rabeprazole
808712|NCT00216489|GERD|gerd
808713|NCT00216489|anti-ulcer agents|anti-ulcer agents
808714|NCT00216489|proton pump inhibitor|proton pump inhibitor
808715|NCT00216476|Schizophrenia, relapse prevention|schizophrenia, relapse prevention
808716|NCT00216476|Antipsychotic agents|antipsychotic agents
808717|NCT00216476|Long-acting risperidone|long-acting risperidone
808718|NCT00216476|Quetiapine|quetiapine
808719|NCT00216476|Aripiprazole|aripiprazole
808720|NCT00216463|LDL-cholesterol|ldl-cholesterol
808721|NCT00216463|apoB-100|apob-100
808722|NCT00216463|apoB-48|apob-48
808723|NCT00216450|rabeprazole|rabeprazole
808724|NCT00216450|proton pump inhibitor|proton pump inhibitor
808725|NCT00216450|Helicobacter infections|helicobacter infections
808726|NCT00216450|Helicobacter pylori|helicobacter pylori
808727|NCT00216450|H pylori|h pylori
808728|NCT00216450|bacterial infections|bacterial infections
808729|NCT00216437|Liver cancer|liver cancer
808730|NCT00216424|Colon cancer|colon cancer
808731|NCT00216424|Rectal cancer|rectal cancer
808732|NCT00216398|acromegaly|acromegaly
808733|NCT00216398|growth hormone|growth hormone
808734|NCT00216385|Tuberculosis|tuberculosis
808735|NCT00216385|Treatment|treatment
808736|NCT00216385|Quinolone|quinolone
808737|NCT00216385|Short course chemotherapy|short course chemotherapy
808738|NCT00216372|carcinomatosis|carcinomatosis
808739|NCT00216359|Treatment Experienced|treatment experienced
808740|NCT00216333|tuberculosis|tuberculosis
808741|NCT00216333|fixed dose combination|fixed dose combination
808742|NCT00216333|DOT|dot
808743|NCT00216333|shot-course chemotherapy|shot-course chemotherapy
808744|NCT00216320|electrical stimulation|electrical stimulation
808745|NCT00216294|Obsessive Compulsive Disorder|obsessive compulsive disorder
808746|NCT00216294|RG 1068 (Synthetic Human Secretin)|rg 1068 (synthetic human secretin)
808747|NCT00216281|Schizophrenia|schizophrenia
808748|NCT00216281|Clozapine|clozapine
808749|NCT00216281|Atomoxetine|atomoxetine
808750|NCT00216255|Persistent Developmental Stuttering|persistent developmental stuttering
808751|NCT00216242|influenza|influenza
808752|NCT00216242|vaccine|vaccine
808753|NCT00216242|efficacy|efficacy
808754|NCT00216242|safety|safety
808755|NCT00216242|immunogenicity|immunogenicity
808756|NCT00216229|combined hepatitis A and B vaccine|combined hepatitis a and b vaccine
808757|NCT00216229|hepatitis B virus|hepatitis b virus
808758|NCT00216229|immunity|immunity
808759|NCT00216203|Non-Small Cell Lung Cancer|non-small cell lung cancer
808760|NCT00216190|Sedation, ICU, Anesthesia, Dexmedetomidine, Midazolam|sedation, icu, anesthesia, dexmedetomidine, midazolam
808761|NCT00216164|Lymphoma|lymphoma
808762|NCT00216151|Multiple Myeloma|multiple myeloma
808763|NCT00216151|Bisphosphonates|bisphosphonates
808764|NCT00216138|Head and Neck Cancer|head and neck cancer
808765|NCT00216125|Non-Small Cell Lung Cancer|non-small cell lung cancer
808766|NCT00216112|Ovarian Cancer|ovarian cancer
808767|NCT00216099|Prostate Cancer|prostate cancer
808768|NCT00216086|Rectal Cancer|rectal cancer
808769|NCT00216073|Breast Cancer|breast cancer
808770|NCT00216047|Breast Cancer|breast cancer
808771|NCT00216034|Gastric Cancer|gastric cancer
808772|NCT00216034|TS-1|ts-1
808773|NCT00216034|PSK|psk
808774|NCT00216034|Disease-free survival|disease-free survival
808775|NCT00216034|Overall survival|overall survival
808776|NCT00216021|Breast Cancer|breast cancer
808777|NCT00215995|esophageal cancer|esophageal cancer
808778|NCT00215995|esophagogastric cancer|esophagogastric cancer
808779|NCT00215995|gastric cancer|gastric cancer
808780|NCT00215982|advanced|advanced
808781|NCT00215982|colon|colon
808782|NCT00215982|rectal|rectal
808783|NCT00215969|Pre-eclampsia|pre-eclampsia
808784|NCT00215969|Pregnancy|pregnancy
808785|NCT00215969|Hypercoagulation|hypercoagulation
808786|NCT00215969|Screening|screening
808787|NCT00215969|Cardiovascular complications|cardiovascular complications
808788|NCT00215956|Topotecan|topotecan
808789|NCT00215956|Rectal Neoplasms|rectal neoplasms
808790|NCT00215956|Radiosensitizing|radiosensitizing
808791|NCT00215943|hematologic malignancy|hematologic malignancy
808792|NCT00215930|malignant pleural effusion|malignant pleural effusion
808793|NCT00215917|Schizophrenia|schizophrenia
808794|NCT00215917|NMDA|nmda
808795|NCT00215917|D-serine|d-serine
808796|NCT00215891|Treatment Experienced|treatment experienced
808797|NCT00215852|Alferon LDO|alferon ldo
808798|NCT00215852|Low Dose Oral Interferon|low dose oral interferon
808799|NCT00215852|Alfa-n3|alfa-n3
808800|NCT00215852|Human Leukocyte Derived|human leukocyte derived
808801|NCT00215852|HIV|hiv
808802|NCT00215852|Asymptomatic HIV|asymptomatic hiv
808803|NCT00215852|Treatment Experienced|treatment experienced
808804|NCT00215839|Treatment Experienced|treatment experienced
808805|NCT00215826|SARS|sars
808806|NCT00215826|Alferon LDO|alferon ldo
808807|NCT00215826|Low Dose Oral Interferon ALFA-n3|low dose oral interferon alfa-n3
808808|NCT00215826|Human Leukocyte Derived|human leukocyte derived
808809|NCT00215826|Exposure to SARS|exposure to sars
808810|NCT00215826|Possible SARS|possible sars
808811|NCT00215813|Chronic Fatigue Syndrome|chronic fatigue syndrome
808812|NCT00215813|CFS|cfs
808813|NCT00215813|ME|me
808814|NCT00215813|Ampligen|ampligen
808815|NCT00215813|poly I:poly C12U|poly i:poly c12u
808816|NCT00215813|Rintatolimod|rintatolimod
808817|NCT00215800|Chronic Fatigue Syndrome|chronic fatigue syndrome
808818|NCT00215800|Myalgic Encephalomyelitis|myalgic encephalomyelitis
808819|NCT00215800|CFS|cfs
808820|NCT00215800|Ampligen|ampligen
808821|NCT00215800|Poly I:ploy C12U|poly i:ploy c12u
808822|NCT00215787|Nasal polyps|nasal polyps
808823|NCT00215787|Gastroesophageal Reflux|gastroesophageal reflux
808824|NCT00215774|Atrial fibrillation|atrial fibrillation
808825|NCT00215761|Atrial fibrillation|atrial fibrillation
808826|NCT00215761|Preventive stimulation|preventive stimulation
808827|NCT00215761|Pacemaker|pacemaker
808828|NCT00215748|Elderly|elderly
808829|NCT00215748|Weekly|weekly
808830|NCT00215735|diabetes|diabetes
808831|NCT00215735|Ulcer|ulcer
808832|NCT00215735|APC|apc
808833|NCT00215709|elderly|elderly
808834|NCT00215683|Prostate Cancer|prostate cancer
808835|NCT00215683|Androgen ablation therapy|androgen ablation therapy
808836|NCT00215670|AMD|amd
808837|NCT00215670|Macugen|macugen
808838|NCT00215670|Pharmacokinetics|pharmacokinetics
809343|NCT00213083|Efficacy|efficacy
808839|NCT00215670|Age-Related Macular Degeneration|age-related macular degeneration
808840|NCT00215670|PK|pk
808841|NCT00215644|Esophagus|esophagus
808842|NCT00215644|Gastric|gastric
808843|NCT00215644|Adenocarcinoma|adenocarcinoma
808844|NCT00215644|EGFR|egfr
808845|NCT00215644|matuzumab|matuzumab
808846|NCT00215644|EMD 72000|emd 72000
808847|NCT00215644|randomized|randomized
808848|NCT00215644|Epirubicin|epirubicin
808849|NCT00215644|cisplatin|cisplatin
808850|NCT00215644|capecitabine|capecitabine
808851|NCT00215644|Metastatic Esophago-Gastric cancer|metastatic esophago-gastric cancer
808852|NCT00215631|prostate cancer|prostate cancer
808853|NCT00215631|radiotherapy|radiotherapy
808854|NCT00215631|erectile dysfunction|erectile dysfunction
808855|NCT00215631|tadalafil|tadalafil
808856|NCT00215605|Advanced Malignancies|advanced malignancies
808857|NCT00215605|Solid Tumor|solid tumor
808858|NCT00215605|Medullary Thyroid Cancer|medullary thyroid cancer
808859|NCT00215566|IBS|ibs
808860|NCT00215566|IBS-c|ibs-c
808861|NCT00215540|Double-blind|double-blind
808862|NCT00215540|Low Birth Weight|low birth weight
808863|NCT00215540|Surfactant|surfactant
808864|NCT00215540|Placebo-Controlled|placebo-controlled
808865|NCT00215540|Premature Birth|premature birth
808866|NCT00215527|mucopolysaccharidosis|mucopolysaccharidosis
808867|NCT00215527|Hurler-Scheie|hurler-scheie
808868|NCT00215527|Scheie|scheie
808869|NCT00215527|laronidase|laronidase
808870|NCT00215527|spinal cord compression|spinal cord compression
808871|NCT00215527|central nervous system|central nervous system
808872|NCT00215527|enzyme replacement therapy|enzyme replacement therapy
808873|NCT00215527|intrathecal|intrathecal
808874|NCT00215527|LA Biomed|la biomed
808875|NCT00215514|adjuvant chemoradiation|adjuvant chemoradiation
808876|NCT00215514|GE junction|ge junction
808877|NCT00215514|epirubicin|epirubicin
808878|NCT00215501|advanced solid tumor malignancy|advanced solid tumor malignancy
808879|NCT00215501|capecitabine|capecitabine
808880|NCT00215501|continuous infusion|continuous infusion
808881|NCT00215501|5-FU|5-fu
808882|NCT00215501|irinotecan|irinotecan
808883|NCT00215501|5-fluorouracil|5-fluorouracil
808884|NCT00215501|cisplatin|cisplatin
808885|NCT00215462|gastric adenocarcinoma|gastric adenocarcinoma
808886|NCT00215462|esophageal adenocarcinoma|esophageal adenocarcinoma
808887|NCT00215462|vinorelbine|vinorelbine
808888|NCT00215449|Chronic Obstructive Pulmonary Disease|chronic obstructive pulmonary disease
808889|NCT00215449|COPD|copd
808890|NCT00215449|formoterol|formoterol
808891|NCT00215449|formoterol fumarate|formoterol fumarate
808892|NCT00215436|Chronic Obstructive Pulmonary Disease|chronic obstructive pulmonary disease
808893|NCT00215436|COPD|copd
808894|NCT00215436|formoterol|formoterol
808895|NCT00215423|COPD|copd
808896|NCT00215423|Chronic Obstructive Pulmonary Disease|chronic obstructive pulmonary disease
808897|NCT00215423|Formoterol Fumarate|formoterol fumarate
808898|NCT00215423|Formoterol|formoterol
808899|NCT00215410|Asthma|asthma
808900|NCT00215410|Formoterol|formoterol
808901|NCT00215410|Fumarate|fumarate
808902|NCT00215397|Asthma|asthma
808903|NCT00215397|Formoterol|formoterol
808904|NCT00215397|Fumarate|fumarate
808905|NCT00215384|COPD|copd
808906|NCT00215384|formoterol|formoterol
808907|NCT00215371|Asthma|asthma
808908|NCT00215371|Pediatric|pediatric
808909|NCT00215371|Formoterol Fumarate|formoterol fumarate
808910|NCT00215371|Foradil|foradil
808911|NCT00215358|Asthma|asthma
808912|NCT00215358|Formoterol|formoterol
808913|NCT00215358|Fumarate|fumarate
808914|NCT00215358|Foradil|foradil
808915|NCT00215345|Celecoxib|celecoxib
808916|NCT00215345|Taxotere|taxotere
808917|NCT00215345|Hormone Refractory Prostate Cancer|hormone refractory prostate cancer
808918|NCT00215332|arthroplasty|arthroplasty
808919|NCT00215332|lumbar|lumbar
808920|NCT00215332|disc|disc
808921|NCT00215319|Degenerative disc disease at up to 2 levels (L2-S1)|degenerative disc disease at up to 2 levels (l2-s1)
808922|NCT00215306|arthroplasty|arthroplasty
808923|NCT00215306|lumbar|lumbar
808924|NCT00215306|spine|spine
808925|NCT00215293|fusion|fusion
808926|NCT00215293|cervical|cervical
808927|NCT00215293|spine|spine
808928|NCT00215280|Mansonella perstans|mansonella perstans
808929|NCT00215280|microfilaraemia|microfilaraemia
808930|NCT00215280|ivermectin|ivermectin
808931|NCT00215280|albendazole|albendazole
808932|NCT00215280|Uganda|uganda
808933|NCT00215267|Schistosoma mansoni|schistosoma mansoni
808934|NCT00215267|hepatosplenomegaly|hepatosplenomegaly
808935|NCT00215267|malaria|malaria
808936|NCT00215267|Uganda|uganda
808937|NCT00215254|quetiapine|quetiapine
808938|NCT00215254|social anxiety disorder|social anxiety disorder
808939|NCT00215254|antipsychotic|antipsychotic
808940|NCT00215254|pilot study|pilot study
808941|NCT00215241|PTSD|ptsd
808942|NCT00215241|sertraline|sertraline
808943|NCT00215241|risperidone|risperidone
808944|NCT00215241|antidepressant|antidepressant
808945|NCT00215241|antipsychotic|antipsychotic
808946|NCT00215241|anxiety|anxiety
808947|NCT00215241|trauma|trauma
808948|NCT00215215|Vagus Nerve Stimulation Therapy|vagus nerve stimulation therapy
808949|NCT00215215|Epilepsies, Partial|epilepsies, partial
808950|NCT00215215|Seizures|seizures
808951|NCT00215215|Antiepileptic Drugs|antiepileptic drugs
808952|NCT00215215|Refractory Partial Seizures|refractory partial seizures
808953|NCT00215202|Adrenocortical Cancer|adrenocortical cancer
808954|NCT00215202|Iressa|iressa
808955|NCT00215202|Adrenal Cancer|adrenal cancer
808956|NCT00215189|health|health
808957|NCT00215189|mental illness|mental illness
808958|NCT00215189|fitness|fitness
808959|NCT00215176|atypical depression|atypical depression
808960|NCT00215176|psychostimulants|psychostimulants
808961|NCT00215176|modafinil|modafinil
808962|NCT00215163|PTSD|ptsd
808963|NCT00215163|Anxiety|anxiety
808965|NCT00215163|Exposure|exposure
808966|NCT00215163|Paroxetine|paroxetine
808967|NCT00215163|Paroxetine-CR|paroxetine-cr
808968|NCT00215150|anxiety disorder|anxiety disorder
808969|NCT00215150|SAD|sad
808970|NCT00215150|ziprasidone|ziprasidone
808971|NCT00215150|sertraline|sertraline
808972|NCT00215150|antidepressant|antidepressant
808973|NCT00215150|antipsychotic|antipsychotic
808974|NCT00215137|OCD|ocd
808975|NCT00215137|SSRI|ssri
808976|NCT00215137|escitalopram|escitalopram
808977|NCT00215137|relapse|relapse
808978|NCT00215111|childhood obesity|childhood obesity
808979|NCT00215111|weight management|weight management
808980|NCT00215111|dietary interventions|dietary interventions
808981|NCT00215111|cardiovascular disease risk factors|cardiovascular disease risk factors
808982|NCT00215098|pediatric health|pediatric health
808983|NCT00215098|cardiac|cardiac
808984|NCT00215098|congenital heart surgery|congenital heart surgery
808985|NCT00215098|post-operative chylous effusions|post-operative chylous effusions
808986|NCT00215098|heart defects|heart defects
808987|NCT00215098|children|children
808988|NCT00215085|pediatric health|pediatric health
808989|NCT00215085|cardiac|cardiac
808990|NCT00215085|cardiac tumor|cardiac tumor
808991|NCT00215085|children|children
808992|NCT00215072|Death after heart surgery|death after heart surgery
808993|NCT00215072|surgical mortality|surgical mortality
808994|NCT00215072|post-operative mortality|post-operative mortality
808995|NCT00215072|pediatric health|pediatric health
808996|NCT00215072|cardiac|cardiac
808997|NCT00215059|angiogenic related growth factor|angiogenic related growth factor
808998|NCT00215046|vinblastine|vinblastine
808999|NCT00215046|methotrexate|methotrexate
809000|NCT00215033|Epstein-Barr virus|epstein-barr virus
809001|NCT00215033|pediatric health|pediatric health
809002|NCT00215033|cardiac|cardiac
809003|NCT00215033|heart transplant|heart transplant
809004|NCT00215033|lymphoproliferative disease|lymphoproliferative disease
809005|NCT00215033|post-transplant|post-transplant
809006|NCT00215033|pediatric transplant|pediatric transplant
809007|NCT00215020|Isoprostanes|isoprostanes
809008|NCT00214981|ADHD|adhd
809009|NCT00214981|Attention Deficit/Hyperactivity Disorder|attention deficit/hyperactivity disorder
809010|NCT00214929|Pulmonary Embolism|pulmonary embolism
809011|NCT00214929|Therapy|therapy
809012|NCT00214929|Home Nursing|home nursing
809013|NCT00214929|Economics|economics
809014|NCT00214916|Tight glycemic control with|tight glycemic control with
809015|NCT00214916|intensive insulin treatment|intensive insulin treatment
809016|NCT00214916|versus conventional glycemic control|versus conventional glycemic control
809017|NCT00214916|in infant or child in ICU|in infant or child in icu
809018|NCT00214903|Postmenopause|postmenopause
809019|NCT00214903|HRT|hrt
809020|NCT00214890|HIV|hiv
809021|NCT00214890|nucleoside pharmacology|nucleoside pharmacology
809022|NCT00214890|drug-drug interaction|drug-drug interaction
809023|NCT00214890|Treatment Naive|treatment naive
809024|NCT00214890|Drug resistance|drug resistance
809025|NCT00214890|Drug pharmacokinetics|drug pharmacokinetics
809026|NCT00214877|methylene blue for cognitive dysfunction in bipolar disorder|methylene blue for cognitive dysfunction in bipolar disorder
809027|NCT00214864|Metastatic Breast Cancer|metastatic breast cancer
809028|NCT00214864|Taxotere (docetaxel)|taxotere (docetaxel)
809029|NCT00214864|Xeloda (capecitabine)|xeloda (capecitabine)
809030|NCT00214851|Familial Cold Urticaria|familial cold urticaria
809031|NCT00214851|Kineret (anakinra)|kineret (anakinra)
809032|NCT00214851|Interleukin 1 beta|interleukin 1 beta
809033|NCT00214851|C-Reactive Protein|c-reactive protein
809034|NCT00214851|Serum Amyloid A protein|serum amyloid a protein
809035|NCT00214838|cancer, atiprimod|cancer, atiprimod
809036|NCT00214812|HIV Seronegativity|hiv seronegativity
809037|NCT00214812|HIV|hiv
809038|NCT00214786|Diabetes Mellitus|diabetes mellitus
809039|NCT00214786|Hypoglycemia|hypoglycemia
809040|NCT00214786|Hyperglycemia|hyperglycemia
809041|NCT00214760|Hip prosthesis|hip prosthesis
809042|NCT00214760|Centralizer|centralizer
809043|NCT00214760|Uncemented|uncemented
809044|NCT00214747|HIV Seronegativity|hiv seronegativity
809045|NCT00214747|HIV|hiv
809046|NCT00214708|Tuberculosis|tuberculosis
809047|NCT00214708|Screening|screening
809048|NCT00214708|Heaf|heaf
809049|NCT00214708|BCG|bcg
809050|NCT00214682|Depression|depression
809052|NCT00214682|Depressive disorder|depressive disorder
809053|NCT00214682|Mental health literacy|mental health literacy
809054|NCT00214682|Older adults|older adults
809055|NCT00214682|Randomzed controlled trial|randomzed controlled trial
809056|NCT00214669|ethnicity|ethnicity
809057|NCT00214669|primary care|primary care
809058|NCT00214669|education|education
809059|NCT00214656|Cardiac surgical procedures|cardiac surgical procedures
809060|NCT00214656|Surgical blood loss|surgical blood loss
809061|NCT00214656|Surgical haemostasis|surgical haemostasis
809062|NCT00214656|Factor VIIa|factor viia
809063|NCT00214656|Anaesthesia|anaesthesia
809064|NCT00214643|Malaria|malaria
809065|NCT00214643|Fosmidomycin|fosmidomycin
809066|NCT00214643|Clindamycin|clindamycin
809067|NCT00214643|Chemotherapy|chemotherapy
809068|NCT00214643|Gabon|gabon
809069|NCT00214617|hypercholesterolemia|hypercholesterolemia
809070|NCT00214617|HMG CoA Reductase Inhibtors|hmg coa reductase inhibtors
809071|NCT00214617|tracer kinetics|tracer kinetics
809856|NCT00210912|chronic|chronic
809072|NCT00214617|Apolipoproteins|apolipoproteins
809073|NCT00214591|Type 2 diabetes|type 2 diabetes
809074|NCT00214578|Schizophrenia|schizophrenia
809075|NCT00214565|Type 2 diabetes|type 2 diabetes
809076|NCT00214552|GERD|gerd
809077|NCT00214552|Gastroesophageal reflux disease|gastroesophageal reflux disease
809078|NCT00214552|Asthma symptoms|asthma symptoms
809079|NCT00214539|Asthma|asthma
809080|NCT00214539|Bronchial Thermoplasty|bronchial thermoplasty
809081|NCT00214526|Asthma|asthma
809082|NCT00214526|Bronchial Thermoplasty|bronchial thermoplasty
809083|NCT00214526|Airway Hyperresponsiveness|airway hyperresponsiveness
809084|NCT00214500|Amicus Therapeutics|amicus therapeutics
809085|NCT00214500|AT1001|at1001
809086|NCT00214500|Galafold|galafold
809087|NCT00214500|Migalastat|migalastat
809088|NCT00214500|Substrate|substrate
809089|NCT00214487|Myopia Progression|myopia progression
809090|NCT00214487|Myopia Control|myopia control
809091|NCT00214487|Bifocal Contact Lenses|bifocal contact lenses
809092|NCT00214487|Esophoria|esophoria
809093|NCT00214487|Fixation Disparity|fixation disparity
809094|NCT00214474|Disease Management|disease management
809095|NCT00214474|Health Literacy|health literacy
809096|NCT00214474|Telephone Care|telephone care
809097|NCT00214474|Group Medical Visits|group medical visits
809098|NCT00214474|Type 2 Diabetes|type 2 diabetes
809099|NCT00214474|Access to Care|access to care
809100|NCT00214474|Technology|technology
809101|NCT00214474|Language Barriers|language barriers
809102|NCT00214461|Clostridium difficile|clostridium difficile
809103|NCT00214448|Multiple genetic conditions will be studied|multiple genetic conditions will be studied
809104|NCT00214435|HIV infection|hiv infection
809105|NCT00214435|AIDS|aids
809106|NCT00214435|Adherence|adherence
809107|NCT00214435|MEMS caps|mems caps
809108|NCT00214435|Treatment Experienced|treatment experienced
809109|NCT00214422|Prostate|prostate
809110|NCT00214422|Radiation|radiation
809111|NCT00214422|Cancer|cancer
809112|NCT00214422|Prostate Cancer|prostate cancer
809113|NCT00214383|pediatric asthma|pediatric asthma
809114|NCT00214370|pediatric|pediatric
809115|NCT00214370|acute leukemia/lymphoma|acute leukemia/lymphoma
809116|NCT00214344|dying|dying
809117|NCT00214227|patient who will undergo definitive radiotherapy|patient who will undergo definitive radiotherapy
809118|NCT00214175|low grade gliomas and benign CNS lesions|low grade gliomas and benign cns lesions
809119|NCT00214045|Bladder cancer surveillance|bladder cancer surveillance
809120|NCT00214045|Voiding dysfunction|voiding dysfunction
809121|NCT00214045|Cystoscopy|cystoscopy
809122|NCT00214032|lymphedema of the arm in breast cancer survivors|lymphedema of the arm in breast cancer survivors
809123|NCT00213980|bone mineral density|bone mineral density
809124|NCT00213980|postmenopausal women|postmenopausal women
809125|NCT00213967|Influenza vaccine|influenza vaccine
809126|NCT00213954|Nerve block anaesthesia|nerve block anaesthesia
809127|NCT00213954|ultrasound-guidance|ultrasound-guidance
809128|NCT00213941|transient tachypnoea of the newborn|transient tachypnoea of the newborn
809129|NCT00213941|surfactant deficiency|surfactant deficiency
809130|NCT00213941|persistant pulmonary hypertension of the neonate|persistant pulmonary hypertension of the neonate
809131|NCT00213941|lung maturity tests|lung maturity tests
809132|NCT00213915|L-arginine|l-arginine
809133|NCT00213915|exercise capacity|exercise capacity
809134|NCT00213915|renal function|renal function
809135|NCT00213915|nitric oxide|nitric oxide
809136|NCT00213915|exercise capacity using a maximal exercise test|exercise capacity using a maximal exercise test
809137|NCT00213915|urinary elimination of a saline load using blood and urinary samples|urinary elimination of a saline load using blood and urinary samples
809138|NCT00213902|Heart failure|heart failure
809139|NCT00213902|Diastolic|diastolic
809140|NCT00213902|functionClonidine|functionclonidine
809141|NCT00213902|Left ventricular diastolic dysfunction with preserved ejection fraction|left ventricular diastolic dysfunction with preserved ejection fraction
809142|NCT00213889|Facial clefting|facial clefting
809143|NCT00213889|twist|twist
809144|NCT00213889|craniofacial development genes|craniofacial development genes
809145|NCT00213889|Human cleft lip and palate|human cleft lip and palate
809344|NCT00213083|HSV|hsv
809146|NCT00213889|cleft lip and palate|cleft lip and palate
809147|NCT00213876|Brain tumours|brain tumours
809148|NCT00213876|oligodendrogliomas|oligodendrogliomas
809149|NCT00213876|allelotyping|allelotyping
809150|NCT00213876|SAGE|sage
809269|NCT00213317|fecal incontinence|fecal incontinence
809151|NCT00213876|Presence of molecular abnormalities statistically linked to survival or response to chemotherapy|presence of molecular abnormalities statistically linked to survival or response to chemotherapy
809152|NCT00213863|porous titanium implants|porous titanium implants
809153|NCT00213863|thyroplasty|thyroplasty
809154|NCT00213863|vocal cord paralysis|vocal cord paralysis
809155|NCT00213863|male or female more than 18 years old|male or female more than 18 years old
809156|NCT00213850|Interrupter technique|interrupter technique
809157|NCT00213850|Respiratory resistance|respiratory resistance
809158|NCT00213850|Normal adults|normal adults
809159|NCT00213837|porous titanium implants|porous titanium implants
809160|NCT00213837|thyroplasty|thyroplasty
809161|NCT00213837|vocal cord paralysis|vocal cord paralysis
809857|NCT00210912|headache|headache
809162|NCT00213837|male or female more than 18 years old|male or female more than 18 years old
809163|NCT00213824|Amyotrophic lateral sclerosis|amyotrophic lateral sclerosis
809164|NCT00213824|Nogo gene|nogo gene
809165|NCT00213824|reticulon genes|reticulon genes
809166|NCT00213811|Bardet-Biedl syndrome, retinitis pigmentosa, obesity, genes|bardet-biedl syndrome, retinitis pigmentosa, obesity, genes
809167|NCT00213798|Lung cancer|lung cancer
809168|NCT00213798|plasma DNA|plasma dna
809169|NCT00213798|allelotyping|allelotyping
809170|NCT00213798|follow-up|follow-up
809171|NCT00213798|Prospective Study|prospective study
809172|NCT00213798|Non-Small Cell Lung Cancer|non-small cell lung cancer
809173|NCT00213798|Small Cell Lung Cancer|small cell lung cancer
809176|NCT00213785|BNP pronostic markers of stroke|bnp pronostic markers of stroke
809177|NCT00213772|Porphyria cutanea tarda|porphyria cutanea tarda
809178|NCT00213772|hepatitis C|hepatitis c
809179|NCT00213772|hemochromatosis|hemochromatosis
809180|NCT00213759|neutropenia|neutropenia
809181|NCT00213759|prematurity|prematurity
809182|NCT00213759|nosocomial infection|nosocomial infection
809183|NCT00213759|G-CSF|g-csf
809184|NCT00213746|Coronary Arteriosclerosis|coronary arteriosclerosis
809185|NCT00213746|Heart Failure, Congestive|heart failure, congestive
809186|NCT00213746|Myocardial Infarction|myocardial infarction
809187|NCT00213746|Myocardial Revascularization|myocardial revascularization
809188|NCT00213746|Tomography, Emission-Computed, Single-Photon|tomography, emission-computed, single-photon
809189|NCT00213746|Dobutamine|dobutamine
809190|NCT00213746|Myocardial Stunning|myocardial stunning
809191|NCT00213746|Myocardial Hibernation|myocardial hibernation
809192|NCT00213733|Lung cancer patients|lung cancer patients
809193|NCT00213733|non-small cell lung cancer|non-small cell lung cancer
809194|NCT00213733|molecular marker|molecular marker
809195|NCT00213733|lymph node completed resected|lymph node completed resected
809196|NCT00213733|Lung cancer samples and paired lymph node resected|lung cancer samples and paired lymph node resected
809197|NCT00213720|Hyperthyroidism|hyperthyroidism
809198|NCT00213720|atrial fibrillation|atrial fibrillation
809199|NCT00213720|quality of life|quality of life
809200|NCT00213720|radioiodine treatment|radioiodine treatment
809201|NCT00213707|Dendritic cells|dendritic cells
809202|NCT00213707|liver transplantation|liver transplantation
809203|NCT00213707|hepatitis C virus|hepatitis c virus
809204|NCT00213707|quasispecies|quasispecies
809205|NCT00213707|virological markers|virological markers
809206|NCT00213707|biochemical markers|biochemical markers
809207|NCT00213707|immunological markers|immunological markers
809208|NCT00213707|clinical markers|clinical markers
809209|NCT00213681|Pulmonary edema, respiratory failure, pressure support ventilation, continuous positive pressure|pulmonary edema, respiratory failure, pressure support ventilation, continuous positive pressure
809210|NCT00213668|glutamine|glutamine
809211|NCT00213668|premature neonate|premature neonate
809212|NCT00213668|gastric emptying|gastric emptying
809213|NCT00213642|Technetium Tc 99m Mertiatide|technetium tc 99m mertiatide
809214|NCT00213642|Radionuclide Imaging|radionuclide imaging
809215|NCT00213642|Cisplatin|cisplatin
809216|NCT00213642|Kidney failure|kidney failure
809217|NCT00213642|Drug Toxicity|drug toxicity
809218|NCT00213642|Cancer|cancer
809219|NCT00213629|myositis|myositis
809220|NCT00213629|cDNA arrays|cdna arrays
809221|NCT00213629|Genes, T-Cell Receptor beta|genes, t-cell receptor beta
809222|NCT00213616|bilateral vocal cord paralysis|bilateral vocal cord paralysis
809223|NCT00213616|reinnervation|reinnervation
809224|NCT00213616|phrenic nerve|phrenic nerve
809225|NCT00213603|precancerous lesions|precancerous lesions
809226|NCT00213603|Lung cancer|lung cancer
809227|NCT00213603|Follow-up|follow-up
809228|NCT00213603|Randomized study|randomized study
809229|NCT00213603|Autofluorescence endoscopy|autofluorescence endoscopy
809230|NCT00213603|precancerous conditions|precancerous conditions
809231|NCT00213577|overactive neurogenic bladder|overactive neurogenic bladder
809232|NCT00213499|Mechanical ventilation|mechanical ventilation
809233|NCT00213499|Weaning|weaning
809234|NCT00213499|Noninvasive ventilation|noninvasive ventilation
809235|NCT00213499|Acute on chronic respiratory failure|acute on chronic respiratory failure
809236|NCT00213473|acquired haemophilia|acquired haemophilia
809237|NCT00213434|prospective|prospective
809238|NCT00213434|randomized|randomized
809239|NCT00213434|polysomnography|polysomnography
809240|NCT00213434|orthodontic appliance, removable|orthodontic appliance, removable
809241|NCT00213408|Arrhythmia|arrhythmia
809242|NCT00213408|atrial flutter|atrial flutter
809243|NCT00213408|catheter ablation|catheter ablation
809244|NCT00213395|Noninvasive ventilation|noninvasive ventilation
809245|NCT00213395|Acute hypercapnic respiratory failure|acute hypercapnic respiratory failure
809246|NCT00213395|Cephalic mask|cephalic mask
809247|NCT00213395|Facial Mask|facial mask
809248|NCT00213382|swallowing|swallowing
809249|NCT00213382|ventilation|ventilation
809250|NCT00213382|pressure|pressure
809251|NCT00213382|EMG|emg
809252|NCT00213382|cortical magnetic stimulation|cortical magnetic stimulation
809253|NCT00213382|Brain Mapping|brain mapping
809254|NCT00213369|aspiration|aspiration
809255|NCT00213369|stroke|stroke
809256|NCT00213369|motor evoked potential|motor evoked potential
809257|NCT00213369|cortical evoked potential|cortical evoked potential
809258|NCT00213369|neuromodulation|neuromodulation
809259|NCT00213356|spinal cord injuries - anal sphincter - evoked potentials|spinal cord injuries - anal sphincter - evoked potentials
809260|NCT00213343|aspiration|aspiration
809261|NCT00213343|phrenic nerve|phrenic nerve
809262|NCT00213343|magnetic stimulation|magnetic stimulation
809263|NCT00213330|cerebral activity|cerebral activity
809264|NCT00213330|rectal distension|rectal distension
809265|NCT00213330|colitis ulcerative|colitis ulcerative
809266|NCT00213330|irritable bowel syndrome|irritable bowel syndrome
809267|NCT00213330|magnetic resonance imaging|magnetic resonance imaging
809268|NCT00213317|sacral magnetic stimulation|sacral magnetic stimulation
809270|NCT00213317|constipation|constipation
809271|NCT00213304|organ transplantation|organ transplantation
809272|NCT00213304|immunosuppression|immunosuppression
809273|NCT00213304|vaccine|vaccine
809274|NCT00213304|varicella|varicella
809275|NCT00213304|pediatrics|pediatrics
809276|NCT00213291|chronic kidney failure|chronic kidney failure
809277|NCT00213291|darbepoetin|darbepoetin
809278|NCT00213291|pediatrics|pediatrics
809279|NCT00213291|anemia|anemia
809280|NCT00213278|glioma|glioma
809281|NCT00213278|brain tumour|brain tumour
809282|NCT00213278|cancer|cancer
809283|NCT00213278|pediatrics|pediatrics
809284|NCT00213278|vinblastine sulfate|vinblastine sulfate
809285|NCT00213265|organ transplantation|organ transplantation
809286|NCT00213265|immunosuppression|immunosuppression
809287|NCT00213265|vaccine|vaccine
809288|NCT00213265|pneumococcal conjugate vaccine|pneumococcal conjugate vaccine
809289|NCT00213265|pediatrics|pediatrics
809290|NCT00213252|asthma, randomized trial, pediatrics|asthma, randomized trial, pediatrics
809291|NCT00213239|spinal puncture|spinal puncture
809292|NCT00213239|remifentanil|remifentanil
809293|NCT00213239|propofol|propofol
809294|NCT00213239|anesthesia|anesthesia
809295|NCT00213239|dose finding|dose finding
809296|NCT00213239|pediatrics|pediatrics
809297|NCT00213226|bronchiolitis|bronchiolitis
809298|NCT00213226|pediatrics|pediatrics
809299|NCT00213226|corticosteroids|corticosteroids
809300|NCT00213213|sucrose|sucrose
809301|NCT00213213|analgesia|analgesia
809302|NCT00213213|pain|pain
809303|NCT00213213|neonates|neonates
809304|NCT00213213|diabetes|diabetes
809305|NCT00213200|pain|pain
809306|NCT00213200|analgesia|analgesia
809307|NCT00213200|morphine|morphine
809308|NCT00213200|amethocaine|amethocaine
809309|NCT00213200|neonate|neonate
809310|NCT00213187|Juvenile Rheumatoid Arthritis,|juvenile rheumatoid arthritis,
809311|NCT00213187|Randomized Control Trial,|randomized control trial,
809312|NCT00213187|attention placebo,|attention placebo,
809313|NCT00213187|exercise testing,|exercise testing,
809314|NCT00213187|aerobics,|aerobics,
809315|NCT00213187|Qi Gong,|qi gong,
809316|NCT00213187|exercise video,|exercise video,
809317|NCT00213187|activities of daily living,|activities of daily living,
809318|NCT00213187|quality of life,|quality of life,
809319|NCT00213187|economy of walking,|economy of walking,
809320|NCT00213187|fitness|fitness
809321|NCT00213187|pediatrics|pediatrics
809322|NCT00213174|pediatrics|pediatrics
809323|NCT00213174|injury|injury
809324|NCT00213174|arm fractures|arm fractures
809325|NCT00213174|trauma|trauma
809326|NCT00213174|playground surfaces|playground surfaces
809327|NCT00213174|fractures|fractures
809328|NCT00213161|anemia|anemia
809329|NCT00213161|iron deficiency|iron deficiency
809330|NCT00213161|iron drops|iron drops
809331|NCT00213161|iron supplement|iron supplement
809332|NCT00213161|malnutrition|malnutrition
809333|NCT00213161|pediatrics|pediatrics
809334|NCT00213122|alpha-glucosidase inhibitor,Insulin|alpha-glucosidase inhibitor,insulin
809335|NCT00213109|alpha-glucosidase inhibitor,Insulin|alpha-glucosidase inhibitor,insulin
809336|NCT00213096|Contraceptive agents|contraceptive agents
809337|NCT00213096|female|female
809338|NCT00213083|Microbicide|microbicide
809339|NCT00213083|HIV|hiv
809340|NCT00213083|AIDS|aids
809341|NCT00213083|STIs|stis
809346|NCT00213083|South Africa|south africa
809347|NCT00213083|seroconversion|seroconversion
809348|NCT00213083|condom|condom
809349|NCT00213083|safe-sex|safe-sex
809350|NCT00213083|vaginal intercourse|vaginal intercourse
809351|NCT00213083|prevention|prevention
809352|NCT00213083|HIV Seronegativity|hiv seronegativity
809353|NCT00213070|alpha-glucosidase inhibitor,Insulin|alpha-glucosidase inhibitor,insulin
809354|NCT00213057|Microbicides|microbicides
809355|NCT00213057|HIV prevention|hiv prevention
809356|NCT00213057|sexually transmitted infections|sexually transmitted infections
809357|NCT00213057|carrageenan|carrageenan
809358|NCT00213057|sero-concordant couples|sero-concordant couples
809359|NCT00213057|HIV Seronegativity|hiv seronegativity
809360|NCT00213057|HIV|hiv
809361|NCT00213044|Microbicides|microbicides
809362|NCT00213044|HIV prevention|hiv prevention
809363|NCT00213044|HIV-positive women|hiv-positive women
809364|NCT00213044|safety|safety
809365|NCT00213044|carrageenan|carrageenan
809366|NCT00213044|HIV|hiv
809367|NCT00213031|microbicides|microbicides
809368|NCT00213031|HIV prevention|hiv prevention
809369|NCT00213031|sexually transmitted infections|sexually transmitted infections
809370|NCT00213031|female-initiated protection|female-initiated protection
809371|NCT00213031|carrageenan|carrageenan
809372|NCT00213031|expanded safety trial|expanded safety trial
809373|NCT00213031|HIV Seronegativity|hiv seronegativity
809374|NCT00213031|HIV|hiv
809375|NCT00213018|microbicides|microbicides
809376|NCT00213018|HIV prevention|hiv prevention
809377|NCT00213018|sexually transmitted infections|sexually transmitted infections
809378|NCT00213018|female-initiated protection|female-initiated protection
809379|NCT00213018|carrageenan|carrageenan
809380|NCT00213018|expanded safety trial|expanded safety trial
809381|NCT00213018|HIV Seronegativity|hiv seronegativity
809382|NCT00213018|HIV|hiv
809383|NCT00213005|Microbicides|microbicides
809384|NCT00213005|HIV prevention|hiv prevention
809385|NCT00213005|HIV positive|hiv positive
809386|NCT00213005|carrageenan|carrageenan
809387|NCT00213005|safety trial|safety trial
809388|NCT00213005|Treatment Experienced|treatment experienced
809389|NCT00213005|HIV|hiv
809390|NCT00212992|defibrillation|defibrillation
809391|NCT00212992|ventricular fibrillation|ventricular fibrillation
809392|NCT00212992|heart arrest|heart arrest
809393|NCT00212979|glomerular filtration rate|glomerular filtration rate
809394|NCT00212979|cystatin C|cystatin c
809395|NCT00212979|creatinine|creatinine
809396|NCT00212966|psychosocial|psychosocial
809397|NCT00212953|Chest Pain,|chest pain,
809398|NCT00212953|Shortness of breath,|shortness of breath,
809399|NCT00212953|Injury,|injury,
809400|NCT00212953|Trauma|trauma
809401|NCT00212940|Treatment Naive|treatment naive
809402|NCT00212940|HIV|hiv
809403|NCT00212901|Diabetes|diabetes
809404|NCT00212901|Proteinuria|proteinuria
809405|NCT00212901|Angiotensin converting enzyme inhibitors|angiotensin converting enzyme inhibitors
809406|NCT00212901|Angiotensin receptor antagonists|angiotensin receptor antagonists
809407|NCT00212888|HIV|hiv
809408|NCT00212888|Vaccination|vaccination
809409|NCT00212875|Chronic Kidney disease|chronic kidney disease
809410|NCT00212875|anemia|anemia
809411|NCT00212862|Anemia|anemia
809412|NCT00212862|Cancer|cancer
809413|NCT00212862|Epoetin alfa|epoetin alfa
809414|NCT00212862|Darbepoetin alfa|darbepoetin alfa
809415|NCT00212862|Registry|registry
809416|NCT00212849|Articular Cartilage Lesions|articular cartilage lesions
809417|NCT00212849|Patellar lesions|patellar lesions
809418|NCT00212849|Trochlear lesions|trochlear lesions
809419|NCT00212849|Patellofemoral joint|patellofemoral joint
809420|NCT00212849|Carticel|carticel
809421|NCT00212849|Autologous Chondrocyte Implantation|autologous chondrocyte implantation
809422|NCT00212823|Migraine|migraine
809423|NCT00212810|Migraine|migraine
809424|NCT00212810|Headache|headache
809425|NCT00212810|Migraine Headache|migraine headache
809426|NCT00212758|Short stature|short stature
809427|NCT00212758|children|children
809428|NCT00212758|kidney failure, chronic|kidney failure, chronic
809429|NCT00212758|Growth|growth
809430|NCT00212745|Behavior Therapy|behavior therapy
809431|NCT00212745|Relaxation Techniques|relaxation techniques
809432|NCT00212732|ONO-8025, KRP-197, overactive bladder, antimuscarinic|ono-8025, krp-197, overactive bladder, antimuscarinic
809433|NCT00212719|ONO-5920, osteoporosis, bisphosphonate|ono-5920, osteoporosis, bisphosphonate
809434|NCT00212706|ONO-8025, KRP-197, overactive bladder, antimuscarinic|ono-8025, krp-197, overactive bladder, antimuscarinic
809435|NCT00212693|ONO-2506PO, Parkinson's disease|ono-2506po, parkinson's disease
809436|NCT00212680|ONO-1101,Landiolol Hydrochloride, Postoperative, Supraventricular Tachyarrhythmia|ono-1101,landiolol hydrochloride, postoperative, supraventricular tachyarrhythmia
809437|NCT00212667|ONO-5920, osteoporosis, bisphosphonate|ono-5920, osteoporosis, bisphosphonate
809438|NCT00212654|ONO-1101|ono-1101
809439|NCT00212654|Landiolol Hydrochloride|landiolol hydrochloride
809440|NCT00212654|Postoperative|postoperative
809441|NCT00212654|supraventricular tachyarrhythmia|supraventricular tachyarrhythmia
809442|NCT00212628|ONO-5920|ono-5920
809443|NCT00212628|osteoporosis|osteoporosis
809444|NCT00212628|bisphosphonate|bisphosphonate
809445|NCT00212615|Colorectal neoplasm|colorectal neoplasm
809446|NCT00212615|Capecitabine (Xeloda)|capecitabine (xeloda)
809447|NCT00212615|Oxaliplatin (Eloxatin)|oxaliplatin (eloxatin)
809448|NCT00212615|Advanced disease|advanced disease
809449|NCT00212615|Metastatic disease|metastatic disease
809450|NCT00212615|First-line treatment|first-line treatment
809451|NCT00212615|Phase II study|phase ii study
809452|NCT00212602|ONO-7436, Aprepitant, Vomiting, Nausea|ono-7436, aprepitant, vomiting, nausea
809453|NCT00212589|Patients preference|patients preference
809454|NCT00212589|Colorectal cancer|colorectal cancer
809455|NCT00212589|Capecitabine|capecitabine
809456|NCT00212589|Fluorouracil + folinic acid|fluorouracil + folinic acid
809457|NCT00212589|Cross-over study|cross-over study
809458|NCT00212576|Child development|child development
809459|NCT00212576|Language Development|language development
809461|NCT00212537|Asthma and normal|asthma and normal
809462|NCT00212485|Hemophilia|hemophilia
809463|NCT00212485|Factor Deficiency|factor deficiency
809464|NCT00212485|synovitis|synovitis
809465|NCT00212485|sonogram|sonogram
809466|NCT00212459|Bleeding logs|bleeding logs
809467|NCT00212459|Factor Infusions|factor infusions
809468|NCT00212446|Tocolysis|tocolysis
809469|NCT00212446|Electrical Pacemaker|electrical pacemaker
809470|NCT00212433|colorectal neoplasia|colorectal neoplasia
809471|NCT00212433|CT colonography|ct colonography
809472|NCT00212433|faecal tagging|faecal tagging
809473|NCT00212420|fistula; enterocutaneous; nutrition;enteral; parenteral; TPN|fistula; enterocutaneous; nutrition;enteral; parenteral; tpn
809474|NCT00212407|Cord blood transplantation|cord blood transplantation
809475|NCT00212407|bone marrow transplantation|bone marrow transplantation
809476|NCT00212394|Tourniquet|tourniquet
809477|NCT00212394|paresis|paresis
809478|NCT00212381|cervical dysplasia, diindolylmethane, pap smear|cervical dysplasia, diindolylmethane, pap smear
809479|NCT00212329|Type 1 Diabetes|type 1 diabetes
809480|NCT00212329|Juvenile Onset Diabetes|juvenile onset diabetes
809481|NCT00212329|Insulin Dependent Diabetes|insulin dependent diabetes
809482|NCT00212329|T1D|t1d
809483|NCT00212316|Huntington's Disease|huntington's disease
809484|NCT00212316|phenylbutyrate|phenylbutyrate
809485|NCT00212316|HDAC inhibitors|hdac inhibitors
809486|NCT00212316|transcription|transcription
809487|NCT00212303|type 2 diabetes|type 2 diabetes
809488|NCT00212303|hypertension|hypertension
809489|NCT00212303|exercise training|exercise training
809490|NCT00212303|cardiac, peripheral|cardiac, peripheral
809491|NCT00212303|body composition|body composition
809492|NCT00212303|physical fitness|physical fitness
809493|NCT00212303|inflammation|inflammation
809494|NCT00212290|impaired glucose tolerance|impaired glucose tolerance
809495|NCT00212264|urinary incontinence|urinary incontinence
809496|NCT00212264|therapy|therapy
809497|NCT00212264|prostatectomy|prostatectomy
809498|NCT00212264|prostate cancer|prostate cancer
809499|NCT00212251|obesity|obesity
809500|NCT00212251|postpartum period|postpartum period
809501|NCT00212251|exercise|exercise
809502|NCT00212251|diet|diet
809503|NCT00212251|motivation|motivation
809504|NCT00212238|obesity|obesity
809505|NCT00212238|weight loss|weight loss
809506|NCT00212238|Internet|internet
809507|NCT00212238|cognitive behavior therapy|cognitive behavior therapy
809508|NCT00212238|computer assisted patient care|computer assisted patient care
809509|NCT00212238|human therapy evaluation|human therapy evaluation
809510|NCT00212238|physical activity|physical activity
809511|NCT00212238|clinical trial|clinical trial
809512|NCT00212238|nutrient intake activity|nutrient intake activity
809513|NCT00212238|outcomes research|outcomes research
809514|NCT00212238|personal log /diary|personal log /diary
809515|NCT00212238|reinforcer|reinforcer
809516|NCT00212238|self care|self care
809517|NCT00212238|social support network|social support network
809518|NCT00212238|weight control|weight control
809519|NCT00212238|behavioral /social science research tag|behavioral /social science research tag
809520|NCT00212238|clinical research|clinical research
809521|NCT00212238|human subject|human subject
809522|NCT00212238|questionnaire|questionnaire
809523|NCT00212225|gastric disease|gastric disease
809524|NCT00212225|H. pylori|h. pylori
809525|NCT00212225|children|children
809526|NCT00212225|Helicobacter pylori|helicobacter pylori
809527|NCT00212225|child|child
809528|NCT00212225|epidemiology|epidemiology
809529|NCT00212212|selenium supplements|selenium supplements
809530|NCT00212212|selenate|selenate
809531|NCT00212212|selenomethionine|selenomethionine
809532|NCT00212212|biomarkers|biomarkers
809533|NCT00212212|plasma selenium concentration|plasma selenium concentration
809534|NCT00212212|plasma glutathione peroxidase|plasma glutathione peroxidase
809535|NCT00212212|selenoprotein P|selenoprotein p
809536|NCT00212199|Obesity Treatment|obesity treatment
809537|NCT00212199|Effectiveness of weight management treatment|effectiveness of weight management treatment
809538|NCT00212199|Counseling for weight management|counseling for weight management
809539|NCT00212173|Adolescent|adolescent
809540|NCT00212173|Weight Management|weight management
809541|NCT00212173|Obesity Treatment|obesity treatment
809542|NCT00212173|Behavioral Treatment|behavioral treatment
809546|NCT00212134|cataract surgery|cataract surgery
809547|NCT00212134|intraocular lens|intraocular lens
809548|NCT00212134|contact lens|contact lens
809549|NCT00212134|infants|infants
809550|NCT00212134|aphakia|aphakia
809551|NCT00212121|breast cancer|breast cancer
809552|NCT00212121|radiotherapy|radiotherapy
809553|NCT00212121|microarrays|microarrays
809554|NCT00212108|celecoxib, NPC, gefitinib|celecoxib, npc, gefitinib
809555|NCT00212095|breast cancer|breast cancer
809556|NCT00212095|docetaxel|docetaxel
809557|NCT00212095|gene expression|gene expression
809558|NCT00212095|proteomics|proteomics
809559|NCT00212082|breast cancer|breast cancer
809560|NCT00212082|chemotherapy response|chemotherapy response
809561|NCT00212082|gene expression profiles|gene expression profiles
809562|NCT00212082|proteomics|proteomics
809563|NCT00212069|breast cancer|breast cancer
809564|NCT00212069|serum proteomics|serum proteomics
809565|NCT00212069|gemcitabine|gemcitabine
809566|NCT00212069|carboplatin|carboplatin
809567|NCT00212069|chemotherapy sensitivity|chemotherapy sensitivity
809568|NCT00212056|Acute myocardial infarction|acute myocardial infarction
809569|NCT00212056|Atrial natriuretic peptide|atrial natriuretic peptide
809570|NCT00212056|Data mining|data mining
809571|NCT00212056|Randomized clinical trial|randomized clinical trial
809572|NCT00212056|SNPs|snps
809573|NCT00212043|randomised phase II trial gemcitabine and carboplatin|randomised phase ii trial gemcitabine and carboplatin
809574|NCT00212030|Acute myocardial infarction|acute myocardial infarction
809575|NCT00212030|Data mining|data mining
809576|NCT00212030|Nicorandil|nicorandil
809577|NCT00212030|Randomized clinical trial|randomized clinical trial
809578|NCT00212030|SNPs|snps
809579|NCT00212017|IGT|igt
809580|NCT00212017|Myocardial Infarction|myocardial infarction
809581|NCT00212017|alpha-glucosidase inhibitor|alpha-glucosidase inhibitor
809582|NCT00212017|re-infarction prevention|re-infarction prevention
809583|NCT00212004|diabetes mellitus|diabetes mellitus
809584|NCT00212004|myocardial infarction|myocardial infarction
809585|NCT00212004|pioglitazone|pioglitazone
809586|NCT00211978|PhosLo (Calcium acetate)|phoslo (calcium acetate)
809587|NCT00211965|Knee replacement surgery|knee replacement surgery
809588|NCT00211965|hip replacement surgery|hip replacement surgery
809589|NCT00211965|nosocomial infections|nosocomial infections
809590|NCT00211965|Arthroplasty|arthroplasty
809591|NCT00211939|PhosLo (Calcium acetate)|phoslo (calcium acetate)
809592|NCT00211939|Renagel (sevelamer, polyallylamine HCL)|renagel (sevelamer, polyallylamine hcl)
809593|NCT00211939|kidney dialysis|kidney dialysis
809594|NCT00211939|hyperphosphatemia|hyperphosphatemia
809595|NCT00211939|Kidney failure|kidney failure
809596|NCT00211926|vaccine|vaccine
809597|NCT00211926|Staphylococcus aureus vaccine|staphylococcus aureus vaccine
809598|NCT00211887|Multiple Sclerosis|multiple sclerosis
809599|NCT00211887|Clinical trial|clinical trial
809600|NCT00211887|treatment trial|treatment trial
809601|NCT00211887|autoimmune disease|autoimmune disease
809602|NCT00211887|Relapsing Remitting|relapsing remitting
809603|NCT00211887|MS Treatment|ms treatment
809604|NCT00211887|interferon beta-1a|interferon beta-1a
809605|NCT00211887|glatiramer acetate|glatiramer acetate
809606|NCT00211874|Congestive heart failure|congestive heart failure
809607|NCT00211874|nurse management|nurse management
809608|NCT00211874|effectiveness trial|effectiveness trial
809609|NCT00211874|quality improvement|quality improvement
809610|NCT00211874|minority communities|minority communities
809611|NCT00211874|disease management|disease management
809612|NCT00211848|Chemical Compounds-drugs|chemical compounds-drugs
809613|NCT00211848|Human Subjects- adults|human subjects- adults
809614|NCT00211848|Gastrointestinal System-liver|gastrointestinal system-liver
809615|NCT00211848|Pathology|pathology
809616|NCT00211835|TBI|tbi
809617|NCT00211835|traumatic brain injury|traumatic brain injury
809618|NCT00211835|depression|depression
809619|NCT00211835|cognitive behavioral therapy|cognitive behavioral therapy
809620|NCT00211835|supportive psychotherapy|supportive psychotherapy
809621|NCT00211835|psychotherapy|psychotherapy
809622|NCT00211822|Pathological Gambling|pathological gambling
809623|NCT00211822|Obsessive-Compulsive Disorder|obsessive-compulsive disorder
809624|NCT00211822|Go No-go|go no-go
809625|NCT00211822|Monetary incentives delay|monetary incentives delay
809626|NCT00211822|fMRI|fmri
809627|NCT00211809|Body Dysmorphic Disorder|body dysmorphic disorder
809628|NCT00211809|SRIs|sris
809629|NCT00211809|Cognitive Behavioral Therapy|cognitive behavioral therapy
809630|NCT00211796|autism|autism
809631|NCT00211796|divalproex sodium ER|divalproex sodium er
809632|NCT00211796|aggression|aggression
809633|NCT00211796|irritability|irritability
809634|NCT00211783|autism|autism
809635|NCT00211783|fMRI|fmri
809636|NCT00211783|response inhibition|response inhibition
809637|NCT00211783|face processing|face processing
809638|NCT00211783|linguistic processing|linguistic processing
809639|NCT00211770|Autism|autism
809640|NCT00211770|Functional Behavioral Assessment|functional behavioral assessment
809641|NCT00211770|Citalopram|citalopram
809642|NCT00211757|autism|autism
809643|NCT00211757|aggression|aggression
809644|NCT00211757|irritability|irritability
809645|NCT00211757|divalproex sodium|divalproex sodium
809646|NCT00211744|OCD|ocd
809647|NCT00211744|Obsessive-Compulsive Disorder|obsessive-compulsive disorder
809648|NCT00211744|OCD treatment|ocd treatment
809649|NCT00211731|Acute stroke|acute stroke
809650|NCT00211731|recurrent stroke preventive measures|recurrent stroke preventive measures
809651|NCT00211731|racial disparities|racial disparities
809652|NCT00211718|shoulder pain|shoulder pain
809653|NCT00211718|arthritis|arthritis
809654|NCT00211718|intra-articular botulinum toxin a|intra-articular botulinum toxin a
809655|NCT00211718|joint pain|joint pain
809656|NCT00211705|Hyperlipidemia|hyperlipidemia
810064|NCT00210210|Analgesia|analgesia
809657|NCT00211705|coronary heart disease|coronary heart disease
809658|NCT00211705|prevention|prevention
809659|NCT00211705|stroke|stroke
809660|NCT00211705|pravastatin|pravastatin
809661|NCT00211692|Hepatitis C|hepatitis c
809662|NCT00211692|interferon alfa|interferon alfa
809663|NCT00211692|ribavirin|ribavirin
809664|NCT00211692|interferon alfacon-1|interferon alfacon-1
809665|NCT00211692|antiviral therapy|antiviral therapy
809666|NCT00211679|Joint pain|joint pain
809667|NCT00211679|Knee Pain|knee pain
809668|NCT00211679|Arthritis|arthritis
809669|NCT00211679|Intra-articular Botulinum Toxin Type A|intra-articular botulinum toxin type a
809670|NCT00211666|Hypertension|hypertension
809671|NCT00211666|blood pressure|blood pressure
809672|NCT00211666|self management|self management
809673|NCT00211666|nurse management|nurse management
809674|NCT00211666|racial disparities|racial disparities
809675|NCT00211666|cardiovascular disease|cardiovascular disease
809676|NCT00211653|Kidney failure|kidney failure
809677|NCT00211653|Thoracic surgery|thoracic surgery
809678|NCT00211653|Acetylcysteine|acetylcysteine
809679|NCT00211614|Obstructive Sleep Apnea|obstructive sleep apnea
809680|NCT00211614|Gastroesophageal Reflux|gastroesophageal reflux
809681|NCT00211614|Proton Pump Inhibitor|proton pump inhibitor
809682|NCT00211614|Lansoprazole (Prevacid)|lansoprazole (prevacid)
809683|NCT00211614|Quality of Life|quality of life
809684|NCT00211588|cognition|cognition
809685|NCT00211562|weight gain|weight gain
809686|NCT00211562|weight gain supplementation|weight gain supplementation
809687|NCT00211562|antioxidants|antioxidants
809688|NCT00211562|olanzapine|olanzapine
809689|NCT00211549|Osteoarthritis|osteoarthritis
809690|NCT00211536|Diabetes|diabetes
809691|NCT00211536|Implantable Insulin Pump|implantable insulin pump
809692|NCT00211536|Intraperitoneal Insulin Delivery|intraperitoneal insulin delivery
809693|NCT00211523|acne|acne
809694|NCT00211523|acne vulgaris|acne vulgaris
809695|NCT00211523|MBI 226|mbi 226
809696|NCT00211523|Propionibacterium acnes|propionibacterium acnes
809697|NCT00211523|lesion counts|lesion counts
809698|NCT00211523|lesions|lesions
809699|NCT00211523|inflammatory|inflammatory
809700|NCT00211523|non-inflammatory|non-inflammatory
809701|NCT00211523|topical|topical
809702|NCT00211510|Diabetes|diabetes
809703|NCT00211510|Continuous Glucose Monitoring|continuous glucose monitoring
809704|NCT00211510|Glycemic Control|glycemic control
809705|NCT00211497|acne vulgaris|acne vulgaris
809706|NCT00211497|acne|acne
809707|NCT00211497|Propionibacterium acnes|propionibacterium acnes
809708|NCT00211497|topical|topical
809709|NCT00211497|inflammatory|inflammatory
809710|NCT00211497|non-inflammatory|non-inflammatory
809711|NCT00211497|lesion counts|lesion counts
809712|NCT00211497|lesions|lesions
809713|NCT00211458|Age-Related Macular Degeneration|age-related macular degeneration
809714|NCT00211419|Exudative Age-Related Macular Degeneration|exudative age-related macular degeneration
809715|NCT00211419|AMD|amd
809716|NCT00211380|cognition|cognition
809717|NCT00211380|schizophrenia|schizophrenia
809718|NCT00211380|schizoaffective disorder|schizoaffective disorder
809719|NCT00211367|Radiation Retinopathy|radiation retinopathy
809720|NCT00211341|Pregnancy|pregnancy
809721|NCT00211341|Mortality|mortality
809722|NCT00211341|Maternal|maternal
809723|NCT00211341|Vitamin A|vitamin a
809724|NCT00211302|Cognition|cognition
809725|NCT00211302|Schizophrenia|schizophrenia
809726|NCT00211302|Schizoaffective disorder|schizoaffective disorder
809727|NCT00211289|Educational Interventions|educational interventions
809728|NCT00211289|Heart Failure|heart failure
809729|NCT00211289|Compliance|compliance
809730|NCT00211263|Bipolar Disorder|bipolar disorder
809731|NCT00211250|Depakote Er and Valproic Acid|depakote er and valproic acid
809732|NCT00211237|Balloon Kyphoplasty|balloon kyphoplasty
809733|NCT00211237|Cancer|cancer
809734|NCT00211237|Vertebral Compression Fracture|vertebral compression fracture
809735|NCT00211237|Back Pain|back pain
809736|NCT00211237|Spine|spine
809737|NCT00211224|multiple system atrophy|multiple system atrophy
809738|NCT00211224|progressive supranuclear palsy|progressive supranuclear palsy
809739|NCT00211224|riluzole|riluzole
809740|NCT00211224|MSA|msa
809741|NCT00211224|PSP|psp
809742|NCT00211211|Osteopenia|osteopenia
809743|NCT00211211|Osteoporosis|osteoporosis
809744|NCT00211211|Multiple Myeloma|multiple myeloma
809745|NCT00211211|Osteolytic Metastatic Tumors|osteolytic metastatic tumors
809746|NCT00211211|Vertebral Compression Fracture|vertebral compression fracture
809747|NCT00211211|Back Pain|back pain
809748|NCT00211211|Spine|spine
809749|NCT00211198|Cutaneous|cutaneous
809750|NCT00211198|T-cell lymphoma|t-cell lymphoma
809751|NCT00211198|ONTAK|ontak
809752|NCT00211198|CD25|cd25
809753|NCT00211172|Acute Myocardial Infarction (AMI)|acute myocardial infarction (ami)
809754|NCT00211172|Heart Attack|heart attack
809755|NCT00211172|Adherence|adherence
809756|NCT00211172|Beta-blocker|beta-blocker
809757|NCT00211172|Behavior change|behavior change
809758|NCT00211159|Alzheimer's disease|alzheimer's disease
809759|NCT00211159|Omega-3 fatty acid|omega-3 fatty acid
809760|NCT00211159|Dietary supplementation|dietary supplementation
809761|NCT00211159|Cognition|cognition
809762|NCT00211159|Safety|safety
809763|NCT00211146|Anemia, erythropoetin, PROCRIT, deep vein thrombosis, thrombovascular event|anemia, erythropoetin, procrit, deep vein thrombosis, thrombovascular event
809764|NCT00211133|Anemia|anemia
809765|NCT00211133|Breast Cancer|breast cancer
809766|NCT00211133|Breast Tumor|breast tumor
809767|NCT00211133|Quality of Life|quality of life
809768|NCT00211133|Women|women
809769|NCT00211133|Female|female
809770|NCT00211133|Chemotherapy|chemotherapy
809771|NCT00211133|Hemoglobin|hemoglobin
809772|NCT00211133|Survival|survival
809773|NCT00211133|Epoetin|epoetin
809774|NCT00211133|Epoetin alfa|epoetin alfa
809775|NCT00211133|erythropoietin|erythropoietin
809776|NCT00211120|Anemia|anemia
809777|NCT00211120|Low Blood Count|low blood count
809778|NCT00211120|Chronic Kidney Failure|chronic kidney failure
809779|NCT00211120|Chronic Kidney Disease|chronic kidney disease
809780|NCT00211107|dapoxetine|dapoxetine
809781|NCT00211107|rapid ejaculation|rapid ejaculation
809782|NCT00211107|premature ejaculation|premature ejaculation
809783|NCT00211107|ejaculation|ejaculation
809784|NCT00211107|sexual dysfunction|sexual dysfunction
809785|NCT00211107|orgasmic disorder|orgasmic disorder
809786|NCT00211107|sexual intercourse|sexual intercourse
809787|NCT00211094|dapoxetine|dapoxetine
809788|NCT00211094|premature ejaculation|premature ejaculation
809789|NCT00211094|ejaculation|ejaculation
809790|NCT00211094|sexual dysfunction|sexual dysfunction
809791|NCT00211094|orgasmic disorder|orgasmic disorder
809792|NCT00211094|sexual intercourse|sexual intercourse
809793|NCT00211081|Congenital Heart Disease|congenital heart disease
809794|NCT00211081|Spironolactone|spironolactone
809795|NCT00211081|>17 years old|>17 years old
809796|NCT00211081|undergone Fontan procedure|undergone fontan procedure
809797|NCT00211081|endothelial function|endothelial function
809798|NCT00211068|Pure red-cell aplasia|pure red-cell aplasia
809799|NCT00211068|Chronic kidney failure|chronic kidney failure
809800|NCT00211068|Epoetin alfa (Eprex)|epoetin alfa (eprex)
809801|NCT00211068|Erythropoietin|erythropoietin
809802|NCT00211068|Kidney disease|kidney disease
809803|NCT00211068|Anemia|anemia
809804|NCT00211055|Critically Ill|critically ill
809805|NCT00211055|Intensive Care Unit|intensive care unit
809806|NCT00211055|Blood transfusion|blood transfusion
809807|NCT00211055|Blood loss|blood loss
809808|NCT00211055|Pediatric|pediatric
809809|NCT00211055|Children|children
809810|NCT00211055|Anemia, Pediatric Intensive Care Unit|anemia, pediatric intensive care unit
809811|NCT00211055|Hemoglobin|hemoglobin
809812|NCT00211055|Transfusion|transfusion
809813|NCT00211042|Pure red-cell aplasia|pure red-cell aplasia
809814|NCT00211042|Anemia|anemia
809815|NCT00211042|Red blood cells|red blood cells
809816|NCT00211042|Epoetin alfa (Eprex)|epoetin alfa (eprex)
809817|NCT00211042|Anti-erythropoietin antibodies|anti-erythropoietin antibodies
809818|NCT00211042|Recombinant human erythropoietin|recombinant human erythropoietin
809819|NCT00211029|Anemia, Hemoglobin, Red Blood Cells, Epoetin alfa|anemia, hemoglobin, red blood cells, epoetin alfa
809820|NCT00211029|Epoetin|epoetin
809821|NCT00211029|erythropoietin|erythropoietin
809822|NCT00211029|Red Cell Aplasia, Pure Red Cell Aplasia|red cell aplasia, pure red cell aplasia
809823|NCT00211029|Chronic Renal Failure|chronic renal failure
809824|NCT00211029|Kidney Failure|kidney failure
809825|NCT00211016|Ventilator-Associated Pneumonia|ventilator-associated pneumonia
809826|NCT00211003|Hospital-Acquired Pneumonia|hospital-acquired pneumonia
809827|NCT00211003|Mechanical Ventilation|mechanical ventilation
809828|NCT00210990|Complicated Urinary Tract Infections|complicated urinary tract infections
809829|NCT00210990|Pyelonephritis|pyelonephritis
809830|NCT00210977|Anemia|anemia
809831|NCT00210977|Erythropoietin|erythropoietin
809832|NCT00210977|Epoetin alfa|epoetin alfa
809833|NCT00210977|Erythropoietin receptor agonist (ERA) therapy|erythropoietin receptor agonist (era) therapy
809834|NCT00210977|Anti-erythropoietin antibodies (anti-EPO Ab)|anti-erythropoietin antibodies (anti-epo ab)
809835|NCT00210977|Recombinant human erythropoietin|recombinant human erythropoietin
809836|NCT00210977|Pure red cell aplasia|pure red cell aplasia
809837|NCT00210977|Darbepoetin|darbepoetin
809838|NCT00210964|Ceftobiprole medocaril|ceftobiprole medocaril
809839|NCT00210964|Nosocominal Pneumonia|nosocominal pneumonia
809840|NCT00210964|Ventilator-Associated Pneumonia|ventilator-associated pneumonia
809841|NCT00210964|Cephalosporins|cephalosporins
809842|NCT00210964|Methicillin-Resistant Staphylococcus Aureus|methicillin-resistant staphylococcus aureus
809843|NCT00210951|Epoetin alfa|epoetin alfa
809844|NCT00210951|Erythropoietin|erythropoietin
809845|NCT00210951|Red Cell Aplasia, Pure|red cell aplasia, pure
809846|NCT00210951|Chronic Renal Failure|chronic renal failure
809847|NCT00210938|Complicated Intra-Abdominal Infections|complicated intra-abdominal infections
809848|NCT00210938|Appendicitis|appendicitis
809849|NCT00210938|Cholecystitis|cholecystitis
809850|NCT00210938|Peritonitis|peritonitis
809851|NCT00210925|alcoholism|alcoholism
809852|NCT00210925|alcohol dependence|alcohol dependence
809853|NCT00210925|medication treatment.|medication treatment.
809854|NCT00210912|prevention|prevention
809858|NCT00210899|Complicated Skin Infections|complicated skin infections
809859|NCT00210899|Infectious Skin Diseases|infectious skin diseases
809860|NCT00210899|Bacterial Skin Diseases|bacterial skin diseases
809861|NCT00210899|Staphylococcal Skin Infections|staphylococcal skin infections
809862|NCT00210899|Cephalosporin|cephalosporin
809863|NCT00210886|complicated urinary tract infection|complicated urinary tract infection
809864|NCT00210886|urinary tract infection|urinary tract infection
809865|NCT00210886|acute pyelonephritis|acute pyelonephritis
809866|NCT00210886|pyelonephritis|pyelonephritis
809867|NCT00210886|kidney infection|kidney infection
809868|NCT00210886|bladder infection|bladder infection
809869|NCT00210873|Migraine|migraine
809870|NCT00210873|headache|headache
809871|NCT00210873|chronic|chronic
809872|NCT00210873|prevention|prevention
809873|NCT00210860|chronic|chronic
809874|NCT00210860|headache|headache
809875|NCT00210860|prevention|prevention
809876|NCT00210860|Migraine|migraine
809877|NCT00210847|peripheral neuropathy|peripheral neuropathy
809878|NCT00210847|Diabetic neuropathy|diabetic neuropathy
809879|NCT00210847|pain|pain
809880|NCT00210847|diabetes|diabetes
809881|NCT00210847|extremities|extremities
809882|NCT00210847|neuropathy|neuropathy
809883|NCT00210847|diabetic|diabetic
809884|NCT00210834|PROCRIT, Erythropoietin, Epoetin alfa, Hemoglobin level|procrit, erythropoietin, epoetin alfa, hemoglobin level
809885|NCT00210821|migraine|migraine
809886|NCT00210821|headache|headache
809887|NCT00210821|analgesics|analgesics
809888|NCT00210821|prophylaxis|prophylaxis
809889|NCT00210821|prevention|prevention
809890|NCT00210808|Binge-Eating Disorder|binge-eating disorder
809891|NCT00210808|medication treatment|medication treatment
809892|NCT00210808|obesity|obesity
809893|NCT00210808|bingeing|bingeing
809894|NCT00210795|Anemia|anemia
809895|NCT00210795|Subcutaneous injection|subcutaneous injection
809896|NCT00210795|PROCRIT|procrit
809897|NCT00210795|Erythropoietin|erythropoietin
809898|NCT00210795|Epoetin Alfa|epoetin alfa
809899|NCT00210795|Hemoglobin Level|hemoglobin level
809900|NCT00210795|Elderly|elderly
809901|NCT00210782|epilepsy|epilepsy
809902|NCT00210782|seizures|seizures
809903|NCT00210782|epileptic seizures|epileptic seizures
809904|NCT00210782|complex partial seizures|complex partial seizures
809905|NCT00210782|generalized tonic-clonic seizures|generalized tonic-clonic seizures
809906|NCT00210769|schizophrenia|schizophrenia
809907|NCT00210769|extended release|extended release
809908|NCT00210769|oral administration|oral administration
809909|NCT00210769|antipsychotic agents|antipsychotic agents
809910|NCT00210769|dementia praecox|dementia praecox
809911|NCT00210769|mental disorders|mental disorders
809912|NCT00210769|paliperidone|paliperidone
809913|NCT00210769|PANSS|panss
809914|NCT00210756|Anemia|anemia
809915|NCT00210756|pharmacokinetics|pharmacokinetics
809916|NCT00210756|erythropoetin|erythropoetin
809917|NCT00210756|Epoetin alfa|epoetin alfa
809918|NCT00210756|erythropoetin recombinant|erythropoetin recombinant
809919|NCT00210756|Critical care|critical care
809920|NCT00210756|critical illness, intensive care,|critical illness, intensive care,
809921|NCT00210743|Anemia|anemia
809922|NCT00210743|chronic kidney disease|chronic kidney disease
809923|NCT00210743|erythropoetin, Epoetin alfa|erythropoetin, epoetin alfa
809924|NCT00210743|erythropoetin recombinant|erythropoetin recombinant
809925|NCT00210743|pre-dialysis|pre-dialysis
809926|NCT00210730|Anemia|anemia
809927|NCT00210730|Neoplasm|neoplasm
809928|NCT00210730|Hemoglobin Level|hemoglobin level
809929|NCT00210717|schizophrenia|schizophrenia
809930|NCT00210717|intramuscular injection|intramuscular injection
809931|NCT00210717|antipsychotic agents|antipsychotic agents
809932|NCT00210717|risperidone|risperidone
809933|NCT00210717|paliperidone palmitate|paliperidone palmitate
809934|NCT00210717|dementia praecox|dementia praecox
809935|NCT00210717|mental disorders|mental disorders
809936|NCT00210717|PANSS|panss
809937|NCT00210704|dapoxetine|dapoxetine
809938|NCT00210704|premature ejaculation|premature ejaculation
809939|NCT00210704|ejaculation|ejaculation
809940|NCT00210704|sexual dysfunction|sexual dysfunction
809941|NCT00210704|orgasmic disorder|orgasmic disorder
809942|NCT00210704|sexual intercourse|sexual intercourse
809943|NCT00210691|Schizophrenia|schizophrenia
810048|NCT00210249|Cancer|cancer
809944|NCT00210691|intramuscular injection|intramuscular injection
809945|NCT00210691|psychotropic agents|psychotropic agents
809946|NCT00210691|long-acting risperidone|long-acting risperidone
809947|NCT00210678|Erectile Dysfunction|erectile dysfunction
809948|NCT00210678|Dapoxetine|dapoxetine
809949|NCT00210678|Premature ejaculation|premature ejaculation
809950|NCT00210678|Ejaculation|ejaculation
809951|NCT00210678|Sexual dysfunction|sexual dysfunction
809952|NCT00210678|Orgasmic disorder|orgasmic disorder
809953|NCT00210665|Sarcoma|sarcoma
809954|NCT00210665|Soft tissue sarcoma|soft tissue sarcoma
809955|NCT00210665|Standard care|standard care
809956|NCT00210665|Trabectedin|trabectedin
809957|NCT00210665|Antitumor agent|antitumor agent
809958|NCT00210665|Safety|safety
809959|NCT00210652|Epilepsy|epilepsy
809960|NCT00210652|Refractory partial epilepsy|refractory partial epilepsy
809961|NCT00210652|seizure disorder|seizure disorder
809962|NCT00210652|antiepileptic drugs|antiepileptic drugs
809963|NCT00210639|Musculoskeletal Diseases|musculoskeletal diseases
809964|NCT00210639|Musculoskeletal Disorders|musculoskeletal disorders
809965|NCT00210639|Childhood Disease|childhood disease
809966|NCT00210639|Bone Diseases|bone diseases
809967|NCT00210639|Joint Diseases|joint diseases
809968|NCT00210639|Levofloxacin|levofloxacin
809969|NCT00210639|Quinolones|quinolones
809970|NCT00210639|Bacterial infections|bacterial infections
809971|NCT00210626|Anemia, erythropoetin, Epoetin alfa, erythropoetin recombinant, Critical care, critical illness, intensive care|anemia, erythropoetin, epoetin alfa, erythropoetin recombinant, critical care, critical illness, intensive care
809972|NCT00210613|dapoxetine|dapoxetine
809973|NCT00210613|premature ejaculation|premature ejaculation
809974|NCT00210613|sexual dysfunction|sexual dysfunction
809975|NCT00210613|orgasmic disorder|orgasmic disorder
809976|NCT00210613|sexual intercourse|sexual intercourse
809977|NCT00210613|ejaculation|ejaculation
809978|NCT00210600|Anemia|anemia
809979|NCT00210600|Hemoglobin level|hemoglobin level
809980|NCT00210587|Anemia|anemia
809981|NCT00210587|Neoplasms|neoplasms
809982|NCT00210587|hemoglobin level|hemoglobin level
809983|NCT00210574|childhood absence epilepsy|childhood absence epilepsy
809984|NCT00210574|epilepsy|epilepsy
809985|NCT00210574|seizures|seizures
809986|NCT00210574|absence seizures|absence seizures
809987|NCT00210561|Pain|pain
809988|NCT00210561|Acute Low Back Pain|acute low back pain
809989|NCT00210561|Back|back
809990|NCT00210561|Lower back|lower back
809991|NCT00210548|schizophrenia|schizophrenia
809992|NCT00210548|intramuscular injection|intramuscular injection
809993|NCT00210548|antipsychotic agents|antipsychotic agents
809994|NCT00210548|dementia praecox|dementia praecox
809995|NCT00210548|paliperidone palmitate|paliperidone palmitate
809996|NCT00210548|mental disorders|mental disorders
809997|NCT00210548|PANSS.|panss.
809998|NCT00210535|Topiramate|topiramate
809999|NCT00210535|Migraine|migraine
810000|NCT00210535|Migraine headache|migraine headache
810001|NCT00210535|Migraine prevention|migraine prevention
810002|NCT00210535|Pediatric|pediatric
810003|NCT00210522|RWJ-333369|rwj-333369
810004|NCT00210522|Anticonvulsants|anticonvulsants
810005|NCT00210522|Epilepsy|epilepsy
810006|NCT00210522|Refractory partial epilepsy|refractory partial epilepsy
810007|NCT00210522|Seizure disorder|seizure disorder
810008|NCT00210522|Antiepileptic drugs|antiepileptic drugs
810009|NCT00210509|aura|aura
810010|NCT00210509|Migraine|migraine
810011|NCT00210509|pain|pain
810012|NCT00210509|headache|headache
810013|NCT00210496|Migraine headache|migraine headache
810014|NCT00210496|Topiramate, Almotriptan malate|topiramate, almotriptan malate
810015|NCT00210483|pain|pain
810016|NCT00210483|Migraine|migraine
810017|NCT00210483|aura|aura
810018|NCT00210483|headache|headache
810019|NCT00210470|Head and Neck Cancer|head and neck cancer
810020|NCT00210470|Immunotherapy|immunotherapy
810021|NCT00210470|IRX-2|irx-2
810022|NCT00210470|Mouth Cancer|mouth cancer
810023|NCT00210470|Throat Cancer|throat cancer
810024|NCT00210418|Malnutrition|malnutrition
810025|NCT00210418|Infant nutrition|infant nutrition
810026|NCT00210418|Food, fortified|food, fortified
810027|NCT00210418|Growth|growth
810028|NCT00210418|Randomized controlled trials|randomized controlled trials
810029|NCT00210418|Evaluation studies|evaluation studies
810030|NCT00210418|Haiti|haiti
810031|NCT00210405|Anemia|anemia
810032|NCT00210405|Infant nutrition|infant nutrition
810033|NCT00210405|Dietary supplements|dietary supplements
810034|NCT00210405|Randomized controlled trials|randomized controlled trials
810035|NCT00210405|Evaluation studies|evaluation studies
810036|NCT00210405|Haiti|haiti
810038|NCT00210301|cognition|cognition
810039|NCT00210301|attention|attention
810040|NCT00210301|fatigue|fatigue
810041|NCT00210288|Healthy Volunteer|healthy volunteer
810042|NCT00210288|Shigella|shigella
810043|NCT00210288|Oral Vaccine|oral vaccine
810044|NCT00210288|Double Blind|double blind
810045|NCT00210288|Placebo|placebo
810046|NCT00210288|Immunogenicity|immunogenicity
810047|NCT00210288|Safety|safety
810050|NCT00210249|geriatric evaluation|geriatric evaluation
810051|NCT00210249|safety|safety
810052|NCT00210249|chemotherapy|chemotherapy
810053|NCT00210236|Breast neoplasms|breast neoplasms
810054|NCT00210236|Local recurrence|local recurrence
810055|NCT00210236|Survival|survival
810056|NCT00210236|Surgery|surgery
810057|NCT00210223|Radiofrequency|radiofrequency
810058|NCT00210223|Percutaneous technique|percutaneous technique
810059|NCT00210223|breast cancer|breast cancer
810060|NCT00210223|tolerance|tolerance
810061|NCT00210210|Post-operative-pain|post-operative-pain
810062|NCT00210210|Breast cancer|breast cancer
810063|NCT00210210|Morphine|morphine
810065|NCT00210197|Hypercoagulability|hypercoagulability
810066|NCT00210197|Plasma coagulation parameters|plasma coagulation parameters
810067|NCT00210197|Breast cancer|breast cancer
810068|NCT00210184|Chemotherapy|chemotherapy
810069|NCT00210184|gastric cancer|gastric cancer
810070|NCT00210184|geriatric evaluation|geriatric evaluation
810071|NCT00210184|efficacy|efficacy
810072|NCT00210184|safety|safety
810073|NCT00210171|Carcinoma|carcinoma
810074|NCT00210171|Stage IIIA Non Small Cell Lung|stage iiia non small cell lung
810075|NCT00210171|Stage IIIB Non-Small-Cell Lung|stage iiib non-small-cell lung
810076|NCT00210171|Concomitant chemo-radiotherapy|concomitant chemo-radiotherapy
810077|NCT00210171|Consolidation chemotherapy|consolidation chemotherapy
810078|NCT00210158|Current opioid treatment|current opioid treatment
810079|NCT00210158|Nitrous oxide|nitrous oxide
810080|NCT00210158|Chronic pain|chronic pain
810081|NCT00210158|Opioid therapy|opioid therapy
810082|NCT00210158|Postoperative hyperalgesia|postoperative hyperalgesia
810083|NCT00210158|Acute opioid tolerance|acute opioid tolerance
810084|NCT00210145|Aesthetic care,|aesthetic care,
810085|NCT00210145|Mastectomy,|mastectomy,
810086|NCT00210145|Breast cancer,|breast cancer,
810087|NCT00210145|Quality of life,|quality of life,
810088|NCT00210145|Body image,|body image,
810089|NCT00210145|Psychological adjustment|psychological adjustment
810090|NCT00210132|Thoracic surgery|thoracic surgery
810091|NCT00210132|postoperative pain|postoperative pain
810092|NCT00210132|ropivacaine|ropivacaine
810093|NCT00210132|inter pleural analgesia|inter pleural analgesia
810094|NCT00210119|Chronic myeloid leukemia|chronic myeloid leukemia
810095|NCT00210119|imatinib mesylate|imatinib mesylate
810096|NCT00210119|zoledronate|zoledronate
810097|NCT00210119|molecular response|molecular response
810098|NCT00210106|Radiofrequency ablation|radiofrequency ablation
810099|NCT00210106|Colorectal cancer|colorectal cancer
810100|NCT00210106|Liver metastases|liver metastases
810101|NCT00210041|Genital Neoplasms, Male|genital neoplasms, male
810102|NCT00210028|Breast Neoplasms|breast neoplasms
810103|NCT00210028|Zarnestra|zarnestra
810104|NCT00210028|Tamoxifen|tamoxifen
810105|NCT00210028|estrogen receptor|estrogen receptor
810106|NCT00210028|progesterone receptor|progesterone receptor
810107|NCT00210002|Neoplasms|neoplasms
810108|NCT00210002|Solid|solid
810109|NCT00210002|Anemia|anemia
810110|NCT00210002|darbepoetin alfa|darbepoetin alfa
810111|NCT00210002|ferric saccharose|ferric saccharose
810112|NCT00210002|Venofer®|venofer®
810113|NCT00210002|Aranesp®|aranesp®
810114|NCT00209989|Glioblastoma Multiforme|glioblastoma multiforme
810115|NCT00209989|Zarnestra|zarnestra
810116|NCT00209989|Radiation therapy|radiation therapy
810117|NCT00209963|Primary insomnia|primary insomnia
810118|NCT00209950|Primary insomnia|primary insomnia
810119|NCT00209937|Primary insomnia|primary insomnia
810120|NCT00209924|Primary insomnia|primary insomnia
810121|NCT00209911|atrial volume|atrial volume
810122|NCT00209911|ventricular volume|ventricular volume
810123|NCT00209911|atrial function|atrial function
810124|NCT00209911|ventricular function|ventricular function
810125|NCT00209911|magnetic resonance imaging|magnetic resonance imaging
810126|NCT00209911|cardioversion|cardioversion
810127|NCT00209911|natriuretic peptides|natriuretic peptides
810128|NCT00209898|Chronic hepatits C|chronic hepatits c
810129|NCT00209898|peginterferon|peginterferon
810130|NCT00209898|ribavirin|ribavirin
810131|NCT00209898|inmate|inmate
810132|NCT00209898|fast initiation procedure|fast initiation procedure
810133|NCT00209846|Primary insomnia|primary insomnia
810134|NCT00209820|low back pain|low back pain
810135|NCT00209820|randomized clinical trial|randomized clinical trial
810136|NCT00209820|Nordic walking|nordic walking
810137|NCT00209820|supervision|supervision
810138|NCT00209820|Advice to stay active|advice to stay active
810139|NCT00209807|major depression|major depression
810140|NCT00209807|pain|pain
810141|NCT00209807|escitalopram|escitalopram
810142|NCT00209807|reboxetine|reboxetine
810143|NCT00209807|visceral sensitivity|visceral sensitivity
810144|NCT00209807|somatic sensitivity|somatic sensitivity
810145|NCT00209768|pediatric intensive care|pediatric intensive care
810146|NCT00209768|critically ill children|critically ill children
810147|NCT00209768|in-line filtration|in-line filtration
810148|NCT00209768|prospective randomized study|prospective randomized study
810149|NCT00209768|complications|complications
810150|NCT00209768|sepsis|sepsis
810153|NCT00209768|organ failure|organ failure
810154|NCT00209755|chronic hepatitis C|chronic hepatitis c
810155|NCT00209742|Colorectal Cancer,UFT,LV,Krestin,adjuvant therapy,phase III|colorectal cancer,uft,lv,krestin,adjuvant therapy,phase iii
810156|NCT00209729|Docetaxel|docetaxel
810158|NCT00209729|Elderly Patients|elderly patients
810159|NCT00209729|Gastric cancer|gastric cancer
810160|NCT00209664|Irinotecan, S-1, Phase II, gastric cancer|irinotecan, s-1, phase ii, gastric cancer
810161|NCT00209651|Irinotecan, S-1, Phase II, colorectal cancer,|irinotecan, s-1, phase ii, colorectal cancer,
810162|NCT00209638|Irinotecan,|irinotecan,
810163|NCT00209638|S-1,|s-1,
810164|NCT00209638|Phase I/II,|phase i/ii,
810165|NCT00209638|gastric cancer|gastric cancer
810166|NCT00209625|Irinotecan, leucovorin, fluorouracil, PhaseI/II, colorectal cancer,|irinotecan, leucovorin, fluorouracil, phasei/ii, colorectal cancer,
810167|NCT00209599|Colonoscopy|colonoscopy
810168|NCT00209599|Seadation|seadation
810169|NCT00209586|Bronchoscopy|bronchoscopy
810170|NCT00209586|Sedation|sedation
810171|NCT00209573|Colonoscopy|colonoscopy
810172|NCT00209573|Sedation|sedation
810173|NCT00209560|AQUAVAN® Injection|aquavan® injection
810174|NCT00209560|Midazolam|midazolam
810175|NCT00209560|Minor surgical procedures|minor surgical procedures
810176|NCT00209560|Sedation|sedation
810177|NCT00209547|AQUAVAN® Injection|aquavan® injection
810178|NCT00209547|Midazolam|midazolam
810179|NCT00209547|Angioplasty|angioplasty
810180|NCT00209547|Coronary catheterization|coronary catheterization
810181|NCT00209521|Coronary Artery Bypass Surgery|coronary artery bypass surgery
810182|NCT00209521|AQUAVAN® Injection|aquavan® injection
810183|NCT00209521|DISOPRIVAN® Injectable Emulsion.|disoprivan® injectable emulsion.
810184|NCT00209521|ischemic coronary artery disease|ischemic coronary artery disease
810185|NCT00209508|Parkinson's Disease|parkinson's disease
810186|NCT00209508|SPECT Scanning|spect scanning
810187|NCT00209495|Abdominal hysterectomy|abdominal hysterectomy
810188|NCT00209495|Pregabalin|pregabalin
810189|NCT00209495|Dexamethasone|dexamethasone
810190|NCT00209495|Multimodal postoperative analgesia|multimodal postoperative analgesia
810191|NCT00209456|Lewy Body Dementia|lewy body dementia
810192|NCT00209456|non-DLB dementia|non-dlb dementia
810193|NCT00209456|Dopamine Transporter|dopamine transporter
810194|NCT00209456|Striatal Uptake|striatal uptake
810195|NCT00209443|Aorto-iliac Stenosis|aorto-iliac stenosis
810196|NCT00209443|Occlusion|occlusion
810197|NCT00209443|Diagnostic Imaging|diagnostic imaging
810198|NCT00209443|Omniscan|omniscan
810199|NCT00209443|Magnetic Resonance Angiography|magnetic resonance angiography
810200|NCT00209443|Contrast Media|contrast media
810201|NCT00209430|Iodixanol|iodixanol
810202|NCT00209430|Iopamidol|iopamidol
810203|NCT00209430|coronary angiography|coronary angiography
810204|NCT00209430|Contrast media-induced nephropathy|contrast media-induced nephropathy
810205|NCT00209417|Iodixanol|iodixanol
810206|NCT00209417|Iopamidol|iopamidol
810207|NCT00209417|computed tomography|computed tomography
810208|NCT00209417|Patients with pre-existing renal impairment and diabetes|patients with pre-existing renal impairment and diabetes
810209|NCT00209404|MDCT|mdct
810210|NCT00209404|Coronary Artery|coronary artery
810211|NCT00209404|Heart Rate|heart rate
810212|NCT00209404|Image Quality|image quality
810213|NCT00209404|Diagnostic Quality|diagnostic quality
810214|NCT00209391|Renal Artery Stenosis|renal artery stenosis
810215|NCT00209391|Occlusion|occlusion
810216|NCT00209391|Diagnostic Imaging|diagnostic imaging
810217|NCT00209391|Omniscan|omniscan
810218|NCT00209391|Magnetic Resonance Angiography|magnetic resonance angiography
810219|NCT00209391|Contrast Media|contrast media
810220|NCT00209378|Continuous venovenous hemofiltration (CVVH)|continuous venovenous hemofiltration (cvvh)
810221|NCT00209378|Continuous renal replacement therapy (CRRT)|continuous renal replacement therapy (crrt)
810222|NCT00209378|Acute Kidney Injury|acute kidney injury
810223|NCT00209378|Regional citrate anticoagulation|regional citrate anticoagulation
810224|NCT00209378|filter survival|filter survival
810225|NCT00209378|trisodium citrate|trisodium citrate
810226|NCT00209378|bleeding complication|bleeding complication
810227|NCT00209378|Hemofiltration|hemofiltration
810228|NCT00209352|Varicella Zoster Virus Infection|varicella zoster virus infection
810229|NCT00209352|VZV infection|vzv infection
810230|NCT00209352|Oral Acyclovir|oral acyclovir
810231|NCT00209352|Allogeneic Bone Marrow Transplantation|allogeneic bone marrow transplantation
810232|NCT00209352|Allogeneic Hematopoietic Cell Transplantation|allogeneic hematopoietic cell transplantation
810233|NCT00209339|Mitral Valve Insufficiency|mitral valve insufficiency
810234|NCT00209339|Mitral Valve Regurgitation|mitral valve regurgitation
810235|NCT00209339|Mitral Valve Incompetence|mitral valve incompetence
810236|NCT00209339|Mitral Regurgitation|mitral regurgitation
810237|NCT00209339|Mitral Insufficiency|mitral insufficiency
810238|NCT00209339|Mitral Valve|mitral valve
810239|NCT00209339|MR|mr
810240|NCT00209339|Mitral Valve Prolapse|mitral valve prolapse
810241|NCT00209339|E2E - Edge to Edge|e2e - edge to edge
810242|NCT00209339|Alfieri Technique|alfieri technique
810243|NCT00209339|MitraClip|mitraclip
810244|NCT00209339|Functional MR|functional mr
810245|NCT00209339|Degenerative MR|degenerative mr
810246|NCT00209339|Echocardiogram|echocardiogram
810247|NCT00209339|CAD - Coronary Artery Disease|cad - coronary artery disease
810248|NCT00209339|Heart Failure|heart failure
810249|NCT00209339|Heart Attack|heart attack
810250|NCT00209339|EVEREST|everest
810251|NCT00209339|EVEREST I|everest i
810252|NCT00209339|EVEREST II|everest ii
810253|NCT00209313|HIV-1|hiv-1
810254|NCT00209313|HSV-2|hsv-2
810255|NCT00209313|Coinfection|coinfection
810256|NCT00209313|Africa|africa
810257|NCT00209313|Cameroon|cameroon
810258|NCT00209300|Ulcerative Colitis for Maintenance of Remission|ulcerative colitis for maintenance of remission
810259|NCT00209287|Ulcerative Colitis for Maintenance of Remission|ulcerative colitis for maintenance of remission
810260|NCT00209274|Mitral Valve Insufficiency|mitral valve insufficiency
810261|NCT00209274|Mitral Valve Regurgitation|mitral valve regurgitation
810262|NCT00209274|Mitral Valve Incompetence|mitral valve incompetence
810263|NCT00209274|Mitral Regurgitation|mitral regurgitation
810264|NCT00209274|Mitral Insufficiency|mitral insufficiency
810265|NCT00209274|Mitral Valve|mitral valve
810266|NCT00209274|MR|mr
810267|NCT00209274|Mitral Valve Prolapse|mitral valve prolapse
810268|NCT00209274|Edge to Edge (E2E)|edge to edge (e2e)
810269|NCT00209274|Alfieri Technique|alfieri technique
810270|NCT00209274|MitraClip|mitraclip
810271|NCT00209274|Functional MR|functional mr
810272|NCT00209274|Degenerative MR|degenerative mr
810273|NCT00209274|Echocardiogram|echocardiogram
810274|NCT00209274|CAD - Coronary Artery Disease|cad - coronary artery disease
810275|NCT00209274|Heart Failure|heart failure
810276|NCT00209274|Heart Attack|heart attack
810277|NCT00209274|EVEREST|everest
810278|NCT00209274|EVEREST I|everest i
810279|NCT00209274|EVEREST II|everest ii
810280|NCT00209274|REALISM|realism
810281|NCT00209235|Pseudohypoparathyroidism Type 1A (PHP 1A)|pseudohypoparathyroidism type 1a (php 1a)
810282|NCT00209235|Albright Hereditary Osteodystrophy|albright hereditary osteodystrophy
810283|NCT00209235|Growth Hormone Deficiency|growth hormone deficiency
810284|NCT00209222|Lymphoma, Mantle-Cell|lymphoma, mantle-cell
810285|NCT00209222|younger patients|younger patients
810286|NCT00209222|chemotherapy|chemotherapy
810287|NCT00209222|high dose therapy|high dose therapy
810288|NCT00209222|C04.557.386.480.300.725.500|c04.557.386.480.300.725.500
810289|NCT00209222|C15.604.515.569.480.300.725.500|c15.604.515.569.480.300.725.500
810290|NCT00209222|C20.683.515.761.480.300.725.500|c20.683.515.761.480.300.725.500
810291|NCT00209209|Lymphoma, Mantle-Cell|lymphoma, mantle-cell
810292|NCT00209209|Elderly patients|elderly patients
810293|NCT00209209|Chemotherapy|chemotherapy
810294|NCT00209209|Maintenance therapy|maintenance therapy
810295|NCT00209209|C04.557.386.480.300.725.500|c04.557.386.480.300.725.500
810296|NCT00209209|C15.604.515.569.480.300.725.500|c15.604.515.569.480.300.725.500
810297|NCT00209209|C20.683.515.761.480.300.725.500|c20.683.515.761.480.300.725.500
810298|NCT00209196|pediatric|pediatric
810299|NCT00209196|transplantation|transplantation
810300|NCT00209196|psychosocial|psychosocial
810301|NCT00209196|kidney transplant recipient|kidney transplant recipient
810302|NCT00209196|liver transplant recipient|liver transplant recipient
810303|NCT00209196|heart transplant recipient|heart transplant recipient
810304|NCT00209196|lung transplant recipient|lung transplant recipient
810305|NCT00209196|heart-lung transplant recipient|heart-lung transplant recipient
810306|NCT00209144|Inflammation|inflammation
810307|NCT00209144|Thrombosis|thrombosis
810308|NCT00209144|Hyperglycemia|hyperglycemia
810309|NCT00209144|Myocardial Infarction|myocardial infarction
810310|NCT00209144|Angioplasty|angioplasty
810311|NCT00209131|urolithiasis|urolithiasis
810312|NCT00209118|Hepatitis C|hepatitis c
810313|NCT00209118|Interferon-alpha associated side effects|interferon-alpha associated side effects
810314|NCT00209118|Antidepressants|antidepressants
810315|NCT00209118|Prevention|prevention
810316|NCT00209105|Child Abuse|child abuse
810317|NCT00209105|Hypothalamic-Pituitary-Adrenal Axis|hypothalamic-pituitary-adrenal axis
810318|NCT00209105|Brain Imaging|brain imaging
810319|NCT00209105|Depression|depression
810320|NCT00209092|Breast Cancer|breast cancer
810321|NCT00209079|Gastric Adenocarcinoma|gastric adenocarcinoma
810322|NCT00209066|Major Depressive Disorder|major depressive disorder
810323|NCT00209066|Electroconvulsive Therapy|electroconvulsive therapy
810324|NCT00209066|Platelet Activation|platelet activation
810325|NCT00209040|PTSD|ptsd
810326|NCT00209040|Acoustic startle|acoustic startle
810327|NCT00209027|schizophrenia|schizophrenia
810328|NCT00209027|reward|reward
810329|NCT00209027|fMRI|fmri
810330|NCT00209014|B-Cell Lymphoma|b-cell lymphoma
810331|NCT00209014|Hodgkin's Disease|hodgkin's disease
810332|NCT00209001|Breast Cancer|breast cancer
810333|NCT00208988|Health literacy|health literacy
810334|NCT00208988|Physician-Patient Relationship|physician-patient relationship
810335|NCT00208988|Prostate Cancer|prostate cancer
810336|NCT00208975|Lymphoma|lymphoma
810337|NCT00208962|Hematologic Diseases|hematologic diseases
810338|NCT00208949|Hematologic Diseases|hematologic diseases
810339|NCT00208936|Esophageal Diseases|esophageal diseases
810340|NCT00208923|Hematologic Malignancies|hematologic malignancies
810341|NCT00208910|Anxiety|anxiety
810342|NCT00208910|Mental Health|mental health
810343|NCT00208897|Early Life Stress|early life stress
810344|NCT00208897|HPA-axis|hpa-axis
810345|NCT00208897|CRF|crf
810346|NCT00208884|pediatric|pediatric
810347|NCT00208884|orthotopic heart transplantation|orthotopic heart transplantation
810348|NCT00208884|graft failure|graft failure
810349|NCT00208871|Stereoscopic digital mammography|stereoscopic digital mammography
810350|NCT00208871|Breast cancer detection|breast cancer detection
810351|NCT00208871|Reduced rate of recall|reduced rate of recall
810352|NCT00208871|Focal abnormalities detection|focal abnormalities detection
810353|NCT00208832|Medication Compliance|medication compliance
810354|NCT00208832|Health Literacy|health literacy
810355|NCT00208819|Alzheimer's Disease|alzheimer's disease
810356|NCT00208819|Geriatric|geriatric
810357|NCT00208819|Dementia|dementia
810358|NCT00208819|Agitation|agitation
810359|NCT00208819|Behavioral Disturbances|behavioral disturbances
810360|NCT00208819|Psychosis|psychosis
810361|NCT00208806|Dilated Cardiomyopathy|dilated cardiomyopathy
810362|NCT00208806|Pediatric|pediatric
810363|NCT00208806|Bi-ventricular Pacemaker|bi-ventricular pacemaker
810364|NCT00208793|colonic polyps|colonic polyps
810365|NCT00208793|adenomatous polyps|adenomatous polyps
810366|NCT00208793|colon cancer prevention|colon cancer prevention
810367|NCT00208793|dietary supplements|dietary supplements
810368|NCT00208780|Oxidative Stress|oxidative stress
810369|NCT00208780|Endothelium|endothelium
810370|NCT00208767|Angiotensin receptor blockade|angiotensin receptor blockade
810371|NCT00208767|Oxidative stress|oxidative stress
810372|NCT00208767|Endothelial dysfunction|endothelial dysfunction
810373|NCT00208754|heart defects|heart defects
810374|NCT00208754|cardiology|cardiology
810375|NCT00208754|adults who have congenital heart defects|adults who have congenital heart defects
810376|NCT00208741|Social Anxiety Disorder|social anxiety disorder
810377|NCT00208741|Mental Health|mental health
810378|NCT00208728|pediatric|pediatric
810379|NCT00208728|congenital heart disease|congenital heart disease
810380|NCT00208728|cardiac surgery|cardiac surgery
810381|NCT00208715|Depression|depression
810382|NCT00208702|Major Depressive Disorder|major depressive disorder
810383|NCT00208702|Mental Health|mental health
810384|NCT00208702|Depression|depression
810385|NCT00208689|pediatric|pediatric
810386|NCT00208689|congenital heart disease|congenital heart disease
810387|NCT00208676|heart defects|heart defects
810388|NCT00208676|pediatrics|pediatrics
810389|NCT00208650|pediatrics|pediatrics
810390|NCT00208650|transplant|transplant
810391|NCT00208650|cardiac|cardiac
810392|NCT00208637|Maori|maori
810393|NCT00208637|insulin sensitivity|insulin sensitivity
810394|NCT00208637|cardiovascular risk|cardiovascular risk
810395|NCT00208637|diabetes prevention|diabetes prevention
810396|NCT00208637|diet modification|diet modification
810397|NCT00208624|arrhythmia|arrhythmia
810398|NCT00208624|pediatrics|pediatrics
810399|NCT00208624|cardiac|cardiac
810400|NCT00208598|Maori|maori
810401|NCT00208598|Body Composition|body composition
810402|NCT00208598|DEXA|dexa
810403|NCT00208598|Cardiovascular disease|cardiovascular disease
810404|NCT00208598|Diabetes|diabetes
810405|NCT00208572|Traumatic Brain Injury; Anxiety Disorders; SRI Treatment|traumatic brain injury; anxiety disorders; sri treatment
810406|NCT00208559|Autism|autism
810407|NCT00208559|Pervasive Developmental Disorder|pervasive developmental disorder
810408|NCT00208559|Ziprasidone|ziprasidone
810409|NCT00208559|Adolescents|adolescents
810410|NCT00208546|capecitabine|capecitabine
810411|NCT00208546|oxaliplatin|oxaliplatin
810412|NCT00208546|bevacizumab|bevacizumab
810413|NCT00208546|cetuximab|cetuximab
810414|NCT00208546|advanced colorectal cancer|advanced colorectal cancer
810415|NCT00208533|Autism|autism
810416|NCT00208533|Pervasive developmental disorder|pervasive developmental disorder
810417|NCT00208533|Aripiprazole|aripiprazole
810418|NCT00208533|Antipsychotic medication|antipsychotic medication
810419|NCT00208533|Adolescents|adolescents
810420|NCT00208520|Epilepsy|epilepsy
810421|NCT00208520|Valproate|valproate
810422|NCT00208520|Levetiracetam|levetiracetam
810423|NCT00208520|Lamotrigine|lamotrigine
810424|NCT00208520|Carbamazepine|carbamazepine
810425|NCT00208507|Joint Diseases|joint diseases
810426|NCT00208507|Non-Inflammatory Degenerative Joint Disease|non-inflammatory degenerative joint disease
810427|NCT00208494|Non-Inflammatory Degenerative Joint Disease|non-inflammatory degenerative joint disease
810428|NCT00208468|Hip|hip
810429|NCT00208468|Cementless|cementless
810430|NCT00208455|Arthroplasty|arthroplasty
810431|NCT00208455|Replacement|replacement
810432|NCT00208455|Hip|hip
810433|NCT00208455|Conservative|conservative
810434|NCT00208455|Anatomic|anatomic
810435|NCT00208455|Cementless|cementless
810436|NCT00208442|Hip|hip
810437|NCT00208442|Cemented|cemented
810438|NCT00208429|Hip|hip
810439|NCT00208429|Cementless|cementless
810440|NCT00208416|Hip|hip
810441|NCT00208416|Surgical Technique|surgical technique
810442|NCT00208403|Hip|hip
810443|NCT00208403|Cement|cement
810444|NCT00208390|Hip|hip
810445|NCT00208390|Cementless|cementless
810447|NCT00208377|Conservative|conservative
810448|NCT00208377|Metal-on-Metal|metal-on-metal
810449|NCT00208377|Resurfacing|resurfacing
810450|NCT00208364|Hip|hip
810451|NCT00208364|Cementless|cementless
810452|NCT00208364|Metal-on-Metal|metal-on-metal
810453|NCT00208351|Hip|hip
810454|NCT00208351|Cemented|cemented
810455|NCT00208338|Rotator cuff tear repair|rotator cuff tear repair
810456|NCT00208312|Lexiscan|lexiscan
810457|NCT00208312|Regadenoson|regadenoson
810458|NCT00208312|Adenoscan®|adenoscan®
810459|NCT00208312|Adenosine|adenosine
810659|NCT00207402|Hepatitis C|hepatitis c
810460|NCT00208312|SPECT Myocardial Perfusion Imaging|spect myocardial perfusion imaging
810461|NCT00208312|Reversible Perfusion Defect|reversible perfusion defect
810462|NCT00208299|Lexiscan|lexiscan
810463|NCT00208299|Regadenoson|regadenoson
810464|NCT00208299|Adenoscan®|adenoscan®
810465|NCT00208299|Adenosine|adenosine
810466|NCT00208299|SPECT Myocardial Perfusion Imaging|spect myocardial perfusion imaging
810467|NCT00208299|Reversible Perfusion Defect|reversible perfusion defect
810468|NCT00208273|Postmenopausal breast cancer, radiohormonotherapy sequences|postmenopausal breast cancer, radiohormonotherapy sequences
810469|NCT00208273|ER+ and/or PgR+,|er+ and/or pgr+,
810470|NCT00208273|Postmenopausal Breast cancer,|postmenopausal breast cancer,
810471|NCT00208273|Adjuvant setting|adjuvant setting
810472|NCT00208234|asthma|asthma
810473|NCT00208221|Hypertension|hypertension
810474|NCT00208221|Diabetes|diabetes
810475|NCT00208221|Microalbuminuria|microalbuminuria
810476|NCT00208221|Blood pressure|blood pressure
810477|NCT00208208|Posttraumatic Stress Disorder|posttraumatic stress disorder
810478|NCT00208208|Post-traumatic Stress Disorder|post-traumatic stress disorder
810479|NCT00208208|PTSD|ptsd
810480|NCT00208208|Geodon|geodon
810481|NCT00208208|Ziprasidone|ziprasidone
810482|NCT00208195|Bipolar Disorder|bipolar disorder
810483|NCT00208195|Mania|mania
810484|NCT00208195|Substance Abuse|substance abuse
810485|NCT00208195|Substance Dependence|substance dependence
810486|NCT00208195|Comorbid|comorbid
810487|NCT00208169|Comorbid substance abuse/dependence|comorbid substance abuse/dependence
810488|NCT00208169|Comorbid diagnoses|comorbid diagnoses
810489|NCT00208169|Substance abuse and/or dependence|substance abuse and/or dependence
810490|NCT00208156|Depression|depression
810491|NCT00208156|Major Depression|major depression
810492|NCT00208156|Psychotic Major Depression|psychotic major depression
810493|NCT00208156|PMD|pmd
810494|NCT00208156|Psychosis|psychosis
810495|NCT00208143|Cocaine Abuse|cocaine abuse
810496|NCT00208143|Cocaine Dependence|cocaine dependence
810497|NCT00208143|Amphetamine Abuse|amphetamine abuse
810498|NCT00208143|Amphetamine Dependence|amphetamine dependence
810499|NCT00208143|Schizophrenia|schizophrenia
810500|NCT00208143|Comorbid|comorbid
810501|NCT00208143|Schizoaffective Disorder|schizoaffective disorder
810502|NCT00208130|PTSD|ptsd
810503|NCT00208130|trauma|trauma
810504|NCT00208117|depression|depression
810505|NCT00208117|inflammation|inflammation
810506|NCT00208117|heart disease|heart disease
810507|NCT00208117|randomized clinical trial|randomized clinical trial
810508|NCT00208117|sertraline|sertraline
810509|NCT00208117|simvastatin|simvastatin
810510|NCT00208117|placebo|placebo
810511|NCT00208104|Hypertension|hypertension
810512|NCT00208104|African Americans|african americans
810513|NCT00208104|Adherence|adherence
810514|NCT00208104|Motivational Interviewing|motivational interviewing
810515|NCT00208091|Myloboc|myloboc
810516|NCT00208091|Botulinum Toxin Type B|botulinum toxin type b
810517|NCT00208091|Focal Dystonia|focal dystonia
810518|NCT00208091|Musicians|musicians
810519|NCT00208091|Muscle Relaxants|muscle relaxants
810520|NCT00208091|Motor Impairments|motor impairments
810521|NCT00208091|Motor Performance|motor performance
810522|NCT00208091|Tremor|tremor
810523|NCT00208091|Abnormal Postures|abnormal postures
810524|NCT00208078|Hypercapnia|hypercapnia
810525|NCT00208078|Non-Invasive Ventilation|non-invasive ventilation
810526|NCT00208065|migraine|migraine
810527|NCT00208065|biological markers|biological markers
810528|NCT00208065|rhinosinusitis|rhinosinusitis
810529|NCT00208065|CGRP|cgrp
810530|NCT00208065|histamine|histamine
810531|NCT00208065|VIP|vip
810532|NCT00208039|Prematurity|prematurity
810533|NCT00208039|Lung Disease|lung disease
810534|NCT00208039|Hyaline Membrane|hyaline membrane
810535|NCT00208039|Surfactant|surfactant
810536|NCT00208013|resting energy expenditure|resting energy expenditure
810537|NCT00208013|cachexia|cachexia
810538|NCT00208013|advanced cancer|advanced cancer
810539|NCT00208013|advanced cancer patients|advanced cancer patients
810540|NCT00207987|controlled hypotension|controlled hypotension
810541|NCT00207974|Hyperuricemia, Anserine, Pharmacokinetic|hyperuricemia, anserine, pharmacokinetic
810542|NCT00207948|Human Immunodeficiency Virus|human immunodeficiency virus
810543|NCT00207948|Protease Inhibitors|protease inhibitors
810544|NCT00207948|Pharmacogenetics|pharmacogenetics
810545|NCT00207948|Genes, MDR1, Cytochrome P-450 enzymes|genes, mdr1, cytochrome p-450 enzymes
810546|NCT00207948|Pharmacokinetics|pharmacokinetics
810548|NCT00207948|Treatment Experienced|treatment experienced
810549|NCT00207935|Seizures|seizures
810550|NCT00207935|Depakote|depakote
810551|NCT00207935|Developmental Delay|developmental delay
810552|NCT00207935|Mental Retardation|mental retardation
810553|NCT00207935|Swallow|swallow
810554|NCT00207922|cytokine|cytokine
810555|NCT00207922|T-cell|t-cell
810556|NCT00207922|chemokine|chemokine
810557|NCT00207922|graft-versus-host disease|graft-versus-host disease
810558|NCT00207909|Acute Renal Failure|acute renal failure
810559|NCT00207909|Contiuous Veno Venous Hemofiltration|contiuous veno venous hemofiltration
810560|NCT00207896|Pediatric Intensive Care|pediatric intensive care
810561|NCT00207896|Neuroendocrine Dysfunction|neuroendocrine dysfunction
810562|NCT00207883|Vascular Access|vascular access
810563|NCT00207883|Ultrasound|ultrasound
810564|NCT00207883|Pediatric|pediatric
810565|NCT00207883|Pediatric intensive care patient|pediatric intensive care patient
810566|NCT00207870|Type II Supracondylar Fracture|type ii supracondylar fracture
810567|NCT00207870|Orthopaedics|orthopaedics
810568|NCT00207857|Duchenne's Muscular Dystrophy|duchenne's muscular dystrophy
810569|NCT00207857|Scoliosis|scoliosis
810570|NCT00207844|Selenium|selenium
810571|NCT00207844|Oxidative stress|oxidative stress
810572|NCT00207844|Septic shock|septic shock
810573|NCT00207844|Sodium selenite|sodium selenite
810574|NCT00207831|rectal cancer|rectal cancer
810575|NCT00207831|neoadjuvant therapy|neoadjuvant therapy
810576|NCT00207831|UFT|uft
810577|NCT00207831|radiochemotherapy|radiochemotherapy
810578|NCT00207818|tissue engineered wound dressing; autologous skin substitute; biological dressing; wound care|tissue engineered wound dressing; autologous skin substitute; biological dressing; wound care
810579|NCT00207792|Granulocyte colony stimulating factor|granulocyte colony stimulating factor
810580|NCT00207779|central venous catheter|central venous catheter
810581|NCT00207779|catheter related bloodstream infection|catheter related bloodstream infection
810582|NCT00207779|heparin|heparin
810583|NCT00207766|Crohn's Disease|crohn's disease
810584|NCT00207766|infusions|infusions
810585|NCT00207753|ascaris|ascaris
810586|NCT00207753|trichuris|trichuris
810587|NCT00207753|strongyloides|strongyloides
810588|NCT00207753|hookworm|hookworm
810589|NCT00207753|head lice|head lice
810590|NCT00207740|Asthma|asthma
810591|NCT00207740|Severe Persistent Asthma|severe persistent asthma
810592|NCT00207740|Subcutaneous injections|subcutaneous injections
810593|NCT00207740|Immunology disorder|immunology disorder
810594|NCT00207740|Breathlesness|breathlesness
810595|NCT00207727|Multiple Sclerosis|multiple sclerosis
810596|NCT00207714|Rheumatoid Arthritis|rheumatoid arthritis
810597|NCT00207714|CNTO 148|cnto 148
810598|NCT00207714|Methotrexate|methotrexate
810599|NCT00207714|Joint pain|joint pain
810600|NCT00207714|Arthritis|arthritis
810601|NCT00207701|Ankylosing Spondylitis|ankylosing spondylitis
810602|NCT00207701|infusion|infusion
810603|NCT00207688|Ulcerative Colitis|ulcerative colitis
810604|NCT00207688|Infliximab|infliximab
810605|NCT00207688|Remicade|remicade
810606|NCT00207688|Safety|safety
810607|NCT00207675|Crohn's Disease|crohn's disease
810608|NCT00207675|pediatric Crohn's Disease|pediatric crohn's disease
810609|NCT00207662|Crohn's Disease|crohn's disease
810610|NCT00207649|shared decision-making|shared decision-making
810611|NCT00207649|prostate cancer screening|prostate cancer screening
810612|NCT00207649|evidence-based medicine|evidence-based medicine
810613|NCT00207649|computer-assisted learning tools|computer-assisted learning tools
810614|NCT00207649|standardized patients|standardized patients
810615|NCT00207649|randomized controlled trial|randomized controlled trial
810616|NCT00207649|educational intervention|educational intervention
810617|NCT00207649|patient education|patient education
810618|NCT00207649|physician education|physician education
810619|NCT00207636|Computer-Assisted Decision Making|computer-assisted decision making
810620|NCT00207636|Workplace|workplace
810621|NCT00207636|Screening|screening
810622|NCT00207623|arthritis|arthritis
810623|NCT00207623|self management|self management
810624|NCT00207623|patient education|patient education
810625|NCT00207610|Anemia|anemia
810626|NCT00207610|Postpartum|postpartum
810627|NCT00207610|iron|iron
810628|NCT00207610|supplements|supplements
810629|NCT00207571|computer|computer
810630|NCT00207571|video|video
810631|NCT00207571|partner notification|partner notification
810632|NCT00207519|overweight|overweight
810633|NCT00207519|obesity|obesity
810634|NCT00207519|adolescent|adolescent
810635|NCT00207506|Latino|latino
810636|NCT00207506|Lay Health|lay health
810637|NCT00207506|Access|access
810638|NCT00207506|Prevention|prevention
810639|NCT00207506|HIV Seronegativity|hiv seronegativity
810640|NCT00207506|HIV|hiv
810641|NCT00207493|sexually transmitted disease|sexually transmitted disease
810642|NCT00207493|structural intervention|structural intervention
810643|NCT00207493|behavioral intervention|behavioral intervention
810644|NCT00207467|patient-delivered partner treatment|patient-delivered partner treatment
810645|NCT00207467|partner referral|partner referral
810646|NCT00207467|sexually transmitted diseases|sexually transmitted diseases
810647|NCT00207454|Partner Referral|partner referral
810648|NCT00207454|Social Cognitive Intervention|social cognitive intervention
810649|NCT00207454|Partner Delivered Medication|partner delivered medication
810650|NCT00207441|arthritis|arthritis
810651|NCT00207441|chronic disease|chronic disease
810652|NCT00207441|self management|self management
810653|NCT00207441|self efficacy|self efficacy
810654|NCT00207428|Bronchial asthma|bronchial asthma
810655|NCT00207428|Carbamazepine|carbamazepine
810656|NCT00207428|Efficacy|efficacy
810657|NCT00207415|arthritis|arthritis
810658|NCT00207415|self management|self management
810660|NCT00207402|Insulin resistance|insulin resistance
810661|NCT00207389|Incretins:GIP , GLP-1|incretins:gip , glp-1
810662|NCT00207389|Gastric bypass surgery|gastric bypass surgery
810663|NCT00207389|Laparoscopic gastric bypass surgery|laparoscopic gastric bypass surgery
810664|NCT00207389|Postprandial expression of GIP|postprandial expression of gip
810665|NCT00207363|Hepatitis C|hepatitis c
810666|NCT00207350|Brain Tumor|brain tumor
810667|NCT00207337|COPD (Chronic Obstructive Pulmonary Disease)|copd (chronic obstructive pulmonary disease)
810668|NCT00207337|Emphysema|emphysema
810669|NCT00207337|Minimally invasive|minimally invasive
810670|NCT00207311|Hepatitis C|hepatitis c
810671|NCT00207311|Fatty Liver|fatty liver
810672|NCT00207311|NASH|nash
810673|NCT00207311|Steatohepatitis|steatohepatitis
810674|NCT00207285|Police|police
810675|NCT00207285|Sleep|sleep
810676|NCT00207285|Fatigue|fatigue
810677|NCT00207285|Work Hours|work hours
810678|NCT00207285|Sleep disorder|sleep disorder
810679|NCT00207285|Performance|performance
810680|NCT00207272|Hypocaloric MCT oil liquid diet|hypocaloric mct oil liquid diet
810681|NCT00207272|Hypocaloric LCT oil liquid diet|hypocaloric lct oil liquid diet
810682|NCT00207272|Visceral and omental adipose tissue|visceral and omental adipose tissue
810683|NCT00207272|Subcutaneous abdominal adipose tissue|subcutaneous abdominal adipose tissue
810684|NCT00207272|Gastric bypass surgery|gastric bypass surgery
810685|NCT00207259|Prostate Cancer|prostate cancer
810686|NCT00207259|Reiki|reiki
810687|NCT00207259|Relaxation Response|relaxation response
810688|NCT00207259|Cognitive Restructuring|cognitive restructuring
810689|NCT00207259|Feasibility|feasibility
810690|NCT00207233|Weight loss|weight loss
810691|NCT00207233|MCT oil hypocaloric liquid diet|mct oil hypocaloric liquid diet
810692|NCT00207233|LCT oil hypocaloric liquid diet|lct oil hypocaloric liquid diet
810693|NCT00207233|Gastric Bypass|gastric bypass
810694|NCT00207220|heart failure|heart failure
810695|NCT00207220|preserved ejection fraction|preserved ejection fraction
810696|NCT00207220|vascular stiffness|vascular stiffness
810697|NCT00207207|Alternate Site|alternate site
810698|NCT00207207|Blood Glucose Testing|blood glucose testing
810699|NCT00207207|Blood Sugar Testing|blood sugar testing
810700|NCT00207207|Hemoglobin A1C|hemoglobin a1c
810701|NCT00207181|Cancer prevention|cancer prevention
810702|NCT00207181|Physical activity|physical activity
810703|NCT00207181|Self-report|self-report
810704|NCT00207181|Paper diary|paper diary
810705|NCT00207181|Electronic|electronic
810706|NCT00207181|Computerized|computerized
810707|NCT00207181|Measurement|measurement
810709|NCT00207181|Accelerometer|accelerometer
810710|NCT00207142|Treatment Naive|treatment naive
810711|NCT00207142|HIV-1 infected treatment naive patients|hiv-1 infected treatment naive patients
810712|NCT00207116|Metastatic Non Small Cell Lung Cancer|metastatic non small cell lung cancer
810713|NCT00207103|Advanced metastatic or solid tumors|advanced metastatic or solid tumors
810714|NCT00207077|Advanced Solid Tumors|advanced solid tumors
810715|NCT00207064|first-episode|first-episode
810716|NCT00207064|altanserin|altanserin
810717|NCT00207064|5-HT2A receptors|5-ht2a receptors
810718|NCT00207064|MRI|mri
810719|NCT00207064|fMRI|fmri
810720|NCT00207064|PPI|ppi
810721|NCT00207064|P300|p300
810722|NCT00207064|P50 gating|p50 gating
810723|NCT00207064|endophenotypes|endophenotypes
810724|NCT00207064|vulnerability indicators|vulnerability indicators
810725|NCT00207064|quetiapine|quetiapine
810726|NCT00207051|Advanced Gastrointestinal Malignancies|advanced gastrointestinal malignancies
810727|NCT00207038|Asthma|asthma
810728|NCT00207038|Airway inflammation|airway inflammation
810729|NCT00207038|Sport|sport
810730|NCT00207025|Patients with advanced solid tumors|patients with advanced solid tumors
810731|NCT00206999|Psychophysiology|psychophysiology
810732|NCT00206999|PPI|ppi
810733|NCT00206999|P50 suppression|p50 suppression
810734|NCT00206999|Imipramine|imipramine
810735|NCT00206986|Schizophrenia|schizophrenia
810736|NCT00206986|Information processing|information processing
810737|NCT00206986|PPI|ppi
810738|NCT00206986|P50 gating|p50 gating
810739|NCT00206986|P300|p300
810740|NCT00206986|mismatch negativity|mismatch negativity
810741|NCT00206986|clonidine|clonidine
810742|NCT00206960|drug-naive|drug-naive
810743|NCT00206960|epidepride|epidepride
810744|NCT00206960|single tomography|single tomography
810745|NCT00206960|D2 receptor|d2 receptor
810746|NCT00206960|information processing|information processing
810747|NCT00206960|PPI|ppi
810748|NCT00206960|antipsychotic treatment|antipsychotic treatment
810749|NCT00206960|MRI|mri
810751|NCT00206960|cognitive disturbances|cognitive disturbances
810752|NCT00206947|Cognitive deficits|cognitive deficits
810753|NCT00206947|Cholinergic Augmentation|cholinergic augmentation
810754|NCT00206947|Schizophrenia|schizophrenia
810755|NCT00206934|PPI|ppi
810756|NCT00206934|P50 suppression|p50 suppression
810757|NCT00206934|P300|p300
810758|NCT00206934|mismatch negativity|mismatch negativity
810759|NCT00206934|escitalopram|escitalopram
810760|NCT00206921|Telangiectasia|telangiectasia
810761|NCT00206921|Skin redness|skin redness
810762|NCT00206882|sunburn|sunburn
810763|NCT00206882|corticosteroids|corticosteroids
810764|NCT00206791|bone substitutes|bone substitutes
810765|NCT00206791|Bone Replacement Materials|bone replacement materials
810766|NCT00206791|bone void filler|bone void filler
810767|NCT00206791|Grafting, Bone|grafting, bone
810768|NCT00206791|Bone Cysts|bone cysts
810769|NCT00206778|Mixed mania|mixed mania
810770|NCT00206778|Bipolar Disorder|bipolar disorder
810771|NCT00206765|panic|panic
810772|NCT00206739|Malaria|malaria
810773|NCT00206739|Anemia|anemia
810774|NCT00206739|IPTi|ipti
810775|NCT00206739|Intermittent Preventive Treatment in Infants|intermittent preventive treatment in infants
810776|NCT00206739|Sulfadoxine-Pyrimethamine|sulfadoxine-pyrimethamine
810777|NCT00206739|Chemoprophylaxis|chemoprophylaxis
810778|NCT00206739|Ghana|ghana
810779|NCT00206713|Crohn Disease|crohn disease
810780|NCT00206674|Morbus Crohn|morbus crohn
810781|NCT00206674|Sargramostim|sargramostim
810782|NCT00206674|Phase III|phase iii
810783|NCT00206674|Placebo Controlled|placebo controlled
810784|NCT00206661|Crohn Disease|crohn disease
810785|NCT00206609|Cancer|cancer
810786|NCT00206609|palliative care|palliative care
810787|NCT00206609|dyspnoea|dyspnoea
810788|NCT00206609|oxygen|oxygen
810789|NCT00206570|Schizophrenia|schizophrenia
810790|NCT00206570|Gender differences|gender differences
810791|NCT00206570|Hormones|hormones
810792|NCT00206570|Estradiol|estradiol
810793|NCT00206570|PANSS|panss
810794|NCT00206557|Schizophrenia|schizophrenia
810795|NCT00206557|Mental Illness|mental illness
810796|NCT00206557|Hormone Therapy|hormone therapy
810797|NCT00206557|Post-menopausal|post-menopausal
810798|NCT00206557|SERM|serm
810799|NCT00206557|Raloxifene|raloxifene
810800|NCT00206544|Bipolar Affective Disorder|bipolar affective disorder
810801|NCT00206544|Mania|mania
810802|NCT00206544|Anti-Estrogen|anti-estrogen
810803|NCT00206544|Schizoaffective Disorder|schizoaffective disorder
810804|NCT00206544|Mood|mood
810805|NCT00206531|HIV-1|hiv-1
810806|NCT00206531|Naive T-cells|naive t-cells
810807|NCT00206531|CD31|cd31
810808|NCT00206531|Treatment Naive|treatment naive
810809|NCT00206518|Breast|breast
810810|NCT00206518|Cancer|cancer
810811|NCT00206518|Taxotere|taxotere
810812|NCT00206518|AC|ac
810813|NCT00206518|Validation|validation
810814|NCT00206518|Neoadjuvant|neoadjuvant
810815|NCT00206505|Breast|breast
810816|NCT00206505|Cancer|cancer
810817|NCT00206505|Neoadjuvant|neoadjuvant
810818|NCT00206505|Taxotere|taxotere
810819|NCT00206492|Breast|breast
810820|NCT00206492|Cancer|cancer
810821|NCT00206492|Neoadjuvant|neoadjuvant
810822|NCT00206492|HER2|her2
810823|NCT00206492|Overexpressing|overexpressing
810824|NCT00206466|neoadjuvant|neoadjuvant
810825|NCT00206466|chemosensitivity|chemosensitivity
810826|NCT00206466|chemotherapy|chemotherapy
810827|NCT00206466|breast cancer|breast cancer
810828|NCT00206466|tumor|tumor
810829|NCT00206466|taxotere|taxotere
810830|NCT00206466|AC|ac
810831|NCT00206453|Breast|breast
810832|NCT00206453|Cancer|cancer
810833|NCT00206453|Gene|gene
810834|NCT00206453|Expression|expression
810835|NCT00206453|Taxotere|taxotere
810836|NCT00206440|chemotherapy|chemotherapy
810837|NCT00206440|nausea|nausea
810838|NCT00206440|vomiting|vomiting
810839|NCT00206440|breast cancer|breast cancer
810840|NCT00206427|Advanced|advanced
810841|NCT00206427|Breast|breast
810842|NCT00206427|Cancer|cancer
810843|NCT00206427|Neoadjuvant|neoadjuvant
810844|NCT00206427|HER2|her2
810845|NCT00206414|HORMONE RECEPTOR POSITIVE BREAST CANCER|hormone receptor positive breast cancer
810846|NCT00206401|Adolescents|adolescents
810847|NCT00206401|Lantus|lantus
810848|NCT00206388|NEUROBLASTOMA|neuroblastoma
810849|NCT00206388|RECURRENT|recurrent
810850|NCT00206388|REFRACTORY|refractory
810851|NCT00206388|CORTICAL|cortical
810852|NCT00206388|BONE|bone
810853|NCT00206375|Hypothyroidism|hypothyroidism
810854|NCT00206375|Growth hormone|growth hormone
810855|NCT00206362|Depression|depression
810856|NCT00206362|Socioeconomic status|socioeconomic status
810857|NCT00206362|Type 1 diabetes mellitus|type 1 diabetes mellitus
810858|NCT00206362|Children|children
810859|NCT00206362|Adolescents|adolescents
810860|NCT00206349|Depression|depression
810861|NCT00206349|Socioeconomic status|socioeconomic status
810862|NCT00206349|Type 1 diabetes mellitus|type 1 diabetes mellitus
810865|NCT00206297|Type 1 diabetes|type 1 diabetes
810866|NCT00206297|hypoglycemia|hypoglycemia
810867|NCT00206297|hyperglycemia|hyperglycemia
810868|NCT00206284|GERD without erosive esophagitis|gerd without erosive esophagitis
810869|NCT00206271|whiplash injuries|whiplash injuries
810870|NCT00206271|neck pain|neck pain
810871|NCT00206271|exercise movement techniques|exercise movement techniques
810872|NCT00206271|immobilisation|immobilisation
810873|NCT00206258|type 1 diabetes|type 1 diabetes
810874|NCT00206258|hypoglycemia|hypoglycemia
810875|NCT00206258|hyperglycemia|hyperglycemia
810876|NCT00206245|GERD with erosive esophagitis|gerd with erosive esophagitis
810877|NCT00206232|Diastolic Heart Failure|diastolic heart failure
810878|NCT00206219|Squamous cell carcinoma of the head and neck|squamous cell carcinoma of the head and neck
810879|NCT00206193|termination of pregnancy|termination of pregnancy
810880|NCT00206141|Bipolar disorder|bipolar disorder
810881|NCT00206141|bipolar depression|bipolar depression
810882|NCT00206141|depression|depression
810883|NCT00206128|Schizophrenia|schizophrenia
810884|NCT00206115|Schizophrenic disorder|schizophrenic disorder
810885|NCT00206102|Schizophrenia|schizophrenia
810886|NCT00206102|Schizoaffective Disorder|schizoaffective disorder
810887|NCT00206089|Prevention of venous thromboembolic events in patients undergoing elective hip replacement or hip fracture surgery|prevention of venous thromboembolic events in patients undergoing elective hip replacement or hip fracture surgery
810888|NCT00206076|Liver transplantation|liver transplantation
810889|NCT00206076|Calcineurin inhibitor withdraw|calcineurin inhibitor withdraw
810890|NCT00206076|mycophenolate mofetil|mycophenolate mofetil
810891|NCT00206076|Immunosuppression side effects|immunosuppression side effects
810892|NCT00206076|Graft rejection|graft rejection
810893|NCT00206037|Tibia osteotomy|tibia osteotomy
810894|NCT00206037|Bone healing|bone healing
810895|NCT00206037|Bone filler|bone filler
810896|NCT00206037|Equine Protein|equine protein
810897|NCT00206037|COLLOSS E|colloss e
810898|NCT00206037|TomoFix|tomofix
810899|NCT00206011|Condylar neck|condylar neck
810900|NCT00206011|fractures|fractures
810901|NCT00206011|endoscopic|endoscopic
810902|NCT00206011|Helkimo Dysfunction index|helkimo dysfunction index
810903|NCT00205998|Locking Compression Plate|locking compression plate
810904|NCT00205998|Conservative treatment|conservative treatment
810905|NCT00205998|Surgical treatment|surgical treatment
810906|NCT00205998|Radius fractures|radius fractures
810907|NCT00205998|AO 23|ao 23
810908|NCT00205985|Return to work|return to work
810909|NCT00205985|Scaphoid fracture|scaphoid fracture
810910|NCT00205985|Operative treatment|operative treatment
810911|NCT00205985|Activity level|activity level
810912|NCT00205972|Fractures|fractures
810913|NCT00205972|Humerus|humerus
810914|NCT00205972|Conservative treatment|conservative treatment
810915|NCT00205972|Operative treatment|operative treatment
810916|NCT00205959|Humerus|humerus
810917|NCT00205959|Fractures|fractures
810918|NCT00205959|Locking Plates|locking plates
810919|NCT00205959|Nail System|nail system
810920|NCT00205946|Reward Processing|reward processing
810921|NCT00205946|Wellbutrin|wellbutrin
810922|NCT00205946|Bupropion|bupropion
810923|NCT00205933|Depression|depression
810924|NCT00205933|Bipolar Disorder|bipolar disorder
810925|NCT00205933|Reward Processing|reward processing
810926|NCT00205920|emphysema|emphysema
810927|NCT00205920|pulmonary emphysema|pulmonary emphysema
810928|NCT00205920|COPD|copd
810929|NCT00205920|COLD|cold
810930|NCT00205920|chronic obstructive pulmonary disease|chronic obstructive pulmonary disease
810931|NCT00205907|BLVR|blvr
810932|NCT00205907|emphysema|emphysema
810933|NCT00205907|COPD|copd
810934|NCT00205907|COLD|cold
810935|NCT00205907|chronic obstructive pulmonary disease|chronic obstructive pulmonary disease
810936|NCT00205907|pulmonary emphysema|pulmonary emphysema
810937|NCT00205894|Headache|headache
810938|NCT00205894|Chronic headache|chronic headache
810939|NCT00205894|Migraine|migraine
810940|NCT00205894|Pain|pain
810941|NCT00205894|Cluster headache|cluster headache
810942|NCT00205881|HiResolution Bionic Ear|hiresolution bionic ear
810943|NCT00205881|severe to profound hearing loss|severe to profound hearing loss
810944|NCT00205881|bilateral implantation|bilateral implantation
810945|NCT00205868|Back Pain|back pain
810946|NCT00205868|Low Back Pain|low back pain
810947|NCT00205868|Chronic Pain|chronic pain
810948|NCT00205868|Spinal Cord Stimulation|spinal cord stimulation
810949|NCT00205855|Pain|pain
810950|NCT00205855|Chronic Pain|chronic pain
810951|NCT00205855|Neurostimulation|neurostimulation
810952|NCT00205829|Chronic headaches|chronic headaches
810953|NCT00205829|greater occipital nerve stimulation|greater occipital nerve stimulation
810954|NCT00205816|Bacterial Infections|bacterial infections
810955|NCT00205803|Infant Vaccine|infant vaccine
810956|NCT00205777|Osteoporosis|osteoporosis
810957|NCT00205777|Postmenopause|postmenopause
810958|NCT00205764|Multiple Myeloma|multiple myeloma
810959|NCT00205764|first line tretment|first line tretment
810960|NCT00205764|high dose chemotherapy|high dose chemotherapy
810961|NCT00205764|stem cell transplantation|stem cell transplantation
810962|NCT00205764|maintenance therapy|maintenance therapy
810963|NCT00205751|Multiple Myeloma|multiple myeloma
810964|NCT00205751|first line treatment|first line treatment
810965|NCT00205751|thalidomide|thalidomide
810966|NCT00205751|melphalan|melphalan
810967|NCT00205738|Schizophrenia|schizophrenia
810968|NCT00205738|BMI|bmi
810969|NCT00205738|T2DM|t2dm
810970|NCT00205725|Schizophrenia|schizophrenia
810971|NCT00205725|BMI|bmi
810972|NCT00205725|T2DM|t2dm
810973|NCT00205712|NMDA antagonist-induced psychosis|nmda antagonist-induced psychosis
810974|NCT00205712|Children|children
810975|NCT00205712|Memory Impairment|memory impairment
810976|NCT00205712|Decreased cognitive function|decreased cognitive function
810977|NCT00205712|Increased memory impairment|increased memory impairment
810978|NCT00205699|Antipsychotic treatment|antipsychotic treatment
810979|NCT00205699|Insulin action/secretion|insulin action/secretion
810980|NCT00205699|Abdominal fat mass, total body fat|abdominal fat mass, total body fat
810981|NCT00205699|Aggression|aggression
810982|NCT00205699|Resting metabolic rates|resting metabolic rates
810983|NCT00205686|Aging, dhea, bone density, muscle mass, insulin action|aging, dhea, bone density, muscle mass, insulin action
810984|NCT00205660|Schizophrenia|schizophrenia
810986|NCT00205660|Hyperglycemia|hyperglycemia
810987|NCT00205660|Dyslipidemia|dyslipidemia
810988|NCT00205660|Type 2 Diabetes Mellitus|type 2 diabetes mellitus
810989|NCT00205647|Chronic Bronchitis|chronic bronchitis
810990|NCT00205647|N-acetylcysteine (NAC)|n-acetylcysteine (nac)
810991|NCT00205647|Quality of Life|quality of life
810992|NCT00205647|Mucus|mucus
810993|NCT00205634|Cystic Fibrosis (CF)|cystic fibrosis (cf)
810994|NCT00205634|Macrolide antiobiotics|macrolide antiobiotics
810995|NCT00205634|airway inflammation|airway inflammation
810996|NCT00205621|Alzheimer's disease|alzheimer's disease
810997|NCT00205621|amyloid|amyloid
810998|NCT00205621|PET|pet
810999|NCT00205621|PIB|pib
811000|NCT00205621|FDDNP|fddnp
811001|NCT00205608|schizophrenia|schizophrenia
811002|NCT00205608|microglia|microglia
811003|NCT00205608|PET|pet
811004|NCT00205595|microglia|microglia
811005|NCT00205595|PET|pet
811006|NCT00205595|PK11195|pk11195
811007|NCT00205582|Traumatic Brain Injury|traumatic brain injury
811008|NCT00205582|PET|pet
811009|NCT00205582|microglia|microglia
811010|NCT00205569|brain injury, acute rehabilitation|brain injury, acute rehabilitation
811011|NCT00205556|online hemodiafiltration|online hemodiafiltration
811012|NCT00205556|low flux hemodialysis|low flux hemodialysis
811013|NCT00205556|cardiovascular disease|cardiovascular disease
811014|NCT00205556|endothelial dysfunction|endothelial dysfunction
811015|NCT00205556|uremic toxicity|uremic toxicity
811016|NCT00205556|quality of life|quality of life
811017|NCT00205556|nutritional status|nutritional status
811018|NCT00205543|obstructive sleep apnea|obstructive sleep apnea
811019|NCT00205543|airway obstruction|airway obstruction
811020|NCT00205543|sleep-disordered breathing|sleep-disordered breathing
811021|NCT00205530|brain injury, family treatment|brain injury, family treatment
811022|NCT00205504|Inflammatory markers, oral contraceptions, obesity, metabolic syndrome X|inflammatory markers, oral contraceptions, obesity, metabolic syndrome x
811023|NCT00205491|depression after brain injury|depression after brain injury
811024|NCT00205491|traumatic brain injury|traumatic brain injury
811025|NCT00205491|Venlafaxine|venlafaxine
811026|NCT00205426|Pulmonary hypertension in lung transplant recipients|pulmonary hypertension in lung transplant recipients
811027|NCT00205413|surveillance for lung cancer|surveillance for lung cancer
811028|NCT00205387|echocardiography|echocardiography
811029|NCT00205387|cardiac elastography|cardiac elastography
811030|NCT00205387|Normal volunteers|normal volunteers
811031|NCT00205309|intubated patients|intubated patients
811032|NCT00205283|HIV|hiv
811033|NCT00205270|Pre or post-lung transplant|pre or post-lung transplant
811034|NCT00205270|Healthy|healthy
811035|NCT00205231|HIV|hiv
811036|NCT00205192|Heart Failure|heart failure
811037|NCT00205192|Cardiac resynchronization|cardiac resynchronization
811038|NCT00205192|echocardiography|echocardiography
811039|NCT00205166|adenosine tracer scans|adenosine tracer scans
811040|NCT00205166|coronary artery disease|coronary artery disease
811041|NCT00205166|caffeine|caffeine
811042|NCT00205153|hypertension in African Americans|hypertension in african americans
811043|NCT00205127|Cardiac PET imaging|cardiac pet imaging
811044|NCT00205127|Radiopharmaceutical tracers|radiopharmaceutical tracers
811045|NCT00205101|Transforaminal lumbar interbody fusion|transforaminal lumbar interbody fusion
811046|NCT00205101|Posterior lumbar interbody fusion|posterior lumbar interbody fusion
811047|NCT00205101|Isthmic spondylolisthesis, degenerative spondylolisthesis|isthmic spondylolisthesis, degenerative spondylolisthesis
811048|NCT00205101|Pseudoarthritis|pseudoarthritis
811049|NCT00205101|Severe Foraminal Stenosis|severe foraminal stenosis
811050|NCT00205049|acute alcoholic hepatitis|acute alcoholic hepatitis
811051|NCT00204997|Cervical Cancer|cervical cancer
811052|NCT00204997|Squamous Cell|squamous cell
811053|NCT00204997|Laparoscopy|laparoscopy
811054|NCT00204997|Ovarian Function|ovarian function
811055|NCT00204984|arterial stiffness|arterial stiffness
811056|NCT00204984|echocardiography|echocardiography
811057|NCT00204984|nesiritide|nesiritide
811058|NCT00204958|bone marrow transplant (BMT)|bone marrow transplant (bmt)
811059|NCT00204958|hematopoietic stem cell transplant (HSCT)|hematopoietic stem cell transplant (hsct)
811060|NCT00204945|arterial stiffness|arterial stiffness
811061|NCT00204945|echocardiography|echocardiography
811062|NCT00204945|nesiritide|nesiritide
811063|NCT00204945|high heart pressures|high heart pressures
811064|NCT00204945|cardiac catheterization|cardiac catheterization
811065|NCT00204919|osteoporosis|osteoporosis
811066|NCT00204919|vitamin D deficiency|vitamin d deficiency
811067|NCT00204867|colorectal|colorectal
811068|NCT00204867|polyps|polyps
811069|NCT00204763|manometry catheters|manometry catheters
811070|NCT00204763|diffuse esophageal spasm or hypertensive LES|diffuse esophageal spasm or hypertensive les
811071|NCT00204763|incontinence|incontinence
811072|NCT00204750|lower esophageal ring|lower esophageal ring
811073|NCT00204750|dysphagia|dysphagia
811074|NCT00204750|electrosurgical incision|electrosurgical incision
811075|NCT00204750|bougie dilation|bougie dilation
811076|NCT00204750|GERD|gerd
811077|NCT00204711|patients having outpatient surgery with sedation|patients having outpatient surgery with sedation
811078|NCT00204711|patients having procedures with sedation|patients having procedures with sedation
811079|NCT00204672|Asthma|asthma
811080|NCT00204659|Rituximab|rituximab
811081|NCT00204659|CHOP|chop
811082|NCT00204659|DLBCL|dlbcl
811083|NCT00204659|gastric lymphoma|gastric lymphoma
811084|NCT00204594|mRNA|mrna
811085|NCT00204594|vaccination|vaccination
811086|NCT00204594|melanoma|melanoma
811087|NCT00204581|Melanoma|melanoma
811088|NCT00204581|Soft tissue metastases|soft tissue metastases
811089|NCT00204581|Interleukin-2|interleukin-2
811090|NCT00204555|nodular basal cell carcinoma|nodular basal cell carcinoma
811091|NCT00204555|Imiquimod|imiquimod
811092|NCT00204555|topical treatment|topical treatment
811093|NCT00204555|Adjuvants, Immunologic|adjuvants, immunologic
811094|NCT00204555|Antineoplastic Agents|antineoplastic agents
811095|NCT00204555|Interferon Inducers|interferon inducers
811096|NCT00204542|actinic keratosis|actinic keratosis
811097|NCT00204542|diclofenac sodium|diclofenac sodium
811098|NCT00204529|malignant melanoma|malignant melanoma
811099|NCT00204529|adjuvant therapy|adjuvant therapy
811100|NCT00204529|Adjuvants, Immunologic|adjuvants, immunologic
811101|NCT00204516|vaccination|vaccination
811102|NCT00204516|mRNA|mrna
811103|NCT00204503|Bipolar I or II|bipolar i or ii
811104|NCT00204503|Depression|depression
811105|NCT00204503|Alcohol Abuse or Dependence|alcohol abuse or dependence
811106|NCT00204503|Mental Health Issues|mental health issues
811107|NCT00204490|soy|soy
811108|NCT00204490|isoflavones|isoflavones
811109|NCT00204490|phytoestrogens|phytoestrogens
811110|NCT00204490|prevention|prevention
811111|NCT00204490|mammographic density|mammographic density
811112|NCT00204490|bone density|bone density
811113|NCT00204477|soy diet|soy diet
811114|NCT00204477|breast cancer|breast cancer
811115|NCT00204477|ovarian hormones|ovarian hormones
811116|NCT00204477|breast density|breast density
811117|NCT00204477|prevention|prevention
811118|NCT00204464|Amyotrophic Lateral Sclerosis|amyotrophic lateral sclerosis
811119|NCT00204464|Exercise|exercise
811120|NCT00204451|emergency contraception|emergency contraception
811121|NCT00204451|follicle|follicle
811122|NCT00204451|ovulation|ovulation
811123|NCT00204451|blood pressure|blood pressure
811124|NCT00204451|Fertility Control|fertility control
811125|NCT00204451|Inhibition of fertilization|inhibition of fertilization
811126|NCT00204438|female contraception|female contraception
811127|NCT00204438|oral contraceptive|oral contraceptive
811128|NCT00204438|emergency contraceptive|emergency contraceptive
811129|NCT00204438|ovary|ovary
811130|NCT00204438|follicle|follicle
811131|NCT00204438|ovulation|ovulation
811132|NCT00204425|Osteoporosis|osteoporosis
811133|NCT00204425|Bone|bone
811134|NCT00204425|Exercise|exercise
811135|NCT00204425|Soy|soy
811136|NCT00204425|Isoflavone|isoflavone
811137|NCT00204425|Phytoestrogen|phytoestrogen
811138|NCT00204425|Menopause|menopause
811139|NCT00204425|Lipids|lipids
811140|NCT00204412|Cholesterol|cholesterol
811141|NCT00204412|High density lipoprotein|high density lipoprotein
811142|NCT00204412|Low density lipoprotein|low density lipoprotein
811143|NCT00204412|Triglyceride|triglyceride
811144|NCT00204412|Glucose|glucose
811145|NCT00204412|Exercise|exercise
811146|NCT00204412|Fitness|fitness
811147|NCT00204412|Flax|flax
811148|NCT00204412|Lignan|lignan
811149|NCT00204412|Phytoestrogen|phytoestrogen
811150|NCT00204412|bone|bone
811151|NCT00204386|Posttraumatic Stress Disorder|posttraumatic stress disorder
811152|NCT00204360|epilepsy|epilepsy
811153|NCT00204347|risperidone|risperidone
811154|NCT00204334|Kidney transplantation|kidney transplantation
811155|NCT00204334|anemia|anemia
811156|NCT00204334|vascular endothelium|vascular endothelium
811157|NCT00204334|monocytes|monocytes
811158|NCT00204334|apoptosis|apoptosis
811159|NCT00204321|rejection|rejection
811160|NCT00204321|vesselwall function|vesselwall function
811161|NCT00204321|endothelial cell function|endothelial cell function
811162|NCT00204321|monocytes|monocytes
811163|NCT00204308|HIV|hiv
811164|NCT00204308|Pregnancy|pregnancy
811165|NCT00204308|Mother-to-child transmission of HIV|mother-to-child transmission of hiv
811166|NCT00204308|Drug resistance|drug resistance
811167|NCT00204308|Nevirapine resistance|nevirapine resistance
811168|NCT00204308|NNRTI resistance|nnrti resistance
811169|NCT00204295|Brain neoplasms|brain neoplasms
811170|NCT00204295|Positron-Emission Tomography|positron-emission tomography
811171|NCT00204295|Amino Acids|amino acids
811172|NCT00204295|Magnetic Resonance Imaging|magnetic resonance imaging
811173|NCT00204282|Diabetes prevention|diabetes prevention
811174|NCT00204269|Hypogonadism|hypogonadism
811175|NCT00204269|Testosterone|testosterone
811176|NCT00204269|Substitution|substitution
811177|NCT00204256|chronic kidney disease|chronic kidney disease
811179|NCT00204256|intravenous iron|intravenous iron
811180|NCT00204256|recombinant human erythropoetin|recombinant human erythropoetin
811181|NCT00204243|naltrexone implant|naltrexone implant
811182|NCT00204243|methadone|methadone
811183|NCT00204243|inmates|inmates
811184|NCT00204243|randomized controlled trial|randomized controlled trial
811185|NCT00204230|Kidney Failure, Chronic|kidney failure, chronic
811186|NCT00204230|Kidney Transplantation|kidney transplantation
811187|NCT00204217|cardiac arrest|cardiac arrest
811188|NCT00204217|resuscitation|resuscitation
811189|NCT00204217|ventilation|ventilation
811190|NCT00204217|impedance|impedance
811191|NCT00204204|multiple trauma|multiple trauma
811192|NCT00204204|traffic accident|traffic accident
811193|NCT00204204|outcome|outcome
811194|NCT00204204|safety|safety
811195|NCT00204204|injury severity|injury severity
811196|NCT00204191|kidney transplantation|kidney transplantation
811197|NCT00204191|Immunosuppression|immunosuppression
811198|NCT00204191|Cyclosporine|cyclosporine
811199|NCT00204191|Tacrolimus|tacrolimus
811200|NCT00204178|Kidney transplantation|kidney transplantation
811201|NCT00204178|Reperfusion injury|reperfusion injury
811202|NCT00204152|Early onset depression|early onset depression
811203|NCT00204152|early adversity|early adversity
811204|NCT00204126|exercise testing|exercise testing
811205|NCT00204126|treadmill|treadmill
811206|NCT00204126|incomplete spinal cord injury|incomplete spinal cord injury
811207|NCT00204126|novel methods|novel methods
811208|NCT00204113|spinal cord injury|spinal cord injury
811209|NCT00204113|standing|standing
811210|NCT00204113|balance|balance
811211|NCT00204113|functional electrical stimulation|functional electrical stimulation
811212|NCT00204100|paraplegia|paraplegia
811213|NCT00204100|spinal cord injury|spinal cord injury
811214|NCT00204100|functional electrical stimulation|functional electrical stimulation
811215|NCT00204100|cycling|cycling
811216|NCT00204100|exercise|exercise
811217|NCT00204100|cardiopulmonary fitness|cardiopulmonary fitness
811218|NCT00204087|Schizophrenia|schizophrenia
811219|NCT00204087|Psychosis|psychosis
811220|NCT00204087|Prodrome|prodrome
811221|NCT00204087|Early Initial Prodromal State|early initial prodromal state
811222|NCT00204087|Early Intervention|early intervention
811223|NCT00204087|Cognitive Behavioral Therapy|cognitive behavioral therapy
811224|NCT00204074|Migraine|migraine
811225|NCT00204074|Menstrual cycle|menstrual cycle
811226|NCT00204074|17 beta-estradiol|17 beta-estradiol
811227|NCT00204074|Transdermal administration|transdermal administration
811228|NCT00204061|schizophrenia|schizophrenia
811229|NCT00204061|psychosis|psychosis
811230|NCT00204061|ultra high risk|ultra high risk
811231|NCT00204061|prodromal state|prodromal state
811232|NCT00204061|early intervention|early intervention
811233|NCT00204061|amisulpride|amisulpride
811234|NCT00204048|Hospitalists|hospitalists
811235|NCT00204035|Training early achievers for careers in health|training early achievers for careers in health
811236|NCT00204022|Lupus nephritis|lupus nephritis
811237|NCT00204022|Treatment|treatment
811238|NCT00204022|Maintenance therapy|maintenance therapy
811239|NCT00204022|Mycophenolate mofetil|mycophenolate mofetil
811240|NCT00204022|Azathioprine|azathioprine
811241|NCT00204009|children and adolescents|children and adolescents
811242|NCT00204009|epidemiology|epidemiology
811243|NCT00203996|polycystic ovary syndrome|polycystic ovary syndrome
811244|NCT00203996|metabolic syndrome|metabolic syndrome
811245|NCT00203996|obstructive sleep apnea|obstructive sleep apnea
811246|NCT00203996|impaired glucose tolerance|impaired glucose tolerance
811247|NCT00203996|insulin resistance|insulin resistance
811248|NCT00203970|Thrombosis|thrombosis
811249|NCT00203970|Low Molecular Weight Heparin|low molecular weight heparin
811250|NCT00203957|Parkinson's Disease|parkinson's disease
811251|NCT00203944|Adoption|adoption
811252|NCT00203944|Stress Response|stress response
811253|NCT00203944|Child Development|child development
811254|NCT00203931|Non-small cell lung cancer|non-small cell lung cancer
811255|NCT00203918|Prostate Cancer|prostate cancer
811256|NCT00203918|Cost-Effectiveness Analysis|cost-effectiveness analysis
811257|NCT00203918|Utility Assessment|utility assessment
811258|NCT00203905|Head and Neck Cancer|head and neck cancer
811259|NCT00203892|Adenocarcinoma|adenocarcinoma
811261|NCT00203879|metastatic melanoma|metastatic melanoma
811262|NCT00203866|Metastatic Renal Cell Carcinoma|metastatic renal cell carcinoma
811263|NCT00203853|HIV|hiv
811264|NCT00203853|HAART|haart
811265|NCT00203853|medication adherance|medication adherance
811266|NCT00203853|pillbox|pillbox
811267|NCT00203853|wristwatch|wristwatch
811268|NCT00203840|Sleep Disorders|sleep disorders
811269|NCT00203827|Sleep Disorders|sleep disorders
811270|NCT00203814|Malaria|malaria
811271|NCT00203814|Efficacy|efficacy
811272|NCT00203814|Pharmacokinetic|pharmacokinetic
811273|NCT00203814|Gametocyte|gametocyte
811274|NCT00203814|Molecular markers|molecular markers
811275|NCT00203814|Sulfadoxine-pyrimethamine|sulfadoxine-pyrimethamine
811276|NCT00203814|Artesunate|artesunate
811277|NCT00203814|Artemisinin|artemisinin
811278|NCT00203801|Malaria|malaria
811279|NCT00203801|Efficacy|efficacy
811280|NCT00203801|Pharmacokinetic|pharmacokinetic
811281|NCT00203801|Gametocyte|gametocyte
811282|NCT00203801|Molecular markers|molecular markers
811283|NCT00203801|Sulfadoxine-pyrimethamine|sulfadoxine-pyrimethamine
811284|NCT00203801|Artesunate|artesunate
811285|NCT00203801|Artemisinin|artemisinin
811286|NCT00203788|work outcome|work outcome
811287|NCT00203788|supported employment|supported employment
811288|NCT00203788|social skills training|social skills training
811289|NCT00203788|risperidone|risperidone
811290|NCT00203788|cognition|cognition
811291|NCT00203788|first-episode schizophrenia|first-episode schizophrenia
811292|NCT00203762|Pragmatic cluster non-randomized controlled trial|pragmatic cluster non-randomized controlled trial
811293|NCT00203762|antiretroviral treatment|antiretroviral treatment
811294|NCT00203762|tuberculosis|tuberculosis
811295|NCT00203762|childhood immunization|childhood immunization
811296|NCT00203762|primary care|primary care
811297|NCT00203762|resource-restricted settings|resource-restricted settings
811298|NCT00203749|HIV|hiv
811299|NCT00203749|Testing|testing
811300|NCT00203749|Counseling|counseling
811301|NCT00203736|Malaria|malaria
811302|NCT00203736|Efficacy|efficacy
811303|NCT00203736|Pharmacokinetic|pharmacokinetic
811304|NCT00203736|Gametocyte|gametocyte
811305|NCT00203736|Molecular Markers|molecular markers
811306|NCT00203736|Sulfadoxine-pyrimethamine|sulfadoxine-pyrimethamine
811307|NCT00203736|Artesunate|artesunate
811308|NCT00203736|Artemisinin|artemisinin
811309|NCT00203723|mood disorder|mood disorder
811310|NCT00203723|affective disorder|affective disorder
811311|NCT00203723|depression|depression
811312|NCT00203723|treatment-resistant|treatment-resistant
811313|NCT00203710|Concentric Retriever Device|concentric retriever device
811314|NCT00203710|embolectomy|embolectomy
811315|NCT00203710|acute ischemic stroke|acute ischemic stroke
811316|NCT00203710|treatment|treatment
811317|NCT00203697|Eric Kleerup|eric kleerup
811318|NCT00203697|Idiopathic Pulmonary Fibrosis|idiopathic pulmonary fibrosis
811319|NCT00203671|renal|renal
811320|NCT00203671|transplant|transplant
811321|NCT00203671|kidney|kidney
811322|NCT00203671|rejection|rejection
811323|NCT00203671|MMF|mmf
811324|NCT00203671|Mycophenolate Mofetil|mycophenolate mofetil
811325|NCT00203671|outcomes|outcomes
811326|NCT00203671|Kidney Transplantation|kidney transplantation
811327|NCT00203645|Problem gambling|problem gambling
811328|NCT00203645|Self-help manual|self-help manual
811329|NCT00203645|Motivation enhancement|motivation enhancement
811330|NCT00203645|Telephone support|telephone support
811331|NCT00203645|Treatment|treatment
811332|NCT00203645|Pathological gambling|pathological gambling
811333|NCT00203632|diabetes mellitus|diabetes mellitus
811334|NCT00203632|endothelium|endothelium
811335|NCT00203632|thiazolidinediones|thiazolidinediones
811336|NCT00203632|atherosclerosis|atherosclerosis
811337|NCT00203593|exercise|exercise
811338|NCT00203593|total peripheral resistance|total peripheral resistance
811339|NCT00203593|venoconstriction|venoconstriction
811340|NCT00203593|blood volume expansion|blood volume expansion
811341|NCT00203593|orthostatic tolerance|orthostatic tolerance
811342|NCT00203580|venous thromboembolism|venous thromboembolism
811343|NCT00203580|low-molecular-weight heparin|low-molecular-weight heparin
811344|NCT00203567|bipolar depression|bipolar depression
811345|NCT00203567|carbamazepine ER|carbamazepine er
811346|NCT00203567|Equetro|equetro
811347|NCT00203554|osteoporosis|osteoporosis
811348|NCT00203554|vertebra|vertebra
811349|NCT00203554|fracture|fracture
811350|NCT00203554|pain|pain
811351|NCT00203554|percutaneous|percutaneous
811352|NCT00203554|vertebroplasty|vertebroplasty
811353|NCT00203554|polymethylmetacrylate|polymethylmetacrylate
811354|NCT00203528|divalproex sodium|divalproex sodium
811355|NCT00203528|risperidone|risperidone
811356|NCT00203528|dual diagnosis|dual diagnosis
811357|NCT00203528|substance use|substance use
811358|NCT00203528|bipolar|bipolar
811359|NCT00203515|Urinary Catheterization|urinary catheterization
811360|NCT00203502|Operable and Locally advanced Breast Cancer|operable and locally advanced breast cancer
811361|NCT00203476|ezetimibe|ezetimibe
811362|NCT00203476|niacin|niacin
811363|NCT00203476|colestipol|colestipol
811364|NCT00203476|hyperlipidemia|hyperlipidemia
811365|NCT00203476|adjunct therapy|adjunct therapy
811366|NCT00203476|zetia|zetia
811367|NCT00203463|topiramate|topiramate
811368|NCT00203463|PTSD|ptsd
811369|NCT00203463|posttraumatic stress disorder|posttraumatic stress disorder
811370|NCT00203463|topamax|topamax
811371|NCT00203450|obesity|obesity
811372|NCT00203450|zonisamide|zonisamide
811373|NCT00203450|zonegran|zonegran
811374|NCT00203450|psychotropic weight gain|psychotropic weight gain
811375|NCT00203450|psychotropic|psychotropic
811376|NCT00203385|divalproex sodium, depakote, ptsd, long-term ptsd treatments|divalproex sodium, depakote, ptsd, long-term ptsd treatments
811377|NCT00203333|Epilepsy|epilepsy
811378|NCT00203281|renal transplantation|renal transplantation
811379|NCT00203268|migraine|migraine
811380|NCT00203268|cutaneous allodynia|cutaneous allodynia
811381|NCT00203255|Menstrually-Associated Migraine|menstrually-associated migraine
811382|NCT00203229|Double-Blind|double-blind
811383|NCT00203229|Placebo-Controlled|placebo-controlled
811384|NCT00203203|Autologous|autologous
811385|NCT00203203|Cardiac|cardiac
811386|NCT00203203|Stem Cell|stem cell
811387|NCT00203203|Transplant|transplant
811388|NCT00203047|Multiple Sclerosis|multiple sclerosis
811389|NCT00203047|brain atrophy|brain atrophy
811390|NCT00203047|Glatiramer Acetate|glatiramer acetate
811391|NCT00203047|Copaxone|copaxone
811392|NCT00203047|Steroids|steroids
811393|NCT00203047|Prednisone|prednisone
811394|NCT00202969|Stomach cancer|stomach cancer
811395|NCT00202943|TCRFVR, LAUP, Snorer|tcrfvr, laup, snorer
811396|NCT00202930|neuroblastoma|neuroblastoma
811397|NCT00202930|Opsoclonus-myoclonus|opsoclonus-myoclonus
811398|NCT00202930|rituximab|rituximab
811399|NCT00202917|haploidentical transplantation|haploidentical transplantation
811400|NCT00202917|immunomagnetic cell sorting|immunomagnetic cell sorting
811401|NCT00202917|allogeneic hematopoietic cell transplantation|allogeneic hematopoietic cell transplantation
811402|NCT00202917|dose reduced conditioning|dose reduced conditioning
811403|NCT00202904|ezetimibe|ezetimibe
811404|NCT00202904|atorvastatin|atorvastatin
811405|NCT00202904|hypercholesterolemia|hypercholesterolemia
811406|NCT00202904|coronary heart disease|coronary heart disease
811407|NCT00202891|pyoderma|pyoderma
811408|NCT00202891|sisomicin|sisomicin
811409|NCT00202891|nadifloxacin|nadifloxacin
811410|NCT00202878|hypercholesterolemia|hypercholesterolemia
811411|NCT00202878|myocardial infarction|myocardial infarction
811412|NCT00202878|cholesterol|cholesterol
811413|NCT00202878|randomized controlled trials|randomized controlled trials
811414|NCT00202878|acute coronary syndrome|acute coronary syndrome
811415|NCT00202878|angina|angina
811416|NCT00202813|CVC|cvc
811417|NCT00202813|central venous catheter|central venous catheter
811418|NCT00202813|infection|infection
811419|NCT00202813|bloodstream infection|bloodstream infection
811420|NCT00202813|catheter infection|catheter infection
811421|NCT00202813|pediatric|pediatric
811422|NCT00202813|children|children
811423|NCT00202813|antibiotic impregnated catheters|antibiotic impregnated catheters
811424|NCT00202800|Pancreatic Cancer|pancreatic cancer
811425|NCT00202800|Gemcitabine/Etoposide|gemcitabine/etoposide
811426|NCT00202800|Ras-mutation|ras-mutation
811427|NCT00202787|colorectal cancer|colorectal cancer
811428|NCT00202787|cetuximab|cetuximab
811429|NCT00202787|FOLFOX4|folfox4
811430|NCT00202774|colorectal cancer, capecitabine, oxaliplatin, 5-fluorouracil|colorectal cancer, capecitabine, oxaliplatin, 5-fluorouracil
811431|NCT00202761|Cerebral palsy|cerebral palsy
811432|NCT00202761|Functional training|functional training
811433|NCT00202761|preschool children|preschool children
811434|NCT00202761|Gross Motor Functional Classification Level|gross motor functional classification level
811435|NCT00202761|Gross motor functional Measure test|gross motor functional measure test
811436|NCT00202761|Pediatric Evaluation of Disability Inventory|pediatric evaluation of disability inventory
811437|NCT00202761|Parental Stress Index|parental stress index
811438|NCT00202748|metabolic syndrome|metabolic syndrome
811439|NCT00202748|lifestyle|lifestyle
811440|NCT00202748|obesity|obesity
811441|NCT00202735|shoulder dislocation|shoulder dislocation
811442|NCT00202735|anterior|anterior
811443|NCT00202735|traumatic|traumatic
811444|NCT00202735|primary|primary
811445|NCT00202735|first time|first time
811446|NCT00202735|initial|initial
811447|NCT00202735|immobilization|immobilization
811448|NCT00202735|external|external
811449|NCT00202735|rotation|rotation
811450|NCT00202722|Remifentanil, parenteral opioids, obstetric analgesia, IVPCA|remifentanil, parenteral opioids, obstetric analgesia, ivpca
811451|NCT00202709|Anxiety disorder|anxiety disorder
811452|NCT00202709|Thought Field Therapy|thought field therapy
811453|NCT00202709|Psychotherapy|psychotherapy
811454|NCT00202709|Agoraphobia|agoraphobia
811455|NCT00202709|Social Phobia|social phobia
811456|NCT00202709|Post Traumatic Stress Disorder|post traumatic stress disorder
811457|NCT00202683|Altitude|altitude
811458|NCT00202683|Anoxemia|anoxemia
811459|NCT00202683|Mitochondria|mitochondria
811460|NCT00202683|Reflex|reflex
811461|NCT00202683|Genetic research|genetic research
811462|NCT00202670|coronary artery disease|coronary artery disease
811463|NCT00202670|stress myocardial scintigraphy|stress myocardial scintigraphy
811464|NCT00202670|stress echocardiography|stress echocardiography
811465|NCT00202657|parkinson's disease|parkinson's disease
811466|NCT00202657|pergolide|pergolide
811467|NCT00202657|heart valve disease|heart valve disease
811468|NCT00202631|tetraplegia|tetraplegia
811469|NCT00202631|quadriplegia|quadriplegia
811470|NCT00202631|spinal cord injury|spinal cord injury
811471|NCT00202631|functional electrical stimulation|functional electrical stimulation
811472|NCT00202631|abdominal stimulation|abdominal stimulation
811473|NCT00202618|Hypertension|hypertension
811474|NCT00202618|Type 2 diabetes mellitus|type 2 diabetes mellitus
811475|NCT00202618|Microalbuminuria|microalbuminuria
811476|NCT00202618|Amlodipine|amlodipine
811477|NCT00202618|Calcium channel blocker|calcium channel blocker
811478|NCT00202618|Valsartan|valsartan
811479|NCT00202618|Angiotensin type 2 receptor blocker|angiotensin type 2 receptor blocker
811480|NCT00202527|Sleep apnea|sleep apnea
811481|NCT00202527|Hypertension|hypertension
811482|NCT00202527|CPAP|cpap
811483|NCT00202514|alcoholism|alcoholism
811484|NCT00202514|alcohol related disorders|alcohol related disorders
811485|NCT00202514|mood disorders|mood disorders
811486|NCT00202514|anticonvulsants|anticonvulsants
811487|NCT00202514|divalproex sodium|divalproex sodium
811488|NCT00202488|anemia, iron-deficiency|anemia, iron-deficiency
811489|NCT00202488|Helicobacter pylori|helicobacter pylori
811490|NCT00202475|Dubble eerythrocytapheresis|dubble eerythrocytapheresis
811491|NCT00202462|testosterone|testosterone
811492|NCT00202462|depression|depression
811493|NCT00202462|subsyndromal depression|subsyndromal depression
811494|NCT00202462|quality of life|quality of life
811495|NCT00202449|Prazosin|prazosin
811496|NCT00202449|Paroxetine|paroxetine
811497|NCT00202449|Stress Disorders, Post-Traumatic|stress disorders, post-traumatic
811498|NCT00202449|Sleep Disorders|sleep disorders
811499|NCT00202423|Multiple sclerosis|multiple sclerosis
811500|NCT00202423|Cannabinoids|cannabinoids
811501|NCT00202423|Spasticity|spasticity
811502|NCT00202423|fMRI|fmri
811503|NCT00202423|TMS|tms
811504|NCT00202410|Multiple Sclerosis|multiple sclerosis
811505|NCT00202410|Tuberculosis vaccine|tuberculosis vaccine
811506|NCT00202410|Therapy|therapy
811507|NCT00202397|cerebellar ataxia|cerebellar ataxia
811508|NCT00202397|deep cerebellar nuclei (DCN)|deep cerebellar nuclei (dcn)
811509|NCT00202397|small-conductance calcium-activated potassium(SK)channels|small-conductance calcium-activated potassium(sk)channels
811510|NCT00202397|riluzole|riluzole
811511|NCT00202397|Sporadic ataxia|sporadic ataxia
811512|NCT00202397|Multiple system atrophy type C|multiple system atrophy type c
811513|NCT00202384|Multiple Sclerosis|multiple sclerosis
811514|NCT00202384|microarrays|microarrays
811515|NCT00202371|MDS, Fatigue, RBC transfusion|mds, fatigue, rbc transfusion
811516|NCT00202358|perioperative|perioperative
811517|NCT00202358|beta-blockers|beta-blockers
811518|NCT00202358|inflammation|inflammation
811519|NCT00202358|outcomes|outcomes
811520|NCT00202345|Creatinine Clearance|creatinine clearance
811521|NCT00202345|Hemoglobin|hemoglobin
811522|NCT00202345|Iron sucrose|iron sucrose
811523|NCT00202345|Oral iron therapy|oral iron therapy
811524|NCT00202345|Ferritin|ferritin
811525|NCT00202345|Transferrin saturation|transferrin saturation
811526|NCT00202345|Iron|iron
811527|NCT00202319|sedation|sedation
811528|NCT00202319|mechanical ventilation|mechanical ventilation
811529|NCT00202319|sedation protocols|sedation protocols
811530|NCT00202319|critical care|critical care
811531|NCT00202319|intensive care outcomes|intensive care outcomes
811532|NCT00202319|staffing|staffing
811533|NCT00202306|at risk mental state|at risk mental state
811534|NCT00202306|prodrome|prodrome
811535|NCT00202306|ultra high risk|ultra high risk
811536|NCT00202306|first episode psychosis|first episode psychosis
811537|NCT00202306|schizophrenia|schizophrenia
811538|NCT00202306|bipolar disorder|bipolar disorder
811539|NCT00202293|Bipolar|bipolar
811540|NCT00202293|Mania|mania
811541|NCT00202293|Drug treatment|drug treatment
811542|NCT00202293|First episode|first episode
811543|NCT00202293|Psychosis|psychosis
811544|NCT00202293|Therapy|therapy
811545|NCT00202293|Antipsychotic|antipsychotic
811546|NCT00202267|leg ulcer, compression, bandage, APBI, venous insufficiency|leg ulcer, compression, bandage, apbi, venous insufficiency
811547|NCT00202254|Mulitple Sclerosis|mulitple sclerosis
811549|NCT00202241|HIV|hiv
811550|NCT00202241|AIDS|aids
811551|NCT00202241|testosterone|testosterone
811552|NCT00202241|anabolic steroid|anabolic steroid
811553|NCT00202241|body composition|body composition
811554|NCT00202241|lipodystrophy|lipodystrophy
811555|NCT00202241|MRI|mri
811556|NCT00202241|BIA|bia
811557|NCT00202241|skinfold measurements|skinfold measurements
811558|NCT00202241|protease inhibitors|protease inhibitors
811559|NCT00202228|HIV|hiv
811560|NCT00202228|HIV/AIDS|hiv/aids
811561|NCT00202228|Lactic Acidosis|lactic acidosis
811562|NCT00202228|Supplementation|supplementation
811563|NCT00202228|Lactate Clearance|lactate clearance
811564|NCT00202228|Mitochondrial Toxicity|mitochondrial toxicity
811566|NCT00202215|Day hospital treatment|day hospital treatment
811567|NCT00202202|personality disorder|personality disorder
811568|NCT00202202|user satisfaction|user satisfaction
811569|NCT00202189|COPD|copd
811570|NCT00202189|Pulmicort|pulmicort
811571|NCT00202189|Budesonide|budesonide
811572|NCT00202189|Chronic|chronic
811573|NCT00202189|Obstructive|obstructive
811574|NCT00202189|Pulmonary|pulmonary
811575|NCT00202189|Disease|disease
811576|NCT00202189|Exercise|exercise
811577|NCT00202189|Emphysema|emphysema
811578|NCT00202176|Chronic|chronic
811579|NCT00202176|Obstructive|obstructive
811580|NCT00202176|Pulmonary|pulmonary
811581|NCT00202176|Disease|disease
811582|NCT00202176|COPD|copd
811583|NCT00202176|Atrovent|atrovent
811584|NCT00202176|Ipratropium|ipratropium
811585|NCT00202176|Bromide|bromide
811586|NCT00202176|Exercise|exercise
811587|NCT00202176|Dyspnea|dyspnea
811588|NCT00202163|ED|ed
811589|NCT00202163|DHEA|dhea
811590|NCT00202163|testosterone|testosterone
811591|NCT00202150|Advanced chronic diseases|advanced chronic diseases
811592|NCT00202150|Heart failure|heart failure
811593|NCT00202150|Chronic obstructive lung disease|chronic obstructive lung disease
811594|NCT00202150|primary care|primary care
811595|NCT00202150|Chronic Care|chronic care
811596|NCT00202137|Home Blood Pressure, Hypertension, Blood Pressure Control|home blood pressure, hypertension, blood pressure control
811597|NCT00202111|Clinical Trial|clinical trial
811598|NCT00202111|Colonic Neoplasms|colonic neoplasms
811599|NCT00202111|Laparoscopic Surgery|laparoscopic surgery
811600|NCT00202111|Morbidity|morbidity
811601|NCT00202111|Port Site Metastasis|port site metastasis
811602|NCT00202111|Disease-Free Survival|disease-free survival
811603|NCT00202098|ARDS|ards
811604|NCT00202098|mechanical ventilation|mechanical ventilation
811605|NCT00202098|variable ventilation|variable ventilation
811606|NCT00202098|chaotic ventilation|chaotic ventilation
811607|NCT00202072|lung|lung
811608|NCT00202072|airway|airway
811609|NCT00202072|pulmonary exacerbation|pulmonary exacerbation
811610|NCT00202072|mucus|mucus
811611|NCT00202059|Breast cancer|breast cancer
811612|NCT00202059|Bone mineral density|bone mineral density
811613|NCT00202059|Chemotherapy|chemotherapy
811614|NCT00202046|Breast cancer|breast cancer
811615|NCT00202046|Lymphedema|lymphedema
811616|NCT00202046|Quality of life|quality of life
811617|NCT00202033|referred to|referred to
811618|NCT00202033|comprehensive|comprehensive
811619|NCT00202033|diabetes|diabetes
811620|NCT00202033|education|education
811621|NCT00202033|program|program
811622|NCT00202020|Cerebral infarction|cerebral infarction
811623|NCT00202020|Prevention|prevention
811624|NCT00202020|Cilostazol|cilostazol
811625|NCT00202020|Aspirin|aspirin
811626|NCT00202020|Stroke|stroke
811627|NCT00202020|Clinical trial|clinical trial
811628|NCT00202007|Aripiprazole|aripiprazole
811629|NCT00202007|Schizophrenia|schizophrenia
811630|NCT00202007|Clinical trial|clinical trial
811631|NCT00202007|Risperidone|risperidone
811632|NCT00201994|Sodium|sodium
811633|NCT00201994|SIADH|siadh
811634|NCT00201994|Vasopressin|vasopressin
811635|NCT00201994|CHF|chf
811636|NCT00201994|Cirrhosis|cirrhosis
811637|NCT00201994|salt|salt
811638|NCT00201994|water|water
811639|NCT00201994|electrolyte|electrolyte
811640|NCT00201981|dry eye|dry eye
811641|NCT00201981|keratoconjunctivitis sicca|keratoconjunctivitis sicca
811642|NCT00201955|dry eye|dry eye
811643|NCT00201955|keratoconjunctivitis sicca|keratoconjunctivitis sicca
811644|NCT00201942|Breast Cancer|breast cancer
811645|NCT00201942|Diagnosis|diagnosis
811646|NCT00201942|PET|pet
811647|NCT00201942|Positronic Emission Tomography|positronic emission tomography
811648|NCT00201942|fluorodeoxyglucose|fluorodeoxyglucose
811649|NCT00201929|breast cancer|breast cancer
811650|NCT00201929|decision aid|decision aid
811651|NCT00201929|Decision Board|decision board
811652|NCT00201929|information transfer|information transfer
811653|NCT00201916|prostate cancer|prostate cancer
811654|NCT00201916|prostate specific antigen|prostate specific antigen
811655|NCT00201916|PSA|psa
811656|NCT00201916|radiation fractionation|radiation fractionation
811657|NCT00201903|venous thromboembolism|venous thromboembolism
811658|NCT00201903|brain tumours|brain tumours
811659|NCT00201903|glioma|glioma
811660|NCT00201903|tissue factor|tissue factor
811661|NCT00201903|blood coagulation|blood coagulation
811662|NCT00201903|tumour progression|tumour progression
811663|NCT00201903|low molecular weight heparin|low molecular weight heparin
811664|NCT00201890|Breast Cancer|breast cancer
811665|NCT00201890|Lymphedema|lymphedema
811666|NCT00201890|Treatment|treatment
811667|NCT00201890|Massage|massage
811668|NCT00201890|Randomized|randomized
811669|NCT00201890|DLT therapy|dlt therapy
811670|NCT00201890|Quality of Life|quality of life
811671|NCT00201890|Decongestive Therapy|decongestive therapy
811672|NCT00201890|Breast Cancer related Lymphedema|breast cancer related lymphedema
811673|NCT00201877|Relapsed/Refractory|relapsed/refractory
811674|NCT00201877|NHL|nhl
811677|NCT00201877|non-Hodgkin's lymphoma|non-hodgkin's lymphoma
811678|NCT00201864|Postmenopausal|postmenopausal
811679|NCT00201864|Women|women
811680|NCT00201851|Asian|asian
811681|NCT00201851|Premenopausal|premenopausal
811682|NCT00201851|Women|women
811683|NCT00201851|Oophorectomy|oophorectomy
811684|NCT00201838|Advanced Stage|advanced stage
811685|NCT00201838|Chemotherapy Naive|chemotherapy naive
811686|NCT00201825|Previously Untreated|previously untreated
811687|NCT00201825|Advanced|advanced
811688|NCT00201812|Advanced Solid Tumors|advanced solid tumors
811689|NCT00201799|Hematopoietic Stem Cell Transplantation|hematopoietic stem cell transplantation
811690|NCT00201786|Corticosteroids|corticosteroids
811691|NCT00201773|Post-Menopause|post-menopause
811692|NCT00201773|Neoadjuvant Therapy|neoadjuvant therapy
811693|NCT00201760|metastatic|metastatic
811694|NCT00201747|Advanced|advanced
811695|NCT00201734|Adenocarcinoma|adenocarcinoma
811696|NCT00201721|Previously Untreated|previously untreated
811697|NCT00201708|Adjuvant Trial|adjuvant trial
811698|NCT00201708|Dose-Dense|dose-dense
811699|NCT00201708|Axillary Node-Positive|axillary node-positive
811700|NCT00201695|Untreated Patients|untreated patients
811701|NCT00201695|Symptomatic|symptomatic
811702|NCT00201682|Leukemia|leukemia
811703|NCT00201682|Lymphoma|lymphoma
811704|NCT00201669|Aggressive|aggressive
811705|NCT00201669|Clofarabine|clofarabine
811706|NCT00201656|PPROM|pprom
811707|NCT00201656|Cerclage|cerclage
811708|NCT00201656|Preterm Premature Rupture of the Membranes with Cerclage|preterm premature rupture of the membranes with cerclage
811709|NCT00201643|Preterm Labor|preterm labor
811710|NCT00201643|Preterm delivery|preterm delivery
811711|NCT00201630|Prostate|prostate
811712|NCT00201630|cancer|cancer
811713|NCT00201630|Brachytherapy|brachytherapy
811714|NCT00201630|Alpha Blocker|alpha blocker
811715|NCT00201617|Unilateral hearing loss|unilateral hearing loss
811716|NCT00201617|Unilateral deafness|unilateral deafness
811717|NCT00201617|Bone anchored hearing aid|bone anchored hearing aid
811718|NCT00201591|Coronary artery disease|coronary artery disease
811719|NCT00201591|Exercise training|exercise training
811720|NCT00201591|Intensity|intensity
811721|NCT00201591|Randomized|randomized
811722|NCT00201591|echocardiography|echocardiography
811723|NCT00201591|Aerobic Exercise|aerobic exercise
811724|NCT00201578|Herbal Drugs|herbal drugs
811725|NCT00201578|Alternative medicine|alternative medicine
811726|NCT00201565|pulse wave velocity|pulse wave velocity
811727|NCT00201565|cardiovascular disease|cardiovascular disease
811728|NCT00201539|analgesics, opioid/pharmacokinetics|analgesics, opioid/pharmacokinetics
811729|NCT00201539|humans|humans
811730|NCT00201539|morphine/therapeutic use*|morphine/therapeutic use*
811731|NCT00201539|neoplasms|neoplasms
811732|NCT00201539|pain/drugtherapy|pain/drugtherapy
811733|NCT00201526|Bipolar Disorder|bipolar disorder
811734|NCT00201513|Muscle, Skeletal|muscle, skeletal
811735|NCT00201513|Neuromuscular control|neuromuscular control
811736|NCT00201513|Stability|stability
811737|NCT00201513|Exercise|exercise
811738|NCT00201513|Anticipatory muscle control|anticipatory muscle control
811739|NCT00201474|brief depressive episodes|brief depressive episodes
811740|NCT00201474|affective disorders|affective disorders
811741|NCT00201474|EEG and QEEG|eeg and qeeg
811742|NCT00201474|epilepsy|epilepsy
811743|NCT00201474|organic brain disorders|organic brain disorders
811744|NCT00201474|acute psychiatry|acute psychiatry
811745|NCT00201461|Patent Foramen Ovale|patent foramen ovale
811746|NCT00201461|STARFlex|starflex
811747|NCT00201461|CLOSURE I|closure i
811748|NCT00201461|Septal Closure System|septal closure system
811749|NCT00201461|Stroke|stroke
811750|NCT00201461|Cerebrovascular Accident|cerebrovascular accident
811751|NCT00201461|Transient Ischemic Attack|transient ischemic attack
811752|NCT00201461|Heart Septal Defects, Atrial|heart septal defects, atrial
811753|NCT00201448|CMV, cytomegalovirus, vaccine, Towne strain|cmv, cytomegalovirus, vaccine, towne strain
811754|NCT00201435|Breast|breast
811755|NCT00201435|Cancer|cancer
811756|NCT00201435|Paclitaxel|paclitaxel
811757|NCT00201435|Docetaxel|docetaxel
811758|NCT00201435|Qulaity of life|qulaity of life
811759|NCT00201422|MALT lymphoma|malt lymphoma
811760|NCT00201422|diffuse large B-cell lymphoma,|diffuse large b-cell lymphoma,
811761|NCT00201422|stomach|stomach
811762|NCT00201422|Helicobacter pylori|helicobacter pylori
811763|NCT00201422|antibiotic therapy|antibiotic therapy
811764|NCT00201396|A Multicenter Phase III Trial|a multicenter phase iii trial
811765|NCT00201396|Induction Chemotherapy|induction chemotherapy
811766|NCT00201396|Concurrent Chemoradiotherapy|concurrent chemoradiotherapy
811767|NCT00201396|Stage IV Nasopharyngeal Carcinoma (NPC)|stage iv nasopharyngeal carcinoma (npc)
811768|NCT00201396|randomization|randomization
811769|NCT00201396|disease-free survival|disease-free survival
811770|NCT00201370|cervical neoplasia;|cervical neoplasia;
811771|NCT00201370|human papillomavirus,|human papillomavirus,
811772|NCT00201370|PCR,|pcr,
811773|NCT00201370|risk factors,|risk factors,
811774|NCT00201370|Taiwan|taiwan
811775|NCT00201357|hormone-refractory prostate cancer|hormone-refractory prostate cancer
811777|NCT00201357|quality of life|quality of life
811778|NCT00201344|Radiotherapy|radiotherapy
811992|NCT00200187|Blood Loss|blood loss
811779|NCT00201344|Adjuvant chemotherapy|adjuvant chemotherapy
811780|NCT00201344|Chemtherapy|chemtherapy
811781|NCT00201344|Nasopharyngeal Carcinoma|nasopharyngeal carcinoma
811782|NCT00201292|Metabolic syndrome|metabolic syndrome
811783|NCT00201292|Diabetes|diabetes
811784|NCT00201292|Insulin resistance|insulin resistance
811785|NCT00201292|pharmacogenetics|pharmacogenetics
811786|NCT00201201|Older Adults|older adults
811787|NCT00201201|Primary Care|primary care
811788|NCT00201201|Hypertension|hypertension
811789|NCT00201201|Adherence|adherence
811790|NCT00201136|Behavioral intervention|behavioral intervention
811791|NCT00201136|Lifestyle modification|lifestyle modification
811792|NCT00201136|Guidelines|guidelines
811793|NCT00201110|African Americans|african americans
811794|NCT00201058|urban|urban
811795|NCT00201058|adolescents|adolescents
811796|NCT00201058|African American|african american
811797|NCT00201058|web-based|web-based
811798|NCT00201058|computer tailoring|computer tailoring
811799|NCT00201058|school based|school based
811800|NCT00201045|Hypertension management|hypertension management
811801|NCT00201045|Pharmacist management|pharmacist management
811802|NCT00201045|Physician pharmacist collaboration|physician pharmacist collaboration
811803|NCT00201045|Blood pressure control|blood pressure control
811804|NCT00200954|prospective|prospective
811805|NCT00200954|intervention|intervention
811806|NCT00200954|randomised|randomised
811807|NCT00200954|probiotics|probiotics
811808|NCT00200954|atopy|atopy
811809|NCT00200941|Restless Legs Syndrome|restless legs syndrome
811810|NCT00200941|Topiramate|topiramate
811811|NCT00200941|Actigraphy|actigraphy
811812|NCT00200941|Polysomnography|polysomnography
811813|NCT00200928|prospective|prospective
811814|NCT00200928|randomised|randomised
811815|NCT00200928|intervention|intervention
811817|NCT00200928|atopy|atopy
811818|NCT00200902|Major depressive disorder|major depressive disorder
811819|NCT00200902|MDD|mdd
811820|NCT00200902|Antidepressant|antidepressant
811821|NCT00200889|Acupuncture|acupuncture
811822|NCT00200889|Magnetic Resonance Imaging, Functional|magnetic resonance imaging, functional
811823|NCT00200889|Brain Mapping|brain mapping
811824|NCT00200889|healthy volunteers|healthy volunteers
811825|NCT00200889|Neuromodulation|neuromodulation
811826|NCT00200889|gastric MRI|gastric mri
811827|NCT00200876|Positron-Emission Tomography|positron-emission tomography
811828|NCT00200876|Endorphins|endorphins
811829|NCT00200876|Pain Relief|pain relief
811830|NCT00200876|Opioid Receptors|opioid receptors
811831|NCT00200876|Stress|stress
811832|NCT00200876|Analgesia|analgesia
811833|NCT00200863|light|light
811834|NCT00200863|wavelength|wavelength
811835|NCT00200863|action spectrum|action spectrum
811836|NCT00200863|circadian|circadian
811837|NCT00200863|melatonin|melatonin
811838|NCT00200863|alertness|alertness
811839|NCT00200863|performance|performance
811840|NCT00200863|arousal|arousal
811841|NCT00200850|Breathing|breathing
811842|NCT00200850|Allergy|allergy
811843|NCT00200850|Mites, House Dust|mites, house dust
811844|NCT00200837|oral mucosal pain|oral mucosal pain
811845|NCT00200837|oral inflammations|oral inflammations
811846|NCT00200837|anisillo|anisillo
811847|NCT00200837|cordonsillo|cordonsillo
811848|NCT00200837|Piperaceae|piperaceae
811849|NCT00200837|oral ulcers|oral ulcers
811850|NCT00200837|oral tumors|oral tumors
811851|NCT00200837|mucosal pain|mucosal pain
811852|NCT00200837|mucosal inflammations|mucosal inflammations
811853|NCT00200837|cordoncillo|cordoncillo
811854|NCT00200824|isoflavones|isoflavones
811855|NCT00200824|soy|soy
811856|NCT00200824|postmenopausal|postmenopausal
811857|NCT00200824|men|men
811858|NCT00200824|prostate|prostate
811859|NCT00200824|breast|breast
811860|NCT00200824|bone|bone
811861|NCT00200798|Milk Thistle|milk thistle
811862|NCT00200798|Silymarin|silymarin
811863|NCT00200798|pharmacokinetics|pharmacokinetics
811864|NCT00200798|drug interactions|drug interactions
811865|NCT00200798|Normal volunteers|normal volunteers
811866|NCT00200785|garlic|garlic
811867|NCT00200759|Vaccinium macrocarpon|vaccinium macrocarpon
811868|NCT00200759|Antioxidants|antioxidants
811869|NCT00200759|Drug Interactions|drug interactions
811870|NCT00200746|Hepatitis|hepatitis
811871|NCT00200746|Liver Diseases|liver diseases
811872|NCT00200746|Alcoholism|alcoholism
811873|NCT00200746|Arginine|arginine
811874|NCT00200733|acupuncture|acupuncture
811875|NCT00200733|patient narratives|patient narratives
811876|NCT00200733|qualitative methods|qualitative methods
811877|NCT00200720|Diet|diet
811878|NCT00200720|Carbohydrates|carbohydrates
811879|NCT00200720|Weight Loss|weight loss
811880|NCT00200707|Cell therapy|cell therapy
811881|NCT00200707|bone marrow mononuclear cells|bone marrow mononuclear cells
811882|NCT00200707|myocardial infarction|myocardial infarction
811883|NCT00200694|Proteinuria|proteinuria
811884|NCT00200694|ACEI|acei
811887|NCT00200694|blood pressure|blood pressure
812591|NCT00197392|EVD|evd
811888|NCT00200694|renal failure|renal failure
811889|NCT00200681|Secretory Multiple Myeloma|secretory multiple myeloma
811890|NCT00200681|First line treatment|first line treatment
811891|NCT00200681|Velcade®|velcade®
811892|NCT00200681|autograft|autograft
811893|NCT00200681|Newly diagnosed secretory Multiple Myeloma (MM)|newly diagnosed secretory multiple myeloma (mm)
811894|NCT00200642|Gastroesophageal reflux. PPI. Radiofrequency|gastroesophageal reflux. ppi. radiofrequency
811895|NCT00200629|Women|women
811896|NCT00200629|Diagnostic Testing|diagnostic testing
811897|NCT00200629|Radionuclide Imaging|radionuclide imaging
811898|NCT00200629|Stress Testing|stress testing
811899|NCT00200629|Adenosine|adenosine
811900|NCT00200616|Urinary tract infection|urinary tract infection
811901|NCT00200616|Vesico-renal reflux|vesico-renal reflux
811902|NCT00200616|Child|child
811903|NCT00200616|Antimicrobial prophylaxis|antimicrobial prophylaxis
811904|NCT00200616|Recurrence of urinary tract infection|recurrence of urinary tract infection
811905|NCT00200603|Calcium phosphate ceramic|calcium phosphate ceramic
811906|NCT00200603|tibial osteotomy|tibial osteotomy
811907|NCT00200603|osteoarthritis|osteoarthritis
811908|NCT00200590|prostaglandin|prostaglandin
811909|NCT00200590|analgesia|analgesia
811910|NCT00200590|congenital|congenital
811911|NCT00200590|heart|heart
811912|NCT00200590|defect|defect
811913|NCT00200590|induced|induced
811914|NCT00200577|Adjuvant therapy|adjuvant therapy
811915|NCT00200577|immunotherapy|immunotherapy
811916|NCT00200577|TIL|til
811917|NCT00200577|melanoma|melanoma
811918|NCT00200564|Pediatrics|pediatrics
811919|NCT00200564|ketamine|ketamine
811920|NCT00200564|postoperative analgesia|postoperative analgesia
811921|NCT00200564|nalbuphine|nalbuphine
811922|NCT00200564|Postoperative analgesia in children|postoperative analgesia in children
811923|NCT00200538|frontotemporal dementia|frontotemporal dementia
811924|NCT00200538|Mémantine|mémantine
811925|NCT00200538|Patients with frontotemporal dementia|patients with frontotemporal dementia
811926|NCT00200499|Nebivolol|nebivolol
811927|NCT00200499|Hypertension|hypertension
811928|NCT00200499|Beta-Blocker|beta-blocker
811929|NCT00200486|genetic microarray|genetic microarray
811930|NCT00200486|head and neck cancer|head and neck cancer
811931|NCT00200473|Nebivolol|nebivolol
811932|NCT00200473|Hypertension|hypertension
811933|NCT00200473|Beta-Blockers|beta-blockers
811934|NCT00200460|Nebivolol|nebivolol
811935|NCT00200460|Hypertension|hypertension
811936|NCT00200460|Beta-Blocker|beta-blocker
811937|NCT00200447|Parkinson|parkinson
811938|NCT00200447|brain imaging|brain imaging
811939|NCT00200434|Nebivolol|nebivolol
811940|NCT00200434|Beta-Blocker|beta-blocker
811941|NCT00200434|Hypertension|hypertension
811942|NCT00200421|Nebivolol|nebivolol
811943|NCT00200421|Atenolol|atenolol
811944|NCT00200421|Exercise|exercise
811945|NCT00200421|Hypertension|hypertension
811946|NCT00200408|cancer of head and neck|cancer of head and neck
811947|NCT00200408|smoking|smoking
811948|NCT00200369|HIV|hiv
811949|NCT00200369|Adherence|adherence
811950|NCT00200369|Antiretroviral therapy|antiretroviral therapy
811951|NCT00200369|Protease inhibitor|protease inhibitor
811952|NCT00200369|Lopinavir|lopinavir
811953|NCT00200343|Chronic hepatitis C, Ursodeoxycholic acid|chronic hepatitis c, ursodeoxycholic acid
811954|NCT00200330|weight loss|weight loss
811955|NCT00200330|physical activity|physical activity
811956|NCT00200330|diet|diet
811957|NCT00200330|home environment|home environment
811958|NCT00200317|Exercise|exercise
811959|NCT00200317|Internet|internet
811960|NCT00200317|Print|print
811961|NCT00200317|Randomized Controlled Trial|randomized controlled trial
811962|NCT00200317|Exercise Intervention|exercise intervention
811963|NCT00200304|Obesity|obesity
811964|NCT00200304|Weight loss|weight loss
811965|NCT00200304|Internet|internet
811966|NCT00200278|Exercise|exercise
811967|NCT00200278|Intervention studies|intervention studies
811968|NCT00200278|Decision-making|decision-making
811969|NCT00200278|computer assisted Expert systems|computer assisted expert systems
811970|NCT00200278|telephone|telephone
811971|NCT00200252|oxytocin|oxytocin
811972|NCT00200252|third stage|third stage
811973|NCT00200252|dose|dose
811974|NCT00200252|route|route
811975|NCT00200252|blood loss|blood loss
811976|NCT00200226|pain/discomfort|pain/discomfort
811977|NCT00200226|cervical dilatation|cervical dilatation
811978|NCT00200226|side effects|side effects
811979|NCT00200200|BEVACIZUMAB (AVASTIN)|bevacizumab (avastin)
811980|NCT00200200|DEXAMETHASONE|dexamethasone
811981|NCT00200200|FLOXURIDINE|floxuridine
811982|NCT00200200|FLUOROURACIL|fluorouracil
811983|NCT00200200|IRINOTECAN (CPT-11) CAMPTOSAR|irinotecan (cpt-11) camptosar
811984|NCT00200200|LEUCOVORIN|leucovorin
811985|NCT00200200|OXALIPLATIN|oxaliplatin
811986|NCT00200200|Colon|colon
811987|NCT00200200|Rectal|rectal
811988|NCT00200200|04-086|04-086
811989|NCT00200200|Adjuvant postoperative chemo for CLM|adjuvant postoperative chemo for clm
811990|NCT00200187|Prostatectomy|prostatectomy
811991|NCT00200187|Anesthesia|anesthesia
811993|NCT00200174|Breast cancer|breast cancer
811994|NCT00200174|estrogen|estrogen
811995|NCT00200174|postmenopausal|postmenopausal
811996|NCT00200148|Pancreaticoduodenectomy|pancreaticoduodenectomy
811997|NCT00200148|Hepatectomy|hepatectomy
811998|NCT00200148|Major Hepatic resection|major hepatic resection
811999|NCT00200148|Acute Normovolemic Hemodilution|acute normovolemic hemodilution
812000|NCT00200135|motorcycle accident|motorcycle accident
812001|NCT00200135|helmet|helmet
812002|NCT00200135|traumatic brain injury|traumatic brain injury
812003|NCT00200135|financial burden|financial burden
812004|NCT00200096|Cancer|cancer
812005|NCT00200096|Fatigue|fatigue
812006|NCT00200083|Obesity|obesity
812007|NCT00200083|Morbid Obesity|morbid obesity
812008|NCT00200083|SHAPE|shape
812009|NCT00200083|IGS|igs
812010|NCT00200083|Implantable Gastric Stimulator|implantable gastric stimulator
812011|NCT00200070|Angina Pectoris Pain|angina pectoris pain
812012|NCT00200057|Fecal Incontinence|fecal incontinence
812013|NCT00200057|InterStim|interstim
812014|NCT00200044|GERD|gerd
812015|NCT00200018|Obesity|obesity
812016|NCT00200018|Morbid obesity|morbid obesity
812017|NCT00200018|Diabetes|diabetes
812018|NCT00200005|Slow transit constipation|slow transit constipation
812019|NCT00200005|Fecal incontinence|fecal incontinence
812020|NCT00200005|Constipation|constipation
812021|NCT00200005|Idiopathic slow transit constipation|idiopathic slow transit constipation
812022|NCT00200005|Chronic constipation|chronic constipation
812023|NCT00199992|acute wounds|acute wounds
812024|NCT00199992|wounds|wounds
812025|NCT00199992|platelets|platelets
812026|NCT00199992|platelet gel|platelet gel
812027|NCT00199979|Antiretroviral Therapy|antiretroviral therapy
812028|NCT00199979|Nevirapine|nevirapine
812029|NCT00199979|HIV Viral Load|hiv viral load
812030|NCT00199979|Adherence|adherence
812031|NCT00199979|Quality of Life|quality of life
812032|NCT00199979|Resistance Mutations|resistance mutations
812033|NCT00199966|Bipolar Disorder; Pediatric Bipolar Disorder; Depakote ER|bipolar disorder; pediatric bipolar disorder; depakote er
812034|NCT00199953|Postnasal drainage|postnasal drainage
812035|NCT00199953|Extraesophageal reflux|extraesophageal reflux
812036|NCT00199940|Schizophrenia|schizophrenia
812037|NCT00199940|Pediatric psychotic disorders|pediatric psychotic disorders
812038|NCT00199940|Ziprasidone|ziprasidone
812039|NCT00199914|Diathermy|diathermy
812040|NCT00199914|Short-wave therapy|short-wave therapy
812041|NCT00199914|Osteoarthritis|osteoarthritis
812042|NCT00199914|Knee|knee
812043|NCT00199901|Phase II|phase ii
812044|NCT00199901|Randomized Controlled Trial|randomized controlled trial
812045|NCT00199901|Double-Blind|double-blind
812046|NCT00199901|Cancer Vaccine|cancer vaccine
812047|NCT00199901|NY-ESO-1 protein, human|ny-eso-1 protein, human
812048|NCT00199901|ISCOMATRIX, immunological adjuvant|iscomatrix, immunological adjuvant
812049|NCT00199888|Kidney Cancer|kidney cancer
812050|NCT00199888|Renal Cancer|renal cancer
812051|NCT00199888|Neoplasms, Kidney|neoplasms, kidney
812052|NCT00199888|cG250|cg250
812053|NCT00199888|antibody|antibody
812054|NCT00199888|Iodine 124|iodine 124
812055|NCT00199875|antibody|antibody
812056|NCT00199875|renal cell carcinoma|renal cell carcinoma
812057|NCT00199875|advanced renal cancer|advanced renal cancer
812058|NCT00199875|cG250|cg250
812059|NCT00199875|^90Y|^90y
812060|NCT00199862|huA33|hua33
812061|NCT00199862|antibody|antibody
812062|NCT00199862|colorectal cancer|colorectal cancer
812063|NCT00199862|Iodine 124|iodine 124
812064|NCT00199862|124I|124i
812065|NCT00199862|03-124|03-124
812066|NCT00199849|NY-ESO-1|ny-eso-1
812067|NCT00199849|DNA|dna
812068|NCT00199836|cancer vaccine|cancer vaccine
812069|NCT00199836|NY-ESO-1b peptide|ny-eso-1b peptide
812070|NCT00199836|CpG 7909|cpg 7909
812071|NCT00199836|Montanide ISA-51|montanide isa-51
812072|NCT00199836|LAGE-1|lage-1
812073|NCT00199836|immune response|immune response
812074|NCT00199836|safety|safety
812075|NCT00199823|Myocardial infarction|myocardial infarction
812076|NCT00199823|bone marrow cells|bone marrow cells
812077|NCT00199823|cell transplantation|cell transplantation
812078|NCT00199810|Cardiac output|cardiac output
812079|NCT00199810|Preeclamptic women|preeclamptic women
812080|NCT00199810|systemic vascular resistance|systemic vascular resistance
812081|NCT00199810|blood pressure|blood pressure
812082|NCT00199797|Colorectal Cancer|colorectal cancer
812083|NCT00199797|huA33|hua33
812084|NCT00199797|antibody|antibody
812085|NCT00199797|chemotherapy|chemotherapy
812086|NCT00199784|Hemodynamic|hemodynamic
812087|NCT00199784|Hypotension|hypotension
812088|NCT00199784|Spinal|spinal
812089|NCT00199784|Anesthesia|anesthesia
812090|NCT00199784|Healthy pregnant women for elective cesarean section|healthy pregnant women for elective cesarean section
812091|NCT00199771|Cardiac Surgery|cardiac surgery
812092|NCT00199771|Infant|infant
812093|NCT00199771|Infant, Newborn|infant, newborn
812094|NCT00199771|Hypertonic Solutions|hypertonic solutions
812095|NCT00199771|Saline Solution, Hypertonic|saline solution, hypertonic
812096|NCT00199771|Capillary leak|capillary leak
812097|NCT00199771|Inflammation Mediators|inflammation mediators
812098|NCT00199758|Non small cell lung carcinoma|non small cell lung carcinoma
812099|NCT00199758|Cisplatin|cisplatin
812100|NCT00199758|Gemcitabine|gemcitabine
812101|NCT00199758|Paclitaxel|paclitaxel
812102|NCT00199745|statin|statin
812103|NCT00199745|statins|statins
812104|NCT00199745|statin therapy|statin therapy
812105|NCT00199745|adverse events|adverse events
812106|NCT00199745|side effect|side effect
812107|NCT00199745|Myotoxicity|myotoxicity
812108|NCT00199745|atorvastatin|atorvastatin
812109|NCT00199745|Atorvastatin Therapy|atorvastatin therapy
812110|NCT00199732|Chronic hepatitis B|chronic hepatitis b
812111|NCT00199732|CCC DNA kinetics|ccc dna kinetics
812112|NCT00199732|Total HBV DNA kinetics|total hbv dna kinetics
812113|NCT00199732|Adefovir-Dipovixil|adefovir-dipovixil
812114|NCT00199732|Peg interferon alpha 2a|peg interferon alpha 2a
812115|NCT00199719|drug monitoring|drug monitoring
812116|NCT00199719|ribavirin-pharmacokinetic|ribavirin-pharmacokinetic
812117|NCT00199719|pharmacodynamics|pharmacodynamics
812118|NCT00199719|chronic hepatitis C|chronic hepatitis c
812119|NCT00199719|non 2 non 3 genotype|non 2 non 3 genotype
812120|NCT00199706|Intracranial Pressure|intracranial pressure
812121|NCT00199706|Intracranial Hypertension|intracranial hypertension
812122|NCT00199706|Hypertonic Solutions|hypertonic solutions
812123|NCT00199706|Saline Solutions, Hypertonic|saline solutions, hypertonic
812124|NCT00199693|Hemodynamic and respiratory changes and pregnancy|hemodynamic and respiratory changes and pregnancy
812125|NCT00199693|Healthy pregnant women|healthy pregnant women
812126|NCT00199680|PETscan, cervical cancer|petscan, cervical cancer
812127|NCT00199667|MMF, Monitoring, area under curve (AUC), kidney transplantation|mmf, monitoring, area under curve (auc), kidney transplantation
812128|NCT00199654|colorectal cancer stage II and III|colorectal cancer stage ii and iii
812129|NCT00199628|fetomaternal tissular alloimmunization|fetomaternal tissular alloimmunization
812130|NCT00199628|Mothers having a child suffering from:|mothers having a child suffering from:
812131|NCT00199628|neonatal membranous glomerulonephritis|neonatal membranous glomerulonephritis
812132|NCT00199628|unexplained neonatal tubular defect|unexplained neonatal tubular defect
812133|NCT00199628|unexplained thrombotic microangiopathy|unexplained thrombotic microangiopathy
812134|NCT00199628|neonatal hemochromatosis|neonatal hemochromatosis
812135|NCT00199615|lung cancer, 18 FDG, PET|lung cancer, 18 fdg, pet
812136|NCT00199589|Spastic equinovarus|spastic equinovarus
812137|NCT00199589|Botox|botox
812138|NCT00199589|Ankle foot orthosis|ankle foot orthosis
812139|NCT00199576|Corticosteroids|corticosteroids
812140|NCT00199576|Laryngotracheal injury|laryngotracheal injury
812141|NCT00199576|Intubation-extubation|intubation-extubation
812142|NCT00199563|Viagra|viagra
812143|NCT00199563|sildenafil|sildenafil
812144|NCT00199550|Transurethral Resection of Prostate|transurethral resection of prostate
812145|NCT00199550|TURP|turp
812146|NCT00199524|ureteroscopy|ureteroscopy
812147|NCT00199524|stone free|stone free
812148|NCT00199511|Brain Tumor|brain tumor
812149|NCT00199511|Intracranial Pressure|intracranial pressure
812150|NCT00199511|Osmolarity|osmolarity
812151|NCT00199511|Seric|seric
812152|NCT00199511|Hypertonic Solution|hypertonic solution
812153|NCT00199498|Permanent Pacemaker Implantation- Lead Position|permanent pacemaker implantation- lead position
812154|NCT00199485|prostate cancer|prostate cancer
812155|NCT00199485|Luteinizing Hormone Releasing Hormone|luteinizing hormone releasing hormone
812156|NCT00199485|LHRH|lhrh
812157|NCT00199459|calculi|calculi
812158|NCT00199459|proteomics|proteomics
812159|NCT00199446|Sleep -Sleep Disorder|sleep -sleep disorder
812160|NCT00199446|Sleep- Restless Legs Syndrome|sleep- restless legs syndrome
812161|NCT00199446|Clinical Trial|clinical trial
812162|NCT00199433|Parkinson's Disease|parkinson's disease
812163|NCT00199433|Movement Disorder|movement disorder
812164|NCT00199433|Neurology,|neurology,
812165|NCT00199433|Clinical Trial|clinical trial
812166|NCT00199420|levodopa|levodopa
812167|NCT00199420|end of dose wearing off|end of dose wearing off
812168|NCT00199420|OFF time|off time
812169|NCT00199407|Parkinson's disease|parkinson's disease
812170|NCT00199407|levodopa|levodopa
812171|NCT00199407|end of dose wearing off|end of dose wearing off
812172|NCT00199407|OFF time|off time
812173|NCT00199394|KW-6002 (istradefylline)|kw-6002 (istradefylline)
812174|NCT00199394|Entacapone|entacapone
812175|NCT00199394|Placebo|placebo
812176|NCT00199394|Parkinson's Disease|parkinson's disease
812177|NCT00199394|Motor Response Complications|motor response complications
812178|NCT00199394|Levodopa Therapy|levodopa therapy
812179|NCT00199381|Parkinson's Disease|parkinson's disease
812180|NCT00199381|levodopa|levodopa
812181|NCT00199381|end of dose wearing off|end of dose wearing off
812182|NCT00199381|OFF time|off time
812183|NCT00199368|Parkinson's disease|parkinson's disease
812184|NCT00199368|levodopa|levodopa
812185|NCT00199368|end of dose wearing off|end of dose wearing off
812186|NCT00199368|OFF time|off time
812187|NCT00199355|Parkinson's Disease|parkinson's disease
812188|NCT00199355|levodopa|levodopa
812189|NCT00199355|end of dose wearing off|end of dose wearing off
812190|NCT00199355|OFF time|off time
812191|NCT00199342|Melanoma|melanoma
812192|NCT00199342|Monoclonal Antibody|monoclonal antibody
812193|NCT00199342|Anti-GD-3|anti-gd-3
812194|NCT00199329|ondansetron|ondansetron
812195|NCT00199329|PCA|pca
812196|NCT00199316|patient who recieve kidney surgery and Patient controlled anesthesia with spinal morphine, intrathecal|patient who recieve kidney surgery and patient controlled anesthesia with spinal morphine, intrathecal
812197|NCT00199303|NMDAreceptor antagonist, dextromethorphan|nmdareceptor antagonist, dextromethorphan
812198|NCT00199303|pain, post-operative|pain, post-operative
812199|NCT00199303|opioid consumption, morphine|opioid consumption, morphine
812200|NCT00199290|Trafermin|trafermin
812201|NCT00199290|Periodontitis|periodontitis
812202|NCT00199264|antifungal oral therapy|antifungal oral therapy
812203|NCT00199264|efficacy acute candidiasis vulvaginitis|efficacy acute candidiasis vulvaginitis
812204|NCT00199251|URTICARIA, WHEALS, FLARE, ANTIHISTAMINE, ANTIHISTAMINE|urticaria, wheals, flare, antihistamine, antihistamine
812205|NCT00199238|ANTIHISTAMINE|antihistamine
812206|NCT00199238|RUPATADINE|rupatadine
812207|NCT00199238|WHEAL|wheal
812208|NCT00199238|FLARE|flare
812209|NCT00199238|DERMATOLOGY|dermatology
812210|NCT00199225|Thorough study QT/QTc|thorough study qt/qtc
812211|NCT00199225|Cardiac repolarization|cardiac repolarization
812212|NCT00199225|QT prolongation|qt prolongation
812213|NCT00199212|HER-2 positive|her-2 positive
812214|NCT00199212|metastatic breast cancer patients|metastatic breast cancer patients
812215|NCT00199173|colorectal cancer|colorectal cancer
812216|NCT00199173|liver metastasis|liver metastasis
812217|NCT00199173|intraarterial hepatic injection|intraarterial hepatic injection
812218|NCT00199173|yttrium loaded microspheres|yttrium loaded microspheres
812219|NCT00199173|colorectal neoplasm metastatic to the liver|colorectal neoplasm metastatic to the liver
812220|NCT00199160|local recurrence and or metastatic disease|local recurrence and or metastatic disease
812221|NCT00199160|Previously treated with platinum|previously treated with platinum
812222|NCT00199160|carcinoma of the head and neck|carcinoma of the head and neck
812223|NCT00199134|neoadjuvant treatment|neoadjuvant treatment
812224|NCT00199108|CNS relapse|cns relapse
812225|NCT00199108|ALL|all
812226|NCT00199108|Treatment|treatment
812227|NCT00199095|ALL|all
812228|NCT00199095|Elderly|elderly
812229|NCT00199095|Chemotherapy|chemotherapy
812230|NCT00199082|High-grade NHL|high-grade nhl
812231|NCT00199082|De novo|de novo
812232|NCT00199082|Mature B-ALL|mature b-all
812233|NCT00199082|Burkitt'S NHL|burkitt's nhl
812234|NCT00199082|Chemotherapy|chemotherapy
812235|NCT00199082|Rituximab|rituximab
812236|NCT00199082|Primary mediastinal diffuse large cell lymphoma|primary mediastinal diffuse large cell lymphoma
812237|NCT00199082|B-precursor lymphoblastic lymphoma|b-precursor lymphoblastic lymphoma
812238|NCT00199069|ALL|all
812239|NCT00199069|Treatment|treatment
812240|NCT00199069|De Novo|de novo
812241|NCT00199069|Adult|adult
812242|NCT00199056|ALL|all
812243|NCT00199056|Treatment|treatment
812244|NCT00199056|De Novo|de novo
812245|NCT00199056|Adult|adult
812246|NCT00199030|Relapse|relapse
812247|NCT00199030|T-ALL|t-all
812248|NCT00199030|T-LBL|t-lbl
812249|NCT00199030|MabCampath|mabcampath
812250|NCT00199030|Minimal residual disease|minimal residual disease
812251|NCT00199030|Lymphoma, lymphoblastic, T-cell|lymphoma, lymphoblastic, t-cell
812252|NCT00199017|T-LBL|t-lbl
812253|NCT00199017|Treatment|treatment
812254|NCT00199017|De novo|de novo
812255|NCT00199017|Chemotherapy|chemotherapy
812256|NCT00199017|Adult|adult
812257|NCT00199017|Lymphoma, lymphoblastic, T-cell|lymphoma, lymphoblastic, t-cell
812258|NCT00199004|ALL|all
812259|NCT00199004|Treatment|treatment
812260|NCT00199004|De novo|de novo
812261|NCT00199004|Minimal residual disease|minimal residual disease
812262|NCT00199004|Rituximab|rituximab
812263|NCT00199004|Adult|adult
812264|NCT00198991|ALL|all
812265|NCT00198991|Treatment|treatment
812266|NCT00198991|de novo|de novo
812267|NCT00198991|Minimal residual disease|minimal residual disease
812268|NCT00198991|Adult|adult
812269|NCT00198978|ALL|all
812270|NCT00198978|Treatment|treatment
812271|NCT00198978|Elderly|elderly
812272|NCT00198978|De novo|de novo
812273|NCT00198939|drug prevention|drug prevention
812274|NCT00198939|adolescence|adolescence
812275|NCT00198939|middle school|middle school
812276|NCT00198939|randomized trial|randomized trial
812277|NCT00198939|family therapy|family therapy
812278|NCT00198939|cognitive-behavioral|cognitive-behavioral
812279|NCT00198939|efficacy|efficacy
812280|NCT00198939|selected youth|selected youth
812281|NCT00198939|indicated youth|indicated youth
812282|NCT00198887|newborn|newborn
812283|NCT00198887|operations research|operations research
812284|NCT00198887|newborn survival|newborn survival
812285|NCT00198887|Neonatal illness/mortality|neonatal illness/mortality
812286|NCT00198887|Delivery complications|delivery complications
812287|NCT00198874|drug abuse|drug abuse
812288|NCT00198874|drug dependence|drug dependence
812289|NCT00198874|treatment|treatment
812290|NCT00198874|randomized trial|randomized trial
812291|NCT00198874|stage II study|stage ii study
812292|NCT00198874|adolescents|adolescents
812293|NCT00198874|young adults|young adults
812294|NCT00198874|efficacy study|efficacy study
812295|NCT00198861|HIV Epidemiology|hiv epidemiology
812296|NCT00198861|Neurology|neurology
812297|NCT00198861|Neuropsychological|neuropsychological
812298|NCT00198861|HIV Risk Factors|hiv risk factors
812299|NCT00198861|Cognitive Risk Factors|cognitive risk factors
812301|NCT00198848|Iron deficiency anemia|iron deficiency anemia
812302|NCT00198848|Adolescent girls|adolescent girls
812303|NCT00198848|India|india
812304|NCT00198835|malnutrition|malnutrition
812305|NCT00198835|anemia|anemia
812306|NCT00198835|infants|infants
812307|NCT00198835|children|children
812308|NCT00198835|India|india
812309|NCT00198822|Maternal mortality|maternal mortality
812310|NCT00198822|Infant mortality|infant mortality
812311|NCT00198822|Vitamin A|vitamin a
812312|NCT00198822|Beta-carotene|beta-carotene
812313|NCT00198822|Micronutrients|micronutrients
812314|NCT00198822|Bangladesh|bangladesh
812315|NCT00198822|Neonatal mortality|neonatal mortality
812316|NCT00198731|maternal health|maternal health
812317|NCT00198731|Bangladesh|bangladesh
812318|NCT00198731|care seeking|care seeking
812319|NCT00198718|Vitamin A supplementation|vitamin a supplementation
812320|NCT00198718|HIV|hiv
812321|NCT00198718|Mother to child transmission of HIV|mother to child transmission of hiv
812322|NCT00198718|Breastfeeding|breastfeeding
812323|NCT00198692|amputation|amputation
812324|NCT00198692|depression|depression
812325|NCT00198692|pain|pain
812326|NCT00198692|anxiety|anxiety
812327|NCT00198692|self-management|self-management
812328|NCT00198692|secondary conditions|secondary conditions
812329|NCT00198679|skin cleansing|skin cleansing
812330|NCT00198679|Bangladesh|bangladesh
812331|NCT00198679|Skin Flora|skin flora
812332|NCT00198679|Newborn|newborn
812333|NCT00198679|infectious disease|infectious disease
812334|NCT00198679|chlorhexidine|chlorhexidine
812335|NCT00198666|Pneumonia|pneumonia
812336|NCT00198666|zinc|zinc
812337|NCT00198653|Hypothermia|hypothermia
812338|NCT00198653|Newborn|newborn
812339|NCT00198653|India|india
812340|NCT00198653|Maternal/Child Health|maternal/child health
812341|NCT00198653|Infant|infant
812342|NCT00198653|Kangaroo Mother Care|kangaroo mother care
812343|NCT00198640|animal antibiotics|animal antibiotics
812344|NCT00198640|human antibiotics|human antibiotics
812345|NCT00198627|Neonatal bacterial infection|neonatal bacterial infection
812346|NCT00198614|Adrenergic beta-Antagonists|adrenergic beta-antagonists
812347|NCT00198614|Carvedilol|carvedilol
812348|NCT00198614|Metoprolol|metoprolol
812349|NCT00198614|Coronary Artery Bypass|coronary artery bypass
812350|NCT00198614|Atrial Fibrillation|atrial fibrillation
812351|NCT00198601|meningitis|meningitis
812352|NCT00198601|neonatal deaths|neonatal deaths
812353|NCT00198601|gentamicin|gentamicin
812354|NCT00198601|Uniject|uniject
812355|NCT00198601|aminoglycoside|aminoglycoside
812356|NCT00198588|heparin-induced thrombocytopenia|heparin-induced thrombocytopenia
812357|NCT00198588|argatroban|argatroban
812358|NCT00198588|cardiac surgery|cardiac surgery
812359|NCT00198588|acute coronary syndrome|acute coronary syndrome
812360|NCT00198588|thrombosis|thrombosis
812361|NCT00198588|amputation|amputation
812362|NCT00198588|anticoagulation|anticoagulation
812363|NCT00198575|heparin-induced thrombocytopenia|heparin-induced thrombocytopenia
812364|NCT00198575|cardiovascular surgery|cardiovascular surgery
812365|NCT00198575|percutaneous coronary intervention|percutaneous coronary intervention
812366|NCT00198562|Antihypertensive therapy|antihypertensive therapy
812367|NCT00198562|Home blood pressure|home blood pressure
812368|NCT00198562|Systolic blood pressure|systolic blood pressure
812369|NCT00198562|Morning blood pressure|morning blood pressure
812370|NCT00198562|Calcium antagonist|calcium antagonist
812371|NCT00198562|Angiotensin receptor antagonist|angiotensin receptor antagonist
812372|NCT00198549|Adjuvants, Anesthesia|adjuvants, anesthesia
812373|NCT00198549|hyaluronate lyase|hyaluronate lyase
812374|NCT00198523|Cataract Extraction|cataract extraction
812375|NCT00198523|Anti-Bacterial Agents|anti-bacterial agents
812376|NCT00198523|Steroids|steroids
812377|NCT00198484|Adjuvants, Anesthesia|adjuvants, anesthesia
812378|NCT00198484|Spreading Factor|spreading factor
812379|NCT00198445|Cataract Extraction|cataract extraction
812380|NCT00198445|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal
812381|NCT00198393|stage IIIB/IV NSCLC|stage iiib/iv nsclc
812382|NCT00198393|patients with performance status 2 or 3.|patients with performance status 2 or 3.
812383|NCT00198380|Adenocarcinoma, Bronchiolo-Alveolar|adenocarcinoma, bronchiolo-alveolar
812384|NCT00198367|operable and resectable stage IIIA (T1-3, N2) NSCLC|operable and resectable stage iiia (t1-3, n2) nsclc
812385|NCT00198341|Post-surgical Non-small cell lung cancer|post-surgical non-small cell lung cancer
812386|NCT00198328|Squamous Cell Carcinoma|squamous cell carcinoma
812387|NCT00198328|carcinoma|carcinoma
812388|NCT00198328|head and neck cancer|head and neck cancer
812389|NCT00198328|larynx|larynx
812390|NCT00198328|electroporation|electroporation
812391|NCT00198328|medpulser|medpulser
812394|NCT00198328|Locally recurrent or second primary squamous cell carcinoma of the base of the tongue, posterior lateral pharyngeal wall, hypopharynx, or larynx|locally recurrent or second primary squamous cell carcinoma of the base of the tongue, posterior lateral pharyngeal wall, hypopharynx, or larynx
812395|NCT00198315|Squamous Cell Carcinoma|squamous cell carcinoma
812396|NCT00198315|Carcinoma|carcinoma
812397|NCT00198315|Head and Neck Cancer|head and neck cancer
812398|NCT00198315|Oral|oral
812399|NCT00198315|Soft Palate|soft palate
812400|NCT00198315|Cancer|cancer
812401|NCT00198315|Medpulser|medpulser
812402|NCT00198315|Electroporation|electroporation
812403|NCT00198315|Local recurrent or second primary squamous cell carcinoma of anterior oral cavity, soft palate, or tonsil|local recurrent or second primary squamous cell carcinoma of anterior oral cavity, soft palate, or tonsil
812404|NCT00198302|staphylococcus aureus|staphylococcus aureus
812405|NCT00198302|bacteremia|bacteremia
812406|NCT00198302|sepsis|sepsis
812407|NCT00198289|Cystic Fibrosis|cystic fibrosis
812408|NCT00198289|Staphylococcus aureus|staphylococcus aureus
812409|NCT00198289|lungs|lungs
812410|NCT00198276|cancer|cancer
812411|NCT00198276|cutaneous|cutaneous
812412|NCT00198276|subcutaneous|subcutaneous
812413|NCT00198276|MedPulser|medpulser
812414|NCT00198276|bleomycin|bleomycin
812415|NCT00198276|electroporation|electroporation
812416|NCT00198276|Cutaneous or subcutaneous cancer|cutaneous or subcutaneous cancer
812417|NCT00198263|head and neck cancer|head and neck cancer
812418|NCT00198263|cancer|cancer
812419|NCT00198263|bleomycin|bleomycin
812420|NCT00198263|medpulser|medpulser
812421|NCT00198263|electroporation|electroporation
812422|NCT00198263|primary oral cavity, primary pharyngeal, primary laryngeal, salivary gland, limited recurrent and second primary tumors|primary oral cavity, primary pharyngeal, primary laryngeal, salivary gland, limited recurrent and second primary tumors
812423|NCT00198250|Breast cancer survivorship|breast cancer survivorship
812424|NCT00198250|hot flashes|hot flashes
812425|NCT00198250|treatment|treatment
812426|NCT00198237|Breast Cancer|breast cancer
812427|NCT00198237|Stage II Breast Cancer|stage ii breast cancer
812428|NCT00198237|Stage III Breast Cancer|stage iii breast cancer
812429|NCT00198224|immunosuppression|immunosuppression
812430|NCT00198185|Full Thickness Tendon Defect of Rotator Cuff|full thickness tendon defect of rotator cuff
812431|NCT00198172|Germ Cell Tumor|germ cell tumor
812432|NCT00198172|Refractory Germ Cell Tumors|refractory germ cell tumors
812433|NCT00198172|Cisplatin plus Epirubicin Salvage Chemotherapy|cisplatin plus epirubicin salvage chemotherapy
812434|NCT00198159|Refractory Germ Cell Tumors|refractory germ cell tumors
812435|NCT00198159|Germ Cell Tumors|germ cell tumors
812436|NCT00198133|Thymoma|thymoma
812437|NCT00198133|Thymic Carcinoma|thymic carcinoma
812438|NCT00198120|Autistic Disorder|autistic disorder
812439|NCT00198120|cycloserine|cycloserine
812440|NCT00198120|pharmacology|pharmacology
812441|NCT00198120|glutamatergic agents|glutamatergic agents
812442|NCT00198120|communication|communication
812443|NCT00198120|social interaction|social interaction
812444|NCT00198120|Double-Blind Method|double-blind method
812445|NCT00198107|Children|children
812446|NCT00198107|Adolescents|adolescents
812447|NCT00198107|Aripiprazole|aripiprazole
812448|NCT00198107|Cycloserine|cycloserine
812449|NCT00198107|Aggression|aggression
812450|NCT00198107|Irritability|irritability
812451|NCT00198107|Self-Injurious Behavior|self-injurious behavior
812452|NCT00198107|Social Interaction|social interaction
812453|NCT00198107|Antipsychotics|antipsychotics
812454|NCT00198107|Pharmacology|pharmacology
812455|NCT00198107|Glutamatergic Agents|glutamatergic agents
812456|NCT00198081|celecoxib for pancreas lesions|celecoxib for pancreas lesions
812457|NCT00198068|Pregnancy outcomes|pregnancy outcomes
812458|NCT00198068|Systemic lupus erythematosus|systemic lupus erythematosus
812459|NCT00198068|Antiphospholipid syndrome|antiphospholipid syndrome
812460|NCT00198055|Aggression|aggression
812461|NCT00198055|Behavioral symptoms|behavioral symptoms
812462|NCT00198042|ACL|acl
812463|NCT00198042|Tunnel|tunnel
812464|NCT00198042|Widening|widening
812465|NCT00198029|Osteoarthritis|osteoarthritis
812466|NCT00198029|Hyaluronan|hyaluronan
812467|NCT00198029|Carpometacarpal|carpometacarpal
812468|NCT00198029|Outcomes|outcomes
812469|NCT00198016|coronary fistulas.|coronary fistulas.
812470|NCT00198016|coils embolization.|coils embolization.
812471|NCT00198003|hip arthritis|hip arthritis
812472|NCT00198003|total hip arthroplasty|total hip arthroplasty
812473|NCT00198003|expectations|expectations
812474|NCT00198003|education|education
812475|NCT00197990|total hip arthroplasty|total hip arthroplasty
812476|NCT00197990|expectations|expectations
812477|NCT00197990|satisfaction|satisfaction
812478|NCT00197990|quality of life|quality of life
812479|NCT00197977|knee arthritis|knee arthritis
812480|NCT00197977|total knee arthroplasty|total knee arthroplasty
812481|NCT00197977|expectations|expectations
812482|NCT00197977|education|education
812483|NCT00197964|Self-management|self-management
812484|NCT00197964|Self-efficacy|self-efficacy
812485|NCT00197964|Quality of life|quality of life
812486|NCT00197964|Resource utilization|resource utilization
812592|NCT00197379|androgenetic alopecia|androgenetic alopecia
812487|NCT00197951|Psychiatric symptoms associated to alcoholism recovery|psychiatric symptoms associated to alcoholism recovery
812488|NCT00197951|Alcoholism treatment|alcoholism treatment
812489|NCT00197951|Alcohol craving|alcohol craving
812490|NCT00197951|Relapse to heavy drinking|relapse to heavy drinking
812491|NCT00197951|Abuse of other substances during alcoholism recovery|abuse of other substances during alcoholism recovery
812492|NCT00197925|breast cancer|breast cancer
812493|NCT00197925|dendritic cells|dendritic cells
812494|NCT00197925|vaccine|vaccine
812495|NCT00197912|dendritic cell|dendritic cell
812496|NCT00197912|cancer vaccine|cancer vaccine
812497|NCT00197912|cyclophosphamide|cyclophosphamide
812498|NCT00197912|melanoma|melanoma
812499|NCT00197873|colorectal cancer|colorectal cancer
812500|NCT00197873|probiotics|probiotics
812501|NCT00197873|chemotherapy|chemotherapy
812502|NCT00197873|prevention|prevention
812503|NCT00197873|adverse effects|adverse effects
812504|NCT00197873|diarrhoea|diarrhoea
812505|NCT00197860|dendritic cell|dendritic cell
812506|NCT00197860|vaccine|vaccine
812507|NCT00197860|renal cell carcinoma|renal cell carcinoma
812508|NCT00197834|Depakote|depakote
812509|NCT00197834|Agitation|agitation
812510|NCT00197834|Dementia|dementia
812511|NCT00197834|Atypical antipsychotic|atypical antipsychotic
812512|NCT00197834|Behavioral Symptoms|behavioral symptoms
812513|NCT00197834|Psychiatric Symptoms|psychiatric symptoms
812514|NCT00197834|Psychological Symptoms|psychological symptoms
812515|NCT00197834|Geriatric|geriatric
812516|NCT00197834|Behavioral and Psychological Symptoms|behavioral and psychological symptoms
812517|NCT00197808|Streptococcus pneumoniae|streptococcus pneumoniae
812518|NCT00197808|Neisseria meningitidis|neisseria meningitidis
812519|NCT00197756|HIV|hiv
812520|NCT00197756|Breastfeeding|breastfeeding
812521|NCT00197756|Vitamins|vitamins
812522|NCT00197756|Tanzania|tanzania
812523|NCT00197756|Children|children
812524|NCT00197743|HIV|hiv
812525|NCT00197743|Multivitamins|multivitamins
812526|NCT00197743|Pregnancy outcomes|pregnancy outcomes
812527|NCT00197743|Tanzania|tanzania
812528|NCT00197743|Women|women
812529|NCT00197730|Birth Outcomes|birth outcomes
812530|NCT00197730|Nutrition|nutrition
812531|NCT00197730|HIV|hiv
812532|NCT00197730|AIDS|aids
812533|NCT00197730|Vitamins|vitamins
812534|NCT00197730|Multivitamins|multivitamins
812535|NCT00197730|Maternal and child health outcomes|maternal and child health outcomes
812536|NCT00197730|Tanzania|tanzania
812537|NCT00197730|Africa|africa
812538|NCT00197704|Tuberculosis|tuberculosis
812539|NCT00197704|HIV|hiv
812540|NCT00197704|Tanzania|tanzania
812541|NCT00197704|multivitamins|multivitamins
812542|NCT00197691|HIV infected mothers|hiv infected mothers
812543|NCT00197691|Infants at risk of HIV-infection|infants at risk of hiv-infection
812544|NCT00197691|Infant lower respiratory tract disease|infant lower respiratory tract disease
812545|NCT00197691|Infant bloodstream infection|infant bloodstream infection
812546|NCT00197678|HIV|hiv
812547|NCT00197678|AIDS|aids
812548|NCT00197678|Multivitamins|multivitamins
812549|NCT00197678|Pregnancy Outcomes|pregnancy outcomes
812550|NCT00197678|Women|women
812551|NCT00197678|Tanzania|tanzania
812552|NCT00197678|Africa|africa
812553|NCT00197652|Prevention of Mother-Infant HIV Transmission|prevention of mother-infant hiv transmission
812554|NCT00197639|indinavir, HIV, ritonavir, pharmacokinetics, Thailand|indinavir, hiv, ritonavir, pharmacokinetics, thailand
812555|NCT00197561|HIV|hiv
812556|NCT00197561|Selenium|selenium
812557|NCT00197561|Nutrition|nutrition
812559|NCT00197561|Pregnancy|pregnancy
812560|NCT00197561|Tanzania|tanzania
812561|NCT00197561|Maternal and child health outcomes|maternal and child health outcomes
812562|NCT00197561|HIV/AIDS|hiv/aids
812563|NCT00197561|Pregnancy Outcome|pregnancy outcome
812564|NCT00197548|Women|women
812565|NCT00197548|Pregnancy Outcomes|pregnancy outcomes
812566|NCT00197548|Nutrition|nutrition
812567|NCT00197548|Vitamins|vitamins
812568|NCT00197548|Tanzania|tanzania
812569|NCT00197548|Maternal and Child Health Outcomes|maternal and child health outcomes
812570|NCT00197522|breast cancer|breast cancer
812571|NCT00197522|vaccination|vaccination
812572|NCT00197522|dendritic cells|dendritic cells
812573|NCT00197522|HER-2|her-2
812574|NCT00197522|CD34+ stem cells|cd34+ stem cells
812575|NCT00197509|Long-Term Care|long-term care
812576|NCT00197509|Clinical Protocols|clinical protocols
812577|NCT00197509|Sit-To-Stand|sit-to-stand
812578|NCT00197483|Pergolide|pergolide
812579|NCT00197483|Dopamine D1|dopamine d1
812580|NCT00197483|Schizophrenia|schizophrenia
812581|NCT00197483|Cognitive disturbance|cognitive disturbance
812582|NCT00197483|Negative symptoms|negative symptoms
812583|NCT00197444|esophageal cancer|esophageal cancer
812584|NCT00197444|Nedaplatin|nedaplatin
812585|NCT00197444|5-FU|5-fu
812586|NCT00197444|chemotherapy|chemotherapy
812587|NCT00197444|radiation|radiation
812588|NCT00197444|chemoradiotherapy|chemoradiotherapy
812589|NCT00197418|H. pylori infection|h. pylori infection
812590|NCT00197392|Ventriculostomy|ventriculostomy
812593|NCT00197379|roxitromycin|roxitromycin
812594|NCT00197379|apoptosis|apoptosis
812595|NCT00197366|pregnancy|pregnancy
812596|NCT00197366|HIV-positive|hiv-positive
812597|NCT00197366|HIV resistance|hiv resistance
812598|NCT00197366|HIV|hiv
812599|NCT00197353|Anesthesia, Epidural|anesthesia, epidural
812600|NCT00197353|Pharmacology|pharmacology
812601|NCT00197353|Dose-Response Relationship, Drug|dose-response relationship, drug
812602|NCT00197353|Sympathectomy|sympathectomy
812603|NCT00197353|Photoplethysmography|photoplethysmography
812604|NCT00197340|Pre-Eclampsia|pre-eclampsia
812605|NCT00197340|Fetal Growth Retardation|fetal growth retardation
812606|NCT00197340|Anesthesia, Epidural|anesthesia, epidural
812607|NCT00197340|Placental Circulation|placental circulation
812608|NCT00197340|Dose-Response Relationship, Drug|dose-response relationship, drug
812609|NCT00197327|Labor Pain|labor pain
812610|NCT00197327|Analgesia, Obstetrical|analgesia, obstetrical
812611|NCT00197327|Pharmacology|pharmacology
812612|NCT00197327|Treatment Outcome|treatment outcome
812613|NCT00197314|Urinary stress incontinence|urinary stress incontinence
812614|NCT00197314|Randomized trial|randomized trial
812615|NCT00197314|circular muscle training|circular muscle training
812616|NCT00197314|pelvic floor training|pelvic floor training
812617|NCT00197314|bioequivalence|bioequivalence
812618|NCT00197301|Intranasal vaccination, Influenza|intranasal vaccination, influenza
812619|NCT00197288|Prophylaxis: Influenza virus infection|prophylaxis: influenza virus infection
812620|NCT00197275|Haemophilus influenzae type b|haemophilus influenzae type b
812621|NCT00197275|diphtheria|diphtheria
812622|NCT00197275|tetanus|tetanus
812623|NCT00197275|Prophylaxis diphtheria|prophylaxis diphtheria
812624|NCT00197275|pertussis|pertussis
812625|NCT00197275|hepatitis B|hepatitis b
812626|NCT00197275|meningococcal serogroups A & C diseases|meningococcal serogroups a & c diseases
812627|NCT00197262|Seasonal Allergic Rhinitis|seasonal allergic rhinitis
812628|NCT00197262|GW685698X|gw685698x
812629|NCT00197262|allergic rhinitis|allergic rhinitis
812630|NCT00197262|Hayfever|hayfever
812631|NCT00197249|Hepatitis A & B|hepatitis a & b
812632|NCT00197249|Typhoid|typhoid
812633|NCT00197236|Hepatitis A|hepatitis a
812634|NCT00197197|HIV-1 GW873140 CCR5 antagonist treatment experienced|hiv-1 gw873140 ccr5 antagonist treatment experienced
812635|NCT00197184|Combined hepatitis A and B vaccine|combined hepatitis a and b vaccine
812636|NCT00197184|Twinrix™|twinrix™
812637|NCT00197145|HIV-1 GW873140 CCR5 antagonist experienced|hiv-1 gw873140 ccr5 antagonist experienced
812638|NCT00197132|Insulin resistance vasodilatory response|insulin resistance vasodilatory response
812639|NCT00197119|Hepatitis B|hepatitis b
812640|NCT00197119|TWINRIX™ Adult|twinrix™ adult
812641|NCT00197119|Hepatitis A|hepatitis a
812642|NCT00197119|TWINRIX™ Junior|twinrix™ junior
812643|NCT00197106|salmeterol/fluticasone combination|salmeterol/fluticasone combination
812644|NCT00197106|Asthma|asthma
812645|NCT00197106|bronchial hyperresponsiveness|bronchial hyperresponsiveness
812646|NCT00197106|Children|children
812647|NCT00197106|symptom control|symptom control
812648|NCT00197093|Schizophrenia|schizophrenia
812649|NCT00197093|safety|safety
812650|NCT00197093|tolerability|tolerability
812651|NCT00197093|pharmacokinetics|pharmacokinetics
812652|NCT00197080|Restless Legs Syndrome|restless legs syndrome
812653|NCT00197080|RLS|rls
812654|NCT00196989|Efficacy|efficacy
812655|NCT00196989|PPARpan|pparpan
812656|NCT00196989|Type 2 Diabetes Mellitus|type 2 diabetes mellitus
812657|NCT00196989|Phase IIb|phase iib
812658|NCT00196989|Safety|safety
812659|NCT00196989|Pharmacokinetics|pharmacokinetics
812660|NCT00196989|GW677954|gw677954
812661|NCT00196989|Pharmacodynamics|pharmacodynamics
812662|NCT00196989|Tolerability|tolerability
812663|NCT00196989|Dose-Ranging|dose-ranging
812664|NCT00196976|Safety|safety
812665|NCT00196976|Meningococcal vaccine|meningococcal vaccine
812666|NCT00196976|Dose selection|dose selection
812667|NCT00196976|Toddlers|toddlers
812668|NCT00196976|Immunogenicity|immunogenicity
812669|NCT00196976|Conjugate vaccine|conjugate vaccine
812670|NCT00196976|Reactogenicity|reactogenicity
812671|NCT00196976|Children|children
812672|NCT00196937|HPV Vaccine Safety|hpv vaccine safety
812673|NCT00196898|Parkinson´s disease|parkinson´s disease
812674|NCT00196898|fibrotic valvular heart fibrosis|fibrotic valvular heart fibrosis
812675|NCT00196898|ergot dopamine agonists|ergot dopamine agonists
812676|NCT00196898|non-ergot dopamine agonists|non-ergot dopamine agonists
812677|NCT00196885|cancer cachexia|cancer cachexia
812678|NCT00196885|muscle wasting|muscle wasting
812679|NCT00196885|weight loss|weight loss
812680|NCT00196885|proteolysis|proteolysis
812681|NCT00196872|dose dense sequence|dose dense sequence
812682|NCT00196872|dose dense combination|dose dense combination
812683|NCT00196872|node positive disease|node positive disease
812684|NCT00196859|Early Breast Cancer in elderly Patients|early breast cancer in elderly patients
812685|NCT00196859|Ibandronate plus/minus Capecitabine in elderly patients|ibandronate plus/minus capecitabine in elderly patients
812686|NCT00196846|hormone insensitive breast cancer|hormone insensitive breast cancer
812782|NCT00196417|UFH|ufh
812881|NCT00195910|Acute|acute
812687|NCT00196846|Prevention of Chemotherapy induced ovarian failure|prevention of chemotherapy induced ovarian failure
812688|NCT00196846|P.O.F.|p.o.f.
812689|NCT00196846|GnRH-Agonist Goserelin|gnrh-agonist goserelin
812690|NCT00196833|Breast Cancer in Pregnancy|breast cancer in pregnancy
812691|NCT00196833|Prospective and Retrospective Register|prospective and retrospective register
812692|NCT00196833|Study|study
812693|NCT00196820|Metastatic breast cancer|metastatic breast cancer
812694|NCT00196820|HER2 negative, medium-risk, metastatic breast cancer|her2 negative, medium-risk, metastatic breast cancer
812695|NCT00196807|prostate cancer screening|prostate cancer screening
812696|NCT00196807|medical decision making|medical decision making
812697|NCT00196807|informed decision making|informed decision making
812698|NCT00196807|patient education|patient education
812699|NCT00196807|male|male
812700|NCT00196794|Pseudomembranous Colitis|pseudomembranous colitis
812701|NCT00196794|Clostridium difficile-associated diarrhea|clostridium difficile-associated diarrhea
812702|NCT00196794|C. difficile|c. difficile
812703|NCT00196794|CDAD|cdad
812704|NCT00196781|prostate cancer treatment|prostate cancer treatment
812705|NCT00196781|medical decision making|medical decision making
812706|NCT00196781|informed decision making|informed decision making
812707|NCT00196781|shared decision making|shared decision making
812708|NCT00196781|decision aid|decision aid
812709|NCT00196781|patient education|patient education
812710|NCT00196768|relapsed|relapsed
812711|NCT00196768|acute promyelocytic leukemia|acute promyelocytic leukemia
812712|NCT00196768|arsenic|arsenic
812713|NCT00196742|alpha Galactosidase A|alpha galactosidase a
812714|NCT00196742|aGAL (alpha-galactosidase)|agal (alpha-galactosidase)
812715|NCT00196742|Fabry|fabry
812716|NCT00196742|GL3 (globotriaosylceramide)|gl3 (globotriaosylceramide)
812717|NCT00196742|Anderson-Fabry Disease|anderson-fabry disease
812718|NCT00196742|angiokeratomas|angiokeratomas
812719|NCT00196742|GLA deficiency (gene deficiency)|gla deficiency (gene deficiency)
812720|NCT00196742|errors in metabolism|errors in metabolism
812721|NCT00196716|alpha Galactosidase A|alpha galactosidase a
812722|NCT00196716|aGAL|agal
812723|NCT00196716|rh aGAL|rh agal
812724|NCT00196716|Fabry|fabry
812725|NCT00196716|GL3|gl3
812726|NCT00196716|Fabrazyme|fabrazyme
812727|NCT00196703|Aphasia|aphasia
812728|NCT00196703|Memantine|memantine
812729|NCT00196703|Constraint-induced language therapy|constraint-induced language therapy
812730|NCT00196703|Event-related potentials|event-related potentials
812731|NCT00196690|Aphasia|aphasia
812732|NCT00196690|Donepezil|donepezil
812733|NCT00196664|Chronic Hepatitis C|chronic hepatitis c
812734|NCT00196664|Paroxetine|paroxetine
812735|NCT00196664|Depression|depression
812736|NCT00196651|HIV infection|hiv infection
812737|NCT00196651|AIDS Vaccines|aids vaccines
812738|NCT00196651|ALVAC vaccine|alvac vaccine
812739|NCT00196651|Interleukin-2|interleukin-2
812740|NCT00196651|Antiretroviral Therapy, Highly Active|antiretroviral therapy, highly active
812741|NCT00196638|HIV infections|hiv infections
812742|NCT00196638|Primary acute infection|primary acute infection
812743|NCT00196638|Interferon-alpha|interferon-alpha
812744|NCT00196625|HIV infections|hiv infections
812745|NCT00196625|Salvage therapy|salvage therapy
812746|NCT00196625|Amprenavir|amprenavir
812747|NCT00196625|Lopinavir|lopinavir
812748|NCT00196625|Ritonavir|ritonavir
812749|NCT00196612|HIV Infections|hiv infections
812750|NCT00196612|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors
812751|NCT00196612|Treatment simplification|treatment simplification
812752|NCT00196599|HIV infections|hiv infections
812753|NCT00196599|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors
812754|NCT00196586|Chronic Hepatitis C|chronic hepatitis c
812755|NCT00196586|HIV infection|hiv infection
812756|NCT00196586|Interleukin-2|interleukin-2
812757|NCT00196586|Pegylated interferon alpha 2 a|pegylated interferon alpha 2 a
812758|NCT00196586|ribavirin|ribavirin
812759|NCT00196573|Rotator Cuff|rotator cuff
812760|NCT00196573|Tendinosis|tendinosis
812761|NCT00196573|Impingement Syndrome|impingement syndrome
812762|NCT00196573|Partial Thickness Tears|partial thickness tears
812763|NCT00196573|Rotator Cuff Tendinosis|rotator cuff tendinosis
812764|NCT00196573|Partial Thickness Rotator Cuff Tears|partial thickness rotator cuff tears
812765|NCT00196560|Immobilization in External Rotation|immobilization in external rotation
812766|NCT00196560|Acute primary anterior shoulder dislocation|acute primary anterior shoulder dislocation
812767|NCT00196547|Asthma|asthma
812768|NCT00196547|Respiratory viral infections|respiratory viral infections
812769|NCT00196547|Exacerbations|exacerbations
812770|NCT00196547|Pediatric|pediatric
812771|NCT00196547|Leukotriene receptor antagonists|leukotriene receptor antagonists
812772|NCT00196547|School|school
812773|NCT00196508|Childbirth|childbirth
812774|NCT00196482|growth|growth
812775|NCT00196482|oral feeding|oral feeding
812776|NCT00196482|nutrition|nutrition
812777|NCT00196456|Photodynamic lasertherapy|photodynamic lasertherapy
812778|NCT00196456|Periodontol disease|periodontol disease
812779|NCT00196417|heparin-induced thrombocytopenia|heparin-induced thrombocytopenia
812780|NCT00196417|HIT|hit
812781|NCT00196417|unfractionated heparin|unfractionated heparin
812783|NCT00196417|low-molecular-weight heparin|low-molecular-weight heparin
812784|NCT00196417|LMWH|lmwh
812785|NCT00196417|thrombosis prophylaxis|thrombosis prophylaxis
812786|NCT00196417|HIT-antibody|hit-antibody
812787|NCT00196404|overactive bladder|overactive bladder
812788|NCT00196404|urge incontinence|urge incontinence
812789|NCT00196404|urinary incontinence|urinary incontinence
812790|NCT00196391|secondary amenorrhea|secondary amenorrhea
812791|NCT00196391|progesterone|progesterone
812792|NCT00196378|vaginal atrophy|vaginal atrophy
812793|NCT00196378|vaginal dryness|vaginal dryness
812794|NCT00196378|vaginal itching|vaginal itching
812795|NCT00196378|vaginal pain|vaginal pain
812796|NCT00196378|dyspareunia|dyspareunia
812797|NCT00196365|cyclic pelvic pain|cyclic pelvic pain
812798|NCT00196365|dysmenorrhea|dysmenorrhea
812799|NCT00196352|oral contraceptives|oral contraceptives
812800|NCT00196352|birth control|birth control
812801|NCT00196352|ethinyl estradiol|ethinyl estradiol
812802|NCT00196352|pregnancy prevention|pregnancy prevention
812803|NCT00196339|prostate cancer|prostate cancer
812804|NCT00196339|hot flashes|hot flashes
812805|NCT00196339|hot flushes|hot flushes
812806|NCT00196339|vasomotor symptoms|vasomotor symptoms
812807|NCT00196326|pregnancy prevention|pregnancy prevention
812808|NCT00196326|oral contraceptives|oral contraceptives
812809|NCT00196313|cyclic pelvic pain|cyclic pelvic pain
812810|NCT00196313|dysmenorrhea|dysmenorrhea
812811|NCT00196313|oral contraceptives|oral contraceptives
812812|NCT00196300|Assessment, Risk|assessment, risk
812813|NCT00196300|Autonomic nervous system|autonomic nervous system
812814|NCT00196300|Aged|aged
812815|NCT00196287|Assessment, risk|assessment, risk
812816|NCT00196287|autonomic nervous system|autonomic nervous system
812817|NCT00196287|Gender|gender
812818|NCT00196274|AUTONOMIC NERVOUS SYSTEM|autonomic nervous system
812819|NCT00196274|Assessment, Risk|assessment, risk
812820|NCT00196261|Assessment, Risk|assessment, risk
812821|NCT00196261|Autonomic nervous system|autonomic nervous system
812822|NCT00196235|Assessment, Risk|assessment, risk
812823|NCT00196235|Diabetes mellitus|diabetes mellitus
812824|NCT00196235|Autonomic nervous system|autonomic nervous system
812825|NCT00196209|atrial fibrillation|atrial fibrillation
812826|NCT00196209|catheter ablation|catheter ablation
812827|NCT00196196|Hydrocephalus|hydrocephalus
812828|NCT00196196|Codman Hakim Programmable Valve|codman hakim programmable valve
812829|NCT00196196|Programmable Valve|programmable valve
812830|NCT00196196|Shunt System|shunt system
812831|NCT00196131|morphine|morphine
812832|NCT00196131|head injury|head injury
812834|NCT00196118|Pulmonary Embolism|pulmonary embolism
812835|NCT00196118|Venous Thromboembolism|venous thromboembolism
812836|NCT00196118|Inferior Vena Cava Filter|inferior vena cava filter
812837|NCT00196118|IVC|ivc
812838|NCT00196118|PE|pe
812839|NCT00196105|Stents|stents
812840|NCT00196105|Stent-graft|stent-graft
812841|NCT00196105|Minimally invasive|minimally invasive
812842|NCT00196105|Biliary Tract Cancer|biliary tract cancer
812843|NCT00196105|Pancreatic Cancer|pancreatic cancer
812844|NCT00196105|Jaundice|jaundice
812845|NCT00196105|Biliary Tract Neoplasms|biliary tract neoplasms
812846|NCT00196105|Pancreatic Neoplasms|pancreatic neoplasms
812847|NCT00196105|Jaundice, Obstructive|jaundice, obstructive
812848|NCT00196105|Zilver|zilver
812849|NCT00196079|coronary artery|coronary artery
812850|NCT00196079|stenosis|stenosis
812851|NCT00196079|drug eluting stent|drug eluting stent
812852|NCT00196079|stent|stent
812853|NCT00196053|Intrathecal pain management|intrathecal pain management
812854|NCT00196053|constant flow pump|constant flow pump
812855|NCT00196014|Registered Nurses|registered nurses
812856|NCT00196014|Workload|workload
812857|NCT00196014|Clinical staff nurses that are currently working|clinical staff nurses that are currently working
812858|NCT00196001|Adrenal sufficiency|adrenal sufficiency
812859|NCT00196001|Low-dose ACTH stimulation|low-dose acth stimulation
812860|NCT00196001|G proteins|g proteins
812861|NCT00195988|immunosuppression,|immunosuppression,
812862|NCT00195988|steroid avoidance,|steroid avoidance,
812863|NCT00195988|liver transplantation,|liver transplantation,
812864|NCT00195988|children|children
812865|NCT00195975|Abdominal Pain|abdominal pain
812866|NCT00195975|Functional Gastrointestinal Disorders|functional gastrointestinal disorders
812867|NCT00195975|Stress|stress
812868|NCT00195975|Anxiety|anxiety
812869|NCT00195975|Autonomic Nervous System|autonomic nervous system
812870|NCT00195962|Breastfeeding|breastfeeding
812871|NCT00195962|Post-partum mothers of healthy breast-fed newborns|post-partum mothers of healthy breast-fed newborns
812872|NCT00195949|Pyloric Stenosis|pyloric stenosis
812873|NCT00195949|Laparoscopy|laparoscopy
812874|NCT00195949|Idiopathic Hypertrophic Pyloric Stenosis|idiopathic hypertrophic pyloric stenosis
812875|NCT00195936|Cinacalcet|cinacalcet
812876|NCT00195936|PTH|pth
812877|NCT00195936|XLH|xlh
812878|NCT00195936|children and adolescents with hypophosphatemic rickets (XLH)|children and adolescents with hypophosphatemic rickets (xlh)
812879|NCT00195923|appendicitis|appendicitis
812880|NCT00195923|perforation|perforation
812882|NCT00195910|Pain|pain
812883|NCT00195910|Emergency Department|emergency department
812884|NCT00195910|Morphine|morphine
812885|NCT00195910|Hydromorphone|hydromorphone
812886|NCT00195910|Dilaudid|dilaudid
812887|NCT00195910|oligoanalgesia|oligoanalgesia
812888|NCT00195897|Lymphoma|lymphoma
812889|NCT00195897|Anthracyclines|anthracyclines
812890|NCT00195897|Heart Failure|heart failure
812891|NCT00195897|Radionuclide|radionuclide
812892|NCT00195897|Magnetic Resonance Imaging|magnetic resonance imaging
812893|NCT00195897|Troponin|troponin
812894|NCT00195897|Natriuretic Peptide, Brain|natriuretic peptide, brain
812895|NCT00195884|Diabetes Mellitus|diabetes mellitus
812896|NCT00195884|Type 2 Diabetes|type 2 diabetes
812897|NCT00195884|Aerobic|aerobic
812898|NCT00195884|Resistance|resistance
812899|NCT00195884|weight training|weight training
812900|NCT00195884|Exercise|exercise
812901|NCT00195871|Non-Hodgkin|non-hodgkin
812902|NCT00195871|Lymphoma|lymphoma
812903|NCT00195871|Lymphoblastic|lymphoblastic
812904|NCT00195858|Youth|youth
812905|NCT00195858|Exercise|exercise
812906|NCT00195858|Physical Activity|physical activity
812907|NCT00195858|Aerobic|aerobic
812908|NCT00195858|Resistance|resistance
812909|NCT00195858|Overweight|overweight
812910|NCT00195858|obese|obese
812911|NCT00195858|Canada|canada
812912|NCT00195858|Sigal|sigal
812913|NCT00195819|ankylosing spondylitis|ankylosing spondylitis
812914|NCT00195819|adalimumab|adalimumab
812915|NCT00195806|Migraine|migraine
812916|NCT00195806|Depakote ER|depakote er
812917|NCT00195806|Divalproex sodium|divalproex sodium
812918|NCT00195793|Hyperlipidemia|hyperlipidemia
812919|NCT00195793|fenofibrate|fenofibrate
812920|NCT00195793|ezetimibe|ezetimibe
812921|NCT00195793|atorvastatin|atorvastatin
812922|NCT00195780|Bipolar I Disorder|bipolar i disorder
812923|NCT00195780|Depakote|depakote
812924|NCT00195767|Bipolar I Disorder|bipolar i disorder
812925|NCT00195767|Depakote ER|depakote er
812926|NCT00195767|divalproex sodium|divalproex sodium
812927|NCT00195754|Migraines|migraines
812928|NCT00195754|Depakote ER|depakote er
812929|NCT00195754|divalproex sodium|divalproex sodium
812930|NCT00195741|Migraine|migraine
812931|NCT00195741|Depakote ER|depakote er
812932|NCT00195728|Hydrocodone/Acetaminophen|hydrocodone/acetaminophen
812933|NCT00195728|Vicodin CR|vicodin cr
812934|NCT00195702|Rheumatoid Arthritis|rheumatoid arthritis
812935|NCT00195663|Early Rheumatoid Arthritis|early rheumatoid arthritis
812936|NCT00195650|Rheumatoid Arthritis|rheumatoid arthritis
812937|NCT00195637|GNE Gene|gne gene
812938|NCT00195637|Alpha-Dystroglycan|alpha-dystroglycan
812939|NCT00195637|Sialic Acid|sialic acid
812940|NCT00195637|Glycosylation|glycosylation
812941|NCT00195637|Dystroglycanopathy|dystroglycanopathy
812942|NCT00195637|Hereditary Inclusion Body Myopathy|hereditary inclusion body myopathy
812943|NCT00195637|Immune Globulin|immune globulin
812944|NCT00195637|HIBM|hibm
812945|NCT00195624|Immunosuppression|immunosuppression
812946|NCT00195624|T-cells|t-cells
812947|NCT00195624|Hematopoiesis|hematopoiesis
812948|NCT00195624|Autoimmunity|autoimmunity
812949|NCT00195624|Thrombocytopenia|thrombocytopenia
812950|NCT00195624|Severe Aplastic Anemia|severe aplastic anemia
812951|NCT00195624|SAA|saa
812952|NCT00195611|Middle Ear Infection|middle ear infection
812953|NCT00195598|Panic Disorders|panic disorders
812954|NCT00195585|Colon Cancer|colon cancer
812955|NCT00195572|Gastric Cancer|gastric cancer
812956|NCT00195572|Advanced/Recurrent Gastric Cancer|advanced/recurrent gastric cancer
812957|NCT00195559|Premenstrual Syndrome (PMS)|premenstrual syndrome (pms)
812958|NCT00195559|Hormone Therapy|hormone therapy
812959|NCT00195546|Menopause|menopause
812960|NCT00195533|Leukemia|leukemia
812961|NCT00195533|Lymphoma|lymphoma
812962|NCT00195533|Myeloma|myeloma
812963|NCT00195520|Menopause|menopause
812964|NCT00195520|Sleep Disorder|sleep disorder
812965|NCT00195520|Hot Flashes|hot flashes
812966|NCT00195507|Psoriasis|psoriasis
812967|NCT00195494|Rheumatoid Arthritis|rheumatoid arthritis
812968|NCT00195481|Kidney|kidney
812969|NCT00195481|Transplant|transplant
812970|NCT00195468|Kidney Failure|kidney failure
812971|NCT00195468|Transplant|transplant
812972|NCT00195455|Postmenopause|postmenopause
812973|NCT00195442|Hemophilia A|hemophilia a
812974|NCT00195429|Kidney|kidney
812975|NCT00195429|Transplant|transplant
812976|NCT00195416|Ankylosing Spondylitis|ankylosing spondylitis
812977|NCT00195403|Rheumatoid Arthritis|rheumatoid arthritis
812978|NCT00195390|Vaccine|vaccine
812979|NCT00195390|heptavalent pneumococcal conjugate vaccine|heptavalent pneumococcal conjugate vaccine
812980|NCT00195364|Rheumatoid Arthritis|rheumatoid arthritis
812981|NCT00195351|Complicated intra-abdominal infection|complicated intra-abdominal infection
812982|NCT00195351|Appendicitis with abscess|appendicitis with abscess
812983|NCT00195351|Perforated diverticulitis|perforated diverticulitis
812984|NCT00195351|Purulent peritonitis|purulent peritonitis
812985|NCT00195351|Complicated cholecystitis|complicated cholecystitis
812986|NCT00195338|Rheumatoid Arthritis|rheumatoid arthritis
813090|NCT00194701|exercise|exercise
812987|NCT00195325|Advanced Malignant Solid Tumors|advanced malignant solid tumors
812988|NCT00195312|HIV|hiv
812989|NCT00195312|Vaccine|vaccine
812990|NCT00195312|Treatment Experienced|treatment experienced
812991|NCT00195299|Carcinoma|carcinoma
812992|NCT00195299|Head|head
812993|NCT00195299|Neck|neck
812994|NCT00195286|Urinary Infections|urinary infections
812995|NCT00195273|Kidney|kidney
812996|NCT00195273|Transplant|transplant
812997|NCT00195260|Solid tumors|solid tumors
812998|NCT00195247|Tumors|tumors
812999|NCT00195247|Advanced malignant solid tumors|advanced malignant solid tumors
813000|NCT00195234|HIV|hiv
813001|NCT00195234|Treatment Experienced|treatment experienced
813002|NCT00195221|Hemophilia B|hemophilia b
813003|NCT00195208|Gastroesophageal Reflux Disease (GERD)|gastroesophageal reflux disease (gerd)
813004|NCT00195195|Transplantation|transplantation
813005|NCT00195182|Hypertension|hypertension
813006|NCT00195182|African-American|african-american
813007|NCT00195182|Perceived Racism|perceived racism
813008|NCT00195182|Psychological Stress|psychological stress
813009|NCT00195182|Medication Adherence|medication adherence
813010|NCT00195169|Myocardial Infarction|myocardial infarction
813011|NCT00195169|Social support|social support
813012|NCT00195156|Solid Tumor Malignancies|solid tumor malignancies
813013|NCT00195143|Parkinson's disease|parkinson's disease
813014|NCT00195143|GABA|gaba
813015|NCT00195143|Subthalamic nucleus|subthalamic nucleus
813016|NCT00195143|Adeno-associated virus|adeno-associated virus
813017|NCT00195143|AAV|aav
813018|NCT00195143|Gene therapy|gene therapy
813019|NCT00195130|prognosis|prognosis
813020|NCT00195130|risk of death|risk of death
813021|NCT00195130|morbidity|morbidity
813022|NCT00195130|mortality|mortality
813023|NCT00195130|quality of life|quality of life
813024|NCT00195117|Asthma|asthma
813025|NCT00195117|Behavior change|behavior change
813026|NCT00195117|Physical activity|physical activity
813027|NCT00195117|Risk reduction|risk reduction
813028|NCT00195104|Myelodysplastic Syndrome|myelodysplastic syndrome
813029|NCT00195078|head and neck cancer|head and neck cancer
813030|NCT00195078|squamous cell carcinoma of the oral cavity|squamous cell carcinoma of the oral cavity
813031|NCT00195078|squamous cell carcinoma of the oropharynx|squamous cell carcinoma of the oropharynx
813032|NCT00195078|squamous cell carcinoma of the larynx|squamous cell carcinoma of the larynx
813033|NCT00195078|squamous cell carcinoma of the hypopharynx|squamous cell carcinoma of the hypopharynx
813034|NCT00195065|Asthma|asthma
813035|NCT00195065|Behavior change|behavior change
813036|NCT00195065|Physical activity|physical activity
813037|NCT00195065|Risk reduction|risk reduction
813038|NCT00195052|epilepsy|epilepsy
813039|NCT00195052|optical imaging|optical imaging
813040|NCT00195052|optical mapping|optical mapping
813041|NCT00195039|Prostate Cancer|prostate cancer
813042|NCT00195000|Acute Myeloid Leukemia|acute myeloid leukemia
813043|NCT00195000|Myelodysplastic Syndrome|myelodysplastic syndrome
813044|NCT00194987|Alloimmune thrombocytopenia|alloimmune thrombocytopenia
813045|NCT00194987|Fetal alloimmune thrombocytopenia|fetal alloimmune thrombocytopenia
813046|NCT00194974|pregnancy|pregnancy
813047|NCT00194974|chronic hypertension|chronic hypertension
813048|NCT00194974|Toxemia|toxemia
813049|NCT00194974|Blood Pressure|blood pressure
813050|NCT00194961|Chronic Kidney Disease|chronic kidney disease
813051|NCT00194961|Growth Failure|growth failure
813052|NCT00194961|Cytokines|cytokines
813053|NCT00194961|leptin|leptin
813054|NCT00194935|Ovarian Cancer|ovarian cancer
813055|NCT00194935|Cancer of the Ovary|cancer of the ovary
813056|NCT00194896|type 2 diabetes mellitus|type 2 diabetes mellitus
813057|NCT00194896|autoantibodies|autoantibodies
813058|NCT00194896|islet proteins|islet proteins
813059|NCT00194896|rosiglitazone|rosiglitazone
813060|NCT00194896|glyburide|glyburide
813061|NCT00194896|c-peptide|c-peptide
813062|NCT00194883|Recombinant Human Growth Hormone|recombinant human growth hormone
813063|NCT00194883|Leptin|leptin
813064|NCT00194883|Cytokines|cytokines
813065|NCT00194883|Chronic Renal Insufficiency|chronic renal insufficiency
813066|NCT00194883|Children|children
813067|NCT00194870|EEG|eeg
813068|NCT00194870|DBS|dbs
813069|NCT00194857|anemia|anemia
813070|NCT00194857|dose reduction|dose reduction
813071|NCT00194857|neutropenia|neutropenia
813072|NCT00194857|hepatitis C virus|hepatitis c virus
813073|NCT00194857|human immunodeficiency virus|human immunodeficiency virus
813074|NCT00194844|caring|caring
813075|NCT00194844|miscarriage|miscarriage
813076|NCT00194844|grief|grief
813077|NCT00194844|couples|couples
813078|NCT00194844|counseling|counseling
813079|NCT00194805|Internet|internet
813080|NCT00194805|Diabetes|diabetes
813081|NCT00194805|Education|education
813082|NCT00194805|Social Support|social support
813083|NCT00194766|Breast cancer|breast cancer
813084|NCT00194766|Soft tissue sarcoma|soft tissue sarcoma
813085|NCT00194753|Breast cancer|breast cancer
813086|NCT00194740|Breast cancer|breast cancer
813087|NCT00194727|Breast cancer|breast cancer
813088|NCT00194701|heart failure|heart failure
813089|NCT00194701|sleep|sleep
813091|NCT00194701|heart rate variability|heart rate variability
813092|NCT00194688|ammonia|ammonia
813093|NCT00194675|androgen deficiency|androgen deficiency
813094|NCT00194675|testosterone|testosterone
813095|NCT00194675|Benign Prostatic Hyperplasia|benign prostatic hyperplasia
813096|NCT00194675|hypogonadism|hypogonadism
813097|NCT00194675|prostate|prostate
813099|NCT00194649|Glycosphingolipids (GSL)|glycosphingolipids (gsl)
813100|NCT00194636|Prostatitis|prostatitis
813101|NCT00194636|Chronic Male Pelvic Pain Syndrome|chronic male pelvic pain syndrome
813102|NCT00194623|prostatitis|prostatitis
813103|NCT00194597|Prostatitis|prostatitis
813104|NCT00194584|children|children
813105|NCT00194584|chronic illness|chronic illness
813106|NCT00194584|parent education|parent education
813107|NCT00194584|parent support|parent support
813108|NCT00194571|breast cancer,|breast cancer,
813109|NCT00194571|child functioning,|child functioning,
813110|NCT00194571|parenting,|parenting,
813111|NCT00194571|self-efficacy,|self-efficacy,
813112|NCT00194571|psychoeducational intervention|psychoeducational intervention
813113|NCT00194571|counseling|counseling
813114|NCT00194558|Diabetes|diabetes
813115|NCT00194558|Health Education|health education
813116|NCT00194558|Information Technology|information technology
813117|NCT00194558|Disease Management|disease management
813118|NCT00194558|Internet|internet
813119|NCT00194558|Patient Education|patient education
813120|NCT00194545|HIV-1|hiv-1
813121|NCT00194545|pediatric adherence|pediatric adherence
813122|NCT00194545|medication diaries|medication diaries
813123|NCT00194545|HAART|haart
813124|NCT00194545|Treatment Naive|treatment naive
813125|NCT00194532|UTI|uti
813126|NCT00194519|HIV infection|hiv infection
813127|NCT00194519|HIV transmission|hiv transmission
813128|NCT00194519|genital herpes|genital herpes
813129|NCT00194519|sexual intercourse|sexual intercourse
813130|NCT00194519|sexual transmitted infection|sexual transmitted infection
813131|NCT00194519|acyclovir|acyclovir
813132|NCT00194519|HIV Seronegativity|hiv seronegativity
813133|NCT00194519|Treatment Naive|treatment naive
813134|NCT00194519|HIV-discordant couples|hiv-discordant couples
813135|NCT00194519|HIV serodiagnosis|hiv serodiagnosis
813136|NCT00194506|Diabetes|diabetes
813137|NCT00194506|Health Education|health education
813138|NCT00194506|Information Technology|information technology
813139|NCT00194506|Disease Management|disease management
813140|NCT00194506|Internet|internet
813141|NCT00194506|Patient Education|patient education
813142|NCT00194493|Cancer|cancer
813143|NCT00194493|Quality of Life|quality of life
813144|NCT00194493|Signs and Symptoms|signs and symptoms
813145|NCT00194493|Computers|computers
813146|NCT00194493|Patient-Reported Outcomes|patient-reported outcomes
813147|NCT00194480|Hepatitis C, peg-Interferon, drug abuse|hepatitis c, peg-interferon, drug abuse
813148|NCT00194454|Depressive symptoms|depressive symptoms
813149|NCT00194454|Behavior and behavior mechanisms|behavior and behavior mechanisms
813150|NCT00194454|Recovery|recovery
813151|NCT00194441|cerebral circulation|cerebral circulation
813152|NCT00194441|monitoring, physiologic|monitoring, physiologic
813153|NCT00194441|informatics|informatics
813154|NCT00194441|nursing care|nursing care
813155|NCT00194441|physiologic variability|physiologic variability
813156|NCT00194441|outcome|outcome
813157|NCT00194441|quality adjusted life years|quality adjusted life years
813158|NCT00194428|Obesity,|obesity,
813159|NCT00194428|Metabolic Syndrome,|metabolic syndrome,
813160|NCT00194428|BMI|bmi
813161|NCT00194402|cholesterol|cholesterol
813162|NCT00194402|dyslipidemia|dyslipidemia
813163|NCT00194402|hypercholesterolemia|hypercholesterolemia
813164|NCT00194402|C-reactive protein|c-reactive protein
813165|NCT00194363|breast cancer|breast cancer
813166|NCT00194363|breast cancer survivors|breast cancer survivors
813167|NCT00194363|lymphedema|lymphedema
813168|NCT00194363|strength training|strength training
813169|NCT00194363|breast cancer survivorship|breast cancer survivorship
813170|NCT00194350|Infertility|infertility
813171|NCT00194350|Factor V Leiden|factor v leiden
813172|NCT00194337|stage I breast cancer|stage i breast cancer
813173|NCT00194337|stage II breast cancer|stage ii breast cancer
813174|NCT00194337|stage IIIA breast cancer|stage iiia breast cancer
813175|NCT00194337|stage IIIB breast cancer|stage iiib breast cancer
813176|NCT00194337|stage IIIC breast cancer|stage iiic breast cancer
813177|NCT00194337|stage IV breast cancer|stage iv breast cancer
813178|NCT00194311|HPV|hpv
813179|NCT00194311|Pregnancy|pregnancy
813180|NCT00194298|diabetic foot disease|diabetic foot disease
813181|NCT00194298|osteomyelitis|osteomyelitis
813182|NCT00194298|charcot|charcot
813183|NCT00194298|neuropathy|neuropathy
813184|NCT00194298|hypoxia|hypoxia
813185|NCT00194298|[18 F] Fluorodeoxyglucose|[18 f] fluorodeoxyglucose
813186|NCT00194298|Positron Emission Tomography Imaging|positron emission tomography imaging
813187|NCT00194285|Prosthesis|prosthesis
813188|NCT00194285|[18 F] Fluorodeoxyglucose|[18 f] fluorodeoxyglucose
813189|NCT00194285|Positron Emission Tomography Imaging|positron emission tomography imaging
813190|NCT00194272|Ectopic pregnancy|ectopic pregnancy
813191|NCT00194272|Methotrexate|methotrexate
813192|NCT00194233|Endometriosis|endometriosis
813193|NCT00194220|Infertility|infertility
813194|NCT00194220|Oxidative stress|oxidative stress
813195|NCT00194207|Ectopic pregnancy|ectopic pregnancy
813196|NCT00194194|BMI|bmi
813197|NCT00194194|RMR|rmr
813198|NCT00194194|Personal Computer|personal computer
813199|NCT00194181|dialysis|dialysis
813200|NCT00194181|fibrin|fibrin
813201|NCT00194181|sheath|sheath
813202|NCT00194181|clot|clot
813203|NCT00194181|tpa|tpa
813204|NCT00194168|ectopic pregnancy|ectopic pregnancy
813205|NCT00194155|cytomegalovirus|cytomegalovirus
813206|NCT00194155|pregnancy|pregnancy
813207|NCT00194155|placenta|placenta
813208|NCT00194142|Pregnancy|pregnancy
813209|NCT00194142|Cytomegalovirus|cytomegalovirus
813210|NCT00194090|pain|pain
813211|NCT00194090|osteoarthritis|osteoarthritis
813212|NCT00194051|obesity|obesity
813213|NCT00194051|gait biomechanics|gait biomechanics
813214|NCT00194051|knee osteoarthritis|knee osteoarthritis
813215|NCT00194038|Bipolar Disorder|bipolar disorder
813216|NCT00194038|Geriatric Psychiatry|geriatric psychiatry
813217|NCT00194038|Aripiprazole|aripiprazole
813218|NCT00194025|Schizophrenia|schizophrenia
813219|NCT00194025|Anticonvulsants|anticonvulsants
813220|NCT00194025|Valproic Acid|valproic acid
813221|NCT00194025|Valproate|valproate
813222|NCT00194012|bipolar disorder|bipolar disorder
813223|NCT00193999|Nasogastric Tubes|nasogastric tubes
813224|NCT00193999|Nausea|nausea
813225|NCT00193999|Vomiting|vomiting
813226|NCT00193999|Cardiac surgery|cardiac surgery
813227|NCT00193986|Prepulse|prepulse
813228|NCT00193986|Defibrillator|defibrillator
813229|NCT00193973|Lymphoma|lymphoma
813230|NCT00193973|PCNSL|pcnsl
813231|NCT00193973|Primary CNS lymphoma|primary cns lymphoma
813232|NCT00193960|Seton surgery, glaucoma, Ahmed valve, intraocular pressure|seton surgery, glaucoma, ahmed valve, intraocular pressure
813233|NCT00193934|Women's Health|women's health
813234|NCT00193934|Multidisciplinary, multicentre prospective study|multidisciplinary, multicentre prospective study
813235|NCT00193934|Cancer:mechanisms of growth, invasion, metastases|cancer:mechanisms of growth, invasion, metastases
813236|NCT00193934|Figo Stages cervical cancer|figo stages cervical cancer
813237|NCT00193934|Advances in diagnosis using radiological methods|advances in diagnosis using radiological methods
813238|NCT00193934|Quantitative Magnetic Resonance Imaging|quantitative magnetic resonance imaging
813239|NCT00193934|Patient Management Strategies|patient management strategies
813240|NCT00193934|Selecting patients for therapy|selecting patients for therapy
813241|NCT00193921|Chemoradiotherapy|chemoradiotherapy
813242|NCT00193921|High dose|high dose
813243|NCT00193921|palliative radiotherapy|palliative radiotherapy
813244|NCT00193921|Quality of life|quality of life
813245|NCT00193908|Skin care|skin care
813246|NCT00193908|Radiotherapy|radiotherapy
813247|NCT00193895|Skin cancer|skin cancer
813248|NCT00193895|radiotherapy|radiotherapy
813249|NCT00193895|chemotherapy|chemotherapy
813250|NCT00193895|surgery|surgery
813251|NCT00193882|Oesophageal|oesophageal
813252|NCT00193882|Dysphagia|dysphagia
813253|NCT00193882|Palliation|palliation
813254|NCT00193882|Quality of Life|quality of life
813255|NCT00193882|Radiotherapy|radiotherapy
813256|NCT00193882|Chemotherapy|chemotherapy
813257|NCT00193869|Radiotherapy|radiotherapy
813258|NCT00193869|Dose fractionation|dose fractionation
813259|NCT00193856|Prostate Cancer|prostate cancer
813260|NCT00193856|Androgen Deprivation|androgen deprivation
813261|NCT00193856|Hormone Therapy|hormone therapy
813262|NCT00193856|RadiotherapyBisphosphonate|radiotherapybisphosphonate
813263|NCT00193856|Prostate Specific Antigen (PSA)|prostate specific antigen (psa)
813264|NCT00193843|Oral cancer|oral cancer
813265|NCT00193843|Head and neck surgery|head and neck surgery
813266|NCT00193843|Accelerated radiotherapy|accelerated radiotherapy
813267|NCT00193843|Chemo-radiotherapy|chemo-radiotherapy
813268|NCT00193830|Cervical Cancer|cervical cancer
813269|NCT00193830|High Dose Rate (HDR) Brachytherapy|high dose rate (hdr) brachytherapy
813270|NCT00193830|Low Dose Rate (LDR) Brachytherapy|low dose rate (ldr) brachytherapy
813271|NCT00193830|Acute Toxicities|acute toxicities
813272|NCT00193830|Late Radiation Sequelae|late radiation sequelae
813273|NCT00193817|Cancer|cancer
813274|NCT00193817|Esophagus|esophagus
813275|NCT00193817|Lymphadenectomy|lymphadenectomy
813276|NCT00193804|Cervical Cancer|cervical cancer
813277|NCT00193804|FIGO STAGE IIB|figo stage iib
813278|NCT00193804|CHEMORADIATION|chemoradiation
813279|NCT00193804|Intensity Modulated Radiation Therapy(IMRT)|intensity modulated radiation therapy(imrt)
813280|NCT00193804|Conventional Radiation Therapy|conventional radiation therapy
813281|NCT00193804|Cancer of the Cervix|cancer of the cervix
813282|NCT00193804|Cervix Cancer|cervix cancer
813283|NCT00193791|Carcinoma Cervix|carcinoma cervix
813284|NCT00193791|FIGO Stage IIIB|figo stage iiib
813285|NCT00193791|Radiation therapy|radiation therapy
813286|NCT00193791|Chemoradiation|chemoradiation
813287|NCT00193791|Treatment related toxicities|treatment related toxicities
813288|NCT00193791|Cervical Cancer|cervical cancer
813289|NCT00193791|Cervix Cancer|cervix cancer
813290|NCT00193778|Metastatic breast cancer|metastatic breast cancer
813291|NCT00193778|Locoregional treatment|locoregional treatment
813292|NCT00193778|Survival|survival
813293|NCT00193765|neck dissection|neck dissection
813294|NCT00193765|survival|survival
813295|NCT00193765|early oral cancer|early oral cancer
813296|NCT00193765|Early oral cavity squamous cancer with node negative neck|early oral cavity squamous cancer with node negative neck
813297|NCT00193752|FDG-PET Imaging|fdg-pet imaging
813298|NCT00193752|Cervical Cancer|cervical cancer
813299|NCT00193752|Post-treatment evaluation|post-treatment evaluation
813300|NCT00193752|Para-aortic Nodal Staging|para-aortic nodal staging
813301|NCT00193752|Extended field Radiation|extended field radiation
813302|NCT00193752|Extended field IMRT|extended field imrt
813303|NCT00193739|Neoadjuvant chemotherapy|neoadjuvant chemotherapy
813304|NCT00193739|Surgery|surgery
813305|NCT00193739|Cervix cancer|cervix cancer
813306|NCT00193739|Concurrent chemoradiation|concurrent chemoradiation
813307|NCT00193726|Estrogen|estrogen
813309|NCT00193726|Adjuvant chemotherapy|adjuvant chemotherapy
813310|NCT00193726|Breast cancer|breast cancer
813311|NCT00193713|double-blind study in the treatment of schizophrenia|double-blind study in the treatment of schizophrenia
813312|NCT00193700|Hypogonadism|hypogonadism
813313|NCT00193687|open-label study in the treatment of schizophrenia|open-label study in the treatment of schizophrenia
813314|NCT00193674|Pregnancy|pregnancy
813315|NCT00193674|Immunology|immunology
813316|NCT00193674|Unexplained recurrent miscarriage|unexplained recurrent miscarriage
813317|NCT00193661|Hypogonadism|hypogonadism
813318|NCT00193648|FSGS|fsgs
813319|NCT00193648|Pharmacokinetics|pharmacokinetics
813320|NCT00193648|Rosiglitazone|rosiglitazone
813321|NCT00193648|PPAR-gamma agonist|ppar-gamma agonist
813322|NCT00193648|Adalimumab|adalimumab
813323|NCT00193648|TNF-alpha antagonist|tnf-alpha antagonist
813324|NCT00193648|Steroid and immunosuppressive drug resistance|steroid and immunosuppressive drug resistance
813325|NCT00193648|Resistant primary FSGS|resistant primary fsgs
813326|NCT00193635|Congenital uropathies|congenital uropathies
813327|NCT00193635|Mycophenolate mofetil|mycophenolate mofetil
813328|NCT00193635|GFR|gfr
813329|NCT00193635|Iothalamate clearance|iothalamate clearance
813330|NCT00193635|Urine cytometry|urine cytometry
813331|NCT00193635|Children|children
813332|NCT00193635|Congenital urological abnormalities which represent stuctural defects in the genitourinary system|congenital urological abnormalities which represent stuctural defects in the genitourinary system
813333|NCT00193609|Neoplasms, Unknown Primary|neoplasms, unknown primary
813334|NCT00193596|Neoplasms, Unknown Primary|neoplasms, unknown primary
813335|NCT00193492|Lymphoma|lymphoma
813336|NCT00193492|Bevacizumab|bevacizumab
813337|NCT00193492|Rituximab|rituximab
813338|NCT00193453|Lung Cancer|lung cancer
813339|NCT00193336|NSCLC Lung Cancer|nsclc lung cancer
813340|NCT00193336|Non Small Cell Lung Cancer|non small cell lung cancer
813341|NCT00193297|Ovary Cancer|ovary cancer
813342|NCT00193258|Recurrent clear cell renal cell carcinoma|recurrent clear cell renal cell carcinoma
813343|NCT00193258|Bevacizumab|bevacizumab
813344|NCT00193258|Erlotinib|erlotinib
813345|NCT00193258|Imatinib|imatinib
813346|NCT00193219|Colon Cancer|colon cancer
813347|NCT00193206|Locally Advanced Breast Cancer|locally advanced breast cancer
813348|NCT00193206|Inflammatory Breast Cancer|inflammatory breast cancer
813349|NCT00193206|Breast Cancer|breast cancer
813350|NCT00193206|Abraxane|abraxane
813351|NCT00193206|nab Paclitaxel|nab paclitaxel
813352|NCT00193206|Epirubicin|epirubicin
813353|NCT00193206|Gemcitabine|gemcitabine
813354|NCT00193206|Gemzar|gemzar
813355|NCT00193180|Breast Cancer|breast cancer
813356|NCT00193154|Kidney Cancer|kidney cancer
813357|NCT00193128|Esophagus Cancer|esophagus cancer
813358|NCT00193037|Breast Cancer|breast cancer
813359|NCT00192998|Affective disorder|affective disorder
813360|NCT00192998|Alzheimer dementia|alzheimer dementia
813361|NCT00192998|healthy controls|healthy controls
813362|NCT00192972|Catheter ablation|catheter ablation
813363|NCT00192972|Atrial fibrillation|atrial fibrillation
813364|NCT00192959|Anaesthesia|anaesthesia
813365|NCT00192959|Surgery|surgery
813366|NCT00192959|Postoperative|postoperative
813367|NCT00192959|Neuropsychological test|neuropsychological test
813368|NCT00192946|Cardiac resynchronization|cardiac resynchronization
813369|NCT00192946|Heart failure|heart failure
813370|NCT00192946|open heart surgery|open heart surgery
813371|NCT00192946|surgery|surgery
813372|NCT00192881|Percutaneous coronary intervention|percutaneous coronary intervention
813373|NCT00192881|Balloon angioplasty|balloon angioplasty
813374|NCT00192881|Restenosis|restenosis
813375|NCT00192881|Stents|stents
813376|NCT00192868|primary PCI|primary pci
813377|NCT00192868|distal protection|distal protection
813378|NCT00192868|drug eluting stent|drug eluting stent
813379|NCT00192868|restenosis|restenosis
813380|NCT00192855|schizophrenia|schizophrenia
813381|NCT00192855|negative symptoms|negative symptoms
813382|NCT00192855|entacapone|entacapone
813383|NCT00192842|carcinoma|carcinoma
813384|NCT00192842|pancreas|pancreas
813385|NCT00192842|gemcitabine|gemcitabine
813386|NCT00192842|curcumin|curcumin
813387|NCT00192829|Lung cancer|lung cancer
813388|NCT00192829|Thrombosis|thrombosis
813389|NCT00192829|Hypercoagulable|hypercoagulable
813390|NCT00192803|niddm|niddm
813391|NCT00192803|ace2|ace2
813392|NCT00192803|NIDDM patients|niddm patients
813393|NCT00192790|Therma,pain, Silent myocardial ischemia, catastrophizing|therma,pain, silent myocardial ischemia, catastrophizing
813394|NCT00192777|Solid Tumors|solid tumors
813395|NCT00192777|Bone Metastases|bone metastases
813396|NCT00192777|Radiotherapy|radiotherapy
813397|NCT00192777|Xeloda|xeloda
813398|NCT00192777|Concurrent|concurrent
813399|NCT00192777|Radiosensitization|radiosensitization
813400|NCT00192764|large cell lymphoma|large cell lymphoma
813401|NCT00192764|CHOP|chop
813402|NCT00192764|cyclophosphamide|cyclophosphamide
813403|NCT00192764|high-dose|high-dose
813404|NCT00192751|Schizophrenia|schizophrenia
813405|NCT00192751|Major depression|major depression
813406|NCT00192751|Bipolar disorder|bipolar disorder
813407|NCT00192751|Compliance|compliance
813408|NCT00192751|Relapse prevention|relapse prevention
813409|NCT00192738|telephone,|telephone,
813410|NCT00192738|internal medicine,|internal medicine,
813411|NCT00192738|readmission,|readmission,
813412|NCT00192738|patients' satisfaction|patients' satisfaction
813413|NCT00192725|bipolar disorder|bipolar disorder
813414|NCT00192725|acute mania|acute mania
813415|NCT00192725|tryptophan depletion|tryptophan depletion
813416|NCT00192725|placebo controlled add-on|placebo controlled add-on
813417|NCT00192725|Bipolar disorder- manic type|bipolar disorder- manic type
813418|NCT00192712|carcinoma|carcinoma
813419|NCT00192712|pancreas|pancreas
813420|NCT00192712|chemotherapy|chemotherapy
813421|NCT00192712|radiotherapy|radiotherapy
813422|NCT00192699|Osteoarthritis|osteoarthritis
813423|NCT00192673|Asparaginase|asparaginase
813424|NCT00192673|intramuscular administration|intramuscular administration
813425|NCT00192673|Silent antibodies|silent antibodies
813426|NCT00192673|Childhood acute lymphoblastic leukemia|childhood acute lymphoblastic leukemia
813427|NCT00192673|Side effects|side effects
813428|NCT00192673|5-year EFS|5-year efs
813429|NCT00192660|HIV|hiv
813430|NCT00192660|Metabolic abnormality|metabolic abnormality
813431|NCT00192660|Lipodystrophy|lipodystrophy
813432|NCT00192660|Cardiovascular disease|cardiovascular disease
813433|NCT00192660|Treatment Naive|treatment naive
813434|NCT00192660|Treatment Experienced|treatment experienced
813435|NCT00192660|HIV Infections|hiv infections
813436|NCT00192634|HIV|hiv
813437|NCT00192634|Antiretroviral therapy|antiretroviral therapy
813438|NCT00192634|nucleoside analogue reverse transcriptase|nucleoside analogue reverse transcriptase
813439|NCT00192634|fixed dose combination|fixed dose combination
813440|NCT00192634|Treatment Experienced|treatment experienced
813441|NCT00192621|HIV negative healthy subjects|hiv negative healthy subjects
813442|NCT00192621|Lipid metabolism|lipid metabolism
813443|NCT00192621|Glucose metabolism|glucose metabolism
813444|NCT00192621|Metabolic abnormality|metabolic abnormality
813445|NCT00192621|Lipodystrophy|lipodystrophy
813446|NCT00192621|Cardiovascular disease|cardiovascular disease
813447|NCT00192621|Treatment Naive|treatment naive
813448|NCT00192621|HIV|hiv
813449|NCT00192608|Pharmacokinetics, atazanavir, saquinavir, ritonavir, HIV|pharmacokinetics, atazanavir, saquinavir, ritonavir, hiv
813450|NCT00192595|Hepatitis B|hepatitis b
813451|NCT00192595|HIV|hiv
813452|NCT00192595|Treatment Naive|treatment naive
813453|NCT00192582|Motivational interview|motivational interview
813454|NCT00192582|Care plan|care plan
813455|NCT00192582|Relapse prevention|relapse prevention
813456|NCT00192582|Psychoeducation|psychoeducation
813457|NCT00192582|Indigenous mental health|indigenous mental health
813458|NCT00192569|Acute Hepatitis C|acute hepatitis c
813459|NCT00192556|tuberculosis|tuberculosis
813460|NCT00192556|nutrition|nutrition
813461|NCT00192556|directly observed therapy|directly observed therapy
813462|NCT00192556|Timor Leste|timor leste
813463|NCT00192556|cost-effectiveness|cost-effectiveness
813464|NCT00192543|dialysis|dialysis
813465|NCT00192543|omega-3 fatty acids|omega-3 fatty acids
813466|NCT00192543|antioxidants|antioxidants
813467|NCT00192543|cardiovascular markers|cardiovascular markers
813468|NCT00192543|Mortality|mortality
813469|NCT00192543|End-stage renal disease|end-stage renal disease
813470|NCT00191971|Transitional cell carcinoma of urothelium|transitional cell carcinoma of urothelium
813471|NCT00191282|diabetes|diabetes
813472|NCT00191282|MI|mi
813473|NCT00191282|heart attack|heart attack
813474|NCT00191269|after|after
813475|NCT00191269|anthracycline|anthracycline
813476|NCT00191269|taxane|taxane
813477|NCT00191269|regimen|regimen
813478|NCT00191243|breast cancer|breast cancer
813479|NCT00191113|syndrome|syndrome
813480|NCT00191113|Turner|turner
813481|NCT00191113|Turner's|turner's
813482|NCT00191113|height|height
813483|NCT00191113|growth|growth
813484|NCT00191113|growth hormone|growth hormone
813485|NCT00191113|somatropin|somatropin
813486|NCT00191113|short stature|short stature
813487|NCT00191113|short|short
813488|NCT00191113|hearing|hearing
813489|NCT00191113|glucose metabolism|glucose metabolism
813490|NCT00190671|Advanced Breast Cancer|advanced breast cancer
813492|NCT00190580|chronic kidney disease|chronic kidney disease
813493|NCT00190580|hypertension|hypertension
813494|NCT00190580|angiotensin II receptor blocker|angiotensin ii receptor blocker
813495|NCT00190580|cardiovascular disease|cardiovascular disease
813496|NCT00190580|valsartan|valsartan
813497|NCT00190580|KVT|kvt
813498|NCT00190554|esophageal cancer|esophageal cancer
813499|NCT00190554|squamous cell carcinoma|squamous cell carcinoma
813500|NCT00190554|esophagectomy|esophagectomy
813501|NCT00190554|neoadjuvant chemotherapy|neoadjuvant chemotherapy
813502|NCT00190554|esophageal squamous cell carcinoma|esophageal squamous cell carcinoma
813503|NCT00190541|Rectal Cancer|rectal cancer
813504|NCT00190541|Lymph Node Dissection|lymph node dissection
813505|NCT00190541|Rectal Surgery|rectal surgery
813506|NCT00190541|Autonomic Nerves|autonomic nerves
813507|NCT00190541|Stage II, III lower rectal cancer|stage ii, iii lower rectal cancer
813508|NCT00190528|cervical cancer|cervical cancer
813509|NCT00190528|drug therapy|drug therapy
813510|NCT00190528|cisplatin|cisplatin
813511|NCT00190528|bleomycin|bleomycin
813512|NCT00190528|mitomycin|mitomycin
813513|NCT00190528|vincristine|vincristine
813514|NCT00190515|adjuvant chemotherapy|adjuvant chemotherapy
813515|NCT00190515|Stage III colorectal cancer|stage iii colorectal cancer
813516|NCT00190515|5-FU+l-LV|5-fu+l-lv
813517|NCT00190515|UFT+LV|uft+lv
813518|NCT00190515|randomized controlled trial|randomized controlled trial
813519|NCT00190502|Type 1 diabetes mellitus|type 1 diabetes mellitus
813520|NCT00190502|Immune intervention|immune intervention
813521|NCT00190502|Polyclonal antibodies|polyclonal antibodies
813522|NCT00190502|Type 1 diabetes of recent onset|type 1 diabetes of recent onset
813523|NCT00190502|C-peptide level 0.3 pmol/l or higher|c-peptide level 0.3 pmol/l or higher
813524|NCT00190502|Positivity of at least one marker of autoimmunity (diabetes)|positivity of at least one marker of autoimmunity (diabetes)
813525|NCT00190489|metastatic breast cancer|metastatic breast cancer
813526|NCT00190489|drug therapy|drug therapy
813527|NCT00190489|doxorubicin|doxorubicin
813528|NCT00190489|docetaxel|docetaxel
813529|NCT00190476|Elderly|elderly
813530|NCT00190476|advanced|advanced
813531|NCT00190476|non-small-cell lung cancer|non-small-cell lung cancer
813532|NCT00190476|cisplatin|cisplatin
813533|NCT00190476|docetaxel|docetaxel
813534|NCT00190476|weekly|weekly
813535|NCT00190476|combination|combination
813536|NCT00190476|chemotherapy|chemotherapy
813537|NCT00190476|randomized trial|randomized trial
813538|NCT00190463|aspergillosis|aspergillosis
813539|NCT00190463|antifungal therapy|antifungal therapy
813540|NCT00190463|empirical antifungal treatment|empirical antifungal treatment
813541|NCT00190450|Huntington|huntington
813542|NCT00190450|graft|graft
813543|NCT00190450|cellular therapy|cellular therapy
813544|NCT00190450|striatum|striatum
813545|NCT00190437|Chronic Obstructive Lung Disease (COLD)|chronic obstructive lung disease (cold)
813546|NCT00190437|Randomized Clinical Trial|randomized clinical trial
813547|NCT00190437|Antibiotics|antibiotics
813548|NCT00190437|Acute Exacerbation|acute exacerbation
813549|NCT00190437|Mechanical|mechanical
813550|NCT00190437|Ventilation|ventilation
813551|NCT00190437|Intensive Care|intensive care
813552|NCT00190437|Length of Stay|length of stay
813553|NCT00190437|Mortality|mortality
813554|NCT00190424|Glioblastoma|glioblastoma
813555|NCT00190424|Immunotherapy|immunotherapy
813556|NCT00190411|Arteries|arteries
813557|NCT00190411|ultrasonography|ultrasonography
813558|NCT00190411|Ehlers Danlos syndrome|ehlers danlos syndrome
813559|NCT00190411|Cardiovascular disease|cardiovascular disease
813560|NCT00190411|beta adrenergic antagonists|beta adrenergic antagonists
813561|NCT00190398|Prospective|prospective
813562|NCT00190398|Randomised|randomised
813563|NCT00190398|Open|open
813564|NCT00190398|Blinded End-point|blinded end-point
813565|NCT00190398|PROBE Study|probe study
813566|NCT00190398|Ischemic stroke|ischemic stroke
813567|NCT00190385|Cirrhosis|cirrhosis
813568|NCT00190385|Hepatocellular carcinoma|hepatocellular carcinoma
813569|NCT00190385|Screening|screening
813570|NCT00190385|Randomized|randomized
813571|NCT00190385|HBV|hbv
813572|NCT00190385|HCV|hcv
813573|NCT00190385|alcohol|alcohol
813574|NCT00190385|hemochromatosis|hemochromatosis
813575|NCT00190372|Alzheimer's disease training programme|alzheimer's disease training programme
813576|NCT00190372|educational programme caregivers carers dementia treatment|educational programme caregivers carers dementia treatment
813577|NCT00190372|Dementia Cognitive disorder|dementia cognitive disorder
813578|NCT00190359|heart failure|heart failure
813579|NCT00190359|hormones|hormones
813580|NCT00190359|growth substances|growth substances
813581|NCT00190346|Acute respiratory distress|acute respiratory distress
813582|NCT00190346|with hypercapnia|with hypercapnia
813583|NCT00190346|with hypoxemia|with hypoxemia
813584|NCT00190346|requiring NIV|requiring niv
813585|NCT00190333|pulmonary hypertension|pulmonary hypertension
813586|NCT00190333|6 minutes walking test|6 minutes walking test
813587|NCT00190333|serotonin|serotonin
813588|NCT00190333|primary or associated pulmonary hypertension|primary or associated pulmonary hypertension
813589|NCT00190320|Fetal macrosomia|fetal macrosomia
813590|NCT00190320|Neonatal traumatism|neonatal traumatism
813591|NCT00190320|Maternal morbidity|maternal morbidity
813592|NCT00190307|Long term antiplatelet therapy|long term antiplatelet therapy
813593|NCT00190307|Scheduled surgery|scheduled surgery
813594|NCT00190294|Pregnancy Complications|pregnancy complications
813595|NCT00190281|FUNCTIONAL STUDY|functional study
813596|NCT00190281|CONTRAST-ENHANCED US|contrast-enhanced us
813597|NCT00190281|PERFUSION|perfusion
813598|NCT00190268|multiple sclerosis|multiple sclerosis
813599|NCT00190268|fatigue|fatigue
813600|NCT00190268|3,4-diaminopyridine|3,4-diaminopyridine
813601|NCT00190255|gastrointestinal haemorrhage|gastrointestinal haemorrhage
813602|NCT00190255|stomach ulcer|stomach ulcer
813603|NCT00190255|anti-inflammatory agents, non-steroidal|anti-inflammatory agents, non-steroidal
813604|NCT00190255|CYP2C9 protein, human|cyp2c9 protein, human
813605|NCT00190255|genotype|genotype
813606|NCT00190255|pharmacogenetics|pharmacogenetics
813607|NCT00190242|HIV|hiv
813608|NCT00190242|hepatitis A|hepatitis a
813609|NCT00190242|vaccine|vaccine
813610|NCT00190242|HBV and/or HCV co-infection|hbv and/or hcv co-infection
813611|NCT00190229|Vasculitis|vasculitis
813612|NCT00190229|Cyclophosphamide|cyclophosphamide
813613|NCT00190229|Renal failure|renal failure
813614|NCT00190216|Resistant depression|resistant depression
813615|NCT00190216|Transcranial Magnetic Stimulation,|transcranial magnetic stimulation,
813616|NCT00190216|Neuroimaging|neuroimaging
813617|NCT00190203|Malignant middle cerebral artery infarction|malignant middle cerebral artery infarction
813618|NCT00190203|Decompressive surgery|decompressive surgery
813619|NCT00190203|Hemicraniectomy|hemicraniectomy
813620|NCT00190203|Brain edema|brain edema
813621|NCT00190190|Macular hole|macular hole
813622|NCT00190190|internal limiting membrane|internal limiting membrane
813623|NCT00190190|retina|retina
813624|NCT00190190|surgery|surgery
813625|NCT00190164|Macular hole|macular hole
813626|NCT00190164|Vitrectomy|vitrectomy
813627|NCT00190164|positioning|positioning
813628|NCT00190164|retina|retina
813629|NCT00190164|surgery|surgery
813630|NCT00190151|ciprofloxacin|ciprofloxacin
813631|NCT00190151|commensal flora|commensal flora
813632|NCT00190151|resistance|resistance
813633|NCT00190151|Pharmacokinetic|pharmacokinetic
813634|NCT00190138|Bi-ventricular pacing|bi-ventricular pacing
813635|NCT00190138|ventricular resynchronization|ventricular resynchronization
813636|NCT00190138|baroreflex sensitivity|baroreflex sensitivity
813637|NCT00190138|heart rate variability|heart rate variability
813638|NCT00190125|Hemodialysis|hemodialysis
813639|NCT00190125|Malnutrition|malnutrition
813640|NCT00190125|Inflammation|inflammation
813641|NCT00190099|In-stent restenosis,|in-stent restenosis,
813642|NCT00190099|Drug eluting stent,|drug eluting stent,
813643|NCT00190099|dexamethasone,|dexamethasone,
813644|NCT00190099|Acute coronary syndrome|acute coronary syndrome
813645|NCT00190073|Epidermal nerves;protein gene product 9.5; ethanol|epidermal nerves;protein gene product 9.5; ethanol
813646|NCT00190060|Frailty|frailty
813647|NCT00190060|Muscle strength|muscle strength
813648|NCT00190060|Physical performance|physical performance
813649|NCT00190060|Bone mineral density|bone mineral density
813650|NCT00190060|Quality of life|quality of life
813651|NCT00190047|Cerebral Ischemia|cerebral ischemia
813652|NCT00190047|Ischemic Brain Injury|ischemic brain injury
813653|NCT00190047|Brain Infarction|brain infarction
813654|NCT00190047|Brain Ischemia|brain ischemia
813655|NCT00190034|Acetylcysteine|acetylcysteine
813656|NCT00190034|cardiac surgery|cardiac surgery
813657|NCT00190034|cardiopulmonary bypass|cardiopulmonary bypass
813658|NCT00190034|acute renal insufficiency|acute renal insufficiency
813659|NCT00190021|Alzheimer's type dementia|alzheimer's type dementia
813660|NCT00190021|donepezil|donepezil
813661|NCT00190021|double-blind|double-blind
813662|NCT00190008|tardive dyskinesia|tardive dyskinesia
813663|NCT00190008|piracetam|piracetam
813664|NCT00189995|schizophrenia|schizophrenia
813665|NCT00189995|aggression|aggression
813666|NCT00189995|clozapine|clozapine
813667|NCT00189995|efficacy|efficacy
813668|NCT00189995|double-blind|double-blind
813669|NCT00189982|Factor VIII Deficiency|factor viii deficiency
813670|NCT00189930|Treatment Experienced|treatment experienced
813671|NCT00189904|HIV|hiv
813672|NCT00189878|chronic idiopathic urticaria|chronic idiopathic urticaria
813673|NCT00189878|methotrexate|methotrexate
813674|NCT00189852|Telecare|telecare
813675|NCT00189852|chronic|chronic
813676|NCT00189852|older people|older people
813677|NCT00189852|heart failure|heart failure
813678|NCT00189839|Tacrolimus|tacrolimus
813679|NCT00189839|Kidney transplantation|kidney transplantation
813680|NCT00189839|Transplantation, kidney|transplantation, kidney
813681|NCT00189839|Renal Transplantation|renal transplantation
813682|NCT00189839|Transplantation, renal|transplantation, renal
813683|NCT00189826|Tacrolimus|tacrolimus
813684|NCT00189826|Liver transplantation|liver transplantation
813784|NCT00189423|ResQPump|resqpump
813685|NCT00189813|Irritable Bowel Syndrome|irritable bowel syndrome
813686|NCT00189813|Diarrhea|diarrhea
813688|NCT00189813|Irribow®|irribow®
813689|NCT00189813|ramosetron|ramosetron
813692|NCT00189800|randomized controlled trial|randomized controlled trial
813693|NCT00189800|double-blind method|double-blind method
813694|NCT00189787|Tacrolimus|tacrolimus
813695|NCT00189787|Immunosuppressant|immunosuppressant
813696|NCT00189787|Anti-asthmatic drug|anti-asthmatic drug
813697|NCT00189787|Administration, inhalation|administration, inhalation
813698|NCT00189774|nateglinide|nateglinide
813699|NCT00189774|pioglitazone|pioglitazone
813700|NCT00189774|combination drug therapy|combination drug therapy
813701|NCT00189774|treatment|treatment
813702|NCT00189761|Tacrolimus|tacrolimus
813703|NCT00189761|Immunosuppression|immunosuppression
813704|NCT00189761|Bone Marrow Transplantation|bone marrow transplantation
813705|NCT00189761|Graft versus Host Disease|graft versus host disease
813706|NCT00189748|Tacrolimus|tacrolimus
813707|NCT00189748|Immunosuppression|immunosuppression
813708|NCT00189748|Bone Marrow Transplantation|bone marrow transplantation
813709|NCT00189748|Graft versus Host Disease|graft versus host disease
813710|NCT00189735|Treatment Efficacy|treatment efficacy
813711|NCT00189735|Treatment Effectiveness|treatment effectiveness
813712|NCT00189735|Anti-rejection therapy|anti-rejection therapy
813713|NCT00189735|Immunosuppression|immunosuppression
813714|NCT00189735|Antirejection|antirejection
813715|NCT00189735|Malononitrilamide|malononitrilamide
813716|NCT00189722|Tacrolimus|tacrolimus
813717|NCT00189722|Immunosuppressant|immunosuppressant
813718|NCT00189722|Anti-asthmatic drug|anti-asthmatic drug
813719|NCT00189722|Administration, inhalation|administration, inhalation
813720|NCT00189709|micafungin|micafungin
813721|NCT00189709|fluconazole|fluconazole
813722|NCT00189709|invasive candidiasis|invasive candidiasis
813723|NCT00189709|candidemia|candidemia
813724|NCT00189696|Irritable Bowel Syndrome, Diarrhea|irritable bowel syndrome, diarrhea
813725|NCT00189618|Peripheral vascular disease|peripheral vascular disease
813726|NCT00189618|Peripheral arterial disease|peripheral arterial disease
813727|NCT00189618|Walking Capacity|walking capacity
813728|NCT00189618|Aspirin|aspirin
813729|NCT00189618|Clopidogrel|clopidogrel
813730|NCT00189605|Plasma disc decompression|plasma disc decompression
813731|NCT00189605|Intradiscal Pressure|intradiscal pressure
813732|NCT00189605|Steroid Injection|steroid injection
813733|NCT00189605|Epidural Steroid Injection|epidural steroid injection
813734|NCT00189605|Selective Nerve Root Injection|selective nerve root injection
813735|NCT00189605|Leg Pain|leg pain
813736|NCT00189605|Radicular Pain|radicular pain
813737|NCT00189605|Coblation|coblation
813738|NCT00189605|SNRI|snri
813739|NCT00189592|plantar fascia|plantar fascia
813740|NCT00189592|plantar fasciitis|plantar fasciitis
813741|NCT00189592|Coblation|coblation
813742|NCT00189592|fasciotomy|fasciotomy
813743|NCT00189592|conventional surgical fasciotomy|conventional surgical fasciotomy
813744|NCT00189592|heel spur|heel spur
813745|NCT00189592|heel pain|heel pain
813746|NCT00189592|aponeurosis|aponeurosis
813747|NCT00189592|plasma based radiofrequency|plasma based radiofrequency
813748|NCT00189592|angiogenesis|angiogenesis
813749|NCT00189579|HERCEPTIN|herceptin
813750|NCT00189579|Carboplatin|carboplatin
813751|NCT00189579|Paclitaxel|paclitaxel
813752|NCT00189579|Relapse|relapse
813753|NCT00189566|Relapse within 6 months|relapse within 6 months
813754|NCT00189566|Previously received taxane derivative|previously received taxane derivative
813755|NCT00189553|Extra-ovarian papillary serous tumors|extra-ovarian papillary serous tumors
813756|NCT00189553|Relapse over 6 months|relapse over 6 months
813757|NCT00189553|Previously received taxane derivative|previously received taxane derivative
813758|NCT00189540|Ischemic ulcers|ischemic ulcers
813759|NCT00189540|Critical Limb Ischemia|critical limb ischemia
813760|NCT00189514|obesity|obesity
813761|NCT00189514|weight loss|weight loss
813762|NCT00189514|Amylin|amylin
813763|NCT00189514|pramlintide|pramlintide
813764|NCT00189501|Chronic Kidney Disease, CKD,|chronic kidney disease, ckd,
813765|NCT00189501|Secondary Hyperparathyroidism, HPT|secondary hyperparathyroidism, hpt
813766|NCT00189488|Hematological Malignancies|hematological malignancies
813767|NCT00189488|Graft-versus-host-disease|graft-versus-host-disease
813768|NCT00189488|Oral Mucositis|oral mucositis
813769|NCT00189488|Allogeneic Transplantation|allogeneic transplantation
813770|NCT00189475|Cold|cold
813771|NCT00189475|Upper Respiratory Infection|upper respiratory infection
813772|NCT00189462|Ear Infections|ear infections
813773|NCT00189462|Otitis Media|otitis media
813774|NCT00189449|Allergic Rhinitis|allergic rhinitis
813775|NCT00189449|Allergy|allergy
813776|NCT00189449|Growth|growth
813777|NCT00189436|Asthma|asthma
813778|NCT00189423|Heart Arrest|heart arrest
813779|NCT00189423|Cardiac Arrest|cardiac arrest
813780|NCT00189423|Cardiopulmonary Resuscitation|cardiopulmonary resuscitation
813781|NCT00189423|Impedance Threshold Device|impedance threshold device
813782|NCT00189423|Active Compression Decompression|active compression decompression
813783|NCT00189423|ResQPOD|resqpod
813785|NCT00189423|Survival|survival
813786|NCT00189423|Out-of-hospital|out-of-hospital
813787|NCT00189423|Prehospital|prehospital
813788|NCT00189423|ResQCPR System|resqcpr system
813789|NCT00189397|Parthenium dermatitis|parthenium dermatitis
813790|NCT00189384|Neonatal sepsis|neonatal sepsis
813791|NCT00189384|Neonatal pneumonia|neonatal pneumonia
813792|NCT00189384|Bacterial infections|bacterial infections
813793|NCT00189384|Young infants|young infants
813795|NCT00189384|Community|community
813796|NCT00189384|Developing country|developing country
813797|NCT00189358|cancer|cancer
813798|NCT00189358|cancer alternative therapies|cancer alternative therapies
813799|NCT00189358|ovarian cancer|ovarian cancer
813800|NCT00189358|tyrosine kinase inhibitor|tyrosine kinase inhibitor
813801|NCT00189345|Cancer|cancer
813802|NCT00189345|Cancer alternative therapies|cancer alternative therapies
813803|NCT00189345|ovarian cancer|ovarian cancer
813804|NCT00189332|Oncology|oncology
813805|NCT00189332|Melanoma|melanoma
813806|NCT00189319|Tambocor|tambocor
813807|NCT00189319|Paroxysmal Atrial Fibrillation|paroxysmal atrial fibrillation
813808|NCT00189319|Quality of Life|quality of life
813809|NCT00189306|Superficial Basal Cell Carcinoma|superficial basal cell carcinoma
813810|NCT00189306|Aldara|aldara
813811|NCT00189293|External Ano-Genital Warts|external ano-genital warts
813812|NCT00189293|Ablative Therapy|ablative therapy
813813|NCT00189293|Aldara|aldara
813814|NCT00189280|Aldara, sBCC|aldara, sbcc
813815|NCT00189267|Aldara|aldara
813816|NCT00189267|Actinic Keratosis|actinic keratosis
813817|NCT00189267|Graft Recipients|graft recipients
813818|NCT00189254|1 year follow up|1 year follow up
813819|NCT00189241|Aldara|aldara
813820|NCT00189241|Superficial Basal Cell Carcinoma|superficial basal cell carcinoma
813821|NCT00189241|Long-Term Study|long-term study
813822|NCT00189215|coronary artery disease|coronary artery disease
813823|NCT00189215|cardiopulmonary bypass|cardiopulmonary bypass
813824|NCT00189215|cognition disorders|cognition disorders
813825|NCT00189189|prevention|prevention
813826|NCT00189189|oppositional defiant disorder|oppositional defiant disorder
813827|NCT00189189|conduct disorder|conduct disorder
813828|NCT00189163|Hepatitis C|hepatitis c
813829|NCT00189163|Genotype 1|genotype 1
813830|NCT00189163|Insulin Resistance|insulin resistance
813831|NCT00189163|Pioglitazone|pioglitazone
813832|NCT00189150|Valganciclovir|valganciclovir
813833|NCT00189150|Mycophenolate Mofetil|mycophenolate mofetil
813834|NCT00189150|Pharmacokinetic|pharmacokinetic
813835|NCT00189150|Interaction|interaction
813837|NCT00189124|Systemic Lupus Erythematosus|systemic lupus erythematosus
813838|NCT00189124|Dehydroepiandrosterone (DHEA)|dehydroepiandrosterone (dhea)
813839|NCT00189124|DHEA|dhea
813840|NCT00189124|SLE|sle
813841|NCT00189124|Lupus|lupus
813842|NCT00189111|peripheral arterial disease|peripheral arterial disease
813843|NCT00189111|computed tomography|computed tomography
813844|NCT00189111|cardiac asymptomatic|cardiac asymptomatic
813845|NCT00189111|dobutamine magnetic resonance imaging|dobutamine magnetic resonance imaging
813846|NCT00189085|Metabolic syndrome|metabolic syndrome
813847|NCT00189072|gabapentin|gabapentin
813848|NCT00189072|neuropathic pain|neuropathic pain
813849|NCT00189072|driving|driving
813850|NCT00189072|attention|attention
813851|NCT00189059|neuropathic pain|neuropathic pain
813852|NCT00189059|erp|erp
813853|NCT00189059|driving|driving
813854|NCT00189059|attention|attention
813855|NCT00189059|amitriptyline|amitriptyline
813856|NCT00189046|driving, chronic pain, attention|driving, chronic pain, attention
813857|NCT00189033|Irritable Bowel Syndrome|irritable bowel syndrome
813858|NCT00189033|Diet Therapy|diet therapy
813859|NCT00189033|Dietary Fiber|dietary fiber
813860|NCT00189033|Randomized Controlled Trial|randomized controlled trial
813861|NCT00189033|Family Practice|family practice
813862|NCT00189020|pneumococcal conjugate vaccination|pneumococcal conjugate vaccination
813863|NCT00189020|nasopharyngeal carriage|nasopharyngeal carriage
813864|NCT00189020|herd immunity|herd immunity
813865|NCT00189020|antipneumococcal antibodies|antipneumococcal antibodies
813866|NCT00189020|respiratory tract infections|respiratory tract infections
813867|NCT00189020|National infant vaccination program|national infant vaccination program
813868|NCT00189007|allopurinol|allopurinol
813869|NCT00189007|neuroprotection|neuroprotection
813870|NCT00189007|reperfusion injury|reperfusion injury
813871|NCT00189007|fetal hypoxia|fetal hypoxia
813872|NCT00189007|post hypoxic-ischemic reperfusion damage|post hypoxic-ischemic reperfusion damage
813873|NCT00188994|Myocardial Protection|myocardial protection
813874|NCT00188994|Myocardial Metabolism|myocardial metabolism
813875|NCT00188994|Ventricular Function|ventricular function
813876|NCT00188994|Cardiovascular Disease|cardiovascular disease
813877|NCT00188994|Cardioplegic Additives|cardioplegic additives
813878|NCT00188981|psychosis|psychosis
813879|NCT00188981|high risk|high risk
813880|NCT00188981|prodrome|prodrome
813881|NCT00188981|Multiple Complex Developmental Disorder|multiple complex developmental disorder
813882|NCT00188968|Xanthines|xanthines
813883|NCT00188968|Reintubation|reintubation
813884|NCT00188968|Nasal Intermittent Ventilation|nasal intermittent ventilation
813885|NCT00188968|Nasal continous positive airway pressure|nasal continous positive airway pressure
813886|NCT00188955|pediatric|pediatric
813887|NCT00188955|chronic allograft nephropathy|chronic allograft nephropathy
813888|NCT00188955|chronic rejection|chronic rejection
814189|NCT00187395|pregnancy|pregnancy
813889|NCT00188955|interstitial fibrosis|interstitial fibrosis
813890|NCT00188942|Magnetic Resonance Imaging|magnetic resonance imaging
813891|NCT00188942|Diagnostic Imaging|diagnostic imaging
813892|NCT00188942|Mood Disorders|mood disorders
813893|NCT00188942|Major Depressive Disorder|major depressive disorder
813894|NCT00188942|Antipsychotic|antipsychotic
813895|NCT00188942|Olanzapine|olanzapine
813896|NCT00188942|Fluoxetine|fluoxetine
813897|NCT00188916|Bronchial blockers|bronchial blockers
813898|NCT00188916|Lung isolation|lung isolation
813899|NCT00188916|Thoracic Anesthesia|thoracic anesthesia
813900|NCT00188903|Cardiac Surgery|cardiac surgery
813901|NCT00188903|Diastolic Dysfunction|diastolic dysfunction
813902|NCT00188903|Atrial Fibrillation|atrial fibrillation
813903|NCT00188890|Lung Cancer|lung cancer
813904|NCT00188890|Mesothelioma|mesothelioma
813905|NCT00188890|Asbestos|asbestos
813906|NCT00188890|Screening|screening
813907|NCT00188890|Early Diagnosis|early diagnosis
813908|NCT00188851|HIV|hiv
813909|NCT00188851|salvage regimen|salvage regimen
813910|NCT00188851|virologic failure|virologic failure
813911|NCT00188851|treatment interruption|treatment interruption
813912|NCT00188851|ARV experienced|arv experienced
813913|NCT00188838|Bipolar Disorder|bipolar disorder
813914|NCT00188838|Psychosocial Factors|psychosocial factors
813915|NCT00188838|Mania|mania
813916|NCT00188838|Depression|depression
813917|NCT00188838|Social Adjustment|social adjustment
813918|NCT00188838|Coping Skills|coping skills
813919|NCT00188825|Lung|lung
813920|NCT00188825|Transplant|transplant
813921|NCT00188825|Rejection|rejection
813922|NCT00188825|BOS|bos
813923|NCT00188812|dementia|dementia
813924|NCT00188812|stroke|stroke
813925|NCT00188773|n-acetylcysteine,|n-acetylcysteine,
813926|NCT00188773|free fatty acid,|free fatty acid,
813927|NCT00188773|glucose stimulated insulin secretion,|glucose stimulated insulin secretion,
813928|NCT00188773|insulin resistance syndrome|insulin resistance syndrome
813929|NCT00188773|antioxidant therapy|antioxidant therapy
813930|NCT00188773|Insulin Resistance|insulin resistance
813931|NCT00188760|Breast Transillumination Spectroscopy|breast transillumination spectroscopy
813932|NCT00188760|Optical Transillumination Spectroscopy|optical transillumination spectroscopy
813933|NCT00188760|Breast Cancer Risk|breast cancer risk
813934|NCT00188747|Coagulopathy|coagulopathy
813935|NCT00188747|Cardiac Surgery|cardiac surgery
813936|NCT00188747|Point of Care|point of care
813937|NCT00188747|Monitoring|monitoring
813938|NCT00188734|Lung Cancer|lung cancer
813939|NCT00188734|Eary Diagnosis|eary diagnosis
813940|NCT00188734|Screening|screening
813941|NCT00188721|Breast Cancer Risk|breast cancer risk
813942|NCT00188721|Optical Transillumination Spectroscopy|optical transillumination spectroscopy
813943|NCT00188721|Transillumination Breast Spectroscopy|transillumination breast spectroscopy
813944|NCT00188682|Optical Transillumination Spectroscopy|optical transillumination spectroscopy
813945|NCT00188682|Transillumination Breast Spectroscopy|transillumination breast spectroscopy
813946|NCT00188682|Breast Cancer Risk|breast cancer risk
813947|NCT00188643|Bipolar Disorder, Depression, Anticonvulsants, Antidepressants|bipolar disorder, depression, anticonvulsants, antidepressants
813948|NCT00188630|Cardiac Surgery|cardiac surgery
813949|NCT00188630|Acute Renal Failure|acute renal failure
813950|NCT00188630|N-acetylcysteine|n-acetylcysteine
813951|NCT00188630|Cardiopulmonary bypass|cardiopulmonary bypass
813952|NCT00188617|LUNG CANCER|lung cancer
813953|NCT00188617|IRESSA|iressa
813954|NCT00188617|GEFITINIB|gefitinib
813955|NCT00188617|STAGE 1A & 1B|stage 1a & 1b
813956|NCT00188617|NEOADJUVANT|neoadjuvant
813957|NCT00188617|PHASE 2|phase 2
813958|NCT00188591|Optical Transillumination Spectroscopy|optical transillumination spectroscopy
813959|NCT00188591|Breast Cancer Risk|breast cancer risk
813960|NCT00188500|epilepsy|epilepsy
813961|NCT00188500|atkins diet|atkins diet
813962|NCT00188396|Major Depressive Disorder|major depressive disorder
813963|NCT00188396|Women's Mental Health|women's mental health
813964|NCT00188396|Hormones|hormones
813965|NCT00188396|Citalopram|citalopram
813966|NCT00188396|Antidepressive agents|antidepressive agents
813967|NCT00188396|Mental Health|mental health
813968|NCT00188383|Hyperalgesia|hyperalgesia
813969|NCT00188383|Quantitative Sensory Testing|quantitative sensory testing
813970|NCT00188383|Pain|pain
813971|NCT00188383|Opioid use|opioid use
813972|NCT00188383|Elderly|elderly
813973|NCT00188344|laparoscopic myotomy|laparoscopic myotomy
813974|NCT00188344|pneumatic dilatation|pneumatic dilatation
813975|NCT00188344|motility disorder|motility disorder
813976|NCT00188344|dysphasia|dysphasia
813977|NCT00188344|health-related quality of life|health-related quality of life
813978|NCT00188331|cognitive function|cognitive function
813979|NCT00188331|fatigue|fatigue
813980|NCT00188331|colorectal cancer|colorectal cancer
813981|NCT00188331|chemotherapy|chemotherapy
813982|NCT00188331|cognitive impairment|cognitive impairment
813983|NCT00188305|Risk counselling|risk counselling
813984|NCT00188305|Health education|health education
813985|NCT00188305|Prevention|prevention
813986|NCT00188305|Behavioral|behavioral
813987|NCT00188305|Screening|screening
813988|NCT00188305|Intervention|intervention
813989|NCT00188305|Telephone vs in person|telephone vs in person
813990|NCT00188292|Human Papillomavirus|human papillomavirus
813991|NCT00188292|Anal|anal
813992|NCT00188292|Cancer screening|cancer screening
813993|NCT00188292|Immunodeficiency|immunodeficiency
813994|NCT00188292|HIV|hiv
813995|NCT00188279|ct|ct
813996|NCT00188279|scan|scan
813997|NCT00188279|lung|lung
813998|NCT00188279|follow-up|follow-up
813999|NCT00188253|Nasopharyngeal carcinoma|nasopharyngeal carcinoma
814000|NCT00188253|PET scan|pet scan
814001|NCT00188253|MRI|mri
814002|NCT00188253|EBV virus|ebv virus
814003|NCT00188240|hepatitis C|hepatitis c
814004|NCT00188240|insulin resistance|insulin resistance
814005|NCT00188240|antiviral therapy|antiviral therapy
814006|NCT00188227|Bone marrow puncture|bone marrow puncture
814007|NCT00188227|Pain|pain
814008|NCT00188214|perfusion|perfusion
814009|NCT00188214|CT|ct
814010|NCT00188214|CAT|cat
814011|NCT00188214|non-small|non-small
814012|NCT00188214|lung|lung
814013|NCT00188201|Hepatitis C|hepatitis c
814014|NCT00188201|neucognitive functions|neucognitive functions
814015|NCT00188201|neuropsychological testing|neuropsychological testing
814016|NCT00188201|antiviral treatment|antiviral treatment
814017|NCT00188188|Endothelial|endothelial
814018|NCT00188188|Dysfunction|dysfunction
814019|NCT00188188|Systemic|systemic
814020|NCT00188188|Lupus|lupus
814021|NCT00188149|Hodgkin's Lymphoma|hodgkin's lymphoma
814022|NCT00188149|Chemotherapy|chemotherapy
814023|NCT00188149|Radiation therapy|radiation therapy
814024|NCT00188149|PET|pet
814025|NCT00188136|AML, allogeneic transplantation, high-risk, karyotype|aml, allogeneic transplantation, high-risk, karyotype
814026|NCT00188123|Myocardial infarction|myocardial infarction
814027|NCT00188123|MRI late enhancement|mri late enhancement
814028|NCT00188123|Atrial fibrillation|atrial fibrillation
814029|NCT00188110|Water-Enema Computed Tomography|water-enema computed tomography
814030|NCT00188110|colon tumor|colon tumor
814031|NCT00188110|coloscopy|coloscopy
814032|NCT00188110|suspicion of colon tumor|suspicion of colon tumor
814033|NCT00188110|coloscopy or surgery|coloscopy or surgery
814034|NCT00188071|medical abortion|medical abortion
814035|NCT00188071|analgesia|analgesia
814036|NCT00188058|Acute respiratory distress syndrome|acute respiratory distress syndrome
814037|NCT00188058|Positive end-expiratory pressure|positive end-expiratory pressure
814038|NCT00188058|Acute lung injury|acute lung injury
814039|NCT00188058|Mechanical ventilation|mechanical ventilation
814040|NCT00188058|Randomized controlled trial|randomized controlled trial
814041|NCT00188045|Portal hypertension, alcoholic cirrhosis, Hepatic venous pressure gradient, hemodynamic, spironolactone, propranolol|portal hypertension, alcoholic cirrhosis, hepatic venous pressure gradient, hemodynamic, spironolactone, propranolol
814042|NCT00188032|pulmonary embolism|pulmonary embolism
814043|NCT00188032|clinical practice|clinical practice
814044|NCT00188032|quality of health care|quality of health care
814045|NCT00188032|diagnostic criteria|diagnostic criteria
814046|NCT00188032|Computer-Assisted Decision Support|computer-assisted decision support
814047|NCT00188032|reminders|reminders
814048|NCT00188006|cardiopulmonary bypass, inflammatory response|cardiopulmonary bypass, inflammatory response
814049|NCT00188006|neurologic injury|neurologic injury
814050|NCT00188006|neurocognitive deficit|neurocognitive deficit
814051|NCT00188006|biomaterials|biomaterials
814052|NCT00188006|coronary artery bypass surgery|coronary artery bypass surgery
814053|NCT00187993|growth hormone deficiency|growth hormone deficiency
814054|NCT00187993|growth hormone|growth hormone
814055|NCT00187993|energy expenditure|energy expenditure
814056|NCT00187993|body composition|body composition
814057|NCT00187954|women|women
814058|NCT00187954|chest pain|chest pain
814059|NCT00187954|microvascular dysfunction|microvascular dysfunction
814060|NCT00187954|retinal photography|retinal photography
814061|NCT00187954|Retinal vascular function|retinal vascular function
814062|NCT00187941|transplant|transplant
814063|NCT00187941|renal|renal
814064|NCT00187941|Cellcept|cellcept
814065|NCT00187941|therapeutic drug level|therapeutic drug level
814066|NCT00187941|MMF|mmf
814067|NCT00187941|MPA|mpa
814068|NCT00187941|immunosuppression|immunosuppression
814069|NCT00187928|Obsessive-Compulsive Disorder|obsessive-compulsive disorder
814070|NCT00187928|Obsessions|obsessions
814071|NCT00187928|Compulsions|compulsions
814072|NCT00187928|Adjunctive treatment|adjunctive treatment
814073|NCT00187915|Renal transplant|renal transplant
814074|NCT00187915|Cellcept|cellcept
814075|NCT00187915|Therapeutic drug level|therapeutic drug level
814076|NCT00187915|Mycophenolate mofetil (MMF)|mycophenolate mofetil (mmf)
814077|NCT00187915|Mycophenolate Acid (MPA)|mycophenolate acid (mpa)
814078|NCT00187915|Oral Bioavailability|oral bioavailability
814079|NCT00187915|Immunosuppression|immunosuppression
814080|NCT00187902|Sexually Transmitted Diseases|sexually transmitted diseases
814081|NCT00187902|Chlamydia trachomatis|chlamydia trachomatis
814082|NCT00187902|Neisseria gonorrhoeae|neisseria gonorrhoeae
814083|NCT00187889|Microvascular Disease|microvascular disease
814084|NCT00187889|Women|women
814085|NCT00187889|Ischemic Heart Disease|ischemic heart disease
814086|NCT00187889|WISE|wise
814087|NCT00187850|Pulp capping|pulp capping
814088|NCT00187850|partial pulpotomy|partial pulpotomy
814089|NCT00187850|Exposure of the pulp|exposure of the pulp
814090|NCT00187837|Stepwise excavation|stepwise excavation
814091|NCT00187824|prospective|prospective
814092|NCT00187824|observational|observational
814093|NCT00187824|hormonal|hormonal
814094|NCT00187824|inflammatory|inflammatory
814095|NCT00187824|vioenergetic|vioenergetic
814096|NCT00187824|immune|immune
814097|NCT00187824|sepsis|sepsis
814098|NCT00187811|Angioplasty,|angioplasty,
814099|NCT00187811|Restenosis,|restenosis,
814100|NCT00187811|Photodynamic therapy|photodynamic therapy
814101|NCT00187798|Healthy Control Twins|healthy control twins
814102|NCT00187785|Hispanic|hispanic
814103|NCT00187785|communication|communication
814104|NCT00187772|domestic violence|domestic violence
814105|NCT00187772|preschoolers|preschoolers
814106|NCT00187772|trauma|trauma
814107|NCT00187772|intervention|intervention
814108|NCT00187759|Abscess|abscess
814109|NCT00187759|Antibitoics|antibitoics
814110|NCT00187759|Methicillin-resistant Staphylococcus aureus|methicillin-resistant staphylococcus aureus
814111|NCT00187746|Healthy Control|healthy control
814112|NCT00187733|L-carnitine|l-carnitine
814113|NCT00187720|Healthy Control|healthy control
814114|NCT00187681|Healthy controls|healthy controls
814115|NCT00187668|Healthy Cohort|healthy cohort
814116|NCT00187655|Healthy volunteers willing to be dosed with cefotaxime|healthy volunteers willing to be dosed with cefotaxime
814117|NCT00187616|adverse events|adverse events
814118|NCT00187616|clinical trial methodology|clinical trial methodology
814119|NCT00187603|tobacco|tobacco
814120|NCT00187603|cessation|cessation
814121|NCT00187603|smoking|smoking
814122|NCT00187603|smoking cessation|smoking cessation
814123|NCT00187590|HIV|hiv
814124|NCT00187590|case management|case management
814125|NCT00187577|Alopecia areata|alopecia areata
814126|NCT00187577|Eyelash growth|eyelash growth
814127|NCT00187577|Latanoprost|latanoprost
814128|NCT00187577|Bimatoprost|bimatoprost
814129|NCT00187564|Diabetes Mellitus, Type 1|diabetes mellitus, type 1
814130|NCT00187564|lipoic acid|lipoic acid
814131|NCT00187564|oxidative stress|oxidative stress
814132|NCT00187551|enfuvirtide|enfuvirtide
814133|NCT00187551|T20|t20
814134|NCT00187551|Fuzeon|fuzeon
814135|NCT00187551|Treatment|treatment
814136|NCT00187551|Interruption|interruption
814137|NCT00187551|Resistance|resistance
814138|NCT00187551|HIV Drug Resistance|hiv drug resistance
814139|NCT00187551|Antiretroviral Agents|antiretroviral agents
814140|NCT00187551|Salvage Therapy|salvage therapy
814141|NCT00187551|Drug Resistance, Multiple|drug resistance, multiple
814142|NCT00187551|Human Immunodeficiency virus|human immunodeficiency virus
814143|NCT00187512|HIV|hiv
814144|NCT00187512|Antiretroviral Agents|antiretroviral agents
814145|NCT00187512|Drug Resistance, Multiple|drug resistance, multiple
814146|NCT00187512|Long Term Non Progression|long term non progression
814147|NCT00187512|Long Term Non Progressor|long term non progressor
814148|NCT00187512|Elite Suppression|elite suppression
814149|NCT00187512|Elite Suppressor|elite suppressor
814150|NCT00187512|Natural History|natural history
814151|NCT00187512|Observational|observational
814152|NCT00187499|Asthma|asthma
814153|NCT00187499|Corticosteroid|corticosteroid
814154|NCT00187499|Gene expression|gene expression
814155|NCT00187486|Glioblastoma Multiforme|glioblastoma multiforme
814156|NCT00187486|Gliosarcoma|gliosarcoma
814157|NCT00187486|GBM|gbm
814158|NCT00187486|GS|gs
814159|NCT00187486|Tarceva|tarceva
814160|NCT00187486|Temodar|temodar
814161|NCT00187486|Radiation|radiation
814162|NCT00187486|Newly Diagnosed|newly diagnosed
814163|NCT00187473|hepatitis C|hepatitis c
814164|NCT00187473|HCV|hcv
814165|NCT00187473|natural history|natural history
814166|NCT00187460|Acute myocardial infarction|acute myocardial infarction
814167|NCT00187460|Congestive heart failure|congestive heart failure
814168|NCT00187460|Quality of care|quality of care
814169|NCT00187460|Reperfusion|reperfusion
814170|NCT00187460|Report cards|report cards
814171|NCT00187460|Quality indicators|quality indicators
814172|NCT00187447|prematurity|prematurity
814173|NCT00187447|chronic lung disease|chronic lung disease
814174|NCT00187447|necrotizing enterocolitis|necrotizing enterocolitis
814175|NCT00187447|indomethacin|indomethacin
814176|NCT00187447|ductus arteriosus|ductus arteriosus
814177|NCT00187434|premature infant|premature infant
814178|NCT00187434|supporting extubation|supporting extubation
814179|NCT00187421|coronary disease|coronary disease
814180|NCT00187421|angiography|angiography
814181|NCT00187421|intraoperative care|intraoperative care
814182|NCT00187421|vascular patency|vascular patency
814183|NCT00187408|Thrombosis|thrombosis
814184|NCT00187408|Pulmonary Embolism|pulmonary embolism
814185|NCT00187408|Low Molecular Weight Heparin|low molecular weight heparin
814186|NCT00187408|Tibial Fractures|tibial fractures
814187|NCT00187395|hypertension|hypertension
814188|NCT00187395|blood pressure|blood pressure
814190|NCT00187382|antenatal corticosteroids|antenatal corticosteroids
814191|NCT00187382|preterm birth|preterm birth
814192|NCT00187382|multiple versus single doses|multiple versus single doses
814193|NCT00187382|follow-up|follow-up
814194|NCT00187369|twins|twins
814195|NCT00187369|twin births|twin births
814196|NCT00187369|multiples|multiples
814197|NCT00187356|Coronary Bypass Surgery|coronary bypass surgery
814198|NCT00187356|Coronary Artery Disease|coronary artery disease
814199|NCT00187356|Angiography|angiography
814200|NCT00187356|Arterial Grafts|arterial grafts
814201|NCT00187356|Radial Artery|radial artery
814202|NCT00187356|Saphenous Vein|saphenous vein
814203|NCT00187343|Radiotherapy|radiotherapy
814204|NCT00187343|IMRT|imrt
814205|NCT00187330|cardiopulmonary bypass|cardiopulmonary bypass
814206|NCT00187330|renal insufficiency|renal insufficiency
814207|NCT00187330|cardiac surgery|cardiac surgery
814208|NCT00187330|n-acetylcysteine|n-acetylcysteine
814209|NCT00187317|Exercise|exercise
814210|NCT00187317|Rehabilitation|rehabilitation
814211|NCT00187317|Postural Balance|postural balance
814212|NCT00187317|Accidental Falls|accidental falls
814213|NCT00187317|Geriatrics|geriatrics
814214|NCT00187291|T-Wave Alternans|t-wave alternans
814215|NCT00187291|ICD|icd
814216|NCT00187291|Primary Prevention|primary prevention
814217|NCT00187278|Standard pacing indication|standard pacing indication
814218|NCT00187252|Ventricular Dyssynchrony|ventricular dyssynchrony
814219|NCT00187239|ICDs|icds
814220|NCT00187239|Ventricular pacing|ventricular pacing
814221|NCT00187239|Patient has been implanted with a dual chamber SJM ICD with AICS for 1 month (± 2 weeks).|patient has been implanted with a dual chamber sjm icd with aics for 1 month (± 2 weeks).
814222|NCT00187239|At the time of enrollment, patient is paced in the RV ≤25% of the time as determined by the device diagnostics.|at the time of enrollment, patient is paced in the rv ≤25% of the time as determined by the device diagnostics.
814223|NCT00187239|Patient is medically stable.|patient is medically stable.
814224|NCT00187226|Brain neoplasm|brain neoplasm
814225|NCT00187226|Brain cancer|brain cancer
814226|NCT00187226|Neoplasm intracranial|neoplasm intracranial
814227|NCT00187213|Ventricular Dyssynchrony|ventricular dyssynchrony
814228|NCT00187174|Brain tumors|brain tumors
814229|NCT00187174|Soft Tissue Sarcomas|soft tissue sarcomas
814230|NCT00187174|Refractory solid tumors|refractory solid tumors
814231|NCT00187174|Recurrent or Refractory Rhabdomyosarcomatous Soft Tissue and Non-Rhabdomyosarcoma Soft Tissue Sarcomas|recurrent or refractory rhabdomyosarcomatous soft tissue and non-rhabdomyosarcoma soft tissue sarcomas
814232|NCT00187161|Mature B-Cell Leukemia|mature b-cell leukemia
814233|NCT00187161|Non-Hodgkin Lymphoma|non-hodgkin lymphoma
814234|NCT00187161|Burkitt's lymphoma|burkitt's lymphoma
814235|NCT00187161|Small noncleaved cell non Hodgkin lymphoma|small noncleaved cell non hodgkin lymphoma
814236|NCT00187161|Large cell lymphoma|large cell lymphoma
814237|NCT00187148|Vaccine|vaccine
814238|NCT00187148|Prevention|prevention
814239|NCT00187148|HIV|hiv
814240|NCT00187148|AIDS|aids
814241|NCT00187135|Pain Management|pain management
814242|NCT00187135|Bone Marrow Aspiration|bone marrow aspiration
814243|NCT00187122|Non-Hodgkin|non-hodgkin
814244|NCT00187122|Lymphoma|lymphoma
814245|NCT00187109|Thrombocytopenia|thrombocytopenia
814246|NCT00187109|Platelets|platelets
814247|NCT00187109|Thrombopoietin|thrombopoietin
814248|NCT00187096|Leukemia|leukemia
814249|NCT00187096|Myeloid|myeloid
814250|NCT00187096|Acute|acute
814251|NCT00187083|Leukemia|leukemia
814252|NCT00187083|Acute Lymphoblastic Leukemia|acute lymphoblastic leukemia
814253|NCT00187083|Refractory Acute Lymphoblastic Leukemia|refractory acute lymphoblastic leukemia
814254|NCT00187083|Relapsed Acute Lymphoblastic Leukemia|relapsed acute lymphoblastic leukemia
814255|NCT00187057|Ataxia|ataxia
814256|NCT00187057|alphafetoprotein|alphafetoprotein
814257|NCT00187044|Vaccine|vaccine
814258|NCT00187044|Prevention|prevention
814259|NCT00187044|HIV|hiv
814260|NCT00187044|AIDS|aids
814261|NCT00187031|Wilms Tumor|wilms tumor
814262|NCT00187018|Collagen Disease|collagen disease
814263|NCT00187005|Leukemia|leukemia
814264|NCT00186992|Sarcoma|sarcoma
814265|NCT00186992|radiation therapy|radiation therapy
814266|NCT00186992|Other musculoskeletal tumors|other musculoskeletal tumors
814267|NCT00186979|Refractory Childhood Solid Tumors|refractory childhood solid tumors
814268|NCT00186953|Ultrasound|ultrasound
814269|NCT00186953|Abdominal tumors|abdominal tumors
814270|NCT00186953|Pelvic tumors|pelvic tumors
814271|NCT00186940|leukemia|leukemia
814272|NCT00186927|Vaccine|vaccine
814273|NCT00186927|Sendai virus vaccine|sendai virus vaccine
814274|NCT00186914|Bone marrow transplant|bone marrow transplant
814275|NCT00186914|bone marrow stromal cells|bone marrow stromal cells
814276|NCT00186914|allogeneic transplant|allogeneic transplant
814277|NCT00186914|Osteodysplasia|osteodysplasia
814278|NCT00186914|Osteogenesis imperfecta|osteogenesis imperfecta
814279|NCT00186914|Gene marking|gene marking
814280|NCT00186914|Stromal cell|stromal cell
814281|NCT00186901|Bone Density|bone density
814282|NCT00186888|Cancer of the Eye|cancer of the eye
814283|NCT00186888|Eye Enucleation|eye enucleation
814284|NCT00186875|Leukemia|leukemia
814285|NCT00186875|Lymphoblastic|lymphoblastic
814286|NCT00186875|Acute|acute
814287|NCT00186875|Lymphoma|lymphoma
814288|NCT00186875|Non-Hodgkin's|non-hodgkin's
814289|NCT00186862|Neuroblastoma|neuroblastoma
814290|NCT00186862|Immunotherapy|immunotherapy
814291|NCT00186862|Gene therapy|gene therapy
814292|NCT00186849|Neuroblastoma|neuroblastoma
814293|NCT00186836|Hepatitis A|hepatitis a
814294|NCT00186836|Hepatitis B|hepatitis b
814295|NCT00186836|Hemodialysis|hemodialysis
814296|NCT00186836|Vaccine|vaccine
814297|NCT00186823|Haploidentical stem cell transplant|haploidentical stem cell transplant
814298|NCT00186823|Allogeneic stem cell transplant|allogeneic stem cell transplant
814299|NCT00186823|Mismatched family member stem cell donor transplant|mismatched family member stem cell donor transplant
814300|NCT00186823|Bone marrow transplantHigh risk hematologic malignancies|bone marrow transplanthigh risk hematologic malignancies
814301|NCT00186810|Anemia|anemia
814302|NCT00186810|Sickle Cell|sickle cell
814303|NCT00186797|Aplastic Anemia|aplastic anemia
814304|NCT00186784|Repetitive Transcranial Magnetic Stimulation|repetitive transcranial magnetic stimulation
814306|NCT00186771|Transcranial Magnetic Stimulation|transcranial magnetic stimulation
814307|NCT00186771|Paired Pulse|paired pulse
814308|NCT00186758|Transcranial Magnetic Stimulation|transcranial magnetic stimulation
814309|NCT00186758|TMS|tms
814310|NCT00186745|Venous thrombosis|venous thrombosis
814311|NCT00186745|Pulmonary embolism|pulmonary embolism
814312|NCT00186745|Kidney failure|kidney failure
814313|NCT00186745|Anticoagulants|anticoagulants
814314|NCT00186745|Heparin, Low-Molecular-Weight|heparin, low-molecular-weight
814315|NCT00186732|wound closure|wound closure
814316|NCT00186732|Pfannenstiel incision|pfannenstiel incision
814317|NCT00186732|surgical staples|surgical staples
814318|NCT00186732|subcuticular suture|subcuticular suture
814319|NCT00186719|Chronic Obstructive Pulmonary Disease|chronic obstructive pulmonary disease
814320|NCT00186719|Smoking Related Disease|smoking related disease
814321|NCT00186719|Immune System Changes|immune system changes
814322|NCT00186706|Selenium|selenium
814323|NCT00186706|Chronic Obstructive Pulmonaary Disease|chronic obstructive pulmonaary disease
814324|NCT00186706|Cardiovascular Disease|cardiovascular disease
814325|NCT00186706|Anti-oxidant|anti-oxidant
814326|NCT00186706|Pulmonary|pulmonary
814327|NCT00186693|Airway remodeling|airway remodeling
814328|NCT00186693|Asthma|asthma
814329|NCT00186693|Hyper-responsiveness|hyper-responsiveness
814330|NCT00186641|chronic Graft vs Host Disease|chronic graft vs host disease
814331|NCT00186537|Insulin resistance|insulin resistance
814332|NCT00186537|Insulin resistance syndrome|insulin resistance syndrome
814333|NCT00186537|dyslipidemia|dyslipidemia
814334|NCT00186537|atherogenic dyslipidemia|atherogenic dyslipidemia
814335|NCT00186537|triglyceride/HDL-C ratio|triglyceride/hdl-c ratio
814336|NCT00186420|Prostate Cancer|prostate cancer
814337|NCT00186420|Taxotere|taxotere
814338|NCT00186368|Prostate cancer|prostate cancer
814339|NCT00186368|Gene expression|gene expression
814340|NCT00186368|tumor markers|tumor markers
814341|NCT00186368|microarray analysis|microarray analysis
814342|NCT00186329|Vasodilation|vasodilation
814343|NCT00186329|Congestive heart failure|congestive heart failure
814344|NCT00186329|Renal insufficiency|renal insufficiency
814345|NCT00186329|Diuresis|diuresis
814346|NCT00186329|Serum creatinine|serum creatinine
814347|NCT00186199|voiding patterns|voiding patterns
814348|NCT00186199|flow rate|flow rate
814349|NCT00186199|ultrasound|ultrasound
814350|NCT00186173|Obesity|obesity
814351|NCT00186173|Physical activity|physical activity
814352|NCT00186134|Physical Activity|physical activity
814353|NCT00186134|Walking|walking
814354|NCT00186134|Primary Schools|primary schools
814355|NCT00186134|Transportation|transportation
814356|NCT00186108|Oral Triamcinalone|oral triamcinalone
814357|NCT00186108|Prostate Cancer|prostate cancer
814358|NCT00186095|Amyloidosis|amyloidosis
814359|NCT00186095|nonmyeloablative|nonmyeloablative
814360|NCT00186095|hematopoietic|hematopoietic
814361|NCT00186095|cell transplantation|cell transplantation
814362|NCT00186030|HIV|hiv
814363|NCT00186030|AIDS|aids
814364|NCT00186030|PTSD|ptsd
814365|NCT00186030|Prevention|prevention
814366|NCT00185978|obesity prevention|obesity prevention
814367|NCT00185978|preadolescents|preadolescents
814368|NCT00185978|schools|schools
814369|NCT00185965|non-Hodgkin|non-hodgkin
814370|NCT00185965|lymphoma|lymphoma
814371|NCT00185965|mycosis|mycosis
814372|NCT00185965|fungoides|fungoides
814373|NCT00185939|dog bites|dog bites
814374|NCT00185939|infection|infection
814375|NCT00185939|prophylactic antibiotics|prophylactic antibiotics
814376|NCT00185939|cost effectiveness|cost effectiveness
814377|NCT00185783|Sepsis|sepsis
814378|NCT00185783|Adrenal Insufficiency|adrenal insufficiency
814379|NCT00185783|Hydrocortisone|hydrocortisone
814380|NCT00185783|Gene Expression|gene expression
814381|NCT00185783|Microarray|microarray
814382|NCT00185783|RNA|rna
814383|NCT00185783|Critically Ill|critically ill
814384|NCT00185770|Obesity prevention|obesity prevention
814385|NCT00185770|Television|television
814388|NCT00185770|Preadolescents|preadolescents
814389|NCT00185705|Insulin resistance|insulin resistance
814390|NCT00185705|obesity|obesity
814391|NCT00185705|hypertension|hypertension
814392|NCT00185705|adolescents|adolescents
814393|NCT00185705|telmisartan|telmisartan
814394|NCT00185705|lifestyle intervention|lifestyle intervention
814395|NCT00185562|Osteoarthritis|osteoarthritis
814396|NCT00185549|Cystic Fibrosis;|cystic fibrosis;
814397|NCT00185549|patient education,|patient education,
814398|NCT00185549|Internet|internet
814399|NCT00185536|Taste|taste
814400|NCT00185536|preschool children|preschool children
814401|NCT00185536|fast food|fast food
814402|NCT00185484|Oral contraception|oral contraception
814403|NCT00185445|Non Hodgkin Lymphoma|non hodgkin lymphoma
814404|NCT00185393|Follicular Non Hodgkin lymphoma|follicular non hodgkin lymphoma
814405|NCT00185354|FC patch|fc patch
814406|NCT00185354|comparator study|comparator study
814407|NCT00185341|Endometriosis associated pelvic pain|endometriosis associated pelvic pain
814408|NCT00185328|Postmenopause|postmenopause
814409|NCT00185302|Non-resectable metastatic melanoma|non-resectable metastatic melanoma
814410|NCT00185276|Structural abnormalities of the infrarenal aorta and peripheral arteries|structural abnormalities of the infrarenal aorta and peripheral arteries
814411|NCT00185263|angina|angina
814412|NCT00185263|FGF-4|fgf-4
814413|NCT00185263|angiogenesis|angiogenesis
814414|NCT00185263|adenovector|adenovector
814415|NCT00185263|growth factor|growth factor
814416|NCT00185263|myocardial ischemia|myocardial ischemia
814417|NCT00185263|revascularization|revascularization
814418|NCT00185250|Cardiomyopathy|cardiomyopathy
814419|NCT00185250|idiopathic chronic heart failure|idiopathic chronic heart failure
814420|NCT00185250|Adenovirus|adenovirus
814421|NCT00185250|Enterovirus|enterovirus
814422|NCT00185250|Parvovirus|parvovirus
814423|NCT00185237|Menopause|menopause
814424|NCT00185198|Partial androgen deficiency of aging males (PADAM)|partial androgen deficiency of aging males (padam)
814425|NCT00185159|Microalbuminuria|microalbuminuria
814426|NCT00185133|Treatment of high blood pressure in mild to severe hypertensive patients|treatment of high blood pressure in mild to severe hypertensive patients
814427|NCT00185120|Hypertension|hypertension
814428|NCT00185120|angiotensin receptor blocker|angiotensin receptor blocker
814429|NCT00185120|calcium channel blocker|calcium channel blocker
814430|NCT00185120|angiotensin converting enzyme inhibitor hydroclorothiazide|angiotensin converting enzyme inhibitor hydroclorothiazide
814431|NCT00185107|Safety|safety
814432|NCT00185107|Efficacy|efficacy
814433|NCT00185107|WelChol®|welchol®
814434|NCT00185107|Zocor®|zocor®
814435|NCT00185107|Zetia®|zetia®
814436|NCT00185081|colon cancer|colon cancer
814437|NCT00185081|radioimmunoscintigraphy|radioimmunoscintigraphy
814438|NCT00185081|colon-specific antigen,|colon-specific antigen,
814439|NCT00185081|radioimmunotherapy,|radioimmunotherapy,
814440|NCT00185081|radioimmunodetection|radioimmunodetection
814441|NCT00185068|Systolic hypertension, Angiotensin receptor blocker|systolic hypertension, angiotensin receptor blocker
814442|NCT00185055|olmesartan|olmesartan
814443|NCT00185055|valsartan|valsartan
814444|NCT00185055|irbesartan|irbesartan
814445|NCT00185055|renin-angiotensin-aldosterone system|renin-angiotensin-aldosterone system
814446|NCT00185042|Atherosclerosis, intravascular ultrasound|atherosclerosis, intravascular ultrasound
814447|NCT00185029|prostate|prostate
814448|NCT00185029|ferumoxtran-10|ferumoxtran-10
814449|NCT00185029|lymph nodes|lymph nodes
814450|NCT00185029|USPIO|uspio
814451|NCT00185016|intimate partner abuse|intimate partner abuse
814452|NCT00185016|gender|gender
814453|NCT00185016|education|education
814454|NCT00185016|attitude|attitude
814455|NCT00185016|family doctor|family doctor
814456|NCT00185016|health care utilisation|health care utilisation
814457|NCT00185016|abused women|abused women
814458|NCT00185003|Endotoxemia|endotoxemia
814459|NCT00185003|vascular potassium channels|vascular potassium channels
814460|NCT00185003|cytokine|cytokine
814461|NCT00185003|norepinephrine|norepinephrine
814462|NCT00185003|regional blood flow,|regional blood flow,
814463|NCT00185003|inflammation,|inflammation,
814464|NCT00185003|ion channels,|ion channels,
814465|NCT00185003|nitric oxide synthase,|nitric oxide synthase,
814466|NCT00185003|pharmacology.|pharmacology.
814467|NCT00184990|Endotoxemia|endotoxemia
814468|NCT00184990|Aminoguanidine|aminoguanidine
814469|NCT00184977|Pulmonary Disease, Chronic Obstructive|pulmonary disease, chronic obstructive
814470|NCT00184977|Randomized Controlled Trial|randomized controlled trial
814471|NCT00184977|Family Practice|family practice
814472|NCT00184977|Respiratory Function Tests|respiratory function tests
814473|NCT00184977|Health Status|health status
814474|NCT00184951|HIV|hiv
814475|NCT00184938|opioids|opioids
814666|NCT00183742|Phase 1|phase 1
814476|NCT00184938|ischemic preconditioning|ischemic preconditioning
814477|NCT00184938|morphine|morphine
814478|NCT00184899|free fatty acids|free fatty acids
814479|NCT00184899|vasodilation|vasodilation
814480|NCT00184899|sympathetic activity|sympathetic activity
814481|NCT00184873|randomized controlled trial|randomized controlled trial
814482|NCT00184873|health-counseling|health-counseling
814483|NCT00184873|multi-center study|multi-center study
814484|NCT00184847|acetylcholine|acetylcholine
814485|NCT00184847|adenosine|adenosine
814486|NCT00184847|caffeine|caffeine
814487|NCT00184847|ischemic preconditioning|ischemic preconditioning
814488|NCT00184834|colorectal|colorectal
814489|NCT00184834|liver|liver
814490|NCT00184834|metastases|metastases
814491|NCT00184834|health-related quality of life|health-related quality of life
814492|NCT00184834|surgery|surgery
814493|NCT00184821|Diabetes|diabetes
814494|NCT00184821|Ischemia|ischemia
814495|NCT00184821|Annexin A5 scintigraphy|annexin a5 scintigraphy
814496|NCT00184795|Hot flashes|hot flashes
814497|NCT00184782|colorectal cancer|colorectal cancer
814498|NCT00184782|liver metastases|liver metastases
814499|NCT00184782|metabolic activity|metabolic activity
814500|NCT00184587|prophylactic|prophylactic
814501|NCT00184587|episodic|episodic
814502|NCT00184587|cluster|cluster
814503|NCT00184587|candesartan|candesartan
814504|NCT00184587|angiotensin II receptor blocker|angiotensin ii receptor blocker
814505|NCT00184587|randomized placebo controlled parallel study|randomized placebo controlled parallel study
814506|NCT00184587|headache diary|headache diary
814507|NCT00184535|Low back pain|low back pain
814508|NCT00184535|Neuromuscular control|neuromuscular control
814509|NCT00184535|Anticipatory motor control|anticipatory motor control
814510|NCT00184535|Musculoskeletal Physiologic Processes|musculoskeletal physiologic processes
814511|NCT00184535|Muscle, Skeletal|muscle, skeletal
814512|NCT00184535|Ultrasonography|ultrasonography
814513|NCT00184535|Electromyography|electromyography
814514|NCT00184522|Gastroesophageal Reflux|gastroesophageal reflux
814515|NCT00184522|Esomeprazole|esomeprazole
814516|NCT00184522|Drug treatment|drug treatment
814517|NCT00184509|schizophrenia|schizophrenia
814518|NCT00184509|psychosocial treatment|psychosocial treatment
814519|NCT00184509|outcome|outcome
814520|NCT00184496|Analgesics, Opioid/pharmacokinetics|analgesics, opioid/pharmacokinetics
814521|NCT00184496|Humans|humans
814522|NCT00184496|Methadone/therapeutic use|methadone/therapeutic use
814523|NCT00184496|Neoplasms/complications|neoplasms/complications
814524|NCT00184496|pain/drug therapy|pain/drug therapy
814525|NCT00184483|Surgery|surgery
814526|NCT00184483|Lichtenstein|lichtenstein
814527|NCT00184483|Prolene Hernia System|prolene hernia system
814528|NCT00184483|Postoperative pain|postoperative pain
814529|NCT00184483|Recurrence|recurrence
814530|NCT00184470|Adult|adult
814531|NCT00184470|Child|child
814532|NCT00184470|Hospitalization/statistics & numerical data|hospitalization/statistics & numerical data
814533|NCT00184470|Retrospective studies|retrospective studies
814534|NCT00184457|Cardiac heart failure|cardiac heart failure
814535|NCT00184457|Leg press|leg press
814536|NCT00184457|Maximal strength training|maximal strength training
814537|NCT00184457|Serum testosterone|serum testosterone
814538|NCT00184457|Work economy|work economy
814539|NCT00184444|angina pectoris|angina pectoris
814540|NCT00184444|hyperoxia|hyperoxia
814541|NCT00184444|endurance training|endurance training
814542|NCT00184444|stroke volume|stroke volume
814543|NCT00184444|cardiac perfusion|cardiac perfusion
814544|NCT00184431|Cerebrovascular Accident|cerebrovascular accident
814545|NCT00184431|Physical Therapy Techniques|physical therapy techniques
814546|NCT00184431|Musculoskeletal Equilibrium|musculoskeletal equilibrium
814547|NCT00184431|Rehabilitation|rehabilitation
814548|NCT00184418|Immunity|immunity
814549|NCT00184418|Immune System|immune system
814550|NCT00184418|Cytokines|cytokines
814551|NCT00184418|Psychophysiology|psychophysiology
814552|NCT00184418|Psychoneuroimmunology|psychoneuroimmunology
814675|NCT00183716|Physical Abuse|physical abuse
814553|NCT00184405|Parents with psychiatric or addictive problems|parents with psychiatric or addictive problems
814554|NCT00184392|Sinus surgery|sinus surgery
814555|NCT00184392|endoscopic|endoscopic
814556|NCT00184392|postoperative care|postoperative care
814557|NCT00184392|debridement|debridement
814558|NCT00184392|randomized|randomized
814559|NCT00184392|acute recurrent rhinosinusitis|acute recurrent rhinosinusitis
814560|NCT00184392|chronic rhinosinusitis|chronic rhinosinusitis
814561|NCT00184392|nasal polyps|nasal polyps
814562|NCT00184392|Chronic rhinosinusitis with nasal polyps|chronic rhinosinusitis with nasal polyps
814563|NCT00184392|Chronic rhinosinusitis without nasal polyps|chronic rhinosinusitis without nasal polyps
814564|NCT00184379|Family|family
814565|NCT00184379|Coping Skills|coping skills
814566|NCT00184379|Psychoeducation|psychoeducation
814567|NCT00184379|Stress, Psychological|stress, psychological
814568|NCT00184379|Health Education|health education
814569|NCT00184366|drug therapy|drug therapy
814570|NCT00184366|efalizumab|efalizumab
814571|NCT00184353|brain metastasis|brain metastasis
814667|NCT00183742|Phase I|phase i
814572|NCT00184353|signal to noise ratio|signal to noise ratio
814573|NCT00184353|spectral resolution|spectral resolution
814574|NCT00184340|eTherapy supplementary|etherapy supplementary
814575|NCT00184327|Severe and longstanding psychiatric symptoms in children|severe and longstanding psychiatric symptoms in children
814576|NCT00184301|Eating disorders|eating disorders
814577|NCT00184301|Anorexia nervosa|anorexia nervosa
814578|NCT00184301|Bulimia nervosa|bulimia nervosa
814579|NCT00184301|Personality disorders|personality disorders
814580|NCT00184301|In-patient treatment|in-patient treatment
814581|NCT00184301|out-patient treatment|out-patient treatment
814582|NCT00184301|group therapy|group therapy
814583|NCT00184288|Lipid|lipid
814584|NCT00184288|choline|choline
814585|NCT00184288|metastasis|metastasis
814586|NCT00184288|magnetic resonance spectroscopy|magnetic resonance spectroscopy
814587|NCT00184288|treatment response|treatment response
814588|NCT00184275|Brain metastasis|brain metastasis
814589|NCT00184275|HR MAS spectroscopy|hr mas spectroscopy
814590|NCT00184275|Tissue micro array|tissue micro array
814591|NCT00184275|DNA micro array|dna micro array
814592|NCT00184249|Catheter ablation|catheter ablation
814593|NCT00184249|Heart/surgery|heart/surgery
814594|NCT00184249|Cardial surgical procedures|cardial surgical procedures
814595|NCT00184236|Exercise Training|exercise training
814596|NCT00184236|Cardiovascular diseases|cardiovascular diseases
814597|NCT00184236|Risk factors|risk factors
814598|NCT00184223|Motivational Interviewing|motivational interviewing
814599|NCT00184223|Substance abuse|substance abuse
814600|NCT00184223|Acuteley admitted psychiatric patients|acuteley admitted psychiatric patients
814601|NCT00184223|Emergency Services, Psychiatric|emergency services, psychiatric
814602|NCT00184210|Magnetic Resonance Spectroscopy|magnetic resonance spectroscopy
814603|NCT00184197|Injection|injection
814604|NCT00184197|Headache|headache
814605|NCT00184197|Cervical muscles|cervical muscles
814606|NCT00184184|Emergency Services, Psychiatric|emergency services, psychiatric
814607|NCT00184184|Tobacco use cessation|tobacco use cessation
814608|NCT00184184|Coffee use cessation|coffee use cessation
814609|NCT00184184|substance use detection|substance use detection
814610|NCT00184184|Substance Abuse Detection|substance abuse detection
814611|NCT00184171|Microscopic colitis|microscopic colitis
814612|NCT00184171|Drug treatment|drug treatment
814613|NCT00184171|Diarrhoea|diarrhoea
814614|NCT00184158|Cubital tunnel|cubital tunnel
814615|NCT00184158|treatment|treatment
814616|NCT00184158|nerve compression|nerve compression
814617|NCT00184145|Specific (Animal) Phobia|specific (animal) phobia
814618|NCT00184145|EMDR|emdr
814619|NCT00184145|Exposure therapy|exposure therapy
814620|NCT00184132|Intensive care units|intensive care units
814621|NCT00184132|Emergency services, psychiatric|emergency services, psychiatric
814622|NCT00184132|Interior Design and Furnishings|interior design and furnishings
814623|NCT00184132|Intensive Care|intensive care
814624|NCT00184119|Emergency services, psychiatric|emergency services, psychiatric
814625|NCT00184119|Intensive care units|intensive care units
814626|NCT00184119|Hospitals, psychiatric|hospitals, psychiatric
814627|NCT00184119|Aggression|aggression
814628|NCT00184119|Violence|violence
814629|NCT00184106|Phobic disorders|phobic disorders
814630|NCT00184106|Therapy, cognitive|therapy, cognitive
814631|NCT00184106|Paroxetine|paroxetine
814632|NCT00184093|Cervical Carcinoma|cervical carcinoma
814633|NCT00183976|Diffuse mixed NHL|diffuse mixed nhl
814634|NCT00183976|Diffuse or follicular large B-cell NHL|diffuse or follicular large b-cell nhl
814635|NCT00183976|Immunoblastic NHL|immunoblastic nhl
814636|NCT00183976|Burkitt or Burkitt-like lymphomas|burkitt or burkitt-like lymphomas
814637|NCT00183898|Gastroesophageal Junction Cancer|gastroesophageal junction cancer
814638|NCT00183872|Gastroesophageal cancer|gastroesophageal cancer
814639|NCT00183872|Gastric Adenocarcinoma|gastric adenocarcinoma
814640|NCT00183872|Gastroesophageal Junction Adenocarcinoma|gastroesophageal junction adenocarcinoma
814641|NCT00183859|solid tumor|solid tumor
814642|NCT00183859|phase I|phase i
814643|NCT00183859|phase one|phase one
814644|NCT00183846|pancreas|pancreas
814645|NCT00183846|stomach|stomach
814646|NCT00183846|common bile duct cancer|common bile duct cancer
814647|NCT00183846|ampulla of Vater cancer|ampulla of vater cancer
814648|NCT00183833|phase 1|phase 1
814649|NCT00183833|phase I|phase i
814650|NCT00183833|phase one|phase one
814651|NCT00183833|colon cancer|colon cancer
814652|NCT00183833|colorectal cancer|colorectal cancer
814653|NCT00183820|Testicular|testicular
814654|NCT00183820|Extra gonadal germ cell neoplasm|extra gonadal germ cell neoplasm
814655|NCT00183794|Primary Peritoneal|primary peritoneal
814656|NCT00183781|HIV|hiv
814657|NCT00183781|Telephone intervention|telephone intervention
814658|NCT00183768|Cognitive Behavioral Treatment For Depression|cognitive behavioral treatment for depression
814659|NCT00183768|Antidepressant Psychopharmacology|antidepressant psychopharmacology
814660|NCT00183768|HIV Risk Behavior|hiv risk behavior
814661|NCT00183768|Injection Drug Use|injection drug use
814662|NCT00183755|Reward Processing|reward processing
814663|NCT00183755|Anhedonia|anhedonia
814664|NCT00183755|Major Depressive Disorder|major depressive disorder
814665|NCT00183755|Depression|depression
814668|NCT00183742|Phase one|phase one
814669|NCT00183742|Solid tumor|solid tumor
814670|NCT00183729|Major depressive disorder|major depressive disorder
814671|NCT00183729|Rehabilitating|rehabilitating
814672|NCT00183729|Elderly|elderly
814673|NCT00183729|Apathy|apathy
814674|NCT00183716|PTSD|ptsd
814676|NCT00183716|Sexual Abuse|sexual abuse
814679|NCT00183716|Group Therapy|group therapy
814680|NCT00183716|Substance Abuse|substance abuse
814681|NCT00183703|Depression, Bipolar|depression, bipolar
814682|NCT00183703|Manic-Depressive Psychosis|manic-depressive psychosis
814683|NCT00183690|PTSD|ptsd
814684|NCT00183690|Anxiety Disorder|anxiety disorder
814685|NCT00183690|Trauma|trauma
814686|NCT00183690|Adolescents|adolescents
814687|NCT00183690|Cognitive Behavioral Therapy|cognitive behavioral therapy
814688|NCT00183677|Brain Bioenergetic Metabolism|brain bioenergetic metabolism
814689|NCT00183677|Magnetic Resonance Spectroscopy|magnetic resonance spectroscopy
814690|NCT00183677|Major Depressive Disorder|major depressive disorder
814691|NCT00183677|Treatment Response|treatment response
814692|NCT00183651|Suicide|suicide
814693|NCT00183651|Women|women
814694|NCT00183651|Emotions|emotions
814695|NCT00183651|Psychotherapy, Group|psychotherapy, group
814696|NCT00183638|Internet|internet
814697|NCT00183638|Interactive Computer Program|interactive computer program
814698|NCT00183638|HIV Prevention|hiv prevention
814699|NCT00183625|Antipsychotic Agents|antipsychotic agents
814700|NCT00183625|Employment|employment
814701|NCT00183612|Child|child
814702|NCT00183612|Adolescent|adolescent
814703|NCT00183612|Mental Health|mental health
814704|NCT00183612|Olanzapine|olanzapine
814705|NCT00183612|Pharmacokinetics|pharmacokinetics
814706|NCT00183612|Pharmacology|pharmacology
814707|NCT00183599|Brief interventions|brief interventions
814708|NCT00183599|Motivational Enhancement Therapy|motivational enhancement therapy
814709|NCT00183599|Cognitive Behavioral Therapy|cognitive behavioral therapy
814710|NCT00183586|Treatment outcomes study|treatment outcomes study
814711|NCT00183586|Anorexia|anorexia
814712|NCT00183586|Anorexia nervosa|anorexia nervosa
814713|NCT00183573|STDs|stds
814714|NCT00183573|Sexual Behavior|sexual behavior
814715|NCT00183573|Health Behavior|health behavior
814716|NCT00183573|HIV Seronegativity|hiv seronegativity
814717|NCT00183560|Depression Recurrence|depression recurrence
814718|NCT00183560|Drug Therapy|drug therapy
814719|NCT00183560|Cognitive Therapy|cognitive therapy
814720|NCT00183560|Relapse|relapse
814721|NCT00183560|Antidepressants|antidepressants
814722|NCT00183547|Postpartum Depression|postpartum depression
814723|NCT00183547|Postpartum Period|postpartum period
814724|NCT00183547|Indians, North American|indians, north american
814725|NCT00183547|Adolescent|adolescent
814726|NCT00183547|Female|female
814728|NCT00183521|Hyperventilation|hyperventilation
814729|NCT00183521|Breathing Exercises|breathing exercises
814730|NCT00183521|Carbon Dioxide|carbon dioxide
814731|NCT00183521|Panic Attack|panic attack
814732|NCT00183508|PTSD|ptsd
814733|NCT00183508|Occupational Health|occupational health
814734|NCT00183508|Trauma|trauma
814735|NCT00183508|Job|job
814736|NCT00183508|CBT|cbt
814737|NCT00183495|Depression, Bipolar|depression, bipolar
814738|NCT00183495|Manic-Depressive Psychosis|manic-depressive psychosis
814739|NCT00183482|Parents|parents
814740|NCT00183482|Child|child
814741|NCT00183482|Stress|stress
814742|NCT00183482|CBT|cbt
814743|NCT00183469|Lamotrigine|lamotrigine
814744|NCT00183469|Divalproex|divalproex
814745|NCT00183469|Antidepressant|antidepressant
814746|NCT00183456|Sex Education|sex education
814747|NCT00183456|Peer Group|peer group
814748|NCT00183456|Social Identity Theory|social identity theory
814749|NCT00183456|HIV Seronegativity|hiv seronegativity
814750|NCT00183456|Intervention|intervention
814751|NCT00183456|women|women
814752|NCT00183456|Social Networks|social networks
814753|NCT00183456|Peer Education|peer education
814754|NCT00183443|Mania|mania
814755|NCT00183443|Manic-depressive|manic-depressive
814756|NCT00183443|Psychotic disorder|psychotic disorder
814757|NCT00183430|Prazosin|prazosin
814758|NCT00183430|Sleep Disorders|sleep disorders
814759|NCT00183417|Adolescent|adolescent
814760|NCT00183417|CBT|cbt
814761|NCT00183404|Drug Treatment|drug treatment
814762|NCT00183404|Child|child
814763|NCT00183404|Olanzapine|olanzapine
814764|NCT00183391|ADHD|adhd
814765|NCT00183391|Child|child
814766|NCT00183391|Adolescent|adolescent
814767|NCT00183391|School|school
814768|NCT00183378|Alzheimer's Disease|alzheimer's disease
814769|NCT00183378|Insomnia|insomnia
814770|NCT00183378|Sleep Problems|sleep problems
814771|NCT00183378|Elderly|elderly
814772|NCT00183378|Caregivers|caregivers
814773|NCT00183365|Family|family
814774|NCT00183365|Parenting|parenting
814775|NCT00183365|Depression|depression
814776|NCT00183365|Group Intervention|group intervention
814777|NCT00183352|Women|women
814778|NCT00183352|Mood|mood
814779|NCT00183352|Menarche|menarche
814780|NCT00183352|Menstruation|menstruation
814782|NCT00183326|Posttraumatic Stress Disorder|posttraumatic stress disorder
814783|NCT00183326|Domestic Violence|domestic violence
814784|NCT00183326|Children|children
814785|NCT00183326|Cognitive Behavioral Therapy|cognitive behavioral therapy
814786|NCT00183326|CBT|cbt
814787|NCT00183313|Mental Health|mental health
814788|NCT00183313|Primary health care|primary health care
814789|NCT00183313|Case management|case management
814790|NCT00183300|Post-traumatic stress disorder|post-traumatic stress disorder
814791|NCT00183300|PTSD|ptsd
814792|NCT00183300|Prolonged Exposure|prolonged exposure
814793|NCT00183300|Cognitive-Behavior Therapy|cognitive-behavior therapy
814794|NCT00183274|Generalized Anxiety Disorder|generalized anxiety disorder
814795|NCT00183274|Chronic Mediation Treatment|chronic mediation treatment
814796|NCT00183274|Double-Blind|double-blind
814797|NCT00183274|Placebo Controlled|placebo controlled
814798|NCT00183274|Venlafaxine XR|venlafaxine xr
814799|NCT00183274|Relapse|relapse
814800|NCT00183261|Treatment Interruption|treatment interruption
814801|NCT00183261|HIV Therapeutic Vaccine|hiv therapeutic vaccine
814802|NCT00183261|Acute Infection|acute infection
814803|NCT00183261|Acute Retroviral Syndrome|acute retroviral syndrome
814804|NCT00183248|kidney|kidney
814805|NCT00183248|kidney transplant|kidney transplant
814806|NCT00183248|kidney transplantation|kidney transplantation
814807|NCT00183248|transplant|transplant
814808|NCT00183248|transplantation|transplantation
814809|NCT00183248|renal|renal
814810|NCT00183248|renal transplant|renal transplant
814811|NCT00183248|renal transplantation|renal transplantation
814812|NCT00183248|kidney disease|kidney disease
814813|NCT00183248|chronic|chronic
814814|NCT00183248|renal failure|renal failure
814815|NCT00183248|kidney failure|kidney failure
814816|NCT00183235|Alcohol dependence|alcohol dependence
814817|NCT00183235|Alcoholism|alcoholism
814818|NCT00183235|Craving|craving
814819|NCT00183222|Alcohol dependence|alcohol dependence
814820|NCT00183222|Alcoholism|alcoholism
814821|NCT00183222|Craving|craving
814822|NCT00183209|Substance use disorders|substance use disorders
814823|NCT00183209|Parent child relationship|parent child relationship
814824|NCT00183196|Alcohol dependence|alcohol dependence
814825|NCT00183196|Alcoholism|alcoholism
814826|NCT00183196|Heavy drinking|heavy drinking
814827|NCT00183183|Alcohol Abuse|alcohol abuse
814828|NCT00183183|Harm Reduction|harm reduction
814829|NCT00183183|Motivational Interviewing|motivational interviewing
814830|NCT00183183|Emergency Department|emergency department
814831|NCT00183183|Risky Drinking|risky drinking
814832|NCT00183183|Prevention|prevention
814833|NCT00183170|Alcohol abuse|alcohol abuse
814834|NCT00183170|Alcoholic beverages (beer)|alcoholic beverages (beer)
814835|NCT00183170|Residual effects|residual effects
814836|NCT00183170|Psychomotor performance|psychomotor performance
814837|NCT00183170|Psychomotor vigilance test|psychomotor vigilance test
814838|NCT00183170|Neurobehavioral Evaluation System|neurobehavioral evaluation system
814839|NCT00183170|Family history of alcohol use|family history of alcohol use
814840|NCT00183170|Alcoholic Consumption|alcoholic consumption
814841|NCT00183170|Unhealthy alcohol use|unhealthy alcohol use
814842|NCT00183170|Alcohol|alcohol
814843|NCT00183157|High risk drinking|high risk drinking
814844|NCT00183157|Alcohol dependence|alcohol dependence
814845|NCT00183157|Alcohol related injury|alcohol related injury
814846|NCT00183144|contingency management|contingency management
814847|NCT00183144|reinforcement|reinforcement
814848|NCT00183144|employment|employment
814849|NCT00183144|Therapeutic Workplace|therapeutic workplace
814850|NCT00183131|Alcohol|alcohol
814851|NCT00183131|Alcohol abuse|alcohol abuse
814852|NCT00183131|Alcohol dependence|alcohol dependence
814853|NCT00183131|Alcohol consumption|alcohol consumption
814854|NCT00183131|Unhealthy alcohol use|unhealthy alcohol use
814855|NCT00183131|Screening|screening
814856|NCT00183131|Brief Intervention|brief intervention
814857|NCT00183131|Effectiveness|effectiveness
814858|NCT00183131|Electronic intervention|electronic intervention
814859|NCT00183131|Web-based intervention|web-based intervention
814860|NCT00183131|College students|college students
814861|NCT00183118|HIV|hiv
814862|NCT00183118|Russia|russia
814863|NCT00183118|Prevention|prevention
814864|NCT00183118|Behavioral intervention|behavioral intervention
814865|NCT00183118|Alcohol dependence|alcohol dependence
814866|NCT00183105|Alcohol|alcohol
814867|NCT00183105|Alcohol abuse|alcohol abuse
814868|NCT00183105|Alcohol dependence|alcohol dependence
814869|NCT00183105|Utilization|utilization
814870|NCT00183105|Alcohol consumption|alcohol consumption
814871|NCT00183105|Unhealthy alcohol use|unhealthy alcohol use
814872|NCT00183105|Hospitalization|hospitalization
814873|NCT00183105|Screening|screening
814874|NCT00183105|Brief Intervention|brief intervention
814875|NCT00183105|Motivational Interviewing|motivational interviewing
814876|NCT00183105|Randomized trial|randomized trial
814877|NCT00183105|Effectiveness|effectiveness
815052|NCT00182442|Cognitive deficits|cognitive deficits
814878|NCT00183105|Unhealthy alcohol use (Risky alcohol consumption amounts, problem alcohol use, hazardous alcohol use, alcohol abuse and alcohol dependence)|unhealthy alcohol use (risky alcohol consumption amounts, problem alcohol use, hazardous alcohol use, alcohol abuse and alcohol dependence)
814879|NCT00183092|dementia|dementia
814880|NCT00183092|spongiform encephalopathy|spongiform encephalopathy
814881|NCT00183092|nervous system disorder|nervous system disorder
814882|NCT00183092|acridine|acridine
814883|NCT00183092|prion|prion
814884|NCT00183092|neuropharmacologic agent|neuropharmacologic agent
814887|NCT00183079|Motivational Interviewing|motivational interviewing
814888|NCT00183053|Hospitalization|hospitalization
814889|NCT00183053|Fall Risk|fall risk
814890|NCT00183053|Frailty|frailty
814891|NCT00183040|andropause|andropause
814892|NCT00183040|hormone therapy|hormone therapy
814893|NCT00183040|HRT|hrt
814894|NCT00183027|Dietary restriction|dietary restriction
814895|NCT00183027|Caloric restriction|caloric restriction
814896|NCT00183014|behavior therapy|behavior therapy
814897|NCT00183014|exercise|exercise
814898|NCT00183014|gait|gait
814899|NCT00183014|physical activity|physical activity
814900|NCT00183001|nutritional supplement|nutritional supplement
814901|NCT00183001|dietary supplement|dietary supplement
814902|NCT00183001|vitamin therapy|vitamin therapy
814903|NCT00183001|Vitamin K deficiency|vitamin k deficiency
814904|NCT00183001|bone density|bone density
814905|NCT00182988|communication behavior|communication behavior
814906|NCT00182988|coping|coping
814907|NCT00182988|functional ability|functional ability
814908|NCT00182988|quality of life|quality of life
814909|NCT00182988|caregiving|caregiving
814910|NCT00182975|Metabolic syndrome|metabolic syndrome
814911|NCT00182962|Activities of Daily Living|activities of daily living
814912|NCT00182962|Low-income|low-income
814913|NCT00182962|geriatric medicine|geriatric medicine
814914|NCT00182962|computer assisted patient care|computer assisted patient care
814915|NCT00182949|Epidemiology|epidemiology
814916|NCT00182949|Genetics|genetics
814917|NCT00182949|Aging|aging
814918|NCT00182949|Sardinian Population|sardinian population
814919|NCT00182949|Cardiovascular Diseases|cardiovascular diseases
814920|NCT00182949|Personality Traits|personality traits
814921|NCT00182949|Frailty|frailty
814922|NCT00182936|Cognition disorder|cognition disorder
814923|NCT00182936|organic brain syndrome|organic brain syndrome
814924|NCT00182936|patient care management|patient care management
814925|NCT00182936|long term care|long term care
814926|NCT00182936|extended care facility|extended care facility
814927|NCT00182923|Blood pressure|blood pressure
814928|NCT00182923|genetics|genetics
814929|NCT00182897|caregiver|caregiver
814930|NCT00182897|home health care|home health care
814931|NCT00182897|coping|coping
814932|NCT00182884|Hospital acquired complications|hospital acquired complications
814933|NCT00182884|adverse effects|adverse effects
814934|NCT00182884|Cognitive Impairment|cognitive impairment
814935|NCT00182884|Aging|aging
814936|NCT00182871|geriatric medicine|geriatric medicine
814937|NCT00182871|hormone therapy|hormone therapy
814938|NCT00182871|HT|ht
814939|NCT00182871|andropause|andropause
814940|NCT00182858|Biologic Sample Collection|biologic sample collection
814941|NCT00182858|Tissue Procurement|tissue procurement
814942|NCT00182845|dementia|dementia
814943|NCT00182845|MCI|mci
814944|NCT00182845|Aricept|aricept
814945|NCT00182845|Adverse Effects|adverse effects
814946|NCT00182845|Hospital Acquired Complications|hospital acquired complications
814947|NCT00182845|Cognitive Impairment|cognitive impairment
814948|NCT00182845|Aging|aging
814949|NCT00182832|Physician Behavior|physician behavior
814950|NCT00182832|Hospital Acquired Complications|hospital acquired complications
814951|NCT00182832|MCI|mci
814952|NCT00182832|Mild Cognitive Impairment|mild cognitive impairment
814953|NCT00182819|adult oligodendroglioma|adult oligodendroglioma
814954|NCT00182819|adult diffuse astrocytoma|adult diffuse astrocytoma
814955|NCT00182819|adult mixed glioma|adult mixed glioma
814956|NCT00182806|recurrent non-small cell lung cancer|recurrent non-small cell lung cancer
814957|NCT00182806|stage IIIA non-small cell lung cancer|stage iiia non-small cell lung cancer
814958|NCT00182806|stage IIIB non-small cell lung cancer|stage iiib non-small cell lung cancer
814959|NCT00182806|stage IV non-small cell lung cancer|stage iv non-small cell lung cancer
814960|NCT00182793|stage IIIB breast cancer|stage iiib breast cancer
814961|NCT00182793|stage IIIC breast cancer|stage iiic breast cancer
814962|NCT00182793|stage IV breast cancer|stage iv breast cancer
814963|NCT00182793|inflammatory breast cancer|inflammatory breast cancer
814964|NCT00182793|male breast cancer|male breast cancer
814965|NCT00182793|recurrent breast cancer|recurrent breast cancer
814966|NCT00182793|invasive ductal breast carcinoma with predominant intraductal component|invasive ductal breast carcinoma with predominant intraductal component
814967|NCT00182793|invasive ductal breast carcinoma|invasive ductal breast carcinoma
814968|NCT00182793|medullary ductal breast carcinoma with lymphocytic infiltrate|medullary ductal breast carcinoma with lymphocytic infiltrate
814969|NCT00182793|mucinous ductal breast carcinoma|mucinous ductal breast carcinoma
815258|NCT00181727|mania|mania
814970|NCT00182793|Paget disease of the breast with invasive ductal carcinoma|paget disease of the breast with invasive ductal carcinoma
814971|NCT00182793|papillary ductal breast carcinoma|papillary ductal breast carcinoma
814972|NCT00182793|tubular ductal breast carcinoma|tubular ductal breast carcinoma
814973|NCT00182793|invasive lobular breast carcinoma with predominant in situ component|invasive lobular breast carcinoma with predominant in situ component
814974|NCT00182793|invasive lobular breast carcinoma|invasive lobular breast carcinoma
814975|NCT00182793|comedo ductal breast carcinoma|comedo ductal breast carcinoma
814976|NCT00182780|fatigue|fatigue
815064|NCT00182403|Low Molecular Weight Heparin|low molecular weight heparin
814977|NCT00182780|unspecified adult solid tumor, protocol specific|unspecified adult solid tumor, protocol specific
814978|NCT00182754|unspecified adult solid tumor, protocol specific|unspecified adult solid tumor, protocol specific
814979|NCT00182754|malignant ascites|malignant ascites
814980|NCT00182741|recurrent prostate cancer|recurrent prostate cancer
814981|NCT00182741|stage IV prostate cancer|stage iv prostate cancer
814982|NCT00182728|invasive ductal breast carcinoma|invasive ductal breast carcinoma
814983|NCT00182728|stage I breast cancer|stage i breast cancer
814984|NCT00182728|stage II breast cancer|stage ii breast cancer
814985|NCT00182715|adenocarcinoma of the colon|adenocarcinoma of the colon
814986|NCT00182715|stage IV colon cancer|stage iv colon cancer
814987|NCT00182715|adenocarcinoma of the rectum|adenocarcinoma of the rectum
814988|NCT00182715|stage IV rectal cancer|stage iv rectal cancer
814989|NCT00182650|recurrent grade 1 follicular lymphoma|recurrent grade 1 follicular lymphoma
814990|NCT00182650|recurrent grade 2 follicular lymphoma|recurrent grade 2 follicular lymphoma
814991|NCT00182650|recurrent grade 3 follicular lymphoma|recurrent grade 3 follicular lymphoma
814992|NCT00182637|recurrent mycosis fungoides/Sezary syndrome|recurrent mycosis fungoides/sezary syndrome
814993|NCT00182637|stage I mycosis fungoides/Sezary syndrome|stage i mycosis fungoides/sezary syndrome
814994|NCT00182637|stage II mycosis fungoides/Sezary syndrome|stage ii mycosis fungoides/sezary syndrome
814995|NCT00182637|stage III mycosis fungoides/Sezary syndrome|stage iii mycosis fungoides/sezary syndrome
814996|NCT00182637|stage IV mycosis fungoides/Sezary syndrome|stage iv mycosis fungoides/sezary syndrome
814997|NCT00182637|stage I cutaneous T-cell non-Hodgkin lymphoma|stage i cutaneous t-cell non-hodgkin lymphoma
814998|NCT00182637|stage II cutaneous T-cell non-Hodgkin lymphoma|stage ii cutaneous t-cell non-hodgkin lymphoma
814999|NCT00182637|stage III cutaneous T-cell non-Hodgkin lymphoma|stage iii cutaneous t-cell non-hodgkin lymphoma
815000|NCT00182637|stage IV cutaneous T-cell non-Hodgkin lymphoma|stage iv cutaneous t-cell non-hodgkin lymphoma
815001|NCT00182637|recurrent cutaneous T-cell non-Hodgkin lymphoma|recurrent cutaneous t-cell non-hodgkin lymphoma
815002|NCT00182624|Prostate Cancer|prostate cancer
815003|NCT00182624|Magnetic Resonance Imaging|magnetic resonance imaging
815004|NCT00182624|Spectroscopy|spectroscopy
815005|NCT00182611|stage III gastric cancer|stage iii gastric cancer
815006|NCT00182611|adenocarcinoma of the stomach|adenocarcinoma of the stomach
815007|NCT00182598|buprenorphine|buprenorphine
815008|NCT00182598|computer|computer
815009|NCT00182598|treatment|treatment
815010|NCT00182598|opioid|opioid
815011|NCT00182598|heroin|heroin
815013|NCT00182585|hepatitis|hepatitis
815014|NCT00182585|STDs|stds
815015|NCT00182585|adolescents|adolescents
815016|NCT00182585|addiction|addiction
815017|NCT00182585|treatment|treatment
815018|NCT00182585|prevention|prevention
815019|NCT00182585|HIV and related risk behavior among youth in drug treatment|hiv and related risk behavior among youth in drug treatment
815020|NCT00182572|heroin|heroin
815021|NCT00182572|opiate|opiate
815022|NCT00182572|addiction|addiction
815023|NCT00182572|adolescent|adolescent
815024|NCT00182572|treatment|treatment
815025|NCT00182559|kidney|kidney
815026|NCT00182559|transplantation|transplantation
815027|NCT00182559|tacrolimus|tacrolimus
815028|NCT00182559|cyclosporine|cyclosporine
815029|NCT00182559|conversion|conversion
815030|NCT00182546|Pulmonary Embolism|pulmonary embolism
815031|NCT00182546|DVT|dvt
815032|NCT00182546|Venous Thrombosis|venous thrombosis
815033|NCT00182546|D dimer|d dimer
815034|NCT00182546|DD|dd
815035|NCT00182546|Thrombosis|thrombosis
815036|NCT00182546|Diagnosis|diagnosis
815037|NCT00182533|Generalized social phobia|generalized social phobia
815038|NCT00182533|Comorbid panic disorder with agoraphobia|comorbid panic disorder with agoraphobia
815039|NCT00182533|Comorbid obsessive compulsive disorder|comorbid obsessive compulsive disorder
815040|NCT00182533|Comorbid generalized anxiety disorder|comorbid generalized anxiety disorder
815041|NCT00182533|Comorbid major depressive disorder/Dysthymia|comorbid major depressive disorder/dysthymia
815042|NCT00182520|Treatment Refractory Obsessive Compulsive Disorder|treatment refractory obsessive compulsive disorder
815043|NCT00182494|Schizophrenia, Diabetes, Weight gain, Antipsychotic drugs|schizophrenia, diabetes, weight gain, antipsychotic drugs
815044|NCT00182481|asthma treatment|asthma treatment
815045|NCT00182481|induced sputum cell counts|induced sputum cell counts
815046|NCT00182481|asthma exacerbations|asthma exacerbations
815047|NCT00182481|eosinophilic bronchitis|eosinophilic bronchitis
815048|NCT00182481|non-eosinophilic bronchitis|non-eosinophilic bronchitis
815049|NCT00182468|Domestic violence|domestic violence
815050|NCT00182468|Spouse Abuse|spouse abuse
815051|NCT00182455|Treatment Refractory Generalized Social Phobia|treatment refractory generalized social phobia
815053|NCT00182442|Psychosocial functioning|psychosocial functioning
815054|NCT00182442|Quality of Life|quality of life
815055|NCT00182429|Antibiotic associated diarrhea|antibiotic associated diarrhea
815056|NCT00182429|C. difficile|c. difficile
815057|NCT00182429|Metronidazole|metronidazole
815058|NCT00182429|Rifampin|rifampin
815059|NCT00182416|pacemakers|pacemakers
815060|NCT00182416|atrial fibrillation|atrial fibrillation
815061|NCT00182416|stroke|stroke
815062|NCT00182416|cardiovascular death|cardiovascular death
815063|NCT00182403|Unfractionated Heparin|unfractionated heparin
815162|NCT00182078|burns|burns
815065|NCT00182403|Venous Thromboembolism|venous thromboembolism
815066|NCT00182403|APTT|aptt
815067|NCT00182403|Treatment|treatment
815068|NCT00182390|ELBW premature infants|elbw premature infants
815069|NCT00182390|neonatal transfusion|neonatal transfusion
815070|NCT00182390|bronchopulmonary dysplasia|bronchopulmonary dysplasia
815071|NCT00182390|periventricular leukomalacia|periventricular leukomalacia
815072|NCT00182390|ventriculomegaly|ventriculomegaly
815073|NCT00182390|retinopathy of prematurity|retinopathy of prematurity
815074|NCT00182377|patients undergoing cardiac surgery requiring cardiopulmonary bypass|patients undergoing cardiac surgery requiring cardiopulmonary bypass
815075|NCT00182364|Critically Ill|critically ill
815076|NCT00182364|Deep Venous Thrombosis|deep venous thrombosis
815077|NCT00182364|Randomized Control Trial|randomized control trial
815078|NCT00182364|Pilot Study|pilot study
815079|NCT00182351|deep vein thrombosis|deep vein thrombosis
815080|NCT00182351|d-dimer|d-dimer
815081|NCT00182351|serial compression ultrasound|serial compression ultrasound
815082|NCT00182338|cardiovascular outcomes|cardiovascular outcomes
815083|NCT00182338|congestive heart failure|congestive heart failure
815084|NCT00182338|Peritoneal Membrane transport properties|peritoneal membrane transport properties
815085|NCT00182338|Arterial stiffening|arterial stiffening
815086|NCT00182338|Inflammatory markers|inflammatory markers
815087|NCT00182325|medical record|medical record
815088|NCT00182325|pregnancy|pregnancy
815089|NCT00182325|Internet|internet
815090|NCT00182312|preterm infants|preterm infants
815091|NCT00182312|very low birthweight|very low birthweight
815092|NCT00182312|apnea of prematurity|apnea of prematurity
815093|NCT00182312|methylxanthines|methylxanthines
815094|NCT00182312|developmental disabilities|developmental disabilities
815095|NCT00182286|Diabetes|diabetes
815096|NCT00182286|Continuity of Care|continuity of care
815097|NCT00182286|Patient Perspective|patient perspective
815098|NCT00182286|Health Service Organization|health service organization
815099|NCT00182273|Benign paroxysmal positional vertigo|benign paroxysmal positional vertigo
815100|NCT00182273|Canalith repositioning maneuver|canalith repositioning maneuver
815101|NCT00182273|Dizziness|dizziness
815102|NCT00182273|Primary Care|primary care
815103|NCT00182247|deep vein thrombosis|deep vein thrombosis
815104|NCT00182247|DVT|dvt
815105|NCT00182247|pulmonary embolism|pulmonary embolism
815106|NCT00182247|PE|pe
815107|NCT00182247|venous thromboembolism|venous thromboembolism
815108|NCT00182247|VTE|vte
815109|NCT00182247|d-dimer|d-dimer
815110|NCT00182247|IPG|ipg
815111|NCT00182234|unmet supportive care needs|unmet supportive care needs
815112|NCT00182221|Pulmonary Embolism|pulmonary embolism
815113|NCT00182221|Deep Vein Thrombosis|deep vein thrombosis
815114|NCT00182221|MDA D-Dimer Testing|mda d-dimer testing
815115|NCT00182221|Diagnostic Algorithm|diagnostic algorithm
815116|NCT00182208|PTS|pts
815117|NCT00182208|Post phlebitic Syndrome|post phlebitic syndrome
815118|NCT00182208|Activities of Daily Living|activities of daily living
815119|NCT00182208|Quality of Life|quality of life
815120|NCT00182182|Heart Failure|heart failure
815121|NCT00182182|Family physicians|family physicians
815122|NCT00182182|academic detailing|academic detailing
815123|NCT00182182|process of care|process of care
815124|NCT00182169|Severe heart failure|severe heart failure
815125|NCT00182169|Growth hormone|growth hormone
815126|NCT00182169|exercise capacity|exercise capacity
815127|NCT00182169|quality of life|quality of life
815128|NCT00182169|cardiac function|cardiac function
815129|NCT00182156|hemodialysis|hemodialysis
815130|NCT00182156|platelet function analyzer|platelet function analyzer
815131|NCT00182156|bioimpedance|bioimpedance
815132|NCT00182156|pulse wave velocity|pulse wave velocity
815133|NCT00182156|end stage renal disease|end stage renal disease
815134|NCT00182143|Critically Ill|critically ill
815135|NCT00182143|Deep Venous ThromboEmbolism|deep venous thromboembolism
815136|NCT00182143|Randomized Controlled Trial|randomized controlled trial
815137|NCT00182130|rectal cancer|rectal cancer
815138|NCT00182130|surgery|surgery
815139|NCT00182130|physician behaviour|physician behaviour
815140|NCT00182130|knowledge translation|knowledge translation
815141|NCT00182117|bleeding|bleeding
815142|NCT00182117|end stage renal disease|end stage renal disease
815143|NCT00182117|antiplatelet therapy|antiplatelet therapy
815144|NCT00182117|anticoagulant therapy|anticoagulant therapy
815145|NCT00182117|hemodialysis|hemodialysis
815146|NCT00182104|Fontan procedure|fontan procedure
815147|NCT00182104|Anticoagulation|anticoagulation
815148|NCT00182104|Thrombosis|thrombosis
815149|NCT00182104|Thromboembolism|thromboembolism
815150|NCT00182104|Prevention|prevention
815151|NCT00182091|Acromegaly|acromegaly
815152|NCT00182091|Growth Hormone Deficiency|growth hormone deficiency
815153|NCT00182091|Cardiovascular Risk|cardiovascular risk
815154|NCT00182091|Pituitary|pituitary
815155|NCT00182091|Hypothalamic|hypothalamic
815156|NCT00182078|sertraline|sertraline
815157|NCT00182078|children|children
815158|NCT00182078|adolescents|adolescents
815159|NCT00182078|posttraumatic stress disorder|posttraumatic stress disorder
815160|NCT00182078|depression|depression
815161|NCT00182078|prevention|prevention
815164|NCT00182065|Heart failure|heart failure
815165|NCT00182065|Functional decline|functional decline
815166|NCT00182065|Cognitive impairment|cognitive impairment
815167|NCT00182065|Neuropsychiatric health|neuropsychiatric health
815168|NCT00182065|Longitudinal|longitudinal
815169|NCT00182065|Long-term care|long-term care
815170|NCT00182065|Elderly|elderly
815171|NCT00182052|rosiglitazone|rosiglitazone
815172|NCT00182052|Avandia|avandia
815173|NCT00182052|androgen dependant prostate cancer|androgen dependant prostate cancer
815174|NCT00182039|randomized controlled trial|randomized controlled trial
815175|NCT00182039|blinded|blinded
815176|NCT00182039|noncardiac surgery|noncardiac surgery
815177|NCT00182039|cardiovascular events|cardiovascular events
815178|NCT00182026|diabetes|diabetes
815179|NCT00182026|community intervention|community intervention
815180|NCT00182026|self-management|self-management
815181|NCT00182026|prevention|prevention
815182|NCT00182000|OCD|ocd
815183|NCT00181987|ADHD|adhd
815184|NCT00181987|bipolar disorder|bipolar disorder
815185|NCT00181987|children|children
815186|NCT00181987|Concerta|concerta
815187|NCT00181974|burns|burns
815188|NCT00181974|hemostasis|hemostasis
815189|NCT00181974|skin graft|skin graft
815190|NCT00181974|Surgical Hemostasis|surgical hemostasis
815191|NCT00181974|Grafting, Skin|grafting, skin
815192|NCT00181961|antidepressant-induced sexual dysfunction|antidepressant-induced sexual dysfunction
815193|NCT00181948|ADHD|adhd
815194|NCT00181948|children|children
815195|NCT00181948|stimulant non-responders|stimulant non-responders
815196|NCT00181948|Strattera|strattera
815197|NCT00181935|bipolar disorder|bipolar disorder
815198|NCT00181935|preschoolers|preschoolers
815199|NCT00181935|risperdal|risperdal
815200|NCT00181935|zyprexa|zyprexa
815201|NCT00181922|bipolar disorder|bipolar disorder
815202|NCT00181922|children|children
815203|NCT00181922|ziprasidone|ziprasidone
815204|NCT00181922|mania|mania
815205|NCT00181909|Pregnancy|pregnancy
815206|NCT00181909|Smoking cessation|smoking cessation
815207|NCT00181896|depression|depression
815208|NCT00181896|bipolar disorder|bipolar disorder
815209|NCT00181896|children|children
815210|NCT00181896|bupropion SR|bupropion sr
815211|NCT00181883|children|children
815212|NCT00181883|bipolar disorder|bipolar disorder
815213|NCT00181883|quetiapine|quetiapine
815214|NCT00181883|preschoolers|preschoolers
815215|NCT00181870|bipolar disorder|bipolar disorder
815216|NCT00181870|children|children
815217|NCT00181870|mania|mania
815218|NCT00181870|Equetro|equetro
815219|NCT00181857|ADHD NOS|adhd nos
815220|NCT00181857|familial risk|familial risk
815221|NCT00181857|children|children
815222|NCT00181844|bipolar disorder|bipolar disorder
815223|NCT00181844|lamotrigine|lamotrigine
815224|NCT00181844|children|children
815225|NCT00181844|mania|mania
815226|NCT00181831|SPECT|spect
815227|NCT00181831|bipolar disorder|bipolar disorder
815228|NCT00181831|ADHD|adhd
815229|NCT00181831|children|children
815230|NCT00181818|Smoking cessation|smoking cessation
815231|NCT00181818|Bupropion SR|bupropion sr
815232|NCT00181818|Hospital intervention|hospital intervention
815233|NCT00181818|Myocardial infarction|myocardial infarction
815234|NCT00181818|Unstable angina|unstable angina
815235|NCT00181805|GER|ger
815236|NCT00181792|ADHD|adhd
815237|NCT00181792|smoking|smoking
815238|NCT00181792|familial risk|familial risk
815239|NCT00181779|mania|mania
815240|NCT00181779|Abilify|abilify
815241|NCT00181779|children|children
815242|NCT00181779|bipolar disorder|bipolar disorder
815243|NCT00181766|ADHD NOS|adhd nos
815244|NCT00181766|Adults|adults
815245|NCT00181766|Strattera (atomoxetine)|strattera (atomoxetine)
815246|NCT00181766|Open-Label|open-label
815247|NCT00181753|glutamine metabolic kinetics|glutamine metabolic kinetics
815248|NCT00181753|glutamate metabolic kinetics|glutamate metabolic kinetics
815249|NCT00181753|enteral nutrition|enteral nutrition
815250|NCT00181753|parenteral nutrition|parenteral nutrition
815251|NCT00181753|burn injury|burn injury
815252|NCT00181753|stable isotopes|stable isotopes
815253|NCT00181740|ADHD NOS|adhd nos
815254|NCT00181740|Adults|adults
815255|NCT00181740|Concerta|concerta
815256|NCT00181740|Open-Label|open-label
815257|NCT00181727|bipolar disorder|bipolar disorder
815259|NCT00181727|depakote ER|depakote er
815260|NCT00181727|children|children
815261|NCT00181714|cigarette smoking|cigarette smoking
815262|NCT00181714|ADHD|adhd
815263|NCT00181714|adolescents|adolescents
815264|NCT00181714|Concerta|concerta
815265|NCT00181701|Ovarian cancer|ovarian cancer
815266|NCT00181701|Epithelial carcinoma of mullerian origin|epithelial carcinoma of mullerian origin
815267|NCT00181701|Intraperitoneal paclitaxel|intraperitoneal paclitaxel
815268|NCT00181701|Intraperitoneal carboplatin|intraperitoneal carboplatin
815269|NCT00181701|Primary peritoneal carcinoma|primary peritoneal carcinoma
815270|NCT00181701|Tubal carcinoma|tubal carcinoma
815271|NCT00181688|Iressa|iressa
815272|NCT00181688|ZD1839|zd1839
815278|NCT00181675|double-blind|double-blind
815279|NCT00181662|Curcumin|curcumin
815280|NCT00181662|Piperine|piperine
815281|NCT00181662|Silybin|silybin
815282|NCT00181662|Healthy volunteer|healthy volunteer
815283|NCT00181662|Female|female
815284|NCT00181649|Lactation|lactation
815285|NCT00181649|Breastfeeding|breastfeeding
815286|NCT00181649|Adoptive mothers|adoptive mothers
815287|NCT00181649|Prolactin|prolactin
815288|NCT00181649|Relative lactation insufficiency|relative lactation insufficiency
815289|NCT00181623|Lactation|lactation
815290|NCT00181623|Breastfeeding|breastfeeding
815291|NCT00181623|Prolactin|prolactin
815292|NCT00181623|Primary lactation insufficiency|primary lactation insufficiency
815293|NCT00181610|Lactation|lactation
815294|NCT00181610|Breastfeeding|breastfeeding
815295|NCT00181610|Premature infants|premature infants
815296|NCT00181610|Prolactin|prolactin
815297|NCT00181610|Primary lactation insufficiency|primary lactation insufficiency
815298|NCT00181597|Trilostane|trilostane
815299|NCT00181597|Androgen-independent prostate cancer|androgen-independent prostate cancer
815300|NCT00181584|Androgen deprivation therapy|androgen deprivation therapy
815301|NCT00181584|bone loss|bone loss
815302|NCT00181584|prostate cancer|prostate cancer
815303|NCT00181584|Zoledronic Acid|zoledronic acid
815304|NCT00181584|Zometa|zometa
815305|NCT00181571|ADHD|adhd
815306|NCT00181571|Adults|adults
815307|NCT00181571|Concerta|concerta
815308|NCT00181571|Double-Blind|double-blind
815309|NCT00181558|Prostate Cancer|prostate cancer
815310|NCT00181558|bone metastases|bone metastases
815311|NCT00181558|Atrasentan|atrasentan
815312|NCT00181558|Zometa|zometa
815313|NCT00181558|Androgen Independent Prostate Cancer|androgen independent prostate cancer
815314|NCT00181545|Non-small cell lung carcinoma|non-small cell lung carcinoma
815315|NCT00181545|radiotherapy|radiotherapy
815316|NCT00181545|mean lung dose|mean lung dose
815317|NCT00181532|NSCLC|nsclc
815318|NCT00181532|cox-2-inhibitor|cox-2-inhibitor
815319|NCT00181532|radiosensitizer|radiosensitizer
815320|NCT00181532|radiotherapy|radiotherapy
815321|NCT00181506|radiotherapy|radiotherapy
815322|NCT00181506|radiation dose|radiation dose
815323|NCT00181506|lung cancer|lung cancer
815324|NCT00181363|Breast cancer|breast cancer
815325|NCT00181363|Breast conserving surgery|breast conserving surgery
815326|NCT00181363|Radiotherapy|radiotherapy
815327|NCT00181363|Pendulous breasts|pendulous breasts
815328|NCT00181350|brain tumor|brain tumor
815329|NCT00181350|fractionated stereotactic radiotherapy|fractionated stereotactic radiotherapy
815330|NCT00181350|fixationsystems|fixationsystems
815331|NCT00181350|repositioning|repositioning
815332|NCT00181311|vaginal hysterectomy|vaginal hysterectomy
815333|NCT00181311|abdominal hysterectomy|abdominal hysterectomy
815334|NCT00181311|complications|complications
815335|NCT00181311|physical well being|physical well being
815336|NCT00181311|mental well being|mental well being
815337|NCT00181298|Memantine|memantine
815339|NCT00181298|Anti NR2|anti nr2
815340|NCT00181298|ANAM|anam
815341|NCT00181298|Cognitive functioning|cognitive functioning
815342|NCT00181272|chronic obstructive pulmonary disease (COPD)|chronic obstructive pulmonary disease (copd)
815343|NCT00181272|undifferentiated asthma/COPD|undifferentiated asthma/copd
815344|NCT00181246|Neuropathic pain|neuropathic pain
815345|NCT00181246|Efficacy|efficacy
815346|NCT00181207|COPD|copd
815347|NCT00181194|Asthma|asthma
815348|NCT00181181|Hypertension|hypertension
815349|NCT00181168|thyroid cancer|thyroid cancer
815350|NCT00181168|PET scan|pet scan
815351|NCT00181168|recombinant thyrotropin|recombinant thyrotropin
815352|NCT00181168|thyroglobulin|thyroglobulin
815353|NCT00181168|Thyroid cancer, differentiated epithelial|thyroid cancer, differentiated epithelial
815354|NCT00181155|metabolism|metabolism
815355|NCT00181155|congestive heart failure|congestive heart failure
815356|NCT00181155|allopurinol|allopurinol
815357|NCT00181155|Adenosine triphosphate (ATP)|adenosine triphosphate (atp)
815358|NCT00181142|Induciton therapy, Daclizumab, Thymoglobulin, lung transplantation|induciton therapy, daclizumab, thymoglobulin, lung transplantation
815359|NCT00181129|Fatigue|fatigue
815360|NCT00181129|Cancer treatment|cancer treatment
815361|NCT00181116|Epilepsy|epilepsy
815362|NCT00181116|Benign rolandic|benign rolandic
815363|NCT00181116|Levetiracetam|levetiracetam
815364|NCT00181090|Epilepsy|epilepsy
815365|NCT00181090|Ketosis|ketosis
815366|NCT00181090|Atkins|atkins
815367|NCT00181090|seizures|seizures
815368|NCT00181077|preeclampsia, hypertonic saline, diuresis|preeclampsia, hypertonic saline, diuresis
815369|NCT00181064|headache|headache
815370|NCT00181064|Atkins|atkins
815371|NCT00181064|ketosis|ketosis
815372|NCT00181064|intractable|intractable
815373|NCT00181038|Oro-Pharyngeal Carcinoma Surgery|oro-pharyngeal carcinoma surgery
815374|NCT00181025|Limbs’ girdle|limbs’ girdle
815375|NCT00181012|Cancer Related Visceral Pain Resistant to Morphinics|cancer related visceral pain resistant to morphinics
815376|NCT00180947|Soft parts tissue|soft parts tissue
815377|NCT00180921|Adenoid cystic carcinoma of the head and neck|adenoid cystic carcinoma of the head and neck
815378|NCT00180908|Osteosarcoma|osteosarcoma
815379|NCT00180895|Burkitt lymphoma|burkitt lymphoma
815380|NCT00180895|B-cell non Hodgkin lymphoma|b-cell non hodgkin lymphoma
815381|NCT00180895|B-cell ALL|b-cell all
815382|NCT00180895|Refractory|refractory
815383|NCT00180895|Relapse|relapse
815384|NCT00180895|Rituximab|rituximab
815385|NCT00180895|Children|children
815386|NCT00180869|cancer|cancer
815387|NCT00180869|peroperative transfusion|peroperative transfusion
815388|NCT00180869|allogeneic red blood cell concentrate|allogeneic red blood cell concentrate
815389|NCT00180869|leuko-reduced red blood cell concentrate|leuko-reduced red blood cell concentrate
815390|NCT00180856|Lung metastasis|lung metastasis
815391|NCT00180856|Lung cancer|lung cancer
815392|NCT00180856|Radiofrequency ablation|radiofrequency ablation
815393|NCT00180791|Brain PNET|brain pnet
815394|NCT00180765|Leukocytes|leukocytes
815395|NCT00180765|Eosinophils|eosinophils
815396|NCT00180765|Neutrophils|neutrophils
815397|NCT00180765|Chronic Obstructive Airway Disease|chronic obstructive airway disease
815398|NCT00180765|Apoptosis|apoptosis
815399|NCT00180765|Signal Transduction|signal transduction
815400|NCT00180739|MR guided FUS|mr guided fus
815401|NCT00180739|Uterine Fibroids|uterine fibroids
815402|NCT00180739|Fertility|fertility
815403|NCT00180739|Pregnancy|pregnancy
815404|NCT00180726|asthma, inflammatory, corticosteroid|asthma, inflammatory, corticosteroid
815405|NCT00180713|Pulmonary hypertension|pulmonary hypertension
815406|NCT00180713|Simvastatin|simvastatin
815407|NCT00180713|Statins|statins
815408|NCT00180700|HIV|hiv
815409|NCT00180700|Stress|stress
815410|NCT00180700|Psychoneuroimmunology|psychoneuroimmunology
815411|NCT00180700|stress management|stress management
815412|NCT00180700|hypnosis|hypnosis
815413|NCT00180700|Johrei|johrei
815414|NCT00180700|psychological intervention|psychological intervention
815415|NCT00180687|Pain|pain
815416|NCT00180687|Nebulisation|nebulisation
815417|NCT00180687|Cholecystectomy|cholecystectomy
815418|NCT00180687|Laparoscopic|laparoscopic
815419|NCT00180687|Bupivacaine|bupivacaine
815420|NCT00180687|Local Anaesthetic|local anaesthetic
815421|NCT00180674|Hepatic fibrosis|hepatic fibrosis
815422|NCT00180674|anticoagulation|anticoagulation
815423|NCT00180674|Coumarin|coumarin
815424|NCT00180674|Warfarin|warfarin
815425|NCT00180674|Chronic hepatitis C virus infection|chronic hepatitis c virus infection
815426|NCT00180661|Severe asthma|severe asthma
815427|NCT00180661|corticosteroid responsiveness|corticosteroid responsiveness
815428|NCT00180648|Short Bowel Syndrome|short bowel syndrome
815429|NCT00180648|Intestinal Failure|intestinal failure
815430|NCT00180648|Glucagon Like Peptide 2|glucagon like peptide 2
815431|NCT00180648|Parenteral Nutrition|parenteral nutrition
815432|NCT00180635|COPD|copd
815433|NCT00180635|Aminoguanidine|aminoguanidine
815434|NCT00180635|Nitric oxide|nitric oxide
815435|NCT00180518|Carotid artery disease|carotid artery disease
815436|NCT00180518|High risk|high risk
815437|NCT00180518|High surgical risk|high surgical risk
815438|NCT00180505|Peripheral Artery Disease|peripheral artery disease
815439|NCT00180505|Restenosis Rate|restenosis rate
815440|NCT00180505|Patency Rates|patency rates
815441|NCT00180505|Self-Expandable Nitinol Stents|self-expandable nitinol stents
815442|NCT00180505|Stent Fractures|stent fractures
815443|NCT00180492|Atherosclerotic disease|atherosclerotic disease
815444|NCT00180479|Everolimus|everolimus
815445|NCT00180466|drug eluting stents|drug eluting stents
815446|NCT00180466|stents|stents
815447|NCT00180466|angioplasty|angioplasty
815448|NCT00180466|coronary artery disease|coronary artery disease
815449|NCT00180466|total coronary occlusion|total coronary occlusion
815450|NCT00180466|coronary artery restenosis|coronary artery restenosis
815451|NCT00180466|stent thrombosis|stent thrombosis
815452|NCT00180466|vascular disease|vascular disease
815453|NCT00180466|myocardial ischemia|myocardial ischemia
815454|NCT00180466|coronary artery stenosis|coronary artery stenosis
815455|NCT00180453|Cardiovascular disease|cardiovascular disease
815456|NCT00180453|Ischemia|ischemia
815457|NCT00180414|heart failure|heart failure
815458|NCT00180388|cardiovascular system|cardiovascular system
815459|NCT00180388|veins|veins
815460|NCT00180388|saphenous vein|saphenous vein
815461|NCT00180336|Heart Failure|heart failure
815462|NCT00180336|Tachycardia|tachycardia
815463|NCT00180336|Atrial Fibrillation|atrial fibrillation
815464|NCT00180336|Atrial Flutter|atrial flutter
815465|NCT00180336|Ventricular Fibrillation|ventricular fibrillation
815466|NCT00180310|drug eluting stents|drug eluting stents
815467|NCT00180310|stents|stents
815468|NCT00180310|angioplasty|angioplasty
815469|NCT00180310|coronary artery disease|coronary artery disease
815470|NCT00180310|total coronary occlusion|total coronary occlusion
815471|NCT00180310|coronary artery restenosis|coronary artery restenosis
815472|NCT00180310|stent thrombosis|stent thrombosis
815473|NCT00180310|vascular disease|vascular disease
815474|NCT00180310|myocardial ischemia|myocardial ischemia
815475|NCT00180310|coronary artery stenosis|coronary artery stenosis
815476|NCT00180284|Pacemaker leads|pacemaker leads
815477|NCT00180284|Electrodes, implantable|electrodes, implantable
815478|NCT00180284|Cardiac pacing, aritificial|cardiac pacing, aritificial
815479|NCT00180271|Defibrillator|defibrillator
815480|NCT00180271|Cardiac Resynchronization Therapy|cardiac resynchronization therapy
815481|NCT00180271|MADIT|madit
815482|NCT00180258|Cardiac Resynchronization Therapy (CRT)|cardiac resynchronization therapy (crt)
815483|NCT00180258|Heart Failure|heart failure
815484|NCT00180258|Defibrillator|defibrillator
815485|NCT00180258|Pacemaker|pacemaker
815486|NCT00180245|Radiation therapy|radiation therapy
815487|NCT00180245|F-18-FDG|f-18-fdg
815488|NCT00180219|G08.520.769.550.408|g08.520.769.550.408
815489|NCT00180219|G08.520.769.550.490|g08.520.769.550.490
815490|NCT00180219|G08.520.769.550.520|g08.520.769.550.520
815491|NCT00180206|Arthritis|arthritis
815492|NCT00180206|Hip|hip
815493|NCT00180206|Hip arthroplasty|hip arthroplasty
815494|NCT00180206|Hip resurfacing arthroplasty|hip resurfacing arthroplasty
815495|NCT00180193|Radiotherapy|radiotherapy
815496|NCT00180193|F-18-OMFD|f-18-omfd
815497|NCT00180180|head-and-neck cancer|head-and-neck cancer
815498|NCT00180180|radiation therapy|radiation therapy
815499|NCT00180180|F-18-FMISO|f-18-fmiso
815500|NCT00180167|Chemotherapy|chemotherapy
815501|NCT00180167|elderly|elderly
815502|NCT00180154|radiation therapy|radiation therapy
815503|NCT00180154|F-18-FDG|f-18-fdg
815504|NCT00180154|NSCLC|nsclc
815505|NCT00180141|Atopic dermatitis on both lower arm.|atopic dermatitis on both lower arm.
815506|NCT00180128|acute promyelocytic leukemia|acute promyelocytic leukemia
815507|NCT00180128|risk adapted therapy|risk adapted therapy
815508|NCT00180115|acute myeloid leukemia|acute myeloid leukemia
815509|NCT00180115|cytarabine postremission dosage|cytarabine postremission dosage
815510|NCT00180115|risk adapted treatment strategy|risk adapted treatment strategy
815511|NCT00180115|allogeneic stem cell transplantation|allogeneic stem cell transplantation
815512|NCT00180115|autologous stem cell transplantation|autologous stem cell transplantation
815513|NCT00180102|acute myeloid leukemia|acute myeloid leukemia
815514|NCT00180102|risk adapted treatment|risk adapted treatment
815515|NCT00180102|early allogeneic stem cell transplantation|early allogeneic stem cell transplantation
815516|NCT00180102|autologous stem cell transplantation|autologous stem cell transplantation
815517|NCT00180089|graft-versus-host disease|graft-versus-host disease
815518|NCT00180089|budesonide|budesonide
815519|NCT00180089|stem cell transplantation|stem cell transplantation
815520|NCT00180076|collagenous colitis|collagenous colitis
815521|NCT00180076|microscopic colitis|microscopic colitis
815522|NCT00180076|budesonide|budesonide
815523|NCT00180050|lymphocytic colitis|lymphocytic colitis
815524|NCT00180050|microscopic colitis|microscopic colitis
815525|NCT00180050|budesonide|budesonide
815526|NCT00180037|Parkinson's disease|parkinson's disease
815527|NCT00180037|Coenzyme Q10|coenzyme q10
815528|NCT00180037|Treatment|treatment
815529|NCT00180037|Neuroprotection|neuroprotection
815530|NCT00180024|AT1-receptor|at1-receptor
815531|NCT00180024|AT2-receptor|at2-receptor
815532|NCT00180024|human pharmacology|human pharmacology
815533|NCT00180011|omalizumab|omalizumab
815534|NCT00180011|severe asthma|severe asthma
815535|NCT00180011|moderate asthma|moderate asthma
815536|NCT00180011|injectable asthma medication|injectable asthma medication
815537|NCT00180011|Xolair|xolair
815538|NCT00179998|Cystic fibrosis|cystic fibrosis
815539|NCT00179998|Infants|infants
815540|NCT00179998|Children|children
815541|NCT00179998|Pulmozyme|pulmozyme
815542|NCT00179998|Pulmonary function|pulmonary function
815543|NCT00179998|Computed tomography|computed tomography
815544|NCT00179985|Developmental Care|developmental care
815545|NCT00179985|Neonatal Intensive Care Unit (NICU)|neonatal intensive care unit (nicu)
815546|NCT00179972|Pulse oximetry|pulse oximetry
815547|NCT00179972|Pulse oximetry sensors|pulse oximetry sensors
815548|NCT00179972|Skin Integrity|skin integrity
815549|NCT00179972|Prematurity|prematurity
815550|NCT00179972|Neonatal Intensive Care Unit|neonatal intensive care unit
815551|NCT00179972|Infant, premature|infant, premature
815552|NCT00179933|developmental care|developmental care
815553|NCT00179933|Neonatal Intensive Care Unit|neonatal intensive care unit
815554|NCT00179894|ADHD|adhd
815555|NCT00179894|Attention Deficit Hyperactivity Disorder|attention deficit hyperactivity disorder
815874|NCT00178568|Caregiving|caregiving
815556|NCT00179881|Brain stem glioma|brain stem glioma
815557|NCT00179868|cancer|cancer
815558|NCT00179868|leukemia|leukemia
815559|NCT00179868|stem cell transplant|stem cell transplant
815560|NCT00179868|complications|complications
815561|NCT00179855|graft versus host disease|graft versus host disease
815563|NCT00179855|extracorporeal photopheresis|extracorporeal photopheresis
815564|NCT00179855|allogeneic transplantation|allogeneic transplantation
815565|NCT00179829|leukemia|leukemia
815566|NCT00179829|acute lymphocytic leukemia|acute lymphocytic leukemia
815567|NCT00179829|chronic myelogenous leukemia|chronic myelogenous leukemia
815568|NCT00179829|acute myelogenous leukemia|acute myelogenous leukemia
815569|NCT00179816|wilm's tumor|wilm's tumor
815570|NCT00179816|stem cell transplantation|stem cell transplantation
815571|NCT00179816|solid tumor|solid tumor
815572|NCT00179803|brain tumor|brain tumor
815573|NCT00179803|medulloblastoma|medulloblastoma
815574|NCT00179803|germ cell tumor|germ cell tumor
815575|NCT00179803|CNS tumor|cns tumor
815576|NCT00179803|glioblastoma|glioblastoma
815577|NCT00179803|astrocytoma|astrocytoma
815578|NCT00179803|pineoblastoma|pineoblastoma
815579|NCT00179803|rhabdoid tumor|rhabdoid tumor
815580|NCT00179803|supratentorial PNET|supratentorial pnet
815581|NCT00179803|high grade astrocytoma|high grade astrocytoma
815582|NCT00179790|cancer|cancer
815583|NCT00179790|hemoglobinopathy|hemoglobinopathy
815584|NCT00179790|immune deficiency|immune deficiency
815585|NCT00179790|photopheresis|photopheresis
815586|NCT00179790|ECP|ecp
815587|NCT00179790|extracorporeal photopheresis|extracorporeal photopheresis
815588|NCT00179777|Diabetes Mellitus, Type 1|diabetes mellitus, type 1
815589|NCT00179777|Genetic Predisposition to Disease|genetic predisposition to disease
815590|NCT00179777|Infant Nutrition|infant nutrition
815591|NCT00179777|Primary Prevention|primary prevention
815592|NCT00179764|Patients with recurrent solid tumors|patients with recurrent solid tumors
815593|NCT00179764|Patients with malignant melanoma|patients with malignant melanoma
815594|NCT00179764|Patients with hematological malignancies|patients with hematological malignancies
815595|NCT00179764|Acute lymphoblastic leukemia (ALL)|acute lymphoblastic leukemia (all)
815596|NCT00179764|Acute myelogenous leukemia (AML)|acute myelogenous leukemia (aml)
815597|NCT00179751|cc-5013|cc-5013
815598|NCT00179751|revlimid|revlimid
815599|NCT00179751|pancreatic cancer|pancreatic cancer
815600|NCT00179738|Androgen Independent Prostate Cancer|androgen independent prostate cancer
815601|NCT00179725|cc-5013|cc-5013
815602|NCT00179725|revlimid|revlimid
815603|NCT00179725|ovarian cancer|ovarian cancer
815604|NCT00179725|celgene|celgene
815605|NCT00179712|cc-5013|cc-5013
815606|NCT00179712|revlimid|revlimid
815607|NCT00179712|ovarian cancer|ovarian cancer
815608|NCT00179712|celgene|celgene
815609|NCT00179699|cc-5013|cc-5013
815610|NCT00179699|Non Small Cell Lung Cancer|non small cell lung cancer
815611|NCT00179699|revlimid|revlimid
815612|NCT00179699|celgene|celgene
815613|NCT00179699|cc5013|cc5013
815614|NCT00179686|celgene|celgene
815615|NCT00179686|cc-5013|cc-5013
815616|NCT00179686|NSCLC|nsclc
815617|NCT00179686|CC5013|cc5013
815618|NCT00179686|Revlimid|revlimid
815619|NCT00179686|Non-Small Cell Lung Cancer|non-small cell lung cancer
815620|NCT00179673|NHL|nhl
815621|NCT00179673|CC5013|cc5013
815622|NCT00179673|Non-Hodgkins Lymphoma|non-hodgkins lymphoma
815623|NCT00179673|revlimid|revlimid
815624|NCT00179673|cc-5013|cc-5013
815625|NCT00179673|celgene|celgene
815626|NCT00179660|celgene|celgene
815627|NCT00179660|cc-5013|cc-5013
815628|NCT00179660|CC5013|cc5013
815629|NCT00179660|NHL|nhl
815630|NCT00179660|Non-Hodgkins Lymphoma|non-hodgkins lymphoma
815631|NCT00179660|Revlimid|revlimid
815632|NCT00179647|Multiple Myeloma|multiple myeloma
815633|NCT00179647|MM|mm
815634|NCT00179647|Revlimid|revlimid
815635|NCT00179647|CC5013|cc5013
815636|NCT00179647|celgene|celgene
815637|NCT00179647|cc-5013|cc-5013
815638|NCT00179647|relapsed/refractory|relapsed/refractory
815639|NCT00179647|lenalidomide|lenalidomide
815640|NCT00179647|dexamethasone|dexamethasone
815641|NCT00179647|Decadron|decadron
815642|NCT00179634|Mastectomy|mastectomy
815643|NCT00179634|Randomized Controlled Trial|randomized controlled trial
815644|NCT00179634|Imagery|imagery
815645|NCT00179621|MDS|mds
815646|NCT00179621|transfusion dependent|transfusion dependent
815647|NCT00179621|anaemia|anaemia
815648|NCT00179621|cytogenetic abnormality 5q-|cytogenetic abnormality 5q-
815649|NCT00179621|erythroid response|erythroid response
815650|NCT00179621|leukaemia|leukaemia
815651|NCT00179621|CC-5013|cc-5013
815652|NCT00179621|Celgene|celgene
815653|NCT00179621|revlimid|revlimid
815654|NCT00179621|lenalidomide|lenalidomide
815655|NCT00179608|CC-5013|cc-5013
815656|NCT00179608|CC5013|cc5013
815657|NCT00179608|celgene|celgene
815658|NCT00179608|Melanoma|melanoma
815659|NCT00179608|Revlimid|revlimid
815660|NCT00179608|Metastatic Malignant Melanoma|metastatic malignant melanoma
815661|NCT00179608|Lenalidomide|lenalidomide
815662|NCT00179595|nitric oxide, volumetric oxygen consumption|nitric oxide, volumetric oxygen consumption
815663|NCT00179582|IBS|ibs
815664|NCT00179582|Functional bowel disorder|functional bowel disorder
815665|NCT00179582|Diarrhea|diarrhea
815666|NCT00179582|probiotic|probiotic
815667|NCT00179556|Hot flashes|hot flashes
815668|NCT00179556|Menopausal symptoms|menopausal symptoms
815669|NCT00179556|Soybean germ|soybean germ
815670|NCT00179556|Aglycones|aglycones
815671|NCT00179556|Menopause|menopause
815672|NCT00179517|Seizure|seizure
815673|NCT00179517|Epilepsy|epilepsy
815674|NCT00179517|Testosterone|testosterone
815675|NCT00179517|Hormone|hormone
815676|NCT00179517|Sexual Dysfunction|sexual dysfunction
815677|NCT00179517|Hypogonadism|hypogonadism
815678|NCT00179517|Men|men
815679|NCT00179491|coronary artery bypass grafting surgery|coronary artery bypass grafting surgery
815680|NCT00179478|Multiple sclerosis|multiple sclerosis
815681|NCT00179478|Interferon Beta|interferon beta
815682|NCT00179478|MRI|mri
815683|NCT00179478|Optic neuritis|optic neuritis
815684|NCT00179478|Transverse Myelitis|transverse myelitis
815685|NCT00179465|Treatment|treatment
815686|NCT00179465|fMRI|fmri
815687|NCT00179465|Cognition|cognition
815688|NCT00179465|Brain development|brain development
815689|NCT00179452|epilepsy, yoga|epilepsy, yoga
815690|NCT00179439|PSC|psc
815691|NCT00179439|IBD|ibd
815692|NCT00179439|CFTR|cftr
815693|NCT00179426|Seizure Disorder|seizure disorder
815694|NCT00179426|Hypogonadism|hypogonadism
815695|NCT00179426|Sexual Function|sexual function
815696|NCT00179426|Epilepsy|epilepsy
815697|NCT00179413|hepatitis C|hepatitis c
815698|NCT00179413|cirrhosis|cirrhosis
815699|NCT00179413|interferon|interferon
815700|NCT00179413|colchicine|colchicine
815701|NCT00179387|Neoplasms|neoplasms
815702|NCT00179387|Needs Assessment|needs assessment
815703|NCT00179387|Adaptation Psychological|adaptation psychological
815704|NCT00179387|Minority Groups|minority groups
815705|NCT00179387|Psychotherapy, Group|psychotherapy, group
815706|NCT00179387|Program Evaluation|program evaluation
815707|NCT00179387|Spirituality|spirituality
815708|NCT00179387|Spiritual Therapies|spiritual therapies
815709|NCT00179374|Medication adherence|medication adherence
815710|NCT00179374|Self-care behaviors|self-care behaviors
815711|NCT00179374|Telephonic intervention|telephonic intervention
815712|NCT00179374|Diabetes|diabetes
815713|NCT00179374|Nutrition|nutrition
815714|NCT00179374|Exercise|exercise
815715|NCT00179335|Regular lopinavir/ritonavir or Efavirenz use|regular lopinavir/ritonavir or efavirenz use
815716|NCT00179335|Age >/= 55 y or </= 35 y|age >/= 55 y or </= 35 y
815717|NCT00179335|HIV+|hiv+
815718|NCT00179322|Sleep Architecture|sleep architecture
815719|NCT00179322|Sleep Measures|sleep measures
815720|NCT00179322|Speech Articulation|speech articulation
815721|NCT00179322|Cerebral Perfusion|cerebral perfusion
815722|NCT00179322|Neuroimaging|neuroimaging
815723|NCT00179322|Healthy Volunteer|healthy volunteer
815724|NCT00179322|HV|hv
815725|NCT00179309|CEA|cea
815726|NCT00179309|MUC-1|muc-1
815727|NCT00179309|Immunotherapy|immunotherapy
815728|NCT00179309|GM-CSF|gm-csf
815729|NCT00179309|Vaccine|vaccine
815730|NCT00179309|Breast Cancer|breast cancer
815731|NCT00179309|Metastatic Breast Cancer|metastatic breast cancer
815732|NCT00179257|Failure to Escitalopram|failure to escitalopram
815733|NCT00179244|Treatment Resistant Depression|treatment resistant depression
815734|NCT00179192|End Stage Renal Disease|end stage renal disease
815735|NCT00179192|ESRD|esrd
815736|NCT00179192|Chronic Maintenance Hemodialysis|chronic maintenance hemodialysis
815737|NCT00179127|Pediatrics|pediatrics
815738|NCT00179127|Diabetes|diabetes
815739|NCT00179127|Emergency Care|emergency care
815740|NCT00179127|Endocrinology|endocrinology
815741|NCT00179127|Critical Care|critical care
815742|NCT00179114|Spasticity|spasticity
815743|NCT00179114|Developmental Disabilities|developmental disabilities
815744|NCT00179114|Intrathecal baclofen (ITB)|intrathecal baclofen (itb)
815745|NCT00179114|Botulinum Toxin Type A (Botox)|botulinum toxin type a (botox)
815746|NCT00179101|Parkinson's Disease|parkinson's disease
815747|NCT00179101|Depression|depression
815748|NCT00179101|Quality of Life|quality of life
815749|NCT00179101|Deep Brain Stimulation|deep brain stimulation
815750|NCT00179088|Weight-Bearing|weight-bearing
815751|NCT00179088|Total Hip Replacement|total hip replacement
815752|NCT00179088|Non-cemented|non-cemented
815753|NCT00179088|Randomized|randomized
815754|NCT00179088|Fiber-Metal-Taper-Stem|fiber-metal-taper-stem
815755|NCT00179088|Hip|hip
815756|NCT00179088|Osteoarthritis|osteoarthritis
815757|NCT00179075|T-Lymphocyte Subsets|t-lymphocyte subsets
815758|NCT00179062|major depression with psychotic features|major depression with psychotic features
815759|NCT00179062|bipolar disorder with psychotic features|bipolar disorder with psychotic features
815760|NCT00179049|T-Lymphocyte Subsets|t-lymphocyte subsets
815761|NCT00179036|Blood supply|blood supply
815762|NCT00179036|Mesentery|mesentery
815763|NCT00179023|OBESITY|obesity
815764|NCT00179023|RESTING ENERGY EXPENDITURE|resting energy expenditure
815765|NCT00179023|SYMPATHETIC NERVOUS SYSTEM|sympathetic nervous system
815766|NCT00179023|HYPERTENSION|hypertension
815767|NCT00179023|AUTONOMIC FAILURE|autonomic failure
815768|NCT00179010|Adenosine|adenosine
815770|NCT00179010|Microdialysis|microdialysis
815771|NCT00179010|Blood Flow|blood flow
815772|NCT00178997|Blood supply|blood supply
815773|NCT00178997|Mesentery|mesentery
815774|NCT00178984|Blood supply|blood supply
815775|NCT00178984|Mesentery|mesentery
815776|NCT00178919|Endothelial Nitric Oxide|endothelial nitric oxide
815777|NCT00178919|L-NMMA|l-nmma
815778|NCT00178919|Trimethaphan|trimethaphan
815779|NCT00178919|Autonomic Nervous System|autonomic nervous system
815780|NCT00178919|Nitric Oxide Inhibition|nitric oxide inhibition
815781|NCT00178906|depression|depression
815782|NCT00178906|suicide|suicide
815783|NCT00178906|voice|voice
815784|NCT00178880|depression|depression
815785|NCT00178880|MRI|mri
815787|NCT00178841|Cutaneous T-cell Lymphoma|cutaneous t-cell lymphoma
815788|NCT00178841|CTCL|ctcl
815789|NCT00178841|Mycosis Fungoides|mycosis fungoides
815790|NCT00178841|Sezary Syndrome|sezary syndrome
815791|NCT00178841|Bexarotene|bexarotene
815792|NCT00178841|Targretin|targretin
815793|NCT00178841|Rosiglitazone|rosiglitazone
815794|NCT00178841|Avandia|avandia
815795|NCT00178828|Depression|depression
815796|NCT00178828|antidepressant|antidepressant
815797|NCT00178828|SSRI|ssri
815798|NCT00178802|breast cancer|breast cancer
815799|NCT00178802|endometrial cancer|endometrial cancer
815800|NCT00178802|cervical cancer|cervical cancer
815801|NCT00178802|ovarian cancer|ovarian cancer
815802|NCT00178789|Deep Venous Thrombosis|deep venous thrombosis
815803|NCT00178789|Blood Clot|blood clot
815804|NCT00178789|Lower Extremity|lower extremity
815805|NCT00178789|Sonography|sonography
815806|NCT00178776|Group|group
815807|NCT00178776|Therapy|therapy
815808|NCT00178776|Cocaine|cocaine
815809|NCT00178776|Drugs|drugs
815810|NCT00178776|Trial|trial
815811|NCT00178776|Outcome|outcome
815812|NCT00178776|Study|study
815813|NCT00178776|Feasibility|feasibility
815814|NCT00178776|Transtheoretical|transtheoretical
815815|NCT00178776|Stages|stages
815816|NCT00178776|Motivation|motivation
815817|NCT00178776|Change|change
815818|NCT00178763|Cancer|cancer
815819|NCT00178763|Pancreatic Cancer|pancreatic cancer
815820|NCT00178763|Pancreas|pancreas
815821|NCT00178763|Neoplasms|neoplasms
815822|NCT00178750|Epidural placement|epidural placement
815823|NCT00178750|CompuFlo®|compuflo®
815824|NCT00178724|spinal cord injury|spinal cord injury
815825|NCT00178724|SCI|sci
815826|NCT00178724|traumatic spinal cord injury|traumatic spinal cord injury
815827|NCT00178724|acute spinal cord injury|acute spinal cord injury
815828|NCT00178724|paralysis|paralysis
815829|NCT00178711|Traumatic Brain Injury|traumatic brain injury
815830|NCT00178711|Hypothermia|hypothermia
815831|NCT00178698|thermochemotherapy|thermochemotherapy
815832|NCT00178698|fever range whole body|fever range whole body
815833|NCT00178698|cisplatin|cisplatin
815834|NCT00178698|gemcitabine|gemcitabine
815835|NCT00178698|daily low dose interferon alpha|daily low dose interferon alpha
815836|NCT00178685|Self-determination|self-determination
815837|NCT00178685|motivation|motivation
815838|NCT00178685|adherence|adherence
815839|NCT00178685|competence|competence
815840|NCT00178685|autonomy|autonomy
815841|NCT00178685|tobacco dependence|tobacco dependence
815842|NCT00178685|Tobacco use and dependence|tobacco use and dependence
815843|NCT00178685|Behavior change|behavior change
815844|NCT00178672|CVA|cva
815845|NCT00178672|TIA|tia
815846|NCT00178672|Carotid disease|carotid disease
815847|NCT00178672|Stroke|stroke
815848|NCT00178672|Neurology|neurology
815849|NCT00178672|Carotid Stenting|carotid stenting
815850|NCT00178659|Traumatic Brain Injury|traumatic brain injury
815851|NCT00178659|TBI (Traumatic Brain Injury)|tbi (traumatic brain injury)
815852|NCT00178659|Proteomics|proteomics
815853|NCT00178646|Stroke|stroke
815854|NCT00178646|Brain Injuries|brain injuries
815855|NCT00178646|Spasticity|spasticity
815856|NCT00178646|Botulinum Toxins|botulinum toxins
815857|NCT00178633|Obesity|obesity
815858|NCT00178633|Insulin Resistance|insulin resistance
815859|NCT00178633|Free Fatty Acids|free fatty acids
815860|NCT00178633|Heart Failure|heart failure
815861|NCT00178620|Heart Disease|heart disease
815862|NCT00178620|Heart Attack|heart attack
815863|NCT00178620|Myocardial Infarction|myocardial infarction
815864|NCT00178620|Thrombolytic Therapy|thrombolytic therapy
815865|NCT00178620|Emergency Medicine|emergency medicine
815866|NCT00178607|Inhibitors|inhibitors
815867|NCT00178594|Hereditary Bleeding disorder|hereditary bleeding disorder
815868|NCT00178594|Thrombotic Disorder|thrombotic disorder
815869|NCT00178581|Trauma|trauma
815870|NCT00178581|Critical Illness|critical illness
815871|NCT00178581|Shock|shock
815872|NCT00178581|Enteral Nutrition|enteral nutrition
815873|NCT00178581|Glutamine|glutamine
815875|NCT00178568|Spousal|spousal
815876|NCT00178568|Sleep disturbances|sleep disturbances
815877|NCT00178568|Progressive dementia|progressive dementia
815878|NCT00178568|Stress|stress
815879|NCT00178568|Health outcomes|health outcomes
815880|NCT00178568|Intervention|intervention
815881|NCT00178568|Affective self-management|affective self-management
815882|NCT00178568|Caregivers M01.526.485.200|caregivers m01.526.485.200
815883|NCT00178568|Spouses F01.829.263.500.660|spouses f01.829.263.500.660
815884|NCT00178568|Alzheimer's disease C10.574.945.249|alzheimer's disease c10.574.945.249
815885|NCT00178568|Parkinson's disease C10.574.812|parkinson's disease c10.574.812
815886|NCT00178568|Sleep disorder C10.886.425.800.800|sleep disorder c10.886.425.800.800
815887|NCT00178555|Endotracheal Intubation, Video Laryngoscopy|endotracheal intubation, video laryngoscopy
815888|NCT00178542|von Willebrand Disease|von willebrand disease
815889|NCT00178542|Healthy Women and Women with von Willebrand Disease|healthy women and women with von willebrand disease
815890|NCT00178529|Stroke|stroke
815891|NCT00178529|Caregivers|caregivers
815892|NCT00178516|male|male
815894|NCT00178490|Neurocognitive Function|neurocognitive function
815895|NCT00178464|sickle cell disease|sickle cell disease
815896|NCT00178464|hemoglobin SS disease|hemoglobin ss disease
815897|NCT00178464|hemoglobin S Beta-0 Thalassemia|hemoglobin s beta-0 thalassemia
815898|NCT00178464|silent infarction in sickle cell disease|silent infarction in sickle cell disease
815899|NCT00178464|overt stroke in sickle cell disease|overt stroke in sickle cell disease
815900|NCT00178464|aspirin|aspirin
815901|NCT00178464|transcranial Doppler ultrasound|transcranial doppler ultrasound
815902|NCT00178464|neurocognitive testing|neurocognitive testing
815903|NCT00178438|capsule endoscopy in small bowel|capsule endoscopy in small bowel
815904|NCT00178425|mycophenolate mofetil hydrochloride|mycophenolate mofetil hydrochloride
815905|NCT00178425|pharmacokinetics|pharmacokinetics
815906|NCT00178425|tacrolimus|tacrolimus
815907|NCT00178412|Hospitalized elders|hospitalized elders
815908|NCT00178412|Family caregivers|family caregivers
815909|NCT00178412|Acute care|acute care
815910|NCT00178386|cancer|cancer
815911|NCT00178386|education|education
815912|NCT00178386|learning|learning
815913|NCT00178386|brain tumor|brain tumor
815914|NCT00178386|school|school
815915|NCT00178373|cancer-related fatigue|cancer-related fatigue
815916|NCT00178373|chemotherapy|chemotherapy
815917|NCT00178373|modafinil|modafinil
815918|NCT00178360|Huntington's Disease, Music Therapy, quality of life|huntington's disease, music therapy, quality of life
815919|NCT00178321|Sleep|sleep
815920|NCT00178321|Criticall Ill|criticall ill
815921|NCT00178321|Children|children
815922|NCT00178321|Earplugs|earplugs
815923|NCT00178217|Botulinum Toxin|botulinum toxin
815924|NCT00178217|Music Therapy|music therapy
815925|NCT00178217|Cerebral Palsy|cerebral palsy
815926|NCT00178217|Procedural Support|procedural support
815927|NCT00178204|delta sleep|delta sleep
815928|NCT00178204|Cancer-related fatigue|cancer-related fatigue
815929|NCT00178204|Sleep Disturbance|sleep disturbance
815930|NCT00178204|chemotherapy|chemotherapy
815931|NCT00178178|anterior cruciate ligament reconstruction|anterior cruciate ligament reconstruction
815932|NCT00178178|Pain Care 3000|pain care 3000
815933|NCT00178178|Catheter Placement|catheter placement
815934|NCT00178178|Pain|pain
815935|NCT00178178|Breg, Inc|breg, inc
815936|NCT00178165|Family Caregivers|family caregivers
815937|NCT00178165|Dementia|dementia
815938|NCT00178165|Alzheimer Disease|alzheimer disease
815939|NCT00178165|Randomized Controlled Trial|randomized controlled trial
815940|NCT00178165|Intervention Studies|intervention studies
815941|NCT00178139|Music Therapy|music therapy
815942|NCT00178139|Mechanical ventilation|mechanical ventilation
815943|NCT00178139|Weaning from mechanical ventilation|weaning from mechanical ventilation
815944|NCT00178139|complementary and alternative therapy|complementary and alternative therapy
815945|NCT00178126|pressure ulcer|pressure ulcer
815946|NCT00178113|Prostatic Intraepithelial Neoplasia|prostatic intraepithelial neoplasia
815947|NCT00178113|Prostate-Specific Antigen|prostate-specific antigen
815948|NCT00178113|lycopene|lycopene
815949|NCT00178100|Depression|depression
815950|NCT00178100|Elderly|elderly
815951|NCT00178100|Late Life|late life
815952|NCT00178087|late-life depression|late-life depression
815953|NCT00178087|mild cognitive impairment|mild cognitive impairment
815954|NCT00178087|dementia|dementia
815955|NCT00178074|depression|depression
815956|NCT00178074|imaging|imaging
815957|NCT00178074|PET|pet
815958|NCT00178074|elderly|elderly
815959|NCT00178074|late life|late life
815960|NCT00178074|sleep deprivation|sleep deprivation
815961|NCT00178048|primary insomnia|primary insomnia
815962|NCT00178048|insomnia|insomnia
815963|NCT00178048|depression|depression
815964|NCT00178048|late life|late life
815965|NCT00178048|elderly|elderly
815966|NCT00178048|sleep disorders|sleep disorders
815967|NCT00178035|Depression|depression
815968|NCT00178035|Unipolar Depression|unipolar depression
815969|NCT00178035|Elderly depression|elderly depression
815970|NCT00178035|Late-Life|late-life
815971|NCT00178022|tbi|tbi
815972|NCT00178022|intervention|intervention
815973|NCT00178022|depression|depression
815974|NCT00178022|anxiety|anxiety
815975|NCT00178009|computer-assisted instruction|computer-assisted instruction
815976|NCT00178009|instruction (video)|instruction (video)
815977|NCT00177996|depression|depression
815978|NCT00177996|anxiety|anxiety
815979|NCT00177983|Schizophrenia|schizophrenia
815980|NCT00177983|Relapse|relapse
815981|NCT00177983|Psychological distress|psychological distress
815982|NCT00177957|Gram negative bacteremia|gram negative bacteremia
815983|NCT00177944|invasive fungal infection|invasive fungal infection
815984|NCT00177931|Liver transplant|liver transplant
815985|NCT00177931|cefepime|cefepime
815986|NCT00177931|antibiotics|antibiotics
815987|NCT00177918|Lung Transplant|lung transplant
815988|NCT00177892|Sleep fragmentation|sleep fragmentation
815989|NCT00177892|Intermittent hypoxia|intermittent hypoxia
815990|NCT00177892|Obstructive Sleep Apnea|obstructive sleep apnea
815991|NCT00177892|Metabolic Syndrome|metabolic syndrome
815992|NCT00177892|Insulin resistance|insulin resistance
815993|NCT00177879|website|website
815995|NCT00177853|Locally advanced pancreatic cancer|locally advanced pancreatic cancer
815996|NCT00177853|invasion of major arteries and veins around pancreas|invasion of major arteries and veins around pancreas
815997|NCT00177853|No prior radiation or chemo|no prior radiation or chemo
815998|NCT00177840|cancer-related fatigue|cancer-related fatigue
815999|NCT00177840|acupuncture|acupuncture
816000|NCT00177840|breast cancer|breast cancer
816001|NCT00177814|pipercillin|pipercillin
816002|NCT00177814|gram negative bacteria infections|gram negative bacteria infections
816003|NCT00177788|liver transplant|liver transplant
816004|NCT00177788|voriconazole prophylaxis|voriconazole prophylaxis
816005|NCT00177788|liver transplantation|liver transplantation
816006|NCT00177788|voriconazole|voriconazole
816007|NCT00177749|invasive fungal infections|invasive fungal infections
816008|NCT00177736|ventilator associated pneumonia|ventilator associated pneumonia
816009|NCT00177723|receiving antibiotic Linezolid clinically|receiving antibiotic linezolid clinically
816010|NCT00177671|Depression|depression
816011|NCT00177671|Dementia|dementia
816012|NCT00177671|Alzheimer's Disease|alzheimer's disease
816013|NCT00177671|Cognitive|cognitive
816014|NCT00177671|Donepezil|donepezil
816015|NCT00177671|Memory|memory
816016|NCT00177671|Function|function
816017|NCT00177671|Elderly|elderly
816018|NCT00177671|Late-Life|late-life
816019|NCT00177658|Salmonella|salmonella
816020|NCT00177645|cystic fibrosis|cystic fibrosis
816021|NCT00177645|mucus clearance|mucus clearance
816022|NCT00177619|Prostatic neoplasms|prostatic neoplasms
816023|NCT00177619|Bisphosphonates|bisphosphonates
816024|NCT00177619|Hypogonadism|hypogonadism
816025|NCT00177606|withdrawal|withdrawal
816026|NCT00177606|life-sustaining|life-sustaining
816027|NCT00177606|treatments|treatments
816028|NCT00177606|UNOS|unos
816029|NCT00177606|organ donation|organ donation
816030|NCT00177580|schizophrenia|schizophrenia
816031|NCT00177580|schizoaffective disorder|schizoaffective disorder
816032|NCT00177580|positive symptoms|positive symptoms
816033|NCT00177580|negative symptoms|negative symptoms
816034|NCT00177580|cognitive functioning|cognitive functioning
816035|NCT00177580|pravastatin|pravastatin
816036|NCT00177567|Bipolar Disorder|bipolar disorder
816037|NCT00177567|Manic Depression|manic depression
816038|NCT00177567|Elderly|elderly
816039|NCT00177567|Late-Life|late-life
816040|NCT00177554|Non-Hodgkin Lymphoma|non-hodgkin lymphoma
816041|NCT00177541|urge incontinence|urge incontinence
816042|NCT00177541|biofeedback|biofeedback
816043|NCT00177541|pelvic floor muscle training|pelvic floor muscle training
816044|NCT00177541|behavior modification|behavior modification
816045|NCT00177528|Elderly|elderly
816046|NCT00177515|emergency contraception|emergency contraception
816047|NCT00177515|folic acid|folic acid
816048|NCT00177515|education|education
816049|NCT00177515|preventive health|preventive health
816050|NCT00177489|Family Caregivers|family caregivers
816051|NCT00177489|Dementia|dementia
816052|NCT00177489|Alzheimer Disease|alzheimer disease
816053|NCT00177489|Randomized Controlled Trial|randomized controlled trial
816054|NCT00177489|Intervention Studies|intervention studies
816055|NCT00177463|L-carnosine|l-carnosine
816056|NCT00177463|Bipolar I disorder|bipolar i disorder
816057|NCT00177463|Cognitive enhancement|cognitive enhancement
816058|NCT00177424|Rehabilitation|rehabilitation
816059|NCT00177411|Endocrine System Diseases|endocrine system diseases
816060|NCT00177411|MusculoSkeletal System Diseases|musculoskeletal system diseases
816061|NCT00177411|Hormone|hormone
816062|NCT00177411|Postmenopausal Women|postmenopausal women
816063|NCT00177398|Type 2 diabetes|type 2 diabetes
816064|NCT00177398|Hyperglycemia|hyperglycemia
816065|NCT00177398|Enteral nutrition|enteral nutrition
816066|NCT00177385|Sleep|sleep
816067|NCT00177385|Sleep Hygiene|sleep hygiene
816068|NCT00177385|Modest sleep deprivation|modest sleep deprivation
816069|NCT00177385|Healthy Aging and sleep|healthy aging and sleep
816070|NCT00177385|Health Promotion|health promotion
816071|NCT00177359|gait impairment|gait impairment
816072|NCT00177333|Abortion, Induced|abortion, induced
816073|NCT00177333|Doxycycline|doxycycline
816074|NCT00177333|Antibiotic Prophylaxis|antibiotic prophylaxis
816075|NCT00177333|Vomiting|vomiting
816076|NCT00177333|Abortion, Therapeutic|abortion, therapeutic
816077|NCT00177320|Rheumatic Disorders|rheumatic disorders
816078|NCT00177320|Computer Use|computer use
816080|NCT00177307|rectum|rectum
816081|NCT00177294|Elderly|elderly
816082|NCT00177294|Remission|remission
816083|NCT00177294|Escitalopram|escitalopram
816084|NCT00177294|Interpersonal Psychotherapy|interpersonal psychotherapy
816085|NCT00177294|Psychotherapy|psychotherapy
816086|NCT00177294|Caregiving|caregiving
816087|NCT00177294|Late-Life|late-life
816088|NCT00177268|Cutaneous T-cell Lymphoma|cutaneous t-cell lymphoma
816089|NCT00177268|Sezary Syndrome|sezary syndrome
816090|NCT00177268|Mycosis Fungoides|mycosis fungoides
816091|NCT00177268|Blood/tissue banking|blood/tissue banking
816092|NCT00177268|eczema|eczema
816093|NCT00177268|atopic dermatitis|atopic dermatitis
816094|NCT00177255|gastric|gastric
816095|NCT00177255|stomach|stomach
816100|NCT00177216|Primary Insomnia|primary insomnia
816101|NCT00177216|Insomnia|insomnia
816102|NCT00177216|Placebo-Controlled|placebo-controlled
816103|NCT00177216|Double-Blind|double-blind
816104|NCT00177216|Polysomnography|polysomnography
816105|NCT00177216|PET Studies|pet studies
816106|NCT00177216|Escitalopram|escitalopram
816107|NCT00177216|Zolpidem|zolpidem
816108|NCT00177203|Insomnia|insomnia
816109|NCT00177203|Sleep Disorders|sleep disorders
816110|NCT00177203|Sleeplessness|sleeplessness
816111|NCT00177203|Chronic Insomnia|chronic insomnia
816112|NCT00177203|Sleep Studies|sleep studies
816113|NCT00177203|Disorders of Initiating and Maintaining Sleep|disorders of initiating and maintaining sleep
816114|NCT00177203|Primary Care|primary care
816115|NCT00177190|Cutaneous T-cell Lymphoma|cutaneous t-cell lymphoma
816116|NCT00177190|Sezary Syndrome|sezary syndrome
816117|NCT00177190|Mycosis Fungoides|mycosis fungoides
816118|NCT00177190|Immune Responses|immune responses
816119|NCT00177177|L-carnosine|l-carnosine
816120|NCT00177177|Schizophrenia|schizophrenia
816121|NCT00177177|Schizoaffective disorder|schizoaffective disorder
816122|NCT00177177|Cognitive enhancement|cognitive enhancement
816123|NCT00177164|Bipolar I Disorder|bipolar i disorder
816124|NCT00177164|Risperidone Consta - Long Acting Injection|risperidone consta - long acting injection
816125|NCT00177164|Oral second generation antipsychotic agents|oral second generation antipsychotic agents
816126|NCT00177138|Campath Study|campath study
816127|NCT00177138|Pancreas After Kidney Transplantation|pancreas after kidney transplantation
816128|NCT00177138|Alemtuzumab|alemtuzumab
816129|NCT00177112|Cystoscopy|cystoscopy
816130|NCT00177047|stem cell transplantation|stem cell transplantation
816131|NCT00177047|chemotherapy|chemotherapy
816132|NCT00177047|multiple myeloma|multiple myeloma
816133|NCT00177047|autologous|autologous
816134|NCT00177034|Keratinocyte|keratinocyte
816135|NCT00177008|Schizophrenia|schizophrenia
816136|NCT00177008|Schizoaffective Disorder|schizoaffective disorder
816137|NCT00177008|Social Anxiety Disorder|social anxiety disorder
816138|NCT00176982|treatment of alopecia areata|treatment of alopecia areata
816139|NCT00176956|Post Pediatric Heart Transplant|post pediatric heart transplant
816140|NCT00176930|stem cell transplant|stem cell transplant
816141|NCT00176930|chronic leukemia|chronic leukemia
816142|NCT00176930|acute leukemia|acute leukemia
816143|NCT00176930|irradiation|irradiation
816144|NCT00176930|chemotherapy|chemotherapy
816145|NCT00176917|stem cell transplant|stem cell transplant
816146|NCT00176917|storage disease|storage disease
816147|NCT00176917|errors of metabolism|errors of metabolism
816148|NCT00176904|Inborn errors|inborn errors
816149|NCT00176904|Storage disease|storage disease
816150|NCT00176904|errors of metabolism|errors of metabolism
816151|NCT00176904|stem cell transplant|stem cell transplant
816152|NCT00176891|Laronidase ERT|laronidase ert
816153|NCT00176891|Stem cell transplant|stem cell transplant
816154|NCT00176891|storage disease|storage disease
816155|NCT00176891|inborn errors of metabolism|inborn errors of metabolism
816156|NCT00176891|hurler syndrome|hurler syndrome
816157|NCT00176891|glycosaminoglycans|glycosaminoglycans
816158|NCT00176891|enzyme replacement|enzyme replacement
816159|NCT00176878|Stem cell transplant|stem cell transplant
816160|NCT00176878|T-cell depletion|t-cell depletion
816161|NCT00176878|TLI|tli
816162|NCT00176878|bone marrow failure disorders|bone marrow failure disorders
816163|NCT00176865|Stem cell transplant|stem cell transplant
816164|NCT00176865|immunodeficiency|immunodeficiency
816165|NCT00176865|donor lymphocyte infusion|donor lymphocyte infusion
816166|NCT00176852|high risk hemoglobinopathy|high risk hemoglobinopathy
816167|NCT00176852|stem cell transplant|stem cell transplant
816168|NCT00176852|donor lymphocyte infusion|donor lymphocyte infusion
816169|NCT00176852|transfusion dependent|transfusion dependent
816170|NCT00176852|stem cell donor|stem cell donor
816171|NCT00176852|cord blood|cord blood
816172|NCT00176852|marrow|marrow
816173|NCT00176852|transfusion dependent non-malignant hematologic disorders|transfusion dependent non-malignant hematologic disorders
816174|NCT00176839|Stem Cell transplant|stem cell transplant
816175|NCT00176839|retransplant|retransplant
816176|NCT00176839|hematological malignancies|hematological malignancies
816177|NCT00176826|Stem Cell Transplant|stem cell transplant
816178|NCT00176826|T-cell depletion|t-cell depletion
816179|NCT00176826|immune deficiencies|immune deficiencies
816180|NCT00176826|Busulfan pharmacokinetics|busulfan pharmacokinetics
816181|NCT00176826|Non-Malignant Hematological Disorders|non-malignant hematological disorders
816182|NCT00176722|Spine Surgery|spine surgery
816183|NCT00176722|Intraocular Pressure|intraocular pressure
816184|NCT00176722|lumbar or thoracic Spine Surgery in the prone position|lumbar or thoracic spine surgery in the prone position
816185|NCT00176722|and its association with visual change|and its association with visual change
816186|NCT00176696|general anesthesia|general anesthesia
816187|NCT00176696|pain|pain
816188|NCT00176696|depth of anesthesia|depth of anesthesia
816189|NCT00176683|intubation|intubation
816190|NCT00176683|capnography|capnography
816191|NCT00176670|presurgical anxiety, children,|presurgical anxiety, children,
816192|NCT00176657|cardiac surgery|cardiac surgery
816194|NCT00176644|prostate cancer|prostate cancer
816195|NCT00176631|adenocarcinoma of the prostate|adenocarcinoma of the prostate
816196|NCT00176631|recurrent prostate cancer|recurrent prostate cancer
816197|NCT00176631|stage IV prostate cancer|stage iv prostate cancer
816198|NCT00176618|Aberrant Crypt Foci|aberrant crypt foci
816199|NCT00176605|prostate cancer|prostate cancer
816200|NCT00176605|recurrent prostate cancer|recurrent prostate cancer
816201|NCT00176605|stage IV prostate cancer|stage iv prostate cancer
816202|NCT00176592|Multiple Sclerosis|multiple sclerosis
816203|NCT00176592|Brain|brain
816204|NCT00176592|Betaseron|betaseron
816205|NCT00176592|Copaxone|copaxone
816206|NCT00176592|MRI|mri
816207|NCT00176579|osteoporosis|osteoporosis
816208|NCT00176579|stage I prostate cancer|stage i prostate cancer
816209|NCT00176566|oral leukoplakia|oral leukoplakia
816210|NCT00176553|methotrexate neurotoxicity|methotrexate neurotoxicity
816211|NCT00176540|unspecified adult solid tumor, protocol specific|unspecified adult solid tumor, protocol specific
816212|NCT00176540|unspecified childhood solid tumor, protocol specific|unspecified childhood solid tumor, protocol specific
816213|NCT00176540|fatigue|fatigue
816214|NCT00176527|recurrent prostate cancer|recurrent prostate cancer
816215|NCT00176527|stage IV prostate cancer|stage iv prostate cancer
816216|NCT00176514|mucositis|mucositis
816217|NCT00176501|recurrent renal cell cancer|recurrent renal cell cancer
816218|NCT00176501|clear cell renal cell carcinoma|clear cell renal cell carcinoma
816219|NCT00176501|stage IV renal cell cancer|stage iv renal cell cancer
816220|NCT00176488|recurrent breast cancer|recurrent breast cancer
816221|NCT00176488|stage II breast cancer|stage ii breast cancer
816222|NCT00176488|stage IIIA breast cancer|stage iiia breast cancer
816223|NCT00176488|stage IIIB breast cancer|stage iiib breast cancer
816224|NCT00176488|stage IV breast cancer|stage iv breast cancer
816225|NCT00176488|male breast cancer|male breast cancer
816226|NCT00176475|extranodal marginal zone B-cell lymphoma of mucosa-associated lymphoid tissue|extranodal marginal zone b-cell lymphoma of mucosa-associated lymphoid tissue
816227|NCT00176475|nodal marginal zone B-cell lymphoma|nodal marginal zone b-cell lymphoma
816228|NCT00176475|recurrent adult Burkitt lymphoma|recurrent adult burkitt lymphoma
816229|NCT00176475|recurrent adult diffuse large cell lymphoma|recurrent adult diffuse large cell lymphoma
816230|NCT00176475|recurrent adult Hodgkin lymphoma|recurrent adult hodgkin lymphoma
816231|NCT00176475|recurrent adult lymphoblastic lymphoma|recurrent adult lymphoblastic lymphoma
816232|NCT00176475|recurrent adult acute lymphoblastic leukemia|recurrent adult acute lymphoblastic leukemia
816233|NCT00176475|refractory chronic lymphocytic leukemia|refractory chronic lymphocytic leukemia
816234|NCT00176475|recurrent small lymphocytic lymphoma|recurrent small lymphocytic lymphoma
816235|NCT00176475|refractory hairy cell leukemia|refractory hairy cell leukemia
816236|NCT00176475|prolymphocytic leukemia|prolymphocytic leukemia
816237|NCT00176475|recurrent marginal zone lymphoma|recurrent marginal zone lymphoma
816238|NCT00176475|recurrent grade 1 follicular lymphoma|recurrent grade 1 follicular lymphoma
816239|NCT00176475|recurrent grade 2 follicular lymphoma|recurrent grade 2 follicular lymphoma
816240|NCT00176475|recurrent grade 3 follicular lymphoma|recurrent grade 3 follicular lymphoma
816241|NCT00176475|refractory multiple myeloma|refractory multiple myeloma
816242|NCT00176475|recurrent mantle cell lymphoma|recurrent mantle cell lymphoma
816243|NCT00176475|recurrent adult grade III lymphomatoid granulomatosis|recurrent adult grade iii lymphomatoid granulomatosis
816244|NCT00176475|Waldenstrom macroglobulinemia|waldenstrom macroglobulinemia
816245|NCT00176475|splenic marginal zone lymphoma|splenic marginal zone lymphoma
816246|NCT00176475|stage II multiple myeloma|stage ii multiple myeloma
816247|NCT00176475|stage III multiple myeloma|stage iii multiple myeloma
816248|NCT00176475|stage IV adult Burkitt lymphoma|stage iv adult burkitt lymphoma
816249|NCT00176475|stage IV adult diffuse large cell lymphoma|stage iv adult diffuse large cell lymphoma
816250|NCT00176475|stage IV adult Hodgkin lymphoma|stage iv adult hodgkin lymphoma
816345|NCT00176163|Fibromyalgia|fibromyalgia
816251|NCT00176475|stage IV adult lymphoblastic lymphoma|stage iv adult lymphoblastic lymphoma
816252|NCT00176475|stage III adult Burkitt lymphoma|stage iii adult burkitt lymphoma
816253|NCT00176475|stage III adult diffuse large cell lymphoma|stage iii adult diffuse large cell lymphoma
816254|NCT00176475|stage III adult Hodgkin lymphoma|stage iii adult hodgkin lymphoma
816255|NCT00176475|stage III adult lymphoblastic lymphoma|stage iii adult lymphoblastic lymphoma
816256|NCT00176475|stage III grade 1 follicular lymphoma|stage iii grade 1 follicular lymphoma
816257|NCT00176475|stage III grade 2 follicular lymphoma|stage iii grade 2 follicular lymphoma
816258|NCT00176475|stage III grade 3 follicular lymphoma|stage iii grade 3 follicular lymphoma
816259|NCT00176475|stage IV grade 1 follicular lymphoma|stage iv grade 1 follicular lymphoma
816260|NCT00176475|stage IV grade 2 follicular lymphoma|stage iv grade 2 follicular lymphoma
816261|NCT00176475|stage IV grade 3 follicular lymphoma|stage iv grade 3 follicular lymphoma
816262|NCT00176475|stage III mantle cell lymphoma|stage iii mantle cell lymphoma
816263|NCT00176475|stage IV mantle cell lymphoma|stage iv mantle cell lymphoma
816264|NCT00176475|stage III marginal zone lymphoma|stage iii marginal zone lymphoma
816265|NCT00176475|stage IV marginal zone lymphoma|stage iv marginal zone lymphoma
816266|NCT00176475|stage III small lymphocytic lymphoma|stage iii small lymphocytic lymphoma
816267|NCT00176475|stage IV small lymphocytic lymphoma|stage iv small lymphocytic lymphoma
816370|NCT00176059|acute rejection|acute rejection
816268|NCT00176475|stage III chronic lymphocytic leukemia|stage iii chronic lymphocytic leukemia
816269|NCT00176475|stage IV chronic lymphocytic leukemia|stage iv chronic lymphocytic leukemia
816270|NCT00176475|progressive hairy cell leukemia, initial treatment|progressive hairy cell leukemia, initial treatment
816271|NCT00176462|Acute Lymphocytic Leukemia|acute lymphocytic leukemia
816272|NCT00176462|Leukemia|leukemia
816273|NCT00176449|Nicotine Dependence|nicotine dependence
816274|NCT00176449|Nicotine Use Disorder|nicotine use disorder
816275|NCT00176449|Tobacco Dependence|tobacco dependence
816276|NCT00176449|Tobacco-Use Disorder|tobacco-use disorder
816277|NCT00176449|Smoking Cessation|smoking cessation
816278|NCT00176436|Weight loss|weight loss
816279|NCT00176436|Support group|support group
816280|NCT00176436|Exercise|exercise
816281|NCT00176436|Atomoxetine|atomoxetine
816282|NCT00176423|schizophrenia|schizophrenia
816283|NCT00176423|acetylcholine|acetylcholine
816284|NCT00176423|cognitive impairments|cognitive impairments
816285|NCT00176423|attention|attention
816286|NCT00176423|processing speed|processing speed
816287|NCT00176423|sensory gating|sensory gating
816288|NCT00176423|eye-tracking|eye-tracking
816289|NCT00176410|aortic valve stenosis|aortic valve stenosis
816290|NCT00176410|statin therapy|statin therapy
816291|NCT00176397|left main coronary artery|left main coronary artery
816292|NCT00176397|coronary artery disease|coronary artery disease
816293|NCT00176384|chronic heart failure|chronic heart failure
816294|NCT00176384|exercise training|exercise training
816295|NCT00176371|Physical fitness|physical fitness
816296|NCT00176345|exercise training|exercise training
816297|NCT00176345|endothelial function|endothelial function
816298|NCT00176332|chronic heart failure|chronic heart failure
816299|NCT00176332|rosuvastatin|rosuvastatin
816300|NCT00176332|endothelial function|endothelial function
816301|NCT00176332|skeletal muscle|skeletal muscle
816302|NCT00176319|heart failure|heart failure
816303|NCT00176319|ageing|ageing
816304|NCT00176293|prostate|prostate
816305|NCT00176293|prostate cancer|prostate cancer
816306|NCT00176293|doxil|doxil
816307|NCT00176293|dexamethasone|dexamethasone
816308|NCT00176293|metastatic|metastatic
816309|NCT00176293|hormone refractory|hormone refractory
816310|NCT00176280|Renal|renal
816311|NCT00176280|Carcinoma|carcinoma
816312|NCT00176280|Renal Cell Carcinoma|renal cell carcinoma
816313|NCT00176280|RCC|rcc
816314|NCT00176280|Leukine|leukine
816315|NCT00176280|Dexamethasone|dexamethasone
816316|NCT00176280|Gemcitabine|gemcitabine
816317|NCT00176280|5 Fluorouracil|5 fluorouracil
816318|NCT00176280|5 FU|5 fu
816319|NCT00176280|Metastatic|metastatic
816320|NCT00176267|head and neck|head and neck
816321|NCT00176267|squamous cell carcinoma|squamous cell carcinoma
816322|NCT00176267|squamous cell|squamous cell
816323|NCT00176267|carcinoma|carcinoma
816324|NCT00176267|paclitaxel|paclitaxel
816325|NCT00176267|carboplatin|carboplatin
816326|NCT00176267|radiotherapy|radiotherapy
816327|NCT00176267|induction therapy|induction therapy
816328|NCT00176254|head and neck|head and neck
816329|NCT00176254|squamous cell carcinoma|squamous cell carcinoma
816330|NCT00176254|squamous cell|squamous cell
816331|NCT00176254|carcinoma|carcinoma
816332|NCT00176254|paclitaxel|paclitaxel
816333|NCT00176254|carboplatin|carboplatin
816334|NCT00176254|radiotherapy|radiotherapy
816335|NCT00176254|induction therapy|induction therapy
816336|NCT00176241|head and neck|head and neck
816337|NCT00176241|Gemcitabine|gemcitabine
816338|NCT00176241|Paclitaxel|paclitaxel
816339|NCT00176241|radiation|radiation
816340|NCT00176241|low-dose radiation|low-dose radiation
816341|NCT00176241|recurrent|recurrent
816342|NCT00176241|metastatic|metastatic
816343|NCT00176189|FPD, all-ceramic|fpd, all-ceramic
816344|NCT00176176|cerebral circulation|cerebral circulation
816346|NCT00176163|Back pain|back pain
816347|NCT00176163|Behavior Therapy|behavior therapy
816348|NCT00176163|Operant learning|operant learning
816349|NCT00176163|Tetrahydrocannabinol|tetrahydrocannabinol
816350|NCT00176150|anorexia nervosa|anorexia nervosa
816351|NCT00176150|multidrug resistance|multidrug resistance
816352|NCT00176150|cholesterol metabolism|cholesterol metabolism
816353|NCT00176137|multimodality treatment|multimodality treatment
816354|NCT00176124|leukocyte depletion, autologous transfusion,|leukocyte depletion, autologous transfusion,
816355|NCT00176124|infection|infection
816356|NCT00176124|bacterial infection|bacterial infection
816357|NCT00176124|sepsis, antibiotics|sepsis, antibiotics
816358|NCT00176111|peripheral nerve stimulation|peripheral nerve stimulation
816359|NCT00176111|saline|saline
816360|NCT00176111|local anesthestics|local anesthestics
816361|NCT00176111|regional anesthestia|regional anesthestia
816362|NCT00176111|nerve damage|nerve damage
816363|NCT00176098|Cataract surgery|cataract surgery
816364|NCT00176098|Hypnosis|hypnosis
816365|NCT00176098|C11.510.245|c11.510.245
816366|NCT00176098|F04.754.424.771|f04.754.424.771
816367|NCT00176098|Suggestion|suggestion
816368|NCT00176059|immunoglobulins, intravenous|immunoglobulins, intravenous
816369|NCT00176059|kidney transplantation|kidney transplantation
816371|NCT00176059|chronic rejection|chronic rejection
816372|NCT00176059|regulatory autoantibodies|regulatory autoantibodies
816373|NCT00176059|Th1|th1
816374|NCT00176059|Th2|th2
816375|NCT00176059|B Cell|b cell
816376|NCT00176059|Monokines|monokines
816377|NCT00176059|Cytokine promoter gene polymorphisms|cytokine promoter gene polymorphisms
816378|NCT00176046|breast cancer|breast cancer
816379|NCT00176046|mistletoe|mistletoe
816380|NCT00176046|complementary therapy|complementary therapy
816381|NCT00176046|quality of life|quality of life
816382|NCT00176046|immune function|immune function
816383|NCT00176046|breast cancer (UICC stage I/II)|breast cancer (uicc stage i/ii)
816384|NCT00176033|ritonavir|ritonavir
816385|NCT00176033|lopinavir|lopinavir
816386|NCT00176033|HIV Infections|hiv infections
816387|NCT00176020|nicotinic acid|nicotinic acid
816388|NCT00176020|flush symptom|flush symptom
816389|NCT00176020|pharmacodynamic|pharmacodynamic
816390|NCT00176020|pharmacokinetic|pharmacokinetic
816391|NCT00175994|voriconazole|voriconazole
816392|NCT00175994|genotype|genotype
816393|NCT00175994|bioavailability|bioavailability
816394|NCT00175994|metabolic clearance|metabolic clearance
816395|NCT00175955|Neuroleptic-induced tardive dyskinesia|neuroleptic-induced tardive dyskinesia
816396|NCT00175955|Keppra, Levetiracetam|keppra, levetiracetam
816397|NCT00175942|acute myocardial infarction|acute myocardial infarction
816398|NCT00175942|ventricular fibrillation|ventricular fibrillation
816399|NCT00175942|coagulation|coagulation
816400|NCT00175942|inflammation|inflammation
816401|NCT00175929|Epilepsy|epilepsy
816402|NCT00175929|Focal Epilepsy|focal epilepsy
816403|NCT00175929|Partial Onset Seizures|partial onset seizures
816404|NCT00175929|Brivaracetam|brivaracetam
816405|NCT00175916|Brivaracetam|brivaracetam
816406|NCT00175916|Epilepsy|epilepsy
816407|NCT00175916|long term|long term
816408|NCT00175903|Newly Diagnosed Epilepsy|newly diagnosed epilepsy
816409|NCT00175903|Levetiracetam|levetiracetam
816410|NCT00175903|Keppra|keppra
816411|NCT00175903|Carbamazepine|carbamazepine
816412|NCT00175903|Valproate|valproate
816413|NCT00175890|Partial Onset Seizure|partial onset seizure
816414|NCT00175890|levetiracetam|levetiracetam
816415|NCT00175890|Video Electroencephalogram|video electroencephalogram
816416|NCT00175890|Keppra|keppra
816417|NCT00175877|Rheumatoid Arthritis|rheumatoid arthritis
816418|NCT00175877|CDP870|cdp870
816419|NCT00175877|Certolizumab Pegol|certolizumab pegol
816420|NCT00175877|Cimzia|cimzia
816421|NCT00175864|Partial Onset, Primary Generalized Seizures, Seletracetam|partial onset, primary generalized seizures, seletracetam
816422|NCT00175851|Partial onset, primary generalized seizures, seletracetam|partial onset, primary generalized seizures, seletracetam
816423|NCT00175838|Primary Thrombocythmeia|primary thrombocythmeia
816424|NCT00175838|Hydroxyurea|hydroxyurea
816425|NCT00175838|Randomised|randomised
816426|NCT00175838|Thrombosis|thrombosis
816427|NCT00175838|Haemorrhage|haemorrhage
816428|NCT00175825|Epilepsy: partial onset seizures|epilepsy: partial onset seizures
816429|NCT00175825|brivaracetam|brivaracetam
816430|NCT00175812|Acute myelogenous leukemia|acute myelogenous leukemia
816431|NCT00175812|Differentiation|differentiation
816432|NCT00175812|All trans retinoic acid|all trans retinoic acid
816433|NCT00175812|Valproic acid|valproic acid
816434|NCT00175812|Theophyllamin|theophyllamin
816435|NCT00175799|Observational study of physiological status at entry into PICU as a predictor of outcome, comparison of two commonly used scores (PRISM and PIM)|observational study of physiological status at entry into picu as a predictor of outcome, comparison of two commonly used scores (prism and pim)
816436|NCT00175799|Data from children admitted to a Paediatric Intensive Care unit|data from children admitted to a paediatric intensive care unit
816437|NCT00175786|Glaucoma|glaucoma
816438|NCT00175786|Normal Tensions Glaucoma|normal tensions glaucoma
816439|NCT00175786|Neuroradiology|neuroradiology
816440|NCT00175786|Tumor|tumor
816441|NCT00175786|MRI|mri
816442|NCT00175786|Magnetic Resonance Imaging|magnetic resonance imaging
816443|NCT00175786|Compressive Lesion|compressive lesion
816444|NCT00175773|Orthostatic stress|orthostatic stress
816445|NCT00175760|TTG|ttg
816446|NCT00175760|pediatric|pediatric
816447|NCT00175760|comparison study|comparison study
816448|NCT00175747|dysplasia|dysplasia
816449|NCT00175747|lung cancer|lung cancer
816450|NCT00175747|chemoprevention|chemoprevention
816451|NCT00175734|Vascular Reactivity|vascular reactivity
816452|NCT00175734|Anemia Correction Therapy|anemia correction therapy
816453|NCT00175734|Hemodialysis patients|hemodialysis patients
816454|NCT00175734|Diabetic and non-diabetic patients|diabetic and non-diabetic patients
816455|NCT00175734|Diabetes in Hemodialysis patients|diabetes in hemodialysis patients
816456|NCT00175721|Combined Clinic|combined clinic
816457|NCT00175721|Chronic Kidney Disease|chronic kidney disease
816458|NCT00175721|Diabetes|diabetes
816459|NCT00175708|Evaluation of an outcome tool|evaluation of an outcome tool
816460|NCT00175708|clubfoot|clubfoot
816461|NCT00175708|foot pressure profiles|foot pressure profiles
816462|NCT00175708|pedobarographs|pedobarographs
816463|NCT00175682|Autonomic Dysreflexia|autonomic dysreflexia
816464|NCT00175682|SCI|sci
816465|NCT00175682|Vibrostimulation|vibrostimulation
816467|NCT00175669|Randomized control trial; placebo-control study|randomized control trial; placebo-control study
816468|NCT00175656|Femur fracture|femur fracture
816469|NCT00175656|titanium elastic nails|titanium elastic nails
816470|NCT00175643|actinic keratoses|actinic keratoses
816471|NCT00175643|imiquimod|imiquimod
816472|NCT00175643|pre-malignant|pre-malignant
816473|NCT00175643|squamous cell carcinoma|squamous cell carcinoma
816474|NCT00175643|immunosuppression|immunosuppression
816475|NCT00175630|ACL reconstruction|acl reconstruction
816476|NCT00175630|morphine sparing|morphine sparing
816477|NCT00175630|preemptive analgesia|preemptive analgesia
816478|NCT00175630|Post-operative pain and post- operative opioid use|post-operative pain and post- operative opioid use
816479|NCT00175604|Botox|botox
816480|NCT00175604|torticollis|torticollis
816481|NCT00175604|Congenital Muscular Torticollis (CMT)|congenital muscular torticollis (cmt)
816482|NCT00175591|Femur fracture|femur fracture
816483|NCT00175591|morphine sparing|morphine sparing
816484|NCT00175591|preemptive analgesia|preemptive analgesia
816485|NCT00175591|Post-operative pain and post- operative opioid use|post-operative pain and post- operative opioid use
816486|NCT00175578|Early stage (0/I) non-small cell lung cancer|early stage (0/i) non-small cell lung cancer
816487|NCT00175565|inflammation|inflammation
816488|NCT00175565|trial|trial
816489|NCT00175565|fluticasone|fluticasone
816490|NCT00175552|Depression|depression
816491|NCT00175552|Adolescents|adolescents
816492|NCT00175552|IPT|ipt
816493|NCT00175552|Knowledge translation|knowledge translation
816494|NCT00175552|Psychotherapy|psychotherapy
816495|NCT00175539|sexual dysfunction|sexual dysfunction
816496|NCT00175539|group treatment|group treatment
816497|NCT00175513|Psychosis|psychosis
816498|NCT00175513|early psychosis|early psychosis
816499|NCT00175513|first episode psychosis|first episode psychosis
816500|NCT00175513|schizophrenia|schizophrenia
816501|NCT00175513|schizoaffective|schizoaffective
816502|NCT00175513|schizophreniform|schizophreniform
816503|NCT00175513|bipolar disorder|bipolar disorder
816504|NCT00175513|valtrex|valtrex
816505|NCT00175513|valacyclovir.|valacyclovir.
816506|NCT00175500|Post-Arthroplasty Hip Dislocation|post-arthroplasty hip dislocation
816507|NCT00175487|Osteoarthritis/Avascular Necrosis|osteoarthritis/avascular necrosis
816508|NCT00175487|Hip|hip
816509|NCT00175435|Topical Immune Modulator|topical immune modulator
816510|NCT00175435|resiquimod gel|resiquimod gel
816511|NCT00175435|Hepatitis B booster response|hepatitis b booster response
816512|NCT00175435|Vaccine Evaluation|vaccine evaluation
816513|NCT00175435|Prevention of Hepatitis B disease|prevention of hepatitis b disease
816514|NCT00175422|Prevention|prevention
816515|NCT00175422|Randomized controlled trial|randomized controlled trial
816516|NCT00175422|Community education|community education
816517|NCT00175422|Shaken Baby Syndrome|shaken baby syndrome
816518|NCT00175422|Crying|crying
816519|NCT00175422|Colic|colic
816520|NCT00175409|Pain Response|pain response
816521|NCT00175396|ASCENDE-RT|ascende-rt
816522|NCT00175383|Prostate cancer, LHRH, hormone therapy, testosterone level|prostate cancer, lhrh, hormone therapy, testosterone level
816523|NCT00175370|Vancomycin|vancomycin
816524|NCT00175370|Coagulase Negative Staphylococcus|coagulase negative staphylococcus
816525|NCT00175370|Central Venous Catheter|central venous catheter
816526|NCT00175370|Bloodstream infection|bloodstream infection
816527|NCT00175370|CNS bloodstream infection|cns bloodstream infection
816528|NCT00175357|Opiate addiction|opiate addiction
816529|NCT00175357|medical heroin|medical heroin
816530|NCT00175357|methadoneRCT|methadonerct
816531|NCT00175344|Breast cancer|breast cancer
816532|NCT00175344|scar massage|scar massage
816533|NCT00175344|breast conserving surgery|breast conserving surgery
816534|NCT00175344|scar pain|scar pain
816535|NCT00175344|quality of life|quality of life
816536|NCT00175344|Breast cancer treated with breast conserving surgery with or without axillary dissection or sentinel node sampling.|breast cancer treated with breast conserving surgery with or without axillary dissection or sentinel node sampling.
816537|NCT00175318|Motivational interviewing|motivational interviewing
816538|NCT00175318|behavioural modification|behavioural modification
816539|NCT00175318|maternal counseling|maternal counseling
816540|NCT00175305|Prader-Willi Syndrome|prader-willi syndrome
816541|NCT00175305|Somatostatin|somatostatin
816542|NCT00175305|Ghrelin|ghrelin
816543|NCT00175305|Obesity|obesity
816544|NCT00175305|Hyperphagia|hyperphagia
816545|NCT00175305|Hyperphagia in Prader-Willi syndrome|hyperphagia in prader-willi syndrome
816546|NCT00175279|coronary disease|coronary disease
816547|NCT00175279|heart failure|heart failure
816548|NCT00175279|quality improvement|quality improvement
816549|NCT00175279|knowledge translation|knowledge translation
816550|NCT00175279|opinion leaders|opinion leaders
816551|NCT00175266|islet|islet
816552|NCT00175266|transplantation|transplantation
816553|NCT00175253|islet|islet
816554|NCT00175253|transplantation|transplantation
816555|NCT00175240|Coronary disease|coronary disease
816556|NCT00175240|quality improvement|quality improvement
816557|NCT00175240|knowledge translation|knowledge translation
816558|NCT00175227|contrast-induced nephropathy|contrast-induced nephropathy
816559|NCT00175227|prevention|prevention
816560|NCT00175227|renal failure|renal failure
816561|NCT00175227|cardiac angiogram|cardiac angiogram
816562|NCT00175214|osteoporosis|osteoporosis
816563|NCT00175214|wrist fractures|wrist fractures
816564|NCT00175214|quality improvement|quality improvement
816565|NCT00175214|knowledge translation|knowledge translation
816566|NCT00175188|RSA|rsa
816567|NCT00175188|DEXA|dexa
816568|NCT00175188|Osteoarthritis|osteoarthritis
816569|NCT00175188|Finger implant|finger implant
816570|NCT00175188|Micromotion|micromotion
816571|NCT00175188|Bone density|bone density
816572|NCT00175188|Cement|cement
816573|NCT00175175|osteoporosis treatment|osteoporosis treatment
816574|NCT00175175|osteoporosis testing|osteoporosis testing
816575|NCT00175175|hip fracture|hip fracture
816576|NCT00175175|quality improvement|quality improvement
816577|NCT00175162|RSA|rsa
816578|NCT00175162|DEXA|dexa
816579|NCT00175162|Genoarthrosis|genoarthrosis
816580|NCT00175162|Knee Arthroplasty|knee arthroplasty
816581|NCT00175162|Micromotion of polyethylene liner|micromotion of polyethylene liner
816582|NCT00175162|Cement|cement
816583|NCT00175149|CKD 3-4|ckd 3-4
816584|NCT00175136|RSA|rsa
816585|NCT00175136|DEXA|dexa
816586|NCT00175136|Gonarthrosis|gonarthrosis
816587|NCT00175136|Knee Arthroplasty|knee arthroplasty
816588|NCT00175136|Micromotion of polyethylen liner|micromotion of polyethylen liner
816589|NCT00175136|Stem arthroplasty design|stem arthroplasty design
816590|NCT00175123|Myelomeningocele|myelomeningocele
816591|NCT00175123|Neurogenic Bladder|neurogenic bladder
816592|NCT00175123|Intervention|intervention
816593|NCT00175123|Botulinum A toxin|botulinum a toxin
816594|NCT00175123|Oxybutynin|oxybutynin
816595|NCT00175110|pre-hypertension|pre-hypertension
816596|NCT00175110|mild hypertension|mild hypertension
816597|NCT00175097|soy protein|soy protein
816598|NCT00175097|lipids|lipids
816599|NCT00175097|lipoproteins|lipoproteins
816600|NCT00175097|apolipoproteins|apolipoproteins
816601|NCT00175097|cholesterol|cholesterol
816602|NCT00175097|endothelial function|endothelial function
816603|NCT00175058|Heart Attack|heart attack
816604|NCT00175045|Intravenous|intravenous
816605|NCT00175045|gastric acid secretion|gastric acid secretion
816606|NCT00175045|Lansoprazole|lansoprazole
816607|NCT00175045|Esophagitis|esophagitis
816608|NCT00175045|reflux|reflux
816609|NCT00175032|Low dose aspirin|low dose aspirin
816610|NCT00175032|Peptic Ulcer|peptic ulcer
816611|NCT00175032|gastric ulcer|gastric ulcer
816612|NCT00175032|duodenal ulcer|duodenal ulcer
816613|NCT00175032|NSAIDs|nsaids
816614|NCT00175019|uric acid|uric acid
816615|NCT00175019|xanthine oxidase|xanthine oxidase
816616|NCT00175019|hyperuricemia|hyperuricemia
816617|NCT00175019|tophi|tophi
816618|NCT00175019|Drug Therapy|drug therapy
816619|NCT00175006|Hyperuricemia|hyperuricemia
816620|NCT00175006|Tophi|tophi
816621|NCT00175006|Tophus|tophus
816622|NCT00175006|Drug Therapy|drug therapy
816623|NCT00174993|Glucose Metabolism Disorder|glucose metabolism disorder
816624|NCT00174993|Dysmetabolic Syndrome|dysmetabolic syndrome
816625|NCT00174993|Type II Diabetes; Diabetes Mellitus|type ii diabetes; diabetes mellitus
816626|NCT00174993|Lipoatrophic|lipoatrophic
816627|NCT00174993|Dyslipidemia|dyslipidemia
816628|NCT00174993|Drug Therapy|drug therapy
816629|NCT00174980|Oxycyte|oxycyte
816630|NCT00174980|perfluorocarbon oxygen carrier|perfluorocarbon oxygen carrier
816631|NCT00174980|brain oxygen tension|brain oxygen tension
816632|NCT00174967|Uric Acid|uric acid
816633|NCT00174967|xanthine oxidase|xanthine oxidase
816634|NCT00174967|tophi|tophi
816635|NCT00174967|Drug Therapy|drug therapy
816636|NCT00174954|Gout|gout
816637|NCT00174954|Tophus|tophus
816638|NCT00174954|MRI|mri
816639|NCT00174941|Uric acid|uric acid
816640|NCT00174941|xanthine oxidase|xanthine oxidase
816641|NCT00174941|tophi|tophi
816642|NCT00174941|Drug Therapy|drug therapy
816643|NCT00174928|Pediatric GERD|pediatric gerd
816644|NCT00174928|Pediatric Gastroesophageal Reflux Disease|pediatric gastroesophageal reflux disease
816645|NCT00174928|Neonates|neonates
816646|NCT00174928|lansoprazole|lansoprazole
816647|NCT00174915|Uric Acid, gout, xanthine oxidase, febuxostat, tophi|uric acid, gout, xanthine oxidase, febuxostat, tophi
816648|NCT00174902|Randomized controlled trial|randomized controlled trial
816649|NCT00174902|Blood platelets|blood platelets
816650|NCT00174902|Hemostasis|hemostasis
816651|NCT00174902|Stress, psychological|stress, psychological
816652|NCT00174902|Adrenergic beta-antagonists|adrenergic beta-antagonists
816653|NCT00174902|Aspirin|aspirin
816654|NCT00174902|Endothelium|endothelium
816655|NCT00174902|Arteriosclerosis|arteriosclerosis
816656|NCT00174889|Schizophrenia|schizophrenia
816657|NCT00174889|Pregnenolone|pregnenolone
816658|NCT00174889|Neurosteroids|neurosteroids
816659|NCT00174876|depression|depression
816660|NCT00174850|anxiety|anxiety
816661|NCT00174850|sexual dysfunction|sexual dysfunction
816662|NCT00174850|ssri|ssri
816663|NCT00174837|Tirapazamine|tirapazamine
816664|NCT00174837|Head and Neck Cancer|head and neck cancer
816668|NCT00174824|Diabetic Retinopathy|diabetic retinopathy
816669|NCT00174811|acute otitis media|acute otitis media
816670|NCT00174811|controlled clinical trial|controlled clinical trial
816671|NCT00174811|telithromycin|telithromycin
816672|NCT00174811|cefuroxime axetil|cefuroxime axetil
816673|NCT00174811|middle ear infections|middle ear infections
816674|NCT00174811|tympanocentecis|tympanocentecis
816675|NCT00174798|Cystometry NK1 Antagonist SSR240600C|cystometry nk1 antagonist ssr240600c
816676|NCT00174785|Mortality, Hospitalization|mortality, hospitalization
816677|NCT00174746|Glucocorticosteroid; Dose response; Bronchospasm|glucocorticosteroid; dose response; bronchospasm
816678|NCT00174733|Glucocorticosteroid. Bronchospasm|glucocorticosteroid. bronchospasm
816679|NCT00174720|Glucocorticosteroid. Bronchospasm|glucocorticosteroid. bronchospasm
816680|NCT00174603|depression|depression
816681|NCT00174603|psychosis|psychosis
816682|NCT00174590|depression|depression
816683|NCT00174538|codeine|codeine
816684|NCT00174538|pain|pain
816685|NCT00174538|CYP2D6|cyp2d6
816686|NCT00174538|genotype|genotype
816687|NCT00174538|morphine|morphine
816688|NCT00174538|sickle cell|sickle cell
816689|NCT00174538|pharmacokinetic|pharmacokinetic
816690|NCT00174525|Alzheimer's Caregivers|alzheimer's caregivers
816691|NCT00174525|Alzheimer disease|alzheimer disease
816692|NCT00174499|Tooth stain|tooth stain
816693|NCT00174213|iliotibial tract|iliotibial tract
816694|NCT00174161|Premenstrual Syndrome,Health Related Quality of Life|premenstrual syndrome,health related quality of life
816695|NCT00174135|Sarcopenia|sarcopenia
816696|NCT00174135|exercise|exercise
816697|NCT00174122|Emergency department|emergency department
816698|NCT00174122|Blood culture|blood culture
816699|NCT00174122|Antimicrobial therapy|antimicrobial therapy
816700|NCT00174109|arecoline, oral cancer, MAP2, cell migration|arecoline, oral cancer, map2, cell migration
816701|NCT00174096|laryngeal cancer|laryngeal cancer
816702|NCT00174096|hypopharyngeal cancer|hypopharyngeal cancer
816703|NCT00174096|CXCR4|cxcr4
816704|NCT00174096|stromal-cell-derived factor-1(SDF-1)|stromal-cell-derived factor-1(sdf-1)
816705|NCT00174096|metastasis|metastasis
816706|NCT00174083|Tuberculosis, TB-ELISPOT, active tuberculosis latent infection interferon|tuberculosis, tb-elispot, active tuberculosis latent infection interferon
816707|NCT00174070|Respiratory failure|respiratory failure
816708|NCT00174070|Community|community
816709|NCT00174057|Graves' ophthalmopathy|graves' ophthalmopathy
816710|NCT00174057|real time PCR|real time pcr
816711|NCT00174057|cytokines|cytokines
816712|NCT00174057|Tsh receptor|tsh receptor
816713|NCT00174031|baseball|baseball
816714|NCT00174031|injury|injury
816715|NCT00174018|subacrominal space|subacrominal space
816716|NCT00174005|muscle|muscle
816717|NCT00174005|tendon|tendon
816718|NCT00173992|Stroke|stroke
816719|NCT00173992|Balance|balance
816720|NCT00173992|Proactive control|proactive control
816721|NCT00173992|Reactive control|reactive control
816722|NCT00173992|Recovery|recovery
816723|NCT00173992|Training|training
816724|NCT00173992|Fall|fall
816725|NCT00173979|muscle|muscle
816726|NCT00173979|tendon|tendon
816727|NCT00173953|H. pylori、immune response、lymphocytic subsets、cytokine|h. pylori、immune response、lymphocytic subsets、cytokine
816728|NCT00173940|chronic diseases, such as hypertension, diabetes, obesity, chronic renal failure, and so on|chronic diseases, such as hypertension, diabetes, obesity, chronic renal failure, and so on
816729|NCT00173927|extracranial atherosclerosis|extracranial atherosclerosis
816730|NCT00173927|imaging|imaging
816731|NCT00173927|biomarkers|biomarkers
816732|NCT00173914|1. Transplant vasculopathy|1. transplant vasculopathy
816733|NCT00173914|2. Endothelial dysfunction|2. endothelial dysfunction
816829|NCT00173368|complication|complication
816734|NCT00173914|3. Myocardial perfusion imaging|3. myocardial perfusion imaging
816735|NCT00173914|4. Intravascular vascular ultrasound|4. intravascular vascular ultrasound
816736|NCT00173901|ceftazidime|ceftazidime
816737|NCT00173901|safety|safety
816738|NCT00173901|infection|infection
816739|NCT00173888|Combination, Chemotherapy,non-small cell lung cancer|combination, chemotherapy,non-small cell lung cancer
816740|NCT00173875|EGFR Non-small cell lung cancer|egfr non-small cell lung cancer
816741|NCT00173862|Combination, Chemotherapy,transitional cell carcinoma|combination, chemotherapy,transitional cell carcinoma
816742|NCT00173849|oral cancer|oral cancer
816743|NCT00173849|CXCR4|cxcr4
816744|NCT00173849|stromal-cell-derived factor-1(SDF-1)|stromal-cell-derived factor-1(sdf-1)
816745|NCT00173849|metastasis|metastasis
816746|NCT00173836|Nasopharyngeal carcinoma|nasopharyngeal carcinoma
816747|NCT00173836|Saliva|saliva
816748|NCT00173836|Swallowing|swallowing
816749|NCT00173836|Videofluoroscopy|videofluoroscopy
816750|NCT00173836|Radiation|radiation
816751|NCT00173810|stroke|stroke
816752|NCT00173810|movement|movement
816753|NCT00173810|psychomterics|psychomterics
816754|NCT00173797|depression|depression
816755|NCT00173797|psychometrics|psychometrics
816756|NCT00173784|psychometrics|psychometrics
816757|NCT00173784|activities of daily living|activities of daily living
816758|NCT00173771|stroke|stroke
816759|NCT00173771|activities of daily living|activities of daily living
816760|NCT00173771|psychometrics|psychometrics
816762|NCT00173758|IL-15 receptor|il-15 receptor
816763|NCT00173758|decidual natural killer cells|decidual natural killer cells
816764|NCT00173758|endometrium|endometrium
816765|NCT00173745|cerebral palsy|cerebral palsy
816766|NCT00173745|drooling|drooling
816767|NCT00173745|botulinum toxin|botulinum toxin
816768|NCT00173732|Preimplantation genetic diagnosis (PGD)|preimplantation genetic diagnosis (pgd)
816769|NCT00173732|single cell|single cell
816770|NCT00173732|Multiple displacement amplification (MDA)|multiple displacement amplification (mda)
816771|NCT00173719|Hemiplegia|hemiplegia
816772|NCT00173719|Assisstive device|assisstive device
816773|NCT00173719|Walking|walking
816774|NCT00173719|Dynamic equilibrium|dynamic equilibrium
816775|NCT00173719|Reaction time|reaction time
816776|NCT00173719|Attention|attention
816777|NCT00173719|Dual task|dual task
816778|NCT00173706|L-Carnitine|l-carnitine
816779|NCT00173706|hemodialysis|hemodialysis
816780|NCT00173706|cardiac complications|cardiac complications
816781|NCT00173706|impaired exercise and functional capacities|impaired exercise and functional capacities
816782|NCT00173706|muscle symptoms|muscle symptoms
816783|NCT00173706|intradialytic hypotension|intradialytic hypotension
816784|NCT00173706|erythropoietin-resistant anemia|erythropoietin-resistant anemia
816785|NCT00173693|CEA, Osteoporosis, Fracture, Prevention, Exercise|cea, osteoporosis, fracture, prevention, exercise
816786|NCT00173615|ECMO|ecmo
816787|NCT00173615|CPR|cpr
816788|NCT00173602|Peritoneal Dialysis|peritoneal dialysis
816789|NCT00173563|Immunology|immunology
816790|NCT00173550|Menopause, premature|menopause, premature
816791|NCT00173550|Hysterectomy|hysterectomy
816792|NCT00173550|Ovariectomy|ovariectomy
816793|NCT00173550|Estrogen Replacement Therapy|estrogen replacement therapy
816794|NCT00173550|Knowledge|knowledge
816795|NCT00173550|Perception|perception
816796|NCT00173550|Attitude|attitude
816797|NCT00173537|idiopathic pulmonary artery hypertension|idiopathic pulmonary artery hypertension
816798|NCT00173524|EGFR Non-small cell lung cancer|egfr non-small cell lung cancer
816799|NCT00173498|atopic dermatitis, skin test|atopic dermatitis, skin test
816800|NCT00173485|peritonitis, peritoneal dialysis, dialysate|peritonitis, peritoneal dialysis, dialysate
816801|NCT00173472|colorectal cancer, MSI, TS, DPD, EGFR, chemotherapy.|colorectal cancer, msi, ts, dpd, egfr, chemotherapy.
816802|NCT00173446|Normal part of the adrenal gland|normal part of the adrenal gland
816803|NCT00173433|tuberculosis|tuberculosis
816804|NCT00173433|relapse|relapse
816805|NCT00173433|reinfection|reinfection
816806|NCT00173433|reactivation|reactivation
816807|NCT00173433|dormancy|dormancy
816808|NCT00173433|tuberculin skin test|tuberculin skin test
816809|NCT00173420|Normal Controls|normal controls
816810|NCT00173407|Ovarian endometrioid carcinoma|ovarian endometrioid carcinoma
816811|NCT00173407|invasion|invasion
816812|NCT00173407|IGFBP-3|igfbp-3
816813|NCT00173407|transfection|transfection
816814|NCT00173407|signal transduction|signal transduction
816815|NCT00173407|PTEN|pten
816816|NCT00173407|methylation|methylation
816817|NCT00173394|ovarian cancer|ovarian cancer
816818|NCT00173394|immunotherapy|immunotherapy
816819|NCT00173394|mesothelin|mesothelin
816820|NCT00173394|normal volunteer|normal volunteer
816821|NCT00173381|lymphangiogenesis|lymphangiogenesis
816822|NCT00173381|head and neck squamous cell carcinoma (HNSCC)|head and neck squamous cell carcinoma (hnscc)
816823|NCT00173381|vascular endothelial growth factor-C (VEGF-C)|vascular endothelial growth factor-c (vegf-c)
816824|NCT00173381|cyclooxygenase-2 (COX-2)|cyclooxygenase-2 (cox-2)
816825|NCT00173381|interleukin-6 (IL-6)|interleukin-6 (il-6)
816826|NCT00173368|Sphincterotomy|sphincterotomy
816827|NCT00173368|needle knife|needle knife
816828|NCT00173368|hemorrhage|hemorrhage
816830|NCT00173355|pediatric Dermatofibrosarcoma Protuberans|pediatric dermatofibrosarcoma protuberans
816831|NCT00173342|Right bundle branch block|right bundle branch block
816832|NCT00173342|Electrocardiography|electrocardiography
816833|NCT00173342|Ion channel|ion channel
816834|NCT00173329|HIV|hiv
816835|NCT00173316|vascular endothelial growth factor-C|vascular endothelial growth factor-c
816836|NCT00173316|VEGF-CR|vegf-cr
816837|NCT00173316|lymphangiogenesis|lymphangiogenesis
816838|NCT00173316|host inflammatory responses|host inflammatory responses
816839|NCT00173316|oral carcinogenesis|oral carcinogenesis
816840|NCT00173316|oral cancers|oral cancers
816841|NCT00173316|oral premalignant lesions|oral premalignant lesions
816842|NCT00173303|Breast neoplasms|breast neoplasms
816843|NCT00173303|Breast radiography|breast radiography
816844|NCT00173303|Cancer screening|cancer screening
816845|NCT00173290|Cervical cancer|cervical cancer
816846|NCT00173290|Breast cancer|breast cancer
816847|NCT00173290|T lymphocyte|t lymphocyte
816848|NCT00173290|NK receptor|nk receptor
816849|NCT00173277|colorectal cancer screening|colorectal cancer screening
816850|NCT00173277|colonoscopy|colonoscopy
816851|NCT00173238|atherosclerosis|atherosclerosis
816852|NCT00173238|optical coherence tomography|optical coherence tomography
816853|NCT00173238|polarization|polarization
816854|NCT00173238|phase retardation|phase retardation
816855|NCT00173238|birefringence|birefringence
816856|NCT00173225|nociceptin|nociceptin
816857|NCT00173225|sunstance P|sunstance p
816862|NCT00173212|cell proliferation|cell proliferation
816863|NCT00173212|Immunocytochemistry|immunocytochemistry
816864|NCT00173186|ventricular septal defect|ventricular septal defect
816865|NCT00173186|aortic regurgitation|aortic regurgitation
816866|NCT00173173|Gifted dance students|gifted dance students
816867|NCT00173173|eating disorders|eating disorders
816868|NCT00173173|prevalence|prevalence
816869|NCT00173173|risk factors|risk factors
816870|NCT00173173|BITE|bite
816871|NCT00173160|Eating disorders|eating disorders
816872|NCT00173160|risk factors|risk factors
816873|NCT00173160|prospective study|prospective study
816874|NCT00173160|case-controled study|case-controled study
816875|NCT00173160|outcome|outcome
816876|NCT00173160|gifted dance students|gifted dance students
816877|NCT00173134|diabetes|diabetes
816878|NCT00173134|erectile dysfunction|erectile dysfunction
816879|NCT00173134|erectile dysfunction related quality of life|erectile dysfunction related quality of life
816880|NCT00173121|enterovirus, environment, aerosol, air|enterovirus, environment, aerosol, air
816881|NCT00173108|Prematurity|prematurity
816882|NCT00173108|Early intervention|early intervention
816883|NCT00173108|Neurodevelopment|neurodevelopment
816884|NCT00173108|Cost-effectiveness|cost-effectiveness
816885|NCT00173082|primary aldosteronism|primary aldosteronism
816886|NCT00173082|Insulin resistance|insulin resistance
816887|NCT00173082|Metabolic syndrome|metabolic syndrome
816888|NCT00173082|OGTT|ogtt
816889|NCT00173069|Schizophrenia|schizophrenia
816890|NCT00173069|PPI|ppi
816891|NCT00173069|P50I|p50i
816892|NCT00173069|MRS|mrs
816893|NCT00173069|Niacin|niacin
816894|NCT00173069|Candidate Genes|candidate genes
816895|NCT00173056|Peritoneal dialysis|peritoneal dialysis
816896|NCT00173017|N95 mask|n95 mask
816897|NCT00173017|medical staff|medical staff
816898|NCT00173017|hypoxemia|hypoxemia
816899|NCT00173017|hypercapnia|hypercapnia
816900|NCT00173017|neurological study|neurological study
816901|NCT00172965|Optic coherence tomography|optic coherence tomography
816902|NCT00172965|oral cancer|oral cancer
816903|NCT00172965|oral precancers|oral precancers
816904|NCT00172952|high myopia, genomic|high myopia, genomic
816905|NCT00172926|Physical Constitution|physical constitution
816906|NCT00172926|Disease Pattern|disease pattern
816907|NCT00172926|Laboratory Data|laboratory data
816908|NCT00172926|Integrative Chinese Medicine and Western Medicine|integrative chinese medicine and western medicine
816909|NCT00172913|Wavefront Aberration|wavefront aberration
816910|NCT00172913|LASIK|lasik
816911|NCT00172913|Contrast Sensitivity|contrast sensitivity
816912|NCT00172913|Visual Performance|visual performance
816913|NCT00172913|Ablation Profile|ablation profile
816914|NCT00172900|Diffusion tensor imaging|diffusion tensor imaging
816915|NCT00172900|MR spectroscopy|mr spectroscopy
816916|NCT00172900|dementia|dementia
816917|NCT00172900|white matter|white matter
816918|NCT00172887|Psychiatrists|psychiatrists
816919|NCT00172874|cross-cultural,|cross-cultural,
816920|NCT00172874|eating disorders,|eating disorders,
816921|NCT00172874|EDI,|edi,
816922|NCT00172874|psychometrics|psychometrics
816923|NCT00172861|gastric cancer, cyclooxygenase-2, microarray|gastric cancer, cyclooxygenase-2, microarray
816924|NCT00172835|pleural effusion|pleural effusion
816925|NCT00172835|procalcitonin|procalcitonin
816926|NCT00172822|appendicitis|appendicitis
816927|NCT00172809|Chronic Hepatitis C|chronic hepatitis c
816928|NCT00172809|End stage renal disease|end stage renal disease
816929|NCT00172809|Hemodialysis|hemodialysis
816930|NCT00172809|Interferon|interferon
816931|NCT00172809|Pegylated interferon|pegylated interferon
816932|NCT00172796|Metabolic syndrome|metabolic syndrome
816933|NCT00172783|TB|tb
816934|NCT00172783|PPD|ppd
816935|NCT00172783|ELISPOT|elispot
816936|NCT00172783|BCG|bcg
816937|NCT00172757|MSI, TS, Colorectal Cancer, DM.|msi, ts, colorectal cancer, dm.
816938|NCT00172744|stem cells|stem cells
816939|NCT00172744|periodontal cells|periodontal cells
816940|NCT00172744|mechanical stress|mechanical stress
816941|NCT00172744|differentiation|differentiation
816942|NCT00172744|periodontal ligament|periodontal ligament
816943|NCT00172692|Chewing efficiency,|chewing efficiency,
816944|NCT00172692|Gum chewing|gum chewing
816945|NCT00172692|Chewing velocity|chewing velocity
816946|NCT00172692|Occlusal surface area|occlusal surface area
816947|NCT00172692|EMG|emg
816948|NCT00172692|Jaw movement|jaw movement
816949|NCT00172679|Tai Chi|tai chi
816950|NCT00172679|NK Cells|nk cells
816951|NCT00172679|T lymphocytes|t lymphocytes
816952|NCT00172679|Exercise|exercise
816953|NCT00172666|SLE|sle
816954|NCT00172666|healthy subjects|healthy subjects
816955|NCT00172653|shoulder, reliability, validity|shoulder, reliability, validity
816956|NCT00172614|metabolic syndrome|metabolic syndrome
816957|NCT00172588|adenomyosis|adenomyosis
816958|NCT00172588|apoptosis|apoptosis
816959|NCT00172588|flowcytometry|flowcytometry
816960|NCT00172575|Lung neoplasms|lung neoplasms
816961|NCT00172575|Magnetic resonance imaging|magnetic resonance imaging
816962|NCT00172562|acute myeloid leukemia|acute myeloid leukemia
817352|NCT00171028|VALSARTAN|valsartan
816963|NCT00172562|age and sex matched normal subjects|age and sex matched normal subjects
816964|NCT00172562|dynamic MRI|dynamic mri
816965|NCT00172562|bone marrow perfusion|bone marrow perfusion
816966|NCT00172562|tumor angiogenesis|tumor angiogenesis
816967|NCT00172497|aggressive acts|aggressive acts
816968|NCT00172484|cerebrovascular accident|cerebrovascular accident
816969|NCT00172484|stroke center|stroke center
816970|NCT00172484|stroke team|stroke team
816971|NCT00172484|intensive care of stroke|intensive care of stroke
816972|NCT00172484|rehabilitation of stroke|rehabilitation of stroke
816973|NCT00172419|statin, inflammation, FDG, positron emission tomography|statin, inflammation, fdg, positron emission tomography
816974|NCT00172393|EV71,|ev71,
816975|NCT00172393|CNS,|cns,
816976|NCT00172393|Outcome,|outcome,
816977|NCT00172393|Neurological,|neurological,
816978|NCT00172393|Psychiatric|psychiatric
816979|NCT00172367|Urothelial carcinoma|urothelial carcinoma
816980|NCT00172367|Lycopene|lycopene
816981|NCT00172367|uremia|uremia
816982|NCT00172367|prevention|prevention
816983|NCT00172367|biomarker|biomarker
816984|NCT00172367|progression|progression
816985|NCT00172367|anti-oxidant|anti-oxidant
816986|NCT00172328|Hepatitis B|hepatitis b
816987|NCT00172328|vaccine|vaccine
816988|NCT00172315|acquired immunodeficiency syndrome|acquired immunodeficiency syndrome
816989|NCT00172315|lipodystrophy|lipodystrophy
816990|NCT00172315|MR spectroscopy|mr spectroscopy
816991|NCT00172289|pulse wave velocity|pulse wave velocity
816992|NCT00172289|sympathetic nerve activity|sympathetic nerve activity
816993|NCT00172289|spinal cord injury|spinal cord injury
816994|NCT00172289|cerebrovascular accident|cerebrovascular accident
816995|NCT00172263|Immunology|immunology
816996|NCT00172237|eye-head coordination|eye-head coordination
816997|NCT00172237|proprioception|proprioception
816998|NCT00172237|cervical spine with degenerative disease|cervical spine with degenerative disease
816999|NCT00172237|degenerated cervical spine|degenerated cervical spine
817000|NCT00172224|osteoporosis|osteoporosis
817001|NCT00172224|compression fracture|compression fracture
817002|NCT00172224|bone marrow perfusion|bone marrow perfusion
817003|NCT00172224|MR spectroscopy|mr spectroscopy
817004|NCT00172224|hormone therapy|hormone therapy
817005|NCT00172211|Physioneal|physioneal
817006|NCT00172211|Peritoneal dialysis|peritoneal dialysis
817007|NCT00172211|Oxidative stress|oxidative stress
817008|NCT00172211|insulin resistance|insulin resistance
817009|NCT00172198|w-3 fish oil|w-3 fish oil
817010|NCT00172198|Nutrition|nutrition
817011|NCT00172198|immune|immune
817012|NCT00172198|intensive care|intensive care
817013|NCT00172198|patients|patients
817014|NCT00172185|Short Bowel Syndrome|short bowel syndrome
817015|NCT00172185|Parenteral Nutrition|parenteral nutrition
817016|NCT00172185|SBS|sbs
817017|NCT00172185|Teduglutide|teduglutide
817018|NCT00172172|Post-menopausal|post-menopausal
817019|NCT00172172|Osteoporosis|osteoporosis
817020|NCT00172172|Parathyroid Hormone|parathyroid hormone
817021|NCT00172172|PTH|pth
817022|NCT00172172|ALX1-11|alx1-11
817023|NCT00172159|Colorectal cancer|colorectal cancer
817024|NCT00172159|Chemotherapy|chemotherapy
817025|NCT00172159|Surgery|surgery
817026|NCT00172159|Liver metastasis|liver metastasis
817027|NCT00172146|Hemiplegia|hemiplegia
817028|NCT00172146|Regular cane|regular cane
817029|NCT00172146|Volitional stepping|volitional stepping
817030|NCT00172146|Dynamic equilibrium|dynamic equilibrium
817031|NCT00172146|Attention|attention
817032|NCT00172146|Dual task|dual task
817033|NCT00172133|Post-menopausal|post-menopausal
817034|NCT00172133|Osteoporosis|osteoporosis
817035|NCT00172133|Parathyroid Hormone|parathyroid hormone
817036|NCT00172133|PTH|pth
817037|NCT00172133|ALX1-11|alx1-11
817038|NCT00172120|Post-menopausal|post-menopausal
817039|NCT00172120|Osteoporosis|osteoporosis
817040|NCT00172120|Parathyroid Hormone|parathyroid hormone
817041|NCT00172120|PTH|pth
817042|NCT00172120|ALX1-11|alx1-11
817043|NCT00172107|Post-menopausal|post-menopausal
817044|NCT00172107|Osteoporosis|osteoporosis
817045|NCT00172107|Parathyroid Hormone|parathyroid hormone
817046|NCT00172107|PTH|pth
817047|NCT00172107|ALX1-11|alx1-11
817048|NCT00172094|Migraine|migraine
817049|NCT00172081|Post-menopausal|post-menopausal
817050|NCT00172081|Osteoporosis|osteoporosis
817051|NCT00172081|Parathyroid Hormone|parathyroid hormone
817052|NCT00172081|PTH|pth
817053|NCT00172081|ALX1-11|alx1-11
817054|NCT00172068|Primary breast cancer|primary breast cancer
817055|NCT00172068|Bone metastases|bone metastases
817056|NCT00172068|Minimal residual disease|minimal residual disease
817057|NCT00172068|Bisphosphonates|bisphosphonates
817058|NCT00172055|Zoledronic acid|zoledronic acid
817059|NCT00172055|Zometa|zometa
817060|NCT00172055|prostate cancer|prostate cancer
817061|NCT00172055|osteoporosis|osteoporosis
817062|NCT00172042|Non-Small-Cell Lung Cancer|non-small-cell lung cancer
817063|NCT00172042|Bisphosphonates|bisphosphonates
817064|NCT00172042|Zoledronic acid|zoledronic acid
817065|NCT00172042|Bone metastases|bone metastases
817066|NCT00172042|Prevention of bone metastases|prevention of bone metastases
817067|NCT00172029|Zoledronic acid|zoledronic acid
817068|NCT00172029|Radiotherapy|radiotherapy
817069|NCT00172029|Bone pain|bone pain
817070|NCT00172029|Breast cancer|breast cancer
817071|NCT00172016|Zoledronic acid|zoledronic acid
817072|NCT00172016|SRE|sre
817073|NCT00172016|Prostate cancer|prostate cancer
817074|NCT00172003|Renal Cell Cancer|renal cell cancer
817075|NCT00172003|Bone metastasis|bone metastasis
817076|NCT00172003|Skeletal related event|skeletal related event
817077|NCT00172003|Renal Cell Cancer patients with bone metastasis|renal cell cancer patients with bone metastasis
817078|NCT00171990|genital herpes|genital herpes
817079|NCT00171990|herpes|herpes
817080|NCT00171990|famciclovir|famciclovir
817081|NCT00171977|GIST|gist
817082|NCT00171977|Imatinib|imatinib
817083|NCT00171977|Postoperative Adjuvant|postoperative adjuvant
817084|NCT00171964|Pain|pain
817085|NCT00171964|Bone metastasis|bone metastasis
817086|NCT00171964|Analgesic consumption|analgesic consumption
817087|NCT00171964|Cancer patients|cancer patients
817088|NCT00171964|Cancer patients with painful bone metastasis|cancer patients with painful bone metastasis
817089|NCT00171951|Cushing's disease|cushing's disease
817090|NCT00171951|ACTH|acth
817091|NCT00171951|Cortisol|cortisol
817092|NCT00171951|ACTH dependent Cushing's disease|acth dependent cushing's disease
817093|NCT00171938|Glioblastoma|glioblastoma
817094|NCT00171938|Brain tumors|brain tumors
817095|NCT00171938|Imatinib|imatinib
817096|NCT00171938|PDGFR|pdgfr
817097|NCT00171925|Multiple Myeloma|multiple myeloma
817098|NCT00171925|Stage I|stage i
817099|NCT00171925|Zoledronic acid|zoledronic acid
817100|NCT00171925|Progression|progression
817101|NCT00171912|Imatinib mesylate|imatinib mesylate
817102|NCT00171912|tyrosine kinases|tyrosine kinases
817103|NCT00171912|imatinib sensitivity|imatinib sensitivity
817104|NCT00171912|Diverse malignancies either associated with|diverse malignancies either associated with
817105|NCT00171912|or thought to be associated with|or thought to be associated with
817106|NCT00171912|activated tyrosine kinase enzymes|activated tyrosine kinase enzymes
817107|NCT00171912|including hypereosinophilic syndrome|including hypereosinophilic syndrome
817108|NCT00171912|systemic mastocytosis|systemic mastocytosis
817109|NCT00171912|chronic myelomonocytic leukaemia,|chronic myelomonocytic leukaemia,
817110|NCT00171912|dermatofibrosarcoma protuberans and other diseases.|dermatofibrosarcoma protuberans and other diseases.
817111|NCT00171912|Not included:|not included:
817112|NCT00171912|patients with chronic myeloid leukemia,|patients with chronic myeloid leukemia,
817113|NCT00171912|some other types of leukemias (abl-mutated)|some other types of leukemias (abl-mutated)
817114|NCT00171912|some types of gastrointestinal stromal tumours (c-KIT-positive),|some types of gastrointestinal stromal tumours (c-kit-positive),
817115|NCT00171912|some systemic mastocytosis (if c-KIT D816V mutation),|some systemic mastocytosis (if c-kit d816v mutation),
817116|NCT00171912|brain,|brain,
817117|NCT00171912|prostate,|prostate,
817118|NCT00171912|breast or lung cancers.|breast or lung cancers.
817119|NCT00171899|Chronic Myelogenous Leukemia|chronic myelogenous leukemia
817120|NCT00171899|Complete cytogenetic response|complete cytogenetic response
817121|NCT00171899|Imatinib mesylate|imatinib mesylate
817122|NCT00171899|Major molecular response|major molecular response
817123|NCT00171899|Chronic phase Ph+ Chronic Myelogenous Leukemia|chronic phase ph+ chronic myelogenous leukemia
817124|NCT00171886|Acromegaly|acromegaly
817125|NCT00171886|Otreotide|otreotide
817126|NCT00171886|Tumor reduction|tumor reduction
817127|NCT00171873|Double blind|double blind
817128|NCT00171873|Phase III|phase iii
817129|NCT00171873|Disease|disease
817130|NCT00171873|Clinical trial|clinical trial
817131|NCT00171873|Octreotide|octreotide
817132|NCT00171873|Neuroendocrine tumor|neuroendocrine tumor
817133|NCT00171873|Cancer|cancer
817134|NCT00171873|Tumor|tumor
817135|NCT00171873|Midgut|midgut
817136|NCT00171860|Hypereosinophilic syndrome|hypereosinophilic syndrome
817137|NCT00171860|Imatinib|imatinib
817138|NCT00171847|Breast cancer|breast cancer
817139|NCT00171847|Metastatic|metastatic
817140|NCT00171847|Trastuzumab|trastuzumab
817141|NCT00171847|Letrozole|letrozole
817142|NCT00171834|EPO|epo
817143|NCT00171834|EPO906|epo906
817144|NCT00171834|Brain metastasis|brain metastasis
817145|NCT00171834|Lung cancer|lung cancer
817146|NCT00171834|Lung metastasis|lung metastasis
817147|NCT00171834|NSCLC|nsclc
817148|NCT00171821|Thalassemia|thalassemia
817149|NCT00171821|Myelodysplastic Syndrome|myelodysplastic syndrome
817150|NCT00171821|MDS|mds
817151|NCT00171821|Sickle cell|sickle cell
817152|NCT00171821|Diamond-Blackfan anemia|diamond-blackfan anemia
817153|NCT00171821|Transfusion|transfusion
817154|NCT00171821|Anemia|anemia
817155|NCT00171821|Fanconi|fanconi
817156|NCT00171821|Chelation|chelation
817157|NCT00171821|Deferasirox|deferasirox
817158|NCT00171808|Endometrial Cancer|endometrial cancer
817159|NCT00171808|Aromatase inhibitor|aromatase inhibitor
817160|NCT00171808|Advanced or recurrent|advanced or recurrent
817161|NCT00171808|hormone receptor positive|hormone receptor positive
817162|NCT00171795|Traumatic brain injury,|traumatic brain injury,
817163|NCT00171795|cognitive impairment,|cognitive impairment,
817164|NCT00171795|rivastigmine|rivastigmine
817165|NCT00171782|HYPERTENSION|hypertension
817166|NCT00171782|VALSARTAN|valsartan
817167|NCT00171782|VALSARTAN AND HYDROCHLOROTHIAZIDE|valsartan and hydrochlorothiazide
817168|NCT00171782|RISK FACTORS|risk factors
817169|NCT00171756|hypertension|hypertension
817170|NCT00171756|valsartan|valsartan
817171|NCT00171743|Adults|adults
817172|NCT00171743|Post transplant diabetes|post transplant diabetes
817173|NCT00171730|Acromegaly|acromegaly
817174|NCT00171730|Pasireotide|pasireotide
817175|NCT00171730|GH|gh
817176|NCT00171730|IGF-1|igf-1
817177|NCT00171717|Cyclosporine, liver transplantation, maintenance, diabetes|cyclosporine, liver transplantation, maintenance, diabetes
817178|NCT00171704|Breast Cancer|breast cancer
817179|NCT00171704|Letrozole|letrozole
817180|NCT00171704|Bone Mineral Density|bone mineral density
817181|NCT00171704|Bone Markers|bone markers
817182|NCT00171704|Serum lipid|serum lipid
817183|NCT00171704|Postmenopausal|postmenopausal
817184|NCT00171691|Knee osteoarthritis, Topical NSAID, Diclofenac sodium|knee osteoarthritis, topical nsaid, diclofenac sodium
817185|NCT00171678|Knee osteoarthritis, Topical NSAID, Diclofenac sodium|knee osteoarthritis, topical nsaid, diclofenac sodium
817186|NCT00171665|Hand osteoarthritis, Topical NSAID, Diclofenac sodium|hand osteoarthritis, topical nsaid, diclofenac sodium
817187|NCT00171652|Hand osteoarthritis, Topical NSAID, Diclofenac sodium|hand osteoarthritis, topical nsaid, diclofenac sodium
817188|NCT00171626|Knee osteoarthritis, Topical NSAID, Diclofenac sodium|knee osteoarthritis, topical nsaid, diclofenac sodium
817189|NCT00171613|Obesity|obesity
817190|NCT00171600|valsartan|valsartan
817191|NCT00171600|lisinopril|lisinopril
817192|NCT00171600|albuminuria|albuminuria
817193|NCT00171600|diabetic nephropathy|diabetic nephropathy
817194|NCT00171587|Metastatic solid tumors|metastatic solid tumors
817195|NCT00171587|PTK787/ZK 222584|ptk787/zk 222584
817196|NCT00171587|Vatalanib|vatalanib
817197|NCT00171587|Capecitabine|capecitabine
817198|NCT00171587|VEGF (vascular endothelial growth factor)|vegf (vascular endothelial growth factor)
817199|NCT00171587|Histologically confirmed metastatic solid tumors|histologically confirmed metastatic solid tumors
817200|NCT00171574|valsartan|valsartan
817201|NCT00171574|lisinopril|lisinopril
817202|NCT00171574|antiproteinuric|antiproteinuric
817203|NCT00171574|diabetic nephropathy|diabetic nephropathy
817204|NCT00171561|hypertension|hypertension
817205|NCT00171561|diabetes|diabetes
817206|NCT00171561|albuminuria|albuminuria
817207|NCT00171561|valsartan|valsartan
817208|NCT00171561|hydrochlorothiazide|hydrochlorothiazide
817209|NCT00171561|amlodipine|amlodipine
817210|NCT00171548|Metabolic syndrome, cardiovascular risk reduction|metabolic syndrome, cardiovascular risk reduction
817211|NCT00171535|hypertension|hypertension
817212|NCT00171535|high blood pressure|high blood pressure
817213|NCT00171535|valsartan|valsartan
817214|NCT00171535|amlodipine|amlodipine
817215|NCT00171522|Constipation|constipation
817216|NCT00171522|Tegaserod|tegaserod
817217|NCT00171522|Polyethylene Glycol 3350|polyethylene glycol 3350
817218|NCT00171522|PEG|peg
817219|NCT00171509|Liver transplant, adults, once a day administration, Immunosuppressants|liver transplant, adults, once a day administration, immunosuppressants
817220|NCT00171496|Kidney transplant, adults, NODM, immunosuppressants|kidney transplant, adults, nodm, immunosuppressants
817221|NCT00171483|GERD|gerd
817222|NCT00171483|PPI|ppi
817223|NCT00171483|heartburn|heartburn
817224|NCT00171483|regurgitation|regurgitation
817225|NCT00171470|dyspepsia|dyspepsia
817226|NCT00171470|hearburn|hearburn
817227|NCT00171470|female|female
817228|NCT00171470|PPI|ppi
817229|NCT00171457|functional heartburn|functional heartburn
817230|NCT00171457|dyspepsia|dyspepsia
817231|NCT00171457|male|male
817232|NCT00171457|female|female
817233|NCT00171457|visceral sensitivity|visceral sensitivity
817234|NCT00171444|hypertension,|hypertension,
817235|NCT00171444|valsartan+hydrochlorothiazide|valsartan+hydrochlorothiazide
817236|NCT00171431|IBS-C|ibs-c
817237|NCT00171431|female|female
817238|NCT00171418|GERD|gerd
817239|NCT00171418|PPI|ppi
817240|NCT00171405|hypertension|hypertension
817241|NCT00171405|aliskiren|aliskiren
817242|NCT00171405|hydrochlorothiazide|hydrochlorothiazide
817243|NCT00171392|Kidney transplantation; acute rejection; gastrointestinal adverse events; quality of life; mycophenolate sodium, tacrolimus.|kidney transplantation; acute rejection; gastrointestinal adverse events; quality of life; mycophenolate sodium, tacrolimus.
817244|NCT00171379|Kidney transplantation; acute rejection; gastrointestinal adverse events; quality of life; mycophenolate sodium.|kidney transplantation; acute rejection; gastrointestinal adverse events; quality of life; mycophenolate sodium.
817245|NCT00171366|amlodipine|amlodipine
817246|NCT00171366|benazepril|benazepril
817247|NCT00171366|hypertension|hypertension
817248|NCT00171366|diastolic|diastolic
817249|NCT00171353|arterial hypertension|arterial hypertension
817250|NCT00171353|albuminuria|albuminuria
817251|NCT00171353|valsartan|valsartan
817252|NCT00171340|Bone Loss|bone loss
817253|NCT00171340|Osteopenia|osteopenia
817254|NCT00171340|Breast cancer|breast cancer
817255|NCT00171340|letrozole|letrozole
817256|NCT00171340|zoledronic acid|zoledronic acid
817257|NCT00171340|postmenopausal|postmenopausal
817258|NCT00171327|arterial hypertension|arterial hypertension
817259|NCT00171327|dyslipidemia|dyslipidemia
817260|NCT00171327|valsartan|valsartan
817261|NCT00171327|fluvastatin|fluvastatin
817262|NCT00171314|breast cancer|breast cancer
817263|NCT00171314|letrozole|letrozole
817264|NCT00171314|zoledronic acid|zoledronic acid
817265|NCT00171314|adjuvant|adjuvant
817266|NCT00171314|postmenopausal|postmenopausal
817267|NCT00171301|Transfusional hemosiderosis|transfusional hemosiderosis
817268|NCT00171301|Beta-thalassemia major|beta-thalassemia major
817269|NCT00171301|Deferasirox|deferasirox
817270|NCT00171301|iron overload|iron overload
817271|NCT00171301|rare anemia|rare anemia
817272|NCT00171301|iron overload due to transfusion|iron overload due to transfusion
817273|NCT00171288|Dyslipidemia, ezetimibe, inflammatory markers, fluvastatin|dyslipidemia, ezetimibe, inflammatory markers, fluvastatin
817274|NCT00171275|Coronary disease|coronary disease
817275|NCT00171275|Myocardial infarction|myocardial infarction
817276|NCT00171275|Statins|statins
817277|NCT00171262|Dyslipidemia, chronic renal disease, fluvastatin|dyslipidemia, chronic renal disease, fluvastatin
817278|NCT00171249|Chronic Myelogenous Leukemia|chronic myelogenous leukemia
817279|NCT00171249|CML|cml
817280|NCT00171249|Philadelphia Chromosome|philadelphia chromosome
817281|NCT00171249|Accelerated phase|accelerated phase
817282|NCT00171249|Acute Myelogenous Leukemia|acute myelogenous leukemia
817283|NCT00171249|AML|aml
817284|NCT00171249|Acute Lymphoblastic Leukemia|acute lymphoblastic leukemia
817285|NCT00171249|ALL|all
817286|NCT00171249|Imatinib mesylate|imatinib mesylate
817287|NCT00171236|Heterozygous familial hypercholesterolemia|heterozygous familial hypercholesterolemia
817288|NCT00171236|mixed dyslipidemia|mixed dyslipidemia
817289|NCT00171223|Chronic Myelogenous Leukemia|chronic myelogenous leukemia
817290|NCT00171223|CML|cml
817291|NCT00171223|Philadelphia Chromosome|philadelphia chromosome
817292|NCT00171223|Accelerated phase|accelerated phase
817293|NCT00171223|Acute Myelogenous Leukemia|acute myelogenous leukemia
817294|NCT00171223|AML|aml
817295|NCT00171223|Acute Lymphoblastic Leukemia|acute lymphoblastic leukemia
817296|NCT00171223|ALL|all
817297|NCT00171223|Imatinib mesylate|imatinib mesylate
817298|NCT00171210|β-thalassemia|β-thalassemia
817299|NCT00171210|iron overload|iron overload
817300|NCT00171210|deferasirox|deferasirox
817301|NCT00171184|Overactive bladder, Darifenacin, M3 muscarinic receptor antagonist, elderly population|overactive bladder, darifenacin, m3 muscarinic receptor antagonist, elderly population
817302|NCT00171171|Thalassemia (beta-thal. major)|thalassemia (beta-thal. major)
817303|NCT00171171|Transfusional hemosiderosis|transfusional hemosiderosis
817304|NCT00171171|Deferasirox|deferasirox
817305|NCT00171171|Beta-thalassemia major patients|beta-thalassemia major patients
817306|NCT00171171|Unable to be chelated with deferoxamine or deferiprone|unable to be chelated with deferoxamine or deferiprone
817307|NCT00171158|Chronic Myelogenous Leukemia|chronic myelogenous leukemia
817308|NCT00171158|CML|cml
817309|NCT00171158|Philadelphia Chromosome|philadelphia chromosome
817310|NCT00171158|Blast crisis|blast crisis
817311|NCT00171158|Imatinib mesylate|imatinib mesylate
817312|NCT00171145|Overactive Bladder, incontinence, antimuscarinic, warning time, darifenacin|overactive bladder, incontinence, antimuscarinic, warning time, darifenacin
817313|NCT00171132|Postmenopausal|postmenopausal
817314|NCT00171132|women|women
817315|NCT00171132|overweight|overweight
817316|NCT00171132|hypertension|hypertension
817317|NCT00171132|impaired|impaired
817318|NCT00171132|exercise|exercise
817319|NCT00171132|capacity|capacity
817320|NCT00171132|valsartan|valsartan
817321|NCT00171132|atenolol|atenolol
817322|NCT00171132|hydrochlorothiazide|hydrochlorothiazide
817323|NCT00171119|HYPERTENSION|hypertension
817324|NCT00171119|DIABETES MELLITUS TYPE II|diabetes mellitus type ii
817325|NCT00171119|VALSARTAN|valsartan
817326|NCT00171119|BENAZAPRIL|benazapril
817327|NCT00171106|diastolic dysfunction|diastolic dysfunction
817328|NCT00171106|heart failure|heart failure
817329|NCT00171106|exercise tolerance|exercise tolerance
817330|NCT00171106|valsartan|valsartan
817331|NCT00171093|HYPERTENSION|hypertension
817332|NCT00171093|HYPERCHOLESTEROLEMIA|hypercholesterolemia
817333|NCT00171093|BLOOD PRESSURE|blood pressure
817334|NCT00171093|CHOLESTEROL|cholesterol
817335|NCT00171093|VALSARTAN|valsartan
817336|NCT00171093|SIMVASTATIN|simvastatin
817337|NCT00171080|Hypertension|hypertension
817338|NCT00171080|Valsartan|valsartan
817339|NCT00171080|Dialysis|dialysis
817340|NCT00171080|Renal Disease|renal disease
817341|NCT00171067|Microalbuminuria, urinary albumin excretion, urinary albumin creatinine ratio, hypertension, valsartan, lisinopril, combination|microalbuminuria, urinary albumin excretion, urinary albumin creatinine ratio, hypertension, valsartan, lisinopril, combination
817342|NCT00171054|hypertension|hypertension
817343|NCT00171054|postmenopausal|postmenopausal
817344|NCT00171054|valsartan|valsartan
817345|NCT00171054|amlodipine|amlodipine
817346|NCT00171054|hydrochlorothiazide|hydrochlorothiazide
817347|NCT00171041|PEDIATRIC HYPERTENSION|pediatric hypertension
817348|NCT00171041|PEDIATRIC|pediatric
817349|NCT00171041|VALSARTAN|valsartan
817350|NCT00171028|PEDIATRIC HYPERTENSION|pediatric hypertension
817351|NCT00171028|PEDIATRIC|pediatric
817354|NCT00171015|HYDROCHLOROTHIAZIDE|hydrochlorothiazide
817355|NCT00171015|OLMESARTAN|olmesartan
817356|NCT00171015|HYPERTENSION|hypertension
817357|NCT00171002|Hypertension, high blood pressure, valsartan, amlodipine|hypertension, high blood pressure, valsartan, amlodipine
817358|NCT00170989|hypertension|hypertension
817359|NCT00170989|high blood pressure|high blood pressure
817360|NCT00170989|valsartan|valsartan
817361|NCT00170989|hydrochlorothiazide|hydrochlorothiazide
817362|NCT00170976|HYPERTENSION, VALSARTAN, AMLODIPINE< SAFETY|hypertension, valsartan, amlodipine< safety
817363|NCT00170963|Hypertension, high blood pressure, valsartan, amlodipine|hypertension, high blood pressure, valsartan, amlodipine
817364|NCT00170950|cardiovascular morbidity|cardiovascular morbidity
817365|NCT00170950|cardiovascular mortality|cardiovascular mortality
817366|NCT00170950|benazepril|benazepril
817367|NCT00170950|amlodipine|amlodipine
817368|NCT00170950|high risk population|high risk population
817369|NCT00170937|METABOLIC SYNDROME, VALSARTAN, HYDROCHLOROTHIAZIDE, HYPERTENSION,|metabolic syndrome, valsartan, hydrochlorothiazide, hypertension,
817370|NCT00170924|Hypertension, High Blood Pressure, Diastolic Dysfunction,|hypertension, high blood pressure, diastolic dysfunction,
817371|NCT00170924|Heart Disease|heart disease
817372|NCT00170911|Osteoporosis|osteoporosis
817373|NCT00170911|Postmenopausal women|postmenopausal women
817374|NCT00170911|Cathepsin K inhibitor|cathepsin k inhibitor
817375|NCT00170898|Musculoskeletal pain|musculoskeletal pain
817376|NCT00170898|cyclooxygenase-2 inhibitors|cyclooxygenase-2 inhibitors
817377|NCT00170898|lumiracoxib|lumiracoxib
817378|NCT00170898|naproxen|naproxen
817379|NCT00170885|acute rejection|acute rejection
817380|NCT00170885|renal function|renal function
817381|NCT00170885|everolimus|everolimus
817382|NCT00170885|cyclosporine microemulsion|cyclosporine microemulsion
817383|NCT00170872|Osteoarthritis|osteoarthritis
817384|NCT00170872|Rheumatoid Arthritis|rheumatoid arthritis
817385|NCT00170872|Cox-2|cox-2
817386|NCT00170872|lumiracoxib|lumiracoxib
817387|NCT00170859|everolimus|everolimus
817388|NCT00170859|cyclosporine microemulsion|cyclosporine microemulsion
817389|NCT00170859|renal function|renal function
817390|NCT00170846|Renal transplantation, everolimus, calcineurin inhibitors, GFR|renal transplantation, everolimus, calcineurin inhibitors, gfr
817391|NCT00170833|Renal/Kidney, transplantation, everolimus, calcineurin sparing|renal/kidney, transplantation, everolimus, calcineurin sparing
817392|NCT00170820|Renal transplantation, maintenance, switch, everolimus, CNI-free|renal transplantation, maintenance, switch, everolimus, cni-free
817393|NCT00170794|cardiac transplantation, everolimus, cyclosporine microemulsion, GFR|cardiac transplantation, everolimus, cyclosporine microemulsion, gfr
817394|NCT00170781|Pain, acute gout, arthritis, cyclooxygenase-2 inhibitors, lumiracoxib, indomethacin|pain, acute gout, arthritis, cyclooxygenase-2 inhibitors, lumiracoxib, indomethacin
817395|NCT00170768|Darifenacin, oxybutynin, cognition, memory|darifenacin, oxybutynin, cognition, memory
817396|NCT00170755|Overactive Bladder, incontinence, antimuscarinic, darifenacin, long-term treatment|overactive bladder, incontinence, antimuscarinic, darifenacin, long-term treatment
817397|NCT00170742|Open label,|open label,
817398|NCT00170742|phase III,|phase iii,
817399|NCT00170742|disease,|disease,
817400|NCT00170742|clinical trial,|clinical trial,
817401|NCT00170742|octreotide,|octreotide,
817402|NCT00170742|proliferative diabetic retinopathy, lasercoagulation|proliferative diabetic retinopathy, lasercoagulation
817403|NCT00170729|Prednisolone acetate,|prednisolone acetate,
817404|NCT00170729|efficacy,|efficacy,
817405|NCT00170729|cataract,|cataract,
817406|NCT00170729|eye drops,|eye drops,
817407|NCT00170729|tolerability,|tolerability,
817408|NCT00170729|inflammation|inflammation
817694|NCT00169234|Vaccination|vaccination
817409|NCT00170716|Motor Cortex Electrical Stimulation|motor cortex electrical stimulation
817410|NCT00170716|Ischemic Stroke|ischemic stroke
817411|NCT00170716|Upper Extremity Hemiparesis|upper extremity hemiparesis
817412|NCT00170716|Rehabilitation|rehabilitation
817413|NCT00170716|Motor Recovery|motor recovery
817414|NCT00170716|Functional MRI|functional mri
817415|NCT00170703|Cortical Electrical Stimulation|cortical electrical stimulation
817416|NCT00170703|Ischemic Stroke|ischemic stroke
817417|NCT00170703|Broca's Aphasia|broca's aphasia
817418|NCT00170703|Speech Rehabilitation|speech rehabilitation
817419|NCT00170703|Functional MRI|functional mri
817420|NCT00170664|Ovarian neoplasms|ovarian neoplasms
817421|NCT00170664|paclitaxel, carboplatin|paclitaxel, carboplatin
817422|NCT00170664|clinical trials, phase II|clinical trials, phase ii
817423|NCT00170664|first-line chemotherapy|first-line chemotherapy
817424|NCT00170664|weekly therapy schedule|weekly therapy schedule
817425|NCT00170638|Tuberculosis, children, infants|tuberculosis, children, infants
817426|NCT00170625|platin-resistant|platin-resistant
817427|NCT00170612|Pneumococcal infections|pneumococcal infections
817429|NCT00170612|infants|infants
817430|NCT00170612|vaccine|vaccine
817431|NCT00170586|Underglove, polyvinylidene fluoride, acrylic polymer|underglove, polyvinylidene fluoride, acrylic polymer
817432|NCT00170573|biweekly schedule of PLD - Ovarian cancer - pegylated liposomal doxorubicin -quality of life - Toxic skin reactions|biweekly schedule of pld - ovarian cancer - pegylated liposomal doxorubicin -quality of life - toxic skin reactions
817433|NCT00170560|hospital, acquired, infections, mortality|hospital, acquired, infections, mortality
817434|NCT00170547|inactivated, trivalent, influenza, vaccine, Fluzone|inactivated, trivalent, influenza, vaccine, fluzone
817435|NCT00170534|India, male, sexually transmitted infection, STI, STD|india, male, sexually transmitted infection, sti, std
817436|NCT00170521|group A streptococci, pharyngitis, epidemiology, Streptococcus pyogenes, children, Nicaragua|group a streptococci, pharyngitis, epidemiology, streptococcus pyogenes, children, nicaragua
817437|NCT00170508|Influenza, sub-study|influenza, sub-study
817438|NCT00170495|respiratory illness, influenza, bronchitis, pneumonia, cold|respiratory illness, influenza, bronchitis, pneumonia, cold
817439|NCT00170482|Fluzone|fluzone
817440|NCT00170482|inactivated|inactivated
817441|NCT00170482|influenza vaccine|influenza vaccine
817442|NCT00170482|sub-study|sub-study
817443|NCT00170482|trivalent|trivalent
817444|NCT00170469|Anthrax|anthrax
817445|NCT00170456|Anthrax vaccine|anthrax vaccine
817446|NCT00170443|Influenza, Baculovirus, Immunogenicity, Geriatrics|influenza, baculovirus, immunogenicity, geriatrics
817447|NCT00170430|HIV-1, sexually transmitted diseases, females, Kenya|hiv-1, sexually transmitted diseases, females, kenya
817448|NCT00170404|HIV Infections, Tuberculosis, Malnutrition, Tanzania|hiv infections, tuberculosis, malnutrition, tanzania
817449|NCT00170391|Insomnia|insomnia
817450|NCT00170391|Sleep|sleep
817451|NCT00170391|PSG|psg
817452|NCT00170391|Behavioural treatment|behavioural treatment
817453|NCT00170378|Enoxaparin|enoxaparin
817454|NCT00170378|Safety|safety
817455|NCT00170365|Stress|stress
817456|NCT00170365|Yoga|yoga
817457|NCT00170352|hyperbaric oxygen|hyperbaric oxygen
817458|NCT00170352|cerebral metabolism|cerebral metabolism
817459|NCT00170352|hyperoxia|hyperoxia
817460|NCT00170352|traumatic brain injury|traumatic brain injury
817461|NCT00170339|Opiate Dependence|opiate dependence
817462|NCT00170339|Methadone Maintenance|methadone maintenance
817463|NCT00170339|Osteoporosis|osteoporosis
817464|NCT00170339|Hypogonadism|hypogonadism
817465|NCT00170326|Permanent Pacing artificial internal|permanent pacing artificial internal
817466|NCT00170313|Heart Failure|heart failure
817467|NCT00170313|Primary Prevention of Sudden Cardiac Death|primary prevention of sudden cardiac death
817468|NCT00170313|Secondary Prevention of Sudden Cardiac Death|secondary prevention of sudden cardiac death
817469|NCT00170313|Cardiac Desynchronization|cardiac desynchronization
817470|NCT00170313|CRT-D|crt-d
817471|NCT00170313|Cardiac Dyssynchrony|cardiac dyssynchrony
817472|NCT00170300|Cardiac resynchronisation therapy (CRT therapy),|cardiac resynchronisation therapy (crt therapy),
817473|NCT00170300|all-cause mortality,|all-cause mortality,
817474|NCT00170300|quality of life assesment,|quality of life assesment,
817475|NCT00170300|echocardiographic left ventricular function,|echocardiographic left ventricular function,
817476|NCT00170300|CRT and neurohormonal activation,|crt and neurohormonal activation,
817477|NCT00170300|CRT and health economics|crt and health economics
817478|NCT00170287|Unstable Ventricular Tachycardia|unstable ventricular tachycardia
817479|NCT00170274|Indication for cardiac pacing|indication for cardiac pacing
817480|NCT00170274|Atrial Arrhythmia|atrial arrhythmia
817481|NCT00170274|Indication for the implantation of a pacemaker according to the German guidelines|indication for the implantation of a pacemaker according to the german guidelines
817482|NCT00170274|Documented (ECG) atrial tachyarrhythmia within the last three months before enrollment|documented (ecg) atrial tachyarrhythmia within the last three months before enrollment
817483|NCT00170261|Syncope of uncertain etiology|syncope of uncertain etiology
817484|NCT00170261|Repeated presyncopes|repeated presyncopes
817485|NCT00170248|Asthma|asthma
817486|NCT00170248|Primary Care|primary care
817487|NCT00170248|Computer-Based Decision Support|computer-based decision support
817488|NCT00170248|Outcome Evaluation|outcome evaluation
817489|NCT00170235|Breast cancer|breast cancer
817490|NCT00170235|Prehabilitation|prehabilitation
817491|NCT00170235|Rehabilitation|rehabilitation
817492|NCT00170235|Exercise|exercise
817493|NCT00170222|Acute bronchitis|acute bronchitis
817494|NCT00170222|antibiotics|antibiotics
817495|NCT00170209|Tuberculosis|tuberculosis
817496|NCT00170209|Children|children
817497|NCT00170196|pneumonia|pneumonia
817498|NCT00170196|corticosteroids|corticosteroids
817499|NCT00170183|Heart failure|heart failure
817500|NCT00170183|Renal dysfunction|renal dysfunction
817501|NCT00170170|cytomegalovirus|cytomegalovirus
817502|NCT00170105|Age 18 years or older|age 18 years or older
817503|NCT00170105|No cognitive impairment or altered mental status|no cognitive impairment or altered mental status
817505|NCT00170105|No aphasia|no aphasia
817506|NCT00170105|English-speaking|english-speaking
817507|NCT00170053|Kidney Transplantation|kidney transplantation
817508|NCT00170001|supraesophageal reflux|supraesophageal reflux
817509|NCT00170001|laryngopharyngeal symptoms|laryngopharyngeal symptoms
817510|NCT00170001|pharynx|pharynx
817511|NCT00170001|esophagus|esophagus
817512|NCT00169988|clinical high risk|clinical high risk
817513|NCT00169988|attenuated positive symptoms|attenuated positive symptoms
817514|NCT00169988|attenuated negative symptoms|attenuated negative symptoms
817515|NCT00169988|cognition|cognition
817516|NCT00169988|functional status|functional status
817517|NCT00169988|prodromal psychosis|prodromal psychosis
817518|NCT00169962|acute disease|acute disease
817519|NCT00169949|early intervention|early intervention
817520|NCT00169949|social functioning|social functioning
817521|NCT00169949|role functioning|role functioning
817522|NCT00169949|cognition|cognition
817523|NCT00169910|Renal Transplantation|renal transplantation
817524|NCT00169910|Calcineurin Inhibitor|calcineurin inhibitor
817525|NCT00169910|Mycophenolate Mofetil|mycophenolate mofetil
817526|NCT00169910|Cardiovascular Disease|cardiovascular disease
817528|NCT00169897|Exercise|exercise
817529|NCT00169897|Self-management|self-management
817530|NCT00169897|Rehabilitation|rehabilitation
817531|NCT00169897|Quality of life|quality of life
817532|NCT00169897|Health economy|health economy
817533|NCT00169897|Cost effectiveness|cost effectiveness
817534|NCT00169897|Health care utilization|health care utilization
817535|NCT00169884|Deliberate Self-Harm,|deliberate self-harm,
817536|NCT00169884|cognitive-behavioural therapy,|cognitive-behavioural therapy,
817537|NCT00169884|integrative approach|integrative approach
817538|NCT00169858|Hepatitis B|hepatitis b
817539|NCT00169858|Vaccination|vaccination
817540|NCT00169858|Engerix-B|engerix-b
817541|NCT00169858|Immunogenicity|immunogenicity
817542|NCT00169858|Long-term immunity|long-term immunity
817543|NCT00169858|Booster dose|booster dose
817544|NCT00169858|Safety|safety
817545|NCT00169845|chemoprevention trial|chemoprevention trial
817546|NCT00169845|antioxidant|antioxidant
817547|NCT00169845|alpha-tocopherol|alpha-tocopherol
817548|NCT00169845|beta-carotene|beta-carotene
817549|NCT00169845|second primary cancer|second primary cancer
817550|NCT00169845|head and neck cancer|head and neck cancer
817551|NCT00169845|adverse effect of radiation therapy|adverse effect of radiation therapy
817552|NCT00169845|quality of life|quality of life
817553|NCT00169845|mortality|mortality
817554|NCT00169845|cancer free survival|cancer free survival
817555|NCT00169845|cancer recurrence|cancer recurrence
817556|NCT00169832|Atherosclerosis progression|atherosclerosis progression
817557|NCT00169832|Ischemic heart disease|ischemic heart disease
817558|NCT00169832|Saphenous vein graft|saphenous vein graft
817559|NCT00169832|Metabolic risk factors|metabolic risk factors
817560|NCT00169832|Rosiglitazone|rosiglitazone
817561|NCT00169819|Same day discharge|same day discharge
817562|NCT00169819|Trans-radial|trans-radial
817563|NCT00169819|Coronary artery stenting|coronary artery stenting
817564|NCT00169819|Abciximab bolus|abciximab bolus
817565|NCT00169806|Randall's Plaque|randall's plaque
817566|NCT00169806|Kidney stones|kidney stones
817567|NCT00169793|Obesity|obesity
817568|NCT00169793|Nephrolithiasis|nephrolithiasis
817569|NCT00169780|Renal Calculi|renal calculi
817570|NCT00169780|Radiology|radiology
817571|NCT00169780|High Reslolution CT|high reslolution ct
817572|NCT00169767|Enlarged Prostate|enlarged prostate
817573|NCT00169767|BPH|bph
817574|NCT00169754|Nephrolithiasis|nephrolithiasis
817575|NCT00169754|Renal Calculi|renal calculi
817576|NCT00169754|Perc|perc
817577|NCT00169754|Attached Stones|attached stones
817578|NCT00169741|Nephrolithiasis|nephrolithiasis
817579|NCT00169741|Renal Calculi|renal calculi
817580|NCT00169728|allogeneic haematopoietic stem cell transplantation|allogeneic haematopoietic stem cell transplantation
817581|NCT00169728|bone marrow transplantation|bone marrow transplantation
817582|NCT00169728|children|children
817583|NCT00169728|vaccination|vaccination
817584|NCT00169728|invasive pneumococcal disease|invasive pneumococcal disease
817585|NCT00169728|tetanus|tetanus
817586|NCT00169728|diphtheria|diphtheria
817587|NCT00169728|poliomyelitis|poliomyelitis
817588|NCT00169728|pertussis|pertussis
817589|NCT00169728|Hepatitis B|hepatitis b
817590|NCT00169728|Haemophilus influenzae type B infection|haemophilus influenzae type b infection
817591|NCT00169715|Kidney stones|kidney stones
817592|NCT00169715|renal Calculi|renal calculi
817593|NCT00169715|Tic|tic
817594|NCT00169715|Caliceal Diverticula|caliceal diverticula
817595|NCT00169702|Schizophrenia, weight management programme|schizophrenia, weight management programme
817596|NCT00169689|schizophrenia, rTMS|schizophrenia, rtms
817597|NCT00169676|Prostate Cancer|prostate cancer
817598|NCT00169663|Brushite Kidney Stones|brushite kidney stones
817599|NCT00169663|Nephrolithiasis|nephrolithiasis
817600|NCT00169650|UPJ Obstruction|upj obstruction
817601|NCT00169650|Renal Obstruction|renal obstruction
817602|NCT00169650|Delayed Renal Flow|delayed renal flow
817603|NCT00169637|Short bowel syndrome|short bowel syndrome
817604|NCT00169637|Growth hormone|growth hormone
817605|NCT00169637|Children|children
817606|NCT00169624|Diabetes,|diabetes,
817607|NCT00169624|coronary endothelial dysfunction,|coronary endothelial dysfunction,
817608|NCT00169624|metformin,|metformin,
817609|NCT00169624|glyclazide,|glyclazide,
817610|NCT00169624|MRI.|mri.
817611|NCT00169611|Neurofibromatosis type 1|neurofibromatosis type 1
817612|NCT00169611|Attention deficit with hyperactivity disorder school difficulties|attention deficit with hyperactivity disorder school difficulties
817613|NCT00169611|methylphenidate|methylphenidate
817614|NCT00169598|Lymphoma|lymphoma
817615|NCT00169598|positron emission tomography|positron emission tomography
817616|NCT00169598|stem cell transplantation|stem cell transplantation
817617|NCT00169598|therapeutic impact|therapeutic impact
817618|NCT00169585|diagnostic-therapeutic pathway|diagnostic-therapeutic pathway
817619|NCT00169585|PSA|psa
817620|NCT00169585|DRE|dre
817621|NCT00169585|Levofloxacin|levofloxacin
817625|NCT00169572|Chemotherapy-induced Nausea and Vomiting|chemotherapy-induced nausea and vomiting
817626|NCT00169572|CINV|cinv
817627|NCT00169559|triglycerides|triglycerides
817628|NCT00169559|Hypertriglyceridemia|hypertriglyceridemia
817629|NCT00169559|cholesterol|cholesterol
817630|NCT00169559|LDL|ldl
817631|NCT00169559|HDL|hdl
817632|NCT00169546|Asthma|asthma
817633|NCT00169546|inhaled corticosteroids|inhaled corticosteroids
817634|NCT00169533|safety|safety
817635|NCT00169533|tolerating lapatinib|tolerating lapatinib
817636|NCT00169533|Lapatinib|lapatinib
817637|NCT00169520|Safety|safety
817638|NCT00169520|tolerability|tolerability
817639|NCT00169520|dose limiting toxicity|dose limiting toxicity
817640|NCT00169520|solid tumors|solid tumors
817641|NCT00169520|docetaxel|docetaxel
817642|NCT00169468|B Lymphoma|b lymphoma
817643|NCT00169468|Velcade|velcade
817644|NCT00169468|Chemotherapy|chemotherapy
817645|NCT00169416|chicken pox|chicken pox
817646|NCT00169416|varicella|varicella
817647|NCT00169416|VZV|vzv
817648|NCT00169416|pharmacokinetics|pharmacokinetics
817649|NCT00169403|Idiopathic dystonia|idiopathic dystonia
817650|NCT00169403|deep brain stimulation|deep brain stimulation
817651|NCT00169403|globus pallidus|globus pallidus
817652|NCT00169403|generalised Idiopathic dystonia|generalised idiopathic dystonia
817653|NCT00169390|smoking|smoking
817654|NCT00169390|pregnancy|pregnancy
817655|NCT00169390|newborns|newborns
817656|NCT00169390|monoamine oxidases|monoamine oxidases
817657|NCT00169377|Obsessive compulsive disorder|obsessive compulsive disorder
817658|NCT00169377|deep brain stimulation|deep brain stimulation
817659|NCT00169377|subthalamic nucleus|subthalamic nucleus
817660|NCT00169364|Parkinson's disease|parkinson's disease
817661|NCT00169364|parkin mutation|parkin mutation
817662|NCT00169364|Juvenile parkinson's disease|juvenile parkinson's disease
817663|NCT00169364|positron emission tomography|positron emission tomography
817664|NCT00169338|Dystonia|dystonia
817665|NCT00169338|deep brain stimulation|deep brain stimulation
817666|NCT00169338|globus pallidus|globus pallidus
817667|NCT00169338|Post-anoxic dystonia|post-anoxic dystonia
817668|NCT00169325|basal ganglia|basal ganglia
817669|NCT00169325|loss of psychic self-activation|loss of psychic self-activation
817670|NCT00169312|unspecified adult solid tumor, protocol specific|unspecified adult solid tumor, protocol specific
817671|NCT00169299|Menopause|menopause
817672|NCT00169299|Vasomotor|vasomotor
817673|NCT00169299|Black cohosh|black cohosh
817674|NCT00169299|Herbs|herbs
817675|NCT00169299|Hot flashes|hot flashes
817676|NCT00169299|HT|ht
817677|NCT00169299|CAM|cam
817678|NCT00169273|Obesity|obesity
817679|NCT00169273|Depression|depression
817680|NCT00169273|Behavioral|behavioral
817681|NCT00169273|Cognitive|cognitive
817682|NCT00169273|Treatment|treatment
817683|NCT00169260|smoking|smoking
817684|NCT00169260|tobacco|tobacco
817685|NCT00169260|behavior therapy|behavior therapy
817686|NCT00169247|larynx cancer|larynx cancer
817687|NCT00169247|hypopharynx cancer|hypopharynx cancer
817688|NCT00169247|larynx preservation|larynx preservation
817689|NCT00169247|concomitant radiochemotherapy|concomitant radiochemotherapy
817690|NCT00169247|cisplatin|cisplatin
817691|NCT00169247|cetuximab|cetuximab
817692|NCT00169247|randomized trial|randomized trial
817693|NCT00169234|Pneumococcal disease|pneumococcal disease
817695|NCT00169234|Immunization|immunization
817696|NCT00169234|PPV23|ppv23
817697|NCT00169234|PCV7|pcv7
817698|NCT00169208|relapsed/refractory.|relapsed/refractory.
817699|NCT00169208|lymphoma, follicular|lymphoma, follicular
817700|NCT00169208|rituximab|rituximab
817701|NCT00169208|chemotherapy|chemotherapy
817702|NCT00169195|B-cell lymphoma|b-cell lymphoma
817703|NCT00169195|Salvage Therapy|salvage therapy
817704|NCT00169195|rituximab|rituximab
817705|NCT00169195|oxaliplatine|oxaliplatine
817706|NCT00169195|gemcitabine|gemcitabine
817707|NCT00169182|Larynx cancer|larynx cancer
817708|NCT00169182|Hypopharynx cancer|hypopharynx cancer
817709|NCT00169182|Chemotherapy|chemotherapy
817710|NCT00169182|Randomized trial|randomized trial
817711|NCT00169182|Larynx preservation|larynx preservation
817712|NCT00169169|Diffuse large B cell lymphoma|diffuse large b cell lymphoma
817713|NCT00169169|Rituximab|rituximab
817714|NCT00169169|Autotransplant|autotransplant
817715|NCT00169156|T-cell angioimmunoblastic lymphoma|t-cell angioimmunoblastic lymphoma
817716|NCT00169156|Rituximab|rituximab
817717|NCT00169143|Diffuse large B cell lymphoma|diffuse large b cell lymphoma
817718|NCT00169143|Pegfilgrastim|pegfilgrastim
817719|NCT00169143|Autotransplant|autotransplant
817720|NCT00169130|lymphoma|lymphoma
817721|NCT00169130|autologous stem cell transplant|autologous stem cell transplant
817722|NCT00169130|chemotherapy|chemotherapy
817723|NCT00169130|BCL2|bcl2
817724|NCT00169117|Mosquito nets|mosquito nets
817725|NCT00169117|Malaria prevention|malaria prevention
817726|NCT00169117|Songs|songs
817727|NCT00169117|Posters|posters
817728|NCT00169117|Net repair|net repair
817729|NCT00169117|Bednets|bednets
817730|NCT00169104|Breast cancer|breast cancer
817732|NCT00169104|Granulocyte Colony Stimulating Factor|granulocyte colony stimulating factor
817733|NCT00169104|Trastuzumab|trastuzumab
817734|NCT00169104|Vinorelbine|vinorelbine
817735|NCT00169104|Antibody-dependent cellular cytotoxicity|antibody-dependent cellular cytotoxicity
817736|NCT00169104|Effector cells|effector cells
817737|NCT00169091|Clozapine|clozapine
817738|NCT00169091|Haloperidol|haloperidol
817739|NCT00169091|Schizophrenia|schizophrenia
817740|NCT00169078|Transmission intensity|transmission intensity
817741|NCT00169078|Insecticide-treated materials|insecticide-treated materials
817742|NCT00169078|antimalarial drug resistance|antimalarial drug resistance
817743|NCT00169065|Clozapine|clozapine
817744|NCT00169065|olanzapine|olanzapine
817745|NCT00169052|geriatric,|geriatric,
817746|NCT00169052|older|older
817747|NCT00169052|serious mental illness|serious mental illness
817748|NCT00169052|SMI|smi
817749|NCT00169039|Clozapine|clozapine
817750|NCT00169039|Chlorpromazine|chlorpromazine
817751|NCT00169039|Schizophrenia|schizophrenia
817752|NCT00169039|Biochemistry|biochemistry
817753|NCT00169026|Clozapine|clozapine
817754|NCT00169026|Atypical Antipsychotic|atypical antipsychotic
817755|NCT00169026|Conventional antipsychotic|conventional antipsychotic
817756|NCT00169026|Schizophrenia|schizophrenia
817757|NCT00169026|Dual Diagnosis|dual diagnosis
817758|NCT00169026|Substance Abuse|substance abuse
817759|NCT00169026|Alcohol Abuse|alcohol abuse
817760|NCT00169000|breast cancer|breast cancer
817761|NCT00169000|capecitabine|capecitabine
817762|NCT00169000|docetaxel|docetaxel
817763|NCT00169000|pharmacokinetic/pharmacodynamic|pharmacokinetic/pharmacodynamic
817764|NCT00169000|bcl-2|bcl-2
817765|NCT00169000|bax|bax
817766|NCT00168987|oral nutritional supplement|oral nutritional supplement
817767|NCT00168987|eicosapentanoic acid|eicosapentanoic acid
817768|NCT00168987|gastroenterological tumors|gastroenterological tumors
817769|NCT00168987|muscle function|muscle function
817770|NCT00168987|quality of life|quality of life
817771|NCT00168987|body composition|body composition
817772|NCT00168961|liver cirrhosis Child B or C|liver cirrhosis child b or c
817773|NCT00168948|Intermittent preventive treatment|intermittent preventive treatment
817774|NCT00168948|IPTi|ipti
817775|NCT00168948|Malaria control|malaria control
817776|NCT00168948|Ghana|ghana
817777|NCT00168922|recurrent SCLC|recurrent sclc
817778|NCT00168909|osteoporosis|osteoporosis
817779|NCT00168909|frailty|frailty
817780|NCT00168909|falls|falls
817781|NCT00168896|SCLC|sclc
817782|NCT00168883|NSCLC|nsclc
817783|NCT00168883|curative non-treatable NSCLC UICC stage IIIB and IV|curative non-treatable nsclc uicc stage iiib and iv
817784|NCT00168870|metastatic ocular melanoma|metastatic ocular melanoma
817785|NCT00168766|Combination therapy for multiple sclerosis|combination therapy for multiple sclerosis
817786|NCT00168753|Extended dosing|extended dosing
817787|NCT00168753|alefacept|alefacept
817788|NCT00168740|rituximab|rituximab
817789|NCT00168740|Rituxan|rituxan
817790|NCT00168740|B-cell lymphoma|b-cell lymphoma
817791|NCT00168740|low-grade|low-grade
817792|NCT00168740|follicular|follicular
817793|NCT00168740|anti-CD20 monoclonal antibody|anti-cd20 monoclonal antibody
817794|NCT00168727|Radioimmunotherapy|radioimmunotherapy
817795|NCT00168727|Antigens, CD20|antigens, cd20
817796|NCT00168714|AVONEX|avonex
817797|NCT00168714|Pregnancy|pregnancy
817798|NCT00168701|Multiple Sclerosis|multiple sclerosis
817799|NCT00168701|MRI|mri
817800|NCT00168688|micronutrient supplementation|micronutrient supplementation
817801|NCT00168688|pregnancy|pregnancy
817802|NCT00168688|birth weight|birth weight
817803|NCT00168688|perinatal mortality|perinatal mortality
817804|NCT00168662|Non-specific effects of vaccines|non-specific effects of vaccines
817805|NCT00168662|Infant mortality|infant mortality
817806|NCT00168662|Child mortality|child mortality
817807|NCT00168662|Mortality|mortality
817808|NCT00168662|Morbidity|morbidity
817809|NCT00168662|Measles vaccine|measles vaccine
817810|NCT00168662|Measles|measles
817811|NCT00168662|Immunisation|immunisation
817812|NCT00168662|Low income country|low income country
817813|NCT00168662|Guinea-Bissau|guinea-bissau
817814|NCT00168662|Bandim Health Project|bandim health project
817815|NCT00168662|Immunology|immunology
817816|NCT00168649|Vitamin A|vitamin a
817817|NCT00168649|Endotoxin|endotoxin
817818|NCT00168649|TNF-alfa|tnf-alfa
817819|NCT00168636|Vitamin A|vitamin a
817820|NCT00168636|Mortality|mortality
817821|NCT00168636|Morbidity|morbidity
817822|NCT00168636|OPV|opv
817823|NCT00168636|Sex|sex
817824|NCT00168623|Vitamin A|vitamin a
817825|NCT00168623|Vaccines|vaccines
817826|NCT00168623|Mortality|mortality
817827|NCT00168623|Morbidity|morbidity
817828|NCT00168610|Vitamin A|vitamin a
817829|NCT00168610|BCG|bcg
817830|NCT00168610|Infant mortality|infant mortality
817831|NCT00168610|Morbidity|morbidity
817832|NCT00168610|Low-income country|low-income country
817833|NCT00168610|Mortality|mortality
817834|NCT00168597|Vitamin A|vitamin a
817835|NCT00168597|BCG|bcg
817836|NCT00168597|Infant mortality|infant mortality
817838|NCT00168597|Low-income country|low-income country
817839|NCT00168584|Vitamin A|vitamin a
817840|NCT00168584|Mortality|mortality
817841|NCT00168584|Morbidity|morbidity
817842|NCT00168584|Doses|doses
817843|NCT00168584|OPV|opv
817844|NCT00168571|Measles vaccine|measles vaccine
817845|NCT00168571|Measles|measles
817846|NCT00168571|Measles antibodies|measles antibodies
817847|NCT00168571|Immunisation|immunisation
817848|NCT00168571|Low income country|low income country
817849|NCT00168571|Guinea-Bissau|guinea-bissau
817850|NCT00168571|Bandim Health Project|bandim health project
817851|NCT00168571|Measles antibody level|measles antibody level
817852|NCT00168558|Non-specific effects of vaccines|non-specific effects of vaccines
817853|NCT00168558|Infant mortality|infant mortality
817854|NCT00168558|Child mortality|child mortality
817855|NCT00168558|Mortality|mortality
817856|NCT00168558|Morbidity|morbidity
817857|NCT00168558|Diphtheria-tetanus-pertussis vaccine|diphtheria-tetanus-pertussis vaccine
817858|NCT00168558|Measles vaccine|measles vaccine
817859|NCT00168558|Measles|measles
817860|NCT00168558|Immunisation|immunisation
817861|NCT00168558|Low income country|low income country
817862|NCT00168558|Guinea-Bissau|guinea-bissau
817863|NCT00168558|Bandim Health Project|bandim health project
817864|NCT00168558|Immunology|immunology
817865|NCT00168545|Non-specific effects of vaccines|non-specific effects of vaccines
817866|NCT00168545|Immunology|immunology
817867|NCT00168545|Cytokines|cytokines
817868|NCT00168545|Infant mortality|infant mortality
817869|NCT00168545|Child mortality|child mortality
817870|NCT00168545|Mortality|mortality
817871|NCT00168545|Morbidity|morbidity
817872|NCT00168545|Diphtheria-tetanus-pertussis vaccine|diphtheria-tetanus-pertussis vaccine
817873|NCT00168545|Measles vaccine|measles vaccine
817874|NCT00168545|Measles|measles
817875|NCT00168545|Immunisation|immunisation
817876|NCT00168545|Low income country|low income country
817877|NCT00168545|Guinea-Bissau|guinea-bissau
817878|NCT00168545|Bandim Health Project|bandim health project
817879|NCT00168545|Immunology of measles and DTP vaccination|immunology of measles and dtp vaccination
817880|NCT00168532|Prophylactic antibiotics|prophylactic antibiotics
817881|NCT00168532|Measles|measles
817882|NCT00168532|Pneumonia|pneumonia
817883|NCT00168532|Post-measles pneumonia|post-measles pneumonia
817884|NCT00168532|Low income country|low income country
817885|NCT00168532|Guinea-Bissau|guinea-bissau
817886|NCT00168532|Bandim Health Project|bandim health project
817887|NCT00168519|Diabetes Mellitus, Type 2|diabetes mellitus, type 2
817888|NCT00168519|Blood Glucose|blood glucose
817889|NCT00168519|Exercise|exercise
817890|NCT00168519|Muscle Contraction|muscle contraction
817891|NCT00168519|Nitric Oxide|nitric oxide
817892|NCT00168519|Nitrates|nitrates
817893|NCT00168506|panic disorder|panic disorder
817894|NCT00168506|cardiac risk|cardiac risk
817895|NCT00168493|Major Depression|major depression
817896|NCT00168493|Cardiac disease|cardiac disease
817897|NCT00168402|Axillary Hyperhidrosis|axillary hyperhidrosis
817898|NCT00168376|Transcranial Magnetic Stimulation|transcranial magnetic stimulation
817899|NCT00168376|Depression|depression
817900|NCT00168311|Transcranial Magnetic Stimulation|transcranial magnetic stimulation
817901|NCT00168311|Schizophrenia|schizophrenia
818205|NCT00167154|suicidality|suicidality
817902|NCT00168311|Negative Symptoms|negative symptoms
817903|NCT00168285|Exercise|exercise
818031|NCT00167804|Exposure Therapy|exposure therapy
817904|NCT00168285|Pulmonary rehabilitation|pulmonary rehabilitation
817905|NCT00168285|Idiopathic pulmonary fibrosis|idiopathic pulmonary fibrosis
817906|NCT00168285|Connective tissue disorders|connective tissue disorders
817907|NCT00168272|Transcranial Magnetic Stimulation|transcranial magnetic stimulation
817908|NCT00168272|Depression|depression
817909|NCT00168259|Treatment Naive|treatment naive
817911|NCT00168246|HIV|hiv
817912|NCT00168233|Treatment Naive|treatment naive
817913|NCT00168233|HIV|hiv
817914|NCT00168220|Treatment Experienced|treatment experienced
817915|NCT00168220|HIV|hiv
817916|NCT00168207|Treatment Experienced|treatment experienced
817917|NCT00168207|HIV|hiv
817918|NCT00168194|HIV|hiv
817919|NCT00168181|salagen|salagen
817920|NCT00168181|gland transfer|gland transfer
817921|NCT00168181|randomized|randomized
817922|NCT00168181|xerostomia|xerostomia
817923|NCT00168168|G-CSF|g-csf
817924|NCT00168168|Filgrastim|filgrastim
817925|NCT00168168|Engraftment time|engraftment time
817926|NCT00168168|Autologus transplant|autologus transplant
817927|NCT00168155|resectable liver metastases|resectable liver metastases
817928|NCT00168155|colorectal adenocarcinoma|colorectal adenocarcinoma
817929|NCT00168155|survival|survival
817930|NCT00168155|neoadjuvant chemotherapy|neoadjuvant chemotherapy
817931|NCT00168142|Helical tomotherapy|helical tomotherapy
817932|NCT00168142|Megavoltage imaging|megavoltage imaging
817933|NCT00168129|tomotherapy|tomotherapy
817934|NCT00168129|bone metastases|bone metastases
817935|NCT00168129|radiotherapy|radiotherapy
817936|NCT00168129|intensity modulated|intensity modulated
817937|NCT00168116|nasopharynx|nasopharynx
817938|NCT00168116|xerostomia|xerostomia
817940|NCT00168103|C1 Inhibitor|c1 inhibitor
817941|NCT00168103|Hereditary angioedema|hereditary angioedema
817942|NCT00168103|Acute HAE attack|acute hae attack
817943|NCT00168090|von Willebrand Factor|von willebrand factor
817944|NCT00168090|Blood Coagulation Disorders|blood coagulation disorders
817945|NCT00168090|Factor VIII|factor viii
817946|NCT00168077|Prothrombin Complex Concentrate|prothrombin complex concentrate
817947|NCT00168077|Anticoagulant reversal|anticoagulant reversal
817948|NCT00168064|Mycosis Fungoides|mycosis fungoides
817949|NCT00168064|Nitrogen Mustard|nitrogen mustard
817950|NCT00168064|Cutaneous T-Cell Lymphoma|cutaneous t-cell lymphoma
817951|NCT00168064|CTCL - Mycosis Fungoides|ctcl - mycosis fungoides
817952|NCT00168051|Hemophilia A|hemophilia a
817953|NCT00168038|Chronic Immune Thrombocytopenic Purpura|chronic immune thrombocytopenic purpura
817954|NCT00168038|Chronic Idiopathic Thrombocytopenic Purpura|chronic idiopathic thrombocytopenic purpura
817955|NCT00168038|Werlhofs Disease|werlhofs disease
817956|NCT00168038|Autoimmune Thrombocytopenia|autoimmune thrombocytopenia
817957|NCT00168038|Immunglobulin Intravenous|immunglobulin intravenous
817958|NCT00168038|Chronic ITP|chronic itp
817959|NCT00168038|Platelet count|platelet count
817960|NCT00168038|Thrombocytopenia|thrombocytopenia
817961|NCT00168025|Immunoglobulin Intravenous|immunoglobulin intravenous
817962|NCT00168025|Agammaglobulinemia|agammaglobulinemia
817963|NCT00168025|Hypogammaglobulinemia|hypogammaglobulinemia
817964|NCT00168025|Common variable immunodeficiency|common variable immunodeficiency
817965|NCT00168025|Immunoglobulin G|immunoglobulin g
817966|NCT00168025|Children|children
817967|NCT00168012|Immunoglobulin intravenous|immunoglobulin intravenous
817968|NCT00168012|Agammaglobulinemia|agammaglobulinemia
817969|NCT00168012|Hypogammaglobulinemia|hypogammaglobulinemia
817970|NCT00168012|Common variable immunodeficiency|common variable immunodeficiency
817971|NCT00168012|Immunoglobulin G|immunoglobulin g
817972|NCT00168012|Children|children
817973|NCT00167999|Bacterial Infections|bacterial infections
817974|NCT00167986|Bacterial Infections|bacterial infections
817975|NCT00167973|Hemophilia B|hemophilia b
817976|NCT00167960|Bacterial Infections|bacterial infections
817977|NCT00167947|Kidney|kidney
817978|NCT00167947|Transplant|transplant
817979|NCT00167934|Diabetes|diabetes
817980|NCT00167934|Metabolic|metabolic
817981|NCT00167895|osteoarthritis|osteoarthritis
817982|NCT00167895|knee|knee
817983|NCT00167895|platelet concentrate|platelet concentrate
817984|NCT00167882|Crohn's disease|crohn's disease
817985|NCT00167882|Ulcerative colitis|ulcerative colitis
817986|NCT00167882|Inflammatory bowel disease|inflammatory bowel disease
817987|NCT00167882|azathioprine|azathioprine
817988|NCT00167882|6-mercaptopurine|6-mercaptopurine
817989|NCT00167882|5-aminosalicylate|5-aminosalicylate
817990|NCT00167882|metabolism|metabolism
817991|NCT00167869|hypertension|hypertension
817992|NCT00167869|blood pressure|blood pressure
817993|NCT00167869|dairy peptides|dairy peptides
817994|NCT00167869|bioactive peptides|bioactive peptides
817995|NCT00167869|randomized controlled trial|randomized controlled trial
817996|NCT00167856|Burning pain|burning pain
817997|NCT00167856|Clinical trial|clinical trial
817998|NCT00167856|Effexor|effexor
817999|NCT00167856|Pain|pain
818000|NCT00167856|Spinal cord injury|spinal cord injury
818001|NCT00167856|Venalafaxine|venalafaxine
818002|NCT00167856|Neuropathic Pain|neuropathic pain
818003|NCT00167843|Malaria|malaria
818004|NCT00167843|Anemia|anemia
818005|NCT00167843|Children|children
818006|NCT00167843|Gabon|gabon
818007|NCT00167843|Intermittent preventive treatment|intermittent preventive treatment
818008|NCT00167830|Pediatric Overweight,|pediatric overweight,
818009|NCT00167830|African American;|african american;
818010|NCT00167830|Adolescent;|adolescent;
818011|NCT00167830|Intervention,|intervention,
818012|NCT00167830|Teasing;|teasing;
818013|NCT00167830|Self-esteem|self-esteem
818014|NCT00167830|Quality of Life|quality of life
818015|NCT00167830|Metabolic syndrome|metabolic syndrome
818016|NCT00167830|Insulin resistance|insulin resistance
818017|NCT00167830|Diabetes|diabetes
818018|NCT00167830|Nutrition|nutrition
818019|NCT00167830|Motivation|motivation
818020|NCT00167830|Culture|culture
818021|NCT00167830|BMI|bmi
818022|NCT00167830|Cardiorespiratory fitness|cardiorespiratory fitness
818023|NCT00167830|Resistance Training|resistance training
818024|NCT00167830|Compliance|compliance
818025|NCT00167817|Schizophrenia|schizophrenia
818026|NCT00167817|Smoking|smoking
818027|NCT00167817|Metabolic|metabolic
818028|NCT00167817|Health|health
818029|NCT00167817|Glucose|glucose
818030|NCT00167817|Lipids|lipids
818032|NCT00167804|Post Traumatic Stress Disorder|post traumatic stress disorder
818033|NCT00167804|Treatment Outcome|treatment outcome
818034|NCT00167804|Veterans|veterans
818035|NCT00167804|Virtual Reality|virtual reality
818036|NCT00167791|transplant|transplant
818037|NCT00167791|desensitization|desensitization
818038|NCT00167791|kidney transplant|kidney transplant
818039|NCT00167778|Amputation|amputation
818041|NCT00167778|Artificial limbs|artificial limbs
818042|NCT00167778|Gait|gait
818045|NCT00167765|stroke, ischemic|stroke, ischemic
818046|NCT00167765|acute ischemic stroke|acute ischemic stroke
818047|NCT00167739|Malaria|malaria
818048|NCT00167739|Quinine|quinine
818049|NCT00167739|Sulfadoxine-pyrimethamine|sulfadoxine-pyrimethamine
818050|NCT00167739|Gabon|gabon
818051|NCT00167713|Malaria|malaria
818052|NCT00167713|Fever|fever
818053|NCT00167713|Ibuprofen|ibuprofen
818054|NCT00167713|Gabon|gabon
818055|NCT00167700|atopic disease|atopic disease
818056|NCT00167700|probiotics|probiotics
818057|NCT00167700|gut microbiota|gut microbiota
818058|NCT00167700|allergy|allergy
818059|NCT00167700|nutrition|nutrition
818060|NCT00167700|growth|growth
818061|NCT00167700|allergic rhinitis|allergic rhinitis
818062|NCT00167700|atopic sensitization|atopic sensitization
818063|NCT00167700|risk-markers of life-style related diseases|risk-markers of life-style related diseases
818064|NCT00167687|Alcoholism|alcoholism
818065|NCT00167687|Randomized Controlled Trial|randomized controlled trial
818066|NCT00167674|breastmilk|breastmilk
818067|NCT00167674|HIV-1|hiv-1
818068|NCT00167674|antiretroviral|antiretroviral
818069|NCT00167674|mother-to-child|mother-to-child
818070|NCT00167674|transmission|transmission
818071|NCT00167661|living or deceased donor renal transplant recipient|living or deceased donor renal transplant recipient
818072|NCT00167635|Irritable Bowel Syndrome|irritable bowel syndrome
818073|NCT00167635|Cognitive-behavioral intervention|cognitive-behavioral intervention
818074|NCT00167635|Psychological distress|psychological distress
818075|NCT00167635|Quality of life|quality of life
818076|NCT00167622|Guillain Barré|guillain barré
818077|NCT00167622|Mechanical ventilation, invasive|mechanical ventilation, invasive
818078|NCT00167622|Mechanical ventilation, non invasive|mechanical ventilation, non invasive
818079|NCT00167622|Pneumonia|pneumonia
818080|NCT00167609|myotonic dystrophy|myotonic dystrophy
818081|NCT00167609|hypersomnia|hypersomnia
818082|NCT00167609|dehydroepiandrosterone|dehydroepiandrosterone
818083|NCT00167596|near infrared spectroscopy|near infrared spectroscopy
818084|NCT00167596|tissue oxygenation|tissue oxygenation
818085|NCT00167596|organ dysfunction|organ dysfunction
818086|NCT00167596|mortality|mortality
818087|NCT00167583|Ocular Behcet`s disease|ocular behcet`s disease
818088|NCT00167583|Panuveitis|panuveitis
818089|NCT00167583|Posterior Uveitis|posterior uveitis
818090|NCT00167583|Retinal vasculitis|retinal vasculitis
818091|NCT00167583|Treatment|treatment
818092|NCT00167583|Interferon-alpha|interferon-alpha
818093|NCT00167583|Cyclosporin A|cyclosporin a
818094|NCT00167570|Artificial Limbs|artificial limbs
818095|NCT00167570|Amputees|amputees
818096|NCT00167570|Computer-Aided Design|computer-aided design
818097|NCT00167557|Liver Transplantation|liver transplantation
818098|NCT00167544|Bronchopulmonary Dysplasia|bronchopulmonary dysplasia
818099|NCT00167544|Encephalomalacia|encephalomalacia
818100|NCT00167544|Brain injury|brain injury
818101|NCT00167544|Neurosensory impairment|neurosensory impairment
818102|NCT00167544|Corticosteroids|corticosteroids
818103|NCT00167544|Anti-Inflammatory Agents|anti-inflammatory agents
818104|NCT00167544|Extremely Low Birth Weight (ELBW) infants|extremely low birth weight (elbw) infants
818105|NCT00167544|Premature Birth|premature birth
818106|NCT00167544|Magnetic Resonance Imaging|magnetic resonance imaging
818107|NCT00167531|Stroke|stroke
818108|NCT00167531|health outcomes|health outcomes
818109|NCT00167531|physiotherapy|physiotherapy
818110|NCT00167531|rehabilitation|rehabilitation
818111|NCT00167531|treadmill|treadmill
818112|NCT00167518|Diabetic macular oedema|diabetic macular oedema
818113|NCT00167518|Triamcinolone acetate|triamcinolone acetate
818114|NCT00167518|Intravitreal injection|intravitreal injection
818115|NCT00167518|Clinical trial|clinical trial
818116|NCT00167518|Laser treatment|laser treatment
818117|NCT00167505|adolescents|adolescents
818118|NCT00167505|sexual health|sexual health
818119|NCT00167505|HIV|hiv
818120|NCT00167505|STD|std
818121|NCT00167505|pregnancy prevention|pregnancy prevention
818122|NCT00167505|abstinence education|abstinence education
818123|NCT00167505|HIV Seronegativity|hiv seronegativity
818124|NCT00167505|human immunodeficiency virus|human immunodeficiency virus
818125|NCT00167479|Bipolar Anxiety|bipolar anxiety
818126|NCT00167479|Bipolar Disorder|bipolar disorder
818127|NCT00167479|Anxiety|anxiety
818128|NCT00167479|Panic Disorder|panic disorder
818129|NCT00167479|Generalized Anxiety Disorder|generalized anxiety disorder
818130|NCT00167479|GAD|gad
818131|NCT00167479|Risperidone|risperidone
818132|NCT00167479|Double-Blind|double-blind
818133|NCT00167479|Placebo Controlled|placebo controlled
818134|NCT00167466|periodontal disease|periodontal disease
818135|NCT00167466|toothbrush|toothbrush
818136|NCT00167466|titanium dioxide semiconductor|titanium dioxide semiconductor
818137|NCT00167466|mild-to-moderate periodontal disease|mild-to-moderate periodontal disease
818138|NCT00167466|adult patients 18 to 70 years of age|adult patients 18 to 70 years of age
818139|NCT00167453|Nervous system disease|nervous system disease
818140|NCT00167453|movement disorder|movement disorder
818141|NCT00167453|exercise|exercise
818142|NCT00167453|balance|balance
818143|NCT00167453|education|education
818144|NCT00167440|cardiac index|cardiac index
818145|NCT00167440|cardiac output|cardiac output
818146|NCT00167440|indwelling central venous catheter|indwelling central venous catheter
818147|NCT00167440|indwelling arterial catheter|indwelling arterial catheter
818148|NCT00167414|conformal radiotherapy|conformal radiotherapy
818149|NCT00167388|anemia|anemia
818150|NCT00167388|prematurity|prematurity
818151|NCT00167388|blood flow velocity|blood flow velocity
818152|NCT00167388|superior mesenteric artery|superior mesenteric artery
818153|NCT00167388|intestinal blood flow in premature infants|intestinal blood flow in premature infants
818154|NCT00167375|Insomnia|insomnia
818155|NCT00167375|polysomnography|polysomnography
818156|NCT00167375|sleep onset|sleep onset
818157|NCT00167375|time series analysis|time series analysis
818158|NCT00167362|Schizophrenia|schizophrenia
818159|NCT00167362|Cognition|cognition
818160|NCT00167362|Enhancement|enhancement
818161|NCT00167362|Randomized|randomized
818162|NCT00167349|cardiac surgery|cardiac surgery
818163|NCT00167349|cardiopulmonary bypass|cardiopulmonary bypass
818164|NCT00167349|cytokines|cytokines
818165|NCT00167336|Computer|computer
818166|NCT00167336|Kinematics|kinematics
818167|NCT00167336|Instrument development|instrument development
818168|NCT00167336|Reliability|reliability
818169|NCT00167336|Cumulative Trauma Disorder|cumulative trauma disorder
818170|NCT00167323|Bipolar|bipolar
818171|NCT00167323|Alcoholism|alcoholism
818172|NCT00167310|Omega-3 fatty acids|omega-3 fatty acids
818173|NCT00167310|Statins|statins
818174|NCT00167310|Antipsychotic drug|antipsychotic drug
818175|NCT00167310|Antidepressant drug|antidepressant drug
818176|NCT00167310|Antimanic drug|antimanic drug
818177|NCT00167310|Placebos|placebos
818178|NCT00167310|Double-blind method|double-blind method
818179|NCT00167310|Bipolar (depressed phase)|bipolar (depressed phase)
818180|NCT00167297|atomoxetine|atomoxetine
818181|NCT00167297|cannabis dependence|cannabis dependence
818182|NCT00167297|treatment|treatment
818183|NCT00167284|chronic care model, diabetes, community, diabetes education|chronic care model, diabetes, community, diabetes education
818184|NCT00167271|Cognitive therapy|cognitive therapy
818185|NCT00167245|Topiramate|topiramate
818186|NCT00167245|alcoholism|alcoholism
818187|NCT00167245|cocaine dependence|cocaine dependence
818188|NCT00167232|naltrexone|naltrexone
818189|NCT00167232|cocaine dependence|cocaine dependence
818190|NCT00167232|alcohol dependence|alcohol dependence
818191|NCT00167232|psychosocial treatment|psychosocial treatment
818192|NCT00167219|Stem cell transplant|stem cell transplant
818193|NCT00167219|long term survival|long term survival
818194|NCT00167219|retinoic acid|retinoic acid
818195|NCT00167206|Stem Cell Transplant|stem cell transplant
818196|NCT00167206|Thymic Shielding|thymic shielding
818197|NCT00167206|Total Body Irradiation|total body irradiation
818198|NCT00167206|Chemotherapy|chemotherapy
818199|NCT00167180|donor lymphocyte infusions|donor lymphocyte infusions
818200|NCT00167180|BMT|bmt
818201|NCT00167180|bone marrow transplant|bone marrow transplant
818202|NCT00167167|Donor Lymphocyte Infusion|donor lymphocyte infusion
818203|NCT00167167|relapse|relapse
818204|NCT00167167|post-transplant|post-transplant
818206|NCT00167154|antipsychotic|antipsychotic
818207|NCT00167154|antidepressant|antidepressant
818208|NCT00167154|treatment|treatment
818209|NCT00167141|male fertility|male fertility
818210|NCT00167141|semen parameters|semen parameters
818211|NCT00167128|Auditory Processing Disorder|auditory processing disorder
818212|NCT00167128|speech-in-noise intelligibility|speech-in-noise intelligibility
818213|NCT00167115|Alcohol|alcohol
818214|NCT00167115|Type 2 diabetes mellitus|type 2 diabetes mellitus
818215|NCT00167115|Plama glucose|plama glucose
818216|NCT00167115|HDL cholesterol|hdl cholesterol
818217|NCT00167102|Alopecia Areata|alopecia areata
818218|NCT00167089|Stroke|stroke
818219|NCT00167089|Hemiplegia|hemiplegia
818220|NCT00167089|Gait|gait
818221|NCT00167089|Ambulation training|ambulation training
818222|NCT00167089|Neurologic physical therapy|neurologic physical therapy
818223|NCT00167076|Stroke|stroke
818224|NCT00167076|Foot pressure|foot pressure
818225|NCT00167076|Walking speed|walking speed
818226|NCT00167076|Gait|gait
818227|NCT00167063|Stroke|stroke
818228|NCT00167063|Fall|fall
818229|NCT00167063|Fall prediction|fall prediction
818230|NCT00167063|Clinical manifestations|clinical manifestations
818231|NCT00167063|Frequent faller|frequent faller
818232|NCT00167037|Hemiplegia|hemiplegia
818233|NCT00167037|Waist pulling perturbation|waist pulling perturbation
818234|NCT00167037|Reactive balance strategy|reactive balance strategy
818235|NCT00167037|Trajectory of center of pressure|trajectory of center of pressure
818236|NCT00167037|Parameters of center of pressure|parameters of center of pressure
818237|NCT00167024|prostate cancer, DNA repair gene, genetic polymorphism|prostate cancer, dna repair gene, genetic polymorphism
818238|NCT00167011|coronary artery|coronary artery
818239|NCT00166998|Breast neoplasms|breast neoplasms
818240|NCT00166998|diagnosis|diagnosis
818241|NCT00166985|endometrial cancer, MRI, Doppler sonography, angiogenesis|endometrial cancer, mri, doppler sonography, angiogenesis
818340|NCT00166608|tylenol overdose|tylenol overdose
818242|NCT00166972|metastasis, survival, malignancy, female, trophinin|metastasis, survival, malignancy, female, trophinin
818243|NCT00166959|Stroke patients|stroke patients
818244|NCT00166959|Falls|falls
818245|NCT00166959|Reliability|reliability
818246|NCT00166959|Validity|validity
818247|NCT00166933|minimal erythema dose|minimal erythema dose
818248|NCT00166933|UVB|uvb
818249|NCT00166933|normal|normal
818250|NCT00166907|Stroke|stroke
818251|NCT00166907|Balance|balance
818252|NCT00166907|Proactive control|proactive control
818253|NCT00166907|Reactive control|reactive control
818254|NCT00166907|Recovery|recovery
818255|NCT00166907|Training|training
818256|NCT00166907|Fall|fall
818257|NCT00166894|pleural effusion|pleural effusion
818258|NCT00166894|TREM-1|trem-1
818259|NCT00166881|Combination, Chemotherapy, Inoperable Gastric Cancer|combination, chemotherapy, inoperable gastric cancer
818260|NCT00166868|Biliary atresia, cholangitis, probiotics, prophylaxis|biliary atresia, cholangitis, probiotics, prophylaxis
818261|NCT00166855|angiogenesis|angiogenesis
818262|NCT00166855|bone marrow perfusion|bone marrow perfusion
818263|NCT00166855|dynamic MRI|dynamic mri
818264|NCT00166855|multiple myeloma|multiple myeloma
818265|NCT00166855|prognosis|prognosis
818266|NCT00166842|Pharmacokinetics|pharmacokinetics
818267|NCT00166842|Sirolimus|sirolimus
818268|NCT00166842|Cyclosporine|cyclosporine
818269|NCT00166842|Tacrolimus|tacrolimus
818270|NCT00166842|Immunosuppressive Agents|immunosuppressive agents
818271|NCT00166842|Immunosuppression|immunosuppression
818272|NCT00166842|Transplantation|transplantation
818273|NCT00166842|Kidney Transplantation|kidney transplantation
818274|NCT00166829|Tacrolimus|tacrolimus
818275|NCT00166829|Sirolimus|sirolimus
818276|NCT00166829|Mycophenolic acid|mycophenolic acid
818277|NCT00166829|Immunosuppressive Agents|immunosuppressive agents
818278|NCT00166829|Immunosuppression|immunosuppression
818279|NCT00166829|Kidney Transplantation|kidney transplantation
818280|NCT00166829|Transplantation|transplantation
818281|NCT00166816|Sirolimus|sirolimus
818282|NCT00166816|Tacrolimus|tacrolimus
818283|NCT00166816|Cyclosporine|cyclosporine
818284|NCT00166816|Pharmacokinetics|pharmacokinetics
818285|NCT00166816|Immunosuppressive Agents|immunosuppressive agents
818286|NCT00166816|Immunosuppression|immunosuppression
818287|NCT00166816|Kidney Transplantation|kidney transplantation
818288|NCT00166816|Transplantation|transplantation
818289|NCT00166803|Diabetes Mellitus, PPARγ agonist, FDG PET|diabetes mellitus, pparγ agonist, fdg pet
818290|NCT00166790|Human Chorionic Gonadotropin|human chorionic gonadotropin
818291|NCT00166790|Dual Polarization Interferometry,|dual polarization interferometry,
818292|NCT00166790|Gestational Trophoblastic Neoplasms|gestational trophoblastic neoplasms
818293|NCT00166764|Psychiatric Disorders|psychiatric disorders
818294|NCT00166764|Evaluation of Mental Health Index|evaluation of mental health index
818295|NCT00166751|Videofluoroscopic examination,|videofluoroscopic examination,
818296|NCT00166751|ultrasound|ultrasound
818297|NCT00166751|laryngeal elevation|laryngeal elevation
818298|NCT00166751|dysphagia|dysphagia
818299|NCT00166738|Schizophrenia|schizophrenia
818300|NCT00166738|multiple genes|multiple genes
818301|NCT00166738|array-comparative genomic hybridization (CGH)|array-comparative genomic hybridization (cgh)
818302|NCT00166738|genomic DNA|genomic dna
818303|NCT00166738|Chinese Han People|chinese han people
818304|NCT00166725|HRPC|hrpc
818305|NCT00166725|octreotide LAR|octreotide lar
818306|NCT00166725|CgA|cga
818307|NCT00166712|Kidney Transplant|kidney transplant
818308|NCT00166712|Living Donor Kidney Transplant Recipients|living donor kidney transplant recipients
818309|NCT00166699|ultrasonography|ultrasonography
818310|NCT00166699|obesity|obesity
818311|NCT00166699|Cesarean Section|cesarean section
818312|NCT00166699|Anesthesia|anesthesia
818313|NCT00166699|Epidural|epidural
818314|NCT00166686|Cancer|cancer
818315|NCT00166686|Clonidine|clonidine
818316|NCT00166686|Neurocognitive sequelae|neurocognitive sequelae
818317|NCT00166673|Diabetes Mellitus, Insulin-Dependent|diabetes mellitus, insulin-dependent
818318|NCT00166673|Type 1 Diabetes|type 1 diabetes
818319|NCT00166673|Continuous Glucose Monitoring Devices|continuous glucose monitoring devices
818320|NCT00166673|Electronic Data Collection|electronic data collection
818321|NCT00166660|Preterm infants|preterm infants
818322|NCT00166660|Developmental Care|developmental care
818323|NCT00166660|NIDCAP|nidcap
818324|NCT00166660|Fetal Growth Restriction|fetal growth restriction
818325|NCT00166660|Neurobehavior|neurobehavior
818326|NCT00166660|APIB|apib
818327|NCT00166660|MRI|mri
818328|NCT00166660|EEG|eeg
818329|NCT00166660|Parent Stress|parent stress
818330|NCT00166647|Cancer|cancer
818331|NCT00166647|Chemotherapy|chemotherapy
818332|NCT00166647|Hematological disorder|hematological disorder
818333|NCT00166634|Hypertension|hypertension
818334|NCT00166634|ABPM|abpm
818335|NCT00166634|Ambulatory Blood Pressure Monitoring|ambulatory blood pressure monitoring
818336|NCT00166621|Autism|autism
818337|NCT00166621|Neuroplasticity|neuroplasticity
818338|NCT00166608|acetaminophen toxicity|acetaminophen toxicity
818339|NCT00166608|liver damage|liver damage
818343|NCT00166595|Pervasive Developmental Disorder (PDD)|pervasive developmental disorder (pdd)
818344|NCT00166582|pediatric asthma, medication adherence, adolescents|pediatric asthma, medication adherence, adolescents
818345|NCT00166569|Polycystic Ovary Syndrome|polycystic ovary syndrome
818346|NCT00166543|locally advanced breast carcinoma|locally advanced breast carcinoma
818347|NCT00166543|locally recurrent inoperable breast carcinoma|locally recurrent inoperable breast carcinoma
818348|NCT00166543|progressive metastatic breast carcinoma|progressive metastatic breast carcinoma
818349|NCT00166517|Gastrointestinal Rotavirus|gastrointestinal rotavirus
818350|NCT00166439|C04.557.386|c04.557.386
818351|NCT00166387|Hemophilia|hemophilia
818352|NCT00166387|Inhibitors|inhibitors
818353|NCT00166361|Extrinsic ureteral obstruction|extrinsic ureteral obstruction
818354|NCT00166361|Memokath 051 Ureteral Stent|memokath 051 ureteral stent
818355|NCT00166361|JJ Stent|jj stent
818356|NCT00166361|Stent|stent
818357|NCT00166348|Cognitive Rehabilitation|cognitive rehabilitation
818358|NCT00166322|IBZM-SPECT|ibzm-spect
818359|NCT00166322|Amphetamine Challenge|amphetamine challenge
818360|NCT00166322|Schizophrenia|schizophrenia
818361|NCT00166322|dopaminergic neurotransmission|dopaminergic neurotransmission
818362|NCT00166322|Persons at risk for the development of schizophrenia|persons at risk for the development of schizophrenia
818363|NCT00166322|healthy subjects|healthy subjects
818364|NCT00166309|Hemophilia A|hemophilia a
818365|NCT00166309|Inhibitors|inhibitors
818366|NCT00166296|Major depressive disorder, chemically induced.|major depressive disorder, chemically induced.
818367|NCT00166296|Peginterferon alfa-2a.|peginterferon alfa-2a.
818368|NCT00166296|Escitalopram.|escitalopram.
818369|NCT00166296|Chronic hepatitis C, psychology.|chronic hepatitis c, psychology.
818370|NCT00166296|Prophylactic treatment.|prophylactic treatment.
818371|NCT00166283|memory|memory
818372|NCT00166283|learning|learning
818373|NCT00166283|Multiple Sclerosis|multiple sclerosis
818374|NCT00166283|Cognition|cognition
818375|NCT00166283|treatment|treatment
818376|NCT00166283|therapy|therapy
818377|NCT00166270|Fibroids|fibroids
818378|NCT00166270|ExAblate|exablate
818379|NCT00166270|MrgFus|mrgfus
818380|NCT00166270|Uterine Fibroids|uterine fibroids
818381|NCT00166257|Paradoxical embolism, Patent foramen ovale,|paradoxical embolism, patent foramen ovale,
818382|NCT00166244|Mycophenolate mofetil|mycophenolate mofetil
818383|NCT00166244|Therapeutic Drug Monitoring|therapeutic drug monitoring
818384|NCT00166244|Adult kidney transplantation|adult kidney transplantation
818385|NCT00166244|Paediatric kidney transplantation|paediatric kidney transplantation
818386|NCT00166231|Innocent heart murmurs|innocent heart murmurs
818387|NCT00166231|Chest pain|chest pain
818388|NCT00166231|pediatric Cardiology|pediatric cardiology
818389|NCT00166231|Somatization|somatization
818390|NCT00166231|life stress|life stress
818391|NCT00166218|pediatrics|pediatrics
818392|NCT00166218|cardiac defects|cardiac defects
818393|NCT00166205|Obesity, Morbid|obesity, morbid
818394|NCT00166205|Obesity|obesity
818395|NCT00166205|Body Weight|body weight
818396|NCT00166192|Melasma|melasma
818397|NCT00166192|Jessner's solution|jessner's solution
818398|NCT00166192|Trichloroacetic acid (TCA)|trichloroacetic acid (tca)
818400|NCT00166166|hyperlipidaemia|hyperlipidaemia
818401|NCT00166166|EDHF|edhf
818402|NCT00166166|FMD|fmd
818403|NCT00166153|cardiac transplantation|cardiac transplantation
818404|NCT00166153|pediatrics|pediatrics
818405|NCT00166153|cardiology|cardiology
818406|NCT00166153|drug metabolism|drug metabolism
818407|NCT00166140|pediatrics|pediatrics
818408|NCT00166140|cardiac|cardiac
818409|NCT00166140|surgery|surgery
818410|NCT00166127|heart failure|heart failure
818411|NCT00166127|cardiac surgery|cardiac surgery
818412|NCT00166127|pharmacokinetics|pharmacokinetics
818413|NCT00166127|pharmacodynamics|pharmacodynamics
818414|NCT00166114|platelet function|platelet function
818415|NCT00166114|childhood abuse|childhood abuse
818416|NCT00166114|depression|depression
818417|NCT00166114|antidepressants|antidepressants
818418|NCT00166114|immune function|immune function
818419|NCT00166114|stress response|stress response
818420|NCT00166101|pediatric|pediatric
818421|NCT00166101|cardiac surgery|cardiac surgery
818422|NCT00166088|Oxidative Stress|oxidative stress
818423|NCT00166088|Diet, Mediterranean|diet, mediterranean
818424|NCT00166075|Suicidality|suicidality
818425|NCT00166075|PTSD|ptsd
818426|NCT00166075|depression|depression
818427|NCT00166062|intimate partner violence|intimate partner violence
818428|NCT00166062|perpetration|perpetration
818429|NCT00166049|Heart failure|heart failure
818430|NCT00166049|Family partnership|family partnership
818431|NCT00166049|Patient family education|patient family education
818432|NCT00166023|pediatric|pediatric
818433|NCT00166023|cardiology|cardiology
818434|NCT00166010|drug|drug
818435|NCT00166010|pediatrics|pediatrics
818436|NCT00166010|cardiac|cardiac
818437|NCT00166010|Children with Cardiac Ventricular Failure|children with cardiac ventricular failure
818438|NCT00165997|pediatrics|pediatrics
818439|NCT00165997|cardiology|cardiology
818440|NCT00165997|Radiofrequency ablation|radiofrequency ablation
818441|NCT00165997|structurally normal heart|structurally normal heart
818445|NCT00165984|hypoplastic heart ventricle|hypoplastic heart ventricle
818446|NCT00165971|Cognitive decline|cognitive decline
818447|NCT00165971|Inflammation|inflammation
818448|NCT00165971|Monitoring|monitoring
818449|NCT00165971|Recovery|recovery
818450|NCT00165971|Bispectral index|bispectral index
818451|NCT00165958|Epidermal cyst|epidermal cyst
818452|NCT00165958|Epidermoid cyst|epidermoid cyst
818453|NCT00165958|Sebaceous cyst|sebaceous cyst
818454|NCT00165958|Pilar cyst|pilar cyst
818455|NCT00165945|pediatric, cardiology, diagnostic imaging using MRI|pediatric, cardiology, diagnostic imaging using mri
818456|NCT00165932|tachycardia|tachycardia
818457|NCT00165932|pediatrics|pediatrics
818458|NCT00165919|Hepatitis C|hepatitis c
818459|NCT00165919|HIV|hiv
818460|NCT00165919|Immunopathogenesis|immunopathogenesis
818461|NCT00165919|HIV-1|hiv-1
818462|NCT00165906|neonates|neonates
818463|NCT00165906|cardiac|cardiac
818464|NCT00165906|non-cardiac|non-cardiac
818465|NCT00165906|surgery|surgery
818466|NCT00165906|anticoagulation|anticoagulation
818467|NCT00165893|low back pain|low back pain
818468|NCT00165893|DDD|ddd
818469|NCT00165841|non-erosive symptomatic GERD|non-erosive symptomatic gerd
818470|NCT00165841|GERD|gerd
818471|NCT00165828|Epilepsy|epilepsy
818472|NCT00165802|Cancer|cancer
818473|NCT00165802|malignant tumors|malignant tumors
818474|NCT00165763|Vascular Dementia|vascular dementia
818475|NCT00165737|Dementia cerebrovascular disease|dementia cerebrovascular disease
818476|NCT00165698|Postmenopausal|postmenopausal
818477|NCT00165698|osteoporosis|osteoporosis
818478|NCT00165672|24-hour esophageal pH monitoring|24-hour esophageal ph monitoring
818479|NCT00165672|non-erosive gastroesophageal reflux disease|non-erosive gastroesophageal reflux disease
818480|NCT00165672|NERD|nerd
818481|NCT00165672|proton pump inhibitor|proton pump inhibitor
818482|NCT00165672|rabeprazole|rabeprazole
818483|NCT00165646|non-erosive gastroesophageal reflux disease|non-erosive gastroesophageal reflux disease
818484|NCT00165646|NERD|nerd
818485|NCT00165646|proton pump inhibitor|proton pump inhibitor
818486|NCT00165646|rabeprazole|rabeprazole
818487|NCT00165633|Hepatocellular|hepatocellular
818488|NCT00165633|Carcinoma|carcinoma
818489|NCT00165633|Hepatitis C Virus|hepatitis c virus
818490|NCT00165633|Hepatitis B Virus|hepatitis b virus
818491|NCT00165633|recurrence|recurrence
818492|NCT00165633|Vitamin K2|vitamin k2
818493|NCT00165633|E0167|e0167
818494|NCT00165594|gastric cancer|gastric cancer
818495|NCT00165594|Phase I|phase i
818496|NCT00165594|Phase IIa|phase iia
818497|NCT00165594|E7070|e7070
818498|NCT00165594|Indisulam|indisulam
818499|NCT00165594|Pharmacogenomic|pharmacogenomic
818500|NCT00165594|2C19|2c19
818501|NCT00165581|Intracavitary brachytherapy|intracavitary brachytherapy
818502|NCT00165581|radiation therapy|radiation therapy
818503|NCT00165581|Stage I breast cancer|stage i breast cancer
818504|NCT00165581|Stage II breast cancer|stage ii breast cancer
818505|NCT00165568|Positron emission tomography|positron emission tomography
818506|NCT00165568|PET|pet
818507|NCT00165568|bevacizumab|bevacizumab
818508|NCT00165568|5fluorouracil|5fluorouracil
818509|NCT00165568|Metastatic colorectal cancer|metastatic colorectal cancer
818510|NCT00165555|cisplatin|cisplatin
818511|NCT00165555|pleurectomy|pleurectomy
818512|NCT00165555|decortication|decortication
818513|NCT00165555|heated cisplatin|heated cisplatin
818514|NCT00165542|A-protein level|a-protein level
818515|NCT00165542|brain tumor|brain tumor
818516|NCT00165516|Extrapleural pneumonectomy|extrapleural pneumonectomy
818517|NCT00165516|cisplatin|cisplatin
818518|NCT00165516|heated cisplatin|heated cisplatin
818519|NCT00165503|pleurectomy|pleurectomy
818520|NCT00165503|decortication|decortication
818521|NCT00165503|cisplatin|cisplatin
818522|NCT00165503|ALIMTA|alimta
818523|NCT00165490|adenocarcinoma of esophagus|adenocarcinoma of esophagus
818524|NCT00165490|squamous cell carcinoma of esophagus|squamous cell carcinoma of esophagus
818525|NCT00165490|combination chemotherapy|combination chemotherapy
818526|NCT00165490|cisplatin|cisplatin
818527|NCT00165490|irinotecan|irinotecan
818528|NCT00165490|radiation therapy|radiation therapy
818529|NCT00165490|resectable esophageal cancer|resectable esophageal cancer
818530|NCT00165477|Glioblastoma|glioblastoma
818531|NCT00165477|Gliosarcoma|gliosarcoma
818532|NCT00165477|Malignant Gliomas|malignant gliomas
818533|NCT00165477|Radiation Therapy|radiation therapy
818534|NCT00165477|IMiD|imid
818535|NCT00165477|Lenalidomide|lenalidomide
818536|NCT00165464|Esophageal Cancer|esophageal cancer
818537|NCT00165464|Gastric Cancer|gastric cancer
818538|NCT00165464|GE Junction|ge junction
818539|NCT00165464|Cisplatin|cisplatin
818540|NCT00165464|Taxotere|taxotere
818541|NCT00165464|CPT-11|cpt-11
818542|NCT00165464|Irinotecan|irinotecan
818543|NCT00165451|Relapsed tumors|relapsed tumors
818544|NCT00165451|Progressive Poor Prognosis Tumors|progressive poor prognosis tumors
818545|NCT00165451|Thalidomide|thalidomide
818546|NCT00165451|Celecoxib|celecoxib
818547|NCT00165451|Etoposide|etoposide
818548|NCT00165451|Cyclophosphamide|cyclophosphamide
818549|NCT00165438|Pulmonary function|pulmonary function
818550|NCT00165438|Bleomycin-based chemotherapy|bleomycin-based chemotherapy
818551|NCT00165438|mediastinal irradiation|mediastinal irradiation
818552|NCT00165425|Cardiac screening|cardiac screening
818553|NCT00165425|Cardiac stress test|cardiac stress test
818554|NCT00165425|Echocardiogram|echocardiogram
818555|NCT00165412|Breast screening|breast screening
818556|NCT00165412|Breast MRI|breast mri
818557|NCT00165412|Mammogram|mammogram
818558|NCT00165412|Mammography|mammography
818559|NCT00165399|Prostate cancer|prostate cancer
818560|NCT00165399|PSA level|psa level
818561|NCT00165399|docetaxel|docetaxel
818562|NCT00165399|estramustine|estramustine
818563|NCT00165399|hormone therapy|hormone therapy
818564|NCT00165399|androgen withdrawal|androgen withdrawal
818565|NCT00165386|MRI-guided bone marrow biopsy|mri-guided bone marrow biopsy
818566|NCT00165373|pediatric solid tumors|pediatric solid tumors
818567|NCT00165373|rhEndostatin|rhendostatin
818568|NCT00165360|low-grade glioma|low-grade glioma
818569|NCT00165360|astrocytoma|astrocytoma
818570|NCT00165360|oligodendroglioma|oligodendroglioma
818571|NCT00165360|oligoastrocytoma|oligoastrocytoma
818572|NCT00165360|temozolomide|temozolomide
818573|NCT00165360|mixed oligoastrocytoma|mixed oligoastrocytoma
818574|NCT00165347|Multiple myeloma|multiple myeloma
818575|NCT00165347|PTK|ptk
818576|NCT00165347|Relapsed multiple myeloma|relapsed multiple myeloma
818577|NCT00165347|Refractory Multiple myeloma|refractory multiple myeloma
818578|NCT00165347|Myeloma|myeloma
818579|NCT00165334|Non-small cell lung cancer|non-small cell lung cancer
818580|NCT00165334|Cetuximab|cetuximab
818581|NCT00165334|Vinorelbine|vinorelbine
818582|NCT00165334|Navelbine|navelbine
818583|NCT00165334|Previously untreated lung cancer|previously untreated lung cancer
818584|NCT00165308|Hodgkin's disease|hodgkin's disease
818585|NCT00165308|breast cancer prevention|breast cancer prevention
818586|NCT00165308|tamoxifen|tamoxifen
818587|NCT00165295|sildenafil citrate|sildenafil citrate
818588|NCT00165295|Viagra|viagra
818589|NCT00165295|Waldenstrom's macroglobulinemia|waldenstrom's macroglobulinemia
818590|NCT00165282|Meditation|meditation
818591|NCT00165282|Mindfulness meditation|mindfulness meditation
818592|NCT00165282|Bone Marrow Transplant|bone marrow transplant
818593|NCT00165282|Stem Cell Transplant|stem cell transplant
818594|NCT00165269|Hodgkin's Disease Stage IA-IIA|hodgkin's disease stage ia-iia
818595|NCT00165269|mantle irradiation|mantle irradiation
818596|NCT00165256|Ductal carcinoma in situ|ductal carcinoma in situ
818597|NCT00165256|DCIS|dcis
818598|NCT00165256|wide excision|wide excision
818599|NCT00165243|Axillary Dissection|axillary dissection
818600|NCT00165243|Tangential Radiation|tangential radiation
818601|NCT00165243|Breast Cancer|breast cancer
818602|NCT00165230|thalidomide|thalidomide
818603|NCT00165230|temodar|temodar
818604|NCT00165230|metastatic neuroendocrine tumor|metastatic neuroendocrine tumor
818704|NCT00164619|behavioral intervention|behavioral intervention
818605|NCT00165230|unresectable neuroendocrine tumor|unresectable neuroendocrine tumor
818606|NCT00165217|capecitabine|capecitabine
818607|NCT00165217|thalidomide|thalidomide
818608|NCT00165217|colorectal cancer|colorectal cancer
818609|NCT00165204|Tibolone|tibolone
818610|NCT00165204|High risk women|high risk women
818611|NCT00165204|Oophorectomy|oophorectomy
818612|NCT00165204|Breast Density|breast density
818613|NCT00165204|Bone Density|bone density
818614|NCT00165191|doxorubicin|doxorubicin
818615|NCT00165191|cisplatin|cisplatin
818616|NCT00165191|5-fluorouracil|5-fluorouracil
818617|NCT00165191|stomach cancer|stomach cancer
818618|NCT00165191|esophagus cancer|esophagus cancer
818619|NCT00165178|Acute lymphoblastic leukemia in children|acute lymphoblastic leukemia in children
818620|NCT00165178|High Risk ALL|high risk all
818621|NCT00165178|Standard Risk ALL|standard risk all
818622|NCT00165178|E. coli asparaginase|e. coli asparaginase
818623|NCT00165152|Genetic testing|genetic testing
818624|NCT00165152|BRCA1 gene|brca1 gene
818625|NCT00165152|BRCA2 gene|brca2 gene
818626|NCT00165152|Counseling interventions|counseling interventions
818627|NCT00165152|Genetic counseling|genetic counseling
818628|NCT00165139|Stem cell transplant|stem cell transplant
818629|NCT00165139|High-risk pediatric tumors|high-risk pediatric tumors
818630|NCT00165126|dosimetric analysis|dosimetric analysis
818631|NCT00165126|vaginal cuff brachytherapy|vaginal cuff brachytherapy
818632|NCT00165100|DAT|dat
818633|NCT00165100|imaging modality|imaging modality
818634|NCT00165087|childhood ALL|childhood all
818635|NCT00165087|standard risk|standard risk
818636|NCT00165087|high risk|high risk
818637|NCT00165087|infant/high risk|infant/high risk
818638|NCT00165074|Prematurity|prematurity
818639|NCT00165074|Lung Disease|lung disease
818640|NCT00165074|Hyaline Membrane|hyaline membrane
818641|NCT00165074|Surfactant|surfactant
818642|NCT00165035|Percutaneous coronary intervention (PCI)|percutaneous coronary intervention (pci)
818643|NCT00165035|Drug eluting stent (DES)|drug eluting stent (des)
818644|NCT00165009|Bleeding Peptic Ulcer|bleeding peptic ulcer
818645|NCT00165009|Endoscopic treatment|endoscopic treatment
818748|NCT00164398|HIV|hiv
818646|NCT00164996|upper endoscopy|upper endoscopy
818647|NCT00164996|local pharyngeal anaesthesia|local pharyngeal anaesthesia
818648|NCT00164996|ultrathin endoscope|ultrathin endoscope
818649|NCT00164944|Colonoscopy|colonoscopy
818650|NCT00164944|First degree relatives|first degree relatives
818651|NCT00164931|Peptic ulcer hemorrhage|peptic ulcer hemorrhage
818652|NCT00164931|Omeprazole|omeprazole
818653|NCT00164931|Scheduled second endoscopy|scheduled second endoscopy
818654|NCT00164905|Peptic ulcer hemorrhage|peptic ulcer hemorrhage
818655|NCT00164905|Doppler ultrasound|doppler ultrasound
818656|NCT00164879|Obstructing|obstructing
818657|NCT00164879|Left-sided|left-sided
818658|NCT00164879|Colorectal neoplasms|colorectal neoplasms
818659|NCT00164879|Obstructing left-sided colorectal cancers|obstructing left-sided colorectal cancers
818660|NCT00164866|Peptic ulcer|peptic ulcer
818661|NCT00164866|IVPPI prior endoscopy|ivppi prior endoscopy
818662|NCT00164840|GERD|gerd
818663|NCT00164788|24 hours pH monitoring|24 hours ph monitoring
818664|NCT00164775|Functional dyspepsia, refractory, antidepressant|functional dyspepsia, refractory, antidepressant
818665|NCT00164762|HIV|hiv
818666|NCT00164762|drug resistance|drug resistance
818667|NCT00164762|nevirapine|nevirapine
818668|NCT00164762|anti-retroviral drugs|anti-retroviral drugs
818669|NCT00164762|mother-to-child transmission|mother-to-child transmission
818670|NCT00164762|Treatment Naive|treatment naive
818671|NCT00164762|pregnancy|pregnancy
818672|NCT00164749|dementia|dementia
818673|NCT00164749|cognition|cognition
818674|NCT00164749|memory|memory
818675|NCT00164749|neurodegenerative disease|neurodegenerative disease
818676|NCT00164749|brain|brain
818677|NCT00164736|HIV|hiv
818678|NCT00164736|Clinical trial|clinical trial
818679|NCT00164736|breastfeeding|breastfeeding
818680|NCT00164736|mother-to-child-transmission|mother-to-child-transmission
818681|NCT00164736|nutrition|nutrition
818682|NCT00164736|HIV Seronegativity|hiv seronegativity
818683|NCT00164723|Capsule Endoscopy|capsule endoscopy
818684|NCT00164710|antimalarials|antimalarials
818685|NCT00164697|Child Development|child development
818686|NCT00164697|Parenting|parenting
818687|NCT00164697|Child Rearing|child rearing
818688|NCT00164697|Parent-Child Relations|parent-child relations
818689|NCT00164684|batterers|batterers
818690|NCT00164684|prevention|prevention
818691|NCT00164684|African American|african american
818692|NCT00164684|Latino|latino
818693|NCT00164671|Male condoms|male condoms
818694|NCT00164671|Female condoms|female condoms
818695|NCT00164671|Self-efficacy|self-efficacy
818696|NCT00164658|family history|family history
818697|NCT00164658|familial risk|familial risk
818698|NCT00164658|behavior change|behavior change
818699|NCT00164645|Emotional outcomes|emotional outcomes
818700|NCT00164645|health outcomes|health outcomes
818701|NCT00164645|traumatic brain injury|traumatic brain injury
818702|NCT00164645|caregiving|caregiving
818703|NCT00164619|controlled clinical trial|controlled clinical trial
819016|NCT00163072|Megace|megace
818705|NCT00164619|prevention intervention|prevention intervention
818706|NCT00164606|child maltreatment|child maltreatment
818707|NCT00164606|child abuse|child abuse
818708|NCT00164606|prevention|prevention
818709|NCT00164593|Youth Violence|youth violence
818710|NCT00164593|Prevention|prevention
818711|NCT00164580|Homosexuality, Male|homosexuality, male
818712|NCT00164580|Adolescents|adolescents
818713|NCT00164580|Minority Groups|minority groups
818714|NCT00164580|Community Participation|community participation
818715|NCT00164580|Community Surveys|community surveys
818716|NCT00164580|HIV Seronegativity|hiv seronegativity
818717|NCT00164580|HIV|hiv
818718|NCT00164567|partner abuse|partner abuse
818719|NCT00164567|screening|screening
818720|NCT00164567|intimate partner violence|intimate partner violence
818721|NCT00164554|treatment|treatment
818722|NCT00164554|control|control
818723|NCT00164541|dating violence|dating violence
818724|NCT00164541|violence against women|violence against women
818725|NCT00164515|obesity, mobility limitations, women, physical activity|obesity, mobility limitations, women, physical activity
818726|NCT00164463|tuberculosis|tuberculosis
818727|NCT00164463|TB|tb
818728|NCT00164450|tuberculosis|tuberculosis
818729|NCT00164450|TB|tb
818730|NCT00164450|pharmacokinetics|pharmacokinetics
818731|NCT00164450|children|children
818732|NCT00164437|screening|screening
818733|NCT00164437|community healt education|community healt education
818734|NCT00164437|decision making|decision making
818735|NCT00164437|computer-assisted decision making|computer-assisted decision making
818736|NCT00164424|HSV2|hsv2
818737|NCT00164424|genital ulcer|genital ulcer
818738|NCT00164424|HIV|hiv
818739|NCT00164424|South Africa|south africa
818740|NCT00164424|Treatment|treatment
818741|NCT00164424|Acyclovir|acyclovir
818742|NCT00164424|Prevention|prevention
818743|NCT00164411|Diptheria-Tetanus vaccine|diptheria-tetanus vaccine
818744|NCT00164411|Pneumococcal vaccine|pneumococcal vaccine
818745|NCT00164411|Adverse events following vaccination|adverse events following vaccination
818746|NCT00164411|Immunization|immunization
818747|NCT00164411|Immunogenicity|immunogenicity
818750|NCT00164372|IV Drug users|iv drug users
818751|NCT00164372|HIV|hiv
818752|NCT00164372|hepatitis C virus|hepatitis c virus
818753|NCT00164372|HIV Seronegativity|hiv seronegativity
818754|NCT00164359|malaria, falciparum|malaria, falciparum
818755|NCT00164359|antimalarials|antimalarials
818756|NCT00164346|fetal alcohol syndrome (FAS)|fetal alcohol syndrome (fas)
818757|NCT00164346|alcohol-related neurodevelopmental disorder (ARND)|alcohol-related neurodevelopmental disorder (arnd)
818758|NCT00164281|TB|tb
818759|NCT00164281|Tuberculosis|tuberculosis
818760|NCT00164281|INH|inh
818761|NCT00164281|Isoniazid|isoniazid
818762|NCT00164281|Preventive therapy|preventive therapy
818763|NCT00164281|HIV|hiv
818764|NCT00164281|AIDS|aids
818765|NCT00164281|Botswana|botswana
818766|NCT00164281|LTBI|ltbi
818767|NCT00164281|Latent TB Infection|latent tb infection
818768|NCT00164268|Intimate partner violence|intimate partner violence
818769|NCT00164268|Sexual violence|sexual violence
818770|NCT00164268|Cultural intervention|cultural intervention
818771|NCT00164268|Native Hawaiian|native hawaiian
818772|NCT00164255|malaria|malaria
818773|NCT00164255|birthweight|birthweight
818774|NCT00164255|placental malaria|placental malaria
818775|NCT00164255|intermittent protective treatment|intermittent protective treatment
818776|NCT00164255|sulfadoxine/ pyrimethamine|sulfadoxine/ pyrimethamine
818777|NCT00164255|artesuate|artesuate
818778|NCT00164255|combination therapy|combination therapy
818779|NCT00164255|Pregnancy|pregnancy
818780|NCT00164242|Tardive dyskinesia|tardive dyskinesia
818781|NCT00164242|Galantamine|galantamine
818782|NCT00164242|Cholinesterase inhibitors|cholinesterase inhibitors
818783|NCT00164229|treatment|treatment
818784|NCT00164229|control|control
818785|NCT00164216|malaria|malaria
818786|NCT00164216|combination therapy|combination therapy
818787|NCT00164216|mefloquine|mefloquine
818788|NCT00164216|artesunate|artesunate
818789|NCT00164216|Peru|peru
818790|NCT00164216|malaria, uncomplicated|malaria, uncomplicated
818791|NCT00164190|Myocardial Infarction|myocardial infarction
818792|NCT00164190|Thrombolysis|thrombolysis
818793|NCT00164190|Angioplasty|angioplasty
818794|NCT00164190|ST Elevation Myocardial Infarction|st elevation myocardial infarction
818795|NCT00164177|virtual colonoscopy|virtual colonoscopy
818796|NCT00164177|colonoscopy preparation|colonoscopy preparation
818797|NCT00164177|bowel prep|bowel prep
818798|NCT00164164|colonoscopy preparation|colonoscopy preparation
818799|NCT00164164|prep|prep
818800|NCT00164151|colonoscopy preparation|colonoscopy preparation
818801|NCT00164151|prep|prep
818802|NCT00164138|Incontinence|incontinence
818803|NCT00164138|physiotherapy|physiotherapy
818804|NCT00164138|treatment|treatment
818805|NCT00164138|pelvic floor muscle function|pelvic floor muscle function
818806|NCT00164138|coughing|coughing
818807|NCT00164138|forced expirations|forced expirations
818808|NCT00164138|lung disease|lung disease
818809|NCT00164112|Cooperstown Cocktail|cooperstown cocktail
818810|NCT00164112|Drug Metabolizing Enzymes|drug metabolizing enzymes
818811|NCT00164112|Drug Interactions|drug interactions
818812|NCT00164112|Phenotyping|phenotyping
818813|NCT00164099|Coronary Artery Bypass|coronary artery bypass
818814|NCT00164099|Postoperative Complications|postoperative complications
818815|NCT00164099|Probiotics|probiotics
818816|NCT00164099|Surgical Wound infection|surgical wound infection
818817|NCT00164099|cystitis|cystitis
818818|NCT00164099|bacteremia|bacteremia
818819|NCT00164099|pneumonia|pneumonia
818820|NCT00164099|Enterocolitis, Pseudomembranous|enterocolitis, pseudomembranous
818821|NCT00164073|HCV and microarray|hcv and microarray
818822|NCT00164073|HCV|hcv
818823|NCT00164060|HCV|hcv
818824|NCT00164060|HIV co-infection|hiv co-infection
818825|NCT00164047|Nitrous Oxide|nitrous oxide
818826|NCT00164047|Anaesthesia|anaesthesia
818827|NCT00164047|Anesthesia|anesthesia
818828|NCT00164047|Recovery|recovery
818829|NCT00164047|Quality|quality
818830|NCT00164034|Trauma|trauma
818831|NCT00164034|Wounds|wounds
818832|NCT00164034|Injuries|injuries
818833|NCT00164021|gastroesophageal reflux, gastric reflux, acid reflux, lung transplantation, physiotherapy, anti-reflux medication|gastroesophageal reflux, gastric reflux, acid reflux, lung transplantation, physiotherapy, anti-reflux medication
818834|NCT00163995|Chronic Liver Disease|chronic liver disease
818835|NCT00163982|HVPG > 12 mmHg|hvpg > 12 mmhg
818836|NCT00163969|Pain|pain
818837|NCT00163969|Wind-up|wind-up
818838|NCT00163969|opioid|opioid
818839|NCT00163969|ketamine|ketamine
818840|NCT00163969|pre-emptive|pre-emptive
818841|NCT00163956|IVC filters|ivc filters
818842|NCT00163956|failed retrieval|failed retrieval
818843|NCT00163943|Metabolic syndrome|metabolic syndrome
818844|NCT00163943|Sympathetic nervous system activity|sympathetic nervous system activity
818845|NCT00163943|Insulin sensitivity|insulin sensitivity
818846|NCT00163943|weight loss|weight loss
818847|NCT00163943|aerobic exercise|aerobic exercise
818848|NCT00163930|Uterine Fibroids|uterine fibroids
818849|NCT00163930|embolisation|embolisation
818850|NCT00163930|pain management|pain management
818851|NCT00163917|Hypnosis|hypnosis
818852|NCT00163917|Analgesia|analgesia
818853|NCT00163904|Heart Failure|heart failure
818854|NCT00163904|Inflammatory mediators|inflammatory mediators
818855|NCT00163904|insulin sensitivity|insulin sensitivity
818856|NCT00163904|overweight|overweight
818857|NCT00163904|high monounsaturated diet|high monounsaturated diet
818858|NCT00163891|Respiratory Therapy|respiratory therapy
818859|NCT00163891|Postoperative Care|postoperative care
818860|NCT00163891|Treatment Outcome|treatment outcome
818861|NCT00163878|Sensory Stimulation Programs|sensory stimulation programs
818862|NCT00163865|Boredom|boredom
818863|NCT00163865|Adolescent|adolescent
818864|NCT00163865|Mental illness|mental illness
818865|NCT00163865|Depression|depression
818866|NCT00163865|Anxiety|anxiety
818867|NCT00163852|Cystic fibrosis|cystic fibrosis
818868|NCT00163852|Metabolic alkalosis|metabolic alkalosis
818869|NCT00163852|Hypercapnia|hypercapnia
818870|NCT00163852|Salt replacement|salt replacement
818871|NCT00163839|Dietary Intervention|dietary intervention
818872|NCT00163839|Pseudoallergen free diet|pseudoallergen free diet
818873|NCT00163826|cervical spine injury|cervical spine injury
818874|NCT00163826|multiple trauma|multiple trauma
818875|NCT00163813|Mechanically-ventilated|mechanically-ventilated
818876|NCT00163813|medical-surgical critically ill patients|medical-surgical critically ill patients
818877|NCT00163813|reduced gastric motility|reduced gastric motility
818878|NCT00163800|Outcome predictors|outcome predictors
818879|NCT00163800|Acute brain injury|acute brain injury
818880|NCT00163787|mobility|mobility
818881|NCT00163787|falls|falls
818882|NCT00163787|activity level|activity level
818883|NCT00163761|Lymphoma|lymphoma
818884|NCT00163748|Lymphoma|lymphoma
818885|NCT00163735|Food allergy|food allergy
818886|NCT00163735|wine|wine
818887|NCT00163735|milk allergy|milk allergy
818888|NCT00163735|egg allergy|egg allergy
818889|NCT00163735|nut allergy|nut allergy
818890|NCT00163735|fish allergy|fish allergy
818891|NCT00163709|Atrial natriuretic factor.|atrial natriuretic factor.
818892|NCT00163709|Biochemistry.|biochemistry.
818893|NCT00163709|Cardiac failure.|cardiac failure.
818894|NCT00163709|Randomised trials.|randomised trials.
818895|NCT00163709|Hormones.|hormones.
818896|NCT00163709|Systolic heart failure.|systolic heart failure.
818897|NCT00163709|Diastolic heart failure.|diastolic heart failure.
818898|NCT00163709|Ischaemic cardiomyopathy.|ischaemic cardiomyopathy.
818899|NCT00163709|Ventricular hypertrophy.|ventricular hypertrophy.
818900|NCT00163709|AMI|ami
818901|NCT00163696|MBNW|mbnw
818902|NCT00163696|Ventilation|ventilation
818903|NCT00163696|small airways|small airways
818904|NCT00163696|Lung Transplant recipients (Bronchiolitis Obliterans syndrome)|lung transplant recipients (bronchiolitis obliterans syndrome)
818905|NCT00163683|Dietary Intervention|dietary intervention
818906|NCT00163657|Hepatitis C Virus|hepatitis c virus
818907|NCT00163657|Immunosuppressive Agents|immunosuppressive agents
820571|NCT00155831|Kinematics|kinematics
818908|NCT00163644|Hematological malignancies.|hematological malignancies.
818909|NCT00163644|Bone- marrow/ haemopoetic transplant|bone- marrow/ haemopoetic transplant
818910|NCT00163644|Exercise|exercise
818911|NCT00163618|tick-borne encephalitis|tick-borne encephalitis
818912|NCT00163605|Sinus augmentation|sinus augmentation
818913|NCT00163605|Alloplastic bone substitute|alloplastic bone substitute
818914|NCT00163605|Hydroxyl apatite|hydroxyl apatite
818915|NCT00163592|Vascular reconstruction|vascular reconstruction
818916|NCT00163592|Polytetraflouroethylene (PTFE) prosthesis|polytetraflouroethylene (ptfe) prosthesis
818917|NCT00163579|premature birth|premature birth
818918|NCT00163579|cerclage|cerclage
818919|NCT00163579|tocolysis|tocolysis
818920|NCT00163579|drug therapy|drug therapy
818922|NCT00163566|depression strength|depression strength
818923|NCT00163566|testosterone|testosterone
818924|NCT00163566|dihydrotestosterone|dihydrotestosterone
818925|NCT00163553|spinal surgery|spinal surgery
818926|NCT00163553|pethidine|pethidine
818927|NCT00163553|analgesia|analgesia
818928|NCT00163540|tick-borne encephalitis|tick-borne encephalitis
818929|NCT00163527|Asthma|asthma
818930|NCT00163527|Roflumilast|roflumilast
818931|NCT00163527|Corticosteroids|corticosteroids
818932|NCT00163514|Allergy|allergy
818933|NCT00163514|Perennial Allergic Rhinitis|perennial allergic rhinitis
818934|NCT00163514|Allergic Rhinitis|allergic rhinitis
818935|NCT00163514|Hay Fever|hay fever
818936|NCT00163501|Allergy|allergy
818937|NCT00163501|Perennial Allergic Rhinitis|perennial allergic rhinitis
818938|NCT00163501|Allergic Rhinitis|allergic rhinitis
818939|NCT00163501|Hay Fever|hay fever
818940|NCT00163488|Allergy|allergy
818941|NCT00163488|Perennial Allergic Rhinitis|perennial allergic rhinitis
818942|NCT00163488|Allergic Rhinitis|allergic rhinitis
818943|NCT00163488|Hay Fever|hay fever
818944|NCT00163475|Asthma|asthma
818945|NCT00163475|Roflumilast|roflumilast
818946|NCT00163462|Asthma|asthma
818947|NCT00163462|Ciclesonide|ciclesonide
818948|NCT00163462|Child|child
818949|NCT00163462|Fluticasone propionate|fluticasone propionate
818950|NCT00163462|Pediatric|pediatric
818951|NCT00163449|Asthma|asthma
818952|NCT00163449|Ciclesonide|ciclesonide
818953|NCT00163449|Child|child
818959|NCT00163423|Fluticasone propionate|fluticasone propionate
818960|NCT00163410|Asthma|asthma
818961|NCT00163410|Ciclesonide|ciclesonide
818962|NCT00163410|Child|child
818963|NCT00163410|Fluticasone propionate|fluticasone propionate
818964|NCT00163410|Pediatric|pediatric
818965|NCT00163397|Asthma|asthma
818966|NCT00163397|Ciclesonide|ciclesonide
818967|NCT00163397|Budesonide|budesonide
818968|NCT00163384|Asthma|asthma
818969|NCT00163384|Ciclesonide|ciclesonide
818970|NCT00163384|Budesonide|budesonide
818971|NCT00163371|Asthma|asthma
818972|NCT00163371|Ciclesonide|ciclesonide
818973|NCT00163371|Child|child
818974|NCT00163371|Fluticasone propionate|fluticasone propionate
818975|NCT00163371|HPA-axis|hpa-axis
818976|NCT00163371|Pediatric|pediatric
818977|NCT00163371|Linear growth rate|linear growth rate
818978|NCT00163358|Asthma|asthma
818979|NCT00163358|Ciclesonide|ciclesonide
818980|NCT00163358|Fluticasone propionate|fluticasone propionate
818981|NCT00163358|Salmeterol|salmeterol
818982|NCT00163345|Asthma|asthma
818983|NCT00163345|Ciclesonide|ciclesonide
818984|NCT00163345|Small Airways|small airways
818985|NCT00163332|Asthma|asthma
818986|NCT00163332|Ciclesonide|ciclesonide
818987|NCT00163332|Fluticasone propionate|fluticasone propionate
818988|NCT00163319|Asthma|asthma
818989|NCT00163319|Ciclesonide|ciclesonide
818990|NCT00163319|Fluticasone propionate|fluticasone propionate
818991|NCT00163306|Gastroesophageal Reflux|gastroesophageal reflux
818992|NCT00163306|Gastroesophageal Reflux Disease|gastroesophageal reflux disease
818993|NCT00163306|Pantoprazole|pantoprazole
818994|NCT00163293|Asthma|asthma
818995|NCT00163293|Ciclesonide|ciclesonide
818996|NCT00163293|Exacerbation|exacerbation
818997|NCT00163280|Mucositis|mucositis
818998|NCT00163280|Peripheral blood stem cell transplant|peripheral blood stem cell transplant
818999|NCT00163267|peripheral arterial intervention|peripheral arterial intervention
819000|NCT00163267|atherosclerosis|atherosclerosis
819001|NCT00163267|platelets|platelets
819002|NCT00163267|Age above 18|age above 18
819003|NCT00163254|Chronic limb ischemia|chronic limb ischemia
819004|NCT00163254|Intervention|intervention
819005|NCT00163254|Restenosis|restenosis
819006|NCT00163254|Patients above 18 years|patients above 18 years
819007|NCT00163228|C05.550.114.606.500|c05.550.114.606.500
819008|NCT00163228|C05.550.114.606.508|c05.550.114.606.508
819009|NCT00163176|cell proliferation|cell proliferation
819010|NCT00163176|PET|pet
819011|NCT00163176|radiotherapy|radiotherapy
819012|NCT00163124|chiropractic|chiropractic
819013|NCT00163124|spinal manipulation|spinal manipulation
819014|NCT00163124|low back pain|low back pain
819015|NCT00163072|transdermal|transdermal
819017|NCT00163072|pharmacokinetics|pharmacokinetics
819018|NCT00163033|phase I study|phase i study
819019|NCT00163020|Preterm Birth|preterm birth
819020|NCT00163020|Preterm Delivery|preterm delivery
819021|NCT00163020|Multiple gestation|multiple gestation
819022|NCT00163020|17-alpha-hydroxyprogesterone caproate|17-alpha-hydroxyprogesterone caproate
819023|NCT00163020|Progesterone|progesterone
819024|NCT00162994|recurrent otitis media|recurrent otitis media
819025|NCT00162994|adenoidectomy|adenoidectomy
819026|NCT00162994|tympanostomy|tympanostomy
819027|NCT00162994|young children|young children
819028|NCT00162994|prevention|prevention
819029|NCT00162994|quality of life|quality of life
819030|NCT00162968|polyneuropathies|polyneuropathies
819031|NCT00162968|pain|pain
819032|NCT00162968|drug effects|drug effects
819033|NCT00162968|escitalopram|escitalopram
819034|NCT00162968|serotonin uptake inhibitors|serotonin uptake inhibitors
819035|NCT00162955|untreated adult Non-Hodgkin's Lymphoma|untreated adult non-hodgkin's lymphoma
819036|NCT00162955|CHOP protocol|chop protocol
819037|NCT00162955|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers
819038|NCT00162955|Cardiomyopathy|cardiomyopathy
819039|NCT00162942|Crohn's Disease|crohn's disease
819040|NCT00162929|metastatic breast cancer|metastatic breast cancer
819041|NCT00162929|locally recurrent breast cancer|locally recurrent breast cancer
819042|NCT00162916|Traumatic Brain Injury|traumatic brain injury
819043|NCT00162916|Depression|depression
819044|NCT00162916|Antidepressant medication|antidepressant medication
819045|NCT00162916|Double-Blind Study|double-blind study
819046|NCT00162916|Brain Injuries|brain injuries
819047|NCT00162916|Antidepressive Agents|antidepressive agents
819048|NCT00162916|Citalopram|citalopram
819049|NCT00162916|Double-Blind Method|double-blind method
819050|NCT00162903|Preterm infant, Patent ductus arteriosus, Nitric oxide,Endothelin-1|preterm infant, patent ductus arteriosus, nitric oxide,endothelin-1
819051|NCT00162890|degenerated cervical spine|degenerated cervical spine
819052|NCT00162890|assessment|assessment
819053|NCT00162890|physical therapy|physical therapy
819054|NCT00162877|rabeprazole, omeprazole, CYP2C19, H. pylori, PK/PD|rabeprazole, omeprazole, cyp2c19, h. pylori, pk/pd
819055|NCT00162864|asthma|asthma
819056|NCT00162864|COPD|copd
819057|NCT00162864|montelukast sodium|montelukast sodium
819058|NCT00162864|leukotriene modifier|leukotriene modifier
819059|NCT00162864|older adults|older adults
819154|NCT00162123|ipilimumab|ipilimumab
819060|NCT00162825|Psoriasis, T cell, inflammation, CD7, cytokine|psoriasis, t cell, inflammation, cd7, cytokine
819061|NCT00162812|neoadjuvant chemotherapy|neoadjuvant chemotherapy
819062|NCT00162812|early breast cancer|early breast cancer
819063|NCT00162812|inflammatory breast cancer|inflammatory breast cancer
819064|NCT00162799|insulin resistance and inflamation|insulin resistance and inflamation
819065|NCT00162799|insulin sensitibity|insulin sensitibity
819066|NCT00162799|obesity-induced insuline resistence|obesity-induced insuline resistence
819067|NCT00162799|obesity-diabetes link|obesity-diabetes link
819068|NCT00162799|salicylate|salicylate
819069|NCT00162799|insulin resistance in obesity health adults|insulin resistance in obesity health adults
819070|NCT00162786|Driving performance|driving performance
819071|NCT00162786|Antihistamine|antihistamine
819072|NCT00162773|asthma|asthma
819073|NCT00162747|Pre-term infants|pre-term infants
819074|NCT00162747|skin infections|skin infections
819075|NCT00162747|infant skin|infant skin
819076|NCT00162747|Aquaphor|aquaphor
819077|NCT00162747|sunflower seed oil|sunflower seed oil
819078|NCT00162747|nutrition|nutrition
819079|NCT00162747|skin care|skin care
819080|NCT00162734|Chronic Hepatitis C|chronic hepatitis c
819081|NCT00162734|Liver|liver
819082|NCT00162734|Pegylated|pegylated
819083|NCT00162734|Interferon|interferon
819084|NCT00162734|Alpha|alpha
819085|NCT00162734|Ribavirin|ribavirin
819086|NCT00162734|Combination|combination
819087|NCT00162734|Nonresponder|nonresponder
819088|NCT00162734|HCV|hcv
819089|NCT00162734|Infergen|infergen
819090|NCT00162734|SVR|svr
819091|NCT00162721|Uterine sarcoma non metastatic|uterine sarcoma non metastatic
819092|NCT00162708|Head and neck squamous cell carcinoma|head and neck squamous cell carcinoma
819093|NCT00162708|Radiotherapy|radiotherapy
819094|NCT00162708|Chemotherapy|chemotherapy
819095|NCT00162682|HIV|hiv
819096|NCT00162682|Highly Active Antiretroviral Therapy|highly active antiretroviral therapy
819097|NCT00162682|Monitoring|monitoring
819098|NCT00162682|Viral load|viral load
819099|NCT00162682|CD4|cd4
819100|NCT00162682|Thailand|thailand
819101|NCT00162682|Future Drug Options|future drug options
819102|NCT00162682|Resistance|resistance
819103|NCT00162682|Developing Country|developing country
819104|NCT00162682|Acquired Immunodeficiency Syndrome|acquired immunodeficiency syndrome
819105|NCT00162669|Hepatocellular carcinoma, advanced, bevacizumab, phase II, VGEF, neovascularization|hepatocellular carcinoma, advanced, bevacizumab, phase ii, vgef, neovascularization
819106|NCT00162656|B-Cell Lymphoma|b-cell lymphoma
819107|NCT00162643|Acquired Immunodeficiency Syndrome|acquired immunodeficiency syndrome
819108|NCT00162643|Antiretroviral Therapy, Highly Active|antiretroviral therapy, highly active
819109|NCT00162643|Protease Inhibitors|protease inhibitors
819110|NCT00162643|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors
819111|NCT00162630|Hip fracture, pain, regional anaesthesia, analgesia|hip fracture, pain, regional anaesthesia, analgesia
819112|NCT00162617|Hip fracture|hip fracture
819113|NCT00162617|Rehabilitation|rehabilitation
819114|NCT00162617|Transfusion|transfusion
819115|NCT00162617|Outcome|outcome
819116|NCT00162604|Prophylactic antibiotic|prophylactic antibiotic
819117|NCT00162604|Postoperative infections|postoperative infections
819118|NCT00162604|Uterine prolapse grade I - II|uterine prolapse grade i - ii
819119|NCT00162604|cystocele|cystocele
819120|NCT00162604|rectocele|rectocele
819121|NCT00162604|enterocele|enterocele
819122|NCT00162604|defects of the perineal body|defects of the perineal body
819123|NCT00162591|Bispectral index|bispectral index
819124|NCT00162591|sedation|sedation
819125|NCT00162591|remifentanyl|remifentanyl
819126|NCT00162591|Bronchoalveolar lavage|bronchoalveolar lavage
819127|NCT00162591|Intensive care|intensive care
819128|NCT00162591|Nociceptive stimuli|nociceptive stimuli
819129|NCT00162591|Sedated patient|sedated patient
819130|NCT00162591|BIS variation|bis variation
819131|NCT00162578|pneumococcal meningitis|pneumococcal meningitis
819132|NCT00162578|intensive care unit|intensive care unit
819133|NCT00162578|vancomycin|vancomycin
819134|NCT00162578|dexamethasone|dexamethasone
819135|NCT00162578|drug diffusion in cerebrospinal fluid|drug diffusion in cerebrospinal fluid
819136|NCT00162565|Heart Failure, Congestive|heart failure, congestive
819137|NCT00162565|beta-Adrenergic Blockers|beta-adrenergic blockers
819138|NCT00162552|multicenter-randomized-trial|multicenter-randomized-trial
819139|NCT00162552|pentoxifyllinE|pentoxifylline
819140|NCT00162552|placebo|placebo
819141|NCT00162552|cirrhosis|cirrhosis
819142|NCT00162552|liver failure|liver failure
819143|NCT00162552|cytokine|cytokine
819144|NCT00162539|foetal thyroid mensuration|foetal thyroid mensuration
819145|NCT00162500|Metastatic solid tumors|metastatic solid tumors
819146|NCT00162474|Healthy Volunteers|healthy volunteers
819147|NCT00162461|Healthy Volunteers|healthy volunteers
819148|NCT00162448|Patients requiring dual-chamber pacemakers or defibrillators|patients requiring dual-chamber pacemakers or defibrillators
819149|NCT00162396|Albuterol|albuterol
819150|NCT00162396|β2 Adrenergic receptor|β2 adrenergic receptor
819151|NCT00162396|Polymorphism|polymorphism
819152|NCT00162240|Metabolics Diabetes New Onset|metabolics diabetes new onset
819153|NCT00162214|Advanced Solid Tumors|advanced solid tumors
819155|NCT00162123|previously treated|previously treated
819156|NCT00162019|Factor VIII Deficiency|factor viii deficiency
819157|NCT00162006|Chronic idiopathic thrombocytopenic purpura|chronic idiopathic thrombocytopenic purpura
819158|NCT00161993|Gammaglobulin|gammaglobulin
819159|NCT00161980|Axillary wound|axillary wound
819160|NCT00161980|Seroma|seroma
819161|NCT00161980|Fistulae|fistulae
819162|NCT00161967|tick-borne encephalitis|tick-borne encephalitis
819163|NCT00161954|Tick-Borne Encephalitis|tick-borne encephalitis
819164|NCT00161941|Meningococcal Vaccine|meningococcal vaccine
819165|NCT00161941|Meningococcal Meningitis, Serogroup C|meningococcal meningitis, serogroup c
819166|NCT00161941|Neisseria Meningitidis|neisseria meningitidis
819167|NCT00161928|Meningococcal Vaccine|meningococcal vaccine
819168|NCT00161928|Meningococcal Meningitis, Serogroup C|meningococcal meningitis, serogroup c
819169|NCT00161928|Neisseria Meningitidis|neisseria meningitidis
819170|NCT00161915|Liver cirrhosis|liver cirrhosis
819171|NCT00161902|Arthroplasty|arthroplasty
819172|NCT00161902|Hip Prosthesis|hip prosthesis
819173|NCT00161902|Cement Free Hip Prosthesis|cement free hip prosthesis
819174|NCT00161902|Femur Head Necrosis|femur head necrosis
819175|NCT00161902|Coxarthrosis|coxarthrosis
819176|NCT00161876|tick-borne encephalitis|tick-borne encephalitis
819177|NCT00161837|Influenza|influenza
819178|NCT00161837|Vaccine|vaccine
819179|NCT00161746|Tick-Borne Encephalitis|tick-borne encephalitis
819180|NCT00161733|Cardiopulmonary bypass|cardiopulmonary bypass
819181|NCT00161733|Median sternotomy|median sternotomy
819182|NCT00161733|Fibrin sealant|fibrin sealant
819183|NCT00161733|Clot|clot
819184|NCT00161733|Cardiac surgery|cardiac surgery
819185|NCT00161720|Severe Congenital Protein C Deficiency|severe congenital protein c deficiency
819186|NCT00161694|pain control|pain control
819187|NCT00161681|Levonorgestrel|levonorgestrel
819188|NCT00161681|ethinyl estradiol|ethinyl estradiol
819189|NCT00161681|premenstrual syndrome|premenstrual syndrome
819190|NCT00161681|menstrual cycle related symptoms|menstrual cycle related symptoms
819191|NCT00161668|Leukemia|leukemia
819192|NCT00161655|Psoriasis|psoriasis
819193|NCT00161655|Arthritis|arthritis
819194|NCT00161642|Malignant Tumors|malignant tumors
819195|NCT00161629|Distal Radius Fractures|distal radius fractures
819196|NCT00161616|Open Diaphyseal Tibia Fractures|open diaphyseal tibia fractures
819197|NCT00161603|Angioplasty|angioplasty
819198|NCT00161603|Behavior change|behavior change
819199|NCT00161603|Physical activity|physical activity
819200|NCT00161603|Risk reduction|risk reduction
819201|NCT00161590|NK cell lymphoma|nk cell lymphoma
819202|NCT00161590|Null cell lymphoma|null cell lymphoma
819203|NCT00161577|Ketorolac|ketorolac
819204|NCT00161564|Idiopathic Thrombocytopenic Purpura|idiopathic thrombocytopenic purpura
819205|NCT00161564|ITP|itp
819206|NCT00161564|Non-Malignant Hematology|non-malignant hematology
819207|NCT00161551|Cardiac Pacing, artificial|cardiac pacing, artificial
819208|NCT00161551|Atrial Fibrillation|atrial fibrillation
819209|NCT00161551|Heart Failure|heart failure
819210|NCT00161551|Pacemaker leads|pacemaker leads
819211|NCT00161551|Pacing Mode|pacing mode
819212|NCT00161538|Cardiac Pacing, artificial|cardiac pacing, artificial
819213|NCT00161538|Atrial fibrillation|atrial fibrillation
819214|NCT00161538|Pacemaker leads|pacemaker leads
819215|NCT00161538|Lead positions|lead positions
819216|NCT00161525|Subretinal Hemorrhage, Perfluorocarbon gas|subretinal hemorrhage, perfluorocarbon gas
819217|NCT00161486|Male contraception|male contraception
819218|NCT00161486|Prostate|prostate
819219|NCT00161486|Acyline|acyline
819220|NCT00161486|Androgen replacement|androgen replacement
819221|NCT00161473|double-blind|double-blind
819222|NCT00161473|treatment|treatment
819223|NCT00161473|prazosin|prazosin
819224|NCT00161460|Colorectal cancer|colorectal cancer
819225|NCT00161460|Mass screening|mass screening
819226|NCT00161447|Male contraception|male contraception
819227|NCT00161447|testosterone|testosterone
819228|NCT00161447|acyline|acyline
819229|NCT00161434|HIV-1|hiv-1
819230|NCT00161421|Male Contraception|male contraception
819231|NCT00161421|Testosterone|testosterone
819232|NCT00161421|Hypogonadism|hypogonadism
819233|NCT00161408|schizophrenia, first episode, cognitive behavioural therapy, psychoeducation|schizophrenia, first episode, cognitive behavioural therapy, psychoeducation
819234|NCT00161395|fertility|fertility
819235|NCT00161395|pregnancy|pregnancy
819236|NCT00161382|HIV Seronegativity|hiv seronegativity
819237|NCT00161382|HIV|hiv
819238|NCT00161369|homocysteine|homocysteine
819239|NCT00161369|asymmetric dimethylarginine|asymmetric dimethylarginine
819240|NCT00161369|atherosclerosis|atherosclerosis
819241|NCT00161369|cardiovascular event|cardiovascular event
819242|NCT00161369|hemodialysis|hemodialysis
819243|NCT00161343|HIV|hiv
819244|NCT00161343|Prevention Intervention|prevention intervention
819245|NCT00161343|Female|female
819246|NCT00161343|Adolescents|adolescents
819247|NCT00161343|STD|std
819248|NCT00161343|HIV Seronegativity|hiv seronegativity
819249|NCT00161330|urinary tract infection,|urinary tract infection,
819250|NCT00161330|antibiotic treatment|antibiotic treatment
819251|NCT00161330|childhood|childhood
819538|NCT00161096|proton pump inhibitor|proton pump inhibitor
819252|NCT00161330|amoxicilline/clavulanic acid|amoxicilline/clavulanic acid
819253|NCT00161330|ceftriaxone|ceftriaxone
819254|NCT00161330|renal ultrasonography|renal ultrasonography
819255|NCT00161330|renal scintigraphy|renal scintigraphy
819256|NCT00161291|Carcinoma of the breast|carcinoma of the breast
819257|NCT00161291|Breast cancer|breast cancer
819258|NCT00161252|Prostate Cancer|prostate cancer
819259|NCT00161239|T-Cell Lymphomas|t-cell lymphomas
819260|NCT00161226|endometrial cancer|endometrial cancer
819261|NCT00161213|recurrent pancreatic cancer|recurrent pancreatic cancer
819262|NCT00161213|stage IV pancreatic cancer|stage iv pancreatic cancer
819263|NCT00161213|stage III pancreatic cancer|stage iii pancreatic cancer
819264|NCT00161213|adenocarcinoma of the pancreas|adenocarcinoma of the pancreas
819265|NCT00161213|stage II pancreatic cancer|stage ii pancreatic cancer
819266|NCT00161200|Esophageal Metaplasia|esophageal metaplasia
819267|NCT00161187|refractory chronic lymphocytic leukemia|refractory chronic lymphocytic leukemia
819268|NCT00161187|recurrent small lymphocytic lymphoma|recurrent small lymphocytic lymphoma
819269|NCT00161187|prolymphocytic leukemia|prolymphocytic leukemia
819270|NCT00161187|extranodal marginal zone B-cell lymphoma of mucosa-associated lymphoid tissue|extranodal marginal zone b-cell lymphoma of mucosa-associated lymphoid tissue
819271|NCT00161187|nodal marginal zone B-cell lymphoma|nodal marginal zone b-cell lymphoma
819272|NCT00161187|recurrent marginal zone lymphoma|recurrent marginal zone lymphoma
819273|NCT00161187|splenic marginal zone lymphoma|splenic marginal zone lymphoma
819274|NCT00161187|recurrent grade 1 follicular lymphoma|recurrent grade 1 follicular lymphoma
819275|NCT00161187|recurrent grade 2 follicular lymphoma|recurrent grade 2 follicular lymphoma
819276|NCT00161187|recurrent grade 3 follicular lymphoma|recurrent grade 3 follicular lymphoma
819277|NCT00161187|stage I multiple myeloma|stage i multiple myeloma
819278|NCT00161187|stage II multiple myeloma|stage ii multiple myeloma
819279|NCT00161187|stage III multiple myeloma|stage iii multiple myeloma
819280|NCT00161187|recurrent mantle cell lymphoma|recurrent mantle cell lymphoma
819593|NCT00160849|Treatment Experienced|treatment experienced
819281|NCT00161187|childhood diffuse large cell lymphoma|childhood diffuse large cell lymphoma
819282|NCT00161187|recurrent adult diffuse large cell lymphoma|recurrent adult diffuse large cell lymphoma
819283|NCT00161187|recurrent adult Burkitt lymphoma|recurrent adult burkitt lymphoma
819284|NCT00161187|recurrent adult grade III lymphomatoid granulomatosis|recurrent adult grade iii lymphomatoid granulomatosis
819285|NCT00161187|recurrent childhood grade III lymphomatoid granulomatosis|recurrent childhood grade iii lymphomatoid granulomatosis
819286|NCT00161187|adult nasal type extranodal NK/T-cell lymphoma|adult nasal type extranodal nk/t-cell lymphoma
819287|NCT00161187|childhood nasal type extranodal NK/T-cell lymphoma|childhood nasal type extranodal nk/t-cell lymphoma
819288|NCT00161187|recurrent mycosis fungoides/Sezary syndrome|recurrent mycosis fungoides/sezary syndrome
819289|NCT00161187|anaplastic large cell lymphoma|anaplastic large cell lymphoma
819430|NCT00161187|stage I pancreatic cancer|stage i pancreatic cancer
819290|NCT00161187|angioimmunoblastic T-cell lymphoma|angioimmunoblastic t-cell lymphoma
819291|NCT00161187|recurrent adult T-cell leukemia/lymphoma|recurrent adult t-cell leukemia/lymphoma
819292|NCT00161187|recurrent adult Hodgkin lymphoma|recurrent adult hodgkin lymphoma
819293|NCT00161187|recurrent/refractory childhood Hodgkin lymphoma|recurrent/refractory childhood hodgkin lymphoma
819294|NCT00161187|recurrent adult acute myeloid leukemia|recurrent adult acute myeloid leukemia
819295|NCT00161187|recurrent childhood acute myeloid leukemia|recurrent childhood acute myeloid leukemia
819296|NCT00161187|childhood chronic myelogenous leukemia|childhood chronic myelogenous leukemia
819297|NCT00161187|chronic phase chronic myelogenous leukemia|chronic phase chronic myelogenous leukemia
819298|NCT00161187|relapsing chronic myelogenous leukemia|relapsing chronic myelogenous leukemia
819299|NCT00161187|recurrent renal cell cancer|recurrent renal cell cancer
819300|NCT00161187|stage IV renal cell cancer|stage iv renal cell cancer
819301|NCT00161187|recurrent bladder cancer|recurrent bladder cancer
819302|NCT00161187|stage IV bladder cancer|stage iv bladder cancer
819303|NCT00161187|recurrent prostate cancer|recurrent prostate cancer
819304|NCT00161187|stage IV prostate cancer|stage iv prostate cancer
819305|NCT00161187|recurrent malignant testicular germ cell tumor|recurrent malignant testicular germ cell tumor
819306|NCT00161187|stage III malignant testicular germ cell tumor|stage iii malignant testicular germ cell tumor
819307|NCT00161187|recurrent gastric cancer|recurrent gastric cancer
819308|NCT00161187|stage IV gastric cancer|stage iv gastric cancer
819309|NCT00161187|recurrent pancreatic cancer|recurrent pancreatic cancer
819310|NCT00161187|stage IV pancreatic cancer|stage iv pancreatic cancer
819311|NCT00161187|localized unresectable adult primary liver cancer|localized unresectable adult primary liver cancer
819312|NCT00161187|recurrent adult primary liver cancer|recurrent adult primary liver cancer
819313|NCT00161187|recurrent childhood liver cancer|recurrent childhood liver cancer
819314|NCT00161187|recurrent colon cancer|recurrent colon cancer
819315|NCT00161187|stage IV colon cancer|stage iv colon cancer
819316|NCT00161187|recurrent rectal cancer|recurrent rectal cancer
819317|NCT00161187|stage IV rectal cancer|stage iv rectal cancer
819318|NCT00161187|recurrent breast cancer|recurrent breast cancer
819319|NCT00161187|stage IV breast cancer|stage iv breast cancer
819320|NCT00161187|extensive stage small cell lung cancer|extensive stage small cell lung cancer
819321|NCT00161187|recurrent non-small cell lung cancer|recurrent non-small cell lung cancer
819322|NCT00161187|recurrent small cell lung cancer|recurrent small cell lung cancer
819323|NCT00161187|stage IV non-small cell lung cancer|stage iv non-small cell lung cancer
819324|NCT00161187|recurrent ovarian epithelial cancer|recurrent ovarian epithelial cancer
819325|NCT00161187|recurrent cervical cancer|recurrent cervical cancer
819326|NCT00161187|recurrent adult soft tissue sarcoma|recurrent adult soft tissue sarcoma
819327|NCT00161187|stage IV adult soft tissue sarcoma|stage iv adult soft tissue sarcoma
819328|NCT00161187|chondrosarcoma|chondrosarcoma
819329|NCT00161187|recurrent osteosarcoma|recurrent osteosarcoma
819330|NCT00161187|previously treated childhood rhabdomyosarcoma|previously treated childhood rhabdomyosarcoma
819331|NCT00161187|recurrent childhood rhabdomyosarcoma|recurrent childhood rhabdomyosarcoma
819332|NCT00161187|ovarian sarcoma|ovarian sarcoma
819333|NCT00161187|recurrent uterine sarcoma|recurrent uterine sarcoma
819334|NCT00161187|stage IV uterine sarcoma|stage iv uterine sarcoma
819335|NCT00161187|stage I small lymphocytic lymphoma|stage i small lymphocytic lymphoma
819336|NCT00161187|contiguous stage II small lymphocytic lymphoma|contiguous stage ii small lymphocytic lymphoma
819337|NCT00161187|noncontiguous stage II small lymphocytic lymphoma|noncontiguous stage ii small lymphocytic lymphoma
819338|NCT00161187|stage III small lymphocytic lymphoma|stage iii small lymphocytic lymphoma
819339|NCT00161187|stage IV small lymphocytic lymphoma|stage iv small lymphocytic lymphoma
819340|NCT00161187|accelerated phase chronic myelogenous leukemia|accelerated phase chronic myelogenous leukemia
819341|NCT00161187|blastic phase chronic myelogenous leukemia|blastic phase chronic myelogenous leukemia
819342|NCT00161187|recurrent childhood large cell lymphoma|recurrent childhood large cell lymphoma
819343|NCT00161187|stage I childhood large cell lymphoma|stage i childhood large cell lymphoma
819344|NCT00161187|stage II childhood large cell lymphoma|stage ii childhood large cell lymphoma
819345|NCT00161187|stage III childhood large cell lymphoma|stage iii childhood large cell lymphoma
819346|NCT00161187|stage IV childhood large cell lymphoma|stage iv childhood large cell lymphoma
819347|NCT00161187|adult primary hepatocellular carcinoma|adult primary hepatocellular carcinoma
819348|NCT00161187|advanced adult primary liver cancer|advanced adult primary liver cancer
819349|NCT00161187|ovarian stromal cancer|ovarian stromal cancer
819350|NCT00161187|stage IA cervical cancer|stage ia cervical cancer
819351|NCT00161187|stage IB cervical cancer|stage ib cervical cancer
819352|NCT00161187|stage IIA cervical cancer|stage iia cervical cancer
819353|NCT00161187|stage IIB cervical cancer|stage iib cervical cancer
819354|NCT00161187|stage III cervical cancer|stage iii cervical cancer
819355|NCT00161187|stage IVA cervical cancer|stage iva cervical cancer
819356|NCT00161187|stage IVB cervical cancer|stage ivb cervical cancer
819357|NCT00161187|recurrent adult acute lymphoblastic leukemia|recurrent adult acute lymphoblastic leukemia
819358|NCT00161187|untreated adult acute lymphoblastic leukemia|untreated adult acute lymphoblastic leukemia
819359|NCT00161187|recurrent childhood acute lymphoblastic leukemia|recurrent childhood acute lymphoblastic leukemia
819360|NCT00161187|untreated childhood acute lymphoblastic leukemia|untreated childhood acute lymphoblastic leukemia
819361|NCT00161187|recurrent endometrial carcinoma|recurrent endometrial carcinoma
819362|NCT00161187|stage I endometrial carcinoma|stage i endometrial carcinoma
819363|NCT00161187|stage II endometrial carcinoma|stage ii endometrial carcinoma
819364|NCT00161187|stage III endometrial carcinoma|stage iii endometrial carcinoma
819365|NCT00161187|stage IV endometrial carcinoma|stage iv endometrial carcinoma
819366|NCT00161187|childhood hepatocellular carcinoma|childhood hepatocellular carcinoma
819367|NCT00161187|stage III childhood liver cancer|stage iii childhood liver cancer
819368|NCT00161187|stage IV childhood liver cancer|stage iv childhood liver cancer
819369|NCT00161187|previously untreated childhood rhabdomyosarcoma|previously untreated childhood rhabdomyosarcoma
819370|NCT00161187|metastatic childhood soft tissue sarcoma|metastatic childhood soft tissue sarcoma
819371|NCT00161187|localized Ewing sarcoma/peripheral primitive neuroectodermal tumor|localized ewing sarcoma/peripheral primitive neuroectodermal tumor
819372|NCT00161187|metastatic Ewing sarcoma/peripheral primitive neuroectodermal tumor|metastatic ewing sarcoma/peripheral primitive neuroectodermal tumor
819373|NCT00161187|recurrent Ewing sarcoma/peripheral primitive neuroectodermal tumor|recurrent ewing sarcoma/peripheral primitive neuroectodermal tumor
819374|NCT00161187|contiguous stage II grade 1 follicular lymphoma|contiguous stage ii grade 1 follicular lymphoma
819375|NCT00161187|contiguous stage II grade 2 follicular lymphoma|contiguous stage ii grade 2 follicular lymphoma
819376|NCT00161187|contiguous stage II grade 3 follicular lymphoma|contiguous stage ii grade 3 follicular lymphoma
819377|NCT00161187|noncontiguous stage II grade 1 follicular lymphoma|noncontiguous stage ii grade 1 follicular lymphoma
819378|NCT00161187|noncontiguous stage II grade 2 follicular lymphoma|noncontiguous stage ii grade 2 follicular lymphoma
819379|NCT00161187|noncontiguous stage II grade 3 follicular lymphoma|noncontiguous stage ii grade 3 follicular lymphoma
819380|NCT00161187|stage I grade 1 follicular lymphoma|stage i grade 1 follicular lymphoma
819381|NCT00161187|stage I grade 2 follicular lymphoma|stage i grade 2 follicular lymphoma
819382|NCT00161187|stage I grade 3 follicular lymphoma|stage i grade 3 follicular lymphoma
819383|NCT00161187|stage III grade 1 follicular lymphoma|stage iii grade 1 follicular lymphoma
819384|NCT00161187|stage III grade 2 follicular lymphoma|stage iii grade 2 follicular lymphoma
819385|NCT00161187|stage III grade 3 follicular lymphoma|stage iii grade 3 follicular lymphoma
819386|NCT00161187|stage IV grade 1 follicular lymphoma|stage iv grade 1 follicular lymphoma
819387|NCT00161187|stage IV grade 2 follicular lymphoma|stage iv grade 2 follicular lymphoma
819388|NCT00161187|stage IV grade 3 follicular lymphoma|stage iv grade 3 follicular lymphoma
819539|NCT00161096|acid suppression|acid suppression
819389|NCT00161187|contiguous stage II marginal zone lymphoma|contiguous stage ii marginal zone lymphoma
819390|NCT00161187|noncontiguous stage II marginal zone lymphoma|noncontiguous stage ii marginal zone lymphoma
819391|NCT00161187|stage I marginal zone lymphoma|stage i marginal zone lymphoma
819392|NCT00161187|stage III marginal zone lymphoma|stage iii marginal zone lymphoma
819393|NCT00161187|stage IV marginal zone lymphoma|stage iv marginal zone lymphoma
819394|NCT00161187|localized osteosarcoma|localized osteosarcoma
819395|NCT00161187|metastatic osteosarcoma|metastatic osteosarcoma
819396|NCT00161187|stage I ovarian epithelial cancer|stage i ovarian epithelial cancer
819397|NCT00161187|stage II ovarian epithelial cancer|stage ii ovarian epithelial cancer
819398|NCT00161187|stage III ovarian epithelial cancer|stage iii ovarian epithelial cancer
819399|NCT00161187|stage IV ovarian epithelial cancer|stage iv ovarian epithelial cancer
819400|NCT00161187|recurrent ovarian germ cell tumor|recurrent ovarian germ cell tumor
819401|NCT00161187|stage I ovarian germ cell tumor|stage i ovarian germ cell tumor
819402|NCT00161187|stage II ovarian germ cell tumor|stage ii ovarian germ cell tumor
819403|NCT00161187|stage III ovarian germ cell tumor|stage iii ovarian germ cell tumor
819404|NCT00161187|stage IV ovarian germ cell tumor|stage iv ovarian germ cell tumor
819405|NCT00161187|limited stage small cell lung cancer|limited stage small cell lung cancer
819406|NCT00161187|refractory multiple myeloma|refractory multiple myeloma
819407|NCT00161187|stage II malignant testicular germ cell tumor|stage ii malignant testicular germ cell tumor
819408|NCT00161187|stage I adult soft tissue sarcoma|stage i adult soft tissue sarcoma
819409|NCT00161187|stage II adult soft tissue sarcoma|stage ii adult soft tissue sarcoma
819410|NCT00161187|stage III adult soft tissue sarcoma|stage iii adult soft tissue sarcoma
819411|NCT00161187|stage I bladder cancer|stage i bladder cancer
819412|NCT00161187|stage II bladder cancer|stage ii bladder cancer
819413|NCT00161187|stage III bladder cancer|stage iii bladder cancer
819414|NCT00161187|male breast cancer|male breast cancer
819415|NCT00161187|stage I breast cancer|stage i breast cancer
819416|NCT00161187|stage II breast cancer|stage ii breast cancer
819417|NCT00161187|stage IIIA breast cancer|stage iiia breast cancer
819418|NCT00161187|stage IIIB breast cancer|stage iiib breast cancer
819419|NCT00161187|stage IIIC breast cancer|stage iiic breast cancer
819420|NCT00161187|stage I colon cancer|stage i colon cancer
819421|NCT00161187|stage II colon cancer|stage ii colon cancer
819422|NCT00161187|stage III colon cancer|stage iii colon cancer
819423|NCT00161187|stage I gastric cancer|stage i gastric cancer
819424|NCT00161187|stage II gastric cancer|stage ii gastric cancer
819425|NCT00161187|stage III gastric cancer|stage iii gastric cancer
819426|NCT00161187|stage I non-small cell lung cancer|stage i non-small cell lung cancer
819427|NCT00161187|stage II non-small cell lung cancer|stage ii non-small cell lung cancer
819428|NCT00161187|stage IIIA non-small cell lung cancer|stage iiia non-small cell lung cancer
819429|NCT00161187|stage IIIB non-small cell lung cancer|stage iiib non-small cell lung cancer
819591|NCT00160875|CPT11|cpt11
819431|NCT00161187|stage II pancreatic cancer|stage ii pancreatic cancer
819432|NCT00161187|stage III pancreatic cancer|stage iii pancreatic cancer
819433|NCT00161187|stage I prostate cancer|stage i prostate cancer
819434|NCT00161187|stage II prostate cancer|stage ii prostate cancer
819435|NCT00161187|stage III prostate cancer|stage iii prostate cancer
819436|NCT00161187|stage I rectal cancer|stage i rectal cancer
819437|NCT00161187|stage II rectal cancer|stage ii rectal cancer
819438|NCT00161187|stage III rectal cancer|stage iii rectal cancer
819439|NCT00161187|stage I renal cell cancer|stage i renal cell cancer
819440|NCT00161187|stage II renal cell cancer|stage ii renal cell cancer
819441|NCT00161187|stage III renal cell cancer|stage iii renal cell cancer
819442|NCT00161187|stage I uterine sarcoma|stage i uterine sarcoma
819443|NCT00161187|stage II uterine sarcoma|stage ii uterine sarcoma
819444|NCT00161187|stage III uterine sarcoma|stage iii uterine sarcoma
819445|NCT00161187|stage I chronic lymphocytic leukemia|stage i chronic lymphocytic leukemia
819446|NCT00161187|stage II chronic lymphocytic leukemia|stage ii chronic lymphocytic leukemia
819447|NCT00161187|stage III chronic lymphocytic leukemia|stage iii chronic lymphocytic leukemia
819448|NCT00161187|stage IV chronic lymphocytic leukemia|stage iv chronic lymphocytic leukemia
819449|NCT00161187|contiguous stage II mantle cell lymphoma|contiguous stage ii mantle cell lymphoma
819450|NCT00161187|noncontiguous stage II mantle cell lymphoma|noncontiguous stage ii mantle cell lymphoma
819451|NCT00161187|stage I mantle cell lymphoma|stage i mantle cell lymphoma
819452|NCT00161187|stage III mantle cell lymphoma|stage iii mantle cell lymphoma
819453|NCT00161187|stage IV mantle cell lymphoma|stage iv mantle cell lymphoma
819454|NCT00161187|Waldenstrom macroglobulinemia|waldenstrom macroglobulinemia
819455|NCT00161187|contiguous stage II adult diffuse large cell lymphoma|contiguous stage ii adult diffuse large cell lymphoma
819456|NCT00161187|noncontiguous stage II adult diffuse large cell lymphoma|noncontiguous stage ii adult diffuse large cell lymphoma
819457|NCT00161187|stage I adult diffuse large cell lymphoma|stage i adult diffuse large cell lymphoma
819458|NCT00161187|stage III adult diffuse large cell lymphoma|stage iii adult diffuse large cell lymphoma
819459|NCT00161187|stage IV adult diffuse large cell lymphoma|stage iv adult diffuse large cell lymphoma
819460|NCT00161187|contiguous stage II adult Burkitt lymphoma|contiguous stage ii adult burkitt lymphoma
819461|NCT00161187|noncontiguous stage II adult Burkitt lymphoma|noncontiguous stage ii adult burkitt lymphoma
819462|NCT00161187|stage I adult Burkitt lymphoma|stage i adult burkitt lymphoma
819463|NCT00161187|stage III adult Burkitt lymphoma|stage iii adult burkitt lymphoma
819464|NCT00161187|stage IV adult Burkitt lymphoma|stage iv adult burkitt lymphoma
819465|NCT00161187|stage I mycosis fungoides/Sezary syndrome|stage i mycosis fungoides/sezary syndrome
819466|NCT00161187|stage II mycosis fungoides/Sezary syndrome|stage ii mycosis fungoides/sezary syndrome
819467|NCT00161187|stage III mycosis fungoides/Sezary syndrome|stage iii mycosis fungoides/sezary syndrome
819468|NCT00161187|stage IV mycosis fungoides/Sezary syndrome|stage iv mycosis fungoides/sezary syndrome
819469|NCT00161187|adult acute myeloid leukemia with 11q23 (MLL) abnormalities|adult acute myeloid leukemia with 11q23 (mll) abnormalities
819470|NCT00161187|adult acute myeloid leukemia with inv(16)(p13;q22)|adult acute myeloid leukemia with inv(16)(p13;q22)
819471|NCT00161187|adult acute myeloid leukemia with t(15;17)(q22;q12)|adult acute myeloid leukemia with t(15;17)(q22;q12)
819472|NCT00161187|adult acute myeloid leukemia with t(16;16)(p13;q22)|adult acute myeloid leukemia with t(16;16)(p13;q22)
819473|NCT00161187|adult acute myeloid leukemia with t(8;21)(q22;q22)|adult acute myeloid leukemia with t(8;21)(q22;q22)
819474|NCT00161187|untreated adult acute myeloid leukemia|untreated adult acute myeloid leukemia
819475|NCT00161187|untreated childhood acute myeloid leukemia and other myeloid malignancies|untreated childhood acute myeloid leukemia and other myeloid malignancies
819476|NCT00161187|de novo myelodysplastic syndromes|de novo myelodysplastic syndromes
819477|NCT00161187|secondary myelodysplastic syndromes|secondary myelodysplastic syndromes
819478|NCT00161187|previously treated myelodysplastic syndromes|previously treated myelodysplastic syndromes
819479|NCT00161187|nonmetastatic childhood soft tissue sarcoma|nonmetastatic childhood soft tissue sarcoma
819480|NCT00161187|recurrent childhood soft tissue sarcoma|recurrent childhood soft tissue sarcoma
819481|NCT00161187|stage I childhood Hodgkin lymphoma|stage i childhood hodgkin lymphoma
819482|NCT00161187|stage II childhood Hodgkin lymphoma|stage ii childhood hodgkin lymphoma
819483|NCT00161187|stage III childhood Hodgkin lymphoma|stage iii childhood hodgkin lymphoma
819484|NCT00161187|stage IV childhood Hodgkin lymphoma|stage iv childhood hodgkin lymphoma
819485|NCT00161187|stage I adult Hodgkin lymphoma|stage i adult hodgkin lymphoma
819486|NCT00161187|stage II adult Hodgkin lymphoma|stage ii adult hodgkin lymphoma
819487|NCT00161187|stage III adult Hodgkin lymphoma|stage iii adult hodgkin lymphoma
819488|NCT00161187|stage IV adult Hodgkin lymphoma|stage iv adult hodgkin lymphoma
819489|NCT00161187|recurrent childhood small noncleaved cell lymphoma|recurrent childhood small noncleaved cell lymphoma
819490|NCT00161187|stage I childhood small noncleaved cell lymphoma|stage i childhood small noncleaved cell lymphoma
819491|NCT00161187|stage II childhood small noncleaved cell lymphoma|stage ii childhood small noncleaved cell lymphoma
819492|NCT00161187|stage III childhood small noncleaved cell lymphoma|stage iii childhood small noncleaved cell lymphoma
819493|NCT00161187|stage IV childhood small noncleaved cell lymphoma|stage iv childhood small noncleaved cell lymphoma
819494|NCT00161187|Burkitt lymphoma|burkitt lymphoma
819495|NCT00161187|stage I adult T-cell leukemia/lymphoma|stage i adult t-cell leukemia/lymphoma
819496|NCT00161187|stage II adult T-cell leukemia/lymphoma|stage ii adult t-cell leukemia/lymphoma
819592|NCT00160875|cisplatin|cisplatin
819497|NCT00161187|stage III adult T-cell leukemia/lymphoma|stage iii adult t-cell leukemia/lymphoma
819498|NCT00161187|stage IV adult T-cell leukemia/lymphoma|stage iv adult t-cell leukemia/lymphoma
819499|NCT00161187|stage I malignant testicular germ cell tumor|stage i malignant testicular germ cell tumor
819500|NCT00161187|childhood myelodysplastic syndromes|childhood myelodysplastic syndromes
819501|NCT00161187|childhood renal cell carcinoma|childhood renal cell carcinoma
819502|NCT00161187|stage IA melanoma|stage ia melanoma
819503|NCT00161187|stage IB melanoma|stage ib melanoma
819504|NCT00161187|stage IIA melanoma|stage iia melanoma
819505|NCT00161187|stage IIB melanoma|stage iib melanoma
819506|NCT00161187|stage IIC melanoma|stage iic melanoma
819507|NCT00161187|stage IIIA melanoma|stage iiia melanoma
819508|NCT00161187|stage IIIB melanoma|stage iiib melanoma
819509|NCT00161187|stage IIIC melanoma|stage iiic melanoma
819510|NCT00161187|stage IV melanoma|stage iv melanoma
819511|NCT00161187|recurrent melanoma|recurrent melanoma
819512|NCT00161174|testicular cancer|testicular cancer
819513|NCT00161174|cardiovascular morbidity|cardiovascular morbidity
819514|NCT00161174|cardiovascular risk factors|cardiovascular risk factors
819515|NCT00161174|pharmacogenomic determinants|pharmacogenomic determinants
819516|NCT00161161|ADHD; MRI; genetics|adhd; mri; genetics
819517|NCT00161148|PSC|psc
819518|NCT00161148|Liver biochemistry|liver biochemistry
819519|NCT00161148|Probiotics|probiotics
819520|NCT00161148|Pruritus|pruritus
819521|NCT00161135|MRI|mri
819522|NCT00161135|PDD-NOS, MCDD|pdd-nos, mcdd
819523|NCT00161109|22q11.2 deletion syndrome|22q11.2 deletion syndrome
819524|NCT00161109|Psychopathology|psychopathology
819525|NCT00161109|Psychiatry|psychiatry
819526|NCT00161109|Neuropsychology|neuropsychology
819527|NCT00161109|Psychiophysiology|psychiophysiology
819528|NCT00161109|Autism|autism
819529|NCT00161109|Psychosis|psychosis
819530|NCT00161109|Deletion size|deletion size
819531|NCT00161109|Candidate genes|candidate genes
819532|NCT00161109|Psychiatric symptoms|psychiatric symptoms
819533|NCT00161109|Neuropsychological impairments|neuropsychological impairments
819534|NCT00161109|Psychophysiological performance|psychophysiological performance
819535|NCT00161096|on-demand therapy|on-demand therapy
819536|NCT00161096|pantoprazole|pantoprazole
819537|NCT00161096|gastro-oesophageal reflux disease|gastro-oesophageal reflux disease
819540|NCT00161096|intermittent|intermittent
819541|NCT00161083|ursodeoxycholic acid|ursodeoxycholic acid
819542|NCT00161083|gallstone|gallstone
819543|NCT00161083|complications|complications
819544|NCT00161083|pancreatitis|pancreatitis
819545|NCT00161083|gallbladder motility|gallbladder motility
819546|NCT00161083|colic|colic
819547|NCT00161070|secondary prevention|secondary prevention
819548|NCT00161070|TIA / minor stroke|tia / minor stroke
819549|NCT00161070|atherosclerotic origin|atherosclerotic origin
819550|NCT00161070|TIA (Transient Ischemic Attack)|tia (transient ischemic attack)
819551|NCT00161070|prevention & control|prevention & control
819552|NCT00161057|Schizophrenia|schizophrenia
819553|NCT00161057|Medication-naive|medication-naive
819554|NCT00161057|Functional MRI|functional mri
819555|NCT00161057|Working memory|working memory
819556|NCT00161057|Language lateralization|language lateralization
819557|NCT00161057|schizoaffective disorder|schizoaffective disorder
819558|NCT00161057|psychotic disorder Not Otherwise Specified|psychotic disorder not otherwise specified
819559|NCT00161005|Acute myocardial infarction|acute myocardial infarction
819560|NCT00161005|Fibrinolysis|fibrinolysis
819561|NCT00161005|Health effects /Quality of life|health effects /quality of life
819562|NCT00160992|Adoptive cell transfer|adoptive cell transfer
819563|NCT00160992|peptide vaccination|peptide vaccination
819564|NCT00160992|melanoma|melanoma
819565|NCT00160992|immunosuppression and homeostatic proliferation|immunosuppression and homeostatic proliferation
819566|NCT00160966|kidney transplantation|kidney transplantation
819567|NCT00160966|polyoma virus associated transplant nephropathy|polyoma virus associated transplant nephropathy
819568|NCT00160966|tacrolimus|tacrolimus
819569|NCT00160966|mycophenolate mofetil|mycophenolate mofetil
819570|NCT00160966|everolimus|everolimus
819571|NCT00160966|cyclosporin A|cyclosporin a
819572|NCT00160966|BK virus PCR|bk virus pcr
819573|NCT00160966|viruria screening|viruria screening
819574|NCT00160966|BK polyomavirus|bk polyomavirus
819575|NCT00160966|immunosuppression|immunosuppression
819576|NCT00160940|gene expression|gene expression
819577|NCT00160940|viral hepatitis|viral hepatitis
819578|NCT00160940|autoimmune disease|autoimmune disease
819579|NCT00160927|microcirculation|microcirculation
819580|NCT00160927|Laser doppler flowmetry|laser doppler flowmetry
819581|NCT00160927|neuropathy|neuropathy
819582|NCT00160927|endothelial function|endothelial function
819583|NCT00160914|Childhood obesity|childhood obesity
819584|NCT00160901|Breast cancer|breast cancer
819585|NCT00160901|Chemotherapy|chemotherapy
819586|NCT00160901|Phytotherapy|phytotherapy
819587|NCT00160901|Nutritional counseling|nutritional counseling
819588|NCT00160875|esophageal|esophageal
819589|NCT00160875|esophagus|esophagus
819590|NCT00160875|irinotecan|irinotecan
819594|NCT00160836|Tissue diagnosis|tissue diagnosis
819595|NCT00160823|Colon cleansing|colon cleansing
819596|NCT00160823|Quality|quality
819597|NCT00160823|Cost-effectiveness|cost-effectiveness
819598|NCT00160810|distal|distal
819599|NCT00160810|radius|radius
819600|NCT00160810|fractures|fractures
819601|NCT00160745|endothelium, NO, renal, statins|endothelium, no, renal, statins
819602|NCT00160732|Islet Cell Transplant|islet cell transplant
819603|NCT00160732|Human islet cell infusion|human islet cell infusion
819604|NCT00160732|Juvenile-onset diabetes|juvenile-onset diabetes
819605|NCT00160693|Rheumatoid Arthritis|rheumatoid arthritis
819606|NCT00160693|America College of Rheumatology|america college of rheumatology
819607|NCT00160693|Disease modifying anti-rheumatic drug|disease modifying anti-rheumatic drug
819608|NCT00160693|Certolizumab Pegol (CDP870)|certolizumab pegol (cdp870)
819609|NCT00160680|Persistent Allergic Rhinitis|persistent allergic rhinitis
819610|NCT00160680|HDM|hdm
819611|NCT00160680|Parietaria|parietaria
819612|NCT00160680|sneezing|sneezing
819613|NCT00160680|rhinorrhea|rhinorrhea
819614|NCT00160680|ocular pruritus|ocular pruritus
819615|NCT00160680|Rhinasthma|rhinasthma
819616|NCT00160680|inflammatory cells|inflammatory cells
819617|NCT00160680|ICAM-1|icam-1
819618|NCT00160680|ATAREAL|atareal
819619|NCT00160680|Xyzal|xyzal
819620|NCT00160680|Levocetirizine|levocetirizine
819621|NCT00160667|Post-herpetic Neuralgia (PHN)|post-herpetic neuralgia (phn)
819622|NCT00160667|Brivaracetam|brivaracetam
819623|NCT00160654|Epilepsy|epilepsy
819624|NCT00160654|Partial Onset Seizures|partial onset seizures
819625|NCT00160654|Keppra|keppra
819626|NCT00160654|Levetiracetam|levetiracetam
819627|NCT00160641|Rheumatoid Arthritis|rheumatoid arthritis
819628|NCT00160641|CDP870|cdp870
819629|NCT00160641|Certolizumab Pegol|certolizumab pegol
819630|NCT00160641|Cimzia|cimzia
819631|NCT00160628|Epilepsy|epilepsy
819632|NCT00160628|Partial Onset Seizures|partial onset seizures
819633|NCT00160628|Keppra|keppra
819634|NCT00160628|Levetiracetam|levetiracetam
819635|NCT00160615|Epilepsy, partial|epilepsy, partial
819636|NCT00160615|Keppra|keppra
819637|NCT00160615|Levetiracetam|levetiracetam
819638|NCT00160602|Rheumatoid Arthritis|rheumatoid arthritis
819639|NCT00160602|Certolizumab Pegol, Cimzia|certolizumab pegol, cimzia
819728|NCT00160095|Tumor hypoxia|tumor hypoxia
819729|NCT00160095|microregional imaging|microregional imaging
819640|NCT00160589|Allergic Rhinits, Symptoms (sneezing, rhinorrhea, nasal/ocular pruritus, nasal congestion), LEADER, Xyzal, Levocetirizine|allergic rhinits, symptoms (sneezing, rhinorrhea, nasal/ocular pruritus, nasal congestion), leader, xyzal, levocetirizine
819641|NCT00160576|Idiopathic Parkinson's Disease, levodopa induced dyskinesia,|idiopathic parkinson's disease, levodopa induced dyskinesia,
819642|NCT00160576|Levetiracetam, Keppra|levetiracetam, keppra
819643|NCT00160563|Pediatry|pediatry
819644|NCT00160563|EPAAC|epaac
819645|NCT00160563|atopic Children|atopic children
819646|NCT00160563|prevention of asthma|prevention of asthma
819647|NCT00160563|Levocetirizine|levocetirizine
819648|NCT00160563|Xyzal|xyzal
819649|NCT00160550|Idiopathic Generalized Epilepsy, tonic-clonic seizures|idiopathic generalized epilepsy, tonic-clonic seizures
819650|NCT00160550|Levetiracetam, Keppra|levetiracetam, keppra
819651|NCT00160537|Seasonal Allergic Rhinitis (SAR), Grass pollen, SAR Symptoms (sneezing, rhinorrhea, nasal / ocular pruritus, nasal congestion)|seasonal allergic rhinitis (sar), grass pollen, sar symptoms (sneezing, rhinorrhea, nasal / ocular pruritus, nasal congestion)
819652|NCT00160537|POPULAR, Xyzal, Levocetirizine|popular, xyzal, levocetirizine
819653|NCT00160524|Certolizumab Pegol|certolizumab pegol
819654|NCT00160524|Cimzia|cimzia
819655|NCT00160524|CDP870|cdp870
819656|NCT00160524|CZP|czp
819657|NCT00160511|Postherpetic Neuralgia (PHN)|postherpetic neuralgia (phn)
819658|NCT00160511|Levetiracetam|levetiracetam
819659|NCT00160511|Keppra|keppra
819660|NCT00160511|Nerve Pain|nerve pain
819661|NCT00160498|Lercanidipine, calcium antagonist, hypertension, obesity|lercanidipine, calcium antagonist, hypertension, obesity
819662|NCT00160485|Gestational Diabetes|gestational diabetes
819663|NCT00160485|Pregnancy|pregnancy
819664|NCT00160485|Glyburide|glyburide
819665|NCT00160485|Insulin|insulin
819666|NCT00160472|vasopressin|vasopressin
819667|NCT00160472|ovarian|ovarian
819668|NCT00160472|neoplasm|neoplasm
819669|NCT00160459|Fibroid Uterus|fibroid uterus
819670|NCT00160459|Leiomyoma|leiomyoma
819671|NCT00160459|Uterine Fibroids|uterine fibroids
819672|NCT00160459|asoprisnil|asoprisnil
819673|NCT00160446|Pelvic pain|pelvic pain
819674|NCT00160446|Dysmenorrhea|dysmenorrhea
819675|NCT00160446|Dyspareunia|dyspareunia
819676|NCT00160446|Infertility|infertility
819677|NCT00160446|Asoprisnil|asoprisnil
819678|NCT00160433|Pelvic pain|pelvic pain
819679|NCT00160433|Dysmenorrhea|dysmenorrhea
819680|NCT00160433|Dyspareunia|dyspareunia
819681|NCT00160433|Infertility|infertility
819682|NCT00160433|asoprisnil|asoprisnil
819683|NCT00160420|Pelvic pain|pelvic pain
819684|NCT00160420|Dysmenorrhea|dysmenorrhea
819685|NCT00160420|Dyspareunia|dyspareunia
819686|NCT00160420|Infertility|infertility
819687|NCT00160420|asoprisnil|asoprisnil
819688|NCT00160407|nonalcoholic steatohepatitis|nonalcoholic steatohepatitis
819689|NCT00160407|enzyme inhibitors|enzyme inhibitors
819690|NCT00160407|lipase|lipase
819691|NCT00160407|obesity|obesity
819692|NCT00160407|insulin resistance|insulin resistance
819693|NCT00160394|Mild to Moderate|mild to moderate
819694|NCT00160381|Symptomatic Uterine Fibroids|symptomatic uterine fibroids
819695|NCT00160381|Excessive Uterine Bleeding|excessive uterine bleeding
819696|NCT00160381|Uterine Hemorrhage|uterine hemorrhage
819697|NCT00160381|asoprisnil|asoprisnil
819698|NCT00160368|Hypertension, potassium salts|hypertension, potassium salts
819699|NCT00160355|Wiskott-Aldrich Syndrome|wiskott-aldrich syndrome
819700|NCT00160355|Immunodeficiency|immunodeficiency
819701|NCT00160355|Haploidentical transplantation|haploidentical transplantation
819702|NCT00160342|Hormone replacement therapy, hot flushes, postmenopause|hormone replacement therapy, hot flushes, postmenopause
819703|NCT00160303|Prolotherapy|prolotherapy
819704|NCT00160303|Lateral Epicondylitis|lateral epicondylitis
819705|NCT00160303|Tennis Elbow|tennis elbow
819706|NCT00160303|Corticosteroid Therapy|corticosteroid therapy
819707|NCT00160290|lactulose|lactulose
819708|NCT00160290|randomised clinical trial|randomised clinical trial
819709|NCT00160290|hemorrhoids|hemorrhoids
819710|NCT00160290|anal fissures|anal fissures
819711|NCT00160277|Efficacy and safety of moxonidine in Indian hypertensives|efficacy and safety of moxonidine in indian hypertensives
819712|NCT00160264|lactulose; randomised clinical trial; osteopenia; postmenopause|lactulose; randomised clinical trial; osteopenia; postmenopause
819713|NCT00160251|PEG-Intron|peg-intron
819714|NCT00160251|Ribavirin|ribavirin
819715|NCT00160251|Protease Inhibitor|protease inhibitor
819716|NCT00160238|Meniere's disease|meniere's disease
819717|NCT00160238|Vestibular neurotomy|vestibular neurotomy
819718|NCT00160225|blood pressure, diabetic nephropathy, proteinuria|blood pressure, diabetic nephropathy, proteinuria
819719|NCT00160212|blood pressure|blood pressure
819720|NCT00160199|To collect additional data on 300 and 400 mg doses of PROMETRIUM in women with secondary amenorrhea|to collect additional data on 300 and 400 mg doses of prometrium in women with secondary amenorrhea
819721|NCT00160173|Post menopausal vasomotor symptoms|post menopausal vasomotor symptoms
819722|NCT00160160|comparator trial|comparator trial
819723|NCT00160160|hypertension|hypertension
819724|NCT00160160|diabetes|diabetes
819725|NCT00160160|blood pressure|blood pressure
819726|NCT00160134|congestive heart failure, adenosine receptor blocker, cardiac hemodynamic|congestive heart failure, adenosine receptor blocker, cardiac hemodynamic
819727|NCT00160095|larynx carcinoma|larynx carcinoma
819730|NCT00160095|hypoxia modifying treatment|hypoxia modifying treatment
819731|NCT00160082|Post Polio Syndrome|post polio syndrome
819732|NCT00160082|PPS|pps
819733|NCT00160082|Poliomyelitis|poliomyelitis
819734|NCT00160082|Paralylic Polio|paralylic polio
819735|NCT00160082|Late effects of polio|late effects of polio
819736|NCT00160082|Late onset polio sequele|late onset polio sequele
819737|NCT00160082|Xepol|xepol
819738|NCT00160082|IvIg|ivig
819739|NCT00160082|Intravenous Immunoglobuline|intravenous immunoglobuline
819740|NCT00160069|Stage IIIB or stage IV non-small-cell lung cancer.|stage iiib or stage iv non-small-cell lung cancer.
819741|NCT00160056|Hypoglycemia unawareness|hypoglycemia unawareness
819742|NCT00160056|Diabetes|diabetes
819743|NCT00160056|adrenal receptor|adrenal receptor
819744|NCT00160056|adrenerg respons|adrenerg respons
819745|NCT00160056|adrenergic beta-agonists|adrenergic beta-agonists
819746|NCT00160056|salbutamol|salbutamol
819747|NCT00160017|Quality assurance health care|quality assurance health care
819748|NCT00160017|Diabetes|diabetes
819749|NCT00160017|Breakthrough collaborative (IHI)|breakthrough collaborative (ihi)
819750|NCT00160017|Evaluation|evaluation
819751|NCT00160004|Amyotrophic Lateral Sclerosis|amyotrophic lateral sclerosis
819752|NCT00160004|Exercise|exercise
819753|NCT00160004|Fatigue|fatigue
819754|NCT00160004|Quality-of-life|quality-of-life
819755|NCT00159991|Coronary artery bypass grafting|coronary artery bypass grafting
819756|NCT00159991|Total arterial revascularization|total arterial revascularization
819757|NCT00159991|Internal mammary artery grafting|internal mammary artery grafting
819758|NCT00159991|Radial artery grafting|radial artery grafting
819759|NCT00159978|head and neck cancer|head and neck cancer
819760|NCT00159978|hypoxia|hypoxia
819761|NCT00159978|tumor cell proliferation|tumor cell proliferation
819762|NCT00159978|PET|pet
819763|NCT00159965|nonepileptic seizure|nonepileptic seizure
819764|NCT00159965|pseudoseizure|pseudoseizure
819765|NCT00159965|conversion disorder|conversion disorder
819766|NCT00159965|psychogenic|psychogenic
819767|NCT00159965|Depression|depression
819768|NCT00159965|Anxiety|anxiety
819769|NCT00159965|Abuse|abuse
819770|NCT00159965|post-traumatic stress disorder|post-traumatic stress disorder
819771|NCT00159965|sertraline|sertraline
819772|NCT00159965|serotonin|serotonin
819773|NCT00159965|randomized controlled trial|randomized controlled trial
819774|NCT00159952|Sepsis|sepsis
819775|NCT00159952|Septic shock|septic shock
819776|NCT00159952|Hyperglycemia|hyperglycemia
819777|NCT00159952|Fibrinolysis|fibrinolysis
819778|NCT00159952|PAI 1|pai 1
819779|NCT00159939|ARDS|ards
819780|NCT00159939|prone position|prone position
819781|NCT00159926|systemic inflammatory response syndrome|systemic inflammatory response syndrome
819782|NCT00159926|coronary artery bypass grafting|coronary artery bypass grafting
819783|NCT00159926|cell saver|cell saver
819784|NCT00159926|interleukins|interleukins
819785|NCT00159926|tumor necrosis factor alfa|tumor necrosis factor alfa
819786|NCT00159900|Impotence|impotence
819787|NCT00159874|children|children
819788|NCT00159627|heart failure, congestive|heart failure, congestive
819789|NCT00159627|diuretic|diuretic
819790|NCT00159614|renal insufficiency|renal insufficiency
819791|NCT00159614|diuretic|diuretic
819792|NCT00159614|heart failure, congestive|heart failure, congestive
819793|NCT00159601|Quality of Life|quality of life
819794|NCT00159601|Mental health|mental health
819795|NCT00159601|Children|children
819796|NCT00159601|Adolescents|adolescents
819797|NCT00159601|Normal population|normal population
819798|NCT00159588|Medication-overuse headache|medication-overuse headache
819799|NCT00159588|preventative medication|preventative medication
819800|NCT00159588|controls|controls
819801|NCT00159588|follow-up|follow-up
819802|NCT00159588|randomized|randomized
819803|NCT00159588|abrupt withdrawal|abrupt withdrawal
819804|NCT00159575|Polycystic ovarian syndrome|polycystic ovarian syndrome
819805|NCT00159575|Clinical pregnancy rate|clinical pregnancy rate
819806|NCT00159575|Oligo- or anovulation|oligo- or anovulation
819807|NCT00159562|Bipolar Disorder|bipolar disorder
819808|NCT00159562|Psycho-education|psycho-education
819809|NCT00159549|Patient education|patient education
819811|NCT00159536|metformin|metformin
819812|NCT00159536|pregnancy|pregnancy
819813|NCT00159536|preeclampsia|preeclampsia
819814|NCT00159536|diabetes|diabetes
819815|NCT00159536|preterm delivery|preterm delivery
819816|NCT00159523|Prevention|prevention
819817|NCT00159523|Probiotics|probiotics
819818|NCT00159523|Allergy|allergy
819819|NCT00159523|Hypersensitivity|hypersensitivity
819820|NCT00159510|sepsis, methylene blue, nitric oxide, acute lung injury|sepsis, methylene blue, nitric oxide, acute lung injury
819821|NCT00159497|THA|tha
819822|NCT00159484|phase 1|phase 1
819823|NCT00159484|phase one|phase one
819824|NCT00159484|phase I|phase i
819825|NCT00159432|colorectal|colorectal
819826|NCT00159432|cancer|cancer
819827|NCT00159419|Osteogenesis Imperfecta|osteogenesis imperfecta
819828|NCT00159419|Fractures|fractures
819829|NCT00159419|Pediatric|pediatric
819830|NCT00159419|Osteoporosis|osteoporosis
819831|NCT00159419|Juvenile Pagets|juvenile pagets
819832|NCT00159406|BPH treatment|bph treatment
819833|NCT00159406|Laser Prostatectomy|laser prostatectomy
819834|NCT00159406|Treatment of enlarged Prostates|treatment of enlarged prostates
819835|NCT00159406|BPH|bph
819836|NCT00159393|Kidney stones|kidney stones
819837|NCT00159393|nephrolithotripsy percutaneous|nephrolithotripsy percutaneous
819838|NCT00159380|Asthma|asthma
819839|NCT00159367|Neuromuscular electrical stimulation|neuromuscular electrical stimulation
819840|NCT00159354|FDG−PET|fdg−pet
819841|NCT00159354|pulmonary inflammation,|pulmonary inflammation,
819842|NCT00159354|smoking,|smoking,
819843|NCT00159354|COPD|copd
819844|NCT00159354|steroid intervention|steroid intervention
819845|NCT00159341|cigarette smoke|cigarette smoke
819846|NCT00159341|nasal|nasal
819847|NCT00159341|whole blood|whole blood
819848|NCT00159341|cytokines|cytokines
819849|NCT00159341|chemokines|chemokines
819850|NCT00159341|nasal fluid|nasal fluid
819851|NCT00159341|filter paper|filter paper
819852|NCT00159328|Magnetic Resonance Guided Focused Ultrasound|magnetic resonance guided focused ultrasound
819853|NCT00159328|Gonadotrophin Releasing Hormone Agonist|gonadotrophin releasing hormone agonist
819854|NCT00159328|Uterine Fibroids|uterine fibroids
819855|NCT00159315|Healthy Volunteers (smokers)|healthy volunteers (smokers)
819856|NCT00159315|Healthy Volunteers (Non-smokers)|healthy volunteers (non-smokers)
819857|NCT00159315|Asthma Patients|asthma patients
819858|NCT00159315|COPD Patients|copd patients
819859|NCT00159289|Mild to moderate Chronic Obstructive Pulmonary Disease (COPD)|mild to moderate chronic obstructive pulmonary disease (copd)
819860|NCT00159289|Volunteers (healthy non-smokers)|volunteers (healthy non-smokers)
819861|NCT00159289|Volunteers (current or ex-smokers)|volunteers (current or ex-smokers)
819862|NCT00159263|Asthma|asthma
819863|NCT00159263|Glucocorticoid|glucocorticoid
819864|NCT00159263|Long-acting beta2-adrenoceptor|long-acting beta2-adrenoceptor
819865|NCT00159263|Inhaled corticosteroids|inhaled corticosteroids
819866|NCT00159250|Duchenne muscular dystrophy;|duchenne muscular dystrophy;
819867|NCT00159250|antisense oligonucleotides;|antisense oligonucleotides;
819868|NCT00159250|gene restoration;|gene restoration;
819869|NCT00159250|deletion|deletion
819871|NCT00159224|Simplification|simplification
819872|NCT00159224|Monotherapy|monotherapy
819873|NCT00159224|Treatment Naive|treatment naive
819874|NCT00159224|HIV-1 infection|hiv-1 infection
819875|NCT00159211|type 2 diabetes|type 2 diabetes
819876|NCT00159198|Amyotrophic lateral sclerosis|amyotrophic lateral sclerosis
819877|NCT00159198|Frontotemporal dementia|frontotemporal dementia
819878|NCT00159198|Mutations spectrum|mutations spectrum
819879|NCT00159198|Linkage studies|linkage studies
819880|NCT00159198|Genetic epidemiology|genetic epidemiology
819881|NCT00159185|Arthroplasty, Replacement, Hip|arthroplasty, replacement, hip
819882|NCT00159185|Epidemiology|epidemiology
819883|NCT00159172|Advanced parkinson disease|advanced parkinson disease
819884|NCT00159172|Stimulation|stimulation
819885|NCT00159172|Motor Cortex|motor cortex
819886|NCT00159172|Parkinson disease C10.574.812|parkinson disease c10.574.812
819887|NCT00159172|Electric Stimulation Therapy E02.831.580.438|electric stimulation therapy e02.831.580.438
819888|NCT00159172|Neuronavigation E05.873.249|neuronavigation e05.873.249
819889|NCT00159159|Cardiac Transplant|cardiac transplant
819890|NCT00159159|ciclosporine|ciclosporine
819891|NCT00159159|immunosuppressive|immunosuppressive
819892|NCT00159146|Major Depression|major depression
819893|NCT00159146|Pindolol|pindolol
819894|NCT00159146|Venlafaxine|venlafaxine
819895|NCT00159146|Augmentation|augmentation
819896|NCT00159146|Major depression (DSM-IVR)|major depression (dsm-ivr)
819897|NCT00159133|Schizophrenia|schizophrenia
819898|NCT00159133|first episode|first episode
819899|NCT00159133|prodrome based early intervention|prodrome based early intervention
819900|NCT00159133|antipsychotics - benzodiazepine|antipsychotics - benzodiazepine
819901|NCT00159133|maintenance treatment|maintenance treatment
819902|NCT00159133|drug discontinuation|drug discontinuation
819903|NCT00159120|Schizophrenia|schizophrenia
819904|NCT00159120|first episode|first episode
819905|NCT00159120|neuroleptic maintenance treatment|neuroleptic maintenance treatment
819906|NCT00159120|drug discontinuation|drug discontinuation
819907|NCT00159120|prodrome based early intervention|prodrome based early intervention
819908|NCT00159107|alcoholism|alcoholism
819909|NCT00159107|abstinence enhancement|abstinence enhancement
819910|NCT00159107|psychotherapy|psychotherapy
819911|NCT00159107|cognitive behavior therapy vs. supportive counseling|cognitive behavior therapy vs. supportive counseling
819912|NCT00159107|Acamprosate vs. Placebo|acamprosate vs. placebo
819913|NCT00159107|multi-center study|multi-center study
819914|NCT00159081|Schizophrenia|schizophrenia
819915|NCT00159081|first episode|first episode
819916|NCT00159081|long-term treatment|long-term treatment
819917|NCT00159081|typical vs. atypical neuroleptics|typical vs. atypical neuroleptics
819918|NCT00159003|drug metabolism and disposition enzymes|drug metabolism and disposition enzymes
819919|NCT00158990|major depression|major depression
819920|NCT00158990|bipolar disorder|bipolar disorder
819921|NCT00158990|unipolar depression|unipolar depression
819922|NCT00158990|sertraline|sertraline
819923|NCT00158990|triiodothyronine|triiodothyronine
820128|NCT00158054|depression|depression
819924|NCT00158977|heart failure|heart failure
819925|NCT00158977|atrial fibrillation|atrial fibrillation
819926|NCT00158977|cardiac resynchronization therapy defibrillator|cardiac resynchronization therapy defibrillator
819927|NCT00158964|left ventricular lead|left ventricular lead
819928|NCT00158964|pacing|pacing
819929|NCT00158964|heart failure|heart failure
819930|NCT00158951|Left Ventricular Lead|left ventricular lead
819931|NCT00158951|Cardiac Resynchronization Therapy|cardiac resynchronization therapy
819932|NCT00158951|Congestive Heart Failure|congestive heart failure
819933|NCT00158938|Artificial Cardiac Pacemaker|artificial cardiac pacemaker
819934|NCT00158938|Implanted Electrodes|implanted electrodes
819935|NCT00158925|Artificial Cardiac Pacing|artificial cardiac pacing
819936|NCT00158925|Implanted Electrodes|implanted electrodes
819937|NCT00158899|HDLc|hdlc
819938|NCT00158899|high-density lipoprotein|high-density lipoprotein
819939|NCT00158899|Dyslipidemia|dyslipidemia
819940|NCT00158886|oral topotecan rectal cancer pelvic radiation|oral topotecan rectal cancer pelvic radiation
819941|NCT00158873|ICU mechanical ventilation analgesia sedation|icu mechanical ventilation analgesia sedation
819942|NCT00158860|VALTREX®|valtrex®
819943|NCT00158860|valaciclovir|valaciclovir
819944|NCT00158860|genital herpes|genital herpes
819945|NCT00158860|HSV-2|hsv-2
819946|NCT00158860|suppression|suppression
819947|NCT00158847|COPD inflammation sputum lung function biopsy|copd inflammation sputum lung function biopsy
819948|NCT00158834|Children|children
819949|NCT00158834|Asthma|asthma
819950|NCT00158834|bronchial hyperresponsiveness|bronchial hyperresponsiveness
819951|NCT00158834|symptoms|symptoms
819952|NCT00158821|HIV|hiv
819953|NCT00158821|Antiretroviral|antiretroviral
819954|NCT00158821|Treatment Experienced|treatment experienced
819955|NCT00158821|HIV-1|hiv-1
819956|NCT00158782|Cancer GW786034 Lapatinib Pazopanib|cancer gw786034 lapatinib pazopanib
819957|NCT00158769|Hepatic Impairment|hepatic impairment
819958|NCT00158769|GR270773|gr270773
819959|NCT00158769|Emulsion|emulsion
819960|NCT00158756|Diphtheria|diphtheria
819961|NCT00158756|Pertussis|pertussis
819962|NCT00158756|Prophylaxis|prophylaxis
819963|NCT00158756|Hepatitis B diseases|hepatitis b diseases
819964|NCT00158756|Tetanus|tetanus
819965|NCT00158743|Pre-eclampsia|pre-eclampsia
819966|NCT00158743|Hypertension|hypertension
819967|NCT00158743|Endogenous digitalis-like factor|endogenous digitalis-like factor
819968|NCT00158743|Anti-digoxin antibody|anti-digoxin antibody
819969|NCT00158743|Digibind|digibind
819970|NCT00158717|Chronic Hepatitis B|chronic hepatitis b
819971|NCT00158704|Chronic Hepatitis B|chronic hepatitis b
819972|NCT00158691|Head and Neck cancer|head and neck cancer
820283|NCT00157170|HIV|hiv
819973|NCT00158691|Radiotherapy|radiotherapy
819974|NCT00158691|Xerostomia|xerostomia
819975|NCT00158691|Randomized trial|randomized trial
819976|NCT00158678|oral cancer|oral cancer
819977|NCT00158678|oropharynx cancer|oropharynx cancer
819978|NCT00158678|hypopharynx cancer|hypopharynx cancer
819979|NCT00158678|IMRT|imrt
819980|NCT00158665|Influenza|influenza
819981|NCT00158665|Vaccination|vaccination
819982|NCT00158665|Immunization|immunization
819983|NCT00158665|Flu|flu
819984|NCT00158665|Immunogenicity|immunogenicity
819985|NCT00158652|Head and neck squamous cell carcinoma|head and neck squamous cell carcinoma
819986|NCT00158652|Radiotherapy|radiotherapy
819987|NCT00158652|Chemotherapy|chemotherapy
819988|NCT00158639|Blood Pressure Monitoring, home|blood pressure monitoring, home
819989|NCT00158639|Pharmaceutical services|pharmaceutical services
819990|NCT00158639|Self care|self care
819991|NCT00158626|physical therapy|physical therapy
819992|NCT00158626|physiotherapy|physiotherapy
819993|NCT00158626|pelvic organ prolapse|pelvic organ prolapse
819994|NCT00158600|Glycogen Storage Disease Type II|glycogen storage disease type ii
819995|NCT00158600|GSD-II|gsd-ii
819996|NCT00158600|Pompe Disease|pompe disease
819997|NCT00158587|Vivax|vivax
819998|NCT00158587|Treatment|treatment
819999|NCT00158587|Primaquine|primaquine
820000|NCT00158587|Asia|asia
820001|NCT00158574|intermittent preventive treatment|intermittent preventive treatment
820002|NCT00158574|malaria|malaria
820003|NCT00158574|efficacy|efficacy
820004|NCT00158574|safety|safety
820005|NCT00158574|drug options|drug options
820006|NCT00158561|vivax|vivax
820007|NCT00158561|treatment|treatment
820008|NCT00158561|Asia|asia
820009|NCT00158548|Falciparum|falciparum
820010|NCT00158548|Vivax|vivax
820011|NCT00158548|Treatment|treatment
820012|NCT00158548|Asia|asia
820013|NCT00158535|Liver Transplantation|liver transplantation
820014|NCT00158535|Hepatitis C|hepatitis c
820015|NCT00158535|HIV Infections|hiv infections
820016|NCT00158522|Acute hepatitis C|acute hepatitis c
820017|NCT00158522|Genotype 4|genotype 4
820018|NCT00158522|Pegylated Interferon|pegylated interferon
820019|NCT00158522|Egypt|egypt
820020|NCT00158509|Valacyclovir|valacyclovir
820021|NCT00158509|HIV-1|hiv-1
820022|NCT00158509|HSV-2|hsv-2
820023|NCT00158509|genital shedding|genital shedding
820024|NCT00158509|herpes genitalis|herpes genitalis
820025|NCT00158509|HIV infection|hiv infection
820026|NCT00158496|Chronic Hepatitis C|chronic hepatitis c
820027|NCT00158496|Genotype 4|genotype 4
820028|NCT00158496|Pegylated Interferon|pegylated interferon
820029|NCT00158496|Ribavirin|ribavirin
820030|NCT00158496|Egypt|egypt
820031|NCT00158483|Genital herpes|genital herpes
820032|NCT00158483|Cofactors of sexual transmission|cofactors of sexual transmission
820033|NCT00158483|Syndromic treatment|syndromic treatment
820034|NCT00158483|Genital viral load|genital viral load
820035|NCT00158483|Ulcer|ulcer
820036|NCT00158470|HIV infection|hiv infection
820037|NCT00158470|injecting drug users|injecting drug users
820038|NCT00158470|HAART|haart
820039|NCT00158470|once daily regimen|once daily regimen
820040|NCT00158470|Treatment Naive|treatment naive
820041|NCT00158457|Simplification regimen|simplification regimen
820042|NCT00158457|HIV infection|hiv infection
820043|NCT00158457|Once a day|once a day
820044|NCT00158457|Naive patients|naive patients
820045|NCT00158457|Sub-saharian Africa|sub-saharian africa
820046|NCT00158457|Treatment Naive|treatment naive
820047|NCT00158431|osteoarthritis|osteoarthritis
820048|NCT00158431|randomized trial|randomized trial
820049|NCT00158431|knee|knee
820050|NCT00158431|quality of life|quality of life
820051|NCT00158418|osteoarthritis|osteoarthritis
820052|NCT00158418|shoulder|shoulder
820053|NCT00158418|randomized trial|randomized trial
820054|NCT00158418|cement|cement
820055|NCT00158405|HIV|hiv
820056|NCT00158405|Structured treatment interruption|structured treatment interruption
820057|NCT00158405|HAART|haart
820058|NCT00158405|Sub-saharian africa|sub-saharian africa
820059|NCT00158405|Treatment Interruption|treatment interruption
820060|NCT00158405|Treatment Naive|treatment naive
820061|NCT00158366|Weight Loss|weight loss
820062|NCT00158353|Mentors|mentors
820063|NCT00158353|Self-esteem|self-esteem
820064|NCT00158353|Adolescent|adolescent
820065|NCT00158353|Mental health|mental health
820066|NCT00158353|Social support|social support
820067|NCT00158353|Substance use|substance use
820068|NCT00158353|Violence|violence
820069|NCT00158353|Exercise|exercise
820070|NCT00158353|Nutrition|nutrition
820071|NCT00158353|Sexual behavior|sexual behavior
820072|NCT00158353|Female|female
820073|NCT00158340|Binge Eating|binge eating
820074|NCT00158340|Overeating|overeating
820075|NCT00158340|Compulsive Eating|compulsive eating
820076|NCT00158340|Hyperphagia|hyperphagia
820077|NCT00158327|Primary Health Care|primary health care
820078|NCT00158314|Pathological gambling|pathological gambling
820079|NCT00158314|Gambler's anonymous|gambler's anonymous
820568|NCT00155831|Stepping|stepping
820080|NCT00158314|Cognitive behavioral therapy|cognitive behavioral therapy
820081|NCT00158314|CBT|cbt
820082|NCT00158301|Child|child
820083|NCT00158301|Adolescent|adolescent
820084|NCT00158301|CBT|cbt
820085|NCT00158301|Drug Therapy|drug therapy
820086|NCT00158288|Substance Use Disorders|substance use disorders
820087|NCT00158275|Cognitive behavioral therapy|cognitive behavioral therapy
820088|NCT00158275|Problem solving therapy|problem solving therapy
820089|NCT00158275|CBT|cbt
820090|NCT00158262|Post-Traumatic Stress Disorder|post-traumatic stress disorder
820091|NCT00158262|Prevention|prevention
820092|NCT00158262|Propranolol|propranolol
820093|NCT00158262|Psychophysiology|psychophysiology
820094|NCT00158249|citicoline, drug abuse, marijuana|citicoline, drug abuse, marijuana
820095|NCT00158236|Opiate Addiction|opiate addiction
820096|NCT00158236|Opiate Dependence|opiate dependence
820097|NCT00158223|Schizophrenia|schizophrenia
820098|NCT00158223|Clozapine|clozapine
820099|NCT00158223|Treatment|treatment
820100|NCT00158223|Combination|combination
820101|NCT00158223|Unresponsive|unresponsive
820102|NCT00158223|Schizoaffective Disorders|schizoaffective disorders
820103|NCT00158197|Adherence|adherence
820104|NCT00158197|Amphetamine-Related Disorders|amphetamine-related disorders
820105|NCT00158197|Behavior Therapy|behavior therapy
820106|NCT00158197|Contingency management|contingency management
820107|NCT00158197|Drug Counseling|drug counseling
820108|NCT00158197|health behaviors|health behaviors
820109|NCT00158197|methamphetamine|methamphetamine
820110|NCT00158197|sexual risk behaviors|sexual risk behaviors
820111|NCT00158197|substance dependence|substance dependence
820112|NCT00158184|Opiate|opiate
820113|NCT00158184|Opioid|opioid
820114|NCT00158184|Abuse Liability|abuse liability
820115|NCT00158184|Abuse Potential|abuse potential
820116|NCT00158171|smoking addiction|smoking addiction
820117|NCT00158158|smoking addiction|smoking addiction
820118|NCT00158132|cocaine|cocaine
820119|NCT00158119|strength training|strength training
820120|NCT00158119|power training|power training
820121|NCT00158119|exercise training|exercise training
820122|NCT00158119|functional performance tasks|functional performance tasks
820123|NCT00158106|functional communicative ability|functional communicative ability
820124|NCT00158106|cost effectiveness|cost effectiveness
820125|NCT00158106|service user preferences|service user preferences
820126|NCT00158067|Epilepsy|epilepsy
820127|NCT00158067|Neurostimulation|neurostimulation
820129|NCT00158054|acute coronary syndrome|acute coronary syndrome
820130|NCT00158054|clinical trials|clinical trials
820131|NCT00158041|Amifostine|amifostine
820132|NCT00158041|Mucositis|mucositis
820133|NCT00158041|Nausea|nausea
820134|NCT00158041|Hypotension|hypotension
820135|NCT00158041|Rash|rash
820136|NCT00158028|Schizotypal Personality Disorder|schizotypal personality disorder
820137|NCT00158028|Risperidone|risperidone
820138|NCT00158028|Treatment|treatment
820139|NCT00158028|Cognitive|cognitive
820140|NCT00158015|Echocardiography|echocardiography
820141|NCT00158015|tissue Doppler Imaging|tissue doppler imaging
820142|NCT00158015|Cardiac Resynchronization Therapy|cardiac resynchronization therapy
820143|NCT00158002|Basilar/Hemiplegic Migraine|basilar/hemiplegic migraine
820144|NCT00158002|Prophylaxis|prophylaxis
820145|NCT00157989|Infant, Premature|infant, premature
820146|NCT00157976|Macular Degeneration|macular degeneration
820148|NCT00157976|Visual Acuity|visual acuity
820149|NCT00157950|Human Papilloma Virus|human papilloma virus
820150|NCT00157885|Falciparum|falciparum
820151|NCT00157885|Vivax|vivax
820152|NCT00157885|Papua|papua
820153|NCT00157885|Amodiaquine|amodiaquine
820154|NCT00157885|Artekin|artekin
820155|NCT00157885|Artemisinin Combination Therapy|artemisinin combination therapy
820156|NCT00157885|Dihydroartemisinin|dihydroartemisinin
820157|NCT00157885|Piperaquine|piperaquine
820158|NCT00157885|Lumefantrine|lumefantrine
820159|NCT00157885|Artemether|artemether
820160|NCT00157859|Falciparum|falciparum
820161|NCT00157859|Vivax|vivax
820162|NCT00157859|Papua|papua
820163|NCT00157859|Chloroquine|chloroquine
820164|NCT00157859|Sulphadoxine-pyrimethamine|sulphadoxine-pyrimethamine
820165|NCT00157846|Heart Failure|heart failure
820166|NCT00157846|LVEF < 35%|lvef < 35%
820167|NCT00157846|Bradycardia|bradycardia
820168|NCT00157833|Coartemether|coartemether
820169|NCT00157833|Artekin|artekin
820170|NCT00157833|Papua|papua
820171|NCT00157833|Uncomplicated malaria|uncomplicated malaria
820172|NCT00157820|Defibrillators, Implantable|defibrillators, implantable
820173|NCT00157820|Atrial Fibrillation|atrial fibrillation
820174|NCT00157820|Ventricular Tachyarrhythmias|ventricular tachyarrhythmias
820175|NCT00157820|Clinical Trial|clinical trial
820176|NCT00157807|Persistent Atrial Fibrillation|persistent atrial fibrillation
820177|NCT00157807|Permanent Atrial Fibrillation|permanent atrial fibrillation
820178|NCT00157807|Mitral Valve Defect|mitral valve defect
820179|NCT00157807|Tricuspid Valve Defect|tricuspid valve defect
820180|NCT00157807|Aortic Valve Defect|aortic valve defect
820181|NCT00157794|Sinus Node Disease|sinus node disease
820182|NCT00157794|Pacemaker|pacemaker
820183|NCT00157794|Dual Chamber Pacemaker|dual chamber pacemaker
820184|NCT00157781|Atrial Fibrillation|atrial fibrillation
820185|NCT00157781|Atrial Tachyarrhythmia|atrial tachyarrhythmia
820186|NCT00157781|Pacing|pacing
820187|NCT00157781|Electrophysiology|electrophysiology
820188|NCT00157768|Acute myocardial infarction|acute myocardial infarction
820189|NCT00157768|Non-sustained ventricular tachycardia|non-sustained ventricular tachycardia
820190|NCT00157768|Left ventricular dysfunction|left ventricular dysfunction
820191|NCT00157768|Implantable cardioverter defibrillator|implantable cardioverter defibrillator
820192|NCT00157768|ICD|icd
820193|NCT00157768|Risk-stratification|risk-stratification
820194|NCT00157755|Nausea and Vomiting|nausea and vomiting
820195|NCT00157742|Angina Pectoris|angina pectoris
820196|NCT00157742|Spinal Cord Stimulation (SCS)|spinal cord stimulation (scs)
820197|NCT00157742|Percutaneous Myocardial Revascularisation (PMR)|percutaneous myocardial revascularisation (pmr)
820198|NCT00157742|Refractory Angina Pectoris|refractory angina pectoris
820199|NCT00157729|Hypertension|hypertension
820200|NCT00157729|antihypertensive agents|antihypertensive agents
820201|NCT00157729|diabetes mellitus type 2|diabetes mellitus type 2
820202|NCT00157729|metabolic syndrome|metabolic syndrome
820203|NCT00157716|Coronary|coronary
820204|NCT00157716|surgery|surgery
820205|NCT00157716|ischemia|ischemia
820206|NCT00157716|reperfusion injury|reperfusion injury
820207|NCT00157716|cardiac|cardiac
820208|NCT00157716|heart|heart
820209|NCT00157716|neurological|neurological
820210|NCT00157716|cardiopulmonary bypass|cardiopulmonary bypass
820211|NCT00157716|cardioprotection|cardioprotection
820212|NCT00157703|Malignant glioma|malignant glioma
820213|NCT00157703|Glioblastoma multiforme|glioblastoma multiforme
820214|NCT00157703|GBM|gbm
820215|NCT00157703|Gliosarcoma|gliosarcoma
820216|NCT00157703|Anaplastic astrocytoma|anaplastic astrocytoma
820217|NCT00157703|Brain cancer|brain cancer
820218|NCT00157703|Brain tumor|brain tumor
820219|NCT00157703|Glioma|glioma
820220|NCT00157703|recurrent/progressive malignant glioma|recurrent/progressive malignant glioma
820221|NCT00157690|Alendronate|alendronate
820222|NCT00157690|Bisphosphonates|bisphosphonates
820223|NCT00157690|Cystic Fibrosis|cystic fibrosis
820224|NCT00157690|Osteoporosis|osteoporosis
820225|NCT00157677|deep vein thrombosis|deep vein thrombosis
820226|NCT00157677|pulmonary embolism|pulmonary embolism
820227|NCT00157677|D-dimer testing|d-dimer testing
820228|NCT00157651|end stage renal disease|end stage renal disease
820229|NCT00157651|thrombosis|thrombosis
820233|NCT00157638|primary care|primary care
820234|NCT00157638|collaboration|collaboration
820235|NCT00157638|therapeutics|therapeutics
820236|NCT00157625|urinary infections, catheters, bacteriuria, trial|urinary infections, catheters, bacteriuria, trial
820237|NCT00157612|pneumonia|pneumonia
820238|NCT00157612|lower respiratory tract infection|lower respiratory tract infection
820239|NCT00157612|clinical pathway|clinical pathway
820240|NCT00157612|nursing home|nursing home
820241|NCT00157612|long-term care|long-term care
820242|NCT00157612|randomized control trial|randomized control trial
820243|NCT00157599|deep vein thrombosis|deep vein thrombosis
820244|NCT00157599|DVT|dvt
820245|NCT00157573|Asymptomatic|asymptomatic
820246|NCT00157573|Clinical trial|clinical trial
820247|NCT00157573|Phase II|phase ii
820248|NCT00157573|GM-CSF|gm-csf
820249|NCT00157573|Immunotherapy|immunotherapy
820250|NCT00157547|Depression|depression
820251|NCT00157547|Quantitative EEG (QEEG)|quantitative eeg (qeeg)
820252|NCT00157547|Antidepressants|antidepressants
820253|NCT00157534|Hepatitis C|hepatitis c
820254|NCT00157534|Celgosivir|celgosivir
820255|NCT00157534|HCV|hcv
820256|NCT00157534|Genotype 1|genotype 1
820257|NCT00157378|first episode,|first episode,
820258|NCT00157378|schizophrenia,|schizophrenia,
820259|NCT00157378|atypical neuroleptics,|atypical neuroleptics,
820260|NCT00157378|negative symptoms|negative symptoms
820261|NCT00157326|High Blood Pressure|high blood pressure
820262|NCT00157313|Schizophrenia|schizophrenia
820263|NCT00157313|First episode psychosis|first episode psychosis
820264|NCT00157313|Psychosocial intervention|psychosocial intervention
820265|NCT00157300|erythropoietin|erythropoietin
820266|NCT00157300|kidney transplantation|kidney transplantation
820267|NCT00157300|delayed graft function|delayed graft function
820268|NCT00157274|Alemtuzumab|alemtuzumab
820269|NCT00157274|Mycosis fungoides|mycosis fungoides
820270|NCT00157274|Sezary|sezary
820271|NCT00157222|Charcot|charcot
820272|NCT00157222|Diabetic|diabetic
820273|NCT00157222|osteoporosis|osteoporosis
820274|NCT00157196|Carcinoma, Non-Small-Cell Lung, L-BLP25, Tecemotide|carcinoma, non-small-cell lung, l-blp25, tecemotide
820275|NCT00157183|cystic fibrosis|cystic fibrosis
820276|NCT00157183|hypoxia|hypoxia
820277|NCT00157183|oxygen|oxygen
820278|NCT00157183|noninvasive ventilation|noninvasive ventilation
820279|NCT00157183|quality of life|quality of life
820280|NCT00157170|exercise|exercise
820281|NCT00157170|self efficacy|self efficacy
820282|NCT00157170|quality of life|quality of life
820284|NCT00157157|Factor VIII Deficiency|factor viii deficiency
820285|NCT00157144|Lung Transplantation|lung transplantation
820286|NCT00157144|Heart Transplantation|heart transplantation
820287|NCT00157131|autologous sheet skin grafts|autologous sheet skin grafts
820288|NCT00157131|FS 4IU VH S/D|fs 4iu vh s/d
820289|NCT00157131|skin grafts|skin grafts
820290|NCT00157131|burn|burn
820291|NCT00157118|Severe congenital protein C deficiency|severe congenital protein c deficiency
820292|NCT00157079|PID|pid
820293|NCT00157079|Immunodeficiency|immunodeficiency
820294|NCT00157079|Immune Thrombocytopenic Purpura (ITP)|immune thrombocytopenic purpura (itp)
820295|NCT00157079|Kawasaki syndrome|kawasaki syndrome
820296|NCT00157066|Latent tuberculosis infection|latent tuberculosis infection
820297|NCT00157066|Active tuberculosis infection|active tuberculosis infection
820298|NCT00157053|Factor VIII Deficiency|factor viii deficiency
820299|NCT00157040|Factor VIII Deficiency|factor viii deficiency
820300|NCT00157027|Treatment Experienced|treatment experienced
820301|NCT00157027|HIV-1 Positive by ELISA Assay|hiv-1 positive by elisa assay
820302|NCT00157027|Confirmed by Western Blot|confirmed by western blot
820303|NCT00157027|Refractory or intolerant to HAART|refractory or intolerant to haart
820304|NCT00157014|Antirejection|antirejection
820305|NCT00157014|Treatment Outcome|treatment outcome
820306|NCT00157014|Immunosuppression|immunosuppression
820307|NCT00157014|Treatment Effectiveness|treatment effectiveness
820308|NCT00157014|Anti-rejection therapy|anti-rejection therapy
820309|NCT00156988|burns|burns
820310|NCT00156988|partial thickness|partial thickness
820311|NCT00156988|cerium flamazine|cerium flamazine
820312|NCT00156988|randomised clinical trial|randomised clinical trial
820313|NCT00156975|Oxaliplatin|oxaliplatin
820314|NCT00156975|Capecitabine|capecitabine
820315|NCT00156975|Chemotherapy|chemotherapy
820316|NCT00156975|Resection|resection
820317|NCT00156975|Liver metastases|liver metastases
820318|NCT00156975|Liver resection|liver resection
820319|NCT00156975|Adjuvant|adjuvant
820320|NCT00156962|Epogen|epogen
820321|NCT00156962|Procrit|procrit
820322|NCT00156962|Chronic Kidney Disease|chronic kidney disease
820323|NCT00156962|Anemia Treatment|anemia treatment
820324|NCT00156949|Epogen|epogen
820325|NCT00156949|Procrit|procrit
820326|NCT00156949|Chronic Kidney Disease|chronic kidney disease
820327|NCT00156949|Anemia Treatment for Dialysis Patients|anemia treatment for dialysis patients
820328|NCT00156923|Alcohol dependence|alcohol dependence
820329|NCT00156897|Non-insulin-dependent diabetes mellitus|non-insulin-dependent diabetes mellitus
820330|NCT00156897|NIDDM|niddm
820331|NCT00156897|Type II diabetes|type ii diabetes
820332|NCT00156897|Obesity|obesity
820333|NCT00156897|Lipase inhibitor|lipase inhibitor
820334|NCT00156884|prostate cancer|prostate cancer
820335|NCT00156884|cisplatin|cisplatin
820336|NCT00156884|strontium-89|strontium-89
820337|NCT00156884|phase II|phase ii
820338|NCT00156871|transplant|transplant
820339|NCT00156871|fatigue|fatigue
820340|NCT00156871|exercise|exercise
820341|NCT00156871|Malignant disease|malignant disease
820342|NCT00156858|pharmacokinetics|pharmacokinetics
820343|NCT00156858|transplantation|transplantation
820344|NCT00156858|busulfan|busulfan
820345|NCT00156845|coronary artery disease|coronary artery disease
820346|NCT00156845|ischemia|ischemia
820347|NCT00156845|echocardiography|echocardiography
820348|NCT00156845|cardiac imaging|cardiac imaging
820349|NCT00156845|heart disease|heart disease
820350|NCT00156845|myocardial contrast enhancement|myocardial contrast enhancement
820351|NCT00156845|myocardial perfusion|myocardial perfusion
820352|NCT00156845|wall motion|wall motion
820353|NCT00156845|ultrasound contrast agent|ultrasound contrast agent
820354|NCT00156819|Asthma|asthma
820355|NCT00156819|Asthma Control|asthma control
820356|NCT00156806|aloe|aloe
820357|NCT00156806|radiation dermatitis|radiation dermatitis
820358|NCT00156806|radiation therapy|radiation therapy
820359|NCT00156793|coronary artery disease|coronary artery disease
820360|NCT00156793|ischemia|ischemia
820361|NCT00156793|echocardiography|echocardiography
820362|NCT00156793|cardiac imaging|cardiac imaging
820363|NCT00156793|heart disease|heart disease
820364|NCT00156793|myocardial contrast enhancement|myocardial contrast enhancement
820365|NCT00156793|myocardial perfusion|myocardial perfusion
820366|NCT00156793|wall motion|wall motion
820367|NCT00156793|ultrasound contrast agent|ultrasound contrast agent
820368|NCT00156780|ultrasound contrast agent|ultrasound contrast agent
820369|NCT00156780|pharmacokinetics|pharmacokinetics
820370|NCT00156780|congestive heart failure|congestive heart failure
820371|NCT00156780|chronic obstructive pulmonary disease|chronic obstructive pulmonary disease
820372|NCT00156780|safety|safety
820373|NCT00156767|Critical Care|critical care
820374|NCT00156767|Adrenal Insufficiency|adrenal insufficiency
820375|NCT00156767|Septic Shock|septic shock
820376|NCT00156767|Cortrosyn|cortrosyn
820377|NCT00156767|Steroids|steroids
820378|NCT00156767|Cortisol|cortisol
820379|NCT00156767|Critical Care Unit|critical care unit
820380|NCT00156767|Adrenal Gland Function|adrenal gland function
820381|NCT00156741|Refined ventricular pacing|refined ventricular pacing
820382|NCT00156728|Pacemaker artificial, congestive heart failure and atrial fibrillation|pacemaker artificial, congestive heart failure and atrial fibrillation
820383|NCT00156715|Quetiapine|quetiapine
820384|NCT00156715|Seroquel|seroquel
820385|NCT00156715|Schizophrenia|schizophrenia
820386|NCT00156715|Dual Diagnosis|dual diagnosis
820387|NCT00156715|Substance Abuse|substance abuse
820388|NCT00156715|Alcohol Abuse|alcohol abuse
820389|NCT00156702|Smoking|smoking
820390|NCT00156702|Adolescents|adolescents
820391|NCT00156702|Motivational Interviewing|motivational interviewing
820392|NCT00156689|polyneuropathy|polyneuropathy
820393|NCT00156676|Disability|disability
820394|NCT00156676|Gait|gait
820395|NCT00156676|Multiple Sclerosis|multiple sclerosis
820396|NCT00156676|Rehabilitation|rehabilitation
820397|NCT00156676|Robot|robot
820398|NCT00156663|Women|women
820399|NCT00156663|Veterans|veterans
820400|NCT00156663|Delivery of Healthcare|delivery of healthcare
820401|NCT00156663|Intervention Studies|intervention studies
820402|NCT00156663|United States Department of Veterans Affairs|united states department of veterans affairs
820403|NCT00156663|Women's Health|women's health
820404|NCT00156650|Male contraception|male contraception
820405|NCT00156650|Testosterone|testosterone
820406|NCT00156637|schizophrenia|schizophrenia
820407|NCT00156637|quality of health care|quality of health care
820408|NCT00156637|quality indicators|quality indicators
820409|NCT00156637|intervention studies|intervention studies
820410|NCT00156624|Intervention|intervention
820411|NCT00156624|Peripheral Vascular Disease|peripheral vascular disease
820412|NCT00156624|Drug|drug
820413|NCT00156624|Restenosis|restenosis
820414|NCT00156624|18 years and above|18 years and above
820415|NCT00156611|peripheral vascular disease|peripheral vascular disease
820416|NCT00156611|intervention|intervention
820417|NCT00156611|restenosis|restenosis
820418|NCT00156611|Age above 18 years|age above 18 years
820419|NCT00156598|metal ion concentration|metal ion concentration
820420|NCT00156585|cerebral metastases|cerebral metastases
820421|NCT00156585|dynamic contrast enhanced magnetic resonance imaging|dynamic contrast enhanced magnetic resonance imaging
820422|NCT00156585|DCE-MRI|dce-mri
820423|NCT00156585|gamma knife|gamma knife
820424|NCT00156559|immunization|immunization
820425|NCT00156559|vaccine|vaccine
820426|NCT00156559|low birth weight infant|low birth weight infant
820427|NCT00156559|premature infant|premature infant
820428|NCT00156546|Urinary tract infections|urinary tract infections
820429|NCT00156546|Children|children
820430|NCT00156546|Antibiotic prophylaxis|antibiotic prophylaxis
820431|NCT00156546|Renal scintigraphy|renal scintigraphy
820432|NCT00156546|Vesico ureteral reflux|vesico ureteral reflux
820433|NCT00156533|Insomnia|insomnia
820434|NCT00156533|Sleep|sleep
820435|NCT00156533|zolpidem|zolpidem
820436|NCT00156533|Ambien|ambien
820437|NCT00156533|Hypnotics|hypnotics
820438|NCT00156455|Children|children
820439|NCT00156455|Hypoplastic left heart syndrome|hypoplastic left heart syndrome
820440|NCT00156455|Obstructive Sleep Apnea Syndrome|obstructive sleep apnea syndrome
820441|NCT00156455|Single Ventricle Physiology|single ventricle physiology
820442|NCT00156442|Obstructive Sleep Apnea Syndrome|obstructive sleep apnea syndrome
820443|NCT00156442|Cleft lip/palate|cleft lip/palate
820444|NCT00156442|Children|children
820445|NCT00156429|genetic testing|genetic testing
820446|NCT00156416|menopause|menopause
820447|NCT00156416|hot flash|hot flash
820448|NCT00156416|night sweat|night sweat
820449|NCT00156416|meditation|meditation
820450|NCT00156416|breast cancer|breast cancer
820451|NCT00156403|pancreatitis, hereditary|pancreatitis, hereditary
820452|NCT00156403|trypsinogen, cationic|trypsinogen, cationic
820453|NCT00156403|pilot study|pilot study
820454|NCT00156377|Mupirocin|mupirocin
820455|NCT00156377|Staphylococcus aureus|staphylococcus aureus
820456|NCT00156377|Nasal Cavity|nasal cavity
820457|NCT00156377|Preventive measures|preventive measures
820458|NCT00156364|Diabetic Nephropathy|diabetic nephropathy
820459|NCT00156364|Kidney Transplant|kidney transplant
820460|NCT00156364|Pancreas Transplant|pancreas transplant
820461|NCT00156364|Renal Interstitium|renal interstitium
820462|NCT00156364|Diabetes Mellitus|diabetes mellitus
820463|NCT00156364|Cyclosporine|cyclosporine
820464|NCT00156364|Tacrolimus|tacrolimus
820465|NCT00156351|African Americans|african americans
820466|NCT00156351|Women|women
820467|NCT00156351|Internet|internet
820468|NCT00156351|Telephone Counseling|telephone counseling
820469|NCT00156338|Fluid therapy|fluid therapy
820470|NCT00156325|Bipolar Disorder|bipolar disorder
820471|NCT00156325|Depression|depression
820472|NCT00156325|Hypomania|hypomania
820473|NCT00156325|Mood Stabilizer|mood stabilizer
820474|NCT00156299|adult acute megakaryoblastic leukemia (M7)|adult acute megakaryoblastic leukemia (m7)
820475|NCT00156299|adult acute minimally differentiated myeloid leukemia (M0)|adult acute minimally differentiated myeloid leukemia (m0)
820476|NCT00156299|adult acute monoblastic leukemia (M5a)|adult acute monoblastic leukemia (m5a)
820477|NCT00156299|adult acute monocytic leukemia (M5b)|adult acute monocytic leukemia (m5b)
820569|NCT00155831|Walking|walking
820570|NCT00155831|Motor development|motor development
820478|NCT00156299|adult acute myeloblastic leukemia with maturation (M2)|adult acute myeloblastic leukemia with maturation (m2)
820479|NCT00156299|adult acute myeloblastic leukemia without maturation (M1)|adult acute myeloblastic leukemia without maturation (m1)
820480|NCT00156299|adult acute myeloid leukemia with 11q23 (MLL) abnormalities|adult acute myeloid leukemia with 11q23 (mll) abnormalities
820481|NCT00156299|adult acute myeloid leukemia with inv(16)(p13;q22)|adult acute myeloid leukemia with inv(16)(p13;q22)
820482|NCT00156299|adult acute myeloid leukemia with t(16;16)(p13;q22)|adult acute myeloid leukemia with t(16;16)(p13;q22)
820483|NCT00156299|adult acute myeloid leukemia with t(8;21)(q22;q22)|adult acute myeloid leukemia with t(8;21)(q22;q22)
820484|NCT00156299|adult acute myelomonocytic leukemia (M4)|adult acute myelomonocytic leukemia (m4)
820485|NCT00156299|adult erythroleukemia (M6a)|adult erythroleukemia (m6a)
820486|NCT00156299|adult pure erythroid leukemia (M6b)|adult pure erythroid leukemia (m6b)
820487|NCT00156299|untreated adult acute myeloid leukemia|untreated adult acute myeloid leukemia
820488|NCT00156247|psoriasis|psoriasis
820489|NCT00156247|etanercept|etanercept
820490|NCT00156247|acitretin|acitretin
820491|NCT00156221|Autism|autism
820492|NCT00156221|MRI|mri
820493|NCT00156221|Developmental Disorders|developmental disorders
820494|NCT00156208|Symptomatic Uterine Fibroids|symptomatic uterine fibroids
820495|NCT00156208|Excessive Uterine Bleeding|excessive uterine bleeding
820496|NCT00156208|Uterine Hemorrhage|uterine hemorrhage
820497|NCT00156208|asoprisnil|asoprisnil
820498|NCT00156195|Symptomatic Uterine Fibroids|symptomatic uterine fibroids
820499|NCT00156195|Excessive Uterine Bleeding|excessive uterine bleeding
820500|NCT00156195|Uterine Hemorrhage|uterine hemorrhage
820501|NCT00156195|asoprisnil|asoprisnil
820502|NCT00156182|Fibroid Uterus|fibroid uterus
820503|NCT00156182|Leiomyoma|leiomyoma
820504|NCT00156182|Uterine Fibroids|uterine fibroids
820505|NCT00156182|asoprisnil|asoprisnil
820506|NCT00156156|Symptomatic Uterine Fibroids|symptomatic uterine fibroids
820507|NCT00156156|Excessive Uterine Bleeding|excessive uterine bleeding
820508|NCT00156156|Uterine Hemorrhage|uterine hemorrhage
820509|NCT00156130|Breast Cancer|breast cancer
820510|NCT00156130|Lumpectomy|lumpectomy
820511|NCT00156130|Radiotherapy|radiotherapy
820512|NCT00156130|Hypofractionated Radiotherapy|hypofractionated radiotherapy
820513|NCT00156130|Long Term Outcomes|long term outcomes
820514|NCT00156052|Breast Cancer|breast cancer
820515|NCT00156052|Hypofractionated Radiotherapy|hypofractionated radiotherapy
820516|NCT00156052|Lumpectomy|lumpectomy
820517|NCT00156039|Breast Cancer|breast cancer
820518|NCT00156039|Follow-up Strategy|follow-up strategy
820519|NCT00156039|Follow-up Care|follow-up care
820520|NCT00156039|Family Physician|family physician
820523|NCT00156026|cervical intraepithelial neoplasia|cervical intraepithelial neoplasia
820524|NCT00156026|cervix|cervix
820525|NCT00156026|cancer|cancer
820526|NCT00156026|loop electrosurgical excision procedure|loop electrosurgical excision procedure
820527|NCT00156026|LEEP|leep
820528|NCT00156026|expectant management|expectant management
820529|NCT00156026|human papilloma virus|human papilloma virus
820530|NCT00156026|HPV|hpv
820531|NCT00156026|colposcopy|colposcopy
820532|NCT00156013|B-Cell NHL|b-cell nhl
820533|NCT00156000|Preterm Delivery|preterm delivery
820534|NCT00156000|Multifetal pregnancy|multifetal pregnancy
820535|NCT00156000|Preterm Birth|preterm birth
820536|NCT00156000|17-alpha Hydroxyprogesterone Caproate|17-alpha hydroxyprogesterone caproate
820537|NCT00156000|Markers of Preterm Birth|markers of preterm birth
820538|NCT00155987|Severe diffuse TBI refractory intracranial hypertension.|severe diffuse tbi refractory intracranial hypertension.
820539|NCT00155974|Influenza|influenza
820540|NCT00155974|Vaccination|vaccination
820541|NCT00155974|Hard-to-Reach Populations|hard-to-reach populations
820542|NCT00155974|Urban|urban
820543|NCT00155974|Disadvantaged|disadvantaged
820544|NCT00155961|Androgens|androgens
820545|NCT00155961|Metabolic syndrome|metabolic syndrome
820546|NCT00155961|Bone mineral density|bone mineral density
820547|NCT00155961|Body composition|body composition
820548|NCT00155961|Questionnaire|questionnaire
820549|NCT00155948|Ultrasonography|ultrasonography
820550|NCT00155948|Cervical Multifidus|cervical multifidus
820551|NCT00155935|ovarian cancer|ovarian cancer
820552|NCT00155935|immunotherapy|immunotherapy
820553|NCT00155935|folate receptor|folate receptor
820554|NCT00155935|Chemotherapy|chemotherapy
820555|NCT00155922|Diabetes mellitus|diabetes mellitus
820556|NCT00155922|Monocyte|monocyte
820557|NCT00155922|Gene expression|gene expression
820558|NCT00155922|Monocyte gene expression|monocyte gene expression
820559|NCT00155909|Radiation Pneumonitis|radiation pneumonitis
820560|NCT00155909|Radiotherapy Planning, Computer-Assisted|radiotherapy planning, computer-assisted
820561|NCT00155896|BRCA1 gene, BRCA2 gene, DHPLC, genetic diagnosis|brca1 gene, brca2 gene, dhplc, genetic diagnosis
820562|NCT00155870|laparoscopic assisted vaginal hysterectomy leiomyoma|laparoscopic assisted vaginal hysterectomy leiomyoma
820563|NCT00155870|adenomyosis|adenomyosis
820564|NCT00155870|quality of life|quality of life
820565|NCT00155857|glaucoma, genetic|glaucoma, genetic
820566|NCT00155831|Premature infants|premature infants
820567|NCT00155831|Kicking|kicking
820572|NCT00155818|DISC1|disc1
820573|NCT00155818|Schizophrenia|schizophrenia
820574|NCT00155818|Chromosome 1q|chromosome 1q
820575|NCT00155818|Polymorphism detection|polymorphism detection
820576|NCT00155818|Association study|association study
820577|NCT00155818|Balanced translocation|balanced translocation
820578|NCT00155818|DHPLC|dhplc
820579|NCT00155805|Gastroesophageal reflux disease|gastroesophageal reflux disease
820580|NCT00155805|reflux esophagitis|reflux esophagitis
820581|NCT00155805|nonerosive reflux disease|nonerosive reflux disease
820582|NCT00155805|Barrett’s esophagus|barrett’s esophagus
820583|NCT00155805|hiatus hernia|hiatus hernia
820584|NCT00155805|lower esophageal sphincter pressure|lower esophageal sphincter pressure
820585|NCT00155805|24 hours esophageal pH monitor|24 hours esophageal ph monitor
820586|NCT00155805|Helicobacter pylori|helicobacter pylori
820587|NCT00155792|ervical cancer, human papillomavirus, immunotherapy|ervical cancer, human papillomavirus, immunotherapy
820588|NCT00155779|adult respiratory distress syndrome|adult respiratory distress syndrome
820589|NCT00155779|angiotensin-converting enzyme|angiotensin-converting enzyme
820590|NCT00155779|polymorphism|polymorphism
820591|NCT00155766|cervical cancer, immunotherapy, DC|cervical cancer, immunotherapy, dc
820592|NCT00155753|pathological myopia, genomic|pathological myopia, genomic
820593|NCT00155740|ovarian cancer|ovarian cancer
820594|NCT00155740|tumor marker|tumor marker
820595|NCT00155740|mesothelin|mesothelin
820596|NCT00155727|colorectal cancer, laparoscopic colectomy|colorectal cancer, laparoscopic colectomy
820597|NCT00155714|pulmonary arterial hypertension|pulmonary arterial hypertension
820598|NCT00155714|type-5 phosphodiesterase Inhibitors|type-5 phosphodiesterase inhibitors
820599|NCT00155714|Sildenafil|sildenafil
820600|NCT00155701|DISC1|disc1
820601|NCT00155701|Schizophrenia|schizophrenia
820602|NCT00155701|Chromosome 1q|chromosome 1q
820603|NCT00155701|Polymorphism detection|polymorphism detection
820604|NCT00155701|Association study|association study
820605|NCT00155701|Balanced translocation|balanced translocation
820606|NCT00155701|DHPLC|dhplc
820607|NCT00155688|Schizophrenia|schizophrenia
820608|NCT00155688|linkage|linkage
820609|NCT00155688|Taiwan|taiwan
820610|NCT00155688|Han Chinese population|han chinese population
820611|NCT00155662|work hardening|work hardening
820612|NCT00155662|chronic low back pain over 3 months|chronic low back pain over 3 months
820613|NCT00155649|schizophrenia|schizophrenia
820614|NCT00155649|vulnerability gene|vulnerability gene
820615|NCT00155649|positional cloning|positional cloning
820616|NCT00155649|subtype definition|subtype definition
820617|NCT00155649|endophenotype|endophenotype
820618|NCT00155649|genetic marker|genetic marker
820619|NCT00155649|genetic linkage|genetic linkage
820993|NCT00153972|Cabergoline|cabergoline
820620|NCT00155649|candidate genes|candidate genes
820621|NCT00155636|Schizophrenia|schizophrenia
820622|NCT00155623|H. pylori, 13C-urea breath test, serology, epidemiology|h. pylori, 13c-urea breath test, serology, epidemiology
820623|NCT00155610|diabetic cystopathy|diabetic cystopathy
820624|NCT00155610|bladder|bladder
820625|NCT00155610|voiding dysfunction|voiding dysfunction
820626|NCT00155610|current perception test|current perception test
820627|NCT00155597|physical therapy|physical therapy
820628|NCT00155597|post surgery|post surgery
820629|NCT00155584|warts|warts
820630|NCT00155584|photodynamic therapy|photodynamic therapy
820631|NCT00155584|5-ALA|5-ala
820632|NCT00155571|betel nut|betel nut
820633|NCT00155571|periodontitis|periodontitis
820634|NCT00155571|periodontal microbiology|periodontal microbiology
820635|NCT00155558|Colorectal Cancer, Maximum tolerated dose|colorectal cancer, maximum tolerated dose
820636|NCT00155545|functional scoliosis|functional scoliosis
820637|NCT00155545|idiopathic scoliosis|idiopathic scoliosis
820638|NCT00155545|leg length discrepancy|leg length discrepancy
820639|NCT00155545|motion analysis|motion analysis
820640|NCT00155545|biomechanics|biomechanics
820641|NCT00155532|Peripheral neuropathy;systemic lupus erythematosus|peripheral neuropathy;systemic lupus erythematosus
820642|NCT00155519|Schizophrenia|schizophrenia
820643|NCT00155519|Latent Schizophrenia|latent schizophrenia
820644|NCT00155519|Schizotypal Disorder|schizotypal disorder
820645|NCT00155519|Psychopathology|psychopathology
820646|NCT00155519|Neuropsychological Function|neuropsychological function
820647|NCT00155519|Family History|family history
820648|NCT00155519|Nosology|nosology
820649|NCT00155519|basic symptoms|basic symptoms
820650|NCT00155506|Schizophrenia|schizophrenia
820651|NCT00155506|Niacin|niacin
820652|NCT00155506|Genotyping|genotyping
820653|NCT00155506|candidate gene|candidate gene
820654|NCT00155506|one proband, normal parents and one normal sibling|one proband, normal parents and one normal sibling
820655|NCT00155480|thoracic aorta|thoracic aorta
820656|NCT00155480|finite element mesh|finite element mesh
820657|NCT00155467|CT|ct
820658|NCT00155467|children|children
820659|NCT00155467|congenital|congenital
820660|NCT00155454|Diabetic retinopathy|diabetic retinopathy
820661|NCT00155454|Vitrectomy|vitrectomy
820662|NCT00155454|Postoperative vitreous hemorrahge|postoperative vitreous hemorrahge
820663|NCT00155454|Intravitreal gas injection|intravitreal gas injection
820664|NCT00155441|sleep disorder|sleep disorder
820665|NCT00155441|peritoneal dialysis|peritoneal dialysis
820666|NCT00155441|cognitive-behavioral therapy|cognitive-behavioral therapy
820667|NCT00155441|sleep disorder:C23.888.592.796|sleep disorder:c23.888.592.796
820668|NCT00155441|peritoneal dialysis: F03.870.664|peritoneal dialysis: f03.870.664
820669|NCT00155428|biomodel|biomodel
820670|NCT00155428|rapid prototyping|rapid prototyping
820671|NCT00155428|computed tomograpgy|computed tomograpgy
820672|NCT00155415|Colonoscopy|colonoscopy
820673|NCT00155415|Polyethylene glycol(PEG)|polyethylene glycol(peg)
820674|NCT00155415|Colon neoplasm|colon neoplasm
820675|NCT00155415|Colon cleansing|colon cleansing
820676|NCT00155415|Timing|timing
820677|NCT00155402|fibrin glue|fibrin glue
820678|NCT00155402|corneal perforation|corneal perforation
820679|NCT00155402|pterygium|pterygium
820680|NCT00155402|conjunctiva|conjunctiva
820681|NCT00155402|corneal ulcer|corneal ulcer
820682|NCT00155389|Helicobacter pylori|helicobacter pylori
820683|NCT00155389|Gastric cancer|gastric cancer
820684|NCT00155389|single nucleotide polymorphism|single nucleotide polymorphism
820685|NCT00155350|atherosclerosis|atherosclerosis
820686|NCT00155350|calcification|calcification
820687|NCT00155350|coronary|coronary
820688|NCT00155350|inflammation|inflammation
820689|NCT00155350|insulin|insulin
820690|NCT00155350|plaque|plaque
820691|NCT00155350|Coronary calcification|coronary calcification
820692|NCT00155350|Plaque vulnerability|plaque vulnerability
820693|NCT00155337|leukoplakia|leukoplakia
820694|NCT00155337|erythroleukoplakia|erythroleukoplakia
820695|NCT00155337|photodynamic therapy|photodynamic therapy
820696|NCT00155324|plantar fasciitis|plantar fasciitis
820697|NCT00155324|ultrasonographic examination|ultrasonographic examination
820698|NCT00155311|orthodontic tooth movement|orthodontic tooth movement
820699|NCT00155311|OPG|opg
820700|NCT00155311|RANKL|rankl
820701|NCT00155285|heart diseases|heart diseases
820702|NCT00155285|congenital|congenital
820703|NCT00155272|Hepatocellular Carcinoma|hepatocellular carcinoma
820704|NCT00155272|Radiotherapy|radiotherapy
820705|NCT00155272|Thalidomide|thalidomide
820706|NCT00155272|Dynamic contrast enhanced MRI|dynamic contrast enhanced mri
820707|NCT00155259|Breast Cancer , Neoadjuvant Chemotherapy|breast cancer , neoadjuvant chemotherapy
820708|NCT00155246|CKD, pentoxifylline|ckd, pentoxifylline
820709|NCT00155233|analgeisa|analgeisa
820710|NCT00155233|postoperatve|postoperatve
820711|NCT00155233|side effects|side effects
820712|NCT00155207|Schizophrenia|schizophrenia
820713|NCT00155207|endophenotype|endophenotype
820714|NCT00155207|risk genetic mutation|risk genetic mutation
820715|NCT00155207|vulnerability genes|vulnerability genes
820716|NCT00155207|affected sib-pairs|affected sib-pairs
821096|NCT00153491|co-artem|co-artem
820717|NCT00155207|case-control design|case-control design
820718|NCT00155207|animal model|animal model
820719|NCT00155207|functional validity|functional validity
820720|NCT00155207|genetic epidemiological analysis|genetic epidemiological analysis
820721|NCT00155181|Epstein-Barr virus|epstein-barr virus
820722|NCT00155181|Nasopharyngeal carcinoma|nasopharyngeal carcinoma
820723|NCT00155181|Carcinogenesis|carcinogenesis
820724|NCT00155168|Spinal muscular atrophy (SMA)|spinal muscular atrophy (sma)
820725|NCT00155168|SMN1/SMN2 gene|smn1/smn2 gene
820726|NCT00155168|denaturing high-performance liquid chromatography (DHPLC)|denaturing high-performance liquid chromatography (dhplc)
820727|NCT00155168|multiplex PCR|multiplex pcr
820728|NCT00155168|gene dose|gene dose
820729|NCT00155168|carrier test|carrier test
820730|NCT00155129|migraine|migraine
820731|NCT00155129|CGRP|cgrp
820732|NCT00155129|nociceptin|nociceptin
820733|NCT00155103|Hepatitis B|hepatitis b
820734|NCT00155103|Carcinoma, Hepatocellular|carcinoma, hepatocellular
820735|NCT00155103|Polymorphism, Genetic|polymorphism, genetic
820736|NCT00155090|Magnetic resonance imaging,|magnetic resonance imaging,
820737|NCT00155090|breast disease|breast disease
820738|NCT00155077|cervical cancer, chemoradiotherapy, angiogenesis|cervical cancer, chemoradiotherapy, angiogenesis
820739|NCT00155064|Primary aldosteronism|primary aldosteronism
820740|NCT00155064|kallikrein|kallikrein
820741|NCT00155064|aldosterone|aldosterone
820742|NCT00155064|captopril|captopril
820743|NCT00155038|Breast neoplasms|breast neoplasms
820744|NCT00155038|breast radiography|breast radiography
820745|NCT00155038|young women.|young women.
820746|NCT00155025|Prostatic neoplasms|prostatic neoplasms
820747|NCT00155025|Family history|family history
820748|NCT00154999|hyperbilirubinemia|hyperbilirubinemia
820749|NCT00154999|free radicals|free radicals
820750|NCT00154999|Health neonate|health neonate
820751|NCT00154986|invasion|invasion
820752|NCT00154986|migration|migration
820753|NCT00154986|metastasis|metastasis
820754|NCT00154986|IGFBP-3|igfbp-3
820755|NCT00154986|transfection|transfection
820756|NCT00154986|signal transduction.|signal transduction.
820757|NCT00154973|oral precancers|oral precancers
820758|NCT00154973|oral cancer|oral cancer
820759|NCT00154973|hypoxia-inducible factor|hypoxia-inducible factor
820760|NCT00154960|Spinal muscular atrophy (SMA)|spinal muscular atrophy (sma)
820761|NCT00154960|SMN1/SMN2 gene|smn1/smn2 gene
820762|NCT00154960|denaturing high-performance liquid chromatography (DHPLC)|denaturing high-performance liquid chromatography (dhplc)
821145|NCT00153270|Efficacy|efficacy
820763|NCT00154960|multiplex PCR|multiplex pcr
820764|NCT00154960|gene dose|gene dose
820765|NCT00154960|carrier test|carrier test
820766|NCT00154960|screen|screen
820767|NCT00154960|stool|stool
820768|NCT00154960|microsatellite|microsatellite
820769|NCT00154895|minocycline|minocycline
820770|NCT00154895|pleurodesis|pleurodesis
820771|NCT00154895|thoracoscopy|thoracoscopy
820772|NCT00154895|primary spontaneous pneumothorax|primary spontaneous pneumothorax
820773|NCT00154895|clinical trial|clinical trial
820774|NCT00154882|Breast Cancer|breast cancer
820775|NCT00154882|First-line|first-line
820776|NCT00154869|Patients with dual chronic hepatitis B and C|patients with dual chronic hepatitis b and c
820777|NCT00154856|osteogenesis|osteogenesis
820778|NCT00154856|Ilizarov fixator|ilizarov fixator
820779|NCT00154856|motion analysis|motion analysis
820781|NCT00154856|bone stress|bone stress
820782|NCT00154843|Lycopene|lycopene
820783|NCT00154843|BPH|bph
820784|NCT00154843|PSA|psa
820785|NCT00154843|IPSS|ipss
820786|NCT00154817|radiotherapy|radiotherapy
820787|NCT00154817|dynamic contrast enhanced MRI|dynamic contrast enhanced mri
820788|NCT00154817|hepatocellular carcinoma|hepatocellular carcinoma
820789|NCT00154804|Concurrent Chemoradiotherapy|concurrent chemoradiotherapy
820790|NCT00154804|Esophageal Cancer|esophageal cancer
820791|NCT00154791|Pancreatic adenocarcinoma|pancreatic adenocarcinoma
820792|NCT00154791|Oxaliplatin|oxaliplatin
820793|NCT00154791|Gemcitabine|gemcitabine
820794|NCT00154791|5-FU|5-fu
820795|NCT00154778|Combination,Chemotherapy,Advanced Gastric Cancer|combination,chemotherapy,advanced gastric cancer
820796|NCT00154752|Rectal cancer, CCRT, Pelvic lymphadenoectomy.|rectal cancer, ccrt, pelvic lymphadenoectomy.
820797|NCT00154739|Combination, Chemotherapy,non-small cell lung cancer|combination, chemotherapy,non-small cell lung cancer
820798|NCT00154726|Paclitaxel-HDFL,Locally Advanced and Recurrent/Metastatic Gastric Cancer|paclitaxel-hdfl,locally advanced and recurrent/metastatic gastric cancer
820799|NCT00154713|colorectal cancer|colorectal cancer
820800|NCT00154713|dendritic cell|dendritic cell
820801|NCT00154713|CEA|cea
820802|NCT00154713|IL-2|il-2
820803|NCT00154700|Combination,Chemotherapy,Esophageal Cancer|combination,chemotherapy,esophageal cancer
820804|NCT00154687|Combination, Chemotherapy,transitional cell carcinoma|combination, chemotherapy,transitional cell carcinoma
820805|NCT00154661|glomerulonephritis|glomerulonephritis
820806|NCT00154648|MRA|mra
820807|NCT00154648|DSA|dsa
820808|NCT00154648|gadovist|gadovist
820809|NCT00154648|angiography|angiography
820810|NCT00154635|Alzheimer's disease|alzheimer's disease
820811|NCT00154635|Fo-ti|fo-ti
820812|NCT00154635|Chinese herbs|chinese herbs
820813|NCT00154622|musculoskeletal disorder, work hardening, return to work|musculoskeletal disorder, work hardening, return to work
820814|NCT00154596|etiology|etiology
820815|NCT00154596|transmission|transmission
820816|NCT00154596|vasculitis|vasculitis
820817|NCT00154596|household|household
820818|NCT00154596|etiology of disease|etiology of disease
820819|NCT00154583|cervical cancer|cervical cancer
820820|NCT00154583|human papillomavirus|human papillomavirus
820821|NCT00154583|cancer vaccine|cancer vaccine
820822|NCT00154583|normal volunteer|normal volunteer
820823|NCT00154570|reflux esophagitis|reflux esophagitis
820824|NCT00154570|24 hour esophageal pH|24 hour esophageal ph
820825|NCT00154570|electrogastrography (EGG)|electrogastrography (egg)
820826|NCT00154570|Running Spectral Analysis (RSA)|running spectral analysis (rsa)
820827|NCT00154557|Judo, Performance, Injury|judo, performance, injury
820828|NCT00154518|orthodontic tooth movement|orthodontic tooth movement
820829|NCT00154518|matrix metalloproteinase|matrix metalloproteinase
820830|NCT00154518|Orthodontics|orthodontics
820831|NCT00154505|Scoliosis|scoliosis
820832|NCT00154505|Spinal Cord Injury|spinal cord injury
820833|NCT00154505|Lateral Trunk Support|lateral trunk support
820834|NCT00154505|Radiography|radiography
820835|NCT00154492|Active variceal bleeding in patients with advanced cirrhosis|active variceal bleeding in patients with advanced cirrhosis
820836|NCT00154479|Cervical cancer|cervical cancer
820837|NCT00154479|Human papillomavirus|human papillomavirus
820838|NCT00154479|Human leukocyte antigen|human leukocyte antigen
820839|NCT00154479|immunologic response|immunologic response
820840|NCT00154479|healthy volunteers|healthy volunteers
820841|NCT00154466|Myocardial infarction, stem cell, cardiac rehabilitation|myocardial infarction, stem cell, cardiac rehabilitation
820842|NCT00154453|Aging|aging
820843|NCT00154453|Orbicularis oculi|orbicularis oculi
820844|NCT00154453|Blepharoplasty|blepharoplasty
820845|NCT00154453|Myosin heavy chain (MHC)|myosin heavy chain (mhc)
820846|NCT00154440|primary gastric MALT lymphoma|primary gastric malt lymphoma
820847|NCT00154440|Helicobacter pylori|helicobacter pylori
820848|NCT00154440|eradication therapy|eradication therapy
820849|NCT00154440|radiation|radiation
820850|NCT00154440|marginal zone B-cell lymphoma|marginal zone b-cell lymphoma
820851|NCT00154440|Mucosa-associated Lymphoid Tissue|mucosa-associated lymphoid tissue
820852|NCT00154440|B-cell Non-Hodgkin's Lymphoma of the stomach|b-cell non-hodgkin's lymphoma of the stomach
820853|NCT00154440|primary gastric lymphoma|primary gastric lymphoma
820854|NCT00154388|adenocarcinoma|adenocarcinoma
820855|NCT00154388|leiomyosarcoma|leiomyosarcoma
820856|NCT00154388|angiosarcoma|angiosarcoma
820857|NCT00154388|synovial sarcoma|synovial sarcoma
820858|NCT00154388|myelodysplastic syndrome/HES|myelodysplastic syndrome/hes
820859|NCT00154388|CMML|cmml
820860|NCT00154388|multiple myeloma|multiple myeloma
820861|NCT00154388|embryonal rhabdomyosarcoma|embryonal rhabdomyosarcoma
820862|NCT00154388|endometrial sarcoma|endometrial sarcoma
820863|NCT00154388|adenoid cystic carcinoma|adenoid cystic carcinoma
820864|NCT00154388|fibromatosis|fibromatosis
820865|NCT00154388|ductal invasive breast carcinoma|ductal invasive breast carcinoma
820866|NCT00154388|chondrosarcoma|chondrosarcoma
820867|NCT00154388|pleural tumor|pleural tumor
820868|NCT00154388|brenner tumor|brenner tumor
820869|NCT00154388|ewing sarcoma|ewing sarcoma
820870|NCT00154388|round cell tumor|round cell tumor
820871|NCT00154388|seminoma|seminoma
820872|NCT00154388|thymic carcinoma|thymic carcinoma
820873|NCT00154388|malignant melanoma|malignant melanoma
820874|NCT00154388|fibrosarcoma breast|fibrosarcoma breast
820875|NCT00154388|dermatofibrosarcoma protuberans|dermatofibrosarcoma protuberans
820876|NCT00154388|DFSP|dfsp
820877|NCT00154388|ovarian stromal tumor|ovarian stromal tumor
820878|NCT00154388|osteosarcoma|osteosarcoma
820879|NCT00154388|chorioideal melanoma|chorioideal melanoma
820880|NCT00154388|hemangiopericytoma|hemangiopericytoma
820881|NCT00154388|myelofibrosis|myelofibrosis
820882|NCT00154388|liposarcoma|liposarcoma
820883|NCT00154388|SCLC|sclc
820884|NCT00154388|small cell lung carcinoma|small cell lung carcinoma
820885|NCT00154388|hypereosinophilic syndrome|hypereosinophilic syndrome
820886|NCT00154388|chronic myelo-monocytic leukemia|chronic myelo-monocytic leukemia
820887|NCT00154388|neurofibrosarcoma|neurofibrosarcoma
820888|NCT00154388|mesothelioma|mesothelioma
820889|NCT00154388|malignant mesenchymoma|malignant mesenchymoma
820890|NCT00154388|malignant schwannoma|malignant schwannoma
820891|NCT00154388|mast cell leukemia / mastocytosis|mast cell leukemia / mastocytosis
820892|NCT00154388|renal cell carcinoma|renal cell carcinoma
820893|NCT00154388|malignant histocytoma|malignant histocytoma
820894|NCT00154388|chordoma|chordoma
820895|NCT00154375|Open label|open label
820896|NCT00154375|Imatinib mesylate|imatinib mesylate
820897|NCT00154375|hydroxyurea|hydroxyurea
820898|NCT00154375|temozolomide|temozolomide
820899|NCT00154375|resistant|resistant
820900|NCT00154375|protein tyrosine kinases|protein tyrosine kinases
820901|NCT00154375|adenocarcinoma|adenocarcinoma
820902|NCT00154375|glioblastoma multiforme|glioblastoma multiforme
820903|NCT00154375|astrocytoma|astrocytoma
820904|NCT00154375|brain tumor|brain tumor
820905|NCT00154375|brain cancer|brain cancer
820906|NCT00154362|Oxcarbazepine, conduct disorder, adolescents|oxcarbazepine, conduct disorder, adolescents
820907|NCT00154349|Ph+ALL|ph+all
820908|NCT00154349|imatinib mesylate|imatinib mesylate
820909|NCT00154336|Rheumatoid arthritis, imatinib, methotrexate|rheumatoid arthritis, imatinib, methotrexate
820910|NCT00154323|Oxcarbazepine, bipolar disorder|oxcarbazepine, bipolar disorder
820911|NCT00154310|Renal transplantation, everolimus, immunosuppressants, CNI-free|renal transplantation, everolimus, immunosuppressants, cni-free
820912|NCT00154297|Renal transplantation|renal transplantation
820913|NCT00154297|everolimus|everolimus
820914|NCT00154297|immunosuppressants|immunosuppressants
820915|NCT00154297|wound-healing|wound-healing
820916|NCT00154284|Renal transplantation,|renal transplantation,
820917|NCT00154284|everolimus,|everolimus,
820918|NCT00154284|immunosuppressants,|immunosuppressants,
820919|NCT00154284|basiliximab,|basiliximab,
820920|NCT00154284|cyclosporine microemulsion discontinuation, cyclosporine microemulsion minimization|cyclosporine microemulsion discontinuation, cyclosporine microemulsion minimization
820921|NCT00154271|Hypertension (HTN)|hypertension (htn)
820922|NCT00154271|High Sensitivity C-Reactive Protein|high sensitivity c-reactive protein
820923|NCT00154258|Schizophrenia, treatment-resistant, clozapine|schizophrenia, treatment-resistant, clozapine
820924|NCT00154245|Enteric-coated mycophenolate sodium, transplantation, de novo, cyclosporine|enteric-coated mycophenolate sodium, transplantation, de novo, cyclosporine
820925|NCT00154232|Renal transplantation, DGF, basiliximab, EC-MPS, cyclosporine|renal transplantation, dgf, basiliximab, ec-mps, cyclosporine
820926|NCT00154219|Osteoarthritis, Hip, Lumiracoxib, Efficacy, Safety|osteoarthritis, hip, lumiracoxib, efficacy, safety
820927|NCT00154206|Enteric-coated mycophenolate sodium,|enteric-coated mycophenolate sodium,
820928|NCT00154206|de novo,|de novo,
820929|NCT00154206|renal transplantation,|renal transplantation,
820930|NCT00154206|pediatric|pediatric
820931|NCT00154206|De novo pediatric renal transplantation|de novo pediatric renal transplantation
820932|NCT00154193|Heart transplant, lung transplant, renal function, cyclosporine C2 Levels|heart transplant, lung transplant, renal function, cyclosporine c2 levels
820933|NCT00154180|Perimenopause|perimenopause
820934|NCT00154180|Coronary Disease|coronary disease
820935|NCT00154180|Estrogen Replacement Therapy|estrogen replacement therapy
820936|NCT00154180|Hormone Replacement Therapy|hormone replacement therapy
820937|NCT00154154|borderline personality disorder|borderline personality disorder
820938|NCT00154154|BPD|bpd
820939|NCT00154154|treatment|treatment
820940|NCT00154154|dialectical behavior therapy|dialectical behavior therapy
820941|NCT00154154|DBT|dbt
821238|NCT00152477|carboplatin|carboplatin
820942|NCT00154154|general Psychiatric management|general psychiatric management
820943|NCT00154154|GPM|gpm
820944|NCT00154154|suicide|suicide
820945|NCT00154154|parasuicide|parasuicide
820946|NCT00154154|randomized control trials|randomized control trials
820947|NCT00154128|temporomandibular disorder|temporomandibular disorder
820948|NCT00154128|craniomandibular disorder|craniomandibular disorder
820949|NCT00154128|occlusal appliance|occlusal appliance
820950|NCT00154128|clinical trial|clinical trial
820951|NCT00154115|heart failure|heart failure
820952|NCT00154115|levosimendan|levosimendan
820953|NCT00154115|cardiac surgery|cardiac surgery
820954|NCT00154102|Metastatic colorectal cancer|metastatic colorectal cancer
820955|NCT00154102|EGFR|egfr
820956|NCT00154102|Irinotecan|irinotecan
820957|NCT00154102|cetuximab|cetuximab
820958|NCT00154102|first-line treatment|first-line treatment
820959|NCT00154089|cervical intraepithelial neoplasia|cervical intraepithelial neoplasia
820960|NCT00154089|CIN|cin
820961|NCT00154089|HPV|hpv
820962|NCT00154050|restenosis|restenosis
820963|NCT00154050|intima hyperproliferation|intima hyperproliferation
820964|NCT00154050|stent angioplasty|stent angioplasty
820965|NCT00154050|pain-free walking distance|pain-free walking distance
820966|NCT00154037|vascular reactivity|vascular reactivity
820967|NCT00154037|venodilation|venodilation
820968|NCT00154037|pulse wave velocity|pulse wave velocity
820969|NCT00154024|venoconstriction|venoconstriction
820970|NCT00154024|venodilation|venodilation
820971|NCT00154024|pleiotropic effects|pleiotropic effects
820972|NCT00154011|vascular reactivity, venodilation|vascular reactivity, venodilation
820973|NCT00153998|Cetuximab|cetuximab
820974|NCT00153998|Oxaliplatin|oxaliplatin
820975|NCT00153998|Irinotecan|irinotecan
820976|NCT00153998|5-FU|5-fu
820977|NCT00153998|Chemotherapy|chemotherapy
820978|NCT00153998|Resection|resection
820979|NCT00153998|Liver resection|liver resection
820980|NCT00153998|Neoadjuvant|neoadjuvant
820981|NCT00153985|Hemoglobinopathies|hemoglobinopathies
820982|NCT00153985|Sickle cell anemia|sickle cell anemia
820983|NCT00153985|sickle cell-hemoglobin C disease|sickle cell-hemoglobin c disease
820984|NCT00153985|sickle cell-B-thalassemia|sickle cell-b-thalassemia
820985|NCT00153985|transfusion-dependant thalassemia|transfusion-dependant thalassemia
820986|NCT00153985|allogeneic transplant|allogeneic transplant
820987|NCT00153985|nonmyeloablative transplant|nonmyeloablative transplant
820988|NCT00153985|Stem cell transfusion|stem cell transfusion
820989|NCT00153985|graft vs. host disease|graft vs. host disease
820990|NCT00153972|Parkinson's disease|parkinson's disease
820991|NCT00153972|Fluoro-Dopa-PET|fluoro-dopa-pet
820992|NCT00153972|Dopamine agonists|dopamine agonists
820994|NCT00153972|Surrogate marker|surrogate marker
820995|NCT00153972|Dopamine turnover|dopamine turnover
820996|NCT00153946|Free Radical Scavenger|free radical scavenger
820997|NCT00153946|Selective Thrombin Inhibitor|selective thrombin inhibitor
820998|NCT00153946|Acute ischemic stroke (nonlacunar and noncardioembolic)|acute ischemic stroke (nonlacunar and noncardioembolic)
820999|NCT00153933|Multiple Myeloma|multiple myeloma
821000|NCT00153933|bortezomib|bortezomib
821001|NCT00153933|Revlimid|revlimid
821002|NCT00153933|CC-5013|cc-5013
821003|NCT00153920|multiple myeloma|multiple myeloma
821004|NCT00153920|Velcade|velcade
821005|NCT00153920|bortezomib|bortezomib
821006|NCT00153907|Xeloda|xeloda
821007|NCT00153907|Navelbine|navelbine
821008|NCT00153907|capecitabine|capecitabine
821009|NCT00153907|metastatic breast cancer|metastatic breast cancer
821010|NCT00153894|Breast cancer survivor|breast cancer survivor
821011|NCT00153894|Insulin levels|insulin levels
821012|NCT00153894|exercise regimen|exercise regimen
821013|NCT00153894|endurance training|endurance training
821014|NCT00153894|strength training|strength training
821015|NCT00153881|Esophageal Cancer|esophageal cancer
821016|NCT00153881|Trimodality|trimodality
821017|NCT00153881|Capecitabine|capecitabine
821018|NCT00153881|Xeloda|xeloda
821019|NCT00153881|Gastro-esophageal Neoplasm|gastro-esophageal neoplasm
821020|NCT00153881|Carcinoma of the Esophagus|carcinoma of the esophagus
821021|NCT00153868|Anemia|anemia
821022|NCT00153868|Cancer|cancer
821023|NCT00153868|Quality of life|quality of life
821024|NCT00153868|Web-based|web-based
821025|NCT00153868|Aranesp|aranesp
821026|NCT00153868|Darbepoetin alfa|darbepoetin alfa
821027|NCT00153855|etiology|etiology
821028|NCT00153855|pathology|pathology
821029|NCT00153842|NSCLC|nsclc
821030|NCT00153842|Bexarotene|bexarotene
821031|NCT00153842|Targretin|targretin
821032|NCT00153829|Chronic Disease|chronic disease
821033|NCT00153829|Quality of Life|quality of life
821034|NCT00153816|Colorectal neoplasms|colorectal neoplasms
821035|NCT00153816|Adenomatous polyps|adenomatous polyps
821036|NCT00153803|Erlotinib|erlotinib
821037|NCT00153803|Tarceva|tarceva
821038|NCT00153803|Web based|web based
821039|NCT00153803|Stage III NSCLC|stage iii nsclc
821040|NCT00153790|green tea|green tea
821041|NCT00153790|weight|weight
821042|NCT00153790|women|women
821043|NCT00153777|HIV prevention|hiv prevention
821044|NCT00153777|Randomized controlled trial|randomized controlled trial
821045|NCT00153777|Women|women
821046|NCT00153777|Sexually transmitted infections|sexually transmitted infections
821047|NCT00153777|HIV Seronegativity|hiv seronegativity
821048|NCT00153764|supplement|supplement
821049|NCT00153764|omega-3 fatty acid|omega-3 fatty acid
821050|NCT00153764|Homocysteine|homocysteine
821051|NCT00153764|LDL cholesterol|ldl cholesterol
821052|NCT00153751|Traditional Chinese Medicine|traditional chinese medicine
821053|NCT00153738|LDL-C, phytosterol|ldl-c, phytosterol
821054|NCT00153712|Non-NSAID|non-nsaid
821055|NCT00153712|Non-Hp Bleeding Peptic Ulcer|non-hp bleeding peptic ulcer
821056|NCT00153699|Side effects|side effects
821057|NCT00153699|Topiramate|topiramate
821058|NCT00153686|Capsule Endoscopy|capsule endoscopy
821059|NCT00153686|Mesenteric angiogram|mesenteric angiogram
821060|NCT00153673|celecoxib|celecoxib
821061|NCT00153673|arthritis|arthritis
821062|NCT00153673|ulcer healing|ulcer healing
821063|NCT00153634|Cystic fibrosis|cystic fibrosis
821064|NCT00153634|Antibiotic susceptibility testing|antibiotic susceptibility testing
821065|NCT00153634|Pseudomonas aeruginosa|pseudomonas aeruginosa
821066|NCT00153634|Chronic bronchitis|chronic bronchitis
821067|NCT00153634|Biofilms|biofilms
821068|NCT00153621|Pediatrics|pediatrics
821069|NCT00153621|Chronic Kidney Failure|chronic kidney failure
821070|NCT00153621|HIV|hiv
821071|NCT00153621|Acquired Immunodeficiency Syndrome|acquired immunodeficiency syndrome
821072|NCT00153621|AIDS-Associated Nephropathy|aids-associated nephropathy
821073|NCT00153595|Allergic rhinitis|allergic rhinitis
821074|NCT00153595|EWO1|ewo1
821075|NCT00153556|Haemophilus influenza type B|haemophilus influenza type b
821076|NCT00153556|Carrier state|carrier state
821077|NCT00153556|Bacterial Vaccines|bacterial vaccines
821078|NCT00153556|Anti-PRP antibody|anti-prp antibody
821079|NCT00153556|Antibody avidity|antibody avidity
821080|NCT00153556|Serum bacteriocidal antibody|serum bacteriocidal antibody
821081|NCT00153556|American Indians/Alaska Natives|american indians/alaska natives
821082|NCT00153556|Case control study|case control study
821083|NCT00153556|Adult vaccines|adult vaccines
821084|NCT00153530|primary central nervous system lymphoma|primary central nervous system lymphoma
821085|NCT00153517|Bacterial Vaginosis|bacterial vaginosis
821086|NCT00153517|Metronidazole|metronidazole
821087|NCT00153504|HIV|hiv
821088|NCT00153504|AIDS|aids
821089|NCT00153504|Homeless|homeless
821090|NCT00153504|Homelessness|homelessness
821091|NCT00153504|Housing|housing
821092|NCT00153504|HIV seropositive|hiv seropositive
821093|NCT00153504|HIV risk behavior|hiv risk behavior
821094|NCT00153491|malaria|malaria
821095|NCT00153491|artemether-lumefantrine|artemether-lumefantrine
821099|NCT00153478|Alcohol-Exposed Pregnancy|alcohol-exposed pregnancy
821100|NCT00153478|Binge drinking|binge drinking
821101|NCT00153478|Frequent drinking|frequent drinking
821102|NCT00153478|Unintended pregnancy|unintended pregnancy
821103|NCT00153478|Fetal Alcohol Syndrome|fetal alcohol syndrome
821104|NCT00153465|Parent training|parent training
821105|NCT00153465|Child maltreatment|child maltreatment
821106|NCT00153465|Motivation|motivation
821107|NCT00153465|Program attrition|program attrition
821108|NCT00153439|parenting|parenting
821109|NCT00153439|motivation|motivation
821110|NCT00153439|child maltreatment|child maltreatment
821111|NCT00153439|program attrition|program attrition
821112|NCT00153400|CVD risk|cvd risk
821113|NCT00153361|HIV Seronegativity|hiv seronegativity
821114|NCT00153361|HIV|hiv
821115|NCT00153335|Health Risk Assessment|health risk assessment
821116|NCT00153335|Behavior Change|behavior change
821117|NCT00153335|Patient-Provider Interaction|patient-provider interaction
821118|NCT00153335|Employee Health|employee health
821119|NCT00153335|Absenteeism|absenteeism
821120|NCT00153335|Tobacco Use|tobacco use
821121|NCT00153335|Substance Use|substance use
821122|NCT00153335|Diet|diet
821123|NCT00153335|Exercise|exercise
821124|NCT00153335|Medication Adherence|medication adherence
821125|NCT00153322|Childhood Obesity|childhood obesity
821126|NCT00153322|Community-based Participatory Research|community-based participatory research
821127|NCT00153322|School intervention|school intervention
821128|NCT00153322|Parental Involvement|parental involvement
821129|NCT00153309|arthritis|arthritis
821130|NCT00153309|exercise|exercise
821131|NCT00153309|physical activity|physical activity
821132|NCT00153309|physical function|physical function
821133|NCT00153309|pain|pain
821134|NCT00153296|Bronchial asthma|bronchial asthma
821135|NCT00153296|Carbamazepine|carbamazepine
821136|NCT00153296|Antiepileptic drugs|antiepileptic drugs
821137|NCT00153296|Efficacy|efficacy
821138|NCT00153283|Bronchial asthma|bronchial asthma
821139|NCT00153283|Gabapentin|gabapentin
821140|NCT00153283|Antiepileptic drug|antiepileptic drug
821141|NCT00153283|Efficacy|efficacy
821142|NCT00153270|Bronchial asthma|bronchial asthma
821143|NCT00153270|Sodium valproate|sodium valproate
821144|NCT00153270|Antiepileptic drug|antiepileptic drug
821146|NCT00153244|Bronchial asthma|bronchial asthma
821147|NCT00153244|Lamotrigine|lamotrigine
821148|NCT00153244|Antiepileptic drug|antiepileptic drug
821149|NCT00153244|Efficacy|efficacy
821150|NCT00153218|Metastatic Breast Cancer|metastatic breast cancer
821151|NCT00153218|Her2neu|her2neu
821152|NCT00153218|trastuzumab|trastuzumab
821153|NCT00153205|medication errors|medication errors
821154|NCT00153205|medical records systems, computerized|medical records systems, computerized
821155|NCT00153205|patient safety|patient safety
821156|NCT00153192|Marinol|marinol
821157|NCT00153192|Dronabinol|dronabinol
821158|NCT00153192|Cannabinoid|cannabinoid
821159|NCT00153192|Chronic Pain|chronic pain
821160|NCT00153179|insulin resistance|insulin resistance
821161|NCT00153179|insulin signaling|insulin signaling
821162|NCT00153179|endothelium-dependent vasodilation|endothelium-dependent vasodilation
821163|NCT00153166|peripheral arterial disease|peripheral arterial disease
821164|NCT00153166|intermittent claudication|intermittent claudication
821165|NCT00152945|intestinal lipoprotein|intestinal lipoprotein
821166|NCT00152945|very low density lipoprotein|very low density lipoprotein
821167|NCT00152945|free fatty acids|free fatty acids
821168|NCT00152945|Apo B48 and Apo B100|apo b48 and apo b100
821169|NCT00152945|triglycerides|triglycerides
821170|NCT00152945|Intestinal lipoprotein production|intestinal lipoprotein production
821171|NCT00152932|Glaucoma|glaucoma
821172|NCT00152932|Intraocular pressure|intraocular pressure
821173|NCT00152932|Ocular blood flow|ocular blood flow
821174|NCT00152932|Laser-Doppler Flowmetry|laser-doppler flowmetry
821175|NCT00152893|HIV|hiv
821176|NCT00152893|blood sugar > 6.1 mmol/l|blood sugar > 6.1 mmol/l
821177|NCT00152893|triglycerides > 2 mmol/l|triglycerides > 2 mmol/l
821178|NCT00152893|total cholesterol > 5.5 mmol/l or HDL < 0.9 mmol/l|total cholesterol > 5.5 mmol/l or hdl < 0.9 mmol/l
821179|NCT00152880|Hepatitis B, apoptosis|hepatitis b, apoptosis
821180|NCT00152867|quality of life|quality of life
821181|NCT00152867|dexamethasone|dexamethasone
821182|NCT00152867|emesis|emesis
821183|NCT00152854|cancer pain|cancer pain
821184|NCT00152854|acetaminophen|acetaminophen
821185|NCT00152854|opioids|opioids
821186|NCT00152815|HIV|hiv
821187|NCT00152815|non-alcoholic fatty liver disease|non-alcoholic fatty liver disease
821188|NCT00152802|liver transplant|liver transplant
821189|NCT00152802|antibody response|antibody response
821190|NCT00152802|opsonophagocytic assay|opsonophagocytic assay
821191|NCT00152802|pneumococcal conjugate vaccine|pneumococcal conjugate vaccine
821192|NCT00152802|pneumococcal polysaccharide vaccine|pneumococcal polysaccharide vaccine
821193|NCT00152776|menopausal symptoms|menopausal symptoms
821194|NCT00152776|complementary medicine|complementary medicine
821195|NCT00152763|health anxiety|health anxiety
821196|NCT00152750|Tourette's Syndrome|tourette's syndrome
821197|NCT00152750|Attention Deficit Hyperactivity Disorder|attention deficit hyperactivity disorder
821199|NCT00152750|Sleep disorders|sleep disorders
821200|NCT00152750|Aggression|aggression
821201|NCT00152737|Intermittent Claudication|intermittent claudication
821202|NCT00152737|Peripheral Vascular Diseases|peripheral vascular diseases
821203|NCT00152737|Blood Gas Monitoring, Transcutaneous|blood gas monitoring, transcutaneous
821204|NCT00152737|Surgery|surgery
821205|NCT00152724|Physiology|physiology
821206|NCT00152724|Microcirculation|microcirculation
821207|NCT00152724|Laser-Doppler Flowmetry|laser-doppler flowmetry
821208|NCT00152659|Epilepsy|epilepsy
821209|NCT00152659|Tumor|tumor
821210|NCT00152659|Surgery|surgery
821211|NCT00152659|Brain|brain
821212|NCT00152633|endothelium, hypertension, retina, AT1|endothelium, hypertension, retina, at1
821213|NCT00152620|Inflammatory Bowel Disease (IBD)|inflammatory bowel disease (ibd)
821214|NCT00152607|Liver Transplantation|liver transplantation
821215|NCT00152607|Living Donors|living donors
821216|NCT00152607|End Stage Liver Disease|end stage liver disease
821217|NCT00152581|HCV, genotype 1, treatment, HCV kinetics, T-cells|hcv, genotype 1, treatment, hcv kinetics, t-cells
821218|NCT00152568|Car Seat Check|car seat check
821219|NCT00152555|SLE,|sle,
821220|NCT00152555|exercize,|exercize,
821221|NCT00152555|physical therapy,|physical therapy,
821222|NCT00152555|Systemic lupus erythematosus|systemic lupus erythematosus
821223|NCT00152555|relaxation therapy|relaxation therapy
821224|NCT00152542|Inhaled nitric oxide,|inhaled nitric oxide,
821225|NCT00152542|Lung recruitment,|lung recruitment,
821226|NCT00152542|Ventilatory approach,|ventilatory approach,
821227|NCT00152542|Neurodevelopmental outcomes,|neurodevelopmental outcomes,
821228|NCT00152542|School age children|school age children
821229|NCT00152529|Depression, educational site for depression|depression, educational site for depression
821230|NCT00152516|Partial Onset Seizures|partial onset seizures
821231|NCT00152516|levetiracetam|levetiracetam
821232|NCT00152516|Epilepsy|epilepsy
821233|NCT00152516|Keppra|keppra
821234|NCT00152503|Epilepsy, Partial Onset Seizures, Seletracetam|epilepsy, partial onset seizures, seletracetam
821235|NCT00152490|Crohn's disease, CDP870, CDAI, clinical response, remission,|crohn's disease, cdp870, cdai, clinical response, remission,
821236|NCT00152490|Certolizumab Pegol, Cimzia|certolizumab pegol, cimzia
821237|NCT00152477|Non-small-cell-lung cancer|non-small-cell-lung cancer
821239|NCT00152477|paclitaxel|paclitaxel
821240|NCT00152477|VEGF|vegf
821241|NCT00152477|monoclonal antibody|monoclonal antibody
821242|NCT00152464|EPAAC|epaac
821243|NCT00152464|Atopic children|atopic children
821244|NCT00152464|Asthma|asthma
821245|NCT00152464|XYZAL|xyzal
821246|NCT00152464|Levocetirizine|levocetirizine
821247|NCT00152451|Epilepsy: partial onset seizures, seletracetam|epilepsy: partial onset seizures, seletracetam
821248|NCT00152438|Vasomotor symptoms|vasomotor symptoms
821249|NCT00152438|Menopause|menopause
821250|NCT00152425|Crohn's disease, CDP870, CDAI, clinical response, remission, Certolizumab Pegol, Cimzia|crohn's disease, cdp870, cdai, clinical response, remission, certolizumab pegol, cimzia
821251|NCT00152412|Allergic Rhinitis, safety, levocetirizine, children|allergic rhinitis, safety, levocetirizine, children
821252|NCT00152412|Xyzal|xyzal
821253|NCT00152399|Peptic ulcer bleeding, upper intestinal bleeding, endoscopy, somatostatin|peptic ulcer bleeding, upper intestinal bleeding, endoscopy, somatostatin
821254|NCT00152386|Rheumatoid Arthritis, CDP870|rheumatoid arthritis, cdp870
821255|NCT00152386|Certolizumab pegol, Cimzia|certolizumab pegol, cimzia
821256|NCT00152373|Epilepsy, Partial Onset Seizures; Keppra; Levetiracetam|epilepsy, partial onset seizures; keppra; levetiracetam
821257|NCT00152360|Obesity|obesity
821258|NCT00152360|weight loss|weight loss
821259|NCT00152360|cardiovascular risk factors|cardiovascular risk factors
821260|NCT00152360|Obesity and obesity related pathology|obesity and obesity related pathology
821261|NCT00152334|Efficacy study|efficacy study
821262|NCT00152334|assessment of patient outcomes following treatment|assessment of patient outcomes following treatment
821263|NCT00152321|osteoporosis|osteoporosis
821264|NCT00152321|wrist fractures|wrist fractures
821265|NCT00152321|quality improvement|quality improvement
821266|NCT00152321|knowledge translation|knowledge translation
821267|NCT00152295|Postmenopausal|postmenopausal
821268|NCT00152295|Amenorrhea|amenorrhea
821269|NCT00152295|Hormone replacement therapy|hormone replacement therapy
821270|NCT00152295|HRT|hrt
821271|NCT00152295|asoprisnil|asoprisnil
821272|NCT00152295|Estrogen Replacement Therapy, postmenopause|estrogen replacement therapy, postmenopause
821273|NCT00152282|Postmenopausal|postmenopausal
821274|NCT00152282|Amenorrhea|amenorrhea
821275|NCT00152282|Hormone replacement therapy|hormone replacement therapy
821276|NCT00152282|HRT|hrt
821277|NCT00152282|asoprisnil|asoprisnil
821278|NCT00152269|Symptomatic Uterine Fibroids|symptomatic uterine fibroids
821279|NCT00152269|Excessive Uterine Bleeding|excessive uterine bleeding
821280|NCT00152269|Uterine Hemorrhage|uterine hemorrhage
821281|NCT00152269|asoprisnil|asoprisnil
821282|NCT00152256|Symptomatic Uterine Fibroids|symptomatic uterine fibroids
821283|NCT00152256|Excessive Uterine Bleeding|excessive uterine bleeding
821284|NCT00152256|Uterine Hemorrhage|uterine hemorrhage
821285|NCT00152243|Stomach Cancer|stomach cancer
821286|NCT00152230|Colorectal Cancer|colorectal cancer
821287|NCT00152217|Stomach cancer|stomach cancer
821288|NCT00152204|Use-Effectiveness|use-effectiveness
821289|NCT00152204|Cost Effectiveness|cost effectiveness
821290|NCT00152204|Patient Acceptance of Health Care|patient acceptance of health care
821291|NCT00152204|Drug Resistance|drug resistance
821292|NCT00152204|Delivery of Health Care|delivery of health care
821293|NCT00152191|Breast Cancer|breast cancer
821294|NCT00152178|Breast Cancer|breast cancer
821295|NCT00152165|spinal motion|spinal motion
821296|NCT00152165|tantalum beads|tantalum beads
821297|NCT00152165|DYNESYS Stabilization system|dynesys stabilization system
821298|NCT00152165|spinal fusion|spinal fusion
821299|NCT00152165|Radiostereometric Analysis following spinal fusion|radiostereometric analysis following spinal fusion
821300|NCT00152165|Radiostereometric Analysis following surgery with DYNESYS Stabilization System|radiostereometric analysis following surgery with dynesys stabilization system
821301|NCT00152152|spinal motion|spinal motion
821302|NCT00152152|tantalum beads|tantalum beads
821303|NCT00152139|High risk hematologic malignancies|high risk hematologic malignancies
821304|NCT00152139|Allogeneic stem cell transplant|allogeneic stem cell transplant
821305|NCT00152139|Matched unrelated donor transplantation|matched unrelated donor transplantation
821306|NCT00152139|Unmanipulated stem cell graft|unmanipulated stem cell graft
821307|NCT00152139|Bone marrow transplantation|bone marrow transplantation
821308|NCT00152126|Autologous stem cell transplantation|autologous stem cell transplantation
821309|NCT00152126|CD133 cell selection|cd133 cell selection
821310|NCT00152126|CliniMACS device|clinimacs device
821311|NCT00152126|Tumor marker|tumor marker
821312|NCT00152126|Tumor purging|tumor purging
821313|NCT00152113|Sickle Cell Anemia|sickle cell anemia
821314|NCT00152113|Stem Cell Transplantation|stem cell transplantation
821315|NCT00152113|Haploidentical stem cell transplant|haploidentical stem cell transplant
821316|NCT00152113|T cell depletion|t cell depletion
821317|NCT00152113|CliniMACS device|clinimacs device
821318|NCT00152100|Severe combined immunodeficiency|severe combined immunodeficiency
821319|NCT00152100|Transplantation|transplantation
821320|NCT00152100|Haploidentical|haploidentical
821321|NCT00152087|Liver cancer|liver cancer
821322|NCT00152087|Brachytherapy|brachytherapy
821323|NCT00152074|Blood pressure|blood pressure
821324|NCT00152074|Sodium|sodium
821325|NCT00152074|Dietary|dietary
821326|NCT00152074|Hypertension or prehypertension|hypertension or prehypertension
821328|NCT00152061|Antiretroviral Drug Resistance|antiretroviral drug resistance
821329|NCT00152061|Treatment Experienced|treatment experienced
821330|NCT00151905|bronchiolitis|bronchiolitis
821331|NCT00151905|hypertonic saline|hypertonic saline
821332|NCT00151879|partial seizures with or without secondary generalization|partial seizures with or without secondary generalization
821333|NCT00151866|Thrombopenia|thrombopenia
821334|NCT00151866|Platelet transfusion|platelet transfusion
821335|NCT00151866|Increment|increment
821336|NCT00151866|Transfusion reactions|transfusion reactions
821337|NCT00151866|Bleeding complication|bleeding complication
821338|NCT00151853|CPB|cpb
821339|NCT00151853|oral anticoagulant therapy|oral anticoagulant therapy
821340|NCT00151853|plasma|plasma
821341|NCT00151853|PCC|pcc
821342|NCT00151840|Purpura, Thrombocytopenic, Idiopathic|purpura, thrombocytopenic, idiopathic
821343|NCT00151840|ITP|itp
821344|NCT00151840|Immunoglobulin, Intravenous|immunoglobulin, intravenous
821345|NCT00151814|Olmesartan PK in children|olmesartan pk in children
821346|NCT00151801|multiple sclerosis|multiple sclerosis
821347|NCT00151801|estroprogestins|estroprogestins
821348|NCT00151801|interferon-beta|interferon-beta
821349|NCT00151801|sex hormones|sex hormones
821350|NCT00151801|MRI|mri
821351|NCT00151775|Treatment of hypertension or high blood pressure in children ages 1-16 years.|treatment of hypertension or high blood pressure in children ages 1-16 years.
821352|NCT00151762|Open label, Diabetes Mellitus|open label, diabetes mellitus
821353|NCT00151762|Long term safety study, extension study|long term safety study, extension study
821354|NCT00151749|Diabetes mellitus|diabetes mellitus
821355|NCT00151736|Chronic Lymphocytic Leukemia|chronic lymphocytic leukemia
821356|NCT00151736|CLL|cll
821357|NCT00151736|Leukemia|leukemia
821358|NCT00151723|endogenous subclinical hyperthyroidism|endogenous subclinical hyperthyroidism
821359|NCT00151697|diabetes|diabetes
821360|NCT00151697|failing oral treatment|failing oral treatment
821361|NCT00151697|weight gain|weight gain
821362|NCT00151684|Obesity|obesity
821363|NCT00151684|Hyperinsulinism|hyperinsulinism
821364|NCT00151684|Diazoxide|diazoxide
821365|NCT00151671|Surgery|surgery
821366|NCT00151671|Liver Cancer|liver cancer
821367|NCT00151671|Cirrhosis|cirrhosis
821368|NCT00151671|Nutrition|nutrition
821369|NCT00151658|Coronary complex lesions|coronary complex lesions
821370|NCT00151658|Restenosis|restenosis
821371|NCT00151658|Drug eluting stents|drug eluting stents
821372|NCT00151645|Immunotherapy|immunotherapy
821373|NCT00151645|Renal cell carcinoma|renal cell carcinoma
821374|NCT00151645|Metastasis|metastasis
821375|NCT00151645|Lymphokine activated killers|lymphokine activated killers
821376|NCT00151645|Cell therapy|cell therapy
821377|NCT00151632|Immunosuppression|immunosuppression
821378|NCT00151632|Liver transplantation|liver transplantation
821379|NCT00151632|Acute graft rejection|acute graft rejection
821380|NCT00151632|Treatment combination|treatment combination
821381|NCT00151619|Calcium channel blockers|calcium channel blockers
821382|NCT00151619|Heart failure|heart failure
821383|NCT00151619|Hemodynamics|hemodynamics
821384|NCT00151606|Infection prevention|infection prevention
821385|NCT00151606|Isolation|isolation
821386|NCT00151606|Resistant bacteria|resistant bacteria
821387|NCT00151606|MRSA colonization|mrsa colonization
821388|NCT00151593|Cold storage|cold storage
821389|NCT00151593|Liver transplantation|liver transplantation
821390|NCT00151593|Preservation solution|preservation solution
821391|NCT00151580|Hepatitis C|hepatitis c
821392|NCT00151580|Viral recurrence|viral recurrence
821393|NCT00151580|Ribavirin / Interferon|ribavirin / interferon
821394|NCT00151567|Ureterolithiasis|ureterolithiasis
821395|NCT00151567|Alpha1-blocker|alpha1-blocker
821396|NCT00151567|Lower ureteral stone|lower ureteral stone
821397|NCT00151554|Anxiety|anxiety
821398|NCT00151554|Intensive Care Unit (ICU)|intensive care unit (icu)
821399|NCT00151554|Preoperative Information|preoperative information
821400|NCT00151554|Randomized Controlled Trial (RCT)|randomized controlled trial (rct)
821401|NCT00151554|Chronic heart disease|chronic heart disease
821402|NCT00151541|Acne Vulgaris|acne vulgaris
821403|NCT00151541|Acne|acne
821404|NCT00151541|Dermatology|dermatology
821405|NCT00151541|Dapsone|dapsone
821406|NCT00151541|Dapsone Topical Gel|dapsone topical gel
821407|NCT00151515|Alopecia, Balding|alopecia, balding
821408|NCT00151476|Familial adenomatous polyposis|familial adenomatous polyposis
821409|NCT00151476|celecoxib|celecoxib
821410|NCT00151476|IRA|ira
821411|NCT00151476|IPAA|ipaa
821412|NCT00151411|Polycystic Ovary Syndrome (PCOS)|polycystic ovary syndrome (pcos)
821413|NCT00151411|Anovulation|anovulation
821414|NCT00151411|Elevated Testosterone|elevated testosterone
821415|NCT00151346|Epidural|epidural
821416|NCT00151346|Labour pain|labour pain
821417|NCT00151346|Pregnant women|pregnant women
821418|NCT00151346|Epidural anesthesia|epidural anesthesia
821419|NCT00151346|Labour, Obstetric|labour, obstetric
821420|NCT00151346|labor pain|labor pain
821421|NCT00151346|labor, obstetric|labor, obstetric
821422|NCT00151346|labor analgesia|labor analgesia
821423|NCT00151320|diffuse large B cell|diffuse large b cell
821424|NCT00151320|mantle cell lymphoma|mantle cell lymphoma
821425|NCT00151307|Heart surgery|heart surgery
821426|NCT00151307|Cerebral oxygen saturation|cerebral oxygen saturation
821427|NCT00151307|Neuropsychological function|neuropsychological function
821428|NCT00151294|Depression (mild to moderate)|depression (mild to moderate)
821429|NCT00151294|Affective symptoms|affective symptoms
821430|NCT00151294|Emotional lability|emotional lability
821431|NCT00151294|Multiple Sclerosis|multiple sclerosis
821432|NCT00151281|relapsed mantle cell lymphoma|relapsed mantle cell lymphoma
821433|NCT00151268|Batten Disease|batten disease
821434|NCT00151268|Late Infantile Neuronal Lipofuscinosis|late infantile neuronal lipofuscinosis
821436|NCT00151255|age > 60 years|age > 60 years
821437|NCT00151229|isolated systolic hypertension|isolated systolic hypertension
821438|NCT00151229|valsartan|valsartan
821439|NCT00151229|target blood pressure|target blood pressure
821440|NCT00151216|Batten Disease|batten disease
821441|NCT00151216|Late Infantile Neuronal Ceroid Lipofuscinosis|late infantile neuronal ceroid lipofuscinosis
821442|NCT00151216|LINCL|lincl
821443|NCT00151203|newly diagnosed multiple myeloma|newly diagnosed multiple myeloma
821444|NCT00151177|ischemic stroke|ischemic stroke
821445|NCT00151177|CPAP ventilation|cpap ventilation
821446|NCT00151164|transplantation tolerance|transplantation tolerance
821447|NCT00151164|thymus|thymus
821448|NCT00151164|bone marrow|bone marrow
821449|NCT00151164|pediatric heart transplantation|pediatric heart transplantation
821450|NCT00151151|pregnancy prevention|pregnancy prevention
821451|NCT00151151|STD prevention|std prevention
821452|NCT00151151|adolescents|adolescents
821453|NCT00151151|motivational interviewing|motivational interviewing
821454|NCT00151151|abstinence|abstinence
821455|NCT00151151|contraception|contraception
821456|NCT00151151|transtheoretical model|transtheoretical model
821457|NCT00151151|sexual behavior|sexual behavior
821458|NCT00151138|cerebral blood flow, positron emission tomography, magnetic resonance imaging, neuropsychology|cerebral blood flow, positron emission tomography, magnetic resonance imaging, neuropsychology
821459|NCT00151125|Von Willebrand Disease|von willebrand disease
821460|NCT00151125|Bleeding|bleeding
821461|NCT00151125|Coagulation|coagulation
821462|NCT00151125|Hemostatic agent|hemostatic agent
821463|NCT00151112|nerve block|nerve block
821464|NCT00151112|regional anesthesia|regional anesthesia
821465|NCT00151112|injuries|injuries
821466|NCT00151112|diverse malformations|diverse malformations
821467|NCT00151099|preoperative nutrition|preoperative nutrition
821468|NCT00151099|postoperative nausea and vomiting|postoperative nausea and vomiting
821469|NCT00151099|Dysgnathia|dysgnathia
821470|NCT00151099|anesthesia|anesthesia
821471|NCT00151073|Zometa|zometa
821472|NCT00151073|Prostate Cancer|prostate cancer
821473|NCT00151073|Metastatic Prostate Cancer|metastatic prostate cancer
821474|NCT00151034|Urothelial Cancer|urothelial cancer
821475|NCT00151034|Herceptin|herceptin
821476|NCT00151034|Advanced Urothelial Cancer|advanced urothelial cancer
821487|NCT00150969|bone mineral density|bone mineral density
821488|NCT00150969|post-menopausal women|post-menopausal women
821489|NCT00150969|randomized double blind placebo controlled trial|randomized double blind placebo controlled trial
821490|NCT00150969|osteoporosis|osteoporosis
821491|NCT00150969|women's health|women's health
821492|NCT00150943|Renal artery stenosis|renal artery stenosis
821493|NCT00150943|Stent|stent
821494|NCT00150943|Renal failure|renal failure
821495|NCT00150943|Atorvastatin|atorvastatin
821496|NCT00150943|Hypertension|hypertension
821497|NCT00150943|Atherosclerosis|atherosclerosis
821498|NCT00150930|psoriasis|psoriasis
821499|NCT00150930|ultraviolet|ultraviolet
821500|NCT00150930|UVB|uvb
821501|NCT00150930|phototherapy|phototherapy
821502|NCT00150930|home care|home care
821503|NCT00150930|narrowband|narrowband
821504|NCT00150917|Breast cancer|breast cancer
821505|NCT00150917|Genetics|genetics
821506|NCT00150917|Psychotherapy|psychotherapy
821507|NCT00150917|Group counselling|group counselling
821508|NCT00150917|Randomized control trial|randomized control trial
821509|NCT00150917|Risk counselling|risk counselling
821510|NCT00150917|Women's mental health|women's mental health
821511|NCT00150917|Familial breast cancer|familial breast cancer
821512|NCT00150904|HIV|hiv
821513|NCT00150904|hepatitis C|hepatitis c
821514|NCT00150904|virologic|virologic
821515|NCT00150904|immunologic|immunologic
821516|NCT00150904|HIV / Hepatitis C coinfection|hiv / hepatitis c coinfection
821517|NCT00150891|Th1|th1
821518|NCT00150891|Th2|th2
821519|NCT00150891|B cell|b cell
821520|NCT00150891|monokines|monokines
821521|NCT00150891|kidney transplantation|kidney transplantation
821522|NCT00150891|acute rejection|acute rejection
821523|NCT00150891|chronic rejection|chronic rejection
821524|NCT00150878|Reduced-intensity conditioning|reduced-intensity conditioning
821525|NCT00150878|Fludarabine|fludarabine
821526|NCT00150878|Acute myeloid Leukemia|acute myeloid leukemia
821527|NCT00150878|Treatment-related mortality|treatment-related mortality
821528|NCT00150865|ropivacaine|ropivacaine
821529|NCT00150865|posterior lumbar plexus block|posterior lumbar plexus block
821530|NCT00150865|hip arthroplasy|hip arthroplasy
821531|NCT00150865|analgesia|analgesia
821532|NCT00150865|postoperative|postoperative
821533|NCT00150852|Gastrostomy|gastrostomy
821534|NCT00150852|Wound infection|wound infection
821535|NCT00150852|Antibiotic prophylaxis|antibiotic prophylaxis
821536|NCT00150839|Depressive Disorder, Major|depressive disorder, major
821537|NCT00150839|Venlafaxine|venlafaxine
821538|NCT00150839|Mirtazapine|mirtazapine
821539|NCT00150839|Double-blind RCT|double-blind rct
821540|NCT00150839|Magnetic resonance imaging|magnetic resonance imaging
821541|NCT00150839|Hippocampal volume|hippocampal volume
821542|NCT00150826|microvascular disease|microvascular disease
821543|NCT00150826|women|women
821544|NCT00150826|renin angiotensin system|renin angiotensin system
821545|NCT00150826|WISE|wise
821546|NCT00150826|ischemic heart disease|ischemic heart disease
821547|NCT00150813|Monotherapy|monotherapy
821548|NCT00150813|Epilepsy|epilepsy
821549|NCT00150813|Keppra|keppra
821550|NCT00150813|Levetiracetam|levetiracetam
821551|NCT00150800|Brivaracetam|brivaracetam
821552|NCT00150800|Epilepsy|epilepsy
821553|NCT00150800|Partial Onset Seizures|partial onset seizures
821554|NCT00150800|open label|open label
821555|NCT00150787|Monotherapy, epilepsy|monotherapy, epilepsy
821556|NCT00150787|Levetiracetam|levetiracetam
821557|NCT00150787|Keppra|keppra
821558|NCT00150774|Idiopathic Generalized Epilepsy, Myoclonic seizures|idiopathic generalized epilepsy, myoclonic seizures
821559|NCT00150774|Keppra - Levetiracetam|keppra - levetiracetam
821680|NCT00149890|steroid reduction|steroid reduction
821560|NCT00150761|Nasal histamine provocation, facial thermography, levocetirizine, cetirizine,|nasal histamine provocation, facial thermography, levocetirizine, cetirizine,
821561|NCT00150761|Xyzal, Zyrtec|xyzal, zyrtec
821562|NCT00150748|Generalized Epilepsy, Primary Generalized Seizures|generalized epilepsy, primary generalized seizures
821563|NCT00150748|Keppra, Levetiracetam|keppra, levetiracetam
821564|NCT00150735|Monotherapy, epilepsy, Levetiracetam, Keppra.|monotherapy, epilepsy, levetiracetam, keppra.
821565|NCT00150722|atherosclerosis|atherosclerosis
821566|NCT00150722|endothelial function|endothelial function
821568|NCT00150722|Niacin|niacin
821569|NCT00150722|statins|statins
821570|NCT00150722|Stable Atherosclerotic Vascular Disease|stable atherosclerotic vascular disease
821571|NCT00150709|Epilepsy, Pediatric , partial onset epilepsy,|epilepsy, pediatric , partial onset epilepsy,
821572|NCT00150709|Levetiracetam (Keppra®)|levetiracetam (keppra®)
821573|NCT00150696|Osteoporosis|osteoporosis
821574|NCT00150696|Spinal Cord Injury|spinal cord injury
821575|NCT00150683|Spinal Cord Injury.|spinal cord injury.
821576|NCT00150683|Osteoporosis.|osteoporosis.
821577|NCT00150683|Standing.|standing.
821578|NCT00150683|Vibration.|vibration.
821579|NCT00150670|Stomach cancer|stomach cancer
821580|NCT00150644|Fibroid Uterus|fibroid uterus
821581|NCT00150644|Leiomyoma|leiomyoma
821582|NCT00150644|Uterine Fibroids|uterine fibroids
821583|NCT00150644|Hysterectomy|hysterectomy
821584|NCT00150644|Asoprisnil|asoprisnil
821585|NCT00150631|Hypertension|hypertension
821586|NCT00150631|Prevention|prevention
821587|NCT00150631|Offspring|offspring
821588|NCT00150631|Prevent or delay development of hypertension|prevent or delay development of hypertension
821589|NCT00150527|antidepressive agents|antidepressive agents
821590|NCT00150514|nasal biopsy grasspollen sublingual immunotherapy|nasal biopsy grasspollen sublingual immunotherapy
821591|NCT00150488|PBS|pbs
821592|NCT00150488|Painful Bladder Syndrome|painful bladder syndrome
821593|NCT00150488|Interstitial Cystitis|interstitial cystitis
821594|NCT00150488|chrondroitin sulfate|chrondroitin sulfate
821595|NCT00150475|Severe Acute Respiratory Syndrome|severe acute respiratory syndrome
821596|NCT00150462|Hematological|hematological
821597|NCT00150462|Proteasome|proteasome
821598|NCT00150462|Myeloma|myeloma
821599|NCT00150462|Lymphoma|lymphoma
821600|NCT00150371|(D006937)|(d006937)
821601|NCT00150345|Neutropenia|neutropenia
821602|NCT00150345|Fever of unknown origin|fever of unknown origin
821603|NCT00150345|Empirical treatment|empirical treatment
821604|NCT00150345|Voriconazole|voriconazole
821605|NCT00150189|Pain|pain
821606|NCT00150189|Procedural Pain|procedural pain
821607|NCT00150189|Sucrose|sucrose
821608|NCT00150189|Infant|infant
821609|NCT00150189|Newborn|newborn
821610|NCT00150163|Androgens|androgens
821611|NCT00150163|Bone|bone
821612|NCT00150163|Muscle|muscle
821613|NCT00150163|Estrogens|estrogens
821614|NCT00150163|Fat|fat
821615|NCT00150163|Lipid and glucose metabolism|lipid and glucose metabolism
821616|NCT00150150|Interventional ultrasound|interventional ultrasound
821617|NCT00150150|interstitial laser theraphy|interstitial laser theraphy
821618|NCT00150150|tumor ablation|tumor ablation
821619|NCT00150150|nodule reduction|nodule reduction
821620|NCT00150150|adverse effects|adverse effects
821621|NCT00150150|patient satesfaction|patient satesfaction
821622|NCT00150137|Radioiodine therapy|radioiodine therapy
821623|NCT00150137|Graves’ disease|graves’ disease
821624|NCT00150137|toxic nodular goiter|toxic nodular goiter
821625|NCT00150137|antithyroid drugs|antithyroid drugs
821626|NCT00150137|radioprotection|radioprotection
821627|NCT00150124|Radioiodine therapy|radioiodine therapy
821628|NCT00150124|Graves' disease|graves' disease
821629|NCT00150124|toxic nodular goiter|toxic nodular goiter
821630|NCT00150124|antithyroid drugs|antithyroid drugs
821631|NCT00150124|levothyroxine|levothyroxine
821632|NCT00150124|radioprotection|radioprotection
821633|NCT00150111|Graves disease|graves disease
821634|NCT00150111|thyroid|thyroid
821635|NCT00150111|ophthalmopathy|ophthalmopathy
821636|NCT00150111|autoimmunity|autoimmunity
821637|NCT00150111|B lymphocyte depletion|b lymphocyte depletion
821638|NCT00150111|rituximab|rituximab
821639|NCT00150111|immunization|immunization
821640|NCT00150098|HIV|hiv
821641|NCT00150098|vaccines|vaccines
821642|NCT00150098|women|women
821643|NCT00150098|substance use|substance use
821644|NCT00150085|diabetes, glucose, tacrolimus, cyclosporine micro-emulsion, liver, kidney, renal|diabetes, glucose, tacrolimus, cyclosporine micro-emulsion, liver, kidney, renal
821645|NCT00150072|chordoma|chordoma
821646|NCT00150072|imatinib|imatinib
821647|NCT00150072|PDGFR|pdgfr
821648|NCT00150059|atopic dermatitis, eczema, mild to moderate, children, IGA|atopic dermatitis, eczema, mild to moderate, children, iga
821649|NCT00150046|Heart transplantation|heart transplantation
821650|NCT00150046|Everolimus|everolimus
821651|NCT00150046|Heart transplant recipient|heart transplant recipient
821652|NCT00150033|thyroid disease|thyroid disease
821653|NCT00150033|Quality of Life|quality of life
821654|NCT00150033|Patient reported outcome|patient reported outcome
821655|NCT00150033|questionnaire|questionnaire
821656|NCT00150033|Quality of Life measurement|quality of life measurement
821657|NCT00150020|Renal/Kidney|renal/kidney
821658|NCT00150020|Transplantation|transplantation
821659|NCT00150020|MPA|mpa
821660|NCT00150020|EC-MPS|ec-mps
821661|NCT00150020|Renal Transplantation Patients with GI Intolerance with MMF|renal transplantation patients with gi intolerance with mmf
821662|NCT00150007|Kidney, maintenance transplant, GI complaints, patient reported outcome|kidney, maintenance transplant, gi complaints, patient reported outcome
821663|NCT00149994|Liver transplant, adults, C2 monitoring|liver transplant, adults, c2 monitoring
821664|NCT00149981|Kidney, heart, lung, liver, pancreas|kidney, heart, lung, liver, pancreas
821665|NCT00149968|Renal transplantation|renal transplantation
821666|NCT00149968|MMF|mmf
821667|NCT00149968|EC-MPS|ec-mps
821668|NCT00149968|GI problems|gi problems
821669|NCT00149942|Enteric coated mycophenolate sodium|enteric coated mycophenolate sodium
821670|NCT00149942|transplantation|transplantation
821671|NCT00149942|gastrointestinal adverse events|gastrointestinal adverse events
821672|NCT00149942|Kidney and liver transplantation patients experiencing GI AEs with current MMF treatment|kidney and liver transplantation patients experiencing gi aes with current mmf treatment
821673|NCT00149929|Renal Transplant, adults, immunosuppressant|renal transplant, adults, immunosuppressant
821674|NCT00149916|Renal Transplant, adults, immunosuppressants|renal transplant, adults, immunosuppressants
821675|NCT00149890|pediatric|pediatric
821676|NCT00149890|liver transplantation|liver transplantation
821677|NCT00149890|Simulect|simulect
821678|NCT00149890|Basiliximab|basiliximab
821679|NCT00149890|ciclosporin microemulsion|ciclosporin microemulsion
821681|NCT00149890|pediatric liver transplantation|pediatric liver transplantation
821682|NCT00149877|Chronic constipation, tegaserod|chronic constipation, tegaserod
821683|NCT00149864|Renal Transplant, adults, immunosuppressant|renal transplant, adults, immunosuppressant
821684|NCT00149851|GERD, heartburn, regurgitation, reflux disease|gerd, heartburn, regurgitation, reflux disease
821685|NCT00149838|Electric Stimulation|electric stimulation
821686|NCT00149838|Magnetic Stimulation|magnetic stimulation
821687|NCT00149838|Prefrontal Cortex|prefrontal cortex
821688|NCT00149838|Brain|brain
821689|NCT00149825|Major Depressive Disorder|major depressive disorder
821690|NCT00149825|Insomnia|insomnia
821691|NCT00149825|Sleep|sleep
821692|NCT00149825|Mental Health|mental health
821693|NCT00149812|Depression|depression
821694|NCT00149812|Child disruptive behavior|child disruptive behavior
821695|NCT00149812|Family functioning|family functioning
821696|NCT00149799|Body Dysmorphic Disorder|body dysmorphic disorder
821697|NCT00149799|Escitalopram|escitalopram
821698|NCT00149799|Lexapro|lexapro
821699|NCT00149799|BDD|bdd
821700|NCT00149799|Body Image|body image
821701|NCT00149786|Anorexia Nervosa|anorexia nervosa
821702|NCT00149786|Adolescents|adolescents
821703|NCT00149786|Family therapy|family therapy
821704|NCT00149786|Individual therapy|individual therapy
821705|NCT00149773|Cognitive therapy|cognitive therapy
821706|NCT00149773|Suicide|suicide
821707|NCT00149773|Older men|older men
821708|NCT00149773|Death ideation|death ideation
821709|NCT00149773|Primary care|primary care
821710|NCT00149760|Cognitive Behavior Therapy|cognitive behavior therapy
821711|NCT00149760|Treatment Outcome|treatment outcome
821712|NCT00149760|Health Care Utilization|health care utilization
821713|NCT00149760|Somatization Disorder|somatization disorder
821714|NCT00149760|Somatoform Disorder|somatoform disorder
821716|NCT00149747|Exercise|exercise
821717|NCT00149747|Older Adults|older adults
821718|NCT00149734|Schizophrenia|schizophrenia
821719|NCT00149734|Ondansetron|ondansetron
821720|NCT00149734|P50 sensory gating|p50 sensory gating
821721|NCT00149734|Evoked potentials|evoked potentials
821722|NCT00149734|5-HT3 receptors|5-ht3 receptors
821723|NCT00149734|Atypical antipsychotics|atypical antipsychotics
821724|NCT00149721|hydrocephalus|hydrocephalus
821725|NCT00149721|pituitary function|pituitary function
821726|NCT00149721|shunting|shunting
821727|NCT00149708|Growth hormone|growth hormone
821728|NCT00149708|Deficiency|deficiency
821729|NCT00149708|Cardiovascular risk|cardiovascular risk
821730|NCT00149708|Body composition|body composition
821731|NCT00149695|Obesity, beverages, weight loss, body mass index, diet|obesity, beverages, weight loss, body mass index, diet
821732|NCT00149682|Obesity|obesity
821733|NCT00149669|Behavior Therapy|behavior therapy
821734|NCT00149669|Cocaine|cocaine
821735|NCT00149669|Cocaine (IV)|cocaine (iv)
821736|NCT00149669|Cocaine Abuse|cocaine abuse
821737|NCT00149669|Cocaine Dependence|cocaine dependence
821738|NCT00149669|Contingency management|contingency management
821739|NCT00149669|HIV risk behaviors|hiv risk behaviors
821740|NCT00149669|Heroin|heroin
821741|NCT00149669|Naltrexone|naltrexone
821742|NCT00149669|Opioid Dependence|opioid dependence
821743|NCT00149669|sexual risk behaviors|sexual risk behaviors
821744|NCT00149656|Treatment Naive|treatment naive
821745|NCT00149656|Multivitamins|multivitamins
821746|NCT00149656|Selenium|selenium
821747|NCT00149656|Supplementation|supplementation
821748|NCT00149656|HIV Disease Progression|hiv disease progression
821749|NCT00149643|Cannabis|cannabis
821750|NCT00149643|MDD|mdd
821751|NCT00149630|Opioid Dependence|opioid dependence
821752|NCT00149630|Substance Related Disorders|substance related disorders
821753|NCT00149617|Marijuana|marijuana
821754|NCT00149617|Mood Disorder|mood disorder
821755|NCT00149604|metabolic syndrome|metabolic syndrome
821756|NCT00149604|hormone therapy|hormone therapy
821757|NCT00149604|abdominal adiposity|abdominal adiposity
821758|NCT00149604|lipolysis|lipolysis
821759|NCT00149591|Myocardial infarction|myocardial infarction
821760|NCT00149591|Viability|viability
821761|NCT00149591|Coronary angioplasty|coronary angioplasty
821762|NCT00149591|Prevention|prevention
821763|NCT00149591|Prognosis|prognosis
821764|NCT00149578|pancreatic cancer|pancreatic cancer
821765|NCT00149578|gemcitabine|gemcitabine
821766|NCT00149578|oxaliplatin|oxaliplatin
821767|NCT00149578|5-Fluorouracil|5-fluorouracil
821768|NCT00149578|radiation|radiation
821769|NCT00149552|Treatment Naive|treatment naive
821770|NCT00149552|Treatment Experienced|treatment experienced
821771|NCT00149461|Asthma Action Plans|asthma action plans
821772|NCT00149461|African Americans|african americans
821773|NCT00149461|Latinos|latinos
821774|NCT00149461|Health Literacy|health literacy
821775|NCT00149461|Asthma Education|asthma education
821776|NCT00149422|NT-proBNP|nt-probnp
821777|NCT00149396|Colorectal cancer metastases to liver|colorectal cancer metastases to liver
821778|NCT00149396|Colorectal Cancer|colorectal cancer
821779|NCT00149396|Colorectal Carcinoma|colorectal carcinoma
821780|NCT00149396|Colorectal Tumors|colorectal tumors
821781|NCT00149396|Colorectal Neoplasms|colorectal neoplasms
821782|NCT00149396|Rectum Cancer|rectum cancer
821783|NCT00149396|Rectum tumors|rectum tumors
821784|NCT00149396|Rectum carcinoma|rectum carcinoma
821785|NCT00149396|Colon cancer|colon cancer
821786|NCT00149396|Colon tumors|colon tumors
821787|NCT00149396|Colon carcinoma|colon carcinoma
821788|NCT00149396|Rectum Neoplasms|rectum neoplasms
821789|NCT00149396|Colon Neoplasms|colon neoplasms
821790|NCT00149396|Liver Neoplasms|liver neoplasms
821791|NCT00149396|Hepatic Neoplasms|hepatic neoplasms
821792|NCT00149396|Liver Tumors|liver tumors
821793|NCT00149396|Liver cancer|liver cancer
821794|NCT00149396|Hepatic Cancer|hepatic cancer
821795|NCT00149396|Hepatic tumors|hepatic tumors
821796|NCT00149396|metastatic to the liver|metastatic to the liver
821797|NCT00149383|randomized controlled trial|randomized controlled trial
821798|NCT00149383|malaria|malaria
821799|NCT00149383|Plasmodium falciparum|plasmodium falciparum
821800|NCT00149383|thiazolidinediones|thiazolidinediones
821801|NCT00149383|rosiglitazone|rosiglitazone
821802|NCT00149383|atovaquone-proguanil|atovaquone-proguanil
821803|NCT00149370|breast hypertrophy|breast hypertrophy
821804|NCT00149370|breast reduction surgery|breast reduction surgery
821805|NCT00149370|health-related quality of life|health-related quality of life
821806|NCT00149370|Health Utilities Index|health utilities index
821807|NCT00149370|HUI|hui
821808|NCT00149370|prospective|prospective
821809|NCT00149370|SF-36|sf-36
821810|NCT00149370|quality-adjusted life years|quality-adjusted life years
821811|NCT00149370|QALY|qaly
821812|NCT00149357|venous thromboembolism|venous thromboembolism
821813|NCT00149357|VTE|vte
821814|NCT00149357|thrombophilia|thrombophilia
821815|NCT00149357|fetal loss|fetal loss
821816|NCT00149344|cost-utility analysis;|cost-utility analysis;
821817|NCT00149344|breast reduction;|breast reduction;
821818|NCT00149344|vertical scar mammoplasty;|vertical scar mammoplasty;
821819|NCT00149344|pedicle reduction mammoplasty|pedicle reduction mammoplasty
821820|NCT00149331|Diabetes, Insulin, Education|diabetes, insulin, education
821821|NCT00149305|Gouty diathesis|gouty diathesis
821822|NCT00149305|Acid uric nephrolithiasis|acid uric nephrolithiasis
821823|NCT00149279|stomach neoplasms|stomach neoplasms
821824|NCT00149279|lymph node excision|lymph node excision
821825|NCT00149279|abdominal aorta|abdominal aorta
821826|NCT00149266|stomach neoplasms|stomach neoplasms
821827|NCT00149266|lymph node resection|lymph node resection
821828|NCT00149266|cardia|cardia
821829|NCT00149266|thoracotomy|thoracotomy
821830|NCT00149253|Abdominal hysterectomy,|abdominal hysterectomy,
821831|NCT00149253|Etoricoxib,|etoricoxib,
821832|NCT00149253|morphine consumption,|morphine consumption,
821833|NCT00149253|pre-emptive analgesia|pre-emptive analgesia
821834|NCT00149240|DYSPORT|dysport
821835|NCT00149240|botulinum toxin A|botulinum toxin a
821836|NCT00149240|myofascial pain syndrome|myofascial pain syndrome
821837|NCT00149227|High risk hypertension|high risk hypertension
821838|NCT00149227|Ischemic heart disease|ischemic heart disease
821839|NCT00149227|Angiotensin receptor blockers|angiotensin receptor blockers
821840|NCT00149227|Cardiovascular mortality- morbidity|cardiovascular mortality- morbidity
821841|NCT00149227|KYOTO HEART Study|kyoto heart study
821842|NCT00149201|gastric cancer|gastric cancer
821843|NCT00149201|peritoneal metastasis|peritoneal metastasis
821844|NCT00149201|randomized trial|randomized trial
821845|NCT00149201|5-FU|5-fu
821847|NCT00149188|Growth Hormone|growth hormone
821848|NCT00149175|Alzheimer's disease|alzheimer's disease
821849|NCT00149175|Dementia|dementia
821850|NCT00149175|Phenotype-genotype correlations|phenotype-genotype correlations
821851|NCT00149175|Candidate genes|candidate genes
821852|NCT00149175|Related disorders|related disorders
821853|NCT00149162|Controlled|controlled
821854|NCT00149162|Multicenter|multicenter
821855|NCT00149162|International|international
821856|NCT00149162|Randomized study|randomized study
821857|NCT00149162|Direct individual benefit|direct individual benefit
821858|NCT00149162|complete remission after chemotherapy|complete remission after chemotherapy
821859|NCT00149162|non allogeneic transplanted|non allogeneic transplanted
821860|NCT00149149|Reduction in NSAID related gut damage|reduction in nsaid related gut damage
821861|NCT00149136|Acute Lymphocytic Leukemia,|acute lymphocytic leukemia,
821862|NCT00149136|Ph+,|ph+,
821863|NCT00149136|elderly patients,|elderly patients,
821864|NCT00149136|Imatinib|imatinib
821865|NCT00149123|Burn|burn
821866|NCT00149123|adrenal insufficiency|adrenal insufficiency
821867|NCT00149123|hydrocortisone|hydrocortisone
821868|NCT00149123|short corticotropin test|short corticotropin test
821869|NCT00149110|Sleep deprivation|sleep deprivation
821870|NCT00149110|Exercise|exercise
821871|NCT00149110|Light therapy|light therapy
821872|NCT00149110|Major depression|major depression
821873|NCT00149110|Bipolar depression|bipolar depression
821874|NCT00149110|Sleep-wake cycle|sleep-wake cycle
821875|NCT00149084|The tailored H. pylori eradication therapy|the tailored h. pylori eradication therapy
821876|NCT00149084|CYP2C19 genotype|cyp2c19 genotype
821877|NCT00149084|23S rRNA|23s rrna
821878|NCT00149084|clarithromycin|clarithromycin
821879|NCT00149084|Lansoprazole|lansoprazole
821880|NCT00149084|Amoxicillin|amoxicillin
821881|NCT00149084|H. pylori infection|h. pylori infection
821882|NCT00149071|Transcranial magnetic stimulation (TMS)|transcranial magnetic stimulation (tms)
821883|NCT00149071|Major depression|major depression
821884|NCT00149071|treatment resistant major depression|treatment resistant major depression
821885|NCT00149058|acute myocardial infarction|acute myocardial infarction
821886|NCT00149058|primary angioplasty|primary angioplasty
821887|NCT00149045|familial peripheral Neuropathy Anticipation|familial peripheral neuropathy anticipation
821888|NCT00149032|Metastatic solid tumor|metastatic solid tumor
821889|NCT00149006|Metastatic solid tumor|metastatic solid tumor
821890|NCT00149006|Mismatch allogeneic cell mediated immunotherapy|mismatch allogeneic cell mediated immunotherapy
821891|NCT00148993|Tumor cell vaccine|tumor cell vaccine
821892|NCT00148980|Myelodysplastic syndrome (MDS)|myelodysplastic syndrome (mds)
821893|NCT00148980|Allogeneic stem cell transplantation|allogeneic stem cell transplantation
821894|NCT00148980|Demineralized bone matrix (DBM)|demineralized bone matrix (dbm)
821895|NCT00148980|Bone marrow microenvironment|bone marrow microenvironment
821896|NCT00148967|right ventricular pacing|right ventricular pacing
821897|NCT00148967|implantable cardioverter defibrillator|implantable cardioverter defibrillator
821898|NCT00148915|Osteoporosis|osteoporosis
821899|NCT00148915|bisphosphonates|bisphosphonates
821900|NCT00148915|bone|bone
821901|NCT00148902|tumor|tumor
821902|NCT00148889|cervical dystonia|cervical dystonia
821903|NCT00148889|torticollis|torticollis
821904|NCT00148889|deep brain stimulation|deep brain stimulation
821905|NCT00148889|pallidal stimulation|pallidal stimulation
821906|NCT00148889|globus pallidus internus|globus pallidus internus
821907|NCT00148876|Progression after treatment with Trastuzumab|progression after treatment with trastuzumab
821908|NCT00148876|Metastatic Breast Cancer|metastatic breast cancer
821909|NCT00148876|Palliative Study|palliative study
821910|NCT00148863|Hepatitis C, Chronic|hepatitis c, chronic
821911|NCT00148863|Interferon Alfa-2a|interferon alfa-2a
821912|NCT00148863|Ribavirin|ribavirin
821913|NCT00148863|Interferon-gamma, Recombinant|interferon-gamma, recombinant
821914|NCT00148850|HIV-Associated Lipodystrophy Syndrome|hiv-associated lipodystrophy syndrome
821915|NCT00148850|pioglitazone|pioglitazone
821916|NCT00148850|HIV infections|hiv infections
821917|NCT00148850|Treatment Experienced|treatment experienced
821918|NCT00148837|Hepatitis C, Chronic|hepatitis c, chronic
821919|NCT00148837|Fibrosis|fibrosis
821920|NCT00148837|Interferon Alfa-2b|interferon alfa-2b
821921|NCT00148837|Ribavirin|ribavirin
821922|NCT00148837|Prazosin|prazosin
821923|NCT00148824|HIV infections|hiv infections
821924|NCT00148824|Pneumococcal vaccines|pneumococcal vaccines
821925|NCT00148824|Treatment Experienced|treatment experienced
821926|NCT00148824|Treatment Naive|treatment naive
821927|NCT00148798|Cetuximab|cetuximab
821928|NCT00148798|Non small cell lung cancer|non small cell lung cancer
821929|NCT00148798|Lung cancer|lung cancer
821930|NCT00148798|Cisplatin/vinorelbine|cisplatin/vinorelbine
821931|NCT00148798|Monoclonal antibody|monoclonal antibody
821932|NCT00148798|Erbitux|erbitux
821933|NCT00148785|Antiretroviral drugs|antiretroviral drugs
821934|NCT00148785|Pharmacokinetic|pharmacokinetic
821935|NCT00148785|Indinavir|indinavir
821936|NCT00148785|Ritonavir|ritonavir
821937|NCT00148785|Fosamprenavir|fosamprenavir
821938|NCT00148772|Prostate Cancer|prostate cancer
821939|NCT00148772|Rising PSA|rising psa
821940|NCT00148772|Erlotinib|erlotinib
821941|NCT00148772|Tarceva|tarceva
821942|NCT00148772|Androgen Deprivation Therapy|androgen deprivation therapy
821943|NCT00148772|Hormone Therapy|hormone therapy
821944|NCT00148772|Rising Prostate Specific Antigen (PSA)|rising prostate specific antigen (psa)
821945|NCT00148772|Non-Metastatic Prostate Cancer|non-metastatic prostate cancer
821946|NCT00148759|Sex differences|sex differences
821947|NCT00148759|Pharmacokinetic|pharmacokinetic
821948|NCT00148759|Lopinavir/ritonavir|lopinavir/ritonavir
821949|NCT00148759|Treatment Experienced|treatment experienced
821950|NCT00148759|HIV-infection|hiv-infection
821951|NCT00148746|atopic dermatitis, atopy|atopic dermatitis, atopy
821952|NCT00148733|Child|child
821953|NCT00148733|pneumonia|pneumonia
821954|NCT00148733|Zinc|zinc
821955|NCT00148733|clinical trial|clinical trial
821956|NCT00148733|Nepal|nepal
821957|NCT00148733|nutrition|nutrition
821958|NCT00148733|therapeutic|therapeutic
821959|NCT00148720|Invasive Breast Cancer|invasive breast cancer
821960|NCT00148720|Operable Breast Cancer|operable breast cancer
821961|NCT00148720|Capecitabine|capecitabine
821962|NCT00148707|Metastatic Breast Cancer|metastatic breast cancer
821963|NCT00148707|HER2-negative Breast Cancer|her2-negative breast cancer
821964|NCT00148707|CT-2103|ct-2103
821965|NCT00148707|Xyotax|xyotax
821966|NCT00148694|Cisplatin|cisplatin
821967|NCT00148694|Early Stage Breast Cancer|early stage breast cancer
821968|NCT00148694|ER Negative Breast Cancer|er negative breast cancer
821969|NCT00148694|PR Negative Breast Cancer|pr negative breast cancer
821970|NCT00148694|HER-2 Negative Breast Cancer|her-2 negative breast cancer
821971|NCT00148681|HER-2 Positive breast cancer|her-2 positive breast cancer
821972|NCT00148681|herceptin|herceptin
821974|NCT00148668|HER-2 Positive Breast Cancer|her-2 positive breast cancer
821975|NCT00148668|herceptin|herceptin
821976|NCT00148668|navelbine|navelbine
821977|NCT00148668|taxotere|taxotere
821978|NCT00148668|carboplatin|carboplatin
821979|NCT00148668|Early stage Breast Cancer|early stage breast cancer
821980|NCT00148655|educational intervention|educational intervention
821981|NCT00148655|decision board|decision board
821982|NCT00148655|DCIS|dcis
821983|NCT00148642|ventilator-associated pneumonia|ventilator-associated pneumonia
821984|NCT00148642|nosocomial pneumonia|nosocomial pneumonia
821985|NCT00148629|Anemia|anemia
821986|NCT00148629|Birth weight|birth weight
821987|NCT00148629|Neonatal Mortality|neonatal mortality
821988|NCT00148629|Tanzania|tanzania
821989|NCT00148629|Pregnancy|pregnancy
821990|NCT00148616|Memantine|memantine
821991|NCT00148616|Negative Syndrome|negative syndrome
821992|NCT00148616|Schizophrenia|schizophrenia
821993|NCT00148616|Cognitive impairment|cognitive impairment
821994|NCT00148603|dyspepsia|dyspepsia
821995|NCT00148603|eosinophilic gastroenteritis|eosinophilic gastroenteritis
821996|NCT00148603|montelukast|montelukast
821997|NCT00148590|Memantine|memantine
821998|NCT00148590|Negative syndrome|negative syndrome
821999|NCT00148590|Schizophrenia|schizophrenia
822000|NCT00148590|Cognitive impairment|cognitive impairment
822001|NCT00148590|Glutamate|glutamate
822002|NCT00148577|Pain Relief, TENS, Acupuncture Points|pain relief, tens, acupuncture points
822003|NCT00148564|weight gain|weight gain
822004|NCT00148564|schizophrenia|schizophrenia
822005|NCT00148564|atypical antipsychotics|atypical antipsychotics
822007|NCT00148551|Triamcinolone|triamcinolone
822008|NCT00148551|Macular Degeneration|macular degeneration
822009|NCT00148538|Type 1 Diabetes|type 1 diabetes
822010|NCT00148538|Resistance Exercise|resistance exercise
822011|NCT00148538|Aerobic Exercise|aerobic exercise
822012|NCT00148538|Exercise & Disease|exercise & disease
822013|NCT00148538|Exercise|exercise
822014|NCT00148538|Diabetes|diabetes
822015|NCT00148525|automated telephony, cancer prevention, healthy diet|automated telephony, cancer prevention, healthy diet
822016|NCT00148473|Cervical ripening.|cervical ripening.
822017|NCT00148473|Induction of labor.|induction of labor.
822018|NCT00148473|Misoprostol.|misoprostol.
822019|NCT00148447|negative symptoms|negative symptoms
822020|NCT00148447|depression|depression
822021|NCT00148447|ssri|ssri
822022|NCT00148447|schizophrenia|schizophrenia
822023|NCT00148434|hypertension|hypertension
822024|NCT00148434|guidelines|guidelines
822025|NCT00148434|patient empowerment|patient empowerment
822026|NCT00148434|anxiety|anxiety
822027|NCT00148421|Non-myeloid malignancy|non-myeloid malignancy
822028|NCT00148421|Chemotherapy-induced anemia|chemotherapy-induced anemia
822029|NCT00148408|Asthma|asthma
822030|NCT00148408|Placebo|placebo
822031|NCT00148408|Education|education
822032|NCT00148382|Obesity|obesity
822033|NCT00148382|Pharmacokinetics|pharmacokinetics
822034|NCT00148382|Pharmacodynamics|pharmacodynamics
822035|NCT00148356|drug eluting stents|drug eluting stents
822036|NCT00148356|stents|stents
822037|NCT00148356|angioplasty|angioplasty
822038|NCT00148356|coronary artery disease|coronary artery disease
822039|NCT00148356|total coronary occlusion|total coronary occlusion
822040|NCT00148356|coronary artery restenosis|coronary artery restenosis
822041|NCT00148356|stent thrombosis|stent thrombosis
822042|NCT00148356|vascular disease|vascular disease
822043|NCT00148356|myocardial ischemia|myocardial ischemia
822044|NCT00148356|coronary artery stenosis|coronary artery stenosis
822045|NCT00148343|hemiplegia|hemiplegia
822046|NCT00148343|hemiparesis|hemiparesis
822047|NCT00148343|stroke|stroke
822048|NCT00148343|foot-drop|foot-drop
822049|NCT00148343|electrical stimulation|electrical stimulation
822050|NCT00148343|ankle-foot-orthosis|ankle-foot-orthosis
822051|NCT00148330|Diabetic macular oedema|diabetic macular oedema
822052|NCT00148330|Triamcinolone acetate|triamcinolone acetate
822053|NCT00148330|Intravitreal injection|intravitreal injection
822054|NCT00148330|Clinical trial|clinical trial
822055|NCT00148330|Laser treatment|laser treatment
822056|NCT00148304|Decision-making|decision-making
822057|NCT00148304|Insulin|insulin
822058|NCT00148304|Preference|preference
822059|NCT00148304|Treatment Variation|treatment variation
822060|NCT00148304|Provider|provider
822061|NCT00148304|Patient|patient
822062|NCT00148278|Catecholamines|catecholamines
822063|NCT00148278|Septic shock|septic shock
822064|NCT00148265|Diabetic macular oedema|diabetic macular oedema
822065|NCT00148265|Triamcinolone acetate|triamcinolone acetate
822066|NCT00148265|Intravitreal injection|intravitreal injection
822067|NCT00148265|Clinical trial|clinical trial
822068|NCT00148265|Laser treatment|laser treatment
822069|NCT00148252|Calcineurin|calcineurin
822070|NCT00148252|reduction|reduction
822071|NCT00148252|immunosuppression|immunosuppression
822072|NCT00148252|cyclosporine A|cyclosporine a
822073|NCT00148252|mycophenolate mofetil|mycophenolate mofetil
822074|NCT00148239|SCI|sci
822075|NCT00148239|Caregiving|caregiving
822076|NCT00148239|Aging|aging
822077|NCT00148239|Disability|disability
822079|NCT00148226|Decision Aid|decision aid
822080|NCT00148226|Faecal Occult Blood Test|faecal occult blood test
822081|NCT00148226|Colorectal Cancer Screening|colorectal cancer screening
822082|NCT00148226|Informed Decision-making|informed decision-making
822083|NCT00148213|differentiated thyroid carcinoma|differentiated thyroid carcinoma
822084|NCT00148213|thyroglobulin|thyroglobulin
822085|NCT00148213|immunoassay|immunoassay
822086|NCT00148213|thyroidectomy|thyroidectomy
822087|NCT00148213|radioiodine therapy|radioiodine therapy
822088|NCT00148200|female sexual dysfunction|female sexual dysfunction
822089|NCT00148200|desire|desire
822090|NCT00148200|arousal|arousal
822091|NCT00148200|lubrification|lubrification
822092|NCT00148200|orgasm|orgasm
822093|NCT00148200|satisfaction|satisfaction
822094|NCT00148200|pain|pain
822095|NCT00148187|Medication adherence|medication adherence
822096|NCT00148187|Patient compliance|patient compliance
822097|NCT00148187|Kidney transplant|kidney transplant
822098|NCT00148187|Organ rejection|organ rejection
822099|NCT00148187|Allograft loss|allograft loss
822100|NCT00148187|Drug monitoring|drug monitoring
822101|NCT00148174|Medication adherence|medication adherence
822102|NCT00148174|Patient compliance|patient compliance
822103|NCT00148174|Kidney transplant|kidney transplant
822104|NCT00148174|Organ rejection|organ rejection
822105|NCT00148174|Allograft loss|allograft loss
822106|NCT00148174|Drug monitoring|drug monitoring
822107|NCT00148161|Magnetoencephalography|magnetoencephalography
822108|NCT00148161|Auditory cortex|auditory cortex
822109|NCT00148161|Stuttering|stuttering
822110|NCT00148161|Non stuttering|non stuttering
822111|NCT00148148|Hematopoietic Stem Cell Transplantation|hematopoietic stem cell transplantation
822112|NCT00148148|Caspofungin|caspofungin
822113|NCT00148148|Liposomal Amphotericin B|liposomal amphotericin b
822114|NCT00148135|Carcinoma of Unknown Primary Site (CUP)|carcinoma of unknown primary site (cup)
822115|NCT00148122|Squamous cell cancer of the oral cavity and pharynx|squamous cell cancer of the oral cavity and pharynx
822116|NCT00148109|Unresectable/metastatic high grade soft tissue bony sarcoma|unresectable/metastatic high grade soft tissue bony sarcoma
822117|NCT00148096|asthma|asthma
822118|NCT00148096|house dust mite|house dust mite
822119|NCT00148096|allergy|allergy
822120|NCT00148096|housing|housing
822121|NCT00148096|avoidance|avoidance
822122|NCT00148096|humidity|humidity
822123|NCT00148083|Schizophrenia|schizophrenia
822124|NCT00148083|Cognition|cognition
822125|NCT00148083|Clinical Trial|clinical trial
822126|NCT00148057|Diet|diet
822127|NCT00148057|Dietary fat|dietary fat
822128|NCT00148057|Breast cancer|breast cancer
822129|NCT00148057|Prevention|prevention
822130|NCT00148031|behavior modification|behavior modification
822131|NCT00148031|health care service utilization|health care service utilization
822132|NCT00148031|hepatitis C,|hepatitis c,
822133|NCT00148031|injection drug use|injection drug use
822134|NCT00148031|therapy compliance|therapy compliance
822135|NCT00148031|alcoholism|alcoholism
822136|NCT00148031|alcohol abuse|alcohol abuse
822137|NCT00148031|prevention|prevention
822138|NCT00148031|drug abuse|drug abuse
822139|NCT00148031|liver disorder|liver disorder
822140|NCT00148031|HCV|hcv
822141|NCT00148031|methadone|methadone
822142|NCT00148018|Hodgkin disease|hodgkin disease
822143|NCT00148018|Bortezomib|bortezomib
822144|NCT00148018|Relapse|relapse
822145|NCT00148018|Lymphoma|lymphoma
822146|NCT00147966|active disease despite concomitant methotrexate|active disease despite concomitant methotrexate
822147|NCT00147953|NHL|nhl
822148|NCT00147953|Lymphoma|lymphoma
822149|NCT00147953|Radiotherapy|radiotherapy
822150|NCT00147953|Rituximab|rituximab
822151|NCT00147953|Palliative treatment|palliative treatment
822152|NCT00147940|Allergy|allergy
822153|NCT00147927|email|email
822154|NCT00147927|internet|internet
822155|NCT00147927|health promotion|health promotion
822156|NCT00147927|behavior change|behavior change
822157|NCT00147927|health status|health status
822158|NCT00147927|work productivity|work productivity
822159|NCT00147927|healthcare cost|healthcare cost
822160|NCT00147927|employee|employee
822161|NCT00147914|Acute bacterial sinusitis|acute bacterial sinusitis
822162|NCT00147901|CLL|cll
822163|NCT00147901|Immunochemotherapy|immunochemotherapy
822164|NCT00147888|Mucosal congestion|mucosal congestion
822165|NCT00147888|Acoustic rhinometry|acoustic rhinometry
822166|NCT00147888|Physiology|physiology
822167|NCT00147875|Lymphoma|lymphoma
822168|NCT00147875|Gemcitabine|gemcitabine
822169|NCT00147875|Advanced stages Hodgkin's lymphoma|advanced stages hodgkin's lymphoma
822170|NCT00147875|Elderly|elderly
822171|NCT00147862|Tranexamic Acid|tranexamic acid
822172|NCT00147862|Antifibrinolytic Agents|antifibrinolytic agents
822173|NCT00147862|Head and Neck Neoplasms|head and neck neoplasms
822174|NCT00147862|Thromboelastography|thromboelastography
822175|NCT00147849|knowledge translation|knowledge translation
822176|NCT00147849|health care utilization|health care utilization
822177|NCT00147849|economic analysis|economic analysis
822178|NCT00147836|type 2 diabetes mellitus|type 2 diabetes mellitus
822179|NCT00147836|therapy|therapy
822180|NCT00147836|sulfonylureas|sulfonylureas
822183|NCT00147823|Bone formation|bone formation
822184|NCT00147823|Bone lesions|bone lesions
822185|NCT00147823|Benign bone lesion|benign bone lesion
822186|NCT00147810|telephone outreach|telephone outreach
822187|NCT00147810|asthma care|asthma care
822188|NCT00147797|Atherosclerosis|atherosclerosis
822189|NCT00147797|intima media thickness|intima media thickness
822190|NCT00147797|aortic stiffness|aortic stiffness
822191|NCT00147797|HIV infection|hiv infection
822192|NCT00147797|Dyslipidemia|dyslipidemia
822193|NCT00147797|Treatment Experienced|treatment experienced
822194|NCT00147784|Chronical Hepatitis C treatment|chronical hepatitis c treatment
822195|NCT00147784|Methadone Maintenance Treatment|methadone maintenance treatment
822196|NCT00147784|Pegylated Interferon and Ribavirin|pegylated interferon and ribavirin
822197|NCT00147784|14 weeks treatment|14 weeks treatment
822198|NCT00147784|Genotype 2 and 3|genotype 2 and 3
822199|NCT00147771|localized scleroderma|localized scleroderma
822201|NCT00147771|imiquimod|imiquimod
822202|NCT00147771|pediatrics|pediatrics
822203|NCT00147758|Diabetes Mellitus|diabetes mellitus
822204|NCT00147745|Mechanism of action insulin sensitivity|mechanism of action insulin sensitivity
822205|NCT00147732|larynx carcinoma|larynx carcinoma
822206|NCT00147732|radiotherapy|radiotherapy
822207|NCT00147732|carbogen|carbogen
822208|NCT00147732|nicotinamide|nicotinamide
822209|NCT00147719|Diabetes Mellitus|diabetes mellitus
822210|NCT00147706|Electronic Health Record|electronic health record
822418|NCT00146731|Africa|africa
822211|NCT00147706|Patient Portal|patient portal
822212|NCT00147706|Chronic Diseases|chronic diseases
822213|NCT00147693|Dementia|dementia
822214|NCT00147693|Alzheimer Disease|alzheimer disease
822215|NCT00147693|Lewy-Body|lewy-body
822216|NCT00147693|Cost*|cost*
822217|NCT00147693|Community (dwelling)|community (dwelling)
822218|NCT00147693|Caregiver(s)|caregiver(s)
822219|NCT00147693|Institutionalization|institutionalization
822220|NCT00147693|Quality of life|quality of life
822221|NCT00147693|Randomized Control Trail|randomized control trail
822222|NCT00147693|Vascular dementia|vascular dementia
822223|NCT00147680|Uterine Papillary Serous Carcinoma (UPSC)|uterine papillary serous carcinoma (upsc)
822224|NCT00147667|COPD|copd
822225|NCT00147667|EXACERBATIONS|exacerbations
822226|NCT00147667|AIRWAY INFLAMMATION|airway inflammation
822227|NCT00147537|non-small cell lung cancer|non-small cell lung cancer
822228|NCT00147537|chemotherapy|chemotherapy
822229|NCT00147537|figitumumab|figitumumab
822230|NCT00147537|insulin-like growth 1 factor receptor|insulin-like growth 1 factor receptor
822231|NCT00147537|IGF-IR|igf-ir
822232|NCT00147537|monoclonal antibody|monoclonal antibody
822233|NCT00147498|oral JAK inhibitor|oral jak inhibitor
822234|NCT00147498|clinical trial|clinical trial
822235|NCT00147498|joint diseases|joint diseases
822236|NCT00147498|anti-Inflammatory agents|anti-inflammatory agents
822237|NCT00147498|rheumatic diseases|rheumatic diseases
822238|NCT00147498|DMARD|dmard
822239|NCT00147498|Antirheumatic Agents|antirheumatic agents
822240|NCT00147498|Autoimmune Diseases|autoimmune diseases
822241|NCT00147498|Immune System Diseases|immune system diseases
822242|NCT00147472|Head and neck|head and neck
822243|NCT00147472|Cancer|cancer
822244|NCT00147472|Diagnosis|diagnosis
822245|NCT00147472|Fluorodeoxyglucose|fluorodeoxyglucose
822246|NCT00147472|Positron-Emission Tomography|positron-emission tomography
822247|NCT00147472|PET|pet
822248|NCT00147472|Oncology|oncology
822249|NCT00147459|hepatitis B virus|hepatitis b virus
822250|NCT00147459|vaccine|vaccine
822251|NCT00147459|booster|booster
822252|NCT00147459|liver transplantation|liver transplantation
822253|NCT00147446|Stress|stress
822254|NCT00147446|Stress Management|stress management
822255|NCT00147446|Behavioral Medicine|behavioral medicine
822256|NCT00147446|Multiple Sclerosis|multiple sclerosis
822257|NCT00147446|Psychoneuroimmunology|psychoneuroimmunology
822258|NCT00147433|free thyroxine|free thyroxine
822259|NCT00147433|pregnancy|pregnancy
822260|NCT00147433|fetal brain development|fetal brain development
822261|NCT00147433|thyroid stimulating hormone|thyroid stimulating hormone
822262|NCT00147433|IQ|iq
822263|NCT00147420|Tibet|tibet
822264|NCT00147420|Third Stage Labor|third stage labor
822265|NCT00147420|Post Partum Hemorrhage|post partum hemorrhage
822266|NCT00147420|Misoprostol|misoprostol
822267|NCT00147420|Zhi Byed 11|zhi byed 11
822268|NCT00147420|Global Network|global network
822269|NCT00147394|Risperidone|risperidone
822270|NCT00147394|Autism|autism
822271|NCT00147394|PDD|pdd
822272|NCT00147394|Pervasive Developmental Disorder|pervasive developmental disorder
822273|NCT00147381|Campath-1H|campath-1h
822274|NCT00147381|Alemtuzumab|alemtuzumab
822275|NCT00147381|Tacrolimus|tacrolimus
822276|NCT00147381|renal transplantation|renal transplantation
822277|NCT00147381|immunosuppression|immunosuppression
822278|NCT00147381|prevention of acute rejection|prevention of acute rejection
822279|NCT00147368|falciparum|falciparum
822280|NCT00147368|malaria|malaria
822281|NCT00147368|arginine|arginine
822282|NCT00147355|rIL-2-toxicity|ril-2-toxicity
822283|NCT00147355|interleukin-2 therapy|interleukin-2 therapy
822285|NCT00147355|Toxicity substudy of ESPRIT|toxicity substudy of esprit
822286|NCT00147342|exercise|exercise
822287|NCT00147342|hypoglycemia|hypoglycemia
822288|NCT00147342|Diabetes Mellitus, Type I|diabetes mellitus, type i
822289|NCT00147342|glucose monitoring|glucose monitoring
822290|NCT00147316|acute stroke|acute stroke
822291|NCT00147316|thrombolytic therapy|thrombolytic therapy
822292|NCT00147316|tissue plasminogen activator|tissue plasminogen activator
822293|NCT00147290|ATP|atp
822294|NCT00147290|Tachycardia|tachycardia
822295|NCT00147290|CRT-D|crt-d
822296|NCT00147277|ATP|atp
822297|NCT00147277|Thachy|thachy
822298|NCT00147277|FVT|fvt
822299|NCT00147264|insulin resistance, myocellular lipids, adipose tissue|insulin resistance, myocellular lipids, adipose tissue
822300|NCT00147251|lowering LDL and BP below current targets|lowering ldl and bp below current targets
822301|NCT00147251|LDL cholesterol treatment|ldl cholesterol treatment
822302|NCT00147251|blood pressure treatment|blood pressure treatment
822303|NCT00147251|carotid intimal medial thickness|carotid intimal medial thickness
822304|NCT00147251|prevent progression of CVD|prevent progression of cvd
822305|NCT00147238|Bladder Cancer|bladder cancer
822306|NCT00147238|Genitourinary Cancer|genitourinary cancer
822307|NCT00147238|Prostate Cancer|prostate cancer
822308|NCT00147238|MR Lymphangiography|mr lymphangiography
822309|NCT00147238|Ferumoxtran-10|ferumoxtran-10
822310|NCT00147238|SPIO|spio
822419|NCT00146731|Tanzania|tanzania
822420|NCT00146718|malaria|malaria
822311|NCT00147238|Ultra-small superparamagnetic agent iron oxide|ultra-small superparamagnetic agent iron oxide
822312|NCT00147225|Advanced Cancer|advanced cancer
822313|NCT00147225|Advanced Malignancy|advanced malignancy
822314|NCT00147225|Solid Tumors|solid tumors
822315|NCT00147225|Thrombocytopenia|thrombocytopenia
822316|NCT00147225|AMG 531|amg 531
822317|NCT00147225|Romiplostim|romiplostim
822318|NCT00147225|Carboplatin|carboplatin
822319|NCT00147225|Paraplatin|paraplatin
822320|NCT00147225|Platelets|platelets
822321|NCT00147225|Adriamycin|adriamycin
822322|NCT00147225|Doxorubicin|doxorubicin
822323|NCT00147225|Rubex|rubex
822324|NCT00147225|Ifosfamide|ifosfamide
822325|NCT00147225|Ifex|ifex
822326|NCT00147212|Advanced Prostate Cancer|advanced prostate cancer
822327|NCT00147212|Prostate Cancer|prostate cancer
822328|NCT00147212|Trabectedin|trabectedin
822329|NCT00147212|ET 743|et 743
822330|NCT00147212|Yondelis|yondelis
822331|NCT00147199|Pulmonary Arterial Hypertension|pulmonary arterial hypertension
822332|NCT00147147|gastric neoplasm|gastric neoplasm
822333|NCT00147147|gastrectomy|gastrectomy
822334|NCT00147147|adjuvant chemotherapy|adjuvant chemotherapy
822335|NCT00147147|randomized trial|randomized trial
822336|NCT00147147|T3 and T4 carcinoma of the stomach/Gastric Neoplasm|t3 and t4 carcinoma of the stomach/gastric neoplasm
822337|NCT00147134|colorectal cancer|colorectal cancer
822338|NCT00147134|laparoscopic surgery|laparoscopic surgery
822339|NCT00147134|randomized controlled trial|randomized controlled trial
822340|NCT00147134|oncological outcome|oncological outcome
822341|NCT00147121|Rituximab|rituximab
822342|NCT00147121|CHOP|chop
822343|NCT00147121|Bi-weekly|bi-weekly
822344|NCT00147121|low-grade B-cell lymphoma|low-grade b-cell lymphoma
822345|NCT00147121|advanced stage|advanced stage
822346|NCT00147121|follicular lymphoma|follicular lymphoma
822347|NCT00147121|G-CSF|g-csf
822348|NCT00147121|Untreated stage III/IV low-grade B-cell lymphoma|untreated stage iii/iv low-grade b-cell lymphoma
822349|NCT00147108|Breast Cancer|breast cancer
822350|NCT00147095|macrophages|macrophages
822351|NCT00147095|neutrophils|neutrophils
822352|NCT00147095|lymphocytes|lymphocytes
822353|NCT00147082|chemokine|chemokine
822354|NCT00147082|chemokine receptor|chemokine receptor
822355|NCT00147082|neutrophil|neutrophil
822356|NCT00147082|lymphocyte|lymphocyte
822357|NCT00147082|monocyte|monocyte
822358|NCT00147069|sputum|sputum
822359|NCT00147069|macrophage|macrophage
822360|NCT00147069|neutrophil|neutrophil
822361|NCT00147056|Brain tumor|brain tumor
822362|NCT00147056|Brain Lesions|brain lesions
822363|NCT00147056|Brain Cancer|brain cancer
822364|NCT00147056|ExAblate|exablate
822365|NCT00147043|Adult stem cells|adult stem cells
822366|NCT00147043|Liver disease|liver disease
822367|NCT00147043|CD34 positive cells|cd34 positive cells
822368|NCT00147030|Hypoxia|hypoxia
822369|NCT00147030|Ischaemia|ischaemia
822370|NCT00147030|Encephalopathy|encephalopathy
822371|NCT00147030|Neonatal|neonatal
822372|NCT00147030|Hypothermia|hypothermia
822373|NCT00147030|Perinatal|perinatal
822374|NCT00147030|Cooling|cooling
822375|NCT00147030|Whole/Total Body|whole/total body
822376|NCT00147017|macrophage|macrophage
822377|NCT00147017|inflammation|inflammation
822378|NCT00147017|COPD|copd
822379|NCT00147004|Septic shock|septic shock
822380|NCT00147004|Steroids|steroids
822381|NCT00147004|Hydrocortisone|hydrocortisone
822382|NCT00147004|Mortality|mortality
822383|NCT00147004|Reversal of shock|reversal of shock
822384|NCT00147004|Adrenal insufficiency|adrenal insufficiency
822385|NCT00146952|Hemineglects|hemineglects
822386|NCT00146926|Propofol|propofol
822388|NCT00146926|general anesthesia|general anesthesia
822389|NCT00146926|prevention|prevention
822390|NCT00146913|Chronic myeloid leukaemia|chronic myeloid leukaemia
822391|NCT00146913|resistant|resistant
822392|NCT00146913|refractory|refractory
822393|NCT00146913|Imatinib mesylate|imatinib mesylate
822394|NCT00146900|Traumatic Events|traumatic events
822395|NCT00146900|Post-traumatic Stress Disorder|post-traumatic stress disorder
822396|NCT00146900|Treatment (psychological)|treatment (psychological)
822397|NCT00146900|Treatment (pharmacological)|treatment (pharmacological)
822398|NCT00146900|Prevention|prevention
822399|NCT00146900|SSRIs|ssris
822400|NCT00146887|Coronary CT|coronary ct
822401|NCT00146887|sensitivity|sensitivity
822402|NCT00146887|specificity|specificity
822403|NCT00146809|Multi-System-Atrophy|multi-system-atrophy
822404|NCT00146809|Minocycline|minocycline
822405|NCT00146796|Malaria|malaria
822406|NCT00146796|Diagnosis|diagnosis
822408|NCT00146796|Africa|africa
822409|NCT00146796|Tanzania|tanzania
822410|NCT00146783|intermittent preventive treatment|intermittent preventive treatment
822411|NCT00146783|malaria|malaria
822412|NCT00146783|pregnancy|pregnancy
822413|NCT00146783|efficacy|efficacy
822414|NCT00146783|safety|safety
822415|NCT00146731|malaria|malaria
822416|NCT00146731|pregnancy|pregnancy
822417|NCT00146731|treatment|treatment
822421|NCT00146718|drug resistance|drug resistance
822422|NCT00146718|antimalarials|antimalarials
822423|NCT00146705|chronic HBV|chronic hbv
822424|NCT00146705|Peginterferon|peginterferon
822425|NCT00146705|long term follow-up|long term follow-up
822426|NCT00146692|Malaria|malaria
822427|NCT00146692|Cost|cost
822428|NCT00146692|Treatment|treatment
822429|NCT00146692|Diagnosis|diagnosis
822430|NCT00146692|Africa|africa
822431|NCT00146692|Ghana|ghana
822432|NCT00146679|Heart failure|heart failure
822433|NCT00146679|Ventricular arrhythmias|ventricular arrhythmias
822434|NCT00146679|ICD|icd
822435|NCT00146679|Psychoeducational intervention|psychoeducational intervention
822436|NCT00146666|Peak walking time|peak walking time
822437|NCT00146666|Absolute claudication distance|absolute claudication distance
822438|NCT00146666|Claudication onset time|claudication onset time
822439|NCT00146666|Initial claudication distance|initial claudication distance
822440|NCT00146666|Intermittent compression|intermittent compression
822441|NCT00146653|pediatrics|pediatrics
822442|NCT00146653|cardiopulmonary bypass|cardiopulmonary bypass
822443|NCT00146653|surgery|surgery
822444|NCT00146640|active disease|active disease
822445|NCT00146640|morning stiffness of joints|morning stiffness of joints
822446|NCT00146640|nighttime application of prednisone|nighttime application of prednisone
822447|NCT00146640|modified release prednisone|modified release prednisone
822448|NCT00146627|Human African Trypanosomiasis|human african trypanosomiasis
822449|NCT00146627|Combination|combination
822450|NCT00146627|Trypanosoma brucei gambiense Human African Trypanosomiasis|trypanosoma brucei gambiense human african trypanosomiasis
822451|NCT00146614|Graft versus Host Disease|graft versus host disease
822452|NCT00146614|GVHD|gvhd
822453|NCT00146614|Stem Cell Transplantation|stem cell transplantation
822454|NCT00146614|Tacrolimus|tacrolimus
822455|NCT00146614|Sirolimus|sirolimus
822456|NCT00146614|Methotrexate|methotrexate
822457|NCT00146614|allogeneic stem cell transplantation|allogeneic stem cell transplantation
822458|NCT00146601|Fulvestrant|fulvestrant
822459|NCT00146601|Advanced breast cancer|advanced breast cancer
822460|NCT00146601|Invasive breast cancer|invasive breast cancer
822461|NCT00146601|Stage IV Breast Cancer|stage iv breast cancer
822462|NCT00146601|Hormone Receptor-Positive Breast Cancer|hormone receptor-positive breast cancer
822463|NCT00146588|Breast cancer|breast cancer
822464|NCT00146588|cytoxan|cytoxan
822465|NCT00146588|epirubicin|epirubicin
822466|NCT00146588|capecitabine|capecitabine
822467|NCT00146562|adjuvant chemotherapy|adjuvant chemotherapy
822468|NCT00146562|G-CSF|g-csf
822469|NCT00146562|pegfilgrastim|pegfilgrastim
822470|NCT00146562|darbepoetin alfa|darbepoetin alfa
822471|NCT00146549|HER2-positive Breast cancer|her2-positive breast cancer
822472|NCT00146549|HER2 overexpressing|her2 overexpressing
822473|NCT00146549|trastuzumab|trastuzumab
822474|NCT00146549|Herceptin|herceptin
822475|NCT00146549|vinorelbine|vinorelbine
822476|NCT00146549|Navelbine|navelbine
822477|NCT00146549|Taxotere|taxotere
822478|NCT00146549|taxol|taxol
822480|NCT00146536|LCIS|lcis
822481|NCT00146536|DCIS|dcis
822482|NCT00146536|adjacent ipsilateral infiltrating carcinoma|adjacent ipsilateral infiltrating carcinoma
822483|NCT00146536|core needle biopsy|core needle biopsy
822484|NCT00146536|Lobular neoplasia of the breast|lobular neoplasia of the breast
822485|NCT00146523|Psychotic Major Depression|psychotic major depression
822486|NCT00146523|PMD|pmd
822487|NCT00146523|Depression|depression
822488|NCT00146523|Major Depression|major depression
822489|NCT00146523|Psychosis|psychosis
822490|NCT00146510|weight control|weight control
822491|NCT00146510|compliance|compliance
822492|NCT00146510|physical activity|physical activity
822493|NCT00146510|nutrition|nutrition
822494|NCT00146510|Health Behavior|health behavior
822495|NCT00146510|Patient Compliance|patient compliance
822496|NCT00146497|Respiratory distress syndrome (RDS)|respiratory distress syndrome (rds)
822497|NCT00146497|Premature infants|premature infants
822498|NCT00146497|Chronic lung disease (CLD)|chronic lung disease (cld)
822499|NCT00146497|Bronchoalveolar lavage fluid (BALF)|bronchoalveolar lavage fluid (balf)
822500|NCT00146497|Cytokines|cytokines
822501|NCT00146484|Diabetes Mellitus, Type 1|diabetes mellitus, type 1
822502|NCT00146484|Child|child
822503|NCT00146484|Adolescent|adolescent
822504|NCT00146484|Disease Management|disease management
822505|NCT00146484|Newly Diagnosed|newly diagnosed
822506|NCT00146484|Hemoglobin A, Glycosylated|hemoglobin a, glycosylated
822507|NCT00146471|alcohol withdrawal|alcohol withdrawal
822508|NCT00146471|detoxification|detoxification
822509|NCT00146471|Inpatients|inpatients
822510|NCT00146471|alcohol dependence according to DSM-IV/ICD-10|alcohol dependence according to dsm-iv/icd-10
822511|NCT00146471|withdrawal symptoms|withdrawal symptoms
822512|NCT00146458|Cervical cancer|cervical cancer
822513|NCT00146458|FDG-PET|fdg-pet
822514|NCT00146458|Lymph node metastasis|lymph node metastasis
822515|NCT00146458|Radiotherapy|radiotherapy
822516|NCT00146458|Chemotherapy|chemotherapy
822517|NCT00146445|IV drug users|iv drug users
822518|NCT00146419|Treatment Experienced|treatment experienced
822519|NCT00146419|Treatment Naive|treatment naive
822620|NCT00146003|eczema|eczema
822520|NCT00146406|Adolescent Health|adolescent health
822521|NCT00146406|Sexually Transmitted Disease|sexually transmitted disease
822522|NCT00146406|Sexual Behavior|sexual behavior
822523|NCT00146393|exercise|exercise
822524|NCT00146393|physical activity|physical activity
822525|NCT00146393|physical conditioning|physical conditioning
822526|NCT00146393|pain|pain
822527|NCT00146393|physical function|physical function
822528|NCT00146380|Prevention Mother-to-Child HIV transmission|prevention mother-to-child hiv transmission
822529|NCT00146380|HIV Seronegativity|hiv seronegativity
822530|NCT00146367|arthritis|arthritis
822531|NCT00146367|osteoarthritis|osteoarthritis
822532|NCT00146367|rheumatoid arthritis|rheumatoid arthritis
822533|NCT00146367|rheumatic disease|rheumatic disease
822534|NCT00146367|exercise|exercise
822535|NCT00146367|physical activity|physical activity
822536|NCT00146367|physical function|physical function
822537|NCT00146367|disability|disability
822538|NCT00146354|Electronic Medical Record|electronic medical record
822539|NCT00146354|Electronic Results Tracking|electronic results tracking
822540|NCT00146354|Patient Safety|patient safety
822541|NCT00146354|Post-Discharge Test Results|post-discharge test results
822542|NCT00146315|Primary Health Care|primary health care
822543|NCT00146315|Family Practice|family practice
822544|NCT00146315|Family Physician|family physician
822545|NCT00146315|Exercise|exercise
822546|NCT00146315|Coronary Heart Disease|coronary heart disease
822547|NCT00146315|Randomized Controlled Trials|randomized controlled trials
822548|NCT00146315|Multicenter Studies|multicenter studies
822549|NCT00146302|Non-specific effects of vaccines|non-specific effects of vaccines
822550|NCT00146302|Infant mortality|infant mortality
822551|NCT00146302|Morbidity|morbidity
822552|NCT00146302|Low income country|low income country
822554|NCT00146302|Vaccine policy|vaccine policy
822555|NCT00146302|immunisation|immunisation
822556|NCT00146302|Low birth weight|low birth weight
822557|NCT00146302|Tuberculin|tuberculin
822558|NCT00146302|Mortality|mortality
822559|NCT00146276|bladder cancer|bladder cancer
822560|NCT00146276|cystectomy|cystectomy
822561|NCT00146276|gemcitabine|gemcitabine
822562|NCT00146276|adjuvant chemotherapy|adjuvant chemotherapy
822563|NCT00146276|locally advanced bladder cancer|locally advanced bladder cancer
822564|NCT00146263|mild cognitive impairment|mild cognitive impairment
822565|NCT00146263|dementia|dementia
822566|NCT00146263|Alzheimer's Disease|alzheimer's disease
822567|NCT00146263|cognitive training|cognitive training
822568|NCT00146237|phenytoin|phenytoin
822569|NCT00146237|SSRI failure|ssri failure
822570|NCT00146237|depression|depression
822571|NCT00146224|anemia|anemia
822572|NCT00146224|chronic kidney disease, CKD|chronic kidney disease, ckd
822573|NCT00146224|hemodialysis|hemodialysis
822574|NCT00146224|epoetin|epoetin
822575|NCT00146224|Epogen®|epogen®
822576|NCT00146211|Trial|trial
822577|NCT00146211|ethyl-EPA|ethyl-epa
822578|NCT00146211|Miraxion™|miraxion™
822579|NCT00146211|treating|treating
822580|NCT00146211|mild|mild
822581|NCT00146211|moderate|moderate
822582|NCT00146211|Huntington's|huntington's
822583|NCT00146198|Postoperative pain|postoperative pain
822584|NCT00146198|Inguinal Hernia Repair|inguinal hernia repair
822585|NCT00146198|Capsaicin|capsaicin
822586|NCT00146185|Needlestick pain|needlestick pain
822587|NCT00146185|Venipuncture pain|venipuncture pain
822588|NCT00146185|Procedural pain|procedural pain
822589|NCT00146172|Tumors|tumors
822590|NCT00146172|Neratinib|neratinib
822591|NCT00146172|HKI-272|hki-272
822592|NCT00146172|Nerlynx|nerlynx
822593|NCT00146159|Multiple Sclerosis|multiple sclerosis
822594|NCT00146146|transsexualism|transsexualism
822595|NCT00146146|testosterone|testosterone
822596|NCT00146146|dihydrotestosterone|dihydrotestosterone
822597|NCT00146146|estradiol|estradiol
822598|NCT00146133|Obesity, Aging, Frailty, exercise, weight loss|obesity, aging, frailty, exercise, weight loss
822599|NCT00146107|obesity|obesity
822600|NCT00146107|aging|aging
822601|NCT00146107|exercise|exercise
822602|NCT00146107|diet|diet
822603|NCT00146107|weight loss|weight loss
822604|NCT00146107|physical function|physical function
822605|NCT00146107|Obesity in the Elderly|obesity in the elderly
822606|NCT00146094|Osteopenia|osteopenia
822607|NCT00146094|osteoporosis|osteoporosis
822608|NCT00146094|bone mineral density|bone mineral density
822609|NCT00146094|HIV infection|hiv infection
822610|NCT00146094|bone metabolism|bone metabolism
822611|NCT00146094|Treatment Naive|treatment naive
822612|NCT00146081|African Americans|african americans
822613|NCT00146081|weight control|weight control
822614|NCT00146081|social support|social support
822615|NCT00146068|Clinically Isolated Syndrome|clinically isolated syndrome
822616|NCT00146029|Patients who participated in UMCC 9900/9901 (Phase II Studies of Tailored-Dose Docetaxel in Metastatic Breast Cancer)|patients who participated in umcc 9900/9901 (phase ii studies of tailored-dose docetaxel in metastatic breast cancer)
822617|NCT00146016|Chronic Hepatitis C|chronic hepatitis c
822618|NCT00146016|Amantadine|amantadine
822619|NCT00146016|Triple therapy|triple therapy
822621|NCT00146003|atopic dermatitis|atopic dermatitis
822622|NCT00146003|efalizumab|efalizumab
822623|NCT00145990|methacholine PC20|methacholine pc20
822624|NCT00145990|dosimeter|dosimeter
822625|NCT00145990|asthma|asthma
822626|NCT00145977|osteoporosis|osteoporosis
822627|NCT00145977|bone density|bone density
822628|NCT00145977|women|women
822629|NCT00145977|endocrine|endocrine
822630|NCT00145977|musculoskeletal|musculoskeletal
822631|NCT00145977|metabolic|metabolic
822632|NCT00145964|Biliary Cirrhosis, Primary|biliary cirrhosis, primary
822633|NCT00145964|genes|genes
822634|NCT00145964|autoimmune disease|autoimmune disease
822635|NCT00145938|Portopulmonary hypertension|portopulmonary hypertension
822636|NCT00145938|PTPH|ptph
822637|NCT00145938|pulmonary hypertension|pulmonary hypertension
822638|NCT00145938|high blood pressure in the pulmonary arteries|high blood pressure in the pulmonary arteries
822639|NCT00145925|Diabetes Mellitus, Type 2|diabetes mellitus, type 2
822640|NCT00145925|Blood Pressure|blood pressure
822641|NCT00145925|Stroke|stroke
822642|NCT00145925|MI|mi
822643|NCT00145912|Depression in adolescents and young adults, depression web-base activity|depression in adolescents and young adults, depression web-base activity
822644|NCT00145886|low bone turnover; sclerosing bone disorders,|low bone turnover; sclerosing bone disorders,
822645|NCT00145886|osteopetrosis|osteopetrosis
822646|NCT00145873|heart failure|heart failure
822647|NCT00145873|nesiritide|nesiritide
822648|NCT00145873|heart disease|heart disease
822649|NCT00145873|cardiovascular disease|cardiovascular disease
822650|NCT00145860|Colorectal Cancer|colorectal cancer
822651|NCT00145847|alcohol|alcohol
822652|NCT00145847|schizophrenia|schizophrenia
822653|NCT00145847|naltrexone|naltrexone
822654|NCT00145834|psychosocial factors|psychosocial factors
822655|NCT00145834|breastfeeding|breastfeeding
822656|NCT00145834|postnatal intervention|postnatal intervention
822657|NCT00145834|health visitor|health visitor
822658|NCT00145808|Ulcerative colitis|ulcerative colitis
822659|NCT00145795|HIV|hiv
822660|NCT00145795|HAART (Highly Active Anti-Retroviral Therapy) partial immune response|haart (highly active anti-retroviral therapy) partial immune response
822661|NCT00145795|no immune response|no immune response
822662|NCT00145795|Treatment Experienced|treatment experienced
822663|NCT00145782|multiphasic screening|multiphasic screening
822664|NCT00145782|primary health care|primary health care
822665|NCT00145782|randomized controlled trial|randomized controlled trial
822666|NCT00145782|Risk factors|risk factors
822667|NCT00145769|rectal cancer|rectal cancer
822668|NCT00145769|radiotherapy|radiotherapy
822669|NCT00145769|chemotherapy|chemotherapy
822670|NCT00145769|chemoradiation|chemoradiation
822671|NCT00145769|adjuvant therapy|adjuvant therapy
822672|NCT00145756|Sodium Chloride|sodium chloride
822673|NCT00145756|Blood Pressure|blood pressure
822674|NCT00145756|Cardiovascular Diseases|cardiovascular diseases
822675|NCT00145756|Clinical Trial|clinical trial
822676|NCT00145743|Quality of Life|quality of life
822677|NCT00145743|Breast Cancer|breast cancer
822678|NCT00145743|Referee's Report|referee's report
822679|NCT00145743|Diagnostics|diagnostics
822680|NCT00145743|Therapy|therapy
822681|NCT00145730|osteoarthritis hip|osteoarthritis hip
822682|NCT00145730|arthroplasty|arthroplasty
822683|NCT00145730|ectopic bone formation|ectopic bone formation
822684|NCT00145730|non-steroidal anti-inflammatory drugs|non-steroidal anti-inflammatory drugs
822685|NCT00145730|disability|disability
822686|NCT00145717|Phytosterols|phytosterols
822687|NCT00145717|Cholesterol|cholesterol
822688|NCT00145717|China|china
822689|NCT00145717|Randomized controlled trial|randomized controlled trial
822690|NCT00145704|osteopenia|osteopenia
822691|NCT00145704|growth hormone deficiency|growth hormone deficiency
822692|NCT00145704|pediatric malignancy|pediatric malignancy
822693|NCT00145678|borderline|borderline
822696|NCT00145678|psychodynamic|psychodynamic
822697|NCT00145678|psychotherapy|psychotherapy
822698|NCT00145678|psychoanalytic|psychoanalytic
822699|NCT00145665|FLT-PET|flt-pet
822700|NCT00145665|colorectal liver metastases|colorectal liver metastases
822701|NCT00145665|proliferation|proliferation
822702|NCT00145665|proliferation markers|proliferation markers
822703|NCT00145665|recurrence|recurrence
822704|NCT00145652|erythropoetin|erythropoetin
822705|NCT00145652|adjuvant iron therapy|adjuvant iron therapy
822706|NCT00145652|anemia|anemia
822707|NCT00145652|cancer|cancer
822708|NCT00145639|Osteosarcoma|osteosarcoma
822709|NCT00145639|Treatment, Carboplatin|treatment, carboplatin
822710|NCT00145626|Stem cell transplantation|stem cell transplantation
822711|NCT00145626|Stem cell transplant|stem cell transplant
822712|NCT00145626|Haploidentical transplant|haploidentical transplant
822713|NCT00145613|Haploidentical stem cell transplant|haploidentical stem cell transplant
822714|NCT00145613|High risk hematologic malignancies|high risk hematologic malignancies
822715|NCT00145613|Allogeneic stem cell transplant|allogeneic stem cell transplant
822716|NCT00145613|Mismatched family member stem cell donor|mismatched family member stem cell donor
822717|NCT00145600|Lymphoma|lymphoma
823206|NCT00142519|Analgesics|analgesics
822718|NCT00145600|Hodgkin Disease|hodgkin disease
822719|NCT00145587|Osteopetrosis|osteopetrosis
822720|NCT00145587|Autosomal recessive bone disease|autosomal recessive bone disease
822721|NCT00145587|Haploidentical stem cell transplantation|haploidentical stem cell transplantation
822722|NCT00145587|Allogeneic stem cell transplantation|allogeneic stem cell transplantation
822723|NCT00145587|T-cell depletion methodology|t-cell depletion methodology
822724|NCT00145587|Miltenyi Biotec CliniMACS stem cell selection device|miltenyi biotec clinimacs stem cell selection device
822725|NCT00145574|Pediatric|pediatric
822726|NCT00145574|hypercholesterolemia|hypercholesterolemia
822727|NCT00145574|colesevelam|colesevelam
822728|NCT00145561|HIV|hiv
822729|NCT00145548|COPD|copd
822730|NCT00145535|Glaucoma|glaucoma
822731|NCT00145535|Glaucoma, open angle|glaucoma, open angle
822732|NCT00145535|Intraocular Pressure|intraocular pressure
822733|NCT00145535|Trabeculoplasty|trabeculoplasty
822734|NCT00145535|laser|laser
822735|NCT00145535|laser, surgery|laser, surgery
822736|NCT00145522|Menopause, IGF-1, HRT|menopause, igf-1, hrt
822737|NCT00145418|Non small Cell Lung Cancer Stage IIIb and IV|non small cell lung cancer stage iiib and iv
822738|NCT00145405|Acromegaly|acromegaly
822739|NCT00145405|somatostatin analogues|somatostatin analogues
822740|NCT00145405|lanreotide|lanreotide
822741|NCT00145405|octreotide|octreotide
822742|NCT00145405|GH|gh
822743|NCT00145405|IGF-I|igf-i
822744|NCT00145405|injection site|injection site
822745|NCT00145392|Polycystic ovary syndrome|polycystic ovary syndrome
822746|NCT00145392|growth hormone|growth hormone
822747|NCT00145392|insulin resistance|insulin resistance
822748|NCT00145392|overweight|overweight
822749|NCT00145392|glucose metabolism|glucose metabolism
822750|NCT00145379|type 1 diabetes mellitus|type 1 diabetes mellitus
822751|NCT00145379|insulin resistance|insulin resistance
822752|NCT00145379|metformin|metformin
822753|NCT00145379|randomized, controlled study|randomized, controlled study
822754|NCT00145366|Benign nontoxic and toxic goiter|benign nontoxic and toxic goiter
822755|NCT00145366|rhTSH|rhtsh
822756|NCT00145366|131I|131i
822757|NCT00145366|goiter reduction|goiter reduction
822758|NCT00145366|131I kinetic|131i kinetic
822759|NCT00145366|thyroid size|thyroid size
822760|NCT00145366|patient satisfaction|patient satisfaction
822761|NCT00145366|adverse effects|adverse effects
822762|NCT00145366|BRT|brt
822763|NCT00145366|Graves' disease|graves' disease
822764|NCT00145353|type 1 diabetes mellitus|type 1 diabetes mellitus
822765|NCT00145353|hypoglycaemia|hypoglycaemia
822766|NCT00145353|insulin profiles|insulin profiles
822767|NCT00145353|growth hormone|growth hormone
822768|NCT00145353|cortisol|cortisol
822769|NCT00145353|glucagon|glucagon
822770|NCT00145340|polycystic ovary syndrome (PCOS)|polycystic ovary syndrome (pcos)
822771|NCT00145340|PPARgamma|ppargamma
822772|NCT00145340|growth hormone|growth hormone
822773|NCT00145340|insulin resistance|insulin resistance
822774|NCT00145340|pioglitazone|pioglitazone
822775|NCT00145340|glucose metabolism|glucose metabolism
822776|NCT00145340|microarray|microarray
822777|NCT00145327|Osteoporosis, Zoledronic Acid|osteoporosis, zoledronic acid
822778|NCT00145314|Metastatic colorectal cancer|metastatic colorectal cancer
822779|NCT00145314|FLOX|flox
822780|NCT00145314|Cetuximab|cetuximab
822781|NCT00145301|Osteoarthritis, lumiracoxib, retention on treatment, efficacy, safety|osteoarthritis, lumiracoxib, retention on treatment, efficacy, safety
822782|NCT00145288|hirsutism|hirsutism
822783|NCT00145288|type 2 diabetes|type 2 diabetes
822784|NCT00145288|polycystic ovary syndrome|polycystic ovary syndrome
822785|NCT00145288|metabolism|metabolism
822786|NCT00145275|zoledronic acid|zoledronic acid
822787|NCT00145275|bisphosphonate|bisphosphonate
822788|NCT00145275|Low bone mass|low bone mass
822789|NCT00145262|critical limb ischemia|critical limb ischemia
822790|NCT00145262|bone marrow mononuclear cells|bone marrow mononuclear cells
822791|NCT00145262|angiogenesis|angiogenesis
822792|NCT00145262|vasculogenesis|vasculogenesis
822793|NCT00145262|Arteriosclerosis Obliterans (ASO)|arteriosclerosis obliterans (aso)
822794|NCT00145262|Ischemic ulcers|ischemic ulcers
822795|NCT00145249|Bacterial infections, HIV infection, cryptococcal meningitis|bacterial infections, hiv infection, cryptococcal meningitis
822796|NCT00145236|Nebivolol|nebivolol
822797|NCT00145236|Beta-Blocker|beta-blocker
822798|NCT00145223|Wuchereria bancrofti, filariasis, Egypt|wuchereria bancrofti, filariasis, egypt
822799|NCT00145210|Nebivolol|nebivolol
822800|NCT00145197|breast cancer|breast cancer
822801|NCT00145197|adjuvant treatment|adjuvant treatment
822802|NCT00145197|racial disparities|racial disparities
822803|NCT00145197|Early-Stage Breast Cancer|early-stage breast cancer
822804|NCT00145184|multivitamin, supplements, tuberculosis, Tanzania|multivitamin, supplements, tuberculosis, tanzania
822805|NCT00145158|Melanoma|melanoma
822806|NCT00145158|Vaccine|vaccine
822807|NCT00145158|Peptide|peptide
822808|NCT00145158|Montanide|montanide
822809|NCT00145145|Melanoma|melanoma
822810|NCT00145145|Vaccine|vaccine
822811|NCT00145145|Peptide|peptide
822812|NCT00145145|MAGE|mage
822813|NCT00145145|CpG|cpg
822814|NCT00145132|depression|depression
822815|NCT00145132|β-CIT-SPECT|β-cit-spect
822816|NCT00145132|SERT|sert
822817|NCT00145132|DAT|dat
822818|NCT00145132|neurophysiology|neurophysiology
822819|NCT00145132|LDAEP|ldaep
822820|NCT00145132|escitalopram|escitalopram
822821|NCT00145132|SSRI|ssri
822822|NCT00145119|Acute myocardial infarction|acute myocardial infarction
822823|NCT00145119|Cardiac arrhythmias|cardiac arrhythmias
822824|NCT00145119|Left ventricular dysfunction|left ventricular dysfunction
822825|NCT00145119|Implantable loop recorder|implantable loop recorder
822826|NCT00145119|Risk stratifiers|risk stratifiers
822827|NCT00145106|acne, tazarotene, minocycline, maintenance, retinoid, efficacy, combination|acne, tazarotene, minocycline, maintenance, retinoid, efficacy, combination
822828|NCT00145093|Diabetes Mellitus, Type 2|diabetes mellitus, type 2
822829|NCT00145093|Chromium|chromium
822830|NCT00145093|Saccharomyces cerevisiae|saccharomyces cerevisiae
822831|NCT00145028|Neoplasms|neoplasms
822832|NCT00145028|Carboplatin|carboplatin
822833|NCT00145028|optimal exposure|optimal exposure
822834|NCT00145028|AUC|auc
822835|NCT00145015|Intervention|intervention
822836|NCT00145015|Adults|adults
822837|NCT00145015|Colorectal cancer|colorectal cancer
822838|NCT00145015|Nutrition|nutrition
822839|NCT00145015|Fish|fish
822840|NCT00145015|n-3 fatty acids|n-3 fatty acids
822841|NCT00145015|Apoptosis|apoptosis
822842|NCT00145015|Ulcerative colitis|ulcerative colitis
822843|NCT00145015|Polyps|polyps
822844|NCT00145015|Gastro-intestinal tract|gastro-intestinal tract
822845|NCT00145002|ATLL|atll
822846|NCT00145002|chemotherapy|chemotherapy
822847|NCT00145002|phase III study|phase iii study
822848|NCT00145002|VCAP-AMP-VECP|vcap-amp-vecp
822849|NCT00145002|biweekly-CHOP|biweekly-chop
822850|NCT00144989|Small-cell lung cancer|small-cell lung cancer
822851|NCT00144989|Limited-Stage Small-Cell Lung Cancer|limited-stage small-cell lung cancer
822852|NCT00144989|Combined modality therapy|combined modality therapy
822853|NCT00144989|chemotherapy|chemotherapy
822854|NCT00144989|radiotherapy|radiotherapy
822855|NCT00144989|Irinotecan|irinotecan
822856|NCT00144989|Cisplatin|cisplatin
822857|NCT00144976|Head and Neck Neoplasms|head and neck neoplasms
822858|NCT00144976|Tarceva|tarceva
822859|NCT00144976|ENT|ent
822860|NCT00144911|exacerbations|exacerbations
822861|NCT00144911|breathing|breathing
822862|NCT00144911|chronic obstructive pulmonary disease|chronic obstructive pulmonary disease
822863|NCT00144898|Breast cancer|breast cancer
822864|NCT00144898|sentinel node resection|sentinel node resection
822865|NCT00144898|survival|survival
822866|NCT00144898|Breast cancer unifocal N0|breast cancer unifocal n0
822867|NCT00144885|Endocarditis|endocarditis
822868|NCT00144885|RMI|rmi
822869|NCT00144885|Impact measure|impact measure
822870|NCT00144872|Absence Seizures|absence seizures
822871|NCT00144872|EEG|eeg
822872|NCT00144872|LTG|ltg
822873|NCT00144872|Typical Absence Epilepsy|typical absence epilepsy
822874|NCT00144872|Epilepsy|epilepsy
822875|NCT00144872|LAMICTAL|lamictal
822876|NCT00144859|P38 map kinase|p38 map kinase
822877|NCT00144859|CRP|crp
822878|NCT00144859|COPD|copd
822879|NCT00144859|safety|safety
822880|NCT00144846|wheezing|wheezing
822881|NCT00144846|bronchospasm|bronchospasm
822882|NCT00144846|albuterol sulfate HFA|albuterol sulfate hfa
822883|NCT00144833|Protease inhibitors-experienced HIV-1 infected patients|protease inhibitors-experienced hiv-1 infected patients
822884|NCT00144833|Highly-resistant HIV-1|highly-resistant hiv-1
822885|NCT00144833|Dual boosted Pis|dual boosted pis
822886|NCT00144833|fosamprenavir|fosamprenavir
822887|NCT00144833|lopinavir|lopinavir
822888|NCT00144820|Hyaluronan|hyaluronan
822889|NCT00144820|Gonarthrosis|gonarthrosis
822890|NCT00144820|Osteoarthritis,knee|osteoarthritis,knee
822891|NCT00144820|Double-blinded|double-blinded
822892|NCT00144820|Placebo controlled|placebo controlled
822894|NCT00144807|lymphoma, diffuse large B-cell|lymphoma, diffuse large b-cell
822895|NCT00144807|rituximab|rituximab
822896|NCT00144807|chemotherapy|chemotherapy
822897|NCT00144807|autologous stem cell transplant|autologous stem cell transplant
822898|NCT00144794|Hurler's Syndrome|hurler's syndrome
822899|NCT00144794|Hurler-Scheie Syndrome|hurler-scheie syndrome
822900|NCT00144794|Scheie Syndrome|scheie syndrome
822901|NCT00144755|lymphoma, diffuse large B-cell|lymphoma, diffuse large b-cell
822902|NCT00144755|rituximab|rituximab
822903|NCT00144755|chemotherapy|chemotherapy
822904|NCT00144755|erythropoetin|erythropoetin
822905|NCT00144755|darbepoetin alfa|darbepoetin alfa
822906|NCT00144716|Vector Control|vector control
822907|NCT00144716|repellent|repellent
822908|NCT00144716|ITN's|itn's
822909|NCT00144716|malaria|malaria
822910|NCT00144716|Amazon|amazon
822911|NCT00144703|Graft versus host disease|graft versus host disease
822912|NCT00144703|GVHD|gvhd
822913|NCT00144703|Stem cell transplantation|stem cell transplantation
822914|NCT00144703|sirolimus|sirolimus
822915|NCT00144703|tacrolimus|tacrolimus
822916|NCT00144690|Epilepsy refractory partial seizures|epilepsy refractory partial seizures
823407|NCT00141791|Asthma|asthma
822917|NCT00144677|Graft versus Host Disease|graft versus host disease
822918|NCT00144677|GVHD|gvhd
822919|NCT00144677|sirolimus|sirolimus
822920|NCT00144677|tacrolimus|tacrolimus
822921|NCT00144677|Stem cell transplant|stem cell transplant
822922|NCT00144443|Aerobiology|aerobiology
822923|NCT00144443|Asthma|asthma
822924|NCT00144443|Indoor Fungi|indoor fungi
822925|NCT00144443|Allergen|allergen
822926|NCT00144443|Home Remediation|home remediation
822927|NCT00144430|chronic graft versus host disease|chronic graft versus host disease
822928|NCT00144430|graft|graft
822929|NCT00144430|host|host
822930|NCT00144430|transplant|transplant
822931|NCT00144430|stem cell|stem cell
822932|NCT00144430|pediatric|pediatric
822933|NCT00144430|GVH0313|gvh0313
822934|NCT00144430|leukemia|leukemia
822935|NCT00144417|tuberculosis|tuberculosis
822936|NCT00144417|TB|tb
822937|NCT00144417|treatment|treatment
822938|NCT00144417|efficacy|efficacy
822939|NCT00144417|safety|safety
822940|NCT00144378|gastric cancer|gastric cancer
822941|NCT00144378|metastatic|metastatic
822942|NCT00144378|irinotecan|irinotecan
822943|NCT00144365|HIV|hiv
822944|NCT00144365|Africa|africa
822945|NCT00144365|Adherence|adherence
822946|NCT00144365|HIV viral load|hiv viral load
822947|NCT00144365|Sexual behavior|sexual behavior
822948|NCT00144365|Voluntary counseling and testing|voluntary counseling and testing
822949|NCT00144352|Malaria|malaria
822950|NCT00144352|HIV|hiv
822951|NCT00144352|AIDS|aids
822952|NCT00144352|drug efficacy|drug efficacy
822953|NCT00144352|Kenya|kenya
822954|NCT00144352|Africa|africa
822955|NCT00144352|Sulfadoxine pyirmethamine|sulfadoxine pyirmethamine
822956|NCT00144352|fansidar|fansidar
822957|NCT00144313|vaccine|vaccine
822958|NCT00144313|hepatitis B|hepatitis b
822959|NCT00144313|immune memory|immune memory
822960|NCT00144144|Hypertension|hypertension
822961|NCT00144144|Diabetes Mellitus, Type 2|diabetes mellitus, type 2
822962|NCT00144144|Calcium Channel Blocker|calcium channel blocker
822963|NCT00144144|Angiotensin II type 1 Receptor Blocker|angiotensin ii type 1 receptor blocker
822964|NCT00144131|Chemotherapy, Anemia|chemotherapy, anemia
822965|NCT00144131|Aranesp®, rHuEPO|aranesp®, rhuepo
822966|NCT00144131|Chemotherapy Induced Anemia|chemotherapy induced anemia
822967|NCT00144131|non-myeloid malignancy|non-myeloid malignancy
822968|NCT00144131|Non-Myeloid Malignancies|non-myeloid malignancies
822969|NCT00144131|Chemotherapy|chemotherapy
822970|NCT00144092|autologous and allogeneic stem cell transplantation|autologous and allogeneic stem cell transplantation
822971|NCT00144092|low grade lymphoma|low grade lymphoma
822972|NCT00144092|mantle cell|mantle cell
822973|NCT00144079|Differentiated thyroid carcinoma|differentiated thyroid carcinoma
822974|NCT00144079|radiotherapy|radiotherapy
822975|NCT00144079|radioiodine therapy|radioiodine therapy
822976|NCT00144079|thyroidectomy|thyroidectomy
822977|NCT00144040|Antibiotics|antibiotics
822978|NCT00144040|Respiratory Infections|respiratory infections
822979|NCT00144040|Quality Assurance, Healthcare|quality assurance, healthcare
822980|NCT00144040|Professional Education|professional education
822981|NCT00144040|Emergency Services, Medical|emergency services, medical
822982|NCT00144040|Education, Patient|education, patient
822983|NCT00144027|patient non-adherence|patient non-adherence
822984|NCT00144027|intervention studies|intervention studies
822985|NCT00144014|Acute|acute
822986|NCT00144014|Ischaemic|ischaemic
822987|NCT00144014|Stroke|stroke
822988|NCT00144001|Epilepsy|epilepsy
822989|NCT00144001|Pharmacoepidemiology|pharmacoepidemiology
822990|NCT00144001|Quality of Care|quality of care
822991|NCT00144001|Outcomes|outcomes
822992|NCT00143988|Blood Pressure|blood pressure
822993|NCT00143988|Heart Rate|heart rate
822994|NCT00143988|Sexual Activity|sexual activity
822995|NCT00143975|Acute myeloid leukemia|acute myeloid leukemia
823283|NCT00142285|efficacy|efficacy
822996|NCT00143975|gemtuzumab ozogamicin|gemtuzumab ozogamicin
822997|NCT00143975|refractory disease|refractory disease
822998|NCT00143962|Weight Loss|weight loss
822999|NCT00143949|diabetes|diabetes
823000|NCT00143949|nephropathy|nephropathy
823001|NCT00143949|kidney|kidney
823002|NCT00143949|retinopathy|retinopathy
823003|NCT00143936|Weight Loss|weight loss
823004|NCT00143923|Cardiovascular Diseases|cardiovascular diseases
823005|NCT00143923|Ethnic Groups|ethnic groups
823006|NCT00143923|Risk Factors|risk factors
823007|NCT00143923|Sleep disordered breathing|sleep disordered breathing
823008|NCT00143923|Environmental exposures|environmental exposures
823009|NCT00143923|Cognitive Function|cognitive function
823010|NCT00143910|Medication adherence|medication adherence
823011|NCT00143910|Patient compliance|patient compliance
823012|NCT00143910|Kidney transplant|kidney transplant
823013|NCT00143910|Organ rejection|organ rejection
823014|NCT00143910|Allograft loss|allograft loss
823015|NCT00143910|Drug monitoring|drug monitoring
823016|NCT00143858|Peripheral Pulse Volume|peripheral pulse volume
823017|NCT00143832|fMRI|fmri
823018|NCT00143819|psoriasis|psoriasis
823019|NCT00143819|dry skin|dry skin
823020|NCT00143819|eczema|eczema
823895|NCT00138983|prevention|prevention
823021|NCT00143819|atopic dermatitis|atopic dermatitis
823022|NCT00143806|psoriasis|psoriasis
823023|NCT00143806|cyclosporine|cyclosporine
823024|NCT00143806|transition|transition
823025|NCT00143806|alefacept|alefacept
823026|NCT00143793|natruretic peptides|natruretic peptides
823027|NCT00143793|NT-proBNP|nt-probnp
823028|NCT00143793|new biomarkers|new biomarkers
823029|NCT00143793|congestive heart failure|congestive heart failure
823030|NCT00143793|atrial fibrillation|atrial fibrillation
823031|NCT00143793|acute myocardial infarction|acute myocardial infarction
823032|NCT00143793|lung embolism|lung embolism
823033|NCT00143780|Bone Marrow Transplant|bone marrow transplant
823034|NCT00143780|Pneumonia|pneumonia
823035|NCT00143780|Vaccine|vaccine
823036|NCT00143780|Conjugate Vaccine|conjugate vaccine
823037|NCT00143780|Polysaccharide Vaccine|polysaccharide vaccine
823038|NCT00143767|Magnetic Resonance Imaging|magnetic resonance imaging
823039|NCT00143741|Kidney Disease, Lipitor, Atorvastatin, Allosensitization|kidney disease, lipitor, atorvastatin, allosensitization
823040|NCT00143728|HIV|hiv
823041|NCT00143728|Treatment Experienced|treatment experienced
823042|NCT00143715|Vitamin K1 (phytonadione)|vitamin k1 (phytonadione)
823043|NCT00143715|Randomized controlled trial|randomized controlled trial
823044|NCT00143715|Warfarin|warfarin
823045|NCT00143715|Coagulopathy|coagulopathy
823046|NCT00143715|Bleeding|bleeding
823047|NCT00143715|Thrombosis|thrombosis
823048|NCT00143715|Warfarin associated coagulopathy defined as an INR of 4.5 and 10.0 (for entry into randomized tria) or greater than 10.0 (for entry into parallel cohort study|warfarin associated coagulopathy defined as an inr of 4.5 and 10.0 (for entry into randomized tria) or greater than 10.0 (for entry into parallel cohort study
823049|NCT00143715|Warfarin associated coagulopathy|warfarin associated coagulopathy
823050|NCT00143702|Elevated Lactic Acid|elevated lactic acid
823051|NCT00143676|Hyperlipidemia|hyperlipidemia
823052|NCT00143676|Dyslipidemia|dyslipidemia
823053|NCT00143676|Drug Therapy|drug therapy
823054|NCT00143663|Hypercholesterolemia|hypercholesterolemia
823055|NCT00143663|Hyperlipidemia|hyperlipidemia
823056|NCT00143663|Drug Therapy|drug therapy
823057|NCT00143650|Upper airway, irritation inflammation, discomfort, house dust, damp buildings, climate chamber, humans|upper airway, irritation inflammation, discomfort, house dust, damp buildings, climate chamber, humans
823058|NCT00143637|Office dust|office dust
823059|NCT00143637|Glucan|glucan
823060|NCT00143637|dose-response|dose-response
823061|NCT00143637|lung function|lung function
823062|NCT00143637|peak expiratory flow|peak expiratory flow
823063|NCT00143637|inflammation|inflammation
823064|NCT00143637|perception|perception
823065|NCT00143624|Treatment Experienced|treatment experienced
823066|NCT00143624|HIV Metabolic Syndrome|hiv metabolic syndrome
823067|NCT00143624|Atherosclerosis in HIV|atherosclerosis in hiv
823068|NCT00143611|Shock, Septic|shock, septic
823069|NCT00143611|Sepsis Syndrome|sepsis syndrome
823070|NCT00143611|Respiratory Insufficiency|respiratory insufficiency
823071|NCT00143611|SIRS (Systemic Inflammatory Response Syndrome)|sirs (systemic inflammatory response syndrome)
823072|NCT00143611|Respiratory Failure|respiratory failure
823073|NCT00143611|Drug Therapy|drug therapy
823074|NCT00143598|Postphlebitic Syndrome|postphlebitic syndrome
823075|NCT00143598|Post-Thrombotic Syndrome|post-thrombotic syndrome
823076|NCT00143598|Elastic Stockings|elastic stockings
823077|NCT00143598|Stockings, Compression|stockings, compression
823078|NCT00143598|Randomized Controlled Trials|randomized controlled trials
823079|NCT00143598|Quality of Life|quality of life
823080|NCT00143585|angiogenesis|angiogenesis
823081|NCT00143585|VEGF|vegf
823082|NCT00143572|Hematologic Diseases|hematologic diseases
823083|NCT00143572|Anemia, Sickle Cell|anemia, sickle cell
823084|NCT00143559|Allogeneic stem cell transplantation|allogeneic stem cell transplantation
823085|NCT00143559|Haploidentical stem cell transplant|haploidentical stem cell transplant
823086|NCT00143559|Mismatched family member stem cell donor transplant|mismatched family member stem cell donor transplant
823087|NCT00143559|Bone marrow transplant|bone marrow transplant
823088|NCT00143559|High risk hematological malignancies|high risk hematological malignancies
823089|NCT00143559|T-cell depletion methodology|t-cell depletion methodology
823090|NCT00143559|Miltenyi Biotec CliniMACS stem cell selection device|miltenyi biotec clinimacs stem cell selection device
823091|NCT00143546|Hepatic Veno-occlusive Disease|hepatic veno-occlusive disease
823092|NCT00143533|Solid Tumors|solid tumors
823093|NCT00143520|Placebo and active control dose response study of rivoglitazone in type 2 diabetics|placebo and active control dose response study of rivoglitazone in type 2 diabetics
823094|NCT00143468|gas exchange|gas exchange
823095|NCT00143468|respiratory mechanics|respiratory mechanics
823096|NCT00143429|Primary Open Angle Glaucoma|primary open angle glaucoma
823097|NCT00143312|Invasive Fungal Infection, Allogenic Stem Cell Transplant, prophylaxis, leukemia, voriconazole|invasive fungal infection, allogenic stem cell transplant, prophylaxis, leukemia, voriconazole
823098|NCT00143130|phase 4, open label, seizures, epilepsy, add-on therapy, pregabalin, lyrica|phase 4, open label, seizures, epilepsy, add-on therapy, pregabalin, lyrica
823099|NCT00143091|Major Depressive Disorder, Recurrent|major depressive disorder, recurrent
823100|NCT00143078|Obesity|obesity
823101|NCT00143078|Reproduction|reproduction
823102|NCT00143078|Weight Loss|weight loss
823103|NCT00143078|Reproductive System|reproductive system
823104|NCT00143065|Antigens, CD5|antigens, cd5
823105|NCT00143065|Antigens, CD19|antigens, cd19
823106|NCT00143065|Antigens, CD20|antigens, cd20
823107|NCT00143052|Hirsutism|hirsutism
823108|NCT00143052|Bone status|bone status
823109|NCT00143052|Androgens|androgens
823110|NCT00143052|insulin|insulin
823111|NCT00143039|NIH|nih
823112|NCT00143039|Severe Symmetrical IUGR|severe symmetrical iugr
823113|NCT00143039|Tandem Mass Spectrometry|tandem mass spectrometry
823114|NCT00143039|Nonimmune Hydrops|nonimmune hydrops
823115|NCT00143039|Severe Symmetrical Intrauterine Growth Restriction|severe symmetrical intrauterine growth restriction
823116|NCT00143026|Parkinson's disease, levodopa, motor fluctuations|parkinson's disease, levodopa, motor fluctuations
823117|NCT00143013|type 2 diabetes|type 2 diabetes
823118|NCT00143013|microarray|microarray
823119|NCT00143013|skeletal muscle|skeletal muscle
823120|NCT00143013|bioinformatics|bioinformatics
823121|NCT00143000|Hepatitis C Virus|hepatitis c virus
823122|NCT00143000|Genotype 2|genotype 2
823123|NCT00143000|Genotype 3|genotype 3
823124|NCT00142987|Tegaserod, IBS-C, women, mixed bowel habit|tegaserod, ibs-c, women, mixed bowel habit
823125|NCT00142974|Diabetes, tegaserod, gastropathy|diabetes, tegaserod, gastropathy
823126|NCT00142961|cannabis abuse|cannabis abuse
823127|NCT00142961|atomoxetine|atomoxetine
823128|NCT00142961|ADHD|adhd
823129|NCT00142948|Heroin Abuse|heroin abuse
823130|NCT00142948|Heroin Addiction|heroin addiction
823131|NCT00142935|HIV Prevention|hiv prevention
823132|NCT00142935|Opioid-Related Disorders|opioid-related disorders
823133|NCT00142935|Medication Assisted Treatment|medication assisted treatment
823134|NCT00142935|Methadone|methadone
823135|NCT00142922|Adherence|adherence
823136|NCT00142922|self-care|self-care
823137|NCT00142922|Behavioral intervention|behavioral intervention
823138|NCT00142922|Diabetes|diabetes
823139|NCT00142909|Opioid dependence|opioid dependence
823140|NCT00142896|Opiate Addiction|opiate addiction
823141|NCT00142896|Opiate Dependence|opiate dependence
823142|NCT00142883|addiction, crack, cocaine|addiction, crack, cocaine
823143|NCT00142870|marijuana|marijuana
823144|NCT00142870|treatment|treatment
823145|NCT00142844|cocaine|cocaine
823146|NCT00142831|nicotine dependence|nicotine dependence
823147|NCT00142818|Alcohol Abuse|alcohol abuse
823148|NCT00142818|Cocaine Abuse|cocaine abuse
823149|NCT00142805|ketones|ketones
823150|NCT00142805|Apolipoprotein E|apolipoprotein e
823151|NCT00142805|ApoE genotype|apoe genotype
823152|NCT00142805|cognitive function|cognitive function
823153|NCT00142805|glucose metabolism|glucose metabolism
823154|NCT00142792|stroke|stroke
823155|NCT00142792|recovery of function|recovery of function
823156|NCT00142792|functional electrical stimulation (FES)|functional electrical stimulation (fes)
823157|NCT00142779|Cocaine Addiction|cocaine addiction
823158|NCT00142779|Cocaine Dependence|cocaine dependence
823159|NCT00142779|Opiate Addiction|opiate addiction
823160|NCT00142779|Opiate Dependence|opiate dependence
823161|NCT00142766|Sedation|sedation
823162|NCT00142766|Mechanical ventilation|mechanical ventilation
823163|NCT00142766|Critical illness|critical illness
823164|NCT00142766|Analgesic|analgesic
823165|NCT00142766|Opioid Withdrawal|opioid withdrawal
823166|NCT00142766|Benzodiazepine Withdrawal|benzodiazepine withdrawal
823167|NCT00142766|Nurse|nurse
823168|NCT00142753|Hepatitis B vaccines|hepatitis b vaccines
823169|NCT00142753|HIV-infected adolescents|hiv-infected adolescents
823170|NCT00142753|Hepatitis B infection|hepatitis b infection
823171|NCT00142740|Hepatitis B vaccines|hepatitis b vaccines
823172|NCT00142740|HIV-infected adolescents|hiv-infected adolescents
823173|NCT00142740|Hepatitis B infection (negative)|hepatitis b infection (negative)
823174|NCT00142740|HIV vaccine trial|hiv vaccine trial
823175|NCT00142714|sexual response|sexual response
823176|NCT00142714|sexual dysfunction in females|sexual dysfunction in females
823177|NCT00142714|spinal cord injury|spinal cord injury
823178|NCT00142636|Chronic Kideny Disease|chronic kideny disease
823179|NCT00142636|Hypertension|hypertension
823180|NCT00142610|alpha tocopherol|alpha tocopherol
823181|NCT00142610|vitamin E|vitamin e
823182|NCT00142610|ascorbate|ascorbate
823183|NCT00142610|vitamin C|vitamin c
823184|NCT00142610|antioxidant|antioxidant
823185|NCT00142610|allergic|allergic
823186|NCT00142610|asthma|asthma
823187|NCT00142597|acupuncture|acupuncture
823188|NCT00142597|analgesia|analgesia
823189|NCT00142597|pain|pain
823190|NCT00142597|fibromyalgia|fibromyalgia
823191|NCT00142597|fMRI|fmri
823192|NCT00142597|PET|pet
823193|NCT00142584|safety and tolerability study|safety and tolerability study
823194|NCT00142584|hypertension|hypertension
823195|NCT00142584|beta-blockers|beta-blockers
823196|NCT00142571|Sarcoma, Soft Tissue|sarcoma, soft tissue
823197|NCT00142571|Gemcitabine|gemcitabine
823198|NCT00142571|Docetaxel|docetaxel
823199|NCT00142558|Arcoxia|arcoxia
823200|NCT00142532|Acupuncture|acupuncture
823201|NCT00142532|Pain|pain
823202|NCT00142532|Lung Cancer|lung cancer
823203|NCT00142532|Thoracotomy|thoracotomy
823204|NCT00142532|Surgery|surgery
823205|NCT00142519|Pain|pain
823207|NCT00142519|Retroperitoneal lymph node dissection|retroperitoneal lymph node dissection
823208|NCT00142506|Prostate Cancer|prostate cancer
823209|NCT00142506|Cancer of the Prostate|cancer of the prostate
823210|NCT00142506|Prostate Neoplasms|prostate neoplasms
823211|NCT00142506|Prostatic Cancer|prostatic cancer
823212|NCT00142506|Viagra|viagra
823213|NCT00142506|05-007|05-007
823214|NCT00142493|Episodic Memory|episodic memory
823215|NCT00142493|Amnesia|amnesia
823216|NCT00142493|Amnesia, Temporary|amnesia, temporary
823217|NCT00142480|locally advanced biliary adenocarcinoma|locally advanced biliary adenocarcinoma
823218|NCT00142480|unresectable biliary adenocarcinoma|unresectable biliary adenocarcinoma
823219|NCT00142480|gallbladder adenocarcinoma|gallbladder adenocarcinoma
823220|NCT00142480|capecitabine|capecitabine
823221|NCT00142480|oxaliplatin|oxaliplatin
823222|NCT00142480|bevacizumab|bevacizumab
823223|NCT00142480|Biliary tract adenocarcinoma|biliary tract adenocarcinoma
823224|NCT00142467|Unresectable hepatocellular carcinoma|unresectable hepatocellular carcinoma
823225|NCT00142467|Metastatic hepatocellular carcinoma|metastatic hepatocellular carcinoma
823226|NCT00142467|gemcitabine|gemcitabine
823227|NCT00142467|oxaliplatin|oxaliplatin
823228|NCT00142467|bevacizumab|bevacizumab
823229|NCT00142467|Avastin|avastin
823230|NCT00142454|Malignant melanoma|malignant melanoma
823231|NCT00142454|Stages IIB-III|stages iib-iii
823232|NCT00142441|Pulsed dye laser|pulsed dye laser
823233|NCT00142441|Keloids|keloids
823234|NCT00142441|Hypertrophic scars|hypertrophic scars
823235|NCT00142441|Pulse width|pulse width
823236|NCT00142441|Pulse duration|pulse duration
823237|NCT00142428|Hepatocellular carcinoma|hepatocellular carcinoma
823238|NCT00142428|cetuximab|cetuximab
823239|NCT00142428|Unresectable hepatocellular carcinoma|unresectable hepatocellular carcinoma
823240|NCT00142428|Metastatic hepatocellular carcinoma|metastatic hepatocellular carcinoma
823241|NCT00142415|Advanced Renal Cell Carcinoma|advanced renal cell carcinoma
823242|NCT00142415|Clear Cell Renal Cell Carcinoma (CCRCC)|clear cell renal cell carcinoma (ccrcc)
823243|NCT00142415|Lutetium-177|lutetium-177
823244|NCT00142415|177-Lu|177-lu
823245|NCT00142415|cG250|cg250
823246|NCT00142415|DOTA-cG250|dota-cg250
823247|NCT00142415|Monoclonal Antibody|monoclonal antibody
823248|NCT00142402|Multiple Sclerosis|multiple sclerosis
823249|NCT00142402|Memory|memory
823250|NCT00142402|New Learning|new learning
823251|NCT00142402|Fatigue|fatigue
823252|NCT00142389|gestational immunization,|gestational immunization,
823253|NCT00142389|infant antibody,|infant antibody,
823254|NCT00142389|cord antibody|cord antibody
823255|NCT00142363|Parkinson's disease|parkinson's disease
823256|NCT00142363|Parkin|parkin
823257|NCT00142363|Epilepsy|epilepsy
823258|NCT00142363|Phenotype-genotype correlations|phenotype-genotype correlations
823259|NCT00142363|Ionic channels|ionic channels
823260|NCT00142350|gastric cancer|gastric cancer
823261|NCT00142350|5-fluorouracil|5-fluorouracil
823262|NCT00142350|irinotecan|irinotecan
823263|NCT00142350|cisplatin|cisplatin
823264|NCT00142350|S-1|s-1
823265|NCT00142350|advanced or recurrent gastric cancer|advanced or recurrent gastric cancer
823266|NCT00142337|zidovudine|zidovudine
823267|NCT00142337|didanosine|didanosine
823268|NCT00142337|Prevention of mother to child transmission of HIV|prevention of mother to child transmission of hiv
823269|NCT00142337|nevirapine|nevirapine
823270|NCT00142337|Thailand|thailand
823271|NCT00142337|Resistance|resistance
823272|NCT00142337|HIV|hiv
823273|NCT00142337|Postpartum period|postpartum period
823274|NCT00142324|Dementia|dementia
823275|NCT00142311|Parkinson's disease|parkinson's disease
823276|NCT00142311|Parkin mutations|parkin mutations
823277|NCT00142311|Metabolic explorations|metabolic explorations
823278|NCT00142311|Clinics|clinics
823279|NCT00142311|Genetics|genetics
823280|NCT00142285|pneumonia|pneumonia
823281|NCT00142285|zinc|zinc
823282|NCT00142285|treatment|treatment
823285|NCT00142272|Ciprofloxacin|ciprofloxacin
823286|NCT00142272|children|children
823287|NCT00142272|V.cholerae O1 and O139|v.cholerae o1 and o139
823288|NCT00142272|drug resistance|drug resistance
823289|NCT00142272|Bangladesh|bangladesh
823290|NCT00142259|deep brain stimulation|deep brain stimulation
823291|NCT00142259|internal globus pallidus|internal globus pallidus
823292|NCT00142259|dystonia|dystonia
823293|NCT00142246|malaria|malaria
823294|NCT00142246|anaemia|anaemia
823295|NCT00142246|school performance|school performance
823296|NCT00142246|education|education
823297|NCT00142246|intermittent preventive treatment|intermittent preventive treatment
823298|NCT00142246|schools|schools
823299|NCT00142233|EUROPAC 2, ANTOX (vers)1.2, MGCT (Magnesiocard)|europac 2, antox (vers)1.2, mgct (magnesiocard)
823300|NCT00142233|Hereditary Pancreatitis|hereditary pancreatitis
823301|NCT00142233|idiopathic chronic pancreatitis|idiopathic chronic pancreatitis
823302|NCT00142207|malaria|malaria
823303|NCT00142207|pregnancy|pregnancy
823304|NCT00142207|intermittent preventive treatment|intermittent preventive treatment
823305|NCT00142207|insecticide-treated nets|insecticide-treated nets
823306|NCT00142194|Atrial Fibrillation|atrial fibrillation
823307|NCT00142194|Oxidative stress|oxidative stress
823308|NCT00142194|Cardiology|cardiology
823309|NCT00142181|Lymphoplasmacytic lymphoma|lymphoplasmacytic lymphoma
823310|NCT00142181|Waldenstrom's Macroglobulinemia|waldenstrom's macroglobulinemia
823311|NCT00142181|Antibody|antibody
823312|NCT00142181|Campath-1H|campath-1h
823313|NCT00142168|CC-5103 (lenalidomide)|cc-5103 (lenalidomide)
823314|NCT00142168|rituximab|rituximab
823315|NCT00142168|Waldenstrom's macroglobulinemia|waldenstrom's macroglobulinemia
823316|NCT00142155|monoclonal antibody|monoclonal antibody
823317|NCT00142155|Fc gamma RIII receptor expression|fc gamma riii receptor expression
823318|NCT00142155|rituximab|rituximab
823319|NCT00142129|bortezomib|bortezomib
823320|NCT00142129|Velcade|velcade
823321|NCT00142129|Waldenstrom's macroglobulinemia|waldenstrom's macroglobulinemia
823322|NCT00142116|thalidomide|thalidomide
823323|NCT00142116|rituximab|rituximab
823324|NCT00142116|Waldenstrom's|waldenstrom's
823325|NCT00142103|Hepatitis c virus|hepatitis c virus
823326|NCT00142103|HCV|hcv
823327|NCT00142103|Liver|liver
823328|NCT00142090|Brain Concussion|brain concussion
823329|NCT00142090|Post-Concussion Syndrome|post-concussion syndrome
823330|NCT00142090|Closed Head Injury|closed head injury
823331|NCT00142090|Traumatic Brain Injury|traumatic brain injury
823332|NCT00142090|Hypertonic Saline Solution|hypertonic saline solution
823333|NCT00142077|Influenza|influenza
823334|NCT00142077|Electronic health record|electronic health record
823335|NCT00142077|Behavior modification|behavior modification
823336|NCT00142064|Topical analgesia|topical analgesia
823337|NCT00142064|Urinary catheterization|urinary catheterization
823338|NCT00142064|FlACC Pain Scale|flacc pain scale
823339|NCT00142064|Lidocaine jelly|lidocaine jelly
823340|NCT00142051|sickle cell disease|sickle cell disease
823341|NCT00142051|pain crisis|pain crisis
823342|NCT00142051|vaso-occlusive crisis|vaso-occlusive crisis
823343|NCT00142051|nitric oxide|nitric oxide
823344|NCT00142038|gastric cancer|gastric cancer
823345|NCT00142038|metastatic|metastatic
823346|NCT00142038|locally advanced|locally advanced
823347|NCT00142038|docetaxel|docetaxel
823348|NCT00142038|capecitabine|capecitabine
823349|NCT00142025|Bronchial asthma|bronchial asthma
823350|NCT00142025|Oxcarbazepine|oxcarbazepine
823351|NCT00142025|Antiepileptic drug|antiepileptic drug
823352|NCT00142025|Efficacy|efficacy
823353|NCT00142012|School-based|school-based
823354|NCT00142012|Obesity|obesity
823355|NCT00142012|Prevention|prevention
823356|NCT00141999|vaccine|vaccine
823357|NCT00141999|hepatitis|hepatitis
823358|NCT00141986|vitamin D|vitamin d
823359|NCT00141986|type 1 diabetes|type 1 diabetes
823360|NCT00141986|prevention trial|prevention trial
823361|NCT00141973|Procalcitonin|procalcitonin
823362|NCT00141973|Sepsis|sepsis
823363|NCT00141973|Corticosteroids|corticosteroids
823364|NCT00141960|Treatment efficacy|treatment efficacy
823365|NCT00141960|Treatment effectiveness|treatment effectiveness
823366|NCT00141960|Gastrointestinal Diseases|gastrointestinal diseases
823367|NCT00141960|Reflux, Gastroesophageal|reflux, gastroesophageal
823368|NCT00141960|GERD|gerd
823369|NCT00141947|bexarotene|bexarotene
823370|NCT00141947|schizophrenia|schizophrenia
823371|NCT00141947|psychopathology|psychopathology
823372|NCT00141947|cognitive impairment|cognitive impairment
823373|NCT00141947|quality of life|quality of life
823374|NCT00141947|open lable trial|open lable trial
823375|NCT00141934|Rheumatoid Arthritis|rheumatoid arthritis
823376|NCT00141934|RA|ra
823377|NCT00141934|ACR20 endpoint|acr20 endpoint
823378|NCT00141934|Tender/swollen joints|tender/swollen joints
823379|NCT00141934|Improvement in pain|improvement in pain
823380|NCT00141934|Health assessment questionnaire|health assessment questionnaire
823381|NCT00141934|Profile of mood states|profile of mood states
823382|NCT00141921|Immunex|immunex
823383|NCT00141921|Amgen|amgen
823384|NCT00141921|Pediatric,|pediatric,
823385|NCT00141921|plaque psoriasis|plaque psoriasis
823386|NCT00141921|clinical trial|clinical trial
823387|NCT00141908|Hydroxyprogesterone Caproate, twins, preterm delivery|hydroxyprogesterone caproate, twins, preterm delivery
823388|NCT00141895|Intrauterine fetal death, 2nd trimester, induction|intrauterine fetal death, 2nd trimester, induction
823389|NCT00141869|Sensory Processing|sensory processing
823390|NCT00141869|Magnetoencephalogram|magnetoencephalogram
823391|NCT00141869|Tourete Syndrome|tourete syndrome
823392|NCT00141869|Trigeminal Nerve|trigeminal nerve
823393|NCT00141869|Tics|tics
823394|NCT00141869|TS|ts
823395|NCT00141869|Healthy Volunteer|healthy volunteer
823396|NCT00141869|HV|hv
823397|NCT00141856|Dis Management|dis management
823398|NCT00141856|Heart Decompensation|heart decompensation
823399|NCT00141856|Hearts|hearts
823400|NCT00141856|Veteran (M01.930)|veteran (m01.930)
823401|NCT00141843|Hemophilia A|hemophilia a
823402|NCT00141830|Rheumatoid Arthritis|rheumatoid arthritis
823403|NCT00141817|Gastrointestinal Reflux Disease|gastrointestinal reflux disease
823404|NCT00141804|renal transplantation|renal transplantation
823405|NCT00141804|immunosuppression|immunosuppression
823406|NCT00141804|prevention of acute rejection|prevention of acute rejection
823408|NCT00141791|Anti-Asthmatic Agents|anti-asthmatic agents
823409|NCT00141791|Receptors|receptors
823410|NCT00141791|Tumor Necrosis Factor|tumor necrosis factor
823411|NCT00141778|atrial fibrillation|atrial fibrillation
823412|NCT00141778|cardiac surgery|cardiac surgery
823413|NCT00141752|Cerebrovascular Accident|cerebrovascular accident
823414|NCT00141752|Deglutition Disorders|deglutition disorders
823415|NCT00141752|stroke|stroke
823416|NCT00141752|dysphagia|dysphagia
823417|NCT00141752|screening|screening
823418|NCT00141739|Stem Cell Transplantation|stem cell transplantation
823419|NCT00141739|Graft-Versus-Host Disease|graft-versus-host disease
823420|NCT00141739|prophylaxis|prophylaxis
823421|NCT00141726|Enbrel|enbrel
823422|NCT00141726|Stem Cell Transplantation|stem cell transplantation
823423|NCT00141726|Lung Injury|lung injury
823424|NCT00141687|External cephalic version|external cephalic version
823425|NCT00141687|Cesarean section|cesarean section
823426|NCT00141687|pregnancy|pregnancy
823427|NCT00141687|labour|labour
823428|NCT00141687|Breech pregnancy|breech pregnancy
823429|NCT00141674|Blood transfusion|blood transfusion
823430|NCT00141674|Age of blood|age of blood
823431|NCT00141674|Traumatic Brain Injury|traumatic brain injury
823432|NCT00141674|Cerebral Oxygen Extraction Ratio|cerebral oxygen extraction ratio
823433|NCT00141674|Age of transfused blood in traumatic brain injury|age of transfused blood in traumatic brain injury
823434|NCT00141661|Interventional, Alzheimer, Safety and Tolerability|interventional, alzheimer, safety and tolerability
823435|NCT00141648|Osteolymphoma|osteolymphoma
823436|NCT00141648|Chemotherapy|chemotherapy
823437|NCT00141648|Radiotherapy|radiotherapy
823438|NCT00141648|Lymphoma|lymphoma
823439|NCT00141635|Quality of Life|quality of life
823440|NCT00141635|Breast Cancer|breast cancer
823441|NCT00141635|Referee's Report|referee's report
823442|NCT00141635|Diagnostics|diagnostics
823443|NCT00141635|Therapy|therapy
823444|NCT00141622|Endothelial dysfunction|endothelial dysfunction
823445|NCT00141622|ADMA|adma
823446|NCT00141622|DDAH|ddah
823447|NCT00141622|Sodium|sodium
823448|NCT00141609|End-stage renal failure|end-stage renal failure
823449|NCT00141609|Haemodialysis|haemodialysis
823450|NCT00141609|Sodium|sodium
823451|NCT00141609|Blood Pressure|blood pressure
823452|NCT00141596|Resistant Hypertension|resistant hypertension
823453|NCT00141596|Extracellular Fluid Volume|extracellular fluid volume
823454|NCT00141583|Renin-angiotensin system|renin-angiotensin system
823455|NCT00141583|ACE Inhibitor|ace inhibitor
823456|NCT00141583|Angiotensin Receptor Blocker|angiotensin receptor blocker
823457|NCT00141570|Menopause; Postmenopause; Estrogen; Hormone Therapy|menopause; postmenopause; estrogen; hormone therapy
823458|NCT00141557|Menopause; Postmenopause; Estrogen; Hormone Therapy|menopause; postmenopause; estrogen; hormone therapy
823459|NCT00141544|Menopause; Postmenopause; Estrogen; Hormone Therapy|menopause; postmenopause; estrogen; hormone therapy
823460|NCT00141531|Bladder cancer|bladder cancer
823461|NCT00141531|Superficial|superficial
823462|NCT00141531|Carcinoma in situ|carcinoma in situ
823463|NCT00141531|Intravesical instillation|intravesical instillation
823464|NCT00141531|Chemotherapy|chemotherapy
823465|NCT00141531|Adjuvant|adjuvant
823466|NCT00141518|Health economics,Quality of life|health economics,quality of life
823467|NCT00141505|drug interaction|drug interaction
823468|NCT00141505|pharmacokinetics|pharmacokinetics
823469|NCT00141505|valproate|valproate
823470|NCT00141505|bipolar|bipolar
823471|NCT00141492|Type 2 diabetes|type 2 diabetes
823472|NCT00141492|hypogonadism|hypogonadism
823473|NCT00141492|testosterone|testosterone
823474|NCT00141492|glycosylated hemoglobin A1C|glycosylated hemoglobin a1c
823475|NCT00141479|Treatment interruption on reinitiation|treatment interruption on reinitiation
823476|NCT00141479|Schizophrenia|schizophrenia
823477|NCT00141479|Schizoaffective disorder|schizoaffective disorder
823478|NCT00141466|Hereditary colorectal cancer|hereditary colorectal cancer
823479|NCT00141466|Microsatellite instability|microsatellite instability
823480|NCT00141466|Physician roles|physician roles
823481|NCT00141466|Health care implementation|health care implementation
823482|NCT00141466|Intervention|intervention
823483|NCT00141453|angiotensin II type I receptor blockers|angiotensin ii type i receptor blockers
823484|NCT00141453|diabetic nephropathy|diabetic nephropathy
823485|NCT00141453|end-stage renal disease|end-stage renal disease
823486|NCT00141453|renal failure|renal failure
823487|NCT00141453|type 2 diabetes|type 2 diabetes
823488|NCT00141453|olmesartan medoxomil|olmesartan medoxomil
823489|NCT00141440|gas exchange|gas exchange
823490|NCT00141440|pressure support ventilation|pressure support ventilation
823491|NCT00141440|respiratory mechanics|respiratory mechanics
823492|NCT00141440|COPD patients|copd patients
823493|NCT00141297|Advanced cancer|advanced cancer
823494|NCT00141271|Bipolar I Disorder|bipolar i disorder
823495|NCT00141115|Substance-induced anxiety disorder|substance-induced anxiety disorder
823496|NCT00141102|GI events in high risk GI arthritis patients|gi events in high risk gi arthritis patients
823497|NCT00141089|Male patients, chronic constipation, tegaserod|male patients, chronic constipation, tegaserod
823498|NCT00141076|obesity|obesity
823499|NCT00141076|glycemic index|glycemic index
823500|NCT00141076|insulin resistance|insulin resistance
823501|NCT00141076|cardiovascular disease|cardiovascular disease
823502|NCT00141076|diabetes|diabetes
823503|NCT00141063|ADHD, children|adhd, children
823504|NCT00141050|ADHD, children|adhd, children
823505|NCT00141037|Organ Rejection|organ rejection
823506|NCT00141037|Corticosteroids|corticosteroids
823507|NCT00141037|Child|child
823508|NCT00141037|Adolescent|adolescent
823509|NCT00141037|Immunosuppression|immunosuppression
823510|NCT00141037|Steroids|steroids
823511|NCT00141024|HIV Seronegativity|hiv seronegativity
823512|NCT00141024|HIV Preventive Vaccine|hiv preventive vaccine
823513|NCT00141011|Stroke|stroke
823514|NCT00141011|Fibrinogen|fibrinogen
823515|NCT00141011|Reperfusion|reperfusion
823516|NCT00141011|Thrombolysis|thrombolysis
823517|NCT00140998|Turner syndrome|turner syndrome
823518|NCT00140998|Hypogonadism|hypogonadism
823519|NCT00140998|GH|gh
823520|NCT00140998|Estrogen|estrogen
823521|NCT00140998|Estrogen Patches|estrogen patches
823522|NCT00140998|IGF-I|igf-i
823523|NCT00140998|Body Composition|body composition
823524|NCT00140998|Protein Metabolism|protein metabolism
823525|NCT00140998|Lipolysis|lipolysis
823526|NCT00140972|Arcoxia|arcoxia
823527|NCT00140894|Osteoarthritis|osteoarthritis
823528|NCT00140894|Cancer Pain|cancer pain
823529|NCT00140868|Colonic Pseudo-Obstruction|colonic pseudo-obstruction
823530|NCT00140868|Large bowel obstruction|large bowel obstruction
823531|NCT00140868|Stents|stents
823532|NCT00140868|Laparotomy|laparotomy
823533|NCT00140868|Palliative Surgery|palliative surgery
823534|NCT00140868|Surgery, Palliative|surgery, palliative
823535|NCT00140868|Palliative Therapy|palliative therapy
823536|NCT00140855|synovial sarcoma|synovial sarcoma
823537|NCT00140855|immunotherapy|immunotherapy
823538|NCT00140855|cancer-testis antigen|cancer-testis antigen
823539|NCT00140855|cancer-germ cell antigen|cancer-germ cell antigen
823540|NCT00140855|soft tissue sarcoma|soft tissue sarcoma
823541|NCT00140855|SYT-SSX chromosomal translocation|syt-ssx chromosomal translocation
823542|NCT00140842|Obesity, adolescent, ghrelin, growth hormone, cortisol|obesity, adolescent, ghrelin, growth hormone, cortisol
823543|NCT00140829|Cerebellar ataxias|cerebellar ataxias
823544|NCT00140829|Spastic paraplegias|spastic paraplegias
823545|NCT00140829|Mutations spectrum|mutations spectrum
823546|NCT00140829|Linkage studies|linkage studies
823547|NCT00140829|Genetic counselling|genetic counselling
823548|NCT00140790|Cardiorenal syndrome|cardiorenal syndrome
823549|NCT00140790|Renal dysfunction|renal dysfunction
823550|NCT00140790|Cardiovascular events|cardiovascular events
823551|NCT00140790|Valsartan|valsartan
823552|NCT00140764|Genitourinary symptoms|genitourinary symptoms
823553|NCT00140751|HIV-1|hiv-1
823554|NCT00140751|Treatment simplification|treatment simplification
823555|NCT00140751|Lopinavir/ritonavir|lopinavir/ritonavir
823556|NCT00140751|Treatment Experienced|treatment experienced
823557|NCT00140751|HIV Seropositivity|hiv seropositivity
823558|NCT00140725|HBeAg-positive|hbeag-positive
823559|NCT00140725|chronic|chronic
823560|NCT00140725|Hepatitis B|hepatitis b
823561|NCT00140725|lamivudine|lamivudine
823562|NCT00140725|seroconversion|seroconversion
823563|NCT00140725|Chronic Hepatitis B|chronic hepatitis b
823564|NCT00140712|RLS|rls
823565|NCT00140712|PLMS|plms
823566|NCT00140712|Adolescent|adolescent
823567|NCT00140712|Periodic Limb Movements of Sleep|periodic limb movements of sleep
823568|NCT00140712|Ropinirole|ropinirole
823569|NCT00140699|Children, Hearing loss, Balance control, Sensory inputs|children, hearing loss, balance control, sensory inputs
823570|NCT00140660|lymphoma, diffuse large B-cell|lymphoma, diffuse large b-cell
823571|NCT00140660|rituximab|rituximab
823572|NCT00140660|chemotherapy|chemotherapy
823573|NCT00140647|atherosclerosis|atherosclerosis
823574|NCT00140647|carotid artery|carotid artery
823575|NCT00140647|ramipril|ramipril
823576|NCT00140647|rosiglitazone|rosiglitazone
823577|NCT00140647|impaired glucose tolerance|impaired glucose tolerance
823578|NCT00140647|impaired fasting glucose|impaired fasting glucose
823579|NCT00140647|diabetes prevention|diabetes prevention
823580|NCT00140621|cardiac fabry disease|cardiac fabry disease
823581|NCT00140608|sinus|sinus
823582|NCT00140595|Lymphoma, diffuse large B-cell|lymphoma, diffuse large b-cell
823583|NCT00140595|rituximab|rituximab
823584|NCT00140595|chemotherapy|chemotherapy
823585|NCT00140582|lymphoma|lymphoma
823586|NCT00140582|follicular|follicular
823587|NCT00140582|maintenance|maintenance
823588|NCT00140569|follicular lymphoma|follicular lymphoma
823589|NCT00140569|CHVP + interferon|chvp + interferon
823590|NCT00140569|fludarabine|fludarabine
823591|NCT00140569|autotransplant|autotransplant
823592|NCT00140556|head and neck cancer|head and neck cancer
823593|NCT00140556|targeted therapy|targeted therapy
823594|NCT00140556|bevacizumab|bevacizumab
823595|NCT00140556|erlotinib|erlotinib
823596|NCT00140556|Tarceva|tarceva
823597|NCT00140556|radiotherapy|radiotherapy
823598|NCT00140556|concurrent chemotherapy|concurrent chemotherapy
823599|NCT00140556|pharynx cancer|pharynx cancer
823600|NCT00140556|tonsil cancer|tonsil cancer
823601|NCT00140556|hyperfractionation|hyperfractionation
823602|NCT00140556|angiogenesis|angiogenesis
823603|NCT00140556|epidermal growth factor|epidermal growth factor
823604|NCT00140556|vascular endothelial growth factor|vascular endothelial growth factor
823605|NCT00140556|magnetic resonance spectroscopy|magnetic resonance spectroscopy
823606|NCT00140556|cancer of the head and neck|cancer of the head and neck
823607|NCT00140556|upper aerodigestive tract neoplasms|upper aerodigestive tract neoplasms
823608|NCT00140556|pharynx neoplasms|pharynx neoplasms
823609|NCT00140543|simultaneous pancreas/kidney transplantation|simultaneous pancreas/kidney transplantation
823610|NCT00140543|Immunosuppression|immunosuppression
823611|NCT00140517|Plasmodium falciparum|plasmodium falciparum
823612|NCT00140517|malaria|malaria
823613|NCT00140517|pregnancy|pregnancy
823614|NCT00140517|resistance|resistance
823615|NCT00140504|Adverse drug event|adverse drug event
823616|NCT00140504|Patient safety|patient safety
823617|NCT00140504|Internet portal|internet portal
823618|NCT00140504|PatientSite|patientsite
823619|NCT00140504|Preventive health|preventive health
823620|NCT00140504|Primary care|primary care
823621|NCT00140491|Non-Arteritic Anterior Ischemic Optic Neuropathy|non-arteritic anterior ischemic optic neuropathy
823622|NCT00140491|Visual Field Defect|visual field defect
823623|NCT00140491|Neuroplasticity|neuroplasticity
823624|NCT00140491|Rehabilitation|rehabilitation
823625|NCT00140478|Androgen Independent Prostate Cancer|androgen independent prostate cancer
823626|NCT00140478|Prostate Cancer|prostate cancer
823627|NCT00140478|Mifepristone|mifepristone
823628|NCT00140478|RU-486|ru-486
823629|NCT00140452|ALS|als
823630|NCT00140439|asthma|asthma
823631|NCT00140439|emergency department|emergency department
823632|NCT00140439|compliance|compliance
823633|NCT00140439|randomized clinical trial|randomized clinical trial
823634|NCT00140426|Anorexia Nervosa|anorexia nervosa
823635|NCT00140426|Risperidone|risperidone
823636|NCT00140426|Atypical Neuroleptics|atypical neuroleptics
823637|NCT00140426|Dopamine|dopamine
823638|NCT00140426|Leptin|leptin
823639|NCT00140426|Body Image|body image
823640|NCT00140426|Adolescents|adolescents
823641|NCT00140413|Optic Nerve Hypoplasia|optic nerve hypoplasia
823642|NCT00140400|Prostate|prostate
823643|NCT00140400|Cancer|cancer
823644|NCT00140400|Advanced prostate cancer|advanced prostate cancer
823645|NCT00140400|Metastatic|metastatic
823646|NCT00140400|Hormone-refractory|hormone-refractory
823647|NCT00140400|GVAX|gvax
823648|NCT00140400|Vaccine|vaccine
823649|NCT00140400|Allogeneic cells|allogeneic cells
823650|NCT00140387|Prostate|prostate
823651|NCT00140387|Cancer|cancer
823652|NCT00140387|GVAX|gvax
823653|NCT00140387|Metastatic|metastatic
823654|NCT00140387|Vaccine|vaccine
823655|NCT00140387|Allogeneic cells|allogeneic cells
823656|NCT00140374|Prostate|prostate
823657|NCT00140374|Cancer|cancer
823658|NCT00140374|Vaccine|vaccine
823659|NCT00140374|GVAX|gvax
823660|NCT00140374|Allogeneic cells|allogeneic cells
823661|NCT00140361|malaria|malaria
823662|NCT00140361|sulfadoxine-pyrimethamine|sulfadoxine-pyrimethamine
823663|NCT00140361|sulfadoxine-pyrimethamine plus artsunate|sulfadoxine-pyrimethamine plus artsunate
823664|NCT00140361|lumefantrine plus artemether|lumefantrine plus artemether
823665|NCT00140361|combination therapy|combination therapy
823666|NCT00140348|Prostate|prostate
823667|NCT00140348|Cancer|cancer
823668|NCT00140348|Advanced Prostate Cancer|advanced prostate cancer
823669|NCT00140348|Metastatic|metastatic
823670|NCT00140348|Hormone-refractory|hormone-refractory
823671|NCT00140348|GVAX|gvax
823672|NCT00140348|Vaccine|vaccine
823673|NCT00140348|Allogeneic cells|allogeneic cells
823674|NCT00140335|handwashing|handwashing
823675|NCT00140335|communicable diseases|communicable diseases
823676|NCT00140335|health education|health education
823677|NCT00140322|falls|falls
823678|NCT00140322|injury|injury
823679|NCT00140322|elderly|elderly
823680|NCT00140309|TB|tb
823681|NCT00140309|Pulmonary Tuberculosis|pulmonary tuberculosis
823682|NCT00140309|Tuberculosis|tuberculosis
823683|NCT00140309|Pulmonary TB|pulmonary tb
823684|NCT00140283|Effectiveness|effectiveness
823685|NCT00140283|Educational intervention|educational intervention
823686|NCT00140283|Primary health care|primary health care
823687|NCT00140257|Myocardial Infarction|myocardial infarction
823688|NCT00140244|leptin|leptin
823689|NCT00140244|lipodystrophy|lipodystrophy
823690|NCT00140244|insulin resistance|insulin resistance
823691|NCT00140244|hyperlipidemia|hyperlipidemia
823692|NCT00140244|metabolic syndrome|metabolic syndrome
823693|NCT00140231|leptin|leptin
823694|NCT00140231|fasting|fasting
823695|NCT00140231|reproductive|reproductive
823696|NCT00140231|neuroendocrine|neuroendocrine
823697|NCT00140231|immune function|immune function
823698|NCT00140231|energy deficiency associated with short-term fasting|energy deficiency associated with short-term fasting
823699|NCT00140218|amyotrophic lateral sclerosis|amyotrophic lateral sclerosis
823700|NCT00140218|pramipexole|pramipexole
823701|NCT00140218|oxidative stress|oxidative stress
823702|NCT00140218|neuroprotection|neuroprotection
823703|NCT00140205|leptin|leptin
823704|NCT00140205|fasting|fasting
823705|NCT00140205|pharmacokinetics|pharmacokinetics
823706|NCT00140192|creatine metabolism|creatine metabolism
823707|NCT00140192|schizophrenia|schizophrenia
823708|NCT00140192|energy metabolism|energy metabolism
823709|NCT00140179|valnoctamide|valnoctamide
823710|NCT00140179|teratogenicity|teratogenicity
823711|NCT00140179|double-blind|double-blind
823712|NCT00140179|mania|mania
823713|NCT00140166|schizophrenia|schizophrenia
823714|NCT00140166|niacinamide|niacinamide
823715|NCT00140153|androgel|androgel
823716|NCT00140153|female sexuale dysfunction|female sexuale dysfunction
823717|NCT00140153|controlled double-blind|controlled double-blind
823718|NCT00140153|testosterone|testosterone
823719|NCT00140140|Breast cancer|breast cancer
823720|NCT00140114|Vaginal, sublingual, misoprostol, cervical ripening|vaginal, sublingual, misoprostol, cervical ripening
823721|NCT00140101|drug eluting stents|drug eluting stents
823722|NCT00140101|stents|stents
823723|NCT00140101|angioplasty|angioplasty
823724|NCT00140101|coronary artery disease|coronary artery disease
823725|NCT00140101|total coronary occlusion|total coronary occlusion
823726|NCT00140101|coronary artery restenosis|coronary artery restenosis
823727|NCT00140101|stent thrombosis|stent thrombosis
823728|NCT00140101|vascular disease|vascular disease
823729|NCT00140101|myocardial ischemia|myocardial ischemia
823730|NCT00140101|coronary artery stenosis|coronary artery stenosis
823731|NCT00140088|Needlestick pain|needlestick pain
823732|NCT00140088|Venipuncture pain|venipuncture pain
823733|NCT00140010|aneurysm|aneurysm
823734|NCT00140010|autoregulation|autoregulation
823735|NCT00140010|erythropoietion|erythropoietion
823736|NCT00140010|stroke|stroke
823737|NCT00140010|subarachnoid hemorrhage|subarachnoid hemorrhage
823738|NCT00140010|vasospasm|vasospasm
823739|NCT00139997|Major Depression|major depression
823740|NCT00139997|Seasonal Affective Disorder (SAD)|seasonal affective disorder (sad)
823741|NCT00139984|Hypertension|hypertension
823742|NCT00139984|Ambulatory blood pressure monitoring|ambulatory blood pressure monitoring
823743|NCT00139984|Blood pressure|blood pressure
823744|NCT00139984|Risk assessment|risk assessment
823745|NCT00139958|Acute coronary syndrome|acute coronary syndrome
823746|NCT00139958|HIV infection|hiv infection
823747|NCT00139958|Prognosis|prognosis
823748|NCT00139958|Coronary heart disease|coronary heart disease
823749|NCT00139958|Revascularization|revascularization
823750|NCT00139919|Decreasing Titration Study|decreasing titration study
823751|NCT00139919|Schizophrenia|schizophrenia
823752|NCT00139919|Bipolar|bipolar
823753|NCT00139919|Pharmacokinetic|pharmacokinetic
823754|NCT00139906|Titration Study|titration study
823755|NCT00139906|Schizophrenia|schizophrenia
823756|NCT00139906|BID dosing|bid dosing
823757|NCT00139906|Pharmacokinetic|pharmacokinetic
823758|NCT00139841|Lymphoma, Non-Hodgkin|lymphoma, non-hodgkin
823759|NCT00139841|Rituximab Refractory|rituximab refractory
823760|NCT00139841|Rituximab Failure|rituximab failure
823761|NCT00139841|Indolent Non-Hodgkins Lymphoma|indolent non-hodgkins lymphoma
823762|NCT00139828|haemophilia B|haemophilia b
823763|NCT00139828|factor IX|factor ix
823764|NCT00139828|Product Surveillance, Postmarketing|product surveillance, postmarketing
823765|NCT00139828|plasma products|plasma products
823766|NCT00139815|unstable angina|unstable angina
823767|NCT00139815|acute coronary syndrome|acute coronary syndrome
823768|NCT00139815|fondaparinux sodium|fondaparinux sodium
823769|NCT00139815|non ST segment elevation myocardial infarction|non st segment elevation myocardial infarction
823770|NCT00139815|myocardial infarction|myocardial infarction
823771|NCT00139776|Chronic treatment osteoarthritis, Celecoxib, Continuous Use, Intermittent Use|chronic treatment osteoarthritis, celecoxib, continuous use, intermittent use
823772|NCT00139737|Open-label extension Ziprasidone study in Schizophrenia|open-label extension ziprasidone study in schizophrenia
823773|NCT00139633|esophageal cancer, chemotherapy, radiation|esophageal cancer, chemotherapy, radiation
823774|NCT00139620|advanced cancer, solid tumor|advanced cancer, solid tumor
823775|NCT00139594|Bipolar disorder, manic episode/treatment/licarbazepine|bipolar disorder, manic episode/treatment/licarbazepine
824335|NCT00136890|Diagnostic|diagnostic
823776|NCT00139581|Atopic dermatitis, children, infants, pimecrolimus, bid, od|atopic dermatitis, children, infants, pimecrolimus, bid, od
823777|NCT00139568|Chronic constipation|chronic constipation
823778|NCT00139568|5-HT,5-HT4,|5-ht,5-ht4,
823779|NCT00139568|functional GI|functional gi
823780|NCT00139568|China|china
823781|NCT00139568|tegaserod|tegaserod
823782|NCT00139555|Hypertension|hypertension
823783|NCT00139555|Left ventricular hypertrophy|left ventricular hypertrophy
823784|NCT00139542|human|human
823785|NCT00139542|ventricular fibrillation|ventricular fibrillation
823786|NCT00139542|out-of-hospital|out-of-hospital
823787|NCT00139542|cardiac arrest|cardiac arrest
823788|NCT00139542|automated external defibrillators (AED)|automated external defibrillators (aed)
823789|NCT00139542|defibrillators|defibrillators
823790|NCT00139542|electrick countershock|electrick countershock
823791|NCT00139542|cardiopulmonary resuscitation|cardiopulmonary resuscitation
823792|NCT00139490|Blood Pressure, High|blood pressure, high
823793|NCT00139451|GH|gh
823794|NCT00139451|Delayed Growth|delayed growth
823795|NCT00139451|Energy Expenditure|energy expenditure
823796|NCT00139451|Puberty|puberty
823797|NCT00139451|Nutrition|nutrition
823798|NCT00139451|Short Stature|short stature
823799|NCT00139399|Coronary artery bypass|coronary artery bypass
823800|NCT00139399|Coronary arteries|coronary arteries
823801|NCT00139399|Atherosclerosis|atherosclerosis
823802|NCT00139399|Angiography|angiography
823803|NCT00139399|Blood flow|blood flow
823804|NCT00139386|Drug-eluting stent|drug-eluting stent
823805|NCT00139386|Candesartan|candesartan
823806|NCT00139386|Randomized control study|randomized control study
823807|NCT00139386|Coronary Angioplasty|coronary angioplasty
823808|NCT00139373|Progressive supranuclear palsy|progressive supranuclear palsy
823809|NCT00139373|Frontal lobe|frontal lobe
823810|NCT00139373|Oculomotor testing|oculomotor testing
823811|NCT00139373|Neuropsychological scores|neuropsychological scores
823812|NCT00139373|Motor disability (UPDRS)|motor disability (updrs)
823813|NCT00139373|Distractibility|distractibility
823814|NCT00139321|Gait disorders|gait disorders
823815|NCT00139321|Postural instability|postural instability
823816|NCT00139321|parkinsonian syndrome|parkinsonian syndrome
823817|NCT00139321|Gait initiation|gait initiation
823818|NCT00139321|Parkinson's disease|parkinson's disease
823819|NCT00139321|Adults|adults
823820|NCT00139308|Tourette's syndrome|tourette's syndrome
823821|NCT00139308|High frequency stimulation|high frequency stimulation
823822|NCT00139308|Globus pallidus|globus pallidus
823823|NCT00139308|Thalamus|thalamus
823824|NCT00139295|musculoskeletal|musculoskeletal
823825|NCT00139295|osteoarthritis of the knee|osteoarthritis of the knee
823826|NCT00139282|wet AMD|wet amd
823827|NCT00139282|macular degeneration|macular degeneration
823828|NCT00139269|Advanced Squamous Cell Carcinoma|advanced squamous cell carcinoma
823829|NCT00139269|Squamous cell Carcinoma of Head and Neck|squamous cell carcinoma of head and neck
823830|NCT00139269|SSCHN|sschn
823831|NCT00139269|Docetaxel|docetaxel
823832|NCT00139256|Glucocorticoid|glucocorticoid
823833|NCT00139256|Antepartum Betamethasone Treatment|antepartum betamethasone treatment
823834|NCT00139256|Elective Cesarean Section|elective cesarean section
823835|NCT00139256|Respiratory Distress in Infants|respiratory distress in infants
823836|NCT00139243|squamous cell carcinoma|squamous cell carcinoma
823837|NCT00139243|Taxotere|taxotere
823838|NCT00139243|carcinoma of head/neck|carcinoma of head/neck
823839|NCT00139243|Cisplatin|cisplatin
823840|NCT00139243|5-Fluorouracil|5-fluorouracil
823841|NCT00139243|Leucovorin|leucovorin
823842|NCT00139230|Squamous Cell Carcinoma of Head and Neck|squamous cell carcinoma of head and neck
823843|NCT00139230|Compressed TPFL|compressed tpfl
823844|NCT00139230|Taxotere|taxotere
823845|NCT00139230|Growth Factor Support|growth factor support
823846|NCT00139217|Persistent pulmonary hypertension|persistent pulmonary hypertension
823847|NCT00139217|Non-invasive inhaled nitric oxide|non-invasive inhaled nitric oxide
823849|NCT00139204|Prostate cancer|prostate cancer
823850|NCT00139204|Hormone-refractory prostate cancer|hormone-refractory prostate cancer
823851|NCT00139204|PET scan|pet scan
823852|NCT00139204|C11-methionine|c11-methionine
823853|NCT00139204|positron emission tomography|positron emission tomography
823854|NCT00139191|Prostate Cancer|prostate cancer
823855|NCT00139191|positron emission tomography|positron emission tomography
823856|NCT00139191|carbon 11 acetate|carbon 11 acetate
823858|NCT00139191|fatty acid synthase|fatty acid synthase
823859|NCT00139191|FAS|fas
823860|NCT00139165|Collagenous colitis|collagenous colitis
823861|NCT00139165|Budesonide treatment|budesonide treatment
823862|NCT00139165|Diarrhea|diarrhea
823863|NCT00139152|moderate to severe allergic asthma|moderate to severe allergic asthma
823864|NCT00139139|hepatitis A|hepatitis a
823865|NCT00139139|hepatitis A vaccine|hepatitis a vaccine
823866|NCT00139139|immune globulin|immune globulin
823867|NCT00139113|hepatitis A|hepatitis a
823868|NCT00139113|hepatitis A vaccine|hepatitis a vaccine
823869|NCT00139074|Bipolar I Disorder (DSM-IV 296.01, DSM-IV 296.4, DSM-IV 296.61)|bipolar i disorder (dsm-iv 296.01, dsm-iv 296.4, dsm-iv 296.61)
823870|NCT00139048|informed choice|informed choice
823871|NCT00139048|shared decision making|shared decision making
823872|NCT00139048|decision aid|decision aid
823873|NCT00139048|mammography screening|mammography screening
823874|NCT00139048|decision support|decision support
823875|NCT00139035|glucose intolerance|glucose intolerance
823876|NCT00139035|insulin|insulin
823877|NCT00139035|microvascular function|microvascular function
823878|NCT00139035|genotyping|genotyping
823879|NCT00139035|CYP3A5|cyp3a5
823880|NCT00139035|pharmacokinetics|pharmacokinetics
823881|NCT00139035|renal transplantation|renal transplantation
823882|NCT00139022|sleep apnea, home monitoring, CPAP|sleep apnea, home monitoring, cpap
823883|NCT00139009|intracellular concentration|intracellular concentration
823884|NCT00139009|cyclosporine A|cyclosporine a
823885|NCT00139009|renal biopsies|renal biopsies
823886|NCT00139009|heart biopsies|heart biopsies
823887|NCT00139009|Renal transplant recipients|renal transplant recipients
823888|NCT00138996|cardiac arrest|cardiac arrest
823889|NCT00138996|resuscitation|resuscitation
823890|NCT00138996|quality|quality
823891|NCT00138996|feedback|feedback
823892|NCT00138996|training|training
823893|NCT00138983|glucocorticoid-induced osteoporosis|glucocorticoid-induced osteoporosis
823894|NCT00138983|rheumatic diseases|rheumatic diseases
823896|NCT00138983|randomized double-blind, double placebo controlled trial|randomized double-blind, double placebo controlled trial
823897|NCT00138983|alendronate versus alfacalcidol|alendronate versus alfacalcidol
823898|NCT00138970|Cadaveric donor|cadaveric donor
823899|NCT00138970|Calcineurine free|calcineurine free
823900|NCT00138957|Laparoscopic parastomal hernia repair|laparoscopic parastomal hernia repair
823901|NCT00138957|Intraperitoneally|intraperitoneally
823902|NCT00138957|Mesh|mesh
823903|NCT00138957|Quality of life|quality of life
823904|NCT00138957|Postoperative pain|postoperative pain
823905|NCT00138957|Recurrence|recurrence
823906|NCT00138944|Essential hypertension|essential hypertension
823907|NCT00138931|Cardiomyopathy|cardiomyopathy
823908|NCT00138931|Arrhythmia|arrhythmia
823909|NCT00138931|Muscular Dystrophy|muscular dystrophy
823910|NCT00138918|Prostate Cancer|prostate cancer
823911|NCT00138918|Clusterin|clusterin
823912|NCT00138918|Neoadjuvant|neoadjuvant
823913|NCT00138918|Phase II|phase ii
823914|NCT00138905|Base station, EMF, human exposure study,Well-being,cognitive|base station, emf, human exposure study,well-being,cognitive
823915|NCT00138892|Quality of life|quality of life
823916|NCT00138892|waiting time|waiting time
823917|NCT00138892|total joint replacement|total joint replacement
823918|NCT00138879|Citrulline|citrulline
823919|NCT00138879|Parenteral Nutrition|parenteral nutrition
823920|NCT00138879|functioning intestinal mass|functioning intestinal mass
823921|NCT00138879|small bowel permeability and absorption|small bowel permeability and absorption
823922|NCT00138879|Granulomatous Enteritis|granulomatous enteritis
823923|NCT00138866|Spinal cord injury|spinal cord injury
823924|NCT00138853|RSA|rsa
823925|NCT00138853|Genoarthrosis|genoarthrosis
823926|NCT00138853|Knee arthroplasty|knee arthroplasty
823927|NCT00138853|Micromotion of polyethylene liner|micromotion of polyethylene liner
823928|NCT00138840|Crohn's disease|crohn's disease
823929|NCT00138840|Gastroenterology|gastroenterology
823930|NCT00138827|Radiotherapy|radiotherapy
823931|NCT00138827|Mucositis|mucositis
823932|NCT00138827|Xerostomia|xerostomia
823933|NCT00138814|Neoplasm recurrence, local|neoplasm recurrence, local
823934|NCT00138814|Radiotherapy dosage|radiotherapy dosage
823935|NCT00138814|Cosmesis|cosmesis
823936|NCT00138814|Mastectomy, segmental|mastectomy, segmental
823937|NCT00138801|Neuroborreliosis|neuroborreliosis
823938|NCT00138788|Radiotherapy|radiotherapy
823939|NCT00138788|Qualify of life|qualify of life
823940|NCT00138788|Neoplasm metastasis of the brain|neoplasm metastasis of the brain
823941|NCT00138775|D-serine|d-serine
823942|NCT00138775|Negative symptoms|negative symptoms
823943|NCT00138775|Cognition|cognition
823944|NCT00138775|Schizophrenia|schizophrenia
823945|NCT00138775|Amino acid|amino acid
823946|NCT00138736|MBL-deficient|mbl-deficient
823947|NCT00138736|chemotherapy|chemotherapy
823948|NCT00138736|neutropenia|neutropenia
823949|NCT00138736|chemotherapy-induced neutropenia|chemotherapy-induced neutropenia
823950|NCT00138710|obesity|obesity
823951|NCT00138710|Hypogonadotrophic hypogonadism|hypogonadotrophic hypogonadism
823952|NCT00138710|aromatase inhibition|aromatase inhibition
823953|NCT00138697|Agammaglobulinemia|agammaglobulinemia
823954|NCT00138697|Hypogammaglobulinemia|hypogammaglobulinemia
823955|NCT00138697|Immunoglobulins, Intravenous|immunoglobulins, intravenous
823956|NCT00138684|insulin resistance|insulin resistance
823957|NCT00138684|iron overload|iron overload
823958|NCT00138684|phlebotomy|phlebotomy
823959|NCT00138684|hepatic iron overload|hepatic iron overload
823960|NCT00138658|NSCLC|nsclc
823961|NCT00138658|custirsen sodium|custirsen sodium
823962|NCT00138658|OGX-011|ogx-011
823963|NCT00138658|Stage IIIB or IV advanced non-small cell lung cancer|stage iiib or iv advanced non-small cell lung cancer
823964|NCT00138632|Wet Age-related macular degeneration|wet age-related macular degeneration
823965|NCT00138632|PTK787|ptk787
823966|NCT00138619|Type 2 diabetes|type 2 diabetes
823967|NCT00138619|vildagliptin|vildagliptin
823968|NCT00138606|Type 2 diabetes|type 2 diabetes
823969|NCT00138606|vildagliptin|vildagliptin
823970|NCT00138593|Type 2 diabetes|type 2 diabetes
823971|NCT00138593|vildagliptin|vildagliptin
823972|NCT00138580|Type 2 diabetes|type 2 diabetes
823973|NCT00138580|vildagliptin|vildagliptin
823974|NCT00138567|Type 2 diabetes|type 2 diabetes
823975|NCT00138567|vildagliptin|vildagliptin
823976|NCT00138554|Type 2 diabetes|type 2 diabetes
823977|NCT00138554|vildagliptin|vildagliptin
823978|NCT00138541|type 2 diabetes|type 2 diabetes
823979|NCT00138541|vildagliptin|vildagliptin
823980|NCT00138528|Metabolic Syndrome, fluvastatin|metabolic syndrome, fluvastatin
823981|NCT00138515|Type 2 diabetes|type 2 diabetes
823982|NCT00138515|vildagliptin|vildagliptin
823983|NCT00138502|Candidiasis, Funguria|candidiasis, funguria
823984|NCT00138489|Malaria, Papua New Guinea, infants, children|malaria, papua new guinea, infants, children
823985|NCT00138476|Norovirus, calicivirus, gastroenteritis, Norwalk virus, challenge|norovirus, calicivirus, gastroenteritis, norwalk virus, challenge
823986|NCT00138463|West Nile Virus, Neuroinvasive Disease|west nile virus, neuroinvasive disease
823987|NCT00138450|Schistosomiasis, S. haematobium, morbidity, Kenya|schistosomiasis, s. haematobium, morbidity, kenya
823988|NCT00138437|leprosy|leprosy
823989|NCT00138437|Colombia|colombia
823990|NCT00138424|Vistide®, Cidofovir, renal transplant, BK Virus Nephropathy|vistide®, cidofovir, renal transplant, bk virus nephropathy
823991|NCT00138411|anthrax, Bacillus anthracis, monoclonal antibody, ETI-204|anthrax, bacillus anthracis, monoclonal antibody, eti-204
823992|NCT00138398|Influenza, T cell, vaccine, Congestive heart failure|influenza, t cell, vaccine, congestive heart failure
823993|NCT00138385|inactivated, attenuated, influenza vaccine, FluMist, Fluzone|inactivated, attenuated, influenza vaccine, flumist, fluzone
823994|NCT00138372|malaria|malaria
823995|NCT00138372|immunity|immunity
823996|NCT00138372|MSP-1|msp-1
823997|NCT00138372|Kenya|kenya
823998|NCT00138372|infants|infants
823999|NCT00138359|T solium, cysticercus, pig triquina, solitaria, intestinal parasites, Niclosamide, tapeworms, Taeniasis|t solium, cysticercus, pig triquina, solitaria, intestinal parasites, niclosamide, tapeworms, taeniasis
824000|NCT00138346|hydatid disease, Echinococcus granulosus, tapeworm|hydatid disease, echinococcus granulosus, tapeworm
824001|NCT00138333|Thimerosal, mercury levels, low birth weight, Argentina|thimerosal, mercury levels, low birth weight, argentina
824002|NCT00138320|Herpes Simplex, vaccine, antibodies, mother|herpes simplex, vaccine, antibodies, mother
824003|NCT00138307|malaria, children, naturally acquired immunity, Ghana|malaria, children, naturally acquired immunity, ghana
824004|NCT00138294|influenza vaccine|influenza vaccine
824005|NCT00138294|live attenuated influenza vaccine (LAIV or FluMist)|live attenuated influenza vaccine (laiv or flumist)
824006|NCT00138294|inactivated influenza vaccine (IIV)|inactivated influenza vaccine (iiv)
824007|NCT00138294|School-based influenza vaccination program|school-based influenza vaccination program
824008|NCT00138294|children|children
824009|NCT00138294|herd protection|herd protection
824010|NCT00138281|influenza, vaccine, respiratory virus, Fluzone, FluMist|influenza, vaccine, respiratory virus, fluzone, flumist
824011|NCT00138268|umbilical cord blood, vaccine, pregnant women|umbilical cord blood, vaccine, pregnant women
824012|NCT00138242|stage I ovarian epithelial cancer|stage i ovarian epithelial cancer
824013|NCT00138242|stage II ovarian epithelial cancer|stage ii ovarian epithelial cancer
824014|NCT00138242|stage III ovarian epithelial cancer|stage iii ovarian epithelial cancer
824015|NCT00138242|stage IV ovarian epithelial cancer|stage iv ovarian epithelial cancer
824016|NCT00138242|fallopian tube cancer|fallopian tube cancer
824017|NCT00138242|primary peritoneal cavity cancer|primary peritoneal cavity cancer
824018|NCT00138229|recurrent melanoma|recurrent melanoma
824019|NCT00138229|stage IV melanoma|stage iv melanoma
824020|NCT00138216|unspecified childhood solid tumor, protocol specific|unspecified childhood solid tumor, protocol specific
824021|NCT00138216|recurrent childhood cerebellar astrocytoma|recurrent childhood cerebellar astrocytoma
824022|NCT00138216|recurrent childhood cerebral astrocytoma|recurrent childhood cerebral astrocytoma
824023|NCT00138216|recurrent childhood brain stem glioma|recurrent childhood brain stem glioma
824024|NCT00138216|recurrent childhood brain tumor|recurrent childhood brain tumor
824025|NCT00138216|recurrent childhood ependymoma|recurrent childhood ependymoma
824026|NCT00138216|recurrent childhood medulloblastoma|recurrent childhood medulloblastoma
824027|NCT00138216|recurrent childhood supratentorial primitive neuroectodermal tumor|recurrent childhood supratentorial primitive neuroectodermal tumor
824028|NCT00138216|recurrent childhood visual pathway and hypothalamic glioma|recurrent childhood visual pathway and hypothalamic glioma
824029|NCT00138216|childhood oligodendroglioma|childhood oligodendroglioma
824030|NCT00138216|childhood craniopharyngioma|childhood craniopharyngioma
824031|NCT00138216|childhood choroid plexus tumor|childhood choroid plexus tumor
824032|NCT00138216|childhood infratentorial ependymoma|childhood infratentorial ependymoma
824033|NCT00138216|childhood supratentorial ependymoma|childhood supratentorial ependymoma
824034|NCT00138216|childhood high-grade cerebral astrocytoma|childhood high-grade cerebral astrocytoma
824035|NCT00138216|childhood low-grade cerebral astrocytoma|childhood low-grade cerebral astrocytoma
824036|NCT00138216|childhood central nervous system germ cell tumor|childhood central nervous system germ cell tumor
824037|NCT00138216|childhood grade I meningioma|childhood grade i meningioma
824038|NCT00138216|childhood grade II meningioma|childhood grade ii meningioma
824039|NCT00138216|childhood grade III meningioma|childhood grade iii meningioma
824040|NCT00138216|recurrent childhood subependymal giant cell astrocytoma|recurrent childhood subependymal giant cell astrocytoma
824041|NCT00138216|childhood atypical teratoid/rhabdoid tumor|childhood atypical teratoid/rhabdoid tumor
824042|NCT00138164|recurrent adult diffuse large cell lymphoma|recurrent adult diffuse large cell lymphoma
824043|NCT00138164|recurrent grade 1 follicular lymphoma|recurrent grade 1 follicular lymphoma
824044|NCT00138164|recurrent grade 2 follicular lymphoma|recurrent grade 2 follicular lymphoma
824045|NCT00138164|recurrent grade 3 follicular lymphoma|recurrent grade 3 follicular lymphoma
824046|NCT00138164|recurrent small lymphocytic lymphoma|recurrent small lymphocytic lymphoma
824047|NCT00138151|recurrent cervical cancer|recurrent cervical cancer
824048|NCT00138151|stage IVB cervical cancer|stage ivb cervical cancer
824049|NCT00138125|stage IV breast cancer|stage iv breast cancer
824050|NCT00138125|recurrent breast cancer|recurrent breast cancer
824051|NCT00138112|Streptococcal Sepsis|streptococcal sepsis
824052|NCT00138112|Hematopoietic Stem Cell Transplantation|hematopoietic stem cell transplantation
824053|NCT00138112|Hematologic Malignancies|hematologic malignancies
824054|NCT00138112|Streptococci|streptococci
824055|NCT00138112|Transplant|transplant
824056|NCT00138099|Critically ill patients (ICU)|critically ill patients (icu)
824057|NCT00138099|Deep Venous Thromboembolism prevention|deep venous thromboembolism prevention
824058|NCT00138099|Renal Failure|renal failure
824059|NCT00138099|Critically ill|critically ill
824060|NCT00138086|lymphoma|lymphoma
824061|NCT00138086|chemotherapy|chemotherapy
824062|NCT00138086|Zevalin ( Yttrium-90 Ibritumomab Tiuxetan)|zevalin ( yttrium-90 ibritumomab tiuxetan)
824063|NCT00138073|pulmonary artery catheter|pulmonary artery catheter
824064|NCT00138073|waveform interpretation|waveform interpretation
824065|NCT00138073|computer-based learning|computer-based learning
824066|NCT00138073|medical education|medical education
824067|NCT00138060|genotypic profile|genotypic profile
824068|NCT00138060|metastatic colorectal cancer|metastatic colorectal cancer
824069|NCT00138047|zinc|zinc
824070|NCT00138047|HIV|hiv
824071|NCT00138047|children|children
824072|NCT00138034|Open infarct-related artery within 72 hours of thrombolysis|open infarct-related artery within 72 hours of thrombolysis
824073|NCT00138021|Serious mental illness|serious mental illness
824074|NCT00138021|Supported Employment|supported employment
824075|NCT00138021|Cognitive remediation|cognitive remediation
824076|NCT00138021|Cognitive impairments|cognitive impairments
824077|NCT00138008|prostate cancer|prostate cancer
824078|NCT00138008|radical prostatectomy|radical prostatectomy
824079|NCT00138008|PSA failure|psa failure
824080|NCT00138008|RCT|rct
824081|NCT00138008|radiation|radiation
824082|NCT00138008|endocrinotherapy|endocrinotherapy
824083|NCT00137995|Lymphoma|lymphoma
824084|NCT00137995|Chemotherapy|chemotherapy
824085|NCT00137995|rituximab|rituximab
824086|NCT00137982|Ectopic pregnancy|ectopic pregnancy
824087|NCT00137982|Surgical treatment|surgical treatment
824088|NCT00137982|Medical treatment|medical treatment
824089|NCT00137982|Fertility|fertility
824090|NCT00137969|Rituxan|rituxan
824091|NCT00137969|SLE|sle
824092|NCT00137969|Lupus|lupus
824093|NCT00137956|Endobronchial Valve|endobronchial valve
824094|NCT00137956|Endobronchial Valve ProcedureEBV|endobronchial valve procedureebv
824095|NCT00137956|EBV Procedure|ebv procedure
824096|NCT00137956|Endobronchial Lung Volume Reduction|endobronchial lung volume reduction
824097|NCT00137956|Lung Volume Reduction|lung volume reduction
824098|NCT00137943|Parent-child communication|parent-child communication
824099|NCT00137943|Primary prevention|primary prevention
824100|NCT00137943|sexual risk prevention|sexual risk prevention
824101|NCT00137943|HIV|hiv
824102|NCT00137930|Prophylaxis of rotavirus gastroenteritis|prophylaxis of rotavirus gastroenteritis
824103|NCT00137917|Prophylaxis meningococcal serogroup B disease|prophylaxis meningococcal serogroup b disease
824104|NCT00137904|multiple sclerosis|multiple sclerosis
824105|NCT00137904|fatigue|fatigue
824106|NCT00137904|sleep disorders|sleep disorders
824107|NCT00137891|Multinodular goiter|multinodular goiter
824108|NCT00137852|Esophageal Cancer|esophageal cancer
824109|NCT00137852|Resectable Esophageal Cancer|resectable esophageal cancer
824110|NCT00137852|Radiation Therapy|radiation therapy
824111|NCT00137852|Celecoxib|celecoxib
824112|NCT00137852|Irinotecan|irinotecan
824113|NCT00137852|Cisplatin|cisplatin
824114|NCT00137839|Tarceva|tarceva
824115|NCT00137839|Erlotinib|erlotinib
824116|NCT00137839|OSI-774|osi-774
824117|NCT00137839|Adenocarcinoma|adenocarcinoma
824118|NCT00137839|Advanced Lung Cancer|advanced lung cancer
824119|NCT00137826|Mesothelioma|mesothelioma
824120|NCT00137826|Avastin|avastin
824121|NCT00137826|Bevacizumab|bevacizumab
824122|NCT00137826|Tarceva|tarceva
824123|NCT00137826|OSI-774|osi-774
824124|NCT00137826|Erlotinib|erlotinib
824125|NCT00137813|Bevacizumab|bevacizumab
824126|NCT00137813|Docetaxel|docetaxel
824127|NCT00137813|AvaTax|avatax
824128|NCT00137813|Metastatic Esophagogastric Cancer|metastatic esophagogastric cancer
824129|NCT00137800|Non-Small Cell Lung Cancer|non-small cell lung cancer
824130|NCT00137800|Elderly Cancer Patients|elderly cancer patients
824131|NCT00137800|Tarceva|tarceva
824132|NCT00137800|Erlotinib|erlotinib
824133|NCT00137800|OSI-774|osi-774
824134|NCT00137800|Stage IIIB or IV Non-Small Cell Lung Cancer|stage iiib or iv non-small cell lung cancer
824135|NCT00137787|febrile neutropenia|febrile neutropenia
824136|NCT00137787|hematologic disease|hematologic disease
824137|NCT00137774|Metastatic Neuroendocrine Tumor|metastatic neuroendocrine tumor
824138|NCT00137774|Advanced Neuroendocrine tumor|advanced neuroendocrine tumor
824139|NCT00137774|Bevacizumab|bevacizumab
824140|NCT00137774|Temozolomide|temozolomide
824141|NCT00137761|Pancreatic Carcinoma|pancreatic carcinoma
824142|NCT00137761|Iressa|iressa
824143|NCT00137761|Docetaxel|docetaxel
824144|NCT00137748|Lung transplantation|lung transplantation
824145|NCT00137735|carpal tunnel syndrome|carpal tunnel syndrome
824146|NCT00137735|gabapentin|gabapentin
824147|NCT00137722|Asthma|asthma
824148|NCT00137722|Disease Management|disease management
824149|NCT00137722|Outcomes|outcomes
824150|NCT00137722|Utilization|utilization
824151|NCT00137709|epilepsy|epilepsy
824152|NCT00137709|hormone|hormone
824153|NCT00137696|polio|polio
824154|NCT00137696|vaccine|vaccine
824155|NCT00137696|immunogenicity|immunogenicity
824156|NCT00137683|screening|screening
824157|NCT00137683|prevention|prevention
824158|NCT00137683|community health education|community health education
824159|NCT00137670|Intervention studies|intervention studies
824161|NCT00137657|HIV|hiv
824162|NCT00137657|malaria|malaria
824163|NCT00137657|E. Coli|e. coli
824164|NCT00137657|S. pneumoniae|s. pneumoniae
824165|NCT00137657|drug resistance|drug resistance
824166|NCT00137657|antifolate|antifolate
824167|NCT00137657|opportunistic infections|opportunistic infections
824168|NCT00137657|Africa|africa
824169|NCT00137657|Kenya|kenya
824170|NCT00137657|East Africa|east africa
824171|NCT00137644|Adolescent|adolescent
824172|NCT00137644|*HIV Infections/ pc [Prevention & Control]|*hiv infections/ pc [prevention & control]
824173|NCT00137644|Male|male
824174|NCT00137644|Humans|humans
824175|NCT00137644|Risk-Taking|risk-taking
824176|NCT00137644|Safe Sex|safe sex
824177|NCT00137644|Sexual Behavior|sexual behavior
824178|NCT00137644|HIV|hiv
824179|NCT00137644|HIV Seronegativity|hiv seronegativity
824180|NCT00137631|Adult|adult
824181|NCT00137631|HIV Infections / pc [Prevention & Control]|hiv infections / pc [prevention & control]
824182|NCT00137631|Homosexuality, Male|homosexuality, male
824183|NCT00137631|Humans|humans
824184|NCT00137631|Male|male
824185|NCT00137631|Risk-Taking|risk-taking
824186|NCT00137631|Safe Sex|safe sex
824187|NCT00137631|Sexual Behavior|sexual behavior
824188|NCT00137631|HIV|hiv
824189|NCT00137618|Prostatic neoplasm|prostatic neoplasm
824190|NCT00137618|Prostate cancer|prostate cancer
824191|NCT00137618|Informed decision making|informed decision making
824192|NCT00137618|Prostate cancer screening|prostate cancer screening
824193|NCT00137618|Prostate specific antigen|prostate specific antigen
824194|NCT00137605|HIV|hiv
824195|NCT00137605|HIV Infections|hiv infections
824196|NCT00137592|screening|screening
824197|NCT00137592|community health education|community health education
824198|NCT00137579|Influenza Vaccines|influenza vaccines
824199|NCT00137579|Acenocoumarol|acenocoumarol
824200|NCT00137579|Drug Administration Routes|drug administration routes
824201|NCT00137579|Anticoagulants|anticoagulants
824202|NCT00137566|malaria|malaria
824203|NCT00137566|treatment|treatment
824204|NCT00137566|paracetamol|paracetamol
824205|NCT00137566|chloroquine|chloroquine
824206|NCT00137566|Guinea-Bissau|guinea-bissau
824207|NCT00137566|children|children
824208|NCT00137566|P.falciparum|p.falciparum
824209|NCT00137553|Children|children
824210|NCT00137553|malaria|malaria
824211|NCT00137553|sulfadoxine-pyrimethamine|sulfadoxine-pyrimethamine
824212|NCT00137553|Guinea-Bissau|guinea-bissau
824213|NCT00137553|treatment|treatment
824214|NCT00137540|First line ablation therapy|first line ablation therapy
824215|NCT00137527|Cardiac Surgery|cardiac surgery
824216|NCT00137527|Cardiopulmonary Bypass|cardiopulmonary bypass
824217|NCT00137527|Cerebral Oxygenation|cerebral oxygenation
824218|NCT00137527|Neurologic Dysfunction|neurologic dysfunction
824219|NCT00137527|Neurocognitive Dysfunction|neurocognitive dysfunction
824220|NCT00137527|Neurological manifestations|neurological manifestations
824221|NCT00137527|Memory loss|memory loss
824222|NCT00137527|Delirium|delirium
824223|NCT00137527|Coronary Artery Bypass|coronary artery bypass
824224|NCT00137514|malaria|malaria
824225|NCT00137514|Plasmodium falciparum|plasmodium falciparum
824226|NCT00137514|chloroquine|chloroquine
824227|NCT00137514|amodiaquine|amodiaquine
824228|NCT00137514|treatment|treatment
824229|NCT00137514|Guinea-Bissau|guinea-bissau
824230|NCT00137514|children|children
824231|NCT00137488|non-enhancing lesion|non-enhancing lesion
824232|NCT00137488|low grade glioma|low grade glioma
824233|NCT00137488|high risk group selection|high risk group selection
824234|NCT00137475|IMRT|imrt
824235|NCT00137475|head and neck cancer|head and neck cancer
824236|NCT00137475|parotid sparing|parotid sparing
824237|NCT00137436|First-line treatment of metastatic hormone-refractory prostate cancer SUTENT in combination with docetaxel and prednisone|first-line treatment of metastatic hormone-refractory prostate cancer sutent in combination with docetaxel and prednisone
824238|NCT00137384|Magnetoencephalogram|magnetoencephalogram
824239|NCT00137384|Functional Connectivity|functional connectivity
824240|NCT00137384|Electroencephalogram (EEG)|electroencephalogram (eeg)
824241|NCT00137384|Focal Hand Dystonia|focal hand dystonia
824242|NCT00137384|Spectral Analysis|spectral analysis
824243|NCT00137384|Healthy Volunteer|healthy volunteer
824244|NCT00137384|HV|hv
824245|NCT00137371|Postmenopause|postmenopause
824246|NCT00137371|Vaginitis|vaginitis
824247|NCT00137358|Cervical|cervical
824248|NCT00137358|Uterine|uterine
824249|NCT00137358|Para-aortic|para-aortic
824250|NCT00137358|Nodes|nodes
824251|NCT00137358|IMRT|imrt
824252|NCT00137358|Cancer|cancer
824253|NCT00137345|Randomized controlled trial|randomized controlled trial
824254|NCT00137345|Clinical Trial Phase III|clinical trial phase iii
824255|NCT00137345|Drug therapy|drug therapy
824256|NCT00137345|Immunosuppression|immunosuppression
824257|NCT00137345|Treatment outcome|treatment outcome
824258|NCT00137345|Kidney transplantation|kidney transplantation
824259|NCT00137345|Kidney function tests|kidney function tests
824260|NCT00137332|Arrhythmia|arrhythmia
824261|NCT00137332|antiarrhythmic|antiarrhythmic
824262|NCT00137332|programmed electrical stimulation|programmed electrical stimulation
824263|NCT00137319|inspiratory impedance threshold device|inspiratory impedance threshold device
824264|NCT00137319|blood pressure regulation|blood pressure regulation
824265|NCT00137319|head-up tilt test|head-up tilt test
824266|NCT00137319|tilt table testing|tilt table testing
824267|NCT00137319|burn injury|burn injury
824268|NCT00137319|Burns|burns
824269|NCT00137306|Guideline Adherence|guideline adherence
824270|NCT00137306|Quality Assurance, Health Care|quality assurance, health care
824271|NCT00137293|Arrhythmia, syncope, antiarrhythmic|arrhythmia, syncope, antiarrhythmic
824272|NCT00137280|Randomized Controlled Trial|randomized controlled trial
824273|NCT00137280|Quality of Health Care|quality of health care
824274|NCT00137280|Health Services Research|health services research
824275|NCT00137280|Guidelines|guidelines
824276|NCT00137280|Medical Informatics Computing|medical informatics computing
824277|NCT00137280|Services, Mental Health|services, mental health
824278|NCT00137280|Medicine, Evidenced-Based|medicine, evidenced-based
824279|NCT00137280|Quality Assurance, Healthcare|quality assurance, healthcare
824280|NCT00137280|Quality Indicators, Health Care|quality indicators, health care
824281|NCT00137280|Veterans|veterans
824282|NCT00137280|Unemployment|unemployment
824283|NCT00137280|Obesity|obesity
824284|NCT00137280|Quality Improvement|quality improvement
824285|NCT00137267|Schizophrenia / disorders w psychotic features|schizophrenia / disorders w psychotic features
824286|NCT00137267|Substance-related disorders|substance-related disorders
824287|NCT00137267|Community Mental Health Services|community mental health services
824288|NCT00137267|Case Management|case management
824289|NCT00137267|Health Education|health education
824290|NCT00137254|Severe burns|severe burns
824291|NCT00137254|Hyperinsulinemia|hyperinsulinemia
824292|NCT00137254|Insulin|insulin
824293|NCT00137254|Muscle protein kinetics|muscle protein kinetics
824294|NCT00137254|Immune function|immune function
824295|NCT00137254|Exercise|exercise
824296|NCT00137241|health literacy|health literacy
824297|NCT00137241|screening|screening
824298|NCT00137241|cancer|cancer
824299|NCT00137241|health disparities|health disparities
824300|NCT00137228|Hand Edema|hand edema
824301|NCT00137228|Figure of eight method|figure of eight method
824302|NCT00137228|Measuring edema in burn patients|measuring edema in burn patients
824303|NCT00137215|burns|burns
824304|NCT00137215|donor site care|donor site care
824305|NCT00137215|Silverlon dressing|silverlon dressing
824306|NCT00137202|pruritus|pruritus
824307|NCT00137202|burn wound|burn wound
824308|NCT00137189|Motivation|motivation
824309|NCT00137189|Music Therapy|music therapy
824310|NCT00137189|Psychotherapy|psychotherapy
824311|NCT00137176|Clinically Isolated Syndrome|clinically isolated syndrome
824312|NCT00137163|burns|burns
824313|NCT00137163|donor site care|donor site care
824314|NCT00137163|Dermafill dressing|dermafill dressing
824315|NCT00137124|Essential hypertension|essential hypertension
824316|NCT00137111|Leukemia|leukemia
824317|NCT00137085|procedural sedation|procedural sedation
824318|NCT00136955|Weekly Irinotecan(60mg/sqm, D1, 8, 15) in combination with Cisplatin (60mg/sqm, D1), Squamous Cell Carcinoma Of The Uterine Cervix|weekly irinotecan(60mg/sqm, d1, 8, 15) in combination with cisplatin (60mg/sqm, d1), squamous cell carcinoma of the uterine cervix
824320|NCT00136929|MI|mi
824321|NCT00136929|Acute myocardial infarction (AMI), (MI)|acute myocardial infarction (ami), (mi)
824322|NCT00136903|Graft vs Host Disease|graft vs host disease
824323|NCT00136903|GVHD|gvhd
824324|NCT00136903|Graft Versus Host Disease|graft versus host disease
824325|NCT00136903|Bone marrow transplant|bone marrow transplant
824326|NCT00136903|Stem cells|stem cells
824327|NCT00136903|Mesenchymal stem cells|mesenchymal stem cells
824328|NCT00136903|Adult stem cells|adult stem cells
824329|NCT00136903|Leukemia|leukemia
824330|NCT00136903|Lymphoma|lymphoma
824331|NCT00136890|Positron-Emission Tomography|positron-emission tomography
824332|NCT00136890|PET Scan|pet scan
824333|NCT00136890|Lung Cancer|lung cancer
824334|NCT00136890|Thoracic Surgery|thoracic surgery
824336|NCT00136890|Randomized Controlled Trial|randomized controlled trial
824337|NCT00136890|Oncology|oncology
824338|NCT00136877|recurrent tonsillitis|recurrent tonsillitis
824339|NCT00136877|streptococcus|streptococcus
824340|NCT00136877|tonsillectomy|tonsillectomy
824341|NCT00136877|prevention|prevention
824342|NCT00136864|Positron-Emission Tomography|positron-emission tomography
824343|NCT00136864|PET Scan|pet scan
824344|NCT00136864|Non-Small-Cell Lung Carcinoma|non-small-cell lung carcinoma
824345|NCT00136864|Diagnosis|diagnosis
824346|NCT00136864|Radiation Oncology|radiation oncology
824347|NCT00136864|Lung Cancer|lung cancer
824348|NCT00136864|Randomized Controlled Trial|randomized controlled trial
824349|NCT00136864|Oncology|oncology
824350|NCT00136864|Radiation Planning|radiation planning
824351|NCT00136851|Hypertension|hypertension
824352|NCT00136838|tobacco use|tobacco use
824353|NCT00136825|cocaine|cocaine
824354|NCT00136825|treatment|treatment
824355|NCT00136812|tobacco|tobacco
824356|NCT00136799|Mixed Dyslipidemia|mixed dyslipidemia
824357|NCT00136799|high cholesterol|high cholesterol
824358|NCT00136799|adults|adults
824359|NCT00136799|fluvastatin|fluvastatin
824360|NCT00136786|tobacco use|tobacco use
824361|NCT00136773|Albuminuria|albuminuria
824362|NCT00136773|Type 2 diabetes mellitus|type 2 diabetes mellitus
824363|NCT00136773|Hypertension|hypertension
824364|NCT00136760|tobacco|tobacco
824365|NCT00136747|tobacco use|tobacco use
824366|NCT00136734|ADHD|adhd
824367|NCT00136734|Cocaine dependence|cocaine dependence
824368|NCT00136734|treatment|treatment
824369|NCT00136734|methylphenidate|methylphenidate
824370|NCT00136721|Parkinson's disease|parkinson's disease
824371|NCT00136721|phenotype-genotype correlations|phenotype-genotype correlations
824372|NCT00136721|mutations spectrum|mutations spectrum
824373|NCT00136721|candidate genes|candidate genes
824374|NCT00136708|Global Network|global network
824375|NCT00136708|Neonatal mortality|neonatal mortality
824376|NCT00136708|Asphyxia|asphyxia
824377|NCT00136708|Maternal and child health|maternal and child health
824378|NCT00136708|International|international
824379|NCT00136708|Zambia|zambia
824380|NCT00136708|Pakistan|pakistan
824381|NCT00136708|India|india
824382|NCT00136708|Democratic Republic of Congo|democratic republic of congo
824383|NCT00136708|Uruguay|uruguay
824384|NCT00136708|Guatemala|guatemala
824385|NCT00136708|Argentina|argentina
824386|NCT00136708|Neonatal resuscitation|neonatal resuscitation
824387|NCT00136695|Aging|aging
824388|NCT00136682|Major abdominal or pelvic surgery|major abdominal or pelvic surgery
824389|NCT00136682|Patient-Controlled Epidural Analgesia (PCEA)|patient-controlled epidural analgesia (pcea)
824390|NCT00136682|Length of hospital stay after surgery|length of hospital stay after surgery
824391|NCT00136669|Acupuncture|acupuncture
824392|NCT00136669|Pain|pain
824393|NCT00136669|Pancreatic Neoplasms|pancreatic neoplasms
824394|NCT00136656|infant|infant
824395|NCT00136656|children|children
824396|NCT00136656|pyelonephritis|pyelonephritis
824397|NCT00136656|Renal scars|renal scars
824398|NCT00136656|DMSA scan|dmsa scan
824399|NCT00136643|microbicide|microbicide
824400|NCT00136643|Women|women
824401|NCT00136643|Prevention|prevention
824402|NCT00136643|HIV|hiv
824403|NCT00136643|STIs|stis
824404|NCT00136643|HIV Seronegativity|hiv seronegativity
824405|NCT00136643|prevention of sexually transmitted infections including HIV.|prevention of sexually transmitted infections including hiv.
824406|NCT00136630|dominant spinocerebellar degenerations|dominant spinocerebellar degenerations
824407|NCT00136630|new rate scales|new rate scales
824408|NCT00136630|natural history|natural history
824409|NCT00136630|molecular biology|molecular biology
824410|NCT00136630|candidate genes|candidate genes
824411|NCT00136617|Short Alcohol Withdrawal Scale|short alcohol withdrawal scale
824412|NCT00136617|Documentation|documentation
824413|NCT00136604|Prophylaxis diphtheria|prophylaxis diphtheria
824414|NCT00136604|Hib & meningococcal serogroup A & C disease|hib & meningococcal serogroup a & c disease
824415|NCT00136591|follicular lymphoma|follicular lymphoma
824416|NCT00136591|bortezomib|bortezomib
824417|NCT00136591|relapse|relapse
824418|NCT00136578|solid tumors|solid tumors
824419|NCT00136578|dose limiting toxicity|dose limiting toxicity
824420|NCT00136578|carboplatin|carboplatin
824421|NCT00136578|tolerability|tolerability
824422|NCT00136578|Safety|safety
824423|NCT00136565|peripheral T-cell lymphomas|peripheral t-cell lymphomas
824424|NCT00136565|bortezomib|bortezomib
824425|NCT00136565|ACVBP regimen|acvbp regimen
824426|NCT00136552|lymphoma|lymphoma
824427|NCT00136552|follicular|follicular
824428|NCT00136552|B-cell|b-cell
824429|NCT00136552|rituximab|rituximab
824430|NCT00136552|interferon|interferon
824431|NCT00136539|Breast Cancer|breast cancer
824432|NCT00136539|Early Stage Breast Cancer|early stage breast cancer
824433|NCT00136539|HER2-positive|her2-positive
824434|NCT00136539|HER2-positive breast cancer|her2-positive breast cancer
824435|NCT00136539|Herceptin|herceptin
824436|NCT00136539|Taxol|taxol
824437|NCT00136539|Stage II Breast Cancer|stage ii breast cancer
824438|NCT00136539|Stage III Breast Cancer|stage iii breast cancer
824439|NCT00136526|Prostate Cancer|prostate cancer
824440|NCT00136526|Hormone refractory prostate cancer|hormone refractory prostate cancer
824441|NCT00136526|Metastatic prostate cancer|metastatic prostate cancer
824442|NCT00136513|Safety|safety
824443|NCT00136513|tolerability|tolerability
824444|NCT00136513|dose limiting toxicity|dose limiting toxicity
824445|NCT00136513|solid tumors|solid tumors
824446|NCT00136500|genetics|genetics
824447|NCT00136500|biomarkers|biomarkers
824448|NCT00136500|pre-symptomatic|pre-symptomatic
824449|NCT00136500|natural history|natural history
824450|NCT00136487|Prostate Cancer|prostate cancer
824451|NCT00136487|Cancer of Prostate|cancer of prostate
824452|NCT00136487|Cancer of the Prostate|cancer of the prostate
824453|NCT00136487|Prostate-Specific Antigen|prostate-specific antigen
824454|NCT00136474|Lymphoma|lymphoma
824455|NCT00136474|Radiation therapy|radiation therapy
824456|NCT00136474|Amifostine|amifostine
824457|NCT00136461|AML|aml
824458|NCT00136461|acute myelogenous leukemia|acute myelogenous leukemia
824459|NCT00136461|MDS|mds
824460|NCT00136461|myelodysplastic syndrome|myelodysplastic syndrome
824461|NCT00136461|bryostatin 1|bryostatin 1
824462|NCT00136461|all-trans retinoic acid|all-trans retinoic acid
824464|NCT00136448|AML|aml
824465|NCT00136448|acute myelogenous leukemia|acute myelogenous leukemia
824466|NCT00136448|cytarabine|cytarabine
824467|NCT00136448|interleukin-2|interleukin-2
824468|NCT00136435|ALL|all
824469|NCT00136435|acute lymphoblastic leukemia|acute lymphoblastic leukemia
824470|NCT00136435|chemotherapy|chemotherapy
824471|NCT00136435|asparaginase|asparaginase
824472|NCT00136422|AML|aml
824473|NCT00136422|acute myelogenous leukemia|acute myelogenous leukemia
824474|NCT00136422|MDS|mds
824475|NCT00136422|myelodysplasia|myelodysplasia
824476|NCT00136422|vaccine|vaccine
824477|NCT00136409|myelofibrosis|myelofibrosis
824478|NCT00136409|agnogenic myeloid metaplasia with myelofibrosis|agnogenic myeloid metaplasia with myelofibrosis
824479|NCT00136409|CMML|cmml
824480|NCT00136409|chronic myelomonocytic leukemia|chronic myelomonocytic leukemia
824481|NCT00136409|imatinib mesylate|imatinib mesylate
824482|NCT00136409|Gleevec|gleevec
824483|NCT00136396|Steroid-refractory Chronic Graft vs. Host Disease|steroid-refractory chronic graft vs. host disease
824484|NCT00136396|Chronic Graft vs. Host Disease|chronic graft vs. host disease
824485|NCT00136396|GVHD|gvhd
824486|NCT00136396|steroid-refractory|steroid-refractory
824487|NCT00136396|rituximab|rituximab
824488|NCT00136370|Chlorhexidine|chlorhexidine
824489|NCT00136370|Prevention|prevention
824490|NCT00136370|Neonatal sepsis|neonatal sepsis
824491|NCT00136370|Peripartum infections|peripartum infections
824492|NCT00136357|posttraumatic stress|posttraumatic stress
824493|NCT00136357|mind-body techniques|mind-body techniques
824494|NCT00136357|war|war
824495|NCT00136357|adolescents|adolescents
824496|NCT00136344|cataract surgery|cataract surgery
824497|NCT00136344|phacoemulsification|phacoemulsification
824498|NCT00136344|post-operative endophthalmitis|post-operative endophthalmitis
824499|NCT00136331|Pandemic|pandemic
824500|NCT00136331|Influenza|influenza
824501|NCT00136331|Prevention|prevention
824502|NCT00136331|Vaccine|vaccine
824503|NCT00136331|Prevention of Pandemic Influenza|prevention of pandemic influenza
824504|NCT00136318|Pegasys-Induced depression|pegasys-induced depression
824505|NCT00136305|pediatric asthma|pediatric asthma
824506|NCT00136305|asthma action plans|asthma action plans
824507|NCT00136305|patient education|patient education
824508|NCT00136305|medication adherence|medication adherence
824509|NCT00136292|Gram-Positive Infection|gram-positive infection
824510|NCT00136279|adolescent behavior|adolescent behavior
824511|NCT00136279|sexual behavior|sexual behavior
824512|NCT00136279|smoking|smoking
824513|NCT00136279|parents|parents
824514|NCT00136279|communication|communication
824515|NCT00136279|health education|health education
824516|NCT00136279|schools|schools
824517|NCT00136279|Sexual initiation|sexual initiation
824518|NCT00136266|Adherence|adherence
824519|NCT00136266|Supplements|supplements
824520|NCT00136266|Iron|iron
824521|NCT00136266|Iron deficiency|iron deficiency
824522|NCT00136266|Anemia|anemia
824523|NCT00136266|Vitamins|vitamins
824524|NCT00136266|Minerals|minerals
824525|NCT00136227|screening,|screening,
824526|NCT00136227|community health education,|community health education,
824527|NCT00136227|decision making,|decision making,
824528|NCT00136227|computer-assisted decision making|computer-assisted decision making
824529|NCT00136201|Peritonitis|peritonitis
824530|NCT00136201|Community-Acquired Infections|community-acquired infections
824531|NCT00136201|Cross Infection|cross infection
824532|NCT00136188|Prediabetes|prediabetes
824533|NCT00136188|Metabolic Syndrome|metabolic syndrome
824534|NCT00136188|Healthy Controls|healthy controls
824535|NCT00136188|Endothelial function|endothelial function
824536|NCT00136175|Neoadjuvant chemotherapy|neoadjuvant chemotherapy
824537|NCT00136110|ALS|als
824538|NCT00136110|Sodium Valproate|sodium valproate
824539|NCT00136110|randomised trial|randomised trial
824540|NCT00136110|Amyotrophic Lateral Sclerosis (ALS)|amyotrophic lateral sclerosis (als)
824541|NCT00136097|colonisation of the catheter|colonisation of the catheter
824542|NCT00136084|Leukemia,Erythroblastic, Acute|leukemia,erythroblastic, acute
824543|NCT00136084|Erythroblastic Leukemia, Acute|erythroblastic leukemia, acute
824544|NCT00136084|Leukemia, Myeloid, Acute|leukemia, myeloid, acute
824545|NCT00136084|Myeloid Leukemia, Acute|myeloid leukemia, acute
824546|NCT00136071|Stress Urinary Incontinence,|stress urinary incontinence,
824547|NCT00136071|TOT,|tot,
824548|NCT00136071|TVT-O|tvt-o
824549|NCT00136058|osteoporosis|osteoporosis
824550|NCT00136058|hip fracture|hip fracture
824551|NCT00136045|Idiopathic RLS|idiopathic rls
824552|NCT00136032|Growth Hormone|growth hormone
824553|NCT00136032|Cardiovascular risk|cardiovascular risk
824554|NCT00136032|Pituitary|pituitary
824555|NCT00136032|Hypothalamic|hypothalamic
824556|NCT00136032|GH Deficiency|gh deficiency
824557|NCT00136032|Pituitary Tumor|pituitary tumor
824558|NCT00136032|Pituitary Disease|pituitary disease
824559|NCT00136019|Epilepsy with partial seizures|epilepsy with partial seizures
824560|NCT00136006|Epidemiology|epidemiology
824561|NCT00136006|Lung health|lung health
824562|NCT00136006|lung function|lung function
824563|NCT00136006|COPD|copd
824564|NCT00135993|Idiopathic Restless Leg syndrome|idiopathic restless leg syndrome
824565|NCT00135967|membranous nephropathy|membranous nephropathy
824566|NCT00135967|mycophenolate mofetil|mycophenolate mofetil
824567|NCT00135967|cyclophosphamide|cyclophosphamide
824568|NCT00135967|prednisone|prednisone
824569|NCT00135954|membranous nephropathy|membranous nephropathy
824570|NCT00135954|cyclophosphamide|cyclophosphamide
824571|NCT00135954|prednisone|prednisone
824572|NCT00135941|Diabetes Mellitus, Type 2|diabetes mellitus, type 2
824573|NCT00135928|ST-elevation myocardial infarction|st-elevation myocardial infarction
824574|NCT00135928|granulocyte-colony stimulating factor angiogenesis|granulocyte-colony stimulating factor angiogenesis
824575|NCT00135928|stem cells|stem cells
824576|NCT00135902|Preterm birth|preterm birth
824577|NCT00135902|Progesterone|progesterone
824578|NCT00135902|Omega-3 fatty acid|omega-3 fatty acid
824579|NCT00135902|Pregnancy|pregnancy
824580|NCT00135889|Total Knee Arthroplasty secondary to osteoarthritis|total knee arthroplasty secondary to osteoarthritis
824581|NCT00135876|deep vein thrombosis|deep vein thrombosis
824582|NCT00135876|pulmonary embolism|pulmonary embolism
824583|NCT00135876|glioma|glioma
824584|NCT00135876|fragmin|fragmin
824585|NCT00135876|anticoagulant|anticoagulant
824586|NCT00135876|prophylaxis|prophylaxis
824587|NCT00135876|dalteparin|dalteparin
824588|NCT00135850|Gene therapy|gene therapy
824589|NCT00135850|VEGF|vegf
824590|NCT00135850|Stem cells|stem cells
824591|NCT00135850|myocardial ischemia|myocardial ischemia
824592|NCT00135850|angiogenesis|angiogenesis
824593|NCT00135837|Age related Macula Degeneration,|age related macula degeneration,
824594|NCT00135837|AMD,|amd,
824595|NCT00135837|choroidal neovascularisation (CNV),|choroidal neovascularisation (cnv),
824596|NCT00135837|occult CNV lesion,|occult cnv lesion,
824597|NCT00135837|verteporfin for injection,|verteporfin for injection,
824598|NCT00135837|photodynamic therapy (PDT)|photodynamic therapy (pdt)
824599|NCT00135824|Artificial eye drops|artificial eye drops
824600|NCT00135824|tolerability|tolerability
824601|NCT00135824|healthy volunteers|healthy volunteers
824602|NCT00135824|povidone|povidone
824603|NCT00135824|healthy subjects|healthy subjects
824604|NCT00135811|Focal Segmental Glomerulosclerosis|focal segmental glomerulosclerosis
824605|NCT00135798|Hepatitis C|hepatitis c
824606|NCT00135798|Ribavirin|ribavirin
824607|NCT00135798|PegInterferon alfa2b|peginterferon alfa2b
824608|NCT00135772|nicotine dependence|nicotine dependence
824609|NCT00135759|opiate dependence|opiate dependence
824610|NCT00135746|tobacco|tobacco
824611|NCT00135733|Lichen Planus|lichen planus
824612|NCT00135733|Mucosal lichen planus|mucosal lichen planus
824613|NCT00135733|Alefacept|alefacept
824614|NCT00135733|T-cell mediated|t-cell mediated
824615|NCT00135733|subcutaneous medication|subcutaneous medication
824616|NCT00135733|Autoimmune disease|autoimmune disease
824617|NCT00135720|Pemphigus Vulgaris|pemphigus vulgaris
824618|NCT00135720|Chronic Pemphigus|chronic pemphigus
824619|NCT00135720|Etanercept|etanercept
824620|NCT00135720|Enbrel|enbrel
824621|NCT00135720|anti-TNF-alpha|anti-tnf-alpha
824622|NCT00135720|TNF-alpha antagonist|tnf-alpha antagonist
824623|NCT00135720|biologic|biologic
824624|NCT00135720|immunomodulator|immunomodulator
824625|NCT00135720|subcutaneous medication|subcutaneous medication
824626|NCT00135707|Antioxidants|antioxidants
824627|NCT00135707|Preeclampsia|preeclampsia
824628|NCT00135707|Pregnancy|pregnancy
824629|NCT00135707|Hypertension|hypertension
824630|NCT00135694|hepatitis|hepatitis
824631|NCT00135694|hepatitis C|hepatitis c
824632|NCT00135694|HCV|hcv
824633|NCT00135694|liver|liver
824634|NCT00135694|liver disease|liver disease
824635|NCT00135694|liver transplant|liver transplant
824636|NCT00135694|liver transplantation|liver transplantation
824637|NCT00135694|transplant|transplant
824638|NCT00135694|hepatic|hepatic
824639|NCT00135694|hepatic transplantation|hepatic transplantation
824640|NCT00135694|immunosuppression|immunosuppression
824641|NCT00135694|rejection|rejection
824642|NCT00135668|children|children
824643|NCT00135668|sodium nitroprusside|sodium nitroprusside
824644|NCT00135668|controlled hypotension|controlled hypotension
824645|NCT00135668|dose-response|dose-response
824646|NCT00135668|pharmacokinetics|pharmacokinetics
824647|NCT00135668|pharmacodynamics|pharmacodynamics
824648|NCT00135668|safety|safety
824649|NCT00135668|efficacy|efficacy
824650|NCT00135655|macular edema|macular edema
824651|NCT00135655|post cataract extraction|post cataract extraction
824652|NCT00135655|cystoid macular edema|cystoid macular edema
824653|NCT00135655|post cataract extraction macular edema|post cataract extraction macular edema
824654|NCT00135642|Hayfever|hayfever
824655|NCT00135642|Subcutaneous Immunotherapy|subcutaneous immunotherapy
824656|NCT00135642|Grass pollen immunotherapy|grass pollen immunotherapy
824657|NCT00135642|Seasonal Allergic Rhinoconjunctivitis|seasonal allergic rhinoconjunctivitis
824658|NCT00135629|Hayfever|hayfever
824659|NCT00135629|Sublingual Immunotherapy|sublingual immunotherapy
824947|NCT00134160|Aged|aged
824660|NCT00135629|Grass pollen immunotherapy|grass pollen immunotherapy
824661|NCT00135629|Late cutaneous response|late cutaneous response
824662|NCT00135629|Intradermal allergen challenge|intradermal allergen challenge
824663|NCT00135629|Seasonal Allergic Rhinoconjunctivitis|seasonal allergic rhinoconjunctivitis
824664|NCT00135616|urinary incontinence|urinary incontinence
824665|NCT00135616|stress incontinence|stress incontinence
824666|NCT00135616|urethra|urethra
824667|NCT00135616|gynaecologic surgical procedures|gynaecologic surgical procedures
824668|NCT00135616|suburethral sling|suburethral sling
824669|NCT00135603|appendicitis.|appendicitis.
824670|NCT00135603|adult.|adult.
824671|NCT00135603|treatment.|treatment.
824672|NCT00135603|antibiotic therapy.|antibiotic therapy.
824673|NCT00135603|CT scanning.|ct scanning.
824674|NCT00135603|randomized trial|randomized trial
824675|NCT00135603|safety|safety
824676|NCT00135590|Protein pulse-feeding|protein pulse-feeding
824677|NCT00135590|Nutritional supplementation|nutritional supplementation
824678|NCT00135590|Protein-energy malnutrition|protein-energy malnutrition
824679|NCT00135590|Elderly subjects|elderly subjects
824680|NCT00135590|Body composition|body composition
824681|NCT00135577|opioids|opioids
824682|NCT00135577|constipation|constipation
824683|NCT00135577|opioid-induced bowel dysfunction|opioid-induced bowel dysfunction
824684|NCT00135564|Haemophilus Influenzae type b/Meningococcal (vaccine)|haemophilus influenzae type b/meningococcal (vaccine)
824685|NCT00135564|Prophylaxis meningococcal serogroup C disease, Hib diseases|prophylaxis meningococcal serogroup c disease, hib diseases
824686|NCT00135551|Hypertension|hypertension
824687|NCT00135551|Multicenter clinical trial|multicenter clinical trial
824688|NCT00135551|PROBE|probe
824689|NCT00135551|Combination therapy|combination therapy
824690|NCT00135551|Benidipine|benidipine
824691|NCT00135551|Essential Hypertension|essential hypertension
824692|NCT00135538|Pulmonary Disease, Chronic Obstructive|pulmonary disease, chronic obstructive
824693|NCT00135538|Intermittent Positive-Pressure Ventilation|intermittent positive-pressure ventilation
824694|NCT00135538|Rehabilitation|rehabilitation
824695|NCT00135525|Generalized Anxiety Disorder|generalized anxiety disorder
824697|NCT00135499|Lymphoma|lymphoma
824698|NCT00135499|chemotherapy|chemotherapy
824699|NCT00135499|rituximab|rituximab
824700|NCT00135486|Haemophilus Influenzae type b/Meningococcal vaccine|haemophilus influenzae type b/meningococcal vaccine
824701|NCT00135486|Prophylaxis meningococcal serogroup C disease, Hib diseases|prophylaxis meningococcal serogroup c disease, hib diseases
824702|NCT00135473|Severe sepsis|severe sepsis
824703|NCT00135473|septic shock|septic shock
824704|NCT00135473|volume substitution|volume substitution
824705|NCT00135473|intensive insulin therapy|intensive insulin therapy
824706|NCT00135473|colloids|colloids
824707|NCT00135473|crystalloids|crystalloids
824708|NCT00135473|outcome|outcome
824709|NCT00135473|safety|safety
824710|NCT00135460|HIV|hiv
824711|NCT00135460|Lipoatrophy|lipoatrophy
824712|NCT00135460|Lipodystrophy|lipodystrophy
824713|NCT00135460|Treatment Naive|treatment naive
824714|NCT00135460|HIV Infections|hiv infections
824715|NCT00135460|Hypercholesterolemia|hypercholesterolemia
824716|NCT00135447|HIV/AIDS|hiv/aids
824717|NCT00135447|Treatment Experienced|treatment experienced
824718|NCT00135408|Unresectable Stage III or IV Malignant Melanoma|unresectable stage iii or iv malignant melanoma
824719|NCT00135395|HIV/AIDS|hiv/aids
824720|NCT00135395|Treatment Experienced|treatment experienced
824721|NCT00135382|HIV/AIDS|hiv/aids
824722|NCT00135369|HIV-AIDS|hiv-aids
824723|NCT00135356|HIV infections|hiv infections
824724|NCT00135343|HIV/AIDS|hiv/aids
824725|NCT00135330|diabetes|diabetes
824726|NCT00135330|exenatide|exenatide
824727|NCT00135330|rosiglitazone|rosiglitazone
824728|NCT00135330|Amylin|amylin
824729|NCT00135330|Lilly|lilly
824730|NCT00135317|oncology|oncology
824731|NCT00135317|darbepoetin alfa|darbepoetin alfa
824732|NCT00135317|Aranesp®|aranesp®
824733|NCT00135317|Amgen|amgen
824734|NCT00135317|Non-myeloid malignancy|non-myeloid malignancy
824737|NCT00135304|Cinacalcet HCl|cinacalcet hcl
824738|NCT00135304|Chronic Kidney Disease|chronic kidney disease
824739|NCT00135291|transfusion-induced immunomodulation|transfusion-induced immunomodulation
824740|NCT00135291|leukoreduction|leukoreduction
824741|NCT00135291|surgical site infections|surgical site infections
824742|NCT00135291|nosocomial infections|nosocomial infections
824743|NCT00135291|transfusion|transfusion
824744|NCT00135291|Infection|infection
824745|NCT00135291|Sepsis|sepsis
824746|NCT00135291|Hemorrhage|hemorrhage
824747|NCT00135278|Neuroprotection|neuroprotection
824748|NCT00135278|inflammation|inflammation
824749|NCT00135278|cytokines|cytokines
824750|NCT00135278|CSF|csf
824751|NCT00135265|smoking cessation|smoking cessation
824752|NCT00135265|adolescents|adolescents
824753|NCT00135252|developing chronic lung disease|developing chronic lung disease
824754|NCT00135239|back|back
824755|NCT00135239|Lower Mechanical Back Pain|lower mechanical back pain
824756|NCT00135239|Rehabilitation|rehabilitation
824757|NCT00135226|Diabetes Mellitus|diabetes mellitus
824758|NCT00135226|Cardiovascular Disease|cardiovascular disease
824760|NCT00135226|Omega-3 fatty acids|omega-3 fatty acids
824761|NCT00135226|Primary prevention|primary prevention
824762|NCT00135226|Randomized Controlled Trial|randomized controlled trial
824763|NCT00135226|Type 1 Diabetes Mellitus|type 1 diabetes mellitus
824764|NCT00135226|Type 2 Diabetes Mellitus|type 2 diabetes mellitus
824765|NCT00135226|n-3 fatty acid|n-3 fatty acid
824766|NCT00135213|passive smoking|passive smoking
824767|NCT00135213|pediatric practice|pediatric practice
824768|NCT00135213|smoking cessation|smoking cessation
824769|NCT00135174|Pacemaker|pacemaker
824770|NCT00135174|routine|routine
824771|NCT00135174|follow-up|follow-up
824772|NCT00135174|complications|complications
824773|NCT00135174|Quality of Life|quality of life
824774|NCT00135161|neoplasms (squamous cell carcinoma of the head and neck region)|neoplasms (squamous cell carcinoma of the head and neck region)
824775|NCT00135135|Cancer|cancer
824776|NCT00135135|Childhood Tumor|childhood tumor
824777|NCT00135135|Neoplasms|neoplasms
824778|NCT00135122|migraine|migraine
824779|NCT00135122|analgesics|analgesics
824780|NCT00135122|tension type headache|tension type headache
824781|NCT00135070|Diabetes Mellitus|diabetes mellitus
824782|NCT00135044|taurine|taurine
824783|NCT00135044|intestinal failure|intestinal failure
824784|NCT00135044|HPN|hpn
824785|NCT00135044|hepatobiliary complications|hepatobiliary complications
824786|NCT00135044|chronic intestinal failure (CIF)|chronic intestinal failure (cif)
824787|NCT00135005|GIST|gist
824788|NCT00135005|AMN107|amn107
824789|NCT00135005|Gastrointestinal Stromal Tumors|gastrointestinal stromal tumors
824790|NCT00134992|Prednisolone acetate|prednisolone acetate
824791|NCT00134992|eye drops|eye drops
824792|NCT00134992|tolerability|tolerability
824793|NCT00134992|Healthy volunteers|healthy volunteers
824794|NCT00134979|COPD, formoterol,|copd, formoterol,
824795|NCT00134966|Parkinson's disease, levodopa, dyskinesia|parkinson's disease, levodopa, dyskinesia
824796|NCT00134953|Mild cognitive impairment|mild cognitive impairment
824797|NCT00134953|Alzheimer's disease|alzheimer's disease
824798|NCT00134953|Dementia|dementia
824799|NCT00134953|Mild Cognitive Impairment (MCI)|mild cognitive impairment (mci)
824800|NCT00134940|Transplantation, heart|transplantation, heart
824801|NCT00134940|Organ transplant|organ transplant
824802|NCT00134914|opiate dependence|opiate dependence
824803|NCT00134901|Cocaine dependence|cocaine dependence
824804|NCT00134901|treatment|treatment
824805|NCT00134901|memantine|memantine
824806|NCT00134888|Opioid Dependence|opioid dependence
824807|NCT00134875|opioid dependence|opioid dependence
824808|NCT00134849|hypertension|hypertension
824809|NCT00134823|Parent Experience of Care|parent experience of care
824810|NCT00134823|Quality Improvement|quality improvement
824811|NCT00134823|Medication Errors|medication errors
824812|NCT00134823|Abnormal Lab Values|abnormal lab values
824813|NCT00134823|Guideline Adherence|guideline adherence
824814|NCT00134810|Myofascial pain syndrome|myofascial pain syndrome
824815|NCT00134797|GFR|gfr
824816|NCT00134797|serum creatinine|serum creatinine
824817|NCT00134784|parkinson|parkinson
824818|NCT00134784|brain imaging|brain imaging
824819|NCT00134771|Infants whose birthweight is less than the 20th centile for gestational age (UK standards)|infants whose birthweight is less than the 20th centile for gestational age (uk standards)
824820|NCT00134771|Infants who are formula fed from birth|infants who are formula fed from birth
824821|NCT00134771|Singletons|singletons
824822|NCT00134771|Infants free from major congenital disease|infants free from major congenital disease
824823|NCT00134758|Treatment of adenomas of the duodenum in FAP patients.|treatment of adenomas of the duodenum in fap patients.
824824|NCT00134758|Adenoma|adenoma
824825|NCT00134745|Turner Syndrome|turner syndrome
824826|NCT00134745|Hormonal replacement therapy|hormonal replacement therapy
824827|NCT00134745|Bone mineralization|bone mineralization
824828|NCT00134745|Uterine size|uterine size
824829|NCT00134745|aortic root dilatation|aortic root dilatation
824830|NCT00134732|Prophylaxis of Rotavirus Gastroenteritis|prophylaxis of rotavirus gastroenteritis
824831|NCT00134719|Invasive Hib & N. meningitidis diseases|invasive hib & n. meningitidis diseases
824832|NCT00134706|Prostate Cancer|prostate cancer
824833|NCT00134706|Cancer of the prostate|cancer of the prostate
824834|NCT00134706|Cancer of prostate|cancer of prostate
824835|NCT00134706|Docetaxel|docetaxel
824836|NCT00134706|Carboplatin|carboplatin
824837|NCT00134693|SB-681323 rheumatoid arthritis CRP biomarkers|sb-681323 rheumatoid arthritis crp biomarkers
824838|NCT00134680|estrogen receptor positive|estrogen receptor positive
824839|NCT00134680|progesterone receptor positive|progesterone receptor positive
824840|NCT00134680|ErbB2 positive|erbb2 positive
824841|NCT00134680|metastatic breast cancer|metastatic breast cancer
824842|NCT00134667|AMD|amd
824843|NCT00134667|Age-Related Macular Degeneration|age-related macular degeneration
824844|NCT00134667|Macular Degeneration|macular degeneration
824845|NCT00134667|Macugen|macugen
824846|NCT00134667|Photodynamic Therapy|photodynamic therapy
824847|NCT00134667|PDT|pdt
824848|NCT00134667|Visudyne|visudyne
824849|NCT00134667|pegaptanib sodium|pegaptanib sodium
824850|NCT00134667|verteporfin|verteporfin
824851|NCT00134667|Predominantly Classic|predominantly classic
824852|NCT00134667|Age-Related Macular Degeneration (AMD)|age-related macular degeneration (amd)
824853|NCT00134654|Androgen-independent prostate cancer|androgen-independent prostate cancer
824854|NCT00134654|Premarin|premarin
824855|NCT00134654|conjugated estrogen|conjugated estrogen
824856|NCT00134641|soft tissue sarcoma|soft tissue sarcoma
824857|NCT00134641|metastatic soft tissue sarcoma|metastatic soft tissue sarcoma
824858|NCT00134641|gemcitabine|gemcitabine
824859|NCT00134641|vinorelbine|vinorelbine
824860|NCT00134628|Hyperbaric Oxygenation|hyperbaric oxygenation
824861|NCT00134628|Radiation injuries|radiation injuries
824862|NCT00134628|Prophylaxis|prophylaxis
824863|NCT00134628|Proctitis|proctitis
824864|NCT00134628|Cystitis|cystitis
824865|NCT00134628|Enteritis|enteritis
824866|NCT00134628|Osteoradionecrosis|osteoradionecrosis
824867|NCT00134615|decision-making|decision-making
824868|NCT00134615|patient activation|patient activation
824869|NCT00134615|empowerment|empowerment
824870|NCT00134615|mental health|mental health
824871|NCT00134615|Depression|depression
824872|NCT00134615|Anxiety|anxiety
824873|NCT00134615|Other Psychiatric Disorder|other psychiatric disorder
824874|NCT00134602|HIV infection, antiretroviral therapy, adherence, pediatric|hiv infection, antiretroviral therapy, adherence, pediatric
824875|NCT00134589|Academic Detailing|academic detailing
824876|NCT00134589|Decision Aid|decision aid
824877|NCT00134589|Colorectal Cancer Screening|colorectal cancer screening
824878|NCT00134589|RECTAL NEOPLASMS|rectal neoplasms
824879|NCT00134589|COLONIC POLYPS|colonic polyps
824880|NCT00134563|Multiple Sclerosis|multiple sclerosis
824881|NCT00134563|Relapsing Remitting|relapsing remitting
824882|NCT00134563|Secondary Progressive|secondary progressive
824883|NCT00134563|Progressive Relapsing|progressive relapsing
824884|NCT00134550|Diabetes Mellitus|diabetes mellitus
824885|NCT00134550|Foot ulcers|foot ulcers
824886|NCT00134550|Complication|complication
824887|NCT00134550|Foot Ulcer, Diabetic|foot ulcer, diabetic
824888|NCT00134537|Degenerative Disc Disease of the lumbar spine|degenerative disc disease of the lumbar spine
824889|NCT00134524|Magnetics|magnetics
824890|NCT00134524|Electromagnetics|electromagnetics
824891|NCT00134524|Diabetic neuropathy|diabetic neuropathy
824892|NCT00134524|Pain|pain
824893|NCT00134472|Hypothermia, induced|hypothermia, induced
824894|NCT00134472|Traumatic Brain injuries|traumatic brain injuries
824895|NCT00134472|Anesthesia|anesthesia
824896|NCT00134472|Neuro-intensive care|neuro-intensive care
824897|NCT00134472|neurochemistry|neurochemistry
824898|NCT00134459|Depression|depression
824899|NCT00134459|Bipolar Disorder|bipolar disorder
824900|NCT00134446|post traumatic stress disorder|post traumatic stress disorder
824901|NCT00134446|PTSD|ptsd
824902|NCT00134446|trauma|trauma
824903|NCT00134446|transcranial magnetic stimulation|transcranial magnetic stimulation
824904|NCT00134446|randomized clinical trial|randomized clinical trial
824905|NCT00134433|Coronary Artery Disease, Diffuse|coronary artery disease, diffuse
824906|NCT00134433|Coronary Artery Disease, Deemed Inoperable|coronary artery disease, deemed inoperable
824907|NCT00134420|Growth Hormone|growth hormone
824908|NCT00134420|Chromosomes, Human, Pair 18|chromosomes, human, pair 18
824909|NCT00134420|Child|child
824910|NCT00134407|Nutrition|nutrition
824911|NCT00134407|Postoperative|postoperative
824912|NCT00134407|oral|oral
824913|NCT00134407|jejunal|jejunal
824914|NCT00134407|feeding|feeding
824915|NCT00134407|Surgery|surgery
824916|NCT00134407|major|major
824917|NCT00134407|abdominal|abdominal
824918|NCT00134407|adult|adult
824919|NCT00134394|psoriasis|psoriasis
824920|NCT00134394|tacrolimus|tacrolimus
824921|NCT00134394|etanercept|etanercept
824922|NCT00134381|Normal volunteer study|normal volunteer study
824923|NCT00134368|vitiligo|vitiligo
824924|NCT00134368|etanercept|etanercept
824925|NCT00134355|antiangiogenesis therapy|antiangiogenesis therapy
824926|NCT00134355|vatalanib|vatalanib
824927|NCT00134342|tuberculosis|tuberculosis
824928|NCT00134342|tuberculin test|tuberculin test
824929|NCT00134342|immunologic tests|immunologic tests
825213|NCT00133744|prenatal|prenatal
824930|NCT00134342|Latent tuberculosis|latent tuberculosis
824931|NCT00134342|end stage renal disease|end stage renal disease
824932|NCT00134342|solid organ transplantation|solid organ transplantation
824933|NCT00134342|bone marrow transplantation|bone marrow transplantation
824934|NCT00134342|rheumatologic disease|rheumatologic disease
824935|NCT00134316|sexual dysfunction|sexual dysfunction
824936|NCT00134251|Parkinson's disease|parkinson's disease
824937|NCT00134251|adjunctive to L-dopa therapy|adjunctive to l-dopa therapy
824938|NCT00134251|Advanced stage Parkinson's disease|advanced stage parkinson's disease
824939|NCT00134225|Musculoskeletal abnormality|musculoskeletal abnormality
824940|NCT00134225|Musculoskeletal physiology|musculoskeletal physiology
824941|NCT00134225|Musculoskeletal disease|musculoskeletal disease
824942|NCT00134225|Musculoskeletal dysfunction|musculoskeletal dysfunction
824943|NCT00134212|Splanchnic perfusion, hepatic damage, oxidative stress.|splanchnic perfusion, hepatic damage, oxidative stress.
824944|NCT00134186|Kidney cancer|kidney cancer
824945|NCT00134186|Renal cell carcinoma|renal cell carcinoma
824946|NCT00134186|Motexafin gadolinium|motexafin gadolinium
824948|NCT00134160|Hypertension|hypertension
824949|NCT00134160|Cardiovascular Diseases|cardiovascular diseases
824950|NCT00134160|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers
824951|NCT00134160|Calcium Channel Blockers|calcium channel blockers
824952|NCT00134160|Combination Drug Therapy|combination drug therapy
824953|NCT00134160|Diabetes Mellitus Type 2|diabetes mellitus type 2
824954|NCT00134134|hidradenitis suppurativa|hidradenitis suppurativa
824955|NCT00134134|efalizumab|efalizumab
824956|NCT00134134|biologic|biologic
824957|NCT00134134|Raptiva|raptiva
824958|NCT00134095|adenocarcinoma of the stomach|adenocarcinoma of the stomach
824959|NCT00134095|stage II gastric cancer|stage ii gastric cancer
824960|NCT00134095|stage III gastric cancer|stage iii gastric cancer
824961|NCT00134095|stage IV gastric cancer|stage iv gastric cancer
824962|NCT00134082|recurrent adult Hodgkin lymphoma|recurrent adult hodgkin lymphoma
824963|NCT00134056|adenocarcinoma of the prostate|adenocarcinoma of the prostate
824964|NCT00134056|stage IV prostate cancer|stage iv prostate cancer
824965|NCT00134056|recurrent prostate cancer|recurrent prostate cancer
824966|NCT00134056|bone metastases|bone metastases
824967|NCT00134017|adult acute myeloid leukemia in remission|adult acute myeloid leukemia in remission
824968|NCT00134017|refractory anemia with excess blasts|refractory anemia with excess blasts
824969|NCT00134017|adult acute myeloid leukemia with 11q23 (MLL) abnormalities|adult acute myeloid leukemia with 11q23 (mll) abnormalities
824970|NCT00134017|adult acute myeloid leukemia with inv(16)(p13;q22)|adult acute myeloid leukemia with inv(16)(p13;q22)
824971|NCT00134017|adult acute myeloid leukemia with t(15;17)(q22;q12)|adult acute myeloid leukemia with t(15;17)(q22;q12)
824972|NCT00134017|adult acute myeloid leukemia with t(16;16)(p13;q22)|adult acute myeloid leukemia with t(16;16)(p13;q22)
824973|NCT00134017|adult acute myeloid leukemia with t(8;21)(q22;q22)|adult acute myeloid leukemia with t(8;21)(q22;q22)
824974|NCT00134017|childhood acute myeloid leukemia in remission|childhood acute myeloid leukemia in remission
824975|NCT00134017|recurrent adult acute myeloid leukemia|recurrent adult acute myeloid leukemia
824976|NCT00134017|recurrent childhood acute myeloid leukemia|recurrent childhood acute myeloid leukemia
824977|NCT00134017|secondary acute myeloid leukemia|secondary acute myeloid leukemia
824978|NCT00134017|de novo myelodysplastic syndromes|de novo myelodysplastic syndromes
824979|NCT00134017|adult acute lymphoblastic leukemia in remission|adult acute lymphoblastic leukemia in remission
824980|NCT00134017|childhood acute lymphoblastic leukemia in remission|childhood acute lymphoblastic leukemia in remission
824981|NCT00134017|recurrent adult acute lymphoblastic leukemia|recurrent adult acute lymphoblastic leukemia
824982|NCT00134017|recurrent childhood acute lymphoblastic leukemia|recurrent childhood acute lymphoblastic leukemia
824983|NCT00134017|accelerated phase chronic myelogenous leukemia|accelerated phase chronic myelogenous leukemia
824984|NCT00134017|blastic phase chronic myelogenous leukemia|blastic phase chronic myelogenous leukemia
824985|NCT00134017|childhood chronic myelogenous leukemia|childhood chronic myelogenous leukemia
824986|NCT00134017|chronic phase chronic myelogenous leukemia|chronic phase chronic myelogenous leukemia
824987|NCT00134017|relapsing chronic myelogenous leukemia|relapsing chronic myelogenous leukemia
824988|NCT00134017|stage III chronic lymphocytic leukemia|stage iii chronic lymphocytic leukemia
824989|NCT00134017|stage IV chronic lymphocytic leukemia|stage iv chronic lymphocytic leukemia
824990|NCT00134017|chronic eosinophilic leukemia|chronic eosinophilic leukemia
824991|NCT00134017|chronic idiopathic myelofibrosis|chronic idiopathic myelofibrosis
824992|NCT00134017|chronic neutrophilic leukemia|chronic neutrophilic leukemia
824993|NCT00134017|stage III adult Hodgkin lymphoma|stage iii adult hodgkin lymphoma
824994|NCT00134017|stage IV adult Hodgkin lymphoma|stage iv adult hodgkin lymphoma
824995|NCT00134017|stage II multiple myeloma|stage ii multiple myeloma
824996|NCT00134017|stage III multiple myeloma|stage iii multiple myeloma
824997|NCT00134017|extranodal marginal zone B-cell lymphoma of mucosa-associated lymphoid tissue|extranodal marginal zone b-cell lymphoma of mucosa-associated lymphoid tissue
824998|NCT00134017|nodal marginal zone B-cell lymphoma|nodal marginal zone b-cell lymphoma
824999|NCT00134017|splenic marginal zone lymphoma|splenic marginal zone lymphoma
825000|NCT00134017|noncontiguous stage II adult Burkitt lymphoma|noncontiguous stage ii adult burkitt lymphoma
825001|NCT00134017|noncontiguous stage II adult diffuse large cell lymphoma|noncontiguous stage ii adult diffuse large cell lymphoma
825125|NCT00134004|polycythemia vera|polycythemia vera
825002|NCT00134017|noncontiguous stage II adult diffuse mixed cell lymphoma|noncontiguous stage ii adult diffuse mixed cell lymphoma
825003|NCT00134017|noncontiguous stage II adult diffuse small cleaved cell lymphoma|noncontiguous stage ii adult diffuse small cleaved cell lymphoma
825004|NCT00134017|noncontiguous stage II adult immunoblastic large cell lymphoma|noncontiguous stage ii adult immunoblastic large cell lymphoma
825005|NCT00134017|noncontiguous stage II adult lymphoblastic lymphoma|noncontiguous stage ii adult lymphoblastic lymphoma
825006|NCT00134017|noncontiguous stage II grade 1 follicular lymphoma|noncontiguous stage ii grade 1 follicular lymphoma
825007|NCT00134017|noncontiguous stage II grade 2 follicular lymphoma|noncontiguous stage ii grade 2 follicular lymphoma
825008|NCT00134017|noncontiguous stage II grade 3 follicular lymphoma|noncontiguous stage ii grade 3 follicular lymphoma
825009|NCT00134017|noncontiguous stage II mantle cell lymphoma|noncontiguous stage ii mantle cell lymphoma
825010|NCT00134017|noncontiguous stage II marginal zone lymphoma|noncontiguous stage ii marginal zone lymphoma
825011|NCT00134017|noncontiguous stage II small lymphocytic lymphoma|noncontiguous stage ii small lymphocytic lymphoma
825012|NCT00134017|previously treated myelodysplastic syndromes|previously treated myelodysplastic syndromes
825013|NCT00134017|recurrent adult Burkitt lymphoma|recurrent adult burkitt lymphoma
825014|NCT00134017|recurrent adult diffuse large cell lymphoma|recurrent adult diffuse large cell lymphoma
825015|NCT00134017|recurrent adult diffuse mixed cell lymphoma|recurrent adult diffuse mixed cell lymphoma
825016|NCT00134017|recurrent adult diffuse small cleaved cell lymphoma|recurrent adult diffuse small cleaved cell lymphoma
825017|NCT00134017|recurrent adult immunoblastic large cell lymphoma|recurrent adult immunoblastic large cell lymphoma
825018|NCT00134017|recurrent adult lymphoblastic lymphoma|recurrent adult lymphoblastic lymphoma
825019|NCT00134017|recurrent childhood large cell lymphoma|recurrent childhood large cell lymphoma
825020|NCT00134017|recurrent childhood lymphoblastic lymphoma|recurrent childhood lymphoblastic lymphoma
825021|NCT00134017|recurrent grade 1 follicular lymphoma|recurrent grade 1 follicular lymphoma
825022|NCT00134017|recurrent grade 2 follicular lymphoma|recurrent grade 2 follicular lymphoma
825023|NCT00134017|recurrent grade 3 follicular lymphoma|recurrent grade 3 follicular lymphoma
825024|NCT00134017|recurrent mantle cell lymphoma|recurrent mantle cell lymphoma
825025|NCT00134017|recurrent childhood small noncleaved cell lymphoma|recurrent childhood small noncleaved cell lymphoma
825026|NCT00134017|recurrent/refractory childhood Hodgkin lymphoma|recurrent/refractory childhood hodgkin lymphoma
825027|NCT00134017|recurrent adult Hodgkin lymphoma|recurrent adult hodgkin lymphoma
825028|NCT00134017|recurrent small lymphocytic lymphoma|recurrent small lymphocytic lymphoma
825029|NCT00134017|recurrent marginal zone lymphoma|recurrent marginal zone lymphoma
825030|NCT00134017|stage III adult Burkitt lymphoma|stage iii adult burkitt lymphoma
825031|NCT00134017|stage III adult diffuse large cell lymphoma|stage iii adult diffuse large cell lymphoma
825032|NCT00134017|stage III adult diffuse mixed cell lymphoma|stage iii adult diffuse mixed cell lymphoma
825033|NCT00134017|stage III adult diffuse small cleaved cell lymphoma|stage iii adult diffuse small cleaved cell lymphoma
825034|NCT00134017|stage III adult immunoblastic large cell lymphoma|stage iii adult immunoblastic large cell lymphoma
825035|NCT00134017|stage III adult lymphoblastic lymphoma|stage iii adult lymphoblastic lymphoma
825036|NCT00134017|stage IV adult Burkitt lymphoma|stage iv adult burkitt lymphoma
825037|NCT00134017|stage IV adult diffuse large cell lymphoma|stage iv adult diffuse large cell lymphoma
825038|NCT00134017|stage IV adult diffuse mixed cell lymphoma|stage iv adult diffuse mixed cell lymphoma
825039|NCT00134017|stage IV adult diffuse small cleaved cell lymphoma|stage iv adult diffuse small cleaved cell lymphoma
825040|NCT00134017|stage IV adult immunoblastic large cell lymphoma|stage iv adult immunoblastic large cell lymphoma
825041|NCT00134017|stage III grade 1 follicular lymphoma|stage iii grade 1 follicular lymphoma
825042|NCT00134017|stage III grade 2 follicular lymphoma|stage iii grade 2 follicular lymphoma
825043|NCT00134017|stage III grade 3 follicular lymphoma|stage iii grade 3 follicular lymphoma
825044|NCT00134017|stage IV grade 1 follicular lymphoma|stage iv grade 1 follicular lymphoma
825045|NCT00134017|stage IV grade 2 follicular lymphoma|stage iv grade 2 follicular lymphoma
825046|NCT00134017|stage IV grade 3 follicular lymphoma|stage iv grade 3 follicular lymphoma
825047|NCT00134017|stage III mantle cell lymphoma|stage iii mantle cell lymphoma
825048|NCT00134017|stage III marginal zone lymphoma|stage iii marginal zone lymphoma
825049|NCT00134017|stage IV mantle cell lymphoma|stage iv mantle cell lymphoma
825050|NCT00134017|stage IV marginal zone lymphoma|stage iv marginal zone lymphoma
825051|NCT00134017|stage III small lymphocytic lymphoma|stage iii small lymphocytic lymphoma
825052|NCT00134017|stage IV small lymphocytic lymphoma|stage iv small lymphocytic lymphoma
825053|NCT00134017|chronic myelomonocytic leukemia|chronic myelomonocytic leukemia
825054|NCT00134017|refractory chronic lymphocytic leukemia|refractory chronic lymphocytic leukemia
825055|NCT00134017|refractory multiple myeloma|refractory multiple myeloma
825056|NCT00134017|secondary myelodysplastic syndromes|secondary myelodysplastic syndromes
825057|NCT00134017|stage IV adult lymphoblastic lymphoma|stage iv adult lymphoblastic lymphoma
825058|NCT00134017|childhood myelodysplastic syndromes|childhood myelodysplastic syndromes
825059|NCT00134004|adult acute lymphoblastic leukemia in remission|adult acute lymphoblastic leukemia in remission
825060|NCT00134004|adult acute myeloid leukemia in remission|adult acute myeloid leukemia in remission
825061|NCT00134004|childhood acute lymphoblastic leukemia in remission|childhood acute lymphoblastic leukemia in remission
825062|NCT00134004|childhood acute myeloid leukemia in remission|childhood acute myeloid leukemia in remission
825063|NCT00134004|childhood chronic myelogenous leukemia|childhood chronic myelogenous leukemia
825064|NCT00134004|chronic phase chronic myelogenous leukemia|chronic phase chronic myelogenous leukemia
825065|NCT00134004|refractory chronic lymphocytic leukemia|refractory chronic lymphocytic leukemia
825066|NCT00134004|extranodal marginal zone B-cell lymphoma of mucosa-associated lymphoid tissue|extranodal marginal zone b-cell lymphoma of mucosa-associated lymphoid tissue
825067|NCT00134004|adult acute myeloid leukemia with 11q23 (MLL) abnormalities|adult acute myeloid leukemia with 11q23 (mll) abnormalities
825068|NCT00134004|adult acute myeloid leukemia with inv(16)(p13;q22)|adult acute myeloid leukemia with inv(16)(p13;q22)
825069|NCT00134004|adult acute myeloid leukemia with t(15;17)(q22;q12)|adult acute myeloid leukemia with t(15;17)(q22;q12)
825070|NCT00134004|adult acute myeloid leukemia with t(16;16)(p13;q22)|adult acute myeloid leukemia with t(16;16)(p13;q22)
825071|NCT00134004|adult acute myeloid leukemia with t(8;21)(q22;q22)|adult acute myeloid leukemia with t(8;21)(q22;q22)
825072|NCT00134004|chronic idiopathic myelofibrosis|chronic idiopathic myelofibrosis
825073|NCT00134004|chronic myelomonocytic leukemia|chronic myelomonocytic leukemia
825074|NCT00134004|de novo myelodysplastic syndromes|de novo myelodysplastic syndromes
825075|NCT00134004|previously treated myelodysplastic syndromes|previously treated myelodysplastic syndromes
825076|NCT00134004|noncontiguous stage II adult Burkitt lymphoma|noncontiguous stage ii adult burkitt lymphoma
825077|NCT00134004|noncontiguous stage II adult diffuse large cell lymphoma|noncontiguous stage ii adult diffuse large cell lymphoma
825078|NCT00134004|noncontiguous stage II adult diffuse mixed cell lymphoma|noncontiguous stage ii adult diffuse mixed cell lymphoma
825079|NCT00134004|noncontiguous stage II adult diffuse small cleaved cell lymphoma|noncontiguous stage ii adult diffuse small cleaved cell lymphoma
825080|NCT00134004|noncontiguous stage II adult immunoblastic large cell lymphoma|noncontiguous stage ii adult immunoblastic large cell lymphoma
825081|NCT00134004|noncontiguous stage II adult lymphoblastic lymphoma|noncontiguous stage ii adult lymphoblastic lymphoma
825082|NCT00134004|noncontiguous stage II grade 1 follicular lymphoma|noncontiguous stage ii grade 1 follicular lymphoma
825083|NCT00134004|noncontiguous stage II grade 2 follicular lymphoma|noncontiguous stage ii grade 2 follicular lymphoma
825084|NCT00134004|noncontiguous stage II grade 3 follicular lymphoma|noncontiguous stage ii grade 3 follicular lymphoma
825085|NCT00134004|noncontiguous stage II mantle cell lymphoma|noncontiguous stage ii mantle cell lymphoma
825086|NCT00134004|noncontiguous stage II marginal zone lymphoma|noncontiguous stage ii marginal zone lymphoma
825087|NCT00134004|noncontiguous stage II small lymphocytic lymphoma|noncontiguous stage ii small lymphocytic lymphoma
825088|NCT00134004|recurrent adult Burkitt lymphoma|recurrent adult burkitt lymphoma
825089|NCT00134004|recurrent adult diffuse large cell lymphoma|recurrent adult diffuse large cell lymphoma
825090|NCT00134004|recurrent adult diffuse mixed cell lymphoma|recurrent adult diffuse mixed cell lymphoma
825091|NCT00134004|recurrent adult diffuse small cleaved cell lymphoma|recurrent adult diffuse small cleaved cell lymphoma
825092|NCT00134004|recurrent adult Hodgkin lymphoma|recurrent adult hodgkin lymphoma
825093|NCT00134004|recurrent adult immunoblastic large cell lymphoma|recurrent adult immunoblastic large cell lymphoma
825094|NCT00134004|recurrent adult lymphoblastic lymphoma|recurrent adult lymphoblastic lymphoma
825095|NCT00134004|recurrent/refractory childhood Hodgkin lymphoma|recurrent/refractory childhood hodgkin lymphoma
825096|NCT00134004|recurrent childhood large cell lymphoma|recurrent childhood large cell lymphoma
825097|NCT00134004|recurrent childhood lymphoblastic lymphoma|recurrent childhood lymphoblastic lymphoma
825206|NCT00133757|Cue-reactivity|cue-reactivity
825098|NCT00134004|recurrent childhood small noncleaved cell lymphoma|recurrent childhood small noncleaved cell lymphoma
825099|NCT00134004|nodal marginal zone B-cell lymphoma|nodal marginal zone b-cell lymphoma
825100|NCT00134004|recurrent grade 1 follicular lymphoma|recurrent grade 1 follicular lymphoma
825101|NCT00134004|recurrent grade 2 follicular lymphoma|recurrent grade 2 follicular lymphoma
825102|NCT00134004|recurrent grade 3 follicular lymphoma|recurrent grade 3 follicular lymphoma
825103|NCT00134004|recurrent mantle cell lymphoma|recurrent mantle cell lymphoma
825104|NCT00134004|recurrent marginal zone lymphoma|recurrent marginal zone lymphoma
825105|NCT00134004|recurrent small lymphocytic lymphoma|recurrent small lymphocytic lymphoma
825106|NCT00134004|refractory multiple myeloma|refractory multiple myeloma
825107|NCT00134004|relapsing chronic myelogenous leukemia|relapsing chronic myelogenous leukemia
825108|NCT00134004|secondary myelodysplastic syndromes|secondary myelodysplastic syndromes
825109|NCT00134004|splenic marginal zone lymphoma|splenic marginal zone lymphoma
825110|NCT00134004|stage I multiple myeloma|stage i multiple myeloma
825111|NCT00134004|stage II multiple myeloma|stage ii multiple myeloma
825112|NCT00134004|stage III multiple myeloma|stage iii multiple myeloma
825113|NCT00134004|stage III adult Burkitt lymphoma|stage iii adult burkitt lymphoma
825114|NCT00134004|stage III adult diffuse large cell lymphoma|stage iii adult diffuse large cell lymphoma
825115|NCT00134004|stage III adult diffuse mixed cell lymphoma|stage iii adult diffuse mixed cell lymphoma
825116|NCT00134004|stage III adult diffuse small cleaved cell lymphoma|stage iii adult diffuse small cleaved cell lymphoma
825117|NCT00134004|stage III adult Hodgkin lymphoma|stage iii adult hodgkin lymphoma
825118|NCT00134004|stage III adult immunoblastic large cell lymphoma|stage iii adult immunoblastic large cell lymphoma
825119|NCT00134004|stage III adult lymphoblastic lymphoma|stage iii adult lymphoblastic lymphoma
825120|NCT00134004|stage III grade 1 follicular lymphoma|stage iii grade 1 follicular lymphoma
825121|NCT00134004|stage III grade 2 follicular lymphoma|stage iii grade 2 follicular lymphoma
825122|NCT00134004|stage III grade 3 follicular lymphoma|stage iii grade 3 follicular lymphoma
825123|NCT00134004|stage III mantle cell lymphoma|stage iii mantle cell lymphoma
825124|NCT00134004|stage III marginal zone lymphoma|stage iii marginal zone lymphoma
825126|NCT00134004|essential thrombocythemia|essential thrombocythemia
825127|NCT00134004|stage III small lymphocytic lymphoma|stage iii small lymphocytic lymphoma
825128|NCT00134004|stage IV mantle cell lymphoma|stage iv mantle cell lymphoma
825129|NCT00134004|stage IV marginal zone lymphoma|stage iv marginal zone lymphoma
825130|NCT00134004|stage IV grade 1 follicular lymphoma|stage iv grade 1 follicular lymphoma
825131|NCT00134004|stage IV grade 2 follicular lymphoma|stage iv grade 2 follicular lymphoma
825132|NCT00134004|stage IV grade 3 follicular lymphoma|stage iv grade 3 follicular lymphoma
825133|NCT00134004|stage IV adult Burkitt lymphoma|stage iv adult burkitt lymphoma
825134|NCT00134004|stage IV adult diffuse large cell lymphoma|stage iv adult diffuse large cell lymphoma
825135|NCT00134004|stage IV adult diffuse mixed cell lymphoma|stage iv adult diffuse mixed cell lymphoma
825136|NCT00134004|stage IV adult diffuse small cleaved cell lymphoma|stage iv adult diffuse small cleaved cell lymphoma
825137|NCT00134004|stage IV adult immunoblastic large cell lymphoma|stage iv adult immunoblastic large cell lymphoma
825138|NCT00134004|stage IV adult lymphoblastic lymphoma|stage iv adult lymphoblastic lymphoma
825139|NCT00134004|stage IV small lymphocytic lymphoma|stage iv small lymphocytic lymphoma
825140|NCT00134004|stage IV adult Hodgkin lymphoma|stage iv adult hodgkin lymphoma
825141|NCT00134004|childhood myelodysplastic syndromes|childhood myelodysplastic syndromes
825142|NCT00133991|untreated adult acute lymphoblastic leukemia|untreated adult acute lymphoblastic leukemia
825143|NCT00133991|L3 adult acute lymphoblastic leukemia|l3 adult acute lymphoblastic leukemia
825144|NCT00133991|contiguous stage II adult Burkitt lymphoma|contiguous stage ii adult burkitt lymphoma
825145|NCT00133991|noncontiguous stage II adult Burkitt lymphoma|noncontiguous stage ii adult burkitt lymphoma
825146|NCT00133991|stage I adult Burkitt lymphoma|stage i adult burkitt lymphoma
825147|NCT00133991|stage III adult Burkitt lymphoma|stage iii adult burkitt lymphoma
825148|NCT00133991|stage IV adult Burkitt lymphoma|stage iv adult burkitt lymphoma
825149|NCT00133978|randomized trial|randomized trial
825150|NCT00133978|antioxidants|antioxidants
825151|NCT00133978|glutamine|glutamine
825152|NCT00133978|organ failure|organ failure
825153|NCT00133965|Advanced Cancer|advanced cancer
825154|NCT00133965|Dignity Care|dignity care
825155|NCT00133965|Supportive Care|supportive care
825156|NCT00133965|Quality of Life|quality of life
825157|NCT00133965|Psychotherapy|psychotherapy
825158|NCT00133965|Palliative Care|palliative care
825159|NCT00133939|Proportional assisted ventilation|proportional assisted ventilation
825160|NCT00133939|Pressure support ventilation|pressure support ventilation
825161|NCT00133939|Synchronism during mechanical ventilation|synchronism during mechanical ventilation
825162|NCT00133939|Patients undergoing partial mechanical ventilation|patients undergoing partial mechanical ventilation
825163|NCT00133926|Periodontal disease|periodontal disease
825164|NCT00133926|Pregnancy|pregnancy
825165|NCT00133926|Pre-term birth|pre-term birth
825166|NCT00133926|Fetal growth|fetal growth
825167|NCT00133926|Pre-eclampsia|pre-eclampsia
825168|NCT00133926|Infant, Low Birth Weight|infant, low birth weight
825169|NCT00133913|metastatic colorectal cancer|metastatic colorectal cancer
825170|NCT00133900|hormone refractory prostate cancer|hormone refractory prostate cancer
825171|NCT00133887|Squamous cell carcinoma|squamous cell carcinoma
825172|NCT00133887|kidney transplant recipients|kidney transplant recipients
825173|NCT00133887|rapamycin|rapamycin
825174|NCT00133887|Skin cancers in kidney transplant recipients|skin cancers in kidney transplant recipients
825175|NCT00133874|topical antibacterial|topical antibacterial
825176|NCT00133874|topical antibiotic|topical antibiotic
825177|NCT00133874|impetigo|impetigo
825178|NCT00133861|cerebral palsy children|cerebral palsy children
825179|NCT00133861|Botulinum toxin|botulinum toxin
825180|NCT00133848|impetigo|impetigo
825181|NCT00133848|topical antibacterial|topical antibacterial
825182|NCT00133848|topical antibiotic|topical antibiotic
825183|NCT00133835|Randomized controlled trial|randomized controlled trial
825184|NCT00133835|Lithotripsy|lithotripsy
825185|NCT00133835|Cholangiopancreatography, Endoscopic Retrograde|cholangiopancreatography, endoscopic retrograde
825186|NCT00133835|Abdominal pain|abdominal pain
825187|NCT00133822|Post-Traumatic Stress Disorder|post-traumatic stress disorder
825188|NCT00133822|Sertraline|sertraline
825189|NCT00133822|Risperidone|risperidone
825190|NCT00133809|Type 1 Diabetes|type 1 diabetes
825191|NCT00133809|Islet Transplantation|islet transplantation
825192|NCT00133809|Immunology|immunology
825193|NCT00133796|Breast Cancer|breast cancer
825194|NCT00133796|Advanced Breast Cancer|advanced breast cancer
825195|NCT00133783|Intermedin|intermedin
825196|NCT00133783|estradiol|estradiol
825197|NCT00133783|female hypertension|female hypertension
825198|NCT00133783|Premenopausal and postmenopausal women|premenopausal and postmenopausal women
825199|NCT00133783|Surgically-induced menopause women|surgically-induced menopause women
825200|NCT00133783|IVF treatment patients|ivf treatment patients
825201|NCT00133770|IV pantoprazole|iv pantoprazole
825202|NCT00133770|Esophagitis|esophagitis
825204|NCT00133757|Nicotine|nicotine
825205|NCT00133757|Bupropion|bupropion
825207|NCT00133757|Craving|craving
825208|NCT00133744|pregnancy|pregnancy
825209|NCT00133744|vitamins|vitamins
825210|NCT00133744|minerals|minerals
825211|NCT00133744|supplements|supplements
825212|NCT00133744|mortality|mortality
825219|NCT00133744|micronutrients|micronutrients
825220|NCT00133744|Stillbirths|stillbirths
825221|NCT00133744|Early neonatal deaths|early neonatal deaths
825222|NCT00133718|Type 2 diabetes mellitus|type 2 diabetes mellitus
825223|NCT00133718|Cardiovascular|cardiovascular
825224|NCT00133718|Coronary artery disease|coronary artery disease
825225|NCT00133718|Glycemic control|glycemic control
825226|NCT00133718|Treatment|treatment
825227|NCT00133718|Diabetes Mellitus|diabetes mellitus
825228|NCT00133705|A benign tumor derived from smooth uterine muscle tissue.|a benign tumor derived from smooth uterine muscle tissue.
825229|NCT00133692|Hypertension|hypertension
825230|NCT00133692|Coronary Artery Disease|coronary artery disease
825231|NCT00133692|INVEST|invest
825232|NCT00133692|Diabetes|diabetes
825233|NCT00133692|Verapamil SR|verapamil sr
825234|NCT00133692|Trandolapril|trandolapril
825235|NCT00133692|Atenolol|atenolol
825236|NCT00133692|HCTZ|hctz
825237|NCT00133679|Chronic lung disease|chronic lung disease
825238|NCT00133679|Nitric oxide|nitric oxide
825239|NCT00133679|cyclic guanosine monophosphate|cyclic guanosine monophosphate
825240|NCT00133679|phosphodiesterase inhibitor|phosphodiesterase inhibitor
825241|NCT00133653|Hypertension; Job Strain; Marital Strain; Blood Pressure|hypertension; job strain; marital strain; blood pressure
825242|NCT00133640|Vitamin D|vitamin d
825243|NCT00133640|Elderly|elderly
825244|NCT00133640|Hip fracture|hip fracture
825245|NCT00133640|Falls|falls
825246|NCT00133640|Physical Therapy|physical therapy
825247|NCT00133640|Disability|disability
825248|NCT00133627|Allergic|allergic
825249|NCT00133627|Conjunctivitis|conjunctivitis
825250|NCT00133627|Ketotifen|ketotifen
825251|NCT00133627|Histamine|histamine
825252|NCT00133588|influenza, vaccine, proteomic profiling, elderly|influenza, vaccine, proteomic profiling, elderly
825253|NCT00133575|MVA, smallpox, Acambis|mva, smallpox, acambis
825254|NCT00133562|Malnutrition, pediatric, Brazil, alanyl-glutamine|malnutrition, pediatric, brazil, alanyl-glutamine
825255|NCT00133549|pneumococcal vaccine, 23-valent polysaccharide vaccine, elderly|pneumococcal vaccine, 23-valent polysaccharide vaccine, elderly
825256|NCT00133536|H5N1, Influenza, children|h5n1, influenza, children
825257|NCT00133523|FLU-VACS, influenza, vaccine|flu-vacs, influenza, vaccine
825258|NCT00133510|children, immunocompromised, influenza, liver transplant|children, immunocompromised, influenza, liver transplant
825259|NCT00133497|cytomegalovirus, vaccine, women, children, parent protocol|cytomegalovirus, vaccine, women, children, parent protocol
825260|NCT00133484|Anthrax, rPA|anthrax, rpa
825261|NCT00133471|Influenza, vaccine, A/H9N2, MF59, adjuvant|influenza, vaccine, a/h9n2, mf59, adjuvant
825262|NCT00133458|Albenza, Subarachnoid cysticercosis|albenza, subarachnoid cysticercosis
825263|NCT00133445|Pentavalent vaccine, Pediarix, DTaP-Hep B-IPV vaccine|pentavalent vaccine, pediarix, dtap-hep b-ipv vaccine
825264|NCT00133432|Pneumonia, acute respiratory infections, zinc, Tanzania, children, infants, hospitalization|pneumonia, acute respiratory infections, zinc, tanzania, children, infants, hospitalization
825265|NCT00133419|micronutrient, supplementation, Africa, children, HIV|micronutrient, supplementation, africa, children, hiv
825266|NCT00133406|Brazil, Child Nutrition Disorders, Deficiency Diseases|brazil, child nutrition disorders, deficiency diseases
825267|NCT00133367|Hematologic malignancy|hematologic malignancy
825268|NCT00133367|Cord blood transfusion|cord blood transfusion
825269|NCT00133367|Graft versus host disease|graft versus host disease
825270|NCT00133367|tacrolimus|tacrolimus
825271|NCT00133367|sirolimus|sirolimus
825272|NCT00133354|Puberty|puberty
825273|NCT00133354|Growth hormone deficiency|growth hormone deficiency
825274|NCT00133354|aromatase inhibitors|aromatase inhibitors
825275|NCT00133354|estrogen|estrogen
825276|NCT00133354|bone mineral density|bone mineral density
825277|NCT00133354|short stature|short stature
825278|NCT00133341|Allergic contact dermatitis,patch testing, dilution series|allergic contact dermatitis,patch testing, dilution series
825279|NCT00133328|stroke|stroke
825280|NCT00133328|myocardial infarction|myocardial infarction
825281|NCT00133328|angina|angina
825282|NCT00133328|renal damage|renal damage
825283|NCT00133302|Non-Hodgkin's lymphoma|non-hodgkin's lymphoma
825284|NCT00133302|intermediate-grade lymphoma|intermediate-grade lymphoma
825285|NCT00133302|high-grade lymphoma|high-grade lymphoma
825286|NCT00133302|CHOP protocol|chop protocol
825287|NCT00133302|granulocyte-colony stimulating factor|granulocyte-colony stimulating factor
825288|NCT00133276|Hepatitis C|hepatitis c
825289|NCT00133276|Peg-interferon|peg-interferon
825290|NCT00133276|Psychiatric side-effects|psychiatric side-effects
825291|NCT00133263|Randomized controlled trial|randomized controlled trial
825292|NCT00133263|Primary Care|primary care
825293|NCT00133224|Advanced Prostate Cancer|advanced prostate cancer
825294|NCT00133224|HRPC|hrpc
825295|NCT00133224|Prostate|prostate
825296|NCT00133224|Cancer|cancer
825297|NCT00133224|Metastatic|metastatic
825298|NCT00133224|Hormone-refractory|hormone-refractory
825299|NCT00133224|GVAX|gvax
825300|NCT00133224|Chemotherapy|chemotherapy
825301|NCT00133224|Taxotere|taxotere
825302|NCT00133224|Docetaxel|docetaxel
825303|NCT00133224|Prednisone|prednisone
825304|NCT00133224|Vaccine|vaccine
825305|NCT00133224|Allogeneic cells|allogeneic cells
825306|NCT00133211|Paroxysmal atrial fibrillation|paroxysmal atrial fibrillation
825307|NCT00133211|Heart arrhythmia|heart arrhythmia
825308|NCT00133211|Ablation|ablation
825309|NCT00133211|Drug treatment|drug treatment
825310|NCT00133172|Treatment Efficacy|treatment efficacy
825311|NCT00133172|Treatment Effectiveness|treatment effectiveness
825312|NCT00133172|Anti-rejection therapy|anti-rejection therapy
825313|NCT00133172|Immunosuppression|immunosuppression
825314|NCT00133172|Antirejection|antirejection
825315|NCT00133172|Renal Transplantation|renal transplantation
825316|NCT00133172|Transplantation, Renal|transplantation, renal
825317|NCT00133172|Transplantation, Kidney|transplantation, kidney
825318|NCT00133172|Grafting, Kidney|grafting, kidney
825319|NCT00133159|Allergy|allergy
825320|NCT00133159|Specific Immunotherapy|specific immunotherapy
825321|NCT00133146|Allergy|allergy
825322|NCT00133146|Specific Immunotherapy|specific immunotherapy
825323|NCT00133133|Postoperative pain|postoperative pain
825324|NCT00133133|Open cholecystectomy|open cholecystectomy
825325|NCT00133133|Capsaicin|capsaicin
825326|NCT00133094|Hypercholesterolemia|hypercholesterolemia
825327|NCT00133094|Decision Support Systems, Clinical|decision support systems, clinical
825328|NCT00133081|epilepsy|epilepsy
825329|NCT00133081|antiepileptic drugs|antiepileptic drugs
825330|NCT00133081|side effects|side effects
825331|NCT00133081|quality of life|quality of life
825332|NCT00133068|High Blood Pressure|high blood pressure
825333|NCT00133068|Health Behaviors|health behaviors
825334|NCT00133068|Patient Compliance|patient compliance
825335|NCT00133055|parenting|parenting
825336|NCT00133055|sleep problems|sleep problems
825337|NCT00133055|behavior problems|behavior problems
825338|NCT00133055|brief intervention|brief intervention
825339|NCT00133055|self-help|self-help
825340|NCT00133055|preschool-age children|preschool-age children
825341|NCT00133055|psychosocial|psychosocial
825342|NCT00133042|anti-IgE, omalizumab|anti-ige, omalizumab
825343|NCT00133016|Induction of labor|induction of labor
825344|NCT00132990|Cervical dystonia|cervical dystonia
825345|NCT00132990|Deep brain stimulation|deep brain stimulation
825346|NCT00132977|Cardiac Resynchronization Therapy|cardiac resynchronization therapy
825347|NCT00132977|Heart Failure|heart failure
825348|NCT00132977|Mechanical Dyssynchrony|mechanical dyssynchrony
825349|NCT00132964|pediatric|pediatric
825350|NCT00132964|ankle fractures|ankle fractures
825351|NCT00132964|randomized controlled trial|randomized controlled trial
825352|NCT00132964|management|management
825353|NCT00132925|allergic rhinitis|allergic rhinitis
825354|NCT00132912|Platelets|platelets
825355|NCT00132912|Platelet Aggregation Inhibitors|platelet aggregation inhibitors
825356|NCT00132912|Protease-Activated Receptor 1|protease-activated receptor 1
825357|NCT00132912|Hemorrhage|hemorrhage
825358|NCT00132899|Crohn's Disease|crohn's disease
825359|NCT00132899|multi-centre randomized placebo-controlled|multi-centre randomized placebo-controlled
825360|NCT00132899|infliximab|infliximab
825361|NCT00132899|methotrexate|methotrexate
825362|NCT00132899|inflammatory bowel disease|inflammatory bowel disease
825363|NCT00132873|Narcolepsy|narcolepsy
825364|NCT00132873|Cataplexy|cataplexy
825365|NCT00132847|Child|child
825366|NCT00132847|Adolescent|adolescent
825367|NCT00132847|Urban Health|urban health
825368|NCT00132821|Nicotine dependence|nicotine dependence
825369|NCT00132821|Sleep disorders|sleep disorders
825370|NCT00132821|smoking cessation|smoking cessation
825371|NCT00132821|Relapse|relapse
825372|NCT00132808|Postmenopausal osteoporosis|postmenopausal osteoporosis
825373|NCT00132808|osteopenia|osteopenia
825374|NCT00132808|zoledronic acid|zoledronic acid
825375|NCT00132808|Osteopenia (osteoporosis prevention)|osteopenia (osteoporosis prevention)
825376|NCT00132795|Cognitive Therapy|cognitive therapy
825377|NCT00132795|Recurrence|recurrence
825378|NCT00132795|Prevention|prevention
825379|NCT00132795|Educational Technology|educational technology
825380|NCT00132756|Hormone Refractory|hormone refractory
825381|NCT00132756|Taxane Refractory|taxane refractory
825382|NCT00132704|Lung cancer metastases to the CNS (adenocarcinomas)|lung cancer metastases to the cns (adenocarcinomas)
825383|NCT00132704|Melanoma metastases to the CNS|melanoma metastases to the cns
825384|NCT00132704|Breast cancer metastases to the CNS (ductal carcinomas)|breast cancer metastases to the cns (ductal carcinomas)
825385|NCT00132704|Central nervous system gliomas|central nervous system gliomas
825386|NCT00132704|Colorectal cancers (adenocarcinomas)|colorectal cancers (adenocarcinomas)
825387|NCT00132704|Ovarian cancers (papillary serous carcinomas)|ovarian cancers (papillary serous carcinomas)
825388|NCT00132704|Endometrial cancers (endometrioid carcinomas)|endometrial cancers (endometrioid carcinomas)
825389|NCT00132704|Cervical cancers (squamous cell carcinomas)|cervical cancers (squamous cell carcinomas)
825390|NCT00132704|Sarcomas (liposarcomas and leiomyosarcomas)|sarcomas (liposarcomas and leiomyosarcomas)
825391|NCT00132704|Thoracic mesotheliomas|thoracic mesotheliomas
825392|NCT00132704|Colorectal cancers metastatic to the liver|colorectal cancers metastatic to the liver
825393|NCT00132704|Primary adenocarcinomas of the lung|primary adenocarcinomas of the lung
825394|NCT00132704|Primary squamous cell carcinomas of the lung|primary squamous cell carcinomas of the lung
825395|NCT00132704|Pancreatic Cancers-adenocarcinoma|pancreatic cancers-adenocarcinoma
825396|NCT00132691|uveitis|uveitis
825397|NCT00132691|non-infectious intermediate uveitis|non-infectious intermediate uveitis
825398|NCT00132691|non-infectious posterior uveitis|non-infectious posterior uveitis
825399|NCT00132691|non-infectious panuveitis|non-infectious panuveitis
825400|NCT00132678|Mood episodes|mood episodes
825401|NCT00132678|Bipolar 1 disorder|bipolar 1 disorder
825402|NCT00132678|Intramuscular Injectable|intramuscular injectable
825403|NCT00132678|risperidone|risperidone
825404|NCT00132678|safety and efficacy|safety and efficacy
825405|NCT00132665|non-small cell lung cancer|non-small cell lung cancer
825406|NCT00132665|elderly patients|elderly patients
825407|NCT00132665|carboplatin|carboplatin
825408|NCT00132665|chemoradiotherapy|chemoradiotherapy
825409|NCT00132639|pulmonary neoplasm|pulmonary neoplasm
825410|NCT00132639|preoperative chemotherapy|preoperative chemotherapy
825411|NCT00132639|cisplatin, docetaxel|cisplatin, docetaxel
825412|NCT00132639|randomized trial|randomized trial
825413|NCT00132639|clinical stage IB or II nonsmall cell lung cancer|clinical stage ib or ii nonsmall cell lung cancer
825414|NCT00132626|parkinson|parkinson
825415|NCT00132626|diagnosis|diagnosis
825416|NCT00132613|pulmonary neoplasm|pulmonary neoplasm
825417|NCT00132613|malignant pericardial effusion|malignant pericardial effusion
825418|NCT00132613|pericardial drainage|pericardial drainage
825419|NCT00132613|randomized trial|randomized trial
825420|NCT00132613|bleomycin|bleomycin
825421|NCT00132613|intrapericardial instillation|intrapericardial instillation
825422|NCT00132600|Allergic contact dermatitis|allergic contact dermatitis
825423|NCT00132600|Patch testing|patch testing
825424|NCT00132600|bacitracin|bacitracin
825425|NCT00132587|Knee arthroplasty|knee arthroplasty
825426|NCT00132587|Femoral loosening|femoral loosening
825427|NCT00132587|Total Knee Arthroplasty|total knee arthroplasty
825428|NCT00132574|acne, dairy|acne, dairy
825429|NCT00132548|Malaria|malaria
825430|NCT00132548|Children|children
825431|NCT00132548|Intermittent preventive treatment|intermittent preventive treatment
825432|NCT00132548|Senegal|senegal
825433|NCT00132535|Malaria in pregnancy|malaria in pregnancy
825434|NCT00132535|IPT|ipt
825435|NCT00132535|Sulphadoxine-pyrimethamine|sulphadoxine-pyrimethamine
825436|NCT00132535|Chloroquine|chloroquine
825437|NCT00132535|HIV|hiv
825438|NCT00132535|Viral load|viral load
825439|NCT00132535|birth weight|birth weight
825440|NCT00132535|anaemia|anaemia
825441|NCT00132522|EpCAM|epcam
825442|NCT00132522|monoclonal-antibody|monoclonal-antibody
825443|NCT00132522|targeted therapy|targeted therapy
825444|NCT00132522|colorectal|colorectal
825445|NCT00132522|prostate|prostate
825446|NCT00132522|non-small cell lung cancer|non-small cell lung cancer
825447|NCT00132522|ovarian|ovarian
825448|NCT00132522|solid tumor|solid tumor
825449|NCT00132509|rt-PA|rt-pa
825450|NCT00132509|thrombolysis|thrombolysis
825451|NCT00132509|Acute ischemic stroke|acute ischemic stroke
825452|NCT00132496|GERD|gerd
825453|NCT00132483|Physical activity|physical activity
825454|NCT00132483|cerebral infarct|cerebral infarct
825455|NCT00132457|Chlamydia|chlamydia
825456|NCT00132457|screening|screening
825457|NCT00132457|Sexually transmitted disease|sexually transmitted disease
825458|NCT00132444|HIV|hiv
825459|NCT00132444|topical microbicides|topical microbicides
825460|NCT00132431|calcimimetic|calcimimetic
825461|NCT00132431|cinacalcet|cinacalcet
825462|NCT00132431|hemodialysis|hemodialysis
825463|NCT00132431|secondary hyperparathyroidism|secondary hyperparathyroidism
825464|NCT00132431|chronic kidney disease|chronic kidney disease
825465|NCT00132418|rheumatoid arthritis and at least 1 qualifying comorbid condition (diabetes, chronic pulmonary disease, recent infection)|rheumatoid arthritis and at least 1 qualifying comorbid condition (diabetes, chronic pulmonary disease, recent infection)
825466|NCT00132418|RA|ra
825467|NCT00132418|rheumatoid arthritis|rheumatoid arthritis
825468|NCT00132405|Needlestick pain|needlestick pain
825469|NCT00132405|Venipuncture pain|venipuncture pain
825470|NCT00132405|Procedural pain|procedural pain
825471|NCT00132392|Arthroplasty|arthroplasty
825472|NCT00132392|Total knee arthroplasty|total knee arthroplasty
825473|NCT00132392|Capsaicin|capsaicin
825474|NCT00132392|Pain|pain
825475|NCT00132392|Analgesia|analgesia
825476|NCT00132366|Neurotransmission|neurotransmission
825477|NCT00132366|Cortical Excitability|cortical excitability
825478|NCT00132366|GABA|gaba
825479|NCT00132366|Seizures|seizures
825480|NCT00132366|Succinic Semialdehyde Dehydrogenase Deficiency|succinic semialdehyde dehydrogenase deficiency
825481|NCT00132366|SSADH|ssadh
825482|NCT00132366|Healthy Volunteer|healthy volunteer
825483|NCT00132366|HV|hv
825484|NCT00132353|Magnetic Stimulation|magnetic stimulation
825485|NCT00132353|Single Fiber EMG|single fiber emg
825486|NCT00132353|Ultrasonography|ultrasonography
825487|NCT00132353|Autonomic Testing|autonomic testing
825488|NCT00132353|Near-nerve recording|near-nerve recording
825489|NCT00132353|Neurological Disorders|neurological disorders
825490|NCT00132353|Neuromuscular Transmission Disorders|neuromuscular transmission disorders
825491|NCT00132353|Central Demyelinating Disorders|central demyelinating disorders
825492|NCT00132353|Myelopathy|myelopathy
825493|NCT00132353|Motor Neuron Disease|motor neuron disease
825494|NCT00132353|Movement Disorders|movement disorders
825495|NCT00132353|Healthy Volunteer|healthy volunteer
825496|NCT00132340|Spasmodic Torticollis|spasmodic torticollis
825497|NCT00132340|Treatment|treatment
825498|NCT00132340|Physiology|physiology
825499|NCT00132340|Surgery|surgery
825500|NCT00132340|Cervical Dystonia|cervical dystonia
825501|NCT00132327|Lyme Disease|lyme disease
825502|NCT00132327|Borrelia Burgdorferi|borrelia burgdorferi
825503|NCT00132327|Inflammation|inflammation
825504|NCT00132327|Skin|skin
825505|NCT00132327|Host Response|host response
825506|NCT00132327|Erythema Migrans Rash|erythema migrans rash
825507|NCT00132327|Healthy Volunteer|healthy volunteer
825508|NCT00132327|HV|hv
825509|NCT00132301|multi-site clinical trial|multi-site clinical trial
825510|NCT00132301|prostate|prostate
825511|NCT00132301|radical prostatectomy|radical prostatectomy
825512|NCT00132301|randomized|randomized
825514|NCT00132288|Frailty|frailty
825515|NCT00132288|Sedentary|sedentary
825516|NCT00132288|Falls|falls
825517|NCT00132288|Physical Activity|physical activity
825518|NCT00132275|bacterial|bacterial
825519|NCT00132275|sinusitis|sinusitis
825520|NCT00132275|treatment|treatment
825521|NCT00132275|diagnosis|diagnosis
825522|NCT00132275|guideline|guideline
825523|NCT00132275|acute bacterial sinusitis|acute bacterial sinusitis
825524|NCT00132262|Screening and Brief Intervention|screening and brief intervention
825525|NCT00132262|Ethnic Differences|ethnic differences
825526|NCT00132262|Trauma Center|trauma center
825527|NCT00132249|Traumatic Brain Injury|traumatic brain injury
825528|NCT00132249|Penetrating head wound|penetrating head wound
825529|NCT00132249|Closed head trauma|closed head trauma
825530|NCT00132249|Vietnam Veteran|vietnam veteran
825531|NCT00132236|smoking cessation|smoking cessation
825532|NCT00132236|nicotine sublingual tablets|nicotine sublingual tablets
825533|NCT00132236|behaviour support|behaviour support
825534|NCT00132236|smoking reduction|smoking reduction
825535|NCT00132236|quality of life|quality of life
825536|NCT00132236|COPD|copd
825537|NCT00132236|weight|weight
825538|NCT00132223|magnetic imaging|magnetic imaging
825539|NCT00132223|angiography|angiography
825540|NCT00132223|contrast agent|contrast agent
825541|NCT00132223|signal/noise ratio|signal/noise ratio
825542|NCT00132223|contrast/noise ratio|contrast/noise ratio
825543|NCT00132223|vessel|vessel
825544|NCT00132210|acute hepatitis C|acute hepatitis c
825545|NCT00132210|HIV|hiv
825546|NCT00132210|pegylated interferon|pegylated interferon
825547|NCT00132197|Functional somatic symptoms|functional somatic symptoms
825548|NCT00132197|Cognitive behavioral therapy|cognitive behavioral therapy
825549|NCT00132197|somatization disorder|somatization disorder
825550|NCT00132197|SF-36|sf-36
825551|NCT00132197|cost-effectiveness|cost-effectiveness
825552|NCT00132197|Medically unexplained symptoms|medically unexplained symptoms
825553|NCT00132184|Vitamin D|vitamin d
825554|NCT00132184|Crohns Disease|crohns disease
825555|NCT00132171|Helicobacter pylori|helicobacter pylori
825556|NCT00132171|Eradication|eradication
825557|NCT00132171|Sequential therapy|sequential therapy
825558|NCT00132171|Standard therapy|standard therapy
825559|NCT00132145|Vascular diseases|vascular diseases
825560|NCT00132145|Computerized decision support systems|computerized decision support systems
825561|NCT00132145|Shared care|shared care
825562|NCT00132145|Patient motivation|patient motivation
825563|NCT00132145|Quality of care|quality of care
825564|NCT00132132|BMI|bmi
825565|NCT00132132|obesity|obesity
825566|NCT00132132|behavioral intervention|behavioral intervention
825567|NCT00132132|longterm randomized controlled trial|longterm randomized controlled trial
825568|NCT00132132|exercise|exercise
825569|NCT00132132|empowerment|empowerment
825570|NCT00132132|nutrition|nutrition
825692|NCT00131625|Morbidity|morbidity
825571|NCT00132093|Left ventricular remodelling|left ventricular remodelling
825572|NCT00132093|Acute myocardial infarction|acute myocardial infarction
825573|NCT00132093|Left ventricular dysfunction|left ventricular dysfunction
825574|NCT00132093|Eplerenone|eplerenone
825575|NCT00132093|Cardiac Magnetic Resonance Imaging|cardiac magnetic resonance imaging
825576|NCT00132054|extensive stage small cell lung cancer|extensive stage small cell lung cancer
825577|NCT00132054|recurrent small cell lung cancer|recurrent small cell lung cancer
825578|NCT00132041|adult primary hepatocellular carcinoma|adult primary hepatocellular carcinoma
825579|NCT00132041|localized unresectable adult primary liver cancer|localized unresectable adult primary liver cancer
825580|NCT00132015|Waldenström macroglobulinemia|waldenström macroglobulinemia
825581|NCT00132015|multicentric Castleman disease|multicentric castleman disease
825582|NCT00132015|unicentric Castleman disease|unicentric castleman disease
825583|NCT00132015|adult grade III lymphomatoid granulomatosis|adult grade iii lymphomatoid granulomatosis
825584|NCT00132015|polycythemia vera|polycythemia vera
825585|NCT00132015|essential thrombocythemia|essential thrombocythemia
825586|NCT00132015|hairy cell leukemia|hairy cell leukemia
825587|NCT00132015|monoclonal gammopathy of undetermined significance|monoclonal gammopathy of undetermined significance
825588|NCT00132015|adult Burkitt lymphoma|adult burkitt lymphoma
825589|NCT00132015|adult diffuse large cell lymphoma|adult diffuse large cell lymphoma
825590|NCT00132015|adult diffuse mixed cell lymphoma|adult diffuse mixed cell lymphoma
825591|NCT00132015|adult diffuse small cleaved cell lymphoma|adult diffuse small cleaved cell lymphoma
825592|NCT00132015|adult immunoblastic large cell lymphoma|adult immunoblastic large cell lymphoma
825593|NCT00132015|adult lymphoblastic lymphoma|adult lymphoblastic lymphoma
825594|NCT00132015|grade 1 follicular lymphoma|grade 1 follicular lymphoma
825595|NCT00132015|grade 2 follicular lymphoma|grade 2 follicular lymphoma
825596|NCT00132015|grade 3 follicular lymphoma|grade 3 follicular lymphoma
825597|NCT00132015|mantle cell lymphoma|mantle cell lymphoma
825598|NCT00132015|marginal zone lymphoma|marginal zone lymphoma
825599|NCT00132015|small lymphocytic lymphoma|small lymphocytic lymphoma
825600|NCT00132015|precancerous condition|precancerous condition
825601|NCT00131963|stage One A (IA) breast cancer|stage one a (ia) breast cancer
825602|NCT00131963|stage Two (II) breast cancer|stage two (ii) breast cancer
825603|NCT00131963|stage Three A (IIIA) breast cancer|stage three a (iiia) breast cancer
825604|NCT00131963|stage Three B(IIIB) breast cancer|stage three b(iiib) breast cancer
825605|NCT00131963|stage Three C(IIIC) breast cancer|stage three c(iiic) breast cancer
825606|NCT00131963|stage One B (IB) breast cancer|stage one b (ib) breast cancer
825607|NCT00131950|breast cancer|breast cancer
825608|NCT00131924|recurrent breast cancer|recurrent breast cancer
825609|NCT00131924|stage IV breast cancer|stage iv breast cancer
825610|NCT00131898|IMRT+Surgery versus Surgery For Sarcoma|imrt+surgery versus surgery for sarcoma
825611|NCT00131885|Menstruation|menstruation
825612|NCT00131885|Complementary Therapies|complementary therapies
825613|NCT00131885|Pharmacokinetics|pharmacokinetics
825614|NCT00131885|Hypericum|hypericum
825615|NCT00131885|St. John's wort|st. john's wort
825616|NCT00131885|Levonorgestrel|levonorgestrel
825617|NCT00131885|Women|women
825618|NCT00131872|vascular access graft|vascular access graft
825619|NCT00131872|hemodialysis|hemodialysis
825620|NCT00131872|dialysis|dialysis
825621|NCT00131872|end stage renal disease|end stage renal disease
825622|NCT00131859|Perinatal brain injury|perinatal brain injury
825623|NCT00131859|Diffusion-tensor imaging|diffusion-tensor imaging
825624|NCT00131846|Thiazide diuretics|thiazide diuretics
825625|NCT00131846|Essential hypertension|essential hypertension
825626|NCT00131846|Type 2 diabetes|type 2 diabetes
825627|NCT00131846|Randomized clinical trial|randomized clinical trial
825628|NCT00131846|Cost-effectiveness|cost-effectiveness
825629|NCT00131833|salmonella|salmonella
825630|NCT00131833|typhoid vaccine|typhoid vaccine
825631|NCT00131833|enteric fever|enteric fever
825632|NCT00131820|Salmonella|salmonella
825633|NCT00131820|typhoid vaccine|typhoid vaccine
825634|NCT00131820|enteric fever|enteric fever
825635|NCT00131820|socioeconomic costs|socioeconomic costs
825636|NCT00131807|Blood Pressure|blood pressure
825637|NCT00131807|HIV|hiv
825638|NCT00131807|Antiretroviral therapy|antiretroviral therapy
825639|NCT00131794|Malaria|malaria
825640|NCT00131794|BCG vaccine|bcg vaccine
825641|NCT00131794|Guinea Bissau|guinea bissau
825642|NCT00131781|Borderline personality disorder|borderline personality disorder
825643|NCT00131781|Controlled trials|controlled trials
825644|NCT00131781|Cognitive Therapy|cognitive therapy
825645|NCT00131781|Supportive Therapy|supportive therapy
825646|NCT00131781|suicide|suicide
825647|NCT00131781|impulsivity|impulsivity
825648|NCT00131768|osteoarthritis of the ankle|osteoarthritis of the ankle
825649|NCT00131768|musculoskeletal|musculoskeletal
825650|NCT00131755|type 1 diabetes|type 1 diabetes
825651|NCT00131755|beta cell rest|beta cell rest
825652|NCT00131755|diazoxide|diazoxide
825653|NCT00131755|insulin secretion|insulin secretion
825654|NCT00131729|Amblyopia|amblyopia
825655|NCT00131729|Occlusion therapy|occlusion therapy
825656|NCT00131729|Compliance|compliance
825657|NCT00131729|Risk factors|risk factors
825658|NCT00131716|prevention|prevention
825659|NCT00131716|recurrence|recurrence
825660|NCT00131716|severe|severe
825661|NCT00131716|anaemia|anaemia
825662|NCT00131703|Screening|screening
825663|NCT00131703|Treatment|treatment
825664|NCT00131703|Amodiaquine|amodiaquine
825665|NCT00131703|Sulphadoxine-pyrimethamine|sulphadoxine-pyrimethamine
825666|NCT00131703|Malaria in pregnancy|malaria in pregnancy
825667|NCT00131690|Caffeine|caffeine
825668|NCT00131690|Coffee|coffee
825669|NCT00131690|Randomized|randomized
825670|NCT00131690|Birth weight|birth weight
825671|NCT00131651|renal|renal
825672|NCT00131651|cancer|cancer
825673|NCT00131651|advanced|advanced
825674|NCT00131651|unresectable|unresectable
825675|NCT00131651|metastatic|metastatic
825676|NCT00131651|recurrent|recurrent
825677|NCT00131651|anti-angiogenic|anti-angiogenic
825678|NCT00131651|targeted|targeted
825679|NCT00131651|ATN-161|atn-161
825680|NCT00131651|Recurrent renal cell cancer|recurrent renal cell cancer
825681|NCT00131651|Renal clear cell carcinoma|renal clear cell carcinoma
825682|NCT00131651|Advanced Renal Cell Cancer|advanced renal cell cancer
825683|NCT00131638|Oncology|oncology
825684|NCT00131638|KGF|kgf
825685|NCT00131638|Palifermin|palifermin
825686|NCT00131638|Oral mucositis|oral mucositis
825687|NCT00131638|Clinical Trial|clinical trial
825688|NCT00131638|Amgen|amgen
825689|NCT00131638|head and neck|head and neck
825690|NCT00131625|Exclusive breast-feeding|exclusive breast-feeding
825691|NCT00131625|Mortality|mortality
825693|NCT00131625|Nutrition|nutrition
825694|NCT00131625|Low income country|low income country
825695|NCT00131612|adjuvant therapy|adjuvant therapy
825696|NCT00131612|epirubicin|epirubicin
825697|NCT00131612|uridine glucuronosyl/transferase 2B7|uridine glucuronosyl/transferase 2b7
825698|NCT00131612|pharmacogenetics|pharmacogenetics
825699|NCT00131599|5-fluorouracil|5-fluorouracil
825700|NCT00131599|thymidylate synthase|thymidylate synthase
825701|NCT00131599|pharmacogenetics|pharmacogenetics
825702|NCT00131586|platinum analogues|platinum analogues
825703|NCT00131586|cisplatin, carboplatin, oxaliplatin|cisplatin, carboplatin, oxaliplatin
825704|NCT00131586|proteomics|proteomics
825705|NCT00131586|hemoglobin|hemoglobin
825706|NCT00131573|Urgency-Frequency|urgency-frequency
825707|NCT00131573|Syndrome|syndrome
825708|NCT00131573|Urinary|urinary
825709|NCT00131573|Refractory|refractory
825710|NCT00131573|Stimulation|stimulation
825711|NCT00131573|Nerve|nerve
825712|NCT00131573|Neuromodulation|neuromodulation
825713|NCT00131573|Microstimulator|microstimulator
825714|NCT00131573|bion|bion
825715|NCT00131573|Pudendal|pudendal
825716|NCT00131573|Overactive bladder|overactive bladder
825717|NCT00131560|HIV, gene therapy, leukapheresis, autologous CD4 T cell, lentivector|hiv, gene therapy, leukapheresis, autologous cd4 t cell, lentivector
825718|NCT00131547|Obesity|obesity
825719|NCT00131547|Obstructive Sleep Apnea|obstructive sleep apnea
825720|NCT00131534|Complex trauma|complex trauma
825721|NCT00131534|Trauma recovery|trauma recovery
825722|NCT00131534|Resiliency|resiliency
825723|NCT00131534|Posttraumatic stress|posttraumatic stress
825724|NCT00131534|Individual psychotherapy|individual psychotherapy
825725|NCT00131534|Group psychotherapy|group psychotherapy
825726|NCT00131521|mucus obstruction, ventilator management|mucus obstruction, ventilator management
825727|NCT00131508|Hemoglobin S Disease|hemoglobin s disease
825728|NCT00131508|Sickle Cell Anemia|sickle cell anemia
825729|NCT00131495|Low Libido|low libido
825730|NCT00131495|Low Desire|low desire
825731|NCT00131495|Distress|distress
825732|NCT00131482|Chrysalin|chrysalin
825733|NCT00131482|TP508|tp508
825734|NCT00131482|Fracture|fracture
825735|NCT00131482|Wrist|wrist
825736|NCT00131482|Healing|healing
825737|NCT00131469|Osteogenesis Imperfecta|osteogenesis imperfecta
825738|NCT00131469|Brittle Bone Disease|brittle bone disease
825739|NCT00131469|Fragility Fractures|fragility fractures
825740|NCT00131456|cannabis dependence|cannabis dependence
825741|NCT00131456|depression|depression
825742|NCT00131456|treatment|treatment
825743|NCT00131456|venlafaxine|venlafaxine
825744|NCT00131443|Basilar/Hemiplegic Migraine|basilar/hemiplegic migraine
825745|NCT00131443|Prophylaxis|prophylaxis
825746|NCT00131417|severe|severe
825747|NCT00131417|malnutrition|malnutrition
825748|NCT00131417|ready-to-use-therapeutic-food|ready-to-use-therapeutic-food
825749|NCT00131417|children|children
825750|NCT00131417|Uganda|uganda
825751|NCT00131378|Visceral obesity|visceral obesity
825752|NCT00131378|Growth hormone|growth hormone
825753|NCT00131378|Cardiovascular risk|cardiovascular risk
825754|NCT00131378|Insulin resistance|insulin resistance
825755|NCT00131365|fibroids|fibroids
825756|NCT00131365|Uterine Fibroids|uterine fibroids
825757|NCT00131365|ExAblate|exablate
825758|NCT00131365|MrgFUS|mrgfus
825759|NCT00131352|Osteoarthritis of the knee|osteoarthritis of the knee
825760|NCT00131352|Musculoskeletal|musculoskeletal
825761|NCT00131339|panic disorder|panic disorder
825762|NCT00131339|cognitive behavioral therapy|cognitive behavioral therapy
825763|NCT00131339|D-cycloserine|d-cycloserine
825764|NCT00131339|medication|medication
825765|NCT00131339|treatment trial|treatment trial
825766|NCT00131339|placebo-controlled|placebo-controlled
825767|NCT00131339|double-blind|double-blind
825768|NCT00131339|randomized|randomized
825769|NCT00131326|osteoarthritis of the hip|osteoarthritis of the hip
825770|NCT00131326|Musculoskeletal Diseases|musculoskeletal diseases
825771|NCT00131313|Leukemia|leukemia
825772|NCT00131313|Cancer|cancer
825773|NCT00131313|Nipent|nipent
825774|NCT00131313|Rituxan|rituxan
825775|NCT00131313|Cytoxan|cytoxan
825776|NCT00131300|Osteoarthritis of the shoulder|osteoarthritis of the shoulder
825777|NCT00131300|Musculoskeletal|musculoskeletal
825778|NCT00131287|Agaricus Blazei Murill|agaricus blazei murill
825779|NCT00131287|type II DM|type ii dm
825780|NCT00131287|insulin index|insulin index
825781|NCT00131274|Pulmonary Fibrosis|pulmonary fibrosis
825782|NCT00131274|Respiratory Diseases|respiratory diseases
825783|NCT00131274|Interstitial Lung Disease|interstitial lung disease
825784|NCT00131274|Usual Interstitial Pneumonia|usual interstitial pneumonia
825785|NCT00131261|Multiple Myeloma|multiple myeloma
825786|NCT00131261|Neoplasms|neoplasms
825787|NCT00131235|Malaria|malaria
825789|NCT00131235|Pregnancy|pregnancy
825790|NCT00131235|Prevention|prevention
825791|NCT00131235|Preterm birth|preterm birth
825792|NCT00131235|Low birth weight|low birth weight
825793|NCT00131235|Sub-Saharan Africa|sub-saharan africa
825794|NCT00131222|Infant|infant
825795|NCT00131222|Malnutrition|malnutrition
825796|NCT00131222|Sub-Saharan Africa|sub-saharan africa
825797|NCT00131222|Treatment|treatment
825798|NCT00131222|Growth|growth
825799|NCT00131222|Haemoglobin|haemoglobin
825800|NCT00131222|Fortified spread|fortified spread
825801|NCT00131222|Food supplement|food supplement
825802|NCT00131209|Infant|infant
825803|NCT00131209|Sub-Saharan Africa|sub-saharan africa
825804|NCT00131209|Complementary feeding|complementary feeding
825805|NCT00131209|Malnutrition|malnutrition
825806|NCT00131209|Growth|growth
825807|NCT00131209|Fortified spread|fortified spread
825808|NCT00131209|Haemoglobin|haemoglobin
825809|NCT00131196|pneumonia|pneumonia
825810|NCT00131196|peritonitis|peritonitis
825811|NCT00131196|sepsis|sepsis
825812|NCT00131196|outcome|outcome
825813|NCT00131196|genomics|genomics
825814|NCT00131183|Angina Pectoris|angina pectoris
825815|NCT00131183|Arteriosclerosis|arteriosclerosis
825816|NCT00131183|Testosterone|testosterone
825817|NCT00131157|Pulmonary Disease, Chronic Obstructive|pulmonary disease, chronic obstructive
825818|NCT00131157|Family Practice|family practice
825819|NCT00131157|Spirometry|spirometry
825820|NCT00131157|Decision Support Systems|decision support systems
825821|NCT00131157|Feedback|feedback
825822|NCT00131144|Diabetic retinopathy,Octreotide Acetate in Microspheres|diabetic retinopathy,octreotide acetate in microspheres
825823|NCT00131131|physical activity|physical activity
825824|NCT00131131|cholelithiasis|cholelithiasis
825825|NCT00131131|pregnancy complication|pregnancy complication
825826|NCT00131118|Osteogenesis Imperfecta, Brittle bone disease, bisphosphonate, children|osteogenesis imperfecta, brittle bone disease, bisphosphonate, children
825827|NCT00131105|Healthy|healthy
825828|NCT00131105|Caregivers|caregivers
825829|NCT00131105|Aging|aging
825830|NCT00131092|exercise|exercise
825831|NCT00131092|aging|aging
825832|NCT00131092|physical activity|physical activity
825833|NCT00131079|Primary Health Care|primary health care
825834|NCT00131079|Physicians, Family|physicians, family
825835|NCT00131079|Family Practice|family practice
825836|NCT00131079|Health Promotion|health promotion
825837|NCT00131079|Randomized Controlled Trials|randomized controlled trials
825838|NCT00131079|Multicenter Studies|multicenter studies
825839|NCT00131079|Physical Fitness|physical fitness
825840|NCT00131079|Quality of Life|quality of life
825841|NCT00131066|Previously enrolled on a MEDI-507 for psoriasis|previously enrolled on a medi-507 for psoriasis
825842|NCT00131053|acute lymphoblastic leukemia|acute lymphoblastic leukemia
825843|NCT00131053|newly diagnosed|newly diagnosed
825844|NCT00131053|BCR-ABL-negative|bcr-abl-negative
825845|NCT00131040|Cardiopulmonary|cardiopulmonary
825846|NCT00131040|Surgery|surgery
825847|NCT00131040|leukocyte|leukocyte
825848|NCT00131040|inflammation|inflammation
825849|NCT00131040|Coronary Artery Bypass Grafting|coronary artery bypass grafting
825850|NCT00131027|acute lymphoblastic leukemia|acute lymphoblastic leukemia
825851|NCT00131027|newly diagnosed|newly diagnosed
825852|NCT00131027|BCR-ABL-negative|bcr-abl-negative
825853|NCT00131014|Non-Hodgkin's Lymphoma|non-hodgkin's lymphoma
825854|NCT00131014|Hodgkin's disease|hodgkin's disease
825855|NCT00131014|Chronic Lymphocytic Leukemia|chronic lymphocytic leukemia
825856|NCT00131014|Lymphoproliferative disorder|lymphoproliferative disorder
825857|NCT00131014|Genetics|genetics
825858|NCT00131001|Carotid artery stenosis|carotid artery stenosis
825859|NCT00131001|cost effectiveness|cost effectiveness
825860|NCT00131001|magnetic resonance angiography|magnetic resonance angiography
825861|NCT00131001|computed tomography angiography|computed tomography angiography
825862|NCT00131001|digital subtraction angiography|digital subtraction angiography
825863|NCT00130988|Somatoform Disorders|somatoform disorders
825864|NCT00130988|Medically unexplained symptoms|medically unexplained symptoms
825865|NCT00130988|Physician-Patient Relations|physician-patient relations
825866|NCT00130988|Primary Health Care|primary health care
825867|NCT00130988|Family Physician|family physician
825868|NCT00130988|psychosocial therapy|psychosocial therapy
825869|NCT00130988|re-attribution of symptoms|re-attribution of symptoms
825870|NCT00130988|cluster randomised controlled trial|cluster randomised controlled trial
825871|NCT00130975|Atrial fibrillation.|atrial fibrillation.
825872|NCT00130975|Cardioversion.|cardioversion.
825873|NCT00130975|Recurrence.|recurrence.
825874|NCT00130975|Candesartan.|candesartan.
825875|NCT00130962|Intermetatarsal neuroma|intermetatarsal neuroma
825876|NCT00130962|Morton's neuroma|morton's neuroma
825877|NCT00130962|ALGRX 4975|algrx 4975
825878|NCT00130962|capsaicin|capsaicin
825879|NCT00130949|Acute lateral epicondylitis|acute lateral epicondylitis
825880|NCT00130949|Tennis elbow|tennis elbow
825881|NCT00130949|Capsaicin|capsaicin
825882|NCT00130936|phase I|phase i
825883|NCT00130936|epirubicin|epirubicin
825884|NCT00130936|solid tumors|solid tumors
825885|NCT00130923|Risperidone|risperidone
825886|NCT00130923|Schizophrenia|schizophrenia
825887|NCT00130923|Substance Use Disorder|substance use disorder
825888|NCT00130923|Alcohol Use Disorder|alcohol use disorder
825889|NCT00130923|Treatment|treatment
825890|NCT00130923|Schizoaffective Disorder|schizoaffective disorder
825892|NCT00130910|Helminthiasis|helminthiasis
825893|NCT00130910|Co-infection|co-infection
825894|NCT00130910|Intestinal immune activation|intestinal immune activation
825895|NCT00130910|Treatment Naive|treatment naive
825896|NCT00130884|levosimendan|levosimendan
825897|NCT00130884|chronic heart failure|chronic heart failure
825898|NCT00130884|oral administration|oral administration
825899|NCT00130871|levosimendan|levosimendan
825900|NCT00130871|weaning|weaning
825901|NCT00130871|cardio-pulmonary bypass|cardio-pulmonary bypass
825902|NCT00130858|Sarcoma, Soft Tissue|sarcoma, soft tissue
825903|NCT00130845|Diabetic retinopathy, Octreotide Acetate in Microspheres|diabetic retinopathy, octreotide acetate in microspheres
825904|NCT00130819|Drug Dependence|drug dependence
825905|NCT00130819|Opiate Dependence|opiate dependence
825906|NCT00130819|Human Immunodeficiency Viruses|human immunodeficiency viruses
825907|NCT00130819|Buprenorphine|buprenorphine
825908|NCT00130780|Multi-modality treatment for lung cancer|multi-modality treatment for lung cancer
825909|NCT00130780|Carcinoma, Squamous Cell|carcinoma, squamous cell
825910|NCT00130780|Bevacizumab|bevacizumab
825911|NCT00130780|BEACON|beacon
825912|NCT00130780|05-052|05-052
825913|NCT00130767|Prostate|prostate
825914|NCT00130767|apoptosis|apoptosis
825915|NCT00130767|finasteride kinetics|finasteride kinetics
825916|NCT00130728|NSCLC|nsclc
825917|NCT00130728|Avastin|avastin
825918|NCT00130728|Tarceva|tarceva
825919|NCT00130728|Lung Cancer|lung cancer
825920|NCT00130715|Patients undergoing a variety of abdominal surgical procedures|patients undergoing a variety of abdominal surgical procedures
825921|NCT00130702|AML|aml
825922|NCT00130702|acute myelogenous leukemia|acute myelogenous leukemia
825923|NCT00130702|gefitinib|gefitinib
825924|NCT00130702|Iressa|iressa
825925|NCT00130689|Esophageal Cancer|esophageal cancer
825926|NCT00130689|Gastric Cancer|gastric cancer
825927|NCT00130689|Metastatic Esophageal Cancer|metastatic esophageal cancer
825928|NCT00130689|Metastatic Gastric Cancer|metastatic gastric cancer
825929|NCT00130689|Cetuximab|cetuximab
825930|NCT00130689|Metastatic Esophageal and Gastric Cancer|metastatic esophageal and gastric cancer
825931|NCT00130676|PMD|pmd
825932|NCT00130676|Psychotic Major Depression|psychotic major depression
825933|NCT00130676|Depression|depression
825934|NCT00130676|Major Depression|major depression
825935|NCT00130676|Psychosis|psychosis
825936|NCT00130650|IV|iv
825937|NCT00130650|cannulation|cannulation
825938|NCT00130650|Injections, Intravenous|injections, intravenous
825939|NCT00130637|Anterior Uveitis|anterior uveitis
825940|NCT00130637|Arthritis, Juvenile Idiopathic|arthritis, juvenile idiopathic
825941|NCT00130637|Daclizumab|daclizumab
825942|NCT00130637|Iritis|iritis
825943|NCT00130637|Immunosuppression|immunosuppression
825944|NCT00130637|Chronic Inflammatory Eye-Disease|chronic inflammatory eye-disease
825945|NCT00130637|Juvenile Idiopathic Arthritis|juvenile idiopathic arthritis
825946|NCT00130624|Falls|falls
825947|NCT00130624|Elderly|elderly
825948|NCT00130624|multidisciplinary assessment|multidisciplinary assessment
825949|NCT00130611|heart failure|heart failure
825950|NCT00130611|cost effectiveness|cost effectiveness
825951|NCT00130611|BNP|bnp
825952|NCT00130611|private practice|private practice
825953|NCT00130611|Acute dyspnoea|acute dyspnoea
825954|NCT00130598|contrast nephropathy|contrast nephropathy
825955|NCT00130598|contrast media|contrast media
825956|NCT00130598|renal dysfunction|renal dysfunction
825957|NCT00130585|Folate|folate
825958|NCT00130585|Bioavailability|bioavailability
825959|NCT00130585|Stable isotopes|stable isotopes
825960|NCT00130559|Respiratory failure|respiratory failure
825961|NCT00130559|BNP|bnp
825962|NCT00130546|coronary artery disease|coronary artery disease
825963|NCT00130546|coronary intervention|coronary intervention
825964|NCT00130546|drug eluting stent implantation|drug eluting stent implantation
825965|NCT00130546|Cypher - Stent|cypher - stent
825966|NCT00130546|Sirolimus|sirolimus
825967|NCT00130546|Taxus - Stent|taxus - stent
825968|NCT00130546|Paclitaxel|paclitaxel
825969|NCT00130533|Triple-Negative Early Breast Cancer|triple-negative early breast cancer
825970|NCT00130533|Maintenance Adjuvant Chemotherapy|maintenance adjuvant chemotherapy
825971|NCT00130533|Capecitabine|capecitabine
825972|NCT00130533|Basal-like genotype|basal-like genotype
825973|NCT00130533|Triple-Negative|triple-negative
825974|NCT00130520|advanced ovarian cancer|advanced ovarian cancer
825975|NCT00130520|refractory ovarian cancer|refractory ovarian cancer
825976|NCT00130520|primary peritoneal cancer|primary peritoneal cancer
825977|NCT00130507|HER2 positive breast cancer.|her2 positive breast cancer.
825978|NCT00130507|Progression to trastuzumab and taxanes.|progression to trastuzumab and taxanes.
825979|NCT00130494|Non-symptomatic bone metastases.|non-symptomatic bone metastases.
825980|NCT00130481|Diabetes|diabetes
825981|NCT00130481|Children|children
825982|NCT00130481|Adolescents|adolescents
825983|NCT00130481|Arterial Compliance|arterial compliance
825984|NCT00130481|Physiology Cardiovascular Endothelium|physiology cardiovascular endothelium
825985|NCT00130442|phase II|phase ii
825986|NCT00130442|metastatic melanoma|metastatic melanoma
825987|NCT00130442|dacarbazine|dacarbazine
825992|NCT00130429|Hopkins verbal learning test|hopkins verbal learning test
825993|NCT00130429|paired associated learning|paired associated learning
825994|NCT00130416|behavior|behavior
825995|NCT00130416|randomized trial|randomized trial
825996|NCT00130416|communication|communication
825997|NCT00130416|patient|patient
825998|NCT00130416|internet|internet
825999|NCT00130416|coaching|coaching
826000|NCT00130416|self-efficacy|self-efficacy
826001|NCT00130416|nurse|nurse
826002|NCT00130416|primary care|primary care
826003|NCT00130416|physician|physician
826004|NCT00130416|screening|screening
826005|NCT00130416|survey|survey
826006|NCT00130416|pain|pain
826007|NCT00130416|mobility|mobility
826008|NCT00130416|disability|disability
826009|NCT00130416|depression|depression
826010|NCT00130390|Crohn's Disease|crohn's disease
826011|NCT00130377|Stem Cell|stem cell
826012|NCT00130377|Heart|heart
826013|NCT00130377|Lung|lung
826014|NCT00130377|Vascular|vascular
826015|NCT00130377|cell therapy registry|cell therapy registry
826016|NCT00130364|Atopic dermatitis|atopic dermatitis
826017|NCT00130364|T-cell|t-cell
826018|NCT00130364|pimecrolimus|pimecrolimus
826019|NCT00130364|children|children
826020|NCT00130364|facial|facial
826021|NCT00130364|Facial atopic dermatitis|facial atopic dermatitis
826022|NCT00130351|asthma, formoterol multi-dose dry powder inhaler (MDDPI)|asthma, formoterol multi-dose dry powder inhaler (mddpi)
826023|NCT00130338|Dementia|dementia
826024|NCT00130338|Vascular|vascular
826025|NCT00130338|Rivastigmine|rivastigmine
826026|NCT00130338|Stroke|stroke
826027|NCT00130338|Memory loss|memory loss
826028|NCT00130325|ELISPOT,|elispot,
826029|NCT00130325|tuberculosis,|tuberculosis,
826030|NCT00130325|Mycobacterium tuberculosis|mycobacterium tuberculosis
826031|NCT00130325|Isoniazid|isoniazid
826032|NCT00130325|Clinical trial|clinical trial
826033|NCT00130312|Diabetes|diabetes
826034|NCT00130312|Diabetic Nephropathy|diabetic nephropathy
826035|NCT00130312|Proteinuria|proteinuria
826036|NCT00130286|Lipodystrophy|lipodystrophy
826037|NCT00130286|HIV|hiv
826038|NCT00130286|Growth hormone|growth hormone
826039|NCT00130286|Rosiglitazone|rosiglitazone
826040|NCT00130286|Visceral fat|visceral fat
826041|NCT00130286|Metabolic syndrome|metabolic syndrome
826042|NCT00130286|Treatment Experienced|treatment experienced
826043|NCT00130286|Visceral fat accumulation|visceral fat accumulation
826044|NCT00130286|fat accumulation|fat accumulation
826045|NCT00130286|HIV-Associated Metabolic Syndrome|hiv-associated metabolic syndrome
826046|NCT00130273|HIV|hiv
826047|NCT00130273|AIDS|aids
826048|NCT00130273|Problem Solving|problem solving
826049|NCT00130273|Antiretroviral Therapy, Highly Active|antiretroviral therapy, highly active
826050|NCT00130273|Patient Compliance|patient compliance
826051|NCT00130260|Staphylococcus aureus|staphylococcus aureus
826052|NCT00130260|Vaccine|vaccine
826053|NCT00130260|Randomized Controlled Trial|randomized controlled trial
826054|NCT00130247|Brazil|brazil
826055|NCT00130247|Philippines|philippines
826056|NCT00130247|Tuberculosis|tuberculosis
826057|NCT00130247|Uganda|uganda
826058|NCT00130234|urticaria|urticaria
826059|NCT00130234|hives|hives
826060|NCT00130234|Xolair|xolair
826061|NCT00130221|Chlorhexidine|chlorhexidine
826062|NCT00130221|Blood stream infections|blood stream infections
826063|NCT00130221|central venous catheter associated|central venous catheter associated
826064|NCT00130221|Nosocomial infection|nosocomial infection
826065|NCT00130221|Bacteremia|bacteremia
826066|NCT00130221|sepsis|sepsis
826067|NCT00130221|Pneumonia|pneumonia
826068|NCT00130221|Urinary tract infection|urinary tract infection
826069|NCT00130221|Clostridium Difficile|clostridium difficile
826070|NCT00130221|intensive care unit|intensive care unit
826071|NCT00130221|catheter|catheter
826072|NCT00130221|nosocomial pneumonia|nosocomial pneumonia
826073|NCT00130221|Infection control|infection control
826074|NCT00130208|Diabetes|diabetes
826075|NCT00130208|Diabetes Mellitus, Type 2|diabetes mellitus, type 2
826076|NCT00130208|Albuminuria|albuminuria
826077|NCT00130208|Diabetic Nephropathy|diabetic nephropathy
826078|NCT00130195|acute lymphoblastic leukemia|acute lymphoblastic leukemia
826079|NCT00130195|BCR-ABL|bcr-abl
826080|NCT00130195|Philadelphia-chromosome|philadelphia-chromosome
826081|NCT00130195|newly diagnosed|newly diagnosed
826082|NCT00130182|lung disease|lung disease
826083|NCT00130169|Cancer|cancer
826084|NCT00130169|malignant tumors|malignant tumors
826085|NCT00130156|Blood pressure|blood pressure
826086|NCT00130156|SBP|sbp
826087|NCT00130156|DBP|dbp
826088|NCT00130117|leptin|leptin
826089|NCT00130117|hypothalamic amenorrhea|hypothalamic amenorrhea
826090|NCT00130117|exercise-induced amenorrhea|exercise-induced amenorrhea
826091|NCT00130117|neuroendocrine function|neuroendocrine function
826092|NCT00130117|bone metabolism|bone metabolism
826093|NCT00130104|digital block|digital block
826094|NCT00130104|regional anesthesia|regional anesthesia
826095|NCT00130104|finger repair|finger repair
826096|NCT00130104|Fingers|fingers
826390|NCT00129168|Adult AML|adult aml
826097|NCT00130104|Anesthesia, Conduction|anesthesia, conduction
826098|NCT00130091|unilateral|unilateral
826099|NCT00130091|hernia|hernia
826100|NCT00130091|hydrocele|hydrocele
826101|NCT00130091|pediatric|pediatric
826102|NCT00130091|clonidine|clonidine
826103|NCT00130091|nerve block|nerve block
826104|NCT00130078|HIV Seronegativity|hiv seronegativity
826105|NCT00130078|HIV transmission|hiv transmission
826106|NCT00130065|Malaria|malaria
826107|NCT00130065|Pregnancy|pregnancy
826108|NCT00130065|Sulfadoxine-pyrimethamine|sulfadoxine-pyrimethamine
826109|NCT00130065|Folic acid|folic acid
826110|NCT00130065|Folate|folate
826111|NCT00130039|Infarction, Cerebral|infarction, cerebral
826112|NCT00130039|cilostazol|cilostazol
826113|NCT00130039|stenosis|stenosis
826114|NCT00130039|atherosclerosis|atherosclerosis
826115|NCT00130039|clopidogrel|clopidogrel
826116|NCT00130013|Children|children
826117|NCT00130013|Non-severe pneumonia|non-severe pneumonia
826118|NCT00130013|Oral amoxicillin|oral amoxicillin
826119|NCT00130000|h5g.1|h5g.1
826120|NCT00130000|Paroxysmal Nocturnal Hemoglobinuria|paroxysmal nocturnal hemoglobinuria
826121|NCT00130000|SHEPHERD|shepherd
826122|NCT00130000|PNH|pnh
826123|NCT00129987|Asthma|asthma
826124|NCT00129974|Lung cancer|lung cancer
826125|NCT00129974|Phase II|phase ii
826126|NCT00129974|Drug Therapy|drug therapy
826127|NCT00129961|Kidney|kidney
826128|NCT00129961|Transplant|transplant
826129|NCT00129961|Skin Cancer|skin cancer
826130|NCT00129948|Acute myeloid leukemia|acute myeloid leukemia
826131|NCT00129948|AML|aml
826132|NCT00129948|refractory|refractory
826133|NCT00129948|relapsed|relapsed
826134|NCT00129935|HER2 negative breast cancer|her2 negative breast cancer
826135|NCT00129935|Node positive breast cancer|node positive breast cancer
826136|NCT00129935|Adjuvant treatment|adjuvant treatment
826137|NCT00129935|Oral chemotherapy|oral chemotherapy
826138|NCT00129922|Axillary node positive breast cancer.|axillary node positive breast cancer.
826139|NCT00129922|Sequential drug administration.|sequential drug administration.
826140|NCT00129922|Weekly paclitaxel.|weekly paclitaxel.
826141|NCT00129909|hypertension|hypertension
826142|NCT00129909|family physicians|family physicians
826143|NCT00129909|fixed dose combination therapy|fixed dose combination therapy
826144|NCT00129909|cluster randomized controlled trial|cluster randomized controlled trial
826145|NCT00129896|Her2neu positive breast cancer.|her2neu positive breast cancer.
826146|NCT00129896|Neoadjuvant treatment.|neoadjuvant treatment.
826147|NCT00129883|quality of care|quality of care
826148|NCT00129883|antibiotic use|antibiotic use
826149|NCT00129883|intervention|intervention
826150|NCT00129883|lower respiratory tract infections|lower respiratory tract infections
826151|NCT00129883|Community acquired Pneumonia|community acquired pneumonia
826152|NCT00129883|Acute Exacerbation of Chronic Bronchitis or COPD|acute exacerbation of chronic bronchitis or copd
826153|NCT00129844|Motexafin Gadolinium|motexafin gadolinium
826154|NCT00129844|non-small cell, lung cancer|non-small cell, lung cancer
826155|NCT00129844|Lung cancer|lung cancer
826156|NCT00129844|cancer of the lung|cancer of the lung
826157|NCT00129844|Carcinoma, Non-Small-Cell Lung|carcinoma, non-small-cell lung
826158|NCT00129831|COPD, indacaterol, PK|copd, indacaterol, pk
826159|NCT00129818|Genital herpes|genital herpes
826160|NCT00129818|viral shedding|viral shedding
826161|NCT00129818|famciclovir|famciclovir
826162|NCT00129818|Symptomatic genital herpes|symptomatic genital herpes
826163|NCT00129818|Asymptomatic genital herpes|asymptomatic genital herpes
826164|NCT00129792|Blood Glucose|blood glucose
826165|NCT00129792|Cholesterol|cholesterol
826166|NCT00129792|Weight Loss|weight loss
826167|NCT00129792|Insulin|insulin
826168|NCT00129792|Complementary Therapies|complementary therapies
826169|NCT00129779|COPD|copd
826170|NCT00129766|Respiratory Syncytial Virus (RSV)|respiratory syncytial virus (rsv)
826171|NCT00129766|motavizumab|motavizumab
826172|NCT00129766|palivizumab|palivizumab
826173|NCT00129766|Synagis|synagis
826174|NCT00129753|Campath-1H Monoclonal Antibody|campath-1h monoclonal antibody
826175|NCT00129753|Alemtuzumab|alemtuzumab
826176|NCT00129753|Campath|campath
826177|NCT00129753|Campath-1H|campath-1h
826178|NCT00129753|Relapsed and Resistant Classical Hodgkin's Disease|relapsed and resistant classical hodgkin's disease
826179|NCT00129753|Lymphoma|lymphoma
826180|NCT00129740|Chronic phase CML|chronic phase cml
826181|NCT00129740|Newly diagnosed chronic phase CML|newly diagnosed chronic phase cml
826182|NCT00129740|AMN107|amn107
826183|NCT00129727|Carboplatin|carboplatin
826184|NCT00129727|Paclitaxel|paclitaxel
826185|NCT00129727|Bevacizumab|bevacizumab
826186|NCT00129727|Ovarian|ovarian
826187|NCT00129727|Cancer|cancer
826188|NCT00129714|cervical radiculopathy conservative treatment|cervical radiculopathy conservative treatment
826189|NCT00129701|phone consultation in secondary care|phone consultation in secondary care
826190|NCT00129688|febrile neutropenia|febrile neutropenia
826191|NCT00129688|once-daily|once-daily
826192|NCT00129688|amikacin|amikacin
826193|NCT00129688|cloxacillin|cloxacillin
826194|NCT00129688|children|children
826195|NCT00129675|parkinson|parkinson
826196|NCT00129675|diagnosis|diagnosis
826197|NCT00129662|Pictorial action plan|pictorial action plan
826198|NCT00129649|Telephone reminder|telephone reminder
826199|NCT00129636|post consultation letter|post consultation letter
826200|NCT00129610|Agoraphobia|agoraphobia
826201|NCT00129610|panic disorder|panic disorder
826202|NCT00129610|Virtual Reality Therapy|virtual reality therapy
826203|NCT00129610|Cognitive Behavior Therapy|cognitive behavior therapy
826204|NCT00129610|cognition|cognition
826205|NCT00129610|spatial cognition|spatial cognition
826206|NCT00129610|PANIC DISORDER WITH AGORAPHOBIA|panic disorder with agoraphobia
826207|NCT00129597|Ketalar|ketalar
826208|NCT00129597|NMDA|nmda
826209|NCT00129597|mastectomy|mastectomy
826210|NCT00129597|postoperative chronic pain|postoperative chronic pain
826211|NCT00129597|Chronic pain after mastectomy for breast cancer|chronic pain after mastectomy for breast cancer
826212|NCT00129584|Endobronchial Valve (EBV) Procedure|endobronchial valve (ebv) procedure
826213|NCT00129584|Bronchoscopic Lung Volume Reduction|bronchoscopic lung volume reduction
826214|NCT00129545|Atrial Fibrillation|atrial fibrillation
826215|NCT00129545|AF|af
826216|NCT00129545|A Fib|a fib
826217|NCT00129545|Stroke|stroke
826218|NCT00129545|Coumadin|coumadin
826219|NCT00129545|Warfarin|warfarin
826220|NCT00129545|Blood thinning medication|blood thinning medication
826221|NCT00129545|transient ischemic attack (TIA)|transient ischemic attack (tia)
826222|NCT00129545|WATCHMAN|watchman
826223|NCT00129545|Left atrial appendage|left atrial appendage
826224|NCT00129545|LAA isolation|laa isolation
826225|NCT00129545|LAA occlusion|laa occlusion
826226|NCT00129532|HIV transmission|hiv transmission
826227|NCT00129519|BCC curettage|bcc curettage
826228|NCT00129506|medical abortion|medical abortion
826229|NCT00129506|methotrexate|methotrexate
826230|NCT00129506|misoprostol|misoprostol
826231|NCT00129493|Practice guidelines|practice guidelines
826232|NCT00129493|Hypertension|hypertension
826233|NCT00129493|Primary health care|primary health care
826234|NCT00129493|Patient-centered care|patient-centered care
826235|NCT00129493|Healthcare quality|healthcare quality
826236|NCT00129493|Office visits|office visits
826237|NCT00129493|Self-efficacy|self-efficacy
826238|NCT00129493|Self care|self care
826239|NCT00129493|Guideline adherence|guideline adherence
826240|NCT00129493|Patient noncompliance|patient noncompliance
826241|NCT00129480|veterans|veterans
826242|NCT00129480|pain and chronic disease|pain and chronic disease
826243|NCT00129480|disease management|disease management
826244|NCT00129480|depression|depression
826245|NCT00129480|primary health care|primary health care
826246|NCT00129480|practice guidelines|practice guidelines
826247|NCT00129480|guideline adherence|guideline adherence
826248|NCT00129480|narcotics|narcotics
826249|NCT00129480|patient compliance|patient compliance
826250|NCT00129480|randomized controlled trial|randomized controlled trial
826251|NCT00129467|Depression|depression
826252|NCT00129467|Hospice Care|hospice care
826253|NCT00129467|Antidepressive Agents|antidepressive agents
826254|NCT00129467|Methylphenidate|methylphenidate
826255|NCT00129467|Central Nervous System Stimulant|central nervous system stimulant
826256|NCT00129467|Pain|pain
826257|NCT00129467|Caregiver Burden|caregiver burden
826258|NCT00129467|Cancer|cancer
826259|NCT00129454|Telemedicine|telemedicine
826260|NCT00129454|Cognitive Behavior Therapy|cognitive behavior therapy
826261|NCT00129454|Utilization|utilization
826262|NCT00129454|Randomized Control Trial|randomized control trial
826263|NCT00129454|Gulf War Illness|gulf war illness
826264|NCT00129454|Symptom-Based Illness|symptom-based illness
826265|NCT00129454|Multisymptom Illness|multisymptom illness
826266|NCT00129454|High utilization|high utilization
826267|NCT00129441|schizophrenia|schizophrenia
826268|NCT00129428|UVB|uvb
826269|NCT00129428|keloid|keloid
826270|NCT00129428|scleroderma|scleroderma
826271|NCT00129428|acne keloidalis nuchae|acne keloidalis nuchae
826272|NCT00129428|scars|scars
826273|NCT00129428|granuloma annulare|granuloma annulare
826274|NCT00129415|UVA1|uva1
826275|NCT00129415|UVB|uvb
826276|NCT00129415|atopic dermatitis|atopic dermatitis
826277|NCT00129415|psoriasis|psoriasis
826278|NCT00129415|alopecia|alopecia
826279|NCT00129415|mycosis fungoides (CTCL)|mycosis fungoides (ctcl)
826280|NCT00129415|urticaria|urticaria
826281|NCT00129415|inflammatory dermatoses|inflammatory dermatoses
826282|NCT00129415|stretch marks|stretch marks
826283|NCT00129402|cholesterol|cholesterol
826284|NCT00129402|drugs|drugs
826285|NCT00129402|hypercholesterolemia|hypercholesterolemia
826286|NCT00129402|adolescent|adolescent
826287|NCT00129402|randomized controlled trials|randomized controlled trials
826288|NCT00129389|Node negative, high risk breast cancer.|node negative, high risk breast cancer.
826289|NCT00129389|Prognostic gene profile.|prognostic gene profile.
826290|NCT00129389|Saint Gallen high risk criteria.|saint gallen high risk criteria.
826291|NCT00129389|Weekly paclitaxel.|weekly paclitaxel.
826292|NCT00129376|Stage II and IIIA breast Cancer.|stage ii and iiia breast cancer.
826293|NCT00129376|Neoadjuvant chemotherapy.|neoadjuvant chemotherapy.
826294|NCT00129376|Weekly docetaxel.|weekly docetaxel.
826295|NCT00129363|Adolescent|adolescent
826296|NCT00129363|Adrenergic alpha-Antagonists/therapeutic use|adrenergic alpha-antagonists/therapeutic use
826297|NCT00129363|Adrenergic alpha-Antagonists/pharmacokinetics|adrenergic alpha-antagonists/pharmacokinetics
826298|NCT00129363|Adrenergic alpha-Antagonists/administration & dosage|adrenergic alpha-antagonists/administration & dosage
826299|NCT00129363|Adrenergic beta-Antagonists/therapeutic use|adrenergic beta-antagonists/therapeutic use
826300|NCT00129363|Adrenergic beta-Antagonists/pharmacokinetics|adrenergic beta-antagonists/pharmacokinetics
826301|NCT00129363|Adrenergic beta-Antagonists/administration & dosage|adrenergic beta-antagonists/administration & dosage
826302|NCT00129363|Age Factors|age factors
826303|NCT00129363|Carbazoles/therapeutic use|carbazoles/therapeutic use
826304|NCT00129363|Carbazoles/administration & dosage|carbazoles/administration & dosage
826305|NCT00129363|Child|child
826306|NCT00129363|Child, Preschool|child, preschool
826307|NCT00129363|Drug Administration Schedule|drug administration schedule
826308|NCT00129363|Female|female
826309|NCT00129363|Heart Failure, Congestive/etiology|heart failure, congestive/etiology
826310|NCT00129363|Heart Failure, Congestive/drug therapy|heart failure, congestive/drug therapy
826311|NCT00129363|Heart Failure, Congestive/blood|heart failure, congestive/blood
826312|NCT00129363|Human|human
826313|NCT00129363|Infant|infant
826314|NCT00129363|Infant, Newborn|infant, newborn
826315|NCT00129363|Male|male
826316|NCT00129363|Natriuretic Peptide, Brain/blood|natriuretic peptide, brain/blood
826317|NCT00129363|Placebos|placebos
826318|NCT00129363|Propanolamines/therapeutic use|propanolamines/therapeutic use
826319|NCT00129363|Propanolamines/administration & dosage|propanolamines/administration & dosage
826320|NCT00129363|Prospective Studies|prospective studies
826321|NCT00129363|Support, Non-U.S. Gov't|support, non-u.s. gov't
826322|NCT00129363|Treatment Outcome|treatment outcome
826323|NCT00129363|Ventricular Dysfunction/drug therapy|ventricular dysfunction/drug therapy
826324|NCT00129363|Ventricular Dysfunction/complications|ventricular dysfunction/complications
826325|NCT00129363|Ventricular Dysfunction/blood|ventricular dysfunction/blood
826326|NCT00129363|Ventricular Function/drug effects|ventricular function/drug effects
826327|NCT00129363|Ventricular Remodeling/drug effects|ventricular remodeling/drug effects
826328|NCT00129350|End Stage Fibrotic Lung Disease|end stage fibrotic lung disease
826329|NCT00129337|monoclonal antibody|monoclonal antibody
826330|NCT00129337|phase 1|phase 1
826331|NCT00129337|solid tumor|solid tumor
826332|NCT00129337|anti-angiogenesis|anti-angiogenesis
826333|NCT00129337|refractory advanced solid tumor malignancy|refractory advanced solid tumor malignancy
826334|NCT00129324|HOME|home
826335|NCT00129324|Environmental Exposure|environmental exposure
826336|NCT00129324|Neurobehavior|neurobehavior
826337|NCT00129324|Child Development|child development
826338|NCT00129324|Lead Exposure|lead exposure
826339|NCT00129324|Child Injury|child injury
826340|NCT00129324|Adolescence|adolescence
826341|NCT00129324|Adiposity|adiposity
826342|NCT00129324|Neuroimaging|neuroimaging
826343|NCT00129311|Tobacco|tobacco
826344|NCT00129298|cocaine abuse|cocaine abuse
826345|NCT00129298|opiate dependent|opiate dependent
826346|NCT00129298|tiagabine|tiagabine
826347|NCT00129298|methadone|methadone
826348|NCT00129285|cocaine|cocaine
826349|NCT00129272|adolescents, cigarettes, smoking, tobacco|adolescents, cigarettes, smoking, tobacco
826350|NCT00129259|T1D|t1d
826351|NCT00129259|type 1 diabetes|type 1 diabetes
826352|NCT00129259|type 1 diabetes mellitus|type 1 diabetes mellitus
826353|NCT00129259|juvenile diabetes|juvenile diabetes
826354|NCT00129259|autoimmune diabetes|autoimmune diabetes
826355|NCT00129259|autoimmune|autoimmune
826356|NCT00129259|anti-CD3 mAb|anti-cd3 mab
826357|NCT00129259|mAb hOKT3g1(Ala-Ala)|mab hokt3g1(ala-ala)
826358|NCT00129259|teplizumab|teplizumab
826359|NCT00129246|Tobacco|tobacco
826360|NCT00129246|Smoking|smoking
826361|NCT00129246|Weight|weight
826362|NCT00129246|Weight perception|weight perception
826363|NCT00129246|Naltrexone|naltrexone
826364|NCT00129246|Bupropion|bupropion
826365|NCT00129233|cardiovascular disease|cardiovascular disease
826366|NCT00129233|rennin-angiotensin system|rennin-angiotensin system
826367|NCT00129233|calcium channel blocker|calcium channel blocker
826368|NCT00129233|impaired glucose tolerance|impaired glucose tolerance
826369|NCT00129220|Manic or mixed episode associated with bipolar I disorder|manic or mixed episode associated with bipolar i disorder
826370|NCT00129207|pharmacokinetic|pharmacokinetic
826371|NCT00129207|pharmacodynamics|pharmacodynamics
826372|NCT00129207|VELCADE|velcade
826373|NCT00129207|Ketoconazole|ketoconazole
826374|NCT00129207|CYP 3A4|cyp 3a4
826375|NCT00129207|Solid Tumor|solid tumor
826376|NCT00129207|Advanced Solid Tumors|advanced solid tumors
826377|NCT00129194|HIV|hiv
826378|NCT00129194|Treatment Experienced|treatment experienced
826379|NCT00129181|parkinson|parkinson
826380|NCT00129181|brain imaging|brain imaging
826381|NCT00129181|diagnosis|diagnosis
826382|NCT00129168|Leukemia, Myeloid|leukemia, myeloid
826383|NCT00129168|Relapse|relapse
826384|NCT00129168|Chemotherapy|chemotherapy
826385|NCT00129168|Zosuquidar|zosuquidar
826386|NCT00129168|Daunorubicin|daunorubicin
826387|NCT00129168|Cytarabine|cytarabine
826388|NCT00129168|Acute|acute
826389|NCT00129168|AML|aml
826391|NCT00129155|Allogenic stem cell transplantation|allogenic stem cell transplantation
826392|NCT00129155|Treosulfan|treosulfan
826393|NCT00129155|Haematological malignancies|haematological malignancies
826394|NCT00129155|allogeneic stem cell transplantation in patients with hematological malignancies|allogeneic stem cell transplantation in patients with hematological malignancies
826395|NCT00129142|Prostate cancer|prostate cancer
826396|NCT00129142|Bone Loss|bone loss
826397|NCT00129142|Osteoporosis|osteoporosis
826398|NCT00129142|Fractures|fractures
826399|NCT00129142|Androgen Deprivation Therapy|androgen deprivation therapy
826400|NCT00129129|Immunogenicity|immunogenicity
826401|NCT00129129|Primary & booster vaccination|primary & booster vaccination
826402|NCT00129129|Infants|infants
826403|NCT00129129|Meningococcal vaccine|meningococcal vaccine
826404|NCT00129129|Safety|safety
826405|NCT00129129|Children|children
826406|NCT00129129|Hib disease|hib disease
826407|NCT00129129|Meningococcal disease|meningococcal disease
826408|NCT00129116|Invasive bacterial disease caused by Hib|invasive bacterial disease caused by hib
826409|NCT00129116|Neisseria meningitidis serogroups C & Y|neisseria meningitidis serogroups c & y
826410|NCT00129077|Pediatric critical care|pediatric critical care
826411|NCT00129077|neuromuscular blocking agents|neuromuscular blocking agents
826412|NCT00129077|corneal abrasions|corneal abrasions
826413|NCT00129064|Referrals|referrals
826414|NCT00129064|Quality of care|quality of care
826415|NCT00129064|Ambulatory care|ambulatory care
826416|NCT00129064|Electronic medical record|electronic medical record
826417|NCT00129064|Referral communication|referral communication
826418|NCT00129051|tomotherapy|tomotherapy
826419|NCT00129051|metastatic carcinoma|metastatic carcinoma
826420|NCT00129025|conformal hypofractionated radiotherapy|conformal hypofractionated radiotherapy
826421|NCT00129025|localized prostate cancer|localized prostate cancer
826422|NCT00129012|radiation therapy|radiation therapy
826423|NCT00129012|carcinoma|carcinoma
826424|NCT00129012|non-small cell lung|non-small cell lung
826425|NCT00128999|radiation therapy|radiation therapy
826426|NCT00128986|radiotherapy|radiotherapy
826427|NCT00128986|brain|brain
826428|NCT00128973|CGD|cgd
826429|NCT00128973|LAD|lad
826430|NCT00128973|XSCID|xscid
826431|NCT00128973|cGVHD|cgvhd
826432|NCT00128973|Infection|infection
826433|NCT00128973|Genetic|genetic
826434|NCT00128973|Inherited Disease|inherited disease
826435|NCT00128973|Immunity|immunity
826436|NCT00128973|Chronic|chronic
826437|NCT00128973|Abnormal Immune Function|abnormal immune function
826438|NCT00128973|Recurrent Infection|recurrent infection
826439|NCT00128973|Chronic Granulomatous Disease|chronic granulomatous disease
826440|NCT00128973|X-Linked Severe Combined Immune Deficiency (XSCID)|x-linked severe combined immune deficiency (xscid)
826561|NCT00128531|safety study|safety study
826441|NCT00128973|Leukocyte Adhesion Deficiency 1|leukocyte adhesion deficiency 1
826442|NCT00128973|Healthy Volunteer|healthy volunteer
826443|NCT00128973|HV|hv
826444|NCT00128960|Allogeneic Hematopoietic Stem Cell Transplant|allogeneic hematopoietic stem cell transplant
826445|NCT00128960|Health Related Quality of Life|health related quality of life
826446|NCT00128960|Symptom Experience|symptom experience
826447|NCT00128960|Fatigue|fatigue
826448|NCT00128960|Functional Status|functional status
826449|NCT00128960|Survey|survey
826450|NCT00128960|Allogeneic Stem Cell Transplant|allogeneic stem cell transplant
826451|NCT00128947|Immunosuppresant|immunosuppresant
826452|NCT00128947|Pharmacogenetics|pharmacogenetics
826453|NCT00128947|Glucuronidation|glucuronidation
826454|NCT00128947|Metabolism|metabolism
826455|NCT00128947|UGT|ugt
826456|NCT00128934|Premenstrual Syndrome (PMS)|premenstrual syndrome (pms)
826457|NCT00128934|Hormone Therapy|hormone therapy
826458|NCT00128921|Multiple Myeloma|multiple myeloma
826459|NCT00128908|HIV-1|hiv-1
826460|NCT00128908|HAART|haart
826461|NCT00128908|sequential HAART|sequential haart
826462|NCT00128908|resistance|resistance
826463|NCT00128908|salvage therapy|salvage therapy
826464|NCT00128908|Treatment Experienced|treatment experienced
826465|NCT00128895|Wegener's granulomatosis, ANCA, vasculitis, proteinase 3|wegener's granulomatosis, anca, vasculitis, proteinase 3
826466|NCT00128895|ANCA-associated vasculitis|anca-associated vasculitis
826467|NCT00128895|ANCA|anca
826468|NCT00128882|Idiopathic Thrombocytopenic Purpura|idiopathic thrombocytopenic purpura
826469|NCT00128882|Treatment|treatment
826470|NCT00128882|Anti-D|anti-d
826471|NCT00128882|Subcutaneous|subcutaneous
826472|NCT00128882|Clinical evaluation|clinical evaluation
826473|NCT00128882|Platelet count|platelet count
826474|NCT00128882|IVIG|ivig
826475|NCT00128869|Manipulation|manipulation
826476|NCT00128869|Mobilization|mobilization
826477|NCT00128869|Neck Pain|neck pain
826478|NCT00128869|Physical Therapy|physical therapy
826479|NCT00128856|Neoadjuvant chemotherapy.|neoadjuvant chemotherapy.
826480|NCT00128856|Stage III disease.|stage iii disease.
826481|NCT00128843|Metastatic breast cancer|metastatic breast cancer
826482|NCT00128843|First line of hormone treatment|first line of hormone treatment
826483|NCT00128843|Postmenopausal women|postmenopausal women
826484|NCT00128843|Positive hormone receptor tumours|positive hormone receptor tumours
826485|NCT00128830|Human Immunodeficiency Virus Type 1|human immunodeficiency virus type 1
826486|NCT00128830|HIV-1 infection|hiv-1 infection
826487|NCT00128830|TMC125|tmc125
826488|NCT00128830|Etravirine|etravirine
826489|NCT00128830|Enfuvirtide|enfuvirtide
826490|NCT00128830|Antiretroviral therapy|antiretroviral therapy
826491|NCT00128817|neoplasm|neoplasm
826492|NCT00128817|larynx|larynx
826493|NCT00128817|surgery|surgery
826494|NCT00128817|radiotherapy|radiotherapy
826495|NCT00128817|chemotherapy|chemotherapy
826496|NCT00128804|vitamin A|vitamin a
826497|NCT00128804|beta Carotene|beta carotene
826498|NCT00128804|diet|diet
826499|NCT00128804|nutrition|nutrition
826500|NCT00128804|nutritional requirements|nutritional requirements
826501|NCT00128791|myocardial infarction|myocardial infarction
826502|NCT00128791|angioplasty|angioplasty
826503|NCT00128791|nitric oxide|nitric oxide
826504|NCT00128791|prevention|prevention
826505|NCT00128791|acute myocardial infarction|acute myocardial infarction
826506|NCT00128778|Breast cancer|breast cancer
826507|NCT00128778|Metastases|metastases
826508|NCT00128778|Maintenance treatment|maintenance treatment
826509|NCT00128765|chronic obstructive pulmonary disease (COPD)|chronic obstructive pulmonary disease (copd)
826510|NCT00128765|self-management|self-management
826511|NCT00128765|practice nurse|practice nurse
826512|NCT00128765|cost-effectiveness|cost-effectiveness
826513|NCT00128765|randomized controlled trial|randomized controlled trial
826514|NCT00128752|vitamin A|vitamin a
826515|NCT00128752|beta Carotene|beta carotene
826516|NCT00128752|diet|diet
826517|NCT00128752|nutrition|nutrition
826518|NCT00128752|nutritional requirements|nutritional requirements
826519|NCT00128726|continuous combined oral contraceptive|continuous combined oral contraceptive
826520|NCT00128726|endometrial and ovarian suppression|endometrial and ovarian suppression
826521|NCT00128713|Blood Transfusion|blood transfusion
826522|NCT00128713|Blood Platelets|blood platelets
826523|NCT00128700|adult glioblastoma|adult glioblastoma
826524|NCT00128700|adult giant cell glioblastoma|adult giant cell glioblastoma
826525|NCT00128700|adult gliosarcoma|adult gliosarcoma
826526|NCT00128661|cervical intraepithelial neoplasia grade 2|cervical intraepithelial neoplasia grade 2
826527|NCT00128661|cervical cancer|cervical cancer
826528|NCT00128661|cervical intraepithelial neoplasia grade 3|cervical intraepithelial neoplasia grade 3
826529|NCT00128635|adult glioblastoma|adult glioblastoma
826530|NCT00128635|adult gliosarcoma|adult gliosarcoma
826531|NCT00128635|adult giant cell glioblastoma|adult giant cell glioblastoma
826532|NCT00128635|recurrent adult brain tumor|recurrent adult brain tumor
826533|NCT00128622|male breast cancer|male breast cancer
826534|NCT00128622|recurrent breast cancer|recurrent breast cancer
826535|NCT00128622|stage IV breast cancer|stage iv breast cancer
826536|NCT00128622|recurrent colon cancer|recurrent colon cancer
826537|NCT00128622|stage IV colon cancer|stage iv colon cancer
826538|NCT00128622|recurrent rectal cancer|recurrent rectal cancer
826539|NCT00128622|stage IV rectal cancer|stage iv rectal cancer
826540|NCT00128622|recurrent pancreatic cancer|recurrent pancreatic cancer
826541|NCT00128622|extensive stage small cell lung cancer|extensive stage small cell lung cancer
826542|NCT00128622|recurrent non-small cell lung cancer|recurrent non-small cell lung cancer
826543|NCT00128622|recurrent small cell lung cancer|recurrent small cell lung cancer
826544|NCT00128622|stage IV non-small cell lung cancer|stage iv non-small cell lung cancer
826545|NCT00128622|unspecified adult solid tumor, protocol specific|unspecified adult solid tumor, protocol specific
826546|NCT00128622|stage IV pancreatic cancer|stage iv pancreatic cancer
826547|NCT00128596|adult primary hepatocellular carcinoma|adult primary hepatocellular carcinoma
826548|NCT00128596|advanced adult primary liver cancer|advanced adult primary liver cancer
826549|NCT00128596|recurrent adult primary liver cancer|recurrent adult primary liver cancer
826550|NCT00128583|stage III melanoma|stage iii melanoma
826551|NCT00128570|unspecified adult solid tumor, protocol specific|unspecified adult solid tumor, protocol specific
826552|NCT00128557|Vitamin A|vitamin a
826553|NCT00128557|Newborn health|newborn health
826554|NCT00128557|Infant Mortality|infant mortality
826555|NCT00128557|Supplementation|supplementation
826556|NCT00128557|Micronutrients|micronutrients
826557|NCT00128557|Bangladesh|bangladesh
826558|NCT00128531|Phase III|phase iii
826559|NCT00128531|open label|open label
826560|NCT00128531|multiple dose|multiple dose
826562|NCT00128531|pharmacokinetic study|pharmacokinetic study
826563|NCT00128531|efficacy study|efficacy study
826564|NCT00128518|Hypertension - Drugs - Blood pressure response - Responders - pharmacogenetics|hypertension - drugs - blood pressure response - responders - pharmacogenetics
826565|NCT00128505|PMD|pmd
826566|NCT00128505|Depression|depression
826567|NCT00128505|Psychosis|psychosis
826568|NCT00128505|Psychotic Major Depression|psychotic major depression
826569|NCT00128505|Major Depression|major depression
826570|NCT00128492|cystic fibrosis|cystic fibrosis
826571|NCT00128492|Pseudomonas aeruginosa|pseudomonas aeruginosa
826572|NCT00128479|PMD|pmd
826573|NCT00128479|Psychotic Depression|psychotic depression
826574|NCT00128479|Psychosis|psychosis
826575|NCT00128479|Major Depression|major depression
826576|NCT00128479|Depression|depression
826577|NCT00128479|Psychotic Major Depression|psychotic major depression
826578|NCT00128466|bubonic plague|bubonic plague
826579|NCT00128466|pneumonic plague|pneumonic plague
826580|NCT00128466|septicemic plague|septicemic plague
826581|NCT00128466|Yersinia pestis|yersinia pestis
826582|NCT00128466|Pasteurella pestis|pasteurella pestis
826583|NCT00128453|Pericarditis|pericarditis
826584|NCT00128453|Recurrence|recurrence
826585|NCT00128453|Therapeutics|therapeutics
826586|NCT00128453|Prevention|prevention
826587|NCT00128453|Colchicine|colchicine
826588|NCT00128427|Postpericardiotomy Syndrome|postpericardiotomy syndrome
826589|NCT00128427|Pericarditis|pericarditis
826590|NCT00128427|Prevention|prevention
826591|NCT00128427|Colchicine|colchicine
826592|NCT00128427|Recurrence|recurrence
826593|NCT00128414|Pericarditis|pericarditis
826594|NCT00128414|Recurrence|recurrence
826595|NCT00128414|Therapeutics|therapeutics
826596|NCT00128414|Prevention|prevention
826597|NCT00128414|Colchicine|colchicine
826598|NCT00128401|Cognitive|cognitive
826599|NCT00128401|Behavioral|behavioral
826600|NCT00128401|Adolescent|adolescent
826601|NCT00128401|Therapy|therapy
826602|NCT00128401|Extinction|extinction
826603|NCT00128401|Social Phobia|social phobia
826604|NCT00128388|panic disorder,|panic disorder,
826605|NCT00128388|psychodynamic psychotherapy,|psychodynamic psychotherapy,
826606|NCT00128388|efficacy trial|efficacy trial
826607|NCT00128375|Smoking Cessation|smoking cessation
826608|NCT00128375|Work-site|work-site
826609|NCT00128375|Incentives|incentives
826610|NCT00128375|Cost Effectiveness|cost effectiveness
826611|NCT00128375|Health Behavior|health behavior
826612|NCT00128375|Smoking|smoking
826613|NCT00128362|Sentinel node|sentinel node
826614|NCT00128362|Axillary sampling|axillary sampling
826615|NCT00128362|Operable breast cancer|operable breast cancer
826616|NCT00128336|Weight|weight
826617|NCT00128336|Diet|diet
826618|NCT00128336|exercise|exercise
826619|NCT00128336|maintenance|maintenance
826620|NCT00128323|Children|children
826621|NCT00128323|oropharyngeal candidiasis|oropharyngeal candidiasis
826622|NCT00128323|GV solution|gv solution
826623|NCT00128323|nystatin drops|nystatin drops
826624|NCT00128310|Drug-resistant metastatic breast cancer|drug-resistant metastatic breast cancer
826625|NCT00128297|Breast cancer patients with symptomatic bone metastases|breast cancer patients with symptomatic bone metastases
826626|NCT00128284|gastroparesis|gastroparesis
826627|NCT00128284|Digestive|digestive
826628|NCT00128284|Gastrointestinal|gastrointestinal
826629|NCT00128284|Stomach|stomach
826630|NCT00128284|Motility|motility
826631|NCT00128284|Non-Invasive|non-invasive
826632|NCT00128284|Capsule|capsule
826634|NCT00128284|Device|device
826635|NCT00128284|Digestive System Diseases|digestive system diseases
826636|NCT00128271|HCV|hcv
826637|NCT00128271|monoclonal antibody|monoclonal antibody
826638|NCT00128271|phase 1|phase 1
826639|NCT00128258|Stem Cell|stem cell
826640|NCT00128258|Heart Failure|heart failure
826641|NCT00128258|Bone Marrow|bone marrow
826642|NCT00128245|KCS|kcs
826643|NCT00128245|dry eye|dry eye
826644|NCT00128245|pimecrolimus|pimecrolimus
826645|NCT00128245|Keratoconjunctivitis sicca (dry eye syndrome)|keratoconjunctivitis sicca (dry eye syndrome)
826646|NCT00128232|Acromegaly|acromegaly
826647|NCT00128232|untreated|untreated
826648|NCT00128232|newly diagnosed|newly diagnosed
826649|NCT00128232|octreotide LAR|octreotide lar
826650|NCT00128219|Group B Streptococcus, women, vaccine|group b streptococcus, women, vaccine
826651|NCT00128206|LTBI, tuberculosis, rifampin, isoniazid, prisoners|ltbi, tuberculosis, rifampin, isoniazid, prisoners
826652|NCT00128193|leprosy, Mycobacterium leprae, Hansen's Disease, skin test, Nepal|leprosy, mycobacterium leprae, hansen's disease, skin test, nepal
826653|NCT00128180|hantaviruses, methylprednisolone, cardiopulmonary syndrome|hantaviruses, methylprednisolone, cardiopulmonary syndrome
826654|NCT00128154|Chromium|chromium
826655|NCT00128154|Chromium picolinate|chromium picolinate
826656|NCT00128154|Blood Glucose|blood glucose
826657|NCT00128154|Cholesterol|cholesterol
826658|NCT00128154|Complementary Therapies|complementary therapies
826659|NCT00128128|Vaccinium macrocarpon|vaccinium macrocarpon
826660|NCT00128128|Cranberry|cranberry
826661|NCT00128128|Complementary Therapies|complementary therapies
826662|NCT00128102|Advanced malignant pleural mesothelioma|advanced malignant pleural mesothelioma
826663|NCT00128089|Obesity|obesity
826664|NCT00128089|Dietary treatment|dietary treatment
826665|NCT00128089|Fasting as medical therapy|fasting as medical therapy
826666|NCT00128076|shoulder surgery|shoulder surgery
826667|NCT00128076|rotator cuff|rotator cuff
826668|NCT00128076|arthroscopic repair|arthroscopic repair
826669|NCT00128076|mini-open repair|mini-open repair
826670|NCT00128063|HIV-1|hiv-1
826671|NCT00128063|succinylated human serum albumin|succinylated human serum albumin
826672|NCT00128063|Treatment Naive|treatment naive
826673|NCT00128050|Spontaneous intracerebral hemorrhage|spontaneous intracerebral hemorrhage
826674|NCT00128050|ICH|ich
826675|NCT00128050|intracerebral rebleeding|intracerebral rebleeding
826676|NCT00128050|cerebral hematoma evacuation|cerebral hematoma evacuation
826677|NCT00128050|cerebral hematoma volume|cerebral hematoma volume
826678|NCT00128037|pulmonary neoplasm|pulmonary neoplasm
826679|NCT00128037|preoperative chemoradiotherapy|preoperative chemoradiotherapy
826680|NCT00128037|surgical resection|surgical resection
826681|NCT00128037|superior sulcus tumor|superior sulcus tumor
826682|NCT00128037|chest wall invasion|chest wall invasion
826683|NCT00128037|mytomicin C|mytomicin c
826684|NCT00128037|vindesine|vindesine
826685|NCT00128037|cisplatin|cisplatin
826686|NCT00128024|randomized prospective study|randomized prospective study
826687|NCT00128024|lipid-lowering therapy with any available statins|lipid-lowering therapy with any available statins
826688|NCT00128024|multicenter study|multicenter study
826689|NCT00128024|Japanese|japanese
826690|NCT00128024|acute myocardial infarction|acute myocardial infarction
826691|NCT00128024|primary percutaneous coronary intervention|primary percutaneous coronary intervention
826692|NCT00128011|watery diarrhea|watery diarrhea
826693|NCT00128011|cholera vaccine|cholera vaccine
826694|NCT00127998|malaria|malaria
826695|NCT00127998|Plasmodium falciparum|plasmodium falciparum
826696|NCT00127998|drug resistance|drug resistance
826697|NCT00127998|antimalarials|antimalarials
826698|NCT00127998|genotype|genotype
826699|NCT00127998|treatment outcome|treatment outcome
826700|NCT00127985|multiple organ dysfunction syndrome|multiple organ dysfunction syndrome
826701|NCT00127985|corticosteroids|corticosteroids
826702|NCT00127985|mortality|mortality
826703|NCT00127972|nevirapine|nevirapine
826704|NCT00127972|efavirenz|efavirenz
826705|NCT00127972|hiv-1|hiv-1
826706|NCT00127972|Treatment Experienced|treatment experienced
826707|NCT00127959|HIV-1|hiv-1
826708|NCT00127959|HBV|hbv
826709|NCT00127959|treatment|treatment
826710|NCT00127959|tenofovir|tenofovir
826711|NCT00127959|emtricitabine|emtricitabine
826712|NCT00127959|Treatment Naive|treatment naive
826713|NCT00127959|HIV-1 infection|hiv-1 infection
826714|NCT00127959|Hepatitis B virus infection|hepatitis b virus infection
826715|NCT00127907|Out-of-hospital cardiac arrest - Vasopressin - Epinephrine|out-of-hospital cardiac arrest - vasopressin - epinephrine
826716|NCT00127881|Refractory or intolerant to Mycosis Fungoides and sezary syndrome|refractory or intolerant to mycosis fungoides and sezary syndrome
826717|NCT00127881|Cutaneous T-cell Lymphoma|cutaneous t-cell lymphoma
826718|NCT00127881|To evaluate the efficacy and safety of zanolimumab in Mycosis Fungoides and sezary syndrome|to evaluate the efficacy and safety of zanolimumab in mycosis fungoides and sezary syndrome
826719|NCT00127868|Tinea Capitis|tinea capitis
826720|NCT00127868|Children|children
826721|NCT00127868|Pediatric|pediatric
826722|NCT00127868|Treatment|treatment
826723|NCT00127868|Therapy|therapy
826724|NCT00127868|Adjunctive|adjunctive
826725|NCT00127868|Selenium Sulfide|selenium sulfide
826726|NCT00127868|Ciclopirox|ciclopirox
826727|NCT00127868|Shampoo|shampoo
826728|NCT00127855|Invasive bacterial disease caused by Hib|invasive bacterial disease caused by hib
826729|NCT00127855|Neisseria meningitidis serogroups C & Y|neisseria meningitidis serogroups c & y
826730|NCT00127842|Psoriatic Arthritis|psoriatic arthritis
826731|NCT00127842|PsA|psa
826732|NCT00127842|Commercial product|commercial product
826733|NCT00127842|American College of Rheumatology|american college of rheumatology
826734|NCT00127842|ACR/PASI|acr/pasi
826735|NCT00127829|Solid Tumors|solid tumors
826736|NCT00127816|brachytherapy|brachytherapy
826737|NCT00127816|implant radiotherapy|implant radiotherapy
826738|NCT00127803|Clostridium difficile|clostridium difficile
826739|NCT00127790|Insomnia|insomnia
826740|NCT00127790|Sleep|sleep
826741|NCT00127790|Pain|pain
826742|NCT00127790|Pain, Chronic|pain, chronic
826743|NCT00127790|Behavior Therapy|behavior therapy
826744|NCT00127790|CBT|cbt
826745|NCT00127790|CBT-I|cbt-i
826746|NCT00127790|cognitive-behavioral|cognitive-behavioral
826747|NCT00127777|HCV genotype 1|hcv genotype 1
826748|NCT00127777|peginterferon alfa-2a|peginterferon alfa-2a
826749|NCT00127777|ribavirin|ribavirin
826750|NCT00127777|amantadine|amantadine
826751|NCT00127777|treatment-naive|treatment-naive
826752|NCT00127764|pemphigus|pemphigus
826753|NCT00127764|dexamethasone|dexamethasone
826754|NCT00127764|glucocorticoids|glucocorticoids
826755|NCT00127764|pulse|pulse
826756|NCT00127764|therapy|therapy
826757|NCT00127764|randomised|randomised
826758|NCT00127764|placebo-controlled|placebo-controlled
826759|NCT00127751|Risk factor reduction|risk factor reduction
826760|NCT00127751|cardiovascular disease prevention|cardiovascular disease prevention
826761|NCT00127738|Hypertension|hypertension
826762|NCT00127738|Renal artery stenosis|renal artery stenosis
826763|NCT00127738|Kidney disease|kidney disease
826764|NCT00127738|Renal vascular disease|renal vascular disease
826765|NCT00127738|Atherosclerosis|atherosclerosis
826766|NCT00127725|tibia|tibia
826767|NCT00127725|fracture|fracture
826768|NCT00127725|PEMF|pemf
826769|NCT00127725|electromagnetic|electromagnetic
826770|NCT00127725|non-union|non-union
826771|NCT00127725|revision|revision
826772|NCT00127725|Diaphyseal fractures of the tibia|diaphyseal fractures of the tibia
826773|NCT00127712|amiodarone|amiodarone
826774|NCT00127712|atrial fibrillation|atrial fibrillation
826775|NCT00127712|surgical procedures, thoracic|surgical procedures, thoracic
826776|NCT00127699|Umbilical cord|umbilical cord
826780|NCT00127686|nocturnal cough|nocturnal cough
826781|NCT00127686|upper respiratory tract infection|upper respiratory tract infection
826782|NCT00127686|sleep quality|sleep quality
826783|NCT00127686|childhood cough|childhood cough
826784|NCT00127686|Dextromethorphan|dextromethorphan
826785|NCT00127686|Honey|honey
826786|NCT00127673|Antidepressants|antidepressants
826787|NCT00127673|Cognitive behavior therapy|cognitive behavior therapy
826788|NCT00127660|Behavior|behavior
827060|NCT00126555|Iressa|iressa
826789|NCT00127621|ICU patients needing prolonged ventilatory support|icu patients needing prolonged ventilatory support
826790|NCT00127595|carcinoma of the urothelial tract|carcinoma of the urothelial tract
826791|NCT00127582|Myotonic dystrophy type 1|myotonic dystrophy type 1
826792|NCT00127582|Sudden cardiac death|sudden cardiac death
826793|NCT00127582|Ventricular tachyarrhythmias|ventricular tachyarrhythmias
826794|NCT00127582|Bradyarrhythmias|bradyarrhythmias
826795|NCT00127569|HIV infections|hiv infections
826796|NCT00127569|Giant Lymph Node Hyperplasia|giant lymph node hyperplasia
826797|NCT00127569|Herpesvirus 8, Human|herpesvirus 8, human
826798|NCT00127569|Rituximab (Mabthera)|rituximab (mabthera)
826799|NCT00127569|Antibodies, Monoclonal|antibodies, monoclonal
826800|NCT00127556|Transfusion|transfusion
826801|NCT00127556|Safety|safety
826802|NCT00127543|Medication Education|medication education
826803|NCT00127543|Pediatric|pediatric
826804|NCT00127530|Walking Ability|walking ability
826805|NCT00127517|Oncology|oncology
826806|NCT00127517|Palliative Care|palliative care
826807|NCT00127517|Advanced Cancer|advanced cancer
826808|NCT00127517|Palliative Cancer Care|palliative cancer care
826809|NCT00127504|Onchocerciasis|onchocerciasis
826810|NCT00127504|Wolbachia|wolbachia
826811|NCT00127504|Therapy|therapy
826812|NCT00127491|Acute Lung Injury|acute lung injury
826813|NCT00127491|Acute Respiratory Distress Syndrome|acute respiratory distress syndrome
826814|NCT00127491|Mechanical Ventilation|mechanical ventilation
826815|NCT00127491|Esophageal Pressures|esophageal pressures
826816|NCT00127491|Randomized Controlled Trial|randomized controlled trial
826817|NCT00127478|Hormone Refractory Prostate Cancer|hormone refractory prostate cancer
826818|NCT00127478|Adenocarcinoma of the Prostate|adenocarcinoma of the prostate
826819|NCT00127465|Medical Informatics|medical informatics
826820|NCT00127465|Patient education|patient education
826821|NCT00127465|Social support|social support
826822|NCT00127465|Cancer|cancer
826823|NCT00127465|Anxiety|anxiety
826824|NCT00127452|alpha-linolenic acid|alpha-linolenic acid
826825|NCT00127452|cardiovascular diseases|cardiovascular diseases
826826|NCT00127452|coronary heart disease|coronary heart disease
826827|NCT00127452|coronary patients|coronary patients
826829|NCT00127452|dietary intervention|dietary intervention
826830|NCT00127452|dietary supplementation|dietary supplementation
826831|NCT00127452|docosahexaenoic acid|docosahexaenoic acid
826832|NCT00127452|eicosapentaenoic acid|eicosapentaenoic acid
826834|NCT00127452|fish oil|fish oil
826835|NCT00127452|fish fatty acids|fish fatty acids
826836|NCT00127452|human subjects|human subjects
826837|NCT00127452|ischaemic heart disease|ischaemic heart disease
826838|NCT00127452|margarine|margarine
826839|NCT00127452|marine fatty acids|marine fatty acids
826840|NCT00127452|mortality|mortality
826841|NCT00127452|myocardial infarction|myocardial infarction
826842|NCT00127452|n-3 fatty acids|n-3 fatty acids
826843|NCT00127452|n-3 polyunsaturated fatty acids|n-3 polyunsaturated fatty acids
826844|NCT00127452|n-3 PUFA|n-3 pufa
826845|NCT00127452|omega-3 fatty acids|omega-3 fatty acids
826846|NCT00127452|omega-3 polyunsaturated fatty acids|omega-3 polyunsaturated fatty acids
826847|NCT00127452|prevention|prevention
826848|NCT00127452|randomized controlled trial|randomized controlled trial
826849|NCT00127452|secondary prevention|secondary prevention
826850|NCT00127439|Ambulatory Disability|ambulatory disability
826851|NCT00127439|Disability Ambulation|disability ambulation
826852|NCT00127439|Locomotion Disorders|locomotion disorders
826853|NCT00127439|Motor Activity|motor activity
826854|NCT00127439|Rehabilitation|rehabilitation
826855|NCT00127439|Spinal Cord Injury|spinal cord injury
826856|NCT00127413|Chronic pain|chronic pain
826857|NCT00127413|Co-morbid|co-morbid
826858|NCT00127413|Intervention|intervention
826859|NCT00127413|Posttraumatic Stress Disorder|posttraumatic stress disorder
826860|NCT00127413|Treatment|treatment
826861|NCT00127400|anger|anger
826862|NCT00127400|intermittent|intermittent
826863|NCT00127400|explosive|explosive
826864|NCT00127387|Bone metastasis|bone metastasis
826865|NCT00127387|Radiation therapy|radiation therapy
826866|NCT00127387|Lung cancer|lung cancer
826867|NCT00127387|Prostate cancer|prostate cancer
826868|NCT00127387|Advanced lung cancer receiving radiation therapy|advanced lung cancer receiving radiation therapy
826869|NCT00127387|Advanced prostate cancer receiving radiation therapy|advanced prostate cancer receiving radiation therapy
826870|NCT00127387|Any cancer with bone mets receiving radiation therapy|any cancer with bone mets receiving radiation therapy
826871|NCT00127374|Overweight; self-esteem; depression|overweight; self-esteem; depression
826872|NCT00127361|doula|doula
826873|NCT00127361|caregivers|caregivers
826874|NCT00127361|labor support|labor support
826875|NCT00127361|being with woman|being with woman
826876|NCT00127361|continuous labor support|continuous labor support
826877|NCT00127361|maternal outcomes|maternal outcomes
826878|NCT00127361|Parturition|parturition
826879|NCT00127335|rhabdomyolysis,|rhabdomyolysis,
826880|NCT00127335|myositis,|myositis,
826881|NCT00127335|myopathy,|myopathy,
826882|NCT00127335|statin side effects,|statin side effects,
826883|NCT00127335|fatty acid oxidation|fatty acid oxidation
826884|NCT00127335|Statin induced Muscle toxicity|statin induced muscle toxicity
826885|NCT00127322|Heart Failure, Congestive|heart failure, congestive
826886|NCT00127322|survival|survival
826887|NCT00127322|patient admission|patient admission
826888|NCT00127309|hangover|hangover
826889|NCT00127309|hangover symptoms|hangover symptoms
826890|NCT00127270|OAB|oab
826891|NCT00127270|Overactive Bladder|overactive bladder
826892|NCT00127270|Bladder hyperactivity|bladder hyperactivity
826893|NCT00127270|Urge Incontinence|urge incontinence
826894|NCT00127270|Incontinence|incontinence
826895|NCT00127270|Bladder|bladder
826896|NCT00127257|Constipation|constipation
826897|NCT00127257|Biofeedback|biofeedback
826898|NCT00127257|Dyssynergia|dyssynergia
826899|NCT00127257|Pelvic floor dyssynergia|pelvic floor dyssynergia
826900|NCT00127257|Outlet dysfunction|outlet dysfunction
826901|NCT00127231|Controlled Clinical Trials, Randomized|controlled clinical trials, randomized
826902|NCT00127231|Alcohol Consumption|alcohol consumption
826903|NCT00127231|Behavioral Research|behavioral research
826904|NCT00127231|HIV|hiv
826905|NCT00127231|Alcohol Abuse|alcohol abuse
826906|NCT00127218|atherosclerotic plaque|atherosclerotic plaque
826907|NCT00127218|MRI|mri
826908|NCT00127218|inflammatory markers|inflammatory markers
826909|NCT00127218|statins|statins
826910|NCT00127205|stage I breast cancer|stage i breast cancer
826911|NCT00127205|stage II breast cancer|stage ii breast cancer
826912|NCT00127205|stage IIIA breast cancer|stage iiia breast cancer
826913|NCT00127205|stage IIIB breast cancer|stage iiib breast cancer
826914|NCT00127205|stage IIIC breast cancer|stage iiic breast cancer
826915|NCT00127127|Solid tumors|solid tumors
826916|NCT00127114|Behavioral disturbance|behavioral disturbance
826917|NCT00127114|Frontotemporal dementia|frontotemporal dementia
826918|NCT00127114|Dementia|dementia
826919|NCT00127114|Amantadine|amantadine
826920|NCT00127114|Behavioral disturbance due to frontotemporal dementia|behavioral disturbance due to frontotemporal dementia
826921|NCT00127088|Patients with localized Gleason 7 pT2a-pT2b adenocarcinoma of the prostate|patients with localized gleason 7 pt2a-pt2b adenocarcinoma of the prostate
826922|NCT00127075|Multiple sclerosis. Relapses. Post partum. Pregnancy. Delivery. Hormones. Progesterone. Estradiol. Clinical trial. Prevention.|multiple sclerosis. relapses. post partum. pregnancy. delivery. hormones. progesterone. estradiol. clinical trial. prevention.
826923|NCT00127062|Exposure to Oxford Street|exposure to oxford street
826924|NCT00127062|Exposure to Hyde Park|exposure to hyde park
826925|NCT00127049|Patients with relapsed non-seminomatous germ-cell tumors (NSGCT)|patients with relapsed non-seminomatous germ-cell tumors (nsgct)
826926|NCT00127036|colon|colon
826927|NCT00127036|adenocarcinoma|adenocarcinoma
826928|NCT00127036|adenocarcinoma-colon|adenocarcinoma-colon
826929|NCT00127036|adenocarcinoma-rectum|adenocarcinoma-rectum
826930|NCT00127023|Prophylaxis measles, mumps, rubella and chickenpox|prophylaxis measles, mumps, rubella and chickenpox
826931|NCT00127010|Prophylaxis measles, mumps, rubella and chickenpox|prophylaxis measles, mumps, rubella and chickenpox
826932|NCT00126997|Prophylaxis measles, mumps, rubella and chickenpox|prophylaxis measles, mumps, rubella and chickenpox
826933|NCT00126984|Safety|safety
826934|NCT00126984|Reactogenicity|reactogenicity
826935|NCT00126984|Immunogenicity|immunogenicity
826936|NCT00126984|Meningococcal vaccine|meningococcal vaccine
826937|NCT00126984|Dose selection|dose selection
826938|NCT00126984|Conjugate vaccine|conjugate vaccine
826939|NCT00126971|malaria|malaria
826940|NCT00126971|pregnancy|pregnancy
826941|NCT00126971|Plasmodium falciparum|plasmodium falciparum
826942|NCT00126971|antimalarials|antimalarials
826943|NCT00126971|pharmacokinetics|pharmacokinetics
826944|NCT00126971|treatment outcome|treatment outcome
826945|NCT00126971|safety|safety
826946|NCT00126958|superficial urothelial cell carcinoma|superficial urothelial cell carcinoma
826947|NCT00126958|urinary analysis|urinary analysis
826948|NCT00126958|Loss of heterozygosity|loss of heterozygosity
826949|NCT00126958|FGFR3 mutation|fgfr3 mutation
826950|NCT00126958|follow-up|follow-up
826951|NCT00126945|Meningococcal serogroups A, C, W-135, Y disease|meningococcal serogroups a, c, w-135, y disease
826952|NCT00126906|Malaria|malaria
826953|NCT00126906|Pregnancy|pregnancy
826954|NCT00126906|HIV|hiv
826955|NCT00126893|Leukemia|leukemia
826956|NCT00126893|AML|aml
826957|NCT00126893|CC401|cc401
826958|NCT00126893|CC-401|cc-401
826959|NCT00126893|Celgene|celgene
826960|NCT00126893|High Risk Myeloid Leukemia|high risk myeloid leukemia
826961|NCT00126893|Myeloid Leukemia|myeloid leukemia
826962|NCT00126880|Human Immunodeficiency Virus|human immunodeficiency virus
826963|NCT00126880|anti-retroviral therapy|anti-retroviral therapy
826964|NCT00126880|nucleoside analogue|nucleoside analogue
826965|NCT00126880|reverse transcriptase|reverse transcriptase
826966|NCT00126880|lamivudine|lamivudine
826967|NCT00126880|resistance mutation|resistance mutation
826968|NCT00126880|Treatment Experienced|treatment experienced
826969|NCT00126867|thymidylate synthase polymers|thymidylate synthase polymers
826970|NCT00126867|rapecitabine|rapecitabine
826971|NCT00126867|adjuvant|adjuvant
826972|NCT00126867|colon cancer|colon cancer
826973|NCT00126867|toxicity|toxicity
826974|NCT00126867|Stage II colon cancer|stage ii colon cancer
827061|NCT00126555|Gefitinib|gefitinib
826975|NCT00126867|Stage III colon cancer|stage iii colon cancer
826976|NCT00126867|adenocarcinoma of the colon|adenocarcinoma of the colon
826977|NCT00126854|brachytherapy|brachytherapy
826978|NCT00126854|magnetic resonance spectroscopy|magnetic resonance spectroscopy
826979|NCT00126841|radiotherapy planning CT/MR fusion|radiotherapy planning ct/mr fusion
826980|NCT00126828|radiotherapy, conformal|radiotherapy, conformal
826981|NCT00126828|lung neoplasm|lung neoplasm
826982|NCT00126828|radiotherapy dosage|radiotherapy dosage
826983|NCT00126815|prostate cancer|prostate cancer
826984|NCT00126815|prostate specific antigen|prostate specific antigen
826985|NCT00126815|radiotherapy|radiotherapy
826986|NCT00126815|mathematical modeling|mathematical modeling
826987|NCT00126802|tomotherapy|tomotherapy
826988|NCT00126802|MRSZ|mrsz
826989|NCT00126802|high risk prostate cancer|high risk prostate cancer
826990|NCT00126789|Pain Cancer|pain cancer
826991|NCT00126789|Chronic Pain|chronic pain
826992|NCT00126776|chronic obstructive pulmonary disease|chronic obstructive pulmonary disease
826993|NCT00126776|case management|case management
826994|NCT00126776|self management|self management
826995|NCT00126763|Chronic Pain|chronic pain
826996|NCT00126763|Pain|pain
826997|NCT00126750|Myocardial Infarction|myocardial infarction
826998|NCT00126750|Comorbidities|comorbidities
826999|NCT00126750|Guidelines|guidelines
827000|NCT00126750|Computer Assisted Instruction|computer assisted instruction
827001|NCT00126750|Physician Practice Instruction|physician practice instruction
827002|NCT00126750|Online Systems|online systems
827003|NCT00126737|Elderly|elderly
827004|NCT00126737|Exercise|exercise
827005|NCT00126737|lean body mass|lean body mass
827006|NCT00126737|muscle strength|muscle strength
827007|NCT00126737|Nutrition program|nutrition program
827008|NCT00126737|Pain control|pain control
827009|NCT00126737|stair climb|stair climb
827010|NCT00126737|walking distance|walking distance
827011|NCT00126737|weight loss|weight loss
827012|NCT00126724|tgAAC94|tgaac94
827013|NCT00126724|Rheumatoid arthritis|rheumatoid arthritis
827014|NCT00126724|Inflammatory arthritis|inflammatory arthritis
827015|NCT00126724|Arthritis|arthritis
827016|NCT00126724|Gene therapy|gene therapy
827017|NCT00126724|AAV|aav
827018|NCT00126698|Bacteriuria|bacteriuria
827019|NCT00126698|Urinary Catheter|urinary catheter
827020|NCT00126698|Urinary tract infection|urinary tract infection
827021|NCT00126698|Prophylaxis|prophylaxis
827022|NCT00126698|Urinary catheter removal|urinary catheter removal
827023|NCT00126685|stage IV melanoma|stage iv melanoma
827024|NCT00126685|recurrent melanoma|recurrent melanoma
827025|NCT00126672|angiomyolipoma|angiomyolipoma
827026|NCT00126646|B-cell chronic lymphocytic leukemia|b-cell chronic lymphocytic leukemia
827027|NCT00126646|refractory chronic lymphocytic leukemia|refractory chronic lymphocytic leukemia
827028|NCT00126646|recurrent grade 1 follicular lymphoma|recurrent grade 1 follicular lymphoma
827029|NCT00126646|recurrent grade 2 follicular lymphoma|recurrent grade 2 follicular lymphoma
827030|NCT00126646|stage III grade 1 follicular lymphoma|stage iii grade 1 follicular lymphoma
827031|NCT00126646|stage III grade 2 follicular lymphoma|stage iii grade 2 follicular lymphoma
827032|NCT00126646|stage IV grade 1 follicular lymphoma|stage iv grade 1 follicular lymphoma
827033|NCT00126646|stage IV grade 2 follicular lymphoma|stage iv grade 2 follicular lymphoma
827034|NCT00126646|extranodal marginal zone B-cell lymphoma of mucosa-associated lymphoid tissue|extranodal marginal zone b-cell lymphoma of mucosa-associated lymphoid tissue
827035|NCT00126646|nodal marginal zone B-cell lymphoma|nodal marginal zone b-cell lymphoma
827036|NCT00126646|recurrent marginal zone lymphoma|recurrent marginal zone lymphoma
827037|NCT00126646|splenic marginal zone lymphoma|splenic marginal zone lymphoma
827038|NCT00126646|stage III marginal zone lymphoma|stage iii marginal zone lymphoma
827039|NCT00126646|stage IV marginal zone lymphoma|stage iv marginal zone lymphoma
827040|NCT00126646|recurrent mantle cell lymphoma|recurrent mantle cell lymphoma
827041|NCT00126646|stage III mantle cell lymphoma|stage iii mantle cell lymphoma
827042|NCT00126646|stage IV mantle cell lymphoma|stage iv mantle cell lymphoma
827043|NCT00126646|recurrent small lymphocytic lymphoma|recurrent small lymphocytic lymphoma
827044|NCT00126646|stage III small lymphocytic lymphoma|stage iii small lymphocytic lymphoma
827045|NCT00126646|stage IV small lymphocytic lymphoma|stage iv small lymphocytic lymphoma
827046|NCT00126646|recurrent adult diffuse small cleaved cell lymphoma|recurrent adult diffuse small cleaved cell lymphoma
827047|NCT00126646|stage III adult diffuse small cleaved cell lymphoma|stage iii adult diffuse small cleaved cell lymphoma
827048|NCT00126646|stage IV adult diffuse small cleaved cell lymphoma|stage iv adult diffuse small cleaved cell lymphoma
827049|NCT00126646|Waldenstrom macroglobulinemia|waldenstrom macroglobulinemia
827050|NCT00126646|prolymphocytic leukemia|prolymphocytic leukemia
827051|NCT00126633|adenocarcinoma of the pancreas|adenocarcinoma of the pancreas
827439|NCT00125229|Mannitol|mannitol
827052|NCT00126633|stage IV pancreatic cancer|stage iv pancreatic cancer
827053|NCT00126620|unspecified adult solid tumor, protocol specific|unspecified adult solid tumor, protocol specific
827054|NCT00126581|A Phase II Randomized Study of OSI-774|a phase ii randomized study of osi-774
827055|NCT00126555|squamous cell carcinoma of the skin|squamous cell carcinoma of the skin
827056|NCT00126555|recurrent skin cancer|recurrent skin cancer
827057|NCT00126555|non-melanomatous skin cancer|non-melanomatous skin cancer
827058|NCT00126555|Radiation|radiation
827059|NCT00126555|ZD1839|zd1839
827062|NCT00126516|silent brain infarction|silent brain infarction
827063|NCT00126516|cognitive decline|cognitive decline
827064|NCT00126516|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers
827065|NCT00126516|Angiotensin-Converting Enzyme Inhibitors|angiotensin-converting enzyme inhibitors
827066|NCT00126516|hypertension|hypertension
827067|NCT00126477|quality of life|quality of life
827068|NCT00126477|de novo myelodysplastic syndromes|de novo myelodysplastic syndromes
827069|NCT00126477|previously treated myelodysplastic syndromes|previously treated myelodysplastic syndromes
827070|NCT00126477|secondary myelodysplastic syndromes|secondary myelodysplastic syndromes
827071|NCT00126477|juvenile myelomonocytic leukemia|juvenile myelomonocytic leukemia
827072|NCT00126477|childhood Hodgkin lymphoma|childhood hodgkin lymphoma
827073|NCT00126477|childhood lymphoblastic lymphoma|childhood lymphoblastic lymphoma
827074|NCT00126477|childhood large cell lymphoma|childhood large cell lymphoma
827075|NCT00126477|childhood small noncleaved cell lymphoma|childhood small noncleaved cell lymphoma
827076|NCT00126477|childhood acute lymphoblastic leukemia in remission|childhood acute lymphoblastic leukemia in remission
827077|NCT00126477|childhood acute myeloid leukemia in remission|childhood acute myeloid leukemia in remission
827078|NCT00126477|childhood chronic myelogenous leukemia|childhood chronic myelogenous leukemia
827079|NCT00126464|ductal breast carcinoma in situ|ductal breast carcinoma in situ
827080|NCT00126464|breast cancer in situ|breast cancer in situ
827081|NCT00126438|Heart Failure|heart failure
827082|NCT00126438|nuclear cardiology|nuclear cardiology
827083|NCT00126438|sympathetic innervation|sympathetic innervation
827084|NCT00126438|123I-mIBG|123i-mibg
827085|NCT00126425|Heart Failure|heart failure
827086|NCT00126425|nuclear cardiology|nuclear cardiology
827087|NCT00126425|sympathetic innervation|sympathetic innervation
827088|NCT00126425|123I-mIBG|123i-mibg
827089|NCT00126412|Phaeochromocytoma|phaeochromocytoma
827090|NCT00126412|Neuroblastoma|neuroblastoma
827091|NCT00126412|diagnosis|diagnosis
827092|NCT00126412|123I-mIBG|123i-mibg
827093|NCT00126399|rosacea|rosacea
827094|NCT00126399|acne rosacea|acne rosacea
827095|NCT00126386|tumor induced hypercalcemia|tumor induced hypercalcemia
827096|NCT00126386|malignant bone pain|malignant bone pain
827097|NCT00126386|bisphosphonates|bisphosphonates
827098|NCT00126386|cancer|cancer
827099|NCT00126386|palliative|palliative
827100|NCT00126386|Zometa|zometa
827101|NCT00126386|palliative patient|palliative patient
827102|NCT00126386|treatment in community|treatment in community
827103|NCT00126373|Crohn disease|crohn disease
827104|NCT00126373|TNF-alpha|tnf-alpha
827105|NCT00126360|Breast Cancer|breast cancer
827106|NCT00126360|Timing of Radiotherapy|timing of radiotherapy
827107|NCT00126360|Local Control|local control
827108|NCT00126347|betaine|betaine
827109|NCT00126347|serine|serine
827110|NCT00126347|folic acid|folic acid
827111|NCT00126347|methionine load|methionine load
827112|NCT00126347|homocysteine|homocysteine
827113|NCT00126347|cardiovascular health|cardiovascular health
827114|NCT00126347|vascular function|vascular function
827115|NCT00126347|human|human
827116|NCT00126334|Myocardial Infarction|myocardial infarction
827117|NCT00126334|Anemia|anemia
827118|NCT00126334|Erythrocyte Transfusion|erythrocyte transfusion
827119|NCT00126321|AML, relapsed|aml, relapsed
827120|NCT00126321|cladribine|cladribine
827121|NCT00126321|chemotherapy|chemotherapy
827122|NCT00126308|HIV|hiv
827123|NCT00126308|Lipodystrophy|lipodystrophy
827124|NCT00126308|Intervention|intervention
827125|NCT00126308|Poly-L-lactic acid|poly-l-lactic acid
827126|NCT00126308|HIV facial lipoatrophy|hiv facial lipoatrophy
827127|NCT00126308|Treatment Experienced|treatment experienced
827128|NCT00126282|obsessive-compulsive disorder|obsessive-compulsive disorder
827129|NCT00126282|behavior therapy|behavior therapy
827130|NCT00126282|D-Cycloserine|d-cycloserine
827131|NCT00126282|medication|medication
827132|NCT00126282|treatment trial|treatment trial
827133|NCT00126282|placebo-controlled|placebo-controlled
827134|NCT00126282|double-blind|double-blind
827135|NCT00126282|randomized|randomized
827136|NCT00126269|Patients with Carcinoma of Unknown Primary and a Predicted Favorable Prognosis|patients with carcinoma of unknown primary and a predicted favorable prognosis
827137|NCT00126256|Colorectal cancer|colorectal cancer
827138|NCT00126256|metastatic|metastatic
827139|NCT00126256|chemotherapy|chemotherapy
827140|NCT00126256|randomized trial|randomized trial
827141|NCT00126243|AIDS related Lymphoma|aids related lymphoma
827142|NCT00126243|chemotherapy|chemotherapy
827143|NCT00126243|rituximab|rituximab
827243|NCT00125918|Hypertension, Pulmonary; Pulmonary Heart Disease|hypertension, pulmonary; pulmonary heart disease
827244|NCT00125905|Primary Care|primary care
827144|NCT00126230|hormone-refractory advanced prostate cancer who achieve a response or a stabilization to docetaxel-estramustine|hormone-refractory advanced prostate cancer who achieve a response or a stabilization to docetaxel-estramustine
827145|NCT00126217|Non-specific effects of vaccines|non-specific effects of vaccines
827146|NCT00126217|Infant mortality|infant mortality
827147|NCT00126217|Morbidity|morbidity
827148|NCT00126217|Low income country|low income country
827149|NCT00126217|Malaria|malaria
827150|NCT00126217|BCG|bcg
827151|NCT00126217|immunisation|immunisation
827152|NCT00126217|BCG revaccination|bcg revaccination
827153|NCT00126217|Tuberculin|tuberculin
827154|NCT00126217|Mortality|mortality
827155|NCT00126204|endoleak|endoleak
827156|NCT00126204|doxycycline|doxycycline
827157|NCT00126204|matrix metalloproteinase|matrix metalloproteinase
827158|NCT00126204|inflammation|inflammation
827159|NCT00126204|endograft|endograft
827160|NCT00126204|circulating markers|circulating markers
827161|NCT00126191|Burkitt Lymphoma|burkitt lymphoma
827162|NCT00126191|atypical Burkitt lymphoma|atypical burkitt lymphoma
827163|NCT00126191|Non-Hodgkin's Lymphoma|non-hodgkin's lymphoma
827164|NCT00126191|rituximab|rituximab
827165|NCT00126178|Kidney Cancer|kidney cancer
827166|NCT00126178|Renal|renal
827167|NCT00126178|Immunotherapy|immunotherapy
827168|NCT00126178|Vaccine|vaccine
827169|NCT00126165|prostate cancer|prostate cancer
827170|NCT00126165|radiotherapy|radiotherapy
827171|NCT00126165|hypofraction|hypofraction
827172|NCT00126165|radiosensitivity|radiosensitivity
827173|NCT00126165|image-guidance|image-guidance
827174|NCT00126152|Falls|falls
827175|NCT00126152|Exercise|exercise
827176|NCT00126152|Fall Risk Factors|fall risk factors
827177|NCT00126152|Older Adults|older adults
827178|NCT00126139|stroke, ischemic|stroke, ischemic
827179|NCT00126139|stenosis, internal carotid artery|stenosis, internal carotid artery
827180|NCT00126139|Acute ischemic stroke|acute ischemic stroke
827181|NCT00126139|Stenosis of extracranial internal carotid artery|stenosis of extracranial internal carotid artery
827182|NCT00126126|Artificial Limbs|artificial limbs
827183|NCT00126126|Evidence based medicine|evidence based medicine
827184|NCT00126126|Exercise|exercise
827185|NCT00126126|Outcomes research|outcomes research
827186|NCT00126126|Physical therapy|physical therapy
827187|NCT00126113|Audiologic rehabilitation|audiologic rehabilitation
827188|NCT00126113|Counseling|counseling
827189|NCT00126100|Stem Cells|stem cells
827190|NCT00126087|dopamine|dopamine
827191|NCT00126087|NMDA receptor|nmda receptor
827192|NCT00126087|brain imaging|brain imaging
827193|NCT00126087|neuroplasticity|neuroplasticity
827194|NCT00126087|learning|learning
827195|NCT00126087|transcranial direct current stimulation|transcranial direct current stimulation
827196|NCT00126087|rehabilitation|rehabilitation
827197|NCT00126087|aging|aging
827198|NCT00126074|Atrial fibrillation, atrial flutter, anti-arrhythmic agents, conversion to normal sinus rhythm|atrial fibrillation, atrial flutter, anti-arrhythmic agents, conversion to normal sinus rhythm
827199|NCT00126061|Atrial fibrillation|atrial fibrillation
827200|NCT00126061|atrial flutter|atrial flutter
827201|NCT00126061|anti-arrhythmic agents|anti-arrhythmic agents
827202|NCT00126061|conversion to normal sinus rhythm|conversion to normal sinus rhythm
827203|NCT00126048|Atopy|atopy
827204|NCT00126048|Statin|statin
827205|NCT00126048|Asthma|asthma
827206|NCT00126048|methacholine|methacholine
827207|NCT00126048|FEV1|fev1
827208|NCT00126035|Acute Migraine|acute migraine
827209|NCT00126035|Device|device
827210|NCT00126035|Migraid|migraid
827211|NCT00126035|Treatment|treatment
827212|NCT00126035|Aura|aura
827213|NCT00126022|Atrial fibrillation|atrial fibrillation
827214|NCT00126022|atrial flutter|atrial flutter
827215|NCT00126022|anti-arrhythmic agents|anti-arrhythmic agents
827216|NCT00126022|conversion to normal sinus rhythm|conversion to normal sinus rhythm
827217|NCT00125996|ANAEMIA|anaemia
827218|NCT00125996|Iron Deficiency|iron deficiency
827219|NCT00125983|Birth Control Pills|birth control pills
827220|NCT00125983|Oral Contraceptives|oral contraceptives
827221|NCT00125983|Contraceptive Patch|contraceptive patch
827222|NCT00125983|Pharmacokinetics|pharmacokinetics
827223|NCT00125983|Antiretroviral Therapy, Highly Active|antiretroviral therapy, highly active
827224|NCT00125983|Protease Inhibitor|protease inhibitor
827225|NCT00125983|Treatment Experienced|treatment experienced
827226|NCT00125983|Treatment Naive|treatment naive
827227|NCT00125983|Contraception|contraception
827228|NCT00125970|HIV Seronegativity|hiv seronegativity
827229|NCT00125970|HIV Preventive Vaccine|hiv preventive vaccine
827230|NCT00125957|depression|depression
827231|NCT00125957|serotonin|serotonin
827232|NCT00125957|norepinephrine|norepinephrine
827233|NCT00125957|SSRI|ssri
827234|NCT00125957|Wellbutrin|wellbutrin
827235|NCT00125957|bupropion|bupropion
827236|NCT00125957|executive function|executive function
827237|NCT00125957|residual symptoms|residual symptoms
827238|NCT00125931|bipolar disorder|bipolar disorder
827239|NCT00125931|mania|mania
827240|NCT00125931|manic state|manic state
827241|NCT00125931|opiate|opiate
827242|NCT00125931|kappa|kappa
827245|NCT00125905|Smoking Cessation|smoking cessation
827246|NCT00125905|Stages of Change Model|stages of change model
827247|NCT00125905|Health Education|health education
827248|NCT00125905|Clinical Practice guideline|clinical practice guideline
827249|NCT00125879|Glycogen Storage Disease Type II|glycogen storage disease type ii
827250|NCT00125879|GSD-II|gsd-ii
827251|NCT00125879|Pompe Disease|pompe disease
827252|NCT00125879|Pompe Disease (Late-onset)|pompe disease (late-onset)
827253|NCT00125879|Acid Maltase Deficiency Disease|acid maltase deficiency disease
827254|NCT00125879|Glycogenosis 2|glycogenosis 2
827255|NCT00125879|Glycogen Storage Disease Type II (GSD-II)|glycogen storage disease type ii (gsd-ii)
827256|NCT00125866|randomised double blind trial|randomised double blind trial
827257|NCT00125866|blood pressure|blood pressure
827258|NCT00125866|cocoa flavonoids|cocoa flavonoids
827259|NCT00125853|blood pressure|blood pressure
827260|NCT00125853|insulin sensitivity|insulin sensitivity
827261|NCT00125853|beta blockers|beta blockers
827262|NCT00125853|randomised double blind crossover trial|randomised double blind crossover trial
827263|NCT00125840|CLO151|clo151
827264|NCT00125840|Clolar|clolar
827265|NCT00125840|Pediatric ALL and AML|pediatric all and aml
827266|NCT00125840|Adult ALL and AML and MDS|adult all and aml and mds
827267|NCT00125827|CLO152|clo152
827268|NCT00125827|Clolar|clolar
827269|NCT00125814|Interferon Alfa-2b|interferon alfa-2b
827270|NCT00125814|HIV infections|hiv infections
827271|NCT00125788|sickle cell disease|sickle cell disease
827272|NCT00125788|sickle cell anemia|sickle cell anemia
827273|NCT00125788|L-glutamine|l-glutamine
827274|NCT00125788|Sickle Cell Anemia (homozygous)|sickle cell anemia (homozygous)
827275|NCT00125788|Sickle ß0-Thalassemia|sickle ß0-thalassemia
827276|NCT00125749|Dendritic|dendritic
827277|NCT00125749|Vaccine|vaccine
827278|NCT00125749|Melanoma|melanoma
827279|NCT00125749|Stage IV metastatic melanoma|stage iv metastatic melanoma
827280|NCT00125723|Phase 4 Clinical Trial|phase 4 clinical trial
827281|NCT00125723|Chemotherapy|chemotherapy
827282|NCT00125723|Neulasta®|neulasta®
827283|NCT00125723|Oncology|oncology
827284|NCT00125723|Malignancy|malignancy
827285|NCT00125710|cryogenic analysis|cryogenic analysis
827286|NCT00125710|oncogenes|oncogenes
827287|NCT00125697|malignant glioma|malignant glioma
827288|NCT00125697|spectroscopy|spectroscopy
827289|NCT00125697|magnetic resonance|magnetic resonance
827290|NCT00125684|transdermal morphine|transdermal morphine
827291|NCT00125684|cancer|cancer
827292|NCT00125684|pain|pain
827293|NCT00125684|bioavailability|bioavailability
827294|NCT00125684|pharmacokinetics|pharmacokinetics
827295|NCT00125684|cancer related pain|cancer related pain
827296|NCT00125684|stable baseline pain|stable baseline pain
827297|NCT00125684|currently taking opioids|currently taking opioids
827298|NCT00125671|Warfarin and Antiplatelet Vascular Evaluation|warfarin and antiplatelet vascular evaluation
827299|NCT00125671|Peripheral vascular disease|peripheral vascular disease
827300|NCT00125671|Atherosclerosis|atherosclerosis
827301|NCT00125671|cardiovascular events|cardiovascular events
827302|NCT00125671|Ischemia|ischemia
827303|NCT00125671|oral anticoagulants|oral anticoagulants
827304|NCT00125671|low ankle-brachial index|low ankle-brachial index
827305|NCT00125671|moderate intensity warfarin|moderate intensity warfarin
827306|NCT00125671|International normalized ratio [INR]|international normalized ratio [inr]
827307|NCT00125658|biomechanics|biomechanics
827308|NCT00125658|Cerebrovascular Accident|cerebrovascular accident
827309|NCT00125658|electromyography|electromyography
827310|NCT00125658|muscular weakness|muscular weakness
827311|NCT00125658|recovery of function|recovery of function
827312|NCT00125658|reflex variability stroke|reflex variability stroke
827313|NCT00125658|upper-extremity kinematics|upper-extremity kinematics
827314|NCT00125645|AMI|ami
827315|NCT00125645|Left ventricular function|left ventricular function
827316|NCT00125645|Myocardial performance index|myocardial performance index
827317|NCT00125645|Acute myocardial infarction (AMI)|acute myocardial infarction (ami)
827318|NCT00125632|Reading|reading
827319|NCT00125632|Rehabilitation|rehabilitation
827320|NCT00125632|Treatment Outcomes|treatment outcomes
827321|NCT00125632|Low vision|low vision
827322|NCT00125619|biomechanics|biomechanics
827323|NCT00125619|stroke|stroke
827324|NCT00125619|electromyography|electromyography
827325|NCT00125619|Gait disability stroke|gait disability stroke
827326|NCT00125619|locomotor therapy|locomotor therapy
827327|NCT00125619|muscular weakness|muscular weakness
827328|NCT00125619|reflex variability stroke|reflex variability stroke
827329|NCT00125606|AML|aml
827330|NCT00125606|allogeneic HSCT|allogeneic hsct
827331|NCT00125606|reduced intensity conditioning|reduced intensity conditioning
827332|NCT00125606|randomized trail|randomized trail
827333|NCT00125593|Kidney Disease, Chronic|kidney disease, chronic
827334|NCT00125593|LDL cholesterol|ldl cholesterol
827335|NCT00125593|simvastatin|simvastatin
827336|NCT00125593|ezetimibe|ezetimibe
827337|NCT00125593|cardiovascular disease|cardiovascular disease
827338|NCT00125593|atherosclerosis|atherosclerosis
827339|NCT00125580|Obesity|obesity
827340|NCT00125580|Childhood Obesity|childhood obesity
827341|NCT00125580|Infant Sleep|infant sleep
827342|NCT00125580|Infant growth|infant growth
827343|NCT00125580|Infant feeding|infant feeding
827344|NCT00125554|Clinical trial|clinical trial
827345|NCT00125554|double-blind|double-blind
827346|NCT00125554|randomized placebo-controlled trial|randomized placebo-controlled trial
827347|NCT00125554|metyrapone|metyrapone
827348|NCT00125554|Major Depression|major depression
827349|NCT00125541|MeSH: angioneurotic edema, complement 1 inactivators|mesh: angioneurotic edema, complement 1 inactivators
827634|NCT00124345|humidity|humidity
827350|NCT00125541|Hereditary Angioedema Type I or II, Acquired Angioedema|hereditary angioedema type i or ii, acquired angioedema
827351|NCT00125528|chronic pain|chronic pain
827352|NCT00125528|low back pain|low back pain
827353|NCT00125528|D-cycloserine|d-cycloserine
827354|NCT00125515|Heroin|heroin
827355|NCT00125515|Opiates|opiates
827356|NCT00125515|naltrexone|naltrexone
827357|NCT00125515|memantine|memantine
827358|NCT00125502|CMV, Cytomegalovirus, vaccine, women, postpartum|cmv, cytomegalovirus, vaccine, women, postpartum
827359|NCT00125489|chloroquine, malaria, sulfadoxine/pyrimethamine, Malawi|chloroquine, malaria, sulfadoxine/pyrimethamine, malawi
827360|NCT00125476|Postmenopause|postmenopause
827361|NCT00125463|Hypertension|hypertension
827362|NCT00125463|clinical trial|clinical trial
827363|NCT00125463|Candesartan Antihypertensive Survival Evaluation in Japan trial|candesartan antihypertensive survival evaluation in japan trial
827364|NCT00125463|candesartan cilexetil|candesartan cilexetil
827365|NCT00125463|amlodipine besilate|amlodipine besilate
827366|NCT00125450|Acute Bronchiolitis|acute bronchiolitis
827367|NCT00125450|Chest Physiotherapy|chest physiotherapy
827368|NCT00125450|Forced Expiratory Techniques|forced expiratory techniques
827369|NCT00125450|Double Blind Trial|double blind trial
827370|NCT00125450|Children|children
827371|NCT00125450|Pediatric|pediatric
827372|NCT00125450|RESPIRATORY SYNCYTIAL VIRUS|respiratory syncytial virus
827373|NCT00125437|aldosterone antagonists|aldosterone antagonists
827374|NCT00125437|spironolactone|spironolactone
827375|NCT00125437|left ventricular remodeling|left ventricular remodeling
827376|NCT00125424|Colonoscopy|colonoscopy
827377|NCT00125424|Sedation|sedation
827378|NCT00125424|AQUAVAN|aquavan
827379|NCT00125424|(fospropofol disodium)|(fospropofol disodium)
827380|NCT00125424|Endoscopic sedation|endoscopic sedation
827381|NCT00125424|Endoscopic outcomes|endoscopic outcomes
827382|NCT00125424|Endoscopy|endoscopy
827383|NCT00125411|satraplatin|satraplatin
827384|NCT00125411|docetaxel|docetaxel
827385|NCT00125411|cancer|cancer
827386|NCT00125411|Phase I|phase i
827387|NCT00125411|advanced solid tumors|advanced solid tumors
827388|NCT00125398|AQUAVAN|aquavan
827389|NCT00125398|GPI 15715|gpi 15715
827390|NCT00125398|ICU|icu
827391|NCT00125398|Sedation|sedation
827392|NCT00125385|IPF|ipf
827393|NCT00125385|Idiopathic|idiopathic
827394|NCT00125385|Pulmonary|pulmonary
827395|NCT00125385|Fibrosis|fibrosis
827396|NCT00125372|tarceva|tarceva
827397|NCT00125372|targretin|targretin
827398|NCT00125372|non-small cell lung cancer|non-small cell lung cancer
827399|NCT00125372|carcinoma, non-small cell lung cancer|carcinoma, non-small cell lung cancer
827400|NCT00125372|nsclc|nsclc
827401|NCT00125359|tarceva|tarceva
827402|NCT00125359|targretin|targretin
827403|NCT00125359|non-small cell lung cancer|non-small cell lung cancer
827404|NCT00125359|Carcinoma, non-small cell lung cancer|carcinoma, non-small cell lung cancer
827405|NCT00125359|NSCLC|nsclc
827406|NCT00125346|Tobramycin Inhalation Powder|tobramycin inhalation powder
827407|NCT00125333|atopic dermatitis, eczema|atopic dermatitis, eczema
827408|NCT00125320|Treatment|treatment
827409|NCT00125307|SLE|sle
827410|NCT00125307|glomerulonephritis|glomerulonephritis
827411|NCT00125307|immunosuppressive therapy|immunosuppressive therapy
827412|NCT00125307|type V (membranous) lupus nephritis|type v (membranous) lupus nephritis
827413|NCT00125294|cancer pain|cancer pain
827414|NCT00125294|breakthrough pain|breakthrough pain
827415|NCT00125294|methadone|methadone
827416|NCT00125294|dose titration|dose titration
827417|NCT00125294|sublingual route of administration|sublingual route of administration
827418|NCT00125294|Cancer related pain|cancer related pain
827419|NCT00125294|currently taking narcotics|currently taking narcotics
827420|NCT00125281|Fatigue|fatigue
827421|NCT00125281|Cirrhosis|cirrhosis
827422|NCT00125281|S-Adenosyl Methionine|s-adenosyl methionine
827423|NCT00125281|Primary Biliary Cirrhosis|primary biliary cirrhosis
827424|NCT00125281|Pruritus|pruritus
827425|NCT00125281|Symptomatic Releif|symptomatic releif
827426|NCT00125281|Serum Liver-Related Enzymes|serum liver-related enzymes
827427|NCT00125281|PBC|pbc
827428|NCT00125281|Liver Disease|liver disease
827429|NCT00125268|painful|painful
827430|NCT00125268|peripheral|peripheral
827431|NCT00125268|neuropathy|neuropathy
827432|NCT00125268|light|light
827433|NCT00125268|therapy|therapy
827434|NCT00125242|Aphasia|aphasia
827435|NCT00125242|Language therapy|language therapy
827436|NCT00125242|Rehabilitation of speech and language disorders|rehabilitation of speech and language disorders
827437|NCT00125242|Speech-language pathology|speech-language pathology
827438|NCT00125229|Hypertonic Saline|hypertonic saline
827440|NCT00125229|Intracranial hypertension|intracranial hypertension
827441|NCT00125229|Cerebral blood flow|cerebral blood flow
827442|NCT00125229|Traumatic brain injury|traumatic brain injury
827443|NCT00125216|Aphasia|aphasia
827444|NCT00125216|Language Therapy|language therapy
827445|NCT00125216|Rehabilitation of speech and language disorders|rehabilitation of speech and language disorders
827446|NCT00125216|Speech-language pathology|speech-language pathology
827447|NCT00125203|ALS|als
827448|NCT00125203|Lou Gehrig's Disease|lou gehrig's disease
827449|NCT00125203|Motor Neuron Disease|motor neuron disease
827450|NCT00125203|Amyotrophic Lateral Sclerosis|amyotrophic lateral sclerosis
827451|NCT00125203|Sialorrhea|sialorrhea
827452|NCT00125203|Hypersalivation|hypersalivation
827453|NCT00125203|Excessive Drooling|excessive drooling
827454|NCT00125203|Myobloc|myobloc
827455|NCT00125203|botulinum toxin type B|botulinum toxin type b
827456|NCT00125203|Clostridium botulinum B toxin|clostridium botulinum b toxin
827457|NCT00125203|botulinum B toxin|botulinum b toxin
827458|NCT00125203|botulinum neurotoxin B|botulinum neurotoxin b
827459|NCT00125203|NeuroBloc|neurobloc
827460|NCT00125190|Primary IGF-1 Deficiency|primary igf-1 deficiency
827461|NCT00125190|IGF-1|igf-1
827462|NCT00125177|pelvic muscle therapy|pelvic muscle therapy
827463|NCT00125177|urinary incontinence therapy|urinary incontinence therapy
827464|NCT00125177|stress incontinence intervention|stress incontinence intervention
827465|NCT00125177|incontinence intervention|incontinence intervention
827466|NCT00125177|Incontinence|incontinence
827467|NCT00125177|SUI|sui
827468|NCT00125177|Stress Incontinence|stress incontinence
827469|NCT00125164|Primary IGF-1 Deficiency|primary igf-1 deficiency
827470|NCT00125151|MeSH: angioneurotic edema, complement 1 inactivators|mesh: angioneurotic edema, complement 1 inactivators
827471|NCT00125151|Hereditary angioedema type I or II, Acquired angioedema|hereditary angioedema type i or ii, acquired angioedema
827472|NCT00125125|Dyslipidemia, adults, fluvastatin|dyslipidemia, adults, fluvastatin
827473|NCT00125112|binge eating|binge eating
827474|NCT00125112|weight loss|weight loss
827475|NCT00125112|obesity|obesity
827476|NCT00125099|Acute Infection|acute infection
827477|NCT00125099|Treatment Experienced|treatment experienced
827478|NCT00125099|Treatment Interruption|treatment interruption
827479|NCT00125099|HIV Therapeutic Vaccine|hiv therapeutic vaccine
827480|NCT00125086|wounds|wounds
827481|NCT00125086|healing|healing
827482|NCT00125086|Acute wounds healing by secondary intention|acute wounds healing by secondary intention
827483|NCT00125073|Standard Care|standard care
827484|NCT00125073|Nutritional Counseling|nutritional counseling
827485|NCT00125060|Aorta|aorta
827486|NCT00125060|Atherosclerosis|atherosclerosis
827487|NCT00125060|MRI|mri
827488|NCT00125060|statin|statin
827489|NCT00125060|inflammatory markers|inflammatory markers
827490|NCT00125047|Salmonellosis|salmonellosis
827491|NCT00125047|typhoid vaccine|typhoid vaccine
827492|NCT00125047|enteric fever|enteric fever
827493|NCT00125034|FOLFOX-4|folfox-4
827494|NCT00125034|Cetuximab|cetuximab
827495|NCT00125034|First-line mCRC|first-line mcrc
827496|NCT00125034|EGFR positive|egfr positive
827497|NCT00125034|metastatic CRC|metastatic crc
827498|NCT00125021|Second Line Therapy|second line therapy
827499|NCT00125021|Gemcitabine Refractory|gemcitabine refractory
827500|NCT00125021|Pancreatic Cancer|pancreatic cancer
827501|NCT00125021|Capecitabine|capecitabine
827502|NCT00125021|Tarceva|tarceva
827503|NCT00125021|OSI-774|osi-774
827504|NCT00125021|Metastatic Pancreatic Cancer|metastatic pancreatic cancer
827505|NCT00125008|Salmonella|salmonella
827506|NCT00125008|Typhoid vaccine|typhoid vaccine
827507|NCT00125008|enteric fever|enteric fever
827508|NCT00124969|End-stage renal disease, hemodialysis|end-stage renal disease, hemodialysis
827509|NCT00124943|Prevention of Instent Restenosis|prevention of instent restenosis
827510|NCT00124930|olanzapine|olanzapine
827511|NCT00124930|haldol|haldol
827512|NCT00124930|cancer|cancer
827513|NCT00124930|nausea|nausea
827514|NCT00124930|second line treatment|second line treatment
827515|NCT00124930|refractory nausea|refractory nausea
827516|NCT00124917|Prostate Cancer|prostate cancer
827517|NCT00124917|MRI|mri
827518|NCT00124917|Fiducial Marker|fiducial marker
827519|NCT00124917|IMRT|imrt
827520|NCT00124904|Biofeedback|biofeedback
827521|NCT00124904|Incontinence|incontinence
827522|NCT00124891|Arrhythmias|arrhythmias
827523|NCT00124878|HIV|hiv
827524|NCT00124878|STDs|stds
827525|NCT00124878|Male circumcision|male circumcision
827526|NCT00124878|HIV+ males|hiv+ males
827527|NCT00124878|HIV-negative males|hiv-negative males
827528|NCT00124878|Female partners|female partners
827529|NCT00124878|STDs such as the following:|stds such as the following:
827530|NCT00124878|HPV|hpv
827531|NCT00124878|HSV-2|hsv-2
827532|NCT00124878|HIV Seronegativity|hiv seronegativity
827533|NCT00124865|Campylobacter|campylobacter
827534|NCT00124865|Bacterial enteritis|bacterial enteritis
827535|NCT00124852|cognition|cognition
827536|NCT00124852|depression|depression
827537|NCT00124852|elderly|elderly
827538|NCT00124839|Dissociation|dissociation
827539|NCT00124839|Flashbacks|flashbacks
827540|NCT00124839|Self-injurious behavior|self-injurious behavior
827541|NCT00124826|stroke|stroke
827542|NCT00124826|cerebrovascular disease|cerebrovascular disease
827543|NCT00124826|hyperglycemia|hyperglycemia
827544|NCT00124826|magnetic resonance imaging|magnetic resonance imaging
827545|NCT00124826|acute ischemic stroke|acute ischemic stroke
827546|NCT00124800|tinnitus|tinnitus
827547|NCT00124774|hernia|hernia
827548|NCT00124774|nucleoplasty|nucleoplasty
827549|NCT00124774|radicular pain|radicular pain
827734|NCT00123929|doxorubicin|doxorubicin
827550|NCT00124774|Contained lumbar herniated disc|contained lumbar herniated disc
827551|NCT00124761|Radiosurgery|radiosurgery
827552|NCT00124761|Brain metastases|brain metastases
827553|NCT00124761|Whole Brain Radiotherapy|whole brain radiotherapy
827554|NCT00124761|Neurosurgery|neurosurgery
827555|NCT00124761|Solitary Brain Metastases|solitary brain metastases
827556|NCT00124761|Adult Tumours Metastatic to Brain|adult tumours metastatic to brain
827558|NCT00124748|Philadelphia positive|philadelphia positive
827559|NCT00124748|Bcr-abl|bcr-abl
827560|NCT00124748|imatinib mesylate|imatinib mesylate
827561|NCT00124748|Chronic myeloid leukemia (CML) in chronic phase|chronic myeloid leukemia (cml) in chronic phase
827562|NCT00124709|Atopic, dermatitis, asthma, children, modification|atopic, dermatitis, asthma, children, modification
827563|NCT00124709|Atopic dermatitis/atopy|atopic dermatitis/atopy
827564|NCT00124696|cocaine dependence|cocaine dependence
827565|NCT00124683|nicotine dependence|nicotine dependence
827566|NCT00124657|adult anaplastic astrocytoma|adult anaplastic astrocytoma
827567|NCT00124657|adult anaplastic oligodendroglioma|adult anaplastic oligodendroglioma
827568|NCT00124657|adult glioblastoma|adult glioblastoma
827569|NCT00124657|adult giant cell glioblastoma|adult giant cell glioblastoma
827570|NCT00124657|adult gliosarcoma|adult gliosarcoma
827571|NCT00124657|adult mixed glioma|adult mixed glioma
827572|NCT00124657|childhood mixed glioma|childhood mixed glioma
827573|NCT00124657|untreated childhood cerebellar astrocytoma|untreated childhood cerebellar astrocytoma
827574|NCT00124657|childhood high-grade cerebral astrocytoma|childhood high-grade cerebral astrocytoma
827575|NCT00124657|childhood low-grade cerebral astrocytoma|childhood low-grade cerebral astrocytoma
827576|NCT00124657|childhood oligodendroglioma|childhood oligodendroglioma
827577|NCT00124657|childhood spinal cord neoplasm|childhood spinal cord neoplasm
827578|NCT00124644|adult acute myeloid leukemia with 11q23 (MLL) abnormalities|adult acute myeloid leukemia with 11q23 (mll) abnormalities
827579|NCT00124644|adult acute myeloid leukemia with t(16;16)(p13;q22)|adult acute myeloid leukemia with t(16;16)(p13;q22)
827580|NCT00124644|untreated adult acute myeloid leukemia|untreated adult acute myeloid leukemia
827581|NCT00124644|secondary acute myeloid leukemia|secondary acute myeloid leukemia
827582|NCT00124618|stage IIIA non-small cell lung cancer|stage iiia non-small cell lung cancer
827583|NCT00124618|stage IIIB non-small cell lung cancer|stage iiib non-small cell lung cancer
827584|NCT00124579|stage I multiple myeloma|stage i multiple myeloma
827585|NCT00124579|stage II multiple myeloma|stage ii multiple myeloma
827586|NCT00124579|stage III multiple myeloma|stage iii multiple myeloma
827587|NCT00124579|refractory multiple myeloma|refractory multiple myeloma
827588|NCT00124566|Irofulven|irofulven
827589|NCT00124566|Docetaxel|docetaxel
827590|NCT00124566|Taxotere|taxotere
827591|NCT00124553|Type 2 diabetes|type 2 diabetes
827592|NCT00124553|cardiovascular risk|cardiovascular risk
827593|NCT00124553|glycaemic control|glycaemic control
827594|NCT00124553|dietary modification|dietary modification
827595|NCT00124540|Misoprostol|misoprostol
827596|NCT00124540|Active management|active management
827597|NCT00124540|Postpartum hemorrhage|postpartum hemorrhage
827598|NCT00124540|Maternal morbidity|maternal morbidity
827599|NCT00124540|Anemia|anemia
827600|NCT00124540|Developing countries|developing countries
827601|NCT00124527|Irofulven, Thyroid Cancer|irofulven, thyroid cancer
827602|NCT00124514|SLE|sle
827603|NCT00124514|Lupus|lupus
827604|NCT00124514|Ovarian damage|ovarian damage
827605|NCT00124514|Menopause|menopause
827606|NCT00124501|Biofeedback|biofeedback
827607|NCT00124488|radiotherapy planning|radiotherapy planning
827608|NCT00124488|computer assisted radiotherapy|computer assisted radiotherapy
827609|NCT00124488|conformal|conformal
827610|NCT00124475|Chronic Hand Dermatitis|chronic hand dermatitis
827611|NCT00124436|Patients who have been enrolled in study protocol BAP089, and whose severe chronic hand dermatitis responded with mild or moderate disease, or who relapsed|patients who have been enrolled in study protocol bap089, and whose severe chronic hand dermatitis responded with mild or moderate disease, or who relapsed
827612|NCT00124423|brachytherapy megavoltage CT imaging|brachytherapy megavoltage ct imaging
827613|NCT00124410|prostate cancer|prostate cancer
827614|NCT00124410|androgen suppression therapy (hormone therapy)|androgen suppression therapy (hormone therapy)
827615|NCT00124410|osteoporosis|osteoporosis
827616|NCT00124384|primary insomnia, stimulants, cognitive behavioral therapy|primary insomnia, stimulants, cognitive behavioral therapy
827617|NCT00124371|coronary artery bypass surgery|coronary artery bypass surgery
827618|NCT00124371|risk factors|risk factors
827619|NCT00124371|nurse-led secondary prevention|nurse-led secondary prevention
827620|NCT00124371|prehabilitation|prehabilitation
827621|NCT00124371|waiting period|waiting period
827622|NCT00124358|Drug Abuse|drug abuse
827623|NCT00124358|Drug Addiction|drug addiction
827624|NCT00124358|Drug Dependence|drug dependence
827625|NCT00124358|Drug Use Disorders|drug use disorders
827626|NCT00124358|Drug Use Disorder|drug use disorder
827627|NCT00124358|Substance Abuse|substance abuse
827628|NCT00124358|Substance Use Disorder|substance use disorder
827629|NCT00124358|Buprenorphine|buprenorphine
827630|NCT00124358|Opiate Addiction|opiate addiction
827631|NCT00124358|Substance-related disorders|substance-related disorders
827632|NCT00124358|HIV|hiv
827633|NCT00124345|temperature|temperature
827635|NCT00124345|non invasive mechanical ventilation|non invasive mechanical ventilation
827636|NCT00124319|Biomechanics|biomechanics
827637|NCT00124319|Neuromuscular|neuromuscular
827638|NCT00124319|Lower limb|lower limb
827639|NCT00124319|Injury|injury
827640|NCT00124319|ACL|acl
827641|NCT00124319|Anterior Cruciate Ligament injury|anterior cruciate ligament injury
827642|NCT00124306|painful bladder syndrome|painful bladder syndrome
827643|NCT00124306|interstitial cystitis|interstitial cystitis
827644|NCT00124306|newly diagnosed|newly diagnosed
827645|NCT00124280|Lung cancer|lung cancer
827646|NCT00124280|non-small cell|non-small cell
827647|NCT00124280|everolimus|everolimus
827648|NCT00124280|Non-small cell lung cancer (NSCLC)|non-small cell lung cancer (nsclc)
827649|NCT00124267|Cerebral|cerebral
827650|NCT00124267|malaria|malaria
827651|NCT00124267|intra-rectal|intra-rectal
827652|NCT00124267|quinine|quinine
827653|NCT00124267|children|children
827654|NCT00124267|Uganda|uganda
827655|NCT00124267|efficacy|efficacy
827656|NCT00124267|safety|safety
827657|NCT00124254|Metacarpophalangeal Joint|metacarpophalangeal joint
827658|NCT00124254|Arthroplasty|arthroplasty
827659|NCT00124254|Outcomes|outcomes
827660|NCT00124254|Michigan Hand Outcomes Questionnaire|michigan hand outcomes questionnaire
827661|NCT00124254|Joint Replacement|joint replacement
827662|NCT00124228|Cirrhosis|cirrhosis
827663|NCT00124228|Infection|infection
827664|NCT00124228|Sepsis|sepsis
827665|NCT00124228|Renal failure|renal failure
827666|NCT00124215|Hepatitis|hepatitis
827667|NCT00124215|HCV|hcv
827668|NCT00124215|vaccine|vaccine
827669|NCT00124215|Hepatitis C Infection|hepatitis c infection
827670|NCT00124202|a fatty meal|a fatty meal
827671|NCT00124202|ERCP|ercp
827672|NCT00124189|Chronic lymphocytic leukemia|chronic lymphocytic leukemia
827673|NCT00124189|T-cell prolymphocytic leukemia|t-cell prolymphocytic leukemia
827674|NCT00124189|Chronic lymphoproliferative diseases|chronic lymphoproliferative diseases
827675|NCT00124189|Telomerase|telomerase
827676|NCT00124189|Telomerase Inhibition|telomerase inhibition
827677|NCT00124176|Asthma|asthma
827678|NCT00124176|Levalbuterol|levalbuterol
827679|NCT00124176|Albuterol|albuterol
827680|NCT00124176|Children|children
827681|NCT00124163|CT Virtual Colonoscopy|ct virtual colonoscopy
827682|NCT00124163|Optical Colonoscopy|optical colonoscopy
827683|NCT00124163|Stool Tagging|stool tagging
827684|NCT00124163|Patient Preparation|patient preparation
827685|NCT00124150|subarachnoid hemorrhage|subarachnoid hemorrhage
827686|NCT00124150|magnesium sulfate|magnesium sulfate
827687|NCT00124137|Ultrafiltration|ultrafiltration
827688|NCT00124137|acute decompensated heart failure|acute decompensated heart failure
827689|NCT00124137|fluid overload|fluid overload
827690|NCT00124137|pulmonary congestion|pulmonary congestion
827691|NCT00124111|clinical trial|clinical trial
827692|NCT00124111|pegfilgrastim|pegfilgrastim
827693|NCT00124111|haematopoietic growth factor|haematopoietic growth factor
827694|NCT00124111|neutropenia|neutropenia
827695|NCT00124111|CMF|cmf
827696|NCT00124111|Cancer|cancer
827697|NCT00124098|Chronic Kidney Disease (CKD)|chronic kidney disease (ckd)
827698|NCT00124098|anemia, clinical trial|anemia, clinical trial
827699|NCT00124098|darbepoetin alfa|darbepoetin alfa
827700|NCT00124098|Aranesp®|aranesp®
827701|NCT00124098|Amgen|amgen
827702|NCT00124072|Myocardial infarction|myocardial infarction
827703|NCT00124072|Coronary heart disease|coronary heart disease
827704|NCT00124072|Cholesterol|cholesterol
827705|NCT00124072|Stroke|stroke
827706|NCT00124059|alcohol dependence|alcohol dependence
827707|NCT00124046|Urinary Incontinence in Children|urinary incontinence in children
827708|NCT00124046|Surgical Section of the Filum Terminale|surgical section of the filum terminale
827709|NCT00124046|Occult Tethered Cord Syndrome|occult tethered cord syndrome
827710|NCT00124046|Urodynamic Scale|urodynamic scale
827711|NCT00124046|Enuresis-Specific Quality of Life Scale|enuresis-specific quality of life scale
827712|NCT00124033|Cholecystectomy|cholecystectomy
827713|NCT00124033|Cholangiopancreatography, Endoscopic Retrograde|cholangiopancreatography, endoscopic retrograde
827714|NCT00124007|HIV Seronegativity|hiv seronegativity
827715|NCT00124007|HIV Preventive Vaccine|hiv preventive vaccine
827716|NCT00123994|TaiChi|taichi
827717|NCT00123994|Hydrotherapy|hydrotherapy
827718|NCT00123994|Exercise|exercise
827719|NCT00123994|Joint pain|joint pain
827720|NCT00123994|Disability|disability
827721|NCT00123981|Off-pump Coronary Artery By-pass Grafting|off-pump coronary artery by-pass grafting
827722|NCT00123981|Randomization|randomization
827723|NCT00123981|stroke|stroke
827724|NCT00123981|myocardial infarction|myocardial infarction
827726|NCT00123981|graft patency|graft patency
827727|NCT00123981|quality of life|quality of life
827728|NCT00123968|HIV Seronegativity|hiv seronegativity
827729|NCT00123968|HIV Preventive Vaccine|hiv preventive vaccine
827730|NCT00123942|CD2+ Lymphoproliferative disorder|cd2+ lymphoproliferative disorder
827731|NCT00123929|breast cancer|breast cancer
827732|NCT00123929|neoadjuvant chemotherapy|neoadjuvant chemotherapy
827733|NCT00123929|genetic signature|genetic signature
827735|NCT00123929|docetaxel|docetaxel
827736|NCT00123916|Chagas Disease|chagas disease
827737|NCT00123916|Trypanosomiasis|trypanosomiasis
827738|NCT00123916|Benznidazole|benznidazole
827739|NCT00123916|Chronic Heart disease|chronic heart disease
827740|NCT00123916|Trypanosoma Cruzi|trypanosoma cruzi
827741|NCT00123903|hypertension|hypertension
827742|NCT00123903|urine albumin:creatinine ratio|urine albumin:creatinine ratio
827743|NCT00123903|microalbuminuria|microalbuminuria
827744|NCT00123890|HIV-1 GW873140 CCR5 antagonist experienced|hiv-1 gw873140 ccr5 antagonist experienced
827745|NCT00123877|Breast|breast
827746|NCT00123877|Cancer|cancer
827747|NCT00123877|Metastasis|metastasis
827748|NCT00123864|intensity modulated radiation therapy|intensity modulated radiation therapy
827749|NCT00123864|parotid|parotid
827750|NCT00123864|nasopharyngeal carcinoma|nasopharyngeal carcinoma
827751|NCT00123851|Colorectal|colorectal
827752|NCT00123851|Metastatic Colorectal Cancer|metastatic colorectal cancer
827753|NCT00123851|Oxaliplatin|oxaliplatin
827754|NCT00123851|Tarceva|tarceva
827755|NCT00123851|Capecitabine|capecitabine
827756|NCT00123851|Xeloda|xeloda
827757|NCT00123838|Prostate|prostate
827758|NCT00123838|Cancer|cancer
827759|NCT00123838|Radiotherapy|radiotherapy
827760|NCT00123838|Neoplasm|neoplasm
827761|NCT00123838|Localization|localization
827762|NCT00123838|Tracking|tracking
827763|NCT00123838|Cancer of Prostate|cancer of prostate
827764|NCT00123838|Neoplasms, Prostate|neoplasms, prostate
827765|NCT00123825|Gallbladder|gallbladder
827766|NCT00123825|Biliary Tract|biliary tract
827767|NCT00123825|Cholangiocarcinoma|cholangiocarcinoma
827768|NCT00123812|quality assurance|quality assurance
827769|NCT00123812|frequency of port films|frequency of port films
827770|NCT00123799|positron emission tomography|positron emission tomography
827771|NCT00123799|fluorodeoxyglucose F18|fluorodeoxyglucose f18
827772|NCT00123799|sentinel lymph node biopsy|sentinel lymph node biopsy
827773|NCT00123786|positron emission tomography|positron emission tomography
827774|NCT00123786|fluorodeoxyglucose F18|fluorodeoxyglucose f18
827775|NCT00123786|tomography scanners, x-ray computed|tomography scanners, x-ray computed
827776|NCT00123773|positron emission tomography|positron emission tomography
827777|NCT00123773|fluorodeoxyglucose F18|fluorodeoxyglucose f18
827778|NCT00123773|Tomography scanners, x-ray computed|tomography scanners, x-ray computed
827779|NCT00123760|Positron-Emission Tomography|positron-emission tomography
827780|NCT00123760|Fluorodeoxyglucose F18|fluorodeoxyglucose f18
827781|NCT00123760|Tomography scanners, X-Ray computed|tomography scanners, x-ray computed
827782|NCT00123747|Positron Emission Tomography|positron emission tomography
827783|NCT00123747|Fluorodeoxyglucose F18|fluorodeoxyglucose f18
827907|NCT00123214|Weight Gain|weight gain
827784|NCT00123747|Tomography scanners, X-Ray Computed|tomography scanners, x-ray computed
827785|NCT00123708|Spasticity|spasticity
827786|NCT00123708|Dystonia|dystonia
827787|NCT00123708|Movement Disorders|movement disorders
827788|NCT00123708|Walking|walking
827789|NCT00123708|Muscle Weakness|muscle weakness
827790|NCT00123708|Resistance|resistance
827791|NCT00123708|Gait|gait
827792|NCT00123708|Cerebral Palsy|cerebral palsy
827793|NCT00123708|CP|cp
827794|NCT00123695|Subarachnoid hemorrhage|subarachnoid hemorrhage
827795|NCT00123695|Takotsubo cardiomyopathy|takotsubo cardiomyopathy
827796|NCT00123695|Cardiac abnormalities|cardiac abnormalities
827797|NCT00123695|outcome|outcome
827798|NCT00123682|Smoking Cessation|smoking cessation
827799|NCT00123682|Care Management|care management
827800|NCT00123682|Substance Use Disorder QUERI|substance use disorder queri
827801|NCT00123682|Primary Care|primary care
827802|NCT00123682|Regional Expansion|regional expansion
827803|NCT00123682|Telephone|telephone
827804|NCT00123669|Cancer of the Breast|cancer of the breast
827805|NCT00123669|Neoplasm|neoplasm
827806|NCT00123656|Eosinophilic esophagitis|eosinophilic esophagitis
827807|NCT00123656|esomeprazole|esomeprazole
827808|NCT00123656|fluticasone|fluticasone
827809|NCT00123643|thiazolidinedione|thiazolidinedione
827810|NCT00123643|sulfonylurea|sulfonylurea
827811|NCT00123643|endothelial function|endothelial function
827812|NCT00123630|eosinophilic esophagitis|eosinophilic esophagitis
827813|NCT00123630|omalizumab|omalizumab
827814|NCT00123617|Chest pain|chest pain
827815|NCT00123617|Women|women
827816|NCT00123617|Syndrome X|syndrome x
827817|NCT00123617|Cardiac rehabilitation|cardiac rehabilitation
827818|NCT00123617|Psychological morbidity|psychological morbidity
827819|NCT00123617|Cardiovascular risk factors|cardiovascular risk factors
827820|NCT00123604|beta-blockers|beta-blockers
827821|NCT00123604|endothelial function|endothelial function
827822|NCT00123565|Coronary Disease|coronary disease
827823|NCT00123552|Uganda, malaria, combination antimalarial therapy|uganda, malaria, combination antimalarial therapy
827824|NCT00123487|Accelerated Phase Chronic Myeloid Leukemia|accelerated phase chronic myeloid leukemia
827825|NCT00123487|Lymphoid Blast Phase Chronic Myeloid Leukemia|lymphoid blast phase chronic myeloid leukemia
827826|NCT00123487|Myeloid Blast Phase Chronic Myeloid Leukemia|myeloid blast phase chronic myeloid leukemia
827827|NCT00123487|Philadelphia Positive Acute Lymphoblastic Leukemia|philadelphia positive acute lymphoblastic leukemia
827828|NCT00123474|Chronic Phase Chronic Myelogenous Leukemia|chronic phase chronic myelogenous leukemia
827829|NCT00123448|Mirror Neurons|mirror neurons
827830|NCT00123448|fMRI|fmri
827831|NCT00123448|Premotor Cortex|premotor cortex
827832|NCT00123448|gesture|gesture
827833|NCT00123448|Healthy Volunteer|healthy volunteer
827834|NCT00123448|HV|hv
827835|NCT00123435|Behavioral Research|behavioral research
827836|NCT00123435|Nutritional management|nutritional management
827837|NCT00123435|Physical activity|physical activity
827838|NCT00123435|Prevention|prevention
827839|NCT00123435|Randomized control trial|randomized control trial
827840|NCT00123435|walking program|walking program
827841|NCT00123435|Weight loss|weight loss
827842|NCT00123435|World wide web|world wide web
827843|NCT00123422|Breathing exercise|breathing exercise
827844|NCT00123422|Exercise Therapy|exercise therapy
827845|NCT00123422|Helium|helium
827846|NCT00123422|Oxygen inhalation therapy|oxygen inhalation therapy
827847|NCT00123422|Pulmonary emphysema|pulmonary emphysema
827848|NCT00123422|Pulmonary ventilation|pulmonary ventilation
827849|NCT00123422|Rehabilitation|rehabilitation
827850|NCT00123409|Primary Care|primary care
827851|NCT00123409|Telephone|telephone
827852|NCT00123409|Quality of Life|quality of life
827853|NCT00123396|Bioterrorism|bioterrorism
827854|NCT00123396|Education, Medical, Continuing|education, medical, continuing
827855|NCT00123396|Internet|internet
827856|NCT00123383|Modafinil|modafinil
827857|NCT00123383|Cocaine Dependence|cocaine dependence
827858|NCT00123383|Randomised placebo-controlled trial|randomised placebo-controlled trial
827859|NCT00123370|Modafinil|modafinil
827860|NCT00123370|Amphetamine Dependence|amphetamine dependence
827861|NCT00123370|Randomised placebo-controlled trial|randomised placebo-controlled trial
827862|NCT00123344|symptomatic bradycardia|symptomatic bradycardia
827863|NCT00123344|paroxysmal atrial fibrillation|paroxysmal atrial fibrillation
827864|NCT00123344|antitachycardia pacing therapies|antitachycardia pacing therapies
827865|NCT00123344|prevention algorithms|prevention algorithms
827866|NCT00123331|Heart transplantation|heart transplantation
827867|NCT00123331|Renal failure|renal failure
827868|NCT00123331|Cyclosporine|cyclosporine
827869|NCT00123331|Rapamycin|rapamycin
827870|NCT00123318|Gastric cancer|gastric cancer
827871|NCT00123318|Radiotherapy|radiotherapy
827872|NCT00123318|Chemotherapy|chemotherapy
827873|NCT00123318|Chemoradiation|chemoradiation
827874|NCT00123305|Stroke|stroke
827875|NCT00123305|Acute Ischemic Stroke|acute ischemic stroke
827876|NCT00123292|arterial occlusion|arterial occlusion
827877|NCT00123292|thromboembolism|thromboembolism
827878|NCT00123292|Acute Peripheral Arterial Occlusion|acute peripheral arterial occlusion
827879|NCT00123279|diabetic macular edema|diabetic macular edema
827880|NCT00123279|macular hole|macular hole
827881|NCT00123279|vitreomacular traction syndrome|vitreomacular traction syndrome
827882|NCT00123266|stroke|stroke
827883|NCT00123266|vertebrobasilar|vertebrobasilar
827884|NCT00123266|basilar|basilar
827885|NCT00123266|Acute vertebrobasilar artery occlusion|acute vertebrobasilar artery occlusion
827886|NCT00123253|HIV|hiv
827887|NCT00123253|Lipodystrophy|lipodystrophy
827888|NCT00123253|Abdominal fat accumulation|abdominal fat accumulation
827889|NCT00123253|Growth hormone releasing factor/Growth hormone releasing hormone|growth hormone releasing factor/growth hormone releasing hormone
827890|NCT00123253|Treatment Experienced|treatment experienced
827891|NCT00123240|overweight|overweight
827892|NCT00123240|obese|obese
827893|NCT00123240|diet|diet
827894|NCT00123227|Randomised controlled trial|randomised controlled trial
827895|NCT00123227|Rosiglitazone|rosiglitazone
827896|NCT00123227|Cardiovascular magnetic resonance|cardiovascular magnetic resonance
827897|NCT00123227|Diabetes Mellitus|diabetes mellitus
827898|NCT00123227|Vascular Diseases|vascular diseases
827899|NCT00123227|Hypertension|hypertension
827900|NCT00123214|Diet|diet
827901|NCT00123214|Chronic sleep deprivation|chronic sleep deprivation
827902|NCT00123214|Weight|weight
827903|NCT00123214|Cognitive impairment|cognitive impairment
827904|NCT00123214|Lipids|lipids
827905|NCT00123214|Inflammation|inflammation
827906|NCT00123214|Resting metabolic rate|resting metabolic rate
827908|NCT00123214|Percent Body Fat|percent body fat
827909|NCT00123214|Hyperlipidemia|hyperlipidemia
827910|NCT00123201|efficacy & safety, migraine headache, placebo-controlled|efficacy & safety, migraine headache, placebo-controlled
827911|NCT00123201|migraine headache with or without aura|migraine headache with or without aura
827912|NCT00123175|Endometrial Hyperplasia without atypia|endometrial hyperplasia without atypia
827913|NCT00123162|Sildenafil|sildenafil
827914|NCT00123149|Anemia|anemia
827915|NCT00123149|Rheumatoid arthritis|rheumatoid arthritis
828770|NCT00120042|Hemorrhage|hemorrhage
827916|NCT00123149|Hemoglobin level|hemoglobin level
827917|NCT00123136|pulsed magnetic field therapy|pulsed magnetic field therapy
827918|NCT00123136|diabetic peripheral neuropathy|diabetic peripheral neuropathy
827919|NCT00123136|neuromodulation|neuromodulation
827920|NCT00123136|diabetic peripheral neuropathic pain|diabetic peripheral neuropathic pain
827921|NCT00123136|sleep benefit|sleep benefit
827922|NCT00123136|diabetic peripheral neuropathic functioning|diabetic peripheral neuropathic functioning
828986|NCT00119093|Adherence|adherence
827923|NCT00123123|Ventilator-associated pneumonia|ventilator-associated pneumonia
827924|NCT00123097|Facial Neoplasms|facial neoplasms
827925|NCT00123097|Head and Neck Neoplasms|head and neck neoplasms
827926|NCT00123097|Head Injuries, Penetrating|head injuries, penetrating
827927|NCT00123097|Birth Injuries|birth injuries
827928|NCT00123084|Parkinson's disease|parkinson's disease
827929|NCT00123084|Swallowing difficulties|swallowing difficulties
827930|NCT00123084|speech|speech
827931|NCT00123084|voice|voice
827932|NCT00123058|Hypertension|hypertension
827933|NCT00123058|Cariovascular Diseases|cariovascular diseases
827934|NCT00123058|Health Illiteracy|health illiteracy
827935|NCT00122980|Blood Diseases|blood diseases
827936|NCT00122954|Fatty Acids, Omega-3|fatty acids, omega-3
827937|NCT00122954|Fish Oils|fish oils
827938|NCT00122954|Complementary Therapies|complementary therapies
827939|NCT00122941|multiple|multiple
827940|NCT00122941|micronutrients|micronutrients
827941|NCT00122941|supplementation|supplementation
827942|NCT00122941|HIV|hiv
827943|NCT00122941|children|children
827944|NCT00122941|randomised|randomised
827945|NCT00122941|trial|trial
827946|NCT00122941|mortality|mortality
827947|NCT00122941|morbidity|morbidity
827948|NCT00122941|growth|growth
827949|NCT00122941|Uganda|uganda
827950|NCT00122928|Worksite|worksite
827951|NCT00122928|Workplace|workplace
827952|NCT00122928|Return on Investment|return on investment
827953|NCT00122928|Financial Impact|financial impact
827954|NCT00122915|Motor Cortex Stimulation|motor cortex stimulation
827955|NCT00122915|Pain treatment|pain treatment
827956|NCT00122915|Central post-stroke pain (CPSP)|central post-stroke pain (cpsp)
827957|NCT00122915|Trigeminal neuropathic pain (TGN)|trigeminal neuropathic pain (tgn)
827958|NCT00122915|Facial pain|facial pain
827959|NCT00122915|Neurostimuation|neurostimuation
827960|NCT00122915|Cortical lead|cortical lead
827961|NCT00122915|Neuropathic pain|neuropathic pain
827962|NCT00122902|HIV|hiv
827963|NCT00122902|AIDS|aids
827964|NCT00122902|Spirituality|spirituality
827965|NCT00122889|Drug Interactions|drug interactions
827966|NCT00122889|Pharmacokinetics|pharmacokinetics
827967|NCT00122889|Garlic|garlic
827968|NCT00122889|Complementary Therapies|complementary therapies
827969|NCT00122889|Complementary and Alternative Medicine|complementary and alternative medicine
827970|NCT00122876|Hepatocellular Carcinoma|hepatocellular carcinoma
827971|NCT00122876|HCC|hcc
827972|NCT00122876|Photodynamic therapy|photodynamic therapy
827973|NCT00122876|Talaporfin Sodium (LS11)|talaporfin sodium (ls11)
827974|NCT00122876|Light emitting diodes (LEDs)|light emitting diodes (leds)
827975|NCT00122876|Litx|litx
827976|NCT00122876|Light Infusion Technology|light infusion technology
827977|NCT00122811|Aged|aged
827978|NCT00122811|Hypertension|hypertension
827979|NCT00122811|Stroke|stroke
827980|NCT00122798|Stroke, stroke treatment, atrial fibrillation, medication, rehabilitation|stroke, stroke treatment, atrial fibrillation, medication, rehabilitation
827981|NCT00122785|bronchiolitis|bronchiolitis
827982|NCT00122785|wheezing|wheezing
827983|NCT00122785|dexamethasone|dexamethasone
827984|NCT00122785|young children|young children
827985|NCT00122759|Mechanical ventilation|mechanical ventilation
827986|NCT00122759|Agitation|agitation
827987|NCT00122746|Cervical Cancer|cervical cancer
827988|NCT00122746|AIDS|aids
827989|NCT00122746|External Beam Radiotherapy|external beam radiotherapy
827990|NCT00122746|Brachytherapy|brachytherapy
827991|NCT00122746|Cisplatin|cisplatin
827992|NCT00122733|Mechanical ventilation|mechanical ventilation
827993|NCT00122733|Agitation|agitation
827994|NCT00122733|Difficult weaning|difficult weaning
827995|NCT00122720|colorectal cancer|colorectal cancer
827996|NCT00122720|erythropoietin|erythropoietin
827997|NCT00122720|rehabilitation|rehabilitation
827998|NCT00122720|physical capacity|physical capacity
827999|NCT00122707|catheter-related infection|catheter-related infection
828000|NCT00122707|mechanical complications of catheters|mechanical complications of catheters
828001|NCT00122694|carbon monoxide|carbon monoxide
828002|NCT00122694|COPD|copd
828003|NCT00122694|inflammation|inflammation
828004|NCT00122694|sputum induction|sputum induction
828005|NCT00122694|stable COPD|stable copd
828006|NCT00122668|HIV Protease Inhibitors|hiv protease inhibitors
828007|NCT00122668|HIV-Associated Lipodystrophy Syndrome|hiv-associated lipodystrophy syndrome
828008|NCT00122668|HIV infections|hiv infections
828009|NCT00122655|HIV infections|hiv infections
828010|NCT00122655|HIV Lipodystrophy Syndrome|hiv lipodystrophy syndrome
828011|NCT00122642|catheterization|catheterization
828012|NCT00122642|Catheters, Indwelling|catheters, indwelling
828013|NCT00122629|Hepatitis C, Chronic|hepatitis c, chronic
828014|NCT00122629|peginterferon alfa-2b|peginterferon alfa-2b
828015|NCT00122629|ribavirin|ribavirin
828016|NCT00122629|Amantadine|amantadine
828017|NCT00122616|HIV infections|hiv infections
828018|NCT00122616|peginterferon alfa-2a|peginterferon alfa-2a
828019|NCT00122616|Treatment Failure|treatment failure
828020|NCT00122616|Hepatitis C, Chronic|hepatitis c, chronic
828021|NCT00122616|Treatment Experienced|treatment experienced
828987|NCT00119093|Viral Load|viral load
828022|NCT00122603|HIV Protease Inhibitors|hiv protease inhibitors
828023|NCT00122603|HIV infections|hiv infections
828024|NCT00122603|Atazanavir|atazanavir
828025|NCT00122603|Saquinavir|saquinavir
828026|NCT00122603|Fosamprenavir|fosamprenavir
828027|NCT00122603|ritonavir|ritonavir
828028|NCT00122603|Treatment Naive|treatment naive
828029|NCT00122590|protease inhibitors|protease inhibitors
828030|NCT00122590|nelfinavir|nelfinavir
828031|NCT00122590|lopinavir|lopinavir
828032|NCT00122590|indinavir|indinavir
828033|NCT00122590|Pharmacokinetics|pharmacokinetics
828034|NCT00122577|HIV infections|hiv infections
828035|NCT00122577|Treatment Failure|treatment failure
828036|NCT00122577|tenofovir|tenofovir
828037|NCT00122577|atazanavir|atazanavir
828038|NCT00122564|HIV Vaccines|hiv vaccines
828039|NCT00122564|HIV Seronegativity|hiv seronegativity
828040|NCT00122551|HIV infections|hiv infections
828041|NCT00122538|HAART|haart
828042|NCT00122538|once-daily|once-daily
828043|NCT00122538|child|child
828044|NCT00122538|africa|africa
828045|NCT00122538|HIV|hiv
828046|NCT00122538|AIDS|aids
828047|NCT00122538|Treatment Naive|treatment naive
828048|NCT00122525|HIV|hiv
828049|NCT00122525|Male circumcision|male circumcision
828050|NCT00122525|Prevention|prevention
828051|NCT00122525|HSV-2|hsv-2
828052|NCT00122525|Africa|africa
828053|NCT00122525|Sexual behavior|sexual behavior
828054|NCT00122512|AE adverse event|ae adverse event
828055|NCT00122512|AIDS acquired immunodeficiency syndrome|aids acquired immunodeficiency syndrome
828056|NCT00122512|ALT (SGPT) alanine aminotransferase|alt (sgpt) alanine aminotransferase
828057|NCT00122512|ART antiretroviral therapy|art antiretroviral therapy
828058|NCT00122512|AST (SGOT) aspartate aminotransferase|ast (sgot) aspartate aminotransferase
828059|NCT00122512|DCF data collection forms|dcf data collection forms
828060|NCT00122512|DMC Data Monitoring Committee|dmc data monitoring committee
828061|NCT00122512|FDA (U.S.) Food and Drug Administration|fda (u.s.) food and drug administration
828062|NCT00122512|GCP Good Clinical Practice guidelines|gcp good clinical practice guidelines
828063|NCT00122512|HB sAg Hepatitis B surface antigen|hb sag hepatitis b surface antigen
828064|NCT00122512|ICH International Conference of Harmonisation|ich international conference of harmonisation
828065|NCT00122512|IND Investigational New Drug Application|ind investigational new drug application
828066|NCT00122512|IRB Institutional Review Board|irb institutional review board
828067|NCT00122512|IU international units|iu international units
828068|NCT00122512|mg milligram(s)|mg milligram(s)
828069|NCT00122512|mm3 cubic millimeter(s)|mm3 cubic millimeter(s)
828070|NCT00122512|PCR polymerase chain reaction|pcr polymerase chain reaction
828071|NCT00122512|SAE serious adverse event|sae serious adverse event
828072|NCT00122512|TDF tenofovir disoproxil fumarate, GS-4331-05, PMPA prodrug|tdf tenofovir disoproxil fumarate, gs-4331-05, pmpa prodrug
828073|NCT00122512|µg microgram|µg microgram
828074|NCT00122512|ULN upper limit of the normal range|uln upper limit of the normal range
828075|NCT00122512|WB Western Blot|wb western blot
828076|NCT00122512|Human Immunodeficiency Virus|human immunodeficiency virus
828077|NCT00122512|HIV Seronegativity|hiv seronegativity
828078|NCT00122499|Prostate cancer|prostate cancer
828079|NCT00122499|Radiotherapy|radiotherapy
828080|NCT00122499|Erectile dysfunction|erectile dysfunction
828081|NCT00122499|Tadalafil|tadalafil
828082|NCT00122486|AE adverse event|ae adverse event
828083|NCT00122486|AIDS acquired immunodeficiency syndrome|aids acquired immunodeficiency syndrome
828084|NCT00122486|ALT (SGPT) alanine aminotransferase|alt (sgpt) alanine aminotransferase
828085|NCT00122486|ART antiretroviral therapy|art antiretroviral therapy
828086|NCT00122486|AST (SGOT) aspartate aminotransferase|ast (sgot) aspartate aminotransferase
828087|NCT00122486|DCF data collection forms|dcf data collection forms
828088|NCT00122486|DMC Data Monitoring Committee|dmc data monitoring committee
828089|NCT00122486|FDA (U.S.) Food and Drug Administration|fda (u.s.) food and drug administration
828090|NCT00122486|GCP Good Clinical Practice guidelines|gcp good clinical practice guidelines
828091|NCT00122486|HB sAg Hepatitis B surface antigen|hb sag hepatitis b surface antigen
828092|NCT00122486|ICH International Conference of Harmonisation|ich international conference of harmonisation
828093|NCT00122486|IND Investigational New Drug Application|ind investigational new drug application
828094|NCT00122486|IRB Institutional Review Board|irb institutional review board
828095|NCT00122486|IU international units|iu international units
828096|NCT00122486|mg milligram(s)|mg milligram(s)
828097|NCT00122486|mm3 cubic millimeter(s)|mm3 cubic millimeter(s)
828098|NCT00122486|PCR polymerase chain reaction|pcr polymerase chain reaction
828099|NCT00122486|SAE serious adverse event|sae serious adverse event
828100|NCT00122486|µg microgram|µg microgram
828101|NCT00122486|ULN upper limit of the normal range|uln upper limit of the normal range
828102|NCT00122486|WB Western Blot|wb western blot
828103|NCT00122486|Human Immunodeficiency Virus|human immunodeficiency virus
828104|NCT00122473|Dermatofibrosarcoma|dermatofibrosarcoma
828105|NCT00122473|Imatinib|imatinib
828106|NCT00122473|Tyrosine Kinase Inhibitor|tyrosine kinase inhibitor
828107|NCT00122460|Head and Neck Cancer|head and neck cancer
828108|NCT00122447|Prediabetic state|prediabetic state
828109|NCT00122447|Cardiovascular disease|cardiovascular disease
828110|NCT00122447|Diabetes|diabetes
829090|NCT00118716|asthma|asthma
828111|NCT00122447|Glucose intolerance|glucose intolerance
828112|NCT00122421|diabetes|diabetes
828113|NCT00122421|quality of care|quality of care
828114|NCT00122421|pharmacist recommendations|pharmacist recommendations
828115|NCT00122408|ventilator-associated pneumonia|ventilator-associated pneumonia
828116|NCT00122408|probiotic|probiotic
828117|NCT00122408|mechanical ventilation|mechanical ventilation
828118|NCT00122408|intensive care|intensive care
828119|NCT00122395|Domestic violence|domestic violence
828120|NCT00122395|Screening|screening
828121|NCT00122395|Emergency department|emergency department
828122|NCT00122382|abatacept, methotrexate, erosive RA|abatacept, methotrexate, erosive ra
828123|NCT00122369|Breast|breast
828124|NCT00122369|Biopsy|biopsy
828125|NCT00122369|Hypnosis|hypnosis
828126|NCT00122369|Relaxation|relaxation
828127|NCT00122369|Anxiety|anxiety
828128|NCT00122369|Pain|pain
828129|NCT00122369|Medical and Surgical Procedures|medical and surgical procedures
828130|NCT00122343|Endometrial|endometrial
828131|NCT00122343|Cancer|cancer
828132|NCT00122317|transfusion dependent|transfusion dependent
828133|NCT00122317|paroxysmal nocturnal hemoglobinuria|paroxysmal nocturnal hemoglobinuria
828134|NCT00122317|hemolytic|hemolytic
828135|NCT00122291|preoperative|preoperative
828136|NCT00122291|chemotherapy|chemotherapy
828137|NCT00122291|radiation therapy|radiation therapy
828138|NCT00122291|rectal cancer|rectal cancer
828139|NCT00122291|transmural rectal wall invasion|transmural rectal wall invasion
828140|NCT00122291|nodal metastasis|nodal metastasis
828141|NCT00122278|migraine, emergency department, dexamethasone|migraine, emergency department, dexamethasone
828142|NCT00122278|Migraine with or without aura or probable migraine without aura as defined by ICHD, 2nd edition|migraine with or without aura or probable migraine without aura as defined by ichd, 2nd edition
828143|NCT00122265|prostate cancer|prostate cancer
828144|NCT00122265|radiotherapy|radiotherapy
828145|NCT00122265|radiation toxicity|radiation toxicity
828146|NCT00122265|single nucleotide polymorphism|single nucleotide polymorphism
828147|NCT00122252|prostate cancer|prostate cancer
828148|NCT00122252|radiotherapy|radiotherapy
828149|NCT00122252|biological imaging|biological imaging
828150|NCT00122239|radiotherapy|radiotherapy
828151|NCT00122239|radiation toxicity|radiation toxicity
828152|NCT00122239|single nucleotide polymorphism|single nucleotide polymorphism
828153|NCT00122239|breast carcinoma|breast carcinoma
828154|NCT00122239|prostate carcinoma|prostate carcinoma
828155|NCT00122239|squamous cell carcinoma of the head and neck|squamous cell carcinoma of the head and neck
828156|NCT00122239|lung carcinoma (non-small cell)|lung carcinoma (non-small cell)
828157|NCT00122226|HIV|hiv
828158|NCT00122226|HIV-associated lipodystrophy syndrome|hiv-associated lipodystrophy syndrome
828159|NCT00122213|Prevention|prevention
828160|NCT00122213|Retirement|retirement
828161|NCT00122213|Physical activity|physical activity
828162|NCT00122213|Diet|diet
828163|NCT00122213|Weight gain|weight gain
828164|NCT00122213|Body composition|body composition
828165|NCT00122187|cancer|cancer
828166|NCT00122187|colonoscopy|colonoscopy
828167|NCT00122187|mass screening|mass screening
828168|NCT00122187|colorectal cancer|colorectal cancer
828169|NCT00122187|colorectal carcinoma|colorectal carcinoma
828170|NCT00122187|reminder systems|reminder systems
828171|NCT00122187|rectal cancers|rectal cancers
828172|NCT00122187|colorectal tumor|colorectal tumor
828173|NCT00122187|guidelines|guidelines
828174|NCT00122187|CRC secondary prevention|crc secondary prevention
828175|NCT00122187|colorectal neoplasms|colorectal neoplasms
828176|NCT00122187|colonic neoplasms|colonic neoplasms
828177|NCT00122187|colonic diseases|colonic diseases
828178|NCT00122187|hemoccult testing|hemoccult testing
828179|NCT00122174|Caregivers|caregivers
828180|NCT00122174|Stress|stress
828181|NCT00122174|Coping|coping
828182|NCT00122174|Immune|immune
828183|NCT00122174|Relaxation|relaxation
828184|NCT00122174|Biofeedback|biofeedback
828185|NCT00122174|Bioinstrumentation|bioinstrumentation
828186|NCT00122174|Homecare|homecare
828187|NCT00122161|Drug therapy|drug therapy
828188|NCT00122161|Practice guidelines|practice guidelines
828189|NCT00122161|Reminder systems|reminder systems
828190|NCT00122161|Ambulatory care|ambulatory care
828191|NCT00122161|Hypertension|hypertension
828192|NCT00122161|Clinical protocols|clinical protocols
828193|NCT00122161|Quality Assurance, Health Care|quality assurance, health care
828194|NCT00122148|Quality of health care|quality of health care
828195|NCT00122148|Feedback|feedback
828196|NCT00122135|end-of-life care|end-of-life care
828197|NCT00122135|clinical decision-making|clinical decision-making
828198|NCT00122135|values inventory|values inventory
828199|NCT00122135|racial disparities|racial disparities
828200|NCT00122109|Posttraumatic Stress Disorder|posttraumatic stress disorder
828201|NCT00122109|Anger Management|anger management
828202|NCT00122109|Telemedicine modality|telemedicine modality
828203|NCT00122096|neurosurgery|neurosurgery
828204|NCT00122096|COX-2|cox-2
828205|NCT00122096|inflammation|inflammation
828206|NCT00122096|pain|pain
828207|NCT00122083|Depression|depression
828208|NCT00122083|Students|students
828209|NCT00122083|Health education|health education
828210|NCT00122070|Borderline Personality Disorder|borderline personality disorder
828211|NCT00122070|Personality Disorder|personality disorder
828212|NCT00122070|Quetiapine|quetiapine
828213|NCT00122070|Atypical Antipsychotics|atypical antipsychotics
828214|NCT00122070|Seroquel|seroquel
828215|NCT00122070|Antipsychotics|antipsychotics
828216|NCT00122057|ventilator-associated tracheobronchitis|ventilator-associated tracheobronchitis
828217|NCT00122057|nosocomial tracheobronchitis|nosocomial tracheobronchitis
828218|NCT00122044|childhood|childhood
828219|NCT00122044|cerebral palsy|cerebral palsy
828220|NCT00122044|dystonia|dystonia
828221|NCT00122044|secondary|secondary
828222|NCT00122044|trihexyphenidyl|trihexyphenidyl
828223|NCT00122044|pediatric dystonia|pediatric dystonia
828224|NCT00122031|Major Depression|major depression
828225|NCT00122031|Treatment Refractory Major Depression|treatment refractory major depression
828226|NCT00122018|Kidney failure|kidney failure
828227|NCT00122018|Cardiac Surgery|cardiac surgery
828228|NCT00122018|Fenoldopam|fenoldopam
828229|NCT00122018|N-acetylcysteine|n-acetylcysteine
828230|NCT00122005|Metastatic|metastatic
828231|NCT00122005|Prostate|prostate
828232|NCT00122005|Advanced|advanced
828233|NCT00122005|Cancer|cancer
828234|NCT00122005|GVAX|gvax
828235|NCT00122005|Vaccine|vaccine
828236|NCT00121992|High risk node negative breast cancer|high risk node negative breast cancer
828237|NCT00121992|Disease-Free survival|disease-free survival
828238|NCT00121992|Quality of life|quality of life
828239|NCT00121979|HIV|hiv
828240|NCT00121979|treatment-experienced|treatment-experienced
828241|NCT00121979|lamivudine|lamivudine
828242|NCT00121979|3TC|3tc
828243|NCT00121966|Type 2 diabetes|type 2 diabetes
828244|NCT00121966|Insulin Aspart|insulin aspart
828245|NCT00121966|Insulin NPH|insulin nph
828246|NCT00121966|Metformin|metformin
828247|NCT00121966|Rosiglitazone|rosiglitazone
828248|NCT00121953|Endometriosis|endometriosis
828249|NCT00121953|Peritoneal fluid|peritoneal fluid
828250|NCT00121953|Cytokines|cytokines
828251|NCT00121953|Peroxisome Proliferator-Activated Receptors|peroxisome proliferator-activated receptors
828252|NCT00121940|Chronic Disease|chronic disease
828253|NCT00121940|Nurses|nurses
828254|NCT00121940|Caregivers|caregivers
828255|NCT00121940|Support Groups|support groups
828256|NCT00121927|intractable|intractable
828257|NCT00121927|ketogenic|ketogenic
828258|NCT00121927|ketosis|ketosis
828259|NCT00121927|Atkins|atkins
828260|NCT00121914|Carcinoma, Hepatocellular,|carcinoma, hepatocellular,
828261|NCT00121914|percutaneous ethanol instillation|percutaneous ethanol instillation
828262|NCT00121914|long-acting somatostatin|long-acting somatostatin
828263|NCT00121901|Pancreatitis|pancreatitis
828264|NCT00121901|Cholangiopancreatograpy, Endoscopic Retrograde/adverse|cholangiopancreatograpy, endoscopic retrograde/adverse
828265|NCT00121901|Nitroglycerin|nitroglycerin
828266|NCT00121901|Randomized Controlled Trial,|randomized controlled trial,
828267|NCT00121888|post traumatic stress disorder|post traumatic stress disorder
828268|NCT00121888|Prolonged Exposure Therapy|prolonged exposure therapy
828269|NCT00121888|pharmacotherapy|pharmacotherapy
828270|NCT00121888|double-blind|double-blind
828271|NCT00121888|Anxiety Disorder|anxiety disorder
828272|NCT00121875|short stature|short stature
828273|NCT00121875|insulin resistance|insulin resistance
828274|NCT00121875|body composition|body composition
828275|NCT00121875|Turner syndrome|turner syndrome
828276|NCT00121875|intramyocellular lipid|intramyocellular lipid
828277|NCT00121875|glucose tolerance|glucose tolerance
828278|NCT00121862|Leishmaniasis|leishmaniasis
828279|NCT00121862|Subunit Vaccine|subunit vaccine
828280|NCT00121862|Prevention|prevention
828281|NCT00121862|T cell|t cell
828282|NCT00121849|Leishmaniasis,|leishmaniasis,
828283|NCT00121849|Subunit Vaccine,|subunit vaccine,
828284|NCT00121849|Prevention,|prevention,
828285|NCT00121849|T cell|t cell
828286|NCT00121823|Malaria|malaria
828288|NCT00121823|Vaccines|vaccines
828289|NCT00121823|Acceptability|acceptability
828290|NCT00121797|Postpartum Period|postpartum period
828291|NCT00121771|Malaria|malaria
828292|NCT00121771|Vaccines|vaccines
828293|NCT00121771|Safety|safety
828294|NCT00121771|Immunogenicity|immunogenicity
828295|NCT00121758|HIV Vaccines|hiv vaccines
828296|NCT00121758|HIV Seronegativity|hiv seronegativity
828297|NCT00121745|gene transfer|gene transfer
828298|NCT00121745|cell cycle control|cell cycle control
828299|NCT00121745|cancer gene therapy|cancer gene therapy
828300|NCT00121745|pathotropic targeting|pathotropic targeting
828301|NCT00121745|tumor targeted retroviral vector|tumor targeted retroviral vector
828302|NCT00121719|Resistant and refractory solid tumors|resistant and refractory solid tumors
828303|NCT00121719|lymphomas|lymphomas
828304|NCT00121719|hodgkins disease|hodgkins disease
828305|NCT00121719|non-hodgkins lymphoma|non-hodgkins lymphoma
828306|NCT00121719|neoplasms|neoplasms
828307|NCT00121693|Fall prevention|fall prevention
828308|NCT00121693|posturography|posturography
828309|NCT00121693|music therapy|music therapy
828310|NCT00121680|cancer|cancer
829360|NCT00117819|diagnosis|diagnosis
828311|NCT00121654|Angina pectoris|angina pectoris
828312|NCT00121654|Spinal cord stimulation|spinal cord stimulation
828313|NCT00121654|Refractory angina pectoris|refractory angina pectoris
828314|NCT00121628|Thyroid cancer|thyroid cancer
828315|NCT00121628|Advanced thyroid cancer|advanced thyroid cancer
828316|NCT00121628|Metastatic thyroid cancer|metastatic thyroid cancer
828317|NCT00121628|Medullary thyroid cancer|medullary thyroid cancer
828318|NCT00121628|Follicular thyroid cancer|follicular thyroid cancer
828319|NCT00121628|Papillary thyroid cancer|papillary thyroid cancer
828320|NCT00121628|Hurthle cell thyroid cancer|hurthle cell thyroid cancer
828321|NCT00121628|Thyroid cancer treatments|thyroid cancer treatments
828322|NCT00121628|Differentiated thyroid cancer and medullary thyroid cancer|differentiated thyroid cancer and medullary thyroid cancer
828323|NCT00121615|Clinical Trials|clinical trials
828324|NCT00121602|Hemodialysis|hemodialysis
828325|NCT00121602|Darbepoetin Alfa|darbepoetin alfa
828326|NCT00121602|Clinical Trials|clinical trials
828327|NCT00121602|Nephrology|nephrology
828328|NCT00121602|Amgen|amgen
828329|NCT00121602|Chronic Kidney Disease (CKD)|chronic kidney disease (ckd)
828330|NCT00121589|AMD|amd
828331|NCT00121589|Macular Pigment|macular pigment
828332|NCT00121589|Serum Lutein Levels|serum lutein levels
828333|NCT00121589|Vitamin Supplementation|vitamin supplementation
828334|NCT00121589|Carotenoids|carotenoids
828335|NCT00121589|Lutein|lutein
828336|NCT00121589|Zeaxanthin|zeaxanthin
828337|NCT00121589|DHA|dha
828338|NCT00121589|Age Related Macular Degeneration|age related macular degeneration
828339|NCT00121563|Cytokines|cytokines
828340|NCT00121563|Inflammation|inflammation
828341|NCT00121563|Pain|pain
828342|NCT00121563|Injury|injury
828343|NCT00121563|Peripheral|peripheral
828344|NCT00121563|Wisdom Teeth|wisdom teeth
828345|NCT00121563|Third Molar Extraction|third molar extraction
828346|NCT00121550|Coronary heart disease|coronary heart disease
828347|NCT00121550|Clarithromycin|clarithromycin
828348|NCT00121550|Macrolides|macrolides
828349|NCT00121550|Cardiovascular mortality|cardiovascular mortality
828350|NCT00121550|Chlamydia pneumoniae|chlamydia pneumoniae
828351|NCT00121537|wounds-open|wounds-open
828352|NCT00121524|cardiac arrest|cardiac arrest
828353|NCT00121524|resuscitation|resuscitation
828354|NCT00121524|epinephrine|epinephrine
828355|NCT00121524|intravenous|intravenous
828356|NCT00121524|survival|survival
828357|NCT00121511|photoaging|photoaging
828358|NCT00121511|Actinic Keratoses|actinic keratoses
828359|NCT00121511|Efudex|efudex
828360|NCT00121511|5 fluorouracil|5 fluorouracil
828361|NCT00121498|Pain|pain
828362|NCT00121498|Hysterectomy|hysterectomy
828363|NCT00121498|Preemptive|preemptive
828364|NCT00121498|Lidocaine|lidocaine
828365|NCT00121485|Heart-assist devices|heart-assist devices
828366|NCT00121472|Heart-assist devices|heart-assist devices
828367|NCT00121459|Diaphragm|diaphragm
828368|NCT00121459|HIV prevention|hiv prevention
828369|NCT00121459|Southern/South Africa, Zimbabwe|southern/south africa, zimbabwe
828370|NCT00121459|female-controlled methods|female-controlled methods
828371|NCT00121459|Replens|replens
828372|NCT00121459|STI prevention|sti prevention
828373|NCT00121459|HIV Seronegativity|hiv seronegativity
828374|NCT00121446|Heart Attack|heart attack
828375|NCT00121446|ST Elevation Myocardial Infarction|st elevation myocardial infarction
828376|NCT00121446|fibrinolytic therapy|fibrinolytic therapy
828377|NCT00121446|percutaneous coronary intervention|percutaneous coronary intervention
828378|NCT00121446|Acute Myocardial Infarction|acute myocardial infarction
828379|NCT00121420|Brain Neoplasms/secondary|brain neoplasms/secondary
828380|NCT00121420|Brain neoplasms/radiotherapy|brain neoplasms/radiotherapy
828381|NCT00121420|Brain metastasis|brain metastasis
828382|NCT00121420|Neoplasm metastasis|neoplasm metastasis
828383|NCT00121420|Cranial irradiation|cranial irradiation
828384|NCT00121420|Radiosurgery|radiosurgery
828385|NCT00121420|Lung Neoplasms|lung neoplasms
828386|NCT00121420|Breast Neoplasms|breast neoplasms
828387|NCT00121420|Kidney Neoplasms|kidney neoplasms
828388|NCT00121420|Melanoma|melanoma
828389|NCT00121420|Radiotherapy|radiotherapy
828390|NCT00121420|Carcinoma, non-small cell lung|carcinoma, non-small cell lung
828391|NCT00121407|Age Related Macular Degeneration (AMD)|age related macular degeneration (amd)
828392|NCT00121407|Photodynamic Therapy (PDT)|photodynamic therapy (pdt)
828393|NCT00121407|Visudyne|visudyne
828394|NCT00121394|Chlorhexidine|chlorhexidine
828395|NCT00121394|Vaginal wash|vaginal wash
828396|NCT00121394|Neonatal mortality|neonatal mortality
828397|NCT00121394|Sepsis|sepsis
828398|NCT00121394|Global Network|global network
828399|NCT00121394|Maternal and child health|maternal and child health
828400|NCT00121394|Women's Health|women's health
828401|NCT00121394|International|international
828402|NCT00121394|Pakistan|pakistan
828403|NCT00121381|Atopic dermatitis|atopic dermatitis
828404|NCT00121381|T-cell|t-cell
828405|NCT00121381|pimecrolimus|pimecrolimus
828406|NCT00121381|children|children
828407|NCT00121381|topical corticosteroids|topical corticosteroids
828408|NCT00121368|Global Network|global network
828409|NCT00121368|Maternal and child health|maternal and child health
828410|NCT00121368|International|international
828411|NCT00121368|Women's health|women's health
828412|NCT00121368|Tobacco|tobacco
828413|NCT00121368|Smoking|smoking
828414|NCT00121368|Africa|africa
828415|NCT00121368|Latin America|latin america
828416|NCT00121368|South America|south america
828417|NCT00121368|Guatemala|guatemala
828418|NCT00121368|Zambia|zambia
828419|NCT00121368|India|india
828420|NCT00121368|Argentina|argentina
828421|NCT00121368|Democratic Republic of the Congo|democratic republic of the congo
828422|NCT00121329|Pain with procedures|pain with procedures
828423|NCT00121316|Atopic dermatitis|atopic dermatitis
828424|NCT00121316|pimecrolimus|pimecrolimus
828425|NCT00121303|adult acute monocytic leukemia (M5b)|adult acute monocytic leukemia (m5b)
828426|NCT00121303|adult erythroleukemia (M6a)|adult erythroleukemia (m6a)
828427|NCT00121303|adult pure erythroid leukemia (M6b)|adult pure erythroid leukemia (m6b)
828428|NCT00121303|adult acute megakaryoblastic leukemia (M7)|adult acute megakaryoblastic leukemia (m7)
828429|NCT00121303|adult acute myeloblastic leukemia with maturation (M2)|adult acute myeloblastic leukemia with maturation (m2)
828430|NCT00121303|adult acute myeloblastic leukemia without maturation (M1)|adult acute myeloblastic leukemia without maturation (m1)
828431|NCT00121303|adult acute myelomonocytic leukemia (M4)|adult acute myelomonocytic leukemia (m4)
828432|NCT00121303|adult acute monoblastic leukemia (M5a)|adult acute monoblastic leukemia (m5a)
828433|NCT00121303|refractory anemia with excess blasts in transformation|refractory anemia with excess blasts in transformation
828434|NCT00121303|refractory anemia with excess blasts|refractory anemia with excess blasts
828435|NCT00121303|secondary acute myeloid leukemia|secondary acute myeloid leukemia
828436|NCT00121303|untreated adult acute myeloid leukemia|untreated adult acute myeloid leukemia
828437|NCT00121303|de novo myelodysplastic syndromes|de novo myelodysplastic syndromes
828438|NCT00121303|adult acute minimally differentiated myeloid leukemia (M0)|adult acute minimally differentiated myeloid leukemia (m0)
828439|NCT00121303|adult acute myeloid leukemia with 11q23 (MLL) abnormalities|adult acute myeloid leukemia with 11q23 (mll) abnormalities
828440|NCT00121303|adult acute myeloid leukemia with inv(16)(p13;q22)|adult acute myeloid leukemia with inv(16)(p13;q22)
828441|NCT00121303|adult acute myeloid leukemia with t(16;16)(p13;q22)|adult acute myeloid leukemia with t(16;16)(p13;q22)
828442|NCT00121303|adult acute myeloid leukemia with t(8;21)(q22;q22)|adult acute myeloid leukemia with t(8;21)(q22;q22)
828443|NCT00121303|secondary myelodysplastic syndromes|secondary myelodysplastic syndromes
828444|NCT00121277|unspecified adult solid tumor, protocol specific|unspecified adult solid tumor, protocol specific
828445|NCT00121212|stage I prostate cancer|stage i prostate cancer
828446|NCT00121212|stage IIB prostate cancer|stage iib prostate cancer
828447|NCT00121212|stage IIA prostate cancer|stage iia prostate cancer
828448|NCT00121212|stage III prostate cancer|stage iii prostate cancer
828449|NCT00121186|recurrent adult Hodgkin lymphoma|recurrent adult hodgkin lymphoma
828450|NCT00121186|recurrent small lymphocytic lymphoma|recurrent small lymphocytic lymphoma
828451|NCT00121186|recurrent mantle cell lymphoma|recurrent mantle cell lymphoma
828452|NCT00121186|recurrent grade 1 follicular lymphoma|recurrent grade 1 follicular lymphoma
828453|NCT00121186|recurrent grade 2 follicular lymphoma|recurrent grade 2 follicular lymphoma
828454|NCT00121186|recurrent grade 3 follicular lymphoma|recurrent grade 3 follicular lymphoma
828455|NCT00121186|recurrent adult diffuse large cell lymphoma|recurrent adult diffuse large cell lymphoma
828456|NCT00121173|cervical cancer|cervical cancer
828457|NCT00121173|cervical intraepithelial neoplasia grade 2|cervical intraepithelial neoplasia grade 2
828458|NCT00121173|cervical intraepithelial neoplasia grade 3|cervical intraepithelial neoplasia grade 3
828459|NCT00121160|immune response to vaccines|immune response to vaccines
828460|NCT00121160|stress management|stress management
828461|NCT00121160|breast cancer|breast cancer
828462|NCT00121147|glaucoma|glaucoma
828463|NCT00121147|pseudoexfoliation|pseudoexfoliation
828464|NCT00121134|Bevacizumab|bevacizumab
828465|NCT00121134|Metronomic Chemotherapy|metronomic chemotherapy
828466|NCT00121134|Breast Cancer Stages II-III|breast cancer stages ii-iii
828467|NCT00121134|Invasive breast cancer stages II-III|invasive breast cancer stages ii-iii
828468|NCT00121121|HIV Vaccines|hiv vaccines
828469|NCT00121121|HIV Seronegativity|hiv seronegativity
828470|NCT00121095|prostate cancer|prostate cancer
828471|NCT00121069|specific phobia|specific phobia
828472|NCT00121069|anxiety|anxiety
828473|NCT00121069|SSRI|ssri
828474|NCT00121069|clinical trial|clinical trial
828475|NCT00121069|escitalopram|escitalopram
828476|NCT00121043|Rheumatoid Arthritis, Inflammation|rheumatoid arthritis, inflammation
828477|NCT00121043|Interleukin-1 (IL-1), r-metHuIL-1ra|interleukin-1 (il-1), r-methuil-1ra
828478|NCT00121043|Autoimmune, Kineret®|autoimmune, kineret®
828479|NCT00121043|Anakinra, Immunex|anakinra, immunex
828480|NCT00121043|Amgen, Clinical Trials|amgen, clinical trials
828481|NCT00121030|uterine cancer|uterine cancer
828482|NCT00121030|ovarian cancer|ovarian cancer
828483|NCT00121030|darbepoetin alfa|darbepoetin alfa
828484|NCT00121030|Amgen|amgen
828485|NCT00121030|Gynecological Malignancies|gynecological malignancies
828486|NCT00121017|HCV Infection|hcv infection
828487|NCT00121017|Treatment Naive|treatment naive
828488|NCT00121004|Advance Directive|advance directive
828489|NCT00121004|Living Will|living will
828490|NCT00121004|Terminal Illness|terminal illness
829361|NCT00117806|Adult|adult
828491|NCT00120991|Coronary artery bypass grafting|coronary artery bypass grafting
828492|NCT00120991|OPCAB|opcab
828493|NCT00120978|Clinical Trial; C-reactive protein; fluticasone; salmeterol|clinical trial; c-reactive protein; fluticasone; salmeterol
828494|NCT00120965|Cardiac arrest|cardiac arrest
828495|NCT00120965|OOH-cardiac arrest|ooh-cardiac arrest
828496|NCT00120965|CPR|cpr
828497|NCT00120965|Chest compressions|chest compressions
828498|NCT00120965|Chest compression device|chest compression device
828499|NCT00120952|RSA|rsa
828500|NCT00120952|Osteoarthritis|osteoarthritis
828501|NCT00120952|Hip arthroplasty|hip arthroplasty
828502|NCT00120952|DEXA|dexa
828503|NCT00120952|Titanium|titanium
828504|NCT00120952|Cobalt chromium|cobalt chromium
828505|NCT00120952|Bone cement|bone cement
828506|NCT00120939|Lung Cancer|lung cancer
828507|NCT00120939|Breast Cancer|breast cancer
828508|NCT00120939|Prostate Cancer|prostate cancer
828509|NCT00120939|Ovarian Cancer|ovarian cancer
828510|NCT00120939|Head and Neck Cancer|head and neck cancer
828511|NCT00120939|Gastrointestinal Cancer|gastrointestinal cancer
828512|NCT00120939|Metastatic Cancer|metastatic cancer
828513|NCT00120939|Advanced Cancer|advanced cancer
828514|NCT00120939|Genitourinary Cancer|genitourinary cancer
828515|NCT00120939|Glioblastoma Multiforme|glioblastoma multiforme
828516|NCT00120939|Recurrent Cancer|recurrent cancer
828517|NCT00120939|Colon Cancer|colon cancer
828518|NCT00120939|Gastric Cancer|gastric cancer
828519|NCT00120939|Stomach Cancer|stomach cancer
828520|NCT00120939|Pancreatic Cancer|pancreatic cancer
828521|NCT00120939|Esophageal Cancer|esophageal cancer
828522|NCT00120939|Throat Cancer|throat cancer
828523|NCT00120939|Bladder Cancer|bladder cancer
828524|NCT00120939|Kidney Cancer|kidney cancer
828525|NCT00120939|Renal Cancer|renal cancer
828526|NCT00120939|Cervical Cancer|cervical cancer
828527|NCT00120939|Endometrial Cancer|endometrial cancer
828528|NCT00120939|Colorectal Cancer|colorectal cancer
828529|NCT00120926|Premature neonate|premature neonate
828530|NCT00120926|Parenteral nutrition|parenteral nutrition
828531|NCT00120926|Growth|growth
828532|NCT00120926|Amino Acids|amino acids
828533|NCT00120926|Nutrition|nutrition
828534|NCT00120913|Breakthrough bleeding while taking continuously dosed oral contraceptives|breakthrough bleeding while taking continuously dosed oral contraceptives
828535|NCT00120900|COX-2 inhibitor|cox-2 inhibitor
828536|NCT00120900|Knee osteoarthritis|knee osteoarthritis
828537|NCT00120887|Atherosclerosis, SLE, statins|atherosclerosis, sle, statins
828538|NCT00120874|Alzheimer's disease|alzheimer's disease
828539|NCT00120874|caregiver training|caregiver training
828540|NCT00120874|caregiver counseling|caregiver counseling
828541|NCT00120874|individualized management|individualized management
828542|NCT00120874|memantine|memantine
828543|NCT00120874|dementia|dementia
828544|NCT00120861|Genotype-1|genotype-1
828545|NCT00120861|Previously failed treatment|previously failed treatment
828546|NCT00120848|HPV vaccine efficacy|hpv vaccine efficacy
828547|NCT00120848|Prophylaxis HPV 16/18 infections|prophylaxis hpv 16/18 infections
828548|NCT00120835|Genotype-1|genotype-1
828549|NCT00120835|Treatment-Naive|treatment-naive
828550|NCT00120822|Malaria|malaria
828551|NCT00120822|Pregnancy|pregnancy
828552|NCT00120822|Folic acid|folic acid
828553|NCT00120822|Sulfadoxine-pyrimethamine|sulfadoxine-pyrimethamine
828554|NCT00120809|Malaria|malaria
828555|NCT00120809|Pregnancy|pregnancy
828556|NCT00120809|Multigravidae|multigravidae
828557|NCT00120809|Intermittent preventative treatment|intermittent preventative treatment
828558|NCT00120809|Sulfadoxine-pyrimethamine|sulfadoxine-pyrimethamine
828559|NCT00120796|Hepatitis B|hepatitis b
828560|NCT00120796|Hepatitis B Vaccines|hepatitis b vaccines
828561|NCT00120796|Lamivudine|lamivudine
828562|NCT00120783|Treatment Failure|treatment failure
828563|NCT00120783|HIV infections|hiv infections
828564|NCT00120770|AE adverse event|ae adverse event
828565|NCT00120770|AIDS acquired immunodeficiency syndrome|aids acquired immunodeficiency syndrome
828566|NCT00120770|ALT (SGPT) alanine aminotransferase|alt (sgpt) alanine aminotransferase
828567|NCT00120770|ART antiretroviral therapy|art antiretroviral therapy
828568|NCT00120770|AST (SGOT) aspartate aminotransferase|ast (sgot) aspartate aminotransferase
828569|NCT00120770|DCF data collection forms|dcf data collection forms
828570|NCT00120770|DMC Data Monitoring Committee|dmc data monitoring committee
828571|NCT00120770|FDA (U.S.) Food and Drug Administration|fda (u.s.) food and drug administration
828572|NCT00120770|GCP Good Clinical Practice guidelines|gcp good clinical practice guidelines
828573|NCT00120770|HB sAg Hepatitis B surface antigen|hb sag hepatitis b surface antigen
829184|NCT00118430|Hip Pain|hip pain
828574|NCT00120770|ICH International Conference of Harmonisation|ich international conference of harmonisation
828575|NCT00120770|IND Investigational New Drug Application|ind investigational new drug application
828576|NCT00120770|IRB Institutional Review Board|irb institutional review board
828577|NCT00120770|IU international units|iu international units
828578|NCT00120770|mg milligram(s)|mg milligram(s)
828579|NCT00120770|mm3 cubic millimeter(s)|mm3 cubic millimeter(s)
828580|NCT00120770|PCR polymerase chain reaction|pcr polymerase chain reaction
828581|NCT00120770|SAE serious adverse event|sae serious adverse event
828582|NCT00120770|µg microgram|µg microgram
828682|NCT00120419|immunomodulatory therapy|immunomodulatory therapy
828583|NCT00120770|ULN upper limit of the normal range|uln upper limit of the normal range
828584|NCT00120770|WB Western Blot|wb western blot
828585|NCT00120770|Human Immunodeficiency Virus|human immunodeficiency virus
828586|NCT00120770|Neisseria gonorrhoeae|neisseria gonorrhoeae
828587|NCT00120770|Chlamydia trachomatis|chlamydia trachomatis
828588|NCT00120770|HIV Seronegativity|hiv seronegativity
828589|NCT00120757|Osteoporosis|osteoporosis
828590|NCT00120731|Recurrent nephrolithiasis|recurrent nephrolithiasis
828591|NCT00120731|Potassium Citrate|potassium citrate
828592|NCT00120731|Hypercalciuria|hypercalciuria
828593|NCT00120731|Distal Renal Tubular Acidosis|distal renal tubular acidosis
828594|NCT00120731|Nephrolithiasis in children|nephrolithiasis in children
828595|NCT00120705|anemia|anemia
828596|NCT00120705|darbepoetin alfa|darbepoetin alfa
828597|NCT00120705|Amgen|amgen
828598|NCT00120705|Non-myeloid Malignancies|non-myeloid malignancies
828599|NCT00120692|breast cancer|breast cancer
828600|NCT00120692|darbepoetin alfa|darbepoetin alfa
828601|NCT00120692|Amgen|amgen
828602|NCT00120679|non-small cell lung cancer|non-small cell lung cancer
828603|NCT00120679|darbepoetin alfa|darbepoetin alfa
828604|NCT00120679|Amgen|amgen
828605|NCT00120666|Exercise|exercise
828606|NCT00120666|Stimulation|stimulation
828607|NCT00120666|Nerve|nerve
828608|NCT00120666|Electrical|electrical
828609|NCT00120666|Muscle|muscle
828610|NCT00120666|Healthy Volunteer|healthy volunteer
828612|NCT00120653|Reglan|reglan
828613|NCT00120653|Prolactin|prolactin
828614|NCT00120653|MDS|mds
828615|NCT00120653|Metoclopramide|metoclopramide
828616|NCT00120653|Myelodysplastic Syndrome|myelodysplastic syndrome
828617|NCT00120640|Premature birth|premature birth
828618|NCT00120640|Premature labor|premature labor
828619|NCT00120640|Progesterone|progesterone
828620|NCT00120627|Randomized Controlled Trial|randomized controlled trial
828621|NCT00120627|Intervention Study|intervention study
828622|NCT00120627|Mindfulness|mindfulness
828623|NCT00120627|Complementary Therapy|complementary therapy
828624|NCT00120627|Mind-Body Relations (Metaphysics)|mind-body relations (metaphysics)
828625|NCT00120627|Spiritual Therapy|spiritual therapy
828626|NCT00120627|Meditation|meditation
828627|NCT00120627|Qualitative Analysis|qualitative analysis
828628|NCT00120614|Premature Infant|premature infant
828629|NCT00120614|Premature Birth|premature birth
828630|NCT00120614|Parenting Interventions|parenting interventions
828631|NCT00120614|NICU Interventional studies|nicu interventional studies
828632|NCT00120614|Parental coping|parental coping
828633|NCT00120614|Low birthweight infant|low birthweight infant
828634|NCT00120614|Coping Behavior|coping behavior
828635|NCT00120614|Infant, Premature|infant, premature
828636|NCT00120601|treatment|treatment
828637|NCT00120601|alcohol|alcohol
828638|NCT00120601|dependence|dependence
828639|NCT00120601|medication|medication
828640|NCT00120588|brain protection|brain protection
828641|NCT00120588|white matter injury|white matter injury
828642|NCT00120588|neurodevelopmental sequelae|neurodevelopmental sequelae
828643|NCT00120588|magnesium sulfate|magnesium sulfate
828644|NCT00120588|intraventricular hemorrhage|intraventricular hemorrhage
828645|NCT00120575|Hemofiltration|hemofiltration
828646|NCT00120575|Pediatrics|pediatrics
828647|NCT00120562|weight loss surgery|weight loss surgery
828648|NCT00120562|gastric bypass surgery|gastric bypass surgery
828649|NCT00120549|Assisted Hatching|assisted hatching
828650|NCT00120549|Cleavage Stage, Ovum|cleavage stage, ovum
828651|NCT00120549|Embryo Transfer|embryo transfer
828652|NCT00120549|Pregnancy|pregnancy
828653|NCT00120549|Embryo Implantation|embryo implantation
828654|NCT00120536|Type 2 diabetes|type 2 diabetes
828655|NCT00120536|vildagliptin|vildagliptin
828656|NCT00120523|Atopic dermatitis, children, infants, pimecrolimus|atopic dermatitis, children, infants, pimecrolimus
828657|NCT00120510|Treatment Naive|treatment naive
828658|NCT00120510|TB|tb
828659|NCT00120497|short stature|short stature
828660|NCT00120497|intrauterine growth restriction|intrauterine growth restriction
828661|NCT00120497|insulin resistance|insulin resistance
828662|NCT00120497|intramyocellular lipid|intramyocellular lipid
828663|NCT00120497|small for gestational age|small for gestational age
828664|NCT00120497|glucose tolerance|glucose tolerance
828665|NCT00120484|Circadian Rhythm|circadian rhythm
828666|NCT00120484|Biological Clock|biological clock
828667|NCT00120484|Complementary and Alternative Medicine|complementary and alternative medicine
828668|NCT00120471|Perinatal Transmission|perinatal transmission
828669|NCT00120471|MTCT|mtct
828670|NCT00120471|HIV Seronegativity|hiv seronegativity
828671|NCT00120458|Black Cohosh|black cohosh
828672|NCT00120458|Cimicifuga|cimicifuga
828673|NCT00120458|Anxiety|anxiety
828674|NCT00120458|Women|women
828675|NCT00120458|Complementary and Alternative Medicine|complementary and alternative medicine
828676|NCT00120445|retinal detachment|retinal detachment
828677|NCT00120445|pneumatic retinopexy|pneumatic retinopexy
828678|NCT00120432|single dose|single dose
828679|NCT00120432|mydriatic drug|mydriatic drug
828680|NCT00120432|pupillary dilation|pupillary dilation
828681|NCT00120419|HIV-1 infection|hiv-1 infection
828683|NCT00120419|Treatment Naive|treatment naive
828684|NCT00120406|Peripheral Arterial Disease (PAD)|peripheral arterial disease (pad)
828685|NCT00120406|Peripheral Vascular Disease|peripheral vascular disease
828686|NCT00120406|Drug-Eluting Stent|drug-eluting stent
828687|NCT00120406|Drug-Coated Stent|drug-coated stent
828688|NCT00120393|Treatment Experienced|treatment experienced
828689|NCT00120380|Idiopathic pulmonary arterial hypertension|idiopathic pulmonary arterial hypertension
828690|NCT00120367|Leukoencephalopathy, Progressive Multifocal|leukoencephalopathy, progressive multifocal
828691|NCT00120367|HIV infections|hiv infections
828692|NCT00120367|HIV Fusion Inhibitors|hiv fusion inhibitors
828693|NCT00120354|Hepatitis B Virus|hepatitis b virus
828694|NCT00120354|Antiviral Resistance|antiviral resistance
828695|NCT00120354|Drug Withdrawal|drug withdrawal
828696|NCT00120354|Immune Response|immune response
828697|NCT00120354|Hepatitis B Surface Antigen|hepatitis b surface antigen
828698|NCT00120354|Liver Biopsy|liver biopsy
828699|NCT00120354|Hepatitis B|hepatitis b
828700|NCT00120328|serum creatinine|serum creatinine
828701|NCT00120328|end stage renal disease|end stage renal disease
828702|NCT00120328|cardiovascular mortality|cardiovascular mortality
828703|NCT00120328|cardiovascular morbidity|cardiovascular morbidity
828704|NCT00120328|non-cardiovascular mortality|non-cardiovascular mortality
828705|NCT00120328|non-cardiovascular morbidity|non-cardiovascular morbidity
828706|NCT00120315|dyspepsia|dyspepsia
828707|NCT00120315|discontinuation|discontinuation
828708|NCT00120315|Primary health care|primary health care
828709|NCT00120315|Helicobacter pylori|helicobacter pylori
828710|NCT00120315|Proton Pump Inhibitor|proton pump inhibitor
828711|NCT00120315|Histamine-2-receptor-antagonist|histamine-2-receptor-antagonist
828712|NCT00120302|Randomised|randomised
828713|NCT00120302|Placebo-controlled|placebo-controlled
828714|NCT00120302|Elidel|elidel
828715|NCT00120302|Quality of Life|quality of life
828716|NCT00120302|Atopic Eczema|atopic eczema
828717|NCT00120276|Functional Mitral Regurgitation (FMR)|functional mitral regurgitation (fmr)
828718|NCT00120276|Ischemic Mitral Regurgitation|ischemic mitral regurgitation
828719|NCT00120276|Less invasive repair|less invasive repair
828720|NCT00120276|Surgical MV repair|surgical mv repair
828721|NCT00120276|Mitral Valve Repair|mitral valve repair
828722|NCT00120276|Heart Failure|heart failure
828723|NCT00120276|Left Ventricular Dysfunction|left ventricular dysfunction
828724|NCT00120263|Plasma Exchange|plasma exchange
828725|NCT00120263|Myeloma|myeloma
828726|NCT00120263|Acute renal failure|acute renal failure
828727|NCT00120263|Light Chains|light chains
828728|NCT00120263|Bence Jones Proteins|bence jones proteins
828729|NCT00120263|Kidney Function|kidney function
828730|NCT00120250|PTSD|ptsd
828731|NCT00120250|Sleep disturbance|sleep disturbance
828732|NCT00120250|Eszopiclone|eszopiclone
828733|NCT00120250|Double-blind|double-blind
828734|NCT00120250|Crossover|crossover
828735|NCT00120237|Postpartum hemorrhage|postpartum hemorrhage
828736|NCT00120237|Misoprostol|misoprostol
828737|NCT00120237|Maternal morbidity|maternal morbidity
828738|NCT00120237|Developing countries|developing countries
828739|NCT00120237|Traditional birth attendants|traditional birth attendants
828740|NCT00120224|Mifepristone|mifepristone
828741|NCT00120224|Medical abortion|medical abortion
828742|NCT00120224|Ultrasound|ultrasound
828743|NCT00120198|NHL|nhl
828744|NCT00120198|elderly|elderly
828745|NCT00120185|HIV Infections|hiv infections
828746|NCT00120185|Interleukin-2|interleukin-2
828747|NCT00120172|colorectal|colorectal
828748|NCT00120172|metastatic|metastatic
828749|NCT00120172|elderly|elderly
828750|NCT00120172|metastatic colorectal cancer|metastatic colorectal cancer
828751|NCT00120159|Necrotizing Enterocolitis|necrotizing enterocolitis
828752|NCT00120133|Osteoporosis|osteoporosis
828753|NCT00120133|Bisphosphonates|bisphosphonates
828754|NCT00120133|Atorvastatin|atorvastatin
828755|NCT00120120|Radiculopathy|radiculopathy
828756|NCT00120120|Back Pain|back pain
828757|NCT00120120|Lumbar Pain|lumbar pain
828758|NCT00120120|CC-5013|cc-5013
828759|NCT00120120|Revlimid|revlimid
828760|NCT00120120|Lenalidomide|lenalidomide
828761|NCT00120094|Syncope|syncope
828762|NCT00120094|Electrocardiographic monitoring|electrocardiographic monitoring
828763|NCT00120081|Vaccine|vaccine
828764|NCT00120081|Hookworm|hookworm
828765|NCT00120081|Phase 1|phase 1
828766|NCT00120081|Human Hookworm Infection|human hookworm infection
828767|NCT00120081|Na-ASP-2|na-asp-2
828768|NCT00120042|Abortion|abortion
828769|NCT00120042|Retained placenta|retained placenta
828771|NCT00120042|Postpartum ultrasound|postpartum ultrasound
828772|NCT00120029|weight loss|weight loss
828773|NCT00120029|survivorship|survivorship
828774|NCT00120029|breast ductal lavage|breast ductal lavage
828775|NCT00120029|exercise|exercise
828776|NCT00120029|diet|diet
828777|NCT00120016|cancer prevention|cancer prevention
828778|NCT00120016|diet|diet
828779|NCT00120016|nutrition|nutrition
828780|NCT00120016|polyunsaturated fat|polyunsaturated fat
828781|NCT00120016|olive oil|olive oil
828782|NCT00120003|Acute stroke|acute stroke
828783|NCT00120003|Elevated blood pressure|elevated blood pressure
828784|NCT00120003|Blood pressure lowering treatment|blood pressure lowering treatment
828785|NCT00119990|vasopressin|vasopressin
828786|NCT00119990|icodextrin|icodextrin
828787|NCT00119990|cardiac output|cardiac output
828788|NCT00119977|cartilage thickness|cartilage thickness
828789|NCT00119977|RSA|rsa
828790|NCT00119977|DEXA|dexa
828791|NCT00119977|ultra sound|ultra sound
828792|NCT00119977|MRI|mri
828793|NCT00119977|osteoarthritis|osteoarthritis
828794|NCT00119977|periacetabular osteotomy|periacetabular osteotomy
828795|NCT00119951|Behavioral|behavioral
828796|NCT00119938|Disease management|disease management
828797|NCT00119938|Patient access to records|patient access to records
828798|NCT00119938|Medical records systems, computerized|medical records systems, computerized
828799|NCT00119938|Questionnaires|questionnaires
828800|NCT00119938|Physician-patient relations|physician-patient relations
828801|NCT00119938|Medical records|medical records
828802|NCT00119925|infertility|infertility
828803|NCT00119925|guideline|guideline
828804|NCT00119925|health care implementation|health care implementation
828805|NCT00119925|intervention|intervention
828806|NCT00119925|gynecology|gynecology
828807|NCT00119912|screening|screening
828808|NCT00119912|flexible sigmoidoscopy|flexible sigmoidoscopy
828809|NCT00119912|fecal occult blood|fecal occult blood
828810|NCT00119912|cancer|cancer
828811|NCT00119912|colon|colon
828812|NCT00119912|rectum|rectum
828813|NCT00119899|Colorectal Cancer;|colorectal cancer;
828814|NCT00119899|Liver;|liver;
828815|NCT00119899|Metastases;|metastases;
828816|NCT00119899|Resection;|resection;
828817|NCT00119899|Fluorodeoxyglucose;|fluorodeoxyglucose;
828818|NCT00119899|Tomography;|tomography;
828819|NCT00119899|Positron-Emission|positron-emission
828820|NCT00119873|HIV Preventive Vaccine|hiv preventive vaccine
828821|NCT00119873|AIDS Vaccines|aids vaccines
828822|NCT00119873|Adenoviridae|adenoviridae
828823|NCT00119847|Stents, myocardial infarction|stents, myocardial infarction
828824|NCT00119834|Heart Failure|heart failure
828825|NCT00119834|Intermacs|intermacs
828826|NCT00119834|Pedimacs|pedimacs
828827|NCT00119834|Mechanical Circulatory Support|mechanical circulatory support
828828|NCT00119834|Ventricular Assist Device|ventricular assist device
828829|NCT00119769|HIV|hiv
828830|NCT00119769|immune stimulation|immune stimulation
828831|NCT00119769|lipodystrophy|lipodystrophy
828832|NCT00119769|growth hormone|growth hormone
828833|NCT00119769|recombinant growth hormone|recombinant growth hormone
828834|NCT00119769|Treatment Experienced|treatment experienced
828835|NCT00119756|Schizophrenia|schizophrenia
828836|NCT00119756|Intramuscular injection|intramuscular injection
828837|NCT00119756|Deltoid muscle|deltoid muscle
828838|NCT00119756|Gluteus muscle|gluteus muscle
828839|NCT00119756|Paliperidone palmitate|paliperidone palmitate
828840|NCT00119743|Prophylaxis pneumococcal vaccine|prophylaxis pneumococcal vaccine
828841|NCT00119730|Fludarabine|fludarabine
828842|NCT00119730|Mitoxantrone|mitoxantrone
828843|NCT00119730|Rituximab|rituximab
828844|NCT00119730|Zevalin|zevalin
828845|NCT00119730|Mantle Cell Lymphoma|mantle cell lymphoma
828846|NCT00119730|Relapsed Mantle Cell Lymphoma|relapsed mantle cell lymphoma
828847|NCT00119717|acute|acute
828848|NCT00119717|ischemic|ischemic
828849|NCT00119717|stroke|stroke
828850|NCT00119717|randomized|randomized
828851|NCT00119717|device|device
828852|NCT00119717|treatment|treatment
828853|NCT00119678|SLE|sle
828854|NCT00119665|Postmenopausal symptoms|postmenopausal symptoms
828855|NCT00119665|Hot Flashes|hot flashes
828856|NCT00119665|Postmenopausal Hot Flashes|postmenopausal hot flashes
828857|NCT00119652|Bipolar disorder|bipolar disorder
828858|NCT00119652|bipolar depression|bipolar depression
828859|NCT00119652|depression|depression
828860|NCT00119626|Stroke, Acute|stroke, acute
828861|NCT00119626|Cerebrovascular Stroke|cerebrovascular stroke
828862|NCT00119613|Oncology|oncology
828863|NCT00119613|Clinical Trial|clinical trial
828864|NCT00119613|Hemoglobin|hemoglobin
828865|NCT00119613|Darbepoetin alfa|darbepoetin alfa
828866|NCT00119613|Survival|survival
828867|NCT00119613|Carboplatin|carboplatin
828868|NCT00119613|Cisplatin|cisplatin
828869|NCT00119613|Etoposide|etoposide
828870|NCT00119613|Extensive Stage Small Cell Lung Cancer|extensive stage small cell lung cancer
828871|NCT00119600|Non-myeloid malignancy|non-myeloid malignancy
828872|NCT00119600|Clinical Trial|clinical trial
828873|NCT00119587|Hemodialysis|hemodialysis
828874|NCT00119587|darbepoetin alfa|darbepoetin alfa
828875|NCT00119587|Clinical Trial|clinical trial
828876|NCT00119587|Amgen|amgen
828877|NCT00119574|Randomized Controlled Trial|randomized controlled trial
828878|NCT00119574|Quality of Health Care|quality of health care
828879|NCT00119574|Health Services Research|health services research
828880|NCT00119574|Guidelines|guidelines
828881|NCT00119574|Medical Informatics Computing|medical informatics computing
828882|NCT00119574|Services, Mental Health|services, mental health
828883|NCT00119574|Medicine, Evidence-Based|medicine, evidence-based
828884|NCT00119574|Quality Assurance, Healthcare|quality assurance, healthcare
828885|NCT00119574|Quality Indicators, Health Care|quality indicators, health care
828886|NCT00119574|Veterans|veterans
828887|NCT00119561|Caregiver|caregiver
828888|NCT00119561|Dementia|dementia
828889|NCT00119561|Alzheimer Disease|alzheimer disease
828890|NCT00119561|Telephone|telephone
828891|NCT00119561|Randomized Controlled Trials|randomized controlled trials
828892|NCT00119548|HIV Rapid Testing|hiv rapid testing
828893|NCT00119548|Cost-effectiveness|cost-effectiveness
828894|NCT00119548|HIV Seronegativity|hiv seronegativity
828895|NCT00119535|Diabetes mellitus|diabetes mellitus
828896|NCT00119535|Diabetic retinopathy|diabetic retinopathy
828897|NCT00119535|Organizational change|organizational change
828898|NCT00119535|Quality improvement|quality improvement
828899|NCT00119535|Quasi-experimental|quasi-experimental
828900|NCT00119522|wheelchairs|wheelchairs
828901|NCT00119522|falls|falls
828902|NCT00119522|spinal cord injury|spinal cord injury
828903|NCT00119522|accidental falls|accidental falls
828904|NCT00119522|safety|safety
828905|NCT00119509|Cervix Neoplasms|cervix neoplasms
828906|NCT00119509|Vaginal smears|vaginal smears
828907|NCT00119509|Papillomavirus - Human|papillomavirus - human
828908|NCT00119496|Corticosteroid|corticosteroid
828909|NCT00119496|Rosiglitazone|rosiglitazone
828910|NCT00119496|Theophylline|theophylline
828911|NCT00119496|Beclomethasone|beclomethasone
828912|NCT00119496|Inflammation|inflammation
828913|NCT00119496|Asthma|asthma
828914|NCT00119496|Smoking|smoking
828915|NCT00119496|Pulmonary|pulmonary
828917|NCT00119483|testosterone|testosterone
828918|NCT00119483|hypogonadal|hypogonadal
828919|NCT00119483|aging|aging
828920|NCT00119483|body composition|body composition
828921|NCT00119483|quality og life|quality og life
828922|NCT00119483|Muscle strength|muscle strength
828923|NCT00119483|Aging male|aging male
828924|NCT00119457|antithrombotic agents|antithrombotic agents
828925|NCT00119457|anticoagulants|anticoagulants
828926|NCT00119457|prophylaxis|prophylaxis
828927|NCT00119457|embolism|embolism
828928|NCT00119457|deep vein thrombosis|deep vein thrombosis
828929|NCT00119457|hip fracture|hip fracture
828931|NCT00119444|Periacetabular osteotomy|periacetabular osteotomy
828932|NCT00119431|Hereditary angioedema type I (MeSH: angioneurotic edema, complement 1 inactivators)|hereditary angioedema type i (mesh: angioneurotic edema, complement 1 inactivators)
828933|NCT00119418|hot flash|hot flash
828934|NCT00119418|menopause|menopause
828935|NCT00119418|herbal medicine|herbal medicine
828936|NCT00119418|kampo|kampo
828937|NCT00119418|alternative medicine|alternative medicine
828938|NCT00119405|Lipoatrophy|lipoatrophy
828939|NCT00119405|Mitochondria|mitochondria
828940|NCT00119405|Treatment Naive|treatment naive
828941|NCT00119379|lipoatrophy|lipoatrophy
828942|NCT00119379|mitochondria|mitochondria
828943|NCT00119379|HIV|hiv
828944|NCT00119379|treatment experienced|treatment experienced
828945|NCT00119340|accelerated phase chronic myelogenous leukemia|accelerated phase chronic myelogenous leukemia
828946|NCT00119340|Philadelphia chromosome positive chronic myelogenous leukemia|philadelphia chromosome positive chronic myelogenous leukemia
828947|NCT00119340|relapsing chronic myelogenous leukemia|relapsing chronic myelogenous leukemia
828948|NCT00119340|chronic phase chronic myelogenous leukemia|chronic phase chronic myelogenous leukemia
828949|NCT00119314|newly diagnosed carcinoma of unknown primary|newly diagnosed carcinoma of unknown primary
828950|NCT00119314|recurrent carcinoma of unknown primary|recurrent carcinoma of unknown primary
828951|NCT00119301|recurrent osteosarcoma|recurrent osteosarcoma
828952|NCT00119210|Tobacco use cessation|tobacco use cessation
828953|NCT00119210|Bupropion|bupropion
828954|NCT00119210|Zyban|zyban
828955|NCT00119210|Puerperium|puerperium
828956|NCT00119197|watery diarrhea|watery diarrhea
828957|NCT00119197|cholera vaccine|cholera vaccine
828958|NCT00119184|anesthesia|anesthesia
828959|NCT00119184|breech|breech
828960|NCT00119184|external cephalic version|external cephalic version
828961|NCT00119184|spinal|spinal
828962|NCT00119184|success|success
828963|NCT00119184|anesthesia,spinal|anesthesia,spinal
828964|NCT00119171|Safety|safety
828965|NCT00119171|tolerability|tolerability
828966|NCT00119171|dose limiting toxicity|dose limiting toxicity
828967|NCT00119171|solid tumors|solid tumors
828968|NCT00119171|capecitabine|capecitabine
828969|NCT00119158|THerapy for acute moderate to severe flares|therapy for acute moderate to severe flares
828970|NCT00119145|antimalarial drugs|antimalarial drugs
828971|NCT00119145|efficacy|efficacy
828972|NCT00119145|safety|safety
828973|NCT00119145|trial|trial
829448|NCT00117533|ribavirin|ribavirin
828974|NCT00119132|intermittent preventive treatment|intermittent preventive treatment
828975|NCT00119132|effectiveness|effectiveness
828976|NCT00119132|malaria|malaria
828977|NCT00119119|Hepatitis C|hepatitis c
828978|NCT00119119|Liver Cirrhosis|liver cirrhosis
828979|NCT00119119|Tocopherols|tocopherols
828980|NCT00119106|HIV|hiv
828981|NCT00119106|Prevention|prevention
828982|NCT00119106|Tenofovir|tenofovir
828983|NCT00119106|HIV Seronegativity|hiv seronegativity
828984|NCT00119093|Antiretroviral therapy|antiretroviral therapy
828985|NCT00119093|HIV|hiv
828988|NCT00119093|Opportunistic illness|opportunistic illness
828989|NCT00119080|Meningococcal carriage|meningococcal carriage
828990|NCT00119080|Conjugate vaccine|conjugate vaccine
828991|NCT00119067|Anthrax|anthrax
828992|NCT00119067|Vaccine|vaccine
828993|NCT00119067|Immunogenicity|immunogenicity
828994|NCT00119067|Reactogenicity|reactogenicity
828995|NCT00119054|Hypertension|hypertension
828996|NCT00119054|Diabetes Mellitus|diabetes mellitus
828997|NCT00119054|Telemedicine|telemedicine
828998|NCT00119054|Nursing Care|nursing care
828999|NCT00119041|Diabetes Mellitus|diabetes mellitus
829000|NCT00119041|Telemedicine|telemedicine
829001|NCT00119041|Referral|referral
829002|NCT00119041|Consultation|consultation
829003|NCT00119028|Quality Improvement|quality improvement
829004|NCT00119028|Cluster Randomized Trial|cluster randomized trial
829005|NCT00119028|Care Model|care model
829006|NCT00119015|perennial allergic rhinitis|perennial allergic rhinitis
829007|NCT00119002|randomized clinical trial|randomized clinical trial
829008|NCT00119002|placebo-controlled|placebo-controlled
829009|NCT00119002|double-blind|double-blind
829010|NCT00119002|double-masked|double-masked
829011|NCT00119002|infant|infant
829012|NCT00119002|dexamethasone|dexamethasone
829013|NCT00119002|wheezing|wheezing
829014|NCT00118989|Curcumin|curcumin
829015|NCT00118989|chemoprevention|chemoprevention
829016|NCT00118989|adenomatous polyps|adenomatous polyps
829017|NCT00118989|colorectal cancer|colorectal cancer
829018|NCT00118976|diabetic nephropathy|diabetic nephropathy
829019|NCT00118976|type 1 diabetes|type 1 diabetes
829020|NCT00118976|albuminuria|albuminuria
829021|NCT00118976|hypertension|hypertension
829022|NCT00118924|Dengue Vaccine|dengue vaccine
829023|NCT00118924|Tick-Borne Illnesses|tick-borne illnesses
829024|NCT00118924|Flavivirus|flavivirus
829025|NCT00118911|Adult|adult
829026|NCT00118911|ADHD|adhd
829027|NCT00118911|ADD|add
829028|NCT00118911|CBT|cbt
829029|NCT00118911|Relaxation Techniques|relaxation techniques
829030|NCT00118911|Education|education
829031|NCT00118898|Treatment Naive|treatment naive
829032|NCT00118885|Shingles|shingles
829033|NCT00118885|depression|depression
829034|NCT00118885|varicella zoster virus|varicella zoster virus
829035|NCT00118885|alternative medicine|alternative medicine
829036|NCT00118885|psychoneuroimmunology|psychoneuroimmunology
829037|NCT00118872|Growth and Development|growth and development
829038|NCT00118872|Pakistan|pakistan
829039|NCT00118872|Weaning|weaning
829040|NCT00118872|Probiotics|probiotics
829041|NCT00118872|Infant|infant
829042|NCT00118872|Lactobacillus GG|lactobacillus gg
829043|NCT00118859|Back Pain|back pain
829044|NCT00118859|Integrative Care|integrative care
829045|NCT00118859|Acupuncture|acupuncture
829046|NCT00118859|Chiropractic|chiropractic
829047|NCT00118859|Exercise|exercise
829048|NCT00118859|Massage Therapy|massage therapy
829049|NCT00118859|Mind-Body Therapy|mind-body therapy
829050|NCT00118859|Nutritional Counseling|nutritional counseling
829051|NCT00118859|Complementary Therapies|complementary therapies
829052|NCT00118859|Complementary and Alternative Medicine|complementary and alternative medicine
829053|NCT00118846|Women|women
829054|NCT00118846|Complementary and Alternative Medicine|complementary and alternative medicine
829055|NCT00118846|CAM|cam
829056|NCT00118833|Social Anxiety Disorder|social anxiety disorder
829057|NCT00118833|Social Phobia|social phobia
829058|NCT00118833|Generalized Anxiety Disorder|generalized anxiety disorder
829059|NCT00118833|Hypericum|hypericum
829060|NCT00118833|St. John's wort|st. john's wort
829061|NCT00118833|Medicine, Herbal|medicine, herbal
829062|NCT00118833|Complementary Therapies|complementary therapies
829063|NCT00118820|Dry socket|dry socket
829064|NCT00118820|Third molar|third molar
829065|NCT00118820|Infection|infection
829066|NCT00118820|postop-infection|postop-infection
829067|NCT00118820|Antibiotic efficacy|antibiotic efficacy
829068|NCT00118820|Infection characterized by pus,erythema,edema and pain|infection characterized by pus,erythema,edema and pain
829069|NCT00118807|malaria treatment|malaria treatment
829070|NCT00118807|artemisinin based combination therapy|artemisinin based combination therapy
829071|NCT00118807|Plasmodium falciparum|plasmodium falciparum
829072|NCT00118807|pragmatic trial|pragmatic trial
829073|NCT00118807|effectiveness|effectiveness
829074|NCT00118794|uncomplicated malaria|uncomplicated malaria
829075|NCT00118794|G6PD deficiency|g6pd deficiency
829076|NCT00118794|haemolytic anaemia|haemolytic anaemia
829077|NCT00118794|Lapdap|lapdap
829185|NCT00118430|Stepped Care|stepped care
829078|NCT00118794|Artemsinin based combination treatment|artemsinin based combination treatment
829079|NCT00118794|compliance|compliance
829080|NCT00118794|pragmatic trials|pragmatic trials
829081|NCT00118781|ventilator-associated pneumonia|ventilator-associated pneumonia
829082|NCT00118781|VAP|vap
829083|NCT00118781|pneumonia|pneumonia
829084|NCT00118781|ICU infection|icu infection
829085|NCT00118768|Genotype-1, Chronic Hepatitis C|genotype-1, chronic hepatitis c
829086|NCT00118729|Ragweed|ragweed
829087|NCT00118729|GW685698X|gw685698x
829088|NCT00118729|seasonal allergic rhinitis|seasonal allergic rhinitis
829089|NCT00118729|onset|onset
829091|NCT00118716|bronchospasm|bronchospasm
829092|NCT00118703|nonallergic rhinitis|nonallergic rhinitis
829093|NCT00118703|GW685698X|gw685698x
829094|NCT00118703|VMR|vmr
829095|NCT00118703|vasomotor rhinitis|vasomotor rhinitis
829096|NCT00118690|bronchospasm|bronchospasm
829097|NCT00118690|asthma|asthma
829098|NCT00118677|HIV Infections|hiv infections
829099|NCT00118664|Septic Shock|septic shock
829100|NCT00118664|Thrombocytopenia|thrombocytopenia
829101|NCT00118664|Multiple Organ Failure|multiple organ failure
829102|NCT00118664|Pediatric|pediatric
829103|NCT00118651|pneumonia|pneumonia
829104|NCT00118651|chest x-ray|chest x-ray
829105|NCT00118651|diagnosis|diagnosis
829106|NCT00118638|Non-myeloid malignancy|non-myeloid malignancy
829107|NCT00118638|Darbepoetin alfa|darbepoetin alfa
829108|NCT00118638|Clinical Trial|clinical trial
829109|NCT00118625|Allergy|allergy
829110|NCT00118625|Specific Immunotherapy|specific immunotherapy
829111|NCT00118625|Adjuvant|adjuvant
829112|NCT00118625|Allergy Vaccination|allergy vaccination
829113|NCT00118625|Allergenicity|allergenicity
829114|NCT00118612|Allergy|allergy
829115|NCT00118612|Specific Immunotherapy|specific immunotherapy
829116|NCT00118612|Allergy Vaccination|allergy vaccination
829117|NCT00118612|Allergenicity|allergenicity
829118|NCT00118586|Neuroanatomy|neuroanatomy
829119|NCT00118586|Brain Damage|brain damage
829120|NCT00118586|Dystonia|dystonia
829121|NCT00118586|Pathology|pathology
829122|NCT00118586|Brain Imaging|brain imaging
829123|NCT00118586|Spasmodic Dysphonia|spasmodic dysphonia
829124|NCT00118586|SD|sd
829125|NCT00118586|Focal Dystonia|focal dystonia
829126|NCT00118586|Healthy Volunteer|healthy volunteer
829127|NCT00118586|HV|hv
829128|NCT00118573|abdominal aortic aneurysm|abdominal aortic aneurysm
829129|NCT00118573|randomized controlled trial|randomized controlled trial
829130|NCT00118573|endovascular aneurysm repair|endovascular aneurysm repair
829131|NCT00118560|Collateral Circulation|collateral circulation
829132|NCT00118560|Exercise Therapy|exercise therapy
829133|NCT00118560|Microcirculation|microcirculation
829134|NCT00118560|Oxygen|oxygen
829135|NCT00118560|Positron-emission tomography|positron-emission tomography
829136|NCT00118560|Walking|walking
829137|NCT00118547|Adherence|adherence
829138|NCT00118547|Medication|medication
829139|NCT00118547|Multiple Sclerosis|multiple sclerosis
829140|NCT00118534|addictive disorders|addictive disorders
829141|NCT00118534|clinical trial|clinical trial
829142|NCT00118534|cost effectiveness|cost effectiveness
829143|NCT00118534|mental health|mental health
829144|NCT00118534|military or environmental exposure|military or environmental exposure
829145|NCT00118534|multi-site trial|multi-site trial
829146|NCT00118534|nicotine|nicotine
829147|NCT00118534|nicotine replacement|nicotine replacement
829148|NCT00118534|post traumatic stress|post traumatic stress
829149|NCT00118534|post traumatic stress disorder|post traumatic stress disorder
829150|NCT00118534|psychiatric|psychiatric
829151|NCT00118534|psychological|psychological
829152|NCT00118534|PTSD|ptsd
829153|NCT00118534|smoking cessation|smoking cessation
829154|NCT00118534|smoking cessation medications|smoking cessation medications
829155|NCT00118534|substance abuse|substance abuse
829156|NCT00118521|Anterior Knee Pain|anterior knee pain
829157|NCT00118495|female sexual dysfunction|female sexual dysfunction
829158|NCT00118495|FSD|fsd
829159|NCT00118495|arousal|arousal
829160|NCT00118495|orgasm|orgasm
829161|NCT00118495|desire|desire
829162|NCT00118495|Zestra|zestra
829163|NCT00118495|Mixed FSD|mixed fsd
829164|NCT00118495|Hypoactive sexual desire disorder|hypoactive sexual desire disorder
829165|NCT00118495|Sexual arousal disorder|sexual arousal disorder
829166|NCT00118495|Orgasmic disorder|orgasmic disorder
829167|NCT00118482|vasovagal syncope|vasovagal syncope
829168|NCT00118482|randomized clinical trial|randomized clinical trial
829169|NCT00118482|quality of life|quality of life
829170|NCT00118469|Adolescent|adolescent
829171|NCT00118469|CBT|cbt
829172|NCT00118469|Parents|parents
829173|NCT00118456|Advanced cancers|advanced cancers
829174|NCT00118456|EGFR|egfr
829175|NCT00118456|Her2|her2
829176|NCT00118456|VEGFR|vegfr
829177|NCT00118443|Suicide Prevention|suicide prevention
829178|NCT00118443|Depression|depression
829179|NCT00118443|Adolescent|adolescent
829180|NCT00118443|Students|students
829181|NCT00118443|School Teachers|school teachers
829182|NCT00118430|Back Pain|back pain
829183|NCT00118430|Knee Pain|knee pain
829186|NCT00118430|Antidepressant|antidepressant
829187|NCT00118430|Relaxation Techniques|relaxation techniques
829188|NCT00118430|Exercise|exercise
829189|NCT00118417|Selective serotonin reuptake inhibitor|selective serotonin reuptake inhibitor
829190|NCT00118417|Anxiety|anxiety
829191|NCT00118417|Pharmacotherapy|pharmacotherapy
829192|NCT00118417|Cognitive behavioral therapy|cognitive behavioral therapy
829193|NCT00118417|CBT|cbt
829194|NCT00118404|Cognitive therapy|cognitive therapy
829195|NCT00118404|Antidepressants|antidepressants
829196|NCT00118404|Psychotherapy|psychotherapy
829197|NCT00118391|Pathological Gambling|pathological gambling
829198|NCT00118391|CBT|cbt
829199|NCT00118391|CM|cm
829200|NCT00118378|HIV|hiv
829201|NCT00118378|AIDS|aids
829202|NCT00118378|Modafinil|modafinil
829203|NCT00118378|Depression|depression
829204|NCT00118339|oral complications|oral complications
829205|NCT00118339|drug/agent toxicity by tissue/organ|drug/agent toxicity by tissue/organ
829206|NCT00118339|stage I multiple myeloma|stage i multiple myeloma
829207|NCT00118339|stage II multiple myeloma|stage ii multiple myeloma
829208|NCT00118339|stage III multiple myeloma|stage iii multiple myeloma
829209|NCT00118326|de novo myelodysplastic syndromes|de novo myelodysplastic syndromes
829210|NCT00118326|disseminated neuroblastoma|disseminated neuroblastoma
829211|NCT00118326|previously treated myelodysplastic syndromes|previously treated myelodysplastic syndromes
829212|NCT00118326|recurrent neuroblastoma|recurrent neuroblastoma
829213|NCT00118326|secondary myelodysplastic syndromes|secondary myelodysplastic syndromes
829214|NCT00118326|childhood acute myeloid leukemia in remission|childhood acute myeloid leukemia in remission
829215|NCT00118326|childhood acute lymphoblastic leukemia in remission|childhood acute lymphoblastic leukemia in remission
829216|NCT00118326|childhood chronic myelogenous leukemia|childhood chronic myelogenous leukemia
829217|NCT00118326|juvenile myelomonocytic leukemia|juvenile myelomonocytic leukemia
829218|NCT00118326|previously treated childhood rhabdomyosarcoma|previously treated childhood rhabdomyosarcoma
829219|NCT00118326|recurrent Wilms tumor and other childhood kidney tumors|recurrent wilms tumor and other childhood kidney tumors
829220|NCT00118326|recurrent/refractory childhood Hodgkin lymphoma|recurrent/refractory childhood hodgkin lymphoma
829221|NCT00118326|recurrent childhood acute lymphoblastic leukemia|recurrent childhood acute lymphoblastic leukemia
829222|NCT00118326|recurrent childhood acute myeloid leukemia|recurrent childhood acute myeloid leukemia
829223|NCT00118326|recurrent childhood large cell lymphoma|recurrent childhood large cell lymphoma
829224|NCT00118326|recurrent childhood lymphoblastic lymphoma|recurrent childhood lymphoblastic lymphoma
829225|NCT00118326|recurrent childhood rhabdomyosarcoma|recurrent childhood rhabdomyosarcoma
829226|NCT00118326|recurrent childhood small noncleaved cell lymphoma|recurrent childhood small noncleaved cell lymphoma
829227|NCT00118326|untreated childhood acute lymphoblastic leukemia|untreated childhood acute lymphoblastic leukemia
829228|NCT00118326|untreated childhood acute myeloid leukemia and other myeloid malignancies|untreated childhood acute myeloid leukemia and other myeloid malignancies
829229|NCT00118313|stage II melanoma|stage ii melanoma
829230|NCT00118313|stage III melanoma|stage iii melanoma
829231|NCT00118313|stage IV melanoma|stage iv melanoma
829232|NCT00118300|stage III cervical cancer|stage iii cervical cancer
829233|NCT00118300|stage IVA cervical cancer|stage iva cervical cancer
829234|NCT00118300|recurrent cervical cancer|recurrent cervical cancer
829235|NCT00118300|stage III endometrial carcinoma|stage iii endometrial carcinoma
829236|NCT00118300|recurrent endometrial carcinoma|recurrent endometrial carcinoma
829237|NCT00118300|stage III ovarian epithelial cancer|stage iii ovarian epithelial cancer
829238|NCT00118300|recurrent ovarian epithelial cancer|recurrent ovarian epithelial cancer
829239|NCT00118300|stage III ovarian germ cell tumor|stage iii ovarian germ cell tumor
829240|NCT00118300|recurrent ovarian germ cell tumor|recurrent ovarian germ cell tumor
829241|NCT00118300|stage III vaginal cancer|stage iii vaginal cancer
829242|NCT00118300|stage IVA vaginal cancer|stage iva vaginal cancer
829243|NCT00118300|recurrent vaginal cancer|recurrent vaginal cancer
829244|NCT00118300|ovarian sarcoma|ovarian sarcoma
829245|NCT00118300|ovarian stromal cancer|ovarian stromal cancer
829246|NCT00118300|stage IV endometrial carcinoma|stage iv endometrial carcinoma
829247|NCT00118300|stage IB cervical cancer|stage ib cervical cancer
829248|NCT00118300|stage IIA cervical cancer|stage iia cervical cancer
829249|NCT00118300|stage IIB cervical cancer|stage iib cervical cancer
829250|NCT00118300|stage II vaginal cancer|stage ii vaginal cancer
829251|NCT00118300|stage I vaginal cancer|stage i vaginal cancer
829252|NCT00118274|stage II melanoma|stage ii melanoma
829253|NCT00118274|stage III melanoma|stage iii melanoma
829254|NCT00118274|stage IV melanoma|stage iv melanoma
829255|NCT00118261|stage IV rectal cancer|stage iv rectal cancer
829256|NCT00118261|stage IV colon cancer|stage iv colon cancer
829257|NCT00118261|recurrent rectal cancer|recurrent rectal cancer
829258|NCT00118261|recurrent colon cancer|recurrent colon cancer
829259|NCT00118222|adult mixed glioma|adult mixed glioma
829260|NCT00118222|adult anaplastic astrocytoma|adult anaplastic astrocytoma
829261|NCT00118222|recurrent adult brain tumor|recurrent adult brain tumor
829262|NCT00118222|adult giant cell glioblastoma|adult giant cell glioblastoma
829263|NCT00118222|adult gliosarcoma|adult gliosarcoma
829264|NCT00118196|de novo myelodysplastic syndromes|de novo myelodysplastic syndromes
829265|NCT00118196|previously treated myelodysplastic syndromes|previously treated myelodysplastic syndromes
829266|NCT00118196|secondary myelodysplastic syndromes|secondary myelodysplastic syndromes
829267|NCT00118196|chronic myelomonocytic leukemia|chronic myelomonocytic leukemia
829268|NCT00118131|stage IIIB non-small cell lung cancer|stage iiib non-small cell lung cancer
829269|NCT00118131|stage IV non-small cell lung cancer|stage iv non-small cell lung cancer
829270|NCT00118131|recurrent non-small cell lung cancer|recurrent non-small cell lung cancer
829271|NCT00118105|recurrent colon cancer|recurrent colon cancer
829272|NCT00118105|stage IV colon cancer|stage iv colon cancer
829273|NCT00118105|recurrent rectal cancer|recurrent rectal cancer
829274|NCT00118105|stage IV rectal cancer|stage iv rectal cancer
829275|NCT00118105|liver metastases|liver metastases
829276|NCT00118066|prostate cancer|prostate cancer
829277|NCT00118066|high grade prostatic intraepithelial neoplasia|high grade prostatic intraepithelial neoplasia
829278|NCT00118053|inflammatory breast cancer|inflammatory breast cancer
829279|NCT00118053|stage II breast cancer|stage ii breast cancer
829280|NCT00118053|stage IIIA breast cancer|stage iiia breast cancer
829281|NCT00118053|stage IIIB breast cancer|stage iiib breast cancer
829282|NCT00118053|stage IIIC breast cancer|stage iiic breast cancer
829283|NCT00118027|Malaria in pregnancy|malaria in pregnancy
829284|NCT00118027|Anaemia|anaemia
829285|NCT00118027|Low birth weight|low birth weight
829286|NCT00118014|Trichotillomania|trichotillomania
829287|NCT00118014|Habit Reversal Training|habit reversal training
829288|NCT00118014|Sertraline|sertraline
829289|NCT00118014|Zoloft|zoloft
829290|NCT00118001|Psychotherapy|psychotherapy
829291|NCT00118001|Generalized Anxiety Disorder|generalized anxiety disorder
829292|NCT00118001|randomized-controlled trial|randomized-controlled trial
829293|NCT00118001|worry exposure|worry exposure
829294|NCT00118001|applied relaxation|applied relaxation
829295|NCT00117975|contiguous stage II grade 1 follicular lymphoma|contiguous stage ii grade 1 follicular lymphoma
829296|NCT00117975|contiguous stage II grade 2 follicular lymphoma|contiguous stage ii grade 2 follicular lymphoma
829297|NCT00117975|noncontiguous stage II grade 1 follicular lymphoma|noncontiguous stage ii grade 1 follicular lymphoma
829298|NCT00117975|noncontiguous stage II grade 2 follicular lymphoma|noncontiguous stage ii grade 2 follicular lymphoma
829299|NCT00117975|noncontiguous stage II grade 3 follicular lymphoma|noncontiguous stage ii grade 3 follicular lymphoma
829300|NCT00117975|stage III grade 1 follicular lymphoma|stage iii grade 1 follicular lymphoma
829301|NCT00117975|stage III grade 2 follicular lymphoma|stage iii grade 2 follicular lymphoma
829302|NCT00117975|stage III grade 3 follicular lymphoma|stage iii grade 3 follicular lymphoma
829303|NCT00117975|stage IV grade 1 follicular lymphoma|stage iv grade 1 follicular lymphoma
829304|NCT00117975|stage IV grade 2 follicular lymphoma|stage iv grade 2 follicular lymphoma
829305|NCT00117975|stage IV grade 3 follicular lymphoma|stage iv grade 3 follicular lymphoma
829306|NCT00117975|contiguous stage II grade 3 follicular lymphoma|contiguous stage ii grade 3 follicular lymphoma
829307|NCT00117962|stage IIIA non-small cell lung cancer|stage iiia non-small cell lung cancer
829308|NCT00117962|stage IIIB non-small cell lung cancer|stage iiib non-small cell lung cancer
829309|NCT00117962|squamous cell lung cancer|squamous cell lung cancer
829310|NCT00117962|large cell lung cancer|large cell lung cancer
829311|NCT00117962|adenocarcinoma of the lung|adenocarcinoma of the lung
829312|NCT00117962|bronchoalveolar cell lung cancer|bronchoalveolar cell lung cancer
829313|NCT00117949|Prostate Cancer|prostate cancer
829314|NCT00117949|Androgen ablation therapy|androgen ablation therapy
829315|NCT00117936|Angiogenesis|angiogenesis
829316|NCT00117936|No-option heart patients|no-option heart patients
829317|NCT00117936|Blocked coronary artery|blocked coronary artery
829318|NCT00117936|Revascularization|revascularization
829319|NCT00117936|FGF-1|fgf-1
829320|NCT00117936|growth factor|growth factor
829321|NCT00117923|Warts|warts
829322|NCT00117923|Adults|adults
829323|NCT00117923|Common Warts|common warts
829324|NCT00117923|Resiquimod|resiquimod
829325|NCT00117910|Aged, Granulocyte Colony-Stimulating Factor|aged, granulocyte colony-stimulating factor
829326|NCT00117910|Combined Modality Therapy, Neutropenia|combined modality therapy, neutropenia
829327|NCT00117910|pegfilgrastim, Neulasta®|pegfilgrastim, neulasta®
829328|NCT00117910|FEC-100, Antineoplastic Agents|fec-100, antineoplastic agents
829329|NCT00117910|Breast Cancer, Female|breast cancer, female
829330|NCT00117897|non-Hodgkin's lymphoma|non-hodgkin's lymphoma
829331|NCT00117897|R-CHOP-14|r-chop-14
829332|NCT00117897|pegfilgrastim|pegfilgrastim
829333|NCT00117897|neutropenia, clinical trial|neutropenia, clinical trial
829334|NCT00117897|haematopoietic growth factor|haematopoietic growth factor
829335|NCT00117884|Papillomavirus infections;|papillomavirus infections;
829336|NCT00117884|Cervix Dysplasia|cervix dysplasia
829337|NCT00117871|Warts|warts
829338|NCT00117871|Adults|adults
829339|NCT00117871|Common Warts|common warts
829340|NCT00117871|Resiquimod|resiquimod
829341|NCT00117858|Frontal Lobe|frontal lobe
829342|NCT00117858|Language|language
829343|NCT00117858|Behavior|behavior
829344|NCT00117858|Degenerative Diseases|degenerative diseases
829345|NCT00117858|Pick's Disease|pick's disease
829346|NCT00117858|Frontotemporal Dementia|frontotemporal dementia
829348|NCT00117845|Denileukin Diftitox (Ontak)|denileukin diftitox (ontak)
829349|NCT00117845|Recombinant Immunotoxin|recombinant immunotoxin
829350|NCT00117845|Human T-Cell Lymphotropic Virus (HTLV1)|human t-cell lymphotropic virus (htlv1)
829351|NCT00117845|CD25 Positive|cd25 positive
829352|NCT00117845|IL-2R|il-2r
829353|NCT00117845|ATL|atl
829354|NCT00117845|Ontak|ontak
829355|NCT00117845|Adult T-Cell Leukemia|adult t-cell leukemia
829356|NCT00117845|Lymphoproliferative Disorders|lymphoproliferative disorders
829357|NCT00117832|allergic rhinitis|allergic rhinitis
829358|NCT00117819|parkinson|parkinson
829359|NCT00117819|family history|family history
829362|NCT00117806|Depression|depression
829363|NCT00117806|Employment, supported|employment, supported
829364|NCT00117806|Health Service/ut|health service/ut
829365|NCT00117806|Humans|humans
829366|NCT00117806|Outcomes|outcomes
829367|NCT00117806|Quality of life|quality of life
829368|NCT00117806|Veterans/rh (rehabilitation)|veterans/rh (rehabilitation)
829369|NCT00117806|Workplace|workplace
829370|NCT00117806|Spinal Cord Injuries|spinal cord injuries
829371|NCT00117793|Amputee|amputee
829372|NCT00117793|Artificial limbs|artificial limbs
829373|NCT00117793|Gait|gait
829374|NCT00117793|Walking|walking
829375|NCT00117767|Terbinafine, Tinea capitis, pediatric, antifungal|terbinafine, tinea capitis, pediatric, antifungal
829376|NCT00117754|Terbinafine, Tinea capitis, pediatric, antifungal|terbinafine, tinea capitis, pediatric, antifungal
829377|NCT00117741|Opiate Dependence|opiate dependence
829379|NCT00117741|Dialectical Behavior Therapy|dialectical behavior therapy
829380|NCT00117741|Drug Counseling|drug counseling
829381|NCT00117741|Therapy, Cognitive Behavior|therapy, cognitive behavior
829382|NCT00117728|Non-nucleoside reverse transcriptase inhibitor|non-nucleoside reverse transcriptase inhibitor
829383|NCT00117728|Drug Resistance|drug resistance
829384|NCT00117728|HIV Seronegativity|hiv seronegativity
829385|NCT00117728|Treatment Naive|treatment naive
829386|NCT00117715|Developmental regulation of CYPs 1A2, 2D6, 3A4|developmental regulation of cyps 1a2, 2d6, 3a4
829387|NCT00117715|Ontogeny|ontogeny
829388|NCT00117715|pharmacokinetics|pharmacokinetics
829389|NCT00117715|drug biotransformation|drug biotransformation
829390|NCT00117715|enzymatic biotransformation of drugs|enzymatic biotransformation of drugs
829391|NCT00117702|GvHD|gvhd
829392|NCT00117702|Tacrolimus|tacrolimus
829393|NCT00117702|Everolimus|everolimus
829394|NCT00117702|Stem cell transplantation|stem cell transplantation
829395|NCT00117689|Anti-T cell antibodies|anti-t cell antibodies
829396|NCT00117689|Primary Liver Transplantation and Renal Dysfunction|primary liver transplantation and renal dysfunction
829397|NCT00117689|Liver Transplant Rejection|liver transplant rejection
829398|NCT00117689|Induction Therapy with reduction of Calcineurin inhibitors|induction therapy with reduction of calcineurin inhibitors
829399|NCT00117689|Primary Liver Transplantation|primary liver transplantation
829400|NCT00117689|Primary Transplant Rejection|primary transplant rejection
829401|NCT00117689|Transplantation, Liver|transplantation, liver
829402|NCT00117689|Rejection, Transplant|rejection, transplant
829403|NCT00117676|tenofovir|tenofovir
829404|NCT00117676|adefovir|adefovir
829405|NCT00117676|hepatitis B virus|hepatitis b virus
829406|NCT00117676|HBeAg Negative|hbeag negative
829407|NCT00117663|Randomized controlled trial|randomized controlled trial
829408|NCT00117663|Mammography|mammography
829409|NCT00117663|health care setting|health care setting
829410|NCT00117663|hormone replacement therapy|hormone replacement therapy
829411|NCT00117663|breast density|breast density
829412|NCT00117663|mammography performance|mammography performance
829413|NCT00117663|Breast Carcinoma|breast carcinoma
829414|NCT00117650|leg pain|leg pain
829415|NCT00117650|gene transfer|gene transfer
829416|NCT00117650|angiogenesis|angiogenesis
829417|NCT00117650|Phase 2|phase 2
829418|NCT00117650|Genzyme|genzyme
829419|NCT00117650|peripheral arterial disease|peripheral arterial disease
829420|NCT00117637|Renal Cell Cancer|renal cell cancer
829421|NCT00117637|RCC|rcc
829422|NCT00117637|Cancer|cancer
829423|NCT00117624|Non-myeloid malignancy|non-myeloid malignancy
829424|NCT00117624|Darbepoetin alfa|darbepoetin alfa
829425|NCT00117624|Clinical Trial|clinical trial
829426|NCT00117611|chronic sinusitis|chronic sinusitis
829427|NCT00117598|Lymphoma|lymphoma
829428|NCT00117585|Aging|aging
829429|NCT00117585|Blood pressure|blood pressure
829430|NCT00117585|Hypotension|hypotension
829431|NCT00117585|Orthostatic|orthostatic
829432|NCT00117585|Rehabilitation|rehabilitation
829433|NCT00117572|Cancer of the Pharynx (Nasopharynx, Oropharynx, Hypopharynx)|cancer of the pharynx (nasopharynx, oropharynx, hypopharynx)
829434|NCT00117572|Cancer of the Nasal Cavity and Paranasal Sinuses|cancer of the nasal cavity and paranasal sinuses
829435|NCT00117559|Psychotherapy,group|psychotherapy,group
829436|NCT00117559|Rehabilitation|rehabilitation
829437|NCT00117559|Telecommunications|telecommunications
829438|NCT00117546|CAPACITY trial|capacity trial
829439|NCT00117546|preeclampsia|preeclampsia
829440|NCT00117546|plasma volume|plasma volume
829441|NCT00117546|sympathetic activity|sympathetic activity
829442|NCT00117546|hypertension|hypertension
829443|NCT00117546|cardiovascular system|cardiovascular system
829444|NCT00117533|chronic hepatitis B;|chronic hepatitis b;
829445|NCT00117533|chronic hepatitis delta;|chronic hepatitis delta;
829446|NCT00117533|treatment;|treatment;
829447|NCT00117533|pegylated interferon alfa-2b;|pegylated interferon alfa-2b;
829449|NCT00117520|caffeine, endurance, postural stability, elderly|caffeine, endurance, postural stability, elderly
829450|NCT00117507|MDS|mds
829451|NCT00117507|Myelodysplastic Syndrome|myelodysplastic syndrome
829452|NCT00117507|ICL-670|icl-670
829453|NCT00117507|ICL-670 and Myelodysplastic Syndrome|icl-670 and myelodysplastic syndrome
829454|NCT00117494|Hyperlipidemia|hyperlipidemia
829455|NCT00117494|HIV infections|hiv infections
829456|NCT00117494|STATINS, HMG-COA|statins, hmg-coa
829457|NCT00117494|Protease Inhibitor|protease inhibitor
829458|NCT00117494|Treatment Experienced|treatment experienced
829459|NCT00117481|endometriosis|endometriosis
829460|NCT00117481|pelvic pain|pelvic pain
829461|NCT00117481|hormonal treatment|hormonal treatment
829462|NCT00117468|luteal phase replacement|luteal phase replacement
829463|NCT00117468|oocyte donation|oocyte donation
829464|NCT00117468|infertility|infertility
829465|NCT00117468|progesterone|progesterone
829466|NCT00117455|ICE|ice
829467|NCT00117455|BEAM|beam
829468|NCT00117455|PBPC transplant|pbpc transplant
829469|NCT00117442|solid tumour|solid tumour
829470|NCT00117442|unknown primary tumour|unknown primary tumour
829471|NCT00117442|carboplatin|carboplatin
829472|NCT00117442|paclitaxel|paclitaxel
829473|NCT00117429|HIV-1|hiv-1
829474|NCT00117429|therapeutic vaccination|therapeutic vaccination
829475|NCT00117429|cellular immunity|cellular immunity
829476|NCT00117429|humoral immunity|humoral immunity
829477|NCT00117429|HAART|haart
829478|NCT00117429|chronic HIV-1 infection|chronic hiv-1 infection
829479|NCT00117429|Treatment Experienced|treatment experienced
829480|NCT00117429|HIV Therapeutic Vaccine|hiv therapeutic vaccine
829481|NCT00117403|dementia|dementia
829482|NCT00117403|anti-oxidant|anti-oxidant
829483|NCT00117403|biomarkers|biomarkers
829484|NCT00117403|alpha-tocopherol|alpha-tocopherol
829485|NCT00117403|CoQ|coq
829486|NCT00117377|Atopic dermatitis, pimecrolimus, cellular, molecular|atopic dermatitis, pimecrolimus, cellular, molecular
829487|NCT00117364|chronic ulcer|chronic ulcer
829488|NCT00117364|poor healing|poor healing
829489|NCT00117364|The patients with a poorly healed wound, in which skin graft is clinically indicated, are included in this study|the patients with a poorly healed wound, in which skin graft is clinically indicated, are included in this study
829490|NCT00117351|Adenocarcinoma|adenocarcinoma
829491|NCT00117351|Bronchiolo-Alveolar|bronchiolo-alveolar
829492|NCT00117351|Carcinoma, Bronchioloalveolar|carcinoma, bronchioloalveolar
829493|NCT00117351|Carcinoma, Non-Small-Cell Lung|carcinoma, non-small-cell lung
829494|NCT00117351|Carcinoma, Bronchiolo-Alveolar|carcinoma, bronchiolo-alveolar
829495|NCT00117325|Vasomotor Rhinitis|vasomotor rhinitis
829496|NCT00117325|VMR|vmr
829497|NCT00117325|nonallergic rhinitis|nonallergic rhinitis
829498|NCT00117325|GW685698X|gw685698x
829499|NCT00117312|Prostate Cancer|prostate cancer
829500|NCT00117312|Androgen ablation therapy|androgen ablation therapy
829501|NCT00117299|Gastrointestinal stromal tumor|gastrointestinal stromal tumor
829502|NCT00117299|GIST|gist
829503|NCT00117299|Sarcoma|sarcoma
829504|NCT00117299|PTK787|ptk787
829505|NCT00117299|ZK 222584|zk 222584
829506|NCT00117299|Tyrosine kinase inhibitor|tyrosine kinase inhibitor
829507|NCT00117299|Tyrosine kinase|tyrosine kinase
829508|NCT00117299|VEGF|vegf
829509|NCT00117299|Vascular endothelial growth factor|vascular endothelial growth factor
829510|NCT00117299|VEGFR|vegfr
829511|NCT00117299|Vascular endothelial growth factor receptor|vascular endothelial growth factor receptor
829513|NCT00117299|KIT|kit
829514|NCT00117299|c-KIT|c-kit
829515|NCT00117299|Platelet derived growth factor receptor|platelet derived growth factor receptor
829516|NCT00117299|PDGFR|pdgfr
829517|NCT00117286|Prostate Cancer|prostate cancer
829518|NCT00117286|Androgen ablation therapy|androgen ablation therapy
829519|NCT00117260|osteopenia|osteopenia
829520|NCT00117260|bone mineral density|bone mineral density
829521|NCT00117260|amenorrhea|amenorrhea
829522|NCT00117260|adolescents|adolescents
829523|NCT00117247|Heart Failure|heart failure
829524|NCT00117234|chronic heart failure|chronic heart failure
829525|NCT00117234|congestive heart failure|congestive heart failure
829526|NCT00117234|low hemoglobin|low hemoglobin
829527|NCT00117234|anemia|anemia
829528|NCT00117234|CHF|chf
829529|NCT00117234|Symptomatic Congestive Heart Failure (CHF)|symptomatic congestive heart failure (chf)
829530|NCT00117221|Magnetic Resonance Imaging|magnetic resonance imaging
829531|NCT00117221|Functional Imaging|functional imaging
829532|NCT00117221|Cerebral Blood Flow|cerebral blood flow
829533|NCT00117221|BOLD Effect|bold effect
829534|NCT00117221|Sleep|sleep
829535|NCT00117208|cystic fibrosis|cystic fibrosis
829536|NCT00117195|parkinson|parkinson
829537|NCT00117195|diagnosis|diagnosis
829538|NCT00117195|screening|screening
829539|NCT00117169|Pulmonary embolism|pulmonary embolism
829540|NCT00117169|multi-detector helical computed tomography clinical probability|multi-detector helical computed tomography clinical probability
829541|NCT00117169|clinical score|clinical score
829542|NCT00117156|Fludarabine|fludarabine
829543|NCT00117156|Rituximab|rituximab
829544|NCT00117156|Marginal Zone Lymphoma|marginal zone lymphoma
829545|NCT00117156|MALT lymphoma|malt lymphoma
829546|NCT00117143|Immune Thrombocytopenic Purpura|immune thrombocytopenic purpura
829547|NCT00117143|Idiopathic Thrombocytopenic Purpura|idiopathic thrombocytopenic purpura
829548|NCT00117143|ITP|itp
829549|NCT00117143|Thrombocytopenia|thrombocytopenia
829550|NCT00117130|Kidney disease, Renal, CKD (Chronic Kidney Disease)|kidney disease, renal, ckd (chronic kidney disease)
829551|NCT00117130|CRI (Chronic Renal Insufficiency), Pre-dialysis, Amgen|cri (chronic renal insufficiency), pre-dialysis, amgen
829552|NCT00117130|Aranesp®, Darbepoetin alfa, QW dosing|aranesp®, darbepoetin alfa, qw dosing
829553|NCT00117130|Q2W dosing, Q4W dosing|q2w dosing, q4w dosing
829554|NCT00117130|Patient preference, Subject preference|patient preference, subject preference
829555|NCT00117117|Chemotherapy induced anemia|chemotherapy induced anemia
829556|NCT00117117|Amgen|amgen
829557|NCT00117117|Aranesp®|aranesp®
829558|NCT00117117|darbepoetin alfa|darbepoetin alfa
829559|NCT00117104|End Stage Renal Disease (ESRD)|end stage renal disease (esrd)
829560|NCT00117104|Kidney Disease, Dialysis|kidney disease, dialysis
829561|NCT00117104|Aranesp®, rHuEPO|aranesp®, rhuepo
829562|NCT00117104|Anemia, Hemoglobin|anemia, hemoglobin
829563|NCT00117104|Dosing, Amgen|dosing, amgen
829564|NCT00117091|Rheumatoid Arthritis|rheumatoid arthritis
829565|NCT00117091|RA|ra
829566|NCT00117091|Anakinra (Kineret®)|anakinra (kineret®)
829567|NCT00117078|Kidney disease, Renal, CKD (Chronic Kidney Disease)|kidney disease, renal, ckd (chronic kidney disease)
829568|NCT00117078|CRI (Chronic Renal Insufficiency), Pre-dialysis, Amgen|cri (chronic renal insufficiency), pre-dialysis, amgen
829569|NCT00117078|Aranesp®, Darbepoetin alfa, QW dosing|aranesp®, darbepoetin alfa, qw dosing
829570|NCT00117078|Q2W dosing, Q4W dosing|q2w dosing, q4w dosing
829571|NCT00117078|Patient preference, Subject preference|patient preference, subject preference
829572|NCT00117065|Kidney transplant, Renal transplant|kidney transplant, renal transplant
829573|NCT00117065|Aranesp®, Darbepoetin alfa|aranesp®, darbepoetin alfa
829574|NCT00117065|Amgen, Q2W dosing, Q4W dosing|amgen, q2w dosing, q4w dosing
829575|NCT00117052|Clinical trial|clinical trial
829576|NCT00117052|Amgen|amgen
829577|NCT00117052|Secondary HyperParaThyroidism (SHPT)|secondary hyperparathyroidism (shpt)
829578|NCT00117052|Dialysis|dialysis
829579|NCT00117052|End Stage Renal Disease (ESRD)|end stage renal disease (esrd)
829580|NCT00117052|KDOQI|kdoqi
829581|NCT00117052|Cinacalcet|cinacalcet
829582|NCT00117039|anemia|anemia
829583|NCT00117039|fatigue|fatigue
829584|NCT00117039|Aranesp®|aranesp®
829585|NCT00117039|clinical trial|clinical trial
829586|NCT00117026|Diabetes Complications|diabetes complications
829587|NCT00117026|benfotiamine|benfotiamine
829588|NCT00117026|type 1 diabetes|type 1 diabetes
829589|NCT00117026|elevated urinary albumin excretion|elevated urinary albumin excretion
829590|NCT00117026|nerve function|nerve function
829591|NCT00117026|advanced glycation end products|advanced glycation end products
829592|NCT00117013|Phase I|phase i
829593|NCT00117013|Antiangiogenesis|antiangiogenesis
829594|NCT00117013|Targeted Therapy|targeted therapy
829595|NCT00117013|Chronic Schedule|chronic schedule
829596|NCT00117013|VEGF|vegf
829597|NCT00117013|Cancer|cancer
829598|NCT00117013|Metastatic Solid Tumor|metastatic solid tumor
829599|NCT00117000|testosterone|testosterone
829600|NCT00117000|food, formulated|food, formulated
829601|NCT00117000|malnutrition|malnutrition
829602|NCT00117000|undernutrition|undernutrition
829603|NCT00117000|aging|aging
829604|NCT00117000|aged|aged
829605|NCT00117000|aged, 80 and over|aged, 80 and over
829606|NCT00117000|frail elderly|frail elderly
829607|NCT00116987|physiologic pacing|physiologic pacing
829608|NCT00116987|ventricular pacing|ventricular pacing
829609|NCT00116987|hospitalizations|hospitalizations
829610|NCT00116974|Dental scaling|dental scaling
829611|NCT00116948|Osteoarthrosis|osteoarthrosis
829612|NCT00116948|RSA|rsa
829613|NCT00116948|DEXA|dexa
829614|NCT00116948|Hip arthroplasty|hip arthroplasty
829615|NCT00116948|Metal ion|metal ion
829616|NCT00116948|Inflammatory response|inflammatory response
829617|NCT00116948|Gait analysis|gait analysis
829618|NCT00116935|Gastrointestinal stromal tumor|gastrointestinal stromal tumor
829619|NCT00116935|GIST|gist
829620|NCT00116935|Sarcoma|sarcoma
829621|NCT00116935|Imatinib|imatinib
829622|NCT00116935|Adjuvant therapy|adjuvant therapy
829623|NCT00116935|KIT|kit
829624|NCT00116935|PDGFRA|pdgfra
829625|NCT00116935|Receptor tyrosine kinase|receptor tyrosine kinase
829626|NCT00116935|Tyrosine kinase inhibitor|tyrosine kinase inhibitor
829627|NCT00116922|Diabetes|diabetes
829628|NCT00116922|Prevention.|prevention.
829629|NCT00116922|Rosiglitazone|rosiglitazone
829630|NCT00116922|Metformin|metformin
829631|NCT00116922|Lifestyle|lifestyle
829632|NCT00116922|Impaired glucose Tolerance|impaired glucose tolerance
829633|NCT00116883|GW685698X|gw685698x
829634|NCT00116883|perennial allergic rhinitis|perennial allergic rhinitis
829635|NCT00116883|pediatric|pediatric
829636|NCT00116883|intranasal corticosteroid|intranasal corticosteroid
829637|NCT00116883|HPA axis function|hpa axis function
829638|NCT00116870|CAD|cad
829639|NCT00116870|familial hypercholesterolemia|familial hypercholesterolemia
829640|NCT00116844|viral shedding|viral shedding
829641|NCT00116844|Recurrent|recurrent
829642|NCT00116844|herpes|herpes
829643|NCT00116844|genital herpes|genital herpes
829644|NCT00116831|atheroma|atheroma
829645|NCT00116831|IVUS|ivus
829646|NCT00116831|Intravascular ultrasound|intravascular ultrasound
829647|NCT00116831|atherosclerosis|atherosclerosis
829648|NCT00116818|perennial allergic rhinitis|perennial allergic rhinitis
829649|NCT00116818|intranasal corticosteroid|intranasal corticosteroid
829650|NCT00116818|HPA axis function|hpa axis function
829651|NCT00116818|GW685698X|gw685698x
829652|NCT00116805|tenofovir|tenofovir
829653|NCT00116805|adefovir|adefovir
829654|NCT00116805|hepatitis B|hepatitis b
829655|NCT00116805|HBeAg Positive|hbeag positive
829657|NCT00116792|Diabetes Mellitus|diabetes mellitus
829658|NCT00116792|Restenosis|restenosis
829659|NCT00116792|ppar gamma|ppar gamma
829660|NCT00116792|glitazone|glitazone
829661|NCT00116779|Prostate Cancer|prostate cancer
829662|NCT00116779|Androgen ablation therapy|androgen ablation therapy
829663|NCT00116766|mosquitoes|mosquitoes
829664|NCT00116766|malaria|malaria
829665|NCT00116766|vector control|vector control
829666|NCT00116766|plant-based|plant-based
829667|NCT00116753|Prostate Cancer|prostate cancer
829668|NCT00116753|Androgen ablation therapy|androgen ablation therapy
829669|NCT00116740|Serotonin|serotonin
829670|NCT00116740|5-HT2c|5-ht2c
829671|NCT00116740|Satiety|satiety
829672|NCT00116740|Obesity|obesity
829673|NCT00116740|Appetite suppressant|appetite suppressant
829674|NCT00116740|Weight Loss|weight loss
829675|NCT00116740|Overweight|overweight
829676|NCT00116727|Rheumatoid Arthritis|rheumatoid arthritis
829677|NCT00116727|DMARD|dmard
829678|NCT00116714|rheumatoid arthritis|rheumatoid arthritis
829679|NCT00116714|RA|ra
829680|NCT00116714|DMARD|dmard
829681|NCT00116701|Chronic Kidney Disease (CKD)|chronic kidney disease (ckd)
829682|NCT00116701|Haemoglobin (Hb)|haemoglobin (hb)
829683|NCT00116701|Erthropoetin (EPO)|erthropoetin (epo)
829684|NCT00116701|End Stage Renal Disease (ESRD)|end stage renal disease (esrd)
829685|NCT00116701|Recombinant Human Erthropoetic (rHuEPO)|recombinant human erthropoetic (rhuepo)
829686|NCT00116701|Anaemia|anaemia
829687|NCT00116701|Darbepoetin Alfa, Aranesp®|darbepoetin alfa, aranesp®
829688|NCT00116701|Haemodialysis|haemodialysis
829689|NCT00116701|Clinical Trial|clinical trial
829690|NCT00116688|Immune (Idiopathic) Thrombocytopenic Purpura (ITP)|immune (idiopathic) thrombocytopenic purpura (itp)
829691|NCT00116688|Thrombocytopenic|thrombocytopenic
829692|NCT00116675|Common Wart(s)|common wart(s)
829693|NCT00116675|Pediatric|pediatric
829694|NCT00116675|Wart(s)|wart(s)
829695|NCT00116675|Children|children
829696|NCT00116675|3M Pharmaceuticals|3m pharmaceuticals
829697|NCT00116675|Resiquimod|resiquimod
829698|NCT00116662|Wart(s)|wart(s)
829699|NCT00116662|Common Wart(s)|common wart(s)
829700|NCT00116662|Children|children
829701|NCT00116662|Pediatric|pediatric
829702|NCT00116662|3M Pharmaceuticals|3m pharmaceuticals
829703|NCT00116662|Resiquimod|resiquimod
829704|NCT00116649|actinic keratosis lesions large head torso extremities|actinic keratosis lesions large head torso extremities
829705|NCT00116649|actinic keratosis|actinic keratosis
829706|NCT00116636|HIV|hiv
829707|NCT00116636|Treatment Naive|treatment naive
829708|NCT00116610|small cell lung cancer|small cell lung cancer
829709|NCT00116610|resistant|resistant
829710|NCT00116610|refractory|refractory
829711|NCT00116610|platinum|platinum
829712|NCT00116610|chemotherapy|chemotherapy
829713|NCT00116610|second-line|second-line
829714|NCT00116610|relapse|relapse
829715|NCT00116610|sensitive|sensitive
829716|NCT00116597|Active Specific Immunotherapy|active specific immunotherapy
829717|NCT00116597|Intranodal|intranodal
829718|NCT00116597|Cancer|cancer
829719|NCT00116597|Melanoma stages IIb to IV|melanoma stages iib to iv
829720|NCT00116597|Gene Therapy|gene therapy
829721|NCT00116597|Recombinant Vaccinia virus|recombinant vaccinia virus
829722|NCT00116597|HLA-A2|hla-a2
829723|NCT00116597|Mart-1/Melan-A, Gp-100, tyrosinase|mart-1/melan-a, gp-100, tyrosinase
829724|NCT00116597|Clinical Trial|clinical trial
829725|NCT00116597|Phase I/II|phase i/ii
829726|NCT00116584|heliox|heliox
829727|NCT00116584|bronchiolitis|bronchiolitis
829728|NCT00116584|racemic epinephrine|racemic epinephrine
829729|NCT00116571|Benign Prostatic Hyperplasia (BPH)|benign prostatic hyperplasia (bph)
829730|NCT00116571|Photodynamic Therapy (PDT)|photodynamic therapy (pdt)
829731|NCT00116571|Lower Urinary Tract Symptoms (LUTS)|lower urinary tract symptoms (luts)
829732|NCT00116558|amyotrophic lateral sclerosis|amyotrophic lateral sclerosis
829733|NCT00116558|ALS|als
829734|NCT00116558|Lou Gehrig's disease|lou gehrig's disease
829735|NCT00116558|nutrition|nutrition
829736|NCT00116558|NIPPV|nippv
829737|NCT00116558|non-invasive positive pressure ventilation|non-invasive positive pressure ventilation
829738|NCT00116558|percutaneous endoscopic gastrostomy|percutaneous endoscopic gastrostomy
829739|NCT00116558|PEG|peg
829740|NCT00116545|IDDM|iddm
829741|NCT00116545|Insulin|insulin
829742|NCT00116545|cardiovascular disease|cardiovascular disease
829743|NCT00116532|Obsessive Compulsive Disorder|obsessive compulsive disorder
829744|NCT00116532|Escitalopram|escitalopram
829745|NCT00116532|SSRI|ssri
829747|NCT00116506|Metastatic Colorectal Cancer|metastatic colorectal cancer
829748|NCT00116506|Bevacizumab|bevacizumab
829749|NCT00116506|Erlotinib|erlotinib
829750|NCT00116506|FOLFOX|folfox
829751|NCT00116493|severe anemia|severe anemia
829752|NCT00116493|anthelminthic|anthelminthic
829753|NCT00116493|multivitamins|multivitamins
829754|NCT00116493|pregnancy|pregnancy
829755|NCT00116493|children|children
829756|NCT00116493|Pakistan|pakistan
829757|NCT00116480|Postpartum Haemorrhage|postpartum haemorrhage
829758|NCT00116480|Misoprostol|misoprostol
829760|NCT00116467|Acute Myelogenous Leukemia|acute myelogenous leukemia
829761|NCT00116467|GVAX|gvax
829762|NCT00116467|Vaccine|vaccine
829763|NCT00116467|Stem Cell Transplant|stem cell transplant
829764|NCT00116467|Autologous|autologous
829765|NCT00116454|Carcinoma, Hepatocellular|carcinoma, hepatocellular
829766|NCT00116454|Viral Hepatitis, Alcoholic Hepatitis|viral hepatitis, alcoholic hepatitis
829767|NCT00116441|Multiple Myeloma|multiple myeloma
829768|NCT00116441|Cancer|cancer
829769|NCT00116441|PSCT|psct
829770|NCT00116441|Peripheral Stem Cell Transplant|peripheral stem cell transplant
829771|NCT00116441|Chemotherapy|chemotherapy
829772|NCT00116441|GVAX|gvax
829773|NCT00116428|Atrial Fibrillation|atrial fibrillation
829774|NCT00116428|Paroxysmal Atrial Fibrillation|paroxysmal atrial fibrillation
829775|NCT00116415|HIV/AIDS|hiv/aids
829776|NCT00116402|COPD|copd
829777|NCT00116402|Chronic Obstructive|chronic obstructive
829778|NCT00116402|Pulmonary Disease|pulmonary disease
829779|NCT00116402|Inhaled Corticosteroids|inhaled corticosteroids
829780|NCT00116402|Airway Inflammation|airway inflammation
829781|NCT00116402|Bronchoscopy|bronchoscopy
829782|NCT00116389|pancreatic cancer|pancreatic cancer
829783|NCT00116389|cancer of the pancreas|cancer of the pancreas
829784|NCT00116389|adenocarcinoma of the pancreas|adenocarcinoma of the pancreas
829785|NCT00116389|pancreatic neoplasms|pancreatic neoplasms
829786|NCT00116389|Metastatic pancreatic cancer (Stage IV)|metastatic pancreatic cancer (stage iv)
829787|NCT00116389|Stage IV Adenocarcinoma of the Pancreas|stage iv adenocarcinoma of the pancreas
829788|NCT00116376|GBM|gbm
829789|NCT00116376|recurrent/relapse|recurrent/relapse
829790|NCT00116376|EGFR|egfr
829791|NCT00116376|VEGFR|vegfr
829792|NCT00116363|gene therapy|gene therapy
829793|NCT00116363|melanoma|melanoma
829794|NCT00116363|adenovirus|adenovirus
829795|NCT00116363|in-transit melanoma|in-transit melanoma
829796|NCT00116363|metastatic melanoma|metastatic melanoma
829797|NCT00116350|Postpartum hemorrhage|postpartum hemorrhage
829798|NCT00116350|Misoprostol|misoprostol
829799|NCT00116350|Developing countries|developing countries
829800|NCT00116350|Maternal morbidity|maternal morbidity
829801|NCT00116350|Randomized controlled trial|randomized controlled trial
829802|NCT00116337|spinal cord injury|spinal cord injury
829803|NCT00116337|paralysis|paralysis
829804|NCT00116337|cough|cough
829805|NCT00116337|cervical spinal cord injury|cervical spinal cord injury
829806|NCT00116337|thoracic spinal cord injury|thoracic spinal cord injury
829807|NCT00116324|Asthma|asthma
829808|NCT00116324|Leukotriene receptor antagonist|leukotriene receptor antagonist
829809|NCT00116324|Hypertonic saline challenge|hypertonic saline challenge
829810|NCT00116311|Adenosine receptors|adenosine receptors
829811|NCT00116311|asthma|asthma
829812|NCT00116311|sputum|sputum
829813|NCT00116311|peripheral blood|peripheral blood
829814|NCT00116311|healthy|healthy
829815|NCT00116298|Antivirals|antivirals
829816|NCT00116298|HIV|hiv
829817|NCT00116285|allergy|allergy
829818|NCT00116285|skin prick test|skin prick test
829819|NCT00116285|allergoid|allergoid
829820|NCT00116285|allergenicity|allergenicity
829821|NCT00116285|specific immunotherapy|specific immunotherapy
829822|NCT00116272|pregnancy|pregnancy
829823|NCT00116272|Autoimmune Disease|autoimmune disease
829824|NCT00116259|clinical trial|clinical trial
829825|NCT00116259|aripiprazole|aripiprazole
829826|NCT00116259|Bipolar Disorder|bipolar disorder
829827|NCT00116259|Attention-Deficit Hyperactivity Disorder|attention-deficit hyperactivity disorder
829828|NCT00116259|ADHD|adhd
829829|NCT00116246|Labour|labour
829830|NCT00116246|vaginal delivery|vaginal delivery
829831|NCT00116246|primigravida|primigravida
829832|NCT00116246|McRobert's Manoeuvre|mcrobert's manoeuvre
829833|NCT00116246|operative delivery|operative delivery
829834|NCT00116233|post operative adhesions|post operative adhesions
829835|NCT00116220|Prostate Cancer|prostate cancer
829836|NCT00116220|Total Androgen Suppression|total androgen suppression
829837|NCT00116220|endorectal coil MRI|endorectal coil mri
829838|NCT00116220|External Beam Radiation Therapy|external beam radiation therapy
829839|NCT00116220|Prostate Cancer- High Risk, clinically Organ-Confined|prostate cancer- high risk, clinically organ-confined
829840|NCT00116207|Type 1 Diabetes|type 1 diabetes
829841|NCT00116207|Oxidative Stress|oxidative stress
829842|NCT00116207|Diabetic Complications|diabetic complications
829843|NCT00116207|Neuropathy|neuropathy
829844|NCT00116194|exercise|exercise
829845|NCT00116194|activities of daily living|activities of daily living
829846|NCT00116194|ADL|adl
829847|NCT00116194|loss of mobility|loss of mobility
829848|NCT00116194|risk of disability|risk of disability
829849|NCT00116194|physical activity|physical activity
829850|NCT00116194|mobility disability|mobility disability
829851|NCT00116155|Hormone Refractory Metastatic Prostate Cancer|hormone refractory metastatic prostate cancer
829852|NCT00116142|Prostate Cancer|prostate cancer
829853|NCT00116142|Hormone Refractory|hormone refractory
829854|NCT00116142|Metastatic|metastatic
829855|NCT00116142|Localized|localized
829856|NCT00116142|Locally Advanced|locally advanced
829857|NCT00116142|Prostate Cancer - High Risk Localized or Locally Advanced|prostate cancer - high risk localized or locally advanced
829858|NCT00116129|Fibromyalgia|fibromyalgia
829859|NCT00116129|Treatment|treatment
829860|NCT00116129|Growth hormone|growth hormone
829861|NCT00116129|IGF-1|igf-1
829862|NCT00116129|MK-0677|mk-0677
829863|NCT00116129|Oral growth hormone secretagogue|oral growth hormone secretagogue
829864|NCT00116116|HIV/AIDS|hiv/aids
829865|NCT00116103|Treatment Effectiveness|treatment effectiveness
829866|NCT00116103|Treatment Efficacy|treatment efficacy
829867|NCT00116103|Investigational, Therapies|investigational, therapies
829868|NCT00116103|Asthma|asthma
829869|NCT00116103|Antiasthmatics|antiasthmatics
829870|NCT00116103|Antiasthmatic agents|antiasthmatic agents
829871|NCT00116090|Uveitis|uveitis
829872|NCT00116090|Immunosuppression|immunosuppression
829873|NCT00116090|Cancer|cancer
829874|NCT00116090|Infections|infections
829875|NCT00116090|Mortality|mortality
829876|NCT00116090|Ocular Inflammatory Disease|ocular inflammatory disease
829877|NCT00116090|Scleritis|scleritis
829878|NCT00116090|Mucous Membranes Pemphigoid|mucous membranes pemphigoid
829879|NCT00116077|PET|pet
829880|NCT00116077|[C-11] NNC-112|[c-11] nnc-112
829881|NCT00116077|[F-18] Fallypride|[f-18] fallypride
829882|NCT00116077|Dopamine Receptors|dopamine receptors
829883|NCT00116077|Mood Disorders|mood disorders
829884|NCT00116077|DA Receptors|da receptors
829885|NCT00116077|Major Depressive Disorder|major depressive disorder
829886|NCT00116077|Bipolar Disorder|bipolar disorder
829887|NCT00116077|MDD|mdd
829888|NCT00116077|Bipolar Depression|bipolar depression
829889|NCT00116077|Healthy Volunteer|healthy volunteer
829890|NCT00116077|HV|hv
829891|NCT00116064|intranasal|intranasal
829892|NCT00116064|lorazepam|lorazepam
829893|NCT00116064|paediatric|paediatric
829894|NCT00116064|convulsions|convulsions
829895|NCT00116051|RSA|rsa
829896|NCT00116051|DEXA|dexa
829897|NCT00116051|Osteoarthritis|osteoarthritis
829898|NCT00116051|Hip arthroplasty|hip arthroplasty
829899|NCT00116038|RSA|rsa
829900|NCT00116038|Osteoarthritis|osteoarthritis
829901|NCT00116038|Hip arthroplasty|hip arthroplasty
829902|NCT00116038|DEXA|dexa
829903|NCT00116012|acute coronary syndrome|acute coronary syndrome
829904|NCT00116012|rNAPc2|rnapc2
829905|NCT00116012|unstable angina|unstable angina
829906|NCT00116012|Non-STE myocardial infarction|non-ste myocardial infarction
829907|NCT00116012|ST elevation|st elevation
829908|NCT00116012|cardiac enzymes|cardiac enzymes
829909|NCT00116012|acute coronary syndromes|acute coronary syndromes
829910|NCT00116012|factor VIIa|factor viia
829911|NCT00116012|tissue factor|tissue factor
829912|NCT00116012|nematode anticoagulant protein c2|nematode anticoagulant protein c2
829913|NCT00116012|anticoagulants|anticoagulants
829914|NCT00116012|thrombin inhibitors|thrombin inhibitors
829915|NCT00116012|thrombosis|thrombosis
829916|NCT00115999|PAO|pao
829917|NCT00115999|acute peripheral arterial occlusion|acute peripheral arterial occlusion
829918|NCT00115999|thrombolysis|thrombolysis
829919|NCT00115999|blood clot|blood clot
829920|NCT00115999|leg attack|leg attack
829921|NCT00115999|alfimeprase|alfimeprase
829922|NCT00115999|thrombus|thrombus
829923|NCT00115999|embolism|embolism
829924|NCT00115999|thromboembolism|thromboembolism
829925|NCT00115999|claudication|claudication
829926|NCT00115999|thrombolytic|thrombolytic
829927|NCT00115999|thrombosis|thrombosis
829928|NCT00115999|plasminogen activator|plasminogen activator
829929|NCT00115999|arterial flow|arterial flow
829930|NCT00115986|A/H5N1, Influenza, Vaccine, parent protocol|a/h5n1, influenza, vaccine, parent protocol
829931|NCT00115973|Pump|pump
829932|NCT00115973|Diabetes|diabetes
829933|NCT00115960|IL-12|il-12
829934|NCT00115960|IL-15|il-15
829935|NCT00115960|HIV Seronegativity|hiv seronegativity
829936|NCT00115960|HIV Preventive Vaccine|hiv preventive vaccine
829937|NCT00115921|Home-based care|home-based care
829938|NCT00115921|Malaria|malaria
829939|NCT00115921|Africa|africa
829940|NCT00115908|Hepatitis C|hepatitis c
829941|NCT00115895|radioiodine|radioiodine
829942|NCT00115895|serum thyroglobulin|serum thyroglobulin
829943|NCT00115895|whole body radioiodine scanning|whole body radioiodine scanning
829944|NCT00115882|Adolescent|adolescent
829945|NCT00115882|smoking|smoking
829946|NCT00115882|smoking cessation|smoking cessation
829947|NCT00115882|counseling|counseling
829948|NCT00115869|smoking prevention|smoking prevention
829949|NCT00115869|tobacco use prevention|tobacco use prevention
829950|NCT00115869|adolescent tobacco use|adolescent tobacco use
829951|NCT00115869|prevention intervention|prevention intervention
829952|NCT00115856|Arterial Disease|arterial disease
829953|NCT00115843|Atrial fibrillation|atrial fibrillation
829954|NCT00115843|Arrhythmia|arrhythmia
829955|NCT00115843|Tachycardia|tachycardia
829956|NCT00115804|Fibromyalgia|fibromyalgia
829957|NCT00115804|Juvenile|juvenile
829958|NCT00115791|Atrial Flutters|atrial flutters
829959|NCT00115791|Atrial Fibrillations|atrial fibrillations
829960|NCT00115791|RSD1235|rsd1235
829961|NCT00115778|Hypogammaglobulinemia|hypogammaglobulinemia
829962|NCT00115778|Lung Transplantation|lung transplantation
829963|NCT00115765|Panitumumab Advanced Colorectal Cancer Evaluation Study (PACCE Study)|panitumumab advanced colorectal cancer evaluation study (pacce study)
829964|NCT00115765|Colorectal, Colon, Rectal Cancer, Metastatic Colorectal|colorectal, colon, rectal cancer, metastatic colorectal
829965|NCT00115765|Cancer|cancer
829966|NCT00115765|EGFr, Clinical Trial|egfr, clinical trial
829967|NCT00115765|Panitumumab, ABX-EGF|panitumumab, abx-egf
829968|NCT00115765|Immunex, Abgenix, Amgen|immunex, abgenix, amgen
829969|NCT00115765|Metastatic Colorectal Cancer|metastatic colorectal cancer
829970|NCT00115765|Oncology|oncology
829971|NCT00115752|Single Nucleotide Polymorphism|single nucleotide polymorphism
829972|NCT00115752|Analgesic Efficacy|analgesic efficacy
829973|NCT00115752|Oral Surgery Model|oral surgery model
829974|NCT00115752|Cyclooxygenase Inhibitor|cyclooxygenase inhibitor
829975|NCT00115752|Gene Expression Profile|gene expression profile
829976|NCT00115752|Wisdom Teeth|wisdom teeth
829977|NCT00115752|Third Molar Extraction|third molar extraction
829978|NCT00115739|Anaplastic Thyroid Cancer|anaplastic thyroid cancer
829979|NCT00115726|anesthesia|anesthesia
829980|NCT00115726|hypotension|hypotension
829981|NCT00115726|furosemide|furosemide
829982|NCT00115726|blood pressure|blood pressure
829983|NCT00115726|peripheral edema|peripheral edema
829984|NCT00115726|diuretic|diuretic
829985|NCT00115726|surgery|surgery
829986|NCT00115726|congestive heart failure|congestive heart failure
829987|NCT00115713|Aerobic Exercise|aerobic exercise
829988|NCT00115713|Weight Lifting|weight lifting
829989|NCT00115713|Breast Cancer|breast cancer
829990|NCT00115713|Quality of Life|quality of life
829991|NCT00115700|Radiotherapy|radiotherapy
829992|NCT00115700|Chemotherapy|chemotherapy
829993|NCT00115700|Rituximab|rituximab
829994|NCT00115700|Randomised Trial|randomised trial
829995|NCT00115700|Stage I-II low grade follicular lymphoma|stage i-ii low grade follicular lymphoma
829996|NCT00115687|nicotine addiction|nicotine addiction
829997|NCT00115661|Peroxisome Proliferator-Activated Receptors|peroxisome proliferator-activated receptors
829998|NCT00115661|treatment of endometriosis|treatment of endometriosis
829999|NCT00115648|HIV|hiv
830000|NCT00115648|MTCT|mtct
830001|NCT00115648|Infants|infants
830002|NCT00115648|africa|africa
830003|NCT00115648|HIV Seronegativity|hiv seronegativity
830004|NCT00115635|Hormonal refractory, chemotherapy, docetaxel, gemcitabine|hormonal refractory, chemotherapy, docetaxel, gemcitabine
830005|NCT00115622|GW685698X|gw685698x
830006|NCT00115622|once daily|once daily
830007|NCT00115622|mountain cedar|mountain cedar
830008|NCT00115622|allergic rhinitis|allergic rhinitis
830009|NCT00115622|fluticasone furoate|fluticasone furoate
830010|NCT00115609|HIV infections|hiv infections
830011|NCT00115609|tuberculosis|tuberculosis
830012|NCT00115609|tuberculosis agents|tuberculosis agents
830013|NCT00115609|Anti HIV agents|anti hiv agents
830014|NCT00115609|Treatment Naive|treatment naive
830015|NCT00115596|Procedure|procedure
830016|NCT00115596|Training|training
830017|NCT00115596|Simulation|simulation
830018|NCT00115596|Pediatrics|pediatrics
830019|NCT00115596|Curriculum|curriculum
830020|NCT00115596|Evaluation|evaluation
830021|NCT00115570|Diabetes,Insulin-Dependent, pediatric,rapid acting injection|diabetes,insulin-dependent, pediatric,rapid acting injection
830022|NCT00115557|translational research|translational research
830023|NCT00115557|prevention|prevention
830024|NCT00115557|primary care|primary care
830025|NCT00115557|practice-based research network|practice-based research network
830026|NCT00115544|neonatal|neonatal
830027|NCT00115544|jaundice|jaundice
830028|NCT00115544|hyperbilirubinemia|hyperbilirubinemia
830029|NCT00115531|Elderly, influenza, vaccine, parent protocol|elderly, influenza, vaccine, parent protocol
830030|NCT00115505|stage IA breast cancer|stage ia breast cancer
830031|NCT00115505|stage II breast cancer|stage ii breast cancer
830032|NCT00115505|stage IB breast cancer|stage ib breast cancer
830033|NCT00115505|estrogen receptor-negative breast cancer|estrogen receptor-negative breast cancer
830034|NCT00115505|estrogen receptor-positive breast cancer|estrogen receptor-positive breast cancer
830035|NCT00115505|progesterone receptor-negative breast cancer|progesterone receptor-negative breast cancer
830036|NCT00115505|progesterone receptor-positive breast cancer|progesterone receptor-positive breast cancer
830037|NCT00115492|Breathing|breathing
830038|NCT00115492|Exacerbation|exacerbation
830039|NCT00115492|Chronic Obstructive Pulmonary Disease|chronic obstructive pulmonary disease
830040|NCT00115479|critical illness|critical illness
830041|NCT00115479|intensive care|intensive care
830042|NCT00115479|outcome|outcome
830043|NCT00115479|insulin|insulin
830044|NCT00115479|blood glucose|blood glucose
830148|NCT00115141|Adults|adults
830045|NCT00115466|ASCs (adult stem cells derived from adipose tissue)|ascs (adult stem cells derived from adipose tissue)
830046|NCT00115466|Fistula|fistula
830047|NCT00115466|Cell Therapy|cell therapy
830048|NCT00115466|Complex perianal fistula|complex perianal fistula
830049|NCT00115453|glioblastoma|glioblastoma
830050|NCT00115453|boron neutron capture therapy|boron neutron capture therapy
830051|NCT00115453|boronophenylalanine|boronophenylalanine
830052|NCT00115453|brain tumor|brain tumor
830053|NCT00115440|glioblastoma|glioblastoma
830054|NCT00115440|anaplastic astrocytoma|anaplastic astrocytoma
830055|NCT00115440|boron neutron capture therapy|boron neutron capture therapy
830056|NCT00115440|radiation therapy|radiation therapy
830057|NCT00115440|boronophenylalanine|boronophenylalanine
830058|NCT00115427|Bilateral, Idiopathic Parkinson's Disease|bilateral, idiopathic parkinson's disease
830059|NCT00115414|Neulasta®|neulasta®
830060|NCT00115414|Chemotherapy|chemotherapy
830061|NCT00115414|TAC|tac
830062|NCT00115414|Amgen|amgen
830063|NCT00019500|breast cancer|breast cancer
830064|NCT00115401|Walking|walking
830065|NCT00115401|Compensation|compensation
830066|NCT00115401|Leg Weakness|leg weakness
830067|NCT00115401|Orthotics|orthotics
830068|NCT00115401|Joint Impairment|joint impairment
830069|NCT00115401|Healthy Volunteer|healthy volunteer
830070|NCT00115401|HV|hv
830071|NCT00115401|Joint Inmpairment|joint inmpairment
830072|NCT00115388|Pelvic inflammatory disease|pelvic inflammatory disease
830073|NCT00115388|Chlamydia trachomatis|chlamydia trachomatis
830074|NCT00115388|Screening|screening
830075|NCT00115375|THROMBOSIS|thrombosis
830076|NCT00115375|PLATELET AGGREGATION|platelet aggregation
830077|NCT00115375|Pediatrics|pediatrics
830078|NCT00115362|functional dyspepsia;|functional dyspepsia;
830079|NCT00115362|Serotonin Uptake Inhibitors;|serotonin uptake inhibitors;
830080|NCT00115362|Antidepressive Agents.|antidepressive agents.
830081|NCT00115336|Blood Diseases|blood diseases
830082|NCT00115336|Sickle Cell Anemia|sickle cell anemia
830083|NCT00115310|dermal assessment|dermal assessment
830084|NCT00115310|pain measurement|pain measurement
830085|NCT00115310|diary|diary
830086|NCT00115310|PHN|phn
830087|NCT00115310|shingles|shingles
830088|NCT00115310|neuropathy|neuropathy
830089|NCT00115310|analgesics|analgesics
830090|NCT00115310|capsaicin|capsaicin
830091|NCT00115310|postherpetic neuralgia|postherpetic neuralgia
830092|NCT00115284|Asthma|asthma
830093|NCT00115284|Education, Medical, Continuing|education, medical, continuing
830094|NCT00115284|American Board of Internal Medicine|american board of internal medicine
830095|NCT00115284|Recertification|recertification
830096|NCT00115284|Continuous Professional Development|continuous professional development
830097|NCT00115284|Practice improvement|practice improvement
830098|NCT00115271|Micronutrients|micronutrients
830099|NCT00115271|Supplementation|supplementation
830100|NCT00115271|Pregnancy|pregnancy
830101|NCT00115271|Birth weight|birth weight
830102|NCT00115271|Infant mortality|infant mortality
830103|NCT00115258|Nutrition, Parenteral|nutrition, parenteral
830104|NCT00115258|Body Composition|body composition
830105|NCT00115258|Energy Expenditure|energy expenditure
830106|NCT00115232|cardiovascular disease|cardiovascular disease
830107|NCT00115232|metabolic syndrome|metabolic syndrome
830108|NCT00115232|hypercholesterolemia|hypercholesterolemia
830109|NCT00115232|child|child
830110|NCT00115232|family history|family history
830111|NCT00115232|inflammation|inflammation
830112|NCT00115219|Rheumatoid Arthritis, RA|rheumatoid arthritis, ra
830113|NCT00115219|Enbrel® (etanercept)|enbrel® (etanercept)
830114|NCT00115219|Clinical Trials, Amgen|clinical trials, amgen
830115|NCT00115219|Immunex, Methotrexate (MTX)|immunex, methotrexate (mtx)
830116|NCT00115219|Rheumatoid Arthritis (RA)|rheumatoid arthritis (ra)
830117|NCT00115206|Non Small Cell Lung Cancer|non small cell lung cancer
830118|NCT00115206|NSCLC|nsclc
830119|NCT00115206|Fever|fever
830120|NCT00115206|Neutropenia|neutropenia
830121|NCT00115206|Neulasta®|neulasta®
830122|NCT00115206|Quality of Life|quality of life
830123|NCT00115206|Chemotherapy|chemotherapy
830124|NCT00115206|Amgen|amgen
830125|NCT00115193|Oncology|oncology
830126|NCT00115193|NHL|nhl
830127|NCT00115193|Mantle cell|mantle cell
830128|NCT00115193|Diffuse large B-cell|diffuse large b-cell
830129|NCT00115193|Chemotherapy|chemotherapy
830130|NCT00115193|RCHOP|rchop
830131|NCT00115193|Neulasta®|neulasta®
830132|NCT00115193|Neutropenia|neutropenia
830133|NCT00115193|Pegfilgrastim|pegfilgrastim
830134|NCT00115193|Amgen|amgen
830135|NCT00115180|analgesia|analgesia
830136|NCT00115180|adult|adult
830137|NCT00115180|opioid|opioid
830138|NCT00115180|Long Bone Fractures|long bone fractures
830139|NCT00115167|Oncology|oncology
830140|NCT00115167|Cancer-related anemia|cancer-related anemia
830141|NCT00115154|Actinic Keratosis|actinic keratosis
830142|NCT00115154|AK|ak
830143|NCT00115154|3M Pharmaceuticals|3m pharmaceuticals
830144|NCT00115154|Aldara|aldara
830145|NCT00115154|Imiquimod|imiquimod
830146|NCT00115154|Actinic Keratosis (AK)|actinic keratosis (ak)
830147|NCT00115141|Wart(s)|wart(s)
830149|NCT00115141|Common Wart(s)|common wart(s)
830150|NCT00115128|normal PBPC donors|normal pbpc donors
830151|NCT00115115|Donor dopamine|donor dopamine
830152|NCT00115115|Immediate graft function|immediate graft function
830349|NCT00114543|Bilirubin|bilirubin
830153|NCT00115115|Kidney transplantation|kidney transplantation
830154|NCT00115102|Atypical odontalgia|atypical odontalgia
830155|NCT00115102|capsaicin|capsaicin
830156|NCT00115102|pain|pain
830157|NCT00115102|neuropathic pain|neuropathic pain
830158|NCT00115089|Allergic Rhinitis|allergic rhinitis
830159|NCT00115089|Nasal Spray|nasal spray
830160|NCT00115089|Seasonal Allergic Rhinitis|seasonal allergic rhinitis
830161|NCT00115076|skin|skin
830162|NCT00115076|psoriasis|psoriasis
830163|NCT00115063|obesity|obesity
830164|NCT00115063|Low Calorie Diet|low calorie diet
830165|NCT00115063|Obesity Pharmacotherapy|obesity pharmacotherapy
830166|NCT00115063|Pragmatic Clinical Trial|pragmatic clinical trial
830167|NCT00115050|HIV infections|hiv infections
830168|NCT00115050|Antiretroviral|antiretroviral
830169|NCT00115050|TMC114|tmc114
830170|NCT00115050|Ritonavir|ritonavir
830171|NCT00115050|Safety, TMC114-C209|safety, tmc114-c209
830172|NCT00115037|Alcoholism|alcoholism
830173|NCT00115037|alcohol abuse|alcohol abuse
830174|NCT00115037|therapy|therapy
830175|NCT00115037|drug resistance|drug resistance
830176|NCT00115037|naltrexone|naltrexone
830177|NCT00115037|patient care management|patient care management
830178|NCT00115037|human subject|human subject
830179|NCT00115024|cardiovascular disease|cardiovascular disease
830181|NCT00115024|estrogen|estrogen
830182|NCT00115024|cholesterol|cholesterol
830183|NCT00115024|LDL|ldl
830184|NCT00115024|lipids|lipids
830185|NCT00115024|postmenopausal|postmenopausal
830186|NCT00115011|Skin Picking|skin picking
830187|NCT00115011|Escitalopram|escitalopram
830188|NCT00115011|Lexapro|lexapro
830189|NCT00115011|Body Focused Repetitive Behaviors|body focused repetitive behaviors
830190|NCT00115011|Obsessive Compulsive Spectrum Disorders|obsessive compulsive spectrum disorders
830191|NCT00114985|Total Androgen Suppression|total androgen suppression
830192|NCT00114985|Simulation|simulation
830193|NCT00114985|3-D Conformal External Beam Radiation Therapy|3-d conformal external beam radiation therapy
830194|NCT00114985|Intra-rectal immobilization device|intra-rectal immobilization device
830195|NCT00114985|Quality of Life Assessment Questionnaire|quality of life assessment questionnaire
830196|NCT00114985|Rectal Bleeding|rectal bleeding
830197|NCT00114985|Late effects|late effects
830198|NCT00114972|Three-vessel coronary artery disease|three-vessel coronary artery disease
830199|NCT00114972|Left main coronary artery disease|left main coronary artery disease
830200|NCT00114959|ChemGenex Pharmaceuticals, Ltd|chemgenex pharmaceuticals, ltd
830201|NCT00114959|ChemGenex Pharmaceuticals|chemgenex pharmaceuticals
830202|NCT00114959|ChemGenex|chemgenex
830203|NCT00114959|Chronic Myeloid Leukemia|chronic myeloid leukemia
830204|NCT00114959|Myeloid Leukemia, Chronic|myeloid leukemia, chronic
830205|NCT00114959|Leukemia|leukemia
830206|NCT00114959|Myeloid Leukemia|myeloid leukemia
830207|NCT00114959|Chronic Phase|chronic phase
830208|NCT00114959|Accelerated Phase|accelerated phase
830209|NCT00114959|Blast Phase|blast phase
830210|NCT00114959|Myeloid, Leukemia, Chronic, Accelerated Phase|myeloid, leukemia, chronic, accelerated phase
830211|NCT00114959|Myeloid, Leukemia, Chronic|myeloid, leukemia, chronic
830212|NCT00114959|Leukemia, Myeloid, Chronic|leukemia, myeloid, chronic
830213|NCT00114959|Leukemia, Myeloid, Chronic-Phase|leukemia, myeloid, chronic-phase
830214|NCT00114959|Leukemia, Myeloid, Chronic Phase|leukemia, myeloid, chronic phase
830215|NCT00114959|Leukemia, Myeloid, Accelerated-Phase|leukemia, myeloid, accelerated-phase
830216|NCT00114959|Myeloid, Leukemia, Chronic, Chronic Phase|myeloid, leukemia, chronic, chronic phase
830217|NCT00114959|Leukemia, Myeloid, Accelerated Phase|leukemia, myeloid, accelerated phase
830218|NCT00114959|Homoharringtonine|homoharringtonine
830219|NCT00114959|Omacetaxine|omacetaxine
830220|NCT00114946|Metastatic Colorectal Cancer OASIS|metastatic colorectal cancer oasis
830221|NCT00114933|HIV|hiv
830222|NCT00114933|AIDS|aids
830223|NCT00114933|Treatment Experienced|treatment experienced
830224|NCT00114920|Wart(s)|wart(s)
830225|NCT00114920|Adults|adults
830226|NCT00114920|Common Wart(s)|common wart(s)
830227|NCT00114907|Tea|tea
830228|NCT00114907|Oxidative stress markers|oxidative stress markers
830229|NCT00114907|cardiovascular disease|cardiovascular disease
830230|NCT00114907|polyphenolics|polyphenolics
830231|NCT00114907|double blind|double blind
830232|NCT00114907|Ischaemic cardiac disease|ischaemic cardiac disease
830233|NCT00114894|Jellyfish|jellyfish
830234|NCT00114894|Stings|stings
830235|NCT00114894|Marine|marine
830236|NCT00114894|Envenomation|envenomation
830237|NCT00114894|Jellyfish stings|jellyfish stings
830238|NCT00114881|Children|children
830239|NCT00114881|Urban Health|urban health
830240|NCT00114881|Pregnancy|pregnancy
830241|NCT00114881|Asthma|asthma
830242|NCT00114868|vitamin A|vitamin a
830243|NCT00114868|mortality|mortality
830244|NCT00114868|newborn|newborn
830245|NCT00114868|liveborn infants|liveborn infants
830246|NCT00114855|Hypocol|hypocol
830247|NCT00114855|Red yeast rice|red yeast rice
830248|NCT00114855|Patients with mild Type IIa, Type IIb or IV hyperlipidaemia (LDL-cholesterol >3.0 mmol/L< 6.0 mmol/L.|patients with mild type iia, type iib or iv hyperlipidaemia (ldl-cholesterol >3.0 mmol/l< 6.0 mmol/l.
830249|NCT00114855|Mildly elevated blood glucose|mildly elevated blood glucose
830250|NCT00114842|colorectal polyps|colorectal polyps
830251|NCT00114842|colorectal cancer|colorectal cancer
830252|NCT00114842|Virtual colonoscopy|virtual colonoscopy
830253|NCT00114842|Fecal tagging|fecal tagging
830254|NCT00114842|MR colonography|mr colonography
830255|NCT00114829|Colorectal cancer|colorectal cancer
830256|NCT00114829|Colorectal tumor|colorectal tumor
830257|NCT00114829|Dynamic contrast uptake|dynamic contrast uptake
830258|NCT00114829|MR colonography|mr colonography
830259|NCT00114816|breast cancer|breast cancer
830260|NCT00114816|chemotherapy|chemotherapy
830261|NCT00114816|adjuvant|adjuvant
830262|NCT00114816|capecitabine|capecitabine
830263|NCT00114816|docetaxel|docetaxel
830264|NCT00114803|bone mineral density|bone mineral density
830265|NCT00114803|osteoporosis|osteoporosis
830266|NCT00114803|osteopenia|osteopenia
830267|NCT00114803|children|children
830268|NCT00114803|adolescents|adolescents
830270|NCT00114790|head and neck cancer|head and neck cancer
830271|NCT00114790|boron neutron capture therapy|boron neutron capture therapy
830272|NCT00114790|radiation therapy|radiation therapy
830273|NCT00114790|boronophenylalanine|boronophenylalanine
830274|NCT00114764|Acute myeloid leukaemia|acute myeloid leukaemia
830275|NCT00114764|Pegfilgrastim|pegfilgrastim
830276|NCT00114764|Neulasta®|neulasta®
830277|NCT00114764|Neutropenia|neutropenia
830278|NCT00114764|Induction chemotherapy|induction chemotherapy
830279|NCT00114764|Consolidation|consolidation
830280|NCT00114738|Proteasome Inhibition|proteasome inhibition
830281|NCT00114738|NF-Kappa-B|nf-kappa-b
830282|NCT00114738|Gene Expression Signature|gene expression signature
830283|NCT00114738|Cyclin D1|cyclin d1
830284|NCT00114738|Translational Studies|translational studies
830285|NCT00114738|Lymphoma|lymphoma
830286|NCT00114738|Mantle Cell Lymphoma|mantle cell lymphoma
830287|NCT00114738|MCL|mcl
830288|NCT00114725|In Vitro Fertilization|in vitro fertilization
830289|NCT00114725|Intracytoplasmic Sperm Injection|intracytoplasmic sperm injection
830290|NCT00114725|Oocytes|oocytes
830291|NCT00114725|Zona Pellucida|zona pellucida
830292|NCT00114725|Oolemma|oolemma
830293|NCT00114725|Fertilization|fertilization
830294|NCT00114725|Preimplantation Embryo Development|preimplantation embryo development
830295|NCT00114712|Birth Defects|birth defects
830296|NCT00114712|Pregnancy|pregnancy
830297|NCT00114712|Ribavirin|ribavirin
830298|NCT00114712|Hepatitis C|hepatitis c
830299|NCT00114699|HIV|hiv
830300|NCT00114699|Treatment Naive|treatment naive
830301|NCT00114686|Bipolar I Disorder|bipolar i disorder
830302|NCT00114686|Alcohol Dependency|alcohol dependency
830303|NCT00114673|Uneven skin color|uneven skin color
830304|NCT00114673|Wrinkles|wrinkles
830305|NCT00114673|Wrinkles and uneven skin color in the area around the eyes|wrinkles and uneven skin color in the area around the eyes
830306|NCT00114660|striae gravidarum|striae gravidarum
830307|NCT00114660|stretch marks|stretch marks
830308|NCT00114660|cocoa butter|cocoa butter
830309|NCT00114660|prevention|prevention
830310|NCT00114647|Blood Collection|blood collection
830311|NCT00114647|Apheresis|apheresis
830312|NCT00114634|SLOS|slos
830313|NCT00114634|RSH syndrome|rsh syndrome
830314|NCT00114634|ABC Checklist|abc checklist
830315|NCT00114634|Cholesterol supplementation|cholesterol supplementation
830316|NCT00114634|Egg yolk|egg yolk
830317|NCT00114634|Smith-Lemli-Opitz Syndrome|smith-lemli-opitz syndrome
830318|NCT00114621|PA|pa
830319|NCT00114621|Phase I|phase i
830320|NCT00114621|Phase 2|phase 2
830321|NCT00114621|Safety|safety
830322|NCT00114621|Immunogenicity|immunogenicity
830323|NCT00114608|Electrical foot stimulation|electrical foot stimulation
830324|NCT00114608|Intermittent pneumatic compression|intermittent pneumatic compression
830325|NCT00114608|Venous thromboembolism|venous thromboembolism
830326|NCT00114608|Immobilization|immobilization
830327|NCT00114608|Total hip replacement|total hip replacement
830328|NCT00114608|Prolonged travel|prolonged travel
830329|NCT00114608|Venous thromboembolic disease (VTE)|venous thromboembolic disease (vte)
830330|NCT00114608|Deep vein thrombosis (DVT)|deep vein thrombosis (dvt)
830331|NCT00114608|Pulmonary embolism (PE)|pulmonary embolism (pe)
830332|NCT00114595|eicosapentaenoic acid|eicosapentaenoic acid
830333|NCT00114595|tardive dyskinesia|tardive dyskinesia
830334|NCT00114595|omega-3|omega-3
830335|NCT00114595|schizophrenia|schizophrenia
830336|NCT00114582|family style dinner|family style dinner
830337|NCT00114582|quality of life|quality of life
830338|NCT00114582|nutritional status|nutritional status
830339|NCT00114582|nursing home residents|nursing home residents
830340|NCT00114569|children|children
830341|NCT00114569|status epilepticus|status epilepticus
830342|NCT00114569|lorazepam|lorazepam
830343|NCT00114569|safety|safety
830344|NCT00114569|pharmacokinetics|pharmacokinetics
830345|NCT00114569|status epilepticus in children|status epilepticus in children
830346|NCT00114556|osteoporosis|osteoporosis
830347|NCT00114556|liver transplantation|liver transplantation
830348|NCT00114543|NICHD Neonatal Research Network|nichd neonatal research network
830350|NCT00114543|Phototherapy|phototherapy
830351|NCT00114543|Very Low Birth Weight (VLBW)|very low birth weight (vlbw)
830352|NCT00114543|Extremely Low Birth Weight (ELBW)|extremely low birth weight (elbw)
830353|NCT00114543|Prematurity|prematurity
830354|NCT00114543|Neurodevelopmental outcome|neurodevelopmental outcome
830355|NCT00114530|systemic sclerosis|systemic sclerosis
830356|NCT00114530|hematopoietic stem cell transplant|hematopoietic stem cell transplant
830357|NCT00114530|clinical trial|clinical trial
830358|NCT00114530|global rank composite score|global rank composite score
830359|NCT00114517|atherosclerosis|atherosclerosis
830360|NCT00114517|CAD|cad
830361|NCT00114517|cardiac computed tomography|cardiac computed tomography
830362|NCT00114517|cardiovascular disease|cardiovascular disease
830363|NCT00114517|carotid artery intima-media thickness|carotid artery intima-media thickness
830364|NCT00114517|cognitive function|cognitive function
830365|NCT00114517|computed tomography|computed tomography
830366|NCT00114517|coronary artery calcium|coronary artery calcium
830367|NCT00114517|coronary artery disease|coronary artery disease
830368|NCT00114517|coronary artery lesions|coronary artery lesions
830369|NCT00114517|CVD|cvd
830370|NCT00114517|estrogen|estrogen
830371|NCT00114517|estrogen therapy|estrogen therapy
830372|NCT00114517|hormone therapy|hormone therapy
830373|NCT00114517|postmenopausal|postmenopausal
830374|NCT00114517|subclinical vascular disease|subclinical vascular disease
830375|NCT00114517|timing hypothesis|timing hypothesis
830376|NCT00114517|ultrasonography|ultrasonography
830377|NCT00114504|atherosclerosis|atherosclerosis
830378|NCT00114504|inflammation|inflammation
830379|NCT00114504|statins|statins
830381|NCT00114504|carotid ultrasonography|carotid ultrasonography
830382|NCT00114491|Aortic Stenosis|aortic stenosis
830383|NCT00114491|Statins|statins
830384|NCT00114491|Hypercholesterolemia|hypercholesterolemia
830385|NCT00114478|Bronchiolitis|bronchiolitis
830386|NCT00114478|disposition|disposition
830387|NCT00114478|pediatric|pediatric
830388|NCT00114478|epinephrine|epinephrine
830389|NCT00114478|albuterol|albuterol
830390|NCT00114465|Randomized|randomized
830391|NCT00114465|Double-Blind|double-blind
830392|NCT00114465|Probiotic|probiotic
830393|NCT00114465|Remission|remission
830394|NCT00114465|Crohn's Disease|crohn's disease
830395|NCT00114452|Acute Myocardial Infarction|acute myocardial infarction
830396|NCT00114452|Heart Attack|heart attack
830397|NCT00114452|Cardiovascular Disease|cardiovascular disease
830398|NCT00114452|Stem cells|stem cells
830399|NCT00114452|Congestive Heart Failure|congestive heart failure
830400|NCT00114452|Heart Attack Repair|heart attack repair
830401|NCT00114439|cannabis withdrawal|cannabis withdrawal
830402|NCT00114439|lithium|lithium
830403|NCT00114439|Cannabis withdrawal syndrome|cannabis withdrawal syndrome
830404|NCT00114426|randomized controlled trial; COPD|randomized controlled trial; copd
830405|NCT00114413|Exhaled Nitric Oxide|exhaled nitric oxide
830406|NCT00114413|Lung|lung
830407|NCT00114413|Urban Health|urban health
830408|NCT00114413|Child|child
830409|NCT00114413|Adolescent|adolescent
830410|NCT00114400|cardiovascular disease|cardiovascular disease
830411|NCT00114400|CVD|cvd
830412|NCT00114387|vitamin E|vitamin e
830413|NCT00114374|Acute Stress Disorder|acute stress disorder
830414|NCT00114374|Posttraumatic Stress Disorder|posttraumatic stress disorder
830415|NCT00114374|Escitalopram|escitalopram
830416|NCT00114374|Double-Blind|double-blind
830417|NCT00114361|HBeAg-negative|hbeag-negative
830418|NCT00114361|chronic|chronic
830419|NCT00114361|hepatitis B|hepatitis b
830420|NCT00114361|viral|viral
830421|NCT00114348|non-B ALL|non-b all
830422|NCT00114348|relapse|relapse
830423|NCT00114348|treatment|treatment
830424|NCT00114348|Relapsed non-B ALL or non-B non-Hodgkin lymphoma|relapsed non-b all or non-b non-hodgkin lymphoma
830425|NCT00114335|low molecular weight heparin|low molecular weight heparin
830426|NCT00114335|unfractionated heparin|unfractionated heparin
830427|NCT00114309|High grade recurrent glioma|high grade recurrent glioma
830428|NCT00114309|Phase II|phase ii
830429|NCT00114309|Multi-Center|multi-center
830430|NCT00114309|Open label|open label
830431|NCT00114309|Multiple dose|multiple dose
830432|NCT00114309|Brain Cancer|brain cancer
830433|NCT00114309|Brain Tumor|brain tumor
830434|NCT00114309|GBM|gbm
830435|NCT00114309|glioma|glioma
830436|NCT00114296|breast cancer|breast cancer
830437|NCT00114270|breast cancer|breast cancer
830438|NCT00114270|osteoporosis|osteoporosis
830439|NCT00114257|recurrent adult acute lymphoblastic leukemia|recurrent adult acute lymphoblastic leukemia
830440|NCT00114257|adult acute myeloid leukemia with 11q23 (MLL) abnormalities|adult acute myeloid leukemia with 11q23 (mll) abnormalities
830441|NCT00114257|adult acute myeloid leukemia with inv(16)(p13;q22)|adult acute myeloid leukemia with inv(16)(p13;q22)
830442|NCT00114257|adult acute myeloid leukemia with t(15;17)(q22;q12)|adult acute myeloid leukemia with t(15;17)(q22;q12)
830443|NCT00114257|adult acute myeloid leukemia with t(16;16)(p13;q22)|adult acute myeloid leukemia with t(16;16)(p13;q22)
830444|NCT00114257|adult acute myeloid leukemia with t(8;21)(q22;q22)|adult acute myeloid leukemia with t(8;21)(q22;q22)
830445|NCT00114257|recurrent adult acute myeloid leukemia|recurrent adult acute myeloid leukemia
831446|NCT00110786|Ragweed|ragweed
830446|NCT00114257|secondary acute myeloid leukemia|secondary acute myeloid leukemia
830447|NCT00114257|untreated adult acute myeloid leukemia|untreated adult acute myeloid leukemia
830448|NCT00114257|adult acute promyelocytic leukemia (M3)|adult acute promyelocytic leukemia (m3)
830449|NCT00114257|relapsing chronic myelogenous leukemia|relapsing chronic myelogenous leukemia
830450|NCT00114257|refractory chronic lymphocytic leukemia|refractory chronic lymphocytic leukemia
830451|NCT00114257|de novo myelodysplastic syndromes|de novo myelodysplastic syndromes
830452|NCT00114257|myelodysplastic/myeloproliferative neoplasm, unclassifiable|myelodysplastic/myeloproliferative neoplasm, unclassifiable
830453|NCT00114257|previously treated myelodysplastic syndromes|previously treated myelodysplastic syndromes
830454|NCT00114257|secondary myelodysplastic syndromes|secondary myelodysplastic syndromes
830455|NCT00114257|atypical chronic myeloid leukemia, BCR-ABL1 negative|atypical chronic myeloid leukemia, bcr-abl1 negative
830456|NCT00114257|chronic myelomonocytic leukemia|chronic myelomonocytic leukemia
830457|NCT00114257|chronic eosinophilic leukemia|chronic eosinophilic leukemia
830458|NCT00114257|primary myelofibrosis|primary myelofibrosis
830459|NCT00114257|chronic neutrophilic leukemia|chronic neutrophilic leukemia
830460|NCT00114257|essential thrombocythemia|essential thrombocythemia
830461|NCT00114257|polycythemia vera|polycythemia vera
830462|NCT00114257|Philadelphia chromosome negative chronic myelogenous leukemia|philadelphia chromosome negative chronic myelogenous leukemia
830463|NCT00114257|chronic myelogenous leukemia, BCR-ABL1 positive|chronic myelogenous leukemia, bcr-abl1 positive
830464|NCT00114257|adult acute minimally differentiated myeloid leukemia (M0)|adult acute minimally differentiated myeloid leukemia (m0)
830465|NCT00114257|adult acute myeloblastic leukemia without maturation (M1)|adult acute myeloblastic leukemia without maturation (m1)
830466|NCT00114257|adult acute myeloblastic leukemia with maturation (M2)|adult acute myeloblastic leukemia with maturation (m2)
830467|NCT00114257|adult acute myelomonocytic leukemia (M4)|adult acute myelomonocytic leukemia (m4)
830468|NCT00114257|adult acute monoblastic leukemia (M5a)|adult acute monoblastic leukemia (m5a)
830469|NCT00114257|adult acute monocytic leukemia (M5b)|adult acute monocytic leukemia (m5b)
830470|NCT00114257|adult erythroleukemia (M6a)|adult erythroleukemia (m6a)
830471|NCT00114257|adult pure erythroid leukemia (M6b)|adult pure erythroid leukemia (m6b)
830472|NCT00114257|adult acute megakaryoblastic leukemia (M7)|adult acute megakaryoblastic leukemia (m7)
830473|NCT00114257|adult acute basophilic leukemia|adult acute basophilic leukemia
830474|NCT00114257|adult acute eosinophilic leukemia|adult acute eosinophilic leukemia
830475|NCT00114231|adenocarcinoma of the rectum|adenocarcinoma of the rectum
830476|NCT00114231|stage I rectal cancer|stage i rectal cancer
830477|NCT00114205|malignant pleural effusion|malignant pleural effusion
830478|NCT00114192|recurrent non-small cell lung cancer|recurrent non-small cell lung cancer
830479|NCT00114192|stage IIIA non-small cell lung cancer|stage iiia non-small cell lung cancer
830480|NCT00114192|stage IIIB non-small cell lung cancer|stage iiib non-small cell lung cancer
830481|NCT00114192|stage IV non-small cell lung cancer|stage iv non-small cell lung cancer
830482|NCT00114166|recurrent ovarian epithelial cancer|recurrent ovarian epithelial cancer
830483|NCT00114166|fallopian tube cancer|fallopian tube cancer
830484|NCT00114166|primary peritoneal cavity cancer|primary peritoneal cavity cancer
830485|NCT00114153|stage III squamous cell carcinoma of the hypopharynx|stage iii squamous cell carcinoma of the hypopharynx
830486|NCT00114153|stage III squamous cell carcinoma of the lip and oral cavity|stage iii squamous cell carcinoma of the lip and oral cavity
830487|NCT00114153|stage III squamous cell carcinoma of the oropharynx|stage iii squamous cell carcinoma of the oropharynx
830488|NCT00114153|stage IV squamous cell carcinoma of the hypopharynx|stage iv squamous cell carcinoma of the hypopharynx
830489|NCT00114153|stage IV squamous cell carcinoma of the lip and oral cavity|stage iv squamous cell carcinoma of the lip and oral cavity
830490|NCT00114153|stage IV squamous cell carcinoma of the oropharynx|stage iv squamous cell carcinoma of the oropharynx
830491|NCT00114140|adult diffuse astrocytoma|adult diffuse astrocytoma
830492|NCT00114140|adult oligodendroglioma|adult oligodendroglioma
830493|NCT00114140|adult mixed glioma|adult mixed glioma
830494|NCT00114127|social anxiety disorder|social anxiety disorder
830495|NCT00114127|social phobia|social phobia
830496|NCT00114127|duloxetine|duloxetine
830497|NCT00114127|serotonin norepinephrine reuptake inhibitor|serotonin norepinephrine reuptake inhibitor
830498|NCT00114127|SNRI|snri
830499|NCT00114127|double blind|double blind
830500|NCT00114114|Testosterone|testosterone
830501|NCT00114114|Bone turnover|bone turnover
830502|NCT00114114|Aging|aging
830503|NCT00114114|Body composition|body composition
830504|NCT00114114|Hypogonadism|hypogonadism
830505|NCT00114114|Sexual function|sexual function
830506|NCT00114088|Hysterectomy,|hysterectomy,
830507|NCT00114088|Endometrial ablation,|endometrial ablation,
830508|NCT00114088|Ovulatory dysfunctional uterine bleeding,|ovulatory dysfunctional uterine bleeding,
830509|NCT00114088|Anovulatory dysfucntional uterine bleeding,|anovulatory dysfucntional uterine bleeding,
830510|NCT00114088|DUB|dub
830511|NCT00114088|Dysfunctional uterine bleeding|dysfunctional uterine bleeding
830512|NCT00114075|gait|gait
830513|NCT00114075|walking|walking
830514|NCT00114075|orthopedic surgery|orthopedic surgery
830515|NCT00114075|orthopaedic surgery|orthopaedic surgery
830517|NCT00114062|macular edema|macular edema
830518|NCT00114062|uveitis associated macular edema|uveitis associated macular edema
830519|NCT00114049|Dental Pain|dental pain
830520|NCT00114049|Dental Surgery|dental surgery
830521|NCT00114049|Cox-2 inhibitor|cox-2 inhibitor
830522|NCT00114036|Antibiotic prophylaxis|antibiotic prophylaxis
830523|NCT00114036|Surgical wound infections|surgical wound infections
830524|NCT00114023|AK|ak
830525|NCT00114023|Imiquimod 5% cream|imiquimod 5% cream
830526|NCT00114023|3M Pharmaceuticals|3m pharmaceuticals
830527|NCT00114023|Aldara|aldara
830528|NCT00114023|Actinic Keratosis|actinic keratosis
830529|NCT00114010|B Cells|b cells
830530|NCT00114010|T Cells|t cells
830531|NCT00114010|Erythrocyte Stage|erythrocyte stage
830532|NCT00114010|Antibody|antibody
830533|NCT00114010|Immunogenicity|immunogenicity
830534|NCT00114010|Healthy Volunteer|healthy volunteer
830535|NCT00113997|Anticoagulant|anticoagulant
830536|NCT00113997|Antidote|antidote
830537|NCT00113997|Pharmacokinetics|pharmacokinetics
830538|NCT00113997|Pharmacodynamics|pharmacodynamics
830539|NCT00113997|Healthy Volunteer|healthy volunteer
830540|NCT00113997|HV|hv
830541|NCT00113984|Monoclonal Antibody|monoclonal antibody
830542|NCT00113984|Vaccine|vaccine
830543|NCT00113984|Cytokines|cytokines
830544|NCT00113984|Immunotherapy|immunotherapy
830545|NCT00113984|Elispot Assay|elispot assay
830546|NCT00113984|Prostate Cancer|prostate cancer
830547|NCT00113984|Metastatic Prostate Cancer|metastatic prostate cancer
830548|NCT00113971|study of epratuzumab in systemic lupus erythematosus|study of epratuzumab in systemic lupus erythematosus
830549|NCT00113971|systemic lupus erythematosus|systemic lupus erythematosus
830550|NCT00113971|SLE|sle
830551|NCT00113958|End Stage Renal Disease (ESRD)|end stage renal disease (esrd)
830552|NCT00113958|secondary hyperparathyroidism (SHPT)|secondary hyperparathyroidism (shpt)
830553|NCT00113958|hemodialysis|hemodialysis
830554|NCT00113958|biPTH|bipth
830555|NCT00113958|AMG 073, Amgen|amg 073, amgen
830556|NCT00113945|End Stage Renal Disease (ESRD)|end stage renal disease (esrd)
830557|NCT00113945|secondary hyperparathyroidism|secondary hyperparathyroidism
830558|NCT00113945|hemodialysis, biPTH|hemodialysis, bipth
830559|NCT00113945|AMG 073, Amgen|amg 073, amgen
830560|NCT00113932|Myeloma|myeloma
830561|NCT00113919|Myeloma, MM|myeloma, mm
830562|NCT00113906|melatonin,|melatonin,
830563|NCT00113906|fatigue,|fatigue,
830564|NCT00113906|sleep quality,|sleep quality,
830565|NCT00113906|circadian,|circadian,
830566|NCT00113906|postoperative|postoperative
830567|NCT00113906|Postoperative fatigue|postoperative fatigue
830568|NCT00113906|postoperative sleep disturbance|postoperative sleep disturbance
830569|NCT00113906|general wellbeing|general wellbeing
830570|NCT00113893|Myelodysplastic syndromes|myelodysplastic syndromes
830571|NCT00113893|p38 MAP kinase|p38 map kinase
830572|NCT00113893|Bone marrow diseases|bone marrow diseases
830573|NCT00113893|SCIO-469|scio-469
830574|NCT00113867|IVF|ivf
830575|NCT00113867|in vitro fertilization|in vitro fertilization
830576|NCT00113867|hormones|hormones
830577|NCT00113867|stress|stress
830578|NCT00113867|memory|memory
830579|NCT00113867|Cognitive Function|cognitive function
830580|NCT00113867|adoption|adoption
830581|NCT00113854|cerebral|cerebral
830582|NCT00113854|malaria|malaria
830583|NCT00113854|children|children
830584|NCT00113854|mannitol|mannitol
830585|NCT00113854|adjunct|adjunct
830586|NCT00113854|therapy|therapy
830587|NCT00113854|Uganda|uganda
830588|NCT00113841|Multiple Myeloma|multiple myeloma
830589|NCT00113841|Diferuloylmethane Derivative|diferuloylmethane derivative
830590|NCT00113841|Curcumin|curcumin
830591|NCT00113841|Bioperine|bioperine
830592|NCT00113828|Non-Myeloablative|non-myeloablative
830593|NCT00113828|Stem Cell Transplantation|stem cell transplantation
830594|NCT00113828|T-cell Depletion|t-cell depletion
830595|NCT00113828|HLA-Matched|hla-matched
830596|NCT00113815|Partial seizure disorder|partial seizure disorder
830597|NCT00113815|Topiramate|topiramate
830598|NCT00113815|Epilepsy|epilepsy
830599|NCT00113815|Infants|infants
830600|NCT00113802|Epratuzumab (hLL2- anti-CD22 humanized antibody)|epratuzumab (hll2- anti-cd22 humanized antibody)
830601|NCT00113802|Waldenstrom's Macroglobulinemia|waldenstrom's macroglobulinemia
830602|NCT00113802|Waldenstrom Macroglobulinemia|waldenstrom macroglobulinemia
830603|NCT00113802|Hematologic Disease|hematologic disease
830604|NCT00113802|Hematologic Diseases|hematologic diseases
830605|NCT00113802|Paraproteinemias|paraproteinemias
830606|NCT00113802|Vascular Hemostatic Disorders|vascular hemostatic disorders
830607|NCT00113802|Lymphoproliferative Disorders|lymphoproliferative disorders
830608|NCT00113789|ovarian cancer|ovarian cancer
830609|NCT00113789|topotecan|topotecan
830610|NCT00113789|neutropenia|neutropenia
830611|NCT00113789|Neulasta®|neulasta®
830612|NCT00113776|Metastatic Colorectal Cancer, Colon|metastatic colorectal cancer, colon
830613|NCT00113776|Colorectal, Rectal Cancer, EGFr|colorectal, rectal cancer, egfr
830614|NCT00113776|Metastatic, Cancer, ABX-EGF|metastatic, cancer, abx-egf
830615|NCT00113776|Panitumumab, Clinical Trial|panitumumab, clinical trial
830616|NCT00113776|Immunex, Abgenix, Amgen|immunex, abgenix, amgen
830617|NCT00113763|Metastatic Colorectal Cancer, Colon|metastatic colorectal cancer, colon
830618|NCT00113763|Colorectal, Rectal Cancer, Cancer|colorectal, rectal cancer, cancer
830619|NCT00113763|Metastatic, EGFr, Clinical Trial|metastatic, egfr, clinical trial
830620|NCT00113763|Panitumumab, ABX-EGF|panitumumab, abx-egf
830621|NCT00113763|Immunex, Abgenix, Amgen|immunex, abgenix, amgen
830622|NCT00113750|Allergy|allergy
830623|NCT00113750|Allergoid|allergoid
830624|NCT00113750|Specific Immunotherapy|specific immunotherapy
830625|NCT00113724|taxane|taxane
830626|NCT00113724|multi-drug resistance|multi-drug resistance
830627|NCT00113724|mutant tubulin binding|mutant tubulin binding
830628|NCT00113724|Advanced malignancies|advanced malignancies
830629|NCT00113724|Hodgkin's or Non-Hodgkin's Lymphoma|hodgkin's or non-hodgkin's lymphoma
830630|NCT00113659|Asthma|asthma
830631|NCT00113659|Probiotics|probiotics
830632|NCT00113659|Prevention|prevention
830633|NCT00113659|Eczema|eczema
830634|NCT00113646|Non-Myeloablative|non-myeloablative
830635|NCT00113646|T-cell Depleted|t-cell depleted
830636|NCT00113646|Mismatched|mismatched
830637|NCT00113646|Stem Cell Transplantation|stem cell transplantation
830638|NCT00113633|Asthma|asthma
830639|NCT00113633|Emergency|emergency
830640|NCT00113633|Primary Care|primary care
830641|NCT00113633|Children|children
830642|NCT00113620|distal symmetrical|distal symmetrical
830643|NCT00113620|pain|pain
830644|NCT00113620|lower extremities|lower extremities
830645|NCT00113620|dextromethorphan|dextromethorphan
830646|NCT00113607|Ovarian cancer|ovarian cancer
830647|NCT00113607|Trabectedin|trabectedin
830648|NCT00113607|Yondelis|yondelis
830649|NCT00113607|Advanced Relapsed Ovarian Cancer|advanced relapsed ovarian cancer
830650|NCT00113607|DOXIL|doxil
830651|NCT00113607|CAELYX|caelyx
830652|NCT00113581|EMD 72000|emd 72000
830653|NCT00113581|matuzumab|matuzumab
830654|NCT00113581|Esophageal adenocarcinoma|esophageal adenocarcinoma
830655|NCT00113581|Gastric adenocarcinoma|gastric adenocarcinoma
830656|NCT00113568|Menorrhagia|menorrhagia
830657|NCT00113568|Heavy Menstrual Bleeding|heavy menstrual bleeding
830658|NCT00113555|urinary incontinence|urinary incontinence
830659|NCT00113542|Psoriasis|psoriasis
830660|NCT00113542|Tetrathiomolybdate|tetrathiomolybdate
830661|NCT00113516|Lung Neoplasms|lung neoplasms
830662|NCT00113503|Inflammatory Bowel Disease, Crohn's disease, Crohn's Colitis|inflammatory bowel disease, crohn's disease, crohn's colitis
830663|NCT00113490|motavizumab, palivizumab, synagis|motavizumab, palivizumab, synagis
830664|NCT00113490|Rezield, MEDI-524|rezield, medi-524
830665|NCT00113477|Q10|q10
830666|NCT00113477|CoQ10|coq10
830667|NCT00113477|Coenzyme Q10|coenzyme q10
830668|NCT00113477|selen|selen
830669|NCT00113477|selenoprotein|selenoprotein
830670|NCT00113477|selenoproteins|selenoproteins
830671|NCT00113477|adverse events|adverse events
830672|NCT00113477|adverse effects|adverse effects
830673|NCT00113477|AE|ae
830674|NCT00113477|myalgia|myalgia
830675|NCT00113477|muscle|muscle
830676|NCT00113477|statin therapy|statin therapy
830677|NCT00113477|Indication for statin therapy|indication for statin therapy
830678|NCT00113464|SCID (Severe Combined Immunodeficiency)|scid (severe combined immunodeficiency)
830679|NCT00113464|TREC (T cell Receptor Excision Circle)|trec (t cell receptor excision circle)
830680|NCT00113464|Bone Marrow Transplant|bone marrow transplant
830681|NCT00113464|Dried Blood Spots|dried blood spots
830682|NCT00113464|Early Detection|early detection
830683|NCT00113464|T Cell Immunodeficiency Diseases|t cell immunodeficiency diseases
830684|NCT00113464|Immunodeficiency Diseases|immunodeficiency diseases
830685|NCT00113464|Primary Immunodeficiency|primary immunodeficiency
830686|NCT00113464|T Cell Immunodeficiency Disease|t cell immunodeficiency disease
830687|NCT00113464|Severe Combined Immunodeficiency|severe combined immunodeficiency
830688|NCT00113464|SCID|scid
830689|NCT00113451|radial artery|radial artery
830690|NCT00113451|angina pectoris|angina pectoris
830691|NCT00113451|infarction|infarction
830692|NCT00113451|bypass|bypass
830693|NCT00113451|angiography|angiography
830694|NCT00113438|cancer|cancer
830695|NCT00113438|tumor|tumor
830696|NCT00113438|imageable|imageable
830697|NCT00113438|CA4P|ca4p
830698|NCT00113438|Combretastatin|combretastatin
830699|NCT00113438|Combretastatin A4 Phosphate|combretastatin a4 phosphate
830700|NCT00113438|Combretastatin A-4 Phosphate|combretastatin a-4 phosphate
830701|NCT00113438|Carboplatin|carboplatin
830702|NCT00113438|Paclitaxel|paclitaxel
830703|NCT00113438|carbo|carbo
830704|NCT00113438|taxol|taxol
830705|NCT00113425|non-ablative laser|non-ablative laser
830706|NCT00113425|acne|acne
830707|NCT00113425|photosensitizer|photosensitizer
830708|NCT00113425|photodynamic therapy|photodynamic therapy
830709|NCT00113412|HIV|hiv
830710|NCT00113412|Treatment Experienced|treatment experienced
830711|NCT00113399|recurrent squamous cell carcinoma of the hypopharynx|recurrent squamous cell carcinoma of the hypopharynx
830712|NCT00113399|recurrent squamous cell carcinoma of the larynx|recurrent squamous cell carcinoma of the larynx
830713|NCT00113399|recurrent squamous cell carcinoma of the lip and oral cavity|recurrent squamous cell carcinoma of the lip and oral cavity
830811|NCT00113165|seizures|seizures
830714|NCT00113399|recurrent squamous cell carcinoma of the oropharynx|recurrent squamous cell carcinoma of the oropharynx
830715|NCT00113399|recurrent metastatic squamous neck cancer with occult primary|recurrent metastatic squamous neck cancer with occult primary
830716|NCT00113399|recurrent lymphoepithelioma of the oropharynx|recurrent lymphoepithelioma of the oropharynx
830717|NCT00113386|stage IIIA non-small cell lung cancer|stage iiia non-small cell lung cancer
830718|NCT00113386|adenocarcinoma of the lung|adenocarcinoma of the lung
830719|NCT00113386|large cell lung cancer|large cell lung cancer
830720|NCT00113386|squamous cell lung cancer|squamous cell lung cancer
830721|NCT00113386|bronchoalveolar cell lung cancer|bronchoalveolar cell lung cancer
830722|NCT00113360|Neuroendocrine Carcinoma|neuroendocrine carcinoma
830723|NCT00113360|Low Grade Neuroendocrine Carcinoma|low grade neuroendocrine carcinoma
830724|NCT00113360|Neuroendocrine Carcinoid|neuroendocrine carcinoid
830725|NCT00113360|Islet Cell Carcinoma|islet cell carcinoma
830726|NCT00113360|RAD001|rad001
830727|NCT00113360|Everolimus|everolimus
830728|NCT00113360|Octreotide Depot|octreotide depot
830729|NCT00113360|Sandostatin LAR|sandostatin lar
830730|NCT00113360|Octreotide long-acting release (LAR)|octreotide long-acting release (lar)
830731|NCT00113360|Octreotide LAR|octreotide lar
830732|NCT00113347|Head and Neck Cancer|head and neck cancer
830733|NCT00113347|Squamous Cell Carcinoma|squamous cell carcinoma
830734|NCT00113347|Erlotinib|erlotinib
830735|NCT00113347|Docetaxel|docetaxel
830736|NCT00113347|Radiation|radiation
830737|NCT00113347|Radiotherapy|radiotherapy
830738|NCT00113347|Concomitant Boost Radiation|concomitant boost radiation
830739|NCT00113334|Head and Neck Cancer|head and neck cancer
830740|NCT00113334|Thrombospondin Analogue|thrombospondin analogue
830741|NCT00113334|ABT-510|abt-510
830742|NCT00113334|Antiangiogenic agent|antiangiogenic agent
830743|NCT00113334|Lung|lung
830744|NCT00113334|Skin|skin
830745|NCT00113334|Thyroid|thyroid
830746|NCT00113321|Myelodysplastic Syndrome|myelodysplastic syndrome
830747|NCT00113321|Chronic Myelomonocytic Leukemia|chronic myelomonocytic leukemia
830748|NCT00113321|Azacytidine Failure|azacytidine failure
830749|NCT00113321|Decitabine|decitabine
830750|NCT00113308|Rheumatoid Arthritis|rheumatoid arthritis
830751|NCT00113308|COX-2 Inhibitor|cox-2 inhibitor
830752|NCT00113295|generalized anxiety disorder|generalized anxiety disorder
830753|NCT00113295|pharmacotherapy|pharmacotherapy
830754|NCT00113295|treatment refractory|treatment refractory
830755|NCT00113295|double-blind|double-blind
830756|NCT00113282|Treatment failure|treatment failure
830757|NCT00113282|Acquired Immunodeficiency Syndrome|acquired immunodeficiency syndrome
830758|NCT00113282|Interleukin-2|interleukin-2
830759|NCT00113282|Treatment Experienced|treatment experienced
830760|NCT00113269|Treatment Effectiveness|treatment effectiveness
830761|NCT00113269|Treatment Efficacy|treatment efficacy
830762|NCT00113269|Anti-rejection therapy|anti-rejection therapy
830763|NCT00113269|Immunosuppression|immunosuppression
830764|NCT00113269|Therapy, antirejection|therapy, antirejection
830765|NCT00113269|Renal Transplantation|renal transplantation
830766|NCT00113269|Transplantation, Kidney|transplantation, kidney
830767|NCT00113269|Transplantation, Renal|transplantation, renal
830768|NCT00113269|Grafting, Kidney|grafting, kidney
830769|NCT00113256|rubitecan|rubitecan
830770|NCT00113256|Orathecin|orathecin
830771|NCT00113256|9-nitrocamptothecin|9-nitrocamptothecin
830772|NCT00113256|gemcitabine|gemcitabine
830773|NCT00113256|Gemzar|gemzar
830774|NCT00113256|pancreatic cancer|pancreatic cancer
830775|NCT00113256|adenocarcinoma|adenocarcinoma
830776|NCT00113256|RFS 2000|rfs 2000
830777|NCT00113230|Rectal Cancer|rectal cancer
830778|NCT00113230|Bevacizumab|bevacizumab
830779|NCT00113230|RHUMAB VEGF|rhumab vegf
830780|NCT00113230|Avastin|avastin
830781|NCT00113230|Capecitabine|capecitabine
830782|NCT00113230|Neoadjuvant Concurrent Capecitabine|neoadjuvant concurrent capecitabine
830783|NCT00113230|Xeloda|xeloda
830784|NCT00113230|Radiation|radiation
830785|NCT00113230|Radiotherapy|radiotherapy
830786|NCT00113230|Radiation Therapy|radiation therapy
830787|NCT00113230|XRT|xrt
830788|NCT00113217|Renal Cell Carcinoma|renal cell carcinoma
830789|NCT00113217|Kidney Cancer|kidney cancer
830790|NCT00113217|Bevacizumab|bevacizumab
830791|NCT00113217|Avastin|avastin
830792|NCT00113217|RCC|rcc
830793|NCT00113204|Multiple myeloma|multiple myeloma
830794|NCT00113204|Relapsed|relapsed
830795|NCT00113204|Relapsed refractory|relapsed refractory
830796|NCT00113204|Hematologic cancer|hematologic cancer
830797|NCT00113204|hematologic disease|hematologic disease
830798|NCT00113204|plasma cells|plasma cells
830799|NCT00113191|late onset sepsis|late onset sepsis
830800|NCT00113191|premature infants|premature infants
830801|NCT00113191|staphylococcus|staphylococcus
830802|NCT00113191|candida|candida
830803|NCT00113191|prevention|prevention
830804|NCT00113178|atrial flutter|atrial flutter
830805|NCT00113178|cryoablation|cryoablation
830806|NCT00113165|partial seizures|partial seizures
830807|NCT00113165|Epilepsy|epilepsy
830808|NCT00113165|antiepileptic drugs|antiepileptic drugs
830809|NCT00113165|anticonvulsants|anticonvulsants
830810|NCT00113165|LAMICTAL|lamictal
830813|NCT00113152|Cardiac Arrhythmias|cardiac arrhythmias
830814|NCT00113152|Diastolic Dysfunction|diastolic dysfunction
830815|NCT00113152|Pulmonary Hypertension|pulmonary hypertension
830816|NCT00113152|Sickle Cell Anemia|sickle cell anemia
830817|NCT00113152|Sudden Death|sudden death
830818|NCT00113152|Thalassemia|thalassemia
830819|NCT00113126|Scheduled treatment interruptions|scheduled treatment interruptions
830821|NCT00113113|rubitecan|rubitecan
830822|NCT00113113|Orathecin|orathecin
830823|NCT00113113|9-nitrocamptothecin|9-nitrocamptothecin
830824|NCT00113113|solid tumors|solid tumors
830825|NCT00113113|organ dysfunction|organ dysfunction
830826|NCT00113113|renal dysfunction|renal dysfunction
830827|NCT00113113|hepatic dysfunction|hepatic dysfunction
830828|NCT00113113|RFS 2000|rfs 2000
830829|NCT00113100|skin|skin
830830|NCT00113100|estrogen|estrogen
830831|NCT00113100|sun damage|sun damage
830832|NCT00113100|Photodamaged Skin|photodamaged skin
830833|NCT00113061|Coronary Heart Disease Risk Reduction|coronary heart disease risk reduction
830834|NCT00113048|CD52 Expressing Hematologic Malignancies|cd52 expressing hematologic malignancies
830835|NCT00113035|Glycogen Storage Disease Type II|glycogen storage disease type ii
830836|NCT00113035|GSD-II|gsd-ii
830837|NCT00113035|Pompe Disease|pompe disease
830838|NCT00113035|Pompe Disease (Late-Onset)|pompe disease (late-onset)
830839|NCT00113035|Glycogen Storage Disease Type II (GSD-II)|glycogen storage disease type ii (gsd-ii)
830840|NCT00113035|Acid Maltase Deficiency|acid maltase deficiency
830841|NCT00113035|Glycogenosis 2|glycogenosis 2
830842|NCT00113022|Depression|depression
830843|NCT00113022|Glutamate|glutamate
830844|NCT00113022|Ampakine|ampakine
830845|NCT00113022|Treatment|treatment
830846|NCT00113022|Memory|memory
830847|NCT00113022|Major Depressive Disorder|major depressive disorder
830848|NCT00113022|AMPA Receptor Activation|ampa receptor activation
830849|NCT00113022|BDNF|bdnf
830850|NCT00113009|Peripheral arterial disease|peripheral arterial disease
830851|NCT00112996|neurotoxicity|neurotoxicity
830852|NCT00112996|unspecified adult solid tumor, protocol specific|unspecified adult solid tumor, protocol specific
830853|NCT00112996|unspecified childhood solid tumor, protocol specific|unspecified childhood solid tumor, protocol specific
830854|NCT00112983|adult acute lymphoblastic leukemia|adult acute lymphoblastic leukemia
830855|NCT00112983|adult acute myeloid leukemia|adult acute myeloid leukemia
830856|NCT00112957|fallopian tube cancer|fallopian tube cancer
830857|NCT00112957|stage II ovarian epithelial cancer|stage ii ovarian epithelial cancer
830858|NCT00112957|stage III ovarian epithelial cancer|stage iii ovarian epithelial cancer
830859|NCT00112957|stage IV ovarian epithelial cancer|stage iv ovarian epithelial cancer
830860|NCT00112957|peritoneal cavity cancer|peritoneal cavity cancer
830861|NCT00112931|stage III grade 1 follicular lymphoma|stage iii grade 1 follicular lymphoma
830862|NCT00112931|stage III grade 2 follicular lymphoma|stage iii grade 2 follicular lymphoma
830863|NCT00112931|stage III grade 3 follicular lymphoma|stage iii grade 3 follicular lymphoma
830864|NCT00112931|stage IV grade 1 follicular lymphoma|stage iv grade 1 follicular lymphoma
830865|NCT00112931|stage IV grade 2 follicular lymphoma|stage iv grade 2 follicular lymphoma
830866|NCT00112931|stage IV grade 3 follicular lymphoma|stage iv grade 3 follicular lymphoma
830867|NCT00112931|noncontiguous stage II grade 1 follicular lymphoma|noncontiguous stage ii grade 1 follicular lymphoma
830868|NCT00112931|noncontiguous stage II grade 2 follicular lymphoma|noncontiguous stage ii grade 2 follicular lymphoma
830869|NCT00112931|noncontiguous stage II grade 3 follicular lymphoma|noncontiguous stage ii grade 3 follicular lymphoma
830870|NCT00112931|contiguous stage II grade 1 follicular lymphoma|contiguous stage ii grade 1 follicular lymphoma
830871|NCT00112931|contiguous stage II grade 2 follicular lymphoma|contiguous stage ii grade 2 follicular lymphoma
830872|NCT00112931|contiguous stage II grade 3 follicular lymphoma|contiguous stage ii grade 3 follicular lymphoma
830873|NCT00112918|stage II colon cancer|stage ii colon cancer
830874|NCT00112918|stage III colon cancer|stage iii colon cancer
830875|NCT00112892|unspecified adult solid tumor, protocol specific|unspecified adult solid tumor, protocol specific
830876|NCT00112775|chronic phase chronic myelogenous leukemia|chronic phase chronic myelogenous leukemia
830877|NCT00112775|chronic myelogenous leukemia, BCR-ABL1 positive|chronic myelogenous leukemia, bcr-abl1 positive
830878|NCT00112775|relapsing chronic myelogenous leukemia|relapsing chronic myelogenous leukemia
830879|NCT00112749|stage I breast cancer|stage i breast cancer
830880|NCT00112749|stage II breast cancer|stage ii breast cancer
830881|NCT00112749|breast cancer in situ|breast cancer in situ
830882|NCT00112749|fatigue|fatigue
830883|NCT00112710|stage IIIB non-small cell lung cancer|stage iiib non-small cell lung cancer
830884|NCT00112710|stage IV non-small cell lung cancer|stage iv non-small cell lung cancer
830885|NCT00112697|adenocarcinoma of the pancreas|adenocarcinoma of the pancreas
830886|NCT00112697|stage IV pancreatic cancer|stage iv pancreatic cancer
830887|NCT00112658|adenocarcinoma of the pancreas|adenocarcinoma of the pancreas
830888|NCT00112658|stage IV pancreatic cancer|stage iv pancreatic cancer
830889|NCT00112645|unspecified childhood solid tumor, protocol specific|unspecified childhood solid tumor, protocol specific
830890|NCT00112645|recurrent neuroblastoma|recurrent neuroblastoma
830891|NCT00112645|recurrent Ewing sarcoma/peripheral primitive neuroectodermal tumor|recurrent ewing sarcoma/peripheral primitive neuroectodermal tumor
830892|NCT00112645|recurrent childhood rhabdomyosarcoma|recurrent childhood rhabdomyosarcoma
830893|NCT00112632|gastrointestinal stromal tumor|gastrointestinal stromal tumor
830894|NCT00112619|AIDS-related diffuse large cell lymphoma|aids-related diffuse large cell lymphoma
830895|NCT00112619|AIDS-related diffuse mixed cell lymphoma|aids-related diffuse mixed cell lymphoma
830896|NCT00112619|AIDS-related diffuse small cleaved cell lymphoma|aids-related diffuse small cleaved cell lymphoma
830897|NCT00112619|AIDS-related immunoblastic large cell lymphoma|aids-related immunoblastic large cell lymphoma
830898|NCT00112619|AIDS-related lymphoblastic lymphoma|aids-related lymphoblastic lymphoma
830899|NCT00112619|AIDS-related peripheral/systemic lymphoma|aids-related peripheral/systemic lymphoma
830900|NCT00112619|AIDS-related primary CNS lymphoma|aids-related primary cns lymphoma
830901|NCT00112619|AIDS-related small noncleaved cell lymphoma|aids-related small noncleaved cell lymphoma
830902|NCT00112619|HIV-associated Hodgkin lymphoma|hiv-associated hodgkin lymphoma
830903|NCT00112619|stage IV childhood Hodgkin lymphoma|stage iv childhood hodgkin lymphoma
830904|NCT00112619|stage IV childhood large cell lymphoma|stage iv childhood large cell lymphoma
830905|NCT00112619|stage IV childhood lymphoblastic lymphoma|stage iv childhood lymphoblastic lymphoma
830906|NCT00112619|stage IV childhood small noncleaved cell lymphoma|stage iv childhood small noncleaved cell lymphoma
830907|NCT00112619|primary central nervous system non-Hodgkin lymphoma|primary central nervous system non-hodgkin lymphoma
830908|NCT00112619|primary central nervous system Hodgkin lymphoma|primary central nervous system hodgkin lymphoma
830909|NCT00112619|recurrent childhood acute lymphoblastic leukemia|recurrent childhood acute lymphoblastic leukemia
830910|NCT00112619|recurrent childhood acute myeloid leukemia|recurrent childhood acute myeloid leukemia
830911|NCT00112619|unspecified childhood solid tumor, protocol specific|unspecified childhood solid tumor, protocol specific
830912|NCT00112619|childhood grade I meningioma|childhood grade i meningioma
830913|NCT00112619|childhood grade II meningioma|childhood grade ii meningioma
830914|NCT00112619|childhood grade III meningioma|childhood grade iii meningioma
830915|NCT00112619|recurrent childhood cerebellar astrocytoma|recurrent childhood cerebellar astrocytoma
830916|NCT00112619|recurrent childhood cerebral astrocytoma|recurrent childhood cerebral astrocytoma
830917|NCT00112619|childhood high-grade cerebral astrocytoma|childhood high-grade cerebral astrocytoma
830918|NCT00112619|childhood low-grade cerebral astrocytoma|childhood low-grade cerebral astrocytoma
830919|NCT00112619|childhood choroid plexus tumor|childhood choroid plexus tumor
830920|NCT00112619|childhood craniopharyngioma|childhood craniopharyngioma
830921|NCT00112619|childhood infratentorial ependymoma|childhood infratentorial ependymoma
830922|NCT00112619|childhood supratentorial ependymoma|childhood supratentorial ependymoma
830923|NCT00112619|recurrent childhood ependymoma|recurrent childhood ependymoma
830924|NCT00112619|recurrent childhood medulloblastoma|recurrent childhood medulloblastoma
830925|NCT00112619|childhood oligodendroglioma|childhood oligodendroglioma
830926|NCT00112619|recurrent childhood supratentorial primitive neuroectodermal tumor|recurrent childhood supratentorial primitive neuroectodermal tumor
830927|NCT00112619|leptomeningeal metastases|leptomeningeal metastases
830928|NCT00112619|recurrent carcinoma of unknown primary|recurrent carcinoma of unknown primary
830929|NCT00112619|childhood central nervous system germ cell tumor|childhood central nervous system germ cell tumor
830930|NCT00112619|childhood chronic myelogenous leukemia|childhood chronic myelogenous leukemia
830931|NCT00112619|juvenile myelomonocytic leukemia|juvenile myelomonocytic leukemia
830932|NCT00112619|recurrent/refractory childhood Hodgkin lymphoma|recurrent/refractory childhood hodgkin lymphoma
830933|NCT00112619|recurrent childhood grade III lymphomatoid granulomatosis|recurrent childhood grade iii lymphomatoid granulomatosis
830934|NCT00112619|recurrent childhood visual pathway and hypothalamic glioma|recurrent childhood visual pathway and hypothalamic glioma
830935|NCT00112619|childhood atypical teratoid/rhabdoid tumor|childhood atypical teratoid/rhabdoid tumor
830936|NCT00112619|recurrent childhood large cell lymphoma|recurrent childhood large cell lymphoma
830937|NCT00112619|recurrent childhood lymphoblastic lymphoma|recurrent childhood lymphoblastic lymphoma
830938|NCT00112619|recurrent childhood small noncleaved cell lymphoma|recurrent childhood small noncleaved cell lymphoma
830939|NCT00112619|relapsing chronic myelogenous leukemia|relapsing chronic myelogenous leukemia
830940|NCT00112619|recurrent childhood pineoblastoma|recurrent childhood pineoblastoma
830941|NCT00112619|recurrent childhood subependymal giant cell astrocytoma|recurrent childhood subependymal giant cell astrocytoma
830942|NCT00112619|meningeal leukemia|meningeal leukemia
830943|NCT00112619|secondary central nervous system Hodgkin lymphoma|secondary central nervous system hodgkin lymphoma
830944|NCT00112619|secondary central nervous system non-Hodgkin lymphoma|secondary central nervous system non-hodgkin lymphoma
830945|NCT00112593|HIV|hiv
830946|NCT00112593|Lymphoma|lymphoma
830947|NCT00112593|Leukemia|leukemia
830948|NCT00112580|recurrent pancreatic cancer|recurrent pancreatic cancer
830949|NCT00112580|adenocarcinoma of the pancreas|adenocarcinoma of the pancreas
830950|NCT00112580|stage IV pancreatic cancer|stage iv pancreatic cancer
830951|NCT00112567|recurrent childhood acute lymphoblastic leukemia|recurrent childhood acute lymphoblastic leukemia
830952|NCT00112567|childhood myelodysplastic syndromes|childhood myelodysplastic syndromes
830953|NCT00112567|childhood acute lymphoblastic leukemia in remission|childhood acute lymphoblastic leukemia in remission
830954|NCT00112567|recurrent childhood acute myeloid leukemia|recurrent childhood acute myeloid leukemia
830955|NCT00112567|childhood acute myeloid leukemia in remission|childhood acute myeloid leukemia in remission
830956|NCT00112567|secondary acute myeloid leukemia|secondary acute myeloid leukemia
830957|NCT00112567|accelerated phase chronic myelogenous leukemia|accelerated phase chronic myelogenous leukemia
830958|NCT00112567|blastic phase chronic myelogenous leukemia|blastic phase chronic myelogenous leukemia
830959|NCT00112567|childhood chronic myelogenous leukemia|childhood chronic myelogenous leukemia
830960|NCT00112567|relapsing chronic myelogenous leukemia|relapsing chronic myelogenous leukemia
830961|NCT00112567|de novo myelodysplastic syndromes|de novo myelodysplastic syndromes
830962|NCT00112567|secondary myelodysplastic syndromes|secondary myelodysplastic syndromes
830963|NCT00112567|previously treated myelodysplastic syndromes|previously treated myelodysplastic syndromes
830964|NCT00112554|adult acute myeloid leukemia with 11q23 (MLL) abnormalities|adult acute myeloid leukemia with 11q23 (mll) abnormalities
830965|NCT00112554|adult acute myeloid leukemia with inv(16)(p13;q22)|adult acute myeloid leukemia with inv(16)(p13;q22)
830966|NCT00112554|adult acute myeloid leukemia with t(16;16)(p13;q22)|adult acute myeloid leukemia with t(16;16)(p13;q22)
830967|NCT00112554|adult acute myeloid leukemia with t(8;21)(q22;q22)|adult acute myeloid leukemia with t(8;21)(q22;q22)
830968|NCT00112554|recurrent adult acute myeloid leukemia|recurrent adult acute myeloid leukemia
830969|NCT00112554|adult acute basophilic leukemia|adult acute basophilic leukemia
830970|NCT00112554|adult acute eosinophilic leukemia|adult acute eosinophilic leukemia
830971|NCT00112554|adult erythroleukemia (M6a)|adult erythroleukemia (m6a)
830972|NCT00112554|adult pure erythroid leukemia (M6b)|adult pure erythroid leukemia (m6b)
830973|NCT00112554|adult acute megakaryoblastic leukemia (M7)|adult acute megakaryoblastic leukemia (m7)
830974|NCT00112554|adult acute minimally differentiated myeloid leukemia (M0)|adult acute minimally differentiated myeloid leukemia (m0)
830975|NCT00112554|adult acute monoblastic leukemia (M5a)|adult acute monoblastic leukemia (m5a)
830976|NCT00112554|adult acute monocytic leukemia (M5b)|adult acute monocytic leukemia (m5b)
830977|NCT00112554|adult acute myeloblastic leukemia with maturation (M2)|adult acute myeloblastic leukemia with maturation (m2)
830978|NCT00112554|adult acute myeloblastic leukemia without maturation (M1)|adult acute myeloblastic leukemia without maturation (m1)
830979|NCT00112554|adult acute myelomonocytic leukemia (M4)|adult acute myelomonocytic leukemia (m4)
830980|NCT00112528|duct cell adenocarcinoma of the pancreas|duct cell adenocarcinoma of the pancreas
830981|NCT00112528|recurrent pancreatic cancer|recurrent pancreatic cancer
830982|NCT00112528|stage IV pancreatic cancer|stage iv pancreatic cancer
830983|NCT00112515|depression|depression
830984|NCT00112515|cognitive/functional effects|cognitive/functional effects
830985|NCT00112515|fatigue|fatigue
830986|NCT00112515|unspecified adult solid tumor, protocol specific|unspecified adult solid tumor, protocol specific
830987|NCT00112502|adult giant cell glioblastoma|adult giant cell glioblastoma
830988|NCT00112502|adult gliosarcoma|adult gliosarcoma
830989|NCT00112502|adult glioblastoma|adult glioblastoma
830990|NCT00112489|recurrent uterine sarcoma|recurrent uterine sarcoma
830991|NCT00112489|stage III uterine sarcoma|stage iii uterine sarcoma
830992|NCT00112489|stage IV uterine sarcoma|stage iv uterine sarcoma
830993|NCT00112489|uterine carcinosarcoma|uterine carcinosarcoma
830994|NCT00112424|Superior cavo-pulmonary anastomosis|superior cavo-pulmonary anastomosis
830995|NCT00112424|Glenn operation|glenn operation
830996|NCT00112424|Congenital heart defects|congenital heart defects
830997|NCT00112424|Cardiac magnetic resonance imaging|cardiac magnetic resonance imaging
830998|NCT00112398|Head injuries|head injuries
830999|NCT00112398|Prehospital|prehospital
831000|NCT00112398|Advanced Interventions|advanced interventions
831001|NCT00112385|dermatomyositis|dermatomyositis
831002|NCT00112385|etanercept|etanercept
831003|NCT00112385|tumor necrosis factor alpha|tumor necrosis factor alpha
831004|NCT00112372|unresectable|unresectable
831005|NCT00112372|metastatic|metastatic
831006|NCT00112372|cancer|cancer
831007|NCT00112372|recurrent|recurrent
831008|NCT00112372|malignancies|malignancies
831009|NCT00112372|progressive|progressive
831010|NCT00112359|Cystic Fibrosis|cystic fibrosis
831011|NCT00112359|Pseudomonas aeruginosa|pseudomonas aeruginosa
831012|NCT00112359|Pulmonary Cystic Fibrosis|pulmonary cystic fibrosis
831013|NCT00112346|Non-Small Lung Cancer|non-small lung cancer
831014|NCT00112333|Dyspepsia, fMRI|dyspepsia, fmri
831015|NCT00112320|Pulmonary Valve Regurgitation|pulmonary valve regurgitation
831016|NCT00112320|Right Ventricular Dysfunction|right ventricular dysfunction
831017|NCT00112320|Heart Diseases|heart diseases
831019|NCT00112307|Brachytherapy|brachytherapy
831020|NCT00112307|Carcinoma|carcinoma
831021|NCT00112307|Cervix|cervix
831022|NCT00112307|Uterus|uterus
831023|NCT00112307|Vagina|vagina
831024|NCT00112307|Vulva|vulva
831025|NCT00112307|Carcinoma of the cervix|carcinoma of the cervix
831026|NCT00112307|Carcinoma of the uterus|carcinoma of the uterus
831027|NCT00112307|Carcinoma of the vagina|carcinoma of the vagina
831028|NCT00112307|Carcinoma of the vulva|carcinoma of the vulva
831029|NCT00112294|Non-Small Cell Lung Cancer|non-small cell lung cancer
831030|NCT00112281|"shock, cardiogenic, myocardial infarction"|"shock, cardiogenic, myocardial infarction"
831031|NCT00112268|randomized controlled trial|randomized controlled trial
831032|NCT00112268|primary health care|primary health care
831033|NCT00112268|smoking cessation|smoking cessation
831034|NCT00112255|Chlamydia trachomatis|chlamydia trachomatis
831035|NCT00112255|Chlamydia infections|chlamydia infections
831036|NCT00112255|Randomized controlled trials|randomized controlled trials
831037|NCT00112255|Contact tracing|contact tracing
831038|NCT00112255|Family practice|family practice
831039|NCT00112242|Immunotherapy|immunotherapy
831042|NCT00112242|Melan-A/Mart-1 peptide|melan-a/mart-1 peptide
831043|NCT00112242|MAGE-A10 peptide|mage-a10 peptide
831044|NCT00112242|NY-ESO-1 peptide|ny-eso-1 peptide
831045|NCT00112242|Montanide|montanide
831046|NCT00112229|Immunotherapy|immunotherapy
831047|NCT00112229|Vaccination|vaccination
831048|NCT00112229|Melanoma|melanoma
831049|NCT00112229|Melan-A/Mart-1 peptide|melan-a/mart-1 peptide
831050|NCT00112229|Tyrosinase peptide|tyrosinase peptide
831051|NCT00112229|CpG|cpg
831052|NCT00112229|Montanide|montanide
831053|NCT00112216|Immunotherapy|immunotherapy
831054|NCT00112216|Vaccination|vaccination
831055|NCT00112216|Melanoma|melanoma
831056|NCT00112216|Melan-A/Mart-1 peptide|melan-a/mart-1 peptide
831057|NCT00112216|Flu peptide|flu peptide
831058|NCT00112216|Mage-A10 peptide|mage-a10 peptide
831059|NCT00112216|SB AS-2 adjuvant|sb as-2 adjuvant
831060|NCT00112216|Montanide adjuvant|montanide adjuvant
831061|NCT00112203|Abdominal Symptom Relief|abdominal symptom relief
831062|NCT00112203|Fullness|fullness
831063|NCT00112203|Bloating|bloating
831064|NCT00112203|Indigestion|indigestion
831065|NCT00112203|Functional dyspepsia|functional dyspepsia
831066|NCT00112190|Functional dyspepsia|functional dyspepsia
831067|NCT00112190|Abdominal Symptom relief|abdominal symptom relief
831068|NCT00112190|Fullness|fullness
831069|NCT00112190|Bloating|bloating
831070|NCT00112190|Indigestion|indigestion
831071|NCT00112177|Functional dyspepsia|functional dyspepsia
831072|NCT00112177|Abdominal Symptom relief|abdominal symptom relief
831073|NCT00112177|Fullness|fullness
831074|NCT00112177|Bloating|bloating
831075|NCT00112177|Indigestion|indigestion
831076|NCT00112164|Acute Respiratory Distress Syndrome|acute respiratory distress syndrome
831077|NCT00112151|andropause|andropause
831078|NCT00112151|hypogonadism|hypogonadism
831079|NCT00112151|AndroGel|androgel
831080|NCT00112151|exercise|exercise
831082|NCT00112151|Testosterone|testosterone
831083|NCT00112151|T supplementation|t supplementation
831084|NCT00112138|gabapentin|gabapentin
831085|NCT00112138|hot flashes or flushes|hot flashes or flushes
831086|NCT00112138|menopause|menopause
831087|NCT00112125|cardiac contractility modulation|cardiac contractility modulation
831088|NCT00112125|heart failure|heart failure
831089|NCT00112125|cardiopulmonary exercise test|cardiopulmonary exercise test
831090|NCT00112125|chronic heart disease|chronic heart disease
831091|NCT00112112|cancer, pediatric, influenza, vaccine|cancer, pediatric, influenza, vaccine
831092|NCT00112099|gastric neoplasm|gastric neoplasm
831093|NCT00112099|gastrectomy|gastrectomy
831094|NCT00112099|splenectomy|splenectomy
831095|NCT00112099|randomized trial|randomized trial
831096|NCT00112099|T2, T3 and T4 carcinoma in the proximal third of the stomach|t2, t3 and t4 carcinoma in the proximal third of the stomach
831097|NCT00112086|ovarian neoplasms|ovarian neoplasms
831098|NCT00112086|laparoscopy|laparoscopy
831099|NCT00112086|neoadjuvant therapy|neoadjuvant therapy
831100|NCT00112086|interval cytoreductive surgery|interval cytoreductive surgery
831101|NCT00112073|Alzheimer's disease|alzheimer's disease
831102|NCT00112073|immunotherapy|immunotherapy
831103|NCT00112073|beta amyloid|beta amyloid
831104|NCT00112060|Talotrexin|talotrexin
831105|NCT00112060|PT-523|pt-523
831106|NCT00112060|Non-Small Cell Lung Carcinoma (NSCLC)|non-small cell lung carcinoma (nsclc)
831107|NCT00112047|Human Immunodeficiency Virus|human immunodeficiency virus
831108|NCT00112034|Multiple Sclerosis|multiple sclerosis
831109|NCT00112034|Relapsing-Remitting|relapsing-remitting
831110|NCT00112034|AVONEX|avonex
831111|NCT00112034|Combination|combination
831112|NCT00112034|Methotrexate|methotrexate
831113|NCT00112034|IV Methylprednisolone|iv methylprednisolone
831114|NCT00112034|IVMP|ivmp
831115|NCT00112034|ACT|act
831116|NCT00112034|MTX|mtx
831117|NCT00112021|obesity|obesity
831118|NCT00112021|weight loss|weight loss
831119|NCT00112021|Amylin|amylin
831120|NCT00112021|pramlintide|pramlintide
831121|NCT00112021|Symlin|symlin
831122|NCT00112008|Anemia|anemia
831123|NCT00111995|Chronic Renal Failure (CRF)|chronic renal failure (crf)
831124|NCT00111995|Anemia|anemia
831125|NCT00111982|bilateral, idiopathic Parkinson's Disease|bilateral, idiopathic parkinson's disease
831126|NCT00111969|Heart failure|heart failure
831127|NCT00111969|Immune modulation therapy|immune modulation therapy
831128|NCT00111969|Inflammation|inflammation
831129|NCT00111969|Chronic systolic heart failure|chronic systolic heart failure
831130|NCT00111956|TNF|tnf
831131|NCT00111956|metabolic syndrome|metabolic syndrome
831132|NCT00111956|inflammation|inflammation
831133|NCT00111956|CRP|crp
831134|NCT00111956|adiponectin|adiponectin
831135|NCT00111943|Anti-Infective Agents, Local|anti-infective agents, local
831136|NCT00111943|HIV Seronegativity|hiv seronegativity
831137|NCT00111943|Tenofovir|tenofovir
831138|NCT00111943|Vaginal gel|vaginal gel
831139|NCT00111943|Microbicide|microbicide
831140|NCT00111943|Vaginal Microbicide|vaginal microbicide
831141|NCT00111943|PMPA|pmpa
831142|NCT00111930|dehydroepiandrosterone|dehydroepiandrosterone
831143|NCT00111930|DHEAS|dheas
831144|NCT00111930|bone mineral density|bone mineral density
831145|NCT00111930|body composition|body composition
831146|NCT00111930|lean mass|lean mass
831147|NCT00111930|fat mass|fat mass
831148|NCT00111930|bone mass|bone mass
831149|NCT00111930|decreased DHEAS levels|decreased dheas levels
831150|NCT00111917|Chronic Beryllium Disease|chronic beryllium disease
831151|NCT00111917|Berylliosis|berylliosis
831152|NCT00111917|Beryllium Disease|beryllium disease
831153|NCT00111917|CBD|cbd
831154|NCT00111917|Infliximab|infliximab
831155|NCT00111904|stage III pancreatic cancer|stage iii pancreatic cancer
831156|NCT00111904|recurrent pancreatic cancer|recurrent pancreatic cancer
831157|NCT00111904|stage IV pancreatic cancer|stage iv pancreatic cancer
831158|NCT00111878|Respiratory Syncytial Virus (RSV) and Parainfluenza Virus Type 3 (PIV3)|respiratory syncytial virus (rsv) and parainfluenza virus type 3 (piv3)
831159|NCT00111865|physical exercise|physical exercise
831160|NCT00111865|quality of life|quality of life
831161|NCT00111865|lymphoma|lymphoma
831162|NCT00111852|Desmoteplase|desmoteplase
831163|NCT00111852|Acute Ischemic Stroke|acute ischemic stroke
831164|NCT00111852|Stroke, Acute|stroke, acute
831165|NCT00111839|Lung cancer|lung cancer
831166|NCT00111826|Intermittent Claudication|intermittent claudication
831167|NCT00111826|Peripheral Arterial Disease|peripheral arterial disease
831168|NCT00111826|Immune modulation therapy|immune modulation therapy
831169|NCT00111826|Inflammation|inflammation
831170|NCT00111800|NIDDM|niddm
831171|NCT00111787|breast cancer|breast cancer
831172|NCT00111774|Colon Cancer, Rectal Cancer|colon cancer, rectal cancer
831173|NCT00111774|Colorectal Carcinoma, EGFr|colorectal carcinoma, egfr
831174|NCT00111774|Metastatic Cancer, ABX-EGF|metastatic cancer, abx-egf
831175|NCT00111774|Panitumumab, Abgenix|panitumumab, abgenix
831176|NCT00111774|Clinical Trial, Immunex, Amgen|clinical trial, immunex, amgen
831177|NCT00111774|Metastatic Colorectal|metastatic colorectal
831178|NCT00111761|Immunex|immunex
831179|NCT00111761|Panitumumab|panitumumab
831180|NCT00111761|ABX-EGF|abx-egf
831181|NCT00111761|Abgenix|abgenix
831182|NCT00111748|Myeloma|myeloma
831183|NCT00111683|Myelodysplastic Syndrome[Refractory Anemia with|myelodysplastic syndrome[refractory anemia with
831184|NCT00111683|Excess Blasts-1 or 2 (WHO Classification)]|excess blasts-1 or 2 (who classification)]
831185|NCT00111683|Chronic Myelogenous Leukemia in blast crisis|chronic myelogenous leukemia in blast crisis
831186|NCT00111657|Gout|gout
831187|NCT00111657|Tophi|tophi
831188|NCT00111657|Tophaceous gout|tophaceous gout
831189|NCT00111657|Allergy to allopurinol|allergy to allopurinol
831190|NCT00111657|Post-transplant gout|post-transplant gout
831191|NCT00111618|vascular disrupting agent|vascular disrupting agent
831192|NCT00111618|safety|safety
831193|NCT00111618|tolerability|tolerability
831194|NCT00111618|efficacy|efficacy
831195|NCT00111618|hormone refractory prostate cancer|hormone refractory prostate cancer
831196|NCT00111605|AIDS Vaccines|aids vaccines
831197|NCT00111605|HIV Vaccines|hiv vaccines
831198|NCT00111605|HIV Preventive Vaccine|hiv preventive vaccine
831199|NCT00111605|HIV Seronegativity|hiv seronegativity
831200|NCT00111592|BPH|bph
831201|NCT00111592|benign prostatic hyperplasia|benign prostatic hyperplasia
831202|NCT00111566|Percutaneous Coronary Intervention (PCI)|percutaneous coronary intervention (pci)
831203|NCT00111566|Glycoprotein IIb/IIIa blockade|glycoprotein iib/iiia blockade
831204|NCT00111566|Ischemic complications following PCI|ischemic complications following pci
831205|NCT00111553|Leishmaniasis|leishmaniasis
831206|NCT00111553|Subunit vaccine|subunit vaccine
831207|NCT00111553|Therapeutic|therapeutic
831208|NCT00111553|T cell|t cell
831209|NCT00111553|Antimony|antimony
831210|NCT00111540|exenatide|exenatide
831211|NCT00111540|diabetes|diabetes
831212|NCT00111540|Amylin|amylin
831213|NCT00111540|exendin-4|exendin-4
831214|NCT00111527|Heart failure|heart failure
831215|NCT00111527|Atrial fibrillation|atrial fibrillation
831216|NCT00111527|Cardiac resynchronization|cardiac resynchronization
831217|NCT00111527|Cardiac pacing|cardiac pacing
831218|NCT00111527|Catheter ablation|catheter ablation
831219|NCT00111527|Quality of life|quality of life
831220|NCT00111527|Echocardiography|echocardiography
831221|NCT00111514|Leishmaniasis|leishmaniasis
831222|NCT00111514|Subunit vaccine|subunit vaccine
831223|NCT00111514|therapeutic|therapeutic
831224|NCT00111514|T-cell|t-cell
831225|NCT00111514|pentavalent antimony|pentavalent antimony
831226|NCT00111501|smoking|smoking
831227|NCT00111501|tobacco|tobacco
831228|NCT00111488|atrial fibrillation|atrial fibrillation
831229|NCT00111475|Immune Thrombocytopenic Purpura|immune thrombocytopenic purpura
831230|NCT00111475|Idiopathic Thrombocytopenic Purpura|idiopathic thrombocytopenic purpura
831231|NCT00111475|Thrombocytopenic|thrombocytopenic
831232|NCT00111475|Thrombocytopenia|thrombocytopenia
831233|NCT00111475|ITP|itp
831234|NCT00111462|non-myeloid malignancy|non-myeloid malignancy
831235|NCT00111462|chemotherapy-induced anemia|chemotherapy-induced anemia
831236|NCT00111449|Psoriasis, adults|psoriasis, adults
831237|NCT00111449|skin, Phase 3|skin, phase 3
831238|NCT00111449|clinical trial, Amgen|clinical trial, amgen
831239|NCT00111449|etanercept, Enbrel®|etanercept, enbrel®
831240|NCT00111449|moderate, severe|moderate, severe
832248|NCT00108901|overweight|overweight
831241|NCT00111436|Psoriasis, adults, skin|psoriasis, adults, skin
831242|NCT00111436|Phase 3, clinical trial|phase 3, clinical trial
831243|NCT00111436|Amgen, etanercept|amgen, etanercept
831244|NCT00111436|Enbrel®, moderate|enbrel®, moderate
831245|NCT00111436|severe, extension|severe, extension
831246|NCT00111423|Rheumatoid Arthritis, Inflammation|rheumatoid arthritis, inflammation
831247|NCT00111423|Pegsunercept, PEG sTNF-RI|pegsunercept, peg stnf-ri
831248|NCT00111423|Autoimmune, Amgen|autoimmune, amgen
831249|NCT00111423|Clinical Trials|clinical trials
831250|NCT00111410|Rheumatoid Arthritis, Inflammation|rheumatoid arthritis, inflammation
831251|NCT00111410|Interleukin-1 (IL-1), r-metHuIL-1ra|interleukin-1 (il-1), r-methuil-1ra
831252|NCT00111410|Autoimmune, Kineret®|autoimmune, kineret®
831253|NCT00111410|Anakinra, Immunex|anakinra, immunex
831254|NCT00111410|Amgen, Clinical Trials|amgen, clinical trials
831255|NCT00111397|Mycobacterial|mycobacterial
831256|NCT00111397|Interferon|interferon
831257|NCT00111397|GM-CSF|gm-csf
831258|NCT00111397|Microarray|microarray
831259|NCT00111397|Proteomics|proteomics
831260|NCT00111397|Mycobacterium Avium Complex Infection|mycobacterium avium complex infection
831261|NCT00111397|MAC|mac
831262|NCT00111384|Phenotype|phenotype
831263|NCT00111384|NF1-associated tumors|nf1-associated tumors
831264|NCT00111384|NF1|nf1
831265|NCT00111384|EQTL|eqtl
831266|NCT00111384|Modifier Genes|modifier genes
831267|NCT00111384|Neurofibroma|neurofibroma
831268|NCT00111384|Neurofibromatosis Type 1|neurofibromatosis type 1
831269|NCT00111371|artificial grammar learning|artificial grammar learning
831270|NCT00111371|dyslexia|dyslexia
831271|NCT00111371|healthy subjects|healthy subjects
831272|NCT00111371|levodopa|levodopa
831273|NCT00111371|drug|drug
831274|NCT00111371|treatment|treatment
831275|NCT00111371|intervention|intervention
831276|NCT00111358|HIV, AIDS, metabolic syndrome|hiv, aids, metabolic syndrome
831277|NCT00111345|Acute|acute
831278|NCT00111345|myeloid|myeloid
831279|NCT00111345|leukemia|leukemia
831280|NCT00111345|Acute myeloid leukemia|acute myeloid leukemia
831281|NCT00111319|Front Line|front line
831282|NCT00111319|Multiple Myeloma|multiple myeloma
831283|NCT00111319|Untreated|untreated
831284|NCT00111306|Lupus|lupus
831285|NCT00111306|Antibody|antibody
831286|NCT00111306|B-cell immunotherapy|b-cell immunotherapy
831287|NCT00111293|Attention|attention
831288|NCT00111293|Executive Function|executive function
831289|NCT00111293|Vision|vision
831290|NCT00111293|fMRI|fmri
831291|NCT00111293|Top-Down|top-down
831292|NCT00111293|Visual Processing|visual processing
831293|NCT00111293|Lesion|lesion
831294|NCT00111293|Prefrontal|prefrontal
831295|NCT00111293|Parietal|parietal
831296|NCT00111293|Focal Brain Lesion|focal brain lesion
831297|NCT00111293|Healthy Volunteer|healthy volunteer
831298|NCT00111280|HIV infection|hiv infection
831299|NCT00111280|TMC125|tmc125
831300|NCT00111280|Nucleoside reverse transcriptase inhibitors (NRTIs)|nucleoside reverse transcriptase inhibitors (nrtis)
831301|NCT00111280|roll-over trial|roll-over trial
831302|NCT00111280|antiretrovirals (ARVs)|antiretrovirals (arvs)
831303|NCT00111267|vitamin B12|vitamin b12
831304|NCT00111267|cognitive function|cognitive function
831305|NCT00111267|oral supplementation|oral supplementation
831306|NCT00111267|elderly|elderly
831307|NCT00111254|microdermabrasion|microdermabrasion
831308|NCT00111254|skin|skin
831309|NCT00111254|wrinkles|wrinkles
831310|NCT00111254|collagen|collagen
831311|NCT00111254|photoaging|photoaging
831312|NCT00111254|wrinkled skin|wrinkled skin
831313|NCT00111241|bone fracture|bone fracture
831314|NCT00111241|cartilage|cartilage
831315|NCT00111241|osteoporosis|osteoporosis
831316|NCT00111241|breast cancer|breast cancer
831317|NCT00111241|aromatase inhibitors|aromatase inhibitors
831318|NCT00111241|knee articular cartilage volume|knee articular cartilage volume
831319|NCT00111228|Diabetes|diabetes
831320|NCT00111215|Menorrhagia|menorrhagia
831321|NCT00111215|Von Willebrand's Disease|von willebrand's disease
831322|NCT00111215|Platelet Disorder|platelet disorder
831323|NCT00111202|Genetic counseling|genetic counseling
831324|NCT00111202|Genetic counselling|genetic counselling
831325|NCT00111202|Genetics|genetics
831326|NCT00111202|Schizophrenia|schizophrenia
831327|NCT00111189|Schizophrenia|schizophrenia
831328|NCT00111189|Paliperidone palmitate|paliperidone palmitate
831329|NCT00111189|R092670|r092670
831330|NCT00111189|antipsychotic|antipsychotic
831331|NCT00111189|recurrence prevention|recurrence prevention
831332|NCT00111176|Thoracic Aortic Aneurysm|thoracic aortic aneurysm
831333|NCT00111176|Descending|descending
831334|NCT00111176|minimally invasive|minimally invasive
831335|NCT00111176|endovascular|endovascular
831336|NCT00111176|rupture|rupture
831337|NCT00111176|back pain|back pain
831338|NCT00111176|stent graft|stent graft
831339|NCT00111176|endovascular aneurysm repair|endovascular aneurysm repair
831340|NCT00111176|aortic aneurysm|aortic aneurysm
831341|NCT00111176|thoracic|thoracic
831342|NCT00111163|malaria|malaria
831343|NCT00111163|anemia|anemia
832249|NCT00108901|obesity|obesity
831344|NCT00111163|Plasmodium falciparum|plasmodium falciparum
831345|NCT00111163|infants|infants
831346|NCT00111163|prevention|prevention
831347|NCT00111163|safety|safety
831348|NCT00111163|efficacy|efficacy
831349|NCT00111163|antimalarials|antimalarials
831350|NCT00111150|HIV incidence|hiv incidence
831351|NCT00111150|HIV prevention|hiv prevention
831352|NCT00111137|darbepoetin alfa|darbepoetin alfa
831353|NCT00111137|anemia|anemia
831354|NCT00111137|Amgen|amgen
831355|NCT00111137|Chemotherapy|chemotherapy
831356|NCT00111124|psoriasis|psoriasis
831357|NCT00111124|arthritis|arthritis
831358|NCT00111124|Enbrel®|enbrel®
831359|NCT00111124|etanercept|etanercept
831360|NCT00111111|Psoriasis|psoriasis
831361|NCT00111098|Anemia|anemia
831362|NCT00111098|Chronic Kidney Disease (CKD)|chronic kidney disease (ckd)
831363|NCT00111085|delayed ischemic neurological deficits (DIND)|delayed ischemic neurological deficits (dind)
831364|NCT00111085|vasospasm|vasospasm
831365|NCT00111085|clazosentan|clazosentan
831366|NCT00111085|cerebral vasospasm|cerebral vasospasm
831367|NCT00111085|computer tomography scan (CT scan)|computer tomography scan (ct scan)
831368|NCT00111085|digital subtraction angiography (DSA)|digital subtraction angiography (dsa)
831369|NCT00111085|endothelin A receptor|endothelin a receptor
831370|NCT00111085|aneurysmal subarachnoid hemorrhage (aSAH)|aneurysmal subarachnoid hemorrhage (asah)
831371|NCT00111059|obesity|obesity
831372|NCT00111059|cardiovascular disease|cardiovascular disease
831373|NCT00111059|depression|depression
831374|NCT00111059|stress|stress
831375|NCT00111046|Pain Relief|pain relief
831376|NCT00111046|Choroidal melanoma|choroidal melanoma
831377|NCT00111046|plaque radiotherapy|plaque radiotherapy
831378|NCT00110981|psoriasis|psoriasis
831379|NCT00110981|dermatology|dermatology
831380|NCT00110981|plaque psoriasis|plaque psoriasis
831381|NCT00110981|skin|skin
831382|NCT00110981|etanercept|etanercept
831383|NCT00110981|ENBREL|enbrel
831384|NCT00110981|NB-UVB, narrow-band UVB, phototherapy|nb-uvb, narrow-band uvb, phototherapy
831385|NCT00110981|combination therapy, 50 mg prefilled syringes|combination therapy, 50 mg prefilled syringes
831386|NCT00110968|Abdominal Symptom relief|abdominal symptom relief
831387|NCT00110968|Fullness|fullness
831388|NCT00110968|Bloating|bloating
831389|NCT00110968|Indigestion|indigestion
831390|NCT00110968|Functional dyspepsia|functional dyspepsia
831391|NCT00110955|Non-myeloid malignancy|non-myeloid malignancy
831392|NCT00110955|Chemotherapy-induced anemia|chemotherapy-induced anemia
831393|NCT00110942|Intra-articular|intra-articular
831394|NCT00110942|Osteoarthritis|osteoarthritis
831396|NCT00110942|anakinra|anakinra
831397|NCT00110942|Amgen|amgen
831398|NCT00110929|Sensipar®|sensipar®
831399|NCT00110929|Secondary HPT|secondary hpt
831400|NCT00110929|Mimpara®|mimpara®
831401|NCT00110929|Cinacalcet|cinacalcet
831402|NCT00110929|calcimimetic|calcimimetic
831403|NCT00110929|End-Stage Renal Disease (ESRD)|end-stage renal disease (esrd)
831404|NCT00110916|Intra-articular|intra-articular
831405|NCT00110916|Osteoarthritis|osteoarthritis
831406|NCT00110916|OA|oa
831407|NCT00110916|anakinra|anakinra
831408|NCT00110916|Amgen|amgen
831409|NCT00110903|Rheumatoid arthritis|rheumatoid arthritis
831410|NCT00110903|RA|ra
831411|NCT00110903|etanercept|etanercept
831412|NCT00110903|Immunex|immunex
831413|NCT00110903|Amgen|amgen
831414|NCT00110890|Secondary HyperParaThyroidism (SHPT)|secondary hyperparathyroidism (shpt)
831415|NCT00110890|Dialysis, End Stage Renal Disease (ESRD)|dialysis, end stage renal disease (esrd)
831416|NCT00110890|KDOQI, Cinacalcet|kdoqi, cinacalcet
831417|NCT00110890|Clinical Trial, Amgen|clinical trial, amgen
831418|NCT00111072|Mucosal Disease|mucosal disease
831419|NCT00111072|Topical Steroids|topical steroids
831420|NCT00111072|Salivary Diagnostics|salivary diagnostics
831421|NCT00111072|Oral Pain|oral pain
831422|NCT00111072|Quality of Life Indicators|quality of life indicators
831423|NCT00111072|Oral Lichen Planus|oral lichen planus
831424|NCT00110877|Human Immunodeficiency Virus|human immunodeficiency virus
831425|NCT00110877|Treatment Experienced|treatment experienced
831426|NCT00110877|TMC114-C214|tmc114-c214
831427|NCT00110864|diabetes, type 2|diabetes, type 2
831428|NCT00110851|diabetes, type 2|diabetes, type 2
831429|NCT00110838|fish oil|fish oil
831430|NCT00110838|n-3 fatty acids|n-3 fatty acids
831431|NCT00110838|n-3 PUFA|n-3 pufa
831432|NCT00110838|omega-3 fatty acids|omega-3 fatty acids
831433|NCT00110838|arrhythmia|arrhythmia
831434|NCT00110838|ICD|icd
831435|NCT00110838|human|human
831436|NCT00110838|Patients with an implantable cardioverter defibrillator|patients with an implantable cardioverter defibrillator
831437|NCT00110812|Treatment Naive|treatment naive
831438|NCT00110812|IL-2|il-2
831439|NCT00110812|rIL-2|ril-2
831440|NCT00110799|thrombopoietin|thrombopoietin
831441|NCT00110799|platelets|platelets
831442|NCT00110799|Hepatitis C-related thrombocytopenia|hepatitis c-related thrombocytopenia
831443|NCT00110799|Hepatitis C|hepatitis c
831444|NCT00110786|Allergy|allergy
831445|NCT00110786|Specific Immunotherapy|specific immunotherapy
831447|NCT00110786|Environmental Exposure Chamber|environmental exposure chamber
831448|NCT00110721|colorectal cancer|colorectal cancer
831450|NCT00110721|5-fluorouracil|5-fluorouracil
831451|NCT00110708|autism|autism
831452|NCT00110708|gastrointestinal dysfunction|gastrointestinal dysfunction
831453|NCT00110708|autistic disorder|autistic disorder
831454|NCT00110708|diarrhea|diarrhea
831455|NCT00110708|constipation|constipation
831456|NCT00110708|abdominal pain|abdominal pain
831457|NCT00110708|gastrointestinal problems associated with autism|gastrointestinal problems associated with autism
831458|NCT00110708|immune globulin|immune globulin
831459|NCT00110708|immunoglobulin|immunoglobulin
831460|NCT00110708|Immunoglobulins, Intravenous|immunoglobulins, intravenous
831461|NCT00110708|Intestinal Mucosa/immunology/pathology|intestinal mucosa/immunology/pathology
831462|NCT00110708|Administration, Oral|administration, oral
831463|NCT00110708|Autistic Disorder/*drug therapy|autistic disorder/*drug therapy
831464|NCT00110708|Child Behavior/*drug effects|child behavior/*drug effects
831465|NCT00110708|Constipation/drug therapy|constipation/drug therapy
831466|NCT00110708|Diarrhea/drug therapy|diarrhea/drug therapy
831467|NCT00110708|Gastrointestinal Agents/*therapeutic use|gastrointestinal agents/*therapeutic use
831468|NCT00110695|NSABP|nsabp
831469|NCT00110695|Abraxis|abraxis
831470|NCT00110695|Abraxane|abraxane
831471|NCT00110695|Locally advanced breast cancer|locally advanced breast cancer
831472|NCT00110695|Fluorouracil|fluorouracil
831473|NCT00110695|Epirubicin|epirubicin
831474|NCT00110695|Cyclophosphamide|cyclophosphamide
831475|NCT00110695|FEC|fec
831476|NCT00110682|Actinic Keratosis|actinic keratosis
831477|NCT00110682|Cryotherapy|cryotherapy
831478|NCT00110682|Imiquimod|imiquimod
831479|NCT00110669|Muscular dystrophy, Duchenne and Beckers|muscular dystrophy, duchenne and beckers
831480|NCT00110669|Beckers Muscular dystrophy|beckers muscular dystrophy
831481|NCT00110656|Kidney transplant|kidney transplant
831482|NCT00110643|Acne|acne
831483|NCT00110643|laser|laser
831484|NCT00110630|nicotine dependence|nicotine dependence
831485|NCT00110617|Sickle Cell Disease|sickle cell disease
831486|NCT00110617|Iron Overload from Repeated Blood Transfusions|iron overload from repeated blood transfusions
831487|NCT00110617|Iron Overload|iron overload
831488|NCT00110617|Blood Transfusions|blood transfusions
831489|NCT00110604|Folic acid|folic acid
831490|NCT00110604|Atherosclerosis|atherosclerosis
831491|NCT00110604|Cognitive function|cognitive function
831492|NCT00110604|Hearing|hearing
831493|NCT00110604|Inflammation|inflammation
831494|NCT00110604|Hemostasis|hemostasis
831495|NCT00110604|Arterial stiffness|arterial stiffness
831496|NCT00110578|Treatment Naive|treatment naive
831497|NCT00110578|Treatment Experienced|treatment experienced
831498|NCT00110565|Magnetics|magnetics
831499|NCT00110565|Pulsed Magnetic Pad|pulsed magnetic pad
831500|NCT00110565|Magnetic Field|magnetic field
831501|NCT00110565|Electromagnetic Field|electromagnetic field
831502|NCT00110565|Women|women
831503|NCT00110565|Pulsed Magnetic Field|pulsed magnetic field
831504|NCT00110539|Medicine, Herbal|medicine, herbal
831505|NCT00110539|Dietary Supplements|dietary supplements
831506|NCT00110539|Complementary and Alternative Medicine|complementary and alternative medicine
831507|NCT00110539|Physicians|physicians
831508|NCT00110526|Prostate Cancer|prostate cancer
831509|NCT00110526|Radiation Therapy|radiation therapy
831510|NCT00110526|Local recurrence|local recurrence
831511|NCT00110526|Gene Therapy|gene therapy
831512|NCT00110513|Antithrombin Deficiency, Congenital or Hereditary|antithrombin deficiency, congenital or hereditary
831513|NCT00110513|Antithrombin III Deficiency|antithrombin iii deficiency
831514|NCT00110513|ATIII|atiii
831515|NCT00110513|Hereditary Antithrombin Deficiency (HD)|hereditary antithrombin deficiency (hd)
831516|NCT00110500|Diabetes|diabetes
831517|NCT00110500|Neuropathy|neuropathy
831518|NCT00110487|Endometriosis|endometriosis
831519|NCT00110474|Glucosamine sulfate|glucosamine sulfate
831520|NCT00110474|Osteoarthritis|osteoarthritis
831521|NCT00110474|Acetaminophen|acetaminophen
831522|NCT00110474|Paracetamol|paracetamol
831523|NCT00110474|Clinical trial|clinical trial
831524|NCT00110461|Aripiprazole|aripiprazole
831525|NCT00110461|Bipolar I Disorder, Manic or Mixed Episode with or without Psychotic Features|bipolar i disorder, manic or mixed episode with or without psychotic features
831526|NCT00110448|type 2 diabetes|type 2 diabetes
831527|NCT00110448|coronary heart diseases|coronary heart diseases
831528|NCT00110448|primary prevention|primary prevention
831529|NCT00110448|atherosclerosis|atherosclerosis
831530|NCT00110448|aspirin|aspirin
831531|NCT00110422|Metabolic Syndrome|metabolic syndrome
831532|NCT00110396|Multiple Sclerosis|multiple sclerosis
831533|NCT00110396|Relapsing forms of multiple sclerosis|relapsing forms of multiple sclerosis
831534|NCT00110344|Cancer|cancer
831535|NCT00110331|Encephalopathy|encephalopathy
831536|NCT00110331|Neuroimaging|neuroimaging
831537|NCT00110331|Cognition|cognition
831538|NCT00110331|Neuroinflammation|neuroinflammation
831539|NCT00110331|Opportunistic Infections|opportunistic infections
831540|NCT00110331|HIV|hiv
831541|NCT00110331|Central Nervous System Disease|central nervous system disease
831542|NCT00110331|Bipolar Disorder|bipolar disorder
831543|NCT00110331|Attention Deficit Hyperactivity Disorder|attention deficit hyperactivity disorder
831545|NCT00110331|Major Depression|major depression
831546|NCT00110331|Psychosis|psychosis
831547|NCT00110318|Tennis Elbow|tennis elbow
831548|NCT00110318|Physical Therapy Techniques|physical therapy techniques
831549|NCT00110318|Evidence-Based Medicine|evidence-based medicine
831550|NCT00110318|Primary Health Care|primary health care
831551|NCT00110305|Human Immunodeficiency Virus Type 1|human immunodeficiency virus type 1
831552|NCT00110305|Human immunodeficiency virus (HIV)|human immunodeficiency virus (hiv)
831553|NCT00110305|Antiretroviral|antiretroviral
831554|NCT00110305|Antiviral|antiviral
831556|NCT00110305|TMC278|tmc278
831557|NCT00110305|Efavirenz|efavirenz
831558|NCT00110305|Combivir|combivir
831559|NCT00110305|Truvada|truvada
831560|NCT00110305|Zidovudine|zidovudine
831561|NCT00110305|Lamivudine|lamivudine
831562|NCT00110305|Tenofovir disoproxil fumarate|tenofovir disoproxil fumarate
831563|NCT00110305|Emtricitabine|emtricitabine
831564|NCT00110292|Public health|public health
831565|NCT00110292|Primary care|primary care
831566|NCT00110292|Parenting education|parenting education
831567|NCT00110292|Child rearing|child rearing
831568|NCT00110292|Parenting newsletters|parenting newsletters
831569|NCT00110292|Child development|child development
831570|NCT00110292|Language delay|language delay
831571|NCT00110279|Bird Flu|bird flu
831572|NCT00110266|ICL670|icl670
831573|NCT00110266|Deferasirox|deferasirox
831574|NCT00110266|Iron chelation|iron chelation
831575|NCT00110266|Chelator|chelator
831576|NCT00110266|Desferal|desferal
831577|NCT00110240|Type 2 diabetes|type 2 diabetes
831578|NCT00110240|vildagliptin|vildagliptin
831579|NCT00110227|Complementary Therapies|complementary therapies
831580|NCT00110227|Tai Chi|tai chi
831581|NCT00110201|Acute renal failure|acute renal failure
831582|NCT00110201|Nesiritide|nesiritide
831583|NCT00110201|Cardiovascular surgery|cardiovascular surgery
831584|NCT00110188|prostate|prostate
831585|NCT00110188|cancer|cancer
831586|NCT00110175|Cortical Reorganization|cortical reorganization
831587|NCT00110175|Motor Function|motor function
831588|NCT00110175|Somatosensory Stimulation|somatosensory stimulation
831589|NCT00110175|Rehabilitation|rehabilitation
831590|NCT00110175|Transcranial Direct Current Stimulation (tDCS)|transcranial direct current stimulation (tdcs)
831591|NCT00110175|Direct Current Stimulation|direct current stimulation
831592|NCT00110175|Stroke|stroke
831593|NCT00110175|Healthy Volunteer|healthy volunteer
831594|NCT00110162|adenocarcinoma of the prostate|adenocarcinoma of the prostate
831595|NCT00110162|stage I prostate cancer|stage i prostate cancer
831596|NCT00110162|stage IIB prostate cancer|stage iib prostate cancer
831597|NCT00110162|stage IIA prostate cancer|stage iia prostate cancer
831598|NCT00110162|stage III prostate cancer|stage iii prostate cancer
831599|NCT00110162|stage IV prostate cancer|stage iv prostate cancer
831600|NCT00110162|recurrent prostate cancer|recurrent prostate cancer
831601|NCT00110149|contiguous stage II grade 1 follicular lymphoma|contiguous stage ii grade 1 follicular lymphoma
831602|NCT00110149|noncontiguous stage II grade 1 follicular lymphoma|noncontiguous stage ii grade 1 follicular lymphoma
831603|NCT00110149|stage I grade 1 follicular lymphoma|stage i grade 1 follicular lymphoma
831604|NCT00110149|stage III grade 1 follicular lymphoma|stage iii grade 1 follicular lymphoma
831605|NCT00110149|stage IV grade 1 follicular lymphoma|stage iv grade 1 follicular lymphoma
831606|NCT00110149|contiguous stage II grade 2 follicular lymphoma|contiguous stage ii grade 2 follicular lymphoma
831607|NCT00110149|noncontiguous stage II grade 2 follicular lymphoma|noncontiguous stage ii grade 2 follicular lymphoma
831608|NCT00110149|stage I grade 2 follicular lymphoma|stage i grade 2 follicular lymphoma
831609|NCT00110149|stage III grade 2 follicular lymphoma|stage iii grade 2 follicular lymphoma
831610|NCT00110149|stage IV grade 2 follicular lymphoma|stage iv grade 2 follicular lymphoma
831611|NCT00110149|contiguous stage II marginal zone lymphoma|contiguous stage ii marginal zone lymphoma
831612|NCT00110149|noncontiguous stage II marginal zone lymphoma|noncontiguous stage ii marginal zone lymphoma
831613|NCT00110149|splenic marginal zone lymphoma|splenic marginal zone lymphoma
831614|NCT00110149|stage I marginal zone lymphoma|stage i marginal zone lymphoma
831615|NCT00110149|stage III marginal zone lymphoma|stage iii marginal zone lymphoma
831616|NCT00110149|stage IV marginal zone lymphoma|stage iv marginal zone lymphoma
831617|NCT00110149|extranodal marginal zone B-cell lymphoma of mucosa-associated lymphoid tissue|extranodal marginal zone b-cell lymphoma of mucosa-associated lymphoid tissue
831618|NCT00110149|nodal marginal zone B-cell lymphoma|nodal marginal zone b-cell lymphoma
831619|NCT00110149|contiguous stage II small lymphocytic lymphoma|contiguous stage ii small lymphocytic lymphoma
831620|NCT00110149|noncontiguous stage II small lymphocytic lymphoma|noncontiguous stage ii small lymphocytic lymphoma
831621|NCT00110149|stage I small lymphocytic lymphoma|stage i small lymphocytic lymphoma
831622|NCT00110149|stage III small lymphocytic lymphoma|stage iii small lymphocytic lymphoma
831623|NCT00110149|stage IV small lymphocytic lymphoma|stage iv small lymphocytic lymphoma
831624|NCT00110136|recurrent breast cancer|recurrent breast cancer
831625|NCT00110136|stage I breast cancer|stage i breast cancer
831626|NCT00110136|stage II breast cancer|stage ii breast cancer
831627|NCT00110136|stage IIIA breast cancer|stage iiia breast cancer
831628|NCT00110136|stage IIIB breast cancer|stage iiib breast cancer
831629|NCT00110136|breast cancer in situ|breast cancer in situ
832251|NCT00108901|exercise|exercise
831630|NCT00110136|ductal breast carcinoma in situ|ductal breast carcinoma in situ
831631|NCT00110136|hot flashes|hot flashes
831632|NCT00110123|liver metastases|liver metastases
831633|NCT00110123|ciliary body and choroid melanoma, medium/large size|ciliary body and choroid melanoma, medium/large size
831634|NCT00110123|iris melanoma|iris melanoma
831635|NCT00110123|extraocular extension melanoma|extraocular extension melanoma
831636|NCT00110123|recurrent intraocular melanoma|recurrent intraocular melanoma
831637|NCT00110123|metastatic intraocular melanoma|metastatic intraocular melanoma
831638|NCT00110110|intraocular retinoblastoma|intraocular retinoblastoma
831639|NCT00110084|recurrent breast cancer|recurrent breast cancer
831640|NCT00110084|stage IV breast cancer|stage iv breast cancer
831641|NCT00110058|accelerated phase chronic myelogenous leukemia|accelerated phase chronic myelogenous leukemia
831642|NCT00110058|childhood chronic myelogenous leukemia|childhood chronic myelogenous leukemia
831643|NCT00110058|chronic phase chronic myelogenous leukemia|chronic phase chronic myelogenous leukemia
831644|NCT00110058|Philadelphia chromosome positive chronic myelogenous leukemia|philadelphia chromosome positive chronic myelogenous leukemia
831645|NCT00110058|relapsing chronic myelogenous leukemia|relapsing chronic myelogenous leukemia
831646|NCT00110045|infection|infection
831647|NCT00110045|ataxia-telangiectasia|ataxia-telangiectasia
831648|NCT00110045|accelerated phase chronic myelogenous leukemia|accelerated phase chronic myelogenous leukemia
831649|NCT00110045|acute undifferentiated leukemia|acute undifferentiated leukemia
831650|NCT00110045|blastic phase chronic myelogenous leukemia|blastic phase chronic myelogenous leukemia
831651|NCT00110045|meningeal chronic myelogenous leukemia|meningeal chronic myelogenous leukemia
831652|NCT00110045|relapsing chronic myelogenous leukemia|relapsing chronic myelogenous leukemia
831653|NCT00110045|chronic eosinophilic leukemia|chronic eosinophilic leukemia
831654|NCT00110045|primary myelofibrosis|primary myelofibrosis
831655|NCT00110045|chronic neutrophilic leukemia|chronic neutrophilic leukemia
831656|NCT00110045|essential thrombocythemia|essential thrombocythemia
831657|NCT00110045|polycythemia vera|polycythemia vera
831658|NCT00110045|adult acute lymphoblastic leukemia in remission|adult acute lymphoblastic leukemia in remission
831659|NCT00110045|recurrent adult acute lymphoblastic leukemia|recurrent adult acute lymphoblastic leukemia
831660|NCT00110045|adult acute myeloid leukemia with 11q23 (MLL) abnormalities|adult acute myeloid leukemia with 11q23 (mll) abnormalities
831661|NCT00110045|adult acute myeloid leukemia with inv(16)(p13;q22)|adult acute myeloid leukemia with inv(16)(p13;q22)
831662|NCT00110045|adult acute myeloid leukemia with t(15;17)(q22;q12)|adult acute myeloid leukemia with t(15;17)(q22;q12)
831663|NCT00110045|adult acute myeloid leukemia with t(16;16)(p13;q22)|adult acute myeloid leukemia with t(16;16)(p13;q22)
831664|NCT00110045|adult acute myeloid leukemia with t(8;21)(q22;q22)|adult acute myeloid leukemia with t(8;21)(q22;q22)
831665|NCT00110045|adult acute myeloid leukemia in remission|adult acute myeloid leukemia in remission
831666|NCT00110045|recurrent adult T-cell leukemia/lymphoma|recurrent adult t-cell leukemia/lymphoma
831667|NCT00110045|stage I adult T-cell leukemia/lymphoma|stage i adult t-cell leukemia/lymphoma
831668|NCT00110045|stage II adult T-cell leukemia/lymphoma|stage ii adult t-cell leukemia/lymphoma
831669|NCT00110045|stage III adult T-cell leukemia/lymphoma|stage iii adult t-cell leukemia/lymphoma
831670|NCT00110045|stage IV adult T-cell leukemia/lymphoma|stage iv adult t-cell leukemia/lymphoma
831948|NCT00109863|recurrent melanoma|recurrent melanoma
831671|NCT00110045|refractory chronic lymphocytic leukemia|refractory chronic lymphocytic leukemia
831672|NCT00110045|stage 0 chronic lymphocytic leukemia|stage 0 chronic lymphocytic leukemia
831673|NCT00110045|stage I chronic lymphocytic leukemia|stage i chronic lymphocytic leukemia
831674|NCT00110045|stage II chronic lymphocytic leukemia|stage ii chronic lymphocytic leukemia
831675|NCT00110045|stage III chronic lymphocytic leukemia|stage iii chronic lymphocytic leukemia
831676|NCT00110045|stage IV chronic lymphocytic leukemia|stage iv chronic lymphocytic leukemia
831677|NCT00110045|progressive hairy cell leukemia, initial treatment|progressive hairy cell leukemia, initial treatment
831678|NCT00110045|refractory hairy cell leukemia|refractory hairy cell leukemia
831679|NCT00110045|prolymphocytic leukemia|prolymphocytic leukemia
831680|NCT00110045|recurrent adult Hodgkin lymphoma|recurrent adult hodgkin lymphoma
831681|NCT00110045|stage I adult Hodgkin lymphoma|stage i adult hodgkin lymphoma
831682|NCT00110045|stage II adult Hodgkin lymphoma|stage ii adult hodgkin lymphoma
831683|NCT00110045|stage III adult Hodgkin lymphoma|stage iii adult hodgkin lymphoma
831684|NCT00110045|stage IV adult Hodgkin lymphoma|stage iv adult hodgkin lymphoma
831685|NCT00110045|anaplastic large cell lymphoma|anaplastic large cell lymphoma
831686|NCT00110045|angioimmunoblastic T-cell lymphoma|angioimmunoblastic t-cell lymphoma
831687|NCT00110045|recurrent mycosis fungoides/Sezary syndrome|recurrent mycosis fungoides/sezary syndrome
831688|NCT00110045|stage I mycosis fungoides/Sezary syndrome|stage i mycosis fungoides/sezary syndrome
831689|NCT00110045|stage II mycosis fungoides/Sezary syndrome|stage ii mycosis fungoides/sezary syndrome
831690|NCT00110045|stage III mycosis fungoides/Sezary syndrome|stage iii mycosis fungoides/sezary syndrome
831691|NCT00110045|stage IV mycosis fungoides/Sezary syndrome|stage iv mycosis fungoides/sezary syndrome
831692|NCT00110045|recurrent cutaneous T-cell non-Hodgkin lymphoma|recurrent cutaneous t-cell non-hodgkin lymphoma
831693|NCT00110045|stage I cutaneous T-cell non-Hodgkin lymphoma|stage i cutaneous t-cell non-hodgkin lymphoma
832043|NCT00109590|Vertical Transmission|vertical transmission
831694|NCT00110045|stage II cutaneous T-cell non-Hodgkin lymphoma|stage ii cutaneous t-cell non-hodgkin lymphoma
831695|NCT00110045|stage III cutaneous T-cell non-Hodgkin lymphoma|stage iii cutaneous t-cell non-hodgkin lymphoma
831696|NCT00110045|stage IV cutaneous T-cell non-Hodgkin lymphoma|stage iv cutaneous t-cell non-hodgkin lymphoma
831697|NCT00110045|adult grade III lymphomatoid granulomatosis|adult grade iii lymphomatoid granulomatosis
831698|NCT00110045|recurrent adult grade III lymphomatoid granulomatosis|recurrent adult grade iii lymphomatoid granulomatosis
831699|NCT00110045|Waldenstrom macroglobulinemia|waldenstrom macroglobulinemia
831700|NCT00110045|extranodal marginal zone B-cell lymphoma of mucosa-associated lymphoid tissue|extranodal marginal zone b-cell lymphoma of mucosa-associated lymphoid tissue
831701|NCT00110045|nodal marginal zone B-cell lymphoma|nodal marginal zone b-cell lymphoma
831702|NCT00110045|recurrent adult Burkitt lymphoma|recurrent adult burkitt lymphoma
831703|NCT00110045|recurrent adult diffuse large cell lymphoma|recurrent adult diffuse large cell lymphoma
831704|NCT00110045|recurrent adult diffuse mixed cell lymphoma|recurrent adult diffuse mixed cell lymphoma
831705|NCT00110045|recurrent adult diffuse small cleaved cell lymphoma|recurrent adult diffuse small cleaved cell lymphoma
831706|NCT00110045|recurrent adult immunoblastic large cell lymphoma|recurrent adult immunoblastic large cell lymphoma
831707|NCT00110045|recurrent adult lymphoblastic lymphoma|recurrent adult lymphoblastic lymphoma
831708|NCT00110045|recurrent grade 3 follicular lymphoma|recurrent grade 3 follicular lymphoma
831709|NCT00110045|recurrent mantle cell lymphoma|recurrent mantle cell lymphoma
831710|NCT00110045|recurrent grade 1 follicular lymphoma|recurrent grade 1 follicular lymphoma
831711|NCT00110045|recurrent grade 2 follicular lymphoma|recurrent grade 2 follicular lymphoma
831712|NCT00110045|recurrent marginal zone lymphoma|recurrent marginal zone lymphoma
831713|NCT00110045|recurrent small lymphocytic lymphoma|recurrent small lymphocytic lymphoma
831714|NCT00110045|contiguous stage II adult Burkitt lymphoma|contiguous stage ii adult burkitt lymphoma
831715|NCT00110045|noncontiguous stage II adult Burkitt lymphoma|noncontiguous stage ii adult burkitt lymphoma
831716|NCT00110045|stage I adult Burkitt lymphoma|stage i adult burkitt lymphoma
831717|NCT00110045|stage III adult Burkitt lymphoma|stage iii adult burkitt lymphoma
831718|NCT00110045|stage IV adult Burkitt lymphoma|stage iv adult burkitt lymphoma
831719|NCT00110045|contiguous stage II adult diffuse large cell lymphoma|contiguous stage ii adult diffuse large cell lymphoma
831720|NCT00110045|noncontiguous stage II adult diffuse large cell lymphoma|noncontiguous stage ii adult diffuse large cell lymphoma
831721|NCT00110045|stage I adult diffuse large cell lymphoma|stage i adult diffuse large cell lymphoma
831722|NCT00110045|stage III adult diffuse large cell lymphoma|stage iii adult diffuse large cell lymphoma
831723|NCT00110045|stage IV adult diffuse large cell lymphoma|stage iv adult diffuse large cell lymphoma
831724|NCT00110045|contiguous stage II adult diffuse mixed cell lymphoma|contiguous stage ii adult diffuse mixed cell lymphoma
831725|NCT00110045|noncontiguous stage II adult diffuse mixed cell lymphoma|noncontiguous stage ii adult diffuse mixed cell lymphoma
831726|NCT00110045|stage I adult diffuse mixed cell lymphoma|stage i adult diffuse mixed cell lymphoma
831727|NCT00110045|stage III adult diffuse mixed cell lymphoma|stage iii adult diffuse mixed cell lymphoma
831728|NCT00110045|stage IV adult diffuse mixed cell lymphoma|stage iv adult diffuse mixed cell lymphoma
831729|NCT00110045|contiguous stage II adult immunoblastic large cell lymphoma|contiguous stage ii adult immunoblastic large cell lymphoma
831730|NCT00110045|noncontiguous stage II adult immunoblastic large cell lymphoma|noncontiguous stage ii adult immunoblastic large cell lymphoma
831731|NCT00110045|stage I adult immunoblastic large cell lymphoma|stage i adult immunoblastic large cell lymphoma
831732|NCT00110045|stage III adult immunoblastic large cell lymphoma|stage iii adult immunoblastic large cell lymphoma
831733|NCT00110045|stage IV adult immunoblastic large cell lymphoma|stage iv adult immunoblastic large cell lymphoma
831734|NCT00110045|contiguous stage II adult lymphoblastic lymphoma|contiguous stage ii adult lymphoblastic lymphoma
831735|NCT00110045|noncontiguous stage II adult lymphoblastic lymphoma|noncontiguous stage ii adult lymphoblastic lymphoma
831736|NCT00110045|stage I adult lymphoblastic lymphoma|stage i adult lymphoblastic lymphoma
831737|NCT00110045|stage III adult lymphoblastic lymphoma|stage iii adult lymphoblastic lymphoma
831738|NCT00110045|stage IV adult lymphoblastic lymphoma|stage iv adult lymphoblastic lymphoma
831739|NCT00110045|contiguous stage II grade 1 follicular lymphoma|contiguous stage ii grade 1 follicular lymphoma
831740|NCT00110045|noncontiguous stage II grade 1 follicular lymphoma|noncontiguous stage ii grade 1 follicular lymphoma
831741|NCT00110045|stage I grade 1 follicular lymphoma|stage i grade 1 follicular lymphoma
831742|NCT00110045|stage III grade 1 follicular lymphoma|stage iii grade 1 follicular lymphoma
831743|NCT00110045|stage IV grade 1 follicular lymphoma|stage iv grade 1 follicular lymphoma
831744|NCT00110045|contiguous stage II grade 2 follicular lymphoma|contiguous stage ii grade 2 follicular lymphoma
831745|NCT00110045|noncontiguous stage II grade 2 follicular lymphoma|noncontiguous stage ii grade 2 follicular lymphoma
831746|NCT00110045|stage I grade 2 follicular lymphoma|stage i grade 2 follicular lymphoma
831747|NCT00110045|stage III grade 2 follicular lymphoma|stage iii grade 2 follicular lymphoma
831748|NCT00110045|stage IV grade 2 follicular lymphoma|stage iv grade 2 follicular lymphoma
831749|NCT00110045|contiguous stage II grade 3 follicular lymphoma|contiguous stage ii grade 3 follicular lymphoma
831750|NCT00110045|noncontiguous stage II grade 3 follicular lymphoma|noncontiguous stage ii grade 3 follicular lymphoma
831751|NCT00110045|stage I grade 3 follicular lymphoma|stage i grade 3 follicular lymphoma
831752|NCT00110045|stage III grade 3 follicular lymphoma|stage iii grade 3 follicular lymphoma
831753|NCT00110045|stage IV grade 3 follicular lymphoma|stage iv grade 3 follicular lymphoma
832245|NCT00108901|prevention|prevention
831754|NCT00110045|contiguous stage II mantle cell lymphoma|contiguous stage ii mantle cell lymphoma
831755|NCT00110045|noncontiguous stage II mantle cell lymphoma|noncontiguous stage ii mantle cell lymphoma
831756|NCT00110045|stage I mantle cell lymphoma|stage i mantle cell lymphoma
831757|NCT00110045|stage III mantle cell lymphoma|stage iii mantle cell lymphoma
831758|NCT00110045|stage IV mantle cell lymphoma|stage iv mantle cell lymphoma
831759|NCT00110045|contiguous stage II marginal zone lymphoma|contiguous stage ii marginal zone lymphoma
831760|NCT00110045|noncontiguous stage II marginal zone lymphoma|noncontiguous stage ii marginal zone lymphoma
831761|NCT00110045|stage I marginal zone lymphoma|stage i marginal zone lymphoma
831949|NCT00109863|stage IV melanoma|stage iv melanoma
831762|NCT00110045|stage III marginal zone lymphoma|stage iii marginal zone lymphoma
831763|NCT00110045|stage IV marginal zone lymphoma|stage iv marginal zone lymphoma
831764|NCT00110045|splenic marginal zone lymphoma|splenic marginal zone lymphoma
831765|NCT00110045|contiguous stage II small lymphocytic lymphoma|contiguous stage ii small lymphocytic lymphoma
831766|NCT00110045|noncontiguous stage II small lymphocytic lymphoma|noncontiguous stage ii small lymphocytic lymphoma
831767|NCT00110045|stage I small lymphocytic lymphoma|stage i small lymphocytic lymphoma
831768|NCT00110045|stage III small lymphocytic lymphoma|stage iii small lymphocytic lymphoma
831769|NCT00110045|stage IV small lymphocytic lymphoma|stage iv small lymphocytic lymphoma
831770|NCT00110045|intraocular lymphoma|intraocular lymphoma
831771|NCT00110045|primary central nervous system non-Hodgkin lymphoma|primary central nervous system non-hodgkin lymphoma
831772|NCT00110045|post-transplant lymphoproliferative disorder|post-transplant lymphoproliferative disorder
831773|NCT00110045|extramedullary plasmacytoma|extramedullary plasmacytoma
831774|NCT00110045|isolated plasmacytoma of bone|isolated plasmacytoma of bone
831775|NCT00110045|monoclonal gammopathy of undetermined significance|monoclonal gammopathy of undetermined significance
831776|NCT00110045|stage I multiple myeloma|stage i multiple myeloma
831777|NCT00110045|stage II multiple myeloma|stage ii multiple myeloma
831778|NCT00110045|stage III multiple myeloma|stage iii multiple myeloma
831779|NCT00110045|primary systemic amyloidosis|primary systemic amyloidosis
831780|NCT00110045|refractory multiple myeloma|refractory multiple myeloma
831781|NCT00110045|de novo myelodysplastic syndromes|de novo myelodysplastic syndromes
831782|NCT00110045|myelodysplastic/myeloproliferative neoplasm, unclassifiable|myelodysplastic/myeloproliferative neoplasm, unclassifiable
831783|NCT00110045|previously treated myelodysplastic syndromes|previously treated myelodysplastic syndromes
831784|NCT00110045|secondary myelodysplastic syndromes|secondary myelodysplastic syndromes
831785|NCT00110045|atypical chronic myeloid leukemia, BCR-ABL1 negative|atypical chronic myeloid leukemia, bcr-abl1 negative
831786|NCT00110045|chronic myelomonocytic leukemia|chronic myelomonocytic leukemia
831787|NCT00110045|disseminated neuroblastoma|disseminated neuroblastoma
831788|NCT00110045|high risk metastatic gestational trophoblastic tumor|high risk metastatic gestational trophoblastic tumor
831789|NCT00110045|recurrent neuroblastoma|recurrent neuroblastoma
831790|NCT00110045|recurrent ovarian epithelial cancer|recurrent ovarian epithelial cancer
831791|NCT00110045|stage II ovarian epithelial cancer|stage ii ovarian epithelial cancer
831792|NCT00110045|stage III ovarian epithelial cancer|stage iii ovarian epithelial cancer
831793|NCT00110045|stage IV ovarian epithelial cancer|stage iv ovarian epithelial cancer
831794|NCT00110045|recurrent ovarian germ cell tumor|recurrent ovarian germ cell tumor
831795|NCT00110045|recurrent malignant testicular germ cell tumor|recurrent malignant testicular germ cell tumor
831796|NCT00110045|stage III malignant testicular germ cell tumor|stage iii malignant testicular germ cell tumor
831797|NCT00110045|secondary acute myeloid leukemia|secondary acute myeloid leukemia
831798|NCT00110045|stage IIIA breast cancer|stage iiia breast cancer
831799|NCT00110045|stage IIIB breast cancer|stage iiib breast cancer
831800|NCT00110045|stage IIIC breast cancer|stage iiic breast cancer
831801|NCT00110045|stage IV breast cancer|stage iv breast cancer
831802|NCT00110045|chronic phase chronic myelogenous leukemia|chronic phase chronic myelogenous leukemia
831803|NCT00110045|contiguous stage II adult diffuse small cleaved cell lymphoma|contiguous stage ii adult diffuse small cleaved cell lymphoma
831804|NCT00110045|noncontiguous stage II adult diffuse small cleaved cell lymphoma|noncontiguous stage ii adult diffuse small cleaved cell lymphoma
831805|NCT00110045|recurrent adult acute myeloid leukemia|recurrent adult acute myeloid leukemia
831806|NCT00110045|stage I adult diffuse small cleaved cell lymphoma|stage i adult diffuse small cleaved cell lymphoma
831807|NCT00110045|stage III adult diffuse small cleaved cell lymphoma|stage iii adult diffuse small cleaved cell lymphoma
831808|NCT00110045|stage IV adult diffuse small cleaved cell lymphoma|stage iv adult diffuse small cleaved cell lymphoma
831809|NCT00110045|T-cell large granular lymphocyte leukemia|t-cell large granular lymphocyte leukemia
831810|NCT00110006|contiguous stage II grade 3 follicular lymphoma|contiguous stage ii grade 3 follicular lymphoma
831811|NCT00110006|noncontiguous stage II grade 3 follicular lymphoma|noncontiguous stage ii grade 3 follicular lymphoma
831812|NCT00110006|stage I grade 3 follicular lymphoma|stage i grade 3 follicular lymphoma
831813|NCT00110006|stage III grade 3 follicular lymphoma|stage iii grade 3 follicular lymphoma
831814|NCT00110006|stage IV grade 3 follicular lymphoma|stage iv grade 3 follicular lymphoma
831815|NCT00110006|contiguous stage II adult diffuse large cell lymphoma|contiguous stage ii adult diffuse large cell lymphoma
831816|NCT00110006|noncontiguous stage II adult diffuse large cell lymphoma|noncontiguous stage ii adult diffuse large cell lymphoma
831817|NCT00110006|stage I adult diffuse large cell lymphoma|stage i adult diffuse large cell lymphoma
832246|NCT00108901|children|children
831818|NCT00110006|stage III adult diffuse large cell lymphoma|stage iii adult diffuse large cell lymphoma
831819|NCT00110006|stage IV adult diffuse large cell lymphoma|stage iv adult diffuse large cell lymphoma
831820|NCT00110006|contiguous stage II mantle cell lymphoma|contiguous stage ii mantle cell lymphoma
831821|NCT00110006|noncontiguous stage II mantle cell lymphoma|noncontiguous stage ii mantle cell lymphoma
831822|NCT00110006|stage I mantle cell lymphoma|stage i mantle cell lymphoma
831823|NCT00110006|stage III mantle cell lymphoma|stage iii mantle cell lymphoma
831824|NCT00110006|stage IV mantle cell lymphoma|stage iv mantle cell lymphoma
831825|NCT00110006|anaplastic large cell lymphoma|anaplastic large cell lymphoma
831826|NCT00109993|graft versus host disease|graft versus host disease
831827|NCT00109993|accelerated phase chronic myelogenous leukemia|accelerated phase chronic myelogenous leukemia
831828|NCT00109993|adult acute lymphoblastic leukemia in remission|adult acute lymphoblastic leukemia in remission
831829|NCT00109993|adult acute myeloid leukemia in remission|adult acute myeloid leukemia in remission
831830|NCT00109993|adult acute myeloid leukemia with 11q23 (MLL) abnormalities|adult acute myeloid leukemia with 11q23 (mll) abnormalities
831831|NCT00109993|adult acute myeloid leukemia with inv(16)(p13;q22)|adult acute myeloid leukemia with inv(16)(p13;q22)
831832|NCT00109993|adult acute myeloid leukemia with t(15;17)(q22;q12)|adult acute myeloid leukemia with t(15;17)(q22;q12)
831833|NCT00109993|adult acute myeloid leukemia with t(16;16)(p13;q22)|adult acute myeloid leukemia with t(16;16)(p13;q22)
831834|NCT00109993|adult acute myeloid leukemia with t(8;21)(q22;q22)|adult acute myeloid leukemia with t(8;21)(q22;q22)
831835|NCT00109993|atypical chronic myeloid leukemia|atypical chronic myeloid leukemia
831836|NCT00109993|blastic phase chronic myelogenous leukemia|blastic phase chronic myelogenous leukemia
831837|NCT00109993|chronic eosinophilic leukemia|chronic eosinophilic leukemia
831838|NCT00109993|chronic idiopathic myelofibrosis|chronic idiopathic myelofibrosis
831839|NCT00109993|chronic myelomonocytic leukemia|chronic myelomonocytic leukemia
831840|NCT00109993|chronic neutrophilic leukemia|chronic neutrophilic leukemia
831841|NCT00109993|chronic phase chronic myelogenous leukemia|chronic phase chronic myelogenous leukemia
831842|NCT00109993|de novo myelodysplastic syndromes|de novo myelodysplastic syndromes
831843|NCT00109993|disseminated neuroblastoma|disseminated neuroblastoma
831844|NCT00109993|extranodal marginal zone B-cell lymphoma of mucosa-associated lymphoid tissue|extranodal marginal zone b-cell lymphoma of mucosa-associated lymphoid tissue
831845|NCT00109993|myelodysplastic/myeloproliferative disease, unclassifiable|myelodysplastic/myeloproliferative disease, unclassifiable
831846|NCT00109993|nodal marginal zone B-cell lymphoma|nodal marginal zone b-cell lymphoma
831847|NCT00109993|noncontiguous stage II adult Burkitt lymphoma|noncontiguous stage ii adult burkitt lymphoma
831848|NCT00109993|noncontiguous stage II adult diffuse large cell lymphoma|noncontiguous stage ii adult diffuse large cell lymphoma
831849|NCT00109993|noncontiguous stage II adult diffuse mixed cell lymphoma|noncontiguous stage ii adult diffuse mixed cell lymphoma
831850|NCT00109993|noncontiguous stage II adult diffuse small cleaved cell lymphoma|noncontiguous stage ii adult diffuse small cleaved cell lymphoma
831851|NCT00109993|noncontiguous stage II adult immunoblastic large cell lymphoma|noncontiguous stage ii adult immunoblastic large cell lymphoma
831852|NCT00109993|noncontiguous stage II adult lymphoblastic lymphoma|noncontiguous stage ii adult lymphoblastic lymphoma
832073|NCT00109512|painful periods|painful periods
831853|NCT00109993|noncontiguous stage II grade 1 follicular lymphoma|noncontiguous stage ii grade 1 follicular lymphoma
831854|NCT00109993|noncontiguous stage II grade 2 follicular lymphoma|noncontiguous stage ii grade 2 follicular lymphoma
831855|NCT00109993|noncontiguous stage II grade 3 follicular lymphoma|noncontiguous stage ii grade 3 follicular lymphoma
831856|NCT00109993|noncontiguous stage II mantle cell lymphoma|noncontiguous stage ii mantle cell lymphoma
831857|NCT00109993|noncontiguous stage II marginal zone lymphoma|noncontiguous stage ii marginal zone lymphoma
831858|NCT00109993|noncontiguous stage II small lymphocytic lymphoma|noncontiguous stage ii small lymphocytic lymphoma
831859|NCT00109993|poor prognosis metastatic gestational trophoblastic tumor|poor prognosis metastatic gestational trophoblastic tumor
831860|NCT00109993|previously treated myelodysplastic syndromes|previously treated myelodysplastic syndromes
831861|NCT00109993|recurrent adult acute lymphoblastic leukemia|recurrent adult acute lymphoblastic leukemia
831862|NCT00109993|recurrent adult acute myeloid leukemia|recurrent adult acute myeloid leukemia
831863|NCT00109993|recurrent adult Burkitt lymphoma|recurrent adult burkitt lymphoma
831864|NCT00109993|recurrent adult diffuse large cell lymphoma|recurrent adult diffuse large cell lymphoma
831865|NCT00109993|recurrent adult diffuse mixed cell lymphoma|recurrent adult diffuse mixed cell lymphoma
831866|NCT00109993|recurrent adult diffuse small cleaved cell lymphoma|recurrent adult diffuse small cleaved cell lymphoma
831867|NCT00109993|recurrent adult Hodgkin lymphoma|recurrent adult hodgkin lymphoma
831868|NCT00109993|recurrent adult immunoblastic large cell lymphoma|recurrent adult immunoblastic large cell lymphoma
831869|NCT00109993|recurrent adult lymphoblastic lymphoma|recurrent adult lymphoblastic lymphoma
831870|NCT00109993|recurrent grade 1 follicular lymphoma|recurrent grade 1 follicular lymphoma
831871|NCT00109993|recurrent grade 2 follicular lymphoma|recurrent grade 2 follicular lymphoma
831872|NCT00109993|recurrent grade 3 follicular lymphoma|recurrent grade 3 follicular lymphoma
831873|NCT00109993|recurrent cutaneous T-cell non-Hodgkin lymphoma|recurrent cutaneous t-cell non-hodgkin lymphoma
831874|NCT00109993|recurrent mantle cell lymphoma|recurrent mantle cell lymphoma
831875|NCT00109993|recurrent mycosis fungoides/Sezary syndrome|recurrent mycosis fungoides/sezary syndrome
831876|NCT00109993|recurrent marginal zone lymphoma|recurrent marginal zone lymphoma
831877|NCT00109993|recurrent neuroblastoma|recurrent neuroblastoma
832247|NCT00108901|diabetes|diabetes
831878|NCT00109993|recurrent ovarian epithelial cancer|recurrent ovarian epithelial cancer
831879|NCT00109993|recurrent ovarian germ cell tumor|recurrent ovarian germ cell tumor
831880|NCT00109993|recurrent small lymphocytic lymphoma|recurrent small lymphocytic lymphoma
831881|NCT00109993|recurrent malignant testicular germ cell tumor|recurrent malignant testicular germ cell tumor
831882|NCT00109993|refractory chronic lymphocytic leukemia|refractory chronic lymphocytic leukemia
831883|NCT00109993|refractory multiple myeloma|refractory multiple myeloma
831884|NCT00109993|refractory hairy cell leukemia|refractory hairy cell leukemia
831885|NCT00109993|relapsing chronic myelogenous leukemia|relapsing chronic myelogenous leukemia
831886|NCT00109993|secondary acute myeloid leukemia|secondary acute myeloid leukemia
831887|NCT00109993|secondary myelodysplastic syndromes|secondary myelodysplastic syndromes
831888|NCT00109993|splenic marginal zone lymphoma|splenic marginal zone lymphoma
831889|NCT00109993|stage I multiple myeloma|stage i multiple myeloma
831890|NCT00109993|stage III adult Burkitt lymphoma|stage iii adult burkitt lymphoma
831891|NCT00109993|stage III adult diffuse large cell lymphoma|stage iii adult diffuse large cell lymphoma
831892|NCT00109993|stage III adult diffuse mixed cell lymphoma|stage iii adult diffuse mixed cell lymphoma
831893|NCT00109993|stage III adult diffuse small cleaved cell lymphoma|stage iii adult diffuse small cleaved cell lymphoma
831894|NCT00109993|stage III adult immunoblastic large cell lymphoma|stage iii adult immunoblastic large cell lymphoma
831895|NCT00109993|stage III adult lymphoblastic lymphoma|stage iii adult lymphoblastic lymphoma
831896|NCT00109993|stage II ovarian epithelial cancer|stage ii ovarian epithelial cancer
831897|NCT00109993|stage III chronic lymphocytic leukemia|stage iii chronic lymphocytic leukemia
831898|NCT00109993|stage III grade 1 follicular lymphoma|stage iii grade 1 follicular lymphoma
831899|NCT00109993|stage III grade 2 follicular lymphoma|stage iii grade 2 follicular lymphoma
831900|NCT00109993|stage III grade 3 follicular lymphoma|stage iii grade 3 follicular lymphoma
831901|NCT00109993|stage III mantle cell lymphoma|stage iii mantle cell lymphoma
831902|NCT00109993|stage III marginal zone lymphoma|stage iii marginal zone lymphoma
831903|NCT00109993|stage III multiple myeloma|stage iii multiple myeloma
831904|NCT00109993|stage III ovarian epithelial cancer|stage iii ovarian epithelial cancer
831905|NCT00109993|stage III small lymphocytic lymphoma|stage iii small lymphocytic lymphoma
831906|NCT00109993|stage III malignant testicular germ cell tumor|stage iii malignant testicular germ cell tumor
831907|NCT00109993|stage IIIA breast cancer|stage iiia breast cancer
831908|NCT00109993|stage IIIB breast cancer|stage iiib breast cancer
831909|NCT00109993|stage IIIC breast cancer|stage iiic breast cancer
831910|NCT00109993|stage IV adult Burkitt lymphoma|stage iv adult burkitt lymphoma
831911|NCT00109993|stage IV adult diffuse large cell lymphoma|stage iv adult diffuse large cell lymphoma
831912|NCT00109993|stage IV adult diffuse mixed cell lymphoma|stage iv adult diffuse mixed cell lymphoma
831913|NCT00109993|stage IV adult diffuse small cleaved cell lymphoma|stage iv adult diffuse small cleaved cell lymphoma
831914|NCT00109993|stage IV adult immunoblastic large cell lymphoma|stage iv adult immunoblastic large cell lymphoma
831915|NCT00109993|stage IV adult lymphoblastic lymphoma|stage iv adult lymphoblastic lymphoma
831916|NCT00109993|stage IV breast cancer|stage iv breast cancer
831917|NCT00109993|stage IV chronic lymphocytic leukemia|stage iv chronic lymphocytic leukemia
831918|NCT00109993|stage IV grade 1 follicular lymphoma|stage iv grade 1 follicular lymphoma
831919|NCT00109993|stage IV grade 2 follicular lymphoma|stage iv grade 2 follicular lymphoma
831920|NCT00109993|stage IV grade 3 follicular lymphoma|stage iv grade 3 follicular lymphoma
831921|NCT00109993|stage IV mantle cell lymphoma|stage iv mantle cell lymphoma
831922|NCT00109993|stage IV marginal zone lymphoma|stage iv marginal zone lymphoma
831923|NCT00109993|stage IV ovarian epithelial cancer|stage iv ovarian epithelial cancer
831924|NCT00109993|stage IV small lymphocytic lymphoma|stage iv small lymphocytic lymphoma
831925|NCT00109980|Complementary Therapies|complementary therapies
831926|NCT00109980|Plants, Medicinal|plants, medicinal
831927|NCT00109980|Dominican Republic|dominican republic
831928|NCT00109980|Hispanic Americans|hispanic americans
831929|NCT00109954|adult primary hepatocellular carcinoma|adult primary hepatocellular carcinoma
831930|NCT00109954|advanced adult primary liver cancer|advanced adult primary liver cancer
831931|NCT00109954|localized unresectable adult primary liver cancer|localized unresectable adult primary liver cancer
831932|NCT00109954|recurrent adult primary liver cancer|recurrent adult primary liver cancer
831933|NCT00109941|recurrent pancreatic cancer|recurrent pancreatic cancer
831934|NCT00109941|stage III pancreatic cancer|stage iii pancreatic cancer
831935|NCT00109941|stage IV pancreatic cancer|stage iv pancreatic cancer
831936|NCT00109928|stage III adult diffuse mixed cell lymphoma|stage iii adult diffuse mixed cell lymphoma
831937|NCT00109928|stage IV adult diffuse mixed cell lymphoma|stage iv adult diffuse mixed cell lymphoma
831938|NCT00109928|contiguous stage II adult diffuse mixed cell lymphoma|contiguous stage ii adult diffuse mixed cell lymphoma
831939|NCT00109928|noncontiguous stage II adult diffuse mixed cell lymphoma|noncontiguous stage ii adult diffuse mixed cell lymphoma
831940|NCT00109928|contiguous stage II adult diffuse large cell lymphoma|contiguous stage ii adult diffuse large cell lymphoma
831941|NCT00109928|noncontiguous stage II adult diffuse large cell lymphoma|noncontiguous stage ii adult diffuse large cell lymphoma
831942|NCT00109928|stage III adult diffuse large cell lymphoma|stage iii adult diffuse large cell lymphoma
831943|NCT00109928|stage IV adult diffuse large cell lymphoma|stage iv adult diffuse large cell lymphoma
831944|NCT00109928|anaplastic large cell lymphoma|anaplastic large cell lymphoma
831945|NCT00109889|extramedullary plasmacytoma|extramedullary plasmacytoma
831946|NCT00109889|isolated plasmacytoma of bone|isolated plasmacytoma of bone
831947|NCT00109876|stage I non-small cell lung cancer|stage i non-small cell lung cancer
831950|NCT00109850|adenocarcinoma of the esophagus|adenocarcinoma of the esophagus
831951|NCT00109850|squamous cell carcinoma of the esophagus|squamous cell carcinoma of the esophagus
831952|NCT00109850|stage III esophageal cancer|stage iii esophageal cancer
831953|NCT00109837|L1 adult acute lymphoblastic leukemia|l1 adult acute lymphoblastic leukemia
831954|NCT00109837|L2 adult acute lymphoblastic leukemia|l2 adult acute lymphoblastic leukemia
831955|NCT00109837|untreated adult acute lymphoblastic leukemia|untreated adult acute lymphoblastic leukemia
831956|NCT00109798|primary central nervous system non-Hodgkin lymphoma|primary central nervous system non-hodgkin lymphoma
831957|NCT00109798|primary central nervous system Hodgkin lymphoma|primary central nervous system hodgkin lymphoma
831958|NCT00109785|stage IIIA breast cancer|stage iiia breast cancer
831959|NCT00109785|stage IIIB breast cancer|stage iiib breast cancer
831960|NCT00109785|stage IIIC breast cancer|stage iiic breast cancer
831961|NCT00109785|male breast cancer|male breast cancer
831962|NCT00109772|CRPS|crps
831963|NCT00109772|RSDS|rsds
831964|NCT00109772|Pain|pain
831965|NCT00109772|CC-5013|cc-5013
831966|NCT00109772|Revlimid|revlimid
831967|NCT00109772|Complex Regional Pain Syndrome|complex regional pain syndrome
831968|NCT00109772|Reflex Sympathy Dystrophy Syndrome|reflex sympathy dystrophy syndrome
831969|NCT00109772|Lenalidomide|lenalidomide
831970|NCT00109772|CRPS Type I|crps type i
831971|NCT00109772|Celgene|celgene
831972|NCT00109759|allergy|allergy
831973|NCT00109759|allergoid|allergoid
831974|NCT00109759|specific immunotherapy|specific immunotherapy
831975|NCT00109759|ragweed|ragweed
831976|NCT00109746|HIV|hiv
831977|NCT00109746|Treatment Experienced|treatment experienced
831978|NCT00109746|Anti-Retroviral Agents|anti-retroviral agents
831979|NCT00109746|Antiretroviral Therapy, Highly Active|antiretroviral therapy, highly active
831980|NCT00109746|Picolinic acid|picolinic acid
831981|NCT00109746|Dietary Supplements|dietary supplements
831982|NCT00109733|Childhood-onset growth hormone deficiency (COGHD)|childhood-onset growth hormone deficiency (coghd)
831983|NCT00109733|Saizen®|saizen®
831984|NCT00109720|Diabetes|diabetes
831985|NCT00109720|Self Management|self management
831986|NCT00109720|Type 2 diabetes|type 2 diabetes
831987|NCT00109707|CML in blast crisis|cml in blast crisis
831988|NCT00109707|CML in chronic phase|cml in chronic phase
831989|NCT00109707|CML in accelerated phase|cml in accelerated phase
831990|NCT00109707|Gleevec resistance|gleevec resistance
831991|NCT00109707|Gleevec intolerant|gleevec intolerant
831992|NCT00109707|Gleevec and CML|gleevec and cml
831993|NCT00109707|imatinib resistance|imatinib resistance
831994|NCT00109707|imatinib intolerant|imatinib intolerant
831995|NCT00109707|Hypereosinophilic Syndrome|hypereosinophilic syndrome
831996|NCT00109707|Systemic Mastocytosis|systemic mastocytosis
831997|NCT00109707|Chronic eosinophilic syndrome|chronic eosinophilic syndrome
831998|NCT00109707|Philadelphia chromosome positive acute lymphoblastic leukemia|philadelphia chromosome positive acute lymphoblastic leukemia
831999|NCT00109707|HES|hes
832000|NCT00109707|CEL|cel
832001|NCT00109707|CML|cml
832002|NCT00109707|SM|sm
832003|NCT00109707|Ph+ ALL refractory to standard therapy|ph+ all refractory to standard therapy
832004|NCT00109707|Ph+ALL relapsed|ph+all relapsed
832005|NCT00109707|AMN107A|amn107a
832006|NCT00109681|ACTIVE|active
832007|NCT00109681|iloprost|iloprost
832008|NCT00109681|idiopathic pulmonary fibrosis|idiopathic pulmonary fibrosis
832009|NCT00109681|pulmonary arterial hypertension|pulmonary arterial hypertension
832010|NCT00109655|Superficial Transitional Cell Carcinoma|superficial transitional cell carcinoma
832011|NCT00109655|Bacillus Calmette-Guerin (BCG)|bacillus calmette-guerin (bcg)
832012|NCT00109655|Superficial Bladder Cancer|superficial bladder cancer
832013|NCT00109655|Gene Therapy|gene therapy
832014|NCT00109655|Vaccine|vaccine
832015|NCT00109655|Adenovirus|adenovirus
832016|NCT00109655|Carcinoma in situ|carcinoma in situ
832017|NCT00109642|Amygdala|amygdala
832018|NCT00109642|Orbitofrontal Cortex|orbitofrontal cortex
832019|NCT00109642|Yohimbine|yohimbine
832020|NCT00109642|Emotion|emotion
832021|NCT00109642|Guanfacine|guanfacine
832022|NCT00109642|Norepinephrine|norepinephrine
832023|NCT00109642|Healthy Volunteer|healthy volunteer
832024|NCT00109629|HIV-Negative|hiv-negative
832025|NCT00109629|Healthy|healthy
832026|NCT00109629|Immunity|immunity
832027|NCT00109629|Preventive|preventive
832028|NCT00109629|Virus|virus
832029|NCT00109629|Healthy Volunteer|healthy volunteer
832030|NCT00109616|neonatal mortality|neonatal mortality
832031|NCT00109616|chlorhexidine|chlorhexidine
832032|NCT00109616|newborn cleansing|newborn cleansing
832033|NCT00109616|umbilical cord care|umbilical cord care
832034|NCT00109616|community-based trial|community-based trial
832035|NCT00109616|prevention trial|prevention trial
832036|NCT00109616|omphalitis|omphalitis
832037|NCT00109603|Treatment Experienced|treatment experienced
832038|NCT00109603|TDF|tdf
832039|NCT00109590|HIV Seronegativity|hiv seronegativity
832040|NCT00109590|Treatment Naive|treatment naive
832041|NCT00109590|Pregnancy|pregnancy
832042|NCT00109590|Perinatal Transmission|perinatal transmission
832044|NCT00109590|Mother-To-Child Transmission|mother-to-child transmission
832045|NCT00109590|MTCT|mtct
832461|NCT00108134|Dermatology|dermatology
832046|NCT00109577|bipolar disorder|bipolar disorder
832047|NCT00109577|mood disorders|mood disorders
832048|NCT00109577|manic depression|manic depression
832049|NCT00109577|nutrition|nutrition
832050|NCT00109564|AAMI|aami
832051|NCT00109564|Memory Impairment|memory impairment
832052|NCT00109564|Decline in Cognitive Function|decline in cognitive function
832053|NCT00109564|Age Associated Memory Impairment|age associated memory impairment
832054|NCT00109551|zinc|zinc
832055|NCT00109551|child mortality|child mortality
832056|NCT00109551|child morbidity|child morbidity
832057|NCT00109551|community trial|community trial
832058|NCT00109551|prevention trial|prevention trial
832059|NCT00109551|dietary supplement|dietary supplement
832060|NCT00109538|Lonafarnib|lonafarnib
832061|NCT00109525|NICHD Neonatal Research Network|nichd neonatal research network
832062|NCT00109525|Fungal Infection|fungal infection
832063|NCT00109525|Mycosis|mycosis
832064|NCT00109525|Extremely Low Birth Weight (ELBW)|extremely low birth weight (elbw)
832065|NCT00109525|Prematurity|prematurity
832066|NCT00109525|Clinical Judgement|clinical judgement
832067|NCT00109525|Polymerase chain reaction (PCR) testing|polymerase chain reaction (pcr) testing
832068|NCT00109525|Beta-glucan assay|beta-glucan assay
832069|NCT00109525|Mass Spectrometry|mass spectrometry
832070|NCT00109525|Lumbar puncture|lumbar puncture
832071|NCT00109512|endometriosis|endometriosis
832072|NCT00109512|pelvic pain|pelvic pain
832074|NCT00109512|dysmenorrhea|dysmenorrhea
832075|NCT00109512|painful menstruation|painful menstruation
832076|NCT00109512|GnRH|gnrh
832077|NCT00109512|agonist|agonist
832078|NCT00109512|antagonist|antagonist
832079|NCT00109512|menstrual pain|menstrual pain
832080|NCT00109499|Wet Age-Related Macular Degeneration|wet age-related macular degeneration
832081|NCT00109499|Age-Related Maculopathies|age-related maculopathies
832082|NCT00109486|GW685698X|gw685698x
832083|NCT00109486|seasonal allergic rhinitis|seasonal allergic rhinitis
832084|NCT00109486|perennial allergic rhinitis|perennial allergic rhinitis
832085|NCT00109486|knemometry|knemometry
832086|NCT00109486|children|children
832087|NCT00109473|Pediatric Crohn's disease|pediatric crohn's disease
832088|NCT00109473|Pediatric|pediatric
832089|NCT00109473|Crohn's Disease|crohn's disease
832090|NCT00024635|Screening|screening
832091|NCT00024635|Psychiatric History|psychiatric history
832092|NCT00024635|Medical History|medical history
832093|NCT00024635|Diagnostic Evaluation|diagnostic evaluation
832094|NCT00024635|Natural History|natural history
832095|NCT00024635|Anxiety|anxiety
832096|NCT00024635|HV|hv
832097|NCT00024635|Healthy Volunteer|healthy volunteer
832098|NCT00024635|Normal Control|normal control
832099|NCT00024635|Mood Disorder|mood disorder
832100|NCT00024635|PTSD|ptsd
832101|NCT00024635|Post-Traumatic Stress Disorder|post-traumatic stress disorder
832102|NCT00109460|Tobacco|tobacco
832103|NCT00109434|exercise|exercise
832104|NCT00109434|hypoglycemia|hypoglycemia
832105|NCT00109434|Diabetes Mellitus, Type I|diabetes mellitus, type i
832106|NCT00109434|glucose monitoring|glucose monitoring
832107|NCT00109421|adolescent|adolescent
832108|NCT00109421|female|female
832109|NCT00109421|community-based|community-based
832110|NCT00109421|social network|social network
832111|NCT00109421|HIV/STI intervention|hiv/sti intervention
832112|NCT00109421|High HIV-risk African American adolescent females|high hiv-risk african american adolescent females
832113|NCT00109395|Lorazepam|lorazepam
832114|NCT00109395|Midazolam|midazolam
832115|NCT00109395|Best Pharmaceuticals for Children Act|best pharmaceuticals for children act
832116|NCT00109395|Critically ill|critically ill
832117|NCT00109395|pediatrics|pediatrics
832118|NCT00109395|mechanical ventilation|mechanical ventilation
832119|NCT00109395|sedation|sedation
832120|NCT00109382|Transient Ischemic Attack|transient ischemic attack
832121|NCT00109382|Stroke|stroke
832122|NCT00109382|Stroke Prevention|stroke prevention
832123|NCT00109382|Recurrence|recurrence
832124|NCT00109382|Neuroprotection|neuroprotection
832125|NCT00109382|Antiplatelet Therapy|antiplatelet therapy
832126|NCT00109382|Statins|statins
832127|NCT00109369|Chronic Disease|chronic disease
832128|NCT00109369|Multi-Hospital Information Systems|multi-hospital information systems
832129|NCT00109369|Clinical Decision Support Systems|clinical decision support systems
832130|NCT00109369|Reminder Systems|reminder systems
832131|NCT00109369|Registries|registries
832132|NCT00109369|Quality of Healthcare|quality of healthcare
832133|NCT00109369|Guideline Adherence|guideline adherence
832134|NCT00109369|Outcome and Process Assessment (Health Care)|outcome and process assessment (health care)
832135|NCT00109369|Technology Assessment, Biomedical|technology assessment, biomedical
832136|NCT00109369|Primary Health Care|primary health care
832137|NCT00109369|Hypercholesterolemia|hypercholesterolemia
832138|NCT00109369|Hypertension|hypertension
832139|NCT00109369|Hyperglycemia|hyperglycemia
832140|NCT00109356|Non-Hodgkin's Lymphoma|non-hodgkin's lymphoma
832141|NCT00109356|Chronic Lymphocytic Leukemia|chronic lymphocytic leukemia
832142|NCT00109356|Small Lymphocytic Leukemia|small lymphocytic leukemia
832143|NCT00109330|Prevention of Diphtheria, Tetanus, Pertussis|prevention of diphtheria, tetanus, pertussis
832144|NCT00109317|Moderate Plaque Psoriasis|moderate plaque psoriasis
832145|NCT00109317|Severe Plaque Psoriasis|severe plaque psoriasis
832146|NCT00109317|Topical|topical
832147|NCT00109304|Venezuelan Equine Encephalitis|venezuelan equine encephalitis
832148|NCT00109304|VEE|vee
832149|NCT00109304|Vaccine|vaccine
832150|NCT00109304|Provide protective immunity against VEE subtypes IA/B|provide protective immunity against vee subtypes ia/b
832151|NCT00109291|anemia|anemia
832152|NCT00109291|chronic kidney disease|chronic kidney disease
832153|NCT00109291|CKD|ckd
832154|NCT00109291|chronic renal failure|chronic renal failure
832155|NCT00109291|CRF|crf
832156|NCT00109291|dialysis|dialysis
832157|NCT00109291|erythropoietin|erythropoietin
832158|NCT00109291|EPO|epo
832159|NCT00109291|erythropoiesis stimulating agent|erythropoiesis stimulating agent
832160|NCT00109291|ESA|esa
832161|NCT00109291|Hematide™|hematide™
832162|NCT00109291|hemoglobin|hemoglobin
832163|NCT00109291|Hb|hb
832164|NCT00109291|Hgb|hgb
832165|NCT00109291|Omontys|omontys
832166|NCT00109291|peginesatide|peginesatide
832167|NCT00109291|red blood cell|red blood cell
832168|NCT00109291|red blood cell production|red blood cell production
832169|NCT00109278|Prevention of Measles|prevention of measles
832170|NCT00109265|Advanced Breast Cancer|advanced breast cancer
832171|NCT00109265|Metastatic Breast Cancer|metastatic breast cancer
832172|NCT00109265|Cancer|cancer
832173|NCT00109252|Plaque Psoriasis|plaque psoriasis
832174|NCT00109252|Topical|topical
832175|NCT00109239|Metastatic Breast Cancer|metastatic breast cancer
832176|NCT00109239|Metastatic|metastatic
832177|NCT00109239|Cancer|cancer
832178|NCT00109226|Metastatic Colorectal Cancer|metastatic colorectal cancer
832179|NCT00109226|Cancer|cancer
832180|NCT00109213|Spinal Stenosis|spinal stenosis
832181|NCT00109213|Lumbar Spine|lumbar spine
832182|NCT00109213|Decompression|decompression
832183|NCT00109213|Fusion|fusion
832184|NCT00109213|Spondylolisthesis|spondylolisthesis
832185|NCT00109213|Prospective, randomized clinical trial|prospective, randomized clinical trial
832186|NCT00109200|Allergic Asthma|allergic asthma
832187|NCT00109200|Severe Allergic Asthma|severe allergic asthma
832188|NCT00109187|Moderate Persistent Asthma|moderate persistent asthma
832189|NCT00109187|Severe Persistent Asthma|severe persistent asthma
832190|NCT00109174|Glutamate|glutamate
832191|NCT00109174|Excitatory Amino Acid|excitatory amino acid
832192|NCT00109174|Neurochemistry|neurochemistry
832193|NCT00109174|Brain|brain
832194|NCT00109174|Magnetic Resonance Spectroscopy|magnetic resonance spectroscopy
832195|NCT00109161|Multiple Sclerosis, MS, CNS, Daclizumab|multiple sclerosis, ms, cns, daclizumab
832196|NCT00109148|Obesity and obesity-related medical conditions|obesity and obesity-related medical conditions
832197|NCT00109083|Migraine|migraine
832198|NCT00109083|Headaches|headaches
832199|NCT00109083|Migraine headaches|migraine headaches
832200|NCT00109083|Head pain|head pain
832201|NCT00109070|Metastatic|metastatic
832202|NCT00109057|Cancer|cancer
832203|NCT00109057|Advanced malignancies|advanced malignancies
832204|NCT00109044|Depression|depression
832205|NCT00109044|Major Depressive Disorder|major depressive disorder
832206|NCT00109044|Escitalopram|escitalopram
832207|NCT00109031|Cancer|cancer
832208|NCT00109031|Oncology|oncology
832209|NCT00109018|Risk Assessment|risk assessment
832210|NCT00109018|Coronary Heart Disease|coronary heart disease
832211|NCT00109018|Vascular Function|vascular function
832212|NCT00109018|Nitric Oxide Metabolites|nitric oxide metabolites
832213|NCT00109018|Blood Tests|blood tests
832214|NCT00109018|Nitrite|nitrite
832215|NCT00109018|Flow-Mediated Dilation|flow-mediated dilation
832216|NCT00109018|Biomarker|biomarker
832217|NCT00109018|Endothelial Dysfunction|endothelial dysfunction
832218|NCT00109018|Coronary Artery Disease|coronary artery disease
832219|NCT00109018|CAD|cad
832220|NCT00109018|Coronary Artery Disease At Risk|coronary artery disease at risk
832221|NCT00109018|Healthy Volunteer|healthy volunteer
832222|NCT00109005|Response Rate|response rate
832223|NCT00109005|Toxicity|toxicity
832224|NCT00109005|Progression-Free Survival|progression-free survival
832225|NCT00109005|Overall Survival|overall survival
832226|NCT00109005|Pharmacokinetic|pharmacokinetic
832227|NCT00109005|Ocular Melanoma|ocular melanoma
832228|NCT00108992|topical NSAID|topical nsaid
832229|NCT00108992|topical diclofenac|topical diclofenac
832230|NCT00108979|Depression|depression
832231|NCT00108979|Major Depressive Disorder|major depressive disorder
832232|NCT00108979|Escitalopram|escitalopram
832233|NCT00108953|Cancer|cancer
832234|NCT00108953|Liver Cancer|liver cancer
832235|NCT00108953|Hepatocellular carcinoma|hepatocellular carcinoma
832236|NCT00108953|HCC|hcc
832237|NCT00108940|stroke|stroke
832238|NCT00108940|ischemic stroke|ischemic stroke
832239|NCT00108940|siblings|siblings
832240|NCT00108927|Clinical trial|clinical trial
832241|NCT00108927|Diabetes|diabetes
832242|NCT00108927|Quality Improvement|quality improvement
832243|NCT00108914|Perennial allergic rhinitis|perennial allergic rhinitis
832244|NCT00108914|pediatric|pediatric
832250|NCT00108901|metabolic syndrome|metabolic syndrome
832252|NCT00108901|insulin resistance|insulin resistance
832254|NCT00108901|male|male
832255|NCT00108901|black, African-American|black, african-american
832256|NCT00108901|white, Caucasian|white, caucasian
832257|NCT00108901|cognition|cognition
832258|NCT00108901|executive function|executive function
832259|NCT00108875|Peptide vaccine therapy|peptide vaccine therapy
832260|NCT00108875|Survivin|survivin
832261|NCT00108862|Treatment Naive|treatment naive
832262|NCT00108862|TB|tb
832263|NCT00108862|HIV|hiv
832264|NCT00108862|Antiretroviral Agents|antiretroviral agents
832265|NCT00108862|Strategy Study|strategy study
832266|NCT00108836|GAD|gad
832267|NCT00108836|Anxiety|anxiety
832268|NCT00108836|XBD173|xbd173
832269|NCT00108836|Generalized Anxiety Disorder|generalized anxiety disorder
832270|NCT00108810|Pain|pain
832271|NCT00108810|Osteoarthritis|osteoarthritis
832272|NCT00108810|OA|oa
832273|NCT00108810|Mild to Moderate Osteoarthritis (OA) Pain of the Knee|mild to moderate osteoarthritis (oa) pain of the knee
832274|NCT00108784|reduced-energy-density diet|reduced-energy-density diet
832275|NCT00108784|fat-restricted diet|fat-restricted diet
832276|NCT00108784|fruit|fruit
832277|NCT00108784|vegetables|vegetables
832278|NCT00108784|ad libitum intake|ad libitum intake
832279|NCT00108784|weight loss|weight loss
832280|NCT00108784|obesity|obesity
832281|NCT00108771|Pain|pain
832282|NCT00108771|Chronic Pain|chronic pain
832283|NCT00108771|Osteoarthritis Pain|osteoarthritis pain
832284|NCT00108771|Osteoarthritis|osteoarthritis
832285|NCT00108706|Acute Stroke|acute stroke
832286|NCT00108706|Cerebrovascular Accident|cerebrovascular accident
832287|NCT00108706|Ischaemic Stroke|ischaemic stroke
832288|NCT00108706|Candesartan|candesartan
832289|NCT00108706|Angiotensin Receptor Blocker|angiotensin receptor blocker
832290|NCT00108680|Hemiparesis|hemiparesis
832291|NCT00108680|Rehabilitation|rehabilitation
832292|NCT00108680|Reaching|reaching
832293|NCT00108680|Interlimb Coupling|interlimb coupling
832294|NCT00108680|Cortical Excitability|cortical excitability
832295|NCT00108680|Stroke|stroke
832296|NCT00108667|Parkinson's Disease|parkinson's disease
832297|NCT00108667|AMPA Antagonist|ampa antagonist
832298|NCT00108667|Dyskinesias|dyskinesias
832299|NCT00108667|Glutamate Antagonist|glutamate antagonist
832300|NCT00108667|Parkinson Disease|parkinson disease
832301|NCT00108667|PD|pd
832302|NCT00108654|HIV-Negative|hiv-negative
832303|NCT00108654|Healthy|healthy
832304|NCT00108654|Immunity|immunity
832305|NCT00108654|Preventive|preventive
832306|NCT00108654|Virus|virus
832307|NCT00108654|Healthy Volunteer|healthy volunteer
832308|NCT00108628|Imagery|imagery
832309|NCT00108628|Nightmares|nightmares
832310|NCT00108628|Post-Traumatic Stress Disorder|post-traumatic stress disorder
832311|NCT00108628|Psychotherapy|psychotherapy
832312|NCT00108602|sleep apnea|sleep apnea
832313|NCT00108602|stroke|stroke
832314|NCT00108602|ventilatory control|ventilatory control
832315|NCT00108589|s-adenosylmethionine|s-adenosylmethionine
832316|NCT00108589|fatty liver|fatty liver
832317|NCT00108589|obesity|obesity
832318|NCT00108589|Non-alcoholic steatohepatitis|non-alcoholic steatohepatitis
832319|NCT00108576|anticonvulsant|anticonvulsant
832320|NCT00108576|anxiety|anxiety
832321|NCT00108576|divalproex|divalproex
832322|NCT00108576|PTSD|ptsd
832323|NCT00108563|Hepatitis C|hepatitis c
832324|NCT00108563|Depression|depression
832325|NCT00108563|Interferon-alpha|interferon-alpha
832326|NCT00108563|Citalopram|citalopram
832327|NCT00108563|ribavirin|ribavirin
832328|NCT00108563|antidepressive agents|antidepressive agents
832329|NCT00108550|analgesia|analgesia
832330|NCT00108550|antidepressant agents|antidepressant agents
832331|NCT00108550|back pain|back pain
832332|NCT00108550|pain|pain
832333|NCT00108537|smoking|smoking
832334|NCT00108537|nicotine|nicotine
832335|NCT00108537|drug therapy|drug therapy
832336|NCT00108537|smoking cessation|smoking cessation
832337|NCT00108524|anti-obesity agents|anti-obesity agents
832338|NCT00108524|diet therapy|diet therapy
832339|NCT00108524|diet, reducing|diet, reducing
832340|NCT00108524|obesity|obesity
832341|NCT00108524|overweight|overweight
832342|NCT00108524|risk factors|risk factors
832343|NCT00108524|weight loss|weight loss
832344|NCT00108511|hypertriglyceridemia|hypertriglyceridemia
832345|NCT00108511|lipoproteins|lipoproteins
832346|NCT00108511|triglycerides|triglycerides
832347|NCT00108511|serum GPI-PLD (glycosylphosphatidylinositol-specific phospholipase D)|serum gpi-pld (glycosylphosphatidylinositol-specific phospholipase d)
832348|NCT00108498|sleep apnea|sleep apnea
832349|NCT00108498|mirtazapine|mirtazapine
832350|NCT00108498|sleep|sleep
832351|NCT00108485|Diabetes Mellitus, Type 2|diabetes mellitus, type 2
832352|NCT00108485|Kidney Failure, Chronic|kidney failure, chronic
832353|NCT00108485|Hyperlipidemia|hyperlipidemia
832354|NCT00108485|Randomized Controlled Trials|randomized controlled trials
832355|NCT00108459|Obesity|obesity
832356|NCT00108459|Type 2 Diabetes|type 2 diabetes
832357|NCT00108459|Hyperlipidemia|hyperlipidemia
832358|NCT00108459|Insulin resistance|insulin resistance
832359|NCT00108446|Irritable Bowel Syndrome|irritable bowel syndrome
832360|NCT00108446|visceral hypersensitivity|visceral hypersensitivity
832361|NCT00108446|cutaneous hypersensitivity|cutaneous hypersensitivity
832362|NCT00108446|lidocaine|lidocaine
832363|NCT00108420|Prazosin|prazosin
832364|NCT00108420|Stress Disorders, Post-traumatic|stress disorders, post-traumatic
832365|NCT00108407|Alcohol Abuse/Dependence|alcohol abuse/dependence
832366|NCT00108407|Alcohol Use Disorders|alcohol use disorders
832367|NCT00108407|Cannabis Abuse/Dependence|cannabis abuse/dependence
832368|NCT00108407|Depression|depression
832369|NCT00108407|Dual diagnosis|dual diagnosis
832370|NCT00108407|Dysthymia|dysthymia
832371|NCT00108407|Stimulant Abuse/Dependence|stimulant abuse/dependence
832372|NCT00108407|Substance Use Disorders|substance use disorders
832374|NCT00108394|Dialysis|dialysis
832375|NCT00108394|Clinical Trials|clinical trials
832376|NCT00108394|Bone Diseases, Metabolic|bone diseases, metabolic
832377|NCT00108394|adynamic bone disease|adynamic bone disease
832378|NCT00108394|low bone turnover|low bone turnover
832379|NCT00108381|chronic back pain|chronic back pain
832380|NCT00108381|cognitive-behavioral|cognitive-behavioral
832381|NCT00108381|pain|pain
832382|NCT00108381|stages of change|stages of change
832383|NCT00108368|schizophrenia|schizophrenia
832384|NCT00108368|cognition|cognition
832385|NCT00108368|antipsychotic medication|antipsychotic medication
832386|NCT00108368|information processing|information processing
832387|NCT00108368|social cognition|social cognition
832388|NCT00108368|Psychotic|psychotic
832389|NCT00108355|albumin|albumin
832390|NCT00108355|ascites|ascites
832391|NCT00108355|paracentesis|paracentesis
832392|NCT00108342|nicotine|nicotine
832393|NCT00108342|drug therapy|drug therapy
832394|NCT00108342|Smoking Cessation|smoking cessation
832395|NCT00108329|aging|aging
832396|NCT00108329|exercise|exercise
832397|NCT00108329|metabolic syndrome|metabolic syndrome
832398|NCT00108329|insulin resistance|insulin resistance
832399|NCT00108316|Depressive Disorder|depressive disorder
832400|NCT00108316|DNA|dna
832401|NCT00108316|Serotonin|serotonin
832402|NCT00108303|schizophrenia|schizophrenia
832403|NCT00108290|Prostate cancer|prostate cancer
832404|NCT00108290|chemotherapy|chemotherapy
832405|NCT00108290|hormone therapy|hormone therapy
832406|NCT00108290|surgery|surgery
832407|NCT00108290|PSA|psa
832408|NCT00108290|Gleason score|gleason score
832409|NCT00108277|Anxiety|anxiety
832410|NCT00108277|Breathing Training|breathing training
832411|NCT00108277|Respiratory Dysregulation|respiratory dysregulation
832412|NCT00108264|Prostatic Neoplasms|prostatic neoplasms
832413|NCT00108264|Neoplasm Metastasis|neoplasm metastasis
832414|NCT00108264|Immunotherapy|immunotherapy
832415|NCT00108264|Active|active
832416|NCT00108264|Dendritic Cells|dendritic cells
832417|NCT00108251|controlled clinical trial|controlled clinical trial
832418|NCT00108251|Diastole|diastole
832419|NCT00108251|Echocardiography|echocardiography
832420|NCT00108251|exercise tolerance|exercise tolerance
832421|NCT00108251|Heart Failure, Congestive|heart failure, congestive
832422|NCT00108251|Receptors, Aldosterone|receptors, aldosterone
832423|NCT00108238|endothelial function|endothelial function
832424|NCT00108238|hormone replacement therapy|hormone replacement therapy
832425|NCT00108238|coronary flow reserve|coronary flow reserve
832426|NCT00108238|posmenopausal women|posmenopausal women
832427|NCT00108238|women's cardiovascular heatlh|women's cardiovascular heatlh
832428|NCT00108225|Cholesterol|cholesterol
832429|NCT00108225|Creatinine Clearance|creatinine clearance
832430|NCT00108225|Diabetes|diabetes
832431|NCT00108225|Glycohemoglobin|glycohemoglobin
832432|NCT00108225|High Protein Diet|high protein diet
832433|NCT00108212|Diet|diet
832434|NCT00108212|triglyceride|triglyceride
832435|NCT00108212|inflammation|inflammation
832436|NCT00108212|Genetic polymorphism|genetic polymorphism
832437|NCT00108199|Schizophrenia|schizophrenia
832438|NCT00108199|vocational rehabilitation|vocational rehabilitation
832439|NCT00108199|neuropsychology|neuropsychology
832440|NCT00108186|cyclooxygenase 2|cyclooxygenase 2
832441|NCT00108186|lung cancer|lung cancer
832442|NCT00108186|lymphocytes|lymphocytes
832443|NCT00108186|non small cell|non small cell
832444|NCT00108186|therapeutics|therapeutics
832445|NCT00108173|Position Emission Tomography (PET)|position emission tomography (pet)
832446|NCT00108173|Nicotine dependence|nicotine dependence
832447|NCT00108173|functional magnetic resonance imaging|functional magnetic resonance imaging
832448|NCT00108173|cigarette cues|cigarette cues
832449|NCT00108160|mupirocin|mupirocin
832450|NCT00108160|prevention and control|prevention and control
832451|NCT00108160|s. aureus|s. aureus
832452|NCT00108147|Aged|aged
832453|NCT00108147|Congestive Heart Failure|congestive heart failure
832454|NCT00108147|Exercise|exercise
832455|NCT00108134|Superficial basal cell carcinoma|superficial basal cell carcinoma
832456|NCT00108134|basal cell carcinoma|basal cell carcinoma
832457|NCT00108134|sBCC|sbcc
832458|NCT00108134|BCC|bcc
832459|NCT00108134|PEP005|pep005
832460|NCT00108134|Topical|topical
832462|NCT00108121|Nodular basal cell carcinoma|nodular basal cell carcinoma
832463|NCT00108121|basal cell carcinoma|basal cell carcinoma
832464|NCT00108121|nBCC|nbcc
832465|NCT00108121|BCC|bcc
832466|NCT00108121|PEP005|pep005
832467|NCT00108121|Topical|topical
832468|NCT00108121|Dermatology|dermatology
832469|NCT00108108|Lymphocytic Leukemia|lymphocytic leukemia
832470|NCT00108095|emesis|emesis
832471|NCT00108095|nausea|nausea
832472|NCT00108095|post operative nausea and vomiting|post operative nausea and vomiting
832473|NCT00108095|vomiting|vomiting
832474|NCT00108095|PONV|ponv
832475|NCT00108082|left ventricular hypertrophy (LVH)|left ventricular hypertrophy (lvh)
832476|NCT00108082|echocardiogram|echocardiogram
832477|NCT00108082|left ventricular mass regression|left ventricular mass regression
832478|NCT00108082|cardiac MRI|cardiac mri
832479|NCT00108082|left ventricular mass index (LVMI)hypertension|left ventricular mass index (lvmi)hypertension
832480|NCT00108069|Brain|brain
832481|NCT00108069|Tumor|tumor
832482|NCT00108069|Malignant|malignant
832483|NCT00108069|Therapy|therapy
832484|NCT00108069|Progression|progression
832485|NCT00108069|Chemotherapy|chemotherapy
832486|NCT00108069|Antiangiogenesis|antiangiogenesis
832487|NCT00108069|Radiation|radiation
832488|NCT00108069|Malignant Brain Tumor|malignant brain tumor
832489|NCT00108069|Malignant Glioma|malignant glioma
832490|NCT00108069|Glioma|glioma
832491|NCT00108056|Brain|brain
832492|NCT00108056|Tumor|tumor
832493|NCT00108056|Malignant|malignant
832494|NCT00108056|Therapy|therapy
832495|NCT00108056|Progression|progression
832496|NCT00108056|Malignant Brain Tumor|malignant brain tumor
832497|NCT00108056|Malignant Glioma|malignant glioma
832498|NCT00108056|Glioma|glioma
832499|NCT00108043|Functional Electrical Stimulation|functional electrical stimulation
832500|NCT00108043|Gait|gait
832501|NCT00108043|Blood pressure|blood pressure
832502|NCT00108043|Orthostatic Hypotension|orthostatic hypotension
832503|NCT00108043|Cardiovascular responses|cardiovascular responses
832504|NCT00108043|Near-infra red spectroscopy|near-infra red spectroscopy
832505|NCT00108030|PBWST training|pbwst training
832506|NCT00108030|Strength training|strength training
832507|NCT00108030|6-min walking endurance|6-min walking endurance
832508|NCT00108030|Cardiovascular fitness|cardiovascular fitness
832509|NCT00108030|Psychosocial attributes|psychosocial attributes
832510|NCT00108017|Ocular hypertension (excessive pressure in the eye)|ocular hypertension (excessive pressure in the eye)
832511|NCT00108004|Diabetes|diabetes
832512|NCT00108004|Amylin|amylin
832513|NCT00108004|Symlin|symlin
832514|NCT00108004|pramlintide acetate|pramlintide acetate
832515|NCT00107991|clinical trial; efficacy; etanercept; hidradenitis suppurativa; quality of life; safety; tnf|clinical trial; efficacy; etanercept; hidradenitis suppurativa; quality of life; safety; tnf
832516|NCT00107978|cSSSI (complicated Skin and Skin Structure Infections)|csssi (complicated skin and skin structure infections)
832517|NCT00107978|Staph (Staphylococcus)|staph (staphylococcus)
832518|NCT00107978|MRSA (Methicillin-resistant Staphylococcus Aureus)|mrsa (methicillin-resistant staphylococcus aureus)
832519|NCT00107965|Actinic Keratosis|actinic keratosis
832520|NCT00107965|Solar Keratosis|solar keratosis
832521|NCT00107965|AK|ak
832522|NCT00107965|Sun spots|sun spots
832523|NCT00107965|PEP005|pep005
832524|NCT00107965|Topical|topical
832525|NCT00107965|Dermatology|dermatology
832526|NCT00107952|Nosocomial pneumonia|nosocomial pneumonia
832527|NCT00107952|MRSA|mrsa
832528|NCT00107939|bipolar disorder|bipolar disorder
832529|NCT00107939|manic episode|manic episode
832530|NCT00107939|treatment|treatment
832531|NCT00107939|licarbazepine|licarbazepine
832532|NCT00107926|bipolar disorder|bipolar disorder
832533|NCT00107926|manic episode|manic episode
832534|NCT00107926|treatment|treatment
832535|NCT00107926|licarbazepine|licarbazepine
832536|NCT00107913|Immune Thrombocytopenic Purpura|immune thrombocytopenic purpura
832537|NCT00107900|Deep Vein Thrombosis,|deep vein thrombosis,
832538|NCT00107900|Anticoagulant,|anticoagulant,
832539|NCT00107900|Venous thromboembolic|venous thromboembolic
832540|NCT00107887|TST|tst
832541|NCT00107887|isoniazid|isoniazid
832542|NCT00107887|HAART|haart
832543|NCT00107887|Brazil|brazil
832544|NCT00107887|HIV|hiv
832545|NCT00107874|Maternal|maternal
832546|NCT00107874|morbidity|morbidity
832547|NCT00107874|mortality|mortality
832548|NCT00107874|pregnancy|pregnancy
832549|NCT00107874|postpartum hemorrhage|postpartum hemorrhage
832550|NCT00107874|Cesarean Section|cesarean section
832551|NCT00107848|Pediatric Narcolepsy|pediatric narcolepsy
832552|NCT00107848|Pediatric OSA|pediatric osa
832553|NCT00107848|CPAP|cpap
832554|NCT00107848|Pediatric Narcolepsy or OSAHS|pediatric narcolepsy or osahs
832555|NCT00107835|Pain|pain
832556|NCT00107822|Pain|pain
832557|NCT00107809|Pediatric Obstructive sleep Apnea|pediatric obstructive sleep apnea
832558|NCT00107809|Excessive sleepiness|excessive sleepiness
832559|NCT00107809|CPAP|cpap
832560|NCT00107809|Pediatric OSAHS|pediatric osahs
832561|NCT00107796|Pediatric Narcolepsy|pediatric narcolepsy
832562|NCT00107796|Excessive sleepiness|excessive sleepiness
832564|NCT00107783|Homogentisic Acid|homogentisic acid
832565|NCT00107783|Corneal Damage|corneal damage
832566|NCT00107783|Tyrosine|tyrosine
832567|NCT00107783|Alkaptonuria|alkaptonuria
832568|NCT00107783|Photophobia|photophobia
832569|NCT00107783|Nitisinone|nitisinone
832571|NCT00107770|histone deacetylase inhibition|histone deacetylase inhibition
832572|NCT00107770|open label|open label
832573|NCT00107770|safety study|safety study
832574|NCT00107770|sodium phenylbutyrate|sodium phenylbutyrate
832575|NCT00107757|pediatric|pediatric
832576|NCT00107757|Seasonal allergic rhinitis|seasonal allergic rhinitis
832577|NCT00107744|Blood Pressure; Lipids; Dietary Protein|blood pressure; lipids; dietary protein
832578|NCT00107731|Bipolar I Disorder|bipolar i disorder
832579|NCT00107731|Manic Depressive Disorder|manic depressive disorder
832580|NCT00107731|Manic Depression|manic depression
832581|NCT00107718|IL-18|il-18
832582|NCT00107718|treatment naive|treatment naive
832583|NCT00107718|Phase 2|phase 2
832584|NCT00107718|melanoma|melanoma
832585|NCT00107705|allergy|allergy
832586|NCT00107705|skin prick test|skin prick test
832587|NCT00107705|allergoid|allergoid
832588|NCT00107705|allergenicity|allergenicity
832589|NCT00107705|specific immunotherapy|specific immunotherapy
832590|NCT00107692|Child Obesity|child obesity
832591|NCT00107692|Physical activity|physical activity
832592|NCT00107692|community intervention study|community intervention study
832593|NCT00107692|competence|competence
832594|NCT00107692|diet and nutrition|diet and nutrition
832595|NCT00107692|Nutrition|nutrition
832596|NCT00107679|Treatment Experienced|treatment experienced
832597|NCT00107679|HIV|hiv
832598|NCT00107679|HPV|hpv
832599|NCT00107679|Antiretroviral Therapy, Highly Active|antiretroviral therapy, highly active
832600|NCT00107679|Papillomavirus, Human|papillomavirus, human
832601|NCT00107666|Coronary artery bypass grafting|coronary artery bypass grafting
832602|NCT00107666|Heart valve prosthesis implantation|heart valve prosthesis implantation
832603|NCT00107666|Cardiopulmonary bypass|cardiopulmonary bypass
832604|NCT00107666|Oxidative stress|oxidative stress
832605|NCT00107666|Inflammation|inflammation
832606|NCT00107666|Endotoxemia|endotoxemia
832607|NCT00107640|At-risk drinking|at-risk drinking
832608|NCT00107640|Alcohol education|alcohol education
832609|NCT00107640|Effectiveness|effectiveness
832610|NCT00107640|Cost-effectiveness|cost-effectiveness
832611|NCT00107627|Gynaecological Cancer|gynaecological cancer
832612|NCT00107627|Surgical Staples|surgical staples
832613|NCT00107627|Subcuticular Sutures|subcuticular sutures
832614|NCT00107614|Waldenstrom|waldenstrom
832615|NCT00107601|Glucose|glucose
832616|NCT00107601|Glucose Control|glucose control
832617|NCT00107601|Insulin|insulin
832618|NCT00107601|Insulin therapy|insulin therapy
832619|NCT00107601|Critically ill|critically ill
832620|NCT00107601|Intensive Care|intensive care
832621|NCT00107588|marijuana dependence|marijuana dependence
832622|NCT00107588|self-efficacy|self-efficacy
832623|NCT00107588|coping skills|coping skills
832624|NCT00107588|attendance|attendance
832625|NCT00107588|marijuana abstinence|marijuana abstinence
832626|NCT00107575|tobacco|tobacco
832627|NCT00107575|alcohol|alcohol
832628|NCT00107562|risk behavior|risk behavior
832629|NCT00107562|social networks|social networks
832630|NCT00107562|behavior|behavior
832631|NCT00107549|Treatment Experienced|treatment experienced
832632|NCT00107549|HIV Therapeutic Vaccine|hiv therapeutic vaccine
832633|NCT00107523|adult acute myeloid leukemia with 11q23 (MLL) abnormalities|adult acute myeloid leukemia with 11q23 (mll) abnormalities
832634|NCT00107523|adult acute myeloid leukemia with inv(16)(p13;q22)|adult acute myeloid leukemia with inv(16)(p13;q22)
832635|NCT00107523|adult acute myeloid leukemia with t(15;17)(q22;q12)|adult acute myeloid leukemia with t(15;17)(q22;q12)
832636|NCT00107523|adult acute myeloid leukemia with t(16;16)(p13;q22)|adult acute myeloid leukemia with t(16;16)(p13;q22)
832637|NCT00107523|adult acute myeloid leukemia with t(8;21)(q22;q22)|adult acute myeloid leukemia with t(8;21)(q22;q22)
832638|NCT00107523|recurrent adult acute myeloid leukemia|recurrent adult acute myeloid leukemia
832639|NCT00107523|untreated adult acute myeloid leukemia|untreated adult acute myeloid leukemia
832640|NCT00107510|stage II breast cancer|stage ii breast cancer
832641|NCT00107510|stage IIIA breast cancer|stage iiia breast cancer
832642|NCT00107510|stage IIIB breast cancer|stage iiib breast cancer
832643|NCT00107510|stage IIIC breast cancer|stage iiic breast cancer
832644|NCT00107510|male breast cancer|male breast cancer
832645|NCT00107497|stage I breast cancer|stage i breast cancer
832646|NCT00107497|stage II breast cancer|stage ii breast cancer
832647|NCT00107484|stage IV breast cancer|stage iv breast cancer
832648|NCT00107484|stage I breast cancer|stage i breast cancer
832649|NCT00107484|stage II breast cancer|stage ii breast cancer
832650|NCT00107484|stage IIIA breast cancer|stage iiia breast cancer
832651|NCT00107484|stage IIIB breast cancer|stage iiib breast cancer
832652|NCT00107484|stage IIIC breast cancer|stage iiic breast cancer
832653|NCT00107484|male breast cancer|male breast cancer
832654|NCT00107471|untreated childhood brain stem glioma|untreated childhood brain stem glioma
832655|NCT00107458|recurrent childhood brain stem glioma|recurrent childhood brain stem glioma
832656|NCT00107458|recurrent childhood brain tumor|recurrent childhood brain tumor
832657|NCT00107458|recurrent childhood cerebellar astrocytoma|recurrent childhood cerebellar astrocytoma
832658|NCT00107458|recurrent childhood cerebral astrocytoma|recurrent childhood cerebral astrocytoma
832659|NCT00107458|recurrent childhood ependymoma|recurrent childhood ependymoma
832660|NCT00107458|recurrent childhood medulloblastoma|recurrent childhood medulloblastoma
832661|NCT00107458|recurrent childhood supratentorial primitive neuroectodermal tumor|recurrent childhood supratentorial primitive neuroectodermal tumor
832662|NCT00107458|unspecified childhood solid tumor, protocol specific|unspecified childhood solid tumor, protocol specific
832663|NCT00107458|recurrent childhood visual pathway and hypothalamic glioma|recurrent childhood visual pathway and hypothalamic glioma
832664|NCT00107458|childhood high-grade cerebral astrocytoma|childhood high-grade cerebral astrocytoma
832665|NCT00107458|childhood low-grade cerebral astrocytoma|childhood low-grade cerebral astrocytoma
832666|NCT00107458|childhood infratentorial ependymoma|childhood infratentorial ependymoma
832667|NCT00107458|childhood supratentorial ependymoma|childhood supratentorial ependymoma
832668|NCT00107458|childhood spinal cord neoplasm|childhood spinal cord neoplasm
832669|NCT00107458|childhood grade I meningioma|childhood grade i meningioma
832670|NCT00107458|childhood grade II meningioma|childhood grade ii meningioma
832671|NCT00107458|childhood grade III meningioma|childhood grade iii meningioma
832672|NCT00107458|childhood craniopharyngioma|childhood craniopharyngioma
832673|NCT00107458|childhood central nervous system germ cell tumor|childhood central nervous system germ cell tumor
832674|NCT00107419|chondrosarcoma|chondrosarcoma
832675|NCT00107393|recurrent breast cancer|recurrent breast cancer
832676|NCT00107393|stage IV breast cancer|stage iv breast cancer
832677|NCT00107380|contiguous stage II adult diffuse large cell lymphoma|contiguous stage ii adult diffuse large cell lymphoma
832678|NCT00107380|noncontiguous stage II adult diffuse large cell lymphoma|noncontiguous stage ii adult diffuse large cell lymphoma
832679|NCT00107380|stage III adult diffuse large cell lymphoma|stage iii adult diffuse large cell lymphoma
832680|NCT00107380|stage IV adult diffuse large cell lymphoma|stage iv adult diffuse large cell lymphoma
832681|NCT00107367|tumors metastatic to brain|tumors metastatic to brain
832682|NCT00107354|recurrent adult acute lymphoblastic leukemia|recurrent adult acute lymphoblastic leukemia
832683|NCT00107354|recurrent adult acute myeloid leukemia|recurrent adult acute myeloid leukemia
832684|NCT00107354|recurrent childhood acute lymphoblastic leukemia|recurrent childhood acute lymphoblastic leukemia
832685|NCT00107354|recurrent childhood acute myeloid leukemia|recurrent childhood acute myeloid leukemia
832686|NCT00107354|secondary acute myeloid leukemia|secondary acute myeloid leukemia
832687|NCT00107354|refractory anemia with excess blasts in transformation|refractory anemia with excess blasts in transformation
832688|NCT00107354|refractory anemia with excess blasts|refractory anemia with excess blasts
832689|NCT00107354|adult acute myeloid leukemia with 11q23 (MLL) abnormalities|adult acute myeloid leukemia with 11q23 (mll) abnormalities
832690|NCT00107354|adult acute myeloid leukemia with inv(16)(p13;q22)|adult acute myeloid leukemia with inv(16)(p13;q22)
832691|NCT00107354|adult acute myeloid leukemia with t(15;17)(q22;q12)|adult acute myeloid leukemia with t(15;17)(q22;q12)
832692|NCT00107354|adult acute myeloid leukemia with t(16;16)(p13;q22)|adult acute myeloid leukemia with t(16;16)(p13;q22)
832693|NCT00107354|adult acute myeloid leukemia with t(8;21)(q22;q22)|adult acute myeloid leukemia with t(8;21)(q22;q22)
832694|NCT00107354|de novo myelodysplastic syndromes|de novo myelodysplastic syndromes
832695|NCT00107354|previously treated myelodysplastic syndromes|previously treated myelodysplastic syndromes
832696|NCT00107354|secondary myelodysplastic syndromes|secondary myelodysplastic syndromes
832697|NCT00107354|T-cell adult acute lymphoblastic leukemia|t-cell adult acute lymphoblastic leukemia
832698|NCT00107354|T-cell childhood acute lymphoblastic leukemia|t-cell childhood acute lymphoblastic leukemia
832699|NCT00107354|B-cell adult acute lymphoblastic leukemia|b-cell adult acute lymphoblastic leukemia
832700|NCT00107354|B-cell childhood acute lymphoblastic leukemia|b-cell childhood acute lymphoblastic leukemia
832701|NCT00107354|childhood myelodysplastic syndromes|childhood myelodysplastic syndromes
832702|NCT00107341|adenocarcinoma of the esophagus|adenocarcinoma of the esophagus
832703|NCT00107341|stage IV esophageal cancer|stage iv esophageal cancer
832704|NCT00107341|recurrent esophageal cancer|recurrent esophageal cancer
832705|NCT00107315|recurrent colon cancer|recurrent colon cancer
832706|NCT00107315|stage IV colon cancer|stage iv colon cancer
832707|NCT00107315|recurrent rectal cancer|recurrent rectal cancer
832708|NCT00107315|stage IV rectal cancer|stage iv rectal cancer
832709|NCT00107289|metastatic pheochromocytoma|metastatic pheochromocytoma
832710|NCT00107289|recurrent pheochromocytoma|recurrent pheochromocytoma
832711|NCT00107289|regional pheochromocytoma|regional pheochromocytoma
832712|NCT00107289|recurrent neuroblastoma|recurrent neuroblastoma
832713|NCT00107289|04-148|04-148
832714|NCT00107276|stage IV breast cancer|stage iv breast cancer
832715|NCT00107276|recurrent breast cancer|recurrent breast cancer
832716|NCT00107263|osteoporosis|osteoporosis
832717|NCT00107263|stage I breast cancer|stage i breast cancer
832718|NCT00107263|stage II breast cancer|stage ii breast cancer
832719|NCT00107263|stage IIIA breast cancer|stage iiia breast cancer
832816|NCT00106899|brain metabolism|brain metabolism
832720|NCT00107250|recurrent non-small cell lung cancer|recurrent non-small cell lung cancer
832721|NCT00107250|stage IIIB non-small cell lung cancer|stage iiib non-small cell lung cancer
832722|NCT00107250|stage IV non-small cell lung cancer|stage iv non-small cell lung cancer
832723|NCT00107250|stage IV colon cancer|stage iv colon cancer
832724|NCT00107250|stage IV rectal cancer|stage iv rectal cancer
832725|NCT00107250|unspecified adult solid tumor, protocol specific|unspecified adult solid tumor, protocol specific
832726|NCT00107237|adult glioblastoma|adult glioblastoma
832727|NCT00107237|recurrent adult brain tumor|recurrent adult brain tumor
832728|NCT00107237|adult giant cell glioblastoma|adult giant cell glioblastoma
832729|NCT00107237|adult gliosarcoma|adult gliosarcoma
832730|NCT00107211|ductal breast carcinoma in situ|ductal breast carcinoma in situ
832731|NCT00107211|breast cancer in situ|breast cancer in situ
832732|NCT00107185|childhood high-grade cerebral astrocytoma|childhood high-grade cerebral astrocytoma
832733|NCT00107185|recurrent childhood cerebral astrocytoma|recurrent childhood cerebral astrocytoma
832734|NCT00107185|childhood oligodendroglioma|childhood oligodendroglioma
832735|NCT00107172|stage I non-small cell lung cancer|stage i non-small cell lung cancer
832736|NCT00107159|recurrent melanoma|recurrent melanoma
832737|NCT00107159|stage III melanoma|stage iii melanoma
832738|NCT00107159|stage IV melanoma|stage iv melanoma
832739|NCT00107120|Major Depressive Disorder|major depressive disorder
832740|NCT00107120|Depression|depression
832741|NCT00107120|Adolescents|adolescents
832742|NCT00107120|Escitalopram|escitalopram
832743|NCT00107120|Pediatrics|pediatrics
832744|NCT00107107|Diabetes|diabetes
832745|NCT00107107|Amylin|amylin
832746|NCT00107107|pramlintide|pramlintide
832747|NCT00107107|Symlin|symlin
832748|NCT00107094|Breast Cancer|breast cancer
832749|NCT00107094|Adriamycin|adriamycin
832750|NCT00107094|Cyclophosphamide|cyclophosphamide
832751|NCT00107094|Abraxane|abraxane
832752|NCT00107081|children|children
832753|NCT00107081|oral antibiotics|oral antibiotics
832754|NCT00107081|outpatient treatment|outpatient treatment
832755|NCT00107081|fever and neutropenia|fever and neutropenia
832756|NCT00107068|Stroke|stroke
832757|NCT00107068|Exercise|exercise
832758|NCT00107068|Aerobic|aerobic
832759|NCT00107068|PRT|prt
832760|NCT00107068|Walking ability|walking ability
832761|NCT00107055|Herniated nucleus pulposus|herniated nucleus pulposus
832762|NCT00107055|Lumbosacral radiculopathy|lumbosacral radiculopathy
832763|NCT00107055|Anti-TNF alpha|anti-tnf alpha
832764|NCT00107055|Tumor necrosis factor alpha|tumor necrosis factor alpha
832765|NCT00107042|Hepatitis B|hepatitis b
832766|NCT00107042|HIV vaccine trial|hiv vaccine trial
832767|NCT00107029|HIV infection|hiv infection
832768|NCT00107029|CD8+ T-cells|cd8+ t-cells
832769|NCT00107029|HIV-1 genotype|hiv-1 genotype
832770|NCT00107016|Breast Cancer|breast cancer
832771|NCT00107016|Cancer of the Breast|cancer of the breast
832772|NCT00107016|Neo-adjuvant|neo-adjuvant
832773|NCT00107016|Primary breast cancer|primary breast cancer
832774|NCT00107016|postmenopausal|postmenopausal
832775|NCT00107016|pre-operative|pre-operative
832776|NCT00107003|Brain|brain
832777|NCT00107003|Tumor|tumor
832778|NCT00107003|Surgery|surgery
832779|NCT00107003|Therapy|therapy
832780|NCT00107003|Trial|trial
832781|NCT00107003|Brain Tumor|brain tumor
832782|NCT00107003|Glioblastoma Multiforme|glioblastoma multiforme
832783|NCT00107003|GBM|gbm
832784|NCT00107003|Gliosarcoma|gliosarcoma
832785|NCT00107003|GS|gs
832786|NCT00106977|Coronal Craniosynostosis|coronal craniosynostosis
832787|NCT00106977|Hearing Loss|hearing loss
832788|NCT00106977|Pro250 Arg Mutation|pro250 arg mutation
832789|NCT00106977|Tarsal Coalition|tarsal coalition
832790|NCT00106977|Carpal Coalition|carpal coalition
832791|NCT00106977|Muenke Syndrome|muenke syndrome
832792|NCT00106977|Craniosynostosis|craniosynostosis
832793|NCT00106964|Hepatitis B vaccines|hepatitis b vaccines
832794|NCT00106964|HIV-infected adolescents|hiv-infected adolescents
832795|NCT00106964|Hepatitis B infection (negative)|hepatitis b infection (negative)
832796|NCT00106951|Surveillance|surveillance
832797|NCT00106951|coronary heart disease|coronary heart disease
832798|NCT00106951|neighborhood SES|neighborhood ses
832799|NCT00106938|Carotid stenting|carotid stenting
832800|NCT00106938|Carotid endarterectomy|carotid endarterectomy
832801|NCT00106938|Carotid artery disease with severe narrowing of the artery|carotid artery disease with severe narrowing of the artery
832802|NCT00106938|Stroke prevention|stroke prevention
832803|NCT00106925|Peripheral Blood Stem Cells|peripheral blood stem cells
832804|NCT00106925|Graft-Versus Leukemia/Myeloma|graft-versus leukemia/myeloma
832805|NCT00106925|Graft-Versus-Host Disease|graft-versus-host disease
832806|NCT00106925|Whole Body Irradiation|whole body irradiation
832807|NCT00106925|Leukemic Relapse|leukemic relapse
832808|NCT00106925|Allogeneic Stem Cell Transplantation Recipient|allogeneic stem cell transplantation recipient
832809|NCT00106912|Genetic|genetic
832810|NCT00106912|Stroke|stroke
832811|NCT00106912|Heart|heart
832812|NCT00106912|Lysosomal|lysosomal
832813|NCT00106912|Glycolipid|glycolipid
832814|NCT00106912|Fabry Disease|fabry disease
832815|NCT00106899|neuroimaging|neuroimaging
832817|NCT00106899|biomarkers|biomarkers
832818|NCT00106899|cognition disorder|cognition disorder
832819|NCT00106899|Mild Cognitive Impairment|mild cognitive impairment
832820|NCT00106886|homocysteine|homocysteine
832821|NCT00106886|folic acid|folic acid
832822|NCT00106886|micronutrients|micronutrients
832823|NCT00106886|multivitamins|multivitamins
832824|NCT00106886|vitamin supplements|vitamin supplements
832825|NCT00106860|Anxiety|anxiety
832826|NCT00106860|Generalized Anxiety Disorder|generalized anxiety disorder
832827|NCT00106847|plaque-type psoriasis|plaque-type psoriasis
832828|NCT00106847|psoriasis|psoriasis
832829|NCT00106847|drug safety|drug safety
832830|NCT00106847|drug efficacy|drug efficacy
832831|NCT00106847|maintenance therapy|maintenance therapy
832832|NCT00106847|induction therapy|induction therapy
832833|NCT00106847|remicade|remicade
832834|NCT00106834|Psoriasis|psoriasis
832835|NCT00106834|Infliximab|infliximab
832836|NCT00106834|Remicade|remicade
832837|NCT00106808|Type 2 Diabetes|type 2 diabetes
832838|NCT00106795|Antiretrovirals|antiretrovirals
832839|NCT00106795|Adipocytes|adipocytes
832840|NCT00106795|Skeletal Muscle|skeletal muscle
832841|NCT00106795|Fatigue|fatigue
832842|NCT00106795|HIV|hiv
832843|NCT00106795|AIDS|aids
832844|NCT00106795|Lymphocytes|lymphocytes
832845|NCT00106795|Lipodystrophy|lipodystrophy
832846|NCT00106795|HIV Positive|hiv positive
832847|NCT00106795|Healthy Volunteer|healthy volunteer
832848|NCT00106795|HV|hv
832849|NCT00106782|Electrical|electrical
832850|NCT00106782|Stimulation|stimulation
832851|NCT00106782|Dystonia|dystonia
832852|NCT00106782|Brain|brain
832853|NCT00106782|Focal Hand Dystonia|focal hand dystonia
832854|NCT00106782|FHD|fhd
832855|NCT00106769|Flavivirus|flavivirus
832856|NCT00106769|Mosquito|mosquito
832857|NCT00106769|Immunity|immunity
832858|NCT00106769|Preventive|preventive
832859|NCT00106769|Virus|virus
832860|NCT00106769|West Nile Fever|west nile fever
832861|NCT00106769|Healthy Volunteer|healthy volunteer
832862|NCT00106769|HV|hv
832863|NCT00106756|Exudation|exudation
832864|NCT00106756|Avascular Retina|avascular retina
832865|NCT00106756|Retina Fold|retina fold
832866|NCT00106743|Usher Syndrome|usher syndrome
832867|NCT00106743|Retinitis Pigmentosa|retinitis pigmentosa
832868|NCT00106743|Congenital Deafness|congenital deafness
832869|NCT00106717|Cancer pain|cancer pain
832870|NCT00106717|Quality of life|quality of life
832871|NCT00106717|Narrative medicine|narrative medicine
832872|NCT00106717|Pain relief|pain relief
832873|NCT00106691|neoplasia|neoplasia
832874|NCT00106691|chemoprevention|chemoprevention
832875|NCT00106691|cancer|cancer
832876|NCT00106691|premalignant|premalignant
832877|NCT00106691|precancerous|precancerous
832878|NCT00106691|Chemoprophylaxis|chemoprophylaxis
832879|NCT00106691|Intraepithelial Prostatic Neoplasia|intraepithelial prostatic neoplasia
832880|NCT00106691|Neoplasia, Prostatic Intraepithelial|neoplasia, prostatic intraepithelial
832881|NCT00106678|HIV|hiv
832882|NCT00106678|Antiretroviral therapy (ART)|antiretroviral therapy (art)
832883|NCT00106678|HAART|haart
832884|NCT00106678|Adherence|adherence
832885|NCT00106678|Barriers|barriers
832886|NCT00106665|ICU acquired weakness|icu acquired weakness
832887|NCT00106665|Critical care polyneuropathy|critical care polyneuropathy
832888|NCT00106665|Critical care myopathy|critical care myopathy
832889|NCT00106652|autism|autism
832890|NCT00106652|neurodevelopment|neurodevelopment
832891|NCT00106652|neurotoxicology|neurotoxicology
832892|NCT00106652|perinatology|perinatology
832893|NCT00106652|teratology|teratology
832894|NCT00106639|tofacitinib|tofacitinib
832895|NCT00106639|CP-690550|cp-690550
832896|NCT00106639|kidney transplant|kidney transplant
832897|NCT00106626|Advanced solid tumors including MPM and NSCLC|advanced solid tumors including mpm and nsclc
832898|NCT00106613|Renal Cell Carcinoma|renal cell carcinoma
832899|NCT00106613|Metastatic Cancer|metastatic cancer
832900|NCT00106613|Metastatic Renal Cell Carcinoma|metastatic renal cell carcinoma
832901|NCT00106600|Relapsed|relapsed
832902|NCT00106600|Refractory|refractory
832903|NCT00106587|in stent restenosis|in stent restenosis
832904|NCT00106587|paclitaxel coated balloon catheter|paclitaxel coated balloon catheter
832905|NCT00106587|paccocath|paccocath
832906|NCT00106587|drug eluting balloon|drug eluting balloon
832907|NCT00106561|spironolactone|spironolactone
832908|NCT00106561|proteinuria|proteinuria
832909|NCT00106561|angiotensin converting enzyme inhibitor|angiotensin converting enzyme inhibitor
832910|NCT00106561|angiotensin receptor blocker|angiotensin receptor blocker
832911|NCT00106561|renin angiotensin aldosterone system|renin angiotensin aldosterone system
832912|NCT00106561|aldosterone|aldosterone
832913|NCT00106509|Clostridium Enterocolitis|clostridium enterocolitis
832914|NCT00106509|Pseudomembranous Colitis|pseudomembranous colitis
832915|NCT00106509|Clostridium difficile-associated diarrhea|clostridium difficile-associated diarrhea
832916|NCT00106509|C. difficile|c. difficile
832917|NCT00106509|CDAD|cdad
832918|NCT00106496|Treatment Effectiveness|treatment effectiveness
832919|NCT00106496|Treatment Efficacy|treatment efficacy
832920|NCT00106496|Immunomodulator, Topical|immunomodulator, topical
832921|NCT00106496|Tacrolimus, Topical|tacrolimus, topical
832922|NCT00106496|Dermatitis, Atopic|dermatitis, atopic
832923|NCT00106496|Eczema, Atopic|eczema, atopic
832924|NCT00106496|Atopic Dermatitis|atopic dermatitis
832925|NCT00106483|Cardiovascular Diseases|cardiovascular diseases
833125|NCT00105586|SERT|sert
832926|NCT00106483|Coronary Disease|coronary disease
832927|NCT00106483|Heart Diseases|heart diseases
832928|NCT00106470|Chronic Obstructive Pulmonary Disease|chronic obstructive pulmonary disease
832929|NCT00106431|romidepsin|romidepsin
832930|NCT00106418|Prostate Cancer|prostate cancer
832931|NCT00106418|Androgen independent metastatic prostate cancer patients with rising PSA|androgen independent metastatic prostate cancer patients with rising psa
832932|NCT00106418|romidepsin|romidepsin
832933|NCT00106405|Bipolar I Disorder|bipolar i disorder
832934|NCT00106405|Mania|mania
832935|NCT00106405|Memantine HCl|memantine hcl
832936|NCT00106392|Treatment effectiveness|treatment effectiveness
832937|NCT00106392|Treatment efficacy|treatment efficacy
832938|NCT00106392|Investigational, Therapies|investigational, therapies
832939|NCT00106392|Immunosuppressant|immunosuppressant
832940|NCT00106392|Erectile dysfunction|erectile dysfunction
832941|NCT00106392|Prostatectomy|prostatectomy
832942|NCT00106379|HIV-1|hiv-1
832943|NCT00106379|Treatment Naive|treatment naive
832944|NCT00106379|Treatment Experienced|treatment experienced
832945|NCT00106366|Diabetes, Type 2|diabetes, type 2
832946|NCT00106353|Pediatric Tumors|pediatric tumors
832947|NCT00106340|type 2 diabetes|type 2 diabetes
832948|NCT00106340|vildagliptin|vildagliptin
832949|NCT00106314|Dehydroepiandrosterone|dehydroepiandrosterone
832950|NCT00106314|DHEA|dhea
832951|NCT00106314|Crohn's disease|crohn's disease
832952|NCT00106314|C-reactive protein|c-reactive protein
832953|NCT00106314|CRP|crp
832954|NCT00106314|Crohn's Disease Activity Index|crohn's disease activity index
832955|NCT00106314|CDAI|cdai
832956|NCT00106314|Inflammatory Bowel Disease Questionnaire|inflammatory bowel disease questionnaire
832957|NCT00106314|IBDQ|ibdq
832958|NCT00106301|FK228|fk228
832959|NCT00106301|Hormone Refractory Prostate Cancer|hormone refractory prostate cancer
832960|NCT00106288|Candidaemia|candidaemia
832961|NCT00106288|Micafungin|micafungin
832962|NCT00106275|Fibromyalgia|fibromyalgia
832963|NCT00106275|Meditation|meditation
832964|NCT00106275|Stress, Psychological|stress, psychological
832965|NCT00106275|Monitoring, Ambulatory|monitoring, ambulatory
832966|NCT00106275|Electrocardiographie, Ambulatory|electrocardiographie, ambulatory
832967|NCT00106275|Psychophysiology|psychophysiology
832968|NCT00106262|advanced cervical cancer|advanced cervical cancer
832969|NCT00106262|metastatic cervical cancer|metastatic cervical cancer
832970|NCT00106249|TMS, Supplementary Motor Area, Obsessive-Compulsive Disorder|tms, supplementary motor area, obsessive-compulsive disorder
832971|NCT00106236|Exercise|exercise
832972|NCT00106236|Fitness Club|fitness club
832973|NCT00106236|Randomized Controlled Trial|randomized controlled trial
832974|NCT00106236|Cardiovascular Risk Factor|cardiovascular risk factor
832975|NCT00106236|Overweight|overweight
832976|NCT00106236|Inactivity|inactivity
832977|NCT00106223|Cognitive Behavioral Therapy|cognitive behavioral therapy
832978|NCT00106223|CBT|cbt
832979|NCT00106223|BDD|bdd
832980|NCT00106223|Body dysmorphic disorder|body dysmorphic disorder
832981|NCT00106210|Child|child
832982|NCT00106197|Sleep, REM|sleep, rem
832983|NCT00106197|Antidepressant|antidepressant
832984|NCT00106197|Adolescent|adolescent
832985|NCT00106197|Cortisol|cortisol
832986|NCT00106184|rituximab|rituximab
832987|NCT00106184|myositis|myositis
832988|NCT00106184|dermatomyositis|dermatomyositis
832989|NCT00106184|polymyositis|polymyositis
832990|NCT00106184|refractory|refractory
832991|NCT00106184|Juvenile Dermatomyositis|juvenile dermatomyositis
832992|NCT00106171|HIV|hiv
832993|NCT00106171|Acute/Early Seroconverters|acute/early seroconverters
832994|NCT00106171|Acute Infection|acute infection
832995|NCT00106171|Treatment Naive|treatment naive
832996|NCT00106171|Primary HIV Infection|primary hiv infection
832997|NCT00106158|cancer/testis antigen|cancer/testis antigen
832998|NCT00106158|cancer vaccine|cancer vaccine
832999|NCT00106158|recombinant protein|recombinant protein
833000|NCT00106145|Advanced Breast Cancer|advanced breast cancer
833001|NCT00106145|Solid Tumors|solid tumors
833002|NCT00106145|Advanced Solid Tumors|advanced solid tumors
833003|NCT00106132|Macular Edema|macular edema
833004|NCT00106132|Steroid|steroid
833005|NCT00106132|Fluorescein Angiogram|fluorescein angiogram
833006|NCT00106132|Ocular Coherence Tomography|ocular coherence tomography
833007|NCT00106132|Laser|laser
833008|NCT00106132|Retinal Vein Occlusion|retinal vein occlusion
833009|NCT00106119|Levothyroxine|levothyroxine
833010|NCT00106119|Liothyronine|liothyronine
833011|NCT00106119|Lipid Metabolism|lipid metabolism
833012|NCT00106119|Gluconeogensis|gluconeogensis
833013|NCT00106119|Thyrotropin Releasing Hormone|thyrotropin releasing hormone
833014|NCT00106119|Deiodinase|deiodinase
833015|NCT00106119|Replacement Thyroid Hormone Therapy|replacement thyroid hormone therapy
833016|NCT00106119|Thyroidectomy|thyroidectomy
834478|NCT00100685|cell|cell
833017|NCT00106119|Near Total Thyroidectomy|near total thyroidectomy
833018|NCT00106106|Alcoholism|alcoholism
833019|NCT00106106|Acamprosate|acamprosate
833020|NCT00106106|Withdrawal|withdrawal
833021|NCT00106106|Glutamate|glutamate
833022|NCT00106106|Magnetic Resonance Spectroscopy|magnetic resonance spectroscopy
833023|NCT00106106|Alcohol Dependence|alcohol dependence
833024|NCT00106106|Healthy Volunteer|healthy volunteer
833025|NCT00106106|HV|hv
833026|NCT00106093|Alcohol|alcohol
833027|NCT00106093|Alcohol Treatment|alcohol treatment
833028|NCT00106093|DNA|dna
833029|NCT00106093|Treatment|treatment
833030|NCT00106093|Alcohol Dependence|alcohol dependence
833031|NCT00106093|Alcoholism|alcoholism
833032|NCT00106093|Alcohol Drinking Related Problems|alcohol drinking related problems
833033|NCT00106080|Communication|communication
833034|NCT00106080|Palliative Care|palliative care
833035|NCT00106067|aging|aging
833036|NCT00106067|behavioral research|behavioral research
833037|NCT00106067|quality of life|quality of life
833038|NCT00106067|end of life|end of life
833039|NCT00106067|family relations|family relations
833040|NCT00106067|supportive care|supportive care
833041|NCT00106067|advanced care|advanced care
833042|NCT00106067|bereavement|bereavement
833043|NCT00106041|end of life care|end of life care
833044|NCT00106041|evaluation studies|evaluation studies
833045|NCT00106041|quality of death and dying|quality of death and dying
833046|NCT00106041|palliative care|palliative care
833047|NCT00106041|coordination of care|coordination of care
833048|NCT00106041|satisfaction with care|satisfaction with care
833049|NCT00106041|healthcare cost|healthcare cost
833050|NCT00106041|utilization of healthcare resources|utilization of healthcare resources
833051|NCT00106041|caregivers|caregivers
833052|NCT00106041|veterans|veterans
833053|NCT00106028|Primary disease: Osteogenesis Imperfecta|primary disease: osteogenesis imperfecta
833054|NCT00106015|inherited pure red cell aplasia|inherited pure red cell aplasia
833055|NCT00105963|abuse|abuse
833056|NCT00105950|ErbB2 overexpressing|erbb2 overexpressing
833057|NCT00105950|ErbB1 expressing|erbb1 expressing
833058|NCT00105950|relapsed breast cancer|relapsed breast cancer
833059|NCT00105950|refractory inflammatory breast cancer|refractory inflammatory breast cancer
833060|NCT00105937|Cancer|cancer
833061|NCT00105937|Pain|pain
833062|NCT00105911|Cognitive Behavioral Therapy|cognitive behavioral therapy
833063|NCT00105898|Diabetes mellitus|diabetes mellitus
833064|NCT00105898|Hypertension|hypertension
833065|NCT00105898|Telemedicine|telemedicine
833066|NCT00105898|Case management|case management
833067|NCT00105885|Telephone|telephone
833068|NCT00105885|Telemedicine|telemedicine
833069|NCT00105885|Psychopharmacology|psychopharmacology
833070|NCT00105872|insomnia|insomnia
833071|NCT00105872|cognitive behavior therapy|cognitive behavior therapy
833072|NCT00105820|Evaluation|evaluation
833073|NCT00105820|Quality improvement|quality improvement
833074|NCT00105820|Cluster randomized trial|cluster randomized trial
833075|NCT00105820|Care model|care model
833076|NCT00105820|Collaborative care|collaborative care
833077|NCT00105820|Informatics|informatics
833078|NCT00105794|advance directives|advance directives
833079|NCT00105794|advance directive adherence|advance directive adherence
833080|NCT00105794|patient-centered care|patient-centered care
833081|NCT00105794|patient satisfaction|patient satisfaction
833082|NCT00105794|coercion|coercion
833083|NCT00105794|informed consent|informed consent
833084|NCT00105794|commitment of mentally ill|commitment of mentally ill
833085|NCT00105794|physician-patient relations|physician-patient relations
833086|NCT00105781|Nurses|nurses
833087|NCT00105781|Telephone|telephone
833088|NCT00105781|Counseling|counseling
833089|NCT00105781|Exercise|exercise
833090|NCT00105755|Activity Cycles|activity cycles
833091|NCT00105755|Amputation|amputation
833092|NCT00105755|Prevention|prevention
833093|NCT00105755|Temperature|temperature
833094|NCT00105729|Self-help groups|self-help groups
833095|NCT00105729|Referral and consultation|referral and consultation
833096|NCT00105716|hypertension|hypertension
833097|NCT00105716|adherence|adherence
833098|NCT00105716|cardiovascular diseases|cardiovascular diseases
833099|NCT00105703|Nurse practitioners|nurse practitioners
833100|NCT00105703|Case management|case management
833101|NCT00105677|Racial/ethnic health disparities|racial/ethnic health disparities
833102|NCT00105677|Attitudes|attitudes
833103|NCT00105677|Osteoarthritis Management|osteoarthritis management
833104|NCT00105677|Patient Perceptions|patient perceptions
833105|NCT00105664|Outcomes Assessment|outcomes assessment
833106|NCT00105664|Primary Health Care|primary health care
833107|NCT00105664|Group Process|group process
833108|NCT00105638|Intervention studies|intervention studies
833109|NCT00105638|Health Care Costs|health care costs
833110|NCT00105638|Telephone|telephone
833111|NCT00105638|Caregivers|caregivers
833112|NCT00105625|Geriatrics|geriatrics
833113|NCT00105625|Nutrition|nutrition
833114|NCT00105625|Immune function|immune function
833115|NCT00105625|Infection|infection
833116|NCT00105625|Rehabilitation|rehabilitation
833117|NCT00105625|Inpatient|inpatient
833118|NCT00105612|Informed Consent|informed consent
833119|NCT00105612|Memory Aid|memory aid
833120|NCT00105586|Anxiety|anxiety
833121|NCT00105586|Elderly|elderly
833122|NCT00105586|Aged|aged
833123|NCT00105586|Serotonin Reuptake Inhibitors|serotonin reuptake inhibitors
833124|NCT00105586|SSRI|ssri
833126|NCT00105573|Mother-Child Relations|mother-child relations
833127|NCT00105573|Infant|infant
833128|NCT00105573|Child Development|child development
833129|NCT00105573|Poverty|poverty
833130|NCT00105560|long-term effects secondary to cancer therapy in children|long-term effects secondary to cancer therapy in children
833131|NCT00105560|untreated childhood medulloblastoma|untreated childhood medulloblastoma
833132|NCT00105560|untreated childhood pineoblastoma|untreated childhood pineoblastoma
833133|NCT00105547|Alzheimer's|alzheimer's
833134|NCT00105547|Dementia|dementia
833135|NCT00105547|Dementia of Alzheimer Type|dementia of alzheimer type
833136|NCT00105534|Bacterial Conjunctivitis|bacterial conjunctivitis
833137|NCT00105534|Pink Eye|pink eye
833138|NCT00105534|Conjunctivitis|conjunctivitis
833139|NCT00105534|Eye Infection|eye infection
833140|NCT00105534|Eye Discharge|eye discharge
833141|NCT00105521|Parkinson's Disease|parkinson's disease
833142|NCT00105521|Dyskinesia|dyskinesia
833143|NCT00105521|Dyskinesia associated with dopaminergic treatment|dyskinesia associated with dopaminergic treatment
833144|NCT00105508|Parkinson's Disease|parkinson's disease
833145|NCT00105508|Dyskinesia|dyskinesia
833146|NCT00105508|Dyskinesia associated with dopaminergic treatment|dyskinesia associated with dopaminergic treatment
833147|NCT00105495|Iron Overload|iron overload
833148|NCT00105495|Thalassemia|thalassemia
833149|NCT00105495|Haemosiderosis|haemosiderosis
833150|NCT00105495|Cardiac|cardiac
833151|NCT00105495|Deferiprone|deferiprone
833152|NCT00105495|Chelation|chelation
833153|NCT00105482|Tobacco|tobacco
833154|NCT00105482|Smoking|smoking
833155|NCT00105482|Weight|weight
833156|NCT00105482|Weight perception|weight perception
833157|NCT00105482|Naltrexone|naltrexone
833158|NCT00105469|Bacterial Conjunctivitis|bacterial conjunctivitis
833159|NCT00105469|Pink Eye|pink eye
833160|NCT00105469|Conjunctivitis|conjunctivitis
833161|NCT00105469|Eye Infection|eye infection
833162|NCT00105456|HER2-Positive Metastatic Breast Cancer|her2-positive metastatic breast cancer
833163|NCT00105456|HER2|her2
833164|NCT00105443|Liver Cancer|liver cancer
833165|NCT00105443|Cancer|cancer
833166|NCT00105430|Surgery|surgery
833167|NCT00105430|Treatment|treatment
833168|NCT00105430|Physiology|physiology
833169|NCT00105430|Pediatric|pediatric
833170|NCT00105430|Neurosurgery|neurosurgery
833171|NCT00105430|Generalized Primary Dystonia|generalized primary dystonia
833172|NCT00105417|Immune Reconstitution|immune reconstitution
833173|NCT00105417|Thymus|thymus
833174|NCT00105417|Cytokines|cytokines
833175|NCT00105417|HIV|hiv
833176|NCT00105404|Steroid|steroid
833177|NCT00105404|Diabetic Macular Edema|diabetic macular edema
833178|NCT00105404|DME|dme
833179|NCT00105378|health care services research|health care services research
833180|NCT00105378|frail elderly|frail elderly
833181|NCT00105378|intermediate care|intermediate care
833182|NCT00105378|patient centered care|patient centered care
833183|NCT00105378|comprehensive health care|comprehensive health care
833184|NCT00105378|geriatric nursing|geriatric nursing
833185|NCT00105378|Behavioral symptoms|behavioral symptoms
833186|NCT00105365|lateral wedge inserts|lateral wedge inserts
833187|NCT00105365|shoe inserts|shoe inserts
833188|NCT00105352|Type 1 Diabetes Study Group|type 1 diabetes study group
833189|NCT00105352|TrialNet|trialnet
833190|NCT00105352|type 1 diabetes|type 1 diabetes
833191|NCT00105352|juvenile onset diabetes|juvenile onset diabetes
833192|NCT00105339|consent form, vaccine trial|consent form, vaccine trial
833193|NCT00105339|Simplified consent form|simplified consent form
833194|NCT00105326|Schizophrenia|schizophrenia
833195|NCT00105326|Schizophrenia-related insomnia|schizophrenia-related insomnia
833196|NCT00105326|insomnia|insomnia
833197|NCT00105326|paliperidone|paliperidone
833198|NCT00105326|placebo|placebo
833199|NCT00105326|polysomnography|polysomnography
833200|NCT00105287|cancer|cancer
833201|NCT00105287|pain|pain
833202|NCT00105287|Breakthrough Pain in cancer patients|breakthrough pain in cancer patients
833203|NCT00105274|Velocardiofacial Syndrome|velocardiofacial syndrome
833204|NCT00105274|Susceptibility Genes|susceptibility genes
833205|NCT00105274|Neuroimaging|neuroimaging
833206|NCT00105274|22q11.2|22q11.2
833207|NCT00105274|Psychosis|psychosis
833208|NCT00105274|Mircodeletion|mircodeletion
833209|NCT00105274|DiGeorge Syndrome|digeorge syndrome
833210|NCT00105274|22q11.2 Syndrome|22q11.2 syndrome
833211|NCT00105248|acute repiratory infections|acute repiratory infections
833212|NCT00105248|antibiotic therapy|antibiotic therapy
833213|NCT00105248|patient-centred communication|patient-centred communication
833214|NCT00105248|randomized controlled trial|randomized controlled trial
833215|NCT00105235|transplantation|transplantation
833216|NCT00105235|liver transplant|liver transplant
833217|NCT00105235|rejection|rejection
833218|NCT00105235|tolerance|tolerance
833219|NCT00105235|antibody induction|antibody induction
833220|NCT00105222|Cycle Ergometer|cycle ergometer
833221|NCT00105222|Exercise Physiology|exercise physiology
833222|NCT00105222|Nitric Oxide|nitric oxide
833223|NCT00105222|Sodium Nitrite|sodium nitrite
833224|NCT00105222|Healthy Volunteers|healthy volunteers
833225|NCT00105222|Normal Volunteer|normal volunteer
833226|NCT00105222|Healthy Volunteer|healthy volunteer
833227|NCT00105222|HV|hv
833228|NCT00105209|Platelets|platelets
833229|NCT00105196|Single or recurrent|single or recurrent
833230|NCT00105196|non-psychotic episode of Major Depressive Disorder|non-psychotic episode of major depressive disorder
833231|NCT00105183|pulmonary transplantation|pulmonary transplantation
833232|NCT00105183|Pulmonary Allograft Rejection|pulmonary allograft rejection
833233|NCT00105170|Monoclonal antibody|monoclonal antibody
833234|NCT00105170|Advanced solid tumors|advanced solid tumors
833235|NCT00105170|Tumors|tumors
833236|NCT00105170|hCBE-11|hcbe-11
833237|NCT00105144|Treatment Effectiveness|treatment effectiveness
833238|NCT00105144|Treatment Efficacy|treatment efficacy
833239|NCT00105144|Investigational, Therapies|investigational, therapies
833240|NCT00105144|Antifungal, Systemic|antifungal, systemic
833241|NCT00105144|Antibiotics, Antifungal|antibiotics, antifungal
833242|NCT00105144|Micafungin|micafungin
833243|NCT00105131|Parkinson's Disease|parkinson's disease
833244|NCT00105131|Movement Disorders|movement disorders
833245|NCT00105131|Tremor|tremor
833246|NCT00105131|Alpha-Synuclein|alpha-synuclein
833247|NCT00105131|Lewy Bodies|lewy bodies
833248|NCT00105131|Parkinson Disease|parkinson disease
833249|NCT00105131|PD|pd
833250|NCT00105131|Movement Disorder|movement disorder
833251|NCT00105131|Healthy Volunteer|healthy volunteer
833252|NCT00105131|HV|hv
833253|NCT00105118|Cognition|cognition
833254|NCT00105118|Alpha|alpha
833255|NCT00105118|Schizophrenia|schizophrenia
833256|NCT00105118|Functional Connectivity|functional connectivity
833257|NCT00105118|Oscillatory Potential|oscillatory potential
833258|NCT00105105|Alzheimers|alzheimers
833259|NCT00105105|cognition|cognition
833260|NCT00105105|acetyl cholinesterase inhibitor|acetyl cholinesterase inhibitor
833261|NCT00105105|GR-II antagonist|gr-ii antagonist
833262|NCT00105066|Metabolic Syndrome|metabolic syndrome
833263|NCT00105066|triglycerides|triglycerides
833264|NCT00105066|HDL|hdl
833265|NCT00105066|LDL|ldl
833266|NCT00105066|High Blood Pressure|high blood pressure
833267|NCT00105066|High Cholesterol|high cholesterol
833268|NCT00105066|High Blood Sugar|high blood sugar
833269|NCT00105040|Partial onset seizures|partial onset seizures
833270|NCT00105040|epilepsy|epilepsy
833271|NCT00105040|levetiracetam|levetiracetam
833272|NCT00105040|Keppra|keppra
833273|NCT00105040|cognition|cognition
833274|NCT00105040|behavior|behavior
833275|NCT00105040|pediatry|pediatry
833276|NCT00105027|macular edema|macular edema
833277|NCT00105027|central retinal vein occlusion (CRVO)|central retinal vein occlusion (crvo)
833278|NCT00105027|branch retinal vein occlusion (BRVO)|branch retinal vein occlusion (brvo)
833279|NCT00104988|stage IV melanoma|stage iv melanoma
833280|NCT00104975|accelerated phase chronic myelogenous leukemia|accelerated phase chronic myelogenous leukemia
833281|NCT00104975|recurrent adult Burkitt lymphoma|recurrent adult burkitt lymphoma
833282|NCT00104975|stage IV adult Burkitt lymphoma|stage iv adult burkitt lymphoma
833283|NCT00104975|recurrent adult lymphoblastic lymphoma|recurrent adult lymphoblastic lymphoma
833284|NCT00104975|stage IV adult lymphoblastic lymphoma|stage iv adult lymphoblastic lymphoma
833285|NCT00104975|recurrent adult immunoblastic large cell lymphoma|recurrent adult immunoblastic large cell lymphoma
833286|NCT00104975|stage IV adult immunoblastic large cell lymphoma|stage iv adult immunoblastic large cell lymphoma
833287|NCT00104975|refractory anemia with excess blasts in transformation|refractory anemia with excess blasts in transformation
833288|NCT00104975|refractory anemia with excess blasts|refractory anemia with excess blasts
833289|NCT00104975|secondary myelodysplastic syndromes|secondary myelodysplastic syndromes
833290|NCT00104975|chronic myelomonocytic leukemia|chronic myelomonocytic leukemia
833291|NCT00104975|blastic phase chronic myelogenous leukemia|blastic phase chronic myelogenous leukemia
833292|NCT00104975|chronic eosinophilic leukemia|chronic eosinophilic leukemia
833293|NCT00104975|primary myelofibrosis|primary myelofibrosis
833294|NCT00104975|chronic neutrophilic leukemia|chronic neutrophilic leukemia
833295|NCT00104975|essential thrombocythemia|essential thrombocythemia
833296|NCT00104975|polycythemia vera|polycythemia vera
833297|NCT00104975|adult acute myeloid leukemia in remission|adult acute myeloid leukemia in remission
833298|NCT00104975|adult acute myeloid leukemia with 11q23 (MLL) abnormalities|adult acute myeloid leukemia with 11q23 (mll) abnormalities
833299|NCT00104975|adult acute myeloid leukemia with inv(16)(p13;q22)|adult acute myeloid leukemia with inv(16)(p13;q22)
833300|NCT00104975|adult acute myeloid leukemia with t(15;17)(q22;q12)|adult acute myeloid leukemia with t(15;17)(q22;q12)
833301|NCT00104975|adult acute myeloid leukemia with t(16;16)(p13;q22)|adult acute myeloid leukemia with t(16;16)(p13;q22)
833302|NCT00104975|adult acute myeloid leukemia with t(8;21)(q22;q22)|adult acute myeloid leukemia with t(8;21)(q22;q22)
833303|NCT00104975|recurrent adult acute myeloid leukemia|recurrent adult acute myeloid leukemia
833304|NCT00104975|refractory chronic lymphocytic leukemia|refractory chronic lymphocytic leukemia
834479|NCT00100685|metastatic|metastatic
833305|NCT00104975|stage III chronic lymphocytic leukemia|stage iii chronic lymphocytic leukemia
833306|NCT00104975|stage IV chronic lymphocytic leukemia|stage iv chronic lymphocytic leukemia
833307|NCT00104975|stage III adult Burkitt lymphoma|stage iii adult burkitt lymphoma
833308|NCT00104975|stage III adult immunoblastic large cell lymphoma|stage iii adult immunoblastic large cell lymphoma
833843|NCT00102947|Cubist|cubist
833309|NCT00104975|stage III adult lymphoblastic lymphoma|stage iii adult lymphoblastic lymphoma
833310|NCT00104975|myelodysplastic/myeloproliferative neoplasm, unclassifiable|myelodysplastic/myeloproliferative neoplasm, unclassifiable
833311|NCT00104975|de novo myelodysplastic syndromes|de novo myelodysplastic syndromes
833312|NCT00104975|previously treated myelodysplastic syndromes|previously treated myelodysplastic syndromes
833313|NCT00104975|atypical chronic myeloid leukemia, BCR-ABL1 negative|atypical chronic myeloid leukemia, bcr-abl1 negative
833314|NCT00104949|adult synovial sarcoma|adult synovial sarcoma
833315|NCT00104949|recurrent adult soft tissue sarcoma|recurrent adult soft tissue sarcoma
833316|NCT00104949|stage III adult soft tissue sarcoma|stage iii adult soft tissue sarcoma
833317|NCT00104949|stage IV adult soft tissue sarcoma|stage iv adult soft tissue sarcoma
833318|NCT00104936|adult grade I meningioma|adult grade i meningioma
833319|NCT00104923|adult acute myeloid leukemia with 11q23 (MLL) abnormalities|adult acute myeloid leukemia with 11q23 (mll) abnormalities
833320|NCT00104923|adult acute myeloid leukemia with inv(16)(p13;q22)|adult acute myeloid leukemia with inv(16)(p13;q22)
833321|NCT00104923|adult acute myeloid leukemia with t(15;17)(q22;q12)|adult acute myeloid leukemia with t(15;17)(q22;q12)
833322|NCT00104923|adult acute myeloid leukemia with t(16;16)(p13;q22)|adult acute myeloid leukemia with t(16;16)(p13;q22)
833323|NCT00104923|adult acute myeloid leukemia with t(8;21)(q22;q22)|adult acute myeloid leukemia with t(8;21)(q22;q22)
833324|NCT00104923|recurrent grade 1 follicular lymphoma|recurrent grade 1 follicular lymphoma
833325|NCT00104923|recurrent grade 2 follicular lymphoma|recurrent grade 2 follicular lymphoma
833326|NCT00104923|recurrent grade 3 follicular lymphoma|recurrent grade 3 follicular lymphoma
833327|NCT00104923|recurrent small lymphocytic lymphoma|recurrent small lymphocytic lymphoma
833328|NCT00104923|recurrent mantle cell lymphoma|recurrent mantle cell lymphoma
833329|NCT00104923|Waldenstrom macroglobulinemia|waldenstrom macroglobulinemia
833330|NCT00104923|adult grade III lymphomatoid granulomatosis|adult grade iii lymphomatoid granulomatosis
833331|NCT00104923|recurrent adult grade III lymphomatoid granulomatosis|recurrent adult grade iii lymphomatoid granulomatosis
833332|NCT00104923|secondary acute myeloid leukemia|secondary acute myeloid leukemia
833333|NCT00104923|recurrent adult Burkitt lymphoma|recurrent adult burkitt lymphoma
833334|NCT00104923|recurrent adult immunoblastic large cell lymphoma|recurrent adult immunoblastic large cell lymphoma
833335|NCT00104923|refractory chronic lymphocytic leukemia|refractory chronic lymphocytic leukemia
833336|NCT00104923|recurrent adult lymphoblastic lymphoma|recurrent adult lymphoblastic lymphoma
833337|NCT00104923|recurrent adult Hodgkin lymphoma|recurrent adult hodgkin lymphoma
833338|NCT00104923|refractory multiple myeloma|refractory multiple myeloma
833339|NCT00104923|recurrent adult acute lymphoblastic leukemia|recurrent adult acute lymphoblastic leukemia
833340|NCT00104923|relapsing chronic myelogenous leukemia|relapsing chronic myelogenous leukemia
833341|NCT00104923|chronic eosinophilic leukemia|chronic eosinophilic leukemia
833342|NCT00104923|primary myelofibrosis|primary myelofibrosis
833343|NCT00104923|chronic neutrophilic leukemia|chronic neutrophilic leukemia
833344|NCT00104923|essential thrombocythemia|essential thrombocythemia
833345|NCT00104923|polycythemia vera|polycythemia vera
833346|NCT00104923|stage II multiple myeloma|stage ii multiple myeloma
833347|NCT00104923|stage III multiple myeloma|stage iii multiple myeloma
833348|NCT00104923|recurrent adult diffuse large cell lymphoma|recurrent adult diffuse large cell lymphoma
833349|NCT00104923|recurrent adult diffuse mixed cell lymphoma|recurrent adult diffuse mixed cell lymphoma
833350|NCT00104923|recurrent adult diffuse small cleaved cell lymphoma|recurrent adult diffuse small cleaved cell lymphoma
833351|NCT00104923|extranodal marginal zone B-cell lymphoma of mucosa-associated lymphoid tissue|extranodal marginal zone b-cell lymphoma of mucosa-associated lymphoid tissue
833352|NCT00104923|nodal marginal zone B-cell lymphoma|nodal marginal zone b-cell lymphoma
833353|NCT00104923|recurrent marginal zone lymphoma|recurrent marginal zone lymphoma
833354|NCT00104923|splenic marginal zone lymphoma|splenic marginal zone lymphoma
833355|NCT00104923|recurrent adult acute myeloid leukemia|recurrent adult acute myeloid leukemia
833356|NCT00104897|recurrent melanoma|recurrent melanoma
833357|NCT00104897|stage IV melanoma|stage iv melanoma
833358|NCT00104884|stage III melanoma|stage iii melanoma
833359|NCT00104884|stage IV melanoma|stage iv melanoma
833360|NCT00104884|Depsipeptide|depsipeptide
833361|NCT00104871|National Thyroid Cancer Treatment Cooperative Study Group|national thyroid cancer treatment cooperative study group
833362|NCT00104871|NTCTCSG|ntctcsg
833363|NCT00104871|bortezomib|bortezomib
833364|NCT00104871|velcade|velcade
833365|NCT00104871|metastatic differentiated thyroid carcinoma|metastatic differentiated thyroid carcinoma
833366|NCT00104871|Differentiated thyroid carcinoma|differentiated thyroid carcinoma
833367|NCT00104871|follicular epithelial thyroid cells|follicular epithelial thyroid cells
833368|NCT00104871|papillary|papillary
833369|NCT00104871|oxyphilic cell|oxyphilic cell
833370|NCT00104871|Hurthle cell|hurthle cell
833371|NCT00104871|insular cell|insular cell
833372|NCT00104871|columnar cell|columnar cell
833373|NCT00104871|tall cell|tall cell
833374|NCT00104845|stage II melanoma|stage ii melanoma
833375|NCT00104845|stage III melanoma|stage iii melanoma
833376|NCT00104845|stage IV melanoma|stage iv melanoma
833377|NCT00104845|recurrent melanoma|recurrent melanoma
833378|NCT00104819|recurrent grade 1 follicular lymphoma|recurrent grade 1 follicular lymphoma
833379|NCT00104819|recurrent grade 2 follicular lymphoma|recurrent grade 2 follicular lymphoma
833380|NCT00104819|recurrent grade 3 follicular lymphoma|recurrent grade 3 follicular lymphoma
833381|NCT00104806|de novo myelodysplastic syndromes|de novo myelodysplastic syndromes
833382|NCT00104806|myelodysplastic/myeloproliferative neoplasm, unclassifiable|myelodysplastic/myeloproliferative neoplasm, unclassifiable
833383|NCT00104806|previously treated myelodysplastic syndromes|previously treated myelodysplastic syndromes
833384|NCT00104806|secondary myelodysplastic syndromes|secondary myelodysplastic syndromes
833385|NCT00104806|refractory anemia with excess blasts in transformation|refractory anemia with excess blasts in transformation
833386|NCT00104806|refractory anemia with excess blasts|refractory anemia with excess blasts
833387|NCT00104806|refractory anemia|refractory anemia
833388|NCT00104806|refractory anemia with ringed sideroblasts|refractory anemia with ringed sideroblasts
833389|NCT00104806|refractory cytopenia with multilineage dysplasia|refractory cytopenia with multilineage dysplasia
833390|NCT00104806|chronic myelomonocytic leukemia|chronic myelomonocytic leukemia
833391|NCT00104806|childhood myelodysplastic syndromes|childhood myelodysplastic syndromes
833392|NCT00104793|extensive stage small cell lung cancer|extensive stage small cell lung cancer
833393|NCT00104780|recurrent non-small cell lung cancer|recurrent non-small cell lung cancer
833394|NCT00104780|stage IIIB non-small cell lung cancer|stage iiib non-small cell lung cancer
833395|NCT00104780|stage IV non-small cell lung cancer|stage iv non-small cell lung cancer
833396|NCT00104767|stage IIIB non-small cell lung cancer|stage iiib non-small cell lung cancer
833397|NCT00104767|stage IV non-small cell lung cancer|stage iv non-small cell lung cancer
833398|NCT00104767|recurrent non-small cell lung cancer|recurrent non-small cell lung cancer
833399|NCT00104754|extensive stage small cell lung cancer|extensive stage small cell lung cancer
833400|NCT00104754|limited stage small cell lung cancer|limited stage small cell lung cancer
833401|NCT00104754|recurrent small cell lung cancer|recurrent small cell lung cancer
833402|NCT00104741|stage IIB prostate cancer|stage iib prostate cancer
833403|NCT00104741|stage IIA prostate cancer|stage iia prostate cancer
833404|NCT00104741|stage III prostate cancer|stage iii prostate cancer
833405|NCT00104728|stage II non-small cell lung cancer|stage ii non-small cell lung cancer
833406|NCT00104728|stage IIIA non-small cell lung cancer|stage iiia non-small cell lung cancer
833407|NCT00104728|stage IA non-small cell lung cancer|stage ia non-small cell lung cancer
833408|NCT00104728|stage IB non-small cell lung cancer|stage ib non-small cell lung cancer
833409|NCT00104715|adenocarcinoma of the prostate|adenocarcinoma of the prostate
833410|NCT00104715|recurrent prostate cancer|recurrent prostate cancer
833411|NCT00104715|stage IV prostate cancer|stage iv prostate cancer
833412|NCT00104702|stage I breast cancer|stage i breast cancer
833413|NCT00104702|stage II breast cancer|stage ii breast cancer
833414|NCT00104689|stage IV colon cancer|stage iv colon cancer
833415|NCT00104689|stage IV rectal cancer|stage iv rectal cancer
833416|NCT00104689|adenocarcinoma of the colon|adenocarcinoma of the colon
833417|NCT00104689|adenocarcinoma of the rectum|adenocarcinoma of the rectum
833418|NCT00104676|stage II malignant testicular germ cell tumor|stage ii malignant testicular germ cell tumor
833419|NCT00104676|stage III malignant testicular germ cell tumor|stage iii malignant testicular germ cell tumor
833420|NCT00104676|testicular choriocarcinoma and embryonal carcinoma|testicular choriocarcinoma and embryonal carcinoma
833421|NCT00104676|testicular choriocarcinoma and teratoma|testicular choriocarcinoma and teratoma
833422|NCT00104676|testicular choriocarcinoma and yolk sac tumor|testicular choriocarcinoma and yolk sac tumor
833423|NCT00104676|testicular choriocarcinoma|testicular choriocarcinoma
833424|NCT00104676|testicular embryonal carcinoma and teratoma|testicular embryonal carcinoma and teratoma
833425|NCT00104676|testicular embryonal carcinoma and yolk sac tumor|testicular embryonal carcinoma and yolk sac tumor
833426|NCT00104676|testicular embryonal carcinoma|testicular embryonal carcinoma
833427|NCT00104676|testicular yolk sac tumor and teratoma|testicular yolk sac tumor and teratoma
833428|NCT00104676|testicular yolk sac tumor|testicular yolk sac tumor
833429|NCT00104676|stage II extragonadal non-seminomatous germ cell tumor|stage ii extragonadal non-seminomatous germ cell tumor
833430|NCT00104676|stage III extragonadal non-seminomatous germ cell tumor|stage iii extragonadal non-seminomatous germ cell tumor
833431|NCT00104676|testicular immature teratoma|testicular immature teratoma
833432|NCT00104676|testicular mature teratoma|testicular mature teratoma
833433|NCT00104676|adult teratoma|adult teratoma
833434|NCT00104663|Creutzfeldt-Jakob disease|creutzfeldt-jakob disease
833435|NCT00104663|inherited|inherited
833436|NCT00104663|sporadic|sporadic
833437|NCT00104663|acquired|acquired
833438|NCT00104663|new variant CJD|new variant cjd
833439|NCT00104650|Bone Metastases|bone metastases
833440|NCT00104650|AMG 162|amg 162
833441|NCT00104650|Bisphosphonates|bisphosphonates
833442|NCT00104650|Solid Tumor Carcinomas|solid tumor carcinomas
833443|NCT00104650|Advanced|advanced
833444|NCT00104637|Chronic Obstructive Pulmonary Disease|chronic obstructive pulmonary disease
833445|NCT00104637|Emphysema|emphysema
833446|NCT00104637|Phosphodiesterase inhibitors|phosphodiesterase inhibitors
833447|NCT00104637|Sildenafil|sildenafil
833448|NCT00104637|Exercise testing|exercise testing
833449|NCT00104637|Quality of life|quality of life
834783|NCT00099580|AC2592|ac2592
833450|NCT00104624|stage IV breast cancer|stage iv breast cancer
833451|NCT00104624|recurrent breast cancer|recurrent breast cancer
833452|NCT00104611|Major Depressive Disorder|major depressive disorder
833453|NCT00104611|Repetitive Transcranial Magnetic Stimulation|repetitive transcranial magnetic stimulation
833454|NCT00104611|rTMS|rtms
834235|NCT00101764|Uveitis|uveitis
833455|NCT00104611|Non-invasive Neuromodulation|non-invasive neuromodulation
833456|NCT00104611|Antidepressant|antidepressant
833457|NCT00104585|Parkinson's disease|parkinson's disease
833458|NCT00104585|PD|pd
833459|NCT00104585|gene|gene
833460|NCT00104585|environment|environment
833461|NCT00104585|early-onset Parkinson's disease|early-onset parkinson's disease
833462|NCT00104572|Estrogen|estrogen
833463|NCT00104572|Glucose Tolerance|glucose tolerance
833464|NCT00104572|Bone Density|bone density
833465|NCT00104572|Quality-of-Life|quality-of-life
833466|NCT00104572|Sarcopenia|sarcopenia
833467|NCT00104559|HIV|hiv
833468|NCT00104559|Informed Consent|informed consent
833469|NCT00104546|Dysmenorrhea|dysmenorrhea
833470|NCT00104546|Acupuncture|acupuncture
833471|NCT00104546|Vitamin K|vitamin k
833472|NCT00104546|Medicine, Chinese Traditional|medicine, chinese traditional
833473|NCT00104546|Women|women
833474|NCT00104546|Menstruation|menstruation
833475|NCT00104546|Pain, Menstrual|pain, menstrual
833476|NCT00104546|China|china
833477|NCT00104533|Static magnetic therapy|static magnetic therapy
833478|NCT00104533|Pain|pain
833479|NCT00104533|Analgesia|analgesia
833480|NCT00104533|Opioids|opioids
833481|NCT00104520|Cystic Fibrosis|cystic fibrosis
833482|NCT00104520|Pseudomonas aeruginosa|pseudomonas aeruginosa
833483|NCT00104520|Pulmonary Cystic Fibrosis|pulmonary cystic fibrosis
833484|NCT00104507|Serotonin|serotonin
833485|NCT00104507|5-HT2c|5-ht2c
833486|NCT00104507|Satiety|satiety
833487|NCT00104507|Obesity|obesity
833488|NCT00104507|Appetite suppressant|appetite suppressant
833489|NCT00104507|Weight Loss|weight loss
833490|NCT00104507|Overweight|overweight
833491|NCT00104494|Cystic Fibrosis|cystic fibrosis
833492|NCT00104494|Zinc supplementation|zinc supplementation
833493|NCT00104494|Nutrition|nutrition
833494|NCT00104494|Zinc absorption|zinc absorption
833495|NCT00104494|Zinc excretion|zinc excretion
833496|NCT00104494|Zinc status|zinc status
833497|NCT00104481|cognitive behavior therapy|cognitive behavior therapy
833498|NCT00104481|coping|coping
833499|NCT00104481|smoking cessation|smoking cessation
833500|NCT00104481|acceptance|acceptance
833501|NCT00104481|expectancies|expectancies
833502|NCT00104481|quit smoking|quit smoking
833503|NCT00104481|quitting smoking|quitting smoking
833504|NCT00104468|Single-arm, open-label, multi-center, dose escalation, continuous infusion, multi-dose, acute myeloid leukemia|single-arm, open-label, multi-center, dose escalation, continuous infusion, multi-dose, acute myeloid leukemia
833505|NCT00104468|Acute myelogenous leukemia (AML) that has been refractory to prior therapy and/or is unlikely to benefit from known therapies|acute myelogenous leukemia (aml) that has been refractory to prior therapy and/or is unlikely to benefit from known therapies
833506|NCT00104455|rFVIIa|rfviia
833507|NCT00104455|Punch Biopsy|punch biopsy
833508|NCT00104455|Dose Response|dose response
833509|NCT00104455|Healthy People Programs|healthy people programs
833510|NCT00104442|Alzheimer's disease|alzheimer's disease
833511|NCT00104442|memory loss|memory loss
833512|NCT00104442|dementia|dementia
833513|NCT00104442|senility|senility
833514|NCT00104442|forgetful|forgetful
833515|NCT00104442|geriatric|geriatric
833516|NCT00104442|behavior|behavior
833517|NCT00104442|mood swings|mood swings
833518|NCT00104429|HIV infections|hiv infections
833519|NCT00104429|therapy naive|therapy naive
833520|NCT00104416|antiepileptic drugs|antiepileptic drugs
833521|NCT00104416|seizures|seizures
833522|NCT00104416|primary generalized tonic-clonic seizures|primary generalized tonic-clonic seizures
833523|NCT00104416|Epilepsy|epilepsy
833524|NCT00104416|lamotrigine|lamotrigine
833525|NCT00104416|anticonvulsants|anticonvulsants
833526|NCT00104416|LAMICTAL|lamictal
833527|NCT00104403|Vomiting|vomiting
833528|NCT00104403|CINV|cinv
833529|NCT00104403|Emesis|emesis
833530|NCT00104403|Nausea|nausea
833531|NCT00104403|Chemotherapy-Induced Nausea and Vomiting|chemotherapy-induced nausea and vomiting
833532|NCT00104390|allergy|allergy
833533|NCT00104390|skin prick test|skin prick test
833534|NCT00104390|allergoid|allergoid
833535|NCT00104390|allergenicity|allergenicity
833536|NCT00104390|specific immunotherapy|specific immunotherapy
833537|NCT00104377|Allergy|allergy
833538|NCT00104377|Allergoid|allergoid
833539|NCT00104377|Specific Immunotherapy|specific immunotherapy
833540|NCT00104338|Investigational Therapies|investigational therapies
833541|NCT00104338|Treatment Effectiveness|treatment effectiveness
833542|NCT00104338|Treatment Efficacy|treatment efficacy
833543|NCT00104338|Immunosuppressant|immunosuppressant
833544|NCT00104338|BK Nephropathy|bk nephropathy
833545|NCT00104338|Polyomavirus, BK|polyomavirus, bk
833546|NCT00104338|Human Polyomavirus BK|human polyomavirus bk
833547|NCT00104338|Polyomavirus hominis 1|polyomavirus hominis 1
833548|NCT00104325|Cytapheresis|cytapheresis
833549|NCT00104325|Blood Collection|blood collection
833550|NCT00104325|Volunteer Donor|volunteer donor
833551|NCT00104325|White Blood Cells|white blood cells
833552|NCT00104325|Immune Studies|immune studies
833553|NCT00104325|Cell Function|cell function
833554|NCT00104325|Cell Seperation|cell seperation
833555|NCT00104325|Machine Seperation|machine seperation
833556|NCT00104312|Knee Osteoarthritis|knee osteoarthritis
833557|NCT00104312|Muscle|muscle
833558|NCT00104312|Cytokine|cytokine
833559|NCT00104312|Mobility|mobility
833560|NCT00104312|Function|function
833561|NCT00104299|ANCA|anca
833562|NCT00104299|Vasculitis|vasculitis
833563|NCT00104299|Wegener's Granulomatosis|wegener's granulomatosis
833564|NCT00104299|microscopic polyangiitis|microscopic polyangiitis
833565|NCT00104299|ANCA-positive|anca-positive
833566|NCT00104299|ANCA-associated|anca-associated
833567|NCT00104299|ANCA-associated vasculitis|anca-associated vasculitis
833568|NCT00104299|MPA|mpa
833569|NCT00104273|Dementia, Alzheimer's Disease|dementia, alzheimer's disease
833570|NCT00104247|Phenylalanine Hydroxylase|phenylalanine hydroxylase
833571|NCT00104195|Anxiety|anxiety
833572|NCT00104195|Adolescence|adolescence
833573|NCT00104195|Generalized Anxiety Disorder|generalized anxiety disorder
833574|NCT00104169|Anemia|anemia
833575|NCT00104169|Frailty|frailty
833576|NCT00104169|Epoetin|epoetin
833577|NCT00104169|Erythropoietin|erythropoietin
833578|NCT00104169|EPO|epo
833579|NCT00104156|Knee pain|knee pain
833580|NCT00104156|Arthritis|arthritis
833581|NCT00104156|Qigong|qigong
833582|NCT00104156|Qi|qi
833583|NCT00104156|Meditation|meditation
833584|NCT00104156|Breathing Exercises|breathing exercises
833585|NCT00104130|prostate|prostate
833586|NCT00104104|Z-MAX, multiple myeloma, zoledronic acid, bone metastases|z-max, multiple myeloma, zoledronic acid, bone metastases
833587|NCT00104091|Gross Total Resection|gross total resection
833588|NCT00104091|Convection Enhanced Delivery|convection enhanced delivery
833589|NCT00104091|Recurrent Glioblastoma Multiforme|recurrent glioblastoma multiforme
833590|NCT00104065|oral mucositis|oral mucositis
833591|NCT00104065|oncology - supportive care|oncology - supportive care
833592|NCT00104065|mouth diseases|mouth diseases
833593|NCT00104039|Amygdala|amygdala
833594|NCT00104039|Orbital Frontal Cortex|orbital frontal cortex
833595|NCT00104039|Serotonin|serotonin
833596|NCT00104039|Orbitofrontal Cortex|orbitofrontal cortex
833597|NCT00104039|Attention Deficit Hyperactivity Disorder|attention deficit hyperactivity disorder
833598|NCT00104039|ADHD|adhd
833599|NCT00104039|Anti-Social Behavior|anti-social behavior
833600|NCT00104039|Healthy Volunteer|healthy volunteer
833601|NCT00104039|HV|hv
833602|NCT00104026|Periodontal Disease|periodontal disease
833603|NCT00104026|Dilantin|dilantin
833604|NCT00104026|Cyclosporin|cyclosporin
833605|NCT00104026|Calcium-Channel Blockers|calcium-channel blockers
833606|NCT00104026|Genetics|genetics
833607|NCT00104026|Hereditary Gingival Fibromatosis|hereditary gingival fibromatosis
833608|NCT00104026|HGF|hgf
833609|NCT00104026|Gingival Overgrowth|gingival overgrowth
833610|NCT00104026|Gum Overgrowth|gum overgrowth
833611|NCT00104000|Neuromuscular|neuromuscular
833612|NCT00104000|Elevation|elevation
833613|NCT00104000|Current|current
833614|NCT00104000|Videofluoroscopy|videofluoroscopy
833615|NCT00104000|Nasoendoscopy|nasoendoscopy
833616|NCT00104000|Healthy Volunteer|healthy volunteer
833617|NCT00104000|HV|hv
833618|NCT00103987|Panic Disorder|panic disorder
833619|NCT00103987|Norepinephrine|norepinephrine
833620|NCT00103987|Yohimbine|yohimbine
833621|NCT00103987|Genes|genes
833622|NCT00103987|Pathophysiology|pathophysiology
833623|NCT00103987|Noradrenergic Mechanisms|noradrenergic mechanisms
833624|NCT00103987|PET Imaging|pet imaging
833625|NCT00103987|PD|pd
833626|NCT00103987|Healthy Volunteer|healthy volunteer
833627|NCT00103987|HV|hv
833628|NCT00103974|multiple sclerosis|multiple sclerosis
833629|NCT00103974|relapsing-remitting|relapsing-remitting
833630|NCT00103974|secondary progressive|secondary progressive
833631|NCT00103961|Acute Infection|acute infection
833632|NCT00103961|HIV|hiv
833633|NCT00103961|AIDS|aids
833634|NCT00103961|Acute HIV|acute hiv
833635|NCT00103961|Early HIV|early hiv
833636|NCT00103935|diabetes|diabetes
833637|NCT00103935|exenatide|exenatide
833638|NCT00103935|long acting release|long acting release
833639|NCT00103935|Amylin|amylin
833640|NCT00103935|Lilly|lilly
833641|NCT00103922|smokers cough|smokers cough
833642|NCT00103896|High-risk youth|high-risk youth
833643|NCT00103896|HIV infected youth|hiv infected youth
833644|NCT00103896|Community mobilization|community mobilization
833645|NCT00103896|HIV serosurveys|hiv serosurveys
833646|NCT00103883|HIV|hiv
833647|NCT00103883|Detuned Assay|detuned assay
833648|NCT00103883|Enzyme Immunoassay (EIA)|enzyme immunoassay (eia)
833649|NCT00103883|HIV Incidence|hiv incidence
833650|NCT00103883|Laboratory assay|laboratory assay
833651|NCT00103883|Sensitive/Less sensitive Assay|sensitive/less sensitive assay
833652|NCT00103883|Acute Infection|acute infection
833653|NCT00103870|Music Therapy|music therapy
833654|NCT00103870|Electric Stimulation|electric stimulation
833655|NCT00103870|Electric Shock|electric shock
833656|NCT00103870|Analgesics|analgesics
833657|NCT00103870|Distraction|distraction
833658|NCT00103844|Chronic Phase Philadelphia chromosome Positive (Ph+) chronic myeloid leukemia|chronic phase philadelphia chromosome positive (ph+) chronic myeloid leukemia
834488|NCT00100672|Antisense|antisense
833659|NCT00103831|NSCLC - non-small cell lung cancer|nsclc - non-small cell lung cancer
833660|NCT00103805|language acquisition|language acquisition
833661|NCT00103805|plasticity|plasticity
833662|NCT00103805|stroke recovery|stroke recovery
833663|NCT00103805|associative learning|associative learning
833664|NCT00103792|Induction therapy|induction therapy
833665|NCT00103792|ANCA-associated vasculitis|anca-associated vasculitis
833666|NCT00103792|Wegener's granulomatosis|wegener's granulomatosis
833667|NCT00103792|microscopic polyangiitis|microscopic polyangiitis
833668|NCT00103792|mycophenolate mofetil|mycophenolate mofetil
833669|NCT00103792|cyclophosphamide|cyclophosphamide
833670|NCT00103779|Antigens, CD40|antigens, cd40
833671|NCT00103779|Antibody, Monoclonal|antibody, monoclonal
833672|NCT00103779|Lymphoma, Non-Hodgkin|lymphoma, non-hodgkin
833673|NCT00103779|Lymphoma, B-Cell|lymphoma, b-cell
833674|NCT00103779|Hematologic Diseases|hematologic diseases
833675|NCT00103779|Immunoproliferative Disorders|immunoproliferative disorders
833676|NCT00103779|Lymphatic Diseases|lymphatic diseases
833677|NCT00103779|Lymphoproliferative Disorders|lymphoproliferative disorders
833678|NCT00103779|Lymphoma|lymphoma
833679|NCT00103766|Alteplase|alteplase
833681|NCT00103766|Complicated Parapneumonic Effusion|complicated parapneumonic effusion
833682|NCT00103753|Randomized Controlled Trial|randomized controlled trial
833683|NCT00103753|Deferiprone|deferiprone
833684|NCT00103753|Deferoxamine|deferoxamine
833685|NCT00103753|Iron chelation|iron chelation
833686|NCT00103753|Beta Thalassemia Major|beta thalassemia major
833687|NCT00103740|Zoledronic acid, risedronate, Paget's disease of bone|zoledronic acid, risedronate, paget's disease of bone
833688|NCT00103727|paranoid|paranoid
833689|NCT00103727|catatonic|catatonic
833690|NCT00103727|undifferentiated types|undifferentiated types
833691|NCT00103727|disorganized|disorganized
833692|NCT00103714|lung disease|lung disease
833693|NCT00103701|Chronic myelogenous leukemia (CML) chronic, accelerated, blast phase|chronic myelogenous leukemia (cml) chronic, accelerated, blast phase
833694|NCT00103701|Philadelphia chromosome positive acute (Ph+ALL)|philadelphia chromosome positive acute (ph+all)
833695|NCT00103675|Acupuncture|acupuncture
833696|NCT00103636|Phlebitis/etiology|phlebitis/etiology
833697|NCT00103636|Infusions|infusions
833698|NCT00103636|Intravenous/adverse effects|intravenous/adverse effects
833699|NCT00103636|Randomised controlled trial|randomised controlled trial
833700|NCT00103636|Phlebitis/prevention|phlebitis/prevention
833701|NCT00103636|Adult|adult
833702|NCT00103636|Time factors|time factors
833703|NCT00103623|Advanced|advanced
833704|NCT00103623|Symptomatic|symptomatic
833705|NCT00103623|Prostate|prostate
833706|NCT00103623|Cancer|cancer
833707|NCT00103623|Advanced Symptomatic Prostate Cancer|advanced symptomatic prostate cancer
833708|NCT00103610|Non-Hodgkin's lymphoma|non-hodgkin's lymphoma
833709|NCT00103610|Stem cell mobilization|stem cell mobilization
833710|NCT00103597|Orthostatic hypotension|orthostatic hypotension
833711|NCT00103597|Parkinson's Disease|parkinson's disease
833712|NCT00103545|Ovarian Cancer|ovarian cancer
833713|NCT00103545|ACA 125|aca 125
833714|NCT00103545|6 or 9 vaccinations|6 or 9 vaccinations
833715|NCT00103545|immune response|immune response
833716|NCT00103545|Fallopian tube cancer|fallopian tube cancer
833717|NCT00103545|Peritoneal cancer|peritoneal cancer
833718|NCT00103532|motivational enhancement|motivational enhancement
833719|NCT00103532|health behaviors|health behaviors
833720|NCT00103532|risk behaviors|risk behaviors
833721|NCT00103519|Heart Failure, DITPA|heart failure, ditpa
833722|NCT00103506|Multiple Myeloma|multiple myeloma
833723|NCT00103506|Doxil|doxil
833724|NCT00103506|Caelyx|caelyx
833725|NCT00103506|Doxorubicin|doxorubicin
833726|NCT00103506|Velcade|velcade
833727|NCT00103506|Bortezomib|bortezomib
833728|NCT00103454|allergic rhinitis|allergic rhinitis
833729|NCT00103454|GW685698X|gw685698x
833730|NCT00103454|Perennial Allergic Rhinitis|perennial allergic rhinitis
833731|NCT00103428|chemotherapy|chemotherapy
833732|NCT00103428|prostate cancer|prostate cancer
833733|NCT00103428|cancer|cancer
833734|NCT00103428|metastatic|metastatic
833735|NCT00103428|hormone refractory|hormone refractory
833736|NCT00103428|chemotherapy naive|chemotherapy naive
833737|NCT00103428|dose escalation|dose escalation
833738|NCT00103415|Depression|depression
833739|NCT00103415|Exercise|exercise
833740|NCT00103415|Job|job
833741|NCT00103402|Prostatitis|prostatitis
833742|NCT00103402|Non-bacterial Prostatitis|non-bacterial prostatitis
833743|NCT00103402|Prostatodynia|prostatodynia
833744|NCT00103402|Alfuzosin|alfuzosin
833745|NCT00103402|Alpha-adrenergic blocker|alpha-adrenergic blocker
833746|NCT00103389|recurrent non-small cell lung cancer|recurrent non-small cell lung cancer
833747|NCT00103389|stage IIIB non-small cell lung cancer|stage iiib non-small cell lung cancer
833748|NCT00103389|stage IV non-small cell lung cancer|stage iv non-small cell lung cancer
833749|NCT00103376|adenocarcinoma of the prostate|adenocarcinoma of the prostate
833750|NCT00103376|recurrent prostate cancer|recurrent prostate cancer
833751|NCT00103363|non-small cell lung cancer|non-small cell lung cancer
833752|NCT00103363|small cell lung cancer|small cell lung cancer
833753|NCT00103350|myocardial infarction|myocardial infarction
833754|NCT00103350|infarct size|infarct size
833755|NCT00103350|angioplasty|angioplasty
833756|NCT00103350|percutaneous coronary intervention|percutaneous coronary intervention
833757|NCT00103350|Acute Myocardial Infarction|acute myocardial infarction
833758|NCT00103298|recurrent colon cancer|recurrent colon cancer
833759|NCT00103298|stage IV colon cancer|stage iv colon cancer
833760|NCT00103298|recurrent rectal cancer|recurrent rectal cancer
833761|NCT00103298|stage IV rectal cancer|stage iv rectal cancer
833762|NCT00103298|liver metastases|liver metastases
833763|NCT00103246|skin cancer|skin cancer
833764|NCT00103246|squamous cell carcinoma of the skin|squamous cell carcinoma of the skin
833765|NCT00103246|basal cell carcinoma of the skin|basal cell carcinoma of the skin
833766|NCT00103246|recurrent skin cancer|recurrent skin cancer
833767|NCT00103246|recurrent mycosis fungoides/Sezary syndrome|recurrent mycosis fungoides/sezary syndrome
833768|NCT00103246|stage I mycosis fungoides/Sezary syndrome|stage i mycosis fungoides/sezary syndrome
833769|NCT00103246|stage II mycosis fungoides/Sezary syndrome|stage ii mycosis fungoides/sezary syndrome
833770|NCT00103246|actinic keratosis|actinic keratosis
833771|NCT00103246|recurrent cutaneous T-cell non-Hodgkin lymphoma|recurrent cutaneous t-cell non-hodgkin lymphoma
833772|NCT00103246|stage I cutaneous T-cell non-Hodgkin lymphoma|stage i cutaneous t-cell non-hodgkin lymphoma
833773|NCT00103246|stage II cutaneous T-cell non-Hodgkin lymphoma|stage ii cutaneous t-cell non-hodgkin lymphoma
833774|NCT00103233|stage IV breast cancer|stage iv breast cancer
833775|NCT00103233|recurrent breast cancer|recurrent breast cancer
833776|NCT00103207|bronchioalveolar carcinoma (BAC)|bronchioalveolar carcinoma (bac)
833777|NCT00103207|adenocarcinoma with BAC features|adenocarcinoma with bac features
833778|NCT00103207|stage IIIB non-small cell lung cancer|stage iiib non-small cell lung cancer
833779|NCT00103207|stage IV non-small cell lung cancer|stage iv non-small cell lung cancer
833780|NCT00103207|recurrent non-small cell lung cancer|recurrent non-small cell lung cancer
833781|NCT00103207|cetuximab|cetuximab
833782|NCT00103181|stage II breast cancer|stage ii breast cancer
833783|NCT00103181|ductal breast carcinoma in situ|ductal breast carcinoma in situ
833784|NCT00103181|breast cancer in situ|breast cancer in situ
833785|NCT00103181|stage IA breast cancer|stage ia breast cancer
833786|NCT00103181|stage IB breast cancer|stage ib breast cancer
833787|NCT00103168|gastrointestinal stromal tumor|gastrointestinal stromal tumor
833788|NCT00103155|stage I papillary thyroid cancer|stage i papillary thyroid cancer
833789|NCT00103142|liver metastases|liver metastases
833790|NCT00103142|adenocarcinoma of the colon|adenocarcinoma of the colon
833791|NCT00103142|recurrent colon cancer|recurrent colon cancer
833792|NCT00103142|stage IV colon cancer|stage iv colon cancer
833793|NCT00103142|adenocarcinoma of the rectum|adenocarcinoma of the rectum
833794|NCT00103142|recurrent rectal cancer|recurrent rectal cancer
833795|NCT00103142|stage IV rectal cancer|stage iv rectal cancer
833796|NCT00103142|lung metastases|lung metastases
833797|NCT00103116|stage I non-small cell lung cancer|stage i non-small cell lung cancer
833798|NCT00103116|stage II non-small cell lung cancer|stage ii non-small cell lung cancer
833799|NCT00103116|stage IIIA non-small cell lung cancer|stage iiia non-small cell lung cancer
833800|NCT00103116|stage IIIB non-small cell lung cancer|stage iiib non-small cell lung cancer
833801|NCT00103116|bronchoalveolar cell lung cancer|bronchoalveolar cell lung cancer
833802|NCT00103103|recurrent gastric cancer|recurrent gastric cancer
833803|NCT00103103|stage IV gastric cancer|stage iv gastric cancer
833804|NCT00103103|adenocarcinoma of the stomach|adenocarcinoma of the stomach
833805|NCT00103051|stage IIIA non-small cell lung cancer|stage iiia non-small cell lung cancer
833806|NCT00103025|Vasodilation|vasodilation
833807|NCT00103025|Hypotension|hypotension
833808|NCT00103025|Hypertension|hypertension
833809|NCT00103025|EDRF|edrf
833810|NCT00103025|Methemoglobinemia|methemoglobinemia
833811|NCT00103025|Healthy Volunteer|healthy volunteer
833812|NCT00103025|HV|hv
833813|NCT00103012|Antiretrovirals|antiretrovirals
833814|NCT00103012|Protease Inhibitors|protease inhibitors
833815|NCT00103012|Herbal Supplements|herbal supplements
833816|NCT00103012|Drug Interactions|drug interactions
833817|NCT00103012|Metabolism|metabolism
833818|NCT00103012|Healthy Volunteer|healthy volunteer
833819|NCT00103012|HV|hv
833820|NCT00102999|Learning|learning
833821|NCT00102999|PAS|pas
833822|NCT00102999|Upper Limb|upper limb
833823|NCT00102999|TMS|tms
833824|NCT00102999|Somatosensory|somatosensory
833825|NCT00102999|Dystonia|dystonia
833826|NCT00102999|Upper Limb Dystonia|upper limb dystonia
833827|NCT00102999|Healthy Volunteer|healthy volunteer
833828|NCT00102999|HV|hv
833829|NCT00102986|Kaletra|kaletra
833830|NCT00102986|Treatment Experienced|treatment experienced
833831|NCT00102973|Ovary|ovary
833832|NCT00102960|Infant|infant
833833|NCT00102960|Perinatal|perinatal
833834|NCT00102960|HIV|hiv
833835|NCT00102960|Disease Transmission, Vertical|disease transmission, vertical
833836|NCT00102960|Anti-Retroviral Agents|anti-retroviral agents
833837|NCT00102960|Treatment Interruption|treatment interruption
833838|NCT00102960|Treatment Naive|treatment naive
833839|NCT00102960|Acute Infection|acute infection
833840|NCT00102960|Mother-to-Child Transmission|mother-to-child transmission
833841|NCT00102947|renal impairment|renal impairment
833842|NCT00102947|daptomycin|daptomycin
833844|NCT00102947|complicated skin and skin structure infections|complicated skin and skin structure infections
833846|NCT00102934|Drug Resistance|drug resistance
833847|NCT00102934|Viral Fitness|viral fitness
833848|NCT00102934|HIV Specific Immunity|hiv specific immunity
833849|NCT00102934|T Cell Activation|t cell activation
833850|NCT00102934|Drug Resistant Viremia|drug resistant viremia
833851|NCT00102934|Treatment Experienced|treatment experienced
833852|NCT00102921|Crohn Disease|crohn disease
833853|NCT00102921|oral medication|oral medication
833854|NCT00102908|Bone Metabolism|bone metabolism
833855|NCT00102908|Osteopenia|osteopenia
833856|NCT00102908|Osteoporosis|osteoporosis
833857|NCT00102908|Treatment Experienced|treatment experienced
833858|NCT00102882|genotype|genotype
833859|NCT00102882|Salmeterol|salmeterol
833860|NCT00102882|ADVAIR|advair
833861|NCT00102869|language acquisition|language acquisition
833862|NCT00102869|plasticity|plasticity
833863|NCT00102869|stroke recovery|stroke recovery
833864|NCT00102869|aphasia treatment|aphasia treatment
833865|NCT00102869|naming|naming
833866|NCT00102869|levodopa|levodopa
833867|NCT00102869|stroke|stroke
833868|NCT00102856|language acquisition|language acquisition
833869|NCT00102856|plasticity|plasticity
833870|NCT00102856|stroke recovery|stroke recovery
833871|NCT00102856|associative learning|associative learning
833872|NCT00102843|folic acid|folic acid
833873|NCT00102843|betaine|betaine
833874|NCT00102843|homocysteine|homocysteine
833875|NCT00102843|cardiovascular disease prevention|cardiovascular disease prevention
833876|NCT00102843|human|human
833877|NCT00102843|Cardiovascular health|cardiovascular health
833878|NCT00102830|Solid Tumor|solid tumor
833879|NCT00102830|Metastatic Cancer|metastatic cancer
833880|NCT00102830|Advanced Solid Tumors|advanced solid tumors
833881|NCT00102817|Growth Hormone Disorder|growth hormone disorder
833882|NCT00102791|Sickle Cell Anemia|sickle cell anemia
833883|NCT00102778|HIV infected|hiv infected
833884|NCT00102778|therapy-naive subjects|therapy-naive subjects
833885|NCT00102765|asthma exacerbation|asthma exacerbation
833886|NCT00102765|asthma|asthma
833887|NCT00102752|Pancreas|pancreas
833888|NCT00102752|Cancer|cancer
833889|NCT00102752|Metastatic|metastatic
833890|NCT00102752|Glufosfamide|glufosfamide
833891|NCT00102752|Advanced|advanced
833892|NCT00102752|Solid|solid
833893|NCT00102752|Tumor|tumor
833894|NCT00102752|Advanced Solid Tumors|advanced solid tumors
833895|NCT00102752|Pancreatic Adenocarcinoma|pancreatic adenocarcinoma
833896|NCT00102739|thrombopoietin|thrombopoietin
833897|NCT00102739|immune thrombocytopenic purpura|immune thrombocytopenic purpura
833898|NCT00102739|platelets|platelets
833899|NCT00102739|chronic thrombocytopenia|chronic thrombocytopenia
833900|NCT00102726|chemotherapy|chemotherapy
833901|NCT00102726|thrombopoietin|thrombopoietin
833902|NCT00102726|platelets|platelets
833903|NCT00102726|chemotherapy induced|chemotherapy induced
833904|NCT00102713|Partial Seizures|partial seizures
833905|NCT00102700|cancer|cancer
833906|NCT00102700|solid tumor|solid tumor
833907|NCT00102700|advanced solid tumor|advanced solid tumor
833908|NCT00102700|pancreas|pancreas
833909|NCT00102700|pancreatic cancer|pancreatic cancer
833910|NCT00102700|cancer of the pancreas|cancer of the pancreas
833911|NCT00102674|cangrelor|cangrelor
833912|NCT00102674|clopidogrel|clopidogrel
833913|NCT00102635|apoptotic activity|apoptotic activity
833914|NCT00102635|4-HPR|4-hpr
833915|NCT00102635|FTI|fti
833916|NCT00102635|Fenretinide|fenretinide
833917|NCT00102635|SCH66336|sch66336
833918|NCT00102635|Farnesyl Transferase Inhibitor|farnesyl transferase inhibitor
833919|NCT00102635|HNC|hnc
833920|NCT00102622|Ovary|ovary
833921|NCT00102622|ovarian cancer|ovarian cancer
833922|NCT00102622|biologic therapy|biologic therapy
833923|NCT00102622|platinum-resistant|platinum-resistant
833924|NCT00102622|platinum-refractory ovarian cancer|platinum-refractory ovarian cancer
833925|NCT00102622|platinum-resistant ovarian cancer|platinum-resistant ovarian cancer
833926|NCT00102622|paclitaxel|paclitaxel
833927|NCT00102622|tgDCC-E1A|tgdcc-e1a
833928|NCT00102622|E1A|e1a
833929|NCT00102622|Taxol|taxol
833930|NCT00102609|Doxorubicin|doxorubicin
833931|NCT00102609|Adriamycin|adriamycin
833932|NCT00102609|Trabectedin|trabectedin
833933|NCT00102609|Yondelis|yondelis
833934|NCT00102609|Ecteinascidin 743|ecteinascidin 743
833935|NCT00102609|Filgrastim, Antineoplastic|filgrastim, antineoplastic
833936|NCT00102609|Antineoplastic Agents|antineoplastic agents
833937|NCT00102609|Pharmacologic Actions|pharmacologic actions
833938|NCT00102609|Alkylating Agents|alkylating agents
833939|NCT00102596|Ethanol|ethanol
833940|NCT00102596|Alcohol Responsive|alcohol responsive
833941|NCT00102596|Movement Disorder|movement disorder
833942|NCT00102596|Gas Chromatography|gas chromatography
833943|NCT00102596|Bioavailability|bioavailability
833944|NCT00102596|Pharmacokinetics|pharmacokinetics
833945|NCT00102596|Essential Tremor|essential tremor
833946|NCT00102583|Dry Eye|dry eye
833947|NCT00102583|Lacrimal Gland|lacrimal gland
833948|NCT00102583|Tear Deficiency|tear deficiency
833949|NCT00102583|Keratitis Sicca|keratitis sicca
833950|NCT00102583|GVHD|gvhd
833951|NCT00102583|Ocular GVHD|ocular gvhd
833952|NCT00102583|Ocular Graft Vs Host Disease|ocular graft vs host disease
833953|NCT00102570|Pediatric|pediatric
833954|NCT00102570|Atopic|atopic
833955|NCT00102570|Asthma|asthma
833956|NCT00102570|Rhinitis|rhinitis
833957|NCT00102570|Outpatient|outpatient
833958|NCT00102570|Allergy|allergy
833959|NCT00102570|Pediatric Allergy|pediatric allergy
833960|NCT00102570|Food Allergy|food allergy
833961|NCT00102570|Stinging Insect Allergy|stinging insect allergy
833962|NCT00102570|Atopic Dermatitis|atopic dermatitis
833963|NCT00102570|Insect Sting|insect sting
833964|NCT00102557|Vesiculobullous|vesiculobullous
833965|NCT00102557|Mucosal Lesions|mucosal lesions
833966|NCT00102557|Oral Health|oral health
833967|NCT00102557|Dermatology|dermatology
833968|NCT00102557|Plaquenil|plaquenil
833969|NCT00102557|Oral Lichen Planus|oral lichen planus
833970|NCT00102557|Mouth Lesions|mouth lesions
833971|NCT00102557|Oral Lesions|oral lesions
833972|NCT00102544|CT-Guided|ct-guided
833973|NCT00102544|Electromagnetic Tracking|electromagnetic tracking
833974|NCT00102544|Ultrasound-Guided Biopsy|ultrasound-guided biopsy
833975|NCT00102544|Ablation|ablation
833976|NCT00102544|Surgical Navigation|surgical navigation
833977|NCT00102531|Osteosarcoma|osteosarcoma
833978|NCT00102531|relapsed|relapsed
833979|NCT00102531|progressive|progressive
833980|NCT00102531|metastatic|metastatic
833981|NCT00102531|lung|lung
833982|NCT00102518|Open Label|open label
833983|NCT00102518|Aripiprazole|aripiprazole
833984|NCT00102518|Bipolar I Disorder, Manic or Mixed Episode|bipolar i disorder, manic or mixed episode
833985|NCT00102505|Non-Small Cell Lung Cancer|non-small cell lung cancer
833986|NCT00102505|Lung Cancer|lung cancer
833987|NCT00102505|Metastatic lung cancer|metastatic lung cancer
833988|NCT00102505|Inoperable lung cancer|inoperable lung cancer
833989|NCT00102505|Advanced lung cancer|advanced lung cancer
833990|NCT00102505|Large-cell lung cancer|large-cell lung cancer
833991|NCT00102505|Adenocarcinoma, lung|adenocarcinoma, lung
833992|NCT00102505|Squamous cell carcinoma, lung|squamous cell carcinoma, lung
833993|NCT00102505|Squamous cell lung cancer|squamous cell lung cancer
833994|NCT00102505|Large cell carcinoma, lung|large cell carcinoma, lung
833995|NCT00102505|Bronchogenic|bronchogenic
833996|NCT00102492|Major Depressive Disorder|major depressive disorder
833997|NCT00102492|Major Depression|major depression
833998|NCT00102492|Mood Disorders|mood disorders
833999|NCT00102492|Major Depressive Episode|major depressive episode
834000|NCT00102479|Pharmacokinetics,|pharmacokinetics,
834001|NCT00102479|Aripiprazole|aripiprazole
834002|NCT00102479|acute mania in pediatric populations|acute mania in pediatric populations
834003|NCT00102466|type 2 diabetes|type 2 diabetes
834004|NCT00102466|vildagliptin|vildagliptin
834005|NCT00102453|Duchenne|duchenne
834006|NCT00102453|Genetics|genetics
834007|NCT00102440|uric Acid|uric acid
834008|NCT00102440|xanthine oxidase|xanthine oxidase
834009|NCT00102440|tophi|tophi
834010|NCT00102440|Drug Therapy|drug therapy
834011|NCT00102427|Anxiety|anxiety
834012|NCT00102427|Panic|panic
834013|NCT00102427|Generalized Anxiety Disorder|generalized anxiety disorder
834014|NCT00102414|Ovarian cancer|ovarian cancer
834015|NCT00102414|Recurrence or progression|recurrence or progression
834016|NCT00102414|Gemcitabine plus Carboplatin vs Carboplatin|gemcitabine plus carboplatin vs carboplatin
834017|NCT00102401|Chronic obstructive pulmonary disease|chronic obstructive pulmonary disease
834018|NCT00102401|Pulmonary Disease, chronic obstructive|pulmonary disease, chronic obstructive
834019|NCT00102401|Lung disease, obstructive|lung disease, obstructive
834020|NCT00102401|Self-care|self-care
834021|NCT00102401|Self-management|self-management
834022|NCT00102401|Patient education|patient education
834023|NCT00102388|type 2 diabetes|type 2 diabetes
834024|NCT00102388|vildagliptin|vildagliptin
834025|NCT00102375|Ovarian Cancer|ovarian cancer
834026|NCT00102375|first-line|first-line
834027|NCT00102375|Topotecan|topotecan
834028|NCT00102362|behavioral intervention|behavioral intervention
834029|NCT00102349|behavioral intervention|behavioral intervention
834030|NCT00102336|immune (idiopathic) thrombocytopenic purpura|immune (idiopathic) thrombocytopenic purpura
834031|NCT00102336|pre-splenectomy|pre-splenectomy
834032|NCT00102336|ITP|itp
834033|NCT00102336|Thrombopenia|thrombopenia
834034|NCT00102323|immune (idiopathic) thrombocytopenic purpura|immune (idiopathic) thrombocytopenic purpura
834035|NCT00102323|post-splenectomy|post-splenectomy
834036|NCT00102323|ITP|itp
834037|NCT00102323|Thrombopenia|thrombopenia
834038|NCT00102310|Nausea|nausea
834039|NCT00102310|Indigestion|indigestion
834040|NCT00102310|Bloating|bloating
834041|NCT00102310|Functional Dyspepsia|functional dyspepsia
834042|NCT00102310|Fullness after Meals|fullness after meals
834043|NCT00102297|Incipient Nephropathy|incipient nephropathy
834044|NCT00102297|Type 1 or Type 2 Diabetes|type 1 or type 2 diabetes
834045|NCT00102284|language acquisition|language acquisition
834046|NCT00102284|plasticity|plasticity
834047|NCT00102284|stroke recovery|stroke recovery
834048|NCT00102284|associative learning|associative learning
834049|NCT00102271|Sodium Nitrite|sodium nitrite
834050|NCT00102271|Oxypurinol|oxypurinol
834051|NCT00102271|Ascorbic Acid|ascorbic acid
834052|NCT00102271|Hypoxic Gas|hypoxic gas
834053|NCT00102271|Forearm Blood Flow|forearm blood flow
834054|NCT00102271|Healthy Volunteer|healthy volunteer
834055|NCT00102271|HV|hv
834056|NCT00102258|Short Stature|short stature
834057|NCT00102258|Constitutional Delay of Growth and Development|constitutional delay of growth and development
834058|NCT00102258|Body Composition|body composition
834059|NCT00102258|Energy Expenditure|energy expenditure
834060|NCT00102258|Dietary Supplements|dietary supplements
834061|NCT00102258|Constitutional Delay of Growth|constitutional delay of growth
834062|NCT00102258|CDGM|cdgm
834063|NCT00102245|Hemoglobin|hemoglobin
834064|NCT00102245|Hemoglobinapathies|hemoglobinapathies
834065|NCT00102245|Human Genome|human genome
834066|NCT00102245|Recombinant DNA Technology|recombinant dna technology
834067|NCT00102245|Sequencing|sequencing
834068|NCT00102245|Erythrocyte|erythrocyte
834069|NCT00102232|phosphatidylcholine|phosphatidylcholine
834070|NCT00102232|choline|choline
834071|NCT00102232|homocysteine|homocysteine
834072|NCT00102232|cardiovascular disease prevention|cardiovascular disease prevention
834073|NCT00102232|human|human
834074|NCT00102232|cardiovascular health|cardiovascular health
834075|NCT00102206|Treatment Experienced|treatment experienced
834076|NCT00102206|Child|child
834077|NCT00102193|Ulcerative Colitis, Apheresis|ulcerative colitis, apheresis
834078|NCT00102141|Postmenopausal|postmenopausal
834079|NCT00102141|vasomotor symptoms|vasomotor symptoms
834080|NCT00102141|essential hypertension|essential hypertension
834081|NCT00102115|Macular disease|macular disease
834082|NCT00102115|Wet AMD|wet amd
834083|NCT00102115|AMD|amd
834084|NCT00102115|Age-Related Macular Disease|age-related macular disease
834085|NCT00102115|PDT|pdt
834086|NCT00102115|Photodynamic Therapy|photodynamic therapy
834087|NCT00102102|Substance P|substance p
834088|NCT00102102|Neurokinin|neurokinin
834089|NCT00102102|Tachykinin|tachykinin
834090|NCT00102102|Anxiety|anxiety
834091|NCT00102102|Neuroreceptor Imaging|neuroreceptor imaging
834092|NCT00102102|Post-Traumatic Stress Disorder|post-traumatic stress disorder
834093|NCT00102102|PTSD|ptsd
834094|NCT00102102|Healthy Volunteer|healthy volunteer
834095|NCT00102102|HV|hv
834096|NCT00102089|HIV-Negative|hiv-negative
834097|NCT00102089|Healthy|healthy
834098|NCT00102089|Immunity|immunity
834099|NCT00102089|Preventive|preventive
834100|NCT00102089|Virus|virus
834101|NCT00102089|Healthy Volunteer|healthy volunteer
834102|NCT00102089|HV|hv
834103|NCT00102076|Minimal|minimal
834104|NCT00102076|Risk|risk
834105|NCT00102076|Regulations|regulations
834106|NCT00102076|Parents|parents
834107|NCT00102076|IRB|irb
834108|NCT00102076|Surgery|surgery
834109|NCT00102076|Assent Requirement|assent requirement
834110|NCT00102063|Schizophrenia|schizophrenia
834111|NCT00102063|Aripiprazole|aripiprazole
834112|NCT00102050|NM-702 tablets|nm-702 tablets
834113|NCT00102050|intermittent claudication|intermittent claudication
834114|NCT00102050|peripheral|peripheral
834115|NCT00102050|arterial|arterial
834116|NCT00102050|vascular|vascular
834117|NCT00102050|peripheral arterial disease|peripheral arterial disease
834118|NCT00102024|Metastatic Colorectal Adenocarcinoma|metastatic colorectal adenocarcinoma
834119|NCT00102024|Anti TAG-72|anti tag-72
834120|NCT00102024|Monoclonal Antibody|monoclonal antibody
834121|NCT00102011|colon cancer|colon cancer
834122|NCT00102011|rectal cancer|rectal cancer
834123|NCT00101998|OBD (Induced Bowel Dysfunction)|obd (induced bowel dysfunction)
834124|NCT00101998|cancer pain|cancer pain
834125|NCT00101998|pain medication|pain medication
834126|NCT00101998|constipation|constipation
834127|NCT00101998|bowel|bowel
834128|NCT00101998|bowel dysfunction|bowel dysfunction
834129|NCT00101985|Quality of Life|quality of life
834130|NCT00101985|Irritable bowel syndrome|irritable bowel syndrome
834131|NCT00101985|IBS|ibs
834132|NCT00101985|SB223412|sb223412
834133|NCT00101985|Qol|qol
834134|NCT00101972|adenocarcinoma of the bladder|adenocarcinoma of the bladder
834135|NCT00101972|adenocarcinoma of the colon|adenocarcinoma of the colon
834136|NCT00101972|adenocarcinoma of the esophagus|adenocarcinoma of the esophagus
834137|NCT00101972|adenocarcinoma of the extrahepatic bile duct|adenocarcinoma of the extrahepatic bile duct
834138|NCT00101972|adenocarcinoma of the gallbladder|adenocarcinoma of the gallbladder
834139|NCT00101972|adenocarcinoma of the lung|adenocarcinoma of the lung
834140|NCT00101972|adenocarcinoma of the pancreas|adenocarcinoma of the pancreas
834141|NCT00101972|adenocarcinoma of the prostate|adenocarcinoma of the prostate
834784|NCT00099580|GLP-1|glp-1
834142|NCT00101972|adenocarcinoma of the rectum|adenocarcinoma of the rectum
834143|NCT00101972|adenocarcinoma of the stomach|adenocarcinoma of the stomach
834144|NCT00101972|adenocarcinoma with squamous metaplasia of the gallbladder|adenocarcinoma with squamous metaplasia of the gallbladder
834145|NCT00101972|cervical adenocarcinoma|cervical adenocarcinoma
834146|NCT00101972|endometrial adenocarcinoma|endometrial adenocarcinoma
834147|NCT00101972|ovarian endometrioid adenocarcinoma|ovarian endometrioid adenocarcinoma
834148|NCT00101972|ovarian undifferentiated adenocarcinoma|ovarian undifferentiated adenocarcinoma
834149|NCT00101972|salivary gland adenocarcinoma|salivary gland adenocarcinoma
834150|NCT00101972|small intestine adenocarcinoma|small intestine adenocarcinoma
834151|NCT00101972|vaginal adenocarcinoma|vaginal adenocarcinoma
834152|NCT00101972|vaginal clear cell adenocarcinoma|vaginal clear cell adenocarcinoma
834153|NCT00101972|ovarian clear cell cystadenocarcinoma|ovarian clear cell cystadenocarcinoma
834154|NCT00101972|ovarian mucinous cystadenocarcinoma|ovarian mucinous cystadenocarcinoma
834155|NCT00101972|ovarian serous cystadenocarcinoma|ovarian serous cystadenocarcinoma
834156|NCT00101972|stage IV bladder cancer|stage iv bladder cancer
834157|NCT00101972|stage IV breast cancer|stage iv breast cancer
834158|NCT00101972|stage IV colon cancer|stage iv colon cancer
834159|NCT00101972|stage IV endometrial carcinoma|stage iv endometrial carcinoma
834160|NCT00101972|stage IV esophageal cancer|stage iv esophageal cancer
834161|NCT00101972|stage IV gastric cancer|stage iv gastric cancer
834162|NCT00101972|stage IV non-small cell lung cancer|stage iv non-small cell lung cancer
834163|NCT00101972|stage IV ovarian epithelial cancer|stage iv ovarian epithelial cancer
834164|NCT00101972|stage IV prostate cancer|stage iv prostate cancer
834165|NCT00101972|stage IV rectal cancer|stage iv rectal cancer
834166|NCT00101972|stage IV renal cell cancer|stage iv renal cell cancer
834167|NCT00101972|stage IV salivary gland cancer|stage iv salivary gland cancer
834168|NCT00101972|stage IVA cervical cancer|stage iva cervical cancer
834169|NCT00101972|stage IVA vaginal cancer|stage iva vaginal cancer
834170|NCT00101972|stage IVB cervical cancer|stage ivb cervical cancer
834171|NCT00101972|stage IVB vaginal cancer|stage ivb vaginal cancer
834172|NCT00101972|recurrent bladder cancer|recurrent bladder cancer
834173|NCT00101972|recurrent breast cancer|recurrent breast cancer
834174|NCT00101972|recurrent cervical cancer|recurrent cervical cancer
834175|NCT00101972|recurrent colon cancer|recurrent colon cancer
834176|NCT00101972|recurrent endometrial carcinoma|recurrent endometrial carcinoma
834177|NCT00101972|recurrent esophageal cancer|recurrent esophageal cancer
834178|NCT00101972|recurrent extrahepatic bile duct cancer|recurrent extrahepatic bile duct cancer
834179|NCT00101972|recurrent gallbladder cancer|recurrent gallbladder cancer
834180|NCT00101972|recurrent gastric cancer|recurrent gastric cancer
834181|NCT00101972|recurrent non-small cell lung cancer|recurrent non-small cell lung cancer
834182|NCT00101972|recurrent ovarian epithelial cancer|recurrent ovarian epithelial cancer
834183|NCT00101972|recurrent pancreatic cancer|recurrent pancreatic cancer
834184|NCT00101972|recurrent prostate cancer|recurrent prostate cancer
834185|NCT00101972|recurrent rectal cancer|recurrent rectal cancer
834186|NCT00101972|recurrent renal cell cancer|recurrent renal cell cancer
834187|NCT00101972|recurrent salivary gland cancer|recurrent salivary gland cancer
834188|NCT00101972|recurrent small intestine cancer|recurrent small intestine cancer
834189|NCT00101972|recurrent vaginal cancer|recurrent vaginal cancer
834190|NCT00101972|unresectable extrahepatic bile duct cancer|unresectable extrahepatic bile duct cancer
834191|NCT00101972|unresectable gallbladder cancer|unresectable gallbladder cancer
834192|NCT00101972|stage IV pancreatic cancer|stage iv pancreatic cancer
834193|NCT00101946|CD|cd
834194|NCT00101946|Crohn's Disease|crohn's disease
834195|NCT00101933|Deep brain stimulation, DBS, SANTE|deep brain stimulation, dbs, sante
834196|NCT00101907|Advanced Cancer|advanced cancer
834197|NCT00101907|AMG 706|amg 706
834198|NCT00101907|Panitumumab|panitumumab
834199|NCT00101907|Gemcitabine-Cisplatin|gemcitabine-cisplatin
834200|NCT00101894|AMG 706|amg 706
834201|NCT00101894|Panitumumab|panitumumab
834202|NCT00101881|Cardiac arrest|cardiac arrest
834203|NCT00101881|Defibrillation|defibrillation
834204|NCT00101881|Biphasic defibrillation|biphasic defibrillation
834205|NCT00101881|Monophasic defibrillation|monophasic defibrillation
834206|NCT00101881|Ventricular fibrillation|ventricular fibrillation
834207|NCT00101868|Aged|aged
834208|NCT00101868|Hospitalists|hospitalists
834209|NCT00101868|Outcome and process assessment (health care)|outcome and process assessment (health care)
834210|NCT00101868|Human|human
834211|NCT00101868|Hospitals, teaching|hospitals, teaching
834212|NCT00101868|Physicians, family|physicians, family
834213|NCT00101868|Medical records|medical records
834214|NCT00101868|Quality assurance, health care|quality assurance, health care
834215|NCT00101868|Medical errors|medical errors
834216|NCT00101855|prevention|prevention
834217|NCT00101855|internet|internet
834218|NCT00101855|quality of care|quality of care
834219|NCT00101829|Autoimmune Diseases|autoimmune diseases
834220|NCT00101816|Myeloid blast phase Chronic Myeloid Leukemia (CML)|myeloid blast phase chronic myeloid leukemia (cml)
834221|NCT00101803|type 2 diabetes|type 2 diabetes
834222|NCT00101803|vildagliptin|vildagliptin
834223|NCT00101790|low back pain|low back pain
834224|NCT00101790|pamidronate|pamidronate
834225|NCT00101777|Anxiety|anxiety
834226|NCT00101777|Ventilation|ventilation
834227|NCT00101777|Panic Disorder|panic disorder
834228|NCT00101777|Children|children
834229|NCT00101777|Healthy Volunteer|healthy volunteer
834230|NCT00101777|HV|hv
834231|NCT00101777|Normal Control|normal control
834232|NCT00101764|AMD|amd
834233|NCT00101764|CRVO|crvo
834234|NCT00101764|BRVO|brvo
834236|NCT00101764|Choroidal Neovascularization|choroidal neovascularization
834237|NCT00101764|Age-Related Macular Degeneration (AMD)|age-related macular degeneration (amd)
834238|NCT00101764|Macular Edema|macular edema
834239|NCT00101764|Central Retinal Vein Occlusion|central retinal vein occlusion
834240|NCT00101764|Branch Retinal Vein Occlusion|branch retinal vein occlusion
834241|NCT00101764|Inflammation|inflammation
834242|NCT00101764|Age Related Macular Degeneration|age related macular degeneration
834243|NCT00101764|Retinal Disorder|retinal disorder
834244|NCT00101738|MPA|mpa
834245|NCT00101738|Kidney Transplantation|kidney transplantation
834246|NCT00101738|Acute rejection|acute rejection
834247|NCT00101738|Kidney function|kidney function
834248|NCT00101725|Diarrhea|diarrhea
834249|NCT00101725|IBS|ibs
834250|NCT00101725|Irritable Bowel Syndrome|irritable bowel syndrome
834251|NCT00101725|Abdominal pain|abdominal pain
834252|NCT00101712|type 2 diabetes|type 2 diabetes
834253|NCT00101712|vildagliptin|vildagliptin
834254|NCT00101699|Women|women
834255|NCT00101699|Soy Foods|soy foods
834256|NCT00101699|Middle Aged|middle aged
834257|NCT00101673|type 2 diabetes|type 2 diabetes
834258|NCT00101673|vildagliptin|vildagliptin
834259|NCT00101660|Chronic phase Philadelphia chromosome chronic myeloid leukemia (Ph+CML)|chronic phase philadelphia chromosome chronic myeloid leukemia (ph+cml)
834260|NCT00101647|Chronic myelogenous leukemia (CML): Accelerated phase|chronic myelogenous leukemia (cml): accelerated phase
834261|NCT00101634|Schizophrenia|schizophrenia
834262|NCT00101634|Paliperidone palmitate|paliperidone palmitate
834263|NCT00101634|R092670|r092670
834264|NCT00101634|antipsychotic|antipsychotic
834265|NCT00101621|cancer|cancer
834266|NCT00101621|pain|pain
834267|NCT00101621|Cancers, Pain|cancers, pain
834268|NCT00101608|urothelium|urothelium
834269|NCT00101595|Lymphoid blast phase chronic myeloid leukemia|lymphoid blast phase chronic myeloid leukemia
834270|NCT00101595|Philadelphia chromosome positive acute lymphoblastic leukemia|philadelphia chromosome positive acute lymphoblastic leukemia
834271|NCT00101582|SCCHN|scchn
834272|NCT00101582|Palifermin|palifermin
834273|NCT00101582|Mucositis|mucositis
834274|NCT00101582|Oral Cavity|oral cavity
834275|NCT00101582|Oropharynx|oropharynx
834276|NCT00101582|Nasopharynx|nasopharynx
834277|NCT00101582|Hypopharynx|hypopharynx
834278|NCT00101582|Larynx|larynx
834279|NCT00101582|Mouth Pain|mouth pain
834280|NCT00101582|Mouth Sores|mouth sores
834281|NCT00101582|Radiation Therapy|radiation therapy
834282|NCT00101582|Radiotherapy|radiotherapy
834283|NCT00101582|Radiochemotherapy|radiochemotherapy
834284|NCT00101582|Concurrent Chemotherapy|concurrent chemotherapy
834285|NCT00101582|Xerostomia|xerostomia
834286|NCT00101582|Stomatitis|stomatitis
834287|NCT00101582|Mucosa|mucosa
834288|NCT00101582|KGF|kgf
834289|NCT00101582|rHuKGF|rhukgf
834290|NCT00101582|Keratinocyte Growth Factor|keratinocyte growth factor
834291|NCT00101582|HNC|hnc
834292|NCT00101582|Head and Neck Cancer|head and neck cancer
834293|NCT00101582|Oral Mucositis|oral mucositis
834294|NCT00101543|Gait Training|gait training
834295|NCT00101543|Motor learning|motor learning
834296|NCT00101543|Electrical stimulation|electrical stimulation
834297|NCT00101543|Body Weight supported Treadmill Training|body weight supported treadmill training
834298|NCT00101543|Cerebrovascular Accident|cerebrovascular accident
834299|NCT00101465|Heart Failure|heart failure
834300|NCT00101452|Depression|depression
834301|NCT00101452|Antidepressive Agents|antidepressive agents
834302|NCT00101452|Complementary Therapies|complementary therapies
834303|NCT00101439|Primary Hypercholesterolemia|primary hypercholesterolemia
834304|NCT00101426|Diabetic sensorimotor polyneuropathy|diabetic sensorimotor polyneuropathy
834305|NCT00101426|Diabetic Neuropathy|diabetic neuropathy
834306|NCT00101413|NSCLC|nsclc
834307|NCT00101400|Cancer|cancer
834308|NCT00101387|Aged|aged
834309|NCT00101387|Acupuncture|acupuncture
834310|NCT00101374|Immunomodulatory Drug|immunomodulatory drug
834311|NCT00101374|Antiviral|antiviral
834312|NCT00101374|Ki67+|ki67+
834313|NCT00101374|Immune Activation|immune activation
834314|NCT00101374|T Cell Proliferation|t cell proliferation
834315|NCT00101374|HIV|hiv
834316|NCT00101374|Activated CD4+T-cell|activated cd4+t-cell
834317|NCT00101374|Proliferation|proliferation
834318|NCT00101361|dermatologic|dermatologic
834319|NCT00101361|skin|skin
834320|NCT00101361|clinical trial|clinical trial
834321|NCT00101361|androgen/anabolic|androgen/anabolic
834322|NCT00101335|hypopharyngeal cancer|hypopharyngeal cancer
834323|NCT00101335|lip and oral cavity cancer|lip and oral cavity cancer
834324|NCT00101335|nasopharyngeal cancer|nasopharyngeal cancer
834325|NCT00101335|oropharyngeal cancer|oropharyngeal cancer
834326|NCT00101335|tongue cancer|tongue cancer
834327|NCT00101335|oral leukoplakia|oral leukoplakia
834328|NCT00101309|recurrent neuroblastoma|recurrent neuroblastoma
834329|NCT00101309|recurrent Ewing sarcoma/peripheral primitive neuroectodermal tumor|recurrent ewing sarcoma/peripheral primitive neuroectodermal tumor
834330|NCT00101283|advanced malignant mesothelioma|advanced malignant mesothelioma
834331|NCT00101283|recurrent malignant mesothelioma|recurrent malignant mesothelioma
834399|NCT00101062|recurrent breast cancer|recurrent breast cancer
834332|NCT00101257|recurrent ovarian epithelial cancer|recurrent ovarian epithelial cancer
834333|NCT00101257|stage III ovarian epithelial cancer|stage iii ovarian epithelial cancer
834334|NCT00101257|stage IV ovarian epithelial cancer|stage iv ovarian epithelial cancer
834335|NCT00101257|peritoneal cavity cancer|peritoneal cavity cancer
834336|NCT00101192|recurrent cervical cancer|recurrent cervical cancer
834337|NCT00101192|cervical adenocarcinoma|cervical adenocarcinoma
834338|NCT00101192|cervical adenosquamous cell carcinoma|cervical adenosquamous cell carcinoma
834339|NCT00101192|cervical small cell carcinoma|cervical small cell carcinoma
834340|NCT00101192|cervical squamous cell carcinoma|cervical squamous cell carcinoma
834341|NCT00101192|stage III cervical cancer|stage iii cervical cancer
834342|NCT00101192|stage IVA cervical cancer|stage iva cervical cancer
834343|NCT00101192|stage IVB cervical cancer|stage ivb cervical cancer
834344|NCT00101166|recurrent melanoma|recurrent melanoma
834345|NCT00101166|stage III melanoma|stage iii melanoma
834346|NCT00101166|stage IV melanoma|stage iv melanoma
834347|NCT00101153|adult acute basophilic leukemia|adult acute basophilic leukemia
834348|NCT00101153|adult acute eosinophilic leukemia|adult acute eosinophilic leukemia
834349|NCT00101153|adult acute megakaryoblastic leukemia (M7)|adult acute megakaryoblastic leukemia (m7)
834350|NCT00101153|adult acute minimally differentiated myeloid leukemia (M0)|adult acute minimally differentiated myeloid leukemia (m0)
834351|NCT00101153|adult acute monoblastic leukemia (M5a)|adult acute monoblastic leukemia (m5a)
834352|NCT00101153|adult acute monocytic leukemia (M5b)|adult acute monocytic leukemia (m5b)
834353|NCT00101153|adult acute myeloblastic leukemia with maturation (M2)|adult acute myeloblastic leukemia with maturation (m2)
834354|NCT00101153|adult acute myeloblastic leukemia without maturation (M1)|adult acute myeloblastic leukemia without maturation (m1)
834355|NCT00101153|adult acute myeloid leukemia with 11q23 (MLL) abnormalities|adult acute myeloid leukemia with 11q23 (mll) abnormalities
834356|NCT00101153|adult acute myeloid leukemia with inv(16)(p13;q22)|adult acute myeloid leukemia with inv(16)(p13;q22)
834357|NCT00101153|adult acute myeloid leukemia with t(16;16)(p13;q22)|adult acute myeloid leukemia with t(16;16)(p13;q22)
834358|NCT00101153|adult acute myeloid leukemia with t(8;21)(q22;q22)|adult acute myeloid leukemia with t(8;21)(q22;q22)
834359|NCT00101153|adult acute myelomonocytic leukemia (M4)|adult acute myelomonocytic leukemia (m4)
834360|NCT00101153|adult erythroleukemia (M6a)|adult erythroleukemia (m6a)
834361|NCT00101153|adult pure erythroid leukemia (M6b)|adult pure erythroid leukemia (m6b)
834362|NCT00101153|untreated adult acute myeloid leukemia|untreated adult acute myeloid leukemia
834363|NCT00101140|adult erythroleukemia (M6a)|adult erythroleukemia (m6a)
834364|NCT00101140|adult acute megakaryoblastic leukemia (M7)|adult acute megakaryoblastic leukemia (m7)
834365|NCT00101140|adult acute minimally differentiated myeloid leukemia (M0)|adult acute minimally differentiated myeloid leukemia (m0)
834366|NCT00101140|adult acute monocytic leukemia (M5b)|adult acute monocytic leukemia (m5b)
834367|NCT00101140|adult acute myeloblastic leukemia with maturation (M2)|adult acute myeloblastic leukemia with maturation (m2)
834368|NCT00101140|adult acute myeloblastic leukemia without maturation (M1)|adult acute myeloblastic leukemia without maturation (m1)
834369|NCT00101140|adult acute myeloid leukemia in remission|adult acute myeloid leukemia in remission
834370|NCT00101140|adult acute myeloid leukemia with 11q23 (MLL) abnormalities|adult acute myeloid leukemia with 11q23 (mll) abnormalities
834371|NCT00101140|adult acute myeloid leukemia with inv(16)(p13;q22)|adult acute myeloid leukemia with inv(16)(p13;q22)
834372|NCT00101140|adult acute myeloid leukemia with t(16;16)(p13;q22)|adult acute myeloid leukemia with t(16;16)(p13;q22)
834373|NCT00101140|adult acute myeloid leukemia with t(8;21)(q22;q22)|adult acute myeloid leukemia with t(8;21)(q22;q22)
834374|NCT00101140|adult acute myelomonocytic leukemia (M4)|adult acute myelomonocytic leukemia (m4)
834375|NCT00101127|recurrent uterine sarcoma|recurrent uterine sarcoma
834376|NCT00101127|stage III uterine sarcoma|stage iii uterine sarcoma
834377|NCT00101127|stage IV uterine sarcoma|stage iv uterine sarcoma
834378|NCT00101127|uterine leiomyosarcoma|uterine leiomyosarcoma
834379|NCT00101101|recurrent mantle cell lymphoma|recurrent mantle cell lymphoma
834380|NCT00101101|contiguous stage II mantle cell lymphoma|contiguous stage ii mantle cell lymphoma
834381|NCT00101101|noncontiguous stage II mantle cell lymphoma|noncontiguous stage ii mantle cell lymphoma
834382|NCT00101101|stage III mantle cell lymphoma|stage iii mantle cell lymphoma
834383|NCT00101101|stage IV mantle cell lymphoma|stage iv mantle cell lymphoma
834384|NCT00101075|high-grade salivary gland mucoepidermoid carcinoma|high-grade salivary gland mucoepidermoid carcinoma
834385|NCT00101075|low-grade salivary gland mucoepidermoid carcinoma|low-grade salivary gland mucoepidermoid carcinoma
834386|NCT00101075|salivary gland acinic cell tumor|salivary gland acinic cell tumor
834387|NCT00101075|salivary gland adenocarcinoma|salivary gland adenocarcinoma
834388|NCT00101075|salivary gland adenoid cystic carcinoma|salivary gland adenoid cystic carcinoma
834389|NCT00101075|salivary gland malignant mixed cell type tumor|salivary gland malignant mixed cell type tumor
834390|NCT00101075|salivary gland poorly differentiated carcinoma|salivary gland poorly differentiated carcinoma
834391|NCT00101075|salivary gland squamous cell carcinoma|salivary gland squamous cell carcinoma
834392|NCT00101075|recurrent salivary gland cancer|recurrent salivary gland cancer
834393|NCT00101075|stage III salivary gland cancer|stage iii salivary gland cancer
834394|NCT00101075|stage IV salivary gland cancer|stage iv salivary gland cancer
834395|NCT00101062|stage IIIA breast cancer|stage iiia breast cancer
834396|NCT00101062|stage IIIB breast cancer|stage iiib breast cancer
834397|NCT00101062|stage IIIC breast cancer|stage iiic breast cancer
834398|NCT00101062|stage IV breast cancer|stage iv breast cancer
834400|NCT00101010|contiguous stage II adult diffuse large cell lymphoma|contiguous stage ii adult diffuse large cell lymphoma
834401|NCT00101010|noncontiguous stage II adult diffuse large cell lymphoma|noncontiguous stage ii adult diffuse large cell lymphoma
834402|NCT00101010|stage III adult diffuse large cell lymphoma|stage iii adult diffuse large cell lymphoma
834403|NCT00101010|stage IV adult diffuse large cell lymphoma|stage iv adult diffuse large cell lymphoma
834404|NCT00100997|chronic myelogenous leukemia, BCR-ABL1 positive|chronic myelogenous leukemia, bcr-abl1 positive
834405|NCT00100997|chronic phase chronic myelogenous leukemia|chronic phase chronic myelogenous leukemia
834406|NCT00100997|relapsing chronic myelogenous leukemia|relapsing chronic myelogenous leukemia
834407|NCT00100971|adult acute myeloid leukemia with 11q23 (MLL) abnormalities|adult acute myeloid leukemia with 11q23 (mll) abnormalities
834408|NCT00100971|adult acute myeloid leukemia with inv(16)(p13;q22)|adult acute myeloid leukemia with inv(16)(p13;q22)
834409|NCT00100971|adult acute myeloid leukemia with t(15;17)(q22;q12)|adult acute myeloid leukemia with t(15;17)(q22;q12)
834410|NCT00100971|adult acute myeloid leukemia with t(16;16)(p13;q22)|adult acute myeloid leukemia with t(16;16)(p13;q22)
834411|NCT00100971|adult acute myeloid leukemia with t(8;21)(q22;q22)|adult acute myeloid leukemia with t(8;21)(q22;q22)
834412|NCT00100971|secondary acute myeloid leukemia|secondary acute myeloid leukemia
834413|NCT00100958|unspecified adult solid tumor, protocol specific|unspecified adult solid tumor, protocol specific
834414|NCT00100945|adenocarcinoma of the esophagus|adenocarcinoma of the esophagus
834415|NCT00100945|stage II esophageal cancer|stage ii esophageal cancer
834416|NCT00100919|Kinesithesia|kinesithesia
834417|NCT00100919|Sensorimotor Function|sensorimotor function
834418|NCT00100919|Somatosensory|somatosensory
834419|NCT00100919|Muscle Spindles|muscle spindles
834420|NCT00100919|Sensory Feedback|sensory feedback
834421|NCT00100919|Healthy Volunteer|healthy volunteer
834422|NCT00100919|HV|hv
834423|NCT00100906|stage IV renal cell cancer|stage iv renal cell cancer
834424|NCT00100906|recurrent renal cell cancer|recurrent renal cell cancer
834425|NCT00100906|clear cell renal cell carcinoma|clear cell renal cell carcinoma
834426|NCT00100893|breast cancer|breast cancer
834427|NCT00100867|Perinatal Transmission|perinatal transmission
834428|NCT00100867|Mother-to-Child Transmission|mother-to-child transmission
834429|NCT00100854|stage IIIB non-small cell lung cancer|stage iiib non-small cell lung cancer
834430|NCT00100854|stage IV non-small cell lung cancer|stage iv non-small cell lung cancer
834431|NCT00100854|recurrent non-small cell lung cancer|recurrent non-small cell lung cancer
834432|NCT00100828|thyroid gland medullary carcinoma|thyroid gland medullary carcinoma
834433|NCT00100828|recurrent thyroid cancer|recurrent thyroid cancer
834434|NCT00100815|adenocarcinoma of the pancreas|adenocarcinoma of the pancreas
834435|NCT00100815|recurrent pancreatic cancer|recurrent pancreatic cancer
834436|NCT00100815|stage IV pancreatic cancer|stage iv pancreatic cancer
834437|NCT00100802|childhood high-grade cerebral astrocytoma|childhood high-grade cerebral astrocytoma
834438|NCT00100802|childhood spinal cord neoplasm|childhood spinal cord neoplasm
834439|NCT00100789|Recurrent|recurrent
834440|NCT00100789|stage IV|stage iv
834441|NCT00100789|squamous cell carcinoma|squamous cell carcinoma
834442|NCT00100789|hypopharynx|hypopharynx
834443|NCT00100789|larynx|larynx
834444|NCT00100789|lip|lip
834445|NCT00100789|oral cavity|oral cavity
834446|NCT00100789|nasopharynx|nasopharynx
834447|NCT00100789|oropharynx|oropharynx
834448|NCT00100789|paranasal|paranasal
834449|NCT00100789|nasal cavity|nasal cavity
834450|NCT00100789|metastatic|metastatic
834451|NCT00100789|neck cancer|neck cancer
834452|NCT00100737|non-hodgkins lymphoma|non-hodgkins lymphoma
834453|NCT00100737|interleukin-2|interleukin-2
834454|NCT00100737|rituximab|rituximab
834455|NCT00100737|CD20+ follicular B-cell non-hodgkins lymphoma (grade I, II,III)|cd20+ follicular b-cell non-hodgkins lymphoma (grade i, ii,iii)
834456|NCT00100724|Anthrax|anthrax
834457|NCT00100724|rPA102|rpa102
834458|NCT00100724|vaccine|vaccine
834459|NCT00100711|Chronic Lymphocytic Leukemia|chronic lymphocytic leukemia
834460|NCT00100711|Small Lymphocytic Lymphoma|small lymphocytic lymphoma
834461|NCT00100711|Leukemia|leukemia
834462|NCT00100711|Lymphoma|lymphoma
834463|NCT00100711|Motexafin Gadolinium|motexafin gadolinium
834464|NCT00100711|Relapsed Chronic Lymphocytic Leukemia|relapsed chronic lymphocytic leukemia
834465|NCT00100711|Relapsed Chronic Lymphocycic Lymphoma|relapsed chronic lymphocycic lymphoma
834466|NCT00100711|Refractory Chronic Lymphocytic Leukemia|refractory chronic lymphocytic leukemia
834467|NCT00100711|Refractory Small Lymphocytic Lymphoma|refractory small lymphocytic lymphoma
834468|NCT00100698|HIV|hiv
834469|NCT00100698|lipodystrophy|lipodystrophy
834470|NCT00100698|growth hormone|growth hormone
834471|NCT00100698|visceral fat|visceral fat
834472|NCT00100698|IGF-I|igf-i
834473|NCT00100698|Treatment Experienced|treatment experienced
834474|NCT00100685|Kidney|kidney
834475|NCT00100685|renal|renal
834476|NCT00100685|cancer|cancer
834477|NCT00100685|carcinoma|carcinoma
834480|NCT00100685|metastatic renal cell carcinoma|metastatic renal cell carcinoma
834481|NCT00100685|RCC|rcc
834482|NCT00100672|LErafAON-ETU|lerafaon-etu
834483|NCT00100672|Signal transduction|signal transduction
834484|NCT00100672|Neoplasm|neoplasm
834485|NCT00100672|Cancer|cancer
834486|NCT00100672|NeoPharm|neopharm
834487|NCT00100672|Liposomes|liposomes
834490|NCT00100672|Advanced neoplasm|advanced neoplasm
834491|NCT00100672|Advanced cancer|advanced cancer
834492|NCT00100672|Chemotherapy|chemotherapy
834493|NCT00100672|Refractory cancer|refractory cancer
834494|NCT00100672|Metastatic cancer|metastatic cancer
834495|NCT00100659|pediatric|pediatric
834496|NCT00100659|hepatitis|hepatitis
834497|NCT00100659|children|children
834498|NCT00100659|HCV|hcv
834499|NCT00100659|PEG|peg
834500|NCT00100659|PEG-2a|peg-2a
834501|NCT00100659|peginterferon alfa-2a|peginterferon alfa-2a
834502|NCT00100659|Pegylated Interferon|pegylated interferon
834503|NCT00100659|RV|rv
834504|NCT00100659|ribavirin|ribavirin
834505|NCT00100659|Pegasys|pegasys
834506|NCT00100659|CHC|chc
834507|NCT00100659|chronic hepatitis C|chronic hepatitis c
834508|NCT00100659|chronic hepatitis C virus|chronic hepatitis c virus
834509|NCT00100659|hepatitis c|hepatitis c
834510|NCT00100659|pediatric hepatitis|pediatric hepatitis
834511|NCT00100659|pediatric HCV|pediatric hcv
834512|NCT00100646|Treatment Interruption|treatment interruption
834513|NCT00100646|Treatment Naive|treatment naive
834514|NCT00100633|Hepatitis B Vaccine|hepatitis b vaccine
834515|NCT00100633|Treatment Experienced|treatment experienced
834516|NCT00100633|Treatment Naive|treatment naive
834517|NCT00100620|Corticosteroid induced osteoporosis|corticosteroid induced osteoporosis
834518|NCT00100620|prevention|prevention
834519|NCT00100620|treatment|treatment
834520|NCT00100620|zoledronic acid|zoledronic acid
834521|NCT00100607|osteoporosis/osteopenia, BMD, postmenopausal|osteoporosis/osteopenia, bmd, postmenopausal
834522|NCT00100594|Treatment Naive|treatment naive
834523|NCT00100581|Treatment Naive|treatment naive
834524|NCT00100568|Treatment Naive|treatment naive
834525|NCT00100555|Osteoporosis, osteopenia, post-menopausal, zoledronic acid|osteoporosis, osteopenia, post-menopausal, zoledronic acid
834526|NCT00100542|Treatment Experienced|treatment experienced
834527|NCT00100542|Treatment Naive|treatment naive
834528|NCT00100542|Psychopathology|psychopathology
834529|NCT00100542|Anti-Retroviral Agents|anti-retroviral agents
834530|NCT00100542|Child|child
834531|NCT00100542|Adolescent|adolescent
834532|NCT00100529|Facial Imaging|facial imaging
834533|NCT00100529|Genetics|genetics
834534|NCT00100529|Growth|growth
834535|NCT00100529|Development|development
834536|NCT00100529|Diagnostics|diagnostics
834537|NCT00100529|Craniofacial Dysmorphologies|craniofacial dysmorphologies
834538|NCT00100529|Facial Features|facial features
834539|NCT00100516|Renal|renal
834540|NCT00100516|Allografts|allografts
834541|NCT00100516|Nephrectomy|nephrectomy
834542|NCT00100516|Pneumoperitoneum|pneumoperitoneum
834543|NCT00100516|LaparoscopIC|laparoscopic
834544|NCT00100516|Kidney Donation|kidney donation
834545|NCT00100503|Rehabilitation|rehabilitation
834546|NCT00100503|Forced Use|forced use
834547|NCT00100503|Hemiplegia|hemiplegia
834548|NCT00100503|Magnetic Resonance Imaging|magnetic resonance imaging
834549|NCT00100503|TMS|tms
834550|NCT00100503|Cerebral Palsy|cerebral palsy
834551|NCT00100503|Spastic Hemiplegia|spastic hemiplegia
834552|NCT00100503|Healthy Volunteer|healthy volunteer
834553|NCT00100503|HV|hv
834554|NCT00100477|Multiple Myeloma|multiple myeloma
834555|NCT00100477|Lymphoma|lymphoma
834556|NCT00100477|Leukemia|leukemia
834557|NCT00100477|Etoposide|etoposide
834558|NCT00100477|Drug Therapy|drug therapy
834559|NCT00100477|Clinical Trials|clinical trials
834560|NCT00100464|Serotonin|serotonin
834561|NCT00100464|Sleep Apnea Syndrome|sleep apnea syndrome
834562|NCT00100464|Pharyngeal Muscles|pharyngeal muscles
834563|NCT00100451|Adipose tissue|adipose tissue
834564|NCT00100451|Aging|aging
834565|NCT00100451|Exercise|exercise
834566|NCT00100451|Lipolysis|lipolysis
834567|NCT00100451|Estrogens|estrogens
834568|NCT00100425|Irritable Bowel Syndrome|irritable bowel syndrome
834569|NCT00100425|Visceral Hypersensitivity|visceral hypersensitivity
834570|NCT00100425|Visceral Pain|visceral pain
834571|NCT00100399|influenza, flu, Fluarix, vaccine, GSK, immunogenicity|influenza, flu, fluarix, vaccine, gsk, immunogenicity
834572|NCT00100386|Hand hygiene, antibiotic resistance, contact precautions|hand hygiene, antibiotic resistance, contact precautions
834573|NCT00100373|Respiratory Syncytial Virus Infections|respiratory syncytial virus infections
834574|NCT00100360|Gonadal Steroids|gonadal steroids
834575|NCT00100360|GnRH Agonist|gnrh agonist
834576|NCT00100360|Depression|depression
834577|NCT00100360|Menstrual Cycle|menstrual cycle
834578|NCT00100360|Menstrually Related Mood Disorder|menstrually related mood disorder
834579|NCT00100360|MRMD|mrmd
834580|NCT00100360|Healthy Volunteer|healthy volunteer
834581|NCT00100360|HV|hv
834582|NCT00100347|non-Hodgkin lymphoma|non-hodgkin lymphoma
834583|NCT00100347|non-Hodgkin’s lymphoma|non-hodgkin’s lymphoma
834584|NCT00100347|NHL|nhl
834585|NCT00100347|MetAP2|metap2
834586|NCT00100347|Solid Tumors|solid tumors
834587|NCT00100334|Alzheimer's Disease|alzheimer's disease
834588|NCT00100321|Tumor Antigen Identification|tumor antigen identification
834589|NCT00100321|Standard Treatment|standard treatment
834590|NCT00100321|Tissue Acquisition|tissue acquisition
834591|NCT00100321|Surgery|surgery
834592|NCT00100321|Adjuvant Chemotherapy|adjuvant chemotherapy
834593|NCT00100321|Pancreatic Cancer|pancreatic cancer
834594|NCT00100321|Pancreatic Tumor|pancreatic tumor
834595|NCT00100308|sepsis|sepsis
834596|NCT00100308|Randomized clinical trial|randomized clinical trial
834597|NCT00100308|Heparin|heparin
834598|NCT00100308|Therapy|therapy
834599|NCT00100295|Adolescent|adolescent
834600|NCT00100295|Child|child
834601|NCT00100295|Phytotherapy|phytotherapy
834602|NCT00100282|Mild-moderate Alzheimer's disease|mild-moderate alzheimer's disease
834603|NCT00100269|Male infertility|male infertility
834604|NCT00100269|sperm|sperm
834605|NCT00100269|pregnancy|pregnancy
834606|NCT00100269|IVF (in vitro fertilisation)|ivf (in vitro fertilisation)
834607|NCT00100269|oxidative stress|oxidative stress
834608|NCT00100269|free radicals|free radicals
834609|NCT00100269|DNA damage|dna damage
834610|NCT00100256|Advanced or recurrent stage IIIb or IV non small cell lung cancer|advanced or recurrent stage iiib or iv non small cell lung cancer
834611|NCT00100256|Disseminated or recurrent small cell lung cancer|disseminated or recurrent small cell lung cancer
834612|NCT00100243|androgen-independent|androgen-independent
834613|NCT00100243|prostate cancer|prostate cancer
834614|NCT00100230|retina|retina
834615|NCT00100230|electroretinography|electroretinography
834616|NCT00100230|clinical trial|clinical trial
834617|NCT00100230|docosahexaenoic acid|docosahexaenoic acid
834618|NCT00100230|omega-3 fatty acid|omega-3 fatty acid
834619|NCT00100230|x-linked inheritance|x-linked inheritance
834620|NCT00100217|Training|training
834621|NCT00100217|Critical Care|critical care
834622|NCT00100217|Heart Failure|heart failure
834623|NCT00100217|Pulmonary Hypertension|pulmonary hypertension
834624|NCT00100217|Infectious Diseases|infectious diseases
834625|NCT00100204|Head and Neck Radiation|head and neck radiation
834626|NCT00100204|Diabetes|diabetes
834627|NCT00100204|Sarcoidosis|sarcoidosis
834628|NCT00100204|Sjogren's Syndrome|sjogren's syndrome
834629|NCT00100204|Caries|caries
834630|NCT00100204|Healthy Volunteer|healthy volunteer
834631|NCT00100204|HV|hv
834632|NCT00100204|Saliva Sample|saliva sample
834633|NCT00100191|hysterectomy|hysterectomy
834634|NCT00100191|fibroids|fibroids
834635|NCT00100191|uterine artery embolization|uterine artery embolization
834636|NCT00100191|therapeutic embolization|therapeutic embolization
834637|NCT00100191|uterus|uterus
834638|NCT00100191|menorrhagia|menorrhagia
834639|NCT00100178|immunosuppressive therapy|immunosuppressive therapy
834640|NCT00100178|Type 1 Diabetes TrialNet|type 1 diabetes trialnet
834641|NCT00100178|TrialNet|trialnet
834642|NCT00100178|POPPII|poppii
834643|NCT00100178|POPPII-1|poppii-1
834644|NCT00100165|Schizophrenia|schizophrenia
834645|NCT00100152|Relapsed or refractory T-cell ALL acute lymphoblastic/leukemia|relapsed or refractory t-cell all acute lymphoblastic/leukemia
834646|NCT00100152|Relapsed/refractory T-cell acute Lymphoblastic/leukemia|relapsed/refractory t-cell acute lymphoblastic/leukemia
834647|NCT00100152|Acute/chronic myelogenous leukemia|acute/chronic myelogenous leukemia
834648|NCT00100152|Poor-risk myelodysplasia|poor-risk myelodysplasia
834649|NCT00100139|Neoplasm|neoplasm
834650|NCT00100139|Cancer|cancer
834651|NCT00100139|NeoPharm|neopharm
834652|NCT00100139|Liposomes|liposomes
834653|NCT00100139|Taxol|taxol
834654|NCT00100139|Paclitaxel|paclitaxel
834655|NCT00100139|Anti-cancer|anti-cancer
834656|NCT00100139|Advanced neoplasm|advanced neoplasm
834657|NCT00100139|Advanced cancer|advanced cancer
834658|NCT00100139|Chemotherapy|chemotherapy
834659|NCT00100139|Refractory cancer|refractory cancer
834660|NCT00100139|Metastatic cancer|metastatic cancer
834661|NCT00100126|Pharyngitis|pharyngitis
834662|NCT00100126|Strep throat|strep throat
834663|NCT00100113|cocaine dependence|cocaine dependence
834664|NCT00100100|cocaine dependence|cocaine dependence
834665|NCT00100087|macular degeneration|macular degeneration
834666|NCT00100087|brachytherapy|brachytherapy
834667|NCT00100087|choroidal neovascularization|choroidal neovascularization
834668|NCT00100087|retinal degeneration|retinal degeneration
834669|NCT00100087|retinal diseases|retinal diseases
834670|NCT00100061|Cranberry|cranberry
834671|NCT00100061|Vaccinium macrocarpon|vaccinium macrocarpon
834672|NCT00100035|Caregivers|caregivers
834673|NCT00100035|Complementary Therapies|complementary therapies
834674|NCT00100009|Steroid|steroid
834675|NCT00100009|Inflammation|inflammation
834676|NCT00100009|Choroidal Neovascularization|choroidal neovascularization
834677|NCT00100009|Intravitreal Injection|intravitreal injection
834678|NCT00100009|Verteporfin|verteporfin
834679|NCT00100009|Age-Related Macular Degeneration|age-related macular degeneration
834680|NCT00100009|Photodynamic Therapy|photodynamic therapy
834681|NCT00100009|Age Related Macular Degeneration|age related macular degeneration
834682|NCT00100009|AMD|amd
834683|NCT00099996|Sitosterolemia|sitosterolemia
834684|NCT00099996|Sitosterol|sitosterol
834685|NCT00099996|Ezetimibe|ezetimibe
834686|NCT00099996|Absorption|absorption
834687|NCT00099996|Intestine|intestine
834688|NCT00099996|Cholesterol|cholesterol
834689|NCT00099996|Atherosclerosis|atherosclerosis
834897|NCT00099242|Dementia|dementia
834690|NCT00099996|Homozygous Sitosterolemia|homozygous sitosterolemia
834691|NCT00099983|PTSD|ptsd
834692|NCT00099970|Solid tumors|solid tumors
834693|NCT00099970|Metastatic melanoma|metastatic melanoma
834694|NCT00099957|type 2 diabetes|type 2 diabetes
834695|NCT00099957|vildagliptin|vildagliptin
834696|NCT00099944|type 2 diabetes|type 2 diabetes
834697|NCT00099944|vildagliptin|vildagliptin
834698|NCT00099931|type 2 diabetes|type 2 diabetes
834699|NCT00099931|vildagliptin|vildagliptin
834700|NCT00099918|type 2 diabetes|type 2 diabetes
834701|NCT00099918|vildagliptin|vildagliptin
834702|NCT00099905|type 2 diabetes|type 2 diabetes
834703|NCT00099905|vildagliptin|vildagliptin
834704|NCT00099892|type 2 diabetes|type 2 diabetes
834705|NCT00099892|vildagliptin|vildagliptin
834706|NCT00099866|type 2 diabetes|type 2 diabetes
834707|NCT00099866|vildagliptin|vildagliptin
834708|NCT00099853|type 2 diabetes|type 2 diabetes
834709|NCT00099853|vildagliptin|vildagliptin
834710|NCT00099840|common cold|common cold
834711|NCT00099840|pharyngitis|pharyngitis
834712|NCT00099840|tonsillitis|tonsillitis
834713|NCT00099840|rhinosinusitis|rhinosinusitis
834714|NCT00099840|tracheo-bronchitis|tracheo-bronchitis
834715|NCT00099840|otitis media|otitis media
834716|NCT00099840|acute exacerbations of asthma|acute exacerbations of asthma
834717|NCT00099840|acute exacerbations of chronic pulmonary disease|acute exacerbations of chronic pulmonary disease
834718|NCT00099840|community acquired pneumonia|community acquired pneumonia
834719|NCT00099827|Depression|depression
834720|NCT00099814|tooth movement|tooth movement
834721|NCT00099814|orthodontics|orthodontics
834722|NCT00099814|force|force
834723|NCT00099814|humans|humans
834724|NCT00099814|clinical trial|clinical trial
834725|NCT00099801|Kidney, Transplantation, Rejection, Immunosuppression|kidney, transplantation, rejection, immunosuppression
834726|NCT00099788|Acute Coronary Syndrome|acute coronary syndrome
834727|NCT00099788|Myocardial Infarction|myocardial infarction
834728|NCT00099788|Heart Attack|heart attack
834729|NCT00099788|Angina|angina
834730|NCT00099788|Chest pain|chest pain
834731|NCT00099788|Ischemia|ischemia
834732|NCT00099788|Non-ST Elevation Acute Coronary Syndrome|non-st elevation acute coronary syndrome
834733|NCT00099775|Mycoses|mycoses
834734|NCT00099775|Candida|candida
834735|NCT00099775|Echinocandin|echinocandin
834736|NCT00099775|Immunocompromised Host|immunocompromised host
834737|NCT00099775|Invasive Fungal Infection|invasive fungal infection
834738|NCT00099775|Fungal Infection|fungal infection
834739|NCT00099762|Tumor Induced Osteomalacia|tumor induced osteomalacia
834741|NCT00099762|Phosphatonin|phosphatonin
834742|NCT00099762|Hypophosphatemia|hypophosphatemia
834743|NCT00099762|Oncogenic Osteomalacia|oncogenic osteomalacia
834744|NCT00099762|Phosphaturic Mesenchymal Tumor|phosphaturic mesenchymal tumor
834745|NCT00099762|TIO|tio
834746|NCT00099762|Osteogenic Osteomalacia|osteogenic osteomalacia
834747|NCT00099762|OOM|oom
834748|NCT00099749|Kidney, immunosuppression, transplant, rejection|kidney, immunosuppression, transplant, rejection
834749|NCT00099736|Kidney, transplantation, rejection, immunosuppression|kidney, transplantation, rejection, immunosuppression
834750|NCT00099723|Hepatic steatosis|hepatic steatosis
834751|NCT00099723|adult-onset diabetes|adult-onset diabetes
834752|NCT00099723|Non-alcoholic fatty liver disease|non-alcoholic fatty liver disease
834753|NCT00099710|Curcumin|curcumin
834754|NCT00099710|Turmeric|turmeric
834755|NCT00099710|Curry|curry
834756|NCT00099710|NSAID|nsaid
834757|NCT00099710|anti-inflammatory|anti-inflammatory
834758|NCT00099710|Cholesterol|cholesterol
834759|NCT00099710|anti-oxidant|anti-oxidant
834760|NCT00099697|abdominal fat|abdominal fat
834761|NCT00099697|dehydroepiandrosterone|dehydroepiandrosterone
834762|NCT00099697|Insulin sensitivity|insulin sensitivity
834763|NCT00099684|Treatment Experienced|treatment experienced
834764|NCT00099671|Treatment Experienced|treatment experienced
834765|NCT00099658|MTCT|mtct
834766|NCT00099645|Mifepristone|mifepristone
834767|NCT00099645|Mifeprex|mifeprex
834768|NCT00099645|RU486|ru486
834769|NCT00099645|VGX-410|vgx-410
834770|NCT00099645|Abortion Pill|abortion pill
834771|NCT00099645|Investigational Drug|investigational drug
834772|NCT00099632|Treatment Naive|treatment naive
834773|NCT00099619|exenatide|exenatide
834774|NCT00099619|exendin-4|exendin-4
834775|NCT00099619|diabetes|diabetes
834776|NCT00099619|Amylin|amylin
834777|NCT00099619|Lilly|lilly
834778|NCT00099593|Cutaneous T-cell lymphoma (CTCL)|cutaneous t-cell lymphoma (ctcl)
834779|NCT00099593|Sezary Syndrome|sezary syndrome
834780|NCT00099593|Mycosis Fungoides|mycosis fungoides
834781|NCT00099593|Vaccine|vaccine
834782|NCT00099580|Congestive Heart Failure|congestive heart failure
834785|NCT00099580|Amylin|amylin
834786|NCT00099580|metabolic abnormality|metabolic abnormality
834787|NCT00099567|Metabolic Syndrome|metabolic syndrome
834788|NCT00099567|Alzheimer's Disease|alzheimer's disease
834789|NCT00099567|Cognitive Impairment|cognitive impairment
834790|NCT00099567|Inflammation|inflammation
834791|NCT00099541|Lung Cancer|lung cancer
834792|NCT00099541|Bone Metastases|bone metastases
834793|NCT00099541|Bone Markers|bone markers
834795|NCT00099541|zoledronic acid|zoledronic acid
834796|NCT00099541|Registry|registry
834797|NCT00099541|Unresectable Stage IV Non Small-cell Lung Cancer (NSCLC)|unresectable stage iv non small-cell lung cancer (nsclc)
834798|NCT00099541|Unresectable Stage IIIB NSCLC with Pleural Effusion|unresectable stage iiib nsclc with pleural effusion
834799|NCT00099528|Post-herpetic neuralgia|post-herpetic neuralgia
834800|NCT00099528|Shingles|shingles
834801|NCT00099528|Herpes Zoster|herpes zoster
834802|NCT00099528|Neuropathic pain|neuropathic pain
834803|NCT00099528|Neuralgia|neuralgia
834804|NCT00099528|Anti-TNF agents|anti-tnf agents
834805|NCT00099528|Inflammatory cytokines|inflammatory cytokines
834806|NCT00099528|Hyperalgesia|hyperalgesia
834807|NCT00099528|Allodynia|allodynia
834808|NCT00099528|Irritable nociceptor|irritable nociceptor
834809|NCT00099502|Relapsing multiple sclerosis|relapsing multiple sclerosis
834810|NCT00099502|interferon beta 1b|interferon beta 1b
834811|NCT00099502|Betaferon|betaferon
834812|NCT00099502|Betaseron|betaseron
834813|NCT00099489|Chronic Inflammatory Demyelinating Polyradiculoneuropathy|chronic inflammatory demyelinating polyradiculoneuropathy
834814|NCT00099489|CIDP|cidp
834815|NCT00099489|IVIg|ivig
834816|NCT00099489|AVONEX|avonex
834817|NCT00099476|Epicatechin|epicatechin
834818|NCT00099476|Polyphenols|polyphenols
834819|NCT00099476|Chocolate|chocolate
834820|NCT00099476|Insulin Resistance|insulin resistance
834821|NCT00099476|Endothelial Dysfunction|endothelial dysfunction
834822|NCT00099476|Hypertension|hypertension
834823|NCT00099463|Coronavirus|coronavirus
834824|NCT00099463|Healthy|healthy
834825|NCT00099463|Immunity|immunity
834826|NCT00099463|Preventive|preventive
834827|NCT00099463|Virus|virus
834828|NCT00099463|Healthy Volunteer|healthy volunteer
834829|NCT00099463|HV|hv
834830|NCT00099450|bleeding|bleeding
834831|NCT00099450|blood transfusion|blood transfusion
834832|NCT00099450|surgeries|surgeries
834833|NCT00099437|Advanced Breast Cancer|advanced breast cancer
834834|NCT00099437|Metastatic Breast Cancer|metastatic breast cancer
834835|NCT00099424|exercise training|exercise training
834836|NCT00099424|resistance training|resistance training
834837|NCT00099424|endurance training|endurance training
834838|NCT00099424|Boeck's Sarcoid|boeck's sarcoid
834839|NCT00099424|Besnier-Boeck Disease|besnier-boeck disease
834840|NCT00099385|social development|social development
834841|NCT00099385|risk behaviors|risk behaviors
834842|NCT00099385|social emotional education|social emotional education
834843|NCT00099385|classroom instruction|classroom instruction
834844|NCT00099372|sacrocolpopexy|sacrocolpopexy
834845|NCT00099372|abdominal sacrocolpopexy|abdominal sacrocolpopexy
834846|NCT00099372|surgical procedure, prolapse|surgical procedure, prolapse
834847|NCT00099372|pelvic organ prolapse|pelvic organ prolapse
834848|NCT00099372|urinary incontinence|urinary incontinence
834849|NCT00099372|stress urinary incontinence|stress urinary incontinence
834850|NCT00099359|HIV|hiv
834851|NCT00099359|Perinatal|perinatal
834852|NCT00099359|Prevention|prevention
834853|NCT00099359|Transmission|transmission
834854|NCT00099359|Nevirapine|nevirapine
834855|NCT00099359|Epivir|epivir
834856|NCT00099359|Zidovudine|zidovudine
834857|NCT00099359|Nelfinavir|nelfinavir
834858|NCT00099359|ZDV|zdv
834859|NCT00099359|NVP|nvp
834860|NCT00099359|3TC|3tc
834861|NCT00099359|NFV|nfv
834862|NCT00099359|Viracept|viracept
834863|NCT00099359|Viramune|viramune
834864|NCT00099359|HIV Seronegativity|hiv seronegativity
834865|NCT00099359|Treatment Naive|treatment naive
834866|NCT00099333|exenatide|exenatide
834867|NCT00099333|exendin-4|exendin-4
834868|NCT00099333|Amylin|amylin
834869|NCT00099333|Eli Lilly|eli lilly
834870|NCT00099333|diabetes|diabetes
834871|NCT00099320|exenatide|exenatide
834872|NCT00099320|exendin-4|exendin-4
834873|NCT00099320|diabetes|diabetes
834874|NCT00099320|Amylin|amylin
834875|NCT00099320|Lilly|lilly
834876|NCT00099307|White Matter|white matter
834877|NCT00099307|Grey Matter|grey matter
834878|NCT00099307|Brain|brain
834879|NCT00099307|Disability|disability
834880|NCT00099307|Lesions|lesions
834881|NCT00099307|Multiple Sclerosis|multiple sclerosis
834882|NCT00099307|MS|ms
834883|NCT00099307|Healthy Volunteer|healthy volunteer
834884|NCT00099307|HV|hv
834885|NCT00099294|Pancreas|pancreas
834886|NCT00099294|Cancer|cancer
834887|NCT00099294|Pancreatic Adenocarcinoma|pancreatic adenocarcinoma
834888|NCT00099294|Metastatic|metastatic
834889|NCT00099294|Glufosfamide|glufosfamide
834890|NCT00099281|Metastatic breast cancer|metastatic breast cancer
834891|NCT00099268|Parkinson's disease, levodopa therapy, dyskinesia|parkinson's disease, levodopa therapy, dyskinesia
834892|NCT00099255|Keyword?|keyword?
834893|NCT00099255|Primary Cutaneous Anaplastic Large Cell Lymphoma|primary cutaneous anaplastic large cell lymphoma
834894|NCT00099255|Large Cell Transformation of Mycosis Fungoides|large cell transformation of mycosis fungoides
834895|NCT00099255|Lymphomatoid Papulosis|lymphomatoid papulosis
834896|NCT00099242|Alzheimer's Disease|alzheimer's disease
834898|NCT00099229|bipolar disorder|bipolar disorder
834899|NCT00099229|manic episode|manic episode
834900|NCT00099229|treatment|treatment
834901|NCT00099229|licarbazepine|licarbazepine
834902|NCT00099216|Dementia,vascular,rivastigmine,stroke,memory loss|dementia,vascular,rivastigmine,stroke,memory loss
834903|NCT00099190|cancer|cancer
834904|NCT00099190|solid tumor|solid tumor
834905|NCT00099190|advanced solid tumor|advanced solid tumor
834906|NCT00099164|preterm birth|preterm birth
834907|NCT00099164|pregnancy|pregnancy
834908|NCT00099164|multifetal|multifetal
834909|NCT00099164|Progesterone|progesterone
834910|NCT00099151|Longevity|longevity
834911|NCT00099151|Dietary restriction|dietary restriction
834912|NCT00099151|Physical activity|physical activity
834913|NCT00099151|Weight Loss|weight loss
834914|NCT00099151|Diabetes|diabetes
834915|NCT00099138|Diet|diet
834916|NCT00099138|Caloric Restriction|caloric restriction
834917|NCT00099138|Exercise|exercise
834918|NCT00099138|Energy Metabolism|energy metabolism
834919|NCT00099138|Primary Aging|primary aging
834920|NCT00099138|Secondary Aging|secondary aging
834921|NCT00099125|adult giant cell glioblastoma|adult giant cell glioblastoma
834922|NCT00099125|adult gliosarcoma|adult gliosarcoma
834923|NCT00099125|adult glioblastoma|adult glioblastoma
834924|NCT00099112|basal cell carcinoma of the skin|basal cell carcinoma of the skin
834925|NCT00099112|squamous cell carcinoma of the skin|squamous cell carcinoma of the skin
834926|NCT00099112|actinic keratosis|actinic keratosis
834927|NCT00099099|Longevity|longevity
834928|NCT00099099|Calorie restriction|calorie restriction
834929|NCT00099099|Physical activity|physical activity
834930|NCT00099099|Weight loss|weight loss
834931|NCT00099086|adenocarcinoma of the prostate|adenocarcinoma of the prostate
834932|NCT00099086|stage IIB prostate cancer|stage iib prostate cancer
834933|NCT00099086|stage IIA prostate cancer|stage iia prostate cancer
834934|NCT00099086|stage III prostate cancer|stage iii prostate cancer
834935|NCT00099086|stage IV prostate cancer|stage iv prostate cancer
834936|NCT00099060|adult giant cell glioblastoma|adult giant cell glioblastoma
834937|NCT00099060|adult gliosarcoma|adult gliosarcoma
834938|NCT00099060|recurrent adult brain tumor|recurrent adult brain tumor
834939|NCT00099008|breast cancer|breast cancer
834940|NCT00099008|endometrial cancer|endometrial cancer
834941|NCT00098995|stage IB cervical cancer|stage ib cervical cancer
834942|NCT00098995|stage IIA cervical cancer|stage iia cervical cancer
834943|NCT00098995|stage IIB cervical cancer|stage iib cervical cancer
834944|NCT00098995|stage III cervical cancer|stage iii cervical cancer
834945|NCT00098995|stage IVA cervical cancer|stage iva cervical cancer
834946|NCT00098995|cervical adenocarcinoma|cervical adenocarcinoma
834947|NCT00098995|cervical adenosquamous cell carcinoma|cervical adenosquamous cell carcinoma
834948|NCT00098995|cervical squamous cell carcinoma|cervical squamous cell carcinoma
834949|NCT00098982|stage III colon cancer|stage iii colon cancer
834950|NCT00098982|stage IV colon cancer|stage iv colon cancer
834951|NCT00098982|stage III rectal cancer|stage iii rectal cancer
834952|NCT00098982|stage IV rectal cancer|stage iv rectal cancer
834953|NCT00098982|recurrent colon cancer|recurrent colon cancer
834954|NCT00098982|recurrent rectal cancer|recurrent rectal cancer
834955|NCT00098969|unspecified adult solid tumor, protocol specific|unspecified adult solid tumor, protocol specific
834956|NCT00098943|unspecified adult solid tumor, protocol specific|unspecified adult solid tumor, protocol specific
834957|NCT00098943|stage IV renal cell cancer|stage iv renal cell cancer
834958|NCT00098943|recurrent renal cell cancer|recurrent renal cell cancer
834959|NCT00098943|stage IV colon cancer|stage iv colon cancer
834960|NCT00098943|recurrent colon cancer|recurrent colon cancer
834961|NCT00098943|anaplastic thyroid cancer|anaplastic thyroid cancer
834962|NCT00098943|insular thyroid cancer|insular thyroid cancer
834963|NCT00098943|thyroid gland medullary carcinoma|thyroid gland medullary carcinoma
834964|NCT00098943|stage IV follicular thyroid cancer|stage iv follicular thyroid cancer
834965|NCT00098943|stage IV papillary thyroid cancer|stage iv papillary thyroid cancer
834966|NCT00098943|recurrent thyroid cancer|recurrent thyroid cancer
834967|NCT00098943|recurrent squamous cell carcinoma of the hypopharynx|recurrent squamous cell carcinoma of the hypopharynx
834968|NCT00098943|recurrent squamous cell carcinoma of the larynx|recurrent squamous cell carcinoma of the larynx
834969|NCT00098943|recurrent squamous cell carcinoma of the lip and oral cavity|recurrent squamous cell carcinoma of the lip and oral cavity
834970|NCT00098943|recurrent squamous cell carcinoma of the nasopharynx|recurrent squamous cell carcinoma of the nasopharynx
834971|NCT00098943|recurrent squamous cell carcinoma of the oropharynx|recurrent squamous cell carcinoma of the oropharynx
834972|NCT00098943|recurrent squamous cell carcinoma of the paranasal sinus and nasal cavity|recurrent squamous cell carcinoma of the paranasal sinus and nasal cavity
835204|NCT00098020|Glomerulosclerosis|glomerulosclerosis
834973|NCT00098943|stage IV squamous cell carcinoma of the hypopharynx|stage iv squamous cell carcinoma of the hypopharynx
834974|NCT00098943|stage IV squamous cell carcinoma of the larynx|stage iv squamous cell carcinoma of the larynx
834975|NCT00098943|stage IV squamous cell carcinoma of the lip and oral cavity|stage iv squamous cell carcinoma of the lip and oral cavity
834976|NCT00098943|stage IV squamous cell carcinoma of the nasopharynx|stage iv squamous cell carcinoma of the nasopharynx
834977|NCT00098943|stage IV squamous cell carcinoma of the oropharynx|stage iv squamous cell carcinoma of the oropharynx
834978|NCT00098943|stage IV squamous cell carcinoma of the paranasal sinus and nasal cavity|stage iv squamous cell carcinoma of the paranasal sinus and nasal cavity
834979|NCT00098943|recurrent verrucous carcinoma of the larynx|recurrent verrucous carcinoma of the larynx
834980|NCT00098943|recurrent verrucous carcinoma of the oral cavity|recurrent verrucous carcinoma of the oral cavity
834981|NCT00098943|stage IV verrucous carcinoma of the oral cavity|stage iv verrucous carcinoma of the oral cavity
834982|NCT00098943|stage IV verrucous carcinoma of the larynx|stage iv verrucous carcinoma of the larynx
834983|NCT00098943|recurrent adenoid cystic carcinoma of the oral cavity|recurrent adenoid cystic carcinoma of the oral cavity
834984|NCT00098943|stage IV adenoid cystic carcinoma of the oral cavity|stage iv adenoid cystic carcinoma of the oral cavity
834985|NCT00098943|recurrent basal cell carcinoma of the lip|recurrent basal cell carcinoma of the lip
834986|NCT00098943|stage IV basal cell carcinoma of the lip|stage iv basal cell carcinoma of the lip
834987|NCT00098943|recurrent mucoepidermoid carcinoma of the oral cavity|recurrent mucoepidermoid carcinoma of the oral cavity
834988|NCT00098943|stage IV mucoepidermoid carcinoma of the oral cavity|stage iv mucoepidermoid carcinoma of the oral cavity
834989|NCT00098943|recurrent lymphoepithelioma of the nasopharynx|recurrent lymphoepithelioma of the nasopharynx
834990|NCT00098943|recurrent lymphoepithelioma of the oropharynx|recurrent lymphoepithelioma of the oropharynx
834991|NCT00098943|stage IV lymphoepithelioma of the nasopharynx|stage iv lymphoepithelioma of the nasopharynx
834992|NCT00098943|stage IV lymphoepithelioma of the oropharynx|stage iv lymphoepithelioma of the oropharynx
834993|NCT00098943|recurrent esthesioneuroblastoma of the paranasal sinus and nasal cavity|recurrent esthesioneuroblastoma of the paranasal sinus and nasal cavity
834994|NCT00098943|stage IV esthesioneuroblastoma of the paranasal sinus and nasal cavity|stage iv esthesioneuroblastoma of the paranasal sinus and nasal cavity
834995|NCT00098943|recurrent inverted papilloma of the paranasal sinus and nasal cavity|recurrent inverted papilloma of the paranasal sinus and nasal cavity
834996|NCT00098943|recurrent midline lethal granuloma of the paranasal sinus and nasal cavity|recurrent midline lethal granuloma of the paranasal sinus and nasal cavity
834997|NCT00098943|stage IV inverted papilloma of the paranasal sinus and nasal cavity|stage iv inverted papilloma of the paranasal sinus and nasal cavity
834998|NCT00098943|stage IV midline lethal granuloma of the paranasal sinus and nasal cavity|stage iv midline lethal granuloma of the paranasal sinus and nasal cavity
834999|NCT00098943|metastatic parathyroid cancer|metastatic parathyroid cancer
835000|NCT00098943|recurrent parathyroid cancer|recurrent parathyroid cancer
835001|NCT00098943|recurrent salivary gland cancer|recurrent salivary gland cancer
835002|NCT00098943|stage IV salivary gland cancer|stage iv salivary gland cancer
835003|NCT00098917|stage I non-small cell lung cancer|stage i non-small cell lung cancer
835004|NCT00098917|stage II non-small cell lung cancer|stage ii non-small cell lung cancer
835005|NCT00098917|stage IIIA non-small cell lung cancer|stage iiia non-small cell lung cancer
835006|NCT00098878|stage I ovarian epithelial cancer|stage i ovarian epithelial cancer
835007|NCT00098878|stage II ovarian epithelial cancer|stage ii ovarian epithelial cancer
835008|NCT00098878|stage III ovarian epithelial cancer|stage iii ovarian epithelial cancer
835009|NCT00098878|stage IV ovarian epithelial cancer|stage iv ovarian epithelial cancer
835010|NCT00098878|fallopian tube cancer|fallopian tube cancer
835011|NCT00098878|primary peritoneal cavity cancer|primary peritoneal cavity cancer
835012|NCT00098852|recurrent thyroid cancer|recurrent thyroid cancer
835013|NCT00098852|stage II follicular thyroid cancer|stage ii follicular thyroid cancer
835014|NCT00098852|stage IV follicular thyroid cancer|stage iv follicular thyroid cancer
835015|NCT00098852|stage II papillary thyroid cancer|stage ii papillary thyroid cancer
835016|NCT00098852|stage IV papillary thyroid cancer|stage iv papillary thyroid cancer
835017|NCT00098800|ovarian epithelial cancer|ovarian epithelial cancer
835018|NCT00098800|BRCA1 mutation carrier|brca1 mutation carrier
835019|NCT00098800|BRCA2 mutation carrier|brca2 mutation carrier
835020|NCT00098787|recurrent colon cancer|recurrent colon cancer
835021|NCT00098787|stage IV colon cancer|stage iv colon cancer
835022|NCT00098787|recurrent rectal cancer|recurrent rectal cancer
835023|NCT00098787|stage IV rectal cancer|stage iv rectal cancer
835024|NCT00098787|adenocarcinoma of the colon|adenocarcinoma of the colon
835025|NCT00098787|adenocarcinoma of the rectum|adenocarcinoma of the rectum
835026|NCT00098774|primary central nervous system non-Hodgkin lymphoma|primary central nervous system non-hodgkin lymphoma
835027|NCT00098761|recurrent childhood brain stem glioma|recurrent childhood brain stem glioma
835028|NCT00098761|recurrent childhood visual pathway and hypothalamic glioma|recurrent childhood visual pathway and hypothalamic glioma
835029|NCT00098761|recurrent childhood cerebellar astrocytoma|recurrent childhood cerebellar astrocytoma
835030|NCT00098761|recurrent childhood cerebral astrocytoma|recurrent childhood cerebral astrocytoma
835031|NCT00098761|recurrent childhood ependymoma|recurrent childhood ependymoma
835032|NCT00098761|recurrent childhood medulloblastoma|recurrent childhood medulloblastoma
835033|NCT00098761|recurrent childhood supratentorial primitive neuroectodermal tumor|recurrent childhood supratentorial primitive neuroectodermal tumor
835205|NCT00098020|Proteinuria|proteinuria
835034|NCT00098761|childhood central nervous system germ cell tumor|childhood central nervous system germ cell tumor
835035|NCT00098761|childhood choroid plexus tumor|childhood choroid plexus tumor
835036|NCT00098761|childhood craniopharyngioma|childhood craniopharyngioma
835037|NCT00098761|childhood infratentorial ependymoma|childhood infratentorial ependymoma
835038|NCT00098761|childhood grade I meningioma|childhood grade i meningioma
835039|NCT00098761|childhood grade II meningioma|childhood grade ii meningioma
835318|NCT00097604|Sleep|sleep
835040|NCT00098761|childhood grade III meningioma|childhood grade iii meningioma
835041|NCT00098761|childhood high-grade cerebral astrocytoma|childhood high-grade cerebral astrocytoma
835042|NCT00098761|childhood low-grade cerebral astrocytoma|childhood low-grade cerebral astrocytoma
835043|NCT00098735|Kidney,Transplantation, rejection, immunosuppression|kidney,transplantation, rejection, immunosuppression
835044|NCT00098709|pregnancy|pregnancy
835045|NCT00098709|labor, obstetric|labor, obstetric
835046|NCT00098709|fetal monitoring|fetal monitoring
835047|NCT00098709|oximetry|oximetry
835048|NCT00098709|fetal heart rate|fetal heart rate
835049|NCT00098709|cardiotocography|cardiotocography
835050|NCT00098683|refractory anemia with excess blasts|refractory anemia with excess blasts
835051|NCT00098683|refractory anemia|refractory anemia
835052|NCT00098683|refractory anemia with ringed sideroblasts|refractory anemia with ringed sideroblasts
835053|NCT00098683|de novo myelodysplastic syndromes|de novo myelodysplastic syndromes
835054|NCT00098683|myelodysplastic/myeloproliferative neoplasm, unclassifiable|myelodysplastic/myeloproliferative neoplasm, unclassifiable
835055|NCT00098683|refractory cytopenia with multilineage dysplasia|refractory cytopenia with multilineage dysplasia
835056|NCT00098566|quality of life|quality of life
835057|NCT00098566|recurrent adult Burkitt lymphoma|recurrent adult burkitt lymphoma
835058|NCT00098566|recurrent adult diffuse large cell lymphoma|recurrent adult diffuse large cell lymphoma
835059|NCT00098566|recurrent adult diffuse mixed cell lymphoma|recurrent adult diffuse mixed cell lymphoma
835060|NCT00098566|recurrent adult diffuse small cleaved cell lymphoma|recurrent adult diffuse small cleaved cell lymphoma
835061|NCT00098566|recurrent adult immunoblastic large cell lymphoma|recurrent adult immunoblastic large cell lymphoma
835062|NCT00098566|recurrent adult lymphoblastic lymphoma|recurrent adult lymphoblastic lymphoma
835063|NCT00098566|recurrent grade 1 follicular lymphoma|recurrent grade 1 follicular lymphoma
835064|NCT00098566|recurrent grade 2 follicular lymphoma|recurrent grade 2 follicular lymphoma
835065|NCT00098566|recurrent grade 3 follicular lymphoma|recurrent grade 3 follicular lymphoma
835066|NCT00098566|recurrent small lymphocytic lymphoma|recurrent small lymphocytic lymphoma
835067|NCT00098566|recurrent mantle cell lymphoma|recurrent mantle cell lymphoma
835068|NCT00098566|recurrent marginal zone lymphoma|recurrent marginal zone lymphoma
835069|NCT00098566|Waldenstrom macroglobulinemia|waldenstrom macroglobulinemia
835070|NCT00098566|recurrent adult grade III lymphomatoid granulomatosis|recurrent adult grade iii lymphomatoid granulomatosis
835071|NCT00098566|splenic marginal zone lymphoma|splenic marginal zone lymphoma
835072|NCT00098566|extranodal marginal zone B-cell lymphoma of mucosa-associated lymphoid tissue|extranodal marginal zone b-cell lymphoma of mucosa-associated lymphoid tissue
835073|NCT00098566|nodal marginal zone B-cell lymphoma|nodal marginal zone b-cell lymphoma
835074|NCT00098553|stage IV melanoma|stage iv melanoma
835075|NCT00098553|recurrent melanoma|recurrent melanoma
835076|NCT00098514|unspecified adult solid tumor, protocol specific|unspecified adult solid tumor, protocol specific
835077|NCT00098462|recurrent non-small cell lung cancer|recurrent non-small cell lung cancer
835078|NCT00098462|stage IIIB non-small cell lung cancer|stage iiib non-small cell lung cancer
835079|NCT00098462|stage IV non-small cell lung cancer|stage iv non-small cell lung cancer
835080|NCT00098436|recurrent adult acute myeloid leukemia|recurrent adult acute myeloid leukemia
835081|NCT00098436|recurrent adult acute lymphoblastic leukemia|recurrent adult acute lymphoblastic leukemia
835082|NCT00098436|blastic phase chronic myelogenous leukemia|blastic phase chronic myelogenous leukemia
835083|NCT00098436|relapsing chronic myelogenous leukemia|relapsing chronic myelogenous leukemia
835084|NCT00098436|secondary acute myeloid leukemia|secondary acute myeloid leukemia
835085|NCT00098436|adult acute myeloid leukemia with 11q23 (MLL) abnormalities|adult acute myeloid leukemia with 11q23 (mll) abnormalities
835086|NCT00098436|adult acute myeloid leukemia with inv(16)(p13;q22)|adult acute myeloid leukemia with inv(16)(p13;q22)
835087|NCT00098436|adult acute myeloid leukemia with t(15;17)(q22;q12)|adult acute myeloid leukemia with t(15;17)(q22;q12)
835088|NCT00098436|adult acute myeloid leukemia with t(16;16)(p13;q22)|adult acute myeloid leukemia with t(16;16)(p13;q22)
835089|NCT00098436|adult acute myeloid leukemia with t(8;21)(q22;q22)|adult acute myeloid leukemia with t(8;21)(q22;q22)
835090|NCT00098384|Travelers’ diarrhea|travelers’ diarrhea
835091|NCT00098384|rifaximin|rifaximin
835092|NCT00098384|prophylaxis|prophylaxis
835093|NCT00098384|enterotoxigenic E. coli|enterotoxigenic e. coli
835094|NCT00098358|Leukotrienes|leukotrienes
835095|NCT00098358|inflammation|inflammation
835096|NCT00098345|Caprelsa (vandetanib)|caprelsa (vandetanib)
835097|NCT00098345|ZD6474|zd6474
835098|NCT00098332|recurrent cutaneous T-cell non-Hodgkin lymphoma|recurrent cutaneous t-cell non-hodgkin lymphoma
835099|NCT00098332|stage II cutaneous T-cell non-Hodgkin lymphoma|stage ii cutaneous t-cell non-hodgkin lymphoma
835100|NCT00098332|stage III cutaneous T-cell non-Hodgkin lymphoma|stage iii cutaneous t-cell non-hodgkin lymphoma
835101|NCT00098332|stage IV cutaneous T-cell non-Hodgkin lymphoma|stage iv cutaneous t-cell non-hodgkin lymphoma
835102|NCT00098332|recurrent mycosis fungoides/Sezary syndrome|recurrent mycosis fungoides/sezary syndrome
835103|NCT00098332|stage II mycosis fungoides/Sezary syndrome|stage ii mycosis fungoides/sezary syndrome
835104|NCT00098332|stage III mycosis fungoides/Sezary syndrome|stage iii mycosis fungoides/sezary syndrome
835105|NCT00098332|stage IV mycosis fungoides/Sezary syndrome|stage iv mycosis fungoides/sezary syndrome
835106|NCT00098319|Cleft palate|cleft palate
835107|NCT00098319|Cleft lip|cleft lip
835108|NCT00098319|Folic acid|folic acid
835109|NCT00098319|Global Network|global network
835110|NCT00098319|Maternal and child health|maternal and child health
835111|NCT00098319|International|international
835112|NCT00098319|Women's health|women's health
835114|NCT00098319|Brasil|brasil
835115|NCT00098319|Latin America|latin america
835116|NCT00098319|ECLAMC|eclamc
835117|NCT00098319|Congenital defects|congenital defects
835118|NCT00098319|Pregnancy|pregnancy
835119|NCT00098293|Aids|aids
835120|NCT00098293|HIV|hiv
835121|NCT00098280|H5g1|h5g1
835122|NCT00098280|PNH|pnh
835123|NCT00098280|TRIUMPH|triumph
835124|NCT00098280|Paroxysmal Nocturnal Hemoglobinuria|paroxysmal nocturnal hemoglobinuria
835125|NCT00098267|Bacteria|bacteria
835126|NCT00098267|Biofilm Formation|biofilm formation
835127|NCT00098267|Secretory Antibodies|secretory antibodies
835128|NCT00098267|Teeth|teeth
835129|NCT00098267|Health and Disease|health and disease
835130|NCT00098254|Non-Small Cell|non-small cell
835131|NCT00098254|Molecular|molecular
835132|NCT00098254|Targeted|targeted
835133|NCT00098254|Therapies|therapies
835134|NCT00098254|Cancer|cancer
835135|NCT00098254|Non-Small Cell Lung Cancer|non-small cell lung cancer
835136|NCT00098254|NSCLC|nsclc
835137|NCT00098241|pediatric|pediatric
835138|NCT00098241|renal|renal
835139|NCT00098241|transplant recipients|transplant recipients
835140|NCT00098241|de novo|de novo
835141|NCT00098241|De novo renal pediatric transplant|de novo renal pediatric transplant
835142|NCT00098228|COPD, adults, QAB149|copd, adults, qab149
835143|NCT00098215|Residency training|residency training
835144|NCT00098202|Global Network|global network
835145|NCT00098202|Micronutrients|micronutrients
835146|NCT00098202|Zinc|zinc
835147|NCT00098202|Maternal and child health|maternal and child health
835148|NCT00098202|Women's health|women's health
835149|NCT00098202|International|international
835150|NCT00098202|Guatemala|guatemala
835151|NCT00098202|Nutrition|nutrition
835152|NCT00098202|Corn|corn
835153|NCT00098202|Maize|maize
835154|NCT00098189|Safety, psoriasis, adverse event, SAE, extension|safety, psoriasis, adverse event, sae, extension
835155|NCT00098163|HIV Seronegativity|hiv seronegativity
835156|NCT00098163|HIV Preventive Vaccine|hiv preventive vaccine
835157|NCT00098150|Safety, atopic dermatitis, adverse event, SAE, extension|safety, atopic dermatitis, adverse event, sae, extension
835158|NCT00098137|atrial fibrillation|atrial fibrillation
835159|NCT00098137|angiotensin II|angiotensin ii
835160|NCT00098137|angiotensin receptor antagonist|angiotensin receptor antagonist
835161|NCT00098137|drug|drug
835162|NCT00098137|controlled clinical trial|controlled clinical trial
835163|NCT00098124|NSRI|nsri
835164|NCT00098124|milnacipran|milnacipran
835165|NCT00098124|fibromyalgia|fibromyalgia
835166|NCT00098111|Crohn's disease|crohn's disease
835167|NCT00098111|inflammatory bowel disease|inflammatory bowel disease
835168|NCT00098111|IMURAN|imuran
835169|NCT00098111|azathioprine|azathioprine
835170|NCT00098098|Botulinum|botulinum
835171|NCT00098098|Recombinant Botulinum Vaccine|recombinant botulinum vaccine
835172|NCT00098098|botulinum neurotoxins|botulinum neurotoxins
835173|NCT00098085|Lung cancer|lung cancer
835174|NCT00098085|Non-small cell lung cancer|non-small cell lung cancer
835175|NCT00098085|Pulmonary|pulmonary
835176|NCT00098085|Immunotherapy|immunotherapy
835177|NCT00098085|Vaccine|vaccine
835178|NCT00098072|Cytometry|cytometry
835179|NCT00098072|Genes|genes
835180|NCT00098072|Hypertension|hypertension
835181|NCT00098072|Lung|lung
835182|NCT00098072|Proteomics|proteomics
835183|NCT00098072|Primary Pulmonary Hypertenion|primary pulmonary hypertenion
835184|NCT00098072|PPH|pph
835185|NCT00098072|Healthy Volunteers|healthy volunteers
835186|NCT00098072|HV|hv
835187|NCT00098059|herpes simplex|herpes simplex
835188|NCT00098059|cold sores|cold sores
835189|NCT00098059|fever blisters|fever blisters
835190|NCT00098059|children|children
835191|NCT00098059|Famvir|famvir
835192|NCT00098059|famciclovir|famciclovir
835193|NCT00098046|chickenpox|chickenpox
835194|NCT00098046|herpes zoster|herpes zoster
835195|NCT00098046|children|children
835196|NCT00098046|Famvir|famvir
835197|NCT00098046|varicella zoster virus|varicella zoster virus
835198|NCT00098033|clinical|clinical
835199|NCT00098033|pharmacodynamics|pharmacodynamics
835200|NCT00098033|investigational drug clofarabine|investigational drug clofarabine
835201|NCT00098033|AML, ALL, CML-accelerated phase, CML-blastic phase|aml, all, cml-accelerated phase, cml-blastic phase
835202|NCT00098033|Chronic Myelogenous Leukemia - accelerated phase|chronic myelogenous leukemia - accelerated phase
835203|NCT00098033|Chronic Myelogenous Leukemia - blastic phase|chronic myelogenous leukemia - blastic phase
835206|NCT00098020|Fibrosis|fibrosis
835207|NCT00098020|Chronic Kidney Disease|chronic kidney disease
835208|NCT00098020|Nephrotic Syndrome|nephrotic syndrome
835209|NCT00098007|Heart transplantation|heart transplantation
835210|NCT00098007|Everolimus|everolimus
835211|NCT00098007|De novo heart transplant patients|de novo heart transplant patients
835212|NCT00097994|Menopause|menopause
835213|NCT00097994|Quality of Life|quality of life
835214|NCT00097994|Health Services|health services
835215|NCT00097994|Complementary Therapies|complementary therapies
835216|NCT00097981|Multiple myeloma|multiple myeloma
835217|NCT00097981|Newly diagnosed multiple myeloma|newly diagnosed multiple myeloma
835218|NCT00097981|Thalidomide|thalidomide
835219|NCT00097981|Dexamethasone|dexamethasone
835220|NCT00097981|DOXIL|doxil
835221|NCT00097981|Pegylated liposomal hydrochloride doxorubicin injection|pegylated liposomal hydrochloride doxorubicin injection
835222|NCT00097968|transplant, heart, adult, everolimus|transplant, heart, adult, everolimus
835223|NCT00097968|allograft rejection|allograft rejection
835224|NCT00097955|diabetes|diabetes
835225|NCT00097955|nephropathy|nephropathy
835226|NCT00097955|hypertension|hypertension
835227|NCT00097955|aliskiren|aliskiren
835228|NCT00097955|losartan|losartan
835229|NCT00097942|memantine|memantine
835230|NCT00097942|adjunctive therapy|adjunctive therapy
835231|NCT00097942|schizophrenia|schizophrenia
835232|NCT00097929|Relapsed Diffuse Large B-cell Lymphoma|relapsed diffuse large b-cell lymphoma
835233|NCT00097916|memantine HCl|memantine hcl
835234|NCT00097916|Dementia|dementia
835235|NCT00097916|Agitation|agitation
835236|NCT00097916|Alzheimer Disease|alzheimer disease
835237|NCT00097903|Carcinoma, Non-Small-Cell Lung|carcinoma, non-small-cell lung
835238|NCT00097903|Solid Tumors|solid tumors
835239|NCT00097903|Oral|oral
835240|NCT00097890|Lysosomes|lysosomes
835241|NCT00097890|Storage|storage
835242|NCT00097890|Glycolipid|glycolipid
835243|NCT00097890|Fabry Disease|fabry disease
835244|NCT00097890|Stroke|stroke
835245|NCT00097877|Type 2 Diabetes|type 2 diabetes
835246|NCT00097851|second-line|second-line
835247|NCT00097851|combination|combination
835248|NCT00097851|chemotherapy|chemotherapy
835249|NCT00097851|anti-angiogenic|anti-angiogenic
835250|NCT00097838|HIV Seronegativity|hiv seronegativity
835251|NCT00097838|HIV Preventive Vaccine|hiv preventive vaccine
835252|NCT00097825|Male Osteoporosis|male osteoporosis
835253|NCT00097812|osteoporosis, osteopenia, post-menopausal, zoledronic acid|osteoporosis, osteopenia, post-menopausal, zoledronic acid
835254|NCT00097786|Prevention|prevention
835255|NCT00097786|Diabetes type 2|diabetes type 2
835256|NCT00097786|valsartan|valsartan
835257|NCT00097786|nateglinide|nateglinide
835258|NCT00097773|Lung Diseases|lung diseases
835259|NCT00097773|Chronic Obstructive Pulmonary Disease|chronic obstructive pulmonary disease
835260|NCT00097760|Multiple Sclerosis|multiple sclerosis
835261|NCT00097760|MS|ms
835262|NCT00097747|anemia|anemia
835263|NCT00097747|chronic kidney disease|chronic kidney disease
835264|NCT00097747|CKD|ckd
835265|NCT00097747|chronic renal failure|chronic renal failure
835266|NCT00097747|CRF|crf
835267|NCT00097747|erythropoietin|erythropoietin
835268|NCT00097747|EPO|epo
835269|NCT00097747|erythropoiesis stimulating agent|erythropoiesis stimulating agent
835270|NCT00097747|ESA|esa
835271|NCT00097747|Hematide™|hematide™
835272|NCT00097747|hemoglobin|hemoglobin
835273|NCT00097747|Hb|hb
835274|NCT00097747|Hgb|hgb
835275|NCT00097747|Omontys|omontys
835276|NCT00097747|peginesatide|peginesatide
835277|NCT00097747|red blood cell|red blood cell
835278|NCT00097747|red blood cell production|red blood cell production
835279|NCT00097734|diverticulitis|diverticulitis
835280|NCT00097734|Invanz|invanz
835281|NCT00097734|Ertapenem|ertapenem
835282|NCT00097734|acute attacks|acute attacks
835283|NCT00097734|sigmoid diverticulitis|sigmoid diverticulitis
835284|NCT00097734|Acute attacks of sigmoid diverticulitis|acute attacks of sigmoid diverticulitis
835285|NCT00097721|breast neoplasm|breast neoplasm
835286|NCT00097721|breast cancer|breast cancer
835287|NCT00097721|breast tumor|breast tumor
835288|NCT00097708|Double Blind, Placebo controlled, Safety and Efficacy|double blind, placebo controlled, safety and efficacy
835289|NCT00097708|Generalized Anxiety Disorder|generalized anxiety disorder
835290|NCT00097695|Hereditary Angioedema|hereditary angioedema
835291|NCT00097695|C1 inhibitor deficiency|c1 inhibitor deficiency
835292|NCT00097695|HAE|hae
835293|NCT00097695|Icatibant|icatibant
835294|NCT00097695|Bradykinin antagonist|bradykinin antagonist
835295|NCT00097695|acute attack|acute attack
835296|NCT00097695|subcutaneous|subcutaneous
835297|NCT00097682|Financial Ties|financial ties
835298|NCT00097682|Institution|institution
835299|NCT00097682|Research Doctor|research doctor
835300|NCT00097682|Oncology|oncology
835301|NCT00097682|Attitudes|attitudes
835302|NCT00097682|Cancer|cancer
835303|NCT00097682|Survey|survey
835304|NCT00097669|VITATOPS|vitatops
835305|NCT00097669|stroke|stroke
835306|NCT00097669|prevention|prevention
835307|NCT00097669|multivitamins|multivitamins
835308|NCT00097669|homocysteine|homocysteine
835309|NCT00097643|exercise|exercise
835310|NCT00097643|health promotion|health promotion
835311|NCT00097643|independent living|independent living
835312|NCT00097643|affective aspects|affective aspects
835313|NCT00097630|mechanical ventilation|mechanical ventilation
835314|NCT00097630|delirium|delirium
835315|NCT00097630|sedation scoring|sedation scoring
835316|NCT00097630|cognitive impairment|cognitive impairment
835317|NCT00097630|ventilation weaning|ventilation weaning
835321|NCT00097604|Complementary Therapies|complementary therapies
835322|NCT00097604|Medicine, Herbal|medicine, herbal
835323|NCT00097565|Follicular Non-Hodgkin's Lymphoma|follicular non-hodgkin's lymphoma
835324|NCT00097539|Pediatric growth disorders|pediatric growth disorders
835325|NCT00097526|Growth Hormone Deficiency|growth hormone deficiency
835326|NCT00097513|Pubertal Growth Hormone Deficiency|pubertal growth hormone deficiency
835327|NCT00097500|diabetes|diabetes
835328|NCT00097500|exenatide|exenatide
835329|NCT00097500|exendin-4|exendin-4
835330|NCT00097500|Amylin|amylin
835331|NCT00097500|Lilly|lilly
835332|NCT00097487|Metastatic Breast Cancer|metastatic breast cancer
835333|NCT00097474|Cortisol|cortisol
835334|NCT00097474|Jet Lag|jet lag
835335|NCT00097474|Healthy Volunteer|healthy volunteer
835336|NCT00097474|HV|hv
835337|NCT00097461|Employee Health|employee health
835338|NCT00097461|Insurance Benefit|insurance benefit
835339|NCT00097461|Fringe Benefit|fringe benefit
835340|NCT00097461|Health Status|health status
835341|NCT00097461|Socioeconomic Factors|socioeconomic factors
835342|NCT00097448|sudden hearing loss|sudden hearing loss
835343|NCT00097448|unilateral sudden sensorineural hearing loss|unilateral sudden sensorineural hearing loss
835344|NCT00097448|sudden sensorineural hearing loss|sudden sensorineural hearing loss
835345|NCT00097448|sudden unilateral hearing loss|sudden unilateral hearing loss
835346|NCT00097422|CDAD, diarrhea|cdad, diarrhea
835347|NCT00097422|Clostridium difficile-Associated Diarrhea|clostridium difficile-associated diarrhea
835348|NCT00097409|ovarian cancer|ovarian cancer
835349|NCT00097409|platinum/taxane-refractory chemotherapy|platinum/taxane-refractory chemotherapy
835350|NCT00097409|Persistent|persistent
835351|NCT00097409|Recurrent|recurrent
835352|NCT00097396|plague|plague
835353|NCT00097396|recombinant plague vaccine|recombinant plague vaccine
835354|NCT00097396|vaccine|vaccine
835355|NCT00097396|plague vaccine|plague vaccine
835356|NCT00097396|Protection against pneumonic plague|protection against pneumonic plague
835357|NCT00097370|Mepolizumab|mepolizumab
835358|NCT00097370|Open-label|open-label
835359|NCT00097370|Anti-IL-5|anti-il-5
835360|NCT00097370|Hypereosinophilic Syndrome|hypereosinophilic syndrome
835361|NCT00097370|Hypereosinophilia|hypereosinophilia
835362|NCT00097357|Prevention of deep vein thrombosis and pulmonary embolism|prevention of deep vein thrombosis and pulmonary embolism
835363|NCT00097357|Preventive therapy|preventive therapy
835364|NCT00097344|Aromatase inhibitor|aromatase inhibitor
835365|NCT00097344|Atamestane|atamestane
835366|NCT00097344|Breast neoplasms|breast neoplasms
835367|NCT00097344|Combined hormonal therapy|combined hormonal therapy
835368|NCT00097344|Complete estrogen blockade|complete estrogen blockade
835369|NCT00097344|Ductal breast carcinoma|ductal breast carcinoma
835370|NCT00097344|Estrogen blocker|estrogen blocker
835371|NCT00097344|Fareston®|fareston®
835372|NCT00097344|Femara®|femara®
835373|NCT00097344|First line therapy|first line therapy
835374|NCT00097344|Letrozole|letrozole
835375|NCT00097344|Lobular breast carcinoma|lobular breast carcinoma
835376|NCT00097344|Locally advanced breast cancer|locally advanced breast cancer
835377|NCT00097344|Locally recurrent breast cancer|locally recurrent breast cancer
835378|NCT00097344|Maximal estrogen inhibition|maximal estrogen inhibition
835379|NCT00097344|Metastatic breast cancer|metastatic breast cancer
835380|NCT00097344|Neoplasms, Hormone-dependent|neoplasms, hormone-dependent
835381|NCT00097344|Receptor-positive|receptor-positive
835382|NCT00097344|Stage IIIA breast cancer|stage iiia breast cancer
835383|NCT00097344|Stage IIIB breast cancer|stage iiib breast cancer
835384|NCT00097344|Stage IV breast cancer|stage iv breast cancer
835385|NCT00097344|Toremifene|toremifene
835386|NCT00097331|multiple sclerosis|multiple sclerosis
835387|NCT00097331|relapsing|relapsing
835388|NCT00097331|remitting|remitting
835389|NCT00097331|Relapsing-Remitting MS (RRMS)|relapsing-remitting ms (rrms)
835390|NCT00097318|Ischemic|ischemic
835391|NCT00097318|Brain|brain
835392|NCT00097318|Inflammation|inflammation
835393|NCT00097318|Clinical Trial|clinical trial
835394|NCT00097318|Stroke|stroke
835395|NCT00097305|Mental Health|mental health
835396|NCT00097305|Psychotherapy|psychotherapy
835397|NCT00097292|"at risk for developing type 1 diabetes"|"at risk for developing type 1 diabetes"
835398|NCT00097292|T1DM|t1dm
835399|NCT00097292|T1D|t1d
835400|NCT00097292|juvenile diabetes|juvenile diabetes
835401|NCT00097292|Type 1 Diabetes TrialNet|type 1 diabetes trialnet
835402|NCT00097292|TrialNet|trialnet
835403|NCT00097266|Bipolar Mania|bipolar mania
835404|NCT00097253|Aromatherapy|aromatherapy
835405|NCT00097253|Smell|smell
835406|NCT00097240|FOLLOW|follow
835407|NCT00097240|Psoriasis|psoriasis
835408|NCT00097240|Pregnancy|pregnancy
835409|NCT00097227|NSCLC|nsclc
835410|NCT00097227|non-small|non-small
835411|NCT00097227|lung|lung
835412|NCT00097227|IIIb|iiib
835413|NCT00097227|IV|iv
835414|NCT00097227|Carboplatin|carboplatin
835415|NCT00097227|Paclitaxel|paclitaxel
835416|NCT00097227|Cetuximab|cetuximab
835417|NCT00097227|Stage IIIB Non-Small Cell Lung Cancer|stage iiib non-small cell lung cancer
835524|NCT00096928|Raptiva|raptiva
835418|NCT00097227|Stage IV Non-Small Cell Lung Cancer|stage iv non-small cell lung cancer
835419|NCT00097214|NSCLC|nsclc
835420|NCT00097214|Non-small|non-small
835421|NCT00097214|Lung|lung
835422|NCT00097214|IIIB|iiib
835423|NCT00097214|IV|iv
835424|NCT00097214|Carboplatin|carboplatin
835425|NCT00097214|Cetuximab|cetuximab
835426|NCT00097214|Stage IIIB non-small cell lung cancer|stage iiib non-small cell lung cancer
835427|NCT00097214|Stage IV non-small cell lung cancer|stage iv non-small cell lung cancer
835428|NCT00097188|Relapsing remitting multiple sclerosis|relapsing remitting multiple sclerosis
835429|NCT00097175|Major Depressive Disorder|major depressive disorder
835430|NCT00097175|Serotonin|serotonin
835431|NCT00097175|Functional MRI|functional mri
835432|NCT00097175|Genotype|genotype
835433|NCT00097175|Negative Affect|negative affect
835434|NCT00097175|MDD|mdd
835435|NCT00097175|Healthy Volunteer|healthy volunteer
835436|NCT00097175|HV|hv
835437|NCT00097162|Anisometropia|anisometropia
835438|NCT00097162|Strabismus|strabismus
835439|NCT00097162|Cortical Suppression|cortical suppression
835440|NCT00097162|Impaired Vision|impaired vision
835441|NCT00097162|Cortical Plasticity|cortical plasticity
835442|NCT00097162|Amblyopia|amblyopia
835443|NCT00097162|Adult Amblyopia|adult amblyopia
835444|NCT00097149|Congenital birth defects|congenital birth defects
835445|NCT00097149|Cleft lip|cleft lip
835446|NCT00097149|Cleft palate|cleft palate
835447|NCT00097149|Global Network|global network
835448|NCT00097149|Neurodevelopmental outcome|neurodevelopmental outcome
835449|NCT00097149|Maternal and child health|maternal and child health
835450|NCT00097149|International|international
835451|NCT00097149|Women's health|women's health
835452|NCT00097149|Brazil|brazil
835453|NCT00097149|Brasil|brasil
835454|NCT00097149|Latin America|latin america
835455|NCT00097149|ECLAMC|eclamc
835456|NCT00097149|Argentina|argentina
835457|NCT00097149|Bolivia|bolivia
835458|NCT00097149|Chile|chile
835459|NCT00097149|Colombia|colombia
835460|NCT00097149|Ecuador|ecuador
835461|NCT00097149|Venezuela|venezuela
835462|NCT00097123|Acute postpartum hemorrhage|acute postpartum hemorrhage
835463|NCT00097123|PPH|pph
835464|NCT00097123|Misoprostol|misoprostol
835465|NCT00097123|Global Network|global network
835466|NCT00097123|Uterotonics|uterotonics
835467|NCT00097123|India|india
835468|NCT00097123|Maternal and child health|maternal and child health
835469|NCT00097123|International|international
835470|NCT00097123|Women's health|women's health
835471|NCT00097110|Vitamin C|vitamin c
835472|NCT00097110|Vitamin E|vitamin e
835473|NCT00097110|Preeclampsia|preeclampsia
835474|NCT00097110|Antioxidants|antioxidants
835475|NCT00097110|Global Network|global network
835476|NCT00097110|Preterm birth|preterm birth
835477|NCT00097110|Low birth weight infants|low birth weight infants
835478|NCT00097110|Brazil|brazil
835479|NCT00097110|Brasil|brasil
835480|NCT00097110|Maternal and child health|maternal and child health
835481|NCT00097110|International|international
835482|NCT00097110|Women's health|women's health
835483|NCT00097097|Asphyxia|asphyxia
835484|NCT00097097|Neonatal mortality|neonatal mortality
835485|NCT00097097|Neonatal morbidity|neonatal morbidity
835486|NCT00097097|Hypoxic ischemic encephalopathy|hypoxic ischemic encephalopathy
835487|NCT00097097|Neurodevelopmental impairment|neurodevelopmental impairment
835488|NCT00097097|Neonatal resuscitation|neonatal resuscitation
835489|NCT00097097|Global Network|global network
835490|NCT00097097|Zambia|zambia
835491|NCT00097097|Africa|africa
835492|NCT00097097|Cerebral palsy|cerebral palsy
835493|NCT00097097|Child health|child health
835494|NCT00097097|International|international
835495|NCT00097071|Diabetes, Type 1|diabetes, type 1
835496|NCT00097058|Aging|aging
835497|NCT00097058|Menopause|menopause
835498|NCT00097058|Estrogen Replacement Therapy|estrogen replacement therapy
835499|NCT00097058|Cognitive Decline|cognitive decline
835500|NCT00097045|Hepatitis C|hepatitis c
835501|NCT00097045|HCV|hcv
835502|NCT00097045|Omega Interferon|omega interferon
835503|NCT00097045|Interferon|interferon
835504|NCT00097045|HCV genotype 1|hcv genotype 1
835505|NCT00097032|Bipolar I Disorder|bipolar i disorder
835506|NCT00097032|risperidone|risperidone
835507|NCT00097032|quetiapine|quetiapine
835508|NCT00097032|sedation|sedation
835509|NCT00097032|cognition|cognition
835510|NCT00097019|Recurrent ovarian cancer|recurrent ovarian cancer
835511|NCT00097019|Refractory ovarian cancer|refractory ovarian cancer
835512|NCT00096993|Omnitarg|omnitarg
835513|NCT00096993|Cancer|cancer
835514|NCT00096993|Platinum-Resistant|platinum-resistant
835515|NCT00096967|Metastatic breast cancer|metastatic breast cancer
835516|NCT00096967|Metastatic colorectal cancer|metastatic colorectal cancer
835517|NCT00096954|Omalizumab (Xolair)|omalizumab (xolair)
835518|NCT00096954|Atopic Asthma|atopic asthma
835519|NCT00096941|Advanced solid cancers|advanced solid cancers
835520|NCT00096941|HER2|her2
835521|NCT00096941|EGFR|egfr
835522|NCT00096928|Plaque Psoriasis|plaque psoriasis
835523|NCT00096928|RESPONSE|response
835526|NCT00096915|chronic kidney disease, CKD|chronic kidney disease, ckd
835527|NCT00096915|renal failure|renal failure
835528|NCT00096915|anemia|anemia
835529|NCT00096915|hemodialysis|hemodialysis
835530|NCT00096915|peritoneal dialysis|peritoneal dialysis
835531|NCT00096915|Aranesp®, Darbepoetin Alfa|aranesp®, darbepoetin alfa
835532|NCT00096902|Orthostatic Intolerance|orthostatic intolerance
835533|NCT00096902|Hypnosis|hypnosis
835534|NCT00096902|Cold Pressor|cold pressor
835535|NCT00096902|Isometric Exercise|isometric exercise
835536|NCT00096902|Behavior|behavior
835537|NCT00096902|Neurocardiogenic Syncope|neurocardiogenic syncope
835538|NCT00096876|Parkinsonian syndrome|parkinsonian syndrome
835539|NCT00096863|Delirium|delirium
835540|NCT00096863|Cognition Disorders|cognition disorders
835541|NCT00096863|Antipsychotics|antipsychotics
835542|NCT00096863|Mechanical Ventilation|mechanical ventilation
835543|NCT00096863|Critical Illness|critical illness
835544|NCT00096850|HIV Seronegativity|hiv seronegativity
835545|NCT00096850|Antitubercular agents|antitubercular agents
835546|NCT00096837|Myeloma|myeloma
835547|NCT00096837|Multiple Myeloma|multiple myeloma
835548|NCT00096837|Relapsed Multiple Myeloma|relapsed multiple myeloma
835549|NCT00096837|Refractory Multiple Myeloma|refractory multiple myeloma
835550|NCT00096824|Acute Infection|acute infection
835551|NCT00096824|Treatment Naive|treatment naive
835552|NCT00096798|Fatty Acids, Omega-3|fatty acids, omega-3
835553|NCT00096798|Antidepressive Agents|antidepressive agents
835554|NCT00096798|Eicosapentanoic Acid|eicosapentanoic acid
835555|NCT00096785|chronic hepatitis B infection|chronic hepatitis b infection
835556|NCT00096772|Genetic Testing|genetic testing
835557|NCT00096772|Genomics|genomics
835558|NCT00096772|Human Genetic Factors|human genetic factors
835559|NCT00096759|Arthritis|arthritis
835560|NCT00096759|Tai Chi|tai chi
835561|NCT00096759|Meditation|meditation
835562|NCT00096759|Relaxation Techniques|relaxation techniques
835563|NCT00096746|Treatment Experienced|treatment experienced
835564|NCT00096733|Living donors|living donors
835565|NCT00096733|Organ procurement|organ procurement
835566|NCT00096733|Liver transplantation|liver transplantation
835567|NCT00096733|Hepatitis C|hepatitis c
835568|NCT00096733|Hepatocellular carcinoma|hepatocellular carcinoma
835569|NCT00096733|Hepatectomy|hepatectomy
835570|NCT00096733|Liver regeneration|liver regeneration
835571|NCT00096733|Graft rejection|graft rejection
835572|NCT00096733|Quality of life|quality of life
835573|NCT00096733|Informed consent|informed consent
835574|NCT00096720|parkinson|parkinson
835575|NCT00096720|brain imaging|brain imaging
835576|NCT00096720|diagnosis|diagnosis
835577|NCT00096707|advanced solid tumors|advanced solid tumors
835578|NCT00096707|cancer|cancer
835579|NCT00096707|docetaxel|docetaxel
835580|NCT00096707|2-deoxy-D-glucose (2DG)|2-deoxy-d-glucose (2dg)
835581|NCT00096707|phase 1|phase 1
835582|NCT00096694|Intrauterine Device|intrauterine device
835583|NCT00096694|IUD|iud
835584|NCT00096694|Contraceptive|contraceptive
835585|NCT00096694|Levonorgestrel|levonorgestrel
835586|NCT00096668|Breast cancer|breast cancer
835587|NCT00096668|TOCOSOL Paclitaxel|tocosol paclitaxel
835588|NCT00096655|Ulcerative colitis|ulcerative colitis
835589|NCT00096655|Infliximab|infliximab
835590|NCT00096655|Remicade|remicade
835591|NCT00096642|cognitive behavioral therapy|cognitive behavioral therapy
835592|NCT00096642|depression|depression
835593|NCT00096642|group therapy|group therapy
835594|NCT00096642|parenting|parenting
835595|NCT00096642|children and adolescents|children and adolescents
835596|NCT00096629|recurrent renal cell cancer|recurrent renal cell cancer
835597|NCT00096629|stage I renal cell cancer|stage i renal cell cancer
835598|NCT00096629|stage II renal cell cancer|stage ii renal cell cancer
835599|NCT00096629|stage III renal cell cancer|stage iii renal cell cancer
835600|NCT00096629|stage IV renal cell cancer|stage iv renal cell cancer
835601|NCT00096603|Moderate to severe plaque psoriasis|moderate to severe plaque psoriasis
835602|NCT00096590|thromboembolism|thromboembolism
835603|NCT00096590|unspecified adult solid tumor, protocol specific|unspecified adult solid tumor, protocol specific
835604|NCT00096564|Mirror Neuron|mirror neuron
835605|NCT00096564|Urge|urge
835606|NCT00096564|Statistical Parametric Mapping|statistical parametric mapping
835607|NCT00096564|Healthy Volunteer|healthy volunteer
835608|NCT00096564|HV|hv
835609|NCT00096551|Biochemical Failure|biochemical failure
835610|NCT00096551|Immunotherapy|immunotherapy
835611|NCT00096551|TRICOM|tricom
835612|NCT00096551|Pox-virus|pox-virus
835613|NCT00096551|Fowlpox|fowlpox
835614|NCT00096551|Prostate Cancer|prostate cancer
835615|NCT00096538|classic Kaposi sarcoma|classic kaposi sarcoma
835616|NCT00096538|recurrent Kaposi sarcoma|recurrent kaposi sarcoma
835617|NCT00096525|recurrent renal cell cancer|recurrent renal cell cancer
835618|NCT00096525|stage III renal cell cancer|stage iii renal cell cancer
835619|NCT00096525|stage IV renal cell cancer|stage iv renal cell cancer
835620|NCT00096486|recurrent non-small cell lung cancer|recurrent non-small cell lung cancer
835621|NCT00096486|stage IIIB non-small cell lung cancer|stage iiib non-small cell lung cancer
835622|NCT00096486|stage IV non-small cell lung cancer|stage iv non-small cell lung cancer
835623|NCT00096473|Alzheimer's Disease|alzheimer's disease
835624|NCT00096473|dementia|dementia
835625|NCT00096473|acetylcholinesterase|acetylcholinesterase
835626|NCT00096473|donepezil|donepezil
835627|NCT00096473|Aricept|aricept
835628|NCT00096473|memory loss|memory loss
835629|NCT00096473|Severe dementia of the Alzheimer's type|severe dementia of the alzheimer's type
835630|NCT00096421|Critical illness|critical illness
835631|NCT00096421|Critical care|critical care
835632|NCT00096421|Hyperglycemia|hyperglycemia
835633|NCT00096421|Intensive care|intensive care
835634|NCT00096421|Intensive Care Units|intensive care units
835635|NCT00096421|Insulin resistance|insulin resistance
835636|NCT00096421|Intensive insulin therapy|intensive insulin therapy
835637|NCT00096421|Conventional insulin therapy|conventional insulin therapy
835638|NCT00096408|Endometrial|endometrial
835639|NCT00096408|Endometrium|endometrium
835640|NCT00096408|Uterus|uterus
835641|NCT00096408|Cancer|cancer
835642|NCT00096408|Carcinoma|carcinoma
835643|NCT00096408|Adenocarcinoma|adenocarcinoma
835644|NCT00096408|Stage 1|stage 1
835645|NCT00096408|Hysterectomy|hysterectomy
835646|NCT00096408|Laparoscopy|laparoscopy
835647|NCT00096408|Abdominal|abdominal
835648|NCT00096408|Total|total
835649|NCT00096408|Surgery|surgery
835650|NCT00096408|Quality of Life|quality of life
835651|NCT00096408|Disease-free survival|disease-free survival
835652|NCT00096382|stage IV melanoma|stage iv melanoma
835653|NCT00096382|recurrent melanoma|recurrent melanoma
835654|NCT00096369|breast cancer|breast cancer
835655|NCT00096369|lobular breast carcinoma in situ|lobular breast carcinoma in situ
835656|NCT00096369|breast cancer in situ|breast cancer in situ
835657|NCT00096356|fatigue|fatigue
835658|NCT00096356|stage I breast cancer|stage i breast cancer
835659|NCT00096356|stage II breast cancer|stage ii breast cancer
835660|NCT00096356|stage IIIA breast cancer|stage iiia breast cancer
835661|NCT00096356|stage IIIB breast cancer|stage iiib breast cancer
835662|NCT00096356|stage IIIC breast cancer|stage iiic breast cancer
835663|NCT00096356|stage IV breast cancer|stage iv breast cancer
835664|NCT00096343|invasive ductal breast carcinoma|invasive ductal breast carcinoma
835665|NCT00096343|invasive lobular breast carcinoma|invasive lobular breast carcinoma
835666|NCT00096343|stage II breast cancer|stage ii breast cancer
835667|NCT00096343|stage IIIA breast cancer|stage iiia breast cancer
835668|NCT00096343|stage IIIB breast cancer|stage iiib breast cancer
835669|NCT00096343|inflammatory breast cancer|inflammatory breast cancer
835670|NCT00096330|colon cancer|colon cancer
835671|NCT00096330|rectal cancer|rectal cancer
835672|NCT00096317|unspecified adult solid tumor, protocol specific|unspecified adult solid tumor, protocol specific
835673|NCT00096304|adenocarcinoma of the prostate|adenocarcinoma of the prostate
835674|NCT00096304|recurrent prostate cancer|recurrent prostate cancer
835675|NCT00096304|stage IV prostate cancer|stage iv prostate cancer
835676|NCT00096291|stage II breast cancer|stage ii breast cancer
835677|NCT00096291|stage IIIA breast cancer|stage iiia breast cancer
835678|NCT00096291|stage IIIB breast cancer|stage iiib breast cancer
835679|NCT00096291|stage IIIC breast cancer|stage iiic breast cancer
835680|NCT00096239|recurrent ovarian epithelial cancer|recurrent ovarian epithelial cancer
835681|NCT00096239|primary peritoneal cavity cancer|primary peritoneal cavity cancer
835682|NCT00096239|fallopian tube cancer|fallopian tube cancer
835683|NCT00096226|stage IIIA non-small cell lung cancer|stage iiia non-small cell lung cancer
835684|NCT00096226|stage IIIB non-small cell lung cancer|stage iiib non-small cell lung cancer
835685|NCT00096213|chondrosarcoma|chondrosarcoma
835686|NCT00096187|low risk metastatic gestational trophoblastic tumor|low risk metastatic gestational trophoblastic tumor
835687|NCT00096187|recurrent gestational trophoblastic tumor|recurrent gestational trophoblastic tumor
835688|NCT00096187|nonmetastatic gestational trophoblastic tumor|nonmetastatic gestational trophoblastic tumor
835689|NCT00096174|stage IV squamous cell carcinoma of the hypopharynx|stage iv squamous cell carcinoma of the hypopharynx
836115|NCT00094809|Chemotherapy|chemotherapy
835690|NCT00096174|stage IV squamous cell carcinoma of the larynx|stage iv squamous cell carcinoma of the larynx
835691|NCT00096174|stage IV squamous cell carcinoma of the lip and oral cavity|stage iv squamous cell carcinoma of the lip and oral cavity
835692|NCT00096174|stage IV squamous cell carcinoma of the oropharynx|stage iv squamous cell carcinoma of the oropharynx
835693|NCT00096135|recurrent childhood acute lymphoblastic leukemia|recurrent childhood acute lymphoblastic leukemia
835694|NCT00096135|B-cell childhood acute lymphoblastic leukemia|b-cell childhood acute lymphoblastic leukemia
835695|NCT00096135|T-cell childhood acute lymphoblastic leukemia|t-cell childhood acute lymphoblastic leukemia
835759|NCT00096096|splenic marginal zone lymphoma|splenic marginal zone lymphoma
835696|NCT00096135|TdT positive childhood acute lymphoblastic leukemia|tdt positive childhood acute lymphoblastic leukemia
835697|NCT00096096|graft versus host disease|graft versus host disease
835698|NCT00096096|accelerated phase chronic myelogenous leukemia|accelerated phase chronic myelogenous leukemia
835699|NCT00096096|relapsing chronic myelogenous leukemia|relapsing chronic myelogenous leukemia
835700|NCT00096096|recurrent adult Hodgkin lymphoma|recurrent adult hodgkin lymphoma
835701|NCT00096096|refractory multiple myeloma|refractory multiple myeloma
835702|NCT00096096|recurrent adult Burkitt lymphoma|recurrent adult burkitt lymphoma
835839|NCT00096057|stage IIIB breast cancer|stage iiib breast cancer
835703|NCT00096096|chronic idiopathic myelofibrosis|chronic idiopathic myelofibrosis
835704|NCT00096096|recurrent adult diffuse large cell lymphoma|recurrent adult diffuse large cell lymphoma
835705|NCT00096096|recurrent adult diffuse mixed cell lymphoma|recurrent adult diffuse mixed cell lymphoma
835706|NCT00096096|recurrent adult diffuse small cleaved cell lymphoma|recurrent adult diffuse small cleaved cell lymphoma
835707|NCT00096096|recurrent adult immunoblastic large cell lymphoma|recurrent adult immunoblastic large cell lymphoma
835708|NCT00096096|recurrent mantle cell lymphoma|recurrent mantle cell lymphoma
835709|NCT00096096|recurrent grade 1 follicular lymphoma|recurrent grade 1 follicular lymphoma
835710|NCT00096096|recurrent grade 2 follicular lymphoma|recurrent grade 2 follicular lymphoma
835711|NCT00096096|recurrent grade 3 follicular lymphoma|recurrent grade 3 follicular lymphoma
835712|NCT00096096|recurrent adult lymphoblastic lymphoma|recurrent adult lymphoblastic lymphoma
835713|NCT00096096|secondary acute myeloid leukemia|secondary acute myeloid leukemia
835714|NCT00096096|secondary myelodysplastic syndromes|secondary myelodysplastic syndromes
835715|NCT00096096|adult acute lymphoblastic leukemia in remission|adult acute lymphoblastic leukemia in remission
835716|NCT00096096|de novo myelodysplastic syndromes|de novo myelodysplastic syndromes
835717|NCT00096096|previously treated myelodysplastic syndromes|previously treated myelodysplastic syndromes
835718|NCT00096096|chronic myelomonocytic leukemia|chronic myelomonocytic leukemia
835719|NCT00096096|refractory anemia with excess blasts in transformation|refractory anemia with excess blasts in transformation
835720|NCT00096096|refractory anemia with excess blasts|refractory anemia with excess blasts
835721|NCT00096096|refractory anemia with ringed sideroblasts|refractory anemia with ringed sideroblasts
835722|NCT00096096|refractory hairy cell leukemia|refractory hairy cell leukemia
835723|NCT00096096|juvenile myelomonocytic leukemia|juvenile myelomonocytic leukemia
835724|NCT00096096|chronic eosinophilic leukemia|chronic eosinophilic leukemia
835725|NCT00096096|chronic neutrophilic leukemia|chronic neutrophilic leukemia
835726|NCT00096096|chronic phase chronic myelogenous leukemia|chronic phase chronic myelogenous leukemia
835727|NCT00096096|recurrent adult acute lymphoblastic leukemia|recurrent adult acute lymphoblastic leukemia
835728|NCT00096096|recurrent adult acute myeloid leukemia|recurrent adult acute myeloid leukemia
835729|NCT00096096|recurrent childhood acute lymphoblastic leukemia|recurrent childhood acute lymphoblastic leukemia
835730|NCT00096096|recurrent childhood acute myeloid leukemia|recurrent childhood acute myeloid leukemia
835731|NCT00096096|recurrent childhood large cell lymphoma|recurrent childhood large cell lymphoma
835732|NCT00096096|recurrent childhood lymphoblastic lymphoma|recurrent childhood lymphoblastic lymphoma
835733|NCT00096096|recurrent childhood small noncleaved cell lymphoma|recurrent childhood small noncleaved cell lymphoma
835734|NCT00096096|recurrent cutaneous T-cell non-Hodgkin lymphoma|recurrent cutaneous t-cell non-hodgkin lymphoma
835735|NCT00096096|recurrent marginal zone lymphoma|recurrent marginal zone lymphoma
835736|NCT00096096|recurrent small lymphocytic lymphoma|recurrent small lymphocytic lymphoma
835737|NCT00096096|recurrent/refractory childhood Hodgkin lymphoma|recurrent/refractory childhood hodgkin lymphoma
835738|NCT00096096|recurrent mycosis fungoides/Sezary syndrome|recurrent mycosis fungoides/sezary syndrome
835739|NCT00096096|refractory chronic lymphocytic leukemia|refractory chronic lymphocytic leukemia
835740|NCT00096096|refractory cytopenia with multilineage dysplasia|refractory cytopenia with multilineage dysplasia
835741|NCT00096096|stage III adult Hodgkin lymphoma|stage iii adult hodgkin lymphoma
835742|NCT00096096|stage IV adult Hodgkin lymphoma|stage iv adult hodgkin lymphoma
835743|NCT00096096|adult acute myeloid leukemia in remission|adult acute myeloid leukemia in remission
835744|NCT00096096|childhood acute myeloid leukemia in remission|childhood acute myeloid leukemia in remission
835745|NCT00096096|adult acute myeloid leukemia with 11q23 (MLL) abnormalities|adult acute myeloid leukemia with 11q23 (mll) abnormalities
835746|NCT00096096|adult acute myeloid leukemia with inv(16)(p13;q22)|adult acute myeloid leukemia with inv(16)(p13;q22)
835747|NCT00096096|adult acute myeloid leukemia with t(15;17)(q22;q12)|adult acute myeloid leukemia with t(15;17)(q22;q12)
835748|NCT00096096|adult acute myeloid leukemia with t(16;16)(p13;q22)|adult acute myeloid leukemia with t(16;16)(p13;q22)
835749|NCT00096096|adult acute myeloid leukemia with t(8;21)(q22;q22)|adult acute myeloid leukemia with t(8;21)(q22;q22)
835750|NCT00096096|childhood acute lymphoblastic leukemia in remission|childhood acute lymphoblastic leukemia in remission
835751|NCT00096096|childhood chronic myelogenous leukemia|childhood chronic myelogenous leukemia
835752|NCT00096096|blastic phase chronic myelogenous leukemia|blastic phase chronic myelogenous leukemia
835753|NCT00096096|stage I multiple myeloma|stage i multiple myeloma
835754|NCT00096096|stage II multiple myeloma|stage ii multiple myeloma
835755|NCT00096096|stage III multiple myeloma|stage iii multiple myeloma
835756|NCT00096096|myelodysplastic/myeloproliferative disease, unclassifiable|myelodysplastic/myeloproliferative disease, unclassifiable
835757|NCT00096096|nodal marginal zone B-cell lymphoma|nodal marginal zone b-cell lymphoma
835758|NCT00096096|extranodal marginal zone B-cell lymphoma of mucosa-associated lymphoid tissue|extranodal marginal zone b-cell lymphoma of mucosa-associated lymphoid tissue
835760|NCT00096096|atypical chronic myeloid leukemia|atypical chronic myeloid leukemia
835761|NCT00096096|stage III childhood large cell lymphoma|stage iii childhood large cell lymphoma
835762|NCT00096096|stage IV childhood large cell lymphoma|stage iv childhood large cell lymphoma
835763|NCT00096096|stage III childhood lymphoblastic lymphoma|stage iii childhood lymphoblastic lymphoma
835764|NCT00096096|stage IV childhood lymphoblastic lymphoma|stage iv childhood lymphoblastic lymphoma
835765|NCT00096096|stage III childhood small noncleaved cell lymphoma|stage iii childhood small noncleaved cell lymphoma
836693|NCT00091936|TB|tb
835766|NCT00096096|stage IV childhood small noncleaved cell lymphoma|stage iv childhood small noncleaved cell lymphoma
835767|NCT00096096|stage III chronic lymphocytic leukemia|stage iii chronic lymphocytic leukemia
835768|NCT00096096|stage IV chronic lymphocytic leukemia|stage iv chronic lymphocytic leukemia
835769|NCT00096096|stage III adult Burkitt lymphoma|stage iii adult burkitt lymphoma
835770|NCT00096096|stage III adult diffuse large cell lymphoma|stage iii adult diffuse large cell lymphoma
835771|NCT00096096|stage III adult diffuse mixed cell lymphoma|stage iii adult diffuse mixed cell lymphoma
835772|NCT00096096|stage III adult diffuse small cleaved cell lymphoma|stage iii adult diffuse small cleaved cell lymphoma
835773|NCT00096096|stage III adult immunoblastic large cell lymphoma|stage iii adult immunoblastic large cell lymphoma
835774|NCT00096096|stage III adult lymphoblastic lymphoma|stage iii adult lymphoblastic lymphoma
835775|NCT00096096|stage III grade 1 follicular lymphoma|stage iii grade 1 follicular lymphoma
835776|NCT00096096|stage III grade 2 follicular lymphoma|stage iii grade 2 follicular lymphoma
835777|NCT00096096|stage III grade 3 follicular lymphoma|stage iii grade 3 follicular lymphoma
835778|NCT00096096|stage IV adult Burkitt lymphoma|stage iv adult burkitt lymphoma
835779|NCT00096096|stage IV adult diffuse large cell lymphoma|stage iv adult diffuse large cell lymphoma
835780|NCT00096096|stage IV adult diffuse mixed cell lymphoma|stage iv adult diffuse mixed cell lymphoma
835781|NCT00096096|stage IV adult diffuse small cleaved cell lymphoma|stage iv adult diffuse small cleaved cell lymphoma
835782|NCT00096096|stage IV adult immunoblastic large cell lymphoma|stage iv adult immunoblastic large cell lymphoma
835783|NCT00096096|stage IV adult lymphoblastic lymphoma|stage iv adult lymphoblastic lymphoma
835784|NCT00096096|stage IV grade 1 follicular lymphoma|stage iv grade 1 follicular lymphoma
835785|NCT00096096|stage IV grade 2 follicular lymphoma|stage iv grade 2 follicular lymphoma
835786|NCT00096096|stage IV grade 3 follicular lymphoma|stage iv grade 3 follicular lymphoma
835787|NCT00096096|stage III marginal zone lymphoma|stage iii marginal zone lymphoma
835788|NCT00096096|stage IV marginal zone lymphoma|stage iv marginal zone lymphoma
835789|NCT00096096|stage III small lymphocytic lymphoma|stage iii small lymphocytic lymphoma
835790|NCT00096096|stage IV small lymphocytic lymphoma|stage iv small lymphocytic lymphoma
835791|NCT00096096|childhood myelodysplastic syndromes|childhood myelodysplastic syndromes
835792|NCT00096083|advanced adult primary liver cancer|advanced adult primary liver cancer
835793|NCT00096083|localized unresectable adult primary liver cancer|localized unresectable adult primary liver cancer
835794|NCT00096083|recurrent adult primary liver cancer|recurrent adult primary liver cancer
835795|NCT00096083|liver metastases|liver metastases
835796|NCT00096083|adenocarcinoma of the colon|adenocarcinoma of the colon
835797|NCT00096083|adenocarcinoma of the esophagus|adenocarcinoma of the esophagus
835798|NCT00096083|adenocarcinoma of the extrahepatic bile duct|adenocarcinoma of the extrahepatic bile duct
835799|NCT00096083|adenocarcinoma of the gallbladder|adenocarcinoma of the gallbladder
835800|NCT00096083|adenocarcinoma of the pancreas|adenocarcinoma of the pancreas
835801|NCT00096083|adenocarcinoma of the rectum|adenocarcinoma of the rectum
835802|NCT00096083|adenocarcinoma of the stomach|adenocarcinoma of the stomach
835803|NCT00096083|carcinoma of the appendix|carcinoma of the appendix
835804|NCT00096083|recurrent gallbladder cancer|recurrent gallbladder cancer
835805|NCT00096083|unresectable gallbladder cancer|unresectable gallbladder cancer
835806|NCT00096083|recurrent colon cancer|recurrent colon cancer
835807|NCT00096083|stage IV colon cancer|stage iv colon cancer
835808|NCT00096083|recurrent esophageal cancer|recurrent esophageal cancer
835809|NCT00096083|stage IV esophageal cancer|stage iv esophageal cancer
835810|NCT00096083|recurrent extrahepatic bile duct cancer|recurrent extrahepatic bile duct cancer
835811|NCT00096083|unresectable extrahepatic bile duct cancer|unresectable extrahepatic bile duct cancer
835812|NCT00096083|recurrent gastric cancer|recurrent gastric cancer
835813|NCT00096083|stage IV gastric cancer|stage iv gastric cancer
835814|NCT00096083|recurrent rectal cancer|recurrent rectal cancer
835815|NCT00096083|stage IV rectal cancer|stage iv rectal cancer
835816|NCT00096083|small intestine adenocarcinoma|small intestine adenocarcinoma
835817|NCT00096083|recurrent small intestine cancer|recurrent small intestine cancer
835818|NCT00096083|recurrent islet cell carcinoma|recurrent islet cell carcinoma
835819|NCT00096083|recurrent pheochromocytoma|recurrent pheochromocytoma
835820|NCT00096083|metastatic pheochromocytoma|metastatic pheochromocytoma
835821|NCT00096083|pulmonary carcinoid tumor|pulmonary carcinoid tumor
835822|NCT00096083|thyroid gland medullary carcinoma|thyroid gland medullary carcinoma
835823|NCT00096083|metastatic gastrointestinal carcinoid tumor|metastatic gastrointestinal carcinoid tumor
835824|NCT00096083|recurrent gastrointestinal carcinoid tumor|recurrent gastrointestinal carcinoid tumor
835825|NCT00096083|recurrent pancreatic cancer|recurrent pancreatic cancer
835826|NCT00096083|insulinoma|insulinoma
835827|NCT00096083|WDHA syndrome|wdha syndrome
835828|NCT00096083|glucagonoma|glucagonoma
835829|NCT00096083|pancreatic polypeptide tumor|pancreatic polypeptide tumor
835830|NCT00096083|somatostatinoma|somatostatinoma
835831|NCT00096083|stage IV pancreatic cancer|stage iv pancreatic cancer
835832|NCT00096083|intraocular melanoma|intraocular melanoma
835833|NCT00096083|conjunctival melanoma|conjunctival melanoma
835834|NCT00096083|iris melanoma|iris melanoma
835835|NCT00096083|recurrent melanoma|recurrent melanoma
835836|NCT00096083|stage IV melanoma|stage iv melanoma
835837|NCT00096057|recurrent breast cancer|recurrent breast cancer
835838|NCT00096057|stage IIIA breast cancer|stage iiia breast cancer
835840|NCT00096057|stage IIIC breast cancer|stage iiic breast cancer
835841|NCT00096057|stage IV breast cancer|stage iv breast cancer
835842|NCT00096044|refractory chronic lymphocytic leukemia|refractory chronic lymphocytic leukemia
835843|NCT00096031|adenocarcinoma of the esophagus|adenocarcinoma of the esophagus
835844|NCT00096031|recurrent esophageal cancer|recurrent esophageal cancer
835845|NCT00096031|stage IV esophageal cancer|stage iv esophageal cancer
835846|NCT00096018|stage I chronic lymphocytic leukemia|stage i chronic lymphocytic leukemia
835847|NCT00096018|stage II chronic lymphocytic leukemia|stage ii chronic lymphocytic leukemia
835848|NCT00096018|stage III chronic lymphocytic leukemia|stage iii chronic lymphocytic leukemia
835849|NCT00096018|stage IV chronic lymphocytic leukemia|stage iv chronic lymphocytic leukemia
835850|NCT00096018|B-cell chronic lymphocytic leukemia|b-cell chronic lymphocytic leukemia
835851|NCT00095992|adult primary hepatocellular carcinoma|adult primary hepatocellular carcinoma
835852|NCT00095992|advanced adult primary liver cancer|advanced adult primary liver cancer
835853|NCT00095992|localized unresectable adult primary liver cancer|localized unresectable adult primary liver cancer
835854|NCT00095992|recurrent adult primary liver cancer|recurrent adult primary liver cancer
835855|NCT00095953|recurrent melanoma|recurrent melanoma
835856|NCT00095953|stage IV melanoma|stage iv melanoma
835857|NCT00095927|radiation toxicity|radiation toxicity
835858|NCT00095927|chemotherapeutic agent toxicity|chemotherapeutic agent toxicity
835859|NCT00095927|mucositis|mucositis
835860|NCT00095927|xerostomia|xerostomia
835861|NCT00095927|stage II squamous cell carcinoma of the lip and oral cavity|stage ii squamous cell carcinoma of the lip and oral cavity
835862|NCT00095927|stage III squamous cell carcinoma of the lip and oral cavity|stage iii squamous cell carcinoma of the lip and oral cavity
835863|NCT00095927|stage IV squamous cell carcinoma of the lip and oral cavity|stage iv squamous cell carcinoma of the lip and oral cavity
835864|NCT00095927|stage II squamous cell carcinoma of the oropharynx|stage ii squamous cell carcinoma of the oropharynx
835865|NCT00095927|stage III squamous cell carcinoma of the oropharynx|stage iii squamous cell carcinoma of the oropharynx
835866|NCT00095927|stage IV squamous cell carcinoma of the oropharynx|stage iv squamous cell carcinoma of the oropharynx
835867|NCT00095927|stage II squamous cell carcinoma of the hypopharynx|stage ii squamous cell carcinoma of the hypopharynx
835868|NCT00095927|stage III squamous cell carcinoma of the hypopharynx|stage iii squamous cell carcinoma of the hypopharynx
835869|NCT00095927|stage IV squamous cell carcinoma of the hypopharynx|stage iv squamous cell carcinoma of the hypopharynx
835870|NCT00095927|stage II squamous cell carcinoma of the larynx|stage ii squamous cell carcinoma of the larynx
835871|NCT00095927|stage III squamous cell carcinoma of the larynx|stage iii squamous cell carcinoma of the larynx
835872|NCT00095927|stage IV squamous cell carcinoma of the larynx|stage iv squamous cell carcinoma of the larynx
835873|NCT00095927|stage II squamous cell carcinoma of the paranasal sinus and nasal cavity|stage ii squamous cell carcinoma of the paranasal sinus and nasal cavity
835874|NCT00095927|stage III squamous cell carcinoma of the paranasal sinus and nasal cavity|stage iii squamous cell carcinoma of the paranasal sinus and nasal cavity
835875|NCT00095927|stage IV squamous cell carcinoma of the paranasal sinus and nasal cavity|stage iv squamous cell carcinoma of the paranasal sinus and nasal cavity
835876|NCT00095927|untreated metastatic squamous neck cancer with occult primary|untreated metastatic squamous neck cancer with occult primary
835877|NCT00095927|metastatic squamous neck cancer with occult primary squamous cell carcinoma|metastatic squamous neck cancer with occult primary squamous cell carcinoma
835878|NCT00095914|unspecified adult solid tumor, protocol specific|unspecified adult solid tumor, protocol specific
836116|NCT00094796|Insulin Resistance|insulin resistance
835879|NCT00095901|recurrent squamous cell carcinoma of the nasopharynx|recurrent squamous cell carcinoma of the nasopharynx
835880|NCT00095901|stage IV squamous cell carcinoma of the nasopharynx|stage iv squamous cell carcinoma of the nasopharynx
835881|NCT00095901|stage III squamous cell carcinoma of the nasopharynx|stage iii squamous cell carcinoma of the nasopharynx
835882|NCT00095901|stage II squamous cell carcinoma of the nasopharynx|stage ii squamous cell carcinoma of the nasopharynx
835883|NCT00095875|stage III squamous cell carcinoma of the hypopharynx|stage iii squamous cell carcinoma of the hypopharynx
835884|NCT00095875|stage III squamous cell carcinoma of the larynx|stage iii squamous cell carcinoma of the larynx
835885|NCT00095875|stage III squamous cell carcinoma of the lip and oral cavity|stage iii squamous cell carcinoma of the lip and oral cavity
835886|NCT00095875|stage III squamous cell carcinoma of the oropharynx|stage iii squamous cell carcinoma of the oropharynx
835887|NCT00095875|stage IV squamous cell carcinoma of the hypopharynx|stage iv squamous cell carcinoma of the hypopharynx
835888|NCT00095875|stage IV squamous cell carcinoma of the larynx|stage iv squamous cell carcinoma of the larynx
835889|NCT00095875|stage IV squamous cell carcinoma of the lip and oral cavity|stage iv squamous cell carcinoma of the lip and oral cavity
835890|NCT00095875|stage IV squamous cell carcinoma of the oropharynx|stage iv squamous cell carcinoma of the oropharynx
835891|NCT00095862|recurrent breast cancer|recurrent breast cancer
835892|NCT00095862|stage IV breast cancer|stage iv breast cancer
835893|NCT00095862|male breast cancer|male breast cancer
835894|NCT00095862|unspecified adult solid tumor, protocol specific|unspecified adult solid tumor, protocol specific
835895|NCT00095836|recurrent thyroid cancer|recurrent thyroid cancer
835896|NCT00095836|stage III follicular thyroid cancer|stage iii follicular thyroid cancer
835897|NCT00095836|stage III papillary thyroid cancer|stage iii papillary thyroid cancer
835898|NCT00095836|stage IV follicular thyroid cancer|stage iv follicular thyroid cancer
835899|NCT00095836|stage IV papillary thyroid cancer|stage iv papillary thyroid cancer
835900|NCT00095836|anaplastic thyroid cancer|anaplastic thyroid cancer
835901|NCT00095836|thyroid gland medullary carcinoma|thyroid gland medullary carcinoma
835902|NCT00095810|Psychosis, Parkinson's Disease|psychosis, parkinson's disease
835903|NCT00095771|untreated childhood brain stem glioma|untreated childhood brain stem glioma
835904|NCT00095771|childhood high-grade cerebral astrocytoma|childhood high-grade cerebral astrocytoma
835905|NCT00095732|Pancreatic Insufficiency|pancreatic insufficiency
835906|NCT00095732|Cystic Fibrosis|cystic fibrosis
835907|NCT00095732|Enzymes|enzymes
835908|NCT00095719|Acute agitation in patients diagnosed with Dementia|acute agitation in patients diagnosed with dementia
835909|NCT00095706|Metastatic breast cancer|metastatic breast cancer
835910|NCT00095706|HER2|her2
835911|NCT00095706|Trastuzumab|trastuzumab
835912|NCT00095706|Herceptin|herceptin
835913|NCT00095706|VEGF|vegf
835914|NCT00095706|Bevacizumab|bevacizumab
835915|NCT00095706|Avastin|avastin
835916|NCT00095680|Multiple Myeloma|multiple myeloma
835917|NCT00095680|SCIO-469|scio-469
835918|NCT00095680|Bortezomib|bortezomib
835919|NCT00095680|p38 MAP kinase|p38 map kinase
835920|NCT00095654|diabetes prevention|diabetes prevention
835921|NCT00095654|ramipril|ramipril
835922|NCT00095654|rosiglitazone|rosiglitazone
835923|NCT00095654|impaired glucose tolerance|impaired glucose tolerance
835924|NCT00095654|isolated impaired fasting glucose|isolated impaired fasting glucose
835925|NCT00095654|Isolated Impaired Glucose Tolerance|isolated impaired glucose tolerance
835926|NCT00095589|bladder cancer|bladder cancer
835927|NCT00095589|stage 0 bladder cancer|stage 0 bladder cancer
835928|NCT00095589|stage I bladder cancer|stage i bladder cancer
835929|NCT00095589|transitional cell carcinoma of the bladder|transitional cell carcinoma of the bladder
835930|NCT00095550|Moderate Hypertension|moderate hypertension
835931|NCT00095537|Solid tumors|solid tumors
835932|NCT00095537|cancer|cancer
835933|NCT00095537|HER-2-expressing tumors|her-2-expressing tumors
835934|NCT00095524|Patient weight change|patient weight change
835935|NCT00095524|changes in metabolic status|changes in metabolic status
835936|NCT00095511|Bipolar Mania|bipolar mania
835937|NCT00095498|arthritis|arthritis
835938|NCT00095498|joint pain|joint pain
835939|NCT00095498|Methotrexate|methotrexate
835940|NCT00095485|Activity Level|activity level
835941|NCT00095485|Musculoskeletal|musculoskeletal
835942|NCT00095485|Healthy Volunteer|healthy volunteer
835943|NCT00095485|Physical Activity|physical activity
835944|NCT00095472|Blood Flow|blood flow
835945|NCT00095472|Nitric Oxide|nitric oxide
835946|NCT00095472|Vascular Function|vascular function
835947|NCT00095472|Vasodilation|vasodilation
835948|NCT00095472|Vaso-Occlusive Pain Crisis|vaso-occlusive pain crisis
835949|NCT00095472|Sickle Cell Disease|sickle cell disease
835950|NCT00095459|Raf-Kinase Inhibitor|raf-kinase inhibitor
835951|NCT00095459|Combinatorial Therapy|combinatorial therapy
835952|NCT00095459|Pathway Profiling|pathway profiling
835953|NCT00095459|VEGFR|vegfr
835954|NCT00095459|Bevacizumab|bevacizumab
835955|NCT00095459|Sorafenib|sorafenib
835956|NCT00095459|Advanced Solid Tumors|advanced solid tumors
835957|NCT00095459|Angiogenesis|angiogenesis
835958|NCT00095459|Targeted Therapy|targeted therapy
835959|NCT00095459|VEGF|vegf
835960|NCT00095459|Cancer|cancer
835961|NCT00095459|Solid Tumor|solid tumor
835962|NCT00095459|Metastatic Uresectable Solid Tumors|metastatic uresectable solid tumors
835963|NCT00095446|Diabetes Mellitus|diabetes mellitus
835964|NCT00095446|Diabetes|diabetes
835965|NCT00095433|AMD|amd
835966|NCT00095433|Neovascular age-related macular degeneration|neovascular age-related macular degeneration
835967|NCT00095420|Interpersonal Relationships|interpersonal relationships
835968|NCT00095420|Child|child
835969|NCT00095407|Social Cognition|social cognition
835970|NCT00095407|Semantic Memory|semantic memory
835971|NCT00095407|Prefrontal Cortex|prefrontal cortex
835972|NCT00095407|Temporal Cortex|temporal cortex
835973|NCT00095407|Conceptual Self|conceptual self
835974|NCT00095394|Severe Hypertension|severe hypertension
835975|NCT00095381|Leukemia, Lymphocytic, T-Cell|leukemia, lymphocytic, t-cell
835976|NCT00095381|Entry Term Lymphocytic Leukemia, T-Cell|entry term lymphocytic leukemia, t-cell
835977|NCT00095381|T-Cell Leukemia|t-cell leukemia
835978|NCT00095381|T-Lymphocytic Leukemia|t-lymphocytic leukemia
835979|NCT00095381|Leukemia, Lymphocytic, T Cell|leukemia, lymphocytic, t cell
835980|NCT00095381|T Lymphocytic Leukemia|t lymphocytic leukemia
835981|NCT00095381|BCX-1777|bcx-1777
835982|NCT00095381|forodesine hydrochloride|forodesine hydrochloride
835983|NCT00095381|BioCryst|biocryst
835984|NCT00095368|Pharyngitis|pharyngitis
835985|NCT00095368|Tonsillitis|tonsillitis
835986|NCT00095355|BDNF|bdnf
835987|NCT00095355|Lithium|lithium
835988|NCT00095355|Divalproex|divalproex
835989|NCT00095355|Huntington Disease|huntington disease
835990|NCT00095355|HD|hd
835991|NCT00095329|relapsing-remitting MS|relapsing-remitting ms
835992|NCT00095329|nonresponsive to standard of care MS|nonresponsive to standard of care ms
835993|NCT00095329|sirolimus|sirolimus
835994|NCT00095316|candidiasis, caspofungin, fungal infection, prophylaxis|candidiasis, caspofungin, fungal infection, prophylaxis
835995|NCT00095303|BSFT|bsft
835996|NCT00095303|Family Therapy|family therapy
835997|NCT00095303|Adolescents|adolescents
835998|NCT00095303|Substance Abuse|substance abuse
835999|NCT00095290|Albuminuria|albuminuria
836000|NCT00095290|Hypertension|hypertension
836001|NCT00095290|Elevated Cardiovascular Risk|elevated cardiovascular risk
836002|NCT00095290|Albuminuria in Hypertensive Subjects at Elevated Cardiovascular Risk|albuminuria in hypertensive subjects at elevated cardiovascular risk
836003|NCT00095277|non-myeloid malignancies|non-myeloid malignancies
836004|NCT00095277|myeloma|myeloma
836005|NCT00095277|Anemia of Cancer|anemia of cancer
836006|NCT00095264|Myelodysplastic Syndrome|myelodysplastic syndrome
836007|NCT00095251|Delirium|delirium
836008|NCT00095251|Hypnotics and Sedatives|hypnotics and sedatives
836009|NCT00095251|Adrenergic alpha-Agonists|adrenergic alpha-agonists
836010|NCT00095251|efficacy of sedation|efficacy of sedation
836011|NCT00095251|cognitive impairment|cognitive impairment
836012|NCT00095225|Recurrent or refractory non-small cell lung cancer|recurrent or refractory non-small cell lung cancer
836013|NCT00095212|HIV|hiv
836014|NCT00095212|women|women
836015|NCT00095212|androgen|androgen
836016|NCT00095212|Treatment Experienced|treatment experienced
836017|NCT00095199|Recurrent or Progressive Non-Small Cell Lung Cancer|recurrent or progressive non-small cell lung cancer
836018|NCT00095199|Second-line therapy|second-line therapy
836019|NCT00095199|Docetaxel|docetaxel
836020|NCT00095199|Pemetrexed|pemetrexed
836021|NCT00095199|Cetuximab|cetuximab
836022|NCT00095199|Failed platinum-based therapy|failed platinum-based therapy
836023|NCT00095199|NSCLC|nsclc
836024|NCT00095186|Cancer|cancer
836025|NCT00095186|Metastatic|metastatic
836026|NCT00095186|Kidney|kidney
836027|NCT00095186|Refractive|refractive
836028|NCT00095186|Lactoferrin|lactoferrin
836029|NCT00095186|Oral|oral
836030|NCT00095173|Juvenile Idiopathic Arthritis|juvenile idiopathic arthritis
836031|NCT00095160|Solid Organ Tumors|solid organ tumors
836032|NCT00095121|Hepatitis B|hepatitis b
836033|NCT00095121|Children|children
836034|NCT00095121|Pediatric|pediatric
836035|NCT00095121|Adefovir Dipivoxil|adefovir dipivoxil
836036|NCT00095108|Metastatic Melanoma|metastatic melanoma
836037|NCT00095108|Metastatic Renal Cell Carcinoma|metastatic renal cell carcinoma
836038|NCT00095095|Spine|spine
836039|NCT00095095|Lumbar spine|lumbar spine
836040|NCT00095095|Spinal fusion|spinal fusion
836041|NCT00095095|Low back pain|low back pain
836042|NCT00095095|Fusion cage|fusion cage
836043|NCT00095095|Posterior lumbar interbody fusion|posterior lumbar interbody fusion
836044|NCT00095095|Bioresorbable|bioresorbable
836045|NCT00095095|Peek|peek
836046|NCT00095082|Diabetes Mellitus, Type I|diabetes mellitus, type i
836047|NCT00095056|Type 2 Diabetes Mellitus and Chronic Renal Insufficiency|type 2 diabetes mellitus and chronic renal insufficiency
836048|NCT00095030|Diabetes|diabetes
836049|NCT00095017|Arcoxia|arcoxia
836050|NCT00094991|Type 2 diabetes|type 2 diabetes
836051|NCT00094978|Apoptosis|apoptosis
836052|NCT00094978|Toxicity|toxicity
836053|NCT00094978|Pharmacokinetic|pharmacokinetic
836054|NCT00094978|Gene Induction|gene induction
836055|NCT00094978|Maximally Tolerated Dose|maximally tolerated dose
836056|NCT00094978|Small Cell Lung Cancer|small cell lung cancer
836057|NCT00094978|SCLC|sclc
836058|NCT00094978|Non-Small Cell Lung Cancer|non-small cell lung cancer
836059|NCT00094978|NSCLC|nsclc
836060|NCT00094978|Esophageal Cancer|esophageal cancer
836061|NCT00094978|Pleural Mesothelioma|pleural mesothelioma
836062|NCT00094965|Advanced Gastrointestinal tumors and normal to severely abnormal renal function|advanced gastrointestinal tumors and normal to severely abnormal renal function
836063|NCT00094952|Mild Cognitive Impairment|mild cognitive impairment
836064|NCT00094952|Alzheimer's disease|alzheimer's disease
836065|NCT00094952|magnetic resonance imaging|magnetic resonance imaging
836066|NCT00094952|cerebrospinal fluid (CSF) biomarkers|cerebrospinal fluid (csf) biomarkers
836067|NCT00094939|mild cognitive impairment|mild cognitive impairment
836068|NCT00094939|Alzheimer disease|alzheimer disease
836069|NCT00094939|magnetic resonance imaging|magnetic resonance imaging
836070|NCT00094939|CSF tau protein|csf tau protein
836071|NCT00094939|Hippocampus|hippocampus
836072|NCT00094926|Risperidal CONSTA|risperidal consta
836073|NCT00094926|Bipolar disorder|bipolar disorder
836074|NCT00094926|mood episodes|mood episodes
836075|NCT00094926|Safety and efficacy, adjuvant therapy|safety and efficacy, adjuvant therapy
836076|NCT00094913|Aging|aging
836077|NCT00094913|Mild Cognitive Impairment|mild cognitive impairment
836078|NCT00094913|Alzheimer disease, preclinical|alzheimer disease, preclinical
836079|NCT00094913|Hippocampal formation|hippocampal formation
836080|NCT00094913|Glucose metabolism|glucose metabolism
836584|NCT00093028|bortezomib|bortezomib
836081|NCT00094900|Muckle Wells Syndrome|muckle wells syndrome
836082|NCT00094900|NOMID|nomid
836083|NCT00094900|Adult Stills Disease|adult stills disease
836084|NCT00094900|Familial Mediterranean|familial mediterranean
836085|NCT00094900|Treatment Trial/Fever|treatment trial/fever
836086|NCT00094900|Autoinflammatory Disease|autoinflammatory disease
836087|NCT00094887|Blood Flow|blood flow
836088|NCT00094887|Nitric Oxide|nitric oxide
836089|NCT00094887|Pain Crisis|pain crisis
836090|NCT00094887|Sickle Cell Anemia|sickle cell anemia
836694|NCT00091910|Anemia|anemia
836091|NCT00094887|Vaso-Occlusive Crisis|vaso-occlusive crisis
836092|NCT00094887|Sickle Cell Disease|sickle cell disease
836093|NCT00094887|SCD|scd
836094|NCT00094874|pelvic pain, bladder pain, urgency, frequency, nocturia|pelvic pain, bladder pain, urgency, frequency, nocturia
836095|NCT00094861|dysphagia|dysphagia
836096|NCT00094861|palifermin, KGF|palifermin, kgf
836097|NCT00094861|chemoradiotherapy|chemoradiotherapy
836098|NCT00094861|NSCLC, non-small cell lung cancer|nsclc, non-small cell lung cancer
836099|NCT00094861|lung cancer|lung cancer
836100|NCT00094861|supportive care|supportive care
836101|NCT00094861|clinical trial|clinical trial
836102|NCT00094861|consolidation chemotherapy|consolidation chemotherapy
836103|NCT00094861|radiotherapy|radiotherapy
836104|NCT00094835|Lung cancer, Non-small cell lung cancer, NSCLC|lung cancer, non-small cell lung cancer, nsclc
836105|NCT00094835|Clinical Trial, Panitumumab, AMG 706|clinical trial, panitumumab, amg 706
836106|NCT00094835|Anti-angiogenesis|anti-angiogenesis
836107|NCT00094835|Immunex, Abgenix, Amgen|immunex, abgenix, amgen
836108|NCT00094835|Stage IIIB, Stage IV, Unresectable|stage iiib, stage iv, unresectable
836109|NCT00094822|Metastatic Cancer|metastatic cancer
836110|NCT00094822|Neulasta®|neulasta®
836111|NCT00094822|pegfilgrastim|pegfilgrastim
836112|NCT00094809|Neulasta®|neulasta®
836113|NCT00094809|pegfilgrastim|pegfilgrastim
836114|NCT00094809|Advanced|advanced
836117|NCT00094796|Brachial Artery Reactivity|brachial artery reactivity
836118|NCT00094796|Endothelial Progenitor Cells|endothelial progenitor cells
836119|NCT00094796|Metabolic Stress Test|metabolic stress test
836120|NCT00094796|Mitochondrial Function|mitochondrial function
836121|NCT00094796|Type 2 Diabetes|type 2 diabetes
836122|NCT00094796|T2DM|t2dm
836123|NCT00094796|Pre-Diabetes|pre-diabetes
836124|NCT00094783|Magnetic Resonance Imaging|magnetic resonance imaging
836125|NCT00094783|Interventional MRI|interventional mri
836126|NCT00094783|Arterial Stenosis|arterial stenosis
836127|NCT00094783|Revascularization|revascularization
836128|NCT00094783|Lllac Artery Stenosis|lllac artery stenosis
836129|NCT00094783|Peripheral Arterial Disease|peripheral arterial disease
836130|NCT00094783|Cardiovascular Disease|cardiovascular disease
836131|NCT00094731|Aging|aging
836132|NCT00094731|Memory|memory
836133|NCT00094731|Mental Recall|mental recall
836134|NCT00094731|Mental Processes|mental processes
836135|NCT00094718|Chimeric Virus Vaccine|chimeric virus vaccine
836136|NCT00094718|West Nile Virus|west nile virus
836137|NCT00094718|Dengue Virus|dengue virus
836138|NCT00094705|Dengue Vaccine|dengue vaccine
836139|NCT00094705|Dengue Virus|dengue virus
836140|NCT00094705|Dengue Hemorrhagic Fever|dengue hemorrhagic fever
836141|NCT00094705|Dengue Shock Syndrome|dengue shock syndrome
836142|NCT00094692|Amblyopia|amblyopia
836143|NCT00094692|Patching|patching
836144|NCT00094692|Spectacles|spectacles
836145|NCT00094653|melanoma|melanoma
836146|NCT00094653|metastatic melanoma|metastatic melanoma
836147|NCT00094653|skin cancer|skin cancer
836148|NCT00094601|Positron Emission Tomograhy|positron emission tomograhy
836149|NCT00094601|[18F] FDOPA|[18f] fdopa
836150|NCT00094601|[11C] NNC-112|[11c] nnc-112
836151|NCT00094601|Dopamine|dopamine
836152|NCT00094601|Molecular Imaging|molecular imaging
836153|NCT00094601|Dopamine D1 Receptor|dopamine d1 receptor
836154|NCT00094601|PET|pet
836155|NCT00094601|Parkinson's Disease|parkinson's disease
836156|NCT00094601|Cognition|cognition
836157|NCT00094601|Parkinson Disease|parkinson disease
836158|NCT00094601|PD|pd
836159|NCT00094601|Healthy Volunteer|healthy volunteer
836160|NCT00094601|HV|hv
836161|NCT00094575|Abdominal|abdominal
836162|NCT00094575|Aortic Aneurysm|aortic aneurysm
836163|NCT00094575|cost of AAA repair|cost of aaa repair
836164|NCT00094575|Endovascular Repair|endovascular repair
836165|NCT00094575|Grafts|grafts
836166|NCT00094575|Long-term survival|long-term survival
836167|NCT00094575|secondary outcomes|secondary outcomes
836168|NCT00094562|Cancer|cancer
836169|NCT00094562|Cancer Cachexia|cancer cachexia
836170|NCT00094562|Weight Loss|weight loss
836171|NCT00094562|Chronic Obstructive Pulmonary Disease|chronic obstructive pulmonary disease
836172|NCT00094562|Chronic Heart Failure|chronic heart failure
836173|NCT00094562|Rheumatoid Arthritis|rheumatoid arthritis
836174|NCT00094536|Menorrhagia|menorrhagia
836175|NCT00094536|Excessive Uterine Bleeding|excessive uterine bleeding
836176|NCT00094536|Cryoablation|cryoablation
836177|NCT00094536|Menstrual disorder|menstrual disorder
836178|NCT00094536|Endometrial ablation|endometrial ablation
836179|NCT00094536|Abnormal uterine bleeding|abnormal uterine bleeding
836180|NCT00094536|Dysfunctional uterine bleeding|dysfunctional uterine bleeding
836181|NCT00094523|fosamprenavir LEXIVA non-inferiority safety tolerability|fosamprenavir lexiva non-inferiority safety tolerability
836182|NCT00094510|Prefrontal GABA|prefrontal gaba
836183|NCT00094510|Stress|stress
836184|NCT00094510|Emotion Recognition|emotion recognition
836185|NCT00094510|Differential Reward|differential reward
836186|NCT00094510|Gabapentin|gabapentin
836187|NCT00094510|GABA|gaba
836188|NCT00094510|Prefrontal Cortex|prefrontal cortex
836189|NCT00094510|Emotional Processing|emotional processing
836190|NCT00094510|Healthy Humans|healthy humans
836191|NCT00094510|Healthy Volunteer|healthy volunteer
836192|NCT00094510|HV|hv
836193|NCT00094484|Sensipar®|sensipar®
836194|NCT00094484|Mimpara®|mimpara®
836195|NCT00094484|Cinacalcet|cinacalcet
836196|NCT00094484|Calcimimetic|calcimimetic
836197|NCT00094484|Chronic Kidney Disease|chronic kidney disease
836198|NCT00094458|Crohn's Disease|crohn's disease
836199|NCT00094458|infliximab|infliximab
836200|NCT00094458|azathioprine|azathioprine
836201|NCT00094458|Remicade|remicade
836202|NCT00094458|SONIC|sonic
836203|NCT00094445|Pancreatic Cancer|pancreatic cancer
836204|NCT00094445|Adenocarcinoma of the pancreas|adenocarcinoma of the pancreas
836205|NCT00094445|Alternative therapy|alternative therapy
836206|NCT00094445|Pancreas|pancreas
836207|NCT00094445|Pancreatic Neoplasm|pancreatic neoplasm
836208|NCT00094445|Cancer of the pancreas|cancer of the pancreas
836209|NCT00094432|depressed|depressed
836210|NCT00094419|Complementary Therapies|complementary therapies
836211|NCT00094406|Lung Permeability|lung permeability
836212|NCT00094406|Endotoxin Tolerance|endotoxin tolerance
836213|NCT00094406|Bronchoscopy|bronchoscopy
836214|NCT00094406|Carbon Monoxide Inhalation|carbon monoxide inhalation
836215|NCT00094393|Ageing|ageing
836216|NCT00094393|Atherosclerosis|atherosclerosis
836217|NCT00094393|Lamin A|lamin a
836218|NCT00094393|Lipodystrophy|lipodystrophy
836219|NCT00094393|Growth Impairment|growth impairment
836220|NCT00094393|Premature Aging|premature aging
836221|NCT00094393|Hutchinson-Gilford Progeria Syndrome|hutchinson-gilford progeria syndrome
836222|NCT00094393|HGPS|hgps
836223|NCT00094380|SLE|sle
836224|NCT00094380|Lupus|lupus
836225|NCT00094380|Systemic Lupus Erythematosus|systemic lupus erythematosus
836226|NCT00094380|Lupus Nephritis|lupus nephritis
836227|NCT00094367|1592U89|1592u89
836228|NCT00094367|GR109714|gr109714
836229|NCT00094367|abacavir|abacavir
836230|NCT00094367|lamivudine|lamivudine
836231|NCT00094367|fixed-dose combination|fixed-dose combination
836232|NCT00094367|once-daily|once-daily
836233|NCT00094367|twice-daily|twice-daily
836234|NCT00094367|HIV infection|hiv infection
836235|NCT00094367|naive|naive
836236|NCT00094354|HIV infected former Plasma Donors|hiv infected former plasma donors
836237|NCT00094354|Needs assessment|needs assessment
836238|NCT00094354|HIV-related stigma and discrimination|hiv-related stigma and discrimination
836239|NCT00094354|In-depth interview|in-depth interview
836240|NCT00094354|Focus Groups|focus groups
836241|NCT00094341|Arthritis|arthritis
836242|NCT00094341|Rheumatology|rheumatology
836243|NCT00094328|Testotoxicosis|testotoxicosis
836244|NCT00094328|Familial Male-limited Precocious Puberty (FMPP)|familial male-limited precocious puberty (fmpp)
836245|NCT00094302|Heart Failure|heart failure
836246|NCT00094302|Diastolic Heart Failure|diastolic heart failure
836247|NCT00094302|Preserved Ejection Fraction|preserved ejection fraction
836248|NCT00094172|Early Multiple Sclerosis|early multiple sclerosis
836250|NCT00094172|Clinically Isolated Syndrome|clinically isolated syndrome
836251|NCT00094146|Primary Insulin Hypersecretion|primary insulin hypersecretion
836252|NCT00094146|PIH|pih
836253|NCT00094146|Obesity|obesity
836254|NCT00094133|cancer survivor|cancer survivor
836255|NCT00094133|stage IA breast cancer|stage ia breast cancer
836256|NCT00094133|stage IB breast cancer|stage ib breast cancer
836257|NCT00094133|stage II breast cancer|stage ii breast cancer
836258|NCT00094133|stage IIIA breast cancer|stage iiia breast cancer
836259|NCT00094133|stage IIIB breast cancer|stage iiib breast cancer
836260|NCT00094133|stage IIIC breast cancer|stage iiic breast cancer
836261|NCT00094133|stage IV breast cancer|stage iv breast cancer
836262|NCT00094133|breast cancer in situ|breast cancer in situ
836263|NCT00094133|inflammatory breast cancer|inflammatory breast cancer
836264|NCT00094133|hot flashes|hot flashes
836265|NCT00094120|Age-Related Macular Degeneration - Wet Type|age-related macular degeneration - wet type
836266|NCT00094107|melanoma|melanoma
836267|NCT00094107|antiangiogenesis|antiangiogenesis
836268|NCT00094081|squamous cell carcinoma|squamous cell carcinoma
836269|NCT00094081|oropharynx|oropharynx
836270|NCT00094081|oral cavity|oral cavity
836271|NCT00094081|larynx|larynx
836272|NCT00094081|hypopharynx|hypopharynx
836273|NCT00091468|Age-Related Memory Loss|age-related memory loss
836274|NCT00091468|Nicotine|nicotine
836275|NCT00091468|Mild Cognitive Impairment (MCI)|mild cognitive impairment (mci)
836276|NCT00094068|Gray Matter|gray matter
836277|NCT00094068|White Matter|white matter
836278|NCT00094068|Cerebral Blood Flow|cerebral blood flow
836279|NCT00094068|Cerebral Blood Volume|cerebral blood volume
836280|NCT00094068|Lesion|lesion
836281|NCT00094068|MRI|mri
836282|NCT00094068|Multiple Sclerosis|multiple sclerosis
836283|NCT00094068|Perfusion|perfusion
836284|NCT00094068|Imaging|imaging
836285|NCT00094068|Sildenafil|sildenafil
836286|NCT00094068|MS|ms
836287|NCT00094068|Healthy Volunteer|healthy volunteer
836288|NCT00094068|HV|hv
836289|NCT00094042|Socioeconomic Factors|socioeconomic factors
836290|NCT00094042|Dietary Supplementation|dietary supplementation
836291|NCT00094003|Liver metastases|liver metastases
836292|NCT00094003|Colorectal cancer|colorectal cancer
836293|NCT00094003|Gastric cancer|gastric cancer
836294|NCT00094003|Esophagus cancer|esophagus cancer
836295|NCT00094003|Breast cancer|breast cancer
836296|NCT00094003|Lung cancer|lung cancer
836297|NCT00094003|Skin cancer|skin cancer
836298|NCT00094003|Renal Cancer|renal cancer
836299|NCT00094003|Liver metastasis|liver metastasis
836300|NCT00093990|Myeloid leukemia acute disease|myeloid leukemia acute disease
836301|NCT00093990|Tipifarnib|tipifarnib
836302|NCT00093990|Bone marrow aspirate|bone marrow aspirate
836303|NCT00093977|Chronic Kidney Disease|chronic kidney disease
836304|NCT00093977|Dialysis|dialysis
836305|NCT00093977|Anemia|anemia
836306|NCT00093977|Nephrology|nephrology
836307|NCT00093964|Brain cancer|brain cancer
836308|NCT00093964|Brain tumor|brain tumor
836309|NCT00093951|Alzheimer disease|alzheimer disease
836310|NCT00093951|memory|memory
836311|NCT00093951|cognition|cognition
836312|NCT00093951|GABA(B)receptor antagonist|gaba(b)receptor antagonist
836313|NCT00093938|Vaccinium macrocarpon|vaccinium macrocarpon
836314|NCT00093938|Asymptomatic Bacteriuria|asymptomatic bacteriuria
836315|NCT00093925|Postoperative hypertension|postoperative hypertension
836316|NCT00093912|Perioperative Hypertension|perioperative hypertension
836317|NCT00093899|Mixed Hyperlipidemia|mixed hyperlipidemia
836318|NCT00093886|Preoperative hypertension|preoperative hypertension
836319|NCT00093873|Cancer|cancer
836320|NCT00093873|antiangiogenesis|antiangiogenesis
836321|NCT00093873|Solid Tumors|solid tumors
836322|NCT00093847|Selective Serotonin Reuptake Inhibitors|selective serotonin reuptake inhibitors
836323|NCT00093847|S-adenosyl Methionine|s-adenosyl methionine
836324|NCT00093847|SSRI|ssri
836325|NCT00093847|SAMe|same
836326|NCT00093834|stage IV breast cancer|stage iv breast cancer
836327|NCT00093834|recurrent breast cancer|recurrent breast cancer
836328|NCT00093808|recurrent breast cancer|recurrent breast cancer
836329|NCT00093808|stage IV breast cancer|stage iv breast cancer
836330|NCT00093808|male breast cancer|male breast cancer
836331|NCT00093795|stage II breast cancer|stage ii breast cancer
836332|NCT00093795|stage IIIA breast cancer|stage iiia breast cancer
836333|NCT00093795|stage IIIC breast cancer|stage iiic breast cancer
836334|NCT00093769|recurrent grade 1 follicular lymphoma|recurrent grade 1 follicular lymphoma
836335|NCT00093769|recurrent grade 2 follicular lymphoma|recurrent grade 2 follicular lymphoma
836336|NCT00093769|recurrent grade 3 follicular lymphoma|recurrent grade 3 follicular lymphoma
836337|NCT00093769|extranodal marginal zone B-cell lymphoma of mucosa-associated lymphoid tissue|extranodal marginal zone b-cell lymphoma of mucosa-associated lymphoid tissue
836338|NCT00093769|nodal marginal zone B-cell lymphoma|nodal marginal zone b-cell lymphoma
836339|NCT00093769|recurrent marginal zone lymphoma|recurrent marginal zone lymphoma
836340|NCT00093769|splenic marginal zone lymphoma|splenic marginal zone lymphoma
836341|NCT00093730|unspecified adult solid tumor, protocol specific|unspecified adult solid tumor, protocol specific
836342|NCT00093704|recurrent adult Hodgkin lymphoma|recurrent adult hodgkin lymphoma
836343|NCT00093704|recurrent adult Burkitt lymphoma|recurrent adult burkitt lymphoma
836344|NCT00093704|post-transplant lymphoproliferative disorder|post-transplant lymphoproliferative disorder
836345|NCT00093704|recurrent adult grade III lymphomatoid granulomatosis|recurrent adult grade iii lymphomatoid granulomatosis
836346|NCT00093704|angioimmunoblastic T-cell lymphoma|angioimmunoblastic t-cell lymphoma
836347|NCT00093704|adult grade III lymphomatoid granulomatosis|adult grade iii lymphomatoid granulomatosis
836348|NCT00093678|pain|pain
836349|NCT00093678|cachexia|cachexia
836350|NCT00093678|unspecified adult solid tumor, protocol specific|unspecified adult solid tumor, protocol specific
836351|NCT00093678|recurrent uterine sarcoma|recurrent uterine sarcoma
836352|NCT00093678|stage III uterine sarcoma|stage iii uterine sarcoma
836353|NCT00093678|stage IV uterine sarcoma|stage iv uterine sarcoma
836354|NCT00093678|ovarian sarcoma|ovarian sarcoma
836355|NCT00093678|recurrent adult soft tissue sarcoma|recurrent adult soft tissue sarcoma
836356|NCT00093678|stage III adult soft tissue sarcoma|stage iii adult soft tissue sarcoma
836357|NCT00093678|stage IV adult soft tissue sarcoma|stage iv adult soft tissue sarcoma
836358|NCT00093678|recurrent melanoma|recurrent melanoma
836359|NCT00093678|stage III melanoma|stage iii melanoma
836360|NCT00093678|stage IV melanoma|stage iv melanoma
836361|NCT00093678|chondrosarcoma|chondrosarcoma
836362|NCT00093678|metastatic osteosarcoma|metastatic osteosarcoma
836363|NCT00093678|recurrent osteosarcoma|recurrent osteosarcoma
836364|NCT00093678|classic Kaposi sarcoma|classic kaposi sarcoma
836365|NCT00093678|AIDS-related Kaposi sarcoma|aids-related kaposi sarcoma
836366|NCT00093678|recurrent Kaposi sarcoma|recurrent kaposi sarcoma
836367|NCT00093678|stage III adult Burkitt lymphoma|stage iii adult burkitt lymphoma
836368|NCT00093678|stage III adult diffuse large cell lymphoma|stage iii adult diffuse large cell lymphoma
836369|NCT00093678|stage III adult diffuse mixed cell lymphoma|stage iii adult diffuse mixed cell lymphoma
836370|NCT00093678|stage III adult diffuse small cleaved cell lymphoma|stage iii adult diffuse small cleaved cell lymphoma
836371|NCT00093678|stage III adult immunoblastic large cell lymphoma|stage iii adult immunoblastic large cell lymphoma
836372|NCT00093678|stage III adult lymphoblastic lymphoma|stage iii adult lymphoblastic lymphoma
836373|NCT00093678|stage III grade 1 follicular lymphoma|stage iii grade 1 follicular lymphoma
836374|NCT00093678|stage III grade 2 follicular lymphoma|stage iii grade 2 follicular lymphoma
836375|NCT00093678|stage III grade 3 follicular lymphoma|stage iii grade 3 follicular lymphoma
836376|NCT00093678|stage III mantle cell lymphoma|stage iii mantle cell lymphoma
836377|NCT00093678|stage III marginal zone lymphoma|stage iii marginal zone lymphoma
836378|NCT00093678|stage III small lymphocytic lymphoma|stage iii small lymphocytic lymphoma
836379|NCT00093678|stage IV adult Burkitt lymphoma|stage iv adult burkitt lymphoma
836380|NCT00093678|stage IV adult diffuse large cell lymphoma|stage iv adult diffuse large cell lymphoma
836381|NCT00093678|stage IV adult diffuse mixed cell lymphoma|stage iv adult diffuse mixed cell lymphoma
836382|NCT00093678|stage IV adult diffuse small cleaved cell lymphoma|stage iv adult diffuse small cleaved cell lymphoma
836383|NCT00093678|stage IV adult immunoblastic large cell lymphoma|stage iv adult immunoblastic large cell lymphoma
836384|NCT00093678|stage IV adult lymphoblastic lymphoma|stage iv adult lymphoblastic lymphoma
836385|NCT00093678|stage IV grade 1 follicular lymphoma|stage iv grade 1 follicular lymphoma
836386|NCT00093678|stage IV grade 2 follicular lymphoma|stage iv grade 2 follicular lymphoma
836387|NCT00093678|stage IV grade 3 follicular lymphoma|stage iv grade 3 follicular lymphoma
836388|NCT00093678|stage IV mantle cell lymphoma|stage iv mantle cell lymphoma
836389|NCT00093678|stage IV marginal zone lymphoma|stage iv marginal zone lymphoma
836390|NCT00093678|stage IV small lymphocytic lymphoma|stage iv small lymphocytic lymphoma
836391|NCT00093678|intraocular lymphoma|intraocular lymphoma
836392|NCT00093678|recurrent adult Burkitt lymphoma|recurrent adult burkitt lymphoma
836393|NCT00093678|recurrent adult diffuse large cell lymphoma|recurrent adult diffuse large cell lymphoma
836394|NCT00093678|recurrent adult diffuse mixed cell lymphoma|recurrent adult diffuse mixed cell lymphoma
836395|NCT00093678|recurrent adult diffuse small cleaved cell lymphoma|recurrent adult diffuse small cleaved cell lymphoma
836396|NCT00093678|recurrent adult immunoblastic large cell lymphoma|recurrent adult immunoblastic large cell lymphoma
836397|NCT00093678|recurrent adult lymphoblastic lymphoma|recurrent adult lymphoblastic lymphoma
836398|NCT00093678|recurrent grade 1 follicular lymphoma|recurrent grade 1 follicular lymphoma
836399|NCT00093678|recurrent grade 2 follicular lymphoma|recurrent grade 2 follicular lymphoma
836400|NCT00093678|recurrent grade 3 follicular lymphoma|recurrent grade 3 follicular lymphoma
836401|NCT00093678|recurrent mantle cell lymphoma|recurrent mantle cell lymphoma
836402|NCT00093678|recurrent marginal zone lymphoma|recurrent marginal zone lymphoma
836403|NCT00093678|recurrent small lymphocytic lymphoma|recurrent small lymphocytic lymphoma
836404|NCT00093678|primary central nervous system lymphoma|primary central nervous system lymphoma
836405|NCT00093678|recurrent adult Hodgkin lymphoma|recurrent adult hodgkin lymphoma
836406|NCT00093678|stage III adult Hodgkin lymphoma|stage iii adult hodgkin lymphoma
836407|NCT00093678|stage IV adult Hodgkin lymphoma|stage iv adult hodgkin lymphoma
836408|NCT00093678|recurrent cutaneous T-cell non-Hodgkin lymphoma|recurrent cutaneous t-cell non-hodgkin lymphoma
836409|NCT00093678|stage III cutaneous T-cell non-Hodgkin lymphoma|stage iii cutaneous t-cell non-hodgkin lymphoma
836410|NCT00093678|stage IV cutaneous T-cell non-Hodgkin lymphoma|stage iv cutaneous t-cell non-hodgkin lymphoma
836411|NCT00093678|anaplastic large cell lymphoma|anaplastic large cell lymphoma
836412|NCT00093678|angioimmunoblastic T-cell lymphoma|angioimmunoblastic t-cell lymphoma
836413|NCT00093678|Waldenstrom macroglobulinemia|waldenstrom macroglobulinemia
836414|NCT00093678|extranodal marginal zone B-cell lymphoma of mucosa-associated lymphoid tissue|extranodal marginal zone b-cell lymphoma of mucosa-associated lymphoid tissue
836415|NCT00093678|nodal marginal zone B-cell lymphoma|nodal marginal zone b-cell lymphoma
836416|NCT00093678|splenic marginal zone lymphoma|splenic marginal zone lymphoma
836417|NCT00093678|adult grade III lymphomatoid granulomatosis|adult grade iii lymphomatoid granulomatosis
836418|NCT00093678|recurrent adult grade III lymphomatoid granulomatosis|recurrent adult grade iii lymphomatoid granulomatosis
836419|NCT00093678|recurrent mycosis fungoides/Sezary syndrome|recurrent mycosis fungoides/sezary syndrome
836420|NCT00093678|stage III mycosis fungoides/Sezary syndrome|stage iii mycosis fungoides/sezary syndrome
836421|NCT00093678|stage IV mycosis fungoides/Sezary syndrome|stage iv mycosis fungoides/sezary syndrome
836422|NCT00093678|recurrent adult T-cell leukemia/lymphoma|recurrent adult t-cell leukemia/lymphoma
836423|NCT00093678|stage III adult T-cell leukemia/lymphoma|stage iii adult t-cell leukemia/lymphoma
836424|NCT00093678|stage IV adult T-cell leukemia/lymphoma|stage iv adult t-cell leukemia/lymphoma
836425|NCT00093678|AIDS-related peripheral/systemic lymphoma|aids-related peripheral/systemic lymphoma
836426|NCT00093678|AIDS-related primary CNS lymphoma|aids-related primary cns lymphoma
836427|NCT00093678|immunosuppressive treatment related Kaposi sarcoma|immunosuppressive treatment related kaposi sarcoma
836428|NCT00093665|stage II lymphoepithelioma of the nasopharynx|stage ii lymphoepithelioma of the nasopharynx
836429|NCT00093665|stage III lymphoepithelioma of the nasopharynx|stage iii lymphoepithelioma of the nasopharynx
836430|NCT00093665|stage IV lymphoepithelioma of the nasopharynx|stage iv lymphoepithelioma of the nasopharynx
836431|NCT00093665|stage II squamous cell carcinoma of the nasopharynx|stage ii squamous cell carcinoma of the nasopharynx
836497|NCT00093379|stage IIIB anal cancer|stage iiib anal cancer
836432|NCT00093665|stage III squamous cell carcinoma of the nasopharynx|stage iii squamous cell carcinoma of the nasopharynx
836433|NCT00093665|stage IV squamous cell carcinoma of the nasopharynx|stage iv squamous cell carcinoma of the nasopharynx
836434|NCT00093652|adenocarcinoma of the esophagus|adenocarcinoma of the esophagus
836435|NCT00093652|recurrent esophageal cancer|recurrent esophageal cancer
836436|NCT00093652|stage II esophageal cancer|stage ii esophageal cancer
836437|NCT00093652|stage III esophageal cancer|stage iii esophageal cancer
836438|NCT00093652|stage IV esophageal cancer|stage iv esophageal cancer
836439|NCT00093652|squamous cell carcinoma of the esophagus|squamous cell carcinoma of the esophagus
836440|NCT00093639|chronic phase chronic myelogenous leukemia|chronic phase chronic myelogenous leukemia
836441|NCT00093639|chronic myelogenous leukemia, BCR-ABL1 positive|chronic myelogenous leukemia, bcr-abl1 positive
836442|NCT00093600|adult acute myeloid leukemia with 11q23 (MLL) abnormalities|adult acute myeloid leukemia with 11q23 (mll) abnormalities
836443|NCT00093600|adult acute myeloid leukemia with inv(16)(p13;q22)|adult acute myeloid leukemia with inv(16)(p13;q22)
836444|NCT00093600|adult acute myeloid leukemia with t(15;17)(q22;q12)|adult acute myeloid leukemia with t(15;17)(q22;q12)
836445|NCT00093600|adult acute myeloid leukemia with t(16;16)(p13;q22)|adult acute myeloid leukemia with t(16;16)(p13;q22)
836446|NCT00093600|adult acute myeloid leukemia with t(8;21)(q22;q22)|adult acute myeloid leukemia with t(8;21)(q22;q22)
836447|NCT00093600|untreated adult acute myeloid leukemia|untreated adult acute myeloid leukemia
836448|NCT00093587|graft versus host disease|graft versus host disease
836449|NCT00093587|adult acute myeloid leukemia with 11q23 (MLL) abnormalities|adult acute myeloid leukemia with 11q23 (mll) abnormalities
836450|NCT00093587|adult acute myeloid leukemia with inv(16)(p13;q22)|adult acute myeloid leukemia with inv(16)(p13;q22)
836451|NCT00093587|adult acute myeloid leukemia with t(15;17)(q22;q12)|adult acute myeloid leukemia with t(15;17)(q22;q12)
836452|NCT00093587|adult acute myeloid leukemia with t(16;16)(p13;q22)|adult acute myeloid leukemia with t(16;16)(p13;q22)
836453|NCT00093587|adult acute myeloid leukemia with t(8;21)(q22;q22)|adult acute myeloid leukemia with t(8;21)(q22;q22)
836454|NCT00093587|secondary acute myeloid leukemia|secondary acute myeloid leukemia
836455|NCT00093587|adult acute lymphoblastic leukemia in remission|adult acute lymphoblastic leukemia in remission
836456|NCT00093587|adult acute myeloid leukemia in remission|adult acute myeloid leukemia in remission
836457|NCT00093561|prostate cancer|prostate cancer
836458|NCT00093548|adult primary hepatocellular carcinoma|adult primary hepatocellular carcinoma
836459|NCT00093548|advanced adult primary liver cancer|advanced adult primary liver cancer
836460|NCT00093548|localized resectable adult primary liver cancer|localized resectable adult primary liver cancer
836461|NCT00093548|localized unresectable adult primary liver cancer|localized unresectable adult primary liver cancer
836462|NCT00093522|recurrent renal cell cancer|recurrent renal cell cancer
836463|NCT00093522|stage IV renal cell cancer|stage iv renal cell cancer
836464|NCT00093509|stage I adult soft tissue sarcoma|stage i adult soft tissue sarcoma
836465|NCT00093509|stage II adult soft tissue sarcoma|stage ii adult soft tissue sarcoma
836466|NCT00093509|stage III adult soft tissue sarcoma|stage iii adult soft tissue sarcoma
836467|NCT00093509|stage IV adult soft tissue sarcoma|stage iv adult soft tissue sarcoma
836468|NCT00093483|adult acute basophilic leukemia|adult acute basophilic leukemia
836469|NCT00093483|adult acute eosinophilic leukemia|adult acute eosinophilic leukemia
836470|NCT00093483|adult erythroleukemia (M6a)|adult erythroleukemia (m6a)
836471|NCT00093483|adult pure erythroid leukemia (M6b)|adult pure erythroid leukemia (m6b)
836472|NCT00093483|adult acute megakaryoblastic leukemia (M7)|adult acute megakaryoblastic leukemia (m7)
836473|NCT00093483|adult acute minimally differentiated myeloid leukemia (M0)|adult acute minimally differentiated myeloid leukemia (m0)
836474|NCT00093483|adult acute monoblastic leukemia (M5a)|adult acute monoblastic leukemia (m5a)
836475|NCT00093483|adult acute monocytic leukemia (M5b)|adult acute monocytic leukemia (m5b)
836476|NCT00093483|adult acute myeloblastic leukemia with maturation (M2)|adult acute myeloblastic leukemia with maturation (m2)
836477|NCT00093483|adult acute myeloblastic leukemia without maturation (M1)|adult acute myeloblastic leukemia without maturation (m1)
836478|NCT00093483|adult acute myelomonocytic leukemia (M4)|adult acute myelomonocytic leukemia (m4)
836479|NCT00093483|adult acute myeloid leukemia with t(8;21)(q22;q22)|adult acute myeloid leukemia with t(8;21)(q22;q22)
836480|NCT00093483|adult acute myeloid leukemia with t(16;16)(p13;q22)|adult acute myeloid leukemia with t(16;16)(p13;q22)
836481|NCT00093483|adult acute myeloid leukemia with inv(16)(p13;q22)|adult acute myeloid leukemia with inv(16)(p13;q22)
836482|NCT00093483|adult acute myeloid leukemia with 11q23 (MLL) abnormalities|adult acute myeloid leukemia with 11q23 (mll) abnormalities
836483|NCT00093483|untreated adult acute myeloid leukemia|untreated adult acute myeloid leukemia
836484|NCT00093483|secondary acute myeloid leukemia|secondary acute myeloid leukemia
836485|NCT00093457|recurrent prostate cancer|recurrent prostate cancer
836486|NCT00093457|stage IV prostate cancer|stage iv prostate cancer
836487|NCT00093457|adenocarcinoma of the prostate|adenocarcinoma of the prostate
836488|NCT00093444|advanced adult primary liver cancer|advanced adult primary liver cancer
836489|NCT00093444|liver metastases|liver metastases
836490|NCT00093444|localized unresectable adult primary liver cancer|localized unresectable adult primary liver cancer
836491|NCT00093444|recurrent adult primary liver cancer|recurrent adult primary liver cancer
836492|NCT00093405|recurrent renal cell cancer|recurrent renal cell cancer
836493|NCT00093405|stage IV renal cell cancer|stage iv renal cell cancer
836494|NCT00093405|clear cell renal cell carcinoma|clear cell renal cell carcinoma
836495|NCT00093379|stage II anal cancer|stage ii anal cancer
836496|NCT00093379|stage IIIA anal cancer|stage iiia anal cancer
836498|NCT00093379|squamous cell carcinoma of the anus|squamous cell carcinoma of the anus
836499|NCT00093379|Capecitabine|capecitabine
836500|NCT00093379|Xeloda|xeloda
836501|NCT00093379|Oxaliplatin|oxaliplatin
836502|NCT00093379|Eloxatin|eloxatin
836503|NCT00093379|Radiotherapy|radiotherapy
836504|NCT00093379|XRT|xrt
836505|NCT00093366|de novo myelodysplastic syndromes|de novo myelodysplastic syndromes
836506|NCT00093366|previously treated myelodysplastic syndromes|previously treated myelodysplastic syndromes
836507|NCT00093366|secondary myelodysplastic syndromes|secondary myelodysplastic syndromes
836508|NCT00093366|myelodysplastic/myeloproliferative disease, unclassifiable|myelodysplastic/myeloproliferative disease, unclassifiable
836509|NCT00093366|atypical chronic myeloid leukemia|atypical chronic myeloid leukemia
836510|NCT00093366|chronic myelomonocytic leukemia|chronic myelomonocytic leukemia
836511|NCT00093353|diarrhea|diarrhea
836512|NCT00093353|drug/agent toxicity by tissue/organ|drug/agent toxicity by tissue/organ
836513|NCT00093353|disseminated neuroblastoma|disseminated neuroblastoma
836514|NCT00093353|recurrent neuroblastoma|recurrent neuroblastoma
836515|NCT00093314|Chronic Lymphocytic Leukemia|chronic lymphocytic leukemia
836516|NCT00093314|B-cell Lymphoma|b-cell lymphoma
836517|NCT00093860|Adrenaline|adrenaline
836518|NCT00093860|Norepinephrine|norepinephrine
836519|NCT00093860|Sympathetic Nervous System|sympathetic nervous system
836520|NCT00093860|Fainting|fainting
836521|NCT00093860|Hypotension|hypotension
836522|NCT00093860|Beta-Adrenoceptors|beta-adrenoceptors
836523|NCT00093860|Neurocardiogenic Syncope|neurocardiogenic syncope
836524|NCT00093860|Chronic Orthostatic Intolerance|chronic orthostatic intolerance
836525|NCT00093860|Sympathoadrenal Imbalance|sympathoadrenal imbalance
836526|NCT00093860|SAI|sai
836527|NCT00093860|Children|children
836528|NCT00093301|Shock|shock
836529|NCT00093301|Levosimendan|levosimendan
836530|NCT00093301|Inotropes|inotropes
836531|NCT00093301|Dobutamine|dobutamine
836532|NCT00093301|Heart failure|heart failure
836533|NCT00093301|Sepsis|sepsis
836534|NCT00093288|MDD|mdd
836535|NCT00093288|bupropion|bupropion
836536|NCT00093288|Depression|depression
836537|NCT00093262|Postoperative Hypertension|postoperative hypertension
836538|NCT00093249|Pre-operative hypertension|pre-operative hypertension
836539|NCT00093223|In-Stent Restenosis|in-stent restenosis
836540|NCT00093184|ST-Segment Elevation|st-segment elevation
836541|NCT00093184|Acute Myocardial Infarction|acute myocardial infarction
836542|NCT00093184|PCI|pci
836543|NCT00093184|Percutaneous Coronary Intervention|percutaneous coronary intervention
836544|NCT00093158|Acute Coronary Syndromes|acute coronary syndromes
836545|NCT00093145|Advanced Breast Cancer|advanced breast cancer
836546|NCT00002543|recurrent childhood rhabdomyosarcoma|recurrent childhood rhabdomyosarcoma
836547|NCT00002543|recurrent childhood brain tumor|recurrent childhood brain tumor
836548|NCT00002543|recurrent neuroblastoma|recurrent neuroblastoma
836549|NCT00002543|recurrent childhood lymphoblastic lymphoma|recurrent childhood lymphoblastic lymphoma
836550|NCT00002543|unspecified childhood solid tumor, protocol specific|unspecified childhood solid tumor, protocol specific
836551|NCT00002543|recurrent childhood small noncleaved cell lymphoma|recurrent childhood small noncleaved cell lymphoma
836552|NCT00002543|recurrent childhood large cell lymphoma|recurrent childhood large cell lymphoma
836553|NCT00002524|AIDS-related peripheral/systemic lymphoma|aids-related peripheral/systemic lymphoma
836554|NCT00002524|AIDS-related primary CNS lymphoma|aids-related primary cns lymphoma
836555|NCT00002524|AIDS-related diffuse large cell lymphoma|aids-related diffuse large cell lymphoma
836556|NCT00002524|AIDS-related immunoblastic large cell lymphoma|aids-related immunoblastic large cell lymphoma
836557|NCT00002524|AIDS-related small noncleaved cell lymphoma|aids-related small noncleaved cell lymphoma
836558|NCT00002524|AIDS-related diffuse mixed cell lymphoma|aids-related diffuse mixed cell lymphoma
836559|NCT00002524|AIDS-related diffuse small cleaved cell lymphoma|aids-related diffuse small cleaved cell lymphoma
836560|NCT00093132|Non-Small Cell Lung Cancer (stage II or III)|non-small cell lung cancer (stage ii or iii)
836561|NCT00093132|NSCLC|nsclc
836562|NCT00093132|Squamous Cell Lung Cancer|squamous cell lung cancer
836563|NCT00093132|adenocarcinoma of the lung|adenocarcinoma of the lung
836564|NCT00093132|adenosquamous cell lung cancer|adenosquamous cell lung cancer
836565|NCT00093132|bronchoalveolar cell lung cancer|bronchoalveolar cell lung cancer
836566|NCT00093132|carcinoma, non-small cell lung|carcinoma, non-small cell lung
836567|NCT00093119|Metastatic Melanoma|metastatic melanoma
836568|NCT00093093|Viramidine|viramidine
836569|NCT00093093|Ribavirin|ribavirin
836570|NCT00093093|Valeant|valeant
836571|NCT00093093|Hepatitis C|hepatitis c
836572|NCT00093093|Pegylated interferon alfa-2a|pegylated interferon alfa-2a
836573|NCT00093080|Metastatic and/or unresectable soft tissue or|metastatic and/or unresectable soft tissue or
836574|NCT00093067|Gram-positive bacterial infections|gram-positive bacterial infections
836575|NCT00093067|Staph Aureus|staph aureus
836576|NCT00093067|endocarditis|endocarditis
836577|NCT00093067|bacteremia|bacteremia
836578|NCT00093067|Cubist|cubist
836579|NCT00093054|Vaccinium macrocarpon|vaccinium macrocarpon
836580|NCT00093041|Head and neck cancer|head and neck cancer
836581|NCT00093041|squamous cell carcinoma of the head and neck|squamous cell carcinoma of the head and neck
836582|NCT00093028|Myeloma|myeloma
836583|NCT00093028|Revlimid|revlimid
836585|NCT00093028|CC-5013|cc-5013
836586|NCT00093028|Dexamethasone|dexamethasone
836587|NCT00091520|Congestive heart failure|congestive heart failure
836588|NCT00091520|Nesiritide|nesiritide
836589|NCT00093002|Early Breast Cancer|early breast cancer
836590|NCT00093002|neoadjuvant therapy|neoadjuvant therapy
836591|NCT00093002|hormonal treatment|hormonal treatment
836592|NCT00093002|newly diagnosed breast cancer|newly diagnosed breast cancer
836691|NCT00091936|Directly Observed Therapy|directly observed therapy
836593|NCT00093002|Estrogen Receptor Positive Breast Cancer|estrogen receptor positive breast cancer
836594|NCT00093002|treatment naïve|treatment naïve
836595|NCT00093002|neoadjuvant treatment|neoadjuvant treatment
836596|NCT00093002|neoadjuvant setting|neoadjuvant setting
836597|NCT00093002|invasive breast cancer|invasive breast cancer
836598|NCT00092976|Hemophilia A|hemophilia a
836599|NCT00092898|Sitosterolemia|sitosterolemia
836600|NCT00092846|High Blood Cholesterol Levels|high blood cholesterol levels
836601|NCT00092820|Homozygous Sitosterolemia|homozygous sitosterolemia
836602|NCT00092807|Homozygous Sitosterolemia|homozygous sitosterolemia
836603|NCT00092781|Arcoxia|arcoxia
836604|NCT00092768|Arcoxia|arcoxia
836605|NCT00092755|Arcoxia|arcoxia
836606|NCT00092742|Arcoxia|arcoxia
836607|NCT00092703|Arcoxia|arcoxia
836608|NCT00092664|Primary hypercholesterolemia|primary hypercholesterolemia
836609|NCT00092651|Primary hypercholesterolemia|primary hypercholesterolemia
836610|NCT00092573|Mixed hyperlipidemia (high cholesterol and high triglycerides)|mixed hyperlipidemia (high cholesterol and high triglycerides)
836611|NCT00092560|mixed hyperlipidemia|mixed hyperlipidemia
836612|NCT00092560|high cholesterol|high cholesterol
836613|NCT00092560|high triglycerides|high triglycerides
836614|NCT00092508|Ulcerative Colitis Remission|ulcerative colitis remission
836615|NCT00092508|ulcerative|ulcerative
836616|NCT00092508|colitis|colitis
836617|NCT00092508|remission|remission
836618|NCT00092508|relapse|relapse
836619|NCT00092508|Asacol®|asacol®
836620|NCT00092508|maintain|maintain
836621|NCT00092508|maintenance|maintenance
836622|NCT00092508|flare|flare
836623|NCT00092508|rectal|rectal
836624|NCT00092508|bleeding|bleeding
836625|NCT00092508|bowel|bowel
836626|NCT00092300|dental surgery|dental surgery
836627|NCT00092300|molar removal|molar removal
836628|NCT00092950|Exercise|exercise
836629|NCT00092950|Pedometer|pedometer
836630|NCT00092950|Physician Prescription|physician prescription
836631|NCT00092950|Biomarkers|biomarkers
836632|NCT00092950|Compliance|compliance
836633|NCT00092950|Breast Cancer Survivor|breast cancer survivor
836634|NCT00092950|Breast Cancer Risk|breast cancer risk
836635|NCT00092937|Chronic Granulomatous Disease|chronic granulomatous disease
836636|NCT00092937|Nonmyeloablative|nonmyeloablative
836637|NCT00092937|CD34 Positive Cells|cd34 positive cells
836638|NCT00092937|Donor Engraftment|donor engraftment
836639|NCT00092937|Myeloid Chimerism|myeloid chimerism
836640|NCT00092638|Elevated Cholesterol|elevated cholesterol
836641|NCT00092625|Elevated Cholesterol|elevated cholesterol
836642|NCT00092612|Elevated Cholesterol|elevated cholesterol
836643|NCT00092599|Elevated Cholesterol|elevated cholesterol
836644|NCT00092378|Bunionectomy|bunionectomy
836645|NCT00092339|dental surgery|dental surgery
836646|NCT00092339|molar removal|molar removal
836647|NCT00092326|dental surgery|dental surgery
836648|NCT00092326|molar removal|molar removal
836649|NCT00092313|dental surgery|dental surgery
836650|NCT00092313|molar removal|molar removal
836651|NCT00092287|Carcinoid Syndrome|carcinoid syndrome
836652|NCT00092287|Neuroendocrine Tumuors|neuroendocrine tumuors
836653|NCT00092274|Follicular Lymphoma|follicular lymphoma
836654|NCT00092274|Non Hodgkin´s Lymphoma|non hodgkin´s lymphoma
836655|NCT00092001|Non-small cell lung cancer, carcinoma, sunitinib, Phase 2|non-small cell lung cancer, carcinoma, sunitinib, phase 2
836656|NCT00092196|Chemotherapy-Induced Nausea and Vomiting|chemotherapy-induced nausea and vomiting
836657|NCT00092183|Chemotherapy-Induced Nausea and Vomiting|chemotherapy-induced nausea and vomiting
836658|NCT00092170|Intra-abdominal infections|intra-abdominal infections
836659|NCT00092170|Acute pelvic infections|acute pelvic infections
836660|NCT00092157|High cholesterol|high cholesterol
836661|NCT00092105|Rhinitis, Allergic|rhinitis, allergic
836662|NCT00092053|Postmenopausal|postmenopausal
836663|NCT00092053|Osteoporosis|osteoporosis
836664|NCT00092235|cGVHD-associated graft-versus-tumor effects (GVT)|cgvhd-associated graft-versus-tumor effects (gvt)
836665|NCT00092235|Allo-HSCT controls|allo-hsct controls
836666|NCT00092235|Leukapheresis|leukapheresis
836667|NCT00092235|Chronic Graft-Versus-Host Disease|chronic graft-versus-host disease
836668|NCT00092235|cGVHD|cgvhd
836669|NCT00092222|HHV-8|hhv-8
836670|NCT00092222|HIV|hiv
836671|NCT00092222|Malignancy|malignancy
836672|NCT00092222|Lymphoproliferation|lymphoproliferation
836673|NCT00092222|Lymph Node Hyperplasia|lymph node hyperplasia
836674|NCT00092222|Multicentric Castleman DIsease|multicentric castleman disease
836675|NCT00092222|MCD|mcd
836676|NCT00092222|KSHV-MCD|kshv-mcd
836677|NCT00092222|KSHV Associated MCD|kshv associated mcd
836678|NCT00092222|HIV Infections|hiv infections
836679|NCT00092222|Herpes Viruses|herpes viruses
836680|NCT00091988|Urinary Incontinence|urinary incontinence
836681|NCT00091988|Weight Loss|weight loss
836682|NCT00091988|Obesity|obesity
836683|NCT00091988|Motivation|motivation
836684|NCT00091975|Chronic Kidney Disease|chronic kidney disease
836685|NCT00091949|stroke|stroke
836686|NCT00091949|heart attack|heart attack
836687|NCT00091949|diabetes|diabetes
836688|NCT00091949|pioglitazone|pioglitazone
836689|NCT00091949|insulin resistance|insulin resistance
836690|NCT00091936|Treatment Naive|treatment naive
836695|NCT00091910|Epoetin alfa|epoetin alfa
836696|NCT00091910|Erythropoietin|erythropoietin
836697|NCT00091910|Blood transfusion|blood transfusion
836698|NCT00091910|Intensive care units|intensive care units
836699|NCT00091858|Cancer-related anemia|cancer-related anemia
836700|NCT00091845|West Nile Fever Myelitis|west nile fever myelitis
836701|NCT00091845|West Nile Fever Encephalitis|west nile fever encephalitis
836702|NCT00091845|West Nile Fever Meningitis|west nile fever meningitis
836703|NCT00091845|West Nile Fever Meningoencephalitis|west nile fever meningoencephalitis
836704|NCT00091832|Breast Cancer|breast cancer
836705|NCT00091832|Cancer|cancer
836706|NCT00091819|staph|staph
836707|NCT00091819|MRSA|mrsa
836708|NCT00091819|cSSSI|csssi
836709|NCT00091806|Targeted Therapy|targeted therapy
836710|NCT00091806|Solid tumors|solid tumors
836711|NCT00091806|ABX-EGF, panitumumab|abx-egf, panitumumab
836712|NCT00091806|EGFr|egfr
836713|NCT00091806|Immunex, Abgenix, Amgen|immunex, abgenix, amgen
836714|NCT00091806|Monoclonal Antibody|monoclonal antibody
836715|NCT00091793|Osteoporosis|osteoporosis
836716|NCT00091793|Postmenopausal|postmenopausal
836717|NCT00091897|RITUXAN|rituxan
836718|NCT00091897|GABA|gaba
836719|NCT00091897|B Cells|b cells
836720|NCT00091897|Humanized Monoclonal Antibodies|humanized monoclonal antibodies
836721|NCT00091897|GAD|gad
836722|NCT00091897|Stiff Person Syndrome|stiff person syndrome
836723|NCT00091897|SPS|sps
836724|NCT00091884|HIV|hiv
836725|NCT00091884|Immune Recovery|immune recovery
836726|NCT00091884|Reactivation|reactivation
836727|NCT00091884|Anti-Viral Medication|anti-viral medication
836728|NCT00091884|HAART|haart
836729|NCT00091884|CMV Retinitis|cmv retinitis
836730|NCT00091884|Retinal Disease|retinal disease
836731|NCT00091871|Hypereosinophilia|hypereosinophilia
836732|NCT00091871|Eosinophil|eosinophil
836733|NCT00091871|Interlukin 5|interlukin 5
836734|NCT00091871|Familial|familial
836735|NCT00091871|Familial Hypereosinophilia|familial hypereosinophilia
836736|NCT00091871|FE|fe
836737|NCT00091741|HIV|hiv
836738|NCT00091741|Treatment Experienced|treatment experienced
836739|NCT00091741|Complementary Therapies|complementary therapies
836740|NCT00091728|epidemiology|epidemiology
836741|NCT00091728|relative risk|relative risk
836742|NCT00091728|cervical ectopy|cervical ectopy
836743|NCT00091728|hormonal contraceptives|hormonal contraceptives
836744|NCT00091728|sexually transmitted infections|sexually transmitted infections
836745|NCT00091715|Pulmonary arterial hypertension|pulmonary arterial hypertension
836746|NCT00091715|PAH|pah
836747|NCT00091715|PPH|pph
836748|NCT00091715|bosentan|bosentan
836749|NCT00091715|early|early
836750|NCT00091702|FluMist|flumist
836751|NCT00091702|Influenza Vaccine|influenza vaccine
836752|NCT00091702|Adolescent|adolescent
836753|NCT00091702|Treatment Experienced|treatment experienced
836754|NCT00091689|Advanced Metastatic Melanoma|advanced metastatic melanoma
836755|NCT00091676|follicular|follicular
836756|NCT00091676|lymphoma|lymphoma
836757|NCT00091676|Non-Hodgkins|non-hodgkins
836758|NCT00091676|idiotype|idiotype
836759|NCT00091676|vaccine|vaccine
836760|NCT00091676|indolent follicular Non-Hodgkins Lymphoma|indolent follicular non-hodgkins lymphoma
836761|NCT00091676|tumor-derived|tumor-derived
836762|NCT00091676|B-cell|b-cell
836763|NCT00091676|cancer|cancer
836764|NCT00091663|Advanced non-small cell lung cancer|advanced non-small cell lung cancer
836765|NCT00004905|recurrent adult acute myeloid leukemia|recurrent adult acute myeloid leukemia
836766|NCT00004905|recurrent adult acute lymphoblastic leukemia|recurrent adult acute lymphoblastic leukemia
836767|NCT00004905|relapsing chronic myelogenous leukemia|relapsing chronic myelogenous leukemia
836768|NCT00004905|chronic phase chronic myelogenous leukemia|chronic phase chronic myelogenous leukemia
836769|NCT00004905|adult acute myeloid leukemia in remission|adult acute myeloid leukemia in remission
836770|NCT00004905|adult acute lymphoblastic leukemia in remission|adult acute lymphoblastic leukemia in remission
836771|NCT00004209|stage IIIB non-small cell lung cancer|stage iiib non-small cell lung cancer
836772|NCT00004209|stage IV non-small cell lung cancer|stage iv non-small cell lung cancer
836773|NCT00004195|stage I colon cancer|stage i colon cancer
836774|NCT00004195|stage II colon cancer|stage ii colon cancer
836775|NCT00004195|stage III colon cancer|stage iii colon cancer
836776|NCT00004195|stage IV colon cancer|stage iv colon cancer
836777|NCT00004195|stage I rectal cancer|stage i rectal cancer
836778|NCT00004195|stage II rectal cancer|stage ii rectal cancer
836779|NCT00004195|stage III rectal cancer|stage iii rectal cancer
836780|NCT00004195|stage IV rectal cancer|stage iv rectal cancer
842737|NCT00084279|Ribavirin|ribavirin
836781|NCT00004195|recurrent colon cancer|recurrent colon cancer
836782|NCT00004195|recurrent rectal cancer|recurrent rectal cancer
836783|NCT00004194|graft versus host disease|graft versus host disease
836784|NCT00004184|stage III melanoma|stage iii melanoma
836785|NCT00004184|stage IV melanoma|stage iv melanoma
836786|NCT00004184|recurrent melanoma|recurrent melanoma
836787|NCT00004172|stage IV breast cancer|stage iv breast cancer
836788|NCT00004172|stage IIIA breast cancer|stage iiia breast cancer
836789|NCT00004172|recurrent breast cancer|recurrent breast cancer
836862|NCT00091611|Intravenous|intravenous
836790|NCT00004172|stage IIIB breast cancer|stage iiib breast cancer
836791|NCT00091624|CC-5013|cc-5013
836792|NCT00091624|CC5013|cc5013
836793|NCT00091624|Revlimid|revlimid
836794|NCT00091624|Lenalidomide|lenalidomide
836795|NCT00091624|Multiple myeloma|multiple myeloma
836796|NCT00091598|Pulmonary Arterial Hypertension|pulmonary arterial hypertension
836797|NCT00091572|Metastatic Melanoma|metastatic melanoma
836798|NCT00091559|CTCL|ctcl
836799|NCT00004089|anaplastic thyroid cancer|anaplastic thyroid cancer
836800|NCT00004083|stage IV ovarian epithelial cancer|stage iv ovarian epithelial cancer
836801|NCT00004083|recurrent ovarian epithelial cancer|recurrent ovarian epithelial cancer
836802|NCT00004014|recurrent prostate cancer|recurrent prostate cancer
836803|NCT00003956|stage IV adult Hodgkin lymphoma|stage iv adult hodgkin lymphoma
836804|NCT00003956|recurrent adult Hodgkin lymphoma|recurrent adult hodgkin lymphoma
836805|NCT00003956|unspecified adult solid tumor, protocol specific|unspecified adult solid tumor, protocol specific
836806|NCT00003956|stage IV grade 1 follicular lymphoma|stage iv grade 1 follicular lymphoma
836807|NCT00003956|stage IV grade 2 follicular lymphoma|stage iv grade 2 follicular lymphoma
836808|NCT00003956|stage IV grade 3 follicular lymphoma|stage iv grade 3 follicular lymphoma
836809|NCT00003956|stage IV adult diffuse small cleaved cell lymphoma|stage iv adult diffuse small cleaved cell lymphoma
836810|NCT00003956|stage IV adult diffuse mixed cell lymphoma|stage iv adult diffuse mixed cell lymphoma
836811|NCT00003956|stage IV adult diffuse large cell lymphoma|stage iv adult diffuse large cell lymphoma
836812|NCT00003956|stage IV adult immunoblastic large cell lymphoma|stage iv adult immunoblastic large cell lymphoma
836813|NCT00003956|stage IV adult lymphoblastic lymphoma|stage iv adult lymphoblastic lymphoma
836814|NCT00003956|stage IV adult Burkitt lymphoma|stage iv adult burkitt lymphoma
836815|NCT00003956|recurrent grade 1 follicular lymphoma|recurrent grade 1 follicular lymphoma
836816|NCT00003956|recurrent grade 2 follicular lymphoma|recurrent grade 2 follicular lymphoma
836817|NCT00003956|recurrent grade 3 follicular lymphoma|recurrent grade 3 follicular lymphoma
836818|NCT00003956|recurrent adult diffuse small cleaved cell lymphoma|recurrent adult diffuse small cleaved cell lymphoma
836819|NCT00003956|recurrent adult diffuse mixed cell lymphoma|recurrent adult diffuse mixed cell lymphoma
836820|NCT00003956|recurrent adult diffuse large cell lymphoma|recurrent adult diffuse large cell lymphoma
836821|NCT00003956|recurrent adult immunoblastic large cell lymphoma|recurrent adult immunoblastic large cell lymphoma
836822|NCT00003956|recurrent adult lymphoblastic lymphoma|recurrent adult lymphoblastic lymphoma
836823|NCT00003956|recurrent adult Burkitt lymphoma|recurrent adult burkitt lymphoma
836824|NCT00003956|stage IV adult T-cell leukemia/lymphoma|stage iv adult t-cell leukemia/lymphoma
836825|NCT00003956|recurrent adult T-cell leukemia/lymphoma|recurrent adult t-cell leukemia/lymphoma
836826|NCT00003956|AIDS-related peripheral/systemic lymphoma|aids-related peripheral/systemic lymphoma
836827|NCT00003956|AIDS-related primary CNS lymphoma|aids-related primary cns lymphoma
836828|NCT00003956|stage IV mantle cell lymphoma|stage iv mantle cell lymphoma
836829|NCT00003956|recurrent mantle cell lymphoma|recurrent mantle cell lymphoma
836830|NCT00003956|angioimmunoblastic T-cell lymphoma|angioimmunoblastic t-cell lymphoma
836831|NCT00003956|anaplastic large cell lymphoma|anaplastic large cell lymphoma
836832|NCT00003956|recurrent marginal zone lymphoma|recurrent marginal zone lymphoma
836833|NCT00003956|recurrent small lymphocytic lymphoma|recurrent small lymphocytic lymphoma
836834|NCT00003956|stage IV small lymphocytic lymphoma|stage iv small lymphocytic lymphoma
836835|NCT00003956|stage IV marginal zone lymphoma|stage iv marginal zone lymphoma
836836|NCT00003956|extranodal marginal zone B-cell lymphoma of mucosa-associated lymphoid tissue|extranodal marginal zone b-cell lymphoma of mucosa-associated lymphoid tissue
836837|NCT00003956|nodal marginal zone B-cell lymphoma|nodal marginal zone b-cell lymphoma
836838|NCT00003956|splenic marginal zone lymphoma|splenic marginal zone lymphoma
836839|NCT00003858|adenocarcinoma of the prostate|adenocarcinoma of the prostate
836840|NCT00003858|stage I prostate cancer|stage i prostate cancer
836841|NCT00003858|stage IIB prostate cancer|stage iib prostate cancer
836842|NCT00003858|stage IIA prostate cancer|stage iia prostate cancer
836843|NCT00003858|stage III prostate cancer|stage iii prostate cancer
836844|NCT00003858|stage IV prostate cancer|stage iv prostate cancer
836845|NCT00003842|recurrent adult brain tumor|recurrent adult brain tumor
836846|NCT00003842|adult glioblastoma|adult glioblastoma
836847|NCT00003842|adult anaplastic astrocytoma|adult anaplastic astrocytoma
836848|NCT00003842|adult giant cell glioblastoma|adult giant cell glioblastoma
836849|NCT00003842|adult gliosarcoma|adult gliosarcoma
836850|NCT00003780|stage II pancreatic cancer|stage ii pancreatic cancer
836851|NCT00003780|stage III pancreatic cancer|stage iii pancreatic cancer
836852|NCT00003780|stage IV pancreatic cancer|stage iv pancreatic cancer
836853|NCT00003775|recurrent adult brain tumor|recurrent adult brain tumor
836854|NCT00003775|adult anaplastic astrocytoma|adult anaplastic astrocytoma
842738|NCT00084279|Combination|combination
836855|NCT00003775|adult mixed glioma|adult mixed glioma
836856|NCT00003714|localized unresectable adult primary liver cancer|localized unresectable adult primary liver cancer
836857|NCT00003714|advanced adult primary liver cancer|advanced adult primary liver cancer
836858|NCT00003714|adult primary hepatocellular carcinoma|adult primary hepatocellular carcinoma
836859|NCT00003714|liver metastases|liver metastases
836860|NCT00003711|unspecified adult solid tumor, protocol specific|unspecified adult solid tumor, protocol specific
836861|NCT00091611|Clinical Response|clinical response
836863|NCT00091611|Intra-Arterial|intra-arterial
836864|NCT00091611|Lymphodepletion|lymphodepletion
836865|NCT00091611|Traffic of Cells|traffic of cells
836866|NCT00091611|T-Cell Transfer|t-cell transfer
836867|NCT00091611|Renal Cell Carcinoma|renal cell carcinoma
836868|NCT00091611|Metastatic Renal Cell Cancer|metastatic renal cell cancer
836869|NCT00091507|Acute Coronary Syndrome|acute coronary syndrome
836870|NCT00091481|Stage V Chronic Kidney Disease|stage v chronic kidney disease
836871|NCT00091442|Breast Cancer|breast cancer
836872|NCT00091442|Advanced breast cancer|advanced breast cancer
836873|NCT00091442|Breast Tumors|breast tumors
836874|NCT00091442|Cancer of Breast|cancer of breast
836875|NCT00091442|Human Mammary Carcinoma|human mammary carcinoma
836876|NCT00091442|Mammary Neoplasms, Human|mammary neoplasms, human
836877|NCT00091442|DOXIL|doxil
836878|NCT00091442|Docetaxel|docetaxel
836879|NCT00004057|recurrent adult Hodgkin lymphoma|recurrent adult hodgkin lymphoma
836880|NCT00004057|unspecified adult solid tumor, protocol specific|unspecified adult solid tumor, protocol specific
836881|NCT00004057|recurrent grade 1 follicular lymphoma|recurrent grade 1 follicular lymphoma
836882|NCT00004057|recurrent grade 2 follicular lymphoma|recurrent grade 2 follicular lymphoma
836883|NCT00004057|recurrent grade 3 follicular lymphoma|recurrent grade 3 follicular lymphoma
836884|NCT00004057|recurrent adult diffuse small cleaved cell lymphoma|recurrent adult diffuse small cleaved cell lymphoma
836885|NCT00004057|recurrent adult diffuse mixed cell lymphoma|recurrent adult diffuse mixed cell lymphoma
836886|NCT00004057|recurrent adult diffuse large cell lymphoma|recurrent adult diffuse large cell lymphoma
836887|NCT00004057|recurrent adult immunoblastic large cell lymphoma|recurrent adult immunoblastic large cell lymphoma
836888|NCT00004057|recurrent adult lymphoblastic lymphoma|recurrent adult lymphoblastic lymphoma
836889|NCT00004057|recurrent adult Burkitt lymphoma|recurrent adult burkitt lymphoma
836890|NCT00004057|recurrent adult T-cell leukemia/lymphoma|recurrent adult t-cell leukemia/lymphoma
836891|NCT00004057|recurrent mantle cell lymphoma|recurrent mantle cell lymphoma
836892|NCT00004057|angioimmunoblastic T-cell lymphoma|angioimmunoblastic t-cell lymphoma
836893|NCT00004057|anaplastic large cell lymphoma|anaplastic large cell lymphoma
836894|NCT00004057|recurrent marginal zone lymphoma|recurrent marginal zone lymphoma
836895|NCT00004057|recurrent small lymphocytic lymphoma|recurrent small lymphocytic lymphoma
836896|NCT00004057|extranodal marginal zone B-cell lymphoma of mucosa-associated lymphoid tissue|extranodal marginal zone b-cell lymphoma of mucosa-associated lymphoid tissue
836897|NCT00004057|nodal marginal zone B-cell lymphoma|nodal marginal zone b-cell lymphoma
836898|NCT00004057|splenic marginal zone lymphoma|splenic marginal zone lymphoma
836899|NCT00004036|stage III adult Hodgkin lymphoma|stage iii adult hodgkin lymphoma
836900|NCT00004036|stage IV adult Hodgkin lymphoma|stage iv adult hodgkin lymphoma
836901|NCT00004036|monoclonal gammopathy of undetermined significance|monoclonal gammopathy of undetermined significance
836902|NCT00004036|recurrent adult Hodgkin lymphoma|recurrent adult hodgkin lymphoma
836903|NCT00004036|isolated plasmacytoma of bone|isolated plasmacytoma of bone
836904|NCT00004036|extramedullary plasmacytoma|extramedullary plasmacytoma
836905|NCT00004036|refractory multiple myeloma|refractory multiple myeloma
836906|NCT00004036|Waldenström macroglobulinemia|waldenström macroglobulinemia
836907|NCT00004036|stage III multiple myeloma|stage iii multiple myeloma
836908|NCT00004036|stage III chronic lymphocytic leukemia|stage iii chronic lymphocytic leukemia
836909|NCT00004036|stage IV chronic lymphocytic leukemia|stage iv chronic lymphocytic leukemia
836910|NCT00004036|recurrent adult acute myeloid leukemia|recurrent adult acute myeloid leukemia
836911|NCT00004036|recurrent adult acute lymphoblastic leukemia|recurrent adult acute lymphoblastic leukemia
836912|NCT00004036|relapsing chronic myelogenous leukemia|relapsing chronic myelogenous leukemia
836913|NCT00004036|refractory chronic lymphocytic leukemia|refractory chronic lymphocytic leukemia
836914|NCT00004036|unspecified adult solid tumor, protocol specific|unspecified adult solid tumor, protocol specific
836915|NCT00004036|chronic phase chronic myelogenous leukemia|chronic phase chronic myelogenous leukemia
836916|NCT00004036|accelerated phase chronic myelogenous leukemia|accelerated phase chronic myelogenous leukemia
836917|NCT00004036|blastic phase chronic myelogenous leukemia|blastic phase chronic myelogenous leukemia
836918|NCT00004036|meningeal chronic myelogenous leukemia|meningeal chronic myelogenous leukemia
836919|NCT00004036|untreated adult acute lymphoblastic leukemia|untreated adult acute lymphoblastic leukemia
836920|NCT00004036|untreated adult acute myeloid leukemia|untreated adult acute myeloid leukemia
836921|NCT00004036|adult acute myeloid leukemia in remission|adult acute myeloid leukemia in remission
836922|NCT00004036|adult acute lymphoblastic leukemia in remission|adult acute lymphoblastic leukemia in remission
836923|NCT00004036|polycythemia vera|polycythemia vera
836924|NCT00004036|primary myelofibrosis|primary myelofibrosis
836925|NCT00004036|essential thrombocythemia|essential thrombocythemia
836926|NCT00004036|untreated hairy cell leukemia|untreated hairy cell leukemia
836927|NCT00004036|progressive hairy cell leukemia, initial treatment|progressive hairy cell leukemia, initial treatment
836928|NCT00004036|refractory hairy cell leukemia|refractory hairy cell leukemia
836929|NCT00004036|chronic myelomonocytic leukemia|chronic myelomonocytic leukemia
836930|NCT00004036|T-cell large granular lymphocyte leukemia|t-cell large granular lymphocyte leukemia
836931|NCT00004036|acute undifferentiated leukemia|acute undifferentiated leukemia
836932|NCT00004036|stage III grade 1 follicular lymphoma|stage iii grade 1 follicular lymphoma
836933|NCT00004036|stage III grade 2 follicular lymphoma|stage iii grade 2 follicular lymphoma
836934|NCT00004036|stage III grade 3 follicular lymphoma|stage iii grade 3 follicular lymphoma
836935|NCT00004036|stage III adult diffuse small cleaved cell lymphoma|stage iii adult diffuse small cleaved cell lymphoma
836936|NCT00004036|stage III adult diffuse mixed cell lymphoma|stage iii adult diffuse mixed cell lymphoma
836937|NCT00004036|stage III adult diffuse large cell lymphoma|stage iii adult diffuse large cell lymphoma
836938|NCT00004036|stage III adult immunoblastic large cell lymphoma|stage iii adult immunoblastic large cell lymphoma
836939|NCT00004036|stage III adult lymphoblastic lymphoma|stage iii adult lymphoblastic lymphoma
836940|NCT00004036|stage III adult Burkitt lymphoma|stage iii adult burkitt lymphoma
836941|NCT00004036|stage IV grade 1 follicular lymphoma|stage iv grade 1 follicular lymphoma
836942|NCT00004036|stage IV grade 2 follicular lymphoma|stage iv grade 2 follicular lymphoma
836943|NCT00004036|stage IV grade 3 follicular lymphoma|stage iv grade 3 follicular lymphoma
836944|NCT00004036|stage IV adult diffuse small cleaved cell lymphoma|stage iv adult diffuse small cleaved cell lymphoma
836945|NCT00004036|stage IV adult diffuse mixed cell lymphoma|stage iv adult diffuse mixed cell lymphoma
836946|NCT00004036|stage IV adult diffuse large cell lymphoma|stage iv adult diffuse large cell lymphoma
836947|NCT00004036|stage IV adult immunoblastic large cell lymphoma|stage iv adult immunoblastic large cell lymphoma
836948|NCT00004036|stage IV adult lymphoblastic lymphoma|stage iv adult lymphoblastic lymphoma
836949|NCT00004036|stage IV adult Burkitt lymphoma|stage iv adult burkitt lymphoma
836950|NCT00004036|recurrent grade 1 follicular lymphoma|recurrent grade 1 follicular lymphoma
836951|NCT00004036|recurrent grade 2 follicular lymphoma|recurrent grade 2 follicular lymphoma
836952|NCT00004036|recurrent grade 3 follicular lymphoma|recurrent grade 3 follicular lymphoma
836953|NCT00004036|recurrent adult diffuse small cleaved cell lymphoma|recurrent adult diffuse small cleaved cell lymphoma
836954|NCT00004036|recurrent adult diffuse mixed cell lymphoma|recurrent adult diffuse mixed cell lymphoma
836955|NCT00004036|recurrent adult diffuse large cell lymphoma|recurrent adult diffuse large cell lymphoma
836956|NCT00004036|recurrent adult immunoblastic large cell lymphoma|recurrent adult immunoblastic large cell lymphoma
836957|NCT00004036|recurrent adult lymphoblastic lymphoma|recurrent adult lymphoblastic lymphoma
836958|NCT00004036|recurrent adult Burkitt lymphoma|recurrent adult burkitt lymphoma
836959|NCT00004036|stage III adult T-cell leukemia/lymphoma|stage iii adult t-cell leukemia/lymphoma
836960|NCT00004036|stage IV adult T-cell leukemia/lymphoma|stage iv adult t-cell leukemia/lymphoma
836961|NCT00004036|recurrent adult T-cell leukemia/lymphoma|recurrent adult t-cell leukemia/lymphoma
836962|NCT00004036|secondary acute myeloid leukemia|secondary acute myeloid leukemia
836963|NCT00004036|de novo myelodysplastic syndromes|de novo myelodysplastic syndromes
836964|NCT00004036|previously treated myelodysplastic syndromes|previously treated myelodysplastic syndromes
836965|NCT00004036|secondary myelodysplastic syndromes|secondary myelodysplastic syndromes
836966|NCT00004036|drug/agent toxicity by tissue/organ|drug/agent toxicity by tissue/organ
836967|NCT00004036|prolymphocytic leukemia|prolymphocytic leukemia
836968|NCT00004036|AIDS-related peripheral/systemic lymphoma|aids-related peripheral/systemic lymphoma
836969|NCT00004036|AIDS-related primary CNS lymphoma|aids-related primary cns lymphoma
836970|NCT00004036|primary systemic amyloidosis|primary systemic amyloidosis
836971|NCT00004036|stage III mantle cell lymphoma|stage iii mantle cell lymphoma
836972|NCT00004036|stage IV mantle cell lymphoma|stage iv mantle cell lymphoma
836973|NCT00004036|recurrent mantle cell lymphoma|recurrent mantle cell lymphoma
836974|NCT00004036|angioimmunoblastic T-cell lymphoma|angioimmunoblastic t-cell lymphoma
836975|NCT00004036|anaplastic large cell lymphoma|anaplastic large cell lymphoma
836976|NCT00004036|recurrent marginal zone lymphoma|recurrent marginal zone lymphoma
836977|NCT00004036|recurrent small lymphocytic lymphoma|recurrent small lymphocytic lymphoma
836978|NCT00004036|stage III small lymphocytic lymphoma|stage iii small lymphocytic lymphoma
836979|NCT00004036|stage III marginal zone lymphoma|stage iii marginal zone lymphoma
836980|NCT00004036|stage IV small lymphocytic lymphoma|stage iv small lymphocytic lymphoma
836981|NCT00004036|stage IV marginal zone lymphoma|stage iv marginal zone lymphoma
836982|NCT00004036|extranodal marginal zone B-cell lymphoma of mucosa-associated lymphoid tissue|extranodal marginal zone b-cell lymphoma of mucosa-associated lymphoid tissue
836983|NCT00004036|nodal marginal zone B-cell lymphoma|nodal marginal zone b-cell lymphoma
836984|NCT00004036|splenic marginal zone lymphoma|splenic marginal zone lymphoma
836985|NCT00004022|stage III melanoma|stage iii melanoma
836986|NCT00004022|stage IV melanoma|stage iv melanoma
836987|NCT00004022|recurrent melanoma|recurrent melanoma
836988|NCT00003673|recurrent adult acute myeloid leukemia|recurrent adult acute myeloid leukemia
836989|NCT00003671|untreated childhood acute lymphoblastic leukemia|untreated childhood acute lymphoblastic leukemia
836990|NCT00003671|B-cell childhood acute lymphoblastic leukemia|b-cell childhood acute lymphoblastic leukemia
836991|NCT00003666|recurrent non-small cell lung cancer|recurrent non-small cell lung cancer
836992|NCT00003666|squamous cell lung cancer|squamous cell lung cancer
836993|NCT00003666|large cell lung cancer|large cell lung cancer
836994|NCT00003666|adenocarcinoma of the lung|adenocarcinoma of the lung
836995|NCT00003666|bronchoalveolar cell lung cancer|bronchoalveolar cell lung cancer
836996|NCT00003634|stage III ovarian epithelial cancer|stage iii ovarian epithelial cancer
836997|NCT00003634|stage IV ovarian epithelial cancer|stage iv ovarian epithelial cancer
836998|NCT00003634|fallopian tube cancer|fallopian tube cancer
836999|NCT00003634|primary peritoneal cavity cancer|primary peritoneal cavity cancer
837000|NCT00003625|untreated childhood brain stem glioma|untreated childhood brain stem glioma
837001|NCT00003599|non-small cell lung cancer|non-small cell lung cancer
837002|NCT00003599|small cell lung cancer|small cell lung cancer
837003|NCT00003591|stage I pancreatic cancer|stage i pancreatic cancer
837004|NCT00003591|stage II pancreatic cancer|stage ii pancreatic cancer
837005|NCT00003591|stage III pancreatic cancer|stage iii pancreatic cancer
837006|NCT00003591|recurrent pancreatic cancer|recurrent pancreatic cancer
837007|NCT00003591|adenocarcinoma of the pancreas|adenocarcinoma of the pancreas
837008|NCT00003587|recurrent non-small cell lung cancer|recurrent non-small cell lung cancer
837009|NCT00003587|squamous cell lung cancer|squamous cell lung cancer
837010|NCT00003587|large cell lung cancer|large cell lung cancer
837011|NCT00003587|stage IIIB non-small cell lung cancer|stage iiib non-small cell lung cancer
837012|NCT00003587|stage IV non-small cell lung cancer|stage iv non-small cell lung cancer
837013|NCT00003587|adenocarcinoma of the lung|adenocarcinoma of the lung
837014|NCT00003564|recurrent adult brain tumor|recurrent adult brain tumor
837015|NCT00003564|adult glioblastoma|adult glioblastoma
837016|NCT00003564|adult anaplastic astrocytoma|adult anaplastic astrocytoma
837017|NCT00003564|adult anaplastic oligodendroglioma|adult anaplastic oligodendroglioma
837018|NCT00003564|adult mixed glioma|adult mixed glioma
837019|NCT00003564|adult giant cell glioblastoma|adult giant cell glioblastoma
837020|NCT00003564|adult gliosarcoma|adult gliosarcoma
837021|NCT00003551|stage III renal cell cancer|stage iii renal cell cancer
837022|NCT00003551|stage IV renal cell cancer|stage iv renal cell cancer
837023|NCT00003551|recurrent renal cell cancer|recurrent renal cell cancer
837024|NCT00003546|stage I pancreatic cancer|stage i pancreatic cancer
837025|NCT00003546|stage II pancreatic cancer|stage ii pancreatic cancer
837026|NCT00003546|stage III pancreatic cancer|stage iii pancreatic cancer
837027|NCT00003546|adenocarcinoma of the pancreas|adenocarcinoma of the pancreas
837028|NCT00003451|stage III adult Hodgkin lymphoma|stage iii adult hodgkin lymphoma
837029|NCT00003451|stage IV adult Hodgkin lymphoma|stage iv adult hodgkin lymphoma
837030|NCT00003451|monoclonal gammopathy of undetermined significance|monoclonal gammopathy of undetermined significance
837031|NCT00003451|recurrent adult Hodgkin lymphoma|recurrent adult hodgkin lymphoma
837032|NCT00003451|isolated plasmacytoma of bone|isolated plasmacytoma of bone
837033|NCT00003451|extramedullary plasmacytoma|extramedullary plasmacytoma
837034|NCT00003451|refractory multiple myeloma|refractory multiple myeloma
837035|NCT00003451|Waldenström macroglobulinemia|waldenström macroglobulinemia
837036|NCT00003451|stage III multiple myeloma|stage iii multiple myeloma
837037|NCT00003451|stage IV chronic lymphocytic leukemia|stage iv chronic lymphocytic leukemia
837038|NCT00003451|recurrent adult acute myeloid leukemia|recurrent adult acute myeloid leukemia
837039|NCT00003451|recurrent adult acute lymphoblastic leukemia|recurrent adult acute lymphoblastic leukemia
837040|NCT00003451|relapsing chronic myelogenous leukemia|relapsing chronic myelogenous leukemia
837041|NCT00003451|refractory chronic lymphocytic leukemia|refractory chronic lymphocytic leukemia
837042|NCT00003451|unspecified adult solid tumor, protocol specific|unspecified adult solid tumor, protocol specific
837043|NCT00003451|chronic phase chronic myelogenous leukemia|chronic phase chronic myelogenous leukemia
837044|NCT00003451|accelerated phase chronic myelogenous leukemia|accelerated phase chronic myelogenous leukemia
837045|NCT00003451|blastic phase chronic myelogenous leukemia|blastic phase chronic myelogenous leukemia
837046|NCT00003451|meningeal chronic myelogenous leukemia|meningeal chronic myelogenous leukemia
837047|NCT00003451|untreated adult acute lymphoblastic leukemia|untreated adult acute lymphoblastic leukemia
837048|NCT00003451|untreated adult acute myeloid leukemia|untreated adult acute myeloid leukemia
837049|NCT00003451|adult acute myeloid leukemia in remission|adult acute myeloid leukemia in remission
837050|NCT00003451|adult acute lymphoblastic leukemia in remission|adult acute lymphoblastic leukemia in remission
837051|NCT00003451|polycythemia vera|polycythemia vera
837052|NCT00003451|primary myelofibrosis|primary myelofibrosis
837053|NCT00003451|essential thrombocythemia|essential thrombocythemia
837054|NCT00003451|untreated hairy cell leukemia|untreated hairy cell leukemia
837055|NCT00003451|progressive hairy cell leukemia, initial treatment|progressive hairy cell leukemia, initial treatment
837056|NCT00003451|refractory hairy cell leukemia|refractory hairy cell leukemia
837057|NCT00003451|chronic myelomonocytic leukemia|chronic myelomonocytic leukemia
837058|NCT00003451|T-cell large granular lymphocyte leukemia|t-cell large granular lymphocyte leukemia
837059|NCT00003451|acute undifferentiated leukemia|acute undifferentiated leukemia
837060|NCT00003451|stage III grade 1 follicular lymphoma|stage iii grade 1 follicular lymphoma
837061|NCT00003451|stage III grade 2 follicular lymphoma|stage iii grade 2 follicular lymphoma
837062|NCT00003451|stage III grade 3 follicular lymphoma|stage iii grade 3 follicular lymphoma
837063|NCT00003451|stage III adult diffuse small cleaved cell lymphoma|stage iii adult diffuse small cleaved cell lymphoma
837064|NCT00003451|stage III adult diffuse mixed cell lymphoma|stage iii adult diffuse mixed cell lymphoma
837065|NCT00003451|stage III adult diffuse large cell lymphoma|stage iii adult diffuse large cell lymphoma
837066|NCT00003451|stage III adult immunoblastic large cell lymphoma|stage iii adult immunoblastic large cell lymphoma
837067|NCT00003451|stage III adult lymphoblastic lymphoma|stage iii adult lymphoblastic lymphoma
837068|NCT00003451|stage III adult Burkitt lymphoma|stage iii adult burkitt lymphoma
837069|NCT00003451|stage IV grade 1 follicular lymphoma|stage iv grade 1 follicular lymphoma
837070|NCT00003451|stage IV grade 2 follicular lymphoma|stage iv grade 2 follicular lymphoma
837071|NCT00003451|stage IV grade 3 follicular lymphoma|stage iv grade 3 follicular lymphoma
837072|NCT00003451|stage IV adult diffuse small cleaved cell lymphoma|stage iv adult diffuse small cleaved cell lymphoma
837073|NCT00003451|stage IV adult diffuse mixed cell lymphoma|stage iv adult diffuse mixed cell lymphoma
837074|NCT00003451|stage IV adult diffuse large cell lymphoma|stage iv adult diffuse large cell lymphoma
837075|NCT00003451|stage IV adult immunoblastic large cell lymphoma|stage iv adult immunoblastic large cell lymphoma
837076|NCT00003451|stage IV adult lymphoblastic lymphoma|stage iv adult lymphoblastic lymphoma
837077|NCT00003451|stage IV adult Burkitt lymphoma|stage iv adult burkitt lymphoma
837078|NCT00003451|recurrent grade 1 follicular lymphoma|recurrent grade 1 follicular lymphoma
837079|NCT00003451|recurrent grade 2 follicular lymphoma|recurrent grade 2 follicular lymphoma
837080|NCT00003451|recurrent grade 3 follicular lymphoma|recurrent grade 3 follicular lymphoma
837081|NCT00003451|recurrent adult diffuse small cleaved cell lymphoma|recurrent adult diffuse small cleaved cell lymphoma
837082|NCT00003451|recurrent adult diffuse mixed cell lymphoma|recurrent adult diffuse mixed cell lymphoma
837083|NCT00003451|recurrent adult diffuse large cell lymphoma|recurrent adult diffuse large cell lymphoma
837084|NCT00003451|recurrent adult immunoblastic large cell lymphoma|recurrent adult immunoblastic large cell lymphoma
837085|NCT00003451|recurrent adult lymphoblastic lymphoma|recurrent adult lymphoblastic lymphoma
837086|NCT00003451|recurrent adult Burkitt lymphoma|recurrent adult burkitt lymphoma
837087|NCT00003451|stage III adult T-cell leukemia/lymphoma|stage iii adult t-cell leukemia/lymphoma
837088|NCT00003451|stage IV adult T-cell leukemia/lymphoma|stage iv adult t-cell leukemia/lymphoma
837089|NCT00003451|recurrent adult T-cell leukemia/lymphoma|recurrent adult t-cell leukemia/lymphoma
837090|NCT00003451|secondary acute myeloid leukemia|secondary acute myeloid leukemia
837091|NCT00003451|de novo myelodysplastic syndromes|de novo myelodysplastic syndromes
837092|NCT00003451|previously treated myelodysplastic syndromes|previously treated myelodysplastic syndromes
837093|NCT00003451|secondary myelodysplastic syndromes|secondary myelodysplastic syndromes
837094|NCT00003451|prolymphocytic leukemia|prolymphocytic leukemia
837095|NCT00003451|primary systemic amyloidosis|primary systemic amyloidosis
837096|NCT00003451|stage III mantle cell lymphoma|stage iii mantle cell lymphoma
837097|NCT00003451|stage IV mantle cell lymphoma|stage iv mantle cell lymphoma
837098|NCT00003451|recurrent mantle cell lymphoma|recurrent mantle cell lymphoma
837099|NCT00003451|angioimmunoblastic T-cell lymphoma|angioimmunoblastic t-cell lymphoma
837100|NCT00003451|anaplastic large cell lymphoma|anaplastic large cell lymphoma
837101|NCT00003451|recurrent marginal zone lymphoma|recurrent marginal zone lymphoma
837102|NCT00003451|recurrent small lymphocytic lymphoma|recurrent small lymphocytic lymphoma
837103|NCT00003451|stage III small lymphocytic lymphoma|stage iii small lymphocytic lymphoma
837104|NCT00003451|stage III marginal zone lymphoma|stage iii marginal zone lymphoma
837105|NCT00003451|stage IV small lymphocytic lymphoma|stage iv small lymphocytic lymphoma
837106|NCT00003451|stage IV marginal zone lymphoma|stage iv marginal zone lymphoma
837107|NCT00003451|extranodal marginal zone B-cell lymphoma of mucosa-associated lymphoid tissue|extranodal marginal zone b-cell lymphoma of mucosa-associated lymphoid tissue
837108|NCT00003451|nodal marginal zone B-cell lymphoma|nodal marginal zone b-cell lymphoma
837109|NCT00003451|splenic marginal zone lymphoma|splenic marginal zone lymphoma
837110|NCT00003451|childhood myelodysplastic syndromes|childhood myelodysplastic syndromes
837111|NCT00003441|stage IV colon cancer|stage iv colon cancer
837112|NCT00003441|stage IV rectal cancer|stage iv rectal cancer
837113|NCT00003441|recurrent colon cancer|recurrent colon cancer
837114|NCT00003441|recurrent rectal cancer|recurrent rectal cancer
837115|NCT00003441|adenocarcinoma of the colon|adenocarcinoma of the colon
837116|NCT00003441|adenocarcinoma of the rectum|adenocarcinoma of the rectum
837117|NCT00003441|6-hydroxymethylacylfulvene|6-hydroxymethylacylfulvene
837118|NCT00003441|MGI-114|mgi-114
837119|NCT00003441|Irofulven|irofulven
837120|NCT00003430|recurrent nasopharyngeal cancer|recurrent nasopharyngeal cancer
837121|NCT00003430|unspecified adult solid tumor, protocol specific|unspecified adult solid tumor, protocol specific
837122|NCT00003430|recurrent lip and oral cavity cancer|recurrent lip and oral cavity cancer
837123|NCT00003430|recurrent hypopharyngeal cancer|recurrent hypopharyngeal cancer
837124|NCT00003430|recurrent laryngeal cancer|recurrent laryngeal cancer
837125|NCT00003430|recurrent paranasal sinus and nasal cavity cancer|recurrent paranasal sinus and nasal cavity cancer
837126|NCT00003430|recurrent oropharyngeal cancer|recurrent oropharyngeal cancer
837127|NCT00003428|stage IV breast cancer|stage iv breast cancer
837128|NCT00003428|recurrent breast cancer|recurrent breast cancer
837129|NCT00003353|primary systemic amyloidosis|primary systemic amyloidosis
837130|NCT00003344|stage II colon cancer|stage ii colon cancer
837131|NCT00003344|stage III colon cancer|stage iii colon cancer
837132|NCT00003344|stage II rectal cancer|stage ii rectal cancer
837133|NCT00003344|stage III rectal cancer|stage iii rectal cancer
837134|NCT00003344|recurrent colon cancer|recurrent colon cancer
837135|NCT00003344|recurrent rectal cancer|recurrent rectal cancer
837136|NCT00003339|recurrent intraocular melanoma|recurrent intraocular melanoma
837137|NCT00003339|stage III melanoma|stage iii melanoma
837138|NCT00003339|stage IV melanoma|stage iv melanoma
837139|NCT00003339|recurrent melanoma|recurrent melanoma
837140|NCT00003331|stage III adult Hodgkin lymphoma|stage iii adult hodgkin lymphoma
837141|NCT00003331|stage IV adult Hodgkin lymphoma|stage iv adult hodgkin lymphoma
837142|NCT00003331|monoclonal gammopathy of undetermined significance|monoclonal gammopathy of undetermined significance
837352|NCT00090961|pulmonary complications|pulmonary complications
837143|NCT00003331|recurrent adult Hodgkin lymphoma|recurrent adult hodgkin lymphoma
837144|NCT00003331|isolated plasmacytoma of bone|isolated plasmacytoma of bone
837145|NCT00003331|extramedullary plasmacytoma|extramedullary plasmacytoma
837146|NCT00003331|refractory multiple myeloma|refractory multiple myeloma
837147|NCT00003331|Waldenstrom macroglobulinemia|waldenstrom macroglobulinemia
837148|NCT00003331|stage III multiple myeloma|stage iii multiple myeloma
837149|NCT00003331|stage IV chronic lymphocytic leukemia|stage iv chronic lymphocytic leukemia
837150|NCT00003331|recurrent adult acute myeloid leukemia|recurrent adult acute myeloid leukemia
837151|NCT00003331|recurrent adult acute lymphoblastic leukemia|recurrent adult acute lymphoblastic leukemia
837152|NCT00003331|relapsing chronic myelogenous leukemia|relapsing chronic myelogenous leukemia
837153|NCT00003331|refractory chronic lymphocytic leukemia|refractory chronic lymphocytic leukemia
837154|NCT00003331|unspecified adult solid tumor, protocol specific|unspecified adult solid tumor, protocol specific
837155|NCT00003331|chronic phase chronic myelogenous leukemia|chronic phase chronic myelogenous leukemia
837156|NCT00003331|accelerated phase chronic myelogenous leukemia|accelerated phase chronic myelogenous leukemia
837157|NCT00003331|blastic phase chronic myelogenous leukemia|blastic phase chronic myelogenous leukemia
837158|NCT00003331|meningeal chronic myelogenous leukemia|meningeal chronic myelogenous leukemia
837159|NCT00003331|untreated adult acute lymphoblastic leukemia|untreated adult acute lymphoblastic leukemia
837160|NCT00003331|untreated adult acute myeloid leukemia|untreated adult acute myeloid leukemia
837161|NCT00003331|adult acute myeloid leukemia in remission|adult acute myeloid leukemia in remission
837162|NCT00003331|adult acute lymphoblastic leukemia in remission|adult acute lymphoblastic leukemia in remission
837163|NCT00003331|polycythemia vera|polycythemia vera
837164|NCT00003331|primary myelofibrosis|primary myelofibrosis
837165|NCT00003331|essential thrombocythemia|essential thrombocythemia
837166|NCT00003331|untreated hairy cell leukemia|untreated hairy cell leukemia
837167|NCT00003331|progressive hairy cell leukemia, initial treatment|progressive hairy cell leukemia, initial treatment
837168|NCT00003331|refractory hairy cell leukemia|refractory hairy cell leukemia
837169|NCT00003331|chronic myelomonocytic leukemia|chronic myelomonocytic leukemia
837170|NCT00003331|T-cell large granular lymphocyte leukemia|t-cell large granular lymphocyte leukemia
837171|NCT00003331|acute undifferentiated leukemia|acute undifferentiated leukemia
837172|NCT00003331|stage III grade 1 follicular lymphoma|stage iii grade 1 follicular lymphoma
837173|NCT00003331|stage III grade 2 follicular lymphoma|stage iii grade 2 follicular lymphoma
837174|NCT00003331|stage III grade 3 follicular lymphoma|stage iii grade 3 follicular lymphoma
837175|NCT00003331|stage III adult diffuse small cleaved cell lymphoma|stage iii adult diffuse small cleaved cell lymphoma
837176|NCT00003331|stage III adult diffuse mixed cell lymphoma|stage iii adult diffuse mixed cell lymphoma
837177|NCT00003331|stage III adult diffuse large cell lymphoma|stage iii adult diffuse large cell lymphoma
837178|NCT00003331|stage III adult immunoblastic large cell lymphoma|stage iii adult immunoblastic large cell lymphoma
837179|NCT00003331|stage III adult lymphoblastic lymphoma|stage iii adult lymphoblastic lymphoma
837180|NCT00003331|stage III adult Burkitt lymphoma|stage iii adult burkitt lymphoma
837181|NCT00003331|stage IV grade 1 follicular lymphoma|stage iv grade 1 follicular lymphoma
837182|NCT00003331|stage IV grade 2 follicular lymphoma|stage iv grade 2 follicular lymphoma
837183|NCT00003331|stage IV grade 3 follicular lymphoma|stage iv grade 3 follicular lymphoma
837184|NCT00003331|stage IV adult diffuse small cleaved cell lymphoma|stage iv adult diffuse small cleaved cell lymphoma
837185|NCT00003331|stage IV adult diffuse mixed cell lymphoma|stage iv adult diffuse mixed cell lymphoma
837186|NCT00003331|stage IV adult diffuse large cell lymphoma|stage iv adult diffuse large cell lymphoma
837187|NCT00003331|stage IV adult immunoblastic large cell lymphoma|stage iv adult immunoblastic large cell lymphoma
837188|NCT00003331|stage IV adult lymphoblastic lymphoma|stage iv adult lymphoblastic lymphoma
837189|NCT00003331|stage IV adult Burkitt lymphoma|stage iv adult burkitt lymphoma
837190|NCT00003331|recurrent grade 1 follicular lymphoma|recurrent grade 1 follicular lymphoma
837191|NCT00003331|recurrent grade 2 follicular lymphoma|recurrent grade 2 follicular lymphoma
837192|NCT00003331|recurrent grade 3 follicular lymphoma|recurrent grade 3 follicular lymphoma
837193|NCT00003331|recurrent adult diffuse small cleaved cell lymphoma|recurrent adult diffuse small cleaved cell lymphoma
837194|NCT00003331|recurrent adult diffuse mixed cell lymphoma|recurrent adult diffuse mixed cell lymphoma
837195|NCT00003331|recurrent adult diffuse large cell lymphoma|recurrent adult diffuse large cell lymphoma
837196|NCT00003331|recurrent adult immunoblastic large cell lymphoma|recurrent adult immunoblastic large cell lymphoma
837197|NCT00003331|recurrent adult lymphoblastic lymphoma|recurrent adult lymphoblastic lymphoma
837198|NCT00003331|recurrent adult Burkitt lymphoma|recurrent adult burkitt lymphoma
837199|NCT00003331|stage III adult T-cell leukemia/lymphoma|stage iii adult t-cell leukemia/lymphoma
837200|NCT00003331|stage IV adult T-cell leukemia/lymphoma|stage iv adult t-cell leukemia/lymphoma
837271|NCT00091351|adult angiosarcoma|adult angiosarcoma
837201|NCT00003331|recurrent adult T-cell leukemia/lymphoma|recurrent adult t-cell leukemia/lymphoma
837202|NCT00003331|secondary acute myeloid leukemia|secondary acute myeloid leukemia
837203|NCT00003331|de novo myelodysplastic syndromes|de novo myelodysplastic syndromes
837204|NCT00003331|previously treated myelodysplastic syndromes|previously treated myelodysplastic syndromes
837205|NCT00003331|secondary myelodysplastic syndromes|secondary myelodysplastic syndromes
837206|NCT00003331|prolymphocytic leukemia|prolymphocytic leukemia
837207|NCT00003331|AIDS-related peripheral/systemic lymphoma|aids-related peripheral/systemic lymphoma
837208|NCT00003331|AIDS-related primary CNS lymphoma|aids-related primary cns lymphoma
837209|NCT00003331|primary systemic amyloidosis|primary systemic amyloidosis
837210|NCT00003331|stage III mantle cell lymphoma|stage iii mantle cell lymphoma
837211|NCT00003331|stage IV mantle cell lymphoma|stage iv mantle cell lymphoma
837212|NCT00003331|recurrent mantle cell lymphoma|recurrent mantle cell lymphoma
837213|NCT00003331|angioimmunoblastic T-cell lymphoma|angioimmunoblastic t-cell lymphoma
837214|NCT00003331|anaplastic large cell lymphoma|anaplastic large cell lymphoma
837215|NCT00003331|recurrent marginal zone lymphoma|recurrent marginal zone lymphoma
837216|NCT00003331|recurrent small lymphocytic lymphoma|recurrent small lymphocytic lymphoma
837217|NCT00003331|stage III small lymphocytic lymphoma|stage iii small lymphocytic lymphoma
837218|NCT00003331|stage III marginal zone lymphoma|stage iii marginal zone lymphoma
837219|NCT00003331|stage IV small lymphocytic lymphoma|stage iv small lymphocytic lymphoma
837220|NCT00003331|stage IV marginal zone lymphoma|stage iv marginal zone lymphoma
837221|NCT00003331|extranodal marginal zone B-cell lymphoma of mucosa-associated lymphoid tissue|extranodal marginal zone b-cell lymphoma of mucosa-associated lymphoid tissue
837222|NCT00003331|nodal marginal zone B-cell lymphoma|nodal marginal zone b-cell lymphoma
837223|NCT00003331|splenic marginal zone lymphoma|splenic marginal zone lymphoma
837224|NCT00003288|unspecified childhood solid tumor, protocol specific|unspecified childhood solid tumor, protocol specific
837225|NCT00003263|localized malignant mesothelioma|localized malignant mesothelioma
837226|NCT00091533|fMRI|fmri
837227|NCT00091533|Mirror Neuron System|mirror neuron system
837228|NCT00091533|Bimodal Neurons|bimodal neurons
837229|NCT00091533|Somatosensory Cortex|somatosensory cortex
837230|NCT00091533|Rehabilitation|rehabilitation
837231|NCT00091533|Healthy Volunteer|healthy volunteer
837232|NCT00091533|HV|hv
837233|NCT00091429|Angina|angina
837234|NCT00091429|Chest Pain|chest pain
837235|NCT00091429|Coronary Artery Disease|coronary artery disease
837236|NCT00091429|Heart Disease|heart disease
837237|NCT00003257|recurrent metastatic squamous neck cancer with occult primary|recurrent metastatic squamous neck cancer with occult primary
837238|NCT00003257|recurrent squamous cell carcinoma of the lip and oral cavity|recurrent squamous cell carcinoma of the lip and oral cavity
837239|NCT00003257|recurrent squamous cell carcinoma of the oropharynx|recurrent squamous cell carcinoma of the oropharynx
837240|NCT00003257|recurrent squamous cell carcinoma of the nasopharynx|recurrent squamous cell carcinoma of the nasopharynx
837241|NCT00003257|recurrent squamous cell carcinoma of the hypopharynx|recurrent squamous cell carcinoma of the hypopharynx
837242|NCT00003257|recurrent squamous cell carcinoma of the larynx|recurrent squamous cell carcinoma of the larynx
837243|NCT00003257|recurrent squamous cell carcinoma of the paranasal sinus and nasal cavity|recurrent squamous cell carcinoma of the paranasal sinus and nasal cavity
837244|NCT00003252|unspecified adult solid tumor, protocol specific|unspecified adult solid tumor, protocol specific
837245|NCT00003252|drug/agent toxicity by tissue/organ|drug/agent toxicity by tissue/organ
837246|NCT00003248|stage I chronic lymphocytic leukemia|stage i chronic lymphocytic leukemia
837247|NCT00003248|stage II chronic lymphocytic leukemia|stage ii chronic lymphocytic leukemia
837248|NCT00003248|stage III chronic lymphocytic leukemia|stage iii chronic lymphocytic leukemia
837249|NCT00003248|stage IV chronic lymphocytic leukemia|stage iv chronic lymphocytic leukemia
837250|NCT00003248|B-cell chronic lymphocytic leukemia|b-cell chronic lymphocytic leukemia
837251|NCT00003241|recurrent childhood brain tumor|recurrent childhood brain tumor
837252|NCT00003241|childhood high-grade cerebral astrocytoma|childhood high-grade cerebral astrocytoma
837253|NCT00003241|untreated childhood brain stem glioma|untreated childhood brain stem glioma
837254|NCT00003241|recurrent childhood brain stem glioma|recurrent childhood brain stem glioma
837255|NCT00003241|recurrent childhood supratentorial primitive neuroectodermal tumor|recurrent childhood supratentorial primitive neuroectodermal tumor
837256|NCT00003241|recurrent childhood cerebellar astrocytoma|recurrent childhood cerebellar astrocytoma
837257|NCT00003241|recurrent childhood cerebral astrocytoma|recurrent childhood cerebral astrocytoma
837258|NCT00003241|recurrent childhood medulloblastoma|recurrent childhood medulloblastoma
837259|NCT00003241|recurrent childhood ependymoma|recurrent childhood ependymoma
837260|NCT00003223|lip and oral cavity cancer|lip and oral cavity cancer
837261|NCT00091416|HIV Seronegativity|hiv seronegativity
837262|NCT00091416|HIV Preventive Vaccine|hiv preventive vaccine
837263|NCT00091390|adenocarcinoma of the prostate|adenocarcinoma of the prostate
837264|NCT00091390|stage IIB prostate cancer|stage iib prostate cancer
837265|NCT00091390|stage IIA prostate cancer|stage iia prostate cancer
837266|NCT00091390|stage III prostate cancer|stage iii prostate cancer
837267|NCT00091377|recurrent ovarian epithelial cancer|recurrent ovarian epithelial cancer
837268|NCT00091377|fallopian tube cancer|fallopian tube cancer
837269|NCT00091377|primary peritoneal cavity cancer|primary peritoneal cavity cancer
837270|NCT00091351|adult alveolar soft-part sarcoma|adult alveolar soft-part sarcoma
837272|NCT00091351|adult epithelioid sarcoma|adult epithelioid sarcoma
837273|NCT00091351|adult fibrosarcoma|adult fibrosarcoma
837274|NCT00091351|adult leiomyosarcoma|adult leiomyosarcoma
837275|NCT00091351|adult liposarcoma|adult liposarcoma
837276|NCT00091351|adult neurofibrosarcoma|adult neurofibrosarcoma
837277|NCT00091351|adult synovial sarcoma|adult synovial sarcoma
837278|NCT00091351|adult malignant fibrous histiocytoma|adult malignant fibrous histiocytoma
837279|NCT00091351|stage I adult soft tissue sarcoma|stage i adult soft tissue sarcoma
837636|NCT00090662|HV|hv
837280|NCT00091351|stage II adult soft tissue sarcoma|stage ii adult soft tissue sarcoma
837281|NCT00091351|stage III adult soft tissue sarcoma|stage iii adult soft tissue sarcoma
837282|NCT00091338|recurrent melanoma|recurrent melanoma
837283|NCT00091338|stage IV melanoma|stage iv melanoma
837284|NCT00091325|unspecified adult solid tumor, protocol specific|unspecified adult solid tumor, protocol specific
837285|NCT00091312|stage II colon cancer|stage ii colon cancer
837286|NCT00091312|adenocarcinoma of the colon|adenocarcinoma of the colon
837287|NCT00091299|unspecified adult solid tumor, protocol specific|unspecified adult solid tumor, protocol specific
837288|NCT00091286|recurrent colon cancer|recurrent colon cancer
837289|NCT00091286|stage IIB colon cancer|stage iib colon cancer
837290|NCT00091286|stage IIIA colon cancer|stage iiia colon cancer
837291|NCT00091286|stage IIIB colon cancer|stage iiib colon cancer
837292|NCT00091286|stage IIIC colon cancer|stage iiic colon cancer
837293|NCT00091286|stage IVA colon cancer|stage iva colon cancer
837294|NCT00091286|stage IVB colon cancer|stage ivb colon cancer
837295|NCT00091286|recurrent rectal cancer|recurrent rectal cancer
837296|NCT00091286|stage IIB rectal cancer|stage iib rectal cancer
837297|NCT00091286|stage IIIA rectal cancer|stage iiia rectal cancer
837298|NCT00091286|stage IIIB rectal cancer|stage iiib rectal cancer
837299|NCT00091286|stage IIIC rectal cancer|stage iiic rectal cancer
837300|NCT00091286|stage IVA rectal cancer|stage iva rectal cancer
837301|NCT00091286|stage IVB rectal cancer|stage ivb rectal cancer
837302|NCT00091273|stage I ovarian epithelial cancer|stage i ovarian epithelial cancer
837303|NCT00091273|stage II ovarian epithelial cancer|stage ii ovarian epithelial cancer
837304|NCT00091273|stage III ovarian epithelial cancer|stage iii ovarian epithelial cancer
837305|NCT00091273|stage IV ovarian epithelial cancer|stage iv ovarian epithelial cancer
837306|NCT00091273|primary peritoneal cavity cancer|primary peritoneal cavity cancer
837307|NCT00091260|primary systemic amyloidosis|primary systemic amyloidosis
837308|NCT00091247|unspecified adult solid tumor, protocol specific|unspecified adult solid tumor, protocol specific
837309|NCT00091234|adult acute myeloid leukemia with 11q23 (MLL) abnormalities|adult acute myeloid leukemia with 11q23 (mll) abnormalities
837310|NCT00091234|adult acute myeloid leukemia with inv(16)(p13;q22)|adult acute myeloid leukemia with inv(16)(p13;q22)
837311|NCT00091234|adult acute myeloid leukemia with t(16;16)(p13;q22)|adult acute myeloid leukemia with t(16;16)(p13;q22)
837312|NCT00091234|adult acute myeloid leukemia with t(8;21)(q22;q22)|adult acute myeloid leukemia with t(8;21)(q22;q22)
837313|NCT00091234|untreated adult acute myeloid leukemia|untreated adult acute myeloid leukemia
837314|NCT00091234|secondary acute myeloid leukemia|secondary acute myeloid leukemia
837315|NCT00091234|adult acute basophilic leukemia|adult acute basophilic leukemia
837316|NCT00091234|adult acute eosinophilic leukemia|adult acute eosinophilic leukemia
837317|NCT00091234|adult erythroleukemia (M6a)|adult erythroleukemia (m6a)
837318|NCT00091234|adult pure erythroid leukemia (M6b)|adult pure erythroid leukemia (m6b)
837319|NCT00091234|adult acute megakaryoblastic leukemia (M7)|adult acute megakaryoblastic leukemia (m7)
837320|NCT00091234|adult acute minimally differentiated myeloid leukemia (M0)|adult acute minimally differentiated myeloid leukemia (m0)
837321|NCT00091234|adult acute monoblastic leukemia (M5a)|adult acute monoblastic leukemia (m5a)
837322|NCT00091234|adult acute monocytic leukemia (M5b)|adult acute monocytic leukemia (m5b)
837323|NCT00091234|adult acute myeloblastic leukemia with maturation (M2)|adult acute myeloblastic leukemia with maturation (m2)
837324|NCT00091234|adult acute myeloblastic leukemia without maturation (M1)|adult acute myeloblastic leukemia without maturation (m1)
837325|NCT00091234|adult acute myelomonocytic leukemia (M4)|adult acute myelomonocytic leukemia (m4)
837326|NCT00091169|fatigue|fatigue
837327|NCT00091169|unspecified adult solid tumor, protocol specific|unspecified adult solid tumor, protocol specific
837328|NCT00091169|levocarnitine|levocarnitine
837329|NCT00091169|depression|depression
837330|NCT00091169|pain|pain
837331|NCT00091169|carnitine deficiency|carnitine deficiency
837332|NCT00091156|stage IIIB non-small cell lung cancer|stage iiib non-small cell lung cancer
837333|NCT00091156|stage IV non-small cell lung cancer|stage iv non-small cell lung cancer
837334|NCT00091143|recurrent melanoma|recurrent melanoma
837335|NCT00091143|stage III melanoma|stage iii melanoma
837336|NCT00091143|stage IV melanoma|stage iv melanoma
837337|NCT00091104|stage IV melanoma|stage iv melanoma
837338|NCT00091104|recurrent melanoma|recurrent melanoma
837339|NCT00091091|long-term effects secondary to cancer therapy in children|long-term effects secondary to cancer therapy in children
837340|NCT00091091|stage I childhood Hodgkin lymphoma|stage i childhood hodgkin lymphoma
837341|NCT00091091|stage II childhood Hodgkin lymphoma|stage ii childhood hodgkin lymphoma
837342|NCT00091091|stage III childhood Hodgkin lymphoma|stage iii childhood hodgkin lymphoma
837343|NCT00091091|stage IV childhood Hodgkin lymphoma|stage iv childhood hodgkin lymphoma
837344|NCT00091052|unspecified adult solid tumor, protocol specific|unspecified adult solid tumor, protocol specific
837431|NCT00003088|stage II breast cancer|stage ii breast cancer
837345|NCT00091039|stage IIIA non-small cell lung cancer|stage iiia non-small cell lung cancer
837346|NCT00091039|stage IIIB non-small cell lung cancer|stage iiib non-small cell lung cancer
837347|NCT00090987|AIDS-related Kaposi sarcoma|aids-related kaposi sarcoma
837348|NCT00090987|recurrent Kaposi sarcoma|recurrent kaposi sarcoma
837349|NCT00090974|stage I breast cancer|stage i breast cancer
837350|NCT00090974|stage II breast cancer|stage ii breast cancer
837351|NCT00090974|stage IIIA breast cancer|stage iiia breast cancer
839265|NCT00088907|docetaxel|docetaxel
837353|NCT00090961|stage IIIA non-small cell lung cancer|stage iiia non-small cell lung cancer
837354|NCT00090961|stage IIIB non-small cell lung cancer|stage iiib non-small cell lung cancer
837355|NCT00090961|squamous cell lung cancer|squamous cell lung cancer
837356|NCT00090961|large cell lung cancer|large cell lung cancer
837357|NCT00090961|adenocarcinoma of the lung|adenocarcinoma of the lung
837358|NCT00090961|bronchoalveolar cell lung cancer|bronchoalveolar cell lung cancer
837359|NCT00090961|limited stage small cell lung cancer|limited stage small cell lung cancer
837360|NCT00090909|recurrent adult Hodgkin lymphoma|recurrent adult hodgkin lymphoma
837361|NCT00090896|recurrent melanoma|recurrent melanoma
837362|NCT00090896|stage III melanoma|stage iii melanoma
837363|NCT00090896|stage IV melanoma|stage iv melanoma
837364|NCT00090870|stage IV renal cell cancer|stage iv renal cell cancer
837365|NCT00090857|breast cancer|breast cancer
837366|NCT00090857|stage I breast cancer|stage i breast cancer
837367|NCT00090857|stage II breast cancer|stage ii breast cancer
837368|NCT00090857|stage IIIA breast cancer|stage iiia breast cancer
837369|NCT00090857|stage IIIB breast cancer|stage iiib breast cancer
837370|NCT00090857|stage IIIC breast cancer|stage iiic breast cancer
837371|NCT00090857|stage IV breast cancer|stage iv breast cancer
837372|NCT00090857|breast cancer in situ|breast cancer in situ
837373|NCT00090857|ductal breast carcinoma in situ|ductal breast carcinoma in situ
837374|NCT00090844|drug/agent toxicity by tissue/organ|drug/agent toxicity by tissue/organ
837375|NCT00090844|hormone changes|hormone changes
837376|NCT00090844|stage I breast cancer|stage i breast cancer
837377|NCT00090844|stage II breast cancer|stage ii breast cancer
837378|NCT00090831|Emotional Learning|emotional learning
837379|NCT00090831|Neurotransmitter|neurotransmitter
837380|NCT00090831|Neural Systems|neural systems
837381|NCT00090831|Response Control|response control
837382|NCT00090831|Orbitofrontal Cortex|orbitofrontal cortex
837383|NCT00090831|Amygdala|amygdala
837384|NCT00090831|Serotonin|serotonin
837385|NCT00090831|Healthy Volunteer|healthy volunteer
837387|NCT00090818|Dental Abnormalities|dental abnormalities
837388|NCT00090818|Lichen Planus|lichen planus
837389|NCT00090818|Oral Mucosal Disease|oral mucosal disease
837390|NCT00090818|Genetic Disease|genetic disease
837391|NCT00090818|Amelogensis Imperfecta|amelogensis imperfecta
837392|NCT00090818|Maxillofacial Abnormalities|maxillofacial abnormalities
837393|NCT00090818|Craniofacial Abnormalities|craniofacial abnormalities
837394|NCT00090818|Craniofacial Genetic Abnormalities|craniofacial genetic abnormalities
837395|NCT00090779|Acute Infection|acute infection
837396|NCT00090779|Treatment Naive|treatment naive
837397|NCT00090727|diffuse|diffuse
837398|NCT00090727|follicular|follicular
837399|NCT00090727|chronic lymphocytic leukemia|chronic lymphocytic leukemia
837400|NCT00090727|colorectal cancer|colorectal cancer
837401|NCT00090727|pancreatic cancer|pancreatic cancer
837402|NCT00090727|acute myelogenous leukemia|acute myelogenous leukemia
837403|NCT00090727|head and neck cancer|head and neck cancer
837404|NCT00090727|breast cancer|breast cancer
837405|NCT00090727|prostate cancer|prostate cancer
837406|NCT00090727|ovarian cancer|ovarian cancer
837407|NCT00090727|bladder cancer|bladder cancer
837408|NCT00090727|hypoxia|hypoxia
837409|NCT00090727|refractory|refractory
837410|NCT00090727|metastatic|metastatic
837411|NCT00090714|DNA|dna
837412|NCT00090714|Circular|circular
837413|NCT00090714|Gene Therapy|gene therapy
837414|NCT00003217|childhood Burkitt lymphoma|childhood burkitt lymphoma
837415|NCT00003217|untreated childhood acute lymphoblastic leukemia|untreated childhood acute lymphoblastic leukemia
837416|NCT00003217|B-cell childhood acute lymphoblastic leukemia|b-cell childhood acute lymphoblastic leukemia
837417|NCT00003217|stage III childhood small noncleaved cell lymphoma|stage iii childhood small noncleaved cell lymphoma
837418|NCT00003217|stage IV childhood small noncleaved cell lymphoma|stage iv childhood small noncleaved cell lymphoma
837419|NCT00003172|stage III gastric cancer|stage iii gastric cancer
837420|NCT00003172|stage IV gastric cancer|stage iv gastric cancer
837421|NCT00003172|recurrent gastric cancer|recurrent gastric cancer
837422|NCT00003139|oral complications|oral complications
837423|NCT00003139|lip and oral cavity squamous cell carcinoma|lip and oral cavity squamous cell carcinoma
837424|NCT00003139|oropharyngeal squamous cell carcinoma|oropharyngeal squamous cell carcinoma
837425|NCT00003134|recurrent adult brain tumor|recurrent adult brain tumor
837426|NCT00003134|adult brain stem glioma|adult brain stem glioma
837427|NCT00003134|adult oligodendroglioma|adult oligodendroglioma
837428|NCT00003134|adult mixed glioma|adult mixed glioma
837429|NCT00003134|adult diffuse astrocytoma|adult diffuse astrocytoma
837430|NCT00003100|unspecified adult solid tumor, protocol specific|unspecified adult solid tumor, protocol specific
837432|NCT00003088|stage IIIA breast cancer|stage iiia breast cancer
837433|NCT00003072|stage III non-small cell lung cancer|stage iii non-small cell lung cancer
837434|NCT00003072|stage III ovarian epithelial cancer|stage iii ovarian epithelial cancer
837435|NCT00003072|stage IV ovarian epithelial cancer|stage iv ovarian epithelial cancer
837436|NCT00003072|stage IV non-small cell lung cancer|stage iv non-small cell lung cancer
837437|NCT00003072|neurotoxicity|neurotoxicity
837438|NCT00003048|de novo myelodysplastic syndromes|de novo myelodysplastic syndromes
837439|NCT00003048|previously treated myelodysplastic syndromes|previously treated myelodysplastic syndromes
837440|NCT00003048|secondary myelodysplastic syndromes|secondary myelodysplastic syndromes
837441|NCT00003048|Amifostine|amifostine
837442|NCT00003048|Ethyol|ethyol
837443|NCT00003048|Ethiofos|ethiofos
837444|NCT00003048|Gammaphos|gammaphos
837445|NCT00003039|recurrent grade 3 follicular lymphoma|recurrent grade 3 follicular lymphoma
837446|NCT00003039|recurrent adult diffuse small cleaved cell lymphoma|recurrent adult diffuse small cleaved cell lymphoma
837447|NCT00003039|recurrent adult diffuse mixed cell lymphoma|recurrent adult diffuse mixed cell lymphoma
837448|NCT00003039|recurrent adult diffuse large cell lymphoma|recurrent adult diffuse large cell lymphoma
837449|NCT00003039|recurrent adult immunoblastic large cell lymphoma|recurrent adult immunoblastic large cell lymphoma
837450|NCT00003039|recurrent adult lymphoblastic lymphoma|recurrent adult lymphoblastic lymphoma
837451|NCT00003039|recurrent adult Burkitt lymphoma|recurrent adult burkitt lymphoma
837452|NCT00003039|recurrent mantle cell lymphoma|recurrent mantle cell lymphoma
837453|NCT00090688|diarrhea|diarrhea
837454|NCT00003005|recurrent adult acute lymphoblastic leukemia|recurrent adult acute lymphoblastic leukemia
837455|NCT00003005|blastic phase chronic myelogenous leukemia|blastic phase chronic myelogenous leukemia
837456|NCT00003005|TdT positive adult acute lymphoblastic leukemia|tdt positive adult acute lymphoblastic leukemia
837457|NCT00002993|stage III uterine sarcoma|stage iii uterine sarcoma
837458|NCT00002993|stage IV uterine sarcoma|stage iv uterine sarcoma
837459|NCT00002993|recurrent uterine sarcoma|recurrent uterine sarcoma
837460|NCT00002980|stage IV adult Hodgkin lymphoma|stage iv adult hodgkin lymphoma
837461|NCT00002980|monoclonal gammopathy of undetermined significance|monoclonal gammopathy of undetermined significance
837462|NCT00002980|recurrent adult Hodgkin lymphoma|recurrent adult hodgkin lymphoma
837463|NCT00002980|isolated plasmacytoma of bone|isolated plasmacytoma of bone
837464|NCT00002980|extramedullary plasmacytoma|extramedullary plasmacytoma
837465|NCT00002980|refractory multiple myeloma|refractory multiple myeloma
837466|NCT00002980|Waldenström macroglobulinemia|waldenström macroglobulinemia
837467|NCT00002980|stage IV chronic lymphocytic leukemia|stage iv chronic lymphocytic leukemia
837468|NCT00002980|recurrent adult acute myeloid leukemia|recurrent adult acute myeloid leukemia
837469|NCT00002980|recurrent adult acute lymphoblastic leukemia|recurrent adult acute lymphoblastic leukemia
837470|NCT00002980|relapsing chronic myelogenous leukemia|relapsing chronic myelogenous leukemia
837471|NCT00002980|refractory chronic lymphocytic leukemia|refractory chronic lymphocytic leukemia
837472|NCT00002980|unspecified adult solid tumor, protocol specific|unspecified adult solid tumor, protocol specific
837473|NCT00002980|chronic phase chronic myelogenous leukemia|chronic phase chronic myelogenous leukemia
837474|NCT00002980|accelerated phase chronic myelogenous leukemia|accelerated phase chronic myelogenous leukemia
837475|NCT00002980|blastic phase chronic myelogenous leukemia|blastic phase chronic myelogenous leukemia
837476|NCT00002980|untreated adult acute lymphoblastic leukemia|untreated adult acute lymphoblastic leukemia
837477|NCT00002980|untreated adult acute myeloid leukemia|untreated adult acute myeloid leukemia
837478|NCT00002980|adult acute myeloid leukemia in remission|adult acute myeloid leukemia in remission
837479|NCT00002980|adult acute lymphoblastic leukemia in remission|adult acute lymphoblastic leukemia in remission
837480|NCT00002980|polycythemia vera|polycythemia vera
837481|NCT00002980|primary myelofibrosis|primary myelofibrosis
837482|NCT00002980|essential thrombocythemia|essential thrombocythemia
837483|NCT00002980|untreated hairy cell leukemia|untreated hairy cell leukemia
837484|NCT00002980|progressive hairy cell leukemia, initial treatment|progressive hairy cell leukemia, initial treatment
837485|NCT00002980|refractory hairy cell leukemia|refractory hairy cell leukemia
837486|NCT00002980|chronic myelomonocytic leukemia|chronic myelomonocytic leukemia
837487|NCT00002980|T-cell large granular lymphocyte leukemia|t-cell large granular lymphocyte leukemia
837488|NCT00002980|acute undifferentiated leukemia|acute undifferentiated leukemia
837489|NCT00002980|stage IV grade 1 follicular lymphoma|stage iv grade 1 follicular lymphoma
837490|NCT00002980|stage IV grade 2 follicular lymphoma|stage iv grade 2 follicular lymphoma
837491|NCT00002980|stage IV grade 3 follicular lymphoma|stage iv grade 3 follicular lymphoma
837492|NCT00002980|stage IV adult diffuse small cleaved cell lymphoma|stage iv adult diffuse small cleaved cell lymphoma
837493|NCT00002980|stage IV adult diffuse mixed cell lymphoma|stage iv adult diffuse mixed cell lymphoma
837494|NCT00002980|stage IV adult diffuse large cell lymphoma|stage iv adult diffuse large cell lymphoma
837495|NCT00002980|stage IV adult immunoblastic large cell lymphoma|stage iv adult immunoblastic large cell lymphoma
837496|NCT00002980|stage IV adult lymphoblastic lymphoma|stage iv adult lymphoblastic lymphoma
837497|NCT00002980|stage IV adult Burkitt lymphoma|stage iv adult burkitt lymphoma
837498|NCT00002980|recurrent grade 1 follicular lymphoma|recurrent grade 1 follicular lymphoma
837499|NCT00002980|recurrent grade 2 follicular lymphoma|recurrent grade 2 follicular lymphoma
837500|NCT00002980|recurrent grade 3 follicular lymphoma|recurrent grade 3 follicular lymphoma
837501|NCT00002980|recurrent adult diffuse small cleaved cell lymphoma|recurrent adult diffuse small cleaved cell lymphoma
837502|NCT00002980|recurrent adult diffuse mixed cell lymphoma|recurrent adult diffuse mixed cell lymphoma
837503|NCT00002980|recurrent adult diffuse large cell lymphoma|recurrent adult diffuse large cell lymphoma
837504|NCT00002980|recurrent adult immunoblastic large cell lymphoma|recurrent adult immunoblastic large cell lymphoma
837505|NCT00002980|recurrent adult lymphoblastic lymphoma|recurrent adult lymphoblastic lymphoma
837506|NCT00002980|recurrent adult Burkitt lymphoma|recurrent adult burkitt lymphoma
837507|NCT00002980|stage IV adult T-cell leukemia/lymphoma|stage iv adult t-cell leukemia/lymphoma
837508|NCT00002980|recurrent adult T-cell leukemia/lymphoma|recurrent adult t-cell leukemia/lymphoma
837509|NCT00002980|secondary acute myeloid leukemia|secondary acute myeloid leukemia
837510|NCT00002980|de novo myelodysplastic syndromes|de novo myelodysplastic syndromes
837511|NCT00002980|previously treated myelodysplastic syndromes|previously treated myelodysplastic syndromes
837512|NCT00002980|secondary myelodysplastic syndromes|secondary myelodysplastic syndromes
837513|NCT00002980|prolymphocytic leukemia|prolymphocytic leukemia
837514|NCT00002980|primary systemic amyloidosis|primary systemic amyloidosis
837515|NCT00002980|stage IV mantle cell lymphoma|stage iv mantle cell lymphoma
837516|NCT00002980|recurrent mantle cell lymphoma|recurrent mantle cell lymphoma
837517|NCT00002980|angioimmunoblastic T-cell lymphoma|angioimmunoblastic t-cell lymphoma
837518|NCT00002980|anaplastic large cell lymphoma|anaplastic large cell lymphoma
837519|NCT00002980|recurrent marginal zone lymphoma|recurrent marginal zone lymphoma
837520|NCT00002980|recurrent small lymphocytic lymphoma|recurrent small lymphocytic lymphoma
837521|NCT00002980|stage IV small lymphocytic lymphoma|stage iv small lymphocytic lymphoma
837522|NCT00002980|stage IV marginal zone lymphoma|stage iv marginal zone lymphoma
837523|NCT00002980|extranodal marginal zone B-cell lymphoma of mucosa-associated lymphoid tissue|extranodal marginal zone b-cell lymphoma of mucosa-associated lymphoid tissue
837524|NCT00002980|nodal marginal zone B-cell lymphoma|nodal marginal zone b-cell lymphoma
837525|NCT00002980|splenic marginal zone lymphoma|splenic marginal zone lymphoma
837526|NCT00002967|stage I breast cancer|stage i breast cancer
837527|NCT00002967|stage II breast cancer|stage ii breast cancer
837528|NCT00002967|invasive ductal breast carcinoma|invasive ductal breast carcinoma
837529|NCT00002946|stage I adult Hodgkin lymphoma|stage i adult hodgkin lymphoma
837530|NCT00002946|stage II adult Hodgkin lymphoma|stage ii adult hodgkin lymphoma
837531|NCT00002946|stage III adult Hodgkin lymphoma|stage iii adult hodgkin lymphoma
837532|NCT00002946|stage IV adult Hodgkin lymphoma|stage iv adult hodgkin lymphoma
837533|NCT00002946|recurrent adult Hodgkin lymphoma|recurrent adult hodgkin lymphoma
837534|NCT00002946|unspecified adult solid tumor, protocol specific|unspecified adult solid tumor, protocol specific
837535|NCT00002946|stage I grade 1 follicular lymphoma|stage i grade 1 follicular lymphoma
837536|NCT00002946|stage I grade 2 follicular lymphoma|stage i grade 2 follicular lymphoma
837537|NCT00002946|stage I grade 3 follicular lymphoma|stage i grade 3 follicular lymphoma
837538|NCT00002946|stage I adult diffuse small cleaved cell lymphoma|stage i adult diffuse small cleaved cell lymphoma
837539|NCT00002946|stage I adult diffuse mixed cell lymphoma|stage i adult diffuse mixed cell lymphoma
837540|NCT00002946|stage I adult diffuse large cell lymphoma|stage i adult diffuse large cell lymphoma
837541|NCT00002946|stage I adult immunoblastic large cell lymphoma|stage i adult immunoblastic large cell lymphoma
837542|NCT00002946|stage I adult lymphoblastic lymphoma|stage i adult lymphoblastic lymphoma
837543|NCT00002946|stage I adult Burkitt lymphoma|stage i adult burkitt lymphoma
837544|NCT00002946|stage III grade 1 follicular lymphoma|stage iii grade 1 follicular lymphoma
837545|NCT00002946|stage III grade 2 follicular lymphoma|stage iii grade 2 follicular lymphoma
837546|NCT00002946|stage III grade 3 follicular lymphoma|stage iii grade 3 follicular lymphoma
837547|NCT00002946|stage III adult diffuse small cleaved cell lymphoma|stage iii adult diffuse small cleaved cell lymphoma
837548|NCT00002946|stage III adult diffuse mixed cell lymphoma|stage iii adult diffuse mixed cell lymphoma
837549|NCT00002946|stage III adult diffuse large cell lymphoma|stage iii adult diffuse large cell lymphoma
837550|NCT00002946|stage III adult immunoblastic large cell lymphoma|stage iii adult immunoblastic large cell lymphoma
837551|NCT00002946|stage III adult lymphoblastic lymphoma|stage iii adult lymphoblastic lymphoma
837552|NCT00002946|stage III adult Burkitt lymphoma|stage iii adult burkitt lymphoma
837553|NCT00002946|stage IV grade 1 follicular lymphoma|stage iv grade 1 follicular lymphoma
837554|NCT00002946|stage IV grade 2 follicular lymphoma|stage iv grade 2 follicular lymphoma
837555|NCT00002946|stage IV grade 3 follicular lymphoma|stage iv grade 3 follicular lymphoma
837556|NCT00002946|stage IV adult diffuse small cleaved cell lymphoma|stage iv adult diffuse small cleaved cell lymphoma
837557|NCT00002946|stage IV adult diffuse mixed cell lymphoma|stage iv adult diffuse mixed cell lymphoma
837558|NCT00002946|stage IV adult diffuse large cell lymphoma|stage iv adult diffuse large cell lymphoma
837559|NCT00002946|stage IV adult immunoblastic large cell lymphoma|stage iv adult immunoblastic large cell lymphoma
837560|NCT00002946|stage IV adult lymphoblastic lymphoma|stage iv adult lymphoblastic lymphoma
837561|NCT00002946|stage IV adult Burkitt lymphoma|stage iv adult burkitt lymphoma
837562|NCT00002946|recurrent grade 1 follicular lymphoma|recurrent grade 1 follicular lymphoma
837563|NCT00002946|recurrent grade 2 follicular lymphoma|recurrent grade 2 follicular lymphoma
837564|NCT00002946|recurrent grade 3 follicular lymphoma|recurrent grade 3 follicular lymphoma
837565|NCT00002946|recurrent adult diffuse small cleaved cell lymphoma|recurrent adult diffuse small cleaved cell lymphoma
838187|NCT00090025|Tumor of biliary tree|tumor of biliary tree
837566|NCT00002946|recurrent adult diffuse mixed cell lymphoma|recurrent adult diffuse mixed cell lymphoma
837567|NCT00002946|recurrent adult diffuse large cell lymphoma|recurrent adult diffuse large cell lymphoma
837568|NCT00002946|recurrent adult immunoblastic large cell lymphoma|recurrent adult immunoblastic large cell lymphoma
837569|NCT00002946|recurrent adult lymphoblastic lymphoma|recurrent adult lymphoblastic lymphoma
837570|NCT00002946|recurrent adult Burkitt lymphoma|recurrent adult burkitt lymphoma
837571|NCT00002946|stage I adult T-cell leukemia/lymphoma|stage i adult t-cell leukemia/lymphoma
837572|NCT00002946|stage II adult T-cell leukemia/lymphoma|stage ii adult t-cell leukemia/lymphoma
837573|NCT00002946|stage III adult T-cell leukemia/lymphoma|stage iii adult t-cell leukemia/lymphoma
837574|NCT00002946|stage IV adult T-cell leukemia/lymphoma|stage iv adult t-cell leukemia/lymphoma
837575|NCT00002946|recurrent adult T-cell leukemia/lymphoma|recurrent adult t-cell leukemia/lymphoma
837576|NCT00002946|AIDS-related peripheral/systemic lymphoma|aids-related peripheral/systemic lymphoma
837577|NCT00002946|AIDS-related primary CNS lymphoma|aids-related primary cns lymphoma
837578|NCT00002946|stage I mantle cell lymphoma|stage i mantle cell lymphoma
837579|NCT00002946|contiguous stage II grade 1 follicular lymphoma|contiguous stage ii grade 1 follicular lymphoma
837580|NCT00002946|contiguous stage II grade 2 follicular lymphoma|contiguous stage ii grade 2 follicular lymphoma
837581|NCT00002946|contiguous stage II grade 3 follicular lymphoma|contiguous stage ii grade 3 follicular lymphoma
837582|NCT00002946|contiguous stage II adult diffuse small cleaved cell lymphoma|contiguous stage ii adult diffuse small cleaved cell lymphoma
837583|NCT00002946|contiguous stage II mantle cell lymphoma|contiguous stage ii mantle cell lymphoma
837584|NCT00002946|contiguous stage II adult diffuse mixed cell lymphoma|contiguous stage ii adult diffuse mixed cell lymphoma
837585|NCT00002946|contiguous stage II adult immunoblastic large cell lymphoma|contiguous stage ii adult immunoblastic large cell lymphoma
837586|NCT00002946|contiguous stage II adult diffuse large cell lymphoma|contiguous stage ii adult diffuse large cell lymphoma
837587|NCT00002946|contiguous stage II adult Burkitt lymphoma|contiguous stage ii adult burkitt lymphoma
837588|NCT00002946|contiguous stage II adult lymphoblastic lymphoma|contiguous stage ii adult lymphoblastic lymphoma
837589|NCT00002946|noncontiguous stage II grade 1 follicular lymphoma|noncontiguous stage ii grade 1 follicular lymphoma
837590|NCT00002946|noncontiguous stage II grade 2 follicular lymphoma|noncontiguous stage ii grade 2 follicular lymphoma
837591|NCT00002946|noncontiguous stage II grade 3 follicular lymphoma|noncontiguous stage ii grade 3 follicular lymphoma
837592|NCT00002946|noncontiguous stage II adult diffuse small cleaved cell lymphoma|noncontiguous stage ii adult diffuse small cleaved cell lymphoma
837593|NCT00002946|noncontiguous stage II mantle cell lymphoma|noncontiguous stage ii mantle cell lymphoma
837594|NCT00002946|noncontiguous stage II adult diffuse mixed cell lymphoma|noncontiguous stage ii adult diffuse mixed cell lymphoma
837595|NCT00002946|noncontiguous stage II adult immunoblastic large cell lymphoma|noncontiguous stage ii adult immunoblastic large cell lymphoma
837596|NCT00002946|noncontiguous stage II adult diffuse large cell lymphoma|noncontiguous stage ii adult diffuse large cell lymphoma
837597|NCT00002946|noncontiguous stage II adult Burkitt lymphoma|noncontiguous stage ii adult burkitt lymphoma
837598|NCT00002946|noncontiguous stage II adult lymphoblastic lymphoma|noncontiguous stage ii adult lymphoblastic lymphoma
837995|NCT00003519|stage II breast cancer|stage ii breast cancer
837599|NCT00002946|stage III mantle cell lymphoma|stage iii mantle cell lymphoma
837600|NCT00002946|stage IV mantle cell lymphoma|stage iv mantle cell lymphoma
837601|NCT00002946|recurrent mantle cell lymphoma|recurrent mantle cell lymphoma
837602|NCT00002946|angioimmunoblastic T-cell lymphoma|angioimmunoblastic t-cell lymphoma
837603|NCT00002946|anaplastic large cell lymphoma|anaplastic large cell lymphoma
837604|NCT00002946|noncontiguous stage II small lymphocytic lymphoma|noncontiguous stage ii small lymphocytic lymphoma
837605|NCT00002946|noncontiguous stage II marginal zone lymphoma|noncontiguous stage ii marginal zone lymphoma
837606|NCT00002946|recurrent marginal zone lymphoma|recurrent marginal zone lymphoma
837607|NCT00002946|recurrent small lymphocytic lymphoma|recurrent small lymphocytic lymphoma
837608|NCT00002946|stage I marginal zone lymphoma|stage i marginal zone lymphoma
837609|NCT00002946|stage I small lymphocytic lymphoma|stage i small lymphocytic lymphoma
837610|NCT00002946|stage III small lymphocytic lymphoma|stage iii small lymphocytic lymphoma
837611|NCT00002946|stage III marginal zone lymphoma|stage iii marginal zone lymphoma
837612|NCT00002946|stage IV small lymphocytic lymphoma|stage iv small lymphocytic lymphoma
837613|NCT00002946|stage IV marginal zone lymphoma|stage iv marginal zone lymphoma
837614|NCT00002946|contiguous stage II marginal zone lymphoma|contiguous stage ii marginal zone lymphoma
837615|NCT00002946|contiguous stage II small lymphocytic lymphoma|contiguous stage ii small lymphocytic lymphoma
837616|NCT00002946|extranodal marginal zone B-cell lymphoma of mucosa-associated lymphoid tissue|extranodal marginal zone b-cell lymphoma of mucosa-associated lymphoid tissue
837617|NCT00002946|nodal marginal zone B-cell lymphoma|nodal marginal zone b-cell lymphoma
837618|NCT00002946|splenic marginal zone lymphoma|splenic marginal zone lymphoma
837619|NCT00002942|stage II breast cancer|stage ii breast cancer
837620|NCT00002942|stage IV breast cancer|stage iv breast cancer
837621|NCT00002942|stage IIIA breast cancer|stage iiia breast cancer
837622|NCT00002942|stage IIIB breast cancer|stage iiib breast cancer
837623|NCT00002937|recurrent breast cancer|recurrent breast cancer
837624|NCT00002932|stage IV squamous cell carcinoma of the lip and oral cavity|stage iv squamous cell carcinoma of the lip and oral cavity
837625|NCT00002932|stage IV squamous cell carcinoma of the oropharynx|stage iv squamous cell carcinoma of the oropharynx
837626|NCT00002932|stage IV squamous cell carcinoma of the hypopharynx|stage iv squamous cell carcinoma of the hypopharynx
837627|NCT00002932|stage IV squamous cell carcinoma of the larynx|stage iv squamous cell carcinoma of the larynx
837628|NCT00002904|unspecified adult solid tumor, protocol specific|unspecified adult solid tumor, protocol specific
837629|NCT00002897|stage II esophageal cancer|stage ii esophageal cancer
837630|NCT00002897|stage III esophageal cancer|stage iii esophageal cancer
837631|NCT00002897|squamous cell carcinoma of the esophagus|squamous cell carcinoma of the esophagus
837632|NCT00090662|Cerebrospinal Fluid|cerebrospinal fluid
837633|NCT00090662|Stool|stool
837634|NCT00090662|Urine|urine
837635|NCT00090662|Healthy Volunteer|healthy volunteer
837637|NCT00002873|stage I breast cancer|stage i breast cancer
837638|NCT00002873|stage II breast cancer|stage ii breast cancer
837639|NCT00002873|medullary ductal breast carcinoma with lymphocytic infiltrate|medullary ductal breast carcinoma with lymphocytic infiltrate
837640|NCT00002873|mucinous ductal breast carcinoma|mucinous ductal breast carcinoma
837641|NCT00002873|invasive ductal breast carcinoma|invasive ductal breast carcinoma
837642|NCT00002873|papillary ductal breast carcinoma|papillary ductal breast carcinoma
837643|NCT00002873|tubular ductal breast carcinoma|tubular ductal breast carcinoma
837644|NCT00002872|malignant pleural effusion|malignant pleural effusion
837645|NCT00002811|actinic keratosis|actinic keratosis
837646|NCT00002805|recurrent childhood acute myeloid leukemia|recurrent childhood acute myeloid leukemia
837647|NCT00002805|secondary acute myeloid leukemia|secondary acute myeloid leukemia
837648|NCT00002805|childhood myelodysplastic syndromes|childhood myelodysplastic syndromes
837649|NCT00002793|stage IV colon cancer|stage iv colon cancer
837650|NCT00002793|stage IV rectal cancer|stage iv rectal cancer
837651|NCT00002793|recurrent colon cancer|recurrent colon cancer
837652|NCT00002793|recurrent rectal cancer|recurrent rectal cancer
837653|NCT00002793|liver metastases|liver metastases
837654|NCT00002791|stage II adult soft tissue sarcoma|stage ii adult soft tissue sarcoma
837655|NCT00002791|stage III adult soft tissue sarcoma|stage iii adult soft tissue sarcoma
837656|NCT00002791|recurrent adult soft tissue sarcoma|recurrent adult soft tissue sarcoma
837657|NCT00002790|childhood acute lymphoblastic leukemia|childhood acute lymphoblastic leukemia
837658|NCT00002790|chronic lymphocytic leukemia|chronic lymphocytic leukemia
837659|NCT00002790|adult acute lymphoblastic leukemia|adult acute lymphoblastic leukemia
837660|NCT00002790|adult acute myeloid leukemia|adult acute myeloid leukemia
837661|NCT00002790|chronic myelogenous leukemia|chronic myelogenous leukemia
837662|NCT00002790|childhood acute myeloid leukemia/other myeloid malignancies|childhood acute myeloid leukemia/other myeloid malignancies
837663|NCT00002790|myelodysplastic syndromes|myelodysplastic syndromes
837664|NCT00002790|graft versus host disease|graft versus host disease
837665|NCT00002790|childhood myelodysplastic syndromes|childhood myelodysplastic syndromes
837666|NCT00002781|stage III melanoma|stage iii melanoma
837667|NCT00002781|recurrent melanoma|recurrent melanoma
837668|NCT00002775|adenocarcinoma of the prostate|adenocarcinoma of the prostate
837669|NCT00002775|stage IV prostate cancer|stage iv prostate cancer
837670|NCT00002775|recurrent prostate cancer|recurrent prostate cancer
837671|NCT00002767|stage IV melanoma|stage iv melanoma
837672|NCT00002767|recurrent melanoma|recurrent melanoma
837673|NCT00090623|Subfoveal neovascular|subfoveal neovascular
837674|NCT00090623|Age-related macular degeneration|age-related macular degeneration
837675|NCT00090623|AMD|amd
837676|NCT00090623|Wet AMD|wet amd
837677|NCT00002744|untreated childhood acute lymphoblastic leukemia|untreated childhood acute lymphoblastic leukemia
837678|NCT00002744|L1 childhood acute lymphoblastic leukemia|l1 childhood acute lymphoblastic leukemia
837679|NCT00002744|L2 childhood acute lymphoblastic leukemia|l2 childhood acute lymphoblastic leukemia
837680|NCT00002735|stage III squamous cell carcinoma of the oropharynx|stage iii squamous cell carcinoma of the oropharynx
837681|NCT00002735|stage IV squamous cell carcinoma of the oropharynx|stage iv squamous cell carcinoma of the oropharynx
837682|NCT00002735|stage III squamous cell carcinoma of the hypopharynx|stage iii squamous cell carcinoma of the hypopharynx
837683|NCT00002735|stage IV squamous cell carcinoma of the hypopharynx|stage iv squamous cell carcinoma of the hypopharynx
837684|NCT00002730|recurrent neuroblastoma|recurrent neuroblastoma
837685|NCT00002703|adenocarcinoma of the prostate|adenocarcinoma of the prostate
837686|NCT00002703|stage I prostate cancer|stage i prostate cancer
837687|NCT00002703|stage IIB prostate cancer|stage iib prostate cancer
837688|NCT00002703|stage IIA prostate cancer|stage iia prostate cancer
837689|NCT00090610|Relapsed ovarian cancer|relapsed ovarian cancer
837690|NCT00090584|Urge urinary incontinence (UUI)|urge urinary incontinence (uui)
837691|NCT00090584|Drug/Behavior treatment|drug/behavior treatment
837692|NCT00090493|Myeloma|myeloma
837693|NCT00090493|Mage-A3|mage-a3
837694|NCT00090493|Transplant|transplant
837695|NCT00090493|Peptide|peptide
837696|NCT00090493|DTPACE|dtpace
837697|NCT00090493|vaccines|vaccines
837698|NCT00090493|Immunotherapy|immunotherapy
837699|NCT00090493|NY-ESO-1|ny-eso-1
837700|NCT00090480|Cancer|cancer
837701|NCT00002659|recurrent squamous cell carcinoma of the lip and oral cavity|recurrent squamous cell carcinoma of the lip and oral cavity
837702|NCT00002659|recurrent squamous cell carcinoma of the oropharynx|recurrent squamous cell carcinoma of the oropharynx
837703|NCT00002659|recurrent squamous cell carcinoma of the nasopharynx|recurrent squamous cell carcinoma of the nasopharynx
837704|NCT00002659|recurrent squamous cell carcinoma of the hypopharynx|recurrent squamous cell carcinoma of the hypopharynx
837705|NCT00002659|recurrent squamous cell carcinoma of the larynx|recurrent squamous cell carcinoma of the larynx
837706|NCT00002659|recurrent squamous cell carcinoma of the paranasal sinus and nasal cavity|recurrent squamous cell carcinoma of the paranasal sinus and nasal cavity
837707|NCT00002631|stage I esophageal cancer|stage i esophageal cancer
837708|NCT00002631|stage II esophageal cancer|stage ii esophageal cancer
837709|NCT00002631|stage III esophageal cancer|stage iii esophageal cancer
837710|NCT00002631|squamous cell carcinoma of the esophagus|squamous cell carcinoma of the esophagus
837711|NCT00002631|adenocarcinoma of the esophagus|adenocarcinoma of the esophagus
837712|NCT00002628|stage IV breast cancer|stage iv breast cancer
837713|NCT00002628|recurrent breast cancer|recurrent breast cancer
837714|NCT00002622|malignant pleural effusion|malignant pleural effusion
837715|NCT00002616|stage IV breast cancer|stage iv breast cancer
837716|NCT00002616|recurrent breast cancer|recurrent breast cancer
837717|NCT00002616|stage IIIB breast cancer|stage iiib breast cancer
837718|NCT00002616|inflammatory breast cancer|inflammatory breast cancer
837719|NCT00002593|stage II colon cancer|stage ii colon cancer
837720|NCT00002593|stage III colon cancer|stage iii colon cancer
837721|NCT00002570|stage III colon cancer|stage iii colon cancer
837722|NCT00002570|stage IV colon cancer|stage iv colon cancer
837723|NCT00002570|stage III rectal cancer|stage iii rectal cancer
837724|NCT00002570|stage IV rectal cancer|stage iv rectal cancer
837725|NCT00002570|recurrent colon cancer|recurrent colon cancer
837726|NCT00002570|recurrent rectal cancer|recurrent rectal cancer
837727|NCT00002554|recurrent adult acute myeloid leukemia|recurrent adult acute myeloid leukemia
837728|NCT00002554|adult acute myeloid leukemia in remission|adult acute myeloid leukemia in remission
837729|NCT00002527|colon cancer|colon cancer
837730|NCT00002527|rectal cancer|rectal cancer
837731|NCT00002509|stage II breast cancer|stage ii breast cancer
837732|NCT00002509|stage IV breast cancer|stage iv breast cancer
837733|NCT00002509|stage IIIA breast cancer|stage iiia breast cancer
837734|NCT00002509|recurrent breast cancer|recurrent breast cancer
837735|NCT00002509|stage IIIB breast cancer|stage iiib breast cancer
837736|NCT00090571|JRA ASPs|jra asps
837737|NCT00090571|Genomics|genomics
837738|NCT00090376|Erectile Dysfunction|erectile dysfunction
837739|NCT00090376|Impotence|impotence
837740|NCT00090376|Prostate Cancer|prostate cancer
837741|NCT00090376|Prostatectomy|prostatectomy
837742|NCT00090363|rising PSA|rising psa
837743|NCT00090363|bone metastases|bone metastases
837744|NCT00090363|Clinical study|clinical study
837745|NCT00090363|pain-free or mildly symptomatic|pain-free or mildly symptomatic
837746|NCT00090324|Schizophrenia|schizophrenia
837747|NCT00090311|Bipolar I Mania|bipolar i mania
837748|NCT00004915|recurrent endometrial carcinoma|recurrent endometrial carcinoma
837749|NCT00004201|recurrent non-small cell lung cancer|recurrent non-small cell lung cancer
837750|NCT00004201|stage IIIB non-small cell lung cancer|stage iiib non-small cell lung cancer
837751|NCT00004201|stage IV non-small cell lung cancer|stage iv non-small cell lung cancer
837752|NCT00004090|unspecified adult solid tumor, protocol specific|unspecified adult solid tumor, protocol specific
837753|NCT00004029|adenocarcinoma of the prostate|adenocarcinoma of the prostate
837754|NCT00004029|stage IV prostate cancer|stage iv prostate cancer
837755|NCT00004029|recurrent prostate cancer|recurrent prostate cancer
837756|NCT00002489|stage II ovarian germ cell tumor|stage ii ovarian germ cell tumor
837757|NCT00002489|stage III ovarian germ cell tumor|stage iii ovarian germ cell tumor
837758|NCT00002489|stage IV ovarian germ cell tumor|stage iv ovarian germ cell tumor
837759|NCT00002489|ovarian teratoma|ovarian teratoma
837760|NCT00002489|extragonadal germ cell tumor|extragonadal germ cell tumor
837761|NCT00002488|recurrent grade 3 follicular lymphoma|recurrent grade 3 follicular lymphoma
837762|NCT00002488|recurrent adult diffuse small cleaved cell lymphoma|recurrent adult diffuse small cleaved cell lymphoma
837763|NCT00002488|recurrent adult diffuse mixed cell lymphoma|recurrent adult diffuse mixed cell lymphoma
837764|NCT00002488|recurrent adult diffuse large cell lymphoma|recurrent adult diffuse large cell lymphoma
837765|NCT00002488|recurrent adult immunoblastic large cell lymphoma|recurrent adult immunoblastic large cell lymphoma
837766|NCT00002488|recurrent adult lymphoblastic lymphoma|recurrent adult lymphoblastic lymphoma
837767|NCT00002488|recurrent adult Burkitt lymphoma|recurrent adult burkitt lymphoma
837768|NCT00002487|recurrent ovarian epithelial cancer|recurrent ovarian epithelial cancer
837769|NCT00002471|childhood Burkitt lymphoma|childhood burkitt lymphoma
837770|NCT00002471|L3 childhood acute lymphoblastic leukemia|l3 childhood acute lymphoblastic leukemia
837771|NCT00002471|B-cell childhood acute lymphoblastic leukemia|b-cell childhood acute lymphoblastic leukemia
837772|NCT00002471|L3 adult acute lymphoblastic leukemia|l3 adult acute lymphoblastic leukemia
837773|NCT00002471|B-cell adult acute lymphoblastic leukemia|b-cell adult acute lymphoblastic leukemia
837774|NCT00002471|recurrent adult non-Hodgkin lymphoma|recurrent adult non-hodgkin lymphoma
837775|NCT00002471|stage III adult diffuse large cell lymphoma|stage iii adult diffuse large cell lymphoma
837776|NCT00002471|stage III adult immunoblastic large cell lymphoma|stage iii adult immunoblastic large cell lymphoma
837777|NCT00002471|stage III adult Burkitt lymphoma|stage iii adult burkitt lymphoma
837778|NCT00002471|stage IV grade 3 follicular lymphoma|stage iv grade 3 follicular lymphoma
837779|NCT00002471|stage IV adult diffuse large cell lymphoma|stage iv adult diffuse large cell lymphoma
837780|NCT00002471|stage IV adult immunoblastic large cell lymphoma|stage iv adult immunoblastic large cell lymphoma
837781|NCT00002471|stage IV adult Burkitt lymphoma|stage iv adult burkitt lymphoma
837782|NCT00002471|recurrent grade 3 follicular lymphoma|recurrent grade 3 follicular lymphoma
837783|NCT00002471|recurrent adult diffuse large cell lymphoma|recurrent adult diffuse large cell lymphoma
837784|NCT00002471|recurrent adult immunoblastic large cell lymphoma|recurrent adult immunoblastic large cell lymphoma
837785|NCT00002471|recurrent adult Burkitt lymphoma|recurrent adult burkitt lymphoma
837786|NCT00002471|stage III childhood small noncleaved cell lymphoma|stage iii childhood small noncleaved cell lymphoma
837787|NCT00002471|stage IV childhood small noncleaved cell lymphoma|stage iv childhood small noncleaved cell lymphoma
837788|NCT00002471|stage IV childhood large cell lymphoma|stage iv childhood large cell lymphoma
837789|NCT00002471|recurrent childhood small noncleaved cell lymphoma|recurrent childhood small noncleaved cell lymphoma
837790|NCT00002471|recurrent childhood large cell lymphoma|recurrent childhood large cell lymphoma
837791|NCT00002458|disseminated neuroblastoma|disseminated neuroblastoma
837792|NCT00002458|recurrent neuroblastoma|recurrent neuroblastoma
837793|NCT00090558|Atherosclerosis|atherosclerosis
837794|NCT00090558|Bone Marrow|bone marrow
837795|NCT00090558|Exercise|exercise
837796|NCT00090558|Endothelium|endothelium
837797|NCT00090558|Nitroglycerin|nitroglycerin
837798|NCT00090558|Coronary Artery Disease|coronary artery disease
837800|NCT00090545|Hormone-Refractory|hormone-refractory
837801|NCT00090545|Proteomics|proteomics
837802|NCT00090545|Angiogenesis|angiogenesis
837803|NCT00090545|VEGFR|vegfr
837804|NCT00090545|Prostate Cancer|prostate cancer
837805|NCT00090545|Metastatic Prostate Cancer|metastatic prostate cancer
837806|NCT00090506|Yoga|yoga
837807|NCT00090506|Meditation|meditation
837808|NCT00090428|Autism|autism
837809|NCT00090428|Applied Behavioral Analysis|applied behavioral analysis
837810|NCT00090428|Gluten|gluten
837811|NCT00090428|Casein|casein
837812|NCT00090415|Autism|autism
837813|NCT00090415|Developmental Delay Disorders|developmental delay disorders
837814|NCT00090285|anogenital warts|anogenital warts
837815|NCT00090181|Arcoxia|arcoxia
837816|NCT00004026|adenocarcinoma of the prostate|adenocarcinoma of the prostate
837817|NCT00004026|stage IV prostate cancer|stage iv prostate cancer
837818|NCT00004026|recurrent prostate cancer|recurrent prostate cancer
837819|NCT00004009|recurrent adult acute myeloid leukemia|recurrent adult acute myeloid leukemia
837820|NCT00004009|recurrent adult acute lymphoblastic leukemia|recurrent adult acute lymphoblastic leukemia
837821|NCT00004009|accelerated phase chronic myelogenous leukemia|accelerated phase chronic myelogenous leukemia
837822|NCT00004009|blastic phase chronic myelogenous leukemia|blastic phase chronic myelogenous leukemia
837823|NCT00004009|untreated adult acute lymphoblastic leukemia|untreated adult acute lymphoblastic leukemia
837824|NCT00004009|untreated adult acute myeloid leukemia|untreated adult acute myeloid leukemia
837825|NCT00004009|adult acute promyelocytic leukemia (M3)|adult acute promyelocytic leukemia (m3)
837826|NCT00004009|secondary acute myeloid leukemia|secondary acute myeloid leukemia
837827|NCT00003989|recurrent non-small cell lung cancer|recurrent non-small cell lung cancer
837828|NCT00003989|stage III melanoma|stage iii melanoma
837829|NCT00003989|stage IV melanoma|stage iv melanoma
837830|NCT00003989|recurrent melanoma|recurrent melanoma
837831|NCT00003989|stage IIIA non-small cell lung cancer|stage iiia non-small cell lung cancer
837832|NCT00003989|stage IIIB non-small cell lung cancer|stage iiib non-small cell lung cancer
837833|NCT00003989|stage IV non-small cell lung cancer|stage iv non-small cell lung cancer
837834|NCT00003962|recurrent childhood acute lymphoblastic leukemia|recurrent childhood acute lymphoblastic leukemia
837835|NCT00003962|recurrent adult Hodgkin lymphoma|recurrent adult hodgkin lymphoma
837836|NCT00003962|refractory multiple myeloma|refractory multiple myeloma
837837|NCT00003962|stage I multiple myeloma|stage i multiple myeloma
837838|NCT00003962|stage II multiple myeloma|stage ii multiple myeloma
837839|NCT00003962|stage III multiple myeloma|stage iii multiple myeloma
837840|NCT00003962|recurrent childhood lymphoblastic lymphoma|recurrent childhood lymphoblastic lymphoma
837841|NCT00003962|recurrent childhood acute myeloid leukemia|recurrent childhood acute myeloid leukemia
837842|NCT00003962|recurrent adult acute myeloid leukemia|recurrent adult acute myeloid leukemia
837843|NCT00003962|recurrent adult acute lymphoblastic leukemia|recurrent adult acute lymphoblastic leukemia
837844|NCT00003962|recurrent/refractory childhood Hodgkin lymphoma|recurrent/refractory childhood hodgkin lymphoma
837845|NCT00003962|chronic myelomonocytic leukemia|chronic myelomonocytic leukemia
837846|NCT00003962|acute undifferentiated leukemia|acute undifferentiated leukemia
837847|NCT00003962|recurrent grade 1 follicular lymphoma|recurrent grade 1 follicular lymphoma
837848|NCT00003962|recurrent grade 2 follicular lymphoma|recurrent grade 2 follicular lymphoma
837849|NCT00003962|recurrent grade 3 follicular lymphoma|recurrent grade 3 follicular lymphoma
837850|NCT00003962|recurrent adult diffuse small cleaved cell lymphoma|recurrent adult diffuse small cleaved cell lymphoma
837851|NCT00003962|recurrent adult diffuse mixed cell lymphoma|recurrent adult diffuse mixed cell lymphoma
837852|NCT00003962|recurrent adult diffuse large cell lymphoma|recurrent adult diffuse large cell lymphoma
837853|NCT00003962|recurrent adult immunoblastic large cell lymphoma|recurrent adult immunoblastic large cell lymphoma
837854|NCT00003962|recurrent adult lymphoblastic lymphoma|recurrent adult lymphoblastic lymphoma
837855|NCT00003962|recurrent adult T-cell leukemia/lymphoma|recurrent adult t-cell leukemia/lymphoma
837856|NCT00003962|secondary acute myeloid leukemia|secondary acute myeloid leukemia
838188|NCT00089999|lapatinib|lapatinib
837857|NCT00003962|AIDS-related peripheral/systemic lymphoma|aids-related peripheral/systemic lymphoma
837858|NCT00003962|recurrent childhood small noncleaved cell lymphoma|recurrent childhood small noncleaved cell lymphoma
837859|NCT00003962|recurrent childhood large cell lymphoma|recurrent childhood large cell lymphoma
837860|NCT00003962|recurrent mantle cell lymphoma|recurrent mantle cell lymphoma
837861|NCT00003962|recurrent marginal zone lymphoma|recurrent marginal zone lymphoma
837862|NCT00003962|recurrent small lymphocytic lymphoma|recurrent small lymphocytic lymphoma
837922|NCT00090337|stage I lymphoepithelioma of the nasopharynx|stage i lymphoepithelioma of the nasopharynx
837863|NCT00003962|extranodal marginal zone B-cell lymphoma of mucosa-associated lymphoid tissue|extranodal marginal zone b-cell lymphoma of mucosa-associated lymphoid tissue
837864|NCT00003962|nodal marginal zone B-cell lymphoma|nodal marginal zone b-cell lymphoma
837865|NCT00003962|splenic marginal zone lymphoma|splenic marginal zone lymphoma
837866|NCT00003778|recurrent adult soft tissue sarcoma|recurrent adult soft tissue sarcoma
837867|NCT00003778|stage IV uterine sarcoma|stage iv uterine sarcoma
837868|NCT00003778|recurrent uterine sarcoma|recurrent uterine sarcoma
837869|NCT00003778|ovarian sarcoma|ovarian sarcoma
837870|NCT00003778|stage IV adult soft tissue sarcoma|stage iv adult soft tissue sarcoma
837871|NCT00090402|Fish Oils|fish oils
837872|NCT00090402|Thioctic Acid|thioctic acid
837873|NCT00090402|Antioxidants|antioxidants
837874|NCT00090402|Dietary Supplements|dietary supplements
837875|NCT00090389|Acupuncture|acupuncture
837876|NCT00090389|Medicine, Chinese Traditional|medicine, chinese traditional
837877|NCT00090337|pain|pain
837878|NCT00090337|recurrent squamous cell carcinoma of the hypopharynx|recurrent squamous cell carcinoma of the hypopharynx
837879|NCT00090337|stage I squamous cell carcinoma of the hypopharynx|stage i squamous cell carcinoma of the hypopharynx
837880|NCT00090337|stage II squamous cell carcinoma of the hypopharynx|stage ii squamous cell carcinoma of the hypopharynx
837881|NCT00090337|stage III squamous cell carcinoma of the hypopharynx|stage iii squamous cell carcinoma of the hypopharynx
837882|NCT00090337|stage IV squamous cell carcinoma of the hypopharynx|stage iv squamous cell carcinoma of the hypopharynx
837883|NCT00090337|recurrent squamous cell carcinoma of the larynx|recurrent squamous cell carcinoma of the larynx
837884|NCT00090337|recurrent verrucous carcinoma of the larynx|recurrent verrucous carcinoma of the larynx
837885|NCT00090337|stage I squamous cell carcinoma of the larynx|stage i squamous cell carcinoma of the larynx
837886|NCT00090337|stage I verrucous carcinoma of the larynx|stage i verrucous carcinoma of the larynx
837887|NCT00090337|stage II squamous cell carcinoma of the larynx|stage ii squamous cell carcinoma of the larynx
837888|NCT00090337|stage II verrucous carcinoma of the larynx|stage ii verrucous carcinoma of the larynx
837889|NCT00090337|stage III squamous cell carcinoma of the larynx|stage iii squamous cell carcinoma of the larynx
837890|NCT00090337|stage III verrucous carcinoma of the larynx|stage iii verrucous carcinoma of the larynx
837891|NCT00090337|stage IV squamous cell carcinoma of the larynx|stage iv squamous cell carcinoma of the larynx
837892|NCT00090337|stage IV verrucous carcinoma of the larynx|stage iv verrucous carcinoma of the larynx
837893|NCT00090337|recurrent squamous cell carcinoma of the lip and oral cavity|recurrent squamous cell carcinoma of the lip and oral cavity
837894|NCT00090337|stage I squamous cell carcinoma of the lip and oral cavity|stage i squamous cell carcinoma of the lip and oral cavity
837895|NCT00090337|stage II squamous cell carcinoma of the lip and oral cavity|stage ii squamous cell carcinoma of the lip and oral cavity
837896|NCT00090337|stage III squamous cell carcinoma of the lip and oral cavity|stage iii squamous cell carcinoma of the lip and oral cavity
837897|NCT00090337|stage IV squamous cell carcinoma of the lip and oral cavity|stage iv squamous cell carcinoma of the lip and oral cavity
837898|NCT00090337|recurrent basal cell carcinoma of the lip|recurrent basal cell carcinoma of the lip
837899|NCT00090337|stage I basal cell carcinoma of the lip|stage i basal cell carcinoma of the lip
837900|NCT00090337|stage II basal cell carcinoma of the lip|stage ii basal cell carcinoma of the lip
837901|NCT00090337|stage III basal cell carcinoma of the lip|stage iii basal cell carcinoma of the lip
837902|NCT00090337|stage IV basal cell carcinoma of the lip|stage iv basal cell carcinoma of the lip
837903|NCT00090337|recurrent adenoid cystic carcinoma of the oral cavity|recurrent adenoid cystic carcinoma of the oral cavity
837904|NCT00090337|recurrent mucoepidermoid carcinoma of the oral cavity|recurrent mucoepidermoid carcinoma of the oral cavity
837905|NCT00090337|recurrent verrucous carcinoma of the oral cavity|recurrent verrucous carcinoma of the oral cavity
837906|NCT00090337|stage I adenoid cystic carcinoma of the oral cavity|stage i adenoid cystic carcinoma of the oral cavity
837907|NCT00090337|stage I mucoepidermoid carcinoma of the oral cavity|stage i mucoepidermoid carcinoma of the oral cavity
837908|NCT00090337|stage I verrucous carcinoma of the oral cavity|stage i verrucous carcinoma of the oral cavity
837909|NCT00090337|stage II adenoid cystic carcinoma of the oral cavity|stage ii adenoid cystic carcinoma of the oral cavity
837910|NCT00090337|stage II mucoepidermoid carcinoma of the oral cavity|stage ii mucoepidermoid carcinoma of the oral cavity
837911|NCT00090337|stage II verrucous carcinoma of the oral cavity|stage ii verrucous carcinoma of the oral cavity
837912|NCT00090337|stage III adenoid cystic carcinoma of the oral cavity|stage iii adenoid cystic carcinoma of the oral cavity
837913|NCT00090337|stage III mucoepidermoid carcinoma of the oral cavity|stage iii mucoepidermoid carcinoma of the oral cavity
837914|NCT00090337|stage III verrucous carcinoma of the oral cavity|stage iii verrucous carcinoma of the oral cavity
837915|NCT00090337|stage IV adenoid cystic carcinoma of the oral cavity|stage iv adenoid cystic carcinoma of the oral cavity
837916|NCT00090337|stage IV mucoepidermoid carcinoma of the oral cavity|stage iv mucoepidermoid carcinoma of the oral cavity
837917|NCT00090337|stage IV verrucous carcinoma of the oral cavity|stage iv verrucous carcinoma of the oral cavity
838189|NCT00089999|advanced|advanced
837918|NCT00090337|metastatic squamous neck cancer with occult primary squamous cell carcinoma|metastatic squamous neck cancer with occult primary squamous cell carcinoma
837919|NCT00090337|recurrent metastatic squamous neck cancer with occult primary|recurrent metastatic squamous neck cancer with occult primary
837920|NCT00090337|recurrent lymphoepithelioma of the nasopharynx|recurrent lymphoepithelioma of the nasopharynx
837921|NCT00090337|recurrent squamous cell carcinoma of the nasopharynx|recurrent squamous cell carcinoma of the nasopharynx
839266|NCT00088907|gefitinib|gefitinib
837923|NCT00090337|stage I squamous cell carcinoma of the nasopharynx|stage i squamous cell carcinoma of the nasopharynx
837924|NCT00090337|stage II lymphoepithelioma of the nasopharynx|stage ii lymphoepithelioma of the nasopharynx
837925|NCT00090337|stage II squamous cell carcinoma of the nasopharynx|stage ii squamous cell carcinoma of the nasopharynx
837926|NCT00090337|stage III lymphoepithelioma of the nasopharynx|stage iii lymphoepithelioma of the nasopharynx
837927|NCT00090337|stage III squamous cell carcinoma of the nasopharynx|stage iii squamous cell carcinoma of the nasopharynx
837928|NCT00090337|stage IV lymphoepithelioma of the nasopharynx|stage iv lymphoepithelioma of the nasopharynx
837929|NCT00090337|stage IV squamous cell carcinoma of the nasopharynx|stage iv squamous cell carcinoma of the nasopharynx
837930|NCT00090337|recurrent lymphoepithelioma of the oropharynx|recurrent lymphoepithelioma of the oropharynx
837931|NCT00090337|recurrent squamous cell carcinoma of the oropharynx|recurrent squamous cell carcinoma of the oropharynx
837932|NCT00090337|stage I lymphoepithelioma of the oropharynx|stage i lymphoepithelioma of the oropharynx
837933|NCT00090337|stage I squamous cell carcinoma of the oropharynx|stage i squamous cell carcinoma of the oropharynx
837934|NCT00090337|stage II lymphoepithelioma of the oropharynx|stage ii lymphoepithelioma of the oropharynx
837935|NCT00090337|stage II squamous cell carcinoma of the oropharynx|stage ii squamous cell carcinoma of the oropharynx
837936|NCT00090337|stage III lymphoepithelioma of the oropharynx|stage iii lymphoepithelioma of the oropharynx
837937|NCT00090337|stage III squamous cell carcinoma of the oropharynx|stage iii squamous cell carcinoma of the oropharynx
837938|NCT00090337|stage IV lymphoepithelioma of the oropharynx|stage iv lymphoepithelioma of the oropharynx
837939|NCT00090337|stage IV squamous cell carcinoma of the oropharynx|stage iv squamous cell carcinoma of the oropharynx
837940|NCT00090337|recurrent esthesioneuroblastoma of the paranasal sinus and nasal cavity|recurrent esthesioneuroblastoma of the paranasal sinus and nasal cavity
837941|NCT00090337|recurrent inverted papilloma of the paranasal sinus and nasal cavity|recurrent inverted papilloma of the paranasal sinus and nasal cavity
837942|NCT00090337|recurrent midline lethal granuloma of the paranasal sinus and nasal cavity|recurrent midline lethal granuloma of the paranasal sinus and nasal cavity
837943|NCT00090337|recurrent squamous cell carcinoma of the paranasal sinus and nasal cavity|recurrent squamous cell carcinoma of the paranasal sinus and nasal cavity
837944|NCT00090337|stage I esthesioneuroblastoma of the paranasal sinus and nasal cavity|stage i esthesioneuroblastoma of the paranasal sinus and nasal cavity
837945|NCT00090337|stage I inverted papilloma of the paranasal sinus and nasal cavity|stage i inverted papilloma of the paranasal sinus and nasal cavity
837946|NCT00090337|stage I midline lethal granuloma of the paranasal sinus and nasal cavity|stage i midline lethal granuloma of the paranasal sinus and nasal cavity
837947|NCT00090337|stage I squamous cell carcinoma of the paranasal sinus and nasal cavity|stage i squamous cell carcinoma of the paranasal sinus and nasal cavity
837948|NCT00090337|stage II esthesioneuroblastoma of the paranasal sinus and nasal cavity|stage ii esthesioneuroblastoma of the paranasal sinus and nasal cavity
837949|NCT00090337|stage II inverted papilloma of the paranasal sinus and nasal cavity|stage ii inverted papilloma of the paranasal sinus and nasal cavity
837950|NCT00090337|stage II midline lethal granuloma of the paranasal sinus and nasal cavity|stage ii midline lethal granuloma of the paranasal sinus and nasal cavity
837951|NCT00090337|stage II squamous cell carcinoma of the paranasal sinus and nasal cavity|stage ii squamous cell carcinoma of the paranasal sinus and nasal cavity
837952|NCT00090337|stage III esthesioneuroblastoma of the paranasal sinus and nasal cavity|stage iii esthesioneuroblastoma of the paranasal sinus and nasal cavity
837953|NCT00090337|stage III inverted papilloma of the paranasal sinus and nasal cavity|stage iii inverted papilloma of the paranasal sinus and nasal cavity
837954|NCT00090337|stage III midline lethal granuloma of the paranasal sinus and nasal cavity|stage iii midline lethal granuloma of the paranasal sinus and nasal cavity
837955|NCT00090337|stage III squamous cell carcinoma of the paranasal sinus and nasal cavity|stage iii squamous cell carcinoma of the paranasal sinus and nasal cavity
837956|NCT00090337|stage IV esthesioneuroblastoma of the paranasal sinus and nasal cavity|stage iv esthesioneuroblastoma of the paranasal sinus and nasal cavity
837957|NCT00090337|stage IV inverted papilloma of the paranasal sinus and nasal cavity|stage iv inverted papilloma of the paranasal sinus and nasal cavity
837958|NCT00090337|stage IV midline lethal granuloma of the paranasal sinus and nasal cavity|stage iv midline lethal granuloma of the paranasal sinus and nasal cavity
837959|NCT00090337|stage IV squamous cell carcinoma of the paranasal sinus and nasal cavity|stage iv squamous cell carcinoma of the paranasal sinus and nasal cavity
837960|NCT00090337|recurrent salivary gland cancer|recurrent salivary gland cancer
837961|NCT00090337|stage I salivary gland cancer|stage i salivary gland cancer
837962|NCT00090337|stage II salivary gland cancer|stage ii salivary gland cancer
837963|NCT00090337|stage III salivary gland cancer|stage iii salivary gland cancer
837964|NCT00090337|stage IV salivary gland cancer|stage iv salivary gland cancer
837965|NCT00090194|Kidney Transplantation|kidney transplantation
837966|NCT00090194|Transplantation, Homologous|transplantation, homologous
837967|NCT00090194|HLA Antigens|hla antigens
837968|NCT00090194|Autoantibodies|autoantibodies
837969|NCT00090194|Immunoglobulins, Intravenous|immunoglobulins, intravenous
837970|NCT00090194|Living Donors|living donors
837971|NCT00090194|Dose-Response Relationship, Immunologic|dose-response relationship, immunologic
837972|NCT00090129|Psoriatic Arthritis|psoriatic arthritis
837973|NCT00090129|Moderate plaque psoriasis|moderate plaque psoriasis
837974|NCT00090129|severe plaque psoriasis|severe plaque psoriasis
837975|NCT00090129|Onercept|onercept
837976|NCT00090129|Placebo|placebo
837977|NCT00090116|Neramexane|neramexane
837978|NCT00090116|NMDA receptor antagonist|nmda receptor antagonist
837979|NCT00090116|Memory Loss|memory loss
839940|NCT00088335|Proteomics|proteomics
837980|NCT00090116|Alzheimer Disease|alzheimer disease
837981|NCT00090103|Combination Therapy|combination therapy
837982|NCT00090103|dutasteride|dutasteride
837983|NCT00090103|BPH|bph
837984|NCT00090077|GW695634G|gw695634g
837985|NCT00090077|GW695634X|gw695634x
837986|NCT00090077|GW678248X|gw678248x
837987|NCT00090077|pharmacokinetics|pharmacokinetics
837988|NCT00090077|NNRTI|nnrti
837989|NCT00090077|HIV|hiv
837990|NCT00003654|stage I breast cancer|stage i breast cancer
837991|NCT00003654|stage II breast cancer|stage ii breast cancer
837992|NCT00003601|melanoma|melanoma
837993|NCT00003588|stage IV ovarian epithelial cancer|stage iv ovarian epithelial cancer
837994|NCT00003588|recurrent ovarian epithelial cancer|recurrent ovarian epithelial cancer
837996|NCT00003519|stage IIIA breast cancer|stage iiia breast cancer
837997|NCT00003519|stage IIIB breast cancer|stage iiib breast cancer
837998|NCT00003406|stage III adult Hodgkin lymphoma|stage iii adult hodgkin lymphoma
837999|NCT00003406|stage IV adult Hodgkin lymphoma|stage iv adult hodgkin lymphoma
838000|NCT00003406|monoclonal gammopathy of undetermined significance|monoclonal gammopathy of undetermined significance
838001|NCT00003406|recurrent adult Hodgkin lymphoma|recurrent adult hodgkin lymphoma
838002|NCT00003406|isolated plasmacytoma of bone|isolated plasmacytoma of bone
838003|NCT00003406|extramedullary plasmacytoma|extramedullary plasmacytoma
838004|NCT00003406|refractory multiple myeloma|refractory multiple myeloma
838005|NCT00003406|Waldenstrom macroglobulinemia|waldenstrom macroglobulinemia
838006|NCT00003406|stage III multiple myeloma|stage iii multiple myeloma
838007|NCT00003406|stage III chronic lymphocytic leukemia|stage iii chronic lymphocytic leukemia
838008|NCT00003406|stage IV chronic lymphocytic leukemia|stage iv chronic lymphocytic leukemia
838009|NCT00003406|recurrent adult acute myeloid leukemia|recurrent adult acute myeloid leukemia
838010|NCT00003406|recurrent adult acute lymphoblastic leukemia|recurrent adult acute lymphoblastic leukemia
838011|NCT00003406|relapsing chronic myelogenous leukemia|relapsing chronic myelogenous leukemia
838012|NCT00003406|refractory chronic lymphocytic leukemia|refractory chronic lymphocytic leukemia
838013|NCT00003406|unspecified adult solid tumor, protocol specific|unspecified adult solid tumor, protocol specific
838014|NCT00003406|chronic phase chronic myelogenous leukemia|chronic phase chronic myelogenous leukemia
838015|NCT00003406|accelerated phase chronic myelogenous leukemia|accelerated phase chronic myelogenous leukemia
838016|NCT00003406|blastic phase chronic myelogenous leukemia|blastic phase chronic myelogenous leukemia
838017|NCT00003406|meningeal chronic myelogenous leukemia|meningeal chronic myelogenous leukemia
838018|NCT00003406|adult acute myeloid leukemia in remission|adult acute myeloid leukemia in remission
838019|NCT00003406|adult acute lymphoblastic leukemia in remission|adult acute lymphoblastic leukemia in remission
838020|NCT00003406|polycythemia vera|polycythemia vera
838021|NCT00003406|chronic idiopathic myelofibrosis|chronic idiopathic myelofibrosis
838022|NCT00003406|essential thrombocythemia|essential thrombocythemia
838023|NCT00003406|progressive hairy cell leukemia, initial treatment|progressive hairy cell leukemia, initial treatment
838024|NCT00003406|refractory hairy cell leukemia|refractory hairy cell leukemia
838025|NCT00003406|chronic myelomonocytic leukemia|chronic myelomonocytic leukemia
838026|NCT00003406|T-cell large granular lymphocyte leukemia|t-cell large granular lymphocyte leukemia
838027|NCT00003406|acute undifferentiated leukemia|acute undifferentiated leukemia
838028|NCT00003406|stage III grade 1 follicular lymphoma|stage iii grade 1 follicular lymphoma
838029|NCT00003406|stage III grade 2 follicular lymphoma|stage iii grade 2 follicular lymphoma
838030|NCT00003406|stage III grade 3 follicular lymphoma|stage iii grade 3 follicular lymphoma
838031|NCT00003406|stage III adult diffuse small cleaved cell lymphoma|stage iii adult diffuse small cleaved cell lymphoma
838032|NCT00003406|stage III adult diffuse mixed cell lymphoma|stage iii adult diffuse mixed cell lymphoma
838033|NCT00003406|stage III adult diffuse large cell lymphoma|stage iii adult diffuse large cell lymphoma
838034|NCT00003406|stage III adult immunoblastic large cell lymphoma|stage iii adult immunoblastic large cell lymphoma
838035|NCT00003406|stage III adult lymphoblastic lymphoma|stage iii adult lymphoblastic lymphoma
838036|NCT00003406|stage III adult Burkitt lymphoma|stage iii adult burkitt lymphoma
838037|NCT00003406|stage IV grade 1 follicular lymphoma|stage iv grade 1 follicular lymphoma
838038|NCT00003406|stage IV grade 2 follicular lymphoma|stage iv grade 2 follicular lymphoma
838039|NCT00003406|stage IV grade 3 follicular lymphoma|stage iv grade 3 follicular lymphoma
838040|NCT00003406|stage IV adult diffuse small cleaved cell lymphoma|stage iv adult diffuse small cleaved cell lymphoma
838041|NCT00003406|stage IV adult diffuse mixed cell lymphoma|stage iv adult diffuse mixed cell lymphoma
838042|NCT00003406|stage IV adult diffuse large cell lymphoma|stage iv adult diffuse large cell lymphoma
838043|NCT00003406|stage IV adult immunoblastic large cell lymphoma|stage iv adult immunoblastic large cell lymphoma
838044|NCT00003406|stage IV adult lymphoblastic lymphoma|stage iv adult lymphoblastic lymphoma
838045|NCT00003406|stage IV adult Burkitt lymphoma|stage iv adult burkitt lymphoma
843116|NCT00083915|Melphalan|melphalan
838046|NCT00003406|recurrent grade 1 follicular lymphoma|recurrent grade 1 follicular lymphoma
838047|NCT00003406|recurrent grade 2 follicular lymphoma|recurrent grade 2 follicular lymphoma
838048|NCT00003406|recurrent grade 3 follicular lymphoma|recurrent grade 3 follicular lymphoma
838049|NCT00003406|recurrent adult diffuse small cleaved cell lymphoma|recurrent adult diffuse small cleaved cell lymphoma
838050|NCT00003406|recurrent adult diffuse mixed cell lymphoma|recurrent adult diffuse mixed cell lymphoma
838199|NCT00004906|recurrent breast cancer|recurrent breast cancer
838051|NCT00003406|recurrent adult diffuse large cell lymphoma|recurrent adult diffuse large cell lymphoma
838052|NCT00003406|recurrent adult immunoblastic large cell lymphoma|recurrent adult immunoblastic large cell lymphoma
838053|NCT00003406|recurrent adult lymphoblastic lymphoma|recurrent adult lymphoblastic lymphoma
838054|NCT00003406|recurrent adult Burkitt lymphoma|recurrent adult burkitt lymphoma
838055|NCT00003406|stage III adult T-cell leukemia/lymphoma|stage iii adult t-cell leukemia/lymphoma
838056|NCT00003406|stage IV adult T-cell leukemia/lymphoma|stage iv adult t-cell leukemia/lymphoma
838057|NCT00003406|recurrent adult T-cell leukemia/lymphoma|recurrent adult t-cell leukemia/lymphoma
838058|NCT00003406|secondary acute myeloid leukemia|secondary acute myeloid leukemia
838059|NCT00003406|de novo myelodysplastic syndromes|de novo myelodysplastic syndromes
838060|NCT00003406|previously treated myelodysplastic syndromes|previously treated myelodysplastic syndromes
838061|NCT00003406|secondary myelodysplastic syndromes|secondary myelodysplastic syndromes
838062|NCT00003406|prolymphocytic leukemia|prolymphocytic leukemia
838063|NCT00003406|AIDS-related peripheral/systemic lymphoma|aids-related peripheral/systemic lymphoma
838064|NCT00003406|AIDS-related primary CNS lymphoma|aids-related primary cns lymphoma
838065|NCT00003406|primary systemic amyloidosis|primary systemic amyloidosis
838066|NCT00003406|non-Hodgkin lymphoma during pregnancy|non-hodgkin lymphoma during pregnancy
838067|NCT00003406|stage III mantle cell lymphoma|stage iii mantle cell lymphoma
838068|NCT00003406|stage IV mantle cell lymphoma|stage iv mantle cell lymphoma
838069|NCT00003406|recurrent mantle cell lymphoma|recurrent mantle cell lymphoma
838070|NCT00003406|angioimmunoblastic T-cell lymphoma|angioimmunoblastic t-cell lymphoma
838071|NCT00003406|anaplastic large cell lymphoma|anaplastic large cell lymphoma
838072|NCT00003406|recurrent marginal zone lymphoma|recurrent marginal zone lymphoma
838073|NCT00003406|recurrent small lymphocytic lymphoma|recurrent small lymphocytic lymphoma
838074|NCT00003406|stage III small lymphocytic lymphoma|stage iii small lymphocytic lymphoma
838075|NCT00003406|stage III marginal zone lymphoma|stage iii marginal zone lymphoma
838076|NCT00003406|stage IV small lymphocytic lymphoma|stage iv small lymphocytic lymphoma
838077|NCT00003406|stage IV marginal zone lymphoma|stage iv marginal zone lymphoma
838078|NCT00003406|extranodal marginal zone B-cell lymphoma of mucosa-associated lymphoid tissue|extranodal marginal zone b-cell lymphoma of mucosa-associated lymphoid tissue
838079|NCT00003406|nodal marginal zone B-cell lymphoma|nodal marginal zone b-cell lymphoma
838080|NCT00003406|splenic marginal zone lymphoma|splenic marginal zone lymphoma
838081|NCT00003406|childhood myelodysplastic syndromes|childhood myelodysplastic syndromes
838082|NCT00003390|stage IV renal cell cancer|stage iv renal cell cancer
838083|NCT00003390|recurrent renal cell cancer|recurrent renal cell cancer
838084|NCT00003378|stage III ovarian epithelial cancer|stage iii ovarian epithelial cancer
838085|NCT00003378|stage IV ovarian epithelial cancer|stage iv ovarian epithelial cancer
838086|NCT00003378|primary peritoneal cavity cancer|primary peritoneal cavity cancer
838087|NCT00003362|stage III melanoma|stage iii melanoma
838088|NCT00003362|stage IV melanoma|stage iv melanoma
838089|NCT00003362|recurrent melanoma|recurrent melanoma
838090|NCT00003315|infection|infection
838091|NCT00003304|adult oligodendroglioma|adult oligodendroglioma
838092|NCT00090064|MDMA|mdma
838093|NCT00090064|Methylenedioxymethamphetamine|methylenedioxymethamphetamine
838094|NCT00090064|PTSD|ptsd
838095|NCT00090064|psychotherapy|psychotherapy
838096|NCT00003279|limited stage small cell lung cancer|limited stage small cell lung cancer
838097|NCT00003260|stage IV colon cancer|stage iv colon cancer
838098|NCT00003260|stage IV rectal cancer|stage iv rectal cancer
838099|NCT00003260|recurrent colon cancer|recurrent colon cancer
838100|NCT00003260|recurrent rectal cancer|recurrent rectal cancer
838101|NCT00003260|adenocarcinoma of the colon|adenocarcinoma of the colon
838102|NCT00003260|adenocarcinoma of the rectum|adenocarcinoma of the rectum
838103|NCT00003237|stage II gastric cancer|stage ii gastric cancer
838104|NCT00003237|stage III gastric cancer|stage iii gastric cancer
838105|NCT00003237|stage II esophageal cancer|stage ii esophageal cancer
838106|NCT00003237|stage III esophageal cancer|stage iii esophageal cancer
838107|NCT00003237|adenocarcinoma of the stomach|adenocarcinoma of the stomach
838108|NCT00003237|adenocarcinoma of the esophagus|adenocarcinoma of the esophagus
838109|NCT00003229|stage IV melanoma|stage iv melanoma
838110|NCT00003229|recurrent melanoma|recurrent melanoma
838111|NCT00003224|stage II melanoma|stage ii melanoma
838112|NCT00003224|stage III melanoma|stage iii melanoma
838113|NCT00003224|stage IV melanoma|stage iv melanoma
838114|NCT00003224|recurrent melanoma|recurrent melanoma
838115|NCT00003151|contiguous stage II marginal zone lymphoma|contiguous stage ii marginal zone lymphoma
838116|NCT00003151|contiguous stage II small lymphocytic lymphoma|contiguous stage ii small lymphocytic lymphoma
838117|NCT00003151|stage I marginal zone lymphoma|stage i marginal zone lymphoma
838118|NCT00003151|stage I small lymphocytic lymphoma|stage i small lymphocytic lymphoma
838190|NCT00089999|metastatic breast cancer|metastatic breast cancer
838191|NCT00089999|GW572016|gw572016
838119|NCT00003151|extranodal marginal zone B-cell lymphoma of mucosa-associated lymphoid tissue|extranodal marginal zone b-cell lymphoma of mucosa-associated lymphoid tissue
838120|NCT00003147|localized unresectable adult primary liver cancer|localized unresectable adult primary liver cancer
838121|NCT00003147|adult primary hepatocellular carcinoma|adult primary hepatocellular carcinoma
838122|NCT00003136|recurrent ovarian epithelial cancer|recurrent ovarian epithelial cancer
839947|NCT00088309|Pamidronate|pamidronate
838123|NCT00003136|primary peritoneal cavity cancer|primary peritoneal cavity cancer
838124|NCT00003131|recurrent adult acute myeloid leukemia|recurrent adult acute myeloid leukemia
838125|NCT00002969|recurrent non-small cell lung cancer|recurrent non-small cell lung cancer
838126|NCT00002969|stage IIIB non-small cell lung cancer|stage iiib non-small cell lung cancer
838127|NCT00002969|stage IV non-small cell lung cancer|stage iv non-small cell lung cancer
838128|NCT00002960|recurrent ovarian epithelial cancer|recurrent ovarian epithelial cancer
838129|NCT00002960|malignant ascites|malignant ascites
838130|NCT00002960|fallopian tube cancer|fallopian tube cancer
838131|NCT00002960|primary peritoneal cavity cancer|primary peritoneal cavity cancer
838132|NCT00002888|stage III squamous cell carcinoma of the lip and oral cavity|stage iii squamous cell carcinoma of the lip and oral cavity
838133|NCT00002888|stage IV squamous cell carcinoma of the lip and oral cavity|stage iv squamous cell carcinoma of the lip and oral cavity
838134|NCT00002888|recurrent squamous cell carcinoma of the lip and oral cavity|recurrent squamous cell carcinoma of the lip and oral cavity
838135|NCT00002888|stage III squamous cell carcinoma of the oropharynx|stage iii squamous cell carcinoma of the oropharynx
838136|NCT00002888|stage IV squamous cell carcinoma of the oropharynx|stage iv squamous cell carcinoma of the oropharynx
838137|NCT00002888|recurrent squamous cell carcinoma of the oropharynx|recurrent squamous cell carcinoma of the oropharynx
838138|NCT00002888|stage III squamous cell carcinoma of the hypopharynx|stage iii squamous cell carcinoma of the hypopharynx
838139|NCT00002888|stage IV squamous cell carcinoma of the hypopharynx|stage iv squamous cell carcinoma of the hypopharynx
838140|NCT00002888|recurrent squamous cell carcinoma of the hypopharynx|recurrent squamous cell carcinoma of the hypopharynx
838141|NCT00002888|stage III squamous cell carcinoma of the larynx|stage iii squamous cell carcinoma of the larynx
838142|NCT00002888|stage IV squamous cell carcinoma of the larynx|stage iv squamous cell carcinoma of the larynx
838143|NCT00002888|recurrent squamous cell carcinoma of the larynx|recurrent squamous cell carcinoma of the larynx
838144|NCT00002888|stage III squamous cell carcinoma of the paranasal sinus and nasal cavity|stage iii squamous cell carcinoma of the paranasal sinus and nasal cavity
838145|NCT00002888|stage IV squamous cell carcinoma of the paranasal sinus and nasal cavity|stage iv squamous cell carcinoma of the paranasal sinus and nasal cavity
838146|NCT00002888|recurrent squamous cell carcinoma of the paranasal sinus and nasal cavity|recurrent squamous cell carcinoma of the paranasal sinus and nasal cavity
838147|NCT00002881|adenocarcinoma of the prostate|adenocarcinoma of the prostate
838148|NCT00002881|stage IV prostate cancer|stage iv prostate cancer
838149|NCT00002881|recurrent prostate cancer|recurrent prostate cancer
838150|NCT00002879|mantle cell lymphoma|mantle cell lymphoma
838151|NCT00002879|stage I mantle cell lymphoma|stage i mantle cell lymphoma
838152|NCT00002879|contiguous stage II mantle cell lymphoma|contiguous stage ii mantle cell lymphoma
838153|NCT00002879|noncontiguous stage II mantle cell lymphoma|noncontiguous stage ii mantle cell lymphoma
838154|NCT00002879|stage III mantle cell lymphoma|stage iii mantle cell lymphoma
838155|NCT00002879|stage IV mantle cell lymphoma|stage iv mantle cell lymphoma
838156|NCT00002879|recurrent mantle cell lymphoma|recurrent mantle cell lymphoma
838157|NCT00002845|stage IV melanoma|stage iv melanoma
838158|NCT00002845|recurrent melanoma|recurrent melanoma
838159|NCT00002783|stage II gastric cancer|stage ii gastric cancer
838160|NCT00002783|stage III gastric cancer|stage iii gastric cancer
838161|NCT00002783|stage IV gastric cancer|stage iv gastric cancer
838162|NCT00002783|adenocarcinoma of the stomach|adenocarcinoma of the stomach
838163|NCT00002755|stage II breast cancer|stage ii breast cancer
838164|NCT00002755|stage IIIA breast cancer|stage iiia breast cancer
838165|NCT00002742|adult Hodgkin lymphoma|adult hodgkin lymphoma
838166|NCT00002742|adult non-Hodgkin lymphoma|adult non-hodgkin lymphoma
838167|NCT00002742|leukemia|leukemia
838168|NCT00002742|childhood non-Hodgkin lymphoma|childhood non-hodgkin lymphoma
838169|NCT00002742|chronic myeloproliferative disorders|chronic myeloproliferative disorders
838170|NCT00002742|myelodysplastic syndromes|myelodysplastic syndromes
838171|NCT00002742|childhood Hodgkin lymphoma|childhood hodgkin lymphoma
838172|NCT00002742|recurrent adult non-Hodgkin lymphoma|recurrent adult non-hodgkin lymphoma
838173|NCT00002742|infection|infection
838174|NCT00002742|multiple myeloma and other plasma cell neoplasms|multiple myeloma and other plasma cell neoplasms
838175|NCT00002742|childhood myelodysplastic syndromes|childhood myelodysplastic syndromes
838176|NCT00002711|stage I esophageal cancer|stage i esophageal cancer
838177|NCT00002711|stage II esophageal cancer|stage ii esophageal cancer
838178|NCT00002711|stage III esophageal cancer|stage iii esophageal cancer
838179|NCT00002711|recurrent esophageal cancer|recurrent esophageal cancer
838180|NCT00002711|squamous cell carcinoma of the esophagus|squamous cell carcinoma of the esophagus
838181|NCT00002711|adenocarcinoma of the esophagus|adenocarcinoma of the esophagus
838182|NCT00090025|Advanced Biliary Cancer|advanced biliary cancer
838183|NCT00090025|Cholangiocarcinoma|cholangiocarcinoma
838184|NCT00090025|Gall bladder tumor|gall bladder tumor
838185|NCT00090025|Gall bladder cancer|gall bladder cancer
838186|NCT00090025|Bile duct tumor|bile duct tumor
838192|NCT00089999|ErbB2|erbb2
838193|NCT00089986|severe sepsis|severe sepsis
838194|NCT00089986|septic shock|septic shock
838195|NCT00089986|Gram-negative infection|gram-negative infection
838196|NCT00089986|phospholipid emulsion|phospholipid emulsion
838197|NCT00005024|unspecified adult solid tumor, protocol specific|unspecified adult solid tumor, protocol specific
838198|NCT00004906|stage IV breast cancer|stage iv breast cancer
838200|NCT00002674|relapsing chronic myelogenous leukemia|relapsing chronic myelogenous leukemia
838201|NCT00002674|chronic phase chronic myelogenous leukemia|chronic phase chronic myelogenous leukemia
838202|NCT00002674|accelerated phase chronic myelogenous leukemia|accelerated phase chronic myelogenous leukemia
838203|NCT00002674|Philadelphia chromosome positive chronic myelogenous leukemia|philadelphia chromosome positive chronic myelogenous leukemia
838204|NCT00002634|localized resectable neuroblastoma|localized resectable neuroblastoma
838205|NCT00002634|regional neuroblastoma|regional neuroblastoma
838206|NCT00002634|disseminated neuroblastoma|disseminated neuroblastoma
838207|NCT00002634|recurrent neuroblastoma|recurrent neuroblastoma
838208|NCT00002634|localized unresectable neuroblastoma|localized unresectable neuroblastoma
838209|NCT00002579|stage I breast cancer|stage i breast cancer
838210|NCT00002579|stage II breast cancer|stage ii breast cancer
838211|NCT00002579|stage IIIA breast cancer|stage iiia breast cancer
838212|NCT00002510|Waldenstrom macroglobulinemia|waldenstrom macroglobulinemia
838213|NCT00002510|recurrent small lymphocytic lymphoma|recurrent small lymphocytic lymphoma
838214|NCT00002510|recurrent grade 1 follicular lymphoma|recurrent grade 1 follicular lymphoma
838215|NCT00002510|recurrent grade 2 follicular lymphoma|recurrent grade 2 follicular lymphoma
838216|NCT00002510|recurrent grade 3 follicular lymphoma|recurrent grade 3 follicular lymphoma
838217|NCT00002499|recurrent childhood acute lymphoblastic leukemia|recurrent childhood acute lymphoblastic leukemia
838218|NCT00002498|stage IV breast cancer|stage iv breast cancer
838219|NCT00002498|recurrent breast cancer|recurrent breast cancer
838220|NCT00002493|stage III endometrial carcinoma|stage iii endometrial carcinoma
838221|NCT00002493|stage IV endometrial carcinoma|stage iv endometrial carcinoma
838222|NCT00002493|endometrial adenocarcinoma|endometrial adenocarcinoma
838223|NCT00002493|endometrial adenosquamous cell carcinoma|endometrial adenosquamous cell carcinoma
838224|NCT00002493|endometrial adenoacanthoma|endometrial adenoacanthoma
838225|NCT00002493|endometrial papillary serous carcinoma|endometrial papillary serous carcinoma
838226|NCT00002493|endometrial clear cell carcinoma|endometrial clear cell carcinoma
838227|NCT00002493|psychosocial effects of cancer and its treatment|psychosocial effects of cancer and its treatment
838228|NCT00002479|stage I cutaneous T-cell non-Hodgkin lymphoma|stage i cutaneous t-cell non-hodgkin lymphoma
838229|NCT00002479|stage II cutaneous T-cell non-Hodgkin lymphoma|stage ii cutaneous t-cell non-hodgkin lymphoma
838230|NCT00002479|stage III cutaneous T-cell non-Hodgkin lymphoma|stage iii cutaneous t-cell non-hodgkin lymphoma
838231|NCT00002479|stage IV cutaneous T-cell non-Hodgkin lymphoma|stage iv cutaneous t-cell non-hodgkin lymphoma
838232|NCT00089973|breast cancer|breast cancer
838233|NCT00089960|GIST|gist
838234|NCT00089947|Anti-T cell antibodies|anti-t cell antibodies
838235|NCT00089947|Living Donor Renal Transplantation|living donor renal transplantation
838236|NCT00089947|Acute Renal Allograft Rejection|acute renal allograft rejection
838237|NCT00089947|Induction Therapy with Reduction of Calcineurin inhibitors|induction therapy with reduction of calcineurin inhibitors
838238|NCT00089921|Rheumatoid Arthritis|rheumatoid arthritis
838239|NCT00089921|DMARDs|dmards
838240|NCT00089921|Methotrexate|methotrexate
838241|NCT00089921|p38 kinase|p38 kinase
838242|NCT00004900|stage IV breast cancer|stage iv breast cancer
838243|NCT00004900|recurrent breast cancer|recurrent breast cancer
838244|NCT00004900|stage IIIB breast cancer|stage iiib breast cancer
838245|NCT00004182|stage IV breast cancer|stage iv breast cancer
838246|NCT00004182|recurrent breast cancer|recurrent breast cancer
838247|NCT00004136|stage III childhood liver cancer|stage iii childhood liver cancer
838248|NCT00004136|stage IV childhood liver cancer|stage iv childhood liver cancer
838249|NCT00004136|recurrent childhood liver cancer|recurrent childhood liver cancer
838250|NCT00004136|localized unresectable adult primary liver cancer|localized unresectable adult primary liver cancer
838251|NCT00004136|advanced adult primary liver cancer|advanced adult primary liver cancer
838252|NCT00004136|recurrent adult primary liver cancer|recurrent adult primary liver cancer
838253|NCT00004136|liver metastases|liver metastases
838254|NCT00004042|stage III colon cancer|stage iii colon cancer
838255|NCT00004042|stage IV colon cancer|stage iv colon cancer
838256|NCT00004042|stage III rectal cancer|stage iii rectal cancer
838257|NCT00004042|stage IV rectal cancer|stage iv rectal cancer
838258|NCT00004042|recurrent colon cancer|recurrent colon cancer
838259|NCT00004042|recurrent rectal cancer|recurrent rectal cancer
838260|NCT00003974|stage I non-small cell lung cancer|stage i non-small cell lung cancer
838261|NCT00003974|stage II non-small cell lung cancer|stage ii non-small cell lung cancer
838262|NCT00003974|localized malignant mesothelioma|localized malignant mesothelioma
838263|NCT00003974|stage IIIA non-small cell lung cancer|stage iiia non-small cell lung cancer
838264|NCT00089908|Dengue Vaccine|dengue vaccine
838265|NCT00089908|Dengue Virus|dengue virus
838266|NCT00089908|Dengue Hemorrhagic Fever|dengue hemorrhagic fever
838267|NCT00089908|Dengue Shock Syndrome|dengue shock syndrome
838268|NCT00089895|myocardial infarction|myocardial infarction
838269|NCT00089895|acute coronary syndrome|acute coronary syndrome
838270|NCT00089895|non-ST-segment elevation|non-st-segment elevation
838271|NCT00089895|eptifibatide|eptifibatide
838272|NCT00089895|Integrilin|integrilin
838273|NCT00089895|glycoprotein IIb/IIIa inhibitor (GP IIb/IIIa)|glycoprotein iib/iiia inhibitor (gp iib/iiia)
838274|NCT00089895|percutaneous coronary intervention (PCI)|percutaneous coronary intervention (pci)
838356|NCT00003400|stage IV prostate cancer|stage iv prostate cancer
838275|NCT00089895|coronary artery bypass graph surgery (CABG)|coronary artery bypass graph surgery (cabg)
838276|NCT00089895|catheterization|catheterization
838277|NCT00089895|angina|angina
838278|NCT00089895|ischemia|ischemia
838279|NCT00089895|cardiac ischemia|cardiac ischemia
838280|NCT00089895|cardiovascular disease|cardiovascular disease
838281|NCT00089882|Alzheimer disease|alzheimer disease
838282|NCT00089882|Apolipoproteins E (APOE)|apolipoproteins e (apoe)
838283|NCT00089882|Genetic susceptibility testing|genetic susceptibility testing
838284|NCT00089856|Prostate|prostate
838285|NCT00089856|Cancer|cancer
838286|NCT00089856|Metastatic|metastatic
838287|NCT00089856|Hormone-refractory|hormone-refractory
838288|NCT00089856|GVAX|gvax
838289|NCT00089856|Chemotherapy|chemotherapy
838290|NCT00089856|Taxotere|taxotere
838291|NCT00089856|Docetaxel|docetaxel
838292|NCT00089856|Prednisone|prednisone
838293|NCT00089856|Vaccine|vaccine
838294|NCT00089856|Allogeneic cells|allogeneic cells
838295|NCT00089856|Advanced Prostate Cancer|advanced prostate cancer
838296|NCT00003951|recurrent pancreatic cancer|recurrent pancreatic cancer
838297|NCT00003951|duct cell adenocarcinoma of the pancreas|duct cell adenocarcinoma of the pancreas
838298|NCT00003951|stage IV pancreatic cancer|stage iv pancreatic cancer
838299|NCT00003897|stage IV melanoma|stage iv melanoma
838300|NCT00003897|recurrent melanoma|recurrent melanoma
838301|NCT00003885|recurrent cutaneous T-cell non-Hodgkin lymphoma|recurrent cutaneous t-cell non-hodgkin lymphoma
838302|NCT00003885|stage I multiple myeloma|stage i multiple myeloma
838303|NCT00003885|stage II multiple myeloma|stage ii multiple myeloma
838304|NCT00003885|stage III multiple myeloma|stage iii multiple myeloma
838305|NCT00003885|recurrent adult acute myeloid leukemia|recurrent adult acute myeloid leukemia
838306|NCT00003885|recurrent adult acute lymphoblastic leukemia|recurrent adult acute lymphoblastic leukemia
838307|NCT00003885|blastic phase chronic myelogenous leukemia|blastic phase chronic myelogenous leukemia
838308|NCT00003885|recurrent grade 1 follicular lymphoma|recurrent grade 1 follicular lymphoma
838309|NCT00003885|recurrent grade 2 follicular lymphoma|recurrent grade 2 follicular lymphoma
838310|NCT00003885|recurrent grade 3 follicular lymphoma|recurrent grade 3 follicular lymphoma
838311|NCT00003885|recurrent adult diffuse small cleaved cell lymphoma|recurrent adult diffuse small cleaved cell lymphoma
838312|NCT00003885|recurrent adult diffuse mixed cell lymphoma|recurrent adult diffuse mixed cell lymphoma
838313|NCT00003885|recurrent adult diffuse large cell lymphoma|recurrent adult diffuse large cell lymphoma
838314|NCT00003885|recurrent adult immunoblastic large cell lymphoma|recurrent adult immunoblastic large cell lymphoma
838315|NCT00003885|recurrent adult lymphoblastic lymphoma|recurrent adult lymphoblastic lymphoma
838316|NCT00003885|recurrent adult Burkitt lymphoma|recurrent adult burkitt lymphoma
838317|NCT00003885|recurrent adult T-cell leukemia/lymphoma|recurrent adult t-cell leukemia/lymphoma
838318|NCT00003885|previously treated myelodysplastic syndromes|previously treated myelodysplastic syndromes
838319|NCT00003885|recurrent mantle cell lymphoma|recurrent mantle cell lymphoma
838320|NCT00003885|recurrent marginal zone lymphoma|recurrent marginal zone lymphoma
838321|NCT00003885|recurrent small lymphocytic lymphoma|recurrent small lymphocytic lymphoma
838322|NCT00003885|extranodal marginal zone B-cell lymphoma of mucosa-associated lymphoid tissue|extranodal marginal zone b-cell lymphoma of mucosa-associated lymphoid tissue
838323|NCT00003885|nodal marginal zone B-cell lymphoma|nodal marginal zone b-cell lymphoma
838324|NCT00003885|splenic marginal zone lymphoma|splenic marginal zone lymphoma
838325|NCT00003776|metastatic osteosarcoma|metastatic osteosarcoma
838326|NCT00003751|adult glioblastoma|adult glioblastoma
838327|NCT00003751|adult giant cell glioblastoma|adult giant cell glioblastoma
838328|NCT00003751|adult gliosarcoma|adult gliosarcoma
838329|NCT00089843|Eating Disorders|eating disorders
838330|NCT00089843|Osteopenia|osteopenia
838331|NCT00089830|Subfoveal Choroidal Neovascularization|subfoveal choroidal neovascularization
838332|NCT00089830|Squalamine Lactate|squalamine lactate
838333|NCT00089804|Lupus|lupus
838334|NCT00089804|Nephritis|nephritis
838335|NCT00089804|Kidney|kidney
838336|NCT00089804|SLE|sle
838337|NCT00089804|Systemic Lupus Erythematosus|systemic lupus erythematosus
838338|NCT00089804|Nephritis, Lupus|nephritis, lupus
838339|NCT00003709|unspecified adult solid tumor, protocol specific|unspecified adult solid tumor, protocol specific
838340|NCT00003686|oral complications|oral complications
838341|NCT00003686|quality of life|quality of life
838342|NCT00003684|unspecified adult solid tumor, protocol specific|unspecified adult solid tumor, protocol specific
838343|NCT00003684|pulmonary complications|pulmonary complications
838344|NCT00003684|quality of life|quality of life
838345|NCT00003626|stage IV prostate cancer|stage iv prostate cancer
838346|NCT00003626|recurrent prostate cancer|recurrent prostate cancer
838347|NCT00003556|stage IV melanoma|stage iv melanoma
838348|NCT00003556|recurrent melanoma|recurrent melanoma
838349|NCT00089791|Postmenopausal Osteoporosis|postmenopausal osteoporosis
843117|NCT00083902|Myeloma|myeloma
838350|NCT00003555|unspecified adult solid tumor, protocol specific|unspecified adult solid tumor, protocol specific
838351|NCT00003543|stage IV colon cancer|stage iv colon cancer
838352|NCT00003543|stage IV rectal cancer|stage iv rectal cancer
838353|NCT00003543|recurrent colon cancer|recurrent colon cancer
838354|NCT00003543|recurrent rectal cancer|recurrent rectal cancer
838355|NCT00003400|adenocarcinoma of the prostate|adenocarcinoma of the prostate
838357|NCT00003400|recurrent prostate cancer|recurrent prostate cancer
838358|NCT00003395|stage IV adult Hodgkin lymphoma|stage iv adult hodgkin lymphoma
838359|NCT00003395|recurrent adult Hodgkin lymphoma|recurrent adult hodgkin lymphoma
838360|NCT00003395|stage IV cutaneous T-cell non-Hodgkin lymphoma|stage iv cutaneous t-cell non-hodgkin lymphoma
838361|NCT00003395|recurrent cutaneous T-cell non-Hodgkin lymphoma|recurrent cutaneous t-cell non-hodgkin lymphoma
838362|NCT00003395|refractory multiple myeloma|refractory multiple myeloma
838363|NCT00003395|Waldenström macroglobulinemia|waldenström macroglobulinemia
838364|NCT00003395|stage III multiple myeloma|stage iii multiple myeloma
838365|NCT00003395|stage IV chronic lymphocytic leukemia|stage iv chronic lymphocytic leukemia
838366|NCT00003395|recurrent adult acute myeloid leukemia|recurrent adult acute myeloid leukemia
838367|NCT00003395|recurrent adult acute lymphoblastic leukemia|recurrent adult acute lymphoblastic leukemia
838368|NCT00003395|relapsing chronic myelogenous leukemia|relapsing chronic myelogenous leukemia
838369|NCT00003395|refractory chronic lymphocytic leukemia|refractory chronic lymphocytic leukemia
838370|NCT00003395|chronic phase chronic myelogenous leukemia|chronic phase chronic myelogenous leukemia
838371|NCT00003395|accelerated phase chronic myelogenous leukemia|accelerated phase chronic myelogenous leukemia
838372|NCT00003395|blastic phase chronic myelogenous leukemia|blastic phase chronic myelogenous leukemia
838373|NCT00003395|meningeal chronic myelogenous leukemia|meningeal chronic myelogenous leukemia
838374|NCT00003395|adult acute erythroid leukemia (M6)|adult acute erythroid leukemia (m6)
838375|NCT00003395|adult acute myeloblastic leukemia without maturation (M1)|adult acute myeloblastic leukemia without maturation (m1)
838376|NCT00003395|adult acute myeloblastic leukemia with maturation (M2)|adult acute myeloblastic leukemia with maturation (m2)
838377|NCT00003395|adult acute myelomonocytic leukemia (M4)|adult acute myelomonocytic leukemia (m4)
838378|NCT00003395|adult acute monoblastic leukemia (M5a)|adult acute monoblastic leukemia (m5a)
838379|NCT00003395|adult acute eosinophilic leukemia|adult acute eosinophilic leukemia
838380|NCT00003395|adult acute basophilic leukemia|adult acute basophilic leukemia
838381|NCT00003395|adult acute megakaryoblastic leukemia (M7)|adult acute megakaryoblastic leukemia (m7)
838382|NCT00003395|progressive hairy cell leukemia, initial treatment|progressive hairy cell leukemia, initial treatment
838383|NCT00003395|refractory hairy cell leukemia|refractory hairy cell leukemia
838384|NCT00003395|acute undifferentiated leukemia|acute undifferentiated leukemia
838385|NCT00003395|stage IV grade 1 follicular lymphoma|stage iv grade 1 follicular lymphoma
838386|NCT00003395|stage IV grade 2 follicular lymphoma|stage iv grade 2 follicular lymphoma
838387|NCT00003395|stage IV grade 3 follicular lymphoma|stage iv grade 3 follicular lymphoma
838388|NCT00003395|stage IV adult diffuse small cleaved cell lymphoma|stage iv adult diffuse small cleaved cell lymphoma
838389|NCT00003395|stage IV adult diffuse mixed cell lymphoma|stage iv adult diffuse mixed cell lymphoma
838390|NCT00003395|stage IV adult diffuse large cell lymphoma|stage iv adult diffuse large cell lymphoma
838391|NCT00003395|stage IV adult immunoblastic large cell lymphoma|stage iv adult immunoblastic large cell lymphoma
838392|NCT00003395|stage IV adult lymphoblastic lymphoma|stage iv adult lymphoblastic lymphoma
838393|NCT00003395|stage IV adult Burkitt lymphoma|stage iv adult burkitt lymphoma
838394|NCT00003395|recurrent grade 1 follicular lymphoma|recurrent grade 1 follicular lymphoma
838395|NCT00003395|recurrent grade 2 follicular lymphoma|recurrent grade 2 follicular lymphoma
838396|NCT00003395|recurrent grade 3 follicular lymphoma|recurrent grade 3 follicular lymphoma
838397|NCT00003395|recurrent adult diffuse small cleaved cell lymphoma|recurrent adult diffuse small cleaved cell lymphoma
838398|NCT00003395|recurrent adult diffuse mixed cell lymphoma|recurrent adult diffuse mixed cell lymphoma
838399|NCT00003395|recurrent adult diffuse large cell lymphoma|recurrent adult diffuse large cell lymphoma
838400|NCT00003395|recurrent adult immunoblastic large cell lymphoma|recurrent adult immunoblastic large cell lymphoma
838401|NCT00003395|recurrent adult lymphoblastic lymphoma|recurrent adult lymphoblastic lymphoma
838402|NCT00003395|recurrent adult Burkitt lymphoma|recurrent adult burkitt lymphoma
838403|NCT00003395|stage IV adult T-cell leukemia/lymphoma|stage iv adult t-cell leukemia/lymphoma
838404|NCT00003395|recurrent adult T-cell leukemia/lymphoma|recurrent adult t-cell leukemia/lymphoma
838405|NCT00003395|secondary acute myeloid leukemia|secondary acute myeloid leukemia
838406|NCT00003395|adult acute monocytic leukemia (M5b)|adult acute monocytic leukemia (m5b)
838407|NCT00003395|primary central nervous system non-Hodgkin lymphoma|primary central nervous system non-hodgkin lymphoma
838408|NCT00003395|AIDS-related peripheral/systemic lymphoma|aids-related peripheral/systemic lymphoma
838409|NCT00003395|AIDS-related primary CNS lymphoma|aids-related primary cns lymphoma
838410|NCT00003395|adult acute minimally differentiated myeloid leukemia (M0)|adult acute minimally differentiated myeloid leukemia (m0)
838411|NCT00003395|intraocular lymphoma|intraocular lymphoma
838412|NCT00003395|stage IV mantle cell lymphoma|stage iv mantle cell lymphoma
838413|NCT00003395|recurrent mantle cell lymphoma|recurrent mantle cell lymphoma
838414|NCT00003395|anaplastic large cell lymphoma|anaplastic large cell lymphoma
838415|NCT00003395|stage IV mycosis fungoides/Sezary syndrome|stage iv mycosis fungoides/sezary syndrome
838416|NCT00003395|recurrent mycosis fungoides/Sezary syndrome|recurrent mycosis fungoides/sezary syndrome
838417|NCT00003395|juvenile myelomonocytic leukemia|juvenile myelomonocytic leukemia
838418|NCT00003395|recurrent marginal zone lymphoma|recurrent marginal zone lymphoma
838419|NCT00003395|recurrent small lymphocytic lymphoma|recurrent small lymphocytic lymphoma
838420|NCT00003395|stage IV small lymphocytic lymphoma|stage iv small lymphocytic lymphoma
838421|NCT00003395|stage IV marginal zone lymphoma|stage iv marginal zone lymphoma
838422|NCT00003395|extranodal marginal zone B-cell lymphoma of mucosa-associated lymphoid tissue|extranodal marginal zone b-cell lymphoma of mucosa-associated lymphoid tissue
838423|NCT00003395|nodal marginal zone B-cell lymphoma|nodal marginal zone b-cell lymphoma
838424|NCT00003395|splenic marginal zone lymphoma|splenic marginal zone lymphoma
838425|NCT00003380|recurrent ovarian epithelial cancer|recurrent ovarian epithelial cancer
838426|NCT00003380|ovarian undifferentiated adenocarcinoma|ovarian undifferentiated adenocarcinoma
838427|NCT00003380|ovarian mixed epithelial carcinoma|ovarian mixed epithelial carcinoma
838428|NCT00003380|ovarian serous cystadenocarcinoma|ovarian serous cystadenocarcinoma
838429|NCT00003380|ovarian mucinous cystadenocarcinoma|ovarian mucinous cystadenocarcinoma
838430|NCT00003380|ovarian endometrioid adenocarcinoma|ovarian endometrioid adenocarcinoma
838431|NCT00003380|ovarian clear cell cystadenocarcinoma|ovarian clear cell cystadenocarcinoma
838432|NCT00003380|fallopian tube cancer|fallopian tube cancer
838433|NCT00003380|primary peritoneal cavity cancer|primary peritoneal cavity cancer
838434|NCT00003380|Brenner tumor|brenner tumor
838435|NCT00003360|stage IV colon cancer|stage iv colon cancer
838436|NCT00003360|stage IV rectal cancer|stage iv rectal cancer
838437|NCT00003360|recurrent colon cancer|recurrent colon cancer
838438|NCT00003360|recurrent rectal cancer|recurrent rectal cancer
838439|NCT00003357|stage I breast cancer|stage i breast cancer
838440|NCT00003357|stage II breast cancer|stage ii breast cancer
838441|NCT00003357|stage III breast cancer|stage iii breast cancer
838442|NCT00003348|recurrent adult brain tumor|recurrent adult brain tumor
838443|NCT00003348|adult glioblastoma|adult glioblastoma
838444|NCT00003348|adult anaplastic astrocytoma|adult anaplastic astrocytoma
838445|NCT00003348|adult giant cell glioblastoma|adult giant cell glioblastoma
838446|NCT00003348|adult gliosarcoma|adult gliosarcoma
838447|NCT00003340|recurrent adult acute myeloid leukemia|recurrent adult acute myeloid leukemia
838448|NCT00003312|stage I prostate cancer|stage i prostate cancer
838449|NCT00003312|stage IIB prostate cancer|stage iib prostate cancer
838450|NCT00003312|stage IIA prostate cancer|stage iia prostate cancer
838451|NCT00089778|Clinical Response|clinical response
838452|NCT00089778|Toxicity|toxicity
838453|NCT00089778|Immunologic Response|immunologic response
838454|NCT00089778|Adjuvant|adjuvant
838455|NCT00089778|IL-2|il-2
838456|NCT00089778|Renal Cancer|renal cancer
838457|NCT00089765|Retinal Angioma|retinal angioma
838458|NCT00089765|Tumor|tumor
838459|NCT00089765|Anti-VEGF|anti-vegf
838460|NCT00089765|Monoclonal Antibody|monoclonal antibody
838461|NCT00089765|Macular Edema|macular edema
838462|NCT00089765|Von Hippel-Lindau Disease|von hippel-lindau disease
838463|NCT00089765|VEGF|vegf
838464|NCT00089765|Ranibizumab|ranibizumab
838465|NCT00089765|VHL|vhl
838466|NCT00003294|stage III adult Hodgkin lymphoma|stage iii adult hodgkin lymphoma
838467|NCT00003294|stage IV adult Hodgkin lymphoma|stage iv adult hodgkin lymphoma
838468|NCT00003294|recurrent adult Hodgkin lymphoma|recurrent adult hodgkin lymphoma
838469|NCT00003294|stage III chronic lymphocytic leukemia|stage iii chronic lymphocytic leukemia
838470|NCT00003294|stage IV chronic lymphocytic leukemia|stage iv chronic lymphocytic leukemia
838471|NCT00003294|recurrent adult acute myeloid leukemia|recurrent adult acute myeloid leukemia
838472|NCT00003294|recurrent adult acute lymphoblastic leukemia|recurrent adult acute lymphoblastic leukemia
838473|NCT00003294|relapsing chronic myelogenous leukemia|relapsing chronic myelogenous leukemia
838474|NCT00003294|refractory chronic lymphocytic leukemia|refractory chronic lymphocytic leukemia
838475|NCT00003294|unspecified adult solid tumor, protocol specific|unspecified adult solid tumor, protocol specific
838476|NCT00003294|chronic phase chronic myelogenous leukemia|chronic phase chronic myelogenous leukemia
838477|NCT00003294|accelerated phase chronic myelogenous leukemia|accelerated phase chronic myelogenous leukemia
838478|NCT00003294|blastic phase chronic myelogenous leukemia|blastic phase chronic myelogenous leukemia
838479|NCT00003294|meningeal chronic myelogenous leukemia|meningeal chronic myelogenous leukemia
838480|NCT00003294|untreated adult acute lymphoblastic leukemia|untreated adult acute lymphoblastic leukemia
838481|NCT00003294|untreated adult acute myeloid leukemia|untreated adult acute myeloid leukemia
838482|NCT00003294|untreated hairy cell leukemia|untreated hairy cell leukemia
838483|NCT00003294|progressive hairy cell leukemia, initial treatment|progressive hairy cell leukemia, initial treatment
838484|NCT00003294|refractory hairy cell leukemia|refractory hairy cell leukemia
838485|NCT00003294|chronic myelomonocytic leukemia|chronic myelomonocytic leukemia
838486|NCT00003294|stage IV grade 1 follicular lymphoma|stage iv grade 1 follicular lymphoma
838487|NCT00003294|stage IV grade 2 follicular lymphoma|stage iv grade 2 follicular lymphoma
838488|NCT00003294|stage IV grade 3 follicular lymphoma|stage iv grade 3 follicular lymphoma
838489|NCT00003294|stage IV adult diffuse small cleaved cell lymphoma|stage iv adult diffuse small cleaved cell lymphoma
838490|NCT00003294|stage IV adult diffuse mixed cell lymphoma|stage iv adult diffuse mixed cell lymphoma
838903|NCT00005056|stage III renal cell cancer|stage iii renal cell cancer
838491|NCT00003294|stage IV adult diffuse large cell lymphoma|stage iv adult diffuse large cell lymphoma
838492|NCT00003294|stage IV adult immunoblastic large cell lymphoma|stage iv adult immunoblastic large cell lymphoma
838493|NCT00003294|stage IV adult lymphoblastic lymphoma|stage iv adult lymphoblastic lymphoma
838494|NCT00003294|stage IV adult Burkitt lymphoma|stage iv adult burkitt lymphoma
838495|NCT00003294|recurrent grade 1 follicular lymphoma|recurrent grade 1 follicular lymphoma
839948|NCT00088309|Osteopenia|osteopenia
838496|NCT00003294|recurrent grade 2 follicular lymphoma|recurrent grade 2 follicular lymphoma
838497|NCT00003294|recurrent grade 3 follicular lymphoma|recurrent grade 3 follicular lymphoma
838498|NCT00003294|recurrent adult diffuse small cleaved cell lymphoma|recurrent adult diffuse small cleaved cell lymphoma
838499|NCT00003294|recurrent adult diffuse mixed cell lymphoma|recurrent adult diffuse mixed cell lymphoma
838500|NCT00003294|recurrent adult diffuse large cell lymphoma|recurrent adult diffuse large cell lymphoma
838501|NCT00003294|recurrent adult immunoblastic large cell lymphoma|recurrent adult immunoblastic large cell lymphoma
838502|NCT00003294|recurrent adult lymphoblastic lymphoma|recurrent adult lymphoblastic lymphoma
838503|NCT00003294|recurrent adult Burkitt lymphoma|recurrent adult burkitt lymphoma
838504|NCT00003294|stage III adult T-cell leukemia/lymphoma|stage iii adult t-cell leukemia/lymphoma
838505|NCT00003294|stage IV adult T-cell leukemia/lymphoma|stage iv adult t-cell leukemia/lymphoma
838506|NCT00003294|recurrent adult T-cell leukemia/lymphoma|recurrent adult t-cell leukemia/lymphoma
838507|NCT00003294|prolymphocytic leukemia|prolymphocytic leukemia
838508|NCT00003294|AIDS-related peripheral/systemic lymphoma|aids-related peripheral/systemic lymphoma
838509|NCT00003294|AIDS-related primary CNS lymphoma|aids-related primary cns lymphoma
838510|NCT00003294|stage IV mantle cell lymphoma|stage iv mantle cell lymphoma
838511|NCT00003294|recurrent mantle cell lymphoma|recurrent mantle cell lymphoma
838512|NCT00003294|angioimmunoblastic T-cell lymphoma|angioimmunoblastic t-cell lymphoma
838513|NCT00003294|anaplastic large cell lymphoma|anaplastic large cell lymphoma
838514|NCT00003294|recurrent marginal zone lymphoma|recurrent marginal zone lymphoma
838515|NCT00003294|recurrent small lymphocytic lymphoma|recurrent small lymphocytic lymphoma
838516|NCT00003294|stage IV small lymphocytic lymphoma|stage iv small lymphocytic lymphoma
838517|NCT00003294|stage IV marginal zone lymphoma|stage iv marginal zone lymphoma
838518|NCT00003294|extranodal marginal zone B-cell lymphoma of mucosa-associated lymphoid tissue|extranodal marginal zone b-cell lymphoma of mucosa-associated lymphoid tissue
838519|NCT00003294|nodal marginal zone B-cell lymphoma|nodal marginal zone b-cell lymphoma
838520|NCT00003294|splenic marginal zone lymphoma|splenic marginal zone lymphoma
838521|NCT00003284|stage II non-small cell lung cancer|stage ii non-small cell lung cancer
838522|NCT00003284|limited stage small cell lung cancer|limited stage small cell lung cancer
838523|NCT00003284|extensive stage small cell lung cancer|extensive stage small cell lung cancer
838524|NCT00003284|recurrent small cell lung cancer|recurrent small cell lung cancer
838525|NCT00003284|stage IIIA non-small cell lung cancer|stage iiia non-small cell lung cancer
838526|NCT00003284|stage IIIB non-small cell lung cancer|stage iiib non-small cell lung cancer
838527|NCT00003284|stage IV non-small cell lung cancer|stage iv non-small cell lung cancer
838528|NCT00003251|stage III nasopharyngeal cancer|stage iii nasopharyngeal cancer
838529|NCT00003251|stage IV nasopharyngeal cancer|stage iv nasopharyngeal cancer
838530|NCT00003251|recurrent nasopharyngeal cancer|recurrent nasopharyngeal cancer
838531|NCT00003251|stage III salivary gland cancer|stage iii salivary gland cancer
838532|NCT00003251|stage IV salivary gland cancer|stage iv salivary gland cancer
838533|NCT00003251|recurrent salivary gland cancer|recurrent salivary gland cancer
838534|NCT00003251|salivary gland squamous cell carcinoma|salivary gland squamous cell carcinoma
838535|NCT00003251|high-grade salivary gland mucoepidermoid carcinoma|high-grade salivary gland mucoepidermoid carcinoma
838536|NCT00003251|stage III lip and oral cavity cancer|stage iii lip and oral cavity cancer
838537|NCT00003251|stage IV lip and oral cavity cancer|stage iv lip and oral cavity cancer
838538|NCT00003251|recurrent lip and oral cavity cancer|recurrent lip and oral cavity cancer
838539|NCT00003251|stage III hypopharyngeal cancer|stage iii hypopharyngeal cancer
838540|NCT00003251|stage IV hypopharyngeal cancer|stage iv hypopharyngeal cancer
838541|NCT00003251|recurrent hypopharyngeal cancer|recurrent hypopharyngeal cancer
838542|NCT00003251|stage III laryngeal cancer|stage iii laryngeal cancer
838543|NCT00003251|stage IV laryngeal cancer|stage iv laryngeal cancer
838544|NCT00003251|recurrent laryngeal cancer|recurrent laryngeal cancer
838545|NCT00003251|stage III paranasal sinus and nasal cavity cancer|stage iii paranasal sinus and nasal cavity cancer
838546|NCT00003251|stage IV paranasal sinus and nasal cavity cancer|stage iv paranasal sinus and nasal cavity cancer
838547|NCT00003251|recurrent paranasal sinus and nasal cavity cancer|recurrent paranasal sinus and nasal cavity cancer
838548|NCT00003251|stage III oropharyngeal cancer|stage iii oropharyngeal cancer
838549|NCT00003251|stage IV oropharyngeal cancer|stage iv oropharyngeal cancer
838550|NCT00003251|recurrent oropharyngeal cancer|recurrent oropharyngeal cancer
838551|NCT00003251|stage III squamous cell carcinoma of the lip and oral cavity|stage iii squamous cell carcinoma of the lip and oral cavity
838552|NCT00003251|stage III mucoepidermoid carcinoma of the oral cavity|stage iii mucoepidermoid carcinoma of the oral cavity
838553|NCT00003251|stage IV squamous cell carcinoma of the lip and oral cavity|stage iv squamous cell carcinoma of the lip and oral cavity
838554|NCT00003251|stage IV mucoepidermoid carcinoma of the oral cavity|stage iv mucoepidermoid carcinoma of the oral cavity
838555|NCT00003251|recurrent squamous cell carcinoma of the lip and oral cavity|recurrent squamous cell carcinoma of the lip and oral cavity
843118|NCT00083902|Thalidomide|thalidomide
838556|NCT00003251|recurrent mucoepidermoid carcinoma of the oral cavity|recurrent mucoepidermoid carcinoma of the oral cavity
838557|NCT00003251|stage III squamous cell carcinoma of the oropharynx|stage iii squamous cell carcinoma of the oropharynx
838558|NCT00003251|stage IV squamous cell carcinoma of the oropharynx|stage iv squamous cell carcinoma of the oropharynx
838559|NCT00003251|recurrent squamous cell carcinoma of the oropharynx|recurrent squamous cell carcinoma of the oropharynx
838560|NCT00003251|stage III squamous cell carcinoma of the nasopharynx|stage iii squamous cell carcinoma of the nasopharynx
838561|NCT00003251|stage IV squamous cell carcinoma of the nasopharynx|stage iv squamous cell carcinoma of the nasopharynx
838562|NCT00003251|recurrent squamous cell carcinoma of the nasopharynx|recurrent squamous cell carcinoma of the nasopharynx
838563|NCT00003251|stage III squamous cell carcinoma of the hypopharynx|stage iii squamous cell carcinoma of the hypopharynx
838564|NCT00003251|stage IV squamous cell carcinoma of the hypopharynx|stage iv squamous cell carcinoma of the hypopharynx
838565|NCT00003251|recurrent squamous cell carcinoma of the hypopharynx|recurrent squamous cell carcinoma of the hypopharynx
838566|NCT00003251|stage III squamous cell carcinoma of the larynx|stage iii squamous cell carcinoma of the larynx
838567|NCT00003251|stage IV squamous cell carcinoma of the larynx|stage iv squamous cell carcinoma of the larynx
838568|NCT00003251|recurrent squamous cell carcinoma of the larynx|recurrent squamous cell carcinoma of the larynx
838569|NCT00003251|stage III squamous cell carcinoma of the paranasal sinus and nasal cavity|stage iii squamous cell carcinoma of the paranasal sinus and nasal cavity
838570|NCT00003251|stage IV squamous cell carcinoma of the paranasal sinus and nasal cavity|stage iv squamous cell carcinoma of the paranasal sinus and nasal cavity
838571|NCT00003251|recurrent squamous cell carcinoma of the paranasal sinus and nasal cavity|recurrent squamous cell carcinoma of the paranasal sinus and nasal cavity
838572|NCT00003251|drug/agent toxicity by tissue/organ|drug/agent toxicity by tissue/organ
838573|NCT00003251|radiation toxicity|radiation toxicity
838574|NCT00003220|stage IV colon cancer|stage iv colon cancer
838575|NCT00003220|stage IV rectal cancer|stage iv rectal cancer
838576|NCT00003220|recurrent colon cancer|recurrent colon cancer
838577|NCT00003220|recurrent rectal cancer|recurrent rectal cancer
838578|NCT00003220|adenocarcinoma of the colon|adenocarcinoma of the colon
838579|NCT00003220|adenocarcinoma of the rectum|adenocarcinoma of the rectum
838580|NCT00003200|stage III squamous cell carcinoma of the lip and oral cavity|stage iii squamous cell carcinoma of the lip and oral cavity
838581|NCT00003200|stage IV squamous cell carcinoma of the lip and oral cavity|stage iv squamous cell carcinoma of the lip and oral cavity
838582|NCT00003200|stage III squamous cell carcinoma of the oropharynx|stage iii squamous cell carcinoma of the oropharynx
838583|NCT00003200|stage III lymphoepithelioma of the oropharynx|stage iii lymphoepithelioma of the oropharynx
838584|NCT00003200|stage IV squamous cell carcinoma of the oropharynx|stage iv squamous cell carcinoma of the oropharynx
838585|NCT00003200|stage IV lymphoepithelioma of the oropharynx|stage iv lymphoepithelioma of the oropharynx
838586|NCT00003200|stage III squamous cell carcinoma of the nasopharynx|stage iii squamous cell carcinoma of the nasopharynx
838587|NCT00003200|stage III lymphoepithelioma of the nasopharynx|stage iii lymphoepithelioma of the nasopharynx
838588|NCT00003200|stage IV squamous cell carcinoma of the nasopharynx|stage iv squamous cell carcinoma of the nasopharynx
838589|NCT00003200|stage IV lymphoepithelioma of the nasopharynx|stage iv lymphoepithelioma of the nasopharynx
838590|NCT00003200|stage III squamous cell carcinoma of the hypopharynx|stage iii squamous cell carcinoma of the hypopharynx
838591|NCT00003200|stage IV squamous cell carcinoma of the hypopharynx|stage iv squamous cell carcinoma of the hypopharynx
838592|NCT00003200|stage III squamous cell carcinoma of the larynx|stage iii squamous cell carcinoma of the larynx
838593|NCT00003200|stage IV squamous cell carcinoma of the larynx|stage iv squamous cell carcinoma of the larynx
838594|NCT00003200|stage III squamous cell carcinoma of the paranasal sinus and nasal cavity|stage iii squamous cell carcinoma of the paranasal sinus and nasal cavity
838595|NCT00003200|stage IV squamous cell carcinoma of the paranasal sinus and nasal cavity|stage iv squamous cell carcinoma of the paranasal sinus and nasal cavity
838596|NCT00089739|Uveitis|uveitis
838597|NCT00089739|Suppressor of Cytokine Secretion|suppressor of cytokine secretion
838598|NCT00089739|GITR|gitr
838599|NCT00089739|Immunosuppression|immunosuppression
838600|NCT00089739|GITR Ligand|gitr ligand
838601|NCT00089739|Intraocular Inflammation|intraocular inflammation
838602|NCT00089726|cancer vaccine|cancer vaccine
838603|NCT00089726|NSCLC|nsclc
838604|NCT00089726|immunotherapy|immunotherapy
838605|NCT00089713|antihypertensive agents/therapeutic use|antihypertensive agents/therapeutic use
838606|NCT00089713|hypertension/drug therapy|hypertension/drug therapy
838607|NCT00089713|blood pressure|blood pressure
838609|NCT00089700|AIDS|aids
838610|NCT00089700|Treatment Experienced|treatment experienced
838611|NCT00089700|Optimized Background Therapy|optimized background therapy
838612|NCT00089700|HIV-1|hiv-1
838613|NCT00003197|unspecified adult solid tumor, protocol specific|unspecified adult solid tumor, protocol specific
838614|NCT00003123|refractory anemia|refractory anemia
838615|NCT00003123|refractory anemia with ringed sideroblasts|refractory anemia with ringed sideroblasts
838616|NCT00003123|refractory anemia with excess blasts|refractory anemia with excess blasts
838617|NCT00003123|refractory anemia with excess blasts in transformation|refractory anemia with excess blasts in transformation
838618|NCT00003115|prostate cancer|prostate cancer
838619|NCT00003115|pain|pain
838620|NCT00003102|stage IV renal cell cancer|stage iv renal cell cancer
838621|NCT00003102|recurrent renal cell cancer|recurrent renal cell cancer
838622|NCT00003058|adult liposarcoma|adult liposarcoma
838623|NCT00003058|recurrent adult soft tissue sarcoma|recurrent adult soft tissue sarcoma
838624|NCT00003044|localized unresectable adult primary liver cancer|localized unresectable adult primary liver cancer
838625|NCT00003025|stage I pancreatic cancer|stage i pancreatic cancer
838626|NCT00003025|stage II pancreatic cancer|stage ii pancreatic cancer
838627|NCT00003025|adenocarcinoma of the pancreas|adenocarcinoma of the pancreas
838628|NCT00003003|recurrent adult acute myeloid leukemia|recurrent adult acute myeloid leukemia
838629|NCT00003003|secondary acute myeloid leukemia|secondary acute myeloid leukemia
838630|NCT00002955|stage IV pancreatic cancer|stage iv pancreatic cancer
838631|NCT00002933|stage IV colon cancer|stage iv colon cancer
838632|NCT00002933|stage IV rectal cancer|stage iv rectal cancer
838633|NCT00002933|recurrent colon cancer|recurrent colon cancer
838634|NCT00002933|recurrent rectal cancer|recurrent rectal cancer
838635|NCT00002933|adenocarcinoma of the colon|adenocarcinoma of the colon
838636|NCT00002933|adenocarcinoma of the rectum|adenocarcinoma of the rectum
838637|NCT00089674|Prostate Cancer|prostate cancer
838638|NCT00089674|Bone Loss with Prostate Cancer|bone loss with prostate cancer
838639|NCT00089674|Treatment of bone loss in patients undergoing androgen deprivation therapy (ADT) for non-metastatic prostate cancer (PC).|treatment of bone loss in patients undergoing androgen deprivation therapy (adt) for non-metastatic prostate cancer (pc).
838640|NCT00089661|Breast Cancer|breast cancer
838641|NCT00089661|Bone loss associated with Aromatase Inhibitor therapy (AIT) for non-metastatic BC|bone loss associated with aromatase inhibitor therapy (ait) for non-metastatic bc
838642|NCT00089661|osteopenia|osteopenia
838643|NCT00089661|Low bone density|low bone density
838644|NCT00089635|Colon, Rectal Cancer|colon, rectal cancer
838645|NCT00089635|ABX-EGF, Panitumumab, EGFr|abx-egf, panitumumab, egfr
838646|NCT00089635|Immunex, Abgenix, Amgen|immunex, abgenix, amgen
838647|NCT00089635|Metastatic Colorectal Cancer|metastatic colorectal cancer
838648|NCT00089635|Vectibix|vectibix
838649|NCT00002914|recurrent bladder cancer|recurrent bladder cancer
838650|NCT00002914|transitional cell carcinoma of the bladder|transitional cell carcinoma of the bladder
838651|NCT00002914|squamous cell carcinoma of the bladder|squamous cell carcinoma of the bladder
838652|NCT00002914|adenocarcinoma of the bladder|adenocarcinoma of the bladder
838653|NCT00002914|recurrent urethral cancer|recurrent urethral cancer
838654|NCT00002914|recurrent transitional cell cancer of the renal pelvis and ureter|recurrent transitional cell cancer of the renal pelvis and ureter
838655|NCT00002909|stage III adult Hodgkin lymphoma|stage iii adult hodgkin lymphoma
838656|NCT00002909|stage IV adult Hodgkin lymphoma|stage iv adult hodgkin lymphoma
838657|NCT00002909|recurrent adult Hodgkin lymphoma|recurrent adult hodgkin lymphoma
838658|NCT00002909|unspecified adult solid tumor, protocol specific|unspecified adult solid tumor, protocol specific
838659|NCT00002909|stage III grade 1 follicular lymphoma|stage iii grade 1 follicular lymphoma
838660|NCT00002909|stage III grade 2 follicular lymphoma|stage iii grade 2 follicular lymphoma
838661|NCT00002909|stage III grade 3 follicular lymphoma|stage iii grade 3 follicular lymphoma
838662|NCT00002909|stage III adult diffuse small cleaved cell lymphoma|stage iii adult diffuse small cleaved cell lymphoma
838663|NCT00002909|stage III adult diffuse mixed cell lymphoma|stage iii adult diffuse mixed cell lymphoma
838664|NCT00002909|stage III adult diffuse large cell lymphoma|stage iii adult diffuse large cell lymphoma
838665|NCT00002909|stage III adult immunoblastic large cell lymphoma|stage iii adult immunoblastic large cell lymphoma
838666|NCT00002909|stage III adult lymphoblastic lymphoma|stage iii adult lymphoblastic lymphoma
838667|NCT00002909|stage III adult Burkitt lymphoma|stage iii adult burkitt lymphoma
838668|NCT00002909|stage IV grade 1 follicular lymphoma|stage iv grade 1 follicular lymphoma
838669|NCT00002909|stage IV grade 2 follicular lymphoma|stage iv grade 2 follicular lymphoma
838670|NCT00002909|stage IV grade 3 follicular lymphoma|stage iv grade 3 follicular lymphoma
838671|NCT00002909|stage IV adult diffuse small cleaved cell lymphoma|stage iv adult diffuse small cleaved cell lymphoma
838672|NCT00002909|stage IV adult diffuse mixed cell lymphoma|stage iv adult diffuse mixed cell lymphoma
838673|NCT00002909|stage IV adult diffuse large cell lymphoma|stage iv adult diffuse large cell lymphoma
838674|NCT00002909|stage IV adult immunoblastic large cell lymphoma|stage iv adult immunoblastic large cell lymphoma
838675|NCT00002909|stage IV adult lymphoblastic lymphoma|stage iv adult lymphoblastic lymphoma
838676|NCT00002909|stage IV adult Burkitt lymphoma|stage iv adult burkitt lymphoma
838677|NCT00002909|recurrent grade 1 follicular lymphoma|recurrent grade 1 follicular lymphoma
838678|NCT00002909|recurrent grade 2 follicular lymphoma|recurrent grade 2 follicular lymphoma
838679|NCT00002909|recurrent grade 3 follicular lymphoma|recurrent grade 3 follicular lymphoma
838680|NCT00002909|recurrent adult diffuse small cleaved cell lymphoma|recurrent adult diffuse small cleaved cell lymphoma
838681|NCT00002909|recurrent adult diffuse mixed cell lymphoma|recurrent adult diffuse mixed cell lymphoma
838682|NCT00002909|recurrent adult diffuse large cell lymphoma|recurrent adult diffuse large cell lymphoma
838683|NCT00002909|recurrent adult immunoblastic large cell lymphoma|recurrent adult immunoblastic large cell lymphoma
838684|NCT00002909|recurrent adult lymphoblastic lymphoma|recurrent adult lymphoblastic lymphoma
838685|NCT00002909|recurrent adult Burkitt lymphoma|recurrent adult burkitt lymphoma
838686|NCT00002909|stage III adult T-cell leukemia/lymphoma|stage iii adult t-cell leukemia/lymphoma
838687|NCT00002909|stage IV adult T-cell leukemia/lymphoma|stage iv adult t-cell leukemia/lymphoma
838688|NCT00002909|stage III mantle cell lymphoma|stage iii mantle cell lymphoma
838689|NCT00002909|stage IV mantle cell lymphoma|stage iv mantle cell lymphoma
843398|NCT00083642|Stroke|stroke
838690|NCT00002909|recurrent mantle cell lymphoma|recurrent mantle cell lymphoma
838691|NCT00002909|angioimmunoblastic T-cell lymphoma|angioimmunoblastic t-cell lymphoma
838692|NCT00002909|anaplastic large cell lymphoma|anaplastic large cell lymphoma
838693|NCT00002909|recurrent marginal zone lymphoma|recurrent marginal zone lymphoma
838694|NCT00002909|recurrent small lymphocytic lymphoma|recurrent small lymphocytic lymphoma
838695|NCT00002909|stage III small lymphocytic lymphoma|stage iii small lymphocytic lymphoma
838696|NCT00002909|stage III marginal zone lymphoma|stage iii marginal zone lymphoma
838697|NCT00002909|stage IV small lymphocytic lymphoma|stage iv small lymphocytic lymphoma
838698|NCT00002909|stage IV marginal zone lymphoma|stage iv marginal zone lymphoma
838699|NCT00002909|extranodal marginal zone B-cell lymphoma of mucosa-associated lymphoid tissue|extranodal marginal zone b-cell lymphoma of mucosa-associated lymphoid tissue
838700|NCT00002909|nodal marginal zone B-cell lymphoma|nodal marginal zone b-cell lymphoma
838701|NCT00002909|splenic marginal zone lymphoma|splenic marginal zone lymphoma
838702|NCT00002890|recurrent adult acute myeloid leukemia|recurrent adult acute myeloid leukemia
838703|NCT00002890|relapsing chronic myelogenous leukemia|relapsing chronic myelogenous leukemia
838704|NCT00002890|accelerated phase chronic myelogenous leukemia|accelerated phase chronic myelogenous leukemia
838705|NCT00002890|blastic phase chronic myelogenous leukemia|blastic phase chronic myelogenous leukemia
838706|NCT00002890|refractory anemia with excess blasts|refractory anemia with excess blasts
838707|NCT00002890|refractory anemia with excess blasts in transformation|refractory anemia with excess blasts in transformation
838708|NCT00002890|chronic myelomonocytic leukemia|chronic myelomonocytic leukemia
838709|NCT00002890|de novo myelodysplastic syndromes|de novo myelodysplastic syndromes
838710|NCT00002890|previously treated myelodysplastic syndromes|previously treated myelodysplastic syndromes
838711|NCT00002890|childhood myelodysplastic syndromes|childhood myelodysplastic syndromes
838712|NCT00002865|recurrent adult acute lymphoblastic leukemia|recurrent adult acute lymphoblastic leukemia
838713|NCT00002749|childhood low-grade cerebral astrocytoma|childhood low-grade cerebral astrocytoma
838714|NCT00002749|recurrent adult brain tumor|recurrent adult brain tumor
838715|NCT00002749|adult brain stem glioma|adult brain stem glioma
838716|NCT00002749|childhood oligodendroglioma|childhood oligodendroglioma
838717|NCT00002749|untreated childhood brain stem glioma|untreated childhood brain stem glioma
838718|NCT00002749|recurrent childhood brain stem glioma|recurrent childhood brain stem glioma
838719|NCT00002749|untreated childhood visual pathway glioma|untreated childhood visual pathway glioma
838720|NCT00002749|recurrent childhood visual pathway glioma|recurrent childhood visual pathway glioma
838721|NCT00002749|untreated childhood cerebellar astrocytoma|untreated childhood cerebellar astrocytoma
838722|NCT00002749|recurrent childhood cerebellar astrocytoma|recurrent childhood cerebellar astrocytoma
838723|NCT00002749|recurrent childhood cerebral astrocytoma|recurrent childhood cerebral astrocytoma
838724|NCT00002749|adult anaplastic astrocytoma|adult anaplastic astrocytoma
838725|NCT00002749|adult oligodendroglioma|adult oligodendroglioma
838726|NCT00002655|localized unresectable adult primary liver cancer|localized unresectable adult primary liver cancer
838727|NCT00002655|recurrent adult primary liver cancer|recurrent adult primary liver cancer
838728|NCT00002655|liver metastases|liver metastases
838729|NCT00002635|stage II cutaneous T-cell non-Hodgkin lymphoma|stage ii cutaneous t-cell non-hodgkin lymphoma
838730|NCT00002635|stage III cutaneous T-cell non-Hodgkin lymphoma|stage iii cutaneous t-cell non-hodgkin lymphoma
838731|NCT00002635|stage IV cutaneous T-cell non-Hodgkin lymphoma|stage iv cutaneous t-cell non-hodgkin lymphoma
838732|NCT00002635|recurrent cutaneous T-cell non-Hodgkin lymphoma|recurrent cutaneous t-cell non-hodgkin lymphoma
838733|NCT00002619|adult brain stem glioma|adult brain stem glioma
838734|NCT00002619|adult glioblastoma|adult glioblastoma
838735|NCT00002619|childhood high-grade cerebral astrocytoma|childhood high-grade cerebral astrocytoma
838736|NCT00002619|untreated childhood brain stem glioma|untreated childhood brain stem glioma
838737|NCT00002619|adult giant cell glioblastoma|adult giant cell glioblastoma
838738|NCT00002619|adult gliosarcoma|adult gliosarcoma
838739|NCT00002609|adult acute myeloid leukemia in remission|adult acute myeloid leukemia in remission
838740|NCT00002609|childhood acute myeloid leukemia in remission|childhood acute myeloid leukemia in remission
838741|NCT00002609|adult acute promyelocytic leukemia (M3)|adult acute promyelocytic leukemia (m3)
838742|NCT00002609|childhood acute promyelocytic leukemia (M3)|childhood acute promyelocytic leukemia (m3)
838743|NCT00002585|stage IV breast cancer|stage iv breast cancer
838744|NCT00002585|recurrent breast cancer|recurrent breast cancer
838745|NCT00089596|umbilical cord blood|umbilical cord blood
838746|NCT00089596|transplant|transplant
838747|NCT00089596|ALL|all
838748|NCT00089596|AML|aml
838749|NCT00089596|MDS|mds
838750|NCT00089596|NHL|nhl
838751|NCT00089596|CML|cml
838752|NCT00089583|antiretroviral therapy|antiretroviral therapy
838753|NCT00089583|pediatrics|pediatrics
838754|NCT00089583|AGENERASE|agenerase
838755|NCT00089583|amprenavir|amprenavir
838756|NCT00089583|fosamprenavir|fosamprenavir
838757|NCT00089583|HIV Infection|hiv infection
838758|NCT00089583|ritonavir|ritonavir
838759|NCT00089583|protease inhibitor|protease inhibitor
838760|NCT00089583|LEXIVA|lexiva
838761|NCT00005626|stage III chronic lymphocytic leukemia|stage iii chronic lymphocytic leukemia
838762|NCT00005626|stage IV chronic lymphocytic leukemia|stage iv chronic lymphocytic leukemia
838763|NCT00005626|refractory chronic lymphocytic leukemia|refractory chronic lymphocytic leukemia
838764|NCT00005626|stage I grade 1 follicular lymphoma|stage i grade 1 follicular lymphoma
838765|NCT00005626|stage I grade 2 follicular lymphoma|stage i grade 2 follicular lymphoma
838766|NCT00005626|stage III grade 1 follicular lymphoma|stage iii grade 1 follicular lymphoma
838767|NCT00005626|stage III grade 2 follicular lymphoma|stage iii grade 2 follicular lymphoma
838768|NCT00005626|stage IV grade 1 follicular lymphoma|stage iv grade 1 follicular lymphoma
838769|NCT00005626|stage IV grade 2 follicular lymphoma|stage iv grade 2 follicular lymphoma
838770|NCT00005626|recurrent grade 1 follicular lymphoma|recurrent grade 1 follicular lymphoma
838771|NCT00005626|recurrent grade 2 follicular lymphoma|recurrent grade 2 follicular lymphoma
838772|NCT00005626|prolymphocytic leukemia|prolymphocytic leukemia
838773|NCT00005626|stage I mantle cell lymphoma|stage i mantle cell lymphoma
838774|NCT00005626|contiguous stage II grade 1 follicular lymphoma|contiguous stage ii grade 1 follicular lymphoma
838775|NCT00005626|contiguous stage II grade 2 follicular lymphoma|contiguous stage ii grade 2 follicular lymphoma
838776|NCT00005626|contiguous stage II mantle cell lymphoma|contiguous stage ii mantle cell lymphoma
838777|NCT00005626|noncontiguous stage II grade 1 follicular lymphoma|noncontiguous stage ii grade 1 follicular lymphoma
838778|NCT00005626|noncontiguous stage II grade 2 follicular lymphoma|noncontiguous stage ii grade 2 follicular lymphoma
838779|NCT00005626|noncontiguous stage II mantle cell lymphoma|noncontiguous stage ii mantle cell lymphoma
838780|NCT00005626|stage III mantle cell lymphoma|stage iii mantle cell lymphoma
838781|NCT00005626|stage IV mantle cell lymphoma|stage iv mantle cell lymphoma
838782|NCT00005626|recurrent mantle cell lymphoma|recurrent mantle cell lymphoma
838783|NCT00005626|noncontiguous stage II small lymphocytic lymphoma|noncontiguous stage ii small lymphocytic lymphoma
838784|NCT00005626|noncontiguous stage II marginal zone lymphoma|noncontiguous stage ii marginal zone lymphoma
838785|NCT00005626|recurrent marginal zone lymphoma|recurrent marginal zone lymphoma
838786|NCT00005626|recurrent small lymphocytic lymphoma|recurrent small lymphocytic lymphoma
838787|NCT00005626|stage I marginal zone lymphoma|stage i marginal zone lymphoma
838788|NCT00005626|stage I small lymphocytic lymphoma|stage i small lymphocytic lymphoma
838789|NCT00005626|stage III small lymphocytic lymphoma|stage iii small lymphocytic lymphoma
838790|NCT00005626|stage III marginal zone lymphoma|stage iii marginal zone lymphoma
838791|NCT00005626|stage IV small lymphocytic lymphoma|stage iv small lymphocytic lymphoma
838792|NCT00005626|stage IV marginal zone lymphoma|stage iv marginal zone lymphoma
838793|NCT00005626|contiguous stage II marginal zone lymphoma|contiguous stage ii marginal zone lymphoma
838794|NCT00005626|contiguous stage II small lymphocytic lymphoma|contiguous stage ii small lymphocytic lymphoma
838795|NCT00005626|extranodal marginal zone B-cell lymphoma of mucosa-associated lymphoid tissue|extranodal marginal zone b-cell lymphoma of mucosa-associated lymphoid tissue
838796|NCT00005626|nodal marginal zone B-cell lymphoma|nodal marginal zone b-cell lymphoma
838797|NCT00005626|splenic marginal zone lymphoma|splenic marginal zone lymphoma
838798|NCT00005607|stage IV gastric cancer|stage iv gastric cancer
838799|NCT00005607|recurrent gastric cancer|recurrent gastric cancer
838800|NCT00005607|stage IV esophageal cancer|stage iv esophageal cancer
838801|NCT00005607|recurrent esophageal cancer|recurrent esophageal cancer
838802|NCT00005607|adenocarcinoma of the stomach|adenocarcinoma of the stomach
838803|NCT00005607|adenocarcinoma of the esophagus|adenocarcinoma of the esophagus
838804|NCT00002574|relapsing chronic myelogenous leukemia|relapsing chronic myelogenous leukemia
838805|NCT00002574|chronic phase chronic myelogenous leukemia|chronic phase chronic myelogenous leukemia
838806|NCT00002562|recurrent cervical cancer|recurrent cervical cancer
838807|NCT00002562|recurrent vaginal cancer|recurrent vaginal cancer
838808|NCT00002562|vaginal clear cell adenocarcinoma|vaginal clear cell adenocarcinoma
838809|NCT00002562|cervical adenocarcinoma|cervical adenocarcinoma
838810|NCT00002507|stage I squamous cell carcinoma of the lip and oral cavity|stage i squamous cell carcinoma of the lip and oral cavity
838811|NCT00002507|stage I adenoid cystic carcinoma of the oral cavity|stage i adenoid cystic carcinoma of the oral cavity
838812|NCT00002507|stage II squamous cell carcinoma of the lip and oral cavity|stage ii squamous cell carcinoma of the lip and oral cavity
838813|NCT00002507|stage II adenoid cystic carcinoma of the oral cavity|stage ii adenoid cystic carcinoma of the oral cavity
838814|NCT00002507|stage III squamous cell carcinoma of the lip and oral cavity|stage iii squamous cell carcinoma of the lip and oral cavity
838815|NCT00002507|stage III adenoid cystic carcinoma of the oral cavity|stage iii adenoid cystic carcinoma of the oral cavity
838816|NCT00002507|stage IV squamous cell carcinoma of the lip and oral cavity|stage iv squamous cell carcinoma of the lip and oral cavity
838817|NCT00002507|stage IV adenoid cystic carcinoma of the oral cavity|stage iv adenoid cystic carcinoma of the oral cavity
838818|NCT00002507|recurrent squamous cell carcinoma of the lip and oral cavity|recurrent squamous cell carcinoma of the lip and oral cavity
838819|NCT00002507|recurrent adenoid cystic carcinoma of the oral cavity|recurrent adenoid cystic carcinoma of the oral cavity
838820|NCT00002507|stage I squamous cell carcinoma of the oropharynx|stage i squamous cell carcinoma of the oropharynx
838821|NCT00002507|stage I lymphoepithelioma of the oropharynx|stage i lymphoepithelioma of the oropharynx
838822|NCT00002507|stage II squamous cell carcinoma of the oropharynx|stage ii squamous cell carcinoma of the oropharynx
838823|NCT00002507|stage II lymphoepithelioma of the oropharynx|stage ii lymphoepithelioma of the oropharynx
838824|NCT00002507|stage III squamous cell carcinoma of the oropharynx|stage iii squamous cell carcinoma of the oropharynx
838825|NCT00002507|stage III lymphoepithelioma of the oropharynx|stage iii lymphoepithelioma of the oropharynx
838826|NCT00002507|stage IV squamous cell carcinoma of the oropharynx|stage iv squamous cell carcinoma of the oropharynx
838827|NCT00002507|stage IV lymphoepithelioma of the oropharynx|stage iv lymphoepithelioma of the oropharynx
838828|NCT00002507|recurrent squamous cell carcinoma of the oropharynx|recurrent squamous cell carcinoma of the oropharynx
838829|NCT00002507|recurrent lymphoepithelioma of the oropharynx|recurrent lymphoepithelioma of the oropharynx
838830|NCT00002507|stage I squamous cell carcinoma of the nasopharynx|stage i squamous cell carcinoma of the nasopharynx
838831|NCT00002507|stage I lymphoepithelioma of the nasopharynx|stage i lymphoepithelioma of the nasopharynx
838832|NCT00002507|stage II squamous cell carcinoma of the nasopharynx|stage ii squamous cell carcinoma of the nasopharynx
838833|NCT00002507|stage II lymphoepithelioma of the nasopharynx|stage ii lymphoepithelioma of the nasopharynx
838834|NCT00002507|stage III squamous cell carcinoma of the nasopharynx|stage iii squamous cell carcinoma of the nasopharynx
838835|NCT00002507|stage III lymphoepithelioma of the nasopharynx|stage iii lymphoepithelioma of the nasopharynx
838836|NCT00002507|stage IV squamous cell carcinoma of the nasopharynx|stage iv squamous cell carcinoma of the nasopharynx
838837|NCT00002507|stage IV lymphoepithelioma of the nasopharynx|stage iv lymphoepithelioma of the nasopharynx
838838|NCT00002507|recurrent squamous cell carcinoma of the nasopharynx|recurrent squamous cell carcinoma of the nasopharynx
838839|NCT00002507|recurrent lymphoepithelioma of the nasopharynx|recurrent lymphoepithelioma of the nasopharynx
838840|NCT00002507|stage I squamous cell carcinoma of the hypopharynx|stage i squamous cell carcinoma of the hypopharynx
838841|NCT00002507|stage II squamous cell carcinoma of the hypopharynx|stage ii squamous cell carcinoma of the hypopharynx
838842|NCT00002507|stage III squamous cell carcinoma of the hypopharynx|stage iii squamous cell carcinoma of the hypopharynx
838843|NCT00002507|stage IV squamous cell carcinoma of the hypopharynx|stage iv squamous cell carcinoma of the hypopharynx
838844|NCT00002507|recurrent squamous cell carcinoma of the hypopharynx|recurrent squamous cell carcinoma of the hypopharynx
838845|NCT00002507|stage I squamous cell carcinoma of the larynx|stage i squamous cell carcinoma of the larynx
838846|NCT00002507|stage II squamous cell carcinoma of the larynx|stage ii squamous cell carcinoma of the larynx
838847|NCT00002507|stage III squamous cell carcinoma of the larynx|stage iii squamous cell carcinoma of the larynx
838848|NCT00002507|stage IV squamous cell carcinoma of the larynx|stage iv squamous cell carcinoma of the larynx
838849|NCT00002507|recurrent squamous cell carcinoma of the larynx|recurrent squamous cell carcinoma of the larynx
838850|NCT00002507|newly diagnosed carcinoma of unknown primary|newly diagnosed carcinoma of unknown primary
838851|NCT00002507|recurrent carcinoma of unknown primary|recurrent carcinoma of unknown primary
838852|NCT00089622|Parkinson's Disease|parkinson's disease
838853|NCT00089622|Motor Fluctuations|motor fluctuations
838854|NCT00089622|Intravenous Levodopa|intravenous levodopa
838855|NCT00089622|Antiparkinsonian Response|antiparkinsonian response
838856|NCT00089622|Lisuride Patch|lisuride patch
838857|NCT00089622|Parkinson Disease|parkinson disease
838858|NCT00089622|PD|pd
838859|NCT00089609|Hormones|hormones
838860|NCT00089609|Angiogenesis|angiogenesis
838861|NCT00089609|Markers|markers
838862|NCT00089609|Tumor|tumor
838863|NCT00089609|Prostate Cancer|prostate cancer
838864|NCT00089570|hepatorenal syndrome|hepatorenal syndrome
838865|NCT00089570|terlipressin|terlipressin
838866|NCT00089557|Dermal assessment|dermal assessment
838867|NCT00089557|Pain assessment|pain assessment
838868|NCT00089557|Diary|diary
838869|NCT00089557|Analgesics|analgesics
838870|NCT00089557|Capsaicin|capsaicin
838871|NCT00089557|Herpes zoster|herpes zoster
838872|NCT00089557|Neuralgia|neuralgia
838873|NCT00089557|Pain|pain
838874|NCT00089557|HIV Infections|hiv infections
838875|NCT00089557|Peripheral Nervous System Diseases|peripheral nervous system diseases
838876|NCT00089557|Diabetic Neuropathies|diabetic neuropathies
838877|NCT00089557|Diabetes Mellitus|diabetes mellitus
838878|NCT00089557|Polyneuropathies|polyneuropathies
838879|NCT00089557|Complementary Therapies|complementary therapies
838880|NCT00005591|stage III pancreatic cancer|stage iii pancreatic cancer
838881|NCT00005591|recurrent pancreatic cancer|recurrent pancreatic cancer
838882|NCT00005591|adenocarcinoma of the pancreas|adenocarcinoma of the pancreas
838883|NCT00005591|stage IV pancreatic cancer|stage iv pancreatic cancer
838884|NCT00005076|stage III colon cancer|stage iii colon cancer
838885|NCT00005076|stage IV colon cancer|stage iv colon cancer
838886|NCT00005076|stage III rectal cancer|stage iii rectal cancer
838887|NCT00005076|stage IV rectal cancer|stage iv rectal cancer
838888|NCT00005076|recurrent colon cancer|recurrent colon cancer
838889|NCT00005076|recurrent rectal cancer|recurrent rectal cancer
838890|NCT00005070|recurrent cervical cancer|recurrent cervical cancer
838891|NCT00005070|stage IVB cervical cancer|stage ivb cervical cancer
838892|NCT00005070|cervical squamous cell carcinoma|cervical squamous cell carcinoma
838893|NCT00005070|cervical adenocarcinoma|cervical adenocarcinoma
838894|NCT00005070|cervical adenosquamous cell carcinoma|cervical adenosquamous cell carcinoma
838895|NCT00005057|stage IV melanoma|stage iv melanoma
838896|NCT00005057|recurrent melanoma|recurrent melanoma
838897|NCT00005057|lentigo maligna malignant melanoma|lentigo maligna malignant melanoma
838898|NCT00005057|superficial spreading malignant melanoma|superficial spreading malignant melanoma
838899|NCT00005057|acral lentiginous malignant melanoma|acral lentiginous malignant melanoma
838900|NCT00005057|nodular malignant melanoma|nodular malignant melanoma
838901|NCT00005056|stage I renal cell cancer|stage i renal cell cancer
838902|NCT00005056|stage II renal cell cancer|stage ii renal cell cancer
838904|NCT00005056|stage IV renal cell cancer|stage iv renal cell cancer
838905|NCT00005056|recurrent renal cell cancer|recurrent renal cell cancer
838906|NCT00004937|recurrent adult brain tumor|recurrent adult brain tumor
838907|NCT00004937|adult glioblastoma|adult glioblastoma
838908|NCT00004937|adult giant cell glioblastoma|adult giant cell glioblastoma
838909|NCT00004937|adult gliosarcoma|adult gliosarcoma
838910|NCT00004219|nausea and vomiting|nausea and vomiting
838911|NCT00004219|stage I malignant testicular germ cell tumor|stage i malignant testicular germ cell tumor
838912|NCT00004219|testicular seminoma|testicular seminoma
838913|NCT00004215|untreated adult acute myeloid leukemia|untreated adult acute myeloid leukemia
838914|NCT00004215|adult acute erythroid leukemia (M6)|adult acute erythroid leukemia (m6)
838915|NCT00004215|adult acute myeloblastic leukemia without maturation (M1)|adult acute myeloblastic leukemia without maturation (m1)
838916|NCT00004215|adult acute myeloblastic leukemia with maturation (M2)|adult acute myeloblastic leukemia with maturation (m2)
838917|NCT00004215|adult acute myelomonocytic leukemia (M4)|adult acute myelomonocytic leukemia (m4)
838918|NCT00004215|adult acute monoblastic leukemia (M5a)|adult acute monoblastic leukemia (m5a)
838919|NCT00004215|adult acute megakaryoblastic leukemia (M7)|adult acute megakaryoblastic leukemia (m7)
838920|NCT00004215|adult acute monocytic leukemia (M5b)|adult acute monocytic leukemia (m5b)
838922|NCT00004215|neutropenia|neutropenia
838923|NCT00004215|thrombocytopenia|thrombocytopenia
838924|NCT00004215|adult acute minimally differentiated myeloid leukemia (M0)|adult acute minimally differentiated myeloid leukemia (m0)
838925|NCT00004207|stage IV breast cancer|stage iv breast cancer
838926|NCT00004207|recurrent breast cancer|recurrent breast cancer
838927|NCT00089531|Healthy|healthy
838928|NCT00089531|Virus|virus
838929|NCT00089531|T-Cells|t-cells
838930|NCT00089531|HIV-Negative|hiv-negative
838931|NCT00089531|Immunity|immunity
838932|NCT00089531|Healthy Volunteer|healthy volunteer
838933|NCT00089531|HV|hv
838934|NCT00089531|HIV Preventive Vaccine|hiv preventive vaccine
838935|NCT00089531|HIV Seronegativity|hiv seronegativity
838936|NCT00089518|Treatment Experienced|treatment experienced
838937|NCT00089505|Treatment Experienced|treatment experienced
838938|NCT00089505|Treatment Naive|treatment naive
838939|NCT00089505|MTCT|mtct
838940|NCT00089505|HIV Seronegativity|hiv seronegativity
838941|NCT00089466|Entry Inhibitors|entry inhibitors
838942|NCT00089466|CXCR4 Entry Inhibitors|cxcr4 entry inhibitors
838943|NCT00089466|Treatment Experienced|treatment experienced
838944|NCT00089466|Treatment Naive|treatment naive
838945|NCT00089453|Myeloma|myeloma
838946|NCT00089453|Transplant|transplant
838947|NCT00089453|Relapsed|relapsed
838948|NCT00089453|Donor|donor
838949|NCT00089453|Stem Cell|stem cell
838950|NCT00089453|Thalidomide|thalidomide
838951|NCT00089453|Dexamethasone|dexamethasone
838952|NCT00089453|Cisplatin|cisplatin
838953|NCT00089453|Adriamycin|adriamycin
838954|NCT00089453|Cyclophosphamide|cyclophosphamide
838955|NCT00089453|Etoposide|etoposide
838956|NCT00089453|Melphalan|melphalan
838957|NCT00089427|brain tumor|brain tumor
838958|NCT00089427|malignant glioma|malignant glioma
838959|NCT00089427|brain neoplasm|brain neoplasm
838960|NCT00089427|central nervous system|central nervous system
838961|NCT00089427|surgery|surgery
838962|NCT00089427|resection|resection
838963|NCT00089427|temozolomide|temozolomide
838964|NCT00089427|infusion|infusion
838965|NCT00089427|glioblastoma multiforme|glioblastoma multiforme
838966|NCT00089427|anaplastic astrocytoma|anaplastic astrocytoma
838967|NCT00089427|oligoastrocytoma|oligoastrocytoma
838968|NCT00089427|Temodar|temodar
838969|NCT00089427|radiation|radiation
838970|NCT00089427|convection-enhanced delivery|convection-enhanced delivery
838971|NCT00089427|GBM|gbm
838972|NCT00089414|Depression|depression
838973|NCT00089414|Menstrual Cycle|menstrual cycle
838974|NCT00089414|Gonadal Steroids|gonadal steroids
838975|NCT00089414|Ethinyl Estradiol|ethinyl estradiol
838976|NCT00089414|Drospirenone|drospirenone
838977|NCT00089414|Menstrually Related Mood Disorder|menstrually related mood disorder
838978|NCT00089414|MRMD|mrmd
838979|NCT00089401|recurrent colon cancer|recurrent colon cancer
838980|NCT00089401|stage IV colon cancer|stage iv colon cancer
838981|NCT00089401|recurrent rectal cancer|recurrent rectal cancer
838982|NCT00089401|stage IV rectal cancer|stage iv rectal cancer
838983|NCT00089401|liver metastases|liver metastases
838984|NCT00089323|stage IA breast cancer|stage ia breast cancer
838985|NCT00089323|stage II breast cancer|stage ii breast cancer
838986|NCT00089323|stage IIIA breast cancer|stage iiia breast cancer
838987|NCT00089323|male breast cancer|male breast cancer
838988|NCT00089323|stage IB breast cancer|stage ib breast cancer
838989|NCT00089310|stage I non-small cell lung cancer|stage i non-small cell lung cancer
838990|NCT00089297|Stage III head and neck cancer|stage iii head and neck cancer
838991|NCT00089297|Stage IV head and neck cancer|stage iv head and neck cancer
838992|NCT00089297|Cetuximab|cetuximab
838993|NCT00089297|Paclitaxel|paclitaxel
838994|NCT00089297|Carboplatin|carboplatin
838995|NCT00089258|localized unresectable neuroblastoma|localized unresectable neuroblastoma
838996|NCT00089258|disseminated neuroblastoma|disseminated neuroblastoma
838997|NCT00089258|regional neuroblastoma|regional neuroblastoma
838998|NCT00089258|stage 4S neuroblastoma|stage 4s neuroblastoma
838999|NCT00089258|recurrent neuroblastoma|recurrent neuroblastoma
839000|NCT00089245|leptomeningeal metastases|leptomeningeal metastases
839001|NCT00089245|recurrent neuroblastoma|recurrent neuroblastoma
839002|NCT00089245|disseminated neuroblastoma|disseminated neuroblastoma
839003|NCT00089245|recurrent adult brain tumor|recurrent adult brain tumor
839004|NCT00089245|recurrent childhood medulloblastoma|recurrent childhood medulloblastoma
839005|NCT00089245|recurrent childhood rhabdomyosarcoma|recurrent childhood rhabdomyosarcoma
839006|NCT00089245|recurrent childhood soft tissue sarcoma|recurrent childhood soft tissue sarcoma
839007|NCT00089245|recurrent osteosarcoma|recurrent osteosarcoma
839008|NCT00089245|recurrent Ewing sarcoma/peripheral primitive neuroectodermal tumor|recurrent ewing sarcoma/peripheral primitive neuroectodermal tumor
839009|NCT00089245|childhood atypical teratoid/rhabdoid tumor|childhood atypical teratoid/rhabdoid tumor
839010|NCT00089245|adult medulloblastoma|adult medulloblastoma
839011|NCT00089245|previously treated childhood rhabdomyosarcoma|previously treated childhood rhabdomyosarcoma
839012|NCT00089245|metastatic Ewing sarcoma/peripheral primitive neuroectodermal tumor|metastatic ewing sarcoma/peripheral primitive neuroectodermal tumor
839013|NCT00089245|metastatic osteosarcoma|metastatic osteosarcoma
839014|NCT00089245|childhood desmoplastic small round cell tumor|childhood desmoplastic small round cell tumor
839015|NCT00089245|metastatic childhood soft tissue sarcoma|metastatic childhood soft tissue sarcoma
839016|NCT00089245|adult rhabdomyosarcoma|adult rhabdomyosarcoma
839017|NCT00089245|recurrent adult soft tissue sarcoma|recurrent adult soft tissue sarcoma
839018|NCT00089245|stage IV adult soft tissue sarcoma|stage iv adult soft tissue sarcoma
839019|NCT00089219|stage III melanoma|stage iii melanoma
839020|NCT00089219|stage IV melanoma|stage iv melanoma
839021|NCT00089219|recurrent melanoma|recurrent melanoma
839022|NCT00089219|ciliary body and choroid melanoma, medium/large size|ciliary body and choroid melanoma, medium/large size
839023|NCT00089219|extraocular extension melanoma|extraocular extension melanoma
839024|NCT00089219|iris melanoma|iris melanoma
839025|NCT00089219|recurrent intraocular melanoma|recurrent intraocular melanoma
839026|NCT00089206|stage III melanoma|stage iii melanoma
839027|NCT00089206|stage IV melanoma|stage iv melanoma
839028|NCT00089206|recurrent melanoma|recurrent melanoma
839029|NCT00089206|recurrent intraocular melanoma|recurrent intraocular melanoma
839030|NCT00089206|iris melanoma|iris melanoma
839031|NCT00089206|extraocular extension melanoma|extraocular extension melanoma
839032|NCT00089206|ciliary body and choroid melanoma, medium/large size|ciliary body and choroid melanoma, medium/large size
839033|NCT00089193|stage II melanoma|stage ii melanoma
839034|NCT00089193|stage III melanoma|stage iii melanoma
839035|NCT00089193|stage IV melanoma|stage iv melanoma
839036|NCT00089193|recurrent melanoma|recurrent melanoma
839037|NCT00089167|primary systemic amyloidosis|primary systemic amyloidosis
839038|NCT00089141|graft versus host disease|graft versus host disease
839039|NCT00089141|accelerated phase chronic myelogenous leukemia|accelerated phase chronic myelogenous leukemia
839040|NCT00089141|adult acute lymphoblastic leukemia in remission|adult acute lymphoblastic leukemia in remission
839041|NCT00089141|adult acute myeloid leukemia in remission|adult acute myeloid leukemia in remission
839042|NCT00089141|childhood acute lymphoblastic leukemia in remission|childhood acute lymphoblastic leukemia in remission
839043|NCT00089141|childhood acute myeloid leukemia in remission|childhood acute myeloid leukemia in remission
839044|NCT00089141|atypical chronic myeloid leukemia|atypical chronic myeloid leukemia
839045|NCT00089141|blastic phase chronic myelogenous leukemia|blastic phase chronic myelogenous leukemia
839046|NCT00089141|childhood chronic myelogenous leukemia|childhood chronic myelogenous leukemia
839047|NCT00089141|chronic eosinophilic leukemia|chronic eosinophilic leukemia
839048|NCT00089141|chronic idiopathic myelofibrosis|chronic idiopathic myelofibrosis
839049|NCT00089141|chronic myelomonocytic leukemia|chronic myelomonocytic leukemia
839050|NCT00089141|chronic neutrophilic leukemia|chronic neutrophilic leukemia
839051|NCT00089141|chronic phase chronic myelogenous leukemia|chronic phase chronic myelogenous leukemia
839052|NCT00089141|de novo myelodysplastic syndromes|de novo myelodysplastic syndromes
839053|NCT00089141|disseminated neuroblastoma|disseminated neuroblastoma
839054|NCT00089141|extranodal marginal zone B-cell lymphoma of mucosa-associated lymphoid tissue|extranodal marginal zone b-cell lymphoma of mucosa-associated lymphoid tissue
839055|NCT00089141|juvenile myelomonocytic leukemia|juvenile myelomonocytic leukemia
839056|NCT00089141|myelodysplastic/myeloproliferative disease, unclassifiable|myelodysplastic/myeloproliferative disease, unclassifiable
839057|NCT00089141|nodal marginal zone B-cell lymphoma|nodal marginal zone b-cell lymphoma
839058|NCT00089141|noncontiguous stage II adult Burkitt lymphoma|noncontiguous stage ii adult burkitt lymphoma
839059|NCT00089141|noncontiguous stage II adult diffuse large cell lymphoma|noncontiguous stage ii adult diffuse large cell lymphoma
839060|NCT00089141|noncontiguous stage II adult diffuse mixed cell lymphoma|noncontiguous stage ii adult diffuse mixed cell lymphoma
839061|NCT00089141|noncontiguous stage II adult diffuse small cleaved cell lymphoma|noncontiguous stage ii adult diffuse small cleaved cell lymphoma
839062|NCT00089141|noncontiguous stage II adult immunoblastic large cell lymphoma|noncontiguous stage ii adult immunoblastic large cell lymphoma
839063|NCT00089141|noncontiguous stage II adult lymphoblastic lymphoma|noncontiguous stage ii adult lymphoblastic lymphoma
839064|NCT00089141|noncontiguous stage II grade 1 follicular lymphoma|noncontiguous stage ii grade 1 follicular lymphoma
839256|NCT00088985|stage IIIC breast cancer|stage iiic breast cancer
839065|NCT00089141|noncontiguous stage II grade 2 follicular lymphoma|noncontiguous stage ii grade 2 follicular lymphoma
839066|NCT00089141|noncontiguous stage II grade 3 follicular lymphoma|noncontiguous stage ii grade 3 follicular lymphoma
839067|NCT00089141|noncontiguous stage II mantle cell lymphoma|noncontiguous stage ii mantle cell lymphoma
839068|NCT00089141|noncontiguous stage II marginal zone lymphoma|noncontiguous stage ii marginal zone lymphoma
839263|NCT00088946|stage 0 bladder cancer|stage 0 bladder cancer
839069|NCT00089141|noncontiguous stage II small lymphocytic lymphoma|noncontiguous stage ii small lymphocytic lymphoma
839070|NCT00089141|poor prognosis metastatic gestational trophoblastic tumor|poor prognosis metastatic gestational trophoblastic tumor
839071|NCT00089141|previously treated childhood rhabdomyosarcoma|previously treated childhood rhabdomyosarcoma
839072|NCT00089141|previously treated myelodysplastic syndromes|previously treated myelodysplastic syndromes
839073|NCT00089141|secondary acute myeloid leukemia|secondary acute myeloid leukemia
839074|NCT00089141|secondary myelodysplastic syndromes|secondary myelodysplastic syndromes
839075|NCT00089141|splenic marginal zone lymphoma|splenic marginal zone lymphoma
839076|NCT00089141|stage I multiple myeloma|stage i multiple myeloma
839077|NCT00089141|stage II multiple myeloma|stage ii multiple myeloma
839078|NCT00089141|stage II ovarian epithelial cancer|stage ii ovarian epithelial cancer
839079|NCT00089141|stage III adult Burkitt lymphoma|stage iii adult burkitt lymphoma
839080|NCT00089141|stage III adult diffuse large cell lymphoma|stage iii adult diffuse large cell lymphoma
839081|NCT00089141|stage III adult diffuse mixed cell lymphoma|stage iii adult diffuse mixed cell lymphoma
839082|NCT00089141|stage III adult diffuse small cleaved cell lymphoma|stage iii adult diffuse small cleaved cell lymphoma
839083|NCT00089141|stage III adult immunoblastic large cell lymphoma|stage iii adult immunoblastic large cell lymphoma
839084|NCT00089141|stage III adult lymphoblastic lymphoma|stage iii adult lymphoblastic lymphoma
839085|NCT00089141|stage III chronic lymphocytic leukemia|stage iii chronic lymphocytic leukemia
839086|NCT00089141|stage III grade 1 follicular lymphoma|stage iii grade 1 follicular lymphoma
839087|NCT00089141|stage III grade 2 follicular lymphoma|stage iii grade 2 follicular lymphoma
839088|NCT00089141|stage III grade 3 follicular lymphoma|stage iii grade 3 follicular lymphoma
839089|NCT00089141|stage III mantle cell lymphoma|stage iii mantle cell lymphoma
839090|NCT00089141|stage III marginal zone lymphoma|stage iii marginal zone lymphoma
839091|NCT00089141|stage III multiple myeloma|stage iii multiple myeloma
839092|NCT00089141|stage III ovarian epithelial cancer|stage iii ovarian epithelial cancer
839093|NCT00089141|stage III small lymphocytic lymphoma|stage iii small lymphocytic lymphoma
839094|NCT00089141|stage III malignant testicular germ cell tumor|stage iii malignant testicular germ cell tumor
839095|NCT00089141|stage IIIA breast cancer|stage iiia breast cancer
839096|NCT00089141|stage IIIB breast cancer|stage iiib breast cancer
839097|NCT00089141|stage IIIC breast cancer|stage iiic breast cancer
839098|NCT00089141|stage IV adult Burkitt lymphoma|stage iv adult burkitt lymphoma
839099|NCT00089141|stage IV adult diffuse large cell lymphoma|stage iv adult diffuse large cell lymphoma
839100|NCT00089141|stage IV adult diffuse mixed cell lymphoma|stage iv adult diffuse mixed cell lymphoma
839101|NCT00089141|stage IV adult diffuse small cleaved cell lymphoma|stage iv adult diffuse small cleaved cell lymphoma
839102|NCT00089141|stage IV adult immunoblastic large cell lymphoma|stage iv adult immunoblastic large cell lymphoma
839103|NCT00089141|stage IV adult lymphoblastic lymphoma|stage iv adult lymphoblastic lymphoma
839104|NCT00089141|stage IV breast cancer|stage iv breast cancer
839105|NCT00089141|stage IV chronic lymphocytic leukemia|stage iv chronic lymphocytic leukemia
839106|NCT00089141|stage IV grade 1 follicular lymphoma|stage iv grade 1 follicular lymphoma
839107|NCT00089141|stage IV grade 2 follicular lymphoma|stage iv grade 2 follicular lymphoma
839108|NCT00089141|stage IV grade 3 follicular lymphoma|stage iv grade 3 follicular lymphoma
839109|NCT00089141|stage IV mantle cell lymphoma|stage iv mantle cell lymphoma
839601|NCT00088686|Acute Pain|acute pain
839110|NCT00089141|stage IV marginal zone lymphoma|stage iv marginal zone lymphoma
839111|NCT00089141|stage IV ovarian epithelial cancer|stage iv ovarian epithelial cancer
839112|NCT00089141|stage IV small lymphocytic lymphoma|stage iv small lymphocytic lymphoma
839113|NCT00089141|childhood myelodysplastic syndromes|childhood myelodysplastic syndromes
839114|NCT00089128|transitional cell carcinoma of the bladder|transitional cell carcinoma of the bladder
839115|NCT00089128|recurrent bladder cancer|recurrent bladder cancer
839116|NCT00089128|stage III bladder cancer|stage iii bladder cancer
839117|NCT00089128|stage IV bladder cancer|stage iv bladder cancer
839118|NCT00089115|contiguous stage II grade 1 follicular lymphoma|contiguous stage ii grade 1 follicular lymphoma
839119|NCT00089115|contiguous stage II grade 2 follicular lymphoma|contiguous stage ii grade 2 follicular lymphoma
839120|NCT00089115|contiguous stage II grade 3 follicular lymphoma|contiguous stage ii grade 3 follicular lymphoma
839121|NCT00089115|noncontiguous stage II grade 1 follicular lymphoma|noncontiguous stage ii grade 1 follicular lymphoma
839122|NCT00089115|noncontiguous stage II grade 2 follicular lymphoma|noncontiguous stage ii grade 2 follicular lymphoma
839123|NCT00089115|noncontiguous stage II grade 3 follicular lymphoma|noncontiguous stage ii grade 3 follicular lymphoma
839124|NCT00089115|stage I grade 1 follicular lymphoma|stage i grade 1 follicular lymphoma
839125|NCT00089115|stage I grade 2 follicular lymphoma|stage i grade 2 follicular lymphoma
839126|NCT00089115|stage I grade 3 follicular lymphoma|stage i grade 3 follicular lymphoma
839127|NCT00089115|stage III grade 1 follicular lymphoma|stage iii grade 1 follicular lymphoma
839128|NCT00089115|stage III grade 2 follicular lymphoma|stage iii grade 2 follicular lymphoma
839129|NCT00089115|stage III grade 3 follicular lymphoma|stage iii grade 3 follicular lymphoma
839130|NCT00089115|stage IV grade 1 follicular lymphoma|stage iv grade 1 follicular lymphoma
839131|NCT00089115|stage IV grade 2 follicular lymphoma|stage iv grade 2 follicular lymphoma
839132|NCT00089115|stage IV grade 3 follicular lymphoma|stage iv grade 3 follicular lymphoma
839133|NCT00089115|recurrent grade 1 follicular lymphoma|recurrent grade 1 follicular lymphoma
839264|NCT00088946|stage I bladder cancer|stage i bladder cancer
839134|NCT00089115|recurrent grade 2 follicular lymphoma|recurrent grade 2 follicular lymphoma
839135|NCT00089115|recurrent grade 3 follicular lymphoma|recurrent grade 3 follicular lymphoma
839136|NCT00089102|recurrent renal cell cancer|recurrent renal cell cancer
839137|NCT00089102|stage III renal cell cancer|stage iii renal cell cancer
839138|NCT00089102|stage IV renal cell cancer|stage iv renal cell cancer
839139|NCT00089050|recurrent adult acute myeloid leukemia|recurrent adult acute myeloid leukemia
839140|NCT00089050|adult acute minimally differentiated myeloid leukemia (M0)|adult acute minimally differentiated myeloid leukemia (m0)
839141|NCT00089050|adult acute myeloblastic leukemia without maturation (M1)|adult acute myeloblastic leukemia without maturation (m1)
839142|NCT00089050|adult acute myeloblastic leukemia with maturation (M2)|adult acute myeloblastic leukemia with maturation (m2)
839143|NCT00089050|adult acute myelomonocytic leukemia (M4)|adult acute myelomonocytic leukemia (m4)
839144|NCT00089050|adult acute monoblastic leukemia (M5a)|adult acute monoblastic leukemia (m5a)
839145|NCT00089050|adult acute monocytic leukemia (M5b)|adult acute monocytic leukemia (m5b)
839146|NCT00089050|adult erythroleukemia (M6a)|adult erythroleukemia (m6a)
839147|NCT00089050|adult pure erythroid leukemia (M6b)|adult pure erythroid leukemia (m6b)
839148|NCT00089050|adult acute megakaryoblastic leukemia (M7)|adult acute megakaryoblastic leukemia (m7)
839149|NCT00089050|adult acute basophilic leukemia|adult acute basophilic leukemia
839150|NCT00089050|adult acute eosinophilic leukemia|adult acute eosinophilic leukemia
839151|NCT00089050|adult acute myeloid leukemia with 11q23 (MLL) abnormalities|adult acute myeloid leukemia with 11q23 (mll) abnormalities
839152|NCT00089050|adult acute myeloid leukemia with inv(16)(p13;q22)|adult acute myeloid leukemia with inv(16)(p13;q22)
839153|NCT00089050|adult acute myeloid leukemia with t(16;16)(p13;q22)|adult acute myeloid leukemia with t(16;16)(p13;q22)
839154|NCT00089050|adult acute myeloid leukemia with t(8;21)(q22;q22)|adult acute myeloid leukemia with t(8;21)(q22;q22)
839155|NCT00089037|graft versus host disease|graft versus host disease
839156|NCT00089037|accelerated phase chronic myelogenous leukemia|accelerated phase chronic myelogenous leukemia
839157|NCT00089037|atypical chronic myeloid leukemia|atypical chronic myeloid leukemia
839158|NCT00089037|blastic phase chronic myelogenous leukemia|blastic phase chronic myelogenous leukemia
839159|NCT00089037|chronic eosinophilic leukemia|chronic eosinophilic leukemia
839160|NCT00089037|chronic idiopathic myelofibrosis|chronic idiopathic myelofibrosis
839161|NCT00089037|chronic myelomonocytic leukemia|chronic myelomonocytic leukemia
839162|NCT00089037|chronic neutrophilic leukemia|chronic neutrophilic leukemia
839163|NCT00089037|myelodysplastic/myeloproliferative disease, unclassifiable|myelodysplastic/myeloproliferative disease, unclassifiable
839164|NCT00089037|previously treated myelodysplastic syndromes|previously treated myelodysplastic syndromes
839165|NCT00089037|recurrent adult acute lymphoblastic leukemia|recurrent adult acute lymphoblastic leukemia
839166|NCT00089037|extranodal marginal zone B-cell lymphoma of mucosa-associated lymphoid tissue|extranodal marginal zone b-cell lymphoma of mucosa-associated lymphoid tissue
839167|NCT00089037|nodal marginal zone B-cell lymphoma|nodal marginal zone b-cell lymphoma
839168|NCT00089037|de novo myelodysplastic syndromes|de novo myelodysplastic syndromes
839169|NCT00089037|adult acute lymphoblastic leukemia in remission|adult acute lymphoblastic leukemia in remission
839170|NCT00089037|adult acute myeloid leukemia in remission|adult acute myeloid leukemia in remission
839171|NCT00089037|childhood acute lymphoblastic leukemia in remission|childhood acute lymphoblastic leukemia in remission
839172|NCT00089037|childhood acute myeloid leukemia in remission|childhood acute myeloid leukemia in remission
839173|NCT00089037|recurrent adult acute myeloid leukemia|recurrent adult acute myeloid leukemia
839174|NCT00089037|recurrent adult Burkitt lymphoma|recurrent adult burkitt lymphoma
839175|NCT00089037|recurrent adult diffuse large cell lymphoma|recurrent adult diffuse large cell lymphoma
839176|NCT00089037|recurrent adult diffuse mixed cell lymphoma|recurrent adult diffuse mixed cell lymphoma
839177|NCT00089037|recurrent adult diffuse small cleaved cell lymphoma|recurrent adult diffuse small cleaved cell lymphoma
839178|NCT00089037|recurrent adult Hodgkin lymphoma|recurrent adult hodgkin lymphoma
839179|NCT00089037|recurrent adult immunoblastic large cell lymphoma|recurrent adult immunoblastic large cell lymphoma
839180|NCT00089037|recurrent adult lymphoblastic lymphoma|recurrent adult lymphoblastic lymphoma
839181|NCT00089037|recurrent grade 1 follicular lymphoma|recurrent grade 1 follicular lymphoma
839182|NCT00089037|recurrent grade 2 follicular lymphoma|recurrent grade 2 follicular lymphoma
839183|NCT00089037|recurrent grade 3 follicular lymphoma|recurrent grade 3 follicular lymphoma
839184|NCT00089037|recurrent mantle cell lymphoma|recurrent mantle cell lymphoma
839185|NCT00089037|recurrent mycosis fungoides/Sezary syndrome|recurrent mycosis fungoides/sezary syndrome
839186|NCT00089037|recurrent small lymphocytic lymphoma|recurrent small lymphocytic lymphoma
839187|NCT00089037|refractory chronic lymphocytic leukemia|refractory chronic lymphocytic leukemia
839188|NCT00089037|refractory hairy cell leukemia|refractory hairy cell leukemia
839189|NCT00089037|refractory multiple myeloma|refractory multiple myeloma
839190|NCT00089037|relapsing chronic myelogenous leukemia|relapsing chronic myelogenous leukemia
839191|NCT00089037|secondary acute myeloid leukemia|secondary acute myeloid leukemia
839192|NCT00089037|secondary myelodysplastic syndromes|secondary myelodysplastic syndromes
839257|NCT00088985|stage IV breast cancer|stage iv breast cancer
839193|NCT00089037|noncontiguous stage II adult Burkitt lymphoma|noncontiguous stage ii adult burkitt lymphoma
839194|NCT00089037|stage III adult Burkitt lymphoma|stage iii adult burkitt lymphoma
839195|NCT00089037|stage IV adult Burkitt lymphoma|stage iv adult burkitt lymphoma
839196|NCT00089037|noncontiguous stage II adult diffuse large cell lymphoma|noncontiguous stage ii adult diffuse large cell lymphoma
839197|NCT00089037|noncontiguous stage II adult diffuse mixed cell lymphoma|noncontiguous stage ii adult diffuse mixed cell lymphoma
839198|NCT00089037|noncontiguous stage II adult diffuse small cleaved cell lymphoma|noncontiguous stage ii adult diffuse small cleaved cell lymphoma
839199|NCT00089037|noncontiguous stage II adult immunoblastic large cell lymphoma|noncontiguous stage ii adult immunoblastic large cell lymphoma
839200|NCT00089037|noncontiguous stage II adult lymphoblastic lymphoma|noncontiguous stage ii adult lymphoblastic lymphoma
839201|NCT00089037|noncontiguous stage II grade 1 follicular lymphoma|noncontiguous stage ii grade 1 follicular lymphoma
839202|NCT00089037|noncontiguous stage II grade 2 follicular lymphoma|noncontiguous stage ii grade 2 follicular lymphoma
839203|NCT00089037|noncontiguous stage II grade 3 follicular lymphoma|noncontiguous stage ii grade 3 follicular lymphoma
839204|NCT00089037|noncontiguous stage II mantle cell lymphoma|noncontiguous stage ii mantle cell lymphoma
839205|NCT00089037|noncontiguous stage II marginal zone lymphoma|noncontiguous stage ii marginal zone lymphoma
839206|NCT00089037|noncontiguous stage II small lymphocytic lymphoma|noncontiguous stage ii small lymphocytic lymphoma
839207|NCT00089037|stage III adult diffuse large cell lymphoma|stage iii adult diffuse large cell lymphoma
839208|NCT00089037|stage III adult diffuse mixed cell lymphoma|stage iii adult diffuse mixed cell lymphoma
839209|NCT00089037|stage III adult diffuse small cleaved cell lymphoma|stage iii adult diffuse small cleaved cell lymphoma
839210|NCT00089037|stage IV adult diffuse large cell lymphoma|stage iv adult diffuse large cell lymphoma
839211|NCT00089037|stage IV adult diffuse mixed cell lymphoma|stage iv adult diffuse mixed cell lymphoma
839212|NCT00089037|stage IV adult diffuse small cleaved cell lymphoma|stage iv adult diffuse small cleaved cell lymphoma
839213|NCT00089037|stage III adult immunoblastic large cell lymphoma|stage iii adult immunoblastic large cell lymphoma
839214|NCT00089037|stage IV adult immunoblastic large cell lymphoma|stage iv adult immunoblastic large cell lymphoma
839215|NCT00089037|stage III grade 1 follicular lymphoma|stage iii grade 1 follicular lymphoma
839216|NCT00089037|stage III grade 2 follicular lymphoma|stage iii grade 2 follicular lymphoma
839217|NCT00089037|stage III grade 3 follicular lymphoma|stage iii grade 3 follicular lymphoma
839218|NCT00089037|stage IV grade 1 follicular lymphoma|stage iv grade 1 follicular lymphoma
839219|NCT00089037|stage IV grade 2 follicular lymphoma|stage iv grade 2 follicular lymphoma
839220|NCT00089037|stage IV grade 3 follicular lymphoma|stage iv grade 3 follicular lymphoma
839221|NCT00089037|stage III mantle cell lymphoma|stage iii mantle cell lymphoma
839222|NCT00089037|stage IV mantle cell lymphoma|stage iv mantle cell lymphoma
839223|NCT00089037|stage III small lymphocytic lymphoma|stage iii small lymphocytic lymphoma
839224|NCT00089037|stage IV small lymphocytic lymphoma|stage iv small lymphocytic lymphoma
839225|NCT00089037|stage III marginal zone lymphoma|stage iii marginal zone lymphoma
839226|NCT00089037|stage IV marginal zone lymphoma|stage iv marginal zone lymphoma
839227|NCT00089037|childhood chronic myelogenous leukemia|childhood chronic myelogenous leukemia
839228|NCT00089037|recurrent childhood acute lymphoblastic leukemia|recurrent childhood acute lymphoblastic leukemia
839229|NCT00089037|recurrent childhood acute myeloid leukemia|recurrent childhood acute myeloid leukemia
839230|NCT00089037|recurrent childhood large cell lymphoma|recurrent childhood large cell lymphoma
839231|NCT00089037|recurrent childhood lymphoblastic lymphoma|recurrent childhood lymphoblastic lymphoma
839232|NCT00089037|recurrent childhood small noncleaved cell lymphoma|recurrent childhood small noncleaved cell lymphoma
839233|NCT00089037|untreated childhood acute lymphoblastic leukemia|untreated childhood acute lymphoblastic leukemia
839234|NCT00089037|untreated childhood acute myeloid leukemia and other myeloid malignancies|untreated childhood acute myeloid leukemia and other myeloid malignancies
839235|NCT00089037|recurrent/refractory childhood Hodgkin lymphoma|recurrent/refractory childhood hodgkin lymphoma
839236|NCT00089037|juvenile myelomonocytic leukemia|juvenile myelomonocytic leukemia
839237|NCT00089037|splenic marginal zone lymphoma|splenic marginal zone lymphoma
839238|NCT00089037|untreated adult acute lymphoblastic leukemia|untreated adult acute lymphoblastic leukemia
839239|NCT00089037|untreated adult acute myeloid leukemia|untreated adult acute myeloid leukemia
839240|NCT00089037|stage III chronic lymphocytic leukemia|stage iii chronic lymphocytic leukemia
839241|NCT00089037|stage IV chronic lymphocytic leukemia|stage iv chronic lymphocytic leukemia
839242|NCT00089037|stage I multiple myeloma|stage i multiple myeloma
839243|NCT00089037|stage II multiple myeloma|stage ii multiple myeloma
839244|NCT00089037|stage III multiple myeloma|stage iii multiple myeloma
839245|NCT00089037|refractory cytopenia with multilineage dysplasia|refractory cytopenia with multilineage dysplasia
839246|NCT00089037|recurrent cutaneous T-cell non-Hodgkin lymphoma|recurrent cutaneous t-cell non-hodgkin lymphoma
839247|NCT00089037|recurrent marginal zone lymphoma|recurrent marginal zone lymphoma
839248|NCT00089024|adenocarcinoma of the pancreas|adenocarcinoma of the pancreas
839249|NCT00089024|stage II pancreatic cancer|stage ii pancreatic cancer
839250|NCT00089024|stage III pancreatic cancer|stage iii pancreatic cancer
839251|NCT00088998|male breast cancer|male breast cancer
839252|NCT00088998|recurrent breast cancer|recurrent breast cancer
839253|NCT00088998|stage IV breast cancer|stage iv breast cancer
839254|NCT00088985|recurrent breast cancer|recurrent breast cancer
839255|NCT00088985|stage IIIB breast cancer|stage iiib breast cancer
839932|NCT00088348|Evaluation|evaluation
839258|NCT00088972|breast cancer|breast cancer
839259|NCT00088972|breast cancer in situ|breast cancer in situ
839260|NCT00088972|lobular breast carcinoma in situ|lobular breast carcinoma in situ
839261|NCT00088972|ductal breast carcinoma|ductal breast carcinoma
839262|NCT00088946|transitional cell carcinoma of the bladder|transitional cell carcinoma of the bladder
839267|NCT00088907|head and neck cancer|head and neck cancer
839268|NCT00088868|unspecified adult solid tumor, protocol specific|unspecified adult solid tumor, protocol specific
839269|NCT00088868|anaplastic large cell lymphoma|anaplastic large cell lymphoma
839270|NCT00088868|intraocular lymphoma|intraocular lymphoma
839271|NCT00088868|recurrent grade 1 follicular lymphoma|recurrent grade 1 follicular lymphoma
839272|NCT00088868|recurrent grade 2 follicular lymphoma|recurrent grade 2 follicular lymphoma
839273|NCT00088868|recurrent grade 3 follicular lymphoma|recurrent grade 3 follicular lymphoma
839274|NCT00088868|recurrent mantle cell lymphoma|recurrent mantle cell lymphoma
839275|NCT00088868|recurrent marginal zone lymphoma|recurrent marginal zone lymphoma
839276|NCT00088868|recurrent small lymphocytic lymphoma|recurrent small lymphocytic lymphoma
839277|NCT00088868|stage III adult Burkitt lymphoma|stage iii adult burkitt lymphoma
839278|NCT00088868|stage III adult diffuse large cell lymphoma|stage iii adult diffuse large cell lymphoma
839279|NCT00088868|stage III adult diffuse mixed cell lymphoma|stage iii adult diffuse mixed cell lymphoma
839280|NCT00088868|stage III adult diffuse small cleaved cell lymphoma|stage iii adult diffuse small cleaved cell lymphoma
839281|NCT00088868|stage III adult Hodgkin lymphoma|stage iii adult hodgkin lymphoma
839282|NCT00088868|stage III adult immunoblastic large cell lymphoma|stage iii adult immunoblastic large cell lymphoma
839283|NCT00088868|stage III adult lymphoblastic lymphoma|stage iii adult lymphoblastic lymphoma
839284|NCT00088868|stage III grade 1 follicular lymphoma|stage iii grade 1 follicular lymphoma
839285|NCT00088868|stage III grade 2 follicular lymphoma|stage iii grade 2 follicular lymphoma
839286|NCT00088868|stage III grade 3 follicular lymphoma|stage iii grade 3 follicular lymphoma
839287|NCT00088868|stage III mantle cell lymphoma|stage iii mantle cell lymphoma
839288|NCT00088868|stage III marginal zone lymphoma|stage iii marginal zone lymphoma
839289|NCT00088868|stage III small lymphocytic lymphoma|stage iii small lymphocytic lymphoma
839290|NCT00088868|stage IV adult Burkitt lymphoma|stage iv adult burkitt lymphoma
839291|NCT00088868|stage IV adult diffuse large cell lymphoma|stage iv adult diffuse large cell lymphoma
839292|NCT00088868|stage IV adult diffuse mixed cell lymphoma|stage iv adult diffuse mixed cell lymphoma
839293|NCT00088868|stage IV adult diffuse small cleaved cell lymphoma|stage iv adult diffuse small cleaved cell lymphoma
839294|NCT00088868|stage IV adult Hodgkin lymphoma|stage iv adult hodgkin lymphoma
839295|NCT00088868|stage IV adult immunoblastic large cell lymphoma|stage iv adult immunoblastic large cell lymphoma
839296|NCT00088868|stage IV adult lymphoblastic lymphoma|stage iv adult lymphoblastic lymphoma
839297|NCT00088868|stage IV grade 1 follicular lymphoma|stage iv grade 1 follicular lymphoma
839298|NCT00088868|stage IV grade 2 follicular lymphoma|stage iv grade 2 follicular lymphoma
839299|NCT00088868|stage IV grade 3 follicular lymphoma|stage iv grade 3 follicular lymphoma
839300|NCT00088868|stage IV mantle cell lymphoma|stage iv mantle cell lymphoma
839301|NCT00088868|stage IV marginal zone lymphoma|stage iv marginal zone lymphoma
839302|NCT00088868|stage IV small lymphocytic lymphoma|stage iv small lymphocytic lymphoma
839303|NCT00088868|recurrent mycosis fungoides/Sezary syndrome|recurrent mycosis fungoides/sezary syndrome
839304|NCT00088868|stage III mycosis fungoides/Sezary syndrome|stage iii mycosis fungoides/sezary syndrome
839305|NCT00088868|stage IV mycosis fungoides/Sezary syndrome|stage iv mycosis fungoides/sezary syndrome
839306|NCT00088868|recurrent adult Burkitt lymphoma|recurrent adult burkitt lymphoma
839307|NCT00088868|recurrent adult diffuse large cell lymphoma|recurrent adult diffuse large cell lymphoma
839308|NCT00088868|recurrent adult diffuse mixed cell lymphoma|recurrent adult diffuse mixed cell lymphoma
839309|NCT00088868|recurrent adult diffuse small cleaved cell lymphoma|recurrent adult diffuse small cleaved cell lymphoma
839310|NCT00088868|recurrent adult Hodgkin lymphoma|recurrent adult hodgkin lymphoma
839311|NCT00088868|recurrent adult immunoblastic large cell lymphoma|recurrent adult immunoblastic large cell lymphoma
839312|NCT00088868|recurrent adult lymphoblastic lymphoma|recurrent adult lymphoblastic lymphoma
839313|NCT00088868|angioimmunoblastic T-cell lymphoma|angioimmunoblastic t-cell lymphoma
839314|NCT00088868|small intestine lymphoma|small intestine lymphoma
839315|NCT00088868|Waldenström macroglobulinemia|waldenström macroglobulinemia
839316|NCT00088868|recurrent cutaneous T-cell non-Hodgkin lymphoma|recurrent cutaneous t-cell non-hodgkin lymphoma
839317|NCT00088868|stage III cutaneous T-cell non-Hodgkin lymphoma|stage iii cutaneous t-cell non-hodgkin lymphoma
839318|NCT00088868|stage IV cutaneous T-cell non-Hodgkin lymphoma|stage iv cutaneous t-cell non-hodgkin lymphoma
839319|NCT00088868|recurrent adult T-cell leukemia/lymphoma|recurrent adult t-cell leukemia/lymphoma
839320|NCT00088868|stage III adult T-cell leukemia/lymphoma|stage iii adult t-cell leukemia/lymphoma
839321|NCT00088868|stage IV adult T-cell leukemia/lymphoma|stage iv adult t-cell leukemia/lymphoma
839322|NCT00088868|extranodal marginal zone B-cell lymphoma of mucosa-associated lymphoid tissue|extranodal marginal zone b-cell lymphoma of mucosa-associated lymphoid tissue
839323|NCT00088868|nodal marginal zone B-cell lymphoma|nodal marginal zone b-cell lymphoma
839324|NCT00088868|splenic marginal zone lymphoma|splenic marginal zone lymphoma
839933|NCT00088348|Screening|screening
839325|NCT00088829|stage II breast cancer|stage ii breast cancer
839326|NCT00088829|stage IIIA breast cancer|stage iiia breast cancer
839327|NCT00088829|stage IIIB breast cancer|stage iiib breast cancer
839328|NCT00088829|stage IIIC breast cancer|stage iiic breast cancer
839329|NCT00088829|stage IV breast cancer|stage iv breast cancer
839330|NCT00088829|stage IA breast cancer|stage ia breast cancer
839331|NCT00088829|stage IB breast cancer|stage ib breast cancer
839332|NCT00088829|HER2-negative breast cancer|her2-negative breast cancer
839333|NCT00088829|HER2-positive breast cancer|her2-positive breast cancer
839334|NCT00088816|stage IV gastric cancer|stage iv gastric cancer
839335|NCT00088816|adenocarcinoma of the stomach|adenocarcinoma of the stomach
839336|NCT00088803|recurrent Wilms tumor and other childhood kidney tumors|recurrent wilms tumor and other childhood kidney tumors
839337|NCT00088803|stage I Wilms tumor|stage i wilms tumor
839338|NCT00088803|stage II Wilms tumor|stage ii wilms tumor
839339|NCT00088803|stage III Wilms tumor|stage iii wilms tumor
839340|NCT00088803|stage IV Wilms tumor|stage iv wilms tumor
839341|NCT00088803|stage V Wilms tumor|stage v wilms tumor
839342|NCT00088790|advanced, solid, malignancies|advanced, solid, malignancies
839343|NCT00088764|Stress|stress
839344|NCT00088764|Coping|coping
839345|NCT00088764|Expressive Writing|expressive writing
839346|NCT00088764|Self-Efficacy|self-efficacy
839347|NCT00088764|Disclosure|disclosure
839348|NCT00004193|stage IV colon cancer|stage iv colon cancer
839349|NCT00004193|stage IV rectal cancer|stage iv rectal cancer
839350|NCT00004193|recurrent colon cancer|recurrent colon cancer
839351|NCT00004193|recurrent rectal cancer|recurrent rectal cancer
839352|NCT00004193|adenocarcinoma of the colon|adenocarcinoma of the colon
839353|NCT00004193|adenocarcinoma of the rectum|adenocarcinoma of the rectum
839354|NCT00004187|stage III colon cancer|stage iii colon cancer
839355|NCT00004187|stage IV colon cancer|stage iv colon cancer
839356|NCT00004187|stage III rectal cancer|stage iii rectal cancer
839357|NCT00004187|stage IV rectal cancer|stage iv rectal cancer
839358|NCT00004187|recurrent colon cancer|recurrent colon cancer
839359|NCT00004187|recurrent rectal cancer|recurrent rectal cancer
839360|NCT00004186|limited stage small cell lung cancer|limited stage small cell lung cancer
839361|NCT00004186|extensive stage small cell lung cancer|extensive stage small cell lung cancer
839362|NCT00004186|recurrent small cell lung cancer|recurrent small cell lung cancer
839363|NCT00004162|AIDS-related diffuse large cell lymphoma|aids-related diffuse large cell lymphoma
839364|NCT00004162|AIDS-related immunoblastic large cell lymphoma|aids-related immunoblastic large cell lymphoma
839365|NCT00004162|AIDS-related small noncleaved cell lymphoma|aids-related small noncleaved cell lymphoma
839366|NCT00004162|AIDS-related diffuse mixed cell lymphoma|aids-related diffuse mixed cell lymphoma
839367|NCT00004162|AIDS-related diffuse small cleaved cell lymphoma|aids-related diffuse small cleaved cell lymphoma
839368|NCT00004162|AIDS-related lymphoblastic lymphoma|aids-related lymphoblastic lymphoma
839369|NCT00004096|stage IIIB non-small cell lung cancer|stage iiib non-small cell lung cancer
839370|NCT00004096|stage IV non-small cell lung cancer|stage iv non-small cell lung cancer
839371|NCT00004080|recurrent adult brain tumor|recurrent adult brain tumor
839372|NCT00004080|adult glioblastoma|adult glioblastoma
839373|NCT00004080|adult anaplastic astrocytoma|adult anaplastic astrocytoma
839374|NCT00004080|adult mixed glioma|adult mixed glioma
839375|NCT00004080|adult giant cell glioblastoma|adult giant cell glioblastoma
839376|NCT00004080|adult gliosarcoma|adult gliosarcoma
839377|NCT00004064|stage I ovarian epithelial cancer|stage i ovarian epithelial cancer
839378|NCT00004064|stage II ovarian epithelial cancer|stage ii ovarian epithelial cancer
839379|NCT00004064|stage III ovarian epithelial cancer|stage iii ovarian epithelial cancer
839380|NCT00004064|stage IV ovarian epithelial cancer|stage iv ovarian epithelial cancer
839381|NCT00004064|fallopian tube cancer|fallopian tube cancer
839382|NCT00004064|primary peritoneal cavity cancer|primary peritoneal cavity cancer
839383|NCT00004040|stage I multiple myeloma|stage i multiple myeloma
839384|NCT00004040|stage II multiple myeloma|stage ii multiple myeloma
839385|NCT00004040|stage III multiple myeloma|stage iii multiple myeloma
839386|NCT00004040|stage I chronic lymphocytic leukemia|stage i chronic lymphocytic leukemia
839387|NCT00004040|stage II chronic lymphocytic leukemia|stage ii chronic lymphocytic leukemia
839388|NCT00004040|stage III chronic lymphocytic leukemia|stage iii chronic lymphocytic leukemia
839389|NCT00004040|stage IV chronic lymphocytic leukemia|stage iv chronic lymphocytic leukemia
839390|NCT00004040|B-cell chronic lymphocytic leukemia|b-cell chronic lymphocytic leukemia
839391|NCT00004039|Waldenstrom macroglobulinemia|waldenstrom macroglobulinemia
839392|NCT00004039|stage II grade 3 follicular lymphoma|stage ii grade 3 follicular lymphoma
839393|NCT00004039|stage II adult diffuse small cleaved cell lymphoma|stage ii adult diffuse small cleaved cell lymphoma
839394|NCT00004039|stage II adult diffuse mixed cell lymphoma|stage ii adult diffuse mixed cell lymphoma
839395|NCT00004039|stage II adult diffuse large cell lymphoma|stage ii adult diffuse large cell lymphoma
839396|NCT00004039|stage II adult immunoblastic large cell lymphoma|stage ii adult immunoblastic large cell lymphoma
839397|NCT00004039|stage II adult Burkitt lymphoma|stage ii adult burkitt lymphoma
839398|NCT00004039|stage III grade 1 follicular lymphoma|stage iii grade 1 follicular lymphoma
839399|NCT00004039|stage III grade 2 follicular lymphoma|stage iii grade 2 follicular lymphoma
839400|NCT00004039|stage III grade 3 follicular lymphoma|stage iii grade 3 follicular lymphoma
850726|NCT00079638|Stroke|stroke
839401|NCT00004039|stage III adult diffuse small cleaved cell lymphoma|stage iii adult diffuse small cleaved cell lymphoma
839402|NCT00004039|stage III adult diffuse mixed cell lymphoma|stage iii adult diffuse mixed cell lymphoma
839403|NCT00004039|stage III adult diffuse large cell lymphoma|stage iii adult diffuse large cell lymphoma
839404|NCT00004039|stage III adult immunoblastic large cell lymphoma|stage iii adult immunoblastic large cell lymphoma
839405|NCT00004039|stage III adult Burkitt lymphoma|stage iii adult burkitt lymphoma
839941|NCT00088335|Parkinson's Disease|parkinson's disease
839406|NCT00004039|stage IV grade 1 follicular lymphoma|stage iv grade 1 follicular lymphoma
839407|NCT00004039|stage IV grade 2 follicular lymphoma|stage iv grade 2 follicular lymphoma
839408|NCT00004039|stage IV grade 3 follicular lymphoma|stage iv grade 3 follicular lymphoma
839409|NCT00004039|stage IV adult diffuse small cleaved cell lymphoma|stage iv adult diffuse small cleaved cell lymphoma
839410|NCT00004039|stage IV adult diffuse mixed cell lymphoma|stage iv adult diffuse mixed cell lymphoma
839411|NCT00004039|stage IV adult diffuse large cell lymphoma|stage iv adult diffuse large cell lymphoma
839412|NCT00004039|stage IV adult immunoblastic large cell lymphoma|stage iv adult immunoblastic large cell lymphoma
839413|NCT00004039|stage IV adult Burkitt lymphoma|stage iv adult burkitt lymphoma
839414|NCT00004039|stage III mantle cell lymphoma|stage iii mantle cell lymphoma
839415|NCT00004039|stage IV mantle cell lymphoma|stage iv mantle cell lymphoma
839416|NCT00003957|recurrent grade 3 follicular lymphoma|recurrent grade 3 follicular lymphoma
839417|NCT00003957|recurrent adult diffuse mixed cell lymphoma|recurrent adult diffuse mixed cell lymphoma
839418|NCT00003957|recurrent adult diffuse large cell lymphoma|recurrent adult diffuse large cell lymphoma
839419|NCT00003957|recurrent adult immunoblastic large cell lymphoma|recurrent adult immunoblastic large cell lymphoma
839420|NCT00003892|stage IV ovarian epithelial cancer|stage iv ovarian epithelial cancer
839421|NCT00003892|recurrent ovarian epithelial cancer|recurrent ovarian epithelial cancer
839422|NCT00003828|stage IV melanoma|stage iv melanoma
839423|NCT00003828|recurrent melanoma|recurrent melanoma
839424|NCT00003821|recurrent endometrial carcinoma|recurrent endometrial carcinoma
839425|NCT00003810|stage III pancreatic cancer|stage iii pancreatic cancer
839426|NCT00003810|stage IV pancreatic cancer|stage iv pancreatic cancer
839427|NCT00003810|recurrent pancreatic cancer|recurrent pancreatic cancer
839428|NCT00003810|adenocarcinoma of the pancreas|adenocarcinoma of the pancreas
839429|NCT00003798|stage II pancreatic cancer|stage ii pancreatic cancer
839430|NCT00003798|stage III pancreatic cancer|stage iii pancreatic cancer
839431|NCT00003798|adenocarcinoma of the pancreas|adenocarcinoma of the pancreas
839432|NCT00003786|stage IV colon cancer|stage iv colon cancer
839433|NCT00003786|stage IV rectal cancer|stage iv rectal cancer
839434|NCT00003786|recurrent colon cancer|recurrent colon cancer
839435|NCT00003786|recurrent rectal cancer|recurrent rectal cancer
839436|NCT00003786|adenocarcinoma of the colon|adenocarcinoma of the colon
839437|NCT00003786|adenocarcinoma of the rectum|adenocarcinoma of the rectum
839438|NCT00003784|Waldenström macroglobulinemia|waldenström macroglobulinemia
839439|NCT00003784|stage III grade 1 follicular lymphoma|stage iii grade 1 follicular lymphoma
839440|NCT00003784|stage III grade 2 follicular lymphoma|stage iii grade 2 follicular lymphoma
839441|NCT00003784|stage III grade 3 follicular lymphoma|stage iii grade 3 follicular lymphoma
839442|NCT00003784|stage IV grade 1 follicular lymphoma|stage iv grade 1 follicular lymphoma
839443|NCT00003784|stage IV grade 2 follicular lymphoma|stage iv grade 2 follicular lymphoma
839444|NCT00003784|stage IV grade 3 follicular lymphoma|stage iv grade 3 follicular lymphoma
839445|NCT00003784|contiguous stage II grade 1 follicular lymphoma|contiguous stage ii grade 1 follicular lymphoma
839446|NCT00003784|contiguous stage II grade 2 follicular lymphoma|contiguous stage ii grade 2 follicular lymphoma
839447|NCT00003784|contiguous stage II grade 3 follicular lymphoma|contiguous stage ii grade 3 follicular lymphoma
839448|NCT00003784|noncontiguous stage II grade 1 follicular lymphoma|noncontiguous stage ii grade 1 follicular lymphoma
839449|NCT00003784|noncontiguous stage II grade 2 follicular lymphoma|noncontiguous stage ii grade 2 follicular lymphoma
839450|NCT00003784|noncontiguous stage II grade 3 follicular lymphoma|noncontiguous stage ii grade 3 follicular lymphoma
839451|NCT00003760|stage III pancreatic cancer|stage iii pancreatic cancer
839452|NCT00003760|stage IV pancreatic cancer|stage iv pancreatic cancer
839453|NCT00003760|recurrent pancreatic cancer|recurrent pancreatic cancer
839454|NCT00003760|adenocarcinoma of the pancreas|adenocarcinoma of the pancreas
839455|NCT00003708|unspecified adult solid tumor, protocol specific|unspecified adult solid tumor, protocol specific
839456|NCT00003681|refractory anemia|refractory anemia
839457|NCT00003681|refractory anemia with ringed sideroblasts|refractory anemia with ringed sideroblasts
839458|NCT00003681|refractory anemia with excess blasts|refractory anemia with excess blasts
839459|NCT00003681|de novo myelodysplastic syndromes|de novo myelodysplastic syndromes
839460|NCT00003681|previously treated myelodysplastic syndromes|previously treated myelodysplastic syndromes
839461|NCT00003681|secondary myelodysplastic syndromes|secondary myelodysplastic syndromes
839462|NCT00003681|anemia|anemia
839463|NCT00003663|Waldenstrom macroglobulinemia|waldenstrom macroglobulinemia
839464|NCT00003663|stage III grade 1 follicular lymphoma|stage iii grade 1 follicular lymphoma
839465|NCT00003663|stage III grade 2 follicular lymphoma|stage iii grade 2 follicular lymphoma
839466|NCT00003663|stage III grade 3 follicular lymphoma|stage iii grade 3 follicular lymphoma
839467|NCT00003663|stage IV grade 1 follicular lymphoma|stage iv grade 1 follicular lymphoma
839468|NCT00003663|stage IV grade 2 follicular lymphoma|stage iv grade 2 follicular lymphoma
839469|NCT00003663|stage IV grade 3 follicular lymphoma|stage iv grade 3 follicular lymphoma
839470|NCT00003663|recurrent grade 1 follicular lymphoma|recurrent grade 1 follicular lymphoma
839471|NCT00003663|recurrent grade 2 follicular lymphoma|recurrent grade 2 follicular lymphoma
839472|NCT00003663|recurrent grade 3 follicular lymphoma|recurrent grade 3 follicular lymphoma
839473|NCT00003663|recurrent marginal zone lymphoma|recurrent marginal zone lymphoma
839474|NCT00003663|recurrent small lymphocytic lymphoma|recurrent small lymphocytic lymphoma
839949|NCT00088309|Pediatric|pediatric
839475|NCT00003663|stage III small lymphocytic lymphoma|stage iii small lymphocytic lymphoma
839476|NCT00003663|stage III marginal zone lymphoma|stage iii marginal zone lymphoma
839477|NCT00003663|stage IV small lymphocytic lymphoma|stage iv small lymphocytic lymphoma
839478|NCT00003663|stage IV marginal zone lymphoma|stage iv marginal zone lymphoma
839479|NCT00003663|extranodal marginal zone B-cell lymphoma of mucosa-associated lymphoid tissue|extranodal marginal zone b-cell lymphoma of mucosa-associated lymphoid tissue
839480|NCT00003663|nodal marginal zone B-cell lymphoma|nodal marginal zone b-cell lymphoma
839481|NCT00003663|splenic marginal zone lymphoma|splenic marginal zone lymphoma
839482|NCT00003662|noninvasive thymoma and thymic carcinoma|noninvasive thymoma and thymic carcinoma
839483|NCT00003662|recurrent thymoma and thymic carcinoma|recurrent thymoma and thymic carcinoma
839484|NCT00003662|refractory anemia|refractory anemia
839485|NCT00003662|refractory anemia with ringed sideroblasts|refractory anemia with ringed sideroblasts
839486|NCT00003662|de novo myelodysplastic syndromes|de novo myelodysplastic syndromes
839487|NCT00003662|previously treated myelodysplastic syndromes|previously treated myelodysplastic syndromes
839488|NCT00003662|secondary myelodysplastic syndromes|secondary myelodysplastic syndromes
839489|NCT00003662|graft versus host disease|graft versus host disease
839490|NCT00003662|childhood myelodysplastic syndromes|childhood myelodysplastic syndromes
839491|NCT00003661|recurrent childhood acute lymphoblastic leukemia|recurrent childhood acute lymphoblastic leukemia
839492|NCT00003661|stage 4S neuroblastoma|stage 4s neuroblastoma
839493|NCT00003661|recurrent childhood lymphoblastic lymphoma|recurrent childhood lymphoblastic lymphoma
839494|NCT00003661|recurrent adult acute lymphoblastic leukemia|recurrent adult acute lymphoblastic leukemia
839495|NCT00003661|chronic phase chronic myelogenous leukemia|chronic phase chronic myelogenous leukemia
839496|NCT00003661|accelerated phase chronic myelogenous leukemia|accelerated phase chronic myelogenous leukemia
839497|NCT00003661|adult acute myeloid leukemia in remission|adult acute myeloid leukemia in remission
839498|NCT00003661|adult acute lymphoblastic leukemia in remission|adult acute lymphoblastic leukemia in remission
839499|NCT00003661|childhood acute myeloid leukemia in remission|childhood acute myeloid leukemia in remission
839500|NCT00003661|childhood acute lymphoblastic leukemia in remission|childhood acute lymphoblastic leukemia in remission
839501|NCT00003661|refractory anemia with excess blasts|refractory anemia with excess blasts
839502|NCT00003661|refractory anemia with excess blasts in transformation|refractory anemia with excess blasts in transformation
839503|NCT00003661|chronic myelomonocytic leukemia|chronic myelomonocytic leukemia
839504|NCT00003661|recurrent grade 1 follicular lymphoma|recurrent grade 1 follicular lymphoma
839505|NCT00003661|recurrent grade 2 follicular lymphoma|recurrent grade 2 follicular lymphoma
839506|NCT00003661|recurrent grade 3 follicular lymphoma|recurrent grade 3 follicular lymphoma
839507|NCT00003661|recurrent adult diffuse small cleaved cell lymphoma|recurrent adult diffuse small cleaved cell lymphoma
839508|NCT00003661|recurrent adult diffuse mixed cell lymphoma|recurrent adult diffuse mixed cell lymphoma
839509|NCT00003661|recurrent adult diffuse large cell lymphoma|recurrent adult diffuse large cell lymphoma
839510|NCT00003661|recurrent adult immunoblastic large cell lymphoma|recurrent adult immunoblastic large cell lymphoma
839511|NCT00003661|recurrent adult lymphoblastic lymphoma|recurrent adult lymphoblastic lymphoma
839512|NCT00003661|recurrent adult Burkitt lymphoma|recurrent adult burkitt lymphoma
839513|NCT00003661|de novo myelodysplastic syndromes|de novo myelodysplastic syndromes
839514|NCT00003661|previously treated myelodysplastic syndromes|previously treated myelodysplastic syndromes
839515|NCT00003661|secondary myelodysplastic syndromes|secondary myelodysplastic syndromes
839516|NCT00003661|graft versus host disease|graft versus host disease
839517|NCT00003661|adult acute minimally differentiated myeloid leukemia (M0)|adult acute minimally differentiated myeloid leukemia (m0)
839518|NCT00003661|childhood acute minimally differentiated myeloid leukemia (M0)|childhood acute minimally differentiated myeloid leukemia (m0)
839519|NCT00003661|recurrent childhood small noncleaved cell lymphoma|recurrent childhood small noncleaved cell lymphoma
839520|NCT00003661|recurrent childhood large cell lymphoma|recurrent childhood large cell lymphoma
839521|NCT00003661|recurrent mantle cell lymphoma|recurrent mantle cell lymphoma
839522|NCT00003661|recurrent marginal zone lymphoma|recurrent marginal zone lymphoma
839523|NCT00003661|recurrent small lymphocytic lymphoma|recurrent small lymphocytic lymphoma
839524|NCT00003661|extranodal marginal zone B-cell lymphoma of mucosa-associated lymphoid tissue|extranodal marginal zone b-cell lymphoma of mucosa-associated lymphoid tissue
839525|NCT00003661|nodal marginal zone B-cell lymphoma|nodal marginal zone b-cell lymphoma
839526|NCT00003661|splenic marginal zone lymphoma|splenic marginal zone lymphoma
839527|NCT00003661|childhood myelodysplastic syndromes|childhood myelodysplastic syndromes
839528|NCT00003605|Waldenstrom macroglobulinemia|waldenstrom macroglobulinemia
839529|NCT00003605|stage III grade 1 follicular lymphoma|stage iii grade 1 follicular lymphoma
839530|NCT00003605|stage III grade 2 follicular lymphoma|stage iii grade 2 follicular lymphoma
839531|NCT00003605|stage III grade 3 follicular lymphoma|stage iii grade 3 follicular lymphoma
839532|NCT00003605|stage III adult diffuse small cleaved cell lymphoma|stage iii adult diffuse small cleaved cell lymphoma
839934|NCT00088348|Ocular Surface Disease|ocular surface disease
839533|NCT00003605|stage IV grade 1 follicular lymphoma|stage iv grade 1 follicular lymphoma
839534|NCT00003605|stage IV grade 2 follicular lymphoma|stage iv grade 2 follicular lymphoma
839535|NCT00003605|stage IV grade 3 follicular lymphoma|stage iv grade 3 follicular lymphoma
839536|NCT00003605|stage IV adult diffuse small cleaved cell lymphoma|stage iv adult diffuse small cleaved cell lymphoma
839942|NCT00088335|Neurodegenerative Disorders|neurodegenerative disorders
839537|NCT00003605|stage III small lymphocytic lymphoma|stage iii small lymphocytic lymphoma
839538|NCT00003605|stage III marginal zone lymphoma|stage iii marginal zone lymphoma
839539|NCT00003605|stage IV small lymphocytic lymphoma|stage iv small lymphocytic lymphoma
839540|NCT00003605|stage IV marginal zone lymphoma|stage iv marginal zone lymphoma
839541|NCT00003605|extranodal marginal zone B-cell lymphoma of mucosa-associated lymphoid tissue|extranodal marginal zone b-cell lymphoma of mucosa-associated lymphoid tissue
839542|NCT00003605|nodal marginal zone B-cell lymphoma|nodal marginal zone b-cell lymphoma
839543|NCT00003605|splenic marginal zone lymphoma|splenic marginal zone lymphoma
839544|NCT00003542|stage III renal cell cancer|stage iii renal cell cancer
839545|NCT00003542|stage IV renal cell cancer|stage iv renal cell cancer
839546|NCT00003539|stage IV breast cancer|stage iv breast cancer
839547|NCT00003539|recurrent breast cancer|recurrent breast cancer
839548|NCT00003431|stage IV colon cancer|stage iv colon cancer
839549|NCT00003431|lung metastases|lung metastases
839550|NCT00003431|liver metastases|liver metastases
839551|NCT00003424|localized unresectable adult primary liver cancer|localized unresectable adult primary liver cancer
839552|NCT00003424|advanced adult primary liver cancer|advanced adult primary liver cancer
839553|NCT00003424|adult primary hepatocellular carcinoma|adult primary hepatocellular carcinoma
839554|NCT00088673|Alzheimer Disease|alzheimer disease
839555|NCT00003416|Waldenström macroglobulinemia|waldenström macroglobulinemia
839556|NCT00003415|refractory anemia with excess blasts|refractory anemia with excess blasts
839557|NCT00003415|refractory anemia with excess blasts in transformation|refractory anemia with excess blasts in transformation
839558|NCT00003415|chronic myelomonocytic leukemia|chronic myelomonocytic leukemia
839559|NCT00003415|de novo myelodysplastic syndromes|de novo myelodysplastic syndromes
839560|NCT00003415|previously treated myelodysplastic syndromes|previously treated myelodysplastic syndromes
839561|NCT00003413|stage III ovarian epithelial cancer|stage iii ovarian epithelial cancer
839562|NCT00003413|stage IV ovarian epithelial cancer|stage iv ovarian epithelial cancer
839563|NCT00003413|recurrent ovarian epithelial cancer|recurrent ovarian epithelial cancer
839564|NCT00088751|Frontotemporal Dementia|frontotemporal dementia
839565|NCT00088751|Alzheimer's Disease|alzheimer's disease
839566|NCT00088751|Atypical Antipsychotic|atypical antipsychotic
839567|NCT00088751|Stimulant|stimulant
839568|NCT00088751|Apathy|apathy
839569|NCT00088751|Disinhibition|disinhibition
839570|NCT00088751|Antipsychotic|antipsychotic
839571|NCT00088751|Biomarkers|biomarkers
839572|NCT00088751|Dementia|dementia
839574|NCT00088738|Tachykinin|tachykinin
839575|NCT00088738|Anxiety|anxiety
839576|NCT00088738|Neuroreceptor|neuroreceptor
839577|NCT00088738|Internalization|internalization
839578|NCT00088738|Carbon Dioxide|carbon dioxide
839579|NCT00088738|Healthy Volunteer|healthy volunteer
839580|NCT00088738|HV|hv
839581|NCT00088738|Panic Disorder|panic disorder
839582|NCT00088712|Behavior and Neurocognition|behavior and neurocognition
839583|NCT00088712|Functional Brian Activity|functional brian activity
839584|NCT00088712|Visual Perception|visual perception
839585|NCT00088712|Selective Attention|selective attention
839586|NCT00088712|Information Processing|information processing
839587|NCT00088712|Age Differences|age differences
839588|NCT00088712|Childhood Growth and Development|childhood growth and development
839589|NCT00088712|Cognitive Development|cognitive development
839590|NCT00088712|Brain Connectivity|brain connectivity
839591|NCT00088712|Healthy Volunteer|healthy volunteer
839592|NCT00088712|HV|hv
839593|NCT00088699|Depression|depression
839594|NCT00088699|NMDA Antagonist|nmda antagonist
839595|NCT00088699|Treatment Resistant|treatment resistant
839596|NCT00088699|Glutamatergic System|glutamatergic system
839597|NCT00088699|Major Depression|major depression
839598|NCT00088686|Preemptive Analgesia|preemptive analgesia
839599|NCT00088686|Vanilloid|vanilloid
839600|NCT00088686|Capsaicin|capsaicin
839602|NCT00088686|Orofacial|orofacial
839603|NCT00088686|Vanilloid Receptor (VR)|vanilloid receptor (vr)
839604|NCT00088686|Visual Analog Scale (VAS)|visual analog scale (vas)
839605|NCT00088686|Wisdom Teeth|wisdom teeth
839606|NCT00088686|Third Molar Extraction|third molar extraction
839607|NCT00088660|Metastatic|metastatic
839608|NCT00088647|advanced malignant solid tumors|advanced malignant solid tumors
839609|NCT00088647|breast cancer|breast cancer
839610|NCT00088634|Schizophrenia|schizophrenia
839611|NCT00088634|Latuda|latuda
839612|NCT00088634|Lurasidone|lurasidone
839613|NCT00088621|Schizophrenia|schizophrenia
839614|NCT00088621|Latuda|latuda
839615|NCT00088621|Lurasidone|lurasidone
839616|NCT00088595|SOM230|som230
839617|NCT00088595|Sandostatin|sandostatin
839618|NCT00088595|Carcinoid syndrome|carcinoid syndrome
839619|NCT00088582|Acromegaly|acromegaly
839620|NCT00088582|SOM230|som230
839621|NCT00088582|Sandostatin|sandostatin
839622|NCT00003358|stage I ovarian epithelial cancer|stage i ovarian epithelial cancer
839935|NCT00088348|Eye|eye
839623|NCT00003358|stage II ovarian epithelial cancer|stage ii ovarian epithelial cancer
839624|NCT00003358|stage III ovarian epithelial cancer|stage iii ovarian epithelial cancer
839625|NCT00003358|stage IV ovarian epithelial cancer|stage iv ovarian epithelial cancer
839626|NCT00003358|recurrent ovarian epithelial cancer|recurrent ovarian epithelial cancer
839627|NCT00003358|fallopian tube cancer|fallopian tube cancer
839628|NCT00003358|primary peritoneal cavity cancer|primary peritoneal cavity cancer
839629|NCT00003305|recurrent childhood acute lymphoblastic leukemia|recurrent childhood acute lymphoblastic leukemia
839630|NCT00003305|recurrent childhood acute myeloid leukemia|recurrent childhood acute myeloid leukemia
839631|NCT00003305|recurrent adult acute myeloid leukemia|recurrent adult acute myeloid leukemia
839632|NCT00003305|recurrent adult acute lymphoblastic leukemia|recurrent adult acute lymphoblastic leukemia
839633|NCT00003259|stage IV prostate cancer|stage iv prostate cancer
839634|NCT00003256|adenocarcinoma of the prostate|adenocarcinoma of the prostate
839635|NCT00003256|stage IV prostate cancer|stage iv prostate cancer
839636|NCT00003214|stage III ovarian epithelial cancer|stage iii ovarian epithelial cancer
839637|NCT00003214|stage IV ovarian epithelial cancer|stage iv ovarian epithelial cancer
839638|NCT00003213|unspecified adult solid tumor, protocol specific|unspecified adult solid tumor, protocol specific
839639|NCT00003213|nausea and vomiting|nausea and vomiting
839640|NCT00003182|stage III nasopharyngeal cancer|stage iii nasopharyngeal cancer
839641|NCT00003182|stage IV nasopharyngeal cancer|stage iv nasopharyngeal cancer
839642|NCT00003182|recurrent nasopharyngeal cancer|recurrent nasopharyngeal cancer
839643|NCT00003182|stage III salivary gland cancer|stage iii salivary gland cancer
839644|NCT00003182|stage IV salivary gland cancer|stage iv salivary gland cancer
839645|NCT00003182|recurrent salivary gland cancer|recurrent salivary gland cancer
839646|NCT00003182|salivary gland squamous cell carcinoma|salivary gland squamous cell carcinoma
839647|NCT00003182|stage III lip and oral cavity cancer|stage iii lip and oral cavity cancer
839648|NCT00003182|stage IV lip and oral cavity cancer|stage iv lip and oral cavity cancer
839649|NCT00003182|recurrent lip and oral cavity cancer|recurrent lip and oral cavity cancer
839650|NCT00003182|stage III hypopharyngeal cancer|stage iii hypopharyngeal cancer
839651|NCT00003182|stage IV hypopharyngeal cancer|stage iv hypopharyngeal cancer
839652|NCT00003182|recurrent hypopharyngeal cancer|recurrent hypopharyngeal cancer
839653|NCT00003182|stage III laryngeal cancer|stage iii laryngeal cancer
839654|NCT00003182|stage IV laryngeal cancer|stage iv laryngeal cancer
839655|NCT00003182|recurrent laryngeal cancer|recurrent laryngeal cancer
839656|NCT00003182|stage III paranasal sinus and nasal cavity cancer|stage iii paranasal sinus and nasal cavity cancer
839657|NCT00003182|stage IV paranasal sinus and nasal cavity cancer|stage iv paranasal sinus and nasal cavity cancer
839658|NCT00003182|recurrent paranasal sinus and nasal cavity cancer|recurrent paranasal sinus and nasal cavity cancer
839659|NCT00003182|stage III oropharyngeal cancer|stage iii oropharyngeal cancer
839660|NCT00003182|stage IV oropharyngeal cancer|stage iv oropharyngeal cancer
839661|NCT00003182|recurrent oropharyngeal cancer|recurrent oropharyngeal cancer
839662|NCT00003182|stage III squamous cell carcinoma of the lip and oral cavity|stage iii squamous cell carcinoma of the lip and oral cavity
839663|NCT00003182|stage IV squamous cell carcinoma of the lip and oral cavity|stage iv squamous cell carcinoma of the lip and oral cavity
839664|NCT00003182|recurrent squamous cell carcinoma of the lip and oral cavity|recurrent squamous cell carcinoma of the lip and oral cavity
839665|NCT00003182|stage III squamous cell carcinoma of the oropharynx|stage iii squamous cell carcinoma of the oropharynx
839666|NCT00003182|stage IV squamous cell carcinoma of the oropharynx|stage iv squamous cell carcinoma of the oropharynx
839667|NCT00003182|recurrent squamous cell carcinoma of the oropharynx|recurrent squamous cell carcinoma of the oropharynx
839668|NCT00003182|stage III squamous cell carcinoma of the nasopharynx|stage iii squamous cell carcinoma of the nasopharynx
839669|NCT00003182|stage IV squamous cell carcinoma of the nasopharynx|stage iv squamous cell carcinoma of the nasopharynx
839670|NCT00003182|recurrent squamous cell carcinoma of the nasopharynx|recurrent squamous cell carcinoma of the nasopharynx
839671|NCT00003182|stage III squamous cell carcinoma of the hypopharynx|stage iii squamous cell carcinoma of the hypopharynx
839672|NCT00003182|stage IV squamous cell carcinoma of the hypopharynx|stage iv squamous cell carcinoma of the hypopharynx
839673|NCT00003182|recurrent squamous cell carcinoma of the hypopharynx|recurrent squamous cell carcinoma of the hypopharynx
839674|NCT00003182|stage III squamous cell carcinoma of the larynx|stage iii squamous cell carcinoma of the larynx
839675|NCT00003182|stage IV squamous cell carcinoma of the larynx|stage iv squamous cell carcinoma of the larynx
839676|NCT00003182|recurrent squamous cell carcinoma of the larynx|recurrent squamous cell carcinoma of the larynx
839677|NCT00003182|stage III squamous cell carcinoma of the paranasal sinus and nasal cavity|stage iii squamous cell carcinoma of the paranasal sinus and nasal cavity
839678|NCT00003182|stage IV squamous cell carcinoma of the paranasal sinus and nasal cavity|stage iv squamous cell carcinoma of the paranasal sinus and nasal cavity
839679|NCT00003182|recurrent squamous cell carcinoma of the paranasal sinus and nasal cavity|recurrent squamous cell carcinoma of the paranasal sinus and nasal cavity
839680|NCT00003158|stage IIIA non-small cell lung cancer|stage iiia non-small cell lung cancer
839681|NCT00003158|stage IIIB non-small cell lung cancer|stage iiib non-small cell lung cancer
839682|NCT00003152|stage III grade 1 follicular lymphoma|stage iii grade 1 follicular lymphoma
839683|NCT00003152|stage III grade 2 follicular lymphoma|stage iii grade 2 follicular lymphoma
839684|NCT00003152|stage III grade 3 follicular lymphoma|stage iii grade 3 follicular lymphoma
839685|NCT00003152|stage IV grade 1 follicular lymphoma|stage iv grade 1 follicular lymphoma
839686|NCT00003152|stage IV grade 2 follicular lymphoma|stage iv grade 2 follicular lymphoma
839687|NCT00003152|stage IV grade 3 follicular lymphoma|stage iv grade 3 follicular lymphoma
839688|NCT00003097|basal cell carcinoma of the skin|basal cell carcinoma of the skin
839689|NCT00003097|squamous cell carcinoma of the skin|squamous cell carcinoma of the skin
839943|NCT00088335|Parkinson Disease|parkinson disease
839690|NCT00003090|recurrent non-small cell lung cancer|recurrent non-small cell lung cancer
839691|NCT00003087|stage II esophageal cancer|stage ii esophageal cancer
839692|NCT00003087|stage III esophageal cancer|stage iii esophageal cancer
839693|NCT00003087|squamous cell carcinoma of the esophagus|squamous cell carcinoma of the esophagus
839694|NCT00003087|adenocarcinoma of the esophagus|adenocarcinoma of the esophagus
839695|NCT00003068|stage IV breast cancer|stage iv breast cancer
839696|NCT00003068|stage IIIA breast cancer|stage iiia breast cancer
839697|NCT00003068|recurrent breast cancer|recurrent breast cancer
839698|NCT00003068|stage IIIB breast cancer|stage iiib breast cancer
839699|NCT00003068|drug/agent toxicity by tissue/organ|drug/agent toxicity by tissue/organ
839700|NCT00088569|Frontal Lobe|frontal lobe
839701|NCT00088569|Working Memory|working memory
839702|NCT00088569|Treatment|treatment
839703|NCT00088569|Transcranial|transcranial
839704|NCT00088569|Electrical|electrical
839705|NCT00088569|Healthy Volunteer|healthy volunteer
839706|NCT00088569|HV|hv
839707|NCT00088556|Non-small cell lung cancer|non-small cell lung cancer
839708|NCT00088543|Acute myelogenous leukemia (AML)|acute myelogenous leukemia (aml)
839709|NCT00088543|Acute lymphocytic leukemia (ALL)|acute lymphocytic leukemia (all)
839710|NCT00088543|Anti-T cell antibodies|anti-t cell antibodies
839711|NCT00088543|Allogenic stem cell transplant|allogenic stem cell transplant
839712|NCT00088543|Graft vs. Host Disease (GvHD)|graft vs. host disease (gvhd)
839713|NCT00003055|stage III gastric cancer|stage iii gastric cancer
839714|NCT00003055|stage IV gastric cancer|stage iv gastric cancer
839715|NCT00003055|recurrent gastric cancer|recurrent gastric cancer
839716|NCT00003055|stage III esophageal cancer|stage iii esophageal cancer
839717|NCT00003055|stage IV esophageal cancer|stage iv esophageal cancer
839718|NCT00003055|recurrent esophageal cancer|recurrent esophageal cancer
839719|NCT00003055|squamous cell carcinoma of the esophagus|squamous cell carcinoma of the esophagus
839720|NCT00003050|stage II breast cancer|stage ii breast cancer
839721|NCT00003050|stage IIIA breast cancer|stage iiia breast cancer
839722|NCT00003050|stage IIIB breast cancer|stage iiib breast cancer
839723|NCT00003002|stage III breast cancer|stage iii breast cancer
839724|NCT00003002|stage IV breast cancer|stage iv breast cancer
839725|NCT00003002|stage III non-small cell lung cancer|stage iii non-small cell lung cancer
839726|NCT00003002|stage III ovarian epithelial cancer|stage iii ovarian epithelial cancer
839727|NCT00003002|stage IV ovarian epithelial cancer|stage iv ovarian epithelial cancer
839728|NCT00003002|stage IV non-small cell lung cancer|stage iv non-small cell lung cancer
839729|NCT00003002|adenocarcinoma of the lung|adenocarcinoma of the lung
839730|NCT00003000|pain|pain
839731|NCT00002984|stage II esophageal cancer|stage ii esophageal cancer
839732|NCT00002984|stage III esophageal cancer|stage iii esophageal cancer
839733|NCT00002984|stage IV esophageal cancer|stage iv esophageal cancer
839734|NCT00002984|squamous cell carcinoma of the esophagus|squamous cell carcinoma of the esophagus
839735|NCT00002984|adenocarcinoma of the esophagus|adenocarcinoma of the esophagus
839736|NCT00002921|stage III adrenocortical carcinoma|stage iii adrenocortical carcinoma
839737|NCT00002921|stage IV adrenocortical carcinoma|stage iv adrenocortical carcinoma
839738|NCT00002833|recurrent adult acute myeloid leukemia|recurrent adult acute myeloid leukemia
839739|NCT00002833|relapsing chronic myelogenous leukemia|relapsing chronic myelogenous leukemia
839740|NCT00002833|chronic phase chronic myelogenous leukemia|chronic phase chronic myelogenous leukemia
839741|NCT00002833|accelerated phase chronic myelogenous leukemia|accelerated phase chronic myelogenous leukemia
839742|NCT00002833|blastic phase chronic myelogenous leukemia|blastic phase chronic myelogenous leukemia
839743|NCT00002833|adult acute myeloid leukemia in remission|adult acute myeloid leukemia in remission
839744|NCT00002833|Philadelphia chromosome positive chronic myelogenous leukemia|philadelphia chromosome positive chronic myelogenous leukemia
839745|NCT00002833|refractory anemia with excess blasts|refractory anemia with excess blasts
839746|NCT00002833|refractory anemia with excess blasts in transformation|refractory anemia with excess blasts in transformation
839747|NCT00002833|chronic myelomonocytic leukemia|chronic myelomonocytic leukemia
839748|NCT00002833|graft versus host disease|graft versus host disease
839749|NCT00088530|Pixantrone|pixantrone
839750|NCT00088530|Non-Hodgkins lymphoma|non-hodgkins lymphoma
839751|NCT00002832|Decitabine|decitabine
839752|NCT00002832|Dacogen|dacogen
839753|NCT00002832|Filgrastim|filgrastim
839754|NCT00002832|G-CSF|g-csf
839755|NCT00002832|Neupogen|neupogen
839756|NCT00002832|Cyclosporine|cyclosporine
839757|NCT00002832|Sandimmune|sandimmune
839758|NCT00002832|CYA|cya
839759|NCT00002832|Cyclosporin A|cyclosporin a
839760|NCT00002832|Peripheral blood stem cells|peripheral blood stem cells
839761|NCT00002832|PBSC|pbsc
839762|NCT00002832|Allogeneic bone marrow transplantation|allogeneic bone marrow transplantation
839763|NCT00002832|recurrent childhood acute lymphoblastic leukemia|recurrent childhood acute lymphoblastic leukemia
839764|NCT00002832|recurrent childhood acute myeloid leukemia|recurrent childhood acute myeloid leukemia
839936|NCT00088348|Ocular Disease|ocular disease
839765|NCT00002832|recurrent adult acute myeloid leukemia|recurrent adult acute myeloid leukemia
839766|NCT00002832|recurrent adult acute lymphoblastic leukemia|recurrent adult acute lymphoblastic leukemia
839767|NCT00002832|accelerated phase chronic myelogenous leukemia|accelerated phase chronic myelogenous leukemia
839944|NCT00088335|PD|pd
839768|NCT00002832|blastic phase chronic myelogenous leukemia|blastic phase chronic myelogenous leukemia
839769|NCT00002832|previously treated myelodysplastic syndromes|previously treated myelodysplastic syndromes
839770|NCT00002832|childhood myelodysplastic syndromes|childhood myelodysplastic syndromes
839771|NCT00002831|recurrent adult acute myeloid leukemia|recurrent adult acute myeloid leukemia
839772|NCT00002831|accelerated phase chronic myelogenous leukemia|accelerated phase chronic myelogenous leukemia
839773|NCT00002831|blastic phase chronic myelogenous leukemia|blastic phase chronic myelogenous leukemia
839774|NCT00002824|recurrent adult brain tumor|recurrent adult brain tumor
839775|NCT00002824|adult glioblastoma|adult glioblastoma
839776|NCT00002824|adult anaplastic astrocytoma|adult anaplastic astrocytoma
839777|NCT00002824|adult giant cell glioblastoma|adult giant cell glioblastoma
839778|NCT00002824|adult gliosarcoma|adult gliosarcoma
839779|NCT00002784|stage II breast cancer|stage ii breast cancer
839780|NCT00002784|stage IIIA breast cancer|stage iiia breast cancer
839781|NCT00002779|Waldenström macroglobulinemia|waldenström macroglobulinemia
839782|NCT00002779|recurrent small lymphocytic lymphoma|recurrent small lymphocytic lymphoma
839783|NCT00002779|recurrent grade 1 follicular lymphoma|recurrent grade 1 follicular lymphoma
839784|NCT00002779|recurrent grade 2 follicular lymphoma|recurrent grade 2 follicular lymphoma
839785|NCT00002779|recurrent mantle cell lymphoma|recurrent mantle cell lymphoma
839786|NCT00002779|recurrent marginal zone lymphoma|recurrent marginal zone lymphoma
839787|NCT00002779|extranodal marginal zone B-cell lymphoma of mucosa-associated lymphoid tissue|extranodal marginal zone b-cell lymphoma of mucosa-associated lymphoid tissue
839788|NCT00002779|nodal marginal zone B-cell lymphoma|nodal marginal zone b-cell lymphoma
839789|NCT00002754|recurrent adult brain tumor|recurrent adult brain tumor
839790|NCT00002754|adult glioblastoma|adult glioblastoma
839791|NCT00002754|stage IV melanoma|stage iv melanoma
839792|NCT00002754|tumors metastatic to brain|tumors metastatic to brain
839793|NCT00002754|childhood high-grade cerebral astrocytoma|childhood high-grade cerebral astrocytoma
839794|NCT00002754|adult anaplastic astrocytoma|adult anaplastic astrocytoma
839795|NCT00002754|adult anaplastic oligodendroglioma|adult anaplastic oligodendroglioma
839796|NCT00002754|adult mixed glioma|adult mixed glioma
839797|NCT00002754|recurrent childhood cerebral astrocytoma|recurrent childhood cerebral astrocytoma
839798|NCT00002754|adult giant cell glioblastoma|adult giant cell glioblastoma
839799|NCT00002754|adult gliosarcoma|adult gliosarcoma
839800|NCT00002753|childhood supratentorial ependymoma|childhood supratentorial ependymoma
839801|NCT00002753|recurrent childhood brain tumor|recurrent childhood brain tumor
839802|NCT00002753|recurrent adult brain tumor|recurrent adult brain tumor
839803|NCT00002753|adult glioblastoma|adult glioblastoma
839804|NCT00002753|adult anaplastic astrocytoma|adult anaplastic astrocytoma
839805|NCT00002753|adult myxopapillary ependymoma|adult myxopapillary ependymoma
839806|NCT00002753|adult anaplastic ependymoma|adult anaplastic ependymoma
839921|NCT00088361|Reconstruction|reconstruction
839807|NCT00002753|adult anaplastic oligodendroglioma|adult anaplastic oligodendroglioma
839808|NCT00002753|adult mixed glioma|adult mixed glioma
839809|NCT00002753|adult ependymoblastoma|adult ependymoblastoma
839810|NCT00002753|recurrent childhood cerebral astrocytoma|recurrent childhood cerebral astrocytoma
839811|NCT00002753|recurrent childhood ependymoma|recurrent childhood ependymoma
839812|NCT00002753|adult giant cell glioblastoma|adult giant cell glioblastoma
839813|NCT00002753|adult gliosarcoma|adult gliosarcoma
839814|NCT00002688|recurrent adult acute myeloid leukemia|recurrent adult acute myeloid leukemia
839815|NCT00002675|intraocular retinoblastoma|intraocular retinoblastoma
839816|NCT00002665|untreated adult acute lymphoblastic leukemia|untreated adult acute lymphoblastic leukemia
839817|NCT00002665|L1 adult acute lymphoblastic leukemia|l1 adult acute lymphoblastic leukemia
839818|NCT00002665|L2 adult acute lymphoblastic leukemia|l2 adult acute lymphoblastic leukemia
839819|NCT00002665|L3 adult acute lymphoblastic leukemia|l3 adult acute lymphoblastic leukemia
839820|NCT00002665|neutropenia|neutropenia
839821|NCT00002665|thrombocytopenia|thrombocytopenia
839822|NCT00002630|refractory multiple myeloma|refractory multiple myeloma
839823|NCT00002630|stage II multiple myeloma|stage ii multiple myeloma
839824|NCT00002630|stage III multiple myeloma|stage iii multiple myeloma
839825|NCT00002627|stage II breast cancer|stage ii breast cancer
839826|NCT00002627|stage IIIA breast cancer|stage iiia breast cancer
839827|NCT00002627|stage IIIB breast cancer|stage iiib breast cancer
839828|NCT00002627|inflammatory breast cancer|inflammatory breast cancer
839829|NCT00002618|childhood diffuse large cell lymphoma|childhood diffuse large cell lymphoma
839830|NCT00002618|childhood immunoblastic large cell lymphoma|childhood immunoblastic large cell lymphoma
839831|NCT00002618|AIDS-related peripheral/systemic lymphoma|aids-related peripheral/systemic lymphoma
839832|NCT00002618|AIDS-related diffuse large cell lymphoma|aids-related diffuse large cell lymphoma
839833|NCT00002618|AIDS-related immunoblastic large cell lymphoma|aids-related immunoblastic large cell lymphoma
839834|NCT00002618|AIDS-related diffuse mixed cell lymphoma|aids-related diffuse mixed cell lymphoma
839835|NCT00002618|stage III childhood large cell lymphoma|stage iii childhood large cell lymphoma
839836|NCT00002618|stage IV childhood large cell lymphoma|stage iv childhood large cell lymphoma
839837|NCT00002604|unspecified adult solid tumor, protocol specific|unspecified adult solid tumor, protocol specific
839838|NCT00002588|recurrent adult acute myeloid leukemia|recurrent adult acute myeloid leukemia
839945|NCT00088309|Drug Resistance|drug resistance
839946|NCT00088309|HAART|haart
839839|NCT00002588|recurrent adult acute lymphoblastic leukemia|recurrent adult acute lymphoblastic leukemia
839840|NCT00002588|relapsing chronic myelogenous leukemia|relapsing chronic myelogenous leukemia
839841|NCT00002588|blastic phase chronic myelogenous leukemia|blastic phase chronic myelogenous leukemia
839842|NCT00002588|L1 adult acute lymphoblastic leukemia|l1 adult acute lymphoblastic leukemia
839843|NCT00002588|L2 adult acute lymphoblastic leukemia|l2 adult acute lymphoblastic leukemia
839844|NCT00002588|adult acute erythroid leukemia (M6)|adult acute erythroid leukemia (m6)
839845|NCT00002588|adult acute myeloblastic leukemia without maturation (M1)|adult acute myeloblastic leukemia without maturation (m1)
839846|NCT00002588|adult acute myeloblastic leukemia with maturation (M2)|adult acute myeloblastic leukemia with maturation (m2)
839847|NCT00002588|adult acute promyelocytic leukemia (M3)|adult acute promyelocytic leukemia (m3)
839848|NCT00002588|adult acute myelomonocytic leukemia (M4)|adult acute myelomonocytic leukemia (m4)
839849|NCT00002588|adult acute monoblastic leukemia (M5a)|adult acute monoblastic leukemia (m5a)
839850|NCT00002588|adult acute megakaryoblastic leukemia (M7)|adult acute megakaryoblastic leukemia (m7)
839851|NCT00002588|secondary acute myeloid leukemia|secondary acute myeloid leukemia
839852|NCT00002588|adult acute monocytic leukemia (M5b)|adult acute monocytic leukemia (m5b)
839853|NCT00002588|adult acute minimally differentiated myeloid leukemia (M0)|adult acute minimally differentiated myeloid leukemia (m0)
839854|NCT00002572|recurrent adult brain tumor|recurrent adult brain tumor
839855|NCT00002572|adult glioblastoma|adult glioblastoma
839856|NCT00002572|adult anaplastic astrocytoma|adult anaplastic astrocytoma
839857|NCT00002572|adult anaplastic oligodendroglioma|adult anaplastic oligodendroglioma
839858|NCT00002572|adult mixed glioma|adult mixed glioma
839859|NCT00002572|adult giant cell glioblastoma|adult giant cell glioblastoma
839860|NCT00002572|adult gliosarcoma|adult gliosarcoma
839861|NCT00002542|stage I breast cancer|stage i breast cancer
839862|NCT00002542|stage II breast cancer|stage ii breast cancer
839863|NCT00002542|stage IIIA breast cancer|stage iiia breast cancer
839864|NCT00002535|stage III melanoma|stage iii melanoma
839865|NCT00002535|stage IV melanoma|stage iv melanoma
839866|NCT00002535|recurrent melanoma|recurrent melanoma
839867|NCT00002529|stage II breast cancer|stage ii breast cancer
839868|NCT00002529|stage IIIA breast cancer|stage iiia breast cancer
839869|NCT00088517|Biodistribution|biodistribution
839870|NCT00088517|MIRD|mird
839871|NCT00088517|Radiation Absorbed Dose|radiation absorbed dose
839872|NCT00088517|Healthy|healthy
839873|NCT00088517|Prefrontal Cortex|prefrontal cortex
839874|NCT00088517|Radiation Exposure|radiation exposure
839875|NCT00088517|PET|pet
839876|NCT00088517|Dopamine D1 Receptor|dopamine d1 receptor
839877|NCT00088517|(11C)NNC-112|(11c)nnc-112
839878|NCT00088517|Healthy Volunteer|healthy volunteer
839879|NCT00088517|HV|hv
839880|NCT00088504|Hepatitis|hepatitis
839881|NCT00088452|childhood absence epilepsy|childhood absence epilepsy
839882|NCT00088452|CAE|cae
839883|NCT00088452|petit mal epilepsy|petit mal epilepsy
839884|NCT00088452|epilepsy|epilepsy
839885|NCT00088452|seizures|seizures
839886|NCT00088452|ethosuximide|ethosuximide
839887|NCT00088452|lamotrigine|lamotrigine
839888|NCT00088452|valproic acid|valproic acid
839889|NCT00088426|GENETIC DISEASE|genetic disease
839890|NCT00088426|Multiple Abnormalies|multiple abnormalies
839891|NCT00088426|Birth Defects|birth defects
839892|NCT00088426|Holoprosencephaly|holoprosencephaly
839893|NCT00088426|HPE|hpe
839894|NCT00088413|CEA|cea
839895|NCT00088413|Vaccine|vaccine
839896|NCT00088413|Immunotherapy|immunotherapy
839897|NCT00088413|MUC-1|muc-1
839898|NCT00088413|Cancer|cancer
839899|NCT00088413|Adenocarcinoma|adenocarcinoma
839900|NCT00088413|Metastatic Adenocarcinoma|metastatic adenocarcinoma
839901|NCT00088400|Transferrin|transferrin
839902|NCT00088400|Brain Tumor|brain tumor
839903|NCT00088400|Convection|convection
839904|NCT00088400|Immunotherapy|immunotherapy
839905|NCT00088400|Targeted Protein Toxin|targeted protein toxin
839906|NCT00088400|Glioblastoma Multiforme|glioblastoma multiforme
839907|NCT00088400|GBM|gbm
839908|NCT00088387|Tau|tau
839909|NCT00088387|T181|t181
839910|NCT00088387|T231|t231
839911|NCT00088387|Amyloid Beta|amyloid beta
839912|NCT00088387|Beta-Catenin|beta-catenin
839913|NCT00088387|Alzheimer Disease|alzheimer disease
839914|NCT00088387|AD|ad
839915|NCT00088374|Kidney Cancer|kidney cancer
839916|NCT00088374|VHL|vhl
839917|NCT00088374|17 AAG|17 aag
839918|NCT00088374|Chemotherapy|chemotherapy
839919|NCT00088374|Von Hippel Lindau Disease|von hippel lindau disease
839920|NCT00088374|Renal Tumor|renal tumor
839922|NCT00088361|PET Artifacts|pet artifacts
839923|NCT00088361|PET/CT Motion Artifacts|pet/ct motion artifacts
839924|NCT00088361|Liver|liver
839925|NCT00088361|Heart|heart
839926|NCT00088361|Respiratory Motion|respiratory motion
839927|NCT00088348|Cornea|cornea
839928|NCT00088348|Conjunctiva|conjunctiva
839929|NCT00088348|Keratitis|keratitis
839930|NCT00088348|Ocular Surface|ocular surface
839931|NCT00088348|Inflammation|inflammation
839937|NCT00088348|Anterior Segment Disease|anterior segment disease
839938|NCT00088335|Parkinsonism|parkinsonism
839939|NCT00088335|Biomarker|biomarker
839952|NCT00088309|Treatment Experienced|treatment experienced
839953|NCT00088296|Osteoarthritis|osteoarthritis
839954|NCT00088296|MS Contin|ms contin
839955|NCT00088296|Placebo|placebo
839956|NCT00088296|Cortisol|cortisol
839957|NCT00088296|Testosterone|testosterone
839958|NCT00088296|Degenerative Joint Disease|degenerative joint disease
839959|NCT00088296|OA|oa
839960|NCT00088296|Arthritis|arthritis
839961|NCT00088296|Joint Pain|joint pain
839962|NCT00088296|Arthritic Pain|arthritic pain
839963|NCT00088296|Opioid|opioid
839964|NCT00088283|CRVO|crvo
839965|NCT00088283|Central Retinal Vein Occlusion|central retinal vein occlusion
839966|NCT00088283|RVO|rvo
839967|NCT00088283|Retinal Vein Occlusion|retinal vein occlusion
839968|NCT00005884|basal cell carcinoma of the skin|basal cell carcinoma of the skin
839969|NCT00005884|squamous cell carcinoma of the skin|squamous cell carcinoma of the skin
839970|NCT00005852|recurrent childhood acute lymphoblastic leukemia|recurrent childhood acute lymphoblastic leukemia
839971|NCT00005852|recurrent adult Hodgkin lymphoma|recurrent adult hodgkin lymphoma
839972|NCT00005852|recurrent cutaneous T-cell non-Hodgkin lymphoma|recurrent cutaneous t-cell non-hodgkin lymphoma
839973|NCT00005852|refractory multiple myeloma|refractory multiple myeloma
839974|NCT00005852|stage I multiple myeloma|stage i multiple myeloma
839975|NCT00005852|stage II multiple myeloma|stage ii multiple myeloma
839976|NCT00005852|stage III multiple myeloma|stage iii multiple myeloma
839977|NCT00005852|recurrent childhood lymphoblastic lymphoma|recurrent childhood lymphoblastic lymphoma
839978|NCT00005852|recurrent childhood acute myeloid leukemia|recurrent childhood acute myeloid leukemia
839979|NCT00005852|recurrent adult acute myeloid leukemia|recurrent adult acute myeloid leukemia
839980|NCT00005852|recurrent adult acute lymphoblastic leukemia|recurrent adult acute lymphoblastic leukemia
839981|NCT00005852|relapsing chronic myelogenous leukemia|relapsing chronic myelogenous leukemia
839982|NCT00005852|refractory chronic lymphocytic leukemia|refractory chronic lymphocytic leukemia
839983|NCT00005852|primary myelofibrosis|primary myelofibrosis
839984|NCT00005852|childhood acute promyelocytic leukemia (M3)|childhood acute promyelocytic leukemia (m3)
839985|NCT00005852|refractory hairy cell leukemia|refractory hairy cell leukemia
839986|NCT00005852|recurrent/refractory childhood Hodgkin lymphoma|recurrent/refractory childhood hodgkin lymphoma
839987|NCT00005852|recurrent grade 1 follicular lymphoma|recurrent grade 1 follicular lymphoma
839988|NCT00005852|recurrent grade 2 follicular lymphoma|recurrent grade 2 follicular lymphoma
839989|NCT00005852|recurrent grade 3 follicular lymphoma|recurrent grade 3 follicular lymphoma
839990|NCT00005852|recurrent adult diffuse small cleaved cell lymphoma|recurrent adult diffuse small cleaved cell lymphoma
839991|NCT00005852|recurrent adult diffuse mixed cell lymphoma|recurrent adult diffuse mixed cell lymphoma
839992|NCT00005852|recurrent adult diffuse large cell lymphoma|recurrent adult diffuse large cell lymphoma
839993|NCT00005852|recurrent adult immunoblastic large cell lymphoma|recurrent adult immunoblastic large cell lymphoma
839994|NCT00005852|recurrent adult lymphoblastic lymphoma|recurrent adult lymphoblastic lymphoma
839995|NCT00005852|recurrent adult Burkitt lymphoma|recurrent adult burkitt lymphoma
839996|NCT00005852|previously treated myelodysplastic syndromes|previously treated myelodysplastic syndromes
839997|NCT00005852|secondary myelodysplastic syndromes|secondary myelodysplastic syndromes
839998|NCT00005852|graft versus host disease|graft versus host disease
839999|NCT00005852|recurrent childhood small noncleaved cell lymphoma|recurrent childhood small noncleaved cell lymphoma
840000|NCT00005852|recurrent childhood large cell lymphoma|recurrent childhood large cell lymphoma
840001|NCT00005852|recurrent mantle cell lymphoma|recurrent mantle cell lymphoma
840002|NCT00005852|recurrent marginal zone lymphoma|recurrent marginal zone lymphoma
840003|NCT00005852|recurrent small lymphocytic lymphoma|recurrent small lymphocytic lymphoma
840004|NCT00005852|extranodal marginal zone B-cell lymphoma of mucosa-associated lymphoid tissue|extranodal marginal zone b-cell lymphoma of mucosa-associated lymphoid tissue
840005|NCT00005852|nodal marginal zone B-cell lymphoma|nodal marginal zone b-cell lymphoma
840006|NCT00005852|splenic marginal zone lymphoma|splenic marginal zone lymphoma
840007|NCT00005852|childhood myelodysplastic syndromes|childhood myelodysplastic syndromes
840008|NCT00005805|stage I adult Hodgkin lymphoma|stage i adult hodgkin lymphoma
840009|NCT00005805|stage II adult Hodgkin lymphoma|stage ii adult hodgkin lymphoma
840010|NCT00005805|stage III adult Hodgkin lymphoma|stage iii adult hodgkin lymphoma
840011|NCT00005805|stage IV adult Hodgkin lymphoma|stage iv adult hodgkin lymphoma
840012|NCT00005805|monoclonal gammopathy of undetermined significance|monoclonal gammopathy of undetermined significance
840013|NCT00005805|recurrent adult Hodgkin lymphoma|recurrent adult hodgkin lymphoma
840014|NCT00005805|stage I cutaneous T-cell non-Hodgkin lymphoma|stage i cutaneous t-cell non-hodgkin lymphoma
850727|NCT00079638|VA-HIT|va-hit
840015|NCT00005805|stage II cutaneous T-cell non-Hodgkin lymphoma|stage ii cutaneous t-cell non-hodgkin lymphoma
840016|NCT00005805|stage III cutaneous T-cell non-Hodgkin lymphoma|stage iii cutaneous t-cell non-hodgkin lymphoma
840017|NCT00005805|stage IV cutaneous T-cell non-Hodgkin lymphoma|stage iv cutaneous t-cell non-hodgkin lymphoma
840018|NCT00005805|recurrent cutaneous T-cell non-Hodgkin lymphoma|recurrent cutaneous t-cell non-hodgkin lymphoma
840019|NCT00005805|childhood Burkitt lymphoma|childhood burkitt lymphoma
840020|NCT00005805|isolated plasmacytoma of bone|isolated plasmacytoma of bone
840021|NCT00005805|extramedullary plasmacytoma|extramedullary plasmacytoma
840022|NCT00005805|refractory multiple myeloma|refractory multiple myeloma
840023|NCT00005805|stage 0 chronic lymphocytic leukemia|stage 0 chronic lymphocytic leukemia
840024|NCT00005805|Waldenström macroglobulinemia|waldenström macroglobulinemia
840025|NCT00005805|stage I multiple myeloma|stage i multiple myeloma
840026|NCT00005805|stage II multiple myeloma|stage ii multiple myeloma
840027|NCT00005805|stage III multiple myeloma|stage iii multiple myeloma
840028|NCT00005805|stage I chronic lymphocytic leukemia|stage i chronic lymphocytic leukemia
840029|NCT00005805|stage II chronic lymphocytic leukemia|stage ii chronic lymphocytic leukemia
840030|NCT00005805|stage III chronic lymphocytic leukemia|stage iii chronic lymphocytic leukemia
840031|NCT00005805|stage IV chronic lymphocytic leukemia|stage iv chronic lymphocytic leukemia
840032|NCT00005805|recurrent childhood acute myeloid leukemia|recurrent childhood acute myeloid leukemia
840033|NCT00005805|recurrent adult acute myeloid leukemia|recurrent adult acute myeloid leukemia
840034|NCT00005805|recurrent adult acute lymphoblastic leukemia|recurrent adult acute lymphoblastic leukemia
840035|NCT00005805|relapsing chronic myelogenous leukemia|relapsing chronic myelogenous leukemia
840036|NCT00005805|refractory chronic lymphocytic leukemia|refractory chronic lymphocytic leukemia
840037|NCT00005805|unspecified adult solid tumor, protocol specific|unspecified adult solid tumor, protocol specific
840038|NCT00005805|chronic phase chronic myelogenous leukemia|chronic phase chronic myelogenous leukemia
840039|NCT00005805|accelerated phase chronic myelogenous leukemia|accelerated phase chronic myelogenous leukemia
840040|NCT00005805|blastic phase chronic myelogenous leukemia|blastic phase chronic myelogenous leukemia
840041|NCT00005805|meningeal chronic myelogenous leukemia|meningeal chronic myelogenous leukemia
840042|NCT00005805|untreated adult acute lymphoblastic leukemia|untreated adult acute lymphoblastic leukemia
840043|NCT00005805|untreated adult acute myeloid leukemia|untreated adult acute myeloid leukemia
840044|NCT00005805|untreated childhood acute myeloid leukemia and other myeloid malignancies|untreated childhood acute myeloid leukemia and other myeloid malignancies
840045|NCT00005805|adult acute lymphoblastic leukemia in remission|adult acute lymphoblastic leukemia in remission
840046|NCT00005805|childhood acute myeloid leukemia in remission|childhood acute myeloid leukemia in remission
840047|NCT00005805|polycythemia vera|polycythemia vera
840048|NCT00005805|primary myelofibrosis|primary myelofibrosis
840049|NCT00005805|essential thrombocythemia|essential thrombocythemia
840050|NCT00005805|untreated hairy cell leukemia|untreated hairy cell leukemia
840051|NCT00005805|progressive hairy cell leukemia, initial treatment|progressive hairy cell leukemia, initial treatment
840052|NCT00005805|refractory hairy cell leukemia|refractory hairy cell leukemia
840053|NCT00005805|stage II childhood Hodgkin lymphoma|stage ii childhood hodgkin lymphoma
840054|NCT00005805|stage I childhood Hodgkin lymphoma|stage i childhood hodgkin lymphoma
840055|NCT00005805|stage III childhood Hodgkin lymphoma|stage iii childhood hodgkin lymphoma
840056|NCT00005805|stage IV childhood Hodgkin lymphoma|stage iv childhood hodgkin lymphoma
840057|NCT00005805|recurrent/refractory childhood Hodgkin lymphoma|recurrent/refractory childhood hodgkin lymphoma
840058|NCT00005805|stage I small lymphocytic lymphoma|stage i small lymphocytic lymphoma
840059|NCT00005805|stage I grade 1 follicular lymphoma|stage i grade 1 follicular lymphoma
840060|NCT00005805|stage I grade 2 follicular lymphoma|stage i grade 2 follicular lymphoma
840061|NCT00005805|stage I grade 3 follicular lymphoma|stage i grade 3 follicular lymphoma
840062|NCT00005805|stage I adult diffuse small cleaved cell lymphoma|stage i adult diffuse small cleaved cell lymphoma
840063|NCT00005805|stage I adult diffuse mixed cell lymphoma|stage i adult diffuse mixed cell lymphoma
840064|NCT00005805|stage I adult diffuse large cell lymphoma|stage i adult diffuse large cell lymphoma
840065|NCT00005805|stage I adult immunoblastic large cell lymphoma|stage i adult immunoblastic large cell lymphoma
840066|NCT00005805|stage I adult lymphoblastic lymphoma|stage i adult lymphoblastic lymphoma
840067|NCT00005805|stage I adult Burkitt lymphoma|stage i adult burkitt lymphoma
840068|NCT00005805|stage I adult non-Hodgkin lymphoma|stage i adult non-hodgkin lymphoma
840069|NCT00005805|stage II adult non-Hodgkin lymphoma|stage ii adult non-hodgkin lymphoma
840070|NCT00005805|stage II small lymphocytic lymphoma|stage ii small lymphocytic lymphoma
840071|NCT00005805|stage II grade 1 follicular lymphoma|stage ii grade 1 follicular lymphoma
840072|NCT00005805|stage II grade 2 follicular lymphoma|stage ii grade 2 follicular lymphoma
840073|NCT00005805|stage II grade 3 follicular lymphoma|stage ii grade 3 follicular lymphoma
840074|NCT00005805|stage II adult diffuse small cleaved cell lymphoma|stage ii adult diffuse small cleaved cell lymphoma
840075|NCT00005805|stage II adult diffuse mixed cell lymphoma|stage ii adult diffuse mixed cell lymphoma
840076|NCT00005805|stage II adult diffuse large cell lymphoma|stage ii adult diffuse large cell lymphoma
840077|NCT00005805|stage II adult immunoblastic large cell lymphoma|stage ii adult immunoblastic large cell lymphoma
840078|NCT00005805|stage II adult lymphoblastic lymphoma|stage ii adult lymphoblastic lymphoma
840079|NCT00005805|stage II adult Burkitt lymphoma|stage ii adult burkitt lymphoma
840205|NCT00004897|stage II esophageal cancer|stage ii esophageal cancer
840080|NCT00005805|stage III small lymphocytic lymphoma|stage iii small lymphocytic lymphoma
840081|NCT00005805|stage III grade 1 follicular lymphoma|stage iii grade 1 follicular lymphoma
840082|NCT00005805|stage III grade 2 follicular lymphoma|stage iii grade 2 follicular lymphoma
840083|NCT00005805|stage III grade 3 follicular lymphoma|stage iii grade 3 follicular lymphoma
840084|NCT00005805|stage III adult diffuse small cleaved cell lymphoma|stage iii adult diffuse small cleaved cell lymphoma
840085|NCT00005805|stage III adult diffuse mixed cell lymphoma|stage iii adult diffuse mixed cell lymphoma
840086|NCT00005805|stage III adult diffuse large cell lymphoma|stage iii adult diffuse large cell lymphoma
840087|NCT00005805|stage III adult immunoblastic large cell lymphoma|stage iii adult immunoblastic large cell lymphoma
840088|NCT00005805|stage III adult lymphoblastic lymphoma|stage iii adult lymphoblastic lymphoma
840089|NCT00005805|stage III adult Burkitt lymphoma|stage iii adult burkitt lymphoma
840090|NCT00005805|stage IV small lymphocytic lymphoma|stage iv small lymphocytic lymphoma
840091|NCT00005805|stage IV grade 1 follicular lymphoma|stage iv grade 1 follicular lymphoma
840092|NCT00005805|stage IV grade 2 follicular lymphoma|stage iv grade 2 follicular lymphoma
840093|NCT00005805|stage IV grade 3 follicular lymphoma|stage iv grade 3 follicular lymphoma
840094|NCT00005805|stage IV adult diffuse small cleaved cell lymphoma|stage iv adult diffuse small cleaved cell lymphoma
840095|NCT00005805|stage IV adult diffuse mixed cell lymphoma|stage iv adult diffuse mixed cell lymphoma
840096|NCT00005805|stage IV adult diffuse large cell lymphoma|stage iv adult diffuse large cell lymphoma
840097|NCT00005805|stage IV adult immunoblastic large cell lymphoma|stage iv adult immunoblastic large cell lymphoma
840098|NCT00005805|stage IV adult lymphoblastic lymphoma|stage iv adult lymphoblastic lymphoma
840099|NCT00005805|stage IV adult Burkitt lymphoma|stage iv adult burkitt lymphoma
840100|NCT00005805|recurrent small lymphocytic lymphoma|recurrent small lymphocytic lymphoma
840101|NCT00005805|recurrent grade 1 follicular lymphoma|recurrent grade 1 follicular lymphoma
840102|NCT00005805|recurrent grade 2 follicular lymphoma|recurrent grade 2 follicular lymphoma
840103|NCT00005805|recurrent grade 3 follicular lymphoma|recurrent grade 3 follicular lymphoma
840104|NCT00005805|recurrent adult diffuse small cleaved cell lymphoma|recurrent adult diffuse small cleaved cell lymphoma
840105|NCT00005805|recurrent adult diffuse mixed cell lymphoma|recurrent adult diffuse mixed cell lymphoma
840106|NCT00005805|recurrent adult diffuse large cell lymphoma|recurrent adult diffuse large cell lymphoma
840107|NCT00005805|recurrent adult immunoblastic large cell lymphoma|recurrent adult immunoblastic large cell lymphoma
840108|NCT00005805|recurrent adult lymphoblastic lymphoma|recurrent adult lymphoblastic lymphoma
840109|NCT00005805|recurrent adult Burkitt lymphoma|recurrent adult burkitt lymphoma
840110|NCT00005805|stage I adult T-cell leukemia/lymphoma|stage i adult t-cell leukemia/lymphoma
840111|NCT00005805|stage II adult T-cell leukemia/lymphoma|stage ii adult t-cell leukemia/lymphoma
840112|NCT00005805|stage III adult T-cell leukemia/lymphoma|stage iii adult t-cell leukemia/lymphoma
840113|NCT00005805|stage IV adult T-cell leukemia/lymphoma|stage iv adult t-cell leukemia/lymphoma
840114|NCT00005805|recurrent adult T-cell leukemia/lymphoma|recurrent adult t-cell leukemia/lymphoma
840115|NCT00005805|de novo myelodysplastic syndromes|de novo myelodysplastic syndromes
840116|NCT00005805|previously treated myelodysplastic syndromes|previously treated myelodysplastic syndromes
840117|NCT00005805|secondary myelodysplastic syndromes|secondary myelodysplastic syndromes
840118|NCT00005805|primary central nervous system non-Hodgkin lymphoma|primary central nervous system non-hodgkin lymphoma
840119|NCT00005805|fatigue|fatigue
840120|NCT00005805|AIDS-related peripheral/systemic lymphoma|aids-related peripheral/systemic lymphoma
840121|NCT00005805|AIDS-related primary CNS lymphoma|aids-related primary cns lymphoma
840122|NCT00005805|primary systemic amyloidosis|primary systemic amyloidosis
840123|NCT00005805|intraocular lymphoma|intraocular lymphoma
840501|NCT00088192|AMD|amd
840124|NCT00005805|stage I mantle cell lymphoma|stage i mantle cell lymphoma
840125|NCT00005805|contiguous stage II adult non-Hodgkin lymphoma|contiguous stage ii adult non-hodgkin lymphoma
840126|NCT00005805|contiguous stage II grade 1 follicular lymphoma|contiguous stage ii grade 1 follicular lymphoma
840127|NCT00005805|contiguous stage II grade 2 follicular lymphoma|contiguous stage ii grade 2 follicular lymphoma
840128|NCT00005805|contiguous stage II grade 3 follicular lymphoma|contiguous stage ii grade 3 follicular lymphoma
840129|NCT00005805|contiguous stage II adult diffuse small cleaved cell lymphoma|contiguous stage ii adult diffuse small cleaved cell lymphoma
840130|NCT00005805|contiguous stage II mantle cell lymphoma|contiguous stage ii mantle cell lymphoma
840131|NCT00005805|contiguous stage II adult diffuse mixed cell lymphoma|contiguous stage ii adult diffuse mixed cell lymphoma
840132|NCT00005805|contiguous stage II adult immunoblastic large cell lymphoma|contiguous stage ii adult immunoblastic large cell lymphoma
840133|NCT00005805|contiguous stage II adult diffuse large cell lymphoma|contiguous stage ii adult diffuse large cell lymphoma
840134|NCT00005805|contiguous stage II adult Burkitt lymphoma|contiguous stage ii adult burkitt lymphoma
840135|NCT00005805|contiguous stage II adult lymphoblastic lymphoma|contiguous stage ii adult lymphoblastic lymphoma
840136|NCT00005805|noncontiguous stage II adult non-Hodgkin lymphoma|noncontiguous stage ii adult non-hodgkin lymphoma
840137|NCT00005805|noncontiguous stage II grade 1 follicular lymphoma|noncontiguous stage ii grade 1 follicular lymphoma
840138|NCT00005805|noncontiguous stage II grade 2 follicular lymphoma|noncontiguous stage ii grade 2 follicular lymphoma
840139|NCT00005805|noncontiguous stage II grade 3 follicular lymphoma|noncontiguous stage ii grade 3 follicular lymphoma
840140|NCT00005805|noncontiguous stage II adult diffuse small cleaved cell lymphoma|noncontiguous stage ii adult diffuse small cleaved cell lymphoma
855446|NCT00072657|Pain|pain
840141|NCT00005805|noncontiguous stage II mantle cell lymphoma|noncontiguous stage ii mantle cell lymphoma
840142|NCT00005805|noncontiguous stage II adult diffuse mixed cell lymphoma|noncontiguous stage ii adult diffuse mixed cell lymphoma
840143|NCT00005805|noncontiguous stage II adult immunoblastic large cell lymphoma|noncontiguous stage ii adult immunoblastic large cell lymphoma
840144|NCT00005805|noncontiguous stage II adult diffuse large cell lymphoma|noncontiguous stage ii adult diffuse large cell lymphoma
840145|NCT00005805|noncontiguous stage II adult Burkitt lymphoma|noncontiguous stage ii adult burkitt lymphoma
840146|NCT00005805|noncontiguous stage II adult lymphoblastic lymphoma|noncontiguous stage ii adult lymphoblastic lymphoma
840147|NCT00005805|stage III mantle cell lymphoma|stage iii mantle cell lymphoma
840148|NCT00005805|stage IV mantle cell lymphoma|stage iv mantle cell lymphoma
840149|NCT00005805|recurrent mantle cell lymphoma|recurrent mantle cell lymphoma
840150|NCT00005805|angioimmunoblastic T-cell lymphoma|angioimmunoblastic t-cell lymphoma
840151|NCT00005805|anaplastic large cell lymphoma|anaplastic large cell lymphoma
840152|NCT00005805|stage II mantle cell lymphoma|stage ii mantle cell lymphoma
840153|NCT00005805|multiple myeloma|multiple myeloma
840154|NCT00005805|noncontiguous stage II small lymphocytic lymphoma|noncontiguous stage ii small lymphocytic lymphoma
840155|NCT00005805|noncontiguous stage II marginal zone lymphoma|noncontiguous stage ii marginal zone lymphoma
840156|NCT00005805|recurrent marginal zone lymphoma|recurrent marginal zone lymphoma
840157|NCT00005805|stage I marginal zone lymphoma|stage i marginal zone lymphoma
840158|NCT00005805|stage II marginal zone lymphoma|stage ii marginal zone lymphoma
840159|NCT00005805|stage III marginal zone lymphoma|stage iii marginal zone lymphoma
840160|NCT00005805|stage IV marginal zone lymphoma|stage iv marginal zone lymphoma
840161|NCT00005805|contiguous stage II marginal zone lymphoma|contiguous stage ii marginal zone lymphoma
840162|NCT00005805|contiguous stage II small lymphocytic lymphoma|contiguous stage ii small lymphocytic lymphoma
840163|NCT00005805|extranodal marginal zone B-cell lymphoma of mucosa-associated lymphoid tissue|extranodal marginal zone b-cell lymphoma of mucosa-associated lymphoid tissue
840164|NCT00005805|nodal marginal zone B-cell lymphoma|nodal marginal zone b-cell lymphoma
840165|NCT00005805|splenic marginal zone lymphoma|splenic marginal zone lymphoma
840166|NCT00005633|stage III melanoma|stage iii melanoma
840167|NCT00005633|stage IV melanoma|stage iv melanoma
840168|NCT00005633|recurrent melanoma|recurrent melanoma
840169|NCT00005624|refractory multiple myeloma|refractory multiple myeloma
840170|NCT00005624|stage II multiple myeloma|stage ii multiple myeloma
840171|NCT00005624|stage III multiple myeloma|stage iii multiple myeloma
840172|NCT00005624|plasma cell neoplasm|plasma cell neoplasm
840173|NCT00005614|stage IV breast cancer|stage iv breast cancer
840174|NCT00005614|recurrent breast cancer|recurrent breast cancer
840175|NCT00005611|unspecified adult solid tumor, protocol specific|unspecified adult solid tumor, protocol specific
840176|NCT00004902|refractory multiple myeloma|refractory multiple myeloma
840177|NCT00004902|stage I multiple myeloma|stage i multiple myeloma
840178|NCT00004902|stage II multiple myeloma|stage ii multiple myeloma
840179|NCT00004902|stage III multiple myeloma|stage iii multiple myeloma
840180|NCT00004901|stage IV hypopharyngeal cancer|stage iv hypopharyngeal cancer
840181|NCT00004901|recurrent hypopharyngeal cancer|recurrent hypopharyngeal cancer
840182|NCT00004901|stage IV squamous cell carcinoma of the lip and oral cavity|stage iv squamous cell carcinoma of the lip and oral cavity
840183|NCT00004901|stage IV verrucous carcinoma of the oral cavity|stage iv verrucous carcinoma of the oral cavity
840184|NCT00004901|stage IV mucoepidermoid carcinoma of the oral cavity|stage iv mucoepidermoid carcinoma of the oral cavity
840185|NCT00004901|stage IV adenoid cystic carcinoma of the oral cavity|stage iv adenoid cystic carcinoma of the oral cavity
840186|NCT00004901|recurrent squamous cell carcinoma of the lip and oral cavity|recurrent squamous cell carcinoma of the lip and oral cavity
840187|NCT00004901|recurrent verrucous carcinoma of the oral cavity|recurrent verrucous carcinoma of the oral cavity
840188|NCT00004901|recurrent mucoepidermoid carcinoma of the oral cavity|recurrent mucoepidermoid carcinoma of the oral cavity
840189|NCT00004901|recurrent adenoid cystic carcinoma of the oral cavity|recurrent adenoid cystic carcinoma of the oral cavity
840190|NCT00004901|stage IV squamous cell carcinoma of the oropharynx|stage iv squamous cell carcinoma of the oropharynx
840191|NCT00004901|stage IV lymphoepithelioma of the oropharynx|stage iv lymphoepithelioma of the oropharynx
840192|NCT00004901|recurrent squamous cell carcinoma of the oropharynx|recurrent squamous cell carcinoma of the oropharynx
840193|NCT00004901|recurrent lymphoepithelioma of the oropharynx|recurrent lymphoepithelioma of the oropharynx
840194|NCT00004901|stage IV squamous cell carcinoma of the nasopharynx|stage iv squamous cell carcinoma of the nasopharynx
840195|NCT00004901|stage IV lymphoepithelioma of the nasopharynx|stage iv lymphoepithelioma of the nasopharynx
840196|NCT00004901|recurrent squamous cell carcinoma of the nasopharynx|recurrent squamous cell carcinoma of the nasopharynx
840197|NCT00004901|recurrent lymphoepithelioma of the nasopharynx|recurrent lymphoepithelioma of the nasopharynx
840198|NCT00004901|stage IV squamous cell carcinoma of the hypopharynx|stage iv squamous cell carcinoma of the hypopharynx
840199|NCT00004901|recurrent squamous cell carcinoma of the hypopharynx|recurrent squamous cell carcinoma of the hypopharynx
840200|NCT00004901|stage IV squamous cell carcinoma of the larynx|stage iv squamous cell carcinoma of the larynx
840201|NCT00004901|stage IV verrucous carcinoma of the larynx|stage iv verrucous carcinoma of the larynx
840202|NCT00004901|recurrent squamous cell carcinoma of the larynx|recurrent squamous cell carcinoma of the larynx
840203|NCT00004901|recurrent verrucous carcinoma of the larynx|recurrent verrucous carcinoma of the larynx
840204|NCT00004897|stage I esophageal cancer|stage i esophageal cancer
840206|NCT00004897|stage III esophageal cancer|stage iii esophageal cancer
840207|NCT00004897|squamous cell carcinoma of the esophagus|squamous cell carcinoma of the esophagus
840208|NCT00004897|adenocarcinoma of the esophagus|adenocarcinoma of the esophagus
840209|NCT00004875|stage I adult Hodgkin lymphoma|stage i adult hodgkin lymphoma
840210|NCT00004875|stage II adult Hodgkin lymphoma|stage ii adult hodgkin lymphoma
840211|NCT00004875|stage III adult Hodgkin lymphoma|stage iii adult hodgkin lymphoma
840212|NCT00004875|stage IV adult Hodgkin lymphoma|stage iv adult hodgkin lymphoma
840213|NCT00004875|recurrent adult Hodgkin lymphoma|recurrent adult hodgkin lymphoma
840214|NCT00004875|unspecified adult solid tumor, protocol specific|unspecified adult solid tumor, protocol specific
840215|NCT00004875|stage I grade 1 follicular lymphoma|stage i grade 1 follicular lymphoma
840216|NCT00004875|stage I grade 2 follicular lymphoma|stage i grade 2 follicular lymphoma
840217|NCT00004875|stage I grade 3 follicular lymphoma|stage i grade 3 follicular lymphoma
840218|NCT00004875|stage I adult diffuse small cleaved cell lymphoma|stage i adult diffuse small cleaved cell lymphoma
840219|NCT00004875|stage I adult diffuse mixed cell lymphoma|stage i adult diffuse mixed cell lymphoma
840220|NCT00004875|stage I adult diffuse large cell lymphoma|stage i adult diffuse large cell lymphoma
840221|NCT00004875|stage I adult immunoblastic large cell lymphoma|stage i adult immunoblastic large cell lymphoma
840222|NCT00004875|stage I adult Burkitt lymphoma|stage i adult burkitt lymphoma
840223|NCT00004875|stage III grade 1 follicular lymphoma|stage iii grade 1 follicular lymphoma
840224|NCT00004875|stage III grade 2 follicular lymphoma|stage iii grade 2 follicular lymphoma
840225|NCT00004875|stage III grade 3 follicular lymphoma|stage iii grade 3 follicular lymphoma
840226|NCT00004875|stage III adult diffuse small cleaved cell lymphoma|stage iii adult diffuse small cleaved cell lymphoma
840227|NCT00004875|stage III adult diffuse mixed cell lymphoma|stage iii adult diffuse mixed cell lymphoma
840228|NCT00004875|stage III adult diffuse large cell lymphoma|stage iii adult diffuse large cell lymphoma
840229|NCT00004875|stage III adult immunoblastic large cell lymphoma|stage iii adult immunoblastic large cell lymphoma
840230|NCT00004875|stage III adult Burkitt lymphoma|stage iii adult burkitt lymphoma
840231|NCT00004875|stage IV grade 1 follicular lymphoma|stage iv grade 1 follicular lymphoma
840232|NCT00004875|stage IV grade 2 follicular lymphoma|stage iv grade 2 follicular lymphoma
840233|NCT00004875|stage IV grade 3 follicular lymphoma|stage iv grade 3 follicular lymphoma
840234|NCT00004875|stage IV adult diffuse small cleaved cell lymphoma|stage iv adult diffuse small cleaved cell lymphoma
840235|NCT00004875|stage IV adult diffuse mixed cell lymphoma|stage iv adult diffuse mixed cell lymphoma
840236|NCT00004875|stage IV adult diffuse large cell lymphoma|stage iv adult diffuse large cell lymphoma
840237|NCT00004875|stage IV adult immunoblastic large cell lymphoma|stage iv adult immunoblastic large cell lymphoma
840238|NCT00004875|stage IV adult Burkitt lymphoma|stage iv adult burkitt lymphoma
840239|NCT00004875|recurrent grade 1 follicular lymphoma|recurrent grade 1 follicular lymphoma
840240|NCT00004875|recurrent grade 2 follicular lymphoma|recurrent grade 2 follicular lymphoma
840241|NCT00004875|recurrent grade 3 follicular lymphoma|recurrent grade 3 follicular lymphoma
840242|NCT00004875|recurrent adult diffuse small cleaved cell lymphoma|recurrent adult diffuse small cleaved cell lymphoma
840243|NCT00004875|recurrent adult diffuse mixed cell lymphoma|recurrent adult diffuse mixed cell lymphoma
840244|NCT00004875|recurrent adult diffuse large cell lymphoma|recurrent adult diffuse large cell lymphoma
840245|NCT00004875|recurrent adult immunoblastic large cell lymphoma|recurrent adult immunoblastic large cell lymphoma
840246|NCT00004875|recurrent adult Burkitt lymphoma|recurrent adult burkitt lymphoma
840247|NCT00004875|AIDS-related peripheral/systemic lymphoma|aids-related peripheral/systemic lymphoma
840248|NCT00004875|AIDS-related primary CNS lymphoma|aids-related primary cns lymphoma
840249|NCT00004875|stage I mantle cell lymphoma|stage i mantle cell lymphoma
840250|NCT00004875|contiguous stage II grade 1 follicular lymphoma|contiguous stage ii grade 1 follicular lymphoma
840251|NCT00004875|contiguous stage II grade 2 follicular lymphoma|contiguous stage ii grade 2 follicular lymphoma
840252|NCT00004875|contiguous stage II grade 3 follicular lymphoma|contiguous stage ii grade 3 follicular lymphoma
840253|NCT00004875|contiguous stage II adult diffuse small cleaved cell lymphoma|contiguous stage ii adult diffuse small cleaved cell lymphoma
840254|NCT00004875|contiguous stage II mantle cell lymphoma|contiguous stage ii mantle cell lymphoma
840255|NCT00004875|contiguous stage II adult diffuse mixed cell lymphoma|contiguous stage ii adult diffuse mixed cell lymphoma
840256|NCT00004875|contiguous stage II adult immunoblastic large cell lymphoma|contiguous stage ii adult immunoblastic large cell lymphoma
840257|NCT00004875|contiguous stage II adult diffuse large cell lymphoma|contiguous stage ii adult diffuse large cell lymphoma
840258|NCT00004875|contiguous stage II adult Burkitt lymphoma|contiguous stage ii adult burkitt lymphoma
840259|NCT00004875|noncontiguous stage II grade 1 follicular lymphoma|noncontiguous stage ii grade 1 follicular lymphoma
840260|NCT00004875|noncontiguous stage II grade 2 follicular lymphoma|noncontiguous stage ii grade 2 follicular lymphoma
840261|NCT00004875|noncontiguous stage II grade 3 follicular lymphoma|noncontiguous stage ii grade 3 follicular lymphoma
840262|NCT00004875|noncontiguous stage II adult diffuse small cleaved cell lymphoma|noncontiguous stage ii adult diffuse small cleaved cell lymphoma
840263|NCT00004875|noncontiguous stage II mantle cell lymphoma|noncontiguous stage ii mantle cell lymphoma
840264|NCT00004875|noncontiguous stage II adult diffuse mixed cell lymphoma|noncontiguous stage ii adult diffuse mixed cell lymphoma
840265|NCT00004875|noncontiguous stage II adult immunoblastic large cell lymphoma|noncontiguous stage ii adult immunoblastic large cell lymphoma
840266|NCT00004875|noncontiguous stage II adult diffuse large cell lymphoma|noncontiguous stage ii adult diffuse large cell lymphoma
840267|NCT00004875|noncontiguous stage II adult Burkitt lymphoma|noncontiguous stage ii adult burkitt lymphoma
840268|NCT00004875|stage III mantle cell lymphoma|stage iii mantle cell lymphoma
840269|NCT00004875|stage IV mantle cell lymphoma|stage iv mantle cell lymphoma
840270|NCT00004875|recurrent mantle cell lymphoma|recurrent mantle cell lymphoma
840271|NCT00004875|angioimmunoblastic T-cell lymphoma|angioimmunoblastic t-cell lymphoma
840272|NCT00004875|anaplastic large cell lymphoma|anaplastic large cell lymphoma
840273|NCT00004875|thromboembolism|thromboembolism
840274|NCT00004875|noncontiguous stage II small lymphocytic lymphoma|noncontiguous stage ii small lymphocytic lymphoma
840275|NCT00004875|noncontiguous stage II marginal zone lymphoma|noncontiguous stage ii marginal zone lymphoma
840276|NCT00004875|recurrent marginal zone lymphoma|recurrent marginal zone lymphoma
840277|NCT00004875|recurrent small lymphocytic lymphoma|recurrent small lymphocytic lymphoma
840278|NCT00004875|stage I marginal zone lymphoma|stage i marginal zone lymphoma
840279|NCT00004875|stage I small lymphocytic lymphoma|stage i small lymphocytic lymphoma
840280|NCT00004875|stage III small lymphocytic lymphoma|stage iii small lymphocytic lymphoma
840281|NCT00004875|stage III marginal zone lymphoma|stage iii marginal zone lymphoma
840282|NCT00004875|stage IV small lymphocytic lymphoma|stage iv small lymphocytic lymphoma
840283|NCT00004875|stage IV marginal zone lymphoma|stage iv marginal zone lymphoma
840284|NCT00004875|contiguous stage II marginal zone lymphoma|contiguous stage ii marginal zone lymphoma
840285|NCT00004875|contiguous stage II small lymphocytic lymphoma|contiguous stage ii small lymphocytic lymphoma
840286|NCT00004875|extranodal marginal zone B-cell lymphoma of mucosa-associated lymphoid tissue|extranodal marginal zone b-cell lymphoma of mucosa-associated lymphoid tissue
840287|NCT00004875|nodal marginal zone B-cell lymphoma|nodal marginal zone b-cell lymphoma
840288|NCT00004875|splenic marginal zone lymphoma|splenic marginal zone lymphoma
840289|NCT00004265|recurrent non-small cell lung cancer|recurrent non-small cell lung cancer
840290|NCT00004264|recurrent non-small cell lung cancer|recurrent non-small cell lung cancer
840291|NCT00004264|stage IV non-small cell lung cancer|stage iv non-small cell lung cancer
840292|NCT00004264|drug/agent toxicity by tissue/organ|drug/agent toxicity by tissue/organ
840293|NCT00004263|recurrent adult acute myeloid leukemia|recurrent adult acute myeloid leukemia
840294|NCT00004263|refractory anemia with excess blasts|refractory anemia with excess blasts
840295|NCT00004263|refractory anemia with excess blasts in transformation|refractory anemia with excess blasts in transformation
840296|NCT00004263|previously treated myelodysplastic syndromes|previously treated myelodysplastic syndromes
840297|NCT00004263|childhood myelodysplastic syndromes|childhood myelodysplastic syndromes
840298|NCT00004263|Ara-C|ara-c
840299|NCT00004263|Cytosar|cytosar
840300|NCT00004263|DepoCyt|depocyt
840301|NCT00004263|Cytosine arabinosine hydrochloride|cytosine arabinosine hydrochloride
840302|NCT00004263|cytarabine|cytarabine
840303|NCT00004263|7-hydroxystaurosporine|7-hydroxystaurosporine
840304|NCT00004263|UCN-01|ucn-01
840305|NCT00004258|stage III adult Hodgkin lymphoma|stage iii adult hodgkin lymphoma
840306|NCT00004258|stage IV adult Hodgkin lymphoma|stage iv adult hodgkin lymphoma
840307|NCT00004258|monoclonal gammopathy of undetermined significance|monoclonal gammopathy of undetermined significance
840308|NCT00004258|recurrent adult Hodgkin lymphoma|recurrent adult hodgkin lymphoma
840309|NCT00004258|stage I cutaneous T-cell non-Hodgkin lymphoma|stage i cutaneous t-cell non-hodgkin lymphoma
840310|NCT00004258|stage II cutaneous T-cell non-Hodgkin lymphoma|stage ii cutaneous t-cell non-hodgkin lymphoma
840311|NCT00004258|stage III cutaneous T-cell non-Hodgkin lymphoma|stage iii cutaneous t-cell non-hodgkin lymphoma
840312|NCT00004258|stage IV cutaneous T-cell non-Hodgkin lymphoma|stage iv cutaneous t-cell non-hodgkin lymphoma
840313|NCT00004258|recurrent cutaneous T-cell non-Hodgkin lymphoma|recurrent cutaneous t-cell non-hodgkin lymphoma
840314|NCT00004258|isolated plasmacytoma of bone|isolated plasmacytoma of bone
840315|NCT00004258|extramedullary plasmacytoma|extramedullary plasmacytoma
840316|NCT00004258|refractory multiple myeloma|refractory multiple myeloma
840317|NCT00004258|Waldenstrom macroglobulinemia|waldenstrom macroglobulinemia
840318|NCT00004258|stage III multiple myeloma|stage iii multiple myeloma
840319|NCT00004258|stage III chronic lymphocytic leukemia|stage iii chronic lymphocytic leukemia
840320|NCT00004258|stage IV chronic lymphocytic leukemia|stage iv chronic lymphocytic leukemia
840321|NCT00004258|recurrent adult acute myeloid leukemia|recurrent adult acute myeloid leukemia
840322|NCT00004258|recurrent adult acute lymphoblastic leukemia|recurrent adult acute lymphoblastic leukemia
840323|NCT00004258|relapsing chronic myelogenous leukemia|relapsing chronic myelogenous leukemia
840324|NCT00004258|refractory chronic lymphocytic leukemia|refractory chronic lymphocytic leukemia
840325|NCT00004258|small intestine lymphoma|small intestine lymphoma
840326|NCT00004258|unspecified adult solid tumor, protocol specific|unspecified adult solid tumor, protocol specific
840327|NCT00004258|chronic phase chronic myelogenous leukemia|chronic phase chronic myelogenous leukemia
840328|NCT00004258|blastic phase chronic myelogenous leukemia|blastic phase chronic myelogenous leukemia
840329|NCT00004258|meningeal chronic myelogenous leukemia|meningeal chronic myelogenous leukemia
840330|NCT00004258|untreated adult acute lymphoblastic leukemia|untreated adult acute lymphoblastic leukemia
840331|NCT00004258|untreated adult acute myeloid leukemia|untreated adult acute myeloid leukemia
840332|NCT00004258|polycythemia vera|polycythemia vera
840333|NCT00004258|essential thrombocythemia|essential thrombocythemia
840334|NCT00004258|untreated hairy cell leukemia|untreated hairy cell leukemia
840335|NCT00004258|progressive hairy cell leukemia, initial treatment|progressive hairy cell leukemia, initial treatment
840336|NCT00004258|refractory hairy cell leukemia|refractory hairy cell leukemia
840337|NCT00004258|chronic myelomonocytic leukemia|chronic myelomonocytic leukemia
840338|NCT00004258|T-cell large granular lymphocyte leukemia|t-cell large granular lymphocyte leukemia
840339|NCT00004258|stage III grade 1 follicular lymphoma|stage iii grade 1 follicular lymphoma
840340|NCT00004258|stage III grade 2 follicular lymphoma|stage iii grade 2 follicular lymphoma
840341|NCT00004258|stage III grade 3 follicular lymphoma|stage iii grade 3 follicular lymphoma
840342|NCT00004258|stage III adult diffuse small cleaved cell lymphoma|stage iii adult diffuse small cleaved cell lymphoma
840343|NCT00004258|stage III adult diffuse mixed cell lymphoma|stage iii adult diffuse mixed cell lymphoma
855460|NCT00072631|NSCLC|nsclc
840344|NCT00004258|stage III adult diffuse large cell lymphoma|stage iii adult diffuse large cell lymphoma
840345|NCT00004258|stage III adult immunoblastic large cell lymphoma|stage iii adult immunoblastic large cell lymphoma
840346|NCT00004258|stage III adult lymphoblastic lymphoma|stage iii adult lymphoblastic lymphoma
840347|NCT00004258|stage III adult Burkitt lymphoma|stage iii adult burkitt lymphoma
840348|NCT00004258|stage IV grade 1 follicular lymphoma|stage iv grade 1 follicular lymphoma
840349|NCT00004258|stage IV grade 2 follicular lymphoma|stage iv grade 2 follicular lymphoma
840350|NCT00004258|stage IV grade 3 follicular lymphoma|stage iv grade 3 follicular lymphoma
840351|NCT00004258|stage IV adult diffuse small cleaved cell lymphoma|stage iv adult diffuse small cleaved cell lymphoma
840352|NCT00004258|stage IV adult diffuse mixed cell lymphoma|stage iv adult diffuse mixed cell lymphoma
840353|NCT00004258|stage IV adult diffuse large cell lymphoma|stage iv adult diffuse large cell lymphoma
840354|NCT00004258|stage IV adult immunoblastic large cell lymphoma|stage iv adult immunoblastic large cell lymphoma
840355|NCT00004258|stage IV adult lymphoblastic lymphoma|stage iv adult lymphoblastic lymphoma
840356|NCT00004258|stage IV adult Burkitt lymphoma|stage iv adult burkitt lymphoma
840357|NCT00004258|recurrent grade 1 follicular lymphoma|recurrent grade 1 follicular lymphoma
840358|NCT00004258|recurrent grade 2 follicular lymphoma|recurrent grade 2 follicular lymphoma
840359|NCT00004258|recurrent grade 3 follicular lymphoma|recurrent grade 3 follicular lymphoma
840360|NCT00004258|recurrent adult diffuse small cleaved cell lymphoma|recurrent adult diffuse small cleaved cell lymphoma
840361|NCT00004258|recurrent adult diffuse mixed cell lymphoma|recurrent adult diffuse mixed cell lymphoma
840362|NCT00004258|recurrent adult diffuse large cell lymphoma|recurrent adult diffuse large cell lymphoma
840363|NCT00004258|recurrent adult immunoblastic large cell lymphoma|recurrent adult immunoblastic large cell lymphoma
840364|NCT00004258|recurrent adult lymphoblastic lymphoma|recurrent adult lymphoblastic lymphoma
840365|NCT00004258|recurrent adult Burkitt lymphoma|recurrent adult burkitt lymphoma
840366|NCT00004258|stage III adult T-cell leukemia/lymphoma|stage iii adult t-cell leukemia/lymphoma
840367|NCT00004258|stage IV adult T-cell leukemia/lymphoma|stage iv adult t-cell leukemia/lymphoma
840368|NCT00004258|recurrent adult T-cell leukemia/lymphoma|recurrent adult t-cell leukemia/lymphoma
840369|NCT00004258|secondary acute myeloid leukemia|secondary acute myeloid leukemia
840370|NCT00004258|de novo myelodysplastic syndromes|de novo myelodysplastic syndromes
840371|NCT00004258|previously treated myelodysplastic syndromes|previously treated myelodysplastic syndromes
840372|NCT00004258|secondary myelodysplastic syndromes|secondary myelodysplastic syndromes
840373|NCT00004258|prolymphocytic leukemia|prolymphocytic leukemia
840374|NCT00004258|primary systemic amyloidosis|primary systemic amyloidosis
840375|NCT00004258|stage III mantle cell lymphoma|stage iii mantle cell lymphoma
840376|NCT00004258|stage IV mantle cell lymphoma|stage iv mantle cell lymphoma
840377|NCT00004258|recurrent mantle cell lymphoma|recurrent mantle cell lymphoma
840378|NCT00004258|angioimmunoblastic T-cell lymphoma|angioimmunoblastic t-cell lymphoma
840379|NCT00004258|chronic idiopathic myelofibrosis|chronic idiopathic myelofibrosis
840380|NCT00004258|recurrent marginal zone lymphoma|recurrent marginal zone lymphoma
840381|NCT00004258|recurrent small lymphocytic lymphoma|recurrent small lymphocytic lymphoma
840382|NCT00004258|stage III small lymphocytic lymphoma|stage iii small lymphocytic lymphoma
840383|NCT00004258|stage III marginal zone lymphoma|stage iii marginal zone lymphoma
840384|NCT00004258|stage IV small lymphocytic lymphoma|stage iv small lymphocytic lymphoma
840385|NCT00004258|stage IV marginal zone lymphoma|stage iv marginal zone lymphoma
840386|NCT00004258|extranodal marginal zone B-cell lymphoma of mucosa-associated lymphoid tissue|extranodal marginal zone b-cell lymphoma of mucosa-associated lymphoid tissue
840387|NCT00004258|nodal marginal zone B-cell lymphoma|nodal marginal zone b-cell lymphoma
840388|NCT00004258|splenic marginal zone lymphoma|splenic marginal zone lymphoma
840389|NCT00004169|recurrent adult Hodgkin lymphoma|recurrent adult hodgkin lymphoma
840390|NCT00004169|recurrent/refractory childhood Hodgkin lymphoma|recurrent/refractory childhood hodgkin lymphoma
840391|NCT00004159|recurrent non-small cell lung cancer|recurrent non-small cell lung cancer
840392|NCT00004159|stage IV non-small cell lung cancer|stage iv non-small cell lung cancer
840393|NCT00003942|AIDS-related peripheral/systemic lymphoma|aids-related peripheral/systemic lymphoma
840394|NCT00003942|AIDS-related diffuse large cell lymphoma|aids-related diffuse large cell lymphoma
840395|NCT00003942|AIDS-related immunoblastic large cell lymphoma|aids-related immunoblastic large cell lymphoma
840396|NCT00003942|AIDS-related small noncleaved cell lymphoma|aids-related small noncleaved cell lymphoma
840397|NCT00003942|AIDS-related diffuse mixed cell lymphoma|aids-related diffuse mixed cell lymphoma
840398|NCT00003942|AIDS-related diffuse small cleaved cell lymphoma|aids-related diffuse small cleaved cell lymphoma
840399|NCT00003942|AIDS-related lymphoblastic lymphoma|aids-related lymphoblastic lymphoma
840400|NCT00003936|recurrent adult Hodgkin lymphoma|recurrent adult hodgkin lymphoma
840401|NCT00003929|primary central nervous system lymphoma|primary central nervous system lymphoma
840402|NCT00003929|AIDS-related primary CNS lymphoma|aids-related primary cns lymphoma
840403|NCT00002506|recurrent non-small cell lung cancer|recurrent non-small cell lung cancer
840404|NCT00002506|recurrent esophageal cancer|recurrent esophageal cancer
840405|NCT00002506|recurrent cervical cancer|recurrent cervical cancer
840406|NCT00002506|squamous cell lung cancer|squamous cell lung cancer
840407|NCT00002506|squamous cell carcinoma of the skin|squamous cell carcinoma of the skin
840408|NCT00002506|recurrent penile cancer|recurrent penile cancer
840409|NCT00002506|recurrent skin cancer|recurrent skin cancer
840410|NCT00002506|squamous cell carcinoma of the esophagus|squamous cell carcinoma of the esophagus
840411|NCT00002506|cervical squamous cell carcinoma|cervical squamous cell carcinoma
840412|NCT00002506|penile squamous cell carcinoma|penile squamous cell carcinoma
840413|NCT00002506|recurrent squamous cell carcinoma of the lip and oral cavity|recurrent squamous cell carcinoma of the lip and oral cavity
840414|NCT00002506|recurrent squamous cell carcinoma of the oropharynx|recurrent squamous cell carcinoma of the oropharynx
840415|NCT00002506|recurrent squamous cell carcinoma of the nasopharynx|recurrent squamous cell carcinoma of the nasopharynx
840416|NCT00002506|recurrent squamous cell carcinoma of the hypopharynx|recurrent squamous cell carcinoma of the hypopharynx
840417|NCT00002506|recurrent squamous cell carcinoma of the larynx|recurrent squamous cell carcinoma of the larynx
840418|NCT00002506|recurrent squamous cell carcinoma of the paranasal sinus and nasal cavity|recurrent squamous cell carcinoma of the paranasal sinus and nasal cavity
840419|NCT00002504|stage IV adult Hodgkin lymphoma|stage iv adult hodgkin lymphoma
840420|NCT00002504|monoclonal gammopathy of undetermined significance|monoclonal gammopathy of undetermined significance
840421|NCT00002504|recurrent adult Hodgkin lymphoma|recurrent adult hodgkin lymphoma
840422|NCT00002504|isolated plasmacytoma of bone|isolated plasmacytoma of bone
840423|NCT00002504|extramedullary plasmacytoma|extramedullary plasmacytoma
840424|NCT00002504|refractory multiple myeloma|refractory multiple myeloma
840425|NCT00002504|Waldenstrom macroglobulinemia|waldenstrom macroglobulinemia
840426|NCT00002504|stage IV chronic lymphocytic leukemia|stage iv chronic lymphocytic leukemia
840427|NCT00002504|recurrent adult acute myeloid leukemia|recurrent adult acute myeloid leukemia
840428|NCT00002504|recurrent adult acute lymphoblastic leukemia|recurrent adult acute lymphoblastic leukemia
840429|NCT00002504|relapsing chronic myelogenous leukemia|relapsing chronic myelogenous leukemia
840430|NCT00002504|refractory chronic lymphocytic leukemia|refractory chronic lymphocytic leukemia
840431|NCT00002504|unspecified adult solid tumor, protocol specific|unspecified adult solid tumor, protocol specific
840432|NCT00002504|chronic phase chronic myelogenous leukemia|chronic phase chronic myelogenous leukemia
840433|NCT00002504|accelerated phase chronic myelogenous leukemia|accelerated phase chronic myelogenous leukemia
840434|NCT00002504|blastic phase chronic myelogenous leukemia|blastic phase chronic myelogenous leukemia
840435|NCT00002504|meningeal chronic myelogenous leukemia|meningeal chronic myelogenous leukemia
840436|NCT00002504|untreated adult acute lymphoblastic leukemia|untreated adult acute lymphoblastic leukemia
840437|NCT00002504|untreated adult acute myeloid leukemia|untreated adult acute myeloid leukemia
840438|NCT00002504|adult acute myeloid leukemia in remission|adult acute myeloid leukemia in remission
840439|NCT00002504|adult acute lymphoblastic leukemia in remission|adult acute lymphoblastic leukemia in remission
840440|NCT00002504|polycythemia vera|polycythemia vera
840441|NCT00002504|chronic idiopathic myelofibrosis|chronic idiopathic myelofibrosis
840442|NCT00002504|essential thrombocythemia|essential thrombocythemia
840443|NCT00002504|untreated hairy cell leukemia|untreated hairy cell leukemia
840444|NCT00002504|progressive hairy cell leukemia, initial treatment|progressive hairy cell leukemia, initial treatment
840445|NCT00002504|refractory hairy cell leukemia|refractory hairy cell leukemia
840446|NCT00002504|chronic myelomonocytic leukemia|chronic myelomonocytic leukemia
840447|NCT00002504|T-cell large granular lymphocyte leukemia|t-cell large granular lymphocyte leukemia
840448|NCT00002504|acute undifferentiated leukemia|acute undifferentiated leukemia
840449|NCT00002504|stage IV grade 1 follicular lymphoma|stage iv grade 1 follicular lymphoma
840450|NCT00002504|stage IV grade 2 follicular lymphoma|stage iv grade 2 follicular lymphoma
840451|NCT00002504|stage IV grade 3 follicular lymphoma|stage iv grade 3 follicular lymphoma
840452|NCT00002504|stage IV adult diffuse small cleaved cell lymphoma|stage iv adult diffuse small cleaved cell lymphoma
840453|NCT00002504|stage IV adult diffuse mixed cell lymphoma|stage iv adult diffuse mixed cell lymphoma
840454|NCT00002504|stage IV adult diffuse large cell lymphoma|stage iv adult diffuse large cell lymphoma
840455|NCT00002504|stage IV adult immunoblastic large cell lymphoma|stage iv adult immunoblastic large cell lymphoma
840456|NCT00002504|stage IV adult lymphoblastic lymphoma|stage iv adult lymphoblastic lymphoma
840457|NCT00002504|stage IV adult Burkitt lymphoma|stage iv adult burkitt lymphoma
840458|NCT00002504|recurrent grade 1 follicular lymphoma|recurrent grade 1 follicular lymphoma
840459|NCT00002504|recurrent grade 2 follicular lymphoma|recurrent grade 2 follicular lymphoma
840460|NCT00002504|recurrent grade 3 follicular lymphoma|recurrent grade 3 follicular lymphoma
840461|NCT00002504|recurrent adult diffuse small cleaved cell lymphoma|recurrent adult diffuse small cleaved cell lymphoma
840462|NCT00002504|recurrent adult diffuse mixed cell lymphoma|recurrent adult diffuse mixed cell lymphoma
840463|NCT00002504|recurrent adult diffuse large cell lymphoma|recurrent adult diffuse large cell lymphoma
840464|NCT00002504|recurrent adult immunoblastic large cell lymphoma|recurrent adult immunoblastic large cell lymphoma
840465|NCT00002504|recurrent adult lymphoblastic lymphoma|recurrent adult lymphoblastic lymphoma
840466|NCT00002504|recurrent adult Burkitt lymphoma|recurrent adult burkitt lymphoma
840467|NCT00002504|stage IV adult T-cell leukemia/lymphoma|stage iv adult t-cell leukemia/lymphoma
840468|NCT00002504|recurrent adult T-cell leukemia/lymphoma|recurrent adult t-cell leukemia/lymphoma
840469|NCT00002504|secondary acute myeloid leukemia|secondary acute myeloid leukemia
840470|NCT00002504|de novo myelodysplastic syndromes|de novo myelodysplastic syndromes
840471|NCT00002504|previously treated myelodysplastic syndromes|previously treated myelodysplastic syndromes
840472|NCT00002504|secondary myelodysplastic syndromes|secondary myelodysplastic syndromes
840473|NCT00002504|prolymphocytic leukemia|prolymphocytic leukemia
840474|NCT00002504|primary systemic amyloidosis|primary systemic amyloidosis
840475|NCT00002504|stage IV mantle cell lymphoma|stage iv mantle cell lymphoma
840476|NCT00002504|recurrent mantle cell lymphoma|recurrent mantle cell lymphoma
840477|NCT00002504|angioimmunoblastic T-cell lymphoma|angioimmunoblastic t-cell lymphoma
840478|NCT00002504|anaplastic large cell lymphoma|anaplastic large cell lymphoma
840479|NCT00002504|recurrent marginal zone lymphoma|recurrent marginal zone lymphoma
840480|NCT00002504|recurrent small lymphocytic lymphoma|recurrent small lymphocytic lymphoma
840481|NCT00002504|stage IV small lymphocytic lymphoma|stage iv small lymphocytic lymphoma
840482|NCT00002504|stage IV marginal zone lymphoma|stage iv marginal zone lymphoma
840483|NCT00002504|extranodal marginal zone B-cell lymphoma of mucosa-associated lymphoid tissue|extranodal marginal zone b-cell lymphoma of mucosa-associated lymphoid tissue
840484|NCT00002504|nodal marginal zone B-cell lymphoma|nodal marginal zone b-cell lymphoma
840485|NCT00002504|splenic marginal zone lymphoma|splenic marginal zone lymphoma
840486|NCT00002462|stage III adult Hodgkin lymphoma|stage iii adult hodgkin lymphoma
840487|NCT00002462|stage IV adult Hodgkin lymphoma|stage iv adult hodgkin lymphoma
840488|NCT00088231|Acute Myelogenous Leukemia (AML)|acute myelogenous leukemia (aml)
840489|NCT00088231|Agnogenic Myeloid Metaplasia (AMM)|agnogenic myeloid metaplasia (amm)
840490|NCT00088231|Chronic Myelogenous Leukemia-Blastic Phase (CML-BP)|chronic myelogenous leukemia-blastic phase (cml-bp)
840491|NCT00088218|Acute Myeloid Leukemia|acute myeloid leukemia
840493|NCT00088218|High-Risk Myelodysplastic Syndrome|high-risk myelodysplastic syndrome
840494|NCT00088218|MDS|mds
840495|NCT00088218|Clofarabine|clofarabine
840496|NCT00088218|Cytarabine|cytarabine
840497|NCT00088218|ara-C|ara-c
840498|NCT00088179|CABG|cabg
840499|NCT00088179|CPB|cpb
840500|NCT00087997|sarcoma|sarcoma
840502|NCT00088192|Age-Related Macular Degeneration|age-related macular degeneration
840503|NCT00088192|Exudative Subfoveal Age Related Macular Degeneration with Subfoveal Choroidal Neovascularization|exudative subfoveal age related macular degeneration with subfoveal choroidal neovascularization
840504|NCT00088166|peritumoral brain edema|peritumoral brain edema
840505|NCT00088166|edema|edema
840506|NCT00088166|malignant brain tumor|malignant brain tumor
840507|NCT00088166|astrocytoma|astrocytoma
840508|NCT00088166|brain tumor|brain tumor
840509|NCT00088166|dexamethasone|dexamethasone
840510|NCT00088166|Decadron|decadron
840511|NCT00003884|hypercalcemia of malignancy|hypercalcemia of malignancy
840512|NCT00003884|pain|pain
840513|NCT00003884|recurrent non-small cell lung cancer|recurrent non-small cell lung cancer
840514|NCT00003884|recurrent small cell lung cancer|recurrent small cell lung cancer
840515|NCT00003884|unspecified adult solid tumor, protocol specific|unspecified adult solid tumor, protocol specific
840516|NCT00003884|bone metastases|bone metastases
840517|NCT00003812|limited stage small cell lung cancer|limited stage small cell lung cancer
840518|NCT00003808|stage 0 chronic lymphocytic leukemia|stage 0 chronic lymphocytic leukemia
840519|NCT00003808|stage I chronic lymphocytic leukemia|stage i chronic lymphocytic leukemia
840520|NCT00003808|stage II chronic lymphocytic leukemia|stage ii chronic lymphocytic leukemia
840521|NCT00003808|B-cell chronic lymphocytic leukemia|b-cell chronic lymphocytic leukemia
840522|NCT00003781|adenocarcinoma of the prostate|adenocarcinoma of the prostate
840523|NCT00003781|stage IV prostate cancer|stage iv prostate cancer
840524|NCT00003781|recurrent prostate cancer|recurrent prostate cancer
840525|NCT00003781|pain|pain
840526|NCT00003763|stage I ovarian epithelial cancer|stage i ovarian epithelial cancer
840527|NCT00003763|stage II ovarian epithelial cancer|stage ii ovarian epithelial cancer
840528|NCT00003763|stage III ovarian epithelial cancer|stage iii ovarian epithelial cancer
840529|NCT00003763|stage IV ovarian epithelial cancer|stage iv ovarian epithelial cancer
840530|NCT00003763|recurrent ovarian epithelial cancer|recurrent ovarian epithelial cancer
840531|NCT00003763|ovarian stromal cancer|ovarian stromal cancer
840532|NCT00003763|stage I ovarian germ cell tumor|stage i ovarian germ cell tumor
840533|NCT00003763|stage II ovarian germ cell tumor|stage ii ovarian germ cell tumor
840534|NCT00003763|stage III ovarian germ cell tumor|stage iii ovarian germ cell tumor
840535|NCT00003763|stage IV ovarian germ cell tumor|stage iv ovarian germ cell tumor
840536|NCT00003763|recurrent ovarian germ cell tumor|recurrent ovarian germ cell tumor
840537|NCT00003763|borderline ovarian surface epithelial-stromal tumor|borderline ovarian surface epithelial-stromal tumor
840538|NCT00003763|ovarian sarcoma|ovarian sarcoma
840539|NCT00003748|stage I gastric cancer|stage i gastric cancer
840540|NCT00003748|stage II gastric cancer|stage ii gastric cancer
840541|NCT00003748|stage III gastric cancer|stage iii gastric cancer
840542|NCT00003748|stage IV gastric cancer|stage iv gastric cancer
840543|NCT00003748|recurrent gastric cancer|recurrent gastric cancer
840544|NCT00003748|stage I esophageal cancer|stage i esophageal cancer
840545|NCT00003748|stage II esophageal cancer|stage ii esophageal cancer
840546|NCT00003748|stage III esophageal cancer|stage iii esophageal cancer
840547|NCT00003748|stage IV esophageal cancer|stage iv esophageal cancer
840548|NCT00003748|recurrent esophageal cancer|recurrent esophageal cancer
840549|NCT00003748|adenocarcinoma of the stomach|adenocarcinoma of the stomach
840550|NCT00003748|adenocarcinoma of the esophagus|adenocarcinoma of the esophagus
840551|NCT00003725|stage 0 bladder cancer|stage 0 bladder cancer
840552|NCT00003725|stage I bladder cancer|stage i bladder cancer
840553|NCT00003725|recurrent bladder cancer|recurrent bladder cancer
840554|NCT00003725|transitional cell carcinoma of the bladder|transitional cell carcinoma of the bladder
840555|NCT00003677|recurrent pancreatic cancer|recurrent pancreatic cancer
840556|NCT00003677|adenocarcinoma of the pancreas|adenocarcinoma of the pancreas
840557|NCT00003677|stage IV pancreatic cancer|stage iv pancreatic cancer
840558|NCT00003675|refractory anemia|refractory anemia
840559|NCT00003675|refractory anemia with ringed sideroblasts|refractory anemia with ringed sideroblasts
840560|NCT00003675|refractory anemia with excess blasts|refractory anemia with excess blasts
840561|NCT00003675|refractory anemia with excess blasts in transformation|refractory anemia with excess blasts in transformation
840562|NCT00003675|chronic myelomonocytic leukemia|chronic myelomonocytic leukemia
840563|NCT00003675|de novo myelodysplastic syndromes|de novo myelodysplastic syndromes
840564|NCT00003675|secondary myelodysplastic syndromes|secondary myelodysplastic syndromes
840565|NCT00003675|refractory cytopenia with multilineage dysplasia|refractory cytopenia with multilineage dysplasia
840566|NCT00003675|childhood myelodysplastic syndromes|childhood myelodysplastic syndromes
840567|NCT00003585|stage IV renal cell cancer|stage iv renal cell cancer
840568|NCT00003585|recurrent renal cell cancer|recurrent renal cell cancer
840569|NCT00003557|advanced adult primary liver cancer|advanced adult primary liver cancer
840570|NCT00003557|recurrent adult primary liver cancer|recurrent adult primary liver cancer
840571|NCT00003557|unresectable gallbladder cancer|unresectable gallbladder cancer
840572|NCT00003557|recurrent gallbladder cancer|recurrent gallbladder cancer
840573|NCT00003557|unresectable extrahepatic bile duct cancer|unresectable extrahepatic bile duct cancer
840574|NCT00003557|recurrent extrahepatic bile duct cancer|recurrent extrahepatic bile duct cancer
840575|NCT00003557|adult primary hepatocellular carcinoma|adult primary hepatocellular carcinoma
840576|NCT00003557|cholangiocarcinoma of the gallbladder|cholangiocarcinoma of the gallbladder
840577|NCT00003392|stage IV breast cancer|stage iv breast cancer
840578|NCT00003392|recurrent breast cancer|recurrent breast cancer
840579|NCT00003391|adenocarcinoma of the prostate|adenocarcinoma of the prostate
840580|NCT00003391|stage IV prostate cancer|stage iv prostate cancer
840581|NCT00003391|recurrent prostate cancer|recurrent prostate cancer
840582|NCT00003267|stage I cervical cancer|stage i cervical cancer
840583|NCT00003267|stage II cervical cancer|stage ii cervical cancer
840584|NCT00003267|stage I vaginal cancer|stage i vaginal cancer
840585|NCT00003267|stage II vaginal cancer|stage ii vaginal cancer
840586|NCT00003267|stage I endometrial carcinoma|stage i endometrial carcinoma
840587|NCT00003267|stage II endometrial carcinoma|stage ii endometrial carcinoma
840588|NCT00003267|infection|infection
840589|NCT00003267|perioperative/postoperative complications|perioperative/postoperative complications
840590|NCT00088153|Anorexia Nervosa|anorexia nervosa
840591|NCT00088153|Amenorrhea|amenorrhea
840592|NCT00088153|Bone Mass|bone mass
840593|NCT00088153|Growth hormone|growth hormone
840594|NCT00088101|Hematological Malignancies|hematological malignancies
840595|NCT00088101|Leukemia|leukemia
840596|NCT00088101|Lymphoma|lymphoma
840597|NCT00088101|Metastatic|metastatic
840598|NCT00088101|Unresectable solid tumors|unresectable solid tumors
840599|NCT00088075|Schizophrenia|schizophrenia
840600|NCT00088075|Risperidone|risperidone
840601|NCT00088075|Adolescents|adolescents
840602|NCT00088062|Crohn's Disease|crohn's disease
840603|NCT00003238|recurrent prostate cancer|recurrent prostate cancer
840604|NCT00003225|stage IV colon cancer|stage iv colon cancer
840605|NCT00003225|stage IV rectal cancer|stage iv rectal cancer
840606|NCT00003225|recurrent colon cancer|recurrent colon cancer
840607|NCT00003225|recurrent rectal cancer|recurrent rectal cancer
840608|NCT00088023|Solid tumors|solid tumors
840609|NCT00087984|Kidney cancer|kidney cancer
840610|NCT00087984|Renal cancer|renal cancer
840611|NCT00087958|Metastatic breast cancer|metastatic breast cancer
840612|NCT00087945|Treatment Experienced|treatment experienced
840613|NCT00087880|smoking cessation|smoking cessation
840614|NCT00087867|Multiple Myeloma|multiple myeloma
840615|NCT00087867|SCIO-469|scio-469
840616|NCT00087867|p38 MAP kinase|p38 map kinase
840617|NCT00087867|myeloma|myeloma
840618|NCT00087867|bone marrow|bone marrow
840619|NCT00005996|unspecified adult solid tumor, protocol specific|unspecified adult solid tumor, protocol specific
840620|NCT00005806|recurrent non-small cell lung cancer|recurrent non-small cell lung cancer
840621|NCT00005806|stage IIIA non-small cell lung cancer|stage iiia non-small cell lung cancer
840622|NCT00005806|stage IIIB non-small cell lung cancer|stage iiib non-small cell lung cancer
840623|NCT00005806|stage IV non-small cell lung cancer|stage iv non-small cell lung cancer
840624|NCT00005632|recurrent prostate cancer|recurrent prostate cancer
840695|NCT00003082|chronic phase chronic myelogenous leukemia|chronic phase chronic myelogenous leukemia
840625|NCT00005619|progressive hairy cell leukemia, initial treatment|progressive hairy cell leukemia, initial treatment
840626|NCT00005619|refractory hairy cell leukemia|refractory hairy cell leukemia
840627|NCT00005042|AIDS-related Kaposi sarcoma|aids-related kaposi sarcoma
840628|NCT00005042|recurrent Kaposi sarcoma|recurrent kaposi sarcoma
840629|NCT00005029|recurrent ovarian epithelial cancer|recurrent ovarian epithelial cancer
840630|NCT00005029|primary peritoneal cavity cancer|primary peritoneal cavity cancer
840631|NCT00004199|recurrent non-small cell lung cancer|recurrent non-small cell lung cancer
840632|NCT00004199|stage IV non-small cell lung cancer|stage iv non-small cell lung cancer
855766|NCT00071734|fMRI|fmri
840633|NCT00004164|stage II nasopharyngeal cancer|stage ii nasopharyngeal cancer
840634|NCT00004164|stage III nasopharyngeal cancer|stage iii nasopharyngeal cancer
840635|NCT00004164|stage IV nasopharyngeal cancer|stage iv nasopharyngeal cancer
840636|NCT00004160|stage IIIA non-small cell lung cancer|stage iiia non-small cell lung cancer
840637|NCT00004160|stage IIIB non-small cell lung cancer|stage iiib non-small cell lung cancer
840638|NCT00004158|refractory multiple myeloma|refractory multiple myeloma
840639|NCT00004158|stage I multiple myeloma|stage i multiple myeloma
840640|NCT00004158|stage II multiple myeloma|stage ii multiple myeloma
840641|NCT00004158|stage III multiple myeloma|stage iii multiple myeloma
840642|NCT00004104|stage III melanoma|stage iii melanoma
840643|NCT00004060|stage III ovarian epithelial cancer|stage iii ovarian epithelial cancer
840644|NCT00004060|stage IV ovarian epithelial cancer|stage iv ovarian epithelial cancer
840645|NCT00004060|recurrent ovarian epithelial cancer|recurrent ovarian epithelial cancer
840646|NCT00004060|fallopian tube cancer|fallopian tube cancer
840647|NCT00004060|primary peritoneal cavity cancer|primary peritoneal cavity cancer
840648|NCT00004047|recurrent childhood acute lymphoblastic leukemia|recurrent childhood acute lymphoblastic leukemia
840649|NCT00004047|recurrent childhood acute myeloid leukemia|recurrent childhood acute myeloid leukemia
840650|NCT00004047|recurrent adult acute myeloid leukemia|recurrent adult acute myeloid leukemia
840651|NCT00004047|recurrent adult acute lymphoblastic leukemia|recurrent adult acute lymphoblastic leukemia
840652|NCT00004047|relapsing chronic myelogenous leukemia|relapsing chronic myelogenous leukemia
840653|NCT00004047|refractory chronic lymphocytic leukemia|refractory chronic lymphocytic leukemia
840654|NCT00004047|blastic phase chronic myelogenous leukemia|blastic phase chronic myelogenous leukemia
840655|NCT00004047|refractory anemia with excess blasts|refractory anemia with excess blasts
840656|NCT00004047|refractory anemia with excess blasts in transformation|refractory anemia with excess blasts in transformation
840657|NCT00004047|chronic myelomonocytic leukemia|chronic myelomonocytic leukemia
840658|NCT00004047|childhood myelodysplastic syndromes|childhood myelodysplastic syndromes
840659|NCT00004041|recurrent adult brain tumor|recurrent adult brain tumor
840660|NCT00004041|adult glioblastoma|adult glioblastoma
840661|NCT00004041|adult anaplastic astrocytoma|adult anaplastic astrocytoma
840662|NCT00004041|adult anaplastic oligodendroglioma|adult anaplastic oligodendroglioma
840663|NCT00004041|adult mixed glioma|adult mixed glioma
840664|NCT00004041|adult giant cell glioblastoma|adult giant cell glioblastoma
840665|NCT00004041|adult gliosarcoma|adult gliosarcoma
840666|NCT00003881|recurrent non-small cell lung cancer|recurrent non-small cell lung cancer
840667|NCT00003881|stage IIIB non-small cell lung cancer|stage iiib non-small cell lung cancer
840668|NCT00003881|stage IV non-small cell lung cancer|stage iv non-small cell lung cancer
840669|NCT00003219|stage IV breast cancer|stage iv breast cancer
840670|NCT00003219|recurrent breast cancer|recurrent breast cancer
840671|NCT00003171|refractory anemia|refractory anemia
840672|NCT00003171|refractory anemia with ringed sideroblasts|refractory anemia with ringed sideroblasts
840673|NCT00003171|refractory anemia with excess blasts|refractory anemia with excess blasts
840674|NCT00003171|refractory anemia with excess blasts in transformation|refractory anemia with excess blasts in transformation
840675|NCT00003171|chronic myelomonocytic leukemia|chronic myelomonocytic leukemia
840676|NCT00003171|de novo myelodysplastic syndromes|de novo myelodysplastic syndromes
840677|NCT00003171|previously treated myelodysplastic syndromes|previously treated myelodysplastic syndromes
840678|NCT00003171|secondary myelodysplastic syndromes|secondary myelodysplastic syndromes
840679|NCT00003082|stage III adult Hodgkin lymphoma|stage iii adult hodgkin lymphoma
840680|NCT00003082|stage IV adult Hodgkin lymphoma|stage iv adult hodgkin lymphoma
840681|NCT00003082|monoclonal gammopathy of undetermined significance|monoclonal gammopathy of undetermined significance
840682|NCT00003082|recurrent adult Hodgkin lymphoma|recurrent adult hodgkin lymphoma
840683|NCT00003082|isolated plasmacytoma of bone|isolated plasmacytoma of bone
840684|NCT00003082|extramedullary plasmacytoma|extramedullary plasmacytoma
840685|NCT00003082|refractory multiple myeloma|refractory multiple myeloma
840686|NCT00003082|Waldenstrom macroglobulinemia|waldenstrom macroglobulinemia
840687|NCT00003082|stage III multiple myeloma|stage iii multiple myeloma
840688|NCT00003082|stage III chronic lymphocytic leukemia|stage iii chronic lymphocytic leukemia
840689|NCT00003082|stage IV chronic lymphocytic leukemia|stage iv chronic lymphocytic leukemia
840690|NCT00003082|recurrent adult acute myeloid leukemia|recurrent adult acute myeloid leukemia
840691|NCT00003082|recurrent adult acute lymphoblastic leukemia|recurrent adult acute lymphoblastic leukemia
840692|NCT00003082|relapsing chronic myelogenous leukemia|relapsing chronic myelogenous leukemia
840693|NCT00003082|refractory chronic lymphocytic leukemia|refractory chronic lymphocytic leukemia
840694|NCT00003082|unspecified adult solid tumor, protocol specific|unspecified adult solid tumor, protocol specific
855447|NCT00072657|Meditation|meditation
840696|NCT00003082|accelerated phase chronic myelogenous leukemia|accelerated phase chronic myelogenous leukemia
840697|NCT00003082|blastic phase chronic myelogenous leukemia|blastic phase chronic myelogenous leukemia
840698|NCT00003082|meningeal chronic myelogenous leukemia|meningeal chronic myelogenous leukemia
840699|NCT00003082|untreated adult acute lymphoblastic leukemia|untreated adult acute lymphoblastic leukemia
840700|NCT00003082|untreated adult acute myeloid leukemia|untreated adult acute myeloid leukemia
840701|NCT00003082|adult acute myeloid leukemia in remission|adult acute myeloid leukemia in remission
840702|NCT00003082|adult acute lymphoblastic leukemia in remission|adult acute lymphoblastic leukemia in remission
840703|NCT00003082|polycythemia vera|polycythemia vera
840704|NCT00003082|chronic idiopathic myelofibrosis|chronic idiopathic myelofibrosis
840705|NCT00003082|essential thrombocythemia|essential thrombocythemia
840706|NCT00003082|untreated hairy cell leukemia|untreated hairy cell leukemia
840707|NCT00003082|progressive hairy cell leukemia, initial treatment|progressive hairy cell leukemia, initial treatment
840708|NCT00003082|refractory hairy cell leukemia|refractory hairy cell leukemia
840709|NCT00003082|chronic myelomonocytic leukemia|chronic myelomonocytic leukemia
841277|NCT00086645|Autism|autism
840710|NCT00003082|T-cell large granular lymphocyte leukemia|t-cell large granular lymphocyte leukemia
840711|NCT00003082|acute undifferentiated leukemia|acute undifferentiated leukemia
840712|NCT00003082|stage III grade 1 follicular lymphoma|stage iii grade 1 follicular lymphoma
840713|NCT00003082|stage III grade 2 follicular lymphoma|stage iii grade 2 follicular lymphoma
840714|NCT00003082|stage III grade 3 follicular lymphoma|stage iii grade 3 follicular lymphoma
840715|NCT00003082|stage III adult diffuse small cleaved cell lymphoma|stage iii adult diffuse small cleaved cell lymphoma
840716|NCT00003082|stage III adult diffuse mixed cell lymphoma|stage iii adult diffuse mixed cell lymphoma
840717|NCT00003082|stage III adult diffuse large cell lymphoma|stage iii adult diffuse large cell lymphoma
840718|NCT00003082|stage III adult immunoblastic large cell lymphoma|stage iii adult immunoblastic large cell lymphoma
840719|NCT00003082|stage III adult lymphoblastic lymphoma|stage iii adult lymphoblastic lymphoma
840720|NCT00003082|stage III adult Burkitt lymphoma|stage iii adult burkitt lymphoma
840721|NCT00003082|stage IV grade 1 follicular lymphoma|stage iv grade 1 follicular lymphoma
840722|NCT00003082|stage IV grade 2 follicular lymphoma|stage iv grade 2 follicular lymphoma
840723|NCT00003082|stage IV grade 3 follicular lymphoma|stage iv grade 3 follicular lymphoma
840724|NCT00003082|stage IV adult diffuse small cleaved cell lymphoma|stage iv adult diffuse small cleaved cell lymphoma
840725|NCT00003082|stage IV adult diffuse mixed cell lymphoma|stage iv adult diffuse mixed cell lymphoma
840726|NCT00003082|stage IV adult diffuse large cell lymphoma|stage iv adult diffuse large cell lymphoma
840727|NCT00003082|stage IV adult immunoblastic large cell lymphoma|stage iv adult immunoblastic large cell lymphoma
840728|NCT00003082|stage IV adult lymphoblastic lymphoma|stage iv adult lymphoblastic lymphoma
840729|NCT00003082|stage IV adult Burkitt lymphoma|stage iv adult burkitt lymphoma
840730|NCT00003082|recurrent grade 1 follicular lymphoma|recurrent grade 1 follicular lymphoma
840731|NCT00003082|recurrent grade 2 follicular lymphoma|recurrent grade 2 follicular lymphoma
840732|NCT00003082|recurrent grade 3 follicular lymphoma|recurrent grade 3 follicular lymphoma
840733|NCT00003082|recurrent adult diffuse small cleaved cell lymphoma|recurrent adult diffuse small cleaved cell lymphoma
840734|NCT00003082|recurrent adult diffuse mixed cell lymphoma|recurrent adult diffuse mixed cell lymphoma
840735|NCT00003082|recurrent adult diffuse large cell lymphoma|recurrent adult diffuse large cell lymphoma
840736|NCT00003082|recurrent adult immunoblastic large cell lymphoma|recurrent adult immunoblastic large cell lymphoma
840737|NCT00003082|recurrent adult lymphoblastic lymphoma|recurrent adult lymphoblastic lymphoma
840738|NCT00003082|recurrent adult Burkitt lymphoma|recurrent adult burkitt lymphoma
840739|NCT00003082|stage III adult T-cell leukemia/lymphoma|stage iii adult t-cell leukemia/lymphoma
840740|NCT00003082|stage IV adult T-cell leukemia/lymphoma|stage iv adult t-cell leukemia/lymphoma
840741|NCT00003082|recurrent adult T-cell leukemia/lymphoma|recurrent adult t-cell leukemia/lymphoma
840742|NCT00003082|secondary acute myeloid leukemia|secondary acute myeloid leukemia
840743|NCT00003082|de novo myelodysplastic syndromes|de novo myelodysplastic syndromes
840744|NCT00003082|previously treated myelodysplastic syndromes|previously treated myelodysplastic syndromes
840745|NCT00003082|secondary myelodysplastic syndromes|secondary myelodysplastic syndromes
840746|NCT00003082|prolymphocytic leukemia|prolymphocytic leukemia
840747|NCT00003082|AIDS-related peripheral/systemic lymphoma|aids-related peripheral/systemic lymphoma
840748|NCT00003082|AIDS-related primary CNS lymphoma|aids-related primary cns lymphoma
840749|NCT00003082|primary systemic amyloidosis|primary systemic amyloidosis
840750|NCT00003082|stage III mantle cell lymphoma|stage iii mantle cell lymphoma
840751|NCT00003082|stage IV mantle cell lymphoma|stage iv mantle cell lymphoma
840752|NCT00003082|recurrent mantle cell lymphoma|recurrent mantle cell lymphoma
840753|NCT00003082|angioimmunoblastic T-cell lymphoma|angioimmunoblastic t-cell lymphoma
840754|NCT00003082|anaplastic large cell lymphoma|anaplastic large cell lymphoma
840755|NCT00003082|recurrent marginal zone lymphoma|recurrent marginal zone lymphoma
840756|NCT00003082|recurrent small lymphocytic lymphoma|recurrent small lymphocytic lymphoma
840757|NCT00003082|stage III small lymphocytic lymphoma|stage iii small lymphocytic lymphoma
840758|NCT00003082|stage III marginal zone lymphoma|stage iii marginal zone lymphoma
840759|NCT00003082|stage IV small lymphocytic lymphoma|stage iv small lymphocytic lymphoma
840760|NCT00003082|stage IV marginal zone lymphoma|stage iv marginal zone lymphoma
855448|NCT00072657|Tai Chi|tai chi
840761|NCT00003082|extranodal marginal zone B-cell lymphoma of mucosa-associated lymphoid tissue|extranodal marginal zone b-cell lymphoma of mucosa-associated lymphoid tissue
840762|NCT00003082|nodal marginal zone B-cell lymphoma|nodal marginal zone b-cell lymphoma
840763|NCT00003082|splenic marginal zone lymphoma|splenic marginal zone lymphoma
840764|NCT00003057|colon cancer|colon cancer
840765|NCT00003057|rectal cancer|rectal cancer
840766|NCT00003057|diarrhea|diarrhea
840767|NCT00002998|stage IV breast cancer|stage iv breast cancer
840768|NCT00002998|recurrent breast cancer|recurrent breast cancer
841024|NCT00087841|Embolization, Therapeutic|embolization, therapeutic
840769|NCT00002994|unspecified adult solid tumor, protocol specific|unspecified adult solid tumor, protocol specific
840770|NCT00002956|recurrent adult Hodgkin lymphoma|recurrent adult hodgkin lymphoma
840771|NCT00002956|recurrent childhood lymphoblastic lymphoma|recurrent childhood lymphoblastic lymphoma
840772|NCT00002956|childhood diffuse large cell lymphoma|childhood diffuse large cell lymphoma
840773|NCT00002956|childhood immunoblastic large cell lymphoma|childhood immunoblastic large cell lymphoma
840774|NCT00002956|recurrent/refractory childhood Hodgkin lymphoma|recurrent/refractory childhood hodgkin lymphoma
840775|NCT00002956|T-cell large granular lymphocyte leukemia|t-cell large granular lymphocyte leukemia
840776|NCT00002956|recurrent grade 1 follicular lymphoma|recurrent grade 1 follicular lymphoma
840777|NCT00002956|recurrent grade 2 follicular lymphoma|recurrent grade 2 follicular lymphoma
840778|NCT00002956|recurrent grade 3 follicular lymphoma|recurrent grade 3 follicular lymphoma
840779|NCT00002956|recurrent adult diffuse small cleaved cell lymphoma|recurrent adult diffuse small cleaved cell lymphoma
840780|NCT00002956|recurrent adult diffuse mixed cell lymphoma|recurrent adult diffuse mixed cell lymphoma
840781|NCT00002956|recurrent adult diffuse large cell lymphoma|recurrent adult diffuse large cell lymphoma
840782|NCT00002956|recurrent adult immunoblastic large cell lymphoma|recurrent adult immunoblastic large cell lymphoma
840783|NCT00002956|recurrent adult lymphoblastic lymphoma|recurrent adult lymphoblastic lymphoma
840784|NCT00002956|recurrent adult Burkitt lymphoma|recurrent adult burkitt lymphoma
840785|NCT00002956|recurrent childhood small noncleaved cell lymphoma|recurrent childhood small noncleaved cell lymphoma
840786|NCT00002956|recurrent childhood large cell lymphoma|recurrent childhood large cell lymphoma
840787|NCT00002956|recurrent mantle cell lymphoma|recurrent mantle cell lymphoma
840788|NCT00002956|recurrent marginal zone lymphoma|recurrent marginal zone lymphoma
840789|NCT00002956|recurrent small lymphocytic lymphoma|recurrent small lymphocytic lymphoma
840790|NCT00002956|extranodal marginal zone B-cell lymphoma of mucosa-associated lymphoid tissue|extranodal marginal zone b-cell lymphoma of mucosa-associated lymphoid tissue
840791|NCT00002956|nodal marginal zone B-cell lymphoma|nodal marginal zone b-cell lymphoma
840792|NCT00002956|splenic marginal zone lymphoma|splenic marginal zone lymphoma
840793|NCT00002925|untreated adult acute myeloid leukemia|untreated adult acute myeloid leukemia
840794|NCT00002925|adult acute erythroid leukemia (M6)|adult acute erythroid leukemia (m6)
840795|NCT00002925|adult acute myeloblastic leukemia without maturation (M1)|adult acute myeloblastic leukemia without maturation (m1)
840796|NCT00002925|adult acute myeloblastic leukemia with maturation (M2)|adult acute myeloblastic leukemia with maturation (m2)
840797|NCT00002925|adult acute myelomonocytic leukemia (M4)|adult acute myelomonocytic leukemia (m4)
840798|NCT00002925|adult acute monoblastic leukemia (M5a)|adult acute monoblastic leukemia (m5a)
840799|NCT00002925|adult acute megakaryoblastic leukemia (M7)|adult acute megakaryoblastic leukemia (m7)
840800|NCT00002925|adult acute monocytic leukemia (M5b)|adult acute monocytic leukemia (m5b)
840801|NCT00002925|adult acute minimally differentiated myeloid leukemia (M0)|adult acute minimally differentiated myeloid leukemia (m0)
840802|NCT00002908|refractory chronic lymphocytic leukemia|refractory chronic lymphocytic leukemia
840803|NCT00002908|recurrent small lymphocytic lymphoma|recurrent small lymphocytic lymphoma
840804|NCT00002908|recurrent grade 1 follicular lymphoma|recurrent grade 1 follicular lymphoma
840805|NCT00002908|recurrent grade 2 follicular lymphoma|recurrent grade 2 follicular lymphoma
840806|NCT00002908|recurrent grade 3 follicular lymphoma|recurrent grade 3 follicular lymphoma
840807|NCT00002908|recurrent adult diffuse small cleaved cell lymphoma|recurrent adult diffuse small cleaved cell lymphoma
840808|NCT00002908|recurrent adult diffuse mixed cell lymphoma|recurrent adult diffuse mixed cell lymphoma
840809|NCT00002908|recurrent adult diffuse large cell lymphoma|recurrent adult diffuse large cell lymphoma
840810|NCT00002908|recurrent adult immunoblastic large cell lymphoma|recurrent adult immunoblastic large cell lymphoma
840811|NCT00002908|recurrent adult lymphoblastic lymphoma|recurrent adult lymphoblastic lymphoma
840812|NCT00002908|recurrent adult Burkitt lymphoma|recurrent adult burkitt lymphoma
840813|NCT00002908|recurrent mantle cell lymphoma|recurrent mantle cell lymphoma
840814|NCT00002908|recurrent marginal zone lymphoma|recurrent marginal zone lymphoma
840815|NCT00002908|extranodal marginal zone B-cell lymphoma of mucosa-associated lymphoid tissue|extranodal marginal zone b-cell lymphoma of mucosa-associated lymphoid tissue
840816|NCT00002908|nodal marginal zone B-cell lymphoma|nodal marginal zone b-cell lymphoma
840817|NCT00002908|splenic marginal zone lymphoma|splenic marginal zone lymphoma
840818|NCT00002907|refractory multiple myeloma|refractory multiple myeloma
840819|NCT00002862|stage IV adult Hodgkin lymphoma|stage iv adult hodgkin lymphoma
840820|NCT00002862|recurrent adult Hodgkin lymphoma|recurrent adult hodgkin lymphoma
840821|NCT00002862|unspecified adult solid tumor, protocol specific|unspecified adult solid tumor, protocol specific
840822|NCT00002862|stage IV grade 1 follicular lymphoma|stage iv grade 1 follicular lymphoma
840823|NCT00002862|stage IV grade 2 follicular lymphoma|stage iv grade 2 follicular lymphoma
840824|NCT00002862|stage IV grade 3 follicular lymphoma|stage iv grade 3 follicular lymphoma
840825|NCT00002862|stage IV adult diffuse small cleaved cell lymphoma|stage iv adult diffuse small cleaved cell lymphoma
840826|NCT00002862|stage IV adult diffuse mixed cell lymphoma|stage iv adult diffuse mixed cell lymphoma
840827|NCT00002862|stage IV adult diffuse large cell lymphoma|stage iv adult diffuse large cell lymphoma
840828|NCT00002862|stage IV adult immunoblastic large cell lymphoma|stage iv adult immunoblastic large cell lymphoma
840829|NCT00002862|stage IV adult lymphoblastic lymphoma|stage iv adult lymphoblastic lymphoma
840830|NCT00002862|stage IV adult Burkitt lymphoma|stage iv adult burkitt lymphoma
855950|NCT00071097|TMC114|tmc114
840831|NCT00002862|recurrent grade 1 follicular lymphoma|recurrent grade 1 follicular lymphoma
840832|NCT00002862|recurrent grade 2 follicular lymphoma|recurrent grade 2 follicular lymphoma
840833|NCT00002862|recurrent grade 3 follicular lymphoma|recurrent grade 3 follicular lymphoma
840834|NCT00002862|recurrent adult diffuse small cleaved cell lymphoma|recurrent adult diffuse small cleaved cell lymphoma
840835|NCT00002862|recurrent adult diffuse mixed cell lymphoma|recurrent adult diffuse mixed cell lymphoma
840836|NCT00002862|recurrent adult diffuse large cell lymphoma|recurrent adult diffuse large cell lymphoma
840837|NCT00002862|recurrent adult immunoblastic large cell lymphoma|recurrent adult immunoblastic large cell lymphoma
840838|NCT00002862|recurrent adult lymphoblastic lymphoma|recurrent adult lymphoblastic lymphoma
840839|NCT00002862|recurrent adult Burkitt lymphoma|recurrent adult burkitt lymphoma
840840|NCT00002862|stage IV adult T-cell leukemia/lymphoma|stage iv adult t-cell leukemia/lymphoma
840841|NCT00002862|recurrent adult T-cell leukemia/lymphoma|recurrent adult t-cell leukemia/lymphoma
840842|NCT00002862|stage IV mantle cell lymphoma|stage iv mantle cell lymphoma
840843|NCT00002862|recurrent mantle cell lymphoma|recurrent mantle cell lymphoma
840844|NCT00002862|angioimmunoblastic T-cell lymphoma|angioimmunoblastic t-cell lymphoma
840845|NCT00002862|anaplastic large cell lymphoma|anaplastic large cell lymphoma
840846|NCT00002862|recurrent marginal zone lymphoma|recurrent marginal zone lymphoma
840847|NCT00002862|recurrent small lymphocytic lymphoma|recurrent small lymphocytic lymphoma
840848|NCT00002862|stage IV small lymphocytic lymphoma|stage iv small lymphocytic lymphoma
840849|NCT00002862|stage IV marginal zone lymphoma|stage iv marginal zone lymphoma
840850|NCT00002862|extranodal marginal zone B-cell lymphoma of mucosa-associated lymphoid tissue|extranodal marginal zone b-cell lymphoma of mucosa-associated lymphoid tissue
840851|NCT00002862|nodal marginal zone B-cell lymphoma|nodal marginal zone b-cell lymphoma
840852|NCT00002862|splenic marginal zone lymphoma|splenic marginal zone lymphoma
840853|NCT00002763|stage III melanoma|stage iii melanoma
840854|NCT00002763|recurrent melanoma|recurrent melanoma
840855|NCT00002760|adenocarcinoma of the prostate|adenocarcinoma of the prostate
840856|NCT00002760|recurrent prostate cancer|recurrent prostate cancer
840857|NCT00002667|stage I non-small cell lung cancer|stage i non-small cell lung cancer
840858|NCT00002620|adult anaplastic astrocytoma|adult anaplastic astrocytoma
840859|NCT00002563|stage I adult Hodgkin lymphoma|stage i adult hodgkin lymphoma
840860|NCT00002563|stage II adult Hodgkin lymphoma|stage ii adult hodgkin lymphoma
840861|NCT00002563|psychosocial effects of cancer and its treatment|psychosocial effects of cancer and its treatment
840862|NCT00002557|stage III cutaneous T-cell non-Hodgkin lymphoma|stage iii cutaneous t-cell non-hodgkin lymphoma
840863|NCT00002557|stage IV cutaneous T-cell non-Hodgkin lymphoma|stage iv cutaneous t-cell non-hodgkin lymphoma
840864|NCT00002557|recurrent cutaneous T-cell non-Hodgkin lymphoma|recurrent cutaneous t-cell non-hodgkin lymphoma
840865|NCT00002549|untreated adult acute myeloid leukemia|untreated adult acute myeloid leukemia
840866|NCT00002549|adult acute erythroid leukemia (M6)|adult acute erythroid leukemia (m6)
840867|NCT00002549|adult acute myeloblastic leukemia without maturation (M1)|adult acute myeloblastic leukemia without maturation (m1)
840868|NCT00002549|adult acute myeloblastic leukemia with maturation (M2)|adult acute myeloblastic leukemia with maturation (m2)
840869|NCT00002549|adult acute myelomonocytic leukemia (M4)|adult acute myelomonocytic leukemia (m4)
840870|NCT00002549|adult acute monoblastic leukemia (M5a)|adult acute monoblastic leukemia (m5a)
840871|NCT00002549|adult acute megakaryoblastic leukemia (M7)|adult acute megakaryoblastic leukemia (m7)
840872|NCT00002549|secondary acute myeloid leukemia|secondary acute myeloid leukemia
840873|NCT00002549|adult acute monocytic leukemia (M5b)|adult acute monocytic leukemia (m5b)
840874|NCT00002545|adult glioblastoma|adult glioblastoma
840875|NCT00002545|adult giant cell glioblastoma|adult giant cell glioblastoma
840876|NCT00002545|adult gliosarcoma|adult gliosarcoma
840877|NCT00002502|stage I adult Hodgkin lymphoma|stage i adult hodgkin lymphoma
840878|NCT00002502|stage II adult Hodgkin lymphoma|stage ii adult hodgkin lymphoma
840879|NCT00002502|stage III adult Hodgkin lymphoma|stage iii adult hodgkin lymphoma
840880|NCT00002502|stage IV adult Hodgkin lymphoma|stage iv adult hodgkin lymphoma
840881|NCT00002502|recurrent childhood acute lymphoblastic leukemia|recurrent childhood acute lymphoblastic leukemia
840882|NCT00002502|recurrent adult Hodgkin lymphoma|recurrent adult hodgkin lymphoma
840883|NCT00002502|stage I cutaneous T-cell non-Hodgkin lymphoma|stage i cutaneous t-cell non-hodgkin lymphoma
840884|NCT00002502|stage II cutaneous T-cell non-Hodgkin lymphoma|stage ii cutaneous t-cell non-hodgkin lymphoma
840885|NCT00002502|stage III cutaneous T-cell non-Hodgkin lymphoma|stage iii cutaneous t-cell non-hodgkin lymphoma
840886|NCT00002502|stage IV cutaneous T-cell non-Hodgkin lymphoma|stage iv cutaneous t-cell non-hodgkin lymphoma
840887|NCT00002502|recurrent cutaneous T-cell non-Hodgkin lymphoma|recurrent cutaneous t-cell non-hodgkin lymphoma
840888|NCT00002502|childhood Burkitt lymphoma|childhood burkitt lymphoma
840889|NCT00002502|refractory multiple myeloma|refractory multiple myeloma
840890|NCT00002502|Waldenström macroglobulinemia|waldenström macroglobulinemia
840891|NCT00002502|stage I multiple myeloma|stage i multiple myeloma
840892|NCT00002502|stage II multiple myeloma|stage ii multiple myeloma
840893|NCT00002502|stage III multiple myeloma|stage iii multiple myeloma
840894|NCT00002502|stage I childhood lymphoblastic lymphoma|stage i childhood lymphoblastic lymphoma
840895|NCT00002502|stage II childhood lymphoblastic lymphoma|stage ii childhood lymphoblastic lymphoma
840896|NCT00002502|stage III childhood lymphoblastic lymphoma|stage iii childhood lymphoblastic lymphoma
840897|NCT00002502|stage IV childhood lymphoblastic lymphoma|stage iv childhood lymphoblastic lymphoma
840898|NCT00002502|recurrent childhood lymphoblastic lymphoma|recurrent childhood lymphoblastic lymphoma
840899|NCT00002502|recurrent childhood acute myeloid leukemia|recurrent childhood acute myeloid leukemia
840900|NCT00002502|recurrent adult acute myeloid leukemia|recurrent adult acute myeloid leukemia
840901|NCT00002502|recurrent adult acute lymphoblastic leukemia|recurrent adult acute lymphoblastic leukemia
840902|NCT00002502|childhood diffuse large cell lymphoma|childhood diffuse large cell lymphoma
840903|NCT00002502|childhood immunoblastic large cell lymphoma|childhood immunoblastic large cell lymphoma
840904|NCT00002502|chronic phase chronic myelogenous leukemia|chronic phase chronic myelogenous leukemia
840905|NCT00002502|accelerated phase chronic myelogenous leukemia|accelerated phase chronic myelogenous leukemia
840906|NCT00002502|blastic phase chronic myelogenous leukemia|blastic phase chronic myelogenous leukemia
840907|NCT00002502|adult acute myeloid leukemia in remission|adult acute myeloid leukemia in remission
840908|NCT00002502|adult acute lymphoblastic leukemia in remission|adult acute lymphoblastic leukemia in remission
840909|NCT00002502|childhood acute myeloid leukemia in remission|childhood acute myeloid leukemia in remission
840910|NCT00002502|childhood acute lymphoblastic leukemia in remission|childhood acute lymphoblastic leukemia in remission
840911|NCT00002502|stage II childhood Hodgkin lymphoma|stage ii childhood hodgkin lymphoma
840912|NCT00002502|stage I childhood Hodgkin lymphoma|stage i childhood hodgkin lymphoma
840913|NCT00002502|stage III childhood Hodgkin lymphoma|stage iii childhood hodgkin lymphoma
840914|NCT00002502|stage IV childhood Hodgkin lymphoma|stage iv childhood hodgkin lymphoma
840915|NCT00002502|recurrent/refractory childhood Hodgkin lymphoma|recurrent/refractory childhood hodgkin lymphoma
840916|NCT00002502|stage I grade 1 follicular lymphoma|stage i grade 1 follicular lymphoma
840917|NCT00002502|stage I grade 2 follicular lymphoma|stage i grade 2 follicular lymphoma
840918|NCT00002502|stage I grade 3 follicular lymphoma|stage i grade 3 follicular lymphoma
840919|NCT00002502|stage I adult diffuse small cleaved cell lymphoma|stage i adult diffuse small cleaved cell lymphoma
840920|NCT00002502|stage I adult diffuse mixed cell lymphoma|stage i adult diffuse mixed cell lymphoma
840921|NCT00002502|stage I adult diffuse large cell lymphoma|stage i adult diffuse large cell lymphoma
840922|NCT00002502|stage I adult immunoblastic large cell lymphoma|stage i adult immunoblastic large cell lymphoma
840923|NCT00002502|stage I adult lymphoblastic lymphoma|stage i adult lymphoblastic lymphoma
840924|NCT00002502|stage I adult Burkitt lymphoma|stage i adult burkitt lymphoma
840925|NCT00002502|refractory anemia|refractory anemia
840926|NCT00002502|refractory anemia with ringed sideroblasts|refractory anemia with ringed sideroblasts
840927|NCT00002502|refractory anemia with excess blasts|refractory anemia with excess blasts
840928|NCT00002502|chronic myelomonocytic leukemia|chronic myelomonocytic leukemia
840929|NCT00002502|stage III grade 1 follicular lymphoma|stage iii grade 1 follicular lymphoma
840930|NCT00002502|stage III grade 2 follicular lymphoma|stage iii grade 2 follicular lymphoma
840931|NCT00002502|stage III grade 3 follicular lymphoma|stage iii grade 3 follicular lymphoma
840932|NCT00002502|stage III adult diffuse small cleaved cell lymphoma|stage iii adult diffuse small cleaved cell lymphoma
840933|NCT00002502|stage III adult diffuse mixed cell lymphoma|stage iii adult diffuse mixed cell lymphoma
840934|NCT00002502|stage III adult diffuse large cell lymphoma|stage iii adult diffuse large cell lymphoma
840935|NCT00002502|stage III adult immunoblastic large cell lymphoma|stage iii adult immunoblastic large cell lymphoma
840936|NCT00002502|stage III adult lymphoblastic lymphoma|stage iii adult lymphoblastic lymphoma
840937|NCT00002502|stage III adult Burkitt lymphoma|stage iii adult burkitt lymphoma
840938|NCT00002502|stage IV grade 1 follicular lymphoma|stage iv grade 1 follicular lymphoma
840939|NCT00002502|stage IV grade 2 follicular lymphoma|stage iv grade 2 follicular lymphoma
840940|NCT00002502|stage IV grade 3 follicular lymphoma|stage iv grade 3 follicular lymphoma
840941|NCT00002502|stage IV adult diffuse small cleaved cell lymphoma|stage iv adult diffuse small cleaved cell lymphoma
840942|NCT00002502|stage IV adult diffuse mixed cell lymphoma|stage iv adult diffuse mixed cell lymphoma
840943|NCT00002502|stage IV adult diffuse large cell lymphoma|stage iv adult diffuse large cell lymphoma
840944|NCT00002502|stage IV adult immunoblastic large cell lymphoma|stage iv adult immunoblastic large cell lymphoma
840945|NCT00002502|stage IV adult lymphoblastic lymphoma|stage iv adult lymphoblastic lymphoma
840946|NCT00002502|stage IV adult Burkitt lymphoma|stage iv adult burkitt lymphoma
840947|NCT00002502|recurrent grade 1 follicular lymphoma|recurrent grade 1 follicular lymphoma
840948|NCT00002502|recurrent grade 2 follicular lymphoma|recurrent grade 2 follicular lymphoma
840949|NCT00002502|recurrent grade 3 follicular lymphoma|recurrent grade 3 follicular lymphoma
840950|NCT00002502|recurrent adult diffuse small cleaved cell lymphoma|recurrent adult diffuse small cleaved cell lymphoma
840951|NCT00002502|recurrent adult diffuse mixed cell lymphoma|recurrent adult diffuse mixed cell lymphoma
840952|NCT00002502|recurrent adult diffuse large cell lymphoma|recurrent adult diffuse large cell lymphoma
840953|NCT00002502|recurrent adult immunoblastic large cell lymphoma|recurrent adult immunoblastic large cell lymphoma
840954|NCT00002502|recurrent adult lymphoblastic lymphoma|recurrent adult lymphoblastic lymphoma
840955|NCT00002502|recurrent adult Burkitt lymphoma|recurrent adult burkitt lymphoma
840956|NCT00002502|secondary acute myeloid leukemia|secondary acute myeloid leukemia
840957|NCT00002502|de novo myelodysplastic syndromes|de novo myelodysplastic syndromes
840958|NCT00002502|previously treated myelodysplastic syndromes|previously treated myelodysplastic syndromes
840959|NCT00002502|secondary myelodysplastic syndromes|secondary myelodysplastic syndromes
840960|NCT00002502|intraocular lymphoma|intraocular lymphoma
841025|NCT00087841|Chemoembolization, Therapeutic|chemoembolization, therapeutic
840961|NCT00002502|stage I childhood small noncleaved cell lymphoma|stage i childhood small noncleaved cell lymphoma
840962|NCT00002502|stage I childhood large cell lymphoma|stage i childhood large cell lymphoma
840963|NCT00002502|stage II childhood small noncleaved cell lymphoma|stage ii childhood small noncleaved cell lymphoma
840964|NCT00002502|stage II childhood large cell lymphoma|stage ii childhood large cell lymphoma
840965|NCT00002502|stage III childhood small noncleaved cell lymphoma|stage iii childhood small noncleaved cell lymphoma
840966|NCT00002502|stage III childhood large cell lymphoma|stage iii childhood large cell lymphoma
840967|NCT00002502|stage IV childhood small noncleaved cell lymphoma|stage iv childhood small noncleaved cell lymphoma
840968|NCT00002502|stage IV childhood large cell lymphoma|stage iv childhood large cell lymphoma
840969|NCT00002502|recurrent childhood small noncleaved cell lymphoma|recurrent childhood small noncleaved cell lymphoma
840970|NCT00002502|recurrent childhood large cell lymphoma|recurrent childhood large cell lymphoma
840971|NCT00002502|stage I mantle cell lymphoma|stage i mantle cell lymphoma
840972|NCT00002502|contiguous stage II grade 1 follicular lymphoma|contiguous stage ii grade 1 follicular lymphoma
840973|NCT00002502|contiguous stage II grade 2 follicular lymphoma|contiguous stage ii grade 2 follicular lymphoma
840974|NCT00002502|contiguous stage II grade 3 follicular lymphoma|contiguous stage ii grade 3 follicular lymphoma
840975|NCT00002502|contiguous stage II adult diffuse small cleaved cell lymphoma|contiguous stage ii adult diffuse small cleaved cell lymphoma
840976|NCT00002502|contiguous stage II mantle cell lymphoma|contiguous stage ii mantle cell lymphoma
840977|NCT00002502|contiguous stage II adult diffuse mixed cell lymphoma|contiguous stage ii adult diffuse mixed cell lymphoma
840978|NCT00002502|contiguous stage II adult immunoblastic large cell lymphoma|contiguous stage ii adult immunoblastic large cell lymphoma
840979|NCT00002502|contiguous stage II adult diffuse large cell lymphoma|contiguous stage ii adult diffuse large cell lymphoma
840980|NCT00002502|contiguous stage II adult Burkitt lymphoma|contiguous stage ii adult burkitt lymphoma
840981|NCT00002502|contiguous stage II adult lymphoblastic lymphoma|contiguous stage ii adult lymphoblastic lymphoma
840982|NCT00002502|noncontiguous stage II grade 1 follicular lymphoma|noncontiguous stage ii grade 1 follicular lymphoma
840983|NCT00002502|noncontiguous stage II grade 2 follicular lymphoma|noncontiguous stage ii grade 2 follicular lymphoma
840984|NCT00002502|noncontiguous stage II grade 3 follicular lymphoma|noncontiguous stage ii grade 3 follicular lymphoma
840985|NCT00002502|noncontiguous stage II adult diffuse small cleaved cell lymphoma|noncontiguous stage ii adult diffuse small cleaved cell lymphoma
840986|NCT00002502|noncontiguous stage II mantle cell lymphoma|noncontiguous stage ii mantle cell lymphoma
840987|NCT00002502|noncontiguous stage II adult diffuse mixed cell lymphoma|noncontiguous stage ii adult diffuse mixed cell lymphoma
840988|NCT00002502|noncontiguous stage II adult immunoblastic large cell lymphoma|noncontiguous stage ii adult immunoblastic large cell lymphoma
840989|NCT00002502|noncontiguous stage II adult diffuse large cell lymphoma|noncontiguous stage ii adult diffuse large cell lymphoma
840990|NCT00002502|noncontiguous stage II adult Burkitt lymphoma|noncontiguous stage ii adult burkitt lymphoma
840991|NCT00002502|noncontiguous stage II adult lymphoblastic lymphoma|noncontiguous stage ii adult lymphoblastic lymphoma
840992|NCT00002502|stage III mantle cell lymphoma|stage iii mantle cell lymphoma
840993|NCT00002502|stage IV mantle cell lymphoma|stage iv mantle cell lymphoma
840994|NCT00002502|recurrent mantle cell lymphoma|recurrent mantle cell lymphoma
840995|NCT00002502|angioimmunoblastic T-cell lymphoma|angioimmunoblastic t-cell lymphoma
840996|NCT00002502|anaplastic large cell lymphoma|anaplastic large cell lymphoma
840997|NCT00002502|noncontiguous stage II small lymphocytic lymphoma|noncontiguous stage ii small lymphocytic lymphoma
840998|NCT00002502|noncontiguous stage II marginal zone lymphoma|noncontiguous stage ii marginal zone lymphoma
840999|NCT00002502|recurrent marginal zone lymphoma|recurrent marginal zone lymphoma
841000|NCT00002502|recurrent small lymphocytic lymphoma|recurrent small lymphocytic lymphoma
841001|NCT00002502|stage I marginal zone lymphoma|stage i marginal zone lymphoma
841002|NCT00002502|stage I small lymphocytic lymphoma|stage i small lymphocytic lymphoma
841003|NCT00002502|stage III small lymphocytic lymphoma|stage iii small lymphocytic lymphoma
841004|NCT00002502|stage III marginal zone lymphoma|stage iii marginal zone lymphoma
841005|NCT00002502|stage IV small lymphocytic lymphoma|stage iv small lymphocytic lymphoma
841006|NCT00002502|stage IV marginal zone lymphoma|stage iv marginal zone lymphoma
841007|NCT00002502|contiguous stage II marginal zone lymphoma|contiguous stage ii marginal zone lymphoma
841008|NCT00002502|contiguous stage II small lymphocytic lymphoma|contiguous stage ii small lymphocytic lymphoma
841009|NCT00002502|extranodal marginal zone B-cell lymphoma of mucosa-associated lymphoid tissue|extranodal marginal zone b-cell lymphoma of mucosa-associated lymphoid tissue
841010|NCT00002502|nodal marginal zone B-cell lymphoma|nodal marginal zone b-cell lymphoma
841011|NCT00002502|splenic marginal zone lymphoma|splenic marginal zone lymphoma
841012|NCT00002502|childhood myelodysplastic syndromes|childhood myelodysplastic syndromes
841013|NCT00002495|stage I adult Hodgkin lymphoma|stage i adult hodgkin lymphoma
841014|NCT00002495|stage II adult Hodgkin lymphoma|stage ii adult hodgkin lymphoma
841015|NCT00002465|stage IV breast cancer|stage iv breast cancer
841016|NCT00002465|recurrent breast cancer|recurrent breast cancer
841017|NCT00002465|advanced malignant mesothelioma|advanced malignant mesothelioma
841018|NCT00002465|recurrent malignant mesothelioma|recurrent malignant mesothelioma
841019|NCT00002465|stage IV endometrial carcinoma|stage iv endometrial carcinoma
841020|NCT00002465|recurrent endometrial carcinoma|recurrent endometrial carcinoma
841021|NCT00087932|Complementary Therapies|complementary therapies
841022|NCT00087841|Hypnosis|hypnosis
841023|NCT00087841|Analgesia|analgesia
841026|NCT00087828|Vaccinium macrocarpon|vaccinium macrocarpon
841027|NCT00087815|cognitive/functional effects|cognitive/functional effects
841028|NCT00087815|radiation toxicity|radiation toxicity
841029|NCT00087815|adult brain tumor|adult brain tumor
841030|NCT00087815|childhood brain tumor|childhood brain tumor
841031|NCT00087789|Alzheimer's Disease|alzheimer's disease
841032|NCT00087789|Gene Transfer|gene transfer
841034|NCT00087763|Age Related Macular Degeneration|age related macular degeneration
841035|NCT00087763|Exudative Subfoveal Age Related Macular Degeneration with Subfoveal Choroidal Neovascularization|exudative subfoveal age related macular degeneration with subfoveal choroidal neovascularization
841036|NCT00082511|Lupus|lupus
841037|NCT00082511|Systemic Lupus Erythematosus|systemic lupus erythematosus
841038|NCT00082511|SLE|sle
841039|NCT00082511|Bone Loss|bone loss
841040|NCT00082511|DHEA|dhea
841041|NCT00003877|stage IV breast cancer|stage iv breast cancer
841042|NCT00003877|recurrent breast cancer|recurrent breast cancer
841043|NCT00003874|recurrent childhood acute lymphoblastic leukemia|recurrent childhood acute lymphoblastic leukemia
841044|NCT00003874|Waldenstrom macroglobulinemia|waldenstrom macroglobulinemia
841045|NCT00003874|recurrent childhood lymphoblastic lymphoma|recurrent childhood lymphoblastic lymphoma
841046|NCT00003874|recurrent adult acute lymphoblastic leukemia|recurrent adult acute lymphoblastic leukemia
841047|NCT00003874|refractory chronic lymphocytic leukemia|refractory chronic lymphocytic leukemia
841048|NCT00003874|B-cell chronic lymphocytic leukemia|b-cell chronic lymphocytic leukemia
841049|NCT00003874|B-cell childhood acute lymphoblastic leukemia|b-cell childhood acute lymphoblastic leukemia
841050|NCT00003874|B-cell adult acute lymphoblastic leukemia|b-cell adult acute lymphoblastic leukemia
841051|NCT00003874|recurrent grade 1 follicular lymphoma|recurrent grade 1 follicular lymphoma
841052|NCT00003874|recurrent grade 2 follicular lymphoma|recurrent grade 2 follicular lymphoma
841053|NCT00003874|recurrent grade 3 follicular lymphoma|recurrent grade 3 follicular lymphoma
841054|NCT00003874|recurrent adult diffuse small cleaved cell lymphoma|recurrent adult diffuse small cleaved cell lymphoma
841055|NCT00003874|recurrent adult diffuse mixed cell lymphoma|recurrent adult diffuse mixed cell lymphoma
841056|NCT00003874|recurrent adult diffuse large cell lymphoma|recurrent adult diffuse large cell lymphoma
841057|NCT00003874|recurrent adult immunoblastic large cell lymphoma|recurrent adult immunoblastic large cell lymphoma
841058|NCT00003874|recurrent adult lymphoblastic lymphoma|recurrent adult lymphoblastic lymphoma
841059|NCT00003874|recurrent adult Burkitt lymphoma|recurrent adult burkitt lymphoma
841060|NCT00003874|recurrent childhood small noncleaved cell lymphoma|recurrent childhood small noncleaved cell lymphoma
841061|NCT00003874|recurrent childhood large cell lymphoma|recurrent childhood large cell lymphoma
841062|NCT00003874|recurrent mantle cell lymphoma|recurrent mantle cell lymphoma
841063|NCT00003874|recurrent marginal zone lymphoma|recurrent marginal zone lymphoma
841064|NCT00003874|recurrent small lymphocytic lymphoma|recurrent small lymphocytic lymphoma
841065|NCT00003874|extranodal marginal zone B-cell lymphoma of mucosa-associated lymphoid tissue|extranodal marginal zone b-cell lymphoma of mucosa-associated lymphoid tissue
841066|NCT00003874|nodal marginal zone B-cell lymphoma|nodal marginal zone b-cell lymphoma
841067|NCT00003874|splenic marginal zone lymphoma|splenic marginal zone lymphoma
841068|NCT00003853|primary systemic amyloidosis|primary systemic amyloidosis
841069|NCT00003805|stage I adult Hodgkin lymphoma|stage i adult hodgkin lymphoma
841070|NCT00003805|stage II adult Hodgkin lymphoma|stage ii adult hodgkin lymphoma
841071|NCT00003805|stage III adult Hodgkin lymphoma|stage iii adult hodgkin lymphoma
841072|NCT00003805|stage IV adult Hodgkin lymphoma|stage iv adult hodgkin lymphoma
841073|NCT00003805|recurrent childhood acute lymphoblastic leukemia|recurrent childhood acute lymphoblastic leukemia
841074|NCT00003805|recurrent adult Hodgkin lymphoma|recurrent adult hodgkin lymphoma
841075|NCT00003805|stage I cutaneous T-cell non-Hodgkin lymphoma|stage i cutaneous t-cell non-hodgkin lymphoma
841076|NCT00003805|stage II cutaneous T-cell non-Hodgkin lymphoma|stage ii cutaneous t-cell non-hodgkin lymphoma
841077|NCT00003805|stage III cutaneous T-cell non-Hodgkin lymphoma|stage iii cutaneous t-cell non-hodgkin lymphoma
841078|NCT00003805|stage IV cutaneous T-cell non-Hodgkin lymphoma|stage iv cutaneous t-cell non-hodgkin lymphoma
841079|NCT00003805|recurrent cutaneous T-cell non-Hodgkin lymphoma|recurrent cutaneous t-cell non-hodgkin lymphoma
841080|NCT00003805|Burkitt lymphoma|burkitt lymphoma
841081|NCT00003805|stage 0 chronic lymphocytic leukemia|stage 0 chronic lymphocytic leukemia
841082|NCT00003805|Waldenstrom macroglobulinemia|waldenstrom macroglobulinemia
841083|NCT00003805|stage I multiple myeloma|stage i multiple myeloma
841084|NCT00003805|stage II multiple myeloma|stage ii multiple myeloma
841085|NCT00003805|stage III multiple myeloma|stage iii multiple myeloma
841086|NCT00003805|stage I childhood lymphoblastic lymphoma|stage i childhood lymphoblastic lymphoma
841087|NCT00003805|stage II childhood lymphoblastic lymphoma|stage ii childhood lymphoblastic lymphoma
841359|NCT00087178|stage I breast cancer|stage i breast cancer
841088|NCT00003805|stage III childhood lymphoblastic lymphoma|stage iii childhood lymphoblastic lymphoma
841089|NCT00003805|stage IV childhood lymphoblastic lymphoma|stage iv childhood lymphoblastic lymphoma
841090|NCT00003805|recurrent childhood lymphoblastic lymphoma|recurrent childhood lymphoblastic lymphoma
841091|NCT00003805|stage I chronic lymphocytic leukemia|stage i chronic lymphocytic leukemia
841092|NCT00003805|stage II chronic lymphocytic leukemia|stage ii chronic lymphocytic leukemia
841093|NCT00003805|stage III chronic lymphocytic leukemia|stage iii chronic lymphocytic leukemia
841094|NCT00003805|stage IV chronic lymphocytic leukemia|stage iv chronic lymphocytic leukemia
841095|NCT00003805|recurrent childhood acute myeloid leukemia|recurrent childhood acute myeloid leukemia
841096|NCT00003805|recurrent adult acute myeloid leukemia|recurrent adult acute myeloid leukemia
841097|NCT00003805|recurrent adult acute lymphoblastic leukemia|recurrent adult acute lymphoblastic leukemia
841098|NCT00003805|relapsing chronic myelogenous leukemia|relapsing chronic myelogenous leukemia
841099|NCT00003805|refractory chronic lymphocytic leukemia|refractory chronic lymphocytic leukemia
841100|NCT00003805|childhood diffuse large cell lymphoma|childhood diffuse large cell lymphoma
841101|NCT00003805|childhood immunoblastic large cell lymphoma|childhood immunoblastic large cell lymphoma
841102|NCT00003805|unspecified childhood solid tumor, protocol specific|unspecified childhood solid tumor, protocol specific
841103|NCT00003805|unspecified adult solid tumor, protocol specific|unspecified adult solid tumor, protocol specific
841104|NCT00003805|chronic phase chronic myelogenous leukemia|chronic phase chronic myelogenous leukemia
841105|NCT00003805|accelerated phase chronic myelogenous leukemia|accelerated phase chronic myelogenous leukemia
841106|NCT00003805|blastic phase chronic myelogenous leukemia|blastic phase chronic myelogenous leukemia
841107|NCT00003805|meningeal chronic myelogenous leukemia|meningeal chronic myelogenous leukemia
841108|NCT00003805|adult acute myeloid leukemia in remission|adult acute myeloid leukemia in remission
841109|NCT00003805|adult acute lymphoblastic leukemia in remission|adult acute lymphoblastic leukemia in remission
841110|NCT00003805|childhood acute myeloid leukemia in remission|childhood acute myeloid leukemia in remission
841111|NCT00003805|childhood acute lymphoblastic leukemia in remission|childhood acute lymphoblastic leukemia in remission
841112|NCT00003805|fever, sweats, and hot flashes|fever, sweats, and hot flashes
841113|NCT00003805|progressive hairy cell leukemia, initial treatment|progressive hairy cell leukemia, initial treatment
841114|NCT00003805|refractory hairy cell leukemia|refractory hairy cell leukemia
841115|NCT00003805|stage II childhood Hodgkin lymphoma|stage ii childhood hodgkin lymphoma
841116|NCT00003805|stage I childhood Hodgkin lymphoma|stage i childhood hodgkin lymphoma
841117|NCT00003805|stage III childhood Hodgkin lymphoma|stage iii childhood hodgkin lymphoma
841118|NCT00003805|stage IV childhood Hodgkin lymphoma|stage iv childhood hodgkin lymphoma
841119|NCT00003805|recurrent/refractory childhood Hodgkin lymphoma|recurrent/refractory childhood hodgkin lymphoma
841120|NCT00003805|stage I grade 2 follicular lymphoma|stage i grade 2 follicular lymphoma
841121|NCT00003805|stage I grade 3 follicular lymphoma|stage i grade 3 follicular lymphoma
841122|NCT00003805|stage I adult diffuse small cleaved cell lymphoma|stage i adult diffuse small cleaved cell lymphoma
841123|NCT00003805|stage I adult diffuse mixed cell lymphoma|stage i adult diffuse mixed cell lymphoma
841124|NCT00003805|stage I adult diffuse large cell lymphoma|stage i adult diffuse large cell lymphoma
841125|NCT00003805|stage I adult immunoblastic large cell lymphoma|stage i adult immunoblastic large cell lymphoma
841126|NCT00003805|stage I adult lymphoblastic lymphoma|stage i adult lymphoblastic lymphoma
841127|NCT00003805|stage I adult Burkitt lymphoma|stage i adult burkitt lymphoma
841128|NCT00003805|stage III grade 1 follicular lymphoma|stage iii grade 1 follicular lymphoma
841129|NCT00003805|stage III grade 2 follicular lymphoma|stage iii grade 2 follicular lymphoma
841130|NCT00003805|stage III grade 3 follicular lymphoma|stage iii grade 3 follicular lymphoma
841131|NCT00003805|stage III adult diffuse small cleaved cell lymphoma|stage iii adult diffuse small cleaved cell lymphoma
841132|NCT00003805|stage III adult diffuse mixed cell lymphoma|stage iii adult diffuse mixed cell lymphoma
841133|NCT00003805|stage III adult diffuse large cell lymphoma|stage iii adult diffuse large cell lymphoma
841134|NCT00003805|stage III adult immunoblastic large cell lymphoma|stage iii adult immunoblastic large cell lymphoma
841135|NCT00003805|stage III adult lymphoblastic lymphoma|stage iii adult lymphoblastic lymphoma
841136|NCT00003805|stage III adult Burkitt lymphoma|stage iii adult burkitt lymphoma
841137|NCT00003805|stage IV grade 1 follicular lymphoma|stage iv grade 1 follicular lymphoma
841138|NCT00003805|stage IV grade 2 follicular lymphoma|stage iv grade 2 follicular lymphoma
841139|NCT00003805|stage IV grade 3 follicular lymphoma|stage iv grade 3 follicular lymphoma
841140|NCT00003805|stage IV adult diffuse small cleaved cell lymphoma|stage iv adult diffuse small cleaved cell lymphoma
841141|NCT00003805|stage IV adult diffuse mixed cell lymphoma|stage iv adult diffuse mixed cell lymphoma
841142|NCT00003805|stage IV adult diffuse large cell lymphoma|stage iv adult diffuse large cell lymphoma
841143|NCT00003805|stage IV adult immunoblastic large cell lymphoma|stage iv adult immunoblastic large cell lymphoma
841144|NCT00003805|stage IV adult lymphoblastic lymphoma|stage iv adult lymphoblastic lymphoma
841145|NCT00003805|stage IV adult Burkitt lymphoma|stage iv adult burkitt lymphoma
841146|NCT00003805|recurrent grade 1 follicular lymphoma|recurrent grade 1 follicular lymphoma
841147|NCT00003805|recurrent grade 2 follicular lymphoma|recurrent grade 2 follicular lymphoma
841148|NCT00003805|recurrent grade 3 follicular lymphoma|recurrent grade 3 follicular lymphoma
841149|NCT00003805|recurrent adult diffuse small cleaved cell lymphoma|recurrent adult diffuse small cleaved cell lymphoma
841150|NCT00003805|recurrent adult diffuse mixed cell lymphoma|recurrent adult diffuse mixed cell lymphoma
841151|NCT00003805|recurrent adult diffuse large cell lymphoma|recurrent adult diffuse large cell lymphoma
841152|NCT00003805|recurrent adult immunoblastic large cell lymphoma|recurrent adult immunoblastic large cell lymphoma
841153|NCT00003805|recurrent adult lymphoblastic lymphoma|recurrent adult lymphoblastic lymphoma
841154|NCT00003805|recurrent adult Burkitt lymphoma|recurrent adult burkitt lymphoma
841155|NCT00003805|stage I adult T-cell leukemia/lymphoma|stage i adult t-cell leukemia/lymphoma
841156|NCT00003805|stage II adult T-cell leukemia/lymphoma|stage ii adult t-cell leukemia/lymphoma
841218|NCT00003743|disseminated neuroblastoma|disseminated neuroblastoma
841157|NCT00003805|stage III adult T-cell leukemia/lymphoma|stage iii adult t-cell leukemia/lymphoma
841158|NCT00003805|stage IV adult T-cell leukemia/lymphoma|stage iv adult t-cell leukemia/lymphoma
841159|NCT00003805|recurrent adult T-cell leukemia/lymphoma|recurrent adult t-cell leukemia/lymphoma
841160|NCT00003805|de novo myelodysplastic syndromes|de novo myelodysplastic syndromes
841161|NCT00003805|previously treated myelodysplastic syndromes|previously treated myelodysplastic syndromes
841162|NCT00003805|secondary myelodysplastic syndromes|secondary myelodysplastic syndromes
841163|NCT00003805|infection|infection
841164|NCT00003805|bone marrow suppression|bone marrow suppression
841165|NCT00003805|stage I childhood small noncleaved cell lymphoma|stage i childhood small noncleaved cell lymphoma
841166|NCT00003805|stage I childhood large cell lymphoma|stage i childhood large cell lymphoma
841167|NCT00003805|stage II childhood small noncleaved cell lymphoma|stage ii childhood small noncleaved cell lymphoma
841168|NCT00003805|stage II childhood large cell lymphoma|stage ii childhood large cell lymphoma
841169|NCT00003805|stage III childhood small noncleaved cell lymphoma|stage iii childhood small noncleaved cell lymphoma
841170|NCT00003805|stage III childhood large cell lymphoma|stage iii childhood large cell lymphoma
841171|NCT00003805|stage IV childhood small noncleaved cell lymphoma|stage iv childhood small noncleaved cell lymphoma
841172|NCT00003805|stage IV childhood large cell lymphoma|stage iv childhood large cell lymphoma
841173|NCT00003805|recurrent childhood small noncleaved cell lymphoma|recurrent childhood small noncleaved cell lymphoma
841174|NCT00003805|recurrent childhood large cell lymphoma|recurrent childhood large cell lymphoma
841175|NCT00003805|stage I mantle cell lymphoma|stage i mantle cell lymphoma
841176|NCT00003805|contiguous stage II grade 1 follicular lymphoma|contiguous stage ii grade 1 follicular lymphoma
841177|NCT00003805|contiguous stage II grade 2 follicular lymphoma|contiguous stage ii grade 2 follicular lymphoma
841178|NCT00003805|contiguous stage II grade 3 follicular lymphoma|contiguous stage ii grade 3 follicular lymphoma
841179|NCT00003805|contiguous stage II adult diffuse small cleaved cell lymphoma|contiguous stage ii adult diffuse small cleaved cell lymphoma
841180|NCT00003805|contiguous stage II mantle cell lymphoma|contiguous stage ii mantle cell lymphoma
841181|NCT00003805|contiguous stage II adult diffuse mixed cell lymphoma|contiguous stage ii adult diffuse mixed cell lymphoma
841182|NCT00003805|contiguous stage II adult immunoblastic large cell lymphoma|contiguous stage ii adult immunoblastic large cell lymphoma
841183|NCT00003805|contiguous stage II adult diffuse large cell lymphoma|contiguous stage ii adult diffuse large cell lymphoma
841184|NCT00003805|contiguous stage II adult Burkitt lymphoma|contiguous stage ii adult burkitt lymphoma
841185|NCT00003805|contiguous stage II adult lymphoblastic lymphoma|contiguous stage ii adult lymphoblastic lymphoma
841186|NCT00003805|noncontiguous stage II grade 1 follicular lymphoma|noncontiguous stage ii grade 1 follicular lymphoma
841187|NCT00003805|noncontiguous stage II grade 2 follicular lymphoma|noncontiguous stage ii grade 2 follicular lymphoma
841188|NCT00003805|noncontiguous stage II grade 3 follicular lymphoma|noncontiguous stage ii grade 3 follicular lymphoma
841189|NCT00003805|noncontiguous stage II adult diffuse small cleaved cell lymphoma|noncontiguous stage ii adult diffuse small cleaved cell lymphoma
841190|NCT00003805|noncontiguous stage II mantle cell lymphoma|noncontiguous stage ii mantle cell lymphoma
841191|NCT00003805|noncontiguous stage II adult diffuse mixed cell lymphoma|noncontiguous stage ii adult diffuse mixed cell lymphoma
841192|NCT00003805|noncontiguous stage II adult immunoblastic large cell lymphoma|noncontiguous stage ii adult immunoblastic large cell lymphoma
841193|NCT00003805|noncontiguous stage II adult diffuse large cell lymphoma|noncontiguous stage ii adult diffuse large cell lymphoma
841194|NCT00003805|noncontiguous stage II adult Burkitt lymphoma|noncontiguous stage ii adult burkitt lymphoma
841195|NCT00003805|noncontiguous stage II adult lymphoblastic lymphoma|noncontiguous stage ii adult lymphoblastic lymphoma
841196|NCT00003805|stage III mantle cell lymphoma|stage iii mantle cell lymphoma
841197|NCT00003805|stage IV mantle cell lymphoma|stage iv mantle cell lymphoma
841198|NCT00003805|recurrent mantle cell lymphoma|recurrent mantle cell lymphoma
841199|NCT00003805|contiguous stage II marginal zone lymphoma|contiguous stage ii marginal zone lymphoma
841200|NCT00003805|contiguous stage II small lymphocytic lymphoma|contiguous stage ii small lymphocytic lymphoma
841201|NCT00003805|noncontiguous stage II small lymphocytic lymphoma|noncontiguous stage ii small lymphocytic lymphoma
841202|NCT00003805|noncontiguous stage II marginal zone lymphoma|noncontiguous stage ii marginal zone lymphoma
841203|NCT00003805|recurrent marginal zone lymphoma|recurrent marginal zone lymphoma
841204|NCT00003805|recurrent small lymphocytic lymphoma|recurrent small lymphocytic lymphoma
841205|NCT00003805|stage I marginal zone lymphoma|stage i marginal zone lymphoma
841206|NCT00003805|stage I small lymphocytic lymphoma|stage i small lymphocytic lymphoma
841207|NCT00003805|stage III small lymphocytic lymphoma|stage iii small lymphocytic lymphoma
841208|NCT00003805|stage III marginal zone lymphoma|stage iii marginal zone lymphoma
841209|NCT00003805|stage IV small lymphocytic lymphoma|stage iv small lymphocytic lymphoma
841210|NCT00003805|stage IV marginal zone lymphoma|stage iv marginal zone lymphoma
841288|NCT00003589|recurrent small cell lung cancer|recurrent small cell lung cancer
841211|NCT00003805|extranodal marginal zone B-cell lymphoma of mucosa-associated lymphoid tissue|extranodal marginal zone b-cell lymphoma of mucosa-associated lymphoid tissue
841212|NCT00003805|nodal marginal zone B-cell lymphoma|nodal marginal zone b-cell lymphoma
841213|NCT00003805|splenic marginal zone lymphoma|splenic marginal zone lymphoma
841214|NCT00003805|childhood myelodysplastic syndromes|childhood myelodysplastic syndromes
841215|NCT00003804|stage I Wilms tumor|stage i wilms tumor
841216|NCT00003792|stage IV melanoma|stage iv melanoma
841217|NCT00003792|recurrent melanoma|recurrent melanoma
841219|NCT00003664|stage IV renal cell cancer|stage iv renal cell cancer
841220|NCT00003664|recurrent renal cell cancer|recurrent renal cell cancer
841221|NCT00003639|stage III grade 1 follicular lymphoma|stage iii grade 1 follicular lymphoma
841222|NCT00003639|stage III grade 2 follicular lymphoma|stage iii grade 2 follicular lymphoma
841223|NCT00003639|stage IV grade 1 follicular lymphoma|stage iv grade 1 follicular lymphoma
841224|NCT00003639|stage IV grade 2 follicular lymphoma|stage iv grade 2 follicular lymphoma
841225|NCT00003639|contiguous stage II grade 1 follicular lymphoma|contiguous stage ii grade 1 follicular lymphoma
841226|NCT00003639|contiguous stage II grade 2 follicular lymphoma|contiguous stage ii grade 2 follicular lymphoma
841227|NCT00003639|noncontiguous stage II grade 1 follicular lymphoma|noncontiguous stage ii grade 1 follicular lymphoma
841228|NCT00003639|noncontiguous stage II grade 2 follicular lymphoma|noncontiguous stage ii grade 2 follicular lymphoma
841229|NCT00003639|noncontiguous stage II small lymphocytic lymphoma|noncontiguous stage ii small lymphocytic lymphoma
841230|NCT00003639|noncontiguous stage II marginal zone lymphoma|noncontiguous stage ii marginal zone lymphoma
841231|NCT00003639|stage III small lymphocytic lymphoma|stage iii small lymphocytic lymphoma
841232|NCT00003639|stage III marginal zone lymphoma|stage iii marginal zone lymphoma
841233|NCT00003639|stage IV small lymphocytic lymphoma|stage iv small lymphocytic lymphoma
841234|NCT00003639|stage IV marginal zone lymphoma|stage iv marginal zone lymphoma
841235|NCT00003639|contiguous stage II marginal zone lymphoma|contiguous stage ii marginal zone lymphoma
841236|NCT00003639|contiguous stage II small lymphocytic lymphoma|contiguous stage ii small lymphocytic lymphoma
841237|NCT00003639|extranodal marginal zone B-cell lymphoma of mucosa-associated lymphoid tissue|extranodal marginal zone b-cell lymphoma of mucosa-associated lymphoid tissue
841238|NCT00003639|nodal marginal zone B-cell lymphoma|nodal marginal zone b-cell lymphoma
841239|NCT00003639|splenic marginal zone lymphoma|splenic marginal zone lymphoma
841240|NCT00003604|stage III renal cell cancer|stage iii renal cell cancer
841241|NCT00003604|stage IV renal cell cancer|stage iv renal cell cancer
841242|NCT00003359|unspecified adult solid tumor, protocol specific|unspecified adult solid tumor, protocol specific
841243|NCT00003343|stage IV prostate cancer|stage iv prostate cancer
841244|NCT00003328|stage III squamous cell carcinoma of the lip and oral cavity|stage iii squamous cell carcinoma of the lip and oral cavity
841245|NCT00003328|stage IV squamous cell carcinoma of the lip and oral cavity|stage iv squamous cell carcinoma of the lip and oral cavity
841246|NCT00003328|stage III squamous cell carcinoma of the oropharynx|stage iii squamous cell carcinoma of the oropharynx
841247|NCT00003328|stage IV squamous cell carcinoma of the oropharynx|stage iv squamous cell carcinoma of the oropharynx
841248|NCT00003328|stage III squamous cell carcinoma of the hypopharynx|stage iii squamous cell carcinoma of the hypopharynx
841249|NCT00003328|stage IV squamous cell carcinoma of the hypopharynx|stage iv squamous cell carcinoma of the hypopharynx
841250|NCT00003328|stage III squamous cell carcinoma of the larynx|stage iii squamous cell carcinoma of the larynx
841251|NCT00003328|stage IV squamous cell carcinoma of the larynx|stage iv squamous cell carcinoma of the larynx
841252|NCT00087685|Recurrent Endometrial Cancer|recurrent endometrial cancer
841253|NCT00087685|Endometrial|endometrial
841254|NCT00087685|Endometrioid|endometrioid
841256|NCT00087685|Uterine Cancer|uterine cancer
841257|NCT00087672|Myelofibrosis|myelofibrosis
841258|NCT00087672|Philadelphia negative myeloproliferative disorder|philadelphia negative myeloproliferative disorder
841259|NCT00087672|CC-5013|cc-5013
841260|NCT00087672|Lenalidomide|lenalidomide
841261|NCT00087672|Revlimid|revlimid
841262|NCT00087672|Antiangiogenesis|antiangiogenesis
841263|NCT00087659|ADT, BMD, US63, H014|adt, bmd, us63, h014
841264|NCT00087555|Fibromyalgia|fibromyalgia
841265|NCT00087555|Pain|pain
841266|NCT00087542|Hallucinosis/Psychosis|hallucinosis/psychosis
841267|NCT00087529|PPMS|ppms
841268|NCT00087529|Primary progressive MS|primary progressive ms
841269|NCT00087529|Primary progressive multiple sclerosis|primary progressive multiple sclerosis
841270|NCT00087529|Rituxan|rituxan
841271|NCT00087529|MS|ms
841272|NCT00087477|Malignant Melanoma, Pivanex, Histone deacetylases inhibitor|malignant melanoma, pivanex, histone deacetylases inhibitor
841273|NCT00087464|Acute Infection|acute infection
841274|NCT00087464|Treatment Naive|treatment naive
841275|NCT00087464|Treatment Interruption|treatment interruption
841276|NCT00087451|Progressive or recurrent malignant glioma|progressive or recurrent malignant glioma
841278|NCT00086645|Asperger Syndrome|asperger syndrome
841279|NCT00086645|Pervasive Developmental Disorder|pervasive developmental disorder
841281|NCT00086645|Rituals|rituals
841282|NCT00086645|Compulsions|compulsions
841283|NCT00086645|Stereotypy|stereotypy
841284|NCT00086645|Routines|routines
841285|NCT00086645|Repetitive behavior|repetitive behavior
841286|NCT00086645|SSRI|ssri
841287|NCT00086645|Serotonin|serotonin
841289|NCT00003589|stage IIIB non-small cell lung cancer|stage iiib non-small cell lung cancer
841290|NCT00003589|stage IV non-small cell lung cancer|stage iv non-small cell lung cancer
841291|NCT00087438|stage I non-small cell lung cancer|stage i non-small cell lung cancer
841292|NCT00087438|stage II non-small cell lung cancer|stage ii non-small cell lung cancer
841293|NCT00087438|squamous cell lung cancer|squamous cell lung cancer
841294|NCT00087438|large cell lung cancer|large cell lung cancer
841295|NCT00087438|adenocarcinoma of the lung|adenocarcinoma of the lung
841296|NCT00087438|bronchoalveolar cell lung cancer|bronchoalveolar cell lung cancer
841369|NCT00087113|stage III cervical cancer|stage iii cervical cancer
841297|NCT00087425|contiguous stage II adult diffuse small cleaved cell lymphoma|contiguous stage ii adult diffuse small cleaved cell lymphoma
841298|NCT00087425|noncontiguous stage II adult diffuse small cleaved cell lymphoma|noncontiguous stage ii adult diffuse small cleaved cell lymphoma
841299|NCT00087425|recurrent adult diffuse small cleaved cell lymphoma|recurrent adult diffuse small cleaved cell lymphoma
841300|NCT00087425|stage III adult diffuse small cleaved cell lymphoma|stage iii adult diffuse small cleaved cell lymphoma
841301|NCT00087425|stage IV adult diffuse small cleaved cell lymphoma|stage iv adult diffuse small cleaved cell lymphoma
841302|NCT00087425|contiguous stage II grade 1 follicular lymphoma|contiguous stage ii grade 1 follicular lymphoma
841303|NCT00087425|noncontiguous stage II grade 1 follicular lymphoma|noncontiguous stage ii grade 1 follicular lymphoma
841304|NCT00087425|recurrent grade 1 follicular lymphoma|recurrent grade 1 follicular lymphoma
841305|NCT00087425|stage III grade 1 follicular lymphoma|stage iii grade 1 follicular lymphoma
841306|NCT00087425|stage IV grade 1 follicular lymphoma|stage iv grade 1 follicular lymphoma
841307|NCT00087425|contiguous stage II grade 2 follicular lymphoma|contiguous stage ii grade 2 follicular lymphoma
841308|NCT00087425|noncontiguous stage II grade 2 follicular lymphoma|noncontiguous stage ii grade 2 follicular lymphoma
841309|NCT00087425|recurrent grade 2 follicular lymphoma|recurrent grade 2 follicular lymphoma
841310|NCT00087425|stage III grade 2 follicular lymphoma|stage iii grade 2 follicular lymphoma
841311|NCT00087425|stage IV grade 2 follicular lymphoma|stage iv grade 2 follicular lymphoma
841312|NCT00087425|contiguous stage II marginal zone lymphoma|contiguous stage ii marginal zone lymphoma
841313|NCT00087425|noncontiguous stage II marginal zone lymphoma|noncontiguous stage ii marginal zone lymphoma
841314|NCT00087425|recurrent marginal zone lymphoma|recurrent marginal zone lymphoma
841315|NCT00087425|stage III marginal zone lymphoma|stage iii marginal zone lymphoma
841316|NCT00087425|stage IV marginal zone lymphoma|stage iv marginal zone lymphoma
841317|NCT00087425|refractory chronic lymphocytic leukemia|refractory chronic lymphocytic leukemia
841318|NCT00087425|Waldenström macroglobulinemia|waldenström macroglobulinemia
841319|NCT00087425|contiguous stage II small lymphocytic lymphoma|contiguous stage ii small lymphocytic lymphoma
841320|NCT00087425|noncontiguous stage II small lymphocytic lymphoma|noncontiguous stage ii small lymphocytic lymphoma
841321|NCT00087425|recurrent small lymphocytic lymphoma|recurrent small lymphocytic lymphoma
841322|NCT00087425|stage III small lymphocytic lymphoma|stage iii small lymphocytic lymphoma
841323|NCT00087425|stage IV small lymphocytic lymphoma|stage iv small lymphocytic lymphoma
841324|NCT00087399|breast cancer|breast cancer
841325|NCT00087399|hot flashes|hot flashes
841326|NCT00087360|colon cancer|colon cancer
841327|NCT00087360|rectal cancer|rectal cancer
841328|NCT00087347|recurrent prostate cancer|recurrent prostate cancer
841329|NCT00087347|stage I prostate cancer|stage i prostate cancer
841330|NCT00087347|stage IIB prostate cancer|stage iib prostate cancer
841331|NCT00087347|stage IIA prostate cancer|stage iia prostate cancer
841332|NCT00087347|stage III prostate cancer|stage iii prostate cancer
841333|NCT00087347|stage IV prostate cancer|stage iv prostate cancer
841334|NCT00087347|stage I breast cancer|stage i breast cancer
841335|NCT00087347|stage II breast cancer|stage ii breast cancer
841336|NCT00087347|stage IIIA breast cancer|stage iiia breast cancer
841337|NCT00087347|stage IIIB breast cancer|stage iiib breast cancer
841338|NCT00087347|stage IIIC breast cancer|stage iiic breast cancer
841339|NCT00087347|stage IV breast cancer|stage iv breast cancer
841340|NCT00087347|recurrent breast cancer|recurrent breast cancer
841341|NCT00087334|recurrent colon cancer|recurrent colon cancer
841342|NCT00087334|stage IV colon cancer|stage iv colon cancer
841343|NCT00087334|recurrent rectal cancer|recurrent rectal cancer
841344|NCT00087334|stage IV rectal cancer|stage iv rectal cancer
841345|NCT00087295|recurrent bladder cancer|recurrent bladder cancer
841346|NCT00087295|stage IV bladder cancer|stage iv bladder cancer
841347|NCT00087295|transitional cell carcinoma of the bladder|transitional cell carcinoma of the bladder
841348|NCT00087295|metastatic transitional cell cancer of the renal pelvis and ureter|metastatic transitional cell cancer of the renal pelvis and ureter
841349|NCT00087295|recurrent transitional cell cancer of the renal pelvis and ureter|recurrent transitional cell cancer of the renal pelvis and ureter
841350|NCT00087295|anterior urethral cancer|anterior urethral cancer
841351|NCT00087295|posterior urethral cancer|posterior urethral cancer
841352|NCT00087295|recurrent urethral cancer|recurrent urethral cancer
841353|NCT00087295|urethral cancer associated with invasive bladder cancer|urethral cancer associated with invasive bladder cancer
841354|NCT00087282|adult primary hepatocellular carcinoma|adult primary hepatocellular carcinoma
841355|NCT00087282|advanced adult primary liver cancer|advanced adult primary liver cancer
841356|NCT00087282|recurrent adult primary liver cancer|recurrent adult primary liver cancer
841357|NCT00087256|stage I colon cancer|stage i colon cancer
841358|NCT00087256|adenocarcinoma of the colon|adenocarcinoma of the colon
841360|NCT00087178|stage II breast cancer|stage ii breast cancer
841361|NCT00087165|adenocarcinoma of the prostate|adenocarcinoma of the prostate
841362|NCT00087165|recurrent prostate cancer|recurrent prostate cancer
841363|NCT00087152|stage IV breast cancer|stage iv breast cancer
841364|NCT00087152|recurrent breast cancer|recurrent breast cancer
841365|NCT00087126|recurrent cervical cancer|recurrent cervical cancer
841366|NCT00087126|cervical squamous cell carcinoma|cervical squamous cell carcinoma
841367|NCT00087113|cervical squamous cell carcinoma|cervical squamous cell carcinoma
841368|NCT00087113|recurrent cervical cancer|recurrent cervical cancer
841370|NCT00087113|stage IVA cervical cancer|stage iva cervical cancer
841371|NCT00087113|stage IVB cervical cancer|stage ivb cervical cancer
841372|NCT00087100|recurrent endometrial carcinoma|recurrent endometrial carcinoma
841373|NCT00087100|endometrial adenocarcinoma|endometrial adenocarcinoma
841374|NCT00087100|stage III endometrial carcinoma|stage iii endometrial carcinoma
841375|NCT00087100|stage IV endometrial carcinoma|stage iv endometrial carcinoma
841376|NCT00087087|recurrent ovarian epithelial cancer|recurrent ovarian epithelial cancer
841377|NCT00087087|primary peritoneal cavity cancer|primary peritoneal cavity cancer
841378|NCT00087061|adult anaplastic oligodendroglioma|adult anaplastic oligodendroglioma
841379|NCT00087061|recurrent adult brain tumor|recurrent adult brain tumor
841380|NCT00087061|adult glioblastoma|adult glioblastoma
841381|NCT00087061|adult anaplastic astrocytoma|adult anaplastic astrocytoma
841382|NCT00087061|adult giant cell glioblastoma|adult giant cell glioblastoma
841383|NCT00087061|adult gliosarcoma|adult gliosarcoma
841384|NCT00087048|extensive stage small cell lung cancer|extensive stage small cell lung cancer
841385|NCT00087048|recurrent small cell lung cancer|recurrent small cell lung cancer
841386|NCT00087035|adenocarcinoma of the prostate|adenocarcinoma of the prostate
841387|NCT00087035|recurrent prostate cancer|recurrent prostate cancer
841388|NCT00087022|clear cell renal cell carcinoma|clear cell renal cell carcinoma
841389|NCT00087022|stage I renal cell cancer|stage i renal cell cancer
841390|NCT00087022|stage II renal cell cancer|stage ii renal cell cancer
841391|NCT00087022|stage III renal cell cancer|stage iii renal cell cancer
841392|NCT00087022|stage IV renal cell cancer|stage iv renal cell cancer
841393|NCT00087009|post-transplant lymphoproliferative disorder|post-transplant lymphoproliferative disorder
841394|NCT00087009|recurrent childhood acute lymphoblastic leukemia|recurrent childhood acute lymphoblastic leukemia
841395|NCT00087009|recurrent childhood large cell lymphoma|recurrent childhood large cell lymphoma
841396|NCT00087009|recurrent childhood lymphoblastic lymphoma|recurrent childhood lymphoblastic lymphoma
841397|NCT00087009|recurrent childhood small noncleaved cell lymphoma|recurrent childhood small noncleaved cell lymphoma
841398|NCT00087009|recurrent/refractory childhood Hodgkin lymphoma|recurrent/refractory childhood hodgkin lymphoma
841399|NCT00087009|AIDS-related peripheral/systemic lymphoma|aids-related peripheral/systemic lymphoma
841400|NCT00087009|AIDS-related primary CNS lymphoma|aids-related primary cns lymphoma
841401|NCT00086996|adenocarcinoma of the esophagus|adenocarcinoma of the esophagus
841402|NCT00086996|stage II esophageal cancer|stage ii esophageal cancer
841403|NCT00086996|stage III esophageal cancer|stage iii esophageal cancer
841404|NCT00086957|stage IV breast cancer|stage iv breast cancer
841405|NCT00086957|male breast cancer|male breast cancer
841406|NCT00086957|recurrent breast cancer|recurrent breast cancer
841407|NCT00086931|adenocarcinoma of the rectum|adenocarcinoma of the rectum
841408|NCT00086931|stage III rectal cancer|stage iii rectal cancer
841409|NCT00086931|stage II rectal cancer|stage ii rectal cancer
841410|NCT00086892|recurrent ovarian epithelial cancer|recurrent ovarian epithelial cancer
841411|NCT00086892|primary peritoneal cavity cancer|primary peritoneal cavity cancer
841412|NCT00086879|adult glioblastoma|adult glioblastoma
841413|NCT00086879|recurrent adult brain tumor|recurrent adult brain tumor
841414|NCT00086879|adult giant cell glioblastoma|adult giant cell glioblastoma
841415|NCT00086879|adult gliosarcoma|adult gliosarcoma
841416|NCT00086866|stage III melanoma|stage iii melanoma
841417|NCT00086866|stage IV melanoma|stage iv melanoma
841418|NCT00086866|recurrent melanoma|recurrent melanoma
841419|NCT00086801|stage I adult Hodgkin lymphoma|stage i adult hodgkin lymphoma
841420|NCT00086801|stage II adult Hodgkin lymphoma|stage ii adult hodgkin lymphoma
841421|NCT00086775|refractory chronic lymphocytic leukemia|refractory chronic lymphocytic leukemia
841422|NCT00086775|B-cell chronic lymphocytic leukemia|b-cell chronic lymphocytic leukemia
841423|NCT00086762|nausea and vomiting|nausea and vomiting
841424|NCT00086762|unspecified adult solid tumor, protocol specific|unspecified adult solid tumor, protocol specific
841425|NCT00086762|mindfulness relaxation|mindfulness relaxation
841426|NCT00086749|breast cancer|breast cancer
841427|NCT00086749|stage I breast cancer|stage i breast cancer
841428|NCT00086749|stage II breast cancer|stage ii breast cancer
841429|NCT00086749|stage IIIA breast cancer|stage iiia breast cancer
841430|NCT00086749|stage IIIB breast cancer|stage iiib breast cancer
841431|NCT00086749|stage IIIC breast cancer|stage iiic breast cancer
841432|NCT00086736|stage I prostate cancer|stage i prostate cancer
841433|NCT00086736|stage IIB prostate cancer|stage iib prostate cancer
841434|NCT00086736|stage IIA prostate cancer|stage iia prostate cancer
841435|NCT00086736|stage III prostate cancer|stage iii prostate cancer
841436|NCT00086723|unspecified adult solid tumor, protocol specific|unspecified adult solid tumor, protocol specific
841437|NCT00086684|Interstitial Cystitis|interstitial cystitis
841438|NCT00086684|Urinary Bladder Pain|urinary bladder pain
841439|NCT00086658|Hypereosinophilic Syndrome Hypereosinophilia|hypereosinophilic syndrome hypereosinophilia
841440|NCT00086658|mepolizumab|mepolizumab
841441|NCT00086658|anti IL-5|anti il-5
841442|NCT00086632|oregovomab|oregovomab
841443|NCT00086632|ovarex|ovarex
841444|NCT00086632|ovarian cancer|ovarian cancer
841445|NCT00086632|ovary|ovary
841446|NCT00086632|ovarian carcinoma|ovarian carcinoma
841447|NCT00086632|front-line|front-line
841448|NCT00086606|Peanut|peanut
841449|NCT00086619|Osteoporosis|osteoporosis
841450|NCT00086619|Parathyroid hormone|parathyroid hormone
841451|NCT00086619|Teriparatide|teriparatide
841452|NCT00086619|Bone formation|bone formation
841453|NCT00086619|Bone resorption|bone resorption
841454|NCT00086593|adjunctive|adjunctive
841455|NCT00086593|atypical antipsychotics|atypical antipsychotics
841456|NCT00086593|add-on|add-on
841457|NCT00086593|Schizophrenia|schizophrenia
841458|NCT00086593|psychosis|psychosis
841459|NCT00003297|stage III ovarian epithelial cancer|stage iii ovarian epithelial cancer
841460|NCT00003297|stage IV ovarian epithelial cancer|stage iv ovarian epithelial cancer
841461|NCT00003297|recurrent ovarian epithelial cancer|recurrent ovarian epithelial cancer
841462|NCT00003296|localized resectable adult primary liver cancer|localized resectable adult primary liver cancer
841463|NCT00003296|localized unresectable adult primary liver cancer|localized unresectable adult primary liver cancer
841464|NCT00003296|advanced adult primary liver cancer|advanced adult primary liver cancer
841465|NCT00003296|recurrent adult primary liver cancer|recurrent adult primary liver cancer
841466|NCT00003296|localized gallbladder cancer|localized gallbladder cancer
841467|NCT00003296|unresectable gallbladder cancer|unresectable gallbladder cancer
841468|NCT00003296|recurrent gallbladder cancer|recurrent gallbladder cancer
841469|NCT00003296|localized extrahepatic bile duct cancer|localized extrahepatic bile duct cancer
841470|NCT00003296|unresectable extrahepatic bile duct cancer|unresectable extrahepatic bile duct cancer
841471|NCT00003296|recurrent extrahepatic bile duct cancer|recurrent extrahepatic bile duct cancer
841472|NCT00003296|adult primary hepatocellular carcinoma|adult primary hepatocellular carcinoma
841473|NCT00003296|cholangiocarcinoma of the gallbladder|cholangiocarcinoma of the gallbladder
841474|NCT00003296|cholangiocarcinoma of the extrahepatic bile duct|cholangiocarcinoma of the extrahepatic bile duct
841475|NCT00003296|adult primary cholangiocellular carcinoma|adult primary cholangiocellular carcinoma
841476|NCT00003230|recurrent adult acute myeloid leukemia|recurrent adult acute myeloid leukemia
841477|NCT00003230|recurrent adult acute lymphoblastic leukemia|recurrent adult acute lymphoblastic leukemia
841478|NCT00003230|blastic phase chronic myelogenous leukemia|blastic phase chronic myelogenous leukemia
841479|NCT00003230|untreated adult acute lymphoblastic leukemia|untreated adult acute lymphoblastic leukemia
841480|NCT00003230|untreated adult acute myeloid leukemia|untreated adult acute myeloid leukemia
841481|NCT00003198|unspecified adult solid tumor, protocol specific|unspecified adult solid tumor, protocol specific
841482|NCT00003109|unspecified adult solid tumor, protocol specific|unspecified adult solid tumor, protocol specific
841483|NCT00086541|Chronic Hepatitis C|chronic hepatitis c
841484|NCT00086541|Liver|liver
841485|NCT00086541|Pegylated|pegylated
841486|NCT00086541|Interferon|interferon
841487|NCT00086541|Alpha|alpha
841488|NCT00086541|Ribavirin|ribavirin
841489|NCT00086541|Combination|combination
841490|NCT00086541|Nonresponder|nonresponder
841492|NCT00086541|Infergen|infergen
841493|NCT00086541|SVR|svr
841494|NCT00086528|Solid Tumors|solid tumors
841495|NCT00086411|light smokers, smoking cessation treatment programs|light smokers, smoking cessation treatment programs
841496|NCT00086385|Smoking cessation|smoking cessation
841497|NCT00086385|Tobacco|tobacco
841498|NCT00003091|stage IV renal cell cancer|stage iv renal cell cancer
841499|NCT00003091|recurrent renal cell cancer|recurrent renal cell cancer
841500|NCT00003091|stage IV melanoma|stage iv melanoma
841501|NCT00003091|recurrent melanoma|recurrent melanoma
841502|NCT00002953|stage IV breast cancer|stage iv breast cancer
841503|NCT00002922|stage IV squamous cell carcinoma of the lip and oral cavity|stage iv squamous cell carcinoma of the lip and oral cavity
841504|NCT00002922|recurrent squamous cell carcinoma of the lip and oral cavity|recurrent squamous cell carcinoma of the lip and oral cavity
841505|NCT00002922|stage IV squamous cell carcinoma of the oropharynx|stage iv squamous cell carcinoma of the oropharynx
841506|NCT00002922|recurrent squamous cell carcinoma of the oropharynx|recurrent squamous cell carcinoma of the oropharynx
841507|NCT00002922|stage IV squamous cell carcinoma of the nasopharynx|stage iv squamous cell carcinoma of the nasopharynx
841508|NCT00002922|recurrent squamous cell carcinoma of the nasopharynx|recurrent squamous cell carcinoma of the nasopharynx
841509|NCT00002922|stage IV squamous cell carcinoma of the hypopharynx|stage iv squamous cell carcinoma of the hypopharynx
841510|NCT00002922|recurrent squamous cell carcinoma of the hypopharynx|recurrent squamous cell carcinoma of the hypopharynx
841511|NCT00002922|stage IV squamous cell carcinoma of the larynx|stage iv squamous cell carcinoma of the larynx
841512|NCT00002922|recurrent squamous cell carcinoma of the larynx|recurrent squamous cell carcinoma of the larynx
841513|NCT00002922|stage IV squamous cell carcinoma of the paranasal sinus and nasal cavity|stage iv squamous cell carcinoma of the paranasal sinus and nasal cavity
841514|NCT00002922|recurrent squamous cell carcinoma of the paranasal sinus and nasal cavity|recurrent squamous cell carcinoma of the paranasal sinus and nasal cavity
841515|NCT00002863|recurrent childhood rhabdomyosarcoma|recurrent childhood rhabdomyosarcoma
841516|NCT00002863|stage I adult soft tissue sarcoma|stage i adult soft tissue sarcoma
841517|NCT00002863|stage II adult soft tissue sarcoma|stage ii adult soft tissue sarcoma
841518|NCT00002863|stage III adult soft tissue sarcoma|stage iii adult soft tissue sarcoma
841519|NCT00002863|recurrent adult soft tissue sarcoma|recurrent adult soft tissue sarcoma
841520|NCT00002863|nonmetastatic childhood soft tissue sarcoma|nonmetastatic childhood soft tissue sarcoma
841521|NCT00002863|recurrent childhood soft tissue sarcoma|recurrent childhood soft tissue sarcoma
841522|NCT00002863|previously untreated childhood rhabdomyosarcoma|previously untreated childhood rhabdomyosarcoma
841523|NCT00002863|stage IV adult soft tissue sarcoma|stage iv adult soft tissue sarcoma
841524|NCT00086567|Blood|blood
841525|NCT00086567|Testing|testing
841526|NCT00086567|Gynecologic|gynecologic
841527|NCT00086567|Urine|urine
841528|NCT00086567|CA125|ca125
841529|NCT00086567|Epithelial Ovarian Cancer|epithelial ovarian cancer
841530|NCT00086567|Peritoneal Cancer|peritoneal cancer
841531|NCT00086567|Fallopian Tube Cancer|fallopian tube cancer
841532|NCT00086554|Surgery|surgery
841533|NCT00086554|Intestinal Resection|intestinal resection
841534|NCT00086554|Blood Sample|blood sample
841535|NCT00086515|Type 2 Diabetes Mellitus|type 2 diabetes mellitus
841536|NCT00086489|metastatic melanoma|metastatic melanoma
841537|NCT00086489|multiple dose|multiple dose
841538|NCT00086463|STEP|step
841540|NCT00086463|iloprost|iloprost
841541|NCT00086463|inhalation|inhalation
841542|NCT00086463|prostacyclin|prostacyclin
841543|NCT00002999|stage III nasopharyngeal cancer|stage iii nasopharyngeal cancer
841544|NCT00002999|stage IV nasopharyngeal cancer|stage iv nasopharyngeal cancer
841545|NCT00086476|Gray Platelet Syndrome|gray platelet syndrome
841546|NCT00086476|Hermansky-Pudlak Syndrome|hermansky-pudlak syndrome
841547|NCT00086476|Storage Pool Deficiency|storage pool deficiency
841548|NCT00086476|Organelle Formation|organelle formation
841549|NCT00086476|Megakaryocyte Development|megakaryocyte development
841550|NCT00086476|Megakaryocytes|megakaryocytes
841551|NCT00086476|Platelets|platelets
841552|NCT00086476|Dense Granules|dense granules
841553|NCT00086476|Alpha Granules|alpha granules
841554|NCT00086476|Lysosome-related Organelles|lysosome-related organelles
841555|NCT00086476|GPS|gps
841556|NCT00086476|HPS|hps
841557|NCT00086476|Griscelli Disease|griscelli disease
841558|NCT00086476|Chediak Higashi Syndrome|chediak higashi syndrome
841559|NCT00086476|Wiskott Aldrich Syndrome|wiskott aldrich syndrome
841560|NCT00086476|Platelet|platelet
841561|NCT00086476|Congenital Bleeding Disorders|congenital bleeding disorders
841562|NCT00086476|SAC|sac
841563|NCT00086476|Vesicle|vesicle
841564|NCT00086346|Liver|liver
841565|NCT00086346|Transplant|transplant
841566|NCT00086333|Carcinoma, Non-Small-Cell Lung|carcinoma, non-small-cell lung
841567|NCT00086333|Taxotere|taxotere
841568|NCT00086333|docetaxel|docetaxel
841569|NCT00086333|taxanes|taxanes
841570|NCT00086372|Acute Infection|acute infection
841571|NCT00086372|Treatment Experienced|treatment experienced
841572|NCT00086372|Treatment Naive|treatment naive
841573|NCT00086359|Treatment Naive|treatment naive
841574|NCT00086359|Perinatal Transmission|perinatal transmission
841575|NCT00086359|Mother-to-Child Transmission|mother-to-child transmission
841576|NCT00086359|MTCT|mtct
841577|NCT00086359|Treatment Experienced|treatment experienced
841578|NCT00086320|Schizophrenia|schizophrenia
841579|NCT00086320|paliperidone|paliperidone
841580|NCT00086320|Risperidone|risperidone
841581|NCT00086281|Sleep-disordered breathing|sleep-disordered breathing
841582|NCT00086281|Obstructive sleep apnea syndrome|obstructive sleep apnea syndrome
841583|NCT00086268|lung cancer|lung cancer
841584|NCT00086268|ZPACT|zpact
841585|NCT00086268|US75|us75
841586|NCT00086268|Bone Metastases|bone metastases
841587|NCT00002837|stage IV breast cancer|stage iv breast cancer
841588|NCT00002837|recurrent breast cancer|recurrent breast cancer
841589|NCT00002804|nonmetastatic childhood soft tissue sarcoma|nonmetastatic childhood soft tissue sarcoma
841590|NCT00002804|metastatic childhood soft tissue sarcoma|metastatic childhood soft tissue sarcoma
841591|NCT00002751|leptomeningeal metastases|leptomeningeal metastases
841592|NCT00002733|stage IV renal cell cancer|stage iv renal cell cancer
841593|NCT00002733|stage IV melanoma|stage iv melanoma
841594|NCT00002733|unspecified adult solid tumor, protocol specific|unspecified adult solid tumor, protocol specific
841595|NCT00002705|recurrent childhood acute lymphoblastic leukemia|recurrent childhood acute lymphoblastic leukemia
841596|NCT00002705|recurrent childhood acute myeloid leukemia|recurrent childhood acute myeloid leukemia
841597|NCT00002705|relapsing chronic myelogenous leukemia|relapsing chronic myelogenous leukemia
841598|NCT00002704|recurrent childhood acute lymphoblastic leukemia|recurrent childhood acute lymphoblastic leukemia
841599|NCT00002704|T-cell childhood acute lymphoblastic leukemia|t-cell childhood acute lymphoblastic leukemia
841600|NCT00002704|B-cell childhood acute lymphoblastic leukemia|b-cell childhood acute lymphoblastic leukemia
841601|NCT00002704|TdT positive childhood acute lymphoblastic leukemia|tdt positive childhood acute lymphoblastic leukemia
841602|NCT00002691|stage III childhood lymphoblastic lymphoma|stage iii childhood lymphoblastic lymphoma
841673|NCT00086177|Pregnancy,|pregnancy,
841603|NCT00002691|stage IV childhood lymphoblastic lymphoma|stage iv childhood lymphoblastic lymphoma
841604|NCT00002691|stage III childhood small noncleaved cell lymphoma|stage iii childhood small noncleaved cell lymphoma
841605|NCT00002691|stage III childhood large cell lymphoma|stage iii childhood large cell lymphoma
841606|NCT00002691|stage IV childhood large cell lymphoma|stage iv childhood large cell lymphoma
841607|NCT00002654|stage III squamous cell carcinoma of the lip and oral cavity|stage iii squamous cell carcinoma of the lip and oral cavity
841608|NCT00002654|stage IV squamous cell carcinoma of the lip and oral cavity|stage iv squamous cell carcinoma of the lip and oral cavity
841609|NCT00002654|stage III squamous cell carcinoma of the oropharynx|stage iii squamous cell carcinoma of the oropharynx
855951|NCT00071097|Ritonavir|ritonavir
841610|NCT00002654|stage IV squamous cell carcinoma of the oropharynx|stage iv squamous cell carcinoma of the oropharynx
841611|NCT00002654|stage III squamous cell carcinoma of the hypopharynx|stage iii squamous cell carcinoma of the hypopharynx
841612|NCT00002654|stage IV squamous cell carcinoma of the hypopharynx|stage iv squamous cell carcinoma of the hypopharynx
841613|NCT00002654|stage III squamous cell carcinoma of the larynx|stage iii squamous cell carcinoma of the larynx
841614|NCT00002654|stage IV squamous cell carcinoma of the larynx|stage iv squamous cell carcinoma of the larynx
841615|NCT00086307|Pramipexole|pramipexole
841616|NCT00086307|Escitalopran|escitalopran
841617|NCT00086307|Antidepressant|antidepressant
841618|NCT00086307|Dopaminergic Receptor Agonist|dopaminergic receptor agonist
841619|NCT00086307|Depression|depression
841620|NCT00086307|Major Depression|major depression
841621|NCT00086294|Non-Dopaminergic|non-dopaminergic
841622|NCT00086294|Dyskinesias|dyskinesias
841623|NCT00086294|Fluctuations|fluctuations
841624|NCT00086294|Inverse Agonist|inverse agonist
841625|NCT00086294|ACP-103|acp-103
841626|NCT00086294|Parkinson Disease|parkinson disease
841627|NCT00086294|PD|pd
841628|NCT00086255|cocaine dependence|cocaine dependence
841629|NCT00086216|Multiple myeloma|multiple myeloma
841630|NCT00002642|squamous cell lung cancer|squamous cell lung cancer
841631|NCT00002642|large cell lung cancer|large cell lung cancer
841632|NCT00002642|stage IIIA non-small cell lung cancer|stage iiia non-small cell lung cancer
841633|NCT00002642|stage IIIB non-small cell lung cancer|stage iiib non-small cell lung cancer
841634|NCT00002642|adenocarcinoma of the lung|adenocarcinoma of the lung
841635|NCT00002642|adenosquamous cell lung cancer|adenosquamous cell lung cancer
841636|NCT00002565|stage I grade 3 follicular lymphoma|stage i grade 3 follicular lymphoma
841637|NCT00002565|stage I adult diffuse mixed cell lymphoma|stage i adult diffuse mixed cell lymphoma
841638|NCT00002565|stage I adult diffuse large cell lymphoma|stage i adult diffuse large cell lymphoma
841639|NCT00002565|stage I adult immunoblastic large cell lymphoma|stage i adult immunoblastic large cell lymphoma
841640|NCT00002565|stage II grade 3 follicular lymphoma|stage ii grade 3 follicular lymphoma
841641|NCT00002565|stage II adult diffuse mixed cell lymphoma|stage ii adult diffuse mixed cell lymphoma
841642|NCT00002565|stage II adult diffuse large cell lymphoma|stage ii adult diffuse large cell lymphoma
841643|NCT00002565|stage II adult immunoblastic large cell lymphoma|stage ii adult immunoblastic large cell lymphoma
841644|NCT00002565|stage III grade 3 follicular lymphoma|stage iii grade 3 follicular lymphoma
841645|NCT00002565|stage III adult diffuse mixed cell lymphoma|stage iii adult diffuse mixed cell lymphoma
841646|NCT00002565|stage III adult diffuse large cell lymphoma|stage iii adult diffuse large cell lymphoma
841647|NCT00002565|stage III adult immunoblastic large cell lymphoma|stage iii adult immunoblastic large cell lymphoma
841648|NCT00002565|stage IV grade 3 follicular lymphoma|stage iv grade 3 follicular lymphoma
841649|NCT00002565|stage IV adult diffuse mixed cell lymphoma|stage iv adult diffuse mixed cell lymphoma
841650|NCT00002565|stage IV adult diffuse large cell lymphoma|stage iv adult diffuse large cell lymphoma
841651|NCT00002565|stage IV adult immunoblastic large cell lymphoma|stage iv adult immunoblastic large cell lymphoma
841652|NCT00002565|contiguous stage II grade 3 follicular lymphoma|contiguous stage ii grade 3 follicular lymphoma
841653|NCT00002565|contiguous stage II adult diffuse mixed cell lymphoma|contiguous stage ii adult diffuse mixed cell lymphoma
841654|NCT00002565|contiguous stage II adult immunoblastic large cell lymphoma|contiguous stage ii adult immunoblastic large cell lymphoma
841655|NCT00002565|contiguous stage II adult diffuse large cell lymphoma|contiguous stage ii adult diffuse large cell lymphoma
841656|NCT00002565|noncontiguous stage II grade 3 follicular lymphoma|noncontiguous stage ii grade 3 follicular lymphoma
841657|NCT00002565|noncontiguous stage II adult diffuse mixed cell lymphoma|noncontiguous stage ii adult diffuse mixed cell lymphoma
841658|NCT00002565|noncontiguous stage II adult immunoblastic large cell lymphoma|noncontiguous stage ii adult immunoblastic large cell lymphoma
841659|NCT00002565|noncontiguous stage II adult diffuse large cell lymphoma|noncontiguous stage ii adult diffuse large cell lymphoma
841660|NCT00086242|psychosocial effects of cancer and its treatment|psychosocial effects of cancer and its treatment
841661|NCT00086242|stage IA cervical cancer|stage ia cervical cancer
841662|NCT00086242|stage IB cervical cancer|stage ib cervical cancer
841663|NCT00086242|stage IIA cervical cancer|stage iia cervical cancer
841664|NCT00086242|stage IIB cervical cancer|stage iib cervical cancer
841665|NCT00086242|stage III cervical cancer|stage iii cervical cancer
841666|NCT00086229|Complementary Therapies|complementary therapies
841667|NCT00086190|Parkinson disease|parkinson disease
841668|NCT00086190|depression|depression
841669|NCT00086190|Parkinson's disease|parkinson's disease
841670|NCT00086190|paroxetine|paroxetine
841671|NCT00086190|venlafaxine|venlafaxine
841672|NCT00086190|antidepressant|antidepressant
841674|NCT00086177|prevention of preterm birth,|prevention of preterm birth,
841675|NCT00086177|prevention of preterm labor,|prevention of preterm labor,
841676|NCT00086164|edifoligide|edifoligide
841677|NCT00086164|E2F Decoy|e2f decoy
841678|NCT00086164|Chronic Renal failure|chronic renal failure
841679|NCT00086164|hemodialysis|hemodialysis
841680|NCT00086164|AV Graft|av graft
841681|NCT00086164|neointimal hyperplasia|neointimal hyperplasia
841682|NCT00086138|Alzheimer's disease|alzheimer's disease
841683|NCT00086138|Depression|depression
841684|NCT00086125|Relapsed or refractory hematologic malignancies|relapsed or refractory hematologic malignancies
841685|NCT00086112|Anxiety|anxiety
841686|NCT00086112|antipsychotic|antipsychotic
841687|NCT00006041|recurrent ovarian epithelial cancer|recurrent ovarian epithelial cancer
841688|NCT00006041|fallopian tube cancer|fallopian tube cancer
841689|NCT00006041|primary peritoneal cavity cancer|primary peritoneal cavity cancer
841690|NCT00005975|stage I breast cancer|stage i breast cancer
841691|NCT00005975|stage II breast cancer|stage ii breast cancer
841692|NCT00005975|hot flashes|hot flashes
841693|NCT00005854|recurrent childhood acute lymphoblastic leukemia|recurrent childhood acute lymphoblastic leukemia
841694|NCT00005854|refractory multiple myeloma|refractory multiple myeloma
841695|NCT00005854|stage I multiple myeloma|stage i multiple myeloma
841696|NCT00005854|stage II multiple myeloma|stage ii multiple myeloma
841697|NCT00005854|stage III multiple myeloma|stage iii multiple myeloma
841698|NCT00005854|recurrent childhood lymphoblastic lymphoma|recurrent childhood lymphoblastic lymphoma
841699|NCT00005854|stage III chronic lymphocytic leukemia|stage iii chronic lymphocytic leukemia
841700|NCT00005854|stage IV chronic lymphocytic leukemia|stage iv chronic lymphocytic leukemia
841701|NCT00005854|recurrent childhood acute myeloid leukemia|recurrent childhood acute myeloid leukemia
841702|NCT00005854|recurrent adult acute myeloid leukemia|recurrent adult acute myeloid leukemia
841703|NCT00005854|recurrent adult acute lymphoblastic leukemia|recurrent adult acute lymphoblastic leukemia
841704|NCT00005854|relapsing chronic myelogenous leukemia|relapsing chronic myelogenous leukemia
841705|NCT00005854|refractory chronic lymphocytic leukemia|refractory chronic lymphocytic leukemia
841706|NCT00005854|accelerated phase chronic myelogenous leukemia|accelerated phase chronic myelogenous leukemia
841707|NCT00005854|blastic phase chronic myelogenous leukemia|blastic phase chronic myelogenous leukemia
841708|NCT00005854|meningeal chronic myelogenous leukemia|meningeal chronic myelogenous leukemia
841709|NCT00005854|adult acute myeloid leukemia in remission|adult acute myeloid leukemia in remission
841710|NCT00005854|adult acute lymphoblastic leukemia in remission|adult acute lymphoblastic leukemia in remission
841711|NCT00005854|childhood acute myeloid leukemia in remission|childhood acute myeloid leukemia in remission
841712|NCT00005854|childhood acute lymphoblastic leukemia in remission|childhood acute lymphoblastic leukemia in remission
841713|NCT00005854|recurrent grade 1 follicular lymphoma|recurrent grade 1 follicular lymphoma
841714|NCT00005854|recurrent grade 2 follicular lymphoma|recurrent grade 2 follicular lymphoma
841715|NCT00005854|recurrent grade 3 follicular lymphoma|recurrent grade 3 follicular lymphoma
841716|NCT00005854|recurrent adult diffuse small cleaved cell lymphoma|recurrent adult diffuse small cleaved cell lymphoma
841717|NCT00005854|recurrent adult diffuse mixed cell lymphoma|recurrent adult diffuse mixed cell lymphoma
841718|NCT00005854|recurrent adult diffuse large cell lymphoma|recurrent adult diffuse large cell lymphoma
841719|NCT00005854|recurrent adult immunoblastic large cell lymphoma|recurrent adult immunoblastic large cell lymphoma
841720|NCT00005854|recurrent adult lymphoblastic lymphoma|recurrent adult lymphoblastic lymphoma
841721|NCT00005854|recurrent adult Burkitt lymphoma|recurrent adult burkitt lymphoma
841722|NCT00005854|secondary acute myeloid leukemia|secondary acute myeloid leukemia
841723|NCT00005854|de novo myelodysplastic syndromes|de novo myelodysplastic syndromes
841724|NCT00005854|previously treated myelodysplastic syndromes|previously treated myelodysplastic syndromes
841725|NCT00005854|secondary myelodysplastic syndromes|secondary myelodysplastic syndromes
841726|NCT00005854|recurrent childhood small noncleaved cell lymphoma|recurrent childhood small noncleaved cell lymphoma
841727|NCT00005854|recurrent childhood large cell lymphoma|recurrent childhood large cell lymphoma
841728|NCT00005854|recurrent mantle cell lymphoma|recurrent mantle cell lymphoma
841729|NCT00005854|recurrent marginal zone lymphoma|recurrent marginal zone lymphoma
841730|NCT00005854|recurrent small lymphocytic lymphoma|recurrent small lymphocytic lymphoma
841731|NCT00005854|extranodal marginal zone B-cell lymphoma of mucosa-associated lymphoid tissue|extranodal marginal zone b-cell lymphoma of mucosa-associated lymphoid tissue
841732|NCT00005854|nodal marginal zone B-cell lymphoma|nodal marginal zone b-cell lymphoma
841733|NCT00005854|splenic marginal zone lymphoma|splenic marginal zone lymphoma
841734|NCT00005854|childhood myelodysplastic syndromes|childhood myelodysplastic syndromes
841735|NCT00002505|unspecified adult solid tumor, protocol specific|unspecified adult solid tumor, protocol specific
841736|NCT00002482|unspecified adult solid tumor, protocol specific|unspecified adult solid tumor, protocol specific
841737|NCT00005613|stage III adult Hodgkin lymphoma|stage iii adult hodgkin lymphoma
841738|NCT00005613|stage IV adult Hodgkin lymphoma|stage iv adult hodgkin lymphoma
841739|NCT00005613|recurrent adult Hodgkin lymphoma|recurrent adult hodgkin lymphoma
841740|NCT00005613|recurrent grade 1 follicular lymphoma|recurrent grade 1 follicular lymphoma
841741|NCT00005613|recurrent grade 2 follicular lymphoma|recurrent grade 2 follicular lymphoma
841742|NCT00005613|recurrent grade 3 follicular lymphoma|recurrent grade 3 follicular lymphoma
841807|NCT00086086|Anaemia|anaemia
841808|NCT00086086|Anemia|anemia
841743|NCT00005613|recurrent adult diffuse small cleaved cell lymphoma|recurrent adult diffuse small cleaved cell lymphoma
841744|NCT00005613|recurrent adult diffuse mixed cell lymphoma|recurrent adult diffuse mixed cell lymphoma
841745|NCT00005613|recurrent adult diffuse large cell lymphoma|recurrent adult diffuse large cell lymphoma
841746|NCT00005613|recurrent adult immunoblastic large cell lymphoma|recurrent adult immunoblastic large cell lymphoma
841747|NCT00005613|recurrent adult Burkitt lymphoma|recurrent adult burkitt lymphoma
841748|NCT00005613|recurrent mantle cell lymphoma|recurrent mantle cell lymphoma
841749|NCT00005613|recurrent marginal zone lymphoma|recurrent marginal zone lymphoma
841750|NCT00005613|recurrent small lymphocytic lymphoma|recurrent small lymphocytic lymphoma
841751|NCT00005613|extranodal marginal zone B-cell lymphoma of mucosa-associated lymphoid tissue|extranodal marginal zone b-cell lymphoma of mucosa-associated lymphoid tissue
841752|NCT00005613|nodal marginal zone B-cell lymphoma|nodal marginal zone b-cell lymphoma
841753|NCT00005613|splenic marginal zone lymphoma|splenic marginal zone lymphoma
841754|NCT00004202|recurrent non-small cell lung cancer|recurrent non-small cell lung cancer
841755|NCT00004202|stage IIIA non-small cell lung cancer|stage iiia non-small cell lung cancer
841756|NCT00004202|stage IIIB non-small cell lung cancer|stage iiib non-small cell lung cancer
841757|NCT00004197|stage I grade 3 follicular lymphoma|stage i grade 3 follicular lymphoma
841758|NCT00004197|stage I adult diffuse mixed cell lymphoma|stage i adult diffuse mixed cell lymphoma
841759|NCT00004197|stage I adult diffuse large cell lymphoma|stage i adult diffuse large cell lymphoma
841760|NCT00004197|stage I adult immunoblastic large cell lymphoma|stage i adult immunoblastic large cell lymphoma
841761|NCT00004197|stage III grade 3 follicular lymphoma|stage iii grade 3 follicular lymphoma
841762|NCT00004197|stage III adult diffuse mixed cell lymphoma|stage iii adult diffuse mixed cell lymphoma
841763|NCT00004197|stage III adult diffuse large cell lymphoma|stage iii adult diffuse large cell lymphoma
841764|NCT00004197|stage III adult immunoblastic large cell lymphoma|stage iii adult immunoblastic large cell lymphoma
841765|NCT00004197|stage IV grade 3 follicular lymphoma|stage iv grade 3 follicular lymphoma
841766|NCT00004197|stage IV adult diffuse mixed cell lymphoma|stage iv adult diffuse mixed cell lymphoma
841767|NCT00004197|stage IV adult diffuse large cell lymphoma|stage iv adult diffuse large cell lymphoma
841768|NCT00004197|stage IV adult immunoblastic large cell lymphoma|stage iv adult immunoblastic large cell lymphoma
841769|NCT00004197|stage I mantle cell lymphoma|stage i mantle cell lymphoma
841770|NCT00004197|contiguous stage II grade 3 follicular lymphoma|contiguous stage ii grade 3 follicular lymphoma
841771|NCT00004197|contiguous stage II mantle cell lymphoma|contiguous stage ii mantle cell lymphoma
841772|NCT00004197|contiguous stage II adult diffuse mixed cell lymphoma|contiguous stage ii adult diffuse mixed cell lymphoma
841773|NCT00004197|contiguous stage II adult immunoblastic large cell lymphoma|contiguous stage ii adult immunoblastic large cell lymphoma
841774|NCT00004197|contiguous stage II adult diffuse large cell lymphoma|contiguous stage ii adult diffuse large cell lymphoma
841775|NCT00004197|noncontiguous stage II grade 3 follicular lymphoma|noncontiguous stage ii grade 3 follicular lymphoma
841776|NCT00004197|noncontiguous stage II mantle cell lymphoma|noncontiguous stage ii mantle cell lymphoma
841777|NCT00004197|noncontiguous stage II adult diffuse mixed cell lymphoma|noncontiguous stage ii adult diffuse mixed cell lymphoma
841778|NCT00004197|noncontiguous stage II adult immunoblastic large cell lymphoma|noncontiguous stage ii adult immunoblastic large cell lymphoma
841779|NCT00004197|noncontiguous stage II adult diffuse large cell lymphoma|noncontiguous stage ii adult diffuse large cell lymphoma
841780|NCT00004197|stage III mantle cell lymphoma|stage iii mantle cell lymphoma
841781|NCT00004197|stage IV mantle cell lymphoma|stage iv mantle cell lymphoma
841782|NCT00004192|neutropenia|neutropenia
841783|NCT00004192|Waldenstrom macroglobulinemia|waldenstrom macroglobulinemia
841784|NCT00004192|recurrent grade 1 follicular lymphoma|recurrent grade 1 follicular lymphoma
841785|NCT00004192|recurrent grade 2 follicular lymphoma|recurrent grade 2 follicular lymphoma
841786|NCT00004192|recurrent grade 3 follicular lymphoma|recurrent grade 3 follicular lymphoma
841787|NCT00004192|recurrent adult diffuse small cleaved cell lymphoma|recurrent adult diffuse small cleaved cell lymphoma
841788|NCT00004192|recurrent adult diffuse mixed cell lymphoma|recurrent adult diffuse mixed cell lymphoma
841789|NCT00004192|recurrent adult diffuse large cell lymphoma|recurrent adult diffuse large cell lymphoma
841790|NCT00004192|recurrent adult immunoblastic large cell lymphoma|recurrent adult immunoblastic large cell lymphoma
841791|NCT00004192|recurrent adult lymphoblastic lymphoma|recurrent adult lymphoblastic lymphoma
841792|NCT00004192|recurrent adult Burkitt lymphoma|recurrent adult burkitt lymphoma
841793|NCT00004192|recurrent mantle cell lymphoma|recurrent mantle cell lymphoma
841794|NCT00004192|recurrent marginal zone lymphoma|recurrent marginal zone lymphoma
841795|NCT00004192|recurrent small lymphocytic lymphoma|recurrent small lymphocytic lymphoma
841796|NCT00004192|extranodal marginal zone B-cell lymphoma of mucosa-associated lymphoid tissue|extranodal marginal zone b-cell lymphoma of mucosa-associated lymphoid tissue
841797|NCT00004192|nodal marginal zone B-cell lymphoma|nodal marginal zone b-cell lymphoma
841798|NCT00004192|splenic marginal zone lymphoma|splenic marginal zone lymphoma
841799|NCT00003995|stage IV colon cancer|stage iv colon cancer
841800|NCT00003995|stage IV rectal cancer|stage iv rectal cancer
841801|NCT00003995|recurrent colon cancer|recurrent colon cancer
841802|NCT00003995|recurrent rectal cancer|recurrent rectal cancer
841803|NCT00003946|stage IV endometrial carcinoma|stage iv endometrial carcinoma
841804|NCT00003946|recurrent endometrial carcinoma|recurrent endometrial carcinoma
841805|NCT00086086|Symptomatic Congestive Heart Failure|symptomatic congestive heart failure
841806|NCT00086086|CHF|chf
841809|NCT00086073|Parkinson disease|parkinson disease
841810|NCT00086073|Parkinson's disease|parkinson's disease
841812|NCT00086073|genetics|genetics
841813|NCT00086073|genes|genes
841814|NCT00086073|siblings|siblings
841815|NCT00086073|family|family
841816|NCT00003762|recurrent non-small cell lung cancer|recurrent non-small cell lung cancer
841817|NCT00003762|stage IIIB non-small cell lung cancer|stage iiib non-small cell lung cancer
841818|NCT00003762|stage IV non-small cell lung cancer|stage iv non-small cell lung cancer
841819|NCT00003723|advanced malignant mesothelioma|advanced malignant mesothelioma
841820|NCT00003723|epithelial mesothelioma|epithelial mesothelioma
841821|NCT00003723|sarcomatous mesothelioma|sarcomatous mesothelioma
841822|NCT00003691|stage III endometrial carcinoma|stage iii endometrial carcinoma
841823|NCT00003691|stage IV endometrial carcinoma|stage iv endometrial carcinoma
841824|NCT00003691|recurrent endometrial carcinoma|recurrent endometrial carcinoma
841825|NCT00003667|nonmetastatic childhood soft tissue sarcoma|nonmetastatic childhood soft tissue sarcoma
841826|NCT00003667|metastatic childhood soft tissue sarcoma|metastatic childhood soft tissue sarcoma
841827|NCT00003667|extraosseous Ewing sarcoma/peripheral primitive neuroectodermal tumor|extraosseous ewing sarcoma/peripheral primitive neuroectodermal tumor
841828|NCT00003667|localized Ewing sarcoma/peripheral primitive neuroectodermal tumor|localized ewing sarcoma/peripheral primitive neuroectodermal tumor
841829|NCT00003667|metastatic Ewing sarcoma/peripheral primitive neuroectodermal tumor|metastatic ewing sarcoma/peripheral primitive neuroectodermal tumor
841830|NCT00003630|unspecified childhood solid tumor, protocol specific|unspecified childhood solid tumor, protocol specific
841831|NCT00003630|unspecified adult solid tumor, protocol specific|unspecified adult solid tumor, protocol specific
841832|NCT00003549|stage II neuroendocrine carcinoma of the skin|stage ii neuroendocrine carcinoma of the skin
841833|NCT00003549|stage III neuroendocrine carcinoma of the skin|stage iii neuroendocrine carcinoma of the skin
841834|NCT00003549|recurrent neuroendocrine carcinoma of the skin|recurrent neuroendocrine carcinoma of the skin
841835|NCT00003369|stage IV cervical cancer|stage iv cervical cancer
841836|NCT00003369|recurrent cervical cancer|recurrent cervical cancer
841837|NCT00003369|cervical squamous cell carcinoma|cervical squamous cell carcinoma
841838|NCT00003369|cervical adenosquamous cell carcinoma|cervical adenosquamous cell carcinoma
841839|NCT00003317|stage IIIA non-small cell lung cancer|stage iiia non-small cell lung cancer
841840|NCT00003127|stage IV endometrial carcinoma|stage iv endometrial carcinoma
841841|NCT00003127|recurrent endometrial carcinoma|recurrent endometrial carcinoma
841842|NCT00003127|endometrial adenocarcinoma|endometrial adenocarcinoma
841843|NCT00003127|endometrial adenosquamous cell carcinoma|endometrial adenosquamous cell carcinoma
841844|NCT00003127|endometrial clear cell carcinoma|endometrial clear cell carcinoma
841845|NCT00086060|Internal-External Control|internal-external control
841846|NCT00086060|Magnetic Resonance Imaging|magnetic resonance imaging
841847|NCT00086060|fMRI|fmri
841848|NCT00086060|Exercise|exercise
841849|NCT00086060|Relaxation|relaxation
841850|NCT00086047|Juvenile Fibromyalgia Syndrome|juvenile fibromyalgia syndrome
841851|NCT00086047|JPFS|jpfs
841852|NCT00086047|Fibromyalgia|fibromyalgia
841853|NCT00086047|Chronic Pain|chronic pain
841854|NCT00086047|Pediatric Pain|pediatric pain
841855|NCT00086047|Juvenile Fibromyalgia|juvenile fibromyalgia
841856|NCT00086034|Lymphoma|lymphoma
841857|NCT00086034|Non-Hodgkin's Lymphoma|non-hodgkin's lymphoma
841858|NCT00086034|Indolent lymphoma|indolent lymphoma
841859|NCT00086034|Relapsed lymphoma|relapsed lymphoma
841860|NCT00086034|Refractory lymphoma|refractory lymphoma
841861|NCT00086034|Motexafin gadolinium|motexafin gadolinium
841862|NCT00003078|stage III cervical cancer|stage iii cervical cancer
841863|NCT00003078|stage IIB cervical cancer|stage iib cervical cancer
841864|NCT00003078|stage IVA cervical cancer|stage iva cervical cancer
841865|NCT00003078|cervical squamous cell carcinoma|cervical squamous cell carcinoma
841866|NCT00003078|cervical adenocarcinoma|cervical adenocarcinoma
841867|NCT00003078|cervical adenosquamous cell carcinoma|cervical adenosquamous cell carcinoma
841868|NCT00002844|refractory chronic lymphocytic leukemia|refractory chronic lymphocytic leukemia
841869|NCT00002844|Cyclophosphamide|cyclophosphamide
841870|NCT00002844|Cytoxan|cytoxan
841871|NCT00002844|Neosar|neosar
841872|NCT00002844|Bone Marrow Transplantation|bone marrow transplantation
841873|NCT00002844|total body irradiation|total body irradiation
841874|NCT00002844|chronic lymphocytic leukemia|chronic lymphocytic leukemia
841875|NCT00002844|allogeneic|allogeneic
841876|NCT00002844|autologous|autologous
841877|NCT00002816|recurrent childhood acute lymphoblastic leukemia|recurrent childhood acute lymphoblastic leukemia
841878|NCT00002747|stage II squamous cell carcinoma of the lip and oral cavity|stage ii squamous cell carcinoma of the lip and oral cavity
841879|NCT00002747|stage III squamous cell carcinoma of the lip and oral cavity|stage iii squamous cell carcinoma of the lip and oral cavity
841880|NCT00002747|stage IV squamous cell carcinoma of the lip and oral cavity|stage iv squamous cell carcinoma of the lip and oral cavity
841881|NCT00002725|recurrent small lymphocytic lymphoma|recurrent small lymphocytic lymphoma
841882|NCT00002725|recurrent grade 1 follicular lymphoma|recurrent grade 1 follicular lymphoma
841883|NCT00002725|recurrent grade 2 follicular lymphoma|recurrent grade 2 follicular lymphoma
841884|NCT00002725|recurrent grade 3 follicular lymphoma|recurrent grade 3 follicular lymphoma
842446|NCT00085683|HV|hv
841885|NCT00002725|recurrent adult diffuse small cleaved cell lymphoma|recurrent adult diffuse small cleaved cell lymphoma
841886|NCT00002725|recurrent adult diffuse mixed cell lymphoma|recurrent adult diffuse mixed cell lymphoma
841887|NCT00002725|recurrent adult diffuse large cell lymphoma|recurrent adult diffuse large cell lymphoma
841888|NCT00002725|recurrent adult immunoblastic large cell lymphoma|recurrent adult immunoblastic large cell lymphoma
841889|NCT00002725|recurrent adult lymphoblastic lymphoma|recurrent adult lymphoblastic lymphoma
841890|NCT00002725|recurrent adult Burkitt lymphoma|recurrent adult burkitt lymphoma
841891|NCT00002725|recurrent mantle cell lymphoma|recurrent mantle cell lymphoma
841892|NCT00002725|recurrent marginal zone lymphoma|recurrent marginal zone lymphoma
856050|NCT00070850|Screening|screening
841893|NCT00002725|extranodal marginal zone B-cell lymphoma of mucosa-associated lymphoid tissue|extranodal marginal zone b-cell lymphoma of mucosa-associated lymphoid tissue
841894|NCT00002725|nodal marginal zone B-cell lymphoma|nodal marginal zone b-cell lymphoma
841895|NCT00002725|splenic marginal zone lymphoma|splenic marginal zone lymphoma
841896|NCT00086021|Headache|headache
841897|NCT00086021|Acupuncture|acupuncture
841898|NCT00085969|diabetes|diabetes
841899|NCT00085969|exenatide|exenatide
841900|NCT00085969|Amylin|amylin
841901|NCT00085969|Lilly|lilly
841902|NCT00006241|recurrent grade 1 follicular lymphoma|recurrent grade 1 follicular lymphoma
841903|NCT00006241|recurrent grade 2 follicular lymphoma|recurrent grade 2 follicular lymphoma
841904|NCT00006241|recurrent grade 3 follicular lymphoma|recurrent grade 3 follicular lymphoma
841905|NCT00006241|recurrent adult diffuse small cleaved cell lymphoma|recurrent adult diffuse small cleaved cell lymphoma
841906|NCT00006241|recurrent adult diffuse mixed cell lymphoma|recurrent adult diffuse mixed cell lymphoma
841907|NCT00006241|recurrent adult diffuse large cell lymphoma|recurrent adult diffuse large cell lymphoma
841908|NCT00006241|recurrent mantle cell lymphoma|recurrent mantle cell lymphoma
841909|NCT00006241|recurrent marginal zone lymphoma|recurrent marginal zone lymphoma
841910|NCT00006241|recurrent small lymphocytic lymphoma|recurrent small lymphocytic lymphoma
841911|NCT00006241|extranodal marginal zone B-cell lymphoma of mucosa-associated lymphoid tissue|extranodal marginal zone b-cell lymphoma of mucosa-associated lymphoid tissue
841912|NCT00006241|nodal marginal zone B-cell lymphoma|nodal marginal zone b-cell lymphoma
841913|NCT00006241|splenic marginal zone lymphoma|splenic marginal zone lymphoma
841914|NCT00006235|recurrent ovarian epithelial cancer|recurrent ovarian epithelial cancer
841915|NCT00006235|ovarian undifferentiated adenocarcinoma|ovarian undifferentiated adenocarcinoma
841916|NCT00006235|ovarian mixed epithelial carcinoma|ovarian mixed epithelial carcinoma
841917|NCT00006235|ovarian serous cystadenocarcinoma|ovarian serous cystadenocarcinoma
841918|NCT00006235|ovarian mucinous cystadenocarcinoma|ovarian mucinous cystadenocarcinoma
841919|NCT00006235|ovarian endometrioid adenocarcinoma|ovarian endometrioid adenocarcinoma
841920|NCT00006235|ovarian clear cell cystadenocarcinoma|ovarian clear cell cystadenocarcinoma
841921|NCT00006235|fallopian tube cancer|fallopian tube cancer
841922|NCT00006235|primary peritoneal cavity cancer|primary peritoneal cavity cancer
841923|NCT00006235|Brenner tumor|brenner tumor
841924|NCT00006214|prostate cancer|prostate cancer
841925|NCT00006117|stage III pancreatic cancer|stage iii pancreatic cancer
841926|NCT00006117|stage IV pancreatic cancer|stage iv pancreatic cancer
841927|NCT00006117|adenocarcinoma of the pancreas|adenocarcinoma of the pancreas
841928|NCT00006116|recurrent non-small cell lung cancer|recurrent non-small cell lung cancer
841929|NCT00006116|squamous cell lung cancer|squamous cell lung cancer
841930|NCT00006116|large cell lung cancer|large cell lung cancer
841931|NCT00006116|stage IIIB non-small cell lung cancer|stage iiib non-small cell lung cancer
841932|NCT00006116|stage IV non-small cell lung cancer|stage iv non-small cell lung cancer
841933|NCT00006116|adenocarcinoma of the lung|adenocarcinoma of the lung
841934|NCT00006088|unspecified adult solid tumor, protocol specific|unspecified adult solid tumor, protocol specific
841935|NCT00002717|stage III ovarian epithelial cancer|stage iii ovarian epithelial cancer
841936|NCT00002717|stage IV ovarian epithelial cancer|stage iv ovarian epithelial cancer
841937|NCT00002717|ovarian undifferentiated adenocarcinoma|ovarian undifferentiated adenocarcinoma
841938|NCT00002717|ovarian mixed epithelial carcinoma|ovarian mixed epithelial carcinoma
841939|NCT00002717|ovarian serous cystadenocarcinoma|ovarian serous cystadenocarcinoma
841940|NCT00002717|ovarian mucinous cystadenocarcinoma|ovarian mucinous cystadenocarcinoma
841941|NCT00002717|ovarian endometrioid adenocarcinoma|ovarian endometrioid adenocarcinoma
841942|NCT00002717|ovarian clear cell cystadenocarcinoma|ovarian clear cell cystadenocarcinoma
841943|NCT00002717|primary peritoneal cavity cancer|primary peritoneal cavity cancer
841944|NCT00002717|Brenner tumor|brenner tumor
841945|NCT00002657|isolated plasmacytoma of bone|isolated plasmacytoma of bone
841946|NCT00002657|extramedullary plasmacytoma|extramedullary plasmacytoma
841947|NCT00002657|refractory multiple myeloma|refractory multiple myeloma
841948|NCT00002657|Waldenstrom macroglobulinemia|waldenstrom macroglobulinemia
841949|NCT00002657|stage I multiple myeloma|stage i multiple myeloma
841950|NCT00002657|stage II multiple myeloma|stage ii multiple myeloma
841951|NCT00002657|stage III multiple myeloma|stage iii multiple myeloma
841952|NCT00002657|stage I small lymphocytic lymphoma|stage i small lymphocytic lymphoma
841953|NCT00002657|stage I grade 1 follicular lymphoma|stage i grade 1 follicular lymphoma
841954|NCT00002657|stage I grade 2 follicular lymphoma|stage i grade 2 follicular lymphoma
841955|NCT00002657|stage I grade 3 follicular lymphoma|stage i grade 3 follicular lymphoma
841956|NCT00002657|stage I adult diffuse small cleaved cell lymphoma|stage i adult diffuse small cleaved cell lymphoma
841957|NCT00002657|stage I adult diffuse mixed cell lymphoma|stage i adult diffuse mixed cell lymphoma
841958|NCT00002657|stage I adult diffuse large cell lymphoma|stage i adult diffuse large cell lymphoma
841959|NCT00002657|stage I adult immunoblastic large cell lymphoma|stage i adult immunoblastic large cell lymphoma
841960|NCT00002657|stage I adult Burkitt lymphoma|stage i adult burkitt lymphoma
841961|NCT00002657|stage II small lymphocytic lymphoma|stage ii small lymphocytic lymphoma
841962|NCT00002657|stage II grade 1 follicular lymphoma|stage ii grade 1 follicular lymphoma
841963|NCT00002657|stage II grade 2 follicular lymphoma|stage ii grade 2 follicular lymphoma
841964|NCT00002657|stage II grade 3 follicular lymphoma|stage ii grade 3 follicular lymphoma
841965|NCT00002657|stage II adult diffuse small cleaved cell lymphoma|stage ii adult diffuse small cleaved cell lymphoma
841966|NCT00002657|stage II adult diffuse mixed cell lymphoma|stage ii adult diffuse mixed cell lymphoma
841967|NCT00002657|stage II adult diffuse large cell lymphoma|stage ii adult diffuse large cell lymphoma
841968|NCT00002657|stage II adult immunoblastic large cell lymphoma|stage ii adult immunoblastic large cell lymphoma
841969|NCT00002657|stage II adult Burkitt lymphoma|stage ii adult burkitt lymphoma
841970|NCT00002657|stage III small lymphocytic lymphoma|stage iii small lymphocytic lymphoma
841971|NCT00002657|stage III grade 1 follicular lymphoma|stage iii grade 1 follicular lymphoma
841972|NCT00002657|stage III grade 2 follicular lymphoma|stage iii grade 2 follicular lymphoma
841973|NCT00002657|stage III grade 3 follicular lymphoma|stage iii grade 3 follicular lymphoma
841974|NCT00002657|stage III adult diffuse small cleaved cell lymphoma|stage iii adult diffuse small cleaved cell lymphoma
841975|NCT00002657|stage III adult diffuse mixed cell lymphoma|stage iii adult diffuse mixed cell lymphoma
841976|NCT00002657|stage III adult diffuse large cell lymphoma|stage iii adult diffuse large cell lymphoma
841977|NCT00002657|stage III adult immunoblastic large cell lymphoma|stage iii adult immunoblastic large cell lymphoma
841978|NCT00002657|stage III adult Burkitt lymphoma|stage iii adult burkitt lymphoma
841979|NCT00002657|stage IV small lymphocytic lymphoma|stage iv small lymphocytic lymphoma
841980|NCT00002657|stage IV grade 1 follicular lymphoma|stage iv grade 1 follicular lymphoma
841981|NCT00002657|stage IV grade 2 follicular lymphoma|stage iv grade 2 follicular lymphoma
841982|NCT00002657|stage IV grade 3 follicular lymphoma|stage iv grade 3 follicular lymphoma
841983|NCT00002657|stage IV adult diffuse small cleaved cell lymphoma|stage iv adult diffuse small cleaved cell lymphoma
841984|NCT00002657|stage IV adult diffuse mixed cell lymphoma|stage iv adult diffuse mixed cell lymphoma
841985|NCT00002657|stage IV adult diffuse large cell lymphoma|stage iv adult diffuse large cell lymphoma
841986|NCT00002657|stage IV adult immunoblastic large cell lymphoma|stage iv adult immunoblastic large cell lymphoma
841987|NCT00002657|stage IV adult Burkitt lymphoma|stage iv adult burkitt lymphoma
841988|NCT00002657|recurrent small lymphocytic lymphoma|recurrent small lymphocytic lymphoma
841989|NCT00002657|recurrent grade 1 follicular lymphoma|recurrent grade 1 follicular lymphoma
841990|NCT00002657|recurrent grade 2 follicular lymphoma|recurrent grade 2 follicular lymphoma
841991|NCT00002657|recurrent grade 3 follicular lymphoma|recurrent grade 3 follicular lymphoma
841992|NCT00002657|recurrent adult diffuse small cleaved cell lymphoma|recurrent adult diffuse small cleaved cell lymphoma
841993|NCT00002657|recurrent adult diffuse mixed cell lymphoma|recurrent adult diffuse mixed cell lymphoma
841994|NCT00002657|recurrent adult diffuse large cell lymphoma|recurrent adult diffuse large cell lymphoma
841995|NCT00002657|recurrent adult immunoblastic large cell lymphoma|recurrent adult immunoblastic large cell lymphoma
841996|NCT00002657|recurrent adult Burkitt lymphoma|recurrent adult burkitt lymphoma
841997|NCT00002657|contiguous stage II grade 1 follicular lymphoma|contiguous stage ii grade 1 follicular lymphoma
841998|NCT00002657|contiguous stage II grade 2 follicular lymphoma|contiguous stage ii grade 2 follicular lymphoma
841999|NCT00002657|contiguous stage II grade 3 follicular lymphoma|contiguous stage ii grade 3 follicular lymphoma
842000|NCT00002657|contiguous stage II adult diffuse small cleaved cell lymphoma|contiguous stage ii adult diffuse small cleaved cell lymphoma
842001|NCT00002657|contiguous stage II adult diffuse mixed cell lymphoma|contiguous stage ii adult diffuse mixed cell lymphoma
842002|NCT00002657|contiguous stage II adult immunoblastic large cell lymphoma|contiguous stage ii adult immunoblastic large cell lymphoma
842003|NCT00002657|contiguous stage II adult diffuse large cell lymphoma|contiguous stage ii adult diffuse large cell lymphoma
842004|NCT00002657|contiguous stage II adult Burkitt lymphoma|contiguous stage ii adult burkitt lymphoma
842005|NCT00002657|noncontiguous stage II grade 1 follicular lymphoma|noncontiguous stage ii grade 1 follicular lymphoma
842006|NCT00002657|noncontiguous stage II grade 2 follicular lymphoma|noncontiguous stage ii grade 2 follicular lymphoma
842007|NCT00002657|noncontiguous stage II grade 3 follicular lymphoma|noncontiguous stage ii grade 3 follicular lymphoma
842008|NCT00002657|noncontiguous stage II adult diffuse small cleaved cell lymphoma|noncontiguous stage ii adult diffuse small cleaved cell lymphoma
842009|NCT00002657|noncontiguous stage II adult diffuse mixed cell lymphoma|noncontiguous stage ii adult diffuse mixed cell lymphoma
842010|NCT00002657|noncontiguous stage II adult immunoblastic large cell lymphoma|noncontiguous stage ii adult immunoblastic large cell lymphoma
842011|NCT00002657|noncontiguous stage II adult diffuse large cell lymphoma|noncontiguous stage ii adult diffuse large cell lymphoma
842012|NCT00002657|noncontiguous stage II adult Burkitt lymphoma|noncontiguous stage ii adult burkitt lymphoma
842013|NCT00002657|noncontiguous stage II small lymphocytic lymphoma|noncontiguous stage ii small lymphocytic lymphoma
842014|NCT00002657|noncontiguous stage II marginal zone lymphoma|noncontiguous stage ii marginal zone lymphoma
842015|NCT00002657|recurrent marginal zone lymphoma|recurrent marginal zone lymphoma
842016|NCT00002657|stage I marginal zone lymphoma|stage i marginal zone lymphoma
842017|NCT00002657|stage III marginal zone lymphoma|stage iii marginal zone lymphoma
842018|NCT00002657|stage IV marginal zone lymphoma|stage iv marginal zone lymphoma
842019|NCT00002657|contiguous stage II marginal zone lymphoma|contiguous stage ii marginal zone lymphoma
842020|NCT00002657|contiguous stage II small lymphocytic lymphoma|contiguous stage ii small lymphocytic lymphoma
842021|NCT00002657|extranodal marginal zone B-cell lymphoma of mucosa-associated lymphoid tissue|extranodal marginal zone b-cell lymphoma of mucosa-associated lymphoid tissue
842022|NCT00002657|nodal marginal zone B-cell lymphoma|nodal marginal zone b-cell lymphoma
842023|NCT00002657|splenic marginal zone lymphoma|splenic marginal zone lymphoma
842024|NCT00085995|Syndesmophyte|syndesmophyte
842025|NCT00085995|Ankylosing Spondylitis|ankylosing spondylitis
842027|NCT00085995|Spondyloarthropathy|spondyloarthropathy
842028|NCT00085995|Spondyloarthritis|spondyloarthritis
842029|NCT00085982|Rabson Mendenhall|rabson mendenhall
842030|NCT00085982|Type B Insulin Resistance|type b insulin resistance
842031|NCT00085982|Type A Insulin Resistance|type a insulin resistance
842032|NCT00085943|ritonavir|ritonavir
842033|NCT00085943|abacavir|abacavir
842034|NCT00085943|HIV|hiv
842035|NCT00085943|lopinavir|lopinavir
842036|NCT00085943|lamivudine|lamivudine
842037|NCT00085943|fosamprenavir|fosamprenavir
842038|NCT00085943|Epzicom|epzicom
842039|NCT00085930|Neuroblastoma|neuroblastoma
842040|NCT00006035|stage III melanoma|stage iii melanoma
842041|NCT00006035|stage IV melanoma|stage iv melanoma
842042|NCT00006035|recurrent melanoma|recurrent melanoma
842043|NCT00006033|recurrent metastatic squamous neck cancer with occult primary|recurrent metastatic squamous neck cancer with occult primary
842044|NCT00006033|stage III squamous cell carcinoma of the lip and oral cavity|stage iii squamous cell carcinoma of the lip and oral cavity
842045|NCT00006033|stage IV squamous cell carcinoma of the lip and oral cavity|stage iv squamous cell carcinoma of the lip and oral cavity
842046|NCT00006033|recurrent squamous cell carcinoma of the lip and oral cavity|recurrent squamous cell carcinoma of the lip and oral cavity
842047|NCT00006033|stage III squamous cell carcinoma of the oropharynx|stage iii squamous cell carcinoma of the oropharynx
842048|NCT00006033|stage IV squamous cell carcinoma of the oropharynx|stage iv squamous cell carcinoma of the oropharynx
842049|NCT00006033|recurrent squamous cell carcinoma of the oropharynx|recurrent squamous cell carcinoma of the oropharynx
842050|NCT00006033|stage III squamous cell carcinoma of the nasopharynx|stage iii squamous cell carcinoma of the nasopharynx
842051|NCT00006033|stage IV squamous cell carcinoma of the nasopharynx|stage iv squamous cell carcinoma of the nasopharynx
842052|NCT00006033|recurrent squamous cell carcinoma of the nasopharynx|recurrent squamous cell carcinoma of the nasopharynx
842053|NCT00006033|stage III squamous cell carcinoma of the hypopharynx|stage iii squamous cell carcinoma of the hypopharynx
842054|NCT00006033|stage IV squamous cell carcinoma of the hypopharynx|stage iv squamous cell carcinoma of the hypopharynx
842055|NCT00006033|recurrent squamous cell carcinoma of the hypopharynx|recurrent squamous cell carcinoma of the hypopharynx
842056|NCT00006033|stage III squamous cell carcinoma of the larynx|stage iii squamous cell carcinoma of the larynx
842057|NCT00006033|stage IV squamous cell carcinoma of the larynx|stage iv squamous cell carcinoma of the larynx
842058|NCT00006033|recurrent squamous cell carcinoma of the larynx|recurrent squamous cell carcinoma of the larynx
842059|NCT00006033|stage III squamous cell carcinoma of the paranasal sinus and nasal cavity|stage iii squamous cell carcinoma of the paranasal sinus and nasal cavity
842060|NCT00006033|stage IV squamous cell carcinoma of the paranasal sinus and nasal cavity|stage iv squamous cell carcinoma of the paranasal sinus and nasal cavity
842061|NCT00006033|recurrent squamous cell carcinoma of the paranasal sinus and nasal cavity|recurrent squamous cell carcinoma of the paranasal sinus and nasal cavity
842062|NCT00005993|stage IV breast cancer|stage iv breast cancer
842063|NCT00005993|stage IIIA breast cancer|stage iiia breast cancer
842064|NCT00005993|recurrent breast cancer|recurrent breast cancer
842065|NCT00005993|stage IIIB breast cancer|stage iiib breast cancer
842066|NCT00005993|recurrent adult Hodgkin lymphoma|recurrent adult hodgkin lymphoma
842067|NCT00005993|stage III grade 3 follicular lymphoma|stage iii grade 3 follicular lymphoma
842068|NCT00005993|stage III adult diffuse mixed cell lymphoma|stage iii adult diffuse mixed cell lymphoma
842069|NCT00005993|stage III adult diffuse large cell lymphoma|stage iii adult diffuse large cell lymphoma
842070|NCT00005993|stage III adult immunoblastic large cell lymphoma|stage iii adult immunoblastic large cell lymphoma
842071|NCT00005993|stage III adult lymphoblastic lymphoma|stage iii adult lymphoblastic lymphoma
842072|NCT00005993|stage III adult Burkitt lymphoma|stage iii adult burkitt lymphoma
842073|NCT00005993|stage IV grade 3 follicular lymphoma|stage iv grade 3 follicular lymphoma
842074|NCT00005993|stage IV adult diffuse mixed cell lymphoma|stage iv adult diffuse mixed cell lymphoma
842075|NCT00005993|stage IV adult diffuse large cell lymphoma|stage iv adult diffuse large cell lymphoma
842076|NCT00005993|stage IV adult immunoblastic large cell lymphoma|stage iv adult immunoblastic large cell lymphoma
842077|NCT00005993|stage IV adult lymphoblastic lymphoma|stage iv adult lymphoblastic lymphoma
842078|NCT00005993|stage IV adult Burkitt lymphoma|stage iv adult burkitt lymphoma
842079|NCT00005993|recurrent grade 1 follicular lymphoma|recurrent grade 1 follicular lymphoma
842080|NCT00005993|recurrent grade 2 follicular lymphoma|recurrent grade 2 follicular lymphoma
842081|NCT00005993|recurrent grade 3 follicular lymphoma|recurrent grade 3 follicular lymphoma
842082|NCT00005993|recurrent adult diffuse small cleaved cell lymphoma|recurrent adult diffuse small cleaved cell lymphoma
842083|NCT00005993|recurrent adult diffuse mixed cell lymphoma|recurrent adult diffuse mixed cell lymphoma
855937|NCT00071162|Sleep|sleep
842084|NCT00005993|recurrent adult diffuse large cell lymphoma|recurrent adult diffuse large cell lymphoma
842085|NCT00005993|recurrent adult immunoblastic large cell lymphoma|recurrent adult immunoblastic large cell lymphoma
842086|NCT00005993|recurrent adult lymphoblastic lymphoma|recurrent adult lymphoblastic lymphoma
842087|NCT00005993|recurrent adult Burkitt lymphoma|recurrent adult burkitt lymphoma
842088|NCT00005993|noncontiguous stage II grade 3 follicular lymphoma|noncontiguous stage ii grade 3 follicular lymphoma
842089|NCT00005993|noncontiguous stage II mantle cell lymphoma|noncontiguous stage ii mantle cell lymphoma
842090|NCT00005993|noncontiguous stage II adult diffuse mixed cell lymphoma|noncontiguous stage ii adult diffuse mixed cell lymphoma
842091|NCT00005993|noncontiguous stage II adult immunoblastic large cell lymphoma|noncontiguous stage ii adult immunoblastic large cell lymphoma
842092|NCT00005993|noncontiguous stage II adult diffuse large cell lymphoma|noncontiguous stage ii adult diffuse large cell lymphoma
842093|NCT00005993|noncontiguous stage II adult Burkitt lymphoma|noncontiguous stage ii adult burkitt lymphoma
842094|NCT00005993|noncontiguous stage II adult lymphoblastic lymphoma|noncontiguous stage ii adult lymphoblastic lymphoma
842095|NCT00005993|stage III mantle cell lymphoma|stage iii mantle cell lymphoma
842096|NCT00005993|stage IV mantle cell lymphoma|stage iv mantle cell lymphoma
842097|NCT00005993|recurrent mantle cell lymphoma|recurrent mantle cell lymphoma
842098|NCT00005993|recurrent marginal zone lymphoma|recurrent marginal zone lymphoma
842099|NCT00005993|recurrent small lymphocytic lymphoma|recurrent small lymphocytic lymphoma
842100|NCT00005993|extranodal marginal zone B-cell lymphoma of mucosa-associated lymphoid tissue|extranodal marginal zone b-cell lymphoma of mucosa-associated lymphoid tissue
842101|NCT00005993|nodal marginal zone B-cell lymphoma|nodal marginal zone b-cell lymphoma
842102|NCT00005993|splenic marginal zone lymphoma|splenic marginal zone lymphoma
842103|NCT00005968|stage IV melanoma|stage iv melanoma
842104|NCT00085904|Advanced cancer|advanced cancer
842105|NCT00085904|IL-18|il-18
842106|NCT00085904|repeat dosing|repeat dosing
842107|NCT00085904|Phase 1|phase 1
842108|NCT00085904|pharmacokinetics|pharmacokinetics
842109|NCT00085904|oncology|oncology
842110|NCT00085891|Schizophrenia|schizophrenia
842111|NCT00085891|Schizophrenic disorder|schizophrenic disorder
842112|NCT00085878|IL-18|il-18
842113|NCT00085878|subcutaneous|subcutaneous
842114|NCT00085878|pharmacokinetics|pharmacokinetics
842115|NCT00085878|Phase 1|phase 1
842116|NCT00005829|refractory chronic lymphocytic leukemia|refractory chronic lymphocytic leukemia
842117|NCT00005829|B-cell chronic lymphocytic leukemia|b-cell chronic lymphocytic leukemia
842118|NCT00005826|adult glioblastoma|adult glioblastoma
842119|NCT00005826|adult giant cell glioblastoma|adult giant cell glioblastoma
842120|NCT00005826|adult gliosarcoma|adult gliosarcoma
842121|NCT00005616|stage I colon cancer|stage i colon cancer
842122|NCT00005616|stage II colon cancer|stage ii colon cancer
842123|NCT00005616|stage III colon cancer|stage iii colon cancer
842124|NCT00005616|stage IV colon cancer|stage iv colon cancer
842125|NCT00005616|stage I rectal cancer|stage i rectal cancer
842126|NCT00005616|stage II rectal cancer|stage ii rectal cancer
842127|NCT00005616|stage III rectal cancer|stage iii rectal cancer
842128|NCT00005616|stage IV rectal cancer|stage iv rectal cancer
842129|NCT00005616|recurrent colon cancer|recurrent colon cancer
842130|NCT00005616|recurrent rectal cancer|recurrent rectal cancer
842131|NCT00005616|liver metastases|liver metastases
842132|NCT00005093|recurrent non-small cell lung cancer|recurrent non-small cell lung cancer
842133|NCT00005093|stage IIIA non-small cell lung cancer|stage iiia non-small cell lung cancer
842134|NCT00005093|stage IIIB non-small cell lung cancer|stage iiib non-small cell lung cancer
842135|NCT00005093|stage IV non-small cell lung cancer|stage iv non-small cell lung cancer
842136|NCT00005073|stage I prostate cancer|stage i prostate cancer
842137|NCT00005073|stage IIB prostate cancer|stage iib prostate cancer
842138|NCT00005073|stage IIA prostate cancer|stage iia prostate cancer
842139|NCT00005073|stage III prostate cancer|stage iii prostate cancer
842140|NCT00005073|recurrent prostate cancer|recurrent prostate cancer
842141|NCT00005048|adenocarcinoma of the prostate|adenocarcinoma of the prostate
842142|NCT00005048|recurrent prostate cancer|recurrent prostate cancer
842143|NCT00005041|extensive stage small cell lung cancer|extensive stage small cell lung cancer
842144|NCT00005041|recurrent small cell lung cancer|recurrent small cell lung cancer
842145|NCT00004929|recurrent prostate cancer|recurrent prostate cancer
842146|NCT00004861|stage II pancreatic cancer|stage ii pancreatic cancer
842147|NCT00004861|stage III pancreatic cancer|stage iii pancreatic cancer
842148|NCT00004861|adenocarcinoma of the pancreas|adenocarcinoma of the pancreas
842149|NCT00004861|stage IV pancreatic cancer|stage iv pancreatic cancer
842150|NCT00004260|stage I grade 1 follicular lymphoma|stage i grade 1 follicular lymphoma
842151|NCT00004260|stage I grade 2 follicular lymphoma|stage i grade 2 follicular lymphoma
842152|NCT00004260|stage I grade 3 follicular lymphoma|stage i grade 3 follicular lymphoma
842153|NCT00004260|stage I adult diffuse small cleaved cell lymphoma|stage i adult diffuse small cleaved cell lymphoma
842154|NCT00004260|stage I adult diffuse mixed cell lymphoma|stage i adult diffuse mixed cell lymphoma
842155|NCT00004260|stage I adult diffuse large cell lymphoma|stage i adult diffuse large cell lymphoma
842156|NCT00004260|stage I adult immunoblastic large cell lymphoma|stage i adult immunoblastic large cell lymphoma
842157|NCT00004260|stage I adult lymphoblastic lymphoma|stage i adult lymphoblastic lymphoma
842158|NCT00004260|stage I adult Burkitt lymphoma|stage i adult burkitt lymphoma
842159|NCT00004260|stage III grade 1 follicular lymphoma|stage iii grade 1 follicular lymphoma
842160|NCT00004260|stage III grade 2 follicular lymphoma|stage iii grade 2 follicular lymphoma
842161|NCT00004260|stage III grade 3 follicular lymphoma|stage iii grade 3 follicular lymphoma
842162|NCT00004260|stage III adult diffuse small cleaved cell lymphoma|stage iii adult diffuse small cleaved cell lymphoma
842163|NCT00004260|stage III adult diffuse mixed cell lymphoma|stage iii adult diffuse mixed cell lymphoma
842164|NCT00004260|stage III adult diffuse large cell lymphoma|stage iii adult diffuse large cell lymphoma
842165|NCT00004260|stage III adult immunoblastic large cell lymphoma|stage iii adult immunoblastic large cell lymphoma
856051|NCT00070850|Prenatal|prenatal
842166|NCT00004260|stage III adult lymphoblastic lymphoma|stage iii adult lymphoblastic lymphoma
842167|NCT00004260|stage III adult Burkitt lymphoma|stage iii adult burkitt lymphoma
842168|NCT00004260|stage IV grade 1 follicular lymphoma|stage iv grade 1 follicular lymphoma
842169|NCT00004260|stage IV grade 2 follicular lymphoma|stage iv grade 2 follicular lymphoma
842170|NCT00004260|stage IV grade 3 follicular lymphoma|stage iv grade 3 follicular lymphoma
842171|NCT00004260|stage IV adult diffuse small cleaved cell lymphoma|stage iv adult diffuse small cleaved cell lymphoma
842172|NCT00004260|stage IV adult diffuse mixed cell lymphoma|stage iv adult diffuse mixed cell lymphoma
842173|NCT00004260|stage IV adult diffuse large cell lymphoma|stage iv adult diffuse large cell lymphoma
842174|NCT00004260|stage IV adult immunoblastic large cell lymphoma|stage iv adult immunoblastic large cell lymphoma
842175|NCT00004260|stage IV adult lymphoblastic lymphoma|stage iv adult lymphoblastic lymphoma
842176|NCT00004260|stage IV adult Burkitt lymphoma|stage iv adult burkitt lymphoma
842177|NCT00004260|recurrent grade 1 follicular lymphoma|recurrent grade 1 follicular lymphoma
842178|NCT00004260|recurrent grade 2 follicular lymphoma|recurrent grade 2 follicular lymphoma
842179|NCT00004260|recurrent grade 3 follicular lymphoma|recurrent grade 3 follicular lymphoma
842180|NCT00004260|recurrent adult diffuse small cleaved cell lymphoma|recurrent adult diffuse small cleaved cell lymphoma
842181|NCT00004260|recurrent adult diffuse mixed cell lymphoma|recurrent adult diffuse mixed cell lymphoma
842182|NCT00004260|recurrent adult diffuse large cell lymphoma|recurrent adult diffuse large cell lymphoma
842183|NCT00004260|recurrent adult immunoblastic large cell lymphoma|recurrent adult immunoblastic large cell lymphoma
842184|NCT00004260|recurrent adult lymphoblastic lymphoma|recurrent adult lymphoblastic lymphoma
842185|NCT00004260|recurrent adult Burkitt lymphoma|recurrent adult burkitt lymphoma
842186|NCT00004260|stage I mantle cell lymphoma|stage i mantle cell lymphoma
842187|NCT00004260|contiguous stage II grade 1 follicular lymphoma|contiguous stage ii grade 1 follicular lymphoma
842188|NCT00004260|contiguous stage II grade 2 follicular lymphoma|contiguous stage ii grade 2 follicular lymphoma
842189|NCT00004260|contiguous stage II grade 3 follicular lymphoma|contiguous stage ii grade 3 follicular lymphoma
842190|NCT00004260|contiguous stage II adult diffuse small cleaved cell lymphoma|contiguous stage ii adult diffuse small cleaved cell lymphoma
842191|NCT00004260|contiguous stage II mantle cell lymphoma|contiguous stage ii mantle cell lymphoma
842192|NCT00004260|contiguous stage II adult diffuse mixed cell lymphoma|contiguous stage ii adult diffuse mixed cell lymphoma
842193|NCT00004260|contiguous stage II adult immunoblastic large cell lymphoma|contiguous stage ii adult immunoblastic large cell lymphoma
842194|NCT00004260|contiguous stage II adult diffuse large cell lymphoma|contiguous stage ii adult diffuse large cell lymphoma
842195|NCT00004260|contiguous stage II adult Burkitt lymphoma|contiguous stage ii adult burkitt lymphoma
842196|NCT00004260|contiguous stage II adult lymphoblastic lymphoma|contiguous stage ii adult lymphoblastic lymphoma
842197|NCT00004260|noncontiguous stage II grade 1 follicular lymphoma|noncontiguous stage ii grade 1 follicular lymphoma
842198|NCT00004260|noncontiguous stage II grade 2 follicular lymphoma|noncontiguous stage ii grade 2 follicular lymphoma
842199|NCT00004260|noncontiguous stage II grade 3 follicular lymphoma|noncontiguous stage ii grade 3 follicular lymphoma
842200|NCT00004260|noncontiguous stage II adult diffuse small cleaved cell lymphoma|noncontiguous stage ii adult diffuse small cleaved cell lymphoma
842201|NCT00004260|noncontiguous stage II mantle cell lymphoma|noncontiguous stage ii mantle cell lymphoma
842202|NCT00004260|noncontiguous stage II adult diffuse mixed cell lymphoma|noncontiguous stage ii adult diffuse mixed cell lymphoma
842203|NCT00004260|noncontiguous stage II adult immunoblastic large cell lymphoma|noncontiguous stage ii adult immunoblastic large cell lymphoma
842204|NCT00004260|noncontiguous stage II adult diffuse large cell lymphoma|noncontiguous stage ii adult diffuse large cell lymphoma
842205|NCT00004260|noncontiguous stage II adult Burkitt lymphoma|noncontiguous stage ii adult burkitt lymphoma
842206|NCT00004260|noncontiguous stage II adult lymphoblastic lymphoma|noncontiguous stage ii adult lymphoblastic lymphoma
842207|NCT00004260|stage III mantle cell lymphoma|stage iii mantle cell lymphoma
842208|NCT00004260|stage IV mantle cell lymphoma|stage iv mantle cell lymphoma
842209|NCT00004260|recurrent mantle cell lymphoma|recurrent mantle cell lymphoma
842210|NCT00004260|noncontiguous stage II small lymphocytic lymphoma|noncontiguous stage ii small lymphocytic lymphoma
842211|NCT00004260|noncontiguous stage II marginal zone lymphoma|noncontiguous stage ii marginal zone lymphoma
842212|NCT00004260|recurrent marginal zone lymphoma|recurrent marginal zone lymphoma
842213|NCT00004260|recurrent small lymphocytic lymphoma|recurrent small lymphocytic lymphoma
842214|NCT00004260|stage I marginal zone lymphoma|stage i marginal zone lymphoma
842215|NCT00004260|stage I small lymphocytic lymphoma|stage i small lymphocytic lymphoma
842216|NCT00004260|stage III small lymphocytic lymphoma|stage iii small lymphocytic lymphoma
842217|NCT00004260|stage III marginal zone lymphoma|stage iii marginal zone lymphoma
842218|NCT00004260|stage IV small lymphocytic lymphoma|stage iv small lymphocytic lymphoma
855938|NCT00071162|Depression|depression
842219|NCT00004260|stage IV marginal zone lymphoma|stage iv marginal zone lymphoma
842220|NCT00004260|contiguous stage II marginal zone lymphoma|contiguous stage ii marginal zone lymphoma
842221|NCT00004260|contiguous stage II small lymphocytic lymphoma|contiguous stage ii small lymphocytic lymphoma
842222|NCT00004260|extranodal marginal zone B-cell lymphoma of mucosa-associated lymphoid tissue|extranodal marginal zone b-cell lymphoma of mucosa-associated lymphoid tissue
842223|NCT00004260|nodal marginal zone B-cell lymphoma|nodal marginal zone b-cell lymphoma
842224|NCT00004260|splenic marginal zone lymphoma|splenic marginal zone lymphoma
842225|NCT00004217|untreated adult acute myeloid leukemia|untreated adult acute myeloid leukemia
842226|NCT00004217|adult acute erythroid leukemia (M6)|adult acute erythroid leukemia (m6)
842227|NCT00004217|adult acute myeloblastic leukemia without maturation (M1)|adult acute myeloblastic leukemia without maturation (m1)
842228|NCT00004217|adult acute myeloblastic leukemia with maturation (M2)|adult acute myeloblastic leukemia with maturation (m2)
842229|NCT00004217|adult acute myelomonocytic leukemia (M4)|adult acute myelomonocytic leukemia (m4)
842230|NCT00004217|adult acute monoblastic leukemia (M5a)|adult acute monoblastic leukemia (m5a)
842231|NCT00004217|adult acute megakaryoblastic leukemia (M7)|adult acute megakaryoblastic leukemia (m7)
842232|NCT00004217|adult acute monocytic leukemia (M5b)|adult acute monocytic leukemia (m5b)
842233|NCT00004217|adult acute minimally differentiated myeloid leukemia (M0)|adult acute minimally differentiated myeloid leukemia (m0)
842234|NCT00085917|Pegasys|pegasys
842235|NCT00085917|Ribavirin|ribavirin
842236|NCT00085917|Early Virological Response|early virological response
842237|NCT00085917|Hepatitis C|hepatitis c
842238|NCT00085917|HIV|hiv
842239|NCT00085852|emphysema|emphysema
842240|NCT00085852|chronic obstructive pulmonary disease|chronic obstructive pulmonary disease
842241|NCT00085852|lung volume reduction|lung volume reduction
842242|NCT00085852|bronchoscopic|bronchoscopic
842243|NCT00085852|bronchoscopy|bronchoscopy
842244|NCT00085852|bronchoscope|bronchoscope
842245|NCT00085839|Tarceva|tarceva
842246|NCT00085839|NSCLC|nsclc
842247|NCT00085839|EGFR|egfr
842248|NCT00085839|ECOG Performance Status 2|ecog performance status 2
842249|NCT00085839|erlotinib|erlotinib
842250|NCT00085839|Non-Small Cell Lung Cancer|non-small cell lung cancer
842251|NCT00085839|OSI-774|osi-774
842252|NCT00085826|Lung Cancer|lung cancer
842253|NCT00085826|NSCLC|nsclc
842254|NCT00085826|Non-small Cell Lung Cancer|non-small cell lung cancer
842255|NCT00085813|Platinum-Refractory|platinum-refractory
842256|NCT00085813|Platinum-Relapsed|platinum-relapsed
842257|NCT00085813|Non-Small Cell Lung Cancer|non-small cell lung cancer
842258|NCT00085774|albuterol|albuterol
842259|NCT00085774|aerosol inhaler|aerosol inhaler
842260|NCT00085774|metered-dose inhaler|metered-dose inhaler
842261|NCT00085774|breath-actuated inhaler|breath-actuated inhaler
842262|NCT00085774|exercise-induced bronchospasm|exercise-induced bronchospasm
842263|NCT00085761|Dermal assessment|dermal assessment
842264|NCT00085761|Pain measurement|pain measurement
842265|NCT00085761|Diary|diary
842266|NCT00085761|Neuropathy|neuropathy
842267|NCT00085761|Analgesics/*therapeutic use|analgesics/*therapeutic use
842268|NCT00085761|Capsaicin/*administration & dosage/adverse effects|capsaicin/*administration & dosage/adverse effects
842269|NCT00085761|HIV Infections/*complications/*drug therapy|hiv infections/*complications/*drug therapy
842270|NCT00085761|Pain|pain
842271|NCT00085761|Complementary Therapies|complementary therapies
842272|NCT00004251|stage IV endometrial carcinoma|stage iv endometrial carcinoma
842273|NCT00004251|recurrent endometrial carcinoma|recurrent endometrial carcinoma
842274|NCT00004251|endometrial adenocarcinoma|endometrial adenocarcinoma
842275|NCT00004251|endometrial adenosquamous cell carcinoma|endometrial adenosquamous cell carcinoma
842276|NCT00004076|unspecified adult solid tumor, protocol specific|unspecified adult solid tumor, protocol specific
842277|NCT00004043|adenocarcinoma of the prostate|adenocarcinoma of the prostate
842278|NCT00004043|recurrent prostate cancer|recurrent prostate cancer
842279|NCT00003996|adult glioblastoma|adult glioblastoma
842280|NCT00003996|adult giant cell glioblastoma|adult giant cell glioblastoma
842281|NCT00003996|adult gliosarcoma|adult gliosarcoma
842282|NCT00003920|stage IV breast cancer|stage iv breast cancer
842283|NCT00003920|recurrent breast cancer|recurrent breast cancer
842284|NCT00003898|unspecified childhood solid tumor, protocol specific|unspecified childhood solid tumor, protocol specific
842285|NCT00003898|oral complications|oral complications
842286|NCT00003894|unspecified childhood solid tumor, protocol specific|unspecified childhood solid tumor, protocol specific
842287|NCT00003894|unspecified adult solid tumor, protocol specific|unspecified adult solid tumor, protocol specific
842288|NCT00003894|graft versus host disease|graft versus host disease
842289|NCT00003891|unspecified adult solid tumor, protocol specific|unspecified adult solid tumor, protocol specific
842290|NCT00085865|5 HT|5 ht
842291|NCT00085865|Neuroreceptors|neuroreceptors
842292|NCT00085865|Radiotracer|radiotracer
842293|NCT00085865|Neuroimaging|neuroimaging
842294|NCT00085865|Serotonin Transporter|serotonin transporter
842295|NCT00085865|Alcoholism|alcoholism
842296|NCT00085865|PET|pet
842297|NCT00085865|Healthy Volunteer|healthy volunteer
842298|NCT00085865|HV|hv
842299|NCT00085748|schizophrenia|schizophrenia
842300|NCT00085748|geriatric|geriatric
842301|NCT00085748|elderly|elderly
842302|NCT00085722|Injection Therapy|injection therapy
842303|NCT00085709|untreated adult acute myeloid leukemia|untreated adult acute myeloid leukemia
842304|NCT00085709|adult acute eosinophilic leukemia|adult acute eosinophilic leukemia
842305|NCT00085709|adult acute basophilic leukemia|adult acute basophilic leukemia
842306|NCT00085709|adult acute monocytic leukemia (M5b)|adult acute monocytic leukemia (m5b)
842307|NCT00085709|adult acute erythroid leukemia (M6)|adult acute erythroid leukemia (m6)
842308|NCT00085709|adult acute megakaryoblastic leukemia (M7)|adult acute megakaryoblastic leukemia (m7)
842309|NCT00085709|adult acute minimally differentiated myeloid leukemia (M0)|adult acute minimally differentiated myeloid leukemia (m0)
858661|NCT00065936|Cortisol|cortisol
842310|NCT00085709|adult acute myeloblastic leukemia with maturation (M2)|adult acute myeloblastic leukemia with maturation (m2)
842311|NCT00085709|adult acute myeloblastic leukemia without maturation (M1)|adult acute myeloblastic leukemia without maturation (m1)
842312|NCT00085709|adult acute myelomonocytic leukemia (M4)|adult acute myelomonocytic leukemia (m4)
842313|NCT00085709|adult acute monoblastic leukemia (M5a)|adult acute monoblastic leukemia (m5a)
842314|NCT00085709|adult acute myeloid leukemia with 11q23 (MLL) abnormalities|adult acute myeloid leukemia with 11q23 (mll) abnormalities
842315|NCT00085709|adult acute myeloid leukemia with inv(16)(p13;q22)|adult acute myeloid leukemia with inv(16)(p13;q22)
842316|NCT00085709|adult acute myeloid leukemia with t(16;16)(p13;q22)|adult acute myeloid leukemia with t(16;16)(p13;q22)
842317|NCT00085709|adult acute myeloid leukemia with t(8;21)(q22;q22)|adult acute myeloid leukemia with t(8;21)(q22;q22)
842318|NCT00003871|stage IV prostate cancer|stage iv prostate cancer
842319|NCT00003871|recurrent prostate cancer|recurrent prostate cancer
842320|NCT00003860|extensive stage small cell lung cancer|extensive stage small cell lung cancer
842321|NCT00003847|recurrent small cell lung cancer|recurrent small cell lung cancer
842322|NCT00003847|intermediate type small cell lung cancer|intermediate type small cell lung cancer
842323|NCT00003829|stage I chronic lymphocytic leukemia|stage i chronic lymphocytic leukemia
842324|NCT00003829|stage II chronic lymphocytic leukemia|stage ii chronic lymphocytic leukemia
842325|NCT00003829|stage III chronic lymphocytic leukemia|stage iii chronic lymphocytic leukemia
842326|NCT00003829|stage IV chronic lymphocytic leukemia|stage iv chronic lymphocytic leukemia
842327|NCT00003829|B-cell chronic lymphocytic leukemia|b-cell chronic lymphocytic leukemia
842328|NCT00003720|AIDS-related Kaposi sarcoma|aids-related kaposi sarcoma
842329|NCT00003720|recurrent Kaposi sarcoma|recurrent kaposi sarcoma
842330|NCT00003624|stage I cervical cancer|stage i cervical cancer
842331|NCT00003624|stage II cervical cancer|stage ii cervical cancer
842332|NCT00003624|stage III cervical cancer|stage iii cervical cancer
842333|NCT00003624|stage IV cervical cancer|stage iv cervical cancer
842334|NCT00003624|stage I ovarian epithelial cancer|stage i ovarian epithelial cancer
842335|NCT00003624|stage II ovarian epithelial cancer|stage ii ovarian epithelial cancer
842336|NCT00003624|stage III ovarian epithelial cancer|stage iii ovarian epithelial cancer
842337|NCT00003624|stage IV ovarian epithelial cancer|stage iv ovarian epithelial cancer
842338|NCT00003624|stage I endometrial carcinoma|stage i endometrial carcinoma
842339|NCT00003624|stage II endometrial carcinoma|stage ii endometrial carcinoma
842340|NCT00003624|stage III endometrial carcinoma|stage iii endometrial carcinoma
842341|NCT00003624|stage IV endometrial carcinoma|stage iv endometrial carcinoma
842342|NCT00003624|endometrial adenocarcinoma|endometrial adenocarcinoma
842343|NCT00003624|fallopian tube cancer|fallopian tube cancer
842344|NCT00003624|primary peritoneal cavity cancer|primary peritoneal cavity cancer
842345|NCT00003624|stage I uterine sarcoma|stage i uterine sarcoma
842346|NCT00003624|stage II uterine sarcoma|stage ii uterine sarcoma
842347|NCT00003624|stage III uterine sarcoma|stage iii uterine sarcoma
842348|NCT00003624|stage IV uterine sarcoma|stage iv uterine sarcoma
842349|NCT00003624|neurotoxicity|neurotoxicity
842350|NCT00003592|stage IV salivary gland cancer|stage iv salivary gland cancer
842351|NCT00003592|recurrent salivary gland cancer|recurrent salivary gland cancer
842352|NCT00003592|salivary gland squamous cell carcinoma|salivary gland squamous cell carcinoma
842353|NCT00003592|stage IV squamous cell carcinoma of the lip and oral cavity|stage iv squamous cell carcinoma of the lip and oral cavity
842354|NCT00003592|recurrent squamous cell carcinoma of the lip and oral cavity|recurrent squamous cell carcinoma of the lip and oral cavity
842355|NCT00003592|stage IV squamous cell carcinoma of the oropharynx|stage iv squamous cell carcinoma of the oropharynx
842356|NCT00003592|recurrent squamous cell carcinoma of the oropharynx|recurrent squamous cell carcinoma of the oropharynx
842357|NCT00003592|stage IV squamous cell carcinoma of the nasopharynx|stage iv squamous cell carcinoma of the nasopharynx
842358|NCT00003592|recurrent squamous cell carcinoma of the nasopharynx|recurrent squamous cell carcinoma of the nasopharynx
842359|NCT00003592|stage IV squamous cell carcinoma of the hypopharynx|stage iv squamous cell carcinoma of the hypopharynx
842360|NCT00003592|recurrent squamous cell carcinoma of the hypopharynx|recurrent squamous cell carcinoma of the hypopharynx
842361|NCT00003592|stage IV squamous cell carcinoma of the larynx|stage iv squamous cell carcinoma of the larynx
842362|NCT00003592|recurrent squamous cell carcinoma of the larynx|recurrent squamous cell carcinoma of the larynx
842363|NCT00003592|stage IV squamous cell carcinoma of the paranasal sinus and nasal cavity|stage iv squamous cell carcinoma of the paranasal sinus and nasal cavity
842364|NCT00003592|recurrent squamous cell carcinoma of the paranasal sinus and nasal cavity|recurrent squamous cell carcinoma of the paranasal sinus and nasal cavity
842365|NCT00003574|recurrent adult brain tumor|recurrent adult brain tumor
842366|NCT00003574|adult glioblastoma|adult glioblastoma
842367|NCT00003574|adult anaplastic astrocytoma|adult anaplastic astrocytoma
842663|NCT00084656|stage IV melanoma|stage iv melanoma
842368|NCT00003574|adult anaplastic oligodendroglioma|adult anaplastic oligodendroglioma
842369|NCT00003574|adult giant cell glioblastoma|adult giant cell glioblastoma
842370|NCT00003574|adult gliosarcoma|adult gliosarcoma
842371|NCT00003254|stage IV colon cancer|stage iv colon cancer
842372|NCT00003254|stage IV rectal cancer|stage iv rectal cancer
842373|NCT00003254|recurrent colon cancer|recurrent colon cancer
842374|NCT00003254|recurrent rectal cancer|recurrent rectal cancer
842375|NCT00003242|unspecified adult solid tumor, protocol specific|unspecified adult solid tumor, protocol specific
859973|NCT00062868|EBV|ebv
842376|NCT00003206|stage IV nasopharyngeal cancer|stage iv nasopharyngeal cancer
842377|NCT00003206|recurrent nasopharyngeal cancer|recurrent nasopharyngeal cancer
842378|NCT00003143|recurrent adult Hodgkin lymphoma|recurrent adult hodgkin lymphoma
842379|NCT00003143|Waldenström macroglobulinemia|waldenström macroglobulinemia
842380|NCT00003143|recurrent grade 1 follicular lymphoma|recurrent grade 1 follicular lymphoma
842381|NCT00003143|recurrent grade 2 follicular lymphoma|recurrent grade 2 follicular lymphoma
842382|NCT00003143|recurrent grade 3 follicular lymphoma|recurrent grade 3 follicular lymphoma
842383|NCT00003143|recurrent adult diffuse small cleaved cell lymphoma|recurrent adult diffuse small cleaved cell lymphoma
842384|NCT00003143|recurrent adult diffuse mixed cell lymphoma|recurrent adult diffuse mixed cell lymphoma
842385|NCT00003143|recurrent adult diffuse large cell lymphoma|recurrent adult diffuse large cell lymphoma
842386|NCT00003143|recurrent adult immunoblastic large cell lymphoma|recurrent adult immunoblastic large cell lymphoma
842387|NCT00003143|recurrent adult lymphoblastic lymphoma|recurrent adult lymphoblastic lymphoma
842388|NCT00003143|recurrent adult Burkitt lymphoma|recurrent adult burkitt lymphoma
842899|NCT00005790|adult glioblastoma|adult glioblastoma
842389|NCT00003143|recurrent mantle cell lymphoma|recurrent mantle cell lymphoma
842390|NCT00003143|recurrent marginal zone lymphoma|recurrent marginal zone lymphoma
842391|NCT00003143|recurrent small lymphocytic lymphoma|recurrent small lymphocytic lymphoma
842392|NCT00003143|extranodal marginal zone B-cell lymphoma of mucosa-associated lymphoid tissue|extranodal marginal zone b-cell lymphoma of mucosa-associated lymphoid tissue
842393|NCT00003143|nodal marginal zone B-cell lymphoma|nodal marginal zone b-cell lymphoma
842394|NCT00003143|splenic marginal zone lymphoma|splenic marginal zone lymphoma
842395|NCT00003099|breast cancer|breast cancer
842396|NCT00003099|Tamoxifen|tamoxifen
842397|NCT00003099|Fenretinide|fenretinide
842398|NCT00003099|Chemoprevention Therapy|chemoprevention therapy
842399|NCT00003099|N-(4-hydroxyphenyl) Retinamide|n-(4-hydroxyphenyl) retinamide
842400|NCT00003099|4-HPR|4-hpr
842401|NCT00003099|Breast Neoplasia|breast neoplasia
842402|NCT00003099|Diagnostic Core Biopsy|diagnostic core biopsy
842403|NCT00003099|Surgery|surgery
842404|NCT00003085|stage I pancreatic cancer|stage i pancreatic cancer
842405|NCT00003085|stage II pancreatic cancer|stage ii pancreatic cancer
842406|NCT00003028|unspecified adult solid tumor, protocol specific|unspecified adult solid tumor, protocol specific
842407|NCT00003009|unspecified adult solid tumor, protocol specific|unspecified adult solid tumor, protocol specific
842408|NCT00002973|stage III melanoma|stage iii melanoma
842409|NCT00002973|stage IV melanoma|stage iv melanoma
842410|NCT00002973|recurrent melanoma|recurrent melanoma
842411|NCT00002949|stage II cervical cancer|stage ii cervical cancer
842412|NCT00002949|stage III cervical cancer|stage iii cervical cancer
842413|NCT00002949|stage IV cervical cancer|stage iv cervical cancer
842414|NCT00002949|stage II vaginal cancer|stage ii vaginal cancer
842415|NCT00002949|stage III vaginal cancer|stage iii vaginal cancer
842416|NCT00002949|stage IVA vaginal cancer|stage iva vaginal cancer
842417|NCT00002949|stage IVB vaginal cancer|stage ivb vaginal cancer
842418|NCT00002949|stage II endometrial carcinoma|stage ii endometrial carcinoma
842419|NCT00002949|stage III endometrial carcinoma|stage iii endometrial carcinoma
842420|NCT00002949|stage IV endometrial carcinoma|stage iv endometrial carcinoma
842421|NCT00002949|stage II bladder cancer|stage ii bladder cancer
842422|NCT00002949|stage III bladder cancer|stage iii bladder cancer
842423|NCT00002949|stage IV bladder cancer|stage iv bladder cancer
842424|NCT00002915|unspecified adult solid tumor, protocol specific|unspecified adult solid tumor, protocol specific
842425|NCT00002864|stage I breast cancer|stage i breast cancer
842426|NCT00002864|stage II breast cancer|stage ii breast cancer
842427|NCT00002864|stage III breast cancer|stage iii breast cancer
842428|NCT00002838|stage III chronic lymphocytic leukemia|stage iii chronic lymphocytic leukemia
842429|NCT00002838|stage IV chronic lymphocytic leukemia|stage iv chronic lymphocytic leukemia
842430|NCT00002838|refractory chronic lymphocytic leukemia|refractory chronic lymphocytic leukemia
842431|NCT00002785|untreated childhood acute lymphoblastic leukemia|untreated childhood acute lymphoblastic leukemia
842432|NCT00002740|disseminated neuroblastoma|disseminated neuroblastoma
842433|NCT00085696|Lymphoma|lymphoma
842434|NCT00085696|Non-Hodgkin's|non-hodgkin's
842435|NCT00085696|NHL|nhl
842436|NCT00085696|B-Cell|b-cell
842437|NCT00085696|Indolent|indolent
842438|NCT00085683|Magnetic Resonance Spectroscopy|magnetic resonance spectroscopy
842439|NCT00085683|Lumbar Puncture|lumbar puncture
842440|NCT00085683|Healthy Control Subjects|healthy control subjects
842441|NCT00085683|Mesial Temporal Sclerosis|mesial temporal sclerosis
842442|NCT00085683|Neuroexcitotoxicity|neuroexcitotoxicity
842443|NCT00085683|Seizure Disorder|seizure disorder
842444|NCT00085683|Epilepsy|epilepsy
842445|NCT00085683|Healthy Volunteer|healthy volunteer
842447|NCT00085670|Tumor Necrosis Factor Alpha (TNF-Alpha)|tumor necrosis factor alpha (tnf-alpha)
842448|NCT00085670|Interferon-Gamma (IFN-Gamma)|interferon-gamma (ifn-gamma)
842449|NCT00085670|Transforming Growth Factor Beta 1 (TGF-B1)|transforming growth factor beta 1 (tgf-b1)
842450|NCT00085670|Interleukin-10 (IL-10)|interleukin-10 (il-10)
842451|NCT00085670|Interleukin-6 (IL-6)|interleukin-6 (il-6)
842452|NCT00085657|Direct Current Stimulation|direct current stimulation
842453|NCT00085657|Cortical Reorganization|cortical reorganization
842454|NCT00085657|Rehabilitation|rehabilitation
842455|NCT00085657|Acute Stroke|acute stroke
842456|NCT00085657|Stroke|stroke
842457|NCT00085631|stage IA cervical cancer|stage ia cervical cancer
842458|NCT00085631|stage IB cervical cancer|stage ib cervical cancer
842459|NCT00085631|stage IIA cervical cancer|stage iia cervical cancer
842460|NCT00085631|stage IIB cervical cancer|stage iib cervical cancer
842461|NCT00085631|stage III cervical cancer|stage iii cervical cancer
842462|NCT00085631|stage IVA cervical cancer|stage iva cervical cancer
842463|NCT00085631|cervical adenocarcinoma|cervical adenocarcinoma
842464|NCT00085631|cervical adenosquamous cell carcinoma|cervical adenosquamous cell carcinoma
842465|NCT00085631|cervical squamous cell carcinoma|cervical squamous cell carcinoma
842466|NCT00085579|stage III melanoma|stage iii melanoma
842467|NCT00085579|stage IV melanoma|stage iv melanoma
842468|NCT00085566|adult glioblastoma|adult glioblastoma
842469|NCT00085566|recurrent prostate cancer|recurrent prostate cancer
842470|NCT00085566|recurrent adult brain tumor|recurrent adult brain tumor
842471|NCT00085566|stage IV prostate cancer|stage iv prostate cancer
842472|NCT00085566|adult giant cell glioblastoma|adult giant cell glioblastoma
842473|NCT00085566|adult gliosarcoma|adult gliosarcoma
842474|NCT00085527|recurrent ovarian epithelial cancer|recurrent ovarian epithelial cancer
842475|NCT00085527|stage III ovarian epithelial cancer|stage iii ovarian epithelial cancer
842476|NCT00085527|stage IV ovarian epithelial cancer|stage iv ovarian epithelial cancer
842477|NCT00085501|recurrent non-small cell lung cancer|recurrent non-small cell lung cancer
842478|NCT00085501|stage IIIB non-small cell lung cancer|stage iiib non-small cell lung cancer
842479|NCT00085501|stage IV non-small cell lung cancer|stage iv non-small cell lung cancer
842480|NCT00085501|adenocarcinoma of the lung|adenocarcinoma of the lung
842481|NCT00085501|squamous cell lung cancer|squamous cell lung cancer
842482|NCT00085501|large cell lung cancer|large cell lung cancer
842483|NCT00085488|recurrent melanoma|recurrent melanoma
842484|NCT00085488|stage III melanoma|stage iii melanoma
842485|NCT00085488|stage IV melanoma|stage iv melanoma
842486|NCT00085475|recurrent adult soft tissue sarcoma|recurrent adult soft tissue sarcoma
842487|NCT00085475|stage III adult soft tissue sarcoma|stage iii adult soft tissue sarcoma
842488|NCT00085475|stage IV adult soft tissue sarcoma|stage iv adult soft tissue sarcoma
842489|NCT00085475|adult fibrosarcoma|adult fibrosarcoma
842490|NCT00085475|adult malignant fibrous histiocytoma|adult malignant fibrous histiocytoma
842491|NCT00085462|recurrent melanoma|recurrent melanoma
842492|NCT00085462|stage IV melanoma|stage iv melanoma
842493|NCT00085449|recurrent adult acute myeloid leukemia|recurrent adult acute myeloid leukemia
842494|NCT00085449|adult acute myeloid leukemia in remission|adult acute myeloid leukemia in remission
842495|NCT00085449|recurrent adult acute lymphoblastic leukemia|recurrent adult acute lymphoblastic leukemia
842496|NCT00085449|adult acute lymphoblastic leukemia in remission|adult acute lymphoblastic leukemia in remission
842497|NCT00085449|myelodysplastic/myeloproliferative neoplasm, unclassifiable|myelodysplastic/myeloproliferative neoplasm, unclassifiable
842498|NCT00085449|previously treated myelodysplastic syndromes|previously treated myelodysplastic syndromes
842499|NCT00085449|atypical chronic myeloid leukemia, BCR-ABL1 negative|atypical chronic myeloid leukemia, bcr-abl1 negative
842500|NCT00085449|chronic myelomonocytic leukemia|chronic myelomonocytic leukemia
842501|NCT00085449|recurrent adult Burkitt lymphoma|recurrent adult burkitt lymphoma
842502|NCT00085449|recurrent grade 1 follicular lymphoma|recurrent grade 1 follicular lymphoma
842503|NCT00085449|recurrent grade 2 follicular lymphoma|recurrent grade 2 follicular lymphoma
842504|NCT00085449|recurrent grade 3 follicular lymphoma|recurrent grade 3 follicular lymphoma
842505|NCT00085449|recurrent adult diffuse small cleaved cell lymphoma|recurrent adult diffuse small cleaved cell lymphoma
842506|NCT00085449|recurrent adult immunoblastic large cell lymphoma|recurrent adult immunoblastic large cell lymphoma
842507|NCT00085449|recurrent small lymphocytic lymphoma|recurrent small lymphocytic lymphoma
842508|NCT00085449|recurrent marginal zone lymphoma|recurrent marginal zone lymphoma
842509|NCT00085449|recurrent mantle cell lymphoma|recurrent mantle cell lymphoma
842510|NCT00085449|recurrent adult lymphoblastic lymphoma|recurrent adult lymphoblastic lymphoma
842511|NCT00085449|accelerated phase chronic myelogenous leukemia|accelerated phase chronic myelogenous leukemia
842512|NCT00085449|chronic phase chronic myelogenous leukemia|chronic phase chronic myelogenous leukemia
842513|NCT00085449|recurrent adult diffuse mixed cell lymphoma|recurrent adult diffuse mixed cell lymphoma
842514|NCT00085449|recurrent adult diffuse large cell lymphoma|recurrent adult diffuse large cell lymphoma
842515|NCT00085449|refractory chronic lymphocytic leukemia|refractory chronic lymphocytic leukemia
842516|NCT00085449|stage III chronic lymphocytic leukemia|stage iii chronic lymphocytic leukemia
842517|NCT00085449|stage IV chronic lymphocytic leukemia|stage iv chronic lymphocytic leukemia
842518|NCT00085449|refractory multiple myeloma|refractory multiple myeloma
842519|NCT00085449|secondary myelodysplastic syndromes|secondary myelodysplastic syndromes
842736|NCT00084279|Gamma|gamma
842520|NCT00085449|de novo myelodysplastic syndromes|de novo myelodysplastic syndromes
842521|NCT00085449|adult acute myeloid leukemia with t(8;21)(q22;q22)|adult acute myeloid leukemia with t(8;21)(q22;q22)
842522|NCT00085449|adult acute myeloid leukemia with t(16;16)(p13;q22)|adult acute myeloid leukemia with t(16;16)(p13;q22)
842523|NCT00085449|adult acute myeloid leukemia with inv(16)(p13;q22)|adult acute myeloid leukemia with inv(16)(p13;q22)
842524|NCT00085449|adult acute myeloid leukemia with 11q23 (MLL) abnormalities|adult acute myeloid leukemia with 11q23 (mll) abnormalities
842670|NCT00084591|stage II rectal cancer|stage ii rectal cancer
842525|NCT00085449|adult acute myeloid leukemia with t(15;17)(q22;q12)|adult acute myeloid leukemia with t(15;17)(q22;q12)
842526|NCT00085436|recurrent renal cell cancer|recurrent renal cell cancer
842527|NCT00085436|stage IV renal cell cancer|stage iv renal cell cancer
842528|NCT00085423|recurrent melanoma|recurrent melanoma
842529|NCT00085423|stage IV melanoma|stage iv melanoma
842530|NCT00085397|recurrent melanoma|recurrent melanoma
842531|NCT00085397|stage III melanoma|stage iii melanoma
842532|NCT00085397|stage IV melanoma|stage iv melanoma
842533|NCT00085384|recurrent ovarian epithelial cancer|recurrent ovarian epithelial cancer
842534|NCT00085384|peritoneal cavity cancer|peritoneal cavity cancer
842535|NCT00085384|fallopian tube cancer|fallopian tube cancer
842536|NCT00085332|recurrent endometrial carcinoma|recurrent endometrial carcinoma
842537|NCT00085332|stage III endometrial carcinoma|stage iii endometrial carcinoma
842538|NCT00085332|stage IV endometrial carcinoma|stage iv endometrial carcinoma
842539|NCT00085306|recurrent melanoma|recurrent melanoma
842540|NCT00085306|stage IV melanoma|stage iv melanoma
842541|NCT00085306|iris melanoma|iris melanoma
842542|NCT00085306|ciliary body and choroid melanoma, medium/large size|ciliary body and choroid melanoma, medium/large size
842543|NCT00085306|extraocular extension melanoma|extraocular extension melanoma
842544|NCT00085306|recurrent intraocular melanoma|recurrent intraocular melanoma
842545|NCT00085228|adenocarcinoma of the prostate|adenocarcinoma of the prostate
842546|NCT00085228|recurrent prostate cancer|recurrent prostate cancer
842547|NCT00085228|stage IV prostate cancer|stage iv prostate cancer
842548|NCT00085202|untreated childhood medulloblastoma|untreated childhood medulloblastoma
842549|NCT00085202|untreated childhood supratentorial primitive neuroectodermal tumor|untreated childhood supratentorial primitive neuroectodermal tumor
842550|NCT00085202|childhood atypical teratoid/rhabdoid tumor|childhood atypical teratoid/rhabdoid tumor
842551|NCT00085202|untreated childhood pineoblastoma|untreated childhood pineoblastoma
842552|NCT00085176|long-term effects secondary to cancer therapy in children|long-term effects secondary to cancer therapy in children
842553|NCT00085176|neurotoxicity|neurotoxicity
842554|NCT00085176|psychosocial effects of cancer and its treatment|psychosocial effects of cancer and its treatment
842555|NCT00085176|childhood acute lymphoblastic leukemia in remission|childhood acute lymphoblastic leukemia in remission
842556|NCT00085163|adenocarcinoma of the colon|adenocarcinoma of the colon
842557|NCT00085163|stage III colon cancer|stage iii colon cancer
842558|NCT00085150|recurrent adult T-cell leukemia/lymphoma|recurrent adult t-cell leukemia/lymphoma
842559|NCT00085150|recurrent childhood acute lymphoblastic leukemia|recurrent childhood acute lymphoblastic leukemia
842560|NCT00085150|childhood Burkitt lymphoma|childhood burkitt lymphoma
842561|NCT00085150|recurrent childhood acute myeloid leukemia|recurrent childhood acute myeloid leukemia
842562|NCT00085150|recurrent childhood large cell lymphoma|recurrent childhood large cell lymphoma
842563|NCT00085150|recurrent childhood lymphoblastic lymphoma|recurrent childhood lymphoblastic lymphoma
842564|NCT00085150|recurrent mycosis fungoides/Sezary syndrome|recurrent mycosis fungoides/sezary syndrome
842565|NCT00085150|recurrent cutaneous T-cell non-Hodgkin lymphoma|recurrent cutaneous t-cell non-hodgkin lymphoma
842566|NCT00085150|recurrent/refractory childhood Hodgkin lymphoma|recurrent/refractory childhood hodgkin lymphoma
842567|NCT00085150|relapsing chronic myelogenous leukemia|relapsing chronic myelogenous leukemia
842568|NCT00085150|acute undifferentiated leukemia|acute undifferentiated leukemia
842569|NCT00085098|childhood central nervous system germ cell tumor|childhood central nervous system germ cell tumor
842570|NCT00085059|stage IV melanoma|stage iv melanoma
842571|NCT00085059|recurrent melanoma|recurrent melanoma
842572|NCT00085020|stage IV breast cancer|stage iv breast cancer
842573|NCT00085020|male breast cancer|male breast cancer
842574|NCT00085020|recurrent breast cancer|recurrent breast cancer
842575|NCT00084942|cholangiocarcinoma of the gallbladder|cholangiocarcinoma of the gallbladder
842576|NCT00084942|recurrent gallbladder cancer|recurrent gallbladder cancer
842577|NCT00084942|unresectable gallbladder cancer|unresectable gallbladder cancer
842578|NCT00084942|cholangiocarcinoma of the extrahepatic bile duct|cholangiocarcinoma of the extrahepatic bile duct
842579|NCT00084942|recurrent extrahepatic bile duct cancer|recurrent extrahepatic bile duct cancer
842580|NCT00084942|unresectable extrahepatic bile duct cancer|unresectable extrahepatic bile duct cancer
842581|NCT00084929|colon cancer|colon cancer
842582|NCT00084929|rectal cancer|rectal cancer
842583|NCT00084903|cervical cancer|cervical cancer
842584|NCT00084903|cervical intraepithelial neoplasia|cervical intraepithelial neoplasia
842585|NCT00084890|stage IVB cervical cancer|stage ivb cervical cancer
842586|NCT00084890|recurrent cervical cancer|recurrent cervical cancer
842587|NCT00084890|cervical squamous cell carcinoma|cervical squamous cell carcinoma
842588|NCT00084864|adenocarcinoma of the prostate|adenocarcinoma of the prostate
842589|NCT00084864|stage II prostate cancer|stage ii prostate cancer
842590|NCT00084864|stage III prostate cancer|stage iii prostate cancer
842591|NCT00084838|childhood atypical teratoid/rhabdoid tumor|childhood atypical teratoid/rhabdoid tumor
842592|NCT00084825|adenocarcinoma of the prostate|adenocarcinoma of the prostate
842593|NCT00084825|recurrent prostate cancer|recurrent prostate cancer
842594|NCT00084825|stage IV prostate cancer|stage iv prostate cancer
842595|NCT00084825|bone metastases|bone metastases
842596|NCT00084812|unspecified adult solid tumor, protocol specific|unspecified adult solid tumor, protocol specific
842597|NCT00084799|recurrent small cell lung cancer|recurrent small cell lung cancer
843128|NCT00083876|Doxorubicin|doxorubicin
842598|NCT00084786|unspecified adult solid tumor, protocol specific|unspecified adult solid tumor, protocol specific
842599|NCT00084773|recurrent rectal cancer|recurrent rectal cancer
842600|NCT00084773|stage II rectal cancer|stage ii rectal cancer
842601|NCT00084773|stage III rectal cancer|stage iii rectal cancer
842602|NCT00084773|adenocarcinoma of the rectum|adenocarcinoma of the rectum
842603|NCT00084747|stage II multiple myeloma|stage ii multiple myeloma
842604|NCT00084747|stage III multiple myeloma|stage iii multiple myeloma
842605|NCT00084734|unspecified adult solid tumor, protocol specific|unspecified adult solid tumor, protocol specific
842606|NCT00084721|diarrhea|diarrhea
842607|NCT00084721|recurrent colon cancer|recurrent colon cancer
842608|NCT00084721|stage IV colon cancer|stage iv colon cancer
842609|NCT00084721|recurrent rectal cancer|recurrent rectal cancer
842610|NCT00084721|stage IV rectal cancer|stage iv rectal cancer
842611|NCT00084721|stage III colon cancer|stage iii colon cancer
842612|NCT00084721|stage III rectal cancer|stage iii rectal cancer
842613|NCT00084708|unspecified adult solid tumor, protocol specific|unspecified adult solid tumor, protocol specific
842614|NCT00084695|childhood myelodysplastic syndromes|childhood myelodysplastic syndromes
842615|NCT00084695|recurrent childhood rhabdomyosarcoma|recurrent childhood rhabdomyosarcoma
842616|NCT00084695|unspecified childhood solid tumor, protocol specific|unspecified childhood solid tumor, protocol specific
842617|NCT00084695|previously treated childhood rhabdomyosarcoma|previously treated childhood rhabdomyosarcoma
842618|NCT00084695|previously untreated childhood rhabdomyosarcoma|previously untreated childhood rhabdomyosarcoma
842619|NCT00084695|disseminated neuroblastoma|disseminated neuroblastoma
842620|NCT00084695|regional neuroblastoma|regional neuroblastoma
842621|NCT00084695|recurrent neuroblastoma|recurrent neuroblastoma
842622|NCT00084695|metastatic Ewing sarcoma/peripheral primitive neuroectodermal tumor|metastatic ewing sarcoma/peripheral primitive neuroectodermal tumor
842623|NCT00084695|recurrent Ewing sarcoma/peripheral primitive neuroectodermal tumor|recurrent ewing sarcoma/peripheral primitive neuroectodermal tumor
842624|NCT00084695|recurrent childhood acute lymphoblastic leukemia|recurrent childhood acute lymphoblastic leukemia
842625|NCT00084695|juvenile myelomonocytic leukemia|juvenile myelomonocytic leukemia
842626|NCT00084695|childhood acute lymphoblastic leukemia in remission|childhood acute lymphoblastic leukemia in remission
842627|NCT00084695|childhood Burkitt lymphoma|childhood burkitt lymphoma
842628|NCT00084695|recurrent childhood lymphoblastic lymphoma|recurrent childhood lymphoblastic lymphoma
842629|NCT00084695|stage III childhood lymphoblastic lymphoma|stage iii childhood lymphoblastic lymphoma
842630|NCT00084695|stage IV childhood lymphoblastic lymphoma|stage iv childhood lymphoblastic lymphoma
842631|NCT00084695|recurrent childhood small noncleaved cell lymphoma|recurrent childhood small noncleaved cell lymphoma
842632|NCT00084695|stage III childhood small noncleaved cell lymphoma|stage iii childhood small noncleaved cell lymphoma
842633|NCT00084695|stage IV childhood small noncleaved cell lymphoma|stage iv childhood small noncleaved cell lymphoma
842634|NCT00084695|recurrent childhood large cell lymphoma|recurrent childhood large cell lymphoma
842635|NCT00084695|stage III childhood large cell lymphoma|stage iii childhood large cell lymphoma
842636|NCT00084695|stage IV childhood large cell lymphoma|stage iv childhood large cell lymphoma
842637|NCT00084695|stage III childhood Hodgkin lymphoma|stage iii childhood hodgkin lymphoma
842638|NCT00084695|stage IV childhood Hodgkin lymphoma|stage iv childhood hodgkin lymphoma
842639|NCT00084695|previously treated myelodysplastic syndromes|previously treated myelodysplastic syndromes
842640|NCT00084695|Fanconi anemia|fanconi anemia
842641|NCT00084695|de novo myelodysplastic syndromes|de novo myelodysplastic syndromes
842642|NCT00084695|secondary myelodysplastic syndromes|secondary myelodysplastic syndromes
842643|NCT00084695|childhood chronic myelogenous leukemia|childhood chronic myelogenous leukemia
842644|NCT00084695|chronic phase chronic myelogenous leukemia|chronic phase chronic myelogenous leukemia
842645|NCT00084695|relapsing chronic myelogenous leukemia|relapsing chronic myelogenous leukemia
842646|NCT00084695|childhood Langerhans cell histiocytosis|childhood langerhans cell histiocytosis
842647|NCT00084695|recurrent childhood acute myeloid leukemia|recurrent childhood acute myeloid leukemia
842648|NCT00084695|recurrent/refractory childhood Hodgkin lymphoma|recurrent/refractory childhood hodgkin lymphoma
842649|NCT00084669|hot flashes|hot flashes
842650|NCT00084669|sleep disorders|sleep disorders
842651|NCT00084669|ductal breast carcinoma in situ|ductal breast carcinoma in situ
842652|NCT00084669|breast cancer in situ|breast cancer in situ
842653|NCT00084669|lobular breast carcinoma in situ|lobular breast carcinoma in situ
842654|NCT00084669|lobular breast carcinoma|lobular breast carcinoma
842655|NCT00084669|recurrent breast cancer|recurrent breast cancer
842656|NCT00084669|stage I breast cancer|stage i breast cancer
842657|NCT00084669|stage II breast cancer|stage ii breast cancer
842658|NCT00084669|stage IIIA breast cancer|stage iiia breast cancer
842659|NCT00084669|stage IIIB breast cancer|stage iiib breast cancer
842660|NCT00084669|stage IIIC breast cancer|stage iiic breast cancer
842661|NCT00084669|stage IV breast cancer|stage iv breast cancer
842662|NCT00084656|stage III melanoma|stage iii melanoma
842664|NCT00084656|ciliary body and choroid melanoma, medium/large size|ciliary body and choroid melanoma, medium/large size
842665|NCT00084656|extraocular extension melanoma|extraocular extension melanoma
842666|NCT00084656|iris melanoma|iris melanoma
842667|NCT00084656|recurrent melanoma|recurrent melanoma
842668|NCT00084656|recurrent intraocular melanoma|recurrent intraocular melanoma
842669|NCT00084656|metastatic intraocular melanoma|metastatic intraocular melanoma
842671|NCT00084591|stage III rectal cancer|stage iii rectal cancer
842672|NCT00084591|adenocarcinoma of the rectum|adenocarcinoma of the rectum
842673|NCT00084578|stage 0 bladder cancer|stage 0 bladder cancer
842674|NCT00084578|stage I bladder cancer|stage i bladder cancer
842675|NCT00084578|stage II bladder cancer|stage ii bladder cancer
842676|NCT00084578|stage III bladder cancer|stage iii bladder cancer
842677|NCT00084578|stage IV bladder cancer|stage iv bladder cancer
842678|NCT00084578|transitional cell carcinoma of the bladder|transitional cell carcinoma of the bladder
842679|NCT00084565|stage IV prostate cancer|stage iv prostate cancer
842680|NCT00084565|adenocarcinoma of the prostate|adenocarcinoma of the prostate
842681|NCT00084552|sexual dysfunction|sexual dysfunction
842682|NCT00084552|sexuality and reproductive issues|sexuality and reproductive issues
842683|NCT00084552|adenocarcinoma of the prostate|adenocarcinoma of the prostate
842684|NCT00084552|stage IIB prostate cancer|stage iib prostate cancer
842685|NCT00084552|stage IIA prostate cancer|stage iia prostate cancer
842686|NCT00084539|stage I breast cancer|stage i breast cancer
842687|NCT00084539|stage II breast cancer|stage ii breast cancer
842688|NCT00084539|breast cancer in situ|breast cancer in situ
842689|NCT00084526|recurrent prostate cancer|recurrent prostate cancer
842690|NCT00084526|stage I prostate cancer|stage i prostate cancer
842691|NCT00084526|stage II prostate cancer|stage ii prostate cancer
842692|NCT00084526|stage III prostate cancer|stage iii prostate cancer
842693|NCT00084526|stage IV prostate cancer|stage iv prostate cancer
842694|NCT00084513|unspecified adult solid tumor, protocol specific|unspecified adult solid tumor, protocol specific
842695|NCT00084448|recurrent ovarian epithelial cancer|recurrent ovarian epithelial cancer
842696|NCT00084448|primary peritoneal cavity cancer|primary peritoneal cavity cancer
842697|NCT00084435|stage III squamous cell carcinoma of the lip and oral cavity|stage iii squamous cell carcinoma of the lip and oral cavity
842698|NCT00084435|stage IV squamous cell carcinoma of the lip and oral cavity|stage iv squamous cell carcinoma of the lip and oral cavity
842699|NCT00084435|stage III squamous cell carcinoma of the paranasal sinus and nasal cavity|stage iii squamous cell carcinoma of the paranasal sinus and nasal cavity
842700|NCT00084435|stage IV squamous cell carcinoma of the paranasal sinus and nasal cavity|stage iv squamous cell carcinoma of the paranasal sinus and nasal cavity
842701|NCT00084435|stage III salivary gland cancer|stage iii salivary gland cancer
842702|NCT00084435|stage IV salivary gland cancer|stage iv salivary gland cancer
842703|NCT00084435|stage III squamous cell carcinoma of the hypopharynx|stage iii squamous cell carcinoma of the hypopharynx
842704|NCT00084435|stage IV squamous cell carcinoma of the hypopharynx|stage iv squamous cell carcinoma of the hypopharynx
842705|NCT00084435|stage III squamous cell carcinoma of the larynx|stage iii squamous cell carcinoma of the larynx
842706|NCT00084435|stage IV squamous cell carcinoma of the larynx|stage iv squamous cell carcinoma of the larynx
842707|NCT00084435|stage III squamous cell carcinoma of the oropharynx|stage iii squamous cell carcinoma of the oropharynx
842708|NCT00084435|stage IV squamous cell carcinoma of the oropharynx|stage iv squamous cell carcinoma of the oropharynx
842709|NCT00084435|salivary gland squamous cell carcinoma|salivary gland squamous cell carcinoma
842710|NCT00084422|recurrent neuroblastoma|recurrent neuroblastoma
842711|NCT00084409|non-small cell lung cancer|non-small cell lung cancer
842712|NCT00084409|squamous lung dysplasia|squamous lung dysplasia
842713|NCT00084396|stage II breast cancer|stage ii breast cancer
842714|NCT00084396|stage IIIA breast cancer|stage iiia breast cancer
842715|NCT00084396|stage IIIB breast cancer|stage iiib breast cancer
842716|NCT00084383|stage I pancreatic cancer|stage i pancreatic cancer
842717|NCT00084383|stage II pancreatic cancer|stage ii pancreatic cancer
842718|NCT00084383|duct cell adenocarcinoma of the pancreas|duct cell adenocarcinoma of the pancreas
842719|NCT00084370|ovarian epithelial cancer|ovarian epithelial cancer
842720|NCT00084370|BRCA1 mutation carrier|brca1 mutation carrier
842721|NCT00084370|BRCA2 mutation carrier|brca2 mutation carrier
842722|NCT00084344|breast cancer|breast cancer
842723|NCT00084318|stage III squamous cell carcinoma of the hypopharynx|stage iii squamous cell carcinoma of the hypopharynx
842724|NCT00084318|stage IV squamous cell carcinoma of the hypopharynx|stage iv squamous cell carcinoma of the hypopharynx
842725|NCT00084318|stage III squamous cell carcinoma of the oropharynx|stage iii squamous cell carcinoma of the oropharynx
842726|NCT00084318|stage IV squamous cell carcinoma of the oropharynx|stage iv squamous cell carcinoma of the oropharynx
842727|NCT00084318|stage III squamous cell carcinoma of the larynx|stage iii squamous cell carcinoma of the larynx
842728|NCT00084318|stage IV squamous cell carcinoma of the larynx|stage iv squamous cell carcinoma of the larynx
842729|NCT00084318|stage III lymphoepithelioma of the oropharynx|stage iii lymphoepithelioma of the oropharynx
842730|NCT00084318|stage IV lymphoepithelioma of the oropharynx|stage iv lymphoepithelioma of the oropharynx
842731|NCT00084279|Chronic Hepatitis C|chronic hepatitis c
842732|NCT00084279|Liver|liver
842733|NCT00084279|Pegylated|pegylated
842734|NCT00084279|Interferon|interferon
842735|NCT00084279|Alpha|alpha
842739|NCT00084279|Nonresponder|nonresponder
842740|NCT00084279|Pegasys|pegasys
842741|NCT00084279|PegIntron|pegintron
842742|NCT00084266|Staphylococcal pneumonia|staphylococcal pneumonia
842743|NCT00084266|Methicillin-resistant staphylococcal pneumonia|methicillin-resistant staphylococcal pneumonia
842744|NCT00084266|healthcare-associated pneumonia|healthcare-associated pneumonia
842746|NCT00084253|Treatment Naive|treatment naive
842747|NCT00084305|Bronchoscopy|bronchoscopy
842748|NCT00084305|Pulmonary Fibrosis|pulmonary fibrosis
842749|NCT00084305|Lung Biopsy (Clinically-Indicated)|lung biopsy (clinically-indicated)
842750|NCT00084292|Ischemia|ischemia
842751|NCT00084292|Pediatric|pediatric
842752|NCT00084292|Etiology|etiology
842753|NCT00084292|Treatment|treatment
842754|NCT00084292|Outcome|outcome
842755|NCT00084292|Childhood Stroke|childhood stroke
842756|NCT00084292|Pediatric Stroke|pediatric stroke
842757|NCT00084292|Ischemic Stroke|ischemic stroke
842758|NCT00084292|Spastic Hemiplegia|spastic hemiplegia
842759|NCT00084292|Hemiplegic cerebral palsy|hemiplegic cerebral palsy
842760|NCT00084214|metastatic|metastatic
842761|NCT00084214|increased antitumor effect|increased antitumor effect
842762|NCT00002682|Antibiotic Treatment|antibiotic treatment
842763|NCT00002682|Gastric Malt Lymphoma|gastric malt lymphoma
842764|NCT00002682|stage I marginal zone lymphoma|stage i marginal zone lymphoma
842765|NCT00002682|extranodal marginal zone B-cell lymphoma of mucosa-associated lymphoid tissue|extranodal marginal zone b-cell lymphoma of mucosa-associated lymphoid tissue
842766|NCT00002676|primary central nervous system non-Hodgkin lymphoma|primary central nervous system non-hodgkin lymphoma
842767|NCT00002670|stage II squamous cell carcinoma of the lip and oral cavity|stage ii squamous cell carcinoma of the lip and oral cavity
842768|NCT00002670|stage III squamous cell carcinoma of the lip and oral cavity|stage iii squamous cell carcinoma of the lip and oral cavity
842769|NCT00002670|stage IV squamous cell carcinoma of the lip and oral cavity|stage iv squamous cell carcinoma of the lip and oral cavity
842770|NCT00002670|stage II squamous cell carcinoma of the oropharynx|stage ii squamous cell carcinoma of the oropharynx
842771|NCT00002670|stage III squamous cell carcinoma of the oropharynx|stage iii squamous cell carcinoma of the oropharynx
842772|NCT00002670|stage IV squamous cell carcinoma of the oropharynx|stage iv squamous cell carcinoma of the oropharynx
842773|NCT00002670|stage II squamous cell carcinoma of the hypopharynx|stage ii squamous cell carcinoma of the hypopharynx
842774|NCT00002670|stage III squamous cell carcinoma of the hypopharynx|stage iii squamous cell carcinoma of the hypopharynx
842775|NCT00002670|stage IV squamous cell carcinoma of the hypopharynx|stage iv squamous cell carcinoma of the hypopharynx
842776|NCT00002670|stage II squamous cell carcinoma of the larynx|stage ii squamous cell carcinoma of the larynx
842777|NCT00002670|stage III squamous cell carcinoma of the larynx|stage iii squamous cell carcinoma of the larynx
842778|NCT00002670|stage IV squamous cell carcinoma of the larynx|stage iv squamous cell carcinoma of the larynx
842779|NCT00002656|recurrent non-small cell lung cancer|recurrent non-small cell lung cancer
842780|NCT00002656|stage IIIB non-small cell lung cancer|stage iiib non-small cell lung cancer
842781|NCT00002656|stage IV non-small cell lung cancer|stage iv non-small cell lung cancer
842782|NCT00002646|stage II breast cancer|stage ii breast cancer
842783|NCT00002646|stage IIIA breast cancer|stage iiia breast cancer
842784|NCT00002637|recurrent prostate cancer|recurrent prostate cancer
842785|NCT00002632|stage IV salivary gland cancer|stage iv salivary gland cancer
842786|NCT00002632|recurrent salivary gland cancer|recurrent salivary gland cancer
842787|NCT00002632|high-grade salivary gland mucoepidermoid carcinoma|high-grade salivary gland mucoepidermoid carcinoma
842788|NCT00002632|salivary gland adenocarcinoma|salivary gland adenocarcinoma
842789|NCT00002625|stage III adult Hodgkin lymphoma|stage iii adult hodgkin lymphoma
842790|NCT00002625|stage IV adult Hodgkin lymphoma|stage iv adult hodgkin lymphoma
842791|NCT00002625|recurrent non-small cell lung cancer|recurrent non-small cell lung cancer
842792|NCT00002625|recurrent adult Hodgkin lymphoma|recurrent adult hodgkin lymphoma
842793|NCT00002625|recurrent esophageal cancer|recurrent esophageal cancer
842794|NCT00002625|stage III cutaneous T-cell non-Hodgkin lymphoma|stage iii cutaneous t-cell non-hodgkin lymphoma
842795|NCT00002625|stage IV cutaneous T-cell non-Hodgkin lymphoma|stage iv cutaneous t-cell non-hodgkin lymphoma
842796|NCT00002625|recurrent cutaneous T-cell non-Hodgkin lymphoma|recurrent cutaneous t-cell non-hodgkin lymphoma
842797|NCT00002625|recurrent small cell lung cancer|recurrent small cell lung cancer
842798|NCT00002625|stage III grade 1 follicular lymphoma|stage iii grade 1 follicular lymphoma
842799|NCT00002625|stage III grade 2 follicular lymphoma|stage iii grade 2 follicular lymphoma
842800|NCT00002625|stage III grade 3 follicular lymphoma|stage iii grade 3 follicular lymphoma
842801|NCT00002625|stage III adult diffuse small cleaved cell lymphoma|stage iii adult diffuse small cleaved cell lymphoma
842802|NCT00002625|stage III adult diffuse mixed cell lymphoma|stage iii adult diffuse mixed cell lymphoma
842803|NCT00002625|stage III adult diffuse large cell lymphoma|stage iii adult diffuse large cell lymphoma
842804|NCT00002625|stage III adult immunoblastic large cell lymphoma|stage iii adult immunoblastic large cell lymphoma
842805|NCT00002625|stage III adult lymphoblastic lymphoma|stage iii adult lymphoblastic lymphoma
842806|NCT00002625|stage III adult Burkitt lymphoma|stage iii adult burkitt lymphoma
842807|NCT00002625|stage IV grade 1 follicular lymphoma|stage iv grade 1 follicular lymphoma
842808|NCT00002625|stage IV grade 2 follicular lymphoma|stage iv grade 2 follicular lymphoma
842809|NCT00002625|stage IV grade 3 follicular lymphoma|stage iv grade 3 follicular lymphoma
842810|NCT00002625|stage IV adult diffuse small cleaved cell lymphoma|stage iv adult diffuse small cleaved cell lymphoma
842811|NCT00002625|stage IV adult diffuse mixed cell lymphoma|stage iv adult diffuse mixed cell lymphoma
842812|NCT00002625|stage IV adult diffuse large cell lymphoma|stage iv adult diffuse large cell lymphoma
842813|NCT00002625|stage IV adult immunoblastic large cell lymphoma|stage iv adult immunoblastic large cell lymphoma
842814|NCT00002625|stage IV adult lymphoblastic lymphoma|stage iv adult lymphoblastic lymphoma
842815|NCT00002625|stage IV adult Burkitt lymphoma|stage iv adult burkitt lymphoma
843129|NCT00083876|Etoposide|etoposide
842816|NCT00002625|recurrent grade 1 follicular lymphoma|recurrent grade 1 follicular lymphoma
842817|NCT00002625|recurrent grade 2 follicular lymphoma|recurrent grade 2 follicular lymphoma
842818|NCT00002625|recurrent grade 3 follicular lymphoma|recurrent grade 3 follicular lymphoma
842819|NCT00002625|recurrent adult diffuse small cleaved cell lymphoma|recurrent adult diffuse small cleaved cell lymphoma
842820|NCT00002625|recurrent adult diffuse mixed cell lymphoma|recurrent adult diffuse mixed cell lymphoma
842821|NCT00002625|recurrent adult diffuse large cell lymphoma|recurrent adult diffuse large cell lymphoma
842822|NCT00002625|recurrent adult immunoblastic large cell lymphoma|recurrent adult immunoblastic large cell lymphoma
842823|NCT00002625|recurrent adult lymphoblastic lymphoma|recurrent adult lymphoblastic lymphoma
842824|NCT00002625|recurrent adult Burkitt lymphoma|recurrent adult burkitt lymphoma
842825|NCT00002625|stage III adult T-cell leukemia/lymphoma|stage iii adult t-cell leukemia/lymphoma
842826|NCT00002625|stage IV adult T-cell leukemia/lymphoma|stage iv adult t-cell leukemia/lymphoma
842827|NCT00002625|recurrent adult T-cell leukemia/lymphoma|recurrent adult t-cell leukemia/lymphoma
842828|NCT00002625|stage III mantle cell lymphoma|stage iii mantle cell lymphoma
842829|NCT00002625|stage IV mantle cell lymphoma|stage iv mantle cell lymphoma
842830|NCT00002625|recurrent mantle cell lymphoma|recurrent mantle cell lymphoma
842831|NCT00002625|recurrent marginal zone lymphoma|recurrent marginal zone lymphoma
842832|NCT00002625|recurrent small lymphocytic lymphoma|recurrent small lymphocytic lymphoma
842833|NCT00002625|stage III small lymphocytic lymphoma|stage iii small lymphocytic lymphoma
842834|NCT00002625|stage III marginal zone lymphoma|stage iii marginal zone lymphoma
842835|NCT00002625|stage IV small lymphocytic lymphoma|stage iv small lymphocytic lymphoma
842836|NCT00002625|stage IV marginal zone lymphoma|stage iv marginal zone lymphoma
842837|NCT00002625|extranodal marginal zone B-cell lymphoma of mucosa-associated lymphoid tissue|extranodal marginal zone b-cell lymphoma of mucosa-associated lymphoid tissue
842838|NCT00002625|nodal marginal zone B-cell lymphoma|nodal marginal zone b-cell lymphoma
842839|NCT00002625|splenic marginal zone lymphoma|splenic marginal zone lymphoma
842840|NCT00002551|stage II rectal cancer|stage ii rectal cancer
842841|NCT00002551|stage III rectal cancer|stage iii rectal cancer
842842|NCT00002551|adenocarcinoma of the rectum|adenocarcinoma of the rectum
842843|NCT00002538|stage I ovarian epithelial cancer|stage i ovarian epithelial cancer
842844|NCT00002538|stage II ovarian epithelial cancer|stage ii ovarian epithelial cancer
842845|NCT00002538|stage III ovarian epithelial cancer|stage iii ovarian epithelial cancer
842846|NCT00002538|ovarian undifferentiated adenocarcinoma|ovarian undifferentiated adenocarcinoma
842847|NCT00002538|ovarian mixed epithelial carcinoma|ovarian mixed epithelial carcinoma
842848|NCT00002538|ovarian serous cystadenocarcinoma|ovarian serous cystadenocarcinoma
842849|NCT00002538|ovarian mucinous cystadenocarcinoma|ovarian mucinous cystadenocarcinoma
842850|NCT00002538|ovarian endometrioid adenocarcinoma|ovarian endometrioid adenocarcinoma
842851|NCT00002538|ovarian clear cell cystadenocarcinoma|ovarian clear cell cystadenocarcinoma
842852|NCT00002538|fallopian tube cancer|fallopian tube cancer
842853|NCT00002538|primary peritoneal cavity cancer|primary peritoneal cavity cancer
842854|NCT00084201|Vaccinium macrocarpon|vaccinium macrocarpon
842855|NCT00084188|behavioral intervention|behavioral intervention
842856|NCT00084175|behavioral intervention|behavioral intervention
842857|NCT00006451|recurrent childhood acute lymphoblastic leukemia|recurrent childhood acute lymphoblastic leukemia
842858|NCT00006451|stage IV childhood lymphoblastic lymphoma|stage iv childhood lymphoblastic lymphoma
842859|NCT00006451|recurrent childhood acute myeloid leukemia|recurrent childhood acute myeloid leukemia
842860|NCT00006451|recurrent adult acute myeloid leukemia|recurrent adult acute myeloid leukemia
842861|NCT00006451|recurrent adult acute lymphoblastic leukemia|recurrent adult acute lymphoblastic leukemia
842862|NCT00006451|chronic phase chronic myelogenous leukemia|chronic phase chronic myelogenous leukemia
842863|NCT00006451|accelerated phase chronic myelogenous leukemia|accelerated phase chronic myelogenous leukemia
842864|NCT00006451|adult acute lymphoblastic leukemia in remission|adult acute lymphoblastic leukemia in remission
842865|NCT00006451|childhood acute lymphoblastic leukemia in remission|childhood acute lymphoblastic leukemia in remission
842866|NCT00006451|acute undifferentiated leukemia|acute undifferentiated leukemia
842867|NCT00006451|stage IV adult lymphoblastic lymphoma|stage iv adult lymphoblastic lymphoma
842868|NCT00006451|graft versus host disease|graft versus host disease
842869|NCT00006387|stage IV colon cancer|stage iv colon cancer
842870|NCT00006387|recurrent pancreatic cancer|recurrent pancreatic cancer
842871|NCT00006387|stage IV rectal cancer|stage iv rectal cancer
842872|NCT00006387|recurrent colon cancer|recurrent colon cancer
842873|NCT00006387|recurrent rectal cancer|recurrent rectal cancer
842874|NCT00006387|adenocarcinoma of the colon|adenocarcinoma of the colon
842875|NCT00006387|adenocarcinoma of the rectum|adenocarcinoma of the rectum
842876|NCT00006387|adenocarcinoma of the pancreas|adenocarcinoma of the pancreas
842877|NCT00006387|stage IV pancreatic cancer|stage iv pancreatic cancer
859074|NCT00065052|Reduce TV|reduce tv
842878|NCT00006382|non-small cell lung cancer|non-small cell lung cancer
842879|NCT00006382|small cell lung cancer|small cell lung cancer
842880|NCT00006380|stage III prostate cancer|stage iii prostate cancer
842881|NCT00006380|stage IV prostate cancer|stage iv prostate cancer
842882|NCT00006380|recurrent prostate cancer|recurrent prostate cancer
842883|NCT00006378|squamous cell lung cancer|squamous cell lung cancer
842884|NCT00006378|large cell lung cancer|large cell lung cancer
843130|NCT00083876|Filgrastim|filgrastim
842885|NCT00006378|stage IIIA non-small cell lung cancer|stage iiia non-small cell lung cancer
842886|NCT00006378|stage IIIB non-small cell lung cancer|stage iiib non-small cell lung cancer
842887|NCT00006378|adenocarcinoma of the lung|adenocarcinoma of the lung
842888|NCT00006378|adenosquamous cell lung cancer|adenosquamous cell lung cancer
842889|NCT00006378|bronchoalveolar cell lung cancer|bronchoalveolar cell lung cancer
842890|NCT00006374|extensive stage small cell lung cancer|extensive stage small cell lung cancer
842891|NCT00006374|recurrent small cell lung cancer|recurrent small cell lung cancer
842892|NCT00005994|nausea and vomiting|nausea and vomiting
842893|NCT00005994|unspecified adult solid tumor, protocol specific|unspecified adult solid tumor, protocol specific
842894|NCT00005790|adult brain stem glioma|adult brain stem glioma
842895|NCT00005790|adult ependymoma|adult ependymoma
842896|NCT00005790|adult craniopharyngioma|adult craniopharyngioma
842897|NCT00005790|adult medulloblastoma|adult medulloblastoma
842898|NCT00005790|adult meningioma|adult meningioma
842900|NCT00005790|adult oligodendroglioma|adult oligodendroglioma
842901|NCT00005790|adult anaplastic astrocytoma|adult anaplastic astrocytoma
842902|NCT00005790|adult myxopapillary ependymoma|adult myxopapillary ependymoma
842903|NCT00005790|adult anaplastic ependymoma|adult anaplastic ependymoma
842904|NCT00005790|adult anaplastic oligodendroglioma|adult anaplastic oligodendroglioma
842905|NCT00005790|adult mixed glioma|adult mixed glioma
842906|NCT00005790|adult pineal parenchymal tumor|adult pineal parenchymal tumor
842907|NCT00005790|adult central nervous system germ cell tumor|adult central nervous system germ cell tumor
842908|NCT00005790|adult pilocytic astrocytoma|adult pilocytic astrocytoma
842909|NCT00005790|adult subependymoma|adult subependymoma
842910|NCT00005790|adult diffuse astrocytoma|adult diffuse astrocytoma
842911|NCT00005790|adult ependymoblastoma|adult ependymoblastoma
842912|NCT00005790|adult pineocytoma|adult pineocytoma
842913|NCT00005790|adult pineoblastoma|adult pineoblastoma
842914|NCT00005790|adult meningeal hemangiopericytoma|adult meningeal hemangiopericytoma
842915|NCT00005790|adult choroid plexus tumor|adult choroid plexus tumor
842916|NCT00005790|adult grade III meningioma|adult grade iii meningioma
842917|NCT00005790|adult giant cell glioblastoma|adult giant cell glioblastoma
842918|NCT00005790|adult gliosarcoma|adult gliosarcoma
842919|NCT00005084|childhood low-grade cerebral astrocytoma|childhood low-grade cerebral astrocytoma
842920|NCT00005084|childhood low-grade cerebellar astrocytoma|childhood low-grade cerebellar astrocytoma
842921|NCT00005084|recurrent childhood cerebral astrocytoma|recurrent childhood cerebral astrocytoma
842922|NCT00005045|stage III renal cell cancer|stage iii renal cell cancer
842923|NCT00005045|stage IV renal cell cancer|stage iv renal cell cancer
842924|NCT00005045|recurrent renal cell cancer|recurrent renal cell cancer
842925|NCT00004236|stage III gastric cancer|stage iii gastric cancer
842926|NCT00004236|stage IV gastric cancer|stage iv gastric cancer
842927|NCT00004236|recurrent gastric cancer|recurrent gastric cancer
842928|NCT00004236|stage III esophageal cancer|stage iii esophageal cancer
842929|NCT00004236|stage IV esophageal cancer|stage iv esophageal cancer
842930|NCT00004236|recurrent esophageal cancer|recurrent esophageal cancer
842931|NCT00004236|adenocarcinoma of the stomach|adenocarcinoma of the stomach
842932|NCT00004236|adenocarcinoma of the esophagus|adenocarcinoma of the esophagus
842933|NCT00003992|stage II breast cancer|stage ii breast cancer
842934|NCT00003992|stage IIIA breast cancer|stage iiia breast cancer
842935|NCT00003859|untreated childhood supratentorial primitive neuroectodermal tumor|untreated childhood supratentorial primitive neuroectodermal tumor
842936|NCT00003859|recurrent childhood supratentorial primitive neuroectodermal tumor|recurrent childhood supratentorial primitive neuroectodermal tumor
842937|NCT00003733|stage II ovarian epithelial cancer|stage ii ovarian epithelial cancer
842938|NCT00003733|stage III ovarian epithelial cancer|stage iii ovarian epithelial cancer
842939|NCT00003733|stage IV ovarian epithelial cancer|stage iv ovarian epithelial cancer
842940|NCT00003584|stage IV renal cell cancer|stage iv renal cell cancer
842941|NCT00003584|recurrent renal cell cancer|recurrent renal cell cancer
842942|NCT00003435|recurrent adult acute lymphoblastic leukemia|recurrent adult acute lymphoblastic leukemia
842943|NCT00003435|secondary acute myeloid leukemia|secondary acute myeloid leukemia
842944|NCT00003435|AIDS-related peripheral/systemic lymphoma|aids-related peripheral/systemic lymphoma
842945|NCT00003435|HIV-associated Hodgkin lymphoma|hiv-associated hodgkin lymphoma
842946|NCT00003410|adult glioblastoma|adult glioblastoma
842947|NCT00003410|adult giant cell glioblastoma|adult giant cell glioblastoma
842948|NCT00003410|adult gliosarcoma|adult gliosarcoma
842949|NCT00003372|recurrent adult brain tumor|recurrent adult brain tumor
842950|NCT00003372|adult anaplastic oligodendroglioma|adult anaplastic oligodendroglioma
842951|NCT00003372|adult mixed glioma|adult mixed glioma
842952|NCT00003236|recurrent breast cancer|recurrent breast cancer
842953|NCT00002905|AIDS-related peripheral/systemic lymphoma|aids-related peripheral/systemic lymphoma
842954|NCT00002496|stage III squamous cell carcinoma of the larynx|stage iii squamous cell carcinoma of the larynx
842955|NCT00002496|stage IV squamous cell carcinoma of the larynx|stage iv squamous cell carcinoma of the larynx
842956|NCT00002478|recurrent cervical cancer|recurrent cervical cancer
842957|NCT00002478|recurrent ovarian epithelial cancer|recurrent ovarian epithelial cancer
842958|NCT00002476|stage II squamous cell carcinoma of the lip and oral cavity|stage ii squamous cell carcinoma of the lip and oral cavity
842959|NCT00002476|stage II verrucous carcinoma of the oral cavity|stage ii verrucous carcinoma of the oral cavity
859974|NCT00062868|Relapse|relapse
842960|NCT00002476|stage III squamous cell carcinoma of the lip and oral cavity|stage iii squamous cell carcinoma of the lip and oral cavity
842961|NCT00002476|stage III verrucous carcinoma of the oral cavity|stage iii verrucous carcinoma of the oral cavity
842962|NCT00002476|stage IV squamous cell carcinoma of the lip and oral cavity|stage iv squamous cell carcinoma of the lip and oral cavity
842963|NCT00002476|stage IV verrucous carcinoma of the oral cavity|stage iv verrucous carcinoma of the oral cavity
842964|NCT00002476|stage II squamous cell carcinoma of the oropharynx|stage ii squamous cell carcinoma of the oropharynx
842965|NCT00002476|stage III squamous cell carcinoma of the oropharynx|stage iii squamous cell carcinoma of the oropharynx
842966|NCT00002476|stage IV squamous cell carcinoma of the oropharynx|stage iv squamous cell carcinoma of the oropharynx
842967|NCT00002476|stage II squamous cell carcinoma of the nasopharynx|stage ii squamous cell carcinoma of the nasopharynx
842968|NCT00002476|stage III squamous cell carcinoma of the nasopharynx|stage iii squamous cell carcinoma of the nasopharynx
842969|NCT00002476|stage IV squamous cell carcinoma of the nasopharynx|stage iv squamous cell carcinoma of the nasopharynx
842970|NCT00002476|stage II squamous cell carcinoma of the hypopharynx|stage ii squamous cell carcinoma of the hypopharynx
842971|NCT00002476|stage III squamous cell carcinoma of the hypopharynx|stage iii squamous cell carcinoma of the hypopharynx
842972|NCT00002476|stage IV squamous cell carcinoma of the hypopharynx|stage iv squamous cell carcinoma of the hypopharynx
842973|NCT00002476|stage II squamous cell carcinoma of the larynx|stage ii squamous cell carcinoma of the larynx
842974|NCT00002476|stage II verrucous carcinoma of the larynx|stage ii verrucous carcinoma of the larynx
842975|NCT00002476|stage III squamous cell carcinoma of the larynx|stage iii squamous cell carcinoma of the larynx
842976|NCT00002476|stage III verrucous carcinoma of the larynx|stage iii verrucous carcinoma of the larynx
842977|NCT00002476|stage IV squamous cell carcinoma of the larynx|stage iv squamous cell carcinoma of the larynx
842978|NCT00002476|stage IV verrucous carcinoma of the larynx|stage iv verrucous carcinoma of the larynx
842979|NCT00002476|stage II squamous cell carcinoma of the paranasal sinus and nasal cavity|stage ii squamous cell carcinoma of the paranasal sinus and nasal cavity
842980|NCT00002476|stage III squamous cell carcinoma of the paranasal sinus and nasal cavity|stage iii squamous cell carcinoma of the paranasal sinus and nasal cavity
842981|NCT00002476|stage IV squamous cell carcinoma of the paranasal sinus and nasal cavity|stage iv squamous cell carcinoma of the paranasal sinus and nasal cavity
842982|NCT00002460|stage I breast cancer|stage i breast cancer
842983|NCT00002460|stage II breast cancer|stage ii breast cancer
842984|NCT00002460|stage IIIA breast cancer|stage iiia breast cancer
842986|NCT00084162|Heart Rate Variability|heart rate variability
842987|NCT00084162|N-Back Task|n-back task
842988|NCT00084162|Isometric Handgrip|isometric handgrip
842989|NCT00084162|MRI|mri
842990|NCT00084162|Depression|depression
842991|NCT00084162|MDD|mdd
842992|NCT00084162|Heart|heart
842993|NCT00084149|Acute Infection|acute infection
842994|NCT00084149|Treatment Naive|treatment naive
842995|NCT00084136|Treatment Naive|treatment naive
842996|NCT00084136|Adherence|adherence
842997|NCT00084136|Drug Resistance|drug resistance
842998|NCT00084136|Treatment Failure|treatment failure
842999|NCT00084123|Relaxation Techniques|relaxation techniques
843000|NCT00084123|Radiation|radiation
843001|NCT00084123|Drug Therapy|drug therapy
843002|NCT00084123|Healing Touch|healing touch
843003|NCT00084110|Aged|aged
843004|NCT00084110|Mexican Americans|mexican americans
843005|NCT00084110|Complementary Therapies|complementary therapies
843006|NCT00083993|Breast Cancer|breast cancer
843007|NCT00005960|adenocarcinoma of the prostate|adenocarcinoma of the prostate
843008|NCT00005960|stage I prostate cancer|stage i prostate cancer
843009|NCT00005960|stage IIB prostate cancer|stage iib prostate cancer
843010|NCT00005960|stage IIA prostate cancer|stage iia prostate cancer
843011|NCT00005960|stage III prostate cancer|stage iii prostate cancer
843012|NCT00005960|stage IV prostate cancer|stage iv prostate cancer
843013|NCT00005960|recurrent prostate cancer|recurrent prostate cancer
843014|NCT00005960|pain|pain
843015|NCT00005641|recurrent childhood acute lymphoblastic leukemia|recurrent childhood acute lymphoblastic leukemia
843016|NCT00005641|refractory multiple myeloma|refractory multiple myeloma
843017|NCT00005641|stage 0 chronic lymphocytic leukemia|stage 0 chronic lymphocytic leukemia
843018|NCT00005641|stage I multiple myeloma|stage i multiple myeloma
843019|NCT00005641|stage II multiple myeloma|stage ii multiple myeloma
843020|NCT00005641|stage III multiple myeloma|stage iii multiple myeloma
843021|NCT00005641|stage I chronic lymphocytic leukemia|stage i chronic lymphocytic leukemia
843022|NCT00005641|stage II chronic lymphocytic leukemia|stage ii chronic lymphocytic leukemia
843023|NCT00005641|stage III chronic lymphocytic leukemia|stage iii chronic lymphocytic leukemia
843024|NCT00005641|stage IV chronic lymphocytic leukemia|stage iv chronic lymphocytic leukemia
843025|NCT00005641|recurrent childhood acute myeloid leukemia|recurrent childhood acute myeloid leukemia
843026|NCT00005641|recurrent adult acute myeloid leukemia|recurrent adult acute myeloid leukemia
843027|NCT00005641|recurrent adult acute lymphoblastic leukemia|recurrent adult acute lymphoblastic leukemia
843028|NCT00005641|relapsing chronic myelogenous leukemia|relapsing chronic myelogenous leukemia
843029|NCT00005641|refractory chronic lymphocytic leukemia|refractory chronic lymphocytic leukemia
843030|NCT00005641|chronic phase chronic myelogenous leukemia|chronic phase chronic myelogenous leukemia
843031|NCT00005641|accelerated phase chronic myelogenous leukemia|accelerated phase chronic myelogenous leukemia
843131|NCT00083876|Interferon-alpha 2b|interferon-alpha 2b
843032|NCT00005641|blastic phase chronic myelogenous leukemia|blastic phase chronic myelogenous leukemia
843033|NCT00005641|adult acute myeloid leukemia in remission|adult acute myeloid leukemia in remission
843034|NCT00005641|adult acute lymphoblastic leukemia in remission|adult acute lymphoblastic leukemia in remission
843035|NCT00005641|polycythemia vera|polycythemia vera
843036|NCT00005641|primary myelofibrosis|primary myelofibrosis
843037|NCT00005641|essential thrombocythemia|essential thrombocythemia
843038|NCT00005641|refractory anemia|refractory anemia
843039|NCT00005641|refractory anemia with ringed sideroblasts|refractory anemia with ringed sideroblasts
843040|NCT00005641|refractory anemia with excess blasts|refractory anemia with excess blasts
843041|NCT00005641|refractory anemia with excess blasts in transformation|refractory anemia with excess blasts in transformation
843042|NCT00005641|chronic myelomonocytic leukemia|chronic myelomonocytic leukemia
843043|NCT00005641|de novo myelodysplastic syndromes|de novo myelodysplastic syndromes
843044|NCT00005641|previously treated myelodysplastic syndromes|previously treated myelodysplastic syndromes
843045|NCT00005641|secondary myelodysplastic syndromes|secondary myelodysplastic syndromes
843046|NCT00005641|graft versus host disease|graft versus host disease
843047|NCT00005641|refractory cytopenia with multilineage dysplasia|refractory cytopenia with multilineage dysplasia
843048|NCT00005641|childhood myelodysplastic syndromes|childhood myelodysplastic syndromes
843049|NCT00005091|recurrent non-small cell lung cancer|recurrent non-small cell lung cancer
843050|NCT00005091|stage IIIB non-small cell lung cancer|stage iiib non-small cell lung cancer
843051|NCT00005091|stage IV non-small cell lung cancer|stage iv non-small cell lung cancer
843052|NCT00005054|stage IV breast cancer|stage iv breast cancer
843053|NCT00005054|stage IIIA breast cancer|stage iiia breast cancer
843054|NCT00005054|recurrent breast cancer|recurrent breast cancer
843055|NCT00005054|stage IIIB breast cancer|stage iiib breast cancer
843056|NCT00005050|stage III colon cancer|stage iii colon cancer
843057|NCT00005050|stage IV colon cancer|stage iv colon cancer
843058|NCT00005050|stage III rectal cancer|stage iii rectal cancer
843059|NCT00005050|stage IV rectal cancer|stage iv rectal cancer
843060|NCT00005050|recurrent colon cancer|recurrent colon cancer
843061|NCT00005050|recurrent rectal cancer|recurrent rectal cancer
843062|NCT00084097|Allergy|allergy
843063|NCT00084097|IgE|ige
843064|NCT00084097|Eosinophil|eosinophil
843065|NCT00084097|Monoclonal Antibody|monoclonal antibody
843066|NCT00084097|Eosinophilic Gastroenteritis|eosinophilic gastroenteritis
843067|NCT00084097|EG|eg
843068|NCT00084084|Lysosomes|lysosomes
843069|NCT00084084|Storage|storage
843070|NCT00084084|Glycolipid|glycolipid
843071|NCT00084084|Fabry disease|fabry disease
843072|NCT00084084|Stroke|stroke
843073|NCT00084084|Children|children
843074|NCT00084084|Pediatrics|pediatrics
843075|NCT00084058|Dose Intensification|dose intensification
843076|NCT00084058|Pharmacokinetic Sampling|pharmacokinetic sampling
843077|NCT00084058|Treatment Experienced|treatment experienced
843078|NCT00084058|Child|child
843079|NCT00084045|HIV Seronegativity|hiv seronegativity
843080|NCT00084045|Treatment Naive|treatment naive
843081|NCT00084045|Pediatric HIV|pediatric hiv
843082|NCT00084045|Perinatal Transmission|perinatal transmission
843083|NCT00084032|Acute Infection|acute infection
843084|NCT00084032|Treatment Interruption|treatment interruption
843085|NCT00084032|Treatment Naive|treatment naive
843086|NCT00084032|Primary HIV Infection|primary hiv infection
843087|NCT00084032|PHI|phi
843088|NCT00084019|Treatment Experienced|treatment experienced
843089|NCT00083980|Kava|kava
843090|NCT00083980|Complementary Therapies|complementary therapies
843091|NCT00083980|Medicine, Herbal|medicine, herbal
843092|NCT00083967|rhegmatogenous retinal detachment|rhegmatogenous retinal detachment
843093|NCT00083967|detached retina|detached retina
843094|NCT00083967|retinal tear|retinal tear
843095|NCT00083967|retinal break|retinal break
843096|NCT00083954|Bipolar I Disorder|bipolar i disorder
843097|NCT00083941|Renal Cell Cancer|renal cell cancer
843098|NCT00083941|Requiring IL-2 treatment|requiring il-2 treatment
843099|NCT00083941|Stage IV Renal Cell Cancer|stage iv renal cell cancer
843100|NCT00083928|Asymptomatic|asymptomatic
843101|NCT00083928|subcutaneous|subcutaneous
843102|NCT00083928|CA125 Progression|ca125 progression
843103|NCT00083928|Angstrom|angstrom
843104|NCT00083928|Ångstrom|ångstrom
843105|NCT00083928|ovarian cancer|ovarian cancer
843106|NCT00083915|Multiple Myeloma|multiple myeloma
843107|NCT00083915|DTPACE|dtpace
843108|NCT00083915|Tandem Transplant|tandem transplant
843109|NCT00083915|Cisplatin|cisplatin
843110|NCT00083915|Cyclophosphamide|cyclophosphamide
843111|NCT00083915|Dexamethasone|dexamethasone
843112|NCT00083915|Doxorubicin|doxorubicin
843113|NCT00083915|Etoposide|etoposide
843114|NCT00083915|Sargramostim|sargramostim
843115|NCT00083915|Thalidomide|thalidomide
843119|NCT00083902|Dexamethasone|dexamethasone
843120|NCT00083876|Multiple Myeloma|multiple myeloma
843121|NCT00083876|D.T. PACE|d.t. pace
843122|NCT00083876|Melphalan|melphalan
843123|NCT00083876|Transplant|transplant
843124|NCT00083876|Thalidomide|thalidomide
843125|NCT00083876|Dexamethasone|dexamethasone
843126|NCT00083876|Cisplatin|cisplatin
843127|NCT00083876|Cyclophosphamide|cyclophosphamide
843132|NCT00083876|Sargramostim|sargramostim
843133|NCT00005032|recurrent small cell lung cancer|recurrent small cell lung cancer
843134|NCT00005030|stage IV colon cancer|stage iv colon cancer
843135|NCT00005030|stage IV rectal cancer|stage iv rectal cancer
843136|NCT00005030|recurrent colon cancer|recurrent colon cancer
843137|NCT00005030|recurrent rectal cancer|recurrent rectal cancer
843138|NCT00005030|liver metastases|liver metastases
843139|NCT00004979|unspecified adult solid tumor, protocol specific|unspecified adult solid tumor, protocol specific
843140|NCT00004927|unspecified adult solid tumor, protocol specific|unspecified adult solid tumor, protocol specific
843141|NCT00004877|unspecified adult solid tumor, protocol specific|unspecified adult solid tumor, protocol specific
843142|NCT00004161|lip and oral cavity cancer|lip and oral cavity cancer
843143|NCT00004071|stage IV prostate cancer|stage iv prostate cancer
843144|NCT00004071|recurrent prostate cancer|recurrent prostate cancer
843145|NCT00004070|recurrent metastatic squamous neck cancer with occult primary|recurrent metastatic squamous neck cancer with occult primary
843146|NCT00004070|metastatic squamous neck cancer with occult primary squamous cell carcinoma|metastatic squamous neck cancer with occult primary squamous cell carcinoma
843147|NCT00004070|stage III squamous cell carcinoma of the lip and oral cavity|stage iii squamous cell carcinoma of the lip and oral cavity
843148|NCT00004070|stage IV squamous cell carcinoma of the lip and oral cavity|stage iv squamous cell carcinoma of the lip and oral cavity
843149|NCT00004070|recurrent squamous cell carcinoma of the lip and oral cavity|recurrent squamous cell carcinoma of the lip and oral cavity
843150|NCT00004070|stage III squamous cell carcinoma of the oropharynx|stage iii squamous cell carcinoma of the oropharynx
843151|NCT00004070|stage IV squamous cell carcinoma of the oropharynx|stage iv squamous cell carcinoma of the oropharynx
843152|NCT00004070|recurrent squamous cell carcinoma of the oropharynx|recurrent squamous cell carcinoma of the oropharynx
843153|NCT00004070|stage III squamous cell carcinoma of the nasopharynx|stage iii squamous cell carcinoma of the nasopharynx
843154|NCT00004070|stage IV squamous cell carcinoma of the nasopharynx|stage iv squamous cell carcinoma of the nasopharynx
843155|NCT00004070|recurrent squamous cell carcinoma of the nasopharynx|recurrent squamous cell carcinoma of the nasopharynx
843156|NCT00004070|stage III squamous cell carcinoma of the hypopharynx|stage iii squamous cell carcinoma of the hypopharynx
843157|NCT00004070|stage IV squamous cell carcinoma of the hypopharynx|stage iv squamous cell carcinoma of the hypopharynx
843158|NCT00004070|recurrent squamous cell carcinoma of the hypopharynx|recurrent squamous cell carcinoma of the hypopharynx
843159|NCT00004070|stage III squamous cell carcinoma of the larynx|stage iii squamous cell carcinoma of the larynx
843160|NCT00004070|stage IV squamous cell carcinoma of the larynx|stage iv squamous cell carcinoma of the larynx
843161|NCT00004070|recurrent squamous cell carcinoma of the larynx|recurrent squamous cell carcinoma of the larynx
843162|NCT00004070|stage III squamous cell carcinoma of the paranasal sinus and nasal cavity|stage iii squamous cell carcinoma of the paranasal sinus and nasal cavity
843163|NCT00004070|stage IV squamous cell carcinoma of the paranasal sinus and nasal cavity|stage iv squamous cell carcinoma of the paranasal sinus and nasal cavity
843164|NCT00004070|recurrent squamous cell carcinoma of the paranasal sinus and nasal cavity|recurrent squamous cell carcinoma of the paranasal sinus and nasal cavity
843165|NCT00004062|stage IV papillary thyroid cancer|stage iv papillary thyroid cancer
843166|NCT00004062|stage IV follicular thyroid cancer|stage iv follicular thyroid cancer
843167|NCT00004062|recurrent thyroid cancer|recurrent thyroid cancer
843168|NCT00083772|Heart failure|heart failure
843169|NCT00083772|Diastolic heart failure|diastolic heart failure
843170|NCT00083772|Congestive heart failure|congestive heart failure
843171|NCT00083772|Nesiritide|nesiritide
843172|NCT00083772|Natrecor|natrecor
843173|NCT00083772|Left ventricular (LV) diastolic function|left ventricular (lv) diastolic function
843174|NCT00083772|Fatigue|fatigue
843175|NCT00083772|Shortness of breath|shortness of breath
843176|NCT00083772|Edema|edema
843177|NCT00083772|Heart disease|heart disease
843178|NCT00004055|extensive stage small cell lung cancer|extensive stage small cell lung cancer
843179|NCT00003998|stage I ovarian epithelial cancer|stage i ovarian epithelial cancer
843180|NCT00003998|stage II ovarian epithelial cancer|stage ii ovarian epithelial cancer
843181|NCT00003998|stage III ovarian epithelial cancer|stage iii ovarian epithelial cancer
843182|NCT00003998|stage IV ovarian epithelial cancer|stage iv ovarian epithelial cancer
843183|NCT00003998|primary peritoneal cavity cancer|primary peritoneal cavity cancer
843184|NCT00003997|recurrent adult acute myeloid leukemia|recurrent adult acute myeloid leukemia
843185|NCT00003997|recurrent adult acute lymphoblastic leukemia|recurrent adult acute lymphoblastic leukemia
843186|NCT00003997|blastic phase chronic myelogenous leukemia|blastic phase chronic myelogenous leukemia
843187|NCT00003997|previously treated myelodysplastic syndromes|previously treated myelodysplastic syndromes
843188|NCT00003997|secondary myelodysplastic syndromes|secondary myelodysplastic syndromes
859772|NCT00063258|Lung Cancer|lung cancer
843189|NCT00003991|adult acute myeloid leukemia in remission|adult acute myeloid leukemia in remission
843190|NCT00003939|adult angiosarcoma|adult angiosarcoma
843191|NCT00003939|adult fibrosarcoma|adult fibrosarcoma
843192|NCT00003939|adult leiomyosarcoma|adult leiomyosarcoma
843193|NCT00003939|adult liposarcoma|adult liposarcoma
843194|NCT00003939|adult neurofibrosarcoma|adult neurofibrosarcoma
843195|NCT00003939|adult synovial sarcoma|adult synovial sarcoma
843196|NCT00003939|stage IV adult soft tissue sarcoma|stage iv adult soft tissue sarcoma
843197|NCT00003939|recurrent adult soft tissue sarcoma|recurrent adult soft tissue sarcoma
860063|NCT00062621|Tolerance|tolerance
843198|NCT00003939|small intestine leiomyosarcoma|small intestine leiomyosarcoma
843199|NCT00003939|adult alveolar soft-part sarcoma|adult alveolar soft-part sarcoma
843200|NCT00003939|adult epithelioid sarcoma|adult epithelioid sarcoma
843201|NCT00003939|adult malignant fibrous histiocytoma|adult malignant fibrous histiocytoma
843202|NCT00003939|adult malignant hemangiopericytoma|adult malignant hemangiopericytoma
843203|NCT00003939|adult malignant mesenchymoma|adult malignant mesenchymoma
843204|NCT00003939|adult rhabdomyosarcoma|adult rhabdomyosarcoma
843205|NCT00003939|stage IV uterine sarcoma|stage iv uterine sarcoma
843206|NCT00003939|recurrent uterine sarcoma|recurrent uterine sarcoma
843207|NCT00003939|uterine carcinosarcoma|uterine carcinosarcoma
843208|NCT00003939|uterine leiomyosarcoma|uterine leiomyosarcoma
843209|NCT00003939|endometrial stromal sarcoma|endometrial stromal sarcoma
843210|NCT00003939|ovarian sarcoma|ovarian sarcoma
843211|NCT00003939|adult meningeal hemangiopericytoma|adult meningeal hemangiopericytoma
843212|NCT00003939|gastrointestinal stromal tumor|gastrointestinal stromal tumor
843213|NCT00003856|recurrent salivary gland cancer|recurrent salivary gland cancer
843214|NCT00003856|recurrent metastatic squamous neck cancer with occult primary|recurrent metastatic squamous neck cancer with occult primary
843215|NCT00003856|recurrent squamous cell carcinoma of the lip and oral cavity|recurrent squamous cell carcinoma of the lip and oral cavity
843417|NCT00083590|Alzheimer disease|alzheimer disease
843216|NCT00003856|recurrent squamous cell carcinoma of the oropharynx|recurrent squamous cell carcinoma of the oropharynx
843217|NCT00003856|recurrent squamous cell carcinoma of the nasopharynx|recurrent squamous cell carcinoma of the nasopharynx
843218|NCT00003856|recurrent squamous cell carcinoma of the hypopharynx|recurrent squamous cell carcinoma of the hypopharynx
843219|NCT00003856|recurrent squamous cell carcinoma of the larynx|recurrent squamous cell carcinoma of the larynx
843220|NCT00003856|recurrent squamous cell carcinoma of the paranasal sinus and nasal cavity|recurrent squamous cell carcinoma of the paranasal sinus and nasal cavity
843221|NCT00003850|recurrent metastatic squamous neck cancer with occult primary|recurrent metastatic squamous neck cancer with occult primary
843222|NCT00003850|metastatic squamous neck cancer with occult primary squamous cell carcinoma|metastatic squamous neck cancer with occult primary squamous cell carcinoma
843223|NCT00003850|stage IV squamous cell carcinoma of the lip and oral cavity|stage iv squamous cell carcinoma of the lip and oral cavity
843224|NCT00003850|recurrent squamous cell carcinoma of the lip and oral cavity|recurrent squamous cell carcinoma of the lip and oral cavity
843225|NCT00003850|stage IV squamous cell carcinoma of the oropharynx|stage iv squamous cell carcinoma of the oropharynx
843226|NCT00003850|recurrent squamous cell carcinoma of the oropharynx|recurrent squamous cell carcinoma of the oropharynx
843227|NCT00003850|stage IV squamous cell carcinoma of the nasopharynx|stage iv squamous cell carcinoma of the nasopharynx
843228|NCT00003850|recurrent squamous cell carcinoma of the nasopharynx|recurrent squamous cell carcinoma of the nasopharynx
843229|NCT00003850|stage IV squamous cell carcinoma of the hypopharynx|stage iv squamous cell carcinoma of the hypopharynx
843230|NCT00003850|recurrent squamous cell carcinoma of the hypopharynx|recurrent squamous cell carcinoma of the hypopharynx
843231|NCT00003850|stage IV squamous cell carcinoma of the larynx|stage iv squamous cell carcinoma of the larynx
843232|NCT00003850|recurrent squamous cell carcinoma of the larynx|recurrent squamous cell carcinoma of the larynx
843233|NCT00003850|stage IV squamous cell carcinoma of the paranasal sinus and nasal cavity|stage iv squamous cell carcinoma of the paranasal sinus and nasal cavity
843234|NCT00003850|recurrent squamous cell carcinoma of the paranasal sinus and nasal cavity|recurrent squamous cell carcinoma of the paranasal sinus and nasal cavity
843235|NCT00003787|stage I breast cancer|stage i breast cancer
843236|NCT00003787|stage II breast cancer|stage ii breast cancer
843237|NCT00003787|stage IIIA breast cancer|stage iiia breast cancer
843238|NCT00003787|recurrent breast cancer|recurrent breast cancer
843239|NCT00003773|recurrent ovarian epithelial cancer|recurrent ovarian epithelial cancer
843240|NCT00003758|recurrent childhood acute myeloid leukemia|recurrent childhood acute myeloid leukemia
843241|NCT00003758|recurrent adult acute myeloid leukemia|recurrent adult acute myeloid leukemia
843242|NCT00003758|adult acute monoblastic leukemia and acute monocytic leukemia (M5)|adult acute monoblastic leukemia and acute monocytic leukemia (m5)
843243|NCT00003758|childhood acute monoblastic leukemia and acute monocytic leukemia (M5)|childhood acute monoblastic leukemia and acute monocytic leukemia (m5)
843244|NCT00003758|adult acute erythroid leukemia (M6)|adult acute erythroid leukemia (m6)
843245|NCT00003758|adult acute myeloblastic leukemia without maturation (M1)|adult acute myeloblastic leukemia without maturation (m1)
843246|NCT00003758|adult acute myeloblastic leukemia with maturation (M2)|adult acute myeloblastic leukemia with maturation (m2)
843247|NCT00003758|adult acute myelomonocytic leukemia (M4)|adult acute myelomonocytic leukemia (m4)
843248|NCT00003758|adult acute eosinophilic leukemia|adult acute eosinophilic leukemia
843249|NCT00003758|adult acute basophilic leukemia|adult acute basophilic leukemia
843250|NCT00003758|adult acute megakaryoblastic leukemia (M7)|adult acute megakaryoblastic leukemia (m7)
859773|NCT00063258|OSI-774|osi-774
843251|NCT00003758|childhood acute myeloblastic leukemia without maturation (M1)|childhood acute myeloblastic leukemia without maturation (m1)
843252|NCT00003758|childhood acute myeloblastic leukemia with maturation (M2)|childhood acute myeloblastic leukemia with maturation (m2)
843253|NCT00003758|childhood acute myelomonocytic leukemia (M4)|childhood acute myelomonocytic leukemia (m4)
843254|NCT00003758|childhood acute erythroleukemia (M6)|childhood acute erythroleukemia (m6)
843255|NCT00003758|childhood acute eosinophilic leukemia|childhood acute eosinophilic leukemia
843256|NCT00003758|childhood acute basophilic leukemia|childhood acute basophilic leukemia
860064|NCT00062621|Chimerism|chimerism
843257|NCT00003758|childhood acute megakaryocytic leukemia (M7)|childhood acute megakaryocytic leukemia (m7)
843258|NCT00003758|adult acute minimally differentiated myeloid leukemia (M0)|adult acute minimally differentiated myeloid leukemia (m0)
843259|NCT00003758|childhood acute minimally differentiated myeloid leukemia (M0)|childhood acute minimally differentiated myeloid leukemia (m0)
843260|NCT00003755|unspecified adult solid tumor, protocol specific|unspecified adult solid tumor, protocol specific
843261|NCT00003740|stage IV prostate cancer|stage iv prostate cancer
843262|NCT00003740|recurrent prostate cancer|recurrent prostate cancer
843263|NCT00003443|stage IV squamous cell carcinoma of the lip and oral cavity|stage iv squamous cell carcinoma of the lip and oral cavity
843264|NCT00003443|recurrent squamous cell carcinoma of the lip and oral cavity|recurrent squamous cell carcinoma of the lip and oral cavity
843265|NCT00003443|stage IV squamous cell carcinoma of the oropharynx|stage iv squamous cell carcinoma of the oropharynx
843266|NCT00003443|recurrent squamous cell carcinoma of the oropharynx|recurrent squamous cell carcinoma of the oropharynx
843267|NCT00003443|stage IV squamous cell carcinoma of the nasopharynx|stage iv squamous cell carcinoma of the nasopharynx
843268|NCT00003443|recurrent squamous cell carcinoma of the nasopharynx|recurrent squamous cell carcinoma of the nasopharynx
843269|NCT00003443|stage IV squamous cell carcinoma of the hypopharynx|stage iv squamous cell carcinoma of the hypopharynx
843270|NCT00003443|recurrent squamous cell carcinoma of the hypopharynx|recurrent squamous cell carcinoma of the hypopharynx
843271|NCT00003443|stage IV squamous cell carcinoma of the larynx|stage iv squamous cell carcinoma of the larynx
843272|NCT00003443|recurrent squamous cell carcinoma of the larynx|recurrent squamous cell carcinoma of the larynx
843273|NCT00003443|stage IV squamous cell carcinoma of the paranasal sinus and nasal cavity|stage iv squamous cell carcinoma of the paranasal sinus and nasal cavity
843274|NCT00003443|recurrent squamous cell carcinoma of the paranasal sinus and nasal cavity|recurrent squamous cell carcinoma of the paranasal sinus and nasal cavity
843275|NCT00003401|refractory multiple myeloma|refractory multiple myeloma
843276|NCT00003401|stage I multiple myeloma|stage i multiple myeloma
843277|NCT00003401|stage II multiple myeloma|stage ii multiple myeloma
843278|NCT00003401|stage III multiple myeloma|stage iii multiple myeloma
843279|NCT00003399|refractory multiple myeloma|refractory multiple myeloma
843280|NCT00003399|stage I multiple myeloma|stage i multiple myeloma
843281|NCT00003399|stage II multiple myeloma|stage ii multiple myeloma
843282|NCT00003399|stage III multiple myeloma|stage iii multiple myeloma
843283|NCT00003396|recurrent childhood acute lymphoblastic leukemia|recurrent childhood acute lymphoblastic leukemia
843284|NCT00003396|recurrent adult Hodgkin lymphoma|recurrent adult hodgkin lymphoma
843285|NCT00003396|refractory multiple myeloma|refractory multiple myeloma
843286|NCT00003396|Waldenstrom macroglobulinemia|waldenstrom macroglobulinemia
843287|NCT00003396|stage I multiple myeloma|stage i multiple myeloma
843288|NCT00003396|stage II multiple myeloma|stage ii multiple myeloma
843289|NCT00003396|stage III multiple myeloma|stage iii multiple myeloma
843290|NCT00003396|recurrent childhood lymphoblastic lymphoma|recurrent childhood lymphoblastic lymphoma
843291|NCT00003396|recurrent childhood acute myeloid leukemia|recurrent childhood acute myeloid leukemia
843292|NCT00003396|recurrent adult acute myeloid leukemia|recurrent adult acute myeloid leukemia
843293|NCT00003396|recurrent adult acute lymphoblastic leukemia|recurrent adult acute lymphoblastic leukemia
843294|NCT00003396|relapsing chronic myelogenous leukemia|relapsing chronic myelogenous leukemia
843295|NCT00003396|refractory chronic lymphocytic leukemia|refractory chronic lymphocytic leukemia
843296|NCT00003396|accelerated phase chronic myelogenous leukemia|accelerated phase chronic myelogenous leukemia
843297|NCT00003396|blastic phase chronic myelogenous leukemia|blastic phase chronic myelogenous leukemia
843298|NCT00003396|adult acute myeloid leukemia in remission|adult acute myeloid leukemia in remission
843299|NCT00003396|adult acute lymphoblastic leukemia in remission|adult acute lymphoblastic leukemia in remission
843300|NCT00003396|childhood acute myeloid leukemia in remission|childhood acute myeloid leukemia in remission
843301|NCT00003396|childhood acute lymphoblastic leukemia in remission|childhood acute lymphoblastic leukemia in remission
843302|NCT00003396|adult acute erythroid leukemia (M6)|adult acute erythroid leukemia (m6)
843303|NCT00003396|adult acute myeloblastic leukemia without maturation (M1)|adult acute myeloblastic leukemia without maturation (m1)
843304|NCT00003396|adult acute myeloblastic leukemia with maturation (M2)|adult acute myeloblastic leukemia with maturation (m2)
843305|NCT00003396|adult acute promyelocytic leukemia (M3)|adult acute promyelocytic leukemia (m3)
843306|NCT00003396|adult acute eosinophilic leukemia|adult acute eosinophilic leukemia
843307|NCT00003396|adult acute basophilic leukemia|adult acute basophilic leukemia
843308|NCT00003396|adult acute megakaryoblastic leukemia (M7)|adult acute megakaryoblastic leukemia (m7)
843309|NCT00003396|childhood acute myeloblastic leukemia without maturation (M1)|childhood acute myeloblastic leukemia without maturation (m1)
843310|NCT00003396|childhood acute myeloblastic leukemia with maturation (M2)|childhood acute myeloblastic leukemia with maturation (m2)
843311|NCT00003396|childhood acute promyelocytic leukemia (M3)|childhood acute promyelocytic leukemia (m3)
843312|NCT00003396|childhood acute erythroleukemia (M6)|childhood acute erythroleukemia (m6)
843313|NCT00003396|childhood acute eosinophilic leukemia|childhood acute eosinophilic leukemia
843314|NCT00003396|childhood acute basophilic leukemia|childhood acute basophilic leukemia
843315|NCT00003396|childhood acute megakaryocytic leukemia (M7)|childhood acute megakaryocytic leukemia (m7)
843316|NCT00003396|recurrent/refractory childhood Hodgkin lymphoma|recurrent/refractory childhood hodgkin lymphoma
843317|NCT00003396|recurrent grade 1 follicular lymphoma|recurrent grade 1 follicular lymphoma
843410|NCT00083629|Compartment Analysis|compartment analysis
843318|NCT00003396|recurrent grade 2 follicular lymphoma|recurrent grade 2 follicular lymphoma
843319|NCT00003396|recurrent grade 3 follicular lymphoma|recurrent grade 3 follicular lymphoma
843320|NCT00003396|recurrent adult diffuse small cleaved cell lymphoma|recurrent adult diffuse small cleaved cell lymphoma
843321|NCT00003396|recurrent adult diffuse mixed cell lymphoma|recurrent adult diffuse mixed cell lymphoma
843322|NCT00003396|recurrent adult diffuse large cell lymphoma|recurrent adult diffuse large cell lymphoma
843323|NCT00003396|recurrent adult immunoblastic large cell lymphoma|recurrent adult immunoblastic large cell lymphoma
843324|NCT00003396|recurrent adult lymphoblastic lymphoma|recurrent adult lymphoblastic lymphoma
843325|NCT00003396|recurrent adult Burkitt lymphoma|recurrent adult burkitt lymphoma
843326|NCT00003396|previously treated myelodysplastic syndromes|previously treated myelodysplastic syndromes
843327|NCT00003396|adult acute minimally differentiated myeloid leukemia (M0)|adult acute minimally differentiated myeloid leukemia (m0)
843328|NCT00003396|childhood acute minimally differentiated myeloid leukemia (M0)|childhood acute minimally differentiated myeloid leukemia (m0)
843329|NCT00003396|recurrent childhood small noncleaved cell lymphoma|recurrent childhood small noncleaved cell lymphoma
843330|NCT00003396|recurrent childhood large cell lymphoma|recurrent childhood large cell lymphoma
843331|NCT00003396|recurrent mantle cell lymphoma|recurrent mantle cell lymphoma
843332|NCT00003396|recurrent marginal zone lymphoma|recurrent marginal zone lymphoma
843333|NCT00003396|recurrent small lymphocytic lymphoma|recurrent small lymphocytic lymphoma
843334|NCT00003396|extranodal marginal zone B-cell lymphoma of mucosa-associated lymphoid tissue|extranodal marginal zone b-cell lymphoma of mucosa-associated lymphoid tissue
843335|NCT00003396|nodal marginal zone B-cell lymphoma|nodal marginal zone b-cell lymphoma
843336|NCT00003396|splenic marginal zone lymphoma|splenic marginal zone lymphoma
843337|NCT00003396|childhood myelodysplastic syndromes|childhood myelodysplastic syndromes
843338|NCT00003293|recurrent adult brain tumor|recurrent adult brain tumor
843339|NCT00003293|adult glioblastoma|adult glioblastoma
843340|NCT00003293|adult giant cell glioblastoma|adult giant cell glioblastoma
843341|NCT00003293|adult gliosarcoma|adult gliosarcoma
843342|NCT00003249|unspecified adult solid tumor, protocol specific|unspecified adult solid tumor, protocol specific
843343|NCT00003231|squamous cell lung cancer|squamous cell lung cancer
843344|NCT00003231|large cell lung cancer|large cell lung cancer
843345|NCT00003231|stage IIIA non-small cell lung cancer|stage iiia non-small cell lung cancer
843346|NCT00003231|adenocarcinoma of the lung|adenocarcinoma of the lung
843347|NCT00083720|EGFR-undetectable|egfr-undetectable
843348|NCT00083720|Metastatic Colorectal Cancer|metastatic colorectal cancer
843349|NCT00083733|Gene Expression|gene expression
843350|NCT00083733|Microarray|microarray
843351|NCT00083733|Stem Cell|stem cell
843352|NCT00083733|Proteomics|proteomics
843353|NCT00083733|Metastases|metastases
843354|NCT00083733|Breast Tissue|breast tissue
843355|NCT00083733|Normal Breast Tissue|normal breast tissue
843356|NCT00083733|Breast Cancer|breast cancer
843357|NCT00083707|Macroglobulinemia|macroglobulinemia
843358|NCT00083707|Waldenstrom|waldenstrom
843359|NCT00083707|Thalidomide|thalidomide
843360|NCT00083694|Leukemia|leukemia
843361|NCT00083694|Thalidomide|thalidomide
843362|NCT00083694|relapsed|relapsed
843363|NCT00083681|Multiple Myeloma|multiple myeloma
843364|NCT00083681|Thalidomide|thalidomide
843365|NCT00083681|G-CSF|g-csf
843366|NCT00083681|Cisplatin|cisplatin
843367|NCT00083681|Etoposide|etoposide
843368|NCT00083681|Dexamethasone|dexamethasone
843369|NCT00083681|Cytoxan|cytoxan
843370|NCT00083681|DCEP|dcep
843371|NCT00083681|Relapse|relapse
843372|NCT00083668|Schizophrenia|schizophrenia
843373|NCT00083668|Paliperidone|paliperidone
843374|NCT00083668|Olanzapine|olanzapine
843375|NCT00083668|PANSS|panss
843376|NCT00083668|Extended release|extended release
843377|NCT00083668|Atypical neuroleptic|atypical neuroleptic
843378|NCT00083616|EGFr|egfr
843379|NCT00083616|Clinical Trial|clinical trial
843380|NCT00083616|Panitumumab|panitumumab
843381|NCT00083616|ABX-EGF|abx-egf
843382|NCT00083616|Immunex|immunex
843383|NCT00083616|Metastatic Cancer|metastatic cancer
843384|NCT00083616|Vectibix|vectibix
843385|NCT00083616|Abgenix|abgenix
843386|NCT00083616|Amgen|amgen
843387|NCT00083564|Multiple myeloma|multiple myeloma
843388|NCT00083564|Primary refractory multiple myeloma|primary refractory multiple myeloma
843389|NCT00083564|STR|str
843390|NCT00083564|Skeletal Targeted Radiotherapy|skeletal targeted radiotherapy
843391|NCT00083564|Holmium-166|holmium-166
843392|NCT00083564|166-Ho-DOTMP|166-ho-dotmp
843393|NCT00083642|Brain Plasticity|brain plasticity
843394|NCT00083642|Functional MRI|functional mri
843395|NCT00083642|Finger Movement|finger movement
843396|NCT00083642|Rehabilitation|rehabilitation
843397|NCT00083642|Improvement|improvement
843399|NCT00083642|Motor Recovery|motor recovery
843400|NCT00083642|Observation|observation
843401|NCT00083642|fMRI|fmri
843402|NCT00083642|Healthy Volunteer|healthy volunteer
843403|NCT00083642|HV|hv
843404|NCT00083629|[18F]FECNT|[18f]fecnt
843405|NCT00083629|Biodistribution|biodistribution
843406|NCT00083629|Dosimetry|dosimetry
843407|NCT00083629|Dopamine Transporter|dopamine transporter
843408|NCT00083629|MIRD|mird
843409|NCT00083629|Kinetic Analysis|kinetic analysis
843411|NCT00083629|Healthy Volunteer|healthy volunteer
843412|NCT00083629|HV|hv
843413|NCT00083603|HIV Seronegativity|hiv seronegativity
843414|NCT00083603|HIV Preventive Vaccine|hiv preventive vaccine
843415|NCT00083603|Vaccinia vector|vaccinia vector
843416|NCT00083603|Pox vector|pox vector
843418|NCT00083590|Cholinesterase inhibitor|cholinesterase inhibitor
843419|NCT00083577|Multiple Myeloma|multiple myeloma
843420|NCT00083577|Thalidomide|thalidomide
843421|NCT00083577|Anti-Angiogenesis|anti-angiogenesis
843422|NCT00083551|Multiple Myeloma|multiple myeloma
843423|NCT00083551|Cancer|cancer
843424|NCT00083551|Therapy|therapy
843425|NCT00083551|Thalidomide|thalidomide
843426|NCT00083551|DTPACE|dtpace
843427|NCT00083551|Transplant|transplant
843428|NCT00083551|VAD|vad
843429|NCT00083551|DCEP|dcep
843430|NCT00083551|CAD|cad
843431|NCT00083551|Consolidation|consolidation
843432|NCT00083551|Melphalan|melphalan
843433|NCT00083538|Multiple Myeloma|multiple myeloma
843434|NCT00083538|DTPACE|dtpace
843435|NCT00083538|Dexamethasone|dexamethasone
843436|NCT00083538|Thalidomide|thalidomide
843437|NCT00083538|Cisplatin|cisplatin
843438|NCT00083538|Cytoxan|cytoxan
843439|NCT00083538|Doxorubicin|doxorubicin
843440|NCT00083538|Etoposide|etoposide
843441|NCT00083538|Dendritic Cell Vaccination|dendritic cell vaccination
843442|NCT00083538|Leukapheresis|leukapheresis
843443|NCT00003160|stage III ovarian epithelial cancer|stage iii ovarian epithelial cancer
843444|NCT00003160|stage IV ovarian epithelial cancer|stage iv ovarian epithelial cancer
843445|NCT00003160|recurrent ovarian epithelial cancer|recurrent ovarian epithelial cancer
843446|NCT00003160|fallopian tube cancer|fallopian tube cancer
843447|NCT00003160|primary peritoneal cavity cancer|primary peritoneal cavity cancer
843448|NCT00003079|recurrent adult acute myeloid leukemia|recurrent adult acute myeloid leukemia
843449|NCT00003079|recurrent adult acute lymphoblastic leukemia|recurrent adult acute lymphoblastic leukemia
843450|NCT00003079|blastic phase chronic myelogenous leukemia|blastic phase chronic myelogenous leukemia
843451|NCT00003079|recurrent adult lymphoblastic lymphoma|recurrent adult lymphoblastic lymphoma
843452|NCT00003075|cervical cancer|cervical cancer
843453|NCT00003075|cervical intraepithelial neoplasia grade 2|cervical intraepithelial neoplasia grade 2
843454|NCT00003075|cervical intraepithelial neoplasia grade 3|cervical intraepithelial neoplasia grade 3
843455|NCT00003031|infection|infection
843456|NCT00003031|pulmonary complications|pulmonary complications
843457|NCT00003015|childhood low-grade cerebral astrocytoma|childhood low-grade cerebral astrocytoma
843458|NCT00003015|childhood oligodendroglioma|childhood oligodendroglioma
843459|NCT00003015|untreated childhood visual pathway glioma|untreated childhood visual pathway glioma
843460|NCT00003015|untreated childhood cerebellar astrocytoma|untreated childhood cerebellar astrocytoma
843461|NCT00083473|Leukemia Lymphocytic Chronic,|leukemia lymphocytic chronic,
843462|NCT00083473|Pivanex,|pivanex,
843463|NCT00083473|Histone deacetylase inhibitor|histone deacetylase inhibitor
843464|NCT00083460|Multiple Myeloma|multiple myeloma
843465|NCT00083460|Thalidomide|thalidomide
843466|NCT00083460|Velcade|velcade
843467|NCT00083460|PS-341|ps-341
843468|NCT00083460|Refractory|refractory
843469|NCT00083460|Bortezomid|bortezomid
843470|NCT00083447|brain tumor|brain tumor
843471|NCT00083447|GBM|gbm
843472|NCT00083447|glioblastoma|glioblastoma
843473|NCT00083447|glioblastoma multiforme|glioblastoma multiforme
843474|NCT00083447|brain cancer|brain cancer
843475|NCT00083447|treatment|treatment
843476|NCT00083434|Anemia|anemia
843477|NCT00083434|Cancer|cancer
843478|NCT00006877|recurrent non-small cell lung cancer|recurrent non-small cell lung cancer
843479|NCT00006877|squamous cell lung cancer|squamous cell lung cancer
843480|NCT00006877|large cell lung cancer|large cell lung cancer
843481|NCT00006877|stage IV non-small cell lung cancer|stage iv non-small cell lung cancer
843482|NCT00006877|adenocarcinoma of the lung|adenocarcinoma of the lung
843483|NCT00006358|recurrent adult brain tumor|recurrent adult brain tumor
843484|NCT00006358|adult glioblastoma|adult glioblastoma
843485|NCT00006358|adult giant cell glioblastoma|adult giant cell glioblastoma
843486|NCT00006358|adult gliosarcoma|adult gliosarcoma
843487|NCT00006343|chronic phase chronic myelogenous leukemia|chronic phase chronic myelogenous leukemia
843488|NCT00006343|chronic myelogenous leukemia, BCR-ABL1 positive|chronic myelogenous leukemia, bcr-abl1 positive
843489|NCT00006222|AIDS-related Kaposi sarcoma|aids-related kaposi sarcoma
843490|NCT00006222|recurrent Kaposi sarcoma|recurrent kaposi sarcoma
843491|NCT00006212|stage II non-small cell lung cancer|stage ii non-small cell lung cancer
843492|NCT00006212|stage IIIA non-small cell lung cancer|stage iiia non-small cell lung cancer
843493|NCT00006212|stage IIIB non-small cell lung cancer|stage iiib non-small cell lung cancer
843494|NCT00006083|stage I adult Hodgkin lymphoma|stage i adult hodgkin lymphoma
843495|NCT00006083|stage II adult Hodgkin lymphoma|stage ii adult hodgkin lymphoma
843496|NCT00006083|stage III adult Hodgkin lymphoma|stage iii adult hodgkin lymphoma
843497|NCT00006083|stage IV adult Hodgkin lymphoma|stage iv adult hodgkin lymphoma
843498|NCT00006083|monoclonal gammopathy of undetermined significance|monoclonal gammopathy of undetermined significance
843499|NCT00006083|recurrent adult Hodgkin lymphoma|recurrent adult hodgkin lymphoma
843500|NCT00006083|stage I cutaneous T-cell non-Hodgkin lymphoma|stage i cutaneous t-cell non-hodgkin lymphoma
843501|NCT00006083|stage II cutaneous T-cell non-Hodgkin lymphoma|stage ii cutaneous t-cell non-hodgkin lymphoma
843502|NCT00006083|stage III cutaneous T-cell non-Hodgkin lymphoma|stage iii cutaneous t-cell non-hodgkin lymphoma
843503|NCT00006083|stage IV cutaneous T-cell non-Hodgkin lymphoma|stage iv cutaneous t-cell non-hodgkin lymphoma
843504|NCT00006083|recurrent cutaneous T-cell non-Hodgkin lymphoma|recurrent cutaneous t-cell non-hodgkin lymphoma
843505|NCT00006083|stage IB cervical cancer|stage ib cervical cancer
843506|NCT00006083|Burkitt lymphoma|burkitt lymphoma
843507|NCT00006083|isolated plasmacytoma of bone|isolated plasmacytoma of bone
843508|NCT00006083|extramedullary plasmacytoma|extramedullary plasmacytoma
843509|NCT00006083|refractory multiple myeloma|refractory multiple myeloma
843510|NCT00006083|stage 0 chronic lymphocytic leukemia|stage 0 chronic lymphocytic leukemia
843511|NCT00006083|stage I multiple myeloma|stage i multiple myeloma
843512|NCT00006083|stage II multiple myeloma|stage ii multiple myeloma
843513|NCT00006083|stage III multiple myeloma|stage iii multiple myeloma
843514|NCT00006083|stage I chronic lymphocytic leukemia|stage i chronic lymphocytic leukemia
843515|NCT00006083|stage II chronic lymphocytic leukemia|stage ii chronic lymphocytic leukemia
843516|NCT00006083|stage IV chronic lymphocytic leukemia|stage iv chronic lymphocytic leukemia
843517|NCT00006083|recurrent adult acute myeloid leukemia|recurrent adult acute myeloid leukemia
843518|NCT00006083|recurrent adult acute lymphoblastic leukemia|recurrent adult acute lymphoblastic leukemia
843519|NCT00006083|relapsing chronic myelogenous leukemia|relapsing chronic myelogenous leukemia
843520|NCT00006083|refractory chronic lymphocytic leukemia|refractory chronic lymphocytic leukemia
843521|NCT00006083|unspecified adult solid tumor, protocol specific|unspecified adult solid tumor, protocol specific
843522|NCT00006083|chronic phase chronic myelogenous leukemia|chronic phase chronic myelogenous leukemia
843523|NCT00006083|accelerated phase chronic myelogenous leukemia|accelerated phase chronic myelogenous leukemia
843524|NCT00006083|blastic phase chronic myelogenous leukemia|blastic phase chronic myelogenous leukemia
843525|NCT00006083|meningeal chronic myelogenous leukemia|meningeal chronic myelogenous leukemia
843526|NCT00006083|untreated adult acute lymphoblastic leukemia|untreated adult acute lymphoblastic leukemia
843527|NCT00006083|untreated adult acute myeloid leukemia|untreated adult acute myeloid leukemia
843528|NCT00006083|adult acute myeloid leukemia in remission|adult acute myeloid leukemia in remission
843529|NCT00006083|adult acute lymphoblastic leukemia in remission|adult acute lymphoblastic leukemia in remission
843530|NCT00006083|chronic idiopathic myelofibrosis|chronic idiopathic myelofibrosis
843531|NCT00006083|essential thrombocythemia|essential thrombocythemia
843532|NCT00006083|untreated hairy cell leukemia|untreated hairy cell leukemia
843533|NCT00006083|progressive hairy cell leukemia, initial treatment|progressive hairy cell leukemia, initial treatment
843534|NCT00006083|refractory hairy cell leukemia|refractory hairy cell leukemia
843535|NCT00006083|stage I grade 1 follicular lymphoma|stage i grade 1 follicular lymphoma
843536|NCT00006083|stage I grade 2 follicular lymphoma|stage i grade 2 follicular lymphoma
843537|NCT00006083|stage I grade 3 follicular lymphoma|stage i grade 3 follicular lymphoma
843538|NCT00006083|stage I adult diffuse small cleaved cell lymphoma|stage i adult diffuse small cleaved cell lymphoma
843539|NCT00006083|stage I adult diffuse mixed cell lymphoma|stage i adult diffuse mixed cell lymphoma
843540|NCT00006083|stage I adult diffuse large cell lymphoma|stage i adult diffuse large cell lymphoma
843541|NCT00006083|stage I adult immunoblastic large cell lymphoma|stage i adult immunoblastic large cell lymphoma
843542|NCT00006083|stage I adult lymphoblastic lymphoma|stage i adult lymphoblastic lymphoma
843543|NCT00006083|stage I adult Burkitt lymphoma|stage i adult burkitt lymphoma
843544|NCT00006083|chronic myelomonocytic leukemia|chronic myelomonocytic leukemia
843545|NCT00006083|T-cell large granular lymphocyte leukemia|t-cell large granular lymphocyte leukemia
843546|NCT00006083|acute undifferentiated leukemia|acute undifferentiated leukemia
843547|NCT00006083|stage III grade 1 follicular lymphoma|stage iii grade 1 follicular lymphoma
843548|NCT00006083|stage III grade 2 follicular lymphoma|stage iii grade 2 follicular lymphoma
843549|NCT00006083|stage III grade 3 follicular lymphoma|stage iii grade 3 follicular lymphoma
843550|NCT00006083|stage III adult diffuse small cleaved cell lymphoma|stage iii adult diffuse small cleaved cell lymphoma
843551|NCT00006083|stage III adult diffuse mixed cell lymphoma|stage iii adult diffuse mixed cell lymphoma
843552|NCT00006083|stage III adult diffuse large cell lymphoma|stage iii adult diffuse large cell lymphoma
843553|NCT00006083|stage III adult immunoblastic large cell lymphoma|stage iii adult immunoblastic large cell lymphoma
843554|NCT00006083|stage III adult lymphoblastic lymphoma|stage iii adult lymphoblastic lymphoma
843555|NCT00006083|stage III adult Burkitt lymphoma|stage iii adult burkitt lymphoma
843556|NCT00006083|stage IV grade 1 follicular lymphoma|stage iv grade 1 follicular lymphoma
843557|NCT00006083|stage IV grade 2 follicular lymphoma|stage iv grade 2 follicular lymphoma
843558|NCT00006083|stage IV grade 3 follicular lymphoma|stage iv grade 3 follicular lymphoma
843559|NCT00006083|stage IV adult diffuse small cleaved cell lymphoma|stage iv adult diffuse small cleaved cell lymphoma
843560|NCT00006083|stage IV adult diffuse mixed cell lymphoma|stage iv adult diffuse mixed cell lymphoma
843561|NCT00006083|stage IV adult diffuse large cell lymphoma|stage iv adult diffuse large cell lymphoma
843562|NCT00006083|stage IV adult immunoblastic large cell lymphoma|stage iv adult immunoblastic large cell lymphoma
843563|NCT00006083|stage IV adult lymphoblastic lymphoma|stage iv adult lymphoblastic lymphoma
843564|NCT00006083|stage IV adult Burkitt lymphoma|stage iv adult burkitt lymphoma
843565|NCT00006083|recurrent grade 1 follicular lymphoma|recurrent grade 1 follicular lymphoma
860065|NCT00062621|ESRD|esrd
843566|NCT00006083|recurrent grade 2 follicular lymphoma|recurrent grade 2 follicular lymphoma
843567|NCT00006083|recurrent grade 3 follicular lymphoma|recurrent grade 3 follicular lymphoma
843568|NCT00006083|recurrent adult diffuse small cleaved cell lymphoma|recurrent adult diffuse small cleaved cell lymphoma
843569|NCT00006083|recurrent adult diffuse mixed cell lymphoma|recurrent adult diffuse mixed cell lymphoma
843570|NCT00006083|recurrent adult diffuse large cell lymphoma|recurrent adult diffuse large cell lymphoma
843571|NCT00006083|recurrent adult immunoblastic large cell lymphoma|recurrent adult immunoblastic large cell lymphoma
843572|NCT00006083|recurrent adult lymphoblastic lymphoma|recurrent adult lymphoblastic lymphoma
843573|NCT00006083|recurrent adult Burkitt lymphoma|recurrent adult burkitt lymphoma
843574|NCT00006083|stage I adult T-cell leukemia/lymphoma|stage i adult t-cell leukemia/lymphoma
843575|NCT00006083|stage II adult T-cell leukemia/lymphoma|stage ii adult t-cell leukemia/lymphoma
843576|NCT00006083|stage III adult T-cell leukemia/lymphoma|stage iii adult t-cell leukemia/lymphoma
843577|NCT00006083|stage IV adult T-cell leukemia/lymphoma|stage iv adult t-cell leukemia/lymphoma
843578|NCT00006083|recurrent adult T-cell leukemia/lymphoma|recurrent adult t-cell leukemia/lymphoma
843579|NCT00006083|secondary acute myeloid leukemia|secondary acute myeloid leukemia
843580|NCT00006083|de novo myelodysplastic syndromes|de novo myelodysplastic syndromes
843581|NCT00006083|previously treated myelodysplastic syndromes|previously treated myelodysplastic syndromes
843582|NCT00006083|secondary myelodysplastic syndromes|secondary myelodysplastic syndromes
843583|NCT00006083|primary central nervous system lymphoma|primary central nervous system lymphoma
843584|NCT00006083|prolymphocytic leukemia|prolymphocytic leukemia
843585|NCT00006083|primary systemic amyloidosis|primary systemic amyloidosis
843586|NCT00006083|veno-occlusive disease|veno-occlusive disease
843587|NCT00006083|stage I mantle cell lymphoma|stage i mantle cell lymphoma
843588|NCT00006083|contiguous stage II grade 1 follicular lymphoma|contiguous stage ii grade 1 follicular lymphoma
843589|NCT00006083|contiguous stage II grade 2 follicular lymphoma|contiguous stage ii grade 2 follicular lymphoma
843590|NCT00006083|contiguous stage II grade 3 follicular lymphoma|contiguous stage ii grade 3 follicular lymphoma
843591|NCT00006083|contiguous stage II adult diffuse small cleaved cell lymphoma|contiguous stage ii adult diffuse small cleaved cell lymphoma
843592|NCT00006083|contiguous stage II mantle cell lymphoma|contiguous stage ii mantle cell lymphoma
843593|NCT00006083|contiguous stage II adult diffuse mixed cell lymphoma|contiguous stage ii adult diffuse mixed cell lymphoma
843594|NCT00006083|contiguous stage II adult immunoblastic large cell lymphoma|contiguous stage ii adult immunoblastic large cell lymphoma
843595|NCT00006083|contiguous stage II adult diffuse large cell lymphoma|contiguous stage ii adult diffuse large cell lymphoma
843596|NCT00006083|contiguous stage II adult Burkitt lymphoma|contiguous stage ii adult burkitt lymphoma
843597|NCT00006083|contiguous stage II adult lymphoblastic lymphoma|contiguous stage ii adult lymphoblastic lymphoma
843598|NCT00006083|noncontiguous stage II grade 1 follicular lymphoma|noncontiguous stage ii grade 1 follicular lymphoma
843599|NCT00006083|noncontiguous stage II grade 2 follicular lymphoma|noncontiguous stage ii grade 2 follicular lymphoma
843600|NCT00006083|noncontiguous stage II grade 3 follicular lymphoma|noncontiguous stage ii grade 3 follicular lymphoma
843601|NCT00006083|noncontiguous stage II adult diffuse small cleaved cell lymphoma|noncontiguous stage ii adult diffuse small cleaved cell lymphoma
843602|NCT00006083|noncontiguous stage II mantle cell lymphoma|noncontiguous stage ii mantle cell lymphoma
843603|NCT00006083|noncontiguous stage II adult diffuse mixed cell lymphoma|noncontiguous stage ii adult diffuse mixed cell lymphoma
843604|NCT00006083|noncontiguous stage II adult immunoblastic large cell lymphoma|noncontiguous stage ii adult immunoblastic large cell lymphoma
843605|NCT00006083|noncontiguous stage II adult diffuse large cell lymphoma|noncontiguous stage ii adult diffuse large cell lymphoma
843606|NCT00006083|noncontiguous stage II adult Burkitt lymphoma|noncontiguous stage ii adult burkitt lymphoma
843607|NCT00006083|noncontiguous stage II adult lymphoblastic lymphoma|noncontiguous stage ii adult lymphoblastic lymphoma
843608|NCT00006083|stage III mantle cell lymphoma|stage iii mantle cell lymphoma
843609|NCT00006083|stage IV mantle cell lymphoma|stage iv mantle cell lymphoma
843610|NCT00006083|recurrent mantle cell lymphoma|recurrent mantle cell lymphoma
843611|NCT00006083|angioimmunoblastic T-cell lymphoma|angioimmunoblastic t-cell lymphoma
843612|NCT00006083|anaplastic large cell lymphoma|anaplastic large cell lymphoma
843613|NCT00006083|noncontiguous stage II small lymphocytic lymphoma|noncontiguous stage ii small lymphocytic lymphoma
843614|NCT00006083|noncontiguous stage II marginal zone lymphoma|noncontiguous stage ii marginal zone lymphoma
843615|NCT00006083|recurrent marginal zone lymphoma|recurrent marginal zone lymphoma
843616|NCT00006083|recurrent small lymphocytic lymphoma|recurrent small lymphocytic lymphoma
843617|NCT00006083|stage I marginal zone lymphoma|stage i marginal zone lymphoma
843618|NCT00006083|stage I small lymphocytic lymphoma|stage i small lymphocytic lymphoma
845254|NCT00083265|Adenosine Receptor|adenosine receptor
843619|NCT00006083|stage III small lymphocytic lymphoma|stage iii small lymphocytic lymphoma
843620|NCT00006083|stage III marginal zone lymphoma|stage iii marginal zone lymphoma
843621|NCT00006083|stage IV small lymphocytic lymphoma|stage iv small lymphocytic lymphoma
843622|NCT00006083|stage IV marginal zone lymphoma|stage iv marginal zone lymphoma
843623|NCT00006083|contiguous stage II marginal zone lymphoma|contiguous stage ii marginal zone lymphoma
843624|NCT00006083|contiguous stage II small lymphocytic lymphoma|contiguous stage ii small lymphocytic lymphoma
843625|NCT00006083|extranodal marginal zone B-cell lymphoma of mucosa-associated lymphoid tissue|extranodal marginal zone b-cell lymphoma of mucosa-associated lymphoid tissue
843626|NCT00006083|nodal marginal zone B-cell lymphoma|nodal marginal zone b-cell lymphoma
843627|NCT00006083|splenic marginal zone lymphoma|splenic marginal zone lymphoma
843628|NCT00006079|cervical cancer|cervical cancer
843629|NCT00006079|cervical intraepithelial neoplasia grade 2|cervical intraepithelial neoplasia grade 2
843630|NCT00006079|cervical intraepithelial neoplasia grade 3|cervical intraepithelial neoplasia grade 3
843631|NCT00006079|Eflornithine|eflornithine
843632|NCT00006001|stage III colon cancer|stage iii colon cancer
843633|NCT00006001|stage IV colon cancer|stage iv colon cancer
843634|NCT00006001|stage III rectal cancer|stage iii rectal cancer
843635|NCT00006001|stage IV rectal cancer|stage iv rectal cancer
843636|NCT00006001|recurrent colon cancer|recurrent colon cancer
843637|NCT00006001|recurrent rectal cancer|recurrent rectal cancer
843638|NCT00006001|adenocarcinoma of the colon|adenocarcinoma of the colon
843639|NCT00006001|adenocarcinoma of the rectum|adenocarcinoma of the rectum
843640|NCT00005939|stage I prostate cancer|stage i prostate cancer
843641|NCT00005939|stage IIB prostate cancer|stage iib prostate cancer
843642|NCT00005939|stage IIA prostate cancer|stage iia prostate cancer
843643|NCT00005939|stage III prostate cancer|stage iii prostate cancer
843644|NCT00005939|recurrent prostate cancer|recurrent prostate cancer
843645|NCT00005841|iris melanoma|iris melanoma
843646|NCT00005841|ciliary body and choroid melanoma, small size|ciliary body and choroid melanoma, small size
843647|NCT00005841|ciliary body and choroid melanoma, medium/large size|ciliary body and choroid melanoma, medium/large size
843648|NCT00005841|extraocular extension melanoma|extraocular extension melanoma
843649|NCT00005841|recurrent intraocular melanoma|recurrent intraocular melanoma
843650|NCT00005841|stage III melanoma|stage iii melanoma
843651|NCT00005841|stage IV melanoma|stage iv melanoma
843652|NCT00005841|recurrent melanoma|recurrent melanoma
843653|NCT00005645|stage III ovarian epithelial cancer|stage iii ovarian epithelial cancer
843654|NCT00005645|stage IV ovarian epithelial cancer|stage iv ovarian epithelial cancer
843655|NCT00005645|recurrent ovarian epithelial cancer|recurrent ovarian epithelial cancer
843656|NCT00005645|liver metastases|liver metastases
843657|NCT00005645|malignant pericardial effusion|malignant pericardial effusion
843658|NCT00005645|malignant pleural effusion|malignant pleural effusion
843659|NCT00005645|malignant ascites|malignant ascites
843660|NCT00005645|fallopian tube cancer|fallopian tube cancer
843661|NCT00005645|primary peritoneal cavity cancer|primary peritoneal cavity cancer
843662|NCT00005640|stage I colon cancer|stage i colon cancer
843663|NCT00005640|stage II colon cancer|stage ii colon cancer
843664|NCT00005640|stage III colon cancer|stage iii colon cancer
843665|NCT00005640|stage I rectal cancer|stage i rectal cancer
843666|NCT00005640|stage II rectal cancer|stage ii rectal cancer
843667|NCT00005640|stage III rectal cancer|stage iii rectal cancer
843668|NCT00005636|localized malignant mesothelioma|localized malignant mesothelioma
843669|NCT00005636|advanced malignant mesothelioma|advanced malignant mesothelioma
843670|NCT00005636|recurrent malignant mesothelioma|recurrent malignant mesothelioma
843671|NCT00005578|stage II childhood Hodgkin lymphoma|stage ii childhood hodgkin lymphoma
843672|NCT00005578|stage I childhood Hodgkin lymphoma|stage i childhood hodgkin lymphoma
843673|NCT00005578|stage III childhood Hodgkin lymphoma|stage iii childhood hodgkin lymphoma
843674|NCT00005578|stage IV childhood Hodgkin lymphoma|stage iv childhood hodgkin lymphoma
843675|NCT00005578|cardiac toxicity|cardiac toxicity
843676|NCT00005088|stage III squamous cell carcinoma of the lip and oral cavity|stage iii squamous cell carcinoma of the lip and oral cavity
843677|NCT00005088|stage IV squamous cell carcinoma of the lip and oral cavity|stage iv squamous cell carcinoma of the lip and oral cavity
843678|NCT00005088|stage III squamous cell carcinoma of the oropharynx|stage iii squamous cell carcinoma of the oropharynx
843679|NCT00005088|stage IV squamous cell carcinoma of the oropharynx|stage iv squamous cell carcinoma of the oropharynx
843680|NCT00005088|stage III squamous cell carcinoma of the hypopharynx|stage iii squamous cell carcinoma of the hypopharynx
843681|NCT00005088|stage IV squamous cell carcinoma of the hypopharynx|stage iv squamous cell carcinoma of the hypopharynx
843682|NCT00005088|stage III squamous cell carcinoma of the larynx|stage iii squamous cell carcinoma of the larynx
843683|NCT00005088|stage IV squamous cell carcinoma of the larynx|stage iv squamous cell carcinoma of the larynx
843684|NCT00005069|stage IV renal cell cancer|stage iv renal cell cancer
843685|NCT00005069|recurrent renal cell cancer|recurrent renal cell cancer
843686|NCT00005059|recurrent non-small cell lung cancer|recurrent non-small cell lung cancer
843687|NCT00005059|stage IV non-small cell lung cancer|stage iv non-small cell lung cancer
843688|NCT00002923|unspecified adult solid tumor, protocol specific|unspecified adult solid tumor, protocol specific
843689|NCT00002917|stage 0 bladder cancer|stage 0 bladder cancer
843690|NCT00002917|stage I bladder cancer|stage i bladder cancer
843691|NCT00002917|transitional cell carcinoma of the bladder|transitional cell carcinoma of the bladder
843692|NCT00002911|stage IIIA non-small cell lung cancer|stage iiia non-small cell lung cancer
844486|NCT00002692|recurrent rectal cancer|recurrent rectal cancer
843693|NCT00002911|stage IIIB non-small cell lung cancer|stage iiib non-small cell lung cancer
843694|NCT00002829|Waldenstrom macroglobulinemia|waldenstrom macroglobulinemia
843695|NCT00002829|recurrent grade 1 follicular lymphoma|recurrent grade 1 follicular lymphoma
843696|NCT00002829|recurrent grade 2 follicular lymphoma|recurrent grade 2 follicular lymphoma
843697|NCT00002829|recurrent marginal zone lymphoma|recurrent marginal zone lymphoma
843698|NCT00002829|recurrent small lymphocytic lymphoma|recurrent small lymphocytic lymphoma
844490|NCT00002673|stage IV breast cancer|stage iv breast cancer
843699|NCT00002829|extranodal marginal zone B-cell lymphoma|extranodal marginal zone b-cell lymphoma
843700|NCT00002829|mucosa-associated lymphoid tissue|mucosa-associated lymphoid tissue
843701|NCT00002829|nodal marginal zone B-cell lymphoma|nodal marginal zone b-cell lymphoma
843702|NCT00002829|splenic marginal zone lymphoma|splenic marginal zone lymphoma
843703|NCT00002827|stage II childhood Hodgkin lymphoma|stage ii childhood hodgkin lymphoma
843704|NCT00002827|stage I childhood Hodgkin lymphoma|stage i childhood hodgkin lymphoma
843705|NCT00002827|stage III childhood Hodgkin lymphoma|stage iii childhood hodgkin lymphoma
843706|NCT00002827|cardiac toxicity|cardiac toxicity
843707|NCT00002819|stage III ovarian epithelial cancer|stage iii ovarian epithelial cancer
843708|NCT00002819|recurrent ovarian epithelial cancer|recurrent ovarian epithelial cancer
843709|NCT00002819|ovarian undifferentiated adenocarcinoma|ovarian undifferentiated adenocarcinoma
843710|NCT00002819|ovarian mixed epithelial carcinoma|ovarian mixed epithelial carcinoma
843711|NCT00002819|ovarian serous cystadenocarcinoma|ovarian serous cystadenocarcinoma
843712|NCT00002819|ovarian mucinous cystadenocarcinoma|ovarian mucinous cystadenocarcinoma
843713|NCT00002819|ovarian endometrioid adenocarcinoma|ovarian endometrioid adenocarcinoma
843714|NCT00002819|ovarian clear cell cystadenocarcinoma|ovarian clear cell cystadenocarcinoma
843715|NCT00002819|Brenner tumor|brenner tumor
843716|NCT00002806|adult diffuse astrocytoma|adult diffuse astrocytoma
843717|NCT00002721|recurrent prostate cancer|recurrent prostate cancer
843718|NCT00002639|recurrent adult brain tumor|recurrent adult brain tumor
843719|NCT00002639|adult glioblastoma|adult glioblastoma
845255|NCT00083265|Panic Disorder|panic disorder
843720|NCT00002639|adult anaplastic astrocytoma|adult anaplastic astrocytoma
843721|NCT00002639|adult anaplastic oligodendroglioma|adult anaplastic oligodendroglioma
843722|NCT00002639|adult mixed glioma|adult mixed glioma
843723|NCT00002639|adult giant cell glioblastoma|adult giant cell glioblastoma
843724|NCT00002639|adult gliosarcoma|adult gliosarcoma
843725|NCT00002602|adenocarcinoma of the prostate|adenocarcinoma of the prostate
843726|NCT00002602|stage IIB prostate cancer|stage iib prostate cancer
843727|NCT00002602|stage IIA prostate cancer|stage iia prostate cancer
843728|NCT00002602|stage III prostate cancer|stage iii prostate cancer
843729|NCT00002555|stage III squamous cell carcinoma of the lip and oral cavity|stage iii squamous cell carcinoma of the lip and oral cavity
843730|NCT00002555|stage IV squamous cell carcinoma of the lip and oral cavity|stage iv squamous cell carcinoma of the lip and oral cavity
843731|NCT00002555|stage III squamous cell carcinoma of the oropharynx|stage iii squamous cell carcinoma of the oropharynx
843732|NCT00002555|stage IV squamous cell carcinoma of the oropharynx|stage iv squamous cell carcinoma of the oropharynx
843733|NCT00002555|stage III squamous cell carcinoma of the hypopharynx|stage iii squamous cell carcinoma of the hypopharynx
843734|NCT00002555|stage IV squamous cell carcinoma of the hypopharynx|stage iv squamous cell carcinoma of the hypopharynx
843735|NCT00002555|stage III squamous cell carcinoma of the larynx|stage iii squamous cell carcinoma of the larynx
843736|NCT00002555|stage IV squamous cell carcinoma of the larynx|stage iv squamous cell carcinoma of the larynx
843737|NCT00002477|stage I ovarian epithelial cancer|stage i ovarian epithelial cancer
843738|NCT00002477|stage II ovarian epithelial cancer|stage ii ovarian epithelial cancer
843739|NCT00083512|Blood|blood
843740|NCT00083512|Urine|urine
843741|NCT00083512|GBM|gbm
843742|NCT00083512|Radiation|radiation
843743|NCT00083512|Glioblastoma Multiforme|glioblastoma multiforme
843744|NCT00083499|Nonmuscle myosin IIB|nonmuscle myosin iib
843745|NCT00083499|Nonmuscle myosin IIA|nonmuscle myosin iia
843746|NCT00083499|Pentology of Cantrell|pentology of cantrell
843747|NCT00083499|thoracoabdominal syndrdome|thoracoabdominal syndrdome
843748|NCT00083499|Nonmuscle Myosin IIC|nonmuscle myosin iic
843749|NCT00083499|Pentalogy of Cantrell|pentalogy of cantrell
843750|NCT00083499|Non-muscle Myosin Heavy Chain Genes|non-muscle myosin heavy chain genes
843751|NCT00083408|Multiple Myeloma|multiple myeloma
843752|NCT00083408|Pamidronate|pamidronate
843753|NCT00083408|Thalidomide|thalidomide
843754|NCT00083408|refractory myeloma|refractory myeloma
843755|NCT00083408|bisphosphonates|bisphosphonates
843756|NCT00083408|Aredia|aredia
843757|NCT00004881|unspecified adult solid tumor, protocol specific|unspecified adult solid tumor, protocol specific
843758|NCT00004200|adult glioblastoma|adult glioblastoma
843759|NCT00004200|adult giant cell glioblastoma|adult giant cell glioblastoma
843760|NCT00004200|adult gliosarcoma|adult gliosarcoma
843761|NCT00004190|stage III pancreatic cancer|stage iii pancreatic cancer
843762|NCT00004190|recurrent pancreatic cancer|recurrent pancreatic cancer
843763|NCT00004190|duct cell adenocarcinoma of the pancreas|duct cell adenocarcinoma of the pancreas
843764|NCT00004190|stage IV pancreatic cancer|stage iv pancreatic cancer
843765|NCT00004176|limited stage small cell lung cancer|limited stage small cell lung cancer
843766|NCT00004176|drug/agent toxicity by tissue/organ|drug/agent toxicity by tissue/organ
843767|NCT00004176|radiation toxicity|radiation toxicity
859774|NCT00063258|Tarceva|tarceva
843768|NCT00004139|recurrent non-small cell lung cancer|recurrent non-small cell lung cancer
843769|NCT00004139|squamous cell lung cancer|squamous cell lung cancer
843770|NCT00004139|large cell lung cancer|large cell lung cancer
843771|NCT00004139|stage IIIB non-small cell lung cancer|stage iiib non-small cell lung cancer
843772|NCT00004139|stage IV non-small cell lung cancer|stage iv non-small cell lung cancer
843773|NCT00004139|adenocarcinoma of the lung|adenocarcinoma of the lung
860066|NCT00062608|Abdominal|abdominal
843774|NCT00004139|bronchoalveolar cell lung cancer|bronchoalveolar cell lung cancer
843775|NCT00004112|stage II adult diffuse small cleaved cell lymphoma|stage ii adult diffuse small cleaved cell lymphoma
843776|NCT00004112|stage II adult diffuse mixed cell lymphoma|stage ii adult diffuse mixed cell lymphoma
843777|NCT00004112|stage II adult diffuse large cell lymphoma|stage ii adult diffuse large cell lymphoma
843778|NCT00004112|stage III adult diffuse small cleaved cell lymphoma|stage iii adult diffuse small cleaved cell lymphoma
843779|NCT00004112|stage III adult diffuse mixed cell lymphoma|stage iii adult diffuse mixed cell lymphoma
843780|NCT00004112|stage III adult diffuse large cell lymphoma|stage iii adult diffuse large cell lymphoma
843781|NCT00004112|stage IV adult diffuse small cleaved cell lymphoma|stage iv adult diffuse small cleaved cell lymphoma
843782|NCT00004112|stage IV adult diffuse mixed cell lymphoma|stage iv adult diffuse mixed cell lymphoma
843783|NCT00004112|stage IV adult diffuse large cell lymphoma|stage iv adult diffuse large cell lymphoma
843784|NCT00004112|stage III mantle cell lymphoma|stage iii mantle cell lymphoma
843785|NCT00004112|stage IV mantle cell lymphoma|stage iv mantle cell lymphoma
843786|NCT00004112|anaplastic large cell lymphoma|anaplastic large cell lymphoma
843787|NCT00004112|stage II mantle cell lymphoma|stage ii mantle cell lymphoma
843788|NCT00004112|stage II small lymphocytic lymphoma|stage ii small lymphocytic lymphoma
843789|NCT00004112|stage II marginal zone lymphoma|stage ii marginal zone lymphoma
843790|NCT00004112|stage III small lymphocytic lymphoma|stage iii small lymphocytic lymphoma
843791|NCT00004112|stage III marginal zone lymphoma|stage iii marginal zone lymphoma
843792|NCT00004112|stage IV small lymphocytic lymphoma|stage iv small lymphocytic lymphoma
843793|NCT00004112|stage IV marginal zone lymphoma|stage iv marginal zone lymphoma
843794|NCT00004112|extranodal marginal zone B-cell lymphoma of mucosa-associated lymphoid tissue|extranodal marginal zone b-cell lymphoma of mucosa-associated lymphoid tissue
843795|NCT00004112|nodal marginal zone B-cell lymphoma|nodal marginal zone b-cell lymphoma
843796|NCT00004112|splenic marginal zone lymphoma|splenic marginal zone lymphoma
843797|NCT00004105|stage III adult Hodgkin lymphoma|stage iii adult hodgkin lymphoma
843798|NCT00004105|stage IV adult Hodgkin lymphoma|stage iv adult hodgkin lymphoma
843799|NCT00004105|recurrent adult Hodgkin lymphoma|recurrent adult hodgkin lymphoma
843800|NCT00004105|stage III chronic lymphocytic leukemia|stage iii chronic lymphocytic leukemia
843801|NCT00004105|stage IV chronic lymphocytic leukemia|stage iv chronic lymphocytic leukemia
843802|NCT00004105|recurrent adult acute myeloid leukemia|recurrent adult acute myeloid leukemia
843803|NCT00004105|unspecified adult solid tumor, protocol specific|unspecified adult solid tumor, protocol specific
843804|NCT00004105|childhood fibrosarcoma|childhood fibrosarcoma
843805|NCT00004105|stage III grade 1 follicular lymphoma|stage iii grade 1 follicular lymphoma
843806|NCT00004105|stage III grade 2 follicular lymphoma|stage iii grade 2 follicular lymphoma
843807|NCT00004105|stage III grade 3 follicular lymphoma|stage iii grade 3 follicular lymphoma
843808|NCT00004105|stage III adult diffuse small cleaved cell lymphoma|stage iii adult diffuse small cleaved cell lymphoma
843809|NCT00004105|stage III adult diffuse mixed cell lymphoma|stage iii adult diffuse mixed cell lymphoma
843810|NCT00004105|stage III adult diffuse large cell lymphoma|stage iii adult diffuse large cell lymphoma
843811|NCT00004105|stage III adult immunoblastic large cell lymphoma|stage iii adult immunoblastic large cell lymphoma
843812|NCT00004105|stage III adult lymphoblastic lymphoma|stage iii adult lymphoblastic lymphoma
843813|NCT00004105|stage III adult Burkitt lymphoma|stage iii adult burkitt lymphoma
843814|NCT00004105|stage IV grade 1 follicular lymphoma|stage iv grade 1 follicular lymphoma
843815|NCT00004105|stage IV grade 2 follicular lymphoma|stage iv grade 2 follicular lymphoma
843816|NCT00004105|stage IV grade 3 follicular lymphoma|stage iv grade 3 follicular lymphoma
843817|NCT00004105|stage IV adult diffuse small cleaved cell lymphoma|stage iv adult diffuse small cleaved cell lymphoma
843818|NCT00004105|stage IV adult diffuse mixed cell lymphoma|stage iv adult diffuse mixed cell lymphoma
843819|NCT00004105|stage IV adult diffuse large cell lymphoma|stage iv adult diffuse large cell lymphoma
843820|NCT00004105|stage IV adult immunoblastic large cell lymphoma|stage iv adult immunoblastic large cell lymphoma
843821|NCT00004105|stage IV adult lymphoblastic lymphoma|stage iv adult lymphoblastic lymphoma
843822|NCT00004105|stage IV adult Burkitt lymphoma|stage iv adult burkitt lymphoma
843823|NCT00004105|recurrent grade 1 follicular lymphoma|recurrent grade 1 follicular lymphoma
843824|NCT00004105|recurrent grade 2 follicular lymphoma|recurrent grade 2 follicular lymphoma
843825|NCT00004105|recurrent grade 3 follicular lymphoma|recurrent grade 3 follicular lymphoma
843826|NCT00004105|recurrent adult diffuse small cleaved cell lymphoma|recurrent adult diffuse small cleaved cell lymphoma
843827|NCT00004105|recurrent adult diffuse mixed cell lymphoma|recurrent adult diffuse mixed cell lymphoma
843828|NCT00004105|recurrent adult diffuse large cell lymphoma|recurrent adult diffuse large cell lymphoma
843829|NCT00004105|recurrent adult immunoblastic large cell lymphoma|recurrent adult immunoblastic large cell lymphoma
843830|NCT00004105|recurrent adult lymphoblastic lymphoma|recurrent adult lymphoblastic lymphoma
843831|NCT00004105|recurrent adult Burkitt lymphoma|recurrent adult burkitt lymphoma
843832|NCT00004105|stage III adult T-cell leukemia/lymphoma|stage iii adult t-cell leukemia/lymphoma
843833|NCT00004105|stage IV adult T-cell leukemia/lymphoma|stage iv adult t-cell leukemia/lymphoma
843834|NCT00004105|recurrent adult T-cell leukemia/lymphoma|recurrent adult t-cell leukemia/lymphoma
843835|NCT00004105|stage III mantle cell lymphoma|stage iii mantle cell lymphoma
843836|NCT00004105|stage IV mantle cell lymphoma|stage iv mantle cell lymphoma
843837|NCT00004105|recurrent mantle cell lymphoma|recurrent mantle cell lymphoma
860067|NCT00062595|Menopause|menopause
843838|NCT00004105|recurrent marginal zone lymphoma|recurrent marginal zone lymphoma
843839|NCT00004105|recurrent small lymphocytic lymphoma|recurrent small lymphocytic lymphoma
843840|NCT00004105|stage III small lymphocytic lymphoma|stage iii small lymphocytic lymphoma
843841|NCT00004105|stage III marginal zone lymphoma|stage iii marginal zone lymphoma
843842|NCT00004105|stage IV small lymphocytic lymphoma|stage iv small lymphocytic lymphoma
843843|NCT00004105|stage IV marginal zone lymphoma|stage iv marginal zone lymphoma
843844|NCT00004105|extranodal marginal zone B-cell lymphoma of mucosa-associated lymphoid tissue|extranodal marginal zone b-cell lymphoma of mucosa-associated lymphoid tissue
843845|NCT00004105|nodal marginal zone B-cell lymphoma|nodal marginal zone b-cell lymphoma
843846|NCT00004105|splenic marginal zone lymphoma|splenic marginal zone lymphoma
843847|NCT00004061|stage I adult Hodgkin lymphoma|stage i adult hodgkin lymphoma
843848|NCT00004061|stage II adult Hodgkin lymphoma|stage ii adult hodgkin lymphoma
843849|NCT00004061|stage III adult Hodgkin lymphoma|stage iii adult hodgkin lymphoma
843850|NCT00004061|stage IV adult Hodgkin lymphoma|stage iv adult hodgkin lymphoma
843851|NCT00004061|recurrent adult Hodgkin lymphoma|recurrent adult hodgkin lymphoma
843852|NCT00004061|stage 0 chronic lymphocytic leukemia|stage 0 chronic lymphocytic leukemia
843853|NCT00004061|stage I chronic lymphocytic leukemia|stage i chronic lymphocytic leukemia
843854|NCT00004061|stage II chronic lymphocytic leukemia|stage ii chronic lymphocytic leukemia
843855|NCT00004061|stage III chronic lymphocytic leukemia|stage iii chronic lymphocytic leukemia
843856|NCT00004061|stage IV chronic lymphocytic leukemia|stage iv chronic lymphocytic leukemia
843857|NCT00004061|recurrent adult acute myeloid leukemia|recurrent adult acute myeloid leukemia
843858|NCT00004061|recurrent adult acute lymphoblastic leukemia|recurrent adult acute lymphoblastic leukemia
843859|NCT00004061|relapsing chronic myelogenous leukemia|relapsing chronic myelogenous leukemia
843860|NCT00004061|refractory chronic lymphocytic leukemia|refractory chronic lymphocytic leukemia
843861|NCT00004061|chronic phase chronic myelogenous leukemia|chronic phase chronic myelogenous leukemia
843862|NCT00004061|accelerated phase chronic myelogenous leukemia|accelerated phase chronic myelogenous leukemia
843863|NCT00004061|blastic phase chronic myelogenous leukemia|blastic phase chronic myelogenous leukemia
843864|NCT00004061|meningeal chronic myelogenous leukemia|meningeal chronic myelogenous leukemia
843865|NCT00004061|untreated adult acute lymphoblastic leukemia|untreated adult acute lymphoblastic leukemia
843866|NCT00004061|untreated adult acute myeloid leukemia|untreated adult acute myeloid leukemia
843867|NCT00004061|adult acute myeloid leukemia in remission|adult acute myeloid leukemia in remission
843868|NCT00004061|adult acute lymphoblastic leukemia in remission|adult acute lymphoblastic leukemia in remission
843869|NCT00004061|oral complications|oral complications
843870|NCT00004061|stage I grade 1 follicular lymphoma|stage i grade 1 follicular lymphoma
843871|NCT00004061|stage I grade 2 follicular lymphoma|stage i grade 2 follicular lymphoma
843872|NCT00004061|stage I grade 3 follicular lymphoma|stage i grade 3 follicular lymphoma
843873|NCT00004061|stage I adult diffuse small cleaved cell lymphoma|stage i adult diffuse small cleaved cell lymphoma
843874|NCT00004061|stage I adult diffuse mixed cell lymphoma|stage i adult diffuse mixed cell lymphoma
843875|NCT00004061|stage I adult diffuse large cell lymphoma|stage i adult diffuse large cell lymphoma
843876|NCT00004061|stage I adult immunoblastic large cell lymphoma|stage i adult immunoblastic large cell lymphoma
843877|NCT00004061|stage I adult lymphoblastic lymphoma|stage i adult lymphoblastic lymphoma
843878|NCT00004061|stage I adult Burkitt lymphoma|stage i adult burkitt lymphoma
843879|NCT00004061|stage III grade 1 follicular lymphoma|stage iii grade 1 follicular lymphoma
843880|NCT00004061|stage III grade 2 follicular lymphoma|stage iii grade 2 follicular lymphoma
843881|NCT00004061|stage III grade 3 follicular lymphoma|stage iii grade 3 follicular lymphoma
843882|NCT00004061|stage III adult diffuse small cleaved cell lymphoma|stage iii adult diffuse small cleaved cell lymphoma
843883|NCT00004061|stage III adult diffuse mixed cell lymphoma|stage iii adult diffuse mixed cell lymphoma
843884|NCT00004061|stage III adult diffuse large cell lymphoma|stage iii adult diffuse large cell lymphoma
843885|NCT00004061|stage III adult immunoblastic large cell lymphoma|stage iii adult immunoblastic large cell lymphoma
843886|NCT00004061|stage III adult lymphoblastic lymphoma|stage iii adult lymphoblastic lymphoma
843887|NCT00004061|stage III adult Burkitt lymphoma|stage iii adult burkitt lymphoma
843888|NCT00004061|stage IV grade 1 follicular lymphoma|stage iv grade 1 follicular lymphoma
843889|NCT00004061|stage IV grade 2 follicular lymphoma|stage iv grade 2 follicular lymphoma
843890|NCT00004061|stage IV grade 3 follicular lymphoma|stage iv grade 3 follicular lymphoma
843891|NCT00004061|stage IV adult diffuse small cleaved cell lymphoma|stage iv adult diffuse small cleaved cell lymphoma
843892|NCT00004061|stage IV adult diffuse mixed cell lymphoma|stage iv adult diffuse mixed cell lymphoma
843893|NCT00004061|stage IV adult diffuse large cell lymphoma|stage iv adult diffuse large cell lymphoma
843894|NCT00004061|stage IV adult immunoblastic large cell lymphoma|stage iv adult immunoblastic large cell lymphoma
843895|NCT00004061|stage IV adult lymphoblastic lymphoma|stage iv adult lymphoblastic lymphoma
843896|NCT00004061|stage IV adult Burkitt lymphoma|stage iv adult burkitt lymphoma
843897|NCT00004061|recurrent grade 1 follicular lymphoma|recurrent grade 1 follicular lymphoma
843898|NCT00004061|recurrent grade 2 follicular lymphoma|recurrent grade 2 follicular lymphoma
843899|NCT00004061|recurrent grade 3 follicular lymphoma|recurrent grade 3 follicular lymphoma
843900|NCT00004061|recurrent adult diffuse small cleaved cell lymphoma|recurrent adult diffuse small cleaved cell lymphoma
843901|NCT00004061|recurrent adult diffuse mixed cell lymphoma|recurrent adult diffuse mixed cell lymphoma
860068|NCT00062595|Vitamin K|vitamin k
843902|NCT00004061|recurrent adult diffuse large cell lymphoma|recurrent adult diffuse large cell lymphoma
843903|NCT00004061|recurrent adult immunoblastic large cell lymphoma|recurrent adult immunoblastic large cell lymphoma
843904|NCT00004061|recurrent adult lymphoblastic lymphoma|recurrent adult lymphoblastic lymphoma
843905|NCT00004061|recurrent adult Burkitt lymphoma|recurrent adult burkitt lymphoma
843906|NCT00004061|secondary acute myeloid leukemia|secondary acute myeloid leukemia
843907|NCT00004061|stage I mantle cell lymphoma|stage i mantle cell lymphoma
843908|NCT00004061|contiguous stage II grade 1 follicular lymphoma|contiguous stage ii grade 1 follicular lymphoma
843909|NCT00004061|contiguous stage II grade 2 follicular lymphoma|contiguous stage ii grade 2 follicular lymphoma
843910|NCT00004061|contiguous stage II grade 3 follicular lymphoma|contiguous stage ii grade 3 follicular lymphoma
843911|NCT00004061|contiguous stage II adult diffuse small cleaved cell lymphoma|contiguous stage ii adult diffuse small cleaved cell lymphoma
843912|NCT00004061|contiguous stage II mantle cell lymphoma|contiguous stage ii mantle cell lymphoma
843913|NCT00004061|contiguous stage II adult diffuse mixed cell lymphoma|contiguous stage ii adult diffuse mixed cell lymphoma
843914|NCT00004061|contiguous stage II adult immunoblastic large cell lymphoma|contiguous stage ii adult immunoblastic large cell lymphoma
843915|NCT00004061|contiguous stage II adult diffuse large cell lymphoma|contiguous stage ii adult diffuse large cell lymphoma
843916|NCT00004061|contiguous stage II adult Burkitt lymphoma|contiguous stage ii adult burkitt lymphoma
843917|NCT00004061|contiguous stage II adult lymphoblastic lymphoma|contiguous stage ii adult lymphoblastic lymphoma
843918|NCT00004061|noncontiguous stage II grade 1 follicular lymphoma|noncontiguous stage ii grade 1 follicular lymphoma
843919|NCT00004061|noncontiguous stage II grade 2 follicular lymphoma|noncontiguous stage ii grade 2 follicular lymphoma
843920|NCT00004061|noncontiguous stage II grade 3 follicular lymphoma|noncontiguous stage ii grade 3 follicular lymphoma
843921|NCT00004061|noncontiguous stage II adult diffuse small cleaved cell lymphoma|noncontiguous stage ii adult diffuse small cleaved cell lymphoma
843922|NCT00004061|noncontiguous stage II mantle cell lymphoma|noncontiguous stage ii mantle cell lymphoma
843923|NCT00004061|noncontiguous stage II adult diffuse mixed cell lymphoma|noncontiguous stage ii adult diffuse mixed cell lymphoma
843924|NCT00004061|noncontiguous stage II adult immunoblastic large cell lymphoma|noncontiguous stage ii adult immunoblastic large cell lymphoma
843925|NCT00004061|noncontiguous stage II adult diffuse large cell lymphoma|noncontiguous stage ii adult diffuse large cell lymphoma
843926|NCT00004061|noncontiguous stage II adult Burkitt lymphoma|noncontiguous stage ii adult burkitt lymphoma
843927|NCT00004061|noncontiguous stage II adult lymphoblastic lymphoma|noncontiguous stage ii adult lymphoblastic lymphoma
843928|NCT00004061|stage III mantle cell lymphoma|stage iii mantle cell lymphoma
843929|NCT00004061|stage IV mantle cell lymphoma|stage iv mantle cell lymphoma
843930|NCT00004061|recurrent mantle cell lymphoma|recurrent mantle cell lymphoma
843931|NCT00004061|noncontiguous stage II small lymphocytic lymphoma|noncontiguous stage ii small lymphocytic lymphoma
843932|NCT00004061|noncontiguous stage II marginal zone lymphoma|noncontiguous stage ii marginal zone lymphoma
843933|NCT00004061|recurrent marginal zone lymphoma|recurrent marginal zone lymphoma
843934|NCT00004061|recurrent small lymphocytic lymphoma|recurrent small lymphocytic lymphoma
843935|NCT00004061|stage I marginal zone lymphoma|stage i marginal zone lymphoma
843936|NCT00004061|stage I small lymphocytic lymphoma|stage i small lymphocytic lymphoma
843937|NCT00004061|stage III small lymphocytic lymphoma|stage iii small lymphocytic lymphoma
843938|NCT00004061|stage III marginal zone lymphoma|stage iii marginal zone lymphoma
843939|NCT00004061|stage IV small lymphocytic lymphoma|stage iv small lymphocytic lymphoma
843940|NCT00004061|stage IV marginal zone lymphoma|stage iv marginal zone lymphoma
843941|NCT00004061|contiguous stage II marginal zone lymphoma|contiguous stage ii marginal zone lymphoma
843942|NCT00004061|contiguous stage II small lymphocytic lymphoma|contiguous stage ii small lymphocytic lymphoma
843943|NCT00004061|extranodal marginal zone B-cell lymphoma of mucosa-associated lymphoid tissue|extranodal marginal zone b-cell lymphoma of mucosa-associated lymphoid tissue
843944|NCT00004061|nodal marginal zone B-cell lymphoma|nodal marginal zone b-cell lymphoma
843945|NCT00004061|splenic marginal zone lymphoma|splenic marginal zone lymphoma
843946|NCT00004030|unspecified adult solid tumor, protocol specific|unspecified adult solid tumor, protocol specific
843947|NCT00004012|recurrent ovarian epithelial cancer|recurrent ovarian epithelial cancer
843948|NCT00004012|fallopian tube cancer|fallopian tube cancer
843949|NCT00004012|primary peritoneal cavity cancer|primary peritoneal cavity cancer
843950|NCT00003985|non-small cell lung cancer|non-small cell lung cancer
843951|NCT00003985|unspecified adult solid tumor, protocol specific|unspecified adult solid tumor, protocol specific
843952|NCT00003984|refractory anemia with excess blasts|refractory anemia with excess blasts
843953|NCT00003984|refractory anemia with excess blasts in transformation|refractory anemia with excess blasts in transformation
843954|NCT00003984|de novo myelodysplastic syndromes|de novo myelodysplastic syndromes
843955|NCT00003984|previously treated myelodysplastic syndromes|previously treated myelodysplastic syndromes
843956|NCT00003984|secondary myelodysplastic syndromes|secondary myelodysplastic syndromes
843957|NCT00003982|unspecified adult solid tumor, protocol specific|unspecified adult solid tumor, protocol specific
844487|NCT00002692|adenocarcinoma of the colon|adenocarcinoma of the colon
843958|NCT00003982|testicular embryonal carcinoma and yolk sac tumor|testicular embryonal carcinoma and yolk sac tumor
843959|NCT00003980|unspecified adult solid tumor, protocol specific|unspecified adult solid tumor, protocol specific
843960|NCT00003944|stage III ovarian epithelial cancer|stage iii ovarian epithelial cancer
843961|NCT00003944|stage IV ovarian epithelial cancer|stage iv ovarian epithelial cancer
843962|NCT00003944|ovarian undifferentiated adenocarcinoma|ovarian undifferentiated adenocarcinoma
843963|NCT00003944|ovarian mixed epithelial carcinoma|ovarian mixed epithelial carcinoma
843964|NCT00003944|ovarian serous cystadenocarcinoma|ovarian serous cystadenocarcinoma
843965|NCT00003944|ovarian mucinous cystadenocarcinoma|ovarian mucinous cystadenocarcinoma
843966|NCT00003944|ovarian endometrioid adenocarcinoma|ovarian endometrioid adenocarcinoma
843967|NCT00003944|ovarian clear cell cystadenocarcinoma|ovarian clear cell cystadenocarcinoma
843968|NCT00003944|fallopian tube cancer|fallopian tube cancer
843969|NCT00003944|peritoneal cavity cancer|peritoneal cavity cancer
843970|NCT00003846|regional neuroblastoma|regional neuroblastoma
843971|NCT00003846|disseminated neuroblastoma|disseminated neuroblastoma
843972|NCT00003846|stage 4S neuroblastoma|stage 4s neuroblastoma
843973|NCT00003846|untreated childhood supratentorial primitive neuroectodermal tumor|untreated childhood supratentorial primitive neuroectodermal tumor
843974|NCT00003846|untreated childhood medulloblastoma|untreated childhood medulloblastoma
843975|NCT00003846|newly diagnosed childhood ependymoma|newly diagnosed childhood ependymoma
843976|NCT00003752|stage IV breast cancer|stage iv breast cancer
843977|NCT00003752|recurrent breast cancer|recurrent breast cancer
843978|NCT00003669|stage IV endometrial carcinoma|stage iv endometrial carcinoma
843979|NCT00003669|recurrent endometrial carcinoma|recurrent endometrial carcinoma
843980|NCT00003580|oral complications|oral complications
843981|NCT00003580|stage III squamous cell carcinoma of the lip and oral cavity|stage iii squamous cell carcinoma of the lip and oral cavity
843982|NCT00003580|stage IV squamous cell carcinoma of the lip and oral cavity|stage iv squamous cell carcinoma of the lip and oral cavity
843983|NCT00003580|stage III squamous cell carcinoma of the oropharynx|stage iii squamous cell carcinoma of the oropharynx
843984|NCT00003580|stage IV squamous cell carcinoma of the oropharynx|stage iv squamous cell carcinoma of the oropharynx
843985|NCT00003580|stage III squamous cell carcinoma of the nasopharynx|stage iii squamous cell carcinoma of the nasopharynx
843986|NCT00003580|stage IV squamous cell carcinoma of the nasopharynx|stage iv squamous cell carcinoma of the nasopharynx
843987|NCT00003580|stage III squamous cell carcinoma of the hypopharynx|stage iii squamous cell carcinoma of the hypopharynx
843988|NCT00003580|stage IV squamous cell carcinoma of the hypopharynx|stage iv squamous cell carcinoma of the hypopharynx
843989|NCT00003580|stage III squamous cell carcinoma of the larynx|stage iii squamous cell carcinoma of the larynx
843990|NCT00003580|stage IV squamous cell carcinoma of the larynx|stage iv squamous cell carcinoma of the larynx
843991|NCT00003580|drug/agent toxicity by tissue/organ|drug/agent toxicity by tissue/organ
843992|NCT00003580|radiation toxicity|radiation toxicity
843993|NCT00083395|ARVC/ARVD|arvc/arvd
843994|NCT00083395|Genetics|genetics
843995|NCT00083395|Sudden Death|sudden death
843996|NCT00083395|Heart|heart
843997|NCT00083395|MRI|mri
843998|NCT00083395|Cardiomyopathy|cardiomyopathy
843999|NCT00083395|Arrhythmogenic Right Ventricular|arrhythmogenic right ventricular
844000|NCT00083395|ARVC|arvc
844001|NCT00083395|Healthy Volunteer|healthy volunteer
844002|NCT00083395|HV|hv
844003|NCT00083382|Myeloma|myeloma
844004|NCT00083382|Thalidomide|thalidomide
844005|NCT00083382|Pamidronate|pamidronate
844006|NCT00083382|Aredia|aredia
844007|NCT00083382|Bisphosphonate|bisphosphonate
844008|NCT00083382|Anti-Angiogenesis|anti-angiogenesis
845256|NCT00083265|Polymorphism|polymorphism
844009|NCT00083382|Smoldering/Indolent Myeloma|smoldering/indolent myeloma
844010|NCT00083382|Zometa|zometa
844011|NCT00008229|stage I multiple myeloma|stage i multiple myeloma
844012|NCT00008229|stage II multiple myeloma|stage ii multiple myeloma
844013|NCT00008229|stage III multiple myeloma|stage iii multiple myeloma
844014|NCT00008073|unspecified adult solid tumor, protocol specific|unspecified adult solid tumor, protocol specific
844015|NCT00006344|limited stage small cell lung cancer|limited stage small cell lung cancer
844016|NCT00006344|extensive stage small cell lung cancer|extensive stage small cell lung cancer
844017|NCT00006269|stage IV colon cancer|stage iv colon cancer
844018|NCT00006269|stage IV rectal cancer|stage iv rectal cancer
844019|NCT00006269|recurrent colon cancer|recurrent colon cancer
844020|NCT00006269|recurrent rectal cancer|recurrent rectal cancer
844021|NCT00006269|diarrhea|diarrhea
844022|NCT00003614|adenocarcinoma of the prostate|adenocarcinoma of the prostate
844023|NCT00003614|stage IV prostate cancer|stage iv prostate cancer
844024|NCT00003614|recurrent prostate cancer|recurrent prostate cancer
844025|NCT00003523|recurrent ovarian epithelial cancer|recurrent ovarian epithelial cancer
844026|NCT00003523|primary peritoneal cavity cancer|primary peritoneal cavity cancer
844027|NCT00003518|stage III malignant testicular germ cell tumor|stage iii malignant testicular germ cell tumor
844028|NCT00003518|recurrent malignant testicular germ cell tumor|recurrent malignant testicular germ cell tumor
844029|NCT00003518|stage IV ovarian germ cell tumor|stage iv ovarian germ cell tumor
844030|NCT00003518|recurrent ovarian germ cell tumor|recurrent ovarian germ cell tumor
844031|NCT00003444|stage III melanoma|stage iii melanoma
844032|NCT00003444|stage IV melanoma|stage iv melanoma
844033|NCT00003444|recurrent melanoma|recurrent melanoma
844034|NCT00003405|untreated adult acute myeloid leukemia|untreated adult acute myeloid leukemia
844035|NCT00003405|untreated childhood acute myeloid leukemia and other myeloid malignancies|untreated childhood acute myeloid leukemia and other myeloid malignancies
844036|NCT00003405|adult acute erythroid leukemia (M6)|adult acute erythroid leukemia (m6)
844491|NCT00002673|stage IIIA breast cancer|stage iiia breast cancer
844037|NCT00003405|adult acute myeloblastic leukemia without maturation (M1)|adult acute myeloblastic leukemia without maturation (m1)
844038|NCT00003405|adult acute myeloblastic leukemia with maturation (M2)|adult acute myeloblastic leukemia with maturation (m2)
844039|NCT00003405|adult acute myelomonocytic leukemia (M4)|adult acute myelomonocytic leukemia (m4)
844040|NCT00003405|adult acute monoblastic leukemia (M5a)|adult acute monoblastic leukemia (m5a)
844041|NCT00003405|adult acute megakaryoblastic leukemia (M7)|adult acute megakaryoblastic leukemia (m7)
844042|NCT00003405|childhood acute myeloblastic leukemia without maturation (M1)|childhood acute myeloblastic leukemia without maturation (m1)
844043|NCT00003405|childhood acute myeloblastic leukemia with maturation (M2)|childhood acute myeloblastic leukemia with maturation (m2)
844044|NCT00003405|childhood acute myelomonocytic leukemia (M4)|childhood acute myelomonocytic leukemia (m4)
844045|NCT00003405|childhood acute monoblastic leukemia (M5a)|childhood acute monoblastic leukemia (m5a)
844046|NCT00003405|childhood acute monocytic leukemia (M5b)|childhood acute monocytic leukemia (m5b)
844047|NCT00003405|childhood acute erythroleukemia (M6)|childhood acute erythroleukemia (m6)
844048|NCT00003405|childhood acute megakaryocytic leukemia (M7)|childhood acute megakaryocytic leukemia (m7)
844049|NCT00003405|adult acute monocytic leukemia (M5b)|adult acute monocytic leukemia (m5b)
844050|NCT00003403|unspecified adult solid tumor, protocol specific|unspecified adult solid tumor, protocol specific
844051|NCT00003269|stage I adult Hodgkin lymphoma|stage i adult hodgkin lymphoma
844052|NCT00003269|stage II adult Hodgkin lymphoma|stage ii adult hodgkin lymphoma
844053|NCT00003269|stage III adult Hodgkin lymphoma|stage iii adult hodgkin lymphoma
844054|NCT00003269|stage IV adult Hodgkin lymphoma|stage iv adult hodgkin lymphoma
844055|NCT00003269|stage I breast cancer|stage i breast cancer
844056|NCT00003269|stage II breast cancer|stage ii breast cancer
844057|NCT00003269|stage IV breast cancer|stage iv breast cancer
844058|NCT00003269|stage IIIA breast cancer|stage iiia breast cancer
844059|NCT00003269|stage I non-small cell lung cancer|stage i non-small cell lung cancer
844060|NCT00003269|stage II non-small cell lung cancer|stage ii non-small cell lung cancer
844061|NCT00003269|stage IIIB breast cancer|stage iiib breast cancer
844062|NCT00003269|stage I cutaneous T-cell non-Hodgkin lymphoma|stage i cutaneous t-cell non-hodgkin lymphoma
844063|NCT00003269|stage II cutaneous T-cell non-Hodgkin lymphoma|stage ii cutaneous t-cell non-hodgkin lymphoma
844064|NCT00003269|stage III cutaneous T-cell non-Hodgkin lymphoma|stage iii cutaneous t-cell non-hodgkin lymphoma
844065|NCT00003269|stage IV cutaneous T-cell non-Hodgkin lymphoma|stage iv cutaneous t-cell non-hodgkin lymphoma
844066|NCT00003269|stage I ovarian epithelial cancer|stage i ovarian epithelial cancer
844067|NCT00003269|stage II ovarian epithelial cancer|stage ii ovarian epithelial cancer
844068|NCT00003269|stage III ovarian epithelial cancer|stage iii ovarian epithelial cancer
844069|NCT00003269|stage IV ovarian epithelial cancer|stage iv ovarian epithelial cancer
844070|NCT00003269|Waldenstrom macroglobulinemia|waldenstrom macroglobulinemia
844071|NCT00003269|limited stage small cell lung cancer|limited stage small cell lung cancer
844072|NCT00003269|extensive stage small cell lung cancer|extensive stage small cell lung cancer
844073|NCT00003269|stage IIIA non-small cell lung cancer|stage iiia non-small cell lung cancer
844074|NCT00003269|stage IIIB non-small cell lung cancer|stage iiib non-small cell lung cancer
844075|NCT00003269|stage IV non-small cell lung cancer|stage iv non-small cell lung cancer
844076|NCT00003269|unspecified adult solid tumor, protocol specific|unspecified adult solid tumor, protocol specific
844077|NCT00003269|stage I grade 1 follicular lymphoma|stage i grade 1 follicular lymphoma
844078|NCT00003269|stage I grade 2 follicular lymphoma|stage i grade 2 follicular lymphoma
844079|NCT00003269|stage I grade 3 follicular lymphoma|stage i grade 3 follicular lymphoma
844080|NCT00003269|stage I adult diffuse small cleaved cell lymphoma|stage i adult diffuse small cleaved cell lymphoma
844081|NCT00003269|stage I adult diffuse mixed cell lymphoma|stage i adult diffuse mixed cell lymphoma
844082|NCT00003269|stage I adult diffuse large cell lymphoma|stage i adult diffuse large cell lymphoma
844083|NCT00003269|stage I adult immunoblastic large cell lymphoma|stage i adult immunoblastic large cell lymphoma
844084|NCT00003269|stage I adult lymphoblastic lymphoma|stage i adult lymphoblastic lymphoma
844085|NCT00003269|stage I adult Burkitt lymphoma|stage i adult burkitt lymphoma
844086|NCT00003269|stage III grade 1 follicular lymphoma|stage iii grade 1 follicular lymphoma
844087|NCT00003269|stage III grade 2 follicular lymphoma|stage iii grade 2 follicular lymphoma
844088|NCT00003269|stage III grade 3 follicular lymphoma|stage iii grade 3 follicular lymphoma
844089|NCT00003269|stage III adult diffuse small cleaved cell lymphoma|stage iii adult diffuse small cleaved cell lymphoma
844090|NCT00003269|stage III adult diffuse mixed cell lymphoma|stage iii adult diffuse mixed cell lymphoma
844091|NCT00003269|stage III adult diffuse large cell lymphoma|stage iii adult diffuse large cell lymphoma
844092|NCT00003269|stage III adult immunoblastic large cell lymphoma|stage iii adult immunoblastic large cell lymphoma
844093|NCT00003269|stage III adult lymphoblastic lymphoma|stage iii adult lymphoblastic lymphoma
844094|NCT00003269|stage III adult Burkitt lymphoma|stage iii adult burkitt lymphoma
844095|NCT00003269|stage IV grade 1 follicular lymphoma|stage iv grade 1 follicular lymphoma
844096|NCT00003269|stage IV grade 2 follicular lymphoma|stage iv grade 2 follicular lymphoma
844097|NCT00003269|stage IV grade 3 follicular lymphoma|stage iv grade 3 follicular lymphoma
844098|NCT00003269|stage IV adult diffuse small cleaved cell lymphoma|stage iv adult diffuse small cleaved cell lymphoma
844099|NCT00003269|stage IV adult diffuse mixed cell lymphoma|stage iv adult diffuse mixed cell lymphoma
844100|NCT00003269|stage IV adult diffuse large cell lymphoma|stage iv adult diffuse large cell lymphoma
844101|NCT00003269|stage IV adult immunoblastic large cell lymphoma|stage iv adult immunoblastic large cell lymphoma
844102|NCT00003269|stage IV adult lymphoblastic lymphoma|stage iv adult lymphoblastic lymphoma
844103|NCT00003269|stage IV adult Burkitt lymphoma|stage iv adult burkitt lymphoma
844104|NCT00003269|stage I adult T-cell leukemia/lymphoma|stage i adult t-cell leukemia/lymphoma
844105|NCT00003269|stage II adult T-cell leukemia/lymphoma|stage ii adult t-cell leukemia/lymphoma
844106|NCT00003269|stage III adult T-cell leukemia/lymphoma|stage iii adult t-cell leukemia/lymphoma
844107|NCT00003269|stage IV adult T-cell leukemia/lymphoma|stage iv adult t-cell leukemia/lymphoma
844108|NCT00003269|drug/agent toxicity by tissue/organ|drug/agent toxicity by tissue/organ
844109|NCT00003269|stage I mantle cell lymphoma|stage i mantle cell lymphoma
844110|NCT00003269|contiguous stage II grade 1 follicular lymphoma|contiguous stage ii grade 1 follicular lymphoma
844111|NCT00003269|contiguous stage II grade 2 follicular lymphoma|contiguous stage ii grade 2 follicular lymphoma
844112|NCT00003269|contiguous stage II grade 3 follicular lymphoma|contiguous stage ii grade 3 follicular lymphoma
844113|NCT00003269|contiguous stage II adult diffuse small cleaved cell lymphoma|contiguous stage ii adult diffuse small cleaved cell lymphoma
844114|NCT00003269|contiguous stage II mantle cell lymphoma|contiguous stage ii mantle cell lymphoma
844115|NCT00003269|contiguous stage II adult diffuse mixed cell lymphoma|contiguous stage ii adult diffuse mixed cell lymphoma
844116|NCT00003269|contiguous stage II adult immunoblastic large cell lymphoma|contiguous stage ii adult immunoblastic large cell lymphoma
844117|NCT00003269|contiguous stage II adult diffuse large cell lymphoma|contiguous stage ii adult diffuse large cell lymphoma
844118|NCT00003269|contiguous stage II adult Burkitt lymphoma|contiguous stage ii adult burkitt lymphoma
844119|NCT00003269|contiguous stage II adult lymphoblastic lymphoma|contiguous stage ii adult lymphoblastic lymphoma
844120|NCT00003269|noncontiguous stage II grade 1 follicular lymphoma|noncontiguous stage ii grade 1 follicular lymphoma
844121|NCT00003269|noncontiguous stage II grade 2 follicular lymphoma|noncontiguous stage ii grade 2 follicular lymphoma
844122|NCT00003269|noncontiguous stage II grade 3 follicular lymphoma|noncontiguous stage ii grade 3 follicular lymphoma
844123|NCT00003269|noncontiguous stage II adult diffuse small cleaved cell lymphoma|noncontiguous stage ii adult diffuse small cleaved cell lymphoma
844124|NCT00003269|noncontiguous stage II mantle cell lymphoma|noncontiguous stage ii mantle cell lymphoma
844125|NCT00003269|noncontiguous stage II adult diffuse mixed cell lymphoma|noncontiguous stage ii adult diffuse mixed cell lymphoma
844126|NCT00003269|noncontiguous stage II adult immunoblastic large cell lymphoma|noncontiguous stage ii adult immunoblastic large cell lymphoma
844127|NCT00003269|noncontiguous stage II adult diffuse large cell lymphoma|noncontiguous stage ii adult diffuse large cell lymphoma
844128|NCT00003269|noncontiguous stage II adult Burkitt lymphoma|noncontiguous stage ii adult burkitt lymphoma
844129|NCT00003269|noncontiguous stage II adult lymphoblastic lymphoma|noncontiguous stage ii adult lymphoblastic lymphoma
844130|NCT00003269|stage III mantle cell lymphoma|stage iii mantle cell lymphoma
844131|NCT00003269|stage IV mantle cell lymphoma|stage iv mantle cell lymphoma
844132|NCT00003269|noncontiguous stage II small lymphocytic lymphoma|noncontiguous stage ii small lymphocytic lymphoma
844133|NCT00003269|noncontiguous stage II marginal zone lymphoma|noncontiguous stage ii marginal zone lymphoma
844134|NCT00003269|stage I marginal zone lymphoma|stage i marginal zone lymphoma
844135|NCT00003269|stage I small lymphocytic lymphoma|stage i small lymphocytic lymphoma
844136|NCT00003269|stage III small lymphocytic lymphoma|stage iii small lymphocytic lymphoma
844137|NCT00003269|stage III marginal zone lymphoma|stage iii marginal zone lymphoma
844138|NCT00003269|stage IV small lymphocytic lymphoma|stage iv small lymphocytic lymphoma
844139|NCT00003269|stage IV marginal zone lymphoma|stage iv marginal zone lymphoma
844140|NCT00003269|contiguous stage II marginal zone lymphoma|contiguous stage ii marginal zone lymphoma
844141|NCT00003269|contiguous stage II small lymphocytic lymphoma|contiguous stage ii small lymphocytic lymphoma
844142|NCT00003269|extranodal marginal zone B-cell lymphoma of mucosa-associated lymphoid tissue|extranodal marginal zone b-cell lymphoma of mucosa-associated lymphoid tissue
844143|NCT00003269|nodal marginal zone B-cell lymphoma|nodal marginal zone b-cell lymphoma
844144|NCT00003269|splenic marginal zone lymphoma|splenic marginal zone lymphoma
844145|NCT00003195|refractory multiple myeloma|refractory multiple myeloma
844146|NCT00003195|stage II multiple myeloma|stage ii multiple myeloma
844147|NCT00003195|stage III multiple myeloma|stage iii multiple myeloma
844148|NCT00003187|recurrent childhood acute lymphoblastic leukemia|recurrent childhood acute lymphoblastic leukemia
844149|NCT00003187|stage IV childhood lymphoblastic lymphoma|stage iv childhood lymphoblastic lymphoma
844150|NCT00003187|recurrent childhood acute myeloid leukemia|recurrent childhood acute myeloid leukemia
844151|NCT00003187|recurrent adult acute myeloid leukemia|recurrent adult acute myeloid leukemia
844152|NCT00003187|recurrent adult acute lymphoblastic leukemia|recurrent adult acute lymphoblastic leukemia
844153|NCT00003187|relapsing chronic myelogenous leukemia|relapsing chronic myelogenous leukemia
844154|NCT00003187|chronic phase chronic myelogenous leukemia|chronic phase chronic myelogenous leukemia
844155|NCT00003187|accelerated phase chronic myelogenous leukemia|accelerated phase chronic myelogenous leukemia
844156|NCT00003187|untreated adult acute lymphoblastic leukemia|untreated adult acute lymphoblastic leukemia
844157|NCT00003187|untreated adult acute myeloid leukemia|untreated adult acute myeloid leukemia
844619|NCT00083330|HV|hv
844158|NCT00003187|untreated childhood acute myeloid leukemia and other myeloid malignancies|untreated childhood acute myeloid leukemia and other myeloid malignancies
844159|NCT00003187|untreated childhood acute lymphoblastic leukemia|untreated childhood acute lymphoblastic leukemia
844492|NCT00002673|stage IIIB breast cancer|stage iiib breast cancer
844160|NCT00003187|adult acute myeloid leukemia in remission|adult acute myeloid leukemia in remission
844161|NCT00003187|adult acute lymphoblastic leukemia in remission|adult acute lymphoblastic leukemia in remission
844162|NCT00003187|childhood acute myeloid leukemia in remission|childhood acute myeloid leukemia in remission
844163|NCT00003187|childhood acute lymphoblastic leukemia in remission|childhood acute lymphoblastic leukemia in remission
844164|NCT00003187|refractory anemia|refractory anemia
844165|NCT00003187|refractory anemia with ringed sideroblasts|refractory anemia with ringed sideroblasts
844166|NCT00003187|refractory anemia with excess blasts|refractory anemia with excess blasts
844167|NCT00003187|refractory anemia with excess blasts in transformation|refractory anemia with excess blasts in transformation
844168|NCT00003187|chronic myelomonocytic leukemia|chronic myelomonocytic leukemia
844169|NCT00003187|acute undifferentiated leukemia|acute undifferentiated leukemia
844170|NCT00003187|stage IV adult lymphoblastic lymphoma|stage iv adult lymphoblastic lymphoma
844171|NCT00003187|de novo myelodysplastic syndromes|de novo myelodysplastic syndromes
844172|NCT00003187|previously treated myelodysplastic syndromes|previously treated myelodysplastic syndromes
844173|NCT00003187|secondary myelodysplastic syndromes|secondary myelodysplastic syndromes
844174|NCT00003187|childhood myelodysplastic syndromes|childhood myelodysplastic syndromes
844175|NCT00003098|breast cancer|breast cancer
844176|NCT00003084|adenocarcinoma of the prostate|adenocarcinoma of the prostate
844177|NCT00003084|stage I prostate cancer|stage i prostate cancer
844178|NCT00003084|stage II prostate cancer|stage ii prostate cancer
844179|NCT00003084|stage III prostate cancer|stage iii prostate cancer
844180|NCT00003084|stage IV prostate cancer|stage iv prostate cancer
844181|NCT00003084|recurrent prostate cancer|recurrent prostate cancer
844182|NCT00003084|Chemotherapy|chemotherapy
844183|NCT00003084|Ketoconazole|ketoconazole
844184|NCT00003084|Estramustine|estramustine
844185|NCT00003084|Etoposide|etoposide
844186|NCT00003084|Paclitaxel|paclitaxel
844187|NCT00003084|Doxorubicin|doxorubicin
844188|NCT00003084|Vinblastine|vinblastine
844189|NCT00003056|recurrent adult diffuse small cleaved cell lymphoma|recurrent adult diffuse small cleaved cell lymphoma
844190|NCT00003056|adult acute myeloid leukemia in remission|adult acute myeloid leukemia in remission
844191|NCT00003056|recurrent grade 2 follicular lymphoma|recurrent grade 2 follicular lymphoma
844192|NCT00003056|accelerated phase chronic myelogenous leukemia|accelerated phase chronic myelogenous leukemia
844193|NCT00003056|adult acute lymphoblastic leukemia in remission|adult acute lymphoblastic leukemia in remission
844194|NCT00003056|recurrent grade 1 follicular lymphoma|recurrent grade 1 follicular lymphoma
844195|NCT00003056|recurrent adult lymphoblastic lymphoma|recurrent adult lymphoblastic lymphoma
844196|NCT00003056|recurrent marginal zone lymphoma|recurrent marginal zone lymphoma
844197|NCT00003056|chronic phase chronic myelogenous leukemia|chronic phase chronic myelogenous leukemia
844198|NCT00003056|recurrent small lymphocytic lymphoma|recurrent small lymphocytic lymphoma
844199|NCT00003056|recurrent grade 3 follicular lymphoma|recurrent grade 3 follicular lymphoma
844200|NCT00003056|recurrent adult Hodgkin lymphoma|recurrent adult hodgkin lymphoma
844201|NCT00003056|recurrent adult acute lymphoblastic leukemia|recurrent adult acute lymphoblastic leukemia
844202|NCT00003056|recurrent adult immunoblastic large cell lymphoma|recurrent adult immunoblastic large cell lymphoma
844203|NCT00003056|graft versus host disease|graft versus host disease
844204|NCT00003056|recurrent adult diffuse mixed cell lymphoma|recurrent adult diffuse mixed cell lymphoma
844205|NCT00003056|recurrent mantle cell lymphoma|recurrent mantle cell lymphoma
844206|NCT00003056|splenic marginal zone lymphoma|splenic marginal zone lymphoma
844207|NCT00003056|recurrent adult acute myeloid leukemia|recurrent adult acute myeloid leukemia
844208|NCT00003056|extranodal marginal zone B-cell lymphoma of mucosa-associated lymphoid tissue|extranodal marginal zone b-cell lymphoma of mucosa-associated lymphoid tissue
844209|NCT00003056|recurrent adult diffuse large cell lymphoma|recurrent adult diffuse large cell lymphoma
844210|NCT00003056|nodal marginal zone B-cell lymphoma|nodal marginal zone b-cell lymphoma
844211|NCT00003056|recurrent adult Burkitt lymphoma|recurrent adult burkitt lymphoma
844212|NCT00003004|unspecified adult solid tumor, protocol specific|unspecified adult solid tumor, protocol specific
844213|NCT00002924|adenocarcinoma of the prostate|adenocarcinoma of the prostate
844214|NCT00002924|recurrent prostate cancer|recurrent prostate cancer
844215|NCT00002902|unspecified adult solid tumor, protocol specific|unspecified adult solid tumor, protocol specific
844216|NCT00002875|untreated childhood medulloblastoma|untreated childhood medulloblastoma
844217|NCT00002780|stage IV breast cancer|stage iv breast cancer
844218|NCT00002780|recurrent breast cancer|recurrent breast cancer
844219|NCT00002780|stage IIIB breast cancer|stage iiib breast cancer
844220|NCT00002750|recurrent childhood acute lymphoblastic leukemia|recurrent childhood acute lymphoblastic leukemia
844221|NCT00002750|recurrent adult Hodgkin lymphoma|recurrent adult hodgkin lymphoma
844222|NCT00002750|Waldenström macroglobulinemia|waldenström macroglobulinemia
844223|NCT00002750|recurrent childhood lymphoblastic lymphoma|recurrent childhood lymphoblastic lymphoma
844224|NCT00002750|childhood central nervous system germ cell tumor|childhood central nervous system germ cell tumor
844225|NCT00002750|recurrent childhood acute myeloid leukemia|recurrent childhood acute myeloid leukemia
844620|NCT00083278|Breast Cancer|breast cancer
844226|NCT00002750|recurrent adult acute myeloid leukemia|recurrent adult acute myeloid leukemia
844227|NCT00002750|recurrent adult acute lymphoblastic leukemia|recurrent adult acute lymphoblastic leukemia
844624|NCT00012350|stage III multiple myeloma|stage iii multiple myeloma
844228|NCT00002750|recurrent/refractory childhood Hodgkin lymphoma|recurrent/refractory childhood hodgkin lymphoma
844229|NCT00002750|recurrent ovarian germ cell tumor|recurrent ovarian germ cell tumor
844230|NCT00002750|recurrent adult non-Hodgkin lymphoma|recurrent adult non-hodgkin lymphoma
844231|NCT00002750|recurrent grade 1 follicular lymphoma|recurrent grade 1 follicular lymphoma
844232|NCT00002750|recurrent grade 2 follicular lymphoma|recurrent grade 2 follicular lymphoma
844233|NCT00002750|recurrent grade 3 follicular lymphoma|recurrent grade 3 follicular lymphoma
844234|NCT00002750|recurrent adult diffuse small cleaved cell lymphoma|recurrent adult diffuse small cleaved cell lymphoma
844235|NCT00002750|recurrent adult diffuse mixed cell lymphoma|recurrent adult diffuse mixed cell lymphoma
844236|NCT00002750|recurrent adult diffuse large cell lymphoma|recurrent adult diffuse large cell lymphoma
844237|NCT00002750|recurrent adult immunoblastic large cell lymphoma|recurrent adult immunoblastic large cell lymphoma
844238|NCT00002750|recurrent adult lymphoblastic lymphoma|recurrent adult lymphoblastic lymphoma
844239|NCT00002750|recurrent adult Burkitt lymphoma|recurrent adult burkitt lymphoma
844240|NCT00002750|extragonadal germ cell tumor|extragonadal germ cell tumor
844241|NCT00002750|leptomeningeal metastases|leptomeningeal metastases
844242|NCT00002750|recurrent childhood small noncleaved cell lymphoma|recurrent childhood small noncleaved cell lymphoma
844243|NCT00002750|recurrent childhood large cell lymphoma|recurrent childhood large cell lymphoma
844244|NCT00002750|recurrent mantle cell lymphoma|recurrent mantle cell lymphoma
844245|NCT00002750|recurrent marginal zone lymphoma|recurrent marginal zone lymphoma
844246|NCT00002750|recurrent small lymphocytic lymphoma|recurrent small lymphocytic lymphoma
844247|NCT00002750|extranodal marginal zone B-cell lymphoma of mucosa-associated lymphoid tissue|extranodal marginal zone b-cell lymphoma of mucosa-associated lymphoid tissue
844248|NCT00002750|nodal marginal zone B-cell lymphoma|nodal marginal zone b-cell lymphoma
844249|NCT00002750|splenic marginal zone lymphoma|splenic marginal zone lymphoma
844250|NCT00002734|recurrent ovarian epithelial cancer|recurrent ovarian epithelial cancer
844251|NCT00002734|primary peritoneal cavity cancer|primary peritoneal cavity cancer
844252|NCT00002671|stage III ovarian epithelial cancer|stage iii ovarian epithelial cancer
844253|NCT00002671|stage IV ovarian epithelial cancer|stage iv ovarian epithelial cancer
844254|NCT00002671|recurrent ovarian epithelial cancer|recurrent ovarian epithelial cancer
844255|NCT00002664|recurrent colon cancer|recurrent colon cancer
844256|NCT00002664|recurrent rectal cancer|recurrent rectal cancer
844257|NCT00002576|stage I adult diffuse mixed cell lymphoma|stage i adult diffuse mixed cell lymphoma
844258|NCT00002576|stage I adult diffuse large cell lymphoma|stage i adult diffuse large cell lymphoma
844259|NCT00002576|stage I adult immunoblastic large cell lymphoma|stage i adult immunoblastic large cell lymphoma
844260|NCT00002576|stage I adult lymphoblastic lymphoma|stage i adult lymphoblastic lymphoma
844261|NCT00002576|stage I adult Burkitt lymphoma|stage i adult burkitt lymphoma
844262|NCT00002576|stage II adult diffuse mixed cell lymphoma|stage ii adult diffuse mixed cell lymphoma
844263|NCT00002576|stage II adult diffuse large cell lymphoma|stage ii adult diffuse large cell lymphoma
844264|NCT00002576|stage II adult immunoblastic large cell lymphoma|stage ii adult immunoblastic large cell lymphoma
844265|NCT00002576|stage II adult lymphoblastic lymphoma|stage ii adult lymphoblastic lymphoma
844266|NCT00002576|stage II adult Burkitt lymphoma|stage ii adult burkitt lymphoma
844267|NCT00002576|stage III adult diffuse mixed cell lymphoma|stage iii adult diffuse mixed cell lymphoma
844268|NCT00002576|stage III adult diffuse large cell lymphoma|stage iii adult diffuse large cell lymphoma
844269|NCT00002576|stage III adult immunoblastic large cell lymphoma|stage iii adult immunoblastic large cell lymphoma
844270|NCT00002576|stage III adult lymphoblastic lymphoma|stage iii adult lymphoblastic lymphoma
844271|NCT00002576|stage III adult Burkitt lymphoma|stage iii adult burkitt lymphoma
844272|NCT00002576|stage IV adult diffuse mixed cell lymphoma|stage iv adult diffuse mixed cell lymphoma
844273|NCT00002576|stage IV adult diffuse large cell lymphoma|stage iv adult diffuse large cell lymphoma
844274|NCT00002576|stage IV adult immunoblastic large cell lymphoma|stage iv adult immunoblastic large cell lymphoma
844275|NCT00002576|stage IV adult lymphoblastic lymphoma|stage iv adult lymphoblastic lymphoma
844276|NCT00002576|stage IV adult Burkitt lymphoma|stage iv adult burkitt lymphoma
844277|NCT00002576|contiguous stage II adult diffuse mixed cell lymphoma|contiguous stage ii adult diffuse mixed cell lymphoma
844278|NCT00002576|contiguous stage II adult immunoblastic large cell lymphoma|contiguous stage ii adult immunoblastic large cell lymphoma
844279|NCT00002576|contiguous stage II adult diffuse large cell lymphoma|contiguous stage ii adult diffuse large cell lymphoma
844280|NCT00002576|contiguous stage II adult Burkitt lymphoma|contiguous stage ii adult burkitt lymphoma
844281|NCT00002576|contiguous stage II adult lymphoblastic lymphoma|contiguous stage ii adult lymphoblastic lymphoma
844282|NCT00002576|noncontiguous stage II adult diffuse mixed cell lymphoma|noncontiguous stage ii adult diffuse mixed cell lymphoma
844283|NCT00002576|noncontiguous stage II adult immunoblastic large cell lymphoma|noncontiguous stage ii adult immunoblastic large cell lymphoma
844284|NCT00002576|noncontiguous stage II adult diffuse large cell lymphoma|noncontiguous stage ii adult diffuse large cell lymphoma
844285|NCT00002576|noncontiguous stage II adult Burkitt lymphoma|noncontiguous stage ii adult burkitt lymphoma
844286|NCT00002576|noncontiguous stage II adult lymphoblastic lymphoma|noncontiguous stage ii adult lymphoblastic lymphoma
844287|NCT00002571|AIDS-related peripheral/systemic lymphoma|aids-related peripheral/systemic lymphoma
859775|NCT00063258|Carboplatin|carboplatin
844288|NCT00002571|AIDS-related diffuse large cell lymphoma|aids-related diffuse large cell lymphoma
844289|NCT00002571|AIDS-related immunoblastic large cell lymphoma|aids-related immunoblastic large cell lymphoma
844290|NCT00002571|AIDS-related small noncleaved cell lymphoma|aids-related small noncleaved cell lymphoma
844291|NCT00002571|AIDS-related diffuse mixed cell lymphoma|aids-related diffuse mixed cell lymphoma
844292|NCT00002571|AIDS-related diffuse small cleaved cell lymphoma|aids-related diffuse small cleaved cell lymphoma
844293|NCT00002567|adult acute myeloid leukemia in remission|adult acute myeloid leukemia in remission
844294|NCT00002567|adult acute lymphoblastic leukemia in remission|adult acute lymphoblastic leukemia in remission
844295|NCT00002567|adult acute erythroid leukemia (M6)|adult acute erythroid leukemia (m6)
844296|NCT00002567|adult acute myeloblastic leukemia without maturation (M1)|adult acute myeloblastic leukemia without maturation (m1)
844297|NCT00002567|adult acute myeloblastic leukemia with maturation (M2)|adult acute myeloblastic leukemia with maturation (m2)
844298|NCT00002567|adult acute promyelocytic leukemia (M3)|adult acute promyelocytic leukemia (m3)
844299|NCT00002567|adult acute myelomonocytic leukemia (M4)|adult acute myelomonocytic leukemia (m4)
844300|NCT00002567|adult acute monoblastic leukemia (M5a)|adult acute monoblastic leukemia (m5a)
844301|NCT00002567|adult acute megakaryoblastic leukemia (M7)|adult acute megakaryoblastic leukemia (m7)
844302|NCT00002567|adult acute monocytic leukemia (M5b)|adult acute monocytic leukemia (m5b)
844303|NCT00002567|bone marrow ablation|bone marrow ablation
844304|NCT00002567|adult acute minimally differentiated myeloid leukemia (M0)|adult acute minimally differentiated myeloid leukemia (m0)
844305|NCT00002552|recurrent adult Hodgkin lymphoma|recurrent adult hodgkin lymphoma
844306|NCT00002552|refractory multiple myeloma|refractory multiple myeloma
844307|NCT00002552|recurrent small lymphocytic lymphoma|recurrent small lymphocytic lymphoma
844308|NCT00002552|recurrent grade 1 follicular lymphoma|recurrent grade 1 follicular lymphoma
844309|NCT00002552|recurrent grade 2 follicular lymphoma|recurrent grade 2 follicular lymphoma
844310|NCT00002552|recurrent grade 3 follicular lymphoma|recurrent grade 3 follicular lymphoma
844311|NCT00002552|recurrent adult diffuse small cleaved cell lymphoma|recurrent adult diffuse small cleaved cell lymphoma
844312|NCT00002552|recurrent adult diffuse mixed cell lymphoma|recurrent adult diffuse mixed cell lymphoma
844313|NCT00002552|recurrent adult diffuse large cell lymphoma|recurrent adult diffuse large cell lymphoma
844314|NCT00002552|recurrent adult immunoblastic large cell lymphoma|recurrent adult immunoblastic large cell lymphoma
844315|NCT00002552|recurrent adult lymphoblastic lymphoma|recurrent adult lymphoblastic lymphoma
844316|NCT00002552|recurrent adult Burkitt lymphoma|recurrent adult burkitt lymphoma
844317|NCT00002552|recurrent mantle cell lymphoma|recurrent mantle cell lymphoma
844318|NCT00002552|recurrent marginal zone lymphoma|recurrent marginal zone lymphoma
844319|NCT00002552|extranodal marginal zone B-cell lymphoma of mucosa-associated lymphoid tissue|extranodal marginal zone b-cell lymphoma of mucosa-associated lymphoid tissue
844320|NCT00002552|nodal marginal zone B-cell lymphoma|nodal marginal zone b-cell lymphoma
844321|NCT00002552|splenic marginal zone lymphoma|splenic marginal zone lymphoma
844322|NCT00002552|adult unfavorable prognosis Hodgkin lymphoma|adult unfavorable prognosis hodgkin lymphoma
844323|NCT00002552|childhood unfavorable prognosis Hodgkin lymphoma|childhood unfavorable prognosis hodgkin lymphoma
844324|NCT00002547|recurrent childhood acute myeloid leukemia|recurrent childhood acute myeloid leukemia
844325|NCT00002547|recurrent adult acute myeloid leukemia|recurrent adult acute myeloid leukemia
844326|NCT00002547|untreated adult acute myeloid leukemia|untreated adult acute myeloid leukemia
844327|NCT00002547|untreated childhood acute myeloid leukemia and other myeloid malignancies|untreated childhood acute myeloid leukemia and other myeloid malignancies
844328|NCT00002547|adult acute myeloid leukemia in remission|adult acute myeloid leukemia in remission
844329|NCT00002547|childhood acute myeloid leukemia in remission|childhood acute myeloid leukemia in remission
844330|NCT00002547|adult acute erythroid leukemia (M6)|adult acute erythroid leukemia (m6)
844331|NCT00002547|adult acute myeloblastic leukemia without maturation (M1)|adult acute myeloblastic leukemia without maturation (m1)
844332|NCT00002547|adult acute myeloblastic leukemia with maturation (M2)|adult acute myeloblastic leukemia with maturation (m2)
844333|NCT00002547|adult acute promyelocytic leukemia (M3)|adult acute promyelocytic leukemia (m3)
844334|NCT00002547|adult acute myelomonocytic leukemia (M4)|adult acute myelomonocytic leukemia (m4)
844335|NCT00002547|adult acute monoblastic leukemia (M5a)|adult acute monoblastic leukemia (m5a)
844336|NCT00002547|adult acute megakaryoblastic leukemia (M7)|adult acute megakaryoblastic leukemia (m7)
844337|NCT00002547|childhood acute myeloblastic leukemia without maturation (M1)|childhood acute myeloblastic leukemia without maturation (m1)
844338|NCT00002547|childhood acute myeloblastic leukemia with maturation (M2)|childhood acute myeloblastic leukemia with maturation (m2)
844339|NCT00002547|childhood acute promyelocytic leukemia (M3)|childhood acute promyelocytic leukemia (m3)
844340|NCT00002547|childhood acute myelomonocytic leukemia (M4)|childhood acute myelomonocytic leukemia (m4)
844341|NCT00002547|childhood acute monoblastic leukemia (M5a)|childhood acute monoblastic leukemia (m5a)
844342|NCT00002547|childhood acute monocytic leukemia (M5b)|childhood acute monocytic leukemia (m5b)
844343|NCT00002547|childhood acute erythroleukemia (M6)|childhood acute erythroleukemia (m6)
844344|NCT00002547|childhood acute megakaryocytic leukemia (M7)|childhood acute megakaryocytic leukemia (m7)
844345|NCT00002547|refractory anemia with excess blasts|refractory anemia with excess blasts
844346|NCT00002547|refractory anemia with excess blasts in transformation|refractory anemia with excess blasts in transformation
844347|NCT00002547|chronic myelomonocytic leukemia|chronic myelomonocytic leukemia
845101|NCT00082706|stage IV bladder cancer|stage iv bladder cancer
844348|NCT00002547|secondary acute myeloid leukemia|secondary acute myeloid leukemia
844349|NCT00002547|adult acute monocytic leukemia (M5b)|adult acute monocytic leukemia (m5b)
844350|NCT00002547|previously treated myelodysplastic syndromes|previously treated myelodysplastic syndromes
844351|NCT00002547|childhood myelodysplastic syndromes|childhood myelodysplastic syndromes
844352|NCT00083356|Pain|pain
844353|NCT00083356|Kinins|kinins
844354|NCT00083356|Inflammation|inflammation
844355|NCT00083356|Gene Expression|gene expression
844356|NCT00083356|Oral Surgey|oral surgey
844357|NCT00083356|Bradykinin B1 Receptors|bradykinin b1 receptors
844358|NCT00083356|Acute Peripheral Inflammation|acute peripheral inflammation
844359|NCT00083356|Inflammatory Gene Expression|inflammatory gene expression
844360|NCT00083356|Wisdom Teeth|wisdom teeth
844361|NCT00083356|Third Molar Extraction|third molar extraction
844362|NCT00005648|Stage II pancreatic cancer|stage ii pancreatic cancer
844363|NCT00005648|Stage III pancreatic cancer|stage iii pancreatic cancer
844364|NCT00005648|Recurrent pancreatic cancer|recurrent pancreatic cancer
844365|NCT00005648|Adenocarcinoma of the pancreas|adenocarcinoma of the pancreas
844366|NCT00005648|Stage IV pancreatic cancer|stage iv pancreatic cancer
844367|NCT00004198|stage III grade 1 follicular lymphoma|stage iii grade 1 follicular lymphoma
844368|NCT00004198|stage III grade 2 follicular lymphoma|stage iii grade 2 follicular lymphoma
844369|NCT00004198|stage IV grade 1 follicular lymphoma|stage iv grade 1 follicular lymphoma
844370|NCT00004198|stage IV grade 2 follicular lymphoma|stage iv grade 2 follicular lymphoma
844371|NCT00004126|recurrent non-small cell lung cancer|recurrent non-small cell lung cancer
844372|NCT00004126|stage IIIB non-small cell lung cancer|stage iiib non-small cell lung cancer
844373|NCT00004126|stage IV non-small cell lung cancer|stage iv non-small cell lung cancer
844374|NCT00004122|stage I bladder cancer|stage i bladder cancer
844375|NCT00004122|recurrent bladder cancer|recurrent bladder cancer
844376|NCT00004122|transitional cell carcinoma of the bladder|transitional cell carcinoma of the bladder
844377|NCT00004113|recurrent adult brain tumor|recurrent adult brain tumor
844378|NCT00004113|adult glioblastoma|adult glioblastoma
844379|NCT00004113|adult anaplastic astrocytoma|adult anaplastic astrocytoma
844380|NCT00004113|adult anaplastic oligodendroglioma|adult anaplastic oligodendroglioma
844381|NCT00004113|adult mixed glioma|adult mixed glioma
844382|NCT00004113|adult giant cell glioblastoma|adult giant cell glioblastoma
844383|NCT00004113|adult gliosarcoma|adult gliosarcoma
844384|NCT00003976|unspecified adult solid tumor, protocol specific|unspecified adult solid tumor, protocol specific
845257|NCT00083265|Challenge Study|challenge study
844385|NCT00003908|recurrent metastatic squamous neck cancer with occult primary|recurrent metastatic squamous neck cancer with occult primary
844386|NCT00003908|metastatic squamous neck cancer with occult primary squamous cell carcinoma|metastatic squamous neck cancer with occult primary squamous cell carcinoma
844387|NCT00003908|stage IV squamous cell carcinoma of the lip and oral cavity|stage iv squamous cell carcinoma of the lip and oral cavity
844388|NCT00003908|recurrent squamous cell carcinoma of the lip and oral cavity|recurrent squamous cell carcinoma of the lip and oral cavity
844389|NCT00003908|stage IV squamous cell carcinoma of the oropharynx|stage iv squamous cell carcinoma of the oropharynx
844390|NCT00003908|recurrent squamous cell carcinoma of the oropharynx|recurrent squamous cell carcinoma of the oropharynx
844391|NCT00003908|stage IV squamous cell carcinoma of the nasopharynx|stage iv squamous cell carcinoma of the nasopharynx
844392|NCT00003908|recurrent squamous cell carcinoma of the nasopharynx|recurrent squamous cell carcinoma of the nasopharynx
844393|NCT00003908|stage IV squamous cell carcinoma of the hypopharynx|stage iv squamous cell carcinoma of the hypopharynx
844394|NCT00003908|recurrent squamous cell carcinoma of the hypopharynx|recurrent squamous cell carcinoma of the hypopharynx
844395|NCT00003908|stage IV squamous cell carcinoma of the larynx|stage iv squamous cell carcinoma of the larynx
844396|NCT00003908|recurrent squamous cell carcinoma of the larynx|recurrent squamous cell carcinoma of the larynx
844397|NCT00003908|stage IV squamous cell carcinoma of the paranasal sinus and nasal cavity|stage iv squamous cell carcinoma of the paranasal sinus and nasal cavity
844398|NCT00003908|recurrent squamous cell carcinoma of the paranasal sinus and nasal cavity|recurrent squamous cell carcinoma of the paranasal sinus and nasal cavity
844399|NCT00003822|unspecified adult solid tumor, protocol specific|unspecified adult solid tumor, protocol specific
844400|NCT00003747|stage IV melanoma|stage iv melanoma
844401|NCT00003747|recurrent melanoma|recurrent melanoma
844402|NCT00003724|lung metastases|lung metastases
844403|NCT00003670|stage IV ovarian epithelial cancer|stage iv ovarian epithelial cancer
844404|NCT00003670|recurrent ovarian epithelial cancer|recurrent ovarian epithelial cancer
844405|NCT00003670|primary peritoneal cavity cancer|primary peritoneal cavity cancer
844406|NCT00003606|extensive stage small cell lung cancer|extensive stage small cell lung cancer
844407|NCT00003562|squamous cell lung cancer|squamous cell lung cancer
844408|NCT00003562|large cell lung cancer|large cell lung cancer
844409|NCT00003562|stage IIIB non-small cell lung cancer|stage iiib non-small cell lung cancer
844410|NCT00003562|stage IV non-small cell lung cancer|stage iv non-small cell lung cancer
844411|NCT00003562|adenocarcinoma of the lung|adenocarcinoma of the lung
844412|NCT00003490|refractory multiple myeloma|refractory multiple myeloma
844413|NCT00003490|stage I multiple myeloma|stage i multiple myeloma
844414|NCT00003490|stage II multiple myeloma|stage ii multiple myeloma
844415|NCT00003490|stage III multiple myeloma|stage iii multiple myeloma
844416|NCT00003447|stage IIIB non-small cell lung cancer|stage iiib non-small cell lung cancer
844417|NCT00003447|stage IV non-small cell lung cancer|stage iv non-small cell lung cancer
844418|NCT00003365|colon cancer|colon cancer
844625|NCT00012350|plasma cell neoplasm|plasma cell neoplasm
844419|NCT00003322|stage III ovarian epithelial cancer|stage iii ovarian epithelial cancer
844420|NCT00003322|recurrent ovarian epithelial cancer|recurrent ovarian epithelial cancer
844421|NCT00003322|ovarian undifferentiated adenocarcinoma|ovarian undifferentiated adenocarcinoma
844422|NCT00003322|ovarian mixed epithelial carcinoma|ovarian mixed epithelial carcinoma
844423|NCT00003322|ovarian serous cystadenocarcinoma|ovarian serous cystadenocarcinoma
844424|NCT00003322|ovarian mucinous cystadenocarcinoma|ovarian mucinous cystadenocarcinoma
844425|NCT00003322|ovarian endometrioid adenocarcinoma|ovarian endometrioid adenocarcinoma
844426|NCT00003322|ovarian clear cell cystadenocarcinoma|ovarian clear cell cystadenocarcinoma
844427|NCT00003322|primary peritoneal cavity cancer|primary peritoneal cavity cancer
844428|NCT00003322|Brenner tumor|brenner tumor
844429|NCT00003289|Waldenstrom macroglobulinemia|waldenstrom macroglobulinemia
844430|NCT00003289|stage III chronic lymphocytic leukemia|stage iii chronic lymphocytic leukemia
844431|NCT00003289|stage IV chronic lymphocytic leukemia|stage iv chronic lymphocytic leukemia
844432|NCT00003289|refractory chronic lymphocytic leukemia|refractory chronic lymphocytic leukemia
844433|NCT00003289|unspecified adult solid tumor, protocol specific|unspecified adult solid tumor, protocol specific
844434|NCT00003289|refractory hairy cell leukemia|refractory hairy cell leukemia
844435|NCT00003289|stage III grade 1 follicular lymphoma|stage iii grade 1 follicular lymphoma
844436|NCT00003289|stage III grade 2 follicular lymphoma|stage iii grade 2 follicular lymphoma
844437|NCT00003289|stage III grade 3 follicular lymphoma|stage iii grade 3 follicular lymphoma
844438|NCT00003289|stage III adult diffuse small cleaved cell lymphoma|stage iii adult diffuse small cleaved cell lymphoma
844439|NCT00003289|stage III adult diffuse mixed cell lymphoma|stage iii adult diffuse mixed cell lymphoma
844440|NCT00003289|stage IV grade 1 follicular lymphoma|stage iv grade 1 follicular lymphoma
844441|NCT00003289|stage IV grade 2 follicular lymphoma|stage iv grade 2 follicular lymphoma
844442|NCT00003289|stage IV adult diffuse small cleaved cell lymphoma|stage iv adult diffuse small cleaved cell lymphoma
844443|NCT00003289|stage IV adult diffuse mixed cell lymphoma|stage iv adult diffuse mixed cell lymphoma
844444|NCT00003289|recurrent grade 1 follicular lymphoma|recurrent grade 1 follicular lymphoma
844445|NCT00003289|recurrent grade 2 follicular lymphoma|recurrent grade 2 follicular lymphoma
844446|NCT00003289|recurrent grade 3 follicular lymphoma|recurrent grade 3 follicular lymphoma
844447|NCT00003289|recurrent adult diffuse small cleaved cell lymphoma|recurrent adult diffuse small cleaved cell lymphoma
844448|NCT00003289|recurrent adult diffuse mixed cell lymphoma|recurrent adult diffuse mixed cell lymphoma
844449|NCT00003289|prolymphocytic leukemia|prolymphocytic leukemia
844450|NCT00003289|stage III mantle cell lymphoma|stage iii mantle cell lymphoma
844451|NCT00003289|stage IV mantle cell lymphoma|stage iv mantle cell lymphoma
844452|NCT00003289|recurrent mantle cell lymphoma|recurrent mantle cell lymphoma
844453|NCT00003289|recurrent marginal zone lymphoma|recurrent marginal zone lymphoma
844454|NCT00003289|recurrent small lymphocytic lymphoma|recurrent small lymphocytic lymphoma
844455|NCT00003289|stage III small lymphocytic lymphoma|stage iii small lymphocytic lymphoma
844456|NCT00003289|stage III marginal zone lymphoma|stage iii marginal zone lymphoma
844457|NCT00003289|stage IV small lymphocytic lymphoma|stage iv small lymphocytic lymphoma
844458|NCT00003289|stage IV marginal zone lymphoma|stage iv marginal zone lymphoma
844459|NCT00003289|extranodal marginal zone B-cell lymphoma of mucosa-associated lymphoid tissue|extranodal marginal zone b-cell lymphoma of mucosa-associated lymphoid tissue
844460|NCT00003289|nodal marginal zone B-cell lymphoma|nodal marginal zone b-cell lymphoma
844461|NCT00003289|splenic marginal zone lymphoma|splenic marginal zone lymphoma
844462|NCT00003250|unspecified adult solid tumor, protocol specific|unspecified adult solid tumor, protocol specific
844463|NCT00003101|adult oligodendroglioma|adult oligodendroglioma
844464|NCT00003101|adult anaplastic oligodendroglioma|adult anaplastic oligodendroglioma
844465|NCT00002880|Waldenstrom macroglobulinemia|waldenstrom macroglobulinemia
844466|NCT00002880|recurrent small lymphocytic lymphoma|recurrent small lymphocytic lymphoma
844467|NCT00002880|recurrent grade 1 follicular lymphoma|recurrent grade 1 follicular lymphoma
844468|NCT00002880|recurrent grade 2 follicular lymphoma|recurrent grade 2 follicular lymphoma
844469|NCT00002880|recurrent grade 3 follicular lymphoma|recurrent grade 3 follicular lymphoma
844470|NCT00002880|recurrent adult diffuse small cleaved cell lymphoma|recurrent adult diffuse small cleaved cell lymphoma
844471|NCT00002880|recurrent adult diffuse mixed cell lymphoma|recurrent adult diffuse mixed cell lymphoma
844472|NCT00002880|recurrent adult diffuse large cell lymphoma|recurrent adult diffuse large cell lymphoma
844473|NCT00002880|recurrent adult immunoblastic large cell lymphoma|recurrent adult immunoblastic large cell lymphoma
844474|NCT00002876|recurrent adult brain tumor|recurrent adult brain tumor
844475|NCT00002876|adult myxopapillary ependymoma|adult myxopapillary ependymoma
844476|NCT00002876|adult anaplastic ependymoma|adult anaplastic ependymoma
844477|NCT00002813|recurrent cervical cancer|recurrent cervical cancer
844478|NCT00002813|stage IVB cervical cancer|stage ivb cervical cancer
844479|NCT00002813|cervical squamous cell carcinoma|cervical squamous cell carcinoma
844480|NCT00002707|stage I breast cancer|stage i breast cancer
844481|NCT00002707|stage II breast cancer|stage ii breast cancer
844482|NCT00002707|stage IIIA breast cancer|stage iiia breast cancer
844483|NCT00002692|stage IV colon cancer|stage iv colon cancer
844484|NCT00002692|stage IV rectal cancer|stage iv rectal cancer
844485|NCT00002692|recurrent colon cancer|recurrent colon cancer
844488|NCT00002692|adenocarcinoma of the rectum|adenocarcinoma of the rectum
844489|NCT00002692|liver metastases|liver metastases
844493|NCT00002673|recurrent childhood acute lymphoblastic leukemia|recurrent childhood acute lymphoblastic leukemia
844494|NCT00002673|recurrent adult Hodgkin lymphoma|recurrent adult hodgkin lymphoma
844495|NCT00002673|recurrent cutaneous T-cell non-Hodgkin lymphoma|recurrent cutaneous t-cell non-hodgkin lymphoma
844496|NCT00002673|recurrent childhood rhabdomyosarcoma|recurrent childhood rhabdomyosarcoma
844497|NCT00002673|stage II ovarian epithelial cancer|stage ii ovarian epithelial cancer
844498|NCT00002673|stage III ovarian epithelial cancer|stage iii ovarian epithelial cancer
844499|NCT00002673|stage IV ovarian epithelial cancer|stage iv ovarian epithelial cancer
844500|NCT00002673|recurrent ovarian epithelial cancer|recurrent ovarian epithelial cancer
844501|NCT00002673|disseminated neuroblastoma|disseminated neuroblastoma
844502|NCT00002673|recurrent neuroblastoma|recurrent neuroblastoma
844503|NCT00002673|recurrent Wilms tumor and other childhood kidney tumors|recurrent wilms tumor and other childhood kidney tumors
844504|NCT00002673|stage I multiple myeloma|stage i multiple myeloma
844505|NCT00002673|stage II multiple myeloma|stage ii multiple myeloma
844506|NCT00002673|stage III multiple myeloma|stage iii multiple myeloma
844507|NCT00002673|recurrent childhood lymphoblastic lymphoma|recurrent childhood lymphoblastic lymphoma
844508|NCT00002673|stage III chronic lymphocytic leukemia|stage iii chronic lymphocytic leukemia
844509|NCT00002673|stage IV chronic lymphocytic leukemia|stage iv chronic lymphocytic leukemia
844510|NCT00002673|recurrent childhood acute myeloid leukemia|recurrent childhood acute myeloid leukemia
844511|NCT00002673|recurrent adult acute myeloid leukemia|recurrent adult acute myeloid leukemia
844512|NCT00002673|recurrent adult acute lymphoblastic leukemia|recurrent adult acute lymphoblastic leukemia
844513|NCT00002673|refractory chronic lymphocytic leukemia|refractory chronic lymphocytic leukemia
844514|NCT00002673|stage III malignant testicular germ cell tumor|stage iii malignant testicular germ cell tumor
844515|NCT00002673|recurrent malignant testicular germ cell tumor|recurrent malignant testicular germ cell tumor
844516|NCT00002673|chronic phase chronic myelogenous leukemia|chronic phase chronic myelogenous leukemia
844517|NCT00002673|accelerated phase chronic myelogenous leukemia|accelerated phase chronic myelogenous leukemia
844518|NCT00002673|blastic phase chronic myelogenous leukemia|blastic phase chronic myelogenous leukemia
844519|NCT00002673|adult acute myeloid leukemia in remission|adult acute myeloid leukemia in remission
844520|NCT00002673|adult acute lymphoblastic leukemia in remission|adult acute lymphoblastic leukemia in remission
844521|NCT00002673|childhood acute myeloid leukemia in remission|childhood acute myeloid leukemia in remission
844522|NCT00002673|childhood acute lymphoblastic leukemia in remission|childhood acute lymphoblastic leukemia in remission
844523|NCT00002673|chronic idiopathic myelofibrosis|chronic idiopathic myelofibrosis
844524|NCT00002673|childhood acute promyelocytic leukemia (M3)|childhood acute promyelocytic leukemia (m3)
844525|NCT00002673|testicular embryonal carcinoma|testicular embryonal carcinoma
844526|NCT00002673|testicular choriocarcinoma|testicular choriocarcinoma
844527|NCT00002673|testicular teratoma|testicular teratoma
844528|NCT00002673|testicular yolk sac tumor|testicular yolk sac tumor
844529|NCT00002673|testicular embryonal carcinoma and teratoma|testicular embryonal carcinoma and teratoma
844530|NCT00002673|testicular embryonal carcinoma and teratoma with seminoma|testicular embryonal carcinoma and teratoma with seminoma
844531|NCT00002673|testicular embryonal carcinoma and yolk sac tumor|testicular embryonal carcinoma and yolk sac tumor
844532|NCT00002673|testicular embryonal carcinoma and yolk sac tumor with seminoma|testicular embryonal carcinoma and yolk sac tumor with seminoma
844533|NCT00002673|testicular embryonal carcinoma and seminoma|testicular embryonal carcinoma and seminoma
844534|NCT00002673|testicular yolk sac tumor and teratoma|testicular yolk sac tumor and teratoma
844535|NCT00002673|testicular yolk sac tumor and teratoma with seminoma|testicular yolk sac tumor and teratoma with seminoma
844536|NCT00002673|testicular choriocarcinoma and yolk sac tumor|testicular choriocarcinoma and yolk sac tumor
844537|NCT00002673|testicular choriocarcinoma and embryonal carcinoma|testicular choriocarcinoma and embryonal carcinoma
844538|NCT00002673|testicular choriocarcinoma and teratoma|testicular choriocarcinoma and teratoma
844539|NCT00002673|testicular choriocarcinoma and seminoma|testicular choriocarcinoma and seminoma
844540|NCT00002673|refractory hairy cell leukemia|refractory hairy cell leukemia
844541|NCT00002673|recurrent/refractory childhood Hodgkin lymphoma|recurrent/refractory childhood hodgkin lymphoma
844542|NCT00002673|ovarian germ cell tumor|ovarian germ cell tumor
844543|NCT00002673|recurrent ovarian germ cell tumor|recurrent ovarian germ cell tumor
844544|NCT00002673|ovarian yolk sac tumor|ovarian yolk sac tumor
844545|NCT00002673|ovarian embryonal carcinoma|ovarian embryonal carcinoma
844546|NCT00002673|ovarian polyembryoma|ovarian polyembryoma
844547|NCT00002673|ovarian choriocarcinoma|ovarian choriocarcinoma
844548|NCT00002673|ovarian teratoma|ovarian teratoma
844549|NCT00002673|ovarian immature teratoma|ovarian immature teratoma
844550|NCT00002673|ovarian mature teratoma|ovarian mature teratoma
844551|NCT00002673|ovarian monodermal and highly specialized teratoma|ovarian monodermal and highly specialized teratoma
844552|NCT00002673|stage II adult lymphoblastic lymphoma|stage ii adult lymphoblastic lymphoma
844553|NCT00002673|stage II adult Burkitt lymphoma|stage ii adult burkitt lymphoma
844554|NCT00002673|stage III grade 1 follicular lymphoma|stage iii grade 1 follicular lymphoma
859776|NCT00063258|Paclitaxel|paclitaxel
844555|NCT00002673|stage III grade 2 follicular lymphoma|stage iii grade 2 follicular lymphoma
844556|NCT00002673|stage III grade 3 follicular lymphoma|stage iii grade 3 follicular lymphoma
844557|NCT00002673|stage III adult diffuse small cleaved cell lymphoma|stage iii adult diffuse small cleaved cell lymphoma
844626|NCT00010088|stage II pancreatic cancer|stage ii pancreatic cancer
844558|NCT00002673|stage III adult diffuse mixed cell lymphoma|stage iii adult diffuse mixed cell lymphoma
844559|NCT00002673|stage III adult diffuse large cell lymphoma|stage iii adult diffuse large cell lymphoma
844560|NCT00002673|stage III adult immunoblastic large cell lymphoma|stage iii adult immunoblastic large cell lymphoma
844561|NCT00002673|stage III adult lymphoblastic lymphoma|stage iii adult lymphoblastic lymphoma
844562|NCT00002673|stage III adult Burkitt lymphoma|stage iii adult burkitt lymphoma
844563|NCT00002673|stage IV grade 1 follicular lymphoma|stage iv grade 1 follicular lymphoma
844564|NCT00002673|stage IV grade 2 follicular lymphoma|stage iv grade 2 follicular lymphoma
844565|NCT00002673|stage IV grade 3 follicular lymphoma|stage iv grade 3 follicular lymphoma
844566|NCT00002673|stage IV adult diffuse small cleaved cell lymphoma|stage iv adult diffuse small cleaved cell lymphoma
844567|NCT00002673|stage IV adult diffuse mixed cell lymphoma|stage iv adult diffuse mixed cell lymphoma
844568|NCT00002673|stage IV adult diffuse large cell lymphoma|stage iv adult diffuse large cell lymphoma
844569|NCT00002673|stage IV adult immunoblastic large cell lymphoma|stage iv adult immunoblastic large cell lymphoma
844570|NCT00002673|stage IV adult lymphoblastic lymphoma|stage iv adult lymphoblastic lymphoma
844571|NCT00002673|stage IV adult Burkitt lymphoma|stage iv adult burkitt lymphoma
844572|NCT00002673|recurrent grade 1 follicular lymphoma|recurrent grade 1 follicular lymphoma
844573|NCT00002673|recurrent grade 2 follicular lymphoma|recurrent grade 2 follicular lymphoma
844574|NCT00002673|recurrent grade 3 follicular lymphoma|recurrent grade 3 follicular lymphoma
844575|NCT00002673|recurrent adult diffuse small cleaved cell lymphoma|recurrent adult diffuse small cleaved cell lymphoma
844576|NCT00002673|recurrent adult diffuse mixed cell lymphoma|recurrent adult diffuse mixed cell lymphoma
844577|NCT00002673|recurrent adult diffuse large cell lymphoma|recurrent adult diffuse large cell lymphoma
844578|NCT00002673|recurrent adult immunoblastic large cell lymphoma|recurrent adult immunoblastic large cell lymphoma
844579|NCT00002673|recurrent adult lymphoblastic lymphoma|recurrent adult lymphoblastic lymphoma
844580|NCT00002673|recurrent adult Burkitt lymphoma|recurrent adult burkitt lymphoma
844581|NCT00002673|poor prognosis metastatic gestational trophoblastic tumor|poor prognosis metastatic gestational trophoblastic tumor
844582|NCT00002673|previously treated myelodysplastic syndromes|previously treated myelodysplastic syndromes
844583|NCT00002673|secondary myelodysplastic syndromes|secondary myelodysplastic syndromes
844584|NCT00002673|infection|infection
844585|NCT00002673|recurrent childhood small noncleaved cell lymphoma|recurrent childhood small noncleaved cell lymphoma
844586|NCT00002673|recurrent childhood large cell lymphoma|recurrent childhood large cell lymphoma
844587|NCT00002673|noncontiguous stage II grade 1 follicular lymphoma|noncontiguous stage ii grade 1 follicular lymphoma
844588|NCT00002673|noncontiguous stage II grade 2 follicular lymphoma|noncontiguous stage ii grade 2 follicular lymphoma
844589|NCT00002673|noncontiguous stage II grade 3 follicular lymphoma|noncontiguous stage ii grade 3 follicular lymphoma
844590|NCT00002673|noncontiguous stage II adult diffuse small cleaved cell lymphoma|noncontiguous stage ii adult diffuse small cleaved cell lymphoma
844591|NCT00002673|noncontiguous stage II mantle cell lymphoma|noncontiguous stage ii mantle cell lymphoma
844592|NCT00002673|noncontiguous stage II adult diffuse mixed cell lymphoma|noncontiguous stage ii adult diffuse mixed cell lymphoma
844593|NCT00002673|noncontiguous stage II adult immunoblastic large cell lymphoma|noncontiguous stage ii adult immunoblastic large cell lymphoma
844594|NCT00002673|noncontiguous stage II adult diffuse large cell lymphoma|noncontiguous stage ii adult diffuse large cell lymphoma
844595|NCT00002673|noncontiguous stage II adult Burkitt lymphoma|noncontiguous stage ii adult burkitt lymphoma
844596|NCT00002673|noncontiguous stage II adult lymphoblastic lymphoma|noncontiguous stage ii adult lymphoblastic lymphoma
844597|NCT00002673|stage III mantle cell lymphoma|stage iii mantle cell lymphoma
844598|NCT00002673|stage IV mantle cell lymphoma|stage iv mantle cell lymphoma
844599|NCT00002673|previously treated childhood rhabdomyosarcoma|previously treated childhood rhabdomyosarcoma
844600|NCT00002673|noncontiguous stage II small lymphocytic lymphoma|noncontiguous stage ii small lymphocytic lymphoma
844601|NCT00002673|noncontiguous stage II marginal zone lymphoma|noncontiguous stage ii marginal zone lymphoma
844602|NCT00002673|recurrent marginal zone lymphoma|recurrent marginal zone lymphoma
844603|NCT00002673|recurrent small lymphocytic lymphoma|recurrent small lymphocytic lymphoma
844604|NCT00002673|stage III small lymphocytic lymphoma|stage iii small lymphocytic lymphoma
844605|NCT00002673|stage III marginal zone lymphoma|stage iii marginal zone lymphoma
844606|NCT00002673|stage IV small lymphocytic lymphoma|stage iv small lymphocytic lymphoma
844607|NCT00002673|stage IV marginal zone lymphoma|stage iv marginal zone lymphoma
844608|NCT00002673|extranodal marginal zone B-cell lymphoma of mucosa-associated lymphoid tissue|extranodal marginal zone b-cell lymphoma of mucosa-associated lymphoid tissue
844609|NCT00002673|nodal marginal zone B-cell lymphoma|nodal marginal zone b-cell lymphoma
844610|NCT00002673|splenic marginal zone lymphoma|splenic marginal zone lymphoma
844611|NCT00002673|childhood myelodysplastic syndromes|childhood myelodysplastic syndromes
844612|NCT00002599|stage I multiple myeloma|stage i multiple myeloma
844613|NCT00002599|stage II multiple myeloma|stage ii multiple myeloma
844614|NCT00002599|stage III multiple myeloma|stage iii multiple myeloma
844615|NCT00083330|Healthy|healthy
844616|NCT00083330|T Cells|t cells
844617|NCT00083330|Immunity|immunity
844618|NCT00083330|Healthy Volunteer|healthy volunteer
844621|NCT00083278|Stage IV adenocarcinoma of the breast|stage iv adenocarcinoma of the breast
844622|NCT00012350|refractory multiple myeloma|refractory multiple myeloma
844623|NCT00012350|stage II multiple myeloma|stage ii multiple myeloma
876630|NCT00051142|POAG|poag
844627|NCT00010088|stage III pancreatic cancer|stage iii pancreatic cancer
844628|NCT00010088|unresectable extrahepatic bile duct cancer|unresectable extrahepatic bile duct cancer
844629|NCT00010088|adenocarcinoma of the extrahepatic bile duct|adenocarcinoma of the extrahepatic bile duct
844630|NCT00010088|adenocarcinoma of the pancreas|adenocarcinoma of the pancreas
844631|NCT00010088|stage IV pancreatic cancer|stage iv pancreatic cancer
844632|NCT00006220|stage III adult Hodgkin lymphoma|stage iii adult hodgkin lymphoma
844633|NCT00006220|stage IV adult Hodgkin lymphoma|stage iv adult hodgkin lymphoma
844634|NCT00006220|recurrent adult Hodgkin lymphoma|recurrent adult hodgkin lymphoma
844635|NCT00006220|refractory multiple myeloma|refractory multiple myeloma
844636|NCT00006220|recurrent adult acute myeloid leukemia|recurrent adult acute myeloid leukemia
844637|NCT00006220|recurrent adult acute lymphoblastic leukemia|recurrent adult acute lymphoblastic leukemia
844638|NCT00006220|relapsing chronic myelogenous leukemia|relapsing chronic myelogenous leukemia
844639|NCT00006220|blastic phase chronic myelogenous leukemia|blastic phase chronic myelogenous leukemia
844640|NCT00006220|refractory anemia with excess blasts|refractory anemia with excess blasts
844641|NCT00006220|refractory anemia with excess blasts in transformation|refractory anemia with excess blasts in transformation
844642|NCT00006220|stage III grade 3 follicular lymphoma|stage iii grade 3 follicular lymphoma
844643|NCT00006220|stage III adult diffuse small cleaved cell lymphoma|stage iii adult diffuse small cleaved cell lymphoma
844644|NCT00006220|stage III adult diffuse mixed cell lymphoma|stage iii adult diffuse mixed cell lymphoma
844645|NCT00006220|stage III adult diffuse large cell lymphoma|stage iii adult diffuse large cell lymphoma
844646|NCT00006220|stage III adult immunoblastic large cell lymphoma|stage iii adult immunoblastic large cell lymphoma
844647|NCT00006220|stage III adult lymphoblastic lymphoma|stage iii adult lymphoblastic lymphoma
844648|NCT00006220|stage III adult Burkitt lymphoma|stage iii adult burkitt lymphoma
844649|NCT00006220|stage IV grade 3 follicular lymphoma|stage iv grade 3 follicular lymphoma
844650|NCT00006220|stage IV adult diffuse small cleaved cell lymphoma|stage iv adult diffuse small cleaved cell lymphoma
844651|NCT00006220|stage IV adult diffuse mixed cell lymphoma|stage iv adult diffuse mixed cell lymphoma
844652|NCT00006220|stage IV adult diffuse large cell lymphoma|stage iv adult diffuse large cell lymphoma
844653|NCT00006220|stage IV adult immunoblastic large cell lymphoma|stage iv adult immunoblastic large cell lymphoma
844654|NCT00006220|stage IV adult lymphoblastic lymphoma|stage iv adult lymphoblastic lymphoma
844655|NCT00006220|stage IV adult Burkitt lymphoma|stage iv adult burkitt lymphoma
844656|NCT00006220|recurrent grade 3 follicular lymphoma|recurrent grade 3 follicular lymphoma
844657|NCT00006220|recurrent adult diffuse small cleaved cell lymphoma|recurrent adult diffuse small cleaved cell lymphoma
844658|NCT00006220|recurrent adult diffuse mixed cell lymphoma|recurrent adult diffuse mixed cell lymphoma
844659|NCT00006220|recurrent adult diffuse large cell lymphoma|recurrent adult diffuse large cell lymphoma
844660|NCT00006220|recurrent adult immunoblastic large cell lymphoma|recurrent adult immunoblastic large cell lymphoma
844661|NCT00006220|recurrent adult lymphoblastic lymphoma|recurrent adult lymphoblastic lymphoma
844662|NCT00006220|recurrent adult Burkitt lymphoma|recurrent adult burkitt lymphoma
844663|NCT00006220|previously treated myelodysplastic syndromes|previously treated myelodysplastic syndromes
844664|NCT00006220|stage III mantle cell lymphoma|stage iii mantle cell lymphoma
844665|NCT00006220|stage IV mantle cell lymphoma|stage iv mantle cell lymphoma
844666|NCT00006220|recurrent mantle cell lymphoma|recurrent mantle cell lymphoma
844667|NCT00006220|childhood myelodysplastic syndromes|childhood myelodysplastic syndromes
844668|NCT00005814|stage III squamous cell carcinoma of the lip and oral cavity|stage iii squamous cell carcinoma of the lip and oral cavity
844669|NCT00005814|stage IV squamous cell carcinoma of the lip and oral cavity|stage iv squamous cell carcinoma of the lip and oral cavity
844670|NCT00005814|recurrent squamous cell carcinoma of the lip and oral cavity|recurrent squamous cell carcinoma of the lip and oral cavity
844671|NCT00005814|stage III squamous cell carcinoma of the oropharynx|stage iii squamous cell carcinoma of the oropharynx
844672|NCT00005814|stage IV squamous cell carcinoma of the oropharynx|stage iv squamous cell carcinoma of the oropharynx
844673|NCT00005814|recurrent squamous cell carcinoma of the oropharynx|recurrent squamous cell carcinoma of the oropharynx
844674|NCT00005814|stage III squamous cell carcinoma of the hypopharynx|stage iii squamous cell carcinoma of the hypopharynx
844675|NCT00005814|stage IV squamous cell carcinoma of the hypopharynx|stage iv squamous cell carcinoma of the hypopharynx
844676|NCT00005814|recurrent squamous cell carcinoma of the hypopharynx|recurrent squamous cell carcinoma of the hypopharynx
844677|NCT00005814|stage III squamous cell carcinoma of the larynx|stage iii squamous cell carcinoma of the larynx
844678|NCT00005814|stage IV squamous cell carcinoma of the larynx|stage iv squamous cell carcinoma of the larynx
844679|NCT00005814|recurrent squamous cell carcinoma of the larynx|recurrent squamous cell carcinoma of the larynx
844680|NCT00005814|stage III squamous cell carcinoma of the paranasal sinus and nasal cavity|stage iii squamous cell carcinoma of the paranasal sinus and nasal cavity
844681|NCT00005814|stage IV squamous cell carcinoma of the paranasal sinus and nasal cavity|stage iv squamous cell carcinoma of the paranasal sinus and nasal cavity
844749|NCT00004132|recurrent grade 1 follicular lymphoma|recurrent grade 1 follicular lymphoma
844682|NCT00005814|recurrent squamous cell carcinoma of the paranasal sinus and nasal cavity|recurrent squamous cell carcinoma of the paranasal sinus and nasal cavity
844683|NCT00005581|stage II breast cancer|stage ii breast cancer
844684|NCT00005581|stage IIIA breast cancer|stage iiia breast cancer
844685|NCT00005581|stage IIIB breast cancer|stage iiib breast cancer
844686|NCT00004880|stage IV renal cell cancer|stage iv renal cell cancer
876631|NCT00051142|OAG|oag
844687|NCT00004880|recurrent renal cell cancer|recurrent renal cell cancer
844688|NCT00004211|stage IV prostate cancer|stage iv prostate cancer
844689|NCT00004211|recurrent prostate cancer|recurrent prostate cancer
844690|NCT00004156|stage I breast cancer|stage i breast cancer
844691|NCT00004156|stage II breast cancer|stage ii breast cancer
844692|NCT00004156|stage IV breast cancer|stage iv breast cancer
844693|NCT00004156|stage IIIA breast cancer|stage iiia breast cancer
844694|NCT00004156|recurrent breast cancer|recurrent breast cancer
844695|NCT00004156|stage IIIB breast cancer|stage iiib breast cancer
844696|NCT00004132|stage I adult Hodgkin lymphoma|stage i adult hodgkin lymphoma
844697|NCT00004132|stage II adult Hodgkin lymphoma|stage ii adult hodgkin lymphoma
844698|NCT00004132|stage III adult Hodgkin lymphoma|stage iii adult hodgkin lymphoma
844699|NCT00004132|stage IV adult Hodgkin lymphoma|stage iv adult hodgkin lymphoma
844700|NCT00004132|recurrent adult Hodgkin lymphoma|recurrent adult hodgkin lymphoma
844701|NCT00004132|childhood Burkitt lymphoma|childhood burkitt lymphoma
844702|NCT00004132|refractory multiple myeloma|refractory multiple myeloma
844703|NCT00004132|stage 0 chronic lymphocytic leukemia|stage 0 chronic lymphocytic leukemia
844704|NCT00004132|stage I multiple myeloma|stage i multiple myeloma
844705|NCT00004132|stage II multiple myeloma|stage ii multiple myeloma
844706|NCT00004132|stage III multiple myeloma|stage iii multiple myeloma
844707|NCT00004132|stage IV childhood lymphoblastic lymphoma|stage iv childhood lymphoblastic lymphoma
844708|NCT00004132|stage I chronic lymphocytic leukemia|stage i chronic lymphocytic leukemia
844709|NCT00004132|stage II chronic lymphocytic leukemia|stage ii chronic lymphocytic leukemia
844710|NCT00004132|stage III chronic lymphocytic leukemia|stage iii chronic lymphocytic leukemia
844711|NCT00004132|stage IV chronic lymphocytic leukemia|stage iv chronic lymphocytic leukemia
844712|NCT00004132|recurrent adult acute myeloid leukemia|recurrent adult acute myeloid leukemia
844713|NCT00004132|recurrent adult acute lymphoblastic leukemia|recurrent adult acute lymphoblastic leukemia
844714|NCT00004132|refractory chronic lymphocytic leukemia|refractory chronic lymphocytic leukemia
844715|NCT00004132|blastic phase chronic myelogenous leukemia|blastic phase chronic myelogenous leukemia
844716|NCT00004132|untreated adult acute lymphoblastic leukemia|untreated adult acute lymphoblastic leukemia
844717|NCT00004132|untreated adult acute myeloid leukemia|untreated adult acute myeloid leukemia
844718|NCT00004132|untreated childhood acute myeloid leukemia and other myeloid malignancies|untreated childhood acute myeloid leukemia and other myeloid malignancies
844719|NCT00004132|untreated childhood acute lymphoblastic leukemia|untreated childhood acute lymphoblastic leukemia
844720|NCT00004132|oral complications|oral complications
844721|NCT00004132|stage IV childhood Hodgkin lymphoma|stage iv childhood hodgkin lymphoma
844722|NCT00004132|stage I grade 1 follicular lymphoma|stage i grade 1 follicular lymphoma
844723|NCT00004132|stage I grade 2 follicular lymphoma|stage i grade 2 follicular lymphoma
844724|NCT00004132|stage I grade 3 follicular lymphoma|stage i grade 3 follicular lymphoma
844725|NCT00004132|stage I adult diffuse small cleaved cell lymphoma|stage i adult diffuse small cleaved cell lymphoma
844726|NCT00004132|stage I adult diffuse mixed cell lymphoma|stage i adult diffuse mixed cell lymphoma
844727|NCT00004132|stage I adult diffuse large cell lymphoma|stage i adult diffuse large cell lymphoma
844728|NCT00004132|stage I adult immunoblastic large cell lymphoma|stage i adult immunoblastic large cell lymphoma
844729|NCT00004132|stage I adult lymphoblastic lymphoma|stage i adult lymphoblastic lymphoma
844730|NCT00004132|stage I adult Burkitt lymphoma|stage i adult burkitt lymphoma
844731|NCT00004132|stage III grade 1 follicular lymphoma|stage iii grade 1 follicular lymphoma
844732|NCT00004132|stage III grade 2 follicular lymphoma|stage iii grade 2 follicular lymphoma
844733|NCT00004132|stage III grade 3 follicular lymphoma|stage iii grade 3 follicular lymphoma
844734|NCT00004132|stage III adult diffuse small cleaved cell lymphoma|stage iii adult diffuse small cleaved cell lymphoma
844735|NCT00004132|stage III adult diffuse mixed cell lymphoma|stage iii adult diffuse mixed cell lymphoma
844736|NCT00004132|stage III adult diffuse large cell lymphoma|stage iii adult diffuse large cell lymphoma
844737|NCT00004132|stage III adult immunoblastic large cell lymphoma|stage iii adult immunoblastic large cell lymphoma
844738|NCT00004132|stage III adult lymphoblastic lymphoma|stage iii adult lymphoblastic lymphoma
844739|NCT00004132|stage III adult Burkitt lymphoma|stage iii adult burkitt lymphoma
844740|NCT00004132|stage IV grade 1 follicular lymphoma|stage iv grade 1 follicular lymphoma
844741|NCT00004132|stage IV grade 2 follicular lymphoma|stage iv grade 2 follicular lymphoma
844742|NCT00004132|stage IV grade 3 follicular lymphoma|stage iv grade 3 follicular lymphoma
844743|NCT00004132|stage IV adult diffuse small cleaved cell lymphoma|stage iv adult diffuse small cleaved cell lymphoma
844744|NCT00004132|stage IV adult diffuse mixed cell lymphoma|stage iv adult diffuse mixed cell lymphoma
844745|NCT00004132|stage IV adult diffuse large cell lymphoma|stage iv adult diffuse large cell lymphoma
844746|NCT00004132|stage IV adult immunoblastic large cell lymphoma|stage iv adult immunoblastic large cell lymphoma
844747|NCT00004132|stage IV adult lymphoblastic lymphoma|stage iv adult lymphoblastic lymphoma
844748|NCT00004132|stage IV adult Burkitt lymphoma|stage iv adult burkitt lymphoma
844882|NCT00003439|recurrent anal cancer|recurrent anal cancer
844750|NCT00004132|recurrent grade 2 follicular lymphoma|recurrent grade 2 follicular lymphoma
844751|NCT00004132|recurrent grade 3 follicular lymphoma|recurrent grade 3 follicular lymphoma
844752|NCT00004132|recurrent adult diffuse small cleaved cell lymphoma|recurrent adult diffuse small cleaved cell lymphoma
844753|NCT00004132|recurrent adult diffuse mixed cell lymphoma|recurrent adult diffuse mixed cell lymphoma
876632|NCT00051142|OHT|oht
844754|NCT00004132|recurrent adult diffuse large cell lymphoma|recurrent adult diffuse large cell lymphoma
844755|NCT00004132|recurrent adult immunoblastic large cell lymphoma|recurrent adult immunoblastic large cell lymphoma
844756|NCT00004132|recurrent adult lymphoblastic lymphoma|recurrent adult lymphoblastic lymphoma
844757|NCT00004132|recurrent adult Burkitt lymphoma|recurrent adult burkitt lymphoma
844758|NCT00004132|primary central nervous system non-Hodgkin lymphoma|primary central nervous system non-hodgkin lymphoma
844759|NCT00004132|drug/agent toxicity by tissue/organ|drug/agent toxicity by tissue/organ
844760|NCT00004132|radiation toxicity|radiation toxicity
844761|NCT00004132|stage IV childhood small noncleaved cell lymphoma|stage iv childhood small noncleaved cell lymphoma
844762|NCT00004132|stage IV childhood large cell lymphoma|stage iv childhood large cell lymphoma
844763|NCT00004132|stage I mantle cell lymphoma|stage i mantle cell lymphoma
844764|NCT00004132|contiguous stage II grade 1 follicular lymphoma|contiguous stage ii grade 1 follicular lymphoma
844765|NCT00004132|contiguous stage II grade 2 follicular lymphoma|contiguous stage ii grade 2 follicular lymphoma
844766|NCT00004132|contiguous stage II grade 3 follicular lymphoma|contiguous stage ii grade 3 follicular lymphoma
844767|NCT00004132|contiguous stage II adult diffuse small cleaved cell lymphoma|contiguous stage ii adult diffuse small cleaved cell lymphoma
844768|NCT00004132|contiguous stage II mantle cell lymphoma|contiguous stage ii mantle cell lymphoma
844769|NCT00004132|contiguous stage II adult diffuse mixed cell lymphoma|contiguous stage ii adult diffuse mixed cell lymphoma
844770|NCT00004132|contiguous stage II adult immunoblastic large cell lymphoma|contiguous stage ii adult immunoblastic large cell lymphoma
844771|NCT00004132|contiguous stage II adult diffuse large cell lymphoma|contiguous stage ii adult diffuse large cell lymphoma
844772|NCT00004132|contiguous stage II adult Burkitt lymphoma|contiguous stage ii adult burkitt lymphoma
844773|NCT00004132|contiguous stage II adult lymphoblastic lymphoma|contiguous stage ii adult lymphoblastic lymphoma
844774|NCT00004132|noncontiguous stage II grade 1 follicular lymphoma|noncontiguous stage ii grade 1 follicular lymphoma
844775|NCT00004132|noncontiguous stage II grade 2 follicular lymphoma|noncontiguous stage ii grade 2 follicular lymphoma
844776|NCT00004132|noncontiguous stage II grade 3 follicular lymphoma|noncontiguous stage ii grade 3 follicular lymphoma
844777|NCT00004132|noncontiguous stage II adult diffuse small cleaved cell lymphoma|noncontiguous stage ii adult diffuse small cleaved cell lymphoma
844778|NCT00004132|noncontiguous stage II mantle cell lymphoma|noncontiguous stage ii mantle cell lymphoma
844779|NCT00004132|noncontiguous stage II adult diffuse mixed cell lymphoma|noncontiguous stage ii adult diffuse mixed cell lymphoma
844780|NCT00004132|noncontiguous stage II adult immunoblastic large cell lymphoma|noncontiguous stage ii adult immunoblastic large cell lymphoma
844781|NCT00004132|noncontiguous stage II adult diffuse large cell lymphoma|noncontiguous stage ii adult diffuse large cell lymphoma
844782|NCT00004132|noncontiguous stage II adult Burkitt lymphoma|noncontiguous stage ii adult burkitt lymphoma
844783|NCT00004132|noncontiguous stage II adult lymphoblastic lymphoma|noncontiguous stage ii adult lymphoblastic lymphoma
844784|NCT00004132|stage III mantle cell lymphoma|stage iii mantle cell lymphoma
844785|NCT00004132|stage IV mantle cell lymphoma|stage iv mantle cell lymphoma
844786|NCT00004132|recurrent mantle cell lymphoma|recurrent mantle cell lymphoma
844787|NCT00004132|anaplastic large cell lymphoma|anaplastic large cell lymphoma
844788|NCT00004132|noncontiguous stage II small lymphocytic lymphoma|noncontiguous stage ii small lymphocytic lymphoma
844789|NCT00004132|noncontiguous stage II marginal zone lymphoma|noncontiguous stage ii marginal zone lymphoma
844790|NCT00004132|recurrent marginal zone lymphoma|recurrent marginal zone lymphoma
844791|NCT00004132|recurrent small lymphocytic lymphoma|recurrent small lymphocytic lymphoma
844792|NCT00004132|stage I marginal zone lymphoma|stage i marginal zone lymphoma
844793|NCT00004132|stage I small lymphocytic lymphoma|stage i small lymphocytic lymphoma
844794|NCT00004132|stage III small lymphocytic lymphoma|stage iii small lymphocytic lymphoma
844795|NCT00004132|stage III marginal zone lymphoma|stage iii marginal zone lymphoma
844796|NCT00004132|stage IV small lymphocytic lymphoma|stage iv small lymphocytic lymphoma
844797|NCT00004132|stage IV marginal zone lymphoma|stage iv marginal zone lymphoma
844798|NCT00004132|contiguous stage II marginal zone lymphoma|contiguous stage ii marginal zone lymphoma
844799|NCT00004132|contiguous stage II small lymphocytic lymphoma|contiguous stage ii small lymphocytic lymphoma
844800|NCT00004132|extranodal marginal zone B-cell lymphoma of mucosa-associated lymphoid tissue|extranodal marginal zone b-cell lymphoma of mucosa-associated lymphoid tissue
844801|NCT00004132|nodal marginal zone B-cell lymphoma|nodal marginal zone b-cell lymphoma
844802|NCT00004132|splenic marginal zone lymphoma|splenic marginal zone lymphoma
844803|NCT00004073|adult glioblastoma|adult glioblastoma
844804|NCT00004073|adult giant cell glioblastoma|adult giant cell glioblastoma
844805|NCT00004073|adult gliosarcoma|adult gliosarcoma
844806|NCT00004056|untreated childhood acute myeloid leukemia and other myeloid malignancies|untreated childhood acute myeloid leukemia and other myeloid malignancies
844807|NCT00004056|childhood acute monoblastic leukemia and acute monocytic leukemia (M5)|childhood acute monoblastic leukemia and acute monocytic leukemia (m5)
844808|NCT00004056|childhood acute myeloblastic leukemia without maturation (M1)|childhood acute myeloblastic leukemia without maturation (m1)
844809|NCT00004056|childhood acute myeloblastic leukemia with maturation (M2)|childhood acute myeloblastic leukemia with maturation (m2)
844810|NCT00004056|childhood acute myelomonocytic leukemia (M4)|childhood acute myelomonocytic leukemia (m4)
844811|NCT00004056|childhood acute erythroleukemia (M6)|childhood acute erythroleukemia (m6)
844812|NCT00004056|childhood acute megakaryocytic leukemia (M7)|childhood acute megakaryocytic leukemia (m7)
844886|NCT00003439|recurrent gastrointestinal carcinoid tumor|recurrent gastrointestinal carcinoid tumor
844813|NCT00004056|childhood acute minimally differentiated myeloid leukemia (M0)|childhood acute minimally differentiated myeloid leukemia (m0)
844814|NCT00004051|unspecified adult solid tumor, protocol specific|unspecified adult solid tumor, protocol specific
844815|NCT00004038|stage I breast cancer|stage i breast cancer
844816|NCT00004038|stage II breast cancer|stage ii breast cancer
844817|NCT00004038|stage IV breast cancer|stage iv breast cancer
844818|NCT00004038|stage IIIA breast cancer|stage iiia breast cancer
844819|NCT00004038|recurrent breast cancer|recurrent breast cancer
844820|NCT00004038|stage IIIB breast cancer|stage iiib breast cancer
844821|NCT00003924|recurrent adult Hodgkin lymphoma|recurrent adult hodgkin lymphoma
844822|NCT00003924|Waldenström macroglobulinemia|waldenström macroglobulinemia
844823|NCT00003924|recurrent grade 1 follicular lymphoma|recurrent grade 1 follicular lymphoma
844824|NCT00003924|recurrent grade 2 follicular lymphoma|recurrent grade 2 follicular lymphoma
844825|NCT00003924|recurrent grade 3 follicular lymphoma|recurrent grade 3 follicular lymphoma
844826|NCT00003924|recurrent adult diffuse small cleaved cell lymphoma|recurrent adult diffuse small cleaved cell lymphoma
844827|NCT00003924|recurrent adult diffuse mixed cell lymphoma|recurrent adult diffuse mixed cell lymphoma
844828|NCT00003924|recurrent adult diffuse large cell lymphoma|recurrent adult diffuse large cell lymphoma
844829|NCT00003924|recurrent adult immunoblastic large cell lymphoma|recurrent adult immunoblastic large cell lymphoma
844830|NCT00003924|recurrent adult lymphoblastic lymphoma|recurrent adult lymphoblastic lymphoma
844831|NCT00003924|recurrent adult Burkitt lymphoma|recurrent adult burkitt lymphoma
844832|NCT00003924|recurrent mantle cell lymphoma|recurrent mantle cell lymphoma
844833|NCT00003924|recurrent marginal zone lymphoma|recurrent marginal zone lymphoma
844834|NCT00003924|recurrent small lymphocytic lymphoma|recurrent small lymphocytic lymphoma
844835|NCT00003924|extranodal marginal zone B-cell lymphoma of mucosa-associated lymphoid tissue|extranodal marginal zone b-cell lymphoma of mucosa-associated lymphoid tissue
844836|NCT00003924|nodal marginal zone B-cell lymphoma|nodal marginal zone b-cell lymphoma
844837|NCT00003924|splenic marginal zone lymphoma|splenic marginal zone lymphoma
844838|NCT00003876|recurrent adult brain tumor|recurrent adult brain tumor
844839|NCT00003876|adult brain stem glioma|adult brain stem glioma
844840|NCT00003876|adult glioblastoma|adult glioblastoma
844841|NCT00003876|adult anaplastic astrocytoma|adult anaplastic astrocytoma
844842|NCT00003876|adult anaplastic oligodendroglioma|adult anaplastic oligodendroglioma
844843|NCT00003876|adult mixed glioma|adult mixed glioma
844844|NCT00003876|adult giant cell glioblastoma|adult giant cell glioblastoma
844845|NCT00003876|adult gliosarcoma|adult gliosarcoma
844846|NCT00003801|long-term effects secondary to cancer therapy in children|long-term effects secondary to cancer therapy in children
844847|NCT00003801|previously treated childhood rhabdomyosarcoma|previously treated childhood rhabdomyosarcoma
844848|NCT00003731|adult oligodendroglioma|adult oligodendroglioma
844849|NCT00003731|adult mixed glioma|adult mixed glioma
844850|NCT00003700|untreated adult acute lymphoblastic leukemia|untreated adult acute lymphoblastic leukemia
844851|NCT00003700|L1 adult acute lymphoblastic leukemia|l1 adult acute lymphoblastic leukemia
844852|NCT00003700|L2 adult acute lymphoblastic leukemia|l2 adult acute lymphoblastic leukemia
844853|NCT00003698|unspecified adult solid tumor, protocol specific|unspecified adult solid tumor, protocol specific
844854|NCT00003697|unspecified adult solid tumor, protocol specific|unspecified adult solid tumor, protocol specific
844855|NCT00003685|stage III non-small cell lung cancer|stage iii non-small cell lung cancer
844856|NCT00003685|recurrent non-small cell lung cancer|recurrent non-small cell lung cancer
844857|NCT00003685|squamous cell lung cancer|squamous cell lung cancer
844858|NCT00003685|large cell lung cancer|large cell lung cancer
844859|NCT00003685|stage IV non-small cell lung cancer|stage iv non-small cell lung cancer
844860|NCT00003685|adenocarcinoma of the lung|adenocarcinoma of the lung
844861|NCT00003685|adenosquamous cell lung cancer|adenosquamous cell lung cancer
844862|NCT00003685|fatigue|fatigue
844863|NCT00003685|nausea and vomiting|nausea and vomiting
844864|NCT00003685|pain|pain
844865|NCT00003685|pulmonary complications|pulmonary complications
844866|NCT00003685|quality of life|quality of life
844867|NCT00003640|stage II bladder cancer|stage ii bladder cancer
844868|NCT00003640|stage III bladder cancer|stage iii bladder cancer
844869|NCT00003640|transitional cell carcinoma of the bladder|transitional cell carcinoma of the bladder
844870|NCT00003575|AIDS-related peripheral/systemic lymphoma|aids-related peripheral/systemic lymphoma
844871|NCT00003575|AIDS-related diffuse large cell lymphoma|aids-related diffuse large cell lymphoma
844872|NCT00003575|AIDS-related immunoblastic large cell lymphoma|aids-related immunoblastic large cell lymphoma
844873|NCT00003575|AIDS-related small noncleaved cell lymphoma|aids-related small noncleaved cell lymphoma
844874|NCT00003439|stage IV colon cancer|stage iv colon cancer
844875|NCT00003439|stage IV gastric cancer|stage iv gastric cancer
844876|NCT00003439|recurrent gastric cancer|recurrent gastric cancer
844877|NCT00003439|recurrent pancreatic cancer|recurrent pancreatic cancer
844878|NCT00003439|stage IV rectal cancer|stage iv rectal cancer
844879|NCT00003439|recurrent colon cancer|recurrent colon cancer
844880|NCT00003439|recurrent rectal cancer|recurrent rectal cancer
844881|NCT00003439|stage IV anal cancer|stage iv anal cancer
844883|NCT00003439|stage IV ovarian epithelial cancer|stage iv ovarian epithelial cancer
844884|NCT00003439|recurrent ovarian epithelial cancer|recurrent ovarian epithelial cancer
844885|NCT00003439|metastatic gastrointestinal carcinoid tumor|metastatic gastrointestinal carcinoid tumor
844887|NCT00003439|advanced adult primary liver cancer|advanced adult primary liver cancer
844888|NCT00003439|recurrent adult primary liver cancer|recurrent adult primary liver cancer
844889|NCT00003439|stage IV endometrial carcinoma|stage iv endometrial carcinoma
844890|NCT00003439|recurrent endometrial carcinoma|recurrent endometrial carcinoma
844891|NCT00003439|small intestine adenocarcinoma|small intestine adenocarcinoma
844892|NCT00003439|unresectable gallbladder cancer|unresectable gallbladder cancer
844893|NCT00003439|recurrent gallbladder cancer|recurrent gallbladder cancer
844894|NCT00003439|unresectable extrahepatic bile duct cancer|unresectable extrahepatic bile duct cancer
844895|NCT00003439|recurrent extrahepatic bile duct cancer|recurrent extrahepatic bile duct cancer
844896|NCT00003439|recurrent small intestine cancer|recurrent small intestine cancer
844897|NCT00003439|stage IV prostate cancer|stage iv prostate cancer
844898|NCT00003439|recurrent prostate cancer|recurrent prostate cancer
844899|NCT00003439|fallopian tube cancer|fallopian tube cancer
844900|NCT00003439|primary peritoneal cavity cancer|primary peritoneal cavity cancer
844901|NCT00003439|stage IV pancreatic cancer|stage iv pancreatic cancer
844902|NCT00003423|stage I childhood lymphoblastic lymphoma|stage i childhood lymphoblastic lymphoma
844903|NCT00003423|stage II childhood lymphoblastic lymphoma|stage ii childhood lymphoblastic lymphoma
844904|NCT00003423|stage III childhood lymphoblastic lymphoma|stage iii childhood lymphoblastic lymphoma
844905|NCT00003423|stage IV childhood lymphoblastic lymphoma|stage iv childhood lymphoblastic lymphoma
844906|NCT00003423|stage I childhood large cell lymphoma|stage i childhood large cell lymphoma
844907|NCT00003423|stage II childhood large cell lymphoma|stage ii childhood large cell lymphoma
844908|NCT00003423|stage III childhood large cell lymphoma|stage iii childhood large cell lymphoma
844909|NCT00003423|stage IV childhood large cell lymphoma|stage iv childhood large cell lymphoma
844910|NCT00003330|unspecified adult solid tumor, protocol specific|unspecified adult solid tumor, protocol specific
844911|NCT00003326|stage IV esophageal cancer|stage iv esophageal cancer
844912|NCT00003326|recurrent esophageal cancer|recurrent esophageal cancer
844913|NCT00003326|squamous cell carcinoma of the esophagus|squamous cell carcinoma of the esophagus
844914|NCT00003326|adenocarcinoma of the esophagus|adenocarcinoma of the esophagus
844915|NCT00003255|recurrent adult acute myeloid leukemia|recurrent adult acute myeloid leukemia
844916|NCT00003255|secondary acute myeloid leukemia|secondary acute myeloid leukemia
844917|NCT00002578|AIDS-related peripheral/systemic lymphoma|aids-related peripheral/systemic lymphoma
844918|NCT00002578|AIDS-related diffuse large cell lymphoma|aids-related diffuse large cell lymphoma
844919|NCT00002578|AIDS-related immunoblastic large cell lymphoma|aids-related immunoblastic large cell lymphoma
844920|NCT00002578|AIDS-related small noncleaved cell lymphoma|aids-related small noncleaved cell lymphoma
844921|NCT00002578|AIDS-related diffuse mixed cell lymphoma|aids-related diffuse mixed cell lymphoma
844922|NCT00002578|AIDS-related diffuse small cleaved cell lymphoma|aids-related diffuse small cleaved cell lymphoma
844923|NCT00002578|AIDS-related lymphoblastic lymphoma|aids-related lymphoblastic lymphoma
844924|NCT00002503|recurrent prostate cancer|recurrent prostate cancer
844925|NCT00002503|bone metastases|bone metastases
844926|NCT00083317|PFC|pfc
844927|NCT00083317|Competition|competition
844928|NCT00083317|Bargaining Games|bargaining games
844929|NCT00083317|Hyper-Brain Scanning|hyper-brain scanning
844930|NCT00083317|fMRI|fmri
844931|NCT00083317|Healthy Volunteer|healthy volunteer
844932|NCT00083317|HV|hv
844933|NCT00083304|Breast|breast
844934|NCT00083304|Brain|brain
844935|NCT00083304|RSR13|rsr13
844936|NCT00083304|efaproxiral|efaproxiral
844937|NCT00083304|Whole Brain Radiation Therapy|whole brain radiation therapy
844938|NCT00083304|Brain metastases|brain metastases
844939|NCT00083304|Metastatic breast cancer|metastatic breast cancer
844940|NCT00083213|recurrent grade 1 follicular lymphoma|recurrent grade 1 follicular lymphoma
844941|NCT00083213|stage IV grade 1 follicular lymphoma|stage iv grade 1 follicular lymphoma
844942|NCT00083213|recurrent grade 2 follicular lymphoma|recurrent grade 2 follicular lymphoma
844943|NCT00083213|stage IV grade 2 follicular lymphoma|stage iv grade 2 follicular lymphoma
844944|NCT00083213|recurrent grade 3 follicular lymphoma|recurrent grade 3 follicular lymphoma
844945|NCT00083213|stage IV grade 3 follicular lymphoma|stage iv grade 3 follicular lymphoma
844946|NCT00083213|recurrent adult diffuse small cleaved cell lymphoma|recurrent adult diffuse small cleaved cell lymphoma
844947|NCT00083213|stage IV adult diffuse small cleaved cell lymphoma|stage iv adult diffuse small cleaved cell lymphoma
844948|NCT00083213|recurrent adult diffuse large cell lymphoma|recurrent adult diffuse large cell lymphoma
844949|NCT00083213|stage IV adult diffuse large cell lymphoma|stage iv adult diffuse large cell lymphoma
844950|NCT00083213|stage IV adult diffuse mixed cell lymphoma|stage iv adult diffuse mixed cell lymphoma
844951|NCT00083213|recurrent adult diffuse mixed cell lymphoma|recurrent adult diffuse mixed cell lymphoma
844952|NCT00083213|recurrent adult immunoblastic large cell lymphoma|recurrent adult immunoblastic large cell lymphoma
844953|NCT00083213|stage IV adult immunoblastic large cell lymphoma|stage iv adult immunoblastic large cell lymphoma
844954|NCT00083213|recurrent adult Burkitt lymphoma|recurrent adult burkitt lymphoma
844955|NCT00083213|stage IV adult Burkitt lymphoma|stage iv adult burkitt lymphoma
844956|NCT00083213|recurrent mantle cell lymphoma|recurrent mantle cell lymphoma
844957|NCT00083213|stage IV mantle cell lymphoma|stage iv mantle cell lymphoma
844958|NCT00083213|recurrent adult lymphoblastic lymphoma|recurrent adult lymphoblastic lymphoma
876633|NCT00051129|AMD|amd
844959|NCT00083213|stage IV adult lymphoblastic lymphoma|stage iv adult lymphoblastic lymphoma
844960|NCT00083213|unspecified adult solid tumor, protocol specific|unspecified adult solid tumor, protocol specific
844961|NCT00083213|recurrent adult soft tissue sarcoma|recurrent adult soft tissue sarcoma
844962|NCT00083213|recurrent adult primary liver cancer|recurrent adult primary liver cancer
844963|NCT00083213|advanced adult primary liver cancer|advanced adult primary liver cancer
844964|NCT00083213|recurrent cervical cancer|recurrent cervical cancer
844965|NCT00083213|stage IVA cervical cancer|stage iva cervical cancer
844966|NCT00083213|stage IVB cervical cancer|stage ivb cervical cancer
844967|NCT00083213|fallopian tube cancer|fallopian tube cancer
844968|NCT00083213|ovarian sarcoma|ovarian sarcoma
844969|NCT00083213|recurrent ovarian epithelial cancer|recurrent ovarian epithelial cancer
844970|NCT00083213|stage IV ovarian epithelial cancer|stage iv ovarian epithelial cancer
844971|NCT00083213|recurrent endometrial carcinoma|recurrent endometrial carcinoma
844972|NCT00083213|stage IV endometrial carcinoma|stage iv endometrial carcinoma
844973|NCT00083213|recurrent uterine sarcoma|recurrent uterine sarcoma
844974|NCT00083213|stage IV uterine sarcoma|stage iv uterine sarcoma
844975|NCT00083213|recurrent ovarian germ cell tumor|recurrent ovarian germ cell tumor
844976|NCT00083213|stage IV ovarian germ cell tumor|stage iv ovarian germ cell tumor
844977|NCT00083213|ovarian stromal cancer|ovarian stromal cancer
844978|NCT00083213|recurrent vaginal cancer|recurrent vaginal cancer
844979|NCT00083213|stage IVA vaginal cancer|stage iva vaginal cancer
844980|NCT00083213|stage IVB vaginal cancer|stage ivb vaginal cancer
844981|NCT00083213|recurrent prostate cancer|recurrent prostate cancer
844982|NCT00083213|stage IV prostate cancer|stage iv prostate cancer
844983|NCT00083213|recurrent penile cancer|recurrent penile cancer
844984|NCT00083213|stage IV penile cancer|stage iv penile cancer
844985|NCT00083213|recurrent malignant testicular germ cell tumor|recurrent malignant testicular germ cell tumor
844986|NCT00083213|stage III malignant testicular germ cell tumor|stage iii malignant testicular germ cell tumor
844987|NCT00083213|recurrent bladder cancer|recurrent bladder cancer
844988|NCT00083213|stage IV bladder cancer|stage iv bladder cancer
844989|NCT00083213|recurrent vulvar cancer|recurrent vulvar cancer
844990|NCT00083213|stage IVB vulvar cancer|stage ivb vulvar cancer
844991|NCT00083213|distal urethral cancer|distal urethral cancer
844992|NCT00083213|proximal urethral cancer|proximal urethral cancer
844993|NCT00083213|recurrent urethral cancer|recurrent urethral cancer
844994|NCT00083213|urethral cancer associated with invasive bladder cancer|urethral cancer associated with invasive bladder cancer
844995|NCT00083213|primary peritoneal cavity cancer|primary peritoneal cavity cancer
844996|NCT00083213|recurrent marginal zone lymphoma|recurrent marginal zone lymphoma
844997|NCT00083213|recurrent small lymphocytic lymphoma|recurrent small lymphocytic lymphoma
844998|NCT00083213|stage IV small lymphocytic lymphoma|stage iv small lymphocytic lymphoma
844999|NCT00083213|stage IV marginal zone lymphoma|stage iv marginal zone lymphoma
845000|NCT00083213|extranodal marginal zone B-cell lymphoma of mucosa-associated lymphoid tissue|extranodal marginal zone b-cell lymphoma of mucosa-associated lymphoid tissue
845001|NCT00083213|nodal marginal zone B-cell lymphoma|nodal marginal zone b-cell lymphoma
845002|NCT00083213|splenic marginal zone lymphoma|splenic marginal zone lymphoma
845003|NCT00083213|stage IV adult soft tissue sarcoma|stage iv adult soft tissue sarcoma
845004|NCT00082940|B-cell chronic lymphocytic leukemia|b-cell chronic lymphocytic leukemia
845005|NCT00082940|refractory chronic lymphocytic leukemia|refractory chronic lymphocytic leukemia
845006|NCT00082927|stage IV prostate cancer|stage iv prostate cancer
845007|NCT00082927|bone metastases|bone metastases
845009|NCT00082927|recurrent prostate cancer|recurrent prostate cancer
845010|NCT00082914|recurrent renal cell cancer|recurrent renal cell cancer
845011|NCT00082914|stage IV renal cell cancer|stage iv renal cell cancer
845012|NCT00082914|recurrent melanoma|recurrent melanoma
845013|NCT00082914|stage IV melanoma|stage iv melanoma
845014|NCT00082862|stage II pancreatic cancer|stage ii pancreatic cancer
845015|NCT00082862|stage III pancreatic cancer|stage iii pancreatic cancer
845016|NCT00082862|recurrent pancreatic cancer|recurrent pancreatic cancer
845017|NCT00082862|stage IV pancreatic cancer|stage iv pancreatic cancer
845018|NCT00082836|primary central nervous system non-Hodgkin lymphoma|primary central nervous system non-hodgkin lymphoma
845019|NCT00082823|recurrent grade 1 follicular lymphoma|recurrent grade 1 follicular lymphoma
845020|NCT00082823|stage IV grade 1 follicular lymphoma|stage iv grade 1 follicular lymphoma
845021|NCT00082823|recurrent grade 2 follicular lymphoma|recurrent grade 2 follicular lymphoma
845022|NCT00082823|stage IV grade 2 follicular lymphoma|stage iv grade 2 follicular lymphoma
845023|NCT00082823|recurrent grade 3 follicular lymphoma|recurrent grade 3 follicular lymphoma
845024|NCT00082823|stage IV grade 3 follicular lymphoma|stage iv grade 3 follicular lymphoma
845025|NCT00082823|recurrent adult diffuse small cleaved cell lymphoma|recurrent adult diffuse small cleaved cell lymphoma
845026|NCT00082823|stage IV adult diffuse small cleaved cell lymphoma|stage iv adult diffuse small cleaved cell lymphoma
845027|NCT00082823|recurrent adult diffuse large cell lymphoma|recurrent adult diffuse large cell lymphoma
845028|NCT00082823|stage IV adult diffuse large cell lymphoma|stage iv adult diffuse large cell lymphoma
845029|NCT00082823|recurrent adult diffuse mixed cell lymphoma|recurrent adult diffuse mixed cell lymphoma
845030|NCT00082823|stage IV adult diffuse mixed cell lymphoma|stage iv adult diffuse mixed cell lymphoma
845031|NCT00082823|recurrent adult immunoblastic large cell lymphoma|recurrent adult immunoblastic large cell lymphoma
845032|NCT00082823|stage IV adult immunoblastic large cell lymphoma|stage iv adult immunoblastic large cell lymphoma
845033|NCT00082823|recurrent adult Burkitt lymphoma|recurrent adult burkitt lymphoma
845034|NCT00082823|stage IV adult Burkitt lymphoma|stage iv adult burkitt lymphoma
845035|NCT00082823|recurrent mantle cell lymphoma|recurrent mantle cell lymphoma
845036|NCT00082823|stage IV mantle cell lymphoma|stage iv mantle cell lymphoma
845037|NCT00082823|recurrent adult lymphoblastic lymphoma|recurrent adult lymphoblastic lymphoma
845038|NCT00082823|stage IV adult lymphoblastic lymphoma|stage iv adult lymphoblastic lymphoma
845039|NCT00082823|unspecified adult solid tumor, protocol specific|unspecified adult solid tumor, protocol specific
845040|NCT00082823|recurrent adult soft tissue sarcoma|recurrent adult soft tissue sarcoma
845041|NCT00082823|advanced adult primary liver cancer|advanced adult primary liver cancer
845042|NCT00082823|recurrent adult primary liver cancer|recurrent adult primary liver cancer
845043|NCT00082823|recurrent cervical cancer|recurrent cervical cancer
845044|NCT00082823|stage IVA cervical cancer|stage iva cervical cancer
845045|NCT00082823|stage IVB cervical cancer|stage ivb cervical cancer
845046|NCT00082823|fallopian tube cancer|fallopian tube cancer
845047|NCT00082823|ovarian sarcoma|ovarian sarcoma
845048|NCT00082823|recurrent ovarian epithelial cancer|recurrent ovarian epithelial cancer
845049|NCT00082823|stage IV ovarian epithelial cancer|stage iv ovarian epithelial cancer
845050|NCT00082823|recurrent endometrial carcinoma|recurrent endometrial carcinoma
845051|NCT00082823|stage IV endometrial carcinoma|stage iv endometrial carcinoma
845052|NCT00082823|recurrent uterine sarcoma|recurrent uterine sarcoma
845053|NCT00082823|stage IV uterine sarcoma|stage iv uterine sarcoma
845054|NCT00082823|recurrent ovarian germ cell tumor|recurrent ovarian germ cell tumor
845055|NCT00082823|stage IV ovarian germ cell tumor|stage iv ovarian germ cell tumor
845056|NCT00082823|ovarian stromal cancer|ovarian stromal cancer
845057|NCT00082823|recurrent vaginal cancer|recurrent vaginal cancer
845058|NCT00082823|stage IVA vaginal cancer|stage iva vaginal cancer
845059|NCT00082823|stage IVB vaginal cancer|stage ivb vaginal cancer
845060|NCT00082823|recurrent prostate cancer|recurrent prostate cancer
845061|NCT00082823|stage IV prostate cancer|stage iv prostate cancer
845062|NCT00082823|recurrent penile cancer|recurrent penile cancer
845063|NCT00082823|stage IV penile cancer|stage iv penile cancer
845064|NCT00082823|recurrent malignant testicular germ cell tumor|recurrent malignant testicular germ cell tumor
845065|NCT00082823|stage III malignant testicular germ cell tumor|stage iii malignant testicular germ cell tumor
845066|NCT00082823|recurrent bladder cancer|recurrent bladder cancer
845067|NCT00082823|stage IV bladder cancer|stage iv bladder cancer
845068|NCT00082823|recurrent vulvar cancer|recurrent vulvar cancer
845069|NCT00082823|stage IVB vulvar cancer|stage ivb vulvar cancer
845070|NCT00082823|distal urethral cancer|distal urethral cancer
845071|NCT00082823|proximal urethral cancer|proximal urethral cancer
845072|NCT00082823|recurrent urethral cancer|recurrent urethral cancer
845073|NCT00082823|urethral cancer associated with invasive bladder cancer|urethral cancer associated with invasive bladder cancer
845074|NCT00082823|primary peritoneal cavity cancer|primary peritoneal cavity cancer
845075|NCT00082823|recurrent marginal zone lymphoma|recurrent marginal zone lymphoma
845076|NCT00082823|recurrent small lymphocytic lymphoma|recurrent small lymphocytic lymphoma
845077|NCT00082823|stage IV small lymphocytic lymphoma|stage iv small lymphocytic lymphoma
845078|NCT00082823|stage IV marginal zone lymphoma|stage iv marginal zone lymphoma
845079|NCT00082823|extranodal marginal zone B-cell lymphoma of mucosa-associated lymphoid tissue|extranodal marginal zone b-cell lymphoma of mucosa-associated lymphoid tissue
845080|NCT00082823|nodal marginal zone B-cell lymphoma|nodal marginal zone b-cell lymphoma
845081|NCT00082823|splenic marginal zone lymphoma|splenic marginal zone lymphoma
845082|NCT00082823|stage IV adult soft tissue sarcoma|stage iv adult soft tissue sarcoma
845083|NCT00082797|adult glioblastoma|adult glioblastoma
845084|NCT00082797|adult giant cell glioblastoma|adult giant cell glioblastoma
845085|NCT00082797|adult gliosarcoma|adult gliosarcoma
845086|NCT00082758|recurrent neuroblastoma|recurrent neuroblastoma
845087|NCT00082732|stage I prostate cancer|stage i prostate cancer
845088|NCT00082732|stage II prostate cancer|stage ii prostate cancer
845089|NCT00082732|adenocarcinoma of the prostate|adenocarcinoma of the prostate
845090|NCT00082719|stage II bladder cancer|stage ii bladder cancer
845091|NCT00082719|stage III bladder cancer|stage iii bladder cancer
845092|NCT00082719|stage IV bladder cancer|stage iv bladder cancer
845093|NCT00082719|localized transitional cell cancer of the renal pelvis and ureter|localized transitional cell cancer of the renal pelvis and ureter
845094|NCT00082719|regional transitional cell cancer of the renal pelvis and ureter|regional transitional cell cancer of the renal pelvis and ureter
845095|NCT00082719|metastatic transitional cell cancer of the renal pelvis and ureter|metastatic transitional cell cancer of the renal pelvis and ureter
845096|NCT00082719|anterior urethral cancer|anterior urethral cancer
845097|NCT00082719|posterior urethral cancer|posterior urethral cancer
845098|NCT00082719|urethral cancer associated with invasive bladder cancer|urethral cancer associated with invasive bladder cancer
845099|NCT00082706|adenocarcinoma of the bladder|adenocarcinoma of the bladder
845100|NCT00082706|recurrent bladder cancer|recurrent bladder cancer
845102|NCT00082706|recurrent urethral cancer|recurrent urethral cancer
845103|NCT00082706|anterior urethral cancer|anterior urethral cancer
845104|NCT00082706|posterior urethral cancer|posterior urethral cancer
845398|NCT00082459|Kidney Cancer|kidney cancer
845105|NCT00082706|urethral cancer associated with invasive bladder cancer|urethral cancer associated with invasive bladder cancer
845106|NCT00082706|stage III bladder cancer|stage iii bladder cancer
845107|NCT00082667|breast cancer in situ|breast cancer in situ
845108|NCT00082667|ductal breast carcinoma in situ|ductal breast carcinoma in situ
845109|NCT00082654|psychosocial effects of cancer and its treatment|psychosocial effects of cancer and its treatment
845110|NCT00082654|accelerated phase chronic myelogenous leukemia|accelerated phase chronic myelogenous leukemia
845111|NCT00082654|adult acute lymphoblastic leukemia in remission|adult acute lymphoblastic leukemia in remission
845112|NCT00082654|adult acute myeloid leukemia in remission|adult acute myeloid leukemia in remission
845113|NCT00082654|atypical chronic myeloid leukemia|atypical chronic myeloid leukemia
845114|NCT00082654|blastic phase chronic myelogenous leukemia|blastic phase chronic myelogenous leukemia
845115|NCT00082654|chronic eosinophilic leukemia|chronic eosinophilic leukemia
845116|NCT00082654|chronic idiopathic myelofibrosis|chronic idiopathic myelofibrosis
845117|NCT00082654|chronic myelomonocytic leukemia|chronic myelomonocytic leukemia
845118|NCT00082654|chronic neutrophilic leukemia|chronic neutrophilic leukemia
845119|NCT00082654|chronic phase chronic myelogenous leukemia|chronic phase chronic myelogenous leukemia
845120|NCT00082654|de novo myelodysplastic syndromes|de novo myelodysplastic syndromes
845121|NCT00082654|disseminated neuroblastoma|disseminated neuroblastoma
845122|NCT00082654|myelodysplastic/myeloproliferative disease, unclassifiable|myelodysplastic/myeloproliferative disease, unclassifiable
845123|NCT00082654|noncontiguous stage II adult Burkitt lymphoma|noncontiguous stage ii adult burkitt lymphoma
845124|NCT00082654|noncontiguous stage II adult diffuse large cell lymphoma|noncontiguous stage ii adult diffuse large cell lymphoma
845125|NCT00082654|noncontiguous stage II adult diffuse mixed cell lymphoma|noncontiguous stage ii adult diffuse mixed cell lymphoma
845126|NCT00082654|noncontiguous stage II adult diffuse small cleaved cell lymphoma|noncontiguous stage ii adult diffuse small cleaved cell lymphoma
845127|NCT00082654|noncontiguous stage II adult immunoblastic large cell lymphoma|noncontiguous stage ii adult immunoblastic large cell lymphoma
845128|NCT00082654|noncontiguous stage II adult lymphoblastic lymphoma|noncontiguous stage ii adult lymphoblastic lymphoma
845129|NCT00082654|noncontiguous stage II grade 1 follicular lymphoma|noncontiguous stage ii grade 1 follicular lymphoma
845130|NCT00082654|noncontiguous stage II grade 2 follicular lymphoma|noncontiguous stage ii grade 2 follicular lymphoma
845131|NCT00082654|noncontiguous stage II grade 3 follicular lymphoma|noncontiguous stage ii grade 3 follicular lymphoma
845132|NCT00082654|noncontiguous stage II mantle cell lymphoma|noncontiguous stage ii mantle cell lymphoma
845133|NCT00082654|poor prognosis metastatic gestational trophoblastic tumor|poor prognosis metastatic gestational trophoblastic tumor
845134|NCT00082654|previously treated myelodysplastic syndromes|previously treated myelodysplastic syndromes
845135|NCT00082654|recurrent adult acute lymphoblastic leukemia|recurrent adult acute lymphoblastic leukemia
845136|NCT00082654|recurrent adult acute myeloid leukemia|recurrent adult acute myeloid leukemia
845137|NCT00082654|recurrent adult Burkitt lymphoma|recurrent adult burkitt lymphoma
845138|NCT00082654|recurrent adult diffuse large cell lymphoma|recurrent adult diffuse large cell lymphoma
845139|NCT00082654|recurrent adult diffuse mixed cell lymphoma|recurrent adult diffuse mixed cell lymphoma
845140|NCT00082654|recurrent adult diffuse small cleaved cell lymphoma|recurrent adult diffuse small cleaved cell lymphoma
845141|NCT00082654|recurrent adult Hodgkin lymphoma|recurrent adult hodgkin lymphoma
845142|NCT00082654|recurrent adult immunoblastic large cell lymphoma|recurrent adult immunoblastic large cell lymphoma
845143|NCT00082654|recurrent adult lymphoblastic lymphoma|recurrent adult lymphoblastic lymphoma
845144|NCT00082654|recurrent cutaneous T-cell non-Hodgkin lymphoma|recurrent cutaneous t-cell non-hodgkin lymphoma
845145|NCT00082654|recurrent grade 1 follicular lymphoma|recurrent grade 1 follicular lymphoma
845146|NCT00082654|recurrent grade 2 follicular lymphoma|recurrent grade 2 follicular lymphoma
845147|NCT00082654|recurrent grade 3 follicular lymphoma|recurrent grade 3 follicular lymphoma
845148|NCT00082654|recurrent mantle cell lymphoma|recurrent mantle cell lymphoma
845149|NCT00082654|recurrent mycosis fungoides/Sezary syndrome|recurrent mycosis fungoides/sezary syndrome
845150|NCT00082654|recurrent neuroblastoma|recurrent neuroblastoma
845151|NCT00082654|recurrent ovarian epithelial cancer|recurrent ovarian epithelial cancer
845152|NCT00082654|recurrent ovarian germ cell tumor|recurrent ovarian germ cell tumor
845153|NCT00082654|recurrent malignant testicular germ cell tumor|recurrent malignant testicular germ cell tumor
845154|NCT00082654|refractory chronic lymphocytic leukemia|refractory chronic lymphocytic leukemia
845155|NCT00082654|refractory hairy cell leukemia|refractory hairy cell leukemia
845156|NCT00082654|refractory multiple myeloma|refractory multiple myeloma
845157|NCT00082654|relapsing chronic myelogenous leukemia|relapsing chronic myelogenous leukemia
845158|NCT00082654|secondary acute myeloid leukemia|secondary acute myeloid leukemia
845159|NCT00082654|secondary myelodysplastic syndromes|secondary myelodysplastic syndromes
845160|NCT00082654|stage I multiple myeloma|stage i multiple myeloma
845161|NCT00082654|stage II multiple myeloma|stage ii multiple myeloma
845162|NCT00082654|stage II ovarian epithelial cancer|stage ii ovarian epithelial cancer
845163|NCT00082654|stage III adult Burkitt lymphoma|stage iii adult burkitt lymphoma
845164|NCT00082654|stage III adult diffuse large cell lymphoma|stage iii adult diffuse large cell lymphoma
845165|NCT00082654|stage III adult diffuse mixed cell lymphoma|stage iii adult diffuse mixed cell lymphoma
845166|NCT00082654|stage III adult diffuse small cleaved cell lymphoma|stage iii adult diffuse small cleaved cell lymphoma
845167|NCT00082654|stage III adult immunoblastic large cell lymphoma|stage iii adult immunoblastic large cell lymphoma
845168|NCT00082654|stage III adult lymphoblastic lymphoma|stage iii adult lymphoblastic lymphoma
845169|NCT00082654|stage III chronic lymphocytic leukemia|stage iii chronic lymphocytic leukemia
845170|NCT00082654|stage III grade 1 follicular lymphoma|stage iii grade 1 follicular lymphoma
845171|NCT00082654|stage III grade 2 follicular lymphoma|stage iii grade 2 follicular lymphoma
845172|NCT00082654|stage III grade 3 follicular lymphoma|stage iii grade 3 follicular lymphoma
845173|NCT00082654|stage III mantle cell lymphoma|stage iii mantle cell lymphoma
845174|NCT00082654|stage III multiple myeloma|stage iii multiple myeloma
845175|NCT00082654|stage III ovarian epithelial cancer|stage iii ovarian epithelial cancer
845176|NCT00082654|stage III malignant testicular germ cell tumor|stage iii malignant testicular germ cell tumor
845177|NCT00082654|stage IIIA breast cancer|stage iiia breast cancer
845178|NCT00082654|stage IIIB breast cancer|stage iiib breast cancer
845179|NCT00082654|stage IIIC breast cancer|stage iiic breast cancer
845180|NCT00082654|stage IV adult Burkitt lymphoma|stage iv adult burkitt lymphoma
845181|NCT00082654|stage IV adult diffuse large cell lymphoma|stage iv adult diffuse large cell lymphoma
845182|NCT00082654|stage IV adult diffuse mixed cell lymphoma|stage iv adult diffuse mixed cell lymphoma
845183|NCT00082654|stage IV adult diffuse small cleaved cell lymphoma|stage iv adult diffuse small cleaved cell lymphoma
845184|NCT00082654|stage IV adult immunoblastic large cell lymphoma|stage iv adult immunoblastic large cell lymphoma
845185|NCT00082654|stage IV adult lymphoblastic lymphoma|stage iv adult lymphoblastic lymphoma
845186|NCT00082654|stage IV breast cancer|stage iv breast cancer
845187|NCT00082654|stage IV chronic lymphocytic leukemia|stage iv chronic lymphocytic leukemia
845188|NCT00082654|stage IV grade 1 follicular lymphoma|stage iv grade 1 follicular lymphoma
845189|NCT00082654|stage IV grade 2 follicular lymphoma|stage iv grade 2 follicular lymphoma
845190|NCT00082654|stage IV grade 3 follicular lymphoma|stage iv grade 3 follicular lymphoma
845191|NCT00082654|stage IV mantle cell lymphoma|stage iv mantle cell lymphoma
845192|NCT00082654|stage IV ovarian epithelial cancer|stage iv ovarian epithelial cancer
845193|NCT00082654|untreated adult acute lymphoblastic leukemia|untreated adult acute lymphoblastic leukemia
845194|NCT00082654|untreated adult acute myeloid leukemia|untreated adult acute myeloid leukemia
845195|NCT00082654|noncontiguous stage II small lymphocytic lymphoma|noncontiguous stage ii small lymphocytic lymphoma
845196|NCT00082654|noncontiguous stage II marginal zone lymphoma|noncontiguous stage ii marginal zone lymphoma
845197|NCT00082654|recurrent marginal zone lymphoma|recurrent marginal zone lymphoma
845198|NCT00082654|recurrent small lymphocytic lymphoma|recurrent small lymphocytic lymphoma
845199|NCT00082654|stage III small lymphocytic lymphoma|stage iii small lymphocytic lymphoma
845200|NCT00082654|stage III marginal zone lymphoma|stage iii marginal zone lymphoma
845201|NCT00082654|stage IV small lymphocytic lymphoma|stage iv small lymphocytic lymphoma
845202|NCT00082654|stage IV marginal zone lymphoma|stage iv marginal zone lymphoma
845203|NCT00082654|extranodal marginal zone B-cell lymphoma of mucosa-associated lymphoid tissue|extranodal marginal zone b-cell lymphoma of mucosa-associated lymphoid tissue
845204|NCT00082654|nodal marginal zone B-cell lymphoma|nodal marginal zone b-cell lymphoma
845205|NCT00082654|splenic marginal zone lymphoma|splenic marginal zone lymphoma
845206|NCT00082654|adult acute myeloid leukemia with t(8;21)(q22;q22)|adult acute myeloid leukemia with t(8;21)(q22;q22)
845207|NCT00082654|adult acute myeloid leukemia with t(16;16)(p13;q22)|adult acute myeloid leukemia with t(16;16)(p13;q22)
845208|NCT00082654|adult acute myeloid leukemia with inv(16)(p13;q22)|adult acute myeloid leukemia with inv(16)(p13;q22)
845209|NCT00082654|adult acute myeloid leukemia with 11q23 (MLL) abnormalities|adult acute myeloid leukemia with 11q23 (mll) abnormalities
845210|NCT00082654|adult acute myeloid leukemia with t(15;17)(q22;q12)|adult acute myeloid leukemia with t(15;17)(q22;q12)
845211|NCT00082641|stage IIIA breast cancer|stage iiia breast cancer
845212|NCT00082641|stage IIIB breast cancer|stage iiib breast cancer
845213|NCT00003186|stage I colon cancer|stage i colon cancer
845214|NCT00003186|stage II colon cancer|stage ii colon cancer
845215|NCT00003186|stage III colon cancer|stage iii colon cancer
845216|NCT00003186|stage IV colon cancer|stage iv colon cancer
845217|NCT00003186|stage I rectal cancer|stage i rectal cancer
845218|NCT00003186|stage II rectal cancer|stage ii rectal cancer
845219|NCT00003186|stage III rectal cancer|stage iii rectal cancer
845220|NCT00003186|stage IV rectal cancer|stage iv rectal cancer
845221|NCT00003186|adenocarcinoma of the colon|adenocarcinoma of the colon
845222|NCT00003186|liver metastases|liver metastases
845223|NCT00003183|adenocarcinoma of the prostate|adenocarcinoma of the prostate
845224|NCT00003183|stage IV prostate cancer|stage iv prostate cancer
845225|NCT00003183|recurrent prostate cancer|recurrent prostate cancer
845226|NCT00003154|stage IIIB non-small cell lung cancer|stage iiib non-small cell lung cancer
845227|NCT00003154|stage IV non-small cell lung cancer|stage iv non-small cell lung cancer
845228|NCT00003118|stage I esophageal cancer|stage i esophageal cancer
845229|NCT00003118|stage II esophageal cancer|stage ii esophageal cancer
845230|NCT00003118|stage III esophageal cancer|stage iii esophageal cancer
845231|NCT00003118|squamous cell carcinoma of the esophagus|squamous cell carcinoma of the esophagus
845232|NCT00003118|adenocarcinoma of the esophagus|adenocarcinoma of the esophagus
845233|NCT00003117|recurrent non-small cell lung cancer|recurrent non-small cell lung cancer
845234|NCT00003117|squamous cell lung cancer|squamous cell lung cancer
845235|NCT00003117|large cell lung cancer|large cell lung cancer
845236|NCT00003117|stage IIIB non-small cell lung cancer|stage iiib non-small cell lung cancer
845399|NCT00082459|Renal|renal
845237|NCT00003117|stage IV non-small cell lung cancer|stage iv non-small cell lung cancer
845238|NCT00003117|adenocarcinoma of the lung|adenocarcinoma of the lung
845239|NCT00003117|adenosquamous cell lung cancer|adenosquamous cell lung cancer
845240|NCT00003095|stage II breast cancer|stage ii breast cancer
845241|NCT00003095|stage III breast cancer|stage iii breast cancer
845242|NCT00003020|leptomeningeal metastases|leptomeningeal metastases
845243|NCT00002988|recurrent adult brain tumor|recurrent adult brain tumor
845244|NCT00002985|AIDS-related Kaposi sarcoma|aids-related kaposi sarcoma
845245|NCT00002961|recurrent childhood acute lymphoblastic leukemia|recurrent childhood acute lymphoblastic leukemia
845246|NCT00002961|childhood acute lymphoblastic leukemia in remission|childhood acute lymphoblastic leukemia in remission
845247|NCT00083291|Dry Eyes|dry eyes
845248|NCT00083291|Conjunctiva|conjunctiva
845249|NCT00083291|Infection|infection
845250|NCT00083291|Antibodies|antibodies
845251|NCT00083291|Inflammation|inflammation
845252|NCT00083291|Ocular Surface Disease|ocular surface disease
845253|NCT00083291|Helicobacter Pylori|helicobacter pylori
845258|NCT00083265|Caffeine|caffeine
845259|NCT00083265|Healthy Volunteer|healthy volunteer
845260|NCT00083265|HV|hv
845261|NCT00083226|doxorubicin|doxorubicin
845262|NCT00083226|doxorubicin hydrochloride|doxorubicin hydrochloride
845263|NCT00083226|bortezomib|bortezomib
845264|NCT00083226|hepatocellular carcinoma|hepatocellular carcinoma
845265|NCT00083187|recurrent adult acute myeloid leukemia|recurrent adult acute myeloid leukemia
845266|NCT00083187|untreated adult acute myeloid leukemia|untreated adult acute myeloid leukemia
845267|NCT00083187|atypical chronic myeloid leukemia, BCR-ABL1 negative|atypical chronic myeloid leukemia, bcr-abl1 negative
845268|NCT00083187|chronic myelomonocytic leukemia|chronic myelomonocytic leukemia
845269|NCT00083187|myelodysplastic/myeloproliferative neoplasm, unclassifiable|myelodysplastic/myeloproliferative neoplasm, unclassifiable
845270|NCT00083187|secondary myelodysplastic syndromes|secondary myelodysplastic syndromes
845271|NCT00083187|de novo myelodysplastic syndromes|de novo myelodysplastic syndromes
845272|NCT00083187|adult acute myeloid leukemia with t(8;21)(q22;q22)|adult acute myeloid leukemia with t(8;21)(q22;q22)
845273|NCT00083187|adult acute myeloid leukemia with t(16;16)(p13;q22)|adult acute myeloid leukemia with t(16;16)(p13;q22)
845274|NCT00083187|adult acute myeloid leukemia with inv(16)(p13;q22)|adult acute myeloid leukemia with inv(16)(p13;q22)
845275|NCT00083187|adult acute myeloid leukemia with 11q23 (MLL) abnormalities|adult acute myeloid leukemia with 11q23 (mll) abnormalities
845276|NCT00083187|adult acute myeloid leukemia with t(15;17)(q22;q12)|adult acute myeloid leukemia with t(15;17)(q22;q12)
845277|NCT00083174|breast cancer|breast cancer
845278|NCT00083161|extensive stage small cell lung cancer|extensive stage small cell lung cancer
845279|NCT00083161|recurrent small cell lung cancer|recurrent small cell lung cancer
845280|NCT00083148|recurrent breast cancer|recurrent breast cancer
845281|NCT00083148|stage IV breast cancer|stage iv breast cancer
845282|NCT00083135|recurrent neuroblastoma|recurrent neuroblastoma
845283|NCT00083096|recurrent adult brain tumor|recurrent adult brain tumor
845284|NCT00083096|adult mixed glioma|adult mixed glioma
845285|NCT00083096|adult anaplastic astrocytoma|adult anaplastic astrocytoma
845286|NCT00083096|adult anaplastic oligodendroglioma|adult anaplastic oligodendroglioma
845287|NCT00083096|adult glioblastoma|adult glioblastoma
845288|NCT00083096|adult pilocytic astrocytoma|adult pilocytic astrocytoma
845289|NCT00083096|adult anaplastic ependymoma|adult anaplastic ependymoma
845290|NCT00083096|adult subependymoma|adult subependymoma
845291|NCT00083096|adult myxopapillary ependymoma|adult myxopapillary ependymoma
845292|NCT00083096|adult oligodendroglioma|adult oligodendroglioma
845293|NCT00083096|adult giant cell glioblastoma|adult giant cell glioblastoma
845294|NCT00083096|adult gliosarcoma|adult gliosarcoma
845295|NCT00083096|adult diffuse astrocytoma|adult diffuse astrocytoma
845296|NCT00083096|adult subependymal giant cell astrocytoma|adult subependymal giant cell astrocytoma
845297|NCT00083096|adult pineal gland astrocytoma|adult pineal gland astrocytoma
845298|NCT00083083|stage II non-small cell lung cancer|stage ii non-small cell lung cancer
845299|NCT00083083|stage IIIA non-small cell lung cancer|stage iiia non-small cell lung cancer
845300|NCT00083083|stage IIIB non-small cell lung cancer|stage iiib non-small cell lung cancer
845301|NCT00083070|recurrent childhood acute lymphoblastic leukemia|recurrent childhood acute lymphoblastic leukemia
845302|NCT00083070|recurrent childhood acute myeloid leukemia|recurrent childhood acute myeloid leukemia
845303|NCT00083070|relapsing chronic myelogenous leukemia|relapsing chronic myelogenous leukemia
845304|NCT00083070|childhood acute promyelocytic leukemia (M3)|childhood acute promyelocytic leukemia (m3)
845305|NCT00083070|blastic phase chronic myelogenous leukemia|blastic phase chronic myelogenous leukemia
845306|NCT00083057|stage III squamous cell carcinoma of the lip and oral cavity|stage iii squamous cell carcinoma of the lip and oral cavity
845307|NCT00083057|stage IV squamous cell carcinoma of the lip and oral cavity|stage iv squamous cell carcinoma of the lip and oral cavity
845308|NCT00083057|recurrent squamous cell carcinoma of the lip and oral cavity|recurrent squamous cell carcinoma of the lip and oral cavity
845309|NCT00083057|stage III squamous cell carcinoma of the hypopharynx|stage iii squamous cell carcinoma of the hypopharynx
845310|NCT00083057|stage IV squamous cell carcinoma of the hypopharynx|stage iv squamous cell carcinoma of the hypopharynx
845311|NCT00083057|recurrent squamous cell carcinoma of the hypopharynx|recurrent squamous cell carcinoma of the hypopharynx
845312|NCT00083057|stage III squamous cell carcinoma of the oropharynx|stage iii squamous cell carcinoma of the oropharynx
845400|NCT00082459|Tumor|tumor
845313|NCT00083057|stage IV squamous cell carcinoma of the oropharynx|stage iv squamous cell carcinoma of the oropharynx
845314|NCT00083057|recurrent squamous cell carcinoma of the oropharynx|recurrent squamous cell carcinoma of the oropharynx
845315|NCT00083057|recurrent squamous cell carcinoma of the nasopharynx|recurrent squamous cell carcinoma of the nasopharynx
845316|NCT00083057|stage III squamous cell carcinoma of the nasopharynx|stage iii squamous cell carcinoma of the nasopharynx
845317|NCT00083057|stage IV squamous cell carcinoma of the nasopharynx|stage iv squamous cell carcinoma of the nasopharynx
845318|NCT00083057|recurrent squamous cell carcinoma of the paranasal sinus and nasal cavity|recurrent squamous cell carcinoma of the paranasal sinus and nasal cavity
845319|NCT00083057|recurrent squamous cell carcinoma of the larynx|recurrent squamous cell carcinoma of the larynx
845320|NCT00083057|stage III squamous cell carcinoma of the larynx|stage iii squamous cell carcinoma of the larynx
845321|NCT00083057|stage IV squamous cell carcinoma of the larynx|stage iv squamous cell carcinoma of the larynx
845322|NCT00083044|breast cancer|breast cancer
845323|NCT00083044|breast cancer in situ|breast cancer in situ
845324|NCT00083044|stage I breast cancer|stage i breast cancer
845325|NCT00083044|lobular breast carcinoma in situ|lobular breast carcinoma in situ
845326|NCT00083044|ductal breast carcinoma in situ|ductal breast carcinoma in situ
845327|NCT00083031|recurrent breast cancer|recurrent breast cancer
845328|NCT00083031|stage IV breast cancer|stage iv breast cancer
845329|NCT00083018|stage II breast cancer|stage ii breast cancer
845330|NCT00083018|stage IIIA breast cancer|stage iiia breast cancer
845331|NCT00083018|stage IIIB breast cancer|stage iiib breast cancer
845332|NCT00083018|stage IIIC breast cancer|stage iiic breast cancer
845333|NCT00083018|stage IA breast cancer|stage ia breast cancer
845334|NCT00083018|stage IB breast cancer|stage ib breast cancer
845335|NCT00083005|adenocarcinoma of the prostate|adenocarcinoma of the prostate
845336|NCT00083005|recurrent prostate cancer|recurrent prostate cancer
845337|NCT00083005|stage IV prostate cancer|stage iv prostate cancer
845338|NCT00082979|breast cancer|breast cancer
845339|NCT00082628|Growth hormone|growth hormone
845340|NCT00082628|Serostim®|serostim®
845341|NCT00082628|Human Adipose Redistribution Syndrome|human adipose redistribution syndrome
845342|NCT00082628|Human Immunodeficiency Virus lipodystrophy|human immunodeficiency virus lipodystrophy
845343|NCT00082602|galantamine|galantamine
845344|NCT00082602|Alzheimer's disease|alzheimer's disease
845345|NCT00082615|Movement Disorders|movement disorders
845346|NCT00082615|Recovery Cycle|recovery cycle
845347|NCT00082615|Blink Reflex|blink reflex
845348|NCT00082615|Cervical Dystonia|cervical dystonia
845349|NCT00082615|Blepharospasm|blepharospasm
845350|NCT00082615|Dystonia|dystonia
845351|NCT00082615|Craniofacial Dystonia|craniofacial dystonia
845352|NCT00082615|Healthy Volunteer|healthy volunteer
845353|NCT00082615|HV|hv
845354|NCT00002936|AIDS-related Kaposi sarcoma|aids-related kaposi sarcoma
845355|NCT00002936|recurrent Kaposi sarcoma|recurrent kaposi sarcoma
845356|NCT00002936|AIDS-related peripheral/systemic lymphoma|aids-related peripheral/systemic lymphoma
845357|NCT00002903|recurrent malignant testicular germ cell tumor|recurrent malignant testicular germ cell tumor
845358|NCT00002903|testicular seminoma|testicular seminoma
845359|NCT00002903|recurrent ovarian germ cell tumor|recurrent ovarian germ cell tumor
845360|NCT00002903|extragonadal germ cell tumor|extragonadal germ cell tumor
845361|NCT00002896|stage II rectal cancer|stage ii rectal cancer
845362|NCT00002896|stage III rectal cancer|stage iii rectal cancer
845363|NCT00002896|recurrent rectal cancer|recurrent rectal cancer
845364|NCT00002896|adenocarcinoma of the rectum|adenocarcinoma of the rectum
845365|NCT00002896|mucinous adenocarcinoma of the rectum|mucinous adenocarcinoma of the rectum
845366|NCT00002893|stage III colon cancer|stage iii colon cancer
845367|NCT00002893|stage IV colon cancer|stage iv colon cancer
845368|NCT00002893|stage III rectal cancer|stage iii rectal cancer
845369|NCT00002893|stage IV rectal cancer|stage iv rectal cancer
845370|NCT00002893|recurrent colon cancer|recurrent colon cancer
845371|NCT00002893|recurrent rectal cancer|recurrent rectal cancer
845372|NCT00002893|adenocarcinoma of the colon|adenocarcinoma of the colon
845373|NCT00002893|adenocarcinoma of the rectum|adenocarcinoma of the rectum
845374|NCT00002892|stage II melanoma|stage ii melanoma
845375|NCT00002892|stage III melanoma|stage iii melanoma
845376|NCT00002892|recurrent melanoma|recurrent melanoma
845377|NCT00082550|Genetics|genetics
845378|NCT00082550|Serotonin Transporter|serotonin transporter
845379|NCT00082550|Brain Imaging|brain imaging
845380|NCT00082550|Neurotransmitter|neurotransmitter
845381|NCT00082550|OCD|ocd
845382|NCT00082550|Obsessive-Compulsive Disorder|obsessive-compulsive disorder
845383|NCT00082550|PET|pet
845384|NCT00082550|Obsessive Compulsive Disorder|obsessive compulsive disorder
845385|NCT00082550|Healthy Volunteer|healthy volunteer
845386|NCT00082550|HV|hv
845387|NCT00082498|SCH-D|sch-d
845388|NCT00082498|Schering D|schering d
845389|NCT00082498|Treatment Experienced|treatment experienced
845390|NCT00082498|Entry Inhibitors|entry inhibitors
845391|NCT00082498|Fusion Inhibitors|fusion inhibitors
845392|NCT00082498|Vicriviroc|vicriviroc
845393|NCT00082485|Cocaine Dependence|cocaine dependence
845394|NCT00082472|NSCLC|nsclc
845395|NCT00082472|Metastatic|metastatic
845396|NCT00082472|Unresectable|unresectable
845397|NCT00082472|No Prior Chemotherapy|no prior chemotherapy
845401|NCT00082459|Immunotherapy|immunotherapy
845402|NCT00082420|Vitamin A malnutrition|vitamin a malnutrition
845403|NCT00082420|low vitamin A status|low vitamin a status
845404|NCT00002870|stage IV breast cancer|stage iv breast cancer
845405|NCT00002870|recurrent breast cancer|recurrent breast cancer
845406|NCT00002826|stage IV breast cancer|stage iv breast cancer
845407|NCT00002826|recurrent breast cancer|recurrent breast cancer
845408|NCT00002803|localized resectable neuroblastoma|localized resectable neuroblastoma
845409|NCT00002803|regional neuroblastoma|regional neuroblastoma
845410|NCT00002803|stage 4S neuroblastoma|stage 4s neuroblastoma
845411|NCT00002803|localized unresectable neuroblastoma|localized unresectable neuroblastoma
845412|NCT00002802|localized resectable neuroblastoma|localized resectable neuroblastoma
845413|NCT00002802|regional neuroblastoma|regional neuroblastoma
845414|NCT00002802|disseminated neuroblastoma|disseminated neuroblastoma
845415|NCT00002802|stage 4S neuroblastoma|stage 4s neuroblastoma
845416|NCT00002802|localized unresectable neuroblastoma|localized unresectable neuroblastoma
845417|NCT00082446|Smallpox, vaccine|smallpox, vaccine
845418|NCT00082381|Diabetes|diabetes
845419|NCT00082381|Insulin glargine|insulin glargine
845420|NCT00082381|comparator|comparator
845421|NCT00082381|Amylin|amylin
845422|NCT00082381|Lilly|lilly
845423|NCT00002788|stage III chronic lymphocytic leukemia|stage iii chronic lymphocytic leukemia
845424|NCT00002788|stage IV chronic lymphocytic leukemia|stage iv chronic lymphocytic leukemia
845425|NCT00002788|refractory chronic lymphocytic leukemia|refractory chronic lymphocytic leukemia
845426|NCT00002788|B-cell chronic lymphocytic leukemia|b-cell chronic lymphocytic leukemia
845427|NCT00002737|stage IV renal cell cancer|stage iv renal cell cancer
845428|NCT00002737|recurrent renal cell cancer|recurrent renal cell cancer
845429|NCT00002677|stage IV prostate cancer|stage iv prostate cancer
845430|NCT00002677|recurrent prostate cancer|recurrent prostate cancer
845431|NCT00002677|unspecified adult solid tumor, protocol specific|unspecified adult solid tumor, protocol specific
845432|NCT00002644|breast cancer|breast cancer
845433|NCT00002644|tamoxifen|tamoxifen
845434|NCT00002644|prevention|prevention
845435|NCT00002644|IBIS|ibis
845436|NCT00002587|unspecified adult solid tumor, protocol specific|unspecified adult solid tumor, protocol specific
845437|NCT00082407|diabetes|diabetes
845438|NCT00082407|exendin|exendin
845439|NCT00082407|Amylin|amylin
845440|NCT00082407|Lilly|lilly
845441|NCT00082407|insulin aspart|insulin aspart
845442|NCT00082394|safety|safety
845443|NCT00082394|drug efficacy|drug efficacy
845444|NCT00082394|TRIZIVIR|trizivir
845445|NCT00082394|tolerability|tolerability
845446|NCT00082394|COMBIVIR|combivir
845447|NCT00082394|HIV|hiv
845448|NCT00082394|atazanavir|atazanavir
845449|NCT00082316|Dermal assessment|dermal assessment
845450|NCT00082316|Pain assessment|pain assessment
845451|NCT00082316|Diary|diary
845452|NCT00082316|Analgesics|analgesics
845453|NCT00082316|Capsaicin|capsaicin
845454|NCT00082316|Herpes zoster|herpes zoster
845455|NCT00082316|Neuralgia|neuralgia
845456|NCT00082316|HIV Infections|hiv infections
845457|NCT00082316|Peripheral Nervous System Diseases|peripheral nervous system diseases
845458|NCT00082316|Diabetic Neuropathies|diabetic neuropathies
845459|NCT00082316|Diabetes Mellitus|diabetes mellitus
845460|NCT00082316|Polyneuropathies|polyneuropathies
845461|NCT00082316|Complementary Therapies|complementary therapies
845462|NCT00082368|Tariquidar|tariquidar
845463|NCT00082368|PET|pet
845464|NCT00082368|Sestamibi|sestamibi
845465|NCT00082368|Cancer|cancer
845466|NCT00082355|r-tPA|r-tpa
845467|NCT00082355|Thrombolysis|thrombolysis
845468|NCT00082355|Clot|clot
845469|NCT00082355|Anticoagulation|anticoagulation
845470|NCT00082355|Fibrinolysis|fibrinolysis
845471|NCT00082355|Deep Vein Thrombosis|deep vein thrombosis
845472|NCT00082355|DVT|dvt
845473|NCT00082342|Human Brain|human brain
845474|NCT00082342|Electrical Stimulation|electrical stimulation
845475|NCT00082342|Parkinson Disease|parkinson disease
845476|NCT00082342|PD|pd
845477|NCT00082329|Hematopoietic Stem Cells|hematopoietic stem cells
845478|NCT00082329|PBSC's|pbsc's
845479|NCT00082329|Mobilization|mobilization
845480|NCT00082329|Alloreactivity|alloreactivity
845481|NCT00082329|T Cell Polarization|t cell polarization
845482|NCT00082329|Dendritic Cells|dendritic cells
845483|NCT00082329|CXCR4|cxcr4
845484|NCT00082329|Plerixafor|plerixafor
845485|NCT00082329|Healthy Volunteer (HV)|healthy volunteer (hv)
845486|NCT00082303|Music Therapy|music therapy
845488|NCT00082303|Depression|depression
845489|NCT00082290|unspecified adult solid tumor, protocol specific|unspecified adult solid tumor, protocol specific
845490|NCT00082290|pain|pain
845491|NCT00082277|hormone-receptor positive, breast cancer|hormone-receptor positive, breast cancer
845492|NCT00082277|Osteopenia|osteopenia
845493|NCT00082277|Osteoporosis|osteoporosis
845494|NCT00082277|risk of fracture|risk of fracture
845495|NCT00082277|bone loss|bone loss
845496|NCT00082251|Dyslipidemia|dyslipidemia
845497|NCT00082251|High Blood Cholesterol|high blood cholesterol
845498|NCT00082251|Coronary Heart Disease|coronary heart disease
845499|NCT00082251|Hypertension|hypertension
845500|NCT00082251|National Cholesterol Education Program|national cholesterol education program
845501|NCT00082251|Adult Treatment Panel III|adult treatment panel iii
845502|NCT00082251|Niacin|niacin
845503|NCT00082251|Simvastatin|simvastatin
845504|NCT00082251|Diabetes|diabetes
845505|NCT00082251|Peripheral Vascular Disease|peripheral vascular disease
845506|NCT00082251|Cerebrovascular disease|cerebrovascular disease
845507|NCT00082251|Stroke|stroke
845508|NCT00082251|High-Density Lipoprotein Cholesterol|high-density lipoprotein cholesterol
845509|NCT00082251|Hydroxymethyl Glutaryl Coenzyme A|hydroxymethyl glutaryl coenzyme a
845510|NCT00082251|High-Sensitivity C-Reactive Protein|high-sensitivity c-reactive protein
845511|NCT00082251|Low-Density Lipoprotein Cholesterol|low-density lipoprotein cholesterol
845512|NCT00082251|Lipoprotein (a)|lipoprotein (a)
845513|NCT00082251|Lipoprotein A-I|lipoprotein a-i
845514|NCT00082251|Total Cholesterol|total cholesterol
845515|NCT00082251|Triglycerides|triglycerides
845516|NCT00082225|Hodgkins|hodgkins
845517|NCT00082225|Non-Hodgkins|non-hodgkins
845518|NCT00082225|Lymphoma|lymphoma
845519|NCT00082212|ovarian|ovarian
845520|NCT00082212|primary peritoneal cancer|primary peritoneal cancer
845521|NCT00082212|Persistent or Recurrent Ovarian Cancer|persistent or recurrent ovarian cancer
845522|NCT00082212|Primary Peritoneal Carcinoma|primary peritoneal carcinoma
845523|NCT00014651|perioperative/postoperative complications|perioperative/postoperative complications
845524|NCT00014651|stage I pancreatic cancer|stage i pancreatic cancer
845525|NCT00010322|stage IV breast cancer|stage iv breast cancer
845526|NCT00010322|recurrent breast cancer|recurrent breast cancer
845527|NCT00008255|non-small cell lung cancer|non-small cell lung cancer
845528|NCT00008255|small cell lung cancer|small cell lung cancer
845529|NCT00002568|stage III ovarian epithelial cancer|stage iii ovarian epithelial cancer
845530|NCT00002568|ovarian undifferentiated adenocarcinoma|ovarian undifferentiated adenocarcinoma
845531|NCT00002568|ovarian mixed epithelial carcinoma|ovarian mixed epithelial carcinoma
845532|NCT00002568|ovarian serous cystadenocarcinoma|ovarian serous cystadenocarcinoma
845533|NCT00002568|ovarian mucinous cystadenocarcinoma|ovarian mucinous cystadenocarcinoma
845534|NCT00002568|ovarian endometrioid adenocarcinoma|ovarian endometrioid adenocarcinoma
845535|NCT00002568|ovarian clear cell cystadenocarcinoma|ovarian clear cell cystadenocarcinoma
845536|NCT00002568|Brenner tumor|brenner tumor
845537|NCT00002516|localized Ewing sarcoma/peripheral primitive neuroectodermal tumor|localized ewing sarcoma/peripheral primitive neuroectodermal tumor
845538|NCT00002516|metastatic Ewing sarcoma/peripheral primitive neuroectodermal tumor|metastatic ewing sarcoma/peripheral primitive neuroectodermal tumor
845539|NCT00082160|Meditation|meditation
845540|NCT00082160|Relaxation|relaxation
845541|NCT00082134|Prostate cancer|prostate cancer
845542|NCT00082134|Hormone-refractory prostate cancer|hormone-refractory prostate cancer
845543|NCT00082134|HRPC|hrpc
845544|NCT00082134|Prostate|prostate
845545|NCT00082134|Docetaxel|docetaxel
845546|NCT00082134|PSA progression|psa progression
845547|NCT00082134|PSA progressed|psa progressed
845548|NCT00082121|cardiac bypass|cardiac bypass
845549|NCT00082121|CABG|cabg
845550|NCT00082121|complement activation|complement activation
845551|NCT00011934|relapsing chronic myelogenous leukemia|relapsing chronic myelogenous leukemia
845552|NCT00011934|chronic phase chronic myelogenous leukemia|chronic phase chronic myelogenous leukemia
845553|NCT00011934|Philadelphia chromosome positive chronic myelogenous leukemia|philadelphia chromosome positive chronic myelogenous leukemia
845554|NCT00011934|Philadelphia chromosome negative chronic myelogenous leukemia|philadelphia chromosome negative chronic myelogenous leukemia
845555|NCT00008242|stage II multiple myeloma|stage ii multiple myeloma
845556|NCT00008242|stage III multiple myeloma|stage iii multiple myeloma
845557|NCT00008125|unspecified adult solid tumor, protocol specific|unspecified adult solid tumor, protocol specific
845558|NCT00008099|stage I pancreatic cancer|stage i pancreatic cancer
845559|NCT00008099|stage II pancreatic cancer|stage ii pancreatic cancer
845560|NCT00008099|stage III pancreatic cancer|stage iii pancreatic cancer
845561|NCT00008099|stage IV pancreatic cancer|stage iv pancreatic cancer
845562|NCT00006682|stage IV breast cancer|stage iv breast cancer
845563|NCT00006682|recurrent breast cancer|recurrent breast cancer
845564|NCT00006669|recurrent grade 3 follicular lymphoma|recurrent grade 3 follicular lymphoma
845565|NCT00006669|recurrent adult diffuse small cleaved cell lymphoma|recurrent adult diffuse small cleaved cell lymphoma
845566|NCT00006669|recurrent adult diffuse mixed cell lymphoma|recurrent adult diffuse mixed cell lymphoma
845567|NCT00006669|recurrent adult diffuse large cell lymphoma|recurrent adult diffuse large cell lymphoma
845568|NCT00006342|stage I adult Hodgkin lymphoma|stage i adult hodgkin lymphoma
845569|NCT00006342|stage II adult Hodgkin lymphoma|stage ii adult hodgkin lymphoma
845570|NCT00006342|stage III adult Hodgkin lymphoma|stage iii adult hodgkin lymphoma
845571|NCT00006342|stage IV adult Hodgkin lymphoma|stage iv adult hodgkin lymphoma
845572|NCT00006342|recurrent adult Hodgkin lymphoma|recurrent adult hodgkin lymphoma
845573|NCT00006342|childhood infratentorial ependymoma|childhood infratentorial ependymoma
845574|NCT00006342|childhood low-grade cerebral astrocytoma|childhood low-grade cerebral astrocytoma
845575|NCT00006342|childhood supratentorial ependymoma|childhood supratentorial ependymoma
845576|NCT00006342|stage II childhood Hodgkin lymphoma|stage ii childhood hodgkin lymphoma
845577|NCT00006342|stage I childhood Hodgkin lymphoma|stage i childhood hodgkin lymphoma
846616|NCT00003434|stage III pancreatic cancer|stage iii pancreatic cancer
845578|NCT00006342|stage III childhood Hodgkin lymphoma|stage iii childhood hodgkin lymphoma
845579|NCT00006342|stage IV childhood Hodgkin lymphoma|stage iv childhood hodgkin lymphoma
845580|NCT00006342|recurrent/refractory childhood Hodgkin lymphoma|recurrent/refractory childhood hodgkin lymphoma
845581|NCT00006342|childhood high-grade cerebral astrocytoma|childhood high-grade cerebral astrocytoma
845582|NCT00006342|untreated childhood brain stem glioma|untreated childhood brain stem glioma
845583|NCT00006342|recurrent childhood brain stem glioma|recurrent childhood brain stem glioma
845584|NCT00006342|untreated childhood supratentorial primitive neuroectodermal tumor|untreated childhood supratentorial primitive neuroectodermal tumor
845585|NCT00006342|recurrent childhood supratentorial primitive neuroectodermal tumor|recurrent childhood supratentorial primitive neuroectodermal tumor
845586|NCT00006342|untreated childhood cerebellar astrocytoma|untreated childhood cerebellar astrocytoma
845587|NCT00006342|recurrent childhood cerebellar astrocytoma|recurrent childhood cerebellar astrocytoma
845588|NCT00006342|recurrent childhood cerebral astrocytoma|recurrent childhood cerebral astrocytoma
845589|NCT00006342|untreated childhood medulloblastoma|untreated childhood medulloblastoma
845590|NCT00006342|recurrent childhood medulloblastoma|recurrent childhood medulloblastoma
845591|NCT00006342|newly diagnosed childhood ependymoma|newly diagnosed childhood ependymoma
845592|NCT00006342|recurrent childhood ependymoma|recurrent childhood ependymoma
845593|NCT00006112|stage IV colon cancer|stage iv colon cancer
845594|NCT00006112|stage IV rectal cancer|stage iv rectal cancer
845595|NCT00006112|adenocarcinoma of the colon|adenocarcinoma of the colon
845596|NCT00006112|adenocarcinoma of the rectum|adenocarcinoma of the rectum
845597|NCT00006112|carcinoma of the appendix|carcinoma of the appendix
845598|NCT00006112|primary peritoneal cavity cancer|primary peritoneal cavity cancer
845599|NCT00006097|refractory chronic lymphocytic leukemia|refractory chronic lymphocytic leukemia
845600|NCT00006097|B-cell chronic lymphocytic leukemia|b-cell chronic lymphocytic leukemia
845601|NCT00006053|relapsing chronic myelogenous leukemia|relapsing chronic myelogenous leukemia
845602|NCT00006053|chronic phase chronic myelogenous leukemia|chronic phase chronic myelogenous leukemia
845603|NCT00006053|chronic myelogenous leukemia, BCR-ABL1 positive|chronic myelogenous leukemia, bcr-abl1 positive
845604|NCT00006053|Philadelphia chromosome negative chronic myelogenous leukemia|philadelphia chromosome negative chronic myelogenous leukemia
845605|NCT00006039|small intestine lymphoma|small intestine lymphoma
845606|NCT00006039|stage III grade 1 follicular lymphoma|stage iii grade 1 follicular lymphoma
845607|NCT00006039|stage III grade 2 follicular lymphoma|stage iii grade 2 follicular lymphoma
845608|NCT00006039|stage IV grade 1 follicular lymphoma|stage iv grade 1 follicular lymphoma
845609|NCT00006039|stage IV grade 2 follicular lymphoma|stage iv grade 2 follicular lymphoma
845610|NCT00006039|recurrent grade 1 follicular lymphoma|recurrent grade 1 follicular lymphoma
845611|NCT00006039|recurrent grade 2 follicular lymphoma|recurrent grade 2 follicular lymphoma
845612|NCT00006039|contiguous stage II grade 1 follicular lymphoma|contiguous stage ii grade 1 follicular lymphoma
845613|NCT00006039|contiguous stage II grade 2 follicular lymphoma|contiguous stage ii grade 2 follicular lymphoma
845614|NCT00006039|noncontiguous stage II grade 1 follicular lymphoma|noncontiguous stage ii grade 1 follicular lymphoma
845615|NCT00006039|noncontiguous stage II grade 2 follicular lymphoma|noncontiguous stage ii grade 2 follicular lymphoma
845616|NCT00006039|noncontiguous stage II small lymphocytic lymphoma|noncontiguous stage ii small lymphocytic lymphoma
845617|NCT00006039|noncontiguous stage II marginal zone lymphoma|noncontiguous stage ii marginal zone lymphoma
845618|NCT00006039|recurrent marginal zone lymphoma|recurrent marginal zone lymphoma
845619|NCT00006039|recurrent small lymphocytic lymphoma|recurrent small lymphocytic lymphoma
845620|NCT00006039|stage III small lymphocytic lymphoma|stage iii small lymphocytic lymphoma
845621|NCT00006039|stage III marginal zone lymphoma|stage iii marginal zone lymphoma
845622|NCT00006039|stage IV small lymphocytic lymphoma|stage iv small lymphocytic lymphoma
845623|NCT00006039|stage IV marginal zone lymphoma|stage iv marginal zone lymphoma
845624|NCT00006039|contiguous stage II marginal zone lymphoma|contiguous stage ii marginal zone lymphoma
845625|NCT00006039|contiguous stage II small lymphocytic lymphoma|contiguous stage ii small lymphocytic lymphoma
845626|NCT00006039|extranodal marginal zone B-cell lymphoma of mucosa-associated lymphoid tissue|extranodal marginal zone b-cell lymphoma of mucosa-associated lymphoid tissue
845627|NCT00006039|nodal marginal zone B-cell lymphoma|nodal marginal zone b-cell lymphoma
845628|NCT00006039|splenic marginal zone lymphoma|splenic marginal zone lymphoma
845629|NCT00005988|recurrent childhood acute lymphoblastic leukemia|recurrent childhood acute lymphoblastic leukemia
845630|NCT00005988|recurrent adult Hodgkin lymphoma|recurrent adult hodgkin lymphoma
845631|NCT00005988|refractory multiple myeloma|refractory multiple myeloma
845632|NCT00005988|stage I multiple myeloma|stage i multiple myeloma
845633|NCT00005988|stage II multiple myeloma|stage ii multiple myeloma
845634|NCT00005988|stage III multiple myeloma|stage iii multiple myeloma
845635|NCT00005988|stage I childhood lymphoblastic lymphoma|stage i childhood lymphoblastic lymphoma
845636|NCT00005988|stage II childhood lymphoblastic lymphoma|stage ii childhood lymphoblastic lymphoma
845637|NCT00005988|stage III childhood lymphoblastic lymphoma|stage iii childhood lymphoblastic lymphoma
845638|NCT00005988|stage IV childhood lymphoblastic lymphoma|stage iv childhood lymphoblastic lymphoma
845639|NCT00005988|recurrent childhood lymphoblastic lymphoma|recurrent childhood lymphoblastic lymphoma
846114|NCT00003038|stage IV prostate cancer|stage iv prostate cancer
845640|NCT00005988|recurrent childhood acute myeloid leukemia|recurrent childhood acute myeloid leukemia
848198|NCT00010283|stage IIIA breast cancer|stage iiia breast cancer
845641|NCT00005988|recurrent adult acute myeloid leukemia|recurrent adult acute myeloid leukemia
845642|NCT00005988|recurrent adult acute lymphoblastic leukemia|recurrent adult acute lymphoblastic leukemia
845643|NCT00005988|childhood diffuse large cell lymphoma|childhood diffuse large cell lymphoma
845644|NCT00005988|childhood immunoblastic large cell lymphoma|childhood immunoblastic large cell lymphoma
845645|NCT00005988|adult acute myeloid leukemia in remission|adult acute myeloid leukemia in remission
845646|NCT00005988|adult acute lymphoblastic leukemia in remission|adult acute lymphoblastic leukemia in remission
845647|NCT00005988|childhood acute myeloid leukemia in remission|childhood acute myeloid leukemia in remission
845648|NCT00005988|childhood acute lymphoblastic leukemia in remission|childhood acute lymphoblastic leukemia in remission
845649|NCT00005988|recurrent/refractory childhood Hodgkin lymphoma|recurrent/refractory childhood hodgkin lymphoma
845650|NCT00005988|stage I grade 3 follicular lymphoma|stage i grade 3 follicular lymphoma
845651|NCT00005988|stage I adult diffuse small cleaved cell lymphoma|stage i adult diffuse small cleaved cell lymphoma
845652|NCT00005988|stage I adult diffuse mixed cell lymphoma|stage i adult diffuse mixed cell lymphoma
845653|NCT00005988|stage I adult diffuse large cell lymphoma|stage i adult diffuse large cell lymphoma
845654|NCT00005988|stage I adult immunoblastic large cell lymphoma|stage i adult immunoblastic large cell lymphoma
845655|NCT00005988|stage I adult lymphoblastic lymphoma|stage i adult lymphoblastic lymphoma
845656|NCT00005988|stage I adult Burkitt lymphoma|stage i adult burkitt lymphoma
845657|NCT00005988|chronic myelomonocytic leukemia|chronic myelomonocytic leukemia
845658|NCT00005988|stage III grade 3 follicular lymphoma|stage iii grade 3 follicular lymphoma
845659|NCT00005988|stage III adult diffuse small cleaved cell lymphoma|stage iii adult diffuse small cleaved cell lymphoma
845660|NCT00005988|stage III adult diffuse mixed cell lymphoma|stage iii adult diffuse mixed cell lymphoma
845661|NCT00005988|stage III adult diffuse large cell lymphoma|stage iii adult diffuse large cell lymphoma
845662|NCT00005988|stage III adult immunoblastic large cell lymphoma|stage iii adult immunoblastic large cell lymphoma
845663|NCT00005988|stage III adult lymphoblastic lymphoma|stage iii adult lymphoblastic lymphoma
845664|NCT00005988|stage III adult Burkitt lymphoma|stage iii adult burkitt lymphoma
845665|NCT00005988|stage IV grade 3 follicular lymphoma|stage iv grade 3 follicular lymphoma
845666|NCT00005988|stage IV adult diffuse mixed cell lymphoma|stage iv adult diffuse mixed cell lymphoma
845667|NCT00005988|stage IV adult diffuse large cell lymphoma|stage iv adult diffuse large cell lymphoma
845668|NCT00005988|stage IV adult immunoblastic large cell lymphoma|stage iv adult immunoblastic large cell lymphoma
845669|NCT00005988|stage IV adult lymphoblastic lymphoma|stage iv adult lymphoblastic lymphoma
845670|NCT00005988|stage IV adult Burkitt lymphoma|stage iv adult burkitt lymphoma
845671|NCT00005988|recurrent grade 3 follicular lymphoma|recurrent grade 3 follicular lymphoma
845672|NCT00005988|recurrent adult diffuse small cleaved cell lymphoma|recurrent adult diffuse small cleaved cell lymphoma
845673|NCT00005988|recurrent adult diffuse mixed cell lymphoma|recurrent adult diffuse mixed cell lymphoma
845674|NCT00005988|recurrent adult diffuse large cell lymphoma|recurrent adult diffuse large cell lymphoma
845675|NCT00005988|recurrent adult immunoblastic large cell lymphoma|recurrent adult immunoblastic large cell lymphoma
845676|NCT00005988|recurrent adult lymphoblastic lymphoma|recurrent adult lymphoblastic lymphoma
845677|NCT00005988|recurrent adult Burkitt lymphoma|recurrent adult burkitt lymphoma
845678|NCT00005988|de novo myelodysplastic syndromes|de novo myelodysplastic syndromes
845679|NCT00005988|previously treated myelodysplastic syndromes|previously treated myelodysplastic syndromes
845680|NCT00005988|secondary myelodysplastic syndromes|secondary myelodysplastic syndromes
845681|NCT00005988|graft versus host disease|graft versus host disease
845682|NCT00005988|stage I childhood small noncleaved cell lymphoma|stage i childhood small noncleaved cell lymphoma
845683|NCT00005988|stage I childhood large cell lymphoma|stage i childhood large cell lymphoma
845684|NCT00005988|stage II childhood small noncleaved cell lymphoma|stage ii childhood small noncleaved cell lymphoma
845685|NCT00005988|stage II childhood large cell lymphoma|stage ii childhood large cell lymphoma
845686|NCT00005988|stage III childhood small noncleaved cell lymphoma|stage iii childhood small noncleaved cell lymphoma
845687|NCT00005988|stage III childhood large cell lymphoma|stage iii childhood large cell lymphoma
845688|NCT00005988|stage IV childhood small noncleaved cell lymphoma|stage iv childhood small noncleaved cell lymphoma
845689|NCT00005988|stage IV childhood large cell lymphoma|stage iv childhood large cell lymphoma
845690|NCT00005988|recurrent childhood small noncleaved cell lymphoma|recurrent childhood small noncleaved cell lymphoma
845691|NCT00005988|recurrent childhood large cell lymphoma|recurrent childhood large cell lymphoma
845692|NCT00005988|contiguous stage II grade 3 follicular lymphoma|contiguous stage ii grade 3 follicular lymphoma
845693|NCT00005988|contiguous stage II adult diffuse small cleaved cell lymphoma|contiguous stage ii adult diffuse small cleaved cell lymphoma
845694|NCT00005988|contiguous stage II adult diffuse mixed cell lymphoma|contiguous stage ii adult diffuse mixed cell lymphoma
845695|NCT00005988|contiguous stage II adult immunoblastic large cell lymphoma|contiguous stage ii adult immunoblastic large cell lymphoma
845696|NCT00005988|contiguous stage II adult diffuse large cell lymphoma|contiguous stage ii adult diffuse large cell lymphoma
845697|NCT00005988|contiguous stage II adult Burkitt lymphoma|contiguous stage ii adult burkitt lymphoma
845698|NCT00005988|contiguous stage II adult lymphoblastic lymphoma|contiguous stage ii adult lymphoblastic lymphoma
845699|NCT00005988|noncontiguous stage II grade 3 follicular lymphoma|noncontiguous stage ii grade 3 follicular lymphoma
845765|NCT00005021|recurrent adult lymphoblastic lymphoma|recurrent adult lymphoblastic lymphoma
845766|NCT00005021|recurrent adult Burkitt lymphoma|recurrent adult burkitt lymphoma
845700|NCT00005988|noncontiguous stage II adult diffuse small cleaved cell lymphoma|noncontiguous stage ii adult diffuse small cleaved cell lymphoma
845701|NCT00005988|noncontiguous stage II adult diffuse mixed cell lymphoma|noncontiguous stage ii adult diffuse mixed cell lymphoma
845702|NCT00005988|noncontiguous stage II adult immunoblastic large cell lymphoma|noncontiguous stage ii adult immunoblastic large cell lymphoma
845703|NCT00005988|noncontiguous stage II adult diffuse large cell lymphoma|noncontiguous stage ii adult diffuse large cell lymphoma
845704|NCT00005988|noncontiguous stage II adult Burkitt lymphoma|noncontiguous stage ii adult burkitt lymphoma
845705|NCT00005988|noncontiguous stage II adult lymphoblastic lymphoma|noncontiguous stage ii adult lymphoblastic lymphoma
845706|NCT00005988|refractory cytopenia with multilineage dysplasia|refractory cytopenia with multilineage dysplasia
845707|NCT00005988|childhood myelodysplastic syndromes|childhood myelodysplastic syndromes
845708|NCT00005974|stage III adult soft tissue sarcoma|stage iii adult soft tissue sarcoma
845709|NCT00005974|stage IV adult soft tissue sarcoma|stage iv adult soft tissue sarcoma
845710|NCT00005871|recurrent pancreatic cancer|recurrent pancreatic cancer
845711|NCT00005871|adenocarcinoma of the pancreas|adenocarcinoma of the pancreas
845712|NCT00005612|stage III ovarian epithelial cancer|stage iii ovarian epithelial cancer
845713|NCT00005612|stage IV ovarian epithelial cancer|stage iv ovarian epithelial cancer
845714|NCT00005612|recurrent ovarian epithelial cancer|recurrent ovarian epithelial cancer
845715|NCT00005594|stage III pancreatic cancer|stage iii pancreatic cancer
845716|NCT00005594|adenocarcinoma of the pancreas|adenocarcinoma of the pancreas
845717|NCT00005594|stage IV pancreatic cancer|stage iv pancreatic cancer
845718|NCT00005081|recurrent adult brain tumor|recurrent adult brain tumor
845719|NCT00005081|adult glioblastoma|adult glioblastoma
845720|NCT00005081|adult anaplastic astrocytoma|adult anaplastic astrocytoma
845721|NCT00005081|adult mixed glioma|adult mixed glioma
845722|NCT00005081|adult giant cell glioblastoma|adult giant cell glioblastoma
845723|NCT00005081|adult gliosarcoma|adult gliosarcoma
845724|NCT00005055|recurrent non-small cell lung cancer|recurrent non-small cell lung cancer
845725|NCT00005055|stage IIIA non-small cell lung cancer|stage iiia non-small cell lung cancer
845726|NCT00005055|stage IIIB non-small cell lung cancer|stage iiib non-small cell lung cancer
845727|NCT00005055|stage IV non-small cell lung cancer|stage iv non-small cell lung cancer
845728|NCT00005053|stage III pancreatic cancer|stage iii pancreatic cancer
845729|NCT00005053|recurrent pancreatic cancer|recurrent pancreatic cancer
845730|NCT00005053|adenocarcinoma of the pancreas|adenocarcinoma of the pancreas
845731|NCT00005053|stage IV pancreatic cancer|stage iv pancreatic cancer
845732|NCT00005021|stage III adult Hodgkin lymphoma|stage iii adult hodgkin lymphoma
845733|NCT00005021|stage IV adult Hodgkin lymphoma|stage iv adult hodgkin lymphoma
845734|NCT00005021|recurrent adult Hodgkin lymphoma|recurrent adult hodgkin lymphoma
845735|NCT00005021|stage III cutaneous T-cell non-Hodgkin lymphoma|stage iii cutaneous t-cell non-hodgkin lymphoma
845736|NCT00005021|stage IV cutaneous T-cell non-Hodgkin lymphoma|stage iv cutaneous t-cell non-hodgkin lymphoma
845737|NCT00005021|recurrent cutaneous T-cell non-Hodgkin lymphoma|recurrent cutaneous t-cell non-hodgkin lymphoma
845738|NCT00005021|small intestine lymphoma|small intestine lymphoma
845739|NCT00005021|unspecified adult solid tumor, protocol specific|unspecified adult solid tumor, protocol specific
845740|NCT00005021|stage III grade 1 follicular lymphoma|stage iii grade 1 follicular lymphoma
845741|NCT00005021|stage III grade 2 follicular lymphoma|stage iii grade 2 follicular lymphoma
845742|NCT00005021|stage III grade 3 follicular lymphoma|stage iii grade 3 follicular lymphoma
845743|NCT00005021|stage III adult diffuse small cleaved cell lymphoma|stage iii adult diffuse small cleaved cell lymphoma
845744|NCT00005021|stage III adult diffuse mixed cell lymphoma|stage iii adult diffuse mixed cell lymphoma
845745|NCT00005021|stage III adult diffuse large cell lymphoma|stage iii adult diffuse large cell lymphoma
845746|NCT00005021|stage III adult immunoblastic large cell lymphoma|stage iii adult immunoblastic large cell lymphoma
845747|NCT00005021|stage III adult lymphoblastic lymphoma|stage iii adult lymphoblastic lymphoma
845748|NCT00005021|stage III adult Burkitt lymphoma|stage iii adult burkitt lymphoma
845749|NCT00005021|stage IV grade 1 follicular lymphoma|stage iv grade 1 follicular lymphoma
845750|NCT00005021|stage IV grade 2 follicular lymphoma|stage iv grade 2 follicular lymphoma
845751|NCT00005021|stage IV grade 3 follicular lymphoma|stage iv grade 3 follicular lymphoma
845752|NCT00005021|stage IV adult diffuse small cleaved cell lymphoma|stage iv adult diffuse small cleaved cell lymphoma
845753|NCT00005021|stage IV adult diffuse mixed cell lymphoma|stage iv adult diffuse mixed cell lymphoma
845754|NCT00005021|stage IV adult diffuse large cell lymphoma|stage iv adult diffuse large cell lymphoma
845755|NCT00005021|stage IV adult immunoblastic large cell lymphoma|stage iv adult immunoblastic large cell lymphoma
845756|NCT00005021|stage IV adult lymphoblastic lymphoma|stage iv adult lymphoblastic lymphoma
845757|NCT00005021|stage IV adult Burkitt lymphoma|stage iv adult burkitt lymphoma
845758|NCT00005021|recurrent grade 1 follicular lymphoma|recurrent grade 1 follicular lymphoma
845759|NCT00005021|recurrent grade 2 follicular lymphoma|recurrent grade 2 follicular lymphoma
845760|NCT00005021|recurrent grade 3 follicular lymphoma|recurrent grade 3 follicular lymphoma
845761|NCT00005021|recurrent adult diffuse small cleaved cell lymphoma|recurrent adult diffuse small cleaved cell lymphoma
845762|NCT00005021|recurrent adult diffuse mixed cell lymphoma|recurrent adult diffuse mixed cell lymphoma
845763|NCT00005021|recurrent adult diffuse large cell lymphoma|recurrent adult diffuse large cell lymphoma
845764|NCT00005021|recurrent adult immunoblastic large cell lymphoma|recurrent adult immunoblastic large cell lymphoma
845963|NCT00003968|stage IV renal cell cancer|stage iv renal cell cancer
845767|NCT00005021|stage III adult T-cell leukemia/lymphoma|stage iii adult t-cell leukemia/lymphoma
845768|NCT00005021|stage IV adult T-cell leukemia/lymphoma|stage iv adult t-cell leukemia/lymphoma
845769|NCT00005021|recurrent adult T-cell leukemia/lymphoma|recurrent adult t-cell leukemia/lymphoma
845770|NCT00005021|primary central nervous system non-Hodgkin lymphoma|primary central nervous system non-hodgkin lymphoma
845771|NCT00005021|AIDS-related peripheral/systemic lymphoma|aids-related peripheral/systemic lymphoma
845772|NCT00005021|AIDS-related primary CNS lymphoma|aids-related primary cns lymphoma
845773|NCT00005021|intraocular lymphoma|intraocular lymphoma
845774|NCT00005021|stage III mantle cell lymphoma|stage iii mantle cell lymphoma
845775|NCT00005021|stage IV mantle cell lymphoma|stage iv mantle cell lymphoma
845776|NCT00005021|recurrent mantle cell lymphoma|recurrent mantle cell lymphoma
845777|NCT00005021|angioimmunoblastic T-cell lymphoma|angioimmunoblastic t-cell lymphoma
845778|NCT00005021|anaplastic large cell lymphoma|anaplastic large cell lymphoma
845779|NCT00005021|stage III mycosis fungoides/Sezary syndrome|stage iii mycosis fungoides/sezary syndrome
845780|NCT00005021|stage IV mycosis fungoides/Sezary syndrome|stage iv mycosis fungoides/sezary syndrome
845781|NCT00005021|recurrent mycosis fungoides/Sezary syndrome|recurrent mycosis fungoides/sezary syndrome
845782|NCT00005021|recurrent marginal zone lymphoma|recurrent marginal zone lymphoma
845783|NCT00005021|recurrent small lymphocytic lymphoma|recurrent small lymphocytic lymphoma
845784|NCT00005021|stage III small lymphocytic lymphoma|stage iii small lymphocytic lymphoma
845785|NCT00005021|stage III marginal zone lymphoma|stage iii marginal zone lymphoma
845786|NCT00005021|stage IV small lymphocytic lymphoma|stage iv small lymphocytic lymphoma
845787|NCT00005021|stage IV marginal zone lymphoma|stage iv marginal zone lymphoma
845788|NCT00005021|extranodal marginal zone B-cell lymphoma of mucosa-associated lymphoid tissue|extranodal marginal zone b-cell lymphoma of mucosa-associated lymphoid tissue
845789|NCT00005021|nodal marginal zone B-cell lymphoma|nodal marginal zone b-cell lymphoma
845790|NCT00005021|splenic marginal zone lymphoma|splenic marginal zone lymphoma
845791|NCT00004893|stage IV breast cancer|stage iv breast cancer
845792|NCT00004893|recurrent breast cancer|recurrent breast cancer
845793|NCT00004892|recurrent adult brain tumor|recurrent adult brain tumor
845794|NCT00004892|adult brain stem glioma|adult brain stem glioma
845795|NCT00004892|adult ependymoma|adult ependymoma
845796|NCT00004892|adult glioblastoma|adult glioblastoma
845797|NCT00004892|adult oligodendroglioma|adult oligodendroglioma
845798|NCT00004892|adult anaplastic astrocytoma|adult anaplastic astrocytoma
845799|NCT00004892|adult mixed glioma|adult mixed glioma
845800|NCT00004892|adult giant cell glioblastoma|adult giant cell glioblastoma
845801|NCT00004892|adult gliosarcoma|adult gliosarcoma
845802|NCT00004884|stage III pancreatic cancer|stage iii pancreatic cancer
845803|NCT00004884|recurrent pancreatic cancer|recurrent pancreatic cancer
845804|NCT00004884|adenocarcinoma of the pancreas|adenocarcinoma of the pancreas
845805|NCT00004884|stage IV pancreatic cancer|stage iv pancreatic cancer
845806|NCT00004246|Radiation Therapy|radiation therapy
845808|NCT00004246|Radiotherapy|radiotherapy
845809|NCT00004246|Fludarabine|fludarabine
845810|NCT00004246|Fludara|fludara
845811|NCT00004246|Fludarabine Phosphate|fludarabine phosphate
845812|NCT00004246|stage III squamous cell carcinoma of the lip and oral cavity|stage iii squamous cell carcinoma of the lip and oral cavity
845813|NCT00004246|stage IV squamous cell carcinoma of the lip and oral cavity|stage iv squamous cell carcinoma of the lip and oral cavity
845814|NCT00004246|stage III squamous cell carcinoma of the oropharynx|stage iii squamous cell carcinoma of the oropharynx
845815|NCT00004246|stage IV squamous cell carcinoma of the oropharynx|stage iv squamous cell carcinoma of the oropharynx
845816|NCT00004246|stage III squamous cell carcinoma of the nasopharynx|stage iii squamous cell carcinoma of the nasopharynx
845817|NCT00004246|stage IV squamous cell carcinoma of the nasopharynx|stage iv squamous cell carcinoma of the nasopharynx
845818|NCT00004246|stage III squamous cell carcinoma of the hypopharynx|stage iii squamous cell carcinoma of the hypopharynx
845819|NCT00004246|stage IV squamous cell carcinoma of the hypopharynx|stage iv squamous cell carcinoma of the hypopharynx
845820|NCT00004246|stage III squamous cell carcinoma of the larynx|stage iii squamous cell carcinoma of the larynx
845821|NCT00004246|stage IV squamous cell carcinoma of the larynx|stage iv squamous cell carcinoma of the larynx
845822|NCT00004230|pulmonary complications|pulmonary complications
845823|NCT00004230|stage IV breast cancer|stage iv breast cancer
845824|NCT00004230|stage IIIA breast cancer|stage iiia breast cancer
845825|NCT00004230|stage IIIB breast cancer|stage iiib breast cancer
845826|NCT00004230|recurrent childhood acute lymphoblastic leukemia|recurrent childhood acute lymphoblastic leukemia
845827|NCT00004230|recurrent adult Hodgkin lymphoma|recurrent adult hodgkin lymphoma
845828|NCT00004230|recurrent cutaneous T-cell non-Hodgkin lymphoma|recurrent cutaneous t-cell non-hodgkin lymphoma
845829|NCT00004230|refractory multiple myeloma|refractory multiple myeloma
845830|NCT00004230|recurrent childhood rhabdomyosarcoma|recurrent childhood rhabdomyosarcoma
845831|NCT00004230|stage II ovarian epithelial cancer|stage ii ovarian epithelial cancer
845832|NCT00004230|stage III ovarian epithelial cancer|stage iii ovarian epithelial cancer
845833|NCT00004230|stage IV ovarian epithelial cancer|stage iv ovarian epithelial cancer
845834|NCT00004230|recurrent ovarian epithelial cancer|recurrent ovarian epithelial cancer
845835|NCT00004230|disseminated neuroblastoma|disseminated neuroblastoma
845836|NCT00004230|recurrent neuroblastoma|recurrent neuroblastoma
845964|NCT00003968|recurrent renal cell cancer|recurrent renal cell cancer
846115|NCT00003038|recurrent prostate cancer|recurrent prostate cancer
845837|NCT00004230|recurrent Wilms tumor and other childhood kidney tumors|recurrent wilms tumor and other childhood kidney tumors
845838|NCT00004230|stage I multiple myeloma|stage i multiple myeloma
845839|NCT00004230|stage II multiple myeloma|stage ii multiple myeloma
845840|NCT00004230|stage III multiple myeloma|stage iii multiple myeloma
845841|NCT00004230|recurrent childhood lymphoblastic lymphoma|recurrent childhood lymphoblastic lymphoma
845842|NCT00004230|stage III chronic lymphocytic leukemia|stage iii chronic lymphocytic leukemia
845843|NCT00004230|stage IV chronic lymphocytic leukemia|stage iv chronic lymphocytic leukemia
845844|NCT00004230|recurrent childhood acute myeloid leukemia|recurrent childhood acute myeloid leukemia
845845|NCT00004230|recurrent adult acute myeloid leukemia|recurrent adult acute myeloid leukemia
845846|NCT00004230|recurrent adult acute lymphoblastic leukemia|recurrent adult acute lymphoblastic leukemia
845847|NCT00004230|relapsing chronic myelogenous leukemia|relapsing chronic myelogenous leukemia
845848|NCT00004230|refractory chronic lymphocytic leukemia|refractory chronic lymphocytic leukemia
845849|NCT00004230|stage III malignant testicular germ cell tumor|stage iii malignant testicular germ cell tumor
845850|NCT00004230|recurrent malignant testicular germ cell tumor|recurrent malignant testicular germ cell tumor
845851|NCT00004230|chronic phase chronic myelogenous leukemia|chronic phase chronic myelogenous leukemia
845852|NCT00004230|accelerated phase chronic myelogenous leukemia|accelerated phase chronic myelogenous leukemia
845853|NCT00004230|blastic phase chronic myelogenous leukemia|blastic phase chronic myelogenous leukemia
845854|NCT00004230|meningeal chronic myelogenous leukemia|meningeal chronic myelogenous leukemia
845855|NCT00004230|chronic idiopathic myelofibrosis|chronic idiopathic myelofibrosis
845856|NCT00004230|childhood acute promyelocytic leukemia (M3)|childhood acute promyelocytic leukemia (m3)
845857|NCT00004230|testicular embryonal carcinoma|testicular embryonal carcinoma
845858|NCT00004230|testicular choriocarcinoma|testicular choriocarcinoma
845859|NCT00004230|testicular teratoma|testicular teratoma
845860|NCT00004230|testicular yolk sac tumor|testicular yolk sac tumor
845861|NCT00004230|testicular embryonal carcinoma and teratoma|testicular embryonal carcinoma and teratoma
845862|NCT00004230|testicular embryonal carcinoma and teratoma with seminoma|testicular embryonal carcinoma and teratoma with seminoma
845863|NCT00004230|testicular embryonal carcinoma and yolk sac tumor|testicular embryonal carcinoma and yolk sac tumor
845864|NCT00004230|testicular embryonal carcinoma and yolk sac tumor with seminoma|testicular embryonal carcinoma and yolk sac tumor with seminoma
845865|NCT00004230|testicular embryonal carcinoma and seminoma|testicular embryonal carcinoma and seminoma
845866|NCT00004230|testicular yolk sac tumor and teratoma|testicular yolk sac tumor and teratoma
845867|NCT00004230|testicular yolk sac tumor and teratoma with seminoma|testicular yolk sac tumor and teratoma with seminoma
845868|NCT00004230|testicular choriocarcinoma and yolk sac tumor|testicular choriocarcinoma and yolk sac tumor
845869|NCT00004230|testicular choriocarcinoma and embryonal carcinoma|testicular choriocarcinoma and embryonal carcinoma
845870|NCT00004230|testicular choriocarcinoma and teratoma|testicular choriocarcinoma and teratoma
845871|NCT00004230|testicular choriocarcinoma and seminoma|testicular choriocarcinoma and seminoma
845872|NCT00004230|refractory hairy cell leukemia|refractory hairy cell leukemia
845873|NCT00004230|recurrent/refractory childhood Hodgkin lymphoma|recurrent/refractory childhood hodgkin lymphoma
845874|NCT00004230|recurrent ovarian germ cell tumor|recurrent ovarian germ cell tumor
845875|NCT00004230|ovarian yolk sac tumor|ovarian yolk sac tumor
845876|NCT00004230|ovarian embryonal carcinoma|ovarian embryonal carcinoma
845877|NCT00004230|ovarian polyembryoma|ovarian polyembryoma
845878|NCT00004230|ovarian choriocarcinoma|ovarian choriocarcinoma
845879|NCT00004230|ovarian immature teratoma|ovarian immature teratoma
845880|NCT00004230|ovarian mature teratoma|ovarian mature teratoma
845881|NCT00004230|ovarian monodermal and highly specialized teratoma|ovarian monodermal and highly specialized teratoma
845882|NCT00004230|ovarian mixed germ cell tumor|ovarian mixed germ cell tumor
845883|NCT00004230|stage III grade 1 follicular lymphoma|stage iii grade 1 follicular lymphoma
845884|NCT00004230|stage III grade 2 follicular lymphoma|stage iii grade 2 follicular lymphoma
845885|NCT00004230|stage III grade 3 follicular lymphoma|stage iii grade 3 follicular lymphoma
845886|NCT00004230|stage III adult diffuse small cleaved cell lymphoma|stage iii adult diffuse small cleaved cell lymphoma
845887|NCT00004230|stage III adult diffuse mixed cell lymphoma|stage iii adult diffuse mixed cell lymphoma
845888|NCT00004230|stage III adult diffuse large cell lymphoma|stage iii adult diffuse large cell lymphoma
845889|NCT00004230|stage III adult immunoblastic large cell lymphoma|stage iii adult immunoblastic large cell lymphoma
845890|NCT00004230|stage III adult lymphoblastic lymphoma|stage iii adult lymphoblastic lymphoma
845891|NCT00004230|stage III adult Burkitt lymphoma|stage iii adult burkitt lymphoma
845892|NCT00004230|stage IV grade 1 follicular lymphoma|stage iv grade 1 follicular lymphoma
845893|NCT00004230|stage IV grade 2 follicular lymphoma|stage iv grade 2 follicular lymphoma
845894|NCT00004230|stage IV grade 3 follicular lymphoma|stage iv grade 3 follicular lymphoma
845895|NCT00004230|stage IV adult diffuse small cleaved cell lymphoma|stage iv adult diffuse small cleaved cell lymphoma
845896|NCT00004230|stage IV adult diffuse mixed cell lymphoma|stage iv adult diffuse mixed cell lymphoma
845897|NCT00004230|stage IV adult diffuse large cell lymphoma|stage iv adult diffuse large cell lymphoma
845898|NCT00004230|stage IV adult immunoblastic large cell lymphoma|stage iv adult immunoblastic large cell lymphoma
845899|NCT00004230|stage IV adult lymphoblastic lymphoma|stage iv adult lymphoblastic lymphoma
845900|NCT00004230|stage IV adult Burkitt lymphoma|stage iv adult burkitt lymphoma
845901|NCT00004230|recurrent grade 1 follicular lymphoma|recurrent grade 1 follicular lymphoma
845902|NCT00004230|recurrent grade 2 follicular lymphoma|recurrent grade 2 follicular lymphoma
845903|NCT00004230|recurrent grade 3 follicular lymphoma|recurrent grade 3 follicular lymphoma
845904|NCT00004230|recurrent adult diffuse small cleaved cell lymphoma|recurrent adult diffuse small cleaved cell lymphoma
845905|NCT00004230|recurrent adult diffuse mixed cell lymphoma|recurrent adult diffuse mixed cell lymphoma
845906|NCT00004230|recurrent adult diffuse large cell lymphoma|recurrent adult diffuse large cell lymphoma
845907|NCT00004230|recurrent adult immunoblastic large cell lymphoma|recurrent adult immunoblastic large cell lymphoma
845908|NCT00004230|recurrent adult lymphoblastic lymphoma|recurrent adult lymphoblastic lymphoma
845909|NCT00004230|recurrent adult Burkitt lymphoma|recurrent adult burkitt lymphoma
845910|NCT00004230|secondary acute myeloid leukemia|secondary acute myeloid leukemia
845911|NCT00004230|de novo myelodysplastic syndromes|de novo myelodysplastic syndromes
845912|NCT00004230|poor prognosis metastatic gestational trophoblastic tumor|poor prognosis metastatic gestational trophoblastic tumor
845913|NCT00004230|previously treated myelodysplastic syndromes|previously treated myelodysplastic syndromes
845914|NCT00004230|secondary myelodysplastic syndromes|secondary myelodysplastic syndromes
845915|NCT00004230|recurrent childhood small noncleaved cell lymphoma|recurrent childhood small noncleaved cell lymphoma
845916|NCT00004230|recurrent childhood large cell lymphoma|recurrent childhood large cell lymphoma
845917|NCT00004230|noncontiguous stage II grade 1 follicular lymphoma|noncontiguous stage ii grade 1 follicular lymphoma
845918|NCT00004230|noncontiguous stage II grade 2 follicular lymphoma|noncontiguous stage ii grade 2 follicular lymphoma
845919|NCT00004230|noncontiguous stage II grade 3 follicular lymphoma|noncontiguous stage ii grade 3 follicular lymphoma
845920|NCT00004230|noncontiguous stage II adult diffuse small cleaved cell lymphoma|noncontiguous stage ii adult diffuse small cleaved cell lymphoma
845921|NCT00004230|noncontiguous stage II mantle cell lymphoma|noncontiguous stage ii mantle cell lymphoma
845922|NCT00004230|noncontiguous stage II adult diffuse mixed cell lymphoma|noncontiguous stage ii adult diffuse mixed cell lymphoma
845923|NCT00004230|noncontiguous stage II adult immunoblastic large cell lymphoma|noncontiguous stage ii adult immunoblastic large cell lymphoma
845924|NCT00004230|noncontiguous stage II adult diffuse large cell lymphoma|noncontiguous stage ii adult diffuse large cell lymphoma
845925|NCT00004230|noncontiguous stage II adult Burkitt lymphoma|noncontiguous stage ii adult burkitt lymphoma
845926|NCT00004230|noncontiguous stage II adult lymphoblastic lymphoma|noncontiguous stage ii adult lymphoblastic lymphoma
845927|NCT00004230|stage III mantle cell lymphoma|stage iii mantle cell lymphoma
845928|NCT00004230|stage IV mantle cell lymphoma|stage iv mantle cell lymphoma
845929|NCT00004230|recurrent mantle cell lymphoma|recurrent mantle cell lymphoma
845930|NCT00004230|previously treated childhood rhabdomyosarcoma|previously treated childhood rhabdomyosarcoma
845931|NCT00004230|recurrent mycosis fungoides/Sezary syndrome|recurrent mycosis fungoides/sezary syndrome
845932|NCT00004230|noncontiguous stage II small lymphocytic lymphoma|noncontiguous stage ii small lymphocytic lymphoma
845933|NCT00004230|noncontiguous stage II marginal zone lymphoma|noncontiguous stage ii marginal zone lymphoma
845934|NCT00004230|recurrent marginal zone lymphoma|recurrent marginal zone lymphoma
845935|NCT00004230|recurrent small lymphocytic lymphoma|recurrent small lymphocytic lymphoma
845936|NCT00004230|stage III small lymphocytic lymphoma|stage iii small lymphocytic lymphoma
845937|NCT00004230|stage III marginal zone lymphoma|stage iii marginal zone lymphoma
845938|NCT00004230|stage IV small lymphocytic lymphoma|stage iv small lymphocytic lymphoma
845939|NCT00004230|stage IV marginal zone lymphoma|stage iv marginal zone lymphoma
845940|NCT00004230|extranodal marginal zone B-cell lymphoma of mucosa-associated lymphoid tissue|extranodal marginal zone b-cell lymphoma of mucosa-associated lymphoid tissue
845941|NCT00004230|nodal marginal zone B-cell lymphoma|nodal marginal zone b-cell lymphoma
845942|NCT00004230|splenic marginal zone lymphoma|splenic marginal zone lymphoma
845943|NCT00004230|childhood myelodysplastic syndromes|childhood myelodysplastic syndromes
845944|NCT00004213|unspecified adult solid tumor, protocol specific|unspecified adult solid tumor, protocol specific
845945|NCT00004101|recurrent grade 1 follicular lymphoma|recurrent grade 1 follicular lymphoma
845946|NCT00004101|recurrent grade 2 follicular lymphoma|recurrent grade 2 follicular lymphoma
845947|NCT00004101|recurrent grade 3 follicular lymphoma|recurrent grade 3 follicular lymphoma
845948|NCT00004101|recurrent adult diffuse small cleaved cell lymphoma|recurrent adult diffuse small cleaved cell lymphoma
845949|NCT00004101|recurrent adult diffuse mixed cell lymphoma|recurrent adult diffuse mixed cell lymphoma
845950|NCT00004101|recurrent adult diffuse large cell lymphoma|recurrent adult diffuse large cell lymphoma
845951|NCT00004101|recurrent adult immunoblastic large cell lymphoma|recurrent adult immunoblastic large cell lymphoma
845952|NCT00004101|recurrent adult lymphoblastic lymphoma|recurrent adult lymphoblastic lymphoma
845953|NCT00004101|recurrent adult Burkitt lymphoma|recurrent adult burkitt lymphoma
845954|NCT00004101|recurrent mantle cell lymphoma|recurrent mantle cell lymphoma
845955|NCT00004101|recurrent marginal zone lymphoma|recurrent marginal zone lymphoma
845956|NCT00004101|recurrent small lymphocytic lymphoma|recurrent small lymphocytic lymphoma
845957|NCT00004101|extranodal marginal zone B-cell lymphoma of mucosa-associated lymphoid tissue|extranodal marginal zone b-cell lymphoma of mucosa-associated lymphoid tissue
845958|NCT00004101|nodal marginal zone B-cell lymphoma|nodal marginal zone b-cell lymphoma
845959|NCT00004101|splenic marginal zone lymphoma|splenic marginal zone lymphoma
845960|NCT00004049|unspecified adult solid tumor, protocol specific|unspecified adult solid tumor, protocol specific
845961|NCT00003972|stage II breast cancer|stage ii breast cancer
845962|NCT00003972|stage IIIA breast cancer|stage iiia breast cancer
859777|NCT00063258|NSCLC|nsclc
845965|NCT00003943|extensive stage small cell lung cancer|extensive stage small cell lung cancer
845966|NCT00003943|newly diagnosed carcinoma of unknown primary|newly diagnosed carcinoma of unknown primary
845967|NCT00003900|recurrent non-small cell lung cancer|recurrent non-small cell lung cancer
845968|NCT00003900|stage IV non-small cell lung cancer|stage iv non-small cell lung cancer
845969|NCT00003849|recurrent adult Hodgkin lymphoma|recurrent adult hodgkin lymphoma
845970|NCT00003849|stage III grade 1 follicular lymphoma|stage iii grade 1 follicular lymphoma
845971|NCT00003849|stage IV grade 1 follicular lymphoma|stage iv grade 1 follicular lymphoma
845972|NCT00003825|radiation enteritis|radiation enteritis
845973|NCT00003825|diarrhea|diarrhea
845974|NCT00003768|unspecified adult solid tumor, protocol specific|unspecified adult solid tumor, protocol specific
845975|NCT00003726|extensive stage small cell lung cancer|extensive stage small cell lung cancer
845976|NCT00003726|recurrent small cell lung cancer|recurrent small cell lung cancer
845977|NCT00003713|unspecified adult solid tumor, protocol specific|unspecified adult solid tumor, protocol specific
845978|NCT00003680|stage III breast cancer|stage iii breast cancer
845979|NCT00003680|inflammatory breast cancer|inflammatory breast cancer
845980|NCT00003646|adult solid tumor|adult solid tumor
845981|NCT00003646|body system/site cancer|body system/site cancer
845982|NCT00003646|cancer|cancer
845983|NCT00003646|melanoma|melanoma
845984|NCT00003646|recurrent melanoma|recurrent melanoma
845985|NCT00003646|skin tumor|skin tumor
845986|NCT00003646|solid tumor|solid tumor
845987|NCT00003646|stage III melanoma|stage iii melanoma
845988|NCT00003646|stage IV melanoma|stage iv melanoma
845989|NCT00003646|stage, melanoma|stage, melanoma
845990|NCT00003638|stage IV breast cancer|stage iv breast cancer
845991|NCT00003638|recurrent breast cancer|recurrent breast cancer
845992|NCT00003622|adenocarcinoma of the prostate|adenocarcinoma of the prostate
845993|NCT00003622|stage IV prostate cancer|stage iv prostate cancer
845994|NCT00003622|recurrent prostate cancer|recurrent prostate cancer
845995|NCT00082147|MRI|mri
845996|NCT00082147|Biopsy|biopsy
845997|NCT00082147|Fiducial Marker|fiducial marker
845998|NCT00082147|Prostate Cancer|prostate cancer
845999|NCT00082108|Registry|registry
846000|NCT00082108|FSHD|fshd
846001|NCT00082108|DM|dm
846002|NCT00082108|Muscular Dystrophy|muscular dystrophy
846003|NCT00082108|Facioscapulohumeral Myotonic Dystrophy|facioscapulohumeral myotonic dystrophy
846004|NCT00082108|Myotonic Dystrophy|myotonic dystrophy
846005|NCT00082108|DM1|dm1
846006|NCT00082108|DM2|dm2
846007|NCT00082108|FSH|fsh
846008|NCT00082108|MMD|mmd
846009|NCT00082095|Metastatic breast cancer|metastatic breast cancer
846010|NCT00082095|Breast Cancer|breast cancer
846011|NCT00082095|Pegylated Liposomal Doxorubicin|pegylated liposomal doxorubicin
846012|NCT00082095|Capecitabine|capecitabine
846013|NCT00082095|DOXIL|doxil
846014|NCT00082095|Xeloda|xeloda
846015|NCT00082069|Shigella|shigella
846016|NCT00082069|diarrhea|diarrhea
846017|NCT00081978|HIV infection|hiv infection
846018|NCT00081978|TMC125|tmc125
846019|NCT00081978|Non-nucleoside reverse transcriptase inhibitor, TMC125-C223|non-nucleoside reverse transcriptase inhibitor, tmc125-c223
846020|NCT00003583|limited stage small cell lung cancer|limited stage small cell lung cancer
846021|NCT00003583|drug/agent toxicity by tissue/organ|drug/agent toxicity by tissue/organ
846022|NCT00003583|radiation toxicity|radiation toxicity
846023|NCT00003563|tumors metastatic to brain|tumors metastatic to brain
846024|NCT00003554|stage I multiple myeloma|stage i multiple myeloma
846025|NCT00003554|stage II multiple myeloma|stage ii multiple myeloma
846026|NCT00003554|stage III multiple myeloma|stage iii multiple myeloma
846027|NCT00003397|stage I grade 3 follicular lymphoma|stage i grade 3 follicular lymphoma
846028|NCT00003397|stage I adult diffuse small cleaved cell lymphoma|stage i adult diffuse small cleaved cell lymphoma
846029|NCT00003397|stage I adult diffuse mixed cell lymphoma|stage i adult diffuse mixed cell lymphoma
846030|NCT00003397|stage I adult diffuse large cell lymphoma|stage i adult diffuse large cell lymphoma
846031|NCT00003397|stage I adult immunoblastic large cell lymphoma|stage i adult immunoblastic large cell lymphoma
846032|NCT00003397|stage I adult lymphoblastic lymphoma|stage i adult lymphoblastic lymphoma
846033|NCT00003397|stage I adult Burkitt lymphoma|stage i adult burkitt lymphoma
846034|NCT00003397|stage III grade 3 follicular lymphoma|stage iii grade 3 follicular lymphoma
846035|NCT00003397|stage III adult diffuse small cleaved cell lymphoma|stage iii adult diffuse small cleaved cell lymphoma
846036|NCT00003397|stage III adult diffuse mixed cell lymphoma|stage iii adult diffuse mixed cell lymphoma
846037|NCT00003397|stage III adult diffuse large cell lymphoma|stage iii adult diffuse large cell lymphoma
846038|NCT00003397|stage III adult immunoblastic large cell lymphoma|stage iii adult immunoblastic large cell lymphoma
846039|NCT00003397|stage III adult lymphoblastic lymphoma|stage iii adult lymphoblastic lymphoma
846040|NCT00003397|stage III adult Burkitt lymphoma|stage iii adult burkitt lymphoma
846041|NCT00003397|stage IV grade 3 follicular lymphoma|stage iv grade 3 follicular lymphoma
846042|NCT00003397|stage IV adult diffuse small cleaved cell lymphoma|stage iv adult diffuse small cleaved cell lymphoma
846043|NCT00003397|stage IV adult diffuse mixed cell lymphoma|stage iv adult diffuse mixed cell lymphoma
846044|NCT00003397|stage IV adult diffuse large cell lymphoma|stage iv adult diffuse large cell lymphoma
846045|NCT00003397|stage IV adult immunoblastic large cell lymphoma|stage iv adult immunoblastic large cell lymphoma
860034|NCT00062764|NASH|nash
846046|NCT00003397|stage IV adult lymphoblastic lymphoma|stage iv adult lymphoblastic lymphoma
846047|NCT00003397|stage IV adult Burkitt lymphoma|stage iv adult burkitt lymphoma
846048|NCT00003397|recurrent grade 3 follicular lymphoma|recurrent grade 3 follicular lymphoma
846049|NCT00003397|recurrent adult diffuse small cleaved cell lymphoma|recurrent adult diffuse small cleaved cell lymphoma
846050|NCT00003397|recurrent adult diffuse mixed cell lymphoma|recurrent adult diffuse mixed cell lymphoma
846051|NCT00003397|recurrent adult diffuse large cell lymphoma|recurrent adult diffuse large cell lymphoma
846052|NCT00003397|recurrent adult immunoblastic large cell lymphoma|recurrent adult immunoblastic large cell lymphoma
846053|NCT00003397|recurrent adult lymphoblastic lymphoma|recurrent adult lymphoblastic lymphoma
846054|NCT00003397|recurrent adult Burkitt lymphoma|recurrent adult burkitt lymphoma
846055|NCT00003397|stage I mantle cell lymphoma|stage i mantle cell lymphoma
846056|NCT00003397|contiguous stage II grade 3 follicular lymphoma|contiguous stage ii grade 3 follicular lymphoma
846057|NCT00003397|contiguous stage II adult diffuse small cleaved cell lymphoma|contiguous stage ii adult diffuse small cleaved cell lymphoma
846058|NCT00003397|contiguous stage II mantle cell lymphoma|contiguous stage ii mantle cell lymphoma
846059|NCT00003397|contiguous stage II adult diffuse mixed cell lymphoma|contiguous stage ii adult diffuse mixed cell lymphoma
846060|NCT00003397|contiguous stage II adult immunoblastic large cell lymphoma|contiguous stage ii adult immunoblastic large cell lymphoma
846061|NCT00003397|contiguous stage II adult diffuse large cell lymphoma|contiguous stage ii adult diffuse large cell lymphoma
846062|NCT00003397|contiguous stage II adult Burkitt lymphoma|contiguous stage ii adult burkitt lymphoma
846063|NCT00003397|contiguous stage II adult lymphoblastic lymphoma|contiguous stage ii adult lymphoblastic lymphoma
846064|NCT00003397|noncontiguous stage II grade 3 follicular lymphoma|noncontiguous stage ii grade 3 follicular lymphoma
846065|NCT00003397|noncontiguous stage II adult diffuse small cleaved cell lymphoma|noncontiguous stage ii adult diffuse small cleaved cell lymphoma
846066|NCT00003397|noncontiguous stage II mantle cell lymphoma|noncontiguous stage ii mantle cell lymphoma
846067|NCT00003397|noncontiguous stage II adult diffuse mixed cell lymphoma|noncontiguous stage ii adult diffuse mixed cell lymphoma
846068|NCT00003397|noncontiguous stage II adult immunoblastic large cell lymphoma|noncontiguous stage ii adult immunoblastic large cell lymphoma
846069|NCT00003397|noncontiguous stage II adult diffuse large cell lymphoma|noncontiguous stage ii adult diffuse large cell lymphoma
846070|NCT00003397|noncontiguous stage II adult Burkitt lymphoma|noncontiguous stage ii adult burkitt lymphoma
846071|NCT00003397|noncontiguous stage II adult lymphoblastic lymphoma|noncontiguous stage ii adult lymphoblastic lymphoma
846072|NCT00003397|stage III mantle cell lymphoma|stage iii mantle cell lymphoma
846073|NCT00003397|stage IV mantle cell lymphoma|stage iv mantle cell lymphoma
846074|NCT00003397|recurrent mantle cell lymphoma|recurrent mantle cell lymphoma
846075|NCT00003394|adenocarcinoma of the prostate|adenocarcinoma of the prostate
846076|NCT00003394|stage I prostate cancer|stage i prostate cancer
846077|NCT00003394|stage IIB prostate cancer|stage iib prostate cancer
846078|NCT00003394|stage IIA prostate cancer|stage iia prostate cancer
846079|NCT00003394|stage III prostate cancer|stage iii prostate cancer
846080|NCT00003394|stage IV prostate cancer|stage iv prostate cancer
846081|NCT00003394|recurrent prostate cancer|recurrent prostate cancer
846082|NCT00003276|unresectable gallbladder cancer|unresectable gallbladder cancer
846083|NCT00003276|recurrent gallbladder cancer|recurrent gallbladder cancer
846084|NCT00003239|chronic phase chronic myelogenous leukemia|chronic phase chronic myelogenous leukemia
846085|NCT00003239|Philadelphia chromosome positive chronic myelogenous leukemia|philadelphia chromosome positive chronic myelogenous leukemia
846086|NCT00003239|Homoharringtonine|homoharringtonine
846087|NCT00003239|HHT|hht
846088|NCT00003239|cephalotaxus alkaloid|cephalotaxus alkaloid
846089|NCT00003239|cytarabine|cytarabine
846090|NCT00003239|Interferon Alpha 2-A|interferon alpha 2-a
846091|NCT00003239|Roferon-A|roferon-a
846092|NCT00003239|Ara-C|ara-c
846093|NCT00003239|DepotCyt|depotcyt
846094|NCT00003239|Cytosine Arabinosine Hydrochloride|cytosine arabinosine hydrochloride
846095|NCT00003181|stage IV renal cell cancer|stage iv renal cell cancer
846096|NCT00003181|recurrent renal cell cancer|recurrent renal cell cancer
846097|NCT00003175|recurrent bladder cancer|recurrent bladder cancer
846098|NCT00003175|transitional cell carcinoma of the bladder|transitional cell carcinoma of the bladder
846099|NCT00003175|recurrent urethral cancer|recurrent urethral cancer
846100|NCT00003175|recurrent transitional cell cancer of the renal pelvis and ureter|recurrent transitional cell cancer of the renal pelvis and ureter
846101|NCT00003165|stage IV breast cancer|stage iv breast cancer
846102|NCT00003165|recurrent breast cancer|recurrent breast cancer
846103|NCT00003133|stage III bladder cancer|stage iii bladder cancer
846104|NCT00003133|stage IV bladder cancer|stage iv bladder cancer
846105|NCT00003133|transitional cell carcinoma of the bladder|transitional cell carcinoma of the bladder
846106|NCT00003133|metastatic transitional cell cancer of the renal pelvis and ureter|metastatic transitional cell cancer of the renal pelvis and ureter
846107|NCT00003133|regional transitional cell cancer of the renal pelvis and ureter|regional transitional cell cancer of the renal pelvis and ureter
846108|NCT00003038|stage IV colon cancer|stage iv colon cancer
846109|NCT00003038|stage IV breast cancer|stage iv breast cancer
846110|NCT00003038|recurrent breast cancer|recurrent breast cancer
846111|NCT00003038|recurrent colon cancer|recurrent colon cancer
846112|NCT00003038|stage IV adrenocortical carcinoma|stage iv adrenocortical carcinoma
846113|NCT00003038|recurrent adrenocortical carcinoma|recurrent adrenocortical carcinoma
846116|NCT00003038|unspecified adult solid tumor, protocol specific|unspecified adult solid tumor, protocol specific
846117|NCT00003019|desmoid tumor|desmoid tumor
846118|NCT00081926|CML|cml
846119|NCT00081926|Chronic Myelogenous Leukemia|chronic myelogenous leukemia
846120|NCT00081926|RIGHT Trial|right trial
846121|NCT00081926|US177|us177
846122|NCT00081926|CSTI571|csti571
846123|NCT00014365|unspecified adult solid tumor, protocol specific|unspecified adult solid tumor, protocol specific
846124|NCT00006483|stage IV renal cell cancer|stage iv renal cell cancer
846125|NCT00006483|recurrent renal cell cancer|recurrent renal cell cancer
846126|NCT00006483|lung metastases|lung metastases
846127|NCT00006261|stage IV breast cancer|stage iv breast cancer
846128|NCT00006261|recurrent breast cancer|recurrent breast cancer
846129|NCT00006106|adult solid tumor|adult solid tumor
846130|NCT00006106|body system/site cancer|body system/site cancer
846131|NCT00006106|cancer|cancer
846132|NCT00006106|cellular diagnosis, hypopharyngeal cancer|cellular diagnosis, hypopharyngeal cancer
846133|NCT00006106|cellular diagnosis, laryngeal cancer|cellular diagnosis, laryngeal cancer
846134|NCT00006106|cellular diagnosis, lip and oral cavity cancer|cellular diagnosis, lip and oral cavity cancer
846135|NCT00006106|cellular diagnosis, nasopharyngeal cancer|cellular diagnosis, nasopharyngeal cancer
846136|NCT00006106|cellular diagnosis, oropharyngeal cancer|cellular diagnosis, oropharyngeal cancer
846137|NCT00006106|cellular diagnosis, paranasal sinus and nasal cavity cancer|cellular diagnosis, paranasal sinus and nasal cavity cancer
846138|NCT00006106|head and neck cancer|head and neck cancer
846139|NCT00006106|hypopharyngeal cancer|hypopharyngeal cancer
846140|NCT00006106|hypopharyngeal squamous cell carcinoma|hypopharyngeal squamous cell carcinoma
846141|NCT00006106|laryngeal cancer|laryngeal cancer
846142|NCT00006106|laryngeal squamous cell carcinoma|laryngeal squamous cell carcinoma
846143|NCT00006106|lip and oral cavity cancer|lip and oral cavity cancer
846144|NCT00006106|lip and oral cavity squamous cell carcinoma|lip and oral cavity squamous cell carcinoma
846145|NCT00006106|metastatic squamous neck cancer with occult primary|metastatic squamous neck cancer with occult primary
846146|NCT00006106|nasopharyngeal cancer|nasopharyngeal cancer
846147|NCT00006106|nasopharyngeal squamous cell carcinoma|nasopharyngeal squamous cell carcinoma
846148|NCT00006106|oropharyngeal cancer|oropharyngeal cancer
846149|NCT00006106|oropharyngeal squamous cell carcinoma|oropharyngeal squamous cell carcinoma
846150|NCT00006106|paranasal sinus and nasal cavity cancer|paranasal sinus and nasal cavity cancer
846151|NCT00006106|paranasal sinus and nasal cavity squamous cell carcinoma|paranasal sinus and nasal cavity squamous cell carcinoma
846152|NCT00006106|recurrent hypopharyngeal cancer|recurrent hypopharyngeal cancer
846153|NCT00006106|recurrent laryngeal cancer|recurrent laryngeal cancer
846154|NCT00006106|recurrent lip and oral cavity cancer|recurrent lip and oral cavity cancer
846155|NCT00006106|recurrent metastatic squamous neck cancer with occult primary|recurrent metastatic squamous neck cancer with occult primary
846156|NCT00006106|recurrent nasopharyngeal cancer|recurrent nasopharyngeal cancer
846157|NCT00006106|recurrent oropharyngeal cancer|recurrent oropharyngeal cancer
846158|NCT00006106|recurrent paranasal sinus and nasal cavity cancer|recurrent paranasal sinus and nasal cavity cancer
846159|NCT00006106|recurrent squamous cell carcinoma of the hypopharynx|recurrent squamous cell carcinoma of the hypopharynx
846160|NCT00006106|recurrent squamous cell carcinoma of the larynx|recurrent squamous cell carcinoma of the larynx
846161|NCT00006106|recurrent squamous cell carcinoma of the lip and oral cavity|recurrent squamous cell carcinoma of the lip and oral cavity
846162|NCT00006106|recurrent squamous cell carcinoma of the nasopharynx|recurrent squamous cell carcinoma of the nasopharynx
846163|NCT00006106|recurrent squamous cell carcinoma of the oropharynx|recurrent squamous cell carcinoma of the oropharynx
846164|NCT00006106|recurrent squamous cell carcinoma of the paranasal sinus and nasal cavity|recurrent squamous cell carcinoma of the paranasal sinus and nasal cavity
846165|NCT00006106|solid tumor|solid tumor
846166|NCT00006106|stage III hypopharyngeal cancer|stage iii hypopharyngeal cancer
846167|NCT00006106|stage III laryngeal cancer|stage iii laryngeal cancer
846168|NCT00006106|stage III lip and oral cavity cancer|stage iii lip and oral cavity cancer
846169|NCT00006106|stage III nasopharyngeal cancer|stage iii nasopharyngeal cancer
846170|NCT00006106|stage III oropharyngeal cancer|stage iii oropharyngeal cancer
846171|NCT00006106|stage III paranasal sinus and nasal cavity cancer|stage iii paranasal sinus and nasal cavity cancer
846172|NCT00006106|stage III squamous cell carcinoma of the hypopharynx|stage iii squamous cell carcinoma of the hypopharynx
846173|NCT00006106|stage III squamous cell carcinoma of the larynx|stage iii squamous cell carcinoma of the larynx
846174|NCT00006106|stage III squamous cell carcinoma of the lip and oral cavity|stage iii squamous cell carcinoma of the lip and oral cavity
846175|NCT00006106|stage III squamous cell carcinoma of the nasopharynx|stage iii squamous cell carcinoma of the nasopharynx
846176|NCT00006106|stage III squamous cell carcinoma of the oropharynx|stage iii squamous cell carcinoma of the oropharynx
846177|NCT00006106|stage III squamous cell carcinoma of the paranasal sinus and nasal cavity|stage iii squamous cell carcinoma of the paranasal sinus and nasal cavity
846178|NCT00006106|stage IV hypopharyngeal cancer|stage iv hypopharyngeal cancer
846179|NCT00006106|stage IV laryngeal cancer|stage iv laryngeal cancer
846180|NCT00006106|stage IV lip and oral cavity cancer|stage iv lip and oral cavity cancer
846181|NCT00006106|stage IV nasopharyngeal cancer|stage iv nasopharyngeal cancer
846182|NCT00006106|stage IV oropharyngeal cancer|stage iv oropharyngeal cancer
846337|NCT00005796|adult gliosarcoma|adult gliosarcoma
846339|NCT00005649|recurrent breast cancer|recurrent breast cancer
846183|NCT00006106|stage IV paranasal sinus and nasal cavity cancer|stage iv paranasal sinus and nasal cavity cancer
846184|NCT00006106|stage IV squamous cell carcinoma of the hypopharynx|stage iv squamous cell carcinoma of the hypopharynx
846185|NCT00006106|stage IV squamous cell carcinoma of the larynx|stage iv squamous cell carcinoma of the larynx
846186|NCT00006106|stage IV squamous cell carcinoma of the lip and oral cavity|stage iv squamous cell carcinoma of the lip and oral cavity
846187|NCT00006106|stage IV squamous cell carcinoma of the nasopharynx|stage iv squamous cell carcinoma of the nasopharynx
846188|NCT00006106|stage IV squamous cell carcinoma of the oropharynx|stage iv squamous cell carcinoma of the oropharynx
846189|NCT00006106|stage IV squamous cell carcinoma of the paranasal sinus and nasal cavity|stage iv squamous cell carcinoma of the paranasal sinus and nasal cavity
846190|NCT00006106|stage, hypopharyngeal cancer|stage, hypopharyngeal cancer
846191|NCT00006106|stage, laryngeal cancer|stage, laryngeal cancer
846192|NCT00006106|stage, lip and oral cavity cancer|stage, lip and oral cavity cancer
846193|NCT00006106|stage, metastatic squamous neck cancer with occult primary|stage, metastatic squamous neck cancer with occult primary
846194|NCT00006106|stage, nasopharyngeal cancer|stage, nasopharyngeal cancer
846195|NCT00006106|stage, oropharyngeal cancer|stage, oropharyngeal cancer
846196|NCT00006106|stage, paranasal sinus and nasal cavity cancer|stage, paranasal sinus and nasal cavity cancer
846197|NCT00003001|stage IV colon cancer|stage iv colon cancer
846198|NCT00003001|stage IV rectal cancer|stage iv rectal cancer
846199|NCT00003001|recurrent colon cancer|recurrent colon cancer
846200|NCT00003001|recurrent rectal cancer|recurrent rectal cancer
846201|NCT00002977|stage III ovarian epithelial cancer|stage iii ovarian epithelial cancer
846202|NCT00002977|stage IV ovarian epithelial cancer|stage iv ovarian epithelial cancer
846203|NCT00002977|recurrent ovarian epithelial cancer|recurrent ovarian epithelial cancer
846204|NCT00002977|ovarian undifferentiated adenocarcinoma|ovarian undifferentiated adenocarcinoma
846205|NCT00002977|ovarian mixed epithelial carcinoma|ovarian mixed epithelial carcinoma
846206|NCT00002977|ovarian serous cystadenocarcinoma|ovarian serous cystadenocarcinoma
846207|NCT00002977|ovarian mucinous cystadenocarcinoma|ovarian mucinous cystadenocarcinoma
846208|NCT00002977|ovarian endometrioid adenocarcinoma|ovarian endometrioid adenocarcinoma
846209|NCT00002977|ovarian clear cell cystadenocarcinoma|ovarian clear cell cystadenocarcinoma
846210|NCT00002977|Brenner tumor|brenner tumor
846211|NCT00002939|unspecified adult solid tumor, protocol specific|unspecified adult solid tumor, protocol specific
846212|NCT00002912|recurrent childhood acute lymphoblastic leukemia|recurrent childhood acute lymphoblastic leukemia
846213|NCT00002912|recurrent childhood acute myeloid leukemia|recurrent childhood acute myeloid leukemia
846214|NCT00002912|secondary acute myeloid leukemia|secondary acute myeloid leukemia
846215|NCT00002884|stage I esophageal cancer|stage i esophageal cancer
846216|NCT00002884|stage II esophageal cancer|stage ii esophageal cancer
846217|NCT00002884|stage III esophageal cancer|stage iii esophageal cancer
846218|NCT00002884|squamous cell carcinoma of the esophagus|squamous cell carcinoma of the esophagus
846219|NCT00002884|adenocarcinoma of the esophagus|adenocarcinoma of the esophagus
846220|NCT00002773|stage II pancreatic cancer|stage ii pancreatic cancer
846221|NCT00002773|stage III pancreatic cancer|stage iii pancreatic cancer
846222|NCT00002773|recurrent pancreatic cancer|recurrent pancreatic cancer
846223|NCT00002773|adenocarcinoma of the pancreas|adenocarcinoma of the pancreas
846224|NCT00002773|stage IV pancreatic cancer|stage iv pancreatic cancer
846225|NCT00002719|untreated adult acute myeloid leukemia|untreated adult acute myeloid leukemia
846226|NCT00002719|adult acute erythroid leukemia (M6)|adult acute erythroid leukemia (m6)
846227|NCT00002719|adult acute myeloblastic leukemia without maturation (M1)|adult acute myeloblastic leukemia without maturation (m1)
846228|NCT00002719|adult acute myeloblastic leukemia with maturation (M2)|adult acute myeloblastic leukemia with maturation (m2)
846229|NCT00002719|adult acute myelomonocytic leukemia (M4)|adult acute myelomonocytic leukemia (m4)
846230|NCT00002719|adult acute monoblastic leukemia (M5a)|adult acute monoblastic leukemia (m5a)
846231|NCT00002719|adult acute megakaryoblastic leukemia (M7)|adult acute megakaryoblastic leukemia (m7)
846232|NCT00002719|secondary acute myeloid leukemia|secondary acute myeloid leukemia
846233|NCT00002719|adult acute monocytic leukemia (M5b)|adult acute monocytic leukemia (m5b)
846234|NCT00002719|neutropenia|neutropenia
846235|NCT00002719|adult acute minimally differentiated myeloid leukemia (M0)|adult acute minimally differentiated myeloid leukemia (m0)
846236|NCT00002680|stage IV breast cancer|stage iv breast cancer
846237|NCT00002680|recurrent breast cancer|recurrent breast cancer
846238|NCT00002590|stage IV childhood lymphoblastic lymphoma|stage iv childhood lymphoblastic lymphoma
846239|NCT00002590|stage IV childhood large cell lymphoma|stage iv childhood large cell lymphoma
846240|NCT00002564|recurrent breast cancer|recurrent breast cancer
846241|NCT00002481|recurrent grade 1 follicular lymphoma|recurrent grade 1 follicular lymphoma
846242|NCT00002481|recurrent grade 2 follicular lymphoma|recurrent grade 2 follicular lymphoma
846243|NCT00002481|recurrent grade 3 follicular lymphoma|recurrent grade 3 follicular lymphoma
846244|NCT00002481|recurrent adult diffuse small cleaved cell lymphoma|recurrent adult diffuse small cleaved cell lymphoma
846245|NCT00002481|recurrent adult diffuse mixed cell lymphoma|recurrent adult diffuse mixed cell lymphoma
846246|NCT00002481|recurrent adult diffuse large cell lymphoma|recurrent adult diffuse large cell lymphoma
846247|NCT00002481|recurrent adult immunoblastic large cell lymphoma|recurrent adult immunoblastic large cell lymphoma
846248|NCT00002481|recurrent adult lymphoblastic lymphoma|recurrent adult lymphoblastic lymphoma
846249|NCT00002481|recurrent adult Burkitt lymphoma|recurrent adult burkitt lymphoma
846250|NCT00002481|recurrent mantle cell lymphoma|recurrent mantle cell lymphoma
846251|NCT00002481|recurrent marginal zone lymphoma|recurrent marginal zone lymphoma
846252|NCT00002481|recurrent small lymphocytic lymphoma|recurrent small lymphocytic lymphoma
846253|NCT00002481|extranodal marginal zone B-cell lymphoma of mucosa-associated lymphoid tissue|extranodal marginal zone b-cell lymphoma of mucosa-associated lymphoid tissue
846254|NCT00002481|nodal marginal zone B-cell lymphoma|nodal marginal zone b-cell lymphoma
846255|NCT00002481|splenic marginal zone lymphoma|splenic marginal zone lymphoma
846256|NCT00082043|Neurosteroids|neurosteroids
846257|NCT00082043|5 Alpha-Reductase Inhibitor|5 alpha-reductase inhibitor
846258|NCT00082043|Depression|depression
846259|NCT00082043|Menstrual Cycle|menstrual cycle
846260|NCT00082043|Gonadal Steroids|gonadal steroids
846261|NCT00082043|Menstrual Cycle Related Mood Disorder|menstrual cycle related mood disorder
846263|NCT00082043|Healthy Volunteer|healthy volunteer
846264|NCT00082030|Depression|depression
846265|NCT00082030|PET|pet
846266|NCT00082030|fMRI|fmri
846267|NCT00082030|Dopamine|dopamine
846376|NCT00004604|recurrent colon cancer|recurrent colon cancer
846268|NCT00082030|Norepinephrine Depletion|norepinephrine depletion
846269|NCT00082030|Emotional Stimuli|emotional stimuli
846270|NCT00082030|Anhedonia|anhedonia
846271|NCT00082030|Norepinephrine|norepinephrine
846272|NCT00082030|Dopamine Depletion|dopamine depletion
846273|NCT00082030|Major Depressive Disorder|major depressive disorder
846274|NCT00082030|MDD|mdd
846275|NCT00082030|Healthy Volunteer|healthy volunteer
846276|NCT00082030|HV|hv
846277|NCT00082017|Protein Kinase Inhibition|protein kinase inhibition
846278|NCT00082017|Soluble Tac|soluble tac
846279|NCT00082017|Gene Expression Profiling|gene expression profiling
846280|NCT00082017|ALK Expression|alk expression
846281|NCT00082017|Apoptosis|apoptosis
846282|NCT00082017|Lymphoma|lymphoma
846283|NCT00082017|Anaplastic Large Cell Lymphoma|anaplastic large cell lymphoma
846284|NCT00082017|ALCL|alcl
846285|NCT00082017|T-Cell Lymphoma|t-cell lymphoma
846286|NCT00081991|Cataract|cataract
846287|NCT00081991|Blindness|blindness
846288|NCT00081991|Clinical|clinical
846289|NCT00081991|Human Aging|human aging
846290|NCT00081991|Dynamic Light Scattering (DLS)|dynamic light scattering (dls)
846291|NCT00081991|Aging-Related Lens Changes|aging-related lens changes
846292|NCT00081991|Early Cataract|early cataract
846293|NCT00081991|Lens|lens
846294|NCT00081991|AREDS Grading|areds grading
846295|NCT00081991|In Vivo|in vivo
846296|NCT00081991|Healthy Volunteer|healthy volunteer
846297|NCT00081965|breast cancer in situ|breast cancer in situ
846298|NCT00081965|stage I breast cancer|stage i breast cancer
846299|NCT00081965|stage II breast cancer|stage ii breast cancer
846300|NCT00081965|stage IIIA breast cancer|stage iiia breast cancer
846301|NCT00081965|stage IIIB breast cancer|stage iiib breast cancer
846302|NCT00081965|stage IV breast cancer|stage iv breast cancer
846303|NCT00081965|recurrent breast cancer|recurrent breast cancer
846304|NCT00081965|stage IIIC breast cancer|stage iiic breast cancer
846305|NCT00081965|hot flashes|hot flashes
846306|NCT00081952|Postmenopause|postmenopause
846307|NCT00081913|Apheresis|apheresis
846308|NCT00081913|Cell Transfer|cell transfer
846309|NCT00081913|Chest Pain|chest pain
846310|NCT00081913|Adult Stem Cell Therapy|adult stem cell therapy
846311|NCT00081900|Carcinoma, Hepatocellular|carcinoma, hepatocellular
846312|NCT00005969|recurrent adult Hodgkin lymphoma|recurrent adult hodgkin lymphoma
846313|NCT00005969|recurrent/refractory childhood Hodgkin lymphoma|recurrent/refractory childhood hodgkin lymphoma
846314|NCT00005883|non-small cell lung cancer|non-small cell lung cancer
846315|NCT00005883|small cell lung cancer|small cell lung cancer
846316|NCT00005796|recurrent adult brain tumor|recurrent adult brain tumor
846317|NCT00005796|adult brain stem glioma|adult brain stem glioma
846318|NCT00005796|adult ependymoma|adult ependymoma
846319|NCT00005796|adult medulloblastoma|adult medulloblastoma
846320|NCT00005796|adult glioblastoma|adult glioblastoma
846321|NCT00005796|childhood high-grade cerebral astrocytoma|childhood high-grade cerebral astrocytoma
846322|NCT00005796|childhood oligodendroglioma|childhood oligodendroglioma
846323|NCT00005796|adult anaplastic astrocytoma|adult anaplastic astrocytoma
846324|NCT00005796|adult anaplastic oligodendroglioma|adult anaplastic oligodendroglioma
846325|NCT00005796|adult mixed glioma|adult mixed glioma
846326|NCT00005796|drug/agent toxicity by tissue/organ|drug/agent toxicity by tissue/organ
846327|NCT00005796|bone marrow suppression|bone marrow suppression
846328|NCT00005796|untreated childhood brain stem glioma|untreated childhood brain stem glioma
846329|NCT00005796|recurrent childhood brain stem glioma|recurrent childhood brain stem glioma
846330|NCT00005796|untreated childhood cerebellar astrocytoma|untreated childhood cerebellar astrocytoma
846331|NCT00005796|recurrent childhood cerebellar astrocytoma|recurrent childhood cerebellar astrocytoma
846332|NCT00005796|recurrent childhood cerebral astrocytoma|recurrent childhood cerebral astrocytoma
846333|NCT00005796|recurrent childhood medulloblastoma|recurrent childhood medulloblastoma
846334|NCT00005796|newly diagnosed childhood ependymoma|newly diagnosed childhood ependymoma
846335|NCT00005796|recurrent childhood ependymoma|recurrent childhood ependymoma
846336|NCT00005796|adult giant cell glioblastoma|adult giant cell glioblastoma
846338|NCT00005649|stage IV breast cancer|stage iv breast cancer
846340|NCT00004933|relapsing chronic myelogenous leukemia|relapsing chronic myelogenous leukemia
846341|NCT00004933|chronic phase chronic myelogenous leukemia|chronic phase chronic myelogenous leukemia
846342|NCT00004933|Philadelphia chromosome positive chronic myelogenous leukemia|philadelphia chromosome positive chronic myelogenous leukemia
846343|NCT00004923|unspecified adult solid tumor, protocol specific|unspecified adult solid tumor, protocol specific
846344|NCT00004903|refractory multiple myeloma|refractory multiple myeloma
846345|NCT00004903|stage I multiple myeloma|stage i multiple myeloma
846346|NCT00004903|stage II multiple myeloma|stage ii multiple myeloma
846347|NCT00004903|stage III multiple myeloma|stage iii multiple myeloma
846348|NCT00004878|chronic phase chronic myelogenous leukemia|chronic phase chronic myelogenous leukemia
846349|NCT00004878|accelerated phase chronic myelogenous leukemia|accelerated phase chronic myelogenous leukemia
846350|NCT00004878|Philadelphia chromosome positive chronic myelogenous leukemia|philadelphia chromosome positive chronic myelogenous leukemia
846351|NCT00004878|graft versus host disease|graft versus host disease
846352|NCT00004872|unspecified adult solid tumor, protocol specific|unspecified adult solid tumor, protocol specific
846353|NCT00004858|recurrent childhood acute lymphoblastic leukemia|recurrent childhood acute lymphoblastic leukemia
846354|NCT00004858|recurrent childhood lymphoblastic lymphoma|recurrent childhood lymphoblastic lymphoma
846355|NCT00004858|recurrent adult acute lymphoblastic leukemia|recurrent adult acute lymphoblastic leukemia
846356|NCT00004858|recurrent grade 1 follicular lymphoma|recurrent grade 1 follicular lymphoma
846357|NCT00004858|recurrent grade 2 follicular lymphoma|recurrent grade 2 follicular lymphoma
846358|NCT00004858|recurrent grade 3 follicular lymphoma|recurrent grade 3 follicular lymphoma
846359|NCT00004858|recurrent adult diffuse small cleaved cell lymphoma|recurrent adult diffuse small cleaved cell lymphoma
846360|NCT00004858|recurrent adult diffuse mixed cell lymphoma|recurrent adult diffuse mixed cell lymphoma
846361|NCT00004858|recurrent adult diffuse large cell lymphoma|recurrent adult diffuse large cell lymphoma
846362|NCT00004858|recurrent adult immunoblastic large cell lymphoma|recurrent adult immunoblastic large cell lymphoma
846363|NCT00004858|recurrent adult lymphoblastic lymphoma|recurrent adult lymphoblastic lymphoma
846364|NCT00004858|recurrent adult Burkitt lymphoma|recurrent adult burkitt lymphoma
846365|NCT00004858|recurrent childhood small noncleaved cell lymphoma|recurrent childhood small noncleaved cell lymphoma
846366|NCT00004858|recurrent childhood large cell lymphoma|recurrent childhood large cell lymphoma
846367|NCT00004858|recurrent small lymphocytic lymphoma|recurrent small lymphocytic lymphoma
846368|NCT00004604|stage IV colon cancer|stage iv colon cancer
846369|NCT00004604|stage IV breast cancer|stage iv breast cancer
846370|NCT00004604|recurrent breast cancer|recurrent breast cancer
846371|NCT00004604|stage IV gastric cancer|stage iv gastric cancer
846372|NCT00004604|recurrent gastric cancer|recurrent gastric cancer
846373|NCT00004604|recurrent non-small cell lung cancer|recurrent non-small cell lung cancer
846374|NCT00004604|recurrent pancreatic cancer|recurrent pancreatic cancer
846375|NCT00004604|stage IV rectal cancer|stage iv rectal cancer
846377|NCT00004604|recurrent rectal cancer|recurrent rectal cancer
846378|NCT00004604|inflammatory breast cancer|inflammatory breast cancer
846379|NCT00004604|stage IV ovarian epithelial cancer|stage iv ovarian epithelial cancer
846380|NCT00004604|recurrent ovarian epithelial cancer|recurrent ovarian epithelial cancer
846381|NCT00004604|extensive stage small cell lung cancer|extensive stage small cell lung cancer
846382|NCT00004604|recurrent small cell lung cancer|recurrent small cell lung cancer
846383|NCT00004604|unresectable gallbladder cancer|unresectable gallbladder cancer
846384|NCT00004604|recurrent gallbladder cancer|recurrent gallbladder cancer
846385|NCT00004604|unresectable extrahepatic bile duct cancer|unresectable extrahepatic bile duct cancer
846386|NCT00004604|recurrent extrahepatic bile duct cancer|recurrent extrahepatic bile duct cancer
846387|NCT00004604|stage III malignant testicular germ cell tumor|stage iii malignant testicular germ cell tumor
846388|NCT00004604|recurrent malignant testicular germ cell tumor|recurrent malignant testicular germ cell tumor
846389|NCT00004604|thyroid gland medullary carcinoma|thyroid gland medullary carcinoma
846390|NCT00004604|stage IV non-small cell lung cancer|stage iv non-small cell lung cancer
846391|NCT00004604|stage IV salivary gland cancer|stage iv salivary gland cancer
846392|NCT00004604|recurrent salivary gland cancer|recurrent salivary gland cancer
846393|NCT00004604|Paget disease of the breast with invasive ductal carcinoma|paget disease of the breast with invasive ductal carcinoma
846394|NCT00004604|adult primary hepatocellular carcinoma|adult primary hepatocellular carcinoma
846395|NCT00004604|testicular yolk sac tumor|testicular yolk sac tumor
846396|NCT00004604|lung metastases|lung metastases
846397|NCT00004604|liver metastases|liver metastases
846398|NCT00004604|cholangiocarcinoma of the gallbladder|cholangiocarcinoma of the gallbladder
846399|NCT00004604|cholangiocarcinoma of the extrahepatic bile duct|cholangiocarcinoma of the extrahepatic bile duct
846400|NCT00004604|male breast cancer|male breast cancer
846401|NCT00004604|stage IV pancreatic cancer|stage iv pancreatic cancer
846402|NCT00004249|limited stage small cell lung cancer|limited stage small cell lung cancer
846403|NCT00004174|stage IV breast cancer|stage iv breast cancer
846404|NCT00004174|stage IIIA breast cancer|stage iiia breast cancer
846405|NCT00004174|recurrent breast cancer|recurrent breast cancer
846406|NCT00004174|stage IIIB breast cancer|stage iiib breast cancer
846407|NCT00003960|refractory multiple myeloma|refractory multiple myeloma
860035|NCT00062751|breast|breast
846408|NCT00003960|chronic phase chronic myelogenous leukemia|chronic phase chronic myelogenous leukemia
846409|NCT00003960|adult acute myeloid leukemia in remission|adult acute myeloid leukemia in remission
846410|NCT00003960|adult acute lymphoblastic leukemia in remission|adult acute lymphoblastic leukemia in remission
846411|NCT00003960|refractory anemia with excess blasts|refractory anemia with excess blasts
846412|NCT00003960|refractory anemia with excess blasts in transformation|refractory anemia with excess blasts in transformation
846413|NCT00003960|acute undifferentiated leukemia|acute undifferentiated leukemia
846414|NCT00003960|secondary acute myeloid leukemia|secondary acute myeloid leukemia
846415|NCT00003960|de novo myelodysplastic syndromes|de novo myelodysplastic syndromes
846416|NCT00003960|previously treated myelodysplastic syndromes|previously treated myelodysplastic syndromes
846417|NCT00003960|secondary myelodysplastic syndromes|secondary myelodysplastic syndromes
846418|NCT00003953|stage II breast cancer|stage ii breast cancer
846419|NCT00003953|stage IIIA breast cancer|stage iiia breast cancer
846420|NCT00003953|stage IIIB breast cancer|stage iiib breast cancer
846421|NCT00081887|Chronic Lymphocytic Leukemia|chronic lymphocytic leukemia
846423|NCT00081887|Leukemia|leukemia
846424|NCT00081887|Clofarabine|clofarabine
846425|NCT00081887|Clofarex|clofarex
846426|NCT00081887|Clolar|clolar
846427|NCT00081874|Leukemia|leukemia
846428|NCT00081874|Mantle cell lymphoma|mantle cell lymphoma
846429|NCT00081874|Myelofibrosis|myelofibrosis
846430|NCT00081874|Relapsed or Refractory Acute Myeloid Leukemia|relapsed or refractory acute myeloid leukemia
846431|NCT00081874|Acute Lymphocytic Leukemia|acute lymphocytic leukemia
846432|NCT00081874|Chronic Myeloid Leukemia in Blastic-Phase|chronic myeloid leukemia in blastic-phase
846433|NCT00081874|Agnogenic Myeloid Metaplasia|agnogenic myeloid metaplasia
846434|NCT00081874|Chronic Lymphocytic Leukemia|chronic lymphocytic leukemia
846435|NCT00081874|T-Cell Leukemia|t-cell leukemia
846436|NCT00081874|RAD001|rad001
846437|NCT00081874|Everolimus|everolimus
846438|NCT00081874|Afinitor|afinitor
846439|NCT00081861|Non-Hodgkin's Lymphoma|non-hodgkin's lymphoma
846440|NCT00081861|B-Cell Lymphoma|b-cell lymphoma
846441|NCT00081861|Lymphoma|lymphoma
846442|NCT00081861|Avastin|avastin
846443|NCT00081861|Bevacizumab|bevacizumab
846444|NCT00081861|Rituximab|rituximab
846445|NCT00081861|Rituxan|rituxan
846446|NCT00003950|stage IV colon cancer|stage iv colon cancer
846447|NCT00003950|stage IV rectal cancer|stage iv rectal cancer
846448|NCT00003950|recurrent colon cancer|recurrent colon cancer
846449|NCT00003950|recurrent rectal cancer|recurrent rectal cancer
846450|NCT00003950|adenocarcinoma of the colon|adenocarcinoma of the colon
846451|NCT00003950|adenocarcinoma of the rectum|adenocarcinoma of the rectum
846452|NCT00003914|stage IV renal cell cancer|stage iv renal cell cancer
846453|NCT00003914|recurrent renal cell cancer|recurrent renal cell cancer
846454|NCT00003887|stage IV breast cancer|stage iv breast cancer
846455|NCT00003887|stage IIIA breast cancer|stage iiia breast cancer
846456|NCT00003887|stage IIIB breast cancer|stage iiib breast cancer
846457|NCT00003887|recurrent childhood acute lymphoblastic leukemia|recurrent childhood acute lymphoblastic leukemia
846458|NCT00003887|recurrent adult Hodgkin lymphoma|recurrent adult hodgkin lymphoma
846459|NCT00003887|recurrent cutaneous T-cell non-Hodgkin lymphoma|recurrent cutaneous t-cell non-hodgkin lymphoma
846460|NCT00003887|refractory multiple myeloma|refractory multiple myeloma
846461|NCT00003887|recurrent childhood rhabdomyosarcoma|recurrent childhood rhabdomyosarcoma
846462|NCT00003887|stage II ovarian epithelial cancer|stage ii ovarian epithelial cancer
846463|NCT00003887|stage III ovarian epithelial cancer|stage iii ovarian epithelial cancer
846464|NCT00003887|stage IV ovarian epithelial cancer|stage iv ovarian epithelial cancer
846465|NCT00003887|recurrent ovarian epithelial cancer|recurrent ovarian epithelial cancer
846466|NCT00003887|disseminated neuroblastoma|disseminated neuroblastoma
846467|NCT00003887|recurrent neuroblastoma|recurrent neuroblastoma
846468|NCT00003887|recurrent Wilms tumor and other childhood kidney tumors|recurrent wilms tumor and other childhood kidney tumors
846469|NCT00003887|stage I multiple myeloma|stage i multiple myeloma
846470|NCT00003887|stage II multiple myeloma|stage ii multiple myeloma
846471|NCT00003887|stage III multiple myeloma|stage iii multiple myeloma
846472|NCT00003887|recurrent childhood lymphoblastic lymphoma|recurrent childhood lymphoblastic lymphoma
846473|NCT00003887|stage III chronic lymphocytic leukemia|stage iii chronic lymphocytic leukemia
846474|NCT00003887|stage IV chronic lymphocytic leukemia|stage iv chronic lymphocytic leukemia
846475|NCT00003887|recurrent childhood acute myeloid leukemia|recurrent childhood acute myeloid leukemia
846476|NCT00003887|recurrent adult acute myeloid leukemia|recurrent adult acute myeloid leukemia
846477|NCT00003887|recurrent adult acute lymphoblastic leukemia|recurrent adult acute lymphoblastic leukemia
846478|NCT00003887|relapsing chronic myelogenous leukemia|relapsing chronic myelogenous leukemia
846479|NCT00003887|refractory chronic lymphocytic leukemia|refractory chronic lymphocytic leukemia
846480|NCT00003887|stage III malignant testicular germ cell tumor|stage iii malignant testicular germ cell tumor
846481|NCT00003887|recurrent malignant testicular germ cell tumor|recurrent malignant testicular germ cell tumor
846482|NCT00003887|chronic phase chronic myelogenous leukemia|chronic phase chronic myelogenous leukemia
846483|NCT00003887|accelerated phase chronic myelogenous leukemia|accelerated phase chronic myelogenous leukemia
846484|NCT00003887|blastic phase chronic myelogenous leukemia|blastic phase chronic myelogenous leukemia
846614|NCT00003434|stage I pancreatic cancer|stage i pancreatic cancer
846485|NCT00003887|meningeal chronic myelogenous leukemia|meningeal chronic myelogenous leukemia
846486|NCT00003887|chronic idiopathic myelofibrosis|chronic idiopathic myelofibrosis
846487|NCT00003887|childhood acute promyelocytic leukemia (M3)|childhood acute promyelocytic leukemia (m3)
846488|NCT00003887|testicular embryonal carcinoma|testicular embryonal carcinoma
846489|NCT00003887|testicular choriocarcinoma|testicular choriocarcinoma
846490|NCT00003887|testicular teratoma|testicular teratoma
846491|NCT00003887|testicular yolk sac tumor|testicular yolk sac tumor
846492|NCT00003887|testicular embryonal carcinoma and teratoma|testicular embryonal carcinoma and teratoma
846493|NCT00003887|testicular embryonal carcinoma and teratoma with seminoma|testicular embryonal carcinoma and teratoma with seminoma
846494|NCT00003887|testicular embryonal carcinoma and yolk sac tumor|testicular embryonal carcinoma and yolk sac tumor
846495|NCT00003887|testicular embryonal carcinoma and yolk sac tumor with seminoma|testicular embryonal carcinoma and yolk sac tumor with seminoma
846496|NCT00003887|testicular embryonal carcinoma and seminoma|testicular embryonal carcinoma and seminoma
846497|NCT00003887|testicular yolk sac tumor and teratoma|testicular yolk sac tumor and teratoma
846498|NCT00003887|testicular yolk sac tumor and teratoma with seminoma|testicular yolk sac tumor and teratoma with seminoma
846499|NCT00003887|testicular choriocarcinoma and yolk sac tumor|testicular choriocarcinoma and yolk sac tumor
846500|NCT00003887|testicular choriocarcinoma and embryonal carcinoma|testicular choriocarcinoma and embryonal carcinoma
846501|NCT00003887|testicular choriocarcinoma and teratoma|testicular choriocarcinoma and teratoma
846502|NCT00003887|testicular choriocarcinoma and seminoma|testicular choriocarcinoma and seminoma
846503|NCT00003887|refractory hairy cell leukemia|refractory hairy cell leukemia
846504|NCT00003887|recurrent/refractory childhood Hodgkin lymphoma|recurrent/refractory childhood hodgkin lymphoma
846505|NCT00003887|recurrent ovarian germ cell tumor|recurrent ovarian germ cell tumor
846506|NCT00003887|ovarian yolk sac tumor|ovarian yolk sac tumor
846507|NCT00003887|ovarian embryonal carcinoma|ovarian embryonal carcinoma
846508|NCT00003887|ovarian polyembryoma|ovarian polyembryoma
846509|NCT00003887|ovarian choriocarcinoma|ovarian choriocarcinoma
846510|NCT00003887|ovarian immature teratoma|ovarian immature teratoma
846511|NCT00003887|ovarian mature teratoma|ovarian mature teratoma
846512|NCT00003887|ovarian monodermal and highly specialized teratoma|ovarian monodermal and highly specialized teratoma
846513|NCT00003887|ovarian mixed germ cell tumor|ovarian mixed germ cell tumor
846514|NCT00003887|stage III grade 1 follicular lymphoma|stage iii grade 1 follicular lymphoma
846515|NCT00003887|stage III grade 2 follicular lymphoma|stage iii grade 2 follicular lymphoma
846516|NCT00003887|stage III grade 3 follicular lymphoma|stage iii grade 3 follicular lymphoma
846517|NCT00003887|stage III adult diffuse small cleaved cell lymphoma|stage iii adult diffuse small cleaved cell lymphoma
846518|NCT00003887|stage III adult diffuse mixed cell lymphoma|stage iii adult diffuse mixed cell lymphoma
846519|NCT00003887|stage III adult diffuse large cell lymphoma|stage iii adult diffuse large cell lymphoma
846520|NCT00003887|stage III adult immunoblastic large cell lymphoma|stage iii adult immunoblastic large cell lymphoma
846521|NCT00003887|stage III adult lymphoblastic lymphoma|stage iii adult lymphoblastic lymphoma
846522|NCT00003887|stage III adult Burkitt lymphoma|stage iii adult burkitt lymphoma
846523|NCT00003887|stage IV grade 1 follicular lymphoma|stage iv grade 1 follicular lymphoma
846524|NCT00003887|stage IV grade 2 follicular lymphoma|stage iv grade 2 follicular lymphoma
846525|NCT00003887|stage IV grade 3 follicular lymphoma|stage iv grade 3 follicular lymphoma
846526|NCT00003887|stage IV adult diffuse small cleaved cell lymphoma|stage iv adult diffuse small cleaved cell lymphoma
846527|NCT00003887|stage IV adult diffuse mixed cell lymphoma|stage iv adult diffuse mixed cell lymphoma
846528|NCT00003887|stage IV adult diffuse large cell lymphoma|stage iv adult diffuse large cell lymphoma
846529|NCT00003887|stage IV adult immunoblastic large cell lymphoma|stage iv adult immunoblastic large cell lymphoma
846530|NCT00003887|stage IV adult lymphoblastic lymphoma|stage iv adult lymphoblastic lymphoma
846531|NCT00003887|stage IV adult Burkitt lymphoma|stage iv adult burkitt lymphoma
846532|NCT00003887|recurrent grade 1 follicular lymphoma|recurrent grade 1 follicular lymphoma
846533|NCT00003887|recurrent grade 2 follicular lymphoma|recurrent grade 2 follicular lymphoma
846534|NCT00003887|recurrent grade 3 follicular lymphoma|recurrent grade 3 follicular lymphoma
846535|NCT00003887|recurrent adult diffuse small cleaved cell lymphoma|recurrent adult diffuse small cleaved cell lymphoma
846536|NCT00003887|recurrent adult diffuse mixed cell lymphoma|recurrent adult diffuse mixed cell lymphoma
846537|NCT00003887|recurrent adult diffuse large cell lymphoma|recurrent adult diffuse large cell lymphoma
846538|NCT00003887|recurrent adult immunoblastic large cell lymphoma|recurrent adult immunoblastic large cell lymphoma
846539|NCT00003887|recurrent adult lymphoblastic lymphoma|recurrent adult lymphoblastic lymphoma
846540|NCT00003887|recurrent adult Burkitt lymphoma|recurrent adult burkitt lymphoma
846541|NCT00003887|stage II adult T-cell leukemia/lymphoma|stage ii adult t-cell leukemia/lymphoma
846542|NCT00003887|secondary acute myeloid leukemia|secondary acute myeloid leukemia
846543|NCT00003887|de novo myelodysplastic syndromes|de novo myelodysplastic syndromes
846544|NCT00003887|poor prognosis metastatic gestational trophoblastic tumor|poor prognosis metastatic gestational trophoblastic tumor
846545|NCT00003887|previously treated myelodysplastic syndromes|previously treated myelodysplastic syndromes
846546|NCT00003887|secondary myelodysplastic syndromes|secondary myelodysplastic syndromes
846547|NCT00003887|recurrent childhood small noncleaved cell lymphoma|recurrent childhood small noncleaved cell lymphoma
846548|NCT00003887|recurrent childhood large cell lymphoma|recurrent childhood large cell lymphoma
860036|NCT00062751|neoplasms|neoplasms
846549|NCT00003887|noncontiguous stage II grade 1 follicular lymphoma|noncontiguous stage ii grade 1 follicular lymphoma
846550|NCT00003887|noncontiguous stage II grade 2 follicular lymphoma|noncontiguous stage ii grade 2 follicular lymphoma
846551|NCT00003887|noncontiguous stage II grade 3 follicular lymphoma|noncontiguous stage ii grade 3 follicular lymphoma
846552|NCT00003887|noncontiguous stage II adult diffuse small cleaved cell lymphoma|noncontiguous stage ii adult diffuse small cleaved cell lymphoma
846553|NCT00003887|noncontiguous stage II mantle cell lymphoma|noncontiguous stage ii mantle cell lymphoma
846554|NCT00003887|noncontiguous stage II adult diffuse mixed cell lymphoma|noncontiguous stage ii adult diffuse mixed cell lymphoma
846555|NCT00003887|noncontiguous stage II adult immunoblastic large cell lymphoma|noncontiguous stage ii adult immunoblastic large cell lymphoma
846556|NCT00003887|noncontiguous stage II adult diffuse large cell lymphoma|noncontiguous stage ii adult diffuse large cell lymphoma
846557|NCT00003887|noncontiguous stage II adult Burkitt lymphoma|noncontiguous stage ii adult burkitt lymphoma
846558|NCT00003887|noncontiguous stage II adult lymphoblastic lymphoma|noncontiguous stage ii adult lymphoblastic lymphoma
846559|NCT00003887|stage III mantle cell lymphoma|stage iii mantle cell lymphoma
846560|NCT00003887|stage IV mantle cell lymphoma|stage iv mantle cell lymphoma
846561|NCT00003887|recurrent mantle cell lymphoma|recurrent mantle cell lymphoma
846562|NCT00003887|previously treated childhood rhabdomyosarcoma|previously treated childhood rhabdomyosarcoma
846563|NCT00003887|recurrent mycosis fungoides/Sezary syndrome|recurrent mycosis fungoides/sezary syndrome
846564|NCT00003887|noncontiguous stage II small lymphocytic lymphoma|noncontiguous stage ii small lymphocytic lymphoma
846565|NCT00003887|noncontiguous stage II marginal zone lymphoma|noncontiguous stage ii marginal zone lymphoma
846566|NCT00003887|recurrent marginal zone lymphoma|recurrent marginal zone lymphoma
846567|NCT00003887|recurrent small lymphocytic lymphoma|recurrent small lymphocytic lymphoma
846568|NCT00003887|stage III small lymphocytic lymphoma|stage iii small lymphocytic lymphoma
846569|NCT00003887|stage III marginal zone lymphoma|stage iii marginal zone lymphoma
846570|NCT00003887|stage IV small lymphocytic lymphoma|stage iv small lymphocytic lymphoma
846571|NCT00003887|stage IV marginal zone lymphoma|stage iv marginal zone lymphoma
846572|NCT00003887|extranodal marginal zone B-cell lymphoma of mucosa-associated lymphoid tissue|extranodal marginal zone b-cell lymphoma of mucosa-associated lymphoid tissue
846856|NCT00006357|adult angiosarcoma|adult angiosarcoma
846573|NCT00003887|nodal marginal zone B-cell lymphoma|nodal marginal zone b-cell lymphoma
846574|NCT00003887|splenic marginal zone lymphoma|splenic marginal zone lymphoma
846575|NCT00003887|childhood myelodysplastic syndromes|childhood myelodysplastic syndromes
846576|NCT00003819|stage I prostate cancer|stage i prostate cancer
846577|NCT00003819|stage IIB prostate cancer|stage iib prostate cancer
846578|NCT00003819|stage IIA prostate cancer|stage iia prostate cancer
846579|NCT00003819|stage III prostate cancer|stage iii prostate cancer
846580|NCT00003819|recurrent prostate cancer|recurrent prostate cancer
846581|NCT00003783|untreated childhood acute lymphoblastic leukemia|untreated childhood acute lymphoblastic leukemia
846582|NCT00003783|L1 childhood acute lymphoblastic leukemia|l1 childhood acute lymphoblastic leukemia
846583|NCT00003783|L2 childhood acute lymphoblastic leukemia|l2 childhood acute lymphoblastic leukemia
846584|NCT00003783|B-cell childhood acute lymphoblastic leukemia|b-cell childhood acute lymphoblastic leukemia
846585|NCT00003765|childhood craniopharyngioma|childhood craniopharyngioma
846586|NCT00003765|childhood central nervous system germ cell tumor|childhood central nervous system germ cell tumor
846587|NCT00003765|childhood oligodendroglioma|childhood oligodendroglioma
846588|NCT00003765|childhood choroid plexus tumor|childhood choroid plexus tumor
846589|NCT00003765|recurrent childhood brain stem glioma|recurrent childhood brain stem glioma
846590|NCT00003765|recurrent childhood supratentorial primitive neuroectodermal tumor|recurrent childhood supratentorial primitive neuroectodermal tumor
846591|NCT00003765|recurrent childhood visual pathway glioma|recurrent childhood visual pathway glioma
846592|NCT00003765|recurrent childhood cerebellar astrocytoma|recurrent childhood cerebellar astrocytoma
846593|NCT00003765|recurrent childhood cerebral astrocytoma|recurrent childhood cerebral astrocytoma
846594|NCT00003765|recurrent childhood medulloblastoma|recurrent childhood medulloblastoma
846595|NCT00003765|recurrent childhood ependymoma|recurrent childhood ependymoma
846596|NCT00003619|recurrent adult acute myeloid leukemia|recurrent adult acute myeloid leukemia
846597|NCT00003619|recurrent adult acute lymphoblastic leukemia|recurrent adult acute lymphoblastic leukemia
846598|NCT00003619|relapsing chronic myelogenous leukemia|relapsing chronic myelogenous leukemia
846599|NCT00003619|blastic phase chronic myelogenous leukemia|blastic phase chronic myelogenous leukemia
846600|NCT00003619|polycythemia vera|polycythemia vera
846601|NCT00003619|primary myelofibrosis|primary myelofibrosis
846602|NCT00003619|refractory anemia|refractory anemia
846603|NCT00003619|refractory anemia with ringed sideroblasts|refractory anemia with ringed sideroblasts
846604|NCT00003619|refractory anemia with excess blasts|refractory anemia with excess blasts
846605|NCT00003619|chronic myelomonocytic leukemia|chronic myelomonocytic leukemia
846606|NCT00003619|secondary acute myeloid leukemia|secondary acute myeloid leukemia
846607|NCT00003619|previously treated myelodysplastic syndromes|previously treated myelodysplastic syndromes
846608|NCT00003619|secondary myelodysplastic syndromes|secondary myelodysplastic syndromes
846609|NCT00003619|thrombocytopenia|thrombocytopenia
846610|NCT00003544|stage IV colon cancer|stage iv colon cancer
846611|NCT00003544|stage IV rectal cancer|stage iv rectal cancer
846612|NCT00003544|recurrent colon cancer|recurrent colon cancer
846613|NCT00003544|recurrent rectal cancer|recurrent rectal cancer
846615|NCT00003434|stage II pancreatic cancer|stage ii pancreatic cancer
846617|NCT00003434|adenocarcinoma of the pancreas|adenocarcinoma of the pancreas
846618|NCT00003427|stage IV colon cancer|stage iv colon cancer
846619|NCT00003427|stage IV gastric cancer|stage iv gastric cancer
846620|NCT00003427|recurrent gastric cancer|recurrent gastric cancer
846621|NCT00003427|recurrent pancreatic cancer|recurrent pancreatic cancer
846622|NCT00003427|stage IV rectal cancer|stage iv rectal cancer
846623|NCT00003427|recurrent colon cancer|recurrent colon cancer
846624|NCT00003427|recurrent rectal cancer|recurrent rectal cancer
846625|NCT00003427|stage IV anal cancer|stage iv anal cancer
846626|NCT00003427|recurrent anal cancer|recurrent anal cancer
846627|NCT00003427|stage IV esophageal cancer|stage iv esophageal cancer
846628|NCT00003427|recurrent esophageal cancer|recurrent esophageal cancer
846629|NCT00003427|metastatic gastrointestinal carcinoid tumor|metastatic gastrointestinal carcinoid tumor
846630|NCT00003427|recurrent gastrointestinal carcinoid tumor|recurrent gastrointestinal carcinoid tumor
846631|NCT00003427|advanced adult primary liver cancer|advanced adult primary liver cancer
846632|NCT00003427|recurrent adult primary liver cancer|recurrent adult primary liver cancer
846633|NCT00003427|unresectable gallbladder cancer|unresectable gallbladder cancer
846634|NCT00003427|recurrent gallbladder cancer|recurrent gallbladder cancer
846635|NCT00003427|unresectable extrahepatic bile duct cancer|unresectable extrahepatic bile duct cancer
846636|NCT00003427|recurrent extrahepatic bile duct cancer|recurrent extrahepatic bile duct cancer
846637|NCT00003427|recurrent small intestine cancer|recurrent small intestine cancer
846638|NCT00003427|stage IV pancreatic cancer|stage iv pancreatic cancer
846639|NCT00003407|recurrent adult acute myeloid leukemia|recurrent adult acute myeloid leukemia
846640|NCT00003407|blastic phase chronic myelogenous leukemia|blastic phase chronic myelogenous leukemia
846641|NCT00003407|untreated adult acute myeloid leukemia|untreated adult acute myeloid leukemia
846642|NCT00003407|refractory anemia with excess blasts in transformation|refractory anemia with excess blasts in transformation
846643|NCT00003407|secondary acute myeloid leukemia|secondary acute myeloid leukemia
846644|NCT00003407|de novo myelodysplastic syndromes|de novo myelodysplastic syndromes
846645|NCT00003407|secondary myelodysplastic syndromes|secondary myelodysplastic syndromes
846646|NCT00003407|drug/agent toxicity by tissue/organ|drug/agent toxicity by tissue/organ
846647|NCT00003407|neutropenia|neutropenia
846648|NCT00003398|stage III adult Hodgkin lymphoma|stage iii adult hodgkin lymphoma
846649|NCT00003398|stage IV adult Hodgkin lymphoma|stage iv adult hodgkin lymphoma
846650|NCT00003398|recurrent childhood acute lymphoblastic leukemia|recurrent childhood acute lymphoblastic leukemia
846651|NCT00003398|recurrent adult Hodgkin lymphoma|recurrent adult hodgkin lymphoma
846652|NCT00003398|Burkitt lymphoma|burkitt lymphoma
846653|NCT00003398|refractory multiple myeloma|refractory multiple myeloma
846654|NCT00003398|Waldenstrom macroglobulinemia|waldenstrom macroglobulinemia
846655|NCT00003398|stage I multiple myeloma|stage i multiple myeloma
846656|NCT00003398|stage II multiple myeloma|stage ii multiple myeloma
846657|NCT00003398|stage III multiple myeloma|stage iii multiple myeloma
846658|NCT00003398|stage I childhood lymphoblastic lymphoma|stage i childhood lymphoblastic lymphoma
846659|NCT00003398|stage II childhood lymphoblastic lymphoma|stage ii childhood lymphoblastic lymphoma
846660|NCT00003398|stage III childhood lymphoblastic lymphoma|stage iii childhood lymphoblastic lymphoma
846661|NCT00003398|stage IV childhood lymphoblastic lymphoma|stage iv childhood lymphoblastic lymphoma
846662|NCT00003398|recurrent childhood lymphoblastic lymphoma|recurrent childhood lymphoblastic lymphoma
846663|NCT00003398|stage I chronic lymphocytic leukemia|stage i chronic lymphocytic leukemia
846664|NCT00003398|stage II chronic lymphocytic leukemia|stage ii chronic lymphocytic leukemia
846665|NCT00003398|stage III chronic lymphocytic leukemia|stage iii chronic lymphocytic leukemia
846666|NCT00003398|stage IV chronic lymphocytic leukemia|stage iv chronic lymphocytic leukemia
846667|NCT00003398|recurrent childhood acute myeloid leukemia|recurrent childhood acute myeloid leukemia
846668|NCT00003398|recurrent adult acute myeloid leukemia|recurrent adult acute myeloid leukemia
846669|NCT00003398|recurrent adult acute lymphoblastic leukemia|recurrent adult acute lymphoblastic leukemia
846670|NCT00003398|refractory chronic lymphocytic leukemia|refractory chronic lymphocytic leukemia
846671|NCT00003398|childhood diffuse large cell lymphoma|childhood diffuse large cell lymphoma
846672|NCT00003398|childhood immunoblastic large cell lymphoma|childhood immunoblastic large cell lymphoma
846673|NCT00003398|chronic phase chronic myelogenous leukemia|chronic phase chronic myelogenous leukemia
846674|NCT00003398|accelerated phase chronic myelogenous leukemia|accelerated phase chronic myelogenous leukemia
846675|NCT00003398|blastic phase chronic myelogenous leukemia|blastic phase chronic myelogenous leukemia
846676|NCT00003398|meningeal chronic myelogenous leukemia|meningeal chronic myelogenous leukemia
846677|NCT00003398|adult acute myeloid leukemia in remission|adult acute myeloid leukemia in remission
846678|NCT00003398|adult acute lymphoblastic leukemia in remission|adult acute lymphoblastic leukemia in remission
846679|NCT00003398|childhood acute myeloid leukemia in remission|childhood acute myeloid leukemia in remission
846680|NCT00003398|childhood acute lymphoblastic leukemia in remission|childhood acute lymphoblastic leukemia in remission
846681|NCT00003398|adult acute myeloblastic leukemia without maturation (M1)|adult acute myeloblastic leukemia without maturation (m1)
846682|NCT00003398|adult acute myeloblastic leukemia with maturation (M2)|adult acute myeloblastic leukemia with maturation (m2)
846683|NCT00003398|adult acute promyelocytic leukemia (M3)|adult acute promyelocytic leukemia (m3)
846684|NCT00003398|adult acute myelomonocytic leukemia (M4)|adult acute myelomonocytic leukemia (m4)
876736|NCT00050804|SSRI|ssri
846685|NCT00003398|adult acute eosinophilic leukemia|adult acute eosinophilic leukemia
846686|NCT00003398|adult acute basophilic leukemia|adult acute basophilic leukemia
846687|NCT00003398|adult acute megakaryoblastic leukemia (M7)|adult acute megakaryoblastic leukemia (m7)
846688|NCT00003398|childhood acute myeloblastic leukemia with maturation (M2)|childhood acute myeloblastic leukemia with maturation (m2)
846689|NCT00003398|childhood acute promyelocytic leukemia (M3)|childhood acute promyelocytic leukemia (m3)
846690|NCT00003398|childhood acute myelomonocytic leukemia (M4)|childhood acute myelomonocytic leukemia (m4)
846691|NCT00003398|childhood acute eosinophilic leukemia|childhood acute eosinophilic leukemia
846692|NCT00003398|childhood acute basophilic leukemia|childhood acute basophilic leukemia
846693|NCT00003398|childhood acute megakaryocytic leukemia (M7)|childhood acute megakaryocytic leukemia (m7)
846694|NCT00003398|stage III childhood Hodgkin lymphoma|stage iii childhood hodgkin lymphoma
846695|NCT00003398|stage IV childhood Hodgkin lymphoma|stage iv childhood hodgkin lymphoma
846696|NCT00003398|recurrent/refractory childhood Hodgkin lymphoma|recurrent/refractory childhood hodgkin lymphoma
846697|NCT00003398|stage I grade 1 follicular lymphoma|stage i grade 1 follicular lymphoma
846698|NCT00003398|stage I grade 2 follicular lymphoma|stage i grade 2 follicular lymphoma
846699|NCT00003398|stage I grade 3 follicular lymphoma|stage i grade 3 follicular lymphoma
846700|NCT00003398|stage I adult diffuse small cleaved cell lymphoma|stage i adult diffuse small cleaved cell lymphoma
846701|NCT00003398|stage I adult diffuse mixed cell lymphoma|stage i adult diffuse mixed cell lymphoma
846702|NCT00003398|stage I adult diffuse large cell lymphoma|stage i adult diffuse large cell lymphoma
846703|NCT00003398|stage I adult immunoblastic large cell lymphoma|stage i adult immunoblastic large cell lymphoma
846704|NCT00003398|stage I adult lymphoblastic lymphoma|stage i adult lymphoblastic lymphoma
846705|NCT00003398|stage I adult Burkitt lymphoma|stage i adult burkitt lymphoma
846706|NCT00003398|stage III grade 1 follicular lymphoma|stage iii grade 1 follicular lymphoma
846707|NCT00003398|stage III grade 2 follicular lymphoma|stage iii grade 2 follicular lymphoma
846708|NCT00003398|stage III grade 3 follicular lymphoma|stage iii grade 3 follicular lymphoma
846709|NCT00003398|stage III adult diffuse small cleaved cell lymphoma|stage iii adult diffuse small cleaved cell lymphoma
846710|NCT00003398|stage III adult diffuse mixed cell lymphoma|stage iii adult diffuse mixed cell lymphoma
846711|NCT00003398|stage III adult diffuse large cell lymphoma|stage iii adult diffuse large cell lymphoma
846712|NCT00003398|stage III adult immunoblastic large cell lymphoma|stage iii adult immunoblastic large cell lymphoma
846713|NCT00003398|stage III adult lymphoblastic lymphoma|stage iii adult lymphoblastic lymphoma
846714|NCT00003398|stage III adult Burkitt lymphoma|stage iii adult burkitt lymphoma
846715|NCT00003398|stage IV grade 1 follicular lymphoma|stage iv grade 1 follicular lymphoma
846716|NCT00003398|stage IV grade 2 follicular lymphoma|stage iv grade 2 follicular lymphoma
846717|NCT00003398|stage IV grade 3 follicular lymphoma|stage iv grade 3 follicular lymphoma
846718|NCT00003398|stage IV adult diffuse small cleaved cell lymphoma|stage iv adult diffuse small cleaved cell lymphoma
846719|NCT00003398|stage IV adult diffuse mixed cell lymphoma|stage iv adult diffuse mixed cell lymphoma
846720|NCT00003398|stage IV adult diffuse large cell lymphoma|stage iv adult diffuse large cell lymphoma
846721|NCT00003398|stage IV adult immunoblastic large cell lymphoma|stage iv adult immunoblastic large cell lymphoma
846722|NCT00003398|stage IV adult lymphoblastic lymphoma|stage iv adult lymphoblastic lymphoma
846723|NCT00003398|stage IV adult Burkitt lymphoma|stage iv adult burkitt lymphoma
846724|NCT00003398|recurrent adult diffuse small cleaved cell lymphoma|recurrent adult diffuse small cleaved cell lymphoma
846725|NCT00003398|recurrent adult diffuse mixed cell lymphoma|recurrent adult diffuse mixed cell lymphoma
846726|NCT00003398|recurrent adult diffuse large cell lymphoma|recurrent adult diffuse large cell lymphoma
846727|NCT00003398|recurrent adult immunoblastic large cell lymphoma|recurrent adult immunoblastic large cell lymphoma
846728|NCT00003398|recurrent adult lymphoblastic lymphoma|recurrent adult lymphoblastic lymphoma
846729|NCT00003398|recurrent adult Burkitt lymphoma|recurrent adult burkitt lymphoma
846730|NCT00003398|de novo myelodysplastic syndromes|de novo myelodysplastic syndromes
846731|NCT00003398|previously treated myelodysplastic syndromes|previously treated myelodysplastic syndromes
846732|NCT00003398|secondary myelodysplastic syndromes|secondary myelodysplastic syndromes
846733|NCT00003398|anemia|anemia
846734|NCT00003398|graft versus host disease|graft versus host disease
846735|NCT00003398|adult acute minimally differentiated myeloid leukemia (M0)|adult acute minimally differentiated myeloid leukemia (m0)
846736|NCT00003398|childhood acute minimally differentiated myeloid leukemia (M0)|childhood acute minimally differentiated myeloid leukemia (m0)
846737|NCT00003398|stage I childhood small noncleaved cell lymphoma|stage i childhood small noncleaved cell lymphoma
846738|NCT00003398|stage I childhood large cell lymphoma|stage i childhood large cell lymphoma
846739|NCT00003398|stage II childhood small noncleaved cell lymphoma|stage ii childhood small noncleaved cell lymphoma
846740|NCT00003398|stage II childhood large cell lymphoma|stage ii childhood large cell lymphoma
846741|NCT00003398|stage III childhood small noncleaved cell lymphoma|stage iii childhood small noncleaved cell lymphoma
846742|NCT00003398|stage III childhood large cell lymphoma|stage iii childhood large cell lymphoma
846743|NCT00003398|stage IV childhood small noncleaved cell lymphoma|stage iv childhood small noncleaved cell lymphoma
846744|NCT00003398|stage IV childhood large cell lymphoma|stage iv childhood large cell lymphoma
846745|NCT00003398|recurrent childhood small noncleaved cell lymphoma|recurrent childhood small noncleaved cell lymphoma
847644|NCT00005608|recurrent breast cancer|recurrent breast cancer
846746|NCT00003398|recurrent childhood large cell lymphoma|recurrent childhood large cell lymphoma
846747|NCT00003398|stage I mantle cell lymphoma|stage i mantle cell lymphoma
846748|NCT00003398|contiguous stage II grade 1 follicular lymphoma|contiguous stage ii grade 1 follicular lymphoma
846749|NCT00003398|contiguous stage II grade 2 follicular lymphoma|contiguous stage ii grade 2 follicular lymphoma
846750|NCT00003398|contiguous stage II grade 3 follicular lymphoma|contiguous stage ii grade 3 follicular lymphoma
846751|NCT00003398|contiguous stage II adult diffuse small cleaved cell lymphoma|contiguous stage ii adult diffuse small cleaved cell lymphoma
846752|NCT00003398|contiguous stage II mantle cell lymphoma|contiguous stage ii mantle cell lymphoma
846753|NCT00003398|contiguous stage II adult diffuse mixed cell lymphoma|contiguous stage ii adult diffuse mixed cell lymphoma
846754|NCT00003398|contiguous stage II adult immunoblastic large cell lymphoma|contiguous stage ii adult immunoblastic large cell lymphoma
846755|NCT00003398|contiguous stage II adult diffuse large cell lymphoma|contiguous stage ii adult diffuse large cell lymphoma
846756|NCT00003398|contiguous stage II adult Burkitt lymphoma|contiguous stage ii adult burkitt lymphoma
846757|NCT00003398|contiguous stage II adult lymphoblastic lymphoma|contiguous stage ii adult lymphoblastic lymphoma
846758|NCT00003398|noncontiguous stage II grade 1 follicular lymphoma|noncontiguous stage ii grade 1 follicular lymphoma
846759|NCT00003398|noncontiguous stage II grade 2 follicular lymphoma|noncontiguous stage ii grade 2 follicular lymphoma
846760|NCT00003398|noncontiguous stage II grade 3 follicular lymphoma|noncontiguous stage ii grade 3 follicular lymphoma
846761|NCT00003398|noncontiguous stage II adult diffuse small cleaved cell lymphoma|noncontiguous stage ii adult diffuse small cleaved cell lymphoma
846762|NCT00003398|noncontiguous stage II mantle cell lymphoma|noncontiguous stage ii mantle cell lymphoma
846763|NCT00003398|noncontiguous stage II adult diffuse mixed cell lymphoma|noncontiguous stage ii adult diffuse mixed cell lymphoma
846764|NCT00003398|noncontiguous stage II adult immunoblastic large cell lymphoma|noncontiguous stage ii adult immunoblastic large cell lymphoma
846765|NCT00003398|noncontiguous stage II adult diffuse large cell lymphoma|noncontiguous stage ii adult diffuse large cell lymphoma
846766|NCT00003398|noncontiguous stage II adult Burkitt lymphoma|noncontiguous stage ii adult burkitt lymphoma
846767|NCT00003398|noncontiguous stage II adult lymphoblastic lymphoma|noncontiguous stage ii adult lymphoblastic lymphoma
846768|NCT00003398|stage III mantle cell lymphoma|stage iii mantle cell lymphoma
846769|NCT00003398|stage IV mantle cell lymphoma|stage iv mantle cell lymphoma
846770|NCT00003398|recurrent mantle cell lymphoma|recurrent mantle cell lymphoma
846771|NCT00003398|noncontiguous stage II small lymphocytic lymphoma|noncontiguous stage ii small lymphocytic lymphoma
846772|NCT00003398|noncontiguous stage II marginal zone lymphoma|noncontiguous stage ii marginal zone lymphoma
846773|NCT00003398|recurrent marginal zone lymphoma|recurrent marginal zone lymphoma
846774|NCT00003398|recurrent small lymphocytic lymphoma|recurrent small lymphocytic lymphoma
846775|NCT00003398|stage I marginal zone lymphoma|stage i marginal zone lymphoma
846776|NCT00003398|stage I small lymphocytic lymphoma|stage i small lymphocytic lymphoma
846777|NCT00003398|stage III small lymphocytic lymphoma|stage iii small lymphocytic lymphoma
846778|NCT00003398|stage III marginal zone lymphoma|stage iii marginal zone lymphoma
846779|NCT00003398|stage IV small lymphocytic lymphoma|stage iv small lymphocytic lymphoma
846780|NCT00003398|stage IV marginal zone lymphoma|stage iv marginal zone lymphoma
846781|NCT00003398|contiguous stage II marginal zone lymphoma|contiguous stage ii marginal zone lymphoma
846782|NCT00003398|contiguous stage II small lymphocytic lymphoma|contiguous stage ii small lymphocytic lymphoma
846783|NCT00003398|extranodal marginal zone B-cell lymphoma of mucosa-associated lymphoid tissue|extranodal marginal zone b-cell lymphoma of mucosa-associated lymphoid tissue
846784|NCT00003398|nodal marginal zone B-cell lymphoma|nodal marginal zone b-cell lymphoma
846785|NCT00003398|splenic marginal zone lymphoma|splenic marginal zone lymphoma
846786|NCT00003398|childhood myelodysplastic syndromes|childhood myelodysplastic syndromes
846787|NCT00003270|recurrent childhood acute lymphoblastic leukemia|recurrent childhood acute lymphoblastic leukemia
846788|NCT00003270|recurrent adult Hodgkin lymphoma|recurrent adult hodgkin lymphoma
846789|NCT00003270|Burkitt lymphoma|burkitt lymphoma
846790|NCT00003270|refractory multiple myeloma|refractory multiple myeloma
846791|NCT00003270|stage I multiple myeloma|stage i multiple myeloma
846792|NCT00003270|stage II multiple myeloma|stage ii multiple myeloma
846793|NCT00003270|stage III multiple myeloma|stage iii multiple myeloma
846794|NCT00003270|recurrent childhood lymphoblastic lymphoma|recurrent childhood lymphoblastic lymphoma
846795|NCT00003270|recurrent childhood acute myeloid leukemia|recurrent childhood acute myeloid leukemia
846796|NCT00003270|recurrent adult acute myeloid leukemia|recurrent adult acute myeloid leukemia
846797|NCT00003270|recurrent adult acute lymphoblastic leukemia|recurrent adult acute lymphoblastic leukemia
846798|NCT00003270|relapsing chronic myelogenous leukemia|relapsing chronic myelogenous leukemia
846799|NCT00003270|childhood diffuse large cell lymphoma|childhood diffuse large cell lymphoma
846800|NCT00003270|childhood immunoblastic large cell lymphoma|childhood immunoblastic large cell lymphoma
846801|NCT00003270|chronic phase chronic myelogenous leukemia|chronic phase chronic myelogenous leukemia
846802|NCT00003270|accelerated phase chronic myelogenous leukemia|accelerated phase chronic myelogenous leukemia
846803|NCT00003270|blastic phase chronic myelogenous leukemia|blastic phase chronic myelogenous leukemia
846804|NCT00003270|meningeal chronic myelogenous leukemia|meningeal chronic myelogenous leukemia
846805|NCT00003270|adult acute myeloid leukemia in remission|adult acute myeloid leukemia in remission
846806|NCT00003270|adult acute lymphoblastic leukemia in remission|adult acute lymphoblastic leukemia in remission
847923|NCT00003834|adenocarcinoma of the colon|adenocarcinoma of the colon
848199|NCT00010283|stage IIIB breast cancer|stage iiib breast cancer
846807|NCT00003270|childhood acute myeloid leukemia in remission|childhood acute myeloid leukemia in remission
846808|NCT00003270|childhood acute lymphoblastic leukemia in remission|childhood acute lymphoblastic leukemia in remission
846809|NCT00003270|recurrent/refractory childhood Hodgkin lymphoma|recurrent/refractory childhood hodgkin lymphoma
846810|NCT00003270|recurrent grade 1 follicular lymphoma|recurrent grade 1 follicular lymphoma
846811|NCT00003270|recurrent grade 2 follicular lymphoma|recurrent grade 2 follicular lymphoma
846812|NCT00003270|recurrent grade 3 follicular lymphoma|recurrent grade 3 follicular lymphoma
846813|NCT00003270|recurrent adult diffuse small cleaved cell lymphoma|recurrent adult diffuse small cleaved cell lymphoma
846814|NCT00003270|recurrent adult diffuse mixed cell lymphoma|recurrent adult diffuse mixed cell lymphoma
846815|NCT00003270|recurrent adult diffuse large cell lymphoma|recurrent adult diffuse large cell lymphoma
846816|NCT00003270|recurrent adult immunoblastic large cell lymphoma|recurrent adult immunoblastic large cell lymphoma
846817|NCT00003270|recurrent adult lymphoblastic lymphoma|recurrent adult lymphoblastic lymphoma
846818|NCT00003270|recurrent adult Burkitt lymphoma|recurrent adult burkitt lymphoma
846819|NCT00003270|secondary acute myeloid leukemia|secondary acute myeloid leukemia
846820|NCT00003270|de novo myelodysplastic syndromes|de novo myelodysplastic syndromes
846821|NCT00003270|previously treated myelodysplastic syndromes|previously treated myelodysplastic syndromes
846822|NCT00003270|secondary myelodysplastic syndromes|secondary myelodysplastic syndromes
846823|NCT00003270|graft versus host disease|graft versus host disease
846824|NCT00003270|recurrent childhood small noncleaved cell lymphoma|recurrent childhood small noncleaved cell lymphoma
846825|NCT00003270|recurrent childhood large cell lymphoma|recurrent childhood large cell lymphoma
846826|NCT00003270|recurrent mantle cell lymphoma|recurrent mantle cell lymphoma
846827|NCT00003270|recurrent marginal zone lymphoma|recurrent marginal zone lymphoma
846828|NCT00003270|recurrent small lymphocytic lymphoma|recurrent small lymphocytic lymphoma
846829|NCT00003270|extranodal marginal zone B-cell lymphoma of mucosa-associated lymphoid tissue|extranodal marginal zone b-cell lymphoma of mucosa-associated lymphoid tissue
846830|NCT00003270|nodal marginal zone B-cell lymphoma|nodal marginal zone b-cell lymphoma
846831|NCT00003270|splenic marginal zone lymphoma|splenic marginal zone lymphoma
846832|NCT00003270|childhood myelodysplastic syndromes|childhood myelodysplastic syndromes
846833|NCT00003144|unspecified adult solid tumor, protocol specific|unspecified adult solid tumor, protocol specific
846834|NCT00003144|drug/agent toxicity by tissue/organ|drug/agent toxicity by tissue/organ
846835|NCT00003094|cervical cancer|cervical cancer
846836|NCT00003081|recurrent childhood rhabdomyosarcoma|recurrent childhood rhabdomyosarcoma
846837|NCT00003081|recurrent adult soft tissue sarcoma|recurrent adult soft tissue sarcoma
846838|NCT00003081|adult rhabdomyosarcoma|adult rhabdomyosarcoma
846839|NCT00003081|recurrent Ewing sarcoma/peripheral primitive neuroectodermal tumor|recurrent ewing sarcoma/peripheral primitive neuroectodermal tumor
846840|NCT00002964|stage 0 oropharyngeal cancer|stage 0 oropharyngeal cancer
846841|NCT00002964|stage 0 laryngeal cancer|stage 0 laryngeal cancer
846842|NCT00002964|stage 0 hypopharyngeal cancer|stage 0 hypopharyngeal cancer
846843|NCT00002964|stage 0 lip and oral cavity cancer|stage 0 lip and oral cavity cancer
846844|NCT00002964|stage I lip and oral cavity cancer|stage i lip and oral cavity cancer
846845|NCT00002964|stage I hypopharyngeal cancer|stage i hypopharyngeal cancer
846846|NCT00002964|stage I laryngeal cancer|stage i laryngeal cancer
846847|NCT00002964|stage I oropharyngeal cancer|stage i oropharyngeal cancer
846848|NCT00002866|stage IV breast cancer|stage iv breast cancer
846849|NCT00002866|recurrent breast cancer|recurrent breast cancer
846850|NCT00002866|neutropenia|neutropenia
846851|NCT00006475|relapsing chronic myelogenous leukemia|relapsing chronic myelogenous leukemia
846852|NCT00006475|blastic phase chronic myelogenous leukemia|blastic phase chronic myelogenous leukemia
846853|NCT00006475|chronic myelogenous leukemia, BCR-ABL1 positive|chronic myelogenous leukemia, bcr-abl1 positive
846854|NCT00006475|Philadelphia chromosome negative chronic myelogenous leukemia|philadelphia chromosome negative chronic myelogenous leukemia
846855|NCT00006463|unspecified childhood solid tumor, protocol specific|unspecified childhood solid tumor, protocol specific
846857|NCT00006357|adult fibrosarcoma|adult fibrosarcoma
846858|NCT00006357|adult leiomyosarcoma|adult leiomyosarcoma
846859|NCT00006357|adult liposarcoma|adult liposarcoma
846860|NCT00006357|adult neurofibrosarcoma|adult neurofibrosarcoma
846861|NCT00006357|adult synovial sarcoma|adult synovial sarcoma
846862|NCT00006357|recurrent adult soft tissue sarcoma|recurrent adult soft tissue sarcoma
846863|NCT00006357|small intestine leiomyosarcoma|small intestine leiomyosarcoma
846864|NCT00006357|adult alveolar soft-part sarcoma|adult alveolar soft-part sarcoma
846865|NCT00006357|adult epithelioid sarcoma|adult epithelioid sarcoma
846866|NCT00006357|adult malignant fibrous histiocytoma|adult malignant fibrous histiocytoma
846867|NCT00006357|adult malignant hemangiopericytoma|adult malignant hemangiopericytoma
846868|NCT00006357|adult malignant mesenchymoma|adult malignant mesenchymoma
846869|NCT00006357|adult rhabdomyosarcoma|adult rhabdomyosarcoma
846870|NCT00006357|ovarian stromal cancer|ovarian stromal cancer
846871|NCT00006357|recurrent uterine sarcoma|recurrent uterine sarcoma
846872|NCT00006357|uterine carcinosarcoma|uterine carcinosarcoma
846873|NCT00006357|uterine leiomyosarcoma|uterine leiomyosarcoma
846874|NCT00006357|endometrial stromal sarcoma|endometrial stromal sarcoma
846875|NCT00006357|ovarian sarcoma|ovarian sarcoma
846876|NCT00006357|gastrointestinal stromal tumor|gastrointestinal stromal tumor
846877|NCT00006216|stage IA malignant mesothelioma|stage ia malignant mesothelioma
846878|NCT00006216|stage IB malignant mesothelioma|stage ib malignant mesothelioma
846879|NCT00006216|stage II malignant mesothelioma|stage ii malignant mesothelioma
846880|NCT00006216|stage III malignant mesothelioma|stage iii malignant mesothelioma
846881|NCT00006049|recurrent non-small cell lung cancer|recurrent non-small cell lung cancer
846882|NCT00006049|stage IIIB non-small cell lung cancer|stage iiib non-small cell lung cancer
846883|NCT00006049|stage IV non-small cell lung cancer|stage iv non-small cell lung cancer
846884|NCT00006048|recurrent non-small cell lung cancer|recurrent non-small cell lung cancer
846885|NCT00006048|stage IIIB non-small cell lung cancer|stage iiib non-small cell lung cancer
846886|NCT00006048|stage IV non-small cell lung cancer|stage iv non-small cell lung cancer
846887|NCT00005870|recurrent pancreatic cancer|recurrent pancreatic cancer
846888|NCT00005870|adenocarcinoma of the pancreas|adenocarcinoma of the pancreas
846889|NCT00005849|recurrent non-small cell lung cancer|recurrent non-small cell lung cancer
846890|NCT00005849|stage IIIB non-small cell lung cancer|stage iiib non-small cell lung cancer
846891|NCT00005849|stage IV non-small cell lung cancer|stage iv non-small cell lung cancer
846892|NCT00005842|stage III colon cancer|stage iii colon cancer
846893|NCT00005842|stage IV colon cancer|stage iv colon cancer
846894|NCT00005842|stage IV breast cancer|stage iv breast cancer
846895|NCT00005842|stage IIIA breast cancer|stage iiia breast cancer
846896|NCT00005842|recurrent breast cancer|recurrent breast cancer
846897|NCT00005842|stage III gastric cancer|stage iii gastric cancer
846898|NCT00005842|stage IV gastric cancer|stage iv gastric cancer
846899|NCT00005842|recurrent gastric cancer|recurrent gastric cancer
846900|NCT00005842|occult non-small cell lung cancer|occult non-small cell lung cancer
846901|NCT00005842|stage IIIB breast cancer|stage iiib breast cancer
846902|NCT00005842|recurrent non-small cell lung cancer|recurrent non-small cell lung cancer
846903|NCT00005842|stage III pancreatic cancer|stage iii pancreatic cancer
846904|NCT00005842|recurrent pancreatic cancer|recurrent pancreatic cancer
846905|NCT00005842|stage III rectal cancer|stage iii rectal cancer
846906|NCT00005842|stage IV rectal cancer|stage iv rectal cancer
846907|NCT00005842|recurrent colon cancer|recurrent colon cancer
846908|NCT00005842|recurrent rectal cancer|recurrent rectal cancer
846909|NCT00005842|stage IV anal cancer|stage iv anal cancer
846910|NCT00005842|recurrent anal cancer|recurrent anal cancer
846911|NCT00005842|stage III esophageal cancer|stage iii esophageal cancer
846912|NCT00005842|stage IV esophageal cancer|stage iv esophageal cancer
846913|NCT00005842|stage IIIA anal cancer|stage iiia anal cancer
846914|NCT00005842|stage IIIB anal cancer|stage iiib anal cancer
846915|NCT00005842|recurrent esophageal cancer|recurrent esophageal cancer
846916|NCT00005842|stage III cervical cancer|stage iii cervical cancer
846917|NCT00005842|recurrent cervical cancer|recurrent cervical cancer
846918|NCT00005842|stage IVB cervical cancer|stage ivb cervical cancer
846919|NCT00005842|stage IVA cervical cancer|stage iva cervical cancer
846920|NCT00005842|inflammatory breast cancer|inflammatory breast cancer
846921|NCT00005842|stage III renal cell cancer|stage iii renal cell cancer
846922|NCT00005842|stage IV renal cell cancer|stage iv renal cell cancer
846923|NCT00005842|recurrent renal cell cancer|recurrent renal cell cancer
846924|NCT00005842|metastatic parathyroid cancer|metastatic parathyroid cancer
846925|NCT00005842|recurrent parathyroid cancer|recurrent parathyroid cancer
846926|NCT00005842|stage III vulvar cancer|stage iii vulvar cancer
846927|NCT00005842|stage IVB vulvar cancer|stage ivb vulvar cancer
846928|NCT00005842|recurrent vulvar cancer|recurrent vulvar cancer
846929|NCT00005842|stage III vaginal cancer|stage iii vaginal cancer
846930|NCT00005842|stage IVA vaginal cancer|stage iva vaginal cancer
846931|NCT00005842|stage IVB vaginal cancer|stage ivb vaginal cancer
846932|NCT00005842|recurrent vaginal cancer|recurrent vaginal cancer
846933|NCT00005842|metastatic gastrointestinal carcinoid tumor|metastatic gastrointestinal carcinoid tumor
846934|NCT00005842|recurrent gastrointestinal carcinoid tumor|recurrent gastrointestinal carcinoid tumor
846935|NCT00005842|localized unresectable adult primary liver cancer|localized unresectable adult primary liver cancer
846936|NCT00005842|advanced adult primary liver cancer|advanced adult primary liver cancer
846937|NCT00005842|recurrent adult primary liver cancer|recurrent adult primary liver cancer
846938|NCT00005842|gastrinoma|gastrinoma
846939|NCT00005842|stage III endometrial carcinoma|stage iii endometrial carcinoma
846940|NCT00005842|stage IV endometrial carcinoma|stage iv endometrial carcinoma
846941|NCT00005842|recurrent endometrial carcinoma|recurrent endometrial carcinoma
846942|NCT00005842|small intestine adenocarcinoma|small intestine adenocarcinoma
846943|NCT00005842|unresectable gallbladder cancer|unresectable gallbladder cancer
846944|NCT00005842|recurrent gallbladder cancer|recurrent gallbladder cancer
846945|NCT00005842|unresectable extrahepatic bile duct cancer|unresectable extrahepatic bile duct cancer
846946|NCT00005842|recurrent extrahepatic bile duct cancer|recurrent extrahepatic bile duct cancer
846947|NCT00005842|recurrent small intestine cancer|recurrent small intestine cancer
846948|NCT00005842|stage III adrenocortical carcinoma|stage iii adrenocortical carcinoma
846949|NCT00005842|stage IV adrenocortical carcinoma|stage iv adrenocortical carcinoma
846950|NCT00005842|recurrent adrenocortical carcinoma|recurrent adrenocortical carcinoma
846951|NCT00005842|stage III bladder cancer|stage iii bladder cancer
846952|NCT00005842|recurrent bladder cancer|recurrent bladder cancer
846953|NCT00005842|stage IV bladder cancer|stage iv bladder cancer
848197|NCT00010283|stage IV breast cancer|stage iv breast cancer
846954|NCT00005842|stage III malignant testicular germ cell tumor|stage iii malignant testicular germ cell tumor
846955|NCT00005842|stage III prostate cancer|stage iii prostate cancer
846956|NCT00005842|stage IV prostate cancer|stage iv prostate cancer
846957|NCT00005842|recurrent prostate cancer|recurrent prostate cancer
846958|NCT00005842|recurrent malignant testicular germ cell tumor|recurrent malignant testicular germ cell tumor
846959|NCT00005842|insulinoma|insulinoma
846960|NCT00005842|recurrent islet cell carcinoma|recurrent islet cell carcinoma
846961|NCT00005842|stage IV papillary thyroid cancer|stage iv papillary thyroid cancer
846962|NCT00005842|stage IV follicular thyroid cancer|stage iv follicular thyroid cancer
846963|NCT00005842|thyroid gland medullary carcinoma|thyroid gland medullary carcinoma
846964|NCT00005842|anaplastic thyroid cancer|anaplastic thyroid cancer
846965|NCT00005842|recurrent thyroid cancer|recurrent thyroid cancer
846966|NCT00005842|stage IIIA non-small cell lung cancer|stage iiia non-small cell lung cancer
846967|NCT00005842|stage IIIB non-small cell lung cancer|stage iiib non-small cell lung cancer
846968|NCT00005842|stage IV non-small cell lung cancer|stage iv non-small cell lung cancer
846969|NCT00005842|stage III salivary gland cancer|stage iii salivary gland cancer
846970|NCT00005842|stage IV salivary gland cancer|stage iv salivary gland cancer
846971|NCT00005842|recurrent salivary gland cancer|recurrent salivary gland cancer
846972|NCT00005842|WDHA syndrome|wdha syndrome
846973|NCT00005842|somatostatinoma|somatostatinoma
846974|NCT00005842|pancreatic polypeptide tumor|pancreatic polypeptide tumor
846975|NCT00005842|glucagonoma|glucagonoma
846976|NCT00005842|stage III follicular thyroid cancer|stage iii follicular thyroid cancer
846977|NCT00005842|stage III papillary thyroid cancer|stage iii papillary thyroid cancer
846978|NCT00005842|recurrent urethral cancer|recurrent urethral cancer
846979|NCT00005842|distal urethral cancer|distal urethral cancer
846980|NCT00005842|proximal urethral cancer|proximal urethral cancer
846981|NCT00005842|urethral cancer associated with invasive bladder cancer|urethral cancer associated with invasive bladder cancer
846982|NCT00005842|metastatic transitional cell cancer of the renal pelvis and ureter|metastatic transitional cell cancer of the renal pelvis and ureter
846983|NCT00005842|pulmonary carcinoid tumor|pulmonary carcinoid tumor
846984|NCT00005842|stage III mucoepidermoid carcinoma of the oral cavity|stage iii mucoepidermoid carcinoma of the oral cavity
846985|NCT00005842|stage III adenoid cystic carcinoma of the oral cavity|stage iii adenoid cystic carcinoma of the oral cavity
846986|NCT00005842|stage IV mucoepidermoid carcinoma of the oral cavity|stage iv mucoepidermoid carcinoma of the oral cavity
846987|NCT00005842|stage IV adenoid cystic carcinoma of the oral cavity|stage iv adenoid cystic carcinoma of the oral cavity
846988|NCT00005842|recurrent mucoepidermoid carcinoma of the oral cavity|recurrent mucoepidermoid carcinoma of the oral cavity
846989|NCT00005842|recurrent adenoid cystic carcinoma of the oral cavity|recurrent adenoid cystic carcinoma of the oral cavity
846990|NCT00005842|tumors metastatic to brain|tumors metastatic to brain
846991|NCT00005842|lung metastases|lung metastases
846992|NCT00005842|liver metastases|liver metastases
846993|NCT00005842|bone metastases|bone metastases
846994|NCT00005842|skin metastases|skin metastases
846995|NCT00005842|leptomeningeal metastases|leptomeningeal metastases
846996|NCT00005842|malignant pericardial effusion|malignant pericardial effusion
846997|NCT00005842|malignant pleural effusion|malignant pleural effusion
846998|NCT00005842|newly diagnosed carcinoma of unknown primary|newly diagnosed carcinoma of unknown primary
846999|NCT00005842|recurrent transitional cell cancer of the renal pelvis and ureter|recurrent transitional cell cancer of the renal pelvis and ureter
847000|NCT00005842|carcinoma of the appendix|carcinoma of the appendix
847001|NCT00005842|primary peritoneal cavity cancer|primary peritoneal cavity cancer
847002|NCT00005842|recurrent carcinoma of unknown primary|recurrent carcinoma of unknown primary
847003|NCT00005842|male breast cancer|male breast cancer
847004|NCT00005842|stage IV pancreatic cancer|stage iv pancreatic cancer
847005|NCT00005832|stage II pancreatic cancer|stage ii pancreatic cancer
847006|NCT00005832|stage III pancreatic cancer|stage iii pancreatic cancer
847007|NCT00005832|duct cell adenocarcinoma of the pancreas|duct cell adenocarcinoma of the pancreas
847008|NCT00005832|adenocarcinoma of the pancreas|adenocarcinoma of the pancreas
847009|NCT00005832|stage IV pancreatic cancer|stage iv pancreatic cancer
847010|NCT00002794|intraocular retinoblastoma|intraocular retinoblastoma
847011|NCT00002553|stage IV adult Hodgkin lymphoma|stage iv adult hodgkin lymphoma
847012|NCT00002553|recurrent childhood acute lymphoblastic leukemia|recurrent childhood acute lymphoblastic leukemia
847013|NCT00002553|recurrent adult Hodgkin lymphoma|recurrent adult hodgkin lymphoma
847014|NCT00002553|Waldenstrom macroglobulinemia|waldenstrom macroglobulinemia
847015|NCT00002553|stage IV childhood lymphoblastic lymphoma|stage iv childhood lymphoblastic lymphoma
847016|NCT00002553|recurrent childhood lymphoblastic lymphoma|recurrent childhood lymphoblastic lymphoma
847017|NCT00002553|recurrent childhood acute myeloid leukemia|recurrent childhood acute myeloid leukemia
847018|NCT00002553|recurrent adult acute myeloid leukemia|recurrent adult acute myeloid leukemia
847019|NCT00002553|recurrent adult acute lymphoblastic leukemia|recurrent adult acute lymphoblastic leukemia
847020|NCT00002553|relapsing chronic myelogenous leukemia|relapsing chronic myelogenous leukemia
847021|NCT00002553|chronic phase chronic myelogenous leukemia|chronic phase chronic myelogenous leukemia
847022|NCT00002553|accelerated phase chronic myelogenous leukemia|accelerated phase chronic myelogenous leukemia
847023|NCT00002553|blastic phase chronic myelogenous leukemia|blastic phase chronic myelogenous leukemia
862768|NCT00058968|leg pain|leg pain
847024|NCT00002553|untreated adult acute lymphoblastic leukemia|untreated adult acute lymphoblastic leukemia
847025|NCT00002553|untreated adult acute myeloid leukemia|untreated adult acute myeloid leukemia
847026|NCT00002553|untreated childhood acute myeloid leukemia and other myeloid malignancies|untreated childhood acute myeloid leukemia and other myeloid malignancies
847027|NCT00002553|untreated childhood acute lymphoblastic leukemia|untreated childhood acute lymphoblastic leukemia
847028|NCT00002553|adult acute myeloid leukemia in remission|adult acute myeloid leukemia in remission
847029|NCT00002553|adult acute lymphoblastic leukemia in remission|adult acute lymphoblastic leukemia in remission
847030|NCT00002553|childhood acute myeloid leukemia in remission|childhood acute myeloid leukemia in remission
847031|NCT00002553|childhood acute lymphoblastic leukemia in remission|childhood acute lymphoblastic leukemia in remission
847032|NCT00002553|stage IV childhood Hodgkin lymphoma|stage iv childhood hodgkin lymphoma
847033|NCT00002553|recurrent/refractory childhood Hodgkin lymphoma|recurrent/refractory childhood hodgkin lymphoma
847034|NCT00002553|recurrent adult non-Hodgkin lymphoma|recurrent adult non-hodgkin lymphoma
847035|NCT00002553|recurrent grade 1 follicular lymphoma|recurrent grade 1 follicular lymphoma
847036|NCT00002553|recurrent grade 2 follicular lymphoma|recurrent grade 2 follicular lymphoma
847037|NCT00002553|recurrent grade 3 follicular lymphoma|recurrent grade 3 follicular lymphoma
847038|NCT00002553|recurrent adult diffuse small cleaved cell lymphoma|recurrent adult diffuse small cleaved cell lymphoma
847039|NCT00002553|recurrent adult diffuse mixed cell lymphoma|recurrent adult diffuse mixed cell lymphoma
847040|NCT00002553|recurrent adult diffuse large cell lymphoma|recurrent adult diffuse large cell lymphoma
847041|NCT00002553|recurrent adult immunoblastic large cell lymphoma|recurrent adult immunoblastic large cell lymphoma
847042|NCT00002553|recurrent adult lymphoblastic lymphoma|recurrent adult lymphoblastic lymphoma
847043|NCT00002553|recurrent adult Burkitt lymphoma|recurrent adult burkitt lymphoma
847044|NCT00002553|stage IV childhood small noncleaved cell lymphoma|stage iv childhood small noncleaved cell lymphoma
847045|NCT00002553|stage IV childhood large cell lymphoma|stage iv childhood large cell lymphoma
847046|NCT00002553|recurrent childhood small noncleaved cell lymphoma|recurrent childhood small noncleaved cell lymphoma
847047|NCT00002553|recurrent childhood large cell lymphoma|recurrent childhood large cell lymphoma
847048|NCT00002553|recurrent mantle cell lymphoma|recurrent mantle cell lymphoma
847049|NCT00002553|recurrent marginal zone lymphoma|recurrent marginal zone lymphoma
847050|NCT00002553|recurrent small lymphocytic lymphoma|recurrent small lymphocytic lymphoma
847051|NCT00002553|extranodal marginal zone B-cell lymphoma of mucosa-associated lymphoid tissue|extranodal marginal zone b-cell lymphoma of mucosa-associated lymphoid tissue
847052|NCT00002553|nodal marginal zone B-cell lymphoma|nodal marginal zone b-cell lymphoma
847053|NCT00002553|splenic marginal zone lymphoma|splenic marginal zone lymphoma
847054|NCT00002485|localized osteosarcoma|localized osteosarcoma
847055|NCT00002485|metastatic osteosarcoma|metastatic osteosarcoma
847056|NCT00002485|recurrent childhood acute lymphoblastic leukemia|recurrent childhood acute lymphoblastic leukemia
847057|NCT00002485|childhood infratentorial ependymoma|childhood infratentorial ependymoma
847058|NCT00002485|childhood low-grade cerebral astrocytoma|childhood low-grade cerebral astrocytoma
847059|NCT00002485|childhood supratentorial ependymoma|childhood supratentorial ependymoma
847060|NCT00002485|childhood craniopharyngioma|childhood craniopharyngioma
847061|NCT00002485|localized resectable neuroblastoma|localized resectable neuroblastoma
847062|NCT00002485|regional neuroblastoma|regional neuroblastoma
847063|NCT00002485|disseminated neuroblastoma|disseminated neuroblastoma
847064|NCT00002485|stage 4S neuroblastoma|stage 4s neuroblastoma
847065|NCT00002485|recurrent neuroblastoma|recurrent neuroblastoma
847066|NCT00002485|stage I childhood liver cancer|stage i childhood liver cancer
847067|NCT00002485|stage II childhood liver cancer|stage ii childhood liver cancer
847068|NCT00002485|stage III childhood liver cancer|stage iii childhood liver cancer
847069|NCT00002485|stage IV childhood liver cancer|stage iv childhood liver cancer
847070|NCT00002485|recurrent childhood liver cancer|recurrent childhood liver cancer
847071|NCT00002485|childhood hepatoblastoma|childhood hepatoblastoma
847072|NCT00002485|stage I childhood lymphoblastic lymphoma|stage i childhood lymphoblastic lymphoma
847073|NCT00002485|stage II childhood lymphoblastic lymphoma|stage ii childhood lymphoblastic lymphoma
847074|NCT00002485|stage III childhood lymphoblastic lymphoma|stage iii childhood lymphoblastic lymphoma
847075|NCT00002485|stage IV childhood lymphoblastic lymphoma|stage iv childhood lymphoblastic lymphoma
847076|NCT00002485|recurrent childhood lymphoblastic lymphoma|recurrent childhood lymphoblastic lymphoma
847077|NCT00002485|childhood central nervous system germ cell tumor|childhood central nervous system germ cell tumor
847078|NCT00002485|recurrent childhood acute myeloid leukemia|recurrent childhood acute myeloid leukemia
847079|NCT00002485|recurrent osteosarcoma|recurrent osteosarcoma
847080|NCT00002485|unspecified childhood solid tumor, protocol specific|unspecified childhood solid tumor, protocol specific
847081|NCT00002485|childhood germ cell tumor|childhood germ cell tumor
847082|NCT00002485|untreated childhood acute myeloid leukemia and other myeloid malignancies|untreated childhood acute myeloid leukemia and other myeloid malignancies
847083|NCT00002485|untreated childhood acute lymphoblastic leukemia|untreated childhood acute lymphoblastic leukemia
847084|NCT00002485|childhood acute myeloid leukemia in remission|childhood acute myeloid leukemia in remission
847085|NCT00002485|childhood acute lymphoblastic leukemia in remission|childhood acute lymphoblastic leukemia in remission
847086|NCT00002485|stage II childhood Hodgkin lymphoma|stage ii childhood hodgkin lymphoma
847087|NCT00002485|stage I childhood Hodgkin lymphoma|stage i childhood hodgkin lymphoma
847088|NCT00002485|stage III childhood Hodgkin lymphoma|stage iii childhood hodgkin lymphoma
847089|NCT00002485|stage IV childhood Hodgkin lymphoma|stage iv childhood hodgkin lymphoma
847090|NCT00002485|recurrent/refractory childhood Hodgkin lymphoma|recurrent/refractory childhood hodgkin lymphoma
847091|NCT00002485|nonmetastatic childhood soft tissue sarcoma|nonmetastatic childhood soft tissue sarcoma
847092|NCT00002485|metastatic childhood soft tissue sarcoma|metastatic childhood soft tissue sarcoma
847093|NCT00002485|recurrent childhood soft tissue sarcoma|recurrent childhood soft tissue sarcoma
847094|NCT00002485|extragonadal germ cell tumor|extragonadal germ cell tumor
847095|NCT00002485|childhood high-grade cerebral astrocytoma|childhood high-grade cerebral astrocytoma
847096|NCT00002485|childhood oligodendroglioma|childhood oligodendroglioma
847097|NCT00002485|childhood choroid plexus tumor|childhood choroid plexus tumor
847098|NCT00002485|childhood meningioma|childhood meningioma
847099|NCT00002485|localized unresectable neuroblastoma|localized unresectable neuroblastoma
847100|NCT00002485|psychosocial effects of cancer and its treatment|psychosocial effects of cancer and its treatment
847101|NCT00002485|stage I childhood small noncleaved cell lymphoma|stage i childhood small noncleaved cell lymphoma
847102|NCT00002485|stage I childhood large cell lymphoma|stage i childhood large cell lymphoma
847103|NCT00002485|stage II childhood small noncleaved cell lymphoma|stage ii childhood small noncleaved cell lymphoma
847104|NCT00002485|stage II childhood large cell lymphoma|stage ii childhood large cell lymphoma
847105|NCT00002485|stage III childhood small noncleaved cell lymphoma|stage iii childhood small noncleaved cell lymphoma
847106|NCT00002485|stage III childhood large cell lymphoma|stage iii childhood large cell lymphoma
847107|NCT00002485|stage IV childhood small noncleaved cell lymphoma|stage iv childhood small noncleaved cell lymphoma
847108|NCT00002485|stage IV childhood large cell lymphoma|stage iv childhood large cell lymphoma
847109|NCT00002485|recurrent childhood small noncleaved cell lymphoma|recurrent childhood small noncleaved cell lymphoma
847110|NCT00002485|recurrent childhood large cell lymphoma|recurrent childhood large cell lymphoma
847111|NCT00002485|untreated childhood brain stem glioma|untreated childhood brain stem glioma
847112|NCT00002485|recurrent childhood brain stem glioma|recurrent childhood brain stem glioma
847113|NCT00002485|untreated childhood supratentorial primitive neuroectodermal tumor|untreated childhood supratentorial primitive neuroectodermal tumor
847114|NCT00002485|recurrent childhood supratentorial primitive neuroectodermal tumor|recurrent childhood supratentorial primitive neuroectodermal tumor
847115|NCT00002485|untreated childhood cerebellar astrocytoma|untreated childhood cerebellar astrocytoma
847116|NCT00002485|recurrent childhood cerebellar astrocytoma|recurrent childhood cerebellar astrocytoma
847117|NCT00002485|recurrent childhood cerebral astrocytoma|recurrent childhood cerebral astrocytoma
847118|NCT00002485|untreated childhood medulloblastoma|untreated childhood medulloblastoma
847119|NCT00002485|recurrent childhood medulloblastoma|recurrent childhood medulloblastoma
847120|NCT00002485|untreated childhood visual pathway and hypothalamic glioma|untreated childhood visual pathway and hypothalamic glioma
847121|NCT00002485|recurrent childhood visual pathway and hypothalamic glioma|recurrent childhood visual pathway and hypothalamic glioma
847122|NCT00002485|newly diagnosed childhood ependymoma|newly diagnosed childhood ependymoma
847123|NCT00002485|recurrent childhood ependymoma|recurrent childhood ependymoma
847124|NCT00002485|childhood teratoma|childhood teratoma
847125|NCT00002485|childhood malignant testicular germ cell tumor|childhood malignant testicular germ cell tumor
847126|NCT00002485|childhood malignant ovarian germ cell tumor|childhood malignant ovarian germ cell tumor
847127|NCT00002485|childhood extragonadal germ cell tumor|childhood extragonadal germ cell tumor
847128|NCT00002485|recurrent childhood malignant germ cell tumor|recurrent childhood malignant germ cell tumor
847129|NCT00002485|childhood atypical teratoid/rhabdoid tumor|childhood atypical teratoid/rhabdoid tumor
847130|NCT00002466|localized osteosarcoma|localized osteosarcoma
847131|NCT00002466|metastatic osteosarcoma|metastatic osteosarcoma
847132|NCT00002466|stage III adult soft tissue sarcoma|stage iii adult soft tissue sarcoma
847133|NCT00002466|stage III Wilms tumor|stage iii wilms tumor
847134|NCT00002466|stage IV Wilms tumor|stage iv wilms tumor
847135|NCT00002466|nonmetastatic childhood soft tissue sarcoma|nonmetastatic childhood soft tissue sarcoma
847136|NCT00002466|metastatic childhood soft tissue sarcoma|metastatic childhood soft tissue sarcoma
847137|NCT00002466|childhood desmoplastic small round cell tumor|childhood desmoplastic small round cell tumor
847138|NCT00002466|localized Ewing sarcoma/peripheral primitive neuroectodermal tumor|localized ewing sarcoma/peripheral primitive neuroectodermal tumor
847139|NCT00002466|metastatic Ewing sarcoma/peripheral primitive neuroectodermal tumor|metastatic ewing sarcoma/peripheral primitive neuroectodermal tumor
847140|NCT00002466|stage IV adult soft tissue sarcoma|stage iv adult soft tissue sarcoma
847141|NCT00002466|Askin tumor|askin tumor
847142|NCT00002466|peripheral primitive neuroectodermal tumor|peripheral primitive neuroectodermal tumor
847143|NCT00002456|recurrent childhood acute lymphoblastic leukemia|recurrent childhood acute lymphoblastic leukemia
847144|NCT00002456|childhood non-Hodgkin lymphoma|childhood non-hodgkin lymphoma
847145|NCT00002456|recurrent childhood lymphoblastic lymphoma|recurrent childhood lymphoblastic lymphoma
847146|NCT00002456|recurrent childhood acute myeloid leukemia|recurrent childhood acute myeloid leukemia
847147|NCT00002456|recurrent adult acute myeloid leukemia|recurrent adult acute myeloid leukemia
847148|NCT00002456|recurrent adult acute lymphoblastic leukemia|recurrent adult acute lymphoblastic leukemia
847149|NCT00002456|relapsing chronic myelogenous leukemia|relapsing chronic myelogenous leukemia
847150|NCT00002456|refractory chronic lymphocytic leukemia|refractory chronic lymphocytic leukemia
863118|NCT00057837|Etoposide|etoposide
847151|NCT00002456|recurrent adult non-Hodgkin lymphoma|recurrent adult non-hodgkin lymphoma
847152|NCT00002456|graft versus host disease|graft versus host disease
847153|NCT00081822|Foran|foran
847154|NCT00081822|clofarabine|clofarabine
847155|NCT00081822|cytosine arabinoside|cytosine arabinoside
847156|NCT00081822|acute myeloid leukemia|acute myeloid leukemia
847157|NCT00081809|non-Hodgkin's lymphoma|non-hodgkin's lymphoma
847158|NCT00081809|Brill-Symmers Disease|brill-symmers disease
847159|NCT00081809|Follicular Lymphoma|follicular lymphoma
847160|NCT00081809|Lymphoma, Giant Follicular|lymphoma, giant follicular
847161|NCT00081809|Lymphoma, Nodular|lymphoma, nodular
847162|NCT00081809|Follicular Lymphoma, Giant|follicular lymphoma, giant
847163|NCT00081809|Giant Follicular Lymphoma|giant follicular lymphoma
847164|NCT00081809|Lymphocytic Lymphoma, Diffuse, Well-Differentiated|lymphocytic lymphoma, diffuse, well-differentiated
847165|NCT00081809|Lymphocytic Lymphoma, Well-Differentiated|lymphocytic lymphoma, well-differentiated
847166|NCT00081809|Lymphoma, Lymphocytic, Diffuse, Well-Differentiated|lymphoma, lymphocytic, diffuse, well-differentiated
847167|NCT00081809|Lymphoma, Lymphocytic, Well-Differentiated|lymphoma, lymphocytic, well-differentiated
847168|NCT00081809|Lymphoma, Lymphoplasmacytoid, CLL|lymphoma, lymphoplasmacytoid, cll
847169|NCT00081809|Lymphoma, Small Lymphocytic, Plasmacytoid|lymphoma, small lymphocytic, plasmacytoid
847170|NCT00081809|Lymphoplasmacytoid Lymphoma, CLL|lymphoplasmacytoid lymphoma, cll
847171|NCT00081809|Diffuse Well-Differentiated Lymphocytic Lymphoma|diffuse well-differentiated lymphocytic lymphoma
847172|NCT00081809|Lymphocytic Lymphoma, Diffuse, Well Differentiated|lymphocytic lymphoma, diffuse, well differentiated
847173|NCT00081809|Lymphocytic Lymphoma, Well Differentiated|lymphocytic lymphoma, well differentiated
847174|NCT00081809|Lymphoma, Lymphocytic, Diffuse, Well Differentiated|lymphoma, lymphocytic, diffuse, well differentiated
847175|NCT00081809|Lymphoma, Lymphocytic, Well Differentiated|lymphoma, lymphocytic, well differentiated
847176|NCT00081809|Lymphoma, Mucosa-Associated Lymphoid Tissue|lymphoma, mucosa-associated lymphoid tissue
847177|NCT00081809|MALT Lymphoma|malt lymphoma
847178|NCT00081809|Lymphoma of Mucosa-Associated Lymphoid Tissue|lymphoma of mucosa-associated lymphoid tissue
847179|NCT00081809|Mucosa-Associated Lymphoid Tissue Lymphoma|mucosa-associated lymphoid tissue lymphoma
847180|NCT00081809|Monocytoid B-cell lymphoma|monocytoid b-cell lymphoma
847181|NCT00081809|Waldenstrom's macroglobulinemia|waldenstrom's macroglobulinemia
847182|NCT00081809|Marginal zone lymphoma|marginal zone lymphoma
847183|NCT00005092|stage III adult Hodgkin lymphoma|stage iii adult hodgkin lymphoma
847184|NCT00005092|stage IV adult Hodgkin lymphoma|stage iv adult hodgkin lymphoma
847185|NCT00005092|recurrent childhood acute lymphoblastic leukemia|recurrent childhood acute lymphoblastic leukemia
847186|NCT00005092|recurrent adult Hodgkin lymphoma|recurrent adult hodgkin lymphoma
847187|NCT00005092|stage III cutaneous T-cell non-Hodgkin lymphoma|stage iii cutaneous t-cell non-hodgkin lymphoma
847188|NCT00005092|stage IV cutaneous T-cell non-Hodgkin lymphoma|stage iv cutaneous t-cell non-hodgkin lymphoma
847189|NCT00005092|recurrent cutaneous T-cell non-Hodgkin lymphoma|recurrent cutaneous t-cell non-hodgkin lymphoma
847190|NCT00005092|refractory multiple myeloma|refractory multiple myeloma
847191|NCT00005092|stage III multiple myeloma|stage iii multiple myeloma
847192|NCT00005092|stage III childhood lymphoblastic lymphoma|stage iii childhood lymphoblastic lymphoma
847193|NCT00005092|stage IV childhood lymphoblastic lymphoma|stage iv childhood lymphoblastic lymphoma
847194|NCT00005092|recurrent childhood lymphoblastic lymphoma|recurrent childhood lymphoblastic lymphoma
847195|NCT00005092|stage III chronic lymphocytic leukemia|stage iii chronic lymphocytic leukemia
847196|NCT00005092|stage IV chronic lymphocytic leukemia|stage iv chronic lymphocytic leukemia
847197|NCT00005092|recurrent childhood acute myeloid leukemia|recurrent childhood acute myeloid leukemia
847198|NCT00005092|recurrent adult acute myeloid leukemia|recurrent adult acute myeloid leukemia
847199|NCT00005092|recurrent adult acute lymphoblastic leukemia|recurrent adult acute lymphoblastic leukemia
847200|NCT00005092|relapsing chronic myelogenous leukemia|relapsing chronic myelogenous leukemia
847201|NCT00005092|refractory chronic lymphocytic leukemia|refractory chronic lymphocytic leukemia
847202|NCT00005092|childhood diffuse large cell lymphoma|childhood diffuse large cell lymphoma
847203|NCT00005092|childhood immunoblastic large cell lymphoma|childhood immunoblastic large cell lymphoma
847204|NCT00005092|chronic phase chronic myelogenous leukemia|chronic phase chronic myelogenous leukemia
847205|NCT00005092|accelerated phase chronic myelogenous leukemia|accelerated phase chronic myelogenous leukemia
847206|NCT00005092|blastic phase chronic myelogenous leukemia|blastic phase chronic myelogenous leukemia
847207|NCT00005092|meningeal chronic myelogenous leukemia|meningeal chronic myelogenous leukemia
847208|NCT00005092|adult acute monoblastic leukemia and acute monocytic leukemia (M5)|adult acute monoblastic leukemia and acute monocytic leukemia (m5)
847209|NCT00005092|childhood acute monoblastic leukemia and acute monocytic leukemia (M5)|childhood acute monoblastic leukemia and acute monocytic leukemia (m5)
847210|NCT00005092|T-cell large granular lymphocyte leukemia|t-cell large granular lymphocyte leukemia
847211|NCT00005092|B-cell chronic lymphocytic leukemia|b-cell chronic lymphocytic leukemia
847212|NCT00005092|Philadelphia chromosome positive chronic myelogenous leukemia|philadelphia chromosome positive chronic myelogenous leukemia
847213|NCT00005092|Philadelphia chromosome negative chronic myelogenous leukemia|philadelphia chromosome negative chronic myelogenous leukemia
847214|NCT00005092|L1 childhood acute lymphoblastic leukemia|l1 childhood acute lymphoblastic leukemia
847215|NCT00005092|L2 childhood acute lymphoblastic leukemia|l2 childhood acute lymphoblastic leukemia
847216|NCT00005092|L3 childhood acute lymphoblastic leukemia|l3 childhood acute lymphoblastic leukemia
847217|NCT00005092|T-cell childhood acute lymphoblastic leukemia|t-cell childhood acute lymphoblastic leukemia
847218|NCT00005092|B-cell childhood acute lymphoblastic leukemia|b-cell childhood acute lymphoblastic leukemia
847219|NCT00005092|non-T, non-B childhood acute lymphoblastic leukemia|non-t, non-b childhood acute lymphoblastic leukemia
847220|NCT00005092|non-T, non-B, cALLa positive childhood acute lymphoblastic leukemia|non-t, non-b, calla positive childhood acute lymphoblastic leukemia
847221|NCT00005092|non-T, non-B, cALLa negative childhood acute lymphoblastic leukemia|non-t, non-b, calla negative childhood acute lymphoblastic leukemia
847222|NCT00005092|non-T, non-B, cALLa positive, pre-B childhood acute lymphoblastic leukemia|non-t, non-b, calla positive, pre-b childhood acute lymphoblastic leukemia
847223|NCT00005092|L1 adult acute lymphoblastic leukemia|l1 adult acute lymphoblastic leukemia
847224|NCT00005092|L2 adult acute lymphoblastic leukemia|l2 adult acute lymphoblastic leukemia
847225|NCT00005092|L3 adult acute lymphoblastic leukemia|l3 adult acute lymphoblastic leukemia
847226|NCT00005092|T-cell adult acute lymphoblastic leukemia|t-cell adult acute lymphoblastic leukemia
847227|NCT00005092|B-cell adult acute lymphoblastic leukemia|b-cell adult acute lymphoblastic leukemia
847228|NCT00005092|non-T, non-B adult acute lymphoblastic leukemia|non-t, non-b adult acute lymphoblastic leukemia
847229|NCT00005092|non-T, non-B, cALLa positive adult acute lymphoblastic leukemia|non-t, non-b, calla positive adult acute lymphoblastic leukemia
847230|NCT00005092|non-T, non-B, cALLa positive, pre-B adult acute lymphoblastic leukemia|non-t, non-b, calla positive, pre-b adult acute lymphoblastic leukemia
847231|NCT00005092|non-T, non-B, cALLa negative adult acute lymphoblastic leukemia|non-t, non-b, calla negative adult acute lymphoblastic leukemia
847232|NCT00005092|TdT positive adult acute lymphoblastic leukemia|tdt positive adult acute lymphoblastic leukemia
847233|NCT00005092|TdT negative adult acute lymphoblastic leukemia|tdt negative adult acute lymphoblastic leukemia
847234|NCT00005092|TdT negative childhood acute lymphoblastic leukemia|tdt negative childhood acute lymphoblastic leukemia
847235|NCT00005092|TdT positive childhood acute lymphoblastic leukemia|tdt positive childhood acute lymphoblastic leukemia
847236|NCT00005092|adult acute erythroid leukemia (M6)|adult acute erythroid leukemia (m6)
847237|NCT00005092|adult acute myeloblastic leukemia without maturation (M1)|adult acute myeloblastic leukemia without maturation (m1)
847238|NCT00005092|adult acute myeloblastic leukemia with maturation (M2)|adult acute myeloblastic leukemia with maturation (m2)
847239|NCT00005092|adult acute promyelocytic leukemia (M3)|adult acute promyelocytic leukemia (m3)
847240|NCT00005092|adult acute myelomonocytic leukemia (M4)|adult acute myelomonocytic leukemia (m4)
847241|NCT00005092|adult acute monoblastic leukemia (M5a)|adult acute monoblastic leukemia (m5a)
847242|NCT00005092|adult acute eosinophilic leukemia|adult acute eosinophilic leukemia
847243|NCT00005092|adult acute basophilic leukemia|adult acute basophilic leukemia
847244|NCT00005092|adult acute megakaryoblastic leukemia (M7)|adult acute megakaryoblastic leukemia (m7)
847245|NCT00005092|childhood acute myeloblastic leukemia without maturation (M1)|childhood acute myeloblastic leukemia without maturation (m1)
847246|NCT00005092|childhood acute myeloblastic leukemia with maturation (M2)|childhood acute myeloblastic leukemia with maturation (m2)
847247|NCT00005092|childhood acute promyelocytic leukemia (M3)|childhood acute promyelocytic leukemia (m3)
847248|NCT00005092|childhood acute myelomonocytic leukemia (M4)|childhood acute myelomonocytic leukemia (m4)
847249|NCT00005092|childhood acute monoblastic leukemia (M5a)|childhood acute monoblastic leukemia (m5a)
847250|NCT00005092|childhood acute monocytic leukemia (M5b)|childhood acute monocytic leukemia (m5b)
847251|NCT00005092|childhood acute erythroleukemia (M6)|childhood acute erythroleukemia (m6)
847252|NCT00005092|childhood acute eosinophilic leukemia|childhood acute eosinophilic leukemia
847253|NCT00005092|childhood acute basophilic leukemia|childhood acute basophilic leukemia
847254|NCT00005092|childhood acute megakaryocytic leukemia (M7)|childhood acute megakaryocytic leukemia (m7)
847255|NCT00005092|untreated hairy cell leukemia|untreated hairy cell leukemia
847256|NCT00005092|chronic myelomonocytic leukemia|chronic myelomonocytic leukemia
847257|NCT00005092|acute undifferentiated leukemia|acute undifferentiated leukemia
847258|NCT00005092|stage III grade 2 follicular lymphoma|stage iii grade 2 follicular lymphoma
847259|NCT00005092|stage III grade 3 follicular lymphoma|stage iii grade 3 follicular lymphoma
847260|NCT00005092|stage III adult diffuse small cleaved cell lymphoma|stage iii adult diffuse small cleaved cell lymphoma
847261|NCT00005092|stage III adult diffuse mixed cell lymphoma|stage iii adult diffuse mixed cell lymphoma
847262|NCT00005092|stage III adult diffuse large cell lymphoma|stage iii adult diffuse large cell lymphoma
847263|NCT00005092|stage III adult immunoblastic large cell lymphoma|stage iii adult immunoblastic large cell lymphoma
847264|NCT00005092|stage III adult lymphoblastic lymphoma|stage iii adult lymphoblastic lymphoma
847265|NCT00005092|stage III adult Burkitt lymphoma|stage iii adult burkitt lymphoma
847266|NCT00005092|stage IV grade 2 follicular lymphoma|stage iv grade 2 follicular lymphoma
847267|NCT00005092|stage IV grade 3 follicular lymphoma|stage iv grade 3 follicular lymphoma
847268|NCT00005092|stage IV adult diffuse small cleaved cell lymphoma|stage iv adult diffuse small cleaved cell lymphoma
847269|NCT00005092|stage IV adult diffuse mixed cell lymphoma|stage iv adult diffuse mixed cell lymphoma
847270|NCT00005092|stage IV adult diffuse large cell lymphoma|stage iv adult diffuse large cell lymphoma
847271|NCT00005092|stage IV adult immunoblastic large cell lymphoma|stage iv adult immunoblastic large cell lymphoma
847272|NCT00005092|stage IV adult lymphoblastic lymphoma|stage iv adult lymphoblastic lymphoma
847273|NCT00005092|recurrent grade 2 follicular lymphoma|recurrent grade 2 follicular lymphoma
847274|NCT00005092|recurrent grade 3 follicular lymphoma|recurrent grade 3 follicular lymphoma
847275|NCT00005092|recurrent adult diffuse small cleaved cell lymphoma|recurrent adult diffuse small cleaved cell lymphoma
847276|NCT00005092|recurrent adult diffuse mixed cell lymphoma|recurrent adult diffuse mixed cell lymphoma
847277|NCT00005092|recurrent adult diffuse large cell lymphoma|recurrent adult diffuse large cell lymphoma
847278|NCT00005092|recurrent adult immunoblastic large cell lymphoma|recurrent adult immunoblastic large cell lymphoma
847279|NCT00005092|recurrent adult lymphoblastic lymphoma|recurrent adult lymphoblastic lymphoma
847280|NCT00005092|stage III adult T-cell leukemia/lymphoma|stage iii adult t-cell leukemia/lymphoma
847281|NCT00005092|stage IV adult T-cell leukemia/lymphoma|stage iv adult t-cell leukemia/lymphoma
847282|NCT00005092|recurrent adult T-cell leukemia/lymphoma|recurrent adult t-cell leukemia/lymphoma
847283|NCT00005092|secondary acute myeloid leukemia|secondary acute myeloid leukemia
847284|NCT00005092|de novo myelodysplastic syndromes|de novo myelodysplastic syndromes
847285|NCT00005092|adult acute monocytic leukemia (M5b)|adult acute monocytic leukemia (m5b)
847286|NCT00005092|previously treated myelodysplastic syndromes|previously treated myelodysplastic syndromes
847287|NCT00005092|secondary myelodysplastic syndromes|secondary myelodysplastic syndromes
847288|NCT00005092|prolymphocytic leukemia|prolymphocytic leukemia
847289|NCT00005092|adult acute minimally differentiated myeloid leukemia (M0)|adult acute minimally differentiated myeloid leukemia (m0)
847290|NCT00005092|childhood acute minimally differentiated myeloid leukemia (M0)|childhood acute minimally differentiated myeloid leukemia (m0)
847291|NCT00005092|intraocular lymphoma|intraocular lymphoma
847292|NCT00005092|stage III childhood large cell lymphoma|stage iii childhood large cell lymphoma
847293|NCT00005092|stage IV childhood large cell lymphoma|stage iv childhood large cell lymphoma
847294|NCT00005092|recurrent childhood large cell lymphoma|recurrent childhood large cell lymphoma
847295|NCT00005092|childhood large cell lymphoma|childhood large cell lymphoma
847296|NCT00005092|stage III mantle cell lymphoma|stage iii mantle cell lymphoma
847297|NCT00005092|stage IV mantle cell lymphoma|stage iv mantle cell lymphoma
847298|NCT00005092|recurrent mantle cell lymphoma|recurrent mantle cell lymphoma
847299|NCT00005092|angioimmunoblastic T-cell lymphoma|angioimmunoblastic t-cell lymphoma
847300|NCT00005092|anaplastic large cell lymphoma|anaplastic large cell lymphoma
847301|NCT00005092|stage III mycosis fungoides/Sezary syndrome|stage iii mycosis fungoides/sezary syndrome
847302|NCT00005092|stage IV mycosis fungoides/Sezary syndrome|stage iv mycosis fungoides/sezary syndrome
847303|NCT00005092|recurrent mycosis fungoides/Sezary syndrome|recurrent mycosis fungoides/sezary syndrome
847304|NCT00005092|childhood myelodysplastic syndromes|childhood myelodysplastic syndromes
847305|NCT00005082|adult medulloblastoma|adult medulloblastoma
847306|NCT00005082|adult glioblastoma|adult glioblastoma
847307|NCT00005082|adult anaplastic astrocytoma|adult anaplastic astrocytoma
847308|NCT00005082|adult myxopapillary ependymoma|adult myxopapillary ependymoma
847309|NCT00005082|adult anaplastic ependymoma|adult anaplastic ependymoma
847310|NCT00005082|adult anaplastic oligodendroglioma|adult anaplastic oligodendroglioma
847311|NCT00005082|adult mixed glioma|adult mixed glioma
847312|NCT00005082|adult pilocytic astrocytoma|adult pilocytic astrocytoma
847313|NCT00005082|adult subependymoma|adult subependymoma
847314|NCT00005082|adult ependymoblastoma|adult ependymoblastoma
847315|NCT00005082|adult oligodendroglioma|adult oligodendroglioma
847316|NCT00005082|adult giant cell glioblastoma|adult giant cell glioblastoma
847317|NCT00005082|adult gliosarcoma|adult gliosarcoma
847318|NCT00005023|stage IV breast cancer|stage iv breast cancer
847319|NCT00005023|stage IIIA breast cancer|stage iiia breast cancer
847320|NCT00005023|stage III non-small cell lung cancer|stage iii non-small cell lung cancer
847321|NCT00005023|stage IIIB breast cancer|stage iiib breast cancer
847322|NCT00005023|stage III ovarian epithelial cancer|stage iii ovarian epithelial cancer
847323|NCT00005023|stage IV ovarian epithelial cancer|stage iv ovarian epithelial cancer
847324|NCT00005023|stage IV non-small cell lung cancer|stage iv non-small cell lung cancer
847325|NCT00005023|adenocarcinoma of the lung|adenocarcinoma of the lung
847326|NCT00004870|stage IV colon cancer|stage iv colon cancer
847327|NCT00004870|stage IV rectal cancer|stage iv rectal cancer
847328|NCT00004870|recurrent colon cancer|recurrent colon cancer
847329|NCT00004870|recurrent rectal cancer|recurrent rectal cancer
847330|NCT00004870|adenocarcinoma of the colon|adenocarcinoma of the colon
847331|NCT00004870|adenocarcinoma of the rectum|adenocarcinoma of the rectum
847332|NCT00004254|localized malignant mesothelioma|localized malignant mesothelioma
847333|NCT00004254|advanced malignant mesothelioma|advanced malignant mesothelioma
847334|NCT00004254|recurrent malignant mesothelioma|recurrent malignant mesothelioma
847335|NCT00004013|stage IV breast cancer|stage iv breast cancer
847336|NCT00004013|recurrent breast cancer|recurrent breast cancer
847337|NCT00003899|unspecified adult solid tumor, protocol specific|unspecified adult solid tumor, protocol specific
847338|NCT00003880|stage III ovarian epithelial cancer|stage iii ovarian epithelial cancer
847339|NCT00003880|ovarian mixed epithelial carcinoma|ovarian mixed epithelial carcinoma
847340|NCT00003880|ovarian serous cystadenocarcinoma|ovarian serous cystadenocarcinoma
847341|NCT00003880|ovarian mucinous cystadenocarcinoma|ovarian mucinous cystadenocarcinoma
847342|NCT00003880|ovarian endometrioid adenocarcinoma|ovarian endometrioid adenocarcinoma
847343|NCT00003880|ovarian clear cell cystadenocarcinoma|ovarian clear cell cystadenocarcinoma
847344|NCT00003880|primary peritoneal cavity cancer|primary peritoneal cavity cancer
847345|NCT00003790|recurrent childhood acute myeloid leukemia|recurrent childhood acute myeloid leukemia
847346|NCT00003790|untreated childhood acute myeloid leukemia and other myeloid malignancies|untreated childhood acute myeloid leukemia and other myeloid malignancies
847347|NCT00003790|de novo myelodysplastic syndromes|de novo myelodysplastic syndromes
847348|NCT00003790|previously treated myelodysplastic syndromes|previously treated myelodysplastic syndromes
847349|NCT00003790|secondary myelodysplastic syndromes|secondary myelodysplastic syndromes
847350|NCT00003735|recurrent childhood acute lymphoblastic leukemia|recurrent childhood acute lymphoblastic leukemia
847351|NCT00003735|recurrent childhood acute myeloid leukemia|recurrent childhood acute myeloid leukemia
847352|NCT00003735|blastic phase chronic myelogenous leukemia|blastic phase chronic myelogenous leukemia
847353|NCT00003715|stage III melanoma|stage iii melanoma
847354|NCT00003701|stage III bladder cancer|stage iii bladder cancer
847355|NCT00003701|transitional cell carcinoma of the bladder|transitional cell carcinoma of the bladder
847356|NCT00003701|urethral cancer associated with invasive bladder cancer|urethral cancer associated with invasive bladder cancer
847357|NCT00003621|adult anaplastic astrocytoma|adult anaplastic astrocytoma
847358|NCT00003445|stage III cervical cancer|stage iii cervical cancer
847359|NCT00003445|stage IIB cervical cancer|stage iib cervical cancer
847360|NCT00003445|stage IVA cervical cancer|stage iva cervical cancer
847361|NCT00003445|cervical squamous cell carcinoma|cervical squamous cell carcinoma
847362|NCT00003386|stage III ovarian epithelial cancer|stage iii ovarian epithelial cancer
847363|NCT00003386|stage IV ovarian epithelial cancer|stage iv ovarian epithelial cancer
847364|NCT00003148|recurrent adult acute myeloid leukemia|recurrent adult acute myeloid leukemia
847365|NCT00003146|stage I multiple myeloma|stage i multiple myeloma
847366|NCT00003146|stage II multiple myeloma|stage ii multiple myeloma
847367|NCT00003146|stage III multiple myeloma|stage iii multiple myeloma
847368|NCT00003076|esophageal cancer|esophageal cancer
847369|NCT00003041|recurrent breast cancer|recurrent breast cancer
847370|NCT00081848|Colon Cancer|colon cancer
847371|NCT00081848|Gastrointestinal Cancer|gastrointestinal cancer
847372|NCT00081848|Cytokines|cytokines
847373|NCT00081848|Immunotherapy|immunotherapy
847374|NCT00081848|Cancer|cancer
847375|NCT00081848|Solid Tumor|solid tumor
847376|NCT00081848|Liver Metastasis|liver metastasis
847377|NCT00081835|Smallpox|smallpox
847378|NCT00081835|Cowpox|cowpox
847379|NCT00081835|Corneal Ulcer|corneal ulcer
847380|NCT00081835|Keratitis|keratitis
847381|NCT00081835|Immune Response, Vaccine|immune response, vaccine
847382|NCT00081835|Cornea|cornea
847383|NCT00081835|Vaccinia|vaccinia
847384|NCT00081835|Vaccinia Immune Globulin (VIG)|vaccinia immune globulin (vig)
847385|NCT00081835|Conjunctivitis|conjunctivitis
847386|NCT00081835|Vaccinia Vaccination|vaccinia vaccination
847387|NCT00081835|Smallpox Vaccination|smallpox vaccination
847388|NCT00081796|Metastatic Breast Cancer|metastatic breast cancer
847389|NCT00081783|T Cells|t cells
847390|NCT00081783|Immunotherapy|immunotherapy
847391|NCT00081783|NHL|nhl
847392|NCT00081783|Xcellerated T Cells|xcellerated t cells
847393|NCT00081757|Advanced|advanced
847394|NCT00081757|Refractory|refractory
847395|NCT00081757|Plasmacytoma|plasmacytoma
847396|NCT00081757|Myeloma Proteins|myeloma proteins
847397|NCT00021346|unspecified adult solid tumor, protocol specific|unspecified adult solid tumor, protocol specific
847398|NCT00019357|unspecified adult solid tumor, protocol specific|unspecified adult solid tumor, protocol specific
847399|NCT00003018|stage II pancreatic cancer|stage ii pancreatic cancer
847400|NCT00003018|stage III pancreatic cancer|stage iii pancreatic cancer
847401|NCT00003018|duct cell adenocarcinoma of the pancreas|duct cell adenocarcinoma of the pancreas
847402|NCT00003017|stage IV cervical cancer|stage iv cervical cancer
847403|NCT00003017|recurrent cervical cancer|recurrent cervical cancer
847404|NCT00003017|cervical squamous cell carcinoma|cervical squamous cell carcinoma
847405|NCT00003017|cervical adenocarcinoma|cervical adenocarcinoma
847406|NCT00003017|cervical adenosquamous cell carcinoma|cervical adenosquamous cell carcinoma
847407|NCT00002952|stage IV melanoma|stage iv melanoma
847408|NCT00002952|recurrent melanoma|recurrent melanoma
847409|NCT00002889|adenocarcinoma of the prostate|adenocarcinoma of the prostate
847410|NCT00002889|stage I prostate cancer|stage i prostate cancer
847411|NCT00002889|stage II prostate cancer|stage ii prostate cancer
847412|NCT00002889|stage III prostate cancer|stage iii prostate cancer
847413|NCT00002889|stage IV prostate cancer|stage iv prostate cancer
847414|NCT00002818|recurrent adult Hodgkin lymphoma|recurrent adult hodgkin lymphoma
847415|NCT00002818|refractory multiple myeloma|refractory multiple myeloma
847416|NCT00002818|recurrent adult acute myeloid leukemia|recurrent adult acute myeloid leukemia
847417|NCT00002818|recurrent adult acute lymphoblastic leukemia|recurrent adult acute lymphoblastic leukemia
847418|NCT00002818|relapsing chronic myelogenous leukemia|relapsing chronic myelogenous leukemia
847419|NCT00002818|blastic phase chronic myelogenous leukemia|blastic phase chronic myelogenous leukemia
847420|NCT00002818|recurrent grade 1 follicular lymphoma|recurrent grade 1 follicular lymphoma
847421|NCT00002818|recurrent grade 2 follicular lymphoma|recurrent grade 2 follicular lymphoma
847422|NCT00002818|recurrent grade 3 follicular lymphoma|recurrent grade 3 follicular lymphoma
847423|NCT00002818|recurrent adult diffuse small cleaved cell lymphoma|recurrent adult diffuse small cleaved cell lymphoma
847424|NCT00002818|recurrent adult diffuse mixed cell lymphoma|recurrent adult diffuse mixed cell lymphoma
847425|NCT00002818|recurrent adult diffuse large cell lymphoma|recurrent adult diffuse large cell lymphoma
847426|NCT00002818|recurrent adult immunoblastic large cell lymphoma|recurrent adult immunoblastic large cell lymphoma
847427|NCT00002818|recurrent adult lymphoblastic lymphoma|recurrent adult lymphoblastic lymphoma
847428|NCT00002818|recurrent adult Burkitt lymphoma|recurrent adult burkitt lymphoma
847429|NCT00002818|drug/agent toxicity by tissue/organ|drug/agent toxicity by tissue/organ
847430|NCT00002818|recurrent mantle cell lymphoma|recurrent mantle cell lymphoma
847431|NCT00002818|recurrent marginal zone lymphoma|recurrent marginal zone lymphoma
847432|NCT00002818|recurrent small lymphocytic lymphoma|recurrent small lymphocytic lymphoma
847433|NCT00002818|extranodal marginal zone B-cell lymphoma of mucosa-associated lymphoid tissue|extranodal marginal zone b-cell lymphoma of mucosa-associated lymphoid tissue
847434|NCT00002818|nodal marginal zone B-cell lymphoma|nodal marginal zone b-cell lymphoma
847435|NCT00002818|splenic marginal zone lymphoma|splenic marginal zone lymphoma
847436|NCT00002800|accelerated phase chronic myelogenous leukemia|accelerated phase chronic myelogenous leukemia
847437|NCT00002800|blastic phase chronic myelogenous leukemia|blastic phase chronic myelogenous leukemia
847438|NCT00002800|untreated adult acute myeloid leukemia|untreated adult acute myeloid leukemia
847439|NCT00002800|refractory anemia with excess blasts|refractory anemia with excess blasts
847440|NCT00002800|refractory anemia with excess blasts in transformation|refractory anemia with excess blasts in transformation
847441|NCT00002800|chronic myelomonocytic leukemia|chronic myelomonocytic leukemia
847442|NCT00002800|de novo myelodysplastic syndromes|de novo myelodysplastic syndromes
847443|NCT00002800|neutropenia|neutropenia
847444|NCT00002772|stage II breast cancer|stage ii breast cancer
847445|NCT00002772|stage IIIA breast cancer|stage iiia breast cancer
847446|NCT00002768|adult acute myeloid leukemia in remission|adult acute myeloid leukemia in remission
847447|NCT00002768|adult acute erythroid leukemia (M6)|adult acute erythroid leukemia (m6)
847448|NCT00002768|adult acute myeloblastic leukemia without maturation (M1)|adult acute myeloblastic leukemia without maturation (m1)
847449|NCT00002768|adult acute myeloblastic leukemia with maturation (M2)|adult acute myeloblastic leukemia with maturation (m2)
847450|NCT00002768|adult acute promyelocytic leukemia (M3)|adult acute promyelocytic leukemia (m3)
847451|NCT00002768|adult acute myelomonocytic leukemia (M4)|adult acute myelomonocytic leukemia (m4)
847452|NCT00002768|adult acute monoblastic leukemia (M5a)|adult acute monoblastic leukemia (m5a)
847453|NCT00002768|adult acute megakaryoblastic leukemia (M7)|adult acute megakaryoblastic leukemia (m7)
847454|NCT00002768|adult acute monocytic leukemia (M5b)|adult acute monocytic leukemia (m5b)
847455|NCT00002768|adult acute minimally differentiated myeloid leukemia (M0)|adult acute minimally differentiated myeloid leukemia (m0)
847456|NCT00002764|adult angiosarcoma|adult angiosarcoma
847457|NCT00002764|adult fibrosarcoma|adult fibrosarcoma
847458|NCT00002764|adult leiomyosarcoma|adult leiomyosarcoma
847459|NCT00002764|adult liposarcoma|adult liposarcoma
847460|NCT00002764|adult neurofibrosarcoma|adult neurofibrosarcoma
847461|NCT00002764|adult synovial sarcoma|adult synovial sarcoma
847462|NCT00002764|recurrent adult soft tissue sarcoma|recurrent adult soft tissue sarcoma
847463|NCT00002764|adult malignant fibrous histiocytoma|adult malignant fibrous histiocytoma
847464|NCT00002764|adult malignant hemangiopericytoma|adult malignant hemangiopericytoma
847465|NCT00002764|adult malignant mesenchymoma|adult malignant mesenchymoma
847466|NCT00002764|localized benign pheochromocytoma|localized benign pheochromocytoma
847467|NCT00002764|regional pheochromocytoma|regional pheochromocytoma
847468|NCT00002764|lung metastases|lung metastases
847469|NCT00002764|stage IV uterine sarcoma|stage iv uterine sarcoma
847470|NCT00002764|recurrent uterine sarcoma|recurrent uterine sarcoma
847471|NCT00002764|uterine leiomyosarcoma|uterine leiomyosarcoma
847472|NCT00002764|endometrial stromal sarcoma|endometrial stromal sarcoma
847473|NCT00002764|ovarian sarcoma|ovarian sarcoma
847474|NCT00002764|clear cell sarcoma of the kidney|clear cell sarcoma of the kidney
847475|NCT00002764|stage IV adult soft tissue sarcoma|stage iv adult soft tissue sarcoma
847476|NCT00002745|Waldenstrom macroglobulinemia|waldenstrom macroglobulinemia
847477|NCT00002745|recurrent grade 1 follicular lymphoma|recurrent grade 1 follicular lymphoma
847478|NCT00002745|recurrent grade 2 follicular lymphoma|recurrent grade 2 follicular lymphoma
847479|NCT00002745|recurrent small lymphocytic lymphoma|recurrent small lymphocytic lymphoma
847480|NCT00002722|stage III gastric cancer|stage iii gastric cancer
847481|NCT00002722|stage IV gastric cancer|stage iv gastric cancer
847482|NCT00002595|desmoid tumor|desmoid tumor
847483|NCT00002583|stage I non-small cell lung cancer|stage i non-small cell lung cancer
847484|NCT00002583|stage II non-small cell lung cancer|stage ii non-small cell lung cancer
847485|NCT00002534|recurrent childhood acute lymphoblastic leukemia|recurrent childhood acute lymphoblastic leukemia
847486|NCT00002534|recurrent childhood acute myeloid leukemia|recurrent childhood acute myeloid leukemia
847487|NCT00002534|recurrent adult acute myeloid leukemia|recurrent adult acute myeloid leukemia
847488|NCT00002534|recurrent adult acute lymphoblastic leukemia|recurrent adult acute lymphoblastic leukemia
847489|NCT00002534|adult acute myeloid leukemia in remission|adult acute myeloid leukemia in remission
847490|NCT00002534|adult acute lymphoblastic leukemia in remission|adult acute lymphoblastic leukemia in remission
847491|NCT00002534|childhood acute myeloid leukemia in remission|childhood acute myeloid leukemia in remission
847492|NCT00002534|childhood acute lymphoblastic leukemia in remission|childhood acute lymphoblastic leukemia in remission
847493|NCT00002534|acute undifferentiated leukemia|acute undifferentiated leukemia
847494|NCT00002519|stage IIIA non-small cell lung cancer|stage iiia non-small cell lung cancer
847495|NCT00002519|stage IIIB non-small cell lung cancer|stage iiib non-small cell lung cancer
863119|NCT00057837|Cisplatin|cisplatin
847496|NCT00002501|stage IV grade 1 follicular lymphoma|stage iv grade 1 follicular lymphoma
847497|NCT00002501|stage IV grade 2 follicular lymphoma|stage iv grade 2 follicular lymphoma
847498|NCT00002501|recurrent grade 1 follicular lymphoma|recurrent grade 1 follicular lymphoma
847499|NCT00002501|recurrent grade 2 follicular lymphoma|recurrent grade 2 follicular lymphoma
847500|NCT00002492|stage I adult soft tissue sarcoma|stage i adult soft tissue sarcoma
847501|NCT00002492|stage II adult soft tissue sarcoma|stage ii adult soft tissue sarcoma
847502|NCT00002492|stage III adult soft tissue sarcoma|stage iii adult soft tissue sarcoma
847503|NCT00002463|childhood infratentorial ependymoma|childhood infratentorial ependymoma
847504|NCT00002463|childhood low-grade cerebral astrocytoma|childhood low-grade cerebral astrocytoma
847505|NCT00002463|childhood low-grade cerebellar astrocytoma|childhood low-grade cerebellar astrocytoma
847506|NCT00002463|childhood supratentorial ependymoma|childhood supratentorial ependymoma
847507|NCT00002463|childhood high-grade cerebral astrocytoma|childhood high-grade cerebral astrocytoma
847508|NCT00002463|untreated childhood supratentorial primitive neuroectodermal tumor|untreated childhood supratentorial primitive neuroectodermal tumor
847509|NCT00002463|untreated childhood cerebellar astrocytoma|untreated childhood cerebellar astrocytoma
847510|NCT00002463|untreated childhood medulloblastoma|untreated childhood medulloblastoma
847511|NCT00002463|untreated childhood visual pathway and hypothalamic glioma|untreated childhood visual pathway and hypothalamic glioma
847512|NCT00002463|newly diagnosed childhood ependymoma|newly diagnosed childhood ependymoma
847513|NCT00081744|Bacterial Infections|bacterial infections
847514|NCT00019344|stage IV adult Hodgkin lymphoma|stage iv adult hodgkin lymphoma
847515|NCT00019344|recurrent adult Hodgkin lymphoma|recurrent adult hodgkin lymphoma
847516|NCT00019344|stage IV cutaneous T-cell non-Hodgkin lymphoma|stage iv cutaneous t-cell non-hodgkin lymphoma
847517|NCT00019344|recurrent cutaneous T-cell non-Hodgkin lymphoma|recurrent cutaneous t-cell non-hodgkin lymphoma
847518|NCT00019344|small intestine lymphoma|small intestine lymphoma
847519|NCT00019344|stage IV prostate cancer|stage iv prostate cancer
847520|NCT00019344|recurrent prostate cancer|recurrent prostate cancer
847521|NCT00019344|unspecified adult solid tumor, protocol specific|unspecified adult solid tumor, protocol specific
847522|NCT00019344|stage IV grade 1 follicular lymphoma|stage iv grade 1 follicular lymphoma
847523|NCT00019344|stage IV grade 2 follicular lymphoma|stage iv grade 2 follicular lymphoma
847524|NCT00019344|stage IV grade 3 follicular lymphoma|stage iv grade 3 follicular lymphoma
847525|NCT00019344|stage IV adult diffuse small cleaved cell lymphoma|stage iv adult diffuse small cleaved cell lymphoma
847526|NCT00019344|stage IV adult diffuse mixed cell lymphoma|stage iv adult diffuse mixed cell lymphoma
847527|NCT00019344|stage IV adult diffuse large cell lymphoma|stage iv adult diffuse large cell lymphoma
847528|NCT00019344|stage IV adult immunoblastic large cell lymphoma|stage iv adult immunoblastic large cell lymphoma
847529|NCT00019344|stage IV adult lymphoblastic lymphoma|stage iv adult lymphoblastic lymphoma
847530|NCT00019344|stage IV adult Burkitt lymphoma|stage iv adult burkitt lymphoma
847531|NCT00019344|recurrent grade 1 follicular lymphoma|recurrent grade 1 follicular lymphoma
847532|NCT00019344|recurrent grade 2 follicular lymphoma|recurrent grade 2 follicular lymphoma
847533|NCT00019344|recurrent grade 3 follicular lymphoma|recurrent grade 3 follicular lymphoma
847534|NCT00019344|recurrent adult diffuse small cleaved cell lymphoma|recurrent adult diffuse small cleaved cell lymphoma
847535|NCT00019344|recurrent adult diffuse mixed cell lymphoma|recurrent adult diffuse mixed cell lymphoma
847536|NCT00019344|recurrent adult diffuse large cell lymphoma|recurrent adult diffuse large cell lymphoma
847537|NCT00019344|recurrent adult immunoblastic large cell lymphoma|recurrent adult immunoblastic large cell lymphoma
847538|NCT00019344|recurrent adult lymphoblastic lymphoma|recurrent adult lymphoblastic lymphoma
847539|NCT00019344|recurrent adult Burkitt lymphoma|recurrent adult burkitt lymphoma
847540|NCT00019344|stage IV adult T-cell leukemia/lymphoma|stage iv adult t-cell leukemia/lymphoma
847541|NCT00019344|recurrent adult T-cell leukemia/lymphoma|recurrent adult t-cell leukemia/lymphoma
847542|NCT00019344|intraocular lymphoma|intraocular lymphoma
847543|NCT00019344|stage IV mantle cell lymphoma|stage iv mantle cell lymphoma
847544|NCT00019344|recurrent mantle cell lymphoma|recurrent mantle cell lymphoma
847545|NCT00019344|angioimmunoblastic T-cell lymphoma|angioimmunoblastic t-cell lymphoma
847546|NCT00019344|anaplastic large cell lymphoma|anaplastic large cell lymphoma
847547|NCT00019344|stage IV mycosis fungoides/Sezary syndrome|stage iv mycosis fungoides/sezary syndrome
847548|NCT00019344|recurrent mycosis fungoides/Sezary syndrome|recurrent mycosis fungoides/sezary syndrome
847549|NCT00019344|recurrent marginal zone lymphoma|recurrent marginal zone lymphoma
847550|NCT00019344|recurrent small lymphocytic lymphoma|recurrent small lymphocytic lymphoma
847551|NCT00019344|stage IV small lymphocytic lymphoma|stage iv small lymphocytic lymphoma
847552|NCT00019344|stage IV marginal zone lymphoma|stage iv marginal zone lymphoma
847553|NCT00019344|extranodal marginal zone B-cell lymphoma of mucosa-associated lymphoid tissue|extranodal marginal zone b-cell lymphoma of mucosa-associated lymphoid tissue
847554|NCT00019344|nodal marginal zone B-cell lymphoma|nodal marginal zone b-cell lymphoma
847555|NCT00019344|splenic marginal zone lymphoma|splenic marginal zone lymphoma
847556|NCT00019240|classic Kaposi sarcoma|classic kaposi sarcoma
847557|NCT00019240|AIDS-related Kaposi sarcoma|aids-related kaposi sarcoma
847558|NCT00019240|recurrent Kaposi sarcoma|recurrent kaposi sarcoma
847559|NCT00016900|stage III esophageal cancer|stage iii esophageal cancer
847560|NCT00016900|stage IV esophageal cancer|stage iv esophageal cancer
847561|NCT00016900|recurrent esophageal cancer|recurrent esophageal cancer
847562|NCT00016900|squamous cell carcinoma of the esophagus|squamous cell carcinoma of the esophagus
847563|NCT00016900|adenocarcinoma of the esophagus|adenocarcinoma of the esophagus
847564|NCT00010010|stage IV breast cancer|stage iv breast cancer
847565|NCT00010010|recurrent breast cancer|recurrent breast cancer
847566|NCT00009828|unspecified adult solid tumor, protocol specific|unspecified adult solid tumor, protocol specific
847567|NCT00081614|Metastatic renal cell carcinoma|metastatic renal cell carcinoma
847568|NCT00081549|Pancreatic Cancer|pancreatic cancer
847569|NCT00081549|Neoplasms Pancreatic|neoplasms pancreatic
847570|NCT00081549|Pancreas Cancer|pancreas cancer
847571|NCT00081549|Pancreas Neoplasms|pancreas neoplasms
847572|NCT00081549|Pancreatic Tumor|pancreatic tumor
847573|NCT00081549|Pancreas Tumor|pancreas tumor
847574|NCT00081549|Unresectable|unresectable
847575|NCT00081549|Metastatic|metastatic
847576|NCT00081549|Refractory|refractory
847577|NCT00081536|Colorectal Neoplasms|colorectal neoplasms
847578|NCT00081536|Colorectal Cancer|colorectal cancer
847579|NCT00081536|Colorectal Carcinoma|colorectal carcinoma
847580|NCT00081536|Colorectal Tumor|colorectal tumor
847581|NCT00081536|Neoplasms, Colorectal|neoplasms, colorectal
847582|NCT00081536|Unresectable|unresectable
847583|NCT00081536|Metastatic|metastatic
847584|NCT00081536|Refractory|refractory
847585|NCT00012129|stage IV breast cancer|stage iv breast cancer
847586|NCT00012129|stage IIIA breast cancer|stage iiia breast cancer
847587|NCT00012129|recurrent breast cancer|recurrent breast cancer
847588|NCT00012129|stage IIIB breast cancer|stage iiib breast cancer
847589|NCT00012129|male breast cancer|male breast cancer
847590|NCT00009815|unspecified adult solid tumor, protocol specific|unspecified adult solid tumor, protocol specific
847591|NCT00005989|recurrent non-small cell lung cancer|recurrent non-small cell lung cancer
847592|NCT00005989|stage IV non-small cell lung cancer|stage iv non-small cell lung cancer
847593|NCT00005958|stage III bladder cancer|stage iii bladder cancer
847594|NCT00005958|recurrent bladder cancer|recurrent bladder cancer
847595|NCT00005958|stage IV bladder cancer|stage iv bladder cancer
847596|NCT00005958|transitional cell carcinoma of the bladder|transitional cell carcinoma of the bladder
847597|NCT00005958|metastatic transitional cell cancer of the renal pelvis and ureter|metastatic transitional cell cancer of the renal pelvis and ureter
847598|NCT00005958|regional transitional cell cancer of the renal pelvis and ureter|regional transitional cell cancer of the renal pelvis and ureter
847599|NCT00005958|recurrent transitional cell cancer of the renal pelvis and ureter|recurrent transitional cell cancer of the renal pelvis and ureter
847600|NCT00005938|localized gallbladder cancer|localized gallbladder cancer
847601|NCT00005938|unresectable gallbladder cancer|unresectable gallbladder cancer
847602|NCT00005938|recurrent gallbladder cancer|recurrent gallbladder cancer
847603|NCT00005938|localized extrahepatic bile duct cancer|localized extrahepatic bile duct cancer
847604|NCT00005938|unresectable extrahepatic bile duct cancer|unresectable extrahepatic bile duct cancer
847605|NCT00005938|recurrent extrahepatic bile duct cancer|recurrent extrahepatic bile duct cancer
847606|NCT00005938|liver and intrahepatic biliary tract cancer|liver and intrahepatic biliary tract cancer
847607|NCT00005938|cholangiocarcinoma of the gallbladder|cholangiocarcinoma of the gallbladder
847608|NCT00005938|cholangiocarcinoma of the extrahepatic bile duct|cholangiocarcinoma of the extrahepatic bile duct
847609|NCT00005938|adult primary cholangiocellular carcinoma|adult primary cholangiocellular carcinoma
847610|NCT00005828|stage IV prostate cancer|stage iv prostate cancer
847611|NCT00005828|recurrent prostate cancer|recurrent prostate cancer
847612|NCT00005827|adenocarcinoma of the prostate|adenocarcinoma of the prostate
847613|NCT00005827|stage II prostate cancer|stage ii prostate cancer
847614|NCT00005827|stage III prostate cancer|stage iii prostate cancer
847615|NCT00005827|stage IV prostate cancer|stage iv prostate cancer
847616|NCT00005827|recurrent prostate cancer|recurrent prostate cancer
847617|NCT00081640|HIV Seronegativity|hiv seronegativity
847618|NCT00081640|Vaginal Microbicide|vaginal microbicide
847619|NCT00081601|prostate cancer|prostate cancer
847620|NCT00081601|prostate specific antigen|prostate specific antigen
847621|NCT00081601|PSA|psa
847622|NCT00081588|TMC114-C215|tmc114-c215
847623|NCT00081588|Ritonavir|ritonavir
847624|NCT00081588|HIV infections|hiv infections
847625|NCT00081588|TMC114-C202|tmc114-c202
847626|NCT00081588|TMC114-C213|tmc114-c213
847627|NCT00081575|Bacterial Pneumonia|bacterial pneumonia
847628|NCT00081380|Bipolar I Disorder|bipolar i disorder
847629|NCT00081380|Manic Depressive Disorder|manic depressive disorder
847630|NCT00081380|Manic Depression, Mixed|manic depression, mixed
847631|NCT00005810|adenocarcinoma of the prostate|adenocarcinoma of the prostate
847632|NCT00005810|stage IV prostate cancer|stage iv prostate cancer
847633|NCT00005810|recurrent prostate cancer|recurrent prostate cancer
847634|NCT00005809|colon cancer|colon cancer
847635|NCT00005809|rectal cancer|rectal cancer
847636|NCT00005643|stage IV uterine sarcoma|stage iv uterine sarcoma
847637|NCT00005643|recurrent uterine sarcoma|recurrent uterine sarcoma
847638|NCT00005643|uterine carcinosarcoma|uterine carcinosarcoma
847639|NCT00005643|uterine leiomyosarcoma|uterine leiomyosarcoma
847640|NCT00005643|endometrial stromal sarcoma|endometrial stromal sarcoma
847641|NCT00005625|metastatic osteosarcoma|metastatic osteosarcoma
847642|NCT00005625|recurrent osteosarcoma|recurrent osteosarcoma
847643|NCT00005608|stage IV breast cancer|stage iv breast cancer
847645|NCT00005071|stage I non-small cell lung cancer|stage i non-small cell lung cancer
847646|NCT00005071|stage II non-small cell lung cancer|stage ii non-small cell lung cancer
847647|NCT00005071|limited stage small cell lung cancer|limited stage small cell lung cancer
847648|NCT00004252|stage IV colon cancer|stage iv colon cancer
847649|NCT00004252|stage IV rectal cancer|stage iv rectal cancer
847650|NCT00004252|recurrent colon cancer|recurrent colon cancer
847651|NCT00004252|recurrent rectal cancer|recurrent rectal cancer
847652|NCT00004252|adenocarcinoma of the colon|adenocarcinoma of the colon
847653|NCT00004229|unspecified adult solid tumor, protocol specific|unspecified adult solid tumor, protocol specific
847654|NCT00004178|stage III colon cancer|stage iii colon cancer
847655|NCT00004178|stage IV colon cancer|stage iv colon cancer
847656|NCT00004178|stage III gastric cancer|stage iii gastric cancer
847657|NCT00004178|stage IV gastric cancer|stage iv gastric cancer
847658|NCT00004178|recurrent gastric cancer|recurrent gastric cancer
847659|NCT00004178|recurrent non-small cell lung cancer|recurrent non-small cell lung cancer
847660|NCT00004178|stage II pancreatic cancer|stage ii pancreatic cancer
847661|NCT00004178|stage III pancreatic cancer|stage iii pancreatic cancer
847662|NCT00004178|recurrent pancreatic cancer|recurrent pancreatic cancer
847663|NCT00004178|stage III rectal cancer|stage iii rectal cancer
847664|NCT00004178|stage IV rectal cancer|stage iv rectal cancer
847665|NCT00004178|recurrent colon cancer|recurrent colon cancer
847666|NCT00004178|recurrent rectal cancer|recurrent rectal cancer
847667|NCT00004178|stage II esophageal cancer|stage ii esophageal cancer
847668|NCT00004178|stage III esophageal cancer|stage iii esophageal cancer
847669|NCT00004178|stage IV esophageal cancer|stage iv esophageal cancer
847670|NCT00004178|recurrent esophageal cancer|recurrent esophageal cancer
847671|NCT00004178|stage III cervical cancer|stage iii cervical cancer
847672|NCT00004178|recurrent cervical cancer|recurrent cervical cancer
847673|NCT00004178|stage IVB cervical cancer|stage ivb cervical cancer
847674|NCT00004178|stage IVA cervical cancer|stage iva cervical cancer
847675|NCT00004178|adenocarcinoma of the prostate|adenocarcinoma of the prostate
847676|NCT00004178|stage III renal cell cancer|stage iii renal cell cancer
847677|NCT00004178|stage IV renal cell cancer|stage iv renal cell cancer
847678|NCT00004178|recurrent renal cell cancer|recurrent renal cell cancer
847679|NCT00004178|stage III ovarian epithelial cancer|stage iii ovarian epithelial cancer
847680|NCT00004178|stage IV ovarian epithelial cancer|stage iv ovarian epithelial cancer
847681|NCT00004178|recurrent ovarian epithelial cancer|recurrent ovarian epithelial cancer
847682|NCT00004178|adenocarcinoma of the stomach|adenocarcinoma of the stomach
847683|NCT00004178|extensive stage small cell lung cancer|extensive stage small cell lung cancer
847684|NCT00004178|recurrent small cell lung cancer|recurrent small cell lung cancer
847685|NCT00004178|stage III vaginal cancer|stage iii vaginal cancer
847686|NCT00004178|stage IVA vaginal cancer|stage iva vaginal cancer
847687|NCT00004178|stage IVB vaginal cancer|stage ivb vaginal cancer
847688|NCT00004178|recurrent vaginal cancer|recurrent vaginal cancer
847689|NCT00004178|localized unresectable adult primary liver cancer|localized unresectable adult primary liver cancer
847690|NCT00004178|advanced adult primary liver cancer|advanced adult primary liver cancer
847691|NCT00004178|recurrent adult primary liver cancer|recurrent adult primary liver cancer
847692|NCT00004178|stage III endometrial carcinoma|stage iii endometrial carcinoma
847693|NCT00004178|stage IV endometrial carcinoma|stage iv endometrial carcinoma
847694|NCT00004178|recurrent endometrial carcinoma|recurrent endometrial carcinoma
847695|NCT00004178|small intestine adenocarcinoma|small intestine adenocarcinoma
847696|NCT00004178|unresectable gallbladder cancer|unresectable gallbladder cancer
847697|NCT00004178|recurrent gallbladder cancer|recurrent gallbladder cancer
847698|NCT00004178|unresectable extrahepatic bile duct cancer|unresectable extrahepatic bile duct cancer
847699|NCT00004178|recurrent extrahepatic bile duct cancer|recurrent extrahepatic bile duct cancer
847700|NCT00004178|recurrent small intestine cancer|recurrent small intestine cancer
847701|NCT00004178|stage III bladder cancer|stage iii bladder cancer
847702|NCT00004178|recurrent bladder cancer|recurrent bladder cancer
847703|NCT00004178|stage IV bladder cancer|stage iv bladder cancer
847704|NCT00004178|stage III prostate cancer|stage iii prostate cancer
847705|NCT00004178|stage IV prostate cancer|stage iv prostate cancer
847706|NCT00004178|recurrent prostate cancer|recurrent prostate cancer
847707|NCT00004178|stage IV non-small cell lung cancer|stage iv non-small cell lung cancer
847708|NCT00004178|stage III salivary gland cancer|stage iii salivary gland cancer
847709|NCT00004178|stage IV salivary gland cancer|stage iv salivary gland cancer
847710|NCT00004178|recurrent salivary gland cancer|recurrent salivary gland cancer
847711|NCT00004178|duct cell adenocarcinoma of the pancreas|duct cell adenocarcinoma of the pancreas
847712|NCT00004178|ovarian undifferentiated adenocarcinoma|ovarian undifferentiated adenocarcinoma
847713|NCT00004178|adenocarcinoma of the lung|adenocarcinoma of the lung
847714|NCT00004178|adenocarcinoma of the esophagus|adenocarcinoma of the esophagus
847715|NCT00004178|intestinal adenocarcinoma of the stomach|intestinal adenocarcinoma of the stomach
847716|NCT00004178|adenocarcinoma of the colon|adenocarcinoma of the colon
847717|NCT00004178|diffuse adenocarcinoma of the stomach|diffuse adenocarcinoma of the stomach
847718|NCT00004178|mixed adenocarcinoma of the stomach|mixed adenocarcinoma of the stomach
847719|NCT00004178|mucinous adenocarcinoma of the colon|mucinous adenocarcinoma of the colon
847720|NCT00004178|signet ring adenocarcinoma of the colon|signet ring adenocarcinoma of the colon
847721|NCT00004178|adenocarcinoma of the rectum|adenocarcinoma of the rectum
847722|NCT00004178|adenocarcinoma of the gallbladder|adenocarcinoma of the gallbladder
847723|NCT00004178|mucinous adenocarcinoma of the rectum|mucinous adenocarcinoma of the rectum
847724|NCT00004178|signet ring adenocarcinoma of the rectum|signet ring adenocarcinoma of the rectum
847725|NCT00004178|adenocarcinoma with squamous metaplasia of the gallbladder|adenocarcinoma with squamous metaplasia of the gallbladder
847726|NCT00004178|adenocarcinoma of the extrahepatic bile duct|adenocarcinoma of the extrahepatic bile duct
847727|NCT00004178|ovarian serous cystadenocarcinoma|ovarian serous cystadenocarcinoma
847728|NCT00004178|ovarian mucinous cystadenocarcinoma|ovarian mucinous cystadenocarcinoma
847729|NCT00004178|ovarian endometrioid adenocarcinoma|ovarian endometrioid adenocarcinoma
847730|NCT00004178|ovarian clear cell cystadenocarcinoma|ovarian clear cell cystadenocarcinoma
847731|NCT00004178|vaginal adenocarcinoma|vaginal adenocarcinoma
847732|NCT00004178|vaginal clear cell adenocarcinoma|vaginal clear cell adenocarcinoma
847733|NCT00004178|endometrial adenocarcinoma|endometrial adenocarcinoma
847734|NCT00004178|cervical adenocarcinoma|cervical adenocarcinoma
847735|NCT00004178|adenocarcinoma of the bladder|adenocarcinoma of the bladder
847736|NCT00004178|salivary gland adenocarcinoma|salivary gland adenocarcinoma
847737|NCT00004178|adenocarcinoma of unknown primary|adenocarcinoma of unknown primary
847738|NCT00004178|adenocarcinoma of the pancreas|adenocarcinoma of the pancreas
847739|NCT00004178|stage IV pancreatic cancer|stage iv pancreatic cancer
847740|NCT00081497|alpha-galactosidase A|alpha-galactosidase a
847742|NCT00081497|r-haGAL|r-hagal
847743|NCT00081497|Fabry|fabry
847744|NCT00081497|GL-3|gl-3
847745|NCT00081497|Fabrazyme|fabrazyme
847746|NCT00004177|recurrent ovarian epithelial cancer|recurrent ovarian epithelial cancer
847747|NCT00004108|localized resectable adult primary liver cancer|localized resectable adult primary liver cancer
847748|NCT00004108|localized unresectable adult primary liver cancer|localized unresectable adult primary liver cancer
847749|NCT00004108|advanced adult primary liver cancer|advanced adult primary liver cancer
847750|NCT00004108|recurrent adult primary liver cancer|recurrent adult primary liver cancer
847751|NCT00004108|adult primary hepatocellular carcinoma|adult primary hepatocellular carcinoma
847752|NCT00004107|Waldenstrom macroglobulinemia|waldenstrom macroglobulinemia
847753|NCT00004107|recurrent adult acute lymphoblastic leukemia|recurrent adult acute lymphoblastic leukemia
847754|NCT00004107|refractory chronic lymphocytic leukemia|refractory chronic lymphocytic leukemia
847755|NCT00004107|B-cell chronic lymphocytic leukemia|b-cell chronic lymphocytic leukemia
847756|NCT00004107|B-cell adult acute lymphoblastic leukemia|b-cell adult acute lymphoblastic leukemia
847757|NCT00004107|recurrent grade 1 follicular lymphoma|recurrent grade 1 follicular lymphoma
847758|NCT00004107|recurrent grade 2 follicular lymphoma|recurrent grade 2 follicular lymphoma
847759|NCT00004107|recurrent grade 3 follicular lymphoma|recurrent grade 3 follicular lymphoma
847760|NCT00004107|recurrent adult diffuse small cleaved cell lymphoma|recurrent adult diffuse small cleaved cell lymphoma
847761|NCT00004107|recurrent adult diffuse mixed cell lymphoma|recurrent adult diffuse mixed cell lymphoma
847762|NCT00004107|recurrent adult diffuse large cell lymphoma|recurrent adult diffuse large cell lymphoma
847763|NCT00004107|recurrent adult immunoblastic large cell lymphoma|recurrent adult immunoblastic large cell lymphoma
847764|NCT00004107|recurrent adult lymphoblastic lymphoma|recurrent adult lymphoblastic lymphoma
847765|NCT00004107|recurrent adult Burkitt lymphoma|recurrent adult burkitt lymphoma
847766|NCT00004107|recurrent mantle cell lymphoma|recurrent mantle cell lymphoma
847767|NCT00004107|recurrent marginal zone lymphoma|recurrent marginal zone lymphoma
847768|NCT00004107|recurrent small lymphocytic lymphoma|recurrent small lymphocytic lymphoma
847769|NCT00004107|extranodal marginal zone B-cell lymphoma of mucosa-associated lymphoid tissue|extranodal marginal zone b-cell lymphoma of mucosa-associated lymphoid tissue
847770|NCT00004107|nodal marginal zone B-cell lymphoma|nodal marginal zone b-cell lymphoma
847771|NCT00004107|splenic marginal zone lymphoma|splenic marginal zone lymphoma
847772|NCT00004100|stage IIIB non-small cell lung cancer|stage iiib non-small cell lung cancer
847773|NCT00004100|stage IV non-small cell lung cancer|stage iv non-small cell lung cancer
847774|NCT00004087|stage IV colon cancer|stage iv colon cancer
847775|NCT00004087|stage IV pancreatic cancer|stage iv pancreatic cancer
847776|NCT00004087|recurrent pancreatic cancer|recurrent pancreatic cancer
847777|NCT00004087|stage IV rectal cancer|stage iv rectal cancer
847778|NCT00004087|recurrent colon cancer|recurrent colon cancer
847779|NCT00004087|recurrent rectal cancer|recurrent rectal cancer
847780|NCT00081523|Hemoglobin|hemoglobin
847781|NCT00081523|Acute Chest Syndrome|acute chest syndrome
847782|NCT00081523|Treatment Options|treatment options
847783|NCT00081523|Nitric Oxide|nitric oxide
847784|NCT00081523|Pulmonary Hypertension|pulmonary hypertension
847785|NCT00081523|Sickle Cell Disease|sickle cell disease
847786|NCT00081523|Sickle Cell Trait|sickle cell trait
847787|NCT00081523|Red Blood Cell Disorder|red blood cell disorder
847788|NCT00081523|Thalassemia|thalassemia
847789|NCT00081523|Paroxysmal Nocturnal Hemoglobinuria|paroxysmal nocturnal hemoglobinuria
847790|NCT00081523|Hemolytic Disorders|hemolytic disorders
847791|NCT00004086|Waldenstrom macroglobulinemia|waldenstrom macroglobulinemia
847792|NCT00004086|refractory chronic lymphocytic leukemia|refractory chronic lymphocytic leukemia
847793|NCT00004086|B-cell chronic lymphocytic leukemia|b-cell chronic lymphocytic leukemia
847794|NCT00004086|refractory hairy cell leukemia|refractory hairy cell leukemia
863120|NCT00057837|Irinotecan|irinotecan
847795|NCT00004086|recurrent grade 1 follicular lymphoma|recurrent grade 1 follicular lymphoma
847796|NCT00004086|recurrent grade 2 follicular lymphoma|recurrent grade 2 follicular lymphoma
847797|NCT00004086|recurrent grade 3 follicular lymphoma|recurrent grade 3 follicular lymphoma
847798|NCT00004086|recurrent adult diffuse small cleaved cell lymphoma|recurrent adult diffuse small cleaved cell lymphoma
847799|NCT00004086|recurrent adult diffuse mixed cell lymphoma|recurrent adult diffuse mixed cell lymphoma
847800|NCT00004086|recurrent adult diffuse large cell lymphoma|recurrent adult diffuse large cell lymphoma
847801|NCT00004086|recurrent adult immunoblastic large cell lymphoma|recurrent adult immunoblastic large cell lymphoma
847802|NCT00004086|recurrent adult lymphoblastic lymphoma|recurrent adult lymphoblastic lymphoma
847803|NCT00004086|recurrent adult Burkitt lymphoma|recurrent adult burkitt lymphoma
847804|NCT00004086|recurrent mantle cell lymphoma|recurrent mantle cell lymphoma
847805|NCT00004086|recurrent marginal zone lymphoma|recurrent marginal zone lymphoma
847806|NCT00004086|recurrent small lymphocytic lymphoma|recurrent small lymphocytic lymphoma
847807|NCT00004086|extranodal marginal zone B-cell lymphoma of mucosa-associated lymphoid tissue|extranodal marginal zone b-cell lymphoma of mucosa-associated lymphoid tissue
847808|NCT00004086|nodal marginal zone B-cell lymphoma|nodal marginal zone b-cell lymphoma
847809|NCT00004086|splenic marginal zone lymphoma|splenic marginal zone lymphoma
847810|NCT00004085|stage IV breast cancer|stage iv breast cancer
847811|NCT00004085|recurrent breast cancer|recurrent breast cancer
847812|NCT00004084|stage I chronic lymphocytic leukemia|stage i chronic lymphocytic leukemia
847813|NCT00004084|stage II chronic lymphocytic leukemia|stage ii chronic lymphocytic leukemia
847814|NCT00004084|stage III chronic lymphocytic leukemia|stage iii chronic lymphocytic leukemia
847815|NCT00004084|stage IV chronic lymphocytic leukemia|stage iv chronic lymphocytic leukemia
847816|NCT00004084|refractory chronic lymphocytic leukemia|refractory chronic lymphocytic leukemia
847817|NCT00004084|stage I grade 1 follicular lymphoma|stage i grade 1 follicular lymphoma
847818|NCT00004084|stage I grade 2 follicular lymphoma|stage i grade 2 follicular lymphoma
847819|NCT00004084|stage I grade 3 follicular lymphoma|stage i grade 3 follicular lymphoma
847820|NCT00004084|stage I adult diffuse mixed cell lymphoma|stage i adult diffuse mixed cell lymphoma
847821|NCT00004084|stage I adult diffuse large cell lymphoma|stage i adult diffuse large cell lymphoma
847822|NCT00004084|stage I adult immunoblastic large cell lymphoma|stage i adult immunoblastic large cell lymphoma
847823|NCT00004084|stage I adult lymphoblastic lymphoma|stage i adult lymphoblastic lymphoma
847824|NCT00004084|stage I adult Burkitt lymphoma|stage i adult burkitt lymphoma
847825|NCT00004084|stage III grade 1 follicular lymphoma|stage iii grade 1 follicular lymphoma
847826|NCT00004084|stage III grade 2 follicular lymphoma|stage iii grade 2 follicular lymphoma
847827|NCT00004084|stage III grade 3 follicular lymphoma|stage iii grade 3 follicular lymphoma
847828|NCT00004084|stage III adult diffuse small cleaved cell lymphoma|stage iii adult diffuse small cleaved cell lymphoma
847829|NCT00004084|stage III adult diffuse mixed cell lymphoma|stage iii adult diffuse mixed cell lymphoma
847830|NCT00004084|stage III adult diffuse large cell lymphoma|stage iii adult diffuse large cell lymphoma
847831|NCT00004084|stage III adult immunoblastic large cell lymphoma|stage iii adult immunoblastic large cell lymphoma
847832|NCT00004084|stage III adult lymphoblastic lymphoma|stage iii adult lymphoblastic lymphoma
847833|NCT00004084|stage III adult Burkitt lymphoma|stage iii adult burkitt lymphoma
847834|NCT00004084|stage IV grade 1 follicular lymphoma|stage iv grade 1 follicular lymphoma
847835|NCT00004084|stage IV grade 2 follicular lymphoma|stage iv grade 2 follicular lymphoma
847836|NCT00004084|stage IV grade 3 follicular lymphoma|stage iv grade 3 follicular lymphoma
847837|NCT00004084|stage IV adult diffuse small cleaved cell lymphoma|stage iv adult diffuse small cleaved cell lymphoma
847838|NCT00004084|stage IV adult diffuse mixed cell lymphoma|stage iv adult diffuse mixed cell lymphoma
847839|NCT00004084|stage IV adult diffuse large cell lymphoma|stage iv adult diffuse large cell lymphoma
847840|NCT00004084|stage IV adult immunoblastic large cell lymphoma|stage iv adult immunoblastic large cell lymphoma
847841|NCT00004084|stage IV adult lymphoblastic lymphoma|stage iv adult lymphoblastic lymphoma
847842|NCT00004084|stage IV adult Burkitt lymphoma|stage iv adult burkitt lymphoma
847843|NCT00004084|recurrent grade 1 follicular lymphoma|recurrent grade 1 follicular lymphoma
847844|NCT00004084|recurrent grade 2 follicular lymphoma|recurrent grade 2 follicular lymphoma
847845|NCT00004084|recurrent grade 3 follicular lymphoma|recurrent grade 3 follicular lymphoma
847846|NCT00004084|recurrent adult diffuse small cleaved cell lymphoma|recurrent adult diffuse small cleaved cell lymphoma
847847|NCT00004084|recurrent adult diffuse mixed cell lymphoma|recurrent adult diffuse mixed cell lymphoma
847848|NCT00004084|recurrent adult diffuse large cell lymphoma|recurrent adult diffuse large cell lymphoma
847849|NCT00004084|recurrent adult immunoblastic large cell lymphoma|recurrent adult immunoblastic large cell lymphoma
847850|NCT00004084|recurrent adult lymphoblastic lymphoma|recurrent adult lymphoblastic lymphoma
847851|NCT00004084|recurrent adult Burkitt lymphoma|recurrent adult burkitt lymphoma
847852|NCT00004084|contiguous stage II grade 1 follicular lymphoma|contiguous stage ii grade 1 follicular lymphoma
847853|NCT00004084|contiguous stage II grade 2 follicular lymphoma|contiguous stage ii grade 2 follicular lymphoma
847854|NCT00004084|contiguous stage II grade 3 follicular lymphoma|contiguous stage ii grade 3 follicular lymphoma
847855|NCT00004084|contiguous stage II adult diffuse small cleaved cell lymphoma|contiguous stage ii adult diffuse small cleaved cell lymphoma
847856|NCT00004084|contiguous stage II mantle cell lymphoma|contiguous stage ii mantle cell lymphoma
847857|NCT00004084|contiguous stage II adult diffuse mixed cell lymphoma|contiguous stage ii adult diffuse mixed cell lymphoma
847858|NCT00004084|contiguous stage II adult immunoblastic large cell lymphoma|contiguous stage ii adult immunoblastic large cell lymphoma
847859|NCT00004084|contiguous stage II adult diffuse large cell lymphoma|contiguous stage ii adult diffuse large cell lymphoma
847860|NCT00004084|contiguous stage II adult Burkitt lymphoma|contiguous stage ii adult burkitt lymphoma
847861|NCT00004084|contiguous stage II adult lymphoblastic lymphoma|contiguous stage ii adult lymphoblastic lymphoma
847862|NCT00004084|noncontiguous stage II grade 1 follicular lymphoma|noncontiguous stage ii grade 1 follicular lymphoma
847863|NCT00004084|noncontiguous stage II grade 2 follicular lymphoma|noncontiguous stage ii grade 2 follicular lymphoma
847864|NCT00004084|noncontiguous stage II grade 3 follicular lymphoma|noncontiguous stage ii grade 3 follicular lymphoma
847865|NCT00004084|noncontiguous stage II adult diffuse small cleaved cell lymphoma|noncontiguous stage ii adult diffuse small cleaved cell lymphoma
847866|NCT00004084|noncontiguous stage II mantle cell lymphoma|noncontiguous stage ii mantle cell lymphoma
847867|NCT00004084|noncontiguous stage II adult diffuse mixed cell lymphoma|noncontiguous stage ii adult diffuse mixed cell lymphoma
847868|NCT00004084|noncontiguous stage II adult immunoblastic large cell lymphoma|noncontiguous stage ii adult immunoblastic large cell lymphoma
847869|NCT00004084|noncontiguous stage II adult diffuse large cell lymphoma|noncontiguous stage ii adult diffuse large cell lymphoma
847870|NCT00004084|noncontiguous stage II adult Burkitt lymphoma|noncontiguous stage ii adult burkitt lymphoma
847871|NCT00004084|noncontiguous stage II adult lymphoblastic lymphoma|noncontiguous stage ii adult lymphoblastic lymphoma
847872|NCT00004084|stage III mantle cell lymphoma|stage iii mantle cell lymphoma
847873|NCT00004084|stage IV mantle cell lymphoma|stage iv mantle cell lymphoma
847874|NCT00004084|recurrent mantle cell lymphoma|recurrent mantle cell lymphoma
847875|NCT00004084|contiguous stage II marginal zone lymphoma|contiguous stage ii marginal zone lymphoma
847876|NCT00004084|contiguous stage II small lymphocytic lymphoma|contiguous stage ii small lymphocytic lymphoma
847877|NCT00004084|noncontiguous stage II small lymphocytic lymphoma|noncontiguous stage ii small lymphocytic lymphoma
847878|NCT00004084|noncontiguous stage II marginal zone lymphoma|noncontiguous stage ii marginal zone lymphoma
847879|NCT00004084|recurrent marginal zone lymphoma|recurrent marginal zone lymphoma
847880|NCT00004084|recurrent small lymphocytic lymphoma|recurrent small lymphocytic lymphoma
847881|NCT00004084|stage I marginal zone lymphoma|stage i marginal zone lymphoma
847882|NCT00004084|stage I small lymphocytic lymphoma|stage i small lymphocytic lymphoma
847883|NCT00004084|stage III small lymphocytic lymphoma|stage iii small lymphocytic lymphoma
847884|NCT00004084|stage III marginal zone lymphoma|stage iii marginal zone lymphoma
847885|NCT00004084|stage IV small lymphocytic lymphoma|stage iv small lymphocytic lymphoma
847886|NCT00004084|stage IV marginal zone lymphoma|stage iv marginal zone lymphoma
847887|NCT00004084|extranodal marginal zone B-cell lymphoma of mucosa-associated lymphoid tissue|extranodal marginal zone b-cell lymphoma of mucosa-associated lymphoid tissue
847888|NCT00004084|nodal marginal zone B-cell lymphoma|nodal marginal zone b-cell lymphoma
847889|NCT00004084|splenic marginal zone lymphoma|splenic marginal zone lymphoma
847890|NCT00004048|thyroid gland medullary carcinoma|thyroid gland medullary carcinoma
847891|NCT00004046|stage IV breast cancer|stage iv breast cancer
847892|NCT00004046|recurrent breast cancer|recurrent breast cancer
847893|NCT00004045|stage IV prostate cancer|stage iv prostate cancer
847894|NCT00004045|recurrent prostate cancer|recurrent prostate cancer
847895|NCT00004033|localized malignant mesothelioma|localized malignant mesothelioma
847896|NCT00004033|advanced malignant mesothelioma|advanced malignant mesothelioma
847897|NCT00004033|recurrent malignant mesothelioma|recurrent malignant mesothelioma
847898|NCT00004016|stage III melanoma|stage iii melanoma
847899|NCT00004016|stage IV melanoma|stage iv melanoma
847900|NCT00004016|recurrent melanoma|recurrent melanoma
847901|NCT00004016|unspecified adult solid tumor, protocol specific|unspecified adult solid tumor, protocol specific
847902|NCT00004010|stage II childhood Hodgkin lymphoma|stage ii childhood hodgkin lymphoma
847903|NCT00004010|stage III childhood Hodgkin lymphoma|stage iii childhood hodgkin lymphoma
847904|NCT00004010|stage IV childhood Hodgkin lymphoma|stage iv childhood hodgkin lymphoma
847905|NCT00004010|childhood lymphocyte predominant Hodgkin lymphoma|childhood lymphocyte predominant hodgkin lymphoma
847906|NCT00004010|childhood lymphocyte depletion Hodgkin lymphoma|childhood lymphocyte depletion hodgkin lymphoma
847907|NCT00004010|childhood nodular sclerosis Hodgkin lymphoma|childhood nodular sclerosis hodgkin lymphoma
847908|NCT00004010|childhood mixed cellularity Hodgkin lymphoma|childhood mixed cellularity hodgkin lymphoma
847909|NCT00081458|Short Bowel Syndrome|short bowel syndrome
847910|NCT00081458|Parenteral Nutrition|parenteral nutrition
847911|NCT00081458|SBS|sbs
847912|NCT00003917|limited stage small cell lung cancer|limited stage small cell lung cancer
847913|NCT00003917|extensive stage small cell lung cancer|extensive stage small cell lung cancer
847914|NCT00003917|recurrent small cell lung cancer|recurrent small cell lung cancer
847915|NCT00003870|recurrent childhood acute lymphoblastic leukemia|recurrent childhood acute lymphoblastic leukemia
847916|NCT00003870|recurrent adult acute lymphoblastic leukemia|recurrent adult acute lymphoblastic leukemia
847917|NCT00003870|adult acute lymphoblastic leukemia in remission|adult acute lymphoblastic leukemia in remission
847918|NCT00003870|childhood acute lymphoblastic leukemia in remission|childhood acute lymphoblastic leukemia in remission
847919|NCT00003834|stage IV colon cancer|stage iv colon cancer
847920|NCT00003834|stage IV rectal cancer|stage iv rectal cancer
847921|NCT00003834|recurrent colon cancer|recurrent colon cancer
847922|NCT00003834|recurrent rectal cancer|recurrent rectal cancer
863216|NCT00057460|HV|hv
847924|NCT00003834|adenocarcinoma of the rectum|adenocarcinoma of the rectum
847925|NCT00003834|liver metastases|liver metastases
847926|NCT00003824|stage 0 bladder cancer|stage 0 bladder cancer
847927|NCT00003824|recurrent bladder cancer|recurrent bladder cancer
847928|NCT00003824|transitional cell carcinoma of the bladder|transitional cell carcinoma of the bladder
847929|NCT00003809|untreated metastatic squamous neck cancer with occult primary|untreated metastatic squamous neck cancer with occult primary
847930|NCT00003809|recurrent metastatic squamous neck cancer with occult primary|recurrent metastatic squamous neck cancer with occult primary
847931|NCT00003809|stage III squamous cell carcinoma of the lip and oral cavity|stage iii squamous cell carcinoma of the lip and oral cavity
847932|NCT00003809|stage IV squamous cell carcinoma of the lip and oral cavity|stage iv squamous cell carcinoma of the lip and oral cavity
847933|NCT00003809|recurrent squamous cell carcinoma of the lip and oral cavity|recurrent squamous cell carcinoma of the lip and oral cavity
847934|NCT00003809|stage III squamous cell carcinoma of the oropharynx|stage iii squamous cell carcinoma of the oropharynx
847935|NCT00003809|stage IV squamous cell carcinoma of the oropharynx|stage iv squamous cell carcinoma of the oropharynx
847936|NCT00003809|recurrent squamous cell carcinoma of the oropharynx|recurrent squamous cell carcinoma of the oropharynx
847937|NCT00003809|stage III squamous cell carcinoma of the hypopharynx|stage iii squamous cell carcinoma of the hypopharynx
847938|NCT00003809|stage IV squamous cell carcinoma of the hypopharynx|stage iv squamous cell carcinoma of the hypopharynx
847939|NCT00003809|recurrent squamous cell carcinoma of the hypopharynx|recurrent squamous cell carcinoma of the hypopharynx
847940|NCT00003809|stage III squamous cell carcinoma of the larynx|stage iii squamous cell carcinoma of the larynx
847941|NCT00003809|stage IV squamous cell carcinoma of the larynx|stage iv squamous cell carcinoma of the larynx
847942|NCT00003809|recurrent squamous cell carcinoma of the larynx|recurrent squamous cell carcinoma of the larynx
847943|NCT00003809|stage III squamous cell carcinoma of the paranasal sinus and nasal cavity|stage iii squamous cell carcinoma of the paranasal sinus and nasal cavity
847944|NCT00003809|stage IV squamous cell carcinoma of the paranasal sinus and nasal cavity|stage iv squamous cell carcinoma of the paranasal sinus and nasal cavity
847945|NCT00003809|recurrent squamous cell carcinoma of the paranasal sinus and nasal cavity|recurrent squamous cell carcinoma of the paranasal sinus and nasal cavity
847946|NCT00003719|stage IV adult soft tissue sarcoma|stage iv adult soft tissue sarcoma
847947|NCT00003719|recurrent adult soft tissue sarcoma|recurrent adult soft tissue sarcoma
847948|NCT00003718|adult angiosarcoma|adult angiosarcoma
847949|NCT00003718|adult fibrosarcoma|adult fibrosarcoma
847950|NCT00003718|adult leiomyosarcoma|adult leiomyosarcoma
847951|NCT00003718|adult liposarcoma|adult liposarcoma
847952|NCT00003718|adult neurofibrosarcoma|adult neurofibrosarcoma
847953|NCT00003718|adult synovial sarcoma|adult synovial sarcoma
847954|NCT00003718|recurrent adult soft tissue sarcoma|recurrent adult soft tissue sarcoma
847955|NCT00003718|adult extraskeletal chondrosarcoma|adult extraskeletal chondrosarcoma
847956|NCT00003718|adult alveolar soft-part sarcoma|adult alveolar soft-part sarcoma
847957|NCT00003718|adult epithelioid sarcoma|adult epithelioid sarcoma
847958|NCT00003718|adult malignant fibrous histiocytoma|adult malignant fibrous histiocytoma
847959|NCT00003718|adult malignant hemangiopericytoma|adult malignant hemangiopericytoma
847960|NCT00003718|adult malignant mesenchymoma|adult malignant mesenchymoma
847961|NCT00003718|adult rhabdomyosarcoma|adult rhabdomyosarcoma
847962|NCT00003718|stage IV uterine sarcoma|stage iv uterine sarcoma
847963|NCT00003718|recurrent uterine sarcoma|recurrent uterine sarcoma
847964|NCT00003718|uterine carcinosarcoma|uterine carcinosarcoma
847965|NCT00003718|uterine leiomyosarcoma|uterine leiomyosarcoma
847966|NCT00003718|endometrial stromal sarcoma|endometrial stromal sarcoma
847967|NCT00003718|ovarian sarcoma|ovarian sarcoma
847968|NCT00003718|stage IV adult soft tissue sarcoma|stage iv adult soft tissue sarcoma
847969|NCT00003717|adenocarcinoma of the prostate|adenocarcinoma of the prostate
847970|NCT00003717|stage IV prostate cancer|stage iv prostate cancer
847971|NCT00003717|recurrent prostate cancer|recurrent prostate cancer
847972|NCT00003674|stage IV colon cancer|stage iv colon cancer
847973|NCT00003674|stage IV breast cancer|stage iv breast cancer
847974|NCT00003674|recurrent breast cancer|recurrent breast cancer
847975|NCT00003674|recurrent non-small cell lung cancer|recurrent non-small cell lung cancer
847976|NCT00003674|stage IV rectal cancer|stage iv rectal cancer
847977|NCT00003674|recurrent colon cancer|recurrent colon cancer
847978|NCT00003674|recurrent rectal cancer|recurrent rectal cancer
847979|NCT00003674|extensive stage small cell lung cancer|extensive stage small cell lung cancer
847980|NCT00003674|recurrent small cell lung cancer|recurrent small cell lung cancer
847981|NCT00003674|stage IV prostate cancer|stage iv prostate cancer
847982|NCT00003674|recurrent prostate cancer|recurrent prostate cancer
847983|NCT00003674|stage IV non-small cell lung cancer|stage iv non-small cell lung cancer
847984|NCT00003674|veno-occlusive disease|veno-occlusive disease
847985|NCT00003493|refractory multiple myeloma|refractory multiple myeloma
847986|NCT00003493|stage I multiple myeloma|stage i multiple myeloma
847987|NCT00003493|stage II multiple myeloma|stage ii multiple myeloma
847988|NCT00003493|stage III multiple myeloma|stage iii multiple myeloma
847989|NCT00003307|adenocarcinoma of the prostate|adenocarcinoma of the prostate
847990|NCT00003307|stage I prostate cancer|stage i prostate cancer
847991|NCT00003307|stage II prostate cancer|stage ii prostate cancer
847992|NCT00003307|stage III prostate cancer|stage iii prostate cancer
847993|NCT00003307|radiation toxicity|radiation toxicity
847994|NCT00003283|invasive thymoma and thymic carcinoma|invasive thymoma and thymic carcinoma
847995|NCT00003283|recurrent thymoma and thymic carcinoma|recurrent thymoma and thymic carcinoma
847996|NCT00003235|squamous cell lung cancer|squamous cell lung cancer
847997|NCT00003235|large cell lung cancer|large cell lung cancer
847998|NCT00003235|stage IIIA non-small cell lung cancer|stage iiia non-small cell lung cancer
847999|NCT00003235|stage IIIB non-small cell lung cancer|stage iiib non-small cell lung cancer
848000|NCT00003235|adenocarcinoma of the lung|adenocarcinoma of the lung
848001|NCT00003209|stage IB cervical cancer|stage ib cervical cancer
848002|NCT00003209|stage IIA cervical cancer|stage iia cervical cancer
848003|NCT00003209|cervical squamous cell carcinoma|cervical squamous cell carcinoma
848004|NCT00003209|cervical adenocarcinoma|cervical adenocarcinoma
848005|NCT00003209|cervical adenosquamous cell carcinoma|cervical adenosquamous cell carcinoma
848006|NCT00003125|stage IV breast cancer|stage iv breast cancer
848007|NCT00003125|stage IIIA breast cancer|stage iiia breast cancer
848008|NCT00003125|stage III gastric cancer|stage iii gastric cancer
848009|NCT00003125|stage IV gastric cancer|stage iv gastric cancer
848010|NCT00003125|stage IIIB breast cancer|stage iiib breast cancer
848011|NCT00003125|stage II pancreatic cancer|stage ii pancreatic cancer
848012|NCT00003125|stage III pancreatic cancer|stage iii pancreatic cancer
848013|NCT00003125|stage II esophageal cancer|stage ii esophageal cancer
848014|NCT00003125|stage III esophageal cancer|stage iii esophageal cancer
848015|NCT00003125|stage IIIA non-small cell lung cancer|stage iiia non-small cell lung cancer
848016|NCT00003125|stage IIIB non-small cell lung cancer|stage iiib non-small cell lung cancer
848017|NCT00003125|unspecified adult solid tumor, protocol specific|unspecified adult solid tumor, protocol specific
848018|NCT00003125|stage IV pancreatic cancer|stage iv pancreatic cancer
848019|NCT00003080|stage III ovarian epithelial cancer|stage iii ovarian epithelial cancer
848020|NCT00003080|stage IV ovarian epithelial cancer|stage iv ovarian epithelial cancer
848021|NCT00003080|recurrent ovarian epithelial cancer|recurrent ovarian epithelial cancer
848022|NCT00003061|primary central nervous system non-Hodgkin lymphoma|primary central nervous system non-hodgkin lymphoma
848023|NCT00003032|stage IV breast cancer|stage iv breast cancer
848024|NCT00003032|recurrent breast cancer|recurrent breast cancer
848025|NCT00003010|recurrent breast cancer|recurrent breast cancer
848026|NCT00021398|stage II rectal cancer|stage ii rectal cancer
848027|NCT00021398|stage III rectal cancer|stage iii rectal cancer
848028|NCT00021398|adenocarcinoma of the rectum|adenocarcinoma of the rectum
848029|NCT00021281|stage IV colon cancer|stage iv colon cancer
848030|NCT00021281|stage IV rectal cancer|stage iv rectal cancer
848031|NCT00021281|recurrent colon cancer|recurrent colon cancer
848032|NCT00021281|recurrent rectal cancer|recurrent rectal cancer
848033|NCT00021281|adenocarcinoma of the colon|adenocarcinoma of the colon
848034|NCT00021281|adenocarcinoma of the rectum|adenocarcinoma of the rectum
848035|NCT00021151|refractory chronic lymphocytic leukemia|refractory chronic lymphocytic leukemia
848036|NCT00021151|prolymphocytic leukemia|prolymphocytic leukemia
848037|NCT00021008|recurrent non-small cell lung cancer|recurrent non-small cell lung cancer
848038|NCT00021008|stage IIIB non-small cell lung cancer|stage iiib non-small cell lung cancer
848039|NCT00021008|stage IV non-small cell lung cancer|stage iv non-small cell lung cancer
848040|NCT00020774|localized resectable adult primary liver cancer|localized resectable adult primary liver cancer
848041|NCT00020774|recurrent adult primary liver cancer|recurrent adult primary liver cancer
848042|NCT00020774|adult primary hepatocellular carcinoma|adult primary hepatocellular carcinoma
848043|NCT00020774|adult primary cholangiocellular carcinoma|adult primary cholangiocellular carcinoma
848044|NCT00019552|recurrent ovarian epithelial cancer|recurrent ovarian epithelial cancer
848045|NCT00019552|fallopian tube cancer|fallopian tube cancer
848046|NCT00019552|primary peritoneal cavity cancer|primary peritoneal cavity cancer
848047|NCT00019474|stage III gastric cancer|stage iii gastric cancer
848048|NCT00019474|stage IV gastric cancer|stage iv gastric cancer
848049|NCT00019474|recurrent gastric cancer|recurrent gastric cancer
848050|NCT00019474|stage II pancreatic cancer|stage ii pancreatic cancer
848051|NCT00019474|stage III pancreatic cancer|stage iii pancreatic cancer
848052|NCT00019474|recurrent pancreatic cancer|recurrent pancreatic cancer
848053|NCT00019474|regional gastrointestinal carcinoid tumor|regional gastrointestinal carcinoid tumor
848054|NCT00019474|metastatic gastrointestinal carcinoid tumor|metastatic gastrointestinal carcinoid tumor
848055|NCT00019474|recurrent gastrointestinal carcinoid tumor|recurrent gastrointestinal carcinoid tumor
848056|NCT00019474|localized unresectable adult primary liver cancer|localized unresectable adult primary liver cancer
848057|NCT00019474|advanced adult primary liver cancer|advanced adult primary liver cancer
848058|NCT00019474|recurrent adult primary liver cancer|recurrent adult primary liver cancer
848059|NCT00019474|small intestine adenocarcinoma|small intestine adenocarcinoma
848060|NCT00019474|unresectable extrahepatic bile duct cancer|unresectable extrahepatic bile duct cancer
848061|NCT00019474|recurrent extrahepatic bile duct cancer|recurrent extrahepatic bile duct cancer
848062|NCT00019474|recurrent small intestine cancer|recurrent small intestine cancer
848063|NCT00019474|adult primary hepatocellular carcinoma|adult primary hepatocellular carcinoma
848064|NCT00019474|stage IV pancreatic cancer|stage iv pancreatic cancer
848065|NCT00019318|stage III cutaneous T-cell non-Hodgkin lymphoma|stage iii cutaneous t-cell non-hodgkin lymphoma
848066|NCT00019318|stage IV cutaneous T-cell non-Hodgkin lymphoma|stage iv cutaneous t-cell non-hodgkin lymphoma
848067|NCT00019318|recurrent cutaneous T-cell non-Hodgkin lymphoma|recurrent cutaneous t-cell non-hodgkin lymphoma
848068|NCT00019318|stage III mycosis fungoides/Sezary syndrome|stage iii mycosis fungoides/sezary syndrome
848069|NCT00019318|stage IV mycosis fungoides/Sezary syndrome|stage iv mycosis fungoides/sezary syndrome
848070|NCT00019318|recurrent mycosis fungoides/Sezary syndrome|recurrent mycosis fungoides/sezary syndrome
848071|NCT00019123|AIDS-related Kaposi sarcoma|aids-related kaposi sarcoma
848072|NCT00014391|stage IV breast cancer|stage iv breast cancer
848073|NCT00014391|stage IIIA breast cancer|stage iiia breast cancer
848074|NCT00014391|stage IIIB breast cancer|stage iiib breast cancer
848075|NCT00014391|recurrent childhood acute lymphoblastic leukemia|recurrent childhood acute lymphoblastic leukemia
848076|NCT00014391|recurrent adult Hodgkin lymphoma|recurrent adult hodgkin lymphoma
848077|NCT00014391|recurrent cutaneous T-cell non-Hodgkin lymphoma|recurrent cutaneous t-cell non-hodgkin lymphoma
848078|NCT00014391|refractory multiple myeloma|refractory multiple myeloma
848079|NCT00014391|recurrent childhood rhabdomyosarcoma|recurrent childhood rhabdomyosarcoma
848080|NCT00014391|stage II ovarian epithelial cancer|stage ii ovarian epithelial cancer
848081|NCT00014391|stage III ovarian epithelial cancer|stage iii ovarian epithelial cancer
848082|NCT00014391|stage IV ovarian epithelial cancer|stage iv ovarian epithelial cancer
848083|NCT00014391|recurrent ovarian epithelial cancer|recurrent ovarian epithelial cancer
848084|NCT00014391|disseminated neuroblastoma|disseminated neuroblastoma
848085|NCT00014391|recurrent neuroblastoma|recurrent neuroblastoma
848086|NCT00014391|recurrent Wilms tumor and other childhood kidney tumors|recurrent wilms tumor and other childhood kidney tumors
848087|NCT00014391|stage I multiple myeloma|stage i multiple myeloma
848088|NCT00014391|stage II multiple myeloma|stage ii multiple myeloma
848089|NCT00014391|stage III multiple myeloma|stage iii multiple myeloma
848090|NCT00014391|recurrent childhood lymphoblastic lymphoma|recurrent childhood lymphoblastic lymphoma
848091|NCT00014391|stage III chronic lymphocytic leukemia|stage iii chronic lymphocytic leukemia
848092|NCT00014391|stage IV chronic lymphocytic leukemia|stage iv chronic lymphocytic leukemia
848093|NCT00014391|recurrent childhood acute myeloid leukemia|recurrent childhood acute myeloid leukemia
848094|NCT00014391|recurrent adult acute myeloid leukemia|recurrent adult acute myeloid leukemia
848095|NCT00014391|recurrent adult acute lymphoblastic leukemia|recurrent adult acute lymphoblastic leukemia
848096|NCT00014391|relapsing chronic myelogenous leukemia|relapsing chronic myelogenous leukemia
848097|NCT00014391|refractory chronic lymphocytic leukemia|refractory chronic lymphocytic leukemia
848098|NCT00014391|stage III malignant testicular germ cell tumor|stage iii malignant testicular germ cell tumor
848099|NCT00014391|recurrent malignant testicular germ cell tumor|recurrent malignant testicular germ cell tumor
848100|NCT00014391|chronic phase chronic myelogenous leukemia|chronic phase chronic myelogenous leukemia
848101|NCT00014391|accelerated phase chronic myelogenous leukemia|accelerated phase chronic myelogenous leukemia
848102|NCT00014391|blastic phase chronic myelogenous leukemia|blastic phase chronic myelogenous leukemia
848103|NCT00014391|meningeal chronic myelogenous leukemia|meningeal chronic myelogenous leukemia
848104|NCT00014391|chronic idiopathic myelofibrosis|chronic idiopathic myelofibrosis
848105|NCT00014391|childhood acute promyelocytic leukemia (M3)|childhood acute promyelocytic leukemia (m3)
848106|NCT00014391|testicular embryonal carcinoma|testicular embryonal carcinoma
848107|NCT00014391|testicular choriocarcinoma|testicular choriocarcinoma
848108|NCT00014391|testicular teratoma|testicular teratoma
848109|NCT00014391|testicular yolk sac tumor|testicular yolk sac tumor
848110|NCT00014391|testicular embryonal carcinoma and teratoma|testicular embryonal carcinoma and teratoma
848111|NCT00014391|testicular embryonal carcinoma and teratoma with seminoma|testicular embryonal carcinoma and teratoma with seminoma
848112|NCT00014391|testicular embryonal carcinoma and yolk sac tumor|testicular embryonal carcinoma and yolk sac tumor
848113|NCT00014391|testicular embryonal carcinoma and yolk sac tumor with seminoma|testicular embryonal carcinoma and yolk sac tumor with seminoma
848114|NCT00014391|testicular embryonal carcinoma and seminoma|testicular embryonal carcinoma and seminoma
848115|NCT00014391|testicular yolk sac tumor and teratoma|testicular yolk sac tumor and teratoma
848116|NCT00014391|testicular yolk sac tumor and teratoma with seminoma|testicular yolk sac tumor and teratoma with seminoma
848117|NCT00014391|testicular choriocarcinoma and yolk sac tumor|testicular choriocarcinoma and yolk sac tumor
848118|NCT00014391|testicular choriocarcinoma and embryonal carcinoma|testicular choriocarcinoma and embryonal carcinoma
848119|NCT00014391|testicular choriocarcinoma and teratoma|testicular choriocarcinoma and teratoma
848120|NCT00014391|testicular choriocarcinoma and seminoma|testicular choriocarcinoma and seminoma
848121|NCT00014391|refractory hairy cell leukemia|refractory hairy cell leukemia
848122|NCT00014391|recurrent/refractory childhood Hodgkin lymphoma|recurrent/refractory childhood hodgkin lymphoma
848123|NCT00014391|recurrent ovarian germ cell tumor|recurrent ovarian germ cell tumor
848124|NCT00014391|ovarian yolk sac tumor|ovarian yolk sac tumor
848125|NCT00014391|ovarian embryonal carcinoma|ovarian embryonal carcinoma
848126|NCT00014391|ovarian polyembryoma|ovarian polyembryoma
848127|NCT00014391|ovarian choriocarcinoma|ovarian choriocarcinoma
848128|NCT00014391|ovarian immature teratoma|ovarian immature teratoma
848129|NCT00014391|ovarian mature teratoma|ovarian mature teratoma
848130|NCT00014391|ovarian monodermal and highly specialized teratoma|ovarian monodermal and highly specialized teratoma
848131|NCT00014391|ovarian mixed germ cell tumor|ovarian mixed germ cell tumor
848132|NCT00014391|stage III grade 1 follicular lymphoma|stage iii grade 1 follicular lymphoma
848133|NCT00014391|stage III grade 2 follicular lymphoma|stage iii grade 2 follicular lymphoma
848134|NCT00014391|stage III grade 3 follicular lymphoma|stage iii grade 3 follicular lymphoma
848135|NCT00014391|stage III adult diffuse small cleaved cell lymphoma|stage iii adult diffuse small cleaved cell lymphoma
848136|NCT00014391|stage III adult diffuse mixed cell lymphoma|stage iii adult diffuse mixed cell lymphoma
848137|NCT00014391|stage III adult diffuse large cell lymphoma|stage iii adult diffuse large cell lymphoma
848138|NCT00014391|stage III adult immunoblastic large cell lymphoma|stage iii adult immunoblastic large cell lymphoma
848139|NCT00014391|stage III adult lymphoblastic lymphoma|stage iii adult lymphoblastic lymphoma
848140|NCT00014391|stage III adult Burkitt lymphoma|stage iii adult burkitt lymphoma
848141|NCT00014391|stage IV grade 1 follicular lymphoma|stage iv grade 1 follicular lymphoma
848142|NCT00014391|stage IV grade 2 follicular lymphoma|stage iv grade 2 follicular lymphoma
848143|NCT00014391|stage IV grade 3 follicular lymphoma|stage iv grade 3 follicular lymphoma
848144|NCT00014391|stage IV adult diffuse small cleaved cell lymphoma|stage iv adult diffuse small cleaved cell lymphoma
848145|NCT00014391|stage IV adult diffuse mixed cell lymphoma|stage iv adult diffuse mixed cell lymphoma
848146|NCT00014391|stage IV adult diffuse large cell lymphoma|stage iv adult diffuse large cell lymphoma
848147|NCT00014391|stage IV adult immunoblastic large cell lymphoma|stage iv adult immunoblastic large cell lymphoma
848148|NCT00014391|stage IV adult lymphoblastic lymphoma|stage iv adult lymphoblastic lymphoma
848149|NCT00014391|stage IV adult Burkitt lymphoma|stage iv adult burkitt lymphoma
848150|NCT00014391|recurrent grade 1 follicular lymphoma|recurrent grade 1 follicular lymphoma
848151|NCT00014391|recurrent grade 2 follicular lymphoma|recurrent grade 2 follicular lymphoma
848152|NCT00014391|recurrent grade 3 follicular lymphoma|recurrent grade 3 follicular lymphoma
848153|NCT00014391|recurrent adult diffuse small cleaved cell lymphoma|recurrent adult diffuse small cleaved cell lymphoma
848154|NCT00014391|recurrent adult diffuse mixed cell lymphoma|recurrent adult diffuse mixed cell lymphoma
848155|NCT00014391|recurrent adult diffuse large cell lymphoma|recurrent adult diffuse large cell lymphoma
848156|NCT00014391|recurrent adult immunoblastic large cell lymphoma|recurrent adult immunoblastic large cell lymphoma
848157|NCT00014391|recurrent adult lymphoblastic lymphoma|recurrent adult lymphoblastic lymphoma
848158|NCT00014391|recurrent adult Burkitt lymphoma|recurrent adult burkitt lymphoma
848159|NCT00014391|secondary acute myeloid leukemia|secondary acute myeloid leukemia
848160|NCT00014391|de novo myelodysplastic syndromes|de novo myelodysplastic syndromes
848161|NCT00014391|poor prognosis metastatic gestational trophoblastic tumor|poor prognosis metastatic gestational trophoblastic tumor
848162|NCT00014391|previously treated myelodysplastic syndromes|previously treated myelodysplastic syndromes
848163|NCT00014391|secondary myelodysplastic syndromes|secondary myelodysplastic syndromes
848164|NCT00014391|infection|infection
848165|NCT00014391|pulmonary complications|pulmonary complications
848166|NCT00014391|recurrent childhood small noncleaved cell lymphoma|recurrent childhood small noncleaved cell lymphoma
848167|NCT00014391|recurrent childhood large cell lymphoma|recurrent childhood large cell lymphoma
848168|NCT00014391|noncontiguous stage II grade 1 follicular lymphoma|noncontiguous stage ii grade 1 follicular lymphoma
848169|NCT00014391|noncontiguous stage II grade 2 follicular lymphoma|noncontiguous stage ii grade 2 follicular lymphoma
848170|NCT00014391|noncontiguous stage II grade 3 follicular lymphoma|noncontiguous stage ii grade 3 follicular lymphoma
848171|NCT00014391|noncontiguous stage II adult diffuse small cleaved cell lymphoma|noncontiguous stage ii adult diffuse small cleaved cell lymphoma
848172|NCT00014391|noncontiguous stage II mantle cell lymphoma|noncontiguous stage ii mantle cell lymphoma
848173|NCT00014391|noncontiguous stage II adult diffuse mixed cell lymphoma|noncontiguous stage ii adult diffuse mixed cell lymphoma
848174|NCT00014391|noncontiguous stage II adult immunoblastic large cell lymphoma|noncontiguous stage ii adult immunoblastic large cell lymphoma
848175|NCT00014391|noncontiguous stage II adult diffuse large cell lymphoma|noncontiguous stage ii adult diffuse large cell lymphoma
848176|NCT00014391|noncontiguous stage II adult Burkitt lymphoma|noncontiguous stage ii adult burkitt lymphoma
848177|NCT00014391|noncontiguous stage II adult lymphoblastic lymphoma|noncontiguous stage ii adult lymphoblastic lymphoma
848178|NCT00014391|stage III mantle cell lymphoma|stage iii mantle cell lymphoma
848179|NCT00014391|stage IV mantle cell lymphoma|stage iv mantle cell lymphoma
848180|NCT00014391|recurrent mantle cell lymphoma|recurrent mantle cell lymphoma
848181|NCT00014391|previously treated childhood rhabdomyosarcoma|previously treated childhood rhabdomyosarcoma
848182|NCT00014391|noncontiguous stage II small lymphocytic lymphoma|noncontiguous stage ii small lymphocytic lymphoma
848183|NCT00014391|noncontiguous stage II marginal zone lymphoma|noncontiguous stage ii marginal zone lymphoma
848184|NCT00014391|recurrent marginal zone lymphoma|recurrent marginal zone lymphoma
848185|NCT00014391|recurrent small lymphocytic lymphoma|recurrent small lymphocytic lymphoma
848186|NCT00014391|stage III small lymphocytic lymphoma|stage iii small lymphocytic lymphoma
848187|NCT00014391|stage III marginal zone lymphoma|stage iii marginal zone lymphoma
848188|NCT00014391|stage IV small lymphocytic lymphoma|stage iv small lymphocytic lymphoma
848189|NCT00014391|stage IV marginal zone lymphoma|stage iv marginal zone lymphoma
848190|NCT00014391|extranodal marginal zone B-cell lymphoma of mucosa-associated lymphoid tissue|extranodal marginal zone b-cell lymphoma of mucosa-associated lymphoid tissue
848191|NCT00014391|nodal marginal zone B-cell lymphoma|nodal marginal zone b-cell lymphoma
848192|NCT00014391|splenic marginal zone lymphoma|splenic marginal zone lymphoma
848193|NCT00014391|childhood myelodysplastic syndromes|childhood myelodysplastic syndromes
848194|NCT00012311|stage IV breast cancer|stage iv breast cancer
848195|NCT00012311|recurrent breast cancer|recurrent breast cancer
848196|NCT00010283|stage III breast cancer|stage iii breast cancer
848200|NCT00010283|recurrent childhood acute lymphoblastic leukemia|recurrent childhood acute lymphoblastic leukemia
848201|NCT00010283|recurrent adult Hodgkin lymphoma|recurrent adult hodgkin lymphoma
848202|NCT00010283|stage IV cutaneous T-cell non-Hodgkin lymphoma|stage iv cutaneous t-cell non-hodgkin lymphoma
848203|NCT00010283|recurrent cutaneous T-cell non-Hodgkin lymphoma|recurrent cutaneous t-cell non-hodgkin lymphoma
848204|NCT00010283|Burkitt lymphoma|burkitt lymphoma
848205|NCT00010283|extramedullary plasmacytoma|extramedullary plasmacytoma
848206|NCT00010283|refractory multiple myeloma|refractory multiple myeloma
848207|NCT00010283|stage II ovarian epithelial cancer|stage ii ovarian epithelial cancer
848208|NCT00010283|stage III ovarian epithelial cancer|stage iii ovarian epithelial cancer
848209|NCT00010283|stage IV ovarian epithelial cancer|stage iv ovarian epithelial cancer
848210|NCT00010283|recurrent ovarian epithelial cancer|recurrent ovarian epithelial cancer
848211|NCT00010283|disseminated neuroblastoma|disseminated neuroblastoma
848212|NCT00010283|recurrent neuroblastoma|recurrent neuroblastoma
848213|NCT00010283|recurrent Wilms tumor and other childhood kidney tumors|recurrent wilms tumor and other childhood kidney tumors
848214|NCT00010283|stage I multiple myeloma|stage i multiple myeloma
848215|NCT00010283|stage II multiple myeloma|stage ii multiple myeloma
848216|NCT00010283|stage III multiple myeloma|stage iii multiple myeloma
848217|NCT00010283|recurrent childhood lymphoblastic lymphoma|recurrent childhood lymphoblastic lymphoma
848218|NCT00010283|stage III chronic lymphocytic leukemia|stage iii chronic lymphocytic leukemia
848219|NCT00010283|stage IV chronic lymphocytic leukemia|stage iv chronic lymphocytic leukemia
848220|NCT00010283|recurrent childhood acute myeloid leukemia|recurrent childhood acute myeloid leukemia
848221|NCT00010283|recurrent adult acute myeloid leukemia|recurrent adult acute myeloid leukemia
848222|NCT00010283|recurrent adult acute lymphoblastic leukemia|recurrent adult acute lymphoblastic leukemia
848223|NCT00010283|relapsing chronic myelogenous leukemia|relapsing chronic myelogenous leukemia
848224|NCT00010283|refractory chronic lymphocytic leukemia|refractory chronic lymphocytic leukemia
848225|NCT00010283|stage III malignant testicular germ cell tumor|stage iii malignant testicular germ cell tumor
848226|NCT00010283|childhood diffuse large cell lymphoma|childhood diffuse large cell lymphoma
848227|NCT00010283|recurrent malignant testicular germ cell tumor|recurrent malignant testicular germ cell tumor
848228|NCT00010283|childhood immunoblastic large cell lymphoma|childhood immunoblastic large cell lymphoma
848229|NCT00010283|chronic phase chronic myelogenous leukemia|chronic phase chronic myelogenous leukemia
848230|NCT00010283|accelerated phase chronic myelogenous leukemia|accelerated phase chronic myelogenous leukemia
848231|NCT00010283|blastic phase chronic myelogenous leukemia|blastic phase chronic myelogenous leukemia
848232|NCT00010283|meningeal chronic myelogenous leukemia|meningeal chronic myelogenous leukemia
848233|NCT00010283|chronic idiopathic myelofibrosis|chronic idiopathic myelofibrosis
848234|NCT00010283|essential thrombocythemia|essential thrombocythemia
848235|NCT00010283|testicular embryonal carcinoma|testicular embryonal carcinoma
848236|NCT00010283|testicular choriocarcinoma|testicular choriocarcinoma
848237|NCT00010283|testicular teratoma|testicular teratoma
848238|NCT00010283|testicular yolk sac tumor|testicular yolk sac tumor
848239|NCT00010283|testicular embryonal carcinoma and teratoma|testicular embryonal carcinoma and teratoma
848240|NCT00010283|testicular embryonal carcinoma and teratoma with seminoma|testicular embryonal carcinoma and teratoma with seminoma
848241|NCT00010283|testicular embryonal carcinoma and yolk sac tumor|testicular embryonal carcinoma and yolk sac tumor
848242|NCT00010283|testicular embryonal carcinoma and yolk sac tumor with seminoma|testicular embryonal carcinoma and yolk sac tumor with seminoma
848243|NCT00010283|testicular embryonal carcinoma and seminoma|testicular embryonal carcinoma and seminoma
848244|NCT00010283|testicular yolk sac tumor and teratoma|testicular yolk sac tumor and teratoma
848245|NCT00010283|testicular yolk sac tumor and teratoma with seminoma|testicular yolk sac tumor and teratoma with seminoma
848246|NCT00010283|testicular choriocarcinoma and yolk sac tumor|testicular choriocarcinoma and yolk sac tumor
848247|NCT00010283|testicular choriocarcinoma and embryonal carcinoma|testicular choriocarcinoma and embryonal carcinoma
848248|NCT00010283|testicular choriocarcinoma and teratoma|testicular choriocarcinoma and teratoma
848249|NCT00010283|testicular choriocarcinoma and seminoma|testicular choriocarcinoma and seminoma
848250|NCT00010283|refractory hairy cell leukemia|refractory hairy cell leukemia
848251|NCT00010283|recurrent/refractory childhood Hodgkin lymphoma|recurrent/refractory childhood hodgkin lymphoma
848252|NCT00010283|recurrent ovarian germ cell tumor|recurrent ovarian germ cell tumor
848253|NCT00010283|chronic myelomonocytic leukemia|chronic myelomonocytic leukemia
848254|NCT00010283|ovarian yolk sac tumor|ovarian yolk sac tumor
848255|NCT00010283|ovarian embryonal carcinoma|ovarian embryonal carcinoma
848256|NCT00010283|ovarian polyembryoma|ovarian polyembryoma
848257|NCT00010283|ovarian choriocarcinoma|ovarian choriocarcinoma
848258|NCT00010283|ovarian immature teratoma|ovarian immature teratoma
848259|NCT00010283|ovarian mature teratoma|ovarian mature teratoma
848260|NCT00010283|ovarian monodermal and highly specialized teratoma|ovarian monodermal and highly specialized teratoma
848261|NCT00010283|ovarian mixed germ cell tumor|ovarian mixed germ cell tumor
848262|NCT00010283|acute undifferentiated leukemia|acute undifferentiated leukemia
848263|NCT00010283|stage III grade 1 follicular lymphoma|stage iii grade 1 follicular lymphoma
848264|NCT00010283|stage III grade 2 follicular lymphoma|stage iii grade 2 follicular lymphoma
848766|NCT00080626|stage IV breast cancer|stage iv breast cancer
848265|NCT00010283|stage III grade 3 follicular lymphoma|stage iii grade 3 follicular lymphoma
848551|NCT00081289|stage II rectal cancer|stage ii rectal cancer
848266|NCT00010283|stage III adult diffuse small cleaved cell lymphoma|stage iii adult diffuse small cleaved cell lymphoma
848267|NCT00010283|stage III adult diffuse mixed cell lymphoma|stage iii adult diffuse mixed cell lymphoma
848268|NCT00010283|stage III adult diffuse large cell lymphoma|stage iii adult diffuse large cell lymphoma
848269|NCT00010283|stage III adult immunoblastic large cell lymphoma|stage iii adult immunoblastic large cell lymphoma
848270|NCT00010283|stage III adult lymphoblastic lymphoma|stage iii adult lymphoblastic lymphoma
848271|NCT00010283|stage III adult Burkitt lymphoma|stage iii adult burkitt lymphoma
848272|NCT00010283|stage IV grade 1 follicular lymphoma|stage iv grade 1 follicular lymphoma
848273|NCT00010283|stage IV grade 2 follicular lymphoma|stage iv grade 2 follicular lymphoma
848274|NCT00010283|stage IV grade 3 follicular lymphoma|stage iv grade 3 follicular lymphoma
848275|NCT00010283|stage IV adult diffuse small cleaved cell lymphoma|stage iv adult diffuse small cleaved cell lymphoma
848276|NCT00010283|stage IV adult diffuse mixed cell lymphoma|stage iv adult diffuse mixed cell lymphoma
848277|NCT00010283|stage IV adult diffuse large cell lymphoma|stage iv adult diffuse large cell lymphoma
848278|NCT00010283|stage IV adult immunoblastic large cell lymphoma|stage iv adult immunoblastic large cell lymphoma
848279|NCT00010283|stage IV adult lymphoblastic lymphoma|stage iv adult lymphoblastic lymphoma
848280|NCT00010283|stage IV adult Burkitt lymphoma|stage iv adult burkitt lymphoma
848281|NCT00010283|recurrent grade 1 follicular lymphoma|recurrent grade 1 follicular lymphoma
848282|NCT00010283|recurrent grade 2 follicular lymphoma|recurrent grade 2 follicular lymphoma
848283|NCT00010283|recurrent grade 3 follicular lymphoma|recurrent grade 3 follicular lymphoma
848284|NCT00010283|recurrent adult diffuse small cleaved cell lymphoma|recurrent adult diffuse small cleaved cell lymphoma
848285|NCT00010283|recurrent adult diffuse mixed cell lymphoma|recurrent adult diffuse mixed cell lymphoma
848286|NCT00010283|recurrent adult diffuse large cell lymphoma|recurrent adult diffuse large cell lymphoma
848287|NCT00010283|recurrent adult immunoblastic large cell lymphoma|recurrent adult immunoblastic large cell lymphoma
848288|NCT00010283|recurrent adult lymphoblastic lymphoma|recurrent adult lymphoblastic lymphoma
848289|NCT00010283|recurrent adult Burkitt lymphoma|recurrent adult burkitt lymphoma
848290|NCT00010283|recurrent adult T-cell leukemia/lymphoma|recurrent adult t-cell leukemia/lymphoma
848291|NCT00010283|secondary acute myeloid leukemia|secondary acute myeloid leukemia
848292|NCT00010283|de novo myelodysplastic syndromes|de novo myelodysplastic syndromes
848293|NCT00010283|poor prognosis metastatic gestational trophoblastic tumor|poor prognosis metastatic gestational trophoblastic tumor
848294|NCT00010283|previously treated myelodysplastic syndromes|previously treated myelodysplastic syndromes
848295|NCT00010283|secondary myelodysplastic syndromes|secondary myelodysplastic syndromes
848296|NCT00010283|graft versus host disease|graft versus host disease
848297|NCT00010283|prolymphocytic leukemia|prolymphocytic leukemia
848298|NCT00010283|primary systemic amyloidosis|primary systemic amyloidosis
848299|NCT00010283|recurrent childhood small noncleaved cell lymphoma|recurrent childhood small noncleaved cell lymphoma
848300|NCT00010283|recurrent childhood large cell lymphoma|recurrent childhood large cell lymphoma
848301|NCT00010283|noncontiguous stage II grade 1 follicular lymphoma|noncontiguous stage ii grade 1 follicular lymphoma
848302|NCT00010283|noncontiguous stage II grade 2 follicular lymphoma|noncontiguous stage ii grade 2 follicular lymphoma
848303|NCT00010283|noncontiguous stage II grade 3 follicular lymphoma|noncontiguous stage ii grade 3 follicular lymphoma
848304|NCT00010283|noncontiguous stage II adult diffuse small cleaved cell lymphoma|noncontiguous stage ii adult diffuse small cleaved cell lymphoma
848305|NCT00010283|noncontiguous stage II mantle cell lymphoma|noncontiguous stage ii mantle cell lymphoma
848306|NCT00010283|noncontiguous stage II adult diffuse mixed cell lymphoma|noncontiguous stage ii adult diffuse mixed cell lymphoma
848307|NCT00010283|noncontiguous stage II adult immunoblastic large cell lymphoma|noncontiguous stage ii adult immunoblastic large cell lymphoma
848308|NCT00010283|noncontiguous stage II adult diffuse large cell lymphoma|noncontiguous stage ii adult diffuse large cell lymphoma
848309|NCT00010283|noncontiguous stage II adult Burkitt lymphoma|noncontiguous stage ii adult burkitt lymphoma
848310|NCT00010283|noncontiguous stage II adult lymphoblastic lymphoma|noncontiguous stage ii adult lymphoblastic lymphoma
848311|NCT00010283|stage III mantle cell lymphoma|stage iii mantle cell lymphoma
848312|NCT00010283|stage IV mantle cell lymphoma|stage iv mantle cell lymphoma
848313|NCT00010283|recurrent mantle cell lymphoma|recurrent mantle cell lymphoma
848314|NCT00010283|anaplastic large cell lymphoma|anaplastic large cell lymphoma
848315|NCT00010283|stage IV mycosis fungoides/Sezary syndrome|stage iv mycosis fungoides/sezary syndrome
848316|NCT00010283|recurrent mycosis fungoides/Sezary syndrome|recurrent mycosis fungoides/sezary syndrome
848317|NCT00010283|noncontiguous stage II small lymphocytic lymphoma|noncontiguous stage ii small lymphocytic lymphoma
848318|NCT00010283|noncontiguous stage II marginal zone lymphoma|noncontiguous stage ii marginal zone lymphoma
848319|NCT00010283|recurrent marginal zone lymphoma|recurrent marginal zone lymphoma
848320|NCT00010283|recurrent small lymphocytic lymphoma|recurrent small lymphocytic lymphoma
848321|NCT00010283|stage III small lymphocytic lymphoma|stage iii small lymphocytic lymphoma
848322|NCT00010283|stage III marginal zone lymphoma|stage iii marginal zone lymphoma
848323|NCT00010283|stage IV small lymphocytic lymphoma|stage iv small lymphocytic lymphoma
848324|NCT00010283|stage IV marginal zone lymphoma|stage iv marginal zone lymphoma
848325|NCT00010283|extranodal marginal zone B-cell lymphoma of mucosa-associated lymphoid tissue|extranodal marginal zone b-cell lymphoma of mucosa-associated lymphoid tissue
848326|NCT00010283|nodal marginal zone B-cell lymphoma|nodal marginal zone b-cell lymphoma
848327|NCT00010283|splenic marginal zone lymphoma|splenic marginal zone lymphoma
848328|NCT00010283|childhood myelodysplastic syndromes|childhood myelodysplastic syndromes
848329|NCT00007943|stage III colon cancer|stage iii colon cancer
848330|NCT00007943|stage IV colon cancer|stage iv colon cancer
848331|NCT00007943|stage III rectal cancer|stage iii rectal cancer
848332|NCT00007943|stage IV rectal cancer|stage iv rectal cancer
848333|NCT00007943|recurrent colon cancer|recurrent colon cancer
848334|NCT00007943|recurrent rectal cancer|recurrent rectal cancer
848335|NCT00006045|recurrent adult acute myeloid leukemia|recurrent adult acute myeloid leukemia
848336|NCT00006045|adult acute erythroid leukemia (M6)|adult acute erythroid leukemia (m6)
848337|NCT00006045|adult acute myeloblastic leukemia without maturation (M1)|adult acute myeloblastic leukemia without maturation (m1)
848338|NCT00006045|adult acute myeloblastic leukemia with maturation (M2)|adult acute myeloblastic leukemia with maturation (m2)
848339|NCT00006045|adult acute myelomonocytic leukemia (M4)|adult acute myelomonocytic leukemia (m4)
848340|NCT00006045|adult acute monoblastic leukemia (M5a)|adult acute monoblastic leukemia (m5a)
848341|NCT00006045|adult acute megakaryoblastic leukemia (M7)|adult acute megakaryoblastic leukemia (m7)
848342|NCT00006045|secondary acute myeloid leukemia|secondary acute myeloid leukemia
848343|NCT00006045|adult acute monocytic leukemia (M5b)|adult acute monocytic leukemia (m5b)
848344|NCT00006045|adult acute minimally differentiated myeloid leukemia (M0)|adult acute minimally differentiated myeloid leukemia (m0)
848345|NCT00005875|stage IV melanoma|stage iv melanoma
848346|NCT00005875|recurrent melanoma|recurrent melanoma
848347|NCT00005874|adult leiomyosarcoma|adult leiomyosarcoma
848348|NCT00005874|stage III adult soft tissue sarcoma|stage iii adult soft tissue sarcoma
848349|NCT00005874|recurrent adult soft tissue sarcoma|recurrent adult soft tissue sarcoma
848350|NCT00005874|small intestine leiomyosarcoma|small intestine leiomyosarcoma
848351|NCT00005874|metastatic childhood soft tissue sarcoma|metastatic childhood soft tissue sarcoma
848352|NCT00005874|recurrent childhood soft tissue sarcoma|recurrent childhood soft tissue sarcoma
848353|NCT00005874|childhood leiomyosarcoma|childhood leiomyosarcoma
848354|NCT00005874|gastrointestinal stromal tumor|gastrointestinal stromal tumor
848355|NCT00005874|stage IV adult soft tissue sarcoma|stage iv adult soft tissue sarcoma
848356|NCT00005873|stage IV breast cancer|stage iv breast cancer
848357|NCT00005873|recurrent breast cancer|recurrent breast cancer
848358|NCT00002708|tumors metastatic to brain|tumors metastatic to brain
848359|NCT00081432|Seizures|seizures
848360|NCT00081432|Language|language
848361|NCT00081432|Memory|memory
848362|NCT00081432|Brain|brain
848363|NCT00081432|Imaging|imaging
848364|NCT00081432|Epilepsy|epilepsy
848365|NCT00081432|Temporal Lobe Epilepsy|temporal lobe epilepsy
848366|NCT00081419|Bereitschaftspotential|bereitschaftspotential
848367|NCT00081419|Timing of Volition|timing of volition
848368|NCT00081419|Urge|urge
848369|NCT00081419|Conscious Will|conscious will
848370|NCT00081419|Libet's Clock|libet's clock
848371|NCT00081419|Tourette Syndrome|tourette syndrome
848372|NCT00081419|Tic Disorder|tic disorder
848373|NCT00081419|Healthy Volunteer|healthy volunteer
848374|NCT00081419|HV|hv
848375|NCT00081367|Minority Groups|minority groups
848376|NCT00005872|recurrent non-small cell lung cancer|recurrent non-small cell lung cancer
848377|NCT00005833|stage IV colon cancer|stage iv colon cancer
848378|NCT00005833|stage IV rectal cancer|stage iv rectal cancer
848379|NCT00005833|recurrent colon cancer|recurrent colon cancer
848380|NCT00005833|recurrent rectal cancer|recurrent rectal cancer
848381|NCT00005833|adenocarcinoma of the colon|adenocarcinoma of the colon
848382|NCT00005833|adenocarcinoma of the rectum|adenocarcinoma of the rectum
848383|NCT00005820|adenocarcinoma of the prostate|adenocarcinoma of the prostate
848384|NCT00005820|stage IV prostate cancer|stage iv prostate cancer
848385|NCT00005820|recurrent prostate cancer|recurrent prostate cancer
848386|NCT00005801|adult acute myeloid leukemia in remission|adult acute myeloid leukemia in remission
848387|NCT00005801|adult acute erythroid leukemia (M6)|adult acute erythroid leukemia (m6)
848388|NCT00005801|adult acute myeloblastic leukemia without maturation (M1)|adult acute myeloblastic leukemia without maturation (m1)
848389|NCT00005801|adult acute myeloblastic leukemia with maturation (M2)|adult acute myeloblastic leukemia with maturation (m2)
848390|NCT00005801|adult acute myelomonocytic leukemia (M4)|adult acute myelomonocytic leukemia (m4)
848391|NCT00005801|adult acute monoblastic leukemia (M5a)|adult acute monoblastic leukemia (m5a)
848392|NCT00005801|adult acute megakaryoblastic leukemia (M7)|adult acute megakaryoblastic leukemia (m7)
848393|NCT00005801|adult acute monocytic leukemia (M5b)|adult acute monocytic leukemia (m5b)
848394|NCT00005077|unspecified adult solid tumor, protocol specific|unspecified adult solid tumor, protocol specific
848395|NCT00005066|recurrent adult soft tissue sarcoma|recurrent adult soft tissue sarcoma
848396|NCT00005066|stage IV adult soft tissue sarcoma|stage iv adult soft tissue sarcoma
848397|NCT00005061|unspecified adult solid tumor, protocol specific|unspecified adult solid tumor, protocol specific
848398|NCT00005058|stage I breast cancer|stage i breast cancer
848399|NCT00005058|stage II breast cancer|stage ii breast cancer
848400|NCT00005058|stage IIIA breast cancer|stage iiia breast cancer
848401|NCT00005058|stage IIIB breast cancer|stage iiib breast cancer
848402|NCT00005058|inflammatory breast cancer|inflammatory breast cancer
848403|NCT00005040|recurrent adult grade III lymphomatoid granulomatosis|recurrent adult grade iii lymphomatoid granulomatosis
863217|NCT00057408|Autism|autism
848404|NCT00005040|recurrent grade 3 follicular lymphoma|recurrent grade 3 follicular lymphoma
848405|NCT00005040|recurrent adult diffuse small cleaved cell lymphoma|recurrent adult diffuse small cleaved cell lymphoma
848406|NCT00005040|recurrent adult diffuse mixed cell lymphoma|recurrent adult diffuse mixed cell lymphoma
848407|NCT00005040|recurrent adult diffuse large cell lymphoma|recurrent adult diffuse large cell lymphoma
848408|NCT00005040|recurrent adult immunoblastic large cell lymphoma|recurrent adult immunoblastic large cell lymphoma
848409|NCT00005040|recurrent adult lymphoblastic lymphoma|recurrent adult lymphoblastic lymphoma
848410|NCT00005040|recurrent adult Burkitt lymphoma|recurrent adult burkitt lymphoma
848411|NCT00005040|recurrent adult T-cell leukemia/lymphoma|recurrent adult t-cell leukemia/lymphoma
848412|NCT00005040|recurrent mantle cell lymphoma|recurrent mantle cell lymphoma
848413|NCT00005040|angioimmunoblastic T-cell lymphoma|angioimmunoblastic t-cell lymphoma
848414|NCT00005040|anaplastic large cell lymphoma|anaplastic large cell lymphoma
848415|NCT00004885|stage IV colon cancer|stage iv colon cancer
848416|NCT00004885|stage IV rectal cancer|stage iv rectal cancer
848417|NCT00004885|recurrent colon cancer|recurrent colon cancer
848418|NCT00004885|recurrent rectal cancer|recurrent rectal cancer
848419|NCT00004885|adenocarcinoma of the colon|adenocarcinoma of the colon
848420|NCT00004885|adenocarcinoma of the rectum|adenocarcinoma of the rectum
848421|NCT00004860|stage III colon cancer|stage iii colon cancer
848422|NCT00004860|stage IV colon cancer|stage iv colon cancer
848423|NCT00004860|stage III rectal cancer|stage iii rectal cancer
848424|NCT00004860|stage IV rectal cancer|stage iv rectal cancer
848425|NCT00004860|recurrent colon cancer|recurrent colon cancer
848426|NCT00004860|recurrent rectal cancer|recurrent rectal cancer
848427|NCT00004860|adenocarcinoma of the colon|adenocarcinoma of the colon
848428|NCT00004860|adenocarcinoma of the rectum|adenocarcinoma of the rectum
848429|NCT00004238|recurrent non-small cell lung cancer|recurrent non-small cell lung cancer
848430|NCT00004238|stage IIIB non-small cell lung cancer|stage iiib non-small cell lung cancer
848431|NCT00004238|stage IV non-small cell lung cancer|stage iv non-small cell lung cancer
848432|NCT00004166|stage I ovarian epithelial cancer|stage i ovarian epithelial cancer
850714|NCT00079651|Aged|aged
848433|NCT00004166|stage II ovarian epithelial cancer|stage ii ovarian epithelial cancer
848434|NCT00004166|stage III ovarian epithelial cancer|stage iii ovarian epithelial cancer
848435|NCT00004166|stage IV ovarian epithelial cancer|stage iv ovarian epithelial cancer
848436|NCT00004166|quality of life|quality of life
848437|NCT00004137|extensive stage small cell lung cancer|extensive stage small cell lung cancer
848438|NCT00004102|stage IV colon cancer|stage iv colon cancer
848439|NCT00004102|stage IV rectal cancer|stage iv rectal cancer
848440|NCT00004102|recurrent colon cancer|recurrent colon cancer
848441|NCT00004102|recurrent rectal cancer|recurrent rectal cancer
848442|NCT00004102|adenocarcinoma of the colon|adenocarcinoma of the colon
848443|NCT00004102|adenocarcinoma of the rectum|adenocarcinoma of the rectum
848444|NCT00004082|stage III ovarian epithelial cancer|stage iii ovarian epithelial cancer
848445|NCT00004082|stage IV ovarian epithelial cancer|stage iv ovarian epithelial cancer
848446|NCT00004082|stage III endometrial carcinoma|stage iii endometrial carcinoma
848447|NCT00004082|stage IV endometrial carcinoma|stage iv endometrial carcinoma
848448|NCT00004082|endometrial adenocarcinoma|endometrial adenocarcinoma
848449|NCT00004082|fallopian tube cancer|fallopian tube cancer
848450|NCT00004082|primary peritoneal cavity cancer|primary peritoneal cavity cancer
848451|NCT00004002|stage IV adult Hodgkin lymphoma|stage iv adult hodgkin lymphoma
848452|NCT00004002|recurrent adult Hodgkin lymphoma|recurrent adult hodgkin lymphoma
848453|NCT00004002|stage IV cutaneous T-cell non-Hodgkin lymphoma|stage iv cutaneous t-cell non-hodgkin lymphoma
848454|NCT00004002|recurrent cutaneous T-cell non-Hodgkin lymphoma|recurrent cutaneous t-cell non-hodgkin lymphoma
848455|NCT00004002|small intestine lymphoma|small intestine lymphoma
848456|NCT00004002|unspecified adult solid tumor, protocol specific|unspecified adult solid tumor, protocol specific
848457|NCT00004002|stage IV grade 1 follicular lymphoma|stage iv grade 1 follicular lymphoma
848458|NCT00004002|stage IV grade 2 follicular lymphoma|stage iv grade 2 follicular lymphoma
848459|NCT00004002|stage IV grade 3 follicular lymphoma|stage iv grade 3 follicular lymphoma
848460|NCT00004002|stage IV adult diffuse small cleaved cell lymphoma|stage iv adult diffuse small cleaved cell lymphoma
848461|NCT00004002|stage IV adult diffuse mixed cell lymphoma|stage iv adult diffuse mixed cell lymphoma
848462|NCT00004002|stage IV adult diffuse large cell lymphoma|stage iv adult diffuse large cell lymphoma
848463|NCT00004002|stage IV adult immunoblastic large cell lymphoma|stage iv adult immunoblastic large cell lymphoma
848464|NCT00004002|stage IV adult lymphoblastic lymphoma|stage iv adult lymphoblastic lymphoma
848465|NCT00004002|stage IV adult Burkitt lymphoma|stage iv adult burkitt lymphoma
848466|NCT00004002|recurrent grade 1 follicular lymphoma|recurrent grade 1 follicular lymphoma
848467|NCT00004002|recurrent grade 2 follicular lymphoma|recurrent grade 2 follicular lymphoma
848468|NCT00004002|recurrent grade 3 follicular lymphoma|recurrent grade 3 follicular lymphoma
848469|NCT00004002|recurrent adult diffuse small cleaved cell lymphoma|recurrent adult diffuse small cleaved cell lymphoma
848470|NCT00004002|recurrent adult diffuse mixed cell lymphoma|recurrent adult diffuse mixed cell lymphoma
848471|NCT00004002|recurrent adult diffuse large cell lymphoma|recurrent adult diffuse large cell lymphoma
848472|NCT00004002|recurrent adult immunoblastic large cell lymphoma|recurrent adult immunoblastic large cell lymphoma
848473|NCT00004002|recurrent adult lymphoblastic lymphoma|recurrent adult lymphoblastic lymphoma
848474|NCT00004002|recurrent adult Burkitt lymphoma|recurrent adult burkitt lymphoma
848475|NCT00004002|stage IV adult T-cell leukemia/lymphoma|stage iv adult t-cell leukemia/lymphoma
848476|NCT00004002|recurrent adult T-cell leukemia/lymphoma|recurrent adult t-cell leukemia/lymphoma
848477|NCT00004002|primary central nervous system non-Hodgkin lymphoma|primary central nervous system non-hodgkin lymphoma
848478|NCT00004002|AIDS-related peripheral/systemic lymphoma|aids-related peripheral/systemic lymphoma
848479|NCT00004002|AIDS-related primary CNS lymphoma|aids-related primary cns lymphoma
848480|NCT00004002|intraocular lymphoma|intraocular lymphoma
848481|NCT00004002|stage IV mantle cell lymphoma|stage iv mantle cell lymphoma
848482|NCT00004002|recurrent mantle cell lymphoma|recurrent mantle cell lymphoma
848483|NCT00004002|angioimmunoblastic T-cell lymphoma|angioimmunoblastic t-cell lymphoma
848484|NCT00004002|anaplastic large cell lymphoma|anaplastic large cell lymphoma
848485|NCT00004002|stage IV mycosis fungoides/Sezary syndrome|stage iv mycosis fungoides/sezary syndrome
848486|NCT00004002|recurrent mycosis fungoides/Sezary syndrome|recurrent mycosis fungoides/sezary syndrome
848487|NCT00004002|recurrent marginal zone lymphoma|recurrent marginal zone lymphoma
848488|NCT00004002|recurrent small lymphocytic lymphoma|recurrent small lymphocytic lymphoma
848489|NCT00004002|stage IV small lymphocytic lymphoma|stage iv small lymphocytic lymphoma
848490|NCT00004002|stage IV marginal zone lymphoma|stage iv marginal zone lymphoma
848491|NCT00004002|extranodal marginal zone B-cell lymphoma of mucosa-associated lymphoid tissue|extranodal marginal zone b-cell lymphoma of mucosa-associated lymphoid tissue
848492|NCT00004002|nodal marginal zone B-cell lymphoma|nodal marginal zone b-cell lymphoma
848493|NCT00004002|splenic marginal zone lymphoma|splenic marginal zone lymphoma
848494|NCT00003911|stage IV melanoma|stage iv melanoma
848495|NCT00003911|recurrent melanoma|recurrent melanoma
848496|NCT00003911|tumors metastatic to brain|tumors metastatic to brain
848497|NCT00003840|recurrent adult acute myeloid leukemia|recurrent adult acute myeloid leukemia
848498|NCT00003840|secondary acute myeloid leukemia|secondary acute myeloid leukemia
848499|NCT00081354|Esophageal Adenocarcinoma|esophageal adenocarcinoma
848500|NCT00081354|Dysplasia|dysplasia
848501|NCT00081354|Surveillance|surveillance
848502|NCT00081354|Proteomics|proteomics
848503|NCT00081354|SNP's|snp's
848504|NCT00081354|Barrett Esophagus|barrett esophagus
848505|NCT00081354|Gastroesophageal Reflux Disease|gastroesophageal reflux disease
848506|NCT00081354|GERD|gerd
848507|NCT00081354|Dysphagia|dysphagia
848508|NCT00081354|Swallowing Difficulty|swallowing difficulty
848509|NCT00081315|- Non-Small cell lung cancer|- non-small cell lung cancer
848510|NCT00005943|stage IV melanoma|stage iv melanoma
848511|NCT00005943|recurrent melanoma|recurrent melanoma
848512|NCT00003754|unspecified childhood solid tumor, protocol specific|unspecified childhood solid tumor, protocol specific
848513|NCT00003710|unspecified adult solid tumor, protocol specific|unspecified adult solid tumor, protocol specific
848514|NCT00003692|occult non-small cell lung cancer|occult non-small cell lung cancer
848515|NCT00003692|stage I non-small cell lung cancer|stage i non-small cell lung cancer
848516|NCT00003692|stage 0 non-small cell lung cancer|stage 0 non-small cell lung cancer
848517|NCT00003642|stage II bladder cancer|stage ii bladder cancer
848518|NCT00003642|stage III bladder cancer|stage iii bladder cancer
848519|NCT00003642|transitional cell carcinoma of the bladder|transitional cell carcinoma of the bladder
848520|NCT00003446|stage IV colon cancer|stage iv colon cancer
848521|NCT00003446|stage IV rectal cancer|stage iv rectal cancer
848522|NCT00003446|recurrent colon cancer|recurrent colon cancer
848523|NCT00003446|recurrent rectal cancer|recurrent rectal cancer
848524|NCT00003376|stage III bladder cancer|stage iii bladder cancer
848525|NCT00003376|stage IV bladder cancer|stage iv bladder cancer
848526|NCT00003376|transitional cell carcinoma of the bladder|transitional cell carcinoma of the bladder
848527|NCT00003376|anterior urethral cancer|anterior urethral cancer
848528|NCT00003376|posterior urethral cancer|posterior urethral cancer
848529|NCT00003376|urethral cancer associated with invasive bladder cancer|urethral cancer associated with invasive bladder cancer
848530|NCT00003376|metastatic transitional cell cancer of the renal pelvis and ureter|metastatic transitional cell cancer of the renal pelvis and ureter
848531|NCT00003376|regional transitional cell cancer of the renal pelvis and ureter|regional transitional cell cancer of the renal pelvis and ureter
848532|NCT00003316|recurrent uterine sarcoma|recurrent uterine sarcoma
848533|NCT00003316|uterine leiomyosarcoma|uterine leiomyosarcoma
848534|NCT00003301|recurrent adult brain tumor|recurrent adult brain tumor
848535|NCT00003301|adult glioblastoma|adult glioblastoma
848536|NCT00003301|adult anaplastic astrocytoma|adult anaplastic astrocytoma
848537|NCT00003301|adult giant cell glioblastoma|adult giant cell glioblastoma
848538|NCT00003301|adult gliosarcoma|adult gliosarcoma
848539|NCT00003232|adenocarcinoma of the prostate|adenocarcinoma of the prostate
848540|NCT00003232|recurrent prostate cancer|recurrent prostate cancer
848542|NCT00003232|quality of life|quality of life
848543|NCT00081302|stage IIIA non-small cell lung cancer|stage iiia non-small cell lung cancer
848544|NCT00081302|stage IIIB non-small cell lung cancer|stage iiib non-small cell lung cancer
848545|NCT00081302|squamous cell lung cancer|squamous cell lung cancer
848546|NCT00081302|large cell lung cancer|large cell lung cancer
848547|NCT00081302|adenocarcinoma of the lung|adenocarcinoma of the lung
848548|NCT00081302|bronchoalveolar cell lung cancer|bronchoalveolar cell lung cancer
848549|NCT00081289|stage III rectal cancer|stage iii rectal cancer
848550|NCT00081289|adenocarcinoma of the rectum|adenocarcinoma of the rectum
848552|NCT00081250|unspecified adult solid tumor, protocol specific|unspecified adult solid tumor, protocol specific
848553|NCT00081250|cachexia|cachexia
848554|NCT00081250|anorexia|anorexia
848555|NCT00081250|weight changes|weight changes
848556|NCT00081237|recurrent colon cancer|recurrent colon cancer
848557|NCT00081237|stage III colon cancer|stage iii colon cancer
848558|NCT00081237|stage IV colon cancer|stage iv colon cancer
848559|NCT00081237|recurrent rectal cancer|recurrent rectal cancer
848560|NCT00081237|stage III rectal cancer|stage iii rectal cancer
848561|NCT00081237|stage IV rectal cancer|stage iv rectal cancer
848562|NCT00081224|adenocarcinoma of the rectum|adenocarcinoma of the rectum
848563|NCT00081224|stage II rectal cancer|stage ii rectal cancer
848564|NCT00081224|stage III rectal cancer|stage iii rectal cancer
848565|NCT00081172|adenocarcinoma of the prostate|adenocarcinoma of the prostate
848566|NCT00081172|recurrent prostate cancer|recurrent prostate cancer
848567|NCT00081172|stage IV prostate cancer|stage iv prostate cancer
848568|NCT00081159|recurrent prostate cancer|recurrent prostate cancer
848569|NCT00081159|stage IV prostate cancer|stage iv prostate cancer
848570|NCT00081159|bone metastases|bone metastases
848571|NCT00081133|accelerated phase chronic myelogenous leukemia|accelerated phase chronic myelogenous leukemia
848572|NCT00081133|blastic phase chronic myelogenous leukemia|blastic phase chronic myelogenous leukemia
848573|NCT00081133|recurrent adult acute lymphoblastic leukemia|recurrent adult acute lymphoblastic leukemia
848574|NCT00081133|untreated adult acute lymphoblastic leukemia|untreated adult acute lymphoblastic leukemia
848575|NCT00081107|recurrent non-small cell lung cancer|recurrent non-small cell lung cancer
848576|NCT00081107|stage IIIB non-small cell lung cancer|stage iiib non-small cell lung cancer
848577|NCT00081107|stage IV non-small cell lung cancer|stage iv non-small cell lung cancer
848578|NCT00081094|adult primary hepatocellular carcinoma|adult primary hepatocellular carcinoma
848579|NCT00081094|recurrent adult primary liver cancer|recurrent adult primary liver cancer
848580|NCT00081094|localized resectable adult primary liver cancer|localized resectable adult primary liver cancer
848581|NCT00081068|Waldenström macroglobulinemia|waldenström macroglobulinemia
848582|NCT00081055|graft versus host disease|graft versus host disease
848583|NCT00081055|adult acute lymphoblastic leukemia in remission|adult acute lymphoblastic leukemia in remission
848584|NCT00081055|recurrent adult acute lymphoblastic leukemia|recurrent adult acute lymphoblastic leukemia
848585|NCT00081055|adult acute myeloid leukemia in remission|adult acute myeloid leukemia in remission
848586|NCT00081055|recurrent adult acute myeloid leukemia|recurrent adult acute myeloid leukemia
848587|NCT00081055|accelerated phase chronic myelogenous leukemia|accelerated phase chronic myelogenous leukemia
848588|NCT00081055|chronic phase chronic myelogenous leukemia|chronic phase chronic myelogenous leukemia
848589|NCT00081055|refractory anemia|refractory anemia
848590|NCT00081055|refractory anemia with excess blasts|refractory anemia with excess blasts
848591|NCT00081055|refractory anemia with ringed sideroblasts|refractory anemia with ringed sideroblasts
848592|NCT00081055|de novo myelodysplastic syndromes|de novo myelodysplastic syndromes
848593|NCT00081055|previously treated myelodysplastic syndromes|previously treated myelodysplastic syndromes
848594|NCT00081055|secondary myelodysplastic syndromes|secondary myelodysplastic syndromes
848595|NCT00081055|adult acute myeloid leukemia with t(8;21)(q22;q22)|adult acute myeloid leukemia with t(8;21)(q22;q22)
848596|NCT00081055|adult acute myeloid leukemia with t(16;16)(p13;q22)|adult acute myeloid leukemia with t(16;16)(p13;q22)
848597|NCT00081055|adult acute myeloid leukemia with inv(16)(p13;q22)|adult acute myeloid leukemia with inv(16)(p13;q22)
848598|NCT00081055|adult acute myeloid leukemia with 11q23 (MLL) abnormalities|adult acute myeloid leukemia with 11q23 (mll) abnormalities
848599|NCT00081055|adult acute myeloid leukemia with t(15;17)(q22;q12)|adult acute myeloid leukemia with t(15;17)(q22;q12)
848600|NCT00081042|recurrent melanoma|recurrent melanoma
848601|NCT00081042|stage III melanoma|stage iii melanoma
848602|NCT00081042|stage IV melanoma|stage iv melanoma
848603|NCT00081029|xerostomia|xerostomia
848604|NCT00081029|radiation toxicity|radiation toxicity
848605|NCT00081029|stage I squamous cell carcinoma of the hypopharynx|stage i squamous cell carcinoma of the hypopharynx
848606|NCT00081029|stage I squamous cell carcinoma of the oropharynx|stage i squamous cell carcinoma of the oropharynx
848607|NCT00081029|stage II squamous cell carcinoma of the hypopharynx|stage ii squamous cell carcinoma of the hypopharynx
848608|NCT00081029|stage II squamous cell carcinoma of the oropharynx|stage ii squamous cell carcinoma of the oropharynx
848609|NCT00081029|stage III squamous cell carcinoma of the hypopharynx|stage iii squamous cell carcinoma of the hypopharynx
848610|NCT00081029|stage III squamous cell carcinoma of the oropharynx|stage iii squamous cell carcinoma of the oropharynx
848611|NCT00081029|stage IV squamous cell carcinoma of the hypopharynx|stage iv squamous cell carcinoma of the hypopharynx
848612|NCT00081029|stage IV squamous cell carcinoma of the oropharynx|stage iv squamous cell carcinoma of the oropharynx
848613|NCT00081003|breast cancer|breast cancer
848614|NCT00080977|recurrent renal cell cancer|recurrent renal cell cancer
848615|NCT00080977|stage IV renal cell cancer|stage iv renal cell cancer
848616|NCT00080951|stage IV colon cancer|stage iv colon cancer
848617|NCT00080951|stage IV rectal cancer|stage iv rectal cancer
848618|NCT00080951|adenocarcinoma of the colon|adenocarcinoma of the colon
848619|NCT00080951|adenocarcinoma of the rectum|adenocarcinoma of the rectum
848620|NCT00080938|recurrent non-small cell lung cancer|recurrent non-small cell lung cancer
848621|NCT00080938|stage IV non-small cell lung cancer|stage iv non-small cell lung cancer
876737|NCT00050804|Startle|startle
848622|NCT00080938|squamous cell lung cancer|squamous cell lung cancer
848623|NCT00080938|adenocarcinoma of the lung|adenocarcinoma of the lung
848624|NCT00080938|large cell lung cancer|large cell lung cancer
848625|NCT00080938|bronchoalveolar cell lung cancer|bronchoalveolar cell lung cancer
848626|NCT00080938|adenosquamous cell lung cancer|adenosquamous cell lung cancer
848627|NCT00080938|tumors metastatic to brain|tumors metastatic to brain
848628|NCT00080925|prolymphocytic leukemia|prolymphocytic leukemia
848629|NCT00080925|accelerated phase chronic myelogenous leukemia|accelerated phase chronic myelogenous leukemia
848630|NCT00080925|chronic phase chronic myelogenous leukemia|chronic phase chronic myelogenous leukemia
848631|NCT00080925|relapsing chronic myelogenous leukemia|relapsing chronic myelogenous leukemia
848632|NCT00080925|refractory chronic lymphocytic leukemia|refractory chronic lymphocytic leukemia
848633|NCT00080925|de novo myelodysplastic syndromes|de novo myelodysplastic syndromes
848634|NCT00080925|myelodysplastic/myeloproliferative neoplasm, unclassifiable|myelodysplastic/myeloproliferative neoplasm, unclassifiable
848635|NCT00080925|previously treated myelodysplastic syndromes|previously treated myelodysplastic syndromes
848636|NCT00080925|secondary myelodysplastic syndromes|secondary myelodysplastic syndromes
848637|NCT00080925|secondary acute myeloid leukemia|secondary acute myeloid leukemia
848638|NCT00080925|recurrent adult Hodgkin lymphoma|recurrent adult hodgkin lymphoma
848639|NCT00080925|refractory anemia with excess blasts|refractory anemia with excess blasts
848640|NCT00080925|refractory multiple myeloma|refractory multiple myeloma
848641|NCT00080925|primary myelofibrosis|primary myelofibrosis
848642|NCT00080925|recurrent adult diffuse large cell lymphoma|recurrent adult diffuse large cell lymphoma
848643|NCT00080925|recurrent adult diffuse mixed cell lymphoma|recurrent adult diffuse mixed cell lymphoma
848644|NCT00080925|recurrent adult diffuse small cleaved cell lymphoma|recurrent adult diffuse small cleaved cell lymphoma
848645|NCT00080925|recurrent adult immunoblastic large cell lymphoma|recurrent adult immunoblastic large cell lymphoma
848646|NCT00080925|recurrent adult lymphoblastic lymphoma|recurrent adult lymphoblastic lymphoma
848647|NCT00080925|recurrent grade 1 follicular lymphoma|recurrent grade 1 follicular lymphoma
848648|NCT00080925|recurrent grade 2 follicular lymphoma|recurrent grade 2 follicular lymphoma
848649|NCT00080925|recurrent grade 3 follicular lymphoma|recurrent grade 3 follicular lymphoma
848650|NCT00080925|recurrent adult Burkitt lymphoma|recurrent adult burkitt lymphoma
848651|NCT00080925|recurrent mantle cell lymphoma|recurrent mantle cell lymphoma
848652|NCT00080925|adult acute lymphoblastic leukemia in remission|adult acute lymphoblastic leukemia in remission
848653|NCT00080925|adult acute myeloid leukemia in remission|adult acute myeloid leukemia in remission
848654|NCT00080925|chronic myelomonocytic leukemia|chronic myelomonocytic leukemia
848655|NCT00080925|polycythemia vera|polycythemia vera
848656|NCT00080925|essential thrombocythemia|essential thrombocythemia
848657|NCT00080925|stage II multiple myeloma|stage ii multiple myeloma
848658|NCT00080925|stage III multiple myeloma|stage iii multiple myeloma
848659|NCT00080925|recurrent marginal zone lymphoma|recurrent marginal zone lymphoma
848660|NCT00080925|recurrent small lymphocytic lymphoma|recurrent small lymphocytic lymphoma
848661|NCT00080925|extranodal marginal zone B-cell lymphoma of mucosa-associated lymphoid tissue|extranodal marginal zone b-cell lymphoma of mucosa-associated lymphoid tissue
848662|NCT00080925|nodal marginal zone B-cell lymphoma|nodal marginal zone b-cell lymphoma
848663|NCT00080925|splenic marginal zone lymphoma|splenic marginal zone lymphoma
848664|NCT00080925|adult acute myeloid leukemia with t(8;21)(q22;q22)|adult acute myeloid leukemia with t(8;21)(q22;q22)
848665|NCT00080925|adult acute myeloid leukemia with t(16;16)(p13;q22)|adult acute myeloid leukemia with t(16;16)(p13;q22)
848666|NCT00080925|adult acute myeloid leukemia with inv(16)(p13;q22)|adult acute myeloid leukemia with inv(16)(p13;q22)
848667|NCT00080925|adult acute myeloid leukemia with 11q23 (MLL) abnormalities|adult acute myeloid leukemia with 11q23 (mll) abnormalities
848668|NCT00080925|adult acute myeloid leukemia with t(15;17)(q22;q12)|adult acute myeloid leukemia with t(15;17)(q22;q12)
848669|NCT00080912|bone metastases|bone metastases
848670|NCT00080912|pain|pain
848671|NCT00080886|recurrent adult Burkitt lymphoma|recurrent adult burkitt lymphoma
848672|NCT00080886|recurrent adult diffuse large cell lymphoma|recurrent adult diffuse large cell lymphoma
848673|NCT00080886|recurrent adult diffuse mixed cell lymphoma|recurrent adult diffuse mixed cell lymphoma
848674|NCT00080886|recurrent adult diffuse small cleaved cell lymphoma|recurrent adult diffuse small cleaved cell lymphoma
848675|NCT00080886|recurrent adult immunoblastic large cell lymphoma|recurrent adult immunoblastic large cell lymphoma
848676|NCT00080886|recurrent adult lymphoblastic lymphoma|recurrent adult lymphoblastic lymphoma
848677|NCT00080886|recurrent grade 1 follicular lymphoma|recurrent grade 1 follicular lymphoma
848678|NCT00080886|recurrent grade 2 follicular lymphoma|recurrent grade 2 follicular lymphoma
848679|NCT00080886|recurrent grade 3 follicular lymphoma|recurrent grade 3 follicular lymphoma
848680|NCT00080886|recurrent mantle cell lymphoma|recurrent mantle cell lymphoma
848681|NCT00080886|recurrent marginal zone lymphoma|recurrent marginal zone lymphoma
848682|NCT00080886|recurrent small lymphocytic lymphoma|recurrent small lymphocytic lymphoma
848683|NCT00080886|extranodal marginal zone B-cell lymphoma of mucosa-associated lymphoid tissue|extranodal marginal zone b-cell lymphoma of mucosa-associated lymphoid tissue
848684|NCT00080886|nodal marginal zone B-cell lymphoma|nodal marginal zone b-cell lymphoma
848685|NCT00080886|splenic marginal zone lymphoma|splenic marginal zone lymphoma
848686|NCT00080873|oral complications|oral complications
848687|NCT00080873|disseminated neuroblastoma|disseminated neuroblastoma
848767|NCT00080600|Post Polio Syndrome|post polio syndrome
848688|NCT00080873|previously treated childhood rhabdomyosarcoma|previously treated childhood rhabdomyosarcoma
848689|NCT00080873|recurrent Wilms tumor and other childhood kidney tumors|recurrent wilms tumor and other childhood kidney tumors
848690|NCT00080873|recurrent/refractory childhood Hodgkin lymphoma|recurrent/refractory childhood hodgkin lymphoma
848691|NCT00080873|recurrent childhood acute lymphoblastic leukemia|recurrent childhood acute lymphoblastic leukemia
848692|NCT00080873|recurrent childhood acute myeloid leukemia|recurrent childhood acute myeloid leukemia
848693|NCT00080873|recurrent childhood large cell lymphoma|recurrent childhood large cell lymphoma
848694|NCT00080873|recurrent childhood lymphoblastic lymphoma|recurrent childhood lymphoblastic lymphoma
848695|NCT00080873|recurrent childhood rhabdomyosarcoma|recurrent childhood rhabdomyosarcoma
848696|NCT00080873|recurrent childhood small noncleaved cell lymphoma|recurrent childhood small noncleaved cell lymphoma
848697|NCT00080873|untreated childhood acute lymphoblastic leukemia|untreated childhood acute lymphoblastic leukemia
848698|NCT00080873|untreated childhood acute myeloid leukemia and other myeloid malignancies|untreated childhood acute myeloid leukemia and other myeloid malignancies
848699|NCT00080873|childhood acute lymphoblastic leukemia in remission|childhood acute lymphoblastic leukemia in remission
848700|NCT00080873|childhood acute myeloid leukemia in remission|childhood acute myeloid leukemia in remission
848701|NCT00080873|childhood chronic myelogenous leukemia|childhood chronic myelogenous leukemia
848702|NCT00080873|juvenile myelomonocytic leukemia|juvenile myelomonocytic leukemia
848703|NCT00080873|recurrent neuroblastoma|recurrent neuroblastoma
848704|NCT00080860|stage II breast cancer|stage ii breast cancer
848705|NCT00080860|stage IIIA breast cancer|stage iiia breast cancer
848706|NCT00080860|stage IIIB breast cancer|stage iiib breast cancer
848707|NCT00080860|stage IIIC breast cancer|stage iiic breast cancer
848708|NCT00080860|stage IV breast cancer|stage iv breast cancer
848709|NCT00080834|adenocarcinoma of the colon|adenocarcinoma of the colon
848710|NCT00080834|adenocarcinoma of the rectum|adenocarcinoma of the rectum
848711|NCT00080834|recurrent colon cancer|recurrent colon cancer
848712|NCT00080834|recurrent rectal cancer|recurrent rectal cancer
848713|NCT00080834|stage III colon cancer|stage iii colon cancer
848714|NCT00080834|stage IV colon cancer|stage iv colon cancer
848715|NCT00080834|stage III rectal cancer|stage iii rectal cancer
848716|NCT00080834|stage IV rectal cancer|stage iv rectal cancer
848717|NCT00080808|perioperative/postoperative complications|perioperative/postoperative complications
848718|NCT00080808|sexual dysfunction and infertility|sexual dysfunction and infertility
848719|NCT00080808|sexuality and reproductive issues|sexuality and reproductive issues
848720|NCT00080808|adenocarcinoma of the prostate|adenocarcinoma of the prostate
848721|NCT00080808|stage I prostate cancer|stage i prostate cancer
848722|NCT00080808|stage II prostate cancer|stage ii prostate cancer
848723|NCT00080808|prostaglandin E1|prostaglandin e1
848724|NCT00080808|papaverine|papaverine
848725|NCT00080808|phentolamine|phentolamine
848726|NCT00080808|Nerve-sparing radical prostatectomy|nerve-sparing radical prostatectomy
848727|NCT00080808|nerve grafting|nerve grafting
848728|NCT00080795|stage III bladder cancer|stage iii bladder cancer
848729|NCT00080795|regional transitional cell cancer of the renal pelvis and ureter|regional transitional cell cancer of the renal pelvis and ureter
848730|NCT00080795|anterior urethral cancer|anterior urethral cancer
848731|NCT00080795|posterior urethral cancer|posterior urethral cancer
848732|NCT00080795|urethral cancer associated with invasive bladder cancer|urethral cancer associated with invasive bladder cancer
848733|NCT00080782|recurrent prostate cancer|recurrent prostate cancer
848734|NCT00080782|stage IV prostate cancer|stage iv prostate cancer
848735|NCT00080782|bone metastases|bone metastases
848736|NCT00080782|Progressive Androgen-Independent Prostate Cancer|progressive androgen-independent prostate cancer
848737|NCT00080782|Metastron|metastron
848738|NCT00080782|Sr-89|sr-89
848739|NCT00080782|Strontium-89|strontium-89
848740|NCT00080782|strontium chloride Sr 89|strontium chloride sr 89
848741|NCT00080782|Celecoxib|celecoxib
848742|NCT00080782|Celebrex|celebrex
848743|NCT00080782|Doxorubicin|doxorubicin
848744|NCT00080782|Rubex|rubex
848745|NCT00080782|Adriamycin|adriamycin
848746|NCT00080756|breast cancer|breast cancer
848747|NCT00080756|BRCA1 mutation carrier|brca1 mutation carrier
848748|NCT00080756|BRCA2 mutation carrier|brca2 mutation carrier
848749|NCT00080743|recurrent breast cancer|recurrent breast cancer
848750|NCT00080743|stage IV breast cancer|stage iv breast cancer
848751|NCT00080678|adenocarcinoma of the prostate|adenocarcinoma of the prostate
848752|NCT00080678|recurrent prostate cancer|recurrent prostate cancer
848753|NCT00080678|stage IV prostate cancer|stage iv prostate cancer
848754|NCT00080678|bone metastases|bone metastases
848755|NCT00080665|male breast cancer|male breast cancer
848756|NCT00080665|stage IIIB breast cancer|stage iiib breast cancer
848757|NCT00080665|stage IIIC breast cancer|stage iiic breast cancer
848758|NCT00080665|stage IV breast cancer|stage iv breast cancer
848759|NCT00080665|recurrent breast cancer|recurrent breast cancer
848760|NCT00080639|ovarian epithelial cancer|ovarian epithelial cancer
848761|NCT00080626|stage I breast cancer|stage i breast cancer
848762|NCT00080626|stage II breast cancer|stage ii breast cancer
848763|NCT00080626|stage IIIA breast cancer|stage iiia breast cancer
848764|NCT00080626|stage IIIB breast cancer|stage iiib breast cancer
848765|NCT00080626|stage IIIC breast cancer|stage iiic breast cancer
848768|NCT00080600|Magnetic Stimulation|magnetic stimulation
848769|NCT00080600|Fatigue|fatigue
848770|NCT00080600|Exercise|exercise
848771|NCT00080600|Weakness|weakness
848772|NCT00080600|Transcranial Magnetic Stimulation|transcranial magnetic stimulation
848773|NCT00080600|Post-Exercise Fatigue|post-exercise fatigue
848774|NCT00080600|Motor Neuron Disease|motor neuron disease
848775|NCT00080600|Cortical Reorganization|cortical reorganization
848776|NCT00080600|Intracortical Facilitation|intracortical facilitation
848777|NCT00080600|Polio|polio
848778|NCT00080600|Healthy Volunteer|healthy volunteer
848779|NCT00080600|HV|hv
848780|NCT00080587|Intravascular Ultrasound|intravascular ultrasound
848781|NCT00080587|Magnetic Resonance Imaging|magnetic resonance imaging
848782|NCT00080587|Hyperlipidemia|hyperlipidemia
848783|NCT00080587|Cholesterol|cholesterol
848784|NCT00080587|Coronary Artery Disease|coronary artery disease
848785|NCT00080574|Pharmacokinetics|pharmacokinetics
848786|NCT00080574|Drug Metabolism|drug metabolism
848787|NCT00080574|Levothyroxine|levothyroxine
848788|NCT00080574|Hypothyroidism|hypothyroidism
848789|NCT00080574|Hyperthyroidism|hyperthyroidism
848790|NCT00080574|Drug Interactions|drug interactions
848791|NCT00080574|Cytochrome P450|cytochrome p450
848792|NCT00080574|P-Glycoprotein|p-glycoprotein
848793|NCT00080574|Drug Transport Proteins|drug transport proteins
848794|NCT00080574|Thyroid Hormone|thyroid hormone
848795|NCT00080574|Thyroid Cancer|thyroid cancer
848796|NCT00080548|Bereitschafts Potential|bereitschafts potential
848797|NCT00080548|Timing of Volition|timing of volition
848798|NCT00080548|Somatic Passivity Phenomenon|somatic passivity phenomenon
848799|NCT00080548|Conscious Will|conscious will
848800|NCT00080548|Libet's Clock|libet's clock
848801|NCT00080548|Schizophrenia|schizophrenia
848802|NCT00080548|Healthy Volunteer|healthy volunteer
848803|NCT00080548|HV|hv
848804|NCT00080535|LMB-2|lmb-2
848805|NCT00080535|Cutaneous T Cell Lymphoma|cutaneous t cell lymphoma
848806|NCT00080535|CTCL|ctcl
848807|NCT00080535|Immunotoxin|immunotoxin
848808|NCT00080535|Oncology|oncology
848809|NCT00080522|Treatment Naive|treatment naive
848810|NCT00080522|Resource Poor Setting|resource poor setting
848811|NCT00080522|Drug Delivery|drug delivery
848812|NCT00080522|Household|household
848813|NCT00080522|South Africa|south africa
848814|NCT00080496|Pneumonia|pneumonia
848815|NCT00003176|recurrent adult brain tumor|recurrent adult brain tumor
848816|NCT00003176|adult glioblastoma|adult glioblastoma
848817|NCT00003176|adult anaplastic astrocytoma|adult anaplastic astrocytoma
848818|NCT00003176|adult mixed glioma|adult mixed glioma
848819|NCT00003176|adult giant cell glioblastoma|adult giant cell glioblastoma
848820|NCT00003176|adult gliosarcoma|adult gliosarcoma
848821|NCT00003156|recurrent uterine sarcoma|recurrent uterine sarcoma
848822|NCT00003156|uterine carcinosarcoma|uterine carcinosarcoma
848823|NCT00003132|unspecified adult solid tumor, protocol specific|unspecified adult solid tumor, protocol specific
848824|NCT00003110|recurrent childhood lymphoblastic lymphoma|recurrent childhood lymphoblastic lymphoma
848825|NCT00003110|recurrent grade 3 follicular lymphoma|recurrent grade 3 follicular lymphoma
848826|NCT00003110|recurrent adult diffuse small cleaved cell lymphoma|recurrent adult diffuse small cleaved cell lymphoma
848827|NCT00003110|recurrent adult diffuse mixed cell lymphoma|recurrent adult diffuse mixed cell lymphoma
848828|NCT00003110|recurrent adult diffuse large cell lymphoma|recurrent adult diffuse large cell lymphoma
848829|NCT00003110|recurrent adult immunoblastic large cell lymphoma|recurrent adult immunoblastic large cell lymphoma
848830|NCT00003110|recurrent adult lymphoblastic lymphoma|recurrent adult lymphoblastic lymphoma
848831|NCT00003110|recurrent adult Burkitt lymphoma|recurrent adult burkitt lymphoma
848832|NCT00003110|AIDS-related peripheral/systemic lymphoma|aids-related peripheral/systemic lymphoma
848833|NCT00003110|AIDS-related diffuse large cell lymphoma|aids-related diffuse large cell lymphoma
848834|NCT00003110|AIDS-related immunoblastic large cell lymphoma|aids-related immunoblastic large cell lymphoma
848835|NCT00003110|AIDS-related small noncleaved cell lymphoma|aids-related small noncleaved cell lymphoma
848836|NCT00003110|AIDS-related diffuse mixed cell lymphoma|aids-related diffuse mixed cell lymphoma
848837|NCT00003110|AIDS-related diffuse small cleaved cell lymphoma|aids-related diffuse small cleaved cell lymphoma
848838|NCT00003110|AIDS-related lymphoblastic lymphoma|aids-related lymphoblastic lymphoma
848839|NCT00003110|recurrent childhood small noncleaved cell lymphoma|recurrent childhood small noncleaved cell lymphoma
848840|NCT00003110|recurrent childhood large cell lymphoma|recurrent childhood large cell lymphoma
848841|NCT00003110|recurrent mantle cell lymphoma|recurrent mantle cell lymphoma
848842|NCT00002997|stage IV colon cancer|stage iv colon cancer
848843|NCT00002997|stage IV rectal cancer|stage iv rectal cancer
848844|NCT00002997|recurrent colon cancer|recurrent colon cancer
848845|NCT00002997|recurrent rectal cancer|recurrent rectal cancer
848846|NCT00002997|adenocarcinoma of the colon|adenocarcinoma of the colon
848847|NCT00002997|adenocarcinoma of the rectum|adenocarcinoma of the rectum
848848|NCT00002997|liver metastases|liver metastases
848849|NCT00024063|stage III colon cancer|stage iii colon cancer
848850|NCT00024063|stage IV colon cancer|stage iv colon cancer
848851|NCT00024063|stage IV breast cancer|stage iv breast cancer
848852|NCT00024063|stage IIIA breast cancer|stage iiia breast cancer
848853|NCT00024063|recurrent breast cancer|recurrent breast cancer
848854|NCT00024063|stage III gastric cancer|stage iii gastric cancer
848855|NCT00024063|stage IV gastric cancer|stage iv gastric cancer
848856|NCT00024063|recurrent gastric cancer|recurrent gastric cancer
848857|NCT00024063|stage IIIB breast cancer|stage iiib breast cancer
848858|NCT00024063|recurrent non-small cell lung cancer|recurrent non-small cell lung cancer
848859|NCT00024063|stage II pancreatic cancer|stage ii pancreatic cancer
848860|NCT00024063|stage III pancreatic cancer|stage iii pancreatic cancer
848861|NCT00024063|recurrent pancreatic cancer|recurrent pancreatic cancer
848862|NCT00024063|stage III rectal cancer|stage iii rectal cancer
848863|NCT00024063|stage IV rectal cancer|stage iv rectal cancer
848864|NCT00024063|recurrent colon cancer|recurrent colon cancer
848865|NCT00024063|recurrent rectal cancer|recurrent rectal cancer
848866|NCT00024063|refractory multiple myeloma|refractory multiple myeloma
848867|NCT00024063|stage III renal cell cancer|stage iii renal cell cancer
848868|NCT00024063|stage IV renal cell cancer|stage iv renal cell cancer
848869|NCT00024063|recurrent renal cell cancer|recurrent renal cell cancer
848870|NCT00024063|stage III multiple myeloma|stage iii multiple myeloma
848871|NCT00024063|stage III prostate cancer|stage iii prostate cancer
848872|NCT00024063|stage IV prostate cancer|stage iv prostate cancer
848873|NCT00024063|recurrent prostate cancer|recurrent prostate cancer
848874|NCT00024063|stage IIIA non-small cell lung cancer|stage iiia non-small cell lung cancer
848875|NCT00024063|stage IIIB non-small cell lung cancer|stage iiib non-small cell lung cancer
848876|NCT00024063|stage IV non-small cell lung cancer|stage iv non-small cell lung cancer
848877|NCT00024063|male breast cancer|male breast cancer
848878|NCT00024063|stage IV pancreatic cancer|stage iv pancreatic cancer
848879|NCT00003107|stage IV breast cancer|stage iv breast cancer
848880|NCT00003107|stage IIIA breast cancer|stage iiia breast cancer
848881|NCT00003107|stage IIIB breast cancer|stage iiib breast cancer
848882|NCT00003107|recurrent adult Hodgkin lymphoma|recurrent adult hodgkin lymphoma
848883|NCT00003107|recurrent cutaneous T-cell non-Hodgkin lymphoma|recurrent cutaneous t-cell non-hodgkin lymphoma
848884|NCT00003107|refractory multiple myeloma|refractory multiple myeloma
848885|NCT00003107|stage II ovarian epithelial cancer|stage ii ovarian epithelial cancer
848886|NCT00003107|stage III ovarian epithelial cancer|stage iii ovarian epithelial cancer
848887|NCT00003107|stage IV ovarian epithelial cancer|stage iv ovarian epithelial cancer
848888|NCT00003107|recurrent ovarian epithelial cancer|recurrent ovarian epithelial cancer
848889|NCT00003107|disseminated neuroblastoma|disseminated neuroblastoma
848890|NCT00003107|recurrent neuroblastoma|recurrent neuroblastoma
848891|NCT00003107|recurrent Wilms tumor and other childhood kidney tumors|recurrent wilms tumor and other childhood kidney tumors
848892|NCT00003107|stage I multiple myeloma|stage i multiple myeloma
848893|NCT00003107|stage II multiple myeloma|stage ii multiple myeloma
848894|NCT00003107|stage III multiple myeloma|stage iii multiple myeloma
848895|NCT00003107|stage III chronic lymphocytic leukemia|stage iii chronic lymphocytic leukemia
848896|NCT00003107|stage IV chronic lymphocytic leukemia|stage iv chronic lymphocytic leukemia
848897|NCT00003107|recurrent adult acute myeloid leukemia|recurrent adult acute myeloid leukemia
848898|NCT00003107|recurrent adult acute lymphoblastic leukemia|recurrent adult acute lymphoblastic leukemia
848899|NCT00003107|relapsing chronic myelogenous leukemia|relapsing chronic myelogenous leukemia
848900|NCT00003107|refractory chronic lymphocytic leukemia|refractory chronic lymphocytic leukemia
848901|NCT00003107|stage III malignant testicular germ cell tumor|stage iii malignant testicular germ cell tumor
848902|NCT00003107|recurrent malignant testicular germ cell tumor|recurrent malignant testicular germ cell tumor
848903|NCT00003107|chronic phase chronic myelogenous leukemia|chronic phase chronic myelogenous leukemia
848904|NCT00003107|accelerated phase chronic myelogenous leukemia|accelerated phase chronic myelogenous leukemia
848905|NCT00003107|blastic phase chronic myelogenous leukemia|blastic phase chronic myelogenous leukemia
848906|NCT00003107|meningeal chronic myelogenous leukemia|meningeal chronic myelogenous leukemia
848907|NCT00003107|chronic idiopathic myelofibrosis|chronic idiopathic myelofibrosis
848908|NCT00003107|testicular embryonal carcinoma|testicular embryonal carcinoma
848909|NCT00003107|testicular choriocarcinoma|testicular choriocarcinoma
848910|NCT00003107|testicular teratoma|testicular teratoma
848911|NCT00003107|testicular yolk sac tumor|testicular yolk sac tumor
848912|NCT00003107|testicular embryonal carcinoma and teratoma|testicular embryonal carcinoma and teratoma
848913|NCT00003107|testicular embryonal carcinoma and teratoma with seminoma|testicular embryonal carcinoma and teratoma with seminoma
848914|NCT00003107|testicular embryonal carcinoma and yolk sac tumor|testicular embryonal carcinoma and yolk sac tumor
848915|NCT00003107|testicular embryonal carcinoma and yolk sac tumor with seminoma|testicular embryonal carcinoma and yolk sac tumor with seminoma
848916|NCT00003107|testicular embryonal carcinoma and seminoma|testicular embryonal carcinoma and seminoma
848917|NCT00003107|testicular yolk sac tumor and teratoma|testicular yolk sac tumor and teratoma
848918|NCT00003107|testicular yolk sac tumor and teratoma with seminoma|testicular yolk sac tumor and teratoma with seminoma
848919|NCT00003107|testicular choriocarcinoma and yolk sac tumor|testicular choriocarcinoma and yolk sac tumor
848920|NCT00003107|testicular choriocarcinoma and embryonal carcinoma|testicular choriocarcinoma and embryonal carcinoma
848921|NCT00003107|testicular choriocarcinoma and teratoma|testicular choriocarcinoma and teratoma
848922|NCT00003107|testicular choriocarcinoma and seminoma|testicular choriocarcinoma and seminoma
848923|NCT00003107|refractory hairy cell leukemia|refractory hairy cell leukemia
848924|NCT00003107|recurrent ovarian germ cell tumor|recurrent ovarian germ cell tumor
848925|NCT00003107|ovarian yolk sac tumor|ovarian yolk sac tumor
848926|NCT00003107|ovarian embryonal carcinoma|ovarian embryonal carcinoma
848927|NCT00003107|ovarian polyembryoma|ovarian polyembryoma
848928|NCT00003107|ovarian choriocarcinoma|ovarian choriocarcinoma
848929|NCT00003107|ovarian immature teratoma|ovarian immature teratoma
848930|NCT00003107|ovarian mature teratoma|ovarian mature teratoma
848931|NCT00003107|ovarian monodermal and highly specialized teratoma|ovarian monodermal and highly specialized teratoma
848932|NCT00003107|ovarian mixed germ cell tumor|ovarian mixed germ cell tumor
848933|NCT00003107|stage III grade 1 follicular lymphoma|stage iii grade 1 follicular lymphoma
848934|NCT00003107|stage III grade 2 follicular lymphoma|stage iii grade 2 follicular lymphoma
848935|NCT00003107|stage III grade 3 follicular lymphoma|stage iii grade 3 follicular lymphoma
848936|NCT00003107|stage III adult diffuse small cleaved cell lymphoma|stage iii adult diffuse small cleaved cell lymphoma
848937|NCT00003107|stage III adult diffuse mixed cell lymphoma|stage iii adult diffuse mixed cell lymphoma
848938|NCT00003107|stage III adult diffuse large cell lymphoma|stage iii adult diffuse large cell lymphoma
848939|NCT00003107|stage III adult immunoblastic large cell lymphoma|stage iii adult immunoblastic large cell lymphoma
848940|NCT00003107|stage III adult lymphoblastic lymphoma|stage iii adult lymphoblastic lymphoma
848941|NCT00003107|stage III adult Burkitt lymphoma|stage iii adult burkitt lymphoma
848942|NCT00003107|stage IV grade 1 follicular lymphoma|stage iv grade 1 follicular lymphoma
848943|NCT00003107|stage IV grade 2 follicular lymphoma|stage iv grade 2 follicular lymphoma
848944|NCT00003107|stage IV grade 3 follicular lymphoma|stage iv grade 3 follicular lymphoma
848945|NCT00003107|stage IV adult diffuse small cleaved cell lymphoma|stage iv adult diffuse small cleaved cell lymphoma
848946|NCT00003107|stage IV adult diffuse mixed cell lymphoma|stage iv adult diffuse mixed cell lymphoma
848947|NCT00003107|stage IV adult diffuse large cell lymphoma|stage iv adult diffuse large cell lymphoma
848948|NCT00003107|stage IV adult immunoblastic large cell lymphoma|stage iv adult immunoblastic large cell lymphoma
848949|NCT00003107|stage IV adult lymphoblastic lymphoma|stage iv adult lymphoblastic lymphoma
848950|NCT00003107|stage IV adult Burkitt lymphoma|stage iv adult burkitt lymphoma
848951|NCT00003107|recurrent grade 1 follicular lymphoma|recurrent grade 1 follicular lymphoma
848952|NCT00003107|recurrent grade 2 follicular lymphoma|recurrent grade 2 follicular lymphoma
848953|NCT00003107|recurrent grade 3 follicular lymphoma|recurrent grade 3 follicular lymphoma
848954|NCT00003107|recurrent adult diffuse small cleaved cell lymphoma|recurrent adult diffuse small cleaved cell lymphoma
848955|NCT00003107|recurrent adult diffuse mixed cell lymphoma|recurrent adult diffuse mixed cell lymphoma
848956|NCT00003107|recurrent adult diffuse large cell lymphoma|recurrent adult diffuse large cell lymphoma
848957|NCT00003107|recurrent adult immunoblastic large cell lymphoma|recurrent adult immunoblastic large cell lymphoma
848958|NCT00003107|recurrent adult lymphoblastic lymphoma|recurrent adult lymphoblastic lymphoma
848959|NCT00003107|recurrent adult Burkitt lymphoma|recurrent adult burkitt lymphoma
848960|NCT00003107|secondary acute myeloid leukemia|secondary acute myeloid leukemia
848961|NCT00003107|de novo myelodysplastic syndromes|de novo myelodysplastic syndromes
848962|NCT00003107|poor prognosis metastatic gestational trophoblastic tumor|poor prognosis metastatic gestational trophoblastic tumor
848963|NCT00003107|previously treated myelodysplastic syndromes|previously treated myelodysplastic syndromes
848964|NCT00003107|secondary myelodysplastic syndromes|secondary myelodysplastic syndromes
848965|NCT00003107|noncontiguous stage II grade 1 follicular lymphoma|noncontiguous stage ii grade 1 follicular lymphoma
848966|NCT00003107|noncontiguous stage II grade 2 follicular lymphoma|noncontiguous stage ii grade 2 follicular lymphoma
848967|NCT00003107|noncontiguous stage II grade 3 follicular lymphoma|noncontiguous stage ii grade 3 follicular lymphoma
848968|NCT00003107|noncontiguous stage II adult diffuse small cleaved cell lymphoma|noncontiguous stage ii adult diffuse small cleaved cell lymphoma
848969|NCT00003107|noncontiguous stage II mantle cell lymphoma|noncontiguous stage ii mantle cell lymphoma
848970|NCT00003107|noncontiguous stage II adult diffuse mixed cell lymphoma|noncontiguous stage ii adult diffuse mixed cell lymphoma
848971|NCT00003107|noncontiguous stage II adult immunoblastic large cell lymphoma|noncontiguous stage ii adult immunoblastic large cell lymphoma
848972|NCT00003107|noncontiguous stage II adult diffuse large cell lymphoma|noncontiguous stage ii adult diffuse large cell lymphoma
848973|NCT00003107|noncontiguous stage II adult Burkitt lymphoma|noncontiguous stage ii adult burkitt lymphoma
848974|NCT00003107|noncontiguous stage II adult lymphoblastic lymphoma|noncontiguous stage ii adult lymphoblastic lymphoma
848975|NCT00003107|stage III mantle cell lymphoma|stage iii mantle cell lymphoma
848976|NCT00003107|stage IV mantle cell lymphoma|stage iv mantle cell lymphoma
848977|NCT00003107|recurrent mantle cell lymphoma|recurrent mantle cell lymphoma
848978|NCT00003107|recurrent mycosis fungoides/Sezary syndrome|recurrent mycosis fungoides/sezary syndrome
848979|NCT00003107|noncontiguous stage II small lymphocytic lymphoma|noncontiguous stage ii small lymphocytic lymphoma
848980|NCT00003107|noncontiguous stage II marginal zone lymphoma|noncontiguous stage ii marginal zone lymphoma
848981|NCT00003107|recurrent marginal zone lymphoma|recurrent marginal zone lymphoma
848982|NCT00003107|recurrent small lymphocytic lymphoma|recurrent small lymphocytic lymphoma
848983|NCT00003107|stage III small lymphocytic lymphoma|stage iii small lymphocytic lymphoma
848984|NCT00003107|stage III marginal zone lymphoma|stage iii marginal zone lymphoma
848985|NCT00003107|stage IV small lymphocytic lymphoma|stage iv small lymphocytic lymphoma
848986|NCT00003107|stage IV marginal zone lymphoma|stage iv marginal zone lymphoma
863317|NCT00056927|Smoking|smoking
849188|NCT00019071|adult giant cell glioblastoma|adult giant cell glioblastoma
848987|NCT00003107|extranodal marginal zone B-cell lymphoma of mucosa-associated lymphoid tissue|extranodal marginal zone b-cell lymphoma of mucosa-associated lymphoid tissue
848988|NCT00003107|nodal marginal zone B-cell lymphoma|nodal marginal zone b-cell lymphoma
848989|NCT00003107|splenic marginal zone lymphoma|splenic marginal zone lymphoma
848990|NCT00003103|stage III colon cancer|stage iii colon cancer
848991|NCT00003103|stage IV colon cancer|stage iv colon cancer
848992|NCT00003103|stage IV breast cancer|stage iv breast cancer
848993|NCT00003103|stage IIIA breast cancer|stage iiia breast cancer
848994|NCT00003103|recurrent breast cancer|recurrent breast cancer
848995|NCT00003103|stage IIIB breast cancer|stage iiib breast cancer
848996|NCT00003103|recurrent non-small cell lung cancer|recurrent non-small cell lung cancer
848997|NCT00003103|stage III rectal cancer|stage iii rectal cancer
848998|NCT00003103|stage IV rectal cancer|stage iv rectal cancer
848999|NCT00003103|recurrent colon cancer|recurrent colon cancer
849000|NCT00003103|recurrent rectal cancer|recurrent rectal cancer
849001|NCT00003103|stage II esophageal cancer|stage ii esophageal cancer
849002|NCT00003103|stage III esophageal cancer|stage iii esophageal cancer
849003|NCT00003103|stage IV esophageal cancer|stage iv esophageal cancer
849004|NCT00003103|recurrent esophageal cancer|recurrent esophageal cancer
849005|NCT00003103|stage III renal cell cancer|stage iii renal cell cancer
849006|NCT00003103|stage IV renal cell cancer|stage iv renal cell cancer
849007|NCT00003103|recurrent renal cell cancer|recurrent renal cell cancer
849008|NCT00003103|stage III ovarian epithelial cancer|stage iii ovarian epithelial cancer
849009|NCT00003103|stage IV ovarian epithelial cancer|stage iv ovarian epithelial cancer
849010|NCT00003103|recurrent ovarian epithelial cancer|recurrent ovarian epithelial cancer
849011|NCT00003103|stage III Wilms tumor|stage iii wilms tumor
849012|NCT00003103|stage IV Wilms tumor|stage iv wilms tumor
849013|NCT00003103|stage V Wilms tumor|stage v wilms tumor
849014|NCT00003103|recurrent Wilms tumor and other childhood kidney tumors|recurrent wilms tumor and other childhood kidney tumors
849015|NCT00003103|stage III bladder cancer|stage iii bladder cancer
849016|NCT00003103|recurrent bladder cancer|recurrent bladder cancer
849017|NCT00003103|stage IV bladder cancer|stage iv bladder cancer
849018|NCT00003103|stage III prostate cancer|stage iii prostate cancer
849019|NCT00003103|stage IV prostate cancer|stage iv prostate cancer
849020|NCT00003103|recurrent prostate cancer|recurrent prostate cancer
849021|NCT00003103|stage IIIA non-small cell lung cancer|stage iiia non-small cell lung cancer
849022|NCT00003103|stage IIIB non-small cell lung cancer|stage iiib non-small cell lung cancer
849023|NCT00003103|stage IV non-small cell lung cancer|stage iv non-small cell lung cancer
849024|NCT00003103|unspecified adult solid tumor, protocol specific|unspecified adult solid tumor, protocol specific
849025|NCT00003103|untreated metastatic squamous neck cancer with occult primary|untreated metastatic squamous neck cancer with occult primary
849026|NCT00003103|recurrent metastatic squamous neck cancer with occult primary|recurrent metastatic squamous neck cancer with occult primary
849027|NCT00003103|ovarian stromal cancer|ovarian stromal cancer
849028|NCT00003103|stage III ovarian germ cell tumor|stage iii ovarian germ cell tumor
849029|NCT00003103|stage IV ovarian germ cell tumor|stage iv ovarian germ cell tumor
849030|NCT00003103|recurrent ovarian germ cell tumor|recurrent ovarian germ cell tumor
849031|NCT00003103|stage III squamous cell carcinoma of the lip and oral cavity|stage iii squamous cell carcinoma of the lip and oral cavity
849032|NCT00003103|stage III basal cell carcinoma of the lip|stage iii basal cell carcinoma of the lip
849033|NCT00003103|stage III verrucous carcinoma of the oral cavity|stage iii verrucous carcinoma of the oral cavity
849034|NCT00003103|stage III mucoepidermoid carcinoma of the oral cavity|stage iii mucoepidermoid carcinoma of the oral cavity
849035|NCT00003103|stage III adenoid cystic carcinoma of the oral cavity|stage iii adenoid cystic carcinoma of the oral cavity
849036|NCT00003103|stage IV squamous cell carcinoma of the lip and oral cavity|stage iv squamous cell carcinoma of the lip and oral cavity
849037|NCT00003103|stage IV basal cell carcinoma of the lip|stage iv basal cell carcinoma of the lip
849038|NCT00003103|stage IV verrucous carcinoma of the oral cavity|stage iv verrucous carcinoma of the oral cavity
849039|NCT00003103|stage IV mucoepidermoid carcinoma of the oral cavity|stage iv mucoepidermoid carcinoma of the oral cavity
849040|NCT00003103|stage IV adenoid cystic carcinoma of the oral cavity|stage iv adenoid cystic carcinoma of the oral cavity
849041|NCT00003103|recurrent squamous cell carcinoma of the lip and oral cavity|recurrent squamous cell carcinoma of the lip and oral cavity
849042|NCT00003103|recurrent basal cell carcinoma of the lip|recurrent basal cell carcinoma of the lip
849043|NCT00003103|recurrent verrucous carcinoma of the oral cavity|recurrent verrucous carcinoma of the oral cavity
849044|NCT00003103|recurrent mucoepidermoid carcinoma of the oral cavity|recurrent mucoepidermoid carcinoma of the oral cavity
849045|NCT00003103|recurrent adenoid cystic carcinoma of the oral cavity|recurrent adenoid cystic carcinoma of the oral cavity
849046|NCT00003103|stage III squamous cell carcinoma of the oropharynx|stage iii squamous cell carcinoma of the oropharynx
849047|NCT00003103|stage III lymphoepithelioma of the oropharynx|stage iii lymphoepithelioma of the oropharynx
849048|NCT00003103|stage IV squamous cell carcinoma of the oropharynx|stage iv squamous cell carcinoma of the oropharynx
849049|NCT00003103|stage IV lymphoepithelioma of the oropharynx|stage iv lymphoepithelioma of the oropharynx
849050|NCT00003103|recurrent squamous cell carcinoma of the oropharynx|recurrent squamous cell carcinoma of the oropharynx
849051|NCT00003103|recurrent lymphoepithelioma of the oropharynx|recurrent lymphoepithelioma of the oropharynx
849052|NCT00003103|stage III squamous cell carcinoma of the nasopharynx|stage iii squamous cell carcinoma of the nasopharynx
849053|NCT00003103|stage III lymphoepithelioma of the nasopharynx|stage iii lymphoepithelioma of the nasopharynx
849054|NCT00003103|stage IV squamous cell carcinoma of the nasopharynx|stage iv squamous cell carcinoma of the nasopharynx
849055|NCT00003103|stage IV lymphoepithelioma of the nasopharynx|stage iv lymphoepithelioma of the nasopharynx
849056|NCT00003103|recurrent squamous cell carcinoma of the nasopharynx|recurrent squamous cell carcinoma of the nasopharynx
849057|NCT00003103|recurrent lymphoepithelioma of the nasopharynx|recurrent lymphoepithelioma of the nasopharynx
849058|NCT00003103|stage III squamous cell carcinoma of the hypopharynx|stage iii squamous cell carcinoma of the hypopharynx
849059|NCT00003103|stage IV squamous cell carcinoma of the hypopharynx|stage iv squamous cell carcinoma of the hypopharynx
849060|NCT00003103|recurrent squamous cell carcinoma of the hypopharynx|recurrent squamous cell carcinoma of the hypopharynx
849061|NCT00003103|stage III squamous cell carcinoma of the larynx|stage iii squamous cell carcinoma of the larynx
849062|NCT00003103|stage III verrucous carcinoma of the larynx|stage iii verrucous carcinoma of the larynx
849063|NCT00003103|stage IV squamous cell carcinoma of the larynx|stage iv squamous cell carcinoma of the larynx
849064|NCT00003103|stage IV verrucous carcinoma of the larynx|stage iv verrucous carcinoma of the larynx
849065|NCT00003103|recurrent squamous cell carcinoma of the larynx|recurrent squamous cell carcinoma of the larynx
849066|NCT00003103|recurrent verrucous carcinoma of the larynx|recurrent verrucous carcinoma of the larynx
849067|NCT00003103|stage III squamous cell carcinoma of the paranasal sinus and nasal cavity|stage iii squamous cell carcinoma of the paranasal sinus and nasal cavity
849068|NCT00003103|stage III inverted papilloma of the paranasal sinus and nasal cavity|stage iii inverted papilloma of the paranasal sinus and nasal cavity
849069|NCT00003103|stage III midline lethal granuloma of the paranasal sinus and nasal cavity|stage iii midline lethal granuloma of the paranasal sinus and nasal cavity
849070|NCT00003103|stage III esthesioneuroblastoma of the paranasal sinus and nasal cavity|stage iii esthesioneuroblastoma of the paranasal sinus and nasal cavity
849071|NCT00003103|stage IV squamous cell carcinoma of the paranasal sinus and nasal cavity|stage iv squamous cell carcinoma of the paranasal sinus and nasal cavity
849072|NCT00003103|stage IV inverted papilloma of the paranasal sinus and nasal cavity|stage iv inverted papilloma of the paranasal sinus and nasal cavity
849073|NCT00003103|stage IV midline lethal granuloma of the paranasal sinus and nasal cavity|stage iv midline lethal granuloma of the paranasal sinus and nasal cavity
849074|NCT00003103|stage IV esthesioneuroblastoma of the paranasal sinus and nasal cavity|stage iv esthesioneuroblastoma of the paranasal sinus and nasal cavity
849075|NCT00003103|recurrent squamous cell carcinoma of the paranasal sinus and nasal cavity|recurrent squamous cell carcinoma of the paranasal sinus and nasal cavity
849076|NCT00003103|recurrent inverted papilloma of the paranasal sinus and nasal cavity|recurrent inverted papilloma of the paranasal sinus and nasal cavity
849077|NCT00003103|recurrent midline lethal granuloma of the paranasal sinus and nasal cavity|recurrent midline lethal granuloma of the paranasal sinus and nasal cavity
849078|NCT00003103|recurrent esthesioneuroblastoma of the paranasal sinus and nasal cavity|recurrent esthesioneuroblastoma of the paranasal sinus and nasal cavity
849079|NCT00003103|borderline ovarian surface epithelial-stromal tumor|borderline ovarian surface epithelial-stromal tumor
849080|NCT00003103|ovarian sarcoma|ovarian sarcoma
849081|NCT00003103|clear cell sarcoma of the kidney|clear cell sarcoma of the kidney
849082|NCT00003103|rhabdoid tumor of the kidney|rhabdoid tumor of the kidney
849083|NCT00003012|stage II breast cancer|stage ii breast cancer
849084|NCT00003012|stage IIIA breast cancer|stage iiia breast cancer
849085|NCT00002987|stage I adult Hodgkin lymphoma|stage i adult hodgkin lymphoma
849086|NCT00002987|stage II adult Hodgkin lymphoma|stage ii adult hodgkin lymphoma
849087|NCT00002814|recurrent adult brain tumor|recurrent adult brain tumor
849088|NCT00002814|adult glioblastoma|adult glioblastoma
849089|NCT00002814|adult anaplastic astrocytoma|adult anaplastic astrocytoma
849090|NCT00002814|adult giant cell glioblastoma|adult giant cell glioblastoma
849091|NCT00002814|adult gliosarcoma|adult gliosarcoma
849092|NCT00002774|stage III|stage iii
849093|NCT00002774|stage IV|stage iv
849094|NCT00002774|recurrent|recurrent
849095|NCT00002714|stage I adult Hodgkin lymphoma|stage i adult hodgkin lymphoma
849096|NCT00002714|stage II adult Hodgkin lymphoma|stage ii adult hodgkin lymphoma
849097|NCT00002600|recurrent ovarian epithelial cancer|recurrent ovarian epithelial cancer
849098|NCT00002600|ovarian undifferentiated adenocarcinoma|ovarian undifferentiated adenocarcinoma
849099|NCT00002600|ovarian mixed epithelial carcinoma|ovarian mixed epithelial carcinoma
849100|NCT00002600|ovarian serous cystadenocarcinoma|ovarian serous cystadenocarcinoma
849101|NCT00002600|ovarian mucinous cystadenocarcinoma|ovarian mucinous cystadenocarcinoma
849102|NCT00002600|ovarian endometrioid adenocarcinoma|ovarian endometrioid adenocarcinoma
849103|NCT00002600|ovarian clear cell cystadenocarcinoma|ovarian clear cell cystadenocarcinoma
849104|NCT00002600|fallopian tube cancer|fallopian tube cancer
849105|NCT00002600|primary peritoneal cavity cancer|primary peritoneal cavity cancer
849106|NCT00002525|stage II colon cancer|stage ii colon cancer
849107|NCT00002525|stage III colon cancer|stage iii colon cancer
849108|NCT00002494|untreated adult acute lymphoblastic leukemia|untreated adult acute lymphoblastic leukemia
849109|NCT00002494|L3 adult acute lymphoblastic leukemia|l3 adult acute lymphoblastic leukemia
849110|NCT00002494|stage I adult Burkitt lymphoma|stage i adult burkitt lymphoma
849111|NCT00002494|stage II adult Burkitt lymphoma|stage ii adult burkitt lymphoma
849112|NCT00002494|stage III adult Burkitt lymphoma|stage iii adult burkitt lymphoma
849113|NCT00002494|stage IV adult Burkitt lymphoma|stage iv adult burkitt lymphoma
849114|NCT00002494|contiguous stage II adult Burkitt lymphoma|contiguous stage ii adult burkitt lymphoma
849115|NCT00002494|noncontiguous stage II adult Burkitt lymphoma|noncontiguous stage ii adult burkitt lymphoma
849116|NCT00080470|Incontinence|incontinence
849117|NCT00080470|Refractory|refractory
849118|NCT00080470|Urinary|urinary
849119|NCT00080470|Urge|urge
849120|NCT00080470|Stimulation|stimulation
849121|NCT00080470|Nerve|nerve
849122|NCT00080470|Microstimulator|microstimulator
849123|NCT00080470|Neuromodulation|neuromodulation
849124|NCT00080457|Primary or secondary pulmonary arterial hypertension|primary or secondary pulmonary arterial hypertension
849125|NCT00080457|Scleroderma|scleroderma
849126|NCT00080457|Connective tissue disease|connective tissue disease
849127|NCT00080457|Congenital heart defects|congenital heart defects
849128|NCT00080457|Lupus|lupus
849129|NCT00080457|Pulmonary Arterial Hypertension|pulmonary arterial hypertension
849130|NCT00023816|stage IV adult Hodgkin lymphoma|stage iv adult hodgkin lymphoma
849131|NCT00023816|recurrent adult Hodgkin lymphoma|recurrent adult hodgkin lymphoma
849132|NCT00023816|stage IV cutaneous T-cell non-Hodgkin lymphoma|stage iv cutaneous t-cell non-hodgkin lymphoma
849133|NCT00023816|recurrent cutaneous T-cell non-Hodgkin lymphoma|recurrent cutaneous t-cell non-hodgkin lymphoma
849134|NCT00023816|unspecified adult solid tumor, protocol specific|unspecified adult solid tumor, protocol specific
849135|NCT00023816|stage IV grade 1 follicular lymphoma|stage iv grade 1 follicular lymphoma
849136|NCT00023816|stage IV grade 2 follicular lymphoma|stage iv grade 2 follicular lymphoma
849137|NCT00023816|stage IV grade 3 follicular lymphoma|stage iv grade 3 follicular lymphoma
849138|NCT00023816|stage IV adult diffuse small cleaved cell lymphoma|stage iv adult diffuse small cleaved cell lymphoma
849139|NCT00023816|stage IV adult diffuse mixed cell lymphoma|stage iv adult diffuse mixed cell lymphoma
849140|NCT00023816|stage IV adult diffuse large cell lymphoma|stage iv adult diffuse large cell lymphoma
849141|NCT00023816|stage IV adult immunoblastic large cell lymphoma|stage iv adult immunoblastic large cell lymphoma
849142|NCT00023816|stage IV adult lymphoblastic lymphoma|stage iv adult lymphoblastic lymphoma
849143|NCT00023816|stage IV adult Burkitt lymphoma|stage iv adult burkitt lymphoma
849144|NCT00023816|recurrent grade 1 follicular lymphoma|recurrent grade 1 follicular lymphoma
849145|NCT00023816|recurrent grade 2 follicular lymphoma|recurrent grade 2 follicular lymphoma
849146|NCT00023816|recurrent grade 3 follicular lymphoma|recurrent grade 3 follicular lymphoma
849147|NCT00023816|recurrent adult diffuse small cleaved cell lymphoma|recurrent adult diffuse small cleaved cell lymphoma
849148|NCT00023816|recurrent adult diffuse mixed cell lymphoma|recurrent adult diffuse mixed cell lymphoma
849149|NCT00023816|recurrent adult diffuse large cell lymphoma|recurrent adult diffuse large cell lymphoma
849150|NCT00023816|recurrent adult immunoblastic large cell lymphoma|recurrent adult immunoblastic large cell lymphoma
849151|NCT00023816|recurrent adult lymphoblastic lymphoma|recurrent adult lymphoblastic lymphoma
849152|NCT00023816|recurrent adult Burkitt lymphoma|recurrent adult burkitt lymphoma
849153|NCT00023816|stage IV adult T-cell leukemia/lymphoma|stage iv adult t-cell leukemia/lymphoma
849154|NCT00023816|recurrent adult T-cell leukemia/lymphoma|recurrent adult t-cell leukemia/lymphoma
849155|NCT00023816|primary central nervous system non-Hodgkin lymphoma|primary central nervous system non-hodgkin lymphoma
849156|NCT00023816|AIDS-related peripheral/systemic lymphoma|aids-related peripheral/systemic lymphoma
849157|NCT00023816|AIDS-related primary CNS lymphoma|aids-related primary cns lymphoma
849158|NCT00023816|intraocular lymphoma|intraocular lymphoma
849159|NCT00023816|stage IV mantle cell lymphoma|stage iv mantle cell lymphoma
849160|NCT00023816|recurrent mantle cell lymphoma|recurrent mantle cell lymphoma
849161|NCT00023816|anaplastic large cell lymphoma|anaplastic large cell lymphoma
849162|NCT00023816|stage IV mycosis fungoides/Sezary syndrome|stage iv mycosis fungoides/sezary syndrome
849163|NCT00023816|recurrent mycosis fungoides/Sezary syndrome|recurrent mycosis fungoides/sezary syndrome
849164|NCT00023816|recurrent marginal zone lymphoma|recurrent marginal zone lymphoma
849165|NCT00023816|recurrent small lymphocytic lymphoma|recurrent small lymphocytic lymphoma
849166|NCT00023816|stage IV small lymphocytic lymphoma|stage iv small lymphocytic lymphoma
849167|NCT00023816|stage IV marginal zone lymphoma|stage iv marginal zone lymphoma
849168|NCT00023816|extranodal marginal zone B-cell lymphoma of mucosa-associated lymphoid tissue|extranodal marginal zone b-cell lymphoma of mucosa-associated lymphoid tissue
849169|NCT00023816|nodal marginal zone B-cell lymphoma|nodal marginal zone b-cell lymphoma
849170|NCT00023816|splenic marginal zone lymphoma|splenic marginal zone lymphoma
849171|NCT00022386|stage I breast cancer|stage i breast cancer
849172|NCT00022386|stage II breast cancer|stage ii breast cancer
849173|NCT00022386|stage IIIA breast cancer|stage iiia breast cancer
849174|NCT00022386|stage IIIB breast cancer|stage iiib breast cancer
849175|NCT00022386|anemia|anemia
849176|NCT00022386|fatigue|fatigue
849177|NCT00022256|adult glioblastoma|adult glioblastoma
849178|NCT00022256|adult giant cell glioblastoma|adult giant cell glioblastoma
849179|NCT00022256|adult gliosarcoma|adult gliosarcoma
849180|NCT00020605|unspecified adult solid tumor, protocol specific|unspecified adult solid tumor, protocol specific
849181|NCT00020605|constipation, impaction, and bowel obstruction|constipation, impaction, and bowel obstruction
849182|NCT00020540|stage IV renal cell cancer|stage iv renal cell cancer
849183|NCT00020540|recurrent renal cell cancer|recurrent renal cell cancer
849184|NCT00020540|stage IV melanoma|stage iv melanoma
849185|NCT00020540|recurrent melanoma|recurrent melanoma
849186|NCT00019071|adult glioblastoma|adult glioblastoma
849187|NCT00019071|adult anaplastic astrocytoma|adult anaplastic astrocytoma
849189|NCT00019071|adult gliosarcoma|adult gliosarcoma
849190|NCT00019058|adult glioblastoma|adult glioblastoma
849191|NCT00019058|adult giant cell glioblastoma|adult giant cell glioblastoma
849192|NCT00019058|adult gliosarcoma|adult gliosarcoma
849193|NCT00016042|stage IV colon cancer|stage iv colon cancer
849194|NCT00016042|stage IV rectal cancer|stage iv rectal cancer
849195|NCT00016042|recurrent colon cancer|recurrent colon cancer
849196|NCT00016042|recurrent rectal cancer|recurrent rectal cancer
849197|NCT00016042|stage IV renal cell cancer|stage iv renal cell cancer
849198|NCT00016042|recurrent renal cell cancer|recurrent renal cell cancer
849199|NCT00014573|childhood infratentorial ependymoma|childhood infratentorial ependymoma
849200|NCT00014573|childhood supratentorial ependymoma|childhood supratentorial ependymoma
849201|NCT00014573|childhood central nervous system germ cell tumor|childhood central nervous system germ cell tumor
849202|NCT00014573|recurrent adult brain tumor|recurrent adult brain tumor
849203|NCT00014573|adult brain stem glioma|adult brain stem glioma
849204|NCT00014573|adult medulloblastoma|adult medulloblastoma
849205|NCT00014573|adult glioblastoma|adult glioblastoma
849206|NCT00014573|childhood high-grade cerebral astrocytoma|childhood high-grade cerebral astrocytoma
849207|NCT00014573|adult anaplastic astrocytoma|adult anaplastic astrocytoma
849208|NCT00014573|childhood choroid plexus tumor|childhood choroid plexus tumor
849209|NCT00014573|childhood grade III meningioma|childhood grade iii meningioma
849210|NCT00014573|adult anaplastic ependymoma|adult anaplastic ependymoma
849211|NCT00014573|adult mixed glioma|adult mixed glioma
849212|NCT00014573|adult central nervous system germ cell tumor|adult central nervous system germ cell tumor
849213|NCT00014573|adult ependymoblastoma|adult ependymoblastoma
849214|NCT00014573|recurrent childhood brain stem glioma|recurrent childhood brain stem glioma
849215|NCT00014573|recurrent childhood supratentorial primitive neuroectodermal tumor|recurrent childhood supratentorial primitive neuroectodermal tumor
849216|NCT00014573|recurrent childhood cerebral astrocytoma|recurrent childhood cerebral astrocytoma
849217|NCT00014573|recurrent childhood medulloblastoma|recurrent childhood medulloblastoma
849218|NCT00014573|adult choroid plexus tumor|adult choroid plexus tumor
849219|NCT00014573|recurrent childhood ependymoma|recurrent childhood ependymoma
849220|NCT00014573|adult grade III meningioma|adult grade iii meningioma
849221|NCT00014573|adult giant cell glioblastoma|adult giant cell glioblastoma
849222|NCT00014573|adult gliosarcoma|adult gliosarcoma
849223|NCT00080418|neoplasm|neoplasm
849224|NCT00080418|cancer|cancer
849225|NCT00080418|NeoPharm|neopharm
849226|NCT00080418|liposomes|liposomes
849227|NCT00080418|Taxol|taxol
849228|NCT00080418|paclitaxel|paclitaxel
849229|NCT00080418|anti-cancer|anti-cancer
849230|NCT00080418|advanced neoplasm|advanced neoplasm
849231|NCT00080418|advanced cancer|advanced cancer
849232|NCT00080418|chemotherapy|chemotherapy
849233|NCT00080418|refractory cancer|refractory cancer
849234|NCT00080418|metastatic cancer|metastatic cancer
849235|NCT00080405|Relapsed|relapsed
849236|NCT00080405|Multiple Myeloma|multiple myeloma
849237|NCT00080405|Pharmacokinetic|pharmacokinetic
849238|NCT00080405|Pharmacodynamic|pharmacodynamic
849239|NCT00009841|untreated metastatic squamous neck cancer with occult primary|untreated metastatic squamous neck cancer with occult primary
849240|NCT00009841|recurrent metastatic squamous neck cancer with occult primary|recurrent metastatic squamous neck cancer with occult primary
849241|NCT00009841|metastatic squamous neck cancer with occult primary squamous cell carcinoma|metastatic squamous neck cancer with occult primary squamous cell carcinoma
849242|NCT00009841|stage IV squamous cell carcinoma of the lip and oral cavity|stage iv squamous cell carcinoma of the lip and oral cavity
849243|NCT00009841|recurrent squamous cell carcinoma of the lip and oral cavity|recurrent squamous cell carcinoma of the lip and oral cavity
849244|NCT00009841|stage IV squamous cell carcinoma of the oropharynx|stage iv squamous cell carcinoma of the oropharynx
849245|NCT00009841|recurrent squamous cell carcinoma of the oropharynx|recurrent squamous cell carcinoma of the oropharynx
849246|NCT00009841|stage IV squamous cell carcinoma of the nasopharynx|stage iv squamous cell carcinoma of the nasopharynx
849247|NCT00009841|recurrent squamous cell carcinoma of the nasopharynx|recurrent squamous cell carcinoma of the nasopharynx
849248|NCT00009841|stage IV squamous cell carcinoma of the hypopharynx|stage iv squamous cell carcinoma of the hypopharynx
849249|NCT00009841|recurrent squamous cell carcinoma of the hypopharynx|recurrent squamous cell carcinoma of the hypopharynx
849250|NCT00009841|stage IV squamous cell carcinoma of the larynx|stage iv squamous cell carcinoma of the larynx
849251|NCT00009841|recurrent squamous cell carcinoma of the larynx|recurrent squamous cell carcinoma of the larynx
849252|NCT00009841|stage IV squamous cell carcinoma of the paranasal sinus and nasal cavity|stage iv squamous cell carcinoma of the paranasal sinus and nasal cavity
849253|NCT00009841|recurrent squamous cell carcinoma of the paranasal sinus and nasal cavity|recurrent squamous cell carcinoma of the paranasal sinus and nasal cavity
849254|NCT00007813|recurrent childhood rhabdomyosarcoma|recurrent childhood rhabdomyosarcoma
849255|NCT00007813|childhood craniopharyngioma|childhood craniopharyngioma
849256|NCT00007813|recurrent childhood brain tumor|recurrent childhood brain tumor
849257|NCT00007813|disseminated neuroblastoma|disseminated neuroblastoma
849258|NCT00007813|stage 4S neuroblastoma|stage 4s neuroblastoma
849259|NCT00007813|recurrent neuroblastoma|recurrent neuroblastoma
849260|NCT00007813|stage IV childhood liver cancer|stage iv childhood liver cancer
849261|NCT00007813|recurrent childhood liver cancer|recurrent childhood liver cancer
849262|NCT00007813|childhood hepatoblastoma|childhood hepatoblastoma
849263|NCT00007813|childhood central nervous system germ cell tumor|childhood central nervous system germ cell tumor
849264|NCT00007813|stage III malignant testicular germ cell tumor|stage iii malignant testicular germ cell tumor
849265|NCT00007813|recurrent malignant testicular germ cell tumor|recurrent malignant testicular germ cell tumor
849266|NCT00007813|childhood germ cell tumor|childhood germ cell tumor
849267|NCT00007813|stage IV ovarian germ cell tumor|stage iv ovarian germ cell tumor
849268|NCT00007813|recurrent ovarian germ cell tumor|recurrent ovarian germ cell tumor
849269|NCT00007813|extragonadal germ cell tumor|extragonadal germ cell tumor
849270|NCT00007813|childhood oligodendroglioma|childhood oligodendroglioma
849271|NCT00007813|childhood choroid plexus tumor|childhood choroid plexus tumor
849272|NCT00007813|childhood grade III meningioma|childhood grade iii meningioma
849273|NCT00007813|recurrent childhood cerebellar astrocytoma|recurrent childhood cerebellar astrocytoma
849274|NCT00007813|recurrent childhood cerebral astrocytoma|recurrent childhood cerebral astrocytoma
849275|NCT00007813|recurrent childhood medulloblastoma|recurrent childhood medulloblastoma
849276|NCT00007813|recurrent childhood visual pathway and hypothalamic glioma|recurrent childhood visual pathway and hypothalamic glioma
849277|NCT00007813|previously treated childhood rhabdomyosarcoma|previously treated childhood rhabdomyosarcoma
849278|NCT00007813|metastatic Ewing sarcoma/peripheral primitive neuroectodermal tumor|metastatic ewing sarcoma/peripheral primitive neuroectodermal tumor
849279|NCT00007813|recurrent Ewing sarcoma/peripheral primitive neuroectodermal tumor|recurrent ewing sarcoma/peripheral primitive neuroectodermal tumor
849280|NCT00007813|recurrent childhood ependymoma|recurrent childhood ependymoma
849281|NCT00007813|childhood teratoma|childhood teratoma
849282|NCT00007813|childhood malignant testicular germ cell tumor|childhood malignant testicular germ cell tumor
849283|NCT00007813|childhood malignant ovarian germ cell tumor|childhood malignant ovarian germ cell tumor
849284|NCT00007813|childhood extragonadal germ cell tumor|childhood extragonadal germ cell tumor
849285|NCT00007813|recurrent childhood malignant germ cell tumor|recurrent childhood malignant germ cell tumor
849286|NCT00007813|childhood atypical teratoid/rhabdoid tumor|childhood atypical teratoid/rhabdoid tumor
849287|NCT00006487|limited stage small cell lung cancer|limited stage small cell lung cancer
849288|NCT00006458|recurrent non-small cell lung cancer|recurrent non-small cell lung cancer
849289|NCT00006458|squamous cell lung cancer|squamous cell lung cancer
849290|NCT00006458|large cell lung cancer|large cell lung cancer
849291|NCT00006458|adenocarcinoma of the lung|adenocarcinoma of the lung
849292|NCT00006458|adenosquamous cell lung cancer|adenosquamous cell lung cancer
849293|NCT00006376|stage II bladder cancer|stage ii bladder cancer
849294|NCT00006376|stage III bladder cancer|stage iii bladder cancer
849295|NCT00006376|recurrent bladder cancer|recurrent bladder cancer
849296|NCT00006376|stage IV bladder cancer|stage iv bladder cancer
849297|NCT00006376|transitional cell carcinoma of the bladder|transitional cell carcinoma of the bladder
849298|NCT00006376|metastatic transitional cell cancer of the renal pelvis and ureter|metastatic transitional cell cancer of the renal pelvis and ureter
849299|NCT00006376|regional transitional cell cancer of the renal pelvis and ureter|regional transitional cell cancer of the renal pelvis and ureter
849300|NCT00006376|recurrent transitional cell cancer of the renal pelvis and ureter|recurrent transitional cell cancer of the renal pelvis and ureter
849301|NCT00006371|adenocarcinoma of the prostate|adenocarcinoma of the prostate
849302|NCT00006371|stage IV prostate cancer|stage iv prostate cancer
849303|NCT00006371|recurrent prostate cancer|recurrent prostate cancer
849304|NCT00006370|stage IV breast cancer|stage iv breast cancer
849305|NCT00006370|recurrent breast cancer|recurrent breast cancer
849306|NCT00006370|recurrent small cell lung cancer|recurrent small cell lung cancer
849307|NCT00006370|male breast cancer|male breast cancer
849308|NCT00006369|stage IV breast cancer|stage iv breast cancer
849309|NCT00006369|recurrent breast cancer|recurrent breast cancer
849310|NCT00006368|stage IV adult Hodgkin lymphoma|stage iv adult hodgkin lymphoma
849311|NCT00006368|stage IV breast cancer|stage iv breast cancer
849312|NCT00006368|recurrent breast cancer|recurrent breast cancer
849313|NCT00006368|recurrent non-small cell lung cancer|recurrent non-small cell lung cancer
849314|NCT00006368|recurrent adult Hodgkin lymphoma|recurrent adult hodgkin lymphoma
849315|NCT00006368|extensive stage small cell lung cancer|extensive stage small cell lung cancer
849316|NCT00006368|recurrent small cell lung cancer|recurrent small cell lung cancer
849317|NCT00006368|metastatic gastrointestinal carcinoid tumor|metastatic gastrointestinal carcinoid tumor
849318|NCT00006368|recurrent gastrointestinal carcinoid tumor|recurrent gastrointestinal carcinoid tumor
849319|NCT00006368|gastrinoma|gastrinoma
849320|NCT00006368|recurrent adult brain tumor|recurrent adult brain tumor
849321|NCT00006368|insulinoma|insulinoma
849322|NCT00006368|recurrent islet cell carcinoma|recurrent islet cell carcinoma
849323|NCT00006368|ACTH-producing pituitary tumor|acth-producing pituitary tumor
849324|NCT00006368|prolactin-producing pituitary tumor|prolactin-producing pituitary tumor
849325|NCT00006368|growth hormone-producing pituitary tumor|growth hormone-producing pituitary tumor
849326|NCT00006368|recurrent pituitary tumor|recurrent pituitary tumor
849327|NCT00006368|TSH producing pituitary tumor|tsh producing pituitary tumor
849328|NCT00006368|nonfunctioning pituitary tumor|nonfunctioning pituitary tumor
849329|NCT00006368|adult brain stem glioma|adult brain stem glioma
849330|NCT00006368|adult craniopharyngioma|adult craniopharyngioma
849331|NCT00006368|adult medulloblastoma|adult medulloblastoma
863320|NCT00056927|Child|child
849332|NCT00006368|adult meningioma|adult meningioma
849333|NCT00006368|adult glioblastoma|adult glioblastoma
849334|NCT00006368|stage IV melanoma|stage iv melanoma
849335|NCT00006368|recurrent melanoma|recurrent melanoma
850715|NCT00079651|Nursing Homes|nursing homes
849336|NCT00006368|stage IV non-small cell lung cancer|stage iv non-small cell lung cancer
849337|NCT00006368|WDHA syndrome|wdha syndrome
849338|NCT00006368|somatostatinoma|somatostatinoma
849339|NCT00006368|pancreatic polypeptide tumor|pancreatic polypeptide tumor
849340|NCT00006368|glucagonoma|glucagonoma
849341|NCT00006368|pulmonary carcinoid tumor|pulmonary carcinoid tumor
849342|NCT00006368|stage IV grade 1 follicular lymphoma|stage iv grade 1 follicular lymphoma
849343|NCT00006368|stage IV grade 2 follicular lymphoma|stage iv grade 2 follicular lymphoma
849344|NCT00006368|stage IV grade 3 follicular lymphoma|stage iv grade 3 follicular lymphoma
849345|NCT00006368|stage IV adult diffuse small cleaved cell lymphoma|stage iv adult diffuse small cleaved cell lymphoma
849346|NCT00006368|stage IV adult diffuse mixed cell lymphoma|stage iv adult diffuse mixed cell lymphoma
849347|NCT00006368|stage IV adult diffuse large cell lymphoma|stage iv adult diffuse large cell lymphoma
849348|NCT00006368|stage IV adult immunoblastic large cell lymphoma|stage iv adult immunoblastic large cell lymphoma
849349|NCT00006368|stage IV adult lymphoblastic lymphoma|stage iv adult lymphoblastic lymphoma
849350|NCT00006368|stage IV adult Burkitt lymphoma|stage iv adult burkitt lymphoma
849351|NCT00006368|recurrent grade 1 follicular lymphoma|recurrent grade 1 follicular lymphoma
849352|NCT00006368|recurrent grade 2 follicular lymphoma|recurrent grade 2 follicular lymphoma
849353|NCT00006368|recurrent grade 3 follicular lymphoma|recurrent grade 3 follicular lymphoma
849354|NCT00006368|recurrent adult diffuse small cleaved cell lymphoma|recurrent adult diffuse small cleaved cell lymphoma
849355|NCT00006368|recurrent adult diffuse mixed cell lymphoma|recurrent adult diffuse mixed cell lymphoma
849356|NCT00006368|recurrent adult diffuse large cell lymphoma|recurrent adult diffuse large cell lymphoma
849357|NCT00006368|recurrent adult immunoblastic large cell lymphoma|recurrent adult immunoblastic large cell lymphoma
849358|NCT00006368|recurrent adult lymphoblastic lymphoma|recurrent adult lymphoblastic lymphoma
849359|NCT00006368|recurrent adult Burkitt lymphoma|recurrent adult burkitt lymphoma
849360|NCT00006368|adult anaplastic astrocytoma|adult anaplastic astrocytoma
849361|NCT00006368|adult myxopapillary ependymoma|adult myxopapillary ependymoma
849362|NCT00006368|adult anaplastic ependymoma|adult anaplastic ependymoma
849363|NCT00006368|adult anaplastic oligodendroglioma|adult anaplastic oligodendroglioma
849364|NCT00006368|adult central nervous system germ cell tumor|adult central nervous system germ cell tumor
849365|NCT00006368|adult pilocytic astrocytoma|adult pilocytic astrocytoma
849366|NCT00006368|adult subependymoma|adult subependymoma
849367|NCT00006368|adult ependymoblastoma|adult ependymoblastoma
849368|NCT00006368|adult pineocytoma|adult pineocytoma
849369|NCT00006368|adult pineoblastoma|adult pineoblastoma
849370|NCT00006368|adult meningeal hemangiopericytoma|adult meningeal hemangiopericytoma
849371|NCT00006368|stage IV mantle cell lymphoma|stage iv mantle cell lymphoma
849372|NCT00006368|recurrent mantle cell lymphoma|recurrent mantle cell lymphoma
849373|NCT00006368|adult choroid plexus tumor|adult choroid plexus tumor
849374|NCT00006368|recurrent marginal zone lymphoma|recurrent marginal zone lymphoma
849375|NCT00006368|recurrent small lymphocytic lymphoma|recurrent small lymphocytic lymphoma
849376|NCT00006368|stage IV small lymphocytic lymphoma|stage iv small lymphocytic lymphoma
849377|NCT00006368|stage IV marginal zone lymphoma|stage iv marginal zone lymphoma
849378|NCT00006368|extranodal marginal zone B-cell lymphoma of mucosa-associated lymphoid tissue|extranodal marginal zone b-cell lymphoma of mucosa-associated lymphoid tissue
849379|NCT00006368|nodal marginal zone B-cell lymphoma|nodal marginal zone b-cell lymphoma
849380|NCT00006368|splenic marginal zone lymphoma|splenic marginal zone lymphoma
849381|NCT00006368|adult grade III meningioma|adult grade iii meningioma
849382|NCT00006368|adult giant cell glioblastoma|adult giant cell glioblastoma
849383|NCT00006368|adult gliosarcoma|adult gliosarcoma
849384|NCT00006052|accelerated phase chronic myelogenous leukemia|accelerated phase chronic myelogenous leukemia
849385|NCT00006052|chronic myelogenous leukemia, BCR-ABL1 positive|chronic myelogenous leukemia, bcr-abl1 positive
849386|NCT00006052|Philadelphia chromosome negative chronic myelogenous leukemia|philadelphia chromosome negative chronic myelogenous leukemia
849387|NCT00006043|stage III malignant testicular germ cell tumor|stage iii malignant testicular germ cell tumor
849388|NCT00006043|recurrent malignant testicular germ cell tumor|recurrent malignant testicular germ cell tumor
849389|NCT00006043|stage IV ovarian germ cell tumor|stage iv ovarian germ cell tumor
849390|NCT00006043|recurrent ovarian germ cell tumor|recurrent ovarian germ cell tumor
849391|NCT00006032|stage IV breast cancer|stage iv breast cancer
849392|NCT00006032|recurrent breast cancer|recurrent breast cancer
849393|NCT00006031|biopsy|biopsy
849394|NCT00006031|radioactive seed|radioactive seed
849395|NCT00006031|nonpalpable lesions|nonpalpable lesions
849396|NCT00005948|relapsing chronic myelogenous leukemia|relapsing chronic myelogenous leukemia
849397|NCT00005948|chronic phase chronic myelogenous leukemia|chronic phase chronic myelogenous leukemia
849398|NCT00005948|accelerated phase chronic myelogenous leukemia|accelerated phase chronic myelogenous leukemia
849399|NCT00005860|stage IV colon cancer|stage iv colon cancer
849400|NCT00005860|stage IV gastric cancer|stage iv gastric cancer
849401|NCT00005860|recurrent gastric cancer|recurrent gastric cancer
849402|NCT00005860|recurrent pancreatic cancer|recurrent pancreatic cancer
863321|NCT00056927|Parents|parents
849403|NCT00005860|recurrent colon cancer|recurrent colon cancer
849404|NCT00005860|regional neuroblastoma|regional neuroblastoma
849405|NCT00005860|stage 4S neuroblastoma|stage 4s neuroblastoma
849406|NCT00005860|recurrent neuroblastoma|recurrent neuroblastoma
849407|NCT00005860|regional gastrointestinal carcinoid tumor|regional gastrointestinal carcinoid tumor
849408|NCT00005860|metastatic gastrointestinal carcinoid tumor|metastatic gastrointestinal carcinoid tumor
849409|NCT00005860|recurrent gastrointestinal carcinoid tumor|recurrent gastrointestinal carcinoid tumor
849410|NCT00005860|advanced adult primary liver cancer|advanced adult primary liver cancer
849411|NCT00005860|recurrent adult primary liver cancer|recurrent adult primary liver cancer
849412|NCT00005860|gastrinoma|gastrinoma
849413|NCT00005860|small intestine adenocarcinoma|small intestine adenocarcinoma
849414|NCT00005860|small intestine lymphoma|small intestine lymphoma
849415|NCT00005860|small intestine leiomyosarcoma|small intestine leiomyosarcoma
849416|NCT00005860|unresectable gallbladder cancer|unresectable gallbladder cancer
849417|NCT00005860|recurrent gallbladder cancer|recurrent gallbladder cancer
849418|NCT00005860|unresectable extrahepatic bile duct cancer|unresectable extrahepatic bile duct cancer
849419|NCT00005860|recurrent extrahepatic bile duct cancer|recurrent extrahepatic bile duct cancer
849420|NCT00005860|recurrent small intestine cancer|recurrent small intestine cancer
849421|NCT00005860|insulinoma|insulinoma
849422|NCT00005860|recurrent islet cell carcinoma|recurrent islet cell carcinoma
849423|NCT00005860|WDHA syndrome|wdha syndrome
849424|NCT00005860|somatostatinoma|somatostatinoma
849425|NCT00005860|pancreatic polypeptide tumor|pancreatic polypeptide tumor
849426|NCT00005860|glucagonoma|glucagonoma
849427|NCT00005860|regional pheochromocytoma|regional pheochromocytoma
849428|NCT00005860|metastatic pheochromocytoma|metastatic pheochromocytoma
849429|NCT00005860|recurrent pheochromocytoma|recurrent pheochromocytoma
849430|NCT00005860|extragonadal germ cell tumor|extragonadal germ cell tumor
849431|NCT00005860|liver metastases|liver metastases
849432|NCT00005860|malignant ascites|malignant ascites
849433|NCT00005860|newly diagnosed carcinoma of unknown primary|newly diagnosed carcinoma of unknown primary
849434|NCT00005860|carcinoma of the appendix|carcinoma of the appendix
849435|NCT00005860|pseudomyxoma peritonei|pseudomyxoma peritonei
849436|NCT00005860|fallopian tube cancer|fallopian tube cancer
849437|NCT00005860|primary peritoneal cavity cancer|primary peritoneal cavity cancer
849438|NCT00005860|recurrent carcinoma of unknown primary|recurrent carcinoma of unknown primary
849439|NCT00005860|gastrointestinal stromal tumor|gastrointestinal stromal tumor
849440|NCT00005860|stage IV pancreatic cancer|stage iv pancreatic cancer
849441|NCT00005798|stage II breast cancer|stage ii breast cancer
849442|NCT00005798|stage IV breast cancer|stage iv breast cancer
849443|NCT00005798|stage IIIA breast cancer|stage iiia breast cancer
849444|NCT00005798|recurrent breast cancer|recurrent breast cancer
849445|NCT00005798|stage IIIB breast cancer|stage iiib breast cancer
849446|NCT00005798|inflammatory breast cancer|inflammatory breast cancer
849447|NCT00005628|recurrent adult soft tissue sarcoma|recurrent adult soft tissue sarcoma
849448|NCT00005628|stage IV adult soft tissue sarcoma|stage iv adult soft tissue sarcoma
849449|NCT00005618|relapsing chronic myelogenous leukemia|relapsing chronic myelogenous leukemia
849450|NCT00005618|chronic phase chronic myelogenous leukemia|chronic phase chronic myelogenous leukemia
849451|NCT00005618|accelerated phase chronic myelogenous leukemia|accelerated phase chronic myelogenous leukemia
849452|NCT00005618|blastic phase chronic myelogenous leukemia|blastic phase chronic myelogenous leukemia
849453|NCT00005615|stage III melanoma|stage iii melanoma
849454|NCT00005615|recurrent melanoma|recurrent melanoma
849455|NCT00005577|unspecified childhood solid tumor, protocol specific|unspecified childhood solid tumor, protocol specific
849456|NCT00005097|squamous cell carcinoma of the skin|squamous cell carcinoma of the skin
849457|NCT00005068|unspecified adult solid tumor, protocol specific|unspecified adult solid tumor, protocol specific
849458|NCT00003864|stage III esophageal cancer|stage iii esophageal cancer
849459|NCT00003864|stage IV esophageal cancer|stage iv esophageal cancer
849460|NCT00003864|squamous cell carcinoma of the esophagus|squamous cell carcinoma of the esophagus
849461|NCT00080431|Reservoir|reservoir
849462|NCT00080431|Viral Load|viral load
849463|NCT00080431|Immunosuppression|immunosuppression
849464|NCT00080431|Activation|activation
849465|NCT00080431|Latency|latency
849467|NCT00080431|HAART|haart
849468|NCT00080431|Immunosuppressive Drug|immunosuppressive drug
849469|NCT00080431|Viral Reservoirs|viral reservoirs
849470|NCT00005031|recurrent endometrial carcinoma|recurrent endometrial carcinoma
849471|NCT00004248|localized unresectable adult primary liver cancer|localized unresectable adult primary liver cancer
849472|NCT00004248|recurrent adult primary liver cancer|recurrent adult primary liver cancer
849473|NCT00004248|adult primary hepatocellular carcinoma|adult primary hepatocellular carcinoma
849474|NCT00004097|stage III nasopharyngeal cancer|stage iii nasopharyngeal cancer
849475|NCT00004097|stage IV nasopharyngeal cancer|stage iv nasopharyngeal cancer
849476|NCT00004097|recurrent nasopharyngeal cancer|recurrent nasopharyngeal cancer
849477|NCT00004097|untreated metastatic squamous neck cancer with occult primary|untreated metastatic squamous neck cancer with occult primary
849478|NCT00004097|recurrent metastatic squamous neck cancer with occult primary|recurrent metastatic squamous neck cancer with occult primary
849479|NCT00004097|stage III lip and oral cavity cancer|stage iii lip and oral cavity cancer
849480|NCT00004097|stage IV lip and oral cavity cancer|stage iv lip and oral cavity cancer
877056|NCT00001906|Phase I|phase i
849481|NCT00004097|recurrent lip and oral cavity cancer|recurrent lip and oral cavity cancer
849482|NCT00004097|stage III hypopharyngeal cancer|stage iii hypopharyngeal cancer
849483|NCT00004097|stage IV hypopharyngeal cancer|stage iv hypopharyngeal cancer
849484|NCT00004097|recurrent hypopharyngeal cancer|recurrent hypopharyngeal cancer
849485|NCT00004097|stage III laryngeal cancer|stage iii laryngeal cancer
849486|NCT00004097|stage IV laryngeal cancer|stage iv laryngeal cancer
849487|NCT00004097|recurrent laryngeal cancer|recurrent laryngeal cancer
849488|NCT00004097|stage III paranasal sinus and nasal cavity cancer|stage iii paranasal sinus and nasal cavity cancer
849489|NCT00004097|stage IV paranasal sinus and nasal cavity cancer|stage iv paranasal sinus and nasal cavity cancer
849490|NCT00004097|recurrent paranasal sinus and nasal cavity cancer|recurrent paranasal sinus and nasal cavity cancer
849491|NCT00004097|stage III oropharyngeal cancer|stage iii oropharyngeal cancer
849492|NCT00004097|stage IV oropharyngeal cancer|stage iv oropharyngeal cancer
849493|NCT00004097|recurrent oropharyngeal cancer|recurrent oropharyngeal cancer
849494|NCT00003967|recurrent ovarian epithelial cancer|recurrent ovarian epithelial cancer
849495|NCT00003967|ovarian undifferentiated adenocarcinoma|ovarian undifferentiated adenocarcinoma
849496|NCT00003967|ovarian mixed epithelial carcinoma|ovarian mixed epithelial carcinoma
849497|NCT00003967|ovarian serous cystadenocarcinoma|ovarian serous cystadenocarcinoma
849498|NCT00003967|ovarian mucinous cystadenocarcinoma|ovarian mucinous cystadenocarcinoma
849499|NCT00003967|ovarian endometrioid adenocarcinoma|ovarian endometrioid adenocarcinoma
849500|NCT00003967|ovarian clear cell cystadenocarcinoma|ovarian clear cell cystadenocarcinoma
849501|NCT00003967|fallopian tube cancer|fallopian tube cancer
849502|NCT00003967|primary peritoneal cavity cancer|primary peritoneal cavity cancer
849503|NCT00003967|Brenner tumor|brenner tumor
849504|NCT00003883|stage IV breast cancer|stage iv breast cancer
849505|NCT00003883|stage IIIA breast cancer|stage iiia breast cancer
849506|NCT00003883|stage IIIB breast cancer|stage iiib breast cancer
849507|NCT00003883|recurrent childhood acute lymphoblastic leukemia|recurrent childhood acute lymphoblastic leukemia
849508|NCT00003883|recurrent adult Hodgkin lymphoma|recurrent adult hodgkin lymphoma
849509|NCT00003883|recurrent cutaneous T-cell non-Hodgkin lymphoma|recurrent cutaneous t-cell non-hodgkin lymphoma
849510|NCT00003883|refractory multiple myeloma|refractory multiple myeloma
849511|NCT00003883|recurrent childhood rhabdomyosarcoma|recurrent childhood rhabdomyosarcoma
849512|NCT00003883|stage II ovarian epithelial cancer|stage ii ovarian epithelial cancer
849513|NCT00003883|stage III ovarian epithelial cancer|stage iii ovarian epithelial cancer
849514|NCT00003883|stage IV ovarian epithelial cancer|stage iv ovarian epithelial cancer
849515|NCT00003883|recurrent ovarian epithelial cancer|recurrent ovarian epithelial cancer
849516|NCT00003883|disseminated neuroblastoma|disseminated neuroblastoma
849517|NCT00003883|recurrent neuroblastoma|recurrent neuroblastoma
849518|NCT00003883|recurrent Wilms tumor and other childhood kidney tumors|recurrent wilms tumor and other childhood kidney tumors
849519|NCT00003883|stage I multiple myeloma|stage i multiple myeloma
849520|NCT00003883|stage II multiple myeloma|stage ii multiple myeloma
849521|NCT00003883|stage III multiple myeloma|stage iii multiple myeloma
849522|NCT00003883|recurrent childhood lymphoblastic lymphoma|recurrent childhood lymphoblastic lymphoma
849523|NCT00003883|stage III chronic lymphocytic leukemia|stage iii chronic lymphocytic leukemia
849524|NCT00003883|stage IV chronic lymphocytic leukemia|stage iv chronic lymphocytic leukemia
849525|NCT00003883|recurrent childhood acute myeloid leukemia|recurrent childhood acute myeloid leukemia
849526|NCT00003883|recurrent adult acute myeloid leukemia|recurrent adult acute myeloid leukemia
849527|NCT00003883|recurrent adult acute lymphoblastic leukemia|recurrent adult acute lymphoblastic leukemia
849528|NCT00003883|relapsing chronic myelogenous leukemia|relapsing chronic myelogenous leukemia
849529|NCT00003883|refractory chronic lymphocytic leukemia|refractory chronic lymphocytic leukemia
849530|NCT00003883|stage III malignant testicular germ cell tumor|stage iii malignant testicular germ cell tumor
849531|NCT00003883|recurrent malignant testicular germ cell tumor|recurrent malignant testicular germ cell tumor
849532|NCT00003883|chronic phase chronic myelogenous leukemia|chronic phase chronic myelogenous leukemia
849533|NCT00003883|accelerated phase chronic myelogenous leukemia|accelerated phase chronic myelogenous leukemia
849534|NCT00003883|blastic phase chronic myelogenous leukemia|blastic phase chronic myelogenous leukemia
849535|NCT00003883|meningeal chronic myelogenous leukemia|meningeal chronic myelogenous leukemia
849536|NCT00003883|chronic idiopathic myelofibrosis|chronic idiopathic myelofibrosis
849537|NCT00003883|childhood acute promyelocytic leukemia (M3)|childhood acute promyelocytic leukemia (m3)
849538|NCT00003883|testicular embryonal carcinoma|testicular embryonal carcinoma
851596|NCT00078715|Depression|depression
849539|NCT00003883|testicular choriocarcinoma|testicular choriocarcinoma
849540|NCT00003883|testicular teratoma|testicular teratoma
849541|NCT00003883|testicular yolk sac tumor|testicular yolk sac tumor
849542|NCT00003883|testicular embryonal carcinoma and teratoma|testicular embryonal carcinoma and teratoma
849543|NCT00003883|testicular embryonal carcinoma and teratoma with seminoma|testicular embryonal carcinoma and teratoma with seminoma
849544|NCT00003883|testicular embryonal carcinoma and yolk sac tumor|testicular embryonal carcinoma and yolk sac tumor
849545|NCT00003883|testicular embryonal carcinoma and yolk sac tumor with seminoma|testicular embryonal carcinoma and yolk sac tumor with seminoma
849546|NCT00003883|testicular embryonal carcinoma and seminoma|testicular embryonal carcinoma and seminoma
850572|NCT00005834|stage III multiple myeloma|stage iii multiple myeloma
850574|NCT00005635|recurrent breast cancer|recurrent breast cancer
849547|NCT00003883|testicular yolk sac tumor and teratoma|testicular yolk sac tumor and teratoma
849548|NCT00003883|testicular yolk sac tumor and teratoma with seminoma|testicular yolk sac tumor and teratoma with seminoma
849549|NCT00003883|testicular choriocarcinoma and yolk sac tumor|testicular choriocarcinoma and yolk sac tumor
849550|NCT00003883|testicular choriocarcinoma and embryonal carcinoma|testicular choriocarcinoma and embryonal carcinoma
849551|NCT00003883|testicular choriocarcinoma and teratoma|testicular choriocarcinoma and teratoma
849552|NCT00003883|testicular choriocarcinoma and seminoma|testicular choriocarcinoma and seminoma
849553|NCT00003883|refractory hairy cell leukemia|refractory hairy cell leukemia
849554|NCT00003883|recurrent/refractory childhood Hodgkin lymphoma|recurrent/refractory childhood hodgkin lymphoma
849555|NCT00003883|recurrent ovarian germ cell tumor|recurrent ovarian germ cell tumor
849556|NCT00003883|ovarian yolk sac tumor|ovarian yolk sac tumor
849557|NCT00003883|ovarian embryonal carcinoma|ovarian embryonal carcinoma
849558|NCT00003883|ovarian polyembryoma|ovarian polyembryoma
849559|NCT00003883|ovarian choriocarcinoma|ovarian choriocarcinoma
849560|NCT00003883|ovarian immature teratoma|ovarian immature teratoma
849561|NCT00003883|ovarian mature teratoma|ovarian mature teratoma
849562|NCT00003883|ovarian monodermal and highly specialized teratoma|ovarian monodermal and highly specialized teratoma
849563|NCT00003883|ovarian mixed germ cell tumor|ovarian mixed germ cell tumor
849564|NCT00003883|stage III grade 1 follicular lymphoma|stage iii grade 1 follicular lymphoma
849565|NCT00003883|stage III grade 2 follicular lymphoma|stage iii grade 2 follicular lymphoma
849566|NCT00003883|stage III grade 3 follicular lymphoma|stage iii grade 3 follicular lymphoma
849567|NCT00003883|stage III adult diffuse small cleaved cell lymphoma|stage iii adult diffuse small cleaved cell lymphoma
849568|NCT00003883|stage III adult diffuse mixed cell lymphoma|stage iii adult diffuse mixed cell lymphoma
849569|NCT00003883|stage III adult diffuse large cell lymphoma|stage iii adult diffuse large cell lymphoma
849570|NCT00003883|stage III adult immunoblastic large cell lymphoma|stage iii adult immunoblastic large cell lymphoma
849571|NCT00003883|stage III adult lymphoblastic lymphoma|stage iii adult lymphoblastic lymphoma
849572|NCT00003883|stage III adult Burkitt lymphoma|stage iii adult burkitt lymphoma
849573|NCT00003883|stage IV grade 1 follicular lymphoma|stage iv grade 1 follicular lymphoma
849574|NCT00003883|stage IV grade 2 follicular lymphoma|stage iv grade 2 follicular lymphoma
849575|NCT00003883|stage IV grade 3 follicular lymphoma|stage iv grade 3 follicular lymphoma
849576|NCT00003883|stage IV adult diffuse small cleaved cell lymphoma|stage iv adult diffuse small cleaved cell lymphoma
849577|NCT00003883|stage IV adult diffuse mixed cell lymphoma|stage iv adult diffuse mixed cell lymphoma
849578|NCT00003883|stage IV adult diffuse large cell lymphoma|stage iv adult diffuse large cell lymphoma
849579|NCT00003883|stage IV adult immunoblastic large cell lymphoma|stage iv adult immunoblastic large cell lymphoma
849580|NCT00003883|stage IV adult lymphoblastic lymphoma|stage iv adult lymphoblastic lymphoma
849581|NCT00003883|stage IV adult Burkitt lymphoma|stage iv adult burkitt lymphoma
849582|NCT00003883|recurrent grade 1 follicular lymphoma|recurrent grade 1 follicular lymphoma
849583|NCT00003883|recurrent grade 2 follicular lymphoma|recurrent grade 2 follicular lymphoma
849584|NCT00003883|recurrent grade 3 follicular lymphoma|recurrent grade 3 follicular lymphoma
849585|NCT00003883|recurrent adult diffuse small cleaved cell lymphoma|recurrent adult diffuse small cleaved cell lymphoma
849586|NCT00003883|recurrent adult diffuse mixed cell lymphoma|recurrent adult diffuse mixed cell lymphoma
849587|NCT00003883|recurrent adult diffuse large cell lymphoma|recurrent adult diffuse large cell lymphoma
849588|NCT00003883|recurrent adult immunoblastic large cell lymphoma|recurrent adult immunoblastic large cell lymphoma
849589|NCT00003883|recurrent adult lymphoblastic lymphoma|recurrent adult lymphoblastic lymphoma
849590|NCT00003883|recurrent adult Burkitt lymphoma|recurrent adult burkitt lymphoma
849591|NCT00003883|secondary acute myeloid leukemia|secondary acute myeloid leukemia
849592|NCT00003883|de novo myelodysplastic syndromes|de novo myelodysplastic syndromes
849593|NCT00003883|poor prognosis metastatic gestational trophoblastic tumor|poor prognosis metastatic gestational trophoblastic tumor
849594|NCT00003883|previously treated myelodysplastic syndromes|previously treated myelodysplastic syndromes
849595|NCT00003883|secondary myelodysplastic syndromes|secondary myelodysplastic syndromes
849596|NCT00003883|infection|infection
849597|NCT00003883|recurrent childhood small noncleaved cell lymphoma|recurrent childhood small noncleaved cell lymphoma
849598|NCT00003883|recurrent childhood large cell lymphoma|recurrent childhood large cell lymphoma
849599|NCT00003883|noncontiguous stage II grade 1 follicular lymphoma|noncontiguous stage ii grade 1 follicular lymphoma
849600|NCT00003883|noncontiguous stage II grade 2 follicular lymphoma|noncontiguous stage ii grade 2 follicular lymphoma
849601|NCT00003883|noncontiguous stage II grade 3 follicular lymphoma|noncontiguous stage ii grade 3 follicular lymphoma
849602|NCT00003883|noncontiguous stage II adult diffuse small cleaved cell lymphoma|noncontiguous stage ii adult diffuse small cleaved cell lymphoma
849603|NCT00003883|noncontiguous stage II mantle cell lymphoma|noncontiguous stage ii mantle cell lymphoma
849604|NCT00003883|noncontiguous stage II adult diffuse mixed cell lymphoma|noncontiguous stage ii adult diffuse mixed cell lymphoma
849605|NCT00003883|noncontiguous stage II adult immunoblastic large cell lymphoma|noncontiguous stage ii adult immunoblastic large cell lymphoma
849606|NCT00003883|noncontiguous stage II adult diffuse large cell lymphoma|noncontiguous stage ii adult diffuse large cell lymphoma
849607|NCT00003883|noncontiguous stage II adult Burkitt lymphoma|noncontiguous stage ii adult burkitt lymphoma
849608|NCT00003883|noncontiguous stage II adult lymphoblastic lymphoma|noncontiguous stage ii adult lymphoblastic lymphoma
849609|NCT00003883|stage III mantle cell lymphoma|stage iii mantle cell lymphoma
849610|NCT00003883|stage IV mantle cell lymphoma|stage iv mantle cell lymphoma
849611|NCT00003883|recurrent mantle cell lymphoma|recurrent mantle cell lymphoma
849612|NCT00003883|previously treated childhood rhabdomyosarcoma|previously treated childhood rhabdomyosarcoma
849613|NCT00003883|recurrent mycosis fungoides/Sezary syndrome|recurrent mycosis fungoides/sezary syndrome
849614|NCT00003883|noncontiguous stage II small lymphocytic lymphoma|noncontiguous stage ii small lymphocytic lymphoma
849615|NCT00003883|noncontiguous stage II marginal zone lymphoma|noncontiguous stage ii marginal zone lymphoma
849616|NCT00003883|recurrent marginal zone lymphoma|recurrent marginal zone lymphoma
849617|NCT00003883|recurrent small lymphocytic lymphoma|recurrent small lymphocytic lymphoma
849618|NCT00003883|stage III small lymphocytic lymphoma|stage iii small lymphocytic lymphoma
849619|NCT00003883|stage III marginal zone lymphoma|stage iii marginal zone lymphoma
849620|NCT00003883|stage IV small lymphocytic lymphoma|stage iv small lymphocytic lymphoma
849621|NCT00003883|stage IV marginal zone lymphoma|stage iv marginal zone lymphoma
849622|NCT00003883|extranodal marginal zone B-cell lymphoma of mucosa-associated lymphoid tissue|extranodal marginal zone b-cell lymphoma of mucosa-associated lymphoid tissue
849623|NCT00003883|nodal marginal zone B-cell lymphoma|nodal marginal zone b-cell lymphoma
849624|NCT00003883|splenic marginal zone lymphoma|splenic marginal zone lymphoma
849625|NCT00003883|childhood myelodysplastic syndromes|childhood myelodysplastic syndromes
849626|NCT00003769|stage II pancreatic cancer|stage ii pancreatic cancer
849627|NCT00003769|stage III pancreatic cancer|stage iii pancreatic cancer
849628|NCT00003769|adenocarcinoma of the pancreas|adenocarcinoma of the pancreas
849629|NCT00003657|metastatic osteosarcoma|metastatic osteosarcoma
849630|NCT00003657|recurrent non-small cell lung cancer|recurrent non-small cell lung cancer
849631|NCT00003657|chondrosarcoma|chondrosarcoma
849632|NCT00003657|stage III adult soft tissue sarcoma|stage iii adult soft tissue sarcoma
849633|NCT00003657|recurrent adult soft tissue sarcoma|recurrent adult soft tissue sarcoma
849634|NCT00003657|stage III ovarian epithelial cancer|stage iii ovarian epithelial cancer
849635|NCT00003657|stage IV ovarian epithelial cancer|stage iv ovarian epithelial cancer
849636|NCT00003657|recurrent ovarian epithelial cancer|recurrent ovarian epithelial cancer
849637|NCT00003657|extensive stage small cell lung cancer|extensive stage small cell lung cancer
849638|NCT00003657|recurrent small cell lung cancer|recurrent small cell lung cancer
849639|NCT00003657|recurrent osteosarcoma|recurrent osteosarcoma
849640|NCT00003657|stage III bladder cancer|stage iii bladder cancer
849641|NCT00003657|recurrent bladder cancer|recurrent bladder cancer
849642|NCT00003657|stage IV bladder cancer|stage iv bladder cancer
849643|NCT00003657|stage III malignant testicular germ cell tumor|stage iii malignant testicular germ cell tumor
849644|NCT00003657|recurrent malignant testicular germ cell tumor|recurrent malignant testicular germ cell tumor
849645|NCT00003657|stage IIIB non-small cell lung cancer|stage iiib non-small cell lung cancer
849646|NCT00003657|unspecified adult solid tumor, protocol specific|unspecified adult solid tumor, protocol specific
849647|NCT00003657|classic Kaposi sarcoma|classic kaposi sarcoma
849648|NCT00003657|immunosuppressive treatment related Kaposi sarcoma|immunosuppressive treatment related kaposi sarcoma
849649|NCT00003657|AIDS-related Kaposi sarcoma|aids-related kaposi sarcoma
849650|NCT00003657|recurrent Kaposi sarcoma|recurrent kaposi sarcoma
849651|NCT00003657|untreated metastatic squamous neck cancer with occult primary|untreated metastatic squamous neck cancer with occult primary
849652|NCT00003657|recurrent metastatic squamous neck cancer with occult primary|recurrent metastatic squamous neck cancer with occult primary
849653|NCT00003657|ovarian stromal cancer|ovarian stromal cancer
849654|NCT00003657|stage III ovarian germ cell tumor|stage iii ovarian germ cell tumor
849655|NCT00003657|stage IV ovarian germ cell tumor|stage iv ovarian germ cell tumor
849656|NCT00003657|recurrent ovarian germ cell tumor|recurrent ovarian germ cell tumor
849657|NCT00003657|stage III squamous cell carcinoma of the lip and oral cavity|stage iii squamous cell carcinoma of the lip and oral cavity
849658|NCT00003657|stage III basal cell carcinoma of the lip|stage iii basal cell carcinoma of the lip
849659|NCT00003657|stage III verrucous carcinoma of the oral cavity|stage iii verrucous carcinoma of the oral cavity
849660|NCT00003657|stage III mucoepidermoid carcinoma of the oral cavity|stage iii mucoepidermoid carcinoma of the oral cavity
849661|NCT00003657|stage III adenoid cystic carcinoma of the oral cavity|stage iii adenoid cystic carcinoma of the oral cavity
849662|NCT00003657|stage IV squamous cell carcinoma of the lip and oral cavity|stage iv squamous cell carcinoma of the lip and oral cavity
849663|NCT00003657|stage IV basal cell carcinoma of the lip|stage iv basal cell carcinoma of the lip
849664|NCT00003657|stage IV verrucous carcinoma of the oral cavity|stage iv verrucous carcinoma of the oral cavity
849665|NCT00003657|stage IV mucoepidermoid carcinoma of the oral cavity|stage iv mucoepidermoid carcinoma of the oral cavity
849666|NCT00003657|stage IV adenoid cystic carcinoma of the oral cavity|stage iv adenoid cystic carcinoma of the oral cavity
849667|NCT00003657|recurrent squamous cell carcinoma of the lip and oral cavity|recurrent squamous cell carcinoma of the lip and oral cavity
849668|NCT00003657|recurrent basal cell carcinoma of the lip|recurrent basal cell carcinoma of the lip
849669|NCT00003657|recurrent verrucous carcinoma of the oral cavity|recurrent verrucous carcinoma of the oral cavity
849670|NCT00003657|recurrent mucoepidermoid carcinoma of the oral cavity|recurrent mucoepidermoid carcinoma of the oral cavity
849671|NCT00003657|recurrent adenoid cystic carcinoma of the oral cavity|recurrent adenoid cystic carcinoma of the oral cavity
849672|NCT00003657|stage III squamous cell carcinoma of the oropharynx|stage iii squamous cell carcinoma of the oropharynx
849673|NCT00003657|stage III lymphoepithelioma of the oropharynx|stage iii lymphoepithelioma of the oropharynx
849674|NCT00003657|stage IV squamous cell carcinoma of the oropharynx|stage iv squamous cell carcinoma of the oropharynx
849675|NCT00003657|stage IV lymphoepithelioma of the oropharynx|stage iv lymphoepithelioma of the oropharynx
849676|NCT00003657|recurrent squamous cell carcinoma of the oropharynx|recurrent squamous cell carcinoma of the oropharynx
849677|NCT00003657|recurrent lymphoepithelioma of the oropharynx|recurrent lymphoepithelioma of the oropharynx
849678|NCT00003657|stage III squamous cell carcinoma of the nasopharynx|stage iii squamous cell carcinoma of the nasopharynx
849679|NCT00003657|stage III lymphoepithelioma of the nasopharynx|stage iii lymphoepithelioma of the nasopharynx
849680|NCT00003657|stage IV squamous cell carcinoma of the nasopharynx|stage iv squamous cell carcinoma of the nasopharynx
849681|NCT00003657|stage IV lymphoepithelioma of the nasopharynx|stage iv lymphoepithelioma of the nasopharynx
849682|NCT00003657|recurrent squamous cell carcinoma of the nasopharynx|recurrent squamous cell carcinoma of the nasopharynx
849683|NCT00003657|recurrent lymphoepithelioma of the nasopharynx|recurrent lymphoepithelioma of the nasopharynx
849684|NCT00003657|stage III squamous cell carcinoma of the hypopharynx|stage iii squamous cell carcinoma of the hypopharynx
849685|NCT00003657|stage IV squamous cell carcinoma of the hypopharynx|stage iv squamous cell carcinoma of the hypopharynx
849686|NCT00003657|recurrent squamous cell carcinoma of the hypopharynx|recurrent squamous cell carcinoma of the hypopharynx
849687|NCT00003657|stage III squamous cell carcinoma of the larynx|stage iii squamous cell carcinoma of the larynx
849688|NCT00003657|stage III verrucous carcinoma of the larynx|stage iii verrucous carcinoma of the larynx
849689|NCT00003657|stage IV squamous cell carcinoma of the larynx|stage iv squamous cell carcinoma of the larynx
849690|NCT00003657|stage IV verrucous carcinoma of the larynx|stage iv verrucous carcinoma of the larynx
849691|NCT00003657|recurrent squamous cell carcinoma of the larynx|recurrent squamous cell carcinoma of the larynx
849692|NCT00003657|recurrent verrucous carcinoma of the larynx|recurrent verrucous carcinoma of the larynx
849693|NCT00003657|stage III squamous cell carcinoma of the paranasal sinus and nasal cavity|stage iii squamous cell carcinoma of the paranasal sinus and nasal cavity
849694|NCT00003657|stage III inverted papilloma of the paranasal sinus and nasal cavity|stage iii inverted papilloma of the paranasal sinus and nasal cavity
849695|NCT00003657|stage III midline lethal granuloma of the paranasal sinus and nasal cavity|stage iii midline lethal granuloma of the paranasal sinus and nasal cavity
849696|NCT00003657|stage III esthesioneuroblastoma of the paranasal sinus and nasal cavity|stage iii esthesioneuroblastoma of the paranasal sinus and nasal cavity
849697|NCT00003657|stage IV squamous cell carcinoma of the paranasal sinus and nasal cavity|stage iv squamous cell carcinoma of the paranasal sinus and nasal cavity
849698|NCT00003657|stage IV inverted papilloma of the paranasal sinus and nasal cavity|stage iv inverted papilloma of the paranasal sinus and nasal cavity
849699|NCT00003657|stage IV midline lethal granuloma of the paranasal sinus and nasal cavity|stage iv midline lethal granuloma of the paranasal sinus and nasal cavity
849700|NCT00003657|stage IV esthesioneuroblastoma of the paranasal sinus and nasal cavity|stage iv esthesioneuroblastoma of the paranasal sinus and nasal cavity
849701|NCT00003657|recurrent squamous cell carcinoma of the paranasal sinus and nasal cavity|recurrent squamous cell carcinoma of the paranasal sinus and nasal cavity
849702|NCT00003657|recurrent inverted papilloma of the paranasal sinus and nasal cavity|recurrent inverted papilloma of the paranasal sinus and nasal cavity
849703|NCT00003657|recurrent midline lethal granuloma of the paranasal sinus and nasal cavity|recurrent midline lethal granuloma of the paranasal sinus and nasal cavity
849704|NCT00003657|recurrent esthesioneuroblastoma of the paranasal sinus and nasal cavity|recurrent esthesioneuroblastoma of the paranasal sinus and nasal cavity
849705|NCT00003657|extragonadal germ cell tumor|extragonadal germ cell tumor
849706|NCT00003657|newly diagnosed carcinoma of unknown primary|newly diagnosed carcinoma of unknown primary
849707|NCT00003657|stage III uterine sarcoma|stage iii uterine sarcoma
849708|NCT00003657|stage IV uterine sarcoma|stage iv uterine sarcoma
849709|NCT00003657|recurrent uterine sarcoma|recurrent uterine sarcoma
849710|NCT00003657|borderline ovarian surface epithelial-stromal tumor|borderline ovarian surface epithelial-stromal tumor
849711|NCT00003657|recurrent carcinoma of unknown primary|recurrent carcinoma of unknown primary
849712|NCT00003657|ovarian sarcoma|ovarian sarcoma
849713|NCT00003657|adult central nervous system germ cell tumor|adult central nervous system germ cell tumor
849714|NCT00003657|metastatic Ewing sarcoma/peripheral primitive neuroectodermal tumor|metastatic ewing sarcoma/peripheral primitive neuroectodermal tumor
849715|NCT00003657|recurrent Ewing sarcoma/peripheral primitive neuroectodermal tumor|recurrent ewing sarcoma/peripheral primitive neuroectodermal tumor
849716|NCT00003657|clear cell sarcoma of the kidney|clear cell sarcoma of the kidney
849717|NCT00003657|stage IV adult soft tissue sarcoma|stage iv adult soft tissue sarcoma
849718|NCT00003635|refractory chronic lymphocytic leukemia|refractory chronic lymphocytic leukemia
849719|NCT00003635|T-cell large granular lymphocyte leukemia|t-cell large granular lymphocyte leukemia
849720|NCT00003635|B-cell chronic lymphocytic leukemia|b-cell chronic lymphocytic leukemia
849721|NCT00003412|stage IV breast cancer|stage iv breast cancer
849722|NCT00003412|recurrent breast cancer|recurrent breast cancer
849723|NCT00003402|Waldenstrom macroglobulinemia|waldenstrom macroglobulinemia
849724|NCT00003402|stage III chronic lymphocytic leukemia|stage iii chronic lymphocytic leukemia
849725|NCT00003402|stage IV chronic lymphocytic leukemia|stage iv chronic lymphocytic leukemia
849726|NCT00003402|refractory chronic lymphocytic leukemia|refractory chronic lymphocytic leukemia
849727|NCT00003402|stage III grade 1 follicular lymphoma|stage iii grade 1 follicular lymphoma
849728|NCT00003402|stage III grade 2 follicular lymphoma|stage iii grade 2 follicular lymphoma
849729|NCT00003402|stage IV grade 1 follicular lymphoma|stage iv grade 1 follicular lymphoma
850573|NCT00005635|stage IV breast cancer|stage iv breast cancer
849730|NCT00003402|stage IV grade 2 follicular lymphoma|stage iv grade 2 follicular lymphoma
849731|NCT00003402|recurrent grade 1 follicular lymphoma|recurrent grade 1 follicular lymphoma
849732|NCT00003402|recurrent grade 2 follicular lymphoma|recurrent grade 2 follicular lymphoma
849733|NCT00003402|stage III mantle cell lymphoma|stage iii mantle cell lymphoma
849734|NCT00003402|stage IV mantle cell lymphoma|stage iv mantle cell lymphoma
849735|NCT00003402|recurrent mantle cell lymphoma|recurrent mantle cell lymphoma
849736|NCT00080392|Gene Transfer|gene transfer
849737|NCT00080392|Therapeutic Angiogenesis|therapeutic angiogenesis
849738|NCT00080392|Peripheral Arterial Disease|peripheral arterial disease
849739|NCT00080392|Perfusion|perfusion
849740|NCT00080392|Magnetic Resonance Imaging|magnetic resonance imaging
849741|NCT00080392|Peripheral Vascular Disease|peripheral vascular disease
849742|NCT00080392|Claudication|claudication
849744|NCT00080392|Leg Claudication|leg claudication
849745|NCT00080392|Intermittent Claudication|intermittent claudication
849746|NCT00080314|Bipolar 1 Disorder, depressed|bipolar 1 disorder, depressed
849747|NCT00080301|Metastatic Breast Cancer|metastatic breast cancer
849748|NCT00003345|stage I ovarian epithelial cancer|stage i ovarian epithelial cancer
849749|NCT00003345|stage II ovarian epithelial cancer|stage ii ovarian epithelial cancer
849750|NCT00003345|stage III ovarian epithelial cancer|stage iii ovarian epithelial cancer
849751|NCT00003345|stage IV ovarian epithelial cancer|stage iv ovarian epithelial cancer
849752|NCT00003345|recurrent ovarian epithelial cancer|recurrent ovarian epithelial cancer
849753|NCT00003345|fallopian tube cancer|fallopian tube cancer
849754|NCT00003345|primary peritoneal cavity cancer|primary peritoneal cavity cancer
849755|NCT00003192|stage III gastric cancer|stage iii gastric cancer
849756|NCT00003192|stage IV gastric cancer|stage iv gastric cancer
849757|NCT00003192|recurrent gastric cancer|recurrent gastric cancer
849758|NCT00003192|stage III esophageal cancer|stage iii esophageal cancer
849759|NCT00003192|stage IV esophageal cancer|stage iv esophageal cancer
849760|NCT00003192|recurrent esophageal cancer|recurrent esophageal cancer
849761|NCT00003192|adenocarcinoma of the stomach|adenocarcinoma of the stomach
849762|NCT00003157|stage IV gastric cancer|stage iv gastric cancer
849763|NCT00003157|recurrent gastric cancer|recurrent gastric cancer
849764|NCT00003157|recurrent pancreatic cancer|recurrent pancreatic cancer
849765|NCT00003157|stage IV pancreatic cancer|stage iv pancreatic cancer
849766|NCT00003149|stage I multiple myeloma|stage i multiple myeloma
849767|NCT00003149|stage II multiple myeloma|stage ii multiple myeloma
849768|NCT00003149|stage III multiple myeloma|stage iii multiple myeloma
849769|NCT00002974|recurrent adult soft tissue sarcoma|recurrent adult soft tissue sarcoma
849770|NCT00002974|stage IV adult soft tissue sarcoma|stage iv adult soft tissue sarcoma
849771|NCT00080366|Essential Tremor|essential tremor
849772|NCT00080366|Cross over Design|cross over design
849773|NCT00080366|Accelerometry|accelerometry
849774|NCT00080366|Placebo|placebo
849775|NCT00080366|Alcohol Responsive|alcohol responsive
849776|NCT00080366|Double Blind|double blind
849777|NCT00080366|1-Octanol|1-octanol
849778|NCT00080353|Complete Tumor Regression|complete tumor regression
849779|NCT00080353|Cell Survival|cell survival
849780|NCT00080353|Chemotherapy Preparative Regimen|chemotherapy preparative regimen
849781|NCT00080353|IL-2|il-2
849782|NCT00080353|Toxicity|toxicity
849783|NCT00080353|Metastatic Melanoma|metastatic melanoma
849784|NCT00080288|Excessive Sleepiness|excessive sleepiness
849785|NCT00080288|Chronic Shift Work Sleep Disorder|chronic shift work sleep disorder
849786|NCT00080288|Chronic SWSD|chronic swsd
849787|NCT00080288|Circadian Rhythm Disorder|circadian rhythm disorder
849788|NCT00080288|Shift Worker|shift worker
849789|NCT00080288|Cephalon|cephalon
849790|NCT00080288|Cephalon, Inc|cephalon, inc
849791|NCT00080288|Nuvigil|nuvigil
849792|NCT00080275|Niacin|niacin
849793|NCT00080275|Statin|statin
849794|NCT00080275|Zocor|zocor
849795|NCT00080275|Simvastatin|simvastatin
849796|NCT00080275|Coronary Heart Disease|coronary heart disease
849797|NCT00080275|Dyslipidemia|dyslipidemia
849798|NCT00080275|Atherosclerosis|atherosclerosis
849799|NCT00080275|Hypercholesterolemia|hypercholesterolemia
849800|NCT00080275|Stroke|stroke
849801|NCT00080275|High-Density Lipoprotein Cholesterol|high-density lipoprotein cholesterol
849802|NCT00080275|Low-Density Lipoprotein Cholesterol|low-density lipoprotein cholesterol
849803|NCT00080275|Lipoprotein|lipoprotein
849804|NCT00080275|Lipid|lipid
849805|NCT00080275|Niacin ER/simvastatin|niacin er/simvastatin
849806|NCT00080275|Total Cholesterol|total cholesterol
849807|NCT00080275|Triglycerides|triglycerides
849808|NCT00080262|Metastatic Breast Cancer|metastatic breast cancer
849809|NCT00080236|Liver Transplantation|liver transplantation
849810|NCT00080223|pulmonary fibrosis|pulmonary fibrosis
849811|NCT00080223|respiratory diseases|respiratory diseases
849812|NCT00080158|Dysthymic Disorder|dysthymic disorder
849813|NCT00080158|Adolescent|adolescent
849814|NCT00012142|stage IV prostate cancer|stage iv prostate cancer
849815|NCT00002950|unspecified adult solid tumor, protocol specific|unspecified adult solid tumor, protocol specific
849816|NCT00002947|stage IV renal cell cancer|stage iv renal cell cancer
849817|NCT00002947|recurrent renal cell cancer|recurrent renal cell cancer
850575|NCT00005085|stage IV colon cancer|stage iv colon cancer
849818|NCT00002947|extensive stage small cell lung cancer|extensive stage small cell lung cancer
849819|NCT00002947|recurrent small cell lung cancer|recurrent small cell lung cancer
849820|NCT00002947|metastatic gastrointestinal carcinoid tumor|metastatic gastrointestinal carcinoid tumor
849821|NCT00002947|recurrent gastrointestinal carcinoid tumor|recurrent gastrointestinal carcinoid tumor
849822|NCT00002947|gastrinoma|gastrinoma
849823|NCT00002947|insulinoma|insulinoma
849824|NCT00002947|recurrent islet cell carcinoma|recurrent islet cell carcinoma
849825|NCT00002947|thyroid gland medullary carcinoma|thyroid gland medullary carcinoma
849826|NCT00002947|prolactin-producing pituitary tumor|prolactin-producing pituitary tumor
849827|NCT00002947|iris melanoma|iris melanoma
849828|NCT00002947|ciliary body and choroid melanoma, medium/large size|ciliary body and choroid melanoma, medium/large size
849829|NCT00002947|extraocular extension melanoma|extraocular extension melanoma
849830|NCT00002947|recurrent intraocular melanoma|recurrent intraocular melanoma
849831|NCT00002947|stage IV melanoma|stage iv melanoma
849832|NCT00002947|recurrent melanoma|recurrent melanoma
849833|NCT00002947|WDHA syndrome|wdha syndrome
849834|NCT00002947|somatostatinoma|somatostatinoma
849835|NCT00002947|pancreatic polypeptide tumor|pancreatic polypeptide tumor
849836|NCT00002947|glucagonoma|glucagonoma
849837|NCT00002947|childhood Langerhans cell histiocytosis|childhood langerhans cell histiocytosis
849838|NCT00002947|metastatic pheochromocytoma|metastatic pheochromocytoma
849839|NCT00002947|recurrent pheochromocytoma|recurrent pheochromocytoma
849840|NCT00002947|pulmonary carcinoid tumor|pulmonary carcinoid tumor
849841|NCT00002947|stage IV esthesioneuroblastoma of the paranasal sinus and nasal cavity|stage iv esthesioneuroblastoma of the paranasal sinus and nasal cavity
849842|NCT00002947|recurrent esthesioneuroblastoma of the paranasal sinus and nasal cavity|recurrent esthesioneuroblastoma of the paranasal sinus and nasal cavity
849843|NCT00002947|stage III neuroendocrine carcinoma of the skin|stage iii neuroendocrine carcinoma of the skin
849844|NCT00002947|recurrent neuroendocrine carcinoma of the skin|recurrent neuroendocrine carcinoma of the skin
849845|NCT00002887|recurrent non-small cell lung cancer|recurrent non-small cell lung cancer
849846|NCT00002759|stage III adult Hodgkin lymphoma|stage iii adult hodgkin lymphoma
849847|NCT00002759|stage IV adult Hodgkin lymphoma|stage iv adult hodgkin lymphoma
849848|NCT00002759|recurrent adult Hodgkin lymphoma|recurrent adult hodgkin lymphoma
849849|NCT00002759|stage III cutaneous T-cell non-Hodgkin lymphoma|stage iii cutaneous t-cell non-hodgkin lymphoma
849850|NCT00002759|stage IV cutaneous T-cell non-Hodgkin lymphoma|stage iv cutaneous t-cell non-hodgkin lymphoma
849851|NCT00002759|recurrent cutaneous T-cell non-Hodgkin lymphoma|recurrent cutaneous t-cell non-hodgkin lymphoma
849852|NCT00002759|small intestine lymphoma|small intestine lymphoma
849853|NCT00002759|unspecified adult solid tumor, protocol specific|unspecified adult solid tumor, protocol specific
849854|NCT00002759|stage III grade 1 follicular lymphoma|stage iii grade 1 follicular lymphoma
849855|NCT00002759|stage III grade 2 follicular lymphoma|stage iii grade 2 follicular lymphoma
849856|NCT00002759|stage III grade 3 follicular lymphoma|stage iii grade 3 follicular lymphoma
849857|NCT00002759|stage III adult diffuse small cleaved cell lymphoma|stage iii adult diffuse small cleaved cell lymphoma
849858|NCT00002759|stage III adult diffuse mixed cell lymphoma|stage iii adult diffuse mixed cell lymphoma
849859|NCT00002759|stage III adult diffuse large cell lymphoma|stage iii adult diffuse large cell lymphoma
849860|NCT00002759|stage III adult immunoblastic large cell lymphoma|stage iii adult immunoblastic large cell lymphoma
849861|NCT00002759|stage III adult lymphoblastic lymphoma|stage iii adult lymphoblastic lymphoma
849862|NCT00002759|stage III adult Burkitt lymphoma|stage iii adult burkitt lymphoma
849863|NCT00002759|stage IV grade 1 follicular lymphoma|stage iv grade 1 follicular lymphoma
849864|NCT00002759|stage IV grade 2 follicular lymphoma|stage iv grade 2 follicular lymphoma
849865|NCT00002759|stage IV grade 3 follicular lymphoma|stage iv grade 3 follicular lymphoma
849866|NCT00002759|stage IV adult diffuse small cleaved cell lymphoma|stage iv adult diffuse small cleaved cell lymphoma
849867|NCT00002759|stage IV adult diffuse mixed cell lymphoma|stage iv adult diffuse mixed cell lymphoma
849868|NCT00002759|stage IV adult diffuse large cell lymphoma|stage iv adult diffuse large cell lymphoma
849869|NCT00002759|stage IV adult immunoblastic large cell lymphoma|stage iv adult immunoblastic large cell lymphoma
849870|NCT00002759|stage IV adult lymphoblastic lymphoma|stage iv adult lymphoblastic lymphoma
849871|NCT00002759|stage IV adult Burkitt lymphoma|stage iv adult burkitt lymphoma
849872|NCT00002759|recurrent grade 1 follicular lymphoma|recurrent grade 1 follicular lymphoma
849873|NCT00002759|recurrent grade 2 follicular lymphoma|recurrent grade 2 follicular lymphoma
849874|NCT00002759|recurrent grade 3 follicular lymphoma|recurrent grade 3 follicular lymphoma
849875|NCT00002759|recurrent adult diffuse small cleaved cell lymphoma|recurrent adult diffuse small cleaved cell lymphoma
849876|NCT00002759|recurrent adult diffuse mixed cell lymphoma|recurrent adult diffuse mixed cell lymphoma
849877|NCT00002759|recurrent adult diffuse large cell lymphoma|recurrent adult diffuse large cell lymphoma
849878|NCT00002759|recurrent adult immunoblastic large cell lymphoma|recurrent adult immunoblastic large cell lymphoma
849879|NCT00002759|recurrent adult lymphoblastic lymphoma|recurrent adult lymphoblastic lymphoma
849880|NCT00002759|recurrent adult Burkitt lymphoma|recurrent adult burkitt lymphoma
849881|NCT00002759|stage III adult T-cell leukemia/lymphoma|stage iii adult t-cell leukemia/lymphoma
849882|NCT00002759|stage IV adult T-cell leukemia/lymphoma|stage iv adult t-cell leukemia/lymphoma
849883|NCT00002759|recurrent adult T-cell leukemia/lymphoma|recurrent adult t-cell leukemia/lymphoma
849957|NCT00008151|refractory anemia with excess blasts|refractory anemia with excess blasts
849884|NCT00002759|primary central nervous system non-Hodgkin lymphoma|primary central nervous system non-hodgkin lymphoma
849885|NCT00002759|drug/agent toxicity by tissue/organ|drug/agent toxicity by tissue/organ
849886|NCT00002759|neutropenia|neutropenia
849887|NCT00002759|AIDS-related peripheral/systemic lymphoma|aids-related peripheral/systemic lymphoma
849888|NCT00002759|AIDS-related primary CNS lymphoma|aids-related primary cns lymphoma
849889|NCT00002759|intraocular lymphoma|intraocular lymphoma
849890|NCT00002759|stage III mantle cell lymphoma|stage iii mantle cell lymphoma
849891|NCT00002759|stage IV mantle cell lymphoma|stage iv mantle cell lymphoma
849892|NCT00002759|recurrent mantle cell lymphoma|recurrent mantle cell lymphoma
849893|NCT00002759|angioimmunoblastic T-cell lymphoma|angioimmunoblastic t-cell lymphoma
849894|NCT00002759|anaplastic large cell lymphoma|anaplastic large cell lymphoma
849895|NCT00002759|stage III mycosis fungoides/Sezary syndrome|stage iii mycosis fungoides/sezary syndrome
849896|NCT00002759|stage IV mycosis fungoides/Sezary syndrome|stage iv mycosis fungoides/sezary syndrome
849897|NCT00002759|recurrent mycosis fungoides/Sezary syndrome|recurrent mycosis fungoides/sezary syndrome
849898|NCT00002759|recurrent marginal zone lymphoma|recurrent marginal zone lymphoma
849899|NCT00002759|recurrent small lymphocytic lymphoma|recurrent small lymphocytic lymphoma
849900|NCT00002759|stage III small lymphocytic lymphoma|stage iii small lymphocytic lymphoma
849901|NCT00002759|stage III marginal zone lymphoma|stage iii marginal zone lymphoma
849902|NCT00002759|stage IV small lymphocytic lymphoma|stage iv small lymphocytic lymphoma
849903|NCT00002759|stage IV marginal zone lymphoma|stage iv marginal zone lymphoma
849904|NCT00002759|extranodal marginal zone B-cell lymphoma of mucosa-associated lymphoid tissue|extranodal marginal zone b-cell lymphoma of mucosa-associated lymphoid tissue
849905|NCT00002759|nodal marginal zone B-cell lymphoma|nodal marginal zone b-cell lymphoma
849906|NCT00002759|splenic marginal zone lymphoma|splenic marginal zone lymphoma
849907|NCT00002592|relapsing chronic myelogenous leukemia|relapsing chronic myelogenous leukemia
849908|NCT00002592|chronic phase chronic myelogenous leukemia|chronic phase chronic myelogenous leukemia
849909|NCT00002592|accelerated phase chronic myelogenous leukemia|accelerated phase chronic myelogenous leukemia
849910|NCT00002536|stage IB cervical cancer|stage ib cervical cancer
849911|NCT00002461|recurrent adult Hodgkin lymphoma|recurrent adult hodgkin lymphoma
849912|NCT00002461|adult lymphocyte predominant Hodgkin lymphoma|adult lymphocyte predominant hodgkin lymphoma
849913|NCT00002461|adult lymphocyte depletion Hodgkin lymphoma|adult lymphocyte depletion hodgkin lymphoma
849914|NCT00002461|adult nodular sclerosis Hodgkin lymphoma|adult nodular sclerosis hodgkin lymphoma
849915|NCT00002461|adult mixed cellularity Hodgkin lymphoma|adult mixed cellularity hodgkin lymphoma
849916|NCT00002461|recurrent grade 1 follicular lymphoma|recurrent grade 1 follicular lymphoma
849917|NCT00002461|recurrent grade 2 follicular lymphoma|recurrent grade 2 follicular lymphoma
849918|NCT00002461|recurrent grade 3 follicular lymphoma|recurrent grade 3 follicular lymphoma
849919|NCT00002461|recurrent adult diffuse small cleaved cell lymphoma|recurrent adult diffuse small cleaved cell lymphoma
849920|NCT00002461|recurrent adult diffuse mixed cell lymphoma|recurrent adult diffuse mixed cell lymphoma
849921|NCT00002461|recurrent adult diffuse large cell lymphoma|recurrent adult diffuse large cell lymphoma
849922|NCT00002461|recurrent adult immunoblastic large cell lymphoma|recurrent adult immunoblastic large cell lymphoma
849923|NCT00002461|recurrent adult lymphoblastic lymphoma|recurrent adult lymphoblastic lymphoma
851597|NCT00078715|Mood Disorder|mood disorder
849924|NCT00002461|recurrent adult Burkitt lymphoma|recurrent adult burkitt lymphoma
849925|NCT00002461|recurrent mantle cell lymphoma|recurrent mantle cell lymphoma
849926|NCT00002461|recurrent small lymphocytic lymphoma|recurrent small lymphocytic lymphoma
849927|NCT00080210|elevated uric acid|elevated uric acid
849928|NCT00080210|Elevated serum uric acid level|elevated serum uric acid level
849929|NCT00080210|Symptomatic gout|symptomatic gout
849930|NCT00080197|Breast Cancer|breast cancer
849931|NCT00080197|Cancer of the Breast|cancer of the breast
849932|NCT00080184|Fibromyalgia|fibromyalgia
849933|NCT00080184|Electroencephalograph (EEG) biofeedback|electroencephalograph (eeg) biofeedback
849934|NCT00080184|Electromagnetic stimulation|electromagnetic stimulation
849935|NCT00080184|Neurofeedback|neurofeedback
849936|NCT00080184|Neurotherapy|neurotherapy
849937|NCT00080184|Complementary and Alternative Medicine|complementary and alternative medicine
849938|NCT00080171|Osteoarthritis|osteoarthritis
849939|NCT00080171|Knee Pain|knee pain
849940|NCT00080171|Knee Health|knee health
849941|NCT00080145|Autistic Disorder|autistic disorder
849942|NCT00080145|Asperger Syndrome|asperger syndrome
849943|NCT00080132|HTG|htg
849944|NCT00080132|Hypertriglyceridemia, Fredrickson Type I|hypertriglyceridemia, fredrickson type i
849945|NCT00080132|Hypertriglyceridemia, Fredrickson Type V|hypertriglyceridemia, fredrickson type v
849946|NCT00080119|Treatment Naive|treatment naive
849947|NCT00080119|INH Prophylaxis|inh prophylaxis
849948|NCT00080119|HIV Seronegativity|hiv seronegativity
849949|NCT00080106|HIV Therapeutic Vaccine|hiv therapeutic vaccine
849950|NCT00080106|Treatment Experienced|treatment experienced
849951|NCT00080106|Treatment Interruption|treatment interruption
849952|NCT00080106|Adenovirus Vector|adenovirus vector
849953|NCT00008320|stage IV breast cancer|stage iv breast cancer
849954|NCT00008320|recurrent breast cancer|recurrent breast cancer
849955|NCT00008151|recurrent childhood acute myeloid leukemia|recurrent childhood acute myeloid leukemia
849956|NCT00008151|recurrent adult acute myeloid leukemia|recurrent adult acute myeloid leukemia
849958|NCT00008151|refractory anemia with excess blasts in transformation|refractory anemia with excess blasts in transformation
849959|NCT00008151|de novo myelodysplastic syndromes|de novo myelodysplastic syndromes
849960|NCT00008151|previously treated myelodysplastic syndromes|previously treated myelodysplastic syndromes
849961|NCT00008151|secondary myelodysplastic syndromes|secondary myelodysplastic syndromes
849962|NCT00008151|childhood myelodysplastic syndromes|childhood myelodysplastic syndromes
849963|NCT00006348|stage IV adult Hodgkin lymphoma|stage iv adult hodgkin lymphoma
849964|NCT00006348|monoclonal gammopathy of undetermined significance|monoclonal gammopathy of undetermined significance
849965|NCT00006348|recurrent childhood acute lymphoblastic leukemia|recurrent childhood acute lymphoblastic leukemia
849966|NCT00006348|recurrent adult Hodgkin lymphoma|recurrent adult hodgkin lymphoma
849967|NCT00006348|stage IV cutaneous T-cell non-Hodgkin lymphoma|stage iv cutaneous t-cell non-hodgkin lymphoma
849968|NCT00006348|recurrent cutaneous T-cell non-Hodgkin lymphoma|recurrent cutaneous t-cell non-hodgkin lymphoma
849969|NCT00006348|isolated plasmacytoma of bone|isolated plasmacytoma of bone
849970|NCT00006348|extramedullary plasmacytoma|extramedullary plasmacytoma
849971|NCT00006348|refractory multiple myeloma|refractory multiple myeloma
849972|NCT00006348|Waldenström macroglobulinemia|waldenström macroglobulinemia
849973|NCT00006348|stage III multiple myeloma|stage iii multiple myeloma
849974|NCT00006348|stage IV childhood lymphoblastic lymphoma|stage iv childhood lymphoblastic lymphoma
849975|NCT00006348|recurrent childhood lymphoblastic lymphoma|recurrent childhood lymphoblastic lymphoma
849976|NCT00006348|stage IV chronic lymphocytic leukemia|stage iv chronic lymphocytic leukemia
849977|NCT00006348|recurrent childhood acute myeloid leukemia|recurrent childhood acute myeloid leukemia
849978|NCT00006348|recurrent adult acute myeloid leukemia|recurrent adult acute myeloid leukemia
849979|NCT00006348|recurrent adult acute lymphoblastic leukemia|recurrent adult acute lymphoblastic leukemia
849980|NCT00006348|relapsing chronic myelogenous leukemia|relapsing chronic myelogenous leukemia
849981|NCT00006348|refractory chronic lymphocytic leukemia|refractory chronic lymphocytic leukemia
849982|NCT00006348|small intestine lymphoma|small intestine lymphoma
849983|NCT00006348|unspecified childhood solid tumor, protocol specific|unspecified childhood solid tumor, protocol specific
849984|NCT00006348|unspecified adult solid tumor, protocol specific|unspecified adult solid tumor, protocol specific
849985|NCT00006348|chronic phase chronic myelogenous leukemia|chronic phase chronic myelogenous leukemia
849986|NCT00006348|accelerated phase chronic myelogenous leukemia|accelerated phase chronic myelogenous leukemia
849987|NCT00006348|blastic phase chronic myelogenous leukemia|blastic phase chronic myelogenous leukemia
849988|NCT00006348|meningeal chronic myelogenous leukemia|meningeal chronic myelogenous leukemia
849989|NCT00006348|untreated adult acute lymphoblastic leukemia|untreated adult acute lymphoblastic leukemia
849990|NCT00006348|untreated adult acute myeloid leukemia|untreated adult acute myeloid leukemia
849991|NCT00006348|untreated childhood acute myeloid leukemia and other myeloid malignancies|untreated childhood acute myeloid leukemia and other myeloid malignancies
849992|NCT00006348|untreated childhood acute lymphoblastic leukemia|untreated childhood acute lymphoblastic leukemia
849993|NCT00006348|polycythemia vera|polycythemia vera
849994|NCT00006348|primary myelofibrosis|primary myelofibrosis
849995|NCT00006348|essential thrombocythemia|essential thrombocythemia
849996|NCT00006348|untreated hairy cell leukemia|untreated hairy cell leukemia
849997|NCT00006348|progressive hairy cell leukemia, initial treatment|progressive hairy cell leukemia, initial treatment
849998|NCT00006348|refractory hairy cell leukemia|refractory hairy cell leukemia
849999|NCT00006348|stage IV childhood Hodgkin lymphoma|stage iv childhood hodgkin lymphoma
850000|NCT00006348|recurrent/refractory childhood Hodgkin lymphoma|recurrent/refractory childhood hodgkin lymphoma
850001|NCT00006348|chronic myelomonocytic leukemia|chronic myelomonocytic leukemia
850002|NCT00006348|T-cell large granular lymphocyte leukemia|t-cell large granular lymphocyte leukemia
850003|NCT00006348|acute undifferentiated leukemia|acute undifferentiated leukemia
850004|NCT00006348|stage IV grade 1 follicular lymphoma|stage iv grade 1 follicular lymphoma
850005|NCT00006348|stage IV grade 2 follicular lymphoma|stage iv grade 2 follicular lymphoma
850006|NCT00006348|stage IV grade 3 follicular lymphoma|stage iv grade 3 follicular lymphoma
850007|NCT00006348|stage IV adult diffuse small cleaved cell lymphoma|stage iv adult diffuse small cleaved cell lymphoma
850008|NCT00006348|stage IV adult diffuse mixed cell lymphoma|stage iv adult diffuse mixed cell lymphoma
850009|NCT00006348|stage IV adult diffuse large cell lymphoma|stage iv adult diffuse large cell lymphoma
850010|NCT00006348|stage IV adult immunoblastic large cell lymphoma|stage iv adult immunoblastic large cell lymphoma
850011|NCT00006348|stage IV adult lymphoblastic lymphoma|stage iv adult lymphoblastic lymphoma
850012|NCT00006348|stage IV adult Burkitt lymphoma|stage iv adult burkitt lymphoma
850013|NCT00006348|recurrent grade 1 follicular lymphoma|recurrent grade 1 follicular lymphoma
850014|NCT00006348|recurrent grade 2 follicular lymphoma|recurrent grade 2 follicular lymphoma
850015|NCT00006348|recurrent grade 3 follicular lymphoma|recurrent grade 3 follicular lymphoma
850016|NCT00006348|recurrent adult diffuse small cleaved cell lymphoma|recurrent adult diffuse small cleaved cell lymphoma
850017|NCT00006348|recurrent adult diffuse mixed cell lymphoma|recurrent adult diffuse mixed cell lymphoma
850018|NCT00006348|recurrent adult diffuse large cell lymphoma|recurrent adult diffuse large cell lymphoma
850019|NCT00006348|recurrent adult immunoblastic large cell lymphoma|recurrent adult immunoblastic large cell lymphoma
850020|NCT00006348|recurrent adult lymphoblastic lymphoma|recurrent adult lymphoblastic lymphoma
850021|NCT00006348|recurrent adult Burkitt lymphoma|recurrent adult burkitt lymphoma
850022|NCT00006348|stage IV adult T-cell leukemia/lymphoma|stage iv adult t-cell leukemia/lymphoma
851598|NCT00078715|Fast|fast
850023|NCT00006348|recurrent adult T-cell leukemia/lymphoma|recurrent adult t-cell leukemia/lymphoma
850024|NCT00006348|secondary acute myeloid leukemia|secondary acute myeloid leukemia
850025|NCT00006348|de novo myelodysplastic syndromes|de novo myelodysplastic syndromes
850026|NCT00006348|previously treated myelodysplastic syndromes|previously treated myelodysplastic syndromes
850027|NCT00006348|secondary myelodysplastic syndromes|secondary myelodysplastic syndromes
850028|NCT00006348|primary central nervous system non-Hodgkin lymphoma|primary central nervous system non-hodgkin lymphoma
850029|NCT00006348|nausea and vomiting|nausea and vomiting
850030|NCT00006348|prolymphocytic leukemia|prolymphocytic leukemia
850031|NCT00006348|AIDS-related peripheral/systemic lymphoma|aids-related peripheral/systemic lymphoma
850032|NCT00006348|AIDS-related primary CNS lymphoma|aids-related primary cns lymphoma
850033|NCT00006348|primary systemic amyloidosis|primary systemic amyloidosis
850034|NCT00006348|intraocular lymphoma|intraocular lymphoma
850035|NCT00006348|stage IV childhood small noncleaved cell lymphoma|stage iv childhood small noncleaved cell lymphoma
850036|NCT00006348|stage IV childhood large cell lymphoma|stage iv childhood large cell lymphoma
850037|NCT00006348|recurrent childhood small noncleaved cell lymphoma|recurrent childhood small noncleaved cell lymphoma
850038|NCT00006348|recurrent childhood large cell lymphoma|recurrent childhood large cell lymphoma
850039|NCT00006348|stage IV mantle cell lymphoma|stage iv mantle cell lymphoma
850040|NCT00006348|recurrent mantle cell lymphoma|recurrent mantle cell lymphoma
850041|NCT00006348|angioimmunoblastic T-cell lymphoma|angioimmunoblastic t-cell lymphoma
850042|NCT00006348|anaplastic large cell lymphoma|anaplastic large cell lymphoma
850043|NCT00006348|stage IV mycosis fungoides/Sezary syndrome|stage iv mycosis fungoides/sezary syndrome
850044|NCT00006348|recurrent mycosis fungoides/Sezary syndrome|recurrent mycosis fungoides/sezary syndrome
850045|NCT00006348|recurrent marginal zone lymphoma|recurrent marginal zone lymphoma
850046|NCT00006348|recurrent small lymphocytic lymphoma|recurrent small lymphocytic lymphoma
850047|NCT00006348|stage IV small lymphocytic lymphoma|stage iv small lymphocytic lymphoma
850048|NCT00006348|stage IV marginal zone lymphoma|stage iv marginal zone lymphoma
850049|NCT00006348|extranodal marginal zone B-cell lymphoma of mucosa-associated lymphoid tissue|extranodal marginal zone b-cell lymphoma of mucosa-associated lymphoid tissue
850050|NCT00006348|nodal marginal zone B-cell lymphoma|nodal marginal zone b-cell lymphoma
850051|NCT00006348|splenic marginal zone lymphoma|splenic marginal zone lymphoma
850052|NCT00006348|childhood myelodysplastic syndromes|childhood myelodysplastic syndromes
850053|NCT00006345|recurrent cutaneous T-cell non-Hodgkin lymphoma|recurrent cutaneous t-cell non-hodgkin lymphoma
850054|NCT00006345|drug/agent toxicity by tissue/organ|drug/agent toxicity by tissue/organ
850055|NCT00006345|recurrent mycosis fungoides/Sezary syndrome|recurrent mycosis fungoides/sezary syndrome
850056|NCT00006262|stage III ovarian epithelial cancer|stage iii ovarian epithelial cancer
850057|NCT00006262|stage IV ovarian epithelial cancer|stage iv ovarian epithelial cancer
850058|NCT00006262|recurrent ovarian epithelial cancer|recurrent ovarian epithelial cancer
850059|NCT00006090|refractory chronic lymphocytic leukemia|refractory chronic lymphocytic leukemia
850060|NCT00006090|B-cell chronic lymphocytic leukemia|b-cell chronic lymphocytic leukemia
850061|NCT00006084|recurrent adult acute myeloid leukemia|recurrent adult acute myeloid leukemia
850062|NCT00006084|adult acute erythroid leukemia (M6)|adult acute erythroid leukemia (m6)
850063|NCT00006084|adult acute myeloblastic leukemia without maturation (M1)|adult acute myeloblastic leukemia without maturation (m1)
850064|NCT00006084|adult acute myeloblastic leukemia with maturation (M2)|adult acute myeloblastic leukemia with maturation (m2)
850065|NCT00006084|adult acute myelomonocytic leukemia (M4)|adult acute myelomonocytic leukemia (m4)
850066|NCT00006084|adult acute monoblastic leukemia (M5a)|adult acute monoblastic leukemia (m5a)
850067|NCT00006084|adult acute megakaryoblastic leukemia (M7)|adult acute megakaryoblastic leukemia (m7)
850068|NCT00006084|secondary acute myeloid leukemia|secondary acute myeloid leukemia
850069|NCT00006084|adult acute monocytic leukemia (M5b)|adult acute monocytic leukemia (m5b)
850070|NCT00006084|adult acute minimally differentiated myeloid leukemia (M0)|adult acute minimally differentiated myeloid leukemia (m0)
850071|NCT00006051|stage I squamous cell carcinoma of the lip and oral cavity|stage i squamous cell carcinoma of the lip and oral cavity
850072|NCT00006051|stage II squamous cell carcinoma of the lip and oral cavity|stage ii squamous cell carcinoma of the lip and oral cavity
850073|NCT00006051|stage III squamous cell carcinoma of the lip and oral cavity|stage iii squamous cell carcinoma of the lip and oral cavity
850074|NCT00006051|stage IV squamous cell carcinoma of the lip and oral cavity|stage iv squamous cell carcinoma of the lip and oral cavity
850075|NCT00006051|stage I squamous cell carcinoma of the oropharynx|stage i squamous cell carcinoma of the oropharynx
850076|NCT00006051|stage II squamous cell carcinoma of the oropharynx|stage ii squamous cell carcinoma of the oropharynx
850077|NCT00006051|stage III squamous cell carcinoma of the oropharynx|stage iii squamous cell carcinoma of the oropharynx
850078|NCT00006051|stage IV squamous cell carcinoma of the oropharynx|stage iv squamous cell carcinoma of the oropharynx
850079|NCT00006051|stage I squamous cell carcinoma of the hypopharynx|stage i squamous cell carcinoma of the hypopharynx
850080|NCT00006051|stage II squamous cell carcinoma of the hypopharynx|stage ii squamous cell carcinoma of the hypopharynx
850081|NCT00006051|stage III squamous cell carcinoma of the hypopharynx|stage iii squamous cell carcinoma of the hypopharynx
850082|NCT00006051|stage IV squamous cell carcinoma of the hypopharynx|stage iv squamous cell carcinoma of the hypopharynx
850083|NCT00006051|stage I squamous cell carcinoma of the larynx|stage i squamous cell carcinoma of the larynx
850084|NCT00006051|stage II squamous cell carcinoma of the larynx|stage ii squamous cell carcinoma of the larynx
850085|NCT00006051|stage III squamous cell carcinoma of the larynx|stage iii squamous cell carcinoma of the larynx
850086|NCT00006051|stage IV squamous cell carcinoma of the larynx|stage iv squamous cell carcinoma of the larynx
850087|NCT00006036|recurrent non-small cell lung cancer|recurrent non-small cell lung cancer
850088|NCT00006036|stage III ovarian epithelial cancer|stage iii ovarian epithelial cancer
850089|NCT00006036|stage IV ovarian epithelial cancer|stage iv ovarian epithelial cancer
850090|NCT00006036|recurrent ovarian epithelial cancer|recurrent ovarian epithelial cancer
850091|NCT00006036|extensive stage small cell lung cancer|extensive stage small cell lung cancer
850092|NCT00006036|recurrent small cell lung cancer|recurrent small cell lung cancer
850093|NCT00006036|stage IV nasopharyngeal cancer|stage iv nasopharyngeal cancer
850094|NCT00006036|stage IIIA non-small cell lung cancer|stage iiia non-small cell lung cancer
850095|NCT00006036|stage IIIB non-small cell lung cancer|stage iiib non-small cell lung cancer
850096|NCT00006036|stage IV non-small cell lung cancer|stage iv non-small cell lung cancer
850097|NCT00006036|unspecified adult solid tumor, protocol specific|unspecified adult solid tumor, protocol specific
850098|NCT00006036|untreated metastatic squamous neck cancer with occult primary|untreated metastatic squamous neck cancer with occult primary
850099|NCT00006036|recurrent metastatic squamous neck cancer with occult primary|recurrent metastatic squamous neck cancer with occult primary
850100|NCT00006036|ovarian stromal cancer|ovarian stromal cancer
850101|NCT00006036|stage III ovarian germ cell tumor|stage iii ovarian germ cell tumor
850102|NCT00006036|stage IV ovarian germ cell tumor|stage iv ovarian germ cell tumor
850103|NCT00006036|recurrent ovarian germ cell tumor|recurrent ovarian germ cell tumor
850104|NCT00006036|stage III squamous cell carcinoma of the lip and oral cavity|stage iii squamous cell carcinoma of the lip and oral cavity
850105|NCT00006036|stage III basal cell carcinoma of the lip|stage iii basal cell carcinoma of the lip
850106|NCT00006036|stage III verrucous carcinoma of the oral cavity|stage iii verrucous carcinoma of the oral cavity
850107|NCT00006036|stage III mucoepidermoid carcinoma of the oral cavity|stage iii mucoepidermoid carcinoma of the oral cavity
850108|NCT00006036|stage III adenoid cystic carcinoma of the oral cavity|stage iii adenoid cystic carcinoma of the oral cavity
850109|NCT00006036|stage IV squamous cell carcinoma of the lip and oral cavity|stage iv squamous cell carcinoma of the lip and oral cavity
850110|NCT00006036|stage IV basal cell carcinoma of the lip|stage iv basal cell carcinoma of the lip
850111|NCT00006036|stage IV verrucous carcinoma of the oral cavity|stage iv verrucous carcinoma of the oral cavity
850112|NCT00006036|stage IV mucoepidermoid carcinoma of the oral cavity|stage iv mucoepidermoid carcinoma of the oral cavity
850113|NCT00006036|stage IV adenoid cystic carcinoma of the oral cavity|stage iv adenoid cystic carcinoma of the oral cavity
850114|NCT00006036|recurrent squamous cell carcinoma of the lip and oral cavity|recurrent squamous cell carcinoma of the lip and oral cavity
850115|NCT00006036|recurrent basal cell carcinoma of the lip|recurrent basal cell carcinoma of the lip
850116|NCT00006036|recurrent verrucous carcinoma of the oral cavity|recurrent verrucous carcinoma of the oral cavity
850117|NCT00006036|recurrent mucoepidermoid carcinoma of the oral cavity|recurrent mucoepidermoid carcinoma of the oral cavity
850118|NCT00006036|recurrent adenoid cystic carcinoma of the oral cavity|recurrent adenoid cystic carcinoma of the oral cavity
850119|NCT00006036|stage III squamous cell carcinoma of the oropharynx|stage iii squamous cell carcinoma of the oropharynx
850120|NCT00006036|stage III lymphoepithelioma of the oropharynx|stage iii lymphoepithelioma of the oropharynx
850121|NCT00006036|stage IV squamous cell carcinoma of the oropharynx|stage iv squamous cell carcinoma of the oropharynx
850122|NCT00006036|stage IV lymphoepithelioma of the oropharynx|stage iv lymphoepithelioma of the oropharynx
850123|NCT00006036|recurrent squamous cell carcinoma of the oropharynx|recurrent squamous cell carcinoma of the oropharynx
850124|NCT00006036|recurrent lymphoepithelioma of the oropharynx|recurrent lymphoepithelioma of the oropharynx
850125|NCT00006036|stage III squamous cell carcinoma of the nasopharynx|stage iii squamous cell carcinoma of the nasopharynx
850126|NCT00006036|stage III lymphoepithelioma of the nasopharynx|stage iii lymphoepithelioma of the nasopharynx
850127|NCT00006036|stage IV squamous cell carcinoma of the nasopharynx|stage iv squamous cell carcinoma of the nasopharynx
850128|NCT00006036|stage IV lymphoepithelioma of the nasopharynx|stage iv lymphoepithelioma of the nasopharynx
850129|NCT00006036|recurrent squamous cell carcinoma of the nasopharynx|recurrent squamous cell carcinoma of the nasopharynx
850130|NCT00006036|recurrent lymphoepithelioma of the nasopharynx|recurrent lymphoepithelioma of the nasopharynx
850131|NCT00006036|stage III squamous cell carcinoma of the hypopharynx|stage iii squamous cell carcinoma of the hypopharynx
850132|NCT00006036|stage IV squamous cell carcinoma of the hypopharynx|stage iv squamous cell carcinoma of the hypopharynx
850133|NCT00006036|recurrent squamous cell carcinoma of the hypopharynx|recurrent squamous cell carcinoma of the hypopharynx
850134|NCT00006036|stage III squamous cell carcinoma of the larynx|stage iii squamous cell carcinoma of the larynx
850135|NCT00006036|stage III verrucous carcinoma of the larynx|stage iii verrucous carcinoma of the larynx
850136|NCT00006036|stage IV squamous cell carcinoma of the larynx|stage iv squamous cell carcinoma of the larynx
850137|NCT00006036|stage IV verrucous carcinoma of the larynx|stage iv verrucous carcinoma of the larynx
850138|NCT00006036|recurrent squamous cell carcinoma of the larynx|recurrent squamous cell carcinoma of the larynx
850139|NCT00006036|recurrent verrucous carcinoma of the larynx|recurrent verrucous carcinoma of the larynx
850140|NCT00006036|stage III squamous cell carcinoma of the paranasal sinus and nasal cavity|stage iii squamous cell carcinoma of the paranasal sinus and nasal cavity
850221|NCT00003693|recurrent adult acute myeloid leukemia|recurrent adult acute myeloid leukemia
850141|NCT00006036|stage III inverted papilloma of the paranasal sinus and nasal cavity|stage iii inverted papilloma of the paranasal sinus and nasal cavity
850142|NCT00006036|stage III midline lethal granuloma of the paranasal sinus and nasal cavity|stage iii midline lethal granuloma of the paranasal sinus and nasal cavity
850143|NCT00006036|stage III esthesioneuroblastoma of the paranasal sinus and nasal cavity|stage iii esthesioneuroblastoma of the paranasal sinus and nasal cavity
850144|NCT00006036|stage IV squamous cell carcinoma of the paranasal sinus and nasal cavity|stage iv squamous cell carcinoma of the paranasal sinus and nasal cavity
850145|NCT00006036|stage IV inverted papilloma of the paranasal sinus and nasal cavity|stage iv inverted papilloma of the paranasal sinus and nasal cavity
850146|NCT00006036|stage IV midline lethal granuloma of the paranasal sinus and nasal cavity|stage iv midline lethal granuloma of the paranasal sinus and nasal cavity
850147|NCT00006036|stage IV esthesioneuroblastoma of the paranasal sinus and nasal cavity|stage iv esthesioneuroblastoma of the paranasal sinus and nasal cavity
850148|NCT00006036|recurrent squamous cell carcinoma of the paranasal sinus and nasal cavity|recurrent squamous cell carcinoma of the paranasal sinus and nasal cavity
850149|NCT00006036|recurrent inverted papilloma of the paranasal sinus and nasal cavity|recurrent inverted papilloma of the paranasal sinus and nasal cavity
850150|NCT00006036|recurrent midline lethal granuloma of the paranasal sinus and nasal cavity|recurrent midline lethal granuloma of the paranasal sinus and nasal cavity
850151|NCT00006036|recurrent esthesioneuroblastoma of the paranasal sinus and nasal cavity|recurrent esthesioneuroblastoma of the paranasal sinus and nasal cavity
850152|NCT00006036|borderline ovarian surface epithelial-stromal tumor|borderline ovarian surface epithelial-stromal tumor
850153|NCT00006036|ovarian sarcoma|ovarian sarcoma
850154|NCT00006030|stage I breast cancer|stage i breast cancer
850156|NCT00080093|HIV Seronegativity|hiv seronegativity
850157|NCT00080093|HIV Prevention|hiv prevention
850158|NCT00080093|Behavioral Intervention|behavioral intervention
850159|NCT00006023|stage IV prostate cancer|stage iv prostate cancer
850160|NCT00006023|recurrent prostate cancer|recurrent prostate cancer
850161|NCT00005992|stage IV prostate cancer|stage iv prostate cancer
850162|NCT00005992|recurrent prostate cancer|recurrent prostate cancer
850163|NCT00005972|recurrent small cell lung cancer|recurrent small cell lung cancer
850164|NCT00005944|recurrent colon cancer|recurrent colon cancer
850165|NCT00005944|recurrent rectal cancer|recurrent rectal cancer
850166|NCT00005944|adenocarcinoma of the colon|adenocarcinoma of the colon
850167|NCT00005944|adenocarcinoma of the rectum|adenocarcinoma of the rectum
850168|NCT00005944|liver metastases|liver metastases
850169|NCT00005944|primary peritoneal cavity cancer|primary peritoneal cavity cancer
850170|NCT00005865|stage IIIB non-small cell lung cancer|stage iiib non-small cell lung cancer
850171|NCT00005865|stage IV non-small cell lung cancer|stage iv non-small cell lung cancer
850172|NCT00080067|Movement|movement
850173|NCT00080067|Anticipation|anticipation
850174|NCT00080067|Stimulation|stimulation
850175|NCT00080067|Timing|timing
850176|NCT00080067|Execution|execution
850177|NCT00080067|Perception|perception
850178|NCT00080067|Rhythm|rhythm
850179|NCT00080067|Healthy Volunteer|healthy volunteer
850180|NCT00080067|HV|hv
850181|NCT00080054|Malignant Glioma|malignant glioma
850182|NCT00080054|Glioblastoma multiforme|glioblastoma multiforme
850183|NCT00080054|GBM|gbm
850184|NCT00080054|Anaplastic astrocytoma|anaplastic astrocytoma
850185|NCT00080054|AA|aa
850186|NCT00080054|Anaplastic oligodendroglioma|anaplastic oligodendroglioma
850187|NCT00080054|Anaplastic mixed glioma|anaplastic mixed glioma
850188|NCT00080054|Brain tumor|brain tumor
850189|NCT00080054|Brain neoplasm|brain neoplasm
850190|NCT00080054|Glioma|glioma
850191|NCT00080041|Antineoplastic Combined Chemotherapy Protocols|antineoplastic combined chemotherapy protocols
850192|NCT00080028|Head and Neck Cancer|head and neck cancer
850193|NCT00080028|SCCHN|scchn
850194|NCT00080028|Oropharynx Cancer|oropharynx cancer
850195|NCT00080028|Hypopharynx Cancer|hypopharynx cancer
850196|NCT00080028|Larynx Cancer|larynx cancer
850197|NCT00080028|Soft palate Cancer|soft palate cancer
850198|NCT00080028|Tonsil Cancer|tonsil cancer
850199|NCT00080028|Base of tongue Cancer|base of tongue cancer
850200|NCT00080028|Supraglottic Cancer|supraglottic cancer
850201|NCT00080028|Glottic Cancer|glottic cancer
850202|NCT00080028|Pyriform Sinus Cancer|pyriform sinus cancer
850203|NCT00080028|Pharyngeal wall Cancer|pharyngeal wall cancer
850204|NCT00080028|Throat cancer|throat cancer
850205|NCT00080002|cancer|cancer
850206|NCT00080002|gastric|gastric
850207|NCT00080002|gastroesophageal junction|gastroesophageal junction
850208|NCT00080002|neoplasms|neoplasms
850209|NCT00080002|gastric cancer|gastric cancer
850210|NCT00080002|gastric neoplasms|gastric neoplasms
850211|NCT00079989|Bacterial Infections|bacterial infections
850212|NCT00005816|stage III renal cell cancer|stage iii renal cell cancer
850213|NCT00005816|stage IV renal cell cancer|stage iv renal cell cancer
850214|NCT00004123|adult leiomyosarcoma|adult leiomyosarcoma
850215|NCT00004123|adult liposarcoma|adult liposarcoma
850216|NCT00004123|stage III adult soft tissue sarcoma|stage iii adult soft tissue sarcoma
850217|NCT00004123|recurrent adult soft tissue sarcoma|recurrent adult soft tissue sarcoma
850218|NCT00004123|stage II adult soft tissue sarcoma|stage ii adult soft tissue sarcoma
850219|NCT00003817|unspecified adult solid tumor, protocol specific|unspecified adult solid tumor, protocol specific
850220|NCT00003817|nausea and vomiting|nausea and vomiting
863425|NCT00056719|Arthritis|arthritis
850222|NCT00003693|recurrent adult acute lymphoblastic leukemia|recurrent adult acute lymphoblastic leukemia
850223|NCT00003693|relapsing chronic myelogenous leukemia|relapsing chronic myelogenous leukemia
850224|NCT00003693|blastic phase chronic myelogenous leukemia|blastic phase chronic myelogenous leukemia
850225|NCT00003693|refractory anemia with excess blasts|refractory anemia with excess blasts
850226|NCT00003693|refractory anemia with excess blasts in transformation|refractory anemia with excess blasts in transformation
850227|NCT00003693|chronic myelomonocytic leukemia|chronic myelomonocytic leukemia
850228|NCT00003693|previously treated myelodysplastic syndromes|previously treated myelodysplastic syndromes
850229|NCT00003693|childhood myelodysplastic syndromes|childhood myelodysplastic syndromes
850230|NCT00003647|adult solid tumor|adult solid tumor
850231|NCT00003647|body system/site cancer|body system/site cancer
850232|NCT00003647|cancer|cancer
850233|NCT00003647|melanoma|melanoma
850234|NCT00003647|recurrent melanoma|recurrent melanoma
850235|NCT00003647|skin tumor|skin tumor
850236|NCT00003647|solid tumor|solid tumor
850237|NCT00003647|stage III melanoma|stage iii melanoma
850238|NCT00003647|stage IV melanoma|stage iv melanoma
850239|NCT00003647|stage, melanoma|stage, melanoma
850240|NCT00079976|Staphylococcus aureus|staphylococcus aureus
850241|NCT00079976|Bacterial Infections|bacterial infections
850242|NCT00079950|soft|soft
850243|NCT00079950|sarcoma|sarcoma
850244|NCT00079950|metastatic|metastatic
850245|NCT00079937|allergic|allergic
850246|NCT00079937|asthma|asthma
850247|NCT00079937|atopic|atopic
850248|NCT00079937|omalizumab|omalizumab
850249|NCT00079937|immunoglobulin E|immunoglobulin e
850250|NCT00079937|IgE|ige
850251|NCT00079937|anti-IgE|anti-ige
850252|NCT00003561|chronic phase chronic myelogenous leukemia|chronic phase chronic myelogenous leukemia
850253|NCT00003561|Philadelphia chromosome positive chronic myelogenous leukemia|philadelphia chromosome positive chronic myelogenous leukemia
850254|NCT00003561|Philadelphia chromosome negative chronic myelogenous leukemia|philadelphia chromosome negative chronic myelogenous leukemia
850255|NCT00003356|stage I grade 1 follicular lymphoma|stage i grade 1 follicular lymphoma
850256|NCT00003356|stage I grade 2 follicular lymphoma|stage i grade 2 follicular lymphoma
850257|NCT00003356|stage III grade 1 follicular lymphoma|stage iii grade 1 follicular lymphoma
850258|NCT00003356|stage III grade 2 follicular lymphoma|stage iii grade 2 follicular lymphoma
850259|NCT00003356|stage IV grade 1 follicular lymphoma|stage iv grade 1 follicular lymphoma
850260|NCT00003356|stage IV grade 2 follicular lymphoma|stage iv grade 2 follicular lymphoma
850261|NCT00003356|recurrent grade 1 follicular lymphoma|recurrent grade 1 follicular lymphoma
850262|NCT00003356|recurrent grade 2 follicular lymphoma|recurrent grade 2 follicular lymphoma
850263|NCT00003356|stage I mantle cell lymphoma|stage i mantle cell lymphoma
850264|NCT00003356|contiguous stage II grade 1 follicular lymphoma|contiguous stage ii grade 1 follicular lymphoma
850265|NCT00003356|contiguous stage II grade 2 follicular lymphoma|contiguous stage ii grade 2 follicular lymphoma
850266|NCT00003356|contiguous stage II mantle cell lymphoma|contiguous stage ii mantle cell lymphoma
850267|NCT00003356|noncontiguous stage II grade 1 follicular lymphoma|noncontiguous stage ii grade 1 follicular lymphoma
850268|NCT00003356|noncontiguous stage II grade 2 follicular lymphoma|noncontiguous stage ii grade 2 follicular lymphoma
850269|NCT00003356|noncontiguous stage II mantle cell lymphoma|noncontiguous stage ii mantle cell lymphoma
850270|NCT00003356|stage III mantle cell lymphoma|stage iii mantle cell lymphoma
850271|NCT00003356|stage IV mantle cell lymphoma|stage iv mantle cell lymphoma
850272|NCT00003356|recurrent mantle cell lymphoma|recurrent mantle cell lymphoma
850273|NCT00003356|noncontiguous stage II small lymphocytic lymphoma|noncontiguous stage ii small lymphocytic lymphoma
850274|NCT00003356|noncontiguous stage II marginal zone lymphoma|noncontiguous stage ii marginal zone lymphoma
850275|NCT00003356|recurrent marginal zone lymphoma|recurrent marginal zone lymphoma
850276|NCT00003356|recurrent small lymphocytic lymphoma|recurrent small lymphocytic lymphoma
850277|NCT00003356|stage I marginal zone lymphoma|stage i marginal zone lymphoma
850278|NCT00003356|stage I small lymphocytic lymphoma|stage i small lymphocytic lymphoma
850279|NCT00003356|stage III small lymphocytic lymphoma|stage iii small lymphocytic lymphoma
850280|NCT00003356|stage III marginal zone lymphoma|stage iii marginal zone lymphoma
850281|NCT00003356|stage IV small lymphocytic lymphoma|stage iv small lymphocytic lymphoma
850282|NCT00003356|stage IV marginal zone lymphoma|stage iv marginal zone lymphoma
850283|NCT00003356|contiguous stage II marginal zone lymphoma|contiguous stage ii marginal zone lymphoma
850284|NCT00003356|contiguous stage II small lymphocytic lymphoma|contiguous stage ii small lymphocytic lymphoma
850285|NCT00003356|extranodal marginal zone B-cell lymphoma of mucosa-associated lymphoid tissue|extranodal marginal zone b-cell lymphoma of mucosa-associated lymphoid tissue
850286|NCT00003356|nodal marginal zone B-cell lymphoma|nodal marginal zone b-cell lymphoma
850287|NCT00003356|splenic marginal zone lymphoma|splenic marginal zone lymphoma
850288|NCT00003327|stage IV nasopharyngeal cancer|stage iv nasopharyngeal cancer
850289|NCT00003327|recurrent nasopharyngeal cancer|recurrent nasopharyngeal cancer
850290|NCT00003327|stage IV lip and oral cavity cancer|stage iv lip and oral cavity cancer
850291|NCT00003327|recurrent lip and oral cavity cancer|recurrent lip and oral cavity cancer
850292|NCT00003327|stage IV hypopharyngeal cancer|stage iv hypopharyngeal cancer
850293|NCT00003327|recurrent hypopharyngeal cancer|recurrent hypopharyngeal cancer
850294|NCT00003327|stage IV laryngeal cancer|stage iv laryngeal cancer
850295|NCT00003327|recurrent laryngeal cancer|recurrent laryngeal cancer
850296|NCT00003327|stage IV paranasal sinus and nasal cavity cancer|stage iv paranasal sinus and nasal cavity cancer
850297|NCT00003327|recurrent paranasal sinus and nasal cavity cancer|recurrent paranasal sinus and nasal cavity cancer
850298|NCT00003327|stage IV oropharyngeal cancer|stage iv oropharyngeal cancer
850299|NCT00003327|recurrent oropharyngeal cancer|recurrent oropharyngeal cancer
850300|NCT00003321|stage I esophageal cancer|stage i esophageal cancer
850301|NCT00003321|stage II esophageal cancer|stage ii esophageal cancer
850302|NCT00003321|stage III esophageal cancer|stage iii esophageal cancer
850303|NCT00003321|stage IV esophageal cancer|stage iv esophageal cancer
850304|NCT00003321|recurrent esophageal cancer|recurrent esophageal cancer
850305|NCT00003274|stage II melanoma|stage ii melanoma
850306|NCT00079911|Herpes|herpes
850307|NCT00079911|Genital Herpes|genital herpes
850308|NCT00079911|HIV|hiv
850309|NCT00079911|HSV|hsv
850310|NCT00079885|Bacterial Pneumonia|bacterial pneumonia
850311|NCT00022360|recurrent adult brain tumor|recurrent adult brain tumor
850312|NCT00022360|adult glioblastoma|adult glioblastoma
850313|NCT00022360|adult anaplastic astrocytoma|adult anaplastic astrocytoma
850314|NCT00022360|adult giant cell glioblastoma|adult giant cell glioblastoma
850315|NCT00022360|adult gliosarcoma|adult gliosarcoma
850316|NCT00022165|unspecified adult solid tumor, protocol specific|unspecified adult solid tumor, protocol specific
851599|NCT00078715|Affective Disorder|affective disorder
850317|NCT00021138|non-small cell lung cancer|non-small cell lung cancer
850318|NCT00021138|small cell lung cancer|small cell lung cancer
850319|NCT00021138|esophageal cancer|esophageal cancer
850320|NCT00021138|hypopharyngeal cancer|hypopharyngeal cancer
850321|NCT00021138|laryngeal cancer|laryngeal cancer
850322|NCT00021138|nasopharyngeal cancer|nasopharyngeal cancer
850323|NCT00021138|oropharyngeal cancer|oropharyngeal cancer
850324|NCT00021138|lip and oral cavity cancer|lip and oral cavity cancer
850325|NCT00021138|paranasal sinus and nasal cavity cancer|paranasal sinus and nasal cavity cancer
850326|NCT00021138|tongue cancer|tongue cancer
850327|NCT00002789|chronic phase chronic myelogenous leukemia|chronic phase chronic myelogenous leukemia
850328|NCT00002789|accelerated phase chronic myelogenous leukemia|accelerated phase chronic myelogenous leukemia
850329|NCT00002789|Philadelphia chromosome positive chronic myelogenous leukemia|philadelphia chromosome positive chronic myelogenous leukemia
850330|NCT00079859|Heterozygous Familial Hypercholesterolemia (HeFH)|heterozygous familial hypercholesterolemia (hefh)
850331|NCT00079846|Homozygous Familial Hypercholesterolemia (HoFH)|homozygous familial hypercholesterolemia (hofh)
850332|NCT00079833|gastric acid hypersecretory conditions|gastric acid hypersecretory conditions
850333|NCT00079833|Idiopathic Hypersecretion|idiopathic hypersecretion
850334|NCT00079833|Excessive Gastric Acid secretion|excessive gastric acid secretion
850335|NCT00079820|Smallpox|smallpox
850336|NCT00079820|Smallpox Vaccine|smallpox vaccine
850337|NCT00079820|Variola virus|variola virus
850338|NCT00079820|Smallpox Virus|smallpox virus
850339|NCT00079820|MODIFIED VACCINIA ANKARA|modified vaccinia ankara
850340|NCT00079820|MVA|mva
850341|NCT00079820|Dryvax|dryvax
850342|NCT00079820|Dryvax vaccine|dryvax vaccine
850343|NCT00079820|Protection against smallpox|protection against smallpox
850344|NCT00020930|stage IV colon cancer|stage iv colon cancer
850345|NCT00020930|stage IV rectal cancer|stage iv rectal cancer
850346|NCT00020930|recurrent colon cancer|recurrent colon cancer
850347|NCT00020930|recurrent rectal cancer|recurrent rectal cancer
850348|NCT00020865|stage I adult Hodgkin lymphoma|stage i adult hodgkin lymphoma
850349|NCT00020865|stage II adult Hodgkin lymphoma|stage ii adult hodgkin lymphoma
850350|NCT00020865|stage III adult Hodgkin lymphoma|stage iii adult hodgkin lymphoma
850351|NCT00020865|stage IV adult Hodgkin lymphoma|stage iv adult hodgkin lymphoma
850352|NCT00020865|recurrent adult Hodgkin lymphoma|recurrent adult hodgkin lymphoma
850353|NCT00020865|stage I cutaneous T-cell non-Hodgkin lymphoma|stage i cutaneous t-cell non-hodgkin lymphoma
850354|NCT00020865|stage II cutaneous T-cell non-Hodgkin lymphoma|stage ii cutaneous t-cell non-hodgkin lymphoma
850355|NCT00020865|stage III cutaneous T-cell non-Hodgkin lymphoma|stage iii cutaneous t-cell non-hodgkin lymphoma
850356|NCT00020865|stage IV cutaneous T-cell non-Hodgkin lymphoma|stage iv cutaneous t-cell non-hodgkin lymphoma
850357|NCT00020865|recurrent cutaneous T-cell non-Hodgkin lymphoma|recurrent cutaneous t-cell non-hodgkin lymphoma
850358|NCT00020865|stage 0 chronic lymphocytic leukemia|stage 0 chronic lymphocytic leukemia
850359|NCT00020865|stage I chronic lymphocytic leukemia|stage i chronic lymphocytic leukemia
850360|NCT00020865|stage II chronic lymphocytic leukemia|stage ii chronic lymphocytic leukemia
850361|NCT00020865|stage III chronic lymphocytic leukemia|stage iii chronic lymphocytic leukemia
850362|NCT00020865|stage IV chronic lymphocytic leukemia|stage iv chronic lymphocytic leukemia
850363|NCT00020865|recurrent adult acute myeloid leukemia|recurrent adult acute myeloid leukemia
850364|NCT00020865|recurrent adult acute lymphoblastic leukemia|recurrent adult acute lymphoblastic leukemia
850365|NCT00020865|relapsing chronic myelogenous leukemia|relapsing chronic myelogenous leukemia
850366|NCT00020865|refractory chronic lymphocytic leukemia|refractory chronic lymphocytic leukemia
850367|NCT00020865|unspecified adult solid tumor, protocol specific|unspecified adult solid tumor, protocol specific
850368|NCT00020865|chronic phase chronic myelogenous leukemia|chronic phase chronic myelogenous leukemia
850369|NCT00020865|accelerated phase chronic myelogenous leukemia|accelerated phase chronic myelogenous leukemia
850370|NCT00020865|blastic phase chronic myelogenous leukemia|blastic phase chronic myelogenous leukemia
850371|NCT00020865|meningeal chronic myelogenous leukemia|meningeal chronic myelogenous leukemia
850372|NCT00020865|adult acute myeloid leukemia in remission|adult acute myeloid leukemia in remission
850373|NCT00020865|adult acute lymphoblastic leukemia in remission|adult acute lymphoblastic leukemia in remission
850374|NCT00020865|fever, sweats, and hot flashes|fever, sweats, and hot flashes
850375|NCT00020865|progressive hairy cell leukemia, initial treatment|progressive hairy cell leukemia, initial treatment
850376|NCT00020865|refractory hairy cell leukemia|refractory hairy cell leukemia
850377|NCT00020865|stage I grade 1 follicular lymphoma|stage i grade 1 follicular lymphoma
850378|NCT00020865|stage I grade 2 follicular lymphoma|stage i grade 2 follicular lymphoma
850379|NCT00020865|stage I grade 3 follicular lymphoma|stage i grade 3 follicular lymphoma
850380|NCT00020865|stage I adult diffuse small cleaved cell lymphoma|stage i adult diffuse small cleaved cell lymphoma
850381|NCT00020865|stage I adult diffuse mixed cell lymphoma|stage i adult diffuse mixed cell lymphoma
850382|NCT00020865|stage I adult diffuse large cell lymphoma|stage i adult diffuse large cell lymphoma
850383|NCT00020865|stage I adult immunoblastic large cell lymphoma|stage i adult immunoblastic large cell lymphoma
850384|NCT00020865|stage I adult lymphoblastic lymphoma|stage i adult lymphoblastic lymphoma
850385|NCT00020865|stage I adult Burkitt lymphoma|stage i adult burkitt lymphoma
850386|NCT00020865|chronic myelomonocytic leukemia|chronic myelomonocytic leukemia
850387|NCT00020865|T-cell large granular lymphocyte leukemia|t-cell large granular lymphocyte leukemia
850388|NCT00020865|acute undifferentiated leukemia|acute undifferentiated leukemia
850389|NCT00020865|stage III grade 1 follicular lymphoma|stage iii grade 1 follicular lymphoma
850390|NCT00020865|stage III grade 2 follicular lymphoma|stage iii grade 2 follicular lymphoma
850391|NCT00020865|stage III grade 3 follicular lymphoma|stage iii grade 3 follicular lymphoma
850392|NCT00020865|stage III adult diffuse small cleaved cell lymphoma|stage iii adult diffuse small cleaved cell lymphoma
850393|NCT00020865|stage III adult diffuse mixed cell lymphoma|stage iii adult diffuse mixed cell lymphoma
850394|NCT00020865|stage III adult diffuse large cell lymphoma|stage iii adult diffuse large cell lymphoma
850395|NCT00020865|stage III adult immunoblastic large cell lymphoma|stage iii adult immunoblastic large cell lymphoma
850396|NCT00020865|stage III adult lymphoblastic lymphoma|stage iii adult lymphoblastic lymphoma
850397|NCT00020865|stage III adult Burkitt lymphoma|stage iii adult burkitt lymphoma
850398|NCT00020865|stage IV grade 1 follicular lymphoma|stage iv grade 1 follicular lymphoma
850399|NCT00020865|stage IV grade 2 follicular lymphoma|stage iv grade 2 follicular lymphoma
850400|NCT00020865|stage IV grade 3 follicular lymphoma|stage iv grade 3 follicular lymphoma
850401|NCT00020865|stage IV adult diffuse small cleaved cell lymphoma|stage iv adult diffuse small cleaved cell lymphoma
850402|NCT00020865|stage IV adult diffuse mixed cell lymphoma|stage iv adult diffuse mixed cell lymphoma
850403|NCT00020865|stage IV adult diffuse large cell lymphoma|stage iv adult diffuse large cell lymphoma
850404|NCT00020865|stage IV adult immunoblastic large cell lymphoma|stage iv adult immunoblastic large cell lymphoma
850405|NCT00020865|stage IV adult lymphoblastic lymphoma|stage iv adult lymphoblastic lymphoma
850406|NCT00020865|stage IV adult Burkitt lymphoma|stage iv adult burkitt lymphoma
850407|NCT00020865|recurrent grade 1 follicular lymphoma|recurrent grade 1 follicular lymphoma
850408|NCT00020865|recurrent grade 2 follicular lymphoma|recurrent grade 2 follicular lymphoma
850409|NCT00020865|recurrent grade 3 follicular lymphoma|recurrent grade 3 follicular lymphoma
850410|NCT00020865|recurrent adult diffuse small cleaved cell lymphoma|recurrent adult diffuse small cleaved cell lymphoma
850411|NCT00020865|recurrent adult diffuse mixed cell lymphoma|recurrent adult diffuse mixed cell lymphoma
850412|NCT00020865|recurrent adult diffuse large cell lymphoma|recurrent adult diffuse large cell lymphoma
850413|NCT00020865|recurrent adult immunoblastic large cell lymphoma|recurrent adult immunoblastic large cell lymphoma
850414|NCT00020865|recurrent adult lymphoblastic lymphoma|recurrent adult lymphoblastic lymphoma
850415|NCT00020865|recurrent adult Burkitt lymphoma|recurrent adult burkitt lymphoma
850416|NCT00020865|stage I adult T-cell leukemia/lymphoma|stage i adult t-cell leukemia/lymphoma
850417|NCT00020865|stage II adult T-cell leukemia/lymphoma|stage ii adult t-cell leukemia/lymphoma
850418|NCT00020865|stage III adult T-cell leukemia/lymphoma|stage iii adult t-cell leukemia/lymphoma
850419|NCT00020865|stage IV adult T-cell leukemia/lymphoma|stage iv adult t-cell leukemia/lymphoma
850420|NCT00020865|recurrent adult T-cell leukemia/lymphoma|recurrent adult t-cell leukemia/lymphoma
850421|NCT00020865|secondary acute myeloid leukemia|secondary acute myeloid leukemia
850422|NCT00020865|primary central nervous system non-Hodgkin lymphoma|primary central nervous system non-hodgkin lymphoma
850423|NCT00020865|neutropenia|neutropenia
850424|NCT00020865|infection|infection
850425|NCT00020865|prolymphocytic leukemia|prolymphocytic leukemia
850426|NCT00020865|AIDS-related peripheral/systemic lymphoma|aids-related peripheral/systemic lymphoma
850427|NCT00020865|AIDS-related primary CNS lymphoma|aids-related primary cns lymphoma
850428|NCT00020865|intraocular lymphoma|intraocular lymphoma
850429|NCT00020865|stage I mantle cell lymphoma|stage i mantle cell lymphoma
850430|NCT00020865|contiguous stage II grade 1 follicular lymphoma|contiguous stage ii grade 1 follicular lymphoma
850431|NCT00020865|contiguous stage II grade 2 follicular lymphoma|contiguous stage ii grade 2 follicular lymphoma
850432|NCT00020865|contiguous stage II grade 3 follicular lymphoma|contiguous stage ii grade 3 follicular lymphoma
850433|NCT00020865|contiguous stage II adult diffuse small cleaved cell lymphoma|contiguous stage ii adult diffuse small cleaved cell lymphoma
850434|NCT00020865|contiguous stage II mantle cell lymphoma|contiguous stage ii mantle cell lymphoma
850571|NCT00005834|stage II multiple myeloma|stage ii multiple myeloma
850435|NCT00020865|contiguous stage II adult diffuse mixed cell lymphoma|contiguous stage ii adult diffuse mixed cell lymphoma
850436|NCT00020865|contiguous stage II adult immunoblastic large cell lymphoma|contiguous stage ii adult immunoblastic large cell lymphoma
850437|NCT00020865|contiguous stage II adult diffuse large cell lymphoma|contiguous stage ii adult diffuse large cell lymphoma
850438|NCT00020865|contiguous stage II adult Burkitt lymphoma|contiguous stage ii adult burkitt lymphoma
850439|NCT00020865|contiguous stage II adult lymphoblastic lymphoma|contiguous stage ii adult lymphoblastic lymphoma
850440|NCT00020865|noncontiguous stage II grade 1 follicular lymphoma|noncontiguous stage ii grade 1 follicular lymphoma
850441|NCT00020865|noncontiguous stage II grade 2 follicular lymphoma|noncontiguous stage ii grade 2 follicular lymphoma
850442|NCT00020865|noncontiguous stage II grade 3 follicular lymphoma|noncontiguous stage ii grade 3 follicular lymphoma
850443|NCT00020865|noncontiguous stage II adult diffuse small cleaved cell lymphoma|noncontiguous stage ii adult diffuse small cleaved cell lymphoma
850444|NCT00020865|noncontiguous stage II mantle cell lymphoma|noncontiguous stage ii mantle cell lymphoma
850445|NCT00020865|noncontiguous stage II adult diffuse mixed cell lymphoma|noncontiguous stage ii adult diffuse mixed cell lymphoma
850446|NCT00020865|noncontiguous stage II adult immunoblastic large cell lymphoma|noncontiguous stage ii adult immunoblastic large cell lymphoma
850447|NCT00020865|noncontiguous stage II adult diffuse large cell lymphoma|noncontiguous stage ii adult diffuse large cell lymphoma
850448|NCT00020865|noncontiguous stage II adult Burkitt lymphoma|noncontiguous stage ii adult burkitt lymphoma
850449|NCT00020865|noncontiguous stage II adult lymphoblastic lymphoma|noncontiguous stage ii adult lymphoblastic lymphoma
850450|NCT00020865|stage III mantle cell lymphoma|stage iii mantle cell lymphoma
850451|NCT00020865|stage IV mantle cell lymphoma|stage iv mantle cell lymphoma
850452|NCT00020865|recurrent mantle cell lymphoma|recurrent mantle cell lymphoma
850453|NCT00020865|angioimmunoblastic T-cell lymphoma|angioimmunoblastic t-cell lymphoma
850454|NCT00020865|anaplastic large cell lymphoma|anaplastic large cell lymphoma
850455|NCT00020865|stage I mycosis fungoides/Sezary syndrome|stage i mycosis fungoides/sezary syndrome
850456|NCT00020865|stage II mycosis fungoides/Sezary syndrome|stage ii mycosis fungoides/sezary syndrome
850457|NCT00020865|stage III mycosis fungoides/Sezary syndrome|stage iii mycosis fungoides/sezary syndrome
850458|NCT00020865|stage IV mycosis fungoides/Sezary syndrome|stage iv mycosis fungoides/sezary syndrome
850459|NCT00020865|recurrent mycosis fungoides/Sezary syndrome|recurrent mycosis fungoides/sezary syndrome
850460|NCT00020865|noncontiguous stage II small lymphocytic lymphoma|noncontiguous stage ii small lymphocytic lymphoma
850461|NCT00020865|noncontiguous stage II marginal zone lymphoma|noncontiguous stage ii marginal zone lymphoma
850462|NCT00020865|recurrent marginal zone lymphoma|recurrent marginal zone lymphoma
850463|NCT00020865|recurrent small lymphocytic lymphoma|recurrent small lymphocytic lymphoma
850464|NCT00020865|stage I marginal zone lymphoma|stage i marginal zone lymphoma
850465|NCT00020865|stage I small lymphocytic lymphoma|stage i small lymphocytic lymphoma
850466|NCT00020865|stage III small lymphocytic lymphoma|stage iii small lymphocytic lymphoma
850467|NCT00020865|stage III marginal zone lymphoma|stage iii marginal zone lymphoma
850468|NCT00020865|stage IV small lymphocytic lymphoma|stage iv small lymphocytic lymphoma
850469|NCT00020865|stage IV marginal zone lymphoma|stage iv marginal zone lymphoma
850470|NCT00020865|contiguous stage II marginal zone lymphoma|contiguous stage ii marginal zone lymphoma
850471|NCT00020865|contiguous stage II small lymphocytic lymphoma|contiguous stage ii small lymphocytic lymphoma
850472|NCT00020865|extranodal marginal zone B-cell lymphoma of mucosa-associated lymphoid tissue|extranodal marginal zone b-cell lymphoma of mucosa-associated lymphoid tissue
850473|NCT00020865|nodal marginal zone B-cell lymphoma|nodal marginal zone b-cell lymphoma
850474|NCT00020865|splenic marginal zone lymphoma|splenic marginal zone lymphoma
850475|NCT00014300|recurrent adult brain tumor|recurrent adult brain tumor
850476|NCT00014300|adult glioblastoma|adult glioblastoma
850477|NCT00014300|adult giant cell glioblastoma|adult giant cell glioblastoma
850478|NCT00014300|adult gliosarcoma|adult gliosarcoma
850479|NCT00012337|stage IV renal cell cancer|stage iv renal cell cancer
850480|NCT00012337|recurrent renal cell cancer|recurrent renal cell cancer
850481|NCT00006812|recurrent ovarian epithelial cancer|recurrent ovarian epithelial cancer
850482|NCT00006812|primary peritoneal cavity cancer|primary peritoneal cavity cancer
850483|NCT00006708|recurrent adult diffuse large cell lymphoma|recurrent adult diffuse large cell lymphoma
850484|NCT00006708|recurrent adult Burkitt lymphoma|recurrent adult burkitt lymphoma
850485|NCT00006218|unspecified adult solid tumor, protocol specific|unspecified adult solid tumor, protocol specific
850486|NCT00006215|stage IIIB non-small cell lung cancer|stage iiib non-small cell lung cancer
850487|NCT00006215|stage IV non-small cell lung cancer|stage iv non-small cell lung cancer
850488|NCT00006098|recurrent adult Hodgkin lymphoma|recurrent adult hodgkin lymphoma
850489|NCT00006098|refractory multiple myeloma|refractory multiple myeloma
850490|NCT00006098|recurrent adult acute myeloid leukemia|recurrent adult acute myeloid leukemia
850491|NCT00006098|recurrent adult acute lymphoblastic leukemia|recurrent adult acute lymphoblastic leukemia
850492|NCT00006098|relapsing chronic myelogenous leukemia|relapsing chronic myelogenous leukemia
850493|NCT00006098|refractory chronic lymphocytic leukemia|refractory chronic lymphocytic leukemia
850494|NCT00006098|refractory anemia with excess blasts|refractory anemia with excess blasts
850495|NCT00006098|refractory anemia with excess blasts in transformation|refractory anemia with excess blasts in transformation
850496|NCT00006098|recurrent grade 1 follicular lymphoma|recurrent grade 1 follicular lymphoma
850497|NCT00006098|recurrent grade 2 follicular lymphoma|recurrent grade 2 follicular lymphoma
850498|NCT00006098|recurrent grade 3 follicular lymphoma|recurrent grade 3 follicular lymphoma
850499|NCT00006098|recurrent adult diffuse small cleaved cell lymphoma|recurrent adult diffuse small cleaved cell lymphoma
850500|NCT00006098|recurrent adult diffuse mixed cell lymphoma|recurrent adult diffuse mixed cell lymphoma
850501|NCT00006098|recurrent adult diffuse large cell lymphoma|recurrent adult diffuse large cell lymphoma
850502|NCT00006098|recurrent adult immunoblastic large cell lymphoma|recurrent adult immunoblastic large cell lymphoma
850503|NCT00006098|recurrent adult lymphoblastic lymphoma|recurrent adult lymphoblastic lymphoma
850504|NCT00006098|recurrent adult Burkitt lymphoma|recurrent adult burkitt lymphoma
850505|NCT00006098|previously treated myelodysplastic syndromes|previously treated myelodysplastic syndromes
850506|NCT00006098|recurrent mantle cell lymphoma|recurrent mantle cell lymphoma
851600|NCT00078715|Rapid Onset|rapid onset
850507|NCT00006098|recurrent marginal zone lymphoma|recurrent marginal zone lymphoma
850508|NCT00006098|recurrent small lymphocytic lymphoma|recurrent small lymphocytic lymphoma
850509|NCT00006098|extranodal marginal zone B-cell lymphoma of mucosa-associated lymphoid tissue|extranodal marginal zone b-cell lymphoma of mucosa-associated lymphoid tissue
850510|NCT00006098|nodal marginal zone B-cell lymphoma|nodal marginal zone b-cell lymphoma
850511|NCT00006098|splenic marginal zone lymphoma|splenic marginal zone lymphoma
850512|NCT00079807|HIV|hiv
850513|NCT00079807|Peripheral neuropathy|peripheral neuropathy
850514|NCT00079807|Alpha-Lipoic Acid|alpha-lipoic acid
850515|NCT00079807|ALA|ala
850516|NCT00079807|Complementary Therapies|complementary therapies
850517|NCT00079794|lung cancer|lung cancer
850518|NCT00079794|herbal medicine|herbal medicine
850519|NCT00079794|non-small cell cancer|non-small cell cancer
850520|NCT00079794|Iscar|iscar
850521|NCT00079794|mistletoe|mistletoe
850522|NCT00079781|Responsive Stimulation|responsive stimulation
850523|NCT00079781|Brain Stimulator|brain stimulator
850524|NCT00079781|Epilepsy|epilepsy
850525|NCT00079781|Seizures|seizures
850526|NCT00079755|Anaplastic Large-Cell Lymphoma|anaplastic large-cell lymphoma
850527|NCT00079755|Lymphoma|lymphoma
850528|NCT00079755|antigens, CD30|antigens, cd30
850529|NCT00079755|Monoclonal Antibody|monoclonal antibody
850530|NCT00079742|Growth restriction in children with cystic fibrosis|growth restriction in children with cystic fibrosis
850531|NCT00079716|Antigens, CD40|antigens, cd40
850532|NCT00079716|Antibody, Monoclonal|antibody, monoclonal
850533|NCT00079716|Blood Coagulation Disorders|blood coagulation disorders
850534|NCT00079716|Hematologic Diseases|hematologic diseases
850535|NCT00079716|Hemorrhagic Disorders|hemorrhagic disorders
850536|NCT00079716|Hemostatic Disorders|hemostatic disorders
850537|NCT00079716|Immunoproliferative Disorders|immunoproliferative disorders
850538|NCT00079716|Lymphoproliferative Disorders|lymphoproliferative disorders
850539|NCT00079716|Paraproteinemias|paraproteinemias
850540|NCT00079716|Vascular Diseases|vascular diseases
850541|NCT00079716|Antibody-Dependent Cell Cytotoxicity|antibody-dependent cell cytotoxicity
850542|NCT00006091|relapsing chronic myelogenous leukemia|relapsing chronic myelogenous leukemia
850543|NCT00006091|chronic phase chronic myelogenous leukemia|chronic phase chronic myelogenous leukemia
850544|NCT00006091|chronic myelogenous leukemia, BCR-ABL1 positive|chronic myelogenous leukemia, bcr-abl1 positive
850545|NCT00006085|unspecified adult solid tumor, protocol specific|unspecified adult solid tumor, protocol specific
850546|NCT00006026|recurrent bladder cancer|recurrent bladder cancer
850547|NCT00006026|stage IV bladder cancer|stage iv bladder cancer
850548|NCT00006026|transitional cell carcinoma of the bladder|transitional cell carcinoma of the bladder
850549|NCT00006026|squamous cell carcinoma of the bladder|squamous cell carcinoma of the bladder
850550|NCT00006026|adenocarcinoma of the bladder|adenocarcinoma of the bladder
850551|NCT00006026|recurrent urethral cancer|recurrent urethral cancer
850552|NCT00006026|anterior urethral cancer|anterior urethral cancer
850553|NCT00006026|posterior urethral cancer|posterior urethral cancer
850554|NCT00006026|urethral cancer associated with invasive bladder cancer|urethral cancer associated with invasive bladder cancer
850555|NCT00006026|metastatic transitional cell cancer of the renal pelvis and ureter|metastatic transitional cell cancer of the renal pelvis and ureter
850556|NCT00006026|regional transitional cell cancer of the renal pelvis and ureter|regional transitional cell cancer of the renal pelvis and ureter
850557|NCT00006026|recurrent transitional cell cancer of the renal pelvis and ureter|recurrent transitional cell cancer of the renal pelvis and ureter
850558|NCT00005866|untreated adult acute myeloid leukemia|untreated adult acute myeloid leukemia
850559|NCT00005866|refractory anemia with excess blasts|refractory anemia with excess blasts
850560|NCT00005866|refractory anemia with excess blasts in transformation|refractory anemia with excess blasts in transformation
850561|NCT00005866|chronic myelomonocytic leukemia|chronic myelomonocytic leukemia
850562|NCT00005866|secondary acute myeloid leukemia|secondary acute myeloid leukemia
850563|NCT00005866|de novo myelodysplastic syndromes|de novo myelodysplastic syndromes
850564|NCT00005866|secondary myelodysplastic syndromes|secondary myelodysplastic syndromes
850565|NCT00005866|childhood myelodysplastic syndromes|childhood myelodysplastic syndromes
850566|NCT00005848|adenocarcinoma of the prostate|adenocarcinoma of the prostate
850567|NCT00005848|stage IV prostate cancer|stage iv prostate cancer
850568|NCT00005848|recurrent prostate cancer|recurrent prostate cancer
850569|NCT00005834|refractory multiple myeloma|refractory multiple myeloma
850570|NCT00005834|stage I multiple myeloma|stage i multiple myeloma
863966|NCT00054951|Hepatoma|hepatoma
850576|NCT00005085|stage IV rectal cancer|stage iv rectal cancer
850577|NCT00005085|recurrent colon cancer|recurrent colon cancer
850578|NCT00005085|recurrent rectal cancer|recurrent rectal cancer
850579|NCT00005085|adenocarcinoma of the colon|adenocarcinoma of the colon
850580|NCT00005085|adenocarcinoma of the rectum|adenocarcinoma of the rectum
850581|NCT00005037|recurrent non-small cell lung cancer|recurrent non-small cell lung cancer
850582|NCT00005037|stage IIIB non-small cell lung cancer|stage iiib non-small cell lung cancer
850583|NCT00005037|stage IV non-small cell lung cancer|stage iv non-small cell lung cancer
850584|NCT00004926|unspecified adult solid tumor, protocol specific|unspecified adult solid tumor, protocol specific
850585|NCT00004913|unspecified adult solid tumor, protocol specific|unspecified adult solid tumor, protocol specific
850586|NCT00004909|recurrent ovarian epithelial cancer|recurrent ovarian epithelial cancer
850587|NCT00004909|peritoneal cavity cancer|peritoneal cavity cancer
850588|NCT00004909|quality of life|quality of life
850589|NCT00004865|recurrent metastatic squamous neck cancer with occult primary|recurrent metastatic squamous neck cancer with occult primary
850590|NCT00004865|metastatic squamous neck cancer with occult primary squamous cell carcinoma|metastatic squamous neck cancer with occult primary squamous cell carcinoma
850591|NCT00004865|stage IV squamous cell carcinoma of the lip and oral cavity|stage iv squamous cell carcinoma of the lip and oral cavity
850592|NCT00004865|recurrent squamous cell carcinoma of the lip and oral cavity|recurrent squamous cell carcinoma of the lip and oral cavity
850593|NCT00004865|stage IV squamous cell carcinoma of the oropharynx|stage iv squamous cell carcinoma of the oropharynx
850594|NCT00004865|recurrent squamous cell carcinoma of the oropharynx|recurrent squamous cell carcinoma of the oropharynx
850595|NCT00004865|stage IV squamous cell carcinoma of the nasopharynx|stage iv squamous cell carcinoma of the nasopharynx
850596|NCT00004865|recurrent squamous cell carcinoma of the nasopharynx|recurrent squamous cell carcinoma of the nasopharynx
850597|NCT00004865|stage IV squamous cell carcinoma of the hypopharynx|stage iv squamous cell carcinoma of the hypopharynx
850598|NCT00004865|recurrent squamous cell carcinoma of the hypopharynx|recurrent squamous cell carcinoma of the hypopharynx
850599|NCT00004865|stage IV squamous cell carcinoma of the larynx|stage iv squamous cell carcinoma of the larynx
850600|NCT00004865|recurrent squamous cell carcinoma of the larynx|recurrent squamous cell carcinoma of the larynx
850601|NCT00004865|stage IV squamous cell carcinoma of the paranasal sinus and nasal cavity|stage iv squamous cell carcinoma of the paranasal sinus and nasal cavity
850602|NCT00004865|recurrent squamous cell carcinoma of the paranasal sinus and nasal cavity|recurrent squamous cell carcinoma of the paranasal sinus and nasal cavity
850603|NCT00004864|unspecified adult solid tumor, protocol specific|unspecified adult solid tumor, protocol specific
850604|NCT00004863|unspecified adult solid tumor, protocol specific|unspecified adult solid tumor, protocol specific
850605|NCT00004163|stage III salivary gland cancer|stage iii salivary gland cancer
851601|NCT00078715|Major Depression|major depression
850606|NCT00004163|stage IV salivary gland cancer|stage iv salivary gland cancer
850607|NCT00004163|recurrent salivary gland cancer|recurrent salivary gland cancer
850608|NCT00004163|salivary gland squamous cell carcinoma|salivary gland squamous cell carcinoma
850609|NCT00004163|salivary gland acinic cell tumor|salivary gland acinic cell tumor
850610|NCT00004163|low-grade salivary gland mucoepidermoid carcinoma|low-grade salivary gland mucoepidermoid carcinoma
850611|NCT00004163|high-grade salivary gland mucoepidermoid carcinoma|high-grade salivary gland mucoepidermoid carcinoma
850612|NCT00004163|salivary gland adenocarcinoma|salivary gland adenocarcinoma
850613|NCT00004163|salivary gland poorly differentiated carcinoma|salivary gland poorly differentiated carcinoma
850614|NCT00004163|salivary gland malignant mixed cell type tumor|salivary gland malignant mixed cell type tumor
850615|NCT00004163|salivary gland adenoid cystic carcinoma|salivary gland adenoid cystic carcinoma
850616|NCT00004151|recurrent non-small cell lung cancer|recurrent non-small cell lung cancer
850617|NCT00004151|stage IIIA non-small cell lung cancer|stage iiia non-small cell lung cancer
850618|NCT00004151|stage IIIB non-small cell lung cancer|stage iiib non-small cell lung cancer
850619|NCT00004151|stage IV non-small cell lung cancer|stage iv non-small cell lung cancer
850620|NCT00004142|stage IV colon cancer|stage iv colon cancer
850621|NCT00004142|stage IV rectal cancer|stage iv rectal cancer
850622|NCT00004142|recurrent colon cancer|recurrent colon cancer
850623|NCT00004142|recurrent rectal cancer|recurrent rectal cancer
850624|NCT00004142|liver metastases|liver metastases
850625|NCT00004109|stage III adult soft tissue sarcoma|stage iii adult soft tissue sarcoma
850626|NCT00004109|recurrent adult soft tissue sarcoma|recurrent adult soft tissue sarcoma
850627|NCT00004109|Doxorubicin|doxorubicin
850628|NCT00004109|External-Beam RT|external-beam rt
850629|NCT00004109|XRT|xrt
850630|NCT00004109|cancer|cancer
850631|NCT00004109|PREOPERATIVE CONCURRENT CHEMORADIATION|preoperative concurrent chemoradiation
850632|NCT00004109|EXTREMITY SOFT TISSUE SARCOMAS|extremity soft tissue sarcomas
850633|NCT00004109|TRUNK SOFT TISSUE SARCOMAS|trunk soft tissue sarcomas
850634|NCT00004109|Concurrent Chemoradiation|concurrent chemoradiation
850635|NCT00004109|Surgical Resection|surgical resection
850636|NCT00004109|Localized Extremity Soft Tissue Sarcomas|localized extremity soft tissue sarcomas
850637|NCT00004109|Body Wall Soft Tissue Sarcomas|body wall soft tissue sarcomas
850638|NCT00003959|refractory anemia|refractory anemia
850639|NCT00003959|refractory anemia with ringed sideroblasts|refractory anemia with ringed sideroblasts
850725|NCT00079638|Atherosclerosis|atherosclerosis
850640|NCT00003959|refractory anemia with excess blasts|refractory anemia with excess blasts
877585|NCT00001523|Cytology|cytology
850641|NCT00003959|chronic myelomonocytic leukemia|chronic myelomonocytic leukemia
850642|NCT00003959|de novo myelodysplastic syndromes|de novo myelodysplastic syndromes
850643|NCT00003959|previously treated myelodysplastic syndromes|previously treated myelodysplastic syndromes
850644|NCT00003959|secondary myelodysplastic syndromes|secondary myelodysplastic syndromes
850645|NCT00003779|stage 0 bladder cancer|stage 0 bladder cancer
850646|NCT00003779|stage I bladder cancer|stage i bladder cancer
850647|NCT00003772|stage I ovarian epithelial cancer|stage i ovarian epithelial cancer
850648|NCT00003772|stage II ovarian epithelial cancer|stage ii ovarian epithelial cancer
850649|NCT00003772|stage III ovarian epithelial cancer|stage iii ovarian epithelial cancer
850650|NCT00003772|stage IV ovarian epithelial cancer|stage iv ovarian epithelial cancer
850651|NCT00003772|recurrent ovarian epithelial cancer|recurrent ovarian epithelial cancer
850652|NCT00003742|unspecified adult solid tumor, protocol specific|unspecified adult solid tumor, protocol specific
850653|NCT00003706|unspecified adult solid tumor, protocol specific|unspecified adult solid tumor, protocol specific
850654|NCT00003705|unspecified adult solid tumor, protocol specific|unspecified adult solid tumor, protocol specific
850655|NCT00003704|stage III colon cancer|stage iii colon cancer
850656|NCT00003704|stage III rectal cancer|stage iii rectal cancer
850657|NCT00003704|recurrent colon cancer|recurrent colon cancer
850658|NCT00003704|recurrent rectal cancer|recurrent rectal cancer
850659|NCT00003704|recurrent anal cancer|recurrent anal cancer
850660|NCT00003704|stage IIIA anal cancer|stage iiia anal cancer
850661|NCT00003704|stage IIIB anal cancer|stage iiib anal cancer
850662|NCT00003704|stage III cervical cancer|stage iii cervical cancer
850663|NCT00003704|recurrent cervical cancer|recurrent cervical cancer
850664|NCT00003704|stage III ovarian epithelial cancer|stage iii ovarian epithelial cancer
850665|NCT00003704|recurrent ovarian epithelial cancer|recurrent ovarian epithelial cancer
850666|NCT00003704|stage III vulvar cancer|stage iii vulvar cancer
850667|NCT00003704|recurrent vulvar cancer|recurrent vulvar cancer
850668|NCT00003704|stage III vaginal cancer|stage iii vaginal cancer
850669|NCT00003704|recurrent vaginal cancer|recurrent vaginal cancer
850670|NCT00003704|stage III penile cancer|stage iii penile cancer
850671|NCT00003704|recurrent penile cancer|recurrent penile cancer
850672|NCT00003704|stage III endometrial carcinoma|stage iii endometrial carcinoma
850673|NCT00003704|recurrent endometrial carcinoma|recurrent endometrial carcinoma
850674|NCT00003704|stage III bladder cancer|stage iii bladder cancer
850675|NCT00003704|recurrent bladder cancer|recurrent bladder cancer
850676|NCT00003704|stage III malignant testicular germ cell tumor|stage iii malignant testicular germ cell tumor
850677|NCT00003704|stage III prostate cancer|stage iii prostate cancer
850678|NCT00003704|recurrent prostate cancer|recurrent prostate cancer
850679|NCT00003704|recurrent malignant testicular germ cell tumor|recurrent malignant testicular germ cell tumor
850680|NCT00003704|ovarian stromal cancer|ovarian stromal cancer
850681|NCT00003704|recurrent urethral cancer|recurrent urethral cancer
850682|NCT00003704|distal urethral cancer|distal urethral cancer
850683|NCT00003704|proximal urethral cancer|proximal urethral cancer
850684|NCT00003704|stage III ovarian germ cell tumor|stage iii ovarian germ cell tumor
850685|NCT00003704|recurrent ovarian germ cell tumor|recurrent ovarian germ cell tumor
850686|NCT00003704|fallopian tube cancer|fallopian tube cancer
850687|NCT00003704|primary peritoneal cavity cancer|primary peritoneal cavity cancer
850688|NCT00003704|stage III uterine sarcoma|stage iii uterine sarcoma
850689|NCT00003704|recurrent uterine sarcoma|recurrent uterine sarcoma
850690|NCT00003704|borderline ovarian surface epithelial-stromal tumor|borderline ovarian surface epithelial-stromal tumor
850691|NCT00003704|ovarian sarcoma|ovarian sarcoma
850692|NCT00003703|unspecified adult solid tumor, protocol specific|unspecified adult solid tumor, protocol specific
850693|NCT00003695|stage II ovarian epithelial cancer|stage ii ovarian epithelial cancer
850694|NCT00003695|stage III ovarian epithelial cancer|stage iii ovarian epithelial cancer
850695|NCT00079768|Inflammation|inflammation
850696|NCT00079768|Myositis|myositis
850697|NCT00079768|Humanized Monoclonal Antibody|humanized monoclonal antibody
850698|NCT00079768|Cytotoxic T Cells|cytotoxic t cells
850699|NCT00079768|Endomysial T Cells|endomysial t cells
850700|NCT00079768|Alemtuzumab|alemtuzumab
850701|NCT00079768|Monoclonal Antibodies|monoclonal antibodies
850702|NCT00079768|IBM|ibm
850703|NCT00079768|Anti-CD 52|anti-cd 52
850704|NCT00079768|Inclusion Body Myositis|inclusion body myositis
850705|NCT00079729|Treatment Experienced|treatment experienced
850706|NCT00079677|Excessive Sleepiness|excessive sleepiness
850707|NCT00079677|Obstructive Sleep Apnea|obstructive sleep apnea
850708|NCT00079677|Obstructive Sleep Hypopnea|obstructive sleep hypopnea
850709|NCT00079677|nCPAP|ncpap
850710|NCT00079677|Cephalon|cephalon
850711|NCT00079677|Cephalon, Inc|cephalon, inc
850712|NCT00079677|Nuvigil|nuvigil
850713|NCT00079664|Tai Ji|tai ji
850716|NCT00079651|Assisted Living Facilities|assisted living facilities
850717|NCT00079638|Niaspan|niaspan
850718|NCT00079638|Niacin|niacin
850719|NCT00079638|Statin|statin
850720|NCT00079638|Cholesterol|cholesterol
850721|NCT00079638|Triglycerides|triglycerides
850722|NCT00079638|Lipid-Modifying Therapies|lipid-modifying therapies
850723|NCT00079638|Dyslipidemia|dyslipidemia
850724|NCT00079638|Coronary Heart Disease|coronary heart disease
850728|NCT00079638|Niacin Statin Combination Threrapy|niacin statin combination threrapy
850729|NCT00079638|High Density Lipoprotein|high density lipoprotein
850730|NCT00079638|Low Density Lipoprotein|low density lipoprotein
850731|NCT00079638|Hypertension|hypertension
850732|NCT00079638|Diabetes|diabetes
850733|NCT00079638|Adult Treatment Panel III|adult treatment panel iii
850734|NCT00078039|Schizophrenia, paliperidone|schizophrenia, paliperidone
850735|NCT00003617|stage I gastric cancer|stage i gastric cancer
850736|NCT00003465|recurrent adult brain tumor|recurrent adult brain tumor
850737|NCT00003465|adult anaplastic oligodendroglioma|adult anaplastic oligodendroglioma
850738|NCT00003421|stage I adult Hodgkin lymphoma|stage i adult hodgkin lymphoma
850739|NCT00003421|stage II adult Hodgkin lymphoma|stage ii adult hodgkin lymphoma
850740|NCT00003421|stage III adult Hodgkin lymphoma|stage iii adult hodgkin lymphoma
850741|NCT00003421|stage IV adult Hodgkin lymphoma|stage iv adult hodgkin lymphoma
850742|NCT00003368|stage III adult Hodgkin lymphoma|stage iii adult hodgkin lymphoma
850743|NCT00003368|stage IV adult Hodgkin lymphoma|stage iv adult hodgkin lymphoma
850744|NCT00003368|recurrent adult Hodgkin lymphoma|recurrent adult hodgkin lymphoma
850745|NCT00003368|stage III cutaneous T-cell non-Hodgkin lymphoma|stage iii cutaneous t-cell non-hodgkin lymphoma
850746|NCT00003368|stage IV cutaneous T-cell non-Hodgkin lymphoma|stage iv cutaneous t-cell non-hodgkin lymphoma
850747|NCT00003368|recurrent cutaneous T-cell non-Hodgkin lymphoma|recurrent cutaneous t-cell non-hodgkin lymphoma
850748|NCT00003368|small intestine lymphoma|small intestine lymphoma
850749|NCT00003368|unspecified adult solid tumor, protocol specific|unspecified adult solid tumor, protocol specific
850750|NCT00003368|stage III grade 1 follicular lymphoma|stage iii grade 1 follicular lymphoma
850751|NCT00003368|stage III grade 2 follicular lymphoma|stage iii grade 2 follicular lymphoma
850752|NCT00003368|stage III grade 3 follicular lymphoma|stage iii grade 3 follicular lymphoma
850753|NCT00003368|stage III adult diffuse small cleaved cell lymphoma|stage iii adult diffuse small cleaved cell lymphoma
850754|NCT00003368|stage III adult diffuse mixed cell lymphoma|stage iii adult diffuse mixed cell lymphoma
850755|NCT00003368|stage III adult diffuse large cell lymphoma|stage iii adult diffuse large cell lymphoma
850756|NCT00003368|stage III adult immunoblastic large cell lymphoma|stage iii adult immunoblastic large cell lymphoma
850757|NCT00003368|stage III adult lymphoblastic lymphoma|stage iii adult lymphoblastic lymphoma
850758|NCT00003368|stage III adult Burkitt lymphoma|stage iii adult burkitt lymphoma
850759|NCT00003368|stage IV grade 1 follicular lymphoma|stage iv grade 1 follicular lymphoma
850760|NCT00003368|stage IV grade 2 follicular lymphoma|stage iv grade 2 follicular lymphoma
850761|NCT00003368|stage IV grade 3 follicular lymphoma|stage iv grade 3 follicular lymphoma
850762|NCT00003368|stage IV adult diffuse small cleaved cell lymphoma|stage iv adult diffuse small cleaved cell lymphoma
850763|NCT00003368|stage IV adult diffuse mixed cell lymphoma|stage iv adult diffuse mixed cell lymphoma
850764|NCT00003368|stage IV adult diffuse large cell lymphoma|stage iv adult diffuse large cell lymphoma
850765|NCT00003368|stage IV adult immunoblastic large cell lymphoma|stage iv adult immunoblastic large cell lymphoma
850766|NCT00003368|stage IV adult lymphoblastic lymphoma|stage iv adult lymphoblastic lymphoma
850767|NCT00003368|stage IV adult Burkitt lymphoma|stage iv adult burkitt lymphoma
850768|NCT00003368|recurrent grade 1 follicular lymphoma|recurrent grade 1 follicular lymphoma
850769|NCT00003368|recurrent grade 2 follicular lymphoma|recurrent grade 2 follicular lymphoma
850770|NCT00003368|recurrent grade 3 follicular lymphoma|recurrent grade 3 follicular lymphoma
850771|NCT00003368|recurrent adult diffuse small cleaved cell lymphoma|recurrent adult diffuse small cleaved cell lymphoma
850772|NCT00003368|recurrent adult diffuse mixed cell lymphoma|recurrent adult diffuse mixed cell lymphoma
850773|NCT00003368|recurrent adult diffuse large cell lymphoma|recurrent adult diffuse large cell lymphoma
850774|NCT00003368|recurrent adult immunoblastic large cell lymphoma|recurrent adult immunoblastic large cell lymphoma
850775|NCT00003368|recurrent adult lymphoblastic lymphoma|recurrent adult lymphoblastic lymphoma
850776|NCT00003368|recurrent adult Burkitt lymphoma|recurrent adult burkitt lymphoma
850777|NCT00003368|stage III adult T-cell leukemia/lymphoma|stage iii adult t-cell leukemia/lymphoma
850778|NCT00003368|stage IV adult T-cell leukemia/lymphoma|stage iv adult t-cell leukemia/lymphoma
850779|NCT00003368|recurrent adult T-cell leukemia/lymphoma|recurrent adult t-cell leukemia/lymphoma
850780|NCT00003368|primary central nervous system non-Hodgkin lymphoma|primary central nervous system non-hodgkin lymphoma
850781|NCT00003368|AIDS-related peripheral/systemic lymphoma|aids-related peripheral/systemic lymphoma
850782|NCT00003368|AIDS-related primary CNS lymphoma|aids-related primary cns lymphoma
850783|NCT00003368|intraocular lymphoma|intraocular lymphoma
850784|NCT00003368|stage III mantle cell lymphoma|stage iii mantle cell lymphoma
850785|NCT00003368|stage IV mantle cell lymphoma|stage iv mantle cell lymphoma
850786|NCT00003368|recurrent mantle cell lymphoma|recurrent mantle cell lymphoma
850787|NCT00003368|angioimmunoblastic T-cell lymphoma|angioimmunoblastic t-cell lymphoma
850788|NCT00003368|anaplastic large cell lymphoma|anaplastic large cell lymphoma
850789|NCT00003368|stage III mycosis fungoides/Sezary syndrome|stage iii mycosis fungoides/sezary syndrome
850790|NCT00003368|stage IV mycosis fungoides/Sezary syndrome|stage iv mycosis fungoides/sezary syndrome
850791|NCT00003368|recurrent mycosis fungoides/Sezary syndrome|recurrent mycosis fungoides/sezary syndrome
850792|NCT00003368|recurrent marginal zone lymphoma|recurrent marginal zone lymphoma
850793|NCT00003368|recurrent small lymphocytic lymphoma|recurrent small lymphocytic lymphoma
850794|NCT00003368|stage III small lymphocytic lymphoma|stage iii small lymphocytic lymphoma
864066|NCT00050531|Gleevec|gleevec
850795|NCT00003368|stage III marginal zone lymphoma|stage iii marginal zone lymphoma
850796|NCT00003368|stage IV small lymphocytic lymphoma|stage iv small lymphocytic lymphoma
850797|NCT00003368|stage IV marginal zone lymphoma|stage iv marginal zone lymphoma
850798|NCT00003368|extranodal marginal zone B-cell lymphoma of mucosa-associated lymphoid tissue|extranodal marginal zone b-cell lymphoma of mucosa-associated lymphoid tissue
850799|NCT00003368|nodal marginal zone B-cell lymphoma|nodal marginal zone b-cell lymphoma
850800|NCT00003368|splenic marginal zone lymphoma|splenic marginal zone lymphoma
850801|NCT00003361|refractory anemia|refractory anemia
850802|NCT00003361|refractory anemia with ringed sideroblasts|refractory anemia with ringed sideroblasts
850803|NCT00003361|refractory anemia with excess blasts|refractory anemia with excess blasts
850804|NCT00003361|refractory anemia with excess blasts in transformation|refractory anemia with excess blasts in transformation
850805|NCT00003361|chronic myelomonocytic leukemia|chronic myelomonocytic leukemia
850806|NCT00003361|de novo myelodysplastic syndromes|de novo myelodysplastic syndromes
850807|NCT00003361|previously treated myelodysplastic syndromes|previously treated myelodysplastic syndromes
850808|NCT00003361|secondary myelodysplastic syndromes|secondary myelodysplastic syndromes
850809|NCT00003361|childhood myelodysplastic syndromes|childhood myelodysplastic syndromes
850810|NCT00003338|stage I grade 1 follicular lymphoma|stage i grade 1 follicular lymphoma
850811|NCT00003338|stage I grade 2 follicular lymphoma|stage i grade 2 follicular lymphoma
850812|NCT00003338|stage I grade 3 follicular lymphoma|stage i grade 3 follicular lymphoma
850813|NCT00003338|stage I adult diffuse small cleaved cell lymphoma|stage i adult diffuse small cleaved cell lymphoma
850814|NCT00003338|stage I adult diffuse mixed cell lymphoma|stage i adult diffuse mixed cell lymphoma
850815|NCT00003338|stage I adult diffuse large cell lymphoma|stage i adult diffuse large cell lymphoma
850816|NCT00003338|stage I adult immunoblastic large cell lymphoma|stage i adult immunoblastic large cell lymphoma
850817|NCT00003338|stage I adult lymphoblastic lymphoma|stage i adult lymphoblastic lymphoma
850818|NCT00003338|stage I adult Burkitt lymphoma|stage i adult burkitt lymphoma
850819|NCT00003338|stage III grade 1 follicular lymphoma|stage iii grade 1 follicular lymphoma
850820|NCT00003338|stage III grade 2 follicular lymphoma|stage iii grade 2 follicular lymphoma
850821|NCT00003338|stage III grade 3 follicular lymphoma|stage iii grade 3 follicular lymphoma
850822|NCT00003338|stage III adult diffuse small cleaved cell lymphoma|stage iii adult diffuse small cleaved cell lymphoma
850823|NCT00003338|stage III adult diffuse mixed cell lymphoma|stage iii adult diffuse mixed cell lymphoma
850824|NCT00003338|stage III adult diffuse large cell lymphoma|stage iii adult diffuse large cell lymphoma
850825|NCT00003338|stage III adult immunoblastic large cell lymphoma|stage iii adult immunoblastic large cell lymphoma
850826|NCT00003338|stage III adult lymphoblastic lymphoma|stage iii adult lymphoblastic lymphoma
850827|NCT00003338|stage III adult Burkitt lymphoma|stage iii adult burkitt lymphoma
850828|NCT00003338|stage IV grade 1 follicular lymphoma|stage iv grade 1 follicular lymphoma
850829|NCT00003338|stage IV grade 2 follicular lymphoma|stage iv grade 2 follicular lymphoma
850830|NCT00003338|stage IV grade 3 follicular lymphoma|stage iv grade 3 follicular lymphoma
850831|NCT00003338|stage IV adult diffuse small cleaved cell lymphoma|stage iv adult diffuse small cleaved cell lymphoma
850832|NCT00003338|stage IV adult diffuse mixed cell lymphoma|stage iv adult diffuse mixed cell lymphoma
850833|NCT00003338|stage IV adult diffuse large cell lymphoma|stage iv adult diffuse large cell lymphoma
850834|NCT00003338|stage IV adult immunoblastic large cell lymphoma|stage iv adult immunoblastic large cell lymphoma
850835|NCT00003338|stage IV adult lymphoblastic lymphoma|stage iv adult lymphoblastic lymphoma
850836|NCT00003338|stage IV adult Burkitt lymphoma|stage iv adult burkitt lymphoma
850837|NCT00003338|recurrent grade 1 follicular lymphoma|recurrent grade 1 follicular lymphoma
850838|NCT00003338|recurrent grade 2 follicular lymphoma|recurrent grade 2 follicular lymphoma
850839|NCT00003338|recurrent grade 3 follicular lymphoma|recurrent grade 3 follicular lymphoma
850840|NCT00003338|recurrent adult diffuse small cleaved cell lymphoma|recurrent adult diffuse small cleaved cell lymphoma
850841|NCT00003338|recurrent adult diffuse mixed cell lymphoma|recurrent adult diffuse mixed cell lymphoma
850842|NCT00003338|recurrent adult diffuse large cell lymphoma|recurrent adult diffuse large cell lymphoma
850843|NCT00003338|recurrent adult immunoblastic large cell lymphoma|recurrent adult immunoblastic large cell lymphoma
850844|NCT00003338|recurrent adult lymphoblastic lymphoma|recurrent adult lymphoblastic lymphoma
850845|NCT00003338|recurrent adult Burkitt lymphoma|recurrent adult burkitt lymphoma
850846|NCT00003338|stage I mantle cell lymphoma|stage i mantle cell lymphoma
850847|NCT00003338|contiguous stage II grade 1 follicular lymphoma|contiguous stage ii grade 1 follicular lymphoma
850848|NCT00003338|contiguous stage II grade 2 follicular lymphoma|contiguous stage ii grade 2 follicular lymphoma
850849|NCT00003338|contiguous stage II grade 3 follicular lymphoma|contiguous stage ii grade 3 follicular lymphoma
850850|NCT00003338|contiguous stage II adult diffuse small cleaved cell lymphoma|contiguous stage ii adult diffuse small cleaved cell lymphoma
850851|NCT00003338|contiguous stage II mantle cell lymphoma|contiguous stage ii mantle cell lymphoma
850852|NCT00003338|contiguous stage II adult diffuse mixed cell lymphoma|contiguous stage ii adult diffuse mixed cell lymphoma
850853|NCT00003338|contiguous stage II adult immunoblastic large cell lymphoma|contiguous stage ii adult immunoblastic large cell lymphoma
850854|NCT00003338|contiguous stage II adult diffuse large cell lymphoma|contiguous stage ii adult diffuse large cell lymphoma
850855|NCT00003338|contiguous stage II adult Burkitt lymphoma|contiguous stage ii adult burkitt lymphoma
850856|NCT00003338|contiguous stage II adult lymphoblastic lymphoma|contiguous stage ii adult lymphoblastic lymphoma
850857|NCT00003338|noncontiguous stage II grade 1 follicular lymphoma|noncontiguous stage ii grade 1 follicular lymphoma
850858|NCT00003338|noncontiguous stage II grade 2 follicular lymphoma|noncontiguous stage ii grade 2 follicular lymphoma
850859|NCT00003338|noncontiguous stage II grade 3 follicular lymphoma|noncontiguous stage ii grade 3 follicular lymphoma
850860|NCT00003338|noncontiguous stage II adult diffuse small cleaved cell lymphoma|noncontiguous stage ii adult diffuse small cleaved cell lymphoma
850861|NCT00003338|noncontiguous stage II mantle cell lymphoma|noncontiguous stage ii mantle cell lymphoma
850862|NCT00003338|noncontiguous stage II adult diffuse mixed cell lymphoma|noncontiguous stage ii adult diffuse mixed cell lymphoma
850863|NCT00003338|noncontiguous stage II adult immunoblastic large cell lymphoma|noncontiguous stage ii adult immunoblastic large cell lymphoma
850864|NCT00003338|noncontiguous stage II adult diffuse large cell lymphoma|noncontiguous stage ii adult diffuse large cell lymphoma
850865|NCT00003338|noncontiguous stage II adult Burkitt lymphoma|noncontiguous stage ii adult burkitt lymphoma
850866|NCT00003338|noncontiguous stage II adult lymphoblastic lymphoma|noncontiguous stage ii adult lymphoblastic lymphoma
850867|NCT00003338|stage III mantle cell lymphoma|stage iii mantle cell lymphoma
850868|NCT00003338|stage IV mantle cell lymphoma|stage iv mantle cell lymphoma
850869|NCT00003338|recurrent mantle cell lymphoma|recurrent mantle cell lymphoma
850870|NCT00003338|noncontiguous stage II small lymphocytic lymphoma|noncontiguous stage ii small lymphocytic lymphoma
850871|NCT00003338|noncontiguous stage II marginal zone lymphoma|noncontiguous stage ii marginal zone lymphoma
850872|NCT00003338|recurrent marginal zone lymphoma|recurrent marginal zone lymphoma
850873|NCT00003338|recurrent small lymphocytic lymphoma|recurrent small lymphocytic lymphoma
850874|NCT00003338|stage I marginal zone lymphoma|stage i marginal zone lymphoma
850875|NCT00003338|stage I small lymphocytic lymphoma|stage i small lymphocytic lymphoma
850876|NCT00003338|stage III small lymphocytic lymphoma|stage iii small lymphocytic lymphoma
850877|NCT00003338|stage III marginal zone lymphoma|stage iii marginal zone lymphoma
850878|NCT00003338|stage IV small lymphocytic lymphoma|stage iv small lymphocytic lymphoma
850879|NCT00003338|stage IV marginal zone lymphoma|stage iv marginal zone lymphoma
850880|NCT00003338|contiguous stage II marginal zone lymphoma|contiguous stage ii marginal zone lymphoma
850881|NCT00003338|contiguous stage II small lymphocytic lymphoma|contiguous stage ii small lymphocytic lymphoma
850882|NCT00003338|extranodal marginal zone B-cell lymphoma of mucosa-associated lymphoid tissue|extranodal marginal zone b-cell lymphoma of mucosa-associated lymphoid tissue
850883|NCT00003338|nodal marginal zone B-cell lymphoma|nodal marginal zone b-cell lymphoma
850884|NCT00003338|splenic marginal zone lymphoma|splenic marginal zone lymphoma
850885|NCT00003337|stage I grade 1 follicular lymphoma|stage i grade 1 follicular lymphoma
850886|NCT00003337|stage I grade 2 follicular lymphoma|stage i grade 2 follicular lymphoma
850887|NCT00003337|stage I grade 3 follicular lymphoma|stage i grade 3 follicular lymphoma
850888|NCT00003337|stage I adult diffuse small cleaved cell lymphoma|stage i adult diffuse small cleaved cell lymphoma
850889|NCT00003337|stage I adult diffuse mixed cell lymphoma|stage i adult diffuse mixed cell lymphoma
850890|NCT00003337|stage I adult diffuse large cell lymphoma|stage i adult diffuse large cell lymphoma
850891|NCT00003337|stage I adult immunoblastic large cell lymphoma|stage i adult immunoblastic large cell lymphoma
850892|NCT00003337|stage I adult lymphoblastic lymphoma|stage i adult lymphoblastic lymphoma
850893|NCT00003337|stage I adult Burkitt lymphoma|stage i adult burkitt lymphoma
850894|NCT00003337|stage III grade 1 follicular lymphoma|stage iii grade 1 follicular lymphoma
850895|NCT00003337|stage III grade 2 follicular lymphoma|stage iii grade 2 follicular lymphoma
850896|NCT00003337|stage III grade 3 follicular lymphoma|stage iii grade 3 follicular lymphoma
850897|NCT00003337|stage III adult diffuse small cleaved cell lymphoma|stage iii adult diffuse small cleaved cell lymphoma
850898|NCT00003337|stage III adult diffuse mixed cell lymphoma|stage iii adult diffuse mixed cell lymphoma
850899|NCT00003337|stage III adult diffuse large cell lymphoma|stage iii adult diffuse large cell lymphoma
850900|NCT00003337|stage III adult immunoblastic large cell lymphoma|stage iii adult immunoblastic large cell lymphoma
850901|NCT00003337|stage III adult lymphoblastic lymphoma|stage iii adult lymphoblastic lymphoma
850902|NCT00003337|stage III adult Burkitt lymphoma|stage iii adult burkitt lymphoma
850903|NCT00003337|stage IV grade 1 follicular lymphoma|stage iv grade 1 follicular lymphoma
850904|NCT00003337|stage IV grade 2 follicular lymphoma|stage iv grade 2 follicular lymphoma
850905|NCT00003337|stage IV grade 3 follicular lymphoma|stage iv grade 3 follicular lymphoma
850906|NCT00003337|stage IV adult diffuse small cleaved cell lymphoma|stage iv adult diffuse small cleaved cell lymphoma
850907|NCT00003337|stage IV adult diffuse mixed cell lymphoma|stage iv adult diffuse mixed cell lymphoma
850908|NCT00003337|stage IV adult diffuse large cell lymphoma|stage iv adult diffuse large cell lymphoma
850909|NCT00003337|stage IV adult immunoblastic large cell lymphoma|stage iv adult immunoblastic large cell lymphoma
850910|NCT00003337|stage IV adult lymphoblastic lymphoma|stage iv adult lymphoblastic lymphoma
850911|NCT00003337|stage IV adult Burkitt lymphoma|stage iv adult burkitt lymphoma
850912|NCT00003337|recurrent grade 1 follicular lymphoma|recurrent grade 1 follicular lymphoma
850913|NCT00003337|recurrent grade 2 follicular lymphoma|recurrent grade 2 follicular lymphoma
850914|NCT00003337|recurrent grade 3 follicular lymphoma|recurrent grade 3 follicular lymphoma
850915|NCT00003337|recurrent adult diffuse small cleaved cell lymphoma|recurrent adult diffuse small cleaved cell lymphoma
850916|NCT00003337|recurrent adult diffuse mixed cell lymphoma|recurrent adult diffuse mixed cell lymphoma
850917|NCT00003337|recurrent adult diffuse large cell lymphoma|recurrent adult diffuse large cell lymphoma
850982|NCT00002930|stage IIIB non-small cell lung cancer|stage iiib non-small cell lung cancer
850918|NCT00003337|recurrent adult immunoblastic large cell lymphoma|recurrent adult immunoblastic large cell lymphoma
850919|NCT00003337|recurrent adult lymphoblastic lymphoma|recurrent adult lymphoblastic lymphoma
850920|NCT00003337|recurrent adult Burkitt lymphoma|recurrent adult burkitt lymphoma
850921|NCT00003337|stage I mantle cell lymphoma|stage i mantle cell lymphoma
850922|NCT00003337|contiguous stage II grade 1 follicular lymphoma|contiguous stage ii grade 1 follicular lymphoma
850923|NCT00003337|contiguous stage II grade 2 follicular lymphoma|contiguous stage ii grade 2 follicular lymphoma
850924|NCT00003337|contiguous stage II grade 3 follicular lymphoma|contiguous stage ii grade 3 follicular lymphoma
850925|NCT00003337|contiguous stage II adult diffuse small cleaved cell lymphoma|contiguous stage ii adult diffuse small cleaved cell lymphoma
850926|NCT00003337|contiguous stage II mantle cell lymphoma|contiguous stage ii mantle cell lymphoma
850927|NCT00003337|contiguous stage II adult diffuse mixed cell lymphoma|contiguous stage ii adult diffuse mixed cell lymphoma
850928|NCT00003337|contiguous stage II adult immunoblastic large cell lymphoma|contiguous stage ii adult immunoblastic large cell lymphoma
850929|NCT00003337|contiguous stage II adult diffuse large cell lymphoma|contiguous stage ii adult diffuse large cell lymphoma
850930|NCT00003337|contiguous stage II adult Burkitt lymphoma|contiguous stage ii adult burkitt lymphoma
850931|NCT00003337|contiguous stage II adult lymphoblastic lymphoma|contiguous stage ii adult lymphoblastic lymphoma
850932|NCT00003337|noncontiguous stage II grade 1 follicular lymphoma|noncontiguous stage ii grade 1 follicular lymphoma
850933|NCT00003337|noncontiguous stage II grade 2 follicular lymphoma|noncontiguous stage ii grade 2 follicular lymphoma
850934|NCT00003337|noncontiguous stage II grade 3 follicular lymphoma|noncontiguous stage ii grade 3 follicular lymphoma
850935|NCT00003337|noncontiguous stage II adult diffuse small cleaved cell lymphoma|noncontiguous stage ii adult diffuse small cleaved cell lymphoma
850936|NCT00003337|noncontiguous stage II mantle cell lymphoma|noncontiguous stage ii mantle cell lymphoma
850937|NCT00003337|noncontiguous stage II adult diffuse mixed cell lymphoma|noncontiguous stage ii adult diffuse mixed cell lymphoma
850938|NCT00003337|noncontiguous stage II adult immunoblastic large cell lymphoma|noncontiguous stage ii adult immunoblastic large cell lymphoma
850939|NCT00003337|noncontiguous stage II adult diffuse large cell lymphoma|noncontiguous stage ii adult diffuse large cell lymphoma
850940|NCT00003337|noncontiguous stage II adult Burkitt lymphoma|noncontiguous stage ii adult burkitt lymphoma
850941|NCT00003337|noncontiguous stage II adult lymphoblastic lymphoma|noncontiguous stage ii adult lymphoblastic lymphoma
850942|NCT00003337|stage III mantle cell lymphoma|stage iii mantle cell lymphoma
850943|NCT00003337|stage IV mantle cell lymphoma|stage iv mantle cell lymphoma
850944|NCT00003337|recurrent mantle cell lymphoma|recurrent mantle cell lymphoma
850945|NCT00003337|noncontiguous stage II small lymphocytic lymphoma|noncontiguous stage ii small lymphocytic lymphoma
850946|NCT00003337|noncontiguous stage II marginal zone lymphoma|noncontiguous stage ii marginal zone lymphoma
850947|NCT00003337|recurrent marginal zone lymphoma|recurrent marginal zone lymphoma
850948|NCT00003337|recurrent small lymphocytic lymphoma|recurrent small lymphocytic lymphoma
850949|NCT00003337|stage I marginal zone lymphoma|stage i marginal zone lymphoma
850950|NCT00003337|stage I small lymphocytic lymphoma|stage i small lymphocytic lymphoma
850951|NCT00003337|stage III small lymphocytic lymphoma|stage iii small lymphocytic lymphoma
850952|NCT00003337|stage III marginal zone lymphoma|stage iii marginal zone lymphoma
850953|NCT00003337|stage IV small lymphocytic lymphoma|stage iv small lymphocytic lymphoma
850954|NCT00003337|stage IV marginal zone lymphoma|stage iv marginal zone lymphoma
850955|NCT00003337|contiguous stage II marginal zone lymphoma|contiguous stage ii marginal zone lymphoma
850956|NCT00003337|contiguous stage II small lymphocytic lymphoma|contiguous stage ii small lymphocytic lymphoma
850957|NCT00003337|extranodal marginal zone B-cell lymphoma of mucosa-associated lymphoid tissue|extranodal marginal zone b-cell lymphoma of mucosa-associated lymphoid tissue
850958|NCT00003337|nodal marginal zone B-cell lymphoma|nodal marginal zone b-cell lymphoma
850959|NCT00003337|splenic marginal zone lymphoma|splenic marginal zone lymphoma
850961|NCT00003212|adult fibrosarcoma|adult fibrosarcoma
850962|NCT00003212|adult leiomyosarcoma|adult leiomyosarcoma
850963|NCT00003212|adult liposarcoma|adult liposarcoma
850964|NCT00003212|adult neurofibrosarcoma|adult neurofibrosarcoma
850965|NCT00003212|adult synovial sarcoma|adult synovial sarcoma
850966|NCT00003212|recurrent adult soft tissue sarcoma|recurrent adult soft tissue sarcoma
850967|NCT00003212|adult malignant fibrous histiocytoma|adult malignant fibrous histiocytoma
850968|NCT00003212|adult malignant hemangiopericytoma|adult malignant hemangiopericytoma
850969|NCT00003212|adult rhabdomyosarcoma|adult rhabdomyosarcoma
850970|NCT00003212|stage IV uterine sarcoma|stage iv uterine sarcoma
850971|NCT00003212|recurrent uterine sarcoma|recurrent uterine sarcoma
850972|NCT00003212|stage IV adult soft tissue sarcoma|stage iv adult soft tissue sarcoma
850973|NCT00003021|unspecified adult solid tumor, protocol specific|unspecified adult solid tumor, protocol specific
850974|NCT00003014|stage I malignant testicular germ cell tumor|stage i malignant testicular germ cell tumor
850975|NCT00003014|testicular seminoma|testicular seminoma
850976|NCT00002930|stage I non-small cell lung cancer|stage i non-small cell lung cancer
850977|NCT00002930|stage II non-small cell lung cancer|stage ii non-small cell lung cancer
850978|NCT00002930|stage I esophageal cancer|stage i esophageal cancer
850979|NCT00002930|stage II esophageal cancer|stage ii esophageal cancer
850980|NCT00002930|stage III esophageal cancer|stage iii esophageal cancer
850981|NCT00002930|stage IIIA non-small cell lung cancer|stage iiia non-small cell lung cancer
850983|NCT00002928|recurrent ovarian epithelial cancer|recurrent ovarian epithelial cancer
850984|NCT00002919|stage II bladder cancer|stage ii bladder cancer
851113|NCT00002526|recurrent uterine sarcoma|recurrent uterine sarcoma
850985|NCT00002919|transitional cell carcinoma of the bladder|transitional cell carcinoma of the bladder
850986|NCT00002901|stage IV breast cancer|stage iv breast cancer
850987|NCT00002901|stage IIIA breast cancer|stage iiia breast cancer
850988|NCT00002901|recurrent breast cancer|recurrent breast cancer
850989|NCT00002901|stage IIIB breast cancer|stage iiib breast cancer
850990|NCT00002901|recurrent non-small cell lung cancer|recurrent non-small cell lung cancer
850991|NCT00002901|stage III ovarian epithelial cancer|stage iii ovarian epithelial cancer
850992|NCT00002901|stage IV ovarian epithelial cancer|stage iv ovarian epithelial cancer
850993|NCT00002901|recurrent ovarian epithelial cancer|recurrent ovarian epithelial cancer
850994|NCT00002901|stage IV nasopharyngeal cancer|stage iv nasopharyngeal cancer
850995|NCT00002901|stage IIIA non-small cell lung cancer|stage iiia non-small cell lung cancer
850996|NCT00002901|stage IIIB non-small cell lung cancer|stage iiib non-small cell lung cancer
850997|NCT00002901|stage IV non-small cell lung cancer|stage iv non-small cell lung cancer
850998|NCT00002901|unspecified adult solid tumor, protocol specific|unspecified adult solid tumor, protocol specific
850999|NCT00002901|recurrent metastatic squamous neck cancer with occult primary|recurrent metastatic squamous neck cancer with occult primary
851000|NCT00002901|ovarian stromal cancer|ovarian stromal cancer
851001|NCT00002901|stage III ovarian germ cell tumor|stage iii ovarian germ cell tumor
851002|NCT00002901|stage IV ovarian germ cell tumor|stage iv ovarian germ cell tumor
851003|NCT00002901|recurrent ovarian germ cell tumor|recurrent ovarian germ cell tumor
851004|NCT00002901|stage III squamous cell carcinoma of the lip and oral cavity|stage iii squamous cell carcinoma of the lip and oral cavity
851005|NCT00002901|stage III basal cell carcinoma of the lip|stage iii basal cell carcinoma of the lip
851006|NCT00002901|stage III verrucous carcinoma of the oral cavity|stage iii verrucous carcinoma of the oral cavity
851007|NCT00002901|stage III mucoepidermoid carcinoma of the oral cavity|stage iii mucoepidermoid carcinoma of the oral cavity
851008|NCT00002901|stage III adenoid cystic carcinoma of the oral cavity|stage iii adenoid cystic carcinoma of the oral cavity
851009|NCT00002901|stage IV squamous cell carcinoma of the lip and oral cavity|stage iv squamous cell carcinoma of the lip and oral cavity
851010|NCT00002901|stage IV basal cell carcinoma of the lip|stage iv basal cell carcinoma of the lip
851011|NCT00002901|stage IV verrucous carcinoma of the oral cavity|stage iv verrucous carcinoma of the oral cavity
851012|NCT00002901|stage IV mucoepidermoid carcinoma of the oral cavity|stage iv mucoepidermoid carcinoma of the oral cavity
851013|NCT00002901|stage IV adenoid cystic carcinoma of the oral cavity|stage iv adenoid cystic carcinoma of the oral cavity
851014|NCT00002901|recurrent squamous cell carcinoma of the lip and oral cavity|recurrent squamous cell carcinoma of the lip and oral cavity
851015|NCT00002901|recurrent basal cell carcinoma of the lip|recurrent basal cell carcinoma of the lip
851016|NCT00002901|recurrent verrucous carcinoma of the oral cavity|recurrent verrucous carcinoma of the oral cavity
851017|NCT00002901|recurrent mucoepidermoid carcinoma of the oral cavity|recurrent mucoepidermoid carcinoma of the oral cavity
851018|NCT00002901|recurrent adenoid cystic carcinoma of the oral cavity|recurrent adenoid cystic carcinoma of the oral cavity
851019|NCT00002901|stage III squamous cell carcinoma of the oropharynx|stage iii squamous cell carcinoma of the oropharynx
851020|NCT00002901|stage III lymphoepithelioma of the oropharynx|stage iii lymphoepithelioma of the oropharynx
851021|NCT00002901|stage IV squamous cell carcinoma of the oropharynx|stage iv squamous cell carcinoma of the oropharynx
851022|NCT00002901|stage IV lymphoepithelioma of the oropharynx|stage iv lymphoepithelioma of the oropharynx
851023|NCT00002901|recurrent squamous cell carcinoma of the oropharynx|recurrent squamous cell carcinoma of the oropharynx
851024|NCT00002901|recurrent lymphoepithelioma of the oropharynx|recurrent lymphoepithelioma of the oropharynx
851025|NCT00002901|stage III squamous cell carcinoma of the nasopharynx|stage iii squamous cell carcinoma of the nasopharynx
851026|NCT00002901|stage III lymphoepithelioma of the nasopharynx|stage iii lymphoepithelioma of the nasopharynx
851027|NCT00002901|stage IV squamous cell carcinoma of the nasopharynx|stage iv squamous cell carcinoma of the nasopharynx
851028|NCT00002901|stage IV lymphoepithelioma of the nasopharynx|stage iv lymphoepithelioma of the nasopharynx
851029|NCT00002901|recurrent squamous cell carcinoma of the nasopharynx|recurrent squamous cell carcinoma of the nasopharynx
851030|NCT00002901|recurrent lymphoepithelioma of the nasopharynx|recurrent lymphoepithelioma of the nasopharynx
851031|NCT00002901|stage III squamous cell carcinoma of the hypopharynx|stage iii squamous cell carcinoma of the hypopharynx
851032|NCT00002901|stage IV squamous cell carcinoma of the hypopharynx|stage iv squamous cell carcinoma of the hypopharynx
851033|NCT00002901|recurrent squamous cell carcinoma of the hypopharynx|recurrent squamous cell carcinoma of the hypopharynx
851034|NCT00002901|stage III squamous cell carcinoma of the larynx|stage iii squamous cell carcinoma of the larynx
851035|NCT00002901|stage III verrucous carcinoma of the larynx|stage iii verrucous carcinoma of the larynx
851036|NCT00002901|stage IV squamous cell carcinoma of the larynx|stage iv squamous cell carcinoma of the larynx
851037|NCT00002901|stage IV verrucous carcinoma of the larynx|stage iv verrucous carcinoma of the larynx
851038|NCT00002901|recurrent squamous cell carcinoma of the larynx|recurrent squamous cell carcinoma of the larynx
851039|NCT00002901|recurrent verrucous carcinoma of the larynx|recurrent verrucous carcinoma of the larynx
851040|NCT00002901|stage III squamous cell carcinoma of the paranasal sinus and nasal cavity|stage iii squamous cell carcinoma of the paranasal sinus and nasal cavity
851041|NCT00002901|stage III inverted papilloma of the paranasal sinus and nasal cavity|stage iii inverted papilloma of the paranasal sinus and nasal cavity
851042|NCT00002901|stage III midline lethal granuloma of the paranasal sinus and nasal cavity|stage iii midline lethal granuloma of the paranasal sinus and nasal cavity
878109|NCT00001193|Stage III|stage iii
851043|NCT00002901|stage III esthesioneuroblastoma of the paranasal sinus and nasal cavity|stage iii esthesioneuroblastoma of the paranasal sinus and nasal cavity
851044|NCT00002901|stage IV squamous cell carcinoma of the paranasal sinus and nasal cavity|stage iv squamous cell carcinoma of the paranasal sinus and nasal cavity
851045|NCT00002901|stage IV inverted papilloma of the paranasal sinus and nasal cavity|stage iv inverted papilloma of the paranasal sinus and nasal cavity
851046|NCT00002901|stage IV midline lethal granuloma of the paranasal sinus and nasal cavity|stage iv midline lethal granuloma of the paranasal sinus and nasal cavity
851047|NCT00002901|stage IV esthesioneuroblastoma of the paranasal sinus and nasal cavity|stage iv esthesioneuroblastoma of the paranasal sinus and nasal cavity
851048|NCT00002901|recurrent squamous cell carcinoma of the paranasal sinus and nasal cavity|recurrent squamous cell carcinoma of the paranasal sinus and nasal cavity
851049|NCT00002901|recurrent inverted papilloma of the paranasal sinus and nasal cavity|recurrent inverted papilloma of the paranasal sinus and nasal cavity
851050|NCT00002901|recurrent midline lethal granuloma of the paranasal sinus and nasal cavity|recurrent midline lethal granuloma of the paranasal sinus and nasal cavity
851051|NCT00002901|recurrent esthesioneuroblastoma of the paranasal sinus and nasal cavity|recurrent esthesioneuroblastoma of the paranasal sinus and nasal cavity
851052|NCT00002901|borderline ovarian surface epithelial-stromal tumor|borderline ovarian surface epithelial-stromal tumor
851053|NCT00002901|ovarian sarcoma|ovarian sarcoma
851054|NCT00002858|limited stage small cell lung cancer|limited stage small cell lung cancer
851055|NCT00079612|Renal Cell Cancer|renal cell cancer
851057|NCT00079612|Cancer|cancer
851058|NCT00079508|Heparin-induced Thrombocytopenia|heparin-induced thrombocytopenia
851059|NCT00079508|Heparin-induced Thrombocytopenia/Thrombosis Syndrome|heparin-induced thrombocytopenia/thrombosis syndrome
851060|NCT00079508|HIT/HITTS|hit/hitts
851061|NCT00079508|Heparin anti-body positive|heparin anti-body positive
851062|NCT00021359|stage I multiple myeloma|stage i multiple myeloma
851063|NCT00021359|stage II multiple myeloma|stage ii multiple myeloma
851064|NCT00021359|stage III multiple myeloma|stage iii multiple myeloma
851065|NCT00017030|stage III adult soft tissue sarcoma|stage iii adult soft tissue sarcoma
851066|NCT00017030|recurrent adult soft tissue sarcoma|recurrent adult soft tissue sarcoma
851067|NCT00017030|stage IV adult soft tissue sarcoma|stage iv adult soft tissue sarcoma
851068|NCT00016978|stage IV colon cancer|stage iv colon cancer
851069|NCT00016978|stage IV rectal cancer|stage iv rectal cancer
851070|NCT00016978|recurrent colon cancer|recurrent colon cancer
851071|NCT00016978|recurrent rectal cancer|recurrent rectal cancer
851072|NCT00016978|adenocarcinoma of the colon|adenocarcinoma of the colon
851073|NCT00016978|adenocarcinoma of the rectum|adenocarcinoma of the rectum
851074|NCT00014547|extensive stage small cell lung cancer|extensive stage small cell lung cancer
851075|NCT00014547|recurrent small cell lung cancer|recurrent small cell lung cancer
851076|NCT00007969|stage III melanoma|stage iii melanoma
851077|NCT00007969|stage IV melanoma|stage iv melanoma
851078|NCT00007969|recurrent melanoma|recurrent melanoma
851079|NCT00002823|stage I non-small cell lung cancer|stage i non-small cell lung cancer
851080|NCT00002823|stage II non-small cell lung cancer|stage ii non-small cell lung cancer
851081|NCT00002823|stage III non-small cell lung cancer|stage iii non-small cell lung cancer
851082|NCT00002823|squamous cell lung cancer|squamous cell lung cancer
851083|NCT00002823|large cell lung cancer|large cell lung cancer
851084|NCT00002823|adenocarcinoma of the lung|adenocarcinoma of the lung
851085|NCT00002823|adenosquamous cell lung cancer|adenosquamous cell lung cancer
851086|NCT00002650|colon cancer|colon cancer
851087|NCT00002650|rectal cancer|rectal cancer
851088|NCT00002601|metastatic osteosarcoma|metastatic osteosarcoma
851089|NCT00002601|recurrent childhood rhabdomyosarcoma|recurrent childhood rhabdomyosarcoma
851090|NCT00002601|recurrent adult soft tissue sarcoma|recurrent adult soft tissue sarcoma
851091|NCT00002601|recurrent osteosarcoma|recurrent osteosarcoma
851092|NCT00002601|adult rhabdomyosarcoma|adult rhabdomyosarcoma
851093|NCT00002601|metastatic childhood soft tissue sarcoma|metastatic childhood soft tissue sarcoma
851094|NCT00002601|recurrent childhood soft tissue sarcoma|recurrent childhood soft tissue sarcoma
851095|NCT00002601|previously treated childhood rhabdomyosarcoma|previously treated childhood rhabdomyosarcoma
851096|NCT00002601|metastatic Ewing sarcoma/peripheral primitive neuroectodermal tumor|metastatic ewing sarcoma/peripheral primitive neuroectodermal tumor
851097|NCT00002601|recurrent Ewing sarcoma/peripheral primitive neuroectodermal tumor|recurrent ewing sarcoma/peripheral primitive neuroectodermal tumor
851098|NCT00002601|stage IV adult soft tissue sarcoma|stage iv adult soft tissue sarcoma
851099|NCT00002581|stage I breast cancer|stage i breast cancer
851100|NCT00002581|stage II breast cancer|stage ii breast cancer
851101|NCT00002581|stage IIIA breast cancer|stage iiia breast cancer
851102|NCT00002580|stage I breast cancer|stage i breast cancer
851103|NCT00002580|stage II breast cancer|stage ii breast cancer
851104|NCT00002580|stage IIIA breast cancer|stage iiia breast cancer
851105|NCT00002537|recurrent non-small cell lung cancer|recurrent non-small cell lung cancer
851106|NCT00002537|stage IIIA non-small cell lung cancer|stage iiia non-small cell lung cancer
851107|NCT00002537|stage IIIB non-small cell lung cancer|stage iiib non-small cell lung cancer
851108|NCT00002537|stage IV non-small cell lung cancer|stage iv non-small cell lung cancer
851109|NCT00002526|stage III adult soft tissue sarcoma|stage iii adult soft tissue sarcoma
851110|NCT00002526|recurrent adult soft tissue sarcoma|recurrent adult soft tissue sarcoma
851111|NCT00002526|stage III uterine sarcoma|stage iii uterine sarcoma
851112|NCT00002526|stage IV uterine sarcoma|stage iv uterine sarcoma
851114|NCT00002526|ovarian sarcoma|ovarian sarcoma
851115|NCT00002526|stage IV adult soft tissue sarcoma|stage iv adult soft tissue sarcoma
851116|NCT00002508|recurrent malignant testicular germ cell tumor|recurrent malignant testicular germ cell tumor
851117|NCT00002508|recurrent ovarian germ cell tumor|recurrent ovarian germ cell tumor
851118|NCT00002508|extragonadal germ cell tumor|extragonadal germ cell tumor
851119|NCT00002480|adenocarcinoma of the prostate|adenocarcinoma of the prostate
851120|NCT00002480|stage IIB prostate cancer|stage iib prostate cancer
851121|NCT00002480|stage IIA prostate cancer|stage iia prostate cancer
851122|NCT00002480|stage III prostate cancer|stage iii prostate cancer
851123|NCT00002459|stage I uterine sarcoma|stage i uterine sarcoma
851124|NCT00002459|stage II uterine sarcoma|stage ii uterine sarcoma
851125|NCT00002459|uterine carcinosarcoma|uterine carcinosarcoma
851126|NCT00002459|uterine leiomyosarcoma|uterine leiomyosarcoma
851127|NCT00002459|endometrial stromal sarcoma|endometrial stromal sarcoma
851128|NCT00079625|Engraftment|engraftment
851129|NCT00079625|Graft-Versus-Host Disease|graft-versus-host disease
851130|NCT00079625|Metastatic Breast Cancer|metastatic breast cancer
851131|NCT00079625|MBC|mbc
851132|NCT00079599|Carnitine Deficiency|carnitine deficiency
851133|NCT00079599|Fatigue|fatigue
851134|NCT00079599|Complementary Therapies|complementary therapies
851135|NCT00079573|Weight Loss|weight loss
851136|NCT00079573|Obesity|obesity
851137|NCT00079573|Overweight|overweight
851138|NCT00079573|Premenopausal women|premenopausal women
851139|NCT00079573|Diet|diet
851140|NCT00079560|HIV|hiv
851141|NCT00079560|Marijuana|marijuana
851142|NCT00079560|Marinol|marinol
851143|NCT00079560|Oral THC|oral thc
851144|NCT00079560|Appetite|appetite
851145|NCT00079560|Complementary Therapies|complementary therapies
851146|NCT00079547|Weight Loss|weight loss
851147|NCT00079534|AIDS|aids
851148|NCT00079534|HIV|hiv
851149|NCT00079534|Prayer|prayer
851150|NCT00079534|Healing|healing
851151|NCT00079534|Complementary Therapies|complementary therapies
851152|NCT00079521|Bone Metabolism|bone metabolism
851153|NCT00079521|Therapeutic Touch|therapeutic touch
851154|NCT00079495|MS|ms
851155|NCT00079495|Autoimmune disease|autoimmune disease
851156|NCT00079495|relapsing|relapsing
851157|NCT00079495|progressive|progressive
851158|NCT00079495|Myelin|myelin
851159|NCT00079495|Myelin Basic Protein|myelin basic protein
851160|NCT00079495|MBP|mbp
851161|NCT00079495|acute fulminating|acute fulminating
851162|NCT00079495|chronic progressive|chronic progressive
851163|NCT00079495|Altered Peptide Ligand|altered peptide ligand
851164|NCT00079495|APL|apl
851165|NCT00079495|Neurocrine|neurocrine
851166|NCT00079495|NBI-5788|nbi-5788
851167|NCT00079495|Relapse|relapse
851168|NCT00079482|AML|aml
851169|NCT00079469|cancer survivor|cancer survivor
851170|NCT00079469|unspecified adult solid tumor, protocol specific|unspecified adult solid tumor, protocol specific
851171|NCT00079391|Chronic Myelogenous Leukemia (CML)|chronic myelogenous leukemia (cml)
851172|NCT00079391|Acute Lymphoblastic Leukemia (ALL)|acute lymphoblastic leukemia (all)
851173|NCT00079391|Acute Myelogenous Leukemia (AML)|acute myelogenous leukemia (aml)
851174|NCT00079391|Chronic Lymphocytic Leukemia (CLL)|chronic lymphocytic leukemia (cll)
851175|NCT00079391|Myelodysplastic Syndromes (MDS)|myelodysplastic syndromes (mds)
851176|NCT00079391|Peripheral Blood Stem Cells|peripheral blood stem cells
851177|NCT00079391|Graft-Versus Leukemia/Myeloma|graft-versus leukemia/myeloma
851178|NCT00079391|Graft-Versus-Host Disease (GVHD)|graft-versus-host disease (gvhd)
851179|NCT00079391|Cyclosporine|cyclosporine
851180|NCT00079391|Fludarabine|fludarabine
851181|NCT00079391|Leukemia|leukemia
851182|NCT00079391|Myelodysplastic Syndrome|myelodysplastic syndrome
851183|NCT00079391|Myeloproliferative Syndrome|myeloproliferative syndrome
851184|NCT00079391|Non-Hodgkin Lymphoma|non-hodgkin lymphoma
851185|NCT00079365|adenocarcinoma of the pancreas|adenocarcinoma of the pancreas
851186|NCT00079365|stage II pancreatic cancer|stage ii pancreatic cancer
851187|NCT00079365|stage III pancreatic cancer|stage iii pancreatic cancer
851188|NCT00079365|stage IV pancreatic cancer|stage iv pancreatic cancer
851189|NCT00079313|CMML|cmml
851190|NCT00079313|CML|cml
851191|NCT00079313|Gleevec|gleevec
851192|NCT00079313|Glivec|glivec
851193|NCT00079313|STI-571|sti-571
851194|NCT00079313|Tyrosine Kinase Inhibitor|tyrosine kinase inhibitor
851195|NCT00079313|Chronic Myelogenous Leukemia|chronic myelogenous leukemia
851196|NCT00079313|Atypical Chronic Myelogenous Leukemia|atypical chronic myelogenous leukemia
851197|NCT00079313|Chronic Myelomoncytic Leukemia|chronic myelomoncytic leukemia
851198|NCT00079313|Leukemia|leukemia
851199|NCT00079300|basal cell carcinoma of the skin|basal cell carcinoma of the skin
851200|NCT00079287|adenocarcinoma of the lung|adenocarcinoma of the lung
851201|NCT00079287|large cell lung cancer|large cell lung cancer
851202|NCT00079287|recurrent non-small cell lung cancer|recurrent non-small cell lung cancer
851203|NCT00079287|squamous cell lung cancer|squamous cell lung cancer
851204|NCT00079287|stage IIIB non-small cell lung cancer|stage iiib non-small cell lung cancer
851205|NCT00079287|stage IV non-small cell lung cancer|stage iv non-small cell lung cancer
851206|NCT00079261|contiguous stage II grade 3 follicular lymphoma|contiguous stage ii grade 3 follicular lymphoma
878961|NCT00045812|Absorption|absorption
851207|NCT00079261|noncontiguous stage II grade 3 follicular lymphoma|noncontiguous stage ii grade 3 follicular lymphoma
851208|NCT00079261|stage III grade 3 follicular lymphoma|stage iii grade 3 follicular lymphoma
851209|NCT00079261|stage IV grade 3 follicular lymphoma|stage iv grade 3 follicular lymphoma
851210|NCT00079261|contiguous stage II adult diffuse large cell lymphoma|contiguous stage ii adult diffuse large cell lymphoma
851211|NCT00079261|noncontiguous stage II adult diffuse large cell lymphoma|noncontiguous stage ii adult diffuse large cell lymphoma
851212|NCT00079261|stage III adult diffuse large cell lymphoma|stage iii adult diffuse large cell lymphoma
851213|NCT00079261|stage IV adult diffuse large cell lymphoma|stage iv adult diffuse large cell lymphoma
851214|NCT00079261|anaplastic large cell lymphoma|anaplastic large cell lymphoma
851215|NCT00079261|angioimmunoblastic T-cell lymphoma|angioimmunoblastic t-cell lymphoma
851216|NCT00079261|adult grade III lymphomatoid granulomatosis|adult grade iii lymphomatoid granulomatosis
851217|NCT00079261|small intestine lymphoma|small intestine lymphoma
851218|NCT00079248|osteoporosis|osteoporosis
851219|NCT00079248|stage I breast cancer|stage i breast cancer
851220|NCT00079248|stage II breast cancer|stage ii breast cancer
851221|NCT00079248|menopausal symptoms|menopausal symptoms
851222|NCT00079248|hot flashes|hot flashes
851223|NCT00079222|infection|infection
851224|NCT00079222|adult acute lymphoblastic leukemia in remission|adult acute lymphoblastic leukemia in remission
851225|NCT00079222|adult acute myeloid leukemia in remission|adult acute myeloid leukemia in remission
851226|NCT00079222|childhood acute lymphoblastic leukemia in remission|childhood acute lymphoblastic leukemia in remission
851227|NCT00079222|childhood acute myeloid leukemia in remission|childhood acute myeloid leukemia in remission
851228|NCT00079222|recurrent adult acute lymphoblastic leukemia|recurrent adult acute lymphoblastic leukemia
851229|NCT00079222|recurrent adult acute myeloid leukemia|recurrent adult acute myeloid leukemia
851230|NCT00079222|recurrent childhood acute lymphoblastic leukemia|recurrent childhood acute lymphoblastic leukemia
851231|NCT00079222|recurrent childhood acute myeloid leukemia|recurrent childhood acute myeloid leukemia
851232|NCT00079222|untreated adult acute lymphoblastic leukemia|untreated adult acute lymphoblastic leukemia
851233|NCT00079222|untreated adult acute myeloid leukemia|untreated adult acute myeloid leukemia
851234|NCT00079222|untreated childhood acute lymphoblastic leukemia|untreated childhood acute lymphoblastic leukemia
851235|NCT00079222|untreated childhood acute myeloid leukemia and other myeloid malignancies|untreated childhood acute myeloid leukemia and other myeloid malignancies
851236|NCT00079222|refractory chronic lymphocytic leukemia|refractory chronic lymphocytic leukemia
851237|NCT00079222|stage III chronic lymphocytic leukemia|stage iii chronic lymphocytic leukemia
851238|NCT00079222|stage IV chronic lymphocytic leukemia|stage iv chronic lymphocytic leukemia
851239|NCT00079222|accelerated phase chronic myelogenous leukemia|accelerated phase chronic myelogenous leukemia
851240|NCT00079222|atypical chronic myeloid leukemia|atypical chronic myeloid leukemia
851241|NCT00079222|blastic phase chronic myelogenous leukemia|blastic phase chronic myelogenous leukemia
851242|NCT00079222|childhood chronic myelogenous leukemia|childhood chronic myelogenous leukemia
851243|NCT00079222|chronic myelomonocytic leukemia|chronic myelomonocytic leukemia
851244|NCT00079222|chronic phase chronic myelogenous leukemia|chronic phase chronic myelogenous leukemia
851245|NCT00079222|relapsing chronic myelogenous leukemia|relapsing chronic myelogenous leukemia
851246|NCT00079222|secondary acute myeloid leukemia|secondary acute myeloid leukemia
851247|NCT00079222|secondary myelodysplastic syndromes|secondary myelodysplastic syndromes
851248|NCT00079222|de novo myelodysplastic syndromes|de novo myelodysplastic syndromes
851249|NCT00079222|myelodysplastic/myeloproliferative disease, unclassifiable|myelodysplastic/myeloproliferative disease, unclassifiable
851250|NCT00079222|previously treated myelodysplastic syndromes|previously treated myelodysplastic syndromes
851251|NCT00079222|chronic eosinophilic leukemia|chronic eosinophilic leukemia
851252|NCT00079222|primary myelofibrosis|primary myelofibrosis
851253|NCT00079222|chronic neutrophilic leukemia|chronic neutrophilic leukemia
851254|NCT00079222|stage I multiple myeloma|stage i multiple myeloma
851255|NCT00079222|stage II multiple myeloma|stage ii multiple myeloma
851256|NCT00079222|stage III multiple myeloma|stage iii multiple myeloma
851257|NCT00079222|refractory hairy cell leukemia|refractory hairy cell leukemia
851258|NCT00079222|refractory multiple myeloma|refractory multiple myeloma
851259|NCT00079222|recurrent adult Burkitt lymphoma|recurrent adult burkitt lymphoma
851260|NCT00079222|recurrent adult diffuse large cell lymphoma|recurrent adult diffuse large cell lymphoma
851261|NCT00079222|recurrent adult diffuse mixed cell lymphoma|recurrent adult diffuse mixed cell lymphoma
851262|NCT00079222|recurrent adult diffuse small cleaved cell lymphoma|recurrent adult diffuse small cleaved cell lymphoma
851263|NCT00079222|recurrent adult Hodgkin lymphoma|recurrent adult hodgkin lymphoma
851264|NCT00079222|recurrent adult immunoblastic large cell lymphoma|recurrent adult immunoblastic large cell lymphoma
851265|NCT00079222|recurrent adult lymphoblastic lymphoma|recurrent adult lymphoblastic lymphoma
851266|NCT00079222|recurrent childhood large cell lymphoma|recurrent childhood large cell lymphoma
851267|NCT00079222|recurrent childhood lymphoblastic lymphoma|recurrent childhood lymphoblastic lymphoma
851268|NCT00079222|recurrent childhood small noncleaved cell lymphoma|recurrent childhood small noncleaved cell lymphoma
851269|NCT00079222|recurrent cutaneous T-cell non-Hodgkin lymphoma|recurrent cutaneous t-cell non-hodgkin lymphoma
851401|NCT00079001|recurrent prostate cancer|recurrent prostate cancer
851270|NCT00079222|recurrent grade 1 follicular lymphoma|recurrent grade 1 follicular lymphoma
851271|NCT00079222|recurrent grade 2 follicular lymphoma|recurrent grade 2 follicular lymphoma
851272|NCT00079222|recurrent grade 3 follicular lymphoma|recurrent grade 3 follicular lymphoma
851273|NCT00079222|recurrent mantle cell lymphoma|recurrent mantle cell lymphoma
851274|NCT00079222|recurrent/refractory childhood Hodgkin lymphoma|recurrent/refractory childhood hodgkin lymphoma
851275|NCT00079222|noncontiguous stage II adult Burkitt lymphoma|noncontiguous stage ii adult burkitt lymphoma
851276|NCT00079222|noncontiguous stage II adult diffuse large cell lymphoma|noncontiguous stage ii adult diffuse large cell lymphoma
851277|NCT00079222|noncontiguous stage II adult diffuse mixed cell lymphoma|noncontiguous stage ii adult diffuse mixed cell lymphoma
851278|NCT00079222|noncontiguous stage II adult diffuse small cleaved cell lymphoma|noncontiguous stage ii adult diffuse small cleaved cell lymphoma
851279|NCT00079222|noncontiguous stage II adult immunoblastic large cell lymphoma|noncontiguous stage ii adult immunoblastic large cell lymphoma
851280|NCT00079222|noncontiguous stage II adult lymphoblastic lymphoma|noncontiguous stage ii adult lymphoblastic lymphoma
851281|NCT00079222|noncontiguous stage II grade 1 follicular lymphoma|noncontiguous stage ii grade 1 follicular lymphoma
851282|NCT00079222|noncontiguous stage II grade 2 follicular lymphoma|noncontiguous stage ii grade 2 follicular lymphoma
851283|NCT00079222|noncontiguous stage II grade 3 follicular lymphoma|noncontiguous stage ii grade 3 follicular lymphoma
851284|NCT00079222|noncontiguous stage II mantle cell lymphoma|noncontiguous stage ii mantle cell lymphoma
851285|NCT00079222|stage III adult Burkitt lymphoma|stage iii adult burkitt lymphoma
851286|NCT00079222|stage III adult diffuse large cell lymphoma|stage iii adult diffuse large cell lymphoma
851287|NCT00079222|stage III adult diffuse mixed cell lymphoma|stage iii adult diffuse mixed cell lymphoma
851288|NCT00079222|stage III adult diffuse small cleaved cell lymphoma|stage iii adult diffuse small cleaved cell lymphoma
851289|NCT00079222|stage III adult immunoblastic large cell lymphoma|stage iii adult immunoblastic large cell lymphoma
851290|NCT00079222|stage III adult lymphoblastic lymphoma|stage iii adult lymphoblastic lymphoma
851291|NCT00079222|stage III grade 1 follicular lymphoma|stage iii grade 1 follicular lymphoma
851292|NCT00079222|stage III grade 2 follicular lymphoma|stage iii grade 2 follicular lymphoma
851293|NCT00079222|stage III grade 3 follicular lymphoma|stage iii grade 3 follicular lymphoma
851294|NCT00079222|stage III mantle cell lymphoma|stage iii mantle cell lymphoma
851295|NCT00079222|stage IV adult Burkitt lymphoma|stage iv adult burkitt lymphoma
851296|NCT00079222|stage IV adult diffuse large cell lymphoma|stage iv adult diffuse large cell lymphoma
851602|NCT00078715|MDD|mdd
851297|NCT00079222|stage IV adult diffuse mixed cell lymphoma|stage iv adult diffuse mixed cell lymphoma
851298|NCT00079222|stage IV adult diffuse small cleaved cell lymphoma|stage iv adult diffuse small cleaved cell lymphoma
851299|NCT00079222|stage IV adult immunoblastic large cell lymphoma|stage iv adult immunoblastic large cell lymphoma
851300|NCT00079222|stage IV adult lymphoblastic lymphoma|stage iv adult lymphoblastic lymphoma
851301|NCT00079222|stage IV grade 1 follicular lymphoma|stage iv grade 1 follicular lymphoma
851302|NCT00079222|stage IV grade 2 follicular lymphoma|stage iv grade 2 follicular lymphoma
851303|NCT00079222|stage IV grade 3 follicular lymphoma|stage iv grade 3 follicular lymphoma
851304|NCT00079222|stage IV mantle cell lymphoma|stage iv mantle cell lymphoma
851305|NCT00079222|recurrent mycosis fungoides/Sezary syndrome|recurrent mycosis fungoides/sezary syndrome
851306|NCT00079222|recurrent malignant testicular germ cell tumor|recurrent malignant testicular germ cell tumor
851307|NCT00079222|stage III malignant testicular germ cell tumor|stage iii malignant testicular germ cell tumor
851308|NCT00079222|recurrent ovarian epithelial cancer|recurrent ovarian epithelial cancer
851309|NCT00079222|stage II ovarian epithelial cancer|stage ii ovarian epithelial cancer
851310|NCT00079222|stage III ovarian epithelial cancer|stage iii ovarian epithelial cancer
851311|NCT00079222|stage IV ovarian epithelial cancer|stage iv ovarian epithelial cancer
851312|NCT00079222|poor prognosis metastatic gestational trophoblastic tumor|poor prognosis metastatic gestational trophoblastic tumor
851313|NCT00079222|disseminated neuroblastoma|disseminated neuroblastoma
851314|NCT00079222|recurrent neuroblastoma|recurrent neuroblastoma
851315|NCT00079222|recurrent ovarian germ cell tumor|recurrent ovarian germ cell tumor
851316|NCT00079222|previously treated childhood rhabdomyosarcoma|previously treated childhood rhabdomyosarcoma
851317|NCT00079222|recurrent childhood rhabdomyosarcoma|recurrent childhood rhabdomyosarcoma
851318|NCT00079222|recurrent Wilms tumor and other childhood kidney tumors|recurrent wilms tumor and other childhood kidney tumors
851319|NCT00079222|stage IIIA breast cancer|stage iiia breast cancer
851320|NCT00079222|stage IIIB breast cancer|stage iiib breast cancer
851321|NCT00079222|stage IIIC breast cancer|stage iiic breast cancer
851322|NCT00079222|stage IV breast cancer|stage iv breast cancer
851323|NCT00079222|juvenile myelomonocytic leukemia|juvenile myelomonocytic leukemia
851324|NCT00079222|noncontiguous stage II small lymphocytic lymphoma|noncontiguous stage ii small lymphocytic lymphoma
851325|NCT00079222|noncontiguous stage II marginal zone lymphoma|noncontiguous stage ii marginal zone lymphoma
851326|NCT00079222|recurrent marginal zone lymphoma|recurrent marginal zone lymphoma
851327|NCT00079222|recurrent small lymphocytic lymphoma|recurrent small lymphocytic lymphoma
851328|NCT00079222|stage III small lymphocytic lymphoma|stage iii small lymphocytic lymphoma
851329|NCT00079222|stage III marginal zone lymphoma|stage iii marginal zone lymphoma
851330|NCT00079222|stage IV small lymphocytic lymphoma|stage iv small lymphocytic lymphoma
851331|NCT00079222|stage IV marginal zone lymphoma|stage iv marginal zone lymphoma
851400|NCT00079001|adenocarcinoma of the prostate|adenocarcinoma of the prostate
851332|NCT00079222|extranodal marginal zone B-cell lymphoma of mucosa-associated lymphoid tissue|extranodal marginal zone b-cell lymphoma of mucosa-associated lymphoid tissue
879069|NCT00044356|Neoplasm|neoplasm
851333|NCT00079222|nodal marginal zone B-cell lymphoma|nodal marginal zone b-cell lymphoma
851334|NCT00079222|splenic marginal zone lymphoma|splenic marginal zone lymphoma
851335|NCT00079222|adult acute myeloid leukemia with t(8;21)(q22;q22)|adult acute myeloid leukemia with t(8;21)(q22;q22)
851336|NCT00079222|adult acute myeloid leukemia with t(16;16)(p13;q22)|adult acute myeloid leukemia with t(16;16)(p13;q22)
851337|NCT00079222|adult acute myeloid leukemia with inv(16)(p13;q22)|adult acute myeloid leukemia with inv(16)(p13;q22)
851338|NCT00079222|adult acute myeloid leukemia with 11q23 (MLL) abnormalities|adult acute myeloid leukemia with 11q23 (mll) abnormalities
851339|NCT00079222|adult acute myeloid leukemia with t(15;17)(q22;q12)|adult acute myeloid leukemia with t(15;17)(q22;q12)
851340|NCT00079222|childhood myelodysplastic syndromes|childhood myelodysplastic syndromes
851341|NCT00079170|male breast cancer|male breast cancer
851342|NCT00079170|recurrent breast cancer|recurrent breast cancer
851343|NCT00079170|stage IIIA breast cancer|stage iiia breast cancer
851344|NCT00079170|stage IIIB breast cancer|stage iiib breast cancer
851345|NCT00079170|stage IIIC breast cancer|stage iiic breast cancer
851346|NCT00079170|stage IV breast cancer|stage iv breast cancer
851347|NCT00079157|recurrent breast cancer|recurrent breast cancer
851348|NCT00079157|stage IV breast cancer|stage iv breast cancer
851349|NCT00079144|recurrent melanoma|recurrent melanoma
851350|NCT00079144|stage IV melanoma|stage iv melanoma
851351|NCT00079118|stage IV breast cancer|stage iv breast cancer
851352|NCT00079118|recurrent breast cancer|recurrent breast cancer
851353|NCT00079118|male breast cancer|male breast cancer
851354|NCT00079105|stage I adult Hodgkin lymphoma|stage i adult hodgkin lymphoma
851355|NCT00079105|stage II adult Hodgkin lymphoma|stage ii adult hodgkin lymphoma
851356|NCT00079105|stage III adult Hodgkin lymphoma|stage iii adult hodgkin lymphoma
851357|NCT00079105|stage IV adult Hodgkin lymphoma|stage iv adult hodgkin lymphoma
851358|NCT00079092|recurrent adult brain tumor|recurrent adult brain tumor
851359|NCT00079092|adult anaplastic astrocytoma|adult anaplastic astrocytoma
851360|NCT00079092|adult anaplastic oligodendroglioma|adult anaplastic oligodendroglioma
851361|NCT00079092|adult glioblastoma|adult glioblastoma
851362|NCT00079092|adult mixed glioma|adult mixed glioma
851363|NCT00079092|adult giant cell glioblastoma|adult giant cell glioblastoma
851364|NCT00079092|adult gliosarcoma|adult gliosarcoma
851365|NCT00079079|stage II salivary gland cancer|stage ii salivary gland cancer
851366|NCT00079079|stage III salivary gland cancer|stage iii salivary gland cancer
851367|NCT00079079|stage IV salivary gland cancer|stage iv salivary gland cancer
851368|NCT00079079|recurrent salivary gland cancer|recurrent salivary gland cancer
851369|NCT00079079|salivary gland acinic cell tumor|salivary gland acinic cell tumor
851370|NCT00079079|salivary gland adenoid cystic carcinoma|salivary gland adenoid cystic carcinoma
851371|NCT00079079|salivary gland poorly differentiated carcinoma|salivary gland poorly differentiated carcinoma
851372|NCT00079079|high-grade salivary gland mucoepidermoid carcinoma|high-grade salivary gland mucoepidermoid carcinoma
851373|NCT00079079|low-grade salivary gland mucoepidermoid carcinoma|low-grade salivary gland mucoepidermoid carcinoma
851374|NCT00079079|salivary gland malignant mixed cell type tumor|salivary gland malignant mixed cell type tumor
851375|NCT00079079|salivary gland adenocarcinoma|salivary gland adenocarcinoma
851376|NCT00079079|salivary gland anaplastic carcinoma|salivary gland anaplastic carcinoma
851377|NCT00079079|salivary gland squamous cell carcinoma|salivary gland squamous cell carcinoma
851378|NCT00079066|quality of life|quality of life
851379|NCT00079066|stage IV colon cancer|stage iv colon cancer
851380|NCT00079066|recurrent colon cancer|recurrent colon cancer
851381|NCT00079066|recurrent rectal cancer|recurrent rectal cancer
851382|NCT00079066|stage IV rectal cancer|stage iv rectal cancer
851383|NCT00079053|stage III squamous cell carcinoma of the hypopharynx|stage iii squamous cell carcinoma of the hypopharynx
851384|NCT00079053|stage III squamous cell carcinoma of the larynx|stage iii squamous cell carcinoma of the larynx
851385|NCT00079053|stage III squamous cell carcinoma of the lip and oral cavity|stage iii squamous cell carcinoma of the lip and oral cavity
851386|NCT00079053|stage III squamous cell carcinoma of the nasopharynx|stage iii squamous cell carcinoma of the nasopharynx
851387|NCT00079053|stage III squamous cell carcinoma of the oropharynx|stage iii squamous cell carcinoma of the oropharynx
851388|NCT00079053|stage III squamous cell carcinoma of the paranasal sinus and nasal cavity|stage iii squamous cell carcinoma of the paranasal sinus and nasal cavity
851389|NCT00079053|stage IV squamous cell carcinoma of the hypopharynx|stage iv squamous cell carcinoma of the hypopharynx
851390|NCT00079053|stage IV squamous cell carcinoma of the larynx|stage iv squamous cell carcinoma of the larynx
851391|NCT00079053|stage IV squamous cell carcinoma of the lip and oral cavity|stage iv squamous cell carcinoma of the lip and oral cavity
851392|NCT00079053|stage IV squamous cell carcinoma of the nasopharynx|stage iv squamous cell carcinoma of the nasopharynx
851393|NCT00079053|stage IV squamous cell carcinoma of the oropharynx|stage iv squamous cell carcinoma of the oropharynx
851394|NCT00079053|stage IV squamous cell carcinoma of the paranasal sinus and nasal cavity|stage iv squamous cell carcinoma of the paranasal sinus and nasal cavity
851395|NCT00079053|salivary gland squamous cell carcinoma|salivary gland squamous cell carcinoma
851396|NCT00079053|stage III salivary gland cancer|stage iii salivary gland cancer
851397|NCT00079053|stage IV salivary gland cancer|stage iv salivary gland cancer
851398|NCT00079027|advanced adult primary liver cancer|advanced adult primary liver cancer
851399|NCT00079027|adult primary hepatocellular carcinoma|adult primary hepatocellular carcinoma
851402|NCT00079001|stage IV prostate cancer|stage iv prostate cancer
851403|NCT00079001|bone metastases|bone metastases
851404|NCT00078988|childhood high-grade cerebral astrocytoma|childhood high-grade cerebral astrocytoma
851405|NCT00078988|recurrent childhood cerebellar astrocytoma|recurrent childhood cerebellar astrocytoma
851406|NCT00078988|recurrent childhood cerebral astrocytoma|recurrent childhood cerebral astrocytoma
851407|NCT00078975|adenocarcinoma of the pancreas|adenocarcinoma of the pancreas
851408|NCT00078975|recurrent pancreatic cancer|recurrent pancreatic cancer
851409|NCT00078975|stage II pancreatic cancer|stage ii pancreatic cancer
851410|NCT00078975|stage III pancreatic cancer|stage iii pancreatic cancer
851411|NCT00078975|stage IV pancreatic cancer|stage iv pancreatic cancer
851412|NCT00078949|anaplastic large cell lymphoma|anaplastic large cell lymphoma
851413|NCT00078949|recurrent adult Burkitt lymphoma|recurrent adult burkitt lymphoma
851414|NCT00078949|recurrent adult diffuse large cell lymphoma|recurrent adult diffuse large cell lymphoma
851415|NCT00078949|angioimmunoblastic T-cell lymphoma|angioimmunoblastic t-cell lymphoma
851416|NCT00078923|stage I prostate cancer|stage i prostate cancer
851417|NCT00078923|stage II prostate cancer|stage ii prostate cancer
851418|NCT00078923|adenocarcinoma of the prostate|adenocarcinoma of the prostate
851419|NCT00078910|adenocarcinoma of the prostate|adenocarcinoma of the prostate
851420|NCT00078910|stage IIB prostate cancer|stage iib prostate cancer
851421|NCT00078910|stage IIA prostate cancer|stage iia prostate cancer
851422|NCT00078910|stage III prostate cancer|stage iii prostate cancer
851423|NCT00078897|colon cancer|colon cancer
851424|NCT00078897|rectal cancer|rectal cancer
851425|NCT00078897|colorectal cancer|colorectal cancer
851426|NCT00078897|adenomatous polyp|adenomatous polyp
851427|NCT00078845|neurotoxicity|neurotoxicity
851428|NCT00078845|unspecified adult solid tumor, protocol specific|unspecified adult solid tumor, protocol specific
851429|NCT00078845|recurrent prostate cancer|recurrent prostate cancer
851430|NCT00078845|stage I prostate cancer|stage i prostate cancer
851431|NCT00078845|stage IIB prostate cancer|stage iib prostate cancer
851432|NCT00078845|stage IIA prostate cancer|stage iia prostate cancer
851433|NCT00078845|stage III prostate cancer|stage iii prostate cancer
851434|NCT00078845|stage IV prostate cancer|stage iv prostate cancer
851435|NCT00078845|recurrent non-small cell lung cancer|recurrent non-small cell lung cancer
851436|NCT00078845|stage I non-small cell lung cancer|stage i non-small cell lung cancer
851437|NCT00078845|stage II non-small cell lung cancer|stage ii non-small cell lung cancer
851438|NCT00078845|stage IIIA non-small cell lung cancer|stage iiia non-small cell lung cancer
851439|NCT00078845|stage IIIB non-small cell lung cancer|stage iiib non-small cell lung cancer
851440|NCT00078845|stage IV non-small cell lung cancer|stage iv non-small cell lung cancer
851441|NCT00078845|limited stage small cell lung cancer|limited stage small cell lung cancer
851442|NCT00078845|extensive stage small cell lung cancer|extensive stage small cell lung cancer
851443|NCT00078845|recurrent small cell lung cancer|recurrent small cell lung cancer
851444|NCT00078845|recurrent breast cancer|recurrent breast cancer
851445|NCT00078845|stage I breast cancer|stage i breast cancer
851446|NCT00078845|stage II breast cancer|stage ii breast cancer
851447|NCT00078845|stage IIIA breast cancer|stage iiia breast cancer
851448|NCT00078845|stage IIIB breast cancer|stage iiib breast cancer
851449|NCT00078845|stage IIIC breast cancer|stage iiic breast cancer
851450|NCT00078845|stage IV breast cancer|stage iv breast cancer
851451|NCT00078845|recurrent ovarian epithelial cancer|recurrent ovarian epithelial cancer
851452|NCT00078845|stage I ovarian epithelial cancer|stage i ovarian epithelial cancer
851453|NCT00078845|stage II ovarian epithelial cancer|stage ii ovarian epithelial cancer
851454|NCT00078845|stage III ovarian epithelial cancer|stage iii ovarian epithelial cancer
851455|NCT00078845|stage IV ovarian epithelial cancer|stage iv ovarian epithelial cancer
851456|NCT00078832|breast cancer, chemoprevention|breast cancer, chemoprevention
851457|NCT00078819|Pediatric Psoriasis|pediatric psoriasis
851458|NCT00078806|Systemic Onset Juvenile Rheumatoid Arthritis|systemic onset juvenile rheumatoid arthritis
851460|NCT00078806|Fever|fever
851461|NCT00078806|Rash|rash
851462|NCT00078806|Joint Pain|joint pain
851463|NCT00078793|JRA|jra
851464|NCT00078793|Registry|registry
851465|NCT00078767|PTSD|ptsd
851466|NCT00078767|Depression|depression
851467|NCT00078767|Anxiety|anxiety
851468|NCT00078741|Psychotic Disorders|psychotic disorders
851469|NCT00078728|Anxiety|anxiety
851470|NCT00078611|Crohn's disease|crohn's disease
851471|NCT00078611|Inflammatory Bowel Disease|inflammatory bowel disease
851472|NCT00078611|IBD|ibd
851473|NCT00078611|Gastroenterology|gastroenterology
851474|NCT00078611|Regional Enteritis|regional enteritis
851475|NCT00078611|Colitis|colitis
851476|NCT00007007|tumors metastatic to brain|tumors metastatic to brain
851477|NCT00007007|radiation toxicity|radiation toxicity
851478|NCT00007007|cognitive/functional effects|cognitive/functional effects
851479|NCT00006890|refractory multiple myeloma|refractory multiple myeloma
851480|NCT00006890|stage I multiple myeloma|stage i multiple myeloma
851481|NCT00006890|stage II multiple myeloma|stage ii multiple myeloma
851482|NCT00006890|stage III multiple myeloma|stage iii multiple myeloma
851483|NCT00006467|stage III pancreatic cancer|stage iii pancreatic cancer
851484|NCT00006467|recurrent pancreatic cancer|recurrent pancreatic cancer
851485|NCT00006467|duct cell adenocarcinoma of the pancreas|duct cell adenocarcinoma of the pancreas
851486|NCT00006467|adenocarcinoma of the pancreas|adenocarcinoma of the pancreas
851487|NCT00006467|stage IV pancreatic cancer|stage iv pancreatic cancer
851488|NCT00006452|adult glioblastoma|adult glioblastoma
851489|NCT00006452|adult giant cell glioblastoma|adult giant cell glioblastoma
851490|NCT00006452|adult gliosarcoma|adult gliosarcoma
851491|NCT00006350|recurrent adult Hodgkin lymphoma|recurrent adult hodgkin lymphoma
851492|NCT00006350|refractory multiple myeloma|refractory multiple myeloma
851493|NCT00006350|stage I multiple myeloma|stage i multiple myeloma
851494|NCT00006350|stage II multiple myeloma|stage ii multiple myeloma
851495|NCT00006350|stage III multiple myeloma|stage iii multiple myeloma
851496|NCT00006350|stage III chronic lymphocytic leukemia|stage iii chronic lymphocytic leukemia
851497|NCT00006350|stage IV chronic lymphocytic leukemia|stage iv chronic lymphocytic leukemia
851498|NCT00006350|recurrent adult acute myeloid leukemia|recurrent adult acute myeloid leukemia
851499|NCT00006350|recurrent adult acute lymphoblastic leukemia|recurrent adult acute lymphoblastic leukemia
851500|NCT00006350|relapsing chronic myelogenous leukemia|relapsing chronic myelogenous leukemia
851501|NCT00006350|refractory chronic lymphocytic leukemia|refractory chronic lymphocytic leukemia
851502|NCT00006350|chronic phase chronic myelogenous leukemia|chronic phase chronic myelogenous leukemia
851503|NCT00006350|accelerated phase chronic myelogenous leukemia|accelerated phase chronic myelogenous leukemia
851504|NCT00006350|blastic phase chronic myelogenous leukemia|blastic phase chronic myelogenous leukemia
851505|NCT00006350|meningeal chronic myelogenous leukemia|meningeal chronic myelogenous leukemia
851506|NCT00006350|adult acute myeloid leukemia in remission|adult acute myeloid leukemia in remission
851507|NCT00006350|adult acute lymphoblastic leukemia in remission|adult acute lymphoblastic leukemia in remission
851508|NCT00006350|stage III grade 1 follicular lymphoma|stage iii grade 1 follicular lymphoma
851509|NCT00006350|stage III grade 2 follicular lymphoma|stage iii grade 2 follicular lymphoma
851510|NCT00006350|stage III grade 3 follicular lymphoma|stage iii grade 3 follicular lymphoma
851511|NCT00006350|stage III adult diffuse small cleaved cell lymphoma|stage iii adult diffuse small cleaved cell lymphoma
851512|NCT00006350|stage III adult diffuse mixed cell lymphoma|stage iii adult diffuse mixed cell lymphoma
851513|NCT00006350|stage III adult diffuse large cell lymphoma|stage iii adult diffuse large cell lymphoma
851514|NCT00006350|stage III adult immunoblastic large cell lymphoma|stage iii adult immunoblastic large cell lymphoma
851515|NCT00006350|stage III adult lymphoblastic lymphoma|stage iii adult lymphoblastic lymphoma
851516|NCT00006350|stage III adult Burkitt lymphoma|stage iii adult burkitt lymphoma
851517|NCT00006350|stage IV grade 1 follicular lymphoma|stage iv grade 1 follicular lymphoma
851518|NCT00006350|stage IV grade 2 follicular lymphoma|stage iv grade 2 follicular lymphoma
851519|NCT00006350|stage IV grade 3 follicular lymphoma|stage iv grade 3 follicular lymphoma
851520|NCT00006350|stage IV adult diffuse small cleaved cell lymphoma|stage iv adult diffuse small cleaved cell lymphoma
851521|NCT00006350|stage IV adult diffuse mixed cell lymphoma|stage iv adult diffuse mixed cell lymphoma
851522|NCT00006350|stage IV adult diffuse large cell lymphoma|stage iv adult diffuse large cell lymphoma
851523|NCT00006350|stage IV adult lymphoblastic lymphoma|stage iv adult lymphoblastic lymphoma
851524|NCT00006350|stage IV adult Burkitt lymphoma|stage iv adult burkitt lymphoma
851525|NCT00006350|recurrent grade 1 follicular lymphoma|recurrent grade 1 follicular lymphoma
851526|NCT00006350|recurrent grade 2 follicular lymphoma|recurrent grade 2 follicular lymphoma
851527|NCT00006350|recurrent grade 3 follicular lymphoma|recurrent grade 3 follicular lymphoma
851528|NCT00006350|recurrent adult diffuse small cleaved cell lymphoma|recurrent adult diffuse small cleaved cell lymphoma
851529|NCT00006350|recurrent adult diffuse mixed cell lymphoma|recurrent adult diffuse mixed cell lymphoma
851530|NCT00006350|recurrent adult diffuse large cell lymphoma|recurrent adult diffuse large cell lymphoma
851531|NCT00006350|recurrent adult immunoblastic large cell lymphoma|recurrent adult immunoblastic large cell lymphoma
851532|NCT00006350|recurrent adult lymphoblastic lymphoma|recurrent adult lymphoblastic lymphoma
851533|NCT00006350|recurrent adult Burkitt lymphoma|recurrent adult burkitt lymphoma
851534|NCT00006350|de novo myelodysplastic syndromes|de novo myelodysplastic syndromes
851535|NCT00006350|previously treated myelodysplastic syndromes|previously treated myelodysplastic syndromes
851536|NCT00006350|secondary myelodysplastic syndromes|secondary myelodysplastic syndromes
851537|NCT00006350|contiguous stage II grade 1 follicular lymphoma|contiguous stage ii grade 1 follicular lymphoma
851538|NCT00006350|contiguous stage II grade 2 follicular lymphoma|contiguous stage ii grade 2 follicular lymphoma
851539|NCT00006350|contiguous stage II grade 3 follicular lymphoma|contiguous stage ii grade 3 follicular lymphoma
851540|NCT00006350|contiguous stage II adult diffuse small cleaved cell lymphoma|contiguous stage ii adult diffuse small cleaved cell lymphoma
851541|NCT00006350|contiguous stage II adult diffuse mixed cell lymphoma|contiguous stage ii adult diffuse mixed cell lymphoma
851542|NCT00006350|contiguous stage II adult immunoblastic large cell lymphoma|contiguous stage ii adult immunoblastic large cell lymphoma
851543|NCT00006350|contiguous stage II adult diffuse large cell lymphoma|contiguous stage ii adult diffuse large cell lymphoma
851544|NCT00006350|contiguous stage II adult Burkitt lymphoma|contiguous stage ii adult burkitt lymphoma
851545|NCT00006350|contiguous stage II adult lymphoblastic lymphoma|contiguous stage ii adult lymphoblastic lymphoma
851546|NCT00006350|noncontiguous stage II grade 1 follicular lymphoma|noncontiguous stage ii grade 1 follicular lymphoma
851547|NCT00006350|noncontiguous stage II grade 2 follicular lymphoma|noncontiguous stage ii grade 2 follicular lymphoma
852616|NCT00003046|stage IV rectal cancer|stage iv rectal cancer
851548|NCT00006350|noncontiguous stage II grade 3 follicular lymphoma|noncontiguous stage ii grade 3 follicular lymphoma
852100|NCT00078377|Sleep Attacks|sleep attacks
851549|NCT00006350|noncontiguous stage II adult diffuse small cleaved cell lymphoma|noncontiguous stage ii adult diffuse small cleaved cell lymphoma
851550|NCT00006350|noncontiguous stage II adult diffuse mixed cell lymphoma|noncontiguous stage ii adult diffuse mixed cell lymphoma
851551|NCT00006350|noncontiguous stage II adult immunoblastic large cell lymphoma|noncontiguous stage ii adult immunoblastic large cell lymphoma
851552|NCT00006350|noncontiguous stage II adult diffuse large cell lymphoma|noncontiguous stage ii adult diffuse large cell lymphoma
851553|NCT00006350|noncontiguous stage II adult Burkitt lymphoma|noncontiguous stage ii adult burkitt lymphoma
851554|NCT00006350|noncontiguous stage II adult lymphoblastic lymphoma|noncontiguous stage ii adult lymphoblastic lymphoma
851555|NCT00006350|recurrent mantle cell lymphoma|recurrent mantle cell lymphoma
851556|NCT00006350|noncontiguous stage II small lymphocytic lymphoma|noncontiguous stage ii small lymphocytic lymphoma
851557|NCT00006350|noncontiguous stage II marginal zone lymphoma|noncontiguous stage ii marginal zone lymphoma
851558|NCT00006350|recurrent marginal zone lymphoma|recurrent marginal zone lymphoma
851559|NCT00006350|recurrent small lymphocytic lymphoma|recurrent small lymphocytic lymphoma
851560|NCT00006350|stage III small lymphocytic lymphoma|stage iii small lymphocytic lymphoma
851561|NCT00006350|stage III marginal zone lymphoma|stage iii marginal zone lymphoma
851562|NCT00006350|stage IV small lymphocytic lymphoma|stage iv small lymphocytic lymphoma
851563|NCT00006350|stage IV marginal zone lymphoma|stage iv marginal zone lymphoma
851564|NCT00006350|contiguous stage II marginal zone lymphoma|contiguous stage ii marginal zone lymphoma
851565|NCT00006350|contiguous stage II small lymphocytic lymphoma|contiguous stage ii small lymphocytic lymphoma
851566|NCT00006350|extranodal marginal zone B-cell lymphoma of mucosa-associated lymphoid tissue|extranodal marginal zone b-cell lymphoma of mucosa-associated lymphoid tissue
851567|NCT00006350|nodal marginal zone B-cell lymphoma|nodal marginal zone b-cell lymphoma
851568|NCT00006350|splenic marginal zone lymphoma|splenic marginal zone lymphoma
851569|NCT00006259|tumors metastatic to brain|tumors metastatic to brain
851571|NCT00006253|cancer|cancer
851572|NCT00006253|chemotherapy treatment|chemotherapy treatment
851573|NCT00006253|Behavioral Research|behavioral research
851574|NCT00006253|Physiological Effects of Drugs|physiological effects of drugs
851575|NCT00006253|Clinical Trial, Phase II|clinical trial, phase ii
851576|NCT00006126|stage IV breast cancer|stage iv breast cancer
851577|NCT00006126|recurrent breast cancer|recurrent breast cancer
851578|NCT00006126|stage IV renal cell cancer|stage iv renal cell cancer
851579|NCT00006126|recurrent renal cell cancer|recurrent renal cell cancer
851580|NCT00006126|extensive stage small cell lung cancer|extensive stage small cell lung cancer
851581|NCT00006126|recurrent small cell lung cancer|recurrent small cell lung cancer
851582|NCT00006126|stage II malignant testicular germ cell tumor|stage ii malignant testicular germ cell tumor
851583|NCT00006126|stage III malignant testicular germ cell tumor|stage iii malignant testicular germ cell tumor
851584|NCT00006126|recurrent malignant testicular germ cell tumor|recurrent malignant testicular germ cell tumor
851585|NCT00006126|stage IV melanoma|stage iv melanoma
851586|NCT00006126|recurrent melanoma|recurrent melanoma
851587|NCT00006115|stage IV colon cancer|stage iv colon cancer
851588|NCT00006115|stage IV rectal cancer|stage iv rectal cancer
851589|NCT00006115|recurrent colon cancer|recurrent colon cancer
851590|NCT00006115|recurrent rectal cancer|recurrent rectal cancer
851591|NCT00006115|adenocarcinoma of the colon|adenocarcinoma of the colon
851592|NCT00006115|adenocarcinoma of the rectum|adenocarcinoma of the rectum
851593|NCT00006018|unspecified adult solid tumor, protocol specific|unspecified adult solid tumor, protocol specific
851594|NCT00078715|Yohimbine|yohimbine
851595|NCT00078715|Sleep Deprivation|sleep deprivation
851603|NCT00078689|Sirolimus|sirolimus
851604|NCT00078689|Daclizumab|daclizumab
851605|NCT00078689|Inflammation|inflammation
851606|NCT00078689|Induce Tolerance|induce tolerance
851607|NCT00078689|Uveitis|uveitis
851608|NCT00078689|Immune Tolerance|immune tolerance
851609|NCT00078689|T Cell|t cell
851610|NCT00006000|unspecified adult solid tumor, protocol specific|unspecified adult solid tumor, protocol specific
851611|NCT00005965|stage III cervical cancer|stage iii cervical cancer
851612|NCT00005965|recurrent cervical cancer|recurrent cervical cancer
851613|NCT00005965|stage IVB cervical cancer|stage ivb cervical cancer
851614|NCT00005965|stage IVA cervical cancer|stage iva cervical cancer
851615|NCT00005965|cervical squamous cell carcinoma|cervical squamous cell carcinoma
851616|NCT00005965|cervical adenocarcinoma|cervical adenocarcinoma
851617|NCT00005965|cervical adenosquamous cell carcinoma|cervical adenosquamous cell carcinoma
851618|NCT00005947|adenocarcinoma of the prostate|adenocarcinoma of the prostate
851619|NCT00005947|stage IV prostate cancer|stage iv prostate cancer
851620|NCT00005947|recurrent prostate cancer|recurrent prostate cancer
851621|NCT00005946|recurrent childhood acute lymphoblastic leukemia|recurrent childhood acute lymphoblastic leukemia
851622|NCT00005946|recurrent adult Hodgkin lymphoma|recurrent adult hodgkin lymphoma
851623|NCT00005946|refractory multiple myeloma|refractory multiple myeloma
851624|NCT00005946|recurrent childhood lymphoblastic lymphoma|recurrent childhood lymphoblastic lymphoma
851625|NCT00005946|recurrent childhood acute myeloid leukemia|recurrent childhood acute myeloid leukemia
851626|NCT00005946|recurrent adult acute myeloid leukemia|recurrent adult acute myeloid leukemia
851627|NCT00005946|recurrent adult acute lymphoblastic leukemia|recurrent adult acute lymphoblastic leukemia
851628|NCT00005946|relapsing chronic myelogenous leukemia|relapsing chronic myelogenous leukemia
851629|NCT00005946|refractory chronic lymphocytic leukemia|refractory chronic lymphocytic leukemia
851630|NCT00005946|chronic phase chronic myelogenous leukemia|chronic phase chronic myelogenous leukemia
851631|NCT00005946|accelerated phase chronic myelogenous leukemia|accelerated phase chronic myelogenous leukemia
851632|NCT00005946|blastic phase chronic myelogenous leukemia|blastic phase chronic myelogenous leukemia
851633|NCT00005946|recurrent/refractory childhood Hodgkin lymphoma|recurrent/refractory childhood hodgkin lymphoma
851634|NCT00005946|recurrent grade 1 follicular lymphoma|recurrent grade 1 follicular lymphoma
851635|NCT00005946|recurrent grade 2 follicular lymphoma|recurrent grade 2 follicular lymphoma
851636|NCT00005946|recurrent grade 3 follicular lymphoma|recurrent grade 3 follicular lymphoma
851637|NCT00005946|recurrent adult diffuse small cleaved cell lymphoma|recurrent adult diffuse small cleaved cell lymphoma
851638|NCT00005946|recurrent adult diffuse mixed cell lymphoma|recurrent adult diffuse mixed cell lymphoma
851639|NCT00005946|recurrent adult diffuse large cell lymphoma|recurrent adult diffuse large cell lymphoma
851640|NCT00005946|recurrent adult immunoblastic large cell lymphoma|recurrent adult immunoblastic large cell lymphoma
851641|NCT00005946|recurrent adult lymphoblastic lymphoma|recurrent adult lymphoblastic lymphoma
851642|NCT00005946|recurrent adult Burkitt lymphoma|recurrent adult burkitt lymphoma
851643|NCT00005946|previously treated myelodysplastic syndromes|previously treated myelodysplastic syndromes
851644|NCT00005946|secondary myelodysplastic syndromes|secondary myelodysplastic syndromes
851645|NCT00005946|recurrent childhood small noncleaved cell lymphoma|recurrent childhood small noncleaved cell lymphoma
851646|NCT00005946|recurrent childhood large cell lymphoma|recurrent childhood large cell lymphoma
851647|NCT00005946|recurrent mantle cell lymphoma|recurrent mantle cell lymphoma
851648|NCT00005946|recurrent marginal zone lymphoma|recurrent marginal zone lymphoma
851649|NCT00005946|recurrent small lymphocytic lymphoma|recurrent small lymphocytic lymphoma
851650|NCT00005946|extranodal marginal zone B-cell lymphoma of mucosa-associated lymphoid tissue|extranodal marginal zone b-cell lymphoma of mucosa-associated lymphoid tissue
851651|NCT00005946|nodal marginal zone B-cell lymphoma|nodal marginal zone b-cell lymphoma
851652|NCT00005946|splenic marginal zone lymphoma|splenic marginal zone lymphoma
851653|NCT00005946|childhood myelodysplastic syndromes|childhood myelodysplastic syndromes
851654|NCT00005843|recurrent pancreatic cancer|recurrent pancreatic cancer
851655|NCT00005843|adenocarcinoma of the pancreas|adenocarcinoma of the pancreas
851656|NCT00005843|stage IV pancreatic cancer|stage iv pancreatic cancer
851657|NCT00078663|Oral Care|oral care
851658|NCT00078663|ICU|icu
851659|NCT00078663|Pneumonia|pneumonia
851660|NCT00078663|Pathogens|pathogens
851661|NCT00078663|Intubation|intubation
851662|NCT00078663|Intubated|intubated
851663|NCT00078663|Oral Hygiene|oral hygiene
851664|NCT00078663|Intensive Care|intensive care
851665|NCT00078624|Osteoarthritis|osteoarthritis
851666|NCT00078624|Knee Joint|knee joint
851667|NCT00078624|Joint Stability|joint stability
851668|NCT00078624|Motor Control|motor control
851669|NCT00078624|Exercise Therapy|exercise therapy
851670|NCT00005595|recurrent adult Hodgkin lymphoma|recurrent adult hodgkin lymphoma
851671|NCT00005096|adenocarcinoma of the prostate|adenocarcinoma of the prostate
851672|NCT00005096|stage II prostate cancer|stage ii prostate cancer
851673|NCT00005096|stage III prostate cancer|stage iii prostate cancer
851674|NCT00005035|metastatic squamous neck cancer with occult primary squamous cell carcinoma|metastatic squamous neck cancer with occult primary squamous cell carcinoma
851675|NCT00005035|stage III squamous cell carcinoma of the lip and oral cavity|stage iii squamous cell carcinoma of the lip and oral cavity
851676|NCT00005035|stage IV squamous cell carcinoma of the lip and oral cavity|stage iv squamous cell carcinoma of the lip and oral cavity
851677|NCT00005035|recurrent squamous cell carcinoma of the lip and oral cavity|recurrent squamous cell carcinoma of the lip and oral cavity
851678|NCT00005035|stage III squamous cell carcinoma of the oropharynx|stage iii squamous cell carcinoma of the oropharynx
851679|NCT00005035|stage IV squamous cell carcinoma of the oropharynx|stage iv squamous cell carcinoma of the oropharynx
851680|NCT00005035|recurrent squamous cell carcinoma of the oropharynx|recurrent squamous cell carcinoma of the oropharynx
851681|NCT00005035|stage III squamous cell carcinoma of the nasopharynx|stage iii squamous cell carcinoma of the nasopharynx
851682|NCT00005035|stage IV squamous cell carcinoma of the nasopharynx|stage iv squamous cell carcinoma of the nasopharynx
851683|NCT00005035|recurrent squamous cell carcinoma of the nasopharynx|recurrent squamous cell carcinoma of the nasopharynx
851684|NCT00005035|stage III squamous cell carcinoma of the hypopharynx|stage iii squamous cell carcinoma of the hypopharynx
851685|NCT00005035|stage IV squamous cell carcinoma of the hypopharynx|stage iv squamous cell carcinoma of the hypopharynx
851686|NCT00005035|recurrent squamous cell carcinoma of the hypopharynx|recurrent squamous cell carcinoma of the hypopharynx
851687|NCT00005035|stage III squamous cell carcinoma of the larynx|stage iii squamous cell carcinoma of the larynx
851688|NCT00005035|stage IV squamous cell carcinoma of the larynx|stage iv squamous cell carcinoma of the larynx
851689|NCT00005035|recurrent squamous cell carcinoma of the larynx|recurrent squamous cell carcinoma of the larynx
851690|NCT00005035|stage III squamous cell carcinoma of the paranasal sinus and nasal cavity|stage iii squamous cell carcinoma of the paranasal sinus and nasal cavity
851691|NCT00005035|stage IV squamous cell carcinoma of the paranasal sinus and nasal cavity|stage iv squamous cell carcinoma of the paranasal sinus and nasal cavity
852617|NCT00003046|recurrent colon cancer|recurrent colon cancer
851692|NCT00005035|recurrent squamous cell carcinoma of the paranasal sinus and nasal cavity|recurrent squamous cell carcinoma of the paranasal sinus and nasal cavity
879070|NCT00044356|Lesion|lesion
851693|NCT00004914|unspecified adult solid tumor, protocol specific|unspecified adult solid tumor, protocol specific
851694|NCT00004914|anemia|anemia
851695|NCT00004914|fatigue|fatigue
851696|NCT00078598|Relapsed|relapsed
851697|NCT00078598|Follicular|follicular
851698|NCT00078572|XELODA|xeloda
851699|NCT00078572|Metastatic|metastatic
851700|NCT00078572|Breast Cancer|breast cancer
851701|NCT00078572|Advanced|advanced
851702|NCT00078572|HERCEPTIN|herceptin
851703|NCT00078507|Outcome and Process Assessment (Health Care)|outcome and process assessment (health care)
851704|NCT00078507|Behavior Control|behavior control
851705|NCT00078507|Sensation|sensation
851706|NCT00078507|Randomized Controlled Trials|randomized controlled trials
851707|NCT00078507|Adolescent|adolescent
851709|NCT00004912|unspecified adult solid tumor, protocol specific|unspecified adult solid tumor, protocol specific
851710|NCT00004912|fatigue|fatigue
851711|NCT00004912|cachexia|cachexia
851712|NCT00004908|recurrent adult Hodgkin lymphoma|recurrent adult hodgkin lymphoma
851713|NCT00004908|recurrent/refractory childhood Hodgkin lymphoma|recurrent/refractory childhood hodgkin lymphoma
851714|NCT00004908|recurrent grade 1 follicular lymphoma|recurrent grade 1 follicular lymphoma
851715|NCT00004908|recurrent grade 2 follicular lymphoma|recurrent grade 2 follicular lymphoma
851716|NCT00004908|recurrent grade 3 follicular lymphoma|recurrent grade 3 follicular lymphoma
851717|NCT00004908|recurrent adult diffuse small cleaved cell lymphoma|recurrent adult diffuse small cleaved cell lymphoma
851718|NCT00004908|recurrent adult diffuse mixed cell lymphoma|recurrent adult diffuse mixed cell lymphoma
851719|NCT00004908|recurrent adult diffuse large cell lymphoma|recurrent adult diffuse large cell lymphoma
851720|NCT00004908|recurrent adult immunoblastic large cell lymphoma|recurrent adult immunoblastic large cell lymphoma
851721|NCT00004908|recurrent childhood large cell lymphoma|recurrent childhood large cell lymphoma
851722|NCT00004908|recurrent marginal zone lymphoma|recurrent marginal zone lymphoma
851723|NCT00004908|recurrent small lymphocytic lymphoma|recurrent small lymphocytic lymphoma
851724|NCT00004908|extranodal marginal zone B-cell lymphoma of mucosa-associated lymphoid tissue|extranodal marginal zone b-cell lymphoma of mucosa-associated lymphoid tissue
851725|NCT00004908|nodal marginal zone B-cell lymphoma|nodal marginal zone b-cell lymphoma
851726|NCT00004908|splenic marginal zone lymphoma|splenic marginal zone lymphoma
851727|NCT00004904|monoclonal gammopathy of undetermined significance|monoclonal gammopathy of undetermined significance
851728|NCT00004904|stage III cutaneous T-cell non-Hodgkin lymphoma|stage iii cutaneous t-cell non-hodgkin lymphoma
851729|NCT00004904|stage IV cutaneous T-cell non-Hodgkin lymphoma|stage iv cutaneous t-cell non-hodgkin lymphoma
851730|NCT00004904|recurrent cutaneous T-cell non-Hodgkin lymphoma|recurrent cutaneous t-cell non-hodgkin lymphoma
851731|NCT00004904|isolated plasmacytoma of bone|isolated plasmacytoma of bone
851732|NCT00004904|extramedullary plasmacytoma|extramedullary plasmacytoma
851733|NCT00004904|refractory multiple myeloma|refractory multiple myeloma
851734|NCT00004904|Waldenstrom macroglobulinemia|waldenstrom macroglobulinemia
851735|NCT00004904|stage III multiple myeloma|stage iii multiple myeloma
851736|NCT00004904|recurrent childhood lymphoblastic lymphoma|recurrent childhood lymphoblastic lymphoma
851737|NCT00004904|recurrent childhood acute myeloid leukemia|recurrent childhood acute myeloid leukemia
851738|NCT00004904|recurrent adult acute myeloid leukemia|recurrent adult acute myeloid leukemia
851739|NCT00004904|recurrent adult acute lymphoblastic leukemia|recurrent adult acute lymphoblastic leukemia
851740|NCT00004904|small intestine lymphoma|small intestine lymphoma
851741|NCT00004904|chronic phase chronic myelogenous leukemia|chronic phase chronic myelogenous leukemia
851742|NCT00004904|accelerated phase chronic myelogenous leukemia|accelerated phase chronic myelogenous leukemia
851743|NCT00004904|blastic phase chronic myelogenous leukemia|blastic phase chronic myelogenous leukemia
851744|NCT00004904|adult acute myeloid leukemia in remission|adult acute myeloid leukemia in remission
851745|NCT00004904|adult acute lymphoblastic leukemia in remission|adult acute lymphoblastic leukemia in remission
851746|NCT00004904|childhood acute myeloid leukemia in remission|childhood acute myeloid leukemia in remission
851747|NCT00004904|polycythemia vera|polycythemia vera
851748|NCT00004904|chronic idiopathic myelofibrosis|chronic idiopathic myelofibrosis
851749|NCT00004904|essential thrombocythemia|essential thrombocythemia
851750|NCT00004904|refractory hairy cell leukemia|refractory hairy cell leukemia
851751|NCT00004904|T-cell large granular lymphocyte leukemia|t-cell large granular lymphocyte leukemia
851752|NCT00004904|acute undifferentiated leukemia|acute undifferentiated leukemia
851753|NCT00004904|stage III grade 1 follicular lymphoma|stage iii grade 1 follicular lymphoma
851754|NCT00004904|stage III grade 2 follicular lymphoma|stage iii grade 2 follicular lymphoma
851755|NCT00004904|stage III grade 3 follicular lymphoma|stage iii grade 3 follicular lymphoma
851756|NCT00004904|stage III adult diffuse small cleaved cell lymphoma|stage iii adult diffuse small cleaved cell lymphoma
851757|NCT00004904|stage III adult diffuse mixed cell lymphoma|stage iii adult diffuse mixed cell lymphoma
851758|NCT00004904|stage III adult diffuse large cell lymphoma|stage iii adult diffuse large cell lymphoma
851759|NCT00004904|stage III adult immunoblastic large cell lymphoma|stage iii adult immunoblastic large cell lymphoma
851760|NCT00004904|stage III adult lymphoblastic lymphoma|stage iii adult lymphoblastic lymphoma
851761|NCT00004904|stage III adult Burkitt lymphoma|stage iii adult burkitt lymphoma
851762|NCT00004904|stage IV grade 1 follicular lymphoma|stage iv grade 1 follicular lymphoma
851763|NCT00004904|stage IV grade 2 follicular lymphoma|stage iv grade 2 follicular lymphoma
852255|NCT00078273|Problem Gambling|problem gambling
851764|NCT00004904|stage IV grade 3 follicular lymphoma|stage iv grade 3 follicular lymphoma
851765|NCT00004904|stage IV adult diffuse small cleaved cell lymphoma|stage iv adult diffuse small cleaved cell lymphoma
851766|NCT00004904|stage IV adult diffuse mixed cell lymphoma|stage iv adult diffuse mixed cell lymphoma
851767|NCT00004904|stage IV adult diffuse large cell lymphoma|stage iv adult diffuse large cell lymphoma
851768|NCT00004904|stage IV adult immunoblastic large cell lymphoma|stage iv adult immunoblastic large cell lymphoma
851769|NCT00004904|stage IV adult lymphoblastic lymphoma|stage iv adult lymphoblastic lymphoma
851770|NCT00004904|stage IV adult Burkitt lymphoma|stage iv adult burkitt lymphoma
851771|NCT00004904|recurrent grade 1 follicular lymphoma|recurrent grade 1 follicular lymphoma
851772|NCT00004904|recurrent grade 2 follicular lymphoma|recurrent grade 2 follicular lymphoma
851773|NCT00004904|recurrent grade 3 follicular lymphoma|recurrent grade 3 follicular lymphoma
851774|NCT00004904|recurrent adult diffuse small cleaved cell lymphoma|recurrent adult diffuse small cleaved cell lymphoma
851775|NCT00004904|recurrent adult diffuse mixed cell lymphoma|recurrent adult diffuse mixed cell lymphoma
851776|NCT00004904|recurrent adult diffuse large cell lymphoma|recurrent adult diffuse large cell lymphoma
851777|NCT00004904|recurrent adult immunoblastic large cell lymphoma|recurrent adult immunoblastic large cell lymphoma
851778|NCT00004904|recurrent adult lymphoblastic lymphoma|recurrent adult lymphoblastic lymphoma
851779|NCT00004904|recurrent adult Burkitt lymphoma|recurrent adult burkitt lymphoma
851780|NCT00004904|stage III adult T-cell leukemia/lymphoma|stage iii adult t-cell leukemia/lymphoma
851781|NCT00004904|stage IV adult T-cell leukemia/lymphoma|stage iv adult t-cell leukemia/lymphoma
851782|NCT00004904|recurrent adult T-cell leukemia/lymphoma|recurrent adult t-cell leukemia/lymphoma
851783|NCT00004904|secondary acute myeloid leukemia|secondary acute myeloid leukemia
851784|NCT00004904|de novo myelodysplastic syndromes|de novo myelodysplastic syndromes
851785|NCT00004904|previously treated myelodysplastic syndromes|previously treated myelodysplastic syndromes
851786|NCT00004904|secondary myelodysplastic syndromes|secondary myelodysplastic syndromes
851787|NCT00004904|graft versus host disease|graft versus host disease
851788|NCT00004904|primary systemic amyloidosis|primary systemic amyloidosis
851789|NCT00004904|intraocular lymphoma|intraocular lymphoma
851790|NCT00004904|recurrent childhood small noncleaved cell lymphoma|recurrent childhood small noncleaved cell lymphoma
851791|NCT00004904|recurrent childhood large cell lymphoma|recurrent childhood large cell lymphoma
851792|NCT00004904|stage III mantle cell lymphoma|stage iii mantle cell lymphoma
851793|NCT00004904|stage IV mantle cell lymphoma|stage iv mantle cell lymphoma
851794|NCT00004904|recurrent mantle cell lymphoma|recurrent mantle cell lymphoma
851795|NCT00004904|stage III mycosis fungoides/Sezary syndrome|stage iii mycosis fungoides/sezary syndrome
851796|NCT00004904|stage IV mycosis fungoides/Sezary syndrome|stage iv mycosis fungoides/sezary syndrome
851797|NCT00004904|recurrent mycosis fungoides/Sezary syndrome|recurrent mycosis fungoides/sezary syndrome
851798|NCT00004904|recurrent marginal zone lymphoma|recurrent marginal zone lymphoma
851799|NCT00004904|recurrent small lymphocytic lymphoma|recurrent small lymphocytic lymphoma
851800|NCT00004904|stage III small lymphocytic lymphoma|stage iii small lymphocytic lymphoma
851801|NCT00004904|stage III marginal zone lymphoma|stage iii marginal zone lymphoma
851802|NCT00004904|stage IV small lymphocytic lymphoma|stage iv small lymphocytic lymphoma
851803|NCT00004904|stage IV marginal zone lymphoma|stage iv marginal zone lymphoma
851804|NCT00004904|extranodal marginal zone B-cell lymphoma of mucosa-associated lymphoid tissue|extranodal marginal zone b-cell lymphoma of mucosa-associated lymphoid tissue
851805|NCT00004904|nodal marginal zone B-cell lymphoma|nodal marginal zone b-cell lymphoma
851806|NCT00004904|splenic marginal zone lymphoma|splenic marginal zone lymphoma
851807|NCT00004904|childhood myelodysplastic syndromes|childhood myelodysplastic syndromes
851808|NCT00004898|recurrent childhood acute lymphoblastic leukemia|recurrent childhood acute lymphoblastic leukemia
851809|NCT00004898|stage I childhood lymphoblastic lymphoma|stage i childhood lymphoblastic lymphoma
851810|NCT00004898|stage II childhood lymphoblastic lymphoma|stage ii childhood lymphoblastic lymphoma
851811|NCT00004898|stage III childhood lymphoblastic lymphoma|stage iii childhood lymphoblastic lymphoma
851812|NCT00004898|stage IV childhood lymphoblastic lymphoma|stage iv childhood lymphoblastic lymphoma
851813|NCT00004898|recurrent childhood lymphoblastic lymphoma|recurrent childhood lymphoblastic lymphoma
851814|NCT00004898|recurrent adult acute lymphoblastic leukemia|recurrent adult acute lymphoblastic leukemia
851815|NCT00004898|adult acute lymphoblastic leukemia in remission|adult acute lymphoblastic leukemia in remission
851816|NCT00004898|childhood acute lymphoblastic leukemia in remission|childhood acute lymphoblastic leukemia in remission
851817|NCT00004898|stage I adult immunoblastic large cell lymphoma|stage i adult immunoblastic large cell lymphoma
851818|NCT00004898|stage I adult lymphoblastic lymphoma|stage i adult lymphoblastic lymphoma
851819|NCT00004898|stage I adult Burkitt lymphoma|stage i adult burkitt lymphoma
851820|NCT00004898|stage II adult immunoblastic large cell lymphoma|stage ii adult immunoblastic large cell lymphoma
851821|NCT00004898|stage II adult lymphoblastic lymphoma|stage ii adult lymphoblastic lymphoma
851822|NCT00004898|stage II adult Burkitt lymphoma|stage ii adult burkitt lymphoma
851823|NCT00004898|stage III adult immunoblastic large cell lymphoma|stage iii adult immunoblastic large cell lymphoma
851824|NCT00004898|stage III adult lymphoblastic lymphoma|stage iii adult lymphoblastic lymphoma
851825|NCT00004898|stage III adult Burkitt lymphoma|stage iii adult burkitt lymphoma
851826|NCT00004898|stage IV adult immunoblastic large cell lymphoma|stage iv adult immunoblastic large cell lymphoma
851827|NCT00004898|stage IV adult lymphoblastic lymphoma|stage iv adult lymphoblastic lymphoma
851828|NCT00004898|stage IV adult Burkitt lymphoma|stage iv adult burkitt lymphoma
851829|NCT00004898|recurrent adult immunoblastic large cell lymphoma|recurrent adult immunoblastic large cell lymphoma
851830|NCT00004898|recurrent adult lymphoblastic lymphoma|recurrent adult lymphoblastic lymphoma
851831|NCT00004898|recurrent adult Burkitt lymphoma|recurrent adult burkitt lymphoma
851832|NCT00004898|stage I childhood small noncleaved cell lymphoma|stage i childhood small noncleaved cell lymphoma
851833|NCT00004898|stage I childhood large cell lymphoma|stage i childhood large cell lymphoma
851834|NCT00004898|stage II childhood small noncleaved cell lymphoma|stage ii childhood small noncleaved cell lymphoma
851835|NCT00004898|stage II childhood large cell lymphoma|stage ii childhood large cell lymphoma
851836|NCT00004898|stage III childhood small noncleaved cell lymphoma|stage iii childhood small noncleaved cell lymphoma
851837|NCT00004898|stage III childhood large cell lymphoma|stage iii childhood large cell lymphoma
851838|NCT00004898|stage IV childhood small noncleaved cell lymphoma|stage iv childhood small noncleaved cell lymphoma
851839|NCT00004898|stage IV childhood large cell lymphoma|stage iv childhood large cell lymphoma
851840|NCT00004898|recurrent childhood small noncleaved cell lymphoma|recurrent childhood small noncleaved cell lymphoma
851841|NCT00004898|recurrent childhood large cell lymphoma|recurrent childhood large cell lymphoma
851842|NCT00004235|stage IV gastric cancer|stage iv gastric cancer
851843|NCT00004235|recurrent gastric cancer|recurrent gastric cancer
851844|NCT00004235|stage II esophageal cancer|stage ii esophageal cancer
851845|NCT00004235|stage III esophageal cancer|stage iii esophageal cancer
851846|NCT00004235|stage IV esophageal cancer|stage iv esophageal cancer
851847|NCT00004235|recurrent esophageal cancer|recurrent esophageal cancer
851848|NCT00004235|adenocarcinoma of the stomach|adenocarcinoma of the stomach
851849|NCT00004235|adenocarcinoma of the esophagus|adenocarcinoma of the esophagus
851850|NCT00004175|stage IIIA breast cancer|stage iiia breast cancer
851851|NCT00004175|stage IIIB breast cancer|stage iiib breast cancer
851852|NCT00078559|Immunosuppression|immunosuppression
851853|NCT00078559|Renal Failure|renal failure
851854|NCT00078546|EBV|ebv
851855|NCT00078546|NASOPHARYNGEAL|nasopharyngeal
851856|NCT00078546|CARCINOMA|carcinoma
851857|NCT00078546|EBV POSITIVE NASOPHARYNGEAL CARCINOMA|ebv positive nasopharyngeal carcinoma
851858|NCT00078533|Allogeneic|allogeneic
851859|NCT00078533|Transplant|transplant
851860|NCT00078533|CMV|cmv
851861|NCT00078533|Stem Cell|stem cell
851862|NCT00078533|Donor|donor
851863|NCT00078533|Allogeneic stem cell recipients at risk for CMV reactivation|allogeneic stem cell recipients at risk for cmv reactivation
851864|NCT00078520|Leukemia|leukemia
851865|NCT00078494|Immunization|immunization
851866|NCT00078494|Vaccine|vaccine
851867|NCT00078494|Nasopharyngeal Cancer|nasopharyngeal cancer
851868|NCT00078494|Immunotherapy|immunotherapy
851869|NCT00078494|Cancer|cancer
851870|NCT00078494|NPC|npc
851871|NCT00078481|Neurodegeneration|neurodegeneration
851872|NCT00078481|Anti-Oxidant|anti-oxidant
851873|NCT00078481|Neuropathy|neuropathy
851874|NCT00078481|Hereditary|hereditary
851875|NCT00078481|Spinocerebellar|spinocerebellar
851876|NCT00078481|Friedreich Ataxia|friedreich ataxia
851877|NCT00078481|FRDA|frda
851878|NCT00078455|NSCLC|nsclc
851879|NCT00078455|Non-small Cell Lung Cancer|non-small cell lung cancer
851880|NCT00078455|Non-small Cell Lung Carcinoma|non-small cell lung carcinoma
851881|NCT00078455|Locally Advanced NSCLC|locally advanced nsclc
851882|NCT00078455|Metastatic NSCLC|metastatic nsclc
851883|NCT00078221|Dry AMD|dry amd
851884|NCT00078221|Age-related Macular Degeneration|age-related macular degeneration
851885|NCT00078221|Rheopheresis|rheopheresis
851886|NCT00004171|recurrent adult Hodgkin lymphoma|recurrent adult hodgkin lymphoma
851887|NCT00004171|childhood immunoblastic large cell lymphoma|childhood immunoblastic large cell lymphoma
851888|NCT00004171|recurrent/refractory childhood Hodgkin lymphoma|recurrent/refractory childhood hodgkin lymphoma
851889|NCT00004171|recurrent grade 3 follicular lymphoma|recurrent grade 3 follicular lymphoma
851890|NCT00004171|recurrent adult diffuse small cleaved cell lymphoma|recurrent adult diffuse small cleaved cell lymphoma
851891|NCT00004171|recurrent adult diffuse mixed cell lymphoma|recurrent adult diffuse mixed cell lymphoma
851892|NCT00004171|recurrent adult diffuse large cell lymphoma|recurrent adult diffuse large cell lymphoma
851893|NCT00004171|recurrent adult immunoblastic large cell lymphoma|recurrent adult immunoblastic large cell lymphoma
851894|NCT00004091|cervical cancer|cervical cancer
851895|NCT00003351|stage IV breast cancer|stage iv breast cancer
851896|NCT00003302|breast cancer|breast cancer
851897|NCT00003264|stage IV salivary gland cancer|stage iv salivary gland cancer
851898|NCT00003264|recurrent salivary gland cancer|recurrent salivary gland cancer
851899|NCT00003264|recurrent metastatic squamous neck cancer with occult primary|recurrent metastatic squamous neck cancer with occult primary
851900|NCT00003264|metastatic squamous neck cancer with occult primary squamous cell carcinoma|metastatic squamous neck cancer with occult primary squamous cell carcinoma
851901|NCT00003264|salivary gland squamous cell carcinoma|salivary gland squamous cell carcinoma
851902|NCT00003264|stage IV squamous cell carcinoma of the lip and oral cavity|stage iv squamous cell carcinoma of the lip and oral cavity
851903|NCT00003264|recurrent squamous cell carcinoma of the lip and oral cavity|recurrent squamous cell carcinoma of the lip and oral cavity
851904|NCT00003264|stage IV squamous cell carcinoma of the oropharynx|stage iv squamous cell carcinoma of the oropharynx
851966|NCT00026429|contiguous stage II mantle cell lymphoma|contiguous stage ii mantle cell lymphoma
851905|NCT00003264|recurrent squamous cell carcinoma of the oropharynx|recurrent squamous cell carcinoma of the oropharynx
851906|NCT00003264|stage IV squamous cell carcinoma of the nasopharynx|stage iv squamous cell carcinoma of the nasopharynx
851907|NCT00003264|recurrent squamous cell carcinoma of the nasopharynx|recurrent squamous cell carcinoma of the nasopharynx
851908|NCT00003264|stage IV squamous cell carcinoma of the hypopharynx|stage iv squamous cell carcinoma of the hypopharynx
851909|NCT00003264|recurrent squamous cell carcinoma of the hypopharynx|recurrent squamous cell carcinoma of the hypopharynx
851910|NCT00003264|stage IV squamous cell carcinoma of the larynx|stage iv squamous cell carcinoma of the larynx
851911|NCT00003264|recurrent squamous cell carcinoma of the larynx|recurrent squamous cell carcinoma of the larynx
851912|NCT00003264|stage IV squamous cell carcinoma of the paranasal sinus and nasal cavity|stage iv squamous cell carcinoma of the paranasal sinus and nasal cavity
851913|NCT00003264|recurrent squamous cell carcinoma of the paranasal sinus and nasal cavity|recurrent squamous cell carcinoma of the paranasal sinus and nasal cavity
851914|NCT00003070|unspecified childhood solid tumor, protocol specific|unspecified childhood solid tumor, protocol specific
851915|NCT00003070|cardiac toxicity|cardiac toxicity
851916|NCT00003040|stage I squamous cell carcinoma of the larynx|stage i squamous cell carcinoma of the larynx
851917|NCT00003040|stage II squamous cell carcinoma of the larynx|stage ii squamous cell carcinoma of the larynx
851918|NCT00003040|stage III squamous cell carcinoma of the larynx|stage iii squamous cell carcinoma of the larynx
851919|NCT00002825|recurrent childhood rhabdomyosarcoma|recurrent childhood rhabdomyosarcoma
851920|NCT00002825|recurrent neuroblastoma|recurrent neuroblastoma
851921|NCT00002825|recurrent osteosarcoma|recurrent osteosarcoma
851922|NCT00002825|recurrent childhood soft tissue sarcoma|recurrent childhood soft tissue sarcoma
851923|NCT00002825|recurrent childhood brain stem glioma|recurrent childhood brain stem glioma
851924|NCT00002825|recurrent childhood supratentorial primitive neuroectodermal tumor|recurrent childhood supratentorial primitive neuroectodermal tumor
851925|NCT00002825|recurrent childhood cerebellar astrocytoma|recurrent childhood cerebellar astrocytoma
851926|NCT00002825|recurrent childhood cerebral astrocytoma|recurrent childhood cerebral astrocytoma
851927|NCT00002825|recurrent childhood medulloblastoma|recurrent childhood medulloblastoma
851928|NCT00002825|recurrent Ewing sarcoma/peripheral primitive neuroectodermal tumor|recurrent ewing sarcoma/peripheral primitive neuroectodermal tumor
851929|NCT00002825|recurrent childhood ependymoma|recurrent childhood ependymoma
851930|NCT00002652|refractory multiple myeloma|refractory multiple myeloma
851931|NCT00026429|stage I chronic lymphocytic leukemia|stage i chronic lymphocytic leukemia
851932|NCT00026429|stage II chronic lymphocytic leukemia|stage ii chronic lymphocytic leukemia
851933|NCT00026429|stage III chronic lymphocytic leukemia|stage iii chronic lymphocytic leukemia
851934|NCT00026429|stage IV chronic lymphocytic leukemia|stage iv chronic lymphocytic leukemia
851935|NCT00026429|refractory chronic lymphocytic leukemia|refractory chronic lymphocytic leukemia
851936|NCT00026429|B-cell chronic lymphocytic leukemia|b-cell chronic lymphocytic leukemia
851937|NCT00026429|stage I grade 1 follicular lymphoma|stage i grade 1 follicular lymphoma
851938|NCT00026429|stage I grade 2 follicular lymphoma|stage i grade 2 follicular lymphoma
851939|NCT00026429|stage I grade 3 follicular lymphoma|stage i grade 3 follicular lymphoma
851940|NCT00026429|stage I adult diffuse small cleaved cell lymphoma|stage i adult diffuse small cleaved cell lymphoma
851941|NCT00026429|stage I adult diffuse mixed cell lymphoma|stage i adult diffuse mixed cell lymphoma
851942|NCT00026429|stage I adult diffuse large cell lymphoma|stage i adult diffuse large cell lymphoma
851943|NCT00026429|stage III grade 1 follicular lymphoma|stage iii grade 1 follicular lymphoma
851944|NCT00026429|stage III grade 2 follicular lymphoma|stage iii grade 2 follicular lymphoma
851945|NCT00026429|stage III grade 3 follicular lymphoma|stage iii grade 3 follicular lymphoma
851946|NCT00026429|stage III adult diffuse small cleaved cell lymphoma|stage iii adult diffuse small cleaved cell lymphoma
851947|NCT00026429|stage III adult diffuse mixed cell lymphoma|stage iii adult diffuse mixed cell lymphoma
851948|NCT00026429|stage III adult diffuse large cell lymphoma|stage iii adult diffuse large cell lymphoma
851949|NCT00026429|stage IV grade 1 follicular lymphoma|stage iv grade 1 follicular lymphoma
851950|NCT00026429|stage IV grade 2 follicular lymphoma|stage iv grade 2 follicular lymphoma
851951|NCT00026429|stage IV grade 3 follicular lymphoma|stage iv grade 3 follicular lymphoma
851952|NCT00026429|stage IV adult diffuse small cleaved cell lymphoma|stage iv adult diffuse small cleaved cell lymphoma
851953|NCT00026429|stage IV adult diffuse mixed cell lymphoma|stage iv adult diffuse mixed cell lymphoma
851954|NCT00026429|stage IV adult diffuse large cell lymphoma|stage iv adult diffuse large cell lymphoma
851955|NCT00026429|recurrent grade 1 follicular lymphoma|recurrent grade 1 follicular lymphoma
851956|NCT00026429|recurrent grade 2 follicular lymphoma|recurrent grade 2 follicular lymphoma
851957|NCT00026429|recurrent grade 3 follicular lymphoma|recurrent grade 3 follicular lymphoma
851958|NCT00026429|recurrent adult diffuse small cleaved cell lymphoma|recurrent adult diffuse small cleaved cell lymphoma
851959|NCT00026429|recurrent adult diffuse mixed cell lymphoma|recurrent adult diffuse mixed cell lymphoma
851960|NCT00026429|recurrent adult diffuse large cell lymphoma|recurrent adult diffuse large cell lymphoma
851961|NCT00026429|stage I mantle cell lymphoma|stage i mantle cell lymphoma
851962|NCT00026429|contiguous stage II grade 1 follicular lymphoma|contiguous stage ii grade 1 follicular lymphoma
851963|NCT00026429|contiguous stage II grade 2 follicular lymphoma|contiguous stage ii grade 2 follicular lymphoma
851964|NCT00026429|contiguous stage II grade 3 follicular lymphoma|contiguous stage ii grade 3 follicular lymphoma
851965|NCT00026429|contiguous stage II adult diffuse small cleaved cell lymphoma|contiguous stage ii adult diffuse small cleaved cell lymphoma
851967|NCT00026429|contiguous stage II adult diffuse mixed cell lymphoma|contiguous stage ii adult diffuse mixed cell lymphoma
851968|NCT00026429|contiguous stage II adult diffuse large cell lymphoma|contiguous stage ii adult diffuse large cell lymphoma
851969|NCT00026429|noncontiguous stage II grade 1 follicular lymphoma|noncontiguous stage ii grade 1 follicular lymphoma
851970|NCT00026429|noncontiguous stage II grade 2 follicular lymphoma|noncontiguous stage ii grade 2 follicular lymphoma
851971|NCT00026429|noncontiguous stage II grade 3 follicular lymphoma|noncontiguous stage ii grade 3 follicular lymphoma
851972|NCT00026429|noncontiguous stage II adult diffuse small cleaved cell lymphoma|noncontiguous stage ii adult diffuse small cleaved cell lymphoma
851973|NCT00026429|noncontiguous stage II mantle cell lymphoma|noncontiguous stage ii mantle cell lymphoma
851974|NCT00026429|noncontiguous stage II adult diffuse mixed cell lymphoma|noncontiguous stage ii adult diffuse mixed cell lymphoma
851975|NCT00026429|noncontiguous stage II adult diffuse large cell lymphoma|noncontiguous stage ii adult diffuse large cell lymphoma
851976|NCT00026429|stage III mantle cell lymphoma|stage iii mantle cell lymphoma
851977|NCT00026429|stage IV mantle cell lymphoma|stage iv mantle cell lymphoma
851978|NCT00026429|recurrent mantle cell lymphoma|recurrent mantle cell lymphoma
851979|NCT00026429|noncontiguous stage II small lymphocytic lymphoma|noncontiguous stage ii small lymphocytic lymphoma
851980|NCT00026429|noncontiguous stage II marginal zone lymphoma|noncontiguous stage ii marginal zone lymphoma
851981|NCT00026429|recurrent marginal zone lymphoma|recurrent marginal zone lymphoma
851982|NCT00026429|recurrent small lymphocytic lymphoma|recurrent small lymphocytic lymphoma
851983|NCT00026429|stage I marginal zone lymphoma|stage i marginal zone lymphoma
851984|NCT00026429|stage I small lymphocytic lymphoma|stage i small lymphocytic lymphoma
851985|NCT00026429|stage III small lymphocytic lymphoma|stage iii small lymphocytic lymphoma
851986|NCT00026429|stage III marginal zone lymphoma|stage iii marginal zone lymphoma
851987|NCT00026429|stage IV small lymphocytic lymphoma|stage iv small lymphocytic lymphoma
851988|NCT00026429|stage IV marginal zone lymphoma|stage iv marginal zone lymphoma
851989|NCT00026429|contiguous stage II marginal zone lymphoma|contiguous stage ii marginal zone lymphoma
851990|NCT00026429|contiguous stage II small lymphocytic lymphoma|contiguous stage ii small lymphocytic lymphoma
851991|NCT00026429|extranodal marginal zone B-cell lymphoma of mucosa-associated lymphoid tissue|extranodal marginal zone b-cell lymphoma of mucosa-associated lymphoid tissue
851992|NCT00025012|basal cell carcinoma of the skin|basal cell carcinoma of the skin
851993|NCT00025012|squamous cell carcinoma of the skin|squamous cell carcinoma of the skin
851995|NCT00024037|oral complications|oral complications
851996|NCT00022308|stage II non-small cell lung cancer|stage ii non-small cell lung cancer
851997|NCT00022308|recurrent non-small cell lung cancer|recurrent non-small cell lung cancer
851998|NCT00022308|stage IIIA non-small cell lung cancer|stage iiia non-small cell lung cancer
851999|NCT00022308|stage IIIB non-small cell lung cancer|stage iiib non-small cell lung cancer
852000|NCT00022217|recurrent salivary gland cancer|recurrent salivary gland cancer
852001|NCT00022217|salivary gland squamous cell carcinoma|salivary gland squamous cell carcinoma
852002|NCT00022217|salivary gland anaplastic carcinoma|salivary gland anaplastic carcinoma
852003|NCT00022217|recurrent squamous cell carcinoma of the lip and oral cavity|recurrent squamous cell carcinoma of the lip and oral cavity
852004|NCT00022217|recurrent verrucous carcinoma of the oral cavity|recurrent verrucous carcinoma of the oral cavity
852005|NCT00022217|recurrent squamous cell carcinoma of the oropharynx|recurrent squamous cell carcinoma of the oropharynx
852006|NCT00022217|recurrent lymphoepithelioma of the oropharynx|recurrent lymphoepithelioma of the oropharynx
852007|NCT00022217|recurrent squamous cell carcinoma of the nasopharynx|recurrent squamous cell carcinoma of the nasopharynx
852008|NCT00022217|recurrent lymphoepithelioma of the nasopharynx|recurrent lymphoepithelioma of the nasopharynx
852009|NCT00022217|recurrent squamous cell carcinoma of the hypopharynx|recurrent squamous cell carcinoma of the hypopharynx
852010|NCT00022217|recurrent squamous cell carcinoma of the larynx|recurrent squamous cell carcinoma of the larynx
852011|NCT00022217|recurrent verrucous carcinoma of the larynx|recurrent verrucous carcinoma of the larynx
852012|NCT00022217|recurrent squamous cell carcinoma of the paranasal sinus and nasal cavity|recurrent squamous cell carcinoma of the paranasal sinus and nasal cavity
852013|NCT00022178|adenocarcinoma of unknown primary|adenocarcinoma of unknown primary
852014|NCT00022178|squamous cell carcinoma of unknown primary|squamous cell carcinoma of unknown primary
852015|NCT00022178|undifferentiated carcinoma of unknown primary|undifferentiated carcinoma of unknown primary
852016|NCT00022178|newly diagnosed carcinoma of unknown primary|newly diagnosed carcinoma of unknown primary
852017|NCT00021996|unspecified adult solid tumor, protocol specific|unspecified adult solid tumor, protocol specific
852018|NCT00021996|pain|pain
852019|NCT00021372|recurrent grade 1 follicular lymphoma|recurrent grade 1 follicular lymphoma
852020|NCT00021372|recurrent grade 2 follicular lymphoma|recurrent grade 2 follicular lymphoma
852021|NCT00021372|recurrent grade 3 follicular lymphoma|recurrent grade 3 follicular lymphoma
852022|NCT00021372|recurrent adult diffuse small cleaved cell lymphoma|recurrent adult diffuse small cleaved cell lymphoma
852023|NCT00021372|recurrent adult diffuse mixed cell lymphoma|recurrent adult diffuse mixed cell lymphoma
852024|NCT00021372|recurrent adult diffuse large cell lymphoma|recurrent adult diffuse large cell lymphoma
852025|NCT00021372|recurrent adult immunoblastic large cell lymphoma|recurrent adult immunoblastic large cell lymphoma
852026|NCT00021372|recurrent adult lymphoblastic lymphoma|recurrent adult lymphoblastic lymphoma
852027|NCT00021372|recurrent adult Burkitt lymphoma|recurrent adult burkitt lymphoma
852028|NCT00021372|recurrent mantle cell lymphoma|recurrent mantle cell lymphoma
852029|NCT00021372|recurrent marginal zone lymphoma|recurrent marginal zone lymphoma
852030|NCT00021372|recurrent small lymphocytic lymphoma|recurrent small lymphocytic lymphoma
852031|NCT00021372|extranodal marginal zone B-cell lymphoma of mucosa-associated lymphoid tissue|extranodal marginal zone b-cell lymphoma of mucosa-associated lymphoid tissue
852032|NCT00021372|nodal marginal zone B-cell lymphoma|nodal marginal zone b-cell lymphoma
852033|NCT00021372|splenic marginal zone lymphoma|splenic marginal zone lymphoma
852034|NCT00020618|unspecified adult solid tumor, protocol specific|unspecified adult solid tumor, protocol specific
852036|NCT00020098|breast cancer|breast cancer
852037|NCT00019409|untreated childhood acute lymphoblastic leukemia|untreated childhood acute lymphoblastic leukemia
852038|NCT00019409|childhood acute lymphoblastic leukemia in remission|childhood acute lymphoblastic leukemia in remission
852039|NCT00019409|L1 childhood acute lymphoblastic leukemia|l1 childhood acute lymphoblastic leukemia
852040|NCT00019409|L2 childhood acute lymphoblastic leukemia|l2 childhood acute lymphoblastic leukemia
852041|NCT00017303|stage III ovarian epithelial cancer|stage iii ovarian epithelial cancer
852042|NCT00017303|ovarian undifferentiated adenocarcinoma|ovarian undifferentiated adenocarcinoma
852043|NCT00017303|ovarian mixed epithelial carcinoma|ovarian mixed epithelial carcinoma
852044|NCT00017303|ovarian serous cystadenocarcinoma|ovarian serous cystadenocarcinoma
852045|NCT00017303|ovarian mucinous cystadenocarcinoma|ovarian mucinous cystadenocarcinoma
852046|NCT00017303|ovarian endometrioid adenocarcinoma|ovarian endometrioid adenocarcinoma
852047|NCT00017303|ovarian clear cell cystadenocarcinoma|ovarian clear cell cystadenocarcinoma
852048|NCT00017303|primary peritoneal cavity cancer|primary peritoneal cavity cancer
852049|NCT00017303|Brenner tumor|brenner tumor
852050|NCT00016367|stage IIIB non-small cell lung cancer|stage iiib non-small cell lung cancer
852051|NCT00016367|stage IV non-small cell lung cancer|stage iv non-small cell lung cancer
852052|NCT00015964|recurrent metastatic squamous neck cancer with occult primary|recurrent metastatic squamous neck cancer with occult primary
852053|NCT00015964|metastatic squamous neck cancer with occult primary squamous cell carcinoma|metastatic squamous neck cancer with occult primary squamous cell carcinoma
852054|NCT00015964|stage IV squamous cell carcinoma of the lip and oral cavity|stage iv squamous cell carcinoma of the lip and oral cavity
852055|NCT00015964|recurrent squamous cell carcinoma of the lip and oral cavity|recurrent squamous cell carcinoma of the lip and oral cavity
852056|NCT00015964|stage IV squamous cell carcinoma of the oropharynx|stage iv squamous cell carcinoma of the oropharynx
852057|NCT00015964|recurrent squamous cell carcinoma of the oropharynx|recurrent squamous cell carcinoma of the oropharynx
852058|NCT00015964|stage IV squamous cell carcinoma of the nasopharynx|stage iv squamous cell carcinoma of the nasopharynx
852059|NCT00015964|recurrent squamous cell carcinoma of the nasopharynx|recurrent squamous cell carcinoma of the nasopharynx
852060|NCT00015964|stage IV squamous cell carcinoma of the hypopharynx|stage iv squamous cell carcinoma of the hypopharynx
852061|NCT00015964|recurrent squamous cell carcinoma of the hypopharynx|recurrent squamous cell carcinoma of the hypopharynx
852062|NCT00015964|stage IV squamous cell carcinoma of the larynx|stage iv squamous cell carcinoma of the larynx
852063|NCT00015964|recurrent squamous cell carcinoma of the larynx|recurrent squamous cell carcinoma of the larynx
852064|NCT00015964|stage IV squamous cell carcinoma of the paranasal sinus and nasal cavity|stage iv squamous cell carcinoma of the paranasal sinus and nasal cavity
852065|NCT00015964|recurrent squamous cell carcinoma of the paranasal sinus and nasal cavity|recurrent squamous cell carcinoma of the paranasal sinus and nasal cavity
852066|NCT00002597|adenocarcinoma of the prostate|adenocarcinoma of the prostate
852067|NCT00002597|stage I prostate cancer|stage i prostate cancer
852068|NCT00002597|stage IIB prostate cancer|stage iib prostate cancer
852069|NCT00002597|stage IIA prostate cancer|stage iia prostate cancer
852070|NCT00002577|stage I non-small cell lung cancer|stage i non-small cell lung cancer
852071|NCT00002577|stage II non-small cell lung cancer|stage ii non-small cell lung cancer
852072|NCT00002577|recurrent non-small cell lung cancer|recurrent non-small cell lung cancer
852073|NCT00002577|squamous cell lung cancer|squamous cell lung cancer
852074|NCT00002577|large cell lung cancer|large cell lung cancer
852075|NCT00002577|stage IIIA non-small cell lung cancer|stage iiia non-small cell lung cancer
852076|NCT00002577|stage IIIB non-small cell lung cancer|stage iiib non-small cell lung cancer
852077|NCT00002577|adenocarcinoma of the lung|adenocarcinoma of the lung
852078|NCT00002454|lung papilloma|lung papilloma
852079|NCT00078442|Treatment Experienced|treatment experienced
852080|NCT00078442|Treatment Interruption|treatment interruption
852081|NCT00078442|Treatment Naive|treatment naive
852082|NCT00078390|Lung cancer|lung cancer
852083|NCT00078390|Lung carcinoma|lung carcinoma
852084|NCT00078390|Non small cell lung cancer|non small cell lung cancer
852085|NCT00078390|Stage IIIA non small cell lung cancer|stage iiia non small cell lung cancer
852086|NCT00078390|Stage IIIB non small cell lung cancer|stage iiib non small cell lung cancer
852087|NCT00078390|NSCLC|nsclc
852088|NCT00078390|Stage III|stage iii
852089|NCT00078390|chemotherapy|chemotherapy
852090|NCT00078390|radiation|radiation
852091|NCT00078390|chemoradiation|chemoradiation
852092|NCT00078390|matrix metalloproteinases|matrix metalloproteinases
852093|NCT00078390|neovascularization|neovascularization
852094|NCT00078390|antiangiogenesis|antiangiogenesis
852095|NCT00078390|type IV collagenases|type iv collagenases
852096|NCT00078390|Unresectable locally advanced non-small cell lung cancer|unresectable locally advanced non-small cell lung cancer
852098|NCT00078377|Excessive Sleepiness|excessive sleepiness
852099|NCT00078377|Cataplexy|cataplexy
852101|NCT00078377|Excessive Sleepiness associated with Narcolepsy|excessive sleepiness associated with narcolepsy
852102|NCT00078377|Cephalon|cephalon
852103|NCT00078377|Cephalon, Inc|cephalon, inc
852104|NCT00078377|Nuvigil|nuvigil
852105|NCT00014690|recurrent ovarian epithelial cancer|recurrent ovarian epithelial cancer
852106|NCT00014690|fallopian tube cancer|fallopian tube cancer
852107|NCT00014690|primary peritoneal cavity cancer|primary peritoneal cavity cancer
852108|NCT00014339|stage II multiple myeloma|stage ii multiple myeloma
852109|NCT00014339|stage III multiple myeloma|stage iii multiple myeloma
852110|NCT00012259|relapsing chronic myelogenous leukemia|relapsing chronic myelogenous leukemia
852111|NCT00012259|blastic phase chronic myelogenous leukemia|blastic phase chronic myelogenous leukemia
852112|NCT00012259|chronic myelogenous leukemia, BCR-ABL1 positive|chronic myelogenous leukemia, bcr-abl1 positive
852113|NCT00010179|stage III ovarian epithelial cancer|stage iii ovarian epithelial cancer
852114|NCT00010179|stage IV ovarian epithelial cancer|stage iv ovarian epithelial cancer
852115|NCT00010179|recurrent ovarian epithelial cancer|recurrent ovarian epithelial cancer
852116|NCT00010179|fallopian tube cancer|fallopian tube cancer
852117|NCT00010179|peritoneal cavity cancer|peritoneal cavity cancer
852118|NCT00006472|stage I esophageal cancer|stage i esophageal cancer
852119|NCT00006472|stage II esophageal cancer|stage ii esophageal cancer
852120|NCT00006472|stage III esophageal cancer|stage iii esophageal cancer
852121|NCT00006472|squamous cell carcinoma of the esophagus|squamous cell carcinoma of the esophagus
852122|NCT00006472|adenocarcinoma of the esophagus|adenocarcinoma of the esophagus
852123|NCT00006365|adenocarcinoma of the prostate|adenocarcinoma of the prostate
852124|NCT00006365|stage I prostate cancer|stage i prostate cancer
852125|NCT00006365|stage IIB prostate cancer|stage iib prostate cancer
852126|NCT00006365|stage IIA prostate cancer|stage iia prostate cancer
852127|NCT00006108|stage IV breast cancer|stage iv breast cancer
852128|NCT00006108|recurrent breast cancer|recurrent breast cancer
852129|NCT00006037|stage IV colon cancer|stage iv colon cancer
852130|NCT00006037|stage IV rectal cancer|stage iv rectal cancer
852131|NCT00006037|recurrent colon cancer|recurrent colon cancer
852132|NCT00006037|recurrent rectal cancer|recurrent rectal cancer
852133|NCT00006037|adenocarcinoma of the colon|adenocarcinoma of the colon
852134|NCT00006037|adenocarcinoma of the rectum|adenocarcinoma of the rectum
852135|NCT00006014|advanced malignant mesothelioma|advanced malignant mesothelioma
852136|NCT00006014|recurrent malignant mesothelioma|recurrent malignant mesothelioma
852137|NCT00006014|epithelial mesothelioma|epithelial mesothelioma
852138|NCT00006014|sarcomatous mesothelioma|sarcomatous mesothelioma
852139|NCT00078403|Treatment Experienced|treatment experienced
852140|NCT00078325|Excessive Sleepiness|excessive sleepiness
852141|NCT00078325|Obstructive Sleep Apnea|obstructive sleep apnea
852142|NCT00078325|Obstructive Sleep Hypopnea|obstructive sleep hypopnea
852143|NCT00078325|nCPAP|ncpap
852144|NCT00078325|Cephalon|cephalon
852145|NCT00078325|Cephalon, Inc|cephalon, inc
852146|NCT00078325|NUVIGIL|nuvigil
852147|NCT00078312|Excessive Sleepiness|excessive sleepiness
852148|NCT00078312|Narcolepsy|narcolepsy
852149|NCT00078312|Cataplexy|cataplexy
852150|NCT00078312|Sleep Attacks|sleep attacks
852151|NCT00078312|Obstructive Sleep Apnea|obstructive sleep apnea
852152|NCT00078312|Obstructive Sleep Hypopnea|obstructive sleep hypopnea
852153|NCT00078312|nCPAP|ncpap
852154|NCT00078312|Chronic Shift Work Sleep Disorder|chronic shift work sleep disorder
852155|NCT00078312|Chronic SWSD|chronic swsd
852156|NCT00078312|Circadian Rhythm Disorder|circadian rhythm disorder
852157|NCT00078312|Shift Worker|shift worker
852158|NCT00078312|Cepahlon|cepahlon
852159|NCT00078312|Cephalon, Inc|cephalon, inc
852160|NCT00078312|Nuvigil|nuvigil
852161|NCT00005991|stage IV breast cancer|stage iv breast cancer
852162|NCT00005991|recurrent breast cancer|recurrent breast cancer
852163|NCT00005880|non-small cell lung cancer|non-small cell lung cancer
852164|NCT00005880|small cell lung cancer|small cell lung cancer
852165|NCT00005869|stage II pancreatic cancer|stage ii pancreatic cancer
852166|NCT00005869|stage III pancreatic cancer|stage iii pancreatic cancer
852167|NCT00005869|recurrent pancreatic cancer|recurrent pancreatic cancer
852168|NCT00005869|adenocarcinoma of the pancreas|adenocarcinoma of the pancreas
852169|NCT00005869|stage IV pancreatic cancer|stage iv pancreatic cancer
852170|NCT00005864|stage IV colon cancer|stage iv colon cancer
852171|NCT00005864|stage IV rectal cancer|stage iv rectal cancer
852172|NCT00005864|recurrent colon cancer|recurrent colon cancer
852173|NCT00005864|recurrent rectal cancer|recurrent rectal cancer
852174|NCT00005593|recurrent childhood acute lymphoblastic leukemia|recurrent childhood acute lymphoblastic leukemia
852175|NCT00005593|recurrent childhood acute myeloid leukemia|recurrent childhood acute myeloid leukemia
852176|NCT00005593|recurrent adult acute myeloid leukemia|recurrent adult acute myeloid leukemia
852177|NCT00005593|recurrent adult acute lymphoblastic leukemia|recurrent adult acute lymphoblastic leukemia
852178|NCT00005593|relapsing chronic myelogenous leukemia|relapsing chronic myelogenous leukemia
852179|NCT00005593|blastic phase chronic myelogenous leukemia|blastic phase chronic myelogenous leukemia
852180|NCT00005593|L1 childhood acute lymphoblastic leukemia|l1 childhood acute lymphoblastic leukemia
852181|NCT00005593|L2 childhood acute lymphoblastic leukemia|l2 childhood acute lymphoblastic leukemia
852182|NCT00005593|L1 adult acute lymphoblastic leukemia|l1 adult acute lymphoblastic leukemia
852183|NCT00005593|L2 adult acute lymphoblastic leukemia|l2 adult acute lymphoblastic leukemia
852184|NCT00005593|adult acute erythroid leukemia (M6)|adult acute erythroid leukemia (m6)
852185|NCT00005593|adult acute myeloblastic leukemia without maturation (M1)|adult acute myeloblastic leukemia without maturation (m1)
852186|NCT00005593|adult acute myeloblastic leukemia with maturation (M2)|adult acute myeloblastic leukemia with maturation (m2)
852187|NCT00005593|adult acute promyelocytic leukemia (M3)|adult acute promyelocytic leukemia (m3)
852188|NCT00005593|adult acute myelomonocytic leukemia (M4)|adult acute myelomonocytic leukemia (m4)
852189|NCT00005593|adult acute monoblastic leukemia (M5a)|adult acute monoblastic leukemia (m5a)
852190|NCT00005593|adult acute megakaryoblastic leukemia (M7)|adult acute megakaryoblastic leukemia (m7)
852191|NCT00005593|childhood acute myeloblastic leukemia without maturation (M1)|childhood acute myeloblastic leukemia without maturation (m1)
852307|NCT00004148|stage IV melanoma|stage iv melanoma
852192|NCT00005593|childhood acute myeloblastic leukemia with maturation (M2)|childhood acute myeloblastic leukemia with maturation (m2)
852193|NCT00005593|childhood acute promyelocytic leukemia (M3)|childhood acute promyelocytic leukemia (m3)
852194|NCT00005593|childhood acute myelomonocytic leukemia (M4)|childhood acute myelomonocytic leukemia (m4)
852195|NCT00005593|childhood acute monoblastic leukemia (M5a)|childhood acute monoblastic leukemia (m5a)
852196|NCT00005593|childhood acute monocytic leukemia (M5b)|childhood acute monocytic leukemia (m5b)
852197|NCT00005593|childhood acute erythroleukemia (M6)|childhood acute erythroleukemia (m6)
852198|NCT00005593|childhood acute megakaryocytic leukemia (M7)|childhood acute megakaryocytic leukemia (m7)
852199|NCT00005593|refractory anemia with excess blasts|refractory anemia with excess blasts
852200|NCT00005593|refractory anemia with excess blasts in transformation|refractory anemia with excess blasts in transformation
852201|NCT00005593|chronic myelomonocytic leukemia|chronic myelomonocytic leukemia
852202|NCT00005593|secondary acute myeloid leukemia|secondary acute myeloid leukemia
852203|NCT00005593|adult acute monocytic leukemia (M5b)|adult acute monocytic leukemia (m5b)
852204|NCT00005593|previously treated myelodysplastic syndromes|previously treated myelodysplastic syndromes
852205|NCT00005593|secondary myelodysplastic syndromes|secondary myelodysplastic syndromes
852206|NCT00005593|adult acute minimally differentiated myeloid leukemia (M0)|adult acute minimally differentiated myeloid leukemia (m0)
852207|NCT00005593|childhood acute minimally differentiated myeloid leukemia (M0)|childhood acute minimally differentiated myeloid leukemia (m0)
852208|NCT00005593|childhood myelodysplastic syndromes|childhood myelodysplastic syndromes
852209|NCT00005075|stage I prostate cancer|stage i prostate cancer
852210|NCT00005075|stage II prostate cancer|stage ii prostate cancer
852211|NCT00005075|recurrent prostate cancer|recurrent prostate cancer
852212|NCT00005026|stage III ovarian epithelial cancer|stage iii ovarian epithelial cancer
852213|NCT00005026|stage IV ovarian epithelial cancer|stage iv ovarian epithelial cancer
852214|NCT00005026|ovarian undifferentiated adenocarcinoma|ovarian undifferentiated adenocarcinoma
852215|NCT00005026|ovarian mixed epithelial carcinoma|ovarian mixed epithelial carcinoma
852216|NCT00005026|ovarian serous cystadenocarcinoma|ovarian serous cystadenocarcinoma
852217|NCT00005026|ovarian mucinous cystadenocarcinoma|ovarian mucinous cystadenocarcinoma
852218|NCT00005026|ovarian endometrioid adenocarcinoma|ovarian endometrioid adenocarcinoma
852219|NCT00005026|ovarian clear cell cystadenocarcinoma|ovarian clear cell cystadenocarcinoma
852220|NCT00005026|primary peritoneal cavity cancer|primary peritoneal cavity cancer
852222|NCT00004223|stage III bladder cancer|stage iii bladder cancer
852223|NCT00004223|recurrent bladder cancer|recurrent bladder cancer
852224|NCT00004223|stage IV bladder cancer|stage iv bladder cancer
852225|NCT00004223|transitional cell carcinoma of the bladder|transitional cell carcinoma of the bladder
852226|NCT00004223|posterior urethral cancer|posterior urethral cancer
852227|NCT00004223|metastatic transitional cell cancer of the renal pelvis and ureter|metastatic transitional cell cancer of the renal pelvis and ureter
852228|NCT00004223|regional transitional cell cancer of the renal pelvis and ureter|regional transitional cell cancer of the renal pelvis and ureter
852229|NCT00004216|unspecified adult solid tumor, protocol specific|unspecified adult solid tumor, protocol specific
852230|NCT00004183|localized malignant mesothelioma|localized malignant mesothelioma
852231|NCT00004183|advanced malignant mesothelioma|advanced malignant mesothelioma
852232|NCT00004183|recurrent malignant mesothelioma|recurrent malignant mesothelioma
852233|NCT00004183|epithelial mesothelioma|epithelial mesothelioma
852234|NCT00004183|sarcomatous mesothelioma|sarcomatous mesothelioma
852235|NCT00078364|MRI|mri
852236|NCT00078364|NSAID Analgesia|nsaid analgesia
852237|NCT00078364|Pain Mechanisms|pain mechanisms
852238|NCT00078364|SNP's|snp's
852239|NCT00078364|Acute Pain|acute pain
852240|NCT00078364|Wisdom Teeth|wisdom teeth
852241|NCT00078364|Third Molar Extraction|third molar extraction
852242|NCT00078364|Third Molar Impaction|third molar impaction
852243|NCT00078351|Chronic Pain|chronic pain
852244|NCT00078351|Synvisc|synvisc
852245|NCT00078351|Temporomandibular Joint|temporomandibular joint
852246|NCT00078351|Osteoarthritis|osteoarthritis
852247|NCT00078351|TMD|tmd
852248|NCT00078351|Temporomandibular Joint Osteoarthritis|temporomandibular joint osteoarthritis
852249|NCT00078351|TMJ OA|tmj oa
852250|NCT00078351|Temporomandibular Joint Disease|temporomandibular joint disease
852251|NCT00078351|TMJ|tmj
852252|NCT00078286|Antidepressive Agents|antidepressive agents
852253|NCT00078273|Gambling|gambling
852254|NCT00078273|Pathological Gambling|pathological gambling
879071|NCT00044356|Metastasis|metastasis
852256|NCT00078273|College Students|college students
852257|NCT00078273|Prevention|prevention
852258|NCT00078299|Cortical|cortical
852259|NCT00078299|Nuclear Sclerosis|nuclear sclerosis
852260|NCT00078299|Posterior Subcapsular|posterior subcapsular
852261|NCT00078299|Photographic Methods|photographic methods
852262|NCT00078299|Reproducibility (intra and interobserver)|reproducibility (intra and interobserver)
852263|NCT00078299|Cataract|cataract
852264|NCT00078299|Agreement|agreement
852265|NCT00078299|Grading System|grading system
852266|NCT00078247|Antiretroviral Therapy|antiretroviral therapy
852267|NCT00078247|Africa|africa
852268|NCT00078234|CLL|cll
852269|NCT00078234|Leukemia|leukemia
852270|NCT00078234|Chronic|chronic
852271|NCT00078234|Cancer|cancer
852272|NCT00078234|Adult|adult
852273|NCT00078234|Lymphocytic|lymphocytic
852274|NCT00078234|Genasense|genasense
852275|NCT00078234|G3139|g3139
852276|NCT00078234|Genta|genta
852277|NCT00078234|Bcl-2|bcl-2
852278|NCT00078234|Antisense|antisense
852279|NCT00078234|Oligonucleotide|oligonucleotide
852280|NCT00078234|oblimersen|oblimersen
852281|NCT00078169|behavioral intervention|behavioral intervention
852282|NCT00078156|behavioral intervention|behavioral intervention
852283|NCT00078143|behavioral intervention|behavioral intervention
852284|NCT00078208|Pediatric|pediatric
852285|NCT00078208|Non-Invasive|non-invasive
852286|NCT00078208|Anti-Inflammatory|anti-inflammatory
852287|NCT00078208|pH|ph
852288|NCT00078208|Mediators|mediators
852289|NCT00078208|Asthma|asthma
852290|NCT00078208|Childhood Asthma|childhood asthma
852291|NCT00078208|Healthy Volunteer|healthy volunteer
852292|NCT00078208|HV|hv
852293|NCT00078195|Ragweed|ragweed
852294|NCT00078195|Immunotherapy|immunotherapy
852295|NCT00078195|Rush Immunotherapy|rush immunotherapy
852296|NCT00078195|RIT|rit
852297|NCT00078195|Hayfever|hayfever
852298|NCT00078195|Seasonal Allergic Rhinitis|seasonal allergic rhinitis
852299|NCT00078182|HIV Prevention|hiv prevention
852300|NCT00078130|opioid dependence|opioid dependence
852301|NCT00078130|behavioral intervention|behavioral intervention
852302|NCT00078117|opiate dependence|opiate dependence
852303|NCT00078065|multiple myeloma|multiple myeloma
852304|NCT00078065|fludarabine|fludarabine
852305|NCT00078065|Xcellerated T Cells|xcellerated t cells
852306|NCT00004148|stage III melanoma|stage iii melanoma
852308|NCT00004148|recurrent melanoma|recurrent melanoma
852309|NCT00003935|untreated childhood brain stem glioma|untreated childhood brain stem glioma
852310|NCT00003814|stage 0 bladder cancer|stage 0 bladder cancer
852311|NCT00003814|stage I bladder cancer|stage i bladder cancer
852312|NCT00003814|recurrent bladder cancer|recurrent bladder cancer
852313|NCT00003814|transitional cell carcinoma of the bladder|transitional cell carcinoma of the bladder
852314|NCT00003766|unspecified adult solid tumor, protocol specific|unspecified adult solid tumor, protocol specific
852315|NCT00003623|recurrent bladder cancer|recurrent bladder cancer
852316|NCT00003615|Waldenstrom macroglobulinemia|waldenstrom macroglobulinemia
852317|NCT00003615|stage I grade 1 follicular lymphoma|stage i grade 1 follicular lymphoma
852318|NCT00003615|stage I grade 2 follicular lymphoma|stage i grade 2 follicular lymphoma
852319|NCT00003615|stage I grade 3 follicular lymphoma|stage i grade 3 follicular lymphoma
852320|NCT00003615|stage I adult diffuse large cell lymphoma|stage i adult diffuse large cell lymphoma
852321|NCT00003615|stage III grade 1 follicular lymphoma|stage iii grade 1 follicular lymphoma
852322|NCT00003615|stage III grade 2 follicular lymphoma|stage iii grade 2 follicular lymphoma
852323|NCT00003615|stage III grade 3 follicular lymphoma|stage iii grade 3 follicular lymphoma
852324|NCT00003615|stage III adult diffuse large cell lymphoma|stage iii adult diffuse large cell lymphoma
852325|NCT00003615|stage IV grade 1 follicular lymphoma|stage iv grade 1 follicular lymphoma
852326|NCT00003615|stage IV grade 2 follicular lymphoma|stage iv grade 2 follicular lymphoma
852327|NCT00003615|stage IV grade 3 follicular lymphoma|stage iv grade 3 follicular lymphoma
852328|NCT00003615|stage IV adult diffuse large cell lymphoma|stage iv adult diffuse large cell lymphoma
852329|NCT00003615|recurrent grade 1 follicular lymphoma|recurrent grade 1 follicular lymphoma
852330|NCT00003615|recurrent grade 2 follicular lymphoma|recurrent grade 2 follicular lymphoma
852331|NCT00003615|recurrent grade 3 follicular lymphoma|recurrent grade 3 follicular lymphoma
852332|NCT00003615|recurrent adult diffuse large cell lymphoma|recurrent adult diffuse large cell lymphoma
852333|NCT00003615|contiguous stage II grade 1 follicular lymphoma|contiguous stage ii grade 1 follicular lymphoma
852334|NCT00003615|contiguous stage II grade 2 follicular lymphoma|contiguous stage ii grade 2 follicular lymphoma
852335|NCT00003615|contiguous stage II grade 3 follicular lymphoma|contiguous stage ii grade 3 follicular lymphoma
852336|NCT00003615|contiguous stage II adult diffuse large cell lymphoma|contiguous stage ii adult diffuse large cell lymphoma
852618|NCT00003046|recurrent rectal cancer|recurrent rectal cancer
852337|NCT00003615|noncontiguous stage II grade 1 follicular lymphoma|noncontiguous stage ii grade 1 follicular lymphoma
852338|NCT00003615|noncontiguous stage II grade 2 follicular lymphoma|noncontiguous stage ii grade 2 follicular lymphoma
852339|NCT00003615|noncontiguous stage II grade 3 follicular lymphoma|noncontiguous stage ii grade 3 follicular lymphoma
852340|NCT00003615|noncontiguous stage II adult diffuse large cell lymphoma|noncontiguous stage ii adult diffuse large cell lymphoma
852770|NCT00008281|recurrent colon cancer|recurrent colon cancer
852341|NCT00003615|contiguous stage II marginal zone lymphoma|contiguous stage ii marginal zone lymphoma
852342|NCT00003615|contiguous stage II small lymphocytic lymphoma|contiguous stage ii small lymphocytic lymphoma
852343|NCT00003615|noncontiguous stage II small lymphocytic lymphoma|noncontiguous stage ii small lymphocytic lymphoma
852344|NCT00003615|noncontiguous stage II marginal zone lymphoma|noncontiguous stage ii marginal zone lymphoma
852345|NCT00003615|recurrent marginal zone lymphoma|recurrent marginal zone lymphoma
852346|NCT00003615|recurrent small lymphocytic lymphoma|recurrent small lymphocytic lymphoma
852347|NCT00003615|stage III small lymphocytic lymphoma|stage iii small lymphocytic lymphoma
852348|NCT00003615|stage III marginal zone lymphoma|stage iii marginal zone lymphoma
852349|NCT00003615|stage IV small lymphocytic lymphoma|stage iv small lymphocytic lymphoma
852350|NCT00003615|stage IV marginal zone lymphoma|stage iv marginal zone lymphoma
852351|NCT00003615|extranodal marginal zone B-cell lymphoma of mucosa-associated lymphoid tissue|extranodal marginal zone b-cell lymphoma of mucosa-associated lymphoid tissue
852352|NCT00003615|nodal marginal zone B-cell lymphoma|nodal marginal zone b-cell lymphoma
852353|NCT00003615|splenic marginal zone lymphoma|splenic marginal zone lymphoma
852354|NCT00003573|untreated childhood medulloblastoma|untreated childhood medulloblastoma
852355|NCT00003572|stage I adult Hodgkin lymphoma|stage i adult hodgkin lymphoma
852356|NCT00003572|stage II adult Hodgkin lymphoma|stage ii adult hodgkin lymphoma
852357|NCT00003572|stage III adult Hodgkin lymphoma|stage iii adult hodgkin lymphoma
852358|NCT00003572|stage IV adult Hodgkin lymphoma|stage iv adult hodgkin lymphoma
852359|NCT00003572|recurrent adult Hodgkin lymphoma|recurrent adult hodgkin lymphoma
852360|NCT00003572|Waldenstrom macroglobulinemia|waldenstrom macroglobulinemia
852361|NCT00003572|stage I multiple myeloma|stage i multiple myeloma
852362|NCT00003572|stage II multiple myeloma|stage ii multiple myeloma
852363|NCT00003572|stage III multiple myeloma|stage iii multiple myeloma
852364|NCT00003572|stage III chronic lymphocytic leukemia|stage iii chronic lymphocytic leukemia
852365|NCT00003572|stage IV chronic lymphocytic leukemia|stage iv chronic lymphocytic leukemia
852366|NCT00003572|chronic phase chronic myelogenous leukemia|chronic phase chronic myelogenous leukemia
852367|NCT00003572|adult acute myeloid leukemia in remission|adult acute myeloid leukemia in remission
852368|NCT00003572|adult acute lymphoblastic leukemia in remission|adult acute lymphoblastic leukemia in remission
852369|NCT00003572|stage I grade 1 follicular lymphoma|stage i grade 1 follicular lymphoma
852370|NCT00003572|stage I grade 2 follicular lymphoma|stage i grade 2 follicular lymphoma
852371|NCT00003572|stage I grade 3 follicular lymphoma|stage i grade 3 follicular lymphoma
852372|NCT00003572|stage I adult diffuse small cleaved cell lymphoma|stage i adult diffuse small cleaved cell lymphoma
852373|NCT00003572|stage I adult diffuse mixed cell lymphoma|stage i adult diffuse mixed cell lymphoma
852374|NCT00003572|stage I adult diffuse large cell lymphoma|stage i adult diffuse large cell lymphoma
852375|NCT00003572|stage I adult immunoblastic large cell lymphoma|stage i adult immunoblastic large cell lymphoma
852376|NCT00003572|stage I adult lymphoblastic lymphoma|stage i adult lymphoblastic lymphoma
852377|NCT00003572|stage I adult Burkitt lymphoma|stage i adult burkitt lymphoma
852378|NCT00003572|stage III grade 1 follicular lymphoma|stage iii grade 1 follicular lymphoma
852379|NCT00003572|stage III grade 2 follicular lymphoma|stage iii grade 2 follicular lymphoma
852380|NCT00003572|stage III grade 3 follicular lymphoma|stage iii grade 3 follicular lymphoma
852381|NCT00003572|stage III adult diffuse small cleaved cell lymphoma|stage iii adult diffuse small cleaved cell lymphoma
852382|NCT00003572|stage III adult diffuse mixed cell lymphoma|stage iii adult diffuse mixed cell lymphoma
852383|NCT00003572|stage III adult diffuse large cell lymphoma|stage iii adult diffuse large cell lymphoma
852384|NCT00003572|stage III adult immunoblastic large cell lymphoma|stage iii adult immunoblastic large cell lymphoma
852385|NCT00003572|stage III adult lymphoblastic lymphoma|stage iii adult lymphoblastic lymphoma
852386|NCT00003572|stage III adult Burkitt lymphoma|stage iii adult burkitt lymphoma
852387|NCT00003572|stage IV grade 1 follicular lymphoma|stage iv grade 1 follicular lymphoma
852388|NCT00003572|stage IV grade 2 follicular lymphoma|stage iv grade 2 follicular lymphoma
852389|NCT00003572|stage IV grade 3 follicular lymphoma|stage iv grade 3 follicular lymphoma
852390|NCT00003572|stage IV adult diffuse small cleaved cell lymphoma|stage iv adult diffuse small cleaved cell lymphoma
852391|NCT00003572|stage IV adult diffuse mixed cell lymphoma|stage iv adult diffuse mixed cell lymphoma
852392|NCT00003572|stage IV adult diffuse large cell lymphoma|stage iv adult diffuse large cell lymphoma
852393|NCT00003572|stage IV adult immunoblastic large cell lymphoma|stage iv adult immunoblastic large cell lymphoma
852394|NCT00003572|stage IV adult lymphoblastic lymphoma|stage iv adult lymphoblastic lymphoma
852395|NCT00003572|stage IV adult Burkitt lymphoma|stage iv adult burkitt lymphoma
852396|NCT00003572|de novo myelodysplastic syndromes|de novo myelodysplastic syndromes
852397|NCT00003572|previously treated myelodysplastic syndromes|previously treated myelodysplastic syndromes
852398|NCT00003572|secondary myelodysplastic syndromes|secondary myelodysplastic syndromes
852399|NCT00003572|stage I mantle cell lymphoma|stage i mantle cell lymphoma
852400|NCT00003572|contiguous stage II grade 1 follicular lymphoma|contiguous stage ii grade 1 follicular lymphoma
852401|NCT00003572|contiguous stage II grade 2 follicular lymphoma|contiguous stage ii grade 2 follicular lymphoma
852402|NCT00003572|contiguous stage II grade 3 follicular lymphoma|contiguous stage ii grade 3 follicular lymphoma
852403|NCT00003572|contiguous stage II adult diffuse small cleaved cell lymphoma|contiguous stage ii adult diffuse small cleaved cell lymphoma
852404|NCT00003572|contiguous stage II mantle cell lymphoma|contiguous stage ii mantle cell lymphoma
879176|NCT00044031|gemcitabine|gemcitabine
852405|NCT00003572|contiguous stage II adult diffuse mixed cell lymphoma|contiguous stage ii adult diffuse mixed cell lymphoma
852406|NCT00003572|contiguous stage II adult immunoblastic large cell lymphoma|contiguous stage ii adult immunoblastic large cell lymphoma
852407|NCT00003572|contiguous stage II adult diffuse large cell lymphoma|contiguous stage ii adult diffuse large cell lymphoma
852408|NCT00003572|contiguous stage II adult Burkitt lymphoma|contiguous stage ii adult burkitt lymphoma
852409|NCT00003572|contiguous stage II adult lymphoblastic lymphoma|contiguous stage ii adult lymphoblastic lymphoma
852410|NCT00003572|noncontiguous stage II grade 1 follicular lymphoma|noncontiguous stage ii grade 1 follicular lymphoma
852411|NCT00003572|noncontiguous stage II grade 2 follicular lymphoma|noncontiguous stage ii grade 2 follicular lymphoma
852412|NCT00003572|noncontiguous stage II grade 3 follicular lymphoma|noncontiguous stage ii grade 3 follicular lymphoma
852413|NCT00003572|noncontiguous stage II adult diffuse small cleaved cell lymphoma|noncontiguous stage ii adult diffuse small cleaved cell lymphoma
852414|NCT00003572|noncontiguous stage II mantle cell lymphoma|noncontiguous stage ii mantle cell lymphoma
852415|NCT00003572|noncontiguous stage II adult diffuse mixed cell lymphoma|noncontiguous stage ii adult diffuse mixed cell lymphoma
852416|NCT00003572|noncontiguous stage II adult immunoblastic large cell lymphoma|noncontiguous stage ii adult immunoblastic large cell lymphoma
852417|NCT00003572|noncontiguous stage II adult diffuse large cell lymphoma|noncontiguous stage ii adult diffuse large cell lymphoma
852418|NCT00003572|noncontiguous stage II adult Burkitt lymphoma|noncontiguous stage ii adult burkitt lymphoma
852419|NCT00003572|noncontiguous stage II adult lymphoblastic lymphoma|noncontiguous stage ii adult lymphoblastic lymphoma
852420|NCT00003572|stage III mantle cell lymphoma|stage iii mantle cell lymphoma
852421|NCT00003572|stage IV mantle cell lymphoma|stage iv mantle cell lymphoma
852422|NCT00003572|noncontiguous stage II small lymphocytic lymphoma|noncontiguous stage ii small lymphocytic lymphoma
852423|NCT00003572|noncontiguous stage II marginal zone lymphoma|noncontiguous stage ii marginal zone lymphoma
852424|NCT00003572|stage I marginal zone lymphoma|stage i marginal zone lymphoma
852425|NCT00003572|stage I small lymphocytic lymphoma|stage i small lymphocytic lymphoma
852426|NCT00003572|stage III small lymphocytic lymphoma|stage iii small lymphocytic lymphoma
852427|NCT00003572|stage III marginal zone lymphoma|stage iii marginal zone lymphoma
852428|NCT00003572|stage IV small lymphocytic lymphoma|stage iv small lymphocytic lymphoma
852429|NCT00003572|stage IV marginal zone lymphoma|stage iv marginal zone lymphoma
852430|NCT00003572|contiguous stage II marginal zone lymphoma|contiguous stage ii marginal zone lymphoma
852431|NCT00003572|contiguous stage II small lymphocytic lymphoma|contiguous stage ii small lymphocytic lymphoma
852432|NCT00003572|extranodal marginal zone B-cell lymphoma of mucosa-associated lymphoid tissue|extranodal marginal zone b-cell lymphoma of mucosa-associated lymphoid tissue
852433|NCT00003572|nodal marginal zone B-cell lymphoma|nodal marginal zone b-cell lymphoma
852434|NCT00003572|splenic marginal zone lymphoma|splenic marginal zone lymphoma
852435|NCT00003548|stage IV colon cancer|stage iv colon cancer
852436|NCT00003548|stage IV breast cancer|stage iv breast cancer
852437|NCT00003548|recurrent breast cancer|recurrent breast cancer
852438|NCT00003548|stage IV gastric cancer|stage iv gastric cancer
852439|NCT00003548|recurrent gastric cancer|recurrent gastric cancer
852440|NCT00003548|recurrent pancreatic cancer|recurrent pancreatic cancer
852441|NCT00003548|stage IV rectal cancer|stage iv rectal cancer
852442|NCT00003548|recurrent colon cancer|recurrent colon cancer
852443|NCT00003548|recurrent rectal cancer|recurrent rectal cancer
852444|NCT00003548|stage IV anal cancer|stage iv anal cancer
852445|NCT00003548|recurrent anal cancer|recurrent anal cancer
852446|NCT00003548|stage IV esophageal cancer|stage iv esophageal cancer
852447|NCT00003548|recurrent esophageal cancer|recurrent esophageal cancer
852448|NCT00003548|stage IV cervical cancer|stage iv cervical cancer
852449|NCT00003548|recurrent cervical cancer|recurrent cervical cancer
852450|NCT00003548|stage IV ovarian epithelial cancer|stage iv ovarian epithelial cancer
852451|NCT00003548|recurrent ovarian epithelial cancer|recurrent ovarian epithelial cancer
852452|NCT00003548|stage IV vulvar cancer|stage iv vulvar cancer
852453|NCT00003548|recurrent vulvar cancer|recurrent vulvar cancer
852454|NCT00003548|stage IVA vaginal cancer|stage iva vaginal cancer
852455|NCT00003548|stage IVB vaginal cancer|stage ivb vaginal cancer
852456|NCT00003548|recurrent vaginal cancer|recurrent vaginal cancer
852457|NCT00003548|metastatic gastrointestinal carcinoid tumor|metastatic gastrointestinal carcinoid tumor
852458|NCT00003548|recurrent gastrointestinal carcinoid tumor|recurrent gastrointestinal carcinoid tumor
852459|NCT00003548|advanced adult primary liver cancer|advanced adult primary liver cancer
852460|NCT00003548|recurrent adult primary liver cancer|recurrent adult primary liver cancer
852461|NCT00003548|recurrent gestational trophoblastic tumor|recurrent gestational trophoblastic tumor
852462|NCT00003548|stage IV endometrial carcinoma|stage iv endometrial carcinoma
852463|NCT00003548|recurrent endometrial carcinoma|recurrent endometrial carcinoma
852464|NCT00003548|unresectable gallbladder cancer|unresectable gallbladder cancer
852465|NCT00003548|recurrent gallbladder cancer|recurrent gallbladder cancer
852466|NCT00003548|unresectable extrahepatic bile duct cancer|unresectable extrahepatic bile duct cancer
852467|NCT00003548|recurrent extrahepatic bile duct cancer|recurrent extrahepatic bile duct cancer
852468|NCT00003548|recurrent small intestine cancer|recurrent small intestine cancer
852469|NCT00003548|carcinoma of the appendix|carcinoma of the appendix
852470|NCT00003548|fallopian tube cancer|fallopian tube cancer
852471|NCT00003548|stage IV uterine sarcoma|stage iv uterine sarcoma
852472|NCT00003548|recurrent uterine sarcoma|recurrent uterine sarcoma
852473|NCT00003548|recurrent carcinoma of unknown primary|recurrent carcinoma of unknown primary
852474|NCT00003548|stage IV pancreatic cancer|stage iv pancreatic cancer
852475|NCT00003425|stage III adult Hodgkin lymphoma|stage iii adult hodgkin lymphoma
852476|NCT00003425|stage IV adult Hodgkin lymphoma|stage iv adult hodgkin lymphoma
852477|NCT00003425|stage IV breast cancer|stage iv breast cancer
852478|NCT00003425|stage IIIA breast cancer|stage iiia breast cancer
852479|NCT00003425|recurrent breast cancer|recurrent breast cancer
852480|NCT00003425|stage IIIB breast cancer|stage iiib breast cancer
852481|NCT00003425|recurrent adult Hodgkin lymphoma|recurrent adult hodgkin lymphoma
852482|NCT00003425|refractory multiple myeloma|refractory multiple myeloma
852483|NCT00003425|stage III ovarian epithelial cancer|stage iii ovarian epithelial cancer
852484|NCT00003425|stage IV ovarian epithelial cancer|stage iv ovarian epithelial cancer
852485|NCT00003425|recurrent ovarian epithelial cancer|recurrent ovarian epithelial cancer
852486|NCT00003425|regional neuroblastoma|regional neuroblastoma
852487|NCT00003425|disseminated neuroblastoma|disseminated neuroblastoma
852488|NCT00003425|stage 4S neuroblastoma|stage 4s neuroblastoma
852489|NCT00003425|recurrent neuroblastoma|recurrent neuroblastoma
852490|NCT00003425|stage III multiple myeloma|stage iii multiple myeloma
852491|NCT00003425|recurrent adult acute myeloid leukemia|recurrent adult acute myeloid leukemia
852492|NCT00003425|recurrent adult acute lymphoblastic leukemia|recurrent adult acute lymphoblastic leukemia
852493|NCT00003425|unspecified adult solid tumor, protocol specific|unspecified adult solid tumor, protocol specific
852494|NCT00003425|untreated adult acute lymphoblastic leukemia|untreated adult acute lymphoblastic leukemia
852495|NCT00003425|untreated adult acute myeloid leukemia|untreated adult acute myeloid leukemia
852496|NCT00003425|adult acute myeloid leukemia in remission|adult acute myeloid leukemia in remission
852497|NCT00003425|adult acute lymphoblastic leukemia in remission|adult acute lymphoblastic leukemia in remission
852498|NCT00003425|ovarian stromal cancer|ovarian stromal cancer
853098|NCT00077337|stage III rectal cancer|stage iii rectal cancer
852499|NCT00003425|stage III ovarian germ cell tumor|stage iii ovarian germ cell tumor
852500|NCT00003425|stage IV ovarian germ cell tumor|stage iv ovarian germ cell tumor
852501|NCT00003425|recurrent ovarian germ cell tumor|recurrent ovarian germ cell tumor
852502|NCT00003425|acute undifferentiated leukemia|acute undifferentiated leukemia
852503|NCT00003425|stage III grade 1 follicular lymphoma|stage iii grade 1 follicular lymphoma
852504|NCT00003425|stage III grade 2 follicular lymphoma|stage iii grade 2 follicular lymphoma
852505|NCT00003425|stage III grade 3 follicular lymphoma|stage iii grade 3 follicular lymphoma
852506|NCT00003425|stage III adult diffuse small cleaved cell lymphoma|stage iii adult diffuse small cleaved cell lymphoma
852507|NCT00003425|stage III adult diffuse mixed cell lymphoma|stage iii adult diffuse mixed cell lymphoma
852508|NCT00003425|stage III adult diffuse large cell lymphoma|stage iii adult diffuse large cell lymphoma
852509|NCT00003425|stage III adult immunoblastic large cell lymphoma|stage iii adult immunoblastic large cell lymphoma
852510|NCT00003425|stage III adult lymphoblastic lymphoma|stage iii adult lymphoblastic lymphoma
852511|NCT00003425|stage III adult Burkitt lymphoma|stage iii adult burkitt lymphoma
852512|NCT00003425|stage IV grade 1 follicular lymphoma|stage iv grade 1 follicular lymphoma
852513|NCT00003425|stage IV grade 2 follicular lymphoma|stage iv grade 2 follicular lymphoma
852514|NCT00003425|stage IV grade 3 follicular lymphoma|stage iv grade 3 follicular lymphoma
852515|NCT00003425|stage IV adult diffuse small cleaved cell lymphoma|stage iv adult diffuse small cleaved cell lymphoma
852516|NCT00003425|stage IV adult diffuse mixed cell lymphoma|stage iv adult diffuse mixed cell lymphoma
852517|NCT00003425|stage IV adult diffuse large cell lymphoma|stage iv adult diffuse large cell lymphoma
852518|NCT00003425|stage IV adult immunoblastic large cell lymphoma|stage iv adult immunoblastic large cell lymphoma
852519|NCT00003425|stage IV adult lymphoblastic lymphoma|stage iv adult lymphoblastic lymphoma
852520|NCT00003425|stage IV adult Burkitt lymphoma|stage iv adult burkitt lymphoma
852521|NCT00003425|recurrent grade 1 follicular lymphoma|recurrent grade 1 follicular lymphoma
852522|NCT00003425|recurrent grade 2 follicular lymphoma|recurrent grade 2 follicular lymphoma
852523|NCT00003425|recurrent grade 3 follicular lymphoma|recurrent grade 3 follicular lymphoma
852524|NCT00003425|recurrent adult diffuse small cleaved cell lymphoma|recurrent adult diffuse small cleaved cell lymphoma
852525|NCT00003425|recurrent adult diffuse mixed cell lymphoma|recurrent adult diffuse mixed cell lymphoma
852526|NCT00003425|recurrent adult diffuse large cell lymphoma|recurrent adult diffuse large cell lymphoma
852527|NCT00003425|recurrent adult immunoblastic large cell lymphoma|recurrent adult immunoblastic large cell lymphoma
852528|NCT00003425|recurrent adult lymphoblastic lymphoma|recurrent adult lymphoblastic lymphoma
852529|NCT00003425|recurrent adult Burkitt lymphoma|recurrent adult burkitt lymphoma
852530|NCT00003425|secondary acute myeloid leukemia|secondary acute myeloid leukemia
852531|NCT00003425|borderline ovarian surface epithelial-stromal tumor|borderline ovarian surface epithelial-stromal tumor
852532|NCT00003425|ovarian sarcoma|ovarian sarcoma
852533|NCT00003425|localized unresectable neuroblastoma|localized unresectable neuroblastoma
852619|NCT00003046|stage IV anal cancer|stage iv anal cancer
852534|NCT00003425|stage III mantle cell lymphoma|stage iii mantle cell lymphoma
852535|NCT00003425|stage IV mantle cell lymphoma|stage iv mantle cell lymphoma
852536|NCT00003425|recurrent mantle cell lymphoma|recurrent mantle cell lymphoma
852537|NCT00003425|metastatic Ewing sarcoma/peripheral primitive neuroectodermal tumor|metastatic ewing sarcoma/peripheral primitive neuroectodermal tumor
852624|NCT00003046|recurrent malignant mesothelioma|recurrent malignant mesothelioma
852538|NCT00003425|recurrent Ewing sarcoma/peripheral primitive neuroectodermal tumor|recurrent ewing sarcoma/peripheral primitive neuroectodermal tumor
852539|NCT00003425|recurrent marginal zone lymphoma|recurrent marginal zone lymphoma
852540|NCT00003425|recurrent small lymphocytic lymphoma|recurrent small lymphocytic lymphoma
852541|NCT00003425|stage III small lymphocytic lymphoma|stage iii small lymphocytic lymphoma
852542|NCT00003425|stage III marginal zone lymphoma|stage iii marginal zone lymphoma
852543|NCT00003425|stage IV small lymphocytic lymphoma|stage iv small lymphocytic lymphoma
852544|NCT00003425|stage IV marginal zone lymphoma|stage iv marginal zone lymphoma
852545|NCT00003425|extranodal marginal zone B-cell lymphoma of mucosa-associated lymphoid tissue|extranodal marginal zone b-cell lymphoma of mucosa-associated lymphoid tissue
852546|NCT00003425|nodal marginal zone B-cell lymphoma|nodal marginal zone b-cell lymphoma
852547|NCT00003425|splenic marginal zone lymphoma|splenic marginal zone lymphoma
852548|NCT00003411|stage II pancreatic cancer|stage ii pancreatic cancer
852549|NCT00003411|stage III pancreatic cancer|stage iii pancreatic cancer
852550|NCT00003411|unresectable gallbladder cancer|unresectable gallbladder cancer
852551|NCT00003411|unresectable extrahepatic bile duct cancer|unresectable extrahepatic bile duct cancer
852552|NCT00003411|stage IV pancreatic cancer|stage iv pancreatic cancer
852553|NCT00003299|extensive stage small cell lung cancer|extensive stage small cell lung cancer
852554|NCT00003240|stage I non-small cell lung cancer|stage i non-small cell lung cancer
852555|NCT00003240|stage II non-small cell lung cancer|stage ii non-small cell lung cancer
852556|NCT00003240|stage IIIA non-small cell lung cancer|stage iiia non-small cell lung cancer
852557|NCT00003240|stage IIIB non-small cell lung cancer|stage iiib non-small cell lung cancer
852558|NCT00003240|stage IV non-small cell lung cancer|stage iv non-small cell lung cancer
852559|NCT00003120|stage III ovarian epithelial cancer|stage iii ovarian epithelial cancer
852560|NCT00003120|stage IV ovarian epithelial cancer|stage iv ovarian epithelial cancer
852561|NCT00003120|recurrent ovarian epithelial cancer|recurrent ovarian epithelial cancer
852562|NCT00003120|fallopian tube cancer|fallopian tube cancer
852563|NCT00003120|peritoneal cavity cancer|peritoneal cavity cancer
852564|NCT00078104|Prostanoid|prostanoid
852565|NCT00078104|Cyclooxygenase (COX)|cyclooxygenase (cox)
852566|NCT00078104|Selective Cox Inhibitor|selective cox inhibitor
852567|NCT00078104|Acute Peripheral Inflammation|acute peripheral inflammation
852568|NCT00078104|Neuronal Expression of COX|neuronal expression of cox
852569|NCT00078104|Pain|pain
852570|NCT00078104|Coxibs|coxibs
852571|NCT00078104|Wisdom Teeth|wisdom teeth
852572|NCT00078104|Third Molar Extraction|third molar extraction
852573|NCT00078104|Third Molar Impaction|third molar impaction
852574|NCT00078091|Obesity|obesity
852575|NCT00078091|Retinopathy|retinopathy
852576|NCT00078091|Dyslipidemia|dyslipidemia
852577|NCT00078091|Insulin Resistance|insulin resistance
852578|NCT00078091|Hypogonadism|hypogonadism
852579|NCT00078091|Polydactyly|polydactyly
852580|NCT00078091|Bardet-Biedl Syndrome|bardet-biedl syndrome
852581|NCT00078091|BBS|bbs
852582|NCT00078078|Organic Acidemias|organic acidemias
852583|NCT00078078|Cobalamin|cobalamin
852584|NCT00078078|Vitamin B12|vitamin b12
852585|NCT00078078|Methylmalonic Acidemia|methylmalonic acidemia
852586|NCT00078078|Hyperhomocysteinemia|hyperhomocysteinemia
852587|NCT00078078|MMA|mma
852588|NCT00078078|Metabolic Disease|metabolic disease
852589|NCT00078026|Apomine|apomine
852590|NCT00078026|Osteoporosis|osteoporosis
852591|NCT00078026|Bone Mass|bone mass
852592|NCT00078026|Postmenopausal|postmenopausal
852593|NCT00030602|adenocarcinoma of the prostate|adenocarcinoma of the prostate
852594|NCT00030602|recurrent prostate cancer|recurrent prostate cancer
852595|NCT00003089|stage II non-small cell lung cancer|stage ii non-small cell lung cancer
852596|NCT00003089|squamous cell lung cancer|squamous cell lung cancer
852597|NCT00003089|large cell lung cancer|large cell lung cancer
852598|NCT00003089|stage IIIA non-small cell lung cancer|stage iiia non-small cell lung cancer
852599|NCT00003089|stage IIIB non-small cell lung cancer|stage iiib non-small cell lung cancer
852600|NCT00003089|adenocarcinoma of the lung|adenocarcinoma of the lung
852601|NCT00003089|drug/agent toxicity by tissue/organ|drug/agent toxicity by tissue/organ
852602|NCT00003046|anal cancer|anal cancer
852603|NCT00003046|carcinoma of the appendix|carcinoma of the appendix
852604|NCT00003046|colorectal cancer|colorectal cancer
852605|NCT00003046|extrahepatic bile duct cancer|extrahepatic bile duct cancer
852606|NCT00003046|gallbladder cancer|gallbladder cancer
852607|NCT00003046|gastric cancer|gastric cancer
852608|NCT00003046|gastrointestinal carcinoid tumor|gastrointestinal carcinoid tumor
852609|NCT00003046|malignant mesothelioma|malignant mesothelioma
852610|NCT00003046|pancreatic cancer|pancreatic cancer
852611|NCT00003046|small intestine cancer|small intestine cancer
852612|NCT00003046|stage IV colon cancer|stage iv colon cancer
852613|NCT00003046|stage IV gastric cancer|stage iv gastric cancer
852614|NCT00003046|recurrent gastric cancer|recurrent gastric cancer
852615|NCT00003046|recurrent pancreatic cancer|recurrent pancreatic cancer
852620|NCT00003046|recurrent anal cancer|recurrent anal cancer
852621|NCT00003046|metastatic gastrointestinal carcinoid tumor|metastatic gastrointestinal carcinoid tumor
852622|NCT00003046|recurrent gastrointestinal carcinoid tumor|recurrent gastrointestinal carcinoid tumor
852623|NCT00003046|advanced malignant mesothelioma|advanced malignant mesothelioma
879177|NCT00044018|Revimid|revimid
852625|NCT00003046|small intestine adenocarcinoma|small intestine adenocarcinoma
852626|NCT00003046|unresectable gallbladder cancer|unresectable gallbladder cancer
852627|NCT00003046|recurrent gallbladder cancer|recurrent gallbladder cancer
852628|NCT00003046|unresectable extrahepatic bile duct cancer|unresectable extrahepatic bile duct cancer
852629|NCT00003046|recurrent extrahepatic bile duct cancer|recurrent extrahepatic bile duct cancer
852630|NCT00003046|recurrent small intestine cancer|recurrent small intestine cancer
852631|NCT00003046|stage IV pancreatic cancer|stage iv pancreatic cancer
852632|NCT00003035|stage IIIA breast cancer|stage iiia breast cancer
852633|NCT00003035|stage IIIB breast cancer|stage iiib breast cancer
852634|NCT00078013|AMI|ami
852635|NCT00078013|STEMI|stemi
852636|NCT00078013|Infarct|infarct
852637|NCT00078013|acute myocardial infarction with ST segment elevation|acute myocardial infarction with st segment elevation
852638|NCT00077961|Non-Hodgkin's Lymphoma|non-hodgkin's lymphoma
852639|NCT00077961|NHL|nhl
852640|NCT00077961|CAMPATH|campath
852641|NCT00077961|alemtuzumab|alemtuzumab
852642|NCT00077948|positive inotrope|positive inotrope
852643|NCT00077948|enoximone|enoximone
852644|NCT00077948|beta-blocker|beta-blocker
852645|NCT00077948|intolerant|intolerant
852646|NCT00077870|Moderate to severe rheumatoid arthritis|moderate to severe rheumatoid arthritis
852647|NCT00077792|Receiving fibrinolytic therapy|receiving fibrinolytic therapy
852648|NCT00077727|Schizophrenia|schizophrenia
852649|NCT00077727|cognitive impairment|cognitive impairment
852650|NCT00077727|galantamine|galantamine
852651|NCT00077727|acetylcholinesterase inhibitors|acetylcholinesterase inhibitors
852652|NCT00077727|antipsychotic drugs|antipsychotic drugs
852653|NCT00077727|BACS|bacs
852654|NCT00077714|Schizophrenia|schizophrenia
852655|NCT00077714|Paliperidone|paliperidone
852656|NCT00076973|RSV Bronchiolitis|rsv bronchiolitis
852657|NCT00027924|relapsing chronic myelogenous leukemia|relapsing chronic myelogenous leukemia
852658|NCT00027924|chronic phase chronic myelogenous leukemia|chronic phase chronic myelogenous leukemia
852659|NCT00027924|accelerated phase chronic myelogenous leukemia|accelerated phase chronic myelogenous leukemia
852660|NCT00027924|blastic phase chronic myelogenous leukemia|blastic phase chronic myelogenous leukemia
852661|NCT00027924|meningeal chronic myelogenous leukemia|meningeal chronic myelogenous leukemia
852662|NCT00027924|Philadelphia chromosome positive chronic myelogenous leukemia|philadelphia chromosome positive chronic myelogenous leukemia
852663|NCT00027924|refractory anemia|refractory anemia
852664|NCT00027924|refractory anemia with ringed sideroblasts|refractory anemia with ringed sideroblasts
852665|NCT00027924|refractory anemia with excess blasts|refractory anemia with excess blasts
852666|NCT00027924|refractory anemia with excess blasts in transformation|refractory anemia with excess blasts in transformation
852667|NCT00027924|chronic myelomonocytic leukemia|chronic myelomonocytic leukemia
852668|NCT00027924|secondary acute myeloid leukemia|secondary acute myeloid leukemia
852669|NCT00027924|de novo myelodysplastic syndromes|de novo myelodysplastic syndromes
852670|NCT00027924|previously treated myelodysplastic syndromes|previously treated myelodysplastic syndromes
852671|NCT00027924|secondary myelodysplastic syndromes|secondary myelodysplastic syndromes
852672|NCT00027924|childhood myelodysplastic syndromes|childhood myelodysplastic syndromes
852673|NCT00023647|stage IV melanoma|stage iv melanoma
852674|NCT00023647|recurrent melanoma|recurrent melanoma
852675|NCT00021294|basal cell carcinoma of the skin|basal cell carcinoma of the skin
852676|NCT00021294|squamous cell carcinoma of the skin|squamous cell carcinoma of the skin
852677|NCT00021294|actinic keratosis|actinic keratosis
852678|NCT00021034|stage II ovarian epithelial cancer|stage ii ovarian epithelial cancer
852679|NCT00021034|stage III ovarian epithelial cancer|stage iii ovarian epithelial cancer
852680|NCT00021034|stage IV ovarian epithelial cancer|stage iv ovarian epithelial cancer
852681|NCT00021034|recurrent ovarian epithelial cancer|recurrent ovarian epithelial cancer
852682|NCT00021034|fallopian tube cancer|fallopian tube cancer
852683|NCT00021034|primary peritoneal cavity cancer|primary peritoneal cavity cancer
852684|NCT00021021|stage IV renal cell cancer|stage iv renal cell cancer
852685|NCT00021021|clear cell renal cell carcinoma|clear cell renal cell carcinoma
852686|NCT00020917|stage IV colon cancer|stage iv colon cancer
852687|NCT00020917|stage IV rectal cancer|stage iv rectal cancer
852688|NCT00020553|psychosocial effects of cancer and its treatment|psychosocial effects of cancer and its treatment
852689|NCT00017459|recurrent non-small cell lung cancer|recurrent non-small cell lung cancer
852690|NCT00017459|stage IIIB non-small cell lung cancer|stage iiib non-small cell lung cancer
852691|NCT00017459|stage IV non-small cell lung cancer|stage iv non-small cell lung cancer
852692|NCT00017199|metastatic gastrointestinal carcinoid tumor|metastatic gastrointestinal carcinoid tumor
852693|NCT00017199|gastrinoma|gastrinoma
852694|NCT00017199|insulinoma|insulinoma
852695|NCT00017199|somatostatinoma|somatostatinoma
852696|NCT00017199|glucagonoma|glucagonoma
852697|NCT00017056|stage IV gastric cancer|stage iv gastric cancer
852698|NCT00017056|recurrent gastric cancer|recurrent gastric cancer
852699|NCT00017056|stage IV esophageal cancer|stage iv esophageal cancer
852700|NCT00017056|recurrent esophageal cancer|recurrent esophageal cancer
852701|NCT00017056|adenocarcinoma of the stomach|adenocarcinoma of the stomach
852702|NCT00017056|adenocarcinoma of the esophagus|adenocarcinoma of the esophagus
852703|NCT00016172|stage III adult Hodgkin lymphoma|stage iii adult hodgkin lymphoma
879178|NCT00044018|CC5013|cc5013
852704|NCT00016172|stage IV adult Hodgkin lymphoma|stage iv adult hodgkin lymphoma
852705|NCT00016172|recurrent adult Hodgkin lymphoma|recurrent adult hodgkin lymphoma
852706|NCT00016172|stage III cutaneous T-cell non-Hodgkin lymphoma|stage iii cutaneous t-cell non-hodgkin lymphoma
852707|NCT00016172|stage IV cutaneous T-cell non-Hodgkin lymphoma|stage iv cutaneous t-cell non-hodgkin lymphoma
852708|NCT00016172|recurrent cutaneous T-cell non-Hodgkin lymphoma|recurrent cutaneous t-cell non-hodgkin lymphoma
852709|NCT00016172|small intestine lymphoma|small intestine lymphoma
852710|NCT00016172|unspecified adult solid tumor, protocol specific|unspecified adult solid tumor, protocol specific
852711|NCT00016172|stage III grade 1 follicular lymphoma|stage iii grade 1 follicular lymphoma
852712|NCT00016172|stage III grade 2 follicular lymphoma|stage iii grade 2 follicular lymphoma
852713|NCT00016172|stage III grade 3 follicular lymphoma|stage iii grade 3 follicular lymphoma
852714|NCT00016172|stage III adult diffuse small cleaved cell lymphoma|stage iii adult diffuse small cleaved cell lymphoma
852715|NCT00016172|stage III adult diffuse mixed cell lymphoma|stage iii adult diffuse mixed cell lymphoma
852716|NCT00016172|stage III adult diffuse large cell lymphoma|stage iii adult diffuse large cell lymphoma
852717|NCT00016172|stage III adult immunoblastic large cell lymphoma|stage iii adult immunoblastic large cell lymphoma
852718|NCT00016172|stage III adult lymphoblastic lymphoma|stage iii adult lymphoblastic lymphoma
852719|NCT00016172|stage III adult Burkitt lymphoma|stage iii adult burkitt lymphoma
852720|NCT00016172|stage IV grade 1 follicular lymphoma|stage iv grade 1 follicular lymphoma
852721|NCT00016172|stage IV grade 2 follicular lymphoma|stage iv grade 2 follicular lymphoma
852722|NCT00016172|stage IV grade 3 follicular lymphoma|stage iv grade 3 follicular lymphoma
852723|NCT00016172|stage IV adult diffuse small cleaved cell lymphoma|stage iv adult diffuse small cleaved cell lymphoma
852724|NCT00016172|stage IV adult diffuse mixed cell lymphoma|stage iv adult diffuse mixed cell lymphoma
852725|NCT00016172|stage IV adult diffuse large cell lymphoma|stage iv adult diffuse large cell lymphoma
852726|NCT00016172|stage IV adult immunoblastic large cell lymphoma|stage iv adult immunoblastic large cell lymphoma
852727|NCT00016172|stage IV adult lymphoblastic lymphoma|stage iv adult lymphoblastic lymphoma
852728|NCT00016172|stage IV adult Burkitt lymphoma|stage iv adult burkitt lymphoma
852729|NCT00016172|recurrent grade 1 follicular lymphoma|recurrent grade 1 follicular lymphoma
852730|NCT00016172|recurrent grade 2 follicular lymphoma|recurrent grade 2 follicular lymphoma
852731|NCT00016172|recurrent grade 3 follicular lymphoma|recurrent grade 3 follicular lymphoma
852732|NCT00016172|recurrent adult diffuse small cleaved cell lymphoma|recurrent adult diffuse small cleaved cell lymphoma
852733|NCT00016172|recurrent adult diffuse mixed cell lymphoma|recurrent adult diffuse mixed cell lymphoma
852734|NCT00016172|recurrent adult diffuse large cell lymphoma|recurrent adult diffuse large cell lymphoma
852735|NCT00016172|recurrent adult immunoblastic large cell lymphoma|recurrent adult immunoblastic large cell lymphoma
852736|NCT00016172|recurrent adult lymphoblastic lymphoma|recurrent adult lymphoblastic lymphoma
852737|NCT00016172|recurrent adult Burkitt lymphoma|recurrent adult burkitt lymphoma
852738|NCT00016172|stage III adult T-cell leukemia/lymphoma|stage iii adult t-cell leukemia/lymphoma
852739|NCT00016172|stage IV adult T-cell leukemia/lymphoma|stage iv adult t-cell leukemia/lymphoma
852740|NCT00016172|recurrent adult T-cell leukemia/lymphoma|recurrent adult t-cell leukemia/lymphoma
852741|NCT00016172|primary central nervous system non-Hodgkin lymphoma|primary central nervous system non-hodgkin lymphoma
852742|NCT00016172|AIDS-related peripheral/systemic lymphoma|aids-related peripheral/systemic lymphoma
852743|NCT00016172|AIDS-related primary CNS lymphoma|aids-related primary cns lymphoma
852744|NCT00016172|intraocular lymphoma|intraocular lymphoma
852745|NCT00016172|stage III mantle cell lymphoma|stage iii mantle cell lymphoma
852746|NCT00016172|stage IV mantle cell lymphoma|stage iv mantle cell lymphoma
852747|NCT00016172|recurrent mantle cell lymphoma|recurrent mantle cell lymphoma
852748|NCT00016172|angioimmunoblastic T-cell lymphoma|angioimmunoblastic t-cell lymphoma
852749|NCT00016172|anaplastic large cell lymphoma|anaplastic large cell lymphoma
852750|NCT00016172|stage III mycosis fungoides/Sezary syndrome|stage iii mycosis fungoides/sezary syndrome
852751|NCT00016172|stage IV mycosis fungoides/Sezary syndrome|stage iv mycosis fungoides/sezary syndrome
852752|NCT00016172|recurrent mycosis fungoides/Sezary syndrome|recurrent mycosis fungoides/sezary syndrome
852753|NCT00016172|recurrent marginal zone lymphoma|recurrent marginal zone lymphoma
852754|NCT00016172|recurrent small lymphocytic lymphoma|recurrent small lymphocytic lymphoma
852755|NCT00016172|stage III small lymphocytic lymphoma|stage iii small lymphocytic lymphoma
852756|NCT00016172|stage III marginal zone lymphoma|stage iii marginal zone lymphoma
852757|NCT00016172|stage IV small lymphocytic lymphoma|stage iv small lymphocytic lymphoma
852758|NCT00016172|stage IV marginal zone lymphoma|stage iv marginal zone lymphoma
852759|NCT00016172|extranodal marginal zone B-cell lymphoma of mucosa-associated lymphoid tissue|extranodal marginal zone b-cell lymphoma of mucosa-associated lymphoid tissue
852760|NCT00016172|nodal marginal zone B-cell lymphoma|nodal marginal zone b-cell lymphoma
852761|NCT00016172|splenic marginal zone lymphoma|splenic marginal zone lymphoma
852762|NCT00014625|stage IV melanoma|stage iv melanoma
852763|NCT00014625|recurrent melanoma|recurrent melanoma
852764|NCT00014430|stage IV breast cancer|stage iv breast cancer
852765|NCT00014430|stage IIIA breast cancer|stage iiia breast cancer
852766|NCT00014430|recurrent breast cancer|recurrent breast cancer
852767|NCT00014430|stage IIIB breast cancer|stage iiib breast cancer
852768|NCT00008281|stage IV colon cancer|stage iv colon cancer
852769|NCT00008281|stage IV rectal cancer|stage iv rectal cancer
879706|NCT00041808|lung cancer|lung cancer
852771|NCT00008281|recurrent rectal cancer|recurrent rectal cancer
852772|NCT00008281|adenocarcinoma of the colon|adenocarcinoma of the colon
852773|NCT00008281|adenocarcinoma of the rectum|adenocarcinoma of the rectum
852774|NCT00006122|untreated adult acute myeloid leukemia|untreated adult acute myeloid leukemia
852775|NCT00006122|adult acute erythroid leukemia (M6)|adult acute erythroid leukemia (m6)
852776|NCT00006122|adult acute myeloblastic leukemia without maturation (M1)|adult acute myeloblastic leukemia without maturation (m1)
852777|NCT00006122|adult acute myeloblastic leukemia with maturation (M2)|adult acute myeloblastic leukemia with maturation (m2)
852778|NCT00006122|adult acute myelomonocytic leukemia (M4)|adult acute myelomonocytic leukemia (m4)
852779|NCT00006122|adult acute monoblastic leukemia (M5a)|adult acute monoblastic leukemia (m5a)
852780|NCT00006122|adult acute megakaryoblastic leukemia (M7)|adult acute megakaryoblastic leukemia (m7)
852781|NCT00006122|secondary acute myeloid leukemia|secondary acute myeloid leukemia
852782|NCT00006122|adult acute monocytic leukemia (M5b)|adult acute monocytic leukemia (m5b)
852783|NCT00006122|adult acute minimally differentiated myeloid leukemia (M0)|adult acute minimally differentiated myeloid leukemia (m0)
852784|NCT00005795|recurrent adult acute myeloid leukemia|recurrent adult acute myeloid leukemia
852785|NCT00005795|untreated adult acute myeloid leukemia|untreated adult acute myeloid leukemia
852786|NCT00005795|adult acute erythroid leukemia (M6)|adult acute erythroid leukemia (m6)
852787|NCT00005795|adult acute myeloblastic leukemia without maturation (M1)|adult acute myeloblastic leukemia without maturation (m1)
852788|NCT00005795|adult acute myeloblastic leukemia with maturation (M2)|adult acute myeloblastic leukemia with maturation (m2)
852789|NCT00005795|adult acute myelomonocytic leukemia (M4)|adult acute myelomonocytic leukemia (m4)
852790|NCT00005795|adult acute monoblastic leukemia (M5a)|adult acute monoblastic leukemia (m5a)
852791|NCT00005795|adult acute megakaryoblastic leukemia (M7)|adult acute megakaryoblastic leukemia (m7)
852792|NCT00005795|secondary acute myeloid leukemia|secondary acute myeloid leukemia
852793|NCT00005795|adult acute monocytic leukemia (M5b)|adult acute monocytic leukemia (m5b)
852794|NCT00005795|adult acute minimally differentiated myeloid leukemia (M0)|adult acute minimally differentiated myeloid leukemia (m0)
852795|NCT00005791|unspecified adult solid tumor, protocol specific|unspecified adult solid tumor, protocol specific
852796|NCT00005631|recurrent adult diffuse large cell lymphoma|recurrent adult diffuse large cell lymphoma
852797|NCT00005631|recurrent adult immunoblastic large cell lymphoma|recurrent adult immunoblastic large cell lymphoma
852798|NCT00005631|anaplastic large cell lymphoma|anaplastic large cell lymphoma
852799|NCT00005609|Waldenström macroglobulinemia|waldenström macroglobulinemia
852800|NCT00005089|stage I adult diffuse large cell lymphoma|stage i adult diffuse large cell lymphoma
852801|NCT00005089|stage I adult Burkitt lymphoma|stage i adult burkitt lymphoma
852802|NCT00005089|stage I mantle cell lymphoma|stage i mantle cell lymphoma
852803|NCT00005089|contiguous stage II mantle cell lymphoma|contiguous stage ii mantle cell lymphoma
852804|NCT00005089|contiguous stage II adult diffuse large cell lymphoma|contiguous stage ii adult diffuse large cell lymphoma
852805|NCT00005089|contiguous stage II adult Burkitt lymphoma|contiguous stage ii adult burkitt lymphoma
852806|NCT00005089|noncontiguous stage II mantle cell lymphoma|noncontiguous stage ii mantle cell lymphoma
852807|NCT00005089|noncontiguous stage II adult diffuse large cell lymphoma|noncontiguous stage ii adult diffuse large cell lymphoma
852808|NCT00005089|noncontiguous stage II adult Burkitt lymphoma|noncontiguous stage ii adult burkitt lymphoma
852809|NCT00004152|stage III melanoma|stage iii melanoma
852810|NCT00004152|stage IV melanoma|stage iv melanoma
852811|NCT00004152|recurrent melanoma|recurrent melanoma
852812|NCT00004145|stage III adult Hodgkin lymphoma|stage iii adult hodgkin lymphoma
852813|NCT00004145|stage IV adult Hodgkin lymphoma|stage iv adult hodgkin lymphoma
852814|NCT00004145|recurrent adult Hodgkin lymphoma|recurrent adult hodgkin lymphoma
852815|NCT00004145|refractory multiple myeloma|refractory multiple myeloma
852816|NCT00004145|stage I multiple myeloma|stage i multiple myeloma
852817|NCT00004145|stage II multiple myeloma|stage ii multiple myeloma
852818|NCT00004145|stage III multiple myeloma|stage iii multiple myeloma
852819|NCT00004145|stage II chronic lymphocytic leukemia|stage ii chronic lymphocytic leukemia
852820|NCT00004145|stage III chronic lymphocytic leukemia|stage iii chronic lymphocytic leukemia
852821|NCT00004145|stage IV chronic lymphocytic leukemia|stage iv chronic lymphocytic leukemia
852822|NCT00004145|recurrent adult acute myeloid leukemia|recurrent adult acute myeloid leukemia
852823|NCT00004145|recurrent adult acute lymphoblastic leukemia|recurrent adult acute lymphoblastic leukemia
852824|NCT00004145|refractory chronic lymphocytic leukemia|refractory chronic lymphocytic leukemia
852825|NCT00004145|chronic phase chronic myelogenous leukemia|chronic phase chronic myelogenous leukemia
852826|NCT00004145|accelerated phase chronic myelogenous leukemia|accelerated phase chronic myelogenous leukemia
852827|NCT00004145|adult acute myeloid leukemia in remission|adult acute myeloid leukemia in remission
852828|NCT00004145|adult acute lymphoblastic leukemia in remission|adult acute lymphoblastic leukemia in remission
852829|NCT00004145|refractory anemia|refractory anemia
852830|NCT00004145|refractory anemia with ringed sideroblasts|refractory anemia with ringed sideroblasts
853109|NCT00077311|adenocarcinoma of the lung|adenocarcinoma of the lung
852831|NCT00004145|refractory anemia with excess blasts|refractory anemia with excess blasts
852832|NCT00004145|refractory anemia with excess blasts in transformation|refractory anemia with excess blasts in transformation
852833|NCT00004145|chronic myelomonocytic leukemia|chronic myelomonocytic leukemia
852834|NCT00004145|stage III grade 1 follicular lymphoma|stage iii grade 1 follicular lymphoma
879805|NCT00040560|Lung Cancer|lung cancer
852835|NCT00004145|stage III grade 2 follicular lymphoma|stage iii grade 2 follicular lymphoma
852836|NCT00004145|stage III grade 3 follicular lymphoma|stage iii grade 3 follicular lymphoma
852837|NCT00004145|stage III adult diffuse small cleaved cell lymphoma|stage iii adult diffuse small cleaved cell lymphoma
852838|NCT00004145|stage III adult diffuse mixed cell lymphoma|stage iii adult diffuse mixed cell lymphoma
852839|NCT00004145|stage III adult diffuse large cell lymphoma|stage iii adult diffuse large cell lymphoma
852840|NCT00004145|stage III adult immunoblastic large cell lymphoma|stage iii adult immunoblastic large cell lymphoma
852841|NCT00004145|stage III adult lymphoblastic lymphoma|stage iii adult lymphoblastic lymphoma
852842|NCT00004145|stage III adult Burkitt lymphoma|stage iii adult burkitt lymphoma
852843|NCT00004145|stage IV grade 1 follicular lymphoma|stage iv grade 1 follicular lymphoma
852844|NCT00004145|stage IV grade 2 follicular lymphoma|stage iv grade 2 follicular lymphoma
852845|NCT00004145|stage IV grade 3 follicular lymphoma|stage iv grade 3 follicular lymphoma
852846|NCT00004145|stage IV adult diffuse small cleaved cell lymphoma|stage iv adult diffuse small cleaved cell lymphoma
852847|NCT00004145|stage IV adult diffuse mixed cell lymphoma|stage iv adult diffuse mixed cell lymphoma
852848|NCT00004145|stage IV adult diffuse large cell lymphoma|stage iv adult diffuse large cell lymphoma
852849|NCT00004145|stage IV adult immunoblastic large cell lymphoma|stage iv adult immunoblastic large cell lymphoma
852850|NCT00004145|stage IV adult lymphoblastic lymphoma|stage iv adult lymphoblastic lymphoma
852851|NCT00004145|stage IV adult Burkitt lymphoma|stage iv adult burkitt lymphoma
852852|NCT00004145|recurrent grade 1 follicular lymphoma|recurrent grade 1 follicular lymphoma
852853|NCT00004145|recurrent grade 2 follicular lymphoma|recurrent grade 2 follicular lymphoma
852854|NCT00004145|recurrent grade 3 follicular lymphoma|recurrent grade 3 follicular lymphoma
852855|NCT00004145|recurrent adult diffuse small cleaved cell lymphoma|recurrent adult diffuse small cleaved cell lymphoma
852856|NCT00004145|recurrent adult diffuse mixed cell lymphoma|recurrent adult diffuse mixed cell lymphoma
852857|NCT00004145|recurrent adult diffuse large cell lymphoma|recurrent adult diffuse large cell lymphoma
852858|NCT00004145|recurrent adult immunoblastic large cell lymphoma|recurrent adult immunoblastic large cell lymphoma
852859|NCT00004145|recurrent adult lymphoblastic lymphoma|recurrent adult lymphoblastic lymphoma
852860|NCT00004145|recurrent adult Burkitt lymphoma|recurrent adult burkitt lymphoma
852861|NCT00004145|secondary acute myeloid leukemia|secondary acute myeloid leukemia
852862|NCT00004145|de novo myelodysplastic syndromes|de novo myelodysplastic syndromes
852863|NCT00004145|previously treated myelodysplastic syndromes|previously treated myelodysplastic syndromes
852864|NCT00004145|secondary myelodysplastic syndromes|secondary myelodysplastic syndromes
852865|NCT00004145|stage III mantle cell lymphoma|stage iii mantle cell lymphoma
852866|NCT00004145|stage IV mantle cell lymphoma|stage iv mantle cell lymphoma
852867|NCT00004145|recurrent mantle cell lymphoma|recurrent mantle cell lymphoma
852868|NCT00004145|recurrent marginal zone lymphoma|recurrent marginal zone lymphoma
852869|NCT00004145|recurrent small lymphocytic lymphoma|recurrent small lymphocytic lymphoma
852870|NCT00004145|stage III small lymphocytic lymphoma|stage iii small lymphocytic lymphoma
852871|NCT00004145|stage III marginal zone lymphoma|stage iii marginal zone lymphoma
852872|NCT00004145|stage IV small lymphocytic lymphoma|stage iv small lymphocytic lymphoma
852873|NCT00004145|stage IV marginal zone lymphoma|stage iv marginal zone lymphoma
852874|NCT00004145|extranodal marginal zone B-cell lymphoma of mucosa-associated lymphoid tissue|extranodal marginal zone b-cell lymphoma of mucosa-associated lymphoid tissue
852875|NCT00004145|nodal marginal zone B-cell lymphoma|nodal marginal zone b-cell lymphoma
852876|NCT00004145|splenic marginal zone lymphoma|splenic marginal zone lymphoma
852877|NCT00004114|recurrent adult Hodgkin lymphoma|recurrent adult hodgkin lymphoma
852878|NCT00004114|recurrent cutaneous T-cell non-Hodgkin lymphoma|recurrent cutaneous t-cell non-hodgkin lymphoma
852879|NCT00004114|recurrent adult acute myeloid leukemia|recurrent adult acute myeloid leukemia
852880|NCT00004114|recurrent adult acute lymphoblastic leukemia|recurrent adult acute lymphoblastic leukemia
852881|NCT00004114|relapsing chronic myelogenous leukemia|relapsing chronic myelogenous leukemia
852882|NCT00004114|refractory chronic lymphocytic leukemia|refractory chronic lymphocytic leukemia
852883|NCT00004114|chronic myelomonocytic leukemia|chronic myelomonocytic leukemia
852884|NCT00004114|recurrent grade 1 follicular lymphoma|recurrent grade 1 follicular lymphoma
852885|NCT00004114|recurrent grade 2 follicular lymphoma|recurrent grade 2 follicular lymphoma
852886|NCT00004114|recurrent grade 3 follicular lymphoma|recurrent grade 3 follicular lymphoma
852887|NCT00004114|recurrent adult diffuse small cleaved cell lymphoma|recurrent adult diffuse small cleaved cell lymphoma
852888|NCT00004114|recurrent adult diffuse mixed cell lymphoma|recurrent adult diffuse mixed cell lymphoma
852889|NCT00004114|recurrent adult diffuse large cell lymphoma|recurrent adult diffuse large cell lymphoma
852890|NCT00004114|recurrent adult immunoblastic large cell lymphoma|recurrent adult immunoblastic large cell lymphoma
852891|NCT00004114|recurrent adult lymphoblastic lymphoma|recurrent adult lymphoblastic lymphoma
852892|NCT00004114|recurrent adult Burkitt lymphoma|recurrent adult burkitt lymphoma
852893|NCT00004114|recurrent adult T-cell leukemia/lymphoma|recurrent adult t-cell leukemia/lymphoma
852894|NCT00004114|previously treated myelodysplastic syndromes|previously treated myelodysplastic syndromes
852895|NCT00004114|AIDS-related peripheral/systemic lymphoma|aids-related peripheral/systemic lymphoma
852896|NCT00004114|recurrent mantle cell lymphoma|recurrent mantle cell lymphoma
852897|NCT00004114|anaplastic large cell lymphoma|anaplastic large cell lymphoma
852898|NCT00004114|refractory cytopenia with multilineage dysplasia|refractory cytopenia with multilineage dysplasia
852899|NCT00004114|recurrent mycosis fungoides/Sezary syndrome|recurrent mycosis fungoides/sezary syndrome
852900|NCT00004114|recurrent marginal zone lymphoma|recurrent marginal zone lymphoma
852901|NCT00004114|recurrent small lymphocytic lymphoma|recurrent small lymphocytic lymphoma
852902|NCT00004114|extranodal marginal zone B-cell lymphoma of mucosa-associated lymphoid tissue|extranodal marginal zone b-cell lymphoma of mucosa-associated lymphoid tissue
852903|NCT00004114|nodal marginal zone B-cell lymphoma|nodal marginal zone b-cell lymphoma
852904|NCT00004114|splenic marginal zone lymphoma|splenic marginal zone lymphoma
852905|NCT00003916|adult glioblastoma|adult glioblastoma
852906|NCT00003916|adult anaplastic astrocytoma|adult anaplastic astrocytoma
852907|NCT00003916|adult giant cell glioblastoma|adult giant cell glioblastoma
852908|NCT00003916|adult gliosarcoma|adult gliosarcoma
852909|NCT00003867|stage III colon cancer|stage iii colon cancer
852910|NCT00003867|stage IV colon cancer|stage iv colon cancer
852911|NCT00003867|stage IV breast cancer|stage iv breast cancer
852912|NCT00003867|stage IIIA breast cancer|stage iiia breast cancer
852913|NCT00003867|recurrent breast cancer|recurrent breast cancer
852914|NCT00003867|stage III gastric cancer|stage iii gastric cancer
852915|NCT00003867|stage IV gastric cancer|stage iv gastric cancer
852916|NCT00003867|recurrent gastric cancer|recurrent gastric cancer
852917|NCT00003867|stage IIIB breast cancer|stage iiib breast cancer
852918|NCT00003867|stage II pancreatic cancer|stage ii pancreatic cancer
852919|NCT00003867|stage III pancreatic cancer|stage iii pancreatic cancer
852920|NCT00003867|recurrent pancreatic cancer|recurrent pancreatic cancer
852921|NCT00003867|stage III rectal cancer|stage iii rectal cancer
852922|NCT00003867|stage IV rectal cancer|stage iv rectal cancer
852923|NCT00003867|recurrent colon cancer|recurrent colon cancer
852924|NCT00003867|recurrent rectal cancer|recurrent rectal cancer
852925|NCT00003867|stage IV anal cancer|stage iv anal cancer
852926|NCT00003867|recurrent anal cancer|recurrent anal cancer
852927|NCT00003867|stage II esophageal cancer|stage ii esophageal cancer
852928|NCT00003867|stage III esophageal cancer|stage iii esophageal cancer
852929|NCT00003867|stage IV esophageal cancer|stage iv esophageal cancer
852930|NCT00003867|stage IIIA anal cancer|stage iiia anal cancer
852931|NCT00003867|stage IIIB anal cancer|stage iiib anal cancer
852932|NCT00003867|recurrent esophageal cancer|recurrent esophageal cancer
852933|NCT00003867|regional gastrointestinal carcinoid tumor|regional gastrointestinal carcinoid tumor
852934|NCT00003867|metastatic gastrointestinal carcinoid tumor|metastatic gastrointestinal carcinoid tumor
852935|NCT00003867|recurrent gastrointestinal carcinoid tumor|recurrent gastrointestinal carcinoid tumor
852936|NCT00003867|localized unresectable adult primary liver cancer|localized unresectable adult primary liver cancer
852937|NCT00003867|advanced adult primary liver cancer|advanced adult primary liver cancer
852938|NCT00003867|recurrent adult primary liver cancer|recurrent adult primary liver cancer
852939|NCT00003867|small intestine adenocarcinoma|small intestine adenocarcinoma
852940|NCT00003867|small intestine lymphoma|small intestine lymphoma
852941|NCT00003867|small intestine leiomyosarcoma|small intestine leiomyosarcoma
852942|NCT00003867|unresectable gallbladder cancer|unresectable gallbladder cancer
852943|NCT00003867|recurrent gallbladder cancer|recurrent gallbladder cancer
852944|NCT00003867|unresectable extrahepatic bile duct cancer|unresectable extrahepatic bile duct cancer
852945|NCT00003867|recurrent extrahepatic bile duct cancer|recurrent extrahepatic bile duct cancer
852946|NCT00003867|recurrent small intestine cancer|recurrent small intestine cancer
852947|NCT00003867|unspecified adult solid tumor, protocol specific|unspecified adult solid tumor, protocol specific
852948|NCT00003867|newly diagnosed carcinoma of unknown primary|newly diagnosed carcinoma of unknown primary
852949|NCT00003867|carcinoma of the appendix|carcinoma of the appendix
852950|NCT00003867|recurrent carcinoma of unknown primary|recurrent carcinoma of unknown primary
852951|NCT00003867|stage IV pancreatic cancer|stage iv pancreatic cancer
852952|NCT00003632|primary central nervous system non-Hodgkin lymphoma|primary central nervous system non-hodgkin lymphoma
852953|NCT00003582|squamous cell carcinoma of unknown primary|squamous cell carcinoma of unknown primary
852954|NCT00003582|stage III squamous cell carcinoma of the lip and oral cavity|stage iii squamous cell carcinoma of the lip and oral cavity
852955|NCT00003582|stage IV squamous cell carcinoma of the lip and oral cavity|stage iv squamous cell carcinoma of the lip and oral cavity
852956|NCT00003582|stage III squamous cell carcinoma of the oropharynx|stage iii squamous cell carcinoma of the oropharynx
852957|NCT00003582|stage IV squamous cell carcinoma of the oropharynx|stage iv squamous cell carcinoma of the oropharynx
852958|NCT00003582|stage III squamous cell carcinoma of the nasopharynx|stage iii squamous cell carcinoma of the nasopharynx
852959|NCT00003582|stage IV squamous cell carcinoma of the nasopharynx|stage iv squamous cell carcinoma of the nasopharynx
852960|NCT00003582|stage III squamous cell carcinoma of the hypopharynx|stage iii squamous cell carcinoma of the hypopharynx
852961|NCT00003582|stage IV squamous cell carcinoma of the hypopharynx|stage iv squamous cell carcinoma of the hypopharynx
852962|NCT00003582|stage III squamous cell carcinoma of the larynx|stage iii squamous cell carcinoma of the larynx
852963|NCT00003582|stage IV squamous cell carcinoma of the larynx|stage iv squamous cell carcinoma of the larynx
854061|NCT00075842|fatigue|fatigue
852964|NCT00003582|stage III squamous cell carcinoma of the paranasal sinus and nasal cavity|stage iii squamous cell carcinoma of the paranasal sinus and nasal cavity
852965|NCT00003582|stage IV squamous cell carcinoma of the paranasal sinus and nasal cavity|stage iv squamous cell carcinoma of the paranasal sinus and nasal cavity
853041|NCT00077558|blastic phase chronic myelogenous leukemia|blastic phase chronic myelogenous leukemia
852966|NCT00003545|recurrent childhood acute lymphoblastic leukemia|recurrent childhood acute lymphoblastic leukemia
852967|NCT00003545|recurrent childhood lymphoblastic lymphoma|recurrent childhood lymphoblastic lymphoma
852968|NCT00003545|recurrent adult acute lymphoblastic leukemia|recurrent adult acute lymphoblastic leukemia
852969|NCT00003545|T-cell childhood acute lymphoblastic leukemia|t-cell childhood acute lymphoblastic leukemia
852970|NCT00003545|T-cell adult acute lymphoblastic leukemia|t-cell adult acute lymphoblastic leukemia
852971|NCT00003545|recurrent adult lymphoblastic lymphoma|recurrent adult lymphoblastic lymphoma
852972|NCT00003545|recurrent adult T-cell leukemia/lymphoma|recurrent adult t-cell leukemia/lymphoma
852973|NCT00003207|unspecified adult solid tumor, protocol specific|unspecified adult solid tumor, protocol specific
852974|NCT00003207|AIDS-related Kaposi sarcoma|aids-related kaposi sarcoma
852975|NCT00003207|recurrent Kaposi sarcoma|recurrent kaposi sarcoma
852976|NCT00003150|stage I adult diffuse mixed cell lymphoma|stage i adult diffuse mixed cell lymphoma
852977|NCT00003150|stage I adult diffuse large cell lymphoma|stage i adult diffuse large cell lymphoma
852978|NCT00003150|stage I adult immunoblastic large cell lymphoma|stage i adult immunoblastic large cell lymphoma
852979|NCT00003150|stage III adult diffuse mixed cell lymphoma|stage iii adult diffuse mixed cell lymphoma
852980|NCT00003150|stage III adult diffuse large cell lymphoma|stage iii adult diffuse large cell lymphoma
852981|NCT00003150|stage III adult immunoblastic large cell lymphoma|stage iii adult immunoblastic large cell lymphoma
852982|NCT00003150|stage IV adult diffuse mixed cell lymphoma|stage iv adult diffuse mixed cell lymphoma
852983|NCT00003150|stage IV adult diffuse large cell lymphoma|stage iv adult diffuse large cell lymphoma
852984|NCT00003150|stage IV adult immunoblastic large cell lymphoma|stage iv adult immunoblastic large cell lymphoma
852985|NCT00003150|contiguous stage II adult diffuse mixed cell lymphoma|contiguous stage ii adult diffuse mixed cell lymphoma
852986|NCT00003150|contiguous stage II adult immunoblastic large cell lymphoma|contiguous stage ii adult immunoblastic large cell lymphoma
852987|NCT00003150|contiguous stage II adult diffuse large cell lymphoma|contiguous stage ii adult diffuse large cell lymphoma
852988|NCT00003150|noncontiguous stage II adult diffuse mixed cell lymphoma|noncontiguous stage ii adult diffuse mixed cell lymphoma
852989|NCT00003150|noncontiguous stage II adult immunoblastic large cell lymphoma|noncontiguous stage ii adult immunoblastic large cell lymphoma
852990|NCT00003150|noncontiguous stage II adult diffuse large cell lymphoma|noncontiguous stage ii adult diffuse large cell lymphoma
852991|NCT00003066|stage IV breast cancer|stage iv breast cancer
852992|NCT00003066|recurrent breast cancer|recurrent breast cancer
852993|NCT00003062|recurrent non-small cell lung cancer|recurrent non-small cell lung cancer
852994|NCT00003062|stage IV non-small cell lung cancer|stage iv non-small cell lung cancer
852995|NCT00003011|recurrent small cell lung cancer|recurrent small cell lung cancer
852996|NCT00002869|chronic phase chronic myelogenous leukemia|chronic phase chronic myelogenous leukemia
852997|NCT00002869|chronic myelogenous leukemia, BCR-ABL1 positive|chronic myelogenous leukemia, bcr-abl1 positive
852998|NCT00002869|Philadelphia chromosome negative chronic myelogenous leukemia|philadelphia chromosome negative chronic myelogenous leukemia
852999|NCT00002868|chronic phase chronic myelogenous leukemia|chronic phase chronic myelogenous leukemia
853000|NCT00002532|recurrent adult acute lymphoblastic leukemia|recurrent adult acute lymphoblastic leukemia
853001|NCT00002531|untreated adult acute lymphoblastic leukemia|untreated adult acute lymphoblastic leukemia
853002|NCT00002531|T-cell adult acute lymphoblastic leukemia|t-cell adult acute lymphoblastic leukemia
853003|NCT00002531|B-cell adult acute lymphoblastic leukemia|b-cell adult acute lymphoblastic leukemia
853004|NCT00002531|non-T, non-B adult acute lymphoblastic leukemia|non-t, non-b adult acute lymphoblastic leukemia
853005|NCT00077922|LMB-2|lmb-2
853006|NCT00077922|Chronic Lymphocytic Leukemia|chronic lymphocytic leukemia
853007|NCT00077922|CLL|cll
853008|NCT00077922|Immunotoxin|immunotoxin
853009|NCT00077922|Oncology|oncology
853010|NCT00077922|Lymphocytes|lymphocytes
853011|NCT00077922|Hematological Disease|hematological disease
853012|NCT00077922|Monoclonal Antibody|monoclonal antibody
853013|NCT00077922|Neutralizing Antibodies|neutralizing antibodies
853014|NCT00077909|Proteomics|proteomics
853015|NCT00077909|Infection|infection
853016|NCT00077909|Pneumonia|pneumonia
853017|NCT00077909|Mass Spectrometry|mass spectrometry
853018|NCT00077909|BAL|bal
853019|NCT00077909|Lung|lung
853020|NCT00077909|Pulmonary Disease|pulmonary disease
853021|NCT00077909|Lung Infiltrates|lung infiltrates
853022|NCT00077896|Treatment|treatment
853023|NCT00077896|Transcranial Stimulation|transcranial stimulation
853024|NCT00077896|Frontal Lobe|frontal lobe
853025|NCT00077896|Pick's Disease|pick's disease
853026|NCT00077896|Cognitive Impairment|cognitive impairment
853027|NCT00077896|Dementia|dementia
853028|NCT00077896|Frontotemporal Dementia|frontotemporal dementia
853029|NCT00077896|FTD|ftd
853030|NCT00077675|Abscess|abscess
853031|NCT00077675|Burns|burns
853032|NCT00077675|Cellulitis|cellulitis
853033|NCT00077675|Ulcer|ulcer
853034|NCT00077675|Wound infections|wound infections
853035|NCT00077662|Pompe Disease|pompe disease
853036|NCT00077662|Glycogen Storage Disease Type II|glycogen storage disease type ii
853037|NCT00077662|GSD-II|gsd-ii
853038|NCT00077662|Acid Maltase Deficiency Disease|acid maltase deficiency disease
853039|NCT00077662|Glycogenosis 2|glycogenosis 2
853040|NCT00077558|accelerated phase chronic myelogenous leukemia|accelerated phase chronic myelogenous leukemia
880021|NCT00039819|Reflexes|reflexes
853042|NCT00077558|relapsing chronic myelogenous leukemia|relapsing chronic myelogenous leukemia
853043|NCT00077558|previously treated myelodysplastic syndromes|previously treated myelodysplastic syndromes
853044|NCT00077558|secondary myelodysplastic syndromes|secondary myelodysplastic syndromes
853045|NCT00077558|refractory chronic lymphocytic leukemia|refractory chronic lymphocytic leukemia
853046|NCT00077558|recurrent adult acute lymphoblastic leukemia|recurrent adult acute lymphoblastic leukemia
853047|NCT00077558|prolymphocytic leukemia|prolymphocytic leukemia
853048|NCT00077558|refractory anemia with excess blasts|refractory anemia with excess blasts
853049|NCT00077558|chronic myelomonocytic leukemia|chronic myelomonocytic leukemia
853050|NCT00077558|recurrent adult acute myeloid leukemia|recurrent adult acute myeloid leukemia
853051|NCT00077558|secondary acute myeloid leukemia|secondary acute myeloid leukemia
853052|NCT00077558|adult acute minimally differentiated myeloid leukemia (M0)|adult acute minimally differentiated myeloid leukemia (m0)
853053|NCT00077558|adult acute monocytic leukemia (M5b)|adult acute monocytic leukemia (m5b)
853054|NCT00077558|adult acute erythroid leukemia (M6)|adult acute erythroid leukemia (m6)
853055|NCT00077558|adult acute megakaryoblastic leukemia (M7)|adult acute megakaryoblastic leukemia (m7)
853056|NCT00077558|adult acute myeloblastic leukemia with maturation (M2)|adult acute myeloblastic leukemia with maturation (m2)
853057|NCT00077558|adult acute myeloblastic leukemia without maturation (M1)|adult acute myeloblastic leukemia without maturation (m1)
853058|NCT00077558|adult acute myelomonocytic leukemia (M4)|adult acute myelomonocytic leukemia (m4)
853059|NCT00077558|adult acute monoblastic leukemia (M5a)|adult acute monoblastic leukemia (m5a)
853060|NCT00077558|adult acute promyelocytic leukemia (M3)|adult acute promyelocytic leukemia (m3)
853061|NCT00077558|adult acute eosinophilic leukemia|adult acute eosinophilic leukemia
853062|NCT00077558|adult acute basophilic leukemia|adult acute basophilic leukemia
853063|NCT00077558|atypical chronic myeloid leukemia|atypical chronic myeloid leukemia
853064|NCT00077558|myelodysplastic/myeloproliferative disease, unclassifiable|myelodysplastic/myeloproliferative disease, unclassifiable
853065|NCT00077558|adult acute myeloid leukemia with t(8;21)(q22;q22)|adult acute myeloid leukemia with t(8;21)(q22;q22)
853066|NCT00077558|adult acute myeloid leukemia with t(16;16)(p13;q22)|adult acute myeloid leukemia with t(16;16)(p13;q22)
853067|NCT00077558|adult acute myeloid leukemia with inv(16)(p13;q22)|adult acute myeloid leukemia with inv(16)(p13;q22)
853068|NCT00077558|adult acute myeloid leukemia with 11q23 (MLL) abnormalities|adult acute myeloid leukemia with 11q23 (mll) abnormalities
853069|NCT00077558|adult acute myeloid leukemia with t(15;17)(q22;q12)|adult acute myeloid leukemia with t(15;17)(q22;q12)
853070|NCT00077532|stage IV melanoma|stage iv melanoma
853071|NCT00077532|recurrent melanoma|recurrent melanoma
853072|NCT00077519|stage II pancreatic cancer|stage ii pancreatic cancer
853073|NCT00077519|stage III pancreatic cancer|stage iii pancreatic cancer
853074|NCT00077519|recurrent pancreatic cancer|recurrent pancreatic cancer
853075|NCT00077493|recurrent childhood acute lymphoblastic leukemia|recurrent childhood acute lymphoblastic leukemia
853076|NCT00077493|Burkitt lymphoma|burkitt lymphoma
853077|NCT00077493|recurrent childhood large cell lymphoma|recurrent childhood large cell lymphoma
853078|NCT00077493|recurrent childhood lymphoblastic lymphoma|recurrent childhood lymphoblastic lymphoma
853079|NCT00077493|childhood non-Hodgkin lymphoma|childhood non-hodgkin lymphoma
853080|NCT00077415|recurrent non-small cell lung cancer|recurrent non-small cell lung cancer
853081|NCT00077415|stage IIIA non-small cell lung cancer|stage iiia non-small cell lung cancer
853082|NCT00077415|stage IIIB non-small cell lung cancer|stage iiib non-small cell lung cancer
853083|NCT00077415|stage IV non-small cell lung cancer|stage iv non-small cell lung cancer
853084|NCT00077415|adenocarcinoma of the lung|adenocarcinoma of the lung
853085|NCT00077415|bronchoalveolar cell lung cancer|bronchoalveolar cell lung cancer
853086|NCT00077415|large cell lung cancer|large cell lung cancer
853087|NCT00077415|squamous cell lung cancer|squamous cell lung cancer
853088|NCT00077402|recurrent prostate cancer|recurrent prostate cancer
853089|NCT00077402|stage III prostate cancer|stage iii prostate cancer
853090|NCT00077402|stage IV prostate cancer|stage iv prostate cancer
853091|NCT00077402|adenocarcinoma of the prostate|adenocarcinoma of the prostate
853092|NCT00077389|childhood hepatoblastoma|childhood hepatoblastoma
853093|NCT00077389|stage IV childhood liver cancer|stage iv childhood liver cancer
853094|NCT00077337|recurrent colon cancer|recurrent colon cancer
853095|NCT00077337|stage III colon cancer|stage iii colon cancer
853096|NCT00077337|stage IV colon cancer|stage iv colon cancer
853097|NCT00077337|recurrent rectal cancer|recurrent rectal cancer
853099|NCT00077337|stage IV rectal cancer|stage iv rectal cancer
853100|NCT00077324|stage I non-small cell lung cancer|stage i non-small cell lung cancer
853101|NCT00077311|drug/agent toxicity by tissue/organ|drug/agent toxicity by tissue/organ
853102|NCT00077311|anemia|anemia
853103|NCT00077311|neutropenia|neutropenia
853104|NCT00077311|stage IV non-small cell lung cancer|stage iv non-small cell lung cancer
853105|NCT00077311|stage IIIB non-small cell lung cancer|stage iiib non-small cell lung cancer
853106|NCT00077311|recurrent non-small cell lung cancer|recurrent non-small cell lung cancer
853107|NCT00077311|squamous cell lung cancer|squamous cell lung cancer
853108|NCT00077311|large cell lung cancer|large cell lung cancer
853110|NCT00077311|bronchoalveolar cell lung cancer|bronchoalveolar cell lung cancer
853111|NCT00077311|adenosquamous cell lung cancer|adenosquamous cell lung cancer
853112|NCT00007852|recurrent grade 1 follicular lymphoma|recurrent grade 1 follicular lymphoma
853113|NCT00007852|recurrent grade 2 follicular lymphoma|recurrent grade 2 follicular lymphoma
853114|NCT00007852|recurrent grade 3 follicular lymphoma|recurrent grade 3 follicular lymphoma
853115|NCT00007852|recurrent adult diffuse small cleaved cell lymphoma|recurrent adult diffuse small cleaved cell lymphoma
853116|NCT00007852|recurrent adult diffuse mixed cell lymphoma|recurrent adult diffuse mixed cell lymphoma
853117|NCT00007852|recurrent adult diffuse large cell lymphoma|recurrent adult diffuse large cell lymphoma
853118|NCT00007852|recurrent adult immunoblastic large cell lymphoma|recurrent adult immunoblastic large cell lymphoma
853119|NCT00007852|recurrent adult Burkitt lymphoma|recurrent adult burkitt lymphoma
853120|NCT00007852|recurrent mantle cell lymphoma|recurrent mantle cell lymphoma
853121|NCT00007852|recurrent marginal zone lymphoma|recurrent marginal zone lymphoma
853122|NCT00007852|recurrent small lymphocytic lymphoma|recurrent small lymphocytic lymphoma
853123|NCT00007852|extranodal marginal zone B-cell lymphoma of mucosa-associated lymphoid tissue|extranodal marginal zone b-cell lymphoma of mucosa-associated lymphoid tissue
853124|NCT00007852|nodal marginal zone B-cell lymphoma|nodal marginal zone b-cell lymphoma
853125|NCT00007852|splenic marginal zone lymphoma|splenic marginal zone lymphoma
853126|NCT00006786|stage IV colon cancer|stage iv colon cancer
853127|NCT00006786|stage IV rectal cancer|stage iv rectal cancer
853128|NCT00006786|recurrent colon cancer|recurrent colon cancer
853129|NCT00006786|recurrent rectal cancer|recurrent rectal cancer
853130|NCT00006786|adenocarcinoma of the colon|adenocarcinoma of the colon
853131|NCT00006786|adenocarcinoma of the rectum|adenocarcinoma of the rectum
853132|NCT00006459|stage IV breast cancer|stage iv breast cancer
853133|NCT00006459|stage IIIA breast cancer|stage iiia breast cancer
853134|NCT00006459|recurrent breast cancer|recurrent breast cancer
853135|NCT00006459|stage IIIB breast cancer|stage iiib breast cancer
853136|NCT00006388|adult glioblastoma|adult glioblastoma
853137|NCT00006388|adult giant cell glioblastoma|adult giant cell glioblastoma
853138|NCT00006388|adult gliosarcoma|adult gliosarcoma
853139|NCT00006375|unspecified adult solid tumor, protocol specific|unspecified adult solid tumor, protocol specific
853140|NCT00006123|stage IV breast cancer|stage iv breast cancer
853141|NCT00006047|unspecified adult solid tumor, protocol specific|unspecified adult solid tumor, protocol specific
853142|NCT00006038|stage II gastric cancer|stage ii gastric cancer
853143|NCT00006038|stage III gastric cancer|stage iii gastric cancer
853144|NCT00006038|stage IV gastric cancer|stage iv gastric cancer
853145|NCT00006038|stage II esophageal cancer|stage ii esophageal cancer
853146|NCT00006038|stage III esophageal cancer|stage iii esophageal cancer
853147|NCT00006038|adenocarcinoma of the stomach|adenocarcinoma of the stomach
853148|NCT00006038|adenocarcinoma of the esophagus|adenocarcinoma of the esophagus
853149|NCT00005995|stage IV renal cell cancer|stage iv renal cell cancer
853150|NCT00005995|recurrent renal cell cancer|recurrent renal cell cancer
853151|NCT00005986|chronic phase chronic myelogenous leukemia|chronic phase chronic myelogenous leukemia
853152|NCT00005986|accelerated phase chronic myelogenous leukemia|accelerated phase chronic myelogenous leukemia
853153|NCT00005986|Philadelphia chromosome positive chronic myelogenous leukemia|philadelphia chromosome positive chronic myelogenous leukemia
853154|NCT00005877|stage III colon cancer|stage iii colon cancer
853155|NCT00005877|stage IV colon cancer|stage iv colon cancer
853156|NCT00005877|stage III rectal cancer|stage iii rectal cancer
853157|NCT00005877|stage IV rectal cancer|stage iv rectal cancer
853158|NCT00005877|recurrent colon cancer|recurrent colon cancer
853159|NCT00005877|recurrent rectal cancer|recurrent rectal cancer
853160|NCT00005862|stage III adult soft tissue sarcoma|stage iii adult soft tissue sarcoma
853161|NCT00005862|recurrent adult soft tissue sarcoma|recurrent adult soft tissue sarcoma
853162|NCT00005862|gastrointestinal stromal tumor|gastrointestinal stromal tumor
853163|NCT00005862|stage IV adult soft tissue sarcoma|stage iv adult soft tissue sarcoma
853164|NCT00005610|stage IV melanoma|stage iv melanoma
853165|NCT00005610|recurrent melanoma|recurrent melanoma
853166|NCT00005610|lung metastases|lung metastases
853167|NCT00004889|Waldenstrom macroglobulinemia|waldenstrom macroglobulinemia
853168|NCT00004203|recurrent bladder cancer|recurrent bladder cancer
853169|NCT00004203|stage IV bladder cancer|stage iv bladder cancer
853170|NCT00004203|transitional cell carcinoma of the bladder|transitional cell carcinoma of the bladder
853171|NCT00004203|metastatic transitional cell cancer of the renal pelvis and ureter|metastatic transitional cell cancer of the renal pelvis and ureter
853172|NCT00004203|recurrent transitional cell cancer of the renal pelvis and ureter|recurrent transitional cell cancer of the renal pelvis and ureter
853173|NCT00004157|stage IV breast cancer|stage iv breast cancer
853174|NCT00004157|stage IIIA breast cancer|stage iiia breast cancer
853175|NCT00004157|stage IIIB breast cancer|stage iiib breast cancer
853176|NCT00004157|recurrent adult Hodgkin lymphoma|recurrent adult hodgkin lymphoma
853177|NCT00004157|recurrent childhood rhabdomyosarcoma|recurrent childhood rhabdomyosarcoma
853178|NCT00004157|stage II ovarian epithelial cancer|stage ii ovarian epithelial cancer
853179|NCT00004157|stage III ovarian epithelial cancer|stage iii ovarian epithelial cancer
853180|NCT00004157|stage IV ovarian epithelial cancer|stage iv ovarian epithelial cancer
853181|NCT00004157|recurrent ovarian epithelial cancer|recurrent ovarian epithelial cancer
853182|NCT00004157|disseminated neuroblastoma|disseminated neuroblastoma
853183|NCT00004157|recurrent neuroblastoma|recurrent neuroblastoma
853184|NCT00004157|recurrent Wilms tumor and other childhood kidney tumors|recurrent wilms tumor and other childhood kidney tumors
853185|NCT00004157|recurrent childhood lymphoblastic lymphoma|recurrent childhood lymphoblastic lymphoma
853477|NCT00002801|stage III rectal cancer|stage iii rectal cancer
853186|NCT00004157|stage III malignant testicular germ cell tumor|stage iii malignant testicular germ cell tumor
853187|NCT00004157|recurrent malignant testicular germ cell tumor|recurrent malignant testicular germ cell tumor
853188|NCT00004157|testicular embryonal carcinoma|testicular embryonal carcinoma
853189|NCT00004157|testicular choriocarcinoma|testicular choriocarcinoma
853190|NCT00004157|testicular teratoma|testicular teratoma
853191|NCT00004157|testicular yolk sac tumor|testicular yolk sac tumor
853192|NCT00004157|testicular embryonal carcinoma and teratoma|testicular embryonal carcinoma and teratoma
853193|NCT00004157|testicular embryonal carcinoma and teratoma with seminoma|testicular embryonal carcinoma and teratoma with seminoma
853194|NCT00004157|testicular embryonal carcinoma and yolk sac tumor|testicular embryonal carcinoma and yolk sac tumor
853195|NCT00004157|testicular embryonal carcinoma and yolk sac tumor with seminoma|testicular embryonal carcinoma and yolk sac tumor with seminoma
853196|NCT00004157|testicular embryonal carcinoma and seminoma|testicular embryonal carcinoma and seminoma
853197|NCT00004157|testicular yolk sac tumor and teratoma|testicular yolk sac tumor and teratoma
853198|NCT00004157|testicular yolk sac tumor and teratoma with seminoma|testicular yolk sac tumor and teratoma with seminoma
853722|NCT00076596|Spastic Hemiplegia|spastic hemiplegia
853199|NCT00004157|testicular choriocarcinoma and yolk sac tumor|testicular choriocarcinoma and yolk sac tumor
853200|NCT00004157|testicular choriocarcinoma and embryonal carcinoma|testicular choriocarcinoma and embryonal carcinoma
853201|NCT00004157|testicular choriocarcinoma and teratoma|testicular choriocarcinoma and teratoma
853202|NCT00004157|testicular choriocarcinoma and seminoma|testicular choriocarcinoma and seminoma
853203|NCT00004157|recurrent/refractory childhood Hodgkin lymphoma|recurrent/refractory childhood hodgkin lymphoma
853204|NCT00004157|recurrent ovarian germ cell tumor|recurrent ovarian germ cell tumor
853205|NCT00004157|ovarian yolk sac tumor|ovarian yolk sac tumor
853206|NCT00004157|ovarian embryonal carcinoma|ovarian embryonal carcinoma
853207|NCT00004157|ovarian polyembryoma|ovarian polyembryoma
853208|NCT00004157|ovarian choriocarcinoma|ovarian choriocarcinoma
853209|NCT00004157|ovarian immature teratoma|ovarian immature teratoma
853210|NCT00004157|ovarian mature teratoma|ovarian mature teratoma
853211|NCT00004157|ovarian monodermal and highly specialized teratoma|ovarian monodermal and highly specialized teratoma
853212|NCT00004157|ovarian mixed germ cell tumor|ovarian mixed germ cell tumor
853213|NCT00004157|stage III grade 1 follicular lymphoma|stage iii grade 1 follicular lymphoma
853214|NCT00004157|stage III grade 2 follicular lymphoma|stage iii grade 2 follicular lymphoma
853215|NCT00004157|stage III grade 3 follicular lymphoma|stage iii grade 3 follicular lymphoma
853216|NCT00004157|stage III adult diffuse small cleaved cell lymphoma|stage iii adult diffuse small cleaved cell lymphoma
853217|NCT00004157|stage III adult diffuse mixed cell lymphoma|stage iii adult diffuse mixed cell lymphoma
853218|NCT00004157|stage III adult diffuse large cell lymphoma|stage iii adult diffuse large cell lymphoma
853219|NCT00004157|stage III adult immunoblastic large cell lymphoma|stage iii adult immunoblastic large cell lymphoma
853220|NCT00004157|stage III adult lymphoblastic lymphoma|stage iii adult lymphoblastic lymphoma
853221|NCT00004157|stage III adult Burkitt lymphoma|stage iii adult burkitt lymphoma
853222|NCT00004157|stage IV grade 1 follicular lymphoma|stage iv grade 1 follicular lymphoma
853223|NCT00004157|stage IV grade 2 follicular lymphoma|stage iv grade 2 follicular lymphoma
853224|NCT00004157|stage IV grade 3 follicular lymphoma|stage iv grade 3 follicular lymphoma
853225|NCT00004157|stage IV adult diffuse small cleaved cell lymphoma|stage iv adult diffuse small cleaved cell lymphoma
853226|NCT00004157|stage IV adult diffuse mixed cell lymphoma|stage iv adult diffuse mixed cell lymphoma
853227|NCT00004157|stage IV adult diffuse large cell lymphoma|stage iv adult diffuse large cell lymphoma
853228|NCT00004157|stage IV adult immunoblastic large cell lymphoma|stage iv adult immunoblastic large cell lymphoma
853229|NCT00004157|stage IV adult lymphoblastic lymphoma|stage iv adult lymphoblastic lymphoma
853230|NCT00004157|stage IV adult Burkitt lymphoma|stage iv adult burkitt lymphoma
853231|NCT00004157|recurrent grade 1 follicular lymphoma|recurrent grade 1 follicular lymphoma
853232|NCT00004157|recurrent grade 2 follicular lymphoma|recurrent grade 2 follicular lymphoma
853233|NCT00004157|recurrent grade 3 follicular lymphoma|recurrent grade 3 follicular lymphoma
853234|NCT00004157|recurrent adult diffuse small cleaved cell lymphoma|recurrent adult diffuse small cleaved cell lymphoma
853235|NCT00004157|recurrent adult diffuse mixed cell lymphoma|recurrent adult diffuse mixed cell lymphoma
853236|NCT00004157|recurrent adult diffuse large cell lymphoma|recurrent adult diffuse large cell lymphoma
853237|NCT00004157|recurrent adult immunoblastic large cell lymphoma|recurrent adult immunoblastic large cell lymphoma
853238|NCT00004157|recurrent adult lymphoblastic lymphoma|recurrent adult lymphoblastic lymphoma
853239|NCT00004157|recurrent adult Burkitt lymphoma|recurrent adult burkitt lymphoma
853240|NCT00004157|poor prognosis metastatic gestational trophoblastic tumor|poor prognosis metastatic gestational trophoblastic tumor
853241|NCT00004157|recurrent childhood small noncleaved cell lymphoma|recurrent childhood small noncleaved cell lymphoma
853242|NCT00004157|recurrent childhood large cell lymphoma|recurrent childhood large cell lymphoma
853243|NCT00004157|noncontiguous stage II grade 1 follicular lymphoma|noncontiguous stage ii grade 1 follicular lymphoma
853244|NCT00004157|noncontiguous stage II grade 2 follicular lymphoma|noncontiguous stage ii grade 2 follicular lymphoma
853245|NCT00004157|noncontiguous stage II grade 3 follicular lymphoma|noncontiguous stage ii grade 3 follicular lymphoma
853246|NCT00004157|noncontiguous stage II adult diffuse small cleaved cell lymphoma|noncontiguous stage ii adult diffuse small cleaved cell lymphoma
853247|NCT00004157|noncontiguous stage II mantle cell lymphoma|noncontiguous stage ii mantle cell lymphoma
880232|NCT00038675|Gleevec|gleevec
853248|NCT00004157|noncontiguous stage II adult diffuse mixed cell lymphoma|noncontiguous stage ii adult diffuse mixed cell lymphoma
853249|NCT00004157|noncontiguous stage II adult immunoblastic large cell lymphoma|noncontiguous stage ii adult immunoblastic large cell lymphoma
853250|NCT00004157|noncontiguous stage II adult diffuse large cell lymphoma|noncontiguous stage ii adult diffuse large cell lymphoma
853251|NCT00004157|noncontiguous stage II adult Burkitt lymphoma|noncontiguous stage ii adult burkitt lymphoma
853252|NCT00004157|noncontiguous stage II adult lymphoblastic lymphoma|noncontiguous stage ii adult lymphoblastic lymphoma
853253|NCT00004157|stage III mantle cell lymphoma|stage iii mantle cell lymphoma
853254|NCT00004157|stage IV mantle cell lymphoma|stage iv mantle cell lymphoma
853255|NCT00004157|recurrent mantle cell lymphoma|recurrent mantle cell lymphoma
853256|NCT00004157|previously treated childhood rhabdomyosarcoma|previously treated childhood rhabdomyosarcoma
853257|NCT00004157|noncontiguous stage II small lymphocytic lymphoma|noncontiguous stage ii small lymphocytic lymphoma
853258|NCT00004157|noncontiguous stage II marginal zone lymphoma|noncontiguous stage ii marginal zone lymphoma
853259|NCT00004157|recurrent marginal zone lymphoma|recurrent marginal zone lymphoma
853260|NCT00004157|recurrent small lymphocytic lymphoma|recurrent small lymphocytic lymphoma
853261|NCT00004157|stage III small lymphocytic lymphoma|stage iii small lymphocytic lymphoma
853262|NCT00004157|stage III marginal zone lymphoma|stage iii marginal zone lymphoma
853263|NCT00004157|stage IV small lymphocytic lymphoma|stage iv small lymphocytic lymphoma
853264|NCT00004157|stage IV marginal zone lymphoma|stage iv marginal zone lymphoma
853265|NCT00004157|extranodal marginal zone B-cell lymphoma of mucosa-associated lymphoid tissue|extranodal marginal zone b-cell lymphoma of mucosa-associated lymphoid tissue
853266|NCT00004157|nodal marginal zone B-cell lymphoma|nodal marginal zone b-cell lymphoma
853267|NCT00004157|splenic marginal zone lymphoma|splenic marginal zone lymphoma
853268|NCT00004003|stage III pancreatic cancer|stage iii pancreatic cancer
853269|NCT00004003|recurrent pancreatic cancer|recurrent pancreatic cancer
853270|NCT00004003|stage IV pancreatic cancer|stage iv pancreatic cancer
853271|NCT00077584|Scleroderma|scleroderma
853272|NCT00077584|Finger Ulcers|finger ulcers
853273|NCT00077584|Digital Ulcers|digital ulcers
853274|NCT00077584|Systemic Sclerosis|systemic sclerosis
853275|NCT00077285|previously untreated childhood rhabdomyosarcoma|previously untreated childhood rhabdomyosarcoma
853276|NCT00077285|embryonal childhood rhabdomyosarcoma|embryonal childhood rhabdomyosarcoma
853277|NCT00077285|alveolar childhood rhabdomyosarcoma|alveolar childhood rhabdomyosarcoma
853278|NCT00077285|adult rhabdomyosarcoma|adult rhabdomyosarcoma
853279|NCT00077285|stage IV adult soft tissue sarcoma|stage iv adult soft tissue sarcoma
853280|NCT00077285|metastatic childhood soft tissue sarcoma|metastatic childhood soft tissue sarcoma
853281|NCT00077285|nonmetastatic childhood soft tissue sarcoma|nonmetastatic childhood soft tissue sarcoma
853282|NCT00077285|childhood malignant mesenchymoma|childhood malignant mesenchymoma
853283|NCT00077285|adult malignant mesenchymoma|adult malignant mesenchymoma
853284|NCT00077285|stage III adult soft tissue sarcoma|stage iii adult soft tissue sarcoma
853285|NCT00077285|stage II adult soft tissue sarcoma|stage ii adult soft tissue sarcoma
853286|NCT00077285|stage I adult soft tissue sarcoma|stage i adult soft tissue sarcoma
853287|NCT00077259|recurrent colon cancer|recurrent colon cancer
853288|NCT00077259|recurrent rectal cancer|recurrent rectal cancer
853289|NCT00077259|stage III colon cancer|stage iii colon cancer
853290|NCT00077259|stage III rectal cancer|stage iii rectal cancer
853291|NCT00077259|stage IV colon cancer|stage iv colon cancer
853292|NCT00077259|stage IV rectal cancer|stage iv rectal cancer
853293|NCT00077259|adenocarcinoma of the colon|adenocarcinoma of the colon
853294|NCT00077259|adenocarcinoma of the rectum|adenocarcinoma of the rectum
853295|NCT00077246|stage IV non-small cell lung cancer|stage iv non-small cell lung cancer
853296|NCT00077246|recurrent non-small cell lung cancer|recurrent non-small cell lung cancer
853297|NCT00077233|adenocarcinoma of the colon|adenocarcinoma of the colon
853298|NCT00077233|adenocarcinoma of the rectum|adenocarcinoma of the rectum
853299|NCT00077233|recurrent colon cancer|recurrent colon cancer
853300|NCT00077233|recurrent rectal cancer|recurrent rectal cancer
853301|NCT00077233|stage IV colon cancer|stage iv colon cancer
853302|NCT00077233|stage IV rectal cancer|stage iv rectal cancer
853303|NCT00077220|stage II non-small cell lung cancer|stage ii non-small cell lung cancer
853304|NCT00077220|stage IIIA non-small cell lung cancer|stage iiia non-small cell lung cancer
853305|NCT00077220|stage IIIB non-small cell lung cancer|stage iiib non-small cell lung cancer
853306|NCT00077207|untreated childhood cerebellar astrocytoma|untreated childhood cerebellar astrocytoma
853307|NCT00077207|untreated childhood visual pathway and hypothalamic glioma|untreated childhood visual pathway and hypothalamic glioma
853308|NCT00077207|childhood spinal cord neoplasm|childhood spinal cord neoplasm
853309|NCT00077207|childhood oligodendroglioma|childhood oligodendroglioma
853310|NCT00077207|childhood low-grade cerebral astrocytoma|childhood low-grade cerebral astrocytoma
853311|NCT00077194|recurrent adult diffuse large cell lymphoma|recurrent adult diffuse large cell lymphoma
853312|NCT00077194|recurrent mantle cell lymphoma|recurrent mantle cell lymphoma
853313|NCT00077194|recurrent adult Burkitt lymphoma|recurrent adult burkitt lymphoma
853314|NCT00077168|ductal breast carcinoma in situ|ductal breast carcinoma in situ
853315|NCT00077168|breast cancer in situ|breast cancer in situ
853316|NCT00077142|advanced adult primary liver cancer|advanced adult primary liver cancer
853317|NCT00077142|recurrent adult primary liver cancer|recurrent adult primary liver cancer
880552|NCT00037570|Hemorrhage|hemorrhage
853318|NCT00077142|adult primary hepatocellular carcinoma|adult primary hepatocellular carcinoma
853319|NCT00077142|localized unresectable adult primary liver cancer|localized unresectable adult primary liver cancer
853321|NCT00077129|stage III renal cell cancer|stage iii renal cell cancer
853322|NCT00077129|stage IV renal cell cancer|stage iv renal cell cancer
853323|NCT00077129|recurrent renal cell cancer|recurrent renal cell cancer
853324|NCT00077116|untreated adult acute myeloid leukemia|untreated adult acute myeloid leukemia
853325|NCT00077116|refractory anemia with excess blasts|refractory anemia with excess blasts
853326|NCT00077116|refractory anemia with excess blasts in transformation|refractory anemia with excess blasts in transformation
853327|NCT00077116|chronic myelomonocytic leukemia|chronic myelomonocytic leukemia
853328|NCT00077116|de novo myelodysplastic syndromes|de novo myelodysplastic syndromes
853329|NCT00077116|secondary myelodysplastic syndromes|secondary myelodysplastic syndromes
853330|NCT00077116|adult acute myeloid leukemia with t(8;21)(q22;q22)|adult acute myeloid leukemia with t(8;21)(q22;q22)
853331|NCT00077116|adult acute myeloid leukemia with t(16;16)(p13;q22)|adult acute myeloid leukemia with t(16;16)(p13;q22)
853332|NCT00077116|adult acute myeloid leukemia with inv(16)(p13;q22)|adult acute myeloid leukemia with inv(16)(p13;q22)
853333|NCT00077116|adult acute myeloid leukemia with 11q23 (MLL) abnormalities|adult acute myeloid leukemia with 11q23 (mll) abnormalities
853334|NCT00077116|adult acute myeloid leukemia with t(15;17)(q22;q12)|adult acute myeloid leukemia with t(15;17)(q22;q12)
853335|NCT00077116|childhood myelodysplastic syndromes|childhood myelodysplastic syndromes
853336|NCT00077103|anaplastic thyroid cancer|anaplastic thyroid cancer
853337|NCT00077090|lymphedema|lymphedema
853338|NCT00077090|radiation fibrosis|radiation fibrosis
853339|NCT00077090|perioperative/postoperative complications|perioperative/postoperative complications
853340|NCT00077090|stage I breast cancer|stage i breast cancer
853341|NCT00077090|stage II breast cancer|stage ii breast cancer
853342|NCT00077090|stage IIIA breast cancer|stage iiia breast cancer
853343|NCT00077077|unspecified adult solid tumor, protocol specific|unspecified adult solid tumor, protocol specific
853344|NCT00077064|radiation fibrosis|radiation fibrosis
853345|NCT00077064|pulmonary complications|pulmonary complications
853346|NCT00077064|limited stage small cell lung cancer|limited stage small cell lung cancer
853347|NCT00077064|stage II non-small cell lung cancer|stage ii non-small cell lung cancer
853348|NCT00077064|stage IIIA non-small cell lung cancer|stage iiia non-small cell lung cancer
853349|NCT00077064|stage IIIB non-small cell lung cancer|stage iiib non-small cell lung cancer
853350|NCT00077064|stage I non-small cell lung cancer|stage i non-small cell lung cancer
853351|NCT00077051|stage III squamous cell carcinoma of the lip and oral cavity|stage iii squamous cell carcinoma of the lip and oral cavity
853352|NCT00077051|stage III squamous cell carcinoma of the oropharynx|stage iii squamous cell carcinoma of the oropharynx
853353|NCT00077051|stage IV squamous cell carcinoma of the lip and oral cavity|stage iv squamous cell carcinoma of the lip and oral cavity
853354|NCT00077051|stage IV squamous cell carcinoma of the oropharynx|stage iv squamous cell carcinoma of the oropharynx
853355|NCT00077025|metastatic breast cancer|metastatic breast cancer
853356|NCT00077012|BPH|bph
853357|NCT00077038|Visual Feedback|visual feedback
853358|NCT00077038|Cortical Connectivity|cortical connectivity
853359|NCT00077038|Magnetoencephalography|magnetoencephalography
853360|NCT00077038|Eye Tracking|eye tracking
853361|NCT00077038|Healthy Volunteer|healthy volunteer
853362|NCT00077038|HV|hv
853363|NCT00076986|brain tumor|brain tumor
853364|NCT00076986|recurrent malignant glioma|recurrent malignant glioma
853365|NCT00076986|brain neoplasm|brain neoplasm
853366|NCT00076986|central nervous system|central nervous system
853367|NCT00076986|surgery|surgery
853368|NCT00076986|resection|resection
853369|NCT00076986|GLIADEL|gliadel
853370|NCT00076986|infusion|infusion
853371|NCT00076986|glioblastoma multiforme|glioblastoma multiforme
853372|NCT00076986|convection-enhanced delivery|convection-enhanced delivery
853373|NCT00076986|first recurrence|first recurrence
853374|NCT00076986|recurrent GBM|recurrent gbm
853375|NCT00076986|GBM|gbm
853376|NCT00076986|supratentorial GBM|supratentorial gbm
853377|NCT00076960|hyperbilirubinemia|hyperbilirubinemia
853378|NCT00076960|jaundice|jaundice
853379|NCT00076960|tin-mesoporphyrin|tin-mesoporphyrin
853380|NCT00076960|stannsoporfin|stannsoporfin
853381|NCT00076960|exchange transfusion|exchange transfusion
853382|NCT00076960|neonatal hyperbilirubinemia|neonatal hyperbilirubinemia
853383|NCT00076947|HIV Preventive Vaccine|hiv preventive vaccine
853384|NCT00076947|HIV Seronegativity|hiv seronegativity
853385|NCT00076947|Protein|protein
853386|NCT00076934|Ataxia|ataxia
853387|NCT00076934|MRI|mri
853388|NCT00076934|MS|ms
853389|NCT00076934|CTLA4-IgG4m|ctla4-igg4m
853390|NCT00076934|Costimulatory Signals|costimulatory signals
853391|NCT00076934|Autoimmune Disorders|autoimmune disorders
853392|NCT00003937|localized osteosarcoma|localized osteosarcoma
853393|NCT00003937|cardiac toxicity|cardiac toxicity
853394|NCT00003923|stage I pancreatic cancer|stage i pancreatic cancer
853395|NCT00003923|stage II pancreatic cancer|stage ii pancreatic cancer
853396|NCT00003923|stage III pancreatic cancer|stage iii pancreatic cancer
853397|NCT00003923|stage IV pancreatic cancer|stage iv pancreatic cancer
853398|NCT00003923|recurrent pancreatic cancer|recurrent pancreatic cancer
853399|NCT00003923|unresectable gallbladder cancer|unresectable gallbladder cancer
853478|NCT00002679|stage II breast cancer|stage ii breast cancer
853400|NCT00003923|recurrent gallbladder cancer|recurrent gallbladder cancer
853401|NCT00003923|unresectable extrahepatic bile duct cancer|unresectable extrahepatic bile duct cancer
853402|NCT00003923|recurrent extrahepatic bile duct cancer|recurrent extrahepatic bile duct cancer
853403|NCT00003923|cholangiocarcinoma of the gallbladder|cholangiocarcinoma of the gallbladder
853404|NCT00003923|cholangiocarcinoma of the extrahepatic bile duct|cholangiocarcinoma of the extrahepatic bile duct
853405|NCT00003923|adult primary cholangiocellular carcinoma|adult primary cholangiocellular carcinoma
853406|NCT00003721|unspecified adult solid tumor, protocol specific|unspecified adult solid tumor, protocol specific
853407|NCT00003665|stage IV melanoma|stage iv melanoma
853408|NCT00003665|recurrent melanoma|recurrent melanoma
853409|NCT00003616|recurrent adult brain tumor|recurrent adult brain tumor
853410|NCT00003616|adult brain stem glioma|adult brain stem glioma
853411|NCT00003616|adult oligodendroglioma|adult oligodendroglioma
853412|NCT00003616|adult mixed glioma|adult mixed glioma
853413|NCT00003616|adult diffuse astrocytoma|adult diffuse astrocytoma
853414|NCT00003370|unspecified childhood solid tumor, protocol specific|unspecified childhood solid tumor, protocol specific
853415|NCT00003367|adenocarcinoma of the prostate|adenocarcinoma of the prostate
853416|NCT00003367|stage I prostate cancer|stage i prostate cancer
853417|NCT00003367|stage IIB prostate cancer|stage iib prostate cancer
853418|NCT00003367|stage IIA prostate cancer|stage iia prostate cancer
853419|NCT00003367|stage III prostate cancer|stage iii prostate cancer
853420|NCT00003367|stage IV prostate cancer|stage iv prostate cancer
853421|NCT00003367|recurrent prostate cancer|recurrent prostate cancer
853422|NCT00003334|stage IV endometrial carcinoma|stage iv endometrial carcinoma
853423|NCT00003334|recurrent endometrial carcinoma|recurrent endometrial carcinoma
853424|NCT00003334|fallopian tube cancer|fallopian tube cancer
853425|NCT00003334|stage IV uterine sarcoma|stage iv uterine sarcoma
853426|NCT00003334|recurrent uterine sarcoma|recurrent uterine sarcoma
853427|NCT00003334|uterine carcinosarcoma|uterine carcinosarcoma
853428|NCT00003334|uterine leiomyosarcoma|uterine leiomyosarcoma
853429|NCT00003334|endometrial stromal sarcoma|endometrial stromal sarcoma
853430|NCT00003334|ovarian sarcoma|ovarian sarcoma
853431|NCT00003334|ovarian carcinosarcoma|ovarian carcinosarcoma
853432|NCT00003222|stage III melanoma|stage iii melanoma
853433|NCT00003222|stage IV melanoma|stage iv melanoma
853434|NCT00003222|recurrent melanoma|recurrent melanoma
853435|NCT00003185|adult glioblastoma|adult glioblastoma
853436|NCT00003185|adult anaplastic astrocytoma|adult anaplastic astrocytoma
853437|NCT00003185|adult giant cell glioblastoma|adult giant cell glioblastoma
853438|NCT00003185|adult gliosarcoma|adult gliosarcoma
853439|NCT00003108|unspecified adult solid tumor, protocol specific|unspecified adult solid tumor, protocol specific
853440|NCT00003086|stage IV breast cancer|stage iv breast cancer
853441|NCT00076869|Definite or probable Invasive Aspergillosis either refractory or intolerant to prior antifungal treatment.|definite or probable invasive aspergillosis either refractory or intolerant to prior antifungal treatment.
853442|NCT00076817|HIV Preventive Vaccine|hiv preventive vaccine
853443|NCT00076817|ALVAC Vaccine|alvac vaccine
853444|NCT00076817|Immunization Site|immunization site
853445|NCT00076817|Deltoid|deltoid
853446|NCT00076817|Groin|groin
853447|NCT00076817|Targeted Inguinal Lymph Node|targeted inguinal lymph node
853448|NCT00076817|TILN|tiln
853449|NCT00076804|Directly Observed Therapy|directly observed therapy
853450|NCT00076804|DOT|dot
853451|NCT00076791|HIV Seronegativity|hiv seronegativity
853452|NCT00033592|non-small cell lung cancer|non-small cell lung cancer
853453|NCT00033592|small cell lung cancer|small cell lung cancer
853454|NCT00026377|adenocarcinoma of the prostate|adenocarcinoma of the prostate
853455|NCT00026377|stage IIB prostate cancer|stage iib prostate cancer
853456|NCT00026377|stage IIA prostate cancer|stage iia prostate cancer
853457|NCT00026377|stage III prostate cancer|stage iii prostate cancer
853458|NCT00026377|stage IV prostate cancer|stage iv prostate cancer
853459|NCT00024362|stage III pancreatic cancer|stage iii pancreatic cancer
853460|NCT00024362|adenocarcinoma of the pancreas|adenocarcinoma of the pancreas
853461|NCT00024362|stage IV pancreatic cancer|stage iv pancreatic cancer
853462|NCT00003320|tumors metastatic to brain|tumors metastatic to brain
853463|NCT00003073|recurrent childhood acute lymphoblastic leukemia|recurrent childhood acute lymphoblastic leukemia
853464|NCT00003073|recurrent childhood lymphoblastic lymphoma|recurrent childhood lymphoblastic lymphoma
853465|NCT00003073|recurrent childhood acute myeloid leukemia|recurrent childhood acute myeloid leukemia
853466|NCT00003073|childhood diffuse large cell lymphoma|childhood diffuse large cell lymphoma
853467|NCT00003073|childhood immunoblastic large cell lymphoma|childhood immunoblastic large cell lymphoma
853468|NCT00003073|unspecified childhood solid tumor, protocol specific|unspecified childhood solid tumor, protocol specific
853469|NCT00003073|recurrent/refractory childhood Hodgkin lymphoma|recurrent/refractory childhood hodgkin lymphoma
853470|NCT00003073|leptomeningeal metastases|leptomeningeal metastases
853471|NCT00003073|recurrent childhood small noncleaved cell lymphoma|recurrent childhood small noncleaved cell lymphoma
853472|NCT00003073|recurrent childhood large cell lymphoma|recurrent childhood large cell lymphoma
853473|NCT00002801|stage II colon cancer|stage ii colon cancer
853474|NCT00002801|stage III colon cancer|stage iii colon cancer
853475|NCT00002801|stage I rectal cancer|stage i rectal cancer
853476|NCT00002801|stage II rectal cancer|stage ii rectal cancer
853558|NCT00076752|Efficacy|efficacy
853479|NCT00002679|stage IIIA breast cancer|stage iiia breast cancer
853480|NCT00002679|male breast cancer|male breast cancer
853481|NCT00076843|Interleukin-15|interleukin-15
853482|NCT00076843|CD8+ T-cells|cd8+ t-cells
853484|NCT00076843|HTLV-1|htlv-1
853485|NCT00076843|HTLV-1 Associated Myelopathy|htlv-1 associated myelopathy
853486|NCT00076843|Tropical Spastic Paraparesis|tropical spastic paraparesis
853487|NCT00076830|Bone|bone
853488|NCT00076830|Growth|growth
853489|NCT00076830|Skin|skin
853490|NCT00076830|Connective Tissue Disorders|connective tissue disorders
853491|NCT00076726|Giant Cell Arteritis|giant cell arteritis
853492|NCT00076726|infliximab|infliximab
853493|NCT00076544|Intrathecal|intrathecal
853494|NCT00076518|Treatment Experienced|treatment experienced
853495|NCT00022373|stage I nasopharyngeal cancer|stage i nasopharyngeal cancer
853496|NCT00022373|stage II nasopharyngeal cancer|stage ii nasopharyngeal cancer
853497|NCT00022373|stage III nasopharyngeal cancer|stage iii nasopharyngeal cancer
853498|NCT00022373|stage IV nasopharyngeal cancer|stage iv nasopharyngeal cancer
853499|NCT00022373|stage I salivary gland cancer|stage i salivary gland cancer
853500|NCT00022373|stage II salivary gland cancer|stage ii salivary gland cancer
853501|NCT00022373|stage III salivary gland cancer|stage iii salivary gland cancer
853502|NCT00022373|stage IV salivary gland cancer|stage iv salivary gland cancer
853503|NCT00022373|recurrent salivary gland cancer|recurrent salivary gland cancer
853504|NCT00022373|untreated metastatic squamous neck cancer with occult primary|untreated metastatic squamous neck cancer with occult primary
853505|NCT00022373|recurrent metastatic squamous neck cancer with occult primary|recurrent metastatic squamous neck cancer with occult primary
853506|NCT00022373|stage I lip and oral cavity cancer|stage i lip and oral cavity cancer
853507|NCT00022373|stage II lip and oral cavity cancer|stage ii lip and oral cavity cancer
853508|NCT00022373|stage III lip and oral cavity cancer|stage iii lip and oral cavity cancer
853509|NCT00022373|stage IV lip and oral cavity cancer|stage iv lip and oral cavity cancer
853510|NCT00022373|stage I hypopharyngeal cancer|stage i hypopharyngeal cancer
853511|NCT00022373|stage II hypopharyngeal cancer|stage ii hypopharyngeal cancer
853512|NCT00022373|stage III hypopharyngeal cancer|stage iii hypopharyngeal cancer
853513|NCT00022373|stage IV hypopharyngeal cancer|stage iv hypopharyngeal cancer
853514|NCT00022373|stage I oropharyngeal cancer|stage i oropharyngeal cancer
853515|NCT00022373|stage II oropharyngeal cancer|stage ii oropharyngeal cancer
853516|NCT00022373|stage III oropharyngeal cancer|stage iii oropharyngeal cancer
853517|NCT00022373|stage IV oropharyngeal cancer|stage iv oropharyngeal cancer
853518|NCT00022373|radiation toxicity|radiation toxicity
853519|NCT00022373|oral complications of radiation therapy|oral complications of radiation therapy
853520|NCT00022243|recurrent non-small cell lung cancer|recurrent non-small cell lung cancer
853521|NCT00022243|stage IIIA non-small cell lung cancer|stage iiia non-small cell lung cancer
853522|NCT00022243|stage IIIB non-small cell lung cancer|stage iiib non-small cell lung cancer
853523|NCT00022243|stage IV non-small cell lung cancer|stage iv non-small cell lung cancer
853524|NCT00022204|stage I breast cancer|stage i breast cancer
853525|NCT00022204|stage II breast cancer|stage ii breast cancer
853526|NCT00022204|stage IIIA breast cancer|stage iiia breast cancer
853527|NCT00022204|lymphedema|lymphedema
853528|NCT00022204|male breast cancer|male breast cancer
853529|NCT00021385|stage III ovarian epithelial cancer|stage iii ovarian epithelial cancer
853530|NCT00021385|stage IV ovarian epithelial cancer|stage iv ovarian epithelial cancer
853531|NCT00021385|recurrent ovarian epithelial cancer|recurrent ovarian epithelial cancer
853532|NCT00021385|ovarian stromal cancer|ovarian stromal cancer
853533|NCT00021385|stage III ovarian germ cell tumor|stage iii ovarian germ cell tumor
853534|NCT00021385|stage IV ovarian germ cell tumor|stage iv ovarian germ cell tumor
853535|NCT00021385|recurrent ovarian germ cell tumor|recurrent ovarian germ cell tumor
853536|NCT00021385|borderline ovarian surface epithelial-stromal tumor|borderline ovarian surface epithelial-stromal tumor
853537|NCT00021385|ovarian sarcoma|ovarian sarcoma
853538|NCT00020696|recurrent ovarian epithelial cancer|recurrent ovarian epithelial cancer
853539|NCT00020696|primary peritoneal cavity cancer|primary peritoneal cavity cancer
853540|NCT00017407|recurrent non-small cell lung cancer|recurrent non-small cell lung cancer
853541|NCT00017407|stage IIIB non-small cell lung cancer|stage iiib non-small cell lung cancer
853542|NCT00017407|stage IV non-small cell lung cancer|stage iv non-small cell lung cancer
853543|NCT00014105|recurrent adult brain tumor|recurrent adult brain tumor
853544|NCT00014105|adult glioblastoma|adult glioblastoma
853545|NCT00014105|adult giant cell glioblastoma|adult giant cell glioblastoma
853546|NCT00014105|adult gliosarcoma|adult gliosarcoma
853547|NCT00014066|stage I non-small cell lung cancer|stage i non-small cell lung cancer
853548|NCT00014066|recurrent non-small cell lung cancer|recurrent non-small cell lung cancer
853549|NCT00014066|limited stage small cell lung cancer|limited stage small cell lung cancer
853550|NCT00014066|recurrent small cell lung cancer|recurrent small cell lung cancer
853551|NCT00014066|stage 0 non-small cell lung cancer|stage 0 non-small cell lung cancer
853552|NCT00010244|stage IIB prostate cancer|stage iib prostate cancer
853553|NCT00010244|stage IIA prostate cancer|stage iia prostate cancer
853554|NCT00010244|stage III prostate cancer|stage iii prostate cancer
853555|NCT00076752|Refractory SLE|refractory sle
853556|NCT00076752|Immunoablation|immunoablation
853557|NCT00076752|Immunological Recovery|immunological recovery
853559|NCT00076752|Mechanism of Disease|mechanism of disease
853560|NCT00076752|Lupus|lupus
853561|NCT00076752|Systemic Lupus Erythematosus|systemic lupus erythematosus
853563|NCT00076739|Prefrontal Cortex|prefrontal cortex
853564|NCT00076739|Semantic Memory|semantic memory
853565|NCT00076739|Semantic Relations|semantic relations
853566|NCT00076739|Priming Paradigm|priming paradigm
853567|NCT00076739|fMRI|fmri
853568|NCT00076739|Healthy Volunteer|healthy volunteer
853570|NCT00076713|Antiphospholipid|antiphospholipid
853571|NCT00009997|stage II breast cancer|stage ii breast cancer
853572|NCT00009997|stage IIIA breast cancer|stage iiia breast cancer
853573|NCT00009997|stage IIIB breast cancer|stage iiib breast cancer
853574|NCT00008333|stage IIIB non-small cell lung cancer|stage iiib non-small cell lung cancer
853575|NCT00008333|stage IV non-small cell lung cancer|stage iv non-small cell lung cancer
853576|NCT00008034|stage II breast cancer|stage ii breast cancer
853577|NCT00008034|stage IIIA breast cancer|stage iiia breast cancer
853578|NCT00008034|stage IIIB breast cancer|stage iiib breast cancer
853579|NCT00008034|inflammatory breast cancer|inflammatory breast cancer
853580|NCT00006460|adult glioblastoma|adult glioblastoma
853581|NCT00006460|adult giant cell glioblastoma|adult giant cell glioblastoma
853582|NCT00006460|adult gliosarcoma|adult gliosarcoma
853583|NCT00006454|stage II ovarian epithelial cancer|stage ii ovarian epithelial cancer
853584|NCT00006454|stage III ovarian epithelial cancer|stage iii ovarian epithelial cancer
853585|NCT00006454|stage IV ovarian epithelial cancer|stage iv ovarian epithelial cancer
853586|NCT00006454|fallopian tube cancer|fallopian tube cancer
853587|NCT00006111|stage II bladder cancer|stage ii bladder cancer
853588|NCT00006111|stage III bladder cancer|stage iii bladder cancer
853589|NCT00006111|stage IV bladder cancer|stage iv bladder cancer
853590|NCT00006111|anterior urethral cancer|anterior urethral cancer
853591|NCT00006111|posterior urethral cancer|posterior urethral cancer
853592|NCT00006111|urethral cancer associated with invasive bladder cancer|urethral cancer associated with invasive bladder cancer
853593|NCT00006111|metastatic transitional cell cancer of the renal pelvis and ureter|metastatic transitional cell cancer of the renal pelvis and ureter
853594|NCT00006111|regional transitional cell cancer of the renal pelvis and ureter|regional transitional cell cancer of the renal pelvis and ureter
853595|NCT00076700|Cross-Modal Plasticity|cross-modal plasticity
853596|NCT00076700|Functional MRI|functional mri
853597|NCT00076700|Behavior|behavior
853598|NCT00076700|Memory|memory
853599|NCT00076700|Blind|blind
853600|NCT00076700|Blindness|blindness
853601|NCT00076700|Healthy Volunteer|healthy volunteer
853602|NCT00076700|HV|hv
853603|NCT00006050|stage IV colon cancer|stage iv colon cancer
853604|NCT00006050|stage IV rectal cancer|stage iv rectal cancer
853605|NCT00006050|liver metastases|liver metastases
853606|NCT00005881|recurrent childhood acute lymphoblastic leukemia|recurrent childhood acute lymphoblastic leukemia
853607|NCT00005881|childhood Burkitt lymphoma|childhood burkitt lymphoma
853608|NCT00005881|stage I childhood lymphoblastic lymphoma|stage i childhood lymphoblastic lymphoma
853609|NCT00005881|stage II childhood lymphoblastic lymphoma|stage ii childhood lymphoblastic lymphoma
853610|NCT00005881|stage III childhood lymphoblastic lymphoma|stage iii childhood lymphoblastic lymphoma
853611|NCT00005881|stage IV childhood lymphoblastic lymphoma|stage iv childhood lymphoblastic lymphoma
853612|NCT00005881|recurrent childhood lymphoblastic lymphoma|recurrent childhood lymphoblastic lymphoma
853613|NCT00005881|recurrent childhood acute myeloid leukemia|recurrent childhood acute myeloid leukemia
853614|NCT00005881|childhood diffuse large cell lymphoma|childhood diffuse large cell lymphoma
853615|NCT00005881|childhood immunoblastic large cell lymphoma|childhood immunoblastic large cell lymphoma
853616|NCT00005881|unspecified childhood solid tumor, protocol specific|unspecified childhood solid tumor, protocol specific
853617|NCT00005881|childhood acute myeloid leukemia in remission|childhood acute myeloid leukemia in remission
853618|NCT00005881|stage II childhood Hodgkin lymphoma|stage ii childhood hodgkin lymphoma
853619|NCT00005881|stage I childhood Hodgkin lymphoma|stage i childhood hodgkin lymphoma
853620|NCT00005881|stage III childhood Hodgkin lymphoma|stage iii childhood hodgkin lymphoma
853621|NCT00005881|stage IV childhood Hodgkin lymphoma|stage iv childhood hodgkin lymphoma
853622|NCT00005881|recurrent/refractory childhood Hodgkin lymphoma|recurrent/refractory childhood hodgkin lymphoma
853623|NCT00005881|stage I childhood small noncleaved cell lymphoma|stage i childhood small noncleaved cell lymphoma
853624|NCT00005881|stage I childhood large cell lymphoma|stage i childhood large cell lymphoma
853625|NCT00005881|stage II childhood small noncleaved cell lymphoma|stage ii childhood small noncleaved cell lymphoma
853626|NCT00005881|stage II childhood large cell lymphoma|stage ii childhood large cell lymphoma
853627|NCT00005881|stage III childhood small noncleaved cell lymphoma|stage iii childhood small noncleaved cell lymphoma
853628|NCT00005881|stage III childhood large cell lymphoma|stage iii childhood large cell lymphoma
853629|NCT00005881|stage IV childhood small noncleaved cell lymphoma|stage iv childhood small noncleaved cell lymphoma
853630|NCT00005881|stage IV childhood large cell lymphoma|stage iv childhood large cell lymphoma
853631|NCT00005881|recurrent childhood small noncleaved cell lymphoma|recurrent childhood small noncleaved cell lymphoma
853632|NCT00005881|recurrent childhood large cell lymphoma|recurrent childhood large cell lymphoma
853633|NCT00005792|refractory multiple myeloma|refractory multiple myeloma
853634|NCT00005792|stage I multiple myeloma|stage i multiple myeloma
853635|NCT00005792|stage II multiple myeloma|stage ii multiple myeloma
853636|NCT00005792|stage III multiple myeloma|stage iii multiple myeloma
853638|NCT00076635|Pulmonary|pulmonary
853639|NCT00076635|Fibrosis|fibrosis
853640|NCT00076635|IPF|ipf
853641|NCT00076635|Lung|lung
853642|NCT00076635|Actimmune|actimmune
853643|NCT00076635|Interferon|interferon
853644|NCT00076635|Gamma|gamma
853645|NCT00076635|InterMune|intermune
853646|NCT00076674|Parkinson's Disease|parkinson's disease
853647|NCT00076674|Keppra|keppra
853648|NCT00076674|Motor Fluctuations|motor fluctuations
853649|NCT00076674|Intravenous Levodopa|intravenous levodopa
853650|NCT00076674|Antiparkinsonian Response|antiparkinsonian response
853651|NCT00076674|Parkinson Disease|parkinson disease
853652|NCT00076674|PD|pd
853653|NCT00076622|Antidepressant drugs|antidepressant drugs
853654|NCT00076622|Nursing Homes|nursing homes
853655|NCT00005022|limited stage small cell lung cancer|limited stage small cell lung cancer
853656|NCT00004862|recurrent adult acute myeloid leukemia|recurrent adult acute myeloid leukemia
853657|NCT00004862|recurrent adult acute lymphoblastic leukemia|recurrent adult acute lymphoblastic leukemia
853658|NCT00004239|recurrent adult Hodgkin lymphoma|recurrent adult hodgkin lymphoma
853659|NCT00004239|recurrent cutaneous T-cell non-Hodgkin lymphoma|recurrent cutaneous t-cell non-hodgkin lymphoma
853660|NCT00004239|refractory multiple myeloma|refractory multiple myeloma
853661|NCT00004239|Waldenstrom macroglobulinemia|waldenstrom macroglobulinemia
853662|NCT00004239|stage III multiple myeloma|stage iii multiple myeloma
853663|NCT00004239|recurrent adult acute myeloid leukemia|recurrent adult acute myeloid leukemia
853664|NCT00004239|recurrent adult acute lymphoblastic leukemia|recurrent adult acute lymphoblastic leukemia
853665|NCT00004239|relapsing chronic myelogenous leukemia|relapsing chronic myelogenous leukemia
853666|NCT00004239|refractory chronic lymphocytic leukemia|refractory chronic lymphocytic leukemia
853667|NCT00004239|polycythemia vera|polycythemia vera
853668|NCT00004239|primary myelofibrosis|primary myelofibrosis
853669|NCT00004239|essential thrombocythemia|essential thrombocythemia
853670|NCT00004239|refractory hairy cell leukemia|refractory hairy cell leukemia
853671|NCT00004239|chronic myelomonocytic leukemia|chronic myelomonocytic leukemia
853672|NCT00004239|recurrent grade 1 follicular lymphoma|recurrent grade 1 follicular lymphoma
853673|NCT00004239|recurrent grade 2 follicular lymphoma|recurrent grade 2 follicular lymphoma
853674|NCT00004239|recurrent grade 3 follicular lymphoma|recurrent grade 3 follicular lymphoma
853675|NCT00004239|recurrent adult diffuse small cleaved cell lymphoma|recurrent adult diffuse small cleaved cell lymphoma
853676|NCT00004239|recurrent adult diffuse mixed cell lymphoma|recurrent adult diffuse mixed cell lymphoma
853677|NCT00004239|recurrent adult diffuse large cell lymphoma|recurrent adult diffuse large cell lymphoma
853678|NCT00004239|recurrent adult immunoblastic large cell lymphoma|recurrent adult immunoblastic large cell lymphoma
853679|NCT00004239|recurrent adult lymphoblastic lymphoma|recurrent adult lymphoblastic lymphoma
853680|NCT00004239|recurrent adult Burkitt lymphoma|recurrent adult burkitt lymphoma
853681|NCT00004239|recurrent adult T-cell leukemia/lymphoma|recurrent adult t-cell leukemia/lymphoma
853682|NCT00004239|previously treated myelodysplastic syndromes|previously treated myelodysplastic syndromes
853683|NCT00004239|prolymphocytic leukemia|prolymphocytic leukemia
853684|NCT00004239|primary systemic amyloidosis|primary systemic amyloidosis
853685|NCT00004239|recurrent mantle cell lymphoma|recurrent mantle cell lymphoma
853686|NCT00004239|anaplastic large cell lymphoma|anaplastic large cell lymphoma
853687|NCT00004239|recurrent mycosis fungoides/Sezary syndrome|recurrent mycosis fungoides/sezary syndrome
853688|NCT00004239|recurrent marginal zone lymphoma|recurrent marginal zone lymphoma
853689|NCT00004239|recurrent small lymphocytic lymphoma|recurrent small lymphocytic lymphoma
853690|NCT00004239|extranodal marginal zone B-cell lymphoma of mucosa-associated lymphoid tissue|extranodal marginal zone b-cell lymphoma of mucosa-associated lymphoid tissue
853691|NCT00004239|nodal marginal zone B-cell lymphoma|nodal marginal zone b-cell lymphoma
853692|NCT00004239|splenic marginal zone lymphoma|splenic marginal zone lymphoma
853693|NCT00003888|stage III squamous cell carcinoma of the lip and oral cavity|stage iii squamous cell carcinoma of the lip and oral cavity
853694|NCT00003888|stage IV squamous cell carcinoma of the lip and oral cavity|stage iv squamous cell carcinoma of the lip and oral cavity
853695|NCT00003888|stage III squamous cell carcinoma of the oropharynx|stage iii squamous cell carcinoma of the oropharynx
853696|NCT00003888|stage IV squamous cell carcinoma of the oropharynx|stage iv squamous cell carcinoma of the oropharynx
853697|NCT00003888|stage III squamous cell carcinoma of the hypopharynx|stage iii squamous cell carcinoma of the hypopharynx
853698|NCT00003888|stage IV squamous cell carcinoma of the hypopharynx|stage iv squamous cell carcinoma of the hypopharynx
853699|NCT00003888|stage III squamous cell carcinoma of the larynx|stage iii squamous cell carcinoma of the larynx
853700|NCT00003888|stage IV squamous cell carcinoma of the larynx|stage iv squamous cell carcinoma of the larynx
853701|NCT00076609|hepatocellular carcinoma|hepatocellular carcinoma
853702|NCT00076609|advanced|advanced
853703|NCT00076609|unresectable|unresectable
853704|NCT00076609|liver cancer|liver cancer
853705|NCT00076609|systemic chemotherapy|systemic chemotherapy
853706|NCT00076609|botanical|botanical
853707|NCT00076609|herbal|herbal
853708|NCT00076609|alternative and complementary medicine|alternative and complementary medicine
853709|NCT00076609|capecitabine|capecitabine
853710|NCT00076609|PHY906|phy906
853711|NCT00076609|oral|oral
853712|NCT00076609|HCC|hcc
854418|NCT00074737|Antisense|antisense
853713|NCT00076609|traditional chinese medicine|traditional chinese medicine
853714|NCT00076609|tcm|tcm
853715|NCT00076609|QOL|qol
853716|NCT00076609|quality of life|quality of life
853717|NCT00076557|Hemophilia B|hemophilia b
853718|NCT00076557|Factor IX|factor ix
853719|NCT00076557|Gene Transfer|gene transfer
853720|NCT00076557|Adeno-Associated Virus (AAV)|adeno-associated virus (aav)
853721|NCT00076596|Corticospinal Tracts|corticospinal tracts
853723|NCT00076596|Spastic Diplegia|spastic diplegia
853724|NCT00076596|Cortical Re-Organization|cortical re-organization
853725|NCT00076596|Functional Outcome|functional outcome
853726|NCT00076596|Cerebral Palsy|cerebral palsy
853727|NCT00076583|Motor Learning|motor learning
853728|NCT00076583|Co-contraction|co-contraction
853729|NCT00076583|Reciprocal Inhibition|reciprocal inhibition
853730|NCT00076583|Spinal Plasticity|spinal plasticity
853731|NCT00076583|Rhythmic Movement|rhythmic movement
853732|NCT00076583|Healthy Volunteer|healthy volunteer
853733|NCT00076583|HV|hv
853734|NCT00076570|Tolerance|tolerance
853735|NCT00076570|Kidney|kidney
853736|NCT00076570|Transplant|transplant
853737|NCT00076570|Polyclonal|polyclonal
853738|NCT00076570|Antibody|antibody
853739|NCT00076570|Kidney Transplant|kidney transplant
853740|NCT00076531|Prostate|prostate
853741|NCT00076531|Cancer|cancer
853742|NCT00076531|PSA|psa
853743|NCT00076531|Leuprolide|leuprolide
853744|NCT00076492|Parkinson's disease|parkinson's disease
853745|NCT00076492|Parkinson disease|parkinson disease
853746|NCT00076492|CoQ10|coq10
853747|NCT00076492|GPI 1485|gpi 1485
853748|NCT00003882|unspecified adult solid tumor, protocol specific|unspecified adult solid tumor, protocol specific
853749|NCT00003852|recurrent malignant testicular germ cell tumor|recurrent malignant testicular germ cell tumor
853750|NCT00003852|childhood germ cell tumor|childhood germ cell tumor
853751|NCT00003852|recurrent ovarian germ cell tumor|recurrent ovarian germ cell tumor
853752|NCT00003852|extragonadal germ cell tumor|extragonadal germ cell tumor
853753|NCT00003683|stage IV renal cell cancer|stage iv renal cell cancer
853754|NCT00003682|stage IV prostate cancer|stage iv prostate cancer
853755|NCT00003682|recurrent prostate cancer|recurrent prostate cancer
853756|NCT00003578|stage III grade 3 follicular lymphoma|stage iii grade 3 follicular lymphoma
853757|NCT00003578|stage III adult diffuse mixed cell lymphoma|stage iii adult diffuse mixed cell lymphoma
853758|NCT00003578|stage III adult diffuse large cell lymphoma|stage iii adult diffuse large cell lymphoma
853759|NCT00003578|stage III adult immunoblastic large cell lymphoma|stage iii adult immunoblastic large cell lymphoma
853760|NCT00003578|stage IV grade 3 follicular lymphoma|stage iv grade 3 follicular lymphoma
853761|NCT00003578|stage IV adult diffuse mixed cell lymphoma|stage iv adult diffuse mixed cell lymphoma
853762|NCT00003578|stage IV adult diffuse large cell lymphoma|stage iv adult diffuse large cell lymphoma
853763|NCT00003578|stage IV adult immunoblastic large cell lymphoma|stage iv adult immunoblastic large cell lymphoma
853764|NCT00076505|Mitochondria|mitochondria
853765|NCT00076505|Proteasome|proteasome
853766|NCT00076505|Lipid|lipid
853767|NCT00076505|Polymorphism|polymorphism
853768|NCT00076505|Genetic|genetic
853769|NCT00076505|Parkinson's Disease|parkinson's disease
853770|NCT00076505|Parkinson Disease|parkinson disease
853771|NCT00076505|PD|pd
853772|NCT00076505|Heredity|heredity
853773|NCT00076505|Parkinson Disease At Risk|parkinson disease at risk
853774|NCT00076505|Healthy Volunteer|healthy volunteer
853775|NCT00076505|HV|hv
853776|NCT00076453|Knee Pain|knee pain
853777|NCT00076453|Degenerative Arthritis|degenerative arthritis
853778|NCT00076453|Cartilage Disease|cartilage disease
853779|NCT00076453|Non-drug Therapy|non-drug therapy
853780|NCT00076440|Alzheimer disease|alzheimer disease
853781|NCT00076401|CLL|cll
853782|NCT00076401|chronic lymphocytic leukemia|chronic lymphocytic leukemia
853783|NCT00076401|relapsed chronic lymphocytic leukemia|relapsed chronic lymphocytic leukemia
853784|NCT00076401|refractory chronic lymphocytic leukemia|refractory chronic lymphocytic leukemia
853785|NCT00076401|Leukemia|leukemia
853786|NCT00076401|Motexafin gadolinium|motexafin gadolinium
853787|NCT00076401|Chronic leukemia|chronic leukemia
853788|NCT00076401|Lymphocytic leukemia, chronic|lymphocytic leukemia, chronic
853789|NCT00076479|Aphasia|aphasia
853790|NCT00076479|Rehabilitation|rehabilitation
853791|NCT00076479|Neuroplasticity|neuroplasticity
853792|NCT00076479|Picture Naming|picture naming
853793|NCT00076479|Transcranial Magnetic|transcranial magnetic
853794|NCT00076479|Stroke|stroke
853795|NCT00076479|Healthy Volunteer|healthy volunteer
853796|NCT00076479|HV|hv
853797|NCT00076466|Brain Excitability|brain excitability
853798|NCT00076466|Reaction Time|reaction time
853799|NCT00076466|Plasticity|plasticity
853800|NCT00076466|Motor Evoked Potential|motor evoked potential
853801|NCT00076466|Transcranial Magnetic Stimulation|transcranial magnetic stimulation
853802|NCT00076466|Healthy Volunteer|healthy volunteer
853803|NCT00076466|HV|hv
853804|NCT00076388|Non-Small-Cell Lung Cancer|non-small-cell lung cancer
853805|NCT00076375|Atopic Dermatitis|atopic dermatitis
853806|NCT00076375|Eczema|eczema
853807|NCT00003541|stage III mantle cell lymphoma|stage iii mantle cell lymphoma
880663|NCT00036569|MR Imaging|mr imaging
853808|NCT00003541|stage IV mantle cell lymphoma|stage iv mantle cell lymphoma
853809|NCT00003418|stage I breast cancer|stage i breast cancer
853810|NCT00003418|stage II breast cancer|stage ii breast cancer
853811|NCT00003418|stage III breast cancer|stage iii breast cancer
853812|NCT00003364|limited stage small cell lung cancer|limited stage small cell lung cancer
853813|NCT00003298|stage II gastric cancer|stage ii gastric cancer
853814|NCT00003298|stage III gastric cancer|stage iii gastric cancer
853815|NCT00003298|stage IV gastric cancer|stage iv gastric cancer
853816|NCT00003298|adenocarcinoma of the stomach|adenocarcinoma of the stomach
853817|NCT00003287|stage IV colon cancer|stage iv colon cancer
853818|NCT00003287|stage IV rectal cancer|stage iv rectal cancer
853819|NCT00003287|recurrent colon cancer|recurrent colon cancer
853820|NCT00003287|recurrent rectal cancer|recurrent rectal cancer
853821|NCT00003287|adenocarcinoma of the colon|adenocarcinoma of the colon
853822|NCT00003287|adenocarcinoma of the rectum|adenocarcinoma of the rectum
853823|NCT00076427|Immunity|immunity
853824|NCT00076427|Liver|liver
853825|NCT00076427|Apheresis|apheresis
853826|NCT00076427|Cytokine|cytokine
853827|NCT00076427|Virology|virology
853828|NCT00076427|Hepatitis C|hepatitis c
853829|NCT00076427|HCV|hcv
853830|NCT00076427|Hepatitis C co-infection|hepatitis c co-infection
853831|NCT00076414|Endothelial Function|endothelial function
853832|NCT00076414|Lopinavir/Ritonavir|lopinavir/ritonavir
853833|NCT00076414|HIV|hiv
853834|NCT00076414|Blood Flow Studies|blood flow studies
853835|NCT00076414|Flow-Mediated Vasodilatation|flow-mediated vasodilatation
853836|NCT00076414|Healthy Volunteer|healthy volunteer
853837|NCT00076414|HV|hv
853838|NCT00076349|Non-Hodgkin's Lymphoma|non-hodgkin's lymphoma
853839|NCT00076349|NHL|nhl
853840|NCT00076349|Rituxan|rituxan
853841|NCT00076349|Mantle Cell|mantle cell
853842|NCT00076349|mabs|mabs
853843|NCT00003137|stage IV gastric cancer|stage iv gastric cancer
853844|NCT00003137|stage IV esophageal cancer|stage iv esophageal cancer
853845|NCT00003137|adenocarcinoma of the esophagus|adenocarcinoma of the esophagus
853846|NCT00003137|intestinal adenocarcinoma of the stomach|intestinal adenocarcinoma of the stomach
853847|NCT00003137|diffuse adenocarcinoma of the stomach|diffuse adenocarcinoma of the stomach
853848|NCT00003137|mixed adenocarcinoma of the stomach|mixed adenocarcinoma of the stomach
853849|NCT00003007|refractory multiple myeloma|refractory multiple myeloma
853850|NCT00003007|stage III multiple myeloma|stage iii multiple myeloma
853851|NCT00002840|recurrent adult brain tumor|recurrent adult brain tumor
853852|NCT00002840|adult anaplastic oligodendroglioma|adult anaplastic oligodendroglioma
853853|NCT00002840|adult mixed glioma|adult mixed glioma
853854|NCT00002817|stage III melanoma|stage iii melanoma
853855|NCT00002817|stage IV melanoma|stage iv melanoma
853856|NCT00002817|recurrent melanoma|recurrent melanoma
853857|NCT00002748|recurrent neuroblastoma|recurrent neuroblastoma
853858|NCT00076323|G6PD|g6pd
853859|NCT00076323|Favism|favism
853860|NCT00076323|G6PD Deficiency|g6pd deficiency
853861|NCT00076323|hemolysis|hemolysis
853862|NCT00076323|drug reaction|drug reaction
853863|NCT00076323|drug-induced hemolysis|drug-induced hemolysis
853864|NCT00076310|Head and Neck Cancer|head and neck cancer
853865|NCT00076310|Squamous Cell Cancer|squamous cell cancer
853866|NCT00076310|OSI-774|osi-774
853867|NCT00076310|Cisplatin|cisplatin
853868|NCT00076310|Platinol®-AQ|platinol®-aq
853869|NCT00076310|Platinol®|platinol®
853870|NCT00076310|CDDP|cddp
853871|NCT00076310|Docetaxel|docetaxel
853872|NCT00076310|Taxotere|taxotere
853873|NCT00076310|Tarceva|tarceva
853874|NCT00076310|HNSCC|hnscc
853875|NCT00076310|Erlotinib Hydrochloride|erlotinib hydrochloride
853876|NCT00076284|CCR5 Antagonist|ccr5 antagonist
853877|NCT00076284|Coreceptor Inhibitor|coreceptor inhibitor
853878|NCT00076284|Fusion Inhibitor|fusion inhibitor
853879|NCT00076284|Entry Inhibitor|entry inhibitor
853880|NCT00076284|Antiretroviral|antiretroviral
853881|NCT00076284|HIV|hiv
853882|NCT00076271|Strabismus|strabismus
853883|NCT00076271|Cataract, Pediatric|cataract, pediatric
853884|NCT00076271|Optic Nerve Anomaly|optic nerve anomaly
853885|NCT00076271|Coloboma|coloboma
853886|NCT00076271|Evaluation and Treatment|evaluation and treatment
853887|NCT00076271|Pediatric Ophthalmology|pediatric ophthalmology
853888|NCT00076271|Genetic Eye Disease|genetic eye disease
853889|NCT00076271|Nystagmus|nystagmus
853890|NCT00076271|Pediatric Eye Disease|pediatric eye disease
853891|NCT00076271|Developmental Eye Condition|developmental eye condition
853892|NCT00076271|Cataract|cataract
853893|NCT00076271|Juvenile Glaucoma|juvenile glaucoma
853894|NCT00076271|Eye Movement Disorder|eye movement disorder
853895|NCT00076258|Exercise therapy|exercise therapy
853896|NCT00076258|Complementary Therapies|complementary therapies
853897|NCT00076245|Phototherapy|phototherapy
853898|NCT00076219|Acute Renal Failure|acute renal failure
853899|NCT00076219|Renal Replacement Therapy|renal replacement therapy
853900|NCT00076219|multi-site randomization trial|multi-site randomization trial
853901|NCT00076219|Hemodialysis|hemodialysis
853902|NCT00076219|Hemofiltration|hemofiltration
853903|NCT00076219|Critical Illness|critical illness
853904|NCT00076219|Hemodiafiltration|hemodiafiltration
853905|NCT00076232|HIV Seronegativity|hiv seronegativity
853906|NCT00076154|ALS|als
853907|NCT00076141|relatively healthy male|relatively healthy male
853908|NCT00076115|Bipolar|bipolar
853909|NCT00076115|Mania|mania
853910|NCT00076115|Manic|manic
853911|NCT00076115|Depressive|depressive
853912|NCT00076115|Manic Depressive|manic depressive
853913|NCT00076115|Bipolar mania|bipolar mania
853914|NCT00076115|risperidone|risperidone
853915|NCT00076115|adolescents|adolescents
853916|NCT00076115|children|children
853917|NCT00076180|cytotoxic activity against T-LGL cells|cytotoxic activity against t-lgl cells
853918|NCT00076180|chronic lymphoproliferative disorder|chronic lymphoproliferative disorder
853919|NCT00076180|T-LGL Leukemia|t-lgl leukemia
853920|NCT00076180|Natural Killer Cells|natural killer cells
853921|NCT00076180|Leukemia|leukemia
853922|NCT00076180|Lymphocytic Leukemia|lymphocytic leukemia
853923|NCT00076180|T-LGL|t-lgl
853924|NCT00076089|Roflumilast|roflumilast
853925|NCT00076089|Chronic obstructive pulmonary disease|chronic obstructive pulmonary disease
853926|NCT00076089|COPD|copd
853927|NCT00076076|Roflumilast|roflumilast
853928|NCT00076076|Asthma|asthma
853929|NCT00033735|recurrent pancreatic cancer|recurrent pancreatic cancer
853930|NCT00033735|duct cell adenocarcinoma of the pancreas|duct cell adenocarcinoma of the pancreas
853931|NCT00027508|advanced malignant mesothelioma|advanced malignant mesothelioma
853932|NCT00027508|recurrent malignant mesothelioma|recurrent malignant mesothelioma
853933|NCT00024401|stage IV colon cancer|stage iv colon cancer
853934|NCT00024401|stage IV rectal cancer|stage iv rectal cancer
853935|NCT00024401|recurrent colon cancer|recurrent colon cancer
853936|NCT00024401|recurrent rectal cancer|recurrent rectal cancer
853937|NCT00002566|recurrent malignant testicular germ cell tumor|recurrent malignant testicular germ cell tumor
853938|NCT00002566|extragonadal germ cell tumor|extragonadal germ cell tumor
853939|NCT00076102|Side Effect|side effect
853940|NCT00076102|Oral Administration|oral administration
853941|NCT00076102|Nerve Sheath Tumor|nerve sheath tumor
853942|NCT00076102|Antifibrotic Agent|antifibrotic agent
853943|NCT00076102|Volumetric Tumor Measurement|volumetric tumor measurement
853944|NCT00076102|Plexiform Neurofibroma|plexiform neurofibroma
853945|NCT00076102|Neurofibromatosis Type 1|neurofibromatosis type 1
853946|NCT00076102|Volumetric MRI Analysis|volumetric mri analysis
853947|NCT00076102|Time to Progression|time to progression
853948|NCT00076102|NF1|nf1
853949|NCT00076063|HIV Seronegativity|hiv seronegativity
853950|NCT00076063|ALVAC-HIV vCP1452|alvac-hiv vcp1452
853951|NCT00076063|ALVAC Vaccine|alvac vaccine
853952|NCT00076063|HIV-1|hiv-1
853953|NCT00076063|Normal Values|normal values
853954|NCT00076063|HIV Preventive Vaccine|hiv preventive vaccine
853955|NCT00076037|HIV Preventive Vaccine|hiv preventive vaccine
853956|NCT00076037|Granulocyte-Macrophage Colony-Stimulating Factor|granulocyte-macrophage colony-stimulating factor
853957|NCT00076037|AIDS Vaccines|aids vaccines
853958|NCT00076037|HIV-1|hiv-1
853959|NCT00076037|HIV Seronegativity|hiv seronegativity
853960|NCT00076037|Injections, Intramuscular|injections, intramuscular
853961|NCT00076037|RC529|rc529
853962|NCT00076037|Epitopes|epitopes
853963|NCT00076037|T-Lymphocytes, Cytotoxic|t-lymphocytes, cytotoxic
853964|NCT00076024|metastatic breast cancer|metastatic breast cancer
853965|NCT00075998|Idiopathic|idiopathic
853966|NCT00075998|Pulmonary|pulmonary
853967|NCT00075998|Fibrosis|fibrosis
853968|NCT00075998|IPF|ipf
853969|NCT00075998|Lung|lung
853970|NCT00075998|Interferon|interferon
853971|NCT00075998|Gamma|gamma
853972|NCT00075998|Actimmune|actimmune
853973|NCT00075998|INSPIRE|inspire
853974|NCT00075998|InterMune|intermune
853975|NCT00075959|Stroke|stroke
853976|NCT00075959|cerebral vascular accident|cerebral vascular accident
853977|NCT00075959|CVA|cva
853978|NCT00075959|Hemorrhage|hemorrhage
853979|NCT00075959|Intracerebral Hemorrhage (ICH)|intracerebral hemorrhage (ich)
853980|NCT00075959|Brain Attack|brain attack
853981|NCT00075959|Cataplexy|cataplexy
853982|NCT00075946|stage III grade 1 follicular lymphoma|stage iii grade 1 follicular lymphoma
853983|NCT00075946|stage III grade 2 follicular lymphoma|stage iii grade 2 follicular lymphoma
853984|NCT00075946|stage IV grade 1 follicular lymphoma|stage iv grade 1 follicular lymphoma
853985|NCT00075946|stage IV grade 2 follicular lymphoma|stage iv grade 2 follicular lymphoma
853986|NCT00075946|stage III small lymphocytic lymphoma|stage iii small lymphocytic lymphoma
853987|NCT00075946|stage III marginal zone lymphoma|stage iii marginal zone lymphoma
853988|NCT00075946|stage IV small lymphocytic lymphoma|stage iv small lymphocytic lymphoma
853989|NCT00075946|stage IV marginal zone lymphoma|stage iv marginal zone lymphoma
853990|NCT00075946|extranodal marginal zone B-cell lymphoma of mucosa-associated lymphoid tissue|extranodal marginal zone b-cell lymphoma of mucosa-associated lymphoid tissue
853991|NCT00075946|nodal marginal zone B-cell lymphoma|nodal marginal zone b-cell lymphoma
853992|NCT00075946|splenic marginal zone lymphoma|splenic marginal zone lymphoma
853993|NCT00024388|stage III renal cell cancer|stage iii renal cell cancer
853994|NCT00024388|stage IV renal cell cancer|stage iv renal cell cancer
853995|NCT00024388|recurrent renal cell cancer|recurrent renal cell cancer
853996|NCT00022347|stage IV ovarian epithelial cancer|stage iv ovarian epithelial cancer
853997|NCT00022347|recurrent ovarian epithelial cancer|recurrent ovarian epithelial cancer
853998|NCT00022347|ovarian undifferentiated adenocarcinoma|ovarian undifferentiated adenocarcinoma
853999|NCT00022347|ovarian mixed epithelial carcinoma|ovarian mixed epithelial carcinoma
854000|NCT00022347|ovarian serous cystadenocarcinoma|ovarian serous cystadenocarcinoma
854001|NCT00022347|ovarian mucinous cystadenocarcinoma|ovarian mucinous cystadenocarcinoma
854002|NCT00022347|ovarian endometrioid adenocarcinoma|ovarian endometrioid adenocarcinoma
854003|NCT00022347|ovarian clear cell cystadenocarcinoma|ovarian clear cell cystadenocarcinoma
854004|NCT00022347|fallopian tube cancer|fallopian tube cancer
854005|NCT00022347|primary peritoneal cavity cancer|primary peritoneal cavity cancer
854006|NCT00022321|refractory anemia|refractory anemia
854007|NCT00022321|refractory anemia with ringed sideroblasts|refractory anemia with ringed sideroblasts
854008|NCT00022321|refractory anemia with excess blasts|refractory anemia with excess blasts
854009|NCT00022321|refractory anemia with excess blasts in transformation|refractory anemia with excess blasts in transformation
854010|NCT00022321|de novo myelodysplastic syndromes|de novo myelodysplastic syndromes
854011|NCT00021333|recurrent non-small cell lung cancer|recurrent non-small cell lung cancer
854012|NCT00021333|recurrent small cell lung cancer|recurrent small cell lung cancer
854013|NCT00021333|recurrent thyroid cancer|recurrent thyroid cancer
854014|NCT00021333|recurrent salivary gland cancer|recurrent salivary gland cancer
854015|NCT00021333|recurrent squamous cell carcinoma of the lip and oral cavity|recurrent squamous cell carcinoma of the lip and oral cavity
854016|NCT00021333|recurrent basal cell carcinoma of the lip|recurrent basal cell carcinoma of the lip
854017|NCT00021333|recurrent verrucous carcinoma of the oral cavity|recurrent verrucous carcinoma of the oral cavity
854018|NCT00021333|recurrent mucoepidermoid carcinoma of the oral cavity|recurrent mucoepidermoid carcinoma of the oral cavity
854019|NCT00021333|recurrent adenoid cystic carcinoma of the oral cavity|recurrent adenoid cystic carcinoma of the oral cavity
854020|NCT00021333|recurrent squamous cell carcinoma of the oropharynx|recurrent squamous cell carcinoma of the oropharynx
854021|NCT00021333|recurrent lymphoepithelioma of the oropharynx|recurrent lymphoepithelioma of the oropharynx
854022|NCT00021333|recurrent squamous cell carcinoma of the nasopharynx|recurrent squamous cell carcinoma of the nasopharynx
854023|NCT00021333|recurrent lymphoepithelioma of the nasopharynx|recurrent lymphoepithelioma of the nasopharynx
854024|NCT00021333|recurrent squamous cell carcinoma of the hypopharynx|recurrent squamous cell carcinoma of the hypopharynx
854025|NCT00021333|recurrent squamous cell carcinoma of the larynx|recurrent squamous cell carcinoma of the larynx
854026|NCT00021333|recurrent verrucous carcinoma of the larynx|recurrent verrucous carcinoma of the larynx
854027|NCT00021333|recurrent squamous cell carcinoma of the paranasal sinus and nasal cavity|recurrent squamous cell carcinoma of the paranasal sinus and nasal cavity
854028|NCT00021333|recurrent inverted papilloma of the paranasal sinus and nasal cavity|recurrent inverted papilloma of the paranasal sinus and nasal cavity
854029|NCT00021333|recurrent midline lethal granuloma of the paranasal sinus and nasal cavity|recurrent midline lethal granuloma of the paranasal sinus and nasal cavity
854030|NCT00021333|recurrent esthesioneuroblastoma of the paranasal sinus and nasal cavity|recurrent esthesioneuroblastoma of the paranasal sinus and nasal cavity
854031|NCT00021307|recurrent adult brain tumor|recurrent adult brain tumor
854032|NCT00021307|adult glioblastoma|adult glioblastoma
854033|NCT00021307|adult giant cell glioblastoma|adult giant cell glioblastoma
854034|NCT00021307|adult gliosarcoma|adult gliosarcoma
854035|NCT00075907|Acute Infection|acute infection
854036|NCT00075907|Treatment Experienced|treatment experienced
854037|NCT00075907|Treatment Naive|treatment naive
854038|NCT00075894|adult anaplastic oligodendroglioma|adult anaplastic oligodendroglioma
854039|NCT00075894|adult anaplastic astrocytoma|adult anaplastic astrocytoma
854040|NCT00075894|adult glioblastoma|adult glioblastoma
854041|NCT00075894|recurrent adult brain tumor|recurrent adult brain tumor
854042|NCT00075894|adult giant cell glioblastoma|adult giant cell glioblastoma
854043|NCT00075894|adult gliosarcoma|adult gliosarcoma
854044|NCT00075868|radiation enteritis|radiation enteritis
854045|NCT00075868|drug/agent toxicity by tissue/organ|drug/agent toxicity by tissue/organ
854046|NCT00075868|stage I rectal cancer|stage i rectal cancer
854047|NCT00075868|stage II rectal cancer|stage ii rectal cancer
854048|NCT00075868|stage III rectal cancer|stage iii rectal cancer
854049|NCT00075868|stage IIIA anal cancer|stage iiia anal cancer
854050|NCT00075868|stage IIIB anal cancer|stage iiib anal cancer
854051|NCT00075868|recurrent anal cancer|recurrent anal cancer
854052|NCT00075868|stage I anal cancer|stage i anal cancer
854053|NCT00075868|stage II anal cancer|stage ii anal cancer
854054|NCT00075868|recurrent rectal cancer|recurrent rectal cancer
854055|NCT00075855|sexual dysfunction|sexual dysfunction
854056|NCT00075855|unspecified adult solid tumor, protocol specific|unspecified adult solid tumor, protocol specific
854057|NCT00075855|sexuality and reproductive issues|sexuality and reproductive issues
854058|NCT00075855|cancer survivor|cancer survivor
854059|NCT00075842|sleep disorders|sleep disorders
854060|NCT00075842|unspecified adult solid tumor, protocol specific|unspecified adult solid tumor, protocol specific
854062|NCT00075829|Stage II Multiple Myeloma|stage ii multiple myeloma
854063|NCT00075829|Stage III Multiple Myeloma|stage iii multiple myeloma
854064|NCT00075829|Refractory Plasma Cell Neoplasm|refractory plasma cell neoplasm
854065|NCT00075803|Myelodysplastic and Myeloproliferative Diseases|myelodysplastic and myeloproliferative diseases
854066|NCT00075777|recurrent Kaposi sarcoma|recurrent kaposi sarcoma
880768|NCT00036166|Anti-Fungal|anti-fungal
854067|NCT00075777|AIDS-related Kaposi sarcoma|aids-related kaposi sarcoma
854068|NCT00075764|stage IV breast cancer|stage iv breast cancer
854069|NCT00075764|recurrent breast cancer|recurrent breast cancer
854182|NCT00075270|ErbB2|erbb2
854070|NCT00075738|stage IV esophageal cancer|stage iv esophageal cancer
854071|NCT00075738|recurrent esophageal cancer|recurrent esophageal cancer
854072|NCT00075725|untreated childhood acute lymphoblastic leukemia|untreated childhood acute lymphoblastic leukemia
854073|NCT00075725|B-cell childhood acute lymphoblastic leukemia|b-cell childhood acute lymphoblastic leukemia
854074|NCT00075725|untreated adult acute lymphoblastic leukemia|untreated adult acute lymphoblastic leukemia
854075|NCT00075725|B-cell adult acute lymphoblastic leukemia|b-cell adult acute lymphoblastic leukemia
854076|NCT00075712|stage IV ovarian epithelial cancer|stage iv ovarian epithelial cancer
854077|NCT00075712|stage IIIA fallopian tube cancer|stage iiia fallopian tube cancer
854078|NCT00075712|stage IIIB fallopian tube cancer|stage iiib fallopian tube cancer
854079|NCT00075712|stage IIIC fallopian tube cancer|stage iiic fallopian tube cancer
854080|NCT00075712|stage IV fallopian tube cancer|stage iv fallopian tube cancer
854081|NCT00075712|stage IIIA primary peritoneal cavity cancer|stage iiia primary peritoneal cavity cancer
854082|NCT00075712|stage IIIB primary peritoneal cavity cancer|stage iiib primary peritoneal cavity cancer
854083|NCT00075712|stage IIIC primary peritoneal cavity cancer|stage iiic primary peritoneal cavity cancer
854084|NCT00075712|stage IV primary peritoneal cavity cancer|stage iv primary peritoneal cavity cancer
854085|NCT00075712|stage IIIA ovarian epithelial cancer|stage iiia ovarian epithelial cancer
854086|NCT00075712|stage IIIB ovarian epithelial cancer|stage iiib ovarian epithelial cancer
854087|NCT00075712|stage IIIC ovarian epithelial cancer|stage iiic ovarian epithelial cancer
854088|NCT00075699|epithelial mesothelioma|epithelial mesothelioma
854089|NCT00075699|localized malignant mesothelioma|localized malignant mesothelioma
854090|NCT00075699|advanced malignant mesothelioma|advanced malignant mesothelioma
854091|NCT00075686|adenocarcinoma of the pancreas|adenocarcinoma of the pancreas
854092|NCT00075686|stage III pancreatic cancer|stage iii pancreatic cancer
854093|NCT00075686|stage IV pancreatic cancer|stage iv pancreatic cancer
854094|NCT00075920|Heart|heart
854095|NCT00075920|Function|function
854096|NCT00075920|Ultrasound|ultrasound
854097|NCT00075920|MRI|mri
854098|NCT00075920|Left Ventricle|left ventricle
854099|NCT00075920|Healthy Volunteer|healthy volunteer
854100|NCT00075920|HV|hv
854101|NCT00075920|Heart Disease|heart disease
854102|NCT00075673|recurrent breast cancer|recurrent breast cancer
854103|NCT00075673|stage IV breast cancer|stage iv breast cancer
854104|NCT00075660|recurrent renal cell cancer|recurrent renal cell cancer
854105|NCT00075660|stage III renal cell cancer|stage iii renal cell cancer
854106|NCT00075660|stage IV renal cell cancer|stage iv renal cell cancer
854107|NCT00075621|primary systemic amyloidosis|primary systemic amyloidosis
854108|NCT00075608|primary systemic amyloidosis|primary systemic amyloidosis
854109|NCT00075595|stage IV colon cancer|stage iv colon cancer
854110|NCT00075595|stage IV rectal cancer|stage iv rectal cancer
854111|NCT00075595|recurrent colon cancer|recurrent colon cancer
854112|NCT00075595|recurrent rectal cancer|recurrent rectal cancer
854113|NCT00075595|adenocarcinoma of the colon|adenocarcinoma of the colon
854114|NCT00075595|adenocarcinoma of the rectum|adenocarcinoma of the rectum
854115|NCT00075569|cervical cancer|cervical cancer
854116|NCT00075569|cervical intraepithelial neoplasia grade 3|cervical intraepithelial neoplasia grade 3
854117|NCT00075556|stage III colon cancer|stage iii colon cancer
854118|NCT00075556|stage IV colon cancer|stage iv colon cancer
854119|NCT00075556|stage III rectal cancer|stage iii rectal cancer
854120|NCT00075556|stage IV rectal cancer|stage iv rectal cancer
854121|NCT00075556|adenocarcinoma of the rectum|adenocarcinoma of the rectum
854122|NCT00075556|adenocarcinoma of the colon|adenocarcinoma of the colon
854123|NCT00075543|recurrent ovarian epithelial cancer|recurrent ovarian epithelial cancer
854124|NCT00075543|stage III ovarian epithelial cancer|stage iii ovarian epithelial cancer
854125|NCT00075543|stage IV ovarian epithelial cancer|stage iv ovarian epithelial cancer
854126|NCT00075517|stage IIIB non-small cell lung cancer|stage iiib non-small cell lung cancer
854127|NCT00075517|stage IV non-small cell lung cancer|stage iv non-small cell lung cancer
854128|NCT00075517|adenocarcinoma of the lung|adenocarcinoma of the lung
854129|NCT00075517|large cell lung cancer|large cell lung cancer
854130|NCT00075517|squamous cell lung cancer|squamous cell lung cancer
854131|NCT00075465|adenocarcinoma of the stomach|adenocarcinoma of the stomach
854132|NCT00075465|stage III gastric cancer|stage iii gastric cancer
854133|NCT00075465|stage IV gastric cancer|stage iv gastric cancer
854134|NCT00075452|adenocarcinoma of the pancreas|adenocarcinoma of the pancreas
854135|NCT00075452|stage II pancreatic cancer|stage ii pancreatic cancer
854136|NCT00075452|stage III pancreatic cancer|stage iii pancreatic cancer
854137|NCT00075452|stage IV pancreatic cancer|stage iv pancreatic cancer
854138|NCT00075426|stage IIIA non-small cell lung cancer|stage iiia non-small cell lung cancer
854728|NCT00073944|intraocular lymphoma|intraocular lymphoma
854139|NCT00075426|stage IIIB non-small cell lung cancer|stage iiib non-small cell lung cancer
854140|NCT00075426|stage IV non-small cell lung cancer|stage iv non-small cell lung cancer
854141|NCT00075426|recurrent non-small cell lung cancer|recurrent non-small cell lung cancer
854142|NCT00075413|stage IIIB breast cancer|stage iiib breast cancer
854143|NCT00075413|stage IIIC breast cancer|stage iiic breast cancer
854144|NCT00075413|stage IV breast cancer|stage iv breast cancer
854145|NCT00075413|recurrent breast cancer|recurrent breast cancer
854146|NCT00075413|stage IIIA breast cancer|stage iiia breast cancer
854147|NCT00075374|stage IIIB non-small cell lung cancer|stage iiib non-small cell lung cancer
854148|NCT00075374|stage IV non-small cell lung cancer|stage iv non-small cell lung cancer
854149|NCT00075374|recurrent non-small cell lung cancer|recurrent non-small cell lung cancer
854150|NCT00075348|renal cell carcinoma|renal cell carcinoma
854151|NCT00075348|von Hippel-Lindau syndrome|von hippel-lindau syndrome
854152|NCT00075335|Hematopoietic Stem Cells|hematopoietic stem cells
854153|NCT00075335|Mobilization|mobilization
854154|NCT00075335|Alloreactivity|alloreactivity
854155|NCT00075335|T Cell Polarization|t cell polarization
854156|NCT00075335|Dendritic Cells|dendritic cells
854157|NCT00075335|Plerixafor|plerixafor
854158|NCT00075335|Mozobil|mozobil
854159|NCT00075335|Healthy Volunteer (HV)|healthy volunteer (hv)
854160|NCT00075296|Major Depressive Disorder|major depressive disorder
854161|NCT00075296|Bipolar Disorder|bipolar disorder
854162|NCT00075296|Negative Feedback|negative feedback
854163|NCT00075296|Cognitive Performance|cognitive performance
854164|NCT00075296|Negative Affect|negative affect
854165|NCT00075296|Depression|depression
854166|NCT00075296|Major Depression|major depression
854167|NCT00075296|MDD|mdd
854168|NCT00075296|Healthy Volunteer|healthy volunteer
854169|NCT00075296|HV|hv
854170|NCT00075283|Physical Therapy|physical therapy
854171|NCT00075283|Locomotion therapy|locomotion therapy
854172|NCT00075283|Gait training|gait training
854173|NCT00075283|Stroke|stroke
854174|NCT00075283|Robotics|robotics
854175|NCT00075283|Rehabilitation|rehabilitation
854176|NCT00075283|Treadmill|treadmill
854177|NCT00075283|Hemiparetic stroke|hemiparetic stroke
854178|NCT00075283|Unilateral brain lesion|unilateral brain lesion
854179|NCT00075270|metastatic breast cancer|metastatic breast cancer
854180|NCT00075270|ErbB1|erbb1
854181|NCT00075270|kinase inhibitor|kinase inhibitor
854183|NCT00075270|EGFR|egfr
854184|NCT00075270|lapatinib|lapatinib
854185|NCT00075270|Her2-neu|her2-neu
854186|NCT00075231|Treatment Naive|treatment naive
854187|NCT00075153|ADOLESCENCE|adolescence
854188|NCT00075153|HIV INFECTION|hiv infection
854189|NCT00075153|PEDIATRIC AIDS|pediatric aids
854190|NCT00075153|QUALITY OF LIFE|quality of life
854191|NCT00075153|HIV|hiv
854192|NCT00020787|stage IV gastric cancer|stage iv gastric cancer
854193|NCT00020787|recurrent gastric cancer|recurrent gastric cancer
854194|NCT00020787|stage IV esophageal cancer|stage iv esophageal cancer
854195|NCT00020787|recurrent esophageal cancer|recurrent esophageal cancer
854196|NCT00020787|adenocarcinoma of the stomach|adenocarcinoma of the stomach
854197|NCT00020787|adenocarcinoma of the esophagus|adenocarcinoma of the esophagus
854198|NCT00017576|adenocarcinoma of the prostate|adenocarcinoma of the prostate
854199|NCT00017576|stage IV prostate cancer|stage iv prostate cancer
854200|NCT00017576|recurrent prostate cancer|recurrent prostate cancer
854201|NCT00017537|stage IV breast cancer|stage iv breast cancer
854202|NCT00017537|recurrent breast cancer|recurrent breast cancer
854203|NCT00017537|stage IV gastric cancer|stage iv gastric cancer
854204|NCT00017537|recurrent gastric cancer|recurrent gastric cancer
854205|NCT00017537|recurrent non-small cell lung cancer|recurrent non-small cell lung cancer
854206|NCT00017537|stage IV ovarian epithelial cancer|stage iv ovarian epithelial cancer
854207|NCT00017537|recurrent ovarian epithelial cancer|recurrent ovarian epithelial cancer
854208|NCT00017537|adenocarcinoma of the stomach|adenocarcinoma of the stomach
854209|NCT00017537|stage IV non-small cell lung cancer|stage iv non-small cell lung cancer
854210|NCT00017537|unspecified adult solid tumor, protocol specific|unspecified adult solid tumor, protocol specific
854211|NCT00017433|refractory multiple myeloma|refractory multiple myeloma
854212|NCT00017433|stage II multiple myeloma|stage ii multiple myeloma
854213|NCT00017433|stage III multiple myeloma|stage iii multiple myeloma
854214|NCT00075244|Lysosomes|lysosomes
854215|NCT00075244|Storage|storage
854216|NCT00075244|Glycolipid|glycolipid
854217|NCT00075244|Fabry Disease|fabry disease
854218|NCT00075244|Stroke|stroke
854219|NCT00017082|stage IV colon cancer|stage iv colon cancer
854220|NCT00017082|stage IV rectal cancer|stage iv rectal cancer
854221|NCT00017082|recurrent colon cancer|recurrent colon cancer
854222|NCT00017082|recurrent rectal cancer|recurrent rectal cancer
854223|NCT00017082|adenocarcinoma of the colon|adenocarcinoma of the colon
854224|NCT00017082|adenocarcinoma of the rectum|adenocarcinoma of the rectum
854225|NCT00016237|recurrent non-small cell lung cancer|recurrent non-small cell lung cancer
854226|NCT00016237|squamous cell lung cancer|squamous cell lung cancer
854227|NCT00016237|stage IV renal cell cancer|stage iv renal cell cancer
854228|NCT00016237|recurrent renal cell cancer|recurrent renal cell cancer
854229|NCT00016237|extensive stage small cell lung cancer|extensive stage small cell lung cancer
854230|NCT00016237|recurrent small cell lung cancer|recurrent small cell lung cancer
854231|NCT00016237|recurrent bladder cancer|recurrent bladder cancer
854232|NCT00016237|stage IV bladder cancer|stage iv bladder cancer
854233|NCT00016237|stage IV non-small cell lung cancer|stage iv non-small cell lung cancer
854234|NCT00016237|transitional cell carcinoma of the bladder|transitional cell carcinoma of the bladder
854235|NCT00016237|squamous cell carcinoma of the bladder|squamous cell carcinoma of the bladder
854236|NCT00016198|stage IV colon cancer|stage iv colon cancer
854237|NCT00016198|stage IV rectal cancer|stage iv rectal cancer
854238|NCT00016198|recurrent colon cancer|recurrent colon cancer
854239|NCT00016198|recurrent rectal cancer|recurrent rectal cancer
854240|NCT00016198|adenocarcinoma of the colon|adenocarcinoma of the colon
854241|NCT00016198|adenocarcinoma of the rectum|adenocarcinoma of the rectum
854242|NCT00014404|lip and oral cavity cancer|lip and oral cavity cancer
854243|NCT00014287|stage 0 bladder cancer|stage 0 bladder cancer
854244|NCT00014287|stage I bladder cancer|stage i bladder cancer
854245|NCT00014287|recurrent bladder cancer|recurrent bladder cancer
854246|NCT00075205|Alcohol Consumption|alcohol consumption
854247|NCT00075205|Alcohol Treatment|alcohol treatment
854248|NCT00075205|Medication Trial|medication trial
854250|NCT00075205|Cannabinoids|cannabinoids
854251|NCT00075205|CB 1 Receptor Antagonist|cb 1 receptor antagonist
854252|NCT00075205|SR141716|sr141716
854253|NCT00075205|Alcoholism|alcoholism
854254|NCT00075179|Pulmonary hypertension|pulmonary hypertension
854255|NCT00075179|cancer|cancer
854256|NCT00075179|lung cancer|lung cancer
854257|NCT00075179|lung disease|lung disease
854258|NCT00075179|cardiothoracic surgery|cardiothoracic surgery
854259|NCT00075179|Nesiritide|nesiritide
854260|NCT00075179|Natrecor|natrecor
854261|NCT00075179|CV Surgery|cv surgery
854262|NCT00075179|Lung Tumor|lung tumor
854263|NCT00075166|Stereotactic|stereotactic
854264|NCT00075166|Carcinoma|carcinoma
854265|NCT00075166|Melanoma|melanoma
854266|NCT00075166|Surgical Resection|surgical resection
854267|NCT00075166|Metastases|metastases
854268|NCT00075166|Metastatic Brain Tumor|metastatic brain tumor
854269|NCT00075166|Surgery|surgery
854270|NCT00075166|Radiosurgery|radiosurgery
854271|NCT00075166|Treatment|treatment
854272|NCT00075140|Patient Care Management|patient care management
854273|NCT00075140|Family|family
854274|NCT00075140|Huntington's Disease|huntington's disease
854275|NCT00075114|Self Care|self care
854276|NCT00075114|Behavior Modification|behavior modification
854277|NCT00075101|Drug Adverse Effect|drug adverse effect
854278|NCT00075101|Pediatric Cancer|pediatric cancer
854279|NCT00075088|Telemedicine|telemedicine
854280|NCT00075088|Emergency Care|emergency care
854281|NCT00075088|Cardiac|cardiac
854282|NCT00075075|Infliximab|infliximab
854283|NCT00075075|Scleritis|scleritis
854284|NCT00075075|Intraocular Inflammatory Disease|intraocular inflammatory disease
854285|NCT00075075|Corticosteroids|corticosteroids
854286|NCT00075075|Immunosuppressives|immunosuppressives
854287|NCT00075049|malaria|malaria
854288|NCT00014183|stage IV renal cell cancer|stage iv renal cell cancer
854289|NCT00014183|recurrent renal cell cancer|recurrent renal cell cancer
854290|NCT00012116|tumors metastatic to brain|tumors metastatic to brain
854291|NCT00009893|localized unresectable adult primary liver cancer|localized unresectable adult primary liver cancer
854292|NCT00009893|advanced adult primary liver cancer|advanced adult primary liver cancer
854293|NCT00009893|recurrent adult primary liver cancer|recurrent adult primary liver cancer
854294|NCT00009893|unresectable gallbladder cancer|unresectable gallbladder cancer
854295|NCT00009893|recurrent gallbladder cancer|recurrent gallbladder cancer
854296|NCT00009893|unresectable extrahepatic bile duct cancer|unresectable extrahepatic bile duct cancer
854297|NCT00009893|recurrent extrahepatic bile duct cancer|recurrent extrahepatic bile duct cancer
854298|NCT00075036|Health Disparities|health disparities
854299|NCT00075036|Transplantation|transplantation
854300|NCT00075036|Trust|trust
854301|NCT00075036|Interview|interview
854302|NCT00075036|Ethnic Bias|ethnic bias
854303|NCT00075023|Stomatitis|stomatitis
854304|NCT00075023|Oropharyngeal pain|oropharyngeal pain
854305|NCT00075023|TNF-alpha|tnf-alpha
854306|NCT00075023|Allogeneic hematopoietic stem cell transplant|allogeneic hematopoietic stem cell transplant
854307|NCT00075023|Inflammation|inflammation
854308|NCT00075023|Thalidomide|thalidomide
854309|NCT00075023|Oral chronic graft-versus-host disease|oral chronic graft-versus-host disease
854310|NCT00075010|Relapsed/Refractory Leukemia|relapsed/refractory leukemia
854311|NCT00075010|Myelodysplastic Syndromes|myelodysplastic syndromes
854312|NCT00074997|Gene Therapy|gene therapy
854313|NCT00074997|Anti-HIV-1 Ribozyme|anti-hiv-1 ribozyme
854314|NCT00074997|OZ1|oz1
854315|NCT00074997|HIV-1 Infections|hiv-1 infections
854316|NCT00009698|recurrent childhood acute myeloid leukemia|recurrent childhood acute myeloid leukemia
854317|NCT00009698|childhood acute myeloid leukemia in remission|childhood acute myeloid leukemia in remission
854318|NCT00009698|childhood acute myeloblastic leukemia without maturation (M1)|childhood acute myeloblastic leukemia without maturation (m1)
854319|NCT00009698|childhood acute myeloblastic leukemia with maturation (M2)|childhood acute myeloblastic leukemia with maturation (m2)
854320|NCT00006481|stage III squamous cell carcinoma of the lip and oral cavity|stage iii squamous cell carcinoma of the lip and oral cavity
854321|NCT00006481|stage IV squamous cell carcinoma of the lip and oral cavity|stage iv squamous cell carcinoma of the lip and oral cavity
854322|NCT00006481|stage III squamous cell carcinoma of the oropharynx|stage iii squamous cell carcinoma of the oropharynx
854323|NCT00006481|stage IV squamous cell carcinoma of the oropharynx|stage iv squamous cell carcinoma of the oropharynx
854324|NCT00006481|stage III squamous cell carcinoma of the hypopharynx|stage iii squamous cell carcinoma of the hypopharynx
854325|NCT00006481|stage IV squamous cell carcinoma of the hypopharynx|stage iv squamous cell carcinoma of the hypopharynx
854326|NCT00006481|stage III squamous cell carcinoma of the larynx|stage iii squamous cell carcinoma of the larynx
854327|NCT00006481|stage IV squamous cell carcinoma of the larynx|stage iv squamous cell carcinoma of the larynx
854328|NCT00006481|skin reactions secondary to radiation therapy|skin reactions secondary to radiation therapy
854329|NCT00006480|disseminated neuroblastoma|disseminated neuroblastoma
854330|NCT00006480|recurrent neuroblastoma|recurrent neuroblastoma
854331|NCT00074984|a-Galactosidase A|a-galactosidase a
854333|NCT00074984|r-haGAL|r-hagal
854334|NCT00074984|Fabry|fabry
854335|NCT00074984|GL-3|gl-3
854336|NCT00074984|Fabrazyme|fabrazyme
854337|NCT00074971|a-Galactosidase A|a-galactosidase a
854338|NCT00074971|aGAL|agal
854339|NCT00074971|r-haGAL|r-hagal
854340|NCT00074971|Fabry|fabry
854341|NCT00074971|GL-3|gl-3
854342|NCT00074971|Fabrazyme|fabrazyme
854343|NCT00074958|a-Galactosidase A|a-galactosidase a
854344|NCT00074958|aGal|agal
854345|NCT00074958|r-haGAL|r-hagal
854346|NCT00074958|Fabry|fabry
854347|NCT00074958|GL-3|gl-3
854348|NCT00074958|Fabrazyme|fabrazyme
854349|NCT00074932|Glycogen Storage Disease Type II|glycogen storage disease type ii
854350|NCT00074932|GSD-II|gsd-ii
854351|NCT00074932|Pompe Disease|pompe disease
854352|NCT00074932|Acid Maltase Deficiency Disease|acid maltase deficiency disease
854353|NCT00074919|Glycogen Storage Disease Type II|glycogen storage disease type ii
854354|NCT00074919|GSD-II|gsd-ii
854355|NCT00074919|Pompe Disease|pompe disease
854356|NCT00074919|Acid Maltase Deficiency Disease|acid maltase deficiency disease
854357|NCT00074906|Aspiration of gastric contents|aspiration of gastric contents
854358|NCT00074945|Obesity|obesity
854359|NCT00074945|Resting Energy Expenditure|resting energy expenditure
854360|NCT00074945|Metabolic Rate|metabolic rate
854361|NCT00074945|Visceral Fat|visceral fat
854362|NCT00074945|Body Fat Distribution|body fat distribution
854363|NCT00074893|Repetitive Strain Injuries|repetitive strain injuries
854364|NCT00074893|Vibration Damping|vibration damping
854365|NCT00074893|Protective Brace|protective brace
854366|NCT00074893|Piezoelectric|piezoelectric
854367|NCT00074893|SmartWear|smartwear
854368|NCT00074841|MALARIA|malaria
854369|NCT00074841|INDIA|india
854370|NCT00074841|CHLOROQUINE|chloroquine
854371|NCT00074841|PLASMODIUM FALCIPARUM|plasmodium falciparum
854372|NCT00074841|SULFADOXINE-PYRIMETHAMINE|sulfadoxine-pyrimethamine
854373|NCT00006384|stage IV renal cell cancer|stage iv renal cell cancer
854374|NCT00006384|recurrent renal cell cancer|recurrent renal cell cancer
854375|NCT00006353|adult glioblastoma|adult glioblastoma
854376|NCT00006353|adult giant cell glioblastoma|adult giant cell glioblastoma
854377|NCT00006353|adult gliosarcoma|adult gliosarcoma
854378|NCT00006247|childhood craniopharyngioma|childhood craniopharyngioma
854379|NCT00006247|childhood central nervous system germ cell tumor|childhood central nervous system germ cell tumor
854380|NCT00006247|childhood oligodendroglioma|childhood oligodendroglioma
854381|NCT00006247|childhood choroid plexus tumor|childhood choroid plexus tumor
854382|NCT00006247|childhood grade I meningioma|childhood grade i meningioma
854383|NCT00006247|childhood grade II meningioma|childhood grade ii meningioma
854384|NCT00006247|childhood grade III meningioma|childhood grade iii meningioma
854385|NCT00006247|recurrent childhood cerebellar astrocytoma|recurrent childhood cerebellar astrocytoma
854386|NCT00006247|recurrent childhood cerebral astrocytoma|recurrent childhood cerebral astrocytoma
854387|NCT00006247|recurrent childhood medulloblastoma|recurrent childhood medulloblastoma
854388|NCT00006247|recurrent childhood visual pathway and hypothalamic glioma|recurrent childhood visual pathway and hypothalamic glioma
854389|NCT00006247|recurrent childhood ependymoma|recurrent childhood ependymoma
854390|NCT00006104|stage IV breast cancer|stage iv breast cancer
854391|NCT00006104|recurrent breast cancer|recurrent breast cancer
854392|NCT00074880|Cardiac Hypertrophy|cardiac hypertrophy
854393|NCT00074880|Diastolic Dysfunction|diastolic dysfunction
854394|NCT00074880|Cardiac Glycosides|cardiac glycosides
854395|NCT00074880|Cardiac Fibrosis|cardiac fibrosis
854396|NCT00074880|Atrial Systole|atrial systole
854397|NCT00074828|elective|elective
854398|NCT00074828|primary unilateral|primary unilateral
854399|NCT00074763|Leukemia|leukemia
854400|NCT00074763|Lymphoma|lymphoma
854401|NCT00074763|ALL|all
854402|NCT00074763|CLL|cll
854403|NCT00074763|AML|aml
854404|NCT00074763|CML|cml
854405|NCT00074763|MDS|mds
854406|NCT00074763|Remission|remission
854407|NCT00074763|Hematologic Disorder|hematologic disorder
854408|NCT00074763|Transfusion|transfusion
854409|NCT00074763|Thrombosol|thrombosol
854410|NCT00074763|Autologous Platelet Transfusion|autologous platelet transfusion
854412|NCT00074763|Single donor platelet apheresis|single donor platelet apheresis
854413|NCT00074763|Cryopreservation|cryopreservation
854414|NCT00074763|Thrombocytopenia|thrombocytopenia
854415|NCT00074750|AML|aml
854416|NCT00074750|CMML|cmml
854843|NCT00004261|stage IV breast cancer|stage iv breast cancer
854417|NCT00074737|Refractory or Relapsed Acute Myelogenous Leukemia (AML)|refractory or relapsed acute myelogenous leukemia (aml)
854419|NCT00006099|ovarian epithelial cancer|ovarian epithelial cancer
854420|NCT00006087|non-small cell lung cancer|non-small cell lung cancer
854421|NCT00006087|small cell lung cancer|small cell lung cancer
854422|NCT00006080|recurrent adult brain tumor|recurrent adult brain tumor
854423|NCT00006080|adult anaplastic astrocytoma|adult anaplastic astrocytoma
854424|NCT00006080|adult anaplastic oligodendroglioma|adult anaplastic oligodendroglioma
854425|NCT00006080|adult mixed glioma|adult mixed glioma
854426|NCT00005978|localized resectable neuroblastoma|localized resectable neuroblastoma
854427|NCT00005978|regional neuroblastoma|regional neuroblastoma
854428|NCT00005978|disseminated neuroblastoma|disseminated neuroblastoma
854429|NCT00005978|stage 4S neuroblastoma|stage 4s neuroblastoma
854430|NCT00005978|recurrent neuroblastoma|recurrent neuroblastoma
854431|NCT00005978|localized unresectable neuroblastoma|localized unresectable neuroblastoma
854432|NCT00005963|stage IV breast cancer|stage iv breast cancer
854433|NCT00005963|recurrent breast cancer|recurrent breast cancer
854434|NCT00074815|Child|child
854435|NCT00074815|Adolescent|adolescent
854436|NCT00074802|Social Phobia|social phobia
854437|NCT00074789|Early Head Start Program|early head start program
854438|NCT00074776|Bipolar Depression|bipolar depression
854439|NCT00074711|Bone Mineral Density|bone mineral density
854440|NCT00074711|Calcium|calcium
854441|NCT00074698|Idiopathic pulmonary fibrosis|idiopathic pulmonary fibrosis
854442|NCT00074698|IPF|ipf
854443|NCT00074698|Pulmonary fibrosis|pulmonary fibrosis
854444|NCT00074698|Respiratory disease|respiratory disease
854445|NCT00074685|Congenital|congenital
854446|NCT00074685|Epidermal nevus|epidermal nevus
854447|NCT00074685|Erythroderma|erythroderma
854448|NCT00074685|Darier|darier
854449|NCT00074685|Hailey-Hailey|hailey-hailey
854450|NCT00074685|Harlequin|harlequin
854451|NCT00074685|Ichthyosiform|ichthyosiform
854452|NCT00074685|Ichthyosiform erythroderma|ichthyosiform erythroderma
854453|NCT00074685|Keratoderma|keratoderma
854454|NCT00074685|Keratosis|keratosis
854455|NCT00074685|Pachyonychia|pachyonychia
854456|NCT00074685|Sjogren-Larsson|sjogren-larsson
854457|NCT00074646|CC-8490|cc-8490
854458|NCT00074646|CC8490|cc8490
854459|NCT00074646|Glio|glio
854460|NCT00074646|Glioblastoma|glioblastoma
854461|NCT00074646|Malignant Gliomas|malignant gliomas
854462|NCT00074633|Type 2 Diabetes|type 2 diabetes
854463|NCT00074633|Self-Esteem|self-esteem
854464|NCT00074620|Haemodialysis|haemodialysis
854465|NCT00074620|PEG-Hirudin|peg-hirudin
854466|NCT00074620|Vascular graft occlusion|vascular graft occlusion
854467|NCT00074620|Renal replacement therapy|renal replacement therapy
854468|NCT00074620|Hemodialysis|hemodialysis
854469|NCT00074672|Prepulse Inhibition|prepulse inhibition
854470|NCT00074672|PPI|ppi
854471|NCT00074672|Dopamine|dopamine
854472|NCT00074672|Sensorimotor Integration|sensorimotor integration
854473|NCT00074672|Dopaminergic|dopaminergic
854474|NCT00074607|Neoplastic meningitis|neoplastic meningitis
854475|NCT00074581|HIV Infections|hiv infections
854476|NCT00074581|HIV Seronegativity|hiv seronegativity
854477|NCT00074568|Genetic Study|genetic study
854478|NCT00074568|Transmission Dysequilibrium Testing|transmission dysequilibrium testing
854479|NCT00074568|Genome Wide Scan|genome wide scan
854480|NCT00074568|Family Study|family study
854481|NCT00074555|African American, Rheumatoid Arthritis|african american, rheumatoid arthritis
854482|NCT00005959|stage III grade 3 follicular lymphoma|stage iii grade 3 follicular lymphoma
854483|NCT00005959|stage III adult diffuse small cleaved cell lymphoma|stage iii adult diffuse small cleaved cell lymphoma
854484|NCT00005959|stage III adult diffuse mixed cell lymphoma|stage iii adult diffuse mixed cell lymphoma
854485|NCT00005959|stage III adult diffuse large cell lymphoma|stage iii adult diffuse large cell lymphoma
854486|NCT00005959|stage III adult immunoblastic large cell lymphoma|stage iii adult immunoblastic large cell lymphoma
854487|NCT00005959|stage III adult Burkitt lymphoma|stage iii adult burkitt lymphoma
854488|NCT00005959|stage IV grade 3 follicular lymphoma|stage iv grade 3 follicular lymphoma
854489|NCT00005959|stage IV adult diffuse small cleaved cell lymphoma|stage iv adult diffuse small cleaved cell lymphoma
854490|NCT00005959|stage IV adult diffuse mixed cell lymphoma|stage iv adult diffuse mixed cell lymphoma
854491|NCT00005959|stage IV adult diffuse large cell lymphoma|stage iv adult diffuse large cell lymphoma
854492|NCT00005959|stage IV adult immunoblastic large cell lymphoma|stage iv adult immunoblastic large cell lymphoma
854493|NCT00005959|stage IV adult Burkitt lymphoma|stage iv adult burkitt lymphoma
854494|NCT00005959|contiguous stage II grade 3 follicular lymphoma|contiguous stage ii grade 3 follicular lymphoma
854495|NCT00005959|contiguous stage II adult diffuse small cleaved cell lymphoma|contiguous stage ii adult diffuse small cleaved cell lymphoma
854496|NCT00005959|contiguous stage II adult diffuse mixed cell lymphoma|contiguous stage ii adult diffuse mixed cell lymphoma
854497|NCT00005959|contiguous stage II adult immunoblastic large cell lymphoma|contiguous stage ii adult immunoblastic large cell lymphoma
854498|NCT00005959|contiguous stage II adult diffuse large cell lymphoma|contiguous stage ii adult diffuse large cell lymphoma
854499|NCT00005959|contiguous stage II adult Burkitt lymphoma|contiguous stage ii adult burkitt lymphoma
854500|NCT00005959|noncontiguous stage II grade 3 follicular lymphoma|noncontiguous stage ii grade 3 follicular lymphoma
854501|NCT00005959|noncontiguous stage II adult diffuse small cleaved cell lymphoma|noncontiguous stage ii adult diffuse small cleaved cell lymphoma
854502|NCT00005959|noncontiguous stage II adult diffuse mixed cell lymphoma|noncontiguous stage ii adult diffuse mixed cell lymphoma
854503|NCT00005959|noncontiguous stage II adult immunoblastic large cell lymphoma|noncontiguous stage ii adult immunoblastic large cell lymphoma
854504|NCT00005959|noncontiguous stage II adult diffuse large cell lymphoma|noncontiguous stage ii adult diffuse large cell lymphoma
854505|NCT00005959|noncontiguous stage II adult Burkitt lymphoma|noncontiguous stage ii adult burkitt lymphoma
854506|NCT00005876|stage III gastric cancer|stage iii gastric cancer
854507|NCT00005876|stage IV gastric cancer|stage iv gastric cancer
854508|NCT00005876|recurrent gastric cancer|recurrent gastric cancer
854509|NCT00005876|stage III esophageal cancer|stage iii esophageal cancer
854510|NCT00005876|stage IV esophageal cancer|stage iv esophageal cancer
854511|NCT00005876|recurrent esophageal cancer|recurrent esophageal cancer
854512|NCT00005876|adenocarcinoma of the stomach|adenocarcinoma of the stomach
854513|NCT00005876|adenocarcinoma of the esophagus|adenocarcinoma of the esophagus
854514|NCT00005646|extensive stage small cell lung cancer|extensive stage small cell lung cancer
854515|NCT00005642|unspecified adult solid tumor, protocol specific|unspecified adult solid tumor, protocol specific
854516|NCT00005634|recurrent adult Hodgkin lymphoma|recurrent adult hodgkin lymphoma
854517|NCT00005634|recurrent cutaneous T-cell non-Hodgkin lymphoma|recurrent cutaneous t-cell non-hodgkin lymphoma
854518|NCT00005634|isolated plasmacytoma of bone|isolated plasmacytoma of bone
854519|NCT00005634|extramedullary plasmacytoma|extramedullary plasmacytoma
854520|NCT00005634|refractory multiple myeloma|refractory multiple myeloma
854521|NCT00005634|recurrent adult acute myeloid leukemia|recurrent adult acute myeloid leukemia
854522|NCT00005634|recurrent adult acute lymphoblastic leukemia|recurrent adult acute lymphoblastic leukemia
854523|NCT00005634|relapsing chronic myelogenous leukemia|relapsing chronic myelogenous leukemia
854524|NCT00005634|refractory chronic lymphocytic leukemia|refractory chronic lymphocytic leukemia
854525|NCT00005634|small intestine lymphoma|small intestine lymphoma
854526|NCT00005634|recurrent prostate cancer|recurrent prostate cancer
854527|NCT00005634|unspecified adult solid tumor, protocol specific|unspecified adult solid tumor, protocol specific
854528|NCT00005634|chronic phase chronic myelogenous leukemia|chronic phase chronic myelogenous leukemia
854529|NCT00005634|refractory hairy cell leukemia|refractory hairy cell leukemia
854530|NCT00005634|chronic myelomonocytic leukemia|chronic myelomonocytic leukemia
854531|NCT00005634|recurrent grade 1 follicular lymphoma|recurrent grade 1 follicular lymphoma
854532|NCT00005634|recurrent grade 2 follicular lymphoma|recurrent grade 2 follicular lymphoma
854533|NCT00005634|recurrent grade 3 follicular lymphoma|recurrent grade 3 follicular lymphoma
854534|NCT00005634|recurrent adult diffuse small cleaved cell lymphoma|recurrent adult diffuse small cleaved cell lymphoma
854535|NCT00005634|recurrent adult diffuse mixed cell lymphoma|recurrent adult diffuse mixed cell lymphoma
854536|NCT00005634|recurrent adult diffuse large cell lymphoma|recurrent adult diffuse large cell lymphoma
854537|NCT00005634|recurrent adult immunoblastic large cell lymphoma|recurrent adult immunoblastic large cell lymphoma
854538|NCT00005634|recurrent adult lymphoblastic lymphoma|recurrent adult lymphoblastic lymphoma
854539|NCT00005634|recurrent adult Burkitt lymphoma|recurrent adult burkitt lymphoma
854540|NCT00005634|recurrent adult T-cell leukemia/lymphoma|recurrent adult t-cell leukemia/lymphoma
854541|NCT00005634|secondary acute myeloid leukemia|secondary acute myeloid leukemia
854542|NCT00005634|recurrent mantle cell lymphoma|recurrent mantle cell lymphoma
854543|NCT00005634|recurrent mycosis fungoides/Sezary syndrome|recurrent mycosis fungoides/sezary syndrome
854544|NCT00005634|recurrent marginal zone lymphoma|recurrent marginal zone lymphoma
854545|NCT00005634|recurrent small lymphocytic lymphoma|recurrent small lymphocytic lymphoma
854546|NCT00005634|extranodal marginal zone B-cell lymphoma of mucosa-associated lymphoid tissue|extranodal marginal zone b-cell lymphoma of mucosa-associated lymphoid tissue
854547|NCT00005634|nodal marginal zone B-cell lymphoma|nodal marginal zone b-cell lymphoma
854548|NCT00005634|splenic marginal zone lymphoma|splenic marginal zone lymphoma
854549|NCT00074542|Crohn's|crohn's
854550|NCT00074542|colon|colon
854551|NCT00074542|small bowel|small bowel
854552|NCT00074542|inflammation|inflammation
854553|NCT00074542|steroid therapy|steroid therapy
854554|NCT00074542|free fatty acids|free fatty acids
854555|NCT00005598|refractory anemia|refractory anemia
854556|NCT00005598|de novo myelodysplastic syndromes|de novo myelodysplastic syndromes
854557|NCT00005598|previously treated myelodysplastic syndromes|previously treated myelodysplastic syndromes
854558|NCT00005598|secondary myelodysplastic syndromes|secondary myelodysplastic syndromes
854559|NCT00005592|recurrent grade 1 follicular lymphoma|recurrent grade 1 follicular lymphoma
854560|NCT00005592|recurrent grade 2 follicular lymphoma|recurrent grade 2 follicular lymphoma
854561|NCT00005592|recurrent grade 3 follicular lymphoma|recurrent grade 3 follicular lymphoma
854562|NCT00005592|recurrent adult diffuse small cleaved cell lymphoma|recurrent adult diffuse small cleaved cell lymphoma
854563|NCT00005592|recurrent marginal zone lymphoma|recurrent marginal zone lymphoma
854564|NCT00005592|recurrent small lymphocytic lymphoma|recurrent small lymphocytic lymphoma
854565|NCT00005592|extranodal marginal zone B-cell lymphoma of mucosa-associated lymphoid tissue|extranodal marginal zone b-cell lymphoma of mucosa-associated lymphoid tissue
854566|NCT00005592|nodal marginal zone B-cell lymphoma|nodal marginal zone b-cell lymphoma
854567|NCT00005592|splenic marginal zone lymphoma|splenic marginal zone lymphoma
854568|NCT00005083|adult glioblastoma|adult glioblastoma
854569|NCT00005083|adult anaplastic astrocytoma|adult anaplastic astrocytoma
881086|NCT00034710|shingles|shingles
854570|NCT00005083|adult myxopapillary ependymoma|adult myxopapillary ependymoma
854571|NCT00005083|adult anaplastic ependymoma|adult anaplastic ependymoma
854572|NCT00005083|adult anaplastic oligodendroglioma|adult anaplastic oligodendroglioma
854573|NCT00005083|adult mixed glioma|adult mixed glioma
854574|NCT00005083|adult pilocytic astrocytoma|adult pilocytic astrocytoma
854575|NCT00005083|adult subependymoma|adult subependymoma
854576|NCT00005083|adult ependymoblastoma|adult ependymoblastoma
854577|NCT00005083|adult oligodendroglioma|adult oligodendroglioma
854578|NCT00005083|adult giant cell glioblastoma|adult giant cell glioblastoma
854579|NCT00005083|adult gliosarcoma|adult gliosarcoma
854580|NCT00004890|stage I renal cell cancer|stage i renal cell cancer
854581|NCT00004890|stage II renal cell cancer|stage ii renal cell cancer
854582|NCT00004890|stage III renal cell cancer|stage iii renal cell cancer
854583|NCT00004890|stage IV renal cell cancer|stage iv renal cell cancer
854584|NCT00004890|recurrent renal cell cancer|recurrent renal cell cancer
854585|NCT00004890|drug extravasation|drug extravasation
854586|NCT00004874|recurrent grade 1 follicular lymphoma|recurrent grade 1 follicular lymphoma
854587|NCT00004874|recurrent grade 2 follicular lymphoma|recurrent grade 2 follicular lymphoma
854588|NCT00004874|recurrent small lymphocytic lymphoma|recurrent small lymphocytic lymphoma
854589|NCT00074516|Immunosuppression|immunosuppression
854590|NCT00074516|Kidney|kidney
854591|NCT00074516|Cysteamine|cysteamine
854592|NCT00074516|Steroid-Free|steroid-free
854593|NCT00074516|Outcomes|outcomes
854594|NCT00074503|Positron Emission Tomography|positron emission tomography
854595|NCT00074503|Phospholipids|phospholipids
854596|NCT00074503|Alcoholism|alcoholism
854597|NCT00074503|[11C]Docosahexaenoate|[11c]docosahexaenoate
854598|NCT00074503|[150]Water|[150]water
854599|NCT00074503|Brain|brain
854600|NCT00074503|Fatty Acids|fatty acids
854601|NCT00074503|Blood Flow|blood flow
854602|NCT00074503|Healthy|healthy
854603|NCT00074490|Leukemia|leukemia
854604|NCT00074490|Lymphoma|lymphoma
854605|NCT00074490|Multiple Myeloma|multiple myeloma
854606|NCT00074490|Bone Marrow Transplantation|bone marrow transplantation
854607|NCT00074490|Immune Therapy|immune therapy
854608|NCT00074477|Schizophrenia|schizophrenia
854609|NCT00074477|Paliperidone palmitate|paliperidone palmitate
854610|NCT00074477|R092670|r092670
854611|NCT00074477|antipsychotic|antipsychotic
854612|NCT00074438|Rituxan|rituxan
854613|NCT00074438|RA|ra
854614|NCT00074425|HIV Seronegativity|hiv seronegativity
854615|NCT00074425|Anti-Infective Agents, Local|anti-infective agents, local
854616|NCT00074425|BufferGel|buffergel
854617|NCT00074425|PRO 2000|pro 2000
854618|NCT00074425|Vagina|vagina
854619|NCT00074425|Risk Factors|risk factors
854620|NCT00074412|HIV Seronegativity|hiv seronegativity
854621|NCT00074412|Treatment Experienced|treatment experienced
854622|NCT00074412|Treatment Naive|treatment naive
854623|NCT00074399|Maternal/Infant Transmisson|maternal/infant transmisson
854624|NCT00074399|Vertical Transmission|vertical transmission
854625|NCT00074399|Pregnancy|pregnancy
854626|NCT00074399|HIV Seronegativity|hiv seronegativity
854627|NCT00074386|HIV|hiv
854628|NCT00074386|Transplant|transplant
854629|NCT00074386|Liver|liver
854630|NCT00074386|Kidney|kidney
854631|NCT00074386|Organ|organ
854632|NCT00074386|Treatment Experienced|treatment experienced
854633|NCT00074386|Kidney Transplant|kidney transplant
854634|NCT00074386|Liver Transplant|liver transplant
854635|NCT00074373|Anti-SSA/Ro Antibodies|anti-ssa/ro antibodies
854636|NCT00074373|Anti-SSB/La Antibodies|anti-ssb/la antibodies
854637|NCT00021983|refractory hairy cell leukemia|refractory hairy cell leukemia
854638|NCT00074360|Ethanol|ethanol
854639|NCT00074360|fMRI|fmri
854640|NCT00074360|Blood Flow|blood flow
854641|NCT00074360|Conditioning|conditioning
854642|NCT00074360|Reinforcement|reinforcement
854643|NCT00074334|childhood high-grade cerebral astrocytoma|childhood high-grade cerebral astrocytoma
854644|NCT00074334|recurrent childhood cerebral astrocytoma|recurrent childhood cerebral astrocytoma
854645|NCT00074334|childhood oligodendroglioma|childhood oligodendroglioma
854646|NCT00074334|childhood supratentorial ependymoma|childhood supratentorial ependymoma
854647|NCT00074334|recurrent childhood ependymoma|recurrent childhood ependymoma
854648|NCT00074334|recurrent childhood brain tumor|recurrent childhood brain tumor
854649|NCT00074295|bronchoalveolar cell lung cancer|bronchoalveolar cell lung cancer
854650|NCT00074295|stage IIIB non-small cell lung cancer|stage iiib non-small cell lung cancer
854651|NCT00074295|stage IV non-small cell lung cancer|stage iv non-small cell lung cancer
854652|NCT00074295|recurrent non-small cell lung cancer|recurrent non-small cell lung cancer
854948|NCT00073801|Healthy Volunteers|healthy volunteers
854653|NCT00074282|refractory chronic lymphocytic leukemia|refractory chronic lymphocytic leukemia
854654|NCT00074282|B-cell chronic lymphocytic leukemia|b-cell chronic lymphocytic leukemia
854655|NCT00074269|recurrent breast cancer|recurrent breast cancer
854656|NCT00074269|stage IV breast cancer|stage iv breast cancer
854657|NCT00074243|adult anaplastic astrocytoma|adult anaplastic astrocytoma
854658|NCT00074243|adult anaplastic oligodendroglioma|adult anaplastic oligodendroglioma
854659|NCT00074243|adult glioblastoma|adult glioblastoma
854660|NCT00074243|adult mixed glioma|adult mixed glioma
881087|NCT00034710|varicella|varicella
854661|NCT00074243|adult brain stem glioma|adult brain stem glioma
854662|NCT00074243|recurrent adult brain tumor|recurrent adult brain tumor
854663|NCT00074243|adult giant cell glioblastoma|adult giant cell glioblastoma
854664|NCT00074243|adult gliosarcoma|adult gliosarcoma
854665|NCT00074230|stage IV melanoma|stage iv melanoma
854666|NCT00074230|recurrent melanoma|recurrent melanoma
854667|NCT00074204|stage IIIB non-small cell lung cancer|stage iiib non-small cell lung cancer
854668|NCT00074204|stage IV non-small cell lung cancer|stage iv non-small cell lung cancer
854669|NCT00074204|recurrent non-small cell lung cancer|recurrent non-small cell lung cancer
854670|NCT00074191|intraocular lymphoma|intraocular lymphoma
854671|NCT00074191|primary central nervous system lymphoma|primary central nervous system lymphoma
854672|NCT00074178|primary central nervous system lymphoma|primary central nervous system lymphoma
854673|NCT00074178|intraocular lymphoma|intraocular lymphoma
854674|NCT00074165|drug/agent toxicity by tissue/organ|drug/agent toxicity by tissue/organ
854675|NCT00074165|thrombocytopenia|thrombocytopenia
854676|NCT00074165|intraocular lymphoma|intraocular lymphoma
854677|NCT00074165|primary central nervous system non-Hodgkin lymphoma|primary central nervous system non-hodgkin lymphoma
854678|NCT00074165|primary central nervous system Hodgkin lymphoma|primary central nervous system hodgkin lymphoma
854679|NCT00074152|recurrent breast cancer|recurrent breast cancer
854680|NCT00074152|stage I breast cancer|stage i breast cancer
854681|NCT00074152|stage II breast cancer|stage ii breast cancer
854682|NCT00074152|stage IIIA breast cancer|stage iiia breast cancer
854683|NCT00074152|stage IIIB breast cancer|stage iiib breast cancer
854684|NCT00074152|stage IIIC breast cancer|stage iiic breast cancer
854685|NCT00074139|stage IIIA breast cancer|stage iiia breast cancer
854686|NCT00074139|recurrent breast cancer|recurrent breast cancer
854687|NCT00074139|stage IIIB breast cancer|stage iiib breast cancer
854688|NCT00074139|stage IIIC breast cancer|stage iiic breast cancer
854689|NCT00074139|stage IV breast cancer|stage iv breast cancer
854690|NCT00074100|stage IV breast cancer|stage iv breast cancer
854691|NCT00074100|recurrent breast cancer|recurrent breast cancer
854692|NCT00074087|stage II mycosis fungoides/Sezary syndrome|stage ii mycosis fungoides/sezary syndrome
854693|NCT00074087|stage IV mycosis fungoides/Sezary syndrome|stage iv mycosis fungoides/sezary syndrome
854694|NCT00074087|recurrent mycosis fungoides/Sezary syndrome|recurrent mycosis fungoides/sezary syndrome
854695|NCT00074087|stage IV cutaneous T-cell non-Hodgkin lymphoma|stage iv cutaneous t-cell non-hodgkin lymphoma
854696|NCT00074087|stage II cutaneous T-cell non-Hodgkin lymphoma|stage ii cutaneous t-cell non-hodgkin lymphoma
854697|NCT00074087|recurrent cutaneous T-cell non-Hodgkin lymphoma|recurrent cutaneous t-cell non-hodgkin lymphoma
854698|NCT00074074|refractory anemia with excess blasts|refractory anemia with excess blasts
854699|NCT00074074|refractory anemia with ringed sideroblasts|refractory anemia with ringed sideroblasts
854700|NCT00074074|refractory anemia|refractory anemia
854701|NCT00074074|de novo myelodysplastic syndromes|de novo myelodysplastic syndromes
854702|NCT00074074|secondary myelodysplastic syndromes|secondary myelodysplastic syndromes
854703|NCT00074074|previously treated myelodysplastic syndromes|previously treated myelodysplastic syndromes
854704|NCT00074048|refractory hairy cell leukemia|refractory hairy cell leukemia
854705|NCT00074009|recurrent gastric cancer|recurrent gastric cancer
854706|NCT00074009|stage III gastric cancer|stage iii gastric cancer
854707|NCT00074009|stage IV gastric cancer|stage iv gastric cancer
854708|NCT00074009|adenocarcinoma of the stomach|adenocarcinoma of the stomach
854709|NCT00073983|recurrent Ewing sarcoma/peripheral primitive neuroectodermal tumor|recurrent ewing sarcoma/peripheral primitive neuroectodermal tumor
854710|NCT00073983|chondrosarcoma|chondrosarcoma
854711|NCT00073983|recurrent osteosarcoma|recurrent osteosarcoma
854712|NCT00073970|recurrent prostate cancer|recurrent prostate cancer
854713|NCT00073970|stage I prostate cancer|stage i prostate cancer
854714|NCT00073970|stage II prostate cancer|stage ii prostate cancer
854715|NCT00073970|adenocarcinoma of the prostate|adenocarcinoma of the prostate
854716|NCT00073957|recurrent adult diffuse large cell lymphoma|recurrent adult diffuse large cell lymphoma
854717|NCT00073957|recurrent adult immunoblastic large cell lymphoma|recurrent adult immunoblastic large cell lymphoma
854718|NCT00073957|anaplastic large cell lymphoma|anaplastic large cell lymphoma
854719|NCT00073944|acute undifferentiated leukemia|acute undifferentiated leukemia
854720|NCT00073944|anaplastic large cell lymphoma|anaplastic large cell lymphoma
854721|NCT00073944|angioimmunoblastic T-cell lymphoma|angioimmunoblastic t-cell lymphoma
854722|NCT00073944|atypical chronic myeloid leukemia, BCR-ABL1 negative|atypical chronic myeloid leukemia, bcr-abl1 negative
854723|NCT00073944|chronic eosinophilic leukemia|chronic eosinophilic leukemia
854724|NCT00073944|primary myelofibrosis|primary myelofibrosis
854725|NCT00073944|chronic myelomonocytic leukemia|chronic myelomonocytic leukemia
854726|NCT00073944|chronic neutrophilic leukemia|chronic neutrophilic leukemia
854727|NCT00073944|essential thrombocythemia|essential thrombocythemia
854729|NCT00073944|myelodysplastic/myeloproliferative neoplasm, unclassifiable|myelodysplastic/myeloproliferative neoplasm, unclassifiable
854730|NCT00073944|polycythemia vera|polycythemia vera
854731|NCT00073944|previously treated myelodysplastic syndromes|previously treated myelodysplastic syndromes
854732|NCT00073944|primary central nervous system non-Hodgkin lymphoma|primary central nervous system non-hodgkin lymphoma
854733|NCT00073944|prolymphocytic leukemia|prolymphocytic leukemia
854734|NCT00073944|recurrent adult acute lymphoblastic leukemia|recurrent adult acute lymphoblastic leukemia
854735|NCT00073944|recurrent adult acute myeloid leukemia|recurrent adult acute myeloid leukemia
854736|NCT00073944|recurrent adult T-cell leukemia/lymphoma|recurrent adult t-cell leukemia/lymphoma
854737|NCT00073944|recurrent adult diffuse large cell lymphoma|recurrent adult diffuse large cell lymphoma
854738|NCT00073944|recurrent adult diffuse mixed cell lymphoma|recurrent adult diffuse mixed cell lymphoma
854739|NCT00073944|recurrent adult diffuse small cleaved cell lymphoma|recurrent adult diffuse small cleaved cell lymphoma
854740|NCT00073944|recurrent adult Burkitt lymphoma|recurrent adult burkitt lymphoma
854741|NCT00073944|recurrent adult Hodgkin lymphoma|recurrent adult hodgkin lymphoma
854742|NCT00073944|recurrent adult immunoblastic large cell lymphoma|recurrent adult immunoblastic large cell lymphoma
854743|NCT00073944|recurrent adult lymphoblastic lymphoma|recurrent adult lymphoblastic lymphoma
854744|NCT00073944|recurrent grade 1 follicular lymphoma|recurrent grade 1 follicular lymphoma
854745|NCT00073944|recurrent grade 2 follicular lymphoma|recurrent grade 2 follicular lymphoma
854746|NCT00073944|recurrent grade 3 follicular lymphoma|recurrent grade 3 follicular lymphoma
854747|NCT00073944|recurrent mantle cell lymphoma|recurrent mantle cell lymphoma
854748|NCT00073944|recurrent mycosis fungoides/Sezary syndrome|recurrent mycosis fungoides/sezary syndrome
854749|NCT00073944|refractory chronic lymphocytic leukemia|refractory chronic lymphocytic leukemia
854750|NCT00073944|refractory hairy cell leukemia|refractory hairy cell leukemia
854751|NCT00073944|refractory multiple myeloma|refractory multiple myeloma
854752|NCT00073944|relapsing chronic myelogenous leukemia|relapsing chronic myelogenous leukemia
854753|NCT00073944|secondary acute myeloid leukemia|secondary acute myeloid leukemia
854754|NCT00073944|secondary myelodysplastic syndromes|secondary myelodysplastic syndromes
854755|NCT00073944|Waldenström macroglobulinemia|waldenström macroglobulinemia
854756|NCT00073944|adenocarcinoma of the colon|adenocarcinoma of the colon
854757|NCT00073944|adenocarcinoma of the esophagus|adenocarcinoma of the esophagus
854758|NCT00073944|adenocarcinoma of the pancreas|adenocarcinoma of the pancreas
854759|NCT00073944|adenocarcinoma of the rectum|adenocarcinoma of the rectum
854760|NCT00073944|recurrent adult brain tumor|recurrent adult brain tumor
854761|NCT00073944|recurrent adult primary liver cancer|recurrent adult primary liver cancer
854762|NCT00073944|recurrent colon cancer|recurrent colon cancer
854763|NCT00073944|recurrent esophageal cancer|recurrent esophageal cancer
854764|NCT00073944|recurrent gastric cancer|recurrent gastric cancer
854765|NCT00073944|recurrent melanoma|recurrent melanoma
854766|NCT00073944|recurrent ovarian epithelial cancer|recurrent ovarian epithelial cancer
854767|NCT00073944|recurrent pancreatic cancer|recurrent pancreatic cancer
854768|NCT00073944|recurrent rectal cancer|recurrent rectal cancer
854769|NCT00073944|adenocarcinoma of the stomach|adenocarcinoma of the stomach
854770|NCT00073944|adult anaplastic astrocytoma|adult anaplastic astrocytoma
854771|NCT00073944|adult glioblastoma|adult glioblastoma
854772|NCT00073944|adult pilocytic astrocytoma|adult pilocytic astrocytoma
854773|NCT00073944|adult subependymoma|adult subependymoma
854774|NCT00073944|adenocarcinoma of the extrahepatic bile duct|adenocarcinoma of the extrahepatic bile duct
854775|NCT00073944|recurrent extrahepatic bile duct cancer|recurrent extrahepatic bile duct cancer
854776|NCT00073944|recurrent cutaneous T-cell non-Hodgkin lymphoma|recurrent cutaneous t-cell non-hodgkin lymphoma
854777|NCT00073944|de novo myelodysplastic syndromes|de novo myelodysplastic syndromes
854778|NCT00073944|recurrent marginal zone lymphoma|recurrent marginal zone lymphoma
854779|NCT00073944|recurrent small lymphocytic lymphoma|recurrent small lymphocytic lymphoma
854780|NCT00073944|extranodal marginal zone B-cell lymphoma of mucosa-associated lymphoid tissue|extranodal marginal zone b-cell lymphoma of mucosa-associated lymphoid tissue
854781|NCT00073944|nodal marginal zone B-cell lymphoma|nodal marginal zone b-cell lymphoma
854782|NCT00073944|splenic marginal zone lymphoma|splenic marginal zone lymphoma
854783|NCT00073944|adult acute myeloid leukemia with t(8;21)(q22;q22)|adult acute myeloid leukemia with t(8;21)(q22;q22)
854784|NCT00073944|adult acute myeloid leukemia with t(16;16)(p13;q22)|adult acute myeloid leukemia with t(16;16)(p13;q22)
854785|NCT00073944|adult acute myeloid leukemia with inv(16)(p13;q22)|adult acute myeloid leukemia with inv(16)(p13;q22)
854786|NCT00073944|adult acute myeloid leukemia with 11q23 (MLL) abnormalities|adult acute myeloid leukemia with 11q23 (mll) abnormalities
854787|NCT00073944|adult acute myeloid leukemia with t(15;17)(q22;q12)|adult acute myeloid leukemia with t(15;17)(q22;q12)
854788|NCT00073944|adult diffuse astrocytoma|adult diffuse astrocytoma
854789|NCT00073944|adult giant cell glioblastoma|adult giant cell glioblastoma
854790|NCT00073944|adult gliosarcoma|adult gliosarcoma
854791|NCT00073944|T-cell large granular lymphocyte leukemia|t-cell large granular lymphocyte leukemia
854792|NCT00073931|recurrent adult diffuse large cell lymphoma|recurrent adult diffuse large cell lymphoma
854793|NCT00073931|recurrent adult diffuse mixed cell lymphoma|recurrent adult diffuse mixed cell lymphoma
854794|NCT00073931|recurrent adult diffuse small cleaved cell lymphoma|recurrent adult diffuse small cleaved cell lymphoma
854795|NCT00073931|recurrent adult Burkitt lymphoma|recurrent adult burkitt lymphoma
854949|NCT00073801|Overlapping Pain Conditions|overlapping pain conditions
854796|NCT00073931|recurrent adult immunoblastic large cell lymphoma|recurrent adult immunoblastic large cell lymphoma
854797|NCT00073931|recurrent adult lymphoblastic lymphoma|recurrent adult lymphoblastic lymphoma
854798|NCT00073931|recurrent grade 1 follicular lymphoma|recurrent grade 1 follicular lymphoma
854799|NCT00073931|recurrent grade 2 follicular lymphoma|recurrent grade 2 follicular lymphoma
854800|NCT00073931|recurrent grade 3 follicular lymphoma|recurrent grade 3 follicular lymphoma
854801|NCT00073931|recurrent mantle cell lymphoma|recurrent mantle cell lymphoma
854802|NCT00073905|unresectable gallbladder cancer|unresectable gallbladder cancer
854803|NCT00073905|adenocarcinoma of the gallbladder|adenocarcinoma of the gallbladder
854804|NCT00073905|adenocarcinoma of the extrahepatic bile duct|adenocarcinoma of the extrahepatic bile duct
854805|NCT00073905|unresectable extrahepatic bile duct cancer|unresectable extrahepatic bile duct cancer
854806|NCT00073905|pain|pain
854807|NCT00073905|recurrent gallbladder cancer|recurrent gallbladder cancer
854808|NCT00073905|recurrent extrahepatic bile duct cancer|recurrent extrahepatic bile duct cancer
854809|NCT00073905|localized unresectable adult primary liver cancer|localized unresectable adult primary liver cancer
854810|NCT00073905|advanced adult primary liver cancer|advanced adult primary liver cancer
854811|NCT00073905|recurrent adult primary liver cancer|recurrent adult primary liver cancer
854812|NCT00073892|unspecified adult solid tumor, protocol specific|unspecified adult solid tumor, protocol specific
854813|NCT00073892|stage IV melanoma|stage iv melanoma
854814|NCT00073892|recurrent melanoma|recurrent melanoma
854815|NCT00073879|stage IV renal cell cancer|stage iv renal cell cancer
854816|NCT00073879|recurrent renal cell cancer|recurrent renal cell cancer
854817|NCT00073866|recurrent non-small cell lung cancer|recurrent non-small cell lung cancer
854818|NCT00073866|stage IIIB non-small cell lung cancer|stage iiib non-small cell lung cancer
854819|NCT00073866|stage IV non-small cell lung cancer|stage iv non-small cell lung cancer
854820|NCT00073853|paraplegia|paraplegia
854821|NCT00073853|quadraplegia|quadraplegia
854822|NCT00073853|tetraplegia|tetraplegia
854823|NCT00073853|paralysis|paralysis
854824|NCT00073853|nerve regeneration|nerve regeneration
854825|NCT00073853|Acute, Complete SCI|acute, complete sci
854826|NCT00073840|levalbuterol|levalbuterol
854827|NCT00073840|asthma|asthma
854828|NCT00073840|bronchoconstriction|bronchoconstriction
854829|NCT00073840|adolescent|adolescent
854830|NCT00073840|adult|adult
854831|NCT00073827|adolescent|adolescent
854832|NCT00073827|adult|adult
854833|NCT00073827|asthma|asthma
854834|NCT00073827|levalbuterol|levalbuterol
854835|NCT00073827|bronchoconstriction|bronchoconstriction
854836|NCT00004857|stage I chronic lymphocytic leukemia|stage i chronic lymphocytic leukemia
854837|NCT00004857|stage II chronic lymphocytic leukemia|stage ii chronic lymphocytic leukemia
854838|NCT00004857|stage III chronic lymphocytic leukemia|stage iii chronic lymphocytic leukemia
854839|NCT00004857|stage IV chronic lymphocytic leukemia|stage iv chronic lymphocytic leukemia
854840|NCT00004857|B-cell chronic lymphocytic leukemia|b-cell chronic lymphocytic leukemia
854841|NCT00004261|stage I breast cancer|stage i breast cancer
854842|NCT00004261|stage II breast cancer|stage ii breast cancer
854844|NCT00004261|stage IIIA breast cancer|stage iiia breast cancer
854845|NCT00004261|breast cancer in situ|breast cancer in situ
854846|NCT00004261|recurrent breast cancer|recurrent breast cancer
854847|NCT00004261|stage IIIB breast cancer|stage iiib breast cancer
854848|NCT00004261|stage 0 cervical cancer|stage 0 cervical cancer
854849|NCT00004261|stage III cervical cancer|stage iii cervical cancer
854850|NCT00004261|recurrent cervical cancer|recurrent cervical cancer
854851|NCT00004261|stage IB cervical cancer|stage ib cervical cancer
854852|NCT00004261|stage IIB cervical cancer|stage iib cervical cancer
854853|NCT00004261|stage IVB cervical cancer|stage ivb cervical cancer
854854|NCT00004261|stage IA cervical cancer|stage ia cervical cancer
854855|NCT00004261|stage IIA cervical cancer|stage iia cervical cancer
854856|NCT00004261|stage IVA cervical cancer|stage iva cervical cancer
854857|NCT00004261|inflammatory breast cancer|inflammatory breast cancer
854858|NCT00004261|stage III adult soft tissue sarcoma|stage iii adult soft tissue sarcoma
854859|NCT00004261|recurrent adult soft tissue sarcoma|recurrent adult soft tissue sarcoma
854860|NCT00004261|stage I prostate cancer|stage i prostate cancer
854861|NCT00004261|stage IIB prostate cancer|stage iib prostate cancer
854862|NCT00004261|stage IIA prostate cancer|stage iia prostate cancer
854863|NCT00004261|stage III prostate cancer|stage iii prostate cancer
854864|NCT00004261|stage IV prostate cancer|stage iv prostate cancer
854865|NCT00004261|recurrent prostate cancer|recurrent prostate cancer
854866|NCT00004261|stage I nasopharyngeal cancer|stage i nasopharyngeal cancer
854867|NCT00004261|stage II nasopharyngeal cancer|stage ii nasopharyngeal cancer
854868|NCT00004261|stage III nasopharyngeal cancer|stage iii nasopharyngeal cancer
854869|NCT00004261|stage IV nasopharyngeal cancer|stage iv nasopharyngeal cancer
854870|NCT00004261|recurrent nasopharyngeal cancer|recurrent nasopharyngeal cancer
854871|NCT00004261|stage 0 paranasal sinus and nasal cavity cancer|stage 0 paranasal sinus and nasal cavity cancer
854872|NCT00004261|stage 0 nasopharyngeal cancer|stage 0 nasopharyngeal cancer
854873|NCT00004261|stage 0 oropharyngeal cancer|stage 0 oropharyngeal cancer
854874|NCT00004261|stage 0 laryngeal cancer|stage 0 laryngeal cancer
854875|NCT00004261|stage 0 hypopharyngeal cancer|stage 0 hypopharyngeal cancer
854876|NCT00004261|stage I salivary gland cancer|stage i salivary gland cancer
854877|NCT00004261|stage II salivary gland cancer|stage ii salivary gland cancer
854878|NCT00004261|stage III salivary gland cancer|stage iii salivary gland cancer
854879|NCT00004261|stage IV salivary gland cancer|stage iv salivary gland cancer
854880|NCT00004261|recurrent salivary gland cancer|recurrent salivary gland cancer
854881|NCT00004261|untreated metastatic squamous neck cancer with occult primary|untreated metastatic squamous neck cancer with occult primary
854958|NCT00073801|Hypothalamic-Pituitary-Adrenal Axis|hypothalamic-pituitary-adrenal axis
854882|NCT00004261|recurrent metastatic squamous neck cancer with occult primary|recurrent metastatic squamous neck cancer with occult primary
854883|NCT00004261|stage 0 lip and oral cavity cancer|stage 0 lip and oral cavity cancer
854884|NCT00004261|stage IV adult soft tissue sarcoma|stage iv adult soft tissue sarcoma
854885|NCT00004261|stage I lip and oral cavity cancer|stage i lip and oral cavity cancer
854886|NCT00004261|stage II lip and oral cavity cancer|stage ii lip and oral cavity cancer
854887|NCT00004261|stage III lip and oral cavity cancer|stage iii lip and oral cavity cancer
854888|NCT00004261|stage IV lip and oral cavity cancer|stage iv lip and oral cavity cancer
854889|NCT00004261|recurrent lip and oral cavity cancer|recurrent lip and oral cavity cancer
854890|NCT00004261|stage I hypopharyngeal cancer|stage i hypopharyngeal cancer
854891|NCT00004261|stage II hypopharyngeal cancer|stage ii hypopharyngeal cancer
854892|NCT00004261|stage III hypopharyngeal cancer|stage iii hypopharyngeal cancer
854893|NCT00004261|stage IV hypopharyngeal cancer|stage iv hypopharyngeal cancer
854894|NCT00004261|recurrent hypopharyngeal cancer|recurrent hypopharyngeal cancer
854895|NCT00004261|stage I laryngeal cancer|stage i laryngeal cancer
854896|NCT00004261|stage II laryngeal cancer|stage ii laryngeal cancer
854897|NCT00004261|stage III laryngeal cancer|stage iii laryngeal cancer
854898|NCT00004261|stage IV laryngeal cancer|stage iv laryngeal cancer
854899|NCT00004261|recurrent laryngeal cancer|recurrent laryngeal cancer
854900|NCT00004261|stage I paranasal sinus and nasal cavity cancer|stage i paranasal sinus and nasal cavity cancer
854901|NCT00004261|stage II paranasal sinus and nasal cavity cancer|stage ii paranasal sinus and nasal cavity cancer
854902|NCT00004261|stage III paranasal sinus and nasal cavity cancer|stage iii paranasal sinus and nasal cavity cancer
854903|NCT00004261|stage IV paranasal sinus and nasal cavity cancer|stage iv paranasal sinus and nasal cavity cancer
854904|NCT00004261|recurrent paranasal sinus and nasal cavity cancer|recurrent paranasal sinus and nasal cavity cancer
854905|NCT00004261|stage I oropharyngeal cancer|stage i oropharyngeal cancer
854906|NCT00004261|stage II oropharyngeal cancer|stage ii oropharyngeal cancer
854907|NCT00004261|stage III oropharyngeal cancer|stage iii oropharyngeal cancer
854908|NCT00004261|stage IV oropharyngeal cancer|stage iv oropharyngeal cancer
854909|NCT00004261|recurrent oropharyngeal cancer|recurrent oropharyngeal cancer
854910|NCT00004261|stage II adult soft tissue sarcoma|stage ii adult soft tissue sarcoma
854911|NCT00004261|stage I adult soft tissue sarcoma|stage i adult soft tissue sarcoma
854912|NCT00004242|unspecified adult solid tumor, protocol specific|unspecified adult solid tumor, protocol specific
854913|NCT00003927|stage II breast cancer|stage ii breast cancer
854914|NCT00003927|stage IV breast cancer|stage iv breast cancer
854915|NCT00003927|stage IIIA breast cancer|stage iiia breast cancer
854916|NCT00003927|stage IIIB breast cancer|stage iiib breast cancer
854917|NCT00073814|levalbuterol|levalbuterol
854918|NCT00073814|pediatric|pediatric
854919|NCT00073814|asthma|asthma
854920|NCT00003811|drug/agent toxicity by tissue/organ|drug/agent toxicity by tissue/organ
854921|NCT00003811|childhood teratoma|childhood teratoma
854922|NCT00003811|childhood malignant testicular germ cell tumor|childhood malignant testicular germ cell tumor
854923|NCT00003811|childhood malignant ovarian germ cell tumor|childhood malignant ovarian germ cell tumor
854924|NCT00003811|childhood extragonadal germ cell tumor|childhood extragonadal germ cell tumor
854925|NCT00003811|recurrent childhood malignant germ cell tumor|recurrent childhood malignant germ cell tumor
854926|NCT00003777|stage III lip and oral cavity cancer|stage iii lip and oral cavity cancer
854927|NCT00003777|stage IV lip and oral cavity cancer|stage iv lip and oral cavity cancer
854928|NCT00003777|recurrent lip and oral cavity cancer|recurrent lip and oral cavity cancer
854929|NCT00003777|stage III hypopharyngeal cancer|stage iii hypopharyngeal cancer
854930|NCT00003777|stage IV hypopharyngeal cancer|stage iv hypopharyngeal cancer
854931|NCT00003777|recurrent hypopharyngeal cancer|recurrent hypopharyngeal cancer
854932|NCT00003777|stage III laryngeal cancer|stage iii laryngeal cancer
854933|NCT00003777|stage IV laryngeal cancer|stage iv laryngeal cancer
854934|NCT00003777|recurrent laryngeal cancer|recurrent laryngeal cancer
854935|NCT00003777|stage III paranasal sinus and nasal cavity cancer|stage iii paranasal sinus and nasal cavity cancer
854936|NCT00003777|stage IV paranasal sinus and nasal cavity cancer|stage iv paranasal sinus and nasal cavity cancer
854937|NCT00003777|recurrent paranasal sinus and nasal cavity cancer|recurrent paranasal sinus and nasal cavity cancer
854938|NCT00003777|stage III oropharyngeal cancer|stage iii oropharyngeal cancer
854939|NCT00003777|stage IV oropharyngeal cancer|stage iv oropharyngeal cancer
854940|NCT00003777|recurrent oropharyngeal cancer|recurrent oropharyngeal cancer
854941|NCT00003761|stage IV breast cancer|stage iv breast cancer
854942|NCT00003761|recurrent breast cancer|recurrent breast cancer
854943|NCT00003729|recurrent childhood acute lymphoblastic leukemia|recurrent childhood acute lymphoblastic leukemia
854944|NCT00003729|L1 childhood acute lymphoblastic leukemia|l1 childhood acute lymphoblastic leukemia
854945|NCT00003729|L2 childhood acute lymphoblastic leukemia|l2 childhood acute lymphoblastic leukemia
854946|NCT00073801|Myofascial Dysfunction|myofascial dysfunction
854947|NCT00073801|Sensitization|sensitization
854950|NCT00073801|Neuromusculoskeletal Pain|neuromusculoskeletal pain
854951|NCT00073801|Laparoscopy|laparoscopy
854952|NCT00073801|Cytokines|cytokines
854953|NCT00073801|HPA Axis|hpa axis
854954|NCT00073801|Neuroimmune|neuroimmune
854955|NCT00073801|Endometriosis|endometriosis
854956|NCT00073801|Surgical Excision|surgical excision
854957|NCT00073801|Inflammatory Cytokines|inflammatory cytokines
854959|NCT00003734|adenocarcinoma of the prostate|adenocarcinoma of the prostate
854960|NCT00003734|stage I prostate cancer|stage i prostate cancer
854961|NCT00003734|stage IIB prostate cancer|stage iib prostate cancer
854962|NCT00003734|stage IIA prostate cancer|stage iia prostate cancer
854963|NCT00003734|stage III prostate cancer|stage iii prostate cancer
854964|NCT00003734|stage IV prostate cancer|stage iv prostate cancer
854965|NCT00073749|B-Cell|b-cell
854966|NCT00073749|Non-Hodgkin's|non-hodgkin's
854967|NCT00073749|Lymphoma|lymphoma
854968|NCT00073736|Hepatocellular|hepatocellular
854969|NCT00073736|Carcinoma|carcinoma
854970|NCT00073736|Liver|liver
854971|NCT00073736|Cancer|cancer
854972|NCT00073723|Non-Small Cell Lung Cancer|non-small cell lung cancer
854973|NCT00073723|Taxol|taxol
854974|NCT00073723|Advanced Non-Small Cell Lung Cancer|advanced non-small cell lung cancer
854975|NCT00003716|childhood Burkitt lymphoma|childhood burkitt lymphoma
854976|NCT00003716|childhood immunoblastic large cell lymphoma|childhood immunoblastic large cell lymphoma
854977|NCT00003716|stage IV adult immunoblastic large cell lymphoma|stage iv adult immunoblastic large cell lymphoma
854978|NCT00003716|stage IV adult Burkitt lymphoma|stage iv adult burkitt lymphoma
854979|NCT00003716|recurrent adult immunoblastic large cell lymphoma|recurrent adult immunoblastic large cell lymphoma
854980|NCT00003716|recurrent adult Burkitt lymphoma|recurrent adult burkitt lymphoma
854981|NCT00003716|stage IV childhood small noncleaved cell lymphoma|stage iv childhood small noncleaved cell lymphoma
854982|NCT00003716|stage IV childhood large cell lymphoma|stage iv childhood large cell lymphoma
854983|NCT00003716|recurrent childhood small noncleaved cell lymphoma|recurrent childhood small noncleaved cell lymphoma
854984|NCT00003716|recurrent childhood large cell lymphoma|recurrent childhood large cell lymphoma
854985|NCT00003679|stage IIIA breast cancer|stage iiia breast cancer
854986|NCT00003679|stage IIIB breast cancer|stage iiib breast cancer
854987|NCT00003679|inflammatory breast cancer|inflammatory breast cancer
854988|NCT00003598|cervical cancer|cervical cancer
854989|NCT00003598|cervical intraepithelial neoplasia grade 2|cervical intraepithelial neoplasia grade 2
854990|NCT00003598|cervical intraepithelial neoplasia grade 3|cervical intraepithelial neoplasia grade 3
854991|NCT00003450|stage IV ovarian epithelial cancer|stage iv ovarian epithelial cancer
854992|NCT00003450|recurrent ovarian epithelial cancer|recurrent ovarian epithelial cancer
854993|NCT00003450|peritoneal cavity cancer|peritoneal cavity cancer
854994|NCT00073710|secondary hyperparathyroidism|secondary hyperparathyroidism
854995|NCT00073697|Psychotherapy|psychotherapy
854996|NCT00073697|Depressive disorder|depressive disorder
854997|NCT00073697|Antidepressive agents|antidepressive agents
854998|NCT00073697|Citalopram|citalopram
854999|NCT00073684|Stress Disorders, Post-Traumatic|stress disorders, post-traumatic
855000|NCT00073684|Depression|depression
855001|NCT00073684|Anxiety|anxiety
855002|NCT00073671|Adolescent|adolescent
855003|NCT00073658|Alzheimer disease|alzheimer disease
855004|NCT00073658|Aggression|aggression
855005|NCT00073658|Delusions|delusions
855006|NCT00073658|Paranoid behavior|paranoid behavior
855007|NCT00073619|Violence|violence
855008|NCT00073619|School based|school based
855009|NCT00073619|Urban Youth|urban youth
855010|NCT00073619|Prevention|prevention
855011|NCT00073619|Community|community
855012|NCT00073606|Spinal Reflexes|spinal reflexes
855013|NCT00073606|Locomotion|locomotion
855014|NCT00073606|Motor Practice|motor practice
855015|NCT00073606|Healthy Volunteer|healthy volunteer
855016|NCT00073606|HV|hv
855017|NCT00003426|stage II pancreatic cancer|stage ii pancreatic cancer
855018|NCT00003426|stage III pancreatic cancer|stage iii pancreatic cancer
855019|NCT00003426|adenocarcinoma of the pancreas|adenocarcinoma of the pancreas
855020|NCT00003414|recurrent adult Hodgkin lymphoma|recurrent adult hodgkin lymphoma
855021|NCT00003414|recurrent childhood lymphoblastic lymphoma|recurrent childhood lymphoblastic lymphoma
855022|NCT00003414|recurrent/refractory childhood Hodgkin lymphoma|recurrent/refractory childhood hodgkin lymphoma
855023|NCT00003414|recurrent grade 1 follicular lymphoma|recurrent grade 1 follicular lymphoma
855024|NCT00003414|recurrent grade 2 follicular lymphoma|recurrent grade 2 follicular lymphoma
855025|NCT00003414|recurrent grade 3 follicular lymphoma|recurrent grade 3 follicular lymphoma
855026|NCT00003414|recurrent adult diffuse small cleaved cell lymphoma|recurrent adult diffuse small cleaved cell lymphoma
855027|NCT00003414|recurrent adult diffuse mixed cell lymphoma|recurrent adult diffuse mixed cell lymphoma
855028|NCT00003414|recurrent adult diffuse large cell lymphoma|recurrent adult diffuse large cell lymphoma
855029|NCT00003414|recurrent adult immunoblastic large cell lymphoma|recurrent adult immunoblastic large cell lymphoma
855030|NCT00003414|recurrent adult lymphoblastic lymphoma|recurrent adult lymphoblastic lymphoma
855031|NCT00003414|recurrent adult Burkitt lymphoma|recurrent adult burkitt lymphoma
855032|NCT00003414|graft versus host disease|graft versus host disease
855348|NCT00072969|MDS|mds
855033|NCT00003414|recurrent childhood small noncleaved cell lymphoma|recurrent childhood small noncleaved cell lymphoma
855034|NCT00003414|recurrent childhood large cell lymphoma|recurrent childhood large cell lymphoma
855035|NCT00003414|recurrent mantle cell lymphoma|recurrent mantle cell lymphoma
855036|NCT00003414|recurrent marginal zone lymphoma|recurrent marginal zone lymphoma
855037|NCT00003414|recurrent small lymphocytic lymphoma|recurrent small lymphocytic lymphoma
855115|NCT00002989|stage I adult diffuse small cleaved cell lymphoma|stage i adult diffuse small cleaved cell lymphoma
855038|NCT00003414|extranodal marginal zone B-cell lymphoma of mucosa-associated lymphoid tissue|extranodal marginal zone b-cell lymphoma of mucosa-associated lymphoid tissue
855039|NCT00003414|nodal marginal zone B-cell lymphoma|nodal marginal zone b-cell lymphoma
855040|NCT00003414|splenic marginal zone lymphoma|splenic marginal zone lymphoma
855041|NCT00003409|adult glioblastoma|adult glioblastoma
855042|NCT00003409|adult giant cell glioblastoma|adult giant cell glioblastoma
855043|NCT00003409|adult gliosarcoma|adult gliosarcoma
855044|NCT00003388|AIDS-related peripheral/systemic lymphoma|aids-related peripheral/systemic lymphoma
855045|NCT00003388|AIDS-related diffuse large cell lymphoma|aids-related diffuse large cell lymphoma
855046|NCT00003388|AIDS-related immunoblastic large cell lymphoma|aids-related immunoblastic large cell lymphoma
855047|NCT00003388|AIDS-related small noncleaved cell lymphoma|aids-related small noncleaved cell lymphoma
855048|NCT00003388|AIDS-related diffuse mixed cell lymphoma|aids-related diffuse mixed cell lymphoma
855049|NCT00003388|AIDS-related diffuse small cleaved cell lymphoma|aids-related diffuse small cleaved cell lymphoma
855050|NCT00003388|AIDS-related lymphoblastic lymphoma|aids-related lymphoblastic lymphoma
855051|NCT00003388|anaplastic large cell lymphoma|anaplastic large cell lymphoma
855052|NCT00073593|Off-Pump Coronary Artery Bypass Graft Surgery|off-pump coronary artery bypass graft surgery
855053|NCT00073593|CABG|cabg
855054|NCT00073593|OPCAB|opcab
855055|NCT00073593|Heparin|heparin
855056|NCT00073593|Patients requiring off-pump CABG|patients requiring off-pump cabg
855057|NCT00073580|HIT|hit
855058|NCT00073580|HITTS|hitts
855059|NCT00073580|Heparin-antibodies|heparin-antibodies
855060|NCT00073580|Coronary artery bypass surgery|coronary artery bypass surgery
855061|NCT00073580|CABG|cabg
855062|NCT00073580|Heparin-induced thrombocytopenia|heparin-induced thrombocytopenia
855063|NCT00073580|Heparin-induced thrombocytopenia and thrombosis syndrome|heparin-induced thrombocytopenia and thrombosis syndrome
855064|NCT00073541|EGFR; HER-1; monoclonal antibody; targeted therapy|egfr; her-1; monoclonal antibody; targeted therapy
855065|NCT00073528|metastatic|metastatic
855066|NCT00073528|advanced breast cancer|advanced breast cancer
855067|NCT00073528|breast cancer|breast cancer
855068|NCT00003387|stage III non-small cell lung cancer|stage iii non-small cell lung cancer
855069|NCT00003387|squamous cell lung cancer|squamous cell lung cancer
855070|NCT00003387|large cell lung cancer|large cell lung cancer
855071|NCT00003387|adenocarcinoma of the lung|adenocarcinoma of the lung
855072|NCT00003313|stage II non-small cell lung cancer|stage ii non-small cell lung cancer
855073|NCT00003313|stage IIIA non-small cell lung cancer|stage iiia non-small cell lung cancer
855074|NCT00003313|stage IIIB non-small cell lung cancer|stage iiib non-small cell lung cancer
855075|NCT00003313|oral complications|oral complications
855076|NCT00003313|drug/agent toxicity by tissue/organ|drug/agent toxicity by tissue/organ
855077|NCT00003313|radiation toxicity|radiation toxicity
855078|NCT00003253|stage IV breast cancer|stage iv breast cancer
855079|NCT00003253|recurrent breast cancer|recurrent breast cancer
855080|NCT00003253|male breast cancer|male breast cancer
855081|NCT00003202|squamous cell lung cancer|squamous cell lung cancer
855082|NCT00003202|large cell lung cancer|large cell lung cancer
855083|NCT00003202|stage IIIA non-small cell lung cancer|stage iiia non-small cell lung cancer
855084|NCT00003202|stage IIIB non-small cell lung cancer|stage iiib non-small cell lung cancer
855085|NCT00003202|adenocarcinoma of the lung|adenocarcinoma of the lung
855086|NCT00003202|adenosquamous cell lung cancer|adenosquamous cell lung cancer
855087|NCT00003191|recurrent neuroblastoma|recurrent neuroblastoma
855088|NCT00003191|unspecified childhood solid tumor, protocol specific|unspecified childhood solid tumor, protocol specific
855089|NCT00073515|central venous access device|central venous access device
855090|NCT00073515|thrombosis|thrombosis
855091|NCT00073515|central venous catheter|central venous catheter
855092|NCT00073515|thrombolysis|thrombolysis
855093|NCT00073515|fibrinolysis|fibrinolysis
855094|NCT00073489|chronic leukemia|chronic leukemia
855095|NCT00073489|leukemia|leukemia
855096|NCT00073489|CLL|cll
855097|NCT00073463|Gene Transfer|gene transfer
855098|NCT00073463|Pulmonary function|pulmonary function
855099|NCT00003130|unspecified adult solid tumor, protocol specific|unspecified adult solid tumor, protocol specific
855100|NCT00003060|recurrent melanoma|recurrent melanoma
855101|NCT00003037|stage IIIA non-small cell lung cancer|stage iiia non-small cell lung cancer
855102|NCT00003037|stage IIIB non-small cell lung cancer|stage iiib non-small cell lung cancer
855103|NCT00002989|stage I multiple myeloma|stage i multiple myeloma
855104|NCT00002989|stage II multiple myeloma|stage ii multiple myeloma
855105|NCT00002989|stage III multiple myeloma|stage iii multiple myeloma
855106|NCT00002989|recurrent adult acute myeloid leukemia|recurrent adult acute myeloid leukemia
855107|NCT00002989|recurrent adult acute lymphoblastic leukemia|recurrent adult acute lymphoblastic leukemia
855108|NCT00002989|relapsing chronic myelogenous leukemia|relapsing chronic myelogenous leukemia
855109|NCT00002989|refractory chronic lymphocytic leukemia|refractory chronic lymphocytic leukemia
855110|NCT00002989|adult acute myeloid leukemia in remission|adult acute myeloid leukemia in remission
855111|NCT00002989|adult acute lymphoblastic leukemia in remission|adult acute lymphoblastic leukemia in remission
855112|NCT00002989|stage I grade 1 follicular lymphoma|stage i grade 1 follicular lymphoma
855113|NCT00002989|stage I grade 2 follicular lymphoma|stage i grade 2 follicular lymphoma
855114|NCT00002989|stage I grade 3 follicular lymphoma|stage i grade 3 follicular lymphoma
855116|NCT00002989|stage I adult diffuse mixed cell lymphoma|stage i adult diffuse mixed cell lymphoma
855117|NCT00002989|stage I adult diffuse large cell lymphoma|stage i adult diffuse large cell lymphoma
855118|NCT00002989|stage I adult immunoblastic large cell lymphoma|stage i adult immunoblastic large cell lymphoma
855119|NCT00002989|stage I adult lymphoblastic lymphoma|stage i adult lymphoblastic lymphoma
855120|NCT00002989|stage I adult Burkitt lymphoma|stage i adult burkitt lymphoma
855121|NCT00002989|stage III grade 2 follicular lymphoma|stage iii grade 2 follicular lymphoma
855122|NCT00002989|stage III grade 3 follicular lymphoma|stage iii grade 3 follicular lymphoma
855123|NCT00002989|stage III adult diffuse small cleaved cell lymphoma|stage iii adult diffuse small cleaved cell lymphoma
855124|NCT00002989|stage III adult diffuse mixed cell lymphoma|stage iii adult diffuse mixed cell lymphoma
855125|NCT00002989|stage III adult diffuse large cell lymphoma|stage iii adult diffuse large cell lymphoma
855126|NCT00002989|stage III adult immunoblastic large cell lymphoma|stage iii adult immunoblastic large cell lymphoma
855127|NCT00002989|stage III adult lymphoblastic lymphoma|stage iii adult lymphoblastic lymphoma
855128|NCT00002989|stage III adult Burkitt lymphoma|stage iii adult burkitt lymphoma
855129|NCT00002989|stage IV grade 1 follicular lymphoma|stage iv grade 1 follicular lymphoma
855130|NCT00002989|stage IV grade 2 follicular lymphoma|stage iv grade 2 follicular lymphoma
855131|NCT00002989|stage IV grade 3 follicular lymphoma|stage iv grade 3 follicular lymphoma
855132|NCT00002989|stage IV adult diffuse small cleaved cell lymphoma|stage iv adult diffuse small cleaved cell lymphoma
855133|NCT00002989|stage IV adult diffuse mixed cell lymphoma|stage iv adult diffuse mixed cell lymphoma
855134|NCT00002989|stage IV adult diffuse large cell lymphoma|stage iv adult diffuse large cell lymphoma
855135|NCT00002989|stage IV adult immunoblastic large cell lymphoma|stage iv adult immunoblastic large cell lymphoma
855136|NCT00002989|stage IV adult lymphoblastic lymphoma|stage iv adult lymphoblastic lymphoma
855137|NCT00002989|stage IV adult Burkitt lymphoma|stage iv adult burkitt lymphoma
855138|NCT00002989|recurrent grade 1 follicular lymphoma|recurrent grade 1 follicular lymphoma
855139|NCT00002989|recurrent grade 2 follicular lymphoma|recurrent grade 2 follicular lymphoma
855140|NCT00002989|recurrent grade 3 follicular lymphoma|recurrent grade 3 follicular lymphoma
855141|NCT00002989|recurrent adult diffuse small cleaved cell lymphoma|recurrent adult diffuse small cleaved cell lymphoma
855142|NCT00002989|recurrent adult diffuse mixed cell lymphoma|recurrent adult diffuse mixed cell lymphoma
855143|NCT00002989|recurrent adult diffuse large cell lymphoma|recurrent adult diffuse large cell lymphoma
855144|NCT00002989|recurrent adult immunoblastic large cell lymphoma|recurrent adult immunoblastic large cell lymphoma
855145|NCT00002989|recurrent adult lymphoblastic lymphoma|recurrent adult lymphoblastic lymphoma
855146|NCT00002989|recurrent adult Burkitt lymphoma|recurrent adult burkitt lymphoma
855147|NCT00002989|previously treated myelodysplastic syndromes|previously treated myelodysplastic syndromes
855148|NCT00002989|stage I mantle cell lymphoma|stage i mantle cell lymphoma
855149|NCT00002989|contiguous stage II grade 1 follicular lymphoma|contiguous stage ii grade 1 follicular lymphoma
855150|NCT00002989|contiguous stage II grade 2 follicular lymphoma|contiguous stage ii grade 2 follicular lymphoma
855151|NCT00002989|contiguous stage II grade 3 follicular lymphoma|contiguous stage ii grade 3 follicular lymphoma
855152|NCT00002989|contiguous stage II adult diffuse small cleaved cell lymphoma|contiguous stage ii adult diffuse small cleaved cell lymphoma
855153|NCT00002989|contiguous stage II mantle cell lymphoma|contiguous stage ii mantle cell lymphoma
855154|NCT00002989|contiguous stage II adult diffuse mixed cell lymphoma|contiguous stage ii adult diffuse mixed cell lymphoma
855155|NCT00002989|contiguous stage II adult immunoblastic large cell lymphoma|contiguous stage ii adult immunoblastic large cell lymphoma
855156|NCT00002989|contiguous stage II adult diffuse large cell lymphoma|contiguous stage ii adult diffuse large cell lymphoma
855157|NCT00002989|contiguous stage II adult Burkitt lymphoma|contiguous stage ii adult burkitt lymphoma
855158|NCT00002989|contiguous stage II adult lymphoblastic lymphoma|contiguous stage ii adult lymphoblastic lymphoma
855159|NCT00002989|noncontiguous stage II grade 1 follicular lymphoma|noncontiguous stage ii grade 1 follicular lymphoma
855160|NCT00002989|noncontiguous stage II grade 2 follicular lymphoma|noncontiguous stage ii grade 2 follicular lymphoma
855161|NCT00002989|noncontiguous stage II grade 3 follicular lymphoma|noncontiguous stage ii grade 3 follicular lymphoma
855162|NCT00002989|noncontiguous stage II adult diffuse small cleaved cell lymphoma|noncontiguous stage ii adult diffuse small cleaved cell lymphoma
855163|NCT00002989|noncontiguous stage II mantle cell lymphoma|noncontiguous stage ii mantle cell lymphoma
855164|NCT00002989|noncontiguous stage II adult diffuse mixed cell lymphoma|noncontiguous stage ii adult diffuse mixed cell lymphoma
855165|NCT00002989|noncontiguous stage II adult immunoblastic large cell lymphoma|noncontiguous stage ii adult immunoblastic large cell lymphoma
855166|NCT00002989|noncontiguous stage II adult diffuse large cell lymphoma|noncontiguous stage ii adult diffuse large cell lymphoma
855167|NCT00002989|noncontiguous stage II adult Burkitt lymphoma|noncontiguous stage ii adult burkitt lymphoma
855168|NCT00002989|noncontiguous stage II adult lymphoblastic lymphoma|noncontiguous stage ii adult lymphoblastic lymphoma
855169|NCT00002989|stage III mantle cell lymphoma|stage iii mantle cell lymphoma
855170|NCT00002989|stage IV mantle cell lymphoma|stage iv mantle cell lymphoma
855171|NCT00002989|recurrent mantle cell lymphoma|recurrent mantle cell lymphoma
855172|NCT00002989|contiguous stage II marginal zone lymphoma|contiguous stage ii marginal zone lymphoma
855173|NCT00002989|contiguous stage II small lymphocytic lymphoma|contiguous stage ii small lymphocytic lymphoma
855174|NCT00002989|noncontiguous stage II small lymphocytic lymphoma|noncontiguous stage ii small lymphocytic lymphoma
855255|NCT00002561|stage I adult Hodgkin lymphoma|stage i adult hodgkin lymphoma
855175|NCT00002989|noncontiguous stage II marginal zone lymphoma|noncontiguous stage ii marginal zone lymphoma
855176|NCT00002989|recurrent marginal zone lymphoma|recurrent marginal zone lymphoma
855177|NCT00002989|recurrent small lymphocytic lymphoma|recurrent small lymphocytic lymphoma
855178|NCT00002989|stage I marginal zone lymphoma|stage i marginal zone lymphoma
855179|NCT00002989|stage I small lymphocytic lymphoma|stage i small lymphocytic lymphoma
855180|NCT00002989|stage III small lymphocytic lymphoma|stage iii small lymphocytic lymphoma
855181|NCT00002989|stage III marginal zone lymphoma|stage iii marginal zone lymphoma
855182|NCT00002989|stage IV small lymphocytic lymphoma|stage iv small lymphocytic lymphoma
855183|NCT00002989|stage IV marginal zone lymphoma|stage iv marginal zone lymphoma
855184|NCT00002989|extranodal marginal zone B-cell lymphoma of mucosa-associated lymphoid tissue|extranodal marginal zone b-cell lymphoma of mucosa-associated lymphoid tissue
855185|NCT00002989|nodal marginal zone B-cell lymphoma|nodal marginal zone b-cell lymphoma
855186|NCT00002989|splenic marginal zone lymphoma|splenic marginal zone lymphoma
855187|NCT00002989|childhood myelodysplastic syndromes|childhood myelodysplastic syndromes
855188|NCT00073450|Squamous Cell Carcinoma of the Head & Neck|squamous cell carcinoma of the head & neck
855189|NCT00073437|Sarcoidosis|sarcoidosis
855190|NCT00073437|Infliximab|infliximab
855191|NCT00073437|Pulmonary involvement|pulmonary involvement
855192|NCT00073437|Remicade|remicade
855193|NCT00002940|AIDS-related primary CNS lymphoma|aids-related primary cns lymphoma
855194|NCT00002836|recurrent breast cancer|recurrent breast cancer
855195|NCT00002828|stage III colon cancer|stage iii colon cancer
855196|NCT00002828|stage IV colon cancer|stage iv colon cancer
855197|NCT00002828|stage III rectal cancer|stage iii rectal cancer
855198|NCT00002828|stage IV rectal cancer|stage iv rectal cancer
855199|NCT00002828|recurrent colon cancer|recurrent colon cancer
855200|NCT00002828|recurrent rectal cancer|recurrent rectal cancer
855201|NCT00002812|untreated childhood acute lymphoblastic leukemia|untreated childhood acute lymphoblastic leukemia
855202|NCT00002812|L1 childhood acute lymphoblastic leukemia|l1 childhood acute lymphoblastic leukemia
855203|NCT00002812|L2 childhood acute lymphoblastic leukemia|l2 childhood acute lymphoblastic leukemia
855204|NCT00002761|relapsing chronic myelogenous leukemia|relapsing chronic myelogenous leukemia
855205|NCT00002761|chronic phase chronic myelogenous leukemia|chronic phase chronic myelogenous leukemia
855206|NCT00002761|chronic myelogenous leukemia, BCR-ABL1 positive|chronic myelogenous leukemia, bcr-abl1 positive
855207|NCT00073424|Treatment Experienced|treatment experienced
855208|NCT00073385|Lung cancer, Docetaxel, Histone deacetylase inhibitor|lung cancer, docetaxel, histone deacetylase inhibitor
855209|NCT00073372|Acute ischemic stroke|acute ischemic stroke
855210|NCT00073372|abciximab|abciximab
855211|NCT00073372|ReoPro|reopro
855212|NCT00073372|drug safety|drug safety
855213|NCT00073372|drug efficacy|drug efficacy
855214|NCT00073372|intracranial hemorrhage|intracranial hemorrhage
855215|NCT00073372|stroke|stroke
855216|NCT00073359|Adolescent|adolescent
855217|NCT00073346|Compulsive Hoarding|compulsive hoarding
855218|NCT00073333|Phobic Disorders|phobic disorders
855219|NCT00073320|Schizophrenia|schizophrenia
855220|NCT00073320|Paliperidone palmitate|paliperidone palmitate
855221|NCT00073320|R092670|r092670
855222|NCT00073320|antipsychotic|antipsychotic
855223|NCT00073307|Renal Cell Cancer (RCC)|renal cell cancer (rcc)
855224|NCT00073307|Cancer|cancer
855225|NCT00036920|recurrent non-small cell lung cancer|recurrent non-small cell lung cancer
855226|NCT00036920|squamous cell lung cancer|squamous cell lung cancer
855227|NCT00036920|large cell lung cancer|large cell lung cancer
855228|NCT00036920|stage IIIB non-small cell lung cancer|stage iiib non-small cell lung cancer
855229|NCT00036920|stage IV non-small cell lung cancer|stage iv non-small cell lung cancer
855230|NCT00036920|adenocarcinoma of the lung|adenocarcinoma of the lung
855231|NCT00036920|adenosquamous cell lung cancer|adenosquamous cell lung cancer
855232|NCT00036920|bronchoalveolar cell lung cancer|bronchoalveolar cell lung cancer
855233|NCT00027521|stage III pancreatic cancer|stage iii pancreatic cancer
855234|NCT00027521|adenocarcinoma of the pancreas|adenocarcinoma of the pancreas
855235|NCT00025532|stage III colon cancer|stage iii colon cancer
855236|NCT00025532|stage IV colon cancer|stage iv colon cancer
855237|NCT00025532|stage III gastric cancer|stage iii gastric cancer
855238|NCT00025532|stage IV gastric cancer|stage iv gastric cancer
855239|NCT00025532|recurrent gastric cancer|recurrent gastric cancer
855240|NCT00025532|stage III pancreatic cancer|stage iii pancreatic cancer
855241|NCT00025532|recurrent pancreatic cancer|recurrent pancreatic cancer
855242|NCT00025532|stage III rectal cancer|stage iii rectal cancer
855243|NCT00025532|stage IV rectal cancer|stage iv rectal cancer
855244|NCT00025532|recurrent colon cancer|recurrent colon cancer
855245|NCT00025532|recurrent rectal cancer|recurrent rectal cancer
855246|NCT00025532|stage III esophageal cancer|stage iii esophageal cancer
855247|NCT00025532|stage IV esophageal cancer|stage iv esophageal cancer
855248|NCT00025532|recurrent esophageal cancer|recurrent esophageal cancer
855249|NCT00025532|adenocarcinoma of the stomach|adenocarcinoma of the stomach
855250|NCT00025532|adenocarcinoma of the esophagus|adenocarcinoma of the esophagus
855251|NCT00025532|adenocarcinoma of the colon|adenocarcinoma of the colon
855252|NCT00025532|adenocarcinoma of the rectum|adenocarcinoma of the rectum
855253|NCT00025532|adenocarcinoma of the pancreas|adenocarcinoma of the pancreas
855254|NCT00025532|stage IV pancreatic cancer|stage iv pancreatic cancer
855256|NCT00002561|stage II adult Hodgkin lymphoma|stage ii adult hodgkin lymphoma
855257|NCT00002561|adult lymphocyte predominant Hodgkin lymphoma|adult lymphocyte predominant hodgkin lymphoma
855258|NCT00002561|adult lymphocyte depletion Hodgkin lymphoma|adult lymphocyte depletion hodgkin lymphoma
855259|NCT00002561|adult nodular sclerosis Hodgkin lymphoma|adult nodular sclerosis hodgkin lymphoma
855260|NCT00002561|adult mixed cellularity Hodgkin lymphoma|adult mixed cellularity hodgkin lymphoma
855261|NCT00073398|Anti-tumor Vaccination|anti-tumor vaccination
855262|NCT00073398|Alpha (1,3) Galactosyltransferase|alpha (1,3) galactosyltransferase
855263|NCT00073398|Allogeneic Tumor Cells|allogeneic tumor cells
855264|NCT00073398|Hyperacute Lung|hyperacute lung
855265|NCT00073398|NSCLC|nsclc
855266|NCT00073398|Lung Cancer|lung cancer
855267|NCT00073398|Non-Small Cell Lung Cancer|non-small cell lung cancer
855268|NCT00073294|diabetes|diabetes
855269|NCT00073281|diabetes|diabetes
855270|NCT00073281|autoimmunity|autoimmunity
855271|NCT00073268|diabetes|diabetes
855272|NCT00073268|adolescent|adolescent
855273|NCT00073242|leptin|leptin
855274|NCT00073242|obesity|obesity
855275|NCT00073229|AIDS|aids
855276|NCT00073229|Vertical Transmission|vertical transmission
855277|NCT00073229|Acute Infection|acute infection
855278|NCT00073216|HIV Seronegativity|hiv seronegativity
855279|NCT00073216|HIV Preventive Vaccine|hiv preventive vaccine
855280|NCT00073190|Patient Education|patient education
855281|NCT00073190|Physician Education|physician education
855282|NCT00073125|Advanced histologically documented renal cell carcinoma|advanced histologically documented renal cell carcinoma
855283|NCT00073047|Ulcerative Colitis|ulcerative colitis
855284|NCT00073047|Inflammatory Bowel Disease|inflammatory bowel disease
855285|NCT00073047|Gastrointestinal|gastrointestinal
855286|NCT00073047|Humanized Monoclonal antibody|humanized monoclonal antibody
855287|NCT00073034|Neuropathic Pain|neuropathic pain
855288|NCT00073034|Diabetic Neuropathy|diabetic neuropathy
855289|NCT00073099|Dry Eye|dry eye
855290|NCT00073099|Lissamine Green|lissamine green
855291|NCT00073099|Fluorescein|fluorescein
855292|NCT00073099|Conjunctiva|conjunctiva
855293|NCT00073099|Cornea|cornea
855294|NCT00073099|Digital Photography|digital photography
855295|NCT00073099|Corneal and Conjunctival Staining|corneal and conjunctival staining
855296|NCT00073086|Coronavirus|coronavirus
855297|NCT00073086|Pneumonia|pneumonia
855298|NCT00073086|Asia|asia
855299|NCT00073086|China|china
855300|NCT00073086|Severe Acut Respiratory Syndrome|severe acut respiratory syndrome
855301|NCT00073086|SARS|sars
855302|NCT00073086|Suspected SARS|suspected sars
855303|NCT00073073|Chemoprevention|chemoprevention
855304|NCT00073073|Mammographic Density|mammographic density
855305|NCT00073073|Bone Mineral Density|bone mineral density
855306|NCT00073073|Biomarkers|biomarkers
855307|NCT00073073|Safety|safety
855308|NCT00073073|Breast Cancer|breast cancer
855309|NCT00073073|Postmenopausal|postmenopausal
855310|NCT00073060|Plateletpheresis|plateletpheresis
855311|NCT00073060|Lymphocytapheresis|lymphocytapheresis
855312|NCT00073060|Calcium|calcium
855313|NCT00073060|Citrate|citrate
855314|NCT00073060|Bone Density|bone density
855315|NCT00073060|Healthy Volunteer|healthy volunteer
855316|NCT00073060|HV|hv
855317|NCT00073008|EGFR|egfr
855318|NCT00073008|ErbB1|erbb1
855319|NCT00073008|ErbB2|erbb2
855320|NCT00073008|metastatic|metastatic
855321|NCT00073008|lapatinib|lapatinib
855322|NCT00073008|Her-2/neu|her-2/neu
855323|NCT00073008|protein kinase inhibitor|protein kinase inhibitor
855324|NCT00073008|BAC|bac
855325|NCT00073008|GW572016|gw572016
855326|NCT00073008|Advanced|advanced
855327|NCT00073008|NSCLC|nsclc
855328|NCT00072982|Fish oil|fish oil
855329|NCT00072982|Borage oil|borage oil
855330|NCT00072943|Crohn's Disease|crohn's disease
855331|NCT00072943|Colitis|colitis
855332|NCT00072943|Monoclonal antibody therapy|monoclonal antibody therapy
855333|NCT00072943|anti-interferon gamma|anti-interferon gamma
855334|NCT00072917|obesity|obesity
855335|NCT00072917|thinness|thinness
855336|NCT00072917|weight gain|weight gain
855337|NCT00072917|physical activity|physical activity
855338|NCT00072917|diet|diet
855339|NCT00072917|fat oxidation|fat oxidation
855340|NCT00072917|hunger|hunger
855341|NCT00072917|feeding behavior|feeding behavior
855342|NCT00072917|overfeeding|overfeeding
855343|NCT00072904|Cystic Fibrosis Related Diabetes|cystic fibrosis related diabetes
855344|NCT00072904|Diabetes without Fasting Hyperglycemia|diabetes without fasting hyperglycemia
855345|NCT00072891|Diabetes|diabetes
855346|NCT00072969|Immunosuppression|immunosuppression
855347|NCT00072969|Myelodysplastic Syndrome|myelodysplastic syndrome
855349|NCT00072956|Transcranial Magnetic Stimulation|transcranial magnetic stimulation
855350|NCT00072956|Torticollis|torticollis
855351|NCT00072956|Cervical Dystonia|cervical dystonia
855352|NCT00072956|Surround Inhibition|surround inhibition
855353|NCT00072956|Sensory Tricks|sensory tricks
855354|NCT00072787|gastric cancer|gastric cancer
855355|NCT00072787|phase 2 clinical trial|phase 2 clinical trial
855356|NCT00072774|Depressive Disorder, Major|depressive disorder, major
855459|NCT00072631|erlotinib|erlotinib
855357|NCT00072774|Melancholia, Involutional|melancholia, involutional
855358|NCT00072774|Depression, Involutional|depression, involutional
855359|NCT00072761|silent cerebral infarct|silent cerebral infarct
855360|NCT00072761|silent stroke|silent stroke
855361|NCT00072761|sickle cell anemia|sickle cell anemia
855362|NCT00072761|stroke|stroke
855363|NCT00072761|transfusion therapy|transfusion therapy
855364|NCT00072748|Advanced Colorectal Cancer|advanced colorectal cancer
855365|NCT00072748|Colorectal Carcinoma|colorectal carcinoma
855366|NCT00072748|Colorectal Tumors|colorectal tumors
855367|NCT00072748|Neoplasms, Colorectal|neoplasms, colorectal
855368|NCT00072722|Prostate Cancer|prostate cancer
855369|NCT00072722|Metastatic Hormone Refractory Prostate Cancer|metastatic hormone refractory prostate cancer
855370|NCT00072722|CC4047|cc4047
855371|NCT00072722|CC-4047|cc-4047
855372|NCT00072722|Prostate Carcinoma|prostate carcinoma
855373|NCT00072722|Celgene|celgene
855374|NCT00017017|recurrent ovarian epithelial cancer|recurrent ovarian epithelial cancer
855375|NCT00017017|fallopian tube cancer|fallopian tube cancer
855376|NCT00017017|primary peritoneal cavity cancer|primary peritoneal cavity cancer
855377|NCT00014677|recurrent adult brain tumor|recurrent adult brain tumor
855378|NCT00014677|adult glioblastoma|adult glioblastoma
855379|NCT00014677|adult giant cell glioblastoma|adult giant cell glioblastoma
855380|NCT00014677|adult gliosarcoma|adult gliosarcoma
855381|NCT00014638|stage IV breast cancer|stage iv breast cancer
855382|NCT00014638|recurrent breast cancer|recurrent breast cancer
855383|NCT00014352|stage III prostate cancer|stage iii prostate cancer
855384|NCT00014352|stage IV prostate cancer|stage iv prostate cancer
855385|NCT00014352|recurrent prostate cancer|recurrent prostate cancer
855386|NCT00014352|thromboembolism|thromboembolism
855387|NCT00072826|3-hydroxy-3-methlglutaryl (HMG)|3-hydroxy-3-methlglutaryl (hmg)
855388|NCT00072826|Inhibitors|inhibitors
855389|NCT00072826|Endothelial Function|endothelial function
855390|NCT00072826|Leukocyte Gene Expression|leukocyte gene expression
855391|NCT00072826|Statins|statins
855392|NCT00072826|Atorvastatin|atorvastatin
855393|NCT00072826|Sickle Cell Disease|sickle cell disease
855394|NCT00072813|Genetics|genetics
855395|NCT00072813|Seizures|seizures
855396|NCT00072813|Brain Imaging|brain imaging
855397|NCT00072813|Diffusion|diffusion
855398|NCT00072813|Temporal Lobe|temporal lobe
855399|NCT00072800|Reliability|reliability
855400|NCT00072800|Muscle Tone Abnormality|muscle tone abnormality
855401|NCT00072800|Spasticity|spasticity
855402|NCT00072800|Dystonia|dystonia
855403|NCT00072800|Rigidity|rigidity
855404|NCT00072800|Cerebral Palsy|cerebral palsy
855405|NCT00072800|CP|cp
855406|NCT00072800|Children|children
855407|NCT00072709|ALS|als
855408|NCT00072709|Lou Gehrig's disease|lou gehrig's disease
855409|NCT00072683|Sodium|sodium
855410|NCT00072683|SIADH|siadh
855411|NCT00072683|Vasopressin|vasopressin
855412|NCT00072683|CHF|chf
855413|NCT00072683|Cirrhosis|cirrhosis
855414|NCT00072683|salt|salt
855415|NCT00072683|water|water
855416|NCT00072683|electrolyte|electrolyte
855417|NCT00072670|Prostate cancer|prostate cancer
855418|NCT00072670|Advanced prostate cancer|advanced prostate cancer
855419|NCT00072670|Metastatic prostate cancer|metastatic prostate cancer
855420|NCT00072670|Trabectedin|trabectedin
855421|NCT00072670|Yondelis|yondelis
855422|NCT00072670|ET-743|et-743
855423|NCT00012090|recurrent ovarian epithelial cancer|recurrent ovarian epithelial cancer
855424|NCT00012090|fallopian tube cancer|fallopian tube cancer
855425|NCT00012090|primary peritoneal cavity cancer|primary peritoneal cavity cancer
855426|NCT00010309|stage II melanoma|stage ii melanoma
855427|NCT00010309|stage III melanoma|stage iii melanoma
855428|NCT00010309|stage IV melanoma|stage iv melanoma
855429|NCT00008372|extensive stage small cell lung cancer|extensive stage small cell lung cancer
855430|NCT00008372|recurrent small cell lung cancer|recurrent small cell lung cancer
855431|NCT00006367|polycythemia vera|polycythemia vera
855432|NCT00006367|chronic idiopathic myelofibrosis|chronic idiopathic myelofibrosis
855433|NCT00006367|essential thrombocythemia|essential thrombocythemia
855434|NCT00006224|recurrent cervical cancer|recurrent cervical cancer
855435|NCT00006224|cervical adenocarcinoma|cervical adenocarcinoma
855436|NCT00006224|cervical adenosquamous cell carcinoma|cervical adenosquamous cell carcinoma
855437|NCT00072735|Use Dependent Plasticity|use dependent plasticity
855438|NCT00072735|Cortical Reorganization|cortical reorganization
855439|NCT00072735|Rehabilitation|rehabilitation
855440|NCT00072735|Somatosensory Nerve|somatosensory nerve
855441|NCT00072735|Amphetamine|amphetamine
855442|NCT00072735|Stroke|stroke
855443|NCT00072735|Healthy Volunteer|healthy volunteer
855444|NCT00072735|HV|hv
855445|NCT00072657|Arthritis|arthritis
855449|NCT00072657|Chronic Illness|chronic illness
855450|NCT00072657|Depression|depression
855451|NCT00072644|HIV|hiv
855452|NCT00072644|Osteonecrosis|osteonecrosis
855453|NCT00072644|Drug Interaction|drug interaction
855454|NCT00072644|P-Glycoprotein|p-glycoprotein
855455|NCT00072644|Cytochrome P 450|cytochrome p 450
855456|NCT00072644|Healthy Volunteer|healthy volunteer
855457|NCT00072644|HV|hv
855458|NCT00072631|Tarceva|tarceva
855461|NCT00072631|Non-Small Cell Lung Cancer|non-small cell lung cancer
855462|NCT00072631|EGFR|egfr
855463|NCT00072631|OSI-774|osi-774
855464|NCT00072501|breast cancer|breast cancer
855465|NCT00072488|disseminated neuroblastoma|disseminated neuroblastoma
855466|NCT00072488|localized resectable neuroblastoma|localized resectable neuroblastoma
855467|NCT00072488|localized unresectable neuroblastoma|localized unresectable neuroblastoma
855468|NCT00072488|regional neuroblastoma|regional neuroblastoma
855469|NCT00072488|stage 4S neuroblastoma|stage 4s neuroblastoma
855470|NCT00072488|previously untreated childhood rhabdomyosarcoma|previously untreated childhood rhabdomyosarcoma
855471|NCT00072488|stage I childhood Hodgkin lymphoma|stage i childhood hodgkin lymphoma
855472|NCT00072488|stage I childhood large cell lymphoma|stage i childhood large cell lymphoma
855473|NCT00072488|stage I childhood lymphoblastic lymphoma|stage i childhood lymphoblastic lymphoma
855474|NCT00072488|stage I childhood small noncleaved cell lymphoma|stage i childhood small noncleaved cell lymphoma
855475|NCT00072488|stage II childhood Hodgkin lymphoma|stage ii childhood hodgkin lymphoma
855476|NCT00072488|stage II childhood large cell lymphoma|stage ii childhood large cell lymphoma
855477|NCT00072488|stage II childhood lymphoblastic lymphoma|stage ii childhood lymphoblastic lymphoma
855478|NCT00072488|stage II childhood small noncleaved cell lymphoma|stage ii childhood small noncleaved cell lymphoma
855479|NCT00072488|stage III childhood Hodgkin lymphoma|stage iii childhood hodgkin lymphoma
855480|NCT00072488|stage III childhood large cell lymphoma|stage iii childhood large cell lymphoma
855481|NCT00072488|stage III childhood lymphoblastic lymphoma|stage iii childhood lymphoblastic lymphoma
855482|NCT00072488|stage III childhood small noncleaved cell lymphoma|stage iii childhood small noncleaved cell lymphoma
855483|NCT00072488|stage IV childhood Hodgkin lymphoma|stage iv childhood hodgkin lymphoma
855484|NCT00072488|stage IV childhood large cell lymphoma|stage iv childhood large cell lymphoma
855485|NCT00072488|stage IV childhood lymphoblastic lymphoma|stage iv childhood lymphoblastic lymphoma
855486|NCT00072488|stage IV childhood small noncleaved cell lymphoma|stage iv childhood small noncleaved cell lymphoma
855487|NCT00072488|localized Ewing sarcoma/peripheral primitive neuroectodermal tumor|localized ewing sarcoma/peripheral primitive neuroectodermal tumor
855488|NCT00072488|metastatic Ewing sarcoma/peripheral primitive neuroectodermal tumor|metastatic ewing sarcoma/peripheral primitive neuroectodermal tumor
855489|NCT00072488|previously treated childhood rhabdomyosarcoma|previously treated childhood rhabdomyosarcoma
855490|NCT00072475|refractory anemia with excess blasts|refractory anemia with excess blasts
855491|NCT00072475|refractory anemia with ringed sideroblasts|refractory anemia with ringed sideroblasts
855492|NCT00072475|refractory cytopenia with multilineage dysplasia|refractory cytopenia with multilineage dysplasia
855493|NCT00072475|chronic myelomonocytic leukemia|chronic myelomonocytic leukemia
855494|NCT00072475|de novo myelodysplastic syndromes|de novo myelodysplastic syndromes
855495|NCT00072475|secondary myelodysplastic syndromes|secondary myelodysplastic syndromes
855496|NCT00072475|myelodysplastic/myeloproliferative neoplasm, unclassifiable|myelodysplastic/myeloproliferative neoplasm, unclassifiable
855497|NCT00072475|refractory anemia|refractory anemia
855498|NCT00072475|previously treated myelodysplastic syndromes|previously treated myelodysplastic syndromes
855499|NCT00072462|ductal breast carcinoma in situ|ductal breast carcinoma in situ
855500|NCT00072462|breast cancer in situ|breast cancer in situ
855501|NCT00072449|primary central nervous system non-Hodgkin lymphoma|primary central nervous system non-hodgkin lymphoma
855502|NCT00072410|recurrent ovarian epithelial cancer|recurrent ovarian epithelial cancer
855503|NCT00072410|stage III ovarian epithelial cancer|stage iii ovarian epithelial cancer
855504|NCT00072358|disseminated neuroblastoma|disseminated neuroblastoma
855505|NCT00072358|localized unresectable neuroblastoma|localized unresectable neuroblastoma
855506|NCT00072358|recurrent neuroblastoma|recurrent neuroblastoma
855507|NCT00072358|regional neuroblastoma|regional neuroblastoma
855508|NCT00072358|stage 4S neuroblastoma|stage 4s neuroblastoma
855509|NCT00072345|stage III melanoma|stage iii melanoma
855510|NCT00072345|stage IV melanoma|stage iv melanoma
855511|NCT00072345|recurrent melanoma|recurrent melanoma
855512|NCT00072345|iris melanoma|iris melanoma
855513|NCT00072345|ciliary body and choroid melanoma, medium/large size|ciliary body and choroid melanoma, medium/large size
855514|NCT00072345|ciliary body and choroid melanoma, small size|ciliary body and choroid melanoma, small size
855515|NCT00072345|extraocular extension melanoma|extraocular extension melanoma
855516|NCT00072345|recurrent intraocular melanoma|recurrent intraocular melanoma
855517|NCT00072332|unspecified adult solid tumor, protocol specific|unspecified adult solid tumor, protocol specific
855518|NCT00072332|stage IV esophageal cancer|stage iv esophageal cancer
855519|NCT00072332|stage IV gastric cancer|stage iv gastric cancer
855520|NCT00072319|stage I breast cancer|stage i breast cancer
855521|NCT00072319|stage II breast cancer|stage ii breast cancer
855522|NCT00072319|stage IIIA breast cancer|stage iiia breast cancer
855523|NCT00072319|stage IIIB breast cancer|stage iiib breast cancer
855524|NCT00072319|stage IIIC breast cancer|stage iiic breast cancer
855525|NCT00072319|inflammatory breast cancer|inflammatory breast cancer
855527|NCT00072293|stage IB breast cancer|stage ib breast cancer
855528|NCT00072293|stage II breast cancer|stage ii breast cancer
855529|NCT00072293|estrogen receptor-negative breast cancer|estrogen receptor-negative breast cancer
855530|NCT00072293|estrogen receptor-positive breast cancer|estrogen receptor-positive breast cancer
855531|NCT00072293|progesterone receptor-negative breast cancer|progesterone receptor-negative breast cancer
855532|NCT00072293|progesterone receptor-positive breast cancer|progesterone receptor-positive breast cancer
855533|NCT00072280|childhood fibrosarcoma|childhood fibrosarcoma
855534|NCT00072280|nonmetastatic childhood soft tissue sarcoma|nonmetastatic childhood soft tissue sarcoma
855535|NCT00072267|stage IV ovarian epithelial cancer|stage iv ovarian epithelial cancer
855536|NCT00072267|recurrent ovarian epithelial cancer|recurrent ovarian epithelial cancer
855537|NCT00072267|primary peritoneal cavity cancer|primary peritoneal cavity cancer
855538|NCT00072267|fallopian tube cancer|fallopian tube cancer
855539|NCT00072267|stage III ovarian epithelial cancer|stage iii ovarian epithelial cancer
855540|NCT00072215|recurrent malignant testicular germ cell tumor|recurrent malignant testicular germ cell tumor
855541|NCT00072215|stage III malignant testicular germ cell tumor|stage iii malignant testicular germ cell tumor
855542|NCT00072215|testicular choriocarcinoma and embryonal carcinoma|testicular choriocarcinoma and embryonal carcinoma
855543|NCT00072215|testicular choriocarcinoma and seminoma|testicular choriocarcinoma and seminoma
855544|NCT00072215|testicular choriocarcinoma and teratoma|testicular choriocarcinoma and teratoma
855545|NCT00072215|testicular choriocarcinoma and yolk sac tumor|testicular choriocarcinoma and yolk sac tumor
855546|NCT00072215|testicular choriocarcinoma|testicular choriocarcinoma
855547|NCT00072215|testicular embryonal carcinoma and seminoma|testicular embryonal carcinoma and seminoma
855548|NCT00072215|testicular embryonal carcinoma and teratoma with seminoma|testicular embryonal carcinoma and teratoma with seminoma
855549|NCT00072215|testicular embryonal carcinoma and teratoma|testicular embryonal carcinoma and teratoma
855550|NCT00072215|testicular embryonal carcinoma and yolk sac tumor with seminoma|testicular embryonal carcinoma and yolk sac tumor with seminoma
855551|NCT00072215|testicular embryonal carcinoma and yolk sac tumor|testicular embryonal carcinoma and yolk sac tumor
855552|NCT00072215|testicular embryonal carcinoma|testicular embryonal carcinoma
855553|NCT00072215|testicular seminoma|testicular seminoma
855554|NCT00072215|testicular yolk sac tumor and teratoma with seminoma|testicular yolk sac tumor and teratoma with seminoma
855555|NCT00072215|testicular yolk sac tumor and teratoma|testicular yolk sac tumor and teratoma
855556|NCT00072215|testicular yolk sac tumor|testicular yolk sac tumor
855557|NCT00072215|recurrent extragonadal non-seminomatous germ cell tumor|recurrent extragonadal non-seminomatous germ cell tumor
855558|NCT00072215|recurrent extragonadal seminoma|recurrent extragonadal seminoma
855559|NCT00072215|stage IV extragonadal non-seminomatous germ cell tumor|stage iv extragonadal non-seminomatous germ cell tumor
855560|NCT00072215|stage IV extragonadal seminoma|stage iv extragonadal seminoma
855561|NCT00072215|testicular immature teratoma|testicular immature teratoma
855562|NCT00072215|testicular mature teratoma|testicular mature teratoma
855563|NCT00072215|recurrent extragonadal germ cell tumor|recurrent extragonadal germ cell tumor
855564|NCT00072124|stage IV melanoma|stage iv melanoma
855565|NCT00072124|recurrent melanoma|recurrent melanoma
855566|NCT00072111|unspecified adult solid tumor, protocol specific|unspecified adult solid tumor, protocol specific
855567|NCT00072098|stage IV colon cancer|stage iv colon cancer
855568|NCT00072098|stage IV rectal cancer|stage iv rectal cancer
855569|NCT00072098|liver metastases|liver metastases
855570|NCT00072098|recurrent rectal cancer|recurrent rectal cancer
855571|NCT00072098|recurrent colon cancer|recurrent colon cancer
855572|NCT00072085|stage IV melanoma|stage iv melanoma
855573|NCT00072085|recurrent melanoma|recurrent melanoma
855574|NCT00072072|recurrent non-small cell lung cancer|recurrent non-small cell lung cancer
855575|NCT00072072|stage IIIB non-small cell lung cancer|stage iiib non-small cell lung cancer
855576|NCT00072072|stage IV non-small cell lung cancer|stage iv non-small cell lung cancer
855577|NCT00072059|anemia|anemia
855578|NCT00072059|stage IIIB non-small cell lung cancer|stage iiib non-small cell lung cancer
855579|NCT00072059|stage IV non-small cell lung cancer|stage iv non-small cell lung cancer
855580|NCT00072059|recurrent non-small cell lung cancer|recurrent non-small cell lung cancer
855581|NCT00072046|stage IV renal cell cancer|stage iv renal cell cancer
855582|NCT00072046|clear cell renal cell carcinoma|clear cell renal cell carcinoma
855583|NCT00072046|recurrent renal cell cancer|recurrent renal cell cancer
855584|NCT00072033|stage II esophageal cancer|stage ii esophageal cancer
855585|NCT00072033|stage III esophageal cancer|stage iii esophageal cancer
855586|NCT00072033|adenocarcinoma of the esophagus|adenocarcinoma of the esophagus
855587|NCT00072033|squamous cell carcinoma of the esophagus|squamous cell carcinoma of the esophagus
855588|NCT00072020|bone metastases|bone metastases
855589|NCT00072020|stage II breast cancer|stage ii breast cancer
855590|NCT00072020|stage IIIA breast cancer|stage iiia breast cancer
855591|NCT00072020|stage IIIB breast cancer|stage iiib breast cancer
855592|NCT00072020|stage IIIC breast cancer|stage iiic breast cancer
855593|NCT00072007|B-cell chronic lymphocytic leukemia|b-cell chronic lymphocytic leukemia
855594|NCT00072007|refractory chronic lymphocytic leukemia|refractory chronic lymphocytic leukemia
855595|NCT00072007|stage II chronic lymphocytic leukemia|stage ii chronic lymphocytic leukemia
855596|NCT00072007|stage III chronic lymphocytic leukemia|stage iii chronic lymphocytic leukemia
855597|NCT00072007|stage I chronic lymphocytic leukemia|stage i chronic lymphocytic leukemia
855598|NCT00072007|stage IV chronic lymphocytic leukemia|stage iv chronic lymphocytic leukemia
855599|NCT00071981|stage IV melanoma|stage iv melanoma
855600|NCT00071981|recurrent melanoma|recurrent melanoma
855601|NCT00071968|adenocarcinoma of the prostate|adenocarcinoma of the prostate
855602|NCT00071968|stage IIB prostate cancer|stage iib prostate cancer
855603|NCT00071968|stage IIA prostate cancer|stage iia prostate cancer
855604|NCT00071968|stage I prostate cancer|stage i prostate cancer
855605|NCT00071955|recurrent grade 1 follicular lymphoma|recurrent grade 1 follicular lymphoma
855606|NCT00071955|recurrent grade 2 follicular lymphoma|recurrent grade 2 follicular lymphoma
855607|NCT00071955|recurrent grade 3 follicular lymphoma|recurrent grade 3 follicular lymphoma
855608|NCT00071955|stage III grade 1 follicular lymphoma|stage iii grade 1 follicular lymphoma
855609|NCT00071955|stage III grade 2 follicular lymphoma|stage iii grade 2 follicular lymphoma
855610|NCT00071955|stage III grade 3 follicular lymphoma|stage iii grade 3 follicular lymphoma
855611|NCT00071955|stage IV grade 1 follicular lymphoma|stage iv grade 1 follicular lymphoma
855612|NCT00071955|stage IV grade 2 follicular lymphoma|stage iv grade 2 follicular lymphoma
855613|NCT00071955|stage IV grade 3 follicular lymphoma|stage iv grade 3 follicular lymphoma
855614|NCT00071929|recurrent endometrial carcinoma|recurrent endometrial carcinoma
855615|NCT00003141|childhood infratentorial ependymoma|childhood infratentorial ependymoma
855616|NCT00003141|childhood supratentorial ependymoma|childhood supratentorial ependymoma
855617|NCT00003141|disseminated neuroblastoma|disseminated neuroblastoma
855618|NCT00003141|stage 4S neuroblastoma|stage 4s neuroblastoma
855619|NCT00003141|embryonal childhood rhabdomyosarcoma|embryonal childhood rhabdomyosarcoma
855620|NCT00003141|childhood high-grade cerebral astrocytoma|childhood high-grade cerebral astrocytoma
855621|NCT00003141|childhood choroid plexus tumor|childhood choroid plexus tumor
855622|NCT00003141|previously untreated childhood rhabdomyosarcoma|previously untreated childhood rhabdomyosarcoma
855623|NCT00003141|untreated childhood brain stem glioma|untreated childhood brain stem glioma
855624|NCT00003141|untreated childhood supratentorial primitive neuroectodermal tumor|untreated childhood supratentorial primitive neuroectodermal tumor
855625|NCT00003141|untreated childhood cerebellar astrocytoma|untreated childhood cerebellar astrocytoma
855626|NCT00003141|untreated childhood medulloblastoma|untreated childhood medulloblastoma
855627|NCT00003141|newly diagnosed childhood ependymoma|newly diagnosed childhood ependymoma
855628|NCT00003141|localized resectable neuroblastoma|localized resectable neuroblastoma
855629|NCT00003141|localized unresectable neuroblastoma|localized unresectable neuroblastoma
855630|NCT00003141|regional neuroblastoma|regional neuroblastoma
855631|NCT00003141|childhood spinal cord neoplasm|childhood spinal cord neoplasm
855632|NCT00003141|childhood atypical teratoid/rhabdoid tumor|childhood atypical teratoid/rhabdoid tumor
855633|NCT00003141|childhood low-grade cerebral astrocytoma|childhood low-grade cerebral astrocytoma
855634|NCT00003141|childhood central nervous system choriocarcinoma|childhood central nervous system choriocarcinoma
855635|NCT00003141|childhood central nervous system embryonal tumor|childhood central nervous system embryonal tumor
855636|NCT00003141|childhood central nervous system germinoma|childhood central nervous system germinoma
855637|NCT00003141|childhood central nervous system mixed germ cell tumor|childhood central nervous system mixed germ cell tumor
855638|NCT00003141|childhood central nervous system teratoma|childhood central nervous system teratoma
855639|NCT00003141|childhood central nervous system yolk sac tumor|childhood central nervous system yolk sac tumor
855640|NCT00072605|Healthy|healthy
855641|NCT00072605|T Cells|t cells
855642|NCT00072605|Immunity|immunity
855643|NCT00072605|Hemorrhagic Fever|hemorrhagic fever
855644|NCT00072605|Healthy Volunteer|healthy volunteer
855645|NCT00072605|HV|hv
855646|NCT00072592|ANCA|anca
855647|NCT00072592|B Lymphocyte|b lymphocyte
855648|NCT00072592|Vasculitis|vasculitis
855649|NCT00072592|Treatment|treatment
855650|NCT00072592|Remission|remission
855651|NCT00072592|Wegener Granulomatosis|wegener granulomatosis
855652|NCT00072592|WG|wg
855653|NCT00072579|chronic phase chronic myelogenous leukemia|chronic phase chronic myelogenous leukemia
855654|NCT00072579|chronic myelogenous leukemia, BCR-ABL1 positive|chronic myelogenous leukemia, bcr-abl1 positive
855655|NCT00072553|stage IV rectal cancer|stage iv rectal cancer
855656|NCT00072553|stage IV colon cancer|stage iv colon cancer
855657|NCT00072553|adenocarcinoma of the colon|adenocarcinoma of the colon
855658|NCT00072553|adenocarcinoma of the rectum|adenocarcinoma of the rectum
855659|NCT00072553|recurrent rectal cancer|recurrent rectal cancer
855660|NCT00072553|recurrent colon cancer|recurrent colon cancer
855661|NCT00072527|limited stage small cell lung cancer|limited stage small cell lung cancer
855662|NCT00071916|Hepatitis C, African Americans, ribavirin|hepatitis c, african americans, ribavirin
855663|NCT00071851|HIV Seronegativity|hiv seronegativity
855664|NCT00071851|HIV Preventive Vaccine|hiv preventive vaccine
855665|NCT00071812|RA|ra
855666|NCT00006008|recurrent adult acute lymphoblastic leukemia|recurrent adult acute lymphoblastic leukemia
855667|NCT00006008|L1 adult acute lymphoblastic leukemia|l1 adult acute lymphoblastic leukemia
855668|NCT00006008|L2 adult acute lymphoblastic leukemia|l2 adult acute lymphoblastic leukemia
855752|NCT00071682|herbal medicine|herbal medicine
855669|NCT00006008|L3 adult acute lymphoblastic leukemia|l3 adult acute lymphoblastic leukemia
855670|NCT00005964|stage III adult diffuse large cell lymphoma|stage iii adult diffuse large cell lymphoma
855671|NCT00005964|stage III adult immunoblastic large cell lymphoma|stage iii adult immunoblastic large cell lymphoma
855672|NCT00005964|stage III adult lymphoblastic lymphoma|stage iii adult lymphoblastic lymphoma
855673|NCT00005964|stage IV adult diffuse large cell lymphoma|stage iv adult diffuse large cell lymphoma
855674|NCT00005964|stage IV adult immunoblastic large cell lymphoma|stage iv adult immunoblastic large cell lymphoma
855675|NCT00005964|stage IV adult lymphoblastic lymphoma|stage iv adult lymphoblastic lymphoma
881088|NCT00034697|Brain mets|brain mets
855676|NCT00005964|contiguous stage II adult immunoblastic large cell lymphoma|contiguous stage ii adult immunoblastic large cell lymphoma
855677|NCT00005964|contiguous stage II adult diffuse large cell lymphoma|contiguous stage ii adult diffuse large cell lymphoma
855678|NCT00005964|contiguous stage II adult lymphoblastic lymphoma|contiguous stage ii adult lymphoblastic lymphoma
855679|NCT00005964|noncontiguous stage II adult immunoblastic large cell lymphoma|noncontiguous stage ii adult immunoblastic large cell lymphoma
855680|NCT00005964|noncontiguous stage II adult diffuse large cell lymphoma|noncontiguous stage ii adult diffuse large cell lymphoma
855681|NCT00005964|noncontiguous stage II adult lymphoblastic lymphoma|noncontiguous stage ii adult lymphoblastic lymphoma
855682|NCT00005962|recurrent adult acute myeloid leukemia|recurrent adult acute myeloid leukemia
855683|NCT00005962|adult acute erythroid leukemia (M6)|adult acute erythroid leukemia (m6)
855684|NCT00005962|adult acute myeloblastic leukemia without maturation (M1)|adult acute myeloblastic leukemia without maturation (m1)
855685|NCT00005962|adult acute myeloblastic leukemia with maturation (M2)|adult acute myeloblastic leukemia with maturation (m2)
855686|NCT00005962|adult acute promyelocytic leukemia (M3)|adult acute promyelocytic leukemia (m3)
855687|NCT00005962|adult acute myelomonocytic leukemia (M4)|adult acute myelomonocytic leukemia (m4)
855688|NCT00005962|adult acute monoblastic leukemia (M5a)|adult acute monoblastic leukemia (m5a)
855689|NCT00005962|adult acute megakaryoblastic leukemia (M7)|adult acute megakaryoblastic leukemia (m7)
855690|NCT00005962|adult acute monocytic leukemia (M5b)|adult acute monocytic leukemia (m5b)
855691|NCT00005962|adult acute minimally differentiated myeloid leukemia (M0)|adult acute minimally differentiated myeloid leukemia (m0)
855692|NCT00071903|Thrombophilia|thrombophilia
855693|NCT00071903|Idiopathic Intracranial Hypertension|idiopathic intracranial hypertension
855694|NCT00071903|Kidney Involvement|kidney involvement
855695|NCT00071903|Lysosomal Storage Disorder|lysosomal storage disorder
855696|NCT00071903|Cystine|cystine
855697|NCT00071903|Pseudotumor Cerebri|pseudotumor cerebri
855698|NCT00071903|Susceptibility to Thrombosis|susceptibility to thrombosis
855699|NCT00071903|Nephropathic Cystinosis|nephropathic cystinosis
855700|NCT00071903|PTC|ptc
855701|NCT00071903|Intracranial Hypertension|intracranial hypertension
855702|NCT00071890|Interleukin 2|interleukin 2
855703|NCT00071890|Treatment Interruption|treatment interruption
855704|NCT00071890|HIV|hiv
855705|NCT00071877|Lysosomal Disease|lysosomal disease
855706|NCT00071877|Hypohidrosis|hypohidrosis
855707|NCT00071877|Pain|pain
855708|NCT00071877|Neuropathy|neuropathy
855709|NCT00071877|X-Linked|x-linked
855710|NCT00071877|Fabry Disease|fabry disease
855711|NCT00071877|Children|children
855712|NCT00005072|stage I prostate cancer|stage i prostate cancer
855713|NCT00005072|stage IIB prostate cancer|stage iib prostate cancer
855714|NCT00005072|stage IIA prostate cancer|stage iia prostate cancer
855715|NCT00005072|recurrent prostate cancer|recurrent prostate cancer
855716|NCT00005046|recurrent ovarian epithelial cancer|recurrent ovarian epithelial cancer
855717|NCT00005046|primary peritoneal cavity cancer|primary peritoneal cavity cancer
855718|NCT00004206|recurrent ovarian epithelial cancer|recurrent ovarian epithelial cancer
855719|NCT00004093|stage IIIA non-small cell lung cancer|stage iiia non-small cell lung cancer
855720|NCT00004093|stage IIIB non-small cell lung cancer|stage iiib non-small cell lung cancer
855721|NCT00071838|Neuroimmunology|neuroimmunology
855722|NCT00071838|Therapy|therapy
855723|NCT00071838|Demyelinating Disease|demyelinating disease
855724|NCT00071838|Immunological Mechanism|immunological mechanism
855725|NCT00071838|MRI|mri
855726|NCT00071838|Multiple Sclerosis|multiple sclerosis
855727|NCT00071838|MS|ms
855728|NCT00071773|diabetic macular edema|diabetic macular edema
855729|NCT00071773|laser photocoagulation|laser photocoagulation
855730|NCT00071773|etdrs|etdrs
855731|NCT00071773|macular grid photocoagulation|macular grid photocoagulation
855732|NCT00071773|DME|dme
855733|NCT00071786|Bipolar Mood Disorder|bipolar mood disorder
855734|NCT00071786|Migraine|migraine
855735|NCT00071786|Behavior Genetics|behavior genetics
855736|NCT00071786|Genetic Epidemiology|genetic epidemiology
855737|NCT00071786|Family Study|family study
855738|NCT00071760|pediatrics|pediatrics
855739|NCT00071760|ritonavir|ritonavir
855740|NCT00071760|amprenavir|amprenavir
855741|NCT00071760|AGENERASE|agenerase
855742|NCT00071760|HIV|hiv
855743|NCT00071760|Lexiva|lexiva
855744|NCT00071760|protease inhibitors|protease inhibitors
855745|NCT00071760|HIV Infection|hiv infection
855746|NCT00071760|fosamprenavir|fosamprenavir
855747|NCT00071747|schizophrenia|schizophrenia
855748|NCT00071747|lamotrigine|lamotrigine
855749|NCT00071721|Alzheimer disease|alzheimer disease
855750|NCT00071721|Agitation|agitation
855751|NCT00071721|Psychosis|psychosis
855753|NCT00071682|alternative medicines|alternative medicines
855754|NCT00071682|anticoagulation|anticoagulation
855755|NCT00071682|side effects|side effects
855756|NCT00071682|bleeding|bleeding
855757|NCT00071682|clotting|clotting
855758|NCT00071669|Mood Disorder|mood disorder
855759|NCT00071669|Acupuncture|acupuncture
855760|NCT00071643|Stroke|stroke
855761|NCT00071630|Adolescent|adolescent
855762|NCT00071617|Suicide|suicide
855763|NCT00071617|Adolescence|adolescence
855764|NCT00071578|Psychotherapy|psychotherapy
855765|NCT00071578|Treatment|treatment
855767|NCT00071734|Auditory Feedback|auditory feedback
855768|NCT00071734|Motor Control|motor control
855769|NCT00071734|Adult|adult
855770|NCT00071734|BOLD|bold
855771|NCT00071734|Healthy Volunteer|healthy volunteer
855772|NCT00071734|HV|hv
855773|NCT00071565|familial intracranial aneurysm|familial intracranial aneurysm
855774|NCT00071565|intracranial aneurysm|intracranial aneurysm
855775|NCT00071565|brain aneurysm|brain aneurysm
855776|NCT00071565|aneurysm|aneurysm
855777|NCT00071565|subarachnoid hemorrhage|subarachnoid hemorrhage
855778|NCT00071565|stroke|stroke
855779|NCT00071552|Poorly Controlled Asthma|poorly controlled asthma
855780|NCT00071539|gross total resection|gross total resection
855781|NCT00004050|stage IIB prostate cancer|stage iib prostate cancer
855782|NCT00004050|stage IIA prostate cancer|stage iia prostate cancer
855783|NCT00004050|stage III prostate cancer|stage iii prostate cancer
855784|NCT00004025|stage III melanoma|stage iii melanoma
855785|NCT00004025|stage IV melanoma|stage iv melanoma
855786|NCT00004025|recurrent melanoma|recurrent melanoma
855787|NCT00003794|stage I ovarian germ cell tumor|stage i ovarian germ cell tumor
855788|NCT00003794|stage II ovarian germ cell tumor|stage ii ovarian germ cell tumor
855789|NCT00003794|stage III ovarian germ cell tumor|stage iii ovarian germ cell tumor
855790|NCT00003794|stage IV ovarian germ cell tumor|stage iv ovarian germ cell tumor
855791|NCT00003794|recurrent ovarian germ cell tumor|recurrent ovarian germ cell tumor
855792|NCT00003648|stage I colon cancer|stage i colon cancer
855793|NCT00003648|stage II colon cancer|stage ii colon cancer
855794|NCT00003648|stage III colon cancer|stage iii colon cancer
855795|NCT00003648|stage IV colon cancer|stage iv colon cancer
855796|NCT00003648|stage I rectal cancer|stage i rectal cancer
855797|NCT00003648|stage II rectal cancer|stage ii rectal cancer
855798|NCT00003648|stage III rectal cancer|stage iii rectal cancer
855799|NCT00003648|stage IV rectal cancer|stage iv rectal cancer
855800|NCT00003648|recurrent colon cancer|recurrent colon cancer
855801|NCT00003648|recurrent rectal cancer|recurrent rectal cancer
855802|NCT00071526|Vitamin C|vitamin c
855803|NCT00071526|Diabetes Mellitus|diabetes mellitus
855804|NCT00071526|Proteinuria|proteinuria
855805|NCT00071526|Plasma Concentrations|plasma concentrations
855806|NCT00071526|Healthy Volunteer|healthy volunteer
855807|NCT00071513|Adolescent|adolescent
855808|NCT00071513|Substance Abuse|substance abuse
855809|NCT00071513|At-risk|at-risk
855810|NCT00071500|Compliance|compliance
855811|NCT00071500|Adherence|adherence
855812|NCT00071500|Computerized|computerized
855813|NCT00071500|Electronic Pillbox|electronic pillbox
855814|NCT00071500|Treatment Experienced|treatment experienced
855815|NCT00071487|SLE|sle
855816|NCT00003595|childhood Burkitt lymphoma|childhood burkitt lymphoma
855817|NCT00003595|AIDS-related peripheral/systemic lymphoma|aids-related peripheral/systemic lymphoma
855818|NCT00003595|AIDS-related diffuse large cell lymphoma|aids-related diffuse large cell lymphoma
855819|NCT00003595|AIDS-related immunoblastic large cell lymphoma|aids-related immunoblastic large cell lymphoma
855820|NCT00003595|AIDS-related small noncleaved cell lymphoma|aids-related small noncleaved cell lymphoma
855821|NCT00003266|unspecified adult solid tumor, protocol specific|unspecified adult solid tumor, protocol specific
855822|NCT00003266|fatigue|fatigue
855823|NCT00003234|recurrent childhood rhabdomyosarcoma|recurrent childhood rhabdomyosarcoma
855824|NCT00003234|recurrent neuroblastoma|recurrent neuroblastoma
855825|NCT00003234|recurrent childhood soft tissue sarcoma|recurrent childhood soft tissue sarcoma
855826|NCT00003234|recurrent childhood supratentorial primitive neuroectodermal tumor|recurrent childhood supratentorial primitive neuroectodermal tumor
855827|NCT00003234|recurrent childhood cerebellar astrocytoma|recurrent childhood cerebellar astrocytoma
855828|NCT00003234|recurrent childhood cerebral astrocytoma|recurrent childhood cerebral astrocytoma
855829|NCT00003234|recurrent Ewing sarcoma/peripheral primitive neuroectodermal tumor|recurrent ewing sarcoma/peripheral primitive neuroectodermal tumor
855830|NCT00003234|recurrent childhood ependymoma|recurrent childhood ependymoma
855831|NCT00003126|renal cell cancer|renal cell cancer
855832|NCT00003126|renal cell carcinoma|renal cell carcinoma
855833|NCT00003126|interleukin-2|interleukin-2
855834|NCT00071474|temporomandibular disroders|temporomandibular disroders
855835|NCT00071474|shamanism|shamanism
855836|NCT00071474|chronic pain|chronic pain
855837|NCT00071461|Idiopathic pulmonary fibrosis|idiopathic pulmonary fibrosis
855838|NCT00071461|Interstitial lung disease|interstitial lung disease
855839|NCT00071461|Bosentan|bosentan
855840|NCT00071461|BUILD|build
855841|NCT00071435|EEG|eeg
855842|NCT00071435|Voluntary Movement|voluntary movement
855843|NCT00071435|Motor Cortex|motor cortex
855844|NCT00071435|Reaction Time|reaction time
855845|NCT00071435|Corticospinal|corticospinal
855846|NCT00071435|Primary Lateral Sclerosis|primary lateral sclerosis
855847|NCT00071435|PLS|pls
855848|NCT00071435|Healthy Volunteer|healthy volunteer
855849|NCT00071435|HV|hv
855850|NCT00071422|Type 2 diabetes|type 2 diabetes
855851|NCT00071409|Type 1 diabetes|type 1 diabetes
855852|NCT00071396|Chronic Lymphocytic Leukemia|chronic lymphocytic leukemia
855853|NCT00071396|CD-52 and CD-20 Positive|cd-52 and cd-20 positive
855854|NCT00071396|Refractory|refractory
855855|NCT00071396|Relapsed|relapsed
881285|NCT00034034|anxiety|anxiety
855856|NCT00033527|non-small cell lung cancer|non-small cell lung cancer
855857|NCT00033527|small cell lung cancer|small cell lung cancer
855858|NCT00025350|stage IV colon cancer|stage iv colon cancer
855859|NCT00025350|stage IV rectal cancer|stage iv rectal cancer
855860|NCT00025350|recurrent colon cancer|recurrent colon cancer
855861|NCT00025350|recurrent rectal cancer|recurrent rectal cancer
855862|NCT00025350|adenocarcinoma of the colon|adenocarcinoma of the colon
855863|NCT00025350|adenocarcinoma of the rectum|adenocarcinoma of the rectum
855864|NCT00002935|stage 0 esophageal cancer|stage 0 esophageal cancer
855865|NCT00002723|adenocarcinoma of the prostate|adenocarcinoma of the prostate
855866|NCT00002723|stage III prostate cancer|stage iii prostate cancer
855867|NCT00002723|stage IV prostate cancer|stage iv prostate cancer
855868|NCT00002723|recurrent prostate cancer|recurrent prostate cancer
855869|NCT00071331|chronic heart failure|chronic heart failure
855870|NCT00071331|heart failure|heart failure
855871|NCT00071292|rheumatoid arthritis|rheumatoid arthritis
855872|NCT00071292|stress reduction|stress reduction
855873|NCT00071292|meditation|meditation
855874|NCT00071292|mindfulness|mindfulness
855875|NCT00071292|MBSR|mbsr
855876|NCT00071292|mindfulness-based stress reduction|mindfulness-based stress reduction
855877|NCT00071292|mind-body skills|mind-body skills
855878|NCT00030420|recurrent non-small cell lung cancer|recurrent non-small cell lung cancer
855879|NCT00030420|stage IIIA non-small cell lung cancer|stage iiia non-small cell lung cancer
855880|NCT00030420|stage IIIB non-small cell lung cancer|stage iiib non-small cell lung cancer
855881|NCT00030420|stage IV non-small cell lung cancer|stage iv non-small cell lung cancer
855882|NCT00026260|recurrent cervical cancer|recurrent cervical cancer
855883|NCT00026260|cervical squamous cell carcinoma|cervical squamous cell carcinoma
855884|NCT00024128|AIDS-related peripheral/systemic lymphoma|aids-related peripheral/systemic lymphoma
855885|NCT00024128|HIV-associated Hodgkin lymphoma|hiv-associated hodgkin lymphoma
855886|NCT00023738|stage III adult soft tissue sarcoma|stage iii adult soft tissue sarcoma
855887|NCT00023738|recurrent adult soft tissue sarcoma|recurrent adult soft tissue sarcoma
855888|NCT00023738|stage II adult soft tissue sarcoma|stage ii adult soft tissue sarcoma
855889|NCT00071370|Magnetoencephalography|magnetoencephalography
855890|NCT00071370|Electroencephalogram (EEG)|electroencephalogram (eeg)
855891|NCT00071370|Interictal Epileptiform Discharges|interictal epileptiform discharges
855892|NCT00071370|Epilepsy|epilepsy
855893|NCT00071370|Sleep Deprivation|sleep deprivation
855894|NCT00071370|Seizure|seizure
855895|NCT00071305|Magnetoencephalography|magnetoencephalography
855896|NCT00071305|Electroencephalography|electroencephalography
855897|NCT00071305|Epilepsy|epilepsy
855898|NCT00071305|Dipole Modeling|dipole modeling
855899|NCT00071305|Surgery|surgery
855900|NCT00071266|Intermittent Claudication|intermittent claudication
855901|NCT00071266|Peripheral Arterial Disease|peripheral arterial disease
855902|NCT00071266|Atherosclerosis|atherosclerosis
855903|NCT00071266|Niacin|niacin
855904|NCT00071266|Lovastatin|lovastatin
855905|NCT00071266|PAD|pad
855906|NCT00071266|IC|ic
855907|NCT00071253|Bipolar Disorder - Mania|bipolar disorder - mania
855908|NCT00071240|Growth Hormone|growth hormone
855909|NCT00071240|HIV|hiv
855910|NCT00071240|AIDS|aids
855911|NCT00071240|Thymus|thymus
855912|NCT00071240|CD4 Cell|cd4 cell
855913|NCT00071240|Immune System|immune system
855914|NCT00071240|Treatment Experienced|treatment experienced
855915|NCT00071214|Staphylococcal infection|staphylococcal infection
855916|NCT00071214|Gram positive bacteria|gram positive bacteria
855917|NCT00071214|Staphylococcus|staphylococcus
855918|NCT00071214|Staphylococcus aureus|staphylococcus aureus
855919|NCT00071214|Staphylococcus aureus infection|staphylococcus aureus infection
855920|NCT00064428|ST-segment elevation myocardial infarction|st-segment elevation myocardial infarction
855921|NCT00064428|fondaparinux|fondaparinux
855922|NCT00064428|Acute Myocardial Infarction|acute myocardial infarction
855923|NCT00064428|acute coronary syndrome|acute coronary syndrome
855924|NCT00071227|Age Related Macular Degeneration|age related macular degeneration
855925|NCT00071227|Macular Edema|macular edema
855926|NCT00071227|Inflammation|inflammation
855927|NCT00071227|Choroidal Neovascularization|choroidal neovascularization
855928|NCT00071227|CRVO|crvo
855929|NCT00071227|Diabetic Retinopathy|diabetic retinopathy
855930|NCT00071227|Age Related Macular Edema|age related macular edema
855931|NCT00071227|AMD|amd
855932|NCT00071188|Non-Small-Cell Lung Carcinoma|non-small-cell lung carcinoma
855933|NCT00071175|Lupus|lupus
855934|NCT00071175|Genetics|genetics
855935|NCT00071162|Pain|pain
855936|NCT00071162|Fatigue|fatigue
855939|NCT00071162|Irritable Bowel Syndrome|irritable bowel syndrome
855940|NCT00071162|Chronic Fatigue Syndrome|chronic fatigue syndrome
855941|NCT00071149|Rheumatoid Arthritis|rheumatoid arthritis
855942|NCT00071149|TCM|tcm
855943|NCT00071149|Diagnosis|diagnosis
855944|NCT00071149|Traditional Chinese Medicine|traditional chinese medicine
855945|NCT00071149|Complementary Therapies|complementary therapies
855946|NCT00071110|Acupuncture|acupuncture
855947|NCT00071110|Electroacupuncture|electroacupuncture
855948|NCT00071110|Alternative therapy|alternative therapy
855949|NCT00071097|HIV|hiv
855952|NCT00071097|Tolerability|tolerability
855953|NCT00071097|Safety and efficacy|safety and efficacy
855954|NCT00071097|TMC114-C211|tmc114-c211
855955|NCT00071084|Skin cancer|skin cancer
855956|NCT00071084|Lymphoma|lymphoma
855957|NCT00071084|Mycosis fungoides|mycosis fungoides
855958|NCT00071084|Sezary syndrome|sezary syndrome
855959|NCT00071071|Skin cancer|skin cancer
855960|NCT00071071|Lymphoma|lymphoma
855961|NCT00071071|Mycosis fungoides|mycosis fungoides
855962|NCT00071071|Sezary syndrome|sezary syndrome
855963|NCT00023725|stage I adult soft tissue sarcoma|stage i adult soft tissue sarcoma
855964|NCT00023699|recurrent ovarian epithelial cancer|recurrent ovarian epithelial cancer
855965|NCT00023699|primary peritoneal cavity cancer|primary peritoneal cavity cancer
855966|NCT00022282|refractory multiple myeloma|refractory multiple myeloma
855967|NCT00016250|stage IV colon cancer|stage iv colon cancer
855968|NCT00016250|stage IV rectal cancer|stage iv rectal cancer
855969|NCT00016250|recurrent colon cancer|recurrent colon cancer
855970|NCT00016250|recurrent rectal cancer|recurrent rectal cancer
855971|NCT00016250|adenocarcinoma of the colon|adenocarcinoma of the colon
855972|NCT00016250|adenocarcinoma of the rectum|adenocarcinoma of the rectum
855973|NCT00015886|stage IV breast cancer|stage iv breast cancer
855974|NCT00015886|recurrent breast cancer|recurrent breast cancer
855975|NCT00015886|stage IIIB breast cancer|stage iiib breast cancer
855976|NCT00014144|recurrent bladder cancer|recurrent bladder cancer
855977|NCT00014144|stage IV bladder cancer|stage iv bladder cancer
855978|NCT00014144|transitional cell carcinoma of the bladder|transitional cell carcinoma of the bladder
855979|NCT00014144|recurrent urethral cancer|recurrent urethral cancer
855980|NCT00014144|urethral cancer associated with invasive bladder cancer|urethral cancer associated with invasive bladder cancer
855981|NCT00014144|metastatic transitional cell cancer of the renal pelvis and ureter|metastatic transitional cell cancer of the renal pelvis and ureter
855982|NCT00014144|recurrent transitional cell cancer of the renal pelvis and ureter|recurrent transitional cell cancer of the renal pelvis and ureter
855983|NCT00014144|anterior urethral cancer|anterior urethral cancer
855984|NCT00014144|posterior urethral cancer|posterior urethral cancer
855985|NCT00007917|unspecified adult solid tumor, protocol specific|unspecified adult solid tumor, protocol specific
855986|NCT00071383|Herceptin|herceptin
855987|NCT00071383|Trastuzumab|trastuzumab
855988|NCT00071383|Microdissection|microdissection
855989|NCT00071383|Proteomics|proteomics
855990|NCT00071383|Microarrays|microarrays
855991|NCT00071383|Metastatic Brain Tumor|metastatic brain tumor
855992|NCT00071383|Breast Cancer|breast cancer
855993|NCT00071383|Brain|brain
855994|NCT00071383|Carcinoma|carcinoma
855995|NCT00071383|Genomics|genomics
855996|NCT00071383|Metastatic Breast Cancer|metastatic breast cancer
855997|NCT00071383|Metastatic Breast Tumor|metastatic breast tumor
855998|NCT00071357|Microarray|microarray
855999|NCT00071357|Herceptin|herceptin
856000|NCT00071357|Trastuzumab|trastuzumab
856001|NCT00071357|Carcinoma|carcinoma
856002|NCT00071357|Proteomics|proteomics
856003|NCT00071357|Breast Cancer|breast cancer
856004|NCT00071357|Metastatic Breast Cancer|metastatic breast cancer
856005|NCT00071357|Metastatic Breast Tumor|metastatic breast tumor
856006|NCT00071344|Microarray|microarray
856007|NCT00071344|Genomics|genomics
856008|NCT00071344|Trastuzumab|trastuzumab
856009|NCT00071344|Carcinoma|carcinoma
856010|NCT00071344|Non-Small Cell Lung Cancer|non-small cell lung cancer
856011|NCT00071344|Metastatic Brain Tumor|metastatic brain tumor
856012|NCT00071344|Brain|brain
856013|NCT00071344|Microarrays|microarrays
856014|NCT00071344|Microdissection|microdissection
856015|NCT00071344|Lung Cancer|lung cancer
856016|NCT00071344|NSCLC|nsclc
856017|NCT00071123|fMRI|fmri
856018|NCT00071123|Habituation|habituation
856019|NCT00071123|Extinction|extinction
856020|NCT00071123|Amygdala|amygdala
856021|NCT00071123|Emotion|emotion
856022|NCT00071123|Major Depressive Disorder|major depressive disorder
856023|NCT00071123|Medial Prefrontal Cortex|medial prefrontal cortex
856024|NCT00071123|Backward Masking|backward masking
856025|NCT00071123|Depression|depression
856026|NCT00071123|MDD|mdd
856027|NCT00071123|Healthy Volunteer|healthy volunteer
856028|NCT00071123|HV|hv
856029|NCT00071032|Blood Disease|blood disease
856030|NCT00071032|blood transfusion|blood transfusion
856031|NCT00070993|ALS|als
856032|NCT00070993|Creatine|creatine
856033|NCT00070980|Complementary Therapies|complementary therapies
856034|NCT00070967|Acupuncture|acupuncture
856035|NCT00070967|Quality of Life|quality of life
856036|NCT00070967|Complementary Therapies|complementary therapies
856038|NCT00070967|Traditional Chinese Medicine|traditional chinese medicine
856039|NCT00070954|ECT|ect
856040|NCT00070954|Memory|memory
856041|NCT00070954|Ginkgo biloba|ginkgo biloba
856042|NCT00070941|Parkinsons Disease|parkinsons disease
856043|NCT00070941|Depression|depression
856044|NCT00070941|SAM-e|sam-e
856045|NCT00070928|Sleep|sleep
856046|NCT00070902|Spinal Manipulation|spinal manipulation
856047|NCT00070902|Chiropractic|chiropractic
856048|NCT00070902|Zygapophysial Joints|zygapophysial joints
856049|NCT00070889|Complementary Therapies|complementary therapies
856052|NCT00070850|Amniocentesis|amniocentesis
856053|NCT00070824|Acupuncture|acupuncture
856054|NCT00070824|SPECT|spect
856055|NCT00070824|f-MRI|f-mri
856056|NCT00070824|Functional brain imaging|functional brain imaging
856057|NCT00070824|RCT|rct
856058|NCT00070811|Facial form|facial form
856059|NCT00070811|Facial animation|facial animation
856060|NCT00070811|Lip muscle reconstruction|lip muscle reconstruction
856061|NCT00070811|Lip form|lip form
856062|NCT00070811|Lip function|lip function
856063|NCT00070720|Behavior change|behavior change
856064|NCT00070720|Change in practitioner behavior|change in practitioner behavior
856065|NCT00070720|Episiotomy|episiotomy
856066|NCT00070720|Active management of third stage of labor|active management of third stage of labor
856067|NCT00070720|Global Network|global network
856068|NCT00070720|Latin America|latin america
856070|NCT00070720|Argentina|argentina
856071|NCT00070720|Maternal and child health|maternal and child health
856072|NCT00070720|International|international
856073|NCT00070720|Women's health|women's health
856074|NCT00071058|P-glycoprotein Inhibition|p-glycoprotein inhibition
856075|NCT00071058|Drug Resistance Reversal|drug resistance reversal
856076|NCT00071058|Pharmacodynamics|pharmacodynamics
856077|NCT00071058|Molecular Target|molecular target
856078|NCT00071058|Endocrine Cancer|endocrine cancer
856079|NCT00071058|Adrenocortical Cancer|adrenocortical cancer
856080|NCT00071058|ACC|acc
856081|NCT00071058|Adrenocortical Tumor|adrenocortical tumor
856082|NCT00071045|Tissue Procurement|tissue procurement
856083|NCT00071045|Sample Collection|sample collection
856084|NCT00071045|Laboratory Research Specimens|laboratory research specimens
856085|NCT00070746|Perinatal mortality [PNM]|perinatal mortality [pnm]
856086|NCT00070746|Neonatal mortality|neonatal mortality
856087|NCT00070746|Low birth weight [LBW]|low birth weight [lbw]
856088|NCT00070746|Spontaneous preterm delivery [SPTD]|spontaneous preterm delivery [sptd]
856089|NCT00070746|Premature rupture of membranes [PROM]|premature rupture of membranes [prom]
856090|NCT00070746|Histological chorioamnionitis|histological chorioamnionitis
856091|NCT00070746|Global Network|global network
856092|NCT00070746|Pakistan|pakistan
856093|NCT00070746|Maternal and child health|maternal and child health
856094|NCT00070746|International|international
856095|NCT00070746|Women's health|women's health
856096|NCT00070733|Testosterone|testosterone
856097|NCT00070733|5-alpha Reductase|5-alpha reductase
856098|NCT00070733|Muscle Strength|muscle strength
856099|NCT00070733|Libido|libido
856100|NCT00070733|Sexual Function|sexual function
856101|NCT00070733|Muscle Mass|muscle mass
856102|NCT00070733|Testosterone 5-alpha-Reductase|testosterone 5-alpha-reductase
856103|NCT00070707|Seasonal Allergic Rhinitis|seasonal allergic rhinitis
856104|NCT00070707|Asthma|asthma
856105|NCT00070876|Child|child
856106|NCT00070876|Adolescent|adolescent
856107|NCT00069433|Psychotic Disorders|psychotic disorders
856108|NCT00017368|regional neuroblastoma|regional neuroblastoma
856109|NCT00017368|disseminated neuroblastoma|disseminated neuroblastoma
856110|NCT00017368|localized unresectable neuroblastoma|localized unresectable neuroblastoma
856111|NCT00017368|stage 4S neuroblastoma|stage 4s neuroblastoma
856112|NCT00003907|localized unresectable adult primary liver cancer|localized unresectable adult primary liver cancer
856113|NCT00003907|advanced adult primary liver cancer|advanced adult primary liver cancer
856114|NCT00003907|recurrent adult primary liver cancer|recurrent adult primary liver cancer
856115|NCT00003907|adult primary hepatocellular carcinoma|adult primary hepatocellular carcinoma
856116|NCT00003907|liver metastases|liver metastases
856117|NCT00070785|Nasopharyngeal Cancer|nasopharyngeal cancer
856118|NCT00070785|EBV Virus|ebv virus
856119|NCT00070785|Epitope Mapping|epitope mapping
856120|NCT00070785|Epstein-Barr Virus|epstein-barr virus
856121|NCT00070785|Latent Protein-2|latent protein-2
856122|NCT00070785|Healthy Volunteer|healthy volunteer
856123|NCT00070785|HV|hv
856124|NCT00070759|Daclizumab|daclizumab
856125|NCT00070759|Uveitis|uveitis
856126|NCT00070759|Active|active
856127|NCT00070759|Acute|acute
856128|NCT00070642|Immunotherapy, skin cancer|immunotherapy, skin cancer
856129|NCT00070629|Immunotherapy|immunotherapy
856130|NCT00070629|lung cancer|lung cancer
856131|NCT00070616|mucositis|mucositis
856132|NCT00070616|chemotherapy|chemotherapy
856133|NCT00070616|radiation therapy|radiation therapy
856134|NCT00070590|Scleroderma|scleroderma
856135|NCT00070590|Fibrosing alveolitis|fibrosing alveolitis
856137|NCT00070590|bosentan|bosentan
856138|NCT00007839|stage I grade 1 follicular lymphoma|stage i grade 1 follicular lymphoma
856139|NCT00007839|stage I grade 2 follicular lymphoma|stage i grade 2 follicular lymphoma
856140|NCT00007839|stage I adult diffuse small cleaved cell lymphoma|stage i adult diffuse small cleaved cell lymphoma
856141|NCT00007839|stage III grade 1 follicular lymphoma|stage iii grade 1 follicular lymphoma
856142|NCT00007839|stage III grade 2 follicular lymphoma|stage iii grade 2 follicular lymphoma
856143|NCT00007839|stage III adult diffuse small cleaved cell lymphoma|stage iii adult diffuse small cleaved cell lymphoma
856144|NCT00007839|stage IV grade 1 follicular lymphoma|stage iv grade 1 follicular lymphoma
856145|NCT00007839|stage IV grade 2 follicular lymphoma|stage iv grade 2 follicular lymphoma
881488|NCT00032825|Microtubule|microtubule
856146|NCT00007839|stage IV adult diffuse small cleaved cell lymphoma|stage iv adult diffuse small cleaved cell lymphoma
856147|NCT00007839|recurrent grade 1 follicular lymphoma|recurrent grade 1 follicular lymphoma
856148|NCT00007839|recurrent grade 2 follicular lymphoma|recurrent grade 2 follicular lymphoma
856149|NCT00007839|recurrent adult diffuse small cleaved cell lymphoma|recurrent adult diffuse small cleaved cell lymphoma
856150|NCT00007839|contiguous stage II grade 1 follicular lymphoma|contiguous stage ii grade 1 follicular lymphoma
856151|NCT00007839|contiguous stage II grade 2 follicular lymphoma|contiguous stage ii grade 2 follicular lymphoma
856152|NCT00007839|contiguous stage II adult diffuse small cleaved cell lymphoma|contiguous stage ii adult diffuse small cleaved cell lymphoma
856153|NCT00007839|noncontiguous stage II grade 1 follicular lymphoma|noncontiguous stage ii grade 1 follicular lymphoma
856154|NCT00007839|noncontiguous stage II grade 2 follicular lymphoma|noncontiguous stage ii grade 2 follicular lymphoma
856155|NCT00007839|noncontiguous stage II adult diffuse small cleaved cell lymphoma|noncontiguous stage ii adult diffuse small cleaved cell lymphoma
856156|NCT00007839|noncontiguous stage II small lymphocytic lymphoma|noncontiguous stage ii small lymphocytic lymphoma
856157|NCT00007839|noncontiguous stage II marginal zone lymphoma|noncontiguous stage ii marginal zone lymphoma
856158|NCT00007839|recurrent marginal zone lymphoma|recurrent marginal zone lymphoma
856159|NCT00007839|recurrent small lymphocytic lymphoma|recurrent small lymphocytic lymphoma
856160|NCT00007839|stage I marginal zone lymphoma|stage i marginal zone lymphoma
856161|NCT00007839|stage I small lymphocytic lymphoma|stage i small lymphocytic lymphoma
856162|NCT00007839|stage III small lymphocytic lymphoma|stage iii small lymphocytic lymphoma
856163|NCT00007839|stage III marginal zone lymphoma|stage iii marginal zone lymphoma
856164|NCT00007839|stage IV small lymphocytic lymphoma|stage iv small lymphocytic lymphoma
856165|NCT00007839|stage IV marginal zone lymphoma|stage iv marginal zone lymphoma
856166|NCT00007839|contiguous stage II marginal zone lymphoma|contiguous stage ii marginal zone lymphoma
856167|NCT00007839|contiguous stage II small lymphocytic lymphoma|contiguous stage ii small lymphocytic lymphoma
856168|NCT00007839|extranodal marginal zone B-cell lymphoma of mucosa-associated lymphoid tissue|extranodal marginal zone b-cell lymphoma of mucosa-associated lymphoid tissue
856169|NCT00007839|nodal marginal zone B-cell lymphoma|nodal marginal zone b-cell lymphoma
856170|NCT00007839|splenic marginal zone lymphoma|splenic marginal zone lymphoma
856171|NCT00006482|recurrent cervical cancer|recurrent cervical cancer
856172|NCT00006482|stage IVB cervical cancer|stage ivb cervical cancer
856173|NCT00006482|stage IVA cervical cancer|stage iva cervical cancer
856174|NCT00006482|cervical squamous cell carcinoma|cervical squamous cell carcinoma
856175|NCT00006466|monoclonal gammopathy of undetermined significance|monoclonal gammopathy of undetermined significance
856176|NCT00006466|isolated plasmacytoma of bone|isolated plasmacytoma of bone
856177|NCT00006466|extramedullary plasmacytoma|extramedullary plasmacytoma
856178|NCT00006466|refractory multiple myeloma|refractory multiple myeloma
856179|NCT00006466|stage I multiple myeloma|stage i multiple myeloma
856180|NCT00006466|stage II multiple myeloma|stage ii multiple myeloma
856181|NCT00006466|stage III multiple myeloma|stage iii multiple myeloma
856182|NCT00006257|unspecified adult solid tumor, protocol specific|unspecified adult solid tumor, protocol specific
856183|NCT00006121|stage III breast cancer|stage iii breast cancer
856184|NCT00006121|stage IV breast cancer|stage iv breast cancer
856185|NCT00006121|recurrent breast cancer|recurrent breast cancer
856186|NCT00006012|drug/agent toxicity by tissue/organ|drug/agent toxicity by tissue/organ
856187|NCT00006012|radiation toxicity|radiation toxicity
856188|NCT00006012|limited stage small cell lung cancer|limited stage small cell lung cancer
856189|NCT00006009|stage I cutaneous T-cell non-Hodgkin lymphoma|stage i cutaneous t-cell non-hodgkin lymphoma
856190|NCT00006009|stage II cutaneous T-cell non-Hodgkin lymphoma|stage ii cutaneous t-cell non-hodgkin lymphoma
856191|NCT00006009|stage III cutaneous T-cell non-Hodgkin lymphoma|stage iii cutaneous t-cell non-hodgkin lymphoma
856192|NCT00006009|stage IV cutaneous T-cell non-Hodgkin lymphoma|stage iv cutaneous t-cell non-hodgkin lymphoma
856193|NCT00006009|recurrent cutaneous T-cell non-Hodgkin lymphoma|recurrent cutaneous t-cell non-hodgkin lymphoma
856194|NCT00006009|small intestine lymphoma|small intestine lymphoma
856195|NCT00006009|stage III adult T-cell leukemia/lymphoma|stage iii adult t-cell leukemia/lymphoma
856196|NCT00006009|stage IV adult T-cell leukemia/lymphoma|stage iv adult t-cell leukemia/lymphoma
856197|NCT00006009|recurrent adult T-cell leukemia/lymphoma|recurrent adult t-cell leukemia/lymphoma
856198|NCT00006009|angioimmunoblastic T-cell lymphoma|angioimmunoblastic t-cell lymphoma
856199|NCT00006009|anaplastic large cell lymphoma|anaplastic large cell lymphoma
856200|NCT00006009|stage I mycosis fungoides/Sezary syndrome|stage i mycosis fungoides/sezary syndrome
856201|NCT00006009|stage II mycosis fungoides/Sezary syndrome|stage ii mycosis fungoides/sezary syndrome
856202|NCT00006009|stage III mycosis fungoides/Sezary syndrome|stage iii mycosis fungoides/sezary syndrome
856203|NCT00006009|stage IV mycosis fungoides/Sezary syndrome|stage iv mycosis fungoides/sezary syndrome
856204|NCT00006009|recurrent mycosis fungoides/Sezary syndrome|recurrent mycosis fungoides/sezary syndrome
856205|NCT00005998|recurrent adult Hodgkin lymphoma|recurrent adult hodgkin lymphoma
856206|NCT00005998|recurrent grade 1 follicular lymphoma|recurrent grade 1 follicular lymphoma
856207|NCT00005998|recurrent grade 2 follicular lymphoma|recurrent grade 2 follicular lymphoma
856208|NCT00005998|recurrent grade 3 follicular lymphoma|recurrent grade 3 follicular lymphoma
856209|NCT00005998|recurrent adult diffuse small cleaved cell lymphoma|recurrent adult diffuse small cleaved cell lymphoma
856210|NCT00005998|recurrent adult diffuse mixed cell lymphoma|recurrent adult diffuse mixed cell lymphoma
856211|NCT00005998|recurrent adult diffuse large cell lymphoma|recurrent adult diffuse large cell lymphoma
856212|NCT00005998|recurrent adult immunoblastic large cell lymphoma|recurrent adult immunoblastic large cell lymphoma
856213|NCT00005998|recurrent adult lymphoblastic lymphoma|recurrent adult lymphoblastic lymphoma
856214|NCT00005998|recurrent adult Burkitt lymphoma|recurrent adult burkitt lymphoma
856215|NCT00005998|recurrent mantle cell lymphoma|recurrent mantle cell lymphoma
856216|NCT00005998|recurrent marginal zone lymphoma|recurrent marginal zone lymphoma
856217|NCT00005998|recurrent small lymphocytic lymphoma|recurrent small lymphocytic lymphoma
856218|NCT00005998|extranodal marginal zone B-cell lymphoma of mucosa-associated lymphoid tissue|extranodal marginal zone b-cell lymphoma of mucosa-associated lymphoid tissue
856219|NCT00005998|nodal marginal zone B-cell lymphoma|nodal marginal zone b-cell lymphoma
856220|NCT00005998|splenic marginal zone lymphoma|splenic marginal zone lymphoma
856221|NCT00005800|stage IIIA breast cancer|stage iiia breast cancer
856222|NCT00005800|stage IIIB breast cancer|stage iiib breast cancer
856223|NCT00005800|inflammatory breast cancer|inflammatory breast cancer
856224|NCT00005794|unspecified adult solid tumor, protocol specific|unspecified adult solid tumor, protocol specific
856225|NCT00070694|Affective Disorders|affective disorders
856226|NCT00070694|Refractory|refractory
856227|NCT00070694|Augmentation|augmentation
856228|NCT00070694|Polysomogram|polysomogram
856229|NCT00070694|Combination Therapy|combination therapy
856230|NCT00070694|Affective Disorder|affective disorder
856231|NCT00070694|Depression|depression
856232|NCT00070694|Major Depression|major depression
856233|NCT00070564|stage II breast cancer|stage ii breast cancer
856234|NCT00070564|stage IA breast cancer|stage ia breast cancer
856235|NCT00070564|stage IB breast cancer|stage ib breast cancer
856236|NCT00070564|stage IIIC breast cancer|stage iiic breast cancer
856237|NCT00070564|male breast cancer|male breast cancer
856238|NCT00070564|HER2-positive breast cancer|her2-positive breast cancer
856239|NCT00070564|estrogen receptor-negative breast cancer|estrogen receptor-negative breast cancer
856240|NCT00070564|estrogen receptor-positive breast cancer|estrogen receptor-positive breast cancer
856241|NCT00070564|progesterone receptor-negative breast cancer|progesterone receptor-negative breast cancer
856242|NCT00070564|progesterone receptor-positive breast cancer|progesterone receptor-positive breast cancer
856243|NCT00070538|recurrent adult acute lymphoblastic leukemia|recurrent adult acute lymphoblastic leukemia
856244|NCT00070538|blastic phase chronic myelogenous leukemia|blastic phase chronic myelogenous leukemia
856245|NCT00070538|relapsing chronic myelogenous leukemia|relapsing chronic myelogenous leukemia
856246|NCT00070538|chronic myelomonocytic leukemia|chronic myelomonocytic leukemia
856247|NCT00070538|refractory anemia with excess blasts in transformation|refractory anemia with excess blasts in transformation
856248|NCT00070538|refractory anemia with excess blasts|refractory anemia with excess blasts
856249|NCT00070538|recurrent adult acute myeloid leukemia|recurrent adult acute myeloid leukemia
856250|NCT00070538|untreated adult acute myeloid leukemia|untreated adult acute myeloid leukemia
856251|NCT00070538|untreated adult acute lymphoblastic leukemia|untreated adult acute lymphoblastic leukemia
856252|NCT00070538|de novo myelodysplastic syndromes|de novo myelodysplastic syndromes
856253|NCT00070538|previously treated myelodysplastic syndromes|previously treated myelodysplastic syndromes
856254|NCT00070538|secondary myelodysplastic syndromes|secondary myelodysplastic syndromes
856255|NCT00070538|adult acute myeloid leukemia with t(8;21)(q22;q22)|adult acute myeloid leukemia with t(8;21)(q22;q22)
856256|NCT00070538|adult acute myeloid leukemia with t(16;16)(p13;q22)|adult acute myeloid leukemia with t(16;16)(p13;q22)
856257|NCT00070538|adult acute myeloid leukemia with inv(16)(p13;q22)|adult acute myeloid leukemia with inv(16)(p13;q22)
856258|NCT00070538|adult acute myeloid leukemia with 11q23 (MLL) abnormalities|adult acute myeloid leukemia with 11q23 (mll) abnormalities
856259|NCT00070538|adult acute myeloid leukemia with t(15;17)(q22;q12)|adult acute myeloid leukemia with t(15;17)(q22;q12)
856260|NCT00070486|stage IV non-small cell lung cancer|stage iv non-small cell lung cancer
856261|NCT00070486|adenocarcinoma of the lung|adenocarcinoma of the lung
856262|NCT00070486|squamous cell lung cancer|squamous cell lung cancer
856263|NCT00070486|large cell lung cancer|large cell lung cancer
856264|NCT00070486|stage IIIB non-small cell lung cancer|stage iiib non-small cell lung cancer
856265|NCT00070473|unspecified childhood solid tumor, protocol specific|unspecified childhood solid tumor, protocol specific
856266|NCT00070447|contiguous stage II mantle cell lymphoma|contiguous stage ii mantle cell lymphoma
856267|NCT00070447|noncontiguous stage II mantle cell lymphoma|noncontiguous stage ii mantle cell lymphoma
856268|NCT00070447|stage III mantle cell lymphoma|stage iii mantle cell lymphoma
856269|NCT00070447|stage IV mantle cell lymphoma|stage iv mantle cell lymphoma
856270|NCT00070434|stage II rectal cancer|stage ii rectal cancer
856271|NCT00070434|stage III rectal cancer|stage iii rectal cancer
856272|NCT00070434|adenocarcinoma of the rectum|adenocarcinoma of the rectum
856273|NCT00070421|psychosocial effects of cancer and its treatment|psychosocial effects of cancer and its treatment
856274|NCT00070421|unspecified childhood solid tumor, protocol specific|unspecified childhood solid tumor, protocol specific
856275|NCT00070421|childhood acute lymphoblastic leukemia in remission|childhood acute lymphoblastic leukemia in remission
856276|NCT00070421|childhood acute myeloid leukemia in remission|childhood acute myeloid leukemia in remission
856277|NCT00070421|recurrent childhood acute lymphoblastic leukemia|recurrent childhood acute lymphoblastic leukemia
856278|NCT00070421|recurrent childhood acute myeloid leukemia|recurrent childhood acute myeloid leukemia
856279|NCT00070421|recurrent childhood large cell lymphoma|recurrent childhood large cell lymphoma
856280|NCT00070421|recurrent childhood lymphoblastic lymphoma|recurrent childhood lymphoblastic lymphoma
856281|NCT00070421|recurrent childhood small noncleaved cell lymphoma|recurrent childhood small noncleaved cell lymphoma
856282|NCT00070421|stage I childhood Hodgkin lymphoma|stage i childhood hodgkin lymphoma
856283|NCT00070421|stage I childhood large cell lymphoma|stage i childhood large cell lymphoma
856284|NCT00070421|stage I childhood lymphoblastic lymphoma|stage i childhood lymphoblastic lymphoma
856285|NCT00070421|stage I childhood small noncleaved cell lymphoma|stage i childhood small noncleaved cell lymphoma
856286|NCT00070421|stage II childhood Hodgkin lymphoma|stage ii childhood hodgkin lymphoma
856287|NCT00070421|stage II childhood large cell lymphoma|stage ii childhood large cell lymphoma
856288|NCT00070421|stage II childhood lymphoblastic lymphoma|stage ii childhood lymphoblastic lymphoma
856289|NCT00070421|stage II childhood small noncleaved cell lymphoma|stage ii childhood small noncleaved cell lymphoma
856290|NCT00070421|stage III childhood Hodgkin lymphoma|stage iii childhood hodgkin lymphoma
856291|NCT00070421|stage III childhood large cell lymphoma|stage iii childhood large cell lymphoma
856292|NCT00070421|stage III childhood lymphoblastic lymphoma|stage iii childhood lymphoblastic lymphoma
856293|NCT00070421|stage III childhood small noncleaved cell lymphoma|stage iii childhood small noncleaved cell lymphoma
856294|NCT00070421|stage IV childhood Hodgkin lymphoma|stage iv childhood hodgkin lymphoma
856295|NCT00070421|stage IV childhood large cell lymphoma|stage iv childhood large cell lymphoma
856296|NCT00070421|stage IV childhood lymphoblastic lymphoma|stage iv childhood lymphoblastic lymphoma
856297|NCT00070421|stage IV childhood small noncleaved cell lymphoma|stage iv childhood small noncleaved cell lymphoma
856298|NCT00070421|recurrent/refractory childhood Hodgkin lymphoma|recurrent/refractory childhood hodgkin lymphoma
856299|NCT00070382|anemia|anemia
856300|NCT00070382|unspecified adult solid tumor, protocol specific|unspecified adult solid tumor, protocol specific
856301|NCT00070382|Waldenstrom macroglobulinemia|waldenstrom macroglobulinemia
856302|NCT00070382|monoclonal gammopathy of undetermined significance|monoclonal gammopathy of undetermined significance
856303|NCT00070382|extramedullary plasmacytoma|extramedullary plasmacytoma
856304|NCT00070382|isolated plasmacytoma of bone|isolated plasmacytoma of bone
856305|NCT00070382|refractory multiple myeloma|refractory multiple myeloma
856306|NCT00070382|primary systemic amyloidosis|primary systemic amyloidosis
856307|NCT00070382|stage I multiple myeloma|stage i multiple myeloma
856308|NCT00070382|stage II multiple myeloma|stage ii multiple myeloma
856309|NCT00070382|stage III multiple myeloma|stage iii multiple myeloma
856310|NCT00070382|post-transplant lymphoproliferative disorder|post-transplant lymphoproliferative disorder
856311|NCT00070382|angioimmunoblastic T-cell lymphoma|angioimmunoblastic t-cell lymphoma
856312|NCT00070382|anaplastic large cell lymphoma|anaplastic large cell lymphoma
856313|NCT00070382|stage I cutaneous T-cell non-Hodgkin lymphoma|stage i cutaneous t-cell non-hodgkin lymphoma
856314|NCT00070382|stage II cutaneous T-cell non-Hodgkin lymphoma|stage ii cutaneous t-cell non-hodgkin lymphoma
856315|NCT00070382|stage III cutaneous T-cell non-Hodgkin lymphoma|stage iii cutaneous t-cell non-hodgkin lymphoma
856316|NCT00070382|stage IV cutaneous T-cell non-Hodgkin lymphoma|stage iv cutaneous t-cell non-hodgkin lymphoma
856317|NCT00070382|recurrent adult T-cell leukemia/lymphoma|recurrent adult t-cell leukemia/lymphoma
856318|NCT00070382|stage I adult T-cell leukemia/lymphoma|stage i adult t-cell leukemia/lymphoma
856319|NCT00070382|stage II adult T-cell leukemia/lymphoma|stage ii adult t-cell leukemia/lymphoma
856320|NCT00070382|stage III adult T-cell leukemia/lymphoma|stage iii adult t-cell leukemia/lymphoma
856321|NCT00070382|stage IV adult T-cell leukemia/lymphoma|stage iv adult t-cell leukemia/lymphoma
856322|NCT00070382|recurrent cutaneous T-cell non-Hodgkin lymphoma|recurrent cutaneous t-cell non-hodgkin lymphoma
856323|NCT00070382|recurrent mycosis fungoides/Sezary syndrome|recurrent mycosis fungoides/sezary syndrome
856324|NCT00070382|stage I mycosis fungoides/Sezary syndrome|stage i mycosis fungoides/sezary syndrome
856325|NCT00070382|stage II mycosis fungoides/Sezary syndrome|stage ii mycosis fungoides/sezary syndrome
856326|NCT00070382|stage III mycosis fungoides/Sezary syndrome|stage iii mycosis fungoides/sezary syndrome
856327|NCT00070382|stage IV mycosis fungoides/Sezary syndrome|stage iv mycosis fungoides/sezary syndrome
856328|NCT00070382|recurrent adult Hodgkin lymphoma|recurrent adult hodgkin lymphoma
856329|NCT00070382|stage I adult Hodgkin lymphoma|stage i adult hodgkin lymphoma
856330|NCT00070382|stage II adult Hodgkin lymphoma|stage ii adult hodgkin lymphoma
856331|NCT00070382|stage III adult Hodgkin lymphoma|stage iii adult hodgkin lymphoma
856332|NCT00070382|stage IV adult Hodgkin lymphoma|stage iv adult hodgkin lymphoma
856333|NCT00070382|T-cell large granular lymphocyte leukemia|t-cell large granular lymphocyte leukemia
856334|NCT00070382|refractory chronic lymphocytic leukemia|refractory chronic lymphocytic leukemia
856335|NCT00070382|stage 0 chronic lymphocytic leukemia|stage 0 chronic lymphocytic leukemia
856336|NCT00070382|stage I chronic lymphocytic leukemia|stage i chronic lymphocytic leukemia
856337|NCT00070382|stage II chronic lymphocytic leukemia|stage ii chronic lymphocytic leukemia
856338|NCT00070382|stage III chronic lymphocytic leukemia|stage iii chronic lymphocytic leukemia
856339|NCT00070382|stage IV chronic lymphocytic leukemia|stage iv chronic lymphocytic leukemia
856340|NCT00070382|prolymphocytic leukemia|prolymphocytic leukemia
856341|NCT00070382|recurrent grade 1 follicular lymphoma|recurrent grade 1 follicular lymphoma
856342|NCT00070382|recurrent grade 2 follicular lymphoma|recurrent grade 2 follicular lymphoma
856343|NCT00070382|recurrent grade 3 follicular lymphoma|recurrent grade 3 follicular lymphoma
856406|NCT00070213|recurrent colon cancer|recurrent colon cancer
856344|NCT00070382|stage I grade 1 follicular lymphoma|stage i grade 1 follicular lymphoma
856345|NCT00070382|stage I grade 2 follicular lymphoma|stage i grade 2 follicular lymphoma
856346|NCT00070382|stage I grade 3 follicular lymphoma|stage i grade 3 follicular lymphoma
856347|NCT00070382|stage III grade 1 follicular lymphoma|stage iii grade 1 follicular lymphoma
856348|NCT00070382|stage III grade 2 follicular lymphoma|stage iii grade 2 follicular lymphoma
856349|NCT00070382|stage III grade 3 follicular lymphoma|stage iii grade 3 follicular lymphoma
856350|NCT00070382|stage IV grade 1 follicular lymphoma|stage iv grade 1 follicular lymphoma
856351|NCT00070382|stage IV grade 2 follicular lymphoma|stage iv grade 2 follicular lymphoma
856352|NCT00070382|stage IV grade 3 follicular lymphoma|stage iv grade 3 follicular lymphoma
856353|NCT00070382|contiguous stage II adult diffuse large cell lymphoma|contiguous stage ii adult diffuse large cell lymphoma
856354|NCT00070382|contiguous stage II adult diffuse mixed cell lymphoma|contiguous stage ii adult diffuse mixed cell lymphoma
856355|NCT00070382|contiguous stage II adult diffuse small cleaved cell lymphoma|contiguous stage ii adult diffuse small cleaved cell lymphoma
856356|NCT00070382|noncontiguous stage II adult diffuse large cell lymphoma|noncontiguous stage ii adult diffuse large cell lymphoma
856357|NCT00070382|noncontiguous stage II adult diffuse mixed cell lymphoma|noncontiguous stage ii adult diffuse mixed cell lymphoma
856358|NCT00070382|noncontiguous stage II adult diffuse small cleaved cell lymphoma|noncontiguous stage ii adult diffuse small cleaved cell lymphoma
856359|NCT00070382|recurrent adult diffuse large cell lymphoma|recurrent adult diffuse large cell lymphoma
856360|NCT00070382|recurrent adult diffuse mixed cell lymphoma|recurrent adult diffuse mixed cell lymphoma
856361|NCT00070382|recurrent adult diffuse small cleaved cell lymphoma|recurrent adult diffuse small cleaved cell lymphoma
856362|NCT00070382|stage I adult diffuse large cell lymphoma|stage i adult diffuse large cell lymphoma
856363|NCT00070382|stage I adult diffuse mixed cell lymphoma|stage i adult diffuse mixed cell lymphoma
856364|NCT00070382|stage I adult diffuse small cleaved cell lymphoma|stage i adult diffuse small cleaved cell lymphoma
856365|NCT00070382|stage III adult diffuse large cell lymphoma|stage iii adult diffuse large cell lymphoma
856366|NCT00070382|stage III adult diffuse mixed cell lymphoma|stage iii adult diffuse mixed cell lymphoma
856367|NCT00070382|stage III adult diffuse small cleaved cell lymphoma|stage iii adult diffuse small cleaved cell lymphoma
856368|NCT00070382|stage IV adult diffuse large cell lymphoma|stage iv adult diffuse large cell lymphoma
856369|NCT00070382|stage IV adult diffuse mixed cell lymphoma|stage iv adult diffuse mixed cell lymphoma
856370|NCT00070382|stage IV adult diffuse small cleaved cell lymphoma|stage iv adult diffuse small cleaved cell lymphoma
856371|NCT00070382|contiguous stage II adult immunoblastic large cell lymphoma|contiguous stage ii adult immunoblastic large cell lymphoma
856372|NCT00070382|noncontiguous stage II adult immunoblastic large cell lymphoma|noncontiguous stage ii adult immunoblastic large cell lymphoma
856373|NCT00070382|recurrent adult immunoblastic large cell lymphoma|recurrent adult immunoblastic large cell lymphoma
856374|NCT00070382|stage I adult immunoblastic large cell lymphoma|stage i adult immunoblastic large cell lymphoma
856375|NCT00070382|stage III adult immunoblastic large cell lymphoma|stage iii adult immunoblastic large cell lymphoma
856376|NCT00070382|stage IV adult immunoblastic large cell lymphoma|stage iv adult immunoblastic large cell lymphoma
856377|NCT00070382|contiguous stage II mantle cell lymphoma|contiguous stage ii mantle cell lymphoma
856378|NCT00070382|noncontiguous stage II mantle cell lymphoma|noncontiguous stage ii mantle cell lymphoma
856379|NCT00070382|recurrent mantle cell lymphoma|recurrent mantle cell lymphoma
856380|NCT00070382|stage I mantle cell lymphoma|stage i mantle cell lymphoma
856381|NCT00070382|stage III mantle cell lymphoma|stage iii mantle cell lymphoma
856382|NCT00070382|stage IV mantle cell lymphoma|stage iv mantle cell lymphoma
856383|NCT00070382|contiguous stage II grade 1 follicular lymphoma|contiguous stage ii grade 1 follicular lymphoma
856384|NCT00070382|contiguous stage II grade 2 follicular lymphoma|contiguous stage ii grade 2 follicular lymphoma
856385|NCT00070382|contiguous stage II grade 3 follicular lymphoma|contiguous stage ii grade 3 follicular lymphoma
856386|NCT00070382|noncontiguous stage II grade 1 follicular lymphoma|noncontiguous stage ii grade 1 follicular lymphoma
856387|NCT00070382|noncontiguous stage II grade 2 follicular lymphoma|noncontiguous stage ii grade 2 follicular lymphoma
856388|NCT00070382|noncontiguous stage II grade 3 follicular lymphoma|noncontiguous stage ii grade 3 follicular lymphoma
856389|NCT00070343|stage IV melanoma|stage iv melanoma
856390|NCT00070343|stage III melanoma|stage iii melanoma
856391|NCT00070304|recurrent/refractory childhood Hodgkin lymphoma|recurrent/refractory childhood hodgkin lymphoma
856392|NCT00070304|childhood lymphocyte predominant Hodgkin lymphoma|childhood lymphocyte predominant hodgkin lymphoma
856393|NCT00070304|childhood lymphocyte depletion Hodgkin lymphoma|childhood lymphocyte depletion hodgkin lymphoma
856394|NCT00070304|childhood nodular sclerosis Hodgkin lymphoma|childhood nodular sclerosis hodgkin lymphoma
856395|NCT00070304|childhood mixed cellularity Hodgkin lymphoma|childhood mixed cellularity hodgkin lymphoma
856396|NCT00070291|angioimmunoblastic T-cell lymphoma|angioimmunoblastic t-cell lymphoma
856397|NCT00070278|stage II breast cancer|stage ii breast cancer
856398|NCT00070278|stage IIIA breast cancer|stage iiia breast cancer
856399|NCT00070278|stage IIIB breast cancer|stage iiib breast cancer
856400|NCT00070278|stage IIIC breast cancer|stage iiic breast cancer
856401|NCT00070213|adenocarcinoma of the colon|adenocarcinoma of the colon
856402|NCT00070213|adenocarcinoma of the rectum|adenocarcinoma of the rectum
856403|NCT00070213|stage IV rectal cancer|stage iv rectal cancer
856404|NCT00070213|stage IV colon cancer|stage iv colon cancer
856405|NCT00070213|recurrent rectal cancer|recurrent rectal cancer
881489|NCT00032825|Hormonal|hormonal
856407|NCT00070200|recurrent neuroblastoma|recurrent neuroblastoma
856408|NCT00070200|stage 4S neuroblastoma|stage 4s neuroblastoma
856409|NCT00070200|localized unresectable neuroblastoma|localized unresectable neuroblastoma
856410|NCT00070200|localized resectable neuroblastoma|localized resectable neuroblastoma
856411|NCT00070200|regional neuroblastoma|regional neuroblastoma
856412|NCT00070200|disseminated neuroblastoma|disseminated neuroblastoma
856413|NCT00070187|recurrent adult Hodgkin lymphoma|recurrent adult hodgkin lymphoma
856414|NCT00070187|recurrent/refractory childhood Hodgkin lymphoma|recurrent/refractory childhood hodgkin lymphoma
856415|NCT00070174|untreated childhood acute myeloid leukemia and other myeloid malignancies|untreated childhood acute myeloid leukemia and other myeloid malignancies
856416|NCT00070174|childhood acute monocytic leukemia (M5b)|childhood acute monocytic leukemia (m5b)
856417|NCT00070174|childhood acute megakaryocytic leukemia (M7)|childhood acute megakaryocytic leukemia (m7)
856418|NCT00070174|childhood acute minimally differentiated myeloid leukemia (M0)|childhood acute minimally differentiated myeloid leukemia (m0)
856419|NCT00070174|childhood acute myeloblastic leukemia with maturation (M2)|childhood acute myeloblastic leukemia with maturation (m2)
856420|NCT00070174|childhood acute myeloblastic leukemia without maturation (M1)|childhood acute myeloblastic leukemia without maturation (m1)
856421|NCT00070174|childhood acute myelomonocytic leukemia (M4)|childhood acute myelomonocytic leukemia (m4)
856422|NCT00070174|childhood acute monoblastic leukemia (M5a)|childhood acute monoblastic leukemia (m5a)
856423|NCT00070174|childhood acute erythroleukemia (M6)|childhood acute erythroleukemia (m6)
856424|NCT00070161|radiation toxicity|radiation toxicity
856425|NCT00070161|adult mixed glioma|adult mixed glioma
856426|NCT00070161|adult central nervous system germ cell tumor|adult central nervous system germ cell tumor
856427|NCT00070161|adult brain stem glioma|adult brain stem glioma
856428|NCT00070161|adult craniopharyngioma|adult craniopharyngioma
856429|NCT00070161|adult medulloblastoma|adult medulloblastoma
856430|NCT00070161|adult meningioma|adult meningioma
856431|NCT00070161|adult choroid plexus tumor|adult choroid plexus tumor
856432|NCT00070161|adult tumors metastatic to brain|adult tumors metastatic to brain
856433|NCT00070161|adult anaplastic oligodendroglioma|adult anaplastic oligodendroglioma
856434|NCT00070161|adult anaplastic astrocytoma|adult anaplastic astrocytoma
856435|NCT00070161|adult pilocytic astrocytoma|adult pilocytic astrocytoma
856436|NCT00070161|adult subependymoma|adult subependymoma
856437|NCT00070161|adult meningeal hemangiopericytoma|adult meningeal hemangiopericytoma
856438|NCT00070161|adult ependymoblastoma|adult ependymoblastoma
856439|NCT00070161|adult anaplastic ependymoma|adult anaplastic ependymoma
856440|NCT00070161|adult pineoblastoma|adult pineoblastoma
856441|NCT00070161|adult pineocytoma|adult pineocytoma
856442|NCT00070161|adult myxopapillary ependymoma|adult myxopapillary ependymoma
856443|NCT00070161|adult glioblastoma|adult glioblastoma
856444|NCT00070161|adult grade III meningioma|adult grade iii meningioma
856445|NCT00070161|adult oligodendroglioma|adult oligodendroglioma
856446|NCT00070161|adult giant cell glioblastoma|adult giant cell glioblastoma
856447|NCT00070161|adult gliosarcoma|adult gliosarcoma
856448|NCT00070161|adult ependymoma|adult ependymoma
856449|NCT00070148|weight changes|weight changes
856450|NCT00070148|unspecified adult solid tumor, protocol specific|unspecified adult solid tumor, protocol specific
856451|NCT00070135|adult acute myeloid leukemia in remission|adult acute myeloid leukemia in remission
856452|NCT00070135|secondary acute myeloid leukemia|secondary acute myeloid leukemia
856453|NCT00070135|adult acute monocytic leukemia (M5b)|adult acute monocytic leukemia (m5b)
856454|NCT00070135|adult acute erythroid leukemia (M6)|adult acute erythroid leukemia (m6)
856455|NCT00070135|adult acute megakaryoblastic leukemia (M7)|adult acute megakaryoblastic leukemia (m7)
856456|NCT00070135|adult acute minimally differentiated myeloid leukemia (M0)|adult acute minimally differentiated myeloid leukemia (m0)
856457|NCT00070135|adult acute myeloblastic leukemia with maturation (M2)|adult acute myeloblastic leukemia with maturation (m2)
856458|NCT00070135|adult acute myeloblastic leukemia without maturation (M1)|adult acute myeloblastic leukemia without maturation (m1)
856459|NCT00070135|adult acute myelomonocytic leukemia (M4)|adult acute myelomonocytic leukemia (m4)
856460|NCT00070135|adult acute monoblastic leukemia (M5a)|adult acute monoblastic leukemia (m5a)
856461|NCT00070135|adult acute myeloid leukemia with t(8;21)(q22;q22)|adult acute myeloid leukemia with t(8;21)(q22;q22)
856670|NCT00069693|Baroreflex|baroreflex
856462|NCT00070135|adult acute myeloid leukemia with t(16;16)(p13;q22)|adult acute myeloid leukemia with t(16;16)(p13;q22)
856463|NCT00070135|adult acute myeloid leukemia with inv(16)(p13;q22)|adult acute myeloid leukemia with inv(16)(p13;q22)
856464|NCT00070135|adult acute myeloid leukemia with 11q23 (MLL) abnormalities|adult acute myeloid leukemia with 11q23 (mll) abnormalities
856465|NCT00070096|stage IV ovarian germ cell tumor|stage iv ovarian germ cell tumor
856466|NCT00070096|recurrent ovarian germ cell tumor|recurrent ovarian germ cell tumor
856467|NCT00070096|adult central nervous system germ cell tumor|adult central nervous system germ cell tumor
856468|NCT00070096|recurrent malignant testicular germ cell tumor|recurrent malignant testicular germ cell tumor
856469|NCT00070096|stage III malignant testicular germ cell tumor|stage iii malignant testicular germ cell tumor
856470|NCT00070096|testicular seminoma|testicular seminoma
856471|NCT00070096|testicular choriocarcinoma and embryonal carcinoma|testicular choriocarcinoma and embryonal carcinoma
856472|NCT00070096|testicular choriocarcinoma and seminoma|testicular choriocarcinoma and seminoma
856473|NCT00070096|testicular choriocarcinoma and teratoma|testicular choriocarcinoma and teratoma
856539|NCT00069953|stage II esophageal cancer|stage ii esophageal cancer
856474|NCT00070096|testicular choriocarcinoma and yolk sac tumor|testicular choriocarcinoma and yolk sac tumor
856475|NCT00070096|testicular choriocarcinoma|testicular choriocarcinoma
856476|NCT00070096|testicular embryonal carcinoma and seminoma|testicular embryonal carcinoma and seminoma
856477|NCT00070096|testicular embryonal carcinoma and teratoma with seminoma|testicular embryonal carcinoma and teratoma with seminoma
856478|NCT00070096|testicular embryonal carcinoma and teratoma|testicular embryonal carcinoma and teratoma
856479|NCT00070096|testicular embryonal carcinoma and yolk sac tumor with seminoma|testicular embryonal carcinoma and yolk sac tumor with seminoma
856480|NCT00070096|testicular embryonal carcinoma and yolk sac tumor|testicular embryonal carcinoma and yolk sac tumor
856481|NCT00070096|testicular embryonal carcinoma|testicular embryonal carcinoma
856482|NCT00070096|testicular yolk sac tumor and teratoma with seminoma|testicular yolk sac tumor and teratoma with seminoma
856483|NCT00070096|testicular yolk sac tumor and teratoma|testicular yolk sac tumor and teratoma
856484|NCT00070096|testicular yolk sac tumor|testicular yolk sac tumor
856485|NCT00070096|recurrent extragonadal non-seminomatous germ cell tumor|recurrent extragonadal non-seminomatous germ cell tumor
856486|NCT00070096|recurrent extragonadal seminoma|recurrent extragonadal seminoma
856487|NCT00070096|stage IV extragonadal non-seminomatous germ cell tumor|stage iv extragonadal non-seminomatous germ cell tumor
856488|NCT00070096|stage IV extragonadal seminoma|stage iv extragonadal seminoma
856489|NCT00070096|recurrent extragonadal germ cell tumor|recurrent extragonadal germ cell tumor
856490|NCT00070096|testicular immature teratoma|testicular immature teratoma
856491|NCT00070096|testicular mature teratoma|testicular mature teratoma
856492|NCT00070083|contiguous stage II adult diffuse large cell lymphoma|contiguous stage ii adult diffuse large cell lymphoma
856493|NCT00070083|noncontiguous stage II adult diffuse large cell lymphoma|noncontiguous stage ii adult diffuse large cell lymphoma
856494|NCT00070083|stage III adult diffuse large cell lymphoma|stage iii adult diffuse large cell lymphoma
856495|NCT00070083|stage IV adult diffuse large cell lymphoma|stage iv adult diffuse large cell lymphoma
856496|NCT00070070|transitional cell carcinoma of the bladder|transitional cell carcinoma of the bladder
856497|NCT00070070|stage I bladder cancer|stage i bladder cancer
856498|NCT00070031|recurrent breast cancer|recurrent breast cancer
856499|NCT00070031|stage IIIA breast cancer|stage iiia breast cancer
856500|NCT00070031|stage IIIB breast cancer|stage iiib breast cancer
856501|NCT00070031|stage IIIC breast cancer|stage iiic breast cancer
856502|NCT00070031|stage IV breast cancer|stage iv breast cancer
856503|NCT00070018|stage I mantle cell lymphoma|stage i mantle cell lymphoma
856504|NCT00070018|stage I adult diffuse large cell lymphoma|stage i adult diffuse large cell lymphoma
856505|NCT00070018|stage I adult Burkitt lymphoma|stage i adult burkitt lymphoma
856506|NCT00070018|anaplastic large cell lymphoma|anaplastic large cell lymphoma
856507|NCT00070018|contiguous stage II adult diffuse large cell lymphoma|contiguous stage ii adult diffuse large cell lymphoma
856508|NCT00070018|contiguous stage II adult Burkitt lymphoma|contiguous stage ii adult burkitt lymphoma
856509|NCT00070018|contiguous stage II mantle cell lymphoma|contiguous stage ii mantle cell lymphoma
856510|NCT00070018|noncontiguous stage II adult diffuse large cell lymphoma|noncontiguous stage ii adult diffuse large cell lymphoma
856511|NCT00070018|noncontiguous stage II adult Burkitt lymphoma|noncontiguous stage ii adult burkitt lymphoma
856512|NCT00070018|noncontiguous stage II mantle cell lymphoma|noncontiguous stage ii mantle cell lymphoma
856513|NCT00070005|perioperative/postoperative complications|perioperative/postoperative complications
856514|NCT00070005|stage I rectal cancer|stage i rectal cancer
856515|NCT00070005|stage II rectal cancer|stage ii rectal cancer
856516|NCT00070005|stage III rectal cancer|stage iii rectal cancer
856517|NCT00070005|adenocarcinoma of the rectum|adenocarcinoma of the rectum
856518|NCT00069992|polycythemia vera|polycythemia vera
856519|NCT00069992|essential thrombocythemia|essential thrombocythemia
856520|NCT00069992|de novo myelodysplastic syndromes|de novo myelodysplastic syndromes
856521|NCT00069992|previously treated myelodysplastic syndromes|previously treated myelodysplastic syndromes
856522|NCT00069992|secondary myelodysplastic syndromes|secondary myelodysplastic syndromes
856523|NCT00069992|primary myelofibrosis|primary myelofibrosis
856524|NCT00069992|chronic myelogenous leukemia|chronic myelogenous leukemia
856525|NCT00069992|adult acute myeloid leukemia with 11q23 (MLL) abnormalities|adult acute myeloid leukemia with 11q23 (mll) abnormalities
856526|NCT00069992|adult acute myeloid leukemia with inv(16)(p13;q22)|adult acute myeloid leukemia with inv(16)(p13;q22)
856527|NCT00069992|adult acute myeloid leukemia with t(15;17)(q22;q12)|adult acute myeloid leukemia with t(15;17)(q22;q12)
856528|NCT00069992|adult acute myeloid leukemia with t(16;16)(p13;q22)|adult acute myeloid leukemia with t(16;16)(p13;q22)
856529|NCT00069992|adult acute myeloid leukemia with t(8;21)(q22;q22)|adult acute myeloid leukemia with t(8;21)(q22;q22)
856530|NCT00069992|childhood myelodysplastic syndromes|childhood myelodysplastic syndromes
856531|NCT00069966|recurrent adult diffuse large cell lymphoma|recurrent adult diffuse large cell lymphoma
856532|NCT00069966|anaplastic large cell lymphoma|anaplastic large cell lymphoma
856533|NCT00069966|recurrent adult diffuse mixed cell lymphoma|recurrent adult diffuse mixed cell lymphoma
856534|NCT00069966|recurrent adult immunoblastic large cell lymphoma|recurrent adult immunoblastic large cell lymphoma
856535|NCT00069966|recurrent grade 3 follicular lymphoma|recurrent grade 3 follicular lymphoma
856536|NCT00069966|recurrent adult Burkitt lymphoma|recurrent adult burkitt lymphoma
856537|NCT00069953|adenocarcinoma of the esophagus|adenocarcinoma of the esophagus
856538|NCT00069953|squamous cell carcinoma of the esophagus|squamous cell carcinoma of the esophagus
856861|NCT00069316|Mosquito|mosquito
856540|NCT00069953|stage III esophageal cancer|stage iii esophageal cancer
856541|NCT00069940|adult glioblastoma|adult glioblastoma
856542|NCT00069940|stage III adult soft tissue sarcoma|stage iii adult soft tissue sarcoma
856543|NCT00069940|stage IV adult soft tissue sarcoma|stage iv adult soft tissue sarcoma
856544|NCT00069940|adult synovial sarcoma|adult synovial sarcoma
856545|NCT00069940|childhood synovial sarcoma|childhood synovial sarcoma
856546|NCT00069940|childhood leiomyosarcoma|childhood leiomyosarcoma
856547|NCT00069940|adult leiomyosarcoma|adult leiomyosarcoma
856548|NCT00069940|adult liposarcoma|adult liposarcoma
856549|NCT00069940|childhood liposarcoma|childhood liposarcoma
856550|NCT00069940|gastrointestinal stromal tumor|gastrointestinal stromal tumor
856551|NCT00069940|recurrent childhood brain tumor|recurrent childhood brain tumor
856552|NCT00069940|recurrent adult brain tumor|recurrent adult brain tumor
856553|NCT00069940|metastatic childhood soft tissue sarcoma|metastatic childhood soft tissue sarcoma
856554|NCT00069940|recurrent childhood soft tissue sarcoma|recurrent childhood soft tissue sarcoma
856555|NCT00069940|recurrent adult soft tissue sarcoma|recurrent adult soft tissue sarcoma
856556|NCT00069940|adult giant cell glioblastoma|adult giant cell glioblastoma
856557|NCT00069940|adult gliosarcoma|adult gliosarcoma
856558|NCT00069940|adult anaplastic astrocytoma|adult anaplastic astrocytoma
856559|NCT00069940|adult oligodendroglioma|adult oligodendroglioma
856560|NCT00069940|adult anaplastic oligodendroglioma|adult anaplastic oligodendroglioma
856561|NCT00069940|adult diffuse astrocytoma|adult diffuse astrocytoma
856562|NCT00069940|adult mixed glioma|adult mixed glioma
856563|NCT00069940|adult myxopapillary ependymoma|adult myxopapillary ependymoma
856564|NCT00069940|adult anaplastic ependymoma|adult anaplastic ependymoma
856565|NCT00069940|childhood high-grade cerebral astrocytoma|childhood high-grade cerebral astrocytoma
856566|NCT00069940|recurrent childhood cerebral astrocytoma|recurrent childhood cerebral astrocytoma
856567|NCT00069940|untreated childhood cerebellar astrocytoma|untreated childhood cerebellar astrocytoma
856568|NCT00069940|recurrent childhood cerebellar astrocytoma|recurrent childhood cerebellar astrocytoma
856569|NCT00069940|childhood infratentorial ependymoma|childhood infratentorial ependymoma
856570|NCT00069940|newly diagnosed childhood ependymoma|newly diagnosed childhood ependymoma
856571|NCT00069940|recurrent childhood ependymoma|recurrent childhood ependymoma
856572|NCT00069940|childhood oligodendroglioma|childhood oligodendroglioma
856573|NCT00069927|unspecified childhood solid tumor, protocol specific|unspecified childhood solid tumor, protocol specific
856574|NCT00069927|depression|depression
856575|NCT00069927|neurotoxicity|neurotoxicity
856576|NCT00006034|stage 0 bladder cancer|stage 0 bladder cancer
856577|NCT00006034|recurrent bladder cancer|recurrent bladder cancer
856578|NCT00003868|recurrent childhood acute myeloid leukemia|recurrent childhood acute myeloid leukemia
856579|NCT00003868|recurrent adult acute myeloid leukemia|recurrent adult acute myeloid leukemia
856580|NCT00003868|secondary acute myeloid leukemia|secondary acute myeloid leukemia
856581|NCT00003868|adult acute myeloid leukemia with t(8;21)(q22;q22)|adult acute myeloid leukemia with t(8;21)(q22;q22)
856582|NCT00003868|adult acute myeloid leukemia with t(16;16)(p13;q22)|adult acute myeloid leukemia with t(16;16)(p13;q22)
856583|NCT00003868|adult acute myeloid leukemia with inv(16)(p13;q22)|adult acute myeloid leukemia with inv(16)(p13;q22)
856584|NCT00003868|adult acute myeloid leukemia with 11q23 (MLL) abnormalities|adult acute myeloid leukemia with 11q23 (mll) abnormalities
856585|NCT00003868|adult acute myeloid leukemia with t(15;17)(q22;q12)|adult acute myeloid leukemia with t(15;17)(q22;q12)
856586|NCT00070577|Alcohol Clamp|alcohol clamp
856587|NCT00070577|Pharmacokinetics|pharmacokinetics
856588|NCT00070577|Pharmacodynamics|pharmacodynamics
856590|NCT00070577|Metabolism|metabolism
856591|NCT00070577|Response|response
856592|NCT00070577|Age|age
856593|NCT00070577|Sex|sex
856594|NCT00070577|Healthy Volunteer|healthy volunteer
856595|NCT00070577|HV|hv
856596|NCT00069901|ovarian cancer|ovarian cancer
856597|NCT00069901|paclitaxel|paclitaxel
856598|NCT00069901|carboplatin|carboplatin
856599|NCT00069784|Impaired Fasting Glucose (IFG)|impaired fasting glucose (ifg)
856600|NCT00069784|Impaired Glucose Tolerance (IGT)|impaired glucose tolerance (igt)
856601|NCT00069745|Prostatic Neoplasms|prostatic neoplasms
856602|NCT00069745|Cancer Treatment Protocols|cancer treatment protocols
856603|NCT00069745|Antineoplastic protocols|antineoplastic protocols
856604|NCT00069745|One Prior Cytotoxic Chemotherapy Regimen|one prior cytotoxic chemotherapy regimen
856605|NCT00069719|open-angle|open-angle
856606|NCT00069719|glaucoma|glaucoma
856607|NCT00069719|ocular|ocular
856608|NCT00069719|hypertension|hypertension
856609|NCT00069719|POAG|poag
856610|NCT00069706|open-angle|open-angle
856611|NCT00069706|glaucoma|glaucoma
856612|NCT00069706|ocular|ocular
856613|NCT00069706|hypertension|hypertension
856614|NCT00069706|POAG|poag
856615|NCT00069914|Immunization|immunization
856616|NCT00069914|Immune Activation|immune activation
856617|NCT00069914|Flu|flu
856618|NCT00069914|Antibodies|antibodies
856619|NCT00069914|Titers|titers
856620|NCT00069914|HIV|hiv
856621|NCT00069914|Healthy Volunteer|healthy volunteer
856622|NCT00069914|HV|hv
856623|NCT00069862|Beta Thalassemia|beta thalassemia
856624|NCT00069836|AVANDAMET insulin type 2 diabetes|avandamet insulin type 2 diabetes
856625|NCT00069732|Overweight|overweight
856862|NCT00069316|Fever|fever
856626|NCT00069732|Weight loss maintenance|weight loss maintenance
856627|NCT00069732|CAM therapy|cam therapy
856628|NCT00069732|Qigong|qigong
856629|NCT00069732|Acupressure|acupressure
856630|NCT00069732|Traditional Chinese Medicine|traditional chinese medicine
856631|NCT00069758|NHL, indolent NHL, non-Hodgkin's lymphoma, lymphoma|nhl, indolent nhl, non-hodgkin's lymphoma, lymphoma
856632|NCT00069641|Mucopolysaccharidosis II|mucopolysaccharidosis ii
856633|NCT00069641|MPS II|mps ii
856634|NCT00069641|Hunter Syndrome|hunter syndrome
856635|NCT00069641|iduronate-2-sulfatase|iduronate-2-sulfatase
856636|NCT00069641|I2S|i2s
856637|NCT00069641|Iduronate-2-sulfatase deficiency|iduronate-2-sulfatase deficiency
856638|NCT00069524|Highly active antiretroviral therapy (HAART)|highly active antiretroviral therapy (haart)
856639|NCT00069524|Ritonavir|ritonavir
856640|NCT00069524|Oyster mushrooms|oyster mushrooms
856641|NCT00069524|Non-HDL cholesterol|non-hdl cholesterol
856642|NCT00069524|Complementary Therapies|complementary therapies
856643|NCT00069524|Treatment Experienced|treatment experienced
856644|NCT00005630|stage I non-small cell lung cancer|stage i non-small cell lung cancer
856645|NCT00005630|stage II non-small cell lung cancer|stage ii non-small cell lung cancer
856646|NCT00005630|large cell lung cancer|large cell lung cancer
856647|NCT00005630|stage IIIA non-small cell lung cancer|stage iiia non-small cell lung cancer
856648|NCT00005630|stage IIIB non-small cell lung cancer|stage iiib non-small cell lung cancer
856649|NCT00005630|stage IV non-small cell lung cancer|stage iv non-small cell lung cancer
856650|NCT00005630|adenocarcinoma of the lung|adenocarcinoma of the lung
856651|NCT00005630|bronchoalveolar cell lung cancer|bronchoalveolar cell lung cancer
856652|NCT00005629|localized resectable adult primary liver cancer|localized resectable adult primary liver cancer
856653|NCT00005629|localized unresectable adult primary liver cancer|localized unresectable adult primary liver cancer
856654|NCT00005629|advanced adult primary liver cancer|advanced adult primary liver cancer
856655|NCT00005629|recurrent adult primary liver cancer|recurrent adult primary liver cancer
856656|NCT00005629|adult primary hepatocellular carcinoma|adult primary hepatocellular carcinoma
856657|NCT00004922|newly diagnosed carcinoma of unknown primary|newly diagnosed carcinoma of unknown primary
856658|NCT00004922|recurrent carcinoma of unknown primary|recurrent carcinoma of unknown primary
856659|NCT00004922|stage III neuroendocrine carcinoma of the skin|stage iii neuroendocrine carcinoma of the skin
856660|NCT00004922|recurrent neuroendocrine carcinoma of the skin|recurrent neuroendocrine carcinoma of the skin
856661|NCT00004922|neuroendocrine carcinoma|neuroendocrine carcinoma
856662|NCT00004886|unspecified adult solid tumor, protocol specific|unspecified adult solid tumor, protocol specific
856663|NCT00069693|Dysautonomia|dysautonomia
856664|NCT00069693|Sympathetic Nervous System|sympathetic nervous system
856665|NCT00069693|Autonomic Nervous System|autonomic nervous system
856666|NCT00069693|Syncope|syncope
856667|NCT00069693|Post Tachycardia Syndrome|post tachycardia syndrome
856668|NCT00069693|POTS|pots
856669|NCT00069693|Neurocardiogenic Syncope|neurocardiogenic syncope
856671|NCT00069693|Norepinephrine|norepinephrine
856672|NCT00069693|Epinephrine|epinephrine
856673|NCT00069693|Neurocardiology|neurocardiology
856674|NCT00069693|Chronic Orthostatic Intolerance|chronic orthostatic intolerance
856675|NCT00069693|COI|coi
856676|NCT00069693|Healthy Volunteer|healthy volunteer
856677|NCT00069693|HV|hv
856678|NCT00069680|Gene Identification|gene identification
856679|NCT00069680|Linkage Analysis|linkage analysis
856680|NCT00069680|Homozygosity Mapping|homozygosity mapping
856681|NCT00069680|Gray Platelet Syndrome|gray platelet syndrome
856682|NCT00069680|GPS|gps
856683|NCT00069680|Platelet Function Defect|platelet function defect
856684|NCT00069680|Bleeding Disorder|bleeding disorder
856685|NCT00069654|Endothelium|endothelium
856686|NCT00069654|Atherosclerosis|atherosclerosis
856687|NCT00069654|Vasodilation|vasodilation
856688|NCT00069654|Ischemia|ischemia
856689|NCT00069654|Exercise|exercise
856690|NCT00069654|Coronary Artery Disease|coronary artery disease
856691|NCT00069654|CAD|cad
856692|NCT00069628|Diabetes Mellitus, Insulin-Dependent|diabetes mellitus, insulin-dependent
856693|NCT00069628|Type 1 Diabetes|type 1 diabetes
856694|NCT00069628|Diabetes in Children|diabetes in children
856695|NCT00069628|Continuous Glucose Monitoring Devices|continuous glucose monitoring devices
856696|NCT00069615|Diabetes Mellitus, Insulin-Dependent|diabetes mellitus, insulin-dependent
856697|NCT00069615|Type 1 Diabetes|type 1 diabetes
856698|NCT00069615|Continuous Glucose Monitoring Devices|continuous glucose monitoring devices
856699|NCT00069615|Electronic Data Collection|electronic data collection
856700|NCT00069602|Continuous Glucose Monitoring Devices|continuous glucose monitoring devices
856701|NCT00069602|Blood glucose profiles in normal children|blood glucose profiles in normal children
856702|NCT00069602|Blood glucose profiles in non-diabetic children|blood glucose profiles in non-diabetic children
856704|NCT00069589|Autoimmunity|autoimmunity
856705|NCT00069589|Hair|hair
856706|NCT00069589|Alopecia Areata|alopecia areata
856707|NCT00069589|Alopecia Partialis|alopecia partialis
856708|NCT00069589|Alopecia Totalis|alopecia totalis
856709|NCT00069589|Alopecia Universalis|alopecia universalis
856710|NCT00069589|Autoimmune Hair Loss|autoimmune hair loss
856711|NCT00069576|Mild gestational diabetes mellitus|mild gestational diabetes mellitus
856863|NCT00069316|WNV|wnv
856712|NCT00069576|Maternal Fetal Medicine Units Network|maternal fetal medicine units network
856713|NCT00069563|Internalizing psychopathology|internalizing psychopathology
856714|NCT00069563|Externalizing psychopathology|externalizing psychopathology
856715|NCT00069550|Glutamate/NMDA receptors|glutamate/nmda receptors
856716|NCT00069550|Cholinergic upregulation|cholinergic upregulation
856717|NCT00069550|Dextromethorphan|dextromethorphan
856718|NCT00069550|Donepezil hydrochloride|donepezil hydrochloride
856719|NCT00069550|Aricept|aricept
856720|NCT00069537|Diabetes Mellitus, Insulin-Dependent|diabetes mellitus, insulin-dependent
856721|NCT00069537|Type 1 Diabetes|type 1 diabetes
856722|NCT00069537|Diabetes in Children|diabetes in children
856723|NCT00069537|Continuous Glucose Monitoring Devices|continuous glucose monitoring devices
856724|NCT00069511|Hepatitis C|hepatitis c
856725|NCT00069498|Mucosa|mucosa
856726|NCT00069498|Inflammation|inflammation
856727|NCT00069498|Tissue Viral Load|tissue viral load
856728|NCT00069498|Anti-inflammatory|anti-inflammatory
856729|NCT00069498|HIV-related diarrhea|hiv-related diarrhea
856730|NCT00069498|Mucosal Inflammation|mucosal inflammation
856731|NCT00069498|Treatment Experienced|treatment experienced
856732|NCT00069485|HIV Seronegativity|hiv seronegativity
856733|NCT00003930|stage II bladder cancer|stage ii bladder cancer
856734|NCT00003930|stage III bladder cancer|stage iii bladder cancer
856735|NCT00069472|Genetics|genetics
856736|NCT00069459|Winter depression, winter blues, depression, seasonal depression, seasonal affective disorder|winter depression, winter blues, depression, seasonal depression, seasonal affective disorder
856737|NCT00069446|Diabetes|diabetes
856738|NCT00069446|Diabetic|diabetic
856739|NCT00069446|Diabetic Foot Ulcer|diabetic foot ulcer
856740|NCT00069368|Healthy|healthy
856741|NCT00069407|Bipolar Disorder|bipolar disorder
856742|NCT00003827|refractory anemia with excess blasts|refractory anemia with excess blasts
856743|NCT00003827|refractory anemia with excess blasts in transformation|refractory anemia with excess blasts in transformation
856744|NCT00003827|de novo myelodysplastic syndromes|de novo myelodysplastic syndromes
856745|NCT00003827|secondary myelodysplastic syndromes|secondary myelodysplastic syndromes
856746|NCT00003827|childhood myelodysplastic syndromes|childhood myelodysplastic syndromes
856747|NCT00003594|stage III colon cancer|stage iii colon cancer
856748|NCT00003594|stage IV colon cancer|stage iv colon cancer
856749|NCT00003594|stage III rectal cancer|stage iii rectal cancer
856750|NCT00003594|stage IV rectal cancer|stage iv rectal cancer
856751|NCT00003594|recurrent colon cancer|recurrent colon cancer
856752|NCT00003594|recurrent rectal cancer|recurrent rectal cancer
856753|NCT00003594|adenocarcinoma of the colon|adenocarcinoma of the colon
856754|NCT00003594|adenocarcinoma of the rectum|adenocarcinoma of the rectum
856755|NCT00003540|stage IV breast cancer|stage iv breast cancer
856756|NCT00003540|recurrent breast cancer|recurrent breast cancer
856757|NCT00003463|recurrent adult brain tumor|recurrent adult brain tumor
856758|NCT00003463|adult brain stem glioma|adult brain stem glioma
856759|NCT00003463|adult glioblastoma|adult glioblastoma
856760|NCT00003463|adult anaplastic astrocytoma|adult anaplastic astrocytoma
856761|NCT00003463|adult mixed glioma|adult mixed glioma
856762|NCT00003463|adult giant cell glioblastoma|adult giant cell glioblastoma
856763|NCT00003463|adult gliosarcoma|adult gliosarcoma
856764|NCT00069355|PTSD|ptsd
856765|NCT00069355|Catecholamines|catecholamines
856766|NCT00069355|Conditioning|conditioning
856767|NCT00069355|Memory|memory
856768|NCT00069355|Psychophysiology|psychophysiology
856769|NCT00069355|Acute Stress Disorder|acute stress disorder
856770|NCT00069355|Post-Traumatic Stress Disorder|post-traumatic stress disorder
856771|NCT00069342|Chronic Pain|chronic pain
856772|NCT00069342|Pain|pain
856773|NCT00069342|Rheumatoid Arthritis|rheumatoid arthritis
856774|NCT00069342|Depression|depression
856775|NCT00069342|Function|function
856776|NCT00069342|Rheumatic Disease|rheumatic disease
856777|NCT00069277|Cancer, tumors|cancer, tumors
856778|NCT00069264|Metastatic Tumors|metastatic tumors
856779|NCT00069264|Advanced Solid Tumors|advanced solid tumors
856780|NCT00069264|Stage IV Tumors|stage iv tumors
856781|NCT00069264|Solid Tumors|solid tumors
856782|NCT00069264|Recurrent Solid Tumors|recurrent solid tumors
856783|NCT00069251|amphetamine dependence|amphetamine dependence
856784|NCT00003449|recurrent ovarian epithelial cancer|recurrent ovarian epithelial cancer
856785|NCT00003281|recurrent small cell lung cancer|recurrent small cell lung cancer
856786|NCT00003280|stage I mantle cell lymphoma|stage i mantle cell lymphoma
856787|NCT00003280|contiguous stage II mantle cell lymphoma|contiguous stage ii mantle cell lymphoma
856892|NCT00069212|Neural Circuits|neural circuits
856788|NCT00003280|noncontiguous stage II mantle cell lymphoma|noncontiguous stage ii mantle cell lymphoma
856789|NCT00003280|stage III mantle cell lymphoma|stage iii mantle cell lymphoma
856790|NCT00003280|stage IV mantle cell lymphoma|stage iv mantle cell lymphoma
856791|NCT00003280|recurrent mantle cell lymphoma|recurrent mantle cell lymphoma
856792|NCT00003245|Waldenström macroglobulinemia|waldenström macroglobulinemia
856793|NCT00003245|recurrent grade 1 follicular lymphoma|recurrent grade 1 follicular lymphoma
856794|NCT00003245|recurrent grade 2 follicular lymphoma|recurrent grade 2 follicular lymphoma
856795|NCT00003245|recurrent grade 3 follicular lymphoma|recurrent grade 3 follicular lymphoma
856864|NCT00069316|Myelitis|myelitis
856796|NCT00003245|recurrent adult diffuse small cleaved cell lymphoma|recurrent adult diffuse small cleaved cell lymphoma
856797|NCT00003245|recurrent adult diffuse mixed cell lymphoma|recurrent adult diffuse mixed cell lymphoma
856798|NCT00003245|recurrent adult diffuse large cell lymphoma|recurrent adult diffuse large cell lymphoma
856799|NCT00003245|recurrent adult immunoblastic large cell lymphoma|recurrent adult immunoblastic large cell lymphoma
856800|NCT00003245|recurrent adult Burkitt lymphoma|recurrent adult burkitt lymphoma
856801|NCT00003245|recurrent mantle cell lymphoma|recurrent mantle cell lymphoma
856802|NCT00003245|recurrent marginal zone lymphoma|recurrent marginal zone lymphoma
856803|NCT00003245|recurrent small lymphocytic lymphoma|recurrent small lymphocytic lymphoma
856804|NCT00003245|extranodal marginal zone B-cell lymphoma of mucosa-associated lymphoid tissue|extranodal marginal zone b-cell lymphoma of mucosa-associated lymphoid tissue
856805|NCT00003245|nodal marginal zone B-cell lymphoma|nodal marginal zone b-cell lymphoma
856806|NCT00003245|splenic marginal zone lymphoma|splenic marginal zone lymphoma
856807|NCT00003113|stage I grade 3 follicular lymphoma|stage i grade 3 follicular lymphoma
856808|NCT00003113|stage I adult diffuse small cleaved cell lymphoma|stage i adult diffuse small cleaved cell lymphoma
856809|NCT00003113|stage I adult diffuse mixed cell lymphoma|stage i adult diffuse mixed cell lymphoma
856810|NCT00003113|stage I adult diffuse large cell lymphoma|stage i adult diffuse large cell lymphoma
856811|NCT00003113|stage I adult immunoblastic large cell lymphoma|stage i adult immunoblastic large cell lymphoma
856812|NCT00003113|stage I adult lymphoblastic lymphoma|stage i adult lymphoblastic lymphoma
856813|NCT00003113|stage I adult Burkitt lymphoma|stage i adult burkitt lymphoma
856814|NCT00003113|stage III grade 3 follicular lymphoma|stage iii grade 3 follicular lymphoma
856815|NCT00003113|stage III adult diffuse small cleaved cell lymphoma|stage iii adult diffuse small cleaved cell lymphoma
856816|NCT00003113|stage III adult diffuse mixed cell lymphoma|stage iii adult diffuse mixed cell lymphoma
856817|NCT00003113|stage III adult diffuse large cell lymphoma|stage iii adult diffuse large cell lymphoma
856818|NCT00003113|stage III adult immunoblastic large cell lymphoma|stage iii adult immunoblastic large cell lymphoma
856819|NCT00003113|stage III adult lymphoblastic lymphoma|stage iii adult lymphoblastic lymphoma
856820|NCT00003113|stage III adult Burkitt lymphoma|stage iii adult burkitt lymphoma
856821|NCT00003113|stage IV grade 3 follicular lymphoma|stage iv grade 3 follicular lymphoma
856822|NCT00003113|stage IV adult diffuse small cleaved cell lymphoma|stage iv adult diffuse small cleaved cell lymphoma
856823|NCT00003113|stage IV adult diffuse mixed cell lymphoma|stage iv adult diffuse mixed cell lymphoma
856824|NCT00003113|stage IV adult diffuse large cell lymphoma|stage iv adult diffuse large cell lymphoma
856825|NCT00003113|stage IV adult immunoblastic large cell lymphoma|stage iv adult immunoblastic large cell lymphoma
856826|NCT00003113|stage IV adult lymphoblastic lymphoma|stage iv adult lymphoblastic lymphoma
856827|NCT00003113|stage IV adult Burkitt lymphoma|stage iv adult burkitt lymphoma
856828|NCT00003113|stage I mantle cell lymphoma|stage i mantle cell lymphoma
856829|NCT00003113|contiguous stage II grade 3 follicular lymphoma|contiguous stage ii grade 3 follicular lymphoma
856830|NCT00003113|contiguous stage II adult diffuse small cleaved cell lymphoma|contiguous stage ii adult diffuse small cleaved cell lymphoma
856831|NCT00003113|contiguous stage II mantle cell lymphoma|contiguous stage ii mantle cell lymphoma
856832|NCT00003113|contiguous stage II adult diffuse mixed cell lymphoma|contiguous stage ii adult diffuse mixed cell lymphoma
856833|NCT00003113|contiguous stage II adult immunoblastic large cell lymphoma|contiguous stage ii adult immunoblastic large cell lymphoma
856834|NCT00003113|contiguous stage II adult diffuse large cell lymphoma|contiguous stage ii adult diffuse large cell lymphoma
856835|NCT00003113|contiguous stage II adult Burkitt lymphoma|contiguous stage ii adult burkitt lymphoma
856836|NCT00003113|contiguous stage II adult lymphoblastic lymphoma|contiguous stage ii adult lymphoblastic lymphoma
856837|NCT00003113|noncontiguous stage II grade 3 follicular lymphoma|noncontiguous stage ii grade 3 follicular lymphoma
856838|NCT00003113|noncontiguous stage II adult diffuse small cleaved cell lymphoma|noncontiguous stage ii adult diffuse small cleaved cell lymphoma
856839|NCT00003113|noncontiguous stage II mantle cell lymphoma|noncontiguous stage ii mantle cell lymphoma
856840|NCT00003113|noncontiguous stage II adult diffuse mixed cell lymphoma|noncontiguous stage ii adult diffuse mixed cell lymphoma
856841|NCT00003113|noncontiguous stage II adult immunoblastic large cell lymphoma|noncontiguous stage ii adult immunoblastic large cell lymphoma
856842|NCT00003113|noncontiguous stage II adult diffuse large cell lymphoma|noncontiguous stage ii adult diffuse large cell lymphoma
856843|NCT00003113|noncontiguous stage II adult Burkitt lymphoma|noncontiguous stage ii adult burkitt lymphoma
856844|NCT00003113|noncontiguous stage II adult lymphoblastic lymphoma|noncontiguous stage ii adult lymphoblastic lymphoma
856845|NCT00003113|stage III mantle cell lymphoma|stage iii mantle cell lymphoma
856846|NCT00003113|stage IV mantle cell lymphoma|stage iv mantle cell lymphoma
856847|NCT00003113|stage II mantle cell lymphoma|stage ii mantle cell lymphoma
856848|NCT00069329|Central Nervous System|central nervous system
856849|NCT00069329|Abnormalities|abnormalities
856850|NCT00069329|Arthropathy|arthropathy
856851|NCT00069329|Urticaria|urticaria
856852|NCT00069329|Papilledema|papilledema
856853|NCT00069329|Auto-Inflammation|auto-inflammation
856854|NCT00069329|Inflammatory Disease|inflammatory disease
856855|NCT00069329|Neonatal Onset Multisystem Inflammatory Disease|neonatal onset multisystem inflammatory disease
856856|NCT00069329|NOMID|nomid
856857|NCT00069329|CINCA Syndrome|cinca syndrome
856858|NCT00069316|West Nile Virus|west nile virus
856859|NCT00069316|Encephalitis|encephalitis
856860|NCT00069316|Virus|virus
856865|NCT00069303|West Nile Virus|west nile virus
856866|NCT00069303|Encephalitis|encephalitis
856867|NCT00069303|Virus|virus
856868|NCT00069303|Mosquito|mosquito
856869|NCT00069303|Fever|fever
856870|NCT00069303|WNV|wnv
856871|NCT00069303|Myelitis|myelitis
856872|NCT00069186|Amyotrophic Lateral Sclerosis|amyotrophic lateral sclerosis
856873|NCT00069186|ALS|als
856874|NCT00069186|Creatine|creatine
856875|NCT00069186|Creatine Monohydrate|creatine monohydrate
856876|NCT00069186|Muscle Strength|muscle strength
856877|NCT00069238|Lymphoma|lymphoma
856878|NCT00069238|T-Cell Lymphoma|t-cell lymphoma
856879|NCT00069238|NK -Cell Lymphoma|nk -cell lymphoma
856880|NCT00069225|fMRI|fmri
856881|NCT00069225|Prolonged Exposure|prolonged exposure
856882|NCT00069225|Brain Activation|brain activation
856883|NCT00069225|Conditioning|conditioning
856884|NCT00069225|Paroxetine|paroxetine
856885|NCT00069225|PTSD|ptsd
856886|NCT00069225|Differential Fear Conditioning|differential fear conditioning
856887|NCT00069225|Masked Faces|masked faces
856888|NCT00069225|Amygdala|amygdala
856889|NCT00069225|Hippocampus|hippocampus
856890|NCT00069225|Post-Traumatic Stress Disorder|post-traumatic stress disorder
856891|NCT00069212|Post-Traumatic Stress Disorder|post-traumatic stress disorder
856893|NCT00069212|Fear|fear
856894|NCT00069212|Emotional Regulation|emotional regulation
856895|NCT00069212|Reward|reward
856896|NCT00069212|PTSD|ptsd
856897|NCT00069199|Reproducibility|reproducibility
856898|NCT00069199|Macular Edema|macular edema
856899|NCT00069199|OCT2|oct2
856900|NCT00069199|OCT3|oct3
856901|NCT00069199|Retina|retina
856902|NCT00002638|recurrent childhood acute lymphoblastic leukemia|recurrent childhood acute lymphoblastic leukemia
856903|NCT00002559|recurrent malignant testicular germ cell tumor|recurrent malignant testicular germ cell tumor
856904|NCT00002559|recurrent ovarian germ cell tumor|recurrent ovarian germ cell tumor
856905|NCT00002533|untreated metastatic squamous neck cancer with occult primary|untreated metastatic squamous neck cancer with occult primary
856906|NCT00002533|recurrent metastatic squamous neck cancer with occult primary|recurrent metastatic squamous neck cancer with occult primary
856907|NCT00002533|metastatic squamous neck cancer with occult primary squamous cell carcinoma|metastatic squamous neck cancer with occult primary squamous cell carcinoma
856908|NCT00002533|oral complications|oral complications
856909|NCT00002533|stage I squamous cell carcinoma of the lip and oral cavity|stage i squamous cell carcinoma of the lip and oral cavity
856910|NCT00002533|stage I basal cell carcinoma of the lip|stage i basal cell carcinoma of the lip
856911|NCT00002533|stage I verrucous carcinoma of the oral cavity|stage i verrucous carcinoma of the oral cavity
856912|NCT00002533|stage I mucoepidermoid carcinoma of the oral cavity|stage i mucoepidermoid carcinoma of the oral cavity
856913|NCT00002533|stage I adenoid cystic carcinoma of the oral cavity|stage i adenoid cystic carcinoma of the oral cavity
856914|NCT00002533|stage II squamous cell carcinoma of the lip and oral cavity|stage ii squamous cell carcinoma of the lip and oral cavity
856915|NCT00002533|stage II basal cell carcinoma of the lip|stage ii basal cell carcinoma of the lip
856916|NCT00002533|stage II verrucous carcinoma of the oral cavity|stage ii verrucous carcinoma of the oral cavity
856917|NCT00002533|stage II mucoepidermoid carcinoma of the oral cavity|stage ii mucoepidermoid carcinoma of the oral cavity
856918|NCT00002533|stage II adenoid cystic carcinoma of the oral cavity|stage ii adenoid cystic carcinoma of the oral cavity
856919|NCT00002533|stage III squamous cell carcinoma of the lip and oral cavity|stage iii squamous cell carcinoma of the lip and oral cavity
856920|NCT00002533|stage III basal cell carcinoma of the lip|stage iii basal cell carcinoma of the lip
856921|NCT00002533|stage III verrucous carcinoma of the oral cavity|stage iii verrucous carcinoma of the oral cavity
856922|NCT00002533|stage III mucoepidermoid carcinoma of the oral cavity|stage iii mucoepidermoid carcinoma of the oral cavity
856923|NCT00002533|stage III adenoid cystic carcinoma of the oral cavity|stage iii adenoid cystic carcinoma of the oral cavity
856924|NCT00002533|stage IV squamous cell carcinoma of the lip and oral cavity|stage iv squamous cell carcinoma of the lip and oral cavity
856925|NCT00002533|stage IV basal cell carcinoma of the lip|stage iv basal cell carcinoma of the lip
856926|NCT00002533|stage IV verrucous carcinoma of the oral cavity|stage iv verrucous carcinoma of the oral cavity
856927|NCT00002533|stage IV mucoepidermoid carcinoma of the oral cavity|stage iv mucoepidermoid carcinoma of the oral cavity
856928|NCT00002533|stage IV adenoid cystic carcinoma of the oral cavity|stage iv adenoid cystic carcinoma of the oral cavity
856929|NCT00002533|recurrent squamous cell carcinoma of the lip and oral cavity|recurrent squamous cell carcinoma of the lip and oral cavity
856930|NCT00002533|recurrent basal cell carcinoma of the lip|recurrent basal cell carcinoma of the lip
856931|NCT00002533|recurrent verrucous carcinoma of the oral cavity|recurrent verrucous carcinoma of the oral cavity
856932|NCT00002533|recurrent mucoepidermoid carcinoma of the oral cavity|recurrent mucoepidermoid carcinoma of the oral cavity
856933|NCT00002533|recurrent adenoid cystic carcinoma of the oral cavity|recurrent adenoid cystic carcinoma of the oral cavity
856934|NCT00002533|stage I squamous cell carcinoma of the oropharynx|stage i squamous cell carcinoma of the oropharynx
856935|NCT00002533|stage I lymphoepithelioma of the oropharynx|stage i lymphoepithelioma of the oropharynx
856936|NCT00002533|stage II squamous cell carcinoma of the oropharynx|stage ii squamous cell carcinoma of the oropharynx
856937|NCT00002533|stage II lymphoepithelioma of the oropharynx|stage ii lymphoepithelioma of the oropharynx
856938|NCT00002533|stage III squamous cell carcinoma of the oropharynx|stage iii squamous cell carcinoma of the oropharynx
856939|NCT00002533|stage III lymphoepithelioma of the oropharynx|stage iii lymphoepithelioma of the oropharynx
856940|NCT00002533|stage IV squamous cell carcinoma of the oropharynx|stage iv squamous cell carcinoma of the oropharynx
856941|NCT00002533|stage IV lymphoepithelioma of the oropharynx|stage iv lymphoepithelioma of the oropharynx
856942|NCT00002533|recurrent squamous cell carcinoma of the oropharynx|recurrent squamous cell carcinoma of the oropharynx
856943|NCT00002533|recurrent lymphoepithelioma of the oropharynx|recurrent lymphoepithelioma of the oropharynx
856944|NCT00002533|stage I squamous cell carcinoma of the nasopharynx|stage i squamous cell carcinoma of the nasopharynx
856945|NCT00002533|stage I lymphoepithelioma of the nasopharynx|stage i lymphoepithelioma of the nasopharynx
856946|NCT00002533|stage II squamous cell carcinoma of the nasopharynx|stage ii squamous cell carcinoma of the nasopharynx
856947|NCT00002533|stage II lymphoepithelioma of the nasopharynx|stage ii lymphoepithelioma of the nasopharynx
856948|NCT00002533|stage III squamous cell carcinoma of the nasopharynx|stage iii squamous cell carcinoma of the nasopharynx
856949|NCT00002533|stage III lymphoepithelioma of the nasopharynx|stage iii lymphoepithelioma of the nasopharynx
856950|NCT00002533|stage IV squamous cell carcinoma of the nasopharynx|stage iv squamous cell carcinoma of the nasopharynx
856951|NCT00002533|stage IV lymphoepithelioma of the nasopharynx|stage iv lymphoepithelioma of the nasopharynx
856952|NCT00002533|recurrent squamous cell carcinoma of the nasopharynx|recurrent squamous cell carcinoma of the nasopharynx
856953|NCT00002533|recurrent lymphoepithelioma of the nasopharynx|recurrent lymphoepithelioma of the nasopharynx
856954|NCT00002533|stage I squamous cell carcinoma of the hypopharynx|stage i squamous cell carcinoma of the hypopharynx
856955|NCT00002533|stage II squamous cell carcinoma of the hypopharynx|stage ii squamous cell carcinoma of the hypopharynx
856956|NCT00002533|stage III squamous cell carcinoma of the hypopharynx|stage iii squamous cell carcinoma of the hypopharynx
856957|NCT00002533|stage IV squamous cell carcinoma of the hypopharynx|stage iv squamous cell carcinoma of the hypopharynx
856958|NCT00002533|recurrent squamous cell carcinoma of the hypopharynx|recurrent squamous cell carcinoma of the hypopharynx
856959|NCT00002533|stage I squamous cell carcinoma of the larynx|stage i squamous cell carcinoma of the larynx
856960|NCT00002533|stage I verrucous carcinoma of the larynx|stage i verrucous carcinoma of the larynx
856961|NCT00002533|stage II squamous cell carcinoma of the larynx|stage ii squamous cell carcinoma of the larynx
856962|NCT00002533|stage II verrucous carcinoma of the larynx|stage ii verrucous carcinoma of the larynx
856963|NCT00002533|stage III squamous cell carcinoma of the larynx|stage iii squamous cell carcinoma of the larynx
856964|NCT00002533|stage III verrucous carcinoma of the larynx|stage iii verrucous carcinoma of the larynx
856965|NCT00002533|stage IV squamous cell carcinoma of the larynx|stage iv squamous cell carcinoma of the larynx
856966|NCT00002533|stage IV verrucous carcinoma of the larynx|stage iv verrucous carcinoma of the larynx
856967|NCT00002533|recurrent squamous cell carcinoma of the larynx|recurrent squamous cell carcinoma of the larynx
856968|NCT00002533|recurrent verrucous carcinoma of the larynx|recurrent verrucous carcinoma of the larynx
856969|NCT00002533|stage I squamous cell carcinoma of the paranasal sinus and nasal cavity|stage i squamous cell carcinoma of the paranasal sinus and nasal cavity
856970|NCT00002533|stage I inverted papilloma of the paranasal sinus and nasal cavity|stage i inverted papilloma of the paranasal sinus and nasal cavity
856971|NCT00002533|stage I midline lethal granuloma of the paranasal sinus and nasal cavity|stage i midline lethal granuloma of the paranasal sinus and nasal cavity
856972|NCT00002533|stage I esthesioneuroblastoma of the paranasal sinus and nasal cavity|stage i esthesioneuroblastoma of the paranasal sinus and nasal cavity
856973|NCT00002533|stage II squamous cell carcinoma of the paranasal sinus and nasal cavity|stage ii squamous cell carcinoma of the paranasal sinus and nasal cavity
856974|NCT00002533|stage II inverted papilloma of the paranasal sinus and nasal cavity|stage ii inverted papilloma of the paranasal sinus and nasal cavity
856975|NCT00002533|stage II midline lethal granuloma of the paranasal sinus and nasal cavity|stage ii midline lethal granuloma of the paranasal sinus and nasal cavity
856976|NCT00002533|stage II esthesioneuroblastoma of the paranasal sinus and nasal cavity|stage ii esthesioneuroblastoma of the paranasal sinus and nasal cavity
856977|NCT00002533|stage III squamous cell carcinoma of the paranasal sinus and nasal cavity|stage iii squamous cell carcinoma of the paranasal sinus and nasal cavity
857096|NCT00068757|stage IIIB breast cancer|stage iiib breast cancer
856978|NCT00002533|stage III inverted papilloma of the paranasal sinus and nasal cavity|stage iii inverted papilloma of the paranasal sinus and nasal cavity
856979|NCT00002533|stage III midline lethal granuloma of the paranasal sinus and nasal cavity|stage iii midline lethal granuloma of the paranasal sinus and nasal cavity
856980|NCT00002533|stage III esthesioneuroblastoma of the paranasal sinus and nasal cavity|stage iii esthesioneuroblastoma of the paranasal sinus and nasal cavity
856981|NCT00002533|stage IV squamous cell carcinoma of the paranasal sinus and nasal cavity|stage iv squamous cell carcinoma of the paranasal sinus and nasal cavity
856982|NCT00002533|stage IV inverted papilloma of the paranasal sinus and nasal cavity|stage iv inverted papilloma of the paranasal sinus and nasal cavity
856983|NCT00002533|stage IV midline lethal granuloma of the paranasal sinus and nasal cavity|stage iv midline lethal granuloma of the paranasal sinus and nasal cavity
856984|NCT00002533|stage IV esthesioneuroblastoma of the paranasal sinus and nasal cavity|stage iv esthesioneuroblastoma of the paranasal sinus and nasal cavity
856985|NCT00002533|recurrent squamous cell carcinoma of the paranasal sinus and nasal cavity|recurrent squamous cell carcinoma of the paranasal sinus and nasal cavity
856986|NCT00002533|recurrent inverted papilloma of the paranasal sinus and nasal cavity|recurrent inverted papilloma of the paranasal sinus and nasal cavity
856987|NCT00002533|recurrent midline lethal granuloma of the paranasal sinus and nasal cavity|recurrent midline lethal granuloma of the paranasal sinus and nasal cavity
857091|NCT00068809|Treatment interruption|treatment interruption
881794|NCT00031057|Lactic Acid|lactic acid
856988|NCT00002533|recurrent esthesioneuroblastoma of the paranasal sinus and nasal cavity|recurrent esthesioneuroblastoma of the paranasal sinus and nasal cavity
856989|NCT00002533|infection|infection
856991|NCT00069173|Sedentary|sedentary
856992|NCT00069173|School-based|school-based
856993|NCT00069134|glutathione kinetics|glutathione kinetics
856994|NCT00069134|oxidant damage|oxidant damage
856995|NCT00069134|anti-oxidant capacity|anti-oxidant capacity
856996|NCT00069134|oxidative stress|oxidative stress
856997|NCT00069134|cysteine kinetics|cysteine kinetics
856998|NCT00069134|severe childhood malnutrition|severe childhood malnutrition
856999|NCT00026286|stage I breast cancer|stage i breast cancer
857000|NCT00026286|stage II breast cancer|stage ii breast cancer
857001|NCT00026286|breast cancer in situ|breast cancer in situ
857002|NCT00026286|ductal breast carcinoma|ductal breast carcinoma
857003|NCT00026286|hot flashes|hot flashes
857004|NCT00026286|menopausal symptoms|menopausal symptoms
857005|NCT00025116|adenocarcinoma of the prostate|adenocarcinoma of the prostate
857006|NCT00025116|recurrent prostate cancer|recurrent prostate cancer
857007|NCT00069160|Pharmacokinetics|pharmacokinetics
857008|NCT00069160|Pharmacodynamics|pharmacodynamics
857009|NCT00069160|Multidrug Resistance Reversal|multidrug resistance reversal
857010|NCT00069160|Molecular Target|molecular target
857011|NCT00069160|P-Glycoprotein Inhibition|p-glycoprotein inhibition
857012|NCT00069160|Lung Cancer|lung cancer
857013|NCT00069160|Ovarian Cancer|ovarian cancer
857014|NCT00069160|Cervical Cancer|cervical cancer
857015|NCT00069160|Renal Cancer|renal cancer
857016|NCT00069082|Headache|headache
857017|NCT00069082|Cluster|cluster
857019|NCT00069082|Episodic Cluster|episodic cluster
857020|NCT00069030|HIV Seronegativity|hiv seronegativity
857021|NCT00069030|HIV Preventive Vaccine|hiv preventive vaccine
857022|NCT00069030|HIV-1|hiv-1
857023|NCT00069030|AIDS Vaccines|aids vaccines
857024|NCT00069030|Vaccines, DNA|vaccines, dna
857025|NCT00069030|Dose-Response Relationship, Immunologic|dose-response relationship, immunologic
857026|NCT00069030|Cytokines|cytokines
857027|NCT00069030|Plasmids|plasmids
857028|NCT00069030|Adjuvants, Immunologic|adjuvants, immunologic
857029|NCT00069030|Drug Administration Schedule|drug administration schedule
857030|NCT00069030|Interleukin|interleukin
857031|NCT00069030|IL2|il2
857032|NCT00069030|Ig|ig
857033|NCT00069030|IL@/Ig|il@/ig
857034|NCT00069004|HIV-Associated Lipodystrophy Syndrome|hiv-associated lipodystrophy syndrome
857035|NCT00069004|HIV Lipodystrophy Syndrome|hiv lipodystrophy syndrome
857036|NCT00069004|Treatment Experienced|treatment experienced
857037|NCT00069004|Lipodystrophy|lipodystrophy
857038|NCT00069004|Dyslipidemia|dyslipidemia
857039|NCT00069004|Osteoporosis|osteoporosis
857040|NCT00069004|Osteopenia|osteopenia
857041|NCT00068991|Behavioral Intervention Study|behavioral intervention study
857042|NCT00068991|Randomized Prevention Trial|randomized prevention trial
857043|NCT00068991|China|china
857044|NCT00068991|Condom Use|condom use
857045|NCT00068991|STDs|stds
857046|NCT00068991|Sexual Partners|sexual partners
857047|NCT00068991|HIV Seronegativity|hiv seronegativity
857048|NCT00068978|HIV Seronegativity|hiv seronegativity
857049|NCT00068978|HIV Preventive Vaccine|hiv preventive vaccine
857050|NCT00068978|HIV Therapeutic Vaccine|hiv therapeutic vaccine
857051|NCT00069069|Stroke|stroke
857052|NCT00069069|TIA|tia
857053|NCT00069056|Grid Laser|grid laser
857054|NCT00069056|Focal Laser|focal laser
857055|NCT00069056|Glycemic Control|glycemic control
857056|NCT00069056|Diabetes|diabetes
857057|NCT00069056|Diabetic Macular Edema|diabetic macular edema
857058|NCT00069056|Macular Edema|macular edema
857059|NCT00068887|type 2 diabetes|type 2 diabetes
857060|NCT00068887|some studies - family history of type 2 diabetes|some studies - family history of type 2 diabetes
857061|NCT00068926|Biodefense|biodefense
857062|NCT00068926|Prevention|prevention
857063|NCT00068926|Emergent|emergent
857064|NCT00068926|Virus|virus
857065|NCT00068926|Immune Response|immune response
857066|NCT00068926|Healthy Volunteer|healthy volunteer
857067|NCT00068926|HV|hv
857068|NCT00068913|Lactic Acidosis|lactic acidosis
857069|NCT00068913|Mitochondrial Disorder|mitochondrial disorder
857070|NCT00068913|Stroke|stroke
857071|NCT00068913|Seizure|seizure
857072|NCT00068874|African American|african american
857073|NCT00068874|Adolescent|adolescent
857074|NCT00068874|Coping|coping
857075|NCT00068874|Adjustment|adjustment
857076|NCT00068874|Quality of Life|quality of life
857077|NCT00068848|Oral Contraceptives|oral contraceptives
857078|NCT00068848|Initiation|initiation
857079|NCT00068848|Continuation|continuation
857080|NCT00068835|Reading|reading
857081|NCT00068835|Brain imaging|brain imaging
857082|NCT00068822|Vertebroplasty|vertebroplasty
857083|NCT00068822|Crushed Vertebrae|crushed vertebrae
857084|NCT00068822|Back Pain|back pain
857085|NCT00068822|Structurally Unstable Vertebrae|structurally unstable vertebrae
857086|NCT00068822|polymethylmethacrylate|polymethylmethacrylate
857087|NCT00068822|INVEST|invest
857088|NCT00068822|PMMA|pmma
857089|NCT00068822|RDQ|rdq
857090|NCT00068809|Treatment experienced|treatment experienced
857092|NCT00068770|adult glioblastoma|adult glioblastoma
857093|NCT00068770|adult giant cell glioblastoma|adult giant cell glioblastoma
857094|NCT00068770|adult gliosarcoma|adult gliosarcoma
857095|NCT00068757|recurrent breast cancer|recurrent breast cancer
857097|NCT00068757|stage IIIC breast cancer|stage iiic breast cancer
857098|NCT00068757|stage IV breast cancer|stage iv breast cancer
857099|NCT00068757|male breast cancer|male breast cancer
857100|NCT00068757|HER2-positive breast cancer|her2-positive breast cancer
857101|NCT00068744|squamous cell carcinoma of the anus|squamous cell carcinoma of the anus
857102|NCT00068744|stage II anal cancer|stage ii anal cancer
857103|NCT00068744|stage IIIA anal cancer|stage iiia anal cancer
857104|NCT00068744|stage IIIB anal cancer|stage iiib anal cancer
857105|NCT00068731|stage IV prostate cancer|stage iv prostate cancer
857106|NCT00068731|recurrent prostate cancer|recurrent prostate cancer
857107|NCT00068692|rectal cancer|rectal cancer
857108|NCT00068692|chemotherapy|chemotherapy
857109|NCT00068692|irinotecan|irinotecan
857110|NCT00068692|oxaliplatin|oxaliplatin
857111|NCT00068666|stage IV melanoma|stage iv melanoma
857112|NCT00068666|recurrent melanoma|recurrent melanoma
857113|NCT00068666|tumors metastatic to brain|tumors metastatic to brain
857114|NCT00068653|recurrent non-small cell lung cancer|recurrent non-small cell lung cancer
857115|NCT00068614|stage IV breast cancer|stage iv breast cancer
857116|NCT00068614|stage II breast cancer|stage ii breast cancer
857117|NCT00068614|stage IIIA breast cancer|stage iiia breast cancer
857118|NCT00068614|stage IIIB breast cancer|stage iiib breast cancer
857119|NCT00068614|stage IIIC breast cancer|stage iiic breast cancer
857120|NCT00068601|infertility|infertility
857121|NCT00068601|menopausal symptoms|menopausal symptoms
857122|NCT00068601|stage II breast cancer|stage ii breast cancer
857123|NCT00068601|stage IIIA breast cancer|stage iiia breast cancer
857124|NCT00068601|stage IA breast cancer|stage ia breast cancer
857125|NCT00068601|stage IB breast cancer|stage ib breast cancer
857126|NCT00068601|estrogen receptor-negative breast cancer|estrogen receptor-negative breast cancer
857127|NCT00068601|progesterone receptor-negative breast cancer|progesterone receptor-negative breast cancer
857128|NCT00068575|stage I pancreatic cancer|stage i pancreatic cancer
857129|NCT00068575|stage II pancreatic cancer|stage ii pancreatic cancer
857130|NCT00068575|stage III pancreatic cancer|stage iii pancreatic cancer
857131|NCT00068575|adenocarcinoma of the pancreas|adenocarcinoma of the pancreas
857132|NCT00068523|refractory multiple myeloma|refractory multiple myeloma
857133|NCT00068523|accelerated phase chronic myelogenous leukemia|accelerated phase chronic myelogenous leukemia
857134|NCT00068523|adult acute lymphoblastic leukemia in remission|adult acute lymphoblastic leukemia in remission
857135|NCT00068523|adult acute myeloid leukemia in remission|adult acute myeloid leukemia in remission
857136|NCT00068523|blastic phase chronic myelogenous leukemia|blastic phase chronic myelogenous leukemia
857137|NCT00068523|recurrent adult acute lymphoblastic leukemia|recurrent adult acute lymphoblastic leukemia
857138|NCT00068523|recurrent adult acute myeloid leukemia|recurrent adult acute myeloid leukemia
857139|NCT00068523|refractory chronic lymphocytic leukemia|refractory chronic lymphocytic leukemia
857140|NCT00068523|relapsing chronic myelogenous leukemia|relapsing chronic myelogenous leukemia
857141|NCT00068523|de novo myelodysplastic syndromes|de novo myelodysplastic syndromes
857142|NCT00068523|previously treated myelodysplastic syndromes|previously treated myelodysplastic syndromes
857143|NCT00068523|recurrent adult diffuse large cell lymphoma|recurrent adult diffuse large cell lymphoma
857144|NCT00068523|recurrent adult diffuse mixed cell lymphoma|recurrent adult diffuse mixed cell lymphoma
857145|NCT00068523|recurrent adult diffuse small cleaved cell lymphoma|recurrent adult diffuse small cleaved cell lymphoma
857146|NCT00068523|recurrent adult Burkitt lymphoma|recurrent adult burkitt lymphoma
857147|NCT00068523|recurrent adult immunoblastic large cell lymphoma|recurrent adult immunoblastic large cell lymphoma
857148|NCT00068523|recurrent adult lymphoblastic lymphoma|recurrent adult lymphoblastic lymphoma
857149|NCT00068523|recurrent grade 1 follicular lymphoma|recurrent grade 1 follicular lymphoma
857150|NCT00068523|recurrent grade 2 follicular lymphoma|recurrent grade 2 follicular lymphoma
857151|NCT00068523|recurrent grade 3 follicular lymphoma|recurrent grade 3 follicular lymphoma
857152|NCT00068523|recurrent mantle cell lymphoma|recurrent mantle cell lymphoma
857153|NCT00068523|refractory anemia with excess blasts in transformation|refractory anemia with excess blasts in transformation
857304|NCT00016939|stage III renal cell cancer|stage iii renal cell cancer
857154|NCT00068523|refractory anemia with excess blasts|refractory anemia with excess blasts
857155|NCT00068523|secondary myelodysplastic syndromes|secondary myelodysplastic syndromes
857156|NCT00068523|Philadelphia chromosome negative chronic myelogenous leukemia|philadelphia chromosome negative chronic myelogenous leukemia
857157|NCT00068523|chronic idiopathic myelofibrosis|chronic idiopathic myelofibrosis
857158|NCT00068523|B-cell chronic lymphocytic leukemia|b-cell chronic lymphocytic leukemia
857159|NCT00068523|T-cell large granular lymphocyte leukemia|t-cell large granular lymphocyte leukemia
857160|NCT00068523|chronic phase chronic myelogenous leukemia|chronic phase chronic myelogenous leukemia
857161|NCT00068523|recurrent adult Hodgkin lymphoma|recurrent adult hodgkin lymphoma
857162|NCT00068523|recurrent adult T-cell leukemia/lymphoma|recurrent adult t-cell leukemia/lymphoma
857163|NCT00068523|stage III chronic lymphocytic leukemia|stage iii chronic lymphocytic leukemia
857164|NCT00068523|stage IV chronic lymphocytic leukemia|stage iv chronic lymphocytic leukemia
857749|NCT00067691|Metastasis|metastasis
857165|NCT00068523|recurrent cutaneous T-cell non-Hodgkin lymphoma|recurrent cutaneous t-cell non-hodgkin lymphoma
857166|NCT00068523|recurrent mycosis fungoides/Sezary syndrome|recurrent mycosis fungoides/sezary syndrome
857167|NCT00068523|secondary acute myeloid leukemia|secondary acute myeloid leukemia
857168|NCT00068523|atypical chronic myeloid leukemia|atypical chronic myeloid leukemia
857169|NCT00068523|myelodysplastic/myeloproliferative disease, unclassifiable|myelodysplastic/myeloproliferative disease, unclassifiable
857170|NCT00068523|recurrent marginal zone lymphoma|recurrent marginal zone lymphoma
857171|NCT00068523|recurrent small lymphocytic lymphoma|recurrent small lymphocytic lymphoma
857172|NCT00068523|extranodal marginal zone B-cell lymphoma of mucosa-associated lymphoid tissue|extranodal marginal zone b-cell lymphoma of mucosa-associated lymphoid tissue
857173|NCT00068523|nodal marginal zone B-cell lymphoma|nodal marginal zone b-cell lymphoma
857174|NCT00068523|splenic marginal zone lymphoma|splenic marginal zone lymphoma
857175|NCT00068523|adult acute myeloid leukemia with t(8;21)(q22;q22)|adult acute myeloid leukemia with t(8;21)(q22;q22)
857176|NCT00068523|adult acute myeloid leukemia with t(16;16)(p13;q22)|adult acute myeloid leukemia with t(16;16)(p13;q22)
857177|NCT00068523|adult acute myeloid leukemia with inv(16)(p13;q22)|adult acute myeloid leukemia with inv(16)(p13;q22)
857178|NCT00068523|adult acute myeloid leukemia with 11q23 (MLL) abnormalities|adult acute myeloid leukemia with 11q23 (mll) abnormalities
857179|NCT00068523|adult acute myeloid leukemia with t(15;17)(q22;q12)|adult acute myeloid leukemia with t(15;17)(q22;q12)
857180|NCT00068510|adult glioblastoma|adult glioblastoma
857181|NCT00068510|adult anaplastic astrocytoma|adult anaplastic astrocytoma
857182|NCT00068510|adult brain tumor|adult brain tumor
857183|NCT00068510|adult giant cell glioblastoma|adult giant cell glioblastoma
857184|NCT00068510|adult gliosarcoma|adult gliosarcoma
857185|NCT00068510|adult anaplastic oligodendroglioma|adult anaplastic oligodendroglioma
857186|NCT00068471|infection|infection
857187|NCT00068471|neutropenia|neutropenia
857188|NCT00068471|unspecified childhood solid tumor, protocol specific|unspecified childhood solid tumor, protocol specific
857189|NCT00068458|weight changes|weight changes
857190|NCT00068458|depression|depression
857191|NCT00068458|stage I breast cancer|stage i breast cancer
857192|NCT00068458|stage II breast cancer|stage ii breast cancer
857193|NCT00068458|stage IIIA breast cancer|stage iiia breast cancer
857194|NCT00068445|neurotoxicity|neurotoxicity
857195|NCT00068445|pain|pain
857196|NCT00068445|unspecified adult solid tumor, protocol specific|unspecified adult solid tumor, protocol specific
857197|NCT00068432|recurrent pancreatic cancer|recurrent pancreatic cancer
857198|NCT00068432|stage IV pancreatic cancer|stage iv pancreatic cancer
857199|NCT00068393|Sarcomatoid|sarcomatoid
857200|NCT00068393|Gemcitabine|gemcitabine
857201|NCT00068393|Doxorubicin|doxorubicin
857202|NCT00068393|Renal cell cancer|renal cell cancer
857203|NCT00068393|Kidney cancer|kidney cancer
857204|NCT00068367|adult neurofibrosarcoma|adult neurofibrosarcoma
857205|NCT00068367|stage III adult soft tissue sarcoma|stage iii adult soft tissue sarcoma
857206|NCT00068367|recurrent adult soft tissue sarcoma|recurrent adult soft tissue sarcoma
857207|NCT00068367|stage II adult soft tissue sarcoma|stage ii adult soft tissue sarcoma
857208|NCT00068367|stage IV adult soft tissue sarcoma|stage iv adult soft tissue sarcoma
857209|NCT00068341|stage IIIA breast cancer|stage iiia breast cancer
857210|NCT00068341|stage IIIB breast cancer|stage iiib breast cancer
857211|NCT00068341|stage IIIC breast cancer|stage iiic breast cancer
857212|NCT00068341|stage II breast cancer|stage ii breast cancer
857213|NCT00068328|psychosocial effects of cancer and its treatment|psychosocial effects of cancer and its treatment
857214|NCT00068328|stage II breast cancer|stage ii breast cancer
857215|NCT00068328|stage IIIA breast cancer|stage iiia breast cancer
857216|NCT00068328|stage IIIB breast cancer|stage iiib breast cancer
857217|NCT00068328|stage IIIC breast cancer|stage iiic breast cancer
857218|NCT00068328|stage IA breast cancer|stage ia breast cancer
857219|NCT00068328|stage IB breast cancer|stage ib breast cancer
857220|NCT00068328|estrogen receptor-negative breast cancer|estrogen receptor-negative breast cancer
857221|NCT00068328|estrogen receptor-positive breast cancer|estrogen receptor-positive breast cancer
857222|NCT00068302|recurrent childhood lymphoblastic lymphoma|recurrent childhood lymphoblastic lymphoma
857223|NCT00068302|recurrent childhood small noncleaved cell lymphoma|recurrent childhood small noncleaved cell lymphoma
857224|NCT00068302|recurrent childhood large cell lymphoma|recurrent childhood large cell lymphoma
857225|NCT00068302|recurrent childhood acute myeloid leukemia|recurrent childhood acute myeloid leukemia
857226|NCT00068302|recurrent childhood acute lymphoblastic leukemia|recurrent childhood acute lymphoblastic leukemia
857227|NCT00068289|extensive stage small cell lung cancer|extensive stage small cell lung cancer
857228|NCT00068289|recurrent small cell lung cancer|recurrent small cell lung cancer
857229|NCT00068276|previously treated myelodysplastic syndromes|previously treated myelodysplastic syndromes
857230|NCT00068276|de novo myelodysplastic syndromes|de novo myelodysplastic syndromes
857231|NCT00068276|secondary myelodysplastic syndromes|secondary myelodysplastic syndromes
857232|NCT00068276|atypical chronic myeloid leukemia, BCR-ABL1 negative|atypical chronic myeloid leukemia, bcr-abl1 negative
857233|NCT00068276|myelodysplastic/myeloproliferative neoplasm, unclassifiable|myelodysplastic/myeloproliferative neoplasm, unclassifiable
857234|NCT00068276|childhood myelodysplastic syndromes|childhood myelodysplastic syndromes
857235|NCT00068263|stage I breast cancer|stage i breast cancer
857236|NCT00068263|stage II breast cancer|stage ii breast cancer
857946|NCT00067028|Idamycin|idamycin
857237|NCT00068250|primary central nervous system non-Hodgkin lymphoma|primary central nervous system non-hodgkin lymphoma
857238|NCT00068250|primary central nervous system Hodgkin lymphoma|primary central nervous system hodgkin lymphoma
857239|NCT00068237|xerostomia|xerostomia
857240|NCT00068237|radiation toxicity|radiation toxicity
857241|NCT00068237|stage II squamous cell carcinoma of the oropharynx|stage ii squamous cell carcinoma of the oropharynx
857242|NCT00068237|stage III squamous cell carcinoma of the oropharynx|stage iii squamous cell carcinoma of the oropharynx
857243|NCT00068237|stage I squamous cell carcinoma of the hypopharynx|stage i squamous cell carcinoma of the hypopharynx
857244|NCT00068237|stage II squamous cell carcinoma of the hypopharynx|stage ii squamous cell carcinoma of the hypopharynx
857245|NCT00068237|stage III squamous cell carcinoma of the hypopharynx|stage iii squamous cell carcinoma of the hypopharynx
857246|NCT00068237|stage III squamous cell carcinoma of the larynx|stage iii squamous cell carcinoma of the larynx
857247|NCT00068237|untreated metastatic squamous neck cancer with occult primary|untreated metastatic squamous neck cancer with occult primary
857248|NCT00068237|stage IV squamous cell carcinoma of the larynx|stage iv squamous cell carcinoma of the larynx
857249|NCT00068237|stage IV squamous cell carcinoma of the hypopharynx|stage iv squamous cell carcinoma of the hypopharynx
857250|NCT00068237|stage IV squamous cell carcinoma of the oropharynx|stage iv squamous cell carcinoma of the oropharynx
857251|NCT00068211|Metastatic Melanoma|metastatic melanoma
857252|NCT00068211|Melanoma|melanoma
857253|NCT00068211|Inoperable Locally Advanced Melanoma|inoperable locally advanced melanoma
857254|NCT00068224|Caroli's Syndrome|caroli's syndrome
857255|NCT00068224|Congenital Hepatic Fibrosis|congenital hepatic fibrosis
857256|NCT00068224|Ductal Plate Malformation|ductal plate malformation
857257|NCT00068224|Polycystic Kidney|polycystic kidney
857258|NCT00068224|Autosomal Recessive Polycystic Kidney Disease|autosomal recessive polycystic kidney disease
857259|NCT00068224|ARPKD|arpkd
857260|NCT00068224|Kidney|kidney
857261|NCT00068224|Liver|liver
857262|NCT00068185|Black cohosh|black cohosh
857263|NCT00068185|Pharmacokinetics|pharmacokinetics
857264|NCT00068185|Alternative therapies|alternative therapies
857265|NCT00068185|Natural product|natural product
857266|NCT00021268|stage IV colon cancer|stage iv colon cancer
857267|NCT00021268|stage IV rectal cancer|stage iv rectal cancer
857268|NCT00021268|recurrent colon cancer|recurrent colon cancer
857269|NCT00021268|recurrent rectal cancer|recurrent rectal cancer
857270|NCT00020904|stage IV breast cancer|stage iv breast cancer
857271|NCT00020904|recurrent breast cancer|recurrent breast cancer
857272|NCT00068159|Hereditary Disease|hereditary disease
857273|NCT00068159|Diastolic Dysfunction|diastolic dysfunction
857274|NCT00068159|Exercise Tolerance|exercise tolerance
857275|NCT00068159|Exercise Stress Echocardiography|exercise stress echocardiography
857277|NCT00068146|Adenopathy|adenopathy
857278|NCT00068146|Genetic Disorder|genetic disorder
857279|NCT00068146|Apoptosis|apoptosis
857280|NCT00068146|Diagnostic Imaging|diagnostic imaging
857281|NCT00068146|Hodgkins|hodgkins
857282|NCT00068146|Autoimmune Lymphoproliferative|autoimmune lymphoproliferative
857283|NCT00068146|Syndrome|syndrome
857284|NCT00068146|ALPS|alps
857285|NCT00068146|ALPS-Associated Lymphoma|alps-associated lymphoma
857286|NCT00068120|Urinary tract infection|urinary tract infection
857287|NCT00068094|Probiotics|probiotics
857288|NCT00068094|Bacteria|bacteria
857289|NCT00068081|Dermal assessment|dermal assessment
857290|NCT00068081|Pain measurement|pain measurement
857291|NCT00068081|Diary|diary
857292|NCT00068081|Analgesics/*therapeutic use|analgesics/*therapeutic use
857293|NCT00068081|Capsaicin/*administration & dosage/adverse effects|capsaicin/*administration & dosage/adverse effects
857294|NCT00068081|Herpes zoster/*complication/drug therapy|herpes zoster/*complication/drug therapy
857295|NCT00068081|Neuralgia/*drug therapy/etiology|neuralgia/*drug therapy/etiology
857296|NCT00068081|Pain|pain
857297|NCT00068081|Peripheral nervous system diseases/*complications|peripheral nervous system diseases/*complications
857298|NCT00017043|stage IV gastric cancer|stage iv gastric cancer
857299|NCT00017043|recurrent gastric cancer|recurrent gastric cancer
857300|NCT00017043|stage IV esophageal cancer|stage iv esophageal cancer
857301|NCT00017043|recurrent esophageal cancer|recurrent esophageal cancer
857302|NCT00017043|adenocarcinoma of the stomach|adenocarcinoma of the stomach
857303|NCT00017043|adenocarcinoma of the esophagus|adenocarcinoma of the esophagus
857823|NCT00067457|PRN|prn
857305|NCT00016939|stage IV renal cell cancer|stage iv renal cell cancer
857306|NCT00016939|recurrent renal cell cancer|recurrent renal cell cancer
857307|NCT00016874|unspecified adult solid tumor, protocol specific|unspecified adult solid tumor, protocol specific
857308|NCT00016341|stage III endometrial carcinoma|stage iii endometrial carcinoma
857309|NCT00016341|stage IV endometrial carcinoma|stage iv endometrial carcinoma
857310|NCT00016341|recurrent endometrial carcinoma|recurrent endometrial carcinoma
857311|NCT00068107|Lysosomal Storage|lysosomal storage
857312|NCT00068107|Renal Insufficiency|renal insufficiency
857313|NCT00068107|Stroke|stroke
857314|NCT00068107|Hypohidrosis|hypohidrosis
857315|NCT00068107|Peripheral Neuropathy|peripheral neuropathy
857316|NCT00068107|Fabry Disease|fabry disease
857317|NCT00068068|Photodynamic therapy|photodynamic therapy
857318|NCT00068068|Liver metastases|liver metastases
857319|NCT00068068|Colorectal cancer|colorectal cancer
857320|NCT00068068|Litx™|litx™
857321|NCT00068068|Light Infusion Technology™|light infusion technology™
857322|NCT00068068|Talaporfin sodium|talaporfin sodium
857323|NCT00068068|LS11|ls11
857324|NCT00068068|Liver mets|liver mets
857325|NCT00068068|Metastatic colorectal cancer|metastatic colorectal cancer
857326|NCT00068068|Light emittting diodes (LED)|light emittting diodes (led)
857327|NCT00068068|Tumor ablation|tumor ablation
857328|NCT00068068|Combination therapy|combination therapy
857329|NCT00068055|West Nile Virus, encephalitis, myelitis, immunoglobulin G|west nile virus, encephalitis, myelitis, immunoglobulin g
857330|NCT00067899|cigarette smoking|cigarette smoking
857331|NCT00067899|tocopherol|tocopherol
857332|NCT00067899|bioavailability|bioavailability
857333|NCT00067899|metabolism|metabolism
857334|NCT00067899|oxidative stress|oxidative stress
857335|NCT00067990|chronic allograft nephropathy|chronic allograft nephropathy
857336|NCT00067990|post transplant proteinuria|post transplant proteinuria
857337|NCT00067951|Hyperglycemia|hyperglycemia
857338|NCT00067951|HbA1c|hba1c
857339|NCT00067951|Hemoglobin A1c|hemoglobin a1c
857340|NCT00067951|Type 2 diabetes mellitus|type 2 diabetes mellitus
857341|NCT00067938|bipolar disorder|bipolar disorder
857342|NCT00067938|lamotrigine|lamotrigine
857343|NCT00068003|Adoptive Cell Therapy|adoptive cell therapy
857344|NCT00068003|Screening|screening
857345|NCT00068003|Cell Harvest|cell harvest
857346|NCT00068003|Blood|blood
857347|NCT00068003|Tumor Tissue|tumor tissue
857348|NCT00067925|Weight-bearing physical activity|weight-bearing physical activity
857349|NCT00067925|Calcium intake|calcium intake
857350|NCT00067925|School-based health education|school-based health education
857351|NCT00067925|Adolescent girls|adolescent girls
857352|NCT00067925|Child nutrition|child nutrition
857353|NCT00067925|Diet|diet
857354|NCT00010036|adult glioblastoma|adult glioblastoma
857355|NCT00010036|adult giant cell glioblastoma|adult giant cell glioblastoma
857356|NCT00010036|adult gliosarcoma|adult gliosarcoma
857357|NCT00008359|stage I adult Hodgkin lymphoma|stage i adult hodgkin lymphoma
857358|NCT00008359|stage II adult Hodgkin lymphoma|stage ii adult hodgkin lymphoma
857359|NCT00008359|stage III adult Hodgkin lymphoma|stage iii adult hodgkin lymphoma
857360|NCT00008359|stage IV adult Hodgkin lymphoma|stage iv adult hodgkin lymphoma
857361|NCT00008359|stage IV breast cancer|stage iv breast cancer
857362|NCT00008359|stage IIIA breast cancer|stage iiia breast cancer
857363|NCT00008359|monoclonal gammopathy of undetermined significance|monoclonal gammopathy of undetermined significance
857364|NCT00008359|stage IIIB breast cancer|stage iiib breast cancer
857365|NCT00008359|recurrent adult Hodgkin lymphoma|recurrent adult hodgkin lymphoma
857366|NCT00008359|stage I cutaneous T-cell non-Hodgkin lymphoma|stage i cutaneous t-cell non-hodgkin lymphoma
857367|NCT00008359|stage II cutaneous T-cell non-Hodgkin lymphoma|stage ii cutaneous t-cell non-hodgkin lymphoma
857368|NCT00008359|stage III cutaneous T-cell non-Hodgkin lymphoma|stage iii cutaneous t-cell non-hodgkin lymphoma
857369|NCT00008359|stage IV cutaneous T-cell non-Hodgkin lymphoma|stage iv cutaneous t-cell non-hodgkin lymphoma
857370|NCT00008359|recurrent cutaneous T-cell non-Hodgkin lymphoma|recurrent cutaneous t-cell non-hodgkin lymphoma
857371|NCT00008359|isolated plasmacytoma of bone|isolated plasmacytoma of bone
857372|NCT00008359|extramedullary plasmacytoma|extramedullary plasmacytoma
857373|NCT00008359|refractory multiple myeloma|refractory multiple myeloma
857374|NCT00008359|stage II ovarian epithelial cancer|stage ii ovarian epithelial cancer
857375|NCT00008359|stage III ovarian epithelial cancer|stage iii ovarian epithelial cancer
857376|NCT00008359|stage IV ovarian epithelial cancer|stage iv ovarian epithelial cancer
857377|NCT00008359|recurrent ovarian epithelial cancer|recurrent ovarian epithelial cancer
857378|NCT00008359|disseminated neuroblastoma|disseminated neuroblastoma
857379|NCT00008359|recurrent neuroblastoma|recurrent neuroblastoma
857380|NCT00008359|recurrent Wilms tumor and other childhood kidney tumors|recurrent wilms tumor and other childhood kidney tumors
857381|NCT00008359|stage 0 chronic lymphocytic leukemia|stage 0 chronic lymphocytic leukemia
857382|NCT00008359|Waldenstrom macroglobulinemia|waldenstrom macroglobulinemia
857383|NCT00008359|stage I multiple myeloma|stage i multiple myeloma
857384|NCT00008359|stage II multiple myeloma|stage ii multiple myeloma
857385|NCT00008359|stage III multiple myeloma|stage iii multiple myeloma
857386|NCT00008359|stage I chronic lymphocytic leukemia|stage i chronic lymphocytic leukemia
857387|NCT00008359|stage II chronic lymphocytic leukemia|stage ii chronic lymphocytic leukemia
857388|NCT00008359|stage III chronic lymphocytic leukemia|stage iii chronic lymphocytic leukemia
857389|NCT00008359|stage IV chronic lymphocytic leukemia|stage iv chronic lymphocytic leukemia
857390|NCT00008359|recurrent adult acute myeloid leukemia|recurrent adult acute myeloid leukemia
857391|NCT00008359|recurrent adult acute lymphoblastic leukemia|recurrent adult acute lymphoblastic leukemia
857392|NCT00008359|relapsing chronic myelogenous leukemia|relapsing chronic myelogenous leukemia
857393|NCT00008359|refractory chronic lymphocytic leukemia|refractory chronic lymphocytic leukemia
857394|NCT00008359|small intestine lymphoma|small intestine lymphoma
857395|NCT00008359|stage III malignant testicular germ cell tumor|stage iii malignant testicular germ cell tumor
857396|NCT00008359|recurrent malignant testicular germ cell tumor|recurrent malignant testicular germ cell tumor
857397|NCT00008359|unspecified adult solid tumor, protocol specific|unspecified adult solid tumor, protocol specific
857398|NCT00008359|chronic phase chronic myelogenous leukemia|chronic phase chronic myelogenous leukemia
858568|NCT00066209|HV|hv
857399|NCT00008359|accelerated phase chronic myelogenous leukemia|accelerated phase chronic myelogenous leukemia
857400|NCT00008359|blastic phase chronic myelogenous leukemia|blastic phase chronic myelogenous leukemia
857401|NCT00008359|meningeal chronic myelogenous leukemia|meningeal chronic myelogenous leukemia
857402|NCT00008359|adult acute myeloid leukemia in remission|adult acute myeloid leukemia in remission
857403|NCT00008359|adult acute lymphoblastic leukemia in remission|adult acute lymphoblastic leukemia in remission
857404|NCT00008359|polycythemia vera|polycythemia vera
857405|NCT00008359|primary myelofibrosis|primary myelofibrosis
857406|NCT00008359|essential thrombocythemia|essential thrombocythemia
857407|NCT00008359|fever, sweats, and hot flashes|fever, sweats, and hot flashes
857408|NCT00008359|testicular embryonal carcinoma|testicular embryonal carcinoma
857409|NCT00008359|testicular choriocarcinoma|testicular choriocarcinoma
857410|NCT00008359|testicular teratoma|testicular teratoma
857411|NCT00008359|testicular yolk sac tumor|testicular yolk sac tumor
857412|NCT00008359|testicular embryonal carcinoma and teratoma|testicular embryonal carcinoma and teratoma
857413|NCT00008359|testicular embryonal carcinoma and teratoma with seminoma|testicular embryonal carcinoma and teratoma with seminoma
857414|NCT00008359|testicular embryonal carcinoma and yolk sac tumor|testicular embryonal carcinoma and yolk sac tumor
857415|NCT00008359|testicular embryonal carcinoma and yolk sac tumor with seminoma|testicular embryonal carcinoma and yolk sac tumor with seminoma
857416|NCT00008359|testicular embryonal carcinoma and seminoma|testicular embryonal carcinoma and seminoma
857417|NCT00008359|testicular yolk sac tumor and teratoma|testicular yolk sac tumor and teratoma
857418|NCT00008359|testicular yolk sac tumor and teratoma with seminoma|testicular yolk sac tumor and teratoma with seminoma
857419|NCT00008359|testicular choriocarcinoma and yolk sac tumor|testicular choriocarcinoma and yolk sac tumor
857420|NCT00008359|testicular choriocarcinoma and embryonal carcinoma|testicular choriocarcinoma and embryonal carcinoma
857421|NCT00008359|testicular choriocarcinoma and teratoma|testicular choriocarcinoma and teratoma
857422|NCT00008359|testicular choriocarcinoma and seminoma|testicular choriocarcinoma and seminoma
857423|NCT00008359|progressive hairy cell leukemia, initial treatment|progressive hairy cell leukemia, initial treatment
857424|NCT00008359|refractory hairy cell leukemia|refractory hairy cell leukemia
857425|NCT00008359|stage I grade 1 follicular lymphoma|stage i grade 1 follicular lymphoma
857426|NCT00008359|stage I grade 2 follicular lymphoma|stage i grade 2 follicular lymphoma
857427|NCT00008359|stage I grade 3 follicular lymphoma|stage i grade 3 follicular lymphoma
857428|NCT00008359|stage I adult diffuse small cleaved cell lymphoma|stage i adult diffuse small cleaved cell lymphoma
857429|NCT00008359|stage I adult diffuse mixed cell lymphoma|stage i adult diffuse mixed cell lymphoma
857430|NCT00008359|stage I adult diffuse large cell lymphoma|stage i adult diffuse large cell lymphoma
857431|NCT00008359|stage I adult immunoblastic large cell lymphoma|stage i adult immunoblastic large cell lymphoma
857432|NCT00008359|stage I adult lymphoblastic lymphoma|stage i adult lymphoblastic lymphoma
857433|NCT00008359|stage I adult Burkitt lymphoma|stage i adult burkitt lymphoma
857434|NCT00008359|recurrent ovarian germ cell tumor|recurrent ovarian germ cell tumor
857435|NCT00008359|chronic myelomonocytic leukemia|chronic myelomonocytic leukemia
857436|NCT00008359|T-cell large granular lymphocyte leukemia|t-cell large granular lymphocyte leukemia
857437|NCT00008359|ovarian yolk sac tumor|ovarian yolk sac tumor
857438|NCT00008359|ovarian embryonal carcinoma|ovarian embryonal carcinoma
857439|NCT00008359|ovarian polyembryoma|ovarian polyembryoma
857440|NCT00008359|ovarian choriocarcinoma|ovarian choriocarcinoma
857441|NCT00008359|ovarian immature teratoma|ovarian immature teratoma
857442|NCT00008359|ovarian mature teratoma|ovarian mature teratoma
857443|NCT00008359|ovarian monodermal and highly specialized teratoma|ovarian monodermal and highly specialized teratoma
857444|NCT00008359|ovarian mixed germ cell tumor|ovarian mixed germ cell tumor
857445|NCT00008359|acute undifferentiated leukemia|acute undifferentiated leukemia
857446|NCT00008359|stage III grade 1 follicular lymphoma|stage iii grade 1 follicular lymphoma
857447|NCT00008359|stage III grade 2 follicular lymphoma|stage iii grade 2 follicular lymphoma
857448|NCT00008359|stage III grade 3 follicular lymphoma|stage iii grade 3 follicular lymphoma
857449|NCT00008359|stage III adult diffuse small cleaved cell lymphoma|stage iii adult diffuse small cleaved cell lymphoma
857450|NCT00008359|stage III adult diffuse mixed cell lymphoma|stage iii adult diffuse mixed cell lymphoma
857451|NCT00008359|stage III adult diffuse large cell lymphoma|stage iii adult diffuse large cell lymphoma
857452|NCT00008359|stage III adult immunoblastic large cell lymphoma|stage iii adult immunoblastic large cell lymphoma
857453|NCT00008359|stage III adult lymphoblastic lymphoma|stage iii adult lymphoblastic lymphoma
857454|NCT00008359|stage III adult Burkitt lymphoma|stage iii adult burkitt lymphoma
857455|NCT00008359|stage IV grade 1 follicular lymphoma|stage iv grade 1 follicular lymphoma
857456|NCT00008359|stage IV grade 2 follicular lymphoma|stage iv grade 2 follicular lymphoma
857457|NCT00008359|stage IV grade 3 follicular lymphoma|stage iv grade 3 follicular lymphoma
857458|NCT00008359|stage IV adult diffuse small cleaved cell lymphoma|stage iv adult diffuse small cleaved cell lymphoma
857459|NCT00008359|stage IV adult diffuse mixed cell lymphoma|stage iv adult diffuse mixed cell lymphoma
857460|NCT00008359|stage IV adult diffuse large cell lymphoma|stage iv adult diffuse large cell lymphoma
857461|NCT00008359|stage IV adult immunoblastic large cell lymphoma|stage iv adult immunoblastic large cell lymphoma
857462|NCT00008359|stage IV adult lymphoblastic lymphoma|stage iv adult lymphoblastic lymphoma
857463|NCT00008359|stage IV adult Burkitt lymphoma|stage iv adult burkitt lymphoma
857464|NCT00008359|recurrent grade 1 follicular lymphoma|recurrent grade 1 follicular lymphoma
857465|NCT00008359|recurrent grade 2 follicular lymphoma|recurrent grade 2 follicular lymphoma
857466|NCT00008359|recurrent grade 3 follicular lymphoma|recurrent grade 3 follicular lymphoma
857467|NCT00008359|recurrent adult diffuse small cleaved cell lymphoma|recurrent adult diffuse small cleaved cell lymphoma
857468|NCT00008359|recurrent adult diffuse mixed cell lymphoma|recurrent adult diffuse mixed cell lymphoma
857469|NCT00008359|recurrent adult diffuse large cell lymphoma|recurrent adult diffuse large cell lymphoma
857470|NCT00008359|recurrent adult immunoblastic large cell lymphoma|recurrent adult immunoblastic large cell lymphoma
857471|NCT00008359|recurrent adult lymphoblastic lymphoma|recurrent adult lymphoblastic lymphoma
857472|NCT00008359|recurrent adult Burkitt lymphoma|recurrent adult burkitt lymphoma
857473|NCT00008359|stage I adult T-cell leukemia/lymphoma|stage i adult t-cell leukemia/lymphoma
857474|NCT00008359|stage II adult T-cell leukemia/lymphoma|stage ii adult t-cell leukemia/lymphoma
857475|NCT00008359|stage III adult T-cell leukemia/lymphoma|stage iii adult t-cell leukemia/lymphoma
857476|NCT00008359|stage IV adult T-cell leukemia/lymphoma|stage iv adult t-cell leukemia/lymphoma
857477|NCT00008359|recurrent adult T-cell leukemia/lymphoma|recurrent adult t-cell leukemia/lymphoma
857478|NCT00008359|secondary acute myeloid leukemia|secondary acute myeloid leukemia
857479|NCT00008359|de novo myelodysplastic syndromes|de novo myelodysplastic syndromes
857480|NCT00008359|high risk metastatic gestational trophoblastic tumor|high risk metastatic gestational trophoblastic tumor
857481|NCT00008359|previously treated myelodysplastic syndromes|previously treated myelodysplastic syndromes
857482|NCT00008359|secondary myelodysplastic syndromes|secondary myelodysplastic syndromes
857483|NCT00008359|primary central nervous system non-Hodgkin lymphoma|primary central nervous system non-hodgkin lymphoma
857484|NCT00008359|neutropenia|neutropenia
857485|NCT00008359|infection|infection
857486|NCT00008359|prolymphocytic leukemia|prolymphocytic leukemia
857487|NCT00008359|AIDS-related peripheral/systemic lymphoma|aids-related peripheral/systemic lymphoma
857488|NCT00008359|AIDS-related primary CNS lymphoma|aids-related primary cns lymphoma
857489|NCT00008359|primary systemic amyloidosis|primary systemic amyloidosis
857490|NCT00008359|intraocular lymphoma|intraocular lymphoma
857491|NCT00008359|stage I mantle cell lymphoma|stage i mantle cell lymphoma
857492|NCT00008359|contiguous stage II grade 1 follicular lymphoma|contiguous stage ii grade 1 follicular lymphoma
857493|NCT00008359|contiguous stage II grade 2 follicular lymphoma|contiguous stage ii grade 2 follicular lymphoma
857494|NCT00008359|contiguous stage II grade 3 follicular lymphoma|contiguous stage ii grade 3 follicular lymphoma
857495|NCT00008359|contiguous stage II adult diffuse small cleaved cell lymphoma|contiguous stage ii adult diffuse small cleaved cell lymphoma
857496|NCT00008359|contiguous stage II mantle cell lymphoma|contiguous stage ii mantle cell lymphoma
857497|NCT00008359|contiguous stage II adult diffuse mixed cell lymphoma|contiguous stage ii adult diffuse mixed cell lymphoma
857498|NCT00008359|contiguous stage II adult immunoblastic large cell lymphoma|contiguous stage ii adult immunoblastic large cell lymphoma
857499|NCT00008359|contiguous stage II adult diffuse large cell lymphoma|contiguous stage ii adult diffuse large cell lymphoma
857500|NCT00008359|contiguous stage II adult Burkitt lymphoma|contiguous stage ii adult burkitt lymphoma
857501|NCT00008359|contiguous stage II adult lymphoblastic lymphoma|contiguous stage ii adult lymphoblastic lymphoma
857502|NCT00008359|noncontiguous stage II grade 1 follicular lymphoma|noncontiguous stage ii grade 1 follicular lymphoma
857503|NCT00008359|noncontiguous stage II grade 2 follicular lymphoma|noncontiguous stage ii grade 2 follicular lymphoma
858647|NCT00065962|Rimland Questionnaire|rimland questionnaire
857504|NCT00008359|noncontiguous stage II grade 3 follicular lymphoma|noncontiguous stage ii grade 3 follicular lymphoma
857505|NCT00008359|noncontiguous stage II adult diffuse small cleaved cell lymphoma|noncontiguous stage ii adult diffuse small cleaved cell lymphoma
857506|NCT00008359|noncontiguous stage II mantle cell lymphoma|noncontiguous stage ii mantle cell lymphoma
857507|NCT00008359|noncontiguous stage II adult diffuse mixed cell lymphoma|noncontiguous stage ii adult diffuse mixed cell lymphoma
857508|NCT00008359|noncontiguous stage II adult immunoblastic large cell lymphoma|noncontiguous stage ii adult immunoblastic large cell lymphoma
857509|NCT00008359|noncontiguous stage II adult diffuse large cell lymphoma|noncontiguous stage ii adult diffuse large cell lymphoma
857510|NCT00008359|noncontiguous stage II adult Burkitt lymphoma|noncontiguous stage ii adult burkitt lymphoma
857511|NCT00008359|noncontiguous stage II adult lymphoblastic lymphoma|noncontiguous stage ii adult lymphoblastic lymphoma
857512|NCT00008359|stage III mantle cell lymphoma|stage iii mantle cell lymphoma
857513|NCT00008359|stage IV mantle cell lymphoma|stage iv mantle cell lymphoma
857514|NCT00008359|recurrent mantle cell lymphoma|recurrent mantle cell lymphoma
857515|NCT00008359|angioimmunoblastic T-cell lymphoma|angioimmunoblastic t-cell lymphoma
857516|NCT00008359|anaplastic large cell lymphoma|anaplastic large cell lymphoma
857517|NCT00008359|stage I mycosis fungoides/Sezary syndrome|stage i mycosis fungoides/sezary syndrome
857518|NCT00008359|stage II mycosis fungoides/Sezary syndrome|stage ii mycosis fungoides/sezary syndrome
857519|NCT00008359|stage III mycosis fungoides/Sezary syndrome|stage iii mycosis fungoides/sezary syndrome
857520|NCT00008359|stage IV mycosis fungoides/Sezary syndrome|stage iv mycosis fungoides/sezary syndrome
857521|NCT00008359|recurrent mycosis fungoides/Sezary syndrome|recurrent mycosis fungoides/sezary syndrome
857522|NCT00008359|noncontiguous stage II small lymphocytic lymphoma|noncontiguous stage ii small lymphocytic lymphoma
857523|NCT00008359|noncontiguous stage II marginal zone lymphoma|noncontiguous stage ii marginal zone lymphoma
857524|NCT00008359|recurrent marginal zone lymphoma|recurrent marginal zone lymphoma
857525|NCT00008359|recurrent small lymphocytic lymphoma|recurrent small lymphocytic lymphoma
857526|NCT00008359|stage I marginal zone lymphoma|stage i marginal zone lymphoma
857527|NCT00008359|stage I small lymphocytic lymphoma|stage i small lymphocytic lymphoma
857528|NCT00008359|stage III small lymphocytic lymphoma|stage iii small lymphocytic lymphoma
857529|NCT00008359|stage III marginal zone lymphoma|stage iii marginal zone lymphoma
857530|NCT00008359|stage IV small lymphocytic lymphoma|stage iv small lymphocytic lymphoma
857531|NCT00008359|stage IV marginal zone lymphoma|stage iv marginal zone lymphoma
857532|NCT00008359|contiguous stage II marginal zone lymphoma|contiguous stage ii marginal zone lymphoma
857533|NCT00008359|contiguous stage II small lymphocytic lymphoma|contiguous stage ii small lymphocytic lymphoma
857534|NCT00008359|extranodal marginal zone B-cell lymphoma of mucosa-associated lymphoid tissue|extranodal marginal zone b-cell lymphoma of mucosa-associated lymphoid tissue
857535|NCT00008359|nodal marginal zone B-cell lymphoma|nodal marginal zone b-cell lymphoma
857536|NCT00008359|splenic marginal zone lymphoma|splenic marginal zone lymphoma
857537|NCT00008359|childhood myelodysplastic syndromes|childhood myelodysplastic syndromes
857538|NCT00008086|recurrent adult brain tumor|recurrent adult brain tumor
857539|NCT00008086|adult brain stem glioma|adult brain stem glioma
857540|NCT00008086|adult craniopharyngioma|adult craniopharyngioma
857541|NCT00008086|adult medulloblastoma|adult medulloblastoma
857542|NCT00008086|adult meningioma|adult meningioma
857543|NCT00008086|adult glioblastoma|adult glioblastoma
857544|NCT00008086|unspecified adult solid tumor, protocol specific|unspecified adult solid tumor, protocol specific
857545|NCT00008086|adult anaplastic astrocytoma|adult anaplastic astrocytoma
857546|NCT00008086|adult myxopapillary ependymoma|adult myxopapillary ependymoma
857547|NCT00008086|adult anaplastic ependymoma|adult anaplastic ependymoma
857548|NCT00008086|adult anaplastic oligodendroglioma|adult anaplastic oligodendroglioma
857549|NCT00008086|adult mixed glioma|adult mixed glioma
857550|NCT00008086|adult central nervous system germ cell tumor|adult central nervous system germ cell tumor
857551|NCT00008086|adult pilocytic astrocytoma|adult pilocytic astrocytoma
857552|NCT00008086|adult subependymoma|adult subependymoma
857553|NCT00008086|adult ependymoblastoma|adult ependymoblastoma
857554|NCT00008086|adult pineocytoma|adult pineocytoma
857555|NCT00008086|adult pineoblastoma|adult pineoblastoma
857556|NCT00008086|adult meningeal hemangiopericytoma|adult meningeal hemangiopericytoma
857557|NCT00008086|adult choroid plexus tumor|adult choroid plexus tumor
857558|NCT00008086|adult grade III meningioma|adult grade iii meningioma
857559|NCT00008086|adult oligodendroglioma|adult oligodendroglioma
857560|NCT00008086|adult giant cell glioblastoma|adult giant cell glioblastoma
857561|NCT00008086|adult gliosarcoma|adult gliosarcoma
857562|NCT00006346|stage II breast cancer|stage ii breast cancer
857563|NCT00006346|stage IV breast cancer|stage iv breast cancer
857564|NCT00006346|stage IIIA breast cancer|stage iiia breast cancer
857565|NCT00006346|stage IIIB breast cancer|stage iiib breast cancer
857566|NCT00006346|psychosocial effects of cancer and its treatment|psychosocial effects of cancer and its treatment
857567|NCT00006265|recurrent adult acute myeloid leukemia|recurrent adult acute myeloid leukemia
857568|NCT00006254|unspecified adult solid tumor, protocol specific|unspecified adult solid tumor, protocol specific
857569|NCT00006223|adult acute myeloid leukemia in remission|adult acute myeloid leukemia in remission
857570|NCT00006223|adult acute erythroid leukemia (M6)|adult acute erythroid leukemia (m6)
857571|NCT00006223|adult acute myeloblastic leukemia without maturation (M1)|adult acute myeloblastic leukemia without maturation (m1)
857572|NCT00006223|adult acute myeloblastic leukemia with maturation (M2)|adult acute myeloblastic leukemia with maturation (m2)
857573|NCT00006223|adult acute promyelocytic leukemia (M3)|adult acute promyelocytic leukemia (m3)
857574|NCT00006223|adult acute myelomonocytic leukemia (M4)|adult acute myelomonocytic leukemia (m4)
857575|NCT00006223|adult acute monoblastic leukemia (M5a)|adult acute monoblastic leukemia (m5a)
857576|NCT00006223|adult acute megakaryoblastic leukemia (M7)|adult acute megakaryoblastic leukemia (m7)
857577|NCT00006223|adult acute monocytic leukemia (M5b)|adult acute monocytic leukemia (m5b)
857578|NCT00006223|adult acute minimally differentiated myeloid leukemia (M0)|adult acute minimally differentiated myeloid leukemia (m0)
857579|NCT00006103|stage III colon cancer|stage iii colon cancer
857580|NCT00006103|stage IV colon cancer|stage iv colon cancer
857581|NCT00006103|stage III rectal cancer|stage iii rectal cancer
857582|NCT00006103|stage IV rectal cancer|stage iv rectal cancer
857583|NCT00006103|recurrent colon cancer|recurrent colon cancer
857584|NCT00006103|recurrent rectal cancer|recurrent rectal cancer
857585|NCT00006103|adenocarcinoma of the colon|adenocarcinoma of the colon
857586|NCT00006103|adenocarcinoma of the rectum|adenocarcinoma of the rectum
857587|NCT00006096|stage I vulvar cancer|stage i vulvar cancer
857588|NCT00006096|stage II vulvar cancer|stage ii vulvar cancer
857589|NCT00006096|stage III vulvar cancer|stage iii vulvar cancer
857590|NCT00006096|stage IVB vulvar cancer|stage ivb vulvar cancer
857591|NCT00006096|squamous cell carcinoma of the vulva|squamous cell carcinoma of the vulva
857593|NCT00067847|food policy|food policy
857594|NCT00067847|physical fitness (Respiratory Burst)|physical fitness (respiratory burst)
857595|NCT00067847|academic achievement|academic achievement
857596|NCT00067834|Electromagnetic Fields|electromagnetic fields
857597|NCT00067834|Bone|bone
857598|NCT00067834|Forelimb|forelimb
857599|NCT00067834|Radius|radius
857600|NCT00006019|recurrent non-small cell lung cancer|recurrent non-small cell lung cancer
857601|NCT00006019|refractory multiple myeloma|refractory multiple myeloma
857602|NCT00006019|recurrent adult acute myeloid leukemia|recurrent adult acute myeloid leukemia
857603|NCT00006019|recurrent prostate cancer|recurrent prostate cancer
858774|NCT00065663|diabetic|diabetic
857604|NCT00006019|adult acute myeloblastic leukemia without maturation (M1)|adult acute myeloblastic leukemia without maturation (m1)
857605|NCT00006019|adult acute myeloblastic leukemia with maturation (M2)|adult acute myeloblastic leukemia with maturation (m2)
857606|NCT00006019|adult acute promyelocytic leukemia (M3)|adult acute promyelocytic leukemia (m3)
857607|NCT00006019|adult acute myelomonocytic leukemia (M4)|adult acute myelomonocytic leukemia (m4)
857608|NCT00006019|adult acute monoblastic leukemia (M5a)|adult acute monoblastic leukemia (m5a)
857609|NCT00006019|recurrent grade 1 follicular lymphoma|recurrent grade 1 follicular lymphoma
857610|NCT00006019|recurrent grade 2 follicular lymphoma|recurrent grade 2 follicular lymphoma
857611|NCT00006019|recurrent grade 3 follicular lymphoma|recurrent grade 3 follicular lymphoma
857612|NCT00006019|recurrent adult diffuse small cleaved cell lymphoma|recurrent adult diffuse small cleaved cell lymphoma
857613|NCT00006019|recurrent adult diffuse mixed cell lymphoma|recurrent adult diffuse mixed cell lymphoma
857614|NCT00006019|recurrent adult diffuse large cell lymphoma|recurrent adult diffuse large cell lymphoma
857615|NCT00006019|adult acute monocytic leukemia (M5b)|adult acute monocytic leukemia (m5b)
857616|NCT00006019|previously treated myelodysplastic syndromes|previously treated myelodysplastic syndromes
857617|NCT00006019|secondary myelodysplastic syndromes|secondary myelodysplastic syndromes
857618|NCT00006019|recurrent marginal zone lymphoma|recurrent marginal zone lymphoma
857619|NCT00006019|recurrent small lymphocytic lymphoma|recurrent small lymphocytic lymphoma
857620|NCT00006019|extranodal marginal zone B-cell lymphoma of mucosa-associated lymphoid tissue|extranodal marginal zone b-cell lymphoma of mucosa-associated lymphoid tissue
857621|NCT00006019|nodal marginal zone B-cell lymphoma|nodal marginal zone b-cell lymphoma
857622|NCT00006019|splenic marginal zone lymphoma|splenic marginal zone lymphoma
857623|NCT00006002|stage IV prostate cancer|stage iv prostate cancer
857624|NCT00006002|recurrent prostate cancer|recurrent prostate cancer
857625|NCT00005887|tumors metastatic to brain|tumors metastatic to brain
857626|NCT00005886|stage I breast cancer|stage i breast cancer
857627|NCT00005886|stage II breast cancer|stage ii breast cancer
857628|NCT00005886|ductal breast carcinoma in situ|ductal breast carcinoma in situ
857629|NCT00005886|breast cancer in situ|breast cancer in situ
857630|NCT00005857|stage IV prostate cancer|stage iv prostate cancer
857631|NCT00005857|recurrent prostate cancer|recurrent prostate cancer
857632|NCT00067821|Brain Tumor|brain tumor
857633|NCT00067821|Children|children
857634|NCT00067821|Metabolic|metabolic
857635|NCT00067821|Spectroscopy|spectroscopy
857636|NCT00067821|PET|pet
857637|NCT00067808|Myelodysplastic Syndrome|myelodysplastic syndrome
857638|NCT00067808|Chronic Myelomonocytic Leukemia|chronic myelomonocytic leukemia
857639|NCT00067808|MDS|mds
857640|NCT00067808|Decitabine|decitabine
857641|NCT00067808|Dacogen|dacogen
857642|NCT00067808|Methylation|methylation
857643|NCT00067795|Treatment Experienced|treatment experienced
857644|NCT00067795|Antiretroviral Therapy, Highly Active|antiretroviral therapy, highly active
857645|NCT00067795|HIV Antigens|hiv antigens
857646|NCT00067795|Cohort Studies|cohort studies
857647|NCT00067795|Immunity, Cellular|immunity, cellular
857648|NCT00067795|T-Lymphocytes|t-lymphocytes
857649|NCT00067782|HIV|hiv
857650|NCT00067782|Treatment Experienced|treatment experienced
857651|NCT00067769|Encopresis|encopresis
857652|NCT00067769|Internet|internet
857653|NCT00067769|Web|web
857654|NCT00067769|Treatment|treatment
857655|NCT00067769|Intervention|intervention
857656|NCT00005804|monoclonal gammopathy of undetermined significance|monoclonal gammopathy of undetermined significance
857657|NCT00005804|recurrent childhood acute lymphoblastic leukemia|recurrent childhood acute lymphoblastic leukemia
857658|NCT00005804|recurrent adult Hodgkin lymphoma|recurrent adult hodgkin lymphoma
857659|NCT00005804|recurrent cutaneous T-cell non-Hodgkin lymphoma|recurrent cutaneous t-cell non-hodgkin lymphoma
857660|NCT00005804|Burkitt lymphoma|burkitt lymphoma
857661|NCT00005804|isolated plasmacytoma of bone|isolated plasmacytoma of bone
857662|NCT00005804|extramedullary plasmacytoma|extramedullary plasmacytoma
857663|NCT00005804|refractory multiple myeloma|refractory multiple myeloma
857664|NCT00005804|Waldenstrom macroglobulinemia|waldenstrom macroglobulinemia
857665|NCT00005804|stage III multiple myeloma|stage iii multiple myeloma
857666|NCT00005804|stage II childhood lymphoblastic lymphoma|stage ii childhood lymphoblastic lymphoma
857667|NCT00005804|stage III childhood lymphoblastic lymphoma|stage iii childhood lymphoblastic lymphoma
857668|NCT00005804|stage IV childhood lymphoblastic lymphoma|stage iv childhood lymphoblastic lymphoma
857669|NCT00005804|recurrent childhood lymphoblastic lymphoma|recurrent childhood lymphoblastic lymphoma
857670|NCT00005804|recurrent childhood acute myeloid leukemia|recurrent childhood acute myeloid leukemia
857671|NCT00005804|recurrent adult acute myeloid leukemia|recurrent adult acute myeloid leukemia
857672|NCT00005804|recurrent adult acute lymphoblastic leukemia|recurrent adult acute lymphoblastic leukemia
857673|NCT00005804|small intestine lymphoma|small intestine lymphoma
857674|NCT00005804|childhood immunoblastic large cell lymphoma|childhood immunoblastic large cell lymphoma
857675|NCT00005804|chronic phase chronic myelogenous leukemia|chronic phase chronic myelogenous leukemia
857676|NCT00005804|accelerated phase chronic myelogenous leukemia|accelerated phase chronic myelogenous leukemia
858569|NCT00066170|Narcolepsy|narcolepsy
857677|NCT00005804|blastic phase chronic myelogenous leukemia|blastic phase chronic myelogenous leukemia
857678|NCT00005804|untreated adult acute lymphoblastic leukemia|untreated adult acute lymphoblastic leukemia
857679|NCT00005804|untreated adult acute myeloid leukemia|untreated adult acute myeloid leukemia
857680|NCT00005804|untreated childhood acute myeloid leukemia and other myeloid malignancies|untreated childhood acute myeloid leukemia and other myeloid malignancies
857681|NCT00005804|untreated childhood acute lymphoblastic leukemia|untreated childhood acute lymphoblastic leukemia
857682|NCT00005804|adult acute myeloid leukemia in remission|adult acute myeloid leukemia in remission
857683|NCT00005804|adult acute lymphoblastic leukemia in remission|adult acute lymphoblastic leukemia in remission
857684|NCT00005804|childhood acute myeloid leukemia in remission|childhood acute myeloid leukemia in remission
857685|NCT00005804|childhood acute lymphoblastic leukemia in remission|childhood acute lymphoblastic leukemia in remission
857686|NCT00005804|polycythemia vera|polycythemia vera
857687|NCT00005804|chronic idiopathic myelofibrosis|chronic idiopathic myelofibrosis
857688|NCT00005804|essential thrombocythemia|essential thrombocythemia
857689|NCT00005804|progressive hairy cell leukemia, initial treatment|progressive hairy cell leukemia, initial treatment
857690|NCT00005804|refractory hairy cell leukemia|refractory hairy cell leukemia
857691|NCT00005804|recurrent/refractory childhood Hodgkin lymphoma|recurrent/refractory childhood hodgkin lymphoma
857692|NCT00005804|chronic myelomonocytic leukemia|chronic myelomonocytic leukemia
857693|NCT00005804|T-cell large granular lymphocyte leukemia|t-cell large granular lymphocyte leukemia
857694|NCT00005804|acute undifferentiated leukemia|acute undifferentiated leukemia
857695|NCT00005804|stage III adult lymphoblastic lymphoma|stage iii adult lymphoblastic lymphoma
857696|NCT00005804|stage IV adult lymphoblastic lymphoma|stage iv adult lymphoblastic lymphoma
857697|NCT00005804|recurrent grade 1 follicular lymphoma|recurrent grade 1 follicular lymphoma
857698|NCT00005804|recurrent grade 2 follicular lymphoma|recurrent grade 2 follicular lymphoma
857699|NCT00005804|recurrent grade 3 follicular lymphoma|recurrent grade 3 follicular lymphoma
857700|NCT00005804|recurrent adult diffuse small cleaved cell lymphoma|recurrent adult diffuse small cleaved cell lymphoma
857701|NCT00005804|recurrent adult diffuse mixed cell lymphoma|recurrent adult diffuse mixed cell lymphoma
857702|NCT00005804|recurrent adult diffuse large cell lymphoma|recurrent adult diffuse large cell lymphoma
857703|NCT00005804|recurrent adult immunoblastic large cell lymphoma|recurrent adult immunoblastic large cell lymphoma
857704|NCT00005804|recurrent adult lymphoblastic lymphoma|recurrent adult lymphoblastic lymphoma
857705|NCT00005804|recurrent adult Burkitt lymphoma|recurrent adult burkitt lymphoma
857706|NCT00005804|recurrent adult T-cell leukemia/lymphoma|recurrent adult t-cell leukemia/lymphoma
857707|NCT00005804|secondary acute myeloid leukemia|secondary acute myeloid leukemia
857708|NCT00005804|de novo myelodysplastic syndromes|de novo myelodysplastic syndromes
857709|NCT00005804|previously treated myelodysplastic syndromes|previously treated myelodysplastic syndromes
857710|NCT00005804|secondary myelodysplastic syndromes|secondary myelodysplastic syndromes
857711|NCT00005804|prolymphocytic leukemia|prolymphocytic leukemia
857712|NCT00005804|primary systemic amyloidosis|primary systemic amyloidosis
857713|NCT00005804|intraocular lymphoma|intraocular lymphoma
857714|NCT00005804|recurrent childhood small noncleaved cell lymphoma|recurrent childhood small noncleaved cell lymphoma
857715|NCT00005804|recurrent childhood large cell lymphoma|recurrent childhood large cell lymphoma
857716|NCT00005804|contiguous stage II adult lymphoblastic lymphoma|contiguous stage ii adult lymphoblastic lymphoma
857717|NCT00005804|noncontiguous stage II adult lymphoblastic lymphoma|noncontiguous stage ii adult lymphoblastic lymphoma
857718|NCT00005804|recurrent mantle cell lymphoma|recurrent mantle cell lymphoma
857719|NCT00005804|angioimmunoblastic T-cell lymphoma|angioimmunoblastic t-cell lymphoma
857720|NCT00005804|anaplastic large cell lymphoma|anaplastic large cell lymphoma
857721|NCT00005804|recurrent mycosis fungoides/Sezary syndrome|recurrent mycosis fungoides/sezary syndrome
857722|NCT00005804|recurrent marginal zone lymphoma|recurrent marginal zone lymphoma
857723|NCT00005804|recurrent small lymphocytic lymphoma|recurrent small lymphocytic lymphoma
857724|NCT00005804|extranodal marginal zone B-cell lymphoma of mucosa-associated lymphoid tissue|extranodal marginal zone b-cell lymphoma of mucosa-associated lymphoid tissue
857725|NCT00005804|nodal marginal zone B-cell lymphoma|nodal marginal zone b-cell lymphoma
857726|NCT00005804|splenic marginal zone lymphoma|splenic marginal zone lymphoma
857727|NCT00005804|childhood myelodysplastic syndromes|childhood myelodysplastic syndromes
857728|NCT00005090|stage III adult Hodgkin lymphoma|stage iii adult hodgkin lymphoma
857729|NCT00005090|stage IV adult Hodgkin lymphoma|stage iv adult hodgkin lymphoma
857730|NCT00067756|Pulmonary Disease|pulmonary disease
857731|NCT00067756|Liver Disease|liver disease
857732|NCT00067743|Pain|pain
857733|NCT00067743|Pain syndrome|pain syndrome
857734|NCT00067743|Reflex sympathetic dystrophy|reflex sympathetic dystrophy
857735|NCT00067743|CC-5013|cc-5013
857736|NCT00067743|CC5013|cc5013
857737|NCT00067743|Revlimid|revlimid
857738|NCT00067743|Celgene|celgene
857739|NCT00067743|CRPS|crps
857740|NCT00067717|breast reconstruction surgery|breast reconstruction surgery
857741|NCT00067717|prayer|prayer
857742|NCT00067717|distance healing|distance healing
857743|NCT00067717|wound healing|wound healing
857744|NCT00067704|Complementary Therapies|complementary therapies
857745|NCT00067691|Lung cancer|lung cancer
857746|NCT00067691|Breast cancer|breast cancer
857747|NCT00067691|Shortness of breath|shortness of breath
857748|NCT00067691|Dyspnea|dyspnea
857750|NCT00067691|Breathlessness|breathlessness
857751|NCT00067691|Acupuncture|acupuncture
857752|NCT00067678|diabetic nephropathy|diabetic nephropathy
857753|NCT00067678|nephropathy|nephropathy
857754|NCT00067678|diabetes|diabetes
857755|NCT00067678|diabetes mellitus|diabetes mellitus
857756|NCT00067678|type I diabetes|type i diabetes
857757|NCT00067678|soy protein|soy protein
857758|NCT00067665|hemodialysis|hemodialysis
857759|NCT00067639|Multiple Myeloma|multiple myeloma
857760|NCT00067639|PBSC mobilization|pbsc mobilization
857761|NCT00067639|Pegfilgrastim|pegfilgrastim
857762|NCT00067639|Neulasta|neulasta
857763|NCT00067639|PEG-G-CSF|peg-g-csf
857764|NCT00067626|glucose tolerance test|glucose tolerance test
857765|NCT00067626|minerals|minerals
857766|NCT00067626|chromium|chromium
857767|NCT00067626|complementary and alternative medicine|complementary and alternative medicine
857768|NCT00067613|NICHD Neonatal Research Network|nichd neonatal research network
857769|NCT00067613|Extremely Low Birth Weight (ELBW)|extremely low birth weight (elbw)
857770|NCT00067613|Very Low Birth Weight (VLBW)|very low birth weight (vlbw)
857771|NCT00067613|Prematurity|prematurity
857772|NCT00067613|Mechanical ventilation|mechanical ventilation
857773|NCT00067613|Benchmarking|benchmarking
857774|NCT00067613|Chronic Lung Disease (CLD)|chronic lung disease (cld)
857775|NCT00067587|Treatment experienced|treatment experienced
857776|NCT00067587|Treatment naive|treatment naive
857777|NCT00067574|Structured treatment interruption|structured treatment interruption
857778|NCT00067574|Treatment experienced|treatment experienced
857779|NCT00067561|Dose-ranging|dose-ranging
857780|NCT00067561|Diarrhea-Predominant Irritable Bowel Syndrome|diarrhea-predominant irritable bowel syndrome
857781|NCT00067561|d-IBS|d-ibs
857782|NCT00067561|IBS|ibs
857783|NCT00067561|Irritable Bowel Syndrome|irritable bowel syndrome
857784|NCT00067548|Advanced Non-Small Cell Lung Cancer|advanced non-small cell lung cancer
857785|NCT00067535|cocaine dependence|cocaine dependence
857786|NCT00067522|Family Planning|family planning
857787|NCT00067522|Sexually Transmitted Diseases|sexually transmitted diseases
857788|NCT00067522|HIV|hiv
857789|NCT00067522|Africa|africa
857790|NCT00067522|Zambia|zambia
857791|NCT00067522|AIDS|aids
857792|NCT00067522|Contraception|contraception
857793|NCT00067522|HIV Prevention|hiv prevention
857794|NCT00067509|Female|female
857795|NCT00004256|stage I laryngeal cancer|stage i laryngeal cancer
857796|NCT00004256|stage II laryngeal cancer|stage ii laryngeal cancer
857797|NCT00004256|recurrent laryngeal cancer|recurrent laryngeal cancer
857798|NCT00004256|oral complications|oral complications
857799|NCT00004256|radiation toxicity|radiation toxicity
857800|NCT00004233|stage III gastric cancer|stage iii gastric cancer
857801|NCT00004233|stage IV gastric cancer|stage iv gastric cancer
857802|NCT00004233|recurrent gastric cancer|recurrent gastric cancer
857803|NCT00004233|stage III esophageal cancer|stage iii esophageal cancer
857804|NCT00004233|stage IV esophageal cancer|stage iv esophageal cancer
857805|NCT00004233|recurrent esophageal cancer|recurrent esophageal cancer
857806|NCT00004233|adenocarcinoma of the stomach|adenocarcinoma of the stomach
857807|NCT00004233|adenocarcinoma of the esophagus|adenocarcinoma of the esophagus
857808|NCT00004125|stage II breast cancer|stage ii breast cancer
857809|NCT00004125|stage IIIA breast cancer|stage iiia breast cancer
857810|NCT00067496|Pain|pain
857811|NCT00067496|Weakness|weakness
857812|NCT00067496|Depression|depression
857813|NCT00067496|Poliomyelitis|poliomyelitis
857814|NCT00067496|Sleep Apnea|sleep apnea
857815|NCT00067496|Post-Polio Syndrome|post-polio syndrome
857816|NCT00067496|PPS|pps
857817|NCT00067483|Cataract|cataract
857818|NCT00067483|Pre-Senile|pre-senile
857819|NCT00067483|Dynamic Light Scattering (DLS)|dynamic light scattering (dls)
857820|NCT00067483|Light Scattering|light scattering
857821|NCT00067483|Lens|lens
857822|NCT00067483|Cataracts|cataracts
857824|NCT00067457|Diarrhea-Predominant Irritable Bowel Syndrome|diarrhea-predominant irritable bowel syndrome
857825|NCT00067457|Irritable Bowel Syndrome (IBS)|irritable bowel syndrome (ibs)
857826|NCT00067444|Elderly|elderly
857827|NCT00067444|Major Depressive Disorder|major depressive disorder
857828|NCT00067444|MDD|mdd
857829|NCT00067431|Partial Seizures|partial seizures
857830|NCT00067405|Fibromyalgia|fibromyalgia
857831|NCT00067405|Intravenous micronutrient therapy|intravenous micronutrient therapy
857832|NCT00067405|IVMT|ivmt
857833|NCT00067405|alternative medicine|alternative medicine
857834|NCT00067405|complementary medicine|complementary medicine
857835|NCT00067405|vitamins|vitamins
857836|NCT00067405|vitamin supplements|vitamin supplements
857837|NCT00067392|Partial edentulism|partial edentulism
857838|NCT00067392|Bone atrophy|bone atrophy
857839|NCT00067392|Bone healing|bone healing
857840|NCT00004004|recurrent adult brain tumor|recurrent adult brain tumor
857841|NCT00004004|adult glioblastoma|adult glioblastoma
857842|NCT00004004|adult anaplastic astrocytoma|adult anaplastic astrocytoma
857843|NCT00004004|adult anaplastic oligodendroglioma|adult anaplastic oligodendroglioma
857844|NCT00004004|adult giant cell glioblastoma|adult giant cell glioblastoma
857845|NCT00004004|adult gliosarcoma|adult gliosarcoma
881795|NCT00031044|HIV-1|hiv-1
857846|NCT00003931|recurrent adult acute myeloid leukemia|recurrent adult acute myeloid leukemia
857847|NCT00003931|adult acute myeloid leukemia in remission|adult acute myeloid leukemia in remission
857848|NCT00003890|unspecified adult solid tumor, protocol specific|unspecified adult solid tumor, protocol specific
857849|NCT00003736|breast cancer|breast cancer
857850|NCT00003464|adult glioblastoma|adult glioblastoma
857851|NCT00003464|adult giant cell glioblastoma|adult giant cell glioblastoma
857852|NCT00003464|adult gliosarcoma|adult gliosarcoma
857853|NCT00067418|Glioma|glioma
857854|NCT00067418|Brain Tumor|brain tumor
857855|NCT00067418|Spectroscopy|spectroscopy
857856|NCT00067353|Early Childhood Caries|early childhood caries
857857|NCT00067327|Relapsing remitting multiple sclerosis|relapsing remitting multiple sclerosis
857858|NCT00067327|Multiple sclerosis|multiple sclerosis
857859|NCT00067327|Peroxynitrite|peroxynitrite
857860|NCT00067327|Uric acid|uric acid
857861|NCT00067327|Inosine|inosine
857862|NCT00067301|depression|depression
857863|NCT00067301|citalopram|citalopram
857864|NCT00067301|Celexa|celexa
857865|NCT00067301|Polyunsaturated Fatty Acids|polyunsaturated fatty acids
857866|NCT00067301|omega-3|omega-3
857867|NCT00067301|EPA|epa
857868|NCT00067301|antidepressants|antidepressants
857869|NCT00067288|Stage 3 cancer;|stage 3 cancer;
857870|NCT00067288|Stage 4 cancer;|stage 4 cancer;
857871|NCT00067288|solid tumor cancer;|solid tumor cancer;
857872|NCT00067288|Non-Hodgkin's Lymphoma;|non-hodgkin's lymphoma;
857873|NCT00067288|solid tumors;|solid tumors;
857874|NCT00067288|end-stage cancer;|end-stage cancer;
857875|NCT00067288|group psychotherapy;|group psychotherapy;
857876|NCT00067288|psychotherapy;|psychotherapy;
857877|NCT00067288|emotional support;|emotional support;
857878|NCT00067288|support groups|support groups
857879|NCT00067262|Bipolar Disorder Type 1 (manic or mixed type)|bipolar disorder type 1 (manic or mixed type)
857880|NCT00067249|Race|race
857881|NCT00067249|Ethnicity|ethnicity
857882|NCT00067249|Complementary and Alternative Medicine|complementary and alternative medicine
857883|NCT00067249|Women's health|women's health
857884|NCT00067249|Social determinants of Health|social determinants of health
857885|NCT00067275|Stroke|stroke
857886|NCT00067275|Motor Training|motor training
857887|NCT00067275|Positron Emission Tomograhy|positron emission tomograhy
857888|NCT00067275|Plasticity|plasticity
857889|NCT00067275|Transcranial Magnetic Stimulation|transcranial magnetic stimulation
857890|NCT00067275|Healthy Volunteer|healthy volunteer
857891|NCT00067275|HV|hv
857892|NCT00067223|Transcranial Magnetic Stimulation (TMS)|transcranial magnetic stimulation (tms)
857893|NCT00067223|Unilateral Finger Movement|unilateral finger movement
857894|NCT00067223|Interhemispheric Inhibition|interhemispheric inhibition
857895|NCT00067223|Motor Training|motor training
857896|NCT00067223|Plasticity|plasticity
857897|NCT00067223|Healthy Volunteer|healthy volunteer
857898|NCT00067223|HV|hv
857899|NCT00067210|Brain|brain
857900|NCT00067210|Epilepsy|epilepsy
857901|NCT00067210|Core|core
857902|NCT00067210|Temperature|temperature
857903|NCT00067197|Transcranial Direct Current Stimulation (tDCS)|transcranial direct current stimulation (tdcs)
857904|NCT00067197|Cortical Reorganization|cortical reorganization
857905|NCT00067197|Rehabilitation|rehabilitation
857906|NCT00067197|Motor Learning|motor learning
857907|NCT00067197|Activity of Daily Living (ADL)|activity of daily living (adl)
857908|NCT00067197|Stroke|stroke
857909|NCT00067197|Healthy Volunteer|healthy volunteer
857910|NCT00067197|HV|hv
857911|NCT00067184|methadone|methadone
857912|NCT00067184|fetus|fetus
857913|NCT00067171|behavioral intervention|behavioral intervention
857914|NCT00067158|nicotine dependence|nicotine dependence
857915|NCT00067119|Graft Failure|graft failure
857916|NCT00067119|Access Blood Flow Monitoring|access blood flow monitoring
857917|NCT00067119|Clinical Trial Vascular Access|clinical trial vascular access
857918|NCT00067119|Fistula Failure|fistula failure
857919|NCT00067119|Hemodialysis|hemodialysis
857920|NCT00067119|Vascular Access|vascular access
857921|NCT00067106|HIV|hiv
857922|NCT00067106|Women|women
857923|NCT00067106|Genital tract|genital tract
857924|NCT00067106|Treatment experienced|treatment experienced
857925|NCT00067106|Drug resistance|drug resistance
857926|NCT00067080|Sickle cell disease|sickle cell disease
857928|NCT00067080|deferoxamine|deferoxamine
857929|NCT00067080|hemosiderosis|hemosiderosis
857930|NCT00067041|Critical Limb Ischemia|critical limb ischemia
857931|NCT00067041|Autogenous Bypass Graft|autogenous bypass graft
857932|NCT00067041|CLI|cli
857933|NCT00067028|Chronic Myeloid Leukemia|chronic myeloid leukemia
857934|NCT00067028|CML Myeloid Blast Phase|cml myeloid blast phase
857935|NCT00067028|Acute Myeloid Leukemia|acute myeloid leukemia
857936|NCT00067028|Myelodysplastic Syndrome|myelodysplastic syndrome
857937|NCT00067028|Clofarabine|clofarabine
857938|NCT00067028|Clofarex|clofarex
857939|NCT00067028|Clolar|clolar
857940|NCT00067028|Ara-C|ara-c
857941|NCT00067028|Cytarabine|cytarabine
857942|NCT00067028|Cytosar|cytosar
857943|NCT00067028|DepoCyt|depocyt
857944|NCT00067028|Cytosine arabinosine hydrochloride|cytosine arabinosine hydrochloride
857945|NCT00067028|Idarubicin|idarubicin
857947|NCT00003433|stage IV colon cancer|stage iv colon cancer
857948|NCT00003433|liver metastases|liver metastases
857949|NCT00003323|adenocarcinoma of the prostate|adenocarcinoma of the prostate
857950|NCT00003323|recurrent prostate cancer|recurrent prostate cancer
857951|NCT00003323|sexual dysfunction and infertility|sexual dysfunction and infertility
857952|NCT00003114|AIDS-related lymphoma|aids-related lymphoma
857953|NCT00003114|HIV-associated Hodgkin lymphoma|hiv-associated hodgkin lymphoma
857954|NCT00003006|stage I non-small cell lung cancer|stage i non-small cell lung cancer
857956|NCT00067067|Brain Tumor|brain tumor
857957|NCT00067067|Endothelial Progenitor Cells|endothelial progenitor cells
857958|NCT00067054|Volunteer|volunteer
857959|NCT00067054|Plasmapheresis|plasmapheresis
857960|NCT00067054|Leukapheresis|leukapheresis
857961|NCT00067054|Immunology|immunology
857962|NCT00067054|Leukocyte|leukocyte
857963|NCT00067054|Healthy Volunteer|healthy volunteer
857964|NCT00067054|HV|hv
857965|NCT00067015|adenocarcinoma of the prostate|adenocarcinoma of the prostate
857966|NCT00067015|stage III prostate cancer|stage iii prostate cancer
857967|NCT00067002|ALL|all
857968|NCT00067002|Leukemia, Lymphocytic, Acute|leukemia, lymphocytic, acute
857969|NCT00067002|AML|aml
857970|NCT00067002|Leukemia, Myelocytic, Acute|leukemia, myelocytic, acute
857971|NCT00067002|CML|cml
857972|NCT00067002|Leukemia, Myeloid, Chronic|leukemia, myeloid, chronic
857973|NCT00067002|NHL|nhl
857974|NCT00067002|Lymphoma, Non-Hodgkin|lymphoma, non-hodgkin
857975|NCT00067002|double cord blood transplant|double cord blood transplant
857976|NCT00067002|expanded cord blood transplant|expanded cord blood transplant
857977|NCT00067002|Rituxan|rituxan
857978|NCT00067002|Rituximab|rituximab
857979|NCT00067002|Melphalan|melphalan
857980|NCT00067002|Alkeran|alkeran
857981|NCT00067002|Thiotepa|thiotepa
857982|NCT00067002|Fludarabine|fludarabine
857983|NCT00067002|Fludarabine phosphate|fludarabine phosphate
857984|NCT00067002|Fludara|fludara
857985|NCT00067002|Cyclophosphamide|cyclophosphamide
857986|NCT00067002|Cytoxan|cytoxan
857987|NCT00067002|Neosar|neosar
857988|NCT00067002|Mesna|mesna
857989|NCT00067002|Mesnex|mesnex
857990|NCT00066989|Staphylococcal infection|staphylococcal infection
857991|NCT00066989|Gram positive bacteria|gram positive bacteria
857992|NCT00066989|Staphylococcus|staphylococcus
857993|NCT00066989|Staphylococcus aureus|staphylococcus aureus
857994|NCT00046878|adult glioblastoma|adult glioblastoma
857995|NCT00046878|adult giant cell glioblastoma|adult giant cell glioblastoma
857996|NCT00046878|adult gliosarcoma|adult gliosarcoma
857997|NCT00002621|recurrent childhood acute lymphoblastic leukemia|recurrent childhood acute lymphoblastic leukemia
857998|NCT00002621|stage I childhood lymphoblastic lymphoma|stage i childhood lymphoblastic lymphoma
857999|NCT00002621|stage II childhood lymphoblastic lymphoma|stage ii childhood lymphoblastic lymphoma
858000|NCT00002621|stage III childhood lymphoblastic lymphoma|stage iii childhood lymphoblastic lymphoma
858001|NCT00002621|stage IV childhood lymphoblastic lymphoma|stage iv childhood lymphoblastic lymphoma
858002|NCT00002621|recurrent childhood lymphoblastic lymphoma|recurrent childhood lymphoblastic lymphoma
858003|NCT00002621|recurrent childhood acute myeloid leukemia|recurrent childhood acute myeloid leukemia
858004|NCT00002621|unspecified childhood solid tumor, protocol specific|unspecified childhood solid tumor, protocol specific
858005|NCT00002621|untreated childhood acute myeloid leukemia and other myeloid malignancies|untreated childhood acute myeloid leukemia and other myeloid malignancies
858006|NCT00002621|untreated childhood acute lymphoblastic leukemia|untreated childhood acute lymphoblastic leukemia
858007|NCT00002621|childhood acute myeloid leukemia in remission|childhood acute myeloid leukemia in remission
858008|NCT00002621|childhood acute lymphoblastic leukemia in remission|childhood acute lymphoblastic leukemia in remission
858009|NCT00002621|AIDS-related peripheral/systemic lymphoma|aids-related peripheral/systemic lymphoma
858010|NCT00002621|AIDS-related primary CNS lymphoma|aids-related primary cns lymphoma
858011|NCT00002621|stage I childhood small noncleaved cell lymphoma|stage i childhood small noncleaved cell lymphoma
858012|NCT00002621|stage I childhood large cell lymphoma|stage i childhood large cell lymphoma
858013|NCT00002621|stage II childhood small noncleaved cell lymphoma|stage ii childhood small noncleaved cell lymphoma
858014|NCT00002621|stage II childhood large cell lymphoma|stage ii childhood large cell lymphoma
858015|NCT00002621|stage III childhood small noncleaved cell lymphoma|stage iii childhood small noncleaved cell lymphoma
858016|NCT00002621|stage III childhood large cell lymphoma|stage iii childhood large cell lymphoma
858017|NCT00002621|stage IV childhood small noncleaved cell lymphoma|stage iv childhood small noncleaved cell lymphoma
858018|NCT00002621|stage IV childhood large cell lymphoma|stage iv childhood large cell lymphoma
858019|NCT00002621|recurrent childhood small noncleaved cell lymphoma|recurrent childhood small noncleaved cell lymphoma
858020|NCT00002621|recurrent childhood large cell lymphoma|recurrent childhood large cell lymphoma
858021|NCT00002548|stage I multiple myeloma|stage i multiple myeloma
858022|NCT00002548|stage II multiple myeloma|stage ii multiple myeloma
858023|NCT00002548|stage III multiple myeloma|stage iii multiple myeloma
858024|NCT00002520|stage I adult Hodgkin lymphoma|stage i adult hodgkin lymphoma
858025|NCT00002520|angioimmunoblastic T-cell lymphoma|angioimmunoblastic t-cell lymphoma
858026|NCT00002520|stage II adult Hodgkin lymphoma|stage ii adult hodgkin lymphoma
858027|NCT00002520|stage III adult Hodgkin lymphoma|stage iii adult hodgkin lymphoma
858028|NCT00002520|stage IV adult Hodgkin lymphoma|stage iv adult hodgkin lymphoma
858029|NCT00002520|stage I colon cancer|stage i colon cancer
858030|NCT00002520|stage II colon cancer|stage ii colon cancer
858031|NCT00002520|stage I breast cancer|stage i breast cancer
858032|NCT00002520|AIDS-related peripheral/systemic lymphoma|aids-related peripheral/systemic lymphoma
858033|NCT00002520|AIDS-related primary CNS lymphoma|aids-related primary cns lymphoma
858034|NCT00002520|anaplastic large cell lymphoma|anaplastic large cell lymphoma
858035|NCT00002520|contiguous stage II adult diffuse large cell lymphoma|contiguous stage ii adult diffuse large cell lymphoma
858036|NCT00002520|contiguous stage II adult diffuse mixed cell lymphoma|contiguous stage ii adult diffuse mixed cell lymphoma
858037|NCT00002520|contiguous stage II adult diffuse small cleaved cell lymphoma|contiguous stage ii adult diffuse small cleaved cell lymphoma
858038|NCT00002520|contiguous stage II adult Burkitt lymphoma|contiguous stage ii adult burkitt lymphoma
858039|NCT00002520|contiguous stage II adult immunoblastic large cell lymphoma|contiguous stage ii adult immunoblastic large cell lymphoma
858040|NCT00002520|contiguous stage II adult lymphoblastic lymphoma|contiguous stage ii adult lymphoblastic lymphoma
858041|NCT00002520|contiguous stage II grade 1 follicular lymphoma|contiguous stage ii grade 1 follicular lymphoma
858042|NCT00002520|contiguous stage II grade 2 follicular lymphoma|contiguous stage ii grade 2 follicular lymphoma
858043|NCT00002520|contiguous stage II grade 3 follicular lymphoma|contiguous stage ii grade 3 follicular lymphoma
858044|NCT00002520|contiguous stage II mantle cell lymphoma|contiguous stage ii mantle cell lymphoma
858045|NCT00002520|intraocular lymphoma|intraocular lymphoma
858046|NCT00002520|limited stage small cell lung cancer|limited stage small cell lung cancer
858047|NCT00002520|noncontiguous stage II adult diffuse large cell lymphoma|noncontiguous stage ii adult diffuse large cell lymphoma
858048|NCT00002520|noncontiguous stage II adult diffuse mixed cell lymphoma|noncontiguous stage ii adult diffuse mixed cell lymphoma
858049|NCT00002520|noncontiguous stage II adult diffuse small cleaved cell lymphoma|noncontiguous stage ii adult diffuse small cleaved cell lymphoma
858050|NCT00002520|noncontiguous stage II adult Burkitt lymphoma|noncontiguous stage ii adult burkitt lymphoma
858051|NCT00002520|noncontiguous stage II adult immunoblastic large cell lymphoma|noncontiguous stage ii adult immunoblastic large cell lymphoma
858052|NCT00002520|noncontiguous stage II adult lymphoblastic lymphoma|noncontiguous stage ii adult lymphoblastic lymphoma
858053|NCT00002520|noncontiguous stage II grade 1 follicular lymphoma|noncontiguous stage ii grade 1 follicular lymphoma
858054|NCT00002520|noncontiguous stage II grade 2 follicular lymphoma|noncontiguous stage ii grade 2 follicular lymphoma
858055|NCT00002520|noncontiguous stage II grade 3 follicular lymphoma|noncontiguous stage ii grade 3 follicular lymphoma
858056|NCT00002520|noncontiguous stage II mantle cell lymphoma|noncontiguous stage ii mantle cell lymphoma
858057|NCT00002520|primary central nervous system lymphoma|primary central nervous system lymphoma
858058|NCT00002520|tobacco use disorder|tobacco use disorder
858059|NCT00002520|stage I adenoid cystic carcinoma of the oral cavity|stage i adenoid cystic carcinoma of the oral cavity
858060|NCT00002520|stage I adult T-cell leukemia/lymphoma|stage i adult t-cell leukemia/lymphoma
858061|NCT00002520|stage I adult diffuse large cell lymphoma|stage i adult diffuse large cell lymphoma
858062|NCT00002520|stage I adult diffuse mixed cell lymphoma|stage i adult diffuse mixed cell lymphoma
858063|NCT00002520|stage I adult diffuse small cleaved cell lymphoma|stage i adult diffuse small cleaved cell lymphoma
858064|NCT00002520|stage I adult Burkitt lymphoma|stage i adult burkitt lymphoma
858065|NCT00002520|stage I adult immunoblastic large cell lymphoma|stage i adult immunoblastic large cell lymphoma
858066|NCT00002520|stage I adult lymphoblastic lymphoma|stage i adult lymphoblastic lymphoma
858067|NCT00002520|stage I basal cell carcinoma of the lip|stage i basal cell carcinoma of the lip
858068|NCT00002520|stage I cutaneous T-cell non-Hodgkin lymphoma|stage i cutaneous t-cell non-hodgkin lymphoma
858069|NCT00002520|stage I esthesioneuroblastoma of the paranasal sinus and nasal cavity|stage i esthesioneuroblastoma of the paranasal sinus and nasal cavity
858070|NCT00002520|stage I grade 1 follicular lymphoma|stage i grade 1 follicular lymphoma
858071|NCT00002520|stage I grade 2 follicular lymphoma|stage i grade 2 follicular lymphoma
858072|NCT00002520|stage I grade 3 follicular lymphoma|stage i grade 3 follicular lymphoma
858073|NCT00002520|stage I inverted papilloma of the paranasal sinus and nasal cavity|stage i inverted papilloma of the paranasal sinus and nasal cavity
858074|NCT00002520|stage I lymphoepithelioma of the nasopharynx|stage i lymphoepithelioma of the nasopharynx
858075|NCT00002520|stage I lymphoepithelioma of the oropharynx|stage i lymphoepithelioma of the oropharynx
858219|NCT00066807|stage II breast cancer|stage ii breast cancer
858076|NCT00002520|stage I mantle cell lymphoma|stage i mantle cell lymphoma
858077|NCT00002520|stage I midline lethal granuloma of the paranasal sinus and nasal cavity|stage i midline lethal granuloma of the paranasal sinus and nasal cavity
858078|NCT00002520|stage I mucoepidermoid carcinoma of the oral cavity|stage i mucoepidermoid carcinoma of the oral cavity
858079|NCT00002520|stage I mycosis fungoides/Sezary syndrome|stage i mycosis fungoides/sezary syndrome
858080|NCT00002520|stage I non-small cell lung cancer|stage i non-small cell lung cancer
858081|NCT00002520|stage I prostate cancer|stage i prostate cancer
858082|NCT00002520|stage I rectal cancer|stage i rectal cancer
858083|NCT00002520|stage I squamous cell carcinoma of the hypopharynx|stage i squamous cell carcinoma of the hypopharynx
858084|NCT00002520|stage I squamous cell carcinoma of the larynx|stage i squamous cell carcinoma of the larynx
858085|NCT00002520|stage I squamous cell carcinoma of the lip and oral cavity|stage i squamous cell carcinoma of the lip and oral cavity
858086|NCT00002520|stage I squamous cell carcinoma of the nasopharynx|stage i squamous cell carcinoma of the nasopharynx
882419|NCT00028080|Infection|infection
858087|NCT00002520|stage I squamous cell carcinoma of the oropharynx|stage i squamous cell carcinoma of the oropharynx
858088|NCT00002520|stage I squamous cell carcinoma of the paranasal sinus and nasal cavity|stage i squamous cell carcinoma of the paranasal sinus and nasal cavity
858089|NCT00002520|stage I malignant testicular germ cell tumor|stage i malignant testicular germ cell tumor
858090|NCT00002520|stage I verrucous carcinoma of the larynx|stage i verrucous carcinoma of the larynx
858091|NCT00002520|stage I verrucous carcinoma of the oral cavity|stage i verrucous carcinoma of the oral cavity
858092|NCT00002520|stage II adult T-cell leukemia/lymphoma|stage ii adult t-cell leukemia/lymphoma
858093|NCT00002520|stage II adenoid cystic carcinoma of the oral cavity|stage ii adenoid cystic carcinoma of the oral cavity
858094|NCT00002520|stage II basal cell carcinoma of the lip|stage ii basal cell carcinoma of the lip
858095|NCT00002520|stage II bladder cancer|stage ii bladder cancer
858096|NCT00002520|stage II breast cancer|stage ii breast cancer
858097|NCT00002520|stage II cutaneous T-cell non-Hodgkin lymphoma|stage ii cutaneous t-cell non-hodgkin lymphoma
858098|NCT00002520|stage II esthesioneuroblastoma of the paranasal sinus and nasal cavity|stage ii esthesioneuroblastoma of the paranasal sinus and nasal cavity
858099|NCT00002520|stage II inverted papilloma of the paranasal sinus and nasal cavity|stage ii inverted papilloma of the paranasal sinus and nasal cavity
858100|NCT00002520|stage II lymphoepithelioma of the nasopharynx|stage ii lymphoepithelioma of the nasopharynx
858101|NCT00002520|stage II lymphoepithelioma of the oropharynx|stage ii lymphoepithelioma of the oropharynx
858102|NCT00002520|stage II midline lethal granuloma of the paranasal sinus and nasal cavity|stage ii midline lethal granuloma of the paranasal sinus and nasal cavity
858103|NCT00002520|stage II mucoepidermoid carcinoma of the oral cavity|stage ii mucoepidermoid carcinoma of the oral cavity
858104|NCT00002520|stage II mycosis fungoides/Sezary syndrome|stage ii mycosis fungoides/sezary syndrome
858105|NCT00002520|stage I bladder cancer|stage i bladder cancer
858106|NCT00002520|stage II non-small cell lung cancer|stage ii non-small cell lung cancer
858107|NCT00002520|stage II prostate cancer|stage ii prostate cancer
858108|NCT00002520|stage II rectal cancer|stage ii rectal cancer
858109|NCT00002520|stage II squamous cell carcinoma of the hypopharynx|stage ii squamous cell carcinoma of the hypopharynx
858110|NCT00002520|stage II squamous cell carcinoma of the larynx|stage ii squamous cell carcinoma of the larynx
858111|NCT00002520|stage II squamous cell carcinoma of the lip and oral cavity|stage ii squamous cell carcinoma of the lip and oral cavity
858112|NCT00002520|stage II squamous cell carcinoma of the nasopharynx|stage ii squamous cell carcinoma of the nasopharynx
858113|NCT00002520|stage II squamous cell carcinoma of the oropharynx|stage ii squamous cell carcinoma of the oropharynx
858114|NCT00002520|stage II squamous cell carcinoma of the paranasal sinus and nasal cavity|stage ii squamous cell carcinoma of the paranasal sinus and nasal cavity
858115|NCT00002520|stage II malignant testicular germ cell tumor|stage ii malignant testicular germ cell tumor
858116|NCT00002520|stage II verrucous carcinoma of the larynx|stage ii verrucous carcinoma of the larynx
858117|NCT00002520|stage II verrucous carcinoma of the oral cavity|stage ii verrucous carcinoma of the oral cavity
858118|NCT00002520|stage III adult T-cell leukemia/lymphoma|stage iii adult t-cell leukemia/lymphoma
858119|NCT00002520|stage III adult diffuse large cell lymphoma|stage iii adult diffuse large cell lymphoma
858120|NCT00002520|stage III adult diffuse mixed cell lymphoma|stage iii adult diffuse mixed cell lymphoma
858121|NCT00002520|stage III adult diffuse small cleaved cell lymphoma|stage iii adult diffuse small cleaved cell lymphoma
858122|NCT00002520|stage III adult Burkitt lymphoma|stage iii adult burkitt lymphoma
858123|NCT00002520|stage III adult immunoblastic large cell lymphoma|stage iii adult immunoblastic large cell lymphoma
858124|NCT00002520|stage III adult lymphoblastic lymphoma|stage iii adult lymphoblastic lymphoma
858125|NCT00002520|stage III cutaneous T-cell non-Hodgkin lymphoma|stage iii cutaneous t-cell non-hodgkin lymphoma
858126|NCT00002520|stage III grade 1 follicular lymphoma|stage iii grade 1 follicular lymphoma
858127|NCT00002520|stage III grade 2 follicular lymphoma|stage iii grade 2 follicular lymphoma
858128|NCT00002520|stage III grade 3 follicular lymphoma|stage iii grade 3 follicular lymphoma
858129|NCT00002520|stage III mantle cell lymphoma|stage iii mantle cell lymphoma
858130|NCT00002520|stage III mycosis fungoides/Sezary syndrome|stage iii mycosis fungoides/sezary syndrome
858131|NCT00002520|stage III prostate cancer|stage iii prostate cancer
858132|NCT00002520|stage III malignant testicular germ cell tumor|stage iii malignant testicular germ cell tumor
858133|NCT00002520|stage IIIA breast cancer|stage iiia breast cancer
858134|NCT00002520|stage IIIB breast cancer|stage iiib breast cancer
858135|NCT00002520|stage IV adult T-cell leukemia/lymphoma|stage iv adult t-cell leukemia/lymphoma
858136|NCT00002520|stage IV adult diffuse large cell lymphoma|stage iv adult diffuse large cell lymphoma
858137|NCT00002520|stage IV adult diffuse mixed cell lymphoma|stage iv adult diffuse mixed cell lymphoma
858138|NCT00002520|stage IV adult diffuse small cleaved cell lymphoma|stage iv adult diffuse small cleaved cell lymphoma
858139|NCT00002520|stage IV adult Burkitt lymphoma|stage iv adult burkitt lymphoma
858140|NCT00002520|stage IV adult immunoblastic large cell lymphoma|stage iv adult immunoblastic large cell lymphoma
858141|NCT00002520|stage IV adult lymphoblastic lymphoma|stage iv adult lymphoblastic lymphoma
858142|NCT00002520|stage IV breast cancer|stage iv breast cancer
858143|NCT00002520|stage IV cutaneous T-cell non-Hodgkin lymphoma|stage iv cutaneous t-cell non-hodgkin lymphoma
858144|NCT00002520|stage IV grade 1 follicular lymphoma|stage iv grade 1 follicular lymphoma
858145|NCT00002520|stage IV grade 2 follicular lymphoma|stage iv grade 2 follicular lymphoma
858146|NCT00002520|stage IV grade 3 follicular lymphoma|stage iv grade 3 follicular lymphoma
858147|NCT00002520|stage IV mantle cell lymphoma|stage iv mantle cell lymphoma
858148|NCT00002520|stage IV mycosis fungoides/Sezary syndrome|stage iv mycosis fungoides/sezary syndrome
858149|NCT00002520|stage IV prostate cancer|stage iv prostate cancer
858150|NCT00002520|unspecified adult solid tumor, protocol specific|unspecified adult solid tumor, protocol specific
858151|NCT00002520|contiguous stage II marginal zone lymphoma|contiguous stage ii marginal zone lymphoma
858152|NCT00002520|contiguous stage II small lymphocytic lymphoma|contiguous stage ii small lymphocytic lymphoma
858153|NCT00002520|noncontiguous stage II small lymphocytic lymphoma|noncontiguous stage ii small lymphocytic lymphoma
858154|NCT00002520|noncontiguous stage II marginal zone lymphoma|noncontiguous stage ii marginal zone lymphoma
858155|NCT00002520|stage I marginal zone lymphoma|stage i marginal zone lymphoma
858156|NCT00002520|stage I small lymphocytic lymphoma|stage i small lymphocytic lymphoma
858157|NCT00002520|stage III small lymphocytic lymphoma|stage iii small lymphocytic lymphoma
858158|NCT00002520|stage III marginal zone lymphoma|stage iii marginal zone lymphoma
858159|NCT00002520|stage IV small lymphocytic lymphoma|stage iv small lymphocytic lymphoma
858160|NCT00002520|stage IV marginal zone lymphoma|stage iv marginal zone lymphoma
858161|NCT00002520|extranodal marginal zone B-cell lymphoma of mucosa-associated lymphoid tissue|extranodal marginal zone b-cell lymphoma of mucosa-associated lymphoid tissue
858162|NCT00002520|nodal marginal zone B-cell lymphoma|nodal marginal zone b-cell lymphoma
858163|NCT00002520|splenic marginal zone lymphoma|splenic marginal zone lymphoma
858164|NCT00066976|Prenatal|prenatal
858165|NCT00066976|Respiration|respiration
858166|NCT00066976|Ultrasound|ultrasound
858167|NCT00066976|Prematurity|prematurity
858168|NCT00066976|Diagnoses|diagnoses
858169|NCT00066976|Fetal Breathing-Movement|fetal breathing-movement
858170|NCT00066976|Doppler Sonography|doppler sonography
858171|NCT00066976|Amniotic Fluid|amniotic fluid
858172|NCT00066976|Oligohydraminos|oligohydraminos
858173|NCT00066976|Polyhydraminos|polyhydraminos
858174|NCT00066976|Pregnancy|pregnancy
858175|NCT00066963|Early Childhood Caries|early childhood caries
858176|NCT00066950|Early childhood caries|early childhood caries
858177|NCT00066924|spirituality|spirituality
858178|NCT00066924|religiosity|religiosity
858179|NCT00066924|immune functioning|immune functioning
858180|NCT00066924|psychoneuroimmunology|psychoneuroimmunology
858181|NCT00066924|cytokines|cytokines
858182|NCT00066924|cancer|cancer
858183|NCT00066924|death|death
858184|NCT00066924|depression|depression
858185|NCT00066898|succinobucol|succinobucol
858186|NCT00066898|AGI-1067|agi-1067
858187|NCT00066898|coronary artery disease|coronary artery disease
858188|NCT00066885|DN101|dn101
858189|NCT00066885|Calcitriol|calcitriol
858190|NCT00066885|Lung Cancer|lung cancer
858191|NCT00066885|NSCLC|nsclc
858192|NCT00066885|Taxotere|taxotere
858193|NCT00011973|stage III renal cell cancer|stage iii renal cell cancer
858194|NCT00011973|stage IV renal cell cancer|stage iv renal cell cancer
858195|NCT00011973|recurrent renal cell cancer|recurrent renal cell cancer
858196|NCT00005027|stage III renal cell cancer|stage iii renal cell cancer
858197|NCT00005027|stage IV renal cell cancer|stage iv renal cell cancer
858198|NCT00005027|recurrent renal cell cancer|recurrent renal cell cancer
858199|NCT00066911|Functional Magnetic Resonance Imaging|functional magnetic resonance imaging
858200|NCT00066911|Vocalization|vocalization
858201|NCT00066911|Spasmodic Dysphonia|spasmodic dysphonia
858202|NCT00066911|Muscular Tension Dysphonia|muscular tension dysphonia
858203|NCT00066911|Topical Lidocaine|topical lidocaine
858204|NCT00066911|Voice Disorders|voice disorders
858205|NCT00066911|Vocal Tremor|vocal tremor
858206|NCT00066911|Healthy Volunteer|healthy volunteer
858207|NCT00066911|HV|hv
858208|NCT00066872|basal cell carcinoma of the skin|basal cell carcinoma of the skin
858209|NCT00066859|depression|depression
858210|NCT00066859|unspecified adult solid tumor, protocol specific|unspecified adult solid tumor, protocol specific
858211|NCT00066846|adenocarcinoma of the colon|adenocarcinoma of the colon
858212|NCT00066846|adenocarcinoma of the rectum|adenocarcinoma of the rectum
858213|NCT00066846|stage IV rectal cancer|stage iv rectal cancer
858214|NCT00066846|recurrent rectal cancer|recurrent rectal cancer
858215|NCT00066846|stage IV colon cancer|stage iv colon cancer
858216|NCT00066846|recurrent colon cancer|recurrent colon cancer
858217|NCT00066807|stage IIIA breast cancer|stage iiia breast cancer
858218|NCT00066807|stage I breast cancer|stage i breast cancer
858220|NCT00066794|adult acute monocytic leukemia (M5b)|adult acute monocytic leukemia (m5b)
858221|NCT00066794|adult acute megakaryoblastic leukemia (M7)|adult acute megakaryoblastic leukemia (m7)
858222|NCT00066794|adult acute minimally differentiated myeloid leukemia (M0)|adult acute minimally differentiated myeloid leukemia (m0)
858223|NCT00066794|adult acute myeloblastic leukemia with maturation (M2)|adult acute myeloblastic leukemia with maturation (m2)
858224|NCT00066794|adult acute myeloblastic leukemia without maturation (M1)|adult acute myeloblastic leukemia without maturation (m1)
858225|NCT00066794|adult acute myelomonocytic leukemia (M4)|adult acute myelomonocytic leukemia (m4)
858226|NCT00066794|adult acute monoblastic leukemia (M5a)|adult acute monoblastic leukemia (m5a)
858227|NCT00066794|untreated adult acute myeloid leukemia|untreated adult acute myeloid leukemia
858228|NCT00066794|adult acute myeloid leukemia with t(8;21)(q22;q22)|adult acute myeloid leukemia with t(8;21)(q22;q22)
858229|NCT00066794|adult acute myeloid leukemia with t(16;16)(p13;q22)|adult acute myeloid leukemia with t(16;16)(p13;q22)
858570|NCT00066170|Daytime Sleepiness|daytime sleepiness
858230|NCT00066794|adult acute myeloid leukemia with inv(16)(p13;q22)|adult acute myeloid leukemia with inv(16)(p13;q22)
858231|NCT00066794|adult acute myeloid leukemia with 11q23 (MLL) abnormalities|adult acute myeloid leukemia with 11q23 (mll) abnormalities
858232|NCT00066794|adult pure erythroid leukemia (M6b)|adult pure erythroid leukemia (m6b)
858233|NCT00066794|adult erythroleukemia (M6a)|adult erythroleukemia (m6a)
858234|NCT00066781|adenocarcinoma of unknown primary|adenocarcinoma of unknown primary
858235|NCT00066781|newly diagnosed carcinoma of unknown primary|newly diagnosed carcinoma of unknown primary
858236|NCT00066781|squamous cell carcinoma of unknown primary|squamous cell carcinoma of unknown primary
858237|NCT00066781|undifferentiated carcinoma of unknown primary|undifferentiated carcinoma of unknown primary
858238|NCT00066729|stage II ovarian epithelial cancer|stage ii ovarian epithelial cancer
858239|NCT00066729|stage III ovarian epithelial cancer|stage iii ovarian epithelial cancer
858240|NCT00066729|stage IV ovarian epithelial cancer|stage iv ovarian epithelial cancer
858241|NCT00066729|primary peritoneal cavity cancer|primary peritoneal cavity cancer
858242|NCT00066729|fallopian tube cancer|fallopian tube cancer
858243|NCT00066716|adenocarcinoma of the esophagus|adenocarcinoma of the esophagus
858244|NCT00066716|squamous cell carcinoma of the esophagus|squamous cell carcinoma of the esophagus
858245|NCT00066716|stage I esophageal cancer|stage i esophageal cancer
858246|NCT00066716|stage II esophageal cancer|stage ii esophageal cancer
858775|NCT00065663|ulcers|ulcers
858247|NCT00066716|stage III esophageal cancer|stage iii esophageal cancer
858248|NCT00066716|stage IV esophageal cancer (lymph node metastasis only)|stage iv esophageal cancer (lymph node metastasis only)
858249|NCT00066703|stage II breast cancer|stage ii breast cancer
858250|NCT00066703|stage IIIA breast cancer|stage iiia breast cancer
858251|NCT00066703|estrogen receptor-positive breast cancer|estrogen receptor-positive breast cancer
858252|NCT00066703|progesterone receptor-positive breast cancer|progesterone receptor-positive breast cancer
858253|NCT00066703|stage IA breast cancer|stage ia breast cancer
858254|NCT00066703|stage IB breast cancer|stage ib breast cancer
858255|NCT00066690|tamoxifen|tamoxifen
858256|NCT00066690|ovarian function suppression + tamoxifen|ovarian function suppression + tamoxifen
858257|NCT00066690|ovarian function suppression + exemestane|ovarian function suppression + exemestane
858258|NCT00066677|adenocarcinoma of the pancreas|adenocarcinoma of the pancreas
858259|NCT00066677|recurrent pancreatic cancer|recurrent pancreatic cancer
858260|NCT00066677|stage IV pancreatic cancer|stage iv pancreatic cancer
858261|NCT00066664|recurrent cutaneous T-cell non-Hodgkin lymphoma|recurrent cutaneous t-cell non-hodgkin lymphoma
858262|NCT00066664|stage I cutaneous T-cell non-Hodgkin lymphoma|stage i cutaneous t-cell non-hodgkin lymphoma
858263|NCT00066664|stage II cutaneous T-cell non-Hodgkin lymphoma|stage ii cutaneous t-cell non-hodgkin lymphoma
858264|NCT00066664|stage III cutaneous T-cell non-Hodgkin lymphoma|stage iii cutaneous t-cell non-hodgkin lymphoma
858265|NCT00066664|stage IV cutaneous T-cell non-Hodgkin lymphoma|stage iv cutaneous t-cell non-hodgkin lymphoma
858266|NCT00066664|recurrent mycosis fungoides/Sezary syndrome|recurrent mycosis fungoides/sezary syndrome
858267|NCT00066664|stage I mycosis fungoides/Sezary syndrome|stage i mycosis fungoides/sezary syndrome
858268|NCT00066664|stage II mycosis fungoides/Sezary syndrome|stage ii mycosis fungoides/sezary syndrome
858269|NCT00066664|stage III mycosis fungoides/Sezary syndrome|stage iii mycosis fungoides/sezary syndrome
858270|NCT00066664|stage IV mycosis fungoides/Sezary syndrome|stage iv mycosis fungoides/sezary syndrome
858271|NCT00066651|ovarian carcinosarcoma|ovarian carcinosarcoma
858272|NCT00066651|ovarian clear cell cystadenocarcinoma|ovarian clear cell cystadenocarcinoma
858273|NCT00066651|ovarian endometrioid adenocarcinoma|ovarian endometrioid adenocarcinoma
858274|NCT00066651|ovarian mixed epithelial carcinoma|ovarian mixed epithelial carcinoma
858275|NCT00066651|ovarian serous cystadenocarcinoma|ovarian serous cystadenocarcinoma
858276|NCT00066651|ovarian undifferentiated adenocarcinoma|ovarian undifferentiated adenocarcinoma
858277|NCT00066651|recurrent ovarian epithelial cancer|recurrent ovarian epithelial cancer
858278|NCT00066651|Brenner tumor|brenner tumor
858279|NCT00066651|primary peritoneal cavity cancer|primary peritoneal cavity cancer
858280|NCT00066651|fallopian tube cancer|fallopian tube cancer
858281|NCT00066651|epithelial mesothelioma|epithelial mesothelioma
858282|NCT00066651|recurrent malignant mesothelioma|recurrent malignant mesothelioma
858283|NCT00066651|recurrent pancreatic cancer|recurrent pancreatic cancer
858284|NCT00066651|cervical squamous cell carcinoma|cervical squamous cell carcinoma
858285|NCT00066651|recurrent cervical cancer|recurrent cervical cancer
858286|NCT00066651|recurrent non-small cell lung cancer|recurrent non-small cell lung cancer
858287|NCT00066651|squamous cell lung cancer|squamous cell lung cancer
858288|NCT00066651|recurrent squamous cell carcinoma of the lip and oral cavity|recurrent squamous cell carcinoma of the lip and oral cavity
858289|NCT00066651|recurrent squamous cell carcinoma of the paranasal sinus and nasal cavity|recurrent squamous cell carcinoma of the paranasal sinus and nasal cavity
858290|NCT00066651|recurrent metastatic squamous neck cancer with occult primary|recurrent metastatic squamous neck cancer with occult primary
858291|NCT00066651|recurrent salivary gland cancer|recurrent salivary gland cancer
858292|NCT00066651|salivary gland squamous cell carcinoma|salivary gland squamous cell carcinoma
858293|NCT00066651|recurrent squamous cell carcinoma of the hypopharynx|recurrent squamous cell carcinoma of the hypopharynx
858294|NCT00066651|recurrent squamous cell carcinoma of the larynx|recurrent squamous cell carcinoma of the larynx
858295|NCT00066651|recurrent squamous cell carcinoma of the oropharynx|recurrent squamous cell carcinoma of the oropharynx
858660|NCT00065936|Met-enkephalin|met-enkephalin
858296|NCT00066651|recurrent squamous cell carcinoma of the nasopharynx|recurrent squamous cell carcinoma of the nasopharynx
858297|NCT00066612|recurrent bladder cancer|recurrent bladder cancer
858298|NCT00066612|stage IV bladder cancer|stage iv bladder cancer
858299|NCT00066612|metastatic transitional cell cancer of the renal pelvis and ureter|metastatic transitional cell cancer of the renal pelvis and ureter
858300|NCT00066612|recurrent transitional cell cancer of the renal pelvis and ureter|recurrent transitional cell cancer of the renal pelvis and ureter
858301|NCT00066612|regional transitional cell cancer of the renal pelvis and ureter|regional transitional cell cancer of the renal pelvis and ureter
858302|NCT00066612|transitional cell carcinoma of the bladder|transitional cell carcinoma of the bladder
858303|NCT00066612|anterior urethral cancer|anterior urethral cancer
858304|NCT00066612|posterior urethral cancer|posterior urethral cancer
858305|NCT00066612|recurrent urethral cancer|recurrent urethral cancer
858306|NCT00066612|urethral cancer associated with invasive bladder cancer|urethral cancer associated with invasive bladder cancer
858307|NCT00066599|neutropenia|neutropenia
858308|NCT00066599|recurrent childhood lymphoblastic lymphoma|recurrent childhood lymphoblastic lymphoma
858309|NCT00066599|stage I childhood lymphoblastic lymphoma|stage i childhood lymphoblastic lymphoma
858310|NCT00066599|stage II childhood lymphoblastic lymphoma|stage ii childhood lymphoblastic lymphoma
858311|NCT00066599|stage III childhood lymphoblastic lymphoma|stage iii childhood lymphoblastic lymphoma
858312|NCT00066599|stage IV childhood lymphoblastic lymphoma|stage iv childhood lymphoblastic lymphoma
858313|NCT00066599|recurrent childhood small noncleaved cell lymphoma|recurrent childhood small noncleaved cell lymphoma
858314|NCT00066599|stage I childhood small noncleaved cell lymphoma|stage i childhood small noncleaved cell lymphoma
858315|NCT00066599|stage II childhood small noncleaved cell lymphoma|stage ii childhood small noncleaved cell lymphoma
858316|NCT00066599|stage III childhood small noncleaved cell lymphoma|stage iii childhood small noncleaved cell lymphoma
858317|NCT00066599|stage IV childhood small noncleaved cell lymphoma|stage iv childhood small noncleaved cell lymphoma
858318|NCT00066599|recurrent childhood large cell lymphoma|recurrent childhood large cell lymphoma
858319|NCT00066599|stage I childhood large cell lymphoma|stage i childhood large cell lymphoma
858320|NCT00066599|stage II childhood large cell lymphoma|stage ii childhood large cell lymphoma
858321|NCT00066599|stage III childhood large cell lymphoma|stage iii childhood large cell lymphoma
858322|NCT00066599|stage IV childhood large cell lymphoma|stage iv childhood large cell lymphoma
858323|NCT00066599|childhood acute myeloid leukemia in remission|childhood acute myeloid leukemia in remission
858324|NCT00066599|recurrent childhood acute myeloid leukemia|recurrent childhood acute myeloid leukemia
858325|NCT00066599|untreated childhood acute myeloid leukemia and other myeloid malignancies|untreated childhood acute myeloid leukemia and other myeloid malignancies
858326|NCT00066599|recurrent/refractory childhood Hodgkin lymphoma|recurrent/refractory childhood hodgkin lymphoma
858327|NCT00066599|stage I childhood Hodgkin lymphoma|stage i childhood hodgkin lymphoma
858328|NCT00066599|stage II childhood Hodgkin lymphoma|stage ii childhood hodgkin lymphoma
858329|NCT00066599|stage III childhood Hodgkin lymphoma|stage iii childhood hodgkin lymphoma
858330|NCT00066599|stage IV childhood Hodgkin lymphoma|stage iv childhood hodgkin lymphoma
858331|NCT00066599|childhood acute promyelocytic leukemia (M3)|childhood acute promyelocytic leukemia (m3)
858332|NCT00066599|previously treated childhood rhabdomyosarcoma|previously treated childhood rhabdomyosarcoma
858333|NCT00066599|recurrent Wilms tumor and other childhood kidney tumors|recurrent wilms tumor and other childhood kidney tumors
858334|NCT00066599|recurrent childhood rhabdomyosarcoma|recurrent childhood rhabdomyosarcoma
858335|NCT00066599|childhood chronic myelogenous leukemia|childhood chronic myelogenous leukemia
858336|NCT00066599|accelerated phase chronic myelogenous leukemia|accelerated phase chronic myelogenous leukemia
858337|NCT00066599|blastic phase chronic myelogenous leukemia|blastic phase chronic myelogenous leukemia
858338|NCT00066599|chronic phase chronic myelogenous leukemia|chronic phase chronic myelogenous leukemia
858339|NCT00066599|meningeal chronic myelogenous leukemia|meningeal chronic myelogenous leukemia
858340|NCT00066599|relapsing chronic myelogenous leukemia|relapsing chronic myelogenous leukemia
858341|NCT00066599|anaplastic large cell lymphoma|anaplastic large cell lymphoma
858342|NCT00066599|angioimmunoblastic T-cell lymphoma|angioimmunoblastic t-cell lymphoma
858343|NCT00066599|intraocular lymphoma|intraocular lymphoma
858344|NCT00066599|primary central nervous system non-Hodgkin lymphoma|primary central nervous system non-hodgkin lymphoma
858345|NCT00066599|recurrent adult T-cell leukemia/lymphoma|recurrent adult t-cell leukemia/lymphoma
858346|NCT00066599|acute undifferentiated leukemia|acute undifferentiated leukemia
858347|NCT00066599|childhood acute lymphoblastic leukemia in remission|childhood acute lymphoblastic leukemia in remission
858348|NCT00066599|recurrent childhood acute lymphoblastic leukemia|recurrent childhood acute lymphoblastic leukemia
858349|NCT00066599|secondary acute myeloid leukemia|secondary acute myeloid leukemia
858350|NCT00066599|untreated childhood acute lymphoblastic leukemia|untreated childhood acute lymphoblastic leukemia
858351|NCT00066599|disseminated neuroblastoma|disseminated neuroblastoma
858352|NCT00066599|de novo myelodysplastic syndromes|de novo myelodysplastic syndromes
858353|NCT00066599|previously treated myelodysplastic syndromes|previously treated myelodysplastic syndromes
858354|NCT00066599|secondary myelodysplastic syndromes|secondary myelodysplastic syndromes
858355|NCT00066599|stage I multiple myeloma|stage i multiple myeloma
858356|NCT00066599|stage II multiple myeloma|stage ii multiple myeloma
858357|NCT00066599|stage III multiple myeloma|stage iii multiple myeloma
858358|NCT00066599|refractory multiple myeloma|refractory multiple myeloma
858359|NCT00066599|stage I cutaneous T-cell non-Hodgkin lymphoma|stage i cutaneous t-cell non-hodgkin lymphoma
858360|NCT00066599|stage II cutaneous T-cell non-Hodgkin lymphoma|stage ii cutaneous t-cell non-hodgkin lymphoma
858361|NCT00066599|stage III cutaneous T-cell non-Hodgkin lymphoma|stage iii cutaneous t-cell non-hodgkin lymphoma
858362|NCT00066599|stage IV cutaneous T-cell non-Hodgkin lymphoma|stage iv cutaneous t-cell non-hodgkin lymphoma
858363|NCT00066599|recurrent neuroblastoma|recurrent neuroblastoma
858364|NCT00066599|atypical chronic myeloid leukemia, BCR-ABL1 negative|atypical chronic myeloid leukemia, bcr-abl1 negative
858365|NCT00066599|myelodysplastic/myeloproliferative neoplasm, unclassifiable|myelodysplastic/myeloproliferative neoplasm, unclassifiable
858366|NCT00066586|breast cancer|breast cancer
858367|NCT00066573|stage IIIA breast cancer|stage iiia breast cancer
858368|NCT00066573|stage I breast cancer|stage i breast cancer
858369|NCT00066573|stage II breast cancer|stage ii breast cancer
858370|NCT00066547|recurrent breast cancer|recurrent breast cancer
858371|NCT00066547|stage IIIA breast cancer|stage iiia breast cancer
858372|NCT00066547|stage IIIB breast cancer|stage iiib breast cancer
858373|NCT00066547|stage IIIC breast cancer|stage iiic breast cancer
858374|NCT00066547|stage IV breast cancer|stage iv breast cancer
858375|NCT00066508|recurrent adult diffuse large cell lymphoma|recurrent adult diffuse large cell lymphoma
858376|NCT00066482|childhood teratoma|childhood teratoma
858377|NCT00066482|childhood extragonadal germ cell tumor|childhood extragonadal germ cell tumor
858378|NCT00066469|post-transplant lymphoproliferative disorder|post-transplant lymphoproliferative disorder
858379|NCT00066443|stage IIIA breast cancer|stage iiia breast cancer
858380|NCT00066443|stage IIIB breast cancer|stage iiib breast cancer
858381|NCT00066443|stage IIIC breast cancer|stage iiic breast cancer
858382|NCT00066443|inflammatory breast cancer|inflammatory breast cancer
858383|NCT00066430|anal cancer|anal cancer
858384|NCT00066430|high-grade squamous intraepithelial lesion|high-grade squamous intraepithelial lesion
858385|NCT00066417|essential thrombocythemia|essential thrombocythemia
858386|NCT00066417|polycythemia vera|polycythemia vera
858387|NCT00066417|blastic phase chronic myelogenous leukemia|blastic phase chronic myelogenous leukemia
858388|NCT00066417|secondary myelodysplastic syndromes|secondary myelodysplastic syndromes
858389|NCT00066417|previously treated myelodysplastic syndromes|previously treated myelodysplastic syndromes
858390|NCT00066417|adult acute myeloid leukemia in remission|adult acute myeloid leukemia in remission
858391|NCT00066417|childhood acute myeloid leukemia in remission|childhood acute myeloid leukemia in remission
858392|NCT00066417|de novo myelodysplastic syndromes|de novo myelodysplastic syndromes
858393|NCT00066417|secondary acute myeloid leukemia|secondary acute myeloid leukemia
858394|NCT00066417|accelerated phase chronic myelogenous leukemia|accelerated phase chronic myelogenous leukemia
858395|NCT00066417|childhood chronic myelogenous leukemia|childhood chronic myelogenous leukemia
858396|NCT00066417|adult acute lymphoblastic leukemia in remission|adult acute lymphoblastic leukemia in remission
858397|NCT00066417|childhood acute lymphoblastic leukemia in remission|childhood acute lymphoblastic leukemia in remission
858398|NCT00066417|recurrent adult acute myeloid leukemia|recurrent adult acute myeloid leukemia
858399|NCT00066417|relapsing chronic myelogenous leukemia|relapsing chronic myelogenous leukemia
858400|NCT00066417|recurrent childhood acute myeloid leukemia|recurrent childhood acute myeloid leukemia
858401|NCT00066417|chronic idiopathic myelofibrosis|chronic idiopathic myelofibrosis
858402|NCT00066417|atypical chronic myeloid leukemia|atypical chronic myeloid leukemia
858403|NCT00066417|myelodysplastic/myeloproliferative disease, unclassifiable|myelodysplastic/myeloproliferative disease, unclassifiable
858404|NCT00066417|adult acute myeloid leukemia with t(8;21)(q22;q22)|adult acute myeloid leukemia with t(8;21)(q22;q22)
858405|NCT00066417|adult acute myeloid leukemia with t(16;16)(p13;q22)|adult acute myeloid leukemia with t(16;16)(p13;q22)
858406|NCT00066417|adult acute myeloid leukemia with inv(16)(p13;q22)|adult acute myeloid leukemia with inv(16)(p13;q22)
858407|NCT00066417|adult acute myeloid leukemia with 11q23 (MLL) abnormalities|adult acute myeloid leukemia with 11q23 (mll) abnormalities
858408|NCT00066417|adult acute myeloid leukemia with t(15;17)(q22;q12)|adult acute myeloid leukemia with t(15;17)(q22;q12)
858409|NCT00066404|advanced malignant mesothelioma|advanced malignant mesothelioma
858410|NCT00066404|male breast cancer|male breast cancer
858411|NCT00066404|localized malignant mesothelioma|localized malignant mesothelioma
858412|NCT00066404|recurrent bladder cancer|recurrent bladder cancer
858413|NCT00066404|recurrent renal cell cancer|recurrent renal cell cancer
858414|NCT00066404|recurrent urethral cancer|recurrent urethral cancer
858415|NCT00066404|recurrent breast cancer|recurrent breast cancer
858416|NCT00066404|recurrent penile cancer|recurrent penile cancer
858417|NCT00066404|recurrent prostate cancer|recurrent prostate cancer
858418|NCT00066404|recurrent anal cancer|recurrent anal cancer
858419|NCT00066404|recurrent colon cancer|recurrent colon cancer
858420|NCT00066404|recurrent esophageal cancer|recurrent esophageal cancer
858421|NCT00066404|recurrent gastric cancer|recurrent gastric cancer
858422|NCT00066404|recurrent pancreatic cancer|recurrent pancreatic cancer
858423|NCT00066404|recurrent rectal cancer|recurrent rectal cancer
858424|NCT00066404|recurrent gastrointestinal carcinoid tumor|recurrent gastrointestinal carcinoid tumor
858425|NCT00066404|recurrent small intestine cancer|recurrent small intestine cancer
858426|NCT00066404|recurrent gallbladder cancer|recurrent gallbladder cancer
858427|NCT00066404|recurrent extrahepatic bile duct cancer|recurrent extrahepatic bile duct cancer
858428|NCT00066404|recurrent adult primary liver cancer|recurrent adult primary liver cancer
858429|NCT00066404|recurrent non-small cell lung cancer|recurrent non-small cell lung cancer
858430|NCT00066404|recurrent small cell lung cancer|recurrent small cell lung cancer
858431|NCT00066404|recurrent thymoma and thymic carcinoma|recurrent thymoma and thymic carcinoma
858432|NCT00066404|recurrent melanoma|recurrent melanoma
858433|NCT00066404|recurrent malignant mesothelioma|recurrent malignant mesothelioma
858434|NCT00066404|recurrent malignant testicular germ cell tumor|recurrent malignant testicular germ cell tumor
858435|NCT00066404|recurrent cervical cancer|recurrent cervical cancer
858436|NCT00066404|recurrent ovarian epithelial cancer|recurrent ovarian epithelial cancer
858437|NCT00066404|fallopian tube cancer|fallopian tube cancer
858438|NCT00066404|recurrent vulvar cancer|recurrent vulvar cancer
858439|NCT00066404|recurrent vaginal cancer|recurrent vaginal cancer
858440|NCT00066404|recurrent gestational trophoblastic tumor|recurrent gestational trophoblastic tumor
858441|NCT00066404|recurrent endometrial carcinoma|recurrent endometrial carcinoma
858442|NCT00066404|recurrent ovarian germ cell tumor|recurrent ovarian germ cell tumor
858443|NCT00066404|malignant pleural effusion|malignant pleural effusion
858444|NCT00066391|penile squamous cell carcinoma|penile squamous cell carcinoma
858445|NCT00066391|stage III penile cancer|stage iii penile cancer
858446|NCT00066391|stage IV penile cancer|stage iv penile cancer
858447|NCT00066378|recurrent breast cancer|recurrent breast cancer
858448|NCT00066378|stage IIIA breast cancer|stage iiia breast cancer
858449|NCT00066378|stage IIIB breast cancer|stage iiib breast cancer
858450|NCT00066378|stage IIIC breast cancer|stage iiic breast cancer
858451|NCT00066378|stage IV breast cancer|stage iv breast cancer
858452|NCT00066365|metastatic osteosarcoma|metastatic osteosarcoma
858453|NCT00066365|recurrent osteosarcoma|recurrent osteosarcoma
858454|NCT00066365|lung metastases|lung metastases
858455|NCT00066352|recurrent bladder cancer|recurrent bladder cancer
858456|NCT00066352|stage IV bladder cancer|stage iv bladder cancer
858457|NCT00066352|metastatic transitional cell cancer of the renal pelvis and ureter|metastatic transitional cell cancer of the renal pelvis and ureter
858458|NCT00066352|recurrent transitional cell cancer of the renal pelvis and ureter|recurrent transitional cell cancer of the renal pelvis and ureter
858459|NCT00066352|regional transitional cell cancer of the renal pelvis and ureter|regional transitional cell cancer of the renal pelvis and ureter
858460|NCT00066352|transitional cell carcinoma of the bladder|transitional cell carcinoma of the bladder
858461|NCT00066339|stage IV breast cancer|stage iv breast cancer
858462|NCT00066339|recurrent breast cancer|recurrent breast cancer
858463|NCT00066326|blastic phase chronic myelogenous leukemia|blastic phase chronic myelogenous leukemia
858464|NCT00066326|Philadelphia chromosome positive chronic myelogenous leukemia|philadelphia chromosome positive chronic myelogenous leukemia
858465|NCT00066326|chronic phase chronic myelogenous leukemia|chronic phase chronic myelogenous leukemia
858466|NCT00066326|accelerated phase chronic myelogenous leukemia|accelerated phase chronic myelogenous leukemia
858467|NCT00066326|relapsing chronic myelogenous leukemia|relapsing chronic myelogenous leukemia
858468|NCT00066313|extensive stage small cell lung cancer|extensive stage small cell lung cancer
858469|NCT00066313|limited stage small cell lung cancer|limited stage small cell lung cancer
858470|NCT00066274|stage IV colon cancer|stage iv colon cancer
858471|NCT00066274|stage IV rectal cancer|stage iv rectal cancer
858472|NCT00066248|cachexia|cachexia
858473|NCT00066248|unspecified childhood solid tumor|unspecified childhood solid tumor
858474|NCT00066248|childhood spinal cord neoplasm|childhood spinal cord neoplasm
858475|NCT00066248|recurrent childhood medulloblastoma|recurrent childhood medulloblastoma
858476|NCT00066248|untreated childhood medulloblastoma|untreated childhood medulloblastoma
858477|NCT00066248|childhood high-grade cerebral astrocytoma|childhood high-grade cerebral astrocytoma
858478|NCT00066248|childhood low-grade cerebral astrocytoma|childhood low-grade cerebral astrocytoma
858479|NCT00066248|recurrent childhood cerebellar astrocytoma|recurrent childhood cerebellar astrocytoma
858480|NCT00066248|recurrent childhood cerebral astrocytoma|recurrent childhood cerebral astrocytoma
858481|NCT00066248|untreated childhood cerebellar astrocytoma|untreated childhood cerebellar astrocytoma
858482|NCT00066248|childhood oligodendroglioma|childhood oligodendroglioma
858483|NCT00066248|recurrent childhood brain stem glioma|recurrent childhood brain stem glioma
858484|NCT00066248|recurrent childhood visual pathway glioma|recurrent childhood visual pathway glioma
858485|NCT00066248|hypothalamic glioma|hypothalamic glioma
858486|NCT00066248|untreated childhood brain stem glioma|untreated childhood brain stem glioma
858487|NCT00066248|untreated childhood visual pathway|untreated childhood visual pathway
858552|NCT00020462|stage IV grade 2 follicular lymphoma|stage iv grade 2 follicular lymphoma
858488|NCT00066248|childhood supratentorial primitive neuroectodermal tumor|childhood supratentorial primitive neuroectodermal tumor
858489|NCT00066248|childhood craniopharyngioma|childhood craniopharyngioma
858490|NCT00066248|childhood infratentorial ependymoma|childhood infratentorial ependymoma
858491|NCT00066248|childhood supratentorial ependymoma|childhood supratentorial ependymoma
858492|NCT00066248|newly diagnosed childhood ependymoma|newly diagnosed childhood ependymoma
858493|NCT00066248|recurrent childhood ependymoma|recurrent childhood ependymoma
858494|NCT00066248|childhood choroid plexus tumor|childhood choroid plexus tumor
858495|NCT00066248|childhood central nervous system germ cell tumor|childhood central nervous system germ cell tumor
858496|NCT00066248|childhood acute lymphoblastic leukemia in remission|childhood acute lymphoblastic leukemia in remission
858497|NCT00066248|recurrent childhood acute lymphoblastic leukemia|recurrent childhood acute lymphoblastic leukemia
858498|NCT00066248|untreated childhood acute lymphoblastic leukemia|untreated childhood acute lymphoblastic leukemia
858499|NCT00066248|childhood acute myeloid leukemia in remission|childhood acute myeloid leukemia in remission
858500|NCT00066248|recurrent childhood acute myeloid leukemia|recurrent childhood acute myeloid leukemia
858501|NCT00066248|untreated childhood acute myeloid leukemia|untreated childhood acute myeloid leukemia
858502|NCT00066248|other myeloid malignancies|other myeloid malignancies
858503|NCT00066248|refractory chronic lymphocytic leukemia|refractory chronic lymphocytic leukemia
858504|NCT00066248|stage I chronic lymphocytic leukemia|stage i chronic lymphocytic leukemia
858505|NCT00066248|stage II chronic lymphocytic leukemia|stage ii chronic lymphocytic leukemia
858506|NCT00066248|stage III chronic lymphocytic leukemia|stage iii chronic lymphocytic leukemia
858507|NCT00066248|stage IV chronic lymphocytic leukemia|stage iv chronic lymphocytic leukemia
858508|NCT00066248|accelerated phase chronic myelogenous leukemia|accelerated phase chronic myelogenous leukemia
858509|NCT00066248|blastic phase chronic myelogenous leukemia|blastic phase chronic myelogenous leukemia
858510|NCT00066248|chronic phase chronic myelogenous leukemia|chronic phase chronic myelogenous leukemia
858511|NCT00066248|meningeal chronic myelogenous leukemia|meningeal chronic myelogenous leukemia
858512|NCT00066248|relapsing chronic myelogenous leukemia|relapsing chronic myelogenous leukemia
858513|NCT00066248|juvenile myelomonocytic leukemia|juvenile myelomonocytic leukemia
858514|NCT00066248|recurrent/refractory childhood Hodgkin lymphoma|recurrent/refractory childhood hodgkin lymphoma
858515|NCT00066248|stage I childhood Hodgkin lymphoma|stage i childhood hodgkin lymphoma
858516|NCT00066248|stage II childhood Hodgkin lymphoma|stage ii childhood hodgkin lymphoma
858517|NCT00066248|stage III childhood Hodgkin lymphoma|stage iii childhood hodgkin lymphoma
858518|NCT00066248|stage IV childhood Hodgkin lymphoma|stage iv childhood hodgkin lymphoma
858519|NCT00066248|AIDS-related peripheral/systemic lymphoma|aids-related peripheral/systemic lymphoma
858520|NCT00066248|AIDS-related primary CNS lymphoma|aids-related primary cns lymphoma
858521|NCT00066248|progressive hairy cell leukemia, initial treatment|progressive hairy cell leukemia, initial treatment
858522|NCT00066248|refractory hairy cell leukemia|refractory hairy cell leukemia
858523|NCT00066248|untreated hairy cell leukemia|untreated hairy cell leukemia
858524|NCT00066248|recurrent childhood lymphoblastic lymphoma|recurrent childhood lymphoblastic lymphoma
858525|NCT00066248|stage I childhood lymphoblastic lymphoma|stage i childhood lymphoblastic lymphoma
858526|NCT00066248|stage II childhood lymphoblastic lymphoma|stage ii childhood lymphoblastic lymphoma
858527|NCT00066248|stage III childhood lymphoblastic lymphoma|stage iii childhood lymphoblastic lymphoma
858528|NCT00066248|stage IV childhood lymphoblastic lymphoma|stage iv childhood lymphoblastic lymphoma
858529|NCT00066248|recurrent childhood small noncleaved cell lymphoma|recurrent childhood small noncleaved cell lymphoma
858530|NCT00066248|stage I childhood small noncleaved cell lymphoma|stage i childhood small noncleaved cell lymphoma
858531|NCT00066248|stage II childhood small noncleaved cell lymphoma|stage ii childhood small noncleaved cell lymphoma
858532|NCT00066248|stage III childhood small noncleaved cell lymphoma|stage iii childhood small noncleaved cell lymphoma
858533|NCT00066248|stage IV childhood small noncleaved cell lymphoma|stage iv childhood small noncleaved cell lymphoma
858534|NCT00066248|recurrent childhood large cell lymphoma|recurrent childhood large cell lymphoma
858535|NCT00066248|stage I childhood large cell lymphoma|stage i childhood large cell lymphoma
858536|NCT00066248|stage II childhood large cell lymphoma|stage ii childhood large cell lymphoma
858537|NCT00066248|stage III childhood large cell lymphoma|stage iii childhood large cell lymphoma
858538|NCT00066248|stage IV childhood large cell lymphoma|stage iv childhood large cell lymphoma
858539|NCT00066248|recurrent childhood brain tumor|recurrent childhood brain tumor
858540|NCT00066248|atypical chronic myeloid leukemia|atypical chronic myeloid leukemia
858541|NCT00066248|myelodysplastic/myeloproliferative disease|myelodysplastic/myeloproliferative disease
858542|NCT00066248|childhood chronic myelogenous leukemia|childhood chronic myelogenous leukemia
858543|NCT00066248|de novo myelodysplastic syndromes|de novo myelodysplastic syndromes
858544|NCT00066248|previously treated myelodysplastic syndromes|previously treated myelodysplastic syndromes
858545|NCT00066248|secondary myelodysplastic syndromes|secondary myelodysplastic syndromes
858546|NCT00066248|chronic myelomonocytic leukemia|chronic myelomonocytic leukemia
858547|NCT00066222|limited stage small cell lung cancer|limited stage small cell lung cancer
858548|NCT00020462|stage III grade 1 follicular lymphoma|stage iii grade 1 follicular lymphoma
858549|NCT00020462|stage III grade 2 follicular lymphoma|stage iii grade 2 follicular lymphoma
858550|NCT00020462|stage III grade 3 follicular lymphoma|stage iii grade 3 follicular lymphoma
858551|NCT00020462|stage IV grade 1 follicular lymphoma|stage iv grade 1 follicular lymphoma
858553|NCT00020462|stage IV grade 3 follicular lymphoma|stage iv grade 3 follicular lymphoma
858554|NCT00020462|recurrent grade 1 follicular lymphoma|recurrent grade 1 follicular lymphoma
858555|NCT00020462|recurrent grade 2 follicular lymphoma|recurrent grade 2 follicular lymphoma
858556|NCT00020462|recurrent grade 3 follicular lymphoma|recurrent grade 3 follicular lymphoma
858557|NCT00019721|stage IV melanoma|stage iv melanoma
858558|NCT00019721|recurrent melanoma|recurrent melanoma
858559|NCT00019383|recurrent melanoma|recurrent melanoma
858560|NCT00066209|Inflammation|inflammation
858561|NCT00066209|Coronavirus|coronavirus
858562|NCT00066209|Immunity|immunity
858563|NCT00066209|Interferon|interferon
858564|NCT00066209|Cytokine|cytokine
858565|NCT00066209|Severe Acute Respiratory Syndrome|severe acute respiratory syndrome
858567|NCT00066209|Healthy Volunteer|healthy volunteer
858571|NCT00066170|Daytime sleepiness in narcolepsy|daytime sleepiness in narcolepsy
858572|NCT00033722|recurrent non-small cell lung cancer|recurrent non-small cell lung cancer
858573|NCT00033722|squamous cell lung cancer|squamous cell lung cancer
858574|NCT00033722|large cell lung cancer|large cell lung cancer
858575|NCT00033722|stage IIIB non-small cell lung cancer|stage iiib non-small cell lung cancer
858576|NCT00033722|stage IV non-small cell lung cancer|stage iv non-small cell lung cancer
858577|NCT00033722|adenocarcinoma of the lung|adenocarcinoma of the lung
858578|NCT00033722|adenosquamous cell lung cancer|adenosquamous cell lung cancer
858579|NCT00033306|stage IV colon cancer|stage iv colon cancer
858580|NCT00033306|stage IV rectal cancer|stage iv rectal cancer
858581|NCT00033306|recurrent colon cancer|recurrent colon cancer
858582|NCT00033306|recurrent rectal cancer|recurrent rectal cancer
858583|NCT00033306|adenocarcinoma of the colon|adenocarcinoma of the colon
858584|NCT00033306|adenocarcinoma of the rectum|adenocarcinoma of the rectum
858585|NCT00031811|stage I breast cancer|stage i breast cancer
858586|NCT00031811|stage II breast cancer|stage ii breast cancer
858587|NCT00031811|stage IIIA breast cancer|stage iiia breast cancer
858588|NCT00031811|stage IIIB breast cancer|stage iiib breast cancer
858589|NCT00031811|osteoporosis|osteoporosis
858590|NCT00031811|menopausal symptoms|menopausal symptoms
858591|NCT00031785|stage I non-small cell lung cancer|stage i non-small cell lung cancer
858592|NCT00031785|stage II non-small cell lung cancer|stage ii non-small cell lung cancer
858593|NCT00031785|limited stage small cell lung cancer|limited stage small cell lung cancer
858594|NCT00031785|stage IIIA non-small cell lung cancer|stage iiia non-small cell lung cancer
858595|NCT00031785|stage IIIB non-small cell lung cancer|stage iiib non-small cell lung cancer
858596|NCT00031785|anorexia|anorexia
858597|NCT00031785|cachexia|cachexia
858598|NCT00066183|Fibroblast Growth Factor 23|fibroblast growth factor 23
858599|NCT00066183|FGF-23|fgf-23
858600|NCT00066183|Hypophosphatemia|hypophosphatemia
858601|NCT00066183|Phosphaturia|phosphaturia
858602|NCT00066183|Phosphorus|phosphorus
858603|NCT00066183|Phosphorus Metabolism|phosphorus metabolism
858604|NCT00066157|Alzheimer disease|alzheimer disease
858605|NCT00066157|Hormone replacement therapy|hormone replacement therapy
858606|NCT00066157|Postmenopausal women|postmenopausal women
858607|NCT00066144|menopause|menopause
858608|NCT00066144|hot flashes|hot flashes
858609|NCT00066144|red clover|red clover
858610|NCT00066144|black cohosh|black cohosh
858611|NCT00066144|sexual dysfunction|sexual dysfunction
858612|NCT00066118|neurologic|neurologic
858613|NCT00066118|nerve conduction|nerve conduction
858614|NCT00066118|neurobehavioral|neurobehavioral
858615|NCT00066118|renal disease|renal disease
858616|NCT00066092|PBPC transplant|pbpc transplant
858617|NCT00066092|Hodgkin's Disease|hodgkin's disease
858618|NCT00066092|Non-Hodgkin's Lymphoma|non-hodgkin's lymphoma
858619|NCT00066092|NHL|nhl
858620|NCT00066092|mobilization|mobilization
858621|NCT00066079|Sickle Cell Pain|sickle cell pain
858622|NCT00066079|Sickle Cell Disease|sickle cell disease
858623|NCT00066079|Chronic Pain|chronic pain
858624|NCT00066079|Alternative Medicine/Therapy|alternative medicine/therapy
858625|NCT00066079|Complementary Medicine|complementary medicine
858626|NCT00066079|Massage Therapy|massage therapy
858627|NCT00066079|Relaxation Technique|relaxation technique
858628|NCT00066079|Home-based Therapy|home-based therapy
858629|NCT00066053|Heart attacks|heart attacks
858630|NCT00066053|Stroke|stroke
858631|NCT00066053|Angina|angina
858632|NCT00066040|mutans streptococci infections|mutans streptococci infections
858633|NCT00066027|periodontitis, metabolic bone diseases, doxycycline|periodontitis, metabolic bone diseases, doxycycline
858634|NCT00066014|Dental Implantation-Osseointegrated|dental implantation-osseointegrated
858635|NCT00066014|Dentures|dentures
858636|NCT00066014|Dental Prostheses|dental prostheses
858637|NCT00066014|Denture, Implant-Supported|denture, implant-supported
858638|NCT00065975|chronic low back pain|chronic low back pain
858639|NCT00065975|acupuncture|acupuncture
858640|NCT00065975|chiropractic|chiropractic
858641|NCT00065975|massage therapy|massage therapy
858642|NCT00065975|CAM therapies|cam therapies
858643|NCT00065962|Pervasive Developmental Disorders|pervasive developmental disorders
858644|NCT00065962|Secretin, synthetic porcine|secretin, synthetic porcine
858645|NCT00065962|Secretin, biological porcine|secretin, biological porcine
858646|NCT00065962|Autism Diagnostic Observation Schedule - Generic (ADOS-G)|autism diagnostic observation schedule - generic (ados-g)
858648|NCT00065962|Expressive Vocabulary Test|expressive vocabulary test
858649|NCT00065962|MacArthur Communication Inventory|macarthur communication inventory
858650|NCT00065962|Aberrant Behavior Checklist|aberrant behavior checklist
858651|NCT00065949|Low birthweight infants|low birthweight infants
858652|NCT00065949|Magnesium supplementation|magnesium supplementation
858653|NCT00065949|Intracranial hemorrhage|intracranial hemorrhage
858654|NCT00065949|Cystic periventricular leukomalacia|cystic periventricular leukomalacia
858655|NCT00065949|Mental retardation|mental retardation
858656|NCT00065936|Intractable self-injurious behavior|intractable self-injurious behavior
858657|NCT00065936|Naltrexone|naltrexone
858658|NCT00065936|Transcutaneous electrical nerve stimulation|transcutaneous electrical nerve stimulation
858659|NCT00065936|Substance P|substance p
858662|NCT00065923|Prader-Willi Syndrome|prader-willi syndrome
858663|NCT00065923|Self-Injurious Behavior|self-injurious behavior
858664|NCT00065910|Joint attention|joint attention
858665|NCT00065910|Developmental delay|developmental delay
858666|NCT00065910|Caregiver interaction|caregiver interaction
858667|NCT00065897|Amniocentesis|amniocentesis
858668|NCT00065897|Transabdominal chorionic villus sampling|transabdominal chorionic villus sampling
858669|NCT00065897|Fluorescence in situ hybridization|fluorescence in situ hybridization
858670|NCT00065897|Alpha fetoprotein|alpha fetoprotein
858671|NCT00065897|Acetylcholinesterase|acetylcholinesterase
858672|NCT00065897|Prenatal testing|prenatal testing
858673|NCT00065897|Prenatal diagnosis|prenatal diagnosis
858674|NCT00065884|Adolescents|adolescents
858675|NCT00065871|Pharmacist prescribers|pharmacist prescribers
858676|NCT00065871|Increased access|increased access
858677|NCT00065871|Hormonal contraception|hormonal contraception
858678|NCT00065871|Birth control pills|birth control pills
858679|NCT00065871|Birth control patch|birth control patch
858680|NCT00065871|Vaginal contraceptive ring|vaginal contraceptive ring
858681|NCT00065858|Contraception|contraception
858682|NCT00065858|Nonoxynol 9|nonoxynol 9
858683|NCT00065858|Microbicide|microbicide
858684|NCT00065858|Spermicide|spermicide
858685|NCT00065845|Urinary incontinence|urinary incontinence
858686|NCT00065845|Pelvic organ prolapse|pelvic organ prolapse
858687|NCT00065845|Stress incontinence|stress incontinence
858688|NCT00065845|Sacrocolpopexy|sacrocolpopexy
858689|NCT00065845|Burch urethropexy|burch urethropexy
858690|NCT00065845|Surgical Trials|surgical trials
858691|NCT00031707|anorexia|anorexia
858692|NCT00031707|cachexia|cachexia
858693|NCT00026273|stage III colon cancer|stage iii colon cancer
858694|NCT00026273|stage III rectal cancer|stage iii rectal cancer
858695|NCT00026273|adenocarcinoma of the colon|adenocarcinoma of the colon
858696|NCT00026273|adenocarcinoma of the rectum|adenocarcinoma of the rectum
858697|NCT00025688|stage IV breast cancer|stage iv breast cancer
858698|NCT00025688|recurrent breast cancer|recurrent breast cancer
858699|NCT00024024|AIDS-related Kaposi sarcoma|aids-related kaposi sarcoma
858700|NCT00024024|recurrent Kaposi sarcoma|recurrent kaposi sarcoma
858701|NCT00022477|stage IV colon cancer|stage iv colon cancer
858702|NCT00022477|stage IV rectal cancer|stage iv rectal cancer
858703|NCT00022477|recurrent colon cancer|recurrent colon cancer
858704|NCT00022477|recurrent rectal cancer|recurrent rectal cancer
858705|NCT00022477|adenocarcinoma of the colon|adenocarcinoma of the colon
858706|NCT00022477|adenocarcinoma of the rectum|adenocarcinoma of the rectum
858707|NCT00065832|Reading disabilities|reading disabilities
858708|NCT00065832|Inner-city|inner-city
858709|NCT00065832|Urban|urban
858710|NCT00065819|HIV|hiv
858711|NCT00065819|African American|african american
858712|NCT00065819|Symptom Management|symptom management
858713|NCT00065806|Pediatric lupus|pediatric lupus
858714|NCT00065806|Atherosclerosis|atherosclerosis
858715|NCT00065806|SLE|sle
858716|NCT00065806|HMG CoA reductase inhibitor|hmg coa reductase inhibitor
858717|NCT00065767|Alzheimer disease|alzheimer disease
858718|NCT00065767|Postmenopausal women|postmenopausal women
858719|NCT00065767|Hormone therapy|hormone therapy
858720|NCT00065754|Placebo|placebo
858721|NCT00065754|Analgesia|analgesia
858722|NCT00065754|Pain|pain
858723|NCT00065754|Brain mechanism|brain mechanism
858724|NCT00065754|Expectation|expectation
858725|NCT00065741|Milk thistle|milk thistle
858726|NCT00065741|silymarin|silymarin
858727|NCT00065741|piperine|piperine
858728|NCT00065741|glucarate|glucarate
858729|NCT00065741|zidovudine|zidovudine
858730|NCT00065741|abacavir|abacavir
858731|NCT00065741|mycophenolate mofetil|mycophenolate mofetil
858732|NCT00065741|HIV|hiv
858733|NCT00065741|pharmacokinetics|pharmacokinetics
858734|NCT00065741|interaction|interaction
858735|NCT00065741|glucuronidation|glucuronidation
858736|NCT00065741|Healthy|healthy
858737|NCT00065741|Complementary Therapies|complementary therapies
858738|NCT00065728|AMD|amd
858739|NCT00065728|age-related macular degeneration|age-related macular degeneration
858740|NCT00065728|Anecortave|anecortave
858741|NCT00065728|Acetate|acetate
858742|NCT00065728|Wet form of age-related macular degeneration|wet form of age-related macular degeneration
858744|NCT00065728|Anecortave Acetate|anecortave acetate
858745|NCT00065715|head cold|head cold
858746|NCT00065715|common cold|common cold
858747|NCT00065715|echinacea|echinacea
858748|NCT00065715|placebo|placebo
858749|NCT00065702|fibromyalgia|fibromyalgia
858750|NCT00065702|homeopathy|homeopathy
858751|NCT00065702|EEG|eeg
858752|NCT00065702|EKG|ekg
858753|NCT00065702|chronic pain|chronic pain
858754|NCT00065689|Alzheimer's disease|alzheimer's disease
858755|NCT00065689|light therapy|light therapy
858756|NCT00065689|long-term care|long-term care
858757|NCT00065689|depression|depression
858758|NCT00065689|sleep|sleep
858759|NCT00065689|agitation|agitation
858760|NCT00065676|Hyperglycemia|hyperglycemia
858761|NCT00065676|Hyperinsulinemia|hyperinsulinemia
858762|NCT00065676|OGTT|ogtt
858763|NCT00065676|GLUT2|glut2
858764|NCT00065676|Post-Prandial|post-prandial
858765|NCT00065676|Type 2 Diabetes|type 2 diabetes
858766|NCT00065676|Obesity|obesity
858767|NCT00065663|gene transfer|gene transfer
858768|NCT00065663|adenovirus|adenovirus
858769|NCT00065663|platelet-derived growth factor-B|platelet-derived growth factor-b
858770|NCT00065663|collagen|collagen
858771|NCT00065663|diabetic ulcer|diabetic ulcer
858772|NCT00065663|foot|foot
858773|NCT00065663|wounds|wounds
858776|NCT00065650|Diabetes Mellitus Type 2|diabetes mellitus type 2
858777|NCT00065650|Vedic medicine|vedic medicine
858778|NCT00065650|Ayurveda|ayurveda
858779|NCT00065650|Transcendental Meditation|transcendental meditation
858780|NCT00065624|Lipoic acid|lipoic acid
858781|NCT00065624|F2-isoprostanes|f2-isoprostanes
858782|NCT00065624|endothelial dysfunction|endothelial dysfunction
858783|NCT00065624|natural product|natural product
858784|NCT00065585|low back pain|low back pain
858785|NCT00065585|acupuncture|acupuncture
858786|NCT00065572|Kidney Cancer|kidney cancer
858787|NCT00065572|Metastatic|metastatic
858788|NCT00065572|Newly diagnosed renal cell carcinoma|newly diagnosed renal cell carcinoma
858789|NCT00014560|refractory chronic lymphocytic leukemia|refractory chronic lymphocytic leukemia
858790|NCT00014560|recurrent grade 1 follicular lymphoma|recurrent grade 1 follicular lymphoma
858791|NCT00014560|recurrent grade 2 follicular lymphoma|recurrent grade 2 follicular lymphoma
858792|NCT00014560|recurrent grade 3 follicular lymphoma|recurrent grade 3 follicular lymphoma
858793|NCT00014560|recurrent adult diffuse small cleaved cell lymphoma|recurrent adult diffuse small cleaved cell lymphoma
858794|NCT00014560|recurrent adult diffuse mixed cell lymphoma|recurrent adult diffuse mixed cell lymphoma
858795|NCT00014560|recurrent adult diffuse large cell lymphoma|recurrent adult diffuse large cell lymphoma
858796|NCT00014560|recurrent adult immunoblastic large cell lymphoma|recurrent adult immunoblastic large cell lymphoma
858797|NCT00014560|recurrent adult lymphoblastic lymphoma|recurrent adult lymphoblastic lymphoma
858798|NCT00014560|recurrent adult Burkitt lymphoma|recurrent adult burkitt lymphoma
858799|NCT00014560|recurrent mantle cell lymphoma|recurrent mantle cell lymphoma
858800|NCT00014560|recurrent small lymphocytic lymphoma|recurrent small lymphocytic lymphoma
858801|NCT00014261|unspecified adult solid tumor, protocol specific|unspecified adult solid tumor, protocol specific
858802|NCT00014248|unspecified adult solid tumor, protocol specific|unspecified adult solid tumor, protocol specific
858803|NCT00014248|cachexia|cachexia
858804|NCT00014209|recurrent adult Hodgkin lymphoma|recurrent adult hodgkin lymphoma
858805|NCT00014209|recurrent adult diffuse mixed cell lymphoma|recurrent adult diffuse mixed cell lymphoma
858806|NCT00014209|recurrent adult diffuse large cell lymphoma|recurrent adult diffuse large cell lymphoma
858807|NCT00014209|recurrent adult immunoblastic large cell lymphoma|recurrent adult immunoblastic large cell lymphoma
858808|NCT00014209|anaplastic large cell lymphoma|anaplastic large cell lymphoma
858809|NCT00010127|adenocarcinoma of the prostate|adenocarcinoma of the prostate
858810|NCT00010127|stage IV prostate cancer|stage iv prostate cancer
858811|NCT00065611|Steroids|steroids
858812|NCT00065611|Osteoporosis|osteoporosis
858813|NCT00065611|Proteinuria|proteinuria
858814|NCT00065611|Minimal Change Disease|minimal change disease
858815|NCT00065611|Focal Segmental Glomerulosclerosis|focal segmental glomerulosclerosis
858816|NCT00065611|FSGS|fsgs
858817|NCT00065611|MCD|mcd
858818|NCT00065611|Kidney Disease|kidney disease
858819|NCT00065507|hepatic decompensation|hepatic decompensation
858820|NCT00006799|untreated metastatic squamous neck cancer with occult primary|untreated metastatic squamous neck cancer with occult primary
858821|NCT00006799|metastatic squamous neck cancer with occult primary squamous cell carcinoma|metastatic squamous neck cancer with occult primary squamous cell carcinoma
858822|NCT00006799|stage I squamous cell carcinoma of the lip and oral cavity|stage i squamous cell carcinoma of the lip and oral cavity
858823|NCT00006799|stage I basal cell carcinoma of the lip|stage i basal cell carcinoma of the lip
858824|NCT00006799|stage I verrucous carcinoma of the oral cavity|stage i verrucous carcinoma of the oral cavity
858825|NCT00006799|stage I mucoepidermoid carcinoma of the oral cavity|stage i mucoepidermoid carcinoma of the oral cavity
858826|NCT00006799|stage I adenoid cystic carcinoma of the oral cavity|stage i adenoid cystic carcinoma of the oral cavity
858827|NCT00006799|stage II squamous cell carcinoma of the lip and oral cavity|stage ii squamous cell carcinoma of the lip and oral cavity
858828|NCT00006799|stage II basal cell carcinoma of the lip|stage ii basal cell carcinoma of the lip
858829|NCT00006799|stage II verrucous carcinoma of the oral cavity|stage ii verrucous carcinoma of the oral cavity
858830|NCT00006799|stage II mucoepidermoid carcinoma of the oral cavity|stage ii mucoepidermoid carcinoma of the oral cavity
858831|NCT00006799|stage II adenoid cystic carcinoma of the oral cavity|stage ii adenoid cystic carcinoma of the oral cavity
858832|NCT00006799|stage III squamous cell carcinoma of the lip and oral cavity|stage iii squamous cell carcinoma of the lip and oral cavity
858833|NCT00006799|stage III basal cell carcinoma of the lip|stage iii basal cell carcinoma of the lip
858834|NCT00006799|stage III verrucous carcinoma of the oral cavity|stage iii verrucous carcinoma of the oral cavity
858835|NCT00006799|stage III mucoepidermoid carcinoma of the oral cavity|stage iii mucoepidermoid carcinoma of the oral cavity
858836|NCT00006799|stage III adenoid cystic carcinoma of the oral cavity|stage iii adenoid cystic carcinoma of the oral cavity
858837|NCT00006799|stage IV squamous cell carcinoma of the lip and oral cavity|stage iv squamous cell carcinoma of the lip and oral cavity
858838|NCT00006799|stage IV basal cell carcinoma of the lip|stage iv basal cell carcinoma of the lip
858990|NCT00065286|Neuroleptic medication|neuroleptic medication
858839|NCT00006799|stage IV verrucous carcinoma of the oral cavity|stage iv verrucous carcinoma of the oral cavity
858840|NCT00006799|stage IV mucoepidermoid carcinoma of the oral cavity|stage iv mucoepidermoid carcinoma of the oral cavity
858841|NCT00006799|stage IV adenoid cystic carcinoma of the oral cavity|stage iv adenoid cystic carcinoma of the oral cavity
858842|NCT00006799|stage I squamous cell carcinoma of the oropharynx|stage i squamous cell carcinoma of the oropharynx
858843|NCT00006799|stage I lymphoepithelioma of the oropharynx|stage i lymphoepithelioma of the oropharynx
858844|NCT00006799|stage II squamous cell carcinoma of the oropharynx|stage ii squamous cell carcinoma of the oropharynx
858845|NCT00006799|stage II lymphoepithelioma of the oropharynx|stage ii lymphoepithelioma of the oropharynx
858846|NCT00006799|stage III squamous cell carcinoma of the oropharynx|stage iii squamous cell carcinoma of the oropharynx
858847|NCT00006799|stage III lymphoepithelioma of the oropharynx|stage iii lymphoepithelioma of the oropharynx
858848|NCT00006799|stage IV squamous cell carcinoma of the oropharynx|stage iv squamous cell carcinoma of the oropharynx
858849|NCT00006799|stage IV lymphoepithelioma of the oropharynx|stage iv lymphoepithelioma of the oropharynx
858850|NCT00006799|stage I squamous cell carcinoma of the nasopharynx|stage i squamous cell carcinoma of the nasopharynx
858851|NCT00006799|stage I lymphoepithelioma of the nasopharynx|stage i lymphoepithelioma of the nasopharynx
858852|NCT00006799|stage II squamous cell carcinoma of the nasopharynx|stage ii squamous cell carcinoma of the nasopharynx
858853|NCT00006799|stage II lymphoepithelioma of the nasopharynx|stage ii lymphoepithelioma of the nasopharynx
858854|NCT00006799|stage III squamous cell carcinoma of the nasopharynx|stage iii squamous cell carcinoma of the nasopharynx
858855|NCT00006799|stage III lymphoepithelioma of the nasopharynx|stage iii lymphoepithelioma of the nasopharynx
858856|NCT00006799|stage IV squamous cell carcinoma of the nasopharynx|stage iv squamous cell carcinoma of the nasopharynx
858857|NCT00006799|stage IV lymphoepithelioma of the nasopharynx|stage iv lymphoepithelioma of the nasopharynx
858858|NCT00006799|stage I squamous cell carcinoma of the hypopharynx|stage i squamous cell carcinoma of the hypopharynx
858859|NCT00006799|stage II squamous cell carcinoma of the hypopharynx|stage ii squamous cell carcinoma of the hypopharynx
858860|NCT00006799|stage III squamous cell carcinoma of the hypopharynx|stage iii squamous cell carcinoma of the hypopharynx
858861|NCT00006799|stage IV squamous cell carcinoma of the hypopharynx|stage iv squamous cell carcinoma of the hypopharynx
858862|NCT00006799|stage I squamous cell carcinoma of the larynx|stage i squamous cell carcinoma of the larynx
858863|NCT00006799|stage I verrucous carcinoma of the larynx|stage i verrucous carcinoma of the larynx
858864|NCT00006799|stage II squamous cell carcinoma of the larynx|stage ii squamous cell carcinoma of the larynx
858865|NCT00006799|stage II verrucous carcinoma of the larynx|stage ii verrucous carcinoma of the larynx
858866|NCT00006799|stage III squamous cell carcinoma of the larynx|stage iii squamous cell carcinoma of the larynx
858867|NCT00006799|stage III verrucous carcinoma of the larynx|stage iii verrucous carcinoma of the larynx
858868|NCT00006799|stage IV squamous cell carcinoma of the larynx|stage iv squamous cell carcinoma of the larynx
858979|NCT00065312|Type 2 diabetes|type 2 diabetes
858869|NCT00006799|stage IV verrucous carcinoma of the larynx|stage iv verrucous carcinoma of the larynx
858870|NCT00006799|stage I squamous cell carcinoma of the paranasal sinus and nasal cavity|stage i squamous cell carcinoma of the paranasal sinus and nasal cavity
858871|NCT00006799|stage I inverted papilloma of the paranasal sinus and nasal cavity|stage i inverted papilloma of the paranasal sinus and nasal cavity
858872|NCT00006799|stage I midline lethal granuloma of the paranasal sinus and nasal cavity|stage i midline lethal granuloma of the paranasal sinus and nasal cavity
858873|NCT00006799|stage I esthesioneuroblastoma of the paranasal sinus and nasal cavity|stage i esthesioneuroblastoma of the paranasal sinus and nasal cavity
858874|NCT00006799|stage II squamous cell carcinoma of the paranasal sinus and nasal cavity|stage ii squamous cell carcinoma of the paranasal sinus and nasal cavity
858875|NCT00006799|stage II inverted papilloma of the paranasal sinus and nasal cavity|stage ii inverted papilloma of the paranasal sinus and nasal cavity
858876|NCT00006799|stage II midline lethal granuloma of the paranasal sinus and nasal cavity|stage ii midline lethal granuloma of the paranasal sinus and nasal cavity
858877|NCT00006799|stage II esthesioneuroblastoma of the paranasal sinus and nasal cavity|stage ii esthesioneuroblastoma of the paranasal sinus and nasal cavity
858878|NCT00006799|stage III squamous cell carcinoma of the paranasal sinus and nasal cavity|stage iii squamous cell carcinoma of the paranasal sinus and nasal cavity
858879|NCT00006799|stage III inverted papilloma of the paranasal sinus and nasal cavity|stage iii inverted papilloma of the paranasal sinus and nasal cavity
858969|NCT00065390|Splenomegaly|splenomegaly
858880|NCT00006799|stage III midline lethal granuloma of the paranasal sinus and nasal cavity|stage iii midline lethal granuloma of the paranasal sinus and nasal cavity
858881|NCT00006799|stage III esthesioneuroblastoma of the paranasal sinus and nasal cavity|stage iii esthesioneuroblastoma of the paranasal sinus and nasal cavity
858882|NCT00006799|stage IV squamous cell carcinoma of the paranasal sinus and nasal cavity|stage iv squamous cell carcinoma of the paranasal sinus and nasal cavity
858883|NCT00006799|stage IV inverted papilloma of the paranasal sinus and nasal cavity|stage iv inverted papilloma of the paranasal sinus and nasal cavity
858884|NCT00006799|stage IV midline lethal granuloma of the paranasal sinus and nasal cavity|stage iv midline lethal granuloma of the paranasal sinus and nasal cavity
858885|NCT00006799|stage IV esthesioneuroblastoma of the paranasal sinus and nasal cavity|stage iv esthesioneuroblastoma of the paranasal sinus and nasal cavity
858886|NCT00006799|anorexia|anorexia
858887|NCT00006799|cachexia|cachexia
858888|NCT00006799|quality of life|quality of life
858889|NCT00006453|recurrent ovarian epithelial cancer|recurrent ovarian epithelial cancer
858890|NCT00006352|limited stage small cell lung cancer|limited stage small cell lung cancer
882420|NCT00028080|Therapy|therapy
858891|NCT00006240|recurrent adult acute myeloid leukemia|recurrent adult acute myeloid leukemia
858892|NCT00065468|Advanced Renal Cell Carcinoma|advanced renal cell carcinoma
858893|NCT00065468|Kidney Cancer|kidney cancer
858894|NCT00006229|stage IIIB non-small cell lung cancer|stage iiib non-small cell lung cancer
858895|NCT00006229|stage IV non-small cell lung cancer|stage iv non-small cell lung cancer
858896|NCT00006081|stage III gastric cancer|stage iii gastric cancer
858897|NCT00006081|stage IV gastric cancer|stage iv gastric cancer
858898|NCT00006081|stage III esophageal cancer|stage iii esophageal cancer
858899|NCT00006081|stage IV esophageal cancer|stage iv esophageal cancer
858900|NCT00006081|adenocarcinoma of the stomach|adenocarcinoma of the stomach
858901|NCT00006081|adenocarcinoma of the esophagus|adenocarcinoma of the esophagus
858902|NCT00065455|Retinitis Pigmentosa|retinitis pigmentosa
858903|NCT00065455|Vitamin A|vitamin a
858904|NCT00065455|ERG|erg
858905|NCT00065455|RP|rp
858906|NCT00065442|prostate cancer|prostate cancer
858907|NCT00065442|prostate|prostate
858908|NCT00065442|AIPC|aipc
858909|NCT00065442|androgen-independent|androgen-independent
858910|NCT00065442|androgen independent|androgen independent
858911|NCT00065442|hormone insensitive|hormone insensitive
858912|NCT00065442|hormone-insensitive|hormone-insensitive
858913|NCT00065442|PSA|psa
858914|NCT00065442|prostatic adenocarcinoma|prostatic adenocarcinoma
858915|NCT00065442|hormone-refractory|hormone-refractory
858916|NCT00065442|hormone refractory|hormone refractory
858917|NCT00065442|HRPC|hrpc
858918|NCT00065442|LHRH|lhrh
858919|NCT00065442|immune therapy|immune therapy
858920|NCT00065442|immunotherapy|immunotherapy
858921|NCT00065442|vaccine|vaccine
858922|NCT00065442|dendritic cells|dendritic cells
858923|NCT00065442|antigen-presenting cells|antigen-presenting cells
858924|NCT00065442|antigen presenting cells|antigen presenting cells
858925|NCT00065442|cancer vaccine|cancer vaccine
858926|NCT00065442|therapeutic vaccine|therapeutic vaccine
858927|NCT00065442|therapeutic cancer vaccine|therapeutic cancer vaccine
858928|NCT00065442|recombinant|recombinant
858929|NCT00065442|biological|biological
858930|NCT00065442|biopharmaceutical|biopharmaceutical
858931|NCT00065442|biotechnology|biotechnology
858932|NCT00065442|biotech|biotech
858933|NCT00004887|stage IIIA non-small cell lung cancer|stage iiia non-small cell lung cancer
858934|NCT00004887|stage IIIB non-small cell lung cancer|stage iiib non-small cell lung cancer
858935|NCT00004887|stage IV non-small cell lung cancer|stage iv non-small cell lung cancer
858936|NCT00065416|neck pain|neck pain
858937|NCT00065416|cervicalgia|cervicalgia
858938|NCT00065416|massage|massage
858939|NCT00065403|Irritable Bowel Syndrome|irritable bowel syndrome
858940|NCT00065403|Acupuncture|acupuncture
858941|NCT00065364|Preterm infant|preterm infant
858942|NCT00065364|Premature infant|premature infant
858943|NCT00065364|Developmental care|developmental care
858944|NCT00065364|MRI|mri
858945|NCT00065364|qEEG|qeeg
858946|NCT00065364|Neurodevelopment|neurodevelopment
858947|NCT00065364|Behavior|behavior
858948|NCT00065364|Infants|infants
858949|NCT00065364|NICU|nicu
858950|NCT00065351|Multiple Myeloma|multiple myeloma
858951|NCT00065351|CC-5013|cc-5013
858952|NCT00065351|Revlimid|revlimid
858953|NCT00065351|MM|mm
858954|NCT00065351|CC5013|cc5013
858955|NCT00065351|relapsed and refractory multiple myeloma|relapsed and refractory multiple myeloma
858956|NCT00065338|Physical activity|physical activity
858957|NCT00065325|Locally advanced breast cancer|locally advanced breast cancer
858958|NCT00065325|metastatic breast cancer|metastatic breast cancer
858959|NCT00065325|Breast Cancer|breast cancer
858960|NCT00065325|Cancer of Breast|cancer of breast
858961|NCT00065325|Cancer of the Breast|cancer of the breast
858962|NCT00004253|stage II non-small cell lung cancer|stage ii non-small cell lung cancer
858963|NCT00004253|stage IIIA non-small cell lung cancer|stage iiia non-small cell lung cancer
858964|NCT00004253|stage IIIB non-small cell lung cancer|stage iiib non-small cell lung cancer
858965|NCT00065390|ALPS|alps
858966|NCT00065390|Pyrimethamine|pyrimethamine
858967|NCT00065390|Folinic Acid|folinic acid
858968|NCT00065390|Lymphadenopathy|lymphadenopathy
858970|NCT00065390|Autoimmune Lymphoproliferative Syndrome|autoimmune lymphoproliferative syndrome
858971|NCT00065377|Diabetes|diabetes
858972|NCT00065377|Insulin Resistance|insulin resistance
858973|NCT00065377|Capillary Blood Flow|capillary blood flow
858974|NCT00065377|Osteoarthritis|osteoarthritis
858975|NCT00065377|Endothelial Dysfunction|endothelial dysfunction
858976|NCT00065377|Obesity|obesity
858977|NCT00065377|Healthy Volunteer|healthy volunteer
858978|NCT00065377|HV|hv
858980|NCT00065299|Hyperphenylalaninemia|hyperphenylalaninemia
858982|NCT00065299|Maternal PKU|maternal pku
858983|NCT00065299|Pregnancy outcome|pregnancy outcome
858984|NCT00065299|Phenylalanine restricted diet|phenylalanine restricted diet
858985|NCT00065299|Tyrosine supplementation|tyrosine supplementation
858986|NCT00065299|Maternal hyperphenylalanemia during pregnancy|maternal hyperphenylalanemia during pregnancy
858987|NCT00065286|Akathisia|akathisia
858988|NCT00065286|Mental retardation|mental retardation
858989|NCT00065286|Schizophrenia|schizophrenia
882421|NCT00028080|Lyme|lyme
858991|NCT00065286|Tardive dyskinesia|tardive dyskinesia
858992|NCT00065286|Brief Psychiatric Rating Scale|brief psychiatric rating scale
858993|NCT00065286|Barnes test|barnes test
858994|NCT00065286|Stereotypy Checklist Test|stereotypy checklist test
858995|NCT00065286|DISCUS Tardive Dyskinesia test|discus tardive dyskinesia test
858996|NCT00065273|Severe aberrant behavior|severe aberrant behavior
858997|NCT00065273|Risperidone|risperidone
858998|NCT00065273|Clozapine|clozapine
858999|NCT00065273|Haloperidol|haloperidol
859000|NCT00065273|Laboratory operant tasks|laboratory operant tasks
859001|NCT00065273|Simple acquisition procedures|simple acquisition procedures
859002|NCT00065273|Matching to sample task|matching to sample task
859003|NCT00065273|Lag sequential analysis|lag sequential analysis
859004|NCT00065247|Bone|bone
859005|NCT00065247|Children|children
859006|NCT00065247|After-school program|after-school program
859007|NCT00065247|Osteoporosis|osteoporosis
859008|NCT00065247|Calcium|calcium
859009|NCT00065247|Physical activity|physical activity
859010|NCT00065234|Colostomy|colostomy
859011|NCT00065234|Ileostomy|ileostomy
859012|NCT00065221|Ginger|ginger
859013|NCT00065221|Plant preparation|plant preparation
859014|NCT00065221|Herbal medicine|herbal medicine
859015|NCT00065221|Chemotherapy|chemotherapy
859016|NCT00065221|Nausea|nausea
859017|NCT00065208|Prostate cancer|prostate cancer
859018|NCT00065208|Reiki|reiki
859019|NCT00065208|Energy Healing|energy healing
859020|NCT00065260|Alemtuzumab (Campath-1H)|alemtuzumab (campath-1h)
859021|NCT00065260|Rabbit ATG|rabbit atg
859022|NCT00065260|Severe Aplastic Anemia|severe aplastic anemia
859023|NCT00065260|Cyclosporine|cyclosporine
859024|NCT00065260|Thrombocytopenia|thrombocytopenia
859025|NCT00065260|Leukopenia|leukopenia
859026|NCT00065260|Neutropenia|neutropenia
859027|NCT00065260|Autoimmunity|autoimmunity
859028|NCT00065260|Relapse|relapse
859029|NCT00065260|Anemia|anemia
859030|NCT00065195|Massage|massage
859031|NCT00065195|Palliative Care|palliative care
859032|NCT00065195|Hospices|hospices
859033|NCT00065195|Cancer|cancer
859034|NCT00065182|HYCAMTIN|hycamtin
859035|NCT00065182|TAXOTERE|taxotere
859036|NCT00065182|non-small cell lung cancer|non-small cell lung cancer
859037|NCT00065182|NSCLC|nsclc
859038|NCT00065182|docetaxel|docetaxel
859039|NCT00065182|topotecan|topotecan
859040|NCT00065182|Stage IIIB/IV|stage iiib/iv
859041|NCT00065182|Advanced|advanced
859042|NCT00065156|MDS|mds
859043|NCT00065156|CC-5013|cc-5013
859044|NCT00065156|Revlimid|revlimid
859045|NCT00065156|Celgene|celgene
859046|NCT00065143|Newly diagnosed and previously untreated acute myeloid leukemia (AML)|newly diagnosed and previously untreated acute myeloid leukemia (aml)
859047|NCT00065143|High-risk myelodysplastic syndrome (MDS) (>/= 10% bone marrow blasts)|high-risk myelodysplastic syndrome (mds) (>/= 10% bone marrow blasts)
859048|NCT00065143|Acute Myeloid Leukemia (AML)|acute myeloid leukemia (aml)
859049|NCT00065143|Myelodysplastic Syndrome (MDS)|myelodysplastic syndrome (mds)
859050|NCT00065117|metastatic|metastatic
859051|NCT00065117|colorectal|colorectal
859052|NCT00065117|first-line|first-line
859053|NCT00065117|adjuvant|adjuvant
859054|NCT00065117|cancer|cancer
859055|NCT00065117|Colorectal Cancer|colorectal cancer
859056|NCT00065117|Colorectal Carcinoma|colorectal carcinoma
859057|NCT00065117|Colorectal Tumors|colorectal tumors
859058|NCT00065117|Neoplasms, Colorectal|neoplasms, colorectal
859059|NCT00065104|HIV|hiv
859060|NCT00065104|DHEA|dhea
859061|NCT00065104|immune system|immune system
859062|NCT00065104|hormones|hormones
859063|NCT00065104|body composition|body composition
859064|NCT00065104|quality of life|quality of life
859065|NCT00065078|Home-visits|home-visits
859066|NCT00065078|Community nurse|community nurse
859067|NCT00065078|Unintended pregnancy|unintended pregnancy
859068|NCT00065065|Rosiglitazone|rosiglitazone
859069|NCT00065065|Ulcerative|ulcerative
859070|NCT00065065|Colitis|colitis
859071|NCT00065052|physical activity|physical activity
859072|NCT00065052|television|television
859073|NCT00065052|child obesity|child obesity
859075|NCT00065052|Usual control|usual control
859076|NCT00065013|obesity|obesity
859077|NCT00065013|gastric bypass|gastric bypass
859078|NCT00065013|obesity surgery|obesity surgery
859079|NCT00065013|bariatric surgery|bariatric surgery
859080|NCT00065013|exercise|exercise
859081|NCT00004204|recurrent adult brain tumor|recurrent adult brain tumor
859082|NCT00004204|adult anaplastic astrocytoma|adult anaplastic astrocytoma
859083|NCT00004204|adult anaplastic oligodendroglioma|adult anaplastic oligodendroglioma
859084|NCT00004006|intraocular retinoblastoma|intraocular retinoblastoma
859085|NCT00004006|extraocular retinoblastoma|extraocular retinoblastoma
859086|NCT00004006|recurrent retinoblastoma|recurrent retinoblastoma
859087|NCT00003795|stage I ovarian epithelial cancer|stage i ovarian epithelial cancer
859088|NCT00003795|stage II ovarian epithelial cancer|stage ii ovarian epithelial cancer
859089|NCT00003795|stage I endometrial carcinoma|stage i endometrial carcinoma
859090|NCT00003795|stage II endometrial carcinoma|stage ii endometrial carcinoma
859091|NCT00003759|stage 0 bladder cancer|stage 0 bladder cancer
859092|NCT00003759|stage I bladder cancer|stage i bladder cancer
859093|NCT00003759|recurrent bladder cancer|recurrent bladder cancer
859094|NCT00064987|Male reproduction hormones|male reproduction hormones
859095|NCT00064987|Hypogonadotropic hypogonadism|hypogonadotropic hypogonadism
859096|NCT00064987|FSH|fsh
859097|NCT00064987|LH|lh
859098|NCT00064987|GnRH|gnrh
859099|NCT00064974|MDS|mds
859100|NCT00064974|CC-5013|cc-5013
859101|NCT00064974|Revlimid|revlimid
859102|NCT00064974|Celgene|celgene
859103|NCT00064961|Smoking Cessation|smoking cessation
859104|NCT00064935|Endometrium|endometrium
859105|NCT00064935|Luteal phase|luteal phase
859106|NCT00064935|Endometrial biopsy|endometrial biopsy
859107|NCT00064922|nicotine dependence|nicotine dependence
859108|NCT00064870|Alzheimer disease|alzheimer disease
859109|NCT00064870|Late Onset Alzheimer disease risk factor genes|late onset alzheimer disease risk factor genes
859110|NCT00064870|Genetics|genetics
859111|NCT00064870|Initiative|initiative
859112|NCT00064870|Dementia|dementia
859113|NCT00064857|lymphedema|lymphedema
859114|NCT00064857|breast|breast
859115|NCT00064857|cancer|cancer
859116|NCT00064857|plant preparation|plant preparation
859117|NCT00064857|herbal preparation|herbal preparation
859118|NCT00064857|pine bark extract|pine bark extract
859119|NCT00064909|Multiple Sclerosis|multiple sclerosis
859120|NCT00064909|MRI|mri
859121|NCT00064909|Perfusion|perfusion
859122|NCT00064909|Imaging|imaging
859123|NCT00064909|Cerebral Blood Flow|cerebral blood flow
859124|NCT00064909|Cerebral Blood Volume|cerebral blood volume
859125|NCT00064909|CO2 Inhalation|co2 inhalation
859126|NCT00064909|Contrast Agent|contrast agent
859127|NCT00064909|Healthy Volunteer|healthy volunteer
859128|NCT00064909|HV|hv
859129|NCT00064896|Blood Flow|blood flow
859130|NCT00064896|Revascularization|revascularization
859131|NCT00064896|Image Fusion|image fusion
859132|NCT00064896|Fluoroscopy|fluoroscopy
859133|NCT00064896|MRI|mri
859134|NCT00064896|Chronic Total Occlusion of Arteries|chronic total occlusion of arteries
859135|NCT00064896|Claudication|claudication
859136|NCT00064896|Safety|safety
859137|NCT00064896|Atherosclerosis|atherosclerosis
859138|NCT00064896|Cardiovascular Disease|cardiovascular disease
859139|NCT00064883|Radiation Therapy|radiation therapy
859140|NCT00064883|Children|children
859141|NCT00064883|Cancer|cancer
859142|NCT00064883|Late Effects|late effects
859143|NCT00064883|Natural History|natural history
859144|NCT00064883|Radiation|radiation
859145|NCT00064844|Smoking|smoking
859146|NCT00064844|Alcoholism|alcoholism
859147|NCT00064831|estrogen stimulation|estrogen stimulation
859148|NCT00064831|relief of hot flashes|relief of hot flashes
859149|NCT00064831|nipple aspirate fluid|nipple aspirate fluid
859150|NCT00064831|body fluid levels of black cohosh|body fluid levels of black cohosh
859151|NCT00064818|connective tissue|connective tissue
859152|NCT00064818|ultrasound|ultrasound
859153|NCT00064818|acupuncture|acupuncture
859154|NCT00064805|Cognitive therapy|cognitive therapy
859155|NCT00064805|Aphasia therapy|aphasia therapy
859156|NCT00064805|Alexia|alexia
859157|NCT00064805|Acquired dyslexia|acquired dyslexia
859158|NCT00064805|Phonological deficits|phonological deficits
859159|NCT00064805|Orthographic deficits|orthographic deficits
859160|NCT00064805|Brain disorders|brain disorders
859161|NCT00064805|Brain injury|brain injury
859162|NCT00064805|Stroke|stroke
859163|NCT00064779|CNS neoplasms|cns neoplasms
859164|NCT00064779|Brain neoplasms|brain neoplasms
859165|NCT00064779|neurosurgery|neurosurgery
859166|NCT00064779|intralesional infusion|intralesional infusion
859167|NCT00064779|recombinant proteins|recombinant proteins
859168|NCT00064779|immunotoxins|immunotoxins
859169|NCT00064766|Norplant|norplant
859170|NCT00064766|Periodontal disease|periodontal disease
859171|NCT00064766|Endometrial bleeding|endometrial bleeding
859172|NCT00064766|Progestin-induced endometrial bleeding|progestin-induced endometrial bleeding
859173|NCT00064753|homocysteine|homocysteine
859174|NCT00064753|multi-vitamin|multi-vitamin
859175|NCT00064753|cardiovascular disease|cardiovascular disease
859176|NCT00064753|renal transplant recipients|renal transplant recipients
859177|NCT00003712|recurrent adult brain tumor|recurrent adult brain tumor
859178|NCT00003712|unspecified adult solid tumor, protocol specific|unspecified adult solid tumor, protocol specific
859179|NCT00003712|tumors metastatic to brain|tumors metastatic to brain
859180|NCT00003707|unspecified adult solid tumor, protocol specific|unspecified adult solid tumor, protocol specific
859181|NCT00003645|stage I prostate cancer|stage i prostate cancer
859182|NCT00003645|stage II prostate cancer|stage ii prostate cancer
859183|NCT00003571|stage III colon cancer|stage iii colon cancer
859184|NCT00003571|adenocarcinoma of the colon|adenocarcinoma of the colon
859185|NCT00003382|stage I ovarian epithelial cancer|stage i ovarian epithelial cancer
859186|NCT00003382|stage II ovarian epithelial cancer|stage ii ovarian epithelial cancer
859187|NCT00003382|stage III ovarian epithelial cancer|stage iii ovarian epithelial cancer
859188|NCT00003382|stage IV ovarian epithelial cancer|stage iv ovarian epithelial cancer
859189|NCT00003382|recurrent ovarian epithelial cancer|recurrent ovarian epithelial cancer
882629|NCT00026884|Serum|serum
859190|NCT00003382|fallopian tube cancer|fallopian tube cancer
859191|NCT00003382|primary peritoneal cavity cancer|primary peritoneal cavity cancer
859192|NCT00064792|Cholesterol|cholesterol
859193|NCT00064792|SLOS|slos
859194|NCT00064792|HMG-COA Reductase Inhibitor|hmg-coa reductase inhibitor
859195|NCT00064792|Malformation Syndrome|malformation syndrome
859196|NCT00064792|Mental Retardation|mental retardation
859197|NCT00064792|Smith-Lemli-Opitz Syndrome|smith-lemli-opitz syndrome
859198|NCT00064740|Human Immunodeficiency Viruses|human immunodeficiency viruses
859199|NCT00064740|Relaxation|relaxation
859200|NCT00064740|Acupuncture|acupuncture
859201|NCT00064740|Complementary therapies|complementary therapies
859202|NCT00064701|De Novo Kidney Transplant|de novo kidney transplant
859203|NCT00064701|cyclosporine|cyclosporine
859204|NCT00064701|Prograf®|prograf®
859205|NCT00064701|mycophenolate mofetil|mycophenolate mofetil
859206|NCT00064701|tacrolimus|tacrolimus
859207|NCT00006073|Evaluation|evaluation
859208|NCT00006073|Endocrinology|endocrinology
859209|NCT00006073|Hormones|hormones
859210|NCT00006073|Metabolism|metabolism
859211|NCT00006073|Teaching|teaching
859212|NCT00006073|Endocrine Disorder|endocrine disorder
859213|NCT00064727|Ventricular Contractile Function|ventricular contractile function
859214|NCT00064727|Diastolic Dysfunction|diastolic dysfunction
859215|NCT00064727|PPAR gamma|ppar gamma
859216|NCT00064727|Gene Expression Patterns|gene expression patterns
859217|NCT00064727|Insulin Sensitization|insulin sensitization
859218|NCT00064727|Glucose Intolerance|glucose intolerance
859219|NCT00064727|Intolerance|intolerance
859220|NCT00064714|Type 1 Diabetes Mellitus (T1DM)|type 1 diabetes mellitus (t1dm)
859221|NCT00064714|Beta-Cell|beta-cell
859222|NCT00064714|C-Peptide|c-peptide
859223|NCT00064714|Immunosuppression|immunosuppression
859224|NCT00064714|Insulin|insulin
859225|NCT00064714|Islet|islet
859226|NCT00064714|Function|function
859227|NCT00064714|AC2993 (Synthetic Exendin-4)|ac2993 (synthetic exendin-4)
859228|NCT00064714|Diabetes Mellitus|diabetes mellitus
859229|NCT00064714|Type I Diabetes Mellitus|type i diabetes mellitus
859230|NCT00064714|T1DM|t1dm
859231|NCT00064662|Stress urinary incontinence|stress urinary incontinence
859232|NCT00064662|Surgery|surgery
859233|NCT00064649|prostate|prostate
859234|NCT00064649|benign disease|benign disease
859235|NCT00064649|TUNA|tuna
859236|NCT00064649|TUMT|tumt
859237|NCT00064649|medical therapy|medical therapy
859238|NCT00064623|Dermal assessment|dermal assessment
859239|NCT00064623|Pain measurement|pain measurement
859240|NCT00064623|Diary|diary
859241|NCT00064623|Analgesics/*therapeutic use|analgesics/*therapeutic use
859242|NCT00064623|Capsaicin/*administration & dosage/adverse effects|capsaicin/*administration & dosage/adverse effects
859243|NCT00064623|HIV Infections/*complications/*drug therapy|hiv infections/*complications/*drug therapy
859244|NCT00064623|Peripheral Nervous System Diseases/*complications/diagnosis/*therapy|peripheral nervous system diseases/*complications/diagnosis/*therapy
859245|NCT00064623|Peripheral Nervous System Diseases/drug therapy/*etiology/physiopathology|peripheral nervous system diseases/drug therapy/*etiology/physiopathology
859246|NCT00064610|Advanced androgen-independent prostate cancer|advanced androgen-independent prostate cancer
859247|NCT00064597|Fetal cells|fetal cells
859248|NCT00064597|Prenatal diagnosis|prenatal diagnosis
859249|NCT00064597|Cytogenetic disorders|cytogenetic disorders
859250|NCT00064597|Chromosomal disorders|chromosomal disorders
859251|NCT00064597|Single gene mutation detection|single gene mutation detection
859252|NCT00064597|Abnormal serum marker profile|abnormal serum marker profile
859253|NCT00064597|Fluorescence activated cell sorting (FACS)|fluorescence activated cell sorting (facs)
859254|NCT00064597|Magnetic activated cell sorting (MACS)|magnetic activated cell sorting (macs)
859255|NCT00064597|Fluorescence in situ hybridization (FISH)|fluorescence in situ hybridization (fish)
859256|NCT00064597|Chromosomal disorders of the fetus|chromosomal disorders of the fetus
859257|NCT00064597|Single gene defects of the fetus|single gene defects of the fetus
859258|NCT00063726|Relapsed Multiple Myeloma|relapsed multiple myeloma
859259|NCT00063726|Refractory Multiple Myeloma|refractory multiple myeloma
859260|NCT00003184|stage IV breast cancer|stage iv breast cancer
859261|NCT00003184|recurrent breast cancer|recurrent breast cancer
859262|NCT00003045|adenocarcinoma of the prostate|adenocarcinoma of the prostate
859263|NCT00003045|stage II prostate cancer|stage ii prostate cancer
859264|NCT00003045|stage III prostate cancer|stage iii prostate cancer
859265|NCT00003008|AIDS-related Kaposi sarcoma|aids-related kaposi sarcoma
859266|NCT00003008|recurrent Kaposi sarcoma|recurrent kaposi sarcoma
859267|NCT00002965|recurrent adult brain tumor|recurrent adult brain tumor
859268|NCT00064571|unilateral vocal fold paralysis|unilateral vocal fold paralysis
859269|NCT00064467|lethargic|lethargic
859270|NCT00064467|decreased interest|decreased interest
859271|NCT00064467|decreased motivation|decreased motivation
859272|NCT00064467|depression|depression
859273|NCT00064454|Ulcerative Colitis|ulcerative colitis
859274|NCT00064441|Ulcerative Colitis|ulcerative colitis
859275|NCT00064376|de novo myelodysplastic syndromes|de novo myelodysplastic syndromes
859276|NCT00064376|previously treated myelodysplastic syndromes|previously treated myelodysplastic syndromes
859277|NCT00064376|secondary myelodysplastic syndromes|secondary myelodysplastic syndromes
859278|NCT00064376|refractory anemia with excess blasts in transformation|refractory anemia with excess blasts in transformation
859279|NCT00064376|refractory anemia with excess blasts|refractory anemia with excess blasts
859280|NCT00064376|refractory anemia with ringed sideroblasts|refractory anemia with ringed sideroblasts
859281|NCT00064376|refractory anemia|refractory anemia
859282|NCT00064376|chronic myelomonocytic leukemia|chronic myelomonocytic leukemia
859283|NCT00064363|recurrent adult brain tumor|recurrent adult brain tumor
859284|NCT00064363|adult anaplastic astrocytoma|adult anaplastic astrocytoma
859285|NCT00064363|adult glioblastoma|adult glioblastoma
859286|NCT00064363|adult anaplastic oligodendroglioma|adult anaplastic oligodendroglioma
859287|NCT00064363|adult mixed glioma|adult mixed glioma
859288|NCT00064363|adult giant cell glioblastoma|adult giant cell glioblastoma
859289|NCT00064363|adult gliosarcoma|adult gliosarcoma
859290|NCT00064363|adult brain stem glioma|adult brain stem glioma
859291|NCT00064350|recurrent non-small cell lung cancer|recurrent non-small cell lung cancer
859292|NCT00064350|stage IIIB non-small cell lung cancer|stage iiib non-small cell lung cancer
859293|NCT00064350|stage IV non-small cell lung cancer|stage iv non-small cell lung cancer
859294|NCT00064350|sorafenib|sorafenib
859295|NCT00064337|primary systemic amyloidosis|primary systemic amyloidosis
859296|NCT00064337|stage II multiple myeloma|stage ii multiple myeloma
859297|NCT00064337|stage III multiple myeloma|stage iii multiple myeloma
859298|NCT00064311|infection|infection
859299|NCT00064311|recurrent cutaneous T-cell non-Hodgkin lymphoma|recurrent cutaneous t-cell non-hodgkin lymphoma
859300|NCT00064311|recurrent adult diffuse large cell lymphoma|recurrent adult diffuse large cell lymphoma
859301|NCT00064311|recurrent adult diffuse mixed cell lymphoma|recurrent adult diffuse mixed cell lymphoma
859302|NCT00064311|recurrent adult diffuse small cleaved cell lymphoma|recurrent adult diffuse small cleaved cell lymphoma
859303|NCT00064311|recurrent adult Burkitt lymphoma|recurrent adult burkitt lymphoma
859304|NCT00064311|recurrent adult Hodgkin lymphoma|recurrent adult hodgkin lymphoma
859305|NCT00064311|recurrent adult immunoblastic large cell lymphoma|recurrent adult immunoblastic large cell lymphoma
859306|NCT00064311|recurrent adult lymphoblastic lymphoma|recurrent adult lymphoblastic lymphoma
859307|NCT00064311|recurrent grade 1 follicular lymphoma|recurrent grade 1 follicular lymphoma
859308|NCT00064311|recurrent grade 2 follicular lymphoma|recurrent grade 2 follicular lymphoma
859309|NCT00064311|recurrent grade 3 follicular lymphoma|recurrent grade 3 follicular lymphoma
859310|NCT00064311|recurrent mantle cell lymphoma|recurrent mantle cell lymphoma
859311|NCT00064311|noncontiguous stage II adult diffuse large cell lymphoma|noncontiguous stage ii adult diffuse large cell lymphoma
859312|NCT00064311|noncontiguous stage II adult diffuse mixed cell lymphoma|noncontiguous stage ii adult diffuse mixed cell lymphoma
859313|NCT00064311|noncontiguous stage II adult Burkitt lymphoma|noncontiguous stage ii adult burkitt lymphoma
859314|NCT00064311|noncontiguous stage II adult immunoblastic large cell lymphoma|noncontiguous stage ii adult immunoblastic large cell lymphoma
859315|NCT00064311|noncontiguous stage II adult lymphoblastic lymphoma|noncontiguous stage ii adult lymphoblastic lymphoma
859316|NCT00064311|noncontiguous stage II grade 3 follicular lymphoma|noncontiguous stage ii grade 3 follicular lymphoma
859317|NCT00064311|noncontiguous stage II mantle cell lymphoma|noncontiguous stage ii mantle cell lymphoma
859318|NCT00064311|stage III adult diffuse large cell lymphoma|stage iii adult diffuse large cell lymphoma
859319|NCT00064311|stage III adult diffuse mixed cell lymphoma|stage iii adult diffuse mixed cell lymphoma
859320|NCT00064311|stage III adult Burkitt lymphoma|stage iii adult burkitt lymphoma
859321|NCT00064311|stage III adult immunoblastic large cell lymphoma|stage iii adult immunoblastic large cell lymphoma
859322|NCT00064311|stage III adult lymphoblastic lymphoma|stage iii adult lymphoblastic lymphoma
859323|NCT00064311|stage III grade 3 follicular lymphoma|stage iii grade 3 follicular lymphoma
859324|NCT00064311|stage III mantle cell lymphoma|stage iii mantle cell lymphoma
859325|NCT00064311|stage IV grade 3 follicular lymphoma|stage iv grade 3 follicular lymphoma
859326|NCT00064311|stage IV adult diffuse large cell lymphoma|stage iv adult diffuse large cell lymphoma
859327|NCT00064311|stage IV adult diffuse mixed cell lymphoma|stage iv adult diffuse mixed cell lymphoma
859328|NCT00064311|stage IV adult Burkitt lymphoma|stage iv adult burkitt lymphoma
859329|NCT00064311|stage IV adult immunoblastic large cell lymphoma|stage iv adult immunoblastic large cell lymphoma
859330|NCT00064311|stage IV adult lymphoblastic lymphoma|stage iv adult lymphoblastic lymphoma
859331|NCT00064311|stage IV mantle cell lymphoma|stage iv mantle cell lymphoma
859332|NCT00064311|refractory chronic lymphocytic leukemia|refractory chronic lymphocytic leukemia
859333|NCT00064311|stage III chronic lymphocytic leukemia|stage iii chronic lymphocytic leukemia
859334|NCT00064311|stage IV chronic lymphocytic leukemia|stage iv chronic lymphocytic leukemia
859335|NCT00064311|accelerated phase chronic myelogenous leukemia|accelerated phase chronic myelogenous leukemia
859336|NCT00064311|blastic phase chronic myelogenous leukemia|blastic phase chronic myelogenous leukemia
859337|NCT00064311|chronic phase chronic myelogenous leukemia|chronic phase chronic myelogenous leukemia
859338|NCT00064311|meningeal chronic myelogenous leukemia|meningeal chronic myelogenous leukemia
859339|NCT00064311|relapsing chronic myelogenous leukemia|relapsing chronic myelogenous leukemia
859340|NCT00064311|refractory hairy cell leukemia|refractory hairy cell leukemia
859341|NCT00064311|de novo myelodysplastic syndromes|de novo myelodysplastic syndromes
859342|NCT00064311|previously treated myelodysplastic syndromes|previously treated myelodysplastic syndromes
859343|NCT00064311|secondary myelodysplastic syndromes|secondary myelodysplastic syndromes
859344|NCT00064311|stage I multiple myeloma|stage i multiple myeloma
859345|NCT00064311|stage II multiple myeloma|stage ii multiple myeloma
859346|NCT00064311|stage III multiple myeloma|stage iii multiple myeloma
859347|NCT00064311|recurrent malignant testicular germ cell tumor|recurrent malignant testicular germ cell tumor
859348|NCT00064311|stage III malignant testicular germ cell tumor|stage iii malignant testicular germ cell tumor
859349|NCT00064311|disseminated neuroblastoma|disseminated neuroblastoma
859350|NCT00064311|recurrent neuroblastoma|recurrent neuroblastoma
859351|NCT00064311|stage II ovarian epithelial cancer|stage ii ovarian epithelial cancer
859352|NCT00064311|recurrent ovarian epithelial cancer|recurrent ovarian epithelial cancer
859353|NCT00064311|stage III ovarian epithelial cancer|stage iii ovarian epithelial cancer
859354|NCT00064311|stage IV ovarian epithelial cancer|stage iv ovarian epithelial cancer
859355|NCT00064311|recurrent ovarian germ cell tumor|recurrent ovarian germ cell tumor
859356|NCT00064311|stage IIIA breast cancer|stage iiia breast cancer
859357|NCT00064311|stage IIIB breast cancer|stage iiib breast cancer
859358|NCT00064311|stage IV breast cancer|stage iv breast cancer
859359|NCT00064311|high risk metastatic gestational trophoblastic tumor|high risk metastatic gestational trophoblastic tumor
859360|NCT00064311|primary myelofibrosis|primary myelofibrosis
859361|NCT00064311|recurrent adult acute lymphoblastic leukemia|recurrent adult acute lymphoblastic leukemia
859362|NCT00064311|adult acute lymphoblastic leukemia in remission|adult acute lymphoblastic leukemia in remission
859363|NCT00064311|recurrent adult acute myeloid leukemia|recurrent adult acute myeloid leukemia
859364|NCT00064311|adult acute myeloid leukemia in remission|adult acute myeloid leukemia in remission
859365|NCT00064311|secondary acute myeloid leukemia|secondary acute myeloid leukemia
859366|NCT00064311|atypical chronic myeloid leukemia, BCR-ABL1 negative|atypical chronic myeloid leukemia, bcr-abl1 negative
859367|NCT00064311|myelodysplastic/myeloproliferative neoplasm, unclassifiable|myelodysplastic/myeloproliferative neoplasm, unclassifiable
859368|NCT00064311|stage IIIC breast cancer|stage iiic breast cancer
859369|NCT00064311|recurrent marginal zone lymphoma|recurrent marginal zone lymphoma
859370|NCT00064311|recurrent small lymphocytic lymphoma|recurrent small lymphocytic lymphoma
859371|NCT00064311|extranodal marginal zone B-cell lymphoma of mucosa-associated lymphoid tissue|extranodal marginal zone b-cell lymphoma of mucosa-associated lymphoid tissue
859372|NCT00064311|nodal marginal zone B-cell lymphoma|nodal marginal zone b-cell lymphoma
859373|NCT00064311|splenic marginal zone lymphoma|splenic marginal zone lymphoma
859374|NCT00064311|adult acute myeloid leukemia with t(8;21)(q22;q22)|adult acute myeloid leukemia with t(8;21)(q22;q22)
859375|NCT00064311|adult acute myeloid leukemia with t(16;16)(p13;q22)|adult acute myeloid leukemia with t(16;16)(p13;q22)
859376|NCT00064311|adult acute myeloid leukemia with inv(16)(p13;q22)|adult acute myeloid leukemia with inv(16)(p13;q22)
859377|NCT00064311|adult acute myeloid leukemia with 11q23 (MLL) abnormalities|adult acute myeloid leukemia with 11q23 (mll) abnormalities
859378|NCT00064311|adult acute myeloid leukemia with t(15;17)(q22;q12)|adult acute myeloid leukemia with t(15;17)(q22;q12)
859379|NCT00064298|stage I squamous cell carcinoma of the hypopharynx|stage i squamous cell carcinoma of the hypopharynx
859380|NCT00064298|stage I squamous cell carcinoma of the larynx|stage i squamous cell carcinoma of the larynx
859381|NCT00064298|stage I squamous cell carcinoma of the lip and oral cavity|stage i squamous cell carcinoma of the lip and oral cavity
859382|NCT00064298|stage I squamous cell carcinoma of the oropharynx|stage i squamous cell carcinoma of the oropharynx
859383|NCT00064298|stage II squamous cell carcinoma of the hypopharynx|stage ii squamous cell carcinoma of the hypopharynx
859384|NCT00064298|stage II squamous cell carcinoma of the larynx|stage ii squamous cell carcinoma of the larynx
859385|NCT00064298|stage II squamous cell carcinoma of the lip and oral cavity|stage ii squamous cell carcinoma of the lip and oral cavity
859386|NCT00064298|stage II squamous cell carcinoma of the oropharynx|stage ii squamous cell carcinoma of the oropharynx
859387|NCT00064298|stage III squamous cell carcinoma of the hypopharynx|stage iii squamous cell carcinoma of the hypopharynx
859388|NCT00064298|stage III squamous cell carcinoma of the larynx|stage iii squamous cell carcinoma of the larynx
859389|NCT00064298|stage III squamous cell carcinoma of the lip and oral cavity|stage iii squamous cell carcinoma of the lip and oral cavity
859390|NCT00064298|stage III squamous cell carcinoma of the oropharynx|stage iii squamous cell carcinoma of the oropharynx
859391|NCT00064298|stage IV squamous cell carcinoma of the hypopharynx|stage iv squamous cell carcinoma of the hypopharynx
859392|NCT00064298|stage IV squamous cell carcinoma of the larynx|stage iv squamous cell carcinoma of the larynx
859393|NCT00064298|stage IV squamous cell carcinoma of the lip and oral cavity|stage iv squamous cell carcinoma of the lip and oral cavity
859394|NCT00064298|stage IV squamous cell carcinoma of the oropharynx|stage iv squamous cell carcinoma of the oropharynx
859395|NCT00064285|chronic phase chronic myelogenous leukemia|chronic phase chronic myelogenous leukemia
859396|NCT00064285|blastic phase chronic myelogenous leukemia|blastic phase chronic myelogenous leukemia
859397|NCT00064285|accelerated phase chronic myelogenous leukemia|accelerated phase chronic myelogenous leukemia
859398|NCT00064285|recurrent adult acute myeloid leukemia|recurrent adult acute myeloid leukemia
859399|NCT00064285|untreated adult acute myeloid leukemia|untreated adult acute myeloid leukemia
859400|NCT00064285|adult acute myeloid leukemia in remission|adult acute myeloid leukemia in remission
859401|NCT00064285|adult acute lymphoblastic leukemia in remission|adult acute lymphoblastic leukemia in remission
859402|NCT00064285|recurrent adult acute lymphoblastic leukemia|recurrent adult acute lymphoblastic leukemia
859403|NCT00064285|untreated adult acute lymphoblastic leukemia|untreated adult acute lymphoblastic leukemia
859404|NCT00064285|relapsing chronic myelogenous leukemia|relapsing chronic myelogenous leukemia
859472|NCT00063960|adenocarcinoma of the rectum|adenocarcinoma of the rectum
859405|NCT00064285|adult acute myeloid leukemia with t(8;21)(q22;q22)|adult acute myeloid leukemia with t(8;21)(q22;q22)
859406|NCT00064285|adult acute myeloid leukemia with t(16;16)(p13;q22)|adult acute myeloid leukemia with t(16;16)(p13;q22)
859407|NCT00064285|adult acute myeloid leukemia with inv(16)(p13;q22)|adult acute myeloid leukemia with inv(16)(p13;q22)
859408|NCT00064285|adult acute myeloid leukemia with 11q23 (MLL) abnormalities|adult acute myeloid leukemia with 11q23 (mll) abnormalities
859409|NCT00064285|adult acute myeloid leukemia with t(15;17)(q22;q12)|adult acute myeloid leukemia with t(15;17)(q22;q12)
859410|NCT00064272|nausea and vomiting|nausea and vomiting
859411|NCT00064272|unspecified adult solid tumor, protocol specific|unspecified adult solid tumor, protocol specific
859412|NCT00064233|chronic phase chronic myelogenous leukemia|chronic phase chronic myelogenous leukemia
859413|NCT00064233|relapsing chronic myelogenous leukemia|relapsing chronic myelogenous leukemia
859414|NCT00064233|Philadelphia chromosome positive chronic myelogenous leukemia|philadelphia chromosome positive chronic myelogenous leukemia
859415|NCT00064220|adult leiomyosarcoma|adult leiomyosarcoma
859416|NCT00064220|adult malignant fibrous histiocytoma|adult malignant fibrous histiocytoma
859417|NCT00064220|adult liposarcoma|adult liposarcoma
859418|NCT00064220|adult rhabdomyosarcoma|adult rhabdomyosarcoma
859419|NCT00064220|adult synovial sarcoma|adult synovial sarcoma
859420|NCT00064220|adult fibrosarcoma|adult fibrosarcoma
859421|NCT00064220|adult angiosarcoma|adult angiosarcoma
859422|NCT00064220|adult malignant hemangiopericytoma|adult malignant hemangiopericytoma
859423|NCT00064220|stage IV adult soft tissue sarcoma|stage iv adult soft tissue sarcoma
859424|NCT00064220|recurrent adult soft tissue sarcoma|recurrent adult soft tissue sarcoma
859425|NCT00064207|adenocarcinoma of the pancreas|adenocarcinoma of the pancreas
859426|NCT00064207|stage I pancreatic cancer|stage i pancreatic cancer
859427|NCT00064207|stage II pancreatic cancer|stage ii pancreatic cancer
859428|NCT00064207|stage III pancreatic cancer|stage iii pancreatic cancer
859429|NCT00064194|prostate cancer|prostate cancer
859430|NCT00064194|high grade prostatic intraepithelial neoplasia|high grade prostatic intraepithelial neoplasia
859431|NCT00064181|adenocarcinoma of the colon|adenocarcinoma of the colon
859432|NCT00064181|adenocarcinoma of the rectum|adenocarcinoma of the rectum
859433|NCT00064181|stage IV colon cancer|stage iv colon cancer
859434|NCT00064181|stage IV rectal cancer|stage iv rectal cancer
859435|NCT00064116|stage I adult diffuse large cell lymphoma|stage i adult diffuse large cell lymphoma
859436|NCT00064116|contiguous stage II adult diffuse large cell lymphoma|contiguous stage ii adult diffuse large cell lymphoma
859437|NCT00064116|noncontiguous stage II adult diffuse large cell lymphoma|noncontiguous stage ii adult diffuse large cell lymphoma
859438|NCT00064116|stage III adult diffuse large cell lymphoma|stage iii adult diffuse large cell lymphoma
859439|NCT00064116|stage IV adult diffuse large cell lymphoma|stage iv adult diffuse large cell lymphoma
859440|NCT00064090|recurrent adult acute lymphoblastic leukemia|recurrent adult acute lymphoblastic leukemia
859441|NCT00064090|recurrent adult acute myeloid leukemia|recurrent adult acute myeloid leukemia
859442|NCT00064090|blastic phase chronic myelogenous leukemia|blastic phase chronic myelogenous leukemia
859443|NCT00064090|refractory chronic lymphocytic leukemia|refractory chronic lymphocytic leukemia
859444|NCT00064090|relapsing chronic myelogenous leukemia|relapsing chronic myelogenous leukemia
859445|NCT00064090|chronic myelomonocytic leukemia|chronic myelomonocytic leukemia
859446|NCT00064090|refractory anemia with excess blasts in transformation|refractory anemia with excess blasts in transformation
859447|NCT00064090|refractory anemia with excess blasts|refractory anemia with excess blasts
859448|NCT00064090|previously treated myelodysplastic syndromes|previously treated myelodysplastic syndromes
859449|NCT00064090|atypical chronic myeloid leukemia, BCR-ABL1 negative|atypical chronic myeloid leukemia, bcr-abl1 negative
859450|NCT00064090|myelodysplastic/myeloproliferative neoplasm, unclassifiable|myelodysplastic/myeloproliferative neoplasm, unclassifiable
859451|NCT00064090|adult acute myeloid leukemia with t(8;21)(q22;q22)|adult acute myeloid leukemia with t(8;21)(q22;q22)
859452|NCT00064090|adult acute myeloid leukemia with t(16;16)(p13;q22)|adult acute myeloid leukemia with t(16;16)(p13;q22)
859453|NCT00064090|adult acute myeloid leukemia with inv(16)(p13;q22)|adult acute myeloid leukemia with inv(16)(p13;q22)
859454|NCT00064090|adult acute myeloid leukemia with 11q23 (MLL) abnormalities|adult acute myeloid leukemia with 11q23 (mll) abnormalities
859455|NCT00064090|adult acute myeloid leukemia with t(15;17)(q22;q12)|adult acute myeloid leukemia with t(15;17)(q22;q12)
859456|NCT00064064|recurrent non-small cell lung cancer|recurrent non-small cell lung cancer
859457|NCT00064064|stage IV non-small cell lung cancer|stage iv non-small cell lung cancer
859458|NCT00064051|stage II pancreatic cancer|stage ii pancreatic cancer
859459|NCT00064051|stage III pancreatic cancer|stage iii pancreatic cancer
859460|NCT00064051|recurrent pancreatic cancer|recurrent pancreatic cancer
859461|NCT00064051|stage IV pancreatic cancer|stage iv pancreatic cancer
859462|NCT00064038|stage I multiple myeloma|stage i multiple myeloma
859463|NCT00064038|stage II multiple myeloma|stage ii multiple myeloma
859464|NCT00064038|stage III multiple myeloma|stage iii multiple myeloma
859465|NCT00064012|stage IIIB non-small cell lung cancer|stage iiib non-small cell lung cancer
859466|NCT00064012|stage IV non-small cell lung cancer|stage iv non-small cell lung cancer
859467|NCT00064012|recurrent non-small cell lung cancer|recurrent non-small cell lung cancer
859468|NCT00063986|esophageal cancer|esophageal cancer
859469|NCT00063986|minimally invasive esophagectomy (MIE)|minimally invasive esophagectomy (mie)
859470|NCT00063960|stage IV colon cancer|stage iv colon cancer
859471|NCT00063960|adenocarcinoma of the colon|adenocarcinoma of the colon
882738|NCT00026624|HIV-1|hiv-1
859473|NCT00063960|stage IV rectal cancer|stage iv rectal cancer
859474|NCT00063960|liver metastases|liver metastases
859475|NCT00063882|stage IIB prostate cancer|stage iib prostate cancer
859476|NCT00063882|stage IIA prostate cancer|stage iia prostate cancer
859477|NCT00063882|adenocarcinoma of the prostate|adenocarcinoma of the prostate
859478|NCT00063869|Idiopathic Pulmonary Fibrosis|idiopathic pulmonary fibrosis
859479|NCT00063869|Fibrosis, Pulmonary|fibrosis, pulmonary
859480|NCT00063869|Pulmonary Fibroses|pulmonary fibroses
859481|NCT00063869|Fibroses, Pulmonary|fibroses, pulmonary
859482|NCT00023907|recurrent ovarian epithelial cancer|recurrent ovarian epithelial cancer
859483|NCT00023907|primary peritoneal cavity cancer|primary peritoneal cavity cancer
859484|NCT00003211|untreated childhood supratentorial primitive neuroectodermal tumor|untreated childhood supratentorial primitive neuroectodermal tumor
859485|NCT00003211|untreated childhood medulloblastoma|untreated childhood medulloblastoma
859486|NCT00002878|refractory multiple myeloma|refractory multiple myeloma
859487|NCT00063856|Smallpox, wetvax|smallpox, wetvax
859488|NCT00063843|Bacillus anthracis (anthrax)|bacillus anthracis (anthrax)
859489|NCT00063830|Ulcerative Colitis|ulcerative colitis
859490|NCT00063817|End-stage renal disease|end-stage renal disease
859491|NCT00063817|Renal Transplant|renal transplant
859492|NCT00063817|Bone Marrow Transplant|bone marrow transplant
859493|NCT00063817|nonmyeloablative conditioning regimen|nonmyeloablative conditioning regimen
859494|NCT00063804|HIV Seronegativity|hiv seronegativity
859496|NCT00063804|AMD11070|amd11070
859497|NCT00063791|Relapsed or Refractory|relapsed or refractory
859498|NCT00063778|HIV Seronegativity|hiv seronegativity
859499|NCT00063778|HIV Preventive Vaccine|hiv preventive vaccine
859500|NCT00063778|AIDS Vaccines|aids vaccines
859501|NCT00063778|Gene Products, gag|gene products, gag
859502|NCT00063778|HIV-1|hiv-1
859503|NCT00063778|Dose-Response Relationship, Immunologic|dose-response relationship, immunologic
859504|NCT00063778|Injections, Subcutaneous|injections, subcutaneous
859505|NCT00045357|recurrent melanoma|recurrent melanoma
859506|NCT00045357|stage IV melanoma|stage iv melanoma
859507|NCT00042900|AIDS-related peripheral/systemic lymphoma|aids-related peripheral/systemic lymphoma
859508|NCT00042900|AIDS-related primary CNS lymphoma|aids-related primary cns lymphoma
859509|NCT00042900|T-cell large granular lymphocyte leukemia|t-cell large granular lymphocyte leukemia
859510|NCT00042900|Waldenström macroglobulinemia|waldenström macroglobulinemia
859511|NCT00042900|accelerated phase chronic myelogenous leukemia|accelerated phase chronic myelogenous leukemia
859512|NCT00042900|acute undifferentiated leukemia|acute undifferentiated leukemia
859513|NCT00042900|adult acute lymphoblastic leukemia in remission|adult acute lymphoblastic leukemia in remission
859514|NCT00042900|adult acute myeloid leukemia in remission|adult acute myeloid leukemia in remission
859515|NCT00042900|primary myelofibrosis|primary myelofibrosis
859516|NCT00042900|anaplastic large cell lymphoma|anaplastic large cell lymphoma
859517|NCT00042900|angioimmunoblastic T-cell lymphoma|angioimmunoblastic t-cell lymphoma
859518|NCT00042900|blastic phase chronic myelogenous leukemia|blastic phase chronic myelogenous leukemia
859519|NCT00042900|chronic myelomonocytic leukemia|chronic myelomonocytic leukemia
859520|NCT00042900|chronic phase chronic myelogenous leukemia|chronic phase chronic myelogenous leukemia
859521|NCT00042900|de novo myelodysplastic syndromes|de novo myelodysplastic syndromes
859522|NCT00042900|essential thrombocythemia|essential thrombocythemia
859621|NCT00033384|recurrent breast cancer|recurrent breast cancer
859523|NCT00042900|extramedullary plasmacytoma|extramedullary plasmacytoma
859524|NCT00042900|intraocular lymphoma|intraocular lymphoma
859525|NCT00042900|isolated plasmacytoma of bone|isolated plasmacytoma of bone
859526|NCT00042900|meningeal chronic myelogenous leukemia|meningeal chronic myelogenous leukemia
859527|NCT00042900|monoclonal gammopathy of undetermined significance|monoclonal gammopathy of undetermined significance
859528|NCT00042900|polycythemia vera|polycythemia vera
859529|NCT00042900|previously treated myelodysplastic syndromes|previously treated myelodysplastic syndromes
859530|NCT00042900|primary central nervous system non-Hodgkin lymphoma|primary central nervous system non-hodgkin lymphoma
859531|NCT00042900|primary systemic amyloidosis|primary systemic amyloidosis
859532|NCT00042900|progressive hairy cell leukemia, initial treatment|progressive hairy cell leukemia, initial treatment
859533|NCT00042900|prolymphocytic leukemia|prolymphocytic leukemia
859534|NCT00042900|recurrent adult Hodgkin lymphoma|recurrent adult hodgkin lymphoma
859535|NCT00042900|recurrent adult T-cell leukemia/lymphoma|recurrent adult t-cell leukemia/lymphoma
859536|NCT00042900|recurrent adult acute lymphoblastic leukemia|recurrent adult acute lymphoblastic leukemia
859537|NCT00042900|recurrent adult acute myeloid leukemia|recurrent adult acute myeloid leukemia
859538|NCT00042900|recurrent adult diffuse large cell lymphoma|recurrent adult diffuse large cell lymphoma
859539|NCT00042900|recurrent adult diffuse mixed cell lymphoma|recurrent adult diffuse mixed cell lymphoma
859540|NCT00042900|recurrent adult diffuse small cleaved cell lymphoma|recurrent adult diffuse small cleaved cell lymphoma
859541|NCT00042900|recurrent adult Burkitt lymphoma|recurrent adult burkitt lymphoma
859542|NCT00042900|recurrent adult immunoblastic large cell lymphoma|recurrent adult immunoblastic large cell lymphoma
859543|NCT00042900|recurrent adult lymphoblastic lymphoma|recurrent adult lymphoblastic lymphoma
859544|NCT00042900|recurrent cutaneous T-cell non-Hodgkin lymphoma|recurrent cutaneous t-cell non-hodgkin lymphoma
859545|NCT00042900|recurrent grade 1 follicular lymphoma|recurrent grade 1 follicular lymphoma
859546|NCT00042900|recurrent grade 2 follicular lymphoma|recurrent grade 2 follicular lymphoma
859547|NCT00042900|recurrent grade 3 follicular lymphoma|recurrent grade 3 follicular lymphoma
859548|NCT00042900|recurrent mantle cell lymphoma|recurrent mantle cell lymphoma
859549|NCT00042900|recurrent mycosis fungoides/Sezary syndrome|recurrent mycosis fungoides/sezary syndrome
859550|NCT00042900|refractory chronic lymphocytic leukemia|refractory chronic lymphocytic leukemia
859551|NCT00042900|refractory hairy cell leukemia|refractory hairy cell leukemia
859552|NCT00042900|refractory multiple myeloma|refractory multiple myeloma
859553|NCT00042900|relapsing chronic myelogenous leukemia|relapsing chronic myelogenous leukemia
859554|NCT00042900|secondary acute myeloid leukemia|secondary acute myeloid leukemia
859555|NCT00042900|secondary myelodysplastic syndromes|secondary myelodysplastic syndromes
859556|NCT00042900|small intestine lymphoma|small intestine lymphoma
859557|NCT00042900|stage III adult Hodgkin lymphoma|stage iii adult hodgkin lymphoma
859558|NCT00042900|stage III adult T-cell leukemia/lymphoma|stage iii adult t-cell leukemia/lymphoma
859559|NCT00042900|stage III adult diffuse mixed cell lymphoma|stage iii adult diffuse mixed cell lymphoma
859560|NCT00042900|stage III adult diffuse large cell lymphoma|stage iii adult diffuse large cell lymphoma
859561|NCT00042900|stage III adult diffuse small cleaved cell lymphoma|stage iii adult diffuse small cleaved cell lymphoma
859562|NCT00042900|stage III adult Burkitt lymphoma|stage iii adult burkitt lymphoma
859563|NCT00042900|stage III adult immunoblastic large cell lymphoma|stage iii adult immunoblastic large cell lymphoma
859564|NCT00042900|stage III adult lymphoblastic lymphoma|stage iii adult lymphoblastic lymphoma
859565|NCT00042900|stage III chronic lymphocytic leukemia|stage iii chronic lymphocytic leukemia
859566|NCT00042900|stage III cutaneous T-cell non-Hodgkin lymphoma|stage iii cutaneous t-cell non-hodgkin lymphoma
859567|NCT00042900|stage III grade 1 follicular lymphoma|stage iii grade 1 follicular lymphoma
859568|NCT00042900|stage III grade 2 follicular lymphoma|stage iii grade 2 follicular lymphoma
859569|NCT00042900|stage III grade 3 follicular lymphoma|stage iii grade 3 follicular lymphoma
859570|NCT00042900|stage III mantle cell lymphoma|stage iii mantle cell lymphoma
859571|NCT00042900|stage III multiple myeloma|stage iii multiple myeloma
859572|NCT00042900|stage III mycosis fungoides/Sezary syndrome|stage iii mycosis fungoides/sezary syndrome
859573|NCT00042900|stage IV adult diffuse large cell lymphoma|stage iv adult diffuse large cell lymphoma
859574|NCT00042900|stage IV adult diffuse mixed cell lymphoma|stage iv adult diffuse mixed cell lymphoma
859575|NCT00042900|stage IV adult diffuse small cleaved cell lymphoma|stage iv adult diffuse small cleaved cell lymphoma
859576|NCT00042900|stage IV adult Burkitt lymphoma|stage iv adult burkitt lymphoma
859577|NCT00042900|stage IV adult immunoblastic large cell lymphoma|stage iv adult immunoblastic large cell lymphoma
859578|NCT00042900|stage IV adult lymphoblastic lymphoma|stage iv adult lymphoblastic lymphoma
859579|NCT00042900|stage IV chronic lymphocytic leukemia|stage iv chronic lymphocytic leukemia
859580|NCT00042900|stage IV cutaneous T-cell non-Hodgkin lymphoma|stage iv cutaneous t-cell non-hodgkin lymphoma
859581|NCT00042900|stage IV grade 1 follicular lymphoma|stage iv grade 1 follicular lymphoma
859582|NCT00042900|stage IV grade 2 follicular lymphoma|stage iv grade 2 follicular lymphoma
859583|NCT00042900|stage IV grade 3 follicular lymphoma|stage iv grade 3 follicular lymphoma
859584|NCT00042900|stage IV mantle cell lymphoma|stage iv mantle cell lymphoma
859585|NCT00042900|stage IV mycosis fungoides/Sezary syndrome|stage iv mycosis fungoides/sezary syndrome
859586|NCT00042900|untreated adult acute lymphoblastic leukemia|untreated adult acute lymphoblastic leukemia
859587|NCT00042900|untreated adult acute myeloid leukemia|untreated adult acute myeloid leukemia
859588|NCT00042900|untreated hairy cell leukemia|untreated hairy cell leukemia
859589|NCT00042900|stage IV adult Hodgkin lymphoma|stage iv adult hodgkin lymphoma
859590|NCT00042900|stage IV adult T-cell leukemia/lymphoma|stage iv adult t-cell leukemia/lymphoma
859591|NCT00042900|unspecified adult solid tumor, protocol specific|unspecified adult solid tumor, protocol specific
859592|NCT00042900|recurrent marginal zone lymphoma|recurrent marginal zone lymphoma
859593|NCT00042900|recurrent small lymphocytic lymphoma|recurrent small lymphocytic lymphoma
859594|NCT00042900|stage III small lymphocytic lymphoma|stage iii small lymphocytic lymphoma
859595|NCT00042900|stage III marginal zone lymphoma|stage iii marginal zone lymphoma
859596|NCT00042900|stage IV small lymphocytic lymphoma|stage iv small lymphocytic lymphoma
859597|NCT00042900|stage IV marginal zone lymphoma|stage iv marginal zone lymphoma
859681|NCT00063609|Bone Mineral Density|bone mineral density
859598|NCT00042900|extranodal marginal zone B-cell lymphoma of mucosa-associated lymphoid tissue|extranodal marginal zone b-cell lymphoma of mucosa-associated lymphoid tissue
859599|NCT00042900|nodal marginal zone B-cell lymphoma|nodal marginal zone b-cell lymphoma
859600|NCT00042900|splenic marginal zone lymphoma|splenic marginal zone lymphoma
859601|NCT00040820|stage III colon cancer|stage iii colon cancer
859602|NCT00040820|stage IV colon cancer|stage iv colon cancer
859603|NCT00040820|stage III rectal cancer|stage iii rectal cancer
859604|NCT00040820|stage IV rectal cancer|stage iv rectal cancer
859605|NCT00040820|recurrent colon cancer|recurrent colon cancer
859606|NCT00040820|recurrent rectal cancer|recurrent rectal cancer
859607|NCT00040820|adenocarcinoma of the colon|adenocarcinoma of the colon
859608|NCT00040820|adenocarcinoma of the rectum|adenocarcinoma of the rectum
859609|NCT00039169|stage III renal cell cancer|stage iii renal cell cancer
859610|NCT00039169|stage IV renal cell cancer|stage iv renal cell cancer
859611|NCT00039169|recurrent renal cell cancer|recurrent renal cell cancer
859612|NCT00036660|recurrent adult brain tumor|recurrent adult brain tumor
859613|NCT00036660|adult glioblastoma|adult glioblastoma
859703|NCT00063323|Nicotine replacement|nicotine replacement
859614|NCT00036660|adult anaplastic astrocytoma|adult anaplastic astrocytoma
859615|NCT00036660|adult giant cell glioblastoma|adult giant cell glioblastoma
859616|NCT00036660|adult gliosarcoma|adult gliosarcoma
859617|NCT00033384|stage III colon cancer|stage iii colon cancer
859618|NCT00033384|stage IV colon cancer|stage iv colon cancer
859619|NCT00033384|stage IV breast cancer|stage iv breast cancer
859620|NCT00033384|stage IIIA breast cancer|stage iiia breast cancer
859622|NCT00033384|stage IIIB breast cancer|stage iiib breast cancer
859623|NCT00033384|recurrent non-small cell lung cancer|recurrent non-small cell lung cancer
859624|NCT00033384|stage II pancreatic cancer|stage ii pancreatic cancer
859625|NCT00033384|stage III pancreatic cancer|stage iii pancreatic cancer
859626|NCT00033384|recurrent pancreatic cancer|recurrent pancreatic cancer
859627|NCT00033384|recurrent colon cancer|recurrent colon cancer
859628|NCT00033384|stage IIIA non-small cell lung cancer|stage iiia non-small cell lung cancer
859629|NCT00033384|stage IIIB non-small cell lung cancer|stage iiib non-small cell lung cancer
859630|NCT00033384|stage IV non-small cell lung cancer|stage iv non-small cell lung cancer
859631|NCT00033384|duct cell adenocarcinoma of the pancreas|duct cell adenocarcinoma of the pancreas
859632|NCT00033384|stage IV pancreatic cancer|stage iv pancreatic cancer
859633|NCT00002752|childhood supratentorial ependymoma|childhood supratentorial ependymoma
859634|NCT00002752|recurrent childhood brain tumor|recurrent childhood brain tumor
859635|NCT00002752|recurrent adult brain tumor|recurrent adult brain tumor
859636|NCT00002752|adult medulloblastoma|adult medulloblastoma
859637|NCT00002752|adult glioblastoma|adult glioblastoma
859638|NCT00002752|tumors metastatic to brain|tumors metastatic to brain
859639|NCT00002752|childhood high-grade cerebral astrocytoma|childhood high-grade cerebral astrocytoma
859640|NCT00002752|adult anaplastic astrocytoma|adult anaplastic astrocytoma
859641|NCT00002752|adult myxopapillary ependymoma|adult myxopapillary ependymoma
859642|NCT00002752|adult anaplastic ependymoma|adult anaplastic ependymoma
859643|NCT00002752|adult anaplastic oligodendroglioma|adult anaplastic oligodendroglioma
859644|NCT00002752|adult mixed glioma|adult mixed glioma
859645|NCT00002752|adult pilocytic astrocytoma|adult pilocytic astrocytoma
859646|NCT00002752|adult subependymoma|adult subependymoma
859647|NCT00002752|adult ependymoblastoma|adult ependymoblastoma
859648|NCT00002752|recurrent childhood supratentorial primitive neuroectodermal tumor|recurrent childhood supratentorial primitive neuroectodermal tumor
859649|NCT00002752|recurrent childhood cerebellar astrocytoma|recurrent childhood cerebellar astrocytoma
859650|NCT00002752|recurrent childhood cerebral astrocytoma|recurrent childhood cerebral astrocytoma
859651|NCT00002752|recurrent childhood medulloblastoma|recurrent childhood medulloblastoma
859652|NCT00002752|newly diagnosed childhood ependymoma|newly diagnosed childhood ependymoma
859653|NCT00002752|recurrent childhood ependymoma|recurrent childhood ependymoma
859654|NCT00002752|adult oligodendroglioma|adult oligodendroglioma
859655|NCT00002752|adult giant cell glioblastoma|adult giant cell glioblastoma
859656|NCT00002752|adult gliosarcoma|adult gliosarcoma
859657|NCT00002582|stage I breast cancer|stage i breast cancer
859658|NCT00002582|stage II breast cancer|stage ii breast cancer
859659|NCT00002582|stage IIIA breast cancer|stage iiia breast cancer
859660|NCT00063765|NT-501|nt-501
859661|NCT00063765|CNTF|cntf
859662|NCT00063765|Retinitis Pigmentosa|retinitis pigmentosa
859664|NCT00063700|obesity in school aged children|obesity in school aged children
859665|NCT00063674|exercise|exercise
859666|NCT00063674|eating|eating
859667|NCT00063674|dance|dance
859668|NCT00063674|health education|health education
859669|NCT00063674|obesity prevention|obesity prevention
859670|NCT00063674|diabetes prevention|diabetes prevention
859671|NCT00063674|children|children
859672|NCT00063648|PTLD|ptld
859673|NCT00063648|CTL Therapy|ctl therapy
859674|NCT00063648|Post-transplant lymphoproliferative disorder|post-transplant lymphoproliferative disorder
859675|NCT00063635|Non alcoholic fatty liver disease|non alcoholic fatty liver disease
859676|NCT00063622|Non alcoholic steatohepatitis|non alcoholic steatohepatitis
859677|NCT00063622|Steatohepatitis|steatohepatitis
859678|NCT00063609|Prostate Cancer|prostate cancer
859679|NCT00063609|Bone Loss|bone loss
859680|NCT00063609|Osteoporosis|osteoporosis
859682|NCT00063609|Androgen Deprivation Therapy|androgen deprivation therapy
859683|NCT00063661|fMRI|fmri
859684|NCT00063661|Brain Activity|brain activity
859685|NCT00063661|Overlearned|overlearned
859686|NCT00063661|Dual-Task|dual-task
859687|NCT00063661|Mechanism|mechanism
859688|NCT00063661|Parkinson Disease|parkinson disease
859689|NCT00063661|PD|pd
859690|NCT00063596|Vitamin A|vitamin a
859691|NCT00063596|Hepatitis B vaccine|hepatitis b vaccine
859692|NCT00063596|Immune responses|immune responses
859693|NCT00063596|T-cell subsets|t-cell subsets
859694|NCT00063596|Chronic lung disease|chronic lung disease
859695|NCT00063596|Cytokines, intracytoplasmic|cytokines, intracytoplasmic
859696|NCT00063596|Antibodies, hepatitis B and tetanus toxoid|antibodies, hepatitis b and tetanus toxoid
859697|NCT00063583|Kidney disease|kidney disease
859698|NCT00063570|Cancer of Breast|cancer of breast
859699|NCT00063570|Cancer of the Breast|cancer of the breast
859700|NCT00063323|Maintenance treatment|maintenance treatment
859701|NCT00063323|Smoking relapse|smoking relapse
859702|NCT00063323|Bupropion|bupropion
859972|NCT00062868|CTL|ctl
859704|NCT00033319|colon cancer|colon cancer
859705|NCT00033319|rectal cancer|rectal cancer
859706|NCT00031954|stage II ovarian epithelial cancer|stage ii ovarian epithelial cancer
859707|NCT00031954|stage I ovarian epithelial cancer|stage i ovarian epithelial cancer
859708|NCT00031954|stage III ovarian epithelial cancer|stage iii ovarian epithelial cancer
859709|NCT00031954|stage IV ovarian epithelial cancer|stage iv ovarian epithelial cancer
859710|NCT00031954|fallopian tube cancer|fallopian tube cancer
859711|NCT00031954|primary peritoneal cavity cancer|primary peritoneal cavity cancer
859712|NCT00031889|adenocarcinoma of the prostate|adenocarcinoma of the prostate
859713|NCT00031889|stage IV prostate cancer|stage iv prostate cancer
859714|NCT00031889|recurrent prostate cancer|recurrent prostate cancer
859715|NCT00031668|Waldenstrom macroglobulinemia|waldenstrom macroglobulinemia
859716|NCT00031668|recurrent adult diffuse large cell lymphoma|recurrent adult diffuse large cell lymphoma
859717|NCT00031668|recurrent adult Burkitt lymphoma|recurrent adult burkitt lymphoma
859718|NCT00031668|recurrent adult T-cell leukemia/lymphoma|recurrent adult t-cell leukemia/lymphoma
859719|NCT00031668|anaplastic large cell lymphoma|anaplastic large cell lymphoma
859720|NCT00028938|squamous cell lung cancer|squamous cell lung cancer
859721|NCT00028938|large cell lung cancer|large cell lung cancer
859722|NCT00028938|stage IIIA non-small cell lung cancer|stage iiia non-small cell lung cancer
859723|NCT00028938|stage IIIB non-small cell lung cancer|stage iiib non-small cell lung cancer
859724|NCT00028938|adenocarcinoma of the lung|adenocarcinoma of the lung
859725|NCT00028938|bronchoalveolar cell lung cancer|bronchoalveolar cell lung cancer
859726|NCT00063479|Osteogenesis Imperfecta|osteogenesis imperfecta
859727|NCT00063479|OI|oi
859728|NCT00063479|bone markers|bone markers
859729|NCT00063479|fracture|fracture
859730|NCT00063479|bone loss|bone loss
859731|NCT00063479|pediatric|pediatric
859732|NCT00063479|bisphosphonate|bisphosphonate
859733|NCT00063479|brittle bone disease|brittle bone disease
859734|NCT00063479|pamidronate|pamidronate
859735|NCT00028925|extensive stage small cell lung cancer|extensive stage small cell lung cancer
859736|NCT00028613|recurrent adult diffuse large cell lymphoma|recurrent adult diffuse large cell lymphoma
859737|NCT00063427|Colorectal Cancer|colorectal cancer
859738|NCT00063427|Colorectal Carcinoma|colorectal carcinoma
859739|NCT00063427|Colorectal Tumors|colorectal tumors
859740|NCT00063427|Neoplasms, Colorectal|neoplasms, colorectal
859741|NCT00063427|Colorectal Neoplasms|colorectal neoplasms
859742|NCT00063401|ovarian|ovarian
859743|NCT00063401|primary peritoneal cancer|primary peritoneal cancer
859744|NCT00063401|fallopian tube cancer|fallopian tube cancer
859745|NCT00063388|Non|non
859746|NCT00063388|Small|small
859747|NCT00063388|Cell|cell
859748|NCT00063388|Lung|lung
859749|NCT00063388|Cancer|cancer
859750|NCT00063362|Depression|depression
859751|NCT00030446|recurrent ovarian epithelial cancer|recurrent ovarian epithelial cancer
859752|NCT00030446|fallopian tube cancer|fallopian tube cancer
859753|NCT00030446|peritoneal cavity cancer|peritoneal cavity cancer
859754|NCT00028483|stage IV breast cancer|stage iv breast cancer
859755|NCT00028483|recurrent breast cancer|recurrent breast cancer
859756|NCT00006968|stage III renal cell cancer|stage iii renal cell cancer
859757|NCT00006968|stage IV renal cell cancer|stage iv renal cell cancer
859758|NCT00006968|recurrent renal cell cancer|recurrent renal cell cancer
859759|NCT00003352|stage IV breast cancer|stage iv breast cancer
859760|NCT00003352|recurrent breast cancer|recurrent breast cancer
859761|NCT00003352|stage IIIB breast cancer|stage iiib breast cancer
859762|NCT00063310|Alzheimer disease|alzheimer disease
859763|NCT00063310|Aging Women|aging women
859764|NCT00063310|Hormone therapy|hormone therapy
859765|NCT00063297|schizophrenia with negative symptoms|schizophrenia with negative symptoms
859766|NCT00040729|unspecified adult solid tumor, protocol specific|unspecified adult solid tumor, protocol specific
859767|NCT00063284|Electrical Stimulation|electrical stimulation
859768|NCT00063284|Human Brain|human brain
859769|NCT00063284|Parkinson Disease|parkinson disease
859770|NCT00063284|PD|pd
859771|NCT00063258|Non-Small Cell Lung Cancer|non-small cell lung cancer
859778|NCT00063219|Non-Small-Cell Lung Carcinoma|non-small-cell lung carcinoma
859779|NCT00063219|Lung Cancer|lung cancer
859780|NCT00063219|Cancer of Lung|cancer of lung
859781|NCT00063206|Depressive Disorder, Major|depressive disorder, major
859782|NCT00063206|Depression, Involutional|depression, involutional
859783|NCT00063193|Parkinson's disease|parkinson's disease
859784|NCT00063193|minocycline|minocycline
859785|NCT00063193|creatine|creatine
859786|NCT00063193|neuroprotection|neuroprotection
859787|NCT00063154|Lung cancer|lung cancer
859788|NCT00030797|stage III colon cancer|stage iii colon cancer
859789|NCT00030797|stage IV colon cancer|stage iv colon cancer
859790|NCT00030797|stage III rectal cancer|stage iii rectal cancer
859791|NCT00030797|stage IV rectal cancer|stage iv rectal cancer
859792|NCT00026520|stage IV melanoma|stage iv melanoma
859793|NCT00026520|recurrent melanoma|recurrent melanoma
859794|NCT00026364|stage IV colon cancer|stage iv colon cancer
859795|NCT00026364|stage IV rectal cancer|stage iv rectal cancer
859796|NCT00026364|recurrent colon cancer|recurrent colon cancer
859797|NCT00026364|recurrent rectal cancer|recurrent rectal cancer
859798|NCT00026364|adenocarcinoma of the colon|adenocarcinoma of the colon
859799|NCT00026364|adenocarcinoma of the rectum|adenocarcinoma of the rectum
859800|NCT00026351|stage I chronic lymphocytic leukemia|stage i chronic lymphocytic leukemia
859801|NCT00026351|stage II chronic lymphocytic leukemia|stage ii chronic lymphocytic leukemia
859802|NCT00026351|stage III chronic lymphocytic leukemia|stage iii chronic lymphocytic leukemia
859803|NCT00026351|stage IV chronic lymphocytic leukemia|stage iv chronic lymphocytic leukemia
859804|NCT00026351|refractory chronic lymphocytic leukemia|refractory chronic lymphocytic leukemia
859805|NCT00026351|B-cell chronic lymphocytic leukemia|b-cell chronic lymphocytic leukemia
859806|NCT00026351|stage I grade 1 follicular lymphoma|stage i grade 1 follicular lymphoma
859807|NCT00026351|stage I grade 2 follicular lymphoma|stage i grade 2 follicular lymphoma
859808|NCT00026351|stage I grade 3 follicular lymphoma|stage i grade 3 follicular lymphoma
859809|NCT00026351|stage III grade 1 follicular lymphoma|stage iii grade 1 follicular lymphoma
859810|NCT00026351|stage III grade 2 follicular lymphoma|stage iii grade 2 follicular lymphoma
859811|NCT00026351|stage III grade 3 follicular lymphoma|stage iii grade 3 follicular lymphoma
859812|NCT00026351|stage IV grade 1 follicular lymphoma|stage iv grade 1 follicular lymphoma
859813|NCT00026351|stage IV grade 2 follicular lymphoma|stage iv grade 2 follicular lymphoma
859814|NCT00026351|stage IV grade 3 follicular lymphoma|stage iv grade 3 follicular lymphoma
859815|NCT00026351|recurrent grade 1 follicular lymphoma|recurrent grade 1 follicular lymphoma
859816|NCT00026351|recurrent grade 2 follicular lymphoma|recurrent grade 2 follicular lymphoma
859817|NCT00026351|recurrent grade 3 follicular lymphoma|recurrent grade 3 follicular lymphoma
859818|NCT00026351|prolymphocytic leukemia|prolymphocytic leukemia
859819|NCT00026351|contiguous stage II grade 1 follicular lymphoma|contiguous stage ii grade 1 follicular lymphoma
859820|NCT00026351|contiguous stage II grade 2 follicular lymphoma|contiguous stage ii grade 2 follicular lymphoma
859821|NCT00026351|contiguous stage II grade 3 follicular lymphoma|contiguous stage ii grade 3 follicular lymphoma
859822|NCT00026351|noncontiguous stage II grade 1 follicular lymphoma|noncontiguous stage ii grade 1 follicular lymphoma
859823|NCT00026351|noncontiguous stage II grade 2 follicular lymphoma|noncontiguous stage ii grade 2 follicular lymphoma
859824|NCT00026351|noncontiguous stage II grade 3 follicular lymphoma|noncontiguous stage ii grade 3 follicular lymphoma
859825|NCT00026351|noncontiguous stage II small lymphocytic lymphoma|noncontiguous stage ii small lymphocytic lymphoma
859826|NCT00026351|noncontiguous stage II marginal zone lymphoma|noncontiguous stage ii marginal zone lymphoma
859827|NCT00026351|recurrent marginal zone lymphoma|recurrent marginal zone lymphoma
859828|NCT00026351|recurrent small lymphocytic lymphoma|recurrent small lymphocytic lymphoma
859829|NCT00026351|stage I marginal zone lymphoma|stage i marginal zone lymphoma
859830|NCT00026351|stage I small lymphocytic lymphoma|stage i small lymphocytic lymphoma
859831|NCT00026351|stage III small lymphocytic lymphoma|stage iii small lymphocytic lymphoma
859832|NCT00026351|stage III marginal zone lymphoma|stage iii marginal zone lymphoma
859833|NCT00026351|stage IV small lymphocytic lymphoma|stage iv small lymphocytic lymphoma
859834|NCT00026351|stage IV marginal zone lymphoma|stage iv marginal zone lymphoma
859835|NCT00026351|contiguous stage II marginal zone lymphoma|contiguous stage ii marginal zone lymphoma
859836|NCT00026351|contiguous stage II small lymphocytic lymphoma|contiguous stage ii small lymphocytic lymphoma
859837|NCT00026351|extranodal marginal zone B-cell lymphoma of mucosa-associated lymphoid tissue|extranodal marginal zone b-cell lymphoma of mucosa-associated lymphoid tissue
859838|NCT00025571|squamous cell lung cancer|squamous cell lung cancer
859839|NCT00025571|large cell lung cancer|large cell lung cancer
859840|NCT00025571|adenocarcinoma of the lung|adenocarcinoma of the lung
859841|NCT00025571|stage I non-small cell lung cancer|stage i non-small cell lung cancer
859842|NCT00025571|stage II non-small cell lung cancer|stage ii non-small cell lung cancer
859843|NCT00006013|refractory multiple myeloma|refractory multiple myeloma
859844|NCT00004037|stage IV ovarian epithelial cancer|stage iv ovarian epithelial cancer
859845|NCT00004037|recurrent ovarian epithelial cancer|recurrent ovarian epithelial cancer
859846|NCT00004037|primary peritoneal cavity cancer|primary peritoneal cavity cancer
859847|NCT00003054|recurrent uterine sarcoma|recurrent uterine sarcoma
859848|NCT00003054|uterine leiomyosarcoma|uterine leiomyosarcoma
859849|NCT00063245|Motor Cortex|motor cortex
859850|NCT00063245|Mood|mood
859851|NCT00063245|Reward|reward
859852|NCT00063245|Transcranial Magnetic Stimulation|transcranial magnetic stimulation
859853|NCT00063245|Magnetic Coil|magnetic coil
859854|NCT00063245|Healthy Volunteer|healthy volunteer
859857|NCT00063232|Obesity|obesity
859858|NCT00063232|Fatty Liver|fatty liver
859859|NCT00063232|Diabetes|diabetes
859860|NCT00063232|Cirrhosis|cirrhosis
859861|NCT00063232|Metformin|metformin
859862|NCT00063232|Insulin Resistance|insulin resistance
859863|NCT00063232|Nonalcoholic Steatohepatitis|nonalcoholic steatohepatitis
859864|NCT00063232|Hepatitis|hepatitis
859865|NCT00063232|NASH|nash
859866|NCT00063180|Diaschisis|diaschisis
859867|NCT00063180|Glucose|glucose
859868|NCT00063180|GABA|gaba
859869|NCT00063180|N-Acetylaspartate|n-acetylaspartate
859870|NCT00063180|Glutamate|glutamate
859871|NCT00063180|Stroke|stroke
859872|NCT00063180|Healthy Volunteer|healthy volunteer
859873|NCT00063180|HV|hv
859874|NCT00063115|Praxis Movements|praxis movements
859875|NCT00063115|Pantomime|pantomime
859876|NCT00063115|Statistical Parametric Mapping|statistical parametric mapping
859877|NCT00063115|Functional Connectivity|functional connectivity
859878|NCT00063115|Path Analysis|path analysis
859879|NCT00063115|Ideomotor Apraxia|ideomotor apraxia
859880|NCT00063115|Healthy Volunteer|healthy volunteer
859881|NCT00063115|HV|hv
859882|NCT00063089|Staphylococcal infection|staphylococcal infection
859883|NCT00063089|Gram positive bacteria|gram positive bacteria
859884|NCT00063089|Staphylococcus|staphylococcus
859885|NCT00063089|Staphylococcus aureus|staphylococcus aureus
859886|NCT00063076|Alopecia Areata|alopecia areata
859887|NCT00063076|Alopecia Totalis|alopecia totalis
859888|NCT00063076|Alopecia Universalis|alopecia universalis
859889|NCT00063076|Targretin Gel|targretin gel
859890|NCT00063063|NICHD Neonatal Research Network|nichd neonatal research network
859891|NCT00063063|Extremely Low Birth Weight (ELBW)|extremely low birth weight (elbw)
859892|NCT00063063|Prematurity|prematurity
859893|NCT00063050|Bone density|bone density
859894|NCT00063050|Children|children
859895|NCT00063050|Adolescents|adolescents
859896|NCT00063050|Behavior|behavior
859897|NCT00063050|Health education|health education
859898|NCT00063050|Health promotion|health promotion
859899|NCT00063050|Physical fitness|physical fitness
859900|NCT00063050|Diet|diet
859901|NCT00063050|Parent training|parent training
859902|NCT00063050|Injury control|injury control
859903|NCT00063037|Bone mass|bone mass
859904|NCT00063037|Calcium intake|calcium intake
859905|NCT00063037|Prevention of osteoporosis|prevention of osteoporosis
859906|NCT00063037|Optimizing peak bone mass|optimizing peak bone mass
859907|NCT00063037|Bone mineral density|bone mineral density
859908|NCT00063024|Bone health|bone health
859909|NCT00063024|Weight-bearing physical activity|weight-bearing physical activity
859910|NCT00063024|Calcium|calcium
859911|NCT00063011|Weight-bearing exercise|weight-bearing exercise
859912|NCT00063011|Calcium-rich diet|calcium-rich diet
859913|NCT00063011|Adolescents|adolescents
859914|NCT00063011|Females|females
859915|NCT00063011|Bone mass|bone mass
859916|NCT00063011|Osteopenia|osteopenia
859917|NCT00025545|recurrent childhood acute lymphoblastic leukemia|recurrent childhood acute lymphoblastic leukemia
859918|NCT00025545|recurrent childhood acute myeloid leukemia|recurrent childhood acute myeloid leukemia
859919|NCT00025545|recurrent adult acute myeloid leukemia|recurrent adult acute myeloid leukemia
859920|NCT00025545|recurrent adult acute lymphoblastic leukemia|recurrent adult acute lymphoblastic leukemia
859921|NCT00025545|adult acute lymphoblastic leukemia in remission|adult acute lymphoblastic leukemia in remission
859922|NCT00025545|childhood acute lymphoblastic leukemia in remission|childhood acute lymphoblastic leukemia in remission
859923|NCT00025545|acute undifferentiated leukemia|acute undifferentiated leukemia
859924|NCT00025545|secondary acute myeloid leukemia|secondary acute myeloid leukemia
859925|NCT00024323|unspecified adult solid tumor, protocol specific|unspecified adult solid tumor, protocol specific
859926|NCT00024310|unspecified adult solid tumor, protocol specific|unspecified adult solid tumor, protocol specific
859927|NCT00024310|drug/agent toxicity by tissue/organ|drug/agent toxicity by tissue/organ
859928|NCT00024141|unspecified adult solid tumor, protocol specific|unspecified adult solid tumor, protocol specific
859929|NCT00062985|obesity treatment|obesity treatment
859930|NCT00062985|weight management|weight management
859931|NCT00062985|managed care|managed care
859932|NCT00062972|Multiple Sclerosis|multiple sclerosis
859933|NCT00062972|Cognitive Dysfunction|cognitive dysfunction
859934|NCT00062972|Treatment Interventions|treatment interventions
859935|NCT00062972|Verbal memory deficits|verbal memory deficits
859936|NCT00062959|Adolescence|adolescence
859937|NCT00062959|Parenting|parenting
859938|NCT00062959|School|school
859939|NCT00062959|Primary Prevention|primary prevention
859940|NCT00062959|School-based intervention|school-based intervention
859941|NCT00062894|Iodine I 131 Tositumomab|iodine i 131 tositumomab
859942|NCT00062894|BEXXAR|bexxar
859943|NCT00062894|non-Hodgkin's lymphoma|non-hodgkin's lymphoma
859944|NCT00062946|Thalamus|thalamus
859945|NCT00062946|Cerebral Cortices|cerebral cortices
859946|NCT00062946|Quantification|quantification
859947|NCT00062946|Reproducibility|reproducibility
859948|NCT00062946|Dopamine Release|dopamine release
859949|NCT00062946|(18F) Fallypride|(18f) fallypride
859950|NCT00062946|D-Amphetamine|d-amphetamine
859951|NCT00062946|Alpha-Methyl-Para-Tyrosine (AMPT)|alpha-methyl-para-tyrosine (ampt)
859952|NCT00062946|PET|pet
859953|NCT00062946|Dopamine D2 Receptor|dopamine d2 receptor
859954|NCT00062946|Healthy Volunteer|healthy volunteer
859955|NCT00062946|HV|hv
859956|NCT00062933|Clinical Response|clinical response
859957|NCT00062933|Duration of Response|duration of response
859958|NCT00062933|Quality of Life|quality of life
859959|NCT00062933|Hyperthermia|hyperthermia
859960|NCT00062933|Survival|survival
859961|NCT00062933|Melanoma|melanoma
859962|NCT00062933|Ocular Melanoma|ocular melanoma
859963|NCT00062933|Eye Cancer|eye cancer
859964|NCT00062881|Cancer|cancer
859965|NCT00062881|Leukemia|leukemia
859966|NCT00062881|Lymphoma|lymphoma
859967|NCT00062881|Solid Tumor|solid tumor
859968|NCT00062868|Lymphoma|lymphoma
859969|NCT00062868|EBV-T/NK lymphoproliferative disease|ebv-t/nk lymphoproliferative disease
859970|NCT00062868|Severe Chronic EBV|severe chronic ebv
859971|NCT00062868|LMP1/2|lmp1/2
859975|NCT00062855|GENE MODIFIED AUTOLOGOUS NEUROBLASTOMA CELLS|gene modified autologous neuroblastoma cells
859976|NCT00062855|Gene Therapy|gene therapy
859977|NCT00062829|Teen driving|teen driving
859978|NCT00062829|Adolescent risk behavior|adolescent risk behavior
859979|NCT00062829|Parenting|parenting
859980|NCT00062829|Checkpoints Program|checkpoints program
859981|NCT00062829|Health Education|health education
859982|NCT00062816|Hepatitis|hepatitis
859983|NCT00062816|Chronic|chronic
859984|NCT00002643|neutropenia|neutropenia
859985|NCT00002643|metastatic Ewing sarcoma/peripheral primitive neuroectodermal tumor|metastatic ewing sarcoma/peripheral primitive neuroectodermal tumor
859986|NCT00062790|Testosterone|testosterone
859987|NCT00062790|DHT|dht
859988|NCT00062790|TURP|turp
859989|NCT00027612|adult glioblastoma|adult glioblastoma
859990|NCT00027612|adult giant cell glioblastoma|adult giant cell glioblastoma
859991|NCT00027612|adult gliosarcoma|adult gliosarcoma
859992|NCT00025376|stage IV renal cell cancer|stage iv renal cell cancer
859993|NCT00025376|recurrent renal cell cancer|recurrent renal cell cancer
859994|NCT00023868|stage IV colon cancer|stage iv colon cancer
859995|NCT00023868|stage IV rectal cancer|stage iv rectal cancer
859996|NCT00023868|recurrent colon cancer|recurrent colon cancer
859997|NCT00023868|recurrent rectal cancer|recurrent rectal cancer
859998|NCT00023868|adenocarcinoma of the colon|adenocarcinoma of the colon
859999|NCT00023868|adenocarcinoma of the rectum|adenocarcinoma of the rectum
860000|NCT00023868|liver metastases|liver metastases
860001|NCT00022594|recurrent metastatic squamous neck cancer with occult primary|recurrent metastatic squamous neck cancer with occult primary
860002|NCT00022594|metastatic squamous neck cancer with occult primary squamous cell carcinoma|metastatic squamous neck cancer with occult primary squamous cell carcinoma
860003|NCT00022594|stage III squamous cell carcinoma of the lip and oral cavity|stage iii squamous cell carcinoma of the lip and oral cavity
860004|NCT00022594|stage IV squamous cell carcinoma of the lip and oral cavity|stage iv squamous cell carcinoma of the lip and oral cavity
860005|NCT00022594|recurrent squamous cell carcinoma of the lip and oral cavity|recurrent squamous cell carcinoma of the lip and oral cavity
860006|NCT00022594|stage III squamous cell carcinoma of the oropharynx|stage iii squamous cell carcinoma of the oropharynx
860007|NCT00022594|stage IV squamous cell carcinoma of the oropharynx|stage iv squamous cell carcinoma of the oropharynx
860008|NCT00022594|recurrent squamous cell carcinoma of the oropharynx|recurrent squamous cell carcinoma of the oropharynx
860009|NCT00022594|stage III squamous cell carcinoma of the hypopharynx|stage iii squamous cell carcinoma of the hypopharynx
860010|NCT00022594|stage IV squamous cell carcinoma of the hypopharynx|stage iv squamous cell carcinoma of the hypopharynx
860011|NCT00022594|recurrent squamous cell carcinoma of the hypopharynx|recurrent squamous cell carcinoma of the hypopharynx
860012|NCT00022594|stage III squamous cell carcinoma of the larynx|stage iii squamous cell carcinoma of the larynx
860013|NCT00022594|stage IV squamous cell carcinoma of the larynx|stage iv squamous cell carcinoma of the larynx
860014|NCT00022594|recurrent squamous cell carcinoma of the larynx|recurrent squamous cell carcinoma of the larynx
860015|NCT00062777|Genetics|genetics
860016|NCT00062777|Populations|populations
860017|NCT00062777|CVD Risk|cvd risk
860018|NCT00062777|Gene Mapping|gene mapping
860019|NCT00062777|Epidemiology|epidemiology
860020|NCT00062777|Framingham Study|framingham study
860021|NCT00062777|Vascular Diseases|vascular diseases
860022|NCT00062764|Insulin Resistance|insulin resistance
860023|NCT00062764|Obesity|obesity
860024|NCT00062764|Fatty Liver|fatty liver
860025|NCT00062764|Cirrhosis|cirrhosis
860026|NCT00062764|Diabetes|diabetes
860027|NCT00062764|Pioglitazone|pioglitazone
860028|NCT00062764|Thiazolidinediones|thiazolidinediones
860029|NCT00062764|Peroxisome Proliferator-Advanced Receptor Gamma|peroxisome proliferator-advanced receptor gamma
860030|NCT00062764|PPAR Gama|ppar gama
860031|NCT00062764|Nonalcoholic Steatohepatitis|nonalcoholic steatohepatitis
860032|NCT00062764|Hepatitis|hepatitis
860033|NCT00062764|Non-Alcoholic Steatohepatitis|non-alcoholic steatohepatitis
860037|NCT00062738|Parkinson's disease|parkinson's disease
860038|NCT00062738|Parkinson disease|parkinson disease
860039|NCT00062738|depression|depression
860040|NCT00062738|antidepressants|antidepressants
860041|NCT00062738|nortriptyline|nortriptyline
860042|NCT00062738|paroxetine|paroxetine
860043|NCT00062712|Immunosuppression|immunosuppression
860044|NCT00062712|Transplant|transplant
860045|NCT00062712|Kidney Transplant|kidney transplant
860046|NCT00062686|Lapatinib|lapatinib
860047|NCT00062686|Metastatic Breast Cancer|metastatic breast cancer
860048|NCT00062686|HERCEPTIN refractory|herceptin refractory
860049|NCT00062634|Female condom use|female condom use
860050|NCT00062634|Male condom use|male condom use
860051|NCT00062634|AIDS education|aids education
860052|NCT00062634|AIDS prevention|aids prevention
860053|NCT00062634|HIV Seronegativity|hiv seronegativity
860054|NCT00062621|Immune tolerance|immune tolerance
860055|NCT00062621|Graft vs host disease|graft vs host disease
860056|NCT00062621|Kidney Failure|kidney failure
860057|NCT00062621|Kidney diseases|kidney diseases
860058|NCT00062621|End Stage Renal Disease|end stage renal disease
860059|NCT00062621|Multiple Myeloma|multiple myeloma
860060|NCT00062621|Bone Marrow Transplant|bone marrow transplant
860061|NCT00062621|Kidney Transplant|kidney transplant
860062|NCT00062621|Renal Transplant|renal transplant
860069|NCT00062595|Bone turnover|bone turnover
860070|NCT00062595|Bone Density|bone density
860071|NCT00062569|Alzheimer disease|alzheimer disease
860072|NCT00062569|Resistiveness to baths|resistiveness to baths
860073|NCT00062569|Caregiver stress|caregiver stress
860074|NCT00062569|Bathing support intervention|bathing support intervention
860075|NCT00062569|Reminiscence|reminiscence
860076|NCT00062569|Agitated behavior|agitated behavior
860077|NCT00062569|Resistiveness to care|resistiveness to care
860078|NCT00062556|Intermittent Claudication|intermittent claudication
860079|NCT00062556|Peripheral Arterial Disease|peripheral arterial disease
860080|NCT00062556|Atherosclerosis|atherosclerosis
860081|NCT00062556|Niacin|niacin
860082|NCT00062556|Lovastatin|lovastatin
860083|NCT00062556|PAD|pad
860084|NCT00062556|IC|ic
860085|NCT00062543|Severe hepatic dysfunction post stem cell transplantation|severe hepatic dysfunction post stem cell transplantation
860086|NCT00062543|Stem Cell Transplantation|stem cell transplantation
860087|NCT00062543|Hepatic Artery Infusion|hepatic artery infusion
860088|NCT00062543|Liver Diseases|liver diseases
860089|NCT00062543|CD34+ Cells|cd34+ cells
860090|NCT00062543|SCT|sct
860091|NCT00062530|AIDS|aids
860092|NCT00062530|HIV seronegativity|hiv seronegativity
860093|NCT00062530|HIV preventive vaccine|hiv preventive vaccine
860094|NCT00022009|stage IIIA non-small cell lung cancer|stage iiia non-small cell lung cancer
860095|NCT00022009|stage IIIB non-small cell lung cancer|stage iiib non-small cell lung cancer
860096|NCT00022009|stage IV non-small cell lung cancer|stage iv non-small cell lung cancer
860097|NCT00018954|stage I childhood lymphoblastic lymphoma|stage i childhood lymphoblastic lymphoma
860098|NCT00018954|stage II childhood lymphoblastic lymphoma|stage ii childhood lymphoblastic lymphoma
860099|NCT00018954|stage III childhood lymphoblastic lymphoma|stage iii childhood lymphoblastic lymphoma
860100|NCT00018954|stage IV childhood lymphoblastic lymphoma|stage iv childhood lymphoblastic lymphoma
860101|NCT00018954|untreated adult acute lymphoblastic leukemia|untreated adult acute lymphoblastic leukemia
860102|NCT00018954|untreated childhood acute lymphoblastic leukemia|untreated childhood acute lymphoblastic leukemia
860103|NCT00018954|stage I adult diffuse small cleaved cell lymphoma|stage i adult diffuse small cleaved cell lymphoma
860104|NCT00018954|stage I adult diffuse mixed cell lymphoma|stage i adult diffuse mixed cell lymphoma
860105|NCT00018954|stage I adult diffuse large cell lymphoma|stage i adult diffuse large cell lymphoma
860106|NCT00018954|stage I adult immunoblastic large cell lymphoma|stage i adult immunoblastic large cell lymphoma
860107|NCT00018954|stage I adult lymphoblastic lymphoma|stage i adult lymphoblastic lymphoma
860108|NCT00018954|stage I adult Burkitt lymphoma|stage i adult burkitt lymphoma
860109|NCT00018954|stage III adult diffuse small cleaved cell lymphoma|stage iii adult diffuse small cleaved cell lymphoma
860110|NCT00018954|stage III adult diffuse mixed cell lymphoma|stage iii adult diffuse mixed cell lymphoma
860111|NCT00018954|stage III adult diffuse large cell lymphoma|stage iii adult diffuse large cell lymphoma
860112|NCT00018954|stage III adult immunoblastic large cell lymphoma|stage iii adult immunoblastic large cell lymphoma
860113|NCT00018954|stage III adult lymphoblastic lymphoma|stage iii adult lymphoblastic lymphoma
860114|NCT00018954|stage III adult Burkitt lymphoma|stage iii adult burkitt lymphoma
860115|NCT00018954|stage IV adult diffuse small cleaved cell lymphoma|stage iv adult diffuse small cleaved cell lymphoma
860116|NCT00018954|stage IV adult diffuse mixed cell lymphoma|stage iv adult diffuse mixed cell lymphoma
860117|NCT00018954|stage IV adult diffuse large cell lymphoma|stage iv adult diffuse large cell lymphoma
860118|NCT00018954|stage IV adult immunoblastic large cell lymphoma|stage iv adult immunoblastic large cell lymphoma
860119|NCT00018954|stage IV adult lymphoblastic lymphoma|stage iv adult lymphoblastic lymphoma
860120|NCT00018954|stage IV adult Burkitt lymphoma|stage iv adult burkitt lymphoma
860121|NCT00018954|stage I childhood small noncleaved cell lymphoma|stage i childhood small noncleaved cell lymphoma
860122|NCT00018954|stage I childhood large cell lymphoma|stage i childhood large cell lymphoma
860123|NCT00018954|stage II childhood small noncleaved cell lymphoma|stage ii childhood small noncleaved cell lymphoma
860124|NCT00018954|stage II childhood large cell lymphoma|stage ii childhood large cell lymphoma
860125|NCT00018954|stage III childhood small noncleaved cell lymphoma|stage iii childhood small noncleaved cell lymphoma
860126|NCT00018954|stage III childhood large cell lymphoma|stage iii childhood large cell lymphoma
860127|NCT00018954|stage IV childhood small noncleaved cell lymphoma|stage iv childhood small noncleaved cell lymphoma
860128|NCT00018954|stage IV childhood large cell lymphoma|stage iv childhood large cell lymphoma
860129|NCT00018954|stage I mantle cell lymphoma|stage i mantle cell lymphoma
860130|NCT00018954|contiguous stage II adult diffuse small cleaved cell lymphoma|contiguous stage ii adult diffuse small cleaved cell lymphoma
860131|NCT00018954|contiguous stage II mantle cell lymphoma|contiguous stage ii mantle cell lymphoma
860132|NCT00018954|contiguous stage II adult diffuse mixed cell lymphoma|contiguous stage ii adult diffuse mixed cell lymphoma
860133|NCT00018954|contiguous stage II adult immunoblastic large cell lymphoma|contiguous stage ii adult immunoblastic large cell lymphoma
860134|NCT00018954|contiguous stage II adult diffuse large cell lymphoma|contiguous stage ii adult diffuse large cell lymphoma
860135|NCT00018954|contiguous stage II adult Burkitt lymphoma|contiguous stage ii adult burkitt lymphoma
860136|NCT00018954|contiguous stage II adult lymphoblastic lymphoma|contiguous stage ii adult lymphoblastic lymphoma
860137|NCT00018954|noncontiguous stage II adult diffuse small cleaved cell lymphoma|noncontiguous stage ii adult diffuse small cleaved cell lymphoma
860915|NCT00019084|recurrent colon cancer|recurrent colon cancer
860138|NCT00018954|noncontiguous stage II mantle cell lymphoma|noncontiguous stage ii mantle cell lymphoma
860139|NCT00018954|noncontiguous stage II adult diffuse mixed cell lymphoma|noncontiguous stage ii adult diffuse mixed cell lymphoma
860140|NCT00018954|noncontiguous stage II adult immunoblastic large cell lymphoma|noncontiguous stage ii adult immunoblastic large cell lymphoma
860141|NCT00018954|noncontiguous stage II adult diffuse large cell lymphoma|noncontiguous stage ii adult diffuse large cell lymphoma
860142|NCT00018954|noncontiguous stage II adult Burkitt lymphoma|noncontiguous stage ii adult burkitt lymphoma
860143|NCT00018954|noncontiguous stage II adult lymphoblastic lymphoma|noncontiguous stage ii adult lymphoblastic lymphoma
860144|NCT00018954|stage III mantle cell lymphoma|stage iii mantle cell lymphoma
860145|NCT00018954|stage IV mantle cell lymphoma|stage iv mantle cell lymphoma
860146|NCT00018954|noncontiguous stage II small lymphocytic lymphoma|noncontiguous stage ii small lymphocytic lymphoma
860147|NCT00018954|noncontiguous stage II marginal zone lymphoma|noncontiguous stage ii marginal zone lymphoma
860148|NCT00018954|stage I marginal zone lymphoma|stage i marginal zone lymphoma
860149|NCT00018954|stage I small lymphocytic lymphoma|stage i small lymphocytic lymphoma
860150|NCT00018954|stage III small lymphocytic lymphoma|stage iii small lymphocytic lymphoma
860151|NCT00018954|stage III marginal zone lymphoma|stage iii marginal zone lymphoma
860152|NCT00018954|stage IV small lymphocytic lymphoma|stage iv small lymphocytic lymphoma
860153|NCT00018954|stage IV marginal zone lymphoma|stage iv marginal zone lymphoma
860154|NCT00018954|contiguous stage II marginal zone lymphoma|contiguous stage ii marginal zone lymphoma
860155|NCT00018954|contiguous stage II small lymphocytic lymphoma|contiguous stage ii small lymphocytic lymphoma
860156|NCT00018954|extranodal marginal zone B-cell lymphoma of mucosa-associated lymphoid tissue|extranodal marginal zone b-cell lymphoma of mucosa-associated lymphoid tissue
860157|NCT00018954|nodal marginal zone B-cell lymphoma|nodal marginal zone b-cell lymphoma
860158|NCT00018954|splenic marginal zone lymphoma|splenic marginal zone lymphoma
860159|NCT00017446|stage III adult soft tissue sarcoma|stage iii adult soft tissue sarcoma
860160|NCT00017446|recurrent adult soft tissue sarcoma|recurrent adult soft tissue sarcoma
860161|NCT00017446|stage IV adult soft tissue sarcoma|stage iv adult soft tissue sarcoma
860162|NCT00017316|stage IV melanoma|stage iv melanoma
860163|NCT00017316|recurrent melanoma|recurrent melanoma
860164|NCT00062582|Roflumilast|roflumilast
860165|NCT00062582|Chronic Obstructive Pulmonary Disease|chronic obstructive pulmonary disease
860166|NCT00062582|COPD|copd
860167|NCT00014664|recurrent grade 1 follicular lymphoma|recurrent grade 1 follicular lymphoma
860168|NCT00014664|recurrent grade 2 follicular lymphoma|recurrent grade 2 follicular lymphoma
860169|NCT00014664|recurrent grade 3 follicular lymphoma|recurrent grade 3 follicular lymphoma
860170|NCT00014664|recurrent marginal zone lymphoma|recurrent marginal zone lymphoma
860171|NCT00014664|recurrent small lymphocytic lymphoma|recurrent small lymphocytic lymphoma
860172|NCT00014664|extranodal marginal zone B-cell lymphoma of mucosa-associated lymphoid tissue|extranodal marginal zone b-cell lymphoma of mucosa-associated lymphoid tissue
860173|NCT00014534|stage III bladder cancer|stage iii bladder cancer
860174|NCT00014534|stage IV bladder cancer|stage iv bladder cancer
860175|NCT00014534|transitional cell carcinoma of the bladder|transitional cell carcinoma of the bladder
860176|NCT00062517|Amygdala|amygdala
860177|NCT00062517|Generalized Anxiety Disorder|generalized anxiety disorder
860178|NCT00062517|Anxiety Disorder|anxiety disorder
860180|NCT00062517|Social Anxiety Disorder|social anxiety disorder
860181|NCT00062517|SAD|sad
860182|NCT00012155|stage IV colon cancer|stage iv colon cancer
860183|NCT00012155|recurrent colon cancer|recurrent colon cancer
860184|NCT00012155|adenocarcinoma of the colon|adenocarcinoma of the colon
860185|NCT00012155|liver metastases|liver metastases
860186|NCT00062465|DMARD|dmard
860187|NCT00062465|Clinical Trial|clinical trial
860188|NCT00062465|Thunder God Vine|thunder god vine
860189|NCT00062465|Chinese Herb|chinese herb
860190|NCT00062465|Rheumatoid Arthritis|rheumatoid arthritis
860191|NCT00062465|RA|ra
860192|NCT00062452|Esophageal|esophageal
860193|NCT00062452|Airway|airway
860194|NCT00062439|stage II non-small cell lung cancer|stage ii non-small cell lung cancer
860195|NCT00062439|stage IIIA non-small cell lung cancer|stage iiia non-small cell lung cancer
860196|NCT00062439|stage IIIB non-small cell lung cancer|stage iiib non-small cell lung cancer
860197|NCT00062426|adenocarcinoma of the colon|adenocarcinoma of the colon
860198|NCT00062426|adenocarcinoma of the rectum|adenocarcinoma of the rectum
860199|NCT00062426|recurrent colon cancer|recurrent colon cancer
860200|NCT00062426|stage IV colon cancer|stage iv colon cancer
860201|NCT00062426|recurrent rectal cancer|recurrent rectal cancer
860202|NCT00062426|stage IV rectal cancer|stage iv rectal cancer
860203|NCT00062400|sexual dysfunction and infertility|sexual dysfunction and infertility
860204|NCT00062400|sexuality and reproductive issues|sexuality and reproductive issues
860205|NCT00062400|psychosocial effects of cancer and its treatment|psychosocial effects of cancer and its treatment
860206|NCT00062400|stage II breast cancer|stage ii breast cancer
860207|NCT00062400|stage IA breast cancer|stage ia breast cancer
860208|NCT00062400|stage IB breast cancer|stage ib breast cancer
860209|NCT00062387|stage IV squamous cell carcinoma of the hypopharynx|stage iv squamous cell carcinoma of the hypopharynx
860210|NCT00062387|stage IV squamous cell carcinoma of the larynx|stage iv squamous cell carcinoma of the larynx
860211|NCT00062387|stage IV squamous cell carcinoma of the lip and oral cavity|stage iv squamous cell carcinoma of the lip and oral cavity
860212|NCT00062387|stage IV squamous cell carcinoma of the nasopharynx|stage iv squamous cell carcinoma of the nasopharynx
860213|NCT00062387|stage IV squamous cell carcinoma of the oropharynx|stage iv squamous cell carcinoma of the oropharynx
860214|NCT00062387|stage IV squamous cell carcinoma of the paranasal sinus and nasal cavity|stage iv squamous cell carcinoma of the paranasal sinus and nasal cavity
860215|NCT00062387|recurrent squamous cell carcinoma of the hypopharynx|recurrent squamous cell carcinoma of the hypopharynx
860216|NCT00062387|recurrent squamous cell carcinoma of the larynx|recurrent squamous cell carcinoma of the larynx
860217|NCT00062387|recurrent squamous cell carcinoma of the lip and oral cavity|recurrent squamous cell carcinoma of the lip and oral cavity
860218|NCT00062387|recurrent squamous cell carcinoma of the nasopharynx|recurrent squamous cell carcinoma of the nasopharynx
860219|NCT00062387|recurrent squamous cell carcinoma of the oropharynx|recurrent squamous cell carcinoma of the oropharynx
860220|NCT00062387|recurrent squamous cell carcinoma of the paranasal sinus and nasal cavity|recurrent squamous cell carcinoma of the paranasal sinus and nasal cavity
860221|NCT00062387|metastatic squamous neck cancer with occult primary squamous cell carcinoma|metastatic squamous neck cancer with occult primary squamous cell carcinoma
860222|NCT00062387|recurrent metastatic squamous neck cancer with occult primary|recurrent metastatic squamous neck cancer with occult primary
860223|NCT00062387|recurrent salivary gland cancer|recurrent salivary gland cancer
860224|NCT00062387|salivary gland squamous cell carcinoma|salivary gland squamous cell carcinoma
860225|NCT00062387|stage IV salivary gland cancer|stage iv salivary gland cancer
860226|NCT00062348|recurrent squamous cell carcinoma of the hypopharynx|recurrent squamous cell carcinoma of the hypopharynx
860227|NCT00062348|recurrent squamous cell carcinoma of the larynx|recurrent squamous cell carcinoma of the larynx
860228|NCT00062348|recurrent squamous cell carcinoma of the lip and oral cavity|recurrent squamous cell carcinoma of the lip and oral cavity
860229|NCT00062348|recurrent squamous cell carcinoma of the nasopharynx|recurrent squamous cell carcinoma of the nasopharynx
860230|NCT00062348|recurrent squamous cell carcinoma of the oropharynx|recurrent squamous cell carcinoma of the oropharynx
860231|NCT00062348|recurrent squamous cell carcinoma of the paranasal sinus and nasal cavity|recurrent squamous cell carcinoma of the paranasal sinus and nasal cavity
860232|NCT00062348|stage IV squamous cell carcinoma of the hypopharynx|stage iv squamous cell carcinoma of the hypopharynx
860233|NCT00062348|stage IV squamous cell carcinoma of the larynx|stage iv squamous cell carcinoma of the larynx
860234|NCT00062348|stage IV squamous cell carcinoma of the lip and oral cavity|stage iv squamous cell carcinoma of the lip and oral cavity
860235|NCT00062348|stage IV squamous cell carcinoma of the nasopharynx|stage iv squamous cell carcinoma of the nasopharynx
860236|NCT00062348|stage IV squamous cell carcinoma of the oropharynx|stage iv squamous cell carcinoma of the oropharynx
860237|NCT00062348|stage IV squamous cell carcinoma of the paranasal sinus and nasal cavity|stage iv squamous cell carcinoma of the paranasal sinus and nasal cavity
860238|NCT00062348|untreated metastatic squamous neck cancer with occult primary|untreated metastatic squamous neck cancer with occult primary
860239|NCT00062348|recurrent thyroid cancer|recurrent thyroid cancer
860240|NCT00062348|stage IV follicular thyroid cancer|stage iv follicular thyroid cancer
860241|NCT00062348|stage IV papillary thyroid cancer|stage iv papillary thyroid cancer
860242|NCT00062348|stage IVA colon cancer|stage iva colon cancer
860243|NCT00062348|stage IVB colon cancer|stage ivb colon cancer
860244|NCT00062348|recurrent colon cancer|recurrent colon cancer
860245|NCT00062348|adenocarcinoma of the colon|adenocarcinoma of the colon
860246|NCT00062348|recurrent rectal cancer|recurrent rectal cancer
860247|NCT00062348|stage IVA rectal cancer|stage iva rectal cancer
860248|NCT00062348|stage IVB rectal cancer|stage ivb rectal cancer
860249|NCT00062348|adenocarcinoma of the rectum|adenocarcinoma of the rectum
860250|NCT00062348|anaplastic thyroid cancer|anaplastic thyroid cancer
860251|NCT00062348|insular thyroid cancer|insular thyroid cancer
860252|NCT00062348|thyroid gland medullary carcinoma|thyroid gland medullary carcinoma
860253|NCT00062348|liver metastases|liver metastases
860254|NCT00062348|stage I squamous cell carcinoma of the hypopharynx|stage i squamous cell carcinoma of the hypopharynx
860255|NCT00062348|stage I squamous cell carcinoma of the larynx|stage i squamous cell carcinoma of the larynx
860256|NCT00062348|stage I squamous cell carcinoma of the lip and oral cavity|stage i squamous cell carcinoma of the lip and oral cavity
860257|NCT00062348|stage I squamous cell carcinoma of the nasopharynx|stage i squamous cell carcinoma of the nasopharynx
860258|NCT00062348|stage I squamous cell carcinoma of the oropharynx|stage i squamous cell carcinoma of the oropharynx
860259|NCT00062348|stage I squamous cell carcinoma of the paranasal sinus and nasal cavity|stage i squamous cell carcinoma of the paranasal sinus and nasal cavity
860260|NCT00062348|stage II squamous cell carcinoma of the hypopharynx|stage ii squamous cell carcinoma of the hypopharynx
860261|NCT00062348|stage II squamous cell carcinoma of the larynx|stage ii squamous cell carcinoma of the larynx
860262|NCT00062348|stage II squamous cell carcinoma of the lip and oral cavity|stage ii squamous cell carcinoma of the lip and oral cavity
860263|NCT00062348|stage II squamous cell carcinoma of the nasopharynx|stage ii squamous cell carcinoma of the nasopharynx
860264|NCT00062348|stage II squamous cell carcinoma of the oropharynx|stage ii squamous cell carcinoma of the oropharynx
860265|NCT00062348|stage II squamous cell carcinoma of the paranasal sinus and nasal cavity|stage ii squamous cell carcinoma of the paranasal sinus and nasal cavity
860266|NCT00062348|stage III squamous cell carcinoma of the hypopharynx|stage iii squamous cell carcinoma of the hypopharynx
860267|NCT00062348|stage III squamous cell carcinoma of the larynx|stage iii squamous cell carcinoma of the larynx
860268|NCT00062348|stage III squamous cell carcinoma of the lip and oral cavity|stage iii squamous cell carcinoma of the lip and oral cavity
882846|NCT00025935|Behavior|behavior
860269|NCT00062348|stage III squamous cell carcinoma of the nasopharynx|stage iii squamous cell carcinoma of the nasopharynx
860270|NCT00062348|stage III squamous cell carcinoma of the oropharynx|stage iii squamous cell carcinoma of the oropharynx
860271|NCT00062348|stage III squamous cell carcinoma of the paranasal sinus and nasal cavity|stage iii squamous cell carcinoma of the paranasal sinus and nasal cavity
860272|NCT00062348|stage I papillary thyroid cancer|stage i papillary thyroid cancer
860273|NCT00062348|stage II papillary thyroid cancer|stage ii papillary thyroid cancer
860274|NCT00062348|stage III papillary thyroid cancer|stage iii papillary thyroid cancer
860275|NCT00062348|stage I follicular thyroid cancer|stage i follicular thyroid cancer
860276|NCT00062348|stage II follicular thyroid cancer|stage ii follicular thyroid cancer
860277|NCT00062348|stage III follicular thyroid cancer|stage iii follicular thyroid cancer
860278|NCT00062348|recurrent metastatic squamous neck cancer with occult primary|recurrent metastatic squamous neck cancer with occult primary
860279|NCT00062348|recurrent salivary gland cancer|recurrent salivary gland cancer
860280|NCT00062348|salivary gland squamous cell carcinoma|salivary gland squamous cell carcinoma
860281|NCT00062348|stage I salivary gland cancer|stage i salivary gland cancer
860282|NCT00062348|stage II salivary gland cancer|stage ii salivary gland cancer
860283|NCT00062348|stage III salivary gland cancer|stage iii salivary gland cancer
860284|NCT00062348|stage IV salivary gland cancer|stage iv salivary gland cancer
860285|NCT00062348|tongue cancer|tongue cancer
860286|NCT00062335|stage I non-small cell lung cancer|stage i non-small cell lung cancer
860287|NCT00062335|stage II non-small cell lung cancer|stage ii non-small cell lung cancer
860288|NCT00062335|stage IIIA non-small cell lung cancer|stage iiia non-small cell lung cancer
860289|NCT00062322|limited stage small cell lung cancer|limited stage small cell lung cancer
860290|NCT00062309|stage II prostate cancer|stage ii prostate cancer
860291|NCT00062309|stage III prostate cancer|stage iii prostate cancer
860292|NCT00062309|adenocarcinoma of the prostate|adenocarcinoma of the prostate
860293|NCT00062296|B-cell chronic lymphocytic leukemia|b-cell chronic lymphocytic leukemia
860294|NCT00062296|refractory chronic lymphocytic leukemia|refractory chronic lymphocytic leukemia
860295|NCT00062296|recurrent adult diffuse large cell lymphoma|recurrent adult diffuse large cell lymphoma
860296|NCT00062296|recurrent adult diffuse mixed cell lymphoma|recurrent adult diffuse mixed cell lymphoma
860297|NCT00062296|recurrent adult diffuse small cleaved cell lymphoma|recurrent adult diffuse small cleaved cell lymphoma
860298|NCT00062296|recurrent adult Burkitt lymphoma|recurrent adult burkitt lymphoma
860299|NCT00062296|recurrent adult immunoblastic large cell lymphoma|recurrent adult immunoblastic large cell lymphoma
860300|NCT00062296|recurrent grade 1 follicular lymphoma|recurrent grade 1 follicular lymphoma
860301|NCT00062296|recurrent grade 2 follicular lymphoma|recurrent grade 2 follicular lymphoma
860302|NCT00062296|recurrent grade 3 follicular lymphoma|recurrent grade 3 follicular lymphoma
860303|NCT00062296|recurrent mantle cell lymphoma|recurrent mantle cell lymphoma
860304|NCT00062296|recurrent adult lymphoblastic lymphoma|recurrent adult lymphoblastic lymphoma
860305|NCT00062296|recurrent marginal zone lymphoma|recurrent marginal zone lymphoma
860306|NCT00062296|recurrent small lymphocytic lymphoma|recurrent small lymphocytic lymphoma
860307|NCT00062296|extranodal marginal zone B-cell lymphoma of mucosa-associated lymphoid tissue|extranodal marginal zone b-cell lymphoma of mucosa-associated lymphoid tissue
860308|NCT00062296|nodal marginal zone B-cell lymphoma|nodal marginal zone b-cell lymphoma
860309|NCT00062296|splenic marginal zone lymphoma|splenic marginal zone lymphoma
860310|NCT00062283|advanced malignant mesothelioma|advanced malignant mesothelioma
860311|NCT00062283|recurrent malignant mesothelioma|recurrent malignant mesothelioma
860312|NCT00062283|metastatic osteosarcoma|metastatic osteosarcoma
860313|NCT00062283|recurrent osteosarcoma|recurrent osteosarcoma
860314|NCT00062283|recurrent adult soft tissue sarcoma|recurrent adult soft tissue sarcoma
860315|NCT00062283|stage IV adult soft tissue sarcoma|stage iv adult soft tissue sarcoma
860316|NCT00062283|chondrosarcoma|chondrosarcoma
860317|NCT00062283|recurrent non-small cell lung cancer|recurrent non-small cell lung cancer
860318|NCT00062283|stage IIIB non-small cell lung cancer|stage iiib non-small cell lung cancer
860319|NCT00062283|stage IV non-small cell lung cancer|stage iv non-small cell lung cancer
860320|NCT00062283|adenocarcinoma of the pancreas|adenocarcinoma of the pancreas
860321|NCT00062283|recurrent pancreatic cancer|recurrent pancreatic cancer
860322|NCT00062283|stage III adult soft tissue sarcoma|stage iii adult soft tissue sarcoma
860323|NCT00062283|stage II adult soft tissue sarcoma|stage ii adult soft tissue sarcoma
860324|NCT00062283|stage IV pancreatic cancer|stage iv pancreatic cancer
860325|NCT00062270|stage IIIA non-small cell lung cancer|stage iiia non-small cell lung cancer
860326|NCT00062270|stage IIIB non-small cell lung cancer|stage iiib non-small cell lung cancer
860327|NCT00062257|recurrent gastric cancer|recurrent gastric cancer
860328|NCT00062257|stage IV gastric cancer|stage iv gastric cancer
860329|NCT00062257|adenocarcinoma of the stomach|adenocarcinoma of the stomach
860330|NCT00062231|infection|infection
860331|NCT00062231|neutropenia|neutropenia
860332|NCT00062231|fever, sweats, and hot flashes|fever, sweats, and hot flashes
860333|NCT00062231|unspecified adult solid tumor, protocol specific|unspecified adult solid tumor, protocol specific
860334|NCT00062231|stage I adult Hodgkin lymphoma|stage i adult hodgkin lymphoma
860335|NCT00062231|stage II adult Hodgkin lymphoma|stage ii adult hodgkin lymphoma
860336|NCT00062231|stage III adult Hodgkin lymphoma|stage iii adult hodgkin lymphoma
860337|NCT00062231|stage IV adult Hodgkin lymphoma|stage iv adult hodgkin lymphoma
882847|NCT00025935|Children|children
860338|NCT00062231|monoclonal gammopathy of undetermined significance|monoclonal gammopathy of undetermined significance
860339|NCT00062231|recurrent adult Hodgkin lymphoma|recurrent adult hodgkin lymphoma
860340|NCT00062231|stage I cutaneous T-cell non-Hodgkin lymphoma|stage i cutaneous t-cell non-hodgkin lymphoma
860341|NCT00062231|stage II cutaneous T-cell non-Hodgkin lymphoma|stage ii cutaneous t-cell non-hodgkin lymphoma
860342|NCT00062231|stage III cutaneous T-cell non-Hodgkin lymphoma|stage iii cutaneous t-cell non-hodgkin lymphoma
860343|NCT00062231|stage IV cutaneous T-cell non-Hodgkin lymphoma|stage iv cutaneous t-cell non-hodgkin lymphoma
860344|NCT00062231|recurrent cutaneous T-cell non-Hodgkin lymphoma|recurrent cutaneous t-cell non-hodgkin lymphoma
860345|NCT00062231|isolated plasmacytoma of bone|isolated plasmacytoma of bone
860346|NCT00062231|extramedullary plasmacytoma|extramedullary plasmacytoma
860347|NCT00062231|refractory multiple myeloma|refractory multiple myeloma
860348|NCT00062231|stage 0 chronic lymphocytic leukemia|stage 0 chronic lymphocytic leukemia
860349|NCT00062231|Waldenstrom macroglobulinemia|waldenstrom macroglobulinemia
860350|NCT00062231|stage I multiple myeloma|stage i multiple myeloma
860351|NCT00062231|stage II multiple myeloma|stage ii multiple myeloma
860352|NCT00062231|stage III multiple myeloma|stage iii multiple myeloma
860353|NCT00062231|stage I chronic lymphocytic leukemia|stage i chronic lymphocytic leukemia
860354|NCT00062231|stage II chronic lymphocytic leukemia|stage ii chronic lymphocytic leukemia
860355|NCT00062231|stage III chronic lymphocytic leukemia|stage iii chronic lymphocytic leukemia
860356|NCT00062231|stage IV chronic lymphocytic leukemia|stage iv chronic lymphocytic leukemia
860357|NCT00062231|recurrent adult acute lymphoblastic leukemia|recurrent adult acute lymphoblastic leukemia
860358|NCT00062231|relapsing chronic myelogenous leukemia|relapsing chronic myelogenous leukemia
860359|NCT00062231|refractory chronic lymphocytic leukemia|refractory chronic lymphocytic leukemia
860360|NCT00062231|accelerated phase chronic myelogenous leukemia|accelerated phase chronic myelogenous leukemia
860361|NCT00062231|blastic phase chronic myelogenous leukemia|blastic phase chronic myelogenous leukemia
860362|NCT00062231|chronic phase chronic myelogenous leukemia|chronic phase chronic myelogenous leukemia
860363|NCT00062231|meningeal chronic myelogenous leukemia|meningeal chronic myelogenous leukemia
860364|NCT00062231|adult acute myeloid leukemia in remission|adult acute myeloid leukemia in remission
860365|NCT00062231|polycythemia vera|polycythemia vera
860366|NCT00062231|primary myelofibrosis|primary myelofibrosis
860367|NCT00062231|essential thrombocythemia|essential thrombocythemia
860368|NCT00062231|progressive hairy cell leukemia, initial treatment|progressive hairy cell leukemia, initial treatment
860369|NCT00062231|refractory hairy cell leukemia|refractory hairy cell leukemia
860370|NCT00062231|contiguous stage II grade 1 follicular lymphoma|contiguous stage ii grade 1 follicular lymphoma
860371|NCT00062231|contiguous stage II grade 2 follicular lymphoma|contiguous stage ii grade 2 follicular lymphoma
860372|NCT00062231|contiguous stage II grade 3 follicular lymphoma|contiguous stage ii grade 3 follicular lymphoma
860373|NCT00062231|noncontiguous stage II grade 1 follicular lymphoma|noncontiguous stage ii grade 1 follicular lymphoma
860374|NCT00062231|noncontiguous stage II grade 2 follicular lymphoma|noncontiguous stage ii grade 2 follicular lymphoma
860375|NCT00062231|noncontiguous stage II grade 3 follicular lymphoma|noncontiguous stage ii grade 3 follicular lymphoma
860376|NCT00062231|recurrent grade 1 follicular lymphoma|recurrent grade 1 follicular lymphoma
860377|NCT00062231|recurrent grade 2 follicular lymphoma|recurrent grade 2 follicular lymphoma
860378|NCT00062231|recurrent grade 3 follicular lymphoma|recurrent grade 3 follicular lymphoma
860379|NCT00062231|stage I grade 1 follicular lymphoma|stage i grade 1 follicular lymphoma
860380|NCT00062231|stage I grade 2 follicular lymphoma|stage i grade 2 follicular lymphoma
860381|NCT00062231|stage I grade 3 follicular lymphoma|stage i grade 3 follicular lymphoma
860382|NCT00062231|stage III grade 1 follicular lymphoma|stage iii grade 1 follicular lymphoma
860383|NCT00062231|stage III grade 2 follicular lymphoma|stage iii grade 2 follicular lymphoma
860384|NCT00062231|stage III grade 3 follicular lymphoma|stage iii grade 3 follicular lymphoma
860385|NCT00062231|stage IV grade 1 follicular lymphoma|stage iv grade 1 follicular lymphoma
860386|NCT00062231|stage IV grade 2 follicular lymphoma|stage iv grade 2 follicular lymphoma
860387|NCT00062231|stage IV grade 3 follicular lymphoma|stage iv grade 3 follicular lymphoma
860388|NCT00062231|contiguous stage II adult diffuse large cell lymphoma|contiguous stage ii adult diffuse large cell lymphoma
860389|NCT00062231|contiguous stage II adult diffuse mixed cell lymphoma|contiguous stage ii adult diffuse mixed cell lymphoma
860390|NCT00062231|contiguous stage II adult diffuse small cleaved cell lymphoma|contiguous stage ii adult diffuse small cleaved cell lymphoma
860391|NCT00062231|contiguous stage II adult Burkitt lymphoma|contiguous stage ii adult burkitt lymphoma
860392|NCT00062231|noncontiguous stage II adult diffuse large cell lymphoma|noncontiguous stage ii adult diffuse large cell lymphoma
860393|NCT00062231|noncontiguous stage II adult diffuse mixed cell lymphoma|noncontiguous stage ii adult diffuse mixed cell lymphoma
860394|NCT00062231|noncontiguous stage II adult diffuse small cleaved cell lymphoma|noncontiguous stage ii adult diffuse small cleaved cell lymphoma
860395|NCT00062231|noncontiguous stage II adult Burkitt lymphoma|noncontiguous stage ii adult burkitt lymphoma
860396|NCT00062231|recurrent adult diffuse large cell lymphoma|recurrent adult diffuse large cell lymphoma
860397|NCT00062231|recurrent adult diffuse mixed cell lymphoma|recurrent adult diffuse mixed cell lymphoma
860398|NCT00062231|recurrent adult diffuse small cleaved cell lymphoma|recurrent adult diffuse small cleaved cell lymphoma
860399|NCT00062231|recurrent adult Burkitt lymphoma|recurrent adult burkitt lymphoma
860400|NCT00062231|stage I adult diffuse large cell lymphoma|stage i adult diffuse large cell lymphoma
860401|NCT00062231|stage I adult diffuse mixed cell lymphoma|stage i adult diffuse mixed cell lymphoma
860402|NCT00062231|stage I adult diffuse small cleaved cell lymphoma|stage i adult diffuse small cleaved cell lymphoma
860403|NCT00062231|stage I adult Burkitt lymphoma|stage i adult burkitt lymphoma
860404|NCT00062231|stage III adult diffuse large cell lymphoma|stage iii adult diffuse large cell lymphoma
860405|NCT00062231|stage III adult diffuse mixed cell lymphoma|stage iii adult diffuse mixed cell lymphoma
860406|NCT00062231|stage III adult diffuse small cleaved cell lymphoma|stage iii adult diffuse small cleaved cell lymphoma
860407|NCT00062231|stage III adult Burkitt lymphoma|stage iii adult burkitt lymphoma
860408|NCT00062231|stage IV adult diffuse large cell lymphoma|stage iv adult diffuse large cell lymphoma
860409|NCT00062231|stage IV adult diffuse mixed cell lymphoma|stage iv adult diffuse mixed cell lymphoma
860410|NCT00062231|stage IV adult diffuse small cleaved cell lymphoma|stage iv adult diffuse small cleaved cell lymphoma
860411|NCT00062231|stage IV adult Burkitt lymphoma|stage iv adult burkitt lymphoma
860412|NCT00062231|stage I adult immunoblastic large cell lymphoma|stage i adult immunoblastic large cell lymphoma
860413|NCT00062231|stage I adult lymphoblastic lymphoma|stage i adult lymphoblastic lymphoma
860414|NCT00062231|chronic myelomonocytic leukemia|chronic myelomonocytic leukemia
860415|NCT00062231|T-cell large granular lymphocyte leukemia|t-cell large granular lymphocyte leukemia
860416|NCT00062231|acute undifferentiated leukemia|acute undifferentiated leukemia
860417|NCT00062231|stage III adult immunoblastic large cell lymphoma|stage iii adult immunoblastic large cell lymphoma
860418|NCT00062231|stage IV adult immunoblastic large cell lymphoma|stage iv adult immunoblastic large cell lymphoma
860419|NCT00062231|recurrent adult immunoblastic large cell lymphoma|recurrent adult immunoblastic large cell lymphoma
860420|NCT00062231|stage III adult lymphoblastic lymphoma|stage iii adult lymphoblastic lymphoma
860421|NCT00062231|stage IV adult lymphoblastic lymphoma|stage iv adult lymphoblastic lymphoma
860422|NCT00062231|recurrent adult lymphoblastic lymphoma|recurrent adult lymphoblastic lymphoma
860423|NCT00062231|recurrent adult T-cell leukemia/lymphoma|recurrent adult t-cell leukemia/lymphoma
860424|NCT00062231|stage I adult T-cell leukemia/lymphoma|stage i adult t-cell leukemia/lymphoma
860425|NCT00062231|stage II adult T-cell leukemia/lymphoma|stage ii adult t-cell leukemia/lymphoma
860426|NCT00062231|stage III adult T-cell leukemia/lymphoma|stage iii adult t-cell leukemia/lymphoma
860427|NCT00062231|stage IV adult T-cell leukemia/lymphoma|stage iv adult t-cell leukemia/lymphoma
860428|NCT00062231|de novo myelodysplastic syndromes|de novo myelodysplastic syndromes
860429|NCT00062231|previously treated myelodysplastic syndromes|previously treated myelodysplastic syndromes
860430|NCT00062231|secondary myelodysplastic syndromes|secondary myelodysplastic syndromes
860431|NCT00062231|prolymphocytic leukemia|prolymphocytic leukemia
860432|NCT00062231|primary systemic amyloidosis|primary systemic amyloidosis
860433|NCT00062231|intraocular lymphoma|intraocular lymphoma
860434|NCT00062231|stage I mantle cell lymphoma|stage i mantle cell lymphoma
860435|NCT00062231|stage III mantle cell lymphoma|stage iii mantle cell lymphoma
860436|NCT00062231|stage IV mantle cell lymphoma|stage iv mantle cell lymphoma
860437|NCT00062231|contiguous stage II mantle cell lymphoma|contiguous stage ii mantle cell lymphoma
860438|NCT00062231|noncontiguous stage II mantle cell lymphoma|noncontiguous stage ii mantle cell lymphoma
860439|NCT00062231|recurrent mantle cell lymphoma|recurrent mantle cell lymphoma
860440|NCT00062231|anaplastic large cell lymphoma|anaplastic large cell lymphoma
860441|NCT00062231|angioimmunoblastic T-cell lymphoma|angioimmunoblastic t-cell lymphoma
860442|NCT00062231|recurrent mycosis fungoides/Sezary syndrome|recurrent mycosis fungoides/sezary syndrome
860443|NCT00062231|stage I mycosis fungoides/Sezary syndrome|stage i mycosis fungoides/sezary syndrome
860444|NCT00062231|stage II mycosis fungoides/Sezary syndrome|stage ii mycosis fungoides/sezary syndrome
860445|NCT00062231|stage III mycosis fungoides/Sezary syndrome|stage iii mycosis fungoides/sezary syndrome
860446|NCT00062231|stage IV mycosis fungoides/Sezary syndrome|stage iv mycosis fungoides/sezary syndrome
860447|NCT00062231|chronic eosinophilic leukemia|chronic eosinophilic leukemia
860448|NCT00062231|chronic neutrophilic leukemia|chronic neutrophilic leukemia
860449|NCT00062231|recurrent adult acute myeloid leukemia|recurrent adult acute myeloid leukemia
860450|NCT00062231|adult acute lymphoblastic leukemia in remission|adult acute lymphoblastic leukemia in remission
860451|NCT00062231|contiguous stage II adult lymphoblastic lymphoma|contiguous stage ii adult lymphoblastic lymphoma
860452|NCT00062231|noncontiguous stage II adult lymphoblastic lymphoma|noncontiguous stage ii adult lymphoblastic lymphoma
860453|NCT00062231|contiguous stage II adult immunoblastic large cell lymphoma|contiguous stage ii adult immunoblastic large cell lymphoma
860454|NCT00062231|noncontiguous stage II adult immunoblastic large cell lymphoma|noncontiguous stage ii adult immunoblastic large cell lymphoma
860455|NCT00062231|atypical chronic myeloid leukemia, BCR-ABL1 negative|atypical chronic myeloid leukemia, bcr-abl1 negative
860456|NCT00062231|myelodysplastic/myeloproliferative neoplasm, unclassifiable|myelodysplastic/myeloproliferative neoplasm, unclassifiable
860457|NCT00062231|contiguous stage II small lymphocytic lymphoma|contiguous stage ii small lymphocytic lymphoma
860458|NCT00062231|contiguous stage II marginal zone lymphoma|contiguous stage ii marginal zone lymphoma
860459|NCT00062231|noncontiguous stage II small lymphocytic lymphoma|noncontiguous stage ii small lymphocytic lymphoma
860460|NCT00062231|noncontiguous stage II marginal zone lymphoma|noncontiguous stage ii marginal zone lymphoma
860869|NCT00061334|Stereotypes|stereotypes
860461|NCT00062231|extranodal marginal zone B-cell lymphoma of mucosa-associated lymphoid tissue|extranodal marginal zone b-cell lymphoma of mucosa-associated lymphoid tissue
860462|NCT00062231|nodal marginal zone B-cell lymphoma|nodal marginal zone b-cell lymphoma
860463|NCT00062231|splenic marginal zone lymphoma|splenic marginal zone lymphoma
860464|NCT00062231|recurrent marginal zone lymphoma|recurrent marginal zone lymphoma
860465|NCT00062231|recurrent small lymphocytic lymphoma|recurrent small lymphocytic lymphoma
860466|NCT00062231|stage I marginal zone lymphoma|stage i marginal zone lymphoma
860467|NCT00062231|stage I small lymphocytic lymphoma|stage i small lymphocytic lymphoma
860468|NCT00062231|stage III small lymphocytic lymphoma|stage iii small lymphocytic lymphoma
860469|NCT00062231|stage III marginal zone lymphoma|stage iii marginal zone lymphoma
860470|NCT00062231|stage IV small lymphocytic lymphoma|stage iv small lymphocytic lymphoma
860471|NCT00062231|stage IV marginal zone lymphoma|stage iv marginal zone lymphoma
860472|NCT00062231|adult acute myeloid leukemia with t(8;21)(q22;q22)|adult acute myeloid leukemia with t(8;21)(q22;q22)
860473|NCT00062231|adult acute myeloid leukemia with t(16;16)(p13;q22)|adult acute myeloid leukemia with t(16;16)(p13;q22)
860474|NCT00062231|adult acute myeloid leukemia with inv(16)(p13;q22)|adult acute myeloid leukemia with inv(16)(p13;q22)
860475|NCT00062231|adult acute myeloid leukemia with 11q23 (MLL) abnormalities|adult acute myeloid leukemia with 11q23 (mll) abnormalities
860476|NCT00062231|adult acute myeloid leukemia with t(15;17)(q22;q12)|adult acute myeloid leukemia with t(15;17)(q22;q12)
860477|NCT00062205|recurrent Ewing sarcoma/peripheral primitive neuroectodermal tumor|recurrent ewing sarcoma/peripheral primitive neuroectodermal tumor
860478|NCT00062179|stage IIIA non-small cell lung cancer|stage iiia non-small cell lung cancer
860479|NCT00062166|Imaging Studies|imaging studies
860480|NCT00062166|Rate of Tumor Growth|rate of tumor growth
860481|NCT00062166|Familial Cancer Syndrome|familial cancer syndrome
860482|NCT00062166|Surgical Resection|surgical resection
860483|NCT00062140|recurrent adult diffuse large cell lymphoma|recurrent adult diffuse large cell lymphoma
860484|NCT00062140|recurrent adult diffuse mixed cell lymphoma|recurrent adult diffuse mixed cell lymphoma
860485|NCT00062140|recurrent adult diffuse small cleaved cell lymphoma|recurrent adult diffuse small cleaved cell lymphoma
860486|NCT00062140|recurrent adult Burkitt lymphoma|recurrent adult burkitt lymphoma
860487|NCT00062140|recurrent adult Hodgkin lymphoma|recurrent adult hodgkin lymphoma
860488|NCT00062140|recurrent adult immunoblastic large cell lymphoma|recurrent adult immunoblastic large cell lymphoma
860489|NCT00062140|recurrent adult lymphoblastic lymphoma|recurrent adult lymphoblastic lymphoma
860490|NCT00062140|recurrent cutaneous T-cell non-Hodgkin lymphoma|recurrent cutaneous t-cell non-hodgkin lymphoma
860491|NCT00062140|recurrent grade 1 follicular lymphoma|recurrent grade 1 follicular lymphoma
860492|NCT00062140|recurrent grade 2 follicular lymphoma|recurrent grade 2 follicular lymphoma
860493|NCT00062140|recurrent grade 3 follicular lymphoma|recurrent grade 3 follicular lymphoma
860494|NCT00062140|recurrent mantle cell lymphoma|recurrent mantle cell lymphoma
860495|NCT00062140|noncontiguous stage II adult diffuse large cell lymphoma|noncontiguous stage ii adult diffuse large cell lymphoma
860496|NCT00062140|noncontiguous stage II adult diffuse mixed cell lymphoma|noncontiguous stage ii adult diffuse mixed cell lymphoma
860497|NCT00062140|noncontiguous stage II adult Burkitt lymphoma|noncontiguous stage ii adult burkitt lymphoma
860498|NCT00062140|noncontiguous stage II adult immunoblastic large cell lymphoma|noncontiguous stage ii adult immunoblastic large cell lymphoma
860499|NCT00062140|noncontiguous stage II adult lymphoblastic lymphoma|noncontiguous stage ii adult lymphoblastic lymphoma
860500|NCT00062140|noncontiguous stage II grade 3 follicular lymphoma|noncontiguous stage ii grade 3 follicular lymphoma
860501|NCT00062140|noncontiguous stage II mantle cell lymphoma|noncontiguous stage ii mantle cell lymphoma
860502|NCT00062140|stage III adult lymphoblastic lymphoma|stage iii adult lymphoblastic lymphoma
860503|NCT00062140|stage IV adult lymphoblastic lymphoma|stage iv adult lymphoblastic lymphoma
860504|NCT00062140|stage III adult Burkitt lymphoma|stage iii adult burkitt lymphoma
860505|NCT00062140|stage IV adult Burkitt lymphoma|stage iv adult burkitt lymphoma
860506|NCT00062140|recurrent adult acute myeloid leukemia|recurrent adult acute myeloid leukemia
860507|NCT00062140|untreated adult acute myeloid leukemia|untreated adult acute myeloid leukemia
860571|NCT00061997|non-small cell lung cancer|non-small cell lung cancer
860508|NCT00062140|accelerated phase chronic myelogenous leukemia|accelerated phase chronic myelogenous leukemia
860509|NCT00062140|blastic phase chronic myelogenous leukemia|blastic phase chronic myelogenous leukemia
860510|NCT00062140|chronic phase chronic myelogenous leukemia|chronic phase chronic myelogenous leukemia
860511|NCT00062140|meningeal chronic myelogenous leukemia|meningeal chronic myelogenous leukemia
860512|NCT00062140|relapsing chronic myelogenous leukemia|relapsing chronic myelogenous leukemia
860513|NCT00062140|de novo myelodysplastic syndromes|de novo myelodysplastic syndromes
860514|NCT00062140|previously treated myelodysplastic syndromes|previously treated myelodysplastic syndromes
860515|NCT00062140|secondary myelodysplastic syndromes|secondary myelodysplastic syndromes
860516|NCT00062140|noncontiguous stage II adult diffuse small cleaved cell lymphoma|noncontiguous stage ii adult diffuse small cleaved cell lymphoma
860517|NCT00062140|noncontiguous stage II grade 1 follicular lymphoma|noncontiguous stage ii grade 1 follicular lymphoma
860518|NCT00062140|noncontiguous stage II grade 2 follicular lymphoma|noncontiguous stage ii grade 2 follicular lymphoma
860519|NCT00062140|recurrent mycosis fungoides/Sezary syndrome|recurrent mycosis fungoides/sezary syndrome
860520|NCT00062140|secondary acute myeloid leukemia|secondary acute myeloid leukemia
860521|NCT00062140|stage III grade 1 follicular lymphoma|stage iii grade 1 follicular lymphoma
860522|NCT00062140|stage III grade 2 follicular lymphoma|stage iii grade 2 follicular lymphoma
860523|NCT00062140|stage III adult diffuse small cleaved cell lymphoma|stage iii adult diffuse small cleaved cell lymphoma
860524|NCT00062140|stage III grade 3 follicular lymphoma|stage iii grade 3 follicular lymphoma
860525|NCT00062140|stage III adult diffuse large cell lymphoma|stage iii adult diffuse large cell lymphoma
860526|NCT00062140|stage III adult diffuse mixed cell lymphoma|stage iii adult diffuse mixed cell lymphoma
860527|NCT00062140|stage III adult immunoblastic large cell lymphoma|stage iii adult immunoblastic large cell lymphoma
860528|NCT00062140|stage III mantle cell lymphoma|stage iii mantle cell lymphoma
860529|NCT00062140|stage IV grade 3 follicular lymphoma|stage iv grade 3 follicular lymphoma
860530|NCT00062140|stage IV adult diffuse large cell lymphoma|stage iv adult diffuse large cell lymphoma
860531|NCT00062140|stage IV adult diffuse mixed cell lymphoma|stage iv adult diffuse mixed cell lymphoma
860532|NCT00062140|stage IV adult immunoblastic large cell lymphoma|stage iv adult immunoblastic large cell lymphoma
860533|NCT00062140|stage IV mantle cell lymphoma|stage iv mantle cell lymphoma
860534|NCT00062140|stage IV adult diffuse small cleaved cell lymphoma|stage iv adult diffuse small cleaved cell lymphoma
860535|NCT00062140|stage IV grade 1 follicular lymphoma|stage iv grade 1 follicular lymphoma
860536|NCT00062140|stage IV grade 2 follicular lymphoma|stage iv grade 2 follicular lymphoma
860537|NCT00062140|recurrent adult acute lymphoblastic leukemia|recurrent adult acute lymphoblastic leukemia
860538|NCT00062140|untreated adult acute lymphoblastic leukemia|untreated adult acute lymphoblastic leukemia
860539|NCT00062140|atypical chronic myeloid leukemia|atypical chronic myeloid leukemia
860540|NCT00062140|myelodysplastic/myeloproliferative disease, unclassifiable|myelodysplastic/myeloproliferative disease, unclassifiable
860541|NCT00062140|noncontiguous stage II small lymphocytic lymphoma|noncontiguous stage ii small lymphocytic lymphoma
860542|NCT00062140|noncontiguous stage II marginal zone lymphoma|noncontiguous stage ii marginal zone lymphoma
860543|NCT00062140|recurrent marginal zone lymphoma|recurrent marginal zone lymphoma
860544|NCT00062140|recurrent small lymphocytic lymphoma|recurrent small lymphocytic lymphoma
860545|NCT00062140|stage III small lymphocytic lymphoma|stage iii small lymphocytic lymphoma
860546|NCT00062140|stage III marginal zone lymphoma|stage iii marginal zone lymphoma
860547|NCT00062140|stage IV small lymphocytic lymphoma|stage iv small lymphocytic lymphoma
860548|NCT00062140|stage IV marginal zone lymphoma|stage iv marginal zone lymphoma
860549|NCT00062140|extranodal marginal zone B-cell lymphoma of mucosa-associated lymphoid tissue|extranodal marginal zone b-cell lymphoma of mucosa-associated lymphoid tissue
860550|NCT00062140|nodal marginal zone B-cell lymphoma|nodal marginal zone b-cell lymphoma
860551|NCT00062140|splenic marginal zone lymphoma|splenic marginal zone lymphoma
860552|NCT00062140|adult acute myeloid leukemia with t(8;21)(q22;q22)|adult acute myeloid leukemia with t(8;21)(q22;q22)
860553|NCT00062140|adult acute myeloid leukemia with t(16;16)(p13;q22)|adult acute myeloid leukemia with t(16;16)(p13;q22)
860554|NCT00062140|adult acute myeloid leukemia with inv(16)(p13;q22)|adult acute myeloid leukemia with inv(16)(p13;q22)
860555|NCT00062140|adult acute myeloid leukemia with 11q23 (MLL) abnormalities|adult acute myeloid leukemia with 11q23 (mll) abnormalities
860556|NCT00062140|adult acute myeloid leukemia with t(15;17)(q22;q12)|adult acute myeloid leukemia with t(15;17)(q22;q12)
860557|NCT00062114|recurrent adult diffuse large cell lymphoma|recurrent adult diffuse large cell lymphoma
860558|NCT00062114|recurrent adult diffuse mixed cell lymphoma|recurrent adult diffuse mixed cell lymphoma
860559|NCT00062114|recurrent adult immunoblastic large cell lymphoma|recurrent adult immunoblastic large cell lymphoma
860560|NCT00062062|stage IV non-small cell lung cancer|stage iv non-small cell lung cancer
860561|NCT00062062|stage IIIB non-small cell lung cancer|stage iiib non-small cell lung cancer
860562|NCT00062049|unspecified adult solid tumor, protocol specific|unspecified adult solid tumor, protocol specific
860563|NCT00062036|stage IV melanoma|stage iv melanoma
860564|NCT00062036|recurrent melanoma|recurrent melanoma
860565|NCT00062023|colorectal cancer|colorectal cancer
860566|NCT00062023|stage I colon cancer|stage i colon cancer
860567|NCT00062023|stage II colon cancer|stage ii colon cancer
860568|NCT00062023|stage III colon cancer|stage iii colon cancer
860569|NCT00062023|stage IV colon cancer|stage iv colon cancer
860570|NCT00062010|recurrent small cell lung cancer|recurrent small cell lung cancer
860886|NCT00061243|HIV|hiv
860572|NCT00061997|small cell lung cancer|small cell lung cancer
860573|NCT00061997|precancerous condition|precancerous condition
860574|NCT00061984|adult angiosarcoma|adult angiosarcoma
860575|NCT00061984|adult epithelioid sarcoma|adult epithelioid sarcoma
860576|NCT00061984|adult fibrosarcoma|adult fibrosarcoma
860577|NCT00061984|adult leiomyosarcoma|adult leiomyosarcoma
860578|NCT00061984|adult liposarcoma|adult liposarcoma
860579|NCT00061984|adult rhabdomyosarcoma|adult rhabdomyosarcoma
860580|NCT00061984|adult synovial sarcoma|adult synovial sarcoma
860581|NCT00061984|stage III adult soft tissue sarcoma|stage iii adult soft tissue sarcoma
860582|NCT00061984|adult malignant fibrous histiocytoma|adult malignant fibrous histiocytoma
860583|NCT00061984|adult neurofibrosarcoma|adult neurofibrosarcoma
860584|NCT00061984|stage II adult soft tissue sarcoma|stage ii adult soft tissue sarcoma
860585|NCT00061984|stage IV adult soft tissue sarcoma|stage iv adult soft tissue sarcoma
860586|NCT00061919|extensive stage small cell lung cancer|extensive stage small cell lung cancer
860587|NCT00061919|limited stage small cell lung cancer|limited stage small cell lung cancer
860588|NCT00061906|insular thyroid cancer|insular thyroid cancer
860589|NCT00061906|recurrent thyroid cancer|recurrent thyroid cancer
860590|NCT00061906|stage II follicular thyroid cancer|stage ii follicular thyroid cancer
860591|NCT00061906|stage II papillary thyroid cancer|stage ii papillary thyroid cancer
860592|NCT00061906|stage IV follicular thyroid cancer|stage iv follicular thyroid cancer
860593|NCT00061906|stage IV papillary thyroid cancer|stage iv papillary thyroid cancer
860594|NCT00061893|metastatic Ewing sarcoma/peripheral primitive neuroectodermal tumor|metastatic ewing sarcoma/peripheral primitive neuroectodermal tumor
860595|NCT00061880|recurrent cutaneous T-cell non-Hodgkin lymphoma|recurrent cutaneous t-cell non-hodgkin lymphoma
860596|NCT00061880|stage I cutaneous T-cell non-Hodgkin lymphoma|stage i cutaneous t-cell non-hodgkin lymphoma
860597|NCT00061880|stage II cutaneous T-cell non-Hodgkin lymphoma|stage ii cutaneous t-cell non-hodgkin lymphoma
860598|NCT00061880|stage III cutaneous T-cell non-Hodgkin lymphoma|stage iii cutaneous t-cell non-hodgkin lymphoma
860599|NCT00061880|stage IV cutaneous T-cell non-Hodgkin lymphoma|stage iv cutaneous t-cell non-hodgkin lymphoma
860600|NCT00061880|recurrent mycosis fungoides/Sezary syndrome|recurrent mycosis fungoides/sezary syndrome
860601|NCT00061880|stage I mycosis fungoides/Sezary syndrome|stage i mycosis fungoides/sezary syndrome
860602|NCT00061880|stage II mycosis fungoides/Sezary syndrome|stage ii mycosis fungoides/sezary syndrome
860603|NCT00061880|stage III mycosis fungoides/Sezary syndrome|stage iii mycosis fungoides/sezary syndrome
860604|NCT00061880|stage IV mycosis fungoides/Sezary syndrome|stage iv mycosis fungoides/sezary syndrome
860605|NCT00061867|adenocarcinoma of the prostate|adenocarcinoma of the prostate
860606|NCT00061867|stage III prostate cancer|stage iii prostate cancer
860607|NCT00061867|stage IV prostate cancer|stage iv prostate cancer
860608|NCT00061854|stage IIIA non-small cell lung cancer|stage iiia non-small cell lung cancer
860609|NCT00061854|stage IIIB non-small cell lung cancer|stage iiib non-small cell lung cancer
860610|NCT00061854|stage IV non-small cell lung cancer|stage iv non-small cell lung cancer
860611|NCT00061854|recurrent non-small cell lung cancer|recurrent non-small cell lung cancer
860612|NCT00010231|adenocarcinoma of the prostate|adenocarcinoma of the prostate
860613|NCT00010231|stage III prostate cancer|stage iii prostate cancer
860614|NCT00010231|stage IV prostate cancer|stage iv prostate cancer
860615|NCT00010231|recurrent prostate cancer|recurrent prostate cancer
860616|NCT00010114|childhood central nervous system germ cell tumor|childhood central nervous system germ cell tumor
860617|NCT00010114|childhood choroid plexus tumor|childhood choroid plexus tumor
860618|NCT00010114|untreated childhood supratentorial primitive neuroectodermal tumor|untreated childhood supratentorial primitive neuroectodermal tumor
860619|NCT00010114|untreated childhood medulloblastoma|untreated childhood medulloblastoma
860620|NCT00010114|newly diagnosed childhood ependymoma|newly diagnosed childhood ependymoma
860621|NCT00009932|unspecified adult solid tumor, protocol specific|unspecified adult solid tumor, protocol specific
860622|NCT00009802|unspecified adult solid tumor, protocol specific|unspecified adult solid tumor, protocol specific
860623|NCT00009789|stage I non-small cell lung cancer|stage i non-small cell lung cancer
860624|NCT00009789|squamous cell lung cancer|squamous cell lung cancer
860625|NCT00009789|large cell lung cancer|large cell lung cancer
860626|NCT00009789|adenocarcinoma of the lung|adenocarcinoma of the lung
860627|NCT00009789|adenosquamous cell lung cancer|adenosquamous cell lung cancer
860628|NCT00009789|bronchoalveolar cell lung cancer|bronchoalveolar cell lung cancer
860629|NCT00008424|unspecified childhood solid tumor, protocol specific|unspecified childhood solid tumor, protocol specific
860630|NCT00008398|stage I nasopharyngeal cancer|stage i nasopharyngeal cancer
860631|NCT00008398|stage II nasopharyngeal cancer|stage ii nasopharyngeal cancer
860632|NCT00008398|stage III nasopharyngeal cancer|stage iii nasopharyngeal cancer
860633|NCT00008398|stage IV nasopharyngeal cancer|stage iv nasopharyngeal cancer
860634|NCT00008398|recurrent nasopharyngeal cancer|recurrent nasopharyngeal cancer
860635|NCT00008398|stage 0 paranasal sinus and nasal cavity cancer|stage 0 paranasal sinus and nasal cavity cancer
860636|NCT00008398|stage 0 nasopharyngeal cancer|stage 0 nasopharyngeal cancer
860637|NCT00008398|stage 0 oropharyngeal cancer|stage 0 oropharyngeal cancer
860638|NCT00008398|stage 0 laryngeal cancer|stage 0 laryngeal cancer
860639|NCT00008398|stage 0 hypopharyngeal cancer|stage 0 hypopharyngeal cancer
860640|NCT00008398|untreated metastatic squamous neck cancer with occult primary|untreated metastatic squamous neck cancer with occult primary
860887|NCT00061243|Vaccine|vaccine
860641|NCT00008398|recurrent metastatic squamous neck cancer with occult primary|recurrent metastatic squamous neck cancer with occult primary
860642|NCT00008398|stage 0 lip and oral cavity cancer|stage 0 lip and oral cavity cancer
860643|NCT00008398|stage I lip and oral cavity cancer|stage i lip and oral cavity cancer
860644|NCT00008398|stage II lip and oral cavity cancer|stage ii lip and oral cavity cancer
860645|NCT00008398|stage III lip and oral cavity cancer|stage iii lip and oral cavity cancer
860646|NCT00008398|stage IV lip and oral cavity cancer|stage iv lip and oral cavity cancer
860647|NCT00008398|recurrent lip and oral cavity cancer|recurrent lip and oral cavity cancer
860648|NCT00008398|stage I hypopharyngeal cancer|stage i hypopharyngeal cancer
860649|NCT00008398|stage II hypopharyngeal cancer|stage ii hypopharyngeal cancer
860650|NCT00008398|stage III hypopharyngeal cancer|stage iii hypopharyngeal cancer
860651|NCT00008398|stage IV hypopharyngeal cancer|stage iv hypopharyngeal cancer
860652|NCT00008398|recurrent hypopharyngeal cancer|recurrent hypopharyngeal cancer
860653|NCT00008398|stage I paranasal sinus and nasal cavity cancer|stage i paranasal sinus and nasal cavity cancer
860654|NCT00008398|stage II paranasal sinus and nasal cavity cancer|stage ii paranasal sinus and nasal cavity cancer
860655|NCT00008398|stage III paranasal sinus and nasal cavity cancer|stage iii paranasal sinus and nasal cavity cancer
860656|NCT00008398|stage IV paranasal sinus and nasal cavity cancer|stage iv paranasal sinus and nasal cavity cancer
860657|NCT00008398|recurrent paranasal sinus and nasal cavity cancer|recurrent paranasal sinus and nasal cavity cancer
860658|NCT00008398|stage I oropharyngeal cancer|stage i oropharyngeal cancer
860659|NCT00008398|stage II oropharyngeal cancer|stage ii oropharyngeal cancer
860660|NCT00008398|stage III oropharyngeal cancer|stage iii oropharyngeal cancer
860661|NCT00008398|stage IV oropharyngeal cancer|stage iv oropharyngeal cancer
860662|NCT00008398|recurrent oropharyngeal cancer|recurrent oropharyngeal cancer
860663|NCT00008398|oral complications|oral complications
860664|NCT00008398|radiation toxicity|radiation toxicity
860665|NCT00008203|stage II breast cancer|stage ii breast cancer
860666|NCT00008203|stage IIIA breast cancer|stage iiia breast cancer
860667|NCT00008203|stage IIIB breast cancer|stage iiib breast cancer
860668|NCT00008112|stage III cervical cancer|stage iii cervical cancer
860669|NCT00008112|stage IIB cervical cancer|stage iib cervical cancer
860670|NCT00008112|stage IVA cervical cancer|stage iva cervical cancer
860671|NCT00008112|cervical squamous cell carcinoma|cervical squamous cell carcinoma
860672|NCT00008112|cervical adenocarcinoma|cervical adenocarcinoma
860673|NCT00008112|cervical adenosquamous cell carcinoma|cervical adenosquamous cell carcinoma
860674|NCT00061789|Schizophrenia|schizophrenia
860675|NCT00061789|SPECT|spect
860676|NCT00061789|Nicotinic Acetylcholine Receptors|nicotinic acetylcholine receptors
860677|NCT00061789|Cigarette Smoking|cigarette smoking
860678|NCT00061789|Cognitive Dysfunction|cognitive dysfunction
860679|NCT00061789|Reproducibility|reproducibility
860680|NCT00061789|Quantification|quantification
860681|NCT00061789|Healthy Volunteer|healthy volunteer
860682|NCT00061789|HV|hv
860683|NCT00061776|Dermal assessment|dermal assessment
860684|NCT00061776|Pain measurement|pain measurement
860685|NCT00061776|Diary|diary
860686|NCT00061776|Shingles|shingles
860687|NCT00061776|Neuropathy|neuropathy
860688|NCT00061776|Analgesics/*therapeutic use|analgesics/*therapeutic use
860689|NCT00061776|Capsaicin/*administration & dosage/adverse effects|capsaicin/*administration & dosage/adverse effects
860690|NCT00061776|Herpes Zoster/*complications/drug therapy|herpes zoster/*complications/drug therapy
860691|NCT00061776|Neuralgia/*drug therapy/etiology|neuralgia/*drug therapy/etiology
860692|NCT00061776|Pain|pain
860693|NCT00061776|Peripheral Nervous System Diseases/*complications|peripheral nervous system diseases/*complications
860694|NCT00061763|beta-thalassemia|beta-thalassemia
860695|NCT00061763|iron overload|iron overload
860696|NCT00061763|deferoxamine|deferoxamine
860697|NCT00061763|Myelodysplastic Syndromes|myelodysplastic syndromes
860698|NCT00061763|Fanconi Syndrome|fanconi syndrome
860699|NCT00061763|Anemia, Diamond-Blackfan|anemia, diamond-blackfan
860700|NCT00061763|Anemia, Aplastic|anemia, aplastic
860701|NCT00061750|Thalassemia, iron overload, deferoxamine, hemosiderosis|thalassemia, iron overload, deferoxamine, hemosiderosis
860702|NCT00061737|Pediatric IBD|pediatric ibd
860703|NCT00061737|Inflammatory|inflammatory
860704|NCT00061737|Bowel|bowel
860705|NCT00061724|Esophageal|esophageal
860706|NCT00061724|Reflux|reflux
860707|NCT00061672|Non-Hodgkin's Lymphoma (NHL)|non-hodgkin's lymphoma (nhl)
860708|NCT00061672|Hodgkin's Lymphoma (HL)|hodgkin's lymphoma (hl)
860709|NCT00061659|high grade locally advanced/metastatic soft tissue sarcoma|high grade locally advanced/metastatic soft tissue sarcoma
860710|NCT00061646|Stage IIIb with pleural effusion or IV NSCLC|stage iiib with pleural effusion or iv nsclc
860711|NCT00051714|Social Behavior Disorders|social behavior disorders
860712|NCT00061620|Investigational|investigational
860713|NCT00061620|Chemotherapy|chemotherapy
860714|NCT00061620|Hematologic Malignancies|hematologic malignancies
860715|NCT00061620|Nucleoside analogue|nucleoside analogue
860716|NCT00059462|Treatment experienced|treatment experienced
860717|NCT00008021|recurrent grade 1 follicular lymphoma|recurrent grade 1 follicular lymphoma
860718|NCT00008021|recurrent grade 2 follicular lymphoma|recurrent grade 2 follicular lymphoma
860719|NCT00008021|recurrent grade 3 follicular lymphoma|recurrent grade 3 follicular lymphoma
860888|NCT00061243|DNA prime|dna prime
860720|NCT00008021|recurrent adult diffuse small cleaved cell lymphoma|recurrent adult diffuse small cleaved cell lymphoma
860721|NCT00008021|recurrent adult diffuse mixed cell lymphoma|recurrent adult diffuse mixed cell lymphoma
860722|NCT00008021|recurrent adult diffuse large cell lymphoma|recurrent adult diffuse large cell lymphoma
860723|NCT00008021|recurrent adult immunoblastic large cell lymphoma|recurrent adult immunoblastic large cell lymphoma
860724|NCT00008021|recurrent adult lymphoblastic lymphoma|recurrent adult lymphoblastic lymphoma
860725|NCT00008021|recurrent adult Burkitt lymphoma|recurrent adult burkitt lymphoma
860726|NCT00008021|recurrent mantle cell lymphoma|recurrent mantle cell lymphoma
860727|NCT00008021|recurrent marginal zone lymphoma|recurrent marginal zone lymphoma
860728|NCT00008021|recurrent small lymphocytic lymphoma|recurrent small lymphocytic lymphoma
860729|NCT00008021|extranodal marginal zone B-cell lymphoma of mucosa-associated lymphoid tissue|extranodal marginal zone b-cell lymphoma of mucosa-associated lymphoid tissue
860730|NCT00008021|nodal marginal zone B-cell lymphoma|nodal marginal zone b-cell lymphoma
860731|NCT00008021|splenic marginal zone lymphoma|splenic marginal zone lymphoma
860732|NCT00006864|stage IV renal cell cancer|stage iv renal cell cancer
860733|NCT00006864|recurrent renal cell cancer|recurrent renal cell cancer
860734|NCT00006864|clear cell renal cell carcinoma|clear cell renal cell carcinoma
860735|NCT00006484|recurrent non-small cell lung cancer|recurrent non-small cell lung cancer
860736|NCT00006484|squamous cell lung cancer|squamous cell lung cancer
860737|NCT00006484|large cell lung cancer|large cell lung cancer
882848|NCT00025935|Adolescent|adolescent
860738|NCT00006484|stage IIIB non-small cell lung cancer|stage iiib non-small cell lung cancer
860739|NCT00006484|stage IV non-small cell lung cancer|stage iv non-small cell lung cancer
860740|NCT00006484|adenocarcinoma of the lung|adenocarcinoma of the lung
860741|NCT00061607|Motor Neuron Disease|motor neuron disease
860742|NCT00061607|Neuromuscular Disease|neuromuscular disease
860743|NCT00061607|Histone Deacytelase Inhibitors|histone deacytelase inhibitors
860744|NCT00061607|Spinal Muscular Atrophy|spinal muscular atrophy
860746|NCT00061594|Neovascular age-related macular degeneration|neovascular age-related macular degeneration
860747|NCT00061542|Glaucoma|glaucoma
860748|NCT00061542|Ocular Hypertension|ocular hypertension
860749|NCT00061529|Open-Angle Glaucoma|open-angle glaucoma
860750|NCT00061529|Ocular Hypertension|ocular hypertension
860751|NCT00061516|Glaucoma|glaucoma
860752|NCT00061516|Ocular Hypertension|ocular hypertension
860753|NCT00061503|Glaucoma|glaucoma
860754|NCT00061503|Ocular Hypertension|ocular hypertension
860755|NCT00006464|unspecified adult solid tumor, protocol specific|unspecified adult solid tumor, protocol specific
860756|NCT00006457|non-small cell lung cancer|non-small cell lung cancer
860757|NCT00006457|small cell lung cancer|small cell lung cancer
860758|NCT00006383|recurrent adult diffuse large cell lymphoma|recurrent adult diffuse large cell lymphoma
860759|NCT00006383|recurrent adult immunoblastic large cell lymphoma|recurrent adult immunoblastic large cell lymphoma
860760|NCT00006383|recurrent adult T-cell leukemia/lymphoma|recurrent adult t-cell leukemia/lymphoma
860761|NCT00006383|anaplastic large cell lymphoma|anaplastic large cell lymphoma
860762|NCT00006377|stage III endometrial carcinoma|stage iii endometrial carcinoma
860763|NCT00006377|stage IV endometrial carcinoma|stage iv endometrial carcinoma
860764|NCT00006377|recurrent endometrial carcinoma|recurrent endometrial carcinoma
860765|NCT00006361|squamous cell carcinoma of the skin|squamous cell carcinoma of the skin
860766|NCT00006361|recurrent skin cancer|recurrent skin cancer
860767|NCT00006361|stage IV nasopharyngeal cancer|stage iv nasopharyngeal cancer
860768|NCT00006361|recurrent metastatic squamous neck cancer with occult primary|recurrent metastatic squamous neck cancer with occult primary
860769|NCT00006361|metastatic squamous neck cancer with occult primary squamous cell carcinoma|metastatic squamous neck cancer with occult primary squamous cell carcinoma
860770|NCT00006361|squamous cell carcinoma of unknown primary|squamous cell carcinoma of unknown primary
860771|NCT00006361|stage IV squamous cell carcinoma of the lip and oral cavity|stage iv squamous cell carcinoma of the lip and oral cavity
860772|NCT00006361|recurrent squamous cell carcinoma of the lip and oral cavity|recurrent squamous cell carcinoma of the lip and oral cavity
860773|NCT00006361|stage IV squamous cell carcinoma of the oropharynx|stage iv squamous cell carcinoma of the oropharynx
860774|NCT00006361|recurrent squamous cell carcinoma of the oropharynx|recurrent squamous cell carcinoma of the oropharynx
860775|NCT00006361|stage IV squamous cell carcinoma of the nasopharynx|stage iv squamous cell carcinoma of the nasopharynx
860776|NCT00006361|recurrent squamous cell carcinoma of the nasopharynx|recurrent squamous cell carcinoma of the nasopharynx
860777|NCT00006361|stage IV squamous cell carcinoma of the hypopharynx|stage iv squamous cell carcinoma of the hypopharynx
860778|NCT00006361|recurrent squamous cell carcinoma of the hypopharynx|recurrent squamous cell carcinoma of the hypopharynx
860779|NCT00006361|stage IV squamous cell carcinoma of the larynx|stage iv squamous cell carcinoma of the larynx
860780|NCT00006361|recurrent squamous cell carcinoma of the larynx|recurrent squamous cell carcinoma of the larynx
860781|NCT00006361|stage IV squamous cell carcinoma of the paranasal sinus and nasal cavity|stage iv squamous cell carcinoma of the paranasal sinus and nasal cavity
860782|NCT00006361|recurrent squamous cell carcinoma of the paranasal sinus and nasal cavity|recurrent squamous cell carcinoma of the paranasal sinus and nasal cavity
860783|NCT00006361|recurrent carcinoma of unknown primary|recurrent carcinoma of unknown primary
860784|NCT00061581|Chronic Myelogenous Leukemia|chronic myelogenous leukemia
860785|NCT00061581|Acute Lymphoblastic Leukemia|acute lymphoblastic leukemia
860786|NCT00061581|Acute Myelogenous Leukemia (AML)|acute myelogenous leukemia (aml)
860787|NCT00061581|Chronic Lymphocytic Leukemia|chronic lymphocytic leukemia
860788|NCT00061581|Myelodysplastic Syndrome|myelodysplastic syndrome
860789|NCT00061581|Non-Hodgkin's Lymphoma|non-hodgkin's lymphoma
860790|NCT00061581|Graft-Versus Leukemia/Myeloma|graft-versus leukemia/myeloma
860791|NCT00061581|Graft-Versus-Host Disease|graft-versus-host disease
860792|NCT00061581|Cyclosporine|cyclosporine
860793|NCT00061581|Fludarabine|fludarabine
860794|NCT00061581|Myelodysplasia Syndrome|myelodysplasia syndrome
860795|NCT00061568|Stem Cell Transplant|stem cell transplant
860796|NCT00061568|Low Dose Radiation|low dose radiation
860797|NCT00061568|Alemtuzumab (Campath)|alemtuzumab (campath)
860798|NCT00061568|Sirolimus (Rapamune)|sirolimus (rapamune)
860799|NCT00061568|Donor Apheresis|donor apheresis
860800|NCT00061568|Sickle Cell Anemia|sickle cell anemia
860801|NCT00061568|SCA|sca
860802|NCT00061568|Thalassemia|thalassemia
860803|NCT00061568|Diamond-Blackfan Anemia|diamond-blackfan anemia
860804|NCT00061568|DBA|dba
860805|NCT00061490|Osteoarthritis|osteoarthritis
860806|NCT00061490|Arthritis|arthritis
860807|NCT00061490|Weight Loss|weight loss
860808|NCT00006349|depression|depression
860809|NCT00006349|delirium|delirium
860810|NCT00006349|cognitive/functional effects|cognitive/functional effects
860811|NCT00006349|radiation toxicity|radiation toxicity
860812|NCT00006349|limited stage small cell lung cancer|limited stage small cell lung cancer
860916|NCT00019084|recurrent cervical cancer|recurrent cervical cancer
860813|NCT00006349|extensive stage small cell lung cancer|extensive stage small cell lung cancer
860814|NCT00006349|recurrent small cell lung cancer|recurrent small cell lung cancer
860815|NCT00006341|stage I lip and oral cavity cancer|stage i lip and oral cavity cancer
860816|NCT00006341|stage II lip and oral cavity cancer|stage ii lip and oral cavity cancer
860817|NCT00006341|stage III lip and oral cavity cancer|stage iii lip and oral cavity cancer
860818|NCT00061438|non-infected necrotizing pancreatitis|non-infected necrotizing pancreatitis
860819|NCT00061438|pancreatic infection|pancreatic infection
860820|NCT00061438|peripancreatic infection|peripancreatic infection
860821|NCT00061425|NHL|nhl
860822|NCT00061425|recurrent B-cell lymphoma|recurrent b-cell lymphoma
860823|NCT00061412|Low reading and writing achievement|low reading and writing achievement
860824|NCT00061412|At-risk students|at-risk students
860825|NCT00061412|Reading Disability|reading disability
860826|NCT00061412|Writing Disability|writing disability
860827|NCT00061399|TBI|tbi
860828|NCT00061399|Prospective memory|prospective memory
860829|NCT00061386|Postpartum|postpartum
860830|NCT00061386|Low income|low income
860831|NCT00061386|Diet|diet
860832|NCT00061386|Physical activity|physical activity
860833|NCT00061321|Nevirapine|nevirapine
860834|NCT00061321|Pregnancy|pregnancy
860835|NCT00061321|Maternal to Infant transmission|maternal to infant transmission
860836|NCT00061321|Infant|infant
860837|NCT00061321|Breastfeeding|breastfeeding
860838|NCT00061321|HIV Seronegativity|hiv seronegativity
860839|NCT00061308|Ovarian cancer|ovarian cancer
860840|NCT00061308|peritoneal cancer|peritoneal cancer
860841|NCT00061308|cancer|cancer
860842|NCT00061308|Fallopian cancer|fallopian cancer
860843|NCT00061295|Locomotion|locomotion
860844|NCT00061295|Spinal Cord Injury|spinal cord injury
860845|NCT00061295|Body Weight Supported Walking|body weight supported walking
860846|NCT00045149|recurrent melanoma|recurrent melanoma
860847|NCT00045149|stage IV melanoma|stage iv melanoma
860848|NCT00019734|stage IV melanoma|stage iv melanoma
860849|NCT00019734|recurrent melanoma|recurrent melanoma
860850|NCT00061373|Alteplase|alteplase
860851|NCT00061373|Recombinant tissue plasminogen activator|recombinant tissue plasminogen activator
860852|NCT00061373|Reperfusion therapy|reperfusion therapy
860853|NCT00061373|Magnetic Resonance Imaging|magnetic resonance imaging
860854|NCT00061373|Clinical Trial|clinical trial
860855|NCT00061373|Tinzaparin|tinzaparin
860856|NCT00061373|Eptifibatide|eptifibatide
860857|NCT00061373|Ischemic Stroke|ischemic stroke
860858|NCT00061360|Bone Marrow Failure|bone marrow failure
860859|NCT00061360|Cyclosporine|cyclosporine
860860|NCT00061360|Anti Thymocyte Globulin|anti thymocyte globulin
860861|NCT00061360|Severe Aplastic Anemia|severe aplastic anemia
860862|NCT00061347|Fiducial Marker|fiducial marker
860863|NCT00061347|MRI|mri
860864|NCT00061347|Prostate Cancer|prostate cancer
860865|NCT00061347|Radiation|radiation
860866|NCT00061334|Attitudes|attitudes
860867|NCT00061334|fMRI|fmri
860868|NCT00061334|Development|development
860871|NCT00061334|Healthy Volunteer|healthy volunteer
860872|NCT00061334|HV|hv
860873|NCT00061282|Pouchitis|pouchitis
860874|NCT00061282|Colitis|colitis
860875|NCT00061282|Ileitis|ileitis
860876|NCT00041353|ductal breast carcinoma in situ|ductal breast carcinoma in situ
860877|NCT00041353|lobular breast carcinoma in situ|lobular breast carcinoma in situ
860878|NCT00019175|stage IV melanoma|stage iv melanoma
860879|NCT00019175|recurrent melanoma|recurrent melanoma
860880|NCT00002786|stage IV melanoma|stage iv melanoma
860881|NCT00002786|recurrent melanoma|recurrent melanoma
860882|NCT00061269|Infected pancreatic necrosis|infected pancreatic necrosis
860883|NCT00061256|Bone Mineral Density|bone mineral density
860884|NCT00061256|Lumbar Vertebrae|lumbar vertebrae
860885|NCT00061256|Treatment Experienced|treatment experienced
860889|NCT00061243|Protein boost|protein boost
860890|NCT00061243|HIV Seronegativity|hiv seronegativity
860891|NCT00061243|HIV preventive vaccine|hiv preventive vaccine
860892|NCT00061230|Relaxation training|relaxation training
860893|NCT00061217|Transtibial amputees|transtibial amputees
860894|NCT00061217|Rectified sockets|rectified sockets
860895|NCT00061217|Unrectified sockets|unrectified sockets
860896|NCT00061217|Gait|gait
860897|NCT00061217|Energy expenditure|energy expenditure
860898|NCT00061217|Prosthetic evaluation questionnaire|prosthetic evaluation questionnaire
860899|NCT00061165|obesity|obesity
860900|NCT00061165|overweight|overweight
860901|NCT00061165|children|children
860902|NCT00061165|adolescents|adolescents
860903|NCT00061165|African American|african american
860904|NCT00061165|diet|diet
860905|NCT00061165|nutrition|nutrition
860906|NCT00061165|physical activity|physical activity
860907|NCT00061165|Chicago|chicago
860908|NCT00019084|stage IV colon cancer|stage iv colon cancer
860909|NCT00019084|stage IV breast cancer|stage iv breast cancer
860910|NCT00019084|recurrent breast cancer|recurrent breast cancer
860911|NCT00019084|recurrent non-small cell lung cancer|recurrent non-small cell lung cancer
860912|NCT00019084|stage II pancreatic cancer|stage ii pancreatic cancer
860913|NCT00019084|stage III pancreatic cancer|stage iii pancreatic cancer
860914|NCT00019084|recurrent pancreatic cancer|recurrent pancreatic cancer
860917|NCT00019084|stage IVB cervical cancer|stage ivb cervical cancer
860918|NCT00019084|stage IV ovarian epithelial cancer|stage iv ovarian epithelial cancer
860919|NCT00019084|recurrent ovarian epithelial cancer|recurrent ovarian epithelial cancer
860920|NCT00019084|extensive stage small cell lung cancer|extensive stage small cell lung cancer
860921|NCT00019084|recurrent small cell lung cancer|recurrent small cell lung cancer
860922|NCT00019084|stage IV non-small cell lung cancer|stage iv non-small cell lung cancer
860923|NCT00019084|stage IV pancreatic cancer|stage iv pancreatic cancer
860924|NCT00004868|recurrent adult brain tumor|recurrent adult brain tumor
860925|NCT00004868|adult meningioma|adult meningioma
860926|NCT00004868|adult glioblastoma|adult glioblastoma
860927|NCT00004868|adult anaplastic astrocytoma|adult anaplastic astrocytoma
860928|NCT00004868|adult anaplastic oligodendroglioma|adult anaplastic oligodendroglioma
860929|NCT00004868|adult mixed glioma|adult mixed glioma
860930|NCT00004868|adult grade III meningioma|adult grade iii meningioma
860931|NCT00004868|adult giant cell glioblastoma|adult giant cell glioblastoma
860932|NCT00004868|adult gliosarcoma|adult gliosarcoma
860933|NCT00003408|stage IV breast cancer|stage iv breast cancer
860934|NCT00003408|recurrent childhood acute lymphoblastic leukemia|recurrent childhood acute lymphoblastic leukemia
860935|NCT00003408|recurrent adult Hodgkin lymphoma|recurrent adult hodgkin lymphoma
860936|NCT00003408|recurrent cutaneous T-cell non-Hodgkin lymphoma|recurrent cutaneous t-cell non-hodgkin lymphoma
860937|NCT00003408|refractory multiple myeloma|refractory multiple myeloma
860938|NCT00003408|recurrent childhood rhabdomyosarcoma|recurrent childhood rhabdomyosarcoma
860939|NCT00003408|stage II ovarian epithelial cancer|stage ii ovarian epithelial cancer
860940|NCT00003408|stage III ovarian epithelial cancer|stage iii ovarian epithelial cancer
860941|NCT00003408|stage IV ovarian epithelial cancer|stage iv ovarian epithelial cancer
860942|NCT00003408|recurrent ovarian epithelial cancer|recurrent ovarian epithelial cancer
860943|NCT00003408|disseminated neuroblastoma|disseminated neuroblastoma
860944|NCT00003408|recurrent neuroblastoma|recurrent neuroblastoma
860945|NCT00003408|recurrent Wilms tumor and other childhood kidney tumors|recurrent wilms tumor and other childhood kidney tumors
860946|NCT00003408|stage I multiple myeloma|stage i multiple myeloma
860947|NCT00003408|stage II multiple myeloma|stage ii multiple myeloma
860948|NCT00003408|stage III multiple myeloma|stage iii multiple myeloma
860949|NCT00003408|recurrent childhood lymphoblastic lymphoma|recurrent childhood lymphoblastic lymphoma
860950|NCT00003408|stage III chronic lymphocytic leukemia|stage iii chronic lymphocytic leukemia
860951|NCT00003408|stage IV chronic lymphocytic leukemia|stage iv chronic lymphocytic leukemia
860952|NCT00003408|recurrent childhood acute myeloid leukemia|recurrent childhood acute myeloid leukemia
860953|NCT00003408|recurrent adult acute myeloid leukemia|recurrent adult acute myeloid leukemia
860954|NCT00003408|recurrent adult acute lymphoblastic leukemia|recurrent adult acute lymphoblastic leukemia
860955|NCT00003408|relapsing chronic myelogenous leukemia|relapsing chronic myelogenous leukemia
860956|NCT00003408|refractory chronic lymphocytic leukemia|refractory chronic lymphocytic leukemia
860957|NCT00003408|stage III malignant testicular germ cell tumor|stage iii malignant testicular germ cell tumor
860958|NCT00003408|recurrent malignant testicular germ cell tumor|recurrent malignant testicular germ cell tumor
860959|NCT00003408|chronic phase chronic myelogenous leukemia|chronic phase chronic myelogenous leukemia
860960|NCT00003408|accelerated phase chronic myelogenous leukemia|accelerated phase chronic myelogenous leukemia
860961|NCT00003408|blastic phase chronic myelogenous leukemia|blastic phase chronic myelogenous leukemia
860962|NCT00003408|meningeal chronic myelogenous leukemia|meningeal chronic myelogenous leukemia
860963|NCT00003408|chronic idiopathic myelofibrosis|chronic idiopathic myelofibrosis
860964|NCT00003408|childhood acute promyelocytic leukemia (M3)|childhood acute promyelocytic leukemia (m3)
860965|NCT00003408|testicular embryonal carcinoma|testicular embryonal carcinoma
860966|NCT00003408|testicular choriocarcinoma|testicular choriocarcinoma
860967|NCT00003408|testicular teratoma|testicular teratoma
860968|NCT00003408|testicular yolk sac tumor|testicular yolk sac tumor
860969|NCT00003408|testicular embryonal carcinoma and teratoma|testicular embryonal carcinoma and teratoma
860970|NCT00003408|testicular embryonal carcinoma and teratoma with seminoma|testicular embryonal carcinoma and teratoma with seminoma
860971|NCT00003408|testicular embryonal carcinoma and yolk sac tumor|testicular embryonal carcinoma and yolk sac tumor
860972|NCT00003408|testicular embryonal carcinoma and yolk sac tumor with seminoma|testicular embryonal carcinoma and yolk sac tumor with seminoma
860973|NCT00003408|testicular embryonal carcinoma and seminoma|testicular embryonal carcinoma and seminoma
860974|NCT00003408|testicular yolk sac tumor and teratoma|testicular yolk sac tumor and teratoma
860975|NCT00003408|testicular yolk sac tumor and teratoma with seminoma|testicular yolk sac tumor and teratoma with seminoma
860976|NCT00003408|testicular choriocarcinoma and yolk sac tumor|testicular choriocarcinoma and yolk sac tumor
860977|NCT00003408|testicular choriocarcinoma and embryonal carcinoma|testicular choriocarcinoma and embryonal carcinoma
860978|NCT00003408|testicular choriocarcinoma and teratoma|testicular choriocarcinoma and teratoma
860979|NCT00003408|testicular choriocarcinoma and seminoma|testicular choriocarcinoma and seminoma
860980|NCT00003408|refractory hairy cell leukemia|refractory hairy cell leukemia
860981|NCT00003408|recurrent/refractory childhood Hodgkin lymphoma|recurrent/refractory childhood hodgkin lymphoma
860982|NCT00003408|recurrent ovarian germ cell tumor|recurrent ovarian germ cell tumor
860983|NCT00003408|ovarian yolk sac tumor|ovarian yolk sac tumor
860984|NCT00003408|ovarian embryonal carcinoma|ovarian embryonal carcinoma
882957|NCT00025727|Viral Load|viral load
860985|NCT00003408|ovarian polyembryoma|ovarian polyembryoma
860986|NCT00003408|ovarian choriocarcinoma|ovarian choriocarcinoma
860987|NCT00003408|ovarian immature teratoma|ovarian immature teratoma
860988|NCT00003408|ovarian mature teratoma|ovarian mature teratoma
860989|NCT00003408|ovarian monodermal and highly specialized teratoma|ovarian monodermal and highly specialized teratoma
860990|NCT00003408|ovarian mixed germ cell tumor|ovarian mixed germ cell tumor
860991|NCT00003408|stage III grade 1 follicular lymphoma|stage iii grade 1 follicular lymphoma
860992|NCT00003408|stage III grade 2 follicular lymphoma|stage iii grade 2 follicular lymphoma
860993|NCT00003408|stage III grade 3 follicular lymphoma|stage iii grade 3 follicular lymphoma
860994|NCT00003408|stage III adult diffuse small cleaved cell lymphoma|stage iii adult diffuse small cleaved cell lymphoma
860995|NCT00003408|stage III adult diffuse mixed cell lymphoma|stage iii adult diffuse mixed cell lymphoma
860996|NCT00003408|stage III adult diffuse large cell lymphoma|stage iii adult diffuse large cell lymphoma
860997|NCT00003408|stage III adult immunoblastic large cell lymphoma|stage iii adult immunoblastic large cell lymphoma
860998|NCT00003408|stage III adult lymphoblastic lymphoma|stage iii adult lymphoblastic lymphoma
860999|NCT00003408|stage III adult Burkitt lymphoma|stage iii adult burkitt lymphoma
861000|NCT00003408|stage IV grade 1 follicular lymphoma|stage iv grade 1 follicular lymphoma
861001|NCT00003408|stage IV grade 2 follicular lymphoma|stage iv grade 2 follicular lymphoma
861002|NCT00003408|stage IV grade 3 follicular lymphoma|stage iv grade 3 follicular lymphoma
861003|NCT00003408|stage IV adult diffuse small cleaved cell lymphoma|stage iv adult diffuse small cleaved cell lymphoma
861004|NCT00003408|stage IV adult diffuse mixed cell lymphoma|stage iv adult diffuse mixed cell lymphoma
861005|NCT00003408|stage IV adult diffuse large cell lymphoma|stage iv adult diffuse large cell lymphoma
861006|NCT00003408|stage IV adult immunoblastic large cell lymphoma|stage iv adult immunoblastic large cell lymphoma
861007|NCT00003408|stage IV adult lymphoblastic lymphoma|stage iv adult lymphoblastic lymphoma
861008|NCT00003408|stage IV adult Burkitt lymphoma|stage iv adult burkitt lymphoma
861009|NCT00003408|recurrent grade 1 follicular lymphoma|recurrent grade 1 follicular lymphoma
861010|NCT00003408|recurrent grade 2 follicular lymphoma|recurrent grade 2 follicular lymphoma
861011|NCT00003408|recurrent grade 3 follicular lymphoma|recurrent grade 3 follicular lymphoma
861012|NCT00003408|recurrent adult diffuse small cleaved cell lymphoma|recurrent adult diffuse small cleaved cell lymphoma
861013|NCT00003408|recurrent adult diffuse mixed cell lymphoma|recurrent adult diffuse mixed cell lymphoma
861014|NCT00003408|recurrent adult diffuse large cell lymphoma|recurrent adult diffuse large cell lymphoma
861015|NCT00003408|recurrent adult immunoblastic large cell lymphoma|recurrent adult immunoblastic large cell lymphoma
861016|NCT00003408|recurrent adult lymphoblastic lymphoma|recurrent adult lymphoblastic lymphoma
861017|NCT00003408|recurrent adult Burkitt lymphoma|recurrent adult burkitt lymphoma
861018|NCT00003408|secondary acute myeloid leukemia|secondary acute myeloid leukemia
861019|NCT00003408|de novo myelodysplastic syndromes|de novo myelodysplastic syndromes
861020|NCT00003408|poor prognosis metastatic gestational trophoblastic tumor|poor prognosis metastatic gestational trophoblastic tumor
861021|NCT00003408|previously treated myelodysplastic syndromes|previously treated myelodysplastic syndromes
861022|NCT00003408|secondary myelodysplastic syndromes|secondary myelodysplastic syndromes
861023|NCT00003408|recurrent childhood small noncleaved cell lymphoma|recurrent childhood small noncleaved cell lymphoma
861024|NCT00003408|recurrent childhood large cell lymphoma|recurrent childhood large cell lymphoma
861025|NCT00003408|noncontiguous stage II grade 1 follicular lymphoma|noncontiguous stage ii grade 1 follicular lymphoma
861026|NCT00003408|noncontiguous stage II grade 2 follicular lymphoma|noncontiguous stage ii grade 2 follicular lymphoma
861027|NCT00003408|noncontiguous stage II grade 3 follicular lymphoma|noncontiguous stage ii grade 3 follicular lymphoma
861028|NCT00003408|noncontiguous stage II adult diffuse small cleaved cell lymphoma|noncontiguous stage ii adult diffuse small cleaved cell lymphoma
861029|NCT00003408|noncontiguous stage II mantle cell lymphoma|noncontiguous stage ii mantle cell lymphoma
861030|NCT00003408|noncontiguous stage II adult diffuse mixed cell lymphoma|noncontiguous stage ii adult diffuse mixed cell lymphoma
861031|NCT00003408|noncontiguous stage II adult immunoblastic large cell lymphoma|noncontiguous stage ii adult immunoblastic large cell lymphoma
861032|NCT00003408|noncontiguous stage II adult diffuse large cell lymphoma|noncontiguous stage ii adult diffuse large cell lymphoma
861033|NCT00003408|noncontiguous stage II adult Burkitt lymphoma|noncontiguous stage ii adult burkitt lymphoma
861034|NCT00003408|noncontiguous stage II adult lymphoblastic lymphoma|noncontiguous stage ii adult lymphoblastic lymphoma
861035|NCT00003408|stage III mantle cell lymphoma|stage iii mantle cell lymphoma
861036|NCT00003408|stage IV mantle cell lymphoma|stage iv mantle cell lymphoma
861037|NCT00003408|recurrent mantle cell lymphoma|recurrent mantle cell lymphoma
861038|NCT00003408|previously treated childhood rhabdomyosarcoma|previously treated childhood rhabdomyosarcoma
861039|NCT00003408|recurrent mycosis fungoides/Sezary syndrome|recurrent mycosis fungoides/sezary syndrome
861040|NCT00003408|noncontiguous stage II small lymphocytic lymphoma|noncontiguous stage ii small lymphocytic lymphoma
861041|NCT00003408|noncontiguous stage II marginal zone lymphoma|noncontiguous stage ii marginal zone lymphoma
861042|NCT00003408|recurrent marginal zone lymphoma|recurrent marginal zone lymphoma
861043|NCT00003408|recurrent small lymphocytic lymphoma|recurrent small lymphocytic lymphoma
861044|NCT00003408|stage III small lymphocytic lymphoma|stage iii small lymphocytic lymphoma
861045|NCT00003408|stage III marginal zone lymphoma|stage iii marginal zone lymphoma
861046|NCT00003408|stage IV small lymphocytic lymphoma|stage iv small lymphocytic lymphoma
882958|NCT00025727|ABT 378|abt 378
861047|NCT00003408|stage IV marginal zone lymphoma|stage iv marginal zone lymphoma
861048|NCT00003408|extranodal marginal zone B-cell lymphoma of mucosa-associated lymphoid tissue|extranodal marginal zone b-cell lymphoma of mucosa-associated lymphoid tissue
861049|NCT00003408|nodal marginal zone B-cell lymphoma|nodal marginal zone b-cell lymphoma
861050|NCT00003408|splenic marginal zone lymphoma|splenic marginal zone lymphoma
861051|NCT00003408|childhood myelodysplastic syndromes|childhood myelodysplastic syndromes
861053|NCT00061204|Susceptibility Artifacts|susceptibility artifacts
861054|NCT00061204|Prefrontal Cortex|prefrontal cortex
861055|NCT00061204|Temporal Lobes|temporal lobes
861056|NCT00061204|Methodology|methodology
861057|NCT00061204|Healthy Volunteer|healthy volunteer
861059|NCT00061152|Pain Measurement|pain measurement
861060|NCT00061152|Diary|diary
861061|NCT00061152|Painful HIV Neuropathy|painful hiv neuropathy
861062|NCT00061152|HIV Neuropathy|hiv neuropathy
861063|NCT00061152|Capsaicin|capsaicin
861064|NCT00061152|Analgesics/*therapeutic use|analgesics/*therapeutic use
861065|NCT00061152|Capsaicin/*administration & dosage/adverse effects|capsaicin/*administration & dosage/adverse effects
861066|NCT00061152|Peripheral Nervous System Diseases/*complications/diagnosis/*therapy|peripheral nervous system diseases/*complications/diagnosis/*therapy
861067|NCT00061152|Peripheral Nervous System Diseases/drug therapy/*etiology/physiopathology|peripheral nervous system diseases/drug therapy/*etiology/physiopathology
861068|NCT00061152|Pain|pain
861069|NCT00061139|Cerebral palsy|cerebral palsy
861070|NCT00061139|Hemiparesis|hemiparesis
861071|NCT00061139|Pediatric CI therapy|pediatric ci therapy
861072|NCT00061139|Upper extremity|upper extremity
861073|NCT00061139|Training|training
861074|NCT00061139|Limb restraint|limb restraint
861075|NCT00061126|Prostate Cancer|prostate cancer
861076|NCT00061126|PSA|psa
861077|NCT00061126|Hormone refractory|hormone refractory
861078|NCT00061126|Rising PSA|rising psa
861079|NCT00061113|alcohol dependence|alcohol dependence
861080|NCT00061113|marijuana dependence|marijuana dependence
861081|NCT00061100|HIV|hiv
861082|NCT00061100|methadone maintenance|methadone maintenance
861083|NCT00061087|ADHD|adhd
861084|NCT00061087|Cocaine|cocaine
861085|NCT00061087|Treatment|treatment
861086|NCT00061087|Methadone|methadone
861087|NCT00061074|Smoking|smoking
861088|NCT00061061|Tobacco Cessation|tobacco cessation
861089|NCT00061061|Postmenopausal Women|postmenopausal women
861090|NCT00061035|Prostate Cancer; Immunotherapy|prostate cancer; immunotherapy
861091|NCT00006095|unspecified childhood solid tumor, protocol specific|unspecified childhood solid tumor, protocol specific
861092|NCT00006086|unspecified adult solid tumor, protocol specific|unspecified adult solid tumor, protocol specific
861093|NCT00006082|extensive stage small cell lung cancer|extensive stage small cell lung cancer
861094|NCT00006082|recurrent small cell lung cancer|recurrent small cell lung cancer
861095|NCT00061048|Monoclonal Antibody|monoclonal antibody
861096|NCT00061048|HTLV-1|htlv-1
861097|NCT00061048|CD52|cd52
861098|NCT00061048|Flow Cytometry|flow cytometry
861099|NCT00061048|Antibody Saturation|antibody saturation
861100|NCT00061048|Adult T-Cell Leukemia (ATL)|adult t-cell leukemia (atl)
861101|NCT00061048|ATL|atl
861102|NCT00061022|Stroke|stroke
861103|NCT00061022|cerebral vascular accident|cerebral vascular accident
861104|NCT00061022|CVA|cva
861105|NCT00061022|Ischemia|ischemia
861106|NCT00061022|Hemorrhage|hemorrhage
861107|NCT00061022|TIA|tia
861108|NCT00061022|Transient Ischemic Attack|transient ischemic attack
861109|NCT00061022|Brain Attack|brain attack
861110|NCT00061022|Cataplexy|cataplexy
861111|NCT00006046|stage IV colon cancer|stage iv colon cancer
861112|NCT00006046|stage IV rectal cancer|stage iv rectal cancer
861113|NCT00006046|recurrent colon cancer|recurrent colon cancer
861114|NCT00006046|recurrent rectal cancer|recurrent rectal cancer
861115|NCT00005999|recurrent cervical cancer|recurrent cervical cancer
861116|NCT00005999|stage IVB cervical cancer|stage ivb cervical cancer
861117|NCT00005999|cervical squamous cell carcinoma|cervical squamous cell carcinoma
861118|NCT00005999|cervical adenocarcinoma|cervical adenocarcinoma
861119|NCT00005977|childhood Burkitt lymphoma|childhood burkitt lymphoma
861120|NCT00005977|L3 childhood acute lymphoblastic leukemia|l3 childhood acute lymphoblastic leukemia
861121|NCT00005977|B-cell childhood acute lymphoblastic leukemia|b-cell childhood acute lymphoblastic leukemia
861122|NCT00005977|L3 adult acute lymphoblastic leukemia|l3 adult acute lymphoblastic leukemia
861123|NCT00005977|B-cell adult acute lymphoblastic leukemia|b-cell adult acute lymphoblastic leukemia
861124|NCT00005977|stage III adult Burkitt lymphoma|stage iii adult burkitt lymphoma
861125|NCT00005977|stage IV adult Burkitt lymphoma|stage iv adult burkitt lymphoma
861126|NCT00005977|stage III childhood small noncleaved cell lymphoma|stage iii childhood small noncleaved cell lymphoma
861127|NCT00005977|stage IV childhood small noncleaved cell lymphoma|stage iv childhood small noncleaved cell lymphoma
861128|NCT00005971|stage IV melanoma|stage iv melanoma
861129|NCT00005956|stage II breast cancer|stage ii breast cancer
861130|NCT00005956|stage IV breast cancer|stage iv breast cancer
861131|NCT00005956|stage IIIA breast cancer|stage iiia breast cancer
861132|NCT00005956|stage II gastric cancer|stage ii gastric cancer
861133|NCT00005956|stage III gastric cancer|stage iii gastric cancer
861134|NCT00005956|stage IV gastric cancer|stage iv gastric cancer
882959|NCT00025727|VX-175|vx-175
861135|NCT00005956|stage IIIB breast cancer|stage iiib breast cancer
861136|NCT00005956|stage III ovarian epithelial cancer|stage iii ovarian epithelial cancer
861137|NCT00005956|stage IV ovarian epithelial cancer|stage iv ovarian epithelial cancer
861138|NCT00005868|stage IIIA non-small cell lung cancer|stage iiia non-small cell lung cancer
861139|NCT00061009|Chronic Orthostatic Intolerance|chronic orthostatic intolerance
861140|NCT00061009|Dysautonomia|dysautonomia
861141|NCT00061009|Postural Tachycardia Syndrome|postural tachycardia syndrome
861142|NCT00061009|Neurocardiogenic|neurocardiogenic
861143|NCT00061009|Syncope|syncope
861144|NCT00061009|Neurocardiogenic Syncope|neurocardiogenic syncope
861145|NCT00061009|COI|coi
861146|NCT00061009|POTS|pots
861147|NCT00061009|Neurocardogenic Syncope|neurocardogenic syncope
861148|NCT00061009|NCS|ncs
861149|NCT00061009|Healthy Volunteer|healthy volunteer
861150|NCT00061009|HV|hv
861151|NCT00060996|Critical Limb Ischemia|critical limb ischemia
861152|NCT00060996|Peripheral Vascular Disease|peripheral vascular disease
861153|NCT00060996|UT-15|ut-15
861154|NCT00060996|Remodulin|remodulin
861155|NCT00060996|treprostinil|treprostinil
861156|NCT00005813|adult glioblastoma|adult glioblastoma
861157|NCT00005813|adult giant cell glioblastoma|adult giant cell glioblastoma
861158|NCT00005813|adult gliosarcoma|adult gliosarcoma
861159|NCT00060983|Locomotion|locomotion
861160|NCT00060983|Spinal Cord Injury, ASIA C|spinal cord injury, asia c
861161|NCT00060983|Body weight support (BWS)|body weight support (bws)
861162|NCT00060983|Functional electrical stimulation (FES)|functional electrical stimulation (fes)
861163|NCT00060983|Gait|gait
861164|NCT00060983|Treadmill training|treadmill training
861165|NCT00060983|Physical Therapy|physical therapy
861166|NCT00060970|Disuse atrophy|disuse atrophy
861167|NCT00060970|Ankle fracture|ankle fracture
861168|NCT00060970|Exercise, therapy|exercise, therapy
861169|NCT00060970|Cast immobilization|cast immobilization
861170|NCT00060970|Deconditioning|deconditioning
861171|NCT00060970|Sarcopenia|sarcopenia
861172|NCT00060957|Cerebral Palsy|cerebral palsy
861173|NCT00060957|Spasticity|spasticity
861174|NCT00060957|Botulinum toxin|botulinum toxin
861175|NCT00060957|BOTOX|botox
861176|NCT00060944|Trabectedin|trabectedin
861177|NCT00060944|Yondelis|yondelis
861178|NCT00060944|ET-743|et-743
861179|NCT00060944|Ecteinascidin|ecteinascidin
861180|NCT00060944|Anthracycline|anthracycline
861181|NCT00060944|Ifosfamide|ifosfamide
861182|NCT00060944|Dexamethasone|dexamethasone
861183|NCT00060944|Intravenous|intravenous
861184|NCT00060944|Cancer|cancer
861185|NCT00060944|Malignant|malignant
861186|NCT00060944|Metastatic|metastatic
861187|NCT00005861|stage III endometrial carcinoma|stage iii endometrial carcinoma
861188|NCT00005861|stage IV endometrial carcinoma|stage iv endometrial carcinoma
861189|NCT00005861|recurrent endometrial carcinoma|recurrent endometrial carcinoma
861190|NCT00005588|stage I breast cancer|stage i breast cancer
861191|NCT00005588|stage II breast cancer|stage ii breast cancer
861192|NCT00005588|stage IIIA breast cancer|stage iiia breast cancer
861193|NCT00005587|stage I breast cancer|stage i breast cancer
861194|NCT00005587|stage II breast cancer|stage ii breast cancer
861195|NCT00005587|stage IIIA breast cancer|stage iiia breast cancer
861196|NCT00003203|untreated childhood supratentorial primitive neuroectodermal tumor|untreated childhood supratentorial primitive neuroectodermal tumor
861197|NCT00003203|untreated childhood medulloblastoma|untreated childhood medulloblastoma
861198|NCT00003203|localized unresectable neuroblastoma|localized unresectable neuroblastoma
861199|NCT00003203|regional neuroblastoma|regional neuroblastoma
861200|NCT00003203|stage 4S neuroblastoma|stage 4s neuroblastoma
861201|NCT00060931|hypertension|hypertension
861202|NCT00060931|beta-blockers|beta-blockers
861203|NCT00060931|Type 2 diabetes|type 2 diabetes
861204|NCT00060918|Type 2 diabetes|type 2 diabetes
861205|NCT00060918|hypertension|hypertension
861206|NCT00060918|beta-blockers|beta-blockers
861207|NCT00060905|Bipolar Disorder (manic or mixed type)|bipolar disorder (manic or mixed type)
861208|NCT00060892|Critical Limb Ischemia|critical limb ischemia
861209|NCT00005086|stage IV bladder cancer|stage iv bladder cancer
861210|NCT00005086|transitional cell carcinoma of the bladder|transitional cell carcinoma of the bladder
861211|NCT00005078|unspecified adult solid tumor, protocol specific|unspecified adult solid tumor, protocol specific
861212|NCT00060866|Beta-Adrenoceptors|beta-adrenoceptors
861213|NCT00060866|Beta-Adrenoceptor Blocker|beta-adrenoceptor blocker
861214|NCT00060866|Neurocardiogenic Syncope|neurocardiogenic syncope
861215|NCT00060866|Chronic Orthostatic Intolerance|chronic orthostatic intolerance
861216|NCT00060866|Neurocardiogenic|neurocardiogenic
861217|NCT00060866|Dysautonomia|dysautonomia
861218|NCT00060866|Autonomic Nervous System|autonomic nervous system
861219|NCT00060866|Nurocardiogenic Syncope|nurocardiogenic syncope
861221|NCT00060866|Sympathoadrenal Imbalance|sympathoadrenal imbalance
861222|NCT00060866|SAI|sai
861223|NCT00060866|Orthostatic Intolerance|orthostatic intolerance
861224|NCT00060840|Left Ventricular Assist Device Implantation|left ventricular assist device implantation
861225|NCT00060840|Progressive Left Ventricular Failure|progressive left ventricular failure
861226|NCT00060827|Mild traumatic brain injury|mild traumatic brain injury
861227|NCT00060853|Amygdala|amygdala
861228|NCT00060853|Orbitofrontal Cortex|orbitofrontal cortex
861229|NCT00060853|Emotion|emotion
861230|NCT00060853|Cognition|cognition
861231|NCT00060853|Theory of Mind|theory of mind
861232|NCT00060853|Healthy Volunteer|healthy volunteer
861233|NCT00060853|HV|hv
861234|NCT00060801|Cystic Fibrosis|cystic fibrosis
861235|NCT00060801|BIIL 284|biil 284
861236|NCT00060801|Boehringer Ingelheim|boehringer ingelheim
861237|NCT00060788|Antisocial behavior|antisocial behavior
861238|NCT00060788|Mauritius Child Health Project|mauritius child health project
861239|NCT00060788|Intergenerational transmission|intergenerational transmission
861240|NCT00004928|adenocarcinoma of the prostate|adenocarcinoma of the prostate
861241|NCT00004928|stage I prostate cancer|stage i prostate cancer
861242|NCT00004928|stage IIB prostate cancer|stage iib prostate cancer
861243|NCT00004928|stage IIA prostate cancer|stage iia prostate cancer
861244|NCT00004928|stage III prostate cancer|stage iii prostate cancer
861245|NCT00004928|stage IV prostate cancer|stage iv prostate cancer
861246|NCT00004928|recurrent prostate cancer|recurrent prostate cancer
861247|NCT00004925|stage IV breast cancer|stage iv breast cancer
861248|NCT00004925|recurrent breast cancer|recurrent breast cancer
861249|NCT00004925|stage IIIB breast cancer|stage iiib breast cancer
861250|NCT00004925|inflammatory breast cancer|inflammatory breast cancer
861251|NCT00004916|recurrent grade 3 follicular lymphoma|recurrent grade 3 follicular lymphoma
861252|NCT00004916|recurrent adult diffuse mixed cell lymphoma|recurrent adult diffuse mixed cell lymphoma
861253|NCT00004916|recurrent adult diffuse large cell lymphoma|recurrent adult diffuse large cell lymphoma
861254|NCT00004916|recurrent adult immunoblastic large cell lymphoma|recurrent adult immunoblastic large cell lymphoma
861255|NCT00004916|recurrent adult Burkitt lymphoma|recurrent adult burkitt lymphoma
861256|NCT00004911|stage I colon cancer|stage i colon cancer
861257|NCT00004911|stage II colon cancer|stage ii colon cancer
861258|NCT00004911|stage III colon cancer|stage iii colon cancer
861259|NCT00004911|stage IV colon cancer|stage iv colon cancer
861260|NCT00004911|stage I gastric cancer|stage i gastric cancer
861261|NCT00004911|stage II gastric cancer|stage ii gastric cancer
861262|NCT00004911|stage III gastric cancer|stage iii gastric cancer
861263|NCT00004911|stage IV gastric cancer|stage iv gastric cancer
861264|NCT00004911|recurrent gastric cancer|recurrent gastric cancer
861265|NCT00004911|stage I rectal cancer|stage i rectal cancer
861266|NCT00004911|stage II rectal cancer|stage ii rectal cancer
861267|NCT00004911|stage III rectal cancer|stage iii rectal cancer
861268|NCT00004911|stage IV rectal cancer|stage iv rectal cancer
861269|NCT00004911|recurrent colon cancer|recurrent colon cancer
861270|NCT00004911|recurrent rectal cancer|recurrent rectal cancer
861271|NCT00004911|localized gastrointestinal carcinoid tumor|localized gastrointestinal carcinoid tumor
861272|NCT00004911|regional gastrointestinal carcinoid tumor|regional gastrointestinal carcinoid tumor
861273|NCT00004911|metastatic gastrointestinal carcinoid tumor|metastatic gastrointestinal carcinoid tumor
861274|NCT00004911|recurrent gastrointestinal carcinoid tumor|recurrent gastrointestinal carcinoid tumor
861275|NCT00004911|small intestine adenocarcinoma|small intestine adenocarcinoma
861276|NCT00004911|small intestine lymphoma|small intestine lymphoma
861277|NCT00004911|small intestine leiomyosarcoma|small intestine leiomyosarcoma
861278|NCT00004911|recurrent small intestine cancer|recurrent small intestine cancer
861279|NCT00004911|constipation, impaction, and bowel obstruction|constipation, impaction, and bowel obstruction
861280|NCT00004911|quality of life|quality of life
861281|NCT00004911|gastrointestinal stromal tumor|gastrointestinal stromal tumor
861282|NCT00060775|Magnetic Resonance Imaging|magnetic resonance imaging
861283|NCT00060775|fMRI|fmri
861284|NCT00060775|Emotion|emotion
861285|NCT00060775|Children|children
861286|NCT00060775|Adolescence|adolescence
861287|NCT00060775|Affective Neuroscience|affective neuroscience
861288|NCT00060775|Neuroimaging|neuroimaging
861289|NCT00060775|Behavioral Inhibition|behavioral inhibition
861290|NCT00060775|Depression|depression
861291|NCT00060775|Anxiety|anxiety
861292|NCT00060775|Normal Volunteers|normal volunteers
861293|NCT00060775|Healthy Volunteer|healthy volunteer
861294|NCT00060775|HV|hv
861295|NCT00060762|Weight Loss|weight loss
861296|NCT00060723|Polysomnography|polysomnography
861297|NCT00060723|Sleep-disordered breathing|sleep-disordered breathing
861298|NCT00060723|Sleep apnea, obstructive|sleep apnea, obstructive
861299|NCT00060723|Hyperactivity|hyperactivity
861300|NCT00060723|Sleep|sleep
861301|NCT00060723|Child|child
861302|NCT00060710|melanoma|melanoma
861303|NCT00060749|Stargardt|stargardt
861304|NCT00060749|Macular Dystrophy|macular dystrophy
861305|NCT00060749|ELOVL4|elovl4
861306|NCT00060749|DHA|dha
861307|NCT00060749|Stargardt's Disease|stargardt's disease
861308|NCT00060749|Autosomal Dominant Macular Dystrophy|autosomal dominant macular dystrophy
861309|NCT00060749|Autosomal Recessive Macular Dystrophy|autosomal recessive macular dystrophy
861310|NCT00060736|Hormone Replacement|hormone replacement
861311|NCT00060736|Gonadal Steroids|gonadal steroids
861312|NCT00060736|Estrogen|estrogen
861313|NCT00060736|Major Depression|major depression
861314|NCT00060736|Minor Depression|minor depression
861315|NCT00060736|Perimenopause|perimenopause
861316|NCT00060736|Estradiol|estradiol
861317|NCT00060736|Depression|depression
861318|NCT00060736|Perimenopausal Depression|perimenopausal depression
861319|NCT00060697|Sexual risk taking|sexual risk taking
861320|NCT00060697|Mother-child communication|mother-child communication
861321|NCT00060697|Problem behaviors|problem behaviors
861322|NCT00060684|Pixantrone|pixantrone
861323|NCT00060684|BBR 2778|bbr 2778
861324|NCT00060684|chemotherapy|chemotherapy
861325|NCT00060684|DNA Intercalator|dna intercalator
861326|NCT00060684|mitoxantrone|mitoxantrone
861327|NCT00060684|fludarabine|fludarabine
861328|NCT00060684|dexamethasone|dexamethasone
861329|NCT00060684|Rituximab|rituximab
861330|NCT00060684|Rituxan|rituxan
861331|NCT00060684|Mabthera|mabthera
861332|NCT00060684|monoclonal antibody|monoclonal antibody
861333|NCT00060684|antibody|antibody
861334|NCT00060684|NHL|nhl
861335|NCT00060684|Non-Hodgkin's lymphoma|non-hodgkin's lymphoma
861336|NCT00060684|indolent|indolent
861337|NCT00060684|low grade|low grade
861338|NCT00060684|Novuspharma|novuspharma
861339|NCT00060671|Pixantrone|pixantrone
861340|NCT00060671|BBR 2778|bbr 2778
861341|NCT00060671|chemotherapy|chemotherapy
861342|NCT00060671|DNA Intercalator|dna intercalator
861343|NCT00060671|Anthracycline|anthracycline
861344|NCT00060671|Rituximab|rituximab
861345|NCT00060671|Rituxan|rituxan
861346|NCT00060671|Mabthera|mabthera
861347|NCT00060671|monoclonal antibody|monoclonal antibody
861348|NCT00060671|antibody|antibody
861349|NCT00060671|NHL|nhl
861350|NCT00060671|Non-Hodgkin's lymphoma|non-hodgkin's lymphoma
861351|NCT00060671|indolent|indolent
861352|NCT00060671|low grade|low grade
861353|NCT00060671|Novuspharma|novuspharma
861354|NCT00060645|Advanced, refractory or recurrent solid tumors|advanced, refractory or recurrent solid tumors
861355|NCT00060632|Advanced, refractory or recurrent solid tumors|advanced, refractory or recurrent solid tumors
861356|NCT00060619|Migraine|migraine
861357|NCT00060619|Functional abdominal pain|functional abdominal pain
861358|NCT00060619|Biofeedback|biofeedback
861359|NCT00060619|Psychological assessment|psychological assessment
861360|NCT00060658|Prefrontal Cortex|prefrontal cortex
861361|NCT00060658|Calculation|calculation
861362|NCT00060658|Mathematician|mathematician
861363|NCT00060658|Cognition|cognition
861364|NCT00060658|Brain Mapping|brain mapping
861365|NCT00060658|Healthy Volunteer|healthy volunteer
861366|NCT00060658|HV|hv
861367|NCT00060606|Maternal fetal surgery|maternal fetal surgery
861368|NCT00060606|Fetal diagnosis|fetal diagnosis
861369|NCT00060606|Myelomeningocele|myelomeningocele
861370|NCT00060606|Meningomyelocele|meningomyelocele
861371|NCT00060606|Open neural tube defect|open neural tube defect
861372|NCT00060606|ONTD|ontd
861373|NCT00060606|Spina bifida|spina bifida
861374|NCT00060567|E7070|e7070
861375|NCT00060567|Irinotecan|irinotecan
861376|NCT00060567|hydrochloride|hydrochloride
861377|NCT00060567|gastrointestinal|gastrointestinal
861378|NCT00060567|cancer|cancer
861379|NCT00004910|stage I colon cancer|stage i colon cancer
861380|NCT00004910|stage II colon cancer|stage ii colon cancer
861381|NCT00004910|stage III colon cancer|stage iii colon cancer
861382|NCT00004910|stage IV colon cancer|stage iv colon cancer
861383|NCT00004910|stage I gastric cancer|stage i gastric cancer
861384|NCT00004910|stage II gastric cancer|stage ii gastric cancer
861385|NCT00004910|stage III gastric cancer|stage iii gastric cancer
861386|NCT00004910|stage IV gastric cancer|stage iv gastric cancer
861387|NCT00004910|recurrent gastric cancer|recurrent gastric cancer
861388|NCT00004910|stage I pancreatic cancer|stage i pancreatic cancer
861389|NCT00004910|stage II pancreatic cancer|stage ii pancreatic cancer
861390|NCT00004910|stage III pancreatic cancer|stage iii pancreatic cancer
861391|NCT00004910|recurrent pancreatic cancer|recurrent pancreatic cancer
861392|NCT00004910|recurrent colon cancer|recurrent colon cancer
861393|NCT00004910|localized gastrointestinal carcinoid tumor|localized gastrointestinal carcinoid tumor
861394|NCT00004910|regional gastrointestinal carcinoid tumor|regional gastrointestinal carcinoid tumor
861395|NCT00004910|metastatic gastrointestinal carcinoid tumor|metastatic gastrointestinal carcinoid tumor
861396|NCT00004910|recurrent gastrointestinal carcinoid tumor|recurrent gastrointestinal carcinoid tumor
861397|NCT00004910|small intestine adenocarcinoma|small intestine adenocarcinoma
861398|NCT00004910|small intestine lymphoma|small intestine lymphoma
861399|NCT00004910|small intestine leiomyosarcoma|small intestine leiomyosarcoma
861400|NCT00004910|localized extrahepatic bile duct cancer|localized extrahepatic bile duct cancer
861401|NCT00004910|unresectable extrahepatic bile duct cancer|unresectable extrahepatic bile duct cancer
861402|NCT00004910|recurrent extrahepatic bile duct cancer|recurrent extrahepatic bile duct cancer
861403|NCT00004910|recurrent small intestine cancer|recurrent small intestine cancer
861404|NCT00004910|constipation, impaction, and bowel obstruction|constipation, impaction, and bowel obstruction
861405|NCT00004910|quality of life|quality of life
861406|NCT00004910|gastrointestinal stromal tumor|gastrointestinal stromal tumor
861407|NCT00004910|stage IV pancreatic cancer|stage iv pancreatic cancer
861408|NCT00004895|stage I colon cancer|stage i colon cancer
861409|NCT00004895|stage II colon cancer|stage ii colon cancer
861410|NCT00004895|stage III colon cancer|stage iii colon cancer
861411|NCT00004895|stage IV colon cancer|stage iv colon cancer
861412|NCT00004895|stage I gastric cancer|stage i gastric cancer
861413|NCT00004895|stage II gastric cancer|stage ii gastric cancer
861414|NCT00004895|stage III gastric cancer|stage iii gastric cancer
861415|NCT00004895|stage IV gastric cancer|stage iv gastric cancer
861416|NCT00004895|recurrent gastric cancer|recurrent gastric cancer
861417|NCT00004895|stage I pancreatic cancer|stage i pancreatic cancer
861418|NCT00004895|stage II pancreatic cancer|stage ii pancreatic cancer
861419|NCT00004895|stage III pancreatic cancer|stage iii pancreatic cancer
861420|NCT00004895|stage IV pancreatic cancer|stage iv pancreatic cancer
861421|NCT00004895|recurrent pancreatic cancer|recurrent pancreatic cancer
861422|NCT00004895|stage I rectal cancer|stage i rectal cancer
861423|NCT00004895|stage II rectal cancer|stage ii rectal cancer
861424|NCT00004895|stage III rectal cancer|stage iii rectal cancer
861425|NCT00004895|stage IV rectal cancer|stage iv rectal cancer
861426|NCT00004895|recurrent colon cancer|recurrent colon cancer
861427|NCT00004895|recurrent rectal cancer|recurrent rectal cancer
861428|NCT00004895|stage I ovarian epithelial cancer|stage i ovarian epithelial cancer
861429|NCT00004895|stage II ovarian epithelial cancer|stage ii ovarian epithelial cancer
861430|NCT00004895|stage III ovarian epithelial cancer|stage iii ovarian epithelial cancer
861431|NCT00004895|stage IV ovarian epithelial cancer|stage iv ovarian epithelial cancer
861432|NCT00004895|recurrent ovarian epithelial cancer|recurrent ovarian epithelial cancer
861433|NCT00004895|small intestine adenocarcinoma|small intestine adenocarcinoma
861434|NCT00004895|small intestine lymphoma|small intestine lymphoma
861435|NCT00004895|small intestine leiomyosarcoma|small intestine leiomyosarcoma
861436|NCT00004895|localized extrahepatic bile duct cancer|localized extrahepatic bile duct cancer
861437|NCT00004895|unresectable extrahepatic bile duct cancer|unresectable extrahepatic bile duct cancer
861438|NCT00004895|recurrent extrahepatic bile duct cancer|recurrent extrahepatic bile duct cancer
861439|NCT00004895|recurrent small intestine cancer|recurrent small intestine cancer
861440|NCT00004895|constipation, impaction, and bowel obstruction|constipation, impaction, and bowel obstruction
861441|NCT00004895|peritoneal cavity cancer|peritoneal cavity cancer
861442|NCT00004895|nausea and vomiting|nausea and vomiting
861443|NCT00004895|gastrointestinal stromal tumor|gastrointestinal stromal tumor
861444|NCT00004255|recurrent childhood acute lymphoblastic leukemia|recurrent childhood acute lymphoblastic leukemia
861445|NCT00004255|recurrent childhood acute myeloid leukemia|recurrent childhood acute myeloid leukemia
861446|NCT00004255|recurrent adult acute myeloid leukemia|recurrent adult acute myeloid leukemia
861447|NCT00004255|recurrent adult acute lymphoblastic leukemia|recurrent adult acute lymphoblastic leukemia
861448|NCT00004255|chronic phase chronic myelogenous leukemia|chronic phase chronic myelogenous leukemia
861449|NCT00004255|accelerated phase chronic myelogenous leukemia|accelerated phase chronic myelogenous leukemia
861450|NCT00004255|adult acute myeloid leukemia in remission|adult acute myeloid leukemia in remission
861451|NCT00004255|adult acute lymphoblastic leukemia in remission|adult acute lymphoblastic leukemia in remission
861452|NCT00004255|childhood acute myeloid leukemia in remission|childhood acute myeloid leukemia in remission
861453|NCT00004255|childhood acute lymphoblastic leukemia in remission|childhood acute lymphoblastic leukemia in remission
861454|NCT00004255|refractory anemia with excess blasts|refractory anemia with excess blasts
861455|NCT00004255|refractory anemia with excess blasts in transformation|refractory anemia with excess blasts in transformation
861456|NCT00004255|secondary acute myeloid leukemia|secondary acute myeloid leukemia
861457|NCT00004255|de novo myelodysplastic syndromes|de novo myelodysplastic syndromes
861458|NCT00004255|previously treated myelodysplastic syndromes|previously treated myelodysplastic syndromes
861459|NCT00004255|secondary myelodysplastic syndromes|secondary myelodysplastic syndromes
861460|NCT00004255|graft versus host disease|graft versus host disease
861461|NCT00004255|childhood myelodysplastic syndromes|childhood myelodysplastic syndromes
861462|NCT00004232|stage I adult Hodgkin lymphoma|stage i adult hodgkin lymphoma
861463|NCT00004232|stage II adult Hodgkin lymphoma|stage ii adult hodgkin lymphoma
861464|NCT00004232|stage III adult Hodgkin lymphoma|stage iii adult hodgkin lymphoma
861465|NCT00004232|stage IV adult Hodgkin lymphoma|stage iv adult hodgkin lymphoma
861466|NCT00004232|monoclonal gammopathy of undetermined significance|monoclonal gammopathy of undetermined significance
861467|NCT00004232|recurrent childhood acute lymphoblastic leukemia|recurrent childhood acute lymphoblastic leukemia
861468|NCT00004232|recurrent adult Hodgkin lymphoma|recurrent adult hodgkin lymphoma
861469|NCT00004232|stage I cutaneous T-cell non-Hodgkin lymphoma|stage i cutaneous t-cell non-hodgkin lymphoma
861470|NCT00004232|stage II cutaneous T-cell non-Hodgkin lymphoma|stage ii cutaneous t-cell non-hodgkin lymphoma
861471|NCT00004232|stage III cutaneous T-cell non-Hodgkin lymphoma|stage iii cutaneous t-cell non-hodgkin lymphoma
861472|NCT00004232|stage IV cutaneous T-cell non-Hodgkin lymphoma|stage iv cutaneous t-cell non-hodgkin lymphoma
861473|NCT00004232|recurrent cutaneous T-cell non-Hodgkin lymphoma|recurrent cutaneous t-cell non-hodgkin lymphoma
861474|NCT00004232|Burkitt lymphoma|burkitt lymphoma
861475|NCT00004232|isolated plasmacytoma of bone|isolated plasmacytoma of bone
861476|NCT00004232|extramedullary plasmacytoma|extramedullary plasmacytoma
861477|NCT00004232|refractory multiple myeloma|refractory multiple myeloma
861478|NCT00004232|stage 0 chronic lymphocytic leukemia|stage 0 chronic lymphocytic leukemia
861479|NCT00004232|stage I multiple myeloma|stage i multiple myeloma
861480|NCT00004232|stage II multiple myeloma|stage ii multiple myeloma
861481|NCT00004232|stage III multiple myeloma|stage iii multiple myeloma
883065|NCT00024622|Parkinson|parkinson
861482|NCT00004232|stage I childhood lymphoblastic lymphoma|stage i childhood lymphoblastic lymphoma
861483|NCT00004232|stage II childhood lymphoblastic lymphoma|stage ii childhood lymphoblastic lymphoma
861484|NCT00004232|stage III childhood lymphoblastic lymphoma|stage iii childhood lymphoblastic lymphoma
861485|NCT00004232|stage IV childhood lymphoblastic lymphoma|stage iv childhood lymphoblastic lymphoma
861486|NCT00004232|recurrent childhood lymphoblastic lymphoma|recurrent childhood lymphoblastic lymphoma
861487|NCT00004232|stage I chronic lymphocytic leukemia|stage i chronic lymphocytic leukemia
861488|NCT00004232|stage II chronic lymphocytic leukemia|stage ii chronic lymphocytic leukemia
861489|NCT00004232|stage IV chronic lymphocytic leukemia|stage iv chronic lymphocytic leukemia
861490|NCT00004232|recurrent childhood acute myeloid leukemia|recurrent childhood acute myeloid leukemia
861491|NCT00004232|recurrent adult acute myeloid leukemia|recurrent adult acute myeloid leukemia
861492|NCT00004232|recurrent adult acute lymphoblastic leukemia|recurrent adult acute lymphoblastic leukemia
861493|NCT00004232|relapsing chronic myelogenous leukemia|relapsing chronic myelogenous leukemia
861494|NCT00004232|refractory chronic lymphocytic leukemia|refractory chronic lymphocytic leukemia
861495|NCT00004232|childhood diffuse large cell lymphoma|childhood diffuse large cell lymphoma
861496|NCT00004232|childhood immunoblastic large cell lymphoma|childhood immunoblastic large cell lymphoma
861497|NCT00004232|chronic phase chronic myelogenous leukemia|chronic phase chronic myelogenous leukemia
861498|NCT00004232|accelerated phase chronic myelogenous leukemia|accelerated phase chronic myelogenous leukemia
861499|NCT00004232|blastic phase chronic myelogenous leukemia|blastic phase chronic myelogenous leukemia
861500|NCT00004232|meningeal chronic myelogenous leukemia|meningeal chronic myelogenous leukemia
861501|NCT00004232|untreated adult acute lymphoblastic leukemia|untreated adult acute lymphoblastic leukemia
861502|NCT00004232|untreated adult acute myeloid leukemia|untreated adult acute myeloid leukemia
861503|NCT00004232|untreated childhood acute myeloid leukemia and other myeloid malignancies|untreated childhood acute myeloid leukemia and other myeloid malignancies
861504|NCT00004232|untreated childhood acute lymphoblastic leukemia|untreated childhood acute lymphoblastic leukemia
861505|NCT00004232|adult acute myeloid leukemia in remission|adult acute myeloid leukemia in remission
861506|NCT00004232|adult acute lymphoblastic leukemia in remission|adult acute lymphoblastic leukemia in remission
861507|NCT00004232|childhood acute myeloid leukemia in remission|childhood acute myeloid leukemia in remission
861508|NCT00004232|childhood acute lymphoblastic leukemia in remission|childhood acute lymphoblastic leukemia in remission
861509|NCT00004232|chronic idiopathic myelofibrosis|chronic idiopathic myelofibrosis
861510|NCT00004232|essential thrombocythemia|essential thrombocythemia
861511|NCT00004232|untreated hairy cell leukemia|untreated hairy cell leukemia
861512|NCT00004232|progressive hairy cell leukemia, initial treatment|progressive hairy cell leukemia, initial treatment
861513|NCT00004232|refractory hairy cell leukemia|refractory hairy cell leukemia
861514|NCT00004232|stage II childhood Hodgkin lymphoma|stage ii childhood hodgkin lymphoma
861515|NCT00004232|stage I childhood Hodgkin lymphoma|stage i childhood hodgkin lymphoma
861516|NCT00004232|stage III childhood Hodgkin lymphoma|stage iii childhood hodgkin lymphoma
861517|NCT00004232|stage IV childhood Hodgkin lymphoma|stage iv childhood hodgkin lymphoma
861518|NCT00004232|recurrent/refractory childhood Hodgkin lymphoma|recurrent/refractory childhood hodgkin lymphoma
861519|NCT00004232|stage I grade 1 follicular lymphoma|stage i grade 1 follicular lymphoma
861520|NCT00004232|stage I grade 2 follicular lymphoma|stage i grade 2 follicular lymphoma
861521|NCT00004232|stage I grade 3 follicular lymphoma|stage i grade 3 follicular lymphoma
861522|NCT00004232|stage I adult diffuse small cleaved cell lymphoma|stage i adult diffuse small cleaved cell lymphoma
861523|NCT00004232|stage I adult diffuse mixed cell lymphoma|stage i adult diffuse mixed cell lymphoma
861524|NCT00004232|stage I adult diffuse large cell lymphoma|stage i adult diffuse large cell lymphoma
861525|NCT00004232|stage I adult immunoblastic large cell lymphoma|stage i adult immunoblastic large cell lymphoma
861526|NCT00004232|stage I adult lymphoblastic lymphoma|stage i adult lymphoblastic lymphoma
861527|NCT00004232|stage I adult Burkitt lymphoma|stage i adult burkitt lymphoma
861528|NCT00004232|chronic myelomonocytic leukemia|chronic myelomonocytic leukemia
861529|NCT00004232|T-cell large granular lymphocyte leukemia|t-cell large granular lymphocyte leukemia
861530|NCT00004232|acute undifferentiated leukemia|acute undifferentiated leukemia
861531|NCT00004232|stage III grade 1 follicular lymphoma|stage iii grade 1 follicular lymphoma
861532|NCT00004232|stage III grade 2 follicular lymphoma|stage iii grade 2 follicular lymphoma
861533|NCT00004232|stage III grade 3 follicular lymphoma|stage iii grade 3 follicular lymphoma
861534|NCT00004232|stage III adult diffuse small cleaved cell lymphoma|stage iii adult diffuse small cleaved cell lymphoma
861535|NCT00004232|stage III adult diffuse mixed cell lymphoma|stage iii adult diffuse mixed cell lymphoma
861536|NCT00004232|stage III adult diffuse large cell lymphoma|stage iii adult diffuse large cell lymphoma
861537|NCT00004232|stage III adult immunoblastic large cell lymphoma|stage iii adult immunoblastic large cell lymphoma
861538|NCT00004232|stage III adult lymphoblastic lymphoma|stage iii adult lymphoblastic lymphoma
861539|NCT00004232|stage III adult Burkitt lymphoma|stage iii adult burkitt lymphoma
861540|NCT00004232|stage IV grade 1 follicular lymphoma|stage iv grade 1 follicular lymphoma
861541|NCT00004232|stage IV grade 2 follicular lymphoma|stage iv grade 2 follicular lymphoma
861542|NCT00004232|stage IV grade 3 follicular lymphoma|stage iv grade 3 follicular lymphoma
861543|NCT00004232|stage IV adult diffuse small cleaved cell lymphoma|stage iv adult diffuse small cleaved cell lymphoma
861544|NCT00004232|stage IV adult diffuse mixed cell lymphoma|stage iv adult diffuse mixed cell lymphoma
861545|NCT00004232|stage IV adult diffuse large cell lymphoma|stage iv adult diffuse large cell lymphoma
861546|NCT00004232|stage IV adult immunoblastic large cell lymphoma|stage iv adult immunoblastic large cell lymphoma
861547|NCT00004232|stage IV adult lymphoblastic lymphoma|stage iv adult lymphoblastic lymphoma
861548|NCT00004232|stage IV adult Burkitt lymphoma|stage iv adult burkitt lymphoma
861549|NCT00004232|recurrent grade 1 follicular lymphoma|recurrent grade 1 follicular lymphoma
861550|NCT00004232|recurrent grade 2 follicular lymphoma|recurrent grade 2 follicular lymphoma
861551|NCT00004232|recurrent grade 3 follicular lymphoma|recurrent grade 3 follicular lymphoma
861552|NCT00004232|recurrent adult diffuse small cleaved cell lymphoma|recurrent adult diffuse small cleaved cell lymphoma
861553|NCT00004232|recurrent adult diffuse mixed cell lymphoma|recurrent adult diffuse mixed cell lymphoma
861554|NCT00004232|recurrent adult diffuse large cell lymphoma|recurrent adult diffuse large cell lymphoma
861555|NCT00004232|recurrent adult immunoblastic large cell lymphoma|recurrent adult immunoblastic large cell lymphoma
861556|NCT00004232|recurrent adult lymphoblastic lymphoma|recurrent adult lymphoblastic lymphoma
861557|NCT00004232|recurrent adult Burkitt lymphoma|recurrent adult burkitt lymphoma
861558|NCT00004232|stage I adult T-cell leukemia/lymphoma|stage i adult t-cell leukemia/lymphoma
861559|NCT00004232|stage II adult T-cell leukemia/lymphoma|stage ii adult t-cell leukemia/lymphoma
861560|NCT00004232|stage III adult T-cell leukemia/lymphoma|stage iii adult t-cell leukemia/lymphoma
861561|NCT00004232|stage IV adult T-cell leukemia/lymphoma|stage iv adult t-cell leukemia/lymphoma
861562|NCT00004232|recurrent adult T-cell leukemia/lymphoma|recurrent adult t-cell leukemia/lymphoma
861563|NCT00004232|secondary acute myeloid leukemia|secondary acute myeloid leukemia
861564|NCT00004232|de novo myelodysplastic syndromes|de novo myelodysplastic syndromes
861565|NCT00004232|previously treated myelodysplastic syndromes|previously treated myelodysplastic syndromes
861566|NCT00004232|secondary myelodysplastic syndromes|secondary myelodysplastic syndromes
861567|NCT00004232|graft versus host disease|graft versus host disease
861568|NCT00004232|prolymphocytic leukemia|prolymphocytic leukemia
861569|NCT00004232|AIDS-related peripheral/systemic lymphoma|aids-related peripheral/systemic lymphoma
861570|NCT00004232|primary systemic amyloidosis|primary systemic amyloidosis
861571|NCT00004232|stage I childhood small noncleaved cell lymphoma|stage i childhood small noncleaved cell lymphoma
861572|NCT00004232|stage I childhood large cell lymphoma|stage i childhood large cell lymphoma
861573|NCT00004232|stage II childhood small noncleaved cell lymphoma|stage ii childhood small noncleaved cell lymphoma
861574|NCT00004232|stage II childhood large cell lymphoma|stage ii childhood large cell lymphoma
861575|NCT00004232|stage III childhood small noncleaved cell lymphoma|stage iii childhood small noncleaved cell lymphoma
861576|NCT00004232|stage III childhood large cell lymphoma|stage iii childhood large cell lymphoma
861577|NCT00004232|stage IV childhood small noncleaved cell lymphoma|stage iv childhood small noncleaved cell lymphoma
861578|NCT00004232|stage IV childhood large cell lymphoma|stage iv childhood large cell lymphoma
861579|NCT00004232|recurrent childhood small noncleaved cell lymphoma|recurrent childhood small noncleaved cell lymphoma
861580|NCT00004232|recurrent childhood large cell lymphoma|recurrent childhood large cell lymphoma
861581|NCT00004232|stage I mantle cell lymphoma|stage i mantle cell lymphoma
861582|NCT00004232|contiguous stage II grade 1 follicular lymphoma|contiguous stage ii grade 1 follicular lymphoma
861583|NCT00004232|contiguous stage II grade 2 follicular lymphoma|contiguous stage ii grade 2 follicular lymphoma
861584|NCT00004232|contiguous stage II grade 3 follicular lymphoma|contiguous stage ii grade 3 follicular lymphoma
861585|NCT00004232|contiguous stage II adult diffuse small cleaved cell lymphoma|contiguous stage ii adult diffuse small cleaved cell lymphoma
861586|NCT00004232|contiguous stage II mantle cell lymphoma|contiguous stage ii mantle cell lymphoma
861587|NCT00004232|contiguous stage II adult diffuse mixed cell lymphoma|contiguous stage ii adult diffuse mixed cell lymphoma
861588|NCT00004232|contiguous stage II adult immunoblastic large cell lymphoma|contiguous stage ii adult immunoblastic large cell lymphoma
861589|NCT00004232|contiguous stage II adult diffuse large cell lymphoma|contiguous stage ii adult diffuse large cell lymphoma
861590|NCT00004232|contiguous stage II adult Burkitt lymphoma|contiguous stage ii adult burkitt lymphoma
861591|NCT00004232|contiguous stage II adult lymphoblastic lymphoma|contiguous stage ii adult lymphoblastic lymphoma
861592|NCT00004232|noncontiguous stage II grade 1 follicular lymphoma|noncontiguous stage ii grade 1 follicular lymphoma
861593|NCT00004232|noncontiguous stage II grade 2 follicular lymphoma|noncontiguous stage ii grade 2 follicular lymphoma
861594|NCT00004232|noncontiguous stage II grade 3 follicular lymphoma|noncontiguous stage ii grade 3 follicular lymphoma
861595|NCT00004232|noncontiguous stage II adult diffuse small cleaved cell lymphoma|noncontiguous stage ii adult diffuse small cleaved cell lymphoma
861596|NCT00004232|noncontiguous stage II mantle cell lymphoma|noncontiguous stage ii mantle cell lymphoma
861597|NCT00004232|noncontiguous stage II adult diffuse mixed cell lymphoma|noncontiguous stage ii adult diffuse mixed cell lymphoma
861598|NCT00004232|noncontiguous stage II adult immunoblastic large cell lymphoma|noncontiguous stage ii adult immunoblastic large cell lymphoma
861599|NCT00004232|noncontiguous stage II adult diffuse large cell lymphoma|noncontiguous stage ii adult diffuse large cell lymphoma
861600|NCT00004232|noncontiguous stage II adult Burkitt lymphoma|noncontiguous stage ii adult burkitt lymphoma
861601|NCT00004232|noncontiguous stage II adult lymphoblastic lymphoma|noncontiguous stage ii adult lymphoblastic lymphoma
861602|NCT00004232|stage III mantle cell lymphoma|stage iii mantle cell lymphoma
861603|NCT00004232|stage IV mantle cell lymphoma|stage iv mantle cell lymphoma
861604|NCT00004232|recurrent mantle cell lymphoma|recurrent mantle cell lymphoma
861680|NCT00060528|Prostate Cancer|prostate cancer
861605|NCT00004232|angioimmunoblastic T-cell lymphoma|angioimmunoblastic t-cell lymphoma
861606|NCT00004232|anaplastic large cell lymphoma|anaplastic large cell lymphoma
861607|NCT00004232|stage I mycosis fungoides/Sezary syndrome|stage i mycosis fungoides/sezary syndrome
861608|NCT00004232|stage II mycosis fungoides/Sezary syndrome|stage ii mycosis fungoides/sezary syndrome
861609|NCT00004232|stage III mycosis fungoides/Sezary syndrome|stage iii mycosis fungoides/sezary syndrome
861610|NCT00004232|stage IV mycosis fungoides/Sezary syndrome|stage iv mycosis fungoides/sezary syndrome
861611|NCT00004232|recurrent mycosis fungoides/Sezary syndrome|recurrent mycosis fungoides/sezary syndrome
861612|NCT00004232|noncontiguous stage II small lymphocytic lymphoma|noncontiguous stage ii small lymphocytic lymphoma
861613|NCT00004232|noncontiguous stage II marginal zone lymphoma|noncontiguous stage ii marginal zone lymphoma
861614|NCT00004232|recurrent marginal zone lymphoma|recurrent marginal zone lymphoma
861615|NCT00004232|recurrent small lymphocytic lymphoma|recurrent small lymphocytic lymphoma
861616|NCT00004232|stage I marginal zone lymphoma|stage i marginal zone lymphoma
861617|NCT00004232|stage I small lymphocytic lymphoma|stage i small lymphocytic lymphoma
861618|NCT00004232|stage III small lymphocytic lymphoma|stage iii small lymphocytic lymphoma
861619|NCT00004232|stage III marginal zone lymphoma|stage iii marginal zone lymphoma
861620|NCT00004232|stage IV small lymphocytic lymphoma|stage iv small lymphocytic lymphoma
861621|NCT00004232|stage IV marginal zone lymphoma|stage iv marginal zone lymphoma
861622|NCT00004232|contiguous stage II marginal zone lymphoma|contiguous stage ii marginal zone lymphoma
861623|NCT00004232|contiguous stage II small lymphocytic lymphoma|contiguous stage ii small lymphocytic lymphoma
861624|NCT00004232|extranodal marginal zone B-cell lymphoma of mucosa-associated lymphoid tissue|extranodal marginal zone b-cell lymphoma of mucosa-associated lymphoid tissue
861625|NCT00004232|nodal marginal zone B-cell lymphoma|nodal marginal zone b-cell lymphoma
861626|NCT00004232|splenic marginal zone lymphoma|splenic marginal zone lymphoma
861627|NCT00004232|childhood myelodysplastic syndromes|childhood myelodysplastic syndromes
861629|NCT00004180|recurrent adult soft tissue sarcoma|recurrent adult soft tissue sarcoma
861630|NCT00060593|Balance|balance
861631|NCT00060593|Functional Connectivity|functional connectivity
861632|NCT00060593|Healthy Volunteer|healthy volunteer
861633|NCT00060593|HV|hv
861634|NCT00060580|Retinal Measurements|retinal measurements
861635|NCT00060580|Lutein in Vivo|lutein in vivo
861636|NCT00060580|Raman Spectroscopy|raman spectroscopy
861637|NCT00060580|Retinal Measurements of Lutein in Vivo in the Human Eye|retinal measurements of lutein in vivo in the human eye
861638|NCT00060580|Healthy Volunteer|healthy volunteer
861639|NCT00060580|HV|hv
861640|NCT00060554|Elective PCI|elective pci
861641|NCT00060554|Heart catherization|heart catherization
861642|NCT00060554|Acute coronary syndromes|acute coronary syndromes
861643|NCT00060502|cachexia|cachexia
861644|NCT00060502|pancreatic cancer|pancreatic cancer
861645|NCT00060502|infliximab|infliximab
861646|NCT00060502|anorexia|anorexia
861647|NCT00060502|anemia|anemia
861648|NCT00060502|Remicade.|remicade.
861649|NCT00060489|Bipolar Depression|bipolar depression
861650|NCT00004094|stage III squamous cell carcinoma of the lip and oral cavity|stage iii squamous cell carcinoma of the lip and oral cavity
861651|NCT00004094|stage IV squamous cell carcinoma of the lip and oral cavity|stage iv squamous cell carcinoma of the lip and oral cavity
861652|NCT00004094|stage IV squamous cell carcinoma of the oropharynx|stage iv squamous cell carcinoma of the oropharynx
861653|NCT00004094|stage IV lymphoepithelioma of the oropharynx|stage iv lymphoepithelioma of the oropharynx
861654|NCT00004094|stage IV squamous cell carcinoma of the nasopharynx|stage iv squamous cell carcinoma of the nasopharynx
861655|NCT00004094|stage IV lymphoepithelioma of the nasopharynx|stage iv lymphoepithelioma of the nasopharynx
861656|NCT00004094|stage III squamous cell carcinoma of the hypopharynx|stage iii squamous cell carcinoma of the hypopharynx
861657|NCT00004094|stage IV squamous cell carcinoma of the hypopharynx|stage iv squamous cell carcinoma of the hypopharynx
861658|NCT00004094|stage IV squamous cell carcinoma of the larynx|stage iv squamous cell carcinoma of the larynx
861659|NCT00004068|childhood high-grade cerebral astrocytoma|childhood high-grade cerebral astrocytoma
861660|NCT00004068|childhood high-grade cerebellar astrocytoma|childhood high-grade cerebellar astrocytoma
861661|NCT00004068|childhood oligodendroglioma|childhood oligodendroglioma
861662|NCT00004068|untreated childhood brain stem glioma|untreated childhood brain stem glioma
861663|NCT00004068|untreated childhood cerebellar astrocytoma|untreated childhood cerebellar astrocytoma
861664|NCT00004059|unspecified adult solid tumor, protocol specific|unspecified adult solid tumor, protocol specific
861665|NCT00004052|relapsing chronic myelogenous leukemia|relapsing chronic myelogenous leukemia
861666|NCT00004052|chronic phase chronic myelogenous leukemia|chronic phase chronic myelogenous leukemia
861667|NCT00004008|stage I ovarian epithelial cancer|stage i ovarian epithelial cancer
861668|NCT00004008|stage II ovarian epithelial cancer|stage ii ovarian epithelial cancer
861669|NCT00004008|stage III ovarian epithelial cancer|stage iii ovarian epithelial cancer
861670|NCT00004008|stage IV ovarian epithelial cancer|stage iv ovarian epithelial cancer
861671|NCT00004008|recurrent ovarian epithelial cancer|recurrent ovarian epithelial cancer
861673|NCT00060541|Epilepsy|epilepsy
861674|NCT00060541|Pituitary Adenoma|pituitary adenoma
861675|NCT00060541|Parkinson's Disease|parkinson's disease
861676|NCT00060541|Spinal Cord Tumor|spinal cord tumor
861677|NCT00060528|Immunotherapy|immunotherapy
861678|NCT00060528|Cytokines|cytokines
861679|NCT00060528|Immune Assays|immune assays
861681|NCT00060463|Emergency contraceptive pills|emergency contraceptive pills
861682|NCT00060463|Pregnancy|pregnancy
861683|NCT00060463|Sexually transmitted infection|sexually transmitted infection
861684|NCT00060463|Chlamydia|chlamydia
861685|NCT00060463|Gonorrhea|gonorrhea
861686|NCT00060463|Trichomonas|trichomonas
861687|NCT00060463|Contraception|contraception
861688|NCT00060450|Ischemia-reperfusion lung injury|ischemia-reperfusion lung injury
861689|NCT00060450|IRLI|irli
861690|NCT00060437|stage IV prostate cancer|stage iv prostate cancer
861691|NCT00060437|recurrent prostate cancer|recurrent prostate cancer
861692|NCT00060437|adenocarcinoma of the prostate|adenocarcinoma of the prostate
861693|NCT00060398|recurrent prostate cancer|recurrent prostate cancer
861694|NCT00060398|anemia|anemia
861695|NCT00060398|fatigue|fatigue
861696|NCT00060385|stage I adult T-cell leukemia/lymphoma|stage i adult t-cell leukemia/lymphoma
861697|NCT00060385|stage I cutaneous T-cell non-Hodgkin lymphoma|stage i cutaneous t-cell non-hodgkin lymphoma
861698|NCT00060385|stage II adult T-cell leukemia/lymphoma|stage ii adult t-cell leukemia/lymphoma
861699|NCT00060385|stage II cutaneous T-cell non-Hodgkin lymphoma|stage ii cutaneous t-cell non-hodgkin lymphoma
861700|NCT00060385|stage III adult T-cell leukemia/lymphoma|stage iii adult t-cell leukemia/lymphoma
861701|NCT00060385|stage III cutaneous T-cell non-Hodgkin lymphoma|stage iii cutaneous t-cell non-hodgkin lymphoma
861702|NCT00060385|stage IV adult T-cell leukemia/lymphoma|stage iv adult t-cell leukemia/lymphoma
861703|NCT00060385|stage IV cutaneous T-cell non-Hodgkin lymphoma|stage iv cutaneous t-cell non-hodgkin lymphoma
861704|NCT00060385|stage I mycosis fungoides/Sezary syndrome|stage i mycosis fungoides/sezary syndrome
861705|NCT00060385|stage II mycosis fungoides/Sezary syndrome|stage ii mycosis fungoides/sezary syndrome
861706|NCT00060385|stage III mycosis fungoides/Sezary syndrome|stage iii mycosis fungoides/sezary syndrome
861707|NCT00060385|stage IV mycosis fungoides/Sezary syndrome|stage iv mycosis fungoides/sezary syndrome
861708|NCT00060385|contiguous stage II adult diffuse large cell lymphoma|contiguous stage ii adult diffuse large cell lymphoma
861709|NCT00060385|noncontiguous stage II adult diffuse large cell lymphoma|noncontiguous stage ii adult diffuse large cell lymphoma
861710|NCT00060385|stage I adult diffuse large cell lymphoma|stage i adult diffuse large cell lymphoma
861711|NCT00060385|stage III adult diffuse large cell lymphoma|stage iii adult diffuse large cell lymphoma
861712|NCT00060385|stage IV adult diffuse large cell lymphoma|stage iv adult diffuse large cell lymphoma
861713|NCT00060346|Waldenstrom macroglobulinemia|waldenstrom macroglobulinemia
861714|NCT00060346|Rituximab|rituximab
861716|NCT00060333|recurrent melanoma|recurrent melanoma
861717|NCT00060333|stage I melanoma|stage i melanoma
861718|NCT00060333|stage II melanoma|stage ii melanoma
861719|NCT00060333|stage III melanoma|stage iii melanoma
861720|NCT00060320|stage IV breast cancer|stage iv breast cancer
861721|NCT00060320|stage I breast cancer|stage i breast cancer
861722|NCT00060320|stage II breast cancer|stage ii breast cancer
861723|NCT00060320|stage IIIA breast cancer|stage iiia breast cancer
861724|NCT00060320|stage IIIB breast cancer|stage iiib breast cancer
861725|NCT00060320|stage IIIC breast cancer|stage iiic breast cancer
861726|NCT00060320|hot flashes|hot flashes
861727|NCT00060294|Waldenström macroglobulinemia|waldenström macroglobulinemia
861728|NCT00060268|recurrent esophageal cancer|recurrent esophageal cancer
861729|NCT00060268|stage I esophageal cancer|stage i esophageal cancer
861730|NCT00060268|stage II esophageal cancer|stage ii esophageal cancer
861731|NCT00060268|stage III esophageal cancer|stage iii esophageal cancer
861732|NCT00060268|stage IV esophageal cancer|stage iv esophageal cancer
861733|NCT00060255|stage IV breast cancer|stage iv breast cancer
861734|NCT00060255|male breast cancer|male breast cancer
861735|NCT00060255|recurrent malignant testicular germ cell tumor|recurrent malignant testicular germ cell tumor
861736|NCT00060255|Waldenstrom macroglobulinemia|waldenstrom macroglobulinemia
861737|NCT00060255|childhood acute lymphoblastic leukemia in remission|childhood acute lymphoblastic leukemia in remission
861738|NCT00060255|adult acute lymphoblastic leukemia in remission|adult acute lymphoblastic leukemia in remission
861739|NCT00060255|recurrent adult acute myeloid leukemia|recurrent adult acute myeloid leukemia
861740|NCT00060255|adult acute myeloid leukemia in remission|adult acute myeloid leukemia in remission
861741|NCT00060255|recurrent childhood acute myeloid leukemia|recurrent childhood acute myeloid leukemia
861742|NCT00060255|childhood acute myeloid leukemia in remission|childhood acute myeloid leukemia in remission
861743|NCT00060255|chronic phase chronic myelogenous leukemia|chronic phase chronic myelogenous leukemia
861744|NCT00060255|accelerated phase chronic myelogenous leukemia|accelerated phase chronic myelogenous leukemia
861745|NCT00060255|blastic phase chronic myelogenous leukemia|blastic phase chronic myelogenous leukemia
861746|NCT00060255|refractory chronic lymphocytic leukemia|refractory chronic lymphocytic leukemia
861747|NCT00060255|recurrent adult diffuse large cell lymphoma|recurrent adult diffuse large cell lymphoma
861748|NCT00060255|recurrent adult diffuse mixed cell lymphoma|recurrent adult diffuse mixed cell lymphoma
861749|NCT00060255|recurrent adult diffuse small cleaved cell lymphoma|recurrent adult diffuse small cleaved cell lymphoma
861750|NCT00060255|recurrent adult Burkitt lymphoma|recurrent adult burkitt lymphoma
861751|NCT00060255|recurrent adult Hodgkin lymphoma|recurrent adult hodgkin lymphoma
861752|NCT00060255|recurrent adult immunoblastic large cell lymphoma|recurrent adult immunoblastic large cell lymphoma
861753|NCT00060255|recurrent childhood large cell lymphoma|recurrent childhood large cell lymphoma
861754|NCT00060255|recurrent childhood lymphoblastic lymphoma|recurrent childhood lymphoblastic lymphoma
861755|NCT00060255|recurrent childhood small noncleaved cell lymphoma|recurrent childhood small noncleaved cell lymphoma
861756|NCT00060255|recurrent grade 1 follicular lymphoma|recurrent grade 1 follicular lymphoma
861757|NCT00060255|recurrent grade 2 follicular lymphoma|recurrent grade 2 follicular lymphoma
861758|NCT00060255|recurrent grade 3 follicular lymphoma|recurrent grade 3 follicular lymphoma
861759|NCT00060255|recurrent mantle cell lymphoma|recurrent mantle cell lymphoma
861760|NCT00060255|recurrent/refractory childhood Hodgkin lymphoma|recurrent/refractory childhood hodgkin lymphoma
861761|NCT00060255|unspecified adult solid tumor, protocol specific|unspecified adult solid tumor, protocol specific
861762|NCT00060255|unspecified childhood solid tumor, protocol specific|unspecified childhood solid tumor, protocol specific
861763|NCT00060255|stage IIIA breast cancer|stage iiia breast cancer
861764|NCT00060255|stage IIIB breast cancer|stage iiib breast cancer
861765|NCT00060255|stage IIIC breast cancer|stage iiic breast cancer
861766|NCT00060255|recurrent breast cancer|recurrent breast cancer
861767|NCT00060255|primary systemic amyloidosis|primary systemic amyloidosis
861768|NCT00060255|refractory multiple myeloma|refractory multiple myeloma
861769|NCT00060255|childhood chronic myelogenous leukemia|childhood chronic myelogenous leukemia
861770|NCT00060255|atypical chronic myeloid leukemia|atypical chronic myeloid leukemia
861771|NCT00060255|recurrent marginal zone lymphoma|recurrent marginal zone lymphoma
861772|NCT00060255|recurrent small lymphocytic lymphoma|recurrent small lymphocytic lymphoma
861773|NCT00060255|extranodal marginal zone B-cell lymphoma of mucosa-associated lymphoid tissue|extranodal marginal zone b-cell lymphoma of mucosa-associated lymphoid tissue
861774|NCT00060255|nodal marginal zone B-cell lymphoma|nodal marginal zone b-cell lymphoma
861775|NCT00060255|splenic marginal zone lymphoma|splenic marginal zone lymphoma
861776|NCT00060255|adult acute myeloid leukemia with t(8;21)(q22;q22)|adult acute myeloid leukemia with t(8;21)(q22;q22)
861777|NCT00060255|adult acute myeloid leukemia with t(16;16)(p13;q22)|adult acute myeloid leukemia with t(16;16)(p13;q22)
861778|NCT00060255|adult acute myeloid leukemia with inv(16)(p13;q22)|adult acute myeloid leukemia with inv(16)(p13;q22)
861779|NCT00060255|adult acute myeloid leukemia with 11q23 (MLL) abnormalities|adult acute myeloid leukemia with 11q23 (mll) abnormalities
861780|NCT00060255|adult acute myeloid leukemia with t(15;17)(q22;q12)|adult acute myeloid leukemia with t(15;17)(q22;q12)
861781|NCT00060242|anaplastic thyroid cancer|anaplastic thyroid cancer
861782|NCT00060242|recurrent thyroid cancer|recurrent thyroid cancer
861783|NCT00060203|stage III multiple myeloma|stage iii multiple myeloma
861784|NCT00060203|refractory multiple myeloma|refractory multiple myeloma
861785|NCT00060151|unspecified adult solid tumor, protocol specific|unspecified adult solid tumor, protocol specific
861786|NCT00060138|hypercalcemia of malignancy|hypercalcemia of malignancy
861787|NCT00060138|stage IV breast cancer|stage iv breast cancer
861788|NCT00060138|recurrent breast cancer|recurrent breast cancer
861789|NCT00060138|bone metastases|bone metastases
861790|NCT00060138|pain|pain
861791|NCT00060099|cervical intraepithelial neoplasia grade 2|cervical intraepithelial neoplasia grade 2
861792|NCT00060099|cervical intraepithelial neoplasia grade 3|cervical intraepithelial neoplasia grade 3
861793|NCT00060099|human papilloma virus infection|human papilloma virus infection
861794|NCT00060086|adenocarcinoma of the prostate|adenocarcinoma of the prostate
861795|NCT00060086|recurrent prostate cancer|recurrent prostate cancer
861796|NCT00060021|oral complications|oral complications
861797|NCT00060021|pain|pain
861798|NCT00060021|accelerated phase chronic myelogenous leukemia|accelerated phase chronic myelogenous leukemia
861799|NCT00060021|blastic phase chronic myelogenous leukemia|blastic phase chronic myelogenous leukemia
861800|NCT00060021|chronic eosinophilic leukemia|chronic eosinophilic leukemia
861801|NCT00060021|primary myelofibrosis|primary myelofibrosis
861802|NCT00060021|chronic neutrophilic leukemia|chronic neutrophilic leukemia
861803|NCT00060021|chronic phase chronic myelogenous leukemia|chronic phase chronic myelogenous leukemia
861804|NCT00060021|de novo myelodysplastic syndromes|de novo myelodysplastic syndromes
861805|NCT00060021|disseminated neuroblastoma|disseminated neuroblastoma
861806|NCT00060021|meningeal chronic myelogenous leukemia|meningeal chronic myelogenous leukemia
861807|NCT00060021|noncontiguous stage II adult diffuse large cell lymphoma|noncontiguous stage ii adult diffuse large cell lymphoma
861808|NCT00060021|noncontiguous stage II adult diffuse mixed cell lymphoma|noncontiguous stage ii adult diffuse mixed cell lymphoma
861809|NCT00060021|noncontiguous stage II adult diffuse small cleaved cell lymphoma|noncontiguous stage ii adult diffuse small cleaved cell lymphoma
861810|NCT00060021|noncontiguous stage II adult Burkitt lymphoma|noncontiguous stage ii adult burkitt lymphoma
861811|NCT00060021|noncontiguous stage II adult immunoblastic large cell lymphoma|noncontiguous stage ii adult immunoblastic large cell lymphoma
861812|NCT00060021|noncontiguous stage II adult lymphoblastic lymphoma|noncontiguous stage ii adult lymphoblastic lymphoma
862541|NCT00059241|Early sexual initiation|early sexual initiation
861813|NCT00060021|noncontiguous stage II grade 1 follicular lymphoma|noncontiguous stage ii grade 1 follicular lymphoma
861814|NCT00060021|noncontiguous stage II grade 2 follicular lymphoma|noncontiguous stage ii grade 2 follicular lymphoma
861815|NCT00060021|noncontiguous stage II grade 3 follicular lymphoma|noncontiguous stage ii grade 3 follicular lymphoma
861816|NCT00060021|noncontiguous stage II mantle cell lymphoma|noncontiguous stage ii mantle cell lymphoma
861817|NCT00060021|ovarian choriocarcinoma|ovarian choriocarcinoma
861818|NCT00060021|ovarian embryonal carcinoma|ovarian embryonal carcinoma
861819|NCT00060021|ovarian yolk sac tumor|ovarian yolk sac tumor
861820|NCT00060021|ovarian immature teratoma|ovarian immature teratoma
883169|NCT00023309|Hepatitis|hepatitis
861821|NCT00060021|ovarian mature teratoma|ovarian mature teratoma
861822|NCT00060021|ovarian monodermal and highly specialized teratoma|ovarian monodermal and highly specialized teratoma
861823|NCT00060021|ovarian polyembryoma|ovarian polyembryoma
861824|NCT00060021|ovarian mixed germ cell tumor|ovarian mixed germ cell tumor
861825|NCT00060021|high risk metastatic gestational trophoblastic tumor|high risk metastatic gestational trophoblastic tumor
861826|NCT00060021|previously treated myelodysplastic syndromes|previously treated myelodysplastic syndromes
861827|NCT00060021|recurrent adult acute lymphoblastic leukemia|recurrent adult acute lymphoblastic leukemia
861828|NCT00060021|recurrent adult diffuse large cell lymphoma|recurrent adult diffuse large cell lymphoma
861829|NCT00060021|recurrent adult diffuse mixed cell lymphoma|recurrent adult diffuse mixed cell lymphoma
861830|NCT00060021|recurrent adult diffuse small cleaved cell lymphoma|recurrent adult diffuse small cleaved cell lymphoma
861831|NCT00060021|recurrent adult Burkitt lymphoma|recurrent adult burkitt lymphoma
861832|NCT00060021|recurrent adult Hodgkin lymphoma|recurrent adult hodgkin lymphoma
861833|NCT00060021|recurrent adult immunoblastic large cell lymphoma|recurrent adult immunoblastic large cell lymphoma
861834|NCT00060021|recurrent adult lymphoblastic lymphoma|recurrent adult lymphoblastic lymphoma
861835|NCT00060021|recurrent cutaneous T-cell non-Hodgkin lymphoma|recurrent cutaneous t-cell non-hodgkin lymphoma
861836|NCT00060021|recurrent grade 1 follicular lymphoma|recurrent grade 1 follicular lymphoma
861837|NCT00060021|recurrent grade 2 follicular lymphoma|recurrent grade 2 follicular lymphoma
861838|NCT00060021|recurrent grade 3 follicular lymphoma|recurrent grade 3 follicular lymphoma
861839|NCT00060021|recurrent mantle cell lymphoma|recurrent mantle cell lymphoma
861840|NCT00060021|recurrent mycosis fungoides/Sezary syndrome|recurrent mycosis fungoides/sezary syndrome
861841|NCT00060021|recurrent neuroblastoma|recurrent neuroblastoma
861842|NCT00060021|recurrent ovarian epithelial cancer|recurrent ovarian epithelial cancer
861843|NCT00060021|recurrent ovarian germ cell tumor|recurrent ovarian germ cell tumor
861844|NCT00060021|recurrent malignant testicular germ cell tumor|recurrent malignant testicular germ cell tumor
861845|NCT00060021|refractory chronic lymphocytic leukemia|refractory chronic lymphocytic leukemia
861846|NCT00060021|relapsing chronic myelogenous leukemia|relapsing chronic myelogenous leukemia
861847|NCT00060021|refractory hairy cell leukemia|refractory hairy cell leukemia
861848|NCT00060021|refractory multiple myeloma|refractory multiple myeloma
861849|NCT00060021|secondary acute myeloid leukemia|secondary acute myeloid leukemia
861850|NCT00060021|secondary myelodysplastic syndromes|secondary myelodysplastic syndromes
861851|NCT00060021|stage I multiple myeloma|stage i multiple myeloma
861852|NCT00060021|stage II multiple myeloma|stage ii multiple myeloma
861853|NCT00060021|stage III multiple myeloma|stage iii multiple myeloma
861854|NCT00060021|stage II ovarian epithelial cancer|stage ii ovarian epithelial cancer
861855|NCT00060021|stage III adult diffuse large cell lymphoma|stage iii adult diffuse large cell lymphoma
861856|NCT00060021|stage III adult diffuse mixed cell lymphoma|stage iii adult diffuse mixed cell lymphoma
861857|NCT00060021|stage III adult diffuse small cleaved cell lymphoma|stage iii adult diffuse small cleaved cell lymphoma
861858|NCT00060021|stage III adult Burkitt lymphoma|stage iii adult burkitt lymphoma
861859|NCT00060021|stage III adult immunoblastic large cell lymphoma|stage iii adult immunoblastic large cell lymphoma
861860|NCT00060021|stage III adult lymphoblastic lymphoma|stage iii adult lymphoblastic lymphoma
861861|NCT00060021|stage III chronic lymphocytic leukemia|stage iii chronic lymphocytic leukemia
861862|NCT00060021|stage III grade 1 follicular lymphoma|stage iii grade 1 follicular lymphoma
861863|NCT00060021|stage III grade 2 follicular lymphoma|stage iii grade 2 follicular lymphoma
861864|NCT00060021|stage III grade 3 follicular lymphoma|stage iii grade 3 follicular lymphoma
861865|NCT00060021|stage III mantle cell lymphoma|stage iii mantle cell lymphoma
861866|NCT00060021|stage III ovarian epithelial cancer|stage iii ovarian epithelial cancer
861867|NCT00060021|stage III malignant testicular germ cell tumor|stage iii malignant testicular germ cell tumor
861868|NCT00060021|stage IIIA breast cancer|stage iiia breast cancer
861869|NCT00060021|stage IIIB breast cancer|stage iiib breast cancer
861870|NCT00060021|stage IIIC breast cancer|stage iiic breast cancer
861871|NCT00060021|stage IV adult diffuse large cell lymphoma|stage iv adult diffuse large cell lymphoma
861872|NCT00060021|stage IV adult diffuse mixed cell lymphoma|stage iv adult diffuse mixed cell lymphoma
861873|NCT00060021|stage IV adult diffuse small cleaved cell lymphoma|stage iv adult diffuse small cleaved cell lymphoma
861874|NCT00060021|stage IV adult Burkitt lymphoma|stage iv adult burkitt lymphoma
861875|NCT00060021|stage IV adult immunoblastic large cell lymphoma|stage iv adult immunoblastic large cell lymphoma
861876|NCT00060021|stage IV adult lymphoblastic lymphoma|stage iv adult lymphoblastic lymphoma
861877|NCT00060021|stage IV breast cancer|stage iv breast cancer
861878|NCT00060021|stage IV chronic lymphocytic leukemia|stage iv chronic lymphocytic leukemia
861879|NCT00060021|stage IV grade 1 follicular lymphoma|stage iv grade 1 follicular lymphoma
861880|NCT00060021|stage IV grade 2 follicular lymphoma|stage iv grade 2 follicular lymphoma
861881|NCT00060021|stage IV grade 3 follicular lymphoma|stage iv grade 3 follicular lymphoma
861882|NCT00060021|stage IV mantle cell lymphoma|stage iv mantle cell lymphoma
861883|NCT00060021|stage IV ovarian epithelial cancer|stage iv ovarian epithelial cancer
861884|NCT00060021|testicular choriocarcinoma and embryonal carcinoma|testicular choriocarcinoma and embryonal carcinoma
861885|NCT00060021|testicular choriocarcinoma and seminoma|testicular choriocarcinoma and seminoma
861886|NCT00060021|testicular choriocarcinoma and teratoma|testicular choriocarcinoma and teratoma
883170|NCT00023309|HBV|hbv
861887|NCT00060021|testicular choriocarcinoma and yolk sac tumor|testicular choriocarcinoma and yolk sac tumor
861888|NCT00060021|testicular embryonal carcinoma and seminoma|testicular embryonal carcinoma and seminoma
861889|NCT00060021|testicular embryonal carcinoma and teratoma with seminoma|testicular embryonal carcinoma and teratoma with seminoma
861890|NCT00060021|testicular embryonal carcinoma and teratoma|testicular embryonal carcinoma and teratoma
861891|NCT00060021|testicular embryonal carcinoma and yolk sac tumor with seminoma|testicular embryonal carcinoma and yolk sac tumor with seminoma
861892|NCT00060021|testicular embryonal carcinoma and yolk sac tumor|testicular embryonal carcinoma and yolk sac tumor
861893|NCT00060021|testicular embryonal carcinoma|testicular embryonal carcinoma
861894|NCT00060021|testicular teratoma|testicular teratoma
861895|NCT00060021|testicular yolk sac tumor and teratoma with seminoma|testicular yolk sac tumor and teratoma with seminoma
861896|NCT00060021|testicular yolk sac tumor and teratoma|testicular yolk sac tumor and teratoma
861897|NCT00060021|testicular yolk sac tumor|testicular yolk sac tumor
861898|NCT00060021|recurrent adult acute myeloid leukemia|recurrent adult acute myeloid leukemia
861899|NCT00060021|testicular choriocarcinoma|testicular choriocarcinoma
861900|NCT00060021|atypical chronic myeloid leukemia, BCR-ABL1 negative|atypical chronic myeloid leukemia, bcr-abl1 negative
861901|NCT00060021|myelodysplastic/myeloproliferative neoplasm, unclassifiable|myelodysplastic/myeloproliferative neoplasm, unclassifiable
861902|NCT00060021|noncontiguous stage II small lymphocytic lymphoma|noncontiguous stage ii small lymphocytic lymphoma
861903|NCT00060021|noncontiguous stage II marginal zone lymphoma|noncontiguous stage ii marginal zone lymphoma
861904|NCT00060021|recurrent marginal zone lymphoma|recurrent marginal zone lymphoma
861905|NCT00060021|recurrent small lymphocytic lymphoma|recurrent small lymphocytic lymphoma
861906|NCT00060021|stage III small lymphocytic lymphoma|stage iii small lymphocytic lymphoma
861907|NCT00060021|stage III marginal zone lymphoma|stage iii marginal zone lymphoma
861908|NCT00060021|stage IV small lymphocytic lymphoma|stage iv small lymphocytic lymphoma
861909|NCT00060021|stage IV marginal zone lymphoma|stage iv marginal zone lymphoma
861910|NCT00060021|extranodal marginal zone B-cell lymphoma of mucosa-associated lymphoid tissue|extranodal marginal zone b-cell lymphoma of mucosa-associated lymphoid tissue
861911|NCT00060021|nodal marginal zone B-cell lymphoma|nodal marginal zone b-cell lymphoma
861912|NCT00060021|splenic marginal zone lymphoma|splenic marginal zone lymphoma
861913|NCT00060008|neurofibromatosis type 1|neurofibromatosis type 1
861914|NCT00060008|plexiform neurofibroma|plexiform neurofibroma
861915|NCT00059995|recurrent adult Hodgkin lymphoma|recurrent adult hodgkin lymphoma
861916|NCT00059995|recurrent/refractory childhood Hodgkin lymphoma|recurrent/refractory childhood hodgkin lymphoma
861917|NCT00059995|anaplastic large cell lymphoma|anaplastic large cell lymphoma
861918|NCT00059995|recurrent adult diffuse large cell lymphoma|recurrent adult diffuse large cell lymphoma
861919|NCT00059995|recurrent childhood large cell lymphoma|recurrent childhood large cell lymphoma
861920|NCT00059995|recurrent cutaneous T-cell non-Hodgkin lymphoma|recurrent cutaneous t-cell non-hodgkin lymphoma
861921|NCT00059982|adenocarcinoma of the pancreas|adenocarcinoma of the pancreas
861922|NCT00059982|stage II pancreatic cancer|stage ii pancreatic cancer
861923|NCT00059982|stage III pancreatic cancer|stage iii pancreatic cancer
861924|NCT00059982|stage IV pancreatic cancer|stage iv pancreatic cancer
861925|NCT00059943|stage IV breast cancer|stage iv breast cancer
861926|NCT00059943|stage IV non-small cell lung cancer|stage iv non-small cell lung cancer
861927|NCT00059943|recurrent non-small cell lung cancer|recurrent non-small cell lung cancer
861928|NCT00059943|recurrent breast cancer|recurrent breast cancer
861929|NCT00059943|stage IV prostate cancer|stage iv prostate cancer
861930|NCT00059943|recurrent prostate cancer|recurrent prostate cancer
861931|NCT00059930|liver metastases|liver metastases
861932|NCT00059930|stage IV colon cancer|stage iv colon cancer
861933|NCT00059930|stage IV rectal cancer|stage iv rectal cancer
861934|NCT00059930|adenocarcinoma of the colon|adenocarcinoma of the colon
861935|NCT00059930|adenocarcinoma of the rectum|adenocarcinoma of the rectum
861936|NCT00059930|recurrent colon cancer|recurrent colon cancer
861937|NCT00059930|recurrent rectal cancer|recurrent rectal cancer
861938|NCT00059917|unspecified adult solid tumor, protocol specific|unspecified adult solid tumor, protocol specific
861939|NCT00059904|recurrent adult diffuse large cell lymphoma|recurrent adult diffuse large cell lymphoma
861940|NCT00059904|recurrent adult diffuse mixed cell lymphoma|recurrent adult diffuse mixed cell lymphoma
861941|NCT00059904|recurrent adult immunoblastic large cell lymphoma|recurrent adult immunoblastic large cell lymphoma
861942|NCT00059891|perioperative/postoperative complications|perioperative/postoperative complications
861943|NCT00059891|stage II anal cancer|stage ii anal cancer
861944|NCT00059891|stage I anal cancer|stage i anal cancer
861945|NCT00059891|stage III anal cancer|stage iii anal cancer
861946|NCT00059891|stage I rectal cancer|stage i rectal cancer
861947|NCT00059891|stage II rectal cancer|stage ii rectal cancer
861948|NCT00059891|stage III rectal cancer|stage iii rectal cancer
861949|NCT00059878|infection|infection
861950|NCT00059878|unspecified adult solid tumor, protocol specific|unspecified adult solid tumor, protocol specific
861951|NCT00059865|advanced adult primary liver cancer|advanced adult primary liver cancer
861952|NCT00059865|unresectable gallbladder cancer|unresectable gallbladder cancer
861953|NCT00059865|unresectable extrahepatic bile duct cancer|unresectable extrahepatic bile duct cancer
861954|NCT00059865|adult primary cholangiocellular carcinoma|adult primary cholangiocellular carcinoma
861955|NCT00059852|male breast cancer|male breast cancer
883171|NCT00023309|Liver|liver
861956|NCT00059852|recurrent breast cancer|recurrent breast cancer
861957|NCT00059852|stage IV breast cancer|stage iv breast cancer
861958|NCT00059839|anaplastic large cell lymphoma|anaplastic large cell lymphoma
861959|NCT00059826|stage I pancreatic cancer|stage i pancreatic cancer
861960|NCT00059826|stage II pancreatic cancer|stage ii pancreatic cancer
861961|NCT00059826|stage III pancreatic cancer|stage iii pancreatic cancer
861962|NCT00059826|adenocarcinoma of the pancreas|adenocarcinoma of the pancreas
861963|NCT00059800|recurrent melanoma|recurrent melanoma
861964|NCT00059800|stage 0 melanoma|stage 0 melanoma
861965|NCT00059800|stage I melanoma|stage i melanoma
861966|NCT00059800|stage II melanoma|stage ii melanoma
861967|NCT00059800|stage III melanoma|stage iii melanoma
861968|NCT00059800|stage IV melanoma|stage iv melanoma
861969|NCT00059761|limited stage small cell lung cancer|limited stage small cell lung cancer
861970|NCT00059735|kidney cancer|kidney cancer
861971|NCT00059735|kidney neoplasms|kidney neoplasms
861972|NCT00059735|renal cell cancer|renal cell cancer
861973|NCT00043108|stage II non-small cell lung cancer|stage ii non-small cell lung cancer
861974|NCT00043108|stage IIIA non-small cell lung cancer|stage iiia non-small cell lung cancer
861975|NCT00043108|stage IIIB non-small cell lung cancer|stage iiib non-small cell lung cancer
861976|NCT00030524|stage III colon cancer|stage iii colon cancer
861977|NCT00030524|stage IV colon cancer|stage iv colon cancer
861978|NCT00030524|stage III rectal cancer|stage iii rectal cancer
861979|NCT00030524|stage IV rectal cancer|stage iv rectal cancer
861980|NCT00030524|recurrent colon cancer|recurrent colon cancer
861981|NCT00030524|recurrent rectal cancer|recurrent rectal cancer
861982|NCT00030524|adenocarcinoma of the colon|adenocarcinoma of the colon
861983|NCT00030524|adenocarcinoma of the rectum|adenocarcinoma of the rectum
861984|NCT00027599|adenocarcinoma of the prostate|adenocarcinoma of the prostate
861985|NCT00027599|stage I prostate cancer|stage i prostate cancer
861986|NCT00027599|stage IIB prostate cancer|stage iib prostate cancer
861987|NCT00027599|stage IIA prostate cancer|stage iia prostate cancer
861988|NCT00027599|stage III prostate cancer|stage iii prostate cancer
861989|NCT00027599|stage IV prostate cancer|stage iv prostate cancer
861990|NCT00027599|recurrent prostate cancer|recurrent prostate cancer
861991|NCT00017134|ovarian epithelial cancer|ovarian epithelial cancer
861992|NCT00016315|stage IIIA non-small cell lung cancer|stage iiia non-small cell lung cancer
861993|NCT00016315|stage IIIB non-small cell lung cancer|stage iiib non-small cell lung cancer
861994|NCT00006225|stage IV adult Hodgkin lymphoma|stage iv adult hodgkin lymphoma
861995|NCT00006225|stage IV breast cancer|stage iv breast cancer
861996|NCT00006225|stage IIIA breast cancer|stage iiia breast cancer
861997|NCT00006225|recurrent breast cancer|recurrent breast cancer
861998|NCT00006225|stage IIIB breast cancer|stage iiib breast cancer
861999|NCT00006225|stage IIIC breast cancer|stage iiic breast cancer
862000|NCT00006225|recurrent adult Hodgkin lymphoma|recurrent adult hodgkin lymphoma
862001|NCT00006225|stage II cutaneous T-cell non-Hodgkin lymphoma|stage ii cutaneous t-cell non-hodgkin lymphoma
862002|NCT00006225|stage III cutaneous T-cell non-Hodgkin lymphoma|stage iii cutaneous t-cell non-hodgkin lymphoma
862003|NCT00006225|stage IV cutaneous T-cell non-Hodgkin lymphoma|stage iv cutaneous t-cell non-hodgkin lymphoma
862004|NCT00006225|recurrent cutaneous T-cell non-Hodgkin lymphoma|recurrent cutaneous t-cell non-hodgkin lymphoma
862005|NCT00006225|isolated plasmacytoma of bone|isolated plasmacytoma of bone
862006|NCT00006225|extramedullary plasmacytoma|extramedullary plasmacytoma
862007|NCT00006225|refractory multiple myeloma|refractory multiple myeloma
862008|NCT00006225|Waldenstrom macroglobulinemia|waldenstrom macroglobulinemia
862009|NCT00006225|stage I multiple myeloma|stage i multiple myeloma
862010|NCT00006225|stage II multiple myeloma|stage ii multiple myeloma
862011|NCT00006225|stage III multiple myeloma|stage iii multiple myeloma
862012|NCT00006225|stage II chronic lymphocytic leukemia|stage ii chronic lymphocytic leukemia
862013|NCT00006225|stage IV chronic lymphocytic leukemia|stage iv chronic lymphocytic leukemia
862014|NCT00006225|recurrent adult acute lymphoblastic leukemia|recurrent adult acute lymphoblastic leukemia
862015|NCT00006225|adult acute myeloid leukemia in remission|adult acute myeloid leukemia in remission
862016|NCT00006225|adult acute lymphoblastic leukemia in remission|adult acute lymphoblastic leukemia in remission
862017|NCT00006225|T-cell large granular lymphocyte leukemia|t-cell large granular lymphocyte leukemia
862018|NCT00006225|acute undifferentiated leukemia|acute undifferentiated leukemia
862019|NCT00006225|stage III grade 1 follicular lymphoma|stage iii grade 1 follicular lymphoma
862020|NCT00006225|stage III grade 2 follicular lymphoma|stage iii grade 2 follicular lymphoma
862021|NCT00006225|stage III grade 3 follicular lymphoma|stage iii grade 3 follicular lymphoma
862022|NCT00006225|stage III adult diffuse small cleaved cell lymphoma|stage iii adult diffuse small cleaved cell lymphoma
862023|NCT00006225|stage III adult diffuse mixed cell lymphoma|stage iii adult diffuse mixed cell lymphoma
862024|NCT00006225|stage III adult diffuse large cell lymphoma|stage iii adult diffuse large cell lymphoma
862025|NCT00006225|stage III adult immunoblastic large cell lymphoma|stage iii adult immunoblastic large cell lymphoma
862026|NCT00006225|stage III adult lymphoblastic lymphoma|stage iii adult lymphoblastic lymphoma
862027|NCT00006225|stage III adult Burkitt lymphoma|stage iii adult burkitt lymphoma
862028|NCT00006225|stage IV grade 1 follicular lymphoma|stage iv grade 1 follicular lymphoma
862029|NCT00006225|stage IV grade 2 follicular lymphoma|stage iv grade 2 follicular lymphoma
862244|NCT00003926|recurrent Wilms tumor|recurrent wilms tumor
862030|NCT00006225|stage IV grade 3 follicular lymphoma|stage iv grade 3 follicular lymphoma
862031|NCT00006225|stage IV adult diffuse small cleaved cell lymphoma|stage iv adult diffuse small cleaved cell lymphoma
862032|NCT00006225|stage IV adult diffuse mixed cell lymphoma|stage iv adult diffuse mixed cell lymphoma
862033|NCT00006225|stage IV adult diffuse large cell lymphoma|stage iv adult diffuse large cell lymphoma
862034|NCT00006225|stage IV adult immunoblastic large cell lymphoma|stage iv adult immunoblastic large cell lymphoma
862035|NCT00006225|stage IV adult lymphoblastic lymphoma|stage iv adult lymphoblastic lymphoma
862036|NCT00006225|stage IV adult Burkitt lymphoma|stage iv adult burkitt lymphoma
862037|NCT00006225|recurrent grade 1 follicular lymphoma|recurrent grade 1 follicular lymphoma
862038|NCT00006225|recurrent grade 2 follicular lymphoma|recurrent grade 2 follicular lymphoma
862039|NCT00006225|recurrent grade 3 follicular lymphoma|recurrent grade 3 follicular lymphoma
862040|NCT00006225|recurrent adult diffuse small cleaved cell lymphoma|recurrent adult diffuse small cleaved cell lymphoma
862041|NCT00006225|recurrent adult diffuse mixed cell lymphoma|recurrent adult diffuse mixed cell lymphoma
862042|NCT00006225|recurrent adult diffuse large cell lymphoma|recurrent adult diffuse large cell lymphoma
862043|NCT00006225|recurrent adult immunoblastic large cell lymphoma|recurrent adult immunoblastic large cell lymphoma
862044|NCT00006225|recurrent adult lymphoblastic lymphoma|recurrent adult lymphoblastic lymphoma
862045|NCT00006225|recurrent adult Burkitt lymphoma|recurrent adult burkitt lymphoma
862046|NCT00006225|stage I adult T-cell leukemia/lymphoma|stage i adult t-cell leukemia/lymphoma
862047|NCT00006225|stage II adult T-cell leukemia/lymphoma|stage ii adult t-cell leukemia/lymphoma
862048|NCT00006225|stage III adult T-cell leukemia/lymphoma|stage iii adult t-cell leukemia/lymphoma
862049|NCT00006225|stage IV adult T-cell leukemia/lymphoma|stage iv adult t-cell leukemia/lymphoma
862050|NCT00006225|recurrent adult T-cell leukemia/lymphoma|recurrent adult t-cell leukemia/lymphoma
862051|NCT00006225|primary central nervous system lymphoma|primary central nervous system lymphoma
862052|NCT00006225|male breast cancer|male breast cancer
862053|NCT00006225|intraocular lymphoma|intraocular lymphoma
862054|NCT00006225|stage I mantle cell lymphoma|stage i mantle cell lymphoma
862055|NCT00006225|contiguous stage II grade 1 follicular lymphoma|contiguous stage ii grade 1 follicular lymphoma
862056|NCT00006225|contiguous stage II grade 2 follicular lymphoma|contiguous stage ii grade 2 follicular lymphoma
862057|NCT00006225|contiguous stage II grade 3 follicular lymphoma|contiguous stage ii grade 3 follicular lymphoma
862058|NCT00006225|contiguous stage II adult diffuse small cleaved cell lymphoma|contiguous stage ii adult diffuse small cleaved cell lymphoma
862059|NCT00006225|contiguous stage II mantle cell lymphoma|contiguous stage ii mantle cell lymphoma
862060|NCT00006225|contiguous stage II adult diffuse mixed cell lymphoma|contiguous stage ii adult diffuse mixed cell lymphoma
862061|NCT00006225|contiguous stage II adult immunoblastic large cell lymphoma|contiguous stage ii adult immunoblastic large cell lymphoma
862062|NCT00006225|contiguous stage II adult diffuse large cell lymphoma|contiguous stage ii adult diffuse large cell lymphoma
862063|NCT00006225|contiguous stage II adult Burkitt lymphoma|contiguous stage ii adult burkitt lymphoma
862064|NCT00006225|contiguous stage II adult lymphoblastic lymphoma|contiguous stage ii adult lymphoblastic lymphoma
862065|NCT00006225|noncontiguous stage II grade 1 follicular lymphoma|noncontiguous stage ii grade 1 follicular lymphoma
862066|NCT00006225|noncontiguous stage II grade 2 follicular lymphoma|noncontiguous stage ii grade 2 follicular lymphoma
862067|NCT00006225|noncontiguous stage II grade 3 follicular lymphoma|noncontiguous stage ii grade 3 follicular lymphoma
862068|NCT00006225|noncontiguous stage II adult diffuse small cleaved cell lymphoma|noncontiguous stage ii adult diffuse small cleaved cell lymphoma
862069|NCT00006225|noncontiguous stage II mantle cell lymphoma|noncontiguous stage ii mantle cell lymphoma
862070|NCT00006225|noncontiguous stage II adult diffuse mixed cell lymphoma|noncontiguous stage ii adult diffuse mixed cell lymphoma
862071|NCT00006225|noncontiguous stage II adult immunoblastic large cell lymphoma|noncontiguous stage ii adult immunoblastic large cell lymphoma
862072|NCT00006225|noncontiguous stage II adult diffuse large cell lymphoma|noncontiguous stage ii adult diffuse large cell lymphoma
862073|NCT00006225|noncontiguous stage II adult Burkitt lymphoma|noncontiguous stage ii adult burkitt lymphoma
862074|NCT00006225|noncontiguous stage II adult lymphoblastic lymphoma|noncontiguous stage ii adult lymphoblastic lymphoma
862075|NCT00006225|stage III mantle cell lymphoma|stage iii mantle cell lymphoma
862076|NCT00006225|stage IV mantle cell lymphoma|stage iv mantle cell lymphoma
862077|NCT00006225|recurrent mantle cell lymphoma|recurrent mantle cell lymphoma
862078|NCT00006225|angioimmunoblastic T-cell lymphoma|angioimmunoblastic t-cell lymphoma
862079|NCT00006225|anaplastic large cell lymphoma|anaplastic large cell lymphoma
862080|NCT00006225|stage I mycosis fungoides/Sezary syndrome|stage i mycosis fungoides/sezary syndrome
862081|NCT00006225|stage II mycosis fungoides/Sezary syndrome|stage ii mycosis fungoides/sezary syndrome
862082|NCT00006225|stage III mycosis fungoides/Sezary syndrome|stage iii mycosis fungoides/sezary syndrome
862083|NCT00006225|stage IV mycosis fungoides/Sezary syndrome|stage iv mycosis fungoides/sezary syndrome
862084|NCT00006225|recurrent mycosis fungoides/Sezary syndrome|recurrent mycosis fungoides/sezary syndrome
862085|NCT00006225|chronic myelomonocytic leukemia|chronic myelomonocytic leukemia
862086|NCT00006225|atypical chronic myeloid leukemia|atypical chronic myeloid leukemia
862087|NCT00006225|myelodysplastic/myeloproliferative disease, unclassifiable|myelodysplastic/myeloproliferative disease, unclassifiable
862088|NCT00006225|noncontiguous stage II small lymphocytic lymphoma|noncontiguous stage ii small lymphocytic lymphoma
862089|NCT00006225|noncontiguous stage II marginal zone lymphoma|noncontiguous stage ii marginal zone lymphoma
862090|NCT00006225|recurrent marginal zone lymphoma|recurrent marginal zone lymphoma
862091|NCT00006225|recurrent small lymphocytic lymphoma|recurrent small lymphocytic lymphoma
862092|NCT00006225|stage III small lymphocytic lymphoma|stage iii small lymphocytic lymphoma
862093|NCT00006225|stage III marginal zone lymphoma|stage iii marginal zone lymphoma
862094|NCT00006225|stage IV small lymphocytic lymphoma|stage iv small lymphocytic lymphoma
862095|NCT00006225|stage IV marginal zone lymphoma|stage iv marginal zone lymphoma
862096|NCT00006225|contiguous stage II marginal zone lymphoma|contiguous stage ii marginal zone lymphoma
862097|NCT00006225|contiguous stage II small lymphocytic lymphoma|contiguous stage ii small lymphocytic lymphoma
862098|NCT00006225|extranodal marginal zone B-cell lymphoma of mucosa-associated lymphoid tissue|extranodal marginal zone b-cell lymphoma of mucosa-associated lymphoid tissue
862099|NCT00006225|nodal marginal zone B-cell lymphoma|nodal marginal zone b-cell lymphoma
862100|NCT00006225|splenic marginal zone lymphoma|splenic marginal zone lymphoma
862101|NCT00005793|untreated adult acute myeloid leukemia|untreated adult acute myeloid leukemia
862102|NCT00005793|adult acute erythroid leukemia (M6)|adult acute erythroid leukemia (m6)
862103|NCT00005793|adult acute myeloblastic leukemia without maturation (M1)|adult acute myeloblastic leukemia without maturation (m1)
862104|NCT00005793|adult acute myeloblastic leukemia with maturation (M2)|adult acute myeloblastic leukemia with maturation (m2)
862105|NCT00005793|adult acute myelomonocytic leukemia (M4)|adult acute myelomonocytic leukemia (m4)
862106|NCT00005793|adult acute monoblastic leukemia (M5a)|adult acute monoblastic leukemia (m5a)
862107|NCT00005793|adult acute megakaryoblastic leukemia (M7)|adult acute megakaryoblastic leukemia (m7)
862108|NCT00005793|adult acute monocytic leukemia (M5b)|adult acute monocytic leukemia (m5b)
862109|NCT00005793|adult acute minimally differentiated myeloid leukemia (M0)|adult acute minimally differentiated myeloid leukemia (m0)
862110|NCT00005793|adult acute myeloid leukemia with 11q23 (MLL) abnormalities|adult acute myeloid leukemia with 11q23 (mll) abnormalities
862111|NCT00005793|adult acute myeloid leukemia with inv(16)(p13;q22)|adult acute myeloid leukemia with inv(16)(p13;q22)
862112|NCT00005793|adult acute myeloid leukemia with t(16;16)(p13;q22)|adult acute myeloid leukemia with t(16;16)(p13;q22)
862113|NCT00005793|adult acute myeloid leukemia with t(8;21)(q22;q22)|adult acute myeloid leukemia with t(8;21)(q22;q22)
862114|NCT00004127|stage IV gastric cancer|stage iv gastric cancer
862115|NCT00004127|recurrent gastric cancer|recurrent gastric cancer
862116|NCT00004127|stage IV esophageal cancer|stage iv esophageal cancer
862117|NCT00004127|recurrent esophageal cancer|recurrent esophageal cancer
862118|NCT00004127|adenocarcinoma of the stomach|adenocarcinoma of the stomach
862119|NCT00004127|adenocarcinoma of the esophagus|adenocarcinoma of the esophagus
862120|NCT00004095|stage IV colon cancer|stage iv colon cancer
862121|NCT00004095|stage IV breast cancer|stage iv breast cancer
862122|NCT00004095|recurrent breast cancer|recurrent breast cancer
862123|NCT00004095|recurrent non-small cell lung cancer|recurrent non-small cell lung cancer
862124|NCT00004095|recurrent pancreatic cancer|recurrent pancreatic cancer
862125|NCT00004095|stage IV rectal cancer|stage iv rectal cancer
862126|NCT00004095|recurrent colon cancer|recurrent colon cancer
862127|NCT00004095|recurrent rectal cancer|recurrent rectal cancer
862128|NCT00004095|stage IV renal cell cancer|stage iv renal cell cancer
862129|NCT00004095|recurrent renal cell cancer|recurrent renal cell cancer
862130|NCT00004095|extensive stage small cell lung cancer|extensive stage small cell lung cancer
862131|NCT00004095|recurrent small cell lung cancer|recurrent small cell lung cancer
862132|NCT00004095|recurrent bladder cancer|recurrent bladder cancer
862133|NCT00004095|stage IV bladder cancer|stage iv bladder cancer
862134|NCT00004095|stage IV non-small cell lung cancer|stage iv non-small cell lung cancer
862135|NCT00004095|stage IV pancreatic cancer|stage iv pancreatic cancer
862136|NCT00059748|Central Nervous System Abnormalities|central nervous system abnormalities
862137|NCT00059748|Arthropathy|arthropathy
862138|NCT00059748|Urticaria|urticaria
862139|NCT00059748|Papilledema|papilledema
862140|NCT00059748|Autoinflammation|autoinflammation
862141|NCT00059748|Myositis|myositis
862142|NCT00059748|JDM|jdm
862143|NCT00059748|Immune Dysregulation|immune dysregulation
862144|NCT00059748|Skin Rash|skin rash
862145|NCT00059748|Inflammation|inflammation
862146|NCT00059748|Neonatal Onset Multisystem Imflammatory|neonatal onset multisystem imflammatory
862147|NCT00059748|Disease|disease
862148|NCT00059748|NOMID|nomid
862149|NCT00019435|stage IV colon cancer|stage iv colon cancer
862150|NCT00019435|stage IV breast cancer|stage iv breast cancer
862151|NCT00019435|recurrent breast cancer|recurrent breast cancer
862152|NCT00019435|stage IV gastric cancer|stage iv gastric cancer
862153|NCT00019435|recurrent gastric cancer|recurrent gastric cancer
862154|NCT00019435|recurrent non-small cell lung cancer|recurrent non-small cell lung cancer
862155|NCT00019435|recurrent pancreatic cancer|recurrent pancreatic cancer
862156|NCT00019435|recurrent colon cancer|recurrent colon cancer
862157|NCT00019435|stage IV esophageal cancer|stage iv esophageal cancer
862158|NCT00019435|recurrent esophageal cancer|recurrent esophageal cancer
862159|NCT00019435|recurrent bladder cancer|recurrent bladder cancer
862160|NCT00019435|stage IV bladder cancer|stage iv bladder cancer
862161|NCT00019435|stage IV non-small cell lung cancer|stage iv non-small cell lung cancer
862162|NCT00019435|stage IV pancreatic cancer|stage iv pancreatic cancer
862163|NCT00002765|recurrent adult Hodgkin lymphoma|recurrent adult hodgkin lymphoma
862164|NCT00002765|stage IV cutaneous T-cell non-Hodgkin lymphoma|stage iv cutaneous t-cell non-hodgkin lymphoma
862165|NCT00002765|recurrent cutaneous T-cell non-Hodgkin lymphoma|recurrent cutaneous t-cell non-hodgkin lymphoma
862166|NCT00002765|Waldenström macroglobulinemia|waldenström macroglobulinemia
862167|NCT00002765|recurrent adult acute myeloid leukemia|recurrent adult acute myeloid leukemia
862168|NCT00002765|recurrent adult acute lymphoblastic leukemia|recurrent adult acute lymphoblastic leukemia
862169|NCT00002765|relapsing chronic myelogenous leukemia|relapsing chronic myelogenous leukemia
862170|NCT00002765|refractory chronic lymphocytic leukemia|refractory chronic lymphocytic leukemia
862171|NCT00002765|refractory hairy cell leukemia|refractory hairy cell leukemia
862172|NCT00002765|recurrent small lymphocytic lymphoma|recurrent small lymphocytic lymphoma
862173|NCT00002765|recurrent grade 1 follicular lymphoma|recurrent grade 1 follicular lymphoma
862174|NCT00002765|recurrent grade 2 follicular lymphoma|recurrent grade 2 follicular lymphoma
862175|NCT00002765|recurrent grade 3 follicular lymphoma|recurrent grade 3 follicular lymphoma
862176|NCT00002765|recurrent adult diffuse small cleaved cell lymphoma|recurrent adult diffuse small cleaved cell lymphoma
862177|NCT00002765|recurrent adult diffuse mixed cell lymphoma|recurrent adult diffuse mixed cell lymphoma
862178|NCT00002765|recurrent adult diffuse large cell lymphoma|recurrent adult diffuse large cell lymphoma
862179|NCT00002765|recurrent adult immunoblastic large cell lymphoma|recurrent adult immunoblastic large cell lymphoma
862180|NCT00002765|recurrent adult lymphoblastic lymphoma|recurrent adult lymphoblastic lymphoma
862181|NCT00002765|recurrent adult Burkitt lymphoma|recurrent adult burkitt lymphoma
862182|NCT00002765|stage I adult T-cell leukemia/lymphoma|stage i adult t-cell leukemia/lymphoma
862183|NCT00002765|stage II adult T-cell leukemia/lymphoma|stage ii adult t-cell leukemia/lymphoma
862184|NCT00002765|stage III adult T-cell leukemia/lymphoma|stage iii adult t-cell leukemia/lymphoma
862185|NCT00002765|stage IV adult T-cell leukemia/lymphoma|stage iv adult t-cell leukemia/lymphoma
862186|NCT00002765|recurrent adult T-cell leukemia/lymphoma|recurrent adult t-cell leukemia/lymphoma
862187|NCT00002765|prolymphocytic leukemia|prolymphocytic leukemia
862188|NCT00002765|recurrent mantle cell lymphoma|recurrent mantle cell lymphoma
862189|NCT00002765|stage IV mycosis fungoides/Sezary syndrome|stage iv mycosis fungoides/sezary syndrome
862190|NCT00002765|recurrent mycosis fungoides/Sezary syndrome|recurrent mycosis fungoides/sezary syndrome
862191|NCT00002765|recurrent marginal zone lymphoma|recurrent marginal zone lymphoma
862192|NCT00002765|extranodal marginal zone B-cell lymphoma of mucosa-associated lymphoid tissue|extranodal marginal zone b-cell lymphoma of mucosa-associated lymphoid tissue
862193|NCT00002765|nodal marginal zone B-cell lymphoma|nodal marginal zone b-cell lymphoma
862194|NCT00002765|splenic marginal zone lymphoma|splenic marginal zone lymphoma
862195|NCT00059722|NSCLC|nsclc
862196|NCT00059722|locally advanced or metastatic|locally advanced or metastatic
862197|NCT00059722|second-line|second-line
862198|NCT00059709|Conflict Resolution training|conflict resolution training
862199|NCT00059709|Children|children
862200|NCT00059696|Constraint-Induced Movement Therapy|constraint-induced movement therapy
862201|NCT00059696|CI therapy|ci therapy
862202|NCT00059696|Rehabilitation|rehabilitation
862203|NCT00059696|Cerebrovascular accident|cerebrovascular accident
862204|NCT00059696|Upper extremity|upper extremity
862945|NCT00058526|Dose escalation|dose escalation
862205|NCT00059696|Concentrated, extended practice|concentrated, extended practice
862206|NCT00059696|Limb restraint|limb restraint
862207|NCT00059696|Motor Deficits|motor deficits
862208|NCT00059683|Preterm Birth|preterm birth
862209|NCT00059683|Premature Birth|premature birth
862210|NCT00059683|Cervical cerclage|cervical cerclage
862211|NCT00059683|Vaginal ultrasound|vaginal ultrasound
862212|NCT00059683|Cervical length|cervical length
862213|NCT00018941|stage IV renal cell cancer|stage iv renal cell cancer
862214|NCT00018941|recurrent renal cell cancer|recurrent renal cell cancer
862215|NCT00005837|recurrent cervical cancer|recurrent cervical cancer
862216|NCT00005837|cervical squamous cell carcinoma|cervical squamous cell carcinoma
862217|NCT00005025|recurrent ovarian epithelial cancer|recurrent ovarian epithelial cancer
862218|NCT00005025|fallopian tube cancer|fallopian tube cancer
862219|NCT00005025|primary peritoneal cavity cancer|primary peritoneal cavity cancer
862220|NCT00002971|recurrent adult brain tumor|recurrent adult brain tumor
862221|NCT00002971|adult glioblastoma|adult glioblastoma
862222|NCT00002971|adult anaplastic astrocytoma|adult anaplastic astrocytoma
862223|NCT00002971|adult giant cell glioblastoma|adult giant cell glioblastoma
862224|NCT00002971|adult gliosarcoma|adult gliosarcoma
862226|NCT00059670|Dysphagia|dysphagia
862227|NCT00059657|Ecraprost in lipid emulsion|ecraprost in lipid emulsion
862228|NCT00059657|CLI|cli
862229|NCT00059657|peripheral, vascular|peripheral, vascular
862230|NCT00059657|amputation|amputation
862231|NCT00059657|Angioplasty|angioplasty
862232|NCT00059657|by-pass|by-pass
862233|NCT00059657|Critical Limb Ischemia due to peripheral arterial disease|critical limb ischemia due to peripheral arterial disease
862234|NCT00059644|Ecraprost in lipid emulsion|ecraprost in lipid emulsion
862235|NCT00059644|CLI|cli
862236|NCT00059644|peripheral|peripheral
862237|NCT00059644|vascular|vascular
862238|NCT00059644|amputation|amputation
862239|NCT00059644|Critical Limb Ischemia due to peripheral arterial disease|critical limb ischemia due to peripheral arterial disease
862240|NCT00003933|recurrent childhood acute lymphoblastic leukemia|recurrent childhood acute lymphoblastic leukemia
862241|NCT00003926|soft tissue sarcoma|soft tissue sarcoma
862242|NCT00003926|regional neuroblastoma|regional neuroblastoma
862243|NCT00003926|disseminated neuroblastoma|disseminated neuroblastoma
883666|NCT00006617|Zidovudine|zidovudine
862245|NCT00003926|recurrent retinoblastoma|recurrent retinoblastoma
862246|NCT00003926|recurrent adult brain tumor|recurrent adult brain tumor
862247|NCT00003926|adult rhabdomyosarcoma|adult rhabdomyosarcoma
862248|NCT00003926|ovarian germ cell tumor|ovarian germ cell tumor
862249|NCT00003926|chordoma|chordoma
862250|NCT00003926|ovarian sarcoma|ovarian sarcoma
862251|NCT00003926|unresectable neuroblastoma|unresectable neuroblastoma
862252|NCT00003926|desmoplastic small round cell tumor|desmoplastic small round cell tumor
862253|NCT00003926|rhabdomyosarcoma|rhabdomyosarcoma
862254|NCT00003926|Ewing sarcoma|ewing sarcoma
862255|NCT00003926|neuroectodermal tumor|neuroectodermal tumor
862256|NCT00003926|teratoma|teratoma
862257|NCT00003926|malignant testicular germ cell tumor|malignant testicular germ cell tumor
862258|NCT00003926|malignant ovarian germ cell tumor|malignant ovarian germ cell tumor
862259|NCT00003926|extragonadal germ cell tumor|extragonadal germ cell tumor
862260|NCT00003926|malignant germ cell tumor|malignant germ cell tumor
862261|NCT00003926|hepatoblastoma|hepatoblastoma
862262|NCT00003926|liver cancer|liver cancer
862263|NCT00003926|medulloblastoma|medulloblastoma
862264|NCT00003926|cerebellar astrocytoma|cerebellar astrocytoma
862265|NCT00003926|brain stem glioma|brain stem glioma
862266|NCT00003926|glioma|glioma
862267|NCT00003926|cerebral astrocytoma|cerebral astrocytoma
862268|NCT00003926|ependymoma|ependymoma
862269|NCT00003925|unspecified adult solid tumor, protocol specific|unspecified adult solid tumor, protocol specific
862270|NCT00003802|iris melanoma|iris melanoma
862271|NCT00003802|ciliary body and choroid melanoma, small size|ciliary body and choroid melanoma, small size
862272|NCT00003802|ciliary body and choroid melanoma, medium/large size|ciliary body and choroid melanoma, medium/large size
862273|NCT00003802|extraocular extension melanoma|extraocular extension melanoma
862274|NCT00003802|recurrent intraocular melanoma|recurrent intraocular melanoma
862275|NCT00003802|stage IV melanoma|stage iv melanoma
862276|NCT00003802|recurrent melanoma|recurrent melanoma
862277|NCT00003797|recurrent pancreatic cancer|recurrent pancreatic cancer
862278|NCT00003797|stage IV pancreatic cancer|stage iv pancreatic cancer
862279|NCT00059631|Prostate Cancer|prostate cancer
862280|NCT00059631|Advanced Androgen-Independent Prostate Cancer|advanced androgen-independent prostate cancer
862281|NCT00059631|AI-PCa|ai-pca
862282|NCT00059631|Advanced Prostate Cancer|advanced prostate cancer
862283|NCT00059631|Novantrone|novantrone
862284|NCT00059631|Mitoxantrone|mitoxantrone
862285|NCT00059631|PS-341|ps-341
862286|NCT00059631|Bortezomib|bortezomib
862287|NCT00059631|Velcade|velcade
862288|NCT00059631|LDP-341|ldp-341
862289|NCT00059631|MLN341|mln341
862290|NCT00059631|20S proteasome|20s proteasome
862291|NCT00059618|Platinum Resistant|platinum resistant
862292|NCT00059618|Taxane Resistant|taxane resistant
862293|NCT00059618|Ovarian Cancer|ovarian cancer
862294|NCT00059618|Primary Peritoneal Cancer|primary peritoneal cancer
862295|NCT00059618|Fallopian Tube Cancer|fallopian tube cancer
862296|NCT00059618|Bortezomib|bortezomib
862297|NCT00059618|PS-341|ps-341
862298|NCT00059618|Velcade|velcade
862299|NCT00059618|LDP-341|ldp-341
862300|NCT00059618|MLN341|mln341
862301|NCT00059618|Carboplatin|carboplatin
862302|NCT00059618|Paraplatin|paraplatin
862303|NCT00059605|Non-Small Cell Lung Cancer|non-small cell lung cancer
862304|NCT00059605|Small Cell Lung Cancer|small cell lung cancer
862305|NCT00059605|Lung Cancer|lung cancer
862306|NCT00059605|NSCLC|nsclc
862307|NCT00059605|SCLC|sclc
862308|NCT00059605|DOTAP:Chol-fus1|dotap:chol-fus1
862309|NCT00059605|gene|gene
862310|NCT00059605|gene transfer|gene transfer
862311|NCT00003757|progressive hairy cell leukemia, initial treatment|progressive hairy cell leukemia, initial treatment
862312|NCT00003757|refractory hairy cell leukemia|refractory hairy cell leukemia
862313|NCT00003649|recurrent non-small cell lung cancer|recurrent non-small cell lung cancer
862314|NCT00003649|stage IIIB non-small cell lung cancer|stage iiib non-small cell lung cancer
862315|NCT00003649|stage IV non-small cell lung cancer|stage iv non-small cell lung cancer
862316|NCT00003649|bronchoalveolar cell lung cancer|bronchoalveolar cell lung cancer
862317|NCT00003627|stage III squamous cell carcinoma of the oropharynx|stage iii squamous cell carcinoma of the oropharynx
862318|NCT00003627|stage IV squamous cell carcinoma of the oropharynx|stage iv squamous cell carcinoma of the oropharynx
862319|NCT00003627|stage III squamous cell carcinoma of the hypopharynx|stage iii squamous cell carcinoma of the hypopharynx
862320|NCT00003627|stage IV squamous cell carcinoma of the hypopharynx|stage iv squamous cell carcinoma of the hypopharynx
862946|NCT00058526|Breast cancer|breast cancer
862321|NCT00003484|localized resectable neuroblastoma|localized resectable neuroblastoma
862322|NCT00003484|recurrent adult brain tumor|recurrent adult brain tumor
862323|NCT00003484|adult craniopharyngioma|adult craniopharyngioma
862324|NCT00003484|adult medulloblastoma|adult medulloblastoma
862325|NCT00003484|adult meningioma|adult meningioma
862326|NCT00003484|adult glioblastoma|adult glioblastoma
862327|NCT00003484|adult oligodendroglioma|adult oligodendroglioma
862328|NCT00003484|adult anaplastic astrocytoma|adult anaplastic astrocytoma
862329|NCT00003484|adult mixed glioma|adult mixed glioma
862330|NCT00003484|adult pineal parenchymal tumor|adult pineal parenchymal tumor
862331|NCT00003484|adult central nervous system germ cell tumor|adult central nervous system germ cell tumor
862332|NCT00003484|adult grade III meningioma|adult grade iii meningioma
862333|NCT00003484|adult pilocytic astrocytoma|adult pilocytic astrocytoma
862334|NCT00003484|adult giant cell glioblastoma|adult giant cell glioblastoma
862335|NCT00003484|adult gliosarcoma|adult gliosarcoma
862336|NCT00003436|untreated childhood acute myeloid leukemia and other myeloid malignancies|untreated childhood acute myeloid leukemia and other myeloid malignancies
862337|NCT00003436|childhood acute promyelocytic leukemia (M3)|childhood acute promyelocytic leukemia (m3)
862338|NCT00003436|refractory anemia with excess blasts|refractory anemia with excess blasts
862339|NCT00003436|refractory anemia with excess blasts in transformation|refractory anemia with excess blasts in transformation
862340|NCT00003436|secondary acute myeloid leukemia|secondary acute myeloid leukemia
862341|NCT00003436|de novo myelodysplastic syndromes|de novo myelodysplastic syndromes
862342|NCT00003436|secondary myelodysplastic syndromes|secondary myelodysplastic syndromes
862343|NCT00003436|childhood myelodysplastic syndromes|childhood myelodysplastic syndromes
862345|NCT00059579|Cortex|cortex
862346|NCT00059579|Dopamine|dopamine
862347|NCT00059579|Neuroimaging|neuroimaging
862348|NCT00059579|Strirtum|strirtum
862349|NCT00059579|Major Depressive Disorder (MDD)|major depressive disorder (mdd)
862350|NCT00059579|Melancholic Features|melancholic features
862351|NCT00059579|Brain Imaging|brain imaging
862352|NCT00059579|Functional Magnetic Resonance Imaging (fMRI)|functional magnetic resonance imaging (fmri)
862353|NCT00059579|Dopaminergic Mechanisms|dopaminergic mechanisms
862354|NCT00059579|Anhedonia|anhedonia
862355|NCT00059579|Depression|depression
862356|NCT00059579|Major Depressive Disorder|major depressive disorder
862357|NCT00059579|MDD|mdd
862358|NCT00059579|Healthy Volunteer|healthy volunteer
862359|NCT00059579|HV|hv
862360|NCT00059553|spinal cord injury|spinal cord injury
862361|NCT00059553|walking|walking
862362|NCT00059553|training|training
862363|NCT00059553|treadmill|treadmill
862364|NCT00059553|incomplete spinal cord injury|incomplete spinal cord injury
862365|NCT00059540|NICHD Neonatal Research Network|nichd neonatal research network
862366|NCT00059540|Maternal Lifestyle Study|maternal lifestyle study
862367|NCT00059540|Cocaine abuse|cocaine abuse
862368|NCT00059540|Cocaine dependence|cocaine dependence
862369|NCT00059540|Opiate abuse|opiate abuse
862370|NCT00059540|Opiate dependence|opiate dependence
862371|NCT00059540|Follow-up|follow-up
862372|NCT00059540|Neurodevelopmental outcome|neurodevelopmental outcome
862373|NCT00059540|Substance-related disorders|substance-related disorders
862374|NCT00059527|Physical Activity|physical activity
862375|NCT00059527|Nutrition|nutrition
862376|NCT00059527|Self Efficacy|self efficacy
862377|NCT00059527|Middle School|middle school
862378|NCT00059527|Intervention|intervention
862379|NCT00059514|Youth|youth
862380|NCT00059514|Adolescents|adolescents
862381|NCT00059514|Smoking cessation|smoking cessation
862382|NCT00059514|Smoking prevention|smoking prevention
862383|NCT00059514|Risk factors|risk factors
862384|NCT00059514|Arab Americans|arab americans
862385|NCT00059449|Enterocolitis|enterocolitis
862386|NCT00005836|recurrent ovarian epithelial cancer|recurrent ovarian epithelial cancer
862387|NCT00005836|primary peritoneal cavity cancer|primary peritoneal cavity cancer
862388|NCT00059501|Postural Stability|postural stability
862389|NCT00059501|EEG|eeg
862390|NCT00059501|Aging|aging
862391|NCT00059501|Falls|falls
862392|NCT00059501|Healthy Volunteer|healthy volunteer
862393|NCT00059501|HV|hv
862394|NCT00059475|Adjuvant Therapy|adjuvant therapy
862395|NCT00059475|MART-1 Peptides|mart-1 peptides
862396|NCT00059475|GP100 Peptide|gp100 peptide
862397|NCT00059475|Immunologic Response|immunologic response
862398|NCT00059475|Melanoma|melanoma
862399|NCT00059436|Muscle strengthening|muscle strengthening
862400|NCT00059436|Skeletal muscle Contractions|skeletal muscle contractions
862401|NCT00059436|Rehabilitative exercise|rehabilitative exercise
862402|NCT00059410|Alzheimer disease|alzheimer disease
862403|NCT00059410|Caregivers|caregivers
862404|NCT00059410|African Americans|african americans
862405|NCT00059410|Perceptions|perceptions
862406|NCT00059410|Cultural Competency|cultural competency
862407|NCT00059423|Leukapheresis|leukapheresis
862408|NCT00059423|G-CSF|g-csf
862409|NCT00059423|Dexamethasone|dexamethasone
862410|NCT00059423|mRNA|mrna
862411|NCT00059423|Benign Ethnic Neutropenia|benign ethnic neutropenia
862412|NCT00059423|BEN|ben
862413|NCT00059423|Healthy Volunteer|healthy volunteer
862414|NCT00059423|HV|hv
862415|NCT00059397|Hepatitis C|hepatitis c
862416|NCT00003432|stage IV breast cancer|stage iv breast cancer
862417|NCT00003346|stage III melanoma|stage iii melanoma
862418|NCT00003346|stage IV melanoma|stage iv melanoma
862419|NCT00003346|recurrent melanoma|recurrent melanoma
862420|NCT00003341|stage II adult Hodgkin lymphoma|stage ii adult hodgkin lymphoma
862421|NCT00003341|stage III adult Hodgkin lymphoma|stage iii adult hodgkin lymphoma
862422|NCT00003341|stage IV adult Hodgkin lymphoma|stage iv adult hodgkin lymphoma
862423|NCT00003341|recurrent adult Hodgkin lymphoma|recurrent adult hodgkin lymphoma
862424|NCT00003341|refractory multiple myeloma|refractory multiple myeloma
862425|NCT00003341|Waldenström macroglobulinemia|waldenström macroglobulinemia
884060|NCT00005764|Zalcitabine|zalcitabine
862426|NCT00003341|stage II multiple myeloma|stage ii multiple myeloma
862427|NCT00003341|stage III multiple myeloma|stage iii multiple myeloma
862428|NCT00003341|stage II chronic lymphocytic leukemia|stage ii chronic lymphocytic leukemia
862429|NCT00003341|stage III chronic lymphocytic leukemia|stage iii chronic lymphocytic leukemia
862430|NCT00003341|stage IV chronic lymphocytic leukemia|stage iv chronic lymphocytic leukemia
862431|NCT00003341|refractory chronic lymphocytic leukemia|refractory chronic lymphocytic leukemia
862432|NCT00003341|stage III grade 1 follicular lymphoma|stage iii grade 1 follicular lymphoma
862433|NCT00003341|stage III grade 2 follicular lymphoma|stage iii grade 2 follicular lymphoma
862434|NCT00003341|stage III grade 3 follicular lymphoma|stage iii grade 3 follicular lymphoma
862435|NCT00003341|stage III adult diffuse small cleaved cell lymphoma|stage iii adult diffuse small cleaved cell lymphoma
862436|NCT00003341|stage III adult diffuse mixed cell lymphoma|stage iii adult diffuse mixed cell lymphoma
862437|NCT00003341|stage III adult diffuse large cell lymphoma|stage iii adult diffuse large cell lymphoma
862438|NCT00003341|stage III adult immunoblastic large cell lymphoma|stage iii adult immunoblastic large cell lymphoma
862439|NCT00003341|stage IV grade 1 follicular lymphoma|stage iv grade 1 follicular lymphoma
862440|NCT00003341|stage IV grade 2 follicular lymphoma|stage iv grade 2 follicular lymphoma
862441|NCT00003341|stage IV grade 3 follicular lymphoma|stage iv grade 3 follicular lymphoma
862442|NCT00003341|stage IV adult diffuse small cleaved cell lymphoma|stage iv adult diffuse small cleaved cell lymphoma
862443|NCT00003341|stage IV adult diffuse mixed cell lymphoma|stage iv adult diffuse mixed cell lymphoma
862444|NCT00003341|stage IV adult diffuse large cell lymphoma|stage iv adult diffuse large cell lymphoma
862445|NCT00003341|stage IV adult immunoblastic large cell lymphoma|stage iv adult immunoblastic large cell lymphoma
862446|NCT00003341|recurrent grade 1 follicular lymphoma|recurrent grade 1 follicular lymphoma
862447|NCT00003341|recurrent grade 2 follicular lymphoma|recurrent grade 2 follicular lymphoma
862448|NCT00003341|recurrent grade 3 follicular lymphoma|recurrent grade 3 follicular lymphoma
862449|NCT00003341|recurrent adult diffuse small cleaved cell lymphoma|recurrent adult diffuse small cleaved cell lymphoma
862450|NCT00003341|recurrent adult diffuse mixed cell lymphoma|recurrent adult diffuse mixed cell lymphoma
862451|NCT00003341|recurrent adult diffuse large cell lymphoma|recurrent adult diffuse large cell lymphoma
862452|NCT00003341|recurrent adult immunoblastic large cell lymphoma|recurrent adult immunoblastic large cell lymphoma
862453|NCT00003341|anemia|anemia
862454|NCT00003341|contiguous stage II grade 1 follicular lymphoma|contiguous stage ii grade 1 follicular lymphoma
862455|NCT00003341|contiguous stage II grade 2 follicular lymphoma|contiguous stage ii grade 2 follicular lymphoma
862456|NCT00003341|contiguous stage II grade 3 follicular lymphoma|contiguous stage ii grade 3 follicular lymphoma
862457|NCT00003341|contiguous stage II adult diffuse small cleaved cell lymphoma|contiguous stage ii adult diffuse small cleaved cell lymphoma
862458|NCT00003341|contiguous stage II mantle cell lymphoma|contiguous stage ii mantle cell lymphoma
862459|NCT00003341|contiguous stage II adult diffuse mixed cell lymphoma|contiguous stage ii adult diffuse mixed cell lymphoma
862460|NCT00003341|contiguous stage II adult immunoblastic large cell lymphoma|contiguous stage ii adult immunoblastic large cell lymphoma
862461|NCT00003341|contiguous stage II adult diffuse large cell lymphoma|contiguous stage ii adult diffuse large cell lymphoma
862462|NCT00003341|noncontiguous stage II grade 1 follicular lymphoma|noncontiguous stage ii grade 1 follicular lymphoma
862463|NCT00003341|noncontiguous stage II grade 2 follicular lymphoma|noncontiguous stage ii grade 2 follicular lymphoma
862464|NCT00003341|noncontiguous stage II grade 3 follicular lymphoma|noncontiguous stage ii grade 3 follicular lymphoma
862465|NCT00003341|noncontiguous stage II adult diffuse small cleaved cell lymphoma|noncontiguous stage ii adult diffuse small cleaved cell lymphoma
862466|NCT00003341|noncontiguous stage II mantle cell lymphoma|noncontiguous stage ii mantle cell lymphoma
862767|NCT00058968|persistent pain|persistent pain
862467|NCT00003341|noncontiguous stage II adult diffuse mixed cell lymphoma|noncontiguous stage ii adult diffuse mixed cell lymphoma
862468|NCT00003341|noncontiguous stage II adult immunoblastic large cell lymphoma|noncontiguous stage ii adult immunoblastic large cell lymphoma
862469|NCT00003341|noncontiguous stage II adult diffuse large cell lymphoma|noncontiguous stage ii adult diffuse large cell lymphoma
862470|NCT00003341|stage III mantle cell lymphoma|stage iii mantle cell lymphoma
862471|NCT00003341|stage IV mantle cell lymphoma|stage iv mantle cell lymphoma
862472|NCT00003341|recurrent mantle cell lymphoma|recurrent mantle cell lymphoma
862473|NCT00003341|noncontiguous stage II small lymphocytic lymphoma|noncontiguous stage ii small lymphocytic lymphoma
862474|NCT00003341|noncontiguous stage II marginal zone lymphoma|noncontiguous stage ii marginal zone lymphoma
862475|NCT00003341|recurrent marginal zone lymphoma|recurrent marginal zone lymphoma
862476|NCT00003341|recurrent small lymphocytic lymphoma|recurrent small lymphocytic lymphoma
862477|NCT00003341|stage III small lymphocytic lymphoma|stage iii small lymphocytic lymphoma
862478|NCT00003341|stage III marginal zone lymphoma|stage iii marginal zone lymphoma
862479|NCT00003341|stage IV small lymphocytic lymphoma|stage iv small lymphocytic lymphoma
862480|NCT00003341|stage IV marginal zone lymphoma|stage iv marginal zone lymphoma
862481|NCT00003341|contiguous stage II marginal zone lymphoma|contiguous stage ii marginal zone lymphoma
862482|NCT00003341|contiguous stage II small lymphocytic lymphoma|contiguous stage ii small lymphocytic lymphoma
862483|NCT00003341|extranodal marginal zone B-cell lymphoma of mucosa-associated lymphoid tissue|extranodal marginal zone b-cell lymphoma of mucosa-associated lymphoid tissue
862484|NCT00003341|nodal marginal zone B-cell lymphoma|nodal marginal zone b-cell lymphoma
862485|NCT00003341|splenic marginal zone lymphoma|splenic marginal zone lymphoma
884061|NCT00005764|Didanosine|didanosine
862486|NCT00003324|tumors metastatic to brain|tumors metastatic to brain
862487|NCT00003311|stage I mantle cell lymphoma|stage i mantle cell lymphoma
862488|NCT00003311|contiguous stage II mantle cell lymphoma|contiguous stage ii mantle cell lymphoma
862489|NCT00003311|noncontiguous stage II mantle cell lymphoma|noncontiguous stage ii mantle cell lymphoma
862490|NCT00003311|stage III mantle cell lymphoma|stage iii mantle cell lymphoma
862491|NCT00003311|stage IV mantle cell lymphoma|stage iv mantle cell lymphoma
862492|NCT00059384|Treatment experienced|treatment experienced
862493|NCT00059384|Therapeutic Drug Monitoring|therapeutic drug monitoring
862494|NCT00059371|Male circumcision|male circumcision
862495|NCT00059371|HIV acquisition|hiv acquisition
862496|NCT00059371|Sexually transmitted infection|sexually transmitted infection
862497|NCT00059371|HIV Seronegativity|hiv seronegativity
862498|NCT00059358|HIV|hiv
862499|NCT00059358|HCV|hcv
862500|NCT00059358|Ribavirin|ribavirin
862501|NCT00059358|Interferon|interferon
862502|NCT00059358|Co-infection|co-infection
862503|NCT00059358|Treatment experienced|treatment experienced
862504|NCT00059345|Acupuncture|acupuncture
862505|NCT00059345|Arthritis|arthritis
862506|NCT00059332|stroke|stroke
862507|NCT00059332|brain attack|brain attack
862508|NCT00059332|magnesium sulfate|magnesium sulfate
862509|NCT00059332|neuroprotection|neuroprotection
862510|NCT00059332|prehospital care|prehospital care
862511|NCT00059332|emergency medical services|emergency medical services
862512|NCT00059319|coronary artery bypass graft surgery|coronary artery bypass graft surgery
862513|NCT00059319|CABG surgery|cabg surgery
862514|NCT00059319|neurobehavioral impairment|neurobehavioral impairment
862515|NCT00059319|aorta clamping|aorta clamping
862516|NCT00059319|aorta manipulation|aorta manipulation
862517|NCT00059319|microemboli|microemboli
862518|NCT00059306|stroke|stroke
862519|NCT00059306|hypertension|hypertension
862520|NCT00059306|high blood pressure|high blood pressure
862521|NCT00059306|lacunar stroke|lacunar stroke
862522|NCT00059306|subcortical stroke|subcortical stroke
862523|NCT00059306|aspirin|aspirin
862524|NCT00059306|clopidogrel|clopidogrel
862525|NCT00058981|Diabetes|diabetes
862526|NCT00058981|LADA|lada
862527|NCT00058981|latent autoimmune diabetes in adults|latent autoimmune diabetes in adults
862528|NCT00059280|Pompe disease|pompe disease
862529|NCT00059280|Glycogen storage disease type II|glycogen storage disease type ii
862530|NCT00059280|GSD-II|gsd-ii
862531|NCT00059280|Acid maltase deficiency disease|acid maltase deficiency disease
862532|NCT00059280|Glycogenosis 2|glycogenosis 2
862533|NCT00059254|fatty acids|fatty acids
862534|NCT00059254|oleic acid|oleic acid
862535|NCT00059254|palmitic acid|palmitic acid
862536|NCT00059254|fat oxidation|fat oxidation
862537|NCT00059254|energy expenditure|energy expenditure
862538|NCT00059254|body composition|body composition
862539|NCT00059254|monounsaturated fat|monounsaturated fat
862540|NCT00059254|human|human
862542|NCT00059241|Prevention of early sexual activity|prevention of early sexual activity
862543|NCT00059241|Middle childhood|middle childhood
862544|NCT00003290|stage IIB prostate cancer|stage iib prostate cancer
862545|NCT00003290|stage IIA prostate cancer|stage iia prostate cancer
862546|NCT00003290|stage III prostate cancer|stage iii prostate cancer
862547|NCT00003262|stage I adult Hodgkin lymphoma|stage i adult hodgkin lymphoma
862548|NCT00003262|stage II adult Hodgkin lymphoma|stage ii adult hodgkin lymphoma
862549|NCT00003262|stage III adult Hodgkin lymphoma|stage iii adult hodgkin lymphoma
862550|NCT00003262|stage IV adult Hodgkin lymphoma|stage iv adult hodgkin lymphoma
862551|NCT00003262|AIDS-related peripheral/systemic lymphoma|aids-related peripheral/systemic lymphoma
862552|NCT00003262|HIV-associated Hodgkin lymphoma|hiv-associated hodgkin lymphoma
862553|NCT00003205|stage IV breast cancer|stage iv breast cancer
862554|NCT00003205|recurrent breast cancer|recurrent breast cancer
862555|NCT00003193|oral complications|oral complications
862556|NCT00003193|stage III squamous cell carcinoma of the lip and oral cavity|stage iii squamous cell carcinoma of the lip and oral cavity
862557|NCT00003193|stage IV squamous cell carcinoma of the lip and oral cavity|stage iv squamous cell carcinoma of the lip and oral cavity
862558|NCT00003193|stage III squamous cell carcinoma of the oropharynx|stage iii squamous cell carcinoma of the oropharynx
862559|NCT00003193|stage IV squamous cell carcinoma of the oropharynx|stage iv squamous cell carcinoma of the oropharynx
862560|NCT00003193|stage III squamous cell carcinoma of the nasopharynx|stage iii squamous cell carcinoma of the nasopharynx
862561|NCT00003193|stage IV squamous cell carcinoma of the nasopharynx|stage iv squamous cell carcinoma of the nasopharynx
862562|NCT00003193|stage III squamous cell carcinoma of the hypopharynx|stage iii squamous cell carcinoma of the hypopharynx
862563|NCT00003193|stage IV squamous cell carcinoma of the hypopharynx|stage iv squamous cell carcinoma of the hypopharynx
862564|NCT00003193|stage III squamous cell carcinoma of the larynx|stage iii squamous cell carcinoma of the larynx
862565|NCT00003193|stage IV squamous cell carcinoma of the larynx|stage iv squamous cell carcinoma of the larynx
862566|NCT00003193|stage III squamous cell carcinoma of the paranasal sinus and nasal cavity|stage iii squamous cell carcinoma of the paranasal sinus and nasal cavity
862567|NCT00003193|stage IV squamous cell carcinoma of the paranasal sinus and nasal cavity|stage iv squamous cell carcinoma of the paranasal sinus and nasal cavity
862568|NCT00003173|intraocular retinoblastoma|intraocular retinoblastoma
862569|NCT00003173|recurrent retinoblastoma|recurrent retinoblastoma
862570|NCT00003173|childhood central nervous system germ cell tumor|childhood central nervous system germ cell tumor
862571|NCT00003173|stage III malignant testicular germ cell tumor|stage iii malignant testicular germ cell tumor
862572|NCT00003173|recurrent malignant testicular germ cell tumor|recurrent malignant testicular germ cell tumor
862573|NCT00003173|unspecified childhood solid tumor, protocol specific|unspecified childhood solid tumor, protocol specific
862574|NCT00003173|unspecified adult solid tumor, protocol specific|unspecified adult solid tumor, protocol specific
862575|NCT00003173|childhood germ cell tumor|childhood germ cell tumor
862576|NCT00003173|stage III ovarian germ cell tumor|stage iii ovarian germ cell tumor
862577|NCT00003173|stage IV ovarian germ cell tumor|stage iv ovarian germ cell tumor
862578|NCT00003173|recurrent ovarian germ cell tumor|recurrent ovarian germ cell tumor
862579|NCT00003173|extragonadal germ cell tumor|extragonadal germ cell tumor
862580|NCT00003173|adult central nervous system germ cell tumor|adult central nervous system germ cell tumor
862581|NCT00003173|childhood teratoma|childhood teratoma
862582|NCT00003173|childhood malignant testicular germ cell tumor|childhood malignant testicular germ cell tumor
862583|NCT00003173|childhood malignant ovarian germ cell tumor|childhood malignant ovarian germ cell tumor
862584|NCT00003173|childhood extragonadal germ cell tumor|childhood extragonadal germ cell tumor
862585|NCT00003173|recurrent childhood malignant germ cell tumor|recurrent childhood malignant germ cell tumor
862586|NCT00059228|Pregnancy|pregnancy
862587|NCT00059228|Gonadal Steroids|gonadal steroids
862588|NCT00059228|Antidepressants|antidepressants
862589|NCT00059228|Puerperium|puerperium
862590|NCT00059228|Depression|depression
862591|NCT00059228|Postpartum|postpartum
862592|NCT00059228|Estradiol|estradiol
862593|NCT00059228|Estrogen Response Element|estrogen response element
862594|NCT00059228|Postpartum Depression|postpartum depression
862595|NCT00059202|Urso|urso
862597|NCT00059189|Occipital Cortex|occipital cortex
862598|NCT00059189|Prefrontal Cortex|prefrontal cortex
862599|NCT00059189|Transcranial Magnetic Stimulation|transcranial magnetic stimulation
862600|NCT00059189|Inhibition|inhibition
862601|NCT00059189|Cortical Excitability|cortical excitability
862602|NCT00059189|Blindness|blindness
862603|NCT00059189|Healthy Volunteer|healthy volunteer
862604|NCT00059189|HV|hv
862605|NCT00005839|unspecified adult solid tumor, protocol specific|unspecified adult solid tumor, protocol specific
862606|NCT00004220|unspecified adult solid tumor, protocol specific|unspecified adult solid tumor, protocol specific
862607|NCT00059137|Gating|gating
862608|NCT00059137|Respiratory Misregistration|respiratory misregistration
862609|NCT00059137|Abdominal Belt|abdominal belt
862610|NCT00059137|Percutaneous|percutaneous
862611|NCT00059137|CT Guided Biopsy|ct guided biopsy
862612|NCT00059137|Respiratory Cycle|respiratory cycle
862613|NCT00059137|Needle Biopsy|needle biopsy
862614|NCT00004257|stage I esophageal cancer|stage i esophageal cancer
862615|NCT00004257|stage II esophageal cancer|stage ii esophageal cancer
862616|NCT00004257|stage III esophageal cancer|stage iii esophageal cancer
862617|NCT00004257|squamous cell carcinoma of the esophagus|squamous cell carcinoma of the esophagus
862618|NCT00004257|adenocarcinoma of the esophagus|adenocarcinoma of the esophagus
862619|NCT00004243|unspecified adult solid tumor, protocol specific|unspecified adult solid tumor, protocol specific
862620|NCT00003597|recurrent childhood rhabdomyosarcoma|recurrent childhood rhabdomyosarcoma
862621|NCT00003597|recurrent renal cell cancer|recurrent renal cell cancer
862622|NCT00003597|recurrent neuroblastoma|recurrent neuroblastoma
862623|NCT00003597|recurrent childhood liver cancer|recurrent childhood liver cancer
862624|NCT00003597|recurrent Wilms tumor and other childhood kidney tumors|recurrent wilms tumor and other childhood kidney tumors
862625|NCT00003597|recurrent retinoblastoma|recurrent retinoblastoma
862626|NCT00003597|childhood central nervous system germ cell tumor|childhood central nervous system germ cell tumor
862627|NCT00003597|recurrent osteosarcoma|recurrent osteosarcoma
862628|NCT00003597|recurrent gestational trophoblastic tumor|recurrent gestational trophoblastic tumor
862629|NCT00003597|recurrent malignant testicular germ cell tumor|recurrent malignant testicular germ cell tumor
862630|NCT00003597|recurrent intraocular melanoma|recurrent intraocular melanoma
862631|NCT00003597|recurrent melanoma|recurrent melanoma
862632|NCT00003597|unspecified childhood solid tumor, protocol specific|unspecified childhood solid tumor, protocol specific
862633|NCT00003597|childhood germ cell tumor|childhood germ cell tumor
862634|NCT00003597|recurrent childhood soft tissue sarcoma|recurrent childhood soft tissue sarcoma
862635|NCT00003597|recurrent ovarian germ cell tumor|recurrent ovarian germ cell tumor
862636|NCT00003597|extragonadal germ cell tumor|extragonadal germ cell tumor
862637|NCT00003597|recurrent uterine sarcoma|recurrent uterine sarcoma
862638|NCT00003597|neutropenia|neutropenia
862639|NCT00003597|thrombocytopenia|thrombocytopenia
862640|NCT00003597|recurrent childhood brain stem glioma|recurrent childhood brain stem glioma
862641|NCT00003597|recurrent childhood supratentorial primitive neuroectodermal tumor|recurrent childhood supratentorial primitive neuroectodermal tumor
862642|NCT00003597|recurrent childhood visual pathway glioma|recurrent childhood visual pathway glioma
862643|NCT00003597|recurrent childhood cerebellar astrocytoma|recurrent childhood cerebellar astrocytoma
862644|NCT00003597|recurrent childhood cerebral astrocytoma|recurrent childhood cerebral astrocytoma
862645|NCT00003597|recurrent childhood medulloblastoma|recurrent childhood medulloblastoma
862870|NCT00058682|Candida Species|candida species
862646|NCT00003597|recurrent Ewing sarcoma/peripheral primitive neuroectodermal tumor|recurrent ewing sarcoma/peripheral primitive neuroectodermal tumor
862647|NCT00003163|refractory multiple myeloma|refractory multiple myeloma
862648|NCT00003163|Waldenström macroglobulinemia|waldenström macroglobulinemia
862649|NCT00003163|stage I multiple myeloma|stage i multiple myeloma
862650|NCT00003163|stage II multiple myeloma|stage ii multiple myeloma
862651|NCT00003163|stage III multiple myeloma|stage iii multiple myeloma
862652|NCT00003163|stage III grade 1 follicular lymphoma|stage iii grade 1 follicular lymphoma
862653|NCT00003163|stage III grade 2 follicular lymphoma|stage iii grade 2 follicular lymphoma
862654|NCT00003163|stage III grade 3 follicular lymphoma|stage iii grade 3 follicular lymphoma
862655|NCT00003163|stage III adult diffuse small cleaved cell lymphoma|stage iii adult diffuse small cleaved cell lymphoma
862656|NCT00003163|stage III adult diffuse mixed cell lymphoma|stage iii adult diffuse mixed cell lymphoma
862657|NCT00003163|stage III adult diffuse large cell lymphoma|stage iii adult diffuse large cell lymphoma
862658|NCT00003163|stage III adult immunoblastic large cell lymphoma|stage iii adult immunoblastic large cell lymphoma
862659|NCT00003163|stage III adult lymphoblastic lymphoma|stage iii adult lymphoblastic lymphoma
862660|NCT00003163|stage III adult Burkitt lymphoma|stage iii adult burkitt lymphoma
862661|NCT00003163|stage IV grade 1 follicular lymphoma|stage iv grade 1 follicular lymphoma
862662|NCT00003163|stage IV grade 2 follicular lymphoma|stage iv grade 2 follicular lymphoma
862663|NCT00003163|stage IV grade 3 follicular lymphoma|stage iv grade 3 follicular lymphoma
862664|NCT00003163|stage IV adult diffuse small cleaved cell lymphoma|stage iv adult diffuse small cleaved cell lymphoma
862665|NCT00003163|stage IV adult diffuse mixed cell lymphoma|stage iv adult diffuse mixed cell lymphoma
862666|NCT00003163|stage IV adult diffuse large cell lymphoma|stage iv adult diffuse large cell lymphoma
862667|NCT00003163|stage IV adult immunoblastic large cell lymphoma|stage iv adult immunoblastic large cell lymphoma
862668|NCT00003163|stage IV adult lymphoblastic lymphoma|stage iv adult lymphoblastic lymphoma
862669|NCT00003163|stage IV adult Burkitt lymphoma|stage iv adult burkitt lymphoma
862670|NCT00003163|recurrent grade 1 follicular lymphoma|recurrent grade 1 follicular lymphoma
862671|NCT00003163|recurrent grade 2 follicular lymphoma|recurrent grade 2 follicular lymphoma
862672|NCT00003163|recurrent grade 3 follicular lymphoma|recurrent grade 3 follicular lymphoma
862673|NCT00003163|recurrent adult diffuse small cleaved cell lymphoma|recurrent adult diffuse small cleaved cell lymphoma
862674|NCT00003163|recurrent adult diffuse mixed cell lymphoma|recurrent adult diffuse mixed cell lymphoma
862675|NCT00003163|recurrent adult diffuse large cell lymphoma|recurrent adult diffuse large cell lymphoma
862676|NCT00003163|recurrent adult immunoblastic large cell lymphoma|recurrent adult immunoblastic large cell lymphoma
862677|NCT00003163|recurrent adult lymphoblastic lymphoma|recurrent adult lymphoblastic lymphoma
862678|NCT00003163|recurrent adult Burkitt lymphoma|recurrent adult burkitt lymphoma
862679|NCT00003163|primary systemic amyloidosis|primary systemic amyloidosis
862680|NCT00003163|contiguous stage II grade 1 follicular lymphoma|contiguous stage ii grade 1 follicular lymphoma
862681|NCT00003163|contiguous stage II grade 2 follicular lymphoma|contiguous stage ii grade 2 follicular lymphoma
862682|NCT00003163|contiguous stage II grade 3 follicular lymphoma|contiguous stage ii grade 3 follicular lymphoma
862683|NCT00003163|contiguous stage II adult diffuse small cleaved cell lymphoma|contiguous stage ii adult diffuse small cleaved cell lymphoma
862684|NCT00003163|contiguous stage II mantle cell lymphoma|contiguous stage ii mantle cell lymphoma
862685|NCT00003163|contiguous stage II adult diffuse mixed cell lymphoma|contiguous stage ii adult diffuse mixed cell lymphoma
862686|NCT00003163|contiguous stage II adult immunoblastic large cell lymphoma|contiguous stage ii adult immunoblastic large cell lymphoma
862687|NCT00003163|contiguous stage II adult diffuse large cell lymphoma|contiguous stage ii adult diffuse large cell lymphoma
862688|NCT00003163|contiguous stage II adult Burkitt lymphoma|contiguous stage ii adult burkitt lymphoma
862689|NCT00003163|contiguous stage II adult lymphoblastic lymphoma|contiguous stage ii adult lymphoblastic lymphoma
862690|NCT00003163|noncontiguous stage II grade 1 follicular lymphoma|noncontiguous stage ii grade 1 follicular lymphoma
862691|NCT00003163|noncontiguous stage II grade 2 follicular lymphoma|noncontiguous stage ii grade 2 follicular lymphoma
862692|NCT00003163|noncontiguous stage II grade 3 follicular lymphoma|noncontiguous stage ii grade 3 follicular lymphoma
862693|NCT00003163|noncontiguous stage II adult diffuse small cleaved cell lymphoma|noncontiguous stage ii adult diffuse small cleaved cell lymphoma
862694|NCT00003163|noncontiguous stage II mantle cell lymphoma|noncontiguous stage ii mantle cell lymphoma
862695|NCT00003163|noncontiguous stage II adult diffuse mixed cell lymphoma|noncontiguous stage ii adult diffuse mixed cell lymphoma
862696|NCT00003163|noncontiguous stage II adult immunoblastic large cell lymphoma|noncontiguous stage ii adult immunoblastic large cell lymphoma
862697|NCT00003163|noncontiguous stage II adult diffuse large cell lymphoma|noncontiguous stage ii adult diffuse large cell lymphoma
862698|NCT00003163|noncontiguous stage II adult Burkitt lymphoma|noncontiguous stage ii adult burkitt lymphoma
862699|NCT00003163|noncontiguous stage II adult lymphoblastic lymphoma|noncontiguous stage ii adult lymphoblastic lymphoma
862700|NCT00003163|stage III mantle cell lymphoma|stage iii mantle cell lymphoma
862701|NCT00003163|stage IV mantle cell lymphoma|stage iv mantle cell lymphoma
862702|NCT00003163|recurrent mantle cell lymphoma|recurrent mantle cell lymphoma
862703|NCT00003163|noncontiguous stage II small lymphocytic lymphoma|noncontiguous stage ii small lymphocytic lymphoma
862704|NCT00003163|noncontiguous stage II marginal zone lymphoma|noncontiguous stage ii marginal zone lymphoma
862705|NCT00003163|recurrent marginal zone lymphoma|recurrent marginal zone lymphoma
862871|NCT00058682|Candidiasis|candidiasis
862706|NCT00003163|recurrent small lymphocytic lymphoma|recurrent small lymphocytic lymphoma
862707|NCT00003163|stage III small lymphocytic lymphoma|stage iii small lymphocytic lymphoma
862708|NCT00003163|stage III marginal zone lymphoma|stage iii marginal zone lymphoma
862709|NCT00003163|stage IV small lymphocytic lymphoma|stage iv small lymphocytic lymphoma
862710|NCT00003163|stage IV marginal zone lymphoma|stage iv marginal zone lymphoma
862711|NCT00003163|contiguous stage II marginal zone lymphoma|contiguous stage ii marginal zone lymphoma
862712|NCT00003163|contiguous stage II small lymphocytic lymphoma|contiguous stage ii small lymphocytic lymphoma
862713|NCT00003163|extranodal marginal zone B-cell lymphoma of mucosa-associated lymphoid tissue|extranodal marginal zone b-cell lymphoma of mucosa-associated lymphoid tissue
862714|NCT00003163|nodal marginal zone B-cell lymphoma|nodal marginal zone b-cell lymphoma
862715|NCT00003163|splenic marginal zone lymphoma|splenic marginal zone lymphoma
862716|NCT00003162|stage IV breast cancer|stage iv breast cancer
862717|NCT00003162|recurrent breast cancer|recurrent breast cancer
862718|NCT00003162|stage IV prostate cancer|stage iv prostate cancer
862719|NCT00003162|recurrent prostate cancer|recurrent prostate cancer
862720|NCT00003162|bone metastases|bone metastases
862722|NCT00003129|stage 0 bladder cancer|stage 0 bladder cancer
862723|NCT00003129|stage I bladder cancer|stage i bladder cancer
862724|NCT00003129|transitional cell carcinoma of the bladder|transitional cell carcinoma of the bladder
862725|NCT00003124|adenocarcinoma of the prostate|adenocarcinoma of the prostate
862726|NCT00003124|stage I prostate cancer|stage i prostate cancer
862727|NCT00003124|stage IIB prostate cancer|stage iib prostate cancer
862728|NCT00003124|stage IIA prostate cancer|stage iia prostate cancer
862729|NCT00003124|stage III prostate cancer|stage iii prostate cancer
862730|NCT00003064|recurrent ovarian epithelial cancer|recurrent ovarian epithelial cancer
862731|NCT00003064|fallopian tube cancer|fallopian tube cancer
862732|NCT00003064|primary peritoneal cavity cancer|primary peritoneal cavity cancer
862733|NCT00002972|recurrent non-small cell lung cancer|recurrent non-small cell lung cancer
862734|NCT00002972|stage IIIB non-small cell lung cancer|stage iiib non-small cell lung cancer
862735|NCT00002972|stage IV non-small cell lung cancer|stage iv non-small cell lung cancer
862736|NCT00002972|adenocarcinoma of the lung|adenocarcinoma of the lung
862737|NCT00059046|Neuroreceptors|neuroreceptors
862738|NCT00059046|PET Measurements|pet measurements
862739|NCT00059046|Kinetic Analysis|kinetic analysis
862740|NCT00059046|Test/Retest|test/retest
862741|NCT00059046|Healthy Volunteer|healthy volunteer
862742|NCT00059046|HV|hv
862743|NCT00059033|6-[18F]Fluorodopamine|6-[18f]fluorodopamine
862744|NCT00059033|Autonomic Failure|autonomic failure
862745|NCT00059033|Parkinson's Disease|parkinson's disease
862746|NCT00059033|Multiple System Atrophy|multiple system atrophy
862747|NCT00059033|Pure Autonomic Failure|pure autonomic failure
862748|NCT00059033|Primary Chronic Autonomic Failure|primary chronic autonomic failure
862749|NCT00059033|CAF|caf
862750|NCT00059020|Glioma|glioma
862751|NCT00059020|Brain Tumor|brain tumor
862752|NCT00059020|Epidermal Growth Factor|epidermal growth factor
862753|NCT00059020|Polymorphisms|polymorphisms
862754|NCT00058994|AMD|amd
862755|NCT00058994|anecortave acetate|anecortave acetate
862756|NCT00058994|wet AMD|wet amd
862757|NCT00058994|age-related macular degeneration|age-related macular degeneration
862758|NCT00058994|Macular Degeneration|macular degeneration
862759|NCT00058994|Maculopathy, Age-Related|maculopathy, age-related
862760|NCT00058994|Age-Related Maculopathies|age-related maculopathies
862761|NCT00058994|Age-Related Maculopathy|age-related maculopathy
862762|NCT00058994|Maculopathies, Age-Related|maculopathies, age-related
862763|NCT00058968|neuropathy|neuropathy
862764|NCT00058968|pain|pain
862765|NCT00058968|diabetes|diabetes
862766|NCT00058968|chronic pain|chronic pain
862769|NCT00058968|peripheral neuropathy|peripheral neuropathy
862770|NCT00058968|foot pain|foot pain
862771|NCT00058968|painful neuropathy|painful neuropathy
862772|NCT00058968|diabetic neuropathy|diabetic neuropathy
862773|NCT00058955|ghb|ghb
862774|NCT00058955|Xyrem|xyrem
862775|NCT00058955|triazolam|triazolam
862776|NCT00058955|pentobarbital|pentobarbital
862777|NCT00058955|sedative|sedative
862778|NCT00058955|abuse|abuse
862779|NCT00058942|Drinking Water|drinking water
862780|NCT00058903|Cholestatic|cholestatic
862781|NCT00058903|Pruritus|pruritus
862782|NCT00058903|Sertraline|sertraline
862783|NCT00058903|primary biliary cirrhosis|primary biliary cirrhosis
862784|NCT00058903|hepatitis C|hepatitis c
862785|NCT00058890|itching|itching
862786|NCT00058890|pruritus|pruritus
862787|NCT00058890|cholestasis|cholestasis
862788|NCT00058890|liver disease|liver disease
862789|NCT00058890|hepatitis|hepatitis
862790|NCT00058890|cirrhosis|cirrhosis
862791|NCT00002945|untreated adult acute myeloid leukemia|untreated adult acute myeloid leukemia
862792|NCT00002945|adult acute monoblastic leukemia and acute monocytic leukemia (M5)|adult acute monoblastic leukemia and acute monocytic leukemia (m5)
862793|NCT00002945|adult acute erythroid leukemia (M6)|adult acute erythroid leukemia (m6)
862794|NCT00002945|adult acute myeloblastic leukemia without maturation (M1)|adult acute myeloblastic leukemia without maturation (m1)
862795|NCT00002945|adult acute myeloblastic leukemia with maturation (M2)|adult acute myeloblastic leukemia with maturation (m2)
863457|NCT00056576|AED|aed
862796|NCT00002945|adult acute myelomonocytic leukemia (M4)|adult acute myelomonocytic leukemia (m4)
862797|NCT00002945|adult acute megakaryoblastic leukemia (M7)|adult acute megakaryoblastic leukemia (m7)
862798|NCT00002945|secondary acute myeloid leukemia|secondary acute myeloid leukemia
862799|NCT00002945|adult acute minimally differentiated myeloid leukemia (M0)|adult acute minimally differentiated myeloid leukemia (m0)
862800|NCT00002934|breast cancer in situ|breast cancer in situ
862801|NCT00002934|ductal breast carcinoma|ductal breast carcinoma
862802|NCT00002835|stage I grade 3 follicular lymphoma|stage i grade 3 follicular lymphoma
862803|NCT00002835|stage I adult diffuse small cleaved cell lymphoma|stage i adult diffuse small cleaved cell lymphoma
862804|NCT00002835|stage I adult diffuse mixed cell lymphoma|stage i adult diffuse mixed cell lymphoma
862805|NCT00002835|stage I adult diffuse large cell lymphoma|stage i adult diffuse large cell lymphoma
862806|NCT00002835|stage I adult immunoblastic large cell lymphoma|stage i adult immunoblastic large cell lymphoma
862807|NCT00002835|stage III grade 3 follicular lymphoma|stage iii grade 3 follicular lymphoma
862808|NCT00002835|stage III adult diffuse small cleaved cell lymphoma|stage iii adult diffuse small cleaved cell lymphoma
862809|NCT00002835|stage III adult diffuse mixed cell lymphoma|stage iii adult diffuse mixed cell lymphoma
862810|NCT00002835|stage III adult diffuse large cell lymphoma|stage iii adult diffuse large cell lymphoma
862811|NCT00002835|stage III adult immunoblastic large cell lymphoma|stage iii adult immunoblastic large cell lymphoma
862812|NCT00002835|stage IV grade 3 follicular lymphoma|stage iv grade 3 follicular lymphoma
862813|NCT00002835|stage IV adult diffuse small cleaved cell lymphoma|stage iv adult diffuse small cleaved cell lymphoma
862814|NCT00002835|stage IV adult diffuse mixed cell lymphoma|stage iv adult diffuse mixed cell lymphoma
862815|NCT00002835|stage IV adult diffuse large cell lymphoma|stage iv adult diffuse large cell lymphoma
862816|NCT00002835|stage IV adult immunoblastic large cell lymphoma|stage iv adult immunoblastic large cell lymphoma
862817|NCT00002835|contiguous stage II grade 3 follicular lymphoma|contiguous stage ii grade 3 follicular lymphoma
862818|NCT00002835|contiguous stage II adult diffuse small cleaved cell lymphoma|contiguous stage ii adult diffuse small cleaved cell lymphoma
862819|NCT00002835|contiguous stage II adult diffuse mixed cell lymphoma|contiguous stage ii adult diffuse mixed cell lymphoma
862820|NCT00002835|contiguous stage II adult immunoblastic large cell lymphoma|contiguous stage ii adult immunoblastic large cell lymphoma
862821|NCT00002835|contiguous stage II adult diffuse large cell lymphoma|contiguous stage ii adult diffuse large cell lymphoma
862822|NCT00002835|noncontiguous stage II grade 3 follicular lymphoma|noncontiguous stage ii grade 3 follicular lymphoma
862823|NCT00002835|noncontiguous stage II adult diffuse small cleaved cell lymphoma|noncontiguous stage ii adult diffuse small cleaved cell lymphoma
862824|NCT00002835|noncontiguous stage II adult diffuse mixed cell lymphoma|noncontiguous stage ii adult diffuse mixed cell lymphoma
862825|NCT00002835|noncontiguous stage II adult immunoblastic large cell lymphoma|noncontiguous stage ii adult immunoblastic large cell lymphoma
862826|NCT00002835|noncontiguous stage II adult diffuse large cell lymphoma|noncontiguous stage ii adult diffuse large cell lymphoma
862827|NCT00002822|limited stage small cell lung cancer|limited stage small cell lung cancer
862828|NCT00002822|extensive stage small cell lung cancer|extensive stage small cell lung cancer
862829|NCT00058851|Manual lymph drainage|manual lymph drainage
862830|NCT00058851|Combined physiotherapy|combined physiotherapy
862831|NCT00058825|Campath|campath
862832|NCT00058825|stem cell transplant|stem cell transplant
862833|NCT00058812|Cytotoxic T Lymphocytes|cytotoxic t lymphocytes
862834|NCT00058812|bone marrow transplant|bone marrow transplant
862835|NCT00058812|EBV+ lymphoproliferative disease|ebv+ lymphoproliferative disease
862836|NCT00058773|Hodgkin disease|hodgkin disease
862837|NCT00058773|non-Hodgkins Lymphoma|non-hodgkins lymphoma
862838|NCT00058773|bone marrow transplant|bone marrow transplant
862839|NCT00058760|Prevention of early sexual behavior|prevention of early sexual behavior
862840|NCT00058760|NIA intervention|nia intervention
862841|NCT00058747|Granulocytic Leukemia, Chronic|granulocytic leukemia, chronic
862842|NCT00058747|Leukemia, Granulocytic, Chronic|leukemia, granulocytic, chronic
862843|NCT00058747|Leukemia, Myelocytic, Chronic|leukemia, myelocytic, chronic
862844|NCT00058747|Leukemia, Myelogenous, Chronic|leukemia, myelogenous, chronic
862845|NCT00058747|Myelocytic Leukemia, Chronic|myelocytic leukemia, chronic
862846|NCT00058747|Myelogenous Leukemia, Chronic|myelogenous leukemia, chronic
862847|NCT00058747|Myeloid Leukemia, Chronic|myeloid leukemia, chronic
862848|NCT00058734|Dendritic Cell|dendritic cell
862849|NCT00058734|Immunotherapy|immunotherapy
862850|NCT00058734|Acute HIV|acute hiv
862851|NCT00058734|Human Immunodeficiency Virus|human immunodeficiency virus
862852|NCT00058734|AIDS|aids
862853|NCT00058734|HIV Therapeutic Vaccine|hiv therapeutic vaccine
862854|NCT00058734|Treatment Experienced|treatment experienced
862855|NCT00058734|Treatment Interruption|treatment interruption
862856|NCT00058721|Dementia|dementia
862857|NCT00058721|Feasibility|feasibility
862858|NCT00058721|Dopamine|dopamine
862859|NCT00058721|Lewy Body|lewy body
862860|NCT00058721|Parkinson Disease|parkinson disease
862861|NCT00058721|PD|pd
862862|NCT00058721|Healthy Volunteer|healthy volunteer
862863|NCT00058721|HV|hv
862864|NCT00058695|Macualar Degeneration|macualar degeneration
862865|NCT00058695|AMD|amd
862866|NCT00058695|Healthy Volunteer|healthy volunteer
862867|NCT00058695|HV|hv
862868|NCT00058682|Fungal Infection|fungal infection
862869|NCT00058682|Mycoses|mycoses
862872|NCT00002777|stage IV breast cancer|stage iv breast cancer
862873|NCT00002777|recurrent breast cancer|recurrent breast cancer
862874|NCT00002701|untreated adult acute myeloid leukemia|untreated adult acute myeloid leukemia
862875|NCT00002701|adult acute promyelocytic leukemia (M3)|adult acute promyelocytic leukemia (m3)
862876|NCT00002695|stage I squamous cell carcinoma of the lip and oral cavity|stage i squamous cell carcinoma of the lip and oral cavity
862877|NCT00002695|stage II squamous cell carcinoma of the lip and oral cavity|stage ii squamous cell carcinoma of the lip and oral cavity
862878|NCT00002695|stage III squamous cell carcinoma of the lip and oral cavity|stage iii squamous cell carcinoma of the lip and oral cavity
862879|NCT00002695|stage IV squamous cell carcinoma of the lip and oral cavity|stage iv squamous cell carcinoma of the lip and oral cavity
862880|NCT00002695|recurrent squamous cell carcinoma of the lip and oral cavity|recurrent squamous cell carcinoma of the lip and oral cavity
862881|NCT00002695|stage I squamous cell carcinoma of the oropharynx|stage i squamous cell carcinoma of the oropharynx
862882|NCT00002695|stage II squamous cell carcinoma of the oropharynx|stage ii squamous cell carcinoma of the oropharynx
862883|NCT00002695|stage III squamous cell carcinoma of the oropharynx|stage iii squamous cell carcinoma of the oropharynx
862884|NCT00002695|stage IV squamous cell carcinoma of the oropharynx|stage iv squamous cell carcinoma of the oropharynx
862885|NCT00002695|recurrent squamous cell carcinoma of the oropharynx|recurrent squamous cell carcinoma of the oropharynx
862886|NCT00002695|stage I squamous cell carcinoma of the hypopharynx|stage i squamous cell carcinoma of the hypopharynx
862887|NCT00002695|stage II squamous cell carcinoma of the hypopharynx|stage ii squamous cell carcinoma of the hypopharynx
862888|NCT00002695|stage III squamous cell carcinoma of the hypopharynx|stage iii squamous cell carcinoma of the hypopharynx
862889|NCT00002695|stage IV squamous cell carcinoma of the hypopharynx|stage iv squamous cell carcinoma of the hypopharynx
862890|NCT00002695|recurrent squamous cell carcinoma of the hypopharynx|recurrent squamous cell carcinoma of the hypopharynx
862891|NCT00002695|stage I squamous cell carcinoma of the larynx|stage i squamous cell carcinoma of the larynx
862892|NCT00002695|stage II squamous cell carcinoma of the larynx|stage ii squamous cell carcinoma of the larynx
862893|NCT00002695|stage III squamous cell carcinoma of the larynx|stage iii squamous cell carcinoma of the larynx
862894|NCT00002695|stage IV squamous cell carcinoma of the larynx|stage iv squamous cell carcinoma of the larynx
862895|NCT00002695|recurrent squamous cell carcinoma of the larynx|recurrent squamous cell carcinoma of the larynx
862896|NCT00002695|stage I squamous cell carcinoma of the paranasal sinus and nasal cavity|stage i squamous cell carcinoma of the paranasal sinus and nasal cavity
862897|NCT00002695|stage II squamous cell carcinoma of the paranasal sinus and nasal cavity|stage ii squamous cell carcinoma of the paranasal sinus and nasal cavity
862898|NCT00002695|stage III squamous cell carcinoma of the paranasal sinus and nasal cavity|stage iii squamous cell carcinoma of the paranasal sinus and nasal cavity
862899|NCT00002695|stage IV squamous cell carcinoma of the paranasal sinus and nasal cavity|stage iv squamous cell carcinoma of the paranasal sinus and nasal cavity
862900|NCT00002695|recurrent squamous cell carcinoma of the paranasal sinus and nasal cavity|recurrent squamous cell carcinoma of the paranasal sinus and nasal cavity
862901|NCT00002693|recurrent adult acute myeloid leukemia|recurrent adult acute myeloid leukemia
862902|NCT00002693|recurrent adult acute lymphoblastic leukemia|recurrent adult acute lymphoblastic leukemia
862903|NCT00002693|relapsing chronic myelogenous leukemia|relapsing chronic myelogenous leukemia
862904|NCT00002693|accelerated phase chronic myelogenous leukemia|accelerated phase chronic myelogenous leukemia
862905|NCT00002693|blastic phase chronic myelogenous leukemia|blastic phase chronic myelogenous leukemia
862906|NCT00002693|neutropenia|neutropenia
862907|NCT00002669|stage IV melanoma|stage iv melanoma
862908|NCT00002669|recurrent melanoma|recurrent melanoma
862909|NCT00058656|Immunotherapy|immunotherapy
862910|NCT00058656|T Cell Therapy|t cell therapy
862911|NCT00058656|Adoptive immunotherapy|adoptive immunotherapy
862912|NCT00058656|Xcellerate|xcellerate
862913|NCT00058656|Xcellerated|xcellerated
862914|NCT00002658|untreated adult acute myeloid leukemia|untreated adult acute myeloid leukemia
862915|NCT00002658|adult acute erythroid leukemia (M6)|adult acute erythroid leukemia (m6)
862916|NCT00002658|adult acute myeloblastic leukemia without maturation (M1)|adult acute myeloblastic leukemia without maturation (m1)
862917|NCT00002658|adult acute myeloblastic leukemia with maturation (M2)|adult acute myeloblastic leukemia with maturation (m2)
862918|NCT00002658|adult acute promyelocytic leukemia (M3)|adult acute promyelocytic leukemia (m3)
862919|NCT00002658|adult acute myelomonocytic leukemia (M4)|adult acute myelomonocytic leukemia (m4)
862920|NCT00002658|adult acute monoblastic leukemia (M5a)|adult acute monoblastic leukemia (m5a)
862921|NCT00002658|adult acute megakaryoblastic leukemia (M7)|adult acute megakaryoblastic leukemia (m7)
862922|NCT00002658|secondary acute myeloid leukemia|secondary acute myeloid leukemia
862923|NCT00002658|adult acute monocytic leukemia (M5b)|adult acute monocytic leukemia (m5b)
862924|NCT00002658|neutropenia|neutropenia
862925|NCT00002658|adult acute minimally differentiated myeloid leukemia (M0)|adult acute minimally differentiated myeloid leukemia (m0)
862926|NCT00002653|stage I multiple myeloma|stage i multiple myeloma
862927|NCT00002653|stage II multiple myeloma|stage ii multiple myeloma
862928|NCT00002653|stage III multiple myeloma|stage iii multiple myeloma
862929|NCT00002575|stage I colon cancer|stage i colon cancer
862930|NCT00002575|stage II colon cancer|stage ii colon cancer
862931|NCT00002575|stage III colon cancer|stage iii colon cancer
862932|NCT00002575|adenocarcinoma of the colon|adenocarcinoma of the colon
862933|NCT00002550|squamous cell lung cancer|squamous cell lung cancer
862934|NCT00002550|large cell lung cancer|large cell lung cancer
862935|NCT00002550|stage IIIA non-small cell lung cancer|stage iiia non-small cell lung cancer
862936|NCT00002550|adenocarcinoma of the lung|adenocarcinoma of the lung
862937|NCT00002550|bronchoalveolar cell lung cancer|bronchoalveolar cell lung cancer
862938|NCT00002539|localized osteosarcoma|localized osteosarcoma
862939|NCT00058617|EBV Positive Hodgkin's Lymphoma|ebv positive hodgkin's lymphoma
862940|NCT00058617|EBV Positive Non-Hodgkin's Lymphoma|ebv positive non-hodgkin's lymphoma
862941|NCT00058617|EBV Specific Cytotoxic T-Lymphocytes|ebv specific cytotoxic t-lymphocytes
862942|NCT00058552|Advanced, refractory, or recurrent ovarian cancer|advanced, refractory, or recurrent ovarian cancer
862943|NCT00058526|dHER2-AS15 ASCI|dher2-as15 asci
862944|NCT00058526|Immunotherapeutic|immunotherapeutic
862947|NCT00058487|adult primary hepatocellular carcinoma|adult primary hepatocellular carcinoma
862948|NCT00058487|advanced adult primary liver cancer|advanced adult primary liver cancer
862949|NCT00058487|localized unresectable adult primary liver cancer|localized unresectable adult primary liver cancer
862950|NCT00058487|recurrent adult primary liver cancer|recurrent adult primary liver cancer
862951|NCT00058474|stage II rectal cancer|stage ii rectal cancer
862952|NCT00058474|stage III rectal cancer|stage iii rectal cancer
862953|NCT00058474|adenocarcinoma of the rectum|adenocarcinoma of the rectum
862954|NCT00058448|stage II penile cancer|stage ii penile cancer
862955|NCT00058448|stage III penile cancer|stage iii penile cancer
862956|NCT00058448|stage IV penile cancer|stage iv penile cancer
862957|NCT00058435|stage II ovarian epithelial cancer|stage ii ovarian epithelial cancer
862958|NCT00058435|stage III ovarian epithelial cancer|stage iii ovarian epithelial cancer
862959|NCT00058435|stage IV ovarian epithelial cancer|stage iv ovarian epithelial cancer
862960|NCT00058435|recurrent ovarian epithelial cancer|recurrent ovarian epithelial cancer
862961|NCT00058435|fallopian tube cancer|fallopian tube cancer
862962|NCT00058435|primary peritoneal cavity cancer|primary peritoneal cavity cancer
862963|NCT00058422|noncontiguous stage II adult diffuse large cell lymphoma|noncontiguous stage ii adult diffuse large cell lymphoma
862964|NCT00058422|stage III adult diffuse large cell lymphoma|stage iii adult diffuse large cell lymphoma
862965|NCT00058422|stage IV adult diffuse large cell lymphoma|stage iv adult diffuse large cell lymphoma
862966|NCT00058396|refractory chronic lymphocytic leukemia|refractory chronic lymphocytic leukemia
862967|NCT00058396|stage I chronic lymphocytic leukemia|stage i chronic lymphocytic leukemia
862968|NCT00058396|stage II chronic lymphocytic leukemia|stage ii chronic lymphocytic leukemia
862969|NCT00058396|stage III chronic lymphocytic leukemia|stage iii chronic lymphocytic leukemia
862970|NCT00058396|stage IV chronic lymphocytic leukemia|stage iv chronic lymphocytic leukemia
862971|NCT00058396|noncontiguous stage II small lymphocytic lymphoma|noncontiguous stage ii small lymphocytic lymphoma
862972|NCT00058396|recurrent small lymphocytic lymphoma|recurrent small lymphocytic lymphoma
862973|NCT00058396|stage I small lymphocytic lymphoma|stage i small lymphocytic lymphoma
862974|NCT00058396|stage III small lymphocytic lymphoma|stage iii small lymphocytic lymphoma
862975|NCT00058396|stage IV small lymphocytic lymphoma|stage iv small lymphocytic lymphoma
862976|NCT00058396|contiguous stage II small lymphocytic lymphoma|contiguous stage ii small lymphocytic lymphoma
862977|NCT00058370|adult medulloblastoma|adult medulloblastoma
862978|NCT00058370|untreated childhood medulloblastoma|untreated childhood medulloblastoma
862979|NCT00058357|unspecified adult solid tumor, protocol specific|unspecified adult solid tumor, protocol specific
862980|NCT00058357|pain|pain
862981|NCT00058318|stage IV renal cell cancer|stage iv renal cell cancer
862982|NCT00058318|stage III renal cell cancer|stage iii renal cell cancer
862983|NCT00058292|recurrent grade 1 follicular lymphoma|recurrent grade 1 follicular lymphoma
862984|NCT00058292|recurrent grade 2 follicular lymphoma|recurrent grade 2 follicular lymphoma
862985|NCT00058292|recurrent grade 3 follicular lymphoma|recurrent grade 3 follicular lymphoma
863318|NCT00056927|Primary Prevention|primary prevention
862986|NCT00058292|recurrent adult diffuse large cell lymphoma|recurrent adult diffuse large cell lymphoma
862987|NCT00058292|recurrent adult diffuse mixed cell lymphoma|recurrent adult diffuse mixed cell lymphoma
862988|NCT00058292|recurrent adult Burkitt lymphoma|recurrent adult burkitt lymphoma
862989|NCT00058292|recurrent adult immunoblastic large cell lymphoma|recurrent adult immunoblastic large cell lymphoma
862990|NCT00058292|recurrent mantle cell lymphoma|recurrent mantle cell lymphoma
862991|NCT00058292|recurrent adult lymphoblastic lymphoma|recurrent adult lymphoblastic lymphoma
862992|NCT00058292|recurrent adult diffuse small cleaved cell lymphoma|recurrent adult diffuse small cleaved cell lymphoma
862993|NCT00058292|recurrent marginal zone lymphoma|recurrent marginal zone lymphoma
862994|NCT00058292|recurrent small lymphocytic lymphoma|recurrent small lymphocytic lymphoma
862995|NCT00058292|extranodal marginal zone B-cell lymphoma of mucosa-associated lymphoid tissue|extranodal marginal zone b-cell lymphoma of mucosa-associated lymphoid tissue
862996|NCT00058292|nodal marginal zone B-cell lymphoma|nodal marginal zone b-cell lymphoma
862997|NCT00058292|splenic marginal zone lymphoma|splenic marginal zone lymphoma
862998|NCT00058279|stage IV melanoma|stage iv melanoma
862999|NCT00058279|extraocular extension melanoma|extraocular extension melanoma
863000|NCT00058279|recurrent melanoma|recurrent melanoma
863001|NCT00058279|iris melanoma|iris melanoma
863002|NCT00058279|ciliary body and choroid melanoma, medium/large size|ciliary body and choroid melanoma, medium/large size
863003|NCT00058279|ciliary body and choroid melanoma, small size|ciliary body and choroid melanoma, small size
863004|NCT00058279|recurrent intraocular melanoma|recurrent intraocular melanoma
863005|NCT00058266|stage I prostate cancer|stage i prostate cancer
863006|NCT00058266|stage II prostate cancer|stage ii prostate cancer
863007|NCT00058201|acinar cell adenocarcinoma of the pancreas|acinar cell adenocarcinoma of the pancreas
863008|NCT00058201|duct cell adenocarcinoma of the pancreas|duct cell adenocarcinoma of the pancreas
863009|NCT00058201|stage I pancreatic cancer|stage i pancreatic cancer
863010|NCT00058201|stage II pancreatic cancer|stage ii pancreatic cancer
863011|NCT00058201|stage III pancreatic cancer|stage iii pancreatic cancer
863012|NCT00058201|stage IV pancreatic cancer|stage iv pancreatic cancer
863013|NCT00058188|osteoporosis|osteoporosis
863014|NCT00058188|stage III prostate cancer|stage iii prostate cancer
863015|NCT00058188|stage IV prostate cancer|stage iv prostate cancer
863016|NCT00058149|stage II pancreatic cancer|stage ii pancreatic cancer
863017|NCT00058149|stage III pancreatic cancer|stage iii pancreatic cancer
863018|NCT00058149|adenocarcinoma of the pancreas|adenocarcinoma of the pancreas
863019|NCT00058149|stage IV pancreatic cancer|stage iv pancreatic cancer
863020|NCT00058123|adult anaplastic astrocytoma|adult anaplastic astrocytoma
863021|NCT00058123|adult mixed glioma|adult mixed glioma
863022|NCT00058123|adult anaplastic oligodendroglioma|adult anaplastic oligodendroglioma
863023|NCT00058123|recurrent adult brain tumor|recurrent adult brain tumor
863024|NCT00058123|adult anaplastic ependymoma|adult anaplastic ependymoma
863025|NCT00058071|peripheral neuropathy|peripheral neuropathy
863026|NCT00058071|neurotoxicity|neurotoxicity
863027|NCT00058071|hydatidiform mole|hydatidiform mole
863028|NCT00058071|unspecified adult solid tumor, protocol specific|unspecified adult solid tumor, protocol specific
863029|NCT00058058|ductal breast carcinoma in situ|ductal breast carcinoma in situ
863030|NCT00058058|invasive ductal breast carcinoma|invasive ductal breast carcinoma
863031|NCT00058058|invasive lobular breast carcinoma|invasive lobular breast carcinoma
863032|NCT00058058|breast cancer in situ|breast cancer in situ
863033|NCT00058058|stage I breast cancer|stage i breast cancer
863034|NCT00058058|stage II breast cancer|stage ii breast cancer
863035|NCT00058058|stage IIIA breast cancer|stage iiia breast cancer
863036|NCT00058058|stage IIIB breast cancer|stage iiib breast cancer
863037|NCT00058058|stage IIIC breast cancer|stage iiic breast cancer
863038|NCT00058058|stage IV breast cancer|stage iv breast cancer
863039|NCT00058058|Magnetic resonance imaging|magnetic resonance imaging
863040|NCT00058058|MRI|mri
863041|NCT00058045|AIDS-related peripheral/systemic lymphoma|aids-related peripheral/systemic lymphoma
863042|NCT00058032|ovarian epithelial cancer|ovarian epithelial cancer
863043|NCT00058006|stage I non-small cell lung cancer|stage i non-small cell lung cancer
863044|NCT00058006|stage I squamous cell carcinoma of the hypopharynx|stage i squamous cell carcinoma of the hypopharynx
863045|NCT00058006|stage I squamous cell carcinoma of the larynx|stage i squamous cell carcinoma of the larynx
863046|NCT00058006|stage I squamous cell carcinoma of the lip and oral cavity|stage i squamous cell carcinoma of the lip and oral cavity
863140|NCT00057733|depression|depression
863047|NCT00058006|stage I squamous cell carcinoma of the nasopharynx|stage i squamous cell carcinoma of the nasopharynx
863048|NCT00058006|stage I squamous cell carcinoma of the oropharynx|stage i squamous cell carcinoma of the oropharynx
863049|NCT00058006|stage I squamous cell carcinoma of the paranasal sinus and nasal cavity|stage i squamous cell carcinoma of the paranasal sinus and nasal cavity
863050|NCT00058006|stage II squamous cell carcinoma of the hypopharynx|stage ii squamous cell carcinoma of the hypopharynx
863051|NCT00058006|stage II squamous cell carcinoma of the larynx|stage ii squamous cell carcinoma of the larynx
863052|NCT00058006|stage II squamous cell carcinoma of the lip and oral cavity|stage ii squamous cell carcinoma of the lip and oral cavity
863053|NCT00058006|stage II squamous cell carcinoma of the nasopharynx|stage ii squamous cell carcinoma of the nasopharynx
863054|NCT00058006|stage II squamous cell carcinoma of the oropharynx|stage ii squamous cell carcinoma of the oropharynx
863319|NCT00056927|Health Education|health education
863055|NCT00058006|stage II squamous cell carcinoma of the paranasal sinus and nasal cavity|stage ii squamous cell carcinoma of the paranasal sinus and nasal cavity
863056|NCT00058006|salivary gland squamous cell carcinoma|salivary gland squamous cell carcinoma
863057|NCT00058006|stage I salivary gland cancer|stage i salivary gland cancer
863058|NCT00058006|stage II salivary gland cancer|stage ii salivary gland cancer
863059|NCT00057993|stage IV breast cancer|stage iv breast cancer
863060|NCT00057993|stage IIIA breast cancer|stage iiia breast cancer
863061|NCT00057993|stage IIIB breast cancer|stage iiib breast cancer
863062|NCT00057993|stage IIIC breast cancer|stage iiic breast cancer
863063|NCT00057980|advanced adult primary liver cancer|advanced adult primary liver cancer
863064|NCT00057980|localized unresectable adult primary liver cancer|localized unresectable adult primary liver cancer
863065|NCT00057980|adult primary hepatocellular carcinoma|adult primary hepatocellular carcinoma
863066|NCT00057967|recurrent mycosis fungoides/Sezary syndrome|recurrent mycosis fungoides/sezary syndrome
863067|NCT00057967|stage I mycosis fungoides/Sezary syndrome|stage i mycosis fungoides/sezary syndrome
863068|NCT00057967|stage II mycosis fungoides/Sezary syndrome|stage ii mycosis fungoides/sezary syndrome
863069|NCT00057967|stage III mycosis fungoides/Sezary syndrome|stage iii mycosis fungoides/sezary syndrome
863070|NCT00057967|stage IV mycosis fungoides/Sezary syndrome|stage iv mycosis fungoides/sezary syndrome
863071|NCT00057967|recurrent cutaneous T-cell non-Hodgkin lymphoma|recurrent cutaneous t-cell non-hodgkin lymphoma
863072|NCT00057967|stage I cutaneous T-cell non-Hodgkin lymphoma|stage i cutaneous t-cell non-hodgkin lymphoma
863073|NCT00057967|stage II cutaneous T-cell non-Hodgkin lymphoma|stage ii cutaneous t-cell non-hodgkin lymphoma
863564|NCT00056303|Prevention|prevention
863074|NCT00057967|stage III cutaneous T-cell non-Hodgkin lymphoma|stage iii cutaneous t-cell non-hodgkin lymphoma
863075|NCT00057967|stage IV cutaneous T-cell non-Hodgkin lymphoma|stage iv cutaneous t-cell non-hodgkin lymphoma
863076|NCT00057954|recurrent adult Hodgkin lymphoma|recurrent adult hodgkin lymphoma
863077|NCT00057954|recurrent adult diffuse large cell lymphoma|recurrent adult diffuse large cell lymphoma
863078|NCT00057954|recurrent adult diffuse mixed cell lymphoma|recurrent adult diffuse mixed cell lymphoma
863079|NCT00057954|recurrent adult diffuse small cleaved cell lymphoma|recurrent adult diffuse small cleaved cell lymphoma
863080|NCT00057954|recurrent adult Burkitt lymphoma|recurrent adult burkitt lymphoma
863081|NCT00057954|recurrent adult immunoblastic large cell lymphoma|recurrent adult immunoblastic large cell lymphoma
863082|NCT00057954|recurrent adult lymphoblastic lymphoma|recurrent adult lymphoblastic lymphoma
863083|NCT00057954|recurrent grade 1 follicular lymphoma|recurrent grade 1 follicular lymphoma
863084|NCT00057954|recurrent grade 2 follicular lymphoma|recurrent grade 2 follicular lymphoma
863085|NCT00057954|recurrent grade 3 follicular lymphoma|recurrent grade 3 follicular lymphoma
863086|NCT00057954|recurrent mantle cell lymphoma|recurrent mantle cell lymphoma
863087|NCT00057954|recurrent mycosis fungoides/Sezary syndrome|recurrent mycosis fungoides/sezary syndrome
863088|NCT00057954|recurrent adult T-cell leukemia/lymphoma|recurrent adult t-cell leukemia/lymphoma
863089|NCT00057954|anaplastic large cell lymphoma|anaplastic large cell lymphoma
863090|NCT00057954|recurrent marginal zone lymphoma|recurrent marginal zone lymphoma
863091|NCT00057954|recurrent small lymphocytic lymphoma|recurrent small lymphocytic lymphoma
863092|NCT00057954|extranodal marginal zone B-cell lymphoma of mucosa-associated lymphoid tissue|extranodal marginal zone b-cell lymphoma of mucosa-associated lymphoid tissue
863093|NCT00057954|nodal marginal zone B-cell lymphoma|nodal marginal zone b-cell lymphoma
863094|NCT00057954|splenic marginal zone lymphoma|splenic marginal zone lymphoma
863095|NCT00057928|recurrent cervical cancer|recurrent cervical cancer
863096|NCT00057928|stage IVB cervical cancer|stage ivb cervical cancer
863097|NCT00057915|unspecified adult solid tumor, protocol specific|unspecified adult solid tumor, protocol specific
863098|NCT00057889|clear cell renal cell carcinoma|clear cell renal cell carcinoma
863099|NCT00057889|stage IV renal cell cancer|stage iv renal cell cancer
863100|NCT00057889|recurrent renal cell cancer|recurrent renal cell cancer
863101|NCT00057876|stage III pancreatic cancer|stage iii pancreatic cancer
863102|NCT00057876|adenocarcinoma of the pancreas|adenocarcinoma of the pancreas
863103|NCT00057850|recurrent squamous cell carcinoma of the hypopharynx|recurrent squamous cell carcinoma of the hypopharynx
863104|NCT00057850|recurrent squamous cell carcinoma of the larynx|recurrent squamous cell carcinoma of the larynx
863105|NCT00057850|recurrent squamous cell carcinoma of the lip and oral cavity|recurrent squamous cell carcinoma of the lip and oral cavity
863106|NCT00057850|recurrent squamous cell carcinoma of the oropharynx|recurrent squamous cell carcinoma of the oropharynx
863107|NCT00057850|recurrent squamous cell carcinoma of the paranasal sinus and nasal cavity|recurrent squamous cell carcinoma of the paranasal sinus and nasal cavity
863108|NCT00057850|stage IV squamous cell carcinoma of the hypopharynx|stage iv squamous cell carcinoma of the hypopharynx
863109|NCT00057850|stage IV squamous cell carcinoma of the larynx|stage iv squamous cell carcinoma of the larynx
863110|NCT00057850|stage IV squamous cell carcinoma of the lip and oral cavity|stage iv squamous cell carcinoma of the lip and oral cavity
863111|NCT00057850|stage IV squamous cell carcinoma of the oropharynx|stage iv squamous cell carcinoma of the oropharynx
863112|NCT00057850|stage IV squamous cell carcinoma of the paranasal sinus and nasal cavity|stage iv squamous cell carcinoma of the paranasal sinus and nasal cavity
863113|NCT00057850|recurrent salivary gland cancer|recurrent salivary gland cancer
863114|NCT00057850|salivary gland squamous cell carcinoma|salivary gland squamous cell carcinoma
863115|NCT00057850|stage IV salivary gland cancer|stage iv salivary gland cancer
863116|NCT00057837|extensive stage small cell lung cancer|extensive stage small cell lung cancer
863117|NCT00057837|Topotecan|topotecan
863121|NCT00057798|stage I non-small cell lung cancer|stage i non-small cell lung cancer
863122|NCT00057798|stage II non-small cell lung cancer|stage ii non-small cell lung cancer
863123|NCT00057798|stage IIIA non-small cell lung cancer|stage iiia non-small cell lung cancer
863124|NCT00057798|stage IIIB non-small cell lung cancer|stage iiib non-small cell lung cancer
863125|NCT00057785|oral complications of radiation therapy|oral complications of radiation therapy
863126|NCT00057785|radiation toxicity|radiation toxicity
863127|NCT00057785|stage I squamous cell carcinoma of the nasopharynx|stage i squamous cell carcinoma of the nasopharynx
863128|NCT00057785|stage II squamous cell carcinoma of the nasopharynx|stage ii squamous cell carcinoma of the nasopharynx
863129|NCT00057785|stage III squamous cell carcinoma of the nasopharynx|stage iii squamous cell carcinoma of the nasopharynx
863130|NCT00057785|stage IV squamous cell carcinoma of the nasopharynx|stage iv squamous cell carcinoma of the nasopharynx
863131|NCT00057759|sexual dysfunction|sexual dysfunction
863132|NCT00057759|sexuality and reproductive issues|sexuality and reproductive issues
863133|NCT00057759|radiation toxicity|radiation toxicity
863134|NCT00057759|stage IIB prostate cancer|stage iib prostate cancer
863135|NCT00057759|stage IIA prostate cancer|stage iia prostate cancer
863136|NCT00057759|stage III prostate cancer|stage iii prostate cancer
863137|NCT00057759|psychosocial effects of cancer and its treatment|psychosocial effects of cancer and its treatment
863138|NCT00057746|limited stage small cell lung cancer|limited stage small cell lung cancer
863139|NCT00057733|anxiety disorder|anxiety disorder
863141|NCT00057733|unspecified adult solid tumor, protocol specific|unspecified adult solid tumor, protocol specific
884264|NCT00004855|Nevirapine|nevirapine
863142|NCT00023673|squamous cell lung cancer|squamous cell lung cancer
863143|NCT00023673|large cell lung cancer|large cell lung cancer
863144|NCT00023673|stage IIIA non-small cell lung cancer|stage iiia non-small cell lung cancer
863145|NCT00023673|stage IIIB non-small cell lung cancer|stage iiib non-small cell lung cancer
863146|NCT00023673|adenocarcinoma of the lung|adenocarcinoma of the lung
863147|NCT00023673|adenosquamous cell lung cancer|adenosquamous cell lung cancer
863148|NCT00057720|ovary|ovary
863149|NCT00057707|Catecholamines|catecholamines
863150|NCT00057707|Dopamine|dopamine
863151|NCT00057707|fMRI|fmri
863152|NCT00057707|Working Memory|working memory
863153|NCT00057707|Clinical Trial|clinical trial
863154|NCT00057707|Stabilization|stabilization
863155|NCT00057707|Inpatients|inpatients
863156|NCT00057707|Placebo|placebo
863157|NCT00057707|Modafinil|modafinil
863158|NCT00057707|Normal Volunteers|normal volunteers
863159|NCT00057707|Schizophrenia|schizophrenia
863160|NCT00057707|Schizoaffective Disorder|schizoaffective disorder
863161|NCT00057707|Healthy Volunteer|healthy volunteer
863163|NCT00057694|Qualitative|qualitative
863164|NCT00057694|Telephone Interviews|telephone interviews
863165|NCT00057694|Genetic Counseling|genetic counseling
863166|NCT00057694|Family History|family history
863167|NCT00057694|Health Information|health information
863168|NCT00057694|Adult Adoptees|adult adoptees
863169|NCT00057694|Adult Adoptee|adult adoptee
863170|NCT00057694|Interview|interview
863171|NCT00057681|Mania|mania
863172|NCT00057655|Social Welfare|social welfare
863173|NCT00057655|Mentally Ill Persons|mentally ill persons
863174|NCT00057655|Mental Health Services|mental health services
863175|NCT00057642|Hispanic Americans|hispanic americans
863176|NCT00057629|Rape|rape
863177|NCT00057629|Sex Offenses|sex offenses
863178|NCT00057616|Metastatic Melanoma|metastatic melanoma
863179|NCT00057616|Melanoma|melanoma
863180|NCT00057616|Revimid|revimid
863181|NCT00057616|CC5013|cc5013
863182|NCT00057564|Newly Diagnosed Multiple Myeloma|newly diagnosed multiple myeloma
863183|NCT00057564|Multiple Myeloma|multiple myeloma
863184|NCT00057538|HIV|hiv
863185|NCT00057538|Randomized Trial|randomized trial
863186|NCT00057538|Stress|stress
863187|NCT00057538|Spirituality|spirituality
863188|NCT00057538|Quality of Life|quality of life
863189|NCT00057538|Complementary Therapies|complementary therapies
863190|NCT00057525|Anthrax|anthrax
863191|NCT00057499|Juvenile diabetes|juvenile diabetes
863192|NCT00057499|Diabetes|diabetes
863193|NCT00057499|Insulin|insulin
863194|NCT00057499|Vaccine|vaccine
863195|NCT00057499|Type 1 Diabetes|type 1 diabetes
863196|NCT00057499|Diabetes Mellitus|diabetes mellitus
863197|NCT00057486|Chronic Diarrhea|chronic diarrhea
863198|NCT00057486|Interleukin 12|interleukin 12
863199|NCT00057473|unspecified childhood solid tumor, protocol specific|unspecified childhood solid tumor, protocol specific
863200|NCT00057447|lymphoma|lymphoma
863201|NCT00057434|Vitamin A|vitamin a
863202|NCT00057421|Tuberculosis|tuberculosis
863203|NCT00057421|HIV infection|hiv infection
863204|NCT00057421|Prednisolone|prednisolone
863205|NCT00057421|Safety|safety
863206|NCT00057421|Immune activation|immune activation
863207|NCT00057460|Antiepileptic Drug|antiepileptic drug
863208|NCT00057460|Neuroprotection|neuroprotection
863209|NCT00057460|Seizure Disorder|seizure disorder
863210|NCT00057460|TMS Stimulation|tms stimulation
863211|NCT00057460|EEG|eeg
863212|NCT00057460|AMPA Antagonist|ampa antagonist
863213|NCT00057460|Dosing|dosing
863214|NCT00057460|Transcranial Magnetic Stimulation|transcranial magnetic stimulation
863215|NCT00057460|Healthy Volunteer|healthy volunteer
863218|NCT00057408|Pervasive Developmental Disorder|pervasive developmental disorder
863219|NCT00057408|Treatment|treatment
863220|NCT00057408|Olanzapine|olanzapine
863221|NCT00057408|Antipsychotic|antipsychotic
863222|NCT00057395|Esophageal Neoplasms|esophageal neoplasms
863223|NCT00057395|Esophagus Neoplasm|esophagus neoplasm
863224|NCT00057395|Esophagus Cancer|esophagus cancer
863225|NCT00057395|Esophageal Cancer|esophageal cancer
863226|NCT00057395|Esophageal Tumors|esophageal tumors
863227|NCT00057395|Esophagus Tumors|esophagus tumors
863228|NCT00057395|Neoplasms, Esophageal|neoplasms, esophageal
863229|NCT00057395|Hepatocellular Carcinoma|hepatocellular carcinoma
863230|NCT00057395|Carcinoma, Hepatocellular|carcinoma, hepatocellular
863231|NCT00057395|Hepatoma|hepatoma
863232|NCT00057395|Colorectal Neoplasms|colorectal neoplasms
863233|NCT00057395|Colorectal Cancer|colorectal cancer
863234|NCT00057395|Colorectal Carcinoma|colorectal carcinoma
863235|NCT00057395|Colorectal Tumor|colorectal tumor
863236|NCT00057395|Neoplasms, Colorectal|neoplasms, colorectal
863237|NCT00057395|Ovarian Neoplasms|ovarian neoplasms
863238|NCT00057395|Ovary Neoplasms|ovary neoplasms
863239|NCT00057395|Ovary Cancer|ovary cancer
863240|NCT00057395|Ovary Carcinoma|ovary carcinoma
863241|NCT00057395|Ovarian Cancer|ovarian cancer
863242|NCT00057395|Ovarian Carcinoma|ovarian carcinoma
863243|NCT00057395|Neoplasms, Ovarian|neoplasms, ovarian
863244|NCT00057395|Pancreatic Neoplasms|pancreatic neoplasms
863245|NCT00057395|Pancreatic Cancer|pancreatic cancer
863246|NCT00057395|Pancreas Neoplasms|pancreas neoplasms
863247|NCT00057395|Pancreas Cancer|pancreas cancer
863248|NCT00057395|Neoplasms, Pancreatic|neoplasms, pancreatic
863249|NCT00057395|Neoplasms, Pancreas|neoplasms, pancreas
863250|NCT00057395|and other solid tumors|and other solid tumors
863251|NCT00057382|liver cancer|liver cancer
863252|NCT00057356|Chronic Heart Failure|chronic heart failure
863253|NCT00057356|YM078|ym078
863254|NCT00057291|Orphanage|orphanage
863255|NCT00057291|Caregiving|caregiving
863256|NCT00057291|Training|training
863257|NCT00057291|Child development|child development
863258|NCT00057031|myelodysplastic syndrome|myelodysplastic syndrome
863259|NCT00057031|MDS|mds
863260|NCT00057278|Gabapentin|gabapentin
863261|NCT00057200|Home Care|home care
863262|NCT00057252|Diagnostic Radiology|diagnostic radiology
863263|NCT00057252|Imaging|imaging
863264|NCT00057252|Algorithms|algorithms
863265|NCT00057252|Healthy Volunteer|healthy volunteer
863266|NCT00057252|HV|hv
863267|NCT00057239|GW353162|gw353162
863268|NCT00057239|Major Depressive Disorder|major depressive disorder
863269|NCT00057239|MDD|mdd
863270|NCT00057226|GW353162,|gw353162,
863271|NCT00057226|Major depressive disorder,|major depressive disorder,
863272|NCT00057226|flexible|flexible
863273|NCT00057213|Major Depressive Disorder (MDD),|major depressive disorder (mdd),
863274|NCT00057213|Flexible|flexible
863275|NCT00057213|GW353162,|gw353162,
863276|NCT00057174|Proton pump inhibitor|proton pump inhibitor
863277|NCT00057148|massage therapy|massage therapy
863278|NCT00057148|pain management|pain management
863279|NCT00057148|post-surgical|post-surgical
863280|NCT00057148|complementary therapy|complementary therapy
863281|NCT00057135|Schizophrenia|schizophrenia
863282|NCT00057135|Treatment Refusal|treatment refusal
863283|NCT00057135|Drug Packaging|drug packaging
863284|NCT00057135|Reminder Systems|reminder systems
863285|NCT00057135|Antipsychotic Agents|antipsychotic agents
863286|NCT00057122|Preventive therapy|preventive therapy
863287|NCT00057083|Telemedicine|telemedicine
863288|NCT00057083|Remote consultation|remote consultation
863289|NCT00057083|Patient Satisfaction|patient satisfaction
863290|NCT00057083|Physician patient relations|physician patient relations
863291|NCT00057083|Provider satisfaction|provider satisfaction
863292|NCT00057083|Doctor-patient relations|doctor-patient relations
863293|NCT00057018|stroke|stroke
863294|NCT00057018|cerebrovascular accident|cerebrovascular accident
863295|NCT00057018|upper extremity|upper extremity
863296|NCT00057018|physical therapy|physical therapy
863297|NCT00057018|constraint-induced therapy|constraint-induced therapy
863298|NCT00057005|LEUKEMIA|leukemia
863299|NCT00056979|Metabolic diseases|metabolic diseases
863300|NCT00056966|Acute myeloid leukemia|acute myeloid leukemia
863301|NCT00056966|Acute lymphoblastic leukemia|acute lymphoblastic leukemia
863302|NCT00056966|Chronic myeloid leukemia|chronic myeloid leukemia
863303|NCT00056966|Non-Hodgkin's lymphoma|non-hodgkin's lymphoma
863304|NCT00056966|Hodgkin's disease|hodgkin's disease
863305|NCT00056966|Myelodysplastic syndrome|myelodysplastic syndrome
863306|NCT00056966|Myeloproliferative disorders|myeloproliferative disorders
863307|NCT00056966|Multiple myeloma|multiple myeloma
863308|NCT00056966|Severe aplastic anemia|severe aplastic anemia
863309|NCT00056953|health behavior|health behavior
863310|NCT00056953|adolescent behavior|adolescent behavior
863311|NCT00056953|peer mentoring|peer mentoring
863312|NCT00056940|Prevention|prevention
863313|NCT00056940|Parenting strategies|parenting strategies
863314|NCT00056940|Media use|media use
863315|NCT00056940|Discipline|discipline
863316|NCT00056940|Firearm storage|firearm storage
863322|NCT00056927|Parenting Education|parenting education
863323|NCT00056927|Communication|communication
863324|NCT00056875|graft versus host disease|graft versus host disease
863325|NCT00056875|bone marrow transplant|bone marrow transplant
863326|NCT00056875|alternative donor|alternative donor
863327|NCT00056914|Magnetic Resonance Imaging|magnetic resonance imaging
863328|NCT00056914|Functional Imaging|functional imaging
863329|NCT00056914|Cerebral Blood Flow|cerebral blood flow
863330|NCT00056914|Parallel Imaging|parallel imaging
863331|NCT00056914|BOLD Effect|bold effect
863332|NCT00056914|Spectroscopic Imaging|spectroscopic imaging
863333|NCT00056914|Healthy Volunteer|healthy volunteer
863334|NCT00056914|HV|hv
863335|NCT00056901|Puerperium|puerperium
863336|NCT00056901|Pregnancy|pregnancy
863337|NCT00056901|Mood Disorders|mood disorders
863338|NCT00056901|Estradiol|estradiol
863339|NCT00056901|Progesterone|progesterone
863340|NCT00056901|Mood|mood
863341|NCT00056901|Behavior|behavior
863342|NCT00056901|Cognition|cognition
863343|NCT00056901|Perimenopause|perimenopause
863344|NCT00056901|Menopause|menopause
863345|NCT00056901|Post Partum Depression|post partum depression
863346|NCT00056901|PPD|ppd
863347|NCT00056901|Healthy Volunteer|healthy volunteer
863348|NCT00056901|HV|hv
863349|NCT00056888|Electroencephalogram|electroencephalogram
863350|NCT00056888|Functional (BOLD) MRI|functional (bold) mri
863351|NCT00056888|Startle Reflex|startle reflex
863352|NCT00056888|Electromyogram|electromyogram
863353|NCT00056888|Psychogenic|psychogenic
863354|NCT00056888|Paroxysmal|paroxysmal
863355|NCT00056888|Dyskinesia|dyskinesia
863356|NCT00056888|Kinesiogenic|kinesiogenic
863357|NCT00056888|EEG|eeg
863358|NCT00056888|Movement-Related Potential|movement-related potential
863359|NCT00056888|Movement Disorder|movement disorder
863360|NCT00056888|Paroxysmal Hyperkinetic Movement|paroxysmal hyperkinetic movement
863361|NCT00056888|Disorder|disorder
863362|NCT00056888|Paroxysmal Dyskinesia|paroxysmal dyskinesia
863363|NCT00056836|AMD|amd
863364|NCT00056836|Neovascular age-related macular degeneration|neovascular age-related macular degeneration
863365|NCT00056823|AMD|amd
863366|NCT00056862|Hepatitis C Virus|hepatitis c virus
863367|NCT00056862|Antiviral Agents|antiviral agents
863368|NCT00056862|Hemolysis|hemolysis
863369|NCT00056862|Neutropenia|neutropenia
863370|NCT00056862|Cirrhosis|cirrhosis
863371|NCT00056862|Hemolytic Anemia|hemolytic anemia
863372|NCT00056862|Viral Hepatitis|viral hepatitis
863373|NCT00056862|Ribavirin|ribavirin
863374|NCT00056862|Alfa Interferon|alfa interferon
863375|NCT00056862|Pegylated Interferon|pegylated interferon
863376|NCT00056862|Hepatitis C|hepatitis c
863377|NCT00056862|HCV|hcv
863378|NCT00056849|Arthritis|arthritis
863379|NCT00056849|Spondyloarthropathy|spondyloarthropathy
863380|NCT00056849|Spine|spine
863381|NCT00056849|Hereditary|hereditary
863382|NCT00056849|Disability|disability
863383|NCT00056849|Ankylosing Spondylitis|ankylosing spondylitis
863384|NCT00056849|AS|as
863385|NCT00056849|Spondyloarthritis|spondyloarthritis
863386|NCT00056810|Guillain Barre Syndrome|guillain barre syndrome
863387|NCT00056810|4-aminopyridine|4-aminopyridine
863388|NCT00056797|HIV Therapeutic vaccine|hiv therapeutic vaccine
863389|NCT00056797|IL-2|il-2
863390|NCT00056797|Structured Treatment Interruption|structured treatment interruption
863391|NCT00056797|Treatment Experienced|treatment experienced
863392|NCT00056784|TGF-Beta|tgf-beta
863393|NCT00056784|Kidney|kidney
863394|NCT00056784|Transplantation|transplantation
863395|NCT00056784|Rejection|rejection
863396|NCT00056784|Immunosuppression|immunosuppression
863397|NCT00056784|Kidney Transplant|kidney transplant
863398|NCT00056784|Chronic Allograft Nephropathy|chronic allograft nephropathy
863399|NCT00056784|CAN|can
863400|NCT00056771|Cataract|cataract
863401|NCT00056771|Congenital Cataracts|congenital cataracts
863402|NCT00056771|Hereditary Cataracts|hereditary cataracts
863403|NCT00056758|HIV-1|hiv-1
863404|NCT00056758|HAART|haart
863405|NCT00056758|Therapeutic immunization|therapeutic immunization
863406|NCT00056758|HIV Therapeutic Vaccine|hiv therapeutic vaccine
863407|NCT00056758|Treatment Experienced|treatment experienced
863408|NCT00056745|HIV seronegativity|hiv seronegativity
863409|NCT00056745|HIV preventive vaccine|hiv preventive vaccine
863410|NCT00056693|Neuroendocrine tumor, advanced disease, sunitinib, Phase 2|neuroendocrine tumor, advanced disease, sunitinib, phase 2
863411|NCT00056680|Prematurity|prematurity
863412|NCT00056680|low birthweight|low birthweight
863413|NCT00056680|parenting|parenting
863414|NCT00056680|intervention|intervention
863415|NCT00056667|Treatment|treatment
863416|NCT00056667|Pain|pain
863417|NCT00056667|Relaxation Response|relaxation response
863418|NCT00056667|Cognitive Behavioral Therapy|cognitive behavioral therapy
863419|NCT00056654|Leuprolide|leuprolide
863420|NCT00056654|Prostatic Neoplasms|prostatic neoplasms
863421|NCT00056654|Testosterone|testosterone
863422|NCT00056654|Prostate-specific Antigen|prostate-specific antigen
863423|NCT00056654|Pharmacokinetics|pharmacokinetics
863424|NCT00056654|luprolide acetate|luprolide acetate
863426|NCT00056719|Spondylarthropathy|spondylarthropathy
863427|NCT00056719|Spine|spine
863428|NCT00056719|Hereditary|hereditary
863429|NCT00056719|Disability|disability
863430|NCT00056719|Ankylosing Spondylitis|ankylosing spondylitis
863431|NCT00056719|Spondyloarthropathy|spondyloarthropathy
863432|NCT00056719|Spondyloarthritis|spondyloarthritis
863433|NCT00056719|AS|as
863434|NCT00056706|Motor Deficit|motor deficit
863435|NCT00056706|Somatosensory Deficit|somatosensory deficit
863436|NCT00056706|Cortical Reorganization|cortical reorganization
863437|NCT00056706|Disinhibition|disinhibition
863438|NCT00056706|Rehabilitation|rehabilitation
863439|NCT00056706|Plasticity|plasticity
863440|NCT00056706|Stroke|stroke
863441|NCT00056628|Alzheimer disease|alzheimer disease
863442|NCT00056628|Dementia|dementia
863443|NCT00056628|Ventriculoperitoneal shunt|ventriculoperitoneal shunt
863444|NCT00056628|Tau|tau
863445|NCT00056628|ABeta|abeta
863446|NCT00056602|Utility|utility
863447|NCT00056602|Health Status|health status
863448|NCT00056602|Preferences|preferences
863449|NCT00056602|Response Criteria|response criteria
863450|NCT00056602|Treatment|treatment
863451|NCT00056602|Rheumatoid Arthritis|rheumatoid arthritis
863452|NCT00056602|RA|ra
863453|NCT00056576|Monotherapy|monotherapy
863454|NCT00056576|Complex Partial Seizures|complex partial seizures
863455|NCT00056576|Epilepsy|epilepsy
863456|NCT00056576|anti-epilepsy drug|anti-epilepsy drug
863458|NCT00056563|Parkinson's disease|parkinson's disease
863459|NCT00056563|levo-dopa|levo-dopa
863460|NCT00056563|tremor|tremor
863461|NCT00056563|dyskinesia|dyskinesia
863462|NCT00056563|subthalamic nucleus|subthalamic nucleus
863463|NCT00056563|globus pallidus|globus pallidus
863464|NCT00056550|Antithrombin Deficiency, Congenital|antithrombin deficiency, congenital
863465|NCT00056550|Antithrombin III Deficiency|antithrombin iii deficiency
863466|NCT00056524|ALS|als
863467|NCT00056524|MS|ms
863468|NCT00056524|CNS|cns
863469|NCT00056524|AD|ad
863470|NCT00056524|TBI|tbi
863471|NCT00056524|Dextromethorphan|dextromethorphan
863472|NCT00056524|IEED|ieed
863473|NCT00056524|Emotional|emotional
863474|NCT00056511|Garlic|garlic
863475|NCT00056511|Supplements|supplements
863476|NCT00056511|Adults|adults
863477|NCT00056511|Hypercholesterolemics|hypercholesterolemics
863478|NCT00056511|Randomized Clinical Trial|randomized clinical trial
863479|NCT00056485|Nursing homes|nursing homes
863480|NCT00056485|Aging|aging
863481|NCT00056472|Major depressive disorder with psychotic features|major depressive disorder with psychotic features
863482|NCT00056472|Delusional Depression|delusional depression
863483|NCT00056472|Randomized Trial|randomized trial
863484|NCT00056472|Combination Treatment|combination treatment
863485|NCT00056472|SSRI|ssri
863486|NCT00056472|Atypical Antipsychotic|atypical antipsychotic
863487|NCT00012454|Transforming Growth Factor-Beta|transforming growth factor-beta
863488|NCT00012454|Stroke|stroke
863489|NCT00012454|Prevention|prevention
863490|NCT00012454|Mucosal Tolerance|mucosal tolerance
863491|NCT00012454|E-selectin|e-selectin
863492|NCT00056459|Colorectal Cancer|colorectal cancer
863493|NCT00056459|PTK787|ptk787
863494|NCT00056459|Vatalanib|vatalanib
863495|NCT00056459|VEGF inhibitor|vegf inhibitor
863496|NCT00056459|Oxaliplatin|oxaliplatin
863497|NCT00056459|Angiogenesis|angiogenesis
863498|NCT00056459|Rectal Cancer|rectal cancer
863499|NCT00056459|Colon Cancer|colon cancer
863500|NCT00056459|Colorectal Carcinoma|colorectal carcinoma
863501|NCT00056459|Colorectal Tumor|colorectal tumor
863502|NCT00056446|Colorectal Cancer|colorectal cancer
863503|NCT00056446|Oxaliplatin|oxaliplatin
863504|NCT00056446|VEGF inhibitor|vegf inhibitor
863505|NCT00056446|Vatalanib|vatalanib
863506|NCT00056446|PTK787|ptk787
863507|NCT00056446|Colon Cancer|colon cancer
863508|NCT00056446|Colorectal Carcinoma|colorectal carcinoma
863509|NCT00056446|Rectal Cancer|rectal cancer
863510|NCT00056446|Colorectal Tumor|colorectal tumor
863511|NCT00056433|Fetal Hemoglobin Induction|fetal hemoglobin induction
863512|NCT00056433|L-Arginine|l-arginine
863513|NCT00056433|Nitric Oxide Therapy|nitric oxide therapy
863514|NCT00056433|Sickle Cell Disease|sickle cell disease
863515|NCT00056433|Sildenafil (Viagra)|sildenafil (viagra)
863516|NCT00056433|Sickle Cell Anemia|sickle cell anemia
863517|NCT00056420|Tourette's Syndrome|tourette's syndrome
863518|NCT00056420|Tic Disorder|tic disorder
863519|NCT00056420|(EEG) Electroencephalography|(eeg) electroencephalography
863520|NCT00056420|Event-Related Desynchronization/Synchronization|event-related desynchronization/synchronization
863521|NCT00056420|Coherence|coherence
863522|NCT00056420|Tourette's|tourette's
863523|NCT00056420|Tourette Syndrome|tourette syndrome
863524|NCT00056420|Healthy Volunteer|healthy volunteer
863525|NCT00056420|HV|hv
863526|NCT00056407|Prostate cancer prevention|prostate cancer prevention
863527|NCT00056407|prostate|prostate
863528|NCT00056407|BPH|bph
863529|NCT00056407|enlarged prostate|enlarged prostate
863530|NCT00056407|PSA|psa
863531|NCT00056407|prostate cancer|prostate cancer
863532|NCT00056394|Early Rheumatoid Arthritis|early rheumatoid arthritis
863533|NCT00056394|Coping Skills Training|coping skills training
863535|NCT00056394|Physical Disability|physical disability
863536|NCT00056394|Psychological Disability|psychological disability
863537|NCT00056394|Daily Diary Measures|daily diary measures
863538|NCT00056381|neutropenia|neutropenia
863539|NCT00056381|fever|fever
863540|NCT00056381|febrile neutropenia|febrile neutropenia
863541|NCT00056368|Candida blood stream infections|candida blood stream infections
863542|NCT00056368|Candida infections|candida infections
863543|NCT00056368|Candidemia|candidemia
863544|NCT00056368|Invasive Candidiasis|invasive candidiasis
863545|NCT00056329|Aging Persons|aging persons
863546|NCT00056329|Down Syndrome|down syndrome
863547|NCT00056329|Vitamin E|vitamin e
863548|NCT00056329|Alzheimer disease|alzheimer disease
863549|NCT00056355|Pheresis|pheresis
863550|NCT00056355|Cytokine|cytokine
863551|NCT00056355|Lymphocyte|lymphocyte
863552|NCT00056355|Remission|remission
863553|NCT00056355|Ultraviolet A Light|ultraviolet a light
863554|NCT00056355|Crohn's Disease|crohn's disease
863555|NCT00056355|Crohn Disease|crohn disease
863556|NCT00056316|Caregiving|caregiving
863557|NCT00056316|Dementia|dementia
863558|NCT00056316|Alzheimer's|alzheimer's
863559|NCT00056316|Depression|depression
863560|NCT00056316|Technology|technology
863561|NCT00056316|Treatment|treatment
863562|NCT00056303|Attachment|attachment
863563|NCT00056303|Intervention|intervention
863565|NCT00056290|Diabetes Mellitus|diabetes mellitus
863566|NCT00056290|Neuropathy|neuropathy
863567|NCT00056290|Peripheral Artery Disease|peripheral artery disease
863568|NCT00056264|Chronic obstructive pulmonary disease|chronic obstructive pulmonary disease
863569|NCT00056264|COPD|copd
863570|NCT00056264|Infliximab|infliximab
863571|NCT00056264|Remicade|remicade
863572|NCT00056251|Interstitial Cystitis|interstitial cystitis
863573|NCT00056251|Bladder|bladder
863574|NCT00056238|Neurologic Diseases (General)|neurologic diseases (general)
863575|NCT00056238|Hemorrhagic Stroke|hemorrhagic stroke
863576|NCT00056238|Cerebral Amyloid Angiopathy|cerebral amyloid angiopathy
863577|NCT00056238|Cerebrovascular Accident|cerebrovascular accident
863578|NCT00056225|homocysteine|homocysteine
863579|NCT00056173|Metastatic Renal Cell Carcinoma|metastatic renal cell carcinoma
863580|NCT00056199|Vision Loss|vision loss
863581|NCT00056199|Optic Nerve Tumors|optic nerve tumors
863582|NCT00056199|Macular Edema|macular edema
863583|NCT00056199|Von Hippel-Lindau Disease|von hippel-lindau disease
863584|NCT00056199|VEGF|vegf
863585|NCT00056199|EYE001|eye001
863586|NCT00056199|VHL|vhl
863587|NCT00056186|Adaptation|adaptation
863588|NCT00056186|Neurodegenerative|neurodegenerative
863589|NCT00056186|Health Care Provider|health care provider
863590|NCT00056186|Psychosocial|psychosocial
863591|NCT00056186|Chronic Illness/Disability|chronic illness/disability
863592|NCT00056186|Friedreich's Ataxia|friedreich's ataxia
863593|NCT00056186|Friedreich Ataxia|friedreich ataxia
863594|NCT00056186|FA|fa
863595|NCT00056160|Multiple Myeloma|multiple myeloma
863596|NCT00056160|Refractory and Relapsed|refractory and relapsed
863597|NCT00056160|Revlimid|revlimid
863598|NCT00056160|CC5013|cc5013
863599|NCT00056147|cystic fibrosis|cystic fibrosis
863600|NCT00056134|recurrent melanoma|recurrent melanoma
863601|NCT00056134|stage IV melanoma|stage iv melanoma
863602|NCT00056134|stage IIIA melanoma|stage iiia melanoma
863603|NCT00056134|stage IIIB melanoma|stage iiib melanoma
863604|NCT00056134|stage IIIC melanoma|stage iiic melanoma
863605|NCT00056095|recurrent renal cell cancer|recurrent renal cell cancer
863606|NCT00056095|stage IV renal cell cancer|stage iv renal cell cancer
863607|NCT00056082|breast cancer|breast cancer
863608|NCT00056069|psychosocial effects of cancer and its treatment|psychosocial effects of cancer and its treatment
863609|NCT00056069|childhood acute lymphoblastic leukemia|childhood acute lymphoblastic leukemia
863610|NCT00056056|stage I mycosis fungoides/Sezary syndrome|stage i mycosis fungoides/sezary syndrome
863611|NCT00056056|stage II mycosis fungoides/Sezary syndrome|stage ii mycosis fungoides/sezary syndrome
863612|NCT00056056|recurrent mycosis fungoides/Sezary syndrome|recurrent mycosis fungoides/sezary syndrome
863613|NCT00056030|liver metastases|liver metastases
863614|NCT00056030|stage IV colon cancer|stage iv colon cancer
863615|NCT00056030|stage IV rectal cancer|stage iv rectal cancer
863616|NCT00056030|adenocarcinoma of the colon|adenocarcinoma of the colon
863617|NCT00056030|adenocarcinoma of the rectum|adenocarcinoma of the rectum
863618|NCT00056004|non-small cell lung cancer|non-small cell lung cancer
863619|NCT00056004|small cell lung cancer|small cell lung cancer
863620|NCT00056004|stage I non-small cell lung cancer|stage i non-small cell lung cancer
863621|NCT00056004|stage I squamous cell carcinoma of the hypopharynx|stage i squamous cell carcinoma of the hypopharynx
863622|NCT00056004|stage I squamous cell carcinoma of the larynx|stage i squamous cell carcinoma of the larynx
863623|NCT00056004|stage I squamous cell carcinoma of the lip and oral cavity|stage i squamous cell carcinoma of the lip and oral cavity
863624|NCT00056004|stage I squamous cell carcinoma of the nasopharynx|stage i squamous cell carcinoma of the nasopharynx
863625|NCT00056004|stage I squamous cell carcinoma of the oropharynx|stage i squamous cell carcinoma of the oropharynx
863626|NCT00056004|stage II squamous cell carcinoma of the hypopharynx|stage ii squamous cell carcinoma of the hypopharynx
863627|NCT00056004|stage II squamous cell carcinoma of the larynx|stage ii squamous cell carcinoma of the larynx
863628|NCT00056004|stage II squamous cell carcinoma of the lip and oral cavity|stage ii squamous cell carcinoma of the lip and oral cavity
863629|NCT00056004|stage II squamous cell carcinoma of the nasopharynx|stage ii squamous cell carcinoma of the nasopharynx
863630|NCT00056004|stage II squamous cell carcinoma of the oropharynx|stage ii squamous cell carcinoma of the oropharynx
863631|NCT00055991|breast cancer|breast cancer
863632|NCT00055978|non-small cell lung cancer|non-small cell lung cancer
863633|NCT00055978|stage I non-small cell lung cancer|stage i non-small cell lung cancer
863634|NCT00055965|stage IIIA non-small cell lung cancer|stage iiia non-small cell lung cancer
863635|NCT00055965|stage IIIB non-small cell lung cancer|stage iiib non-small cell lung cancer
863636|NCT00055965|stage IV non-small cell lung cancer|stage iv non-small cell lung cancer
863637|NCT00055952|childhood desmoplastic small round cell tumor|childhood desmoplastic small round cell tumor
863638|NCT00055952|metastatic childhood soft tissue sarcoma|metastatic childhood soft tissue sarcoma
863639|NCT00055952|nonmetastatic childhood soft tissue sarcoma|nonmetastatic childhood soft tissue sarcoma
863640|NCT00055952|recurrent childhood soft tissue sarcoma|recurrent childhood soft tissue sarcoma
863641|NCT00055952|localized Ewing sarcoma/peripheral primitive neuroectodermal tumor|localized ewing sarcoma/peripheral primitive neuroectodermal tumor
863642|NCT00055952|metastatic Ewing sarcoma/peripheral primitive neuroectodermal tumor|metastatic ewing sarcoma/peripheral primitive neuroectodermal tumor
863719|NCT00055679|stage I breast cancer|stage i breast cancer
884265|NCT00004855|Stavudine|stavudine
863643|NCT00055952|recurrent Ewing sarcoma/peripheral primitive neuroectodermal tumor|recurrent ewing sarcoma/peripheral primitive neuroectodermal tumor
863644|NCT00055939|previously treated childhood rhabdomyosarcoma|previously treated childhood rhabdomyosarcoma
863645|NCT00055939|recurrent childhood rhabdomyosarcoma|recurrent childhood rhabdomyosarcoma
863646|NCT00055926|recurrent breast cancer|recurrent breast cancer
863647|NCT00055926|stage IV breast cancer|stage iv breast cancer
863648|NCT00055926|male breast cancer|male breast cancer
863649|NCT00055887|stage IIIB non-small cell lung cancer|stage iiib non-small cell lung cancer
863650|NCT00055887|stage IIIA non-small cell lung cancer|stage iiia non-small cell lung cancer
863651|NCT00055887|adenocarcinoma of the lung|adenocarcinoma of the lung
863652|NCT00055887|squamous cell lung cancer|squamous cell lung cancer
863653|NCT00055887|large cell lung cancer|large cell lung cancer
863654|NCT00055874|chronic phase chronic myelogenous leukemia|chronic phase chronic myelogenous leukemia
863655|NCT00055874|childhood chronic myelogenous leukemia|childhood chronic myelogenous leukemia
863656|NCT00055874|chronic myelogenous leukemia, BCR-ABL1 positive|chronic myelogenous leukemia, bcr-abl1 positive
863657|NCT00055848|adenocarcinoma of the colon|adenocarcinoma of the colon
863658|NCT00055848|stage I colon cancer|stage i colon cancer
863659|NCT00055848|stage II colon cancer|stage ii colon cancer
863660|NCT00055848|stage III colon cancer|stage iii colon cancer
863661|NCT00055848|stage IV colon cancer|stage iv colon cancer
863662|NCT00055835|recurrent bladder cancer|recurrent bladder cancer
863663|NCT00055835|stage III bladder cancer|stage iii bladder cancer
863664|NCT00055835|squamous cell carcinoma of the bladder|squamous cell carcinoma of the bladder
863665|NCT00055835|stage II bladder cancer|stage ii bladder cancer
863666|NCT00055835|recurrent urethral cancer|recurrent urethral cancer
863667|NCT00055835|urethral cancer associated with invasive bladder cancer|urethral cancer associated with invasive bladder cancer
863668|NCT00055835|distal urethral cancer|distal urethral cancer
863669|NCT00055835|proximal urethral cancer|proximal urethral cancer
863670|NCT00055835|stage IV bladder cancer|stage iv bladder cancer
863671|NCT00055835|transitional cell carcinoma of the bladder|transitional cell carcinoma of the bladder
863672|NCT00055822|adenocarcinoma of the colon|adenocarcinoma of the colon
863673|NCT00055822|recurrent colon cancer|recurrent colon cancer
863674|NCT00055822|stage III colon cancer|stage iii colon cancer
863675|NCT00055822|stage IV colon cancer|stage iv colon cancer
863676|NCT00055822|adenocarcinoma of the rectum|adenocarcinoma of the rectum
863677|NCT00055822|recurrent rectal cancer|recurrent rectal cancer
863678|NCT00055822|stage III rectal cancer|stage iii rectal cancer
863679|NCT00055822|stage IV rectal cancer|stage iv rectal cancer
863680|NCT00055783|recurrent adult Hodgkin lymphoma|recurrent adult hodgkin lymphoma
863681|NCT00055731|stage III prostate cancer|stage iii prostate cancer
863682|NCT00055731|stage IIB prostate cancer|stage iib prostate cancer
863683|NCT00055731|stage IIA prostate cancer|stage iia prostate cancer
863684|NCT00055718|drug/agent toxicity by tissue/organ|drug/agent toxicity by tissue/organ
863685|NCT00055718|childhood acute lymphoblastic leukemia|childhood acute lymphoblastic leukemia
863686|NCT00055705|recurrent ovarian epithelial cancer|recurrent ovarian epithelial cancer
863687|NCT00055705|stage IV ovarian epithelial cancer|stage iv ovarian epithelial cancer
863688|NCT00055705|fallopian tube cancer|fallopian tube cancer
863689|NCT00055705|primary peritoneal cavity cancer|primary peritoneal cavity cancer
863690|NCT00055705|recurrent colon cancer|recurrent colon cancer
863691|NCT00055705|stage IV colon cancer|stage iv colon cancer
863692|NCT00055705|ovarian sarcoma|ovarian sarcoma
863693|NCT00055705|recurrent ovarian germ cell tumor|recurrent ovarian germ cell tumor
863694|NCT00055705|stage IV ovarian germ cell tumor|stage iv ovarian germ cell tumor
863695|NCT00055705|recurrent endometrial carcinoma|recurrent endometrial carcinoma
863696|NCT00055705|stage IV endometrial carcinoma|stage iv endometrial carcinoma
863697|NCT00055705|recurrent uterine sarcoma|recurrent uterine sarcoma
863698|NCT00055705|stage IV uterine sarcoma|stage iv uterine sarcoma
863699|NCT00055705|ovarian stromal cancer|ovarian stromal cancer
863700|NCT00055705|recurrent rectal cancer|recurrent rectal cancer
863701|NCT00055705|stage IV rectal cancer|stage iv rectal cancer
863702|NCT00055705|metastatic gastrointestinal carcinoid tumor|metastatic gastrointestinal carcinoid tumor
863703|NCT00055705|recurrent gastrointestinal carcinoid tumor|recurrent gastrointestinal carcinoid tumor
863704|NCT00055705|gastrointestinal stromal tumor|gastrointestinal stromal tumor
863705|NCT00055705|advanced malignant mesothelioma|advanced malignant mesothelioma
863706|NCT00055705|recurrent malignant mesothelioma|recurrent malignant mesothelioma
863707|NCT00055705|recurrent gastric cancer|recurrent gastric cancer
863708|NCT00055705|stage IV gastric cancer|stage iv gastric cancer
863709|NCT00055705|carcinoma of the appendix|carcinoma of the appendix
863710|NCT00055705|small intestine adenocarcinoma|small intestine adenocarcinoma
863711|NCT00055705|small intestine leiomyosarcoma|small intestine leiomyosarcoma
863712|NCT00055705|small intestine lymphoma|small intestine lymphoma
863713|NCT00055705|recurrent small intestine cancer|recurrent small intestine cancer
863714|NCT00055705|recurrent gallbladder cancer|recurrent gallbladder cancer
863715|NCT00055705|unresectable gallbladder cancer|unresectable gallbladder cancer
863716|NCT00055705|advanced adult primary liver cancer|advanced adult primary liver cancer
863717|NCT00055705|localized unresectable adult primary liver cancer|localized unresectable adult primary liver cancer
863718|NCT00055705|recurrent adult primary liver cancer|recurrent adult primary liver cancer
863720|NCT00055666|graft versus host disease|graft versus host disease
863721|NCT00055653|refractory anemia with excess blasts in transformation|refractory anemia with excess blasts in transformation
863722|NCT00055653|refractory anemia with excess blasts|refractory anemia with excess blasts
863723|NCT00055653|refractory anemia with ringed sideroblasts|refractory anemia with ringed sideroblasts
863724|NCT00055653|refractory anemia|refractory anemia
863725|NCT00055653|chronic myelomonocytic leukemia|chronic myelomonocytic leukemia
863726|NCT00055653|childhood acute myeloid leukemia in remission|childhood acute myeloid leukemia in remission
863727|NCT00055653|recurrent childhood acute myeloid leukemia|recurrent childhood acute myeloid leukemia
863728|NCT00055653|secondary acute myeloid leukemia|secondary acute myeloid leukemia
863729|NCT00055653|childhood acute lymphoblastic leukemia in remission|childhood acute lymphoblastic leukemia in remission
863730|NCT00055653|recurrent childhood acute lymphoblastic leukemia|recurrent childhood acute lymphoblastic leukemia
863731|NCT00055653|accelerated phase chronic myelogenous leukemia|accelerated phase chronic myelogenous leukemia
863732|NCT00055653|blastic phase chronic myelogenous leukemia|blastic phase chronic myelogenous leukemia
863733|NCT00055653|chronic phase chronic myelogenous leukemia|chronic phase chronic myelogenous leukemia
863734|NCT00055653|acute undifferentiated leukemia|acute undifferentiated leukemia
863735|NCT00055653|recurrent/refractory childhood Hodgkin lymphoma|recurrent/refractory childhood hodgkin lymphoma
863736|NCT00055653|recurrent childhood large cell lymphoma|recurrent childhood large cell lymphoma
863737|NCT00055653|recurrent childhood lymphoblastic lymphoma|recurrent childhood lymphoblastic lymphoma
863738|NCT00055653|recurrent childhood small noncleaved cell lymphoma|recurrent childhood small noncleaved cell lymphoma
863739|NCT00055653|untreated childhood acute lymphoblastic leukemia|untreated childhood acute lymphoblastic leukemia
863740|NCT00055653|untreated childhood acute myeloid leukemia and other myeloid malignancies|untreated childhood acute myeloid leukemia and other myeloid malignancies
863741|NCT00055653|de novo myelodysplastic syndromes|de novo myelodysplastic syndromes
863742|NCT00055653|previously treated myelodysplastic syndromes|previously treated myelodysplastic syndromes
863743|NCT00055653|secondary myelodysplastic syndromes|secondary myelodysplastic syndromes
863744|NCT00055653|atypical chronic myeloid leukemia|atypical chronic myeloid leukemia
863745|NCT00055653|myelodysplastic/myeloproliferative disease, unclassifiable|myelodysplastic/myeloproliferative disease, unclassifiable
863746|NCT00055640|stage I adult diffuse large cell lymphoma|stage i adult diffuse large cell lymphoma
863747|NCT00055640|contiguous stage II adult diffuse large cell lymphoma|contiguous stage ii adult diffuse large cell lymphoma
863748|NCT00055640|stage III adult diffuse large cell lymphoma|stage iii adult diffuse large cell lymphoma
863749|NCT00055640|noncontiguous stage II adult diffuse large cell lymphoma|noncontiguous stage ii adult diffuse large cell lymphoma
863750|NCT00055640|stage IV adult diffuse large cell lymphoma|stage iv adult diffuse large cell lymphoma
863751|NCT00055614|stage III ovarian epithelial cancer|stage iii ovarian epithelial cancer
863752|NCT00055614|stage IV ovarian epithelial cancer|stage iv ovarian epithelial cancer
863753|NCT00055614|fallopian tube cancer|fallopian tube cancer
863754|NCT00055614|primary peritoneal cavity cancer|primary peritoneal cavity cancer
863755|NCT00055601|stage II bladder cancer|stage ii bladder cancer
863756|NCT00055601|stage III bladder cancer|stage iii bladder cancer
863757|NCT00022139|stage III gastric cancer|stage iii gastric cancer
863758|NCT00022139|stage II esophageal cancer|stage ii esophageal cancer
863759|NCT00022139|stage III esophageal cancer|stage iii esophageal cancer
863760|NCT00022139|adenocarcinoma of the stomach|adenocarcinoma of the stomach
863761|NCT00022139|squamous cell carcinoma of the esophagus|squamous cell carcinoma of the esophagus
863762|NCT00022139|adenocarcinoma of the esophagus|adenocarcinoma of the esophagus
863763|NCT00005028|adenocarcinoma of the prostate|adenocarcinoma of the prostate
863764|NCT00005028|stage IV prostate cancer|stage iv prostate cancer
863765|NCT00005028|recurrent prostate cancer|recurrent prostate cancer
863766|NCT00055588|Spinal Reflexes|spinal reflexes
863767|NCT00055588|Motor Practice|motor practice
863768|NCT00055588|Spinal Cord Injury|spinal cord injury
863769|NCT00055588|Locomotion|locomotion
863770|NCT00055588|Healthy Volunteer|healthy volunteer
863771|NCT00055588|HV|hv
863772|NCT00055575|Scopolamine|scopolamine
863773|NCT00055575|Depression|depression
863774|NCT00055575|fMRI|fmri
863775|NCT00055575|Cognition|cognition
863776|NCT00055575|Emotion|emotion
863777|NCT00055575|Brain|brain
863778|NCT00055575|Bipolar Disorder|bipolar disorder
863779|NCT00055575|Major Depressive Disorder|major depressive disorder
863780|NCT00055575|MDD|mdd
863781|NCT00055575|Healthy Volunteer|healthy volunteer
863782|NCT00055575|HV|hv
863783|NCT00055562|Metastatic Melanoma|metastatic melanoma
863784|NCT00055562|Metastatic Malignant Melanoma|metastatic malignant melanoma
863785|NCT00055562|Revimid|revimid
863786|NCT00055562|CC5013|cc5013
863787|NCT00055549|Dextromethorphan|dextromethorphan
863788|NCT00055549|Sensorimotor Modulation|sensorimotor modulation
863789|NCT00055549|Spasmodic Dysphonia|spasmodic dysphonia
863790|NCT00055549|Muscular Tension Dysphonia|muscular tension dysphonia
863791|NCT00055549|Voice Tremor|voice tremor
863792|NCT00055549|Lorazepam|lorazepam
863793|NCT00055549|Dysphonia|dysphonia
863794|NCT00055549|Macular Tension Dysphonia|macular tension dysphonia
863795|NCT00055510|BO-653|bo-653
863796|NCT00055510|Coronary restenosis|coronary restenosis
863797|NCT00055510|Stent restenosis|stent restenosis
863798|NCT00055510|LDL oxidative inhibitor|ldl oxidative inhibitor
863799|NCT00055510|Antioxidant|antioxidant
863800|NCT00055484|Migraine Headache|migraine headache
863801|NCT00055484|prophylaxis|prophylaxis
863802|NCT00055484|AED|aed
863803|NCT00055484|migraine prophylaxis|migraine prophylaxis
863804|NCT00055471|prostate cancer|prostate cancer
863805|NCT00055471|Metastatic prostate cancer|metastatic prostate cancer
863806|NCT00055471|bone metastases|bone metastases
863807|NCT00055445|Complementary Therapies|complementary therapies
863808|NCT00055445|IdB 1016|idb 1016
863809|NCT00055445|Silybin|silybin
863810|NCT00055445|Antioxidant|antioxidant
863811|NCT00055445|Hepatitis C Virus|hepatitis c virus
863812|NCT00055445|Phosphatidylcholine|phosphatidylcholine
863813|NCT00055432|recurrent ovarian cancer|recurrent ovarian cancer
863814|NCT00055432|platinum-resistant|platinum-resistant
863815|NCT00055432|platinum-sensitive|platinum-sensitive
863816|NCT00055432|folate receptor antagonist|folate receptor antagonist
863817|NCT00055419|Stage IV colorectal cancer|stage iv colorectal cancer
863818|NCT00055380|Molecular Targets|molecular targets
863819|NCT00055380|Keratinocytes|keratinocytes
863820|NCT00055380|Cell Cycle|cell cycle
863821|NCT00055380|Small Molecule|small molecule
863822|NCT00055380|Gene Expression|gene expression
863823|NCT00055380|Pharmacodynamics|pharmacodynamics
863824|NCT00055380|Surrogate Markers|surrogate markers
863825|NCT00055380|Targeted Therapy|targeted therapy
863826|NCT00055380|Buccal Mucosa|buccal mucosa
863827|NCT00055380|Pharmacogenomics|pharmacogenomics
863828|NCT00055380|Oral Mucosa|oral mucosa
863829|NCT00055354|Acupuncture|acupuncture
863830|NCT00055354|Medicine, Chinese Traditional|medicine, chinese traditional
863831|NCT00055302|vaginal bleeding|vaginal bleeding
863832|NCT00055302|advanced bone age|advanced bone age
863833|NCT00055302|fibrous dysplasia|fibrous dysplasia
863834|NCT00055302|MAS|mas
863835|NCT00055302|McCune-Albright Syndrome|mccune-albright syndrome
863836|NCT00055263|advanced solid tumor malignancies|advanced solid tumor malignancies
863837|NCT00055289|Transcranial Magnetic Stimulation|transcranial magnetic stimulation
863838|NCT00055289|Counting|counting
863839|NCT00055289|Sensorimotor Integration|sensorimotor integration
863840|NCT00055289|Superior Temporal Cortex|superior temporal cortex
863841|NCT00055289|Dorsal Premotor Cortex|dorsal premotor cortex
863842|NCT00055289|Healthy Volunteer|healthy volunteer
863843|NCT00055289|HV|hv
863844|NCT00055237|Angiogenesis|angiogenesis
863845|NCT00055237|Cancer|cancer
863846|NCT00055237|HHV-8|hhv-8
863847|NCT00055237|KSHV|kshv
863848|NCT00055237|Skin|skin
863849|NCT00055237|Kaposi Sarcoma|kaposi sarcoma
863850|NCT00055237|KS|ks
863851|NCT00055224|Anxiety Disorder|anxiety disorder
863852|NCT00055224|Fear|fear
863853|NCT00055224|Aversive Conditioning|aversive conditioning
863854|NCT00055224|Psychophysiology|psychophysiology
863855|NCT00055224|Predictability|predictability
863856|NCT00055224|Startle|startle
863857|NCT00055224|Context Conditioning|context conditioning
863858|NCT00055224|Fear Conditioning|fear conditioning
863859|NCT00055224|Agoraphobia|agoraphobia
863860|NCT00055224|Panic Disorder|panic disorder
863861|NCT00055224|Generalized Anxiety Disorder|generalized anxiety disorder
863862|NCT00055224|GAD|gad
863863|NCT00055224|Healthy Volunteer|healthy volunteer
863864|NCT00055224|HV|hv
863865|NCT00055198|Gram positive bacterial infections|gram positive bacterial infections
863866|NCT00055198|expanded access program|expanded access program
863867|NCT00055198|resistant infections|resistant infections
863868|NCT00055198|bacteremia|bacteremia
863869|NCT00055198|Bacterial and fungal infections|bacterial and fungal infections
863870|NCT00055198|bacterial infections|bacterial infections
863871|NCT00055185|Treatment Experienced|treatment experienced
863872|NCT00055133|rheumatoid arthritis|rheumatoid arthritis
863874|NCT00055133|Micellar Paclitaxel|micellar paclitaxel
863875|NCT00055172|Cytokines|cytokines
863876|NCT00055172|Inherited Immunodeficiency|inherited immunodeficiency
863877|NCT00055172|Immunodeficiency|immunodeficiency
863878|NCT00055159|RT PA|rt pa
863879|NCT00055159|Blood Clots|blood clots
863880|NCT00055159|Catheter Directed Thrombolytic Therapy|catheter directed thrombolytic therapy
863881|NCT00055159|Alteplase|alteplase
863882|NCT00055159|Deep Vein Thrombosis|deep vein thrombosis
863883|NCT00055159|DVT|dvt
863884|NCT00055120|Anti-HIV Agents|anti-hiv agents
863885|NCT00055120|Disease Progression|disease progression
863886|NCT00055120|Drug Administration Schedule|drug administration schedule
863887|NCT00055120|Viral Load|viral load
863888|NCT00055120|HIV-1|hiv-1
863889|NCT00055120|Treatment Outcome|treatment outcome
863890|NCT00055120|Survival Analysis|survival analysis
863891|NCT00055120|Treatment Naive|treatment naive
863892|NCT00055107|Nitazoxanide|nitazoxanide
863893|NCT00055107|Antiprotozoal Agents|antiprotozoal agents
863894|NCT00055107|Cryptosporidiosis|cryptosporidiosis
863895|NCT00055107|Cryptosporidium parvum|cryptosporidium parvum
863896|NCT00055107|AIDS-Related Opportunistic Infections|aids-related opportunistic infections
863897|NCT00055107|Pharmacokinetics|pharmacokinetics
863898|NCT00055107|Drug Adminstration Schedule|drug adminstration schedule
863899|NCT00055094|Immune system|immune system
863900|NCT00055094|Helper T-Cells|helper t-cells
863901|NCT00055094|Acute Infection|acute infection
863902|NCT00055094|Treatment naive|treatment naive
863903|NCT00055081|Homeless Persons|homeless persons
863904|NCT00055055|Autoimmunity Pathogenesis|autoimmunity pathogenesis
863905|NCT00055055|Microarray Analyses|microarray analyses
863906|NCT00055055|Microchimerism|microchimerism
863907|NCT00055055|Genetic and Environmental Risk Factors|genetic and environmental risk factors
863908|NCT00055055|Adult and Pediatric Disease|adult and pediatric disease
863909|NCT00055055|Rheumatoid Arthritis|rheumatoid arthritis
863910|NCT00055055|Systemic Lupus Erythematosus|systemic lupus erythematosus
863911|NCT00055055|Systemic Sclerosis|systemic sclerosis
863912|NCT00055055|Idiopathic Inflammatory Myopathies|idiopathic inflammatory myopathies
863913|NCT00055055|Juvenile Polymyositis|juvenile polymyositis
863914|NCT00055055|Juvenile Idiopathic Arthritis|juvenile idiopathic arthritis
863915|NCT00055055|Inflammatory Myopathies|inflammatory myopathies
863916|NCT00055055|Dermatomyositis|dermatomyositis
863917|NCT00055055|Scleroderma|scleroderma
863918|NCT00055055|SLE|sle
863919|NCT00055055|Lupus|lupus
863920|NCT00055055|Rheumatic Disease|rheumatic disease
863921|NCT00055055|RA|ra
863922|NCT00055055|Healthy Volunteer|healthy volunteer
863923|NCT00055055|HV|hv
863924|NCT00055042|Types 1 and 2 Diabetes|types 1 and 2 diabetes
863925|NCT00055042|Diode Laser Photocoagulation|diode laser photocoagulation
863926|NCT00055042|Vitamin E|vitamin e
863927|NCT00055042|Elevated Low-Density Lipoprotein (LDL-C) Cholesterol|elevated low-density lipoprotein (ldl-c) cholesterol
863928|NCT00055042|Diabetes Type I|diabetes type i
863929|NCT00055042|Diabetes Type II|diabetes type ii
863930|NCT00055042|Diabetic Macular Edema|diabetic macular edema
863931|NCT00055029|Retinoschisis|retinoschisis
863932|NCT00055029|Genomic DNA|genomic dna
863933|NCT00055029|Pedigree Analysis|pedigree analysis
863934|NCT00055029|Genetic Analysis|genetic analysis
863935|NCT00055029|Macular Degeneration|macular degeneration
863936|NCT00055029|Juvenile Retinoschisis|juvenile retinoschisis
863937|NCT00055029|X-Linked Juvenile Retinoschisis|x-linked juvenile retinoschisis
863938|NCT00055029|XLRS|xlrs
863939|NCT00055016|Lysosomal Disease|lysosomal disease
863940|NCT00055016|Renal Function|renal function
863941|NCT00055016|Stroke|stroke
863942|NCT00055016|Cardiac Disease|cardiac disease
863943|NCT00055016|Natural History|natural history
863944|NCT00055016|Fabry Disease|fabry disease
863945|NCT00055003|Amygdala|amygdala
863946|NCT00055003|Medial Prefrontal Cortex|medial prefrontal cortex
863947|NCT00055003|Orbitofrontal Cortex|orbitofrontal cortex
863948|NCT00055003|Cortisol|cortisol
863949|NCT00055003|Memory|memory
863950|NCT00055003|Glucocorticoid|glucocorticoid
863951|NCT00055003|Hydrocortisone|hydrocortisone
863952|NCT00055003|Stress|stress
863953|NCT00055003|Perception|perception
863954|NCT00055003|Affect|affect
863955|NCT00055003|Healthy Volunteer|healthy volunteer
863956|NCT00055003|HV|hv
863957|NCT00054990|Antiepileptic Drugs|antiepileptic drugs
863958|NCT00054990|Cortical Excitability|cortical excitability
863959|NCT00054990|Transcranial Magnetic Stimulation|transcranial magnetic stimulation
863960|NCT00054990|Epilepsy|epilepsy
863961|NCT00054990|TMS|tms
863962|NCT00054990|Healthy Volunteer|healthy volunteer
863963|NCT00054990|HV|hv
863964|NCT00054977|cancer|cancer
863965|NCT00054977|tumor|tumor
863967|NCT00054951|Liver Cancer|liver cancer
863968|NCT00054938|SLE|sle
863969|NCT00054938|Accelerated Atherosclerosis|accelerated atherosclerosis
863970|NCT00054938|Cholesterol|cholesterol
863971|NCT00054912|vaccine|vaccine
863972|NCT00054912|colon|colon
863973|NCT00054912|cancer|cancer
863974|NCT00054912|colorectal|colorectal
863975|NCT00054912|neoplasm|neoplasm
863976|NCT00054912|Colonic Cancer|colonic cancer
863977|NCT00054912|Colon Cancer|colon cancer
863978|NCT00054912|Cancer of the Colon|cancer of the colon
863979|NCT00054899|vaccine|vaccine
863980|NCT00054899|lung|lung
863981|NCT00054899|cancer|cancer
863982|NCT00054899|Carcinoma, Large Cell|carcinoma, large cell
863983|NCT00054899|Non-Small-Cell Lung Carcinoma|non-small-cell lung carcinoma
863984|NCT00054873|Adenocarcinoma of the esophagus or stomach|adenocarcinoma of the esophagus or stomach
863985|NCT00054860|HIV Preventive Vaccine|hiv preventive vaccine
863986|NCT00054860|HIV Seronegativity|hiv seronegativity
863987|NCT00054860|HIV-1|hiv-1
863988|NCT00054860|AIDS Vaccines|aids vaccines
863989|NCT00054860|Vaccines, DNA|vaccines, dna
863990|NCT00054860|Dose-Response Relationship, Immunologic|dose-response relationship, immunologic
863991|NCT00054860|CD4-Positive T-Lymphocytes|cd4-positive t-lymphocytes
863992|NCT00054860|CD8-Positive T-Lymphocytes|cd8-positive t-lymphocytes
863993|NCT00054860|Epitopes|epitopes
863994|NCT00054847|CABG|cabg
863995|NCT00054847|cardiovascular|cardiovascular
863996|NCT00054847|chronic diseases|chronic diseases
863997|NCT00054847|clinical trial|clinical trial
863998|NCT00054847|heart|heart
863999|NCT00054847|multi-site trial|multi-site trial
864000|NCT00054847|prospective|prospective
864001|NCT00054821|Osteoarthritis, Ankle|osteoarthritis, ankle
864002|NCT00054821|Ankle Distraction|ankle distraction
864003|NCT00054808|Gallium Nitrate|gallium nitrate
864004|NCT00054808|Ganite|ganite
864005|NCT00054808|NHL|nhl
864006|NCT00054808|Relapsed|relapsed
864007|NCT00054795|Brain Neoplasms/radiotherapy|brain neoplasms/radiotherapy
864008|NCT00054795|Neoplasms/complications/prevention & control,|neoplasms/complications/prevention & control,
864009|NCT00054795|Neuropsychological Tests,|neuropsychological tests,
864010|NCT00054795|Metalloporphyrins/therapeutic use,|metalloporphyrins/therapeutic use,
864011|NCT00054795|Combined Modality Therapy,|combined modality therapy,
864012|NCT00054795|Drug therapy,|drug therapy,
864013|NCT00054795|Quality of Life,|quality of life,
864014|NCT00054795|Cranial Irradiation,|cranial irradiation,
864015|NCT00054795|Radiotherapy/Targeted,|radiotherapy/targeted,
864016|NCT00054795|Prospective Studies,|prospective studies,
864017|NCT00054795|Neoplasm Recurrence/Local,|neoplasm recurrence/local,
864018|NCT00054795|Treatment Outcome|treatment outcome
864019|NCT00054795|Brain metastases|brain metastases
864020|NCT00054795|Brain Neoplasms/secondary|brain neoplasms/secondary
864021|NCT00054795|Non-small cell lung cancer|non-small cell lung cancer
864022|NCT00054769|Pediatrics|pediatrics
864023|NCT00054769|Polymerase Chain Reaction|polymerase chain reaction
864024|NCT00054730|Fragile X Syndrome|fragile x syndrome
864025|NCT00054730|Autism|autism
864026|NCT00054756|Hypothalamic Releasing Factor|hypothalamic releasing factor
864027|NCT00054756|Neuropeptide|neuropeptide
864028|NCT00054756|Diagnostic Testing|diagnostic testing
864029|NCT00054756|Pituitary Tumors|pituitary tumors
864030|NCT00054756|Central Hypothyroidism|central hypothyroidism
864031|NCT00054756|Pituitary Disorder|pituitary disorder
864032|NCT00054756|Thyroid Disorder|thyroid disorder
864033|NCT00054756|Healthy Volunteer|healthy volunteer
864034|NCT00054743|Race|race
864035|NCT00054743|Ethnicity|ethnicity
864036|NCT00054743|Pharmacogenetics|pharmacogenetics
864037|NCT00054743|Cytochrome P450|cytochrome p450
864038|NCT00054743|Population Pharmacokinetics|population pharmacokinetics
864039|NCT00054743|HIV|hiv
864040|NCT00054704|Riluzole|riluzole
864041|NCT00054704|Neuroprotective|neuroprotective
864042|NCT00054704|Open-Label Study|open-label study
864043|NCT00054704|Glutamate Dysfunction|glutamate dysfunction
864044|NCT00054704|Bipolar Mood Disorder|bipolar mood disorder
864045|NCT00054704|Bipolar Disorder|bipolar disorder
864046|NCT00054704|Mood Disorder|mood disorder
864047|NCT00054691|Skin Cancer|skin cancer
864048|NCT00054691|Squamous Cell Carcinoma of the Skin|squamous cell carcinoma of the skin
864049|NCT00054691|Gefitinib|gefitinib
864050|NCT00054691|ZD1839|zd1839
864051|NCT00054691|Iressa|iressa
864052|NCT00054691|Epidermal Growth Factor Receptor|epidermal growth factor receptor
864053|NCT00054691|EGFR|egfr
864054|NCT00054678|Myocardial infarction|myocardial infarction
864055|NCT00054678|Heart disease|heart disease
864056|NCT00054678|Endoventricular|endoventricular
864057|NCT00054678|Cardiovascular|cardiovascular
864058|NCT00054678|Interventional|interventional
864059|NCT00054678|ICD|icd
864060|NCT00054678|Heart failure|heart failure
864061|NCT00054678|Implantable Cardioverter Defibrillator|implantable cardioverter defibrillator
864062|NCT00050531|Chronic Myelogenous Leukemia|chronic myelogenous leukemia
864063|NCT00050531|CML|cml
864064|NCT00050531|Early Chronic Phase Chronic Myelogenous Leukemia|early chronic phase chronic myelogenous leukemia
864065|NCT00050531|Imatinib Mesylate|imatinib mesylate
864067|NCT00050531|Peg-Alpha Interferon|peg-alpha interferon
864068|NCT00050531|Peg-Intron|peg-intron
864069|NCT00050531|Sargramostim|sargramostim
864070|NCT00050531|GM-CSF|gm-csf
864071|NCT00054665|BCL-2|bcl-2
864072|NCT00054665|NFK-B|nfk-b
864073|NCT00054665|Drug Resistance|drug resistance
864074|NCT00054665|Translational|translational
864075|NCT00054665|Lymphoma|lymphoma
864076|NCT00054665|Large B-Cell Lymphoma|large b-cell lymphoma
864077|NCT00054652|Geste Antagoniste|geste antagoniste
864078|NCT00054652|TMS|tms
864079|NCT00054652|Sensorimotor Integration|sensorimotor integration
864080|NCT00054652|Writer's Cramp|writer's cramp
864081|NCT00054652|Sensory Input|sensory input
864082|NCT00054652|Focal Dystonia|focal dystonia
864083|NCT00054626|stage II bladder cancer|stage ii bladder cancer
864084|NCT00054626|stage III bladder cancer|stage iii bladder cancer
864085|NCT00054626|stage IV bladder cancer|stage iv bladder cancer
864086|NCT00054626|transitional cell carcinoma of the bladder|transitional cell carcinoma of the bladder
864087|NCT00054613|Graft-versus-Host Disease|graft-versus-host disease
864088|NCT00054613|Extracorporeal Photopheresis|extracorporeal photopheresis
864089|NCT00054600|Extracorporeal Photopheresis|extracorporeal photopheresis
864090|NCT00054600|Graft-versus-Host Disease|graft-versus-host disease
864091|NCT00054587|stage II breast cancer|stage ii breast cancer
864092|NCT00054587|stage IIIA breast cancer|stage iiia breast cancer
864093|NCT00054574|recurrent prostate cancer|recurrent prostate cancer
864094|NCT00054574|stage I prostate cancer|stage i prostate cancer
864095|NCT00054574|stage II prostate cancer|stage ii prostate cancer
864096|NCT00054574|stage III prostate cancer|stage iii prostate cancer
864229|NCT00054236|refractory chronic lymphocytic leukemia|refractory chronic lymphocytic leukemia
864097|NCT00054561|stage III squamous cell carcinoma of the lip and oral cavity|stage iii squamous cell carcinoma of the lip and oral cavity
864098|NCT00054561|stage IV squamous cell carcinoma of the lip and oral cavity|stage iv squamous cell carcinoma of the lip and oral cavity
864099|NCT00054561|stage III squamous cell carcinoma of the oropharynx|stage iii squamous cell carcinoma of the oropharynx
864100|NCT00054561|stage IV squamous cell carcinoma of the oropharynx|stage iv squamous cell carcinoma of the oropharynx
864101|NCT00054561|stage III squamous cell carcinoma of the larynx|stage iii squamous cell carcinoma of the larynx
864102|NCT00054561|stage IV squamous cell carcinoma of the larynx|stage iv squamous cell carcinoma of the larynx
864103|NCT00054561|stage III squamous cell carcinoma of the hypopharynx|stage iii squamous cell carcinoma of the hypopharynx
864104|NCT00054561|stage IV squamous cell carcinoma of the hypopharynx|stage iv squamous cell carcinoma of the hypopharynx
864105|NCT00054535|stage IV melanoma|stage iv melanoma
864106|NCT00054535|recurrent melanoma|recurrent melanoma
864107|NCT00054522|adenocarcinoma of the prostate|adenocarcinoma of the prostate
864108|NCT00054522|recurrent prostate cancer|recurrent prostate cancer
864109|NCT00054496|adult glioblastoma|adult glioblastoma
864110|NCT00054496|recurrent adult brain tumor|recurrent adult brain tumor
864111|NCT00054496|adult giant cell glioblastoma|adult giant cell glioblastoma
864112|NCT00054496|adult gliosarcoma|adult gliosarcoma
864113|NCT00054470|stage IV breast cancer|stage iv breast cancer
864114|NCT00054470|recurrent breast cancer|recurrent breast cancer
864115|NCT00054470|male breast cancer|male breast cancer
864116|NCT00054457|adenocarcinoma of the stomach|adenocarcinoma of the stomach
864117|NCT00054457|adenocarcinoma of the esophagus|adenocarcinoma of the esophagus
864118|NCT00054457|stage IV gastric cancer|stage iv gastric cancer
864119|NCT00054457|recurrent gastric cancer|recurrent gastric cancer
864120|NCT00054457|stage IV esophageal cancer|stage iv esophageal cancer
864121|NCT00054457|recurrent esophageal cancer|recurrent esophageal cancer
864122|NCT00054418|osteoporosis|osteoporosis
864123|NCT00054418|stage I breast cancer|stage i breast cancer
864124|NCT00054418|stage II breast cancer|stage ii breast cancer
864125|NCT00054418|stage IIIA breast cancer|stage iiia breast cancer
864126|NCT00054418|stage IIIB breast cancer|stage iiib breast cancer
864127|NCT00054392|adenosquamous cell lung cancer|adenosquamous cell lung cancer
864128|NCT00054392|bronchoalveolar cell lung cancer|bronchoalveolar cell lung cancer
864129|NCT00054392|large cell lung cancer|large cell lung cancer
864130|NCT00054392|recurrent non-small cell lung cancer|recurrent non-small cell lung cancer
864131|NCT00054392|squamous cell lung cancer|squamous cell lung cancer
864132|NCT00054392|stage IIIB non-small cell lung cancer|stage iiib non-small cell lung cancer
864133|NCT00054392|stage IV non-small cell lung cancer|stage iv non-small cell lung cancer
864134|NCT00054392|adenocarcinoma of the lung|adenocarcinoma of the lung
864135|NCT00054340|graft versus host disease|graft versus host disease
864136|NCT00054340|polycythemia vera|polycythemia vera
864137|NCT00054340|chronic idiopathic myelofibrosis|chronic idiopathic myelofibrosis
864138|NCT00054340|essential thrombocythemia|essential thrombocythemia
864139|NCT00054340|untreated adult acute myeloid leukemia|untreated adult acute myeloid leukemia
864140|NCT00054340|recurrent adult acute myeloid leukemia|recurrent adult acute myeloid leukemia
864141|NCT00054340|recurrent childhood acute myeloid leukemia|recurrent childhood acute myeloid leukemia
864142|NCT00054340|untreated childhood acute myeloid leukemia and other myeloid malignancies|untreated childhood acute myeloid leukemia and other myeloid malignancies
864143|NCT00054340|de novo myelodysplastic syndromes|de novo myelodysplastic syndromes
864144|NCT00054340|previously treated myelodysplastic syndromes|previously treated myelodysplastic syndromes
864145|NCT00054340|secondary myelodysplastic syndromes|secondary myelodysplastic syndromes
864146|NCT00054340|chronic eosinophilic leukemia|chronic eosinophilic leukemia
864147|NCT00054340|chronic neutrophilic leukemia|chronic neutrophilic leukemia
864148|NCT00054340|myelodysplastic/myeloproliferative disease, unclassifiable|myelodysplastic/myeloproliferative disease, unclassifiable
864149|NCT00054340|adult acute myeloid leukemia with t(8;21)(q22;q22)|adult acute myeloid leukemia with t(8;21)(q22;q22)
864150|NCT00054340|adult acute myeloid leukemia with t(16;16)(p13;q22)|adult acute myeloid leukemia with t(16;16)(p13;q22)
864151|NCT00054340|adult acute myeloid leukemia with inv(16)(p13;q22)|adult acute myeloid leukemia with inv(16)(p13;q22)
864152|NCT00054340|adult acute myeloid leukemia with 11q23 (MLL) abnormalities|adult acute myeloid leukemia with 11q23 (mll) abnormalities
864153|NCT00054340|adult acute myeloid leukemia with t(15;17)(q22;q12)|adult acute myeloid leukemia with t(15;17)(q22;q12)
864154|NCT00054340|childhood myelodysplastic syndromes|childhood myelodysplastic syndromes
864155|NCT00054327|adult acute myeloid leukemia in remission|adult acute myeloid leukemia in remission
864156|NCT00054327|childhood acute myeloid leukemia in remission|childhood acute myeloid leukemia in remission
864157|NCT00054327|recurrent adult acute myeloid leukemia|recurrent adult acute myeloid leukemia
864158|NCT00054327|recurrent childhood acute myeloid leukemia|recurrent childhood acute myeloid leukemia
864159|NCT00054327|adult acute lymphoblastic leukemia in remission|adult acute lymphoblastic leukemia in remission
864160|NCT00054327|childhood acute lymphoblastic leukemia in remission|childhood acute lymphoblastic leukemia in remission
864161|NCT00054327|refractory anemia with excess blasts in transformation|refractory anemia with excess blasts in transformation
864162|NCT00054327|refractory anemia with excess blasts|refractory anemia with excess blasts
864163|NCT00054327|recurrent adult diffuse large cell lymphoma|recurrent adult diffuse large cell lymphoma
864164|NCT00054327|recurrent adult diffuse mixed cell lymphoma|recurrent adult diffuse mixed cell lymphoma
864165|NCT00054327|recurrent adult diffuse small cleaved cell lymphoma|recurrent adult diffuse small cleaved cell lymphoma
864166|NCT00054327|recurrent adult Burkitt lymphoma|recurrent adult burkitt lymphoma
864167|NCT00054327|recurrent adult immunoblastic large cell lymphoma|recurrent adult immunoblastic large cell lymphoma
864168|NCT00054327|recurrent adult lymphoblastic lymphoma|recurrent adult lymphoblastic lymphoma
864169|NCT00054327|recurrent grade 3 follicular lymphoma|recurrent grade 3 follicular lymphoma
864170|NCT00054327|secondary acute myeloid leukemia|secondary acute myeloid leukemia
864171|NCT00054327|accelerated phase chronic myelogenous leukemia|accelerated phase chronic myelogenous leukemia
864172|NCT00054327|blastic phase chronic myelogenous leukemia|blastic phase chronic myelogenous leukemia
864173|NCT00054327|chronic phase chronic myelogenous leukemia|chronic phase chronic myelogenous leukemia
864174|NCT00054327|recurrent childhood large cell lymphoma|recurrent childhood large cell lymphoma
864175|NCT00054327|recurrent childhood lymphoblastic lymphoma|recurrent childhood lymphoblastic lymphoma
864176|NCT00054327|recurrent childhood small noncleaved cell lymphoma|recurrent childhood small noncleaved cell lymphoma
864177|NCT00054327|recurrent mantle cell lymphoma|recurrent mantle cell lymphoma
864178|NCT00054327|refractory anemia with ringed sideroblasts|refractory anemia with ringed sideroblasts
864180|NCT00054327|chronic myelomonocytic leukemia|chronic myelomonocytic leukemia
864181|NCT00054327|refractory cytopenia with multilineage dysplasia|refractory cytopenia with multilineage dysplasia
864182|NCT00054327|previously treated myelodysplastic syndromes|previously treated myelodysplastic syndromes
864183|NCT00054327|de novo myelodysplastic syndromes|de novo myelodysplastic syndromes
864184|NCT00054327|secondary myelodysplastic syndromes|secondary myelodysplastic syndromes
864185|NCT00054327|relapsing chronic myelogenous leukemia|relapsing chronic myelogenous leukemia
864186|NCT00054327|childhood chronic myelogenous leukemia|childhood chronic myelogenous leukemia
864187|NCT00054327|atypical chronic myeloid leukemia|atypical chronic myeloid leukemia
864188|NCT00054327|myelodysplastic/myeloproliferative disease, unclassifiable|myelodysplastic/myeloproliferative disease, unclassifiable
864189|NCT00054327|juvenile myelomonocytic leukemia|juvenile myelomonocytic leukemia
864190|NCT00054327|adult acute myeloid leukemia with t(8;21)(q22;q22)|adult acute myeloid leukemia with t(8;21)(q22;q22)
864191|NCT00054327|adult acute myeloid leukemia with t(16;16)(p13;q22)|adult acute myeloid leukemia with t(16;16)(p13;q22)
864192|NCT00054327|adult acute myeloid leukemia with inv(16)(p13;q22)|adult acute myeloid leukemia with inv(16)(p13;q22)
864193|NCT00054327|adult acute myeloid leukemia with 11q23 (MLL) abnormalities|adult acute myeloid leukemia with 11q23 (mll) abnormalities
864194|NCT00054327|adult acute myeloid leukemia with t(15;17)(q22;q12)|adult acute myeloid leukemia with t(15;17)(q22;q12)
864195|NCT00054327|childhood myelodysplastic syndromes|childhood myelodysplastic syndromes
864196|NCT00054314|recurrent non-small cell lung cancer|recurrent non-small cell lung cancer
864197|NCT00054301|stage I breast cancer|stage i breast cancer
864198|NCT00054301|stage II breast cancer|stage ii breast cancer
864199|NCT00054301|stage IIIA breast cancer|stage iiia breast cancer
864200|NCT00054301|ductal breast carcinoma in situ|ductal breast carcinoma in situ
864201|NCT00054301|breast cancer in situ|breast cancer in situ
864202|NCT00054288|unspecified adult solid tumor, protocol specific|unspecified adult solid tumor, protocol specific
864203|NCT00054275|recurrent breast cancer|recurrent breast cancer
864204|NCT00054275|stage IV breast cancer|stage iv breast cancer
864205|NCT00054275|male breast cancer|male breast cancer
864206|NCT00054262|localized unresectable adult primary liver cancer|localized unresectable adult primary liver cancer
864207|NCT00054262|advanced adult primary liver cancer|advanced adult primary liver cancer
864208|NCT00054262|adult primary hepatocellular carcinoma|adult primary hepatocellular carcinoma
864209|NCT00054249|recurrent gastric cancer|recurrent gastric cancer
864210|NCT00054236|refractory anemia with excess blasts in transformation|refractory anemia with excess blasts in transformation
864211|NCT00054236|refractory anemia with excess blasts|refractory anemia with excess blasts
864212|NCT00054236|adult acute myeloid leukemia in remission|adult acute myeloid leukemia in remission
864213|NCT00054236|childhood acute myeloid leukemia in remission|childhood acute myeloid leukemia in remission
864214|NCT00054236|recurrent adult acute myeloid leukemia|recurrent adult acute myeloid leukemia
864215|NCT00054236|recurrent childhood acute myeloid leukemia|recurrent childhood acute myeloid leukemia
864216|NCT00054236|adult erythroleukemia (M6a)|adult erythroleukemia (m6a)
864217|NCT00054236|childhood acute erythroleukemia (M6)|childhood acute erythroleukemia (m6)
864218|NCT00054236|adult acute minimally differentiated myeloid leukemia (M0)|adult acute minimally differentiated myeloid leukemia (m0)
864219|NCT00054236|childhood acute minimally differentiated myeloid leukemia (M0)|childhood acute minimally differentiated myeloid leukemia (m0)
864220|NCT00054236|adult acute megakaryoblastic leukemia (M7)|adult acute megakaryoblastic leukemia (m7)
864221|NCT00054236|childhood acute megakaryocytic leukemia (M7)|childhood acute megakaryocytic leukemia (m7)
864222|NCT00054236|adult acute lymphoblastic leukemia in remission|adult acute lymphoblastic leukemia in remission
864223|NCT00054236|childhood acute lymphoblastic leukemia in remission|childhood acute lymphoblastic leukemia in remission
864224|NCT00054236|recurrent adult acute lymphoblastic leukemia|recurrent adult acute lymphoblastic leukemia
864225|NCT00054236|recurrent childhood acute lymphoblastic leukemia|recurrent childhood acute lymphoblastic leukemia
864226|NCT00054236|accelerated phase chronic myelogenous leukemia|accelerated phase chronic myelogenous leukemia
864227|NCT00054236|chronic phase chronic myelogenous leukemia|chronic phase chronic myelogenous leukemia
864228|NCT00054236|previously treated myelodysplastic syndromes|previously treated myelodysplastic syndromes
864230|NCT00054236|stage I multiple myeloma|stage i multiple myeloma
864231|NCT00054236|stage II multiple myeloma|stage ii multiple myeloma
864232|NCT00054236|stage III multiple myeloma|stage iii multiple myeloma
864233|NCT00054236|recurrent/refractory childhood Hodgkin lymphoma|recurrent/refractory childhood hodgkin lymphoma
864235|NCT00054236|primary myelofibrosis|primary myelofibrosis
864236|NCT00054236|essential thrombocythemia|essential thrombocythemia
864237|NCT00054236|refractory multiple myeloma|refractory multiple myeloma
864238|NCT00054236|recurrent grade 1 follicular lymphoma|recurrent grade 1 follicular lymphoma
864239|NCT00054236|recurrent grade 2 follicular lymphoma|recurrent grade 2 follicular lymphoma
864240|NCT00054236|recurrent grade 3 follicular lymphoma|recurrent grade 3 follicular lymphoma
864241|NCT00054236|recurrent adult diffuse large cell lymphoma|recurrent adult diffuse large cell lymphoma
864242|NCT00054236|recurrent adult diffuse mixed cell lymphoma|recurrent adult diffuse mixed cell lymphoma
864243|NCT00054236|recurrent adult diffuse small cleaved cell lymphoma|recurrent adult diffuse small cleaved cell lymphoma
864244|NCT00054236|recurrent adult Burkitt lymphoma|recurrent adult burkitt lymphoma
864245|NCT00054236|recurrent adult immunoblastic large cell lymphoma|recurrent adult immunoblastic large cell lymphoma
864246|NCT00054236|recurrent adult lymphoblastic lymphoma|recurrent adult lymphoblastic lymphoma
864247|NCT00054236|recurrent mantle cell lymphoma|recurrent mantle cell lymphoma
864248|NCT00054236|recurrent childhood large cell lymphoma|recurrent childhood large cell lymphoma
864249|NCT00054236|recurrent childhood lymphoblastic lymphoma|recurrent childhood lymphoblastic lymphoma
864250|NCT00054236|recurrent childhood small noncleaved cell lymphoma|recurrent childhood small noncleaved cell lymphoma
864251|NCT00054236|childhood diffuse large cell lymphoma|childhood diffuse large cell lymphoma
864252|NCT00054236|childhood immunoblastic large cell lymphoma|childhood immunoblastic large cell lymphoma
864253|NCT00054236|Burkitt lymphoma|burkitt lymphoma
864254|NCT00054236|anaplastic large cell lymphoma|anaplastic large cell lymphoma
864255|NCT00054236|recurrent adult Hodgkin lymphoma|recurrent adult hodgkin lymphoma
864256|NCT00054236|childhood chronic myelogenous leukemia|childhood chronic myelogenous leukemia
864257|NCT00054236|chronic eosinophilic leukemia|chronic eosinophilic leukemia
864258|NCT00054236|chronic neutrophilic leukemia|chronic neutrophilic leukemia
864259|NCT00054236|myelodysplastic/myeloproliferative disease, unclassifiable|myelodysplastic/myeloproliferative disease, unclassifiable
864260|NCT00054236|atypical chronic myeloid leukemia|atypical chronic myeloid leukemia
864261|NCT00054236|recurrent marginal zone lymphoma|recurrent marginal zone lymphoma
864262|NCT00054236|recurrent small lymphocytic lymphoma|recurrent small lymphocytic lymphoma
864263|NCT00054236|extranodal marginal zone B-cell lymphoma of mucosa-associated lymphoid tissue|extranodal marginal zone b-cell lymphoma of mucosa-associated lymphoid tissue
864264|NCT00054236|nodal marginal zone B-cell lymphoma|nodal marginal zone b-cell lymphoma
864265|NCT00054236|splenic marginal zone lymphoma|splenic marginal zone lymphoma
864266|NCT00054236|adult acute myeloid leukemia with t(8;21)(q22;q22)|adult acute myeloid leukemia with t(8;21)(q22;q22)
864267|NCT00054236|adult acute myeloid leukemia with t(16;16)(p13;q22)|adult acute myeloid leukemia with t(16;16)(p13;q22)
864268|NCT00054236|adult acute myeloid leukemia with inv(16)(p13;q22)|adult acute myeloid leukemia with inv(16)(p13;q22)
864269|NCT00054236|adult acute myeloid leukemia with 11q23 (MLL) abnormalities|adult acute myeloid leukemia with 11q23 (mll) abnormalities
864270|NCT00054236|adult acute myeloid leukemia with t(15;17)(q22;q12)|adult acute myeloid leukemia with t(15;17)(q22;q12)
864271|NCT00054236|childhood myelodysplastic syndromes|childhood myelodysplastic syndromes
864272|NCT00054223|psychosocial effects of cancer and its treatment|psychosocial effects of cancer and its treatment
864273|NCT00054223|unspecified adult solid tumor, protocol specific|unspecified adult solid tumor, protocol specific
864274|NCT00054210|recurrent non-small cell lung cancer|recurrent non-small cell lung cancer
864275|NCT00054210|stage IIIB non-small cell lung cancer|stage iiib non-small cell lung cancer
864276|NCT00054210|stage IV non-small cell lung cancer|stage iv non-small cell lung cancer
864277|NCT00054197|recurrent non-small cell lung cancer|recurrent non-small cell lung cancer
864278|NCT00054197|stage IIIB non-small cell lung cancer|stage iiib non-small cell lung cancer
864279|NCT00054197|stage IV non-small cell lung cancer|stage iv non-small cell lung cancer
864280|NCT00054184|recurrent non-small cell lung cancer|recurrent non-small cell lung cancer
864281|NCT00054184|stage IV non-small cell lung cancer|stage iv non-small cell lung cancer
864282|NCT00054184|stage IIIB non-small cell lung cancer|stage iiib non-small cell lung cancer
864283|NCT00054171|B-cell chronic lymphocytic leukemia|b-cell chronic lymphocytic leukemia
864284|NCT00054171|stage I cutaneous T-cell non-Hodgkin lymphoma|stage i cutaneous t-cell non-hodgkin lymphoma
864285|NCT00054171|stage I mycosis fungoides/Sezary syndrome|stage i mycosis fungoides/sezary syndrome
864286|NCT00054171|stage 0 chronic lymphocytic leukemia|stage 0 chronic lymphocytic leukemia
864287|NCT00054171|stage I chronic lymphocytic leukemia|stage i chronic lymphocytic leukemia
864288|NCT00054158|stage I multiple myeloma|stage i multiple myeloma
864289|NCT00054158|stage II multiple myeloma|stage ii multiple myeloma
864290|NCT00054158|stage III multiple myeloma|stage iii multiple myeloma
864291|NCT00054145|male breast cancer|male breast cancer
864292|NCT00054145|recurrent breast cancer|recurrent breast cancer
864293|NCT00054145|stage IV breast cancer|stage iv breast cancer
864294|NCT00054145|stage IIIA breast cancer|stage iiia breast cancer
864295|NCT00054145|stage IIIB breast cancer|stage iiib breast cancer
864296|NCT00054145|stage IIIC breast cancer|stage iiic breast cancer
864297|NCT00054106|adenocarcinoma of the prostate|adenocarcinoma of the prostate
864298|NCT00054106|stage III prostate cancer|stage iii prostate cancer
864299|NCT00054106|stage II prostate cancer|stage ii prostate cancer
864300|NCT00054067|cervical adenocarcinoma|cervical adenocarcinoma
864301|NCT00054067|cervical adenosquamous cell carcinoma|cervical adenosquamous cell carcinoma
864302|NCT00054067|cervical squamous cell carcinoma|cervical squamous cell carcinoma
864303|NCT00054067|stage IB cervical cancer|stage ib cervical cancer
864304|NCT00054054|stage III squamous cell carcinoma of the hypopharynx|stage iii squamous cell carcinoma of the hypopharynx
864305|NCT00054054|stage III squamous cell carcinoma of the larynx|stage iii squamous cell carcinoma of the larynx
864306|NCT00054054|stage III squamous cell carcinoma of the oropharynx|stage iii squamous cell carcinoma of the oropharynx
864307|NCT00054054|stage IV squamous cell carcinoma of the hypopharynx|stage iv squamous cell carcinoma of the hypopharynx
864308|NCT00054054|stage IV squamous cell carcinoma of the larynx|stage iv squamous cell carcinoma of the larynx
864309|NCT00054054|stage IV squamous cell carcinoma of the oropharynx|stage iv squamous cell carcinoma of the oropharynx
864310|NCT00054015|recurrent prostate cancer|recurrent prostate cancer
864311|NCT00054015|stage IV prostate cancer|stage iv prostate cancer
864312|NCT00054002|localized malignant mesothelioma|localized malignant mesothelioma
864313|NCT00054002|recurrent malignant mesothelioma|recurrent malignant mesothelioma
864314|NCT00054002|epithelial mesothelioma|epithelial mesothelioma
864315|NCT00054002|sarcomatous mesothelioma|sarcomatous mesothelioma
864316|NCT00053989|accelerated phase chronic myelogenous leukemia|accelerated phase chronic myelogenous leukemia
864317|NCT00053989|chronic myelomonocytic leukemia|chronic myelomonocytic leukemia
864318|NCT00053989|primary myelofibrosis|primary myelofibrosis
864319|NCT00053989|de novo myelodysplastic syndromes|de novo myelodysplastic syndromes
864320|NCT00053989|chronic phase chronic myelogenous leukemia|chronic phase chronic myelogenous leukemia
864321|NCT00053989|relapsing chronic myelogenous leukemia|relapsing chronic myelogenous leukemia
864322|NCT00053989|refractory anemia with excess blasts|refractory anemia with excess blasts
864323|NCT00053989|stage I multiple myeloma|stage i multiple myeloma
864324|NCT00053989|stage II multiple myeloma|stage ii multiple myeloma
864325|NCT00053989|stage III multiple myeloma|stage iii multiple myeloma
864326|NCT00053989|Waldenstrom macroglobulinemia|waldenstrom macroglobulinemia
864327|NCT00053989|stage III adult lymphoblastic lymphoma|stage iii adult lymphoblastic lymphoma
864328|NCT00053989|stage IV adult lymphoblastic lymphoma|stage iv adult lymphoblastic lymphoma
864329|NCT00053989|noncontiguous stage II adult Burkitt lymphoma|noncontiguous stage ii adult burkitt lymphoma
864330|NCT00053989|stage III adult Burkitt lymphoma|stage iii adult burkitt lymphoma
864331|NCT00053989|stage IV adult Burkitt lymphoma|stage iv adult burkitt lymphoma
864332|NCT00053989|recurrent adult Hodgkin lymphoma|recurrent adult hodgkin lymphoma
864333|NCT00053989|adult acute myeloid leukemia in remission|adult acute myeloid leukemia in remission
864334|NCT00053989|secondary acute myeloid leukemia|secondary acute myeloid leukemia
864335|NCT00053989|recurrent childhood acute lymphoblastic leukemia|recurrent childhood acute lymphoblastic leukemia
864336|NCT00053989|recurrent adult acute myeloid leukemia|recurrent adult acute myeloid leukemia
864337|NCT00053989|childhood acute lymphoblastic leukemia in remission|childhood acute lymphoblastic leukemia in remission
864338|NCT00053989|adult acute lymphoblastic leukemia in remission|adult acute lymphoblastic leukemia in remission
864339|NCT00053989|noncontiguous stage II adult lymphoblastic lymphoma|noncontiguous stage ii adult lymphoblastic lymphoma
864340|NCT00053989|refractory multiple myeloma|refractory multiple myeloma
864341|NCT00053989|refractory anemia|refractory anemia
864342|NCT00053989|refractory chronic lymphocytic leukemia|refractory chronic lymphocytic leukemia
864343|NCT00053989|previously treated myelodysplastic syndromes|previously treated myelodysplastic syndromes
864344|NCT00053989|secondary myelodysplastic syndromes|secondary myelodysplastic syndromes
864345|NCT00053989|grade 1 follicular lymphoma|grade 1 follicular lymphoma
864346|NCT00053989|grade 2 follicular lymphoma|grade 2 follicular lymphoma
864347|NCT00053989|recurrent/refractory childhood Hodgkin lymphoma|recurrent/refractory childhood hodgkin lymphoma
864348|NCT00053989|recurrent adult acute lymphoblastic leukemia|recurrent adult acute lymphoblastic leukemia
864349|NCT00053989|recurrent childhood acute myeloid leukemia|recurrent childhood acute myeloid leukemia
864350|NCT00053989|childhood acute myeloid leukemia in remission|childhood acute myeloid leukemia in remission
864351|NCT00053989|childhood chronic myelogenous leukemia|childhood chronic myelogenous leukemia
864352|NCT00053989|atypical chronic myeloid leukemia|atypical chronic myeloid leukemia
864353|NCT00053989|myelodysplastic/myeloproliferative disease, unclassifiable|myelodysplastic/myeloproliferative disease, unclassifiable
864354|NCT00053989|recurrent marginal zone lymphoma|recurrent marginal zone lymphoma
864355|NCT00053989|recurrent small lymphocytic lymphoma|recurrent small lymphocytic lymphoma
864356|NCT00053989|extranodal marginal zone B-cell lymphoma of mucosa-associated lymphoid tissue|extranodal marginal zone b-cell lymphoma of mucosa-associated lymphoid tissue
864357|NCT00053989|nodal marginal zone B-cell lymphoma|nodal marginal zone b-cell lymphoma
864358|NCT00053989|splenic marginal zone lymphoma|splenic marginal zone lymphoma
864359|NCT00053989|adult acute myeloid leukemia with t(8;21)(q22;q22)|adult acute myeloid leukemia with t(8;21)(q22;q22)
864360|NCT00053989|adult acute myeloid leukemia with t(16;16)(p13;q22)|adult acute myeloid leukemia with t(16;16)(p13;q22)
864361|NCT00053989|adult acute myeloid leukemia with inv(16)(p13;q22)|adult acute myeloid leukemia with inv(16)(p13;q22)
864362|NCT00053989|adult acute myeloid leukemia with 11q23 (MLL) abnormalities|adult acute myeloid leukemia with 11q23 (mll) abnormalities
864524|NCT00053391|stage IV melanoma|stage iv melanoma
864363|NCT00053989|adult acute myeloid leukemia with t(15;17)(q22;q12)|adult acute myeloid leukemia with t(15;17)(q22;q12)
864364|NCT00053989|childhood myelodysplastic syndromes|childhood myelodysplastic syndromes
864365|NCT00053976|graft versus host disease|graft versus host disease
864366|NCT00053937|plexiform neurofibroma|plexiform neurofibroma
864367|NCT00053937|neurofibromatosis type 1|neurofibromatosis type 1
864368|NCT00053924|recurrent pancreatic cancer|recurrent pancreatic cancer
864369|NCT00053924|stage II pancreatic cancer|stage ii pancreatic cancer
864370|NCT00053924|adenocarcinoma of the pancreas|adenocarcinoma of the pancreas
864371|NCT00053924|stage III pancreatic cancer|stage iii pancreatic cancer
864372|NCT00053924|stage IV pancreatic cancer|stage iv pancreatic cancer
864373|NCT00053911|recurrent breast cancer|recurrent breast cancer
864374|NCT00053911|stage I breast cancer|stage i breast cancer
864375|NCT00053911|stage II breast cancer|stage ii breast cancer
864376|NCT00053911|stage IIIA breast cancer|stage iiia breast cancer
864377|NCT00053898|breast cancer in situ|breast cancer in situ
864378|NCT00053898|ductal breast carcinoma in situ|ductal breast carcinoma in situ
864379|NCT00053885|advanced malignant mesothelioma|advanced malignant mesothelioma
864380|NCT00053885|epithelial mesothelioma|epithelial mesothelioma
864381|NCT00053885|recurrent malignant mesothelioma|recurrent malignant mesothelioma
864382|NCT00053885|sarcomatous mesothelioma|sarcomatous mesothelioma
864383|NCT00053872|untreated childhood medulloblastoma|untreated childhood medulloblastoma
864384|NCT00053846|dyspnea|dyspnea
864385|NCT00053846|pulmonary complications|pulmonary complications
864386|NCT00053846|unspecified adult solid tumor, protocol specific|unspecified adult solid tumor, protocol specific
864387|NCT00053833|recurrent ovarian epithelial cancer|recurrent ovarian epithelial cancer
864388|NCT00053833|fallopian tube cancer|fallopian tube cancer
864389|NCT00053833|primary peritoneal cavity cancer|primary peritoneal cavity cancer
864390|NCT00053833|stage III ovarian epithelial cancer|stage iii ovarian epithelial cancer
864391|NCT00053833|stage IV ovarian epithelial cancer|stage iv ovarian epithelial cancer
864392|NCT00053820|stage IV renal cell cancer|stage iv renal cell cancer
864393|NCT00053807|stage III renal cell cancer|stage iii renal cell cancer
864394|NCT00053807|stage IV renal cell cancer|stage iv renal cell cancer
864395|NCT00053794|adult alveolar soft-part sarcoma|adult alveolar soft-part sarcoma
864396|NCT00053794|adult angiosarcoma|adult angiosarcoma
864397|NCT00053794|adult fibrosarcoma|adult fibrosarcoma
864398|NCT00053794|adult leiomyosarcoma|adult leiomyosarcoma
864399|NCT00053794|adult liposarcoma|adult liposarcoma
864400|NCT00053794|adult synovial sarcoma|adult synovial sarcoma
864401|NCT00053794|endometrial stromal sarcoma|endometrial stromal sarcoma
864402|NCT00053794|uterine leiomyosarcoma|uterine leiomyosarcoma
864403|NCT00053794|adult malignant hemangiopericytoma|adult malignant hemangiopericytoma
864404|NCT00053794|stage III adult soft tissue sarcoma|stage iii adult soft tissue sarcoma
864405|NCT00053794|stage III uterine sarcoma|stage iii uterine sarcoma
864406|NCT00053794|stage IV uterine sarcoma|stage iv uterine sarcoma
864407|NCT00053794|recurrent adult soft tissue sarcoma|recurrent adult soft tissue sarcoma
864408|NCT00053794|recurrent uterine sarcoma|recurrent uterine sarcoma
864409|NCT00053794|adult malignant fibrous histiocytoma|adult malignant fibrous histiocytoma
864410|NCT00053794|adult neurofibrosarcoma|adult neurofibrosarcoma
864411|NCT00053794|adult rhabdomyosarcoma|adult rhabdomyosarcoma
864412|NCT00053794|stage IV adult soft tissue sarcoma|stage iv adult soft tissue sarcoma
864413|NCT00053781|recurrent melanoma|recurrent melanoma
864415|NCT00053768|contiguous stage II grade 3 follicular lymphoma|contiguous stage ii grade 3 follicular lymphoma
864416|NCT00053768|noncontiguous stage II grade 3 follicular lymphoma|noncontiguous stage ii grade 3 follicular lymphoma
864417|NCT00053768|stage I grade 3 follicular lymphoma|stage i grade 3 follicular lymphoma
864418|NCT00053768|stage III grade 3 follicular lymphoma|stage iii grade 3 follicular lymphoma
864419|NCT00053768|stage IV grade 3 follicular lymphoma|stage iv grade 3 follicular lymphoma
864420|NCT00053768|contiguous stage II adult diffuse mixed cell lymphoma|contiguous stage ii adult diffuse mixed cell lymphoma
864421|NCT00053768|noncontiguous stage II adult diffuse mixed cell lymphoma|noncontiguous stage ii adult diffuse mixed cell lymphoma
864422|NCT00053768|stage I adult diffuse mixed cell lymphoma|stage i adult diffuse mixed cell lymphoma
864423|NCT00053768|stage III adult diffuse mixed cell lymphoma|stage iii adult diffuse mixed cell lymphoma
864424|NCT00053768|stage IV adult diffuse mixed cell lymphoma|stage iv adult diffuse mixed cell lymphoma
864425|NCT00053768|contiguous stage II adult diffuse large cell lymphoma|contiguous stage ii adult diffuse large cell lymphoma
864426|NCT00053768|contiguous stage II adult Burkitt lymphoma|contiguous stage ii adult burkitt lymphoma
864427|NCT00053768|noncontiguous stage II adult diffuse large cell lymphoma|noncontiguous stage ii adult diffuse large cell lymphoma
864428|NCT00053768|noncontiguous stage II adult Burkitt lymphoma|noncontiguous stage ii adult burkitt lymphoma
864429|NCT00053768|stage I adult diffuse large cell lymphoma|stage i adult diffuse large cell lymphoma
864430|NCT00053768|stage I adult Burkitt lymphoma|stage i adult burkitt lymphoma
864431|NCT00053768|stage III adult diffuse large cell lymphoma|stage iii adult diffuse large cell lymphoma
864432|NCT00053768|stage III adult Burkitt lymphoma|stage iii adult burkitt lymphoma
864433|NCT00053768|stage IV adult diffuse large cell lymphoma|stage iv adult diffuse large cell lymphoma
864434|NCT00053768|stage IV adult Burkitt lymphoma|stage iv adult burkitt lymphoma
864435|NCT00053768|contiguous stage II adult immunoblastic large cell lymphoma|contiguous stage ii adult immunoblastic large cell lymphoma
884854|NCT00002372|VX 478|vx 478
864436|NCT00053768|noncontiguous stage II adult immunoblastic large cell lymphoma|noncontiguous stage ii adult immunoblastic large cell lymphoma
864437|NCT00053768|stage I adult immunoblastic large cell lymphoma|stage i adult immunoblastic large cell lymphoma
864438|NCT00053768|stage III adult immunoblastic large cell lymphoma|stage iii adult immunoblastic large cell lymphoma
864439|NCT00053768|stage IV adult immunoblastic large cell lymphoma|stage iv adult immunoblastic large cell lymphoma
864440|NCT00053768|contiguous stage II adult lymphoblastic lymphoma|contiguous stage ii adult lymphoblastic lymphoma
864441|NCT00053768|noncontiguous stage II adult lymphoblastic lymphoma|noncontiguous stage ii adult lymphoblastic lymphoma
864442|NCT00053768|stage I adult lymphoblastic lymphoma|stage i adult lymphoblastic lymphoma
864443|NCT00053768|stage III adult lymphoblastic lymphoma|stage iii adult lymphoblastic lymphoma
864444|NCT00053768|stage IV adult lymphoblastic lymphoma|stage iv adult lymphoblastic lymphoma
864445|NCT00053768|contiguous stage II mantle cell lymphoma|contiguous stage ii mantle cell lymphoma
864446|NCT00053768|noncontiguous stage II mantle cell lymphoma|noncontiguous stage ii mantle cell lymphoma
864447|NCT00053768|stage I mantle cell lymphoma|stage i mantle cell lymphoma
864448|NCT00053768|stage III mantle cell lymphoma|stage iii mantle cell lymphoma
864449|NCT00053768|stage IV mantle cell lymphoma|stage iv mantle cell lymphoma
864450|NCT00053716|Angioplasty & PGE1 Treatment of Peripheral Vascular Disease|angioplasty & pge1 treatment of peripheral vascular disease
864451|NCT00045123|adenocarcinoma of the prostate|adenocarcinoma of the prostate
864452|NCT00045123|recurrent prostate cancer|recurrent prostate cancer
864453|NCT00028678|adult glioblastoma|adult glioblastoma
864454|NCT00028678|adult giant cell glioblastoma|adult giant cell glioblastoma
864455|NCT00028678|adult gliosarcoma|adult gliosarcoma
864456|NCT00017342|recurrent adult acute myeloid leukemia|recurrent adult acute myeloid leukemia
864457|NCT00017342|adult acute myeloid leukemia with t(8;21)(q22;q22)|adult acute myeloid leukemia with t(8;21)(q22;q22)
864458|NCT00017342|adult acute myeloid leukemia with t(16;16)(p13;q22)|adult acute myeloid leukemia with t(16;16)(p13;q22)
864459|NCT00017342|adult acute myeloid leukemia with inv(16)(p13;q22)|adult acute myeloid leukemia with inv(16)(p13;q22)
864460|NCT00017342|adult acute myeloid leukemia with 11q23 (MLL) abnormalities|adult acute myeloid leukemia with 11q23 (mll) abnormalities
864461|NCT00017342|adult acute myeloid leukemia with t(15;17)(q22;q12)|adult acute myeloid leukemia with t(15;17)(q22;q12)
864462|NCT00053742|Smallpox|smallpox
864463|NCT00053742|Vaccine|vaccine
864464|NCT00053742|Vaccination|vaccination
864465|NCT00053742|Variola|variola
864466|NCT00053742|Adults|adults
864467|NCT00053742|Healthy Volunteer|healthy volunteer
864468|NCT00053742|HV|hv
864469|NCT00053742|Smallpox Vaccine|smallpox vaccine
864470|NCT00053703|Psychotic Disorders|psychotic disorders
864471|NCT00053703|Schizophreniform Disorder|schizophreniform disorder
864472|NCT00053690|Comorbidity|comorbidity
864473|NCT00053690|Schizophrenia|schizophrenia
864474|NCT00053690|Bipolar Disorder|bipolar disorder
864475|NCT00053690|Depression|depression
864476|NCT00053677|Impulse Control Disorders|impulse control disorders
864477|NCT00053638|HIV-1 Efavirenz Tenofovir|hiv-1 efavirenz tenofovir
864478|NCT00053625|Parkinson's disease|parkinson's disease
864479|NCT00053625|PD|pd
864480|NCT00053625|deep brain stimulation|deep brain stimulation
864481|NCT00053625|DBS|dbs
864482|NCT00053612|HIV-1|hiv-1
864483|NCT00053612|Women|women
864484|NCT00053612|Vitamin A|vitamin a
864485|NCT00053612|Shedding|shedding
864486|NCT00053599|Cholesterol-lowering drug|cholesterol-lowering drug
864487|NCT00053599|Mild to Moderate Alzheimer disease|mild to moderate alzheimer disease
864488|NCT00053573|Glycogen Storage Disease Type II|glycogen storage disease type ii
864489|NCT00053573|GSD-II|gsd-ii
864490|NCT00053573|Pompe Disease|pompe disease
864491|NCT00053560|lupus|lupus
864492|NCT00053560|systemic lupus erythematosus|systemic lupus erythematosus
864493|NCT00053560|SLE|sle
864494|NCT00053560|bone loss|bone loss
864495|NCT00053560|DHEA|dhea
864496|NCT00053495|Smallpox|smallpox
864497|NCT00053482|Smallpox vaccines|smallpox vaccines
864498|NCT00053482|Dryvax®|dryvax®
864499|NCT00053482|Orthopoxvirus|orthopoxvirus
864500|NCT00053482|Vaccinia virus|vaccinia virus
864501|NCT00053482|ACAM2000|acam2000
864502|NCT00053469|Cognitive Development|cognitive development
864503|NCT00053469|Motor Planning|motor planning
864504|NCT00053469|Categorization|categorization
864505|NCT00053469|Perception|perception
864506|NCT00053469|Adaptation|adaptation
864507|NCT00053456|Endothelium|endothelium
864508|NCT00053456|Nitric Oxide|nitric oxide
864509|NCT00053456|Myocardial Ischemia|myocardial ischemia
864510|NCT00053456|Exercise|exercise
864511|NCT00053456|Endothelial Progenitor Cells|endothelial progenitor cells
864512|NCT00053443|Adherence|adherence
864513|NCT00053443|Treatment Experienced|treatment experienced
864514|NCT00053430|Immune Modulation|immune modulation
864515|NCT00053430|Thalidomide|thalidomide
864516|NCT00053430|Immune reconstitution|immune reconstitution
864517|NCT00053430|Treatment Experienced|treatment experienced
864518|NCT00053417|Walking Ability|walking ability
864519|NCT00053417|Muscle strength|muscle strength
864520|NCT00053417|Spasticity|spasticity
864521|NCT00053404|Treatment Experienced|treatment experienced
864522|NCT00053404|Drug Resistance|drug resistance
864523|NCT00053391|stage III melanoma|stage iii melanoma
864525|NCT00053391|recurrent melanoma|recurrent melanoma
864526|NCT00053378|hypocalcemia, ionized calcium, intensive care|hypocalcemia, ionized calcium, intensive care
864527|NCT00053300|extensive stage small cell lung cancer|extensive stage small cell lung cancer
864528|NCT00053287|adult acute promyelocytic leukemia (M3)|adult acute promyelocytic leukemia (m3)
864529|NCT00053287|refractory anemia with excess blasts in transformation|refractory anemia with excess blasts in transformation
864530|NCT00053287|refractory anemia with excess blasts|refractory anemia with excess blasts
864531|NCT00053287|de novo myelodysplastic syndromes|de novo myelodysplastic syndromes
864532|NCT00053287|recurrent adult acute myeloid leukemia|recurrent adult acute myeloid leukemia
864533|NCT00053287|secondary acute myeloid leukemia|secondary acute myeloid leukemia
864534|NCT00053287|untreated adult acute myeloid leukemia|untreated adult acute myeloid leukemia
864535|NCT00053287|blastic phase chronic myelogenous leukemia|blastic phase chronic myelogenous leukemia
864536|NCT00053287|relapsing chronic myelogenous leukemia|relapsing chronic myelogenous leukemia
864537|NCT00053287|previously treated myelodysplastic syndromes|previously treated myelodysplastic syndromes
864538|NCT00053287|secondary myelodysplastic syndromes|secondary myelodysplastic syndromes
864539|NCT00053287|atypical chronic myeloid leukemia|atypical chronic myeloid leukemia
864540|NCT00053287|myelodysplastic/myeloproliferative disease, unclassifiable|myelodysplastic/myeloproliferative disease, unclassifiable
864541|NCT00053287|adult acute myeloid leukemia with t(8;21)(q22;q22)|adult acute myeloid leukemia with t(8;21)(q22;q22)
864542|NCT00053287|adult acute myeloid leukemia with t(16;16)(p13;q22)|adult acute myeloid leukemia with t(16;16)(p13;q22)
864543|NCT00053287|adult acute myeloid leukemia with inv(16)(p13;q22)|adult acute myeloid leukemia with inv(16)(p13;q22)
864544|NCT00053287|adult acute myeloid leukemia with 11q23 (MLL) abnormalities|adult acute myeloid leukemia with 11q23 (mll) abnormalities
864545|NCT00053287|adult acute myeloid leukemia with t(15;17)(q22;q12)|adult acute myeloid leukemia with t(15;17)(q22;q12)
864546|NCT00053261|sexuality and reproductive issues|sexuality and reproductive issues
864547|NCT00053261|stage IB cervical cancer|stage ib cervical cancer
864548|NCT00053248|chronic phase chronic myelogenous leukemia|chronic phase chronic myelogenous leukemia
864549|NCT00053248|Philadelphia chromosome positive chronic myelogenous leukemia|philadelphia chromosome positive chronic myelogenous leukemia
864550|NCT00053222|recurrent pancreatic cancer|recurrent pancreatic cancer
864551|NCT00053222|stage II pancreatic cancer|stage ii pancreatic cancer
864552|NCT00053222|stage III pancreatic cancer|stage iii pancreatic cancer
864553|NCT00053222|adenocarcinoma of the pancreas|adenocarcinoma of the pancreas
864554|NCT00053222|stage IV pancreatic cancer|stage iv pancreatic cancer
864555|NCT00053209|metastatic transitional cell cancer of the renal pelvis and ureter|metastatic transitional cell cancer of the renal pelvis and ureter
864556|NCT00053209|recurrent transitional cell cancer of the renal pelvis and ureter|recurrent transitional cell cancer of the renal pelvis and ureter
864557|NCT00053209|regional transitional cell cancer of the renal pelvis and ureter|regional transitional cell cancer of the renal pelvis and ureter
864558|NCT00053209|transitional cell carcinoma of the bladder|transitional cell carcinoma of the bladder
864559|NCT00053209|recurrent bladder cancer|recurrent bladder cancer
864560|NCT00053209|stage III bladder cancer|stage iii bladder cancer
864561|NCT00053209|stage IV bladder cancer|stage iv bladder cancer
864562|NCT00053209|anterior urethral cancer|anterior urethral cancer
864563|NCT00053209|posterior urethral cancer|posterior urethral cancer
864564|NCT00053209|recurrent urethral cancer|recurrent urethral cancer
864565|NCT00053209|urethral cancer associated with invasive bladder cancer|urethral cancer associated with invasive bladder cancer
864566|NCT00053196|refractory chronic lymphocytic leukemia|refractory chronic lymphocytic leukemia
864567|NCT00053196|prolymphocytic leukemia|prolymphocytic leukemia
864568|NCT00053196|recurrent adult Hodgkin lymphoma|recurrent adult hodgkin lymphoma
864569|NCT00053196|stage I multiple myeloma|stage i multiple myeloma
864570|NCT00053196|stage II multiple myeloma|stage ii multiple myeloma
864571|NCT00053196|stage III multiple myeloma|stage iii multiple myeloma
864572|NCT00053196|refractory multiple myeloma|refractory multiple myeloma
864573|NCT00053196|previously treated myelodysplastic syndromes|previously treated myelodysplastic syndromes
864574|NCT00053196|recurrent adult diffuse large cell lymphoma|recurrent adult diffuse large cell lymphoma
864575|NCT00053196|recurrent adult diffuse mixed cell lymphoma|recurrent adult diffuse mixed cell lymphoma
864576|NCT00053196|recurrent adult diffuse small cleaved cell lymphoma|recurrent adult diffuse small cleaved cell lymphoma
864577|NCT00053196|recurrent adult Burkitt lymphoma|recurrent adult burkitt lymphoma
864578|NCT00053196|recurrent adult immunoblastic large cell lymphoma|recurrent adult immunoblastic large cell lymphoma
864579|NCT00053196|recurrent grade 1 follicular lymphoma|recurrent grade 1 follicular lymphoma
864580|NCT00053196|recurrent grade 2 follicular lymphoma|recurrent grade 2 follicular lymphoma
864581|NCT00053196|recurrent grade 3 follicular lymphoma|recurrent grade 3 follicular lymphoma
864582|NCT00053196|secondary myelodysplastic syndromes|secondary myelodysplastic syndromes
864583|NCT00053196|de novo myelodysplastic syndromes|de novo myelodysplastic syndromes
864584|NCT00053196|recurrent adult acute myeloid leukemia|recurrent adult acute myeloid leukemia
864585|NCT00053196|recurrent childhood acute myeloid leukemia|recurrent childhood acute myeloid leukemia
864586|NCT00053196|recurrent childhood large cell lymphoma|recurrent childhood large cell lymphoma
864587|NCT00053196|recurrent childhood lymphoblastic lymphoma|recurrent childhood lymphoblastic lymphoma
864588|NCT00053196|recurrent childhood small noncleaved cell lymphoma|recurrent childhood small noncleaved cell lymphoma
864912|NCT00052507|stage IV rectal cancer|stage iv rectal cancer
864589|NCT00053196|recurrent/refractory childhood Hodgkin lymphoma|recurrent/refractory childhood hodgkin lymphoma
864590|NCT00053196|atypical chronic myeloid leukemia, BCR-ABL negative|atypical chronic myeloid leukemia, bcr-abl negative
864591|NCT00053196|myelodysplastic/myeloproliferative neoplasm, unclassifiable|myelodysplastic/myeloproliferative neoplasm, unclassifiable
864592|NCT00053196|recurrent marginal zone lymphoma|recurrent marginal zone lymphoma
864593|NCT00053196|recurrent small lymphocytic lymphoma|recurrent small lymphocytic lymphoma
864594|NCT00053196|extranodal marginal zone B-cell lymphoma of mucosa-associated lymphoid tissue|extranodal marginal zone b-cell lymphoma of mucosa-associated lymphoid tissue
864595|NCT00053196|nodal marginal zone B-cell lymphoma|nodal marginal zone b-cell lymphoma
864596|NCT00053196|splenic marginal zone lymphoma|splenic marginal zone lymphoma
864597|NCT00053196|adult acute myeloid leukemia with t(8;21)(q22;q22)|adult acute myeloid leukemia with t(8;21)(q22;q22)
867297|NCT00031798|quality of life|quality of life
864598|NCT00053196|adult acute myeloid leukemia with t(16;16)(p13;q22)|adult acute myeloid leukemia with t(16;16)(p13;q22)
864599|NCT00053196|adult acute myeloid leukemia with inv(16)(p13;q22)|adult acute myeloid leukemia with inv(16)(p13;q22)
864600|NCT00053196|adult acute myeloid leukemia with 11q23 (MLL) abnormalities|adult acute myeloid leukemia with 11q23 (mll) abnormalities
864601|NCT00053196|adult acute myeloid leukemia with t(15;17)(q22;q12)|adult acute myeloid leukemia with t(15;17)(q22;q12)
864602|NCT00053196|childhood myelodysplastic syndromes|childhood myelodysplastic syndromes
864603|NCT00053183|adult glioblastoma|adult glioblastoma
864604|NCT00053183|adult giant cell glioblastoma|adult giant cell glioblastoma
864605|NCT00053183|adult gliosarcoma|adult gliosarcoma
864606|NCT00053157|graft versus host disease|graft versus host disease
864607|NCT00053157|accelerated phase chronic myelogenous leukemia|accelerated phase chronic myelogenous leukemia
864608|NCT00053157|chronic phase chronic myelogenous leukemia|chronic phase chronic myelogenous leukemia
864609|NCT00053157|primary myelofibrosis|primary myelofibrosis
864610|NCT00053157|childhood acute myeloid leukemia/other myeloid malignancies|childhood acute myeloid leukemia/other myeloid malignancies
864611|NCT00053157|childhood acute promyelocytic leukemia (M3)|childhood acute promyelocytic leukemia (m3)
864612|NCT00053157|recurrent childhood acute lymphoblastic leukemia|recurrent childhood acute lymphoblastic leukemia
864613|NCT00053157|recurrent childhood acute myeloid leukemia|recurrent childhood acute myeloid leukemia
864614|NCT00053157|recurrent childhood large cell lymphoma|recurrent childhood large cell lymphoma
864615|NCT00053157|recurrent childhood lymphoblastic lymphoma|recurrent childhood lymphoblastic lymphoma
864616|NCT00053157|recurrent childhood small noncleaved cell lymphoma|recurrent childhood small noncleaved cell lymphoma
864617|NCT00053157|recurrent/refractory childhood Hodgkin lymphoma|recurrent/refractory childhood hodgkin lymphoma
864618|NCT00053157|de novo myelodysplastic syndromes|de novo myelodysplastic syndromes
864619|NCT00053157|previously treated myelodysplastic syndromes|previously treated myelodysplastic syndromes
864620|NCT00053157|secondary myelodysplastic syndromes|secondary myelodysplastic syndromes
864621|NCT00053157|meningeal chronic myelogenous leukemia|meningeal chronic myelogenous leukemia
864622|NCT00053157|noncontiguous stage II adult diffuse large cell lymphoma|noncontiguous stage ii adult diffuse large cell lymphoma
864623|NCT00053157|noncontiguous stage II adult diffuse mixed cell lymphoma|noncontiguous stage ii adult diffuse mixed cell lymphoma
864624|NCT00053157|noncontiguous stage II adult diffuse small cleaved cell lymphoma|noncontiguous stage ii adult diffuse small cleaved cell lymphoma
864625|NCT00053157|noncontiguous stage II adult Burkitt lymphoma|noncontiguous stage ii adult burkitt lymphoma
867404|NCT00030784|adult synovial sarcoma|adult synovial sarcoma
864626|NCT00053157|noncontiguous stage II adult immunoblastic large cell lymphoma|noncontiguous stage ii adult immunoblastic large cell lymphoma
864627|NCT00053157|noncontiguous stage II adult lymphoblastic lymphoma|noncontiguous stage ii adult lymphoblastic lymphoma
864628|NCT00053157|noncontiguous stage II grade 1 follicular lymphoma|noncontiguous stage ii grade 1 follicular lymphoma
864629|NCT00053157|noncontiguous stage II grade 2 follicular lymphoma|noncontiguous stage ii grade 2 follicular lymphoma
864630|NCT00053157|noncontiguous stage II grade 3 follicular lymphoma|noncontiguous stage ii grade 3 follicular lymphoma
864631|NCT00053157|noncontiguous stage II mantle cell lymphoma|noncontiguous stage ii mantle cell lymphoma
864632|NCT00053157|recurrent adult diffuse large cell lymphoma|recurrent adult diffuse large cell lymphoma
864633|NCT00053157|recurrent adult diffuse mixed cell lymphoma|recurrent adult diffuse mixed cell lymphoma
864634|NCT00053157|recurrent adult diffuse small cleaved cell lymphoma|recurrent adult diffuse small cleaved cell lymphoma
864635|NCT00053157|recurrent adult Burkitt lymphoma|recurrent adult burkitt lymphoma
864636|NCT00053157|recurrent adult immunoblastic large cell lymphoma|recurrent adult immunoblastic large cell lymphoma
864637|NCT00053157|recurrent adult lymphoblastic lymphoma|recurrent adult lymphoblastic lymphoma
864638|NCT00053157|recurrent adult acute lymphoblastic leukemia|recurrent adult acute lymphoblastic leukemia
864639|NCT00053157|recurrent adult acute myeloid leukemia|recurrent adult acute myeloid leukemia
864640|NCT00053157|recurrent adult Hodgkin lymphoma|recurrent adult hodgkin lymphoma
864641|NCT00053157|recurrent cutaneous T-cell non-Hodgkin lymphoma|recurrent cutaneous t-cell non-hodgkin lymphoma
864642|NCT00053157|recurrent grade 1 follicular lymphoma|recurrent grade 1 follicular lymphoma
864643|NCT00053157|recurrent grade 2 follicular lymphoma|recurrent grade 2 follicular lymphoma
864644|NCT00053157|recurrent grade 3 follicular lymphoma|recurrent grade 3 follicular lymphoma
864645|NCT00053157|recurrent mantle cell lymphoma|recurrent mantle cell lymphoma
864646|NCT00053157|relapsing chronic myelogenous leukemia|relapsing chronic myelogenous leukemia
864647|NCT00053157|secondary acute myeloid leukemia|secondary acute myeloid leukemia
884855|NCT00002371|HIV-1|hiv-1
864648|NCT00053157|refractory chronic lymphocytic leukemia|refractory chronic lymphocytic leukemia
864649|NCT00053157|stage III adult diffuse large cell lymphoma|stage iii adult diffuse large cell lymphoma
864650|NCT00053157|stage III adult diffuse mixed cell lymphoma|stage iii adult diffuse mixed cell lymphoma
864651|NCT00053157|stage III adult diffuse small cleaved cell lymphoma|stage iii adult diffuse small cleaved cell lymphoma
864652|NCT00053157|stage III adult Burkitt lymphoma|stage iii adult burkitt lymphoma
864653|NCT00053157|stage III adult immunoblastic large cell lymphoma|stage iii adult immunoblastic large cell lymphoma
864654|NCT00053157|stage III adult lymphoblastic lymphoma|stage iii adult lymphoblastic lymphoma
864655|NCT00053157|stage III grade 1 follicular lymphoma|stage iii grade 1 follicular lymphoma
864656|NCT00053157|stage III grade 2 follicular lymphoma|stage iii grade 2 follicular lymphoma
864657|NCT00053157|stage III grade 3 follicular lymphoma|stage iii grade 3 follicular lymphoma
864658|NCT00053157|stage III mantle cell lymphoma|stage iii mantle cell lymphoma
864659|NCT00053157|stage III chronic lymphocytic leukemia|stage iii chronic lymphocytic leukemia
864660|NCT00053157|stage IV adult diffuse large cell lymphoma|stage iv adult diffuse large cell lymphoma
864661|NCT00053157|stage IV adult diffuse mixed cell lymphoma|stage iv adult diffuse mixed cell lymphoma
864662|NCT00053157|stage IV adult diffuse small cleaved cell lymphoma|stage iv adult diffuse small cleaved cell lymphoma
864663|NCT00053157|stage IV adult Burkitt lymphoma|stage iv adult burkitt lymphoma
864664|NCT00053157|stage IV adult immunoblastic large cell lymphoma|stage iv adult immunoblastic large cell lymphoma
864665|NCT00053157|stage IV adult lymphoblastic lymphoma|stage iv adult lymphoblastic lymphoma
864666|NCT00053157|stage IV grade 1 follicular lymphoma|stage iv grade 1 follicular lymphoma
864667|NCT00053157|stage IV grade 2 follicular lymphoma|stage iv grade 2 follicular lymphoma
864668|NCT00053157|stage IV grade 3 follicular lymphoma|stage iv grade 3 follicular lymphoma
864669|NCT00053157|stage IV mantle cell lymphoma|stage iv mantle cell lymphoma
864670|NCT00053157|stage IV chronic lymphocytic leukemia|stage iv chronic lymphocytic leukemia
864671|NCT00053157|untreated adult acute lymphoblastic leukemia|untreated adult acute lymphoblastic leukemia
864672|NCT00053157|untreated adult acute myeloid leukemia|untreated adult acute myeloid leukemia
864673|NCT00053157|untreated childhood acute lymphoblastic leukemia|untreated childhood acute lymphoblastic leukemia
864674|NCT00053157|untreated childhood acute myeloid leukemia and other myeloid malignancies|untreated childhood acute myeloid leukemia and other myeloid malignancies
864675|NCT00053157|childhood chronic myelogenous leukemia|childhood chronic myelogenous leukemia
864676|NCT00053157|chronic eosinophilic leukemia|chronic eosinophilic leukemia
864677|NCT00053157|chronic neutrophilic leukemia|chronic neutrophilic leukemia
864678|NCT00053157|atypical chronic myeloid leukemia, BCR-ABL1 negative|atypical chronic myeloid leukemia, bcr-abl1 negative
864679|NCT00053157|myelodysplastic/myeloproliferative neoplasm, unclassifiable|myelodysplastic/myeloproliferative neoplasm, unclassifiable
864680|NCT00053157|noncontiguous stage II small lymphocytic lymphoma|noncontiguous stage ii small lymphocytic lymphoma
864681|NCT00053157|noncontiguous stage II marginal zone lymphoma|noncontiguous stage ii marginal zone lymphoma
864682|NCT00053157|recurrent marginal zone lymphoma|recurrent marginal zone lymphoma
864683|NCT00053157|recurrent small lymphocytic lymphoma|recurrent small lymphocytic lymphoma
864684|NCT00053157|stage III small lymphocytic lymphoma|stage iii small lymphocytic lymphoma
864685|NCT00053157|stage III marginal zone lymphoma|stage iii marginal zone lymphoma
864686|NCT00053157|stage IV small lymphocytic lymphoma|stage iv small lymphocytic lymphoma
864687|NCT00053157|stage IV marginal zone lymphoma|stage iv marginal zone lymphoma
864688|NCT00053157|extranodal marginal zone B-cell lymphoma of mucosa-associated lymphoid tissue|extranodal marginal zone b-cell lymphoma of mucosa-associated lymphoid tissue
864689|NCT00053157|nodal marginal zone B-cell lymphoma|nodal marginal zone b-cell lymphoma
864690|NCT00053157|splenic marginal zone lymphoma|splenic marginal zone lymphoma
864691|NCT00053157|adult acute myeloid leukemia with t(8;21)(q22;q22)|adult acute myeloid leukemia with t(8;21)(q22;q22)
864692|NCT00053157|adult acute myeloid leukemia with t(16;16)(p13;q22)|adult acute myeloid leukemia with t(16;16)(p13;q22)
864693|NCT00053157|adult acute myeloid leukemia with inv(16)(p13;q22)|adult acute myeloid leukemia with inv(16)(p13;q22)
864694|NCT00053157|adult acute myeloid leukemia with 11q23 (MLL) abnormalities|adult acute myeloid leukemia with 11q23 (mll) abnormalities
864695|NCT00053157|adult acute myeloid leukemia with t(15;17)(q22;q12)|adult acute myeloid leukemia with t(15;17)(q22;q12)
864696|NCT00053157|childhood myelodysplastic syndromes|childhood myelodysplastic syndromes
864697|NCT00053144|recurrent adult acute myeloid leukemia|recurrent adult acute myeloid leukemia
864698|NCT00053144|Philadelphia chromosome positive chronic myelogenous leukemia|philadelphia chromosome positive chronic myelogenous leukemia
864699|NCT00053144|secondary acute myeloid leukemia|secondary acute myeloid leukemia
864700|NCT00053144|blastic phase chronic myelogenous leukemia|blastic phase chronic myelogenous leukemia
864701|NCT00053144|relapsing chronic myelogenous leukemia|relapsing chronic myelogenous leukemia
864702|NCT00053144|adult acute monocytic leukemia (M5b)|adult acute monocytic leukemia (m5b)
864703|NCT00053144|adult acute erythroid leukemia (M6)|adult acute erythroid leukemia (m6)
864704|NCT00053144|adult acute megakaryoblastic leukemia (M7)|adult acute megakaryoblastic leukemia (m7)
864705|NCT00053144|adult acute minimally differentiated myeloid leukemia (M0)|adult acute minimally differentiated myeloid leukemia (m0)
864706|NCT00053144|adult acute myeloblastic leukemia with maturation (M2)|adult acute myeloblastic leukemia with maturation (m2)
864707|NCT00053144|adult acute myeloblastic leukemia without maturation (M1)|adult acute myeloblastic leukemia without maturation (m1)
864708|NCT00053144|adult acute myelomonocytic leukemia (M4)|adult acute myelomonocytic leukemia (m4)
864709|NCT00053144|adult acute monoblastic leukemia (M5a)|adult acute monoblastic leukemia (m5a)
864710|NCT00053144|adult acute promyelocytic leukemia (M3)|adult acute promyelocytic leukemia (m3)
864711|NCT00053131|recurrent adult acute myeloid leukemia|recurrent adult acute myeloid leukemia
864712|NCT00053131|recurrent childhood acute myeloid leukemia|recurrent childhood acute myeloid leukemia
864713|NCT00053131|recurrent adult acute lymphoblastic leukemia|recurrent adult acute lymphoblastic leukemia
864714|NCT00053131|recurrent childhood acute lymphoblastic leukemia|recurrent childhood acute lymphoblastic leukemia
864715|NCT00053118|childhood central nervous system germ cell tumor|childhood central nervous system germ cell tumor
864716|NCT00053118|childhood choroid plexus tumor|childhood choroid plexus tumor
864717|NCT00053118|childhood craniopharyngioma|childhood craniopharyngioma
864718|NCT00053118|childhood grade I meningioma|childhood grade i meningioma
864719|NCT00053118|childhood grade II meningioma|childhood grade ii meningioma
864720|NCT00053118|childhood grade III meningioma|childhood grade iii meningioma
864721|NCT00053118|recurrent childhood brain stem glioma|recurrent childhood brain stem glioma
864722|NCT00053118|recurrent childhood cerebellar astrocytoma|recurrent childhood cerebellar astrocytoma
864723|NCT00053118|recurrent childhood cerebral astrocytoma|recurrent childhood cerebral astrocytoma
864724|NCT00053118|recurrent childhood ependymoma|recurrent childhood ependymoma
864725|NCT00053118|recurrent childhood medulloblastoma|recurrent childhood medulloblastoma
864726|NCT00053118|recurrent childhood supratentorial primitive neuroectodermal tumor|recurrent childhood supratentorial primitive neuroectodermal tumor
864727|NCT00053118|recurrent neuroblastoma|recurrent neuroblastoma
864728|NCT00053118|recurrent retinoblastoma|recurrent retinoblastoma
864729|NCT00053118|childhood visual pathway and hypothalamic glioma|childhood visual pathway and hypothalamic glioma
864730|NCT00053118|childhood atypical teratoid/rhabdoid tumor|childhood atypical teratoid/rhabdoid tumor
864731|NCT00053118|primary central nervous system non-Hodgkin lymphoma|primary central nervous system non-hodgkin lymphoma
864732|NCT00053105|recurrent adult diffuse large cell lymphoma|recurrent adult diffuse large cell lymphoma
864733|NCT00053105|recurrent grade 3 follicular lymphoma|recurrent grade 3 follicular lymphoma
864734|NCT00053105|recurrent cutaneous T-cell non-Hodgkin lymphoma|recurrent cutaneous t-cell non-hodgkin lymphoma
864735|NCT00053105|recurrent adult immunoblastic large cell lymphoma|recurrent adult immunoblastic large cell lymphoma
864736|NCT00053092|contiguous stage II mantle cell lymphoma|contiguous stage ii mantle cell lymphoma
864737|NCT00053092|noncontiguous stage II mantle cell lymphoma|noncontiguous stage ii mantle cell lymphoma
864738|NCT00053092|stage I mantle cell lymphoma|stage i mantle cell lymphoma
864739|NCT00053092|stage III mantle cell lymphoma|stage iii mantle cell lymphoma
864740|NCT00053092|stage IV mantle cell lymphoma|stage iv mantle cell lymphoma
864741|NCT00053053|unspecified adult solid tumor, protocol specific|unspecified adult solid tumor, protocol specific
864742|NCT00053053|cachexia|cachexia
864743|NCT00053053|recurrent adult diffuse large cell lymphoma|recurrent adult diffuse large cell lymphoma
864744|NCT00053053|recurrent adult diffuse mixed cell lymphoma|recurrent adult diffuse mixed cell lymphoma
864745|NCT00053053|recurrent adult diffuse small cleaved cell lymphoma|recurrent adult diffuse small cleaved cell lymphoma
864746|NCT00053053|recurrent adult Hodgkin lymphoma|recurrent adult hodgkin lymphoma
864747|NCT00053053|recurrent adult immunoblastic large cell lymphoma|recurrent adult immunoblastic large cell lymphoma
864748|NCT00053053|recurrent adult lymphoblastic lymphoma|recurrent adult lymphoblastic lymphoma
864749|NCT00053053|recurrent cutaneous T-cell non-Hodgkin lymphoma|recurrent cutaneous t-cell non-hodgkin lymphoma
864750|NCT00053053|recurrent grade 1 follicular lymphoma|recurrent grade 1 follicular lymphoma
864751|NCT00053053|recurrent grade 2 follicular lymphoma|recurrent grade 2 follicular lymphoma
864752|NCT00053053|recurrent grade 3 follicular lymphoma|recurrent grade 3 follicular lymphoma
864753|NCT00053053|recurrent mantle cell lymphoma|recurrent mantle cell lymphoma
864754|NCT00053053|stage III adult diffuse large cell lymphoma|stage iii adult diffuse large cell lymphoma
864755|NCT00053053|stage III adult diffuse mixed cell lymphoma|stage iii adult diffuse mixed cell lymphoma
864756|NCT00053053|stage III adult diffuse small cleaved cell lymphoma|stage iii adult diffuse small cleaved cell lymphoma
864757|NCT00053053|stage III adult Burkitt lymphoma|stage iii adult burkitt lymphoma
864758|NCT00053053|stage III adult Hodgkin lymphoma|stage iii adult hodgkin lymphoma
864759|NCT00053053|stage III adult immunoblastic large cell lymphoma|stage iii adult immunoblastic large cell lymphoma
864760|NCT00053053|stage III adult lymphoblastic lymphoma|stage iii adult lymphoblastic lymphoma
864761|NCT00053053|stage III cutaneous T-cell non-Hodgkin lymphoma|stage iii cutaneous t-cell non-hodgkin lymphoma
864762|NCT00053053|stage III grade 1 follicular lymphoma|stage iii grade 1 follicular lymphoma
864763|NCT00053053|stage III grade 2 follicular lymphoma|stage iii grade 2 follicular lymphoma
864764|NCT00053053|stage III grade 3 follicular lymphoma|stage iii grade 3 follicular lymphoma
864765|NCT00053053|stage III mantle cell lymphoma|stage iii mantle cell lymphoma
864766|NCT00053053|stage IV adult diffuse large cell lymphoma|stage iv adult diffuse large cell lymphoma
864767|NCT00053053|stage IV adult diffuse mixed cell lymphoma|stage iv adult diffuse mixed cell lymphoma
864768|NCT00053053|stage IV adult diffuse small cleaved cell lymphoma|stage iv adult diffuse small cleaved cell lymphoma
864769|NCT00053053|stage IV adult Burkitt lymphoma|stage iv adult burkitt lymphoma
864770|NCT00053053|stage IV adult Hodgkin lymphoma|stage iv adult hodgkin lymphoma
864771|NCT00053053|stage IV adult immunoblastic large cell lymphoma|stage iv adult immunoblastic large cell lymphoma
864772|NCT00053053|stage IV adult lymphoblastic lymphoma|stage iv adult lymphoblastic lymphoma
885040|NCT00002332|Thymopentin|thymopentin
864773|NCT00053053|stage IV cutaneous T-cell non-Hodgkin lymphoma|stage iv cutaneous t-cell non-hodgkin lymphoma
864774|NCT00053053|stage IV grade 1 follicular lymphoma|stage iv grade 1 follicular lymphoma
864775|NCT00053053|stage IV grade 2 follicular lymphoma|stage iv grade 2 follicular lymphoma
864776|NCT00053053|stage IV grade 3 follicular lymphoma|stage iv grade 3 follicular lymphoma
864777|NCT00053053|stage IV mantle cell lymphoma|stage iv mantle cell lymphoma
864778|NCT00053053|intraocular lymphoma|intraocular lymphoma
864779|NCT00053053|AIDS-related peripheral/systemic lymphoma|aids-related peripheral/systemic lymphoma
864780|NCT00053053|recurrent adult Burkitt lymphoma|recurrent adult burkitt lymphoma
864781|NCT00053053|anaplastic large cell lymphoma|anaplastic large cell lymphoma
864782|NCT00053053|post-transplant lymphoproliferative disorder|post-transplant lymphoproliferative disorder
864783|NCT00053053|recurrent marginal zone lymphoma|recurrent marginal zone lymphoma
864784|NCT00053053|recurrent small lymphocytic lymphoma|recurrent small lymphocytic lymphoma
864785|NCT00053053|stage III small lymphocytic lymphoma|stage iii small lymphocytic lymphoma
864786|NCT00053053|stage III marginal zone lymphoma|stage iii marginal zone lymphoma
864787|NCT00053053|stage IV small lymphocytic lymphoma|stage iv small lymphocytic lymphoma
864788|NCT00053053|stage IV marginal zone lymphoma|stage iv marginal zone lymphoma
864789|NCT00053053|extranodal marginal zone B-cell lymphoma of mucosa-associated lymphoid tissue|extranodal marginal zone b-cell lymphoma of mucosa-associated lymphoid tissue
864790|NCT00053053|nodal marginal zone B-cell lymphoma|nodal marginal zone b-cell lymphoma
864791|NCT00053053|splenic marginal zone lymphoma|splenic marginal zone lymphoma
864792|NCT00053040|recurrent childhood brain tumor|recurrent childhood brain tumor
864793|NCT00053027|contiguous stage II mantle cell lymphoma|contiguous stage ii mantle cell lymphoma
864794|NCT00053027|noncontiguous stage II mantle cell lymphoma|noncontiguous stage ii mantle cell lymphoma
864795|NCT00053027|stage I mantle cell lymphoma|stage i mantle cell lymphoma
864796|NCT00053027|stage III mantle cell lymphoma|stage iii mantle cell lymphoma
864797|NCT00053027|stage IV mantle cell lymphoma|stage iv mantle cell lymphoma
864798|NCT00053014|adult acute myeloid leukemia in remission|adult acute myeloid leukemia in remission
864799|NCT00053014|adult acute myeloid leukemia with t(8;21)(q22;q22)|adult acute myeloid leukemia with t(8;21)(q22;q22)
864800|NCT00053014|adult acute myeloid leukemia with t(16;16)(p13;q22)|adult acute myeloid leukemia with t(16;16)(p13;q22)
864801|NCT00053014|adult acute myeloid leukemia with inv(16)(p13;q22)|adult acute myeloid leukemia with inv(16)(p13;q22)
864802|NCT00053014|adult acute myeloid leukemia with 11q23 (MLL) abnormalities|adult acute myeloid leukemia with 11q23 (mll) abnormalities
864803|NCT00053001|de novo myelodysplastic syndromes|de novo myelodysplastic syndromes
864804|NCT00053001|secondary myelodysplastic syndromes|secondary myelodysplastic syndromes
864805|NCT00053001|previously treated myelodysplastic syndromes|previously treated myelodysplastic syndromes
864806|NCT00053001|anemia|anemia
864807|NCT00053001|atypical chronic myeloid leukemia, BCR-ABL1 negative|atypical chronic myeloid leukemia, bcr-abl1 negative
864808|NCT00053001|myelodysplastic/myeloproliferative neoplasm, unclassifiable|myelodysplastic/myeloproliferative neoplasm, unclassifiable
864809|NCT00053001|childhood myelodysplastic syndromes|childhood myelodysplastic syndromes
864810|NCT00041275|localized unresectable adult primary liver cancer|localized unresectable adult primary liver cancer
864811|NCT00041275|advanced adult primary liver cancer|advanced adult primary liver cancer
864812|NCT00041275|adult primary hepatocellular carcinoma|adult primary hepatocellular carcinoma
864813|NCT00003830|stage I breast cancer|stage i breast cancer
864814|NCT00003830|stage II breast cancer|stage ii breast cancer
864815|NCT00052962|Appendiceal Cancer|appendiceal cancer
864816|NCT00052962|Regional Therapy|regional therapy
864817|NCT00052962|Carcinomatosis|carcinomatosis
864818|NCT00052962|Hyperthermia|hyperthermia
864819|NCT00052936|anaplastic large cell lymphoma|anaplastic large cell lymphoma
864820|NCT00052936|angioimmunoblastic T-cell lymphoma|angioimmunoblastic t-cell lymphoma
864821|NCT00052936|stage III grade 1 follicular lymphoma|stage iii grade 1 follicular lymphoma
864822|NCT00052936|stage III grade 3 follicular lymphoma|stage iii grade 3 follicular lymphoma
864823|NCT00052936|stage III grade 2 follicular lymphoma|stage iii grade 2 follicular lymphoma
864824|NCT00052936|stage I adult T-cell leukemia/lymphoma|stage i adult t-cell leukemia/lymphoma
864825|NCT00052936|stage II adult T-cell leukemia/lymphoma|stage ii adult t-cell leukemia/lymphoma
864826|NCT00052936|stage III adult T-cell leukemia/lymphoma|stage iii adult t-cell leukemia/lymphoma
864827|NCT00052936|stage IV adult T-cell leukemia/lymphoma|stage iv adult t-cell leukemia/lymphoma
864828|NCT00052936|contiguous stage II adult lymphoblastic lymphoma|contiguous stage ii adult lymphoblastic lymphoma
864829|NCT00052936|noncontiguous stage II adult lymphoblastic lymphoma|noncontiguous stage ii adult lymphoblastic lymphoma
864830|NCT00052936|stage I adult lymphoblastic lymphoma|stage i adult lymphoblastic lymphoma
864831|NCT00052936|stage III adult lymphoblastic lymphoma|stage iii adult lymphoblastic lymphoma
864832|NCT00052936|stage IV adult lymphoblastic lymphoma|stage iv adult lymphoblastic lymphoma
864833|NCT00052936|contiguous stage II adult diffuse large cell lymphoma|contiguous stage ii adult diffuse large cell lymphoma
864834|NCT00052936|noncontiguous stage II adult diffuse large cell lymphoma|noncontiguous stage ii adult diffuse large cell lymphoma
864835|NCT00052936|stage I adult diffuse large cell lymphoma|stage i adult diffuse large cell lymphoma
864836|NCT00052936|stage III adult diffuse large cell lymphoma|stage iii adult diffuse large cell lymphoma
864837|NCT00052936|stage IV adult diffuse large cell lymphoma|stage iv adult diffuse large cell lymphoma
864838|NCT00052936|contiguous stage II mantle cell lymphoma|contiguous stage ii mantle cell lymphoma
864839|NCT00052936|noncontiguous stage II mantle cell lymphoma|noncontiguous stage ii mantle cell lymphoma
864840|NCT00052936|stage I mantle cell lymphoma|stage i mantle cell lymphoma
864841|NCT00052936|stage III mantle cell lymphoma|stage iii mantle cell lymphoma
864842|NCT00052936|stage IV mantle cell lymphoma|stage iv mantle cell lymphoma
864843|NCT00052936|contiguous stage II adult Burkitt lymphoma|contiguous stage ii adult burkitt lymphoma
864844|NCT00052936|noncontiguous stage II adult Burkitt lymphoma|noncontiguous stage ii adult burkitt lymphoma
864845|NCT00052936|stage I adult Burkitt lymphoma|stage i adult burkitt lymphoma
864846|NCT00052936|stage III adult Burkitt lymphoma|stage iii adult burkitt lymphoma
864847|NCT00052936|stage IV adult Burkitt lymphoma|stage iv adult burkitt lymphoma
864848|NCT00052936|contiguous stage II marginal zone lymphoma|contiguous stage ii marginal zone lymphoma
864849|NCT00052936|noncontiguous stage II marginal zone lymphoma|noncontiguous stage ii marginal zone lymphoma
864850|NCT00052936|extranodal marginal zone B-cell lymphoma of mucosa-associated lymphoid tissue|extranodal marginal zone b-cell lymphoma of mucosa-associated lymphoid tissue
864851|NCT00052936|nodal marginal zone B-cell lymphoma|nodal marginal zone b-cell lymphoma
864852|NCT00052936|splenic marginal zone lymphoma|splenic marginal zone lymphoma
864853|NCT00052936|stage I marginal zone lymphoma|stage i marginal zone lymphoma
864854|NCT00052936|stage III marginal zone lymphoma|stage iii marginal zone lymphoma
864855|NCT00052936|stage IV marginal zone lymphoma|stage iv marginal zone lymphoma
864856|NCT00052923|recurrent adult diffuse large cell lymphoma|recurrent adult diffuse large cell lymphoma
864857|NCT00052910|stage I gastric cancer|stage i gastric cancer
864858|NCT00052910|stage II gastric cancer|stage ii gastric cancer
864859|NCT00052910|stage III gastric cancer|stage iii gastric cancer
864860|NCT00052910|adenocarcinoma of the stomach|adenocarcinoma of the stomach
864861|NCT00052910|adenocarcinoma of the esophagus|adenocarcinoma of the esophagus
864862|NCT00052910|stage I esophageal cancer|stage i esophageal cancer
864863|NCT00052910|stage II esophageal cancer|stage ii esophageal cancer
864864|NCT00052910|stage III esophageal cancer|stage iii esophageal cancer
864865|NCT00052897|anal cancer|anal cancer
864866|NCT00052884|drug/agent toxicity by tissue/organ|drug/agent toxicity by tissue/organ
864867|NCT00052884|primary systemic amyloidosis|primary systemic amyloidosis
864868|NCT00052845|adenocarcinoma of the prostate|adenocarcinoma of the prostate
864869|NCT00052845|recurrent prostate cancer|recurrent prostate cancer
864870|NCT00052845|stage IV prostate cancer|stage iv prostate cancer
864871|NCT00052832|chronic myelomonocytic leukemia|chronic myelomonocytic leukemia
864872|NCT00052832|previously treated myelodysplastic syndromes|previously treated myelodysplastic syndromes
864873|NCT00052832|secondary myelodysplastic syndromes|secondary myelodysplastic syndromes
864874|NCT00052832|de novo myelodysplastic syndromes|de novo myelodysplastic syndromes
864875|NCT00052832|atypical chronic myeloid leukemia|atypical chronic myeloid leukemia
864975|NCT00052416|splenic marginal zone lymphoma|splenic marginal zone lymphoma
864876|NCT00052832|myelodysplastic/myeloproliferative disease, unclassifiable|myelodysplastic/myeloproliferative disease, unclassifiable
864877|NCT00052754|adult synovial sarcoma|adult synovial sarcoma
864878|NCT00052754|stage III adult soft tissue sarcoma|stage iii adult soft tissue sarcoma
864879|NCT00052754|recurrent adult soft tissue sarcoma|recurrent adult soft tissue sarcoma
864880|NCT00052754|stage IV adult soft tissue sarcoma|stage iv adult soft tissue sarcoma
864881|NCT00052728|stage IV breast cancer|stage iv breast cancer
864882|NCT00052728|recurrent breast cancer|recurrent breast cancer
864883|NCT00052715|adult glioblastoma|adult glioblastoma
864884|NCT00052715|adult giant cell glioblastoma|adult giant cell glioblastoma
864886|NCT00052676|stage I breast cancer|stage i breast cancer
864887|NCT00052676|stage II breast cancer|stage ii breast cancer
864888|NCT00052637|bladder cancer|bladder cancer
864889|NCT00052637|recurrent bladder cancer|recurrent bladder cancer
864890|NCT00052637|stage 0 bladder cancer|stage 0 bladder cancer
864891|NCT00052624|recurrent childhood cerebral astrocytoma|recurrent childhood cerebral astrocytoma
864892|NCT00052611|lip and oral cavity cancer|lip and oral cavity cancer
864893|NCT00052611|paranasal sinus and nasal cavity cancer|paranasal sinus and nasal cavity cancer
864894|NCT00052611|hypopharyngeal cancer|hypopharyngeal cancer
864895|NCT00052611|laryngeal cancer|laryngeal cancer
864896|NCT00052611|oropharyngeal cancer|oropharyngeal cancer
864897|NCT00052611|nasopharyngeal cancer|nasopharyngeal cancer
864898|NCT00052611|salivary gland cancer|salivary gland cancer
864899|NCT00052572|refractory chronic lymphocytic leukemia|refractory chronic lymphocytic leukemia
864900|NCT00052572|B-cell chronic lymphocytic leukemia|b-cell chronic lymphocytic leukemia
864901|NCT00052572|recurrent grade 1 follicular lymphoma|recurrent grade 1 follicular lymphoma
864902|NCT00052572|recurrent grade 2 follicular lymphoma|recurrent grade 2 follicular lymphoma
864903|NCT00052572|recurrent grade 3 follicular lymphoma|recurrent grade 3 follicular lymphoma
864904|NCT00052572|Waldenström macroglobulinemia|waldenström macroglobulinemia
864905|NCT00052572|recurrent marginal zone lymphoma|recurrent marginal zone lymphoma
864906|NCT00052572|recurrent small lymphocytic lymphoma|recurrent small lymphocytic lymphoma
864907|NCT00052572|recurrent mantle cell lymphoma|recurrent mantle cell lymphoma
864908|NCT00052572|extranodal marginal zone B-cell lymphoma of mucosa-associated lymphoid tissue|extranodal marginal zone b-cell lymphoma of mucosa-associated lymphoid tissue
864909|NCT00052572|nodal marginal zone B-cell lymphoma|nodal marginal zone b-cell lymphoma
864910|NCT00052572|splenic marginal zone lymphoma|splenic marginal zone lymphoma
864911|NCT00052507|stage IV colon cancer|stage iv colon cancer
864913|NCT00052507|adenocarcinoma of the colon|adenocarcinoma of the colon
864914|NCT00052507|adenocarcinoma of the rectum|adenocarcinoma of the rectum
864915|NCT00052507|recurrent colon cancer|recurrent colon cancer
864916|NCT00052507|recurrent rectal cancer|recurrent rectal cancer
864917|NCT00052494|extensive stage small cell lung cancer|extensive stage small cell lung cancer
864918|NCT00052494|recurrent small cell lung cancer|recurrent small cell lung cancer
864919|NCT00052481|stage IIB prostate cancer|stage iib prostate cancer
864920|NCT00052481|stage IIA prostate cancer|stage iia prostate cancer
864921|NCT00052481|adenocarcinoma of the prostate|adenocarcinoma of the prostate
864922|NCT00052468|stage I ovarian epithelial cancer|stage i ovarian epithelial cancer
864923|NCT00052468|stage II ovarian epithelial cancer|stage ii ovarian epithelial cancer
864924|NCT00052468|stage III ovarian epithelial cancer|stage iii ovarian epithelial cancer
864925|NCT00052468|stage IV ovarian epithelial cancer|stage iv ovarian epithelial cancer
864926|NCT00052468|fallopian tube cancer|fallopian tube cancer
864927|NCT00052455|adult glioblastoma|adult glioblastoma
864928|NCT00052455|adult anaplastic astrocytoma|adult anaplastic astrocytoma
864929|NCT00052455|recurrent adult brain tumor|recurrent adult brain tumor
864930|NCT00052455|adult giant cell glioblastoma|adult giant cell glioblastoma
864931|NCT00052455|adult gliosarcoma|adult gliosarcoma
864932|NCT00052442|recurrent adult diffuse large cell lymphoma|recurrent adult diffuse large cell lymphoma
864933|NCT00052442|recurrent adult diffuse mixed cell lymphoma|recurrent adult diffuse mixed cell lymphoma
864934|NCT00052442|recurrent adult Burkitt lymphoma|recurrent adult burkitt lymphoma
864935|NCT00052442|recurrent adult immunoblastic large cell lymphoma|recurrent adult immunoblastic large cell lymphoma
864936|NCT00052442|recurrent adult lymphoblastic lymphoma|recurrent adult lymphoblastic lymphoma
864937|NCT00052442|recurrent mantle cell lymphoma|recurrent mantle cell lymphoma
864938|NCT00052442|recurrent adult Hodgkin lymphoma|recurrent adult hodgkin lymphoma
864939|NCT00052442|recurrent grade 3 follicular lymphoma|recurrent grade 3 follicular lymphoma
864940|NCT00052429|stage II lymphoepithelioma of the nasopharynx|stage ii lymphoepithelioma of the nasopharynx
864941|NCT00052429|stage II squamous cell carcinoma of the nasopharynx|stage ii squamous cell carcinoma of the nasopharynx
864942|NCT00052429|stage III lymphoepithelioma of the nasopharynx|stage iii lymphoepithelioma of the nasopharynx
864943|NCT00052429|stage III squamous cell carcinoma of the nasopharynx|stage iii squamous cell carcinoma of the nasopharynx
864944|NCT00052429|stage IV lymphoepithelioma of the nasopharynx|stage iv lymphoepithelioma of the nasopharynx
864945|NCT00052429|stage IV squamous cell carcinoma of the nasopharynx|stage iv squamous cell carcinoma of the nasopharynx
864946|NCT00052416|B-cell chronic lymphocytic leukemia|b-cell chronic lymphocytic leukemia
864947|NCT00052416|stage 0 chronic lymphocytic leukemia|stage 0 chronic lymphocytic leukemia
864948|NCT00052416|stage I chronic lymphocytic leukemia|stage i chronic lymphocytic leukemia
864949|NCT00052416|stage II chronic lymphocytic leukemia|stage ii chronic lymphocytic leukemia
864950|NCT00052416|stage III chronic lymphocytic leukemia|stage iii chronic lymphocytic leukemia
864951|NCT00052416|stage IV chronic lymphocytic leukemia|stage iv chronic lymphocytic leukemia
864952|NCT00052416|stage I grade 1 follicular lymphoma|stage i grade 1 follicular lymphoma
864953|NCT00052416|stage III grade 1 follicular lymphoma|stage iii grade 1 follicular lymphoma
864954|NCT00052416|stage IV grade 1 follicular lymphoma|stage iv grade 1 follicular lymphoma
864955|NCT00052416|contiguous stage II grade 1 follicular lymphoma|contiguous stage ii grade 1 follicular lymphoma
864956|NCT00052416|noncontiguous stage II grade 1 follicular lymphoma|noncontiguous stage ii grade 1 follicular lymphoma
864957|NCT00052416|contiguous stage II grade 2 follicular lymphoma|contiguous stage ii grade 2 follicular lymphoma
864958|NCT00052416|noncontiguous stage II grade 2 follicular lymphoma|noncontiguous stage ii grade 2 follicular lymphoma
864959|NCT00052416|stage I grade 2 follicular lymphoma|stage i grade 2 follicular lymphoma
864960|NCT00052416|stage III grade 2 follicular lymphoma|stage iii grade 2 follicular lymphoma
864961|NCT00052416|stage IV grade 2 follicular lymphoma|stage iv grade 2 follicular lymphoma
864962|NCT00052416|Waldenström macroglobulinemia|waldenström macroglobulinemia
864963|NCT00052416|contiguous stage II marginal zone lymphoma|contiguous stage ii marginal zone lymphoma
864964|NCT00052416|contiguous stage II small lymphocytic lymphoma|contiguous stage ii small lymphocytic lymphoma
864965|NCT00052416|noncontiguous stage II small lymphocytic lymphoma|noncontiguous stage ii small lymphocytic lymphoma
864966|NCT00052416|noncontiguous stage II marginal zone lymphoma|noncontiguous stage ii marginal zone lymphoma
864967|NCT00052416|stage I marginal zone lymphoma|stage i marginal zone lymphoma
864968|NCT00052416|stage I small lymphocytic lymphoma|stage i small lymphocytic lymphoma
864969|NCT00052416|stage III small lymphocytic lymphoma|stage iii small lymphocytic lymphoma
864970|NCT00052416|stage III marginal zone lymphoma|stage iii marginal zone lymphoma
864971|NCT00052416|stage IV small lymphocytic lymphoma|stage iv small lymphocytic lymphoma
864972|NCT00052416|stage IV marginal zone lymphoma|stage iv marginal zone lymphoma
864973|NCT00052416|extranodal marginal zone B-cell lymphoma of mucosa-associated lymphoid tissue|extranodal marginal zone b-cell lymphoma of mucosa-associated lymphoid tissue
864974|NCT00052416|nodal marginal zone B-cell lymphoma|nodal marginal zone b-cell lymphoma
864976|NCT00052390|recurrent adult soft tissue sarcoma|recurrent adult soft tissue sarcoma
864977|NCT00052390|stage III adult soft tissue sarcoma|stage iii adult soft tissue sarcoma
864978|NCT00052390|stage IV adult soft tissue sarcoma|stage iv adult soft tissue sarcoma
864979|NCT00052351|stage II breast cancer|stage ii breast cancer
864980|NCT00052351|stage IIIA breast cancer|stage iiia breast cancer
864981|NCT00052351|stage IIIB breast cancer|stage iiib breast cancer
864982|NCT00052325|stage IV non-small cell lung cancer|stage iv non-small cell lung cancer
864983|NCT00052325|stage IIIB non-small cell lung cancer|stage iiib non-small cell lung cancer
864984|NCT00052312|recurrent endometrial carcinoma|recurrent endometrial carcinoma
864985|NCT00052312|stage III endometrial carcinoma|stage iii endometrial carcinoma
864986|NCT00052312|stage IV endometrial carcinoma|stage iv endometrial carcinoma
864987|NCT00052312|endometrial papillary serous carcinoma|endometrial papillary serous carcinoma
864988|NCT00052299|adult acute monocytic leukemia (M5b)|adult acute monocytic leukemia (m5b)
864989|NCT00052299|adult acute erythroid leukemia (M6)|adult acute erythroid leukemia (m6)
864990|NCT00052299|adult acute megakaryoblastic leukemia (M7)|adult acute megakaryoblastic leukemia (m7)
864991|NCT00052299|adult acute minimally differentiated myeloid leukemia (M0)|adult acute minimally differentiated myeloid leukemia (m0)
864992|NCT00052299|adult acute myeloblastic leukemia with maturation (M2)|adult acute myeloblastic leukemia with maturation (m2)
864993|NCT00052299|adult acute myeloblastic leukemia without maturation (M1)|adult acute myeloblastic leukemia without maturation (m1)
864994|NCT00052299|adult acute myelomonocytic leukemia (M4)|adult acute myelomonocytic leukemia (m4)
864995|NCT00052299|adult acute monoblastic leukemia (M5a)|adult acute monoblastic leukemia (m5a)
864996|NCT00052299|untreated adult acute myeloid leukemia|untreated adult acute myeloid leukemia
864997|NCT00052299|secondary acute myeloid leukemia|secondary acute myeloid leukemia
864998|NCT00052299|adult acute myeloid leukemia with 11q23 (MLL) abnormalities|adult acute myeloid leukemia with 11q23 (mll) abnormalities
864999|NCT00052299|adult acute myeloid leukemia with inv(16)(p13;q22)|adult acute myeloid leukemia with inv(16)(p13;q22)
865000|NCT00052299|adult acute myeloid leukemia with t(16;16)(p13;q22)|adult acute myeloid leukemia with t(16;16)(p13;q22)
865001|NCT00052299|adult acute myeloid leukemia with t(8;21)(q22;q22)|adult acute myeloid leukemia with t(8;21)(q22;q22)
865002|NCT00052286|adult brain tumor|adult brain tumor
865004|NCT00052286|cognitive/functional effects|cognitive/functional effects
865005|NCT00052273|unspecified adult solid tumor|unspecified adult solid tumor
865006|NCT00052273|protocol specific|protocol specific
865007|NCT00052221|unspecified adult solid tumor, protocol specific|unspecified adult solid tumor, protocol specific
865008|NCT00052221|fatigue|fatigue
865009|NCT00052195|Mycobacterium vaccae|mycobacterium vaccae
865010|NCT00052195|BCG|bcg
865011|NCT00052195|Disseminated tuberculosis|disseminated tuberculosis
865012|NCT00052195|SRL-172|srl-172
865013|NCT00052195|DAR-901|dar-901
865014|NCT00052182|HIV Therapeutic Vaccine|hiv therapeutic vaccine
865015|NCT00052182|CTL Epitope|ctl epitope
865016|NCT00052182|Treatment Experienced|treatment experienced
865017|NCT00052169|metastatic breast cancer|metastatic breast cancer
865018|NCT00052169|docetaxel|docetaxel
865019|NCT00052169|Taxotere|taxotere
865020|NCT00052169|ZD 1839|zd 1839
865021|NCT00052169|gefitinib|gefitinib
865022|NCT00052169|NSABP|nsabp
865023|NCT00052169|advanced breast cancer|advanced breast cancer
865024|NCT00052169|AstraZeneca|astrazeneca
865025|NCT00049712|anaplastic large cell lymphoma|anaplastic large cell lymphoma
865026|NCT00049712|angioimmunoblastic T-cell lymphoma|angioimmunoblastic t-cell lymphoma
865027|NCT00049712|intraocular lymphoma|intraocular lymphoma
865028|NCT00049712|primary central nervous system lymphoma|primary central nervous system lymphoma
865029|NCT00049712|recurrent adult diffuse large cell lymphoma|recurrent adult diffuse large cell lymphoma
865030|NCT00049712|recurrent adult diffuse mixed cell lymphoma|recurrent adult diffuse mixed cell lymphoma
865031|NCT00049712|recurrent adult diffuse small cleaved cell lymphoma|recurrent adult diffuse small cleaved cell lymphoma
865032|NCT00049712|recurrent adult Burkitt lymphoma|recurrent adult burkitt lymphoma
865033|NCT00049712|recurrent adult Hodgkin lymphoma|recurrent adult hodgkin lymphoma
865034|NCT00049712|recurrent adult immunoblastic large cell lymphoma|recurrent adult immunoblastic large cell lymphoma
865035|NCT00049712|recurrent adult lymphoblastic lymphoma|recurrent adult lymphoblastic lymphoma
865036|NCT00049712|recurrent adult T-cell leukemia/lymphoma|recurrent adult t-cell leukemia/lymphoma
865037|NCT00049712|recurrent cutaneous T-cell non-Hodgkin lymphoma|recurrent cutaneous t-cell non-hodgkin lymphoma
865038|NCT00049712|recurrent grade 1 follicular lymphoma|recurrent grade 1 follicular lymphoma
865039|NCT00049712|recurrent grade 2 follicular lymphoma|recurrent grade 2 follicular lymphoma
865040|NCT00049712|recurrent grade 3 follicular lymphoma|recurrent grade 3 follicular lymphoma
865041|NCT00049712|recurrent mantle cell lymphoma|recurrent mantle cell lymphoma
865042|NCT00049712|recurrent mycosis fungoides/Sezary syndrome|recurrent mycosis fungoides/sezary syndrome
865043|NCT00049712|small intestine lymphoma|small intestine lymphoma
865044|NCT00049712|stage IV adult diffuse large cell lymphoma|stage iv adult diffuse large cell lymphoma
865045|NCT00049712|stage IV adult diffuse mixed cell lymphoma|stage iv adult diffuse mixed cell lymphoma
865046|NCT00049712|stage IV adult diffuse small cleaved cell lymphoma|stage iv adult diffuse small cleaved cell lymphoma
865047|NCT00049712|stage IV adult Burkitt lymphoma|stage iv adult burkitt lymphoma
865048|NCT00049712|stage IV adult Hodgkin lymphoma|stage iv adult hodgkin lymphoma
865049|NCT00049712|stage IV adult immunoblastic large cell lymphoma|stage iv adult immunoblastic large cell lymphoma
865050|NCT00049712|stage IV adult T-cell leukemia/lymphoma|stage iv adult t-cell leukemia/lymphoma
865051|NCT00049712|stage IV cutaneous T-cell non-Hodgkin lymphoma|stage iv cutaneous t-cell non-hodgkin lymphoma
865052|NCT00049712|stage IV grade 1 follicular lymphoma|stage iv grade 1 follicular lymphoma
865053|NCT00049712|stage IV grade 2 follicular lymphoma|stage iv grade 2 follicular lymphoma
865054|NCT00049712|stage IV grade 3 follicular lymphoma|stage iv grade 3 follicular lymphoma
865055|NCT00049712|stage IV mantle cell lymphoma|stage iv mantle cell lymphoma
865056|NCT00049712|stage IV mycosis fungoides/Sezary syndrome|stage iv mycosis fungoides/sezary syndrome
865057|NCT00049712|unspecified adult solid tumor, protocol specific|unspecified adult solid tumor, protocol specific
865058|NCT00049712|stage IV adult lymphoblastic lymphoma|stage iv adult lymphoblastic lymphoma
865059|NCT00049712|stage III adult diffuse large cell lymphoma|stage iii adult diffuse large cell lymphoma
865060|NCT00049712|stage III adult diffuse mixed cell lymphoma|stage iii adult diffuse mixed cell lymphoma
865061|NCT00049712|stage III adult diffuse small cleaved cell lymphoma|stage iii adult diffuse small cleaved cell lymphoma
865062|NCT00049712|stage III adult Burkitt lymphoma|stage iii adult burkitt lymphoma
865063|NCT00049712|stage III adult Hodgkin lymphoma|stage iii adult hodgkin lymphoma
865064|NCT00049712|stage III adult immunoblastic large cell lymphoma|stage iii adult immunoblastic large cell lymphoma
865065|NCT00049712|stage III adult lymphoblastic lymphoma|stage iii adult lymphoblastic lymphoma
865066|NCT00049712|stage III cutaneous T-cell non-Hodgkin lymphoma|stage iii cutaneous t-cell non-hodgkin lymphoma
865067|NCT00049712|stage III grade 1 follicular lymphoma|stage iii grade 1 follicular lymphoma
865068|NCT00049712|stage III grade 2 follicular lymphoma|stage iii grade 2 follicular lymphoma
865069|NCT00049712|stage III grade 3 follicular lymphoma|stage iii grade 3 follicular lymphoma
865070|NCT00049712|stage III mantle cell lymphoma|stage iii mantle cell lymphoma
865071|NCT00049712|stage III mycosis fungoides/Sezary syndrome|stage iii mycosis fungoides/sezary syndrome
865072|NCT00049712|stage III adult T-cell leukemia/lymphoma|stage iii adult t-cell leukemia/lymphoma
865073|NCT00049712|recurrent marginal zone lymphoma|recurrent marginal zone lymphoma
865074|NCT00049712|recurrent small lymphocytic lymphoma|recurrent small lymphocytic lymphoma
865075|NCT00049712|stage III small lymphocytic lymphoma|stage iii small lymphocytic lymphoma
865076|NCT00049712|stage III marginal zone lymphoma|stage iii marginal zone lymphoma
865077|NCT00049712|stage IV small lymphocytic lymphoma|stage iv small lymphocytic lymphoma
865078|NCT00049712|stage IV marginal zone lymphoma|stage iv marginal zone lymphoma
865079|NCT00049712|extranodal marginal zone B-cell lymphoma of mucosa-associated lymphoid tissue|extranodal marginal zone b-cell lymphoma of mucosa-associated lymphoid tissue
865080|NCT00049712|nodal marginal zone B-cell lymphoma|nodal marginal zone b-cell lymphoma
865081|NCT00049712|splenic marginal zone lymphoma|splenic marginal zone lymphoma
865082|NCT00049699|anaplastic large cell lymphoma|anaplastic large cell lymphoma
865083|NCT00049699|angioimmunoblastic T-cell lymphoma|angioimmunoblastic t-cell lymphoma
865084|NCT00049699|intraocular lymphoma|intraocular lymphoma
865085|NCT00049699|primary central nervous system non-Hodgkin lymphoma|primary central nervous system non-hodgkin lymphoma
865086|NCT00049699|recurrent adult diffuse large cell lymphoma|recurrent adult diffuse large cell lymphoma
865087|NCT00049699|recurrent adult diffuse mixed cell lymphoma|recurrent adult diffuse mixed cell lymphoma
865088|NCT00049699|recurrent adult diffuse small cleaved cell lymphoma|recurrent adult diffuse small cleaved cell lymphoma
865089|NCT00049699|recurrent adult Burkitt lymphoma|recurrent adult burkitt lymphoma
865090|NCT00049699|recurrent adult Hodgkin lymphoma|recurrent adult hodgkin lymphoma
865091|NCT00049699|recurrent adult immunoblastic large cell lymphoma|recurrent adult immunoblastic large cell lymphoma
865092|NCT00049699|recurrent adult lymphoblastic lymphoma|recurrent adult lymphoblastic lymphoma
865093|NCT00049699|recurrent adult T-cell leukemia/lymphoma|recurrent adult t-cell leukemia/lymphoma
865094|NCT00049699|recurrent cutaneous T-cell non-Hodgkin lymphoma|recurrent cutaneous t-cell non-hodgkin lymphoma
865095|NCT00049699|recurrent grade 1 follicular lymphoma|recurrent grade 1 follicular lymphoma
865096|NCT00049699|recurrent grade 2 follicular lymphoma|recurrent grade 2 follicular lymphoma
865097|NCT00049699|recurrent grade 3 follicular lymphoma|recurrent grade 3 follicular lymphoma
865098|NCT00049699|recurrent mantle cell lymphoma|recurrent mantle cell lymphoma
865099|NCT00049699|recurrent mycosis fungoides/Sezary syndrome|recurrent mycosis fungoides/sezary syndrome
865100|NCT00049699|small intestine lymphoma|small intestine lymphoma
865101|NCT00049699|stage IV adult diffuse large cell lymphoma|stage iv adult diffuse large cell lymphoma
865102|NCT00049699|stage IV adult diffuse mixed cell lymphoma|stage iv adult diffuse mixed cell lymphoma
865103|NCT00049699|stage IV adult diffuse small cleaved cell lymphoma|stage iv adult diffuse small cleaved cell lymphoma
865104|NCT00049699|stage IV adult Burkitt lymphoma|stage iv adult burkitt lymphoma
865105|NCT00049699|stage IV adult Hodgkin lymphoma|stage iv adult hodgkin lymphoma
865106|NCT00049699|stage IV adult immunoblastic large cell lymphoma|stage iv adult immunoblastic large cell lymphoma
865107|NCT00049699|stage IV adult lymphoblastic lymphoma|stage iv adult lymphoblastic lymphoma
865108|NCT00049699|stage IV adult T-cell leukemia/lymphoma|stage iv adult t-cell leukemia/lymphoma
865109|NCT00049699|stage IV cutaneous T-cell non-Hodgkin lymphoma|stage iv cutaneous t-cell non-hodgkin lymphoma
865110|NCT00049699|stage IV grade 1 follicular lymphoma|stage iv grade 1 follicular lymphoma
865111|NCT00049699|stage IV grade 2 follicular lymphoma|stage iv grade 2 follicular lymphoma
865112|NCT00049699|stage IV grade 3 follicular lymphoma|stage iv grade 3 follicular lymphoma
865113|NCT00049699|stage IV mantle cell lymphoma|stage iv mantle cell lymphoma
865114|NCT00049699|stage IV mycosis fungoides/Sezary syndrome|stage iv mycosis fungoides/sezary syndrome
865115|NCT00049699|unspecified adult solid tumor, protocol specific|unspecified adult solid tumor, protocol specific
865116|NCT00049699|recurrent marginal zone lymphoma|recurrent marginal zone lymphoma
865117|NCT00049699|recurrent small lymphocytic lymphoma|recurrent small lymphocytic lymphoma
885225|NCT00002295|Zidovudine|zidovudine
865118|NCT00049699|stage IV small lymphocytic lymphoma|stage iv small lymphocytic lymphoma
865119|NCT00049699|stage IV marginal zone lymphoma|stage iv marginal zone lymphoma
865120|NCT00049699|extranodal marginal zone B-cell lymphoma of mucosa-associated lymphoid tissue|extranodal marginal zone b-cell lymphoma of mucosa-associated lymphoid tissue
865121|NCT00049699|nodal marginal zone B-cell lymphoma|nodal marginal zone b-cell lymphoma
865122|NCT00049699|splenic marginal zone lymphoma|splenic marginal zone lymphoma
865123|NCT00049686|acute undifferentiated leukemia|acute undifferentiated leukemia
865124|NCT00049686|chronic myelomonocytic leukemia|chronic myelomonocytic leukemia
865125|NCT00049686|previously treated myelodysplastic syndromes|previously treated myelodysplastic syndromes
865126|NCT00049686|prolymphocytic leukemia|prolymphocytic leukemia
865127|NCT00049686|recurrent adult acute lymphoblastic leukemia|recurrent adult acute lymphoblastic leukemia
865128|NCT00049686|recurrent adult acute myeloid leukemia|recurrent adult acute myeloid leukemia
865129|NCT00049686|refractory chronic lymphocytic leukemia|refractory chronic lymphocytic leukemia
865130|NCT00049686|refractory anemia with excess blasts|refractory anemia with excess blasts
865131|NCT00049686|refractory cytopenia with multilineage dysplasia|refractory cytopenia with multilineage dysplasia
865132|NCT00049686|refractory hairy cell leukemia|refractory hairy cell leukemia
865133|NCT00049686|relapsing chronic myelogenous leukemia|relapsing chronic myelogenous leukemia
865134|NCT00049686|secondary acute myeloid leukemia|secondary acute myeloid leukemia
865135|NCT00049686|secondary myelodysplastic syndromes|secondary myelodysplastic syndromes
865136|NCT00049686|atypical chronic myeloid leukemia, BCR-ABL1 negative|atypical chronic myeloid leukemia, bcr-abl1 negative
865137|NCT00049686|myelodysplastic/myeloproliferative neoplasm, unclassifiable|myelodysplastic/myeloproliferative neoplasm, unclassifiable
865138|NCT00049673|stage I multiple myeloma|stage i multiple myeloma
865139|NCT00049673|stage II multiple myeloma|stage ii multiple myeloma
865140|NCT00049673|stage III multiple myeloma|stage iii multiple myeloma
865141|NCT00049660|stage IV breast cancer|stage iv breast cancer
865142|NCT00049634|chronic myelomonocytic leukemia|chronic myelomonocytic leukemia
865143|NCT00049634|de novo myelodysplastic syndromes|de novo myelodysplastic syndromes
865144|NCT00049634|essential thrombocythemia|essential thrombocythemia
865145|NCT00049634|polycythemia vera|polycythemia vera
865146|NCT00049634|previously treated myelodysplastic syndromes|previously treated myelodysplastic syndromes
865147|NCT00049634|refractory anemia with excess blasts|refractory anemia with excess blasts
865148|NCT00049634|refractory anemia with excess blasts in transformation|refractory anemia with excess blasts in transformation
865149|NCT00049634|secondary acute myeloid leukemia|secondary acute myeloid leukemia
865150|NCT00049634|secondary myelodysplastic syndromes|secondary myelodysplastic syndromes
865151|NCT00049634|chronic eosinophilic leukemia|chronic eosinophilic leukemia
865152|NCT00049634|chronic neutrophilic leukemia|chronic neutrophilic leukemia
865153|NCT00049634|atypical chronic myeloid leukemia|atypical chronic myeloid leukemia
865154|NCT00049634|myelodysplastic/myeloproliferative disease, unclassifiable|myelodysplastic/myeloproliferative disease, unclassifiable
865155|NCT00049608|male breast cancer|male breast cancer
865156|NCT00049608|recurrent breast cancer|recurrent breast cancer
865157|NCT00049608|recurrent colon cancer|recurrent colon cancer
865158|NCT00049608|recurrent non-small cell lung cancer|recurrent non-small cell lung cancer
865159|NCT00049608|recurrent pancreatic cancer|recurrent pancreatic cancer
865160|NCT00049608|recurrent rectal cancer|recurrent rectal cancer
865161|NCT00049608|stage III colon cancer|stage iii colon cancer
865162|NCT00049608|stage III pancreatic cancer|stage iii pancreatic cancer
865163|NCT00049608|stage III rectal cancer|stage iii rectal cancer
865164|NCT00049608|stage IIIA breast cancer|stage iiia breast cancer
865165|NCT00049608|stage IIIB breast cancer|stage iiib breast cancer
865166|NCT00049608|stage IIIC breast cancer|stage iiic breast cancer
865167|NCT00049608|stage IV breast cancer|stage iv breast cancer
865168|NCT00049608|stage IV colon cancer|stage iv colon cancer
865169|NCT00049608|stage IV non-small cell lung cancer|stage iv non-small cell lung cancer
865170|NCT00049608|stage IV rectal cancer|stage iv rectal cancer
865171|NCT00049608|stage IIIA non-small cell lung cancer|stage iiia non-small cell lung cancer
865172|NCT00049608|stage IIIB non-small cell lung cancer|stage iiib non-small cell lung cancer
865173|NCT00049608|stage IV pancreatic cancer|stage iv pancreatic cancer
865174|NCT00049595|adult lymphocyte depletion Hodgkin lymphoma|adult lymphocyte depletion hodgkin lymphoma
865175|NCT00049595|adult mixed cellularity Hodgkin lymphoma|adult mixed cellularity hodgkin lymphoma
865176|NCT00049595|adult nodular sclerosis Hodgkin lymphoma|adult nodular sclerosis hodgkin lymphoma
865177|NCT00049595|stage III adult Hodgkin lymphoma|stage iii adult hodgkin lymphoma
865178|NCT00049595|stage IV adult Hodgkin lymphoma|stage iv adult hodgkin lymphoma
865179|NCT00049556|fallopian tube cancer|fallopian tube cancer
865180|NCT00049556|borderline ovarian surface epithelial-stromal tumor|borderline ovarian surface epithelial-stromal tumor
865181|NCT00049556|primary peritoneal cavity cancer|primary peritoneal cavity cancer
865182|NCT00049556|recurrent cervical cancer|recurrent cervical cancer
865183|NCT00049556|recurrent ovarian epithelial cancer|recurrent ovarian epithelial cancer
865184|NCT00049530|recurrent melanoma|recurrent melanoma
865185|NCT00049530|stage IV melanoma|stage iv melanoma
865186|NCT00049517|acute myeloid leukemia|acute myeloid leukemia
865187|NCT00049517|autologous transplantation|autologous transplantation
865188|NCT00049517|gemtuzumab ozogamicin|gemtuzumab ozogamicin
865189|NCT00049465|depression|depression
865191|NCT00049465|menopausal symptoms|menopausal symptoms
865192|NCT00049465|transitional care planning|transitional care planning
865193|NCT00049465|psychosocial effects of cancer and its treatment|psychosocial effects of cancer and its treatment
865194|NCT00049465|accelerated phase chronic myelogenous leukemia|accelerated phase chronic myelogenous leukemia
865195|NCT00049465|chronic idiopathic myelofibrosis|chronic idiopathic myelofibrosis
865196|NCT00049465|blastic phase chronic myelogenous leukemia|blastic phase chronic myelogenous leukemia
865197|NCT00049465|chronic phase chronic myelogenous leukemia|chronic phase chronic myelogenous leukemia
865198|NCT00049465|de novo myelodysplastic syndromes|de novo myelodysplastic syndromes
865199|NCT00049465|disseminated neuroblastoma|disseminated neuroblastoma
865200|NCT00049465|meningeal chronic myelogenous leukemia|meningeal chronic myelogenous leukemia
865201|NCT00049465|noncontiguous stage II adult diffuse large cell lymphoma|noncontiguous stage ii adult diffuse large cell lymphoma
865202|NCT00049465|noncontiguous stage II adult diffuse mixed cell lymphoma|noncontiguous stage ii adult diffuse mixed cell lymphoma
865203|NCT00049465|noncontiguous stage II adult diffuse small cleaved cell lymphoma|noncontiguous stage ii adult diffuse small cleaved cell lymphoma
865204|NCT00049465|noncontiguous stage II adult Burkitt lymphoma|noncontiguous stage ii adult burkitt lymphoma
865205|NCT00049465|noncontiguous stage II adult immunoblastic large cell lymphoma|noncontiguous stage ii adult immunoblastic large cell lymphoma
865206|NCT00049465|noncontiguous stage II adult lymphoblastic lymphoma|noncontiguous stage ii adult lymphoblastic lymphoma
865207|NCT00049465|noncontiguous stage II grade 1 follicular lymphoma|noncontiguous stage ii grade 1 follicular lymphoma
865208|NCT00049465|noncontiguous stage II grade 2 follicular lymphoma|noncontiguous stage ii grade 2 follicular lymphoma
865209|NCT00049465|noncontiguous stage II grade 3 follicular lymphoma|noncontiguous stage ii grade 3 follicular lymphoma
865210|NCT00049465|noncontiguous stage II mantle cell lymphoma|noncontiguous stage ii mantle cell lymphoma
865211|NCT00049465|ovarian choriocarcinoma|ovarian choriocarcinoma
865212|NCT00049465|ovarian embryonal carcinoma|ovarian embryonal carcinoma
865213|NCT00049465|ovarian yolk sac tumor|ovarian yolk sac tumor
865214|NCT00049465|ovarian immature teratoma|ovarian immature teratoma
865215|NCT00049465|ovarian mature teratoma|ovarian mature teratoma
865216|NCT00049465|ovarian monodermal and highly specialized teratoma|ovarian monodermal and highly specialized teratoma
865217|NCT00049465|ovarian polyembryoma|ovarian polyembryoma
865218|NCT00049465|ovarian mixed germ cell tumor|ovarian mixed germ cell tumor
865219|NCT00049465|poor prognosis metastatic gestational trophoblastic tumor|poor prognosis metastatic gestational trophoblastic tumor
865220|NCT00049465|previously treated myelodysplastic syndromes|previously treated myelodysplastic syndromes
865221|NCT00049465|recurrent adult acute lymphoblastic leukemia|recurrent adult acute lymphoblastic leukemia
865222|NCT00049465|recurrent adult acute myeloid leukemia|recurrent adult acute myeloid leukemia
865223|NCT00049465|recurrent adult diffuse large cell lymphoma|recurrent adult diffuse large cell lymphoma
865224|NCT00049465|recurrent adult diffuse mixed cell lymphoma|recurrent adult diffuse mixed cell lymphoma
865225|NCT00049465|recurrent adult diffuse small cleaved cell lymphoma|recurrent adult diffuse small cleaved cell lymphoma
865226|NCT00049465|recurrent adult Burkitt lymphoma|recurrent adult burkitt lymphoma
865227|NCT00049465|recurrent adult Hodgkin lymphoma|recurrent adult hodgkin lymphoma
865228|NCT00049465|recurrent adult immunoblastic large cell lymphoma|recurrent adult immunoblastic large cell lymphoma
865229|NCT00049465|recurrent adult lymphoblastic lymphoma|recurrent adult lymphoblastic lymphoma
865230|NCT00049465|recurrent cutaneous T-cell non-Hodgkin lymphoma|recurrent cutaneous t-cell non-hodgkin lymphoma
865231|NCT00049465|recurrent grade 1 follicular lymphoma|recurrent grade 1 follicular lymphoma
865232|NCT00049465|recurrent grade 2 follicular lymphoma|recurrent grade 2 follicular lymphoma
865233|NCT00049465|recurrent grade 3 follicular lymphoma|recurrent grade 3 follicular lymphoma
865234|NCT00049465|recurrent mantle cell lymphoma|recurrent mantle cell lymphoma
865235|NCT00049465|recurrent mycosis fungoides/Sezary syndrome|recurrent mycosis fungoides/sezary syndrome
865237|NCT00049465|recurrent ovarian epithelial cancer|recurrent ovarian epithelial cancer
865238|NCT00049465|recurrent ovarian germ cell tumor|recurrent ovarian germ cell tumor
865239|NCT00049465|recurrent malignant testicular germ cell tumor|recurrent malignant testicular germ cell tumor
865240|NCT00049465|refractory chronic lymphocytic leukemia|refractory chronic lymphocytic leukemia
865241|NCT00049465|refractory hairy cell leukemia|refractory hairy cell leukemia
865242|NCT00049465|refractory multiple myeloma|refractory multiple myeloma
865243|NCT00049465|relapsing chronic myelogenous leukemia|relapsing chronic myelogenous leukemia
865244|NCT00049465|secondary acute myeloid leukemia|secondary acute myeloid leukemia
865245|NCT00049465|secondary myelodysplastic syndromes|secondary myelodysplastic syndromes
865246|NCT00049465|stage I multiple myeloma|stage i multiple myeloma
865247|NCT00049465|stage II multiple myeloma|stage ii multiple myeloma
865248|NCT00049465|stage II ovarian epithelial cancer|stage ii ovarian epithelial cancer
865249|NCT00049465|stage III adult diffuse large cell lymphoma|stage iii adult diffuse large cell lymphoma
865250|NCT00049465|stage III adult diffuse mixed cell lymphoma|stage iii adult diffuse mixed cell lymphoma
865251|NCT00049465|stage III adult diffuse small cleaved cell lymphoma|stage iii adult diffuse small cleaved cell lymphoma
865252|NCT00049465|stage III adult Burkitt lymphoma|stage iii adult burkitt lymphoma
865253|NCT00049465|stage III adult immunoblastic large cell lymphoma|stage iii adult immunoblastic large cell lymphoma
865254|NCT00049465|stage III adult lymphoblastic lymphoma|stage iii adult lymphoblastic lymphoma
865255|NCT00049465|stage III chronic lymphocytic leukemia|stage iii chronic lymphocytic leukemia
887471|NCT00001028|Dapsone|dapsone
865256|NCT00049465|stage III grade 1 follicular lymphoma|stage iii grade 1 follicular lymphoma
865257|NCT00049465|stage III grade 2 follicular lymphoma|stage iii grade 2 follicular lymphoma
865258|NCT00049465|stage III grade 3 follicular lymphoma|stage iii grade 3 follicular lymphoma
865259|NCT00049465|stage III mantle cell lymphoma|stage iii mantle cell lymphoma
865260|NCT00049465|stage III ovarian epithelial cancer|stage iii ovarian epithelial cancer
865261|NCT00049465|stage III malignant testicular germ cell tumor|stage iii malignant testicular germ cell tumor
865262|NCT00049465|stage IIIA breast cancer|stage iiia breast cancer
865263|NCT00049465|stage IIIB breast cancer|stage iiib breast cancer
865264|NCT00049465|stage IIIC breast cancer|stage iiic breast cancer
865265|NCT00049465|stage IV adult diffuse large cell lymphoma|stage iv adult diffuse large cell lymphoma
865266|NCT00049465|stage IV adult diffuse mixed cell lymphoma|stage iv adult diffuse mixed cell lymphoma
865267|NCT00049465|stage IV adult diffuse small cleaved cell lymphoma|stage iv adult diffuse small cleaved cell lymphoma
865268|NCT00049465|stage IV adult Burkitt lymphoma|stage iv adult burkitt lymphoma
865269|NCT00049465|stage IV adult immunoblastic large cell lymphoma|stage iv adult immunoblastic large cell lymphoma
865270|NCT00049465|stage IV adult lymphoblastic lymphoma|stage iv adult lymphoblastic lymphoma
865271|NCT00049465|stage IV breast cancer|stage iv breast cancer
865272|NCT00049465|stage IV chronic lymphocytic leukemia|stage iv chronic lymphocytic leukemia
865273|NCT00049465|stage IV grade 1 follicular lymphoma|stage iv grade 1 follicular lymphoma
865274|NCT00049465|stage IV grade 2 follicular lymphoma|stage iv grade 2 follicular lymphoma
865275|NCT00049465|stage IV grade 3 follicular lymphoma|stage iv grade 3 follicular lymphoma
865276|NCT00049465|stage IV mantle cell lymphoma|stage iv mantle cell lymphoma
865277|NCT00049465|stage IV ovarian epithelial cancer|stage iv ovarian epithelial cancer
865278|NCT00049465|testicular choriocarcinoma and embryonal carcinoma|testicular choriocarcinoma and embryonal carcinoma
865279|NCT00049465|testicular choriocarcinoma and seminoma|testicular choriocarcinoma and seminoma
865280|NCT00049465|testicular choriocarcinoma and teratoma|testicular choriocarcinoma and teratoma
865281|NCT00049465|testicular choriocarcinoma and yolk sac tumor|testicular choriocarcinoma and yolk sac tumor
865282|NCT00049465|testicular choriocarcinoma|testicular choriocarcinoma
865283|NCT00049465|testicular embryonal carcinoma and seminoma|testicular embryonal carcinoma and seminoma
865284|NCT00049465|testicular embryonal carcinoma and teratoma with seminoma|testicular embryonal carcinoma and teratoma with seminoma
865285|NCT00049465|testicular embryonal carcinoma and teratoma|testicular embryonal carcinoma and teratoma
865286|NCT00049465|testicular embryonal carcinoma and yolk sac tumor with seminoma|testicular embryonal carcinoma and yolk sac tumor with seminoma
865287|NCT00049465|testicular embryonal carcinoma and yolk sac tumor|testicular embryonal carcinoma and yolk sac tumor
865288|NCT00049465|testicular embryonal carcinoma|testicular embryonal carcinoma
865289|NCT00049465|testicular teratoma|testicular teratoma
865290|NCT00049465|testicular yolk sac tumor and teratoma with seminoma|testicular yolk sac tumor and teratoma with seminoma
865291|NCT00049465|testicular yolk sac tumor and teratoma|testicular yolk sac tumor and teratoma
865292|NCT00049465|testicular yolk sac tumor|testicular yolk sac tumor
865293|NCT00049465|stage III multiple myeloma|stage iii multiple myeloma
865294|NCT00049465|chronic eosinophilic leukemia|chronic eosinophilic leukemia
865295|NCT00049465|chronic neutrophilic leukemia|chronic neutrophilic leukemia
865296|NCT00049465|atypical chronic myeloid leukemia|atypical chronic myeloid leukemia
865297|NCT00049465|myelodysplastic/myeloproliferative disease, unclassifiable|myelodysplastic/myeloproliferative disease, unclassifiable
865298|NCT00049465|noncontiguous stage II small lymphocytic lymphoma|noncontiguous stage ii small lymphocytic lymphoma
865299|NCT00049465|noncontiguous stage II marginal zone lymphoma|noncontiguous stage ii marginal zone lymphoma
865300|NCT00049465|recurrent marginal zone lymphoma|recurrent marginal zone lymphoma
865301|NCT00049465|recurrent small lymphocytic lymphoma|recurrent small lymphocytic lymphoma
865302|NCT00049465|stage III small lymphocytic lymphoma|stage iii small lymphocytic lymphoma
865303|NCT00049465|stage III marginal zone lymphoma|stage iii marginal zone lymphoma
865304|NCT00049465|stage IV small lymphocytic lymphoma|stage iv small lymphocytic lymphoma
865305|NCT00049465|stage IV marginal zone lymphoma|stage iv marginal zone lymphoma
865306|NCT00049465|extranodal marginal zone B-cell lymphoma of mucosa-associated lymphoid tissue|extranodal marginal zone b-cell lymphoma of mucosa-associated lymphoid tissue
865307|NCT00049465|nodal marginal zone B-cell lymphoma|nodal marginal zone b-cell lymphoma
865308|NCT00049465|splenic marginal zone lymphoma|splenic marginal zone lymphoma
865309|NCT00049452|osteoporosis|osteoporosis
865310|NCT00049452|stage I breast cancer|stage i breast cancer
865311|NCT00049452|stage II breast cancer|stage ii breast cancer
865312|NCT00049439|AIDS-related diffuse large cell lymphoma|aids-related diffuse large cell lymphoma
865313|NCT00049439|AIDS-related diffuse mixed cell lymphoma|aids-related diffuse mixed cell lymphoma
865314|NCT00049439|AIDS-related diffuse small cleaved cell lymphoma|aids-related diffuse small cleaved cell lymphoma
865315|NCT00049439|AIDS-related immunoblastic large cell lymphoma|aids-related immunoblastic large cell lymphoma
865316|NCT00049439|AIDS-related lymphoblastic lymphoma|aids-related lymphoblastic lymphoma
865317|NCT00049439|AIDS-related small noncleaved cell lymphoma|aids-related small noncleaved cell lymphoma
865318|NCT00049413|B-cell chronic lymphocytic leukemia|b-cell chronic lymphocytic leukemia
865319|NCT00049413|refractory chronic lymphocytic leukemia|refractory chronic lymphocytic leukemia
865320|NCT00049413|stage I chronic lymphocytic leukemia|stage i chronic lymphocytic leukemia
865321|NCT00049413|stage II chronic lymphocytic leukemia|stage ii chronic lymphocytic leukemia
865322|NCT00049413|stage III chronic lymphocytic leukemia|stage iii chronic lymphocytic leukemia
865323|NCT00049413|stage IV chronic lymphocytic leukemia|stage iv chronic lymphocytic leukemia
865324|NCT00049413|contiguous stage II small lymphocytic lymphoma|contiguous stage ii small lymphocytic lymphoma
865325|NCT00049413|noncontiguous stage II small lymphocytic lymphoma|noncontiguous stage ii small lymphocytic lymphoma
865326|NCT00049413|recurrent small lymphocytic lymphoma|recurrent small lymphocytic lymphoma
865327|NCT00049413|stage I small lymphocytic lymphoma|stage i small lymphocytic lymphoma
865328|NCT00049413|stage III small lymphocytic lymphoma|stage iii small lymphocytic lymphoma
865329|NCT00049413|stage IV small lymphocytic lymphoma|stage iv small lymphocytic lymphoma
865330|NCT00049400|unspecified adult solid tumor, protocol specific|unspecified adult solid tumor, protocol specific
865331|NCT00049400|anaplastic large cell lymphoma|anaplastic large cell lymphoma
865332|NCT00049400|angioimmunoblastic T-cell lymphoma|angioimmunoblastic t-cell lymphoma
865333|NCT00049400|intraocular lymphoma|intraocular lymphoma
865334|NCT00049400|primary central nervous system lymphoma|primary central nervous system lymphoma
865335|NCT00049400|recurrent adult diffuse large cell lymphoma|recurrent adult diffuse large cell lymphoma
865336|NCT00049400|recurrent adult Hodgkin lymphoma|recurrent adult hodgkin lymphoma
865337|NCT00049400|recurrent adult immunoblastic large cell lymphoma|recurrent adult immunoblastic large cell lymphoma
865338|NCT00049400|recurrent adult T-cell leukemia/lymphoma|recurrent adult t-cell leukemia/lymphoma
865339|NCT00049400|recurrent cutaneous T-cell non-Hodgkin lymphoma|recurrent cutaneous t-cell non-hodgkin lymphoma
865340|NCT00049400|recurrent grade 1, 2, or 3 follicular lymphoma|recurrent grade 1, 2, or 3 follicular lymphoma
865341|NCT00049400|recurrent mantle cell lymphoma|recurrent mantle cell lymphoma
865342|NCT00049400|small intestine lymphoma|small intestine lymphoma
865343|NCT00049400|stage IV adult diffuse large cell or mixed cell lymphoma|stage iv adult diffuse large cell or mixed cell lymphoma
865344|NCT00049400|stage IV adult diffuse small cleaved cell lymphoma|stage iv adult diffuse small cleaved cell lymphoma
865345|NCT00049400|stage IV adult Burkitt lymphoma or Hodgkin lymphoma|stage iv adult burkitt lymphoma or hodgkin lymphoma
865346|NCT00049400|stage IV adult immunoblastic large cell lymphoma|stage iv adult immunoblastic large cell lymphoma
865347|NCT00049400|stage IV adult lymphoblastic lymphoma|stage iv adult lymphoblastic lymphoma
865348|NCT00049400|stage IV adult T-cell leukemia/lymphoma|stage iv adult t-cell leukemia/lymphoma
865349|NCT00049400|stage IV cutaneous T-cell non-Hodgkin lymphoma|stage iv cutaneous t-cell non-hodgkin lymphoma
865350|NCT00049400|stage IV grade 1, 2, or 3 follicular lymphoma|stage iv grade 1, 2, or 3 follicular lymphoma
865351|NCT00049400|stage IV mantle cell lymphoma|stage iv mantle cell lymphoma
865352|NCT00049400|recurrent marginal zone lymphoma|recurrent marginal zone lymphoma
865353|NCT00049400|recurrent small lymphocytic lymphoma|recurrent small lymphocytic lymphoma
865354|NCT00049400|stage IV small lymphocytic lymphoma|stage iv small lymphocytic lymphoma
865355|NCT00049400|stage IV marginal zone lymphoma|stage iv marginal zone lymphoma
865356|NCT00049400|extranodal marginal zone B-cell lymphoma of MALT|extranodal marginal zone b-cell lymphoma of malt
865357|NCT00049400|nodal marginal zone B-cell lymphoma|nodal marginal zone b-cell lymphoma
865358|NCT00049400|splenic marginal zone lymphoma|splenic marginal zone lymphoma
865433|NCT00049296|recurrent colon cancer|recurrent colon cancer
865359|NCT00049400|recurrent adult Burkitt lymphoma|recurrent adult burkitt lymphoma
865360|NCT00049400|recurrent adult lymphoblastic lymphoma|recurrent adult lymphoblastic lymphoma
865361|NCT00049400|recurrent adult diffuse small cleaved cell lymphoma|recurrent adult diffuse small cleaved cell lymphoma
865362|NCT00049400|recurrent adult diffuse mixed cell lymphoma|recurrent adult diffuse mixed cell lymphoma
865363|NCT00049374|refractory multiple myeloma|refractory multiple myeloma
865364|NCT00049361|adult tumors metastatic to brain|adult tumors metastatic to brain
865365|NCT00049361|unspecified adult solid tumor, protocol specific|unspecified adult solid tumor, protocol specific
865366|NCT00049348|adenocarcinoma of the pancreas|adenocarcinoma of the pancreas
865367|NCT00049348|stage II pancreatic cancer|stage ii pancreatic cancer
865368|NCT00049348|stage III pancreatic cancer|stage iii pancreatic cancer
865369|NCT00049335|recurrent colon cancer|recurrent colon cancer
865370|NCT00049335|stage IV colon cancer|stage iv colon cancer
865371|NCT00049335|recurrent rectal cancer|recurrent rectal cancer
865372|NCT00049335|stage IV rectal cancer|stage iv rectal cancer
865373|NCT00049322|localized unresectable adult primary liver cancer|localized unresectable adult primary liver cancer
865374|NCT00049322|recurrent adult primary liver cancer|recurrent adult primary liver cancer
865375|NCT00049322|adult primary hepatocellular carcinoma|adult primary hepatocellular carcinoma
865376|NCT00049309|stage I prostate cancer|stage i prostate cancer
865377|NCT00049309|stage IIB prostate cancer|stage iib prostate cancer
865378|NCT00049309|stage IIA prostate cancer|stage iia prostate cancer
865379|NCT00049309|stage III prostate cancer|stage iii prostate cancer
865380|NCT00049296|adult anaplastic astrocytoma|adult anaplastic astrocytoma
865381|NCT00049296|male breast cancer|male breast cancer
865382|NCT00049296|adult anaplastic oligodendroglioma|adult anaplastic oligodendroglioma
865383|NCT00049296|adult meningeal hemangiopericytoma|adult meningeal hemangiopericytoma
865384|NCT00049296|adult brain stem glioma|adult brain stem glioma
865385|NCT00049296|adult central nervous system germ cell tumor|adult central nervous system germ cell tumor
865386|NCT00049296|adult choroid plexus tumor|adult choroid plexus tumor
865387|NCT00049296|adult craniopharyngioma|adult craniopharyngioma
865388|NCT00049296|adult ependymoblastoma|adult ependymoblastoma
865389|NCT00049296|adult glioblastoma|adult glioblastoma
865390|NCT00049296|adult pilocytic astrocytoma|adult pilocytic astrocytoma
865391|NCT00049296|adult anaplastic ependymoma|adult anaplastic ependymoma
865392|NCT00049296|adult medulloblastoma|adult medulloblastoma
865393|NCT00049296|adult meningioma|adult meningioma
865394|NCT00049296|adult pineoblastoma|adult pineoblastoma
865395|NCT00049296|adult pineocytoma|adult pineocytoma
865396|NCT00049296|adult subependymoma|adult subependymoma
865397|NCT00049296|adult myxopapillary ependymoma|adult myxopapillary ependymoma
865398|NCT00049296|advanced adult primary liver cancer|advanced adult primary liver cancer
865399|NCT00049296|anterior urethral cancer|anterior urethral cancer
865400|NCT00049296|carcinoma of the appendix|carcinoma of the appendix
865401|NCT00049296|chondrosarcoma|chondrosarcoma
865402|NCT00049296|classic Kaposi sarcoma|classic kaposi sarcoma
865403|NCT00049296|AIDS-related Kaposi sarcoma|aids-related kaposi sarcoma
865404|NCT00049296|immunosuppressive treatment related Kaposi sarcoma|immunosuppressive treatment related kaposi sarcoma
865405|NCT00049296|recurrent Kaposi sarcoma|recurrent kaposi sarcoma
865406|NCT00049296|clear cell sarcoma of the kidney|clear cell sarcoma of the kidney
865407|NCT00049296|disseminated neuroblastoma|disseminated neuroblastoma
865408|NCT00049296|extensive stage small cell lung cancer|extensive stage small cell lung cancer
865409|NCT00049296|gastrointestinal stromal tumor|gastrointestinal stromal tumor
865410|NCT00049296|metastatic gastrointestinal carcinoid tumor|metastatic gastrointestinal carcinoid tumor
865411|NCT00049296|metastatic osteosarcoma|metastatic osteosarcoma
865412|NCT00049296|metastatic transitional cell cancer of the renal pelvis and ureter|metastatic transitional cell cancer of the renal pelvis and ureter
865413|NCT00049296|metastatic Ewing sarcoma/peripheral primitive neuroectodermal tumor|metastatic ewing sarcoma/peripheral primitive neuroectodermal tumor
865414|NCT00049296|adult mixed glioma|adult mixed glioma
865415|NCT00049296|ovarian sarcoma|ovarian sarcoma
865416|NCT00049296|posterior urethral cancer|posterior urethral cancer
865417|NCT00049296|primary central nervous system lymphoma|primary central nervous system lymphoma
865418|NCT00049296|pulmonary carcinoid tumor|pulmonary carcinoid tumor
865419|NCT00049296|recurrent adenoid cystic carcinoma of the oral cavity|recurrent adenoid cystic carcinoma of the oral cavity
865420|NCT00049296|recurrent adult brain tumor|recurrent adult brain tumor
865421|NCT00049296|recurrent adult diffuse large cell lymphoma|recurrent adult diffuse large cell lymphoma
865422|NCT00049296|recurrent adult diffuse mixed cell lymphoma|recurrent adult diffuse mixed cell lymphoma
865423|NCT00049296|recurrent adult diffuse small cleaved cell lymphoma|recurrent adult diffuse small cleaved cell lymphoma
865424|NCT00049296|recurrent adult Burkitt lymphoma|recurrent adult burkitt lymphoma
865425|NCT00049296|recurrent adult immunoblastic large cell lymphoma|recurrent adult immunoblastic large cell lymphoma
865426|NCT00049296|recurrent adult lymphoblastic lymphoma|recurrent adult lymphoblastic lymphoma
865427|NCT00049296|recurrent adult primary liver cancer|recurrent adult primary liver cancer
865428|NCT00049296|recurrent adult soft tissue sarcoma|recurrent adult soft tissue sarcoma
865429|NCT00049296|recurrent anal cancer|recurrent anal cancer
865430|NCT00049296|recurrent basal cell carcinoma of the lip|recurrent basal cell carcinoma of the lip
865431|NCT00049296|recurrent bladder cancer|recurrent bladder cancer
865432|NCT00049296|recurrent breast cancer|recurrent breast cancer
865434|NCT00049296|recurrent esophageal cancer|recurrent esophageal cancer
865435|NCT00049296|recurrent esthesioneuroblastoma of the paranasal sinus and nasal cavity|recurrent esthesioneuroblastoma of the paranasal sinus and nasal cavity
865436|NCT00049296|recurrent extrahepatic bile duct cancer|recurrent extrahepatic bile duct cancer
865437|NCT00049296|recurrent gallbladder cancer|recurrent gallbladder cancer
865438|NCT00049296|recurrent gastric cancer|recurrent gastric cancer
865439|NCT00049296|recurrent gastrointestinal carcinoid tumor|recurrent gastrointestinal carcinoid tumor
865440|NCT00049296|recurrent grade 1 follicular lymphoma|recurrent grade 1 follicular lymphoma
865441|NCT00049296|recurrent grade 2 follicular lymphoma|recurrent grade 2 follicular lymphoma
865442|NCT00049296|recurrent grade 3 follicular lymphoma|recurrent grade 3 follicular lymphoma
865443|NCT00049296|recurrent inverted papilloma of the paranasal sinus and nasal cavity|recurrent inverted papilloma of the paranasal sinus and nasal cavity
865444|NCT00049296|recurrent lymphoepithelioma of the nasopharynx|recurrent lymphoepithelioma of the nasopharynx
865445|NCT00049296|recurrent lymphoepithelioma of the oropharynx|recurrent lymphoepithelioma of the oropharynx
865446|NCT00049296|recurrent mantle cell lymphoma|recurrent mantle cell lymphoma
865447|NCT00049296|recurrent melanoma|recurrent melanoma
865448|NCT00049296|recurrent metastatic squamous neck cancer with occult primary|recurrent metastatic squamous neck cancer with occult primary
865449|NCT00049296|recurrent midline lethal granuloma of the paranasal sinus and nasal cavity|recurrent midline lethal granuloma of the paranasal sinus and nasal cavity
865450|NCT00049296|recurrent mucoepidermoid carcinoma of the oral cavity|recurrent mucoepidermoid carcinoma of the oral cavity
865451|NCT00049296|recurrent neuroblastoma|recurrent neuroblastoma
865452|NCT00049296|recurrent non-small cell lung cancer|recurrent non-small cell lung cancer
865453|NCT00049296|recurrent osteosarcoma|recurrent osteosarcoma
865454|NCT00049296|recurrent pancreatic cancer|recurrent pancreatic cancer
865455|NCT00049296|recurrent rectal cancer|recurrent rectal cancer
865456|NCT00049296|recurrent renal cell cancer|recurrent renal cell cancer
865457|NCT00049296|recurrent small cell lung cancer|recurrent small cell lung cancer
865458|NCT00049296|recurrent small intestine cancer|recurrent small intestine cancer
865459|NCT00049296|recurrent squamous cell carcinoma of the hypopharynx|recurrent squamous cell carcinoma of the hypopharynx
887652|NCT00001003|Lung|lung
865460|NCT00049296|recurrent squamous cell carcinoma of the larynx|recurrent squamous cell carcinoma of the larynx
865461|NCT00049296|recurrent squamous cell carcinoma of the lip and oral cavity|recurrent squamous cell carcinoma of the lip and oral cavity
865462|NCT00049296|recurrent squamous cell carcinoma of the nasopharynx|recurrent squamous cell carcinoma of the nasopharynx
865463|NCT00049296|recurrent squamous cell carcinoma of the oropharynx|recurrent squamous cell carcinoma of the oropharynx
865464|NCT00049296|recurrent squamous cell carcinoma of the paranasal sinus and nasal cavity|recurrent squamous cell carcinoma of the paranasal sinus and nasal cavity
865465|NCT00049296|recurrent transitional cell cancer of the renal pelvis and ureter|recurrent transitional cell cancer of the renal pelvis and ureter
865466|NCT00049296|recurrent Ewing sarcoma/peripheral primitive neuroectodermal tumor|recurrent ewing sarcoma/peripheral primitive neuroectodermal tumor
865467|NCT00049296|recurrent urethral cancer|recurrent urethral cancer
865468|NCT00049296|recurrent uterine sarcoma|recurrent uterine sarcoma
865469|NCT00049296|recurrent verrucous carcinoma of the larynx|recurrent verrucous carcinoma of the larynx
865470|NCT00049296|recurrent verrucous carcinoma of the oral cavity|recurrent verrucous carcinoma of the oral cavity
865471|NCT00049296|refractory multiple myeloma|refractory multiple myeloma
865472|NCT00049296|rhabdoid tumor of the kidney|rhabdoid tumor of the kidney
865473|NCT00049296|small intestine adenocarcinoma|small intestine adenocarcinoma
865474|NCT00049296|small intestine leiomyosarcoma|small intestine leiomyosarcoma
865475|NCT00049296|small intestine lymphoma|small intestine lymphoma
865476|NCT00049296|stage II esophageal cancer|stage ii esophageal cancer
865477|NCT00049296|stage II pancreatic cancer|stage ii pancreatic cancer
865478|NCT00049296|stage III esophageal cancer|stage iii esophageal cancer
865479|NCT00049296|stage III multiple myeloma|stage iii multiple myeloma
865480|NCT00049296|stage III pancreatic cancer|stage iii pancreatic cancer
865481|NCT00049296|stage IV adenoid cystic carcinoma of the oral cavity|stage iv adenoid cystic carcinoma of the oral cavity
865482|NCT00049296|stage IV adult diffuse large cell lymphoma|stage iv adult diffuse large cell lymphoma
865483|NCT00049296|stage IV adult diffuse mixed cell lymphoma|stage iv adult diffuse mixed cell lymphoma
865484|NCT00049296|stage IV adult diffuse small cleaved cell lymphoma|stage iv adult diffuse small cleaved cell lymphoma
865485|NCT00049296|stage IV adult Burkitt lymphoma|stage iv adult burkitt lymphoma
865486|NCT00049296|stage IV adult immunoblastic large cell lymphoma|stage iv adult immunoblastic large cell lymphoma
865487|NCT00049296|stage IV adult lymphoblastic lymphoma|stage iv adult lymphoblastic lymphoma
865488|NCT00049296|stage IV anal cancer|stage iv anal cancer
865489|NCT00049296|stage IV basal cell carcinoma of the lip|stage iv basal cell carcinoma of the lip
865490|NCT00049296|stage IV bladder cancer|stage iv bladder cancer
865491|NCT00049296|stage IV breast cancer|stage iv breast cancer
865492|NCT00049296|stage IV colon cancer|stage iv colon cancer
865493|NCT00049296|stage IV esophageal cancer|stage iv esophageal cancer
865494|NCT00049296|stage IV esthesioneuroblastoma of the paranasal sinus and nasal cavity|stage iv esthesioneuroblastoma of the paranasal sinus and nasal cavity
865495|NCT00049296|stage IV gastric cancer|stage iv gastric cancer
865496|NCT00049296|stage IV grade 1 follicular lymphoma|stage iv grade 1 follicular lymphoma
865497|NCT00049296|stage IV grade 2 follicular lymphoma|stage iv grade 2 follicular lymphoma
866681|NCT00039546|stage II breast cancer|stage ii breast cancer
865498|NCT00049296|stage IV grade 3 follicular lymphoma|stage iv grade 3 follicular lymphoma
865499|NCT00049296|stage IV inverted papilloma of the paranasal sinus and nasal cavity|stage iv inverted papilloma of the paranasal sinus and nasal cavity
865500|NCT00049296|stage IV lymphoepithelioma of the nasopharynx|stage iv lymphoepithelioma of the nasopharynx
865501|NCT00049296|stage IV lymphoepithelioma of the oropharynx|stage iv lymphoepithelioma of the oropharynx
865502|NCT00049296|stage IV mantle cell lymphoma|stage iv mantle cell lymphoma
865503|NCT00049296|stage IV melanoma|stage iv melanoma
865504|NCT00049296|stage IV midline lethal granuloma of the paranasal sinus and nasal cavity|stage iv midline lethal granuloma of the paranasal sinus and nasal cavity
865505|NCT00049296|stage IV mucoepidermoid carcinoma of the oral cavity|stage iv mucoepidermoid carcinoma of the oral cavity
865506|NCT00049296|stage IV non-small cell lung cancer|stage iv non-small cell lung cancer
865507|NCT00049296|stage IV rectal cancer|stage iv rectal cancer
865508|NCT00049296|stage IV renal cell cancer|stage iv renal cell cancer
865509|NCT00049296|stage IV squamous cell carcinoma of the hypopharynx|stage iv squamous cell carcinoma of the hypopharynx
865510|NCT00049296|stage IV squamous cell carcinoma of the larynx|stage iv squamous cell carcinoma of the larynx
865511|NCT00049296|stage IV squamous cell carcinoma of the lip and oral cavity|stage iv squamous cell carcinoma of the lip and oral cavity
865512|NCT00049296|stage IV squamous cell carcinoma of the nasopharynx|stage iv squamous cell carcinoma of the nasopharynx
865513|NCT00049296|stage IV squamous cell carcinoma of the oropharynx|stage iv squamous cell carcinoma of the oropharynx
865514|NCT00049296|stage IV squamous cell carcinoma of the paranasal sinus and nasal cavity|stage iv squamous cell carcinoma of the paranasal sinus and nasal cavity
865515|NCT00049296|stage IV uterine sarcoma|stage iv uterine sarcoma
865516|NCT00049296|stage IV verrucous carcinoma of the larynx|stage iv verrucous carcinoma of the larynx
865517|NCT00049296|stage IV verrucous carcinoma of the oral cavity|stage iv verrucous carcinoma of the oral cavity
865518|NCT00049296|unresectable extrahepatic bile duct cancer|unresectable extrahepatic bile duct cancer
865519|NCT00049296|unresectable gallbladder cancer|unresectable gallbladder cancer
865520|NCT00049296|unspecified adult solid tumor, protocol specific|unspecified adult solid tumor, protocol specific
865521|NCT00049296|urethral cancer associated with invasive bladder cancer|urethral cancer associated with invasive bladder cancer
865522|NCT00049296|recurrent salivary gland cancer|recurrent salivary gland cancer
865523|NCT00049296|stage IV salivary gland cancer|stage iv salivary gland cancer
865524|NCT00049296|recurrent marginal zone lymphoma|recurrent marginal zone lymphoma
865525|NCT00049296|recurrent small lymphocytic lymphoma|recurrent small lymphocytic lymphoma
865526|NCT00049296|stage IV small lymphocytic lymphoma|stage iv small lymphocytic lymphoma
865527|NCT00049296|stage IV marginal zone lymphoma|stage iv marginal zone lymphoma
865528|NCT00049296|extranodal marginal zone B-cell lymphoma of mucosa-associated lymphoid tissue|extranodal marginal zone b-cell lymphoma of mucosa-associated lymphoid tissue
865529|NCT00049296|nodal marginal zone B-cell lymphoma|nodal marginal zone b-cell lymphoma
865530|NCT00049296|splenic marginal zone lymphoma|splenic marginal zone lymphoma
865531|NCT00049296|stage IV adult soft tissue sarcoma|stage iv adult soft tissue sarcoma
865532|NCT00049296|adult grade III meningioma|adult grade iii meningioma
865533|NCT00049296|adult oligodendroglioma|adult oligodendroglioma
865534|NCT00049296|adult giant cell glioblastoma|adult giant cell glioblastoma
865535|NCT00049296|adult gliosarcoma|adult gliosarcoma
865536|NCT00049296|stage IV pancreatic cancer|stage iv pancreatic cancer
865537|NCT00049257|adenocarcinoma of the prostate|adenocarcinoma of the prostate
865538|NCT00049257|recurrent prostate cancer|recurrent prostate cancer
865539|NCT00049257|stage IV prostate cancer|stage iv prostate cancer
865540|NCT00049244|recurrent breast cancer|recurrent breast cancer
865541|NCT00049244|stage IV breast cancer|stage iv breast cancer
865542|NCT00049231|cervical adenocarcinoma|cervical adenocarcinoma
865543|NCT00049231|cervical adenosquamous cell carcinoma|cervical adenosquamous cell carcinoma
865544|NCT00049231|cervical squamous cell carcinoma|cervical squamous cell carcinoma
865545|NCT00049231|stage IIB cervical cancer|stage iib cervical cancer
865546|NCT00049231|stage III cervical cancer|stage iii cervical cancer
865547|NCT00049231|stage IVA cervical cancer|stage iva cervical cancer
865548|NCT00049218|extensive stage small cell lung cancer|extensive stage small cell lung cancer
865549|NCT00049179|adult acute monocytic leukemia (M5b)|adult acute monocytic leukemia (m5b)
865550|NCT00049179|adult acute erythroid leukemia (M6)|adult acute erythroid leukemia (m6)
865551|NCT00049179|adult acute megakaryoblastic leukemia (M7)|adult acute megakaryoblastic leukemia (m7)
865552|NCT00049179|adult acute myeloblastic leukemia with maturation (M2)|adult acute myeloblastic leukemia with maturation (m2)
865553|NCT00049179|adult acute myeloblastic leukemia without maturation (M1)|adult acute myeloblastic leukemia without maturation (m1)
865554|NCT00049179|adult acute myelomonocytic leukemia (M4)|adult acute myelomonocytic leukemia (m4)
865555|NCT00049179|adult acute monoblastic leukemia (M5a)|adult acute monoblastic leukemia (m5a)
865649|NCT00047294|adult gliosarcoma|adult gliosarcoma
865556|NCT00049179|recurrent adult acute myeloid leukemia|recurrent adult acute myeloid leukemia
865557|NCT00049179|secondary acute myeloid leukemia|secondary acute myeloid leukemia
865558|NCT00049179|adult acute myeloid leukemia with t(8;21)(q22;q22)|adult acute myeloid leukemia with t(8;21)(q22;q22)
865559|NCT00049179|adult acute myeloid leukemia with t(16;16)(p13;q22)|adult acute myeloid leukemia with t(16;16)(p13;q22)
865560|NCT00049179|adult acute myeloid leukemia with inv(16)(p13;q22)|adult acute myeloid leukemia with inv(16)(p13;q22)
865561|NCT00049179|adult acute myeloid leukemia with 11q23 (MLL) abnormalities|adult acute myeloid leukemia with 11q23 (mll) abnormalities
865562|NCT00049140|stage I squamous cell carcinoma of the hypopharynx|stage i squamous cell carcinoma of the hypopharynx
865563|NCT00049140|stage I squamous cell carcinoma of the larynx|stage i squamous cell carcinoma of the larynx
865564|NCT00049140|stage I squamous cell carcinoma of the lip and oral cavity|stage i squamous cell carcinoma of the lip and oral cavity
865565|NCT00049140|stage I squamous cell carcinoma of the nasopharynx|stage i squamous cell carcinoma of the nasopharynx
865566|NCT00049140|stage I squamous cell carcinoma of the oropharynx|stage i squamous cell carcinoma of the oropharynx
865567|NCT00049140|stage I squamous cell carcinoma of the paranasal sinus and nasal cavity|stage i squamous cell carcinoma of the paranasal sinus and nasal cavity
865568|NCT00049140|stage II squamous cell carcinoma of the hypopharynx|stage ii squamous cell carcinoma of the hypopharynx
865569|NCT00049140|stage II squamous cell carcinoma of the larynx|stage ii squamous cell carcinoma of the larynx
865570|NCT00049140|stage II squamous cell carcinoma of the lip and oral cavity|stage ii squamous cell carcinoma of the lip and oral cavity
865571|NCT00049140|stage II squamous cell carcinoma of the nasopharynx|stage ii squamous cell carcinoma of the nasopharynx
865572|NCT00049140|stage II squamous cell carcinoma of the oropharynx|stage ii squamous cell carcinoma of the oropharynx
865573|NCT00049140|stage II squamous cell carcinoma of the paranasal sinus and nasal cavity|stage ii squamous cell carcinoma of the paranasal sinus and nasal cavity
865574|NCT00049140|stage III squamous cell carcinoma of the hypopharynx|stage iii squamous cell carcinoma of the hypopharynx
865575|NCT00049140|stage III squamous cell carcinoma of the larynx|stage iii squamous cell carcinoma of the larynx
865576|NCT00049140|stage III squamous cell carcinoma of the lip and oral cavity|stage iii squamous cell carcinoma of the lip and oral cavity
865577|NCT00049140|stage III squamous cell carcinoma of the nasopharynx|stage iii squamous cell carcinoma of the nasopharynx
865578|NCT00049140|stage III squamous cell carcinoma of the oropharynx|stage iii squamous cell carcinoma of the oropharynx
865579|NCT00049140|stage III squamous cell carcinoma of the paranasal sinus and nasal cavity|stage iii squamous cell carcinoma of the paranasal sinus and nasal cavity
865580|NCT00049140|stage IV squamous cell carcinoma of the hypopharynx|stage iv squamous cell carcinoma of the hypopharynx
865581|NCT00049140|stage IV squamous cell carcinoma of the larynx|stage iv squamous cell carcinoma of the larynx
865582|NCT00049140|stage IV squamous cell carcinoma of the lip and oral cavity|stage iv squamous cell carcinoma of the lip and oral cavity
865583|NCT00049140|stage IV squamous cell carcinoma of the nasopharynx|stage iv squamous cell carcinoma of the nasopharynx
865584|NCT00049140|stage IV squamous cell carcinoma of the oropharynx|stage iv squamous cell carcinoma of the oropharynx
865585|NCT00049140|stage IV squamous cell carcinoma of the paranasal sinus and nasal cavity|stage iv squamous cell carcinoma of the paranasal sinus and nasal cavity
865586|NCT00049140|stage I salivary gland cancer|stage i salivary gland cancer
865587|NCT00049140|stage II salivary gland cancer|stage ii salivary gland cancer
865588|NCT00049140|stage III salivary gland cancer|stage iii salivary gland cancer
865589|NCT00049140|stage IV salivary gland cancer|stage iv salivary gland cancer
865590|NCT00049140|salivary gland squamous cell carcinoma|salivary gland squamous cell carcinoma
865591|NCT00049101|recurrent colon cancer|recurrent colon cancer
865592|NCT00049101|stage IV colon cancer|stage iv colon cancer
865593|NCT00049101|recurrent rectal cancer|recurrent rectal cancer
865594|NCT00049101|stage IV rectal cancer|stage iv rectal cancer
865595|NCT00049075|B-cell chronic lymphocytic leukemia|b-cell chronic lymphocytic leukemia
865596|NCT00049075|stage I chronic lymphocytic leukemia|stage i chronic lymphocytic leukemia
865597|NCT00049075|stage II chronic lymphocytic leukemia|stage ii chronic lymphocytic leukemia
865598|NCT00049075|stage III chronic lymphocytic leukemia|stage iii chronic lymphocytic leukemia
865599|NCT00049075|stage IV chronic lymphocytic leukemia|stage iv chronic lymphocytic leukemia
865600|NCT00049062|recurrent breast cancer|recurrent breast cancer
865601|NCT00049062|stage IIIB breast cancer|stage iiib breast cancer
865602|NCT00049062|stage IIIC breast cancer|stage iiic breast cancer
865603|NCT00049062|stage IV breast cancer|stage iv breast cancer
865604|NCT00049023|childhood grade III meningioma|childhood grade iii meningioma
865605|NCT00049023|disseminated neuroblastoma|disseminated neuroblastoma
865606|NCT00049023|localized unresectable neuroblastoma|localized unresectable neuroblastoma
865607|NCT00049023|metastatic pheochromocytoma|metastatic pheochromocytoma
865608|NCT00049023|metastatic Ewing sarcoma/peripheral primitive neuroectodermal tumor|metastatic ewing sarcoma/peripheral primitive neuroectodermal tumor
865609|NCT00049023|recurrent childhood brain tumor|recurrent childhood brain tumor
865610|NCT00049023|recurrent childhood medulloblastoma|recurrent childhood medulloblastoma
865611|NCT00049023|recurrent neuroblastoma|recurrent neuroblastoma
865612|NCT00049023|recurrent pheochromocytoma|recurrent pheochromocytoma
865613|NCT00049023|recurrent Ewing sarcoma/peripheral primitive neuroectodermal tumor|recurrent ewing sarcoma/peripheral primitive neuroectodermal tumor
865614|NCT00049023|regional neuroblastoma|regional neuroblastoma
865615|NCT00049023|regional pheochromocytoma|regional pheochromocytoma
865616|NCT00049023|unspecified childhood solid tumor, protocol specific|unspecified childhood solid tumor, protocol specific
865617|NCT00049023|recurrent childhood ependymoma|recurrent childhood ependymoma
865618|NCT00049023|childhood infratentorial ependymoma|childhood infratentorial ependymoma
865619|NCT00049023|childhood supratentorial ependymoma|childhood supratentorial ependymoma
865620|NCT00049023|recurrent islet cell carcinoma|recurrent islet cell carcinoma
865621|NCT00049023|gastrinoma|gastrinoma
865622|NCT00049023|insulinoma|insulinoma
865623|NCT00049023|metastatic gastrointestinal carcinoid tumor|metastatic gastrointestinal carcinoid tumor
865624|NCT00049023|recurrent gastrointestinal carcinoid tumor|recurrent gastrointestinal carcinoid tumor
865625|NCT00049023|regional gastrointestinal carcinoid tumor|regional gastrointestinal carcinoid tumor
865626|NCT00049010|stage I melanoma|stage i melanoma
865627|NCT00049010|stage II melanoma|stage ii melanoma
865628|NCT00048997|stage IIIA non-small cell lung cancer|stage iiia non-small cell lung cancer
865629|NCT00048997|stage IIIB non-small cell lung cancer|stage iiib non-small cell lung cancer
865630|NCT00048971|adenocarcinoma of the colon|adenocarcinoma of the colon
865631|NCT00048971|stage III colon cancer|stage iii colon cancer
865632|NCT00048971|diarrhea|diarrhea
865633|NCT00048971|neutropenia|neutropenia
865634|NCT00047385|small cell lung cancer|small cell lung cancer
865635|NCT00047385|non-small cell lung cancer|non-small cell lung cancer
865636|NCT00047320|childhood central nervous system germ cell tumor|childhood central nervous system germ cell tumor
865637|NCT00047320|childhood teratoma|childhood teratoma
865638|NCT00047320|recurrent childhood malignant germ cell tumor|recurrent childhood malignant germ cell tumor
865639|NCT00047320|childhood central nervous system choriocarcinoma|childhood central nervous system choriocarcinoma
865640|NCT00047320|childhood central nervous system embryonal tumor|childhood central nervous system embryonal tumor
865641|NCT00047320|childhood central nervous system germinoma|childhood central nervous system germinoma
865642|NCT00047320|childhood central nervous system mixed germ cell tumor|childhood central nervous system mixed germ cell tumor
865643|NCT00047320|childhood central nervous system teratoma|childhood central nervous system teratoma
865644|NCT00047320|childhood central nervous system yolk sac tumor|childhood central nervous system yolk sac tumor
865645|NCT00047320|recurrent childhood central nervous system embryonal tumor|recurrent childhood central nervous system embryonal tumor
865646|NCT00047294|adult mixed glioma|adult mixed glioma
865647|NCT00047294|adult glioblastoma|adult glioblastoma
865648|NCT00047294|adult giant cell glioblastoma|adult giant cell glioblastoma
865650|NCT00047281|adult anaplastic astrocytoma|adult anaplastic astrocytoma
865651|NCT00047281|adult anaplastic oligodendroglioma|adult anaplastic oligodendroglioma
865652|NCT00047281|adult glioblastoma|adult glioblastoma
865653|NCT00047281|adult mixed glioma|adult mixed glioma
865654|NCT00047281|recurrent adult brain tumor|recurrent adult brain tumor
865655|NCT00047281|adult giant cell glioblastoma|adult giant cell glioblastoma
865656|NCT00047281|adult gliosarcoma|adult gliosarcoma
865657|NCT00047268|juvenile myelomonocytic leukemia|juvenile myelomonocytic leukemia
865658|NCT00047268|childhood myelodysplastic syndromes|childhood myelodysplastic syndromes
865659|NCT00047268|atypical chronic myeloid leukemia, BCR-ABL1 negative|atypical chronic myeloid leukemia, bcr-abl1 negative
865660|NCT00047268|myelodysplastic/myeloproliferative neoplasm, unclassifiable|myelodysplastic/myeloproliferative neoplasm, unclassifiable
865661|NCT00047268|chronic myelomonocytic leukemia|chronic myelomonocytic leukemia
865662|NCT00047255|stage IIIB breast cancer|stage iiib breast cancer
865663|NCT00047255|stage IIIC breast cancer|stage iiic breast cancer
865664|NCT00047255|stage IV breast cancer|stage iv breast cancer
865665|NCT00047255|recurrent breast cancer|recurrent breast cancer
865666|NCT00047242|unspecified adult solid tumor, protocol specific|unspecified adult solid tumor, protocol specific
865667|NCT00047229|adult primary hepatocellular carcinoma|adult primary hepatocellular carcinoma
865668|NCT00047229|advanced adult primary liver cancer|advanced adult primary liver cancer
865669|NCT00047229|localized unresectable adult primary liver cancer|localized unresectable adult primary liver cancer
865670|NCT00047229|recurrent adult primary liver cancer|recurrent adult primary liver cancer
865671|NCT00047216|recurrent bladder cancer|recurrent bladder cancer
865672|NCT00047216|stage 0 bladder cancer|stage 0 bladder cancer
865673|NCT00047216|stage I bladder cancer|stage i bladder cancer
865674|NCT00047216|transitional cell carcinoma of the bladder|transitional cell carcinoma of the bladder
865675|NCT00047177|recurrent childhood medulloblastoma|recurrent childhood medulloblastoma
865676|NCT00047177|recurrent childhood supratentorial primitive neuroectodermal tumor|recurrent childhood supratentorial primitive neuroectodermal tumor
865677|NCT00047177|recurrent childhood ependymoma|recurrent childhood ependymoma
865678|NCT00047177|childhood atypical teratoid/rhabdoid tumor|childhood atypical teratoid/rhabdoid tumor
865679|NCT00047164|recurrent grade 1 follicular lymphoma|recurrent grade 1 follicular lymphoma
865680|NCT00047164|recurrent grade 2 follicular lymphoma|recurrent grade 2 follicular lymphoma
865681|NCT00047164|contiguous stage II adult lymphoblastic lymphoma|contiguous stage ii adult lymphoblastic lymphoma
865682|NCT00047164|noncontiguous stage II adult lymphoblastic lymphoma|noncontiguous stage ii adult lymphoblastic lymphoma
865683|NCT00047164|recurrent adult lymphoblastic lymphoma|recurrent adult lymphoblastic lymphoma
865684|NCT00047164|stage I adult lymphoblastic lymphoma|stage i adult lymphoblastic lymphoma
865685|NCT00047164|stage III adult lymphoblastic lymphoma|stage iii adult lymphoblastic lymphoma
865686|NCT00047164|stage IV adult lymphoblastic lymphoma|stage iv adult lymphoblastic lymphoma
865687|NCT00047164|noncontiguous stage II grade 3 follicular lymphoma|noncontiguous stage ii grade 3 follicular lymphoma
865688|NCT00047164|recurrent grade 3 follicular lymphoma|recurrent grade 3 follicular lymphoma
865689|NCT00047164|stage I grade 3 follicular lymphoma|stage i grade 3 follicular lymphoma
865690|NCT00047164|stage III grade 3 follicular lymphoma|stage iii grade 3 follicular lymphoma
865691|NCT00047164|stage IV grade 3 follicular lymphoma|stage iv grade 3 follicular lymphoma
865692|NCT00047164|contiguous stage II grade 3 follicular lymphoma|contiguous stage ii grade 3 follicular lymphoma
865693|NCT00047164|contiguous stage II grade 2 follicular lymphoma|contiguous stage ii grade 2 follicular lymphoma
865893|NCT00045747|adenocarcinoma of the pancreas|adenocarcinoma of the pancreas
865694|NCT00047164|contiguous stage II grade 1 follicular lymphoma|contiguous stage ii grade 1 follicular lymphoma
865695|NCT00047164|contiguous stage II adult diffuse mixed cell lymphoma|contiguous stage ii adult diffuse mixed cell lymphoma
865696|NCT00047164|noncontiguous stage II adult diffuse mixed cell lymphoma|noncontiguous stage ii adult diffuse mixed cell lymphoma
865697|NCT00047164|recurrent adult diffuse mixed cell lymphoma|recurrent adult diffuse mixed cell lymphoma
865698|NCT00047164|stage I adult diffuse mixed cell lymphoma|stage i adult diffuse mixed cell lymphoma
865699|NCT00047164|stage III adult diffuse mixed cell lymphoma|stage iii adult diffuse mixed cell lymphoma
865700|NCT00047164|stage IV adult diffuse mixed cell lymphoma|stage iv adult diffuse mixed cell lymphoma
865701|NCT00047164|contiguous stage II adult diffuse large cell lymphoma|contiguous stage ii adult diffuse large cell lymphoma
865702|NCT00047164|noncontiguous stage II adult diffuse large cell lymphoma|noncontiguous stage ii adult diffuse large cell lymphoma
865703|NCT00047164|recurrent adult diffuse large cell lymphoma|recurrent adult diffuse large cell lymphoma
865704|NCT00047164|stage I adult diffuse large cell lymphoma|stage i adult diffuse large cell lymphoma
865705|NCT00047164|stage III adult diffuse large cell lymphoma|stage iii adult diffuse large cell lymphoma
865706|NCT00047164|stage IV adult diffuse large cell lymphoma|stage iv adult diffuse large cell lymphoma
865707|NCT00047164|contiguous stage II adult immunoblastic large cell lymphoma|contiguous stage ii adult immunoblastic large cell lymphoma
865708|NCT00047164|noncontiguous stage II adult immunoblastic large cell lymphoma|noncontiguous stage ii adult immunoblastic large cell lymphoma
865709|NCT00047164|recurrent adult immunoblastic large cell lymphoma|recurrent adult immunoblastic large cell lymphoma
865710|NCT00047164|stage I adult immunoblastic large cell lymphoma|stage i adult immunoblastic large cell lymphoma
865711|NCT00047164|stage III adult immunoblastic large cell lymphoma|stage iii adult immunoblastic large cell lymphoma
865712|NCT00047164|stage IV adult immunoblastic large cell lymphoma|stage iv adult immunoblastic large cell lymphoma
865713|NCT00047164|contiguous stage II adult Burkitt lymphoma|contiguous stage ii adult burkitt lymphoma
865714|NCT00047164|noncontiguous stage II adult Burkitt lymphoma|noncontiguous stage ii adult burkitt lymphoma
865715|NCT00047164|recurrent adult Burkitt lymphoma|recurrent adult burkitt lymphoma
865716|NCT00047164|stage I adult Burkitt lymphoma|stage i adult burkitt lymphoma
865785|NCT00047060|Mycosis Fungoides|mycosis fungoides
865717|NCT00047164|stage III adult Burkitt lymphoma|stage iii adult burkitt lymphoma
865718|NCT00047164|stage IV adult Burkitt lymphoma|stage iv adult burkitt lymphoma
865719|NCT00047164|contiguous stage II mantle cell lymphoma|contiguous stage ii mantle cell lymphoma
865720|NCT00047164|noncontiguous stage II mantle cell lymphoma|noncontiguous stage ii mantle cell lymphoma
865721|NCT00047164|recurrent mantle cell lymphoma|recurrent mantle cell lymphoma
865722|NCT00047164|stage I mantle cell lymphoma|stage i mantle cell lymphoma
865723|NCT00047164|stage III mantle cell lymphoma|stage iii mantle cell lymphoma
865724|NCT00047164|stage IV mantle cell lymphoma|stage iv mantle cell lymphoma
865725|NCT00047164|recurrent adult Hodgkin lymphoma|recurrent adult hodgkin lymphoma
865726|NCT00047164|stage I adult Hodgkin lymphoma|stage i adult hodgkin lymphoma
865727|NCT00047164|stage II adult Hodgkin lymphoma|stage ii adult hodgkin lymphoma
865728|NCT00047164|stage III adult Hodgkin lymphoma|stage iii adult hodgkin lymphoma
865729|NCT00047164|stage IV adult Hodgkin lymphoma|stage iv adult hodgkin lymphoma
865730|NCT00047164|recurrent adult diffuse small cleaved cell lymphoma|recurrent adult diffuse small cleaved cell lymphoma
865731|NCT00047164|stage I adult diffuse small cleaved cell lymphoma|stage i adult diffuse small cleaved cell lymphoma
865732|NCT00047164|stage II adult diffuse small cleaved cell lymphoma|stage ii adult diffuse small cleaved cell lymphoma
865733|NCT00047164|stage III adult diffuse small cleaved cell lymphoma|stage iii adult diffuse small cleaved cell lymphoma
865734|NCT00047164|stage IV adult diffuse small cleaved cell lymphoma|stage iv adult diffuse small cleaved cell lymphoma
865735|NCT00047164|contiguous stage II marginal zone lymphoma|contiguous stage ii marginal zone lymphoma
865736|NCT00047164|extranodal marginal zone B-cell lymphoma of mucosa-associated lymphoid tissue|extranodal marginal zone b-cell lymphoma of mucosa-associated lymphoid tissue
865737|NCT00047164|nodal marginal zone B-cell lymphoma|nodal marginal zone b-cell lymphoma
865738|NCT00047164|noncontiguous stage II marginal zone lymphoma|noncontiguous stage ii marginal zone lymphoma
865739|NCT00047164|recurrent marginal zone lymphoma|recurrent marginal zone lymphoma
865740|NCT00047164|splenic marginal zone lymphoma|splenic marginal zone lymphoma
865741|NCT00047164|stage I marginal zone lymphoma|stage i marginal zone lymphoma
865742|NCT00047164|stage III marginal zone lymphoma|stage iii marginal zone lymphoma
865743|NCT00047164|stage IV marginal zone lymphoma|stage iv marginal zone lymphoma
865744|NCT00047164|contiguous stage II small lymphocytic lymphoma|contiguous stage ii small lymphocytic lymphoma
865745|NCT00047164|noncontiguous stage II small lymphocytic lymphoma|noncontiguous stage ii small lymphocytic lymphoma
865746|NCT00047164|recurrent small lymphocytic lymphoma|recurrent small lymphocytic lymphoma
865747|NCT00047164|stage I small lymphocytic lymphoma|stage i small lymphocytic lymphoma
865748|NCT00047164|stage III small lymphocytic lymphoma|stage iii small lymphocytic lymphoma
865749|NCT00047164|stage IV small lymphocytic lymphoma|stage iv small lymphocytic lymphoma
865750|NCT00047164|recurrent adult T-cell leukemia/lymphoma|recurrent adult t-cell leukemia/lymphoma
865751|NCT00047164|recurrent cutaneous T-cell non-Hodgkin lymphoma|recurrent cutaneous t-cell non-hodgkin lymphoma
865752|NCT00047164|stage I adult T-cell leukemia/lymphoma|stage i adult t-cell leukemia/lymphoma
865753|NCT00047164|stage I cutaneous T-cell non-Hodgkin lymphoma|stage i cutaneous t-cell non-hodgkin lymphoma
865754|NCT00047164|stage II adult T-cell leukemia/lymphoma|stage ii adult t-cell leukemia/lymphoma
865894|NCT00045747|recurrent pancreatic cancer|recurrent pancreatic cancer
865755|NCT00047164|stage II cutaneous T-cell non-Hodgkin lymphoma|stage ii cutaneous t-cell non-hodgkin lymphoma
865756|NCT00047164|stage III adult T-cell leukemia/lymphoma|stage iii adult t-cell leukemia/lymphoma
865757|NCT00047164|stage III cutaneous T-cell non-Hodgkin lymphoma|stage iii cutaneous t-cell non-hodgkin lymphoma
865758|NCT00047164|stage IV adult T-cell leukemia/lymphoma|stage iv adult t-cell leukemia/lymphoma
865759|NCT00047164|stage IV cutaneous T-cell non-Hodgkin lymphoma|stage iv cutaneous t-cell non-hodgkin lymphoma
865760|NCT00047138|blastema predominant Wilms tumor|blastema predominant wilms tumor
865761|NCT00047138|epithelial predominant Wilms tumor|epithelial predominant wilms tumor
865762|NCT00047138|mixed cell type Wilms tumor|mixed cell type wilms tumor
865763|NCT00047138|stage I Wilms tumor|stage i wilms tumor
865764|NCT00047138|stage II Wilms tumor|stage ii wilms tumor
865765|NCT00047138|stage III Wilms tumor|stage iii wilms tumor
865766|NCT00047138|stage IV Wilms tumor|stage iv wilms tumor
865767|NCT00047138|stage V Wilms tumor|stage v wilms tumor
865768|NCT00047138|stromal predominant Wilms tumor|stromal predominant wilms tumor
865769|NCT00047125|newly diagnosed carcinoma of unknown primary|newly diagnosed carcinoma of unknown primary
865770|NCT00047125|squamous cell carcinoma of unknown primary|squamous cell carcinoma of unknown primary
865771|NCT00047112|adenocarcinoma of the esophagus|adenocarcinoma of the esophagus
865772|NCT00047112|squamous cell carcinoma of the esophagus|squamous cell carcinoma of the esophagus
865773|NCT00047112|stage I esophageal cancer|stage i esophageal cancer
865774|NCT00047112|stage II esophageal cancer|stage ii esophageal cancer
865775|NCT00047099|stage II breast cancer|stage ii breast cancer
865776|NCT00047099|stage IIIA breast cancer|stage iiia breast cancer
865777|NCT00047099|stage IIIB breast cancer|stage iiib breast cancer
865778|NCT00047073|recurrent adult brain tumor|recurrent adult brain tumor
865779|NCT00047073|adult glioblastoma|adult glioblastoma
865780|NCT00047073|adult giant cell glioblastoma|adult giant cell glioblastoma
865781|NCT00047073|adult gliosarcoma|adult gliosarcoma
865782|NCT00047060|Cutaneous T Cell Lymphoma|cutaneous t cell lymphoma
865783|NCT00047060|Allogeneic PBSCT|allogeneic pbsct
865784|NCT00047060|Low Intensity Regimen|low intensity regimen
865786|NCT00047060|Sezary Syndrome|sezary syndrome
865788|NCT00047021|accelerated phase chronic myelogenous leukemia|accelerated phase chronic myelogenous leukemia
865789|NCT00047021|blastic phase chronic myelogenous leukemia|blastic phase chronic myelogenous leukemia
865790|NCT00047021|recurrent adult acute lymphoblastic leukemia|recurrent adult acute lymphoblastic leukemia
865791|NCT00047021|recurrent adult acute myeloid leukemia|recurrent adult acute myeloid leukemia
865792|NCT00047021|recurrent adult diffuse large cell lymphoma|recurrent adult diffuse large cell lymphoma
865793|NCT00047021|recurrent adult diffuse mixed cell lymphoma|recurrent adult diffuse mixed cell lymphoma
865794|NCT00047021|recurrent adult diffuse small cleaved cell lymphoma|recurrent adult diffuse small cleaved cell lymphoma
865795|NCT00047021|recurrent adult Burkitt lymphoma|recurrent adult burkitt lymphoma
865796|NCT00047021|recurrent adult Hodgkin lymphoma|recurrent adult hodgkin lymphoma
865797|NCT00047021|recurrent adult immunoblastic large cell lymphoma|recurrent adult immunoblastic large cell lymphoma
865798|NCT00047021|recurrent adult lymphoblastic lymphoma|recurrent adult lymphoblastic lymphoma
865799|NCT00047021|recurrent childhood acute lymphoblastic leukemia|recurrent childhood acute lymphoblastic leukemia
865800|NCT00047021|recurrent childhood acute myeloid leukemia|recurrent childhood acute myeloid leukemia
865801|NCT00047021|recurrent childhood large cell lymphoma|recurrent childhood large cell lymphoma
865802|NCT00047021|recurrent childhood lymphoblastic lymphoma|recurrent childhood lymphoblastic lymphoma
865803|NCT00047021|recurrent childhood small noncleaved cell lymphoma|recurrent childhood small noncleaved cell lymphoma
865804|NCT00047021|recurrent grade 1 follicular lymphoma|recurrent grade 1 follicular lymphoma
865805|NCT00047021|recurrent grade 2 follicular lymphoma|recurrent grade 2 follicular lymphoma
865806|NCT00047021|recurrent grade 3 follicular lymphoma|recurrent grade 3 follicular lymphoma
865807|NCT00047021|recurrent mantle cell lymphoma|recurrent mantle cell lymphoma
865808|NCT00047021|recurrent/refractory childhood Hodgkin lymphoma|recurrent/refractory childhood hodgkin lymphoma
865809|NCT00047021|relapsing chronic myelogenous leukemia|relapsing chronic myelogenous leukemia
865810|NCT00047021|secondary acute myeloid leukemia|secondary acute myeloid leukemia
865811|NCT00047021|childhood chronic myelogenous leukemia|childhood chronic myelogenous leukemia
865812|NCT00047021|atypical chronic myeloid leukemia|atypical chronic myeloid leukemia
865813|NCT00047021|recurrent marginal zone lymphoma|recurrent marginal zone lymphoma
865814|NCT00047021|recurrent small lymphocytic lymphoma|recurrent small lymphocytic lymphoma
865815|NCT00047021|extranodal marginal zone B-cell lymphoma of mucosa-associated lymphoid tissue|extranodal marginal zone b-cell lymphoma of mucosa-associated lymphoid tissue
865816|NCT00047021|nodal marginal zone B-cell lymphoma|nodal marginal zone b-cell lymphoma
865817|NCT00047021|splenic marginal zone lymphoma|splenic marginal zone lymphoma
865818|NCT00047021|adult acute myeloid leukemia with t(8;21)(q22;q22)|adult acute myeloid leukemia with t(8;21)(q22;q22)
865819|NCT00047021|adult acute myeloid leukemia with t(16;16)(p13;q22)|adult acute myeloid leukemia with t(16;16)(p13;q22)
865820|NCT00047021|adult acute myeloid leukemia with inv(16)(p13;q22)|adult acute myeloid leukemia with inv(16)(p13;q22)
865821|NCT00047021|adult acute myeloid leukemia with 11q23 (MLL) abnormalities|adult acute myeloid leukemia with 11q23 (mll) abnormalities
865822|NCT00047021|adult acute myeloid leukemia with t(15;17)(q22;q12)|adult acute myeloid leukemia with t(15;17)(q22;q12)
865823|NCT00047008|stage III squamous cell carcinoma of the hypopharynx|stage iii squamous cell carcinoma of the hypopharynx
865824|NCT00047008|stage III squamous cell carcinoma of the larynx|stage iii squamous cell carcinoma of the larynx
865825|NCT00047008|stage III squamous cell carcinoma of the lip and oral cavity|stage iii squamous cell carcinoma of the lip and oral cavity
865826|NCT00047008|stage III squamous cell carcinoma of the oropharynx|stage iii squamous cell carcinoma of the oropharynx
865827|NCT00047008|stage IV squamous cell carcinoma of the hypopharynx|stage iv squamous cell carcinoma of the hypopharynx
865828|NCT00047008|stage IV squamous cell carcinoma of the larynx|stage iv squamous cell carcinoma of the larynx
865829|NCT00047008|stage IV squamous cell carcinoma of the lip and oral cavity|stage iv squamous cell carcinoma of the lip and oral cavity
865830|NCT00047008|stage IV squamous cell carcinoma of the oropharynx|stage iv squamous cell carcinoma of the oropharynx
865831|NCT00046995|adenocarcinoma of the colon|adenocarcinoma of the colon
865832|NCT00046995|stage IIB colon cancer|stage iib colon cancer
865833|NCT00046995|stage IIIA colon cancer|stage iiia colon cancer
865834|NCT00046995|stage IIIB colon cancer|stage iiib colon cancer
865835|NCT00046995|stage IIIC colon cancer|stage iiic colon cancer
865836|NCT00046969|anemia|anemia
865837|NCT00046969|stage IIB cervical cancer|stage iib cervical cancer
865838|NCT00046969|stage III cervical cancer|stage iii cervical cancer
866405|NCT00042783|stage IV melanoma|stage iv melanoma
865839|NCT00046969|stage IVA cervical cancer|stage iva cervical cancer
865840|NCT00046969|cervical adenosquamous cell carcinoma|cervical adenosquamous cell carcinoma
865841|NCT00046969|cervical squamous cell carcinoma|cervical squamous cell carcinoma
865842|NCT00046969|cervical adenocarcinoma|cervical adenocarcinoma
865843|NCT00046943|adenocarcinoma of the prostate|adenocarcinoma of the prostate
865844|NCT00046943|recurrent prostate cancer|recurrent prostate cancer
865845|NCT00046943|stage IIB prostate cancer|stage iib prostate cancer
865846|NCT00046943|stage IIA prostate cancer|stage iia prostate cancer
865847|NCT00046943|stage III prostate cancer|stage iii prostate cancer
865848|NCT00046943|stage IV prostate cancer|stage iv prostate cancer
865849|NCT00046930|adult acute monocytic leukemia (M5b)|adult acute monocytic leukemia (m5b)
865850|NCT00046930|adult acute erythroid leukemia (M6)|adult acute erythroid leukemia (m6)
866307|NCT00044967|adenocarcinoma of the colon|adenocarcinoma of the colon
865851|NCT00046930|adult acute megakaryoblastic leukemia (M7)|adult acute megakaryoblastic leukemia (m7)
865852|NCT00046930|adult acute myeloblastic leukemia with maturation (M2)|adult acute myeloblastic leukemia with maturation (m2)
865853|NCT00046930|adult acute myeloblastic leukemia without maturation (M1)|adult acute myeloblastic leukemia without maturation (m1)
865854|NCT00046930|adult acute myelomonocytic leukemia (M4)|adult acute myelomonocytic leukemia (m4)
865855|NCT00046930|adult acute monoblastic leukemia (M5a)|adult acute monoblastic leukemia (m5a)
865856|NCT00046930|refractory anemia with excess blasts in transformation|refractory anemia with excess blasts in transformation
865857|NCT00046930|refractory anemia with excess blasts|refractory anemia with excess blasts
865858|NCT00046930|secondary acute myeloid leukemia|secondary acute myeloid leukemia
865859|NCT00046930|untreated adult acute myeloid leukemia|untreated adult acute myeloid leukemia
865860|NCT00046930|de novo myelodysplastic syndromes|de novo myelodysplastic syndromes
865861|NCT00046930|adult acute minimally differentiated myeloid leukemia (M0)|adult acute minimally differentiated myeloid leukemia (m0)
865862|NCT00046930|adult acute myeloid leukemia with 11q23 (MLL) abnormalities|adult acute myeloid leukemia with 11q23 (mll) abnormalities
865863|NCT00046930|adult acute myeloid leukemia with inv(16)(p13;q22)|adult acute myeloid leukemia with inv(16)(p13;q22)
865864|NCT00046930|adult acute myeloid leukemia with t(16;16)(p13;q22)|adult acute myeloid leukemia with t(16;16)(p13;q22)
865865|NCT00046930|adult acute myeloid leukemia with t(8;21)(q22;q22)|adult acute myeloid leukemia with t(8;21)(q22;q22)
865866|NCT00046904|unspecified adult solid tumor, protocol specific|unspecified adult solid tumor, protocol specific
865867|NCT00046904|anorexia|anorexia
865868|NCT00046904|cachexia|cachexia
865869|NCT00046891|neurotoxicity|neurotoxicity
865870|NCT00046891|stage I breast cancer|stage i breast cancer
865871|NCT00046891|stage II breast cancer|stage ii breast cancer
865872|NCT00046891|stage IIIA breast cancer|stage iiia breast cancer
865873|NCT00046891|stage IIIB breast cancer|stage iiib breast cancer
865874|NCT00046891|stage IIIC breast cancer|stage iiic breast cancer
865875|NCT00046865|nausea and vomiting|nausea and vomiting
865876|NCT00046865|stage I breast cancer|stage i breast cancer
865877|NCT00046865|stage II breast cancer|stage ii breast cancer
865878|NCT00046865|stage IIIA breast cancer|stage iiia breast cancer
865879|NCT00046865|stage IIIB breast cancer|stage iiib breast cancer
865880|NCT00046865|stage IIIC breast cancer|stage iiic breast cancer
865881|NCT00046865|stage IV breast cancer|stage iv breast cancer
865882|NCT00046852|infection|infection
865883|NCT00046852|refractory multiple myeloma|refractory multiple myeloma
865884|NCT00046852|stage I multiple myeloma|stage i multiple myeloma
865885|NCT00046852|stage II multiple myeloma|stage ii multiple myeloma
865886|NCT00046852|stage III multiple myeloma|stage iii multiple myeloma
865887|NCT00046839|stage II non-small cell lung cancer|stage ii non-small cell lung cancer
865888|NCT00046839|stage IIIA non-small cell lung cancer|stage iiia non-small cell lung cancer
865889|NCT00046839|stage IIIB non-small cell lung cancer|stage iiib non-small cell lung cancer
865890|NCT00046826|adenocarcinoma of the prostate|adenocarcinoma of the prostate
865891|NCT00046826|stage IV prostate cancer|stage iv prostate cancer
865892|NCT00046826|recurrent prostate cancer|recurrent prostate cancer
865895|NCT00045747|stage IV pancreatic cancer|stage iv pancreatic cancer
865896|NCT00045721|recurrent childhood cerebral astrocytoma|recurrent childhood cerebral astrocytoma
865897|NCT00045695|Waldenstrom macroglobulinemia|waldenstrom macroglobulinemia
865898|NCT00045669|recurrent salivary gland cancer|recurrent salivary gland cancer
865899|NCT00045669|salivary gland adenoid cystic carcinoma|salivary gland adenoid cystic carcinoma
865900|NCT00045669|stage III salivary gland cancer|stage iii salivary gland cancer
865901|NCT00045669|stage IV salivary gland cancer|stage iv salivary gland cancer
865902|NCT00045630|anterior urethral cancer|anterior urethral cancer
865903|NCT00045630|localized transitional cell cancer of the renal pelvis and ureter|localized transitional cell cancer of the renal pelvis and ureter
865904|NCT00045630|posterior urethral cancer|posterior urethral cancer
865906|NCT00045630|stage III bladder cancer|stage iii bladder cancer
865907|NCT00045630|transitional cell carcinoma of the bladder|transitional cell carcinoma of the bladder
865908|NCT00045630|urethral cancer associated with invasive bladder cancer|urethral cancer associated with invasive bladder cancer
865909|NCT00045630|regional transitional cell cancer of the renal pelvis and ureter|regional transitional cell cancer of the renal pelvis and ureter
865910|NCT00045617|limited stage small cell lung cancer|limited stage small cell lung cancer
865911|NCT00045604|extensive stage small cell lung cancer|extensive stage small cell lung cancer
865912|NCT00045591|recurrent breast cancer|recurrent breast cancer
865913|NCT00045591|stage IV breast cancer|stage iv breast cancer
865914|NCT00045539|primary central nervous system non-Hodgkin lymphoma|primary central nervous system non-hodgkin lymphoma
865915|NCT00045513|refractory chronic lymphocytic leukemia|refractory chronic lymphocytic leukemia
865916|NCT00045513|recurrent small lymphocytic lymphoma|recurrent small lymphocytic lymphoma
865917|NCT00045500|anaplastic large cell lymphoma|anaplastic large cell lymphoma
865918|NCT00045500|angioimmunoblastic T-cell lymphoma|angioimmunoblastic t-cell lymphoma
865919|NCT00045500|intraocular lymphoma|intraocular lymphoma
865920|NCT00045500|primary central nervous system non-Hodgkin lymphoma|primary central nervous system non-hodgkin lymphoma
865921|NCT00045500|recurrent adult Hodgkin lymphoma|recurrent adult hodgkin lymphoma
865922|NCT00045500|recurrent adult T-cell leukemia/lymphoma|recurrent adult t-cell leukemia/lymphoma
865923|NCT00045500|recurrent adult diffuse large cell lymphoma|recurrent adult diffuse large cell lymphoma
865924|NCT00045500|recurrent adult diffuse mixed cell lymphoma|recurrent adult diffuse mixed cell lymphoma
865925|NCT00045500|recurrent adult diffuse small cleaved cell lymphoma|recurrent adult diffuse small cleaved cell lymphoma
865926|NCT00045500|recurrent adult immunoblastic large cell lymphoma|recurrent adult immunoblastic large cell lymphoma
865927|NCT00045500|recurrent adult lymphoblastic lymphoma|recurrent adult lymphoblastic lymphoma
865928|NCT00045500|recurrent cutaneous T-cell non-Hodgkin lymphoma|recurrent cutaneous t-cell non-hodgkin lymphoma
865929|NCT00045500|recurrent grade 1 follicular lymphoma|recurrent grade 1 follicular lymphoma
865930|NCT00045500|recurrent grade 2 follicular lymphoma|recurrent grade 2 follicular lymphoma
865931|NCT00045500|recurrent mantle cell lymphoma|recurrent mantle cell lymphoma
865932|NCT00045500|unspecified adult solid tumor, protocol specific|unspecified adult solid tumor, protocol specific
865933|NCT00045500|recurrent adult Burkitt lymphoma|recurrent adult burkitt lymphoma
865934|NCT00045500|recurrent grade 3 follicular lymphoma|recurrent grade 3 follicular lymphoma
865935|NCT00045500|recurrent marginal zone lymphoma|recurrent marginal zone lymphoma
865936|NCT00045500|recurrent small lymphocytic lymphoma|recurrent small lymphocytic lymphoma
866406|NCT00042783|recurrent melanoma|recurrent melanoma
865937|NCT00045500|extranodal marginal zone B-cell lymphoma of mucosa-associated lymphoid tissue|extranodal marginal zone b-cell lymphoma of mucosa-associated lymphoid tissue
865938|NCT00045500|nodal marginal zone B-cell lymphoma|nodal marginal zone b-cell lymphoma
865939|NCT00045500|splenic marginal zone lymphoma|splenic marginal zone lymphoma
865940|NCT00045487|recurrent renal cell cancer|recurrent renal cell cancer
865941|NCT00045487|stage III renal cell cancer|stage iii renal cell cancer
865942|NCT00045487|stage IV renal cell cancer|stage iv renal cell cancer
865943|NCT00045474|adult anaplastic astrocytoma|adult anaplastic astrocytoma
865944|NCT00045474|adult anaplastic oligodendroglioma|adult anaplastic oligodendroglioma
865945|NCT00045474|adult glioblastoma|adult glioblastoma
865946|NCT00045474|recurrent adult brain tumor|recurrent adult brain tumor
865947|NCT00045474|adult giant cell glioblastoma|adult giant cell glioblastoma
865948|NCT00045474|adult gliosarcoma|adult gliosarcoma
865949|NCT00045461|recurrent ovarian epithelial cancer|recurrent ovarian epithelial cancer
865950|NCT00045461|recurrent fallopian tube cancer|recurrent fallopian tube cancer
865951|NCT00045461|stage IIIA fallopian tube cancer|stage iiia fallopian tube cancer
865952|NCT00045461|stage IIIB fallopian tube cancer|stage iiib fallopian tube cancer
865953|NCT00045461|stage IIIC fallopian tube cancer|stage iiic fallopian tube cancer
865954|NCT00045461|stage IV fallopian tube cancer|stage iv fallopian tube cancer
865955|NCT00045461|recurrent primary peritoneal cavity cancer|recurrent primary peritoneal cavity cancer
865956|NCT00045461|stage IIIA primary peritoneal cavity cancer|stage iiia primary peritoneal cavity cancer
865957|NCT00045461|stage IIIB primary peritoneal cavity cancer|stage iiib primary peritoneal cavity cancer
865958|NCT00045461|stage IIIC primary peritoneal cavity cancer|stage iiic primary peritoneal cavity cancer
865959|NCT00045461|stage IV primary peritoneal cavity cancer|stage iv primary peritoneal cavity cancer
865960|NCT00045461|stage IIIA ovarian epithelial cancer|stage iiia ovarian epithelial cancer
865961|NCT00045461|stage IIIB ovarian epithelial cancer|stage iiib ovarian epithelial cancer
865962|NCT00045461|stage IIIC ovarian epithelial cancer|stage iiic ovarian epithelial cancer
865963|NCT00045461|stage IV ovarian epithelial cancer|stage iv ovarian epithelial cancer
865964|NCT00045448|unspecified adult solid tumor, protocol specific|unspecified adult solid tumor, protocol specific
865965|NCT00045422|chronic myelogenous leukemia, BCR-ABL1 positive|chronic myelogenous leukemia, bcr-abl1 positive
865966|NCT00045422|chronic phase chronic myelogenous leukemia|chronic phase chronic myelogenous leukemia
865967|NCT00045422|childhood chronic myelogenous leukemia|childhood chronic myelogenous leukemia
865968|NCT00045370|recurrent renal cell cancer|recurrent renal cell cancer
865969|NCT00045370|stage III renal cell cancer|stage iii renal cell cancer
865970|NCT00045370|stage IV renal cell cancer|stage iv renal cell cancer
865971|NCT00045331|recurrent prostate cancer|recurrent prostate cancer
865972|NCT00045331|stage I prostate cancer|stage i prostate cancer
865973|NCT00045331|stage IIB prostate cancer|stage iib prostate cancer
865974|NCT00045331|stage IIA prostate cancer|stage iia prostate cancer
865975|NCT00045331|stage III prostate cancer|stage iii prostate cancer
865976|NCT00045331|stage IV prostate cancer|stage iv prostate cancer
865977|NCT00045318|unspecified adult solid tumor, protocol specific|unspecified adult solid tumor, protocol specific
865978|NCT00045305|chronic myelomonocytic leukemia|chronic myelomonocytic leukemia
865979|NCT00045305|de novo myelodysplastic syndromes|de novo myelodysplastic syndromes
865980|NCT00045305|previously treated myelodysplastic syndromes|previously treated myelodysplastic syndromes
865981|NCT00045305|refractory anemia|refractory anemia
865982|NCT00045305|refractory anemia with excess blasts|refractory anemia with excess blasts
865983|NCT00045305|refractory anemia with ringed sideroblasts|refractory anemia with ringed sideroblasts
865984|NCT00045305|secondary myelodysplastic syndromes|secondary myelodysplastic syndromes
865985|NCT00045305|atypical chronic myeloid leukemia, BCR-ABL1 negative|atypical chronic myeloid leukemia, bcr-abl1 negative
865986|NCT00045305|myelodysplastic/myeloproliferative neoplasm, unclassifiable|myelodysplastic/myeloproliferative neoplasm, unclassifiable
865987|NCT00045292|infection|infection
865988|NCT00045292|accelerated phase chronic myelogenous leukemia|accelerated phase chronic myelogenous leukemia
865989|NCT00045292|blastic phase chronic myelogenous leukemia|blastic phase chronic myelogenous leukemia
865990|NCT00045292|childhood chronic myelogenous leukemia|childhood chronic myelogenous leukemia
865991|NCT00045292|chronic phase chronic myelogenous leukemia|chronic phase chronic myelogenous leukemia
865992|NCT00045292|relapsing chronic myelogenous leukemia|relapsing chronic myelogenous leukemia
865993|NCT00045292|adult acute lymphoblastic leukemia in remission|adult acute lymphoblastic leukemia in remission
865994|NCT00045292|childhood acute lymphoblastic leukemia in remission|childhood acute lymphoblastic leukemia in remission
865995|NCT00045292|recurrent adult acute lymphoblastic leukemia|recurrent adult acute lymphoblastic leukemia
865996|NCT00045292|recurrent childhood acute lymphoblastic leukemia|recurrent childhood acute lymphoblastic leukemia
865997|NCT00045292|untreated adult acute lymphoblastic leukemia|untreated adult acute lymphoblastic leukemia
865998|NCT00045292|untreated childhood acute lymphoblastic leukemia|untreated childhood acute lymphoblastic leukemia
865999|NCT00045292|adult acute myeloid leukemia in remission|adult acute myeloid leukemia in remission
866000|NCT00045292|childhood acute myeloid leukemia in remission|childhood acute myeloid leukemia in remission
866001|NCT00045292|recurrent adult acute myeloid leukemia|recurrent adult acute myeloid leukemia
866002|NCT00045292|recurrent childhood acute myeloid leukemia|recurrent childhood acute myeloid leukemia
866003|NCT00045292|secondary acute myeloid leukemia|secondary acute myeloid leukemia
866004|NCT00045292|untreated adult acute myeloid leukemia|untreated adult acute myeloid leukemia
866005|NCT00045292|untreated childhood acute myeloid leukemia and other myeloid malignancies|untreated childhood acute myeloid leukemia and other myeloid malignancies
866006|NCT00045292|atypical chronic myeloid leukemia|atypical chronic myeloid leukemia
866007|NCT00045292|chronic eosinophilic leukemia|chronic eosinophilic leukemia
866008|NCT00045292|chronic idiopathic myelofibrosis|chronic idiopathic myelofibrosis
866009|NCT00045292|chronic neutrophilic leukemia|chronic neutrophilic leukemia
866010|NCT00045292|chronic myelomonocytic leukemia|chronic myelomonocytic leukemia
866011|NCT00045292|juvenile myelomonocytic leukemia|juvenile myelomonocytic leukemia
866012|NCT00045292|de novo myelodysplastic syndromes|de novo myelodysplastic syndromes
866013|NCT00045292|myelodysplastic/myeloproliferative disease, unclassifiable|myelodysplastic/myeloproliferative disease, unclassifiable
866014|NCT00045292|previously treated myelodysplastic syndromes|previously treated myelodysplastic syndromes
866015|NCT00045292|secondary myelodysplastic syndromes|secondary myelodysplastic syndromes
866016|NCT00045292|disseminated neuroblastoma|disseminated neuroblastoma
866017|NCT00045292|recurrent neuroblastoma|recurrent neuroblastoma
866018|NCT00045292|noncontiguous stage II adult diffuse large cell lymphoma|noncontiguous stage ii adult diffuse large cell lymphoma
866019|NCT00045292|recurrent adult diffuse large cell lymphoma|recurrent adult diffuse large cell lymphoma
866020|NCT00045292|stage III adult diffuse large cell lymphoma|stage iii adult diffuse large cell lymphoma
866021|NCT00045292|stage IV adult diffuse large cell lymphoma|stage iv adult diffuse large cell lymphoma
866022|NCT00045292|noncontiguous stage II adult Burkitt lymphoma|noncontiguous stage ii adult burkitt lymphoma
866023|NCT00045292|recurrent adult Burkitt lymphoma|recurrent adult burkitt lymphoma
866024|NCT00045292|stage III adult Burkitt lymphoma|stage iii adult burkitt lymphoma
866025|NCT00045292|stage IV adult Burkitt lymphoma|stage iv adult burkitt lymphoma
866026|NCT00045292|noncontiguous stage II adult diffuse mixed cell lymphoma|noncontiguous stage ii adult diffuse mixed cell lymphoma
866027|NCT00045292|recurrent adult diffuse mixed cell lymphoma|recurrent adult diffuse mixed cell lymphoma
866028|NCT00045292|stage III adult diffuse mixed cell lymphoma|stage iii adult diffuse mixed cell lymphoma
866029|NCT00045292|stage IV adult diffuse mixed cell lymphoma|stage iv adult diffuse mixed cell lymphoma
866030|NCT00045292|noncontiguous stage II adult diffuse small cleaved cell lymphoma|noncontiguous stage ii adult diffuse small cleaved cell lymphoma
866031|NCT00045292|recurrent adult diffuse small cleaved cell lymphoma|recurrent adult diffuse small cleaved cell lymphoma
866032|NCT00045292|stage III adult diffuse small cleaved cell lymphoma|stage iii adult diffuse small cleaved cell lymphoma
866033|NCT00045292|stage IV adult diffuse small cleaved cell lymphoma|stage iv adult diffuse small cleaved cell lymphoma
866034|NCT00045292|noncontiguous stage II adult immunoblastic large cell lymphoma|noncontiguous stage ii adult immunoblastic large cell lymphoma
866035|NCT00045292|recurrent adult immunoblastic large cell lymphoma|recurrent adult immunoblastic large cell lymphoma
866036|NCT00045292|stage III adult immunoblastic large cell lymphoma|stage iii adult immunoblastic large cell lymphoma
866037|NCT00045292|stage IV adult immunoblastic large cell lymphoma|stage iv adult immunoblastic large cell lymphoma
866038|NCT00045292|noncontiguous stage II adult lymphoblastic lymphoma|noncontiguous stage ii adult lymphoblastic lymphoma
866039|NCT00045292|recurrent adult lymphoblastic lymphoma|recurrent adult lymphoblastic lymphoma
866040|NCT00045292|recurrent childhood lymphoblastic lymphoma|recurrent childhood lymphoblastic lymphoma
866041|NCT00045292|stage III adult lymphoblastic lymphoma|stage iii adult lymphoblastic lymphoma
866042|NCT00045292|stage IV adult lymphoblastic lymphoma|stage iv adult lymphoblastic lymphoma
866043|NCT00045292|noncontiguous stage II grade 1 follicular lymphoma|noncontiguous stage ii grade 1 follicular lymphoma
866044|NCT00045292|noncontiguous stage II grade 2 follicular lymphoma|noncontiguous stage ii grade 2 follicular lymphoma
866045|NCT00045292|noncontiguous stage II grade 3 follicular lymphoma|noncontiguous stage ii grade 3 follicular lymphoma
866046|NCT00045292|recurrent grade 1 follicular lymphoma|recurrent grade 1 follicular lymphoma
866047|NCT00045292|recurrent grade 2 follicular lymphoma|recurrent grade 2 follicular lymphoma
866048|NCT00045292|recurrent grade 3 follicular lymphoma|recurrent grade 3 follicular lymphoma
866049|NCT00045292|stage III grade 1 follicular lymphoma|stage iii grade 1 follicular lymphoma
866050|NCT00045292|stage III grade 2 follicular lymphoma|stage iii grade 2 follicular lymphoma
866051|NCT00045292|stage III grade 3 follicular lymphoma|stage iii grade 3 follicular lymphoma
866052|NCT00045292|stage IV grade 1 follicular lymphoma|stage iv grade 1 follicular lymphoma
866053|NCT00045292|stage IV grade 2 follicular lymphoma|stage iv grade 2 follicular lymphoma
866054|NCT00045292|stage IV grade 3 follicular lymphoma|stage iv grade 3 follicular lymphoma
866055|NCT00045292|noncontiguous stage II mantle cell lymphoma|noncontiguous stage ii mantle cell lymphoma
866056|NCT00045292|recurrent mantle cell lymphoma|recurrent mantle cell lymphoma
866057|NCT00045292|stage III mantle cell lymphoma|stage iii mantle cell lymphoma
866058|NCT00045292|stage IV mantle cell lymphoma|stage iv mantle cell lymphoma
866059|NCT00045292|poor prognosis metastatic gestational trophoblastic tumor|poor prognosis metastatic gestational trophoblastic tumor
866060|NCT00045292|previously treated childhood rhabdomyosarcoma|previously treated childhood rhabdomyosarcoma
866061|NCT00045292|recurrent Wilms tumor and other childhood kidney tumors|recurrent wilms tumor and other childhood kidney tumors
866062|NCT00045292|recurrent adult Hodgkin lymphoma|recurrent adult hodgkin lymphoma
866063|NCT00045292|recurrent/refractory childhood Hodgkin lymphoma|recurrent/refractory childhood hodgkin lymphoma
866064|NCT00045292|recurrent childhood rhabdomyosarcoma|recurrent childhood rhabdomyosarcoma
866065|NCT00045292|recurrent childhood large cell lymphoma|recurrent childhood large cell lymphoma
866066|NCT00045292|recurrent childhood small noncleaved cell lymphoma|recurrent childhood small noncleaved cell lymphoma
866067|NCT00045292|recurrent cutaneous T-cell non-Hodgkin lymphoma|recurrent cutaneous t-cell non-hodgkin lymphoma
866068|NCT00045292|recurrent mycosis fungoides/Sezary syndrome|recurrent mycosis fungoides/sezary syndrome
866069|NCT00045292|recurrent ovarian epithelial cancer|recurrent ovarian epithelial cancer
866070|NCT00045292|recurrent ovarian germ cell tumor|recurrent ovarian germ cell tumor
866071|NCT00045292|stage II ovarian epithelial cancer|stage ii ovarian epithelial cancer
866072|NCT00045292|stage III ovarian epithelial cancer|stage iii ovarian epithelial cancer
866073|NCT00045292|stage IV ovarian epithelial cancer|stage iv ovarian epithelial cancer
866074|NCT00045292|recurrent malignant testicular germ cell tumor|recurrent malignant testicular germ cell tumor
866075|NCT00045292|stage III malignant testicular germ cell tumor|stage iii malignant testicular germ cell tumor
866076|NCT00045292|refractory chronic lymphocytic leukemia|refractory chronic lymphocytic leukemia
866077|NCT00045292|stage III chronic lymphocytic leukemia|stage iii chronic lymphocytic leukemia
866078|NCT00045292|stage IV chronic lymphocytic leukemia|stage iv chronic lymphocytic leukemia
866079|NCT00045292|refractory hairy cell leukemia|refractory hairy cell leukemia
866080|NCT00045292|refractory multiple myeloma|refractory multiple myeloma
866081|NCT00045292|stage I multiple myeloma|stage i multiple myeloma
866082|NCT00045292|stage II multiple myeloma|stage ii multiple myeloma
866083|NCT00045292|stage III multiple myeloma|stage iii multiple myeloma
866084|NCT00045292|stage IIIA breast cancer|stage iiia breast cancer
866085|NCT00045292|stage IIIB breast cancer|stage iiib breast cancer
866086|NCT00045292|stage IIIC breast cancer|stage iiic breast cancer
866087|NCT00045292|stage IV breast cancer|stage iv breast cancer
866088|NCT00045292|noncontiguous stage II small lymphocytic lymphoma|noncontiguous stage ii small lymphocytic lymphoma
866089|NCT00045292|noncontiguous stage II marginal zone lymphoma|noncontiguous stage ii marginal zone lymphoma
866090|NCT00045292|recurrent marginal zone lymphoma|recurrent marginal zone lymphoma
866091|NCT00045292|recurrent small lymphocytic lymphoma|recurrent small lymphocytic lymphoma
866092|NCT00045292|stage III small lymphocytic lymphoma|stage iii small lymphocytic lymphoma
866093|NCT00045292|stage III marginal zone lymphoma|stage iii marginal zone lymphoma
866094|NCT00045292|stage IV small lymphocytic lymphoma|stage iv small lymphocytic lymphoma
866095|NCT00045292|stage IV marginal zone lymphoma|stage iv marginal zone lymphoma
866096|NCT00045292|extranodal marginal zone B-cell lymphoma of mucosa-associated lymphoid tissue|extranodal marginal zone b-cell lymphoma of mucosa-associated lymphoid tissue
866097|NCT00045292|nodal marginal zone B-cell lymphoma|nodal marginal zone b-cell lymphoma
866098|NCT00045292|splenic marginal zone lymphoma|splenic marginal zone lymphoma
866099|NCT00045292|childhood myelodysplastic syndromes|childhood myelodysplastic syndromes
866100|NCT00045279|stage IV renal cell cancer|stage iv renal cell cancer
866101|NCT00045266|recurrent adult diffuse large cell lymphoma|recurrent adult diffuse large cell lymphoma
866102|NCT00045266|recurrent adult diffuse mixed cell lymphoma|recurrent adult diffuse mixed cell lymphoma
866103|NCT00045266|recurrent adult diffuse small cleaved cell lymphoma|recurrent adult diffuse small cleaved cell lymphoma
866104|NCT00045266|recurrent adult Burkitt lymphoma|recurrent adult burkitt lymphoma
866105|NCT00045266|recurrent adult immunoblastic large cell lymphoma|recurrent adult immunoblastic large cell lymphoma
866106|NCT00045266|recurrent adult lymphoblastic lymphoma|recurrent adult lymphoblastic lymphoma
866107|NCT00045266|recurrent grade 1 follicular lymphoma|recurrent grade 1 follicular lymphoma
866108|NCT00045266|recurrent grade 2 follicular lymphoma|recurrent grade 2 follicular lymphoma
866109|NCT00045266|recurrent grade 3 follicular lymphoma|recurrent grade 3 follicular lymphoma
866110|NCT00045266|recurrent mantle cell lymphoma|recurrent mantle cell lymphoma
866111|NCT00045266|stage IV adult diffuse large cell lymphoma|stage iv adult diffuse large cell lymphoma
866112|NCT00045266|stage IV adult diffuse mixed cell lymphoma|stage iv adult diffuse mixed cell lymphoma
866113|NCT00045266|stage IV adult diffuse small cleaved cell lymphoma|stage iv adult diffuse small cleaved cell lymphoma
866114|NCT00045266|stage IV adult Burkitt lymphoma|stage iv adult burkitt lymphoma
866115|NCT00045266|stage IV adult immunoblastic large cell lymphoma|stage iv adult immunoblastic large cell lymphoma
866116|NCT00045266|stage IV adult lymphoblastic lymphoma|stage iv adult lymphoblastic lymphoma
866791|NCT00036959|metastatic osteosarcoma|metastatic osteosarcoma
866117|NCT00045266|stage IV grade 1 follicular lymphoma|stage iv grade 1 follicular lymphoma
866118|NCT00045266|stage IV grade 2 follicular lymphoma|stage iv grade 2 follicular lymphoma
866119|NCT00045266|stage IV grade 3 follicular lymphoma|stage iv grade 3 follicular lymphoma
866120|NCT00045266|stage IV mantle cell lymphoma|stage iv mantle cell lymphoma
866121|NCT00045266|unspecified adult solid tumor, protocol specific|unspecified adult solid tumor, protocol specific
866122|NCT00045266|recurrent marginal zone lymphoma|recurrent marginal zone lymphoma
866123|NCT00045266|recurrent small lymphocytic lymphoma|recurrent small lymphocytic lymphoma
866124|NCT00045266|stage IV small lymphocytic lymphoma|stage iv small lymphocytic lymphoma
866125|NCT00045266|stage IV marginal zone lymphoma|stage iv marginal zone lymphoma
866126|NCT00045266|extranodal marginal zone B-cell lymphoma of mucosa-associated lymphoid tissue|extranodal marginal zone b-cell lymphoma of mucosa-associated lymphoid tissue
866127|NCT00045266|nodal marginal zone B-cell lymphoma|nodal marginal zone b-cell lymphoma
866128|NCT00045266|splenic marginal zone lymphoma|splenic marginal zone lymphoma
866129|NCT00045227|adenocarcinoma of the prostate|adenocarcinoma of the prostate
866130|NCT00045227|recurrent prostate cancer|recurrent prostate cancer
866131|NCT00045227|stage IV prostate cancer|stage iv prostate cancer
866132|NCT00045175|primary peritoneal cavity cancer|primary peritoneal cavity cancer
866133|NCT00045175|recurrent ovarian epithelial cancer|recurrent ovarian epithelial cancer
866134|NCT00045175|fallopian tube cancer|fallopian tube cancer
866135|NCT00045162|extensive stage small cell lung cancer|extensive stage small cell lung cancer
866136|NCT00045136|refractory multiple myeloma|refractory multiple myeloma
866137|NCT00045136|stage I multiple myeloma|stage i multiple myeloma
866138|NCT00045136|stage II multiple myeloma|stage ii multiple myeloma
866139|NCT00045136|stage III multiple myeloma|stage iii multiple myeloma
866140|NCT00045097|male breast cancer|male breast cancer
866141|NCT00045097|recurrent breast cancer|recurrent breast cancer
866142|NCT00045097|stage IIIB breast cancer|stage iiib breast cancer
866143|NCT00045097|stage IIIC breast cancer|stage iiic breast cancer
866144|NCT00045097|stage IV breast cancer|stage iv breast cancer
866145|NCT00045045|stage I malignant testicular germ cell tumor|stage i malignant testicular germ cell tumor
866146|NCT00045045|testicular choriocarcinoma|testicular choriocarcinoma
866147|NCT00045045|testicular choriocarcinoma and embryonal carcinoma|testicular choriocarcinoma and embryonal carcinoma
866148|NCT00045045|testicular choriocarcinoma and seminoma|testicular choriocarcinoma and seminoma
866149|NCT00045045|testicular choriocarcinoma and teratoma|testicular choriocarcinoma and teratoma
866150|NCT00045045|testicular choriocarcinoma and yolk sac tumor|testicular choriocarcinoma and yolk sac tumor
866151|NCT00045045|testicular embryonal carcinoma and seminoma|testicular embryonal carcinoma and seminoma
866152|NCT00045045|testicular embryonal carcinoma and teratoma with seminoma|testicular embryonal carcinoma and teratoma with seminoma
866153|NCT00045045|testicular embryonal carcinoma and teratoma|testicular embryonal carcinoma and teratoma
866154|NCT00045045|testicular embryonal carcinoma and yolk sac tumor with seminoma|testicular embryonal carcinoma and yolk sac tumor with seminoma
866155|NCT00045045|testicular embryonal carcinoma and yolk sac tumor|testicular embryonal carcinoma and yolk sac tumor
866156|NCT00045045|testicular embryonal carcinoma|testicular embryonal carcinoma
866157|NCT00045045|testicular teratoma|testicular teratoma
866158|NCT00045045|testicular yolk sac tumor and teratoma with seminoma|testicular yolk sac tumor and teratoma with seminoma
866159|NCT00045045|testicular yolk sac tumor and teratoma|testicular yolk sac tumor and teratoma
866160|NCT00045045|testicular yolk sac tumor|testicular yolk sac tumor
866161|NCT00045019|unspecified adult solid tumor, protocol specific|unspecified adult solid tumor, protocol specific
866162|NCT00045006|acute undifferentiated leukemia|acute undifferentiated leukemia
866163|NCT00045006|de novo myelodysplastic syndromes|de novo myelodysplastic syndromes
866164|NCT00045006|borderline ovarian surface epithelial-stromal tumor|borderline ovarian surface epithelial-stromal tumor
866165|NCT00045006|ovarian sarcoma|ovarian sarcoma
866166|NCT00045006|ovarian stromal cancer|ovarian stromal cancer
866167|NCT00045006|previously treated myelodysplastic syndromes|previously treated myelodysplastic syndromes
866168|NCT00045006|prolymphocytic leukemia|prolymphocytic leukemia
866169|NCT00045006|recurrent adult Hodgkin lymphoma|recurrent adult hodgkin lymphoma
866170|NCT00045006|recurrent adult T-cell leukemia/lymphoma|recurrent adult t-cell leukemia/lymphoma
866171|NCT00045006|recurrent adult acute lymphoblastic leukemia|recurrent adult acute lymphoblastic leukemia
866172|NCT00045006|recurrent adult acute myeloid leukemia|recurrent adult acute myeloid leukemia
866173|NCT00045006|recurrent adult diffuse large cell lymphoma|recurrent adult diffuse large cell lymphoma
866174|NCT00045006|recurrent adult diffuse small cleaved cell lymphoma|recurrent adult diffuse small cleaved cell lymphoma
866175|NCT00045006|recurrent adult diffuse mixed cell lymphoma|recurrent adult diffuse mixed cell lymphoma
866176|NCT00045006|recurrent bladder cancer|recurrent bladder cancer
866177|NCT00045006|recurrent breast cancer|recurrent breast cancer
866178|NCT00045006|recurrent cutaneous T-cell non-Hodgkin lymphoma|recurrent cutaneous t-cell non-hodgkin lymphoma
866179|NCT00045006|recurrent grade 1 follicular lymphoma|recurrent grade 1 follicular lymphoma
866180|NCT00045006|recurrent grade 2 follicular lymphoma|recurrent grade 2 follicular lymphoma
866181|NCT00045006|recurrent grade 3 follicular lymphoma|recurrent grade 3 follicular lymphoma
866182|NCT00045006|recurrent metastatic squamous neck cancer with occult primary|recurrent metastatic squamous neck cancer with occult primary
866183|NCT00045006|recurrent mycosis fungoides/Sezary syndrome|recurrent mycosis fungoides/sezary syndrome
888220|NCT00000908|RNA, Viral|rna, viral
866184|NCT00045006|recurrent non-small cell lung cancer|recurrent non-small cell lung cancer
866185|NCT00045006|recurrent ovarian epithelial cancer|recurrent ovarian epithelial cancer
866186|NCT00045006|recurrent ovarian germ cell tumor|recurrent ovarian germ cell tumor
866187|NCT00045006|recurrent prostate cancer|recurrent prostate cancer
866188|NCT00045006|recurrent renal cell cancer|recurrent renal cell cancer
866189|NCT00045006|refractory chronic lymphocytic leukemia|refractory chronic lymphocytic leukemia
866190|NCT00045006|refractory hairy cell leukemia|refractory hairy cell leukemia
866191|NCT00045006|refractory multiple myeloma|refractory multiple myeloma
866192|NCT00045006|relapsing chronic myelogenous leukemia|relapsing chronic myelogenous leukemia
866193|NCT00045006|secondary acute myeloid leukemia|secondary acute myeloid leukemia
866194|NCT00045006|secondary myelodysplastic syndromes|secondary myelodysplastic syndromes
866195|NCT00045006|stage III multiple myeloma|stage iii multiple myeloma
866196|NCT00045006|stage III mycosis fungoides/Sezary syndrome|stage iii mycosis fungoides/sezary syndrome
866197|NCT00045006|stage III ovarian germ cell tumor|stage iii ovarian germ cell tumor
866198|NCT00045006|stage IV mycosis fungoides/Sezary syndrome|stage iv mycosis fungoides/sezary syndrome
866199|NCT00045006|stage IV ovarian germ cell tumor|stage iv ovarian germ cell tumor
866200|NCT00045006|unspecified adult solid tumor, protocol specific|unspecified adult solid tumor, protocol specific
866201|NCT00045006|stage III adult Hodgkin lymphoma|stage iii adult hodgkin lymphoma
866202|NCT00045006|stage IV adult Hodgkin lymphoma|stage iv adult hodgkin lymphoma
866203|NCT00045006|stage III adult T-cell leukemia/lymphoma|stage iii adult t-cell leukemia/lymphoma
866204|NCT00045006|stage IV adult T-cell leukemia/lymphoma|stage iv adult t-cell leukemia/lymphoma
866205|NCT00045006|stage III adult diffuse large cell lymphoma|stage iii adult diffuse large cell lymphoma
866206|NCT00045006|stage III adult diffuse mixed cell lymphoma|stage iii adult diffuse mixed cell lymphoma
866207|NCT00045006|stage III adult diffuse small cleaved cell lymphoma|stage iii adult diffuse small cleaved cell lymphoma
866208|NCT00045006|stage IV adult diffuse large cell lymphoma|stage iv adult diffuse large cell lymphoma
866209|NCT00045006|stage IV adult diffuse mixed cell lymphoma|stage iv adult diffuse mixed cell lymphoma
866210|NCT00045006|stage IV adult diffuse small cleaved cell lymphoma|stage iv adult diffuse small cleaved cell lymphoma
866211|NCT00045006|stage III bladder cancer|stage iii bladder cancer
866212|NCT00045006|stage IV bladder cancer|stage iv bladder cancer
866213|NCT00045006|stage IIIA breast cancer|stage iiia breast cancer
866214|NCT00045006|stage IIIB breast cancer|stage iiib breast cancer
866215|NCT00045006|stage IIIC breast cancer|stage iiic breast cancer
866216|NCT00045006|stage IV breast cancer|stage iv breast cancer
866217|NCT00045006|stage III cutaneous T-cell non-Hodgkin lymphoma|stage iii cutaneous t-cell non-hodgkin lymphoma
866218|NCT00045006|stage IV cutaneous T-cell non-Hodgkin lymphoma|stage iv cutaneous t-cell non-hodgkin lymphoma
866219|NCT00045006|stage III grade 1 follicular lymphoma|stage iii grade 1 follicular lymphoma
866696|NCT00039364|adult mixed glioma|adult mixed glioma
866220|NCT00045006|stage III grade 2 follicular lymphoma|stage iii grade 2 follicular lymphoma
866221|NCT00045006|stage III grade 3 follicular lymphoma|stage iii grade 3 follicular lymphoma
866222|NCT00045006|stage IV grade 1 follicular lymphoma|stage iv grade 1 follicular lymphoma
866223|NCT00045006|stage IV grade 2 follicular lymphoma|stage iv grade 2 follicular lymphoma
866224|NCT00045006|stage IV grade 3 follicular lymphoma|stage iv grade 3 follicular lymphoma
866225|NCT00045006|stage IIIA non-small cell lung cancer|stage iiia non-small cell lung cancer
866226|NCT00045006|stage IIIB non-small cell lung cancer|stage iiib non-small cell lung cancer
866227|NCT00045006|stage IV non-small cell lung cancer|stage iv non-small cell lung cancer
866228|NCT00045006|stage III oropharyngeal cancer|stage iii oropharyngeal cancer
866229|NCT00045006|stage IV oropharyngeal cancer|stage iv oropharyngeal cancer
866230|NCT00045006|stage III ovarian epithelial cancer|stage iii ovarian epithelial cancer
866231|NCT00045006|stage IV ovarian epithelial cancer|stage iv ovarian epithelial cancer
866232|NCT00045006|stage III prostate cancer|stage iii prostate cancer
866233|NCT00045006|stage IV prostate cancer|stage iv prostate cancer
866234|NCT00045006|stage III renal cell cancer|stage iii renal cell cancer
866235|NCT00045006|stage IV renal cell cancer|stage iv renal cell cancer
866236|NCT00045006|stage III chronic lymphocytic leukemia|stage iii chronic lymphocytic leukemia
866237|NCT00045006|stage IV chronic lymphocytic leukemia|stage iv chronic lymphocytic leukemia
866238|NCT00045006|recurrent salivary gland cancer|recurrent salivary gland cancer
866239|NCT00045006|stage IV salivary gland cancer|stage iv salivary gland cancer
866240|NCT00045006|stage III salivary gland cancer|stage iii salivary gland cancer
866241|NCT00045006|recurrent squamous cell carcinoma of the hypopharynx|recurrent squamous cell carcinoma of the hypopharynx
866242|NCT00045006|stage III squamous cell carcinoma of the hypopharynx|stage iii squamous cell carcinoma of the hypopharynx
866243|NCT00045006|stage IV squamous cell carcinoma of the hypopharynx|stage iv squamous cell carcinoma of the hypopharynx
866244|NCT00045006|recurrent squamous cell carcinoma of the larynx|recurrent squamous cell carcinoma of the larynx
866245|NCT00045006|recurrent verrucous carcinoma of the larynx|recurrent verrucous carcinoma of the larynx
866246|NCT00045006|stage III squamous cell carcinoma of the larynx|stage iii squamous cell carcinoma of the larynx
866247|NCT00045006|stage III verrucous carcinoma of the larynx|stage iii verrucous carcinoma of the larynx
866248|NCT00045006|stage IV squamous cell carcinoma of the larynx|stage iv squamous cell carcinoma of the larynx
866249|NCT00045006|stage IV verrucous carcinoma of the larynx|stage iv verrucous carcinoma of the larynx
866857|NCT00036894|recurrent adult brain tumor|recurrent adult brain tumor
866250|NCT00045006|recurrent squamous cell carcinoma of the lip and oral cavity|recurrent squamous cell carcinoma of the lip and oral cavity
866251|NCT00045006|stage III squamous cell carcinoma of the lip and oral cavity|stage iii squamous cell carcinoma of the lip and oral cavity
866252|NCT00045006|stage IV squamous cell carcinoma of the lip and oral cavity|stage iv squamous cell carcinoma of the lip and oral cavity
866253|NCT00045006|recurrent lymphoepithelioma of the nasopharynx|recurrent lymphoepithelioma of the nasopharynx
866254|NCT00045006|recurrent squamous cell carcinoma of the nasopharynx|recurrent squamous cell carcinoma of the nasopharynx
866255|NCT00045006|stage III lymphoepithelioma of the nasopharynx|stage iii lymphoepithelioma of the nasopharynx
866256|NCT00045006|stage III squamous cell carcinoma of the nasopharynx|stage iii squamous cell carcinoma of the nasopharynx
866257|NCT00045006|stage IV lymphoepithelioma of the nasopharynx|stage iv lymphoepithelioma of the nasopharynx
866258|NCT00045006|stage IV squamous cell carcinoma of the nasopharynx|stage iv squamous cell carcinoma of the nasopharynx
866259|NCT00045006|recurrent lymphoepithelioma of the oropharynx|recurrent lymphoepithelioma of the oropharynx
866260|NCT00045006|recurrent squamous cell carcinoma of the oropharynx|recurrent squamous cell carcinoma of the oropharynx
866261|NCT00045006|stage III lymphoepithelioma of the oropharynx|stage iii lymphoepithelioma of the oropharynx
866262|NCT00045006|stage III squamous cell carcinoma of the oropharynx|stage iii squamous cell carcinoma of the oropharynx
866263|NCT00045006|stage IV lymphoepithelioma of the oropharynx|stage iv lymphoepithelioma of the oropharynx
866264|NCT00045006|stage IV squamous cell carcinoma of the oropharynx|stage iv squamous cell carcinoma of the oropharynx
866265|NCT00045006|recurrent esthesioneuroblastoma of the paranasal sinus and nasal cavity|recurrent esthesioneuroblastoma of the paranasal sinus and nasal cavity
866266|NCT00045006|recurrent inverted papilloma of the paranasal sinus and nasal cavity|recurrent inverted papilloma of the paranasal sinus and nasal cavity
866267|NCT00045006|recurrent midline lethal granuloma of the paranasal sinus and nasal cavity|recurrent midline lethal granuloma of the paranasal sinus and nasal cavity
866268|NCT00045006|recurrent squamous cell carcinoma of the paranasal sinus and nasal cavity|recurrent squamous cell carcinoma of the paranasal sinus and nasal cavity
866269|NCT00045006|stage III esthesioneuroblastoma of the paranasal sinus and nasal cavity|stage iii esthesioneuroblastoma of the paranasal sinus and nasal cavity
866270|NCT00045006|stage III inverted papilloma of the paranasal sinus and nasal cavity|stage iii inverted papilloma of the paranasal sinus and nasal cavity
866271|NCT00045006|stage III midline lethal granuloma of the paranasal sinus and nasal cavity|stage iii midline lethal granuloma of the paranasal sinus and nasal cavity
866272|NCT00045006|stage III squamous cell carcinoma of the paranasal sinus and nasal cavity|stage iii squamous cell carcinoma of the paranasal sinus and nasal cavity
866273|NCT00045006|stage IV esthesioneuroblastoma of the paranasal sinus and nasal cavity|stage iv esthesioneuroblastoma of the paranasal sinus and nasal cavity
866274|NCT00045006|stage IV inverted papilloma of the paranasal sinus and nasal cavity|stage iv inverted papilloma of the paranasal sinus and nasal cavity
866275|NCT00045006|stage IV midline lethal granuloma of the paranasal sinus and nasal cavity|stage iv midline lethal granuloma of the paranasal sinus and nasal cavity
866276|NCT00045006|stage IV squamous cell carcinoma of the paranasal sinus and nasal cavity|stage iv squamous cell carcinoma of the paranasal sinus and nasal cavity
866277|NCT00045006|recurrent basal cell carcinoma of the lip|recurrent basal cell carcinoma of the lip
866278|NCT00045006|stage III basal cell carcinoma of the lip|stage iii basal cell carcinoma of the lip
866279|NCT00045006|stage IV basal cell carcinoma of the lip|stage iv basal cell carcinoma of the lip
866280|NCT00045006|recurrent mucoepidermoid carcinoma of the oral cavity|recurrent mucoepidermoid carcinoma of the oral cavity
866281|NCT00045006|stage III mucoepidermoid carcinoma of the oral cavity|stage iii mucoepidermoid carcinoma of the oral cavity
866282|NCT00045006|stage IV mucoepidermoid carcinoma of the oral cavity|stage iv mucoepidermoid carcinoma of the oral cavity
866283|NCT00045006|recurrent adenoid cystic carcinoma of the oral cavity|recurrent adenoid cystic carcinoma of the oral cavity
866284|NCT00045006|stage III adenoid cystic carcinoma of the oral cavity|stage iii adenoid cystic carcinoma of the oral cavity
866285|NCT00045006|stage IV adenoid cystic carcinoma of the oral cavity|stage iv adenoid cystic carcinoma of the oral cavity
866286|NCT00045006|recurrent verrucous carcinoma of the oral cavity|recurrent verrucous carcinoma of the oral cavity
866287|NCT00045006|stage III verrucous carcinoma of the oral cavity|stage iii verrucous carcinoma of the oral cavity
866288|NCT00045006|stage IV verrucous carcinoma of the oral cavity|stage iv verrucous carcinoma of the oral cavity
866289|NCT00045006|atypical chronic myeloid leukemia, BCR-ABL1 negative|atypical chronic myeloid leukemia, bcr-abl1 negative
866290|NCT00045006|myelodysplastic/myeloproliferative neoplasm, unclassifiable|myelodysplastic/myeloproliferative neoplasm, unclassifiable
866291|NCT00045006|male breast cancer|male breast cancer
866292|NCT00044993|male breast cancer|male breast cancer
866293|NCT00044993|stage IIIA breast cancer|stage iiia breast cancer
866294|NCT00044993|stage IIIB breast cancer|stage iiib breast cancer
866295|NCT00044993|stage IIIC breast cancer|stage iiic breast cancer
866296|NCT00044993|stage IV breast cancer|stage iv breast cancer
866297|NCT00044980|malnutrition|malnutrition
866298|NCT00044980|stage I prostate cancer|stage i prostate cancer
866299|NCT00044980|stage II B prostate cancer|stage ii b prostate cancer
866300|NCT00044980|stage II A prostate cancer|stage ii a prostate cancer
866301|NCT00044967|stage I colon cancer|stage i colon cancer
866302|NCT00044967|stage II colon cancer|stage ii colon cancer
866303|NCT00044967|stage III colon cancer|stage iii colon cancer
866304|NCT00044967|stage I rectal cancer|stage i rectal cancer
866305|NCT00044967|stage II rectal cancer|stage ii rectal cancer
866306|NCT00044967|stage III rectal cancer|stage iii rectal cancer
866308|NCT00044967|adenocarcinoma of the rectum|adenocarcinoma of the rectum
866309|NCT00044954|recurrent adult Hodgkin lymphoma|recurrent adult hodgkin lymphoma
866310|NCT00044954|stage I multiple myeloma|stage i multiple myeloma
866311|NCT00044954|stage II multiple myeloma|stage ii multiple myeloma
866312|NCT00044954|stage III multiple myeloma|stage iii multiple myeloma
866313|NCT00044954|chronic phase chronic myelogenous leukemia|chronic phase chronic myelogenous leukemia
866314|NCT00044954|accelerated phase chronic myelogenous leukemia|accelerated phase chronic myelogenous leukemia
866315|NCT00044954|adult acute myeloid leukemia in remission|adult acute myeloid leukemia in remission
866316|NCT00044954|recurrent grade 3 follicular lymphoma|recurrent grade 3 follicular lymphoma
866317|NCT00044954|recurrent adult diffuse large cell lymphoma|recurrent adult diffuse large cell lymphoma
866318|NCT00044954|de novo myelodysplastic syndromes|de novo myelodysplastic syndromes
866319|NCT00044954|previously treated myelodysplastic syndromes|previously treated myelodysplastic syndromes
866320|NCT00044954|secondary myelodysplastic syndromes|secondary myelodysplastic syndromes
866321|NCT00044954|recurrent mantle cell lymphoma|recurrent mantle cell lymphoma
866322|NCT00044954|stage III mantle cell lymphoma|stage iii mantle cell lymphoma
866323|NCT00044954|stage IV mantle cell lymphoma|stage iv mantle cell lymphoma
866324|NCT00044954|refractory multiple myeloma|refractory multiple myeloma
866325|NCT00044954|stage I mantle cell lymphoma|stage i mantle cell lymphoma
866326|NCT00044954|contiguous stage II mantle cell lymphoma|contiguous stage ii mantle cell lymphoma
866327|NCT00044954|noncontiguous stage II mantle cell lymphoma|noncontiguous stage ii mantle cell lymphoma
866328|NCT00044954|atypical chronic myeloid leukemia|atypical chronic myeloid leukemia
866329|NCT00044954|myelodysplastic/myeloproliferative disease, unclassifiable|myelodysplastic/myeloproliferative disease, unclassifiable
866330|NCT00044954|refractory chronic lymphocytic leukemia|refractory chronic lymphocytic leukemia
866331|NCT00044954|adult acute myeloid leukemia with t(8;21)(q22;q22)|adult acute myeloid leukemia with t(8;21)(q22;q22)
866332|NCT00044954|adult acute myeloid leukemia with t(16;16)(p13;q22)|adult acute myeloid leukemia with t(16;16)(p13;q22)
866333|NCT00044954|adult acute myeloid leukemia with inv(16)(p13;q22)|adult acute myeloid leukemia with inv(16)(p13;q22)
866334|NCT00044954|adult acute myeloid leukemia with 11q23 (MLL) abnormalities|adult acute myeloid leukemia with 11q23 (mll) abnormalities
866335|NCT00044954|adult acute myeloid leukemia with t(15;17)(q22;q12)|adult acute myeloid leukemia with t(15;17)(q22;q12)
866336|NCT00043147|graft versus host disease|graft versus host disease
866337|NCT00043134|chronic myelomonocytic leukemia|chronic myelomonocytic leukemia
866338|NCT00043134|de novo myelodysplastic syndromes|de novo myelodysplastic syndromes
866339|NCT00043134|previously treated myelodysplastic syndromes|previously treated myelodysplastic syndromes
866340|NCT00043134|refractory anemia|refractory anemia
866341|NCT00043134|refractory anemia with excess blasts|refractory anemia with excess blasts
866342|NCT00043134|refractory anemia with excess blasts in transformation|refractory anemia with excess blasts in transformation
866343|NCT00043134|refractory anemia with ringed sideroblasts|refractory anemia with ringed sideroblasts
866344|NCT00043134|refractory cytopenia with multilineage dysplasia|refractory cytopenia with multilineage dysplasia
866345|NCT00043134|secondary myelodysplastic syndromes|secondary myelodysplastic syndromes
866346|NCT00043134|atypical chronic myeloid leukemia, BCR-ABL negative|atypical chronic myeloid leukemia, bcr-abl negative
866347|NCT00043134|myelodysplastic/myeloproliferative neoplasm, unclassifiable|myelodysplastic/myeloproliferative neoplasm, unclassifiable
866348|NCT00043095|unspecified adult solid tumor, protocol specific|unspecified adult solid tumor, protocol specific
866349|NCT00043082|peritoneal cavity cancer|peritoneal cavity cancer
866350|NCT00043082|recurrent ovarian epithelial cancer|recurrent ovarian epithelial cancer
866351|NCT00043082|stage III ovarian epithelial cancer|stage iii ovarian epithelial cancer
866352|NCT00043082|stage IV ovarian epithelial cancer|stage iv ovarian epithelial cancer
866353|NCT00043069|osteoporosis|osteoporosis
866354|NCT00043069|stage I prostate cancer|stage i prostate cancer
866355|NCT00043069|stage IIB prostate cancer|stage iib prostate cancer
866356|NCT00043069|stage IIA prostate cancer|stage iia prostate cancer
866357|NCT00043069|stage III prostate cancer|stage iii prostate cancer
866358|NCT00043043|colorectal cancer|colorectal cancer
866359|NCT00043030|psychosocial effects of cancer and its treatment|psychosocial effects of cancer and its treatment
866360|NCT00043030|unspecified adult solid tumor, protocol specific|unspecified adult solid tumor, protocol specific
866361|NCT00043017|stage IIIA breast cancer|stage iiia breast cancer
866362|NCT00043017|stage IIIB breast cancer|stage iiib breast cancer
866363|NCT00043017|stage IIIC breast cancer|stage iiic breast cancer
866364|NCT00043004|liver metastases|liver metastases
866365|NCT00043004|stage IV colon cancer|stage iv colon cancer
866366|NCT00043004|stage IV rectal cancer|stage iv rectal cancer
866367|NCT00042965|recurrent renal cell cancer|recurrent renal cell cancer
866368|NCT00042965|stage IV renal cell cancer|stage iv renal cell cancer
866369|NCT00042939|pancreatic cancer|pancreatic cancer
866370|NCT00042939|metastatic pancreatic cancer|metastatic pancreatic cancer
866371|NCT00042939|EGF-r|egf-r
866372|NCT00042939|irinotecan|irinotecan
866373|NCT00042939|docetaxel|docetaxel
866374|NCT00042939|cetuximab|cetuximab
866375|NCT00042926|stage I squamous cell carcinoma of the lip and oral cavity|stage i squamous cell carcinoma of the lip and oral cavity
866376|NCT00042926|stage II squamous cell carcinoma of the lip and oral cavity|stage ii squamous cell carcinoma of the lip and oral cavity
867064|NCT00033657|stage IV esophageal cancer|stage iv esophageal cancer
866377|NCT00042913|recurrent adult diffuse large cell lymphoma|recurrent adult diffuse large cell lymphoma
866378|NCT00042887|stage 0 bladder cancer|stage 0 bladder cancer
866379|NCT00042887|stage I bladder cancer|stage i bladder cancer
866380|NCT00042887|recurrent bladder cancer|recurrent bladder cancer
866381|NCT00042887|transitional cell carcinoma of the bladder|transitional cell carcinoma of the bladder
866382|NCT00042861|unspecified adult solid tumor, protocol specific|unspecified adult solid tumor, protocol specific
866383|NCT00042848|fatigue|fatigue
866384|NCT00042848|unspecified adult solid tumor, protocol specific|unspecified adult solid tumor, protocol specific
866385|NCT00042822|recurrent adult acute myeloid leukemia|recurrent adult acute myeloid leukemia
866386|NCT00042822|refractory anemia with excess blasts|refractory anemia with excess blasts
866387|NCT00042822|refractory anemia with excess blasts in transformation|refractory anemia with excess blasts in transformation
866388|NCT00042822|chronic myelomonocytic leukemia|chronic myelomonocytic leukemia
866389|NCT00042822|recurrent grade 3 follicular lymphoma|recurrent grade 3 follicular lymphoma
866390|NCT00042822|previously treated myelodysplastic syndromes|previously treated myelodysplastic syndromes
866391|NCT00042822|secondary myelodysplastic syndromes|secondary myelodysplastic syndromes
866392|NCT00042822|untreated adult acute myeloid leukemia|untreated adult acute myeloid leukemia
866393|NCT00042822|recurrent grade 1 follicular lymphoma|recurrent grade 1 follicular lymphoma
866394|NCT00042822|recurrent grade 2 follicular lymphoma|recurrent grade 2 follicular lymphoma
866395|NCT00042822|recurrent adult diffuse large cell lymphoma|recurrent adult diffuse large cell lymphoma
866396|NCT00042822|recurrent adult diffuse mixed cell lymphoma|recurrent adult diffuse mixed cell lymphoma
866397|NCT00042822|recurrent adult diffuse small cleaved cell lymphoma|recurrent adult diffuse small cleaved cell lymphoma
866398|NCT00042822|atypical chronic myeloid leukemia, BCR-ABL1 negative|atypical chronic myeloid leukemia, bcr-abl1 negative
866399|NCT00042822|myelodysplastic/myeloproliferative neoplasm, unclassifiable|myelodysplastic/myeloproliferative neoplasm, unclassifiable
866400|NCT00042822|adult acute myeloid leukemia with t(8;21)(q22;q22)|adult acute myeloid leukemia with t(8;21)(q22;q22)
866401|NCT00042822|adult acute myeloid leukemia with t(16;16)(p13;q22)|adult acute myeloid leukemia with t(16;16)(p13;q22)
866402|NCT00042822|adult acute myeloid leukemia with inv(16)(p13;q22)|adult acute myeloid leukemia with inv(16)(p13;q22)
866403|NCT00042822|adult acute myeloid leukemia with 11q23 (MLL) abnormalities|adult acute myeloid leukemia with 11q23 (mll) abnormalities
866404|NCT00042822|adult acute myeloid leukemia with t(15;17)(q22;q12)|adult acute myeloid leukemia with t(15;17)(q22;q12)
866407|NCT00042770|malignant pleural effusion|malignant pleural effusion
866408|NCT00042770|pulmonary complications|pulmonary complications
866409|NCT00042731|stage I prostate cancer|stage i prostate cancer
866410|NCT00042731|stage IIB prostate cancer|stage iib prostate cancer
866411|NCT00042731|stage IIA prostate cancer|stage iia prostate cancer
866412|NCT00041379|Waldenström macroglobulinemia|waldenström macroglobulinemia
866413|NCT00041327|stage I adult T-cell leukemia/lymphoma|stage i adult t-cell leukemia/lymphoma
866414|NCT00041327|stage II adult T-cell leukemia/lymphoma|stage ii adult t-cell leukemia/lymphoma
866415|NCT00041327|stage III adult T-cell leukemia/lymphoma|stage iii adult t-cell leukemia/lymphoma
866416|NCT00041327|stage IV adult T-cell leukemia/lymphoma|stage iv adult t-cell leukemia/lymphoma
866679|NCT00039559|ovarian epithelial cancer|ovarian epithelial cancer
866417|NCT00041314|recurrent non-small cell lung cancer|recurrent non-small cell lung cancer
866418|NCT00041314|stage IIIB non-small cell lung cancer|stage iiib non-small cell lung cancer
866419|NCT00041314|stage IV non-small cell lung cancer|stage iv non-small cell lung cancer
866420|NCT00041301|stage I prostate cancer|stage i prostate cancer
866421|NCT00041301|stage IIB prostate cancer|stage iib prostate cancer
866422|NCT00041301|stage IIA prostate cancer|stage iia prostate cancer
866423|NCT00041301|stage III prostate cancer|stage iii prostate cancer
866424|NCT00041301|stage IV prostate cancer|stage iv prostate cancer
866425|NCT00041288|Waldenstrom macroglobulinemia|waldenstrom macroglobulinemia
866426|NCT00041288|refractory chronic lymphocytic leukemia|refractory chronic lymphocytic leukemia
866427|NCT00041288|recurrent grade 1 follicular lymphoma|recurrent grade 1 follicular lymphoma
866428|NCT00041288|recurrent grade 2 follicular lymphoma|recurrent grade 2 follicular lymphoma
866429|NCT00041288|recurrent adult diffuse small cleaved cell lymphoma|recurrent adult diffuse small cleaved cell lymphoma
866430|NCT00041288|recurrent small lymphocytic lymphoma|recurrent small lymphocytic lymphoma
866431|NCT00041262|stage IIB esophageal cancer|stage iib esophageal cancer
866432|NCT00041262|stage IIIA esophageal cancer|stage iiia esophageal cancer
866433|NCT00041262|stage IIIB esophageal cancer|stage iiib esophageal cancer
866434|NCT00041262|adenocarcinoma of the esophagus|adenocarcinoma of the esophagus
866435|NCT00041249|adult angiosarcoma|adult angiosarcoma
866436|NCT00041249|adult fibrosarcoma|adult fibrosarcoma
866437|NCT00041249|adult leiomyosarcoma|adult leiomyosarcoma
866438|NCT00041249|adult liposarcoma|adult liposarcoma
866439|NCT00041249|adult neurofibrosarcoma|adult neurofibrosarcoma
866440|NCT00041249|adult synovial sarcoma|adult synovial sarcoma
866441|NCT00041249|stage III adult soft tissue sarcoma|stage iii adult soft tissue sarcoma
866442|NCT00041249|recurrent adult soft tissue sarcoma|recurrent adult soft tissue sarcoma
866443|NCT00041249|adult malignant fibrous histiocytoma|adult malignant fibrous histiocytoma
866444|NCT00041249|adult malignant hemangiopericytoma|adult malignant hemangiopericytoma
866445|NCT00041249|adult rhabdomyosarcoma|adult rhabdomyosarcoma
866446|NCT00041249|gastrointestinal stromal tumor|gastrointestinal stromal tumor
888319|NCT00000897|Sex Factors|sex factors
866447|NCT00041249|stage IV adult soft tissue sarcoma|stage iv adult soft tissue sarcoma
866448|NCT00041236|adult angiosarcoma|adult angiosarcoma
866449|NCT00041236|adult fibrosarcoma|adult fibrosarcoma
866450|NCT00041236|adult leiomyosarcoma|adult leiomyosarcoma
866451|NCT00041236|adult liposarcoma|adult liposarcoma
866452|NCT00041236|adult neurofibrosarcoma|adult neurofibrosarcoma
866453|NCT00041236|adult synovial sarcoma|adult synovial sarcoma
866454|NCT00041236|stage IV adult soft tissue sarcoma|stage iv adult soft tissue sarcoma
866455|NCT00041236|recurrent adult soft tissue sarcoma|recurrent adult soft tissue sarcoma
866456|NCT00041236|adult malignant fibrous histiocytoma|adult malignant fibrous histiocytoma
866457|NCT00041236|adult malignant hemangiopericytoma|adult malignant hemangiopericytoma
866458|NCT00041236|adult rhabdomyosarcoma|adult rhabdomyosarcoma
866459|NCT00041236|stage IV uterine sarcoma|stage iv uterine sarcoma
866460|NCT00041236|recurrent uterine sarcoma|recurrent uterine sarcoma
866461|NCT00041236|uterine leiomyosarcoma|uterine leiomyosarcoma
866462|NCT00041223|radiation fibrosis|radiation fibrosis
866463|NCT00041223|stage I breast cancer|stage i breast cancer
866464|NCT00041223|stage II breast cancer|stage ii breast cancer
866465|NCT00041223|stage IIIA breast cancer|stage iiia breast cancer
866466|NCT00041210|stage I adult Hodgkin lymphoma|stage i adult hodgkin lymphoma
866467|NCT00041210|stage II adult Hodgkin lymphoma|stage ii adult hodgkin lymphoma
866468|NCT00041210|stage III adult Hodgkin lymphoma|stage iii adult hodgkin lymphoma
866469|NCT00041210|stage IV adult Hodgkin lymphoma|stage iv adult hodgkin lymphoma
866470|NCT00041210|adult lymphocyte predominant Hodgkin lymphoma|adult lymphocyte predominant hodgkin lymphoma
866471|NCT00041210|adult lymphocyte depletion Hodgkin lymphoma|adult lymphocyte depletion hodgkin lymphoma
866472|NCT00041210|adult nodular sclerosis Hodgkin lymphoma|adult nodular sclerosis hodgkin lymphoma
866473|NCT00041210|adult mixed cellularity Hodgkin lymphoma|adult mixed cellularity hodgkin lymphoma
866474|NCT00041171|stage IV breast cancer|stage iv breast cancer
866475|NCT00041171|stage IIIA breast cancer|stage iiia breast cancer
866476|NCT00041171|recurrent breast cancer|recurrent breast cancer
866477|NCT00041171|stage IIIB breast cancer|stage iiib breast cancer
866478|NCT00041171|recurrent non-small cell lung cancer|recurrent non-small cell lung cancer
866479|NCT00041171|extensive stage small cell lung cancer|extensive stage small cell lung cancer
866480|NCT00041171|recurrent small cell lung cancer|recurrent small cell lung cancer
866481|NCT00041171|stage III bladder cancer|stage iii bladder cancer
866482|NCT00041171|recurrent bladder cancer|recurrent bladder cancer
866483|NCT00041171|stage IV bladder cancer|stage iv bladder cancer
866484|NCT00041171|stage III prostate cancer|stage iii prostate cancer
866485|NCT00041171|stage IV prostate cancer|stage iv prostate cancer
866486|NCT00041171|recurrent prostate cancer|recurrent prostate cancer
866487|NCT00041171|stage IIIA non-small cell lung cancer|stage iiia non-small cell lung cancer
866488|NCT00041171|stage IIIB non-small cell lung cancer|stage iiib non-small cell lung cancer
866489|NCT00041171|stage IV non-small cell lung cancer|stage iv non-small cell lung cancer
866490|NCT00041171|unspecified adult solid tumor, protocol specific|unspecified adult solid tumor, protocol specific
866491|NCT00041171|untreated metastatic squamous neck cancer with occult primary|untreated metastatic squamous neck cancer with occult primary
866492|NCT00041171|recurrent metastatic squamous neck cancer with occult primary|recurrent metastatic squamous neck cancer with occult primary
866493|NCT00041171|metastatic squamous neck cancer with occult primary squamous cell carcinoma|metastatic squamous neck cancer with occult primary squamous cell carcinoma
866494|NCT00041171|stage III squamous cell carcinoma of the lip and oral cavity|stage iii squamous cell carcinoma of the lip and oral cavity
866495|NCT00041171|stage III basal cell carcinoma of the lip|stage iii basal cell carcinoma of the lip
866496|NCT00041171|stage III verrucous carcinoma of the oral cavity|stage iii verrucous carcinoma of the oral cavity
866497|NCT00041171|stage III mucoepidermoid carcinoma of the oral cavity|stage iii mucoepidermoid carcinoma of the oral cavity
866498|NCT00041171|stage III adenoid cystic carcinoma of the oral cavity|stage iii adenoid cystic carcinoma of the oral cavity
866499|NCT00041171|stage IV squamous cell carcinoma of the lip and oral cavity|stage iv squamous cell carcinoma of the lip and oral cavity
866500|NCT00041171|stage IV basal cell carcinoma of the lip|stage iv basal cell carcinoma of the lip
866501|NCT00041171|stage IV verrucous carcinoma of the oral cavity|stage iv verrucous carcinoma of the oral cavity
866502|NCT00041171|stage IV mucoepidermoid carcinoma of the oral cavity|stage iv mucoepidermoid carcinoma of the oral cavity
866503|NCT00041171|stage IV adenoid cystic carcinoma of the oral cavity|stage iv adenoid cystic carcinoma of the oral cavity
866504|NCT00041171|recurrent squamous cell carcinoma of the lip and oral cavity|recurrent squamous cell carcinoma of the lip and oral cavity
866505|NCT00041171|recurrent basal cell carcinoma of the lip|recurrent basal cell carcinoma of the lip
866506|NCT00041171|recurrent verrucous carcinoma of the oral cavity|recurrent verrucous carcinoma of the oral cavity
866507|NCT00041171|recurrent mucoepidermoid carcinoma of the oral cavity|recurrent mucoepidermoid carcinoma of the oral cavity
866508|NCT00041171|recurrent adenoid cystic carcinoma of the oral cavity|recurrent adenoid cystic carcinoma of the oral cavity
866509|NCT00041171|stage III squamous cell carcinoma of the oropharynx|stage iii squamous cell carcinoma of the oropharynx
866510|NCT00041171|stage III lymphoepithelioma of the oropharynx|stage iii lymphoepithelioma of the oropharynx
866511|NCT00041171|stage IV squamous cell carcinoma of the oropharynx|stage iv squamous cell carcinoma of the oropharynx
866512|NCT00041171|stage IV lymphoepithelioma of the oropharynx|stage iv lymphoepithelioma of the oropharynx
888514|NCT00000874|Zidovudine|zidovudine
866513|NCT00041171|recurrent squamous cell carcinoma of the oropharynx|recurrent squamous cell carcinoma of the oropharynx
866514|NCT00041171|recurrent lymphoepithelioma of the oropharynx|recurrent lymphoepithelioma of the oropharynx
866515|NCT00041171|stage III squamous cell carcinoma of the nasopharynx|stage iii squamous cell carcinoma of the nasopharynx
866516|NCT00041171|stage III lymphoepithelioma of the nasopharynx|stage iii lymphoepithelioma of the nasopharynx
866517|NCT00041171|stage IV squamous cell carcinoma of the nasopharynx|stage iv squamous cell carcinoma of the nasopharynx
866518|NCT00041171|stage IV lymphoepithelioma of the nasopharynx|stage iv lymphoepithelioma of the nasopharynx
866519|NCT00041171|recurrent squamous cell carcinoma of the nasopharynx|recurrent squamous cell carcinoma of the nasopharynx
866520|NCT00041171|recurrent lymphoepithelioma of the nasopharynx|recurrent lymphoepithelioma of the nasopharynx
866521|NCT00041171|stage III squamous cell carcinoma of the hypopharynx|stage iii squamous cell carcinoma of the hypopharynx
866522|NCT00041171|stage IV squamous cell carcinoma of the hypopharynx|stage iv squamous cell carcinoma of the hypopharynx
866523|NCT00041171|recurrent squamous cell carcinoma of the hypopharynx|recurrent squamous cell carcinoma of the hypopharynx
866524|NCT00041171|stage III squamous cell carcinoma of the larynx|stage iii squamous cell carcinoma of the larynx
866525|NCT00041171|stage III verrucous carcinoma of the larynx|stage iii verrucous carcinoma of the larynx
866526|NCT00041171|stage IV squamous cell carcinoma of the larynx|stage iv squamous cell carcinoma of the larynx
866527|NCT00041171|stage IV verrucous carcinoma of the larynx|stage iv verrucous carcinoma of the larynx
866528|NCT00041171|recurrent squamous cell carcinoma of the larynx|recurrent squamous cell carcinoma of the larynx
866529|NCT00041171|recurrent verrucous carcinoma of the larynx|recurrent verrucous carcinoma of the larynx
866530|NCT00041171|stage III squamous cell carcinoma of the paranasal sinus and nasal cavity|stage iii squamous cell carcinoma of the paranasal sinus and nasal cavity
866531|NCT00041171|stage III inverting papilloma of the paranasal sinus and nasal cavity|stage iii inverting papilloma of the paranasal sinus and nasal cavity
866532|NCT00041171|stage III midline lethal granuloma of the paranasal sinus and nasal cavity|stage iii midline lethal granuloma of the paranasal sinus and nasal cavity
866533|NCT00041171|stage III esthesioneuroblastoma of the paranasal sinus and nasal cavity|stage iii esthesioneuroblastoma of the paranasal sinus and nasal cavity
866534|NCT00041171|stage IV squamous cell carcinoma of the paranasal sinus and nasal cavity|stage iv squamous cell carcinoma of the paranasal sinus and nasal cavity
866535|NCT00041171|stage IV inverting papilloma of the paranasal sinus and nasal cavity|stage iv inverting papilloma of the paranasal sinus and nasal cavity
866536|NCT00041171|stage IV midline lethal granuloma of the paranasal sinus and nasal cavity|stage iv midline lethal granuloma of the paranasal sinus and nasal cavity
866537|NCT00041171|stage IV esthesioneuroblastoma of the paranasal sinus and nasal cavity|stage iv esthesioneuroblastoma of the paranasal sinus and nasal cavity
866538|NCT00041171|recurrent squamous cell carcinoma of the paranasal sinus and nasal cavity|recurrent squamous cell carcinoma of the paranasal sinus and nasal cavity
866539|NCT00041171|recurrent inverting papilloma of the paranasal sinus and nasal cavity|recurrent inverting papilloma of the paranasal sinus and nasal cavity
866540|NCT00041171|recurrent midline lethal granuloma of the paranasal sinus and nasal cavity|recurrent midline lethal granuloma of the paranasal sinus and nasal cavity
866541|NCT00041171|recurrent esthesioneuroblastoma of the paranasal sinus and nasal cavity|recurrent esthesioneuroblastoma of the paranasal sinus and nasal cavity
866542|NCT00041171|recurrent salivary gland cancer|recurrent salivary gland cancer
866543|NCT00041171|stage III salivary gland cancer|stage iii salivary gland cancer
866544|NCT00041171|stage IV salivary gland cancer|stage iv salivary gland cancer
866545|NCT00041132|stage III mantle cell lymphoma|stage iii mantle cell lymphoma
866546|NCT00041132|stage IV mantle cell lymphoma|stage iv mantle cell lymphoma
866547|NCT00041132|contiguous stage II mantle cell lymphoma|contiguous stage ii mantle cell lymphoma
866548|NCT00041132|noncontiguous stage II mantle cell lymphoma|noncontiguous stage ii mantle cell lymphoma
866549|NCT00041119|stage IB breast cancer|stage ib breast cancer
866550|NCT00041119|stage II breast cancer|stage ii breast cancer
866551|NCT00041067|stage IV breast cancer|stage iv breast cancer
866552|NCT00041067|recurrent breast cancer|recurrent breast cancer
866553|NCT00041054|extensive stage small cell lung cancer|extensive stage small cell lung cancer
866554|NCT00041028|stage I non-small cell lung cancer|stage i non-small cell lung cancer
866555|NCT00041028|stage II non-small cell lung cancer|stage ii non-small cell lung cancer
866556|NCT00041028|stage IIIA non-small cell lung cancer|stage iiia non-small cell lung cancer
866557|NCT00041028|stage IIIB non-small cell lung cancer|stage iiib non-small cell lung cancer
866558|NCT00041015|extensive stage small cell lung cancer|extensive stage small cell lung cancer
866559|NCT00041015|recurrent small cell lung cancer|recurrent small cell lung cancer
866560|NCT00040950|recurrent grade 1 follicular lymphoma|recurrent grade 1 follicular lymphoma
866561|NCT00040950|recurrent grade 2 follicular lymphoma|recurrent grade 2 follicular lymphoma
866562|NCT00040950|recurrent grade 3 follicular lymphoma|recurrent grade 3 follicular lymphoma
866563|NCT00040950|recurrent adult diffuse small cleaved cell lymphoma|recurrent adult diffuse small cleaved cell lymphoma
866564|NCT00040950|recurrent adult diffuse mixed cell lymphoma|recurrent adult diffuse mixed cell lymphoma
866565|NCT00040950|recurrent adult diffuse large cell lymphoma|recurrent adult diffuse large cell lymphoma
866566|NCT00040950|recurrent adult immunoblastic large cell lymphoma|recurrent adult immunoblastic large cell lymphoma
866567|NCT00040950|recurrent adult lymphoblastic lymphoma|recurrent adult lymphoblastic lymphoma
866568|NCT00040950|recurrent adult Burkitt lymphoma|recurrent adult burkitt lymphoma
866569|NCT00040950|recurrent mantle cell lymphoma|recurrent mantle cell lymphoma
866570|NCT00040950|recurrent marginal zone lymphoma|recurrent marginal zone lymphoma
866571|NCT00040950|recurrent small lymphocytic lymphoma|recurrent small lymphocytic lymphoma
866572|NCT00040950|extranodal marginal zone B-cell lymphoma of mucosa-associated lymphoid tissue|extranodal marginal zone b-cell lymphoma of mucosa-associated lymphoid tissue
866573|NCT00040950|nodal marginal zone B-cell lymphoma|nodal marginal zone b-cell lymphoma
866574|NCT00040950|splenic marginal zone lymphoma|splenic marginal zone lymphoma
866575|NCT00040937|stage I multiple myeloma|stage i multiple myeloma
866576|NCT00040937|stage II multiple myeloma|stage ii multiple myeloma
866577|NCT00040937|stage III multiple myeloma|stage iii multiple myeloma
866578|NCT00040911|nausea and vomiting|nausea and vomiting
866579|NCT00040911|localized osteosarcoma|localized osteosarcoma
866580|NCT00040911|metastatic osteosarcoma|metastatic osteosarcoma
866581|NCT00040911|nonmetastatic childhood soft tissue sarcoma|nonmetastatic childhood soft tissue sarcoma
866582|NCT00040911|metastatic childhood soft tissue sarcoma|metastatic childhood soft tissue sarcoma
866583|NCT00040911|previously untreated childhood rhabdomyosarcoma|previously untreated childhood rhabdomyosarcoma
866584|NCT00040911|localized Ewing sarcoma/peripheral primitive neuroectodermal tumor|localized ewing sarcoma/peripheral primitive neuroectodermal tumor
866585|NCT00040911|metastatic Ewing sarcoma/peripheral primitive neuroectodermal tumor|metastatic ewing sarcoma/peripheral primitive neuroectodermal tumor
866586|NCT00040911|childhood teratoma|childhood teratoma
866587|NCT00040911|childhood extragonadal germ cell tumor|childhood extragonadal germ cell tumor
866588|NCT00040911|childhood malignant testicular germ cell tumor|childhood malignant testicular germ cell tumor
866589|NCT00040911|childhood malignant ovarian germ cell tumor|childhood malignant ovarian germ cell tumor
866590|NCT00040911|childhood central nervous system germ cell tumor|childhood central nervous system germ cell tumor
866591|NCT00040911|localized resectable neuroblastoma|localized resectable neuroblastoma
866592|NCT00040911|localized unresectable neuroblastoma|localized unresectable neuroblastoma
866593|NCT00040911|disseminated neuroblastoma|disseminated neuroblastoma
866594|NCT00040911|regional neuroblastoma|regional neuroblastoma
866595|NCT00040911|stage 4S neuroblastoma|stage 4s neuroblastoma
866596|NCT00040911|stage I lymphoepithelioma of the nasopharynx|stage i lymphoepithelioma of the nasopharynx
866597|NCT00040911|stage I squamous cell carcinoma of the nasopharynx|stage i squamous cell carcinoma of the nasopharynx
866598|NCT00040911|stage II lymphoepithelioma of the nasopharynx|stage ii lymphoepithelioma of the nasopharynx
866599|NCT00040911|stage II squamous cell carcinoma of the nasopharynx|stage ii squamous cell carcinoma of the nasopharynx
866600|NCT00040911|stage III lymphoepithelioma of the nasopharynx|stage iii lymphoepithelioma of the nasopharynx
866601|NCT00040911|stage III squamous cell carcinoma of the nasopharynx|stage iii squamous cell carcinoma of the nasopharynx
866602|NCT00040911|stage IV lymphoepithelioma of the nasopharynx|stage iv lymphoepithelioma of the nasopharynx
866603|NCT00040911|stage IV squamous cell carcinoma of the nasopharynx|stage iv squamous cell carcinoma of the nasopharynx
866604|NCT00040911|stage I adult Hodgkin lymphoma|stage i adult hodgkin lymphoma
866605|NCT00040911|stage I childhood Hodgkin lymphoma|stage i childhood hodgkin lymphoma
866606|NCT00040911|stage II adult Hodgkin lymphoma|stage ii adult hodgkin lymphoma
866607|NCT00040911|stage II childhood Hodgkin lymphoma|stage ii childhood hodgkin lymphoma
866608|NCT00040911|stage III adult Hodgkin lymphoma|stage iii adult hodgkin lymphoma
866680|NCT00039546|stage I breast cancer|stage i breast cancer
866609|NCT00040911|stage III childhood Hodgkin lymphoma|stage iii childhood hodgkin lymphoma
866610|NCT00040911|stage IV adult Hodgkin lymphoma|stage iv adult hodgkin lymphoma
866611|NCT00040911|stage IV childhood Hodgkin lymphoma|stage iv childhood hodgkin lymphoma
866612|NCT00040898|localized unresectable adult primary liver cancer|localized unresectable adult primary liver cancer
866613|NCT00040898|advanced adult primary liver cancer|advanced adult primary liver cancer
866614|NCT00040898|recurrent adult primary liver cancer|recurrent adult primary liver cancer
866615|NCT00040898|adult primary hepatocellular carcinoma|adult primary hepatocellular carcinoma
866616|NCT00040885|recurrent non-small cell lung cancer|recurrent non-small cell lung cancer
866617|NCT00040885|stage IIIA non-small cell lung cancer|stage iiia non-small cell lung cancer
866618|NCT00040885|stage IIIB non-small cell lung cancer|stage iiib non-small cell lung cancer
866619|NCT00040885|stage IV non-small cell lung cancer|stage iv non-small cell lung cancer
866620|NCT00040885|fatigue|fatigue
866621|NCT00040885|anorexia|anorexia
866622|NCT00040885|cachexia|cachexia
866623|NCT00040872|regional neuroblastoma|regional neuroblastoma
866624|NCT00040872|disseminated neuroblastoma|disseminated neuroblastoma
866625|NCT00040872|recurrent neuroblastoma|recurrent neuroblastoma
866626|NCT00040872|localized unresectable neuroblastoma|localized unresectable neuroblastoma
866627|NCT00040859|stage IV gastric cancer|stage iv gastric cancer
866628|NCT00040859|recurrent gastric cancer|recurrent gastric cancer
866629|NCT00040859|stage III esophageal cancer|stage iii esophageal cancer
866630|NCT00040859|stage IV esophageal cancer|stage iv esophageal cancer
866631|NCT00040859|recurrent esophageal cancer|recurrent esophageal cancer
866632|NCT00040859|adenocarcinoma of the stomach|adenocarcinoma of the stomach
866633|NCT00040859|adenocarcinoma of the esophagus|adenocarcinoma of the esophagus
866634|NCT00040833|stage III pancreatic cancer|stage iii pancreatic cancer
866635|NCT00040833|recurrent pancreatic cancer|recurrent pancreatic cancer
866636|NCT00040833|pain|pain
866637|NCT00040833|stage IV pancreatic cancer|stage iv pancreatic cancer
866638|NCT00040807|recurrent metastatic squamous neck cancer with occult primary|recurrent metastatic squamous neck cancer with occult primary
867140|NCT00032162|stage IIA cervical cancer|stage iia cervical cancer
866639|NCT00040807|metastatic squamous neck cancer with occult primary squamous cell carcinoma|metastatic squamous neck cancer with occult primary squamous cell carcinoma
866640|NCT00040807|stage IV squamous cell carcinoma of the lip and oral cavity|stage iv squamous cell carcinoma of the lip and oral cavity
866641|NCT00040807|recurrent squamous cell carcinoma of the lip and oral cavity|recurrent squamous cell carcinoma of the lip and oral cavity
866642|NCT00040807|stage IV squamous cell carcinoma of the oropharynx|stage iv squamous cell carcinoma of the oropharynx
866643|NCT00040807|recurrent squamous cell carcinoma of the oropharynx|recurrent squamous cell carcinoma of the oropharynx
866644|NCT00040807|stage IV squamous cell carcinoma of the nasopharynx|stage iv squamous cell carcinoma of the nasopharynx
866645|NCT00040807|recurrent squamous cell carcinoma of the nasopharynx|recurrent squamous cell carcinoma of the nasopharynx
866646|NCT00040807|stage IV squamous cell carcinoma of the hypopharynx|stage iv squamous cell carcinoma of the hypopharynx
866647|NCT00040807|recurrent squamous cell carcinoma of the hypopharynx|recurrent squamous cell carcinoma of the hypopharynx
866648|NCT00040807|stage IV squamous cell carcinoma of the larynx|stage iv squamous cell carcinoma of the larynx
866649|NCT00040807|recurrent squamous cell carcinoma of the larynx|recurrent squamous cell carcinoma of the larynx
866650|NCT00040807|stage IV squamous cell carcinoma of the paranasal sinus and nasal cavity|stage iv squamous cell carcinoma of the paranasal sinus and nasal cavity
866651|NCT00040807|recurrent squamous cell carcinoma of the paranasal sinus and nasal cavity|recurrent squamous cell carcinoma of the paranasal sinus and nasal cavity
866652|NCT00040807|recurrent salivary gland cancer|recurrent salivary gland cancer
866653|NCT00040807|salivary gland squamous cell carcinoma|salivary gland squamous cell carcinoma
866654|NCT00040807|stage IV salivary gland cancer|stage iv salivary gland cancer
866655|NCT00040742|nausea|nausea
866656|NCT00040742|vomiting|vomiting
866657|NCT00040690|untreated adult acute lymphoblastic leukemia|untreated adult acute lymphoblastic leukemia
866658|NCT00040690|L3 adult acute lymphoblastic leukemia|l3 adult acute lymphoblastic leukemia
866659|NCT00040690|stage I adult Burkitt lymphoma|stage i adult burkitt lymphoma
866660|NCT00040690|stage III adult Burkitt lymphoma|stage iii adult burkitt lymphoma
866661|NCT00040690|stage IV adult Burkitt lymphoma|stage iv adult burkitt lymphoma
866662|NCT00040690|contiguous stage II adult Burkitt lymphoma|contiguous stage ii adult burkitt lymphoma
866663|NCT00040690|noncontiguous stage II adult Burkitt lymphoma|noncontiguous stage ii adult burkitt lymphoma
866664|NCT00039611|stage III colon cancer|stage iii colon cancer
866665|NCT00039611|stage IV colon cancer|stage iv colon cancer
866666|NCT00039611|stage III rectal cancer|stage iii rectal cancer
866667|NCT00039611|stage IV rectal cancer|stage iv rectal cancer
866668|NCT00039611|recurrent colon cancer|recurrent colon cancer
866669|NCT00039611|recurrent rectal cancer|recurrent rectal cancer
866670|NCT00039585|recurrent ovarian epithelial cancer|recurrent ovarian epithelial cancer
866671|NCT00039585|fallopian tube cancer|fallopian tube cancer
866672|NCT00039585|primary peritoneal cavity cancer|primary peritoneal cavity cancer
866673|NCT00039585|borderline ovarian surface epithelial-stromal tumor|borderline ovarian surface epithelial-stromal tumor
866674|NCT00039572|adult glioblastoma|adult glioblastoma
866675|NCT00039572|stage IV melanoma|stage iv melanoma
866676|NCT00039572|tumors metastatic to brain|tumors metastatic to brain
866677|NCT00039572|adult giant cell glioblastoma|adult giant cell glioblastoma
866678|NCT00039572|adult gliosarcoma|adult gliosarcoma
866682|NCT00039520|stage IV breast cancer|stage iv breast cancer
866683|NCT00039520|recurrent breast cancer|recurrent breast cancer
866684|NCT00039507|stage I non-small cell lung cancer|stage i non-small cell lung cancer
866685|NCT00039507|stage II non-small cell lung cancer|stage ii non-small cell lung cancer
866686|NCT00039468|adult glioblastoma|adult glioblastoma
866687|NCT00039468|recurrent adult brain tumor|recurrent adult brain tumor
866688|NCT00039468|adult giant cell glioblastoma|adult giant cell glioblastoma
866689|NCT00039468|adult gliosarcoma|adult gliosarcoma
866690|NCT00039429|stage IV renal cell cancer|stage iv renal cell cancer
866691|NCT00039429|recurrent renal cell cancer|recurrent renal cell cancer
866692|NCT00039364|recurrent adult brain tumor|recurrent adult brain tumor
866693|NCT00039364|adult glioblastoma|adult glioblastoma
866694|NCT00039364|adult anaplastic astrocytoma|adult anaplastic astrocytoma
866695|NCT00039364|adult anaplastic oligodendroglioma|adult anaplastic oligodendroglioma
866697|NCT00039364|adult pilocytic astrocytoma|adult pilocytic astrocytoma
866698|NCT00039364|adult subependymoma|adult subependymoma
866699|NCT00039364|adult giant cell glioblastoma|adult giant cell glioblastoma
866700|NCT00039364|adult gliosarcoma|adult gliosarcoma
866701|NCT00039364|adult diffuse astrocytoma|adult diffuse astrocytoma
866702|NCT00039351|stage I adult diffuse large cell lymphoma|stage i adult diffuse large cell lymphoma
866703|NCT00039351|stage III adult diffuse large cell lymphoma|stage iii adult diffuse large cell lymphoma
866704|NCT00039351|stage IV adult diffuse large cell lymphoma|stage iv adult diffuse large cell lymphoma
866705|NCT00039351|contiguous stage II adult diffuse large cell lymphoma|contiguous stage ii adult diffuse large cell lymphoma
866706|NCT00039351|noncontiguous stage II adult diffuse large cell lymphoma|noncontiguous stage ii adult diffuse large cell lymphoma
866707|NCT00039351|angioimmunoblastic T-cell lymphoma|angioimmunoblastic t-cell lymphoma
866708|NCT00039338|stage IB cervical cancer|stage ib cervical cancer
866709|NCT00039338|stage IIB cervical cancer|stage iib cervical cancer
866710|NCT00039338|stage IIA cervical cancer|stage iia cervical cancer
866711|NCT00039338|cervical squamous cell carcinoma|cervical squamous cell carcinoma
866712|NCT00039338|cervical adenocarcinoma|cervical adenocarcinoma
866713|NCT00039338|cervical adenosquamous cell carcinoma|cervical adenosquamous cell carcinoma
866714|NCT00039325|stage IV melanoma|stage iv melanoma
866715|NCT00039325|recurrent melanoma|recurrent melanoma
866716|NCT00039312|cervical cancer|cervical cancer
866717|NCT00039299|adenocarcinoma of the prostate|adenocarcinoma of the prostate
866718|NCT00039299|recurrent prostate cancer|recurrent prostate cancer
866719|NCT00039286|stage II breast cancer|stage ii breast cancer
866720|NCT00039286|stage IIIA breast cancer|stage iiia breast cancer
866721|NCT00039286|recurrent breast cancer|recurrent breast cancer
866722|NCT00039273|stage IV colon cancer|stage iv colon cancer
866723|NCT00039273|stage IV rectal cancer|stage iv rectal cancer
866724|NCT00039273|recurrent colon cancer|recurrent colon cancer
866725|NCT00039273|recurrent rectal cancer|recurrent rectal cancer
866726|NCT00039234|stage IV melanoma|stage iv melanoma
866727|NCT00039234|recurrent melanoma|recurrent melanoma
866728|NCT00039234|liver metastases|liver metastases
866729|NCT00039208|stage III colon cancer|stage iii colon cancer
866730|NCT00039208|stage IV colon cancer|stage iv colon cancer
866731|NCT00039208|stage III rectal cancer|stage iii rectal cancer
866732|NCT00039208|stage IV rectal cancer|stage iv rectal cancer
866733|NCT00039208|recurrent colon cancer|recurrent colon cancer
866734|NCT00039208|recurrent rectal cancer|recurrent rectal cancer
866735|NCT00039195|stage I adult diffuse large cell lymphoma|stage i adult diffuse large cell lymphoma
866736|NCT00039195|stage III adult diffuse large cell lymphoma|stage iii adult diffuse large cell lymphoma
866737|NCT00039195|stage IV adult diffuse large cell lymphoma|stage iv adult diffuse large cell lymphoma
866738|NCT00039195|contiguous stage II adult diffuse large cell lymphoma|contiguous stage ii adult diffuse large cell lymphoma
866739|NCT00039195|noncontiguous stage II adult diffuse large cell lymphoma|noncontiguous stage ii adult diffuse large cell lymphoma
866740|NCT00039156|recurrent grade 3 follicular lymphoma|recurrent grade 3 follicular lymphoma
866741|NCT00039156|recurrent adult diffuse mixed cell lymphoma|recurrent adult diffuse mixed cell lymphoma
866742|NCT00039156|recurrent adult diffuse large cell lymphoma|recurrent adult diffuse large cell lymphoma
866743|NCT00039156|recurrent adult immunoblastic large cell lymphoma|recurrent adult immunoblastic large cell lymphoma
866744|NCT00039156|recurrent adult lymphoblastic lymphoma|recurrent adult lymphoblastic lymphoma
866745|NCT00039156|recurrent adult Burkitt lymphoma|recurrent adult burkitt lymphoma
866746|NCT00039156|recurrent mantle cell lymphoma|recurrent mantle cell lymphoma
866747|NCT00039130|untreated adult acute lymphoblastic leukemia|untreated adult acute lymphoblastic leukemia
866748|NCT00039130|L3 adult acute lymphoblastic leukemia|l3 adult acute lymphoblastic leukemia
866749|NCT00039130|stage I adult Burkitt lymphoma|stage i adult burkitt lymphoma
866750|NCT00039130|stage III adult Burkitt lymphoma|stage iii adult burkitt lymphoma
866751|NCT00039130|stage IV adult Burkitt lymphoma|stage iv adult burkitt lymphoma
866752|NCT00039130|contiguous stage II adult Burkitt lymphoma|contiguous stage ii adult burkitt lymphoma
866753|NCT00039130|noncontiguous stage II adult Burkitt lymphoma|noncontiguous stage ii adult burkitt lymphoma
866754|NCT00039078|localized unresectable adult primary liver cancer|localized unresectable adult primary liver cancer
866755|NCT00039078|recurrent adult primary liver cancer|recurrent adult primary liver cancer
866756|NCT00039078|adult primary hepatocellular carcinoma|adult primary hepatocellular carcinoma
866757|NCT00039052|stage IV breast cancer|stage iv breast cancer
866758|NCT00039052|recurrent breast cancer|recurrent breast cancer
866759|NCT00039052|recurrent non-small cell lung cancer|recurrent non-small cell lung cancer
866760|NCT00039052|stage IV renal cell cancer|stage iv renal cell cancer
866761|NCT00039052|recurrent renal cell cancer|recurrent renal cell cancer
866762|NCT00039052|stage IV non-small cell lung cancer|stage iv non-small cell lung cancer
866764|NCT00039039|recurrent non-small cell lung cancer|recurrent non-small cell lung cancer
866765|NCT00039039|stage IIIA non-small cell lung cancer|stage iiia non-small cell lung cancer
866766|NCT00039039|stage IIIB non-small cell lung cancer|stage iiib non-small cell lung cancer
866767|NCT00037037|stage III melanoma|stage iii melanoma
866768|NCT00037037|stage IV melanoma|stage iv melanoma
866769|NCT00037037|recurrent melanoma|recurrent melanoma
866770|NCT00037024|stage I breast cancer|stage i breast cancer
866771|NCT00037024|stage II breast cancer|stage ii breast cancer
866772|NCT00037024|stage I prostate cancer|stage i prostate cancer
866773|NCT00037024|stage II B prostate cancer|stage ii b prostate cancer
866774|NCT00037024|stage II A prostate cancer|stage ii a prostate cancer
866775|NCT00037024|male breast cancer|male breast cancer
866776|NCT00037024|fatigue|fatigue
866777|NCT00037024|malnutrition|malnutrition
866778|NCT00037024|psychosocial effects of cancer and its treatment|psychosocial effects of cancer and its treatment
866779|NCT00037024|depression|depression
866780|NCT00037011|disseminated neuroblastoma|disseminated neuroblastoma
866781|NCT00037011|recurrent neuroblastoma|recurrent neuroblastoma
866782|NCT00036998|stage I breast cancer|stage i breast cancer
866783|NCT00036998|stage II breast cancer|stage ii breast cancer
866784|NCT00036985|stage IIIA breast cancer|stage iiia breast cancer
866785|NCT00036972|recurrent adult brain tumor|recurrent adult brain tumor
866786|NCT00036972|adult glioblastoma|adult glioblastoma
866787|NCT00036972|adult anaplastic astrocytoma|adult anaplastic astrocytoma
866788|NCT00036972|adult mixed glioma|adult mixed glioma
866789|NCT00036972|adult giant cell glioblastoma|adult giant cell glioblastoma
866790|NCT00036972|adult gliosarcoma|adult gliosarcoma
888515|NCT00000874|Stavudine|stavudine
866792|NCT00036959|childhood infratentorial ependymoma|childhood infratentorial ependymoma
866793|NCT00036959|recurrent childhood rhabdomyosarcoma|recurrent childhood rhabdomyosarcoma
866794|NCT00036959|childhood supratentorial ependymoma|childhood supratentorial ependymoma
866795|NCT00036959|childhood craniopharyngioma|childhood craniopharyngioma
866796|NCT00036959|disseminated neuroblastoma|disseminated neuroblastoma
866797|NCT00036959|recurrent neuroblastoma|recurrent neuroblastoma
866798|NCT00036959|recurrent childhood liver cancer|recurrent childhood liver cancer
866799|NCT00036959|stage IV childhood liver cancer|stage iv childhood liver cancer
866800|NCT00036959|recurrent Wilms tumor and other childhood kidney tumors|recurrent wilms tumor and other childhood kidney tumors
866801|NCT00036959|stage IV Wilms tumor|stage iv wilms tumor
866802|NCT00036959|childhood central nervous system germ cell tumor|childhood central nervous system germ cell tumor
866803|NCT00036959|recurrent osteosarcoma|recurrent osteosarcoma
866804|NCT00036959|unspecified childhood solid tumor, protocol specific|unspecified childhood solid tumor, protocol specific
866805|NCT00036959|childhood germ cell tumor|childhood germ cell tumor
866806|NCT00036959|metastatic childhood soft tissue sarcoma|metastatic childhood soft tissue sarcoma
866807|NCT00036959|recurrent childhood soft tissue sarcoma|recurrent childhood soft tissue sarcoma
866808|NCT00036959|childhood high-grade cerebral astrocytoma|childhood high-grade cerebral astrocytoma
866809|NCT00036959|childhood oligodendroglioma|childhood oligodendroglioma
866810|NCT00036959|childhood choroid plexus tumor|childhood choroid plexus tumor
866811|NCT00036959|childhood grade I meningioma|childhood grade i meningioma
866812|NCT00036959|childhood grade II meningioma|childhood grade ii meningioma
866813|NCT00036959|childhood grade III meningioma|childhood grade iii meningioma
866814|NCT00036959|recurrent childhood cerebellar astrocytoma|recurrent childhood cerebellar astrocytoma
866815|NCT00036959|recurrent childhood cerebral astrocytoma|recurrent childhood cerebral astrocytoma
866816|NCT00036959|recurrent childhood medulloblastoma|recurrent childhood medulloblastoma
866817|NCT00036959|recurrent childhood visual pathway and hypothalamic glioma|recurrent childhood visual pathway and hypothalamic glioma
866818|NCT00036959|previously treated childhood rhabdomyosarcoma|previously treated childhood rhabdomyosarcoma
866819|NCT00036959|metastatic Ewing sarcoma/peripheral primitive neuroectodermal tumor|metastatic ewing sarcoma/peripheral primitive neuroectodermal tumor
866820|NCT00036959|recurrent Ewing sarcoma/peripheral primitive neuroectodermal tumor|recurrent ewing sarcoma/peripheral primitive neuroectodermal tumor
866821|NCT00036959|recurrent childhood ependymoma|recurrent childhood ependymoma
866822|NCT00036959|childhood teratoma|childhood teratoma
866823|NCT00036959|childhood malignant testicular germ cell tumor|childhood malignant testicular germ cell tumor
866824|NCT00036959|childhood malignant ovarian germ cell tumor|childhood malignant ovarian germ cell tumor
866825|NCT00036959|childhood extragonadal germ cell tumor|childhood extragonadal germ cell tumor
866826|NCT00036959|recurrent childhood malignant germ cell tumor|recurrent childhood malignant germ cell tumor
866827|NCT00036946|unspecified adult solid tumor, protocol specific|unspecified adult solid tumor, protocol specific
866828|NCT00036946|stage IV grade 1 follicular lymphoma|stage iv grade 1 follicular lymphoma
866829|NCT00036946|stage IV grade 2 follicular lymphoma|stage iv grade 2 follicular lymphoma
866830|NCT00036946|stage IV grade 3 follicular lymphoma|stage iv grade 3 follicular lymphoma
866831|NCT00036946|stage IV adult diffuse small cleaved cell lymphoma|stage iv adult diffuse small cleaved cell lymphoma
866832|NCT00036946|stage IV adult diffuse mixed cell lymphoma|stage iv adult diffuse mixed cell lymphoma
866833|NCT00036946|stage IV adult diffuse large cell lymphoma|stage iv adult diffuse large cell lymphoma
866834|NCT00036946|stage IV adult immunoblastic large cell lymphoma|stage iv adult immunoblastic large cell lymphoma
866835|NCT00036946|stage IV adult lymphoblastic lymphoma|stage iv adult lymphoblastic lymphoma
866836|NCT00036946|stage IV adult Burkitt lymphoma|stage iv adult burkitt lymphoma
866837|NCT00036946|recurrent grade 1 follicular lymphoma|recurrent grade 1 follicular lymphoma
866838|NCT00036946|recurrent grade 2 follicular lymphoma|recurrent grade 2 follicular lymphoma
866839|NCT00036946|recurrent grade 3 follicular lymphoma|recurrent grade 3 follicular lymphoma
866840|NCT00036946|recurrent adult diffuse small cleaved cell lymphoma|recurrent adult diffuse small cleaved cell lymphoma
866841|NCT00036946|recurrent adult diffuse mixed cell lymphoma|recurrent adult diffuse mixed cell lymphoma
866842|NCT00036946|recurrent adult diffuse large cell lymphoma|recurrent adult diffuse large cell lymphoma
866843|NCT00036946|recurrent adult immunoblastic large cell lymphoma|recurrent adult immunoblastic large cell lymphoma
866844|NCT00036946|recurrent adult lymphoblastic lymphoma|recurrent adult lymphoblastic lymphoma
866845|NCT00036946|recurrent adult Burkitt lymphoma|recurrent adult burkitt lymphoma
866846|NCT00036946|stage IV mantle cell lymphoma|stage iv mantle cell lymphoma
866847|NCT00036946|recurrent mantle cell lymphoma|recurrent mantle cell lymphoma
866848|NCT00036946|recurrent marginal zone lymphoma|recurrent marginal zone lymphoma
866849|NCT00036946|recurrent small lymphocytic lymphoma|recurrent small lymphocytic lymphoma
866850|NCT00036946|stage IV small lymphocytic lymphoma|stage iv small lymphocytic lymphoma
866851|NCT00036946|stage IV marginal zone lymphoma|stage iv marginal zone lymphoma
866852|NCT00036946|extranodal marginal zone B-cell lymphoma of mucosa-associated lymphoid tissue|extranodal marginal zone b-cell lymphoma of mucosa-associated lymphoid tissue
866853|NCT00036946|nodal marginal zone B-cell lymphoma|nodal marginal zone b-cell lymphoma
866854|NCT00036946|splenic marginal zone lymphoma|splenic marginal zone lymphoma
866855|NCT00036933|stage III prostate cancer|stage iii prostate cancer
866856|NCT00036933|recurrent prostate cancer|recurrent prostate cancer
888613|NCT00000862|Labor|labor
866859|NCT00036894|adult anaplastic astrocytoma|adult anaplastic astrocytoma
866860|NCT00036894|adult anaplastic oligodendroglioma|adult anaplastic oligodendroglioma
866861|NCT00036894|adult mixed glioma|adult mixed glioma
866862|NCT00036894|adult ependymoblastoma|adult ependymoblastoma
866863|NCT00036894|adult anaplastic ependymoma|adult anaplastic ependymoma
866864|NCT00036894|adult myxopapillary ependymoma|adult myxopapillary ependymoma
866865|NCT00036894|adult meningioma|adult meningioma
866866|NCT00036894|adult meningeal hemangiopericytoma|adult meningeal hemangiopericytoma
866867|NCT00036894|adult brain stem glioma|adult brain stem glioma
866868|NCT00036894|adult grade III meningioma|adult grade iii meningioma
866869|NCT00036894|adult giant cell glioblastoma|adult giant cell glioblastoma
866870|NCT00036894|adult gliosarcoma|adult gliosarcoma
866871|NCT00036868|stage IV breast cancer|stage iv breast cancer
866872|NCT00036868|recurrent breast cancer|recurrent breast cancer
866873|NCT00036842|recurrent malignant testicular germ cell tumor|recurrent malignant testicular germ cell tumor
866874|NCT00036842|extragonadal germ cell tumor|extragonadal germ cell tumor
866875|NCT00036829|unspecified adult solid tumor, protocol specific|unspecified adult solid tumor, protocol specific
866876|NCT00036829|pain|pain
866877|NCT00036816|ciliary body and choroid melanoma, medium/large size|ciliary body and choroid melanoma, medium/large size
866878|NCT00036790|stage III adult Hodgkin lymphoma|stage iii adult hodgkin lymphoma
866879|NCT00036790|stage IV adult Hodgkin lymphoma|stage iv adult hodgkin lymphoma
866880|NCT00036790|recurrent adult Hodgkin lymphoma|recurrent adult hodgkin lymphoma
866881|NCT00036790|stage III cutaneous T-cell non-Hodgkin lymphoma|stage iii cutaneous t-cell non-hodgkin lymphoma
866882|NCT00036790|stage IV cutaneous T-cell non-Hodgkin lymphoma|stage iv cutaneous t-cell non-hodgkin lymphoma
866883|NCT00036790|recurrent cutaneous T-cell non-Hodgkin lymphoma|recurrent cutaneous t-cell non-hodgkin lymphoma
866884|NCT00036790|isolated plasmacytoma of bone|isolated plasmacytoma of bone
866885|NCT00036790|extramedullary plasmacytoma|extramedullary plasmacytoma
866886|NCT00036790|refractory multiple myeloma|refractory multiple myeloma
866887|NCT00036790|Waldenstrom macroglobulinemia|waldenstrom macroglobulinemia
866888|NCT00036790|stage III multiple myeloma|stage iii multiple myeloma
866889|NCT00036790|stage III chronic lymphocytic leukemia|stage iii chronic lymphocytic leukemia
866890|NCT00036790|stage IV chronic lymphocytic leukemia|stage iv chronic lymphocytic leukemia
866891|NCT00036790|recurrent adult acute myeloid leukemia|recurrent adult acute myeloid leukemia
866892|NCT00036790|recurrent adult acute lymphoblastic leukemia|recurrent adult acute lymphoblastic leukemia
866893|NCT00036790|relapsing chronic myelogenous leukemia|relapsing chronic myelogenous leukemia
866894|NCT00036790|refractory chronic lymphocytic leukemia|refractory chronic lymphocytic leukemia
866895|NCT00036790|small intestine lymphoma|small intestine lymphoma
866896|NCT00036790|unspecified adult solid tumor, protocol specific|unspecified adult solid tumor, protocol specific
866897|NCT00036790|chronic phase chronic myelogenous leukemia|chronic phase chronic myelogenous leukemia
867094|NCT00033436|stage I bladder cancer|stage i bladder cancer
866898|NCT00036790|accelerated phase chronic myelogenous leukemia|accelerated phase chronic myelogenous leukemia
866899|NCT00036790|blastic phase chronic myelogenous leukemia|blastic phase chronic myelogenous leukemia
866900|NCT00036790|meningeal chronic myelogenous leukemia|meningeal chronic myelogenous leukemia
866901|NCT00036790|untreated adult acute lymphoblastic leukemia|untreated adult acute lymphoblastic leukemia
866902|NCT00036790|untreated adult acute myeloid leukemia|untreated adult acute myeloid leukemia
866903|NCT00036790|refractory hairy cell leukemia|refractory hairy cell leukemia
866904|NCT00036790|chronic myelomonocytic leukemia|chronic myelomonocytic leukemia
866905|NCT00036790|T-cell large granular lymphocyte leukemia|t-cell large granular lymphocyte leukemia
866906|NCT00036790|acute undifferentiated leukemia|acute undifferentiated leukemia
866907|NCT00036790|stage III grade 1 follicular lymphoma|stage iii grade 1 follicular lymphoma
866908|NCT00036790|stage III grade 2 follicular lymphoma|stage iii grade 2 follicular lymphoma
866909|NCT00036790|stage III grade 3 follicular lymphoma|stage iii grade 3 follicular lymphoma
866910|NCT00036790|stage III adult diffuse small cleaved cell lymphoma|stage iii adult diffuse small cleaved cell lymphoma
866911|NCT00036790|stage III adult diffuse mixed cell lymphoma|stage iii adult diffuse mixed cell lymphoma
866912|NCT00036790|stage III adult diffuse large cell lymphoma|stage iii adult diffuse large cell lymphoma
866913|NCT00036790|stage III adult immunoblastic large cell lymphoma|stage iii adult immunoblastic large cell lymphoma
866914|NCT00036790|stage III adult lymphoblastic lymphoma|stage iii adult lymphoblastic lymphoma
866915|NCT00036790|stage III adult Burkitt lymphoma|stage iii adult burkitt lymphoma
866916|NCT00036790|stage IV grade 1 follicular lymphoma|stage iv grade 1 follicular lymphoma
866917|NCT00036790|stage IV grade 2 follicular lymphoma|stage iv grade 2 follicular lymphoma
866918|NCT00036790|stage IV grade 3 follicular lymphoma|stage iv grade 3 follicular lymphoma
866919|NCT00036790|stage IV adult diffuse small cleaved cell lymphoma|stage iv adult diffuse small cleaved cell lymphoma
866920|NCT00036790|stage IV adult diffuse mixed cell lymphoma|stage iv adult diffuse mixed cell lymphoma
866921|NCT00036790|stage IV adult diffuse large cell lymphoma|stage iv adult diffuse large cell lymphoma
866922|NCT00036790|stage IV adult immunoblastic large cell lymphoma|stage iv adult immunoblastic large cell lymphoma
866923|NCT00036790|stage IV adult lymphoblastic lymphoma|stage iv adult lymphoblastic lymphoma
866924|NCT00036790|stage IV adult Burkitt lymphoma|stage iv adult burkitt lymphoma
866925|NCT00036790|recurrent grade 1 follicular lymphoma|recurrent grade 1 follicular lymphoma
888710|NCT00000846|HIV-1|hiv-1
866926|NCT00036790|recurrent grade 2 follicular lymphoma|recurrent grade 2 follicular lymphoma
866927|NCT00036790|recurrent grade 3 follicular lymphoma|recurrent grade 3 follicular lymphoma
866928|NCT00036790|recurrent adult diffuse small cleaved cell lymphoma|recurrent adult diffuse small cleaved cell lymphoma
866929|NCT00036790|recurrent adult diffuse mixed cell lymphoma|recurrent adult diffuse mixed cell lymphoma
866930|NCT00036790|recurrent adult diffuse large cell lymphoma|recurrent adult diffuse large cell lymphoma
866931|NCT00036790|recurrent adult immunoblastic large cell lymphoma|recurrent adult immunoblastic large cell lymphoma
866932|NCT00036790|recurrent adult lymphoblastic lymphoma|recurrent adult lymphoblastic lymphoma
866933|NCT00036790|recurrent adult Burkitt lymphoma|recurrent adult burkitt lymphoma
866934|NCT00036790|stage III adult T-cell leukemia/lymphoma|stage iii adult t-cell leukemia/lymphoma
866935|NCT00036790|stage IV adult T-cell leukemia/lymphoma|stage iv adult t-cell leukemia/lymphoma
866936|NCT00036790|recurrent adult T-cell leukemia/lymphoma|recurrent adult t-cell leukemia/lymphoma
866937|NCT00036790|secondary acute myeloid leukemia|secondary acute myeloid leukemia
866938|NCT00036790|prolymphocytic leukemia|prolymphocytic leukemia
866939|NCT00036790|stage III mantle cell lymphoma|stage iii mantle cell lymphoma
866940|NCT00036790|stage IV mantle cell lymphoma|stage iv mantle cell lymphoma
866941|NCT00036790|recurrent mantle cell lymphoma|recurrent mantle cell lymphoma
866942|NCT00036790|angioimmunoblastic T-cell lymphoma|angioimmunoblastic t-cell lymphoma
866943|NCT00036790|anaplastic large cell lymphoma|anaplastic large cell lymphoma
866944|NCT00036790|stage III mycosis fungoides/Sezary syndrome|stage iii mycosis fungoides/sezary syndrome
866945|NCT00036790|stage IV mycosis fungoides/Sezary syndrome|stage iv mycosis fungoides/sezary syndrome
866946|NCT00036790|recurrent mycosis fungoides/Sezary syndrome|recurrent mycosis fungoides/sezary syndrome
866947|NCT00036790|chronic eosinophilic leukemia|chronic eosinophilic leukemia
866948|NCT00036790|chronic neutrophilic leukemia|chronic neutrophilic leukemia
866949|NCT00036790|recurrent non-small cell lung cancer|recurrent non-small cell lung cancer
866950|NCT00036790|recurrent small cell lung cancer|recurrent small cell lung cancer
866951|NCT00036790|stage IIIA non-small cell lung cancer|stage iiia non-small cell lung cancer
866952|NCT00036790|stage IIIB non-small cell lung cancer|stage iiib non-small cell lung cancer
866953|NCT00036790|stage IV non-small cell lung cancer|stage iv non-small cell lung cancer
866954|NCT00036790|extensive stage small cell lung cancer|extensive stage small cell lung cancer
866955|NCT00036790|limited stage small cell lung cancer|limited stage small cell lung cancer
866956|NCT00036790|recurrent breast cancer|recurrent breast cancer
866957|NCT00036790|stage IIIA breast cancer|stage iiia breast cancer
866958|NCT00036790|stage IIIB breast cancer|stage iiib breast cancer
866959|NCT00036790|stage IIIC breast cancer|stage iiic breast cancer
866960|NCT00036790|stage IV breast cancer|stage iv breast cancer
866961|NCT00036790|recurrent colon cancer|recurrent colon cancer
866962|NCT00036790|stage III colon cancer|stage iii colon cancer
866963|NCT00036790|stage IV colon cancer|stage iv colon cancer
866964|NCT00036790|recurrent prostate cancer|recurrent prostate cancer
866965|NCT00036790|stage III prostate cancer|stage iii prostate cancer
866966|NCT00036790|stage IV prostate cancer|stage iv prostate cancer
866967|NCT00036790|recurrent lip and oral cavity cancer|recurrent lip and oral cavity cancer
866968|NCT00036790|stage III lip and oral cavity cancer|stage iii lip and oral cavity cancer
866969|NCT00036790|stage IV lip and oral cavity cancer|stage iv lip and oral cavity cancer
866970|NCT00036790|recurrent paranasal sinus and nasal cavity cancer|recurrent paranasal sinus and nasal cavity cancer
866971|NCT00036790|stage III paranasal sinus and nasal cavity cancer|stage iii paranasal sinus and nasal cavity cancer
866972|NCT00036790|stage IV paranasal sinus and nasal cavity cancer|stage iv paranasal sinus and nasal cavity cancer
866973|NCT00036790|recurrent metastatic squamous neck cancer with occult primary|recurrent metastatic squamous neck cancer with occult primary
866974|NCT00036790|recurrent hypopharyngeal cancer|recurrent hypopharyngeal cancer
866975|NCT00036790|stage III hypopharyngeal cancer|stage iii hypopharyngeal cancer
866976|NCT00036790|stage IV hypopharyngeal cancer|stage iv hypopharyngeal cancer
866977|NCT00036790|recurrent laryngeal cancer|recurrent laryngeal cancer
866978|NCT00036790|stage III laryngeal cancer|stage iii laryngeal cancer
866979|NCT00036790|stage IV laryngeal cancer|stage iv laryngeal cancer
866980|NCT00036790|recurrent oropharyngeal cancer|recurrent oropharyngeal cancer
866981|NCT00036790|stage III oropharyngeal cancer|stage iii oropharyngeal cancer
866982|NCT00036790|stage IV oropharyngeal cancer|stage iv oropharyngeal cancer
866983|NCT00036790|recurrent nasopharyngeal cancer|recurrent nasopharyngeal cancer
866984|NCT00036790|stage III nasopharyngeal cancer|stage iii nasopharyngeal cancer
866985|NCT00036790|stage IV nasopharyngeal cancer|stage iv nasopharyngeal cancer
866986|NCT00036790|atypical chronic myeloid leukemia|atypical chronic myeloid leukemia
866987|NCT00036790|myelodysplastic/myeloproliferative disease, unclassifiable|myelodysplastic/myeloproliferative disease, unclassifiable
866988|NCT00036790|recurrent marginal zone lymphoma|recurrent marginal zone lymphoma
866989|NCT00036790|recurrent small lymphocytic lymphoma|recurrent small lymphocytic lymphoma
866990|NCT00036790|stage III small lymphocytic lymphoma|stage iii small lymphocytic lymphoma
866991|NCT00036790|stage III marginal zone lymphoma|stage iii marginal zone lymphoma
866992|NCT00036790|stage IV small lymphocytic lymphoma|stage iv small lymphocytic lymphoma
866993|NCT00036790|stage IV marginal zone lymphoma|stage iv marginal zone lymphoma
867095|NCT00033436|stage II bladder cancer|stage ii bladder cancer
867141|NCT00032162|stage IVA cervical cancer|stage iva cervical cancer
866994|NCT00036790|extranodal marginal zone B-cell lymphoma of mucosa-associated lymphoid tissue|extranodal marginal zone b-cell lymphoma of mucosa-associated lymphoid tissue
866995|NCT00036790|nodal marginal zone B-cell lymphoma|nodal marginal zone b-cell lymphoma
866996|NCT00036790|splenic marginal zone lymphoma|splenic marginal zone lymphoma
866997|NCT00036790|adult acute myeloid leukemia with t(8;21)(q22;q22)|adult acute myeloid leukemia with t(8;21)(q22;q22)
866998|NCT00036790|adult acute myeloid leukemia with t(16;16)(p13;q22)|adult acute myeloid leukemia with t(16;16)(p13;q22)
866999|NCT00036790|adult acute myeloid leukemia with inv(16)(p13;q22)|adult acute myeloid leukemia with inv(16)(p13;q22)
867000|NCT00036790|adult acute myeloid leukemia with 11q23 (MLL) abnormalities|adult acute myeloid leukemia with 11q23 (mll) abnormalities
867001|NCT00036790|adult acute myeloid leukemia with t(15;17)(q22;q12)|adult acute myeloid leukemia with t(15;17)(q22;q12)
867002|NCT00036712|recurrent childhood acute lymphoblastic leukemia|recurrent childhood acute lymphoblastic leukemia
867003|NCT00036712|refractory multiple myeloma|refractory multiple myeloma
867004|NCT00036712|recurrent childhood rhabdomyosarcoma|recurrent childhood rhabdomyosarcoma
867005|NCT00036712|disseminated neuroblastoma|disseminated neuroblastoma
867006|NCT00036712|recurrent neuroblastoma|recurrent neuroblastoma
867007|NCT00036712|recurrent Wilms tumor and other childhood kidney tumors|recurrent wilms tumor and other childhood kidney tumors
867008|NCT00036712|recurrent childhood lymphoblastic lymphoma|recurrent childhood lymphoblastic lymphoma
867009|NCT00036712|stage III chronic lymphocytic leukemia|stage iii chronic lymphocytic leukemia
867010|NCT00036712|stage IV chronic lymphocytic leukemia|stage iv chronic lymphocytic leukemia
867011|NCT00036712|recurrent childhood acute myeloid leukemia|recurrent childhood acute myeloid leukemia
867012|NCT00036712|relapsing chronic myelogenous leukemia|relapsing chronic myelogenous leukemia
867013|NCT00036712|refractory chronic lymphocytic leukemia|refractory chronic lymphocytic leukemia
867014|NCT00036712|chronic phase chronic myelogenous leukemia|chronic phase chronic myelogenous leukemia
867015|NCT00036712|accelerated phase chronic myelogenous leukemia|accelerated phase chronic myelogenous leukemia
867016|NCT00036712|blastic phase chronic myelogenous leukemia|blastic phase chronic myelogenous leukemia
867017|NCT00036712|primary myelofibrosis|primary myelofibrosis
867018|NCT00036712|childhood acute promyelocytic leukemia (M3)|childhood acute promyelocytic leukemia (m3)
867019|NCT00036712|refractory hairy cell leukemia|refractory hairy cell leukemia
867020|NCT00036712|oral complications|oral complications
867021|NCT00036712|recurrent/refractory childhood Hodgkin lymphoma|recurrent/refractory childhood hodgkin lymphoma
867022|NCT00036712|de novo myelodysplastic syndromes|de novo myelodysplastic syndromes
867023|NCT00036712|previously treated myelodysplastic syndromes|previously treated myelodysplastic syndromes
867024|NCT00036712|secondary myelodysplastic syndromes|secondary myelodysplastic syndromes
867025|NCT00036712|pain|pain
867026|NCT00036712|recurrent childhood small noncleaved cell lymphoma|recurrent childhood small noncleaved cell lymphoma
867027|NCT00036712|recurrent childhood large cell lymphoma|recurrent childhood large cell lymphoma
867028|NCT00036712|previously treated childhood rhabdomyosarcoma|previously treated childhood rhabdomyosarcoma
867029|NCT00036712|childhood malignant ovarian germ cell tumor|childhood malignant ovarian germ cell tumor
867030|NCT00036712|childhood chronic myelogenous leukemia|childhood chronic myelogenous leukemia
867031|NCT00036712|atypical chronic myeloid leukemia, BCR-ABL1 negative|atypical chronic myeloid leukemia, bcr-abl1 negative
867032|NCT00036712|myelodysplastic/myeloproliferative neoplasm, unclassifiable|myelodysplastic/myeloproliferative neoplasm, unclassifiable
867033|NCT00036712|childhood myelodysplastic syndromes|childhood myelodysplastic syndromes
867034|NCT00036686|stage I breast cancer|stage i breast cancer
867035|NCT00036686|stage II breast cancer|stage ii breast cancer
867036|NCT00036686|stage IIIA breast cancer|stage iiia breast cancer
867037|NCT00036686|stage IIIB breast cancer|stage iiib breast cancer
867038|NCT00036686|stage IIIC breast cancer|stage iiic breast cancer
867039|NCT00036686|recurrent breast cancer|recurrent breast cancer
867040|NCT00036686|stage IV breast cancer|stage iv breast cancer
867041|NCT00033748|stage IV colon cancer|stage iv colon cancer
867042|NCT00033748|stage IV rectal cancer|stage iv rectal cancer
867043|NCT00033748|recurrent colon cancer|recurrent colon cancer
867044|NCT00033748|recurrent rectal cancer|recurrent rectal cancer
867045|NCT00033748|liver metastases|liver metastases
867046|NCT00033709|adult leiomyosarcoma|adult leiomyosarcoma
867047|NCT00033709|stage III adult soft tissue sarcoma|stage iii adult soft tissue sarcoma
867048|NCT00033709|recurrent adult soft tissue sarcoma|recurrent adult soft tissue sarcoma
867049|NCT00033709|stage III uterine sarcoma|stage iii uterine sarcoma
867050|NCT00033709|stage IV uterine sarcoma|stage iv uterine sarcoma
867051|NCT00033709|recurrent uterine sarcoma|recurrent uterine sarcoma
867052|NCT00033709|uterine leiomyosarcoma|uterine leiomyosarcoma
867053|NCT00033709|stage IV adult soft tissue sarcoma|stage iv adult soft tissue sarcoma
867054|NCT00033696|limited stage small cell lung cancer|limited stage small cell lung cancer
867055|NCT00033683|stage I breast cancer|stage i breast cancer
867056|NCT00033683|stage II breast cancer|stage ii breast cancer
867057|NCT00033657|stage I gastric cancer|stage i gastric cancer
867058|NCT00033657|stage II gastric cancer|stage ii gastric cancer
867059|NCT00033657|stage III gastric cancer|stage iii gastric cancer
867060|NCT00033657|stage IV gastric cancer|stage iv gastric cancer
867061|NCT00033657|stage I esophageal cancer|stage i esophageal cancer
867062|NCT00033657|stage II esophageal cancer|stage ii esophageal cancer
867063|NCT00033657|stage III esophageal cancer|stage iii esophageal cancer
888895|NCT00000813|Avipoxvirus|avipoxvirus
867065|NCT00033657|adenocarcinoma of the stomach|adenocarcinoma of the stomach
867066|NCT00033657|adenocarcinoma of the esophagus|adenocarcinoma of the esophagus
867067|NCT00033644|stage IV uterine sarcoma|stage iv uterine sarcoma
867068|NCT00033644|recurrent uterine sarcoma|recurrent uterine sarcoma
867069|NCT00033644|uterine leiomyosarcoma|uterine leiomyosarcoma
867070|NCT00033631|adenocarcinoma of the prostate|adenocarcinoma of the prostate
867071|NCT00033631|stage IIB prostate cancer|stage iib prostate cancer
867072|NCT00033631|stage IIA prostate cancer|stage iia prostate cancer
867073|NCT00033566|unspecified adult solid tumor, protocol specific|unspecified adult solid tumor, protocol specific
867074|NCT00033553|squamous cell lung cancer|squamous cell lung cancer
867075|NCT00033553|large cell lung cancer|large cell lung cancer
867076|NCT00033553|stage IIIA non-small cell lung cancer|stage iiia non-small cell lung cancer
867077|NCT00033553|stage IIIB non-small cell lung cancer|stage iiib non-small cell lung cancer
867078|NCT00033553|adenocarcinoma of the lung|adenocarcinoma of the lung
867079|NCT00033553|bronchoalveolar cell lung cancer|bronchoalveolar cell lung cancer
867080|NCT00033540|unresectable gallbladder cancer|unresectable gallbladder cancer
867081|NCT00033540|recurrent gallbladder cancer|recurrent gallbladder cancer
867082|NCT00033540|unresectable extrahepatic bile duct cancer|unresectable extrahepatic bile duct cancer
867083|NCT00033540|recurrent extrahepatic bile duct cancer|recurrent extrahepatic bile duct cancer
867084|NCT00033540|adenocarcinoma of the gallbladder|adenocarcinoma of the gallbladder
867085|NCT00033540|adenocarcinoma with squamous metaplasia of the gallbladder|adenocarcinoma with squamous metaplasia of the gallbladder
867086|NCT00033540|squamous cell carcinoma of the gallbladder|squamous cell carcinoma of the gallbladder
867087|NCT00033540|adenocarcinoma of the extrahepatic bile duct|adenocarcinoma of the extrahepatic bile duct
867088|NCT00033540|cholangiocarcinoma of the gallbladder|cholangiocarcinoma of the gallbladder
867089|NCT00033540|cholangiocarcinoma of the extrahepatic bile duct|cholangiocarcinoma of the extrahepatic bile duct
867090|NCT00033514|stage IV breast cancer|stage iv breast cancer
867091|NCT00033514|recurrent breast cancer|recurrent breast cancer
867092|NCT00033488|ovarian epithelial cancer|ovarian epithelial cancer
867093|NCT00033475|post-transplant lymphoproliferative disorder|post-transplant lymphoproliferative disorder
867096|NCT00033436|stage III bladder cancer|stage iii bladder cancer
867097|NCT00033436|transitional cell carcinoma of the bladder|transitional cell carcinoma of the bladder
867098|NCT00033423|recurrent grade 1 follicular lymphoma|recurrent grade 1 follicular lymphoma
867099|NCT00033423|recurrent grade 2 follicular lymphoma|recurrent grade 2 follicular lymphoma
867100|NCT00033423|recurrent grade 3 follicular lymphoma|recurrent grade 3 follicular lymphoma
867101|NCT00033423|recurrent marginal zone lymphoma|recurrent marginal zone lymphoma
867102|NCT00033423|recurrent small lymphocytic lymphoma|recurrent small lymphocytic lymphoma
867103|NCT00033423|extranodal marginal zone B-cell lymphoma of mucosa-associated lymphoid tissue|extranodal marginal zone b-cell lymphoma of mucosa-associated lymphoid tissue
867104|NCT00033423|nodal marginal zone B-cell lymphoma|nodal marginal zone b-cell lymphoma
867105|NCT00033423|splenic marginal zone lymphoma|splenic marginal zone lymphoma
867106|NCT00033410|stage II non-small cell lung cancer|stage ii non-small cell lung cancer
867107|NCT00033410|squamous cell lung cancer|squamous cell lung cancer
867108|NCT00033410|large cell lung cancer|large cell lung cancer
867109|NCT00033410|stage IIIA non-small cell lung cancer|stage iiia non-small cell lung cancer
867110|NCT00033410|stage IIIB non-small cell lung cancer|stage iiib non-small cell lung cancer
867111|NCT00033410|adenocarcinoma of the lung|adenocarcinoma of the lung
867112|NCT00033397|stage II breast cancer|stage ii breast cancer
867113|NCT00033397|stage IV breast cancer|stage iv breast cancer
867114|NCT00033397|stage IIIA breast cancer|stage iiia breast cancer
867115|NCT00033397|stage IIIB breast cancer|stage iiib breast cancer
867116|NCT00033397|stage IIIC breast cancer|stage iiic breast cancer
867117|NCT00033397|inflammatory breast cancer|inflammatory breast cancer
867118|NCT00033345|breast cancer|breast cancer
867119|NCT00033332|stage I multiple myeloma|stage i multiple myeloma
867120|NCT00033332|stage II multiple myeloma|stage ii multiple myeloma
867121|NCT00033332|stage III multiple myeloma|stage iii multiple myeloma
867122|NCT00033280|adult anaplastic oligodendroglioma|adult anaplastic oligodendroglioma
867123|NCT00033280|adult mixed glioma|adult mixed glioma
867124|NCT00033241|stage II pancreatic cancer|stage ii pancreatic cancer
867125|NCT00033241|stage III pancreatic cancer|stage iii pancreatic cancer
867126|NCT00033241|recurrent pancreatic cancer|recurrent pancreatic cancer
867127|NCT00033241|unspecified adult solid tumor, protocol specific|unspecified adult solid tumor, protocol specific
867128|NCT00033241|stage IV pancreatic cancer|stage iv pancreatic cancer
867129|NCT00033228|stage IV melanoma|stage iv melanoma
867130|NCT00033228|recurrent melanoma|recurrent melanoma
867131|NCT00032175|stage III pancreatic cancer|stage iii pancreatic cancer
867132|NCT00032175|duct cell adenocarcinoma of the pancreas|duct cell adenocarcinoma of the pancreas
867133|NCT00032175|stage IV pancreatic cancer|stage iv pancreatic cancer
867134|NCT00032162|stage III cervical cancer|stage iii cervical cancer
867135|NCT00032162|recurrent cervical cancer|recurrent cervical cancer
867136|NCT00032162|stage IB cervical cancer|stage ib cervical cancer
867137|NCT00032162|stage IIB cervical cancer|stage iib cervical cancer
867138|NCT00032162|stage IVB cervical cancer|stage ivb cervical cancer
867139|NCT00032162|stage IA cervical cancer|stage ia cervical cancer
890198|NCT00022893|Tositumomab|tositumomab
867142|NCT00032162|stage I endometrial carcinoma|stage i endometrial carcinoma
867143|NCT00032162|stage II endometrial carcinoma|stage ii endometrial carcinoma
867144|NCT00032162|stage III endometrial carcinoma|stage iii endometrial carcinoma
867145|NCT00032162|stage IV endometrial carcinoma|stage iv endometrial carcinoma
867146|NCT00032162|recurrent endometrial carcinoma|recurrent endometrial carcinoma
867147|NCT00032162|fallopian tube cancer|fallopian tube cancer
867148|NCT00032162|stage I uterine sarcoma|stage i uterine sarcoma
867149|NCT00032162|stage II uterine sarcoma|stage ii uterine sarcoma
867150|NCT00032162|stage III uterine sarcoma|stage iii uterine sarcoma
867151|NCT00032162|stage IV uterine sarcoma|stage iv uterine sarcoma
867152|NCT00032162|recurrent uterine sarcoma|recurrent uterine sarcoma
867153|NCT00032162|ovarian sarcoma|ovarian sarcoma
867154|NCT00032162|ovarian carcinosarcoma|ovarian carcinosarcoma
867155|NCT00032149|AIDS-related peripheral/systemic lymphoma|aids-related peripheral/systemic lymphoma
867156|NCT00032149|AIDS-related primary CNS lymphoma|aids-related primary cns lymphoma
867157|NCT00032149|AIDS-related diffuse large cell lymphoma|aids-related diffuse large cell lymphoma
867158|NCT00032149|AIDS-related immunoblastic large cell lymphoma|aids-related immunoblastic large cell lymphoma
867159|NCT00032149|AIDS-related small noncleaved cell lymphoma|aids-related small noncleaved cell lymphoma
867160|NCT00032149|AIDS-related diffuse mixed cell lymphoma|aids-related diffuse mixed cell lymphoma
867161|NCT00032149|AIDS-related diffuse small cleaved cell lymphoma|aids-related diffuse small cleaved cell lymphoma
867162|NCT00032149|AIDS-related lymphoblastic lymphoma|aids-related lymphoblastic lymphoma
867163|NCT00032136|stage I breast cancer|stage i breast cancer
867164|NCT00032136|stage II breast cancer|stage ii breast cancer
867165|NCT00032123|stage IV gastric cancer|stage iv gastric cancer
867166|NCT00032123|stage IV esophageal cancer|stage iv esophageal cancer
867167|NCT00032123|adenocarcinoma of the stomach|adenocarcinoma of the stomach
867168|NCT00032123|adenocarcinoma of the esophagus|adenocarcinoma of the esophagus
867169|NCT00032123|recurrent esophageal cancer|recurrent esophageal cancer
867170|NCT00032123|recurrent gastric cancer|recurrent gastric cancer
867171|NCT00032097|adult glioblastoma|adult glioblastoma
867172|NCT00032097|adult giant cell glioblastoma|adult giant cell glioblastoma
867173|NCT00032097|adult gliosarcoma|adult gliosarcoma
867174|NCT00032084|non-small cell lung cancer|non-small cell lung cancer
867175|NCT00032084|stage I non-small cell lung cancer|stage i non-small cell lung cancer
867176|NCT00032084|stage II non-small cell lung cancer|stage ii non-small cell lung cancer
867177|NCT00032058|adenocarcinoma of the prostate|adenocarcinoma of the prostate
867178|NCT00032058|stage I prostate cancer|stage i prostate cancer
867179|NCT00032058|stage IIB prostate cancer|stage iib prostate cancer
867180|NCT00032058|stage IIA prostate cancer|stage iia prostate cancer
867181|NCT00032045|iris melanoma|iris melanoma
867182|NCT00032045|ciliary body and choroid melanoma, small size|ciliary body and choroid melanoma, small size
867183|NCT00032045|ciliary body and choroid melanoma, medium/large size|ciliary body and choroid melanoma, medium/large size
867184|NCT00032045|extraocular extension melanoma|extraocular extension melanoma
867185|NCT00032045|recurrent intraocular melanoma|recurrent intraocular melanoma
867186|NCT00032045|stage IV melanoma|stage iv melanoma
867187|NCT00032045|recurrent melanoma|recurrent melanoma
867188|NCT00032032|stage I non-small cell lung cancer|stage i non-small cell lung cancer
867189|NCT00032032|stage II non-small cell lung cancer|stage ii non-small cell lung cancer
867190|NCT00032032|stage IIIA non-small cell lung cancer|stage iiia non-small cell lung cancer
867191|NCT00032032|stage IIIB non-small cell lung cancer|stage iiib non-small cell lung cancer
867192|NCT00032019|stage III adult diffuse large cell lymphoma|stage iii adult diffuse large cell lymphoma
867193|NCT00032019|stage III adult immunoblastic large cell lymphoma|stage iii adult immunoblastic large cell lymphoma
867194|NCT00032019|stage IV adult diffuse large cell lymphoma|stage iv adult diffuse large cell lymphoma
867195|NCT00032019|stage IV adult immunoblastic large cell lymphoma|stage iv adult immunoblastic large cell lymphoma
867196|NCT00032019|contiguous stage II adult immunoblastic large cell lymphoma|contiguous stage ii adult immunoblastic large cell lymphoma
867197|NCT00032019|contiguous stage II adult diffuse large cell lymphoma|contiguous stage ii adult diffuse large cell lymphoma
867296|NCT00031798|depression|depression
867198|NCT00032019|noncontiguous stage II adult immunoblastic large cell lymphoma|noncontiguous stage ii adult immunoblastic large cell lymphoma
867199|NCT00032019|noncontiguous stage II adult diffuse large cell lymphoma|noncontiguous stage ii adult diffuse large cell lymphoma
867200|NCT00032006|adenocarcinoma of the prostate|adenocarcinoma of the prostate
867201|NCT00032006|stage I prostate cancer|stage i prostate cancer
867202|NCT00032006|stage IIB prostate cancer|stage iib prostate cancer
867203|NCT00032006|stage IIA prostate cancer|stage iia prostate cancer
867204|NCT00032006|recurrent prostate cancer|recurrent prostate cancer
867205|NCT00031980|stage I chronic lymphocytic leukemia|stage i chronic lymphocytic leukemia
867206|NCT00031980|stage II chronic lymphocytic leukemia|stage ii chronic lymphocytic leukemia
867207|NCT00031980|stage III chronic lymphocytic leukemia|stage iii chronic lymphocytic leukemia
867208|NCT00031980|stage IV chronic lymphocytic leukemia|stage iv chronic lymphocytic leukemia
867209|NCT00031980|T-cell large granular lymphocyte leukemia|t-cell large granular lymphocyte leukemia
867210|NCT00031980|anemia|anemia
867211|NCT00031980|neutropenia|neutropenia
867212|NCT00031980|thrombocytopenia|thrombocytopenia
867213|NCT00031967|unspecified adult solid tumor, protocol specific|unspecified adult solid tumor, protocol specific
867214|NCT00031967|tumors metastatic to brain|tumors metastatic to brain
867215|NCT00031967|radiation toxicity|radiation toxicity
867216|NCT00031941|stage IV adult Hodgkin lymphoma|stage iv adult hodgkin lymphoma
867217|NCT00031941|recurrent adult Hodgkin lymphoma|recurrent adult hodgkin lymphoma
867218|NCT00031941|stage IV cutaneous T-cell non-Hodgkin lymphoma|stage iv cutaneous t-cell non-hodgkin lymphoma
867219|NCT00031941|recurrent cutaneous T-cell non-Hodgkin lymphoma|recurrent cutaneous t-cell non-hodgkin lymphoma
867220|NCT00031941|unspecified adult solid tumor, protocol specific|unspecified adult solid tumor, protocol specific
867221|NCT00031941|stage IV grade 1 follicular lymphoma|stage iv grade 1 follicular lymphoma
867222|NCT00031941|stage IV grade 2 follicular lymphoma|stage iv grade 2 follicular lymphoma
867223|NCT00031941|stage IV grade 3 follicular lymphoma|stage iv grade 3 follicular lymphoma
867224|NCT00031941|stage IV adult diffuse small cleaved cell lymphoma|stage iv adult diffuse small cleaved cell lymphoma
867225|NCT00031941|stage IV adult diffuse mixed cell lymphoma|stage iv adult diffuse mixed cell lymphoma
867226|NCT00031941|stage IV adult diffuse large cell lymphoma|stage iv adult diffuse large cell lymphoma
867227|NCT00031941|stage IV adult immunoblastic large cell lymphoma|stage iv adult immunoblastic large cell lymphoma
867228|NCT00031941|stage IV adult lymphoblastic lymphoma|stage iv adult lymphoblastic lymphoma
867229|NCT00031941|stage IV adult Burkitt lymphoma|stage iv adult burkitt lymphoma
867230|NCT00031941|recurrent grade 1 follicular lymphoma|recurrent grade 1 follicular lymphoma
867231|NCT00031941|recurrent grade 2 follicular lymphoma|recurrent grade 2 follicular lymphoma
867232|NCT00031941|recurrent grade 3 follicular lymphoma|recurrent grade 3 follicular lymphoma
867233|NCT00031941|recurrent adult diffuse small cleaved cell lymphoma|recurrent adult diffuse small cleaved cell lymphoma
867234|NCT00031941|recurrent adult diffuse mixed cell lymphoma|recurrent adult diffuse mixed cell lymphoma
867235|NCT00031941|recurrent adult diffuse large cell lymphoma|recurrent adult diffuse large cell lymphoma
867236|NCT00031941|recurrent adult immunoblastic large cell lymphoma|recurrent adult immunoblastic large cell lymphoma
867237|NCT00031941|recurrent adult lymphoblastic lymphoma|recurrent adult lymphoblastic lymphoma
867238|NCT00031941|recurrent adult Burkitt lymphoma|recurrent adult burkitt lymphoma
867239|NCT00031941|stage IV adult T-cell leukemia/lymphoma|stage iv adult t-cell leukemia/lymphoma
867240|NCT00031941|recurrent adult T-cell leukemia/lymphoma|recurrent adult t-cell leukemia/lymphoma
867241|NCT00031941|stage IV mantle cell lymphoma|stage iv mantle cell lymphoma
867242|NCT00031941|recurrent mantle cell lymphoma|recurrent mantle cell lymphoma
867243|NCT00031941|angioimmunoblastic T-cell lymphoma|angioimmunoblastic t-cell lymphoma
867244|NCT00031941|anaplastic large cell lymphoma|anaplastic large cell lymphoma
867245|NCT00031941|recurrent mycosis fungoides/Sezary syndrome|recurrent mycosis fungoides/sezary syndrome
867246|NCT00031941|stage IV mycosis fungoides/Sezary syndrome|stage iv mycosis fungoides/sezary syndrome
867247|NCT00031941|small intestine lymphoma|small intestine lymphoma
867248|NCT00031941|recurrent marginal zone lymphoma|recurrent marginal zone lymphoma
867249|NCT00031941|recurrent small lymphocytic lymphoma|recurrent small lymphocytic lymphoma
867250|NCT00031941|stage IV small lymphocytic lymphoma|stage iv small lymphocytic lymphoma
867251|NCT00031941|stage IV marginal zone lymphoma|stage iv marginal zone lymphoma
867252|NCT00031941|extranodal marginal zone B-cell lymphoma of mucosa-associated lymphoid tissue|extranodal marginal zone b-cell lymphoma of mucosa-associated lymphoid tissue
867253|NCT00031941|nodal marginal zone B-cell lymphoma|nodal marginal zone b-cell lymphoma
867254|NCT00031941|splenic marginal zone lymphoma|splenic marginal zone lymphoma
867255|NCT00031928|leptomeningeal metastases|leptomeningeal metastases
867256|NCT00031915|metastatic osteosarcoma|metastatic osteosarcoma
867257|NCT00031915|recurrent childhood rhabdomyosarcoma|recurrent childhood rhabdomyosarcoma
867258|NCT00031915|recurrent osteosarcoma|recurrent osteosarcoma
867259|NCT00031915|embryonal childhood rhabdomyosarcoma|embryonal childhood rhabdomyosarcoma
867260|NCT00031915|alveolar childhood rhabdomyosarcoma|alveolar childhood rhabdomyosarcoma
867261|NCT00031915|pleomorphic childhood rhabdomyosarcoma|pleomorphic childhood rhabdomyosarcoma
867262|NCT00031915|metastatic childhood soft tissue sarcoma|metastatic childhood soft tissue sarcoma
867263|NCT00031915|recurrent childhood soft tissue sarcoma|recurrent childhood soft tissue sarcoma
867264|NCT00031915|childhood fibrosarcoma|childhood fibrosarcoma
867265|NCT00031915|childhood synovial sarcoma|childhood synovial sarcoma
867266|NCT00031915|childhood liposarcoma|childhood liposarcoma
867267|NCT00031915|childhood alveolar soft-part sarcoma|childhood alveolar soft-part sarcoma
867268|NCT00031915|childhood neurofibrosarcoma|childhood neurofibrosarcoma
867269|NCT00031915|childhood angiosarcoma|childhood angiosarcoma
867270|NCT00031915|childhood malignant fibrous histiocytoma of bone|childhood malignant fibrous histiocytoma of bone
867271|NCT00031915|previously treated childhood rhabdomyosarcoma|previously treated childhood rhabdomyosarcoma
867272|NCT00031915|metastatic Ewing sarcoma/peripheral primitive neuroectodermal tumor|metastatic ewing sarcoma/peripheral primitive neuroectodermal tumor
867273|NCT00031915|recurrent Ewing sarcoma/peripheral primitive neuroectodermal tumor|recurrent ewing sarcoma/peripheral primitive neuroectodermal tumor
867274|NCT00031915|fibrosarcomatous osteosarcoma|fibrosarcomatous osteosarcoma
867275|NCT00031902|AIDS-related peripheral/systemic lymphoma|aids-related peripheral/systemic lymphoma
867276|NCT00031902|AIDS-related diffuse large cell lymphoma|aids-related diffuse large cell lymphoma
867277|NCT00031902|AIDS-related immunoblastic large cell lymphoma|aids-related immunoblastic large cell lymphoma
867278|NCT00031902|AIDS-related small noncleaved cell lymphoma|aids-related small noncleaved cell lymphoma
867710|NCT00028015|recurrent colon cancer|recurrent colon cancer
867279|NCT00031902|AIDS-related diffuse mixed cell lymphoma|aids-related diffuse mixed cell lymphoma
867280|NCT00031902|AIDS-related diffuse small cleaved cell lymphoma|aids-related diffuse small cleaved cell lymphoma
867281|NCT00031902|AIDS-related lymphoblastic lymphoma|aids-related lymphoblastic lymphoma
867282|NCT00031876|stage IV breast cancer|stage iv breast cancer
867283|NCT00031876|recurrent breast cancer|recurrent breast cancer
867284|NCT00031863|stage II colon cancer|stage ii colon cancer
867285|NCT00031863|stage III colon cancer|stage iii colon cancer
867286|NCT00031863|stage II rectal cancer|stage ii rectal cancer
867287|NCT00031863|stage III rectal cancer|stage iii rectal cancer
867288|NCT00031850|breast cancer|breast cancer
867289|NCT00031837|thromboembolism|thromboembolism
867290|NCT00031837|stage III pancreatic cancer|stage iii pancreatic cancer
867291|NCT00031837|recurrent pancreatic cancer|recurrent pancreatic cancer
867292|NCT00031837|adenocarcinoma of the pancreas|adenocarcinoma of the pancreas
867293|NCT00031837|stage IV pancreatic cancer|stage iv pancreatic cancer
867294|NCT00031824|graft versus host disease|graft versus host disease
867295|NCT00031798|fatigue|fatigue
867298|NCT00031798|cognitive/functional effects|cognitive/functional effects
867299|NCT00031798|recurrent adult brain tumor|recurrent adult brain tumor
867300|NCT00031798|adult brain stem glioma|adult brain stem glioma
867301|NCT00031798|adult glioblastoma|adult glioblastoma
867302|NCT00031798|adult tumors metastatic to brain|adult tumors metastatic to brain
867303|NCT00031798|adult anaplastic astrocytoma|adult anaplastic astrocytoma
867304|NCT00031798|adult anaplastic oligodendroglioma|adult anaplastic oligodendroglioma
867305|NCT00031798|adult mixed glioma|adult mixed glioma
867306|NCT00031798|adult meningioma|adult meningioma
867307|NCT00031798|adult anaplastic ependymoma|adult anaplastic ependymoma
867308|NCT00031798|adult myxopapillary ependymoma|adult myxopapillary ependymoma
867309|NCT00031798|adult ependymoblastoma|adult ependymoblastoma
867310|NCT00031798|adult pilocytic astrocytoma|adult pilocytic astrocytoma
867311|NCT00031798|adult subependymoma|adult subependymoma
867312|NCT00031798|adult grade III meningioma|adult grade iii meningioma
867313|NCT00031798|adult giant cell glioblastoma|adult giant cell glioblastoma
867314|NCT00031798|adult gliosarcoma|adult gliosarcoma
867315|NCT00031798|adult grade II meningioma|adult grade ii meningioma
867316|NCT00031772|recurrent breast cancer|recurrent breast cancer
867317|NCT00031772|psychosocial effects of cancer and its treatment|psychosocial effects of cancer and its treatment
867318|NCT00031759|cervical cancer|cervical cancer
867319|NCT00031759|cervical intraepithelial neoplasia grade 1|cervical intraepithelial neoplasia grade 1
867320|NCT00031759|cervical intraepithelial neoplasia grade 2|cervical intraepithelial neoplasia grade 2
867321|NCT00031759|cervical intraepithelial neoplasia grade 3|cervical intraepithelial neoplasia grade 3
867322|NCT00031746|prostate cancer|prostate cancer
867323|NCT00031733|iris melanoma|iris melanoma
867324|NCT00031733|ciliary body and choroid melanoma, small size|ciliary body and choroid melanoma, small size
867325|NCT00031733|ciliary body and choroid melanoma, medium/large size|ciliary body and choroid melanoma, medium/large size
867326|NCT00031733|extraocular extension melanoma|extraocular extension melanoma
867327|NCT00031733|recurrent intraocular melanoma|recurrent intraocular melanoma
867328|NCT00031733|stage II melanoma|stage ii melanoma
867329|NCT00031733|stage III melanoma|stage iii melanoma
867330|NCT00031733|stage IV melanoma|stage iv melanoma
867331|NCT00031733|recurrent melanoma|recurrent melanoma
867332|NCT00031720|lobular breast carcinoma in situ|lobular breast carcinoma in situ
867333|NCT00031720|stage I breast cancer|stage i breast cancer
867334|NCT00031720|stage II breast cancer|stage ii breast cancer
867335|NCT00031720|stage IIIA breast cancer|stage iiia breast cancer
867336|NCT00031720|recurrent breast cancer|recurrent breast cancer
867337|NCT00031720|ductal breast carcinoma in situ|ductal breast carcinoma in situ
867338|NCT00031720|hot flashes|hot flashes
867339|NCT00031642|recurrent grade 1 follicular lymphoma|recurrent grade 1 follicular lymphoma
867340|NCT00031642|recurrent grade 2 follicular lymphoma|recurrent grade 2 follicular lymphoma
867341|NCT00031642|recurrent grade 3 follicular lymphoma|recurrent grade 3 follicular lymphoma
867342|NCT00031642|recurrent adult diffuse small cleaved cell lymphoma|recurrent adult diffuse small cleaved cell lymphoma
867343|NCT00031642|recurrent adult diffuse mixed cell lymphoma|recurrent adult diffuse mixed cell lymphoma
867344|NCT00031642|recurrent adult diffuse large cell lymphoma|recurrent adult diffuse large cell lymphoma
867345|NCT00031642|recurrent adult immunoblastic large cell lymphoma|recurrent adult immunoblastic large cell lymphoma
867346|NCT00031642|recurrent adult Burkitt lymphoma|recurrent adult burkitt lymphoma
867347|NCT00031642|recurrent mantle cell lymphoma|recurrent mantle cell lymphoma
867348|NCT00031642|recurrent marginal zone lymphoma|recurrent marginal zone lymphoma
867349|NCT00031642|recurrent small lymphocytic lymphoma|recurrent small lymphocytic lymphoma
867350|NCT00031642|extranodal marginal zone B-cell lymphoma of mucosa-associated lymphoid tissue|extranodal marginal zone b-cell lymphoma of mucosa-associated lymphoid tissue
867351|NCT00031642|nodal marginal zone B-cell lymphoma|nodal marginal zone b-cell lymphoma
867352|NCT00031642|splenic marginal zone lymphoma|splenic marginal zone lymphoma
867353|NCT00031616|stage IV colon cancer|stage iv colon cancer
867354|NCT00031616|stage IV rectal cancer|stage iv rectal cancer
867355|NCT00031616|recurrent colon cancer|recurrent colon cancer
867356|NCT00031616|recurrent rectal cancer|recurrent rectal cancer
867357|NCT00031616|adenocarcinoma of the colon|adenocarcinoma of the colon
867358|NCT00031616|adenocarcinoma of the rectum|adenocarcinoma of the rectum
867359|NCT00031590|average risk medulloblastoma|average risk medulloblastoma
867360|NCT00031590|craniospinal radiotherapy|craniospinal radiotherapy
867361|NCT00031590|newly diagnosed|newly diagnosed
867362|NCT00031577|untreated childhood brain stem glioma|untreated childhood brain stem glioma
867363|NCT00031564|stage IV|stage iv
867364|NCT00031564|renal cell carcinoma|renal cell carcinoma
867365|NCT00030914|hot flashes|hot flashes
867366|NCT00030901|prostate cancer|prostate cancer
867367|NCT00030901|high grade prostatic intraepithelial neoplasia|high grade prostatic intraepithelial neoplasia
867368|NCT00030888|stage III renal cell cancer|stage iii renal cell cancer
867369|NCT00030888|stage IV renal cell cancer|stage iv renal cell cancer
867370|NCT00030888|recurrent renal cell cancer|recurrent renal cell cancer
867371|NCT00030875|stage I mantle cell lymphoma|stage i mantle cell lymphoma
867372|NCT00030875|contiguous stage II mantle cell lymphoma|contiguous stage ii mantle cell lymphoma
867373|NCT00030875|noncontiguous stage II mantle cell lymphoma|noncontiguous stage ii mantle cell lymphoma
867374|NCT00030875|stage III mantle cell lymphoma|stage iii mantle cell lymphoma
867375|NCT00030875|stage IV mantle cell lymphoma|stage iv mantle cell lymphoma
867376|NCT00030875|recurrent mantle cell lymphoma|recurrent mantle cell lymphoma
867377|NCT00030862|stage II esophageal cancer|stage ii esophageal cancer
867378|NCT00030862|stage III esophageal cancer|stage iii esophageal cancer
867379|NCT00030862|stage IV esophageal cancer|stage iv esophageal cancer
867380|NCT00030862|squamous cell carcinoma of the esophagus|squamous cell carcinoma of the esophagus
867381|NCT00030862|adenocarcinoma of the esophagus|adenocarcinoma of the esophagus
867382|NCT00030849|stage I cutaneous T-cell non-Hodgkin lymphoma|stage i cutaneous t-cell non-hodgkin lymphoma
867383|NCT00030849|stage II cutaneous T-cell non-Hodgkin lymphoma|stage ii cutaneous t-cell non-hodgkin lymphoma
867384|NCT00030849|stage III cutaneous T-cell non-Hodgkin lymphoma|stage iii cutaneous t-cell non-hodgkin lymphoma
867385|NCT00030849|stage IV cutaneous T-cell non-Hodgkin lymphoma|stage iv cutaneous t-cell non-hodgkin lymphoma
867386|NCT00030849|recurrent cutaneous T-cell non-Hodgkin lymphoma|recurrent cutaneous t-cell non-hodgkin lymphoma
867387|NCT00030823|stage I breast cancer|stage i breast cancer
867388|NCT00030823|stage II breast cancer|stage ii breast cancer
867389|NCT00030823|stage IV breast cancer|stage iv breast cancer
867390|NCT00030823|stage IIIA breast cancer|stage iiia breast cancer
867391|NCT00030823|recurrent breast cancer|recurrent breast cancer
867392|NCT00030823|stage IIIB breast cancer|stage iiib breast cancer
867393|NCT00030823|stage IIIC breast cancer|stage iiic breast cancer
867394|NCT00030823|male breast cancer|male breast cancer
867395|NCT00030810|squamous cell lung cancer|squamous cell lung cancer
867396|NCT00030810|large cell lung cancer|large cell lung cancer
867397|NCT00030810|stage IIIB non-small cell lung cancer|stage iiib non-small cell lung cancer
867398|NCT00030810|adenosquamous cell lung cancer|adenosquamous cell lung cancer
867399|NCT00030784|adult angiosarcoma|adult angiosarcoma
867400|NCT00030784|adult fibrosarcoma|adult fibrosarcoma
867401|NCT00030784|adult leiomyosarcoma|adult leiomyosarcoma
867402|NCT00030784|adult liposarcoma|adult liposarcoma
867403|NCT00030784|adult neurofibrosarcoma|adult neurofibrosarcoma
867405|NCT00030784|stage III adult soft tissue sarcoma|stage iii adult soft tissue sarcoma
867406|NCT00030784|adult alveolar soft-part sarcoma|adult alveolar soft-part sarcoma
867407|NCT00030784|adult epithelioid sarcoma|adult epithelioid sarcoma
867408|NCT00030784|adult malignant fibrous histiocytoma|adult malignant fibrous histiocytoma
867409|NCT00030784|adult malignant hemangiopericytoma|adult malignant hemangiopericytoma
867410|NCT00030784|adult malignant mesenchymoma|adult malignant mesenchymoma
867411|NCT00030784|adult rhabdomyosarcoma|adult rhabdomyosarcoma
867412|NCT00030784|stage IV adult soft tissue sarcoma|stage iv adult soft tissue sarcoma
867413|NCT00030771|squamous cell lung cancer|squamous cell lung cancer
867414|NCT00030771|large cell lung cancer|large cell lung cancer
867415|NCT00030771|stage IIIA non-small cell lung cancer|stage iiia non-small cell lung cancer
867416|NCT00030771|adenosquamous cell lung cancer|adenosquamous cell lung cancer
867417|NCT00030758|neutropenia|neutropenia
867418|NCT00030758|stage I breast cancer|stage i breast cancer
867419|NCT00030758|stage II breast cancer|stage ii breast cancer
867420|NCT00030745|stage IA malignant mesothelioma|stage ia malignant mesothelioma
867421|NCT00030745|stage IB malignant mesothelioma|stage ib malignant mesothelioma
867422|NCT00030745|stage II malignant mesothelioma|stage ii malignant mesothelioma
867423|NCT00030745|stage III malignant mesothelioma|stage iii malignant mesothelioma
867424|NCT00030732|stage III pancreatic cancer|stage iii pancreatic cancer
867425|NCT00030732|recurrent pancreatic cancer|recurrent pancreatic cancer
867426|NCT00030732|adenocarcinoma of the pancreas|adenocarcinoma of the pancreas
867427|NCT00030732|stage IV pancreatic cancer|stage iv pancreatic cancer
867428|NCT00030719|regional neuroblastoma|regional neuroblastoma
867429|NCT00030719|disseminated neuroblastoma|disseminated neuroblastoma
867430|NCT00030719|stage 4S neuroblastoma|stage 4s neuroblastoma
867431|NCT00030719|localized unresectable neuroblastoma|localized unresectable neuroblastoma
867432|NCT00030706|stage III ovarian epithelial cancer|stage iii ovarian epithelial cancer
867433|NCT00030706|stage IV ovarian epithelial cancer|stage iv ovarian epithelial cancer
867434|NCT00030706|recurrent ovarian epithelial cancer|recurrent ovarian epithelial cancer
867435|NCT00030706|peritoneal cavity cancer|peritoneal cavity cancer
867436|NCT00030680|desmoid tumor|desmoid tumor
867437|NCT00030654|adenocarcinoma of the prostate|adenocarcinoma of the prostate
867438|NCT00030654|stage IIB prostate cancer|stage iib prostate cancer
867439|NCT00030654|stage IIA prostate cancer|stage iia prostate cancer
867440|NCT00030654|stage III prostate cancer|stage iii prostate cancer
867441|NCT00030654|stage IV prostate cancer|stage iv prostate cancer
867442|NCT00030654|recurrent prostate cancer|recurrent prostate cancer
867443|NCT00030641|recurrent non-small cell lung cancer|recurrent non-small cell lung cancer
867444|NCT00030641|stage IIIB non-small cell lung cancer|stage iiib non-small cell lung cancer
867445|NCT00030641|stage IV non-small cell lung cancer|stage iv non-small cell lung cancer
867446|NCT00030628|tumors metastatic to brain|tumors metastatic to brain
867447|NCT00030589|stage I cutaneous T-cell non-Hodgkin lymphoma|stage i cutaneous t-cell non-hodgkin lymphoma
867448|NCT00030589|stage II cutaneous T-cell non-Hodgkin lymphoma|stage ii cutaneous t-cell non-hodgkin lymphoma
867449|NCT00030589|recurrent cutaneous T-cell non-Hodgkin lymphoma|recurrent cutaneous t-cell non-hodgkin lymphoma
867450|NCT00030589|stage I mycosis fungoides/Sezary syndrome|stage i mycosis fungoides/sezary syndrome
867451|NCT00030589|stage II mycosis fungoides/Sezary syndrome|stage ii mycosis fungoides/sezary syndrome
867452|NCT00030589|recurrent mycosis fungoides/Sezary syndrome|recurrent mycosis fungoides/sezary syndrome
867453|NCT00030576|recurrent metastatic squamous neck cancer occult primary|recurrent metastatic squamous neck cancer occult primary
867454|NCT00030576|neck cancer with occult primary squamous carcinoma|neck cancer with occult primary squamous carcinoma
867455|NCT00030576|stage IV squamous cell carcinoma of the lip and oral cavity|stage iv squamous cell carcinoma of the lip and oral cavity
867456|NCT00030576|recurrent squamous cell carcinoma of the lip and oral cavity|recurrent squamous cell carcinoma of the lip and oral cavity
867457|NCT00030576|stage IV squamous cell carcinoma of the oropharynx|stage iv squamous cell carcinoma of the oropharynx
867458|NCT00030576|recurrent squamous cell carcinoma of the oropharynx|recurrent squamous cell carcinoma of the oropharynx
867459|NCT00030576|stage IV squamous cell carcinoma of the nasopharynx|stage iv squamous cell carcinoma of the nasopharynx
867460|NCT00030576|recurrent squamous cell carcinoma of the nasopharynx|recurrent squamous cell carcinoma of the nasopharynx
867461|NCT00030576|stage IV squamous cell carcinoma of the hypopharynx|stage iv squamous cell carcinoma of the hypopharynx
867462|NCT00030576|recurrent squamous cell carcinoma of the hypopharynx|recurrent squamous cell carcinoma of the hypopharynx
867463|NCT00030576|stage IV squamous cell carcinoma of the larynx|stage iv squamous cell carcinoma of the larynx
867464|NCT00030576|recurrent squamous cell carcinoma of the larynx|recurrent squamous cell carcinoma of the larynx
867465|NCT00030576|squamous cell carcinoma of paranasal sinus and nasal cavity|squamous cell carcinoma of paranasal sinus and nasal cavity
867466|NCT00030576|recurrent squamous cell carcinoma of sinus and nasal cavity|recurrent squamous cell carcinoma of sinus and nasal cavity
867467|NCT00030563|liver metastases|liver metastases
867468|NCT00030563|stage IV colon cancer|stage iv colon cancer
867469|NCT00030563|stage IV rectal cancer|stage iv rectal cancer
867470|NCT00030563|adenocarcinoma of the colon|adenocarcinoma of the colon
867471|NCT00030563|adenocarcinoma of the rectum|adenocarcinoma of the rectum
867472|NCT00030563|recurrent colon cancer|recurrent colon cancer
867473|NCT00030563|recurrent rectal cancer|recurrent rectal cancer
867474|NCT00030550|refractory anemia|refractory anemia
867475|NCT00030550|refractory anemia with ringed sideroblasts|refractory anemia with ringed sideroblasts
867476|NCT00030550|refractory anemia with excess blasts|refractory anemia with excess blasts
867477|NCT00030550|de novo myelodysplastic syndromes|de novo myelodysplastic syndromes
867478|NCT00030550|chronic myelomonocytic leukemia|chronic myelomonocytic leukemia
867479|NCT00030550|previously treated myelodysplastic syndromes|previously treated myelodysplastic syndromes
867480|NCT00030550|myelodysplastic/myeloproliferative neoplasm, unclassifiable|myelodysplastic/myeloproliferative neoplasm, unclassifiable
867481|NCT00030550|atypical chronic myeloid leukemia, BCR-ABL1 negative|atypical chronic myeloid leukemia, bcr-abl1 negative
867482|NCT00030537|stage IV breast cancer|stage iv breast cancer
867483|NCT00030537|recurrent breast cancer|recurrent breast cancer
867484|NCT00030537|stage IIIB breast cancer|stage iiib breast cancer
867485|NCT00030537|male breast cancer|male breast cancer
867486|NCT00030511|localized resectable adult primary liver cancer|localized resectable adult primary liver cancer
867487|NCT00030511|recurrent adult primary liver cancer|recurrent adult primary liver cancer
867488|NCT00030511|localized extrahepatic bile duct cancer|localized extrahepatic bile duct cancer
867489|NCT00030511|recurrent extrahepatic bile duct cancer|recurrent extrahepatic bile duct cancer
867490|NCT00030485|stage IV endometrial carcinoma|stage iv endometrial carcinoma
867491|NCT00030485|recurrent endometrial carcinoma|recurrent endometrial carcinoma
867492|NCT00030485|endometrial adenocarcinoma|endometrial adenocarcinoma
867493|NCT00030485|endometrial adenosquamous cell carcinoma|endometrial adenosquamous cell carcinoma
867494|NCT00030472|recurrent cervical cancer|recurrent cervical cancer
867495|NCT00030472|stage IVB cervical cancer|stage ivb cervical cancer
867496|NCT00030472|cervical squamous cell carcinoma|cervical squamous cell carcinoma
867497|NCT00030459|localized malignant mesothelioma|localized malignant mesothelioma
867498|NCT00030459|advanced malignant mesothelioma|advanced malignant mesothelioma
867499|NCT00030459|recurrent malignant mesothelioma|recurrent malignant mesothelioma
867500|NCT00030433|extensive stage small cell lung cancer|extensive stage small cell lung cancer
867501|NCT00030407|stage IIIB non-small cell lung cancer|stage iiib non-small cell lung cancer
867502|NCT00030407|stage IV non-small cell lung cancer|stage iv non-small cell lung cancer
891123|NCT00013546|Turner's|turner's
867503|NCT00030355|recurrent childhood acute myeloid leukemia|recurrent childhood acute myeloid leukemia
867504|NCT00030355|recurrent adult acute myeloid leukemia|recurrent adult acute myeloid leukemia
867505|NCT00030355|adult acute promyelocytic leukemia (M3)|adult acute promyelocytic leukemia (m3)
867506|NCT00030355|childhood acute promyelocytic leukemia (M3)|childhood acute promyelocytic leukemia (m3)
867507|NCT00030355|adult acute myeloid leukemia with t(15;17)(q22;q12)|adult acute myeloid leukemia with t(15;17)(q22;q12)
867508|NCT00030342|stage IV colon cancer|stage iv colon cancer
867509|NCT00030342|stage IV rectal cancer|stage iv rectal cancer
867510|NCT00030342|recurrent colon cancer|recurrent colon cancer
867511|NCT00030342|recurrent rectal cancer|recurrent rectal cancer
867512|NCT00030342|stage IV renal cell cancer|stage iv renal cell cancer
867513|NCT00030342|recurrent renal cell cancer|recurrent renal cell cancer
867514|NCT00030303|chronic phase chronic myelogenous leukemia|chronic phase chronic myelogenous leukemia
867515|NCT00030303|chronic myelogenous leukemia, BCR-ABL1 positive|chronic myelogenous leukemia, bcr-abl1 positive
867516|NCT00030290|stage I prostate cancer|stage i prostate cancer
867517|NCT00030290|stage IIB prostate cancer|stage iib prostate cancer
867518|NCT00030290|stage IIA prostate cancer|stage iia prostate cancer
867519|NCT00030277|stage I prostate cancer|stage i prostate cancer
867520|NCT00030277|stage IIB prostate cancer|stage iib prostate cancer
867521|NCT00030277|stage IIA prostate cancer|stage iia prostate cancer
867522|NCT00030277|recurrent prostate cancer|recurrent prostate cancer
867523|NCT00030264|plexiform neurofibroma|plexiform neurofibroma
867524|NCT00030264|neurofibromatosis type 1|neurofibromatosis type 1
867525|NCT00030108|recurrent childhood rhabdomyosarcoma|recurrent childhood rhabdomyosarcoma
867526|NCT00030108|childhood craniopharyngioma|childhood craniopharyngioma
867527|NCT00030108|recurrent neuroblastoma|recurrent neuroblastoma
867528|NCT00030108|recurrent childhood liver cancer|recurrent childhood liver cancer
867529|NCT00030108|recurrent Wilms tumor and other childhood kidney tumors|recurrent wilms tumor and other childhood kidney tumors
867530|NCT00030108|childhood central nervous system germ cell tumor|childhood central nervous system germ cell tumor
867531|NCT00030108|recurrent osteosarcoma|recurrent osteosarcoma
867532|NCT00030108|unspecified childhood solid tumor, protocol specific|unspecified childhood solid tumor, protocol specific
867533|NCT00030108|childhood germ cell tumor|childhood germ cell tumor
867534|NCT00030108|recurrent childhood soft tissue sarcoma|recurrent childhood soft tissue sarcoma
867535|NCT00030108|childhood oligodendroglioma|childhood oligodendroglioma
867536|NCT00030108|childhood choroid plexus tumor|childhood choroid plexus tumor
867537|NCT00030108|childhood grade I meningioma|childhood grade i meningioma
867538|NCT00030108|childhood grade II meningioma|childhood grade ii meningioma
867539|NCT00030108|childhood grade III meningioma|childhood grade iii meningioma
867540|NCT00030108|recurrent childhood cerebellar astrocytoma|recurrent childhood cerebellar astrocytoma
867541|NCT00030108|recurrent childhood cerebral astrocytoma|recurrent childhood cerebral astrocytoma
867542|NCT00030108|recurrent childhood medulloblastoma|recurrent childhood medulloblastoma
867543|NCT00030108|recurrent childhood visual pathway and hypothalamic glioma|recurrent childhood visual pathway and hypothalamic glioma
867544|NCT00030108|previously treated childhood rhabdomyosarcoma|previously treated childhood rhabdomyosarcoma
867545|NCT00030108|recurrent Ewing sarcoma/peripheral primitive neuroectodermal tumor|recurrent ewing sarcoma/peripheral primitive neuroectodermal tumor
867546|NCT00030108|recurrent childhood ependymoma|recurrent childhood ependymoma
867547|NCT00030108|childhood teratoma|childhood teratoma
867548|NCT00030108|childhood malignant testicular germ cell tumor|childhood malignant testicular germ cell tumor
867549|NCT00030108|childhood malignant ovarian germ cell tumor|childhood malignant ovarian germ cell tumor
867550|NCT00030108|childhood extragonadal germ cell tumor|childhood extragonadal germ cell tumor
867551|NCT00030108|recurrent childhood malignant germ cell tumor|recurrent childhood malignant germ cell tumor
867552|NCT00030108|B-cell childhood acute lymphoblastic leukemia|b-cell childhood acute lymphoblastic leukemia
867553|NCT00030108|childhood acute basophilic leukemia|childhood acute basophilic leukemia
867554|NCT00030108|childhood acute eosinophilic leukemia|childhood acute eosinophilic leukemia
867555|NCT00030108|childhood acute lymphoblastic leukemia|childhood acute lymphoblastic leukemia
867556|NCT00030108|childhood acute myeloid leukemia in remission|childhood acute myeloid leukemia in remission
867557|NCT00030108|childhood acute promyelocytic leukemia (M3)|childhood acute promyelocytic leukemia (m3)
867558|NCT00030108|L1 childhood acute lymphoblastic leukemia|l1 childhood acute lymphoblastic leukemia
867559|NCT00030108|L2 childhood acute lymphoblastic leukemia|l2 childhood acute lymphoblastic leukemia
867560|NCT00030108|L3 childhood acute lymphoblastic leukemia|l3 childhood acute lymphoblastic leukemia
867561|NCT00030108|non-T, non-B, cALLa negative childhood acute lymphoblastic leukemia|non-t, non-b, calla negative childhood acute lymphoblastic leukemia
867562|NCT00030108|non-T, non-B, cALLa positive childhood acute lymphoblastic leukemia|non-t, non-b, calla positive childhood acute lymphoblastic leukemia
867563|NCT00030108|non-T, non-B, cALLa positive, pre-B childhood acute lymphoblastic leukemia|non-t, non-b, calla positive, pre-b childhood acute lymphoblastic leukemia
867564|NCT00030108|recurrent childhood acute lymphoblastic leukemia|recurrent childhood acute lymphoblastic leukemia
867565|NCT00030108|recurrent childhood acute myeloid leukemia|recurrent childhood acute myeloid leukemia
867566|NCT00030108|TdT negative childhood acute lymphoblastic leukemia|tdt negative childhood acute lymphoblastic leukemia
867567|NCT00030108|TdT positive childhood acute lymphoblastic leukemia|tdt positive childhood acute lymphoblastic leukemia
867568|NCT00030108|chronic myelogenous leukemia, BCR-ABL1 positive|chronic myelogenous leukemia, bcr-abl1 positive
867569|NCT00030108|childhood chronic myelogenous leukemia|childhood chronic myelogenous leukemia
867570|NCT00030095|unspecified adult solid tumor, protocol specific|unspecified adult solid tumor, protocol specific
867571|NCT00030082|localized unresectable adult primary liver cancer|localized unresectable adult primary liver cancer
867572|NCT00030082|advanced adult primary liver cancer|advanced adult primary liver cancer
867573|NCT00030082|recurrent adult primary liver cancer|recurrent adult primary liver cancer
867574|NCT00030082|liver metastases|liver metastases
867575|NCT00029029|bone metastases|bone metastases
867576|NCT00029029|pain|pain
867577|NCT00028990|stage IV breast cancer|stage iv breast cancer
867578|NCT00028990|recurrent breast cancer|recurrent breast cancer
867579|NCT00028990|male breast cancer|male breast cancer
867580|NCT00028977|stage IV breast cancer|stage iv breast cancer
867581|NCT00028977|recurrent breast cancer|recurrent breast cancer
867582|NCT00028964|stage I breast cancer|stage i breast cancer
867583|NCT00028964|stage II breast cancer|stage ii breast cancer
867584|NCT00028964|stage IIIA breast cancer|stage iiia breast cancer
867585|NCT00028964|recurrent breast cancer|recurrent breast cancer
867586|NCT00028964|drug/agent toxicity by tissue/organ|drug/agent toxicity by tissue/organ
867587|NCT00028951|lymphedema|lymphedema
867588|NCT00028951|perioperative/postoperative complications|perioperative/postoperative complications
867589|NCT00028951|stage I vulvar cancer|stage i vulvar cancer
867590|NCT00028951|stage II vulvar cancer|stage ii vulvar cancer
867591|NCT00028951|stage III vulvar cancer|stage iii vulvar cancer
867592|NCT00028951|stage IVB vulvar cancer|stage ivb vulvar cancer
867593|NCT00028912|recurrent ovarian epithelial cancer|recurrent ovarian epithelial cancer
867594|NCT00028912|primary peritoneal cavity cancer|primary peritoneal cavity cancer
867595|NCT00028912|fallopian tube cancer|fallopian tube cancer
867596|NCT00028899|recurrent childhood acute myeloid leukemia|recurrent childhood acute myeloid leukemia
867597|NCT00028899|secondary acute myeloid leukemia|secondary acute myeloid leukemia
867598|NCT00028899|previously treated myelodysplastic syndromes|previously treated myelodysplastic syndromes
867599|NCT00028886|stage II multiple myeloma|stage ii multiple myeloma
867600|NCT00028886|stage III multiple myeloma|stage iii multiple myeloma
867601|NCT00028873|stage IV breast cancer|stage iv breast cancer
867602|NCT00028873|recurrent breast cancer|recurrent breast cancer
867603|NCT00028860|stage III bladder cancer|stage iii bladder cancer
867604|NCT00028860|stage IV bladder cancer|stage iv bladder cancer
867605|NCT00028860|transitional cell carcinoma of the bladder|transitional cell carcinoma of the bladder
867606|NCT00028860|localized transitional cell cancer of the renal pelvis and ureter|localized transitional cell cancer of the renal pelvis and ureter
867607|NCT00028860|regional transitional cell cancer of the renal pelvis and ureter|regional transitional cell cancer of the renal pelvis and ureter
867608|NCT00028847|chronic phase chronic myelogenous leukemia|chronic phase chronic myelogenous leukemia
867609|NCT00028847|chronic myelogenous leukemia, BCR-ABL1 positive|chronic myelogenous leukemia, bcr-abl1 positive
876595|NCT00051285|failure|failure
867610|NCT00028795|childhood brain stem glioma|childhood brain stem glioma
867611|NCT00028795|childhood high-grade cerebral astrocytoma|childhood high-grade cerebral astrocytoma
867612|NCT00028795|childhood spinal cord neoplasm|childhood spinal cord neoplasm
867613|NCT00028795|untreated childhood brain stem glioma|untreated childhood brain stem glioma
867614|NCT00028769|adenocarcinoma of the prostate|adenocarcinoma of the prostate
867615|NCT00028769|stage IV prostate cancer|stage iv prostate cancer
867616|NCT00028769|recurrent prostate cancer|recurrent prostate cancer
867617|NCT00028743|stage II ovarian epithelial cancer|stage ii ovarian epithelial cancer
867618|NCT00028743|stage III ovarian epithelial cancer|stage iii ovarian epithelial cancer
867619|NCT00028743|stage IV ovarian epithelial cancer|stage iv ovarian epithelial cancer
867620|NCT00028743|fallopian tube cancer|fallopian tube cancer
867621|NCT00028743|peritoneal cavity cancer|peritoneal cavity cancer
867622|NCT00028730|recurrent childhood lymphoblastic lymphoma|recurrent childhood lymphoblastic lymphoma
867623|NCT00028730|chronic phase chronic myelogenous leukemia|chronic phase chronic myelogenous leukemia
867624|NCT00028730|childhood acute myeloid leukemia in remission|childhood acute myeloid leukemia in remission
867625|NCT00028730|childhood acute lymphoblastic leukemia in remission|childhood acute lymphoblastic leukemia in remission
867626|NCT00028730|secondary acute myeloid leukemia|secondary acute myeloid leukemia
867627|NCT00028730|de novo myelodysplastic syndromes|de novo myelodysplastic syndromes
867628|NCT00028730|previously treated myelodysplastic syndromes|previously treated myelodysplastic syndromes
867629|NCT00028730|secondary myelodysplastic syndromes|secondary myelodysplastic syndromes
867630|NCT00028730|recurrent childhood small noncleaved cell lymphoma|recurrent childhood small noncleaved cell lymphoma
867631|NCT00028730|recurrent childhood large cell lymphoma|recurrent childhood large cell lymphoma
867632|NCT00028730|myelodysplastic/myeloproliferative neoplasm, unclassifiable|myelodysplastic/myeloproliferative neoplasm, unclassifiable
867633|NCT00028717|stage I grade 3 follicular lymphoma|stage i grade 3 follicular lymphoma
867634|NCT00028717|stage I adult diffuse large cell lymphoma|stage i adult diffuse large cell lymphoma
867635|NCT00028717|stage III grade 3 follicular lymphoma|stage iii grade 3 follicular lymphoma
867636|NCT00028717|stage III adult diffuse large cell lymphoma|stage iii adult diffuse large cell lymphoma
867637|NCT00028717|stage IV grade 3 follicular lymphoma|stage iv grade 3 follicular lymphoma
867638|NCT00028717|stage IV adult diffuse large cell lymphoma|stage iv adult diffuse large cell lymphoma
867639|NCT00028717|stage I mantle cell lymphoma|stage i mantle cell lymphoma
867640|NCT00028717|contiguous stage II grade 3 follicular lymphoma|contiguous stage ii grade 3 follicular lymphoma
867641|NCT00028717|contiguous stage II mantle cell lymphoma|contiguous stage ii mantle cell lymphoma
867642|NCT00028717|contiguous stage II adult diffuse large cell lymphoma|contiguous stage ii adult diffuse large cell lymphoma
867643|NCT00028717|noncontiguous stage II grade 3 follicular lymphoma|noncontiguous stage ii grade 3 follicular lymphoma
867644|NCT00028717|noncontiguous stage II mantle cell lymphoma|noncontiguous stage ii mantle cell lymphoma
867645|NCT00028717|noncontiguous stage II adult diffuse large cell lymphoma|noncontiguous stage ii adult diffuse large cell lymphoma
867646|NCT00028717|stage III mantle cell lymphoma|stage iii mantle cell lymphoma
867647|NCT00028717|stage IV mantle cell lymphoma|stage iv mantle cell lymphoma
867648|NCT00028704|stage II breast cancer|stage ii breast cancer
867649|NCT00028704|stage IIIA breast cancer|stage iiia breast cancer
867650|NCT00028704|stage IIIB breast cancer|stage iiib breast cancer
867651|NCT00028704|inflammatory breast cancer|inflammatory breast cancer
867652|NCT00028691|stage III grade 1 follicular lymphoma|stage iii grade 1 follicular lymphoma
867653|NCT00028691|stage III grade 2 follicular lymphoma|stage iii grade 2 follicular lymphoma
867654|NCT00028691|stage III grade 3 follicular lymphoma|stage iii grade 3 follicular lymphoma
867655|NCT00028691|stage IV grade 1 follicular lymphoma|stage iv grade 1 follicular lymphoma
867656|NCT00028691|stage IV grade 2 follicular lymphoma|stage iv grade 2 follicular lymphoma
867657|NCT00028691|stage IV grade 3 follicular lymphoma|stage iv grade 3 follicular lymphoma
867658|NCT00028665|stage III grade 1 follicular lymphoma|stage iii grade 1 follicular lymphoma
867659|NCT00028665|stage III grade 2 follicular lymphoma|stage iii grade 2 follicular lymphoma
867660|NCT00028665|stage III grade 3 follicular lymphoma|stage iii grade 3 follicular lymphoma
867661|NCT00028665|stage III adult diffuse small cleaved cell lymphoma|stage iii adult diffuse small cleaved cell lymphoma
867662|NCT00028665|stage III adult diffuse mixed cell lymphoma|stage iii adult diffuse mixed cell lymphoma
867663|NCT00028665|stage III adult diffuse large cell lymphoma|stage iii adult diffuse large cell lymphoma
867664|NCT00028665|stage III adult immunoblastic large cell lymphoma|stage iii adult immunoblastic large cell lymphoma
867665|NCT00028665|stage III adult lymphoblastic lymphoma|stage iii adult lymphoblastic lymphoma
867666|NCT00028665|stage IV grade 1 follicular lymphoma|stage iv grade 1 follicular lymphoma
867667|NCT00028665|stage IV grade 2 follicular lymphoma|stage iv grade 2 follicular lymphoma
867668|NCT00028665|stage IV grade 3 follicular lymphoma|stage iv grade 3 follicular lymphoma
867669|NCT00028665|stage IV adult diffuse small cleaved cell lymphoma|stage iv adult diffuse small cleaved cell lymphoma
867670|NCT00028665|stage IV adult diffuse mixed cell lymphoma|stage iv adult diffuse mixed cell lymphoma
867671|NCT00028665|stage IV adult diffuse large cell lymphoma|stage iv adult diffuse large cell lymphoma
867672|NCT00028665|stage IV adult immunoblastic large cell lymphoma|stage iv adult immunoblastic large cell lymphoma
867673|NCT00028665|stage IV adult lymphoblastic lymphoma|stage iv adult lymphoblastic lymphoma
867674|NCT00028665|recurrent grade 1 follicular lymphoma|recurrent grade 1 follicular lymphoma
867675|NCT00028665|recurrent grade 2 follicular lymphoma|recurrent grade 2 follicular lymphoma
867676|NCT00028665|recurrent grade 3 follicular lymphoma|recurrent grade 3 follicular lymphoma
867677|NCT00028665|recurrent adult diffuse small cleaved cell lymphoma|recurrent adult diffuse small cleaved cell lymphoma
867678|NCT00028665|recurrent adult diffuse mixed cell lymphoma|recurrent adult diffuse mixed cell lymphoma
867679|NCT00028665|recurrent adult diffuse large cell lymphoma|recurrent adult diffuse large cell lymphoma
867680|NCT00028665|recurrent adult immunoblastic large cell lymphoma|recurrent adult immunoblastic large cell lymphoma
867681|NCT00028665|stage III mantle cell lymphoma|stage iii mantle cell lymphoma
867682|NCT00028665|stage IV mantle cell lymphoma|stage iv mantle cell lymphoma
867683|NCT00028665|recurrent mantle cell lymphoma|recurrent mantle cell lymphoma
867684|NCT00028652|skin metastases|skin metastases
867685|NCT00028639|stage IV breast cancer|stage iv breast cancer
867686|NCT00028639|recurrent breast cancer|recurrent breast cancer
867687|NCT00028626|liver metastases|liver metastases
867688|NCT00028626|adenocarcinoma of the colon|adenocarcinoma of the colon
867689|NCT00028626|recurrent colon cancer|recurrent colon cancer
867690|NCT00028626|stage IV colon cancer|stage iv colon cancer
867691|NCT00028626|adenocarcinoma of the rectum|adenocarcinoma of the rectum
867692|NCT00028626|recurrent rectal cancer|recurrent rectal cancer
867693|NCT00028626|stage IV rectal cancer|stage iv rectal cancer
867694|NCT00028600|refractory multiple myeloma|refractory multiple myeloma
867695|NCT00028600|stage I multiple myeloma|stage i multiple myeloma
867696|NCT00028600|stage II multiple myeloma|stage ii multiple myeloma
867697|NCT00028600|stage III multiple myeloma|stage iii multiple myeloma
867698|NCT00028574|stage I prostate cancer|stage i prostate cancer
867699|NCT00028574|stage IIB prostate cancer|stage iib prostate cancer
867700|NCT00028574|stage IIA prostate cancer|stage iia prostate cancer
867701|NCT00028574|stage III prostate cancer|stage iii prostate cancer
867702|NCT00028574|stage IV prostate cancer|stage iv prostate cancer
867703|NCT00028574|recurrent prostate cancer|recurrent prostate cancer
867704|NCT00028574|hot flashes|hot flashes
867705|NCT00028548|unspecified adult solid tumor, protocol specific|unspecified adult solid tumor, protocol specific
867706|NCT00028509|neurotoxicity|neurotoxicity
867707|NCT00028509|long-term effects secondary to cancer therapy in children|long-term effects secondary to cancer therapy in children
867708|NCT00028015|stage IV colon cancer|stage iv colon cancer
867709|NCT00028015|stage IV rectal cancer|stage iv rectal cancer
867711|NCT00028015|recurrent rectal cancer|recurrent rectal cancer
867712|NCT00027989|stage IV breast cancer|stage iv breast cancer
867713|NCT00027976|actinic keratosis|actinic keratosis
867714|NCT00027963|neurotoxicity|neurotoxicity
867715|NCT00027963|pain|pain
867716|NCT00027937|stage I adult Hodgkin lymphoma|stage i adult hodgkin lymphoma
867717|NCT00027937|stage II adult Hodgkin lymphoma|stage ii adult hodgkin lymphoma
867718|NCT00027937|stage III adult Hodgkin lymphoma|stage iii adult hodgkin lymphoma
867719|NCT00027937|stage IV adult Hodgkin lymphoma|stage iv adult hodgkin lymphoma
867720|NCT00027937|recurrent adult Hodgkin lymphoma|recurrent adult hodgkin lymphoma
867721|NCT00027937|unspecified childhood solid tumor, protocol specific|unspecified childhood solid tumor, protocol specific
867722|NCT00027937|unspecified adult solid tumor, protocol specific|unspecified adult solid tumor, protocol specific
867723|NCT00027937|stage II childhood Hodgkin lymphoma|stage ii childhood hodgkin lymphoma
867724|NCT00027937|stage I childhood Hodgkin lymphoma|stage i childhood hodgkin lymphoma
867725|NCT00027937|stage III childhood Hodgkin lymphoma|stage iii childhood hodgkin lymphoma
867726|NCT00027937|stage IV childhood Hodgkin lymphoma|stage iv childhood hodgkin lymphoma
867727|NCT00027937|recurrent/refractory childhood Hodgkin lymphoma|recurrent/refractory childhood hodgkin lymphoma
867728|NCT00027937|stage I grade 1 follicular lymphoma|stage i grade 1 follicular lymphoma
867729|NCT00027937|stage I grade 2 follicular lymphoma|stage i grade 2 follicular lymphoma
867730|NCT00027937|stage I grade 3 follicular lymphoma|stage i grade 3 follicular lymphoma
867731|NCT00027937|stage I adult diffuse small cleaved cell lymphoma|stage i adult diffuse small cleaved cell lymphoma
867732|NCT00027937|stage I adult diffuse mixed cell lymphoma|stage i adult diffuse mixed cell lymphoma
867733|NCT00027937|stage I adult diffuse large cell lymphoma|stage i adult diffuse large cell lymphoma
867734|NCT00027937|stage I adult immunoblastic large cell lymphoma|stage i adult immunoblastic large cell lymphoma
867735|NCT00027937|stage I adult lymphoblastic lymphoma|stage i adult lymphoblastic lymphoma
867736|NCT00027937|stage I adult Burkitt lymphoma|stage i adult burkitt lymphoma
867737|NCT00027937|stage III grade 1 follicular lymphoma|stage iii grade 1 follicular lymphoma
867738|NCT00027937|stage III grade 2 follicular lymphoma|stage iii grade 2 follicular lymphoma
867739|NCT00027937|stage III grade 3 follicular lymphoma|stage iii grade 3 follicular lymphoma
867740|NCT00027937|stage III adult diffuse small cleaved cell lymphoma|stage iii adult diffuse small cleaved cell lymphoma
867741|NCT00027937|stage III adult diffuse mixed cell lymphoma|stage iii adult diffuse mixed cell lymphoma
867742|NCT00027937|stage III adult diffuse large cell lymphoma|stage iii adult diffuse large cell lymphoma
867743|NCT00027937|stage III adult immunoblastic large cell lymphoma|stage iii adult immunoblastic large cell lymphoma
867744|NCT00027937|stage III adult lymphoblastic lymphoma|stage iii adult lymphoblastic lymphoma
867745|NCT00027937|stage III adult Burkitt lymphoma|stage iii adult burkitt lymphoma
867746|NCT00027937|stage IV grade 1 follicular lymphoma|stage iv grade 1 follicular lymphoma
876596|NCT00051285|congestive|congestive
867747|NCT00027937|stage IV grade 2 follicular lymphoma|stage iv grade 2 follicular lymphoma
867748|NCT00027937|stage IV grade 3 follicular lymphoma|stage iv grade 3 follicular lymphoma
867749|NCT00027937|stage IV adult diffuse small cleaved cell lymphoma|stage iv adult diffuse small cleaved cell lymphoma
867750|NCT00027937|stage IV adult diffuse mixed cell lymphoma|stage iv adult diffuse mixed cell lymphoma
867751|NCT00027937|stage IV adult diffuse large cell lymphoma|stage iv adult diffuse large cell lymphoma
867752|NCT00027937|stage IV adult immunoblastic large cell lymphoma|stage iv adult immunoblastic large cell lymphoma
867753|NCT00027937|stage IV adult lymphoblastic lymphoma|stage iv adult lymphoblastic lymphoma
867754|NCT00027937|stage IV adult Burkitt lymphoma|stage iv adult burkitt lymphoma
867755|NCT00027937|recurrent grade 1 follicular lymphoma|recurrent grade 1 follicular lymphoma
867756|NCT00027937|recurrent grade 2 follicular lymphoma|recurrent grade 2 follicular lymphoma
867757|NCT00027937|recurrent grade 3 follicular lymphoma|recurrent grade 3 follicular lymphoma
867758|NCT00027937|recurrent adult diffuse small cleaved cell lymphoma|recurrent adult diffuse small cleaved cell lymphoma
867759|NCT00027937|recurrent adult diffuse mixed cell lymphoma|recurrent adult diffuse mixed cell lymphoma
867760|NCT00027937|recurrent adult diffuse large cell lymphoma|recurrent adult diffuse large cell lymphoma
867761|NCT00027937|recurrent adult immunoblastic large cell lymphoma|recurrent adult immunoblastic large cell lymphoma
867762|NCT00027937|recurrent adult lymphoblastic lymphoma|recurrent adult lymphoblastic lymphoma
867763|NCT00027937|recurrent adult Burkitt lymphoma|recurrent adult burkitt lymphoma
867764|NCT00027937|stage I childhood small noncleaved cell lymphoma|stage i childhood small noncleaved cell lymphoma
867765|NCT00027937|stage I childhood large cell lymphoma|stage i childhood large cell lymphoma
867766|NCT00027937|stage II childhood small noncleaved cell lymphoma|stage ii childhood small noncleaved cell lymphoma
867767|NCT00027937|stage II childhood large cell lymphoma|stage ii childhood large cell lymphoma
867768|NCT00027937|stage III childhood small noncleaved cell lymphoma|stage iii childhood small noncleaved cell lymphoma
867769|NCT00027937|stage III childhood large cell lymphoma|stage iii childhood large cell lymphoma
867770|NCT00027937|stage IV childhood small noncleaved cell lymphoma|stage iv childhood small noncleaved cell lymphoma
867771|NCT00027937|stage IV childhood large cell lymphoma|stage iv childhood large cell lymphoma
867772|NCT00027937|recurrent childhood small noncleaved cell lymphoma|recurrent childhood small noncleaved cell lymphoma
867773|NCT00027937|recurrent childhood large cell lymphoma|recurrent childhood large cell lymphoma
867774|NCT00027937|stage I mantle cell lymphoma|stage i mantle cell lymphoma
867987|NCT00026403|stage III pancreatic cancer|stage iii pancreatic cancer
867775|NCT00027937|contiguous stage II grade 1 follicular lymphoma|contiguous stage ii grade 1 follicular lymphoma
867776|NCT00027937|contiguous stage II grade 2 follicular lymphoma|contiguous stage ii grade 2 follicular lymphoma
867777|NCT00027937|contiguous stage II grade 3 follicular lymphoma|contiguous stage ii grade 3 follicular lymphoma
867778|NCT00027937|contiguous stage II adult diffuse small cleaved cell lymphoma|contiguous stage ii adult diffuse small cleaved cell lymphoma
867779|NCT00027937|contiguous stage II mantle cell lymphoma|contiguous stage ii mantle cell lymphoma
867780|NCT00027937|contiguous stage II adult diffuse mixed cell lymphoma|contiguous stage ii adult diffuse mixed cell lymphoma
867781|NCT00027937|contiguous stage II adult immunoblastic large cell lymphoma|contiguous stage ii adult immunoblastic large cell lymphoma
867782|NCT00027937|contiguous stage II adult diffuse large cell lymphoma|contiguous stage ii adult diffuse large cell lymphoma
867783|NCT00027937|contiguous stage II adult Burkitt lymphoma|contiguous stage ii adult burkitt lymphoma
867784|NCT00027937|contiguous stage II adult lymphoblastic lymphoma|contiguous stage ii adult lymphoblastic lymphoma
867785|NCT00027937|noncontiguous stage II grade 1 follicular lymphoma|noncontiguous stage ii grade 1 follicular lymphoma
867786|NCT00027937|noncontiguous stage II grade 2 follicular lymphoma|noncontiguous stage ii grade 2 follicular lymphoma
867787|NCT00027937|noncontiguous stage II grade 3 follicular lymphoma|noncontiguous stage ii grade 3 follicular lymphoma
867788|NCT00027937|noncontiguous stage II adult diffuse small cleaved cell lymphoma|noncontiguous stage ii adult diffuse small cleaved cell lymphoma
867789|NCT00027937|noncontiguous stage II mantle cell lymphoma|noncontiguous stage ii mantle cell lymphoma
867790|NCT00027937|noncontiguous stage II adult diffuse mixed cell lymphoma|noncontiguous stage ii adult diffuse mixed cell lymphoma
867791|NCT00027937|noncontiguous stage II adult immunoblastic large cell lymphoma|noncontiguous stage ii adult immunoblastic large cell lymphoma
867792|NCT00027937|noncontiguous stage II adult diffuse large cell lymphoma|noncontiguous stage ii adult diffuse large cell lymphoma
867793|NCT00027937|noncontiguous stage II adult Burkitt lymphoma|noncontiguous stage ii adult burkitt lymphoma
867794|NCT00027937|noncontiguous stage II adult lymphoblastic lymphoma|noncontiguous stage ii adult lymphoblastic lymphoma
867795|NCT00027937|stage III mantle cell lymphoma|stage iii mantle cell lymphoma
867796|NCT00027937|stage IV mantle cell lymphoma|stage iv mantle cell lymphoma
867797|NCT00027937|recurrent mantle cell lymphoma|recurrent mantle cell lymphoma
867798|NCT00027937|noncontiguous stage II small lymphocytic lymphoma|noncontiguous stage ii small lymphocytic lymphoma
867799|NCT00027937|noncontiguous stage II marginal zone lymphoma|noncontiguous stage ii marginal zone lymphoma
867800|NCT00027937|recurrent marginal zone lymphoma|recurrent marginal zone lymphoma
867801|NCT00027937|recurrent small lymphocytic lymphoma|recurrent small lymphocytic lymphoma
867802|NCT00027937|stage I marginal zone lymphoma|stage i marginal zone lymphoma
867803|NCT00027937|stage I small lymphocytic lymphoma|stage i small lymphocytic lymphoma
867804|NCT00027937|stage III small lymphocytic lymphoma|stage iii small lymphocytic lymphoma
867805|NCT00027937|stage III marginal zone lymphoma|stage iii marginal zone lymphoma
867806|NCT00027937|stage IV small lymphocytic lymphoma|stage iv small lymphocytic lymphoma
867807|NCT00027937|stage IV marginal zone lymphoma|stage iv marginal zone lymphoma
867808|NCT00027937|contiguous stage II marginal zone lymphoma|contiguous stage ii marginal zone lymphoma
867809|NCT00027937|contiguous stage II small lymphocytic lymphoma|contiguous stage ii small lymphocytic lymphoma
867810|NCT00027937|extranodal marginal zone B-cell lymphoma of mucosa-associated lymphoid tissue|extranodal marginal zone b-cell lymphoma of mucosa-associated lymphoid tissue
867811|NCT00027937|nodal marginal zone B-cell lymphoma|nodal marginal zone b-cell lymphoma
867812|NCT00027937|splenic marginal zone lymphoma|splenic marginal zone lymphoma
867813|NCT00027911|adult synovial sarcoma|adult synovial sarcoma
867814|NCT00027911|stage III adult soft tissue sarcoma|stage iii adult soft tissue sarcoma
867815|NCT00027911|recurrent adult soft tissue sarcoma|recurrent adult soft tissue sarcoma
867816|NCT00027911|stage IV adult soft tissue sarcoma|stage iv adult soft tissue sarcoma
867817|NCT00027911|stage II adult soft tissue sarcoma|stage ii adult soft tissue sarcoma
867818|NCT00027885|stage IV breast cancer|stage iv breast cancer
867819|NCT00027885|stage IIIA breast cancer|stage iiia breast cancer
867820|NCT00027885|stage IIIB breast cancer|stage iiib breast cancer
867821|NCT00027885|stage IIIC breast cancer|stage iiic breast cancer
867822|NCT00027885|male breast cancer|male breast cancer
867823|NCT00027859|adenocarcinoma of the prostate|adenocarcinoma of the prostate
867824|NCT00027859|stage III prostate cancer|stage iii prostate cancer
867825|NCT00027846|childhood supratentorial ependymoma|childhood supratentorial ependymoma
867826|NCT00027846|newly diagnosed childhood ependymoma|newly diagnosed childhood ependymoma
867827|NCT00027846|childhood infratentorial ependymoma|childhood infratentorial ependymoma
867828|NCT00027833|stage IV colon cancer|stage iv colon cancer
867829|NCT00027833|stage IV rectal cancer|stage iv rectal cancer
867830|NCT00027833|adenocarcinoma of the colon|adenocarcinoma of the colon
867831|NCT00027833|adenocarcinoma of the rectum|adenocarcinoma of the rectum
867832|NCT00027807|stage IV breast cancer|stage iv breast cancer
867833|NCT00027807|recurrent breast cancer|recurrent breast cancer
867834|NCT00027807|ductal breast carcinoma|ductal breast carcinoma
867835|NCT00027794|adenocarcinoma of the prostate|adenocarcinoma of the prostate
867836|NCT00027794|stage III prostate cancer|stage iii prostate cancer
867837|NCT00027781|adenocarcinoma of the prostate|adenocarcinoma of the prostate
867838|NCT00027781|recurrent prostate cancer|recurrent prostate cancer
867839|NCT00027768|localized resectable adult primary liver cancer|localized resectable adult primary liver cancer
891124|NCT00013546|TS|ts
867840|NCT00027768|adult primary hepatocellular carcinoma|adult primary hepatocellular carcinoma
867841|NCT00027742|iris melanoma|iris melanoma
867842|NCT00027742|extraocular extension melanoma|extraocular extension melanoma
867843|NCT00027742|recurrent intraocular melanoma|recurrent intraocular melanoma
867844|NCT00027742|stage III melanoma|stage iii melanoma
867845|NCT00027742|stage IV melanoma|stage iv melanoma
867846|NCT00027742|recurrent melanoma|recurrent melanoma
867847|NCT00027729|recurrent colon cancer|recurrent colon cancer
867848|NCT00027729|recurrent rectal cancer|recurrent rectal cancer
867849|NCT00027716|metastatic osteosarcoma|metastatic osteosarcoma
867850|NCT00027716|recurrent adult soft tissue sarcoma|recurrent adult soft tissue sarcoma
867851|NCT00027716|recurrent osteosarcoma|recurrent osteosarcoma
867852|NCT00027716|adult rhabdomyosarcoma|adult rhabdomyosarcoma
867853|NCT00027716|metastatic Ewing sarcoma/peripheral primitive neuroectodermal tumor|metastatic ewing sarcoma/peripheral primitive neuroectodermal tumor
867854|NCT00027716|recurrent Ewing sarcoma/peripheral primitive neuroectodermal tumor|recurrent ewing sarcoma/peripheral primitive neuroectodermal tumor
867855|NCT00027716|stage IV adult soft tissue sarcoma|stage iv adult soft tissue sarcoma
867856|NCT00027677|unspecified adult solid tumor, protocol specific|unspecified adult solid tumor, protocol specific
867857|NCT00027664|stage IV renal cell cancer|stage iv renal cell cancer
867858|NCT00027638|metastatic gastrointestinal carcinoid tumor|metastatic gastrointestinal carcinoid tumor
867859|NCT00027638|recurrent gastrointestinal carcinoid tumor|recurrent gastrointestinal carcinoid tumor
867860|NCT00027638|gastrinoma|gastrinoma
867861|NCT00027638|insulinoma|insulinoma
867862|NCT00027638|recurrent islet cell carcinoma|recurrent islet cell carcinoma
867863|NCT00027638|WDHA syndrome|wdha syndrome
867864|NCT00027638|somatostatinoma|somatostatinoma
867865|NCT00027638|pancreatic polypeptide tumor|pancreatic polypeptide tumor
867866|NCT00027638|glucagonoma|glucagonoma
867867|NCT00027638|pulmonary carcinoid tumor|pulmonary carcinoid tumor
867868|NCT00027625|recurrent adult brain tumor|recurrent adult brain tumor
867869|NCT00027625|adult glioblastoma|adult glioblastoma
867870|NCT00027625|adult anaplastic astrocytoma|adult anaplastic astrocytoma
867871|NCT00027625|adult anaplastic oligodendroglioma|adult anaplastic oligodendroglioma
867872|NCT00027625|adult mixed glioma|adult mixed glioma
867873|NCT00027625|adult giant cell glioblastoma|adult giant cell glioblastoma
867874|NCT00027625|adult gliosarcoma|adult gliosarcoma
867875|NCT00027586|stage IV melanoma|stage iv melanoma
867876|NCT00027586|recurrent melanoma|recurrent melanoma
867877|NCT00027586|Imatinib Mesylate|imatinib mesylate
867878|NCT00027586|Gleevec|gleevec
867879|NCT00027586|protein tyrosine kinases|protein tyrosine kinases
867880|NCT00027586|PTK|ptk
867881|NCT00027586|Gleevec targets|gleevec targets
867882|NCT00027586|metastatic melanoma|metastatic melanoma
867883|NCT00027573|stage IV renal cell cancer|stage iv renal cell cancer
867884|NCT00027573|recurrent renal cell cancer|recurrent renal cell cancer
867885|NCT00027573|clear cell renal cell carcinoma|clear cell renal cell carcinoma
867886|NCT00027573|papillary renal cell carcinoma|papillary renal cell carcinoma
867887|NCT00027560|recurrent childhood acute lymphoblastic leukemia|recurrent childhood acute lymphoblastic leukemia
867888|NCT00027560|recurrent adult Hodgkin lymphoma|recurrent adult hodgkin lymphoma
867889|NCT00027560|refractory multiple myeloma|refractory multiple myeloma
867890|NCT00027560|stage II multiple myeloma|stage ii multiple myeloma
867891|NCT00027560|stage III multiple myeloma|stage iii multiple myeloma
867892|NCT00027560|recurrent childhood lymphoblastic lymphoma|recurrent childhood lymphoblastic lymphoma
867893|NCT00027560|recurrent childhood acute myeloid leukemia|recurrent childhood acute myeloid leukemia
867894|NCT00027560|recurrent adult acute myeloid leukemia|recurrent adult acute myeloid leukemia
867895|NCT00027560|recurrent adult acute lymphoblastic leukemia|recurrent adult acute lymphoblastic leukemia
867896|NCT00027560|relapsing chronic myelogenous leukemia|relapsing chronic myelogenous leukemia
867897|NCT00027560|refractory chronic lymphocytic leukemia|refractory chronic lymphocytic leukemia
867898|NCT00027560|recurrent/refractory childhood Hodgkin lymphoma|recurrent/refractory childhood hodgkin lymphoma
867899|NCT00027560|recurrent grade 1 follicular lymphoma|recurrent grade 1 follicular lymphoma
867900|NCT00027560|recurrent grade 2 follicular lymphoma|recurrent grade 2 follicular lymphoma
867901|NCT00027560|recurrent grade 3 follicular lymphoma|recurrent grade 3 follicular lymphoma
867902|NCT00027560|recurrent adult diffuse small cleaved cell lymphoma|recurrent adult diffuse small cleaved cell lymphoma
867903|NCT00027560|recurrent adult diffuse mixed cell lymphoma|recurrent adult diffuse mixed cell lymphoma
867904|NCT00027560|recurrent adult diffuse large cell lymphoma|recurrent adult diffuse large cell lymphoma
867905|NCT00027560|recurrent adult immunoblastic large cell lymphoma|recurrent adult immunoblastic large cell lymphoma
867906|NCT00027560|recurrent adult lymphoblastic lymphoma|recurrent adult lymphoblastic lymphoma
867907|NCT00027560|recurrent adult Burkitt lymphoma|recurrent adult burkitt lymphoma
867908|NCT00027560|previously treated myelodysplastic syndromes|previously treated myelodysplastic syndromes
867909|NCT00027560|recurrent childhood small noncleaved cell lymphoma|recurrent childhood small noncleaved cell lymphoma
867910|NCT00027560|recurrent childhood large cell lymphoma|recurrent childhood large cell lymphoma
867911|NCT00027560|recurrent mantle cell lymphoma|recurrent mantle cell lymphoma
867912|NCT00027560|Waldenström macroglobulinemia|waldenström macroglobulinemia
867913|NCT00027560|childhood chronic myelogenous leukemia|childhood chronic myelogenous leukemia
867988|NCT00026403|adenocarcinoma of the pancreas|adenocarcinoma of the pancreas
867914|NCT00027560|atypical chronic myeloid leukemia, BCR-ABL1 negative|atypical chronic myeloid leukemia, bcr-abl1 negative
867915|NCT00027560|myelodysplastic/myeloproliferative neoplasm, unclassifiable|myelodysplastic/myeloproliferative neoplasm, unclassifiable
867916|NCT00027560|recurrent marginal zone lymphoma|recurrent marginal zone lymphoma
867917|NCT00027560|recurrent small lymphocytic lymphoma|recurrent small lymphocytic lymphoma
867918|NCT00027560|extranodal marginal zone B-cell lymphoma of mucosa-associated lymphoid tissue|extranodal marginal zone b-cell lymphoma of mucosa-associated lymphoid tissue
867919|NCT00027560|nodal marginal zone B-cell lymphoma|nodal marginal zone b-cell lymphoma
867920|NCT00027560|splenic marginal zone lymphoma|splenic marginal zone lymphoma
867921|NCT00027560|adult acute myeloid leukemia with 11q23 (MLL) abnormalities|adult acute myeloid leukemia with 11q23 (mll) abnormalities
867922|NCT00027560|childhood myelodysplastic syndromes|childhood myelodysplastic syndromes
867923|NCT00027547|adult acute lymphoblastic leukemia in remission|adult acute lymphoblastic leukemia in remission
867924|NCT00027547|childhood acute lymphoblastic leukemia in remission|childhood acute lymphoblastic leukemia in remission
867925|NCT00027534|recurrent colon cancer|recurrent colon cancer
867926|NCT00027534|stage III colon cancer|stage iii colon cancer
867927|NCT00027534|stage IV colon cancer|stage iv colon cancer
867928|NCT00027534|recurrent breast cancer|recurrent breast cancer
867929|NCT00027534|stage IIIA breast cancer|stage iiia breast cancer
867930|NCT00027534|stage IIIB breast cancer|stage iiib breast cancer
867931|NCT00027534|stage IIIC breast cancer|stage iiic breast cancer
867932|NCT00027534|stage IV breast cancer|stage iv breast cancer
867933|NCT00027534|recurrent gastric cancer|recurrent gastric cancer
867934|NCT00027534|stage III gastric cancer|stage iii gastric cancer
867935|NCT00027534|stage IV gastric cancer|stage iv gastric cancer
867936|NCT00027534|recurrent pancreatic cancer|recurrent pancreatic cancer
867937|NCT00027534|stage II pancreatic cancer|stage ii pancreatic cancer
867938|NCT00027534|stage III pancreatic cancer|stage iii pancreatic cancer
867939|NCT00027534|recurrent rectal cancer|recurrent rectal cancer
867940|NCT00027534|stage III rectal cancer|stage iii rectal cancer
867941|NCT00027534|stage IV rectal cancer|stage iv rectal cancer
867942|NCT00027534|advanced adult primary liver cancer|advanced adult primary liver cancer
867943|NCT00027534|recurrent adult primary liver cancer|recurrent adult primary liver cancer
867944|NCT00027534|recurrent gallbladder cancer|recurrent gallbladder cancer
867945|NCT00027534|unresectable gallbladder cancer|unresectable gallbladder cancer
867946|NCT00027534|thyroid gland medullary carcinoma|thyroid gland medullary carcinoma
867947|NCT00027534|recurrent salivary gland cancer|recurrent salivary gland cancer
867948|NCT00027534|stage III salivary gland cancer|stage iii salivary gland cancer
867949|NCT00027534|stage IV salivary gland cancer|stage iv salivary gland cancer
867950|NCT00027534|Paget disease of the breast with intraductal carcinoma|paget disease of the breast with intraductal carcinoma
867951|NCT00027534|Paget disease of the breast with invasive ductal carcinoma|paget disease of the breast with invasive ductal carcinoma
867952|NCT00027534|adult primary hepatocellular carcinoma|adult primary hepatocellular carcinoma
867953|NCT00027534|diffuse adenocarcinoma of the stomach|diffuse adenocarcinoma of the stomach
867954|NCT00027534|intestinal adenocarcinoma of the stomach|intestinal adenocarcinoma of the stomach
867955|NCT00027534|mixed adenocarcinoma of the stomach|mixed adenocarcinoma of the stomach
867956|NCT00027534|adenocarcinoma of the colon|adenocarcinoma of the colon
867957|NCT00027534|adenocarcinoma of the gallbladder|adenocarcinoma of the gallbladder
867958|NCT00027534|adenocarcinoma of the rectum|adenocarcinoma of the rectum
867959|NCT00027534|recurrent malignant testicular germ cell tumor|recurrent malignant testicular germ cell tumor
867960|NCT00027534|stage II malignant testicular germ cell tumor|stage ii malignant testicular germ cell tumor
867961|NCT00027534|stage III malignant testicular germ cell tumor|stage iii malignant testicular germ cell tumor
867962|NCT00027534|male breast cancer|male breast cancer
867963|NCT00027534|adenocarcinoma of the pancreas|adenocarcinoma of the pancreas
867964|NCT00027534|cholangiocarcinoma of the gallbladder|cholangiocarcinoma of the gallbladder
867965|NCT00027534|salivary gland adenocarcinoma|salivary gland adenocarcinoma
867966|NCT00027534|ovarian endometrioid adenocarcinoma|ovarian endometrioid adenocarcinoma
867967|NCT00027534|stage IV pancreatic cancer|stage iv pancreatic cancer
867968|NCT00027495|colon cancer|colon cancer
867969|NCT00026533|stage IV papillary thyroid cancer|stage iv papillary thyroid cancer
867970|NCT00026533|stage IV follicular thyroid cancer|stage iv follicular thyroid cancer
867971|NCT00026533|thyroid gland medullary carcinoma|thyroid gland medullary carcinoma
867972|NCT00026533|recurrent thyroid cancer|recurrent thyroid cancer
867973|NCT00026533|insular thyroid cancer|insular thyroid cancer
867974|NCT00026494|tumors metastatic to brain|tumors metastatic to brain
867975|NCT00026468|colon cancer|colon cancer
867976|NCT00026468|rectal cancer|rectal cancer
867977|NCT00026468|small intestine cancer|small intestine cancer
867978|NCT00026442|stage IV breast cancer|stage iv breast cancer
867979|NCT00026442|stage IIIA breast cancer|stage iiia breast cancer
867980|NCT00026442|stage IIIB breast cancer|stage iiib breast cancer
867981|NCT00026442|stage IIIC breast cancer|stage iiic breast cancer
867982|NCT00026416|stage III adult soft tissue sarcoma|stage iii adult soft tissue sarcoma
867983|NCT00026416|localized osteosarcoma|localized osteosarcoma
867984|NCT00026416|metastatic osteosarcoma|metastatic osteosarcoma
867985|NCT00026416|stage II adult soft tissue sarcoma|stage ii adult soft tissue sarcoma
867986|NCT00026416|stage IV adult soft tissue sarcoma|stage iv adult soft tissue sarcoma
867989|NCT00026403|stage IV pancreatic cancer|stage iv pancreatic cancer
867990|NCT00026338|stage III pancreatic cancer|stage iii pancreatic cancer
867991|NCT00026338|adenocarcinoma of the pancreas|adenocarcinoma of the pancreas
867992|NCT00026338|stage IV pancreatic cancer|stage iv pancreatic cancer
867993|NCT00026299|stage IV colon cancer|stage iv colon cancer
867994|NCT00026299|stage IV rectal cancer|stage iv rectal cancer
867995|NCT00026299|recurrent colon cancer|recurrent colon cancer
867996|NCT00026299|recurrent rectal cancer|recurrent rectal cancer
867997|NCT00026299|adenocarcinoma of the colon|adenocarcinoma of the colon
867998|NCT00026299|adenocarcinoma of the rectum|adenocarcinoma of the rectum
867999|NCT00026247|bone metastases|bone metastases
868001|NCT00026247|unspecified adult solid tumor, protocol specific|unspecified adult solid tumor, protocol specific
868002|NCT00026195|unspecified adult solid tumor, protocol specific|unspecified adult solid tumor, protocol specific
868003|NCT00026156|recurrent non-small cell lung cancer|recurrent non-small cell lung cancer
868004|NCT00026156|squamous cell lung cancer|squamous cell lung cancer
868005|NCT00026156|large cell lung cancer|large cell lung cancer
868006|NCT00026156|stage IIIB non-small cell lung cancer|stage iiib non-small cell lung cancer
868007|NCT00026156|stage IV non-small cell lung cancer|stage iv non-small cell lung cancer
868008|NCT00026156|adenocarcinoma of the lung|adenocarcinoma of the lung
868009|NCT00026130|stage II pancreatic cancer|stage ii pancreatic cancer
868010|NCT00026130|stage III pancreatic cancer|stage iii pancreatic cancer
868011|NCT00026130|adenocarcinoma of the pancreas|adenocarcinoma of the pancreas
868012|NCT00026117|stage IV colon cancer|stage iv colon cancer
868013|NCT00026117|stage IV breast cancer|stage iv breast cancer
868014|NCT00026117|recurrent breast cancer|recurrent breast cancer
868015|NCT00026117|stage IV rectal cancer|stage iv rectal cancer
868016|NCT00026117|recurrent colon cancer|recurrent colon cancer
868017|NCT00026117|recurrent rectal cancer|recurrent rectal cancer
868018|NCT00026117|male breast cancer|male breast cancer
868019|NCT00026078|stage IV breast cancer|stage iv breast cancer
868020|NCT00026078|recurrent breast cancer|recurrent breast cancer
868021|NCT00025675|recurrent adult brain tumor|recurrent adult brain tumor
868022|NCT00025675|adult meningioma|adult meningioma
868023|NCT00025675|adult glioblastoma|adult glioblastoma
868024|NCT00025675|adult anaplastic astrocytoma|adult anaplastic astrocytoma
868025|NCT00025675|adult anaplastic oligodendroglioma|adult anaplastic oligodendroglioma
868026|NCT00025675|adult pilocytic astrocytoma|adult pilocytic astrocytoma
868027|NCT00025675|adult subependymoma|adult subependymoma
868028|NCT00025675|adult mixed glioma|adult mixed glioma
868029|NCT00025675|adult meningeal hemangiopericytoma|adult meningeal hemangiopericytoma
868030|NCT00025675|adult grade III meningioma|adult grade iii meningioma
868031|NCT00025675|adult giant cell glioblastoma|adult giant cell glioblastoma
868032|NCT00025675|adult gliosarcoma|adult gliosarcoma
868033|NCT00025675|adult grade I meningioma|adult grade i meningioma
868034|NCT00025675|adult grade II meningioma|adult grade ii meningioma
868035|NCT00025662|Peripheral Blood Stem Cell|peripheral blood stem cell
868036|NCT00025662|Melphalan|melphalan
868037|NCT00025662|Fludarabine|fludarabine
868038|NCT00025662|Donor Apheresis|donor apheresis
868039|NCT00025662|Non-Myeloablative|non-myeloablative
868040|NCT00025662|MDS|mds
868041|NCT00025662|Chronic Myeloid Leukemia|chronic myeloid leukemia
868042|NCT00025662|CML|cml
868043|NCT00025662|Chronic Lymphocytic Leukemia|chronic lymphocytic leukemia
868044|NCT00025662|CLL|cll
868045|NCT00025662|Lymphoma|lymphoma
868046|NCT00025662|Non-Hodgkin's Lymphoma|non-hodgkin's lymphoma
868047|NCT00025662|Hodgkin's Disease|hodgkin's disease
868048|NCT00025662|Mantle Cell Lymphoma|mantle cell lymphoma
868049|NCT00025662|Acute Myelogenous Leukemia (AML)|acute myelogenous leukemia (aml)
868050|NCT00025662|Chronic Myeloid Leukemia (CML)|chronic myeloid leukemia (cml)
868051|NCT00025662|Chronic Lymphocytic Leukemia (CLL)|chronic lymphocytic leukemia (cll)
868052|NCT00025662|Myelodysplasia (MDS)|myelodysplasia (mds)
868053|NCT00025662|Acute Lymphoblastic Leukemia (ALL)|acute lymphoblastic leukemia (all)
868054|NCT00025662|Bone Marrow Transplant|bone marrow transplant
868055|NCT00025649|localized resectable neuroblastoma|localized resectable neuroblastoma
868056|NCT00025649|regional neuroblastoma|regional neuroblastoma
868057|NCT00025649|disseminated neuroblastoma|disseminated neuroblastoma
868058|NCT00025649|stage 4S neuroblastoma|stage 4s neuroblastoma
868059|NCT00025649|localized unresectable neuroblastoma|localized unresectable neuroblastoma
868060|NCT00025636|recurrent adult Hodgkin lymphoma|recurrent adult hodgkin lymphoma
868061|NCT00025623|disseminated neuroblastoma|disseminated neuroblastoma
868062|NCT00025610|disseminated neuroblastoma|disseminated neuroblastoma
868063|NCT00025610|stage 4S neuroblastoma|stage 4s neuroblastoma
868064|NCT00025597|localized unresectable neuroblastoma|localized unresectable neuroblastoma
868065|NCT00025558|childhood central nervous system germ cell tumor|childhood central nervous system germ cell tumor
868066|NCT00025558|recurrent adult brain tumor|recurrent adult brain tumor
868067|NCT00025558|adult medulloblastoma|adult medulloblastoma
868068|NCT00025558|adult glioblastoma|adult glioblastoma
868069|NCT00025558|adult anaplastic astrocytoma|adult anaplastic astrocytoma
868070|NCT00025558|adult anaplastic oligodendroglioma|adult anaplastic oligodendroglioma
868071|NCT00025558|adult mixed glioma|adult mixed glioma
868141|NCT00025194|recurrent prostate cancer|recurrent prostate cancer
868072|NCT00025558|adult central nervous system germ cell tumor|adult central nervous system germ cell tumor
868073|NCT00025558|adult pineoblastoma|adult pineoblastoma
868074|NCT00025558|recurrent childhood supratentorial primitive neuroectodermal tumor|recurrent childhood supratentorial primitive neuroectodermal tumor
868075|NCT00025558|recurrent childhood medulloblastoma|recurrent childhood medulloblastoma
868076|NCT00025558|recurrent childhood ependymoma|recurrent childhood ependymoma
868077|NCT00025558|adult giant cell glioblastoma|adult giant cell glioblastoma
868078|NCT00025558|adult gliosarcoma|adult gliosarcoma
868079|NCT00025558|adult anaplastic ependymoma|adult anaplastic ependymoma
868080|NCT00025558|adult supratentorial primitive neuroectodermal tumor (PNET)|adult supratentorial primitive neuroectodermal tumor (pnet)
868081|NCT00025519|stage IV renal cell cancer|stage iv renal cell cancer
868082|NCT00025519|recurrent renal cell cancer|recurrent renal cell cancer
868083|NCT00025519|clear cell renal cell carcinoma|clear cell renal cell carcinoma
868084|NCT00025493|stage IV breast cancer|stage iv breast cancer
868085|NCT00025493|recurrent breast cancer|recurrent breast cancer
868086|NCT00025480|stage IIIA non-small cell lung cancer|stage iiia non-small cell lung cancer
868087|NCT00025480|stage IIIB non-small cell lung cancer|stage iiib non-small cell lung cancer
868088|NCT00025454|unspecified adult solid tumor, protocol specific|unspecified adult solid tumor, protocol specific
868089|NCT00025441|chondrosarcoma|chondrosarcoma
868090|NCT00025441|small intestine leiomyosarcoma|small intestine leiomyosarcoma
868091|NCT00025441|fibrosarcomatous osteosarcoma|fibrosarcomatous osteosarcoma
868092|NCT00025441|embryonal childhood rhabdomyosarcoma|embryonal childhood rhabdomyosarcoma
868093|NCT00025441|alveolar childhood rhabdomyosarcoma|alveolar childhood rhabdomyosarcoma
868094|NCT00025441|pleomorphic childhood rhabdomyosarcoma|pleomorphic childhood rhabdomyosarcoma
868095|NCT00025441|mixed childhood rhabdomyosarcoma|mixed childhood rhabdomyosarcoma
868096|NCT00025441|embryonal-botryoid childhood rhabdomyosarcoma|embryonal-botryoid childhood rhabdomyosarcoma
868097|NCT00025441|metastatic childhood soft tissue sarcoma|metastatic childhood soft tissue sarcoma
868098|NCT00025441|extraosseous Ewing sarcoma/peripheral primitive neuroectodermal tumor|extraosseous ewing sarcoma/peripheral primitive neuroectodermal tumor
868099|NCT00025441|childhood fibrosarcoma|childhood fibrosarcoma
868100|NCT00025441|childhood synovial sarcoma|childhood synovial sarcoma
868101|NCT00025441|childhood malignant hemangiopericytoma|childhood malignant hemangiopericytoma
868102|NCT00025441|childhood liposarcoma|childhood liposarcoma
868103|NCT00025441|childhood alveolar soft-part sarcoma|childhood alveolar soft-part sarcoma
868104|NCT00025441|childhood leiomyosarcoma|childhood leiomyosarcoma
868105|NCT00025441|childhood angiosarcoma|childhood angiosarcoma
868106|NCT00025441|childhood epithelioid sarcoma|childhood epithelioid sarcoma
868107|NCT00025441|childhood malignant mesenchymoma|childhood malignant mesenchymoma
868108|NCT00025441|stage IV uterine sarcoma|stage iv uterine sarcoma
868109|NCT00025441|uterine leiomyosarcoma|uterine leiomyosarcoma
868110|NCT00025441|ovarian sarcoma|ovarian sarcoma
868376|NCT00023829|stage IIB prostate cancer|stage iib prostate cancer
868111|NCT00025441|previously untreated childhood rhabdomyosarcoma|previously untreated childhood rhabdomyosarcoma
868112|NCT00025441|childhood desmoplastic small round cell tumor|childhood desmoplastic small round cell tumor
868113|NCT00025428|localized unresectable neuroblastoma|localized unresectable neuroblastoma
868114|NCT00025402|chronic phase chronic myelogenous leukemia|chronic phase chronic myelogenous leukemia
868115|NCT00025402|chronic myelogenous leukemia, BCR-ABL1 positive|chronic myelogenous leukemia, bcr-abl1 positive
868116|NCT00025402|Philadelphia chromosome negative chronic myelogenous leukemia|philadelphia chromosome negative chronic myelogenous leukemia
868117|NCT00025402|childhood chronic myelogenous leukemia|childhood chronic myelogenous leukemia
868118|NCT00025402|atypical chronic myeloid leukemia, BCR-ABL1 negative|atypical chronic myeloid leukemia, bcr-abl1 negative
868119|NCT00025389|stage I non-small cell lung cancer|stage i non-small cell lung cancer
868120|NCT00025389|stage II non-small cell lung cancer|stage ii non-small cell lung cancer
868121|NCT00025389|stage IIIA non-small cell lung cancer|stage iiia non-small cell lung cancer
868122|NCT00025324|childhood central nervous system germ cell tumor|childhood central nervous system germ cell tumor
868123|NCT00025324|adult central nervous system germ cell tumor|adult central nervous system germ cell tumor
868124|NCT00025311|leptomeningeal metastases|leptomeningeal metastases
868125|NCT00025298|stage II nasopharyngeal cancer|stage ii nasopharyngeal cancer
868126|NCT00025298|stage III nasopharyngeal cancer|stage iii nasopharyngeal cancer
868127|NCT00025298|stage IV nasopharyngeal cancer|stage iv nasopharyngeal cancer
868128|NCT00025298|oral complications|oral complications
868129|NCT00025298|drug/agent toxicity by tissue/organ|drug/agent toxicity by tissue/organ
868130|NCT00025298|radiation toxicity|radiation toxicity
868131|NCT00025285|squamous cell lung cancer|squamous cell lung cancer
868132|NCT00025285|large cell lung cancer|large cell lung cancer
868133|NCT00025285|stage IIIB non-small cell lung cancer|stage iiib non-small cell lung cancer
868134|NCT00025285|stage IV non-small cell lung cancer|stage iv non-small cell lung cancer
868135|NCT00025285|adenocarcinoma of the lung|adenocarcinoma of the lung
868136|NCT00025285|adenosquamous cell lung cancer|adenosquamous cell lung cancer
868137|NCT00025285|bronchoalveolar cell lung cancer|bronchoalveolar cell lung cancer
868138|NCT00025272|extensive stage small cell lung cancer|extensive stage small cell lung cancer
868139|NCT00025194|adenocarcinoma of the prostate|adenocarcinoma of the prostate
868140|NCT00025194|stage IV prostate cancer|stage iv prostate cancer
891125|NCT00013533|Leukemia|leukemia
868142|NCT00025181|iris melanoma|iris melanoma
868143|NCT00025181|ciliary body and choroid melanoma, small size|ciliary body and choroid melanoma, small size
868144|NCT00025181|ciliary body and choroid melanoma, medium/large size|ciliary body and choroid melanoma, medium/large size
868145|NCT00025181|extraocular extension melanoma|extraocular extension melanoma
868146|NCT00025181|recurrent intraocular melanoma|recurrent intraocular melanoma
868147|NCT00025181|stage III melanoma|stage iii melanoma
868148|NCT00025181|stage IV melanoma|stage iv melanoma
868149|NCT00025181|recurrent melanoma|recurrent melanoma
868150|NCT00025168|stage III pancreatic cancer|stage iii pancreatic cancer
868151|NCT00025142|stage IV colon cancer|stage iv colon cancer
868152|NCT00025142|stage IV rectal cancer|stage iv rectal cancer
868153|NCT00025142|recurrent colon cancer|recurrent colon cancer
868154|NCT00025142|recurrent rectal cancer|recurrent rectal cancer
868155|NCT00025142|adenocarcinoma of the colon|adenocarcinoma of the colon
868156|NCT00025142|adenocarcinoma of the rectum|adenocarcinoma of the rectum
868157|NCT00025129|stage IV adult Hodgkin lymphoma|stage iv adult hodgkin lymphoma
868158|NCT00025129|recurrent adult Hodgkin lymphoma|recurrent adult hodgkin lymphoma
868159|NCT00025129|stage IV cutaneous T-cell non-Hodgkin lymphoma|stage iv cutaneous t-cell non-hodgkin lymphoma
868160|NCT00025129|recurrent cutaneous T-cell non-Hodgkin lymphoma|recurrent cutaneous t-cell non-hodgkin lymphoma
868161|NCT00025129|small intestine lymphoma|small intestine lymphoma
868162|NCT00025129|unspecified adult solid tumor, protocol specific|unspecified adult solid tumor, protocol specific
868163|NCT00025129|stage IV grade 1 follicular lymphoma|stage iv grade 1 follicular lymphoma
868164|NCT00025129|stage IV grade 2 follicular lymphoma|stage iv grade 2 follicular lymphoma
868165|NCT00025129|stage IV grade 3 follicular lymphoma|stage iv grade 3 follicular lymphoma
868166|NCT00025129|stage IV adult diffuse small cleaved cell lymphoma|stage iv adult diffuse small cleaved cell lymphoma
868167|NCT00025129|stage IV adult diffuse mixed cell lymphoma|stage iv adult diffuse mixed cell lymphoma
868168|NCT00025129|stage IV adult diffuse large cell lymphoma|stage iv adult diffuse large cell lymphoma
868169|NCT00025129|stage IV adult immunoblastic large cell lymphoma|stage iv adult immunoblastic large cell lymphoma
868170|NCT00025129|stage IV adult lymphoblastic lymphoma|stage iv adult lymphoblastic lymphoma
868171|NCT00025129|stage IV adult Burkitt lymphoma|stage iv adult burkitt lymphoma
868172|NCT00025129|recurrent grade 1 follicular lymphoma|recurrent grade 1 follicular lymphoma
868173|NCT00025129|recurrent grade 2 follicular lymphoma|recurrent grade 2 follicular lymphoma
868174|NCT00025129|recurrent grade 3 follicular lymphoma|recurrent grade 3 follicular lymphoma
868175|NCT00025129|recurrent adult diffuse small cleaved cell lymphoma|recurrent adult diffuse small cleaved cell lymphoma
868176|NCT00025129|recurrent adult diffuse mixed cell lymphoma|recurrent adult diffuse mixed cell lymphoma
868177|NCT00025129|recurrent adult diffuse large cell lymphoma|recurrent adult diffuse large cell lymphoma
868178|NCT00025129|recurrent adult immunoblastic large cell lymphoma|recurrent adult immunoblastic large cell lymphoma
868179|NCT00025129|recurrent adult lymphoblastic lymphoma|recurrent adult lymphoblastic lymphoma
868180|NCT00025129|recurrent adult Burkitt lymphoma|recurrent adult burkitt lymphoma
868181|NCT00025129|stage IV adult T-cell leukemia/lymphoma|stage iv adult t-cell leukemia/lymphoma
868182|NCT00025129|recurrent adult T-cell leukemia/lymphoma|recurrent adult t-cell leukemia/lymphoma
868183|NCT00025129|primary central nervous system non-Hodgkin lymphoma|primary central nervous system non-hodgkin lymphoma
868184|NCT00025129|intraocular lymphoma|intraocular lymphoma
868185|NCT00025129|stage IV mantle cell lymphoma|stage iv mantle cell lymphoma
868186|NCT00025129|recurrent mantle cell lymphoma|recurrent mantle cell lymphoma
868187|NCT00025129|angioimmunoblastic T-cell lymphoma|angioimmunoblastic t-cell lymphoma
868188|NCT00025129|anaplastic large cell lymphoma|anaplastic large cell lymphoma
868189|NCT00025129|stage IV mycosis fungoides/Sezary syndrome|stage iv mycosis fungoides/sezary syndrome
868190|NCT00025129|recurrent mycosis fungoides/Sezary syndrome|recurrent mycosis fungoides/sezary syndrome
868191|NCT00025129|recurrent marginal zone lymphoma|recurrent marginal zone lymphoma
868192|NCT00025129|recurrent small lymphocytic lymphoma|recurrent small lymphocytic lymphoma
868193|NCT00025129|stage IV small lymphocytic lymphoma|stage iv small lymphocytic lymphoma
868194|NCT00025129|stage IV marginal zone lymphoma|stage iv marginal zone lymphoma
868195|NCT00025129|extranodal marginal zone B-cell lymphoma of mucosa-associated lymphoid tissue|extranodal marginal zone b-cell lymphoma of mucosa-associated lymphoid tissue
868196|NCT00025129|nodal marginal zone B-cell lymphoma|nodal marginal zone b-cell lymphoma
868197|NCT00025129|splenic marginal zone lymphoma|splenic marginal zone lymphoma
868198|NCT00025103|recurrent Wilms tumor and other childhood kidney tumors|recurrent wilms tumor and other childhood kidney tumors
868199|NCT00025103|clear cell sarcoma of the kidney|clear cell sarcoma of the kidney
868200|NCT00025090|stage I anal cancer|stage i anal cancer
868201|NCT00025090|stage II anal cancer|stage ii anal cancer
868202|NCT00025090|stage IIIA anal cancer|stage iiia anal cancer
868203|NCT00025090|stage IIIB anal cancer|stage iiib anal cancer
868204|NCT00025090|squamous cell carcinoma of the anus|squamous cell carcinoma of the anus
868205|NCT00025090|cloacogenic carcinoma of the anus|cloacogenic carcinoma of the anus
868206|NCT00025090|basaloid carcinoma of the anus|basaloid carcinoma of the anus
868207|NCT00025077|recurrent childhood supratentorial primitive neuroectodermal tumor|recurrent childhood supratentorial primitive neuroectodermal tumor
868208|NCT00025077|recurrent childhood medulloblastoma|recurrent childhood medulloblastoma
868209|NCT00025064|stage II childhood Hodgkin lymphoma|stage ii childhood hodgkin lymphoma
891616|NCT00008827|Obesity|obesity
868210|NCT00025064|stage I childhood Hodgkin lymphoma|stage i childhood hodgkin lymphoma
868211|NCT00025064|stage III childhood Hodgkin lymphoma|stage iii childhood hodgkin lymphoma
868212|NCT00025064|stage IV childhood Hodgkin lymphoma|stage iv childhood hodgkin lymphoma
868213|NCT00025064|recurrent/refractory childhood Hodgkin lymphoma|recurrent/refractory childhood hodgkin lymphoma
868214|NCT00025051|basal cell carcinoma of the skin|basal cell carcinoma of the skin
868215|NCT00025051|squamous cell carcinoma of the skin|squamous cell carcinoma of the skin
868216|NCT00025025|colon cancer|colon cancer
868217|NCT00025025|rectal cancer|rectal cancer
868218|NCT00024466|stage I multiple myeloma|stage i multiple myeloma
868219|NCT00024466|stage II multiple myeloma|stage ii multiple myeloma
868220|NCT00024466|stage III multiple myeloma|stage iii multiple myeloma
868221|NCT00024453|infection|infection
868222|NCT00024440|refractory chronic lymphocytic leukemia|refractory chronic lymphocytic leukemia
868223|NCT00024440|B-cell chronic lymphocytic leukemia|b-cell chronic lymphocytic leukemia
868224|NCT00024427|drug/agent toxicity by tissue/organ|drug/agent toxicity by tissue/organ
868225|NCT00024427|stage II pancreatic cancer|stage ii pancreatic cancer
868226|NCT00024427|stage III pancreatic cancer|stage iii pancreatic cancer
868227|NCT00024427|recurrent pancreatic cancer|recurrent pancreatic cancer
868228|NCT00024427|adenocarcinoma of the pancreas|adenocarcinoma of the pancreas
868229|NCT00024427|stage IV pancreatic cancer|stage iv pancreatic cancer
868230|NCT00024414|adenocarcinoma of the prostate|adenocarcinoma of the prostate
868231|NCT00024414|stage IV prostate cancer|stage iv prostate cancer
868232|NCT00024414|recurrent prostate cancer|recurrent prostate cancer
868233|NCT00024375|recurrent pancreatic cancer|recurrent pancreatic cancer
868234|NCT00024375|stage IV pancreatic cancer|stage iv pancreatic cancer
868235|NCT00024349|stage II bladder cancer|stage ii bladder cancer
868236|NCT00024349|stage III bladder cancer|stage iii bladder cancer
868237|NCT00024349|transitional cell carcinoma of the bladder|transitional cell carcinoma of the bladder
868238|NCT00024349|squamous cell carcinoma of the bladder|squamous cell carcinoma of the bladder
868239|NCT00024349|adenocarcinoma of the bladder|adenocarcinoma of the bladder
868240|NCT00024336|untreated childhood brain stem glioma|untreated childhood brain stem glioma
868241|NCT00024297|thromboembolism|thromboembolism
868242|NCT00024284|unspecified childhood solid tumor, protocol specific|unspecified childhood solid tumor, protocol specific
868243|NCT00024271|localized malignant mesothelioma|localized malignant mesothelioma
868244|NCT00024271|advanced malignant mesothelioma|advanced malignant mesothelioma
868245|NCT00024271|recurrent malignant mesothelioma|recurrent malignant mesothelioma
868246|NCT00024258|metastatic osteosarcoma|metastatic osteosarcoma
868247|NCT00024258|recurrent childhood rhabdomyosarcoma|recurrent childhood rhabdomyosarcoma
868248|NCT00024258|regional neuroblastoma|regional neuroblastoma
868249|NCT00024258|disseminated neuroblastoma|disseminated neuroblastoma
868250|NCT00024258|stage 4S neuroblastoma|stage 4s neuroblastoma
868251|NCT00024258|recurrent neuroblastoma|recurrent neuroblastoma
868377|NCT00023829|stage IIA prostate cancer|stage iia prostate cancer
868252|NCT00024258|stage III childhood liver cancer|stage iii childhood liver cancer
868253|NCT00024258|stage IV childhood liver cancer|stage iv childhood liver cancer
868254|NCT00024258|recurrent childhood liver cancer|recurrent childhood liver cancer
868255|NCT00024258|childhood hepatoblastoma|childhood hepatoblastoma
868256|NCT00024258|stage III Wilms tumor|stage iii wilms tumor
868257|NCT00024258|stage IV Wilms tumor|stage iv wilms tumor
868258|NCT00024258|stage V Wilms tumor|stage v wilms tumor
868259|NCT00024258|recurrent Wilms tumor and other childhood kidney tumors|recurrent wilms tumor and other childhood kidney tumors
868260|NCT00024258|intraocular retinoblastoma|intraocular retinoblastoma
868261|NCT00024258|extraocular retinoblastoma|extraocular retinoblastoma
868262|NCT00024258|recurrent retinoblastoma|recurrent retinoblastoma
868263|NCT00024258|recurrent osteosarcoma|recurrent osteosarcoma
868264|NCT00024258|childhood germ cell tumor|childhood germ cell tumor
868265|NCT00024258|metastatic childhood soft tissue sarcoma|metastatic childhood soft tissue sarcoma
868266|NCT00024258|recurrent childhood soft tissue sarcoma|recurrent childhood soft tissue sarcoma
868267|NCT00024258|localized unresectable neuroblastoma|localized unresectable neuroblastoma
868268|NCT00024258|previously untreated childhood rhabdomyosarcoma|previously untreated childhood rhabdomyosarcoma
868269|NCT00024258|childhood desmoplastic small round cell tumor|childhood desmoplastic small round cell tumor
868270|NCT00024258|untreated childhood medulloblastoma|untreated childhood medulloblastoma
868271|NCT00024258|recurrent childhood medulloblastoma|recurrent childhood medulloblastoma
868272|NCT00024258|previously treated childhood rhabdomyosarcoma|previously treated childhood rhabdomyosarcoma
868273|NCT00024258|metastatic Ewing sarcoma/peripheral primitive neuroectodermal tumor|metastatic ewing sarcoma/peripheral primitive neuroectodermal tumor
868274|NCT00024258|recurrent Ewing sarcoma/peripheral primitive neuroectodermal tumor|recurrent ewing sarcoma/peripheral primitive neuroectodermal tumor
868275|NCT00024258|childhood teratoma|childhood teratoma
868276|NCT00024258|childhood malignant testicular germ cell tumor|childhood malignant testicular germ cell tumor
868277|NCT00024258|childhood malignant ovarian germ cell tumor|childhood malignant ovarian germ cell tumor
868278|NCT00024258|childhood extragonadal germ cell tumor|childhood extragonadal germ cell tumor
868279|NCT00024258|recurrent childhood malignant germ cell tumor|recurrent childhood malignant germ cell tumor
868280|NCT00024245|unspecified adult solid tumor, protocol specific|unspecified adult solid tumor, protocol specific
892598|NCT00005922|Lesions|lesions
868281|NCT00024232|stage IV prostate cancer|stage iv prostate cancer
868282|NCT00024232|recurrent prostate cancer|recurrent prostate cancer
868283|NCT00024193|stage 4S neuroblastoma|stage 4s neuroblastoma
868284|NCT00024180|Waldenström macroglobulinemia|waldenström macroglobulinemia
868285|NCT00024180|recurrent adult acute myeloid leukemia|recurrent adult acute myeloid leukemia
868286|NCT00024180|recurrent adult acute lymphoblastic leukemia|recurrent adult acute lymphoblastic leukemia
868287|NCT00024180|refractory chronic lymphocytic leukemia|refractory chronic lymphocytic leukemia
868288|NCT00024180|untreated adult acute lymphoblastic leukemia|untreated adult acute lymphoblastic leukemia
868289|NCT00024180|untreated adult acute myeloid leukemia|untreated adult acute myeloid leukemia
868290|NCT00024180|recurrent small lymphocytic lymphoma|recurrent small lymphocytic lymphoma
868291|NCT00024167|adenocarcinoma of the prostate|adenocarcinoma of the prostate
868292|NCT00024167|stage IV prostate cancer|stage iv prostate cancer
868293|NCT00024167|recurrent prostate cancer|recurrent prostate cancer
868294|NCT00024167|Strontium-89|strontium-89
868295|NCT00024167|Induction Chemotherapy|induction chemotherapy
868296|NCT00024167|Androgen-Independent Prostate Cancer|androgen-independent prostate cancer
868297|NCT00024115|refractory chronic lymphocytic leukemia|refractory chronic lymphocytic leukemia
868298|NCT00024115|B-cell chronic lymphocytic leukemia|b-cell chronic lymphocytic leukemia
868299|NCT00024115|stage III grade I follicular small cleaved cell lymphoma|stage iii grade i follicular small cleaved cell lymphoma
868300|NCT00024115|stage III grade II follicular mixed cell lymphoma|stage iii grade ii follicular mixed cell lymphoma
868301|NCT00024115|stage III adult diffuse small cleaved cell lymphoma|stage iii adult diffuse small cleaved cell lymphoma
868302|NCT00024115|stage IV grade I follicular small cleaved cell lymphoma|stage iv grade i follicular small cleaved cell lymphoma
868303|NCT00024115|stage IV grade II follicular mixed cell lymphoma|stage iv grade ii follicular mixed cell lymphoma
868304|NCT00024115|stage IV adult diffuse small cleaved cell lymphoma|stage iv adult diffuse small cleaved cell lymphoma
868305|NCT00024115|recurrent grade I follicular small cleaved cell lymphoma|recurrent grade i follicular small cleaved cell lymphoma
868306|NCT00024115|recurrent grade II follicular mixed cell lymphoma|recurrent grade ii follicular mixed cell lymphoma
868307|NCT00024115|recurrent grade III follicular large cell lymphoma|recurrent grade iii follicular large cell lymphoma
868308|NCT00024115|recurrent adult diffuse small cleaved cell lymphoma|recurrent adult diffuse small cleaved cell lymphoma
868309|NCT00024115|recurrent adult diffuse mixed cell lymphoma|recurrent adult diffuse mixed cell lymphoma
868310|NCT00024115|recurrent adult diffuse large cell lymphoma|recurrent adult diffuse large cell lymphoma
868311|NCT00024115|recurrent adult immunoblastic large cell lymphoma|recurrent adult immunoblastic large cell lymphoma
868312|NCT00024115|recurrent adult lymphoblastic lymphoma|recurrent adult lymphoblastic lymphoma
868313|NCT00024115|recurrent adult diffuse small noncleaved cell/Burkitt's lymphoma|recurrent adult diffuse small noncleaved cell/burkitt's lymphoma
868314|NCT00024115|prolymphocytic leukemia|prolymphocytic leukemia
868315|NCT00024115|contiguous stage II grade I follicular small cleaved cell lymphoma|contiguous stage ii grade i follicular small cleaved cell lymphoma
868378|NCT00023790|stage IV breast cancer|stage iv breast cancer
868316|NCT00024115|contiguous stage II grade II follicular mixed cell lymphoma|contiguous stage ii grade ii follicular mixed cell lymphoma
868317|NCT00024115|contiguous stage II adult diffuse small cleaved cell lymphoma|contiguous stage ii adult diffuse small cleaved cell lymphoma
868318|NCT00024115|noncontiguous stage II grade I follicular small cleaved cell lymphoma|noncontiguous stage ii grade i follicular small cleaved cell lymphoma
868319|NCT00024115|noncontiguous stage II grade II follicular mixed cell lymphoma|noncontiguous stage ii grade ii follicular mixed cell lymphoma
868320|NCT00024115|noncontiguous stage II adult diffuse small cleaved cell lymphoma|noncontiguous stage ii adult diffuse small cleaved cell lymphoma
868321|NCT00024115|stage III diffuse small lymphocytic/marginal zone lymphoma|stage iii diffuse small lymphocytic/marginal zone lymphoma
868322|NCT00024115|contiguous stage II diffuse small lymphocytic/marginal zone lymphoma|contiguous stage ii diffuse small lymphocytic/marginal zone lymphoma
868323|NCT00024115|noncontiguous stage II diffuse small lymphocytic/marginal zone lymphoma|noncontiguous stage ii diffuse small lymphocytic/marginal zone lymphoma
868324|NCT00024115|stage IV diffuse small lymphocytic/marginal zone lymphoma|stage iv diffuse small lymphocytic/marginal zone lymphoma
868325|NCT00024115|recurrent diffuse small lymphocytic/marginal zone lymphoma|recurrent diffuse small lymphocytic/marginal zone lymphoma
868326|NCT00024115|recurrent mantle cell lymphoma|recurrent mantle cell lymphoma
868327|NCT00024102|stage I breast cancer|stage i breast cancer
868328|NCT00024102|stage II breast cancer|stage ii breast cancer
868329|NCT00024102|stage IIIA breast cancer|stage iiia breast cancer
868330|NCT00024102|stage IIIB breast cancer|stage iiib breast cancer
868331|NCT00024102|stage IIIC breast cancer|stage iiic breast cancer
868332|NCT00024089|recurrent metastatic squamous neck cancer with occult primary|recurrent metastatic squamous neck cancer with occult primary
868333|NCT00024089|metastatic squamous neck cancer with occult primary squamous cell carcinoma|metastatic squamous neck cancer with occult primary squamous cell carcinoma
868334|NCT00024089|stage IV squamous cell carcinoma of the lip and oral cavity|stage iv squamous cell carcinoma of the lip and oral cavity
868335|NCT00024089|recurrent squamous cell carcinoma of the lip and oral cavity|recurrent squamous cell carcinoma of the lip and oral cavity
868336|NCT00024089|stage IV squamous cell carcinoma of the oropharynx|stage iv squamous cell carcinoma of the oropharynx
868337|NCT00024089|recurrent squamous cell carcinoma of the oropharynx|recurrent squamous cell carcinoma of the oropharynx
868338|NCT00024089|stage IV squamous cell carcinoma of the nasopharynx|stage iv squamous cell carcinoma of the nasopharynx
893915|NCT00001961|Perfusion|perfusion
868339|NCT00024089|recurrent squamous cell carcinoma of the nasopharynx|recurrent squamous cell carcinoma of the nasopharynx
868340|NCT00024089|stage IV squamous cell carcinoma of the hypopharynx|stage iv squamous cell carcinoma of the hypopharynx
868341|NCT00024089|recurrent squamous cell carcinoma of the hypopharynx|recurrent squamous cell carcinoma of the hypopharynx
868342|NCT00024089|stage IV squamous cell carcinoma of the larynx|stage iv squamous cell carcinoma of the larynx
868343|NCT00024089|recurrent squamous cell carcinoma of the larynx|recurrent squamous cell carcinoma of the larynx
868344|NCT00024089|stage IV squamous cell carcinoma of the paranasal sinus and nasal cavity|stage iv squamous cell carcinoma of the paranasal sinus and nasal cavity
868345|NCT00024089|recurrent squamous cell carcinoma of the paranasal sinus and nasal cavity|recurrent squamous cell carcinoma of the paranasal sinus and nasal cavity
868346|NCT00024089|salivary gland squamous cell carcinoma|salivary gland squamous cell carcinoma
868347|NCT00024076|recurrent non-small cell lung cancer|recurrent non-small cell lung cancer
868348|NCT00024076|recurrent small cell lung cancer|recurrent small cell lung cancer
868349|NCT00024076|recurrent malignant mesothelioma|recurrent malignant mesothelioma
868350|NCT00024076|recurrent thymoma and thymic carcinoma|recurrent thymoma and thymic carcinoma
868351|NCT00024076|stage IIIB non-small cell lung cancer|stage iiib non-small cell lung cancer
868352|NCT00024076|stage IV non-small cell lung cancer|stage iv non-small cell lung cancer
868353|NCT00024076|pulmonary carcinoid tumor|pulmonary carcinoid tumor
868354|NCT00024076|lung metastases|lung metastases
868355|NCT00024050|refractory anemia|refractory anemia
868356|NCT00024050|refractory anemia with ringed sideroblasts|refractory anemia with ringed sideroblasts
868357|NCT00024050|de novo myelodysplastic syndromes|de novo myelodysplastic syndromes
868358|NCT00024050|previously treated myelodysplastic syndromes|previously treated myelodysplastic syndromes
868359|NCT00024050|secondary myelodysplastic syndromes|secondary myelodysplastic syndromes
868360|NCT00024050|childhood myelodysplastic syndromes|childhood myelodysplastic syndromes
868361|NCT00023985|stage I non-small cell lung cancer|stage i non-small cell lung cancer
868362|NCT00023985|stage II non-small cell lung cancer|stage ii non-small cell lung cancer
868363|NCT00023985|stage IIIA non-small cell lung cancer|stage iiia non-small cell lung cancer
868364|NCT00023972|stage III pancreatic cancer|stage iii pancreatic cancer
868365|NCT00023972|stage IV pancreatic cancer|stage iv pancreatic cancer
868366|NCT00023894|recurrent endometrial carcinoma|recurrent endometrial carcinoma
868367|NCT00023881|relapsing chronic myelogenous leukemia|relapsing chronic myelogenous leukemia
868368|NCT00023881|chronic phase chronic myelogenous leukemia|chronic phase chronic myelogenous leukemia
868369|NCT00023881|accelerated phase chronic myelogenous leukemia|accelerated phase chronic myelogenous leukemia
868370|NCT00023881|chronic myelogenous leukemia, BCR-ABL1 positive|chronic myelogenous leukemia, bcr-abl1 positive
868371|NCT00023855|unspecified adult solid tumor, protocol specific|unspecified adult solid tumor, protocol specific
868372|NCT00023842|stage 0 bladder cancer|stage 0 bladder cancer
868373|NCT00023842|recurrent bladder cancer|recurrent bladder cancer
868374|NCT00023842|transitional cell carcinoma of the bladder|transitional cell carcinoma of the bladder
868375|NCT00023829|stage III prostate cancer|stage iii prostate cancer
868379|NCT00023790|recurrent breast cancer|recurrent breast cancer
868380|NCT00023790|stage I cutaneous T-cell non-Hodgkin lymphoma|stage i cutaneous t-cell non-hodgkin lymphoma
868381|NCT00023790|stage II cutaneous T-cell non-Hodgkin lymphoma|stage ii cutaneous t-cell non-hodgkin lymphoma
868382|NCT00023790|stage IV cutaneous T-cell non-Hodgkin lymphoma|stage iv cutaneous t-cell non-hodgkin lymphoma
868383|NCT00023790|recurrent cutaneous T-cell non-Hodgkin lymphoma|recurrent cutaneous t-cell non-hodgkin lymphoma
868384|NCT00023790|basal cell carcinoma of the skin|basal cell carcinoma of the skin
868385|NCT00023790|squamous cell carcinoma of the skin|squamous cell carcinoma of the skin
868386|NCT00023790|recurrent skin cancer|recurrent skin cancer
868387|NCT00023790|classic Kaposi sarcoma|classic kaposi sarcoma
868388|NCT00023790|immunosuppressive treatment related Kaposi sarcoma|immunosuppressive treatment related kaposi sarcoma
868389|NCT00023790|AIDS-related Kaposi sarcoma|aids-related kaposi sarcoma
868390|NCT00023790|recurrent Kaposi sarcoma|recurrent kaposi sarcoma
868391|NCT00023790|stage IV squamous cell carcinoma of the lip and oral cavity|stage iv squamous cell carcinoma of the lip and oral cavity
868392|NCT00023790|stage IV basal cell carcinoma of the lip|stage iv basal cell carcinoma of the lip
868393|NCT00023790|stage IV verrucous carcinoma of the oral cavity|stage iv verrucous carcinoma of the oral cavity
868394|NCT00023790|stage IV mucoepidermoid carcinoma of the oral cavity|stage iv mucoepidermoid carcinoma of the oral cavity
868395|NCT00023790|stage IV adenoid cystic carcinoma of the oral cavity|stage iv adenoid cystic carcinoma of the oral cavity
868396|NCT00023790|recurrent squamous cell carcinoma of the lip and oral cavity|recurrent squamous cell carcinoma of the lip and oral cavity
868397|NCT00023790|recurrent basal cell carcinoma of the lip|recurrent basal cell carcinoma of the lip
868398|NCT00023790|recurrent verrucous carcinoma of the oral cavity|recurrent verrucous carcinoma of the oral cavity
868399|NCT00023790|recurrent mucoepidermoid carcinoma of the oral cavity|recurrent mucoepidermoid carcinoma of the oral cavity
868400|NCT00023790|recurrent adenoid cystic carcinoma of the oral cavity|recurrent adenoid cystic carcinoma of the oral cavity
868401|NCT00023790|stage IV squamous cell carcinoma of the oropharynx|stage iv squamous cell carcinoma of the oropharynx
868402|NCT00023790|stage IV lymphoepithelioma of the oropharynx|stage iv lymphoepithelioma of the oropharynx
868403|NCT00023790|recurrent squamous cell carcinoma of the oropharynx|recurrent squamous cell carcinoma of the oropharynx
868404|NCT00023790|recurrent lymphoepithelioma of the oropharynx|recurrent lymphoepithelioma of the oropharynx
868405|NCT00023790|stage IV squamous cell carcinoma of the nasopharynx|stage iv squamous cell carcinoma of the nasopharynx
868406|NCT00023790|stage IV lymphoepithelioma of the nasopharynx|stage iv lymphoepithelioma of the nasopharynx
868407|NCT00023790|recurrent squamous cell carcinoma of the nasopharynx|recurrent squamous cell carcinoma of the nasopharynx
868408|NCT00023790|recurrent lymphoepithelioma of the nasopharynx|recurrent lymphoepithelioma of the nasopharynx
868409|NCT00023790|stage IV squamous cell carcinoma of the hypopharynx|stage iv squamous cell carcinoma of the hypopharynx
868410|NCT00023790|recurrent squamous cell carcinoma of the hypopharynx|recurrent squamous cell carcinoma of the hypopharynx
868411|NCT00023790|stage IV squamous cell carcinoma of the larynx|stage iv squamous cell carcinoma of the larynx
868412|NCT00023790|stage IV verrucous carcinoma of the larynx|stage iv verrucous carcinoma of the larynx
868413|NCT00023790|recurrent squamous cell carcinoma of the larynx|recurrent squamous cell carcinoma of the larynx
868414|NCT00023790|recurrent verrucous carcinoma of the larynx|recurrent verrucous carcinoma of the larynx
868415|NCT00023790|stage IV squamous cell carcinoma of the paranasal sinus and nasal cavity|stage iv squamous cell carcinoma of the paranasal sinus and nasal cavity
868416|NCT00023790|stage IV inverted papilloma of the paranasal sinus and nasal cavity|stage iv inverted papilloma of the paranasal sinus and nasal cavity
868417|NCT00023790|stage IV midline lethal granuloma of the paranasal sinus and nasal cavity|stage iv midline lethal granuloma of the paranasal sinus and nasal cavity
868418|NCT00023790|stage IV esthesioneuroblastoma of the paranasal sinus and nasal cavity|stage iv esthesioneuroblastoma of the paranasal sinus and nasal cavity
868419|NCT00023790|recurrent squamous cell carcinoma of the paranasal sinus and nasal cavity|recurrent squamous cell carcinoma of the paranasal sinus and nasal cavity
868420|NCT00023790|recurrent inverted papilloma of the paranasal sinus and nasal cavity|recurrent inverted papilloma of the paranasal sinus and nasal cavity
868421|NCT00023790|recurrent midline lethal granuloma of the paranasal sinus and nasal cavity|recurrent midline lethal granuloma of the paranasal sinus and nasal cavity
868422|NCT00023790|recurrent esthesioneuroblastoma of the paranasal sinus and nasal cavity|recurrent esthesioneuroblastoma of the paranasal sinus and nasal cavity
868423|NCT00023790|skin metastases|skin metastases
868424|NCT00023790|stage I mycosis fungoides/Sezary syndrome|stage i mycosis fungoides/sezary syndrome
868425|NCT00023790|stage II mycosis fungoides/Sezary syndrome|stage ii mycosis fungoides/sezary syndrome
868426|NCT00023790|stage IV mycosis fungoides/Sezary syndrome|stage iv mycosis fungoides/sezary syndrome
868427|NCT00023790|recurrent mycosis fungoides/Sezary syndrome|recurrent mycosis fungoides/sezary syndrome
868428|NCT00023790|male breast cancer|male breast cancer
868429|NCT00023777|untreated adult acute myeloid leukemia|untreated adult acute myeloid leukemia
868430|NCT00023777|adult acute erythroid leukemia (M6)|adult acute erythroid leukemia (m6)
868431|NCT00023777|adult acute myeloblastic leukemia without maturation (M1)|adult acute myeloblastic leukemia without maturation (m1)
868432|NCT00023777|adult acute myeloblastic leukemia with maturation (M2)|adult acute myeloblastic leukemia with maturation (m2)
868433|NCT00023777|adult acute myelomonocytic leukemia (M4)|adult acute myelomonocytic leukemia (m4)
868434|NCT00023777|adult acute monoblastic leukemia (M5a)|adult acute monoblastic leukemia (m5a)
868435|NCT00023777|adult acute eosinophilic leukemia|adult acute eosinophilic leukemia
876597|NCT00051285|enoximone|enoximone
868436|NCT00023777|adult acute basophilic leukemia|adult acute basophilic leukemia
868437|NCT00023777|adult acute megakaryoblastic leukemia (M7)|adult acute megakaryoblastic leukemia (m7)
868438|NCT00023777|adult acute monocytic leukemia (M5b)|adult acute monocytic leukemia (m5b)
868439|NCT00023777|adult acute minimally differentiated myeloid leukemia (M0)|adult acute minimally differentiated myeloid leukemia (m0)
868440|NCT00023751|stage I rectal cancer|stage i rectal cancer
868441|NCT00023751|adenocarcinoma of the rectum|adenocarcinoma of the rectum
868442|NCT00023686|adenocarcinoma of the prostate|adenocarcinoma of the prostate
868443|NCT00023686|stage IIB prostate cancer|stage iib prostate cancer
868444|NCT00023686|stage IIA prostate cancer|stage iia prostate cancer
868445|NCT00023660|stage III cervical cancer|stage iii cervical cancer
868446|NCT00023660|stage IB cervical cancer|stage ib cervical cancer
868447|NCT00023660|stage IIB cervical cancer|stage iib cervical cancer
868448|NCT00023660|stage IIA cervical cancer|stage iia cervical cancer
868449|NCT00023660|stage IVA cervical cancer|stage iva cervical cancer
868450|NCT00023660|cervical squamous cell carcinoma|cervical squamous cell carcinoma
868451|NCT00023660|cervical adenocarcinoma|cervical adenocarcinoma
868452|NCT00023660|cervical adenosquamous cell carcinoma|cervical adenosquamous cell carcinoma
868453|NCT00023634|stage II gastric cancer|stage ii gastric cancer
868454|NCT00023634|stage III gastric cancer|stage iii gastric cancer
868455|NCT00023634|stage IV gastric cancer|stage iv gastric cancer
868456|NCT00023634|recurrent gastric cancer|recurrent gastric cancer
868457|NCT00023634|adenocarcinoma of the prostate|adenocarcinoma of the prostate
868458|NCT00023634|stage II ovarian epithelial cancer|stage ii ovarian epithelial cancer
868459|NCT00023634|stage III ovarian epithelial cancer|stage iii ovarian epithelial cancer
868460|NCT00023634|stage IV ovarian epithelial cancer|stage iv ovarian epithelial cancer
868461|NCT00023634|recurrent adult brain tumor|recurrent adult brain tumor
868462|NCT00023634|stage IV prostate cancer|stage iv prostate cancer
868463|NCT00023634|recurrent prostate cancer|recurrent prostate cancer
868464|NCT00023634|adult anaplastic astrocytoma|adult anaplastic astrocytoma
868465|NCT00023621|basal cell carcinoma of the skin|basal cell carcinoma of the skin
868466|NCT00022724|recurrent adult brain tumor|recurrent adult brain tumor
868467|NCT00022724|adult glioblastoma|adult glioblastoma
869006|NCT00020358|stage I melanoma|stage i melanoma
868468|NCT00022724|adult anaplastic astrocytoma|adult anaplastic astrocytoma
868469|NCT00022724|adult anaplastic oligodendroglioma|adult anaplastic oligodendroglioma
868470|NCT00022724|adult mixed glioma|adult mixed glioma
868471|NCT00022724|adult giant cell glioblastoma|adult giant cell glioblastoma
868472|NCT00022724|adult gliosarcoma|adult gliosarcoma
868473|NCT00022711|recurrent small cell lung cancer|recurrent small cell lung cancer
868474|NCT00022711|intermediate type small cell lung cancer|intermediate type small cell lung cancer
868475|NCT00022698|stage III colon cancer|stage iii colon cancer
868476|NCT00022698|stage IV colon cancer|stage iv colon cancer
868477|NCT00022698|stage III rectal cancer|stage iii rectal cancer
868478|NCT00022698|stage IV rectal cancer|stage iv rectal cancer
868479|NCT00022698|recurrent colon cancer|recurrent colon cancer
868480|NCT00022698|recurrent rectal cancer|recurrent rectal cancer
868481|NCT00022698|adenocarcinoma of the colon|adenocarcinoma of the colon
868482|NCT00022698|adenocarcinoma of the rectum|adenocarcinoma of the rectum
868483|NCT00022685|recurrent grade 1 follicular lymphoma|recurrent grade 1 follicular lymphoma
868484|NCT00022685|recurrent grade 2 follicular lymphoma|recurrent grade 2 follicular lymphoma
868485|NCT00022646|stage IIIB non-small cell lung cancer|stage iiib non-small cell lung cancer
868486|NCT00022646|stage IV non-small cell lung cancer|stage iv non-small cell lung cancer
868487|NCT00022633|recurrent bladder cancer|recurrent bladder cancer
868488|NCT00022633|stage IV bladder cancer|stage iv bladder cancer
868489|NCT00022633|transitional cell carcinoma of the bladder|transitional cell carcinoma of the bladder
868490|NCT00022633|squamous cell carcinoma of the bladder|squamous cell carcinoma of the bladder
868491|NCT00022633|adenocarcinoma of the bladder|adenocarcinoma of the bladder
868492|NCT00022633|recurrent urethral cancer|recurrent urethral cancer
868493|NCT00022633|anterior urethral cancer|anterior urethral cancer
868494|NCT00022633|posterior urethral cancer|posterior urethral cancer
868495|NCT00022633|urethral cancer associated with invasive bladder cancer|urethral cancer associated with invasive bladder cancer
868496|NCT00022633|metastatic transitional cell cancer of the renal pelvis and ureter|metastatic transitional cell cancer of the renal pelvis and ureter
868497|NCT00022633|regional transitional cell cancer of the renal pelvis and ureter|regional transitional cell cancer of the renal pelvis and ureter
868498|NCT00022633|recurrent transitional cell cancer of the renal pelvis and ureter|recurrent transitional cell cancer of the renal pelvis and ureter
868499|NCT00022620|recurrent endometrial carcinoma|recurrent endometrial carcinoma
868500|NCT00022620|endometrial papillary serous carcinoma|endometrial papillary serous carcinoma
868501|NCT00022607|refractory multiple myeloma|refractory multiple myeloma
868502|NCT00022607|stage I multiple myeloma|stage i multiple myeloma
868503|NCT00022607|stage II multiple myeloma|stage ii multiple myeloma
868504|NCT00022607|stage III multiple myeloma|stage iii multiple myeloma
868505|NCT00022568|stage IV melanoma|stage iv melanoma
868506|NCT00022568|recurrent melanoma|recurrent melanoma
868507|NCT00022516|stage IA breast cancer|stage ia breast cancer
868508|NCT00022516|stage II breast cancer|stage ii breast cancer
868509|NCT00022516|stage IIIA breast cancer|stage iiia breast cancer
868510|NCT00022516|stage IIIB breast cancer|stage iiib breast cancer
868511|NCT00022516|stage IB breast cancer|stage ib breast cancer
868512|NCT00022516|estrogen receptor-negative breast cancer|estrogen receptor-negative breast cancer
868513|NCT00022516|progesterone receptor-negative breast cancer|progesterone receptor-negative breast cancer
868514|NCT00022516|triple-negative breast cancer|triple-negative breast cancer
868515|NCT00022516|low-dose maintenance chemotherapy|low-dose maintenance chemotherapy
868516|NCT00022516|stroma|stroma
868517|NCT00022516|angiogenesis|angiogenesis
868518|NCT00022490|chronic phase chronic myelogenous leukemia|chronic phase chronic myelogenous leukemia
868519|NCT00022490|Philadelphia chromosome positive chronic myelogenous leukemia|philadelphia chromosome positive chronic myelogenous leukemia
868520|NCT00022464|stage IV melanoma|stage iv melanoma
868521|NCT00022464|recurrent melanoma|recurrent melanoma
868522|NCT00022451|recurrent childhood acute lymphoblastic leukemia|recurrent childhood acute lymphoblastic leukemia
868523|NCT00022451|recurrent childhood acute myeloid leukemia|recurrent childhood acute myeloid leukemia
868524|NCT00022451|relapsing chronic myelogenous leukemia|relapsing chronic myelogenous leukemia
868525|NCT00022451|blastic phase chronic myelogenous leukemia|blastic phase chronic myelogenous leukemia
868526|NCT00022451|chronic myelogenous leukemia, BCR-ABL1 positive|chronic myelogenous leukemia, bcr-abl1 positive
868527|NCT00022451|childhood acute promyelocytic leukemia (M3)|childhood acute promyelocytic leukemia (m3)
868528|NCT00022451|acute undifferentiated leukemia|acute undifferentiated leukemia
868529|NCT00022451|juvenile myelomonocytic leukemia|juvenile myelomonocytic leukemia
868530|NCT00022451|childhood chronic myelogenous leukemia|childhood chronic myelogenous leukemia
868531|NCT00022438|stage IV melanoma|stage iv melanoma
868532|NCT00022438|recurrent melanoma|recurrent melanoma
868533|NCT00022425|recurrent breast cancer|recurrent breast cancer
868534|NCT00022412|adenocarcinoma of the prostate|adenocarcinoma of the prostate
868535|NCT00022412|stage I prostate cancer|stage i prostate cancer
868536|NCT00022412|stage II prostate cancer|stage ii prostate cancer
868537|NCT00022399|stage I prostate cancer|stage i prostate cancer
868538|NCT00022399|stage IIB prostate cancer|stage iib prostate cancer
868539|NCT00022399|stage IIA prostate cancer|stage iia prostate cancer
868540|NCT00022399|adenocarcinoma of the prostate|adenocarcinoma of the prostate
869007|NCT00020358|stage II melanoma|stage ii melanoma
868541|NCT00022334|localized resectable adult primary liver cancer|localized resectable adult primary liver cancer
868542|NCT00022334|localized unresectable adult primary liver cancer|localized unresectable adult primary liver cancer
868543|NCT00022334|advanced adult primary liver cancer|advanced adult primary liver cancer
868544|NCT00022334|recurrent adult primary liver cancer|recurrent adult primary liver cancer
868545|NCT00022334|adult primary hepatocellular carcinoma|adult primary hepatocellular carcinoma
868546|NCT00022295|unspecified adult solid tumor, protocol specific|unspecified adult solid tumor, protocol specific
868547|NCT00022230|stage II breast cancer|stage ii breast cancer
868548|NCT00022230|stage IIIA breast cancer|stage iiia breast cancer
868549|NCT00022230|stage IIIB breast cancer|stage iiib breast cancer
868550|NCT00022230|stage IIIC breast cancer|stage iiic breast cancer
868551|NCT00022191|stage IV bladder cancer|stage iv bladder cancer
868552|NCT00022191|transitional cell carcinoma of the bladder|transitional cell carcinoma of the bladder
868553|NCT00022191|urethral cancer associated with invasive bladder cancer|urethral cancer associated with invasive bladder cancer
868554|NCT00022191|metastatic transitional cell cancer of the renal pelvis and ureter|metastatic transitional cell cancer of the renal pelvis and ureter
868555|NCT00022191|regional transitional cell cancer of the renal pelvis and ureter|regional transitional cell cancer of the renal pelvis and ureter
868556|NCT00022152|stage IV breast cancer|stage iv breast cancer
868557|NCT00022152|recurrent breast cancer|recurrent breast cancer
868558|NCT00022126|untreated childhood acute lymphoblastic leukemia|untreated childhood acute lymphoblastic leukemia
868559|NCT00022126|L1 childhood acute lymphoblastic leukemia|l1 childhood acute lymphoblastic leukemia
868560|NCT00022126|L2 childhood acute lymphoblastic leukemia|l2 childhood acute lymphoblastic leukemia
868561|NCT00022126|acute undifferentiated leukemia|acute undifferentiated leukemia
868562|NCT00022087|osteoporosis|osteoporosis
868563|NCT00022087|stage I breast cancer|stage i breast cancer
868564|NCT00022087|stage II breast cancer|stage ii breast cancer
868565|NCT00022087|stage IV breast cancer|stage iv breast cancer
868566|NCT00022087|stage IIIA breast cancer|stage iiia breast cancer
868567|NCT00022087|stage IIIB breast cancer|stage iiib breast cancer
868568|NCT00022087|stage IIIC breast cancer|stage iiic breast cancer
868569|NCT00022074|stage I breast cancer|stage i breast cancer
868570|NCT00022074|stage II breast cancer|stage ii breast cancer
868571|NCT00022074|stage IV breast cancer|stage iv breast cancer
868572|NCT00022074|stage IIIA breast cancer|stage iiia breast cancer
868573|NCT00022074|recurrent breast cancer|recurrent breast cancer
868574|NCT00022074|stage IIIB breast cancer|stage iiib breast cancer
868575|NCT00022074|stage IIIC breast cancer|stage iiic breast cancer
868576|NCT00022074|anxiety disorder|anxiety disorder
868577|NCT00022074|depression|depression
868578|NCT00022074|hot flashes|hot flashes
868579|NCT00022048|refractory anemia|refractory anemia
868580|NCT00022048|refractory anemia with ringed sideroblasts|refractory anemia with ringed sideroblasts
868581|NCT00022048|refractory anemia with excess blasts|refractory anemia with excess blasts
868582|NCT00022048|refractory anemia with excess blasts in transformation|refractory anemia with excess blasts in transformation
868583|NCT00022048|chronic myelomonocytic leukemia|chronic myelomonocytic leukemia
877021|NCT00001930|Chorea|chorea
868584|NCT00022048|de novo myelodysplastic syndromes|de novo myelodysplastic syndromes
868585|NCT00022048|previously treated myelodysplastic syndromes|previously treated myelodysplastic syndromes
868586|NCT00022048|myelodysplastic/myeloproliferative neoplasm, unclassifiable|myelodysplastic/myeloproliferative neoplasm, unclassifiable
868587|NCT00022048|atypical chronic myeloid leukemia, BCR-ABL1 negative|atypical chronic myeloid leukemia, bcr-abl1 negative
868588|NCT00022035|childhood acute lymphoblastic leukemia in remission|childhood acute lymphoblastic leukemia in remission
868589|NCT00022035|infection|infection
868590|NCT00022022|recurrent non-small cell lung cancer|recurrent non-small cell lung cancer
868591|NCT00022022|stage IIIB non-small cell lung cancer|stage iiib non-small cell lung cancer
868592|NCT00022022|stage IV non-small cell lung cancer|stage iv non-small cell lung cancer
868593|NCT00021450|stage IIB prostate cancer|stage iib prostate cancer
868594|NCT00021450|stage IIA prostate cancer|stage iia prostate cancer
868595|NCT00021424|stage IV squamous cell carcinoma of the lip and oral cavity|stage iv squamous cell carcinoma of the lip and oral cavity
868596|NCT00021424|recurrent squamous cell carcinoma of the lip and oral cavity|recurrent squamous cell carcinoma of the lip and oral cavity
868597|NCT00021424|stage IV squamous cell carcinoma of the oropharynx|stage iv squamous cell carcinoma of the oropharynx
868598|NCT00021424|recurrent squamous cell carcinoma of the oropharynx|recurrent squamous cell carcinoma of the oropharynx
868599|NCT00021424|skin metastases|skin metastases
868600|NCT00021320|stage 0 esophageal cancer|stage 0 esophageal cancer
868601|NCT00021320|stage I esophageal cancer|stage i esophageal cancer
868602|NCT00021320|stage II esophageal cancer|stage ii esophageal cancer
868603|NCT00021320|stage III esophageal cancer|stage iii esophageal cancer
868604|NCT00021320|squamous cell carcinoma of the esophagus|squamous cell carcinoma of the esophagus
868605|NCT00021320|adenocarcinoma of the esophagus|adenocarcinoma of the esophagus
868606|NCT00021242|recurrent childhood acute lymphoblastic leukemia|recurrent childhood acute lymphoblastic leukemia
868607|NCT00021242|recurrent childhood acute myeloid leukemia|recurrent childhood acute myeloid leukemia
868608|NCT00021242|childhood acute promyelocytic leukemia (M3)|childhood acute promyelocytic leukemia (m3)
868609|NCT00021229|childhood central nervous system germ cell tumor|childhood central nervous system germ cell tumor
868610|NCT00021229|childhood high-grade cerebral astrocytoma|childhood high-grade cerebral astrocytoma
868611|NCT00021229|untreated childhood brain stem glioma|untreated childhood brain stem glioma
868612|NCT00021229|recurrent childhood brain stem glioma|recurrent childhood brain stem glioma
868613|NCT00021229|recurrent childhood cerebral astrocytoma|recurrent childhood cerebral astrocytoma
868614|NCT00021164|stage IV melanoma|stage iv melanoma
868615|NCT00021164|recurrent melanoma|recurrent melanoma
868616|NCT00021164|unspecified adult solid tumor, protocol specific|unspecified adult solid tumor, protocol specific
868617|NCT00021125|squamous cell carcinoma of the skin|squamous cell carcinoma of the skin
868618|NCT00021125|stage I squamous cell carcinoma of the lip and oral cavity|stage i squamous cell carcinoma of the lip and oral cavity
868619|NCT00021125|stage II squamous cell carcinoma of the lip and oral cavity|stage ii squamous cell carcinoma of the lip and oral cavity
868620|NCT00021125|stage III squamous cell carcinoma of the lip and oral cavity|stage iii squamous cell carcinoma of the lip and oral cavity
868621|NCT00021125|stage IV squamous cell carcinoma of the lip and oral cavity|stage iv squamous cell carcinoma of the lip and oral cavity
868622|NCT00021125|stage I squamous cell carcinoma of the oropharynx|stage i squamous cell carcinoma of the oropharynx
868623|NCT00021125|stage II squamous cell carcinoma of the oropharynx|stage ii squamous cell carcinoma of the oropharynx
868624|NCT00021125|stage III squamous cell carcinoma of the oropharynx|stage iii squamous cell carcinoma of the oropharynx
868625|NCT00021125|stage IV squamous cell carcinoma of the oropharynx|stage iv squamous cell carcinoma of the oropharynx
868626|NCT00021125|stage I squamous cell carcinoma of the hypopharynx|stage i squamous cell carcinoma of the hypopharynx
868627|NCT00021125|stage II squamous cell carcinoma of the hypopharynx|stage ii squamous cell carcinoma of the hypopharynx
868628|NCT00021125|stage III squamous cell carcinoma of the hypopharynx|stage iii squamous cell carcinoma of the hypopharynx
868629|NCT00021125|stage IV squamous cell carcinoma of the hypopharynx|stage iv squamous cell carcinoma of the hypopharynx
868630|NCT00021125|stage I squamous cell carcinoma of the larynx|stage i squamous cell carcinoma of the larynx
868631|NCT00021125|stage II squamous cell carcinoma of the larynx|stage ii squamous cell carcinoma of the larynx
868632|NCT00021125|stage III squamous cell carcinoma of the larynx|stage iii squamous cell carcinoma of the larynx
868633|NCT00021125|stage IV squamous cell carcinoma of the larynx|stage iv squamous cell carcinoma of the larynx
868634|NCT00021125|stage I squamous cell carcinoma of the paranasal sinus and nasal cavity|stage i squamous cell carcinoma of the paranasal sinus and nasal cavity
868635|NCT00021125|stage II squamous cell carcinoma of the paranasal sinus and nasal cavity|stage ii squamous cell carcinoma of the paranasal sinus and nasal cavity
868636|NCT00021125|stage III squamous cell carcinoma of the paranasal sinus and nasal cavity|stage iii squamous cell carcinoma of the paranasal sinus and nasal cavity
868637|NCT00021125|stage IV squamous cell carcinoma of the paranasal sinus and nasal cavity|stage iv squamous cell carcinoma of the paranasal sinus and nasal cavity
868638|NCT00021125|salivary gland squamous cell carcinoma|salivary gland squamous cell carcinoma
868639|NCT00021125|stage I salivary gland cancer|stage i salivary gland cancer
868640|NCT00021125|stage II salivary gland cancer|stage ii salivary gland cancer
868641|NCT00021125|stage III salivary gland cancer|stage iii salivary gland cancer
868642|NCT00021125|stage IV salivary gland cancer|stage iv salivary gland cancer
868643|NCT00021112|stage IIIB non-small cell lung cancer|stage iiib non-small cell lung cancer
877127|NCT00001840|Ischemia|ischemia
868644|NCT00021047|stage IV gastric cancer|stage iv gastric cancer
868645|NCT00021047|recurrent gastric cancer|recurrent gastric cancer
868646|NCT00021047|stage II esophageal cancer|stage ii esophageal cancer
868647|NCT00021047|stage III esophageal cancer|stage iii esophageal cancer
868648|NCT00021047|stage IV esophageal cancer|stage iv esophageal cancer
868649|NCT00021047|recurrent esophageal cancer|recurrent esophageal cancer
868650|NCT00021047|advanced adult primary liver cancer|advanced adult primary liver cancer
868651|NCT00021047|recurrent adult primary liver cancer|recurrent adult primary liver cancer
868652|NCT00021047|unresectable extrahepatic bile duct cancer|unresectable extrahepatic bile duct cancer
868653|NCT00021047|recurrent extrahepatic bile duct cancer|recurrent extrahepatic bile duct cancer
868654|NCT00021047|unspecified adult solid tumor, protocol specific|unspecified adult solid tumor, protocol specific
868655|NCT00021047|untreated metastatic squamous neck cancer with occult primary|untreated metastatic squamous neck cancer with occult primary
868656|NCT00021047|recurrent metastatic squamous neck cancer with occult primary|recurrent metastatic squamous neck cancer with occult primary
868657|NCT00021047|stage IV squamous cell carcinoma of the lip and oral cavity|stage iv squamous cell carcinoma of the lip and oral cavity
868658|NCT00021047|stage IV basal cell carcinoma of the lip|stage iv basal cell carcinoma of the lip
868659|NCT00021047|stage IV verrucous carcinoma of the oral cavity|stage iv verrucous carcinoma of the oral cavity
868660|NCT00021047|stage IV mucoepidermoid carcinoma of the oral cavity|stage iv mucoepidermoid carcinoma of the oral cavity
868661|NCT00021047|stage IV adenoid cystic carcinoma of the oral cavity|stage iv adenoid cystic carcinoma of the oral cavity
868662|NCT00021047|recurrent squamous cell carcinoma of the lip and oral cavity|recurrent squamous cell carcinoma of the lip and oral cavity
868663|NCT00021047|recurrent basal cell carcinoma of the lip|recurrent basal cell carcinoma of the lip
868664|NCT00021047|recurrent verrucous carcinoma of the oral cavity|recurrent verrucous carcinoma of the oral cavity
868665|NCT00021047|recurrent mucoepidermoid carcinoma of the oral cavity|recurrent mucoepidermoid carcinoma of the oral cavity
868666|NCT00021047|recurrent adenoid cystic carcinoma of the oral cavity|recurrent adenoid cystic carcinoma of the oral cavity
868667|NCT00021047|stage IV squamous cell carcinoma of the oropharynx|stage iv squamous cell carcinoma of the oropharynx
868668|NCT00021047|stage IV lymphoepithelioma of the oropharynx|stage iv lymphoepithelioma of the oropharynx
868669|NCT00021047|recurrent squamous cell carcinoma of the oropharynx|recurrent squamous cell carcinoma of the oropharynx
868670|NCT00021047|recurrent lymphoepithelioma of the oropharynx|recurrent lymphoepithelioma of the oropharynx
868671|NCT00021047|stage IV squamous cell carcinoma of the nasopharynx|stage iv squamous cell carcinoma of the nasopharynx
868672|NCT00021047|stage IV lymphoepithelioma of the nasopharynx|stage iv lymphoepithelioma of the nasopharynx
868673|NCT00021047|recurrent squamous cell carcinoma of the nasopharynx|recurrent squamous cell carcinoma of the nasopharynx
868674|NCT00021047|recurrent lymphoepithelioma of the nasopharynx|recurrent lymphoepithelioma of the nasopharynx
869164|NCT00019773|recurrent rectal cancer|recurrent rectal cancer
868675|NCT00021047|stage IV squamous cell carcinoma of the hypopharynx|stage iv squamous cell carcinoma of the hypopharynx
868676|NCT00021047|recurrent squamous cell carcinoma of the hypopharynx|recurrent squamous cell carcinoma of the hypopharynx
868677|NCT00021047|stage IV squamous cell carcinoma of the larynx|stage iv squamous cell carcinoma of the larynx
868678|NCT00021047|stage IV verrucous carcinoma of the larynx|stage iv verrucous carcinoma of the larynx
868679|NCT00021047|recurrent squamous cell carcinoma of the larynx|recurrent squamous cell carcinoma of the larynx
868680|NCT00021047|recurrent verrucous carcinoma of the larynx|recurrent verrucous carcinoma of the larynx
868681|NCT00021047|stage IV squamous cell carcinoma of the paranasal sinus and nasal cavity|stage iv squamous cell carcinoma of the paranasal sinus and nasal cavity
868682|NCT00021047|stage IV inverted papilloma of the paranasal sinus and nasal cavity|stage iv inverted papilloma of the paranasal sinus and nasal cavity
868683|NCT00021047|stage IV midline lethal granuloma of the paranasal sinus and nasal cavity|stage iv midline lethal granuloma of the paranasal sinus and nasal cavity
868684|NCT00021047|stage IV esthesioneuroblastoma of the paranasal sinus and nasal cavity|stage iv esthesioneuroblastoma of the paranasal sinus and nasal cavity
868685|NCT00021047|recurrent squamous cell carcinoma of the paranasal sinus and nasal cavity|recurrent squamous cell carcinoma of the paranasal sinus and nasal cavity
868686|NCT00021047|recurrent inverted papilloma of the paranasal sinus and nasal cavity|recurrent inverted papilloma of the paranasal sinus and nasal cavity
868687|NCT00021047|recurrent midline lethal granuloma of the paranasal sinus and nasal cavity|recurrent midline lethal granuloma of the paranasal sinus and nasal cavity
868688|NCT00021047|recurrent esthesioneuroblastoma of the paranasal sinus and nasal cavity|recurrent esthesioneuroblastoma of the paranasal sinus and nasal cavity
868689|NCT00021047|recurrent salivary gland cancer|recurrent salivary gland cancer
868690|NCT00021047|stage IV salivary gland cancer|stage iv salivary gland cancer
868691|NCT00020995|adenocarcinoma of the prostate|adenocarcinoma of the prostate
868692|NCT00020995|stage I prostate cancer|stage i prostate cancer
868693|NCT00020995|stage IIB prostate cancer|stage iib prostate cancer
868694|NCT00020995|stage IIA prostate cancer|stage iia prostate cancer
868695|NCT00020995|stage III prostate cancer|stage iii prostate cancer
868696|NCT00020995|stage IV prostate cancer|stage iv prostate cancer
868697|NCT00020969|refractory anemia|refractory anemia
868698|NCT00020969|refractory anemia with ringed sideroblasts|refractory anemia with ringed sideroblasts
868699|NCT00020969|refractory anemia with excess blasts|refractory anemia with excess blasts
868700|NCT00020969|refractory anemia with excess blasts in transformation|refractory anemia with excess blasts in transformation
868701|NCT00020969|chronic myelomonocytic leukemia|chronic myelomonocytic leukemia
868702|NCT00020969|de novo myelodysplastic syndromes|de novo myelodysplastic syndromes
868703|NCT00020969|previously treated myelodysplastic syndromes|previously treated myelodysplastic syndromes
868704|NCT00020969|secondary myelodysplastic syndromes|secondary myelodysplastic syndromes
868705|NCT00020969|atypical chronic myeloid leukemia, BCR-ABL1 negative|atypical chronic myeloid leukemia, bcr-abl1 negative
868706|NCT00020969|myelodysplastic/myeloproliferative neoplasm, unclassifiable|myelodysplastic/myeloproliferative neoplasm, unclassifiable
868707|NCT00020943|stage I mantle cell lymphoma|stage i mantle cell lymphoma
868708|NCT00020943|contiguous stage II mantle cell lymphoma|contiguous stage ii mantle cell lymphoma
868709|NCT00020943|noncontiguous stage II mantle cell lymphoma|noncontiguous stage ii mantle cell lymphoma
868710|NCT00020943|stage III mantle cell lymphoma|stage iii mantle cell lymphoma
868711|NCT00020943|stage IV mantle cell lymphoma|stage iv mantle cell lymphoma
868712|NCT00020891|stage I prostate cancer|stage i prostate cancer
868713|NCT00020891|stage IIB prostate cancer|stage iib prostate cancer
868714|NCT00020891|stage IIA prostate cancer|stage iia prostate cancer
868715|NCT00020891|stage III prostate cancer|stage iii prostate cancer
868716|NCT00020891|stage IV prostate cancer|stage iv prostate cancer
868717|NCT00020891|recurrent prostate cancer|recurrent prostate cancer
868718|NCT00020878|non-small cell lung cancer|non-small cell lung cancer
868719|NCT00020852|stage I breast cancer|stage i breast cancer
868720|NCT00020852|stage II breast cancer|stage ii breast cancer
868721|NCT00020839|stage IV melanoma|stage iv melanoma
868722|NCT00020839|recurrent melanoma|recurrent melanoma
868723|NCT00020839|tumors metastatic to brain|tumors metastatic to brain
868724|NCT00020826|adenocarcinoma of the stomach|adenocarcinoma of the stomach
868725|NCT00020800|Waldenström macroglobulinemia|waldenström macroglobulinemia
868726|NCT00020761|stage IV gastric cancer|stage iv gastric cancer
868727|NCT00020761|recurrent gastric cancer|recurrent gastric cancer
868728|NCT00020761|stage IV esophageal cancer|stage iv esophageal cancer
868729|NCT00020761|recurrent esophageal cancer|recurrent esophageal cancer
868730|NCT00020761|adenocarcinoma of the stomach|adenocarcinoma of the stomach
868731|NCT00020761|adenocarcinoma of the esophagus|adenocarcinoma of the esophagus
868732|NCT00020748|unspecified adult solid tumor, protocol specific|unspecified adult solid tumor, protocol specific
868733|NCT00020735|adenocarcinoma of the prostate|adenocarcinoma of the prostate
868734|NCT00020735|stage I prostate cancer|stage i prostate cancer
868735|NCT00020735|stage II prostate cancer|stage ii prostate cancer
868736|NCT00020722|stage IV breast cancer|stage iv breast cancer
868737|NCT00020722|recurrent breast cancer|recurrent breast cancer
868738|NCT00020670|recurrent childhood acute lymphoblastic leukemia|recurrent childhood acute lymphoblastic leukemia
868739|NCT00020670|recurrent adult acute lymphoblastic leukemia|recurrent adult acute lymphoblastic leukemia
868740|NCT00020670|B-cell childhood acute lymphoblastic leukemia|b-cell childhood acute lymphoblastic leukemia
868741|NCT00020670|B-cell adult acute lymphoblastic leukemia|b-cell adult acute lymphoblastic leukemia
868742|NCT00020657|nausea and vomiting|nausea and vomiting
868743|NCT00020657|unspecified adult solid tumor, protocol specific|unspecified adult solid tumor, protocol specific
868744|NCT00020644|unspecified adult solid tumor, protocol specific|unspecified adult solid tumor, protocol specific
868745|NCT00020631|radiation fibrosis|radiation fibrosis
868746|NCT00020579|stage IV cutaneous T-cell non-Hodgkin lymphoma|stage iv cutaneous t-cell non-hodgkin lymphoma
868747|NCT00020579|recurrent cutaneous T-cell non-Hodgkin lymphoma|recurrent cutaneous t-cell non-hodgkin lymphoma
868748|NCT00020579|small intestine lymphoma|small intestine lymphoma
868749|NCT00020579|stage IV grade 1 follicular lymphoma|stage iv grade 1 follicular lymphoma
868750|NCT00020579|stage IV grade 2 follicular lymphoma|stage iv grade 2 follicular lymphoma
868751|NCT00020579|stage IV grade 3 follicular lymphoma|stage iv grade 3 follicular lymphoma
868752|NCT00020579|stage IV adult diffuse small cleaved cell lymphoma|stage iv adult diffuse small cleaved cell lymphoma
868753|NCT00020579|stage IV adult diffuse mixed cell lymphoma|stage iv adult diffuse mixed cell lymphoma
868754|NCT00020579|stage IV adult diffuse large cell lymphoma|stage iv adult diffuse large cell lymphoma
868755|NCT00020579|stage IV adult immunoblastic large cell lymphoma|stage iv adult immunoblastic large cell lymphoma
868756|NCT00020579|stage IV adult lymphoblastic lymphoma|stage iv adult lymphoblastic lymphoma
868757|NCT00020579|stage IV adult Burkitt lymphoma|stage iv adult burkitt lymphoma
868758|NCT00020579|recurrent grade 1 follicular lymphoma|recurrent grade 1 follicular lymphoma
868759|NCT00020579|recurrent grade 2 follicular lymphoma|recurrent grade 2 follicular lymphoma
868760|NCT00020579|recurrent grade 3 follicular lymphoma|recurrent grade 3 follicular lymphoma
868761|NCT00020579|recurrent adult diffuse small cleaved cell lymphoma|recurrent adult diffuse small cleaved cell lymphoma
868762|NCT00020579|recurrent adult diffuse mixed cell lymphoma|recurrent adult diffuse mixed cell lymphoma
868763|NCT00020579|recurrent adult diffuse large cell lymphoma|recurrent adult diffuse large cell lymphoma
868764|NCT00020579|recurrent adult immunoblastic large cell lymphoma|recurrent adult immunoblastic large cell lymphoma
868765|NCT00020579|recurrent adult lymphoblastic lymphoma|recurrent adult lymphoblastic lymphoma
868766|NCT00020579|recurrent adult Burkitt lymphoma|recurrent adult burkitt lymphoma
868767|NCT00020579|stage IV adult T-cell leukemia/lymphoma|stage iv adult t-cell leukemia/lymphoma
868768|NCT00020579|recurrent adult T-cell leukemia/lymphoma|recurrent adult t-cell leukemia/lymphoma
868769|NCT00020579|primary central nervous system non-Hodgkin lymphoma|primary central nervous system non-hodgkin lymphoma
868770|NCT00020579|intraocular lymphoma|intraocular lymphoma
868771|NCT00020579|stage IV mantle cell lymphoma|stage iv mantle cell lymphoma
868772|NCT00020579|recurrent mantle cell lymphoma|recurrent mantle cell lymphoma
868773|NCT00020579|angioimmunoblastic T-cell lymphoma|angioimmunoblastic t-cell lymphoma
868774|NCT00020579|anaplastic large cell lymphoma|anaplastic large cell lymphoma
868775|NCT00020579|stage IV mycosis fungoides/Sezary syndrome|stage iv mycosis fungoides/sezary syndrome
868776|NCT00020579|recurrent mycosis fungoides/Sezary syndrome|recurrent mycosis fungoides/sezary syndrome
868777|NCT00020579|recurrent marginal zone lymphoma|recurrent marginal zone lymphoma
868778|NCT00020579|recurrent small lymphocytic lymphoma|recurrent small lymphocytic lymphoma
868779|NCT00020579|stage IV small lymphocytic lymphoma|stage iv small lymphocytic lymphoma
868780|NCT00020579|stage IV marginal zone lymphoma|stage iv marginal zone lymphoma
868781|NCT00020579|extranodal marginal zone B-cell lymphoma of mucosa-associated lymphoid tissue|extranodal marginal zone b-cell lymphoma of mucosa-associated lymphoid tissue
868782|NCT00020579|nodal marginal zone B-cell lymphoma|nodal marginal zone b-cell lymphoma
868783|NCT00020579|splenic marginal zone lymphoma|splenic marginal zone lymphoma
868784|NCT00020579|male breast cancer|male breast cancer
868785|NCT00020579|stage IIIA breast cancer|stage iiia breast cancer
868786|NCT00020579|stage IIIB breast cancer|stage iiib breast cancer
868787|NCT00020579|stage IIIC breast cancer|stage iiic breast cancer
868788|NCT00020579|stage IV breast cancer|stage iv breast cancer
868789|NCT00020579|recurrent pancreatic cancer|recurrent pancreatic cancer
868790|NCT00020579|stage III pancreatic cancer|stage iii pancreatic cancer
868791|NCT00020579|recurrent colon cancer|recurrent colon cancer
868792|NCT00020579|stage III colon cancer|stage iii colon cancer
868793|NCT00020579|stage IV colon cancer|stage iv colon cancer
868794|NCT00020579|recurrent rectal cancer|recurrent rectal cancer
868795|NCT00020579|stage III rectal cancer|stage iii rectal cancer
868796|NCT00020579|stage IV rectal cancer|stage iv rectal cancer
868797|NCT00020579|recurrent ovarian epithelial cancer|recurrent ovarian epithelial cancer
868798|NCT00020579|recurrent ovarian germ cell tumor|recurrent ovarian germ cell tumor
868799|NCT00020579|stage III ovarian epithelial cancer|stage iii ovarian epithelial cancer
868800|NCT00020579|stage III ovarian germ cell tumor|stage iii ovarian germ cell tumor
868801|NCT00020579|stage IV ovarian epithelial cancer|stage iv ovarian epithelial cancer
868802|NCT00020579|stage IV ovarian germ cell tumor|stage iv ovarian germ cell tumor
868803|NCT00020579|recurrent malignant testicular germ cell tumor|recurrent malignant testicular germ cell tumor
868804|NCT00020579|stage III malignant testicular germ cell tumor|stage iii malignant testicular germ cell tumor
868805|NCT00020579|recurrent cervical cancer|recurrent cervical cancer
868806|NCT00020579|stage III cervical cancer|stage iii cervical cancer
868807|NCT00020579|stage IVA cervical cancer|stage iva cervical cancer
868808|NCT00020579|stage IVB cervical cancer|stage ivb cervical cancer
868809|NCT00020579|recurrent endometrial carcinoma|recurrent endometrial carcinoma
868810|NCT00020579|stage III endometrial carcinoma|stage iii endometrial carcinoma
868811|NCT00020579|stage IV endometrial carcinoma|stage iv endometrial carcinoma
868812|NCT00020579|fallopian tube cancer|fallopian tube cancer
868813|NCT00020579|primary peritoneal cavity cancer|primary peritoneal cavity cancer
868814|NCT00020579|recurrent uterine sarcoma|recurrent uterine sarcoma
868815|NCT00020579|stage III uterine sarcoma|stage iii uterine sarcoma
868816|NCT00020579|stage IV uterine sarcoma|stage iv uterine sarcoma
868817|NCT00020579|recurrent vaginal cancer|recurrent vaginal cancer
868818|NCT00020579|stage III vaginal cancer|stage iii vaginal cancer
868819|NCT00020579|stage IVA vaginal cancer|stage iva vaginal cancer
868820|NCT00020579|stage IVB vaginal cancer|stage ivb vaginal cancer
868821|NCT00020579|recurrent vulvar cancer|recurrent vulvar cancer
868822|NCT00020579|stage III vulvar cancer|stage iii vulvar cancer
868823|NCT00020579|stage IV vulvar cancer|stage iv vulvar cancer
868824|NCT00020579|recurrent anal cancer|recurrent anal cancer
868825|NCT00020579|stage IIIA anal cancer|stage iiia anal cancer
868826|NCT00020579|stage IIIB anal cancer|stage iiib anal cancer
868827|NCT00020579|stage IV anal cancer|stage iv anal cancer
868828|NCT00020579|recurrent esophageal cancer|recurrent esophageal cancer
868829|NCT00020579|stage III esophageal cancer|stage iii esophageal cancer
868830|NCT00020579|stage IV esophageal cancer|stage iv esophageal cancer
868831|NCT00020579|recurrent gastric cancer|recurrent gastric cancer
868832|NCT00020579|stage III gastric cancer|stage iii gastric cancer
868833|NCT00020579|stage IV gastric cancer|stage iv gastric cancer
868834|NCT00020579|recurrent extrahepatic bile duct cancer|recurrent extrahepatic bile duct cancer
868835|NCT00020579|unresectable extrahepatic bile duct cancer|unresectable extrahepatic bile duct cancer
868836|NCT00020579|advanced adult primary liver cancer|advanced adult primary liver cancer
868837|NCT00020579|localized unresectable adult primary liver cancer|localized unresectable adult primary liver cancer
868838|NCT00020579|recurrent adult primary liver cancer|recurrent adult primary liver cancer
868839|NCT00020579|recurrent squamous cell carcinoma of the larynx|recurrent squamous cell carcinoma of the larynx
868840|NCT00020579|recurrent verrucous carcinoma of the larynx|recurrent verrucous carcinoma of the larynx
868841|NCT00020579|stage III squamous cell carcinoma of the larynx|stage iii squamous cell carcinoma of the larynx
868842|NCT00020579|stage III verrucous carcinoma of the larynx|stage iii verrucous carcinoma of the larynx
868843|NCT00020579|stage IV squamous cell carcinoma of the larynx|stage iv squamous cell carcinoma of the larynx
868844|NCT00020579|stage IV verrucous carcinoma of the larynx|stage iv verrucous carcinoma of the larynx
868845|NCT00020579|recurrent basal cell carcinoma of the lip|recurrent basal cell carcinoma of the lip
868846|NCT00020579|recurrent squamous cell carcinoma of the lip and oral cavity|recurrent squamous cell carcinoma of the lip and oral cavity
868847|NCT00020579|stage III basal cell carcinoma of the lip|stage iii basal cell carcinoma of the lip
868848|NCT00020579|stage III squamous cell carcinoma of the lip and oral cavity|stage iii squamous cell carcinoma of the lip and oral cavity
868849|NCT00020579|stage IV basal cell carcinoma of the lip|stage iv basal cell carcinoma of the lip
868850|NCT00020579|stage IV squamous cell carcinoma of the lip and oral cavity|stage iv squamous cell carcinoma of the lip and oral cavity
868851|NCT00020579|recurrent lymphoepithelioma of the oropharynx|recurrent lymphoepithelioma of the oropharynx
868852|NCT00020579|recurrent squamous cell carcinoma of the oropharynx|recurrent squamous cell carcinoma of the oropharynx
868853|NCT00020579|stage III lymphoepithelioma of the oropharynx|stage iii lymphoepithelioma of the oropharynx
868854|NCT00020579|stage III squamous cell carcinoma of the oropharynx|stage iii squamous cell carcinoma of the oropharynx
868855|NCT00020579|stage IV lymphoepithelioma of the oropharynx|stage iv lymphoepithelioma of the oropharynx
868856|NCT00020579|stage IV squamous cell carcinoma of the oropharynx|stage iv squamous cell carcinoma of the oropharynx
868857|NCT00020579|recurrent lymphoepithelioma of the nasopharynx|recurrent lymphoepithelioma of the nasopharynx
868858|NCT00020579|recurrent squamous cell carcinoma of the nasopharynx|recurrent squamous cell carcinoma of the nasopharynx
868859|NCT00020579|stage III lymphoepithelioma of the nasopharynx|stage iii lymphoepithelioma of the nasopharynx
868860|NCT00020579|stage III squamous cell carcinoma of the nasopharynx|stage iii squamous cell carcinoma of the nasopharynx
868861|NCT00020579|stage IV lymphoepithelioma of the nasopharynx|stage iv lymphoepithelioma of the nasopharynx
868862|NCT00020579|stage IV squamous cell carcinoma of the nasopharynx|stage iv squamous cell carcinoma of the nasopharynx
868863|NCT00020579|recurrent esthesioneuroblastoma of the paranasal sinus and nasal cavity|recurrent esthesioneuroblastoma of the paranasal sinus and nasal cavity
868864|NCT00020579|recurrent inverted papilloma of the paranasal sinus and nasal cavity|recurrent inverted papilloma of the paranasal sinus and nasal cavity
868865|NCT00020579|recurrent midline lethal granuloma of the paranasal sinus and nasal cavity|recurrent midline lethal granuloma of the paranasal sinus and nasal cavity
869008|NCT00020358|stage III melanoma|stage iii melanoma
868866|NCT00020579|recurrent squamous cell carcinoma of the paranasal sinus and nasal cavity|recurrent squamous cell carcinoma of the paranasal sinus and nasal cavity
868867|NCT00020579|stage III esthesioneuroblastoma of the paranasal sinus and nasal cavity|stage iii esthesioneuroblastoma of the paranasal sinus and nasal cavity
868868|NCT00020579|stage III inverted papilloma of the paranasal sinus and nasal cavity|stage iii inverted papilloma of the paranasal sinus and nasal cavity
868869|NCT00020579|stage III midline lethal granuloma of the paranasal sinus and nasal cavity|stage iii midline lethal granuloma of the paranasal sinus and nasal cavity
868870|NCT00020579|stage III squamous cell carcinoma of the paranasal sinus and nasal cavity|stage iii squamous cell carcinoma of the paranasal sinus and nasal cavity
868871|NCT00020579|stage IV esthesioneuroblastoma of the paranasal sinus and nasal cavity|stage iv esthesioneuroblastoma of the paranasal sinus and nasal cavity
868872|NCT00020579|stage IV inverted papilloma of the paranasal sinus and nasal cavity|stage iv inverted papilloma of the paranasal sinus and nasal cavity
868873|NCT00020579|stage IV midline lethal granuloma of the paranasal sinus and nasal cavity|stage iv midline lethal granuloma of the paranasal sinus and nasal cavity
868874|NCT00020579|stage IV squamous cell carcinoma of the paranasal sinus and nasal cavity|stage iv squamous cell carcinoma of the paranasal sinus and nasal cavity
868875|NCT00020579|metastatic parathyroid cancer|metastatic parathyroid cancer
868876|NCT00020579|recurrent parathyroid cancer|recurrent parathyroid cancer
868877|NCT00020579|recurrent salivary gland cancer|recurrent salivary gland cancer
868878|NCT00020579|stage III salivary gland cancer|stage iii salivary gland cancer
868879|NCT00020579|stage IV salivary gland cancer|stage iv salivary gland cancer
868880|NCT00020579|recurrent bladder cancer|recurrent bladder cancer
868881|NCT00020579|recurrent gallbladder cancer|recurrent gallbladder cancer
868882|NCT00020579|stage III bladder cancer|stage iii bladder cancer
868883|NCT00020579|stage IV bladder cancer|stage iv bladder cancer
868884|NCT00020579|unresectable gallbladder cancer|unresectable gallbladder cancer
868885|NCT00020579|recurrent renal cell cancer|recurrent renal cell cancer
868886|NCT00020579|stage III renal cell cancer|stage iii renal cell cancer
868887|NCT00020579|stage IV renal cell cancer|stage iv renal cell cancer
868888|NCT00020579|stage III Wilms tumor|stage iii wilms tumor
868889|NCT00020579|stage IV Wilms tumor|stage iv wilms tumor
868890|NCT00020579|stage V Wilms tumor|stage v wilms tumor
868891|NCT00020579|metastatic transitional cell cancer of the renal pelvis and ureter|metastatic transitional cell cancer of the renal pelvis and ureter
868892|NCT00020579|recurrent transitional cell cancer of the renal pelvis and ureter|recurrent transitional cell cancer of the renal pelvis and ureter
868893|NCT00020579|regional transitional cell cancer of the renal pelvis and ureter|regional transitional cell cancer of the renal pelvis and ureter
868894|NCT00020579|anterior urethral cancer|anterior urethral cancer
868895|NCT00020579|posterior urethral cancer|posterior urethral cancer
868896|NCT00020579|recurrent urethral cancer|recurrent urethral cancer
868897|NCT00020579|recurrent penile cancer|recurrent penile cancer
868898|NCT00020579|stage III penile cancer|stage iii penile cancer
868899|NCT00020579|stage IV penile cancer|stage iv penile cancer
868900|NCT00020579|recurrent prostate cancer|recurrent prostate cancer
868901|NCT00020579|stage III prostate cancer|stage iii prostate cancer
868902|NCT00020579|stage IV prostate cancer|stage iv prostate cancer
868903|NCT00020579|metastatic Ewing sarcoma/peripheral primitive neuroectodermal tumor|metastatic ewing sarcoma/peripheral primitive neuroectodermal tumor
868904|NCT00020579|recurrent Ewing sarcoma/peripheral primitive neuroectodermal tumor|recurrent ewing sarcoma/peripheral primitive neuroectodermal tumor
868905|NCT00020579|metastatic osteosarcoma|metastatic osteosarcoma
868906|NCT00020579|recurrent osteosarcoma|recurrent osteosarcoma
868907|NCT00020579|recurrent adult soft tissue sarcoma|recurrent adult soft tissue sarcoma
868908|NCT00020579|stage III adult soft tissue sarcoma|stage iii adult soft tissue sarcoma
868909|NCT00020579|stage IV adult soft tissue sarcoma|stage iv adult soft tissue sarcoma
868910|NCT00020579|classic Kaposi sarcoma|classic kaposi sarcoma
868911|NCT00020579|AIDS-related Kaposi sarcoma|aids-related kaposi sarcoma
868912|NCT00020579|recurrent Kaposi sarcoma|recurrent kaposi sarcoma
868913|NCT00020579|stage III cutaneous T-cell non-Hodgkin lymphoma|stage iii cutaneous t-cell non-hodgkin lymphoma
868914|NCT00020579|ciliary body and choroid melanoma, medium/large size|ciliary body and choroid melanoma, medium/large size
868915|NCT00020579|ciliary body and choroid melanoma, small size|ciliary body and choroid melanoma, small size
868916|NCT00020579|extraocular extension melanoma|extraocular extension melanoma
868917|NCT00020579|iris melanoma|iris melanoma
868918|NCT00020579|recurrent intraocular melanoma|recurrent intraocular melanoma
868919|NCT00020579|recurrent melanoma|recurrent melanoma
868920|NCT00020579|stage III melanoma|stage iii melanoma
868921|NCT00020579|stage IV melanoma|stage iv melanoma
868922|NCT00020579|extensive stage small cell lung cancer|extensive stage small cell lung cancer
868923|NCT00020579|recurrent non-small cell lung cancer|recurrent non-small cell lung cancer
868924|NCT00020579|recurrent small cell lung cancer|recurrent small cell lung cancer
868925|NCT00020579|stage IIIA non-small cell lung cancer|stage iiia non-small cell lung cancer
868926|NCT00020579|stage IIIB non-small cell lung cancer|stage iiib non-small cell lung cancer
868927|NCT00020579|stage IV non-small cell lung cancer|stage iv non-small cell lung cancer
868928|NCT00020579|recurrent thymoma and thymic carcinoma|recurrent thymoma and thymic carcinoma
868929|NCT00020579|advanced malignant mesothelioma|advanced malignant mesothelioma
868930|NCT00020579|recurrent malignant mesothelioma|recurrent malignant mesothelioma
868931|NCT00020579|recurrent adrenocortical carcinoma|recurrent adrenocortical carcinoma
868932|NCT00020579|stage III adrenocortical carcinoma|stage iii adrenocortical carcinoma
868933|NCT00020579|stage IV adrenocortical carcinoma|stage iv adrenocortical carcinoma
868934|NCT00020579|metastatic gastrointestinal carcinoid tumor|metastatic gastrointestinal carcinoid tumor
868935|NCT00020579|recurrent gastrointestinal carcinoid tumor|recurrent gastrointestinal carcinoid tumor
868936|NCT00020579|regional gastrointestinal carcinoid tumor|regional gastrointestinal carcinoid tumor
868937|NCT00020579|desmoid tumor|desmoid tumor
868938|NCT00020579|newly diagnosed carcinoma of unknown primary|newly diagnosed carcinoma of unknown primary
868939|NCT00020579|recurrent carcinoma of unknown primary|recurrent carcinoma of unknown primary
868940|NCT00020579|undifferentiated carcinoma of unknown primary|undifferentiated carcinoma of unknown primary
868941|NCT00020579|carcinoma of the appendix|carcinoma of the appendix
868942|NCT00020579|recurrent metastatic squamous neck cancer with occult primary|recurrent metastatic squamous neck cancer with occult primary
868943|NCT00020579|untreated metastatic squamous neck cancer with occult primary|untreated metastatic squamous neck cancer with occult primary
868944|NCT00020579|recurrent pituitary tumor|recurrent pituitary tumor
868945|NCT00020579|adult anaplastic astrocytoma|adult anaplastic astrocytoma
868946|NCT00020579|adult astrocytic tumors|adult astrocytic tumors
868947|NCT00020579|adult diffuse astrocytoma|adult diffuse astrocytoma
868948|NCT00020579|adult pilocytic astrocytoma|adult pilocytic astrocytoma
868949|NCT00020579|adult anaplastic oligodendroglioma|adult anaplastic oligodendroglioma
868950|NCT00020579|adult brain stem glioma|adult brain stem glioma
868951|NCT00020579|adult oligodendroglioma|adult oligodendroglioma
868952|NCT00020579|adult mixed glioma|adult mixed glioma
868953|NCT00020579|adult central nervous system germ cell tumor|adult central nervous system germ cell tumor
868954|NCT00020579|adult choroid plexus tumor|adult choroid plexus tumor
868955|NCT00020579|adult craniopharyngioma|adult craniopharyngioma
868956|NCT00020579|adult anaplastic ependymoma|adult anaplastic ependymoma
868957|NCT00020579|adult subependymoma|adult subependymoma
868958|NCT00020579|adult medulloblastoma|adult medulloblastoma
868959|NCT00020579|adult supratentorial primitive neuroectodermal tumor (PNET)|adult supratentorial primitive neuroectodermal tumor (pnet)
868960|NCT00020579|adult ependymoblastoma|adult ependymoblastoma
868961|NCT00020579|adult ependymoma|adult ependymoma
868962|NCT00020579|adult myxopapillary ependymoma|adult myxopapillary ependymoma
868963|NCT00020579|adult anaplastic meningioma|adult anaplastic meningioma
868964|NCT00020579|adult meningeal hemangiopericytoma|adult meningeal hemangiopericytoma
868965|NCT00020579|adult meningioma|adult meningioma
868966|NCT00020579|adult papillary meningioma|adult papillary meningioma
868967|NCT00020579|adult grade I meningioma|adult grade i meningioma
868968|NCT00020579|adult grade II meningioma|adult grade ii meningioma
868969|NCT00020579|adult grade III meningioma|adult grade iii meningioma
868970|NCT00020579|adult pineal parenchymal tumor|adult pineal parenchymal tumor
868971|NCT00020579|recurrent adult brain tumor|recurrent adult brain tumor
868972|NCT00020579|stage IV pancreatic cancer|stage iv pancreatic cancer
868973|NCT00020579|stage III thymoma|stage iii thymoma
868974|NCT00020579|stage IVA thymoma|stage iva thymoma
868975|NCT00020579|stage IVB thymoma|stage ivb thymoma
868976|NCT00020566|localized Ewing sarcoma/peripheral primitive neuroectodermal tumor|localized ewing sarcoma/peripheral primitive neuroectodermal tumor
868977|NCT00020566|metastatic Ewing sarcoma/peripheral primitive neuroectodermal tumor|metastatic ewing sarcoma/peripheral primitive neuroectodermal tumor
868978|NCT00020527|recurrent childhood acute lymphoblastic leukemia|recurrent childhood acute lymphoblastic leukemia
868979|NCT00020527|recurrent childhood rhabdomyosarcoma|recurrent childhood rhabdomyosarcoma
868980|NCT00020527|disseminated neuroblastoma|disseminated neuroblastoma
868981|NCT00020527|recurrent neuroblastoma|recurrent neuroblastoma
868982|NCT00020527|recurrent Wilms tumor and other childhood kidney tumors|recurrent wilms tumor and other childhood kidney tumors
868983|NCT00020527|recurrent childhood lymphoblastic lymphoma|recurrent childhood lymphoblastic lymphoma
868984|NCT00020527|recurrent childhood acute myeloid leukemia|recurrent childhood acute myeloid leukemia
868985|NCT00020527|fever, sweats, and hot flashes|fever, sweats, and hot flashes
868986|NCT00020527|childhood acute promyelocytic leukemia (M3)|childhood acute promyelocytic leukemia (m3)
868987|NCT00020527|recurrent/refractory childhood Hodgkin lymphoma|recurrent/refractory childhood hodgkin lymphoma
868988|NCT00020527|neutropenia|neutropenia
868989|NCT00020527|infection|infection
868990|NCT00020527|recurrent childhood small noncleaved cell lymphoma|recurrent childhood small noncleaved cell lymphoma
868991|NCT00020527|recurrent childhood large cell lymphoma|recurrent childhood large cell lymphoma
868992|NCT00020527|previously treated childhood rhabdomyosarcoma|previously treated childhood rhabdomyosarcoma
868993|NCT00020501|stage IV colon cancer|stage iv colon cancer
868994|NCT00020501|stage IV rectal cancer|stage iv rectal cancer
868995|NCT00020501|recurrent colon cancer|recurrent colon cancer
868996|NCT00020501|recurrent rectal cancer|recurrent rectal cancer
868997|NCT00020501|liver metastases|liver metastases
868998|NCT00020488|unspecified adult solid tumor, protocol specific|unspecified adult solid tumor, protocol specific
868999|NCT00020449|AIDS-related Kaposi sarcoma|aids-related kaposi sarcoma
869000|NCT00020449|recurrent Kaposi sarcoma|recurrent kaposi sarcoma
869001|NCT00020410|stage IV breast cancer|stage iv breast cancer
869002|NCT00020410|recurrent breast cancer|recurrent breast cancer
869003|NCT00020410|male breast cancer|male breast cancer
869004|NCT00020397|recurrent melanoma|recurrent melanoma
869005|NCT00020397|stage IV melanoma|stage iv melanoma
869009|NCT00020358|stage IV melanoma|stage iv melanoma
869010|NCT00020358|recurrent melanoma|recurrent melanoma
869011|NCT00020332|stage IV breast cancer|stage iv breast cancer
869012|NCT00020332|stage IIIA breast cancer|stage iiia breast cancer
869013|NCT00020332|recurrent breast cancer|recurrent breast cancer
869014|NCT00020332|stage IIIB breast cancer|stage iiib breast cancer
869015|NCT00020332|male breast cancer|male breast cancer
869016|NCT00020254|adenocarcinoma of the prostate|adenocarcinoma of the prostate
869017|NCT00020254|recurrent prostate cancer|recurrent prostate cancer
869018|NCT00020189|thromboembolism|thromboembolism
869019|NCT00020189|untreated metastatic squamous neck cancer with occult primary|untreated metastatic squamous neck cancer with occult primary
869020|NCT00020189|recurrent metastatic squamous neck cancer with occult primary|recurrent metastatic squamous neck cancer with occult primary
869021|NCT00020189|metastatic squamous neck cancer with occult primary squamous cell carcinoma|metastatic squamous neck cancer with occult primary squamous cell carcinoma
869022|NCT00020189|stage IV squamous cell carcinoma of the lip and oral cavity|stage iv squamous cell carcinoma of the lip and oral cavity
869023|NCT00020189|recurrent squamous cell carcinoma of the lip and oral cavity|recurrent squamous cell carcinoma of the lip and oral cavity
869024|NCT00020189|stage IV squamous cell carcinoma of the oropharynx|stage iv squamous cell carcinoma of the oropharynx
869025|NCT00020189|recurrent squamous cell carcinoma of the oropharynx|recurrent squamous cell carcinoma of the oropharynx
869026|NCT00020189|stage IV squamous cell carcinoma of the hypopharynx|stage iv squamous cell carcinoma of the hypopharynx
869027|NCT00020189|recurrent squamous cell carcinoma of the hypopharynx|recurrent squamous cell carcinoma of the hypopharynx
869028|NCT00020189|stage IV squamous cell carcinoma of the larynx|stage iv squamous cell carcinoma of the larynx
869029|NCT00020189|recurrent squamous cell carcinoma of the larynx|recurrent squamous cell carcinoma of the larynx
869030|NCT00020189|stage IV squamous cell carcinoma of the paranasal sinus and nasal cavity|stage iv squamous cell carcinoma of the paranasal sinus and nasal cavity
869031|NCT00020189|recurrent squamous cell carcinoma of the paranasal sinus and nasal cavity|recurrent squamous cell carcinoma of the paranasal sinus and nasal cavity
869032|NCT00020189|recurrent salivary gland cancer|recurrent salivary gland cancer
869033|NCT00020189|salivary gland squamous cell carcinoma|salivary gland squamous cell carcinoma
869034|NCT00020189|stage IV salivary gland cancer|stage iv salivary gland cancer
869035|NCT00020176|stage IV breast cancer|stage iv breast cancer
869036|NCT00020176|recurrent breast cancer|recurrent breast cancer
869037|NCT00020176|male breast cancer|male breast cancer
869038|NCT00020150|recurrent childhood rhabdomyosarcoma|recurrent childhood rhabdomyosarcoma
869039|NCT00020150|childhood craniopharyngioma|childhood craniopharyngioma
869040|NCT00020150|recurrent childhood brain tumor|recurrent childhood brain tumor
869041|NCT00020150|recurrent neuroblastoma|recurrent neuroblastoma
869042|NCT00020150|recurrent childhood liver cancer|recurrent childhood liver cancer
869043|NCT00020150|recurrent Wilms tumor and other childhood kidney tumors|recurrent wilms tumor and other childhood kidney tumors
869044|NCT00020150|childhood central nervous system germ cell tumor|childhood central nervous system germ cell tumor
869045|NCT00020150|recurrent osteosarcoma|recurrent osteosarcoma
877128|NCT00001840|MRI|mri
869046|NCT00020150|unspecified childhood solid tumor, protocol specific|unspecified childhood solid tumor, protocol specific
869047|NCT00020150|childhood germ cell tumor|childhood germ cell tumor
869048|NCT00020150|recurrent childhood soft tissue sarcoma|recurrent childhood soft tissue sarcoma
869049|NCT00020150|childhood oligodendroglioma|childhood oligodendroglioma
869050|NCT00020150|childhood choroid plexus tumor|childhood choroid plexus tumor
869051|NCT00020150|childhood grade I meningioma|childhood grade i meningioma
869052|NCT00020150|childhood grade II meningioma|childhood grade ii meningioma
869053|NCT00020150|childhood grade III meningioma|childhood grade iii meningioma
869054|NCT00020150|recurrent childhood cerebellar astrocytoma|recurrent childhood cerebellar astrocytoma
869055|NCT00020150|recurrent childhood cerebral astrocytoma|recurrent childhood cerebral astrocytoma
869056|NCT00020150|recurrent childhood medulloblastoma|recurrent childhood medulloblastoma
869057|NCT00020150|recurrent childhood visual pathway and hypothalamic glioma|recurrent childhood visual pathway and hypothalamic glioma
869058|NCT00020150|previously treated childhood rhabdomyosarcoma|previously treated childhood rhabdomyosarcoma
869059|NCT00020150|recurrent Ewing sarcoma/peripheral primitive neuroectodermal tumor|recurrent ewing sarcoma/peripheral primitive neuroectodermal tumor
869060|NCT00020150|recurrent childhood ependymoma|recurrent childhood ependymoma
869061|NCT00020150|childhood teratoma|childhood teratoma
869062|NCT00020150|childhood malignant testicular germ cell tumor|childhood malignant testicular germ cell tumor
869063|NCT00020150|childhood extragonadal germ cell tumor|childhood extragonadal germ cell tumor
869064|NCT00020150|childhood malignant ovarian germ cell tumor|childhood malignant ovarian germ cell tumor
869065|NCT00020150|recurrent childhood malignant germ cell tumor|recurrent childhood malignant germ cell tumor
869066|NCT00020124|recurrent non-small cell lung cancer|recurrent non-small cell lung cancer
869067|NCT00020124|extensive stage small cell lung cancer|extensive stage small cell lung cancer
869068|NCT00020124|recurrent small cell lung cancer|recurrent small cell lung cancer
869069|NCT00020124|advanced malignant mesothelioma|advanced malignant mesothelioma
869070|NCT00020124|recurrent malignant mesothelioma|recurrent malignant mesothelioma
869071|NCT00020124|stage IIIB non-small cell lung cancer|stage iiib non-small cell lung cancer
869072|NCT00020124|stage IV non-small cell lung cancer|stage iv non-small cell lung cancer
869073|NCT00020124|pulmonary carcinoid tumor|pulmonary carcinoid tumor
893916|NCT00001960|HCM|hcm
869074|NCT00020124|lung metastases|lung metastases
869075|NCT00020111|recurrent childhood acute myeloid leukemia|recurrent childhood acute myeloid leukemia
869076|NCT00020111|childhood acute promyelocytic leukemia (M3)|childhood acute promyelocytic leukemia (m3)
869077|NCT00020111|recurrent childhood acute lymphoblastic leukemia|recurrent childhood acute lymphoblastic leukemia
869078|NCT00020111|recurrent childhood large cell lymphoma|recurrent childhood large cell lymphoma
869079|NCT00020111|recurrent childhood lymphoblastic lymphoma|recurrent childhood lymphoblastic lymphoma
869080|NCT00020111|recurrent childhood small noncleaved cell lymphoma|recurrent childhood small noncleaved cell lymphoma
869081|NCT00020111|recurrent/refractory childhood Hodgkin lymphoma|recurrent/refractory childhood hodgkin lymphoma
869082|NCT00020111|childhood chronic myelogenous leukemia|childhood chronic myelogenous leukemia
869083|NCT00020111|atypical chronic myeloid leukemia, BCR-ABL1 negative|atypical chronic myeloid leukemia, bcr-abl1 negative
869084|NCT00020072|cutaneous T-cell non-Hodgkin lymphoma|cutaneous t-cell non-hodgkin lymphoma
869085|NCT00020072|mycosis fungoides/Sezary syndrome|mycosis fungoides/sezary syndrome
869086|NCT00020007|recurrent non-small cell lung cancer|recurrent non-small cell lung cancer
869087|NCT00020007|limited stage small cell lung cancer|limited stage small cell lung cancer
869088|NCT00020007|extensive stage small cell lung cancer|extensive stage small cell lung cancer
869089|NCT00020007|recurrent small cell lung cancer|recurrent small cell lung cancer
869090|NCT00020007|stage IIIA non-small cell lung cancer|stage iiia non-small cell lung cancer
869091|NCT00020007|stage IIIB non-small cell lung cancer|stage iiib non-small cell lung cancer
869092|NCT00020007|stage IV non-small cell lung cancer|stage iv non-small cell lung cancer
869093|NCT00020007|lung metastases|lung metastases
869094|NCT00020007|bronchoalveolar cell lung cancer|bronchoalveolar cell lung cancer
869095|NCT00020007|pulmonary carcinoid tumor|pulmonary carcinoid tumor
869096|NCT00019994|stage IV melanoma|stage iv melanoma
869097|NCT00019994|recurrent melanoma|recurrent melanoma
869098|NCT00019955|stage I renal cell cancer|stage i renal cell cancer
869099|NCT00019955|stage II renal cell cancer|stage ii renal cell cancer
869100|NCT00019929|stage IIIA non-small cell lung cancer|stage iiia non-small cell lung cancer
869101|NCT00019929|stage IIIB non-small cell lung cancer|stage iiib non-small cell lung cancer
869102|NCT00019916|stage IV breast cancer|stage iv breast cancer
869103|NCT00019916|recurrent breast cancer|recurrent breast cancer
869104|NCT00019916|recurrent ovarian epithelial cancer|recurrent ovarian epithelial cancer
869105|NCT00019916|stage IV ovarian epithelial cancer|stage iv ovarian epithelial cancer
869106|NCT00019864|cardiac toxicity|cardiac toxicity
869107|NCT00019864|localized osteosarcoma|localized osteosarcoma
869108|NCT00019864|metastatic osteosarcoma|metastatic osteosarcoma
869109|NCT00019864|recurrent osteosarcoma|recurrent osteosarcoma
869110|NCT00019838|Waldenström macroglobulinemia|waldenström macroglobulinemia
869111|NCT00019838|refractory chronic lymphocytic leukemia|refractory chronic lymphocytic leukemia
869112|NCT00019838|refractory hairy cell leukemia|refractory hairy cell leukemia
869113|NCT00019838|recurrent grade 1 follicular lymphoma|recurrent grade 1 follicular lymphoma
869114|NCT00019838|recurrent grade 2 follicular lymphoma|recurrent grade 2 follicular lymphoma
869115|NCT00019838|recurrent mantle cell lymphoma|recurrent mantle cell lymphoma
869116|NCT00019838|recurrent marginal zone lymphoma|recurrent marginal zone lymphoma
869117|NCT00019838|recurrent small lymphocytic lymphoma|recurrent small lymphocytic lymphoma
869118|NCT00019838|extranodal marginal zone B-cell lymphoma of mucosa-associated lymphoid tissue|extranodal marginal zone b-cell lymphoma of mucosa-associated lymphoid tissue
869119|NCT00019838|nodal marginal zone B-cell lymphoma|nodal marginal zone b-cell lymphoma
869120|NCT00019838|splenic marginal zone lymphoma|splenic marginal zone lymphoma
869121|NCT00019825|recurrent non-small cell lung cancer|recurrent non-small cell lung cancer
869122|NCT00019825|stage II esophageal cancer|stage ii esophageal cancer
869123|NCT00019825|stage III esophageal cancer|stage iii esophageal cancer
869124|NCT00019825|stage IV esophageal cancer|stage iv esophageal cancer
869125|NCT00019825|recurrent esophageal cancer|recurrent esophageal cancer
869126|NCT00019825|extensive stage small cell lung cancer|extensive stage small cell lung cancer
869127|NCT00019825|recurrent small cell lung cancer|recurrent small cell lung cancer
869128|NCT00019825|advanced malignant mesothelioma|advanced malignant mesothelioma
869129|NCT00019825|recurrent malignant mesothelioma|recurrent malignant mesothelioma
869130|NCT00019825|stage IIIB non-small cell lung cancer|stage iiib non-small cell lung cancer
869131|NCT00019825|stage IV non-small cell lung cancer|stage iv non-small cell lung cancer
869132|NCT00019825|malignant pleural effusion|malignant pleural effusion
869133|NCT00019812|stage IV breast cancer|stage iv breast cancer
869134|NCT00019812|male breast cancer|male breast cancer
869135|NCT00019786|stage IV colon cancer|stage iv colon cancer
869136|NCT00019786|stage IV rectal cancer|stage iv rectal cancer
869137|NCT00019786|recurrent colon cancer|recurrent colon cancer
869138|NCT00019786|recurrent rectal cancer|recurrent rectal cancer
869139|NCT00019786|localized unresectable adult primary liver cancer|localized unresectable adult primary liver cancer
869140|NCT00019786|recurrent adult primary liver cancer|recurrent adult primary liver cancer
869141|NCT00019786|recurrent islet cell carcinoma|recurrent islet cell carcinoma
869142|NCT00019786|adult primary hepatocellular carcinoma|adult primary hepatocellular carcinoma
869143|NCT00019786|adenocarcinoma of the colon|adenocarcinoma of the colon
869144|NCT00019786|adenocarcinoma of the rectum|adenocarcinoma of the rectum
869145|NCT00019786|liver metastases|liver metastases
869146|NCT00019786|adult primary cholangiocellular carcinoma|adult primary cholangiocellular carcinoma
869147|NCT00019786|advanced adult primary liver cancer|advanced adult primary liver cancer
869148|NCT00019786|recurrent childhood liver cancer|recurrent childhood liver cancer
869149|NCT00019786|childhood hepatocellular carcinoma|childhood hepatocellular carcinoma
869150|NCT00019786|stage III childhood liver cancer|stage iii childhood liver cancer
869151|NCT00019786|stage IV childhood liver cancer|stage iv childhood liver cancer
869152|NCT00019786|neuroendocrine carcinoma|neuroendocrine carcinoma
869153|NCT00019773|stage I colon cancer|stage i colon cancer
869154|NCT00019773|stage II colon cancer|stage ii colon cancer
869155|NCT00019773|stage III colon cancer|stage iii colon cancer
869156|NCT00019773|stage IV colon cancer|stage iv colon cancer
869157|NCT00019773|stage 0 colon cancer|stage 0 colon cancer
869158|NCT00019773|stage 0 rectal cancer|stage 0 rectal cancer
869159|NCT00019773|stage I rectal cancer|stage i rectal cancer
869160|NCT00019773|stage II rectal cancer|stage ii rectal cancer
869161|NCT00019773|stage III rectal cancer|stage iii rectal cancer
869162|NCT00019773|stage IV rectal cancer|stage iv rectal cancer
869163|NCT00019773|recurrent colon cancer|recurrent colon cancer
869165|NCT00019773|small intestine adenocarcinoma|small intestine adenocarcinoma
869166|NCT00019773|small intestine lymphoma|small intestine lymphoma
869167|NCT00019773|small intestine leiomyosarcoma|small intestine leiomyosarcoma
869168|NCT00019773|recurrent small intestine cancer|recurrent small intestine cancer
869169|NCT00019773|carcinoma of the appendix|carcinoma of the appendix
869170|NCT00019747|stage IV colon cancer|stage iv colon cancer
869171|NCT00019747|stage IV rectal cancer|stage iv rectal cancer
869172|NCT00019747|recurrent colon cancer|recurrent colon cancer
869173|NCT00019747|recurrent rectal cancer|recurrent rectal cancer
869174|NCT00019669|stage IV melanoma|stage iv melanoma
869175|NCT00019669|recurrent melanoma|recurrent melanoma
869176|NCT00019656|stage IV chronic lymphocytic leukemia|stage iv chronic lymphocytic leukemia
869177|NCT00019656|refractory chronic lymphocytic leukemia|refractory chronic lymphocytic leukemia
869178|NCT00019656|unspecified adult solid tumor, protocol specific|unspecified adult solid tumor, protocol specific
869179|NCT00019656|previously treated myelodysplastic syndromes|previously treated myelodysplastic syndromes
869180|NCT00019656|de novo myelodysplastic syndromes|de novo myelodysplastic syndromes
869181|NCT00019656|recurrent adult diffuse large cell lymphoma|recurrent adult diffuse large cell lymphoma
869182|NCT00019656|recurrent adult diffuse mixed cell lymphoma|recurrent adult diffuse mixed cell lymphoma
869183|NCT00019656|recurrent adult diffuse small cleaved cell lymphoma|recurrent adult diffuse small cleaved cell lymphoma
869184|NCT00019656|recurrent adult Burkitt lymphoma|recurrent adult burkitt lymphoma
869185|NCT00019656|recurrent adult Hodgkin lymphoma|recurrent adult hodgkin lymphoma
869186|NCT00019656|recurrent adult immunoblastic large cell lymphoma|recurrent adult immunoblastic large cell lymphoma
869187|NCT00019656|recurrent adult lymphoblastic lymphoma|recurrent adult lymphoblastic lymphoma
869188|NCT00019656|recurrent grade 1 follicular lymphoma|recurrent grade 1 follicular lymphoma
869189|NCT00019656|recurrent grade 2 follicular lymphoma|recurrent grade 2 follicular lymphoma
869190|NCT00019656|recurrent grade 3 follicular lymphoma|recurrent grade 3 follicular lymphoma
869191|NCT00019656|recurrent mantle cell lymphoma|recurrent mantle cell lymphoma
869192|NCT00019656|secondary myelodysplastic syndromes|secondary myelodysplastic syndromes
869193|NCT00019656|stage IV adult diffuse large cell lymphoma|stage iv adult diffuse large cell lymphoma
869194|NCT00019656|stage IV adult diffuse mixed cell lymphoma|stage iv adult diffuse mixed cell lymphoma
869195|NCT00019656|stage IV adult diffuse small cleaved cell lymphoma|stage iv adult diffuse small cleaved cell lymphoma
869196|NCT00019656|stage IV adult Burkitt lymphoma|stage iv adult burkitt lymphoma
869197|NCT00019656|stage IV adult Hodgkin lymphoma|stage iv adult hodgkin lymphoma
869198|NCT00019656|stage IV adult immunoblastic large cell lymphoma|stage iv adult immunoblastic large cell lymphoma
869199|NCT00019656|stage IV adult lymphoblastic lymphoma|stage iv adult lymphoblastic lymphoma
869200|NCT00019656|stage IV grade 1 follicular lymphoma|stage iv grade 1 follicular lymphoma
869201|NCT00019656|stage IV grade 2 follicular lymphoma|stage iv grade 2 follicular lymphoma
869202|NCT00019656|stage IV grade 3 follicular lymphoma|stage iv grade 3 follicular lymphoma
869203|NCT00019656|stage IV mantle cell lymphoma|stage iv mantle cell lymphoma
869204|NCT00019656|chronic myelomonocytic leukemia|chronic myelomonocytic leukemia
869205|NCT00019656|atypical chronic myeloid leukemia, BCR-ABL1 negative|atypical chronic myeloid leukemia, bcr-abl1 negative
869206|NCT00019656|myelodysplastic/myeloproliferative neoplasm, unclassifiable|myelodysplastic/myeloproliferative neoplasm, unclassifiable
869207|NCT00019656|recurrent marginal zone lymphoma|recurrent marginal zone lymphoma
869208|NCT00019656|recurrent small lymphocytic lymphoma|recurrent small lymphocytic lymphoma
869209|NCT00019656|stage IV small lymphocytic lymphoma|stage iv small lymphocytic lymphoma
869210|NCT00019656|stage IV marginal zone lymphoma|stage iv marginal zone lymphoma
869211|NCT00019656|extranodal marginal zone B-cell lymphoma of mucosa-associated lymphoid tissue|extranodal marginal zone b-cell lymphoma of mucosa-associated lymphoid tissue
869212|NCT00019656|nodal marginal zone B-cell lymphoma|nodal marginal zone b-cell lymphoma
869213|NCT00019656|splenic marginal zone lymphoma|splenic marginal zone lymphoma
869214|NCT00019604|localized unresectable adult primary liver cancer|localized unresectable adult primary liver cancer
869215|NCT00019604|recurrent adult primary liver cancer|recurrent adult primary liver cancer
869216|NCT00019604|liver metastases|liver metastases
869217|NCT00019604|unspecified adult solid tumor, protocol specific|unspecified adult solid tumor, protocol specific
869218|NCT00019591|stage III colon cancer|stage iii colon cancer
869219|NCT00019591|stage IV colon cancer|stage iv colon cancer
869220|NCT00019591|stage III rectal cancer|stage iii rectal cancer
869221|NCT00019591|stage IV rectal cancer|stage iv rectal cancer
869222|NCT00019591|recurrent colon cancer|recurrent colon cancer
869223|NCT00019591|recurrent rectal cancer|recurrent rectal cancer
869224|NCT00019565|unspecified adult solid tumor, protocol specific|unspecified adult solid tumor, protocol specific
869225|NCT00019513|stage IV adult Hodgkin lymphoma|stage iv adult hodgkin lymphoma
869226|NCT00019513|recurrent adult Hodgkin lymphoma|recurrent adult hodgkin lymphoma
869227|NCT00019513|stage IV cutaneous T-cell non-Hodgkin lymphoma|stage iv cutaneous t-cell non-hodgkin lymphoma
869228|NCT00019513|recurrent cutaneous T-cell non-Hodgkin lymphoma|recurrent cutaneous t-cell non-hodgkin lymphoma
869229|NCT00019513|small intestine lymphoma|small intestine lymphoma
869230|NCT00019513|unspecified adult solid tumor, protocol specific|unspecified adult solid tumor, protocol specific
869231|NCT00019513|stage IV grade 1 follicular lymphoma|stage iv grade 1 follicular lymphoma
869232|NCT00019513|stage IV grade 2 follicular lymphoma|stage iv grade 2 follicular lymphoma
869233|NCT00019513|stage IV grade 3 follicular lymphoma|stage iv grade 3 follicular lymphoma
869234|NCT00019513|stage IV adult diffuse small cleaved cell lymphoma|stage iv adult diffuse small cleaved cell lymphoma
869235|NCT00019513|stage IV adult diffuse mixed cell lymphoma|stage iv adult diffuse mixed cell lymphoma
869236|NCT00019513|stage IV adult diffuse large cell lymphoma|stage iv adult diffuse large cell lymphoma
869237|NCT00019513|stage IV adult immunoblastic large cell lymphoma|stage iv adult immunoblastic large cell lymphoma
869238|NCT00019513|stage IV adult lymphoblastic lymphoma|stage iv adult lymphoblastic lymphoma
869239|NCT00019513|stage IV adult Burkitt lymphoma|stage iv adult burkitt lymphoma
869240|NCT00019513|recurrent grade 1 follicular lymphoma|recurrent grade 1 follicular lymphoma
869241|NCT00019513|recurrent grade 2 follicular lymphoma|recurrent grade 2 follicular lymphoma
869242|NCT00019513|recurrent grade 3 follicular lymphoma|recurrent grade 3 follicular lymphoma
869243|NCT00019513|recurrent adult diffuse small cleaved cell lymphoma|recurrent adult diffuse small cleaved cell lymphoma
869244|NCT00019513|recurrent adult diffuse mixed cell lymphoma|recurrent adult diffuse mixed cell lymphoma
869245|NCT00019513|recurrent adult diffuse large cell lymphoma|recurrent adult diffuse large cell lymphoma
869246|NCT00019513|recurrent adult immunoblastic large cell lymphoma|recurrent adult immunoblastic large cell lymphoma
869247|NCT00019513|recurrent adult lymphoblastic lymphoma|recurrent adult lymphoblastic lymphoma
869248|NCT00019513|recurrent adult Burkitt lymphoma|recurrent adult burkitt lymphoma
869249|NCT00019513|stage IV adult T-cell leukemia/lymphoma|stage iv adult t-cell leukemia/lymphoma
869250|NCT00019513|recurrent adult T-cell leukemia/lymphoma|recurrent adult t-cell leukemia/lymphoma
869251|NCT00019513|stage IV mantle cell lymphoma|stage iv mantle cell lymphoma
869252|NCT00019513|recurrent mantle cell lymphoma|recurrent mantle cell lymphoma
869253|NCT00019513|anaplastic large cell lymphoma|anaplastic large cell lymphoma
869254|NCT00019513|stage IV mycosis fungoides/Sezary syndrome|stage iv mycosis fungoides/sezary syndrome
869758|NCT00016926|stage III cervical cancer|stage iii cervical cancer
869255|NCT00019513|recurrent mycosis fungoides/Sezary syndrome|recurrent mycosis fungoides/sezary syndrome
869256|NCT00019513|recurrent adult primary liver cancer|recurrent adult primary liver cancer
869257|NCT00019513|advanced adult primary liver cancer|advanced adult primary liver cancer
869258|NCT00019513|adult primary cholangiocellular carcinoma|adult primary cholangiocellular carcinoma
869259|NCT00019513|stage IV non-small cell lung cancer|stage iv non-small cell lung cancer
869260|NCT00019513|recurrent non-small cell lung cancer|recurrent non-small cell lung cancer
869261|NCT00019513|extensive stage small cell lung cancer|extensive stage small cell lung cancer
869262|NCT00019513|recurrent small cell lung cancer|recurrent small cell lung cancer
869263|NCT00019513|recurrent pancreatic cancer|recurrent pancreatic cancer
869264|NCT00019513|stage IV esophageal cancer|stage iv esophageal cancer
869265|NCT00019513|recurrent esophageal cancer|recurrent esophageal cancer
869266|NCT00019513|recurrent colon cancer|recurrent colon cancer
869267|NCT00019513|stage IV colon cancer|stage iv colon cancer
869268|NCT00019513|recurrent gallbladder cancer|recurrent gallbladder cancer
869269|NCT00019513|unresectable gallbladder cancer|unresectable gallbladder cancer
869270|NCT00019513|cholangiocarcinoma of the gallbladder|cholangiocarcinoma of the gallbladder
869271|NCT00019513|unresectable extrahepatic bile duct cancer|unresectable extrahepatic bile duct cancer
869272|NCT00019513|recurrent extrahepatic bile duct cancer|recurrent extrahepatic bile duct cancer
869273|NCT00019513|cholangiocarcinoma of the extrahepatic bile duct|cholangiocarcinoma of the extrahepatic bile duct
869274|NCT00019513|recurrent marginal zone lymphoma|recurrent marginal zone lymphoma
869275|NCT00019513|recurrent small lymphocytic lymphoma|recurrent small lymphocytic lymphoma
869276|NCT00019513|stage IV small lymphocytic lymphoma|stage iv small lymphocytic lymphoma
869277|NCT00019513|stage IV marginal zone lymphoma|stage iv marginal zone lymphoma
869278|NCT00019513|extranodal marginal zone B-cell lymphoma of mucosa-associated lymphoid tissue|extranodal marginal zone b-cell lymphoma of mucosa-associated lymphoid tissue
869279|NCT00019513|nodal marginal zone B-cell lymphoma|nodal marginal zone b-cell lymphoma
869280|NCT00019513|splenic marginal zone lymphoma|splenic marginal zone lymphoma
869281|NCT00019513|stage IV pancreatic cancer|stage iv pancreatic cancer
869282|NCT00019487|stage IV melanoma|stage iv melanoma
869283|NCT00019487|recurrent melanoma|recurrent melanoma
869284|NCT00019461|recurrent ovarian epithelial cancer|recurrent ovarian epithelial cancer
869285|NCT00019461|fallopian tube cancer|fallopian tube cancer
869286|NCT00019461|primary peritoneal cavity cancer|primary peritoneal cavity cancer
869287|NCT00019422|childhood low-grade cerebral astrocytoma|childhood low-grade cerebral astrocytoma
869288|NCT00019422|recurrent childhood supratentorial primitive neuroectodermal tumor|recurrent childhood supratentorial primitive neuroectodermal tumor
869289|NCT00019422|recurrent childhood cerebellar astrocytoma|recurrent childhood cerebellar astrocytoma
869290|NCT00019422|recurrent childhood cerebral astrocytoma|recurrent childhood cerebral astrocytoma
869291|NCT00019422|recurrent childhood medulloblastoma|recurrent childhood medulloblastoma
869292|NCT00019422|untreated childhood visual pathway and hypothalamic glioma|untreated childhood visual pathway and hypothalamic glioma
869293|NCT00019422|recurrent childhood visual pathway and hypothalamic glioma|recurrent childhood visual pathway and hypothalamic glioma
869294|NCT00019422|recurrent childhood ependymoma|recurrent childhood ependymoma
869295|NCT00019331|stage IV colon cancer|stage iv colon cancer
869296|NCT00019331|recurrent non-small cell lung cancer|recurrent non-small cell lung cancer
869297|NCT00019331|stage II pancreatic cancer|stage ii pancreatic cancer
869298|NCT00019331|stage III pancreatic cancer|stage iii pancreatic cancer
869299|NCT00019331|recurrent pancreatic cancer|recurrent pancreatic cancer
869300|NCT00019331|recurrent colon cancer|recurrent colon cancer
869301|NCT00019331|extensive stage small cell lung cancer|extensive stage small cell lung cancer
869302|NCT00019331|recurrent small cell lung cancer|recurrent small cell lung cancer
869303|NCT00019331|advanced adult primary liver cancer|advanced adult primary liver cancer
869304|NCT00019331|recurrent adult primary liver cancer|recurrent adult primary liver cancer
869305|NCT00019331|stage IV endometrial carcinoma|stage iv endometrial carcinoma
869306|NCT00019331|recurrent endometrial carcinoma|recurrent endometrial carcinoma
869307|NCT00019331|stage III malignant testicular germ cell tumor|stage iii malignant testicular germ cell tumor
869308|NCT00019331|recurrent malignant testicular germ cell tumor|recurrent malignant testicular germ cell tumor
869309|NCT00019331|stage IV papillary thyroid cancer|stage iv papillary thyroid cancer
869310|NCT00019331|stage IV follicular thyroid cancer|stage iv follicular thyroid cancer
869311|NCT00019331|thyroid gland medullary carcinoma|thyroid gland medullary carcinoma
869312|NCT00019331|anaplastic thyroid cancer|anaplastic thyroid cancer
869313|NCT00019331|recurrent thyroid cancer|recurrent thyroid cancer
869314|NCT00019331|stage IV melanoma|stage iv melanoma
869315|NCT00019331|recurrent melanoma|recurrent melanoma
869316|NCT00019331|stage IV non-small cell lung cancer|stage iv non-small cell lung cancer
869317|NCT00019331|unspecified adult solid tumor, protocol specific|unspecified adult solid tumor, protocol specific
869318|NCT00019331|untreated metastatic squamous neck cancer with occult primary|untreated metastatic squamous neck cancer with occult primary
869319|NCT00019331|recurrent metastatic squamous neck cancer with occult primary|recurrent metastatic squamous neck cancer with occult primary
869320|NCT00019331|adult primary hepatocellular carcinoma|adult primary hepatocellular carcinoma
869321|NCT00019331|pulmonary carcinoid tumor|pulmonary carcinoid tumor
869322|NCT00019331|stage IV squamous cell carcinoma of the lip and oral cavity|stage iv squamous cell carcinoma of the lip and oral cavity
869323|NCT00019331|stage IV basal cell carcinoma of the lip|stage iv basal cell carcinoma of the lip
869324|NCT00019331|stage IV verrucous carcinoma of the oral cavity|stage iv verrucous carcinoma of the oral cavity
869325|NCT00019331|stage IV mucoepidermoid carcinoma of the oral cavity|stage iv mucoepidermoid carcinoma of the oral cavity
869326|NCT00019331|stage IV adenoid cystic carcinoma of the oral cavity|stage iv adenoid cystic carcinoma of the oral cavity
869327|NCT00019331|recurrent squamous cell carcinoma of the lip and oral cavity|recurrent squamous cell carcinoma of the lip and oral cavity
869328|NCT00019331|recurrent basal cell carcinoma of the lip|recurrent basal cell carcinoma of the lip
869329|NCT00019331|recurrent verrucous carcinoma of the oral cavity|recurrent verrucous carcinoma of the oral cavity
869330|NCT00019331|recurrent mucoepidermoid carcinoma of the oral cavity|recurrent mucoepidermoid carcinoma of the oral cavity
869331|NCT00019331|recurrent adenoid cystic carcinoma of the oral cavity|recurrent adenoid cystic carcinoma of the oral cavity
869332|NCT00019331|stage IV squamous cell carcinoma of the oropharynx|stage iv squamous cell carcinoma of the oropharynx
869333|NCT00019331|stage IV lymphoepithelioma of the oropharynx|stage iv lymphoepithelioma of the oropharynx
869334|NCT00019331|recurrent squamous cell carcinoma of the oropharynx|recurrent squamous cell carcinoma of the oropharynx
869335|NCT00019331|recurrent lymphoepithelioma of the oropharynx|recurrent lymphoepithelioma of the oropharynx
869336|NCT00019331|stage IV squamous cell carcinoma of the nasopharynx|stage iv squamous cell carcinoma of the nasopharynx
869337|NCT00019331|stage IV lymphoepithelioma of the nasopharynx|stage iv lymphoepithelioma of the nasopharynx
869338|NCT00019331|recurrent squamous cell carcinoma of the nasopharynx|recurrent squamous cell carcinoma of the nasopharynx
869339|NCT00019331|recurrent lymphoepithelioma of the nasopharynx|recurrent lymphoepithelioma of the nasopharynx
869340|NCT00019331|stage IV squamous cell carcinoma of the hypopharynx|stage iv squamous cell carcinoma of the hypopharynx
869341|NCT00019331|recurrent squamous cell carcinoma of the hypopharynx|recurrent squamous cell carcinoma of the hypopharynx
869342|NCT00019331|stage IV squamous cell carcinoma of the larynx|stage iv squamous cell carcinoma of the larynx
869343|NCT00019331|stage IV verrucous carcinoma of the larynx|stage iv verrucous carcinoma of the larynx
869344|NCT00019331|recurrent squamous cell carcinoma of the larynx|recurrent squamous cell carcinoma of the larynx
869345|NCT00019331|recurrent verrucous carcinoma of the larynx|recurrent verrucous carcinoma of the larynx
869346|NCT00019331|stage IV squamous cell carcinoma of the paranasal sinus and nasal cavity|stage iv squamous cell carcinoma of the paranasal sinus and nasal cavity
869347|NCT00019331|stage IV inverted papilloma of the paranasal sinus and nasal cavity|stage iv inverted papilloma of the paranasal sinus and nasal cavity
869348|NCT00019331|stage IV midline lethal granuloma of the paranasal sinus and nasal cavity|stage iv midline lethal granuloma of the paranasal sinus and nasal cavity
869349|NCT00019331|stage IV esthesioneuroblastoma of the paranasal sinus and nasal cavity|stage iv esthesioneuroblastoma of the paranasal sinus and nasal cavity
869350|NCT00019331|recurrent squamous cell carcinoma of the paranasal sinus and nasal cavity|recurrent squamous cell carcinoma of the paranasal sinus and nasal cavity
869351|NCT00019331|recurrent inverted papilloma of the paranasal sinus and nasal cavity|recurrent inverted papilloma of the paranasal sinus and nasal cavity
869352|NCT00019331|recurrent midline lethal granuloma of the paranasal sinus and nasal cavity|recurrent midline lethal granuloma of the paranasal sinus and nasal cavity
869353|NCT00019331|recurrent esthesioneuroblastoma of the paranasal sinus and nasal cavity|recurrent esthesioneuroblastoma of the paranasal sinus and nasal cavity
869354|NCT00019331|insular thyroid cancer|insular thyroid cancer
869355|NCT00019331|recurrent salivary gland cancer|recurrent salivary gland cancer
869356|NCT00019331|stage IV salivary gland cancer|stage iv salivary gland cancer
869357|NCT00019331|stage IV pancreatic cancer|stage iv pancreatic cancer
869358|NCT00019227|stage I adult T-cell leukemia/lymphoma|stage i adult t-cell leukemia/lymphoma
869359|NCT00019227|stage II adult T-cell leukemia/lymphoma|stage ii adult t-cell leukemia/lymphoma
869360|NCT00019227|stage III adult T-cell leukemia/lymphoma|stage iii adult t-cell leukemia/lymphoma
869361|NCT00019227|stage IV adult T-cell leukemia/lymphoma|stage iv adult t-cell leukemia/lymphoma
869362|NCT00019227|recurrent adult T-cell leukemia/lymphoma|recurrent adult t-cell leukemia/lymphoma
869363|NCT00019227|radiation toxicity|radiation toxicity
869364|NCT00019214|recurrent melanoma|recurrent melanoma
869365|NCT00019201|stage I non-small cell lung cancer|stage i non-small cell lung cancer
869366|NCT00019201|stage II non-small cell lung cancer|stage ii non-small cell lung cancer
869367|NCT00019201|stage III non-small cell lung cancer|stage iii non-small cell lung cancer
869368|NCT00019201|limited stage small cell lung cancer|limited stage small cell lung cancer
869369|NCT00019201|stage I nasopharyngeal cancer|stage i nasopharyngeal cancer
869370|NCT00019201|stage II nasopharyngeal cancer|stage ii nasopharyngeal cancer
869371|NCT00019201|stage III nasopharyngeal cancer|stage iii nasopharyngeal cancer
869372|NCT00019201|stage I lip and oral cavity cancer|stage i lip and oral cavity cancer
869373|NCT00019201|stage II lip and oral cavity cancer|stage ii lip and oral cavity cancer
869374|NCT00019201|stage III lip and oral cavity cancer|stage iii lip and oral cavity cancer
869375|NCT00019201|stage I hypopharyngeal cancer|stage i hypopharyngeal cancer
869376|NCT00019201|stage II hypopharyngeal cancer|stage ii hypopharyngeal cancer
869377|NCT00019201|stage III hypopharyngeal cancer|stage iii hypopharyngeal cancer
869378|NCT00019201|stage I laryngeal cancer|stage i laryngeal cancer
869379|NCT00019201|stage II laryngeal cancer|stage ii laryngeal cancer
869380|NCT00019201|stage III laryngeal cancer|stage iii laryngeal cancer
869381|NCT00019201|stage I paranasal sinus and nasal cavity cancer|stage i paranasal sinus and nasal cavity cancer
869382|NCT00019201|stage II paranasal sinus and nasal cavity cancer|stage ii paranasal sinus and nasal cavity cancer
869383|NCT00019201|stage III paranasal sinus and nasal cavity cancer|stage iii paranasal sinus and nasal cavity cancer
869384|NCT00019201|stage I oropharyngeal cancer|stage i oropharyngeal cancer
869385|NCT00019201|stage II oropharyngeal cancer|stage ii oropharyngeal cancer
869386|NCT00019201|stage III oropharyngeal cancer|stage iii oropharyngeal cancer
869387|NCT00019136|recurrent ovarian epithelial cancer|recurrent ovarian epithelial cancer
869388|NCT00019110|stage IV anal cancer|stage iv anal cancer
869389|NCT00019110|recurrent anal cancer|recurrent anal cancer
869390|NCT00019110|stage II esophageal cancer|stage ii esophageal cancer
869391|NCT00019110|stage III esophageal cancer|stage iii esophageal cancer
869392|NCT00019110|stage IV esophageal cancer|stage iv esophageal cancer
869393|NCT00019110|stage IIIA anal cancer|stage iiia anal cancer
869394|NCT00019110|stage IIIB anal cancer|stage iiib anal cancer
869395|NCT00019110|recurrent esophageal cancer|recurrent esophageal cancer
869396|NCT00019110|stage III cervical cancer|stage iii cervical cancer
869397|NCT00019110|stage IV cervical cancer|stage iv cervical cancer
869398|NCT00019110|recurrent cervical cancer|recurrent cervical cancer
869399|NCT00019110|stage III vulvar cancer|stage iii vulvar cancer
869400|NCT00019110|stage IVB vulvar cancer|stage ivb vulvar cancer
869401|NCT00019110|recurrent vulvar cancer|recurrent vulvar cancer
869402|NCT00019110|stage III penile cancer|stage iii penile cancer
869403|NCT00019110|stage IV penile cancer|stage iv penile cancer
869404|NCT00019110|recurrent penile cancer|recurrent penile cancer
869405|NCT00019110|recurrent metastatic squamous neck cancer with occult primary|recurrent metastatic squamous neck cancer with occult primary
869406|NCT00019110|metastatic squamous neck cancer with occult primary squamous cell carcinoma|metastatic squamous neck cancer with occult primary squamous cell carcinoma
869407|NCT00019110|stage III squamous cell carcinoma of the lip and oral cavity|stage iii squamous cell carcinoma of the lip and oral cavity
869408|NCT00019110|stage III basal cell carcinoma of the lip|stage iii basal cell carcinoma of the lip
869409|NCT00019110|stage III verrucous carcinoma of the oral cavity|stage iii verrucous carcinoma of the oral cavity
869410|NCT00019110|stage III mucoepidermoid carcinoma of the oral cavity|stage iii mucoepidermoid carcinoma of the oral cavity
869411|NCT00019110|stage III adenoid cystic carcinoma of the oral cavity|stage iii adenoid cystic carcinoma of the oral cavity
869412|NCT00019110|stage IV squamous cell carcinoma of the lip and oral cavity|stage iv squamous cell carcinoma of the lip and oral cavity
869413|NCT00019110|stage IV basal cell carcinoma of the lip|stage iv basal cell carcinoma of the lip
869414|NCT00019110|stage IV verrucous carcinoma of the oral cavity|stage iv verrucous carcinoma of the oral cavity
869415|NCT00019110|stage IV mucoepidermoid carcinoma of the oral cavity|stage iv mucoepidermoid carcinoma of the oral cavity
869416|NCT00019110|recurrent squamous cell carcinoma of the lip and oral cavity|recurrent squamous cell carcinoma of the lip and oral cavity
869417|NCT00019110|recurrent basal cell carcinoma of the lip|recurrent basal cell carcinoma of the lip
869418|NCT00019110|recurrent verrucous carcinoma of the oral cavity|recurrent verrucous carcinoma of the oral cavity
869419|NCT00019110|recurrent mucoepidermoid carcinoma of the oral cavity|recurrent mucoepidermoid carcinoma of the oral cavity
869420|NCT00019110|recurrent adenoid cystic carcinoma of the oral cavity|recurrent adenoid cystic carcinoma of the oral cavity
869421|NCT00019110|stage III squamous cell carcinoma of the oropharynx|stage iii squamous cell carcinoma of the oropharynx
869422|NCT00019110|stage III lymphoepithelioma of the oropharynx|stage iii lymphoepithelioma of the oropharynx
869423|NCT00019110|stage IV squamous cell carcinoma of the oropharynx|stage iv squamous cell carcinoma of the oropharynx
869424|NCT00019110|stage IV lymphoepithelioma of the oropharynx|stage iv lymphoepithelioma of the oropharynx
869425|NCT00019110|recurrent squamous cell carcinoma of the oropharynx|recurrent squamous cell carcinoma of the oropharynx
869426|NCT00019110|recurrent lymphoepithelioma of the oropharynx|recurrent lymphoepithelioma of the oropharynx
869427|NCT00019110|stage III squamous cell carcinoma of the nasopharynx|stage iii squamous cell carcinoma of the nasopharynx
869428|NCT00019110|stage III lymphoepithelioma of the nasopharynx|stage iii lymphoepithelioma of the nasopharynx
869429|NCT00019110|stage IV squamous cell carcinoma of the nasopharynx|stage iv squamous cell carcinoma of the nasopharynx
869430|NCT00019110|stage IV lymphoepithelioma of the nasopharynx|stage iv lymphoepithelioma of the nasopharynx
869431|NCT00019110|recurrent squamous cell carcinoma of the nasopharynx|recurrent squamous cell carcinoma of the nasopharynx
869432|NCT00019110|recurrent lymphoepithelioma of the nasopharynx|recurrent lymphoepithelioma of the nasopharynx
869433|NCT00019110|stage III squamous cell carcinoma of the hypopharynx|stage iii squamous cell carcinoma of the hypopharynx
869434|NCT00019110|stage IV squamous cell carcinoma of the hypopharynx|stage iv squamous cell carcinoma of the hypopharynx
869435|NCT00019110|recurrent squamous cell carcinoma of the hypopharynx|recurrent squamous cell carcinoma of the hypopharynx
869436|NCT00019110|stage III squamous cell carcinoma of the larynx|stage iii squamous cell carcinoma of the larynx
869437|NCT00019110|stage III verrucous carcinoma of the larynx|stage iii verrucous carcinoma of the larynx
869438|NCT00019110|stage IV squamous cell carcinoma of the larynx|stage iv squamous cell carcinoma of the larynx
869439|NCT00019110|stage IV verrucous carcinoma of the larynx|stage iv verrucous carcinoma of the larynx
869440|NCT00019110|recurrent squamous cell carcinoma of the larynx|recurrent squamous cell carcinoma of the larynx
869441|NCT00019110|recurrent verrucous carcinoma of the larynx|recurrent verrucous carcinoma of the larynx
869442|NCT00019110|stage III squamous cell carcinoma of the paranasal sinus and nasal cavity|stage iii squamous cell carcinoma of the paranasal sinus and nasal cavity
869443|NCT00019110|stage III inverted papilloma of the paranasal sinus and nasal cavity|stage iii inverted papilloma of the paranasal sinus and nasal cavity
877343|NCT00001685|IL-2|il-2
869539|NCT00019019|anaplastic large cell lymphoma|anaplastic large cell lymphoma
869444|NCT00019110|stage III midline lethal granuloma of the paranasal sinus and nasal cavity|stage iii midline lethal granuloma of the paranasal sinus and nasal cavity
869445|NCT00019110|stage III esthesioneuroblastoma of the paranasal sinus and nasal cavity|stage iii esthesioneuroblastoma of the paranasal sinus and nasal cavity
869446|NCT00019110|stage IV squamous cell carcinoma of the paranasal sinus and nasal cavity|stage iv squamous cell carcinoma of the paranasal sinus and nasal cavity
869447|NCT00019110|stage IV inverted papilloma of the paranasal sinus and nasal cavity|stage iv inverted papilloma of the paranasal sinus and nasal cavity
869448|NCT00019110|stage IV midline lethal granuloma of the paranasal sinus and nasal cavity|stage iv midline lethal granuloma of the paranasal sinus and nasal cavity
869449|NCT00019110|stage IV esthesioneuroblastoma of the paranasal sinus and nasal cavity|stage iv esthesioneuroblastoma of the paranasal sinus and nasal cavity
869450|NCT00019110|recurrent squamous cell carcinoma of the paranasal sinus and nasal cavity|recurrent squamous cell carcinoma of the paranasal sinus and nasal cavity
869451|NCT00019110|recurrent inverted papilloma of the paranasal sinus and nasal cavity|recurrent inverted papilloma of the paranasal sinus and nasal cavity
869452|NCT00019110|recurrent midline lethal granuloma of the paranasal sinus and nasal cavity|recurrent midline lethal granuloma of the paranasal sinus and nasal cavity
869453|NCT00019110|recurrent esthesioneuroblastoma of the paranasal sinus and nasal cavity|recurrent esthesioneuroblastoma of the paranasal sinus and nasal cavity
869454|NCT00019110|recurrent salivary gland cancer|recurrent salivary gland cancer
869455|NCT00019110|stage IV salivary gland cancer|stage iv salivary gland cancer
869456|NCT00019110|stage III salivary gland cancer|stage iii salivary gland cancer
869457|NCT00019032|refractory chronic lymphocytic leukemia|refractory chronic lymphocytic leukemia
869458|NCT00019032|T-cell large granular lymphocyte leukemia|t-cell large granular lymphocyte leukemia
869459|NCT00019019|stage III adult Hodgkin lymphoma|stage iii adult hodgkin lymphoma
869460|NCT00019019|stage IV adult Hodgkin lymphoma|stage iv adult hodgkin lymphoma
869461|NCT00019019|stage IV breast cancer|stage iv breast cancer
869462|NCT00019019|stage IIIA breast cancer|stage iiia breast cancer
869463|NCT00019019|recurrent breast cancer|recurrent breast cancer
869464|NCT00019019|stage IIIB breast cancer|stage iiib breast cancer
869465|NCT00019019|recurrent non-small cell lung cancer|recurrent non-small cell lung cancer
869466|NCT00019019|recurrent adult Hodgkin lymphoma|recurrent adult hodgkin lymphoma
869467|NCT00019019|stage III cutaneous T-cell non-Hodgkin lymphoma|stage iii cutaneous t-cell non-hodgkin lymphoma
869468|NCT00019019|stage IV cutaneous T-cell non-Hodgkin lymphoma|stage iv cutaneous t-cell non-hodgkin lymphoma
869469|NCT00019019|recurrent cutaneous T-cell non-Hodgkin lymphoma|recurrent cutaneous t-cell non-hodgkin lymphoma
869470|NCT00019019|stage III renal cell cancer|stage iii renal cell cancer
869471|NCT00019019|stage IV renal cell cancer|stage iv renal cell cancer
869472|NCT00019019|recurrent renal cell cancer|recurrent renal cell cancer
869473|NCT00019019|stage III ovarian epithelial cancer|stage iii ovarian epithelial cancer
869474|NCT00019019|stage IV ovarian epithelial cancer|stage iv ovarian epithelial cancer
869475|NCT00019019|recurrent ovarian epithelial cancer|recurrent ovarian epithelial cancer
869476|NCT00019019|recurrent adult brain tumor|recurrent adult brain tumor
869477|NCT00019019|small intestine lymphoma|small intestine lymphoma
869478|NCT00019019|adult brain stem glioma|adult brain stem glioma
869479|NCT00019019|adult craniopharyngioma|adult craniopharyngioma
869480|NCT00019019|adult medulloblastoma|adult medulloblastoma
869481|NCT00019019|adult meningioma|adult meningioma
869482|NCT00019019|adult glioblastoma|adult glioblastoma
869483|NCT00019019|stage III melanoma|stage iii melanoma
869484|NCT00019019|stage IV melanoma|stage iv melanoma
869485|NCT00019019|recurrent melanoma|recurrent melanoma
869486|NCT00019019|stage IIIA non-small cell lung cancer|stage iiia non-small cell lung cancer
869487|NCT00019019|stage IIIB non-small cell lung cancer|stage iiib non-small cell lung cancer
869488|NCT00019019|stage IIIC breast cancer|stage iiic breast cancer
869489|NCT00019019|stage IV non-small cell lung cancer|stage iv non-small cell lung cancer
869490|NCT00019019|unspecified adult solid tumor, protocol specific|unspecified adult solid tumor, protocol specific
869491|NCT00019019|stage III grade 1 follicular lymphoma|stage iii grade 1 follicular lymphoma
869492|NCT00019019|stage III grade 2 follicular lymphoma|stage iii grade 2 follicular lymphoma
869493|NCT00019019|stage III grade 3 follicular lymphoma|stage iii grade 3 follicular lymphoma
869494|NCT00019019|stage III adult diffuse small cleaved cell lymphoma|stage iii adult diffuse small cleaved cell lymphoma
869495|NCT00019019|stage III adult diffuse mixed cell lymphoma|stage iii adult diffuse mixed cell lymphoma
869496|NCT00019019|stage III adult diffuse large cell lymphoma|stage iii adult diffuse large cell lymphoma
869497|NCT00019019|stage III adult immunoblastic large cell lymphoma|stage iii adult immunoblastic large cell lymphoma
869498|NCT00019019|stage III adult lymphoblastic lymphoma|stage iii adult lymphoblastic lymphoma
869499|NCT00019019|stage III adult Burkitt lymphoma|stage iii adult burkitt lymphoma
869500|NCT00019019|stage IV grade 1 follicular lymphoma|stage iv grade 1 follicular lymphoma
869501|NCT00019019|stage IV grade 2 follicular lymphoma|stage iv grade 2 follicular lymphoma
869502|NCT00019019|stage IV grade 3 follicular lymphoma|stage iv grade 3 follicular lymphoma
869503|NCT00019019|stage IV adult diffuse small cleaved cell lymphoma|stage iv adult diffuse small cleaved cell lymphoma
869504|NCT00019019|stage IV adult diffuse mixed cell lymphoma|stage iv adult diffuse mixed cell lymphoma
869505|NCT00019019|stage IV adult diffuse large cell lymphoma|stage iv adult diffuse large cell lymphoma
869506|NCT00019019|stage IV adult immunoblastic large cell lymphoma|stage iv adult immunoblastic large cell lymphoma
869507|NCT00019019|stage IV adult lymphoblastic lymphoma|stage iv adult lymphoblastic lymphoma
869508|NCT00019019|stage IV adult Burkitt lymphoma|stage iv adult burkitt lymphoma
869509|NCT00019019|recurrent grade 1 follicular lymphoma|recurrent grade 1 follicular lymphoma
869510|NCT00019019|recurrent grade 2 follicular lymphoma|recurrent grade 2 follicular lymphoma
869511|NCT00019019|recurrent grade 3 follicular lymphoma|recurrent grade 3 follicular lymphoma
869512|NCT00019019|recurrent adult diffuse small cleaved cell lymphoma|recurrent adult diffuse small cleaved cell lymphoma
869513|NCT00019019|recurrent adult diffuse mixed cell lymphoma|recurrent adult diffuse mixed cell lymphoma
869514|NCT00019019|recurrent adult diffuse large cell lymphoma|recurrent adult diffuse large cell lymphoma
869515|NCT00019019|recurrent adult immunoblastic large cell lymphoma|recurrent adult immunoblastic large cell lymphoma
869516|NCT00019019|recurrent adult lymphoblastic lymphoma|recurrent adult lymphoblastic lymphoma
869517|NCT00019019|recurrent adult Burkitt lymphoma|recurrent adult burkitt lymphoma
869518|NCT00019019|stage III adult T-cell leukemia/lymphoma|stage iii adult t-cell leukemia/lymphoma
869519|NCT00019019|stage IV adult T-cell leukemia/lymphoma|stage iv adult t-cell leukemia/lymphoma
869520|NCT00019019|recurrent adult T-cell leukemia/lymphoma|recurrent adult t-cell leukemia/lymphoma
869521|NCT00019019|adult anaplastic astrocytoma|adult anaplastic astrocytoma
869522|NCT00019019|adult myxopapillary ependymoma|adult myxopapillary ependymoma
869523|NCT00019019|adult anaplastic ependymoma|adult anaplastic ependymoma
869524|NCT00019019|adult anaplastic oligodendroglioma|adult anaplastic oligodendroglioma
869525|NCT00019019|adult mixed glioma|adult mixed glioma
869526|NCT00019019|adult central nervous system germ cell tumor|adult central nervous system germ cell tumor
869527|NCT00019019|primary central nervous system non-Hodgkin lymphoma|primary central nervous system non-hodgkin lymphoma
869528|NCT00019019|adult pilocytic astrocytoma|adult pilocytic astrocytoma
869529|NCT00019019|adult subependymoma|adult subependymoma
869530|NCT00019019|adult ependymoblastoma|adult ependymoblastoma
869531|NCT00019019|adult pineocytoma|adult pineocytoma
869532|NCT00019019|adult pineoblastoma|adult pineoblastoma
869533|NCT00019019|adult meningeal hemangiopericytoma|adult meningeal hemangiopericytoma
869534|NCT00019019|intraocular lymphoma|intraocular lymphoma
869535|NCT00019019|stage III mantle cell lymphoma|stage iii mantle cell lymphoma
869536|NCT00019019|stage IV mantle cell lymphoma|stage iv mantle cell lymphoma
869537|NCT00019019|recurrent mantle cell lymphoma|recurrent mantle cell lymphoma
869538|NCT00019019|angioimmunoblastic T-cell lymphoma|angioimmunoblastic t-cell lymphoma
869540|NCT00019019|adult choroid plexus tumor|adult choroid plexus tumor
869541|NCT00019019|stage III mycosis fungoides/Sezary syndrome|stage iii mycosis fungoides/sezary syndrome
869542|NCT00019019|stage IV mycosis fungoides/Sezary syndrome|stage iv mycosis fungoides/sezary syndrome
869543|NCT00019019|recurrent mycosis fungoides/Sezary syndrome|recurrent mycosis fungoides/sezary syndrome
869544|NCT00019019|recurrent marginal zone lymphoma|recurrent marginal zone lymphoma
869545|NCT00019019|recurrent small lymphocytic lymphoma|recurrent small lymphocytic lymphoma
869546|NCT00019019|stage III small lymphocytic lymphoma|stage iii small lymphocytic lymphoma
869547|NCT00019019|stage III marginal zone lymphoma|stage iii marginal zone lymphoma
869548|NCT00019019|stage IV small lymphocytic lymphoma|stage iv small lymphocytic lymphoma
869549|NCT00019019|stage IV marginal zone lymphoma|stage iv marginal zone lymphoma
869550|NCT00019019|extranodal marginal zone B-cell lymphoma of mucosa-associated lymphoid tissue|extranodal marginal zone b-cell lymphoma of mucosa-associated lymphoid tissue
869551|NCT00019019|nodal marginal zone B-cell lymphoma|nodal marginal zone b-cell lymphoma
869552|NCT00019019|splenic marginal zone lymphoma|splenic marginal zone lymphoma
869553|NCT00019019|adult grade III meningioma|adult grade iii meningioma
869554|NCT00019019|adult oligodendroglioma|adult oligodendroglioma
869555|NCT00019019|adult giant cell glioblastoma|adult giant cell glioblastoma
869556|NCT00019019|adult gliosarcoma|adult gliosarcoma
869557|NCT00018967|unspecified childhood solid tumor, protocol specific|unspecified childhood solid tumor, protocol specific
869558|NCT00018967|unspecified adult solid tumor, protocol specific|unspecified adult solid tumor, protocol specific
869559|NCT00018967|neurotoxicity|neurotoxicity
869560|NCT00017602|refractory multiple myeloma|refractory multiple myeloma
869561|NCT00017602|stage I multiple myeloma|stage i multiple myeloma
869562|NCT00017602|stage II multiple myeloma|stage ii multiple myeloma
869563|NCT00017602|stage III multiple myeloma|stage iii multiple myeloma
869564|NCT00017589|recurrent adult acute myeloid leukemia|recurrent adult acute myeloid leukemia
869565|NCT00017563|adenocarcinoma of the prostate|adenocarcinoma of the prostate
869566|NCT00017563|stage II prostate cancer|stage ii prostate cancer
869567|NCT00017563|stage III prostate cancer|stage iii prostate cancer
869568|NCT00017550|refractory anemia|refractory anemia
869569|NCT00017550|refractory anemia with excess blasts|refractory anemia with excess blasts
869570|NCT00017550|de novo myelodysplastic syndromes|de novo myelodysplastic syndromes
869571|NCT00017550|previously treated myelodysplastic syndromes|previously treated myelodysplastic syndromes
869572|NCT00017524|unspecified adult solid tumor, protocol specific|unspecified adult solid tumor, protocol specific
869573|NCT00017511|stage I salivary gland cancer|stage i salivary gland cancer
869574|NCT00017511|stage II salivary gland cancer|stage ii salivary gland cancer
869575|NCT00017511|stage III salivary gland cancer|stage iii salivary gland cancer
869576|NCT00017511|stage IV salivary gland cancer|stage iv salivary gland cancer
869577|NCT00017511|recurrent salivary gland cancer|recurrent salivary gland cancer
869759|NCT00016926|recurrent cervical cancer|recurrent cervical cancer
869578|NCT00017511|untreated metastatic squamous neck cancer with occult primary|untreated metastatic squamous neck cancer with occult primary
869579|NCT00017511|recurrent metastatic squamous neck cancer with occult primary|recurrent metastatic squamous neck cancer with occult primary
869580|NCT00017511|metastatic squamous neck cancer with occult primary squamous cell carcinoma|metastatic squamous neck cancer with occult primary squamous cell carcinoma
869581|NCT00017511|oral complications|oral complications
869582|NCT00017511|stage I squamous cell carcinoma of the lip and oral cavity|stage i squamous cell carcinoma of the lip and oral cavity
869583|NCT00017511|stage I basal cell carcinoma of the lip|stage i basal cell carcinoma of the lip
869584|NCT00017511|stage I verrucous carcinoma of the oral cavity|stage i verrucous carcinoma of the oral cavity
869585|NCT00017511|stage I mucoepidermoid carcinoma of the oral cavity|stage i mucoepidermoid carcinoma of the oral cavity
869586|NCT00017511|stage I adenoid cystic carcinoma of the oral cavity|stage i adenoid cystic carcinoma of the oral cavity
869587|NCT00017511|stage II squamous cell carcinoma of the lip and oral cavity|stage ii squamous cell carcinoma of the lip and oral cavity
869588|NCT00017511|stage II basal cell carcinoma of the lip|stage ii basal cell carcinoma of the lip
869589|NCT00017511|stage II verrucous carcinoma of the oral cavity|stage ii verrucous carcinoma of the oral cavity
869590|NCT00017511|stage II mucoepidermoid carcinoma of the oral cavity|stage ii mucoepidermoid carcinoma of the oral cavity
869591|NCT00017511|stage II adenoid cystic carcinoma of the oral cavity|stage ii adenoid cystic carcinoma of the oral cavity
869592|NCT00017511|stage III squamous cell carcinoma of the lip and oral cavity|stage iii squamous cell carcinoma of the lip and oral cavity
869593|NCT00017511|stage III basal cell carcinoma of the lip|stage iii basal cell carcinoma of the lip
869594|NCT00017511|stage III verrucous carcinoma of the oral cavity|stage iii verrucous carcinoma of the oral cavity
869595|NCT00017511|stage III mucoepidermoid carcinoma of the oral cavity|stage iii mucoepidermoid carcinoma of the oral cavity
869596|NCT00017511|stage III adenoid cystic carcinoma of the oral cavity|stage iii adenoid cystic carcinoma of the oral cavity
869597|NCT00017511|stage IV squamous cell carcinoma of the lip and oral cavity|stage iv squamous cell carcinoma of the lip and oral cavity
869598|NCT00017511|stage IV basal cell carcinoma of the lip|stage iv basal cell carcinoma of the lip
869599|NCT00017511|stage IV verrucous carcinoma of the oral cavity|stage iv verrucous carcinoma of the oral cavity
869600|NCT00017511|stage IV mucoepidermoid carcinoma of the oral cavity|stage iv mucoepidermoid carcinoma of the oral cavity
869601|NCT00017511|stage IV adenoid cystic carcinoma of the oral cavity|stage iv adenoid cystic carcinoma of the oral cavity
869602|NCT00017511|recurrent squamous cell carcinoma of the lip and oral cavity|recurrent squamous cell carcinoma of the lip and oral cavity
869603|NCT00017511|recurrent basal cell carcinoma of the lip|recurrent basal cell carcinoma of the lip
869604|NCT00017511|recurrent verrucous carcinoma of the oral cavity|recurrent verrucous carcinoma of the oral cavity
869605|NCT00017511|recurrent mucoepidermoid carcinoma of the oral cavity|recurrent mucoepidermoid carcinoma of the oral cavity
869606|NCT00017511|recurrent adenoid cystic carcinoma of the oral cavity|recurrent adenoid cystic carcinoma of the oral cavity
869607|NCT00017511|stage I squamous cell carcinoma of the oropharynx|stage i squamous cell carcinoma of the oropharynx
869608|NCT00017511|stage I lymphoepithelioma of the oropharynx|stage i lymphoepithelioma of the oropharynx
869609|NCT00017511|stage II squamous cell carcinoma of the oropharynx|stage ii squamous cell carcinoma of the oropharynx
869610|NCT00017511|stage II lymphoepithelioma of the oropharynx|stage ii lymphoepithelioma of the oropharynx
869611|NCT00017511|stage III squamous cell carcinoma of the oropharynx|stage iii squamous cell carcinoma of the oropharynx
869612|NCT00017511|stage III lymphoepithelioma of the oropharynx|stage iii lymphoepithelioma of the oropharynx
869613|NCT00017511|stage IV squamous cell carcinoma of the oropharynx|stage iv squamous cell carcinoma of the oropharynx
869614|NCT00017511|stage IV lymphoepithelioma of the oropharynx|stage iv lymphoepithelioma of the oropharynx
869615|NCT00017511|recurrent squamous cell carcinoma of the oropharynx|recurrent squamous cell carcinoma of the oropharynx
869616|NCT00017511|recurrent lymphoepithelioma of the oropharynx|recurrent lymphoepithelioma of the oropharynx
869617|NCT00017511|stage I squamous cell carcinoma of the nasopharynx|stage i squamous cell carcinoma of the nasopharynx
869618|NCT00017511|stage I lymphoepithelioma of the nasopharynx|stage i lymphoepithelioma of the nasopharynx
869619|NCT00017511|stage II squamous cell carcinoma of the nasopharynx|stage ii squamous cell carcinoma of the nasopharynx
869620|NCT00017511|stage II lymphoepithelioma of the nasopharynx|stage ii lymphoepithelioma of the nasopharynx
869621|NCT00017511|stage III squamous cell carcinoma of the nasopharynx|stage iii squamous cell carcinoma of the nasopharynx
869622|NCT00017511|stage III lymphoepithelioma of the nasopharynx|stage iii lymphoepithelioma of the nasopharynx
869623|NCT00017511|stage IV squamous cell carcinoma of the nasopharynx|stage iv squamous cell carcinoma of the nasopharynx
869624|NCT00017511|stage IV lymphoepithelioma of the nasopharynx|stage iv lymphoepithelioma of the nasopharynx
869625|NCT00017511|recurrent squamous cell carcinoma of the nasopharynx|recurrent squamous cell carcinoma of the nasopharynx
869626|NCT00017511|recurrent lymphoepithelioma of the nasopharynx|recurrent lymphoepithelioma of the nasopharynx
869627|NCT00017511|stage I squamous cell carcinoma of the hypopharynx|stage i squamous cell carcinoma of the hypopharynx
869628|NCT00017511|stage II squamous cell carcinoma of the hypopharynx|stage ii squamous cell carcinoma of the hypopharynx
869918|NCT00014599|stage IV vulvar cancer|stage iv vulvar cancer
869629|NCT00017511|stage III squamous cell carcinoma of the hypopharynx|stage iii squamous cell carcinoma of the hypopharynx
869630|NCT00017511|stage IV squamous cell carcinoma of the hypopharynx|stage iv squamous cell carcinoma of the hypopharynx
869631|NCT00017511|recurrent squamous cell carcinoma of the hypopharynx|recurrent squamous cell carcinoma of the hypopharynx
869632|NCT00017511|stage I squamous cell carcinoma of the larynx|stage i squamous cell carcinoma of the larynx
869633|NCT00017511|stage I verrucous carcinoma of the larynx|stage i verrucous carcinoma of the larynx
869634|NCT00017511|stage II squamous cell carcinoma of the larynx|stage ii squamous cell carcinoma of the larynx
869635|NCT00017511|stage II verrucous carcinoma of the larynx|stage ii verrucous carcinoma of the larynx
869636|NCT00017511|stage III squamous cell carcinoma of the larynx|stage iii squamous cell carcinoma of the larynx
869637|NCT00017511|stage III verrucous carcinoma of the larynx|stage iii verrucous carcinoma of the larynx
869638|NCT00017511|stage IV squamous cell carcinoma of the larynx|stage iv squamous cell carcinoma of the larynx
869639|NCT00017511|stage IV verrucous carcinoma of the larynx|stage iv verrucous carcinoma of the larynx
869640|NCT00017511|recurrent squamous cell carcinoma of the larynx|recurrent squamous cell carcinoma of the larynx
869641|NCT00017511|recurrent verrucous carcinoma of the larynx|recurrent verrucous carcinoma of the larynx
869642|NCT00017511|stage I squamous cell carcinoma of the paranasal sinus and nasal cavity|stage i squamous cell carcinoma of the paranasal sinus and nasal cavity
869643|NCT00017511|stage I inverted papilloma of the paranasal sinus and nasal cavity|stage i inverted papilloma of the paranasal sinus and nasal cavity
869644|NCT00017511|stage I midline lethal granuloma of the paranasal sinus and nasal cavity|stage i midline lethal granuloma of the paranasal sinus and nasal cavity
869645|NCT00017511|stage I esthesioneuroblastoma of the paranasal sinus and nasal cavity|stage i esthesioneuroblastoma of the paranasal sinus and nasal cavity
869646|NCT00017511|stage II squamous cell carcinoma of the paranasal sinus and nasal cavity|stage ii squamous cell carcinoma of the paranasal sinus and nasal cavity
869647|NCT00017511|stage II inverted papilloma of the paranasal sinus and nasal cavity|stage ii inverted papilloma of the paranasal sinus and nasal cavity
869648|NCT00017511|stage II midline lethal granuloma of the paranasal sinus and nasal cavity|stage ii midline lethal granuloma of the paranasal sinus and nasal cavity
869649|NCT00017511|stage II esthesioneuroblastoma of the paranasal sinus and nasal cavity|stage ii esthesioneuroblastoma of the paranasal sinus and nasal cavity
869650|NCT00017511|stage III squamous cell carcinoma of the paranasal sinus and nasal cavity|stage iii squamous cell carcinoma of the paranasal sinus and nasal cavity
869651|NCT00017511|stage III inverted papilloma of the paranasal sinus and nasal cavity|stage iii inverted papilloma of the paranasal sinus and nasal cavity
869791|NCT00016380|stage II gastric cancer|stage ii gastric cancer
869652|NCT00017511|stage III midline lethal granuloma of the paranasal sinus and nasal cavity|stage iii midline lethal granuloma of the paranasal sinus and nasal cavity
869653|NCT00017511|stage III esthesioneuroblastoma of the paranasal sinus and nasal cavity|stage iii esthesioneuroblastoma of the paranasal sinus and nasal cavity
869654|NCT00017511|stage IV squamous cell carcinoma of the paranasal sinus and nasal cavity|stage iv squamous cell carcinoma of the paranasal sinus and nasal cavity
869655|NCT00017511|stage IV inverted papilloma of the paranasal sinus and nasal cavity|stage iv inverted papilloma of the paranasal sinus and nasal cavity
869656|NCT00017511|stage IV midline lethal granuloma of the paranasal sinus and nasal cavity|stage iv midline lethal granuloma of the paranasal sinus and nasal cavity
869657|NCT00017511|stage IV esthesioneuroblastoma of the paranasal sinus and nasal cavity|stage iv esthesioneuroblastoma of the paranasal sinus and nasal cavity
869658|NCT00017511|recurrent squamous cell carcinoma of the paranasal sinus and nasal cavity|recurrent squamous cell carcinoma of the paranasal sinus and nasal cavity
869659|NCT00017511|recurrent inverted papilloma of the paranasal sinus and nasal cavity|recurrent inverted papilloma of the paranasal sinus and nasal cavity
869660|NCT00017511|recurrent midline lethal granuloma of the paranasal sinus and nasal cavity|recurrent midline lethal granuloma of the paranasal sinus and nasal cavity
869661|NCT00017511|recurrent esthesioneuroblastoma of the paranasal sinus and nasal cavity|recurrent esthesioneuroblastoma of the paranasal sinus and nasal cavity
869662|NCT00017511|radiation toxicity|radiation toxicity
869663|NCT00017498|stage IV salivary gland cancer|stage iv salivary gland cancer
869664|NCT00017498|recurrent salivary gland cancer|recurrent salivary gland cancer
869665|NCT00017498|salivary gland adenoid cystic carcinoma|salivary gland adenoid cystic carcinoma
869666|NCT00017498|stage IV adenoid cystic carcinoma of the oral cavity|stage iv adenoid cystic carcinoma of the oral cavity
869667|NCT00017498|recurrent adenoid cystic carcinoma of the oral cavity|recurrent adenoid cystic carcinoma of the oral cavity
869668|NCT00017485|basal cell carcinoma of the skin|basal cell carcinoma of the skin
869669|NCT00017485|recurrent skin cancer|recurrent skin cancer
869670|NCT00017355|stage IV melanoma|stage iv melanoma
869671|NCT00017355|recurrent melanoma|recurrent melanoma
869672|NCT00017329|stage IV renal cell cancer|stage iv renal cell cancer
869673|NCT00017290|stage III grade 1 follicular lymphoma|stage iii grade 1 follicular lymphoma
869674|NCT00017290|stage III grade 2 follicular lymphoma|stage iii grade 2 follicular lymphoma
869675|NCT00017290|stage III grade 3 follicular lymphoma|stage iii grade 3 follicular lymphoma
869676|NCT00017290|stage IV grade 1 follicular lymphoma|stage iv grade 1 follicular lymphoma
869677|NCT00017290|stage IV grade 2 follicular lymphoma|stage iv grade 2 follicular lymphoma
869678|NCT00017290|stage IV grade 3 follicular lymphoma|stage iv grade 3 follicular lymphoma
869679|NCT00017277|stage I squamous cell carcinoma of the lip and oral cavity|stage i squamous cell carcinoma of the lip and oral cavity
869680|NCT00017277|stage II squamous cell carcinoma of the lip and oral cavity|stage ii squamous cell carcinoma of the lip and oral cavity
869681|NCT00017277|stage III squamous cell carcinoma of the lip and oral cavity|stage iii squamous cell carcinoma of the lip and oral cavity
869682|NCT00017277|stage IV squamous cell carcinoma of the lip and oral cavity|stage iv squamous cell carcinoma of the lip and oral cavity
869683|NCT00017277|stage I squamous cell carcinoma of the oropharynx|stage i squamous cell carcinoma of the oropharynx
869684|NCT00017277|stage II squamous cell carcinoma of the oropharynx|stage ii squamous cell carcinoma of the oropharynx
877448|NCT00001624|Insulin|insulin
869685|NCT00017277|stage III squamous cell carcinoma of the oropharynx|stage iii squamous cell carcinoma of the oropharynx
869686|NCT00017277|stage IV squamous cell carcinoma of the oropharynx|stage iv squamous cell carcinoma of the oropharynx
869687|NCT00017277|stage I squamous cell carcinoma of the hypopharynx|stage i squamous cell carcinoma of the hypopharynx
869688|NCT00017277|stage II squamous cell carcinoma of the hypopharynx|stage ii squamous cell carcinoma of the hypopharynx
869689|NCT00017277|stage III squamous cell carcinoma of the hypopharynx|stage iii squamous cell carcinoma of the hypopharynx
869690|NCT00017277|stage IV squamous cell carcinoma of the hypopharynx|stage iv squamous cell carcinoma of the hypopharynx
869691|NCT00017277|stage I squamous cell carcinoma of the larynx|stage i squamous cell carcinoma of the larynx
869692|NCT00017277|stage II squamous cell carcinoma of the larynx|stage ii squamous cell carcinoma of the larynx
869693|NCT00017277|stage III squamous cell carcinoma of the larynx|stage iii squamous cell carcinoma of the larynx
869694|NCT00017277|stage IV squamous cell carcinoma of the larynx|stage iv squamous cell carcinoma of the larynx
869695|NCT00017264|recurrent adult brain tumor|recurrent adult brain tumor
869696|NCT00017264|adult glioblastoma|adult glioblastoma
869697|NCT00017264|adult anaplastic astrocytoma|adult anaplastic astrocytoma
869698|NCT00017264|adult anaplastic oligodendroglioma|adult anaplastic oligodendroglioma
869699|NCT00017264|adult giant cell glioblastoma|adult giant cell glioblastoma
869700|NCT00017264|adult gliosarcoma|adult gliosarcoma
869701|NCT00017225|localized resectable neuroblastoma|localized resectable neuroblastoma
869702|NCT00017225|regional neuroblastoma|regional neuroblastoma
869703|NCT00017225|disseminated neuroblastoma|disseminated neuroblastoma
869704|NCT00017225|stage 4S neuroblastoma|stage 4s neuroblastoma
869705|NCT00017225|recurrent neuroblastoma|recurrent neuroblastoma
869706|NCT00017225|localized unresectable neuroblastoma|localized unresectable neuroblastoma
869707|NCT00017212|stage III gastric cancer|stage iii gastric cancer
869708|NCT00017212|stage IV gastric cancer|stage iv gastric cancer
869709|NCT00017212|recurrent gastric cancer|recurrent gastric cancer
869710|NCT00017212|stage III esophageal cancer|stage iii esophageal cancer
869711|NCT00017212|stage IV esophageal cancer|stage iv esophageal cancer
869712|NCT00017212|recurrent esophageal cancer|recurrent esophageal cancer
869713|NCT00017212|adenocarcinoma of the stomach|adenocarcinoma of the stomach
869714|NCT00017212|adenocarcinoma of the esophagus|adenocarcinoma of the esophagus
869715|NCT00017186|localized malignant mesothelioma|localized malignant mesothelioma
869716|NCT00017186|advanced malignant mesothelioma|advanced malignant mesothelioma
869717|NCT00017186|recurrent malignant mesothelioma|recurrent malignant mesothelioma
869718|NCT00017173|stage III squamous cell carcinoma of the lip and oral cavity|stage iii squamous cell carcinoma of the lip and oral cavity
869719|NCT00017173|stage IV squamous cell carcinoma of the lip and oral cavity|stage iv squamous cell carcinoma of the lip and oral cavity
869720|NCT00017173|stage III squamous cell carcinoma of the oropharynx|stage iii squamous cell carcinoma of the oropharynx
869721|NCT00017173|stage IV squamous cell carcinoma of the oropharynx|stage iv squamous cell carcinoma of the oropharynx
869722|NCT00017173|stage III squamous cell carcinoma of the hypopharynx|stage iii squamous cell carcinoma of the hypopharynx
869723|NCT00017173|stage III squamous cell carcinoma of the larynx|stage iii squamous cell carcinoma of the larynx
869724|NCT00017173|stage IV squamous cell carcinoma of the hypopharynx|stage iv squamous cell carcinoma of the hypopharynx
869725|NCT00017173|stage IV verrucous carcinoma of the larynx|stage iv verrucous carcinoma of the larynx
869726|NCT00017147|adult glioblastoma|adult glioblastoma
869727|NCT00017147|adult giant cell glioblastoma|adult giant cell glioblastoma
869728|NCT00017147|adult gliosarcoma|adult gliosarcoma
869729|NCT00017121|stage IV melanoma|stage iv melanoma
869730|NCT00017121|recurrent melanoma|recurrent melanoma
869731|NCT00017121|lung metastases|lung metastases
869732|NCT00017108|stage III chronic lymphocytic leukemia|stage iii chronic lymphocytic leukemia
869733|NCT00017108|stage IV chronic lymphocytic leukemia|stage iv chronic lymphocytic leukemia
869734|NCT00017108|B-cell chronic lymphocytic leukemia|b-cell chronic lymphocytic leukemia
869735|NCT00017095|stage II breast cancer|stage ii breast cancer
869736|NCT00017095|stage IIIA breast cancer|stage iiia breast cancer
869737|NCT00017095|stage IIIB breast cancer|stage iiib breast cancer
869738|NCT00017095|stage IIIC breast cancer|stage iiic breast cancer
869739|NCT00017095|inflammatory breast cancer|inflammatory breast cancer
869740|NCT00017069|refractory multiple myeloma|refractory multiple myeloma
869741|NCT00017069|stage II multiple myeloma|stage ii multiple myeloma
869742|NCT00017069|stage III multiple myeloma|stage iii multiple myeloma
869743|NCT00016991|recurrent adult brain tumor|recurrent adult brain tumor
869744|NCT00016991|adult glioblastoma|adult glioblastoma
869745|NCT00016991|adult giant cell glioblastoma|adult giant cell glioblastoma
869746|NCT00016991|adult gliosarcoma|adult gliosarcoma
869747|NCT00016965|stage II pancreatic cancer|stage ii pancreatic cancer
869748|NCT00016965|stage III pancreatic cancer|stage iii pancreatic cancer
869749|NCT00016965|recurrent pancreatic cancer|recurrent pancreatic cancer
869750|NCT00016965|adenocarcinoma of the pancreas|adenocarcinoma of the pancreas
869751|NCT00016965|stage IV pancreatic cancer|stage iv pancreatic cancer
869752|NCT00016952|stage IV colon cancer|stage iv colon cancer
869753|NCT00016952|stage IV rectal cancer|stage iv rectal cancer
869754|NCT00016952|recurrent colon cancer|recurrent colon cancer
869755|NCT00016952|recurrent rectal cancer|recurrent rectal cancer
869756|NCT00016952|adenocarcinoma of the colon|adenocarcinoma of the colon
869757|NCT00016952|adenocarcinoma of the rectum|adenocarcinoma of the rectum
869760|NCT00016926|stage IVB cervical cancer|stage ivb cervical cancer
869761|NCT00016926|stage IVA cervical cancer|stage iva cervical cancer
869762|NCT00016926|cervical squamous cell carcinoma|cervical squamous cell carcinoma
869763|NCT00016913|adenocarcinoma of the prostate|adenocarcinoma of the prostate
869764|NCT00016913|stage III prostate cancer|stage iii prostate cancer
869765|NCT00016887|stage III mantle cell lymphoma|stage iii mantle cell lymphoma
869766|NCT00016887|stage IV mantle cell lymphoma|stage iv mantle cell lymphoma
869767|NCT00016861|unspecified childhood solid tumor, protocol specific|unspecified childhood solid tumor, protocol specific
869768|NCT00016432|stage I breast cancer|stage i breast cancer
869769|NCT00016432|stage II breast cancer|stage ii breast cancer
869770|NCT00016432|stage IIIA breast cancer|stage iiia breast cancer
869771|NCT00016419|refractory anemia|refractory anemia
869772|NCT00016419|refractory anemia with ringed sideroblasts|refractory anemia with ringed sideroblasts
869773|NCT00016419|refractory anemia with excess blasts|refractory anemia with excess blasts
869774|NCT00016419|de novo myelodysplastic syndromes|de novo myelodysplastic syndromes
869775|NCT00016419|secondary myelodysplastic syndromes|secondary myelodysplastic syndromes
869776|NCT00016419|childhood myelodysplastic syndromes|childhood myelodysplastic syndromes
869777|NCT00016406|stage II breast cancer|stage ii breast cancer
869778|NCT00016406|stage IIIA breast cancer|stage iiia breast cancer
869779|NCT00016406|stage IIIB breast cancer|stage iiib breast cancer
869780|NCT00016406|stage IIIC breast cancer|stage iiic breast cancer
869781|NCT00016406|inflammatory breast cancer|inflammatory breast cancer
869782|NCT00016393|adenocarcinoma of the prostate|adenocarcinoma of the prostate
869783|NCT00016393|stage IV prostate cancer|stage iv prostate cancer
869784|NCT00016393|recurrent prostate cancer|recurrent prostate cancer
869785|NCT00016380|nausea and vomiting|nausea and vomiting
869786|NCT00016380|stage I colon cancer|stage i colon cancer
869787|NCT00016380|stage II colon cancer|stage ii colon cancer
869788|NCT00016380|stage III colon cancer|stage iii colon cancer
869789|NCT00016380|stage IV colon cancer|stage iv colon cancer
869790|NCT00016380|stage I gastric cancer|stage i gastric cancer
869792|NCT00016380|stage III gastric cancer|stage iii gastric cancer
869793|NCT00016380|stage IV gastric cancer|stage iv gastric cancer
869794|NCT00016380|recurrent gastric cancer|recurrent gastric cancer
869795|NCT00016380|stage I pancreatic cancer|stage i pancreatic cancer
869796|NCT00016380|stage II pancreatic cancer|stage ii pancreatic cancer
869797|NCT00016380|stage III pancreatic cancer|stage iii pancreatic cancer
869798|NCT00016380|recurrent pancreatic cancer|recurrent pancreatic cancer
869799|NCT00016380|recurrent colon cancer|recurrent colon cancer
869800|NCT00016380|recurrent cervical cancer|recurrent cervical cancer
869801|NCT00016380|stage IB cervical cancer|stage ib cervical cancer
869802|NCT00016380|stage IIB cervical cancer|stage iib cervical cancer
869803|NCT00016380|stage IVB cervical cancer|stage ivb cervical cancer
869804|NCT00016380|stage IA cervical cancer|stage ia cervical cancer
869805|NCT00016380|stage IIA cervical cancer|stage iia cervical cancer
869806|NCT00016380|stage IVA cervical cancer|stage iva cervical cancer
869807|NCT00016380|stage I ovarian epithelial cancer|stage i ovarian epithelial cancer
869808|NCT00016380|stage II ovarian epithelial cancer|stage ii ovarian epithelial cancer
869809|NCT00016380|stage III ovarian epithelial cancer|stage iii ovarian epithelial cancer
869810|NCT00016380|stage IV ovarian epithelial cancer|stage iv ovarian epithelial cancer
869811|NCT00016380|recurrent ovarian epithelial cancer|recurrent ovarian epithelial cancer
869812|NCT00016380|localized gastrointestinal carcinoid tumor|localized gastrointestinal carcinoid tumor
869813|NCT00016380|regional gastrointestinal carcinoid tumor|regional gastrointestinal carcinoid tumor
869814|NCT00016380|metastatic gastrointestinal carcinoid tumor|metastatic gastrointestinal carcinoid tumor
869815|NCT00016380|recurrent gastrointestinal carcinoid tumor|recurrent gastrointestinal carcinoid tumor
869816|NCT00016380|localized resectable adult primary liver cancer|localized resectable adult primary liver cancer
869817|NCT00016380|localized unresectable adult primary liver cancer|localized unresectable adult primary liver cancer
869818|NCT00016380|advanced adult primary liver cancer|advanced adult primary liver cancer
869819|NCT00016380|recurrent adult primary liver cancer|recurrent adult primary liver cancer
869820|NCT00016380|small intestine adenocarcinoma|small intestine adenocarcinoma
869821|NCT00016380|small intestine lymphoma|small intestine lymphoma
869822|NCT00016380|small intestine leiomyosarcoma|small intestine leiomyosarcoma
869823|NCT00016380|localized gallbladder cancer|localized gallbladder cancer
869824|NCT00016380|unresectable gallbladder cancer|unresectable gallbladder cancer
869825|NCT00016380|recurrent gallbladder cancer|recurrent gallbladder cancer
869826|NCT00016380|localized extrahepatic bile duct cancer|localized extrahepatic bile duct cancer
869827|NCT00016380|unresectable extrahepatic bile duct cancer|unresectable extrahepatic bile duct cancer
869828|NCT00016380|recurrent extrahepatic bile duct cancer|recurrent extrahepatic bile duct cancer
869829|NCT00016380|recurrent small intestine cancer|recurrent small intestine cancer
869830|NCT00016380|testicular seminoma|testicular seminoma
869831|NCT00016380|carcinoma of the appendix|carcinoma of the appendix
869832|NCT00016380|quality of life|quality of life
869833|NCT00016380|stage IV pancreatic cancer|stage iv pancreatic cancer
869834|NCT00016354|unspecified adult solid tumor, protocol specific|unspecified adult solid tumor, protocol specific
869835|NCT00016263|stage III melanoma|stage iii melanoma
869836|NCT00016263|stage IV melanoma|stage iv melanoma
869837|NCT00016263|recurrent melanoma|recurrent melanoma
869838|NCT00016224|recurrent ovarian epithelial cancer|recurrent ovarian epithelial cancer
869839|NCT00016211|extensive stage small cell lung cancer|extensive stage small cell lung cancer
869840|NCT00016185|unspecified adult solid tumor, protocol specific|unspecified adult solid tumor, protocol specific
869841|NCT00016159|adult acute myeloid leukemia in remission|adult acute myeloid leukemia in remission
869842|NCT00016159|childhood acute myeloid leukemia in remission|childhood acute myeloid leukemia in remission
869843|NCT00016159|adult acute promyelocytic leukemia (M3)|adult acute promyelocytic leukemia (m3)
869844|NCT00016159|childhood acute promyelocytic leukemia (M3)|childhood acute promyelocytic leukemia (m3)
869845|NCT00016159|adult acute myeloid leukemia with t(15;17)(q22;q12)|adult acute myeloid leukemia with t(15;17)(q22;q12)
869846|NCT00016146|recurrent prostate cancer|recurrent prostate cancer
869847|NCT00016133|stage II colon cancer|stage ii colon cancer
869848|NCT00016133|stage III colon cancer|stage iii colon cancer
869849|NCT00016133|adenocarcinoma of the colon|adenocarcinoma of the colon
869850|NCT00016081|infection|infection
869851|NCT00016068|infection|infection
869852|NCT00016055|stage IV melanoma|stage iv melanoma
869853|NCT00016055|recurrent melanoma|recurrent melanoma
869854|NCT00016029|colon cancer|colon cancer
869855|NCT00016029|rectal cancer|rectal cancer
869856|NCT00015977|adenocarcinoma of the prostate|adenocarcinoma of the prostate
869857|NCT00015977|stage IV prostate cancer|stage iv prostate cancer
869858|NCT00015977|recurrent prostate cancer|recurrent prostate cancer
869859|NCT00015951|recurrent adult acute myeloid leukemia|recurrent adult acute myeloid leukemia
869860|NCT00015951|relapsing chronic myelogenous leukemia|relapsing chronic myelogenous leukemia
869861|NCT00015951|blastic phase chronic myelogenous leukemia|blastic phase chronic myelogenous leukemia
869862|NCT00015951|refractory anemia with excess blasts|refractory anemia with excess blasts
869863|NCT00015951|refractory anemia with excess blasts in transformation|refractory anemia with excess blasts in transformation
869864|NCT00015951|chronic myelomonocytic leukemia|chronic myelomonocytic leukemia
869865|NCT00015951|secondary acute myeloid leukemia|secondary acute myeloid leukemia
869866|NCT00015951|previously treated myelodysplastic syndromes|previously treated myelodysplastic syndromes
869867|NCT00015951|childhood myelodysplastic syndromes|childhood myelodysplastic syndromes
869868|NCT00015938|stage IV breast cancer|stage iv breast cancer
869869|NCT00015938|recurrent breast cancer|recurrent breast cancer
869870|NCT00015925|refractory multiple myeloma|refractory multiple myeloma
869871|NCT00015925|recurrent adult acute myeloid leukemia|recurrent adult acute myeloid leukemia
869872|NCT00015925|recurrent adult acute lymphoblastic leukemia|recurrent adult acute lymphoblastic leukemia
869873|NCT00015925|relapsing chronic myelogenous leukemia|relapsing chronic myelogenous leukemia
869874|NCT00015925|chronic phase chronic myelogenous leukemia|chronic phase chronic myelogenous leukemia
869875|NCT00015925|accelerated phase chronic myelogenous leukemia|accelerated phase chronic myelogenous leukemia
869876|NCT00015925|blastic phase chronic myelogenous leukemia|blastic phase chronic myelogenous leukemia
869877|NCT00015925|untreated adult acute lymphoblastic leukemia|untreated adult acute lymphoblastic leukemia
869878|NCT00015925|untreated adult acute myeloid leukemia|untreated adult acute myeloid leukemia
869879|NCT00015925|adult acute promyelocytic leukemia (M3)|adult acute promyelocytic leukemia (m3)
869880|NCT00015925|refractory anemia with excess blasts|refractory anemia with excess blasts
869881|NCT00015925|refractory anemia with excess blasts in transformation|refractory anemia with excess blasts in transformation
869882|NCT00015925|chronic myelomonocytic leukemia|chronic myelomonocytic leukemia
869883|NCT00015925|secondary acute myeloid leukemia|secondary acute myeloid leukemia
869884|NCT00015925|de novo myelodysplastic syndromes|de novo myelodysplastic syndromes
869885|NCT00015925|previously treated myelodysplastic syndromes|previously treated myelodysplastic syndromes
869886|NCT00015925|atypical chronic myeloid leukemia|atypical chronic myeloid leukemia
869887|NCT00015925|myelodysplastic/myeloproliferative disease, unclassifiable|myelodysplastic/myeloproliferative disease, unclassifiable
869888|NCT00015925|adult acute myeloid leukemia with t(8;21)(q22;q22)|adult acute myeloid leukemia with t(8;21)(q22;q22)
869889|NCT00015925|adult acute myeloid leukemia with t(16;16)(p13;q22)|adult acute myeloid leukemia with t(16;16)(p13;q22)
869890|NCT00015925|adult acute myeloid leukemia with inv(16)(p13;q22)|adult acute myeloid leukemia with inv(16)(p13;q22)
869891|NCT00015925|adult acute myeloid leukemia with 11q23 (MLL) abnormalities|adult acute myeloid leukemia with 11q23 (mll) abnormalities
869892|NCT00015925|adult acute myeloid leukemia with t(15;17)(q22;q12)|adult acute myeloid leukemia with t(15;17)(q22;q12)
869893|NCT00015899|childhood craniopharyngioma|childhood craniopharyngioma
869894|NCT00015899|childhood central nervous system germ cell tumor|childhood central nervous system germ cell tumor
869895|NCT00015899|childhood oligodendroglioma|childhood oligodendroglioma
869896|NCT00015899|childhood choroid plexus tumor|childhood choroid plexus tumor
869897|NCT00015899|childhood grade I meningioma|childhood grade i meningioma
869898|NCT00015899|childhood grade II meningioma|childhood grade ii meningioma
869899|NCT00015899|childhood grade III meningioma|childhood grade iii meningioma
869900|NCT00015899|recurrent childhood cerebellar astrocytoma|recurrent childhood cerebellar astrocytoma
869901|NCT00015899|recurrent childhood cerebral astrocytoma|recurrent childhood cerebral astrocytoma
869902|NCT00015899|recurrent childhood medulloblastoma|recurrent childhood medulloblastoma
869903|NCT00015899|recurrent childhood visual pathway and hypothalamic glioma|recurrent childhood visual pathway and hypothalamic glioma
869904|NCT00015899|recurrent childhood ependymoma|recurrent childhood ependymoma
869905|NCT00015899|childhood atypical teratoid/rhabdoid tumor|childhood atypical teratoid/rhabdoid tumor
869906|NCT00015899|childhood spinal cord neoplasm|childhood spinal cord neoplasm
869907|NCT00015873|untreated childhood acute lymphoblastic leukemia|untreated childhood acute lymphoblastic leukemia
869908|NCT00015860|recurrent adult acute lymphoblastic leukemia|recurrent adult acute lymphoblastic leukemia
869909|NCT00015860|relapsing chronic myelogenous leukemia|relapsing chronic myelogenous leukemia
869910|NCT00015860|blastic phase chronic myelogenous leukemia|blastic phase chronic myelogenous leukemia
869911|NCT00015847|relapsing chronic myelogenous leukemia|relapsing chronic myelogenous leukemia
869912|NCT00015847|chronic phase chronic myelogenous leukemia|chronic phase chronic myelogenous leukemia
869913|NCT00015847|Philadelphia chromosome positive chronic myelogenous leukemia|philadelphia chromosome positive chronic myelogenous leukemia
869914|NCT00014612|stage IA breast cancer|stage ia breast cancer
869915|NCT00014612|stage IB breast cancer|stage ib breast cancer
869916|NCT00014612|stage II breast cancer|stage ii breast cancer
869917|NCT00014599|stage III vulvar cancer|stage iii vulvar cancer
869919|NCT00014599|recurrent vulvar cancer|recurrent vulvar cancer
869920|NCT00014599|squamous cell carcinoma of the vulva|squamous cell carcinoma of the vulva
869921|NCT00014586|stage I prostate cancer|stage i prostate cancer
869922|NCT00014586|stage IIB prostate cancer|stage iib prostate cancer
869923|NCT00014586|stage IIA prostate cancer|stage iia prostate cancer
869924|NCT00014586|stage III prostate cancer|stage iii prostate cancer
869925|NCT00014521|recurrent adult brain tumor|recurrent adult brain tumor
869926|NCT00014521|adult glioblastoma|adult glioblastoma
869927|NCT00014521|adult anaplastic astrocytoma|adult anaplastic astrocytoma
869928|NCT00014521|adult anaplastic oligodendroglioma|adult anaplastic oligodendroglioma
869929|NCT00014521|adult giant cell glioblastoma|adult giant cell glioblastoma
869930|NCT00014521|adult gliosarcoma|adult gliosarcoma
869931|NCT00014508|refractory multiple myeloma|refractory multiple myeloma
869932|NCT00014508|stage I multiple myeloma|stage i multiple myeloma
869933|NCT00014508|stage II multiple myeloma|stage ii multiple myeloma
869934|NCT00014508|stage III multiple myeloma|stage iii multiple myeloma
869935|NCT00014495|recurrent childhood acute myeloid leukemia|recurrent childhood acute myeloid leukemia
869936|NCT00014495|recurrent adult acute myeloid leukemia|recurrent adult acute myeloid leukemia
869937|NCT00014495|accelerated phase chronic myelogenous leukemia|accelerated phase chronic myelogenous leukemia
869938|NCT00014495|blastic phase chronic myelogenous leukemia|blastic phase chronic myelogenous leukemia
869939|NCT00014495|untreated adult acute myeloid leukemia|untreated adult acute myeloid leukemia
869940|NCT00014495|untreated childhood acute myeloid leukemia and other myeloid malignancies|untreated childhood acute myeloid leukemia and other myeloid malignancies
869941|NCT00014495|refractory anemia with excess blasts|refractory anemia with excess blasts
869942|NCT00014495|refractory anemia with excess blasts in transformation|refractory anemia with excess blasts in transformation
869943|NCT00014495|chronic myelomonocytic leukemia|chronic myelomonocytic leukemia
869944|NCT00014495|previously treated myelodysplastic syndromes|previously treated myelodysplastic syndromes
869945|NCT00014495|secondary myelodysplastic syndromes|secondary myelodysplastic syndromes
869946|NCT00014495|childhood chronic myelogenous leukemia|childhood chronic myelogenous leukemia
869947|NCT00014495|atypical chronic myeloid leukemia, BCR-ABL1 negative|atypical chronic myeloid leukemia, bcr-abl1 negative
869948|NCT00014495|myelodysplastic/myeloproliferative neoplasm, unclassifiable|myelodysplastic/myeloproliferative neoplasm, unclassifiable
869949|NCT00014495|adult acute myeloid leukemia with t(8;21)(q22;q22)|adult acute myeloid leukemia with t(8;21)(q22;q22)
869950|NCT00014495|adult acute myeloid leukemia with t(16;16)(p13;q22)|adult acute myeloid leukemia with t(16;16)(p13;q22)
869951|NCT00014495|adult acute myeloid leukemia with inv(16)(p13;q22)|adult acute myeloid leukemia with inv(16)(p13;q22)
869952|NCT00014495|adult acute myeloid leukemia with 11q23 (MLL) abnormalities|adult acute myeloid leukemia with 11q23 (mll) abnormalities
869953|NCT00014495|adult acute myeloid leukemia with t(15;17)(q22;q12)|adult acute myeloid leukemia with t(15;17)(q22;q12)
869954|NCT00014495|childhood myelodysplastic syndromes|childhood myelodysplastic syndromes
869955|NCT00014482|anxiety disorder|anxiety disorder
869956|NCT00014482|depression|depression
869957|NCT00014482|pain|pain
869958|NCT00014482|recurrent adult Hodgkin lymphoma|recurrent adult hodgkin lymphoma
869959|NCT00014482|recurrent cutaneous T-cell non-Hodgkin lymphoma|recurrent cutaneous t-cell non-hodgkin lymphoma
869960|NCT00014482|refractory multiple myeloma|refractory multiple myeloma
869961|NCT00014482|stage I multiple myeloma|stage i multiple myeloma
869962|NCT00014482|stage II multiple myeloma|stage ii multiple myeloma
869963|NCT00014482|stage III multiple myeloma|stage iii multiple myeloma
869964|NCT00014482|primary myelofibrosis|primary myelofibrosis
869965|NCT00014482|stage III grade 1 follicular lymphoma|stage iii grade 1 follicular lymphoma
869966|NCT00014482|stage III grade 2 follicular lymphoma|stage iii grade 2 follicular lymphoma
869967|NCT00014482|stage III grade 3 follicular lymphoma|stage iii grade 3 follicular lymphoma
869968|NCT00014482|stage III adult diffuse small cleaved cell lymphoma|stage iii adult diffuse small cleaved cell lymphoma
869969|NCT00014482|stage III adult diffuse mixed cell lymphoma|stage iii adult diffuse mixed cell lymphoma
869970|NCT00014482|stage III adult diffuse large cell lymphoma|stage iii adult diffuse large cell lymphoma
869971|NCT00014482|stage III adult immunoblastic large cell lymphoma|stage iii adult immunoblastic large cell lymphoma
869972|NCT00014482|stage III adult lymphoblastic lymphoma|stage iii adult lymphoblastic lymphoma
869973|NCT00014482|stage III adult Burkitt lymphoma|stage iii adult burkitt lymphoma
869974|NCT00014482|stage IV grade 1 follicular lymphoma|stage iv grade 1 follicular lymphoma
869975|NCT00014482|stage IV grade 2 follicular lymphoma|stage iv grade 2 follicular lymphoma
869976|NCT00014482|stage IV grade 3 follicular lymphoma|stage iv grade 3 follicular lymphoma
869977|NCT00014482|stage IV adult diffuse small cleaved cell lymphoma|stage iv adult diffuse small cleaved cell lymphoma
869978|NCT00014482|stage IV adult diffuse mixed cell lymphoma|stage iv adult diffuse mixed cell lymphoma
869979|NCT00014482|stage IV adult diffuse large cell lymphoma|stage iv adult diffuse large cell lymphoma
869980|NCT00014482|stage IV adult immunoblastic large cell lymphoma|stage iv adult immunoblastic large cell lymphoma
869981|NCT00014482|stage IV adult lymphoblastic lymphoma|stage iv adult lymphoblastic lymphoma
869982|NCT00014482|stage IV adult Burkitt lymphoma|stage iv adult burkitt lymphoma
869983|NCT00014482|recurrent grade 1 follicular lymphoma|recurrent grade 1 follicular lymphoma
869984|NCT00014482|recurrent grade 2 follicular lymphoma|recurrent grade 2 follicular lymphoma
869985|NCT00014482|recurrent grade 3 follicular lymphoma|recurrent grade 3 follicular lymphoma
869986|NCT00014482|recurrent adult diffuse small cleaved cell lymphoma|recurrent adult diffuse small cleaved cell lymphoma
869987|NCT00014482|recurrent adult diffuse mixed cell lymphoma|recurrent adult diffuse mixed cell lymphoma
869988|NCT00014482|recurrent adult diffuse large cell lymphoma|recurrent adult diffuse large cell lymphoma
869989|NCT00014482|recurrent adult immunoblastic large cell lymphoma|recurrent adult immunoblastic large cell lymphoma
869990|NCT00014482|recurrent adult lymphoblastic lymphoma|recurrent adult lymphoblastic lymphoma
869991|NCT00014482|recurrent adult Burkitt lymphoma|recurrent adult burkitt lymphoma
869992|NCT00014482|de novo myelodysplastic syndromes|de novo myelodysplastic syndromes
869993|NCT00014482|previously treated myelodysplastic syndromes|previously treated myelodysplastic syndromes
869994|NCT00014482|secondary myelodysplastic syndromes|secondary myelodysplastic syndromes
869995|NCT00014482|noncontiguous stage II grade 1 follicular lymphoma|noncontiguous stage ii grade 1 follicular lymphoma
869996|NCT00014482|noncontiguous stage II grade 2 follicular lymphoma|noncontiguous stage ii grade 2 follicular lymphoma
869997|NCT00014482|noncontiguous stage II grade 3 follicular lymphoma|noncontiguous stage ii grade 3 follicular lymphoma
893917|NCT00001960|Pediatric|pediatric
869998|NCT00014482|noncontiguous stage II adult diffuse small cleaved cell lymphoma|noncontiguous stage ii adult diffuse small cleaved cell lymphoma
869999|NCT00014482|noncontiguous stage II mantle cell lymphoma|noncontiguous stage ii mantle cell lymphoma
870000|NCT00014482|noncontiguous stage II adult diffuse mixed cell lymphoma|noncontiguous stage ii adult diffuse mixed cell lymphoma
870001|NCT00014482|noncontiguous stage II adult immunoblastic large cell lymphoma|noncontiguous stage ii adult immunoblastic large cell lymphoma
870002|NCT00014482|noncontiguous stage II adult diffuse large cell lymphoma|noncontiguous stage ii adult diffuse large cell lymphoma
870003|NCT00014482|noncontiguous stage II adult Burkitt lymphoma|noncontiguous stage ii adult burkitt lymphoma
870004|NCT00014482|noncontiguous stage II adult lymphoblastic lymphoma|noncontiguous stage ii adult lymphoblastic lymphoma
870005|NCT00014482|stage III mantle cell lymphoma|stage iii mantle cell lymphoma
870006|NCT00014482|stage IV mantle cell lymphoma|stage iv mantle cell lymphoma
870007|NCT00014482|recurrent mantle cell lymphoma|recurrent mantle cell lymphoma
870008|NCT00014482|recurrent mycosis fungoides/Sezary syndrome|recurrent mycosis fungoides/sezary syndrome
870009|NCT00014482|noncontiguous stage II small lymphocytic lymphoma|noncontiguous stage ii small lymphocytic lymphoma
870010|NCT00014482|noncontiguous stage II marginal zone lymphoma|noncontiguous stage ii marginal zone lymphoma
870011|NCT00014482|recurrent marginal zone lymphoma|recurrent marginal zone lymphoma
872460|NCT00005639|intraocular lymphoma|intraocular lymphoma
870012|NCT00014482|recurrent small lymphocytic lymphoma|recurrent small lymphocytic lymphoma
870013|NCT00014482|stage III small lymphocytic lymphoma|stage iii small lymphocytic lymphoma
870014|NCT00014482|stage III marginal zone lymphoma|stage iii marginal zone lymphoma
870015|NCT00014482|stage IV small lymphocytic lymphoma|stage iv small lymphocytic lymphoma
870016|NCT00014482|stage IV marginal zone lymphoma|stage iv marginal zone lymphoma
870017|NCT00014482|extranodal marginal zone B-cell lymphoma of mucosa-associated lymphoid tissue|extranodal marginal zone b-cell lymphoma of mucosa-associated lymphoid tissue
870018|NCT00014482|nodal marginal zone B-cell lymphoma|nodal marginal zone b-cell lymphoma
870019|NCT00014482|splenic marginal zone lymphoma|splenic marginal zone lymphoma
870020|NCT00014469|recurrent childhood acute lymphoblastic leukemia|recurrent childhood acute lymphoblastic leukemia
870021|NCT00014469|recurrent childhood acute myeloid leukemia|recurrent childhood acute myeloid leukemia
870022|NCT00014469|recurrent adult acute myeloid leukemia|recurrent adult acute myeloid leukemia
870023|NCT00014469|recurrent adult acute lymphoblastic leukemia|recurrent adult acute lymphoblastic leukemia
870024|NCT00014469|relapsing chronic myelogenous leukemia|relapsing chronic myelogenous leukemia
870025|NCT00014469|refractory chronic lymphocytic leukemia|refractory chronic lymphocytic leukemia
870026|NCT00014469|chronic phase chronic myelogenous leukemia|chronic phase chronic myelogenous leukemia
870027|NCT00014469|accelerated phase chronic myelogenous leukemia|accelerated phase chronic myelogenous leukemia
870028|NCT00014469|blastic phase chronic myelogenous leukemia|blastic phase chronic myelogenous leukemia
870029|NCT00014469|adult acute myeloid leukemia in remission|adult acute myeloid leukemia in remission
870030|NCT00014469|adult acute lymphoblastic leukemia in remission|adult acute lymphoblastic leukemia in remission
870031|NCT00014469|childhood acute myeloid leukemia in remission|childhood acute myeloid leukemia in remission
870032|NCT00014469|childhood acute lymphoblastic leukemia in remission|childhood acute lymphoblastic leukemia in remission
877657|NCT00001482|Depression|depression
870033|NCT00014469|refractory anemia with excess blasts|refractory anemia with excess blasts
870034|NCT00014469|refractory anemia with excess blasts in transformation|refractory anemia with excess blasts in transformation
870035|NCT00014469|chronic myelomonocytic leukemia|chronic myelomonocytic leukemia
870036|NCT00014469|acute undifferentiated leukemia|acute undifferentiated leukemia
870037|NCT00014469|secondary acute myeloid leukemia|secondary acute myeloid leukemia
870038|NCT00014469|de novo myelodysplastic syndromes|de novo myelodysplastic syndromes
870039|NCT00014469|previously treated myelodysplastic syndromes|previously treated myelodysplastic syndromes
870040|NCT00014469|secondary myelodysplastic syndromes|secondary myelodysplastic syndromes
870041|NCT00014469|graft versus host disease|graft versus host disease
870042|NCT00014469|refractory cytopenia with multilineage dysplasia|refractory cytopenia with multilineage dysplasia
870043|NCT00014469|juvenile myelomonocytic leukemia|juvenile myelomonocytic leukemia
870044|NCT00014469|childhood chronic myelogenous leukemia|childhood chronic myelogenous leukemia
870045|NCT00014469|atypical chronic myeloid leukemia, BCR-ABL1 negative|atypical chronic myeloid leukemia, bcr-abl1 negative
870046|NCT00014469|myelodysplastic/myeloproliferative neoplasm, unclassifiable|myelodysplastic/myeloproliferative neoplasm, unclassifiable
870047|NCT00014469|adult acute myeloid leukemia with t(8;21)(q22;q22)|adult acute myeloid leukemia with t(8;21)(q22;q22)
870048|NCT00014469|adult acute myeloid leukemia with t(16;16)(p13;q22)|adult acute myeloid leukemia with t(16;16)(p13;q22)
870049|NCT00014469|adult acute myeloid leukemia with inv(16)(p13;q22)|adult acute myeloid leukemia with inv(16)(p13;q22)
870050|NCT00014469|adult acute myeloid leukemia with 11q23 (MLL) abnormalities|adult acute myeloid leukemia with 11q23 (mll) abnormalities
870051|NCT00014469|adult acute myeloid leukemia with t(15;17)(q22;q12)|adult acute myeloid leukemia with t(15;17)(q22;q12)
870052|NCT00014456|stage IV breast cancer|stage iv breast cancer
870053|NCT00014456|recurrent breast cancer|recurrent breast cancer
870054|NCT00014456|stage IV gastric cancer|stage iv gastric cancer
870055|NCT00014456|recurrent gastric cancer|recurrent gastric cancer
870056|NCT00014456|metastatic osteosarcoma|metastatic osteosarcoma
870057|NCT00014456|recurrent non-small cell lung cancer|recurrent non-small cell lung cancer
870058|NCT00014456|stage II pancreatic cancer|stage ii pancreatic cancer
870059|NCT00014456|stage III pancreatic cancer|stage iii pancreatic cancer
870060|NCT00014456|recurrent pancreatic cancer|recurrent pancreatic cancer
870061|NCT00014456|stage II esophageal cancer|stage ii esophageal cancer
870062|NCT00014456|stage III esophageal cancer|stage iii esophageal cancer
870063|NCT00014456|stage IV esophageal cancer|stage iv esophageal cancer
870064|NCT00014456|recurrent esophageal cancer|recurrent esophageal cancer
870065|NCT00014456|chondrosarcoma|chondrosarcoma
870066|NCT00014456|recurrent adult soft tissue sarcoma|recurrent adult soft tissue sarcoma
870067|NCT00014456|stage IV ovarian epithelial cancer|stage iv ovarian epithelial cancer
870068|NCT00014456|recurrent ovarian epithelial cancer|recurrent ovarian epithelial cancer
870069|NCT00014456|extensive stage small cell lung cancer|extensive stage small cell lung cancer
870070|NCT00014456|recurrent small cell lung cancer|recurrent small cell lung cancer
870071|NCT00014456|recurrent osteosarcoma|recurrent osteosarcoma
870072|NCT00014456|recurrent bladder cancer|recurrent bladder cancer
870073|NCT00014456|stage IV bladder cancer|stage iv bladder cancer
870074|NCT00014456|stage IV prostate cancer|stage iv prostate cancer
870075|NCT00014456|recurrent prostate cancer|recurrent prostate cancer
870076|NCT00014456|stage IV melanoma|stage iv melanoma
870077|NCT00014456|recurrent melanoma|recurrent melanoma
870078|NCT00014456|stage IV non-small cell lung cancer|stage iv non-small cell lung cancer
870079|NCT00014456|stage IV salivary gland cancer|stage iv salivary gland cancer
870080|NCT00014456|recurrent salivary gland cancer|recurrent salivary gland cancer
870081|NCT00014456|classic Kaposi sarcoma|classic kaposi sarcoma
870082|NCT00014456|AIDS-related Kaposi sarcoma|aids-related kaposi sarcoma
870083|NCT00014456|recurrent Kaposi sarcoma|recurrent kaposi sarcoma
870084|NCT00014456|recurrent metastatic squamous neck cancer with occult primary|recurrent metastatic squamous neck cancer with occult primary
870085|NCT00014456|stage IV ovarian germ cell tumor|stage iv ovarian germ cell tumor
870086|NCT00014456|recurrent ovarian germ cell tumor|recurrent ovarian germ cell tumor
870087|NCT00014456|stage IV uterine sarcoma|stage iv uterine sarcoma
870088|NCT00014456|recurrent uterine sarcoma|recurrent uterine sarcoma
870089|NCT00014456|borderline ovarian surface epithelial-stromal tumor|borderline ovarian surface epithelial-stromal tumor
870090|NCT00014456|recurrent carcinoma of unknown primary|recurrent carcinoma of unknown primary
870091|NCT00014456|ovarian sarcoma|ovarian sarcoma
870092|NCT00014456|metastatic Ewing sarcoma/peripheral primitive neuroectodermal tumor|metastatic ewing sarcoma/peripheral primitive neuroectodermal tumor
870093|NCT00014456|recurrent Ewing sarcoma/peripheral primitive neuroectodermal tumor|recurrent ewing sarcoma/peripheral primitive neuroectodermal tumor
870094|NCT00014456|recurrent squamous cell carcinoma of the hypopharynx|recurrent squamous cell carcinoma of the hypopharynx
870095|NCT00014456|stage IV squamous cell carcinoma of the hypopharynx|stage iv squamous cell carcinoma of the hypopharynx
870096|NCT00014456|recurrent squamous cell carcinoma of the larynx|recurrent squamous cell carcinoma of the larynx
870097|NCT00014456|recurrent verrucous carcinoma of the larynx|recurrent verrucous carcinoma of the larynx
870098|NCT00014456|stage IV squamous cell carcinoma of the larynx|stage iv squamous cell carcinoma of the larynx
870099|NCT00014456|stage IV verrucous carcinoma of the larynx|stage iv verrucous carcinoma of the larynx
870100|NCT00014456|recurrent squamous cell carcinoma of the lip and oral cavity|recurrent squamous cell carcinoma of the lip and oral cavity
870101|NCT00014456|stage IV squamous cell carcinoma of the lip and oral cavity|stage iv squamous cell carcinoma of the lip and oral cavity
870102|NCT00014456|recurrent lymphoepithelioma of the nasopharynx|recurrent lymphoepithelioma of the nasopharynx
870103|NCT00014456|recurrent squamous cell carcinoma of the nasopharynx|recurrent squamous cell carcinoma of the nasopharynx
870104|NCT00014456|stage IV lymphoepithelioma of the nasopharynx|stage iv lymphoepithelioma of the nasopharynx
870105|NCT00014456|stage IV squamous cell carcinoma of the nasopharynx|stage iv squamous cell carcinoma of the nasopharynx
873314|NCT00004129|adult gliosarcoma|adult gliosarcoma
870106|NCT00014456|recurrent lymphoepithelioma of the oropharynx|recurrent lymphoepithelioma of the oropharynx
870107|NCT00014456|recurrent squamous cell carcinoma of the oropharynx|recurrent squamous cell carcinoma of the oropharynx
870108|NCT00014456|stage IV lymphoepithelioma of the oropharynx|stage iv lymphoepithelioma of the oropharynx
870109|NCT00014456|stage IV squamous cell carcinoma of the oropharynx|stage iv squamous cell carcinoma of the oropharynx
870110|NCT00014456|recurrent esthesioneuroblastoma of the paranasal sinus and nasal cavity|recurrent esthesioneuroblastoma of the paranasal sinus and nasal cavity
870111|NCT00014456|recurrent inverted papilloma of the paranasal sinus and nasal cavity|recurrent inverted papilloma of the paranasal sinus and nasal cavity
870112|NCT00014456|recurrent midline lethal granuloma of the paranasal sinus and nasal cavity|recurrent midline lethal granuloma of the paranasal sinus and nasal cavity
870113|NCT00014456|recurrent squamous cell carcinoma of the paranasal sinus and nasal cavity|recurrent squamous cell carcinoma of the paranasal sinus and nasal cavity
870114|NCT00014456|stage IV esthesioneuroblastoma of the paranasal sinus and nasal cavity|stage iv esthesioneuroblastoma of the paranasal sinus and nasal cavity
870115|NCT00014456|stage IV inverted papilloma of the paranasal sinus and nasal cavity|stage iv inverted papilloma of the paranasal sinus and nasal cavity
870116|NCT00014456|stage IV midline lethal granuloma of the paranasal sinus and nasal cavity|stage iv midline lethal granuloma of the paranasal sinus and nasal cavity
870117|NCT00014456|stage IV squamous cell carcinoma of the paranasal sinus and nasal cavity|stage iv squamous cell carcinoma of the paranasal sinus and nasal cavity
870118|NCT00014456|recurrent verrucous carcinoma of the oral cavity|recurrent verrucous carcinoma of the oral cavity
870119|NCT00014456|stage IV verrucous carcinoma of the oral cavity|stage iv verrucous carcinoma of the oral cavity
893918|NCT00001960|Pacemaker|pacemaker
870120|NCT00014456|recurrent basal cell carcinoma of the lip|recurrent basal cell carcinoma of the lip
870121|NCT00014456|stage IV basal cell carcinoma of the lip|stage iv basal cell carcinoma of the lip
870122|NCT00014456|recurrent mucoepidermoid carcinoma of the oral cavity|recurrent mucoepidermoid carcinoma of the oral cavity
870123|NCT00014456|stage IV mucoepidermoid carcinoma of the oral cavity|stage iv mucoepidermoid carcinoma of the oral cavity
870124|NCT00014456|recurrent adenoid cystic carcinoma of the oral cavity|recurrent adenoid cystic carcinoma of the oral cavity
870125|NCT00014456|stage IV adenoid cystic carcinoma of the oral cavity|stage iv adenoid cystic carcinoma of the oral cavity
870126|NCT00014456|stage IV adult soft tissue sarcoma|stage iv adult soft tissue sarcoma
870127|NCT00014456|stage IV pancreatic cancer|stage iv pancreatic cancer
870128|NCT00014443|recurrent adult brain tumor|recurrent adult brain tumor
870129|NCT00014443|adult glioblastoma|adult glioblastoma
870130|NCT00014443|adult anaplastic astrocytoma|adult anaplastic astrocytoma
870131|NCT00014443|adult giant cell glioblastoma|adult giant cell glioblastoma
870132|NCT00014443|adult gliosarcoma|adult gliosarcoma
870133|NCT00014378|unspecified adult solid tumor, protocol specific|unspecified adult solid tumor, protocol specific
870134|NCT00014326|stage I grade 1 follicular lymphoma|stage i grade 1 follicular lymphoma
870135|NCT00014326|stage I grade 2 follicular lymphoma|stage i grade 2 follicular lymphoma
870136|NCT00014326|stage I grade 3 follicular lymphoma|stage i grade 3 follicular lymphoma
870137|NCT00014326|contiguous stage II grade 1 follicular lymphoma|contiguous stage ii grade 1 follicular lymphoma
870138|NCT00014326|contiguous stage II grade 2 follicular lymphoma|contiguous stage ii grade 2 follicular lymphoma
870139|NCT00014326|contiguous stage II grade 3 follicular lymphoma|contiguous stage ii grade 3 follicular lymphoma
870140|NCT00014326|noncontiguous stage II grade 1 follicular lymphoma|noncontiguous stage ii grade 1 follicular lymphoma
870141|NCT00014326|noncontiguous stage II grade 2 follicular lymphoma|noncontiguous stage ii grade 2 follicular lymphoma
870142|NCT00014326|noncontiguous stage II grade 3 follicular lymphoma|noncontiguous stage ii grade 3 follicular lymphoma
870143|NCT00014326|contiguous stage II small lymphocytic lymphoma|contiguous stage ii small lymphocytic lymphoma
870144|NCT00014326|contiguous stage II marginal zone lymphoma|contiguous stage ii marginal zone lymphoma
870145|NCT00014326|noncontiguous stage II small lymphocytic lymphoma|noncontiguous stage ii small lymphocytic lymphoma
870146|NCT00014326|noncontiguous stage II marginal zone lymphoma|noncontiguous stage ii marginal zone lymphoma
870147|NCT00014326|nodal marginal zone B-cell lymphoma|nodal marginal zone b-cell lymphoma
870148|NCT00014326|stage I marginal zone lymphoma|stage i marginal zone lymphoma
870149|NCT00014326|stage I small lymphocytic lymphoma|stage i small lymphocytic lymphoma
870150|NCT00014313|metastatic Ewing sarcoma/peripheral primitive neuroectodermal tumor|metastatic ewing sarcoma/peripheral primitive neuroectodermal tumor
870151|NCT00014274|stage III bladder cancer|stage iii bladder cancer
870152|NCT00014274|stage IV bladder cancer|stage iv bladder cancer
870153|NCT00014274|transitional cell carcinoma of the bladder|transitional cell carcinoma of the bladder
870154|NCT00014274|anterior urethral cancer|anterior urethral cancer
870155|NCT00014274|posterior urethral cancer|posterior urethral cancer
870156|NCT00014274|urethral cancer associated with invasive bladder cancer|urethral cancer associated with invasive bladder cancer
870157|NCT00014274|metastatic transitional cell cancer of the renal pelvis and ureter|metastatic transitional cell cancer of the renal pelvis and ureter
870158|NCT00014274|regional transitional cell cancer of the renal pelvis and ureter|regional transitional cell cancer of the renal pelvis and ureter
870159|NCT00014222|stage I breast cancer|stage i breast cancer
870160|NCT00014222|stage II breast cancer|stage ii breast cancer
870161|NCT00014222|stage IIIA breast cancer|stage iiia breast cancer
870162|NCT00014222|stage IIIB breast cancer|stage iiib breast cancer
870163|NCT00014196|squamous cell lung cancer|squamous cell lung cancer
870164|NCT00014196|large cell lung cancer|large cell lung cancer
870165|NCT00014196|stage IIIB non-small cell lung cancer|stage iiib non-small cell lung cancer
870166|NCT00014196|adenocarcinoma of the lung|adenocarcinoma of the lung
870167|NCT00014131|stage III renal cell cancer|stage iii renal cell cancer
870168|NCT00014131|stage IV renal cell cancer|stage iv renal cell cancer
870169|NCT00014131|recurrent renal cell cancer|recurrent renal cell cancer
870170|NCT00014118|stage III squamous cell carcinoma of the oropharynx|stage iii squamous cell carcinoma of the oropharynx
870171|NCT00014118|stage IV squamous cell carcinoma of the oropharynx|stage iv squamous cell carcinoma of the oropharynx
870172|NCT00014118|stage III squamous cell carcinoma of the larynx|stage iii squamous cell carcinoma of the larynx
870173|NCT00014118|stage IV squamous cell carcinoma of the larynx|stage iv squamous cell carcinoma of the larynx
870174|NCT00014092|stage IV melanoma|stage iv melanoma
870175|NCT00014092|recurrent melanoma|recurrent melanoma
870176|NCT00014079|colon cancer|colon cancer
870177|NCT00014079|rectal cancer|rectal cancer
870178|NCT00012389|stage IV colon cancer|stage iv colon cancer
870179|NCT00012389|stage IV rectal cancer|stage iv rectal cancer
870180|NCT00012389|recurrent colon cancer|recurrent colon cancer
870181|NCT00012389|recurrent rectal cancer|recurrent rectal cancer
870182|NCT00012363|stage IV gastric cancer|stage iv gastric cancer
870183|NCT00012363|recurrent gastric cancer|recurrent gastric cancer
870184|NCT00012363|stage IV esophageal cancer|stage iv esophageal cancer
870185|NCT00012363|recurrent esophageal cancer|recurrent esophageal cancer
870186|NCT00012363|adenocarcinoma of the stomach|adenocarcinoma of the stomach
870187|NCT00012363|squamous cell carcinoma of the esophagus|squamous cell carcinoma of the esophagus
870260|NCT00012025|recurrent breast cancer|recurrent breast cancer
870188|NCT00012363|adenocarcinoma of the esophagus|adenocarcinoma of the esophagus
870189|NCT00012324|localized unresectable adult primary liver cancer|localized unresectable adult primary liver cancer
870190|NCT00012324|advanced adult primary liver cancer|advanced adult primary liver cancer
870191|NCT00012324|recurrent adult primary liver cancer|recurrent adult primary liver cancer
870192|NCT00012324|adult primary hepatocellular carcinoma|adult primary hepatocellular carcinoma
870193|NCT00012246|stage II colon cancer|stage ii colon cancer
870194|NCT00012246|stage III colon cancer|stage iii colon cancer
870195|NCT00012246|stage IV colon cancer|stage iv colon cancer
870196|NCT00012246|stage II gastric cancer|stage ii gastric cancer
870197|NCT00012246|stage III gastric cancer|stage iii gastric cancer
870198|NCT00012246|stage IV gastric cancer|stage iv gastric cancer
870199|NCT00012246|recurrent gastric cancer|recurrent gastric cancer
870200|NCT00012246|stage II pancreatic cancer|stage ii pancreatic cancer
870201|NCT00012246|stage III pancreatic cancer|stage iii pancreatic cancer
870202|NCT00012246|recurrent pancreatic cancer|recurrent pancreatic cancer
870203|NCT00012246|stage II rectal cancer|stage ii rectal cancer
870204|NCT00012246|stage III rectal cancer|stage iii rectal cancer
870205|NCT00012246|stage IV rectal cancer|stage iv rectal cancer
870206|NCT00012246|recurrent colon cancer|recurrent colon cancer
870207|NCT00012246|recurrent rectal cancer|recurrent rectal cancer
870208|NCT00012246|stage II esophageal cancer|stage ii esophageal cancer
870209|NCT00012246|stage III esophageal cancer|stage iii esophageal cancer
870210|NCT00012246|stage IV esophageal cancer|stage iv esophageal cancer
870211|NCT00012246|recurrent esophageal cancer|recurrent esophageal cancer
870212|NCT00012246|adenocarcinoma of the stomach|adenocarcinoma of the stomach
870213|NCT00012246|small intestine adenocarcinoma|small intestine adenocarcinoma
870214|NCT00012246|localized gallbladder cancer|localized gallbladder cancer
870215|NCT00012246|unresectable gallbladder cancer|unresectable gallbladder cancer
870216|NCT00012246|recurrent gallbladder cancer|recurrent gallbladder cancer
870217|NCT00012246|localized extrahepatic bile duct cancer|localized extrahepatic bile duct cancer
870218|NCT00012246|unresectable extrahepatic bile duct cancer|unresectable extrahepatic bile duct cancer
870219|NCT00012246|recurrent extrahepatic bile duct cancer|recurrent extrahepatic bile duct cancer
870220|NCT00012246|recurrent small intestine cancer|recurrent small intestine cancer
870221|NCT00012246|adenocarcinoma of the esophagus|adenocarcinoma of the esophagus
870222|NCT00012246|adenocarcinoma of the colon|adenocarcinoma of the colon
870223|NCT00012246|adenocarcinoma of the rectum|adenocarcinoma of the rectum
870224|NCT00012246|adenocarcinoma of the gallbladder|adenocarcinoma of the gallbladder
870225|NCT00012246|adenocarcinoma of the extrahepatic bile duct|adenocarcinoma of the extrahepatic bile duct
870226|NCT00012246|adenocarcinoma of the pancreas|adenocarcinoma of the pancreas
870227|NCT00012246|stage IV pancreatic cancer|stage iv pancreatic cancer
870228|NCT00012220|adenocarcinoma of the pancreas|adenocarcinoma of the pancreas
870229|NCT00012220|stage IV pancreatic cancer|stage iv pancreatic cancer
870230|NCT00012207|recurrent grade 1 follicular lymphoma|recurrent grade 1 follicular lymphoma
870231|NCT00012207|recurrent grade 2 follicular lymphoma|recurrent grade 2 follicular lymphoma
870232|NCT00012207|recurrent grade 3 follicular lymphoma|recurrent grade 3 follicular lymphoma
870233|NCT00012207|recurrent mantle cell lymphoma|recurrent mantle cell lymphoma
870234|NCT00012207|recurrent marginal zone lymphoma|recurrent marginal zone lymphoma
870235|NCT00012207|recurrent small lymphocytic lymphoma|recurrent small lymphocytic lymphoma
870236|NCT00012207|refractory chronic lymphocytic leukemia|refractory chronic lymphocytic leukemia
870237|NCT00012168|stage 0 oropharyngeal cancer|stage 0 oropharyngeal cancer
870238|NCT00012168|stage 0 lip and oral cavity cancer|stage 0 lip and oral cavity cancer
870239|NCT00012168|stage I squamous cell carcinoma of the lip and oral cavity|stage i squamous cell carcinoma of the lip and oral cavity
870240|NCT00012168|stage II squamous cell carcinoma of the lip and oral cavity|stage ii squamous cell carcinoma of the lip and oral cavity
870241|NCT00012168|stage III squamous cell carcinoma of the lip and oral cavity|stage iii squamous cell carcinoma of the lip and oral cavity
870242|NCT00012168|stage IV squamous cell carcinoma of the lip and oral cavity|stage iv squamous cell carcinoma of the lip and oral cavity
870243|NCT00012168|stage I squamous cell carcinoma of the oropharynx|stage i squamous cell carcinoma of the oropharynx
870244|NCT00012168|stage II squamous cell carcinoma of the oropharynx|stage ii squamous cell carcinoma of the oropharynx
870245|NCT00012168|stage III squamous cell carcinoma of the oropharynx|stage iii squamous cell carcinoma of the oropharynx
870246|NCT00012168|stage IV squamous cell carcinoma of the oropharynx|stage iv squamous cell carcinoma of the oropharynx
870247|NCT00012103|non-small cell lung cancer|non-small cell lung cancer
870248|NCT00012103|small cell lung cancer|small cell lung cancer
870249|NCT00012064|stage IV melanoma|stage iv melanoma
870250|NCT00012064|recurrent melanoma|recurrent melanoma
870251|NCT00012051|recurrent grade 3 follicular lymphoma|recurrent grade 3 follicular lymphoma
870252|NCT00012051|recurrent adult diffuse large cell lymphoma|recurrent adult diffuse large cell lymphoma
870253|NCT00012038|recurrent adult brain tumor|recurrent adult brain tumor
870254|NCT00012038|adult glioblastoma|adult glioblastoma
870255|NCT00012038|adult anaplastic astrocytoma|adult anaplastic astrocytoma
870256|NCT00012038|adult anaplastic oligodendroglioma|adult anaplastic oligodendroglioma
870257|NCT00012038|adult giant cell glioblastoma|adult giant cell glioblastoma
870258|NCT00012038|adult gliosarcoma|adult gliosarcoma
870259|NCT00012025|stage IV breast cancer|stage iv breast cancer
893919|NCT00001960|Treatment|treatment
870261|NCT00012025|stage IIIB breast cancer|stage iiib breast cancer
870262|NCT00012025|stage IIIC breast cancer|stage iiic breast cancer
870263|NCT00012012|radiation toxicity|radiation toxicity
870264|NCT00012012|stage III cervical cancer|stage iii cervical cancer
870265|NCT00012012|stage IVA cervical cancer|stage iva cervical cancer
870266|NCT00012012|cervical squamous cell carcinoma|cervical squamous cell carcinoma
870267|NCT00012012|cervical adenocarcinoma|cervical adenocarcinoma
870268|NCT00012012|cervical adenosquamous cell carcinoma|cervical adenosquamous cell carcinoma
870269|NCT00011999|stage III squamous cell carcinoma of the lip and oral cavity|stage iii squamous cell carcinoma of the lip and oral cavity
870270|NCT00011999|stage IV squamous cell carcinoma of the lip and oral cavity|stage iv squamous cell carcinoma of the lip and oral cavity
870271|NCT00011999|stage III squamous cell carcinoma of the oropharynx|stage iii squamous cell carcinoma of the oropharynx
870272|NCT00011999|stage IV squamous cell carcinoma of the oropharynx|stage iv squamous cell carcinoma of the oropharynx
870273|NCT00011999|stage III squamous cell carcinoma of the hypopharynx|stage iii squamous cell carcinoma of the hypopharynx
870274|NCT00011999|stage IV squamous cell carcinoma of the hypopharynx|stage iv squamous cell carcinoma of the hypopharynx
870275|NCT00011999|stage III squamous cell carcinoma of the larynx|stage iii squamous cell carcinoma of the larynx
870276|NCT00011999|stage IV squamous cell carcinoma of the larynx|stage iv squamous cell carcinoma of the larynx
870277|NCT00011960|stage I gastric cancer|stage i gastric cancer
870278|NCT00011960|stage II gastric cancer|stage ii gastric cancer
870279|NCT00011960|stage III gastric cancer|stage iii gastric cancer
870280|NCT00011960|stage I esophageal cancer|stage i esophageal cancer
870281|NCT00011960|stage II esophageal cancer|stage ii esophageal cancer
870282|NCT00011960|stage III esophageal cancer|stage iii esophageal cancer
870283|NCT00011960|adenocarcinoma of the stomach|adenocarcinoma of the stomach
870284|NCT00011960|adenocarcinoma of the esophagus|adenocarcinoma of the esophagus
870285|NCT00011921|limited stage small cell lung cancer|limited stage small cell lung cancer
870286|NCT00011921|extensive stage small cell lung cancer|extensive stage small cell lung cancer
870287|NCT00010270|stage IV colon cancer|stage iv colon cancer
870288|NCT00010270|stage IV rectal cancer|stage iv rectal cancer
870289|NCT00010270|recurrent colon cancer|recurrent colon cancer
870290|NCT00010270|recurrent rectal cancer|recurrent rectal cancer
870291|NCT00010270|adenocarcinoma of the colon|adenocarcinoma of the colon
870292|NCT00010270|stage III pancreatic cancer|stage iii pancreatic cancer
870293|NCT00010270|stage II pancreatic cancer|stage ii pancreatic cancer
870294|NCT00010270|recurrent pancreatic cancer|recurrent pancreatic cancer
870295|NCT00010270|adenocarcinoma of the pancreas|adenocarcinoma of the pancreas
870296|NCT00010270|stage IV gastric cancer|stage iv gastric cancer
870297|NCT00010270|adenocarcinoma of the stomach|adenocarcinoma of the stomach
870298|NCT00010270|recurrent gastric cancer|recurrent gastric cancer
870299|NCT00010270|adenocarcinoma of the esophagus|adenocarcinoma of the esophagus
870300|NCT00010270|stage IV esophageal cancer|stage iv esophageal cancer
870301|NCT00010270|stage III esophageal cancer|stage iii esophageal cancer
870302|NCT00010270|recurrent esophageal cancer|recurrent esophageal cancer
870303|NCT00010270|stage II esophageal cancer|stage ii esophageal cancer
870304|NCT00010270|adenocarcinoma of the rectum|adenocarcinoma of the rectum
870305|NCT00010270|stage III colon cancer|stage iii colon cancer
870306|NCT00010270|stage III rectal cancer|stage iii rectal cancer
870307|NCT00010270|stage III gastric cancer|stage iii gastric cancer
870308|NCT00010270|stage IV pancreatic cancer|stage iv pancreatic cancer
870309|NCT00010257|thymoma|thymoma
870310|NCT00010257|thymic carcinoma|thymic carcinoma
870311|NCT00010218|recurrent non-small cell lung cancer|recurrent non-small cell lung cancer
870312|NCT00010218|squamous cell lung cancer|squamous cell lung cancer
870313|NCT00010218|large cell lung cancer|large cell lung cancer
870314|NCT00010218|adenocarcinoma of the lung|adenocarcinoma of the lung
870315|NCT00010218|adenosquamous cell lung cancer|adenosquamous cell lung cancer
870316|NCT00010218|bronchoalveolar cell lung cancer|bronchoalveolar cell lung cancer
870317|NCT00010166|stage I pancreatic cancer|stage i pancreatic cancer
870318|NCT00010166|adenocarcinoma of the pancreas|adenocarcinoma of the pancreas
870319|NCT00010153|stage I breast cancer|stage i breast cancer
870320|NCT00010153|stage II breast cancer|stage ii breast cancer
870321|NCT00010140|stage II breast cancer|stage ii breast cancer
870322|NCT00010140|stage IIIA breast cancer|stage iiia breast cancer
870323|NCT00010140|stage IIIB breast cancer|stage iiib breast cancer
870324|NCT00010140|stage IIIC breast cancer|stage iiic breast cancer
870325|NCT00010101|childhood choroid plexus tumor|childhood choroid plexus tumor
870326|NCT00010101|untreated childhood supratentorial primitive neuroectodermal tumor|untreated childhood supratentorial primitive neuroectodermal tumor
870327|NCT00010101|untreated childhood medulloblastoma|untreated childhood medulloblastoma
870328|NCT00010101|childhood atypical teratoid/rhabdoid tumor|childhood atypical teratoid/rhabdoid tumor
870329|NCT00010075|stage IV breast cancer|stage iv breast cancer
870330|NCT00010075|recurrent breast cancer|recurrent breast cancer
870331|NCT00010062|stage I pancreatic cancer|stage i pancreatic cancer
870332|NCT00010062|stage II pancreatic cancer|stage ii pancreatic cancer
870333|NCT00010062|stage III pancreatic cancer|stage iii pancreatic cancer
870334|NCT00010062|adenocarcinoma of the pancreas|adenocarcinoma of the pancreas
870335|NCT00010062|stage IV pancreatic cancer|stage iv pancreatic cancer
870336|NCT00010049|recurrent adult brain tumor|recurrent adult brain tumor
870337|NCT00010049|adult meningioma|adult meningioma
870338|NCT00010049|adult glioblastoma|adult glioblastoma
870339|NCT00010049|adult anaplastic astrocytoma|adult anaplastic astrocytoma
870340|NCT00010049|adult anaplastic oligodendroglioma|adult anaplastic oligodendroglioma
870341|NCT00010049|adult mixed glioma|adult mixed glioma
870342|NCT00010049|adult pilocytic astrocytoma|adult pilocytic astrocytoma
870343|NCT00010049|adult subependymoma|adult subependymoma
870344|NCT00010049|adult grade III meningioma|adult grade iii meningioma
870345|NCT00010049|adult giant cell glioblastoma|adult giant cell glioblastoma
870346|NCT00010049|adult gliosarcoma|adult gliosarcoma
870347|NCT00010023|stage IV breast cancer|stage iv breast cancer
870348|NCT00010023|stage IIIA breast cancer|stage iiia breast cancer
870349|NCT00010023|recurrent breast cancer|recurrent breast cancer
870350|NCT00010023|stage III gastric cancer|stage iii gastric cancer
870351|NCT00010023|stage IV gastric cancer|stage iv gastric cancer
870352|NCT00010023|recurrent gastric cancer|recurrent gastric cancer
870353|NCT00010023|stage IIIB breast cancer|stage iiib breast cancer
870354|NCT00010023|stage IIIC breast cancer|stage iiic breast cancer
870355|NCT00010023|recurrent non-small cell lung cancer|recurrent non-small cell lung cancer
870356|NCT00010023|stage III pancreatic cancer|stage iii pancreatic cancer
870357|NCT00010023|recurrent pancreatic cancer|recurrent pancreatic cancer
870358|NCT00010023|stage III esophageal cancer|stage iii esophageal cancer
870359|NCT00010023|stage IV esophageal cancer|stage iv esophageal cancer
870360|NCT00010023|recurrent esophageal cancer|recurrent esophageal cancer
870361|NCT00010023|extensive stage small cell lung cancer|extensive stage small cell lung cancer
870362|NCT00010023|recurrent small cell lung cancer|recurrent small cell lung cancer
870363|NCT00010023|metastatic gastrointestinal carcinoid tumor|metastatic gastrointestinal carcinoid tumor
870364|NCT00010023|recurrent gastrointestinal carcinoid tumor|recurrent gastrointestinal carcinoid tumor
870365|NCT00010023|localized unresectable adult primary liver cancer|localized unresectable adult primary liver cancer
870366|NCT00010023|advanced adult primary liver cancer|advanced adult primary liver cancer
870367|NCT00010023|recurrent adult primary liver cancer|recurrent adult primary liver cancer
870368|NCT00010023|small intestine adenocarcinoma|small intestine adenocarcinoma
870369|NCT00010023|unresectable gallbladder cancer|unresectable gallbladder cancer
870370|NCT00010023|recurrent gallbladder cancer|recurrent gallbladder cancer
870371|NCT00010023|unresectable extrahepatic bile duct cancer|unresectable extrahepatic bile duct cancer
870372|NCT00010023|recurrent extrahepatic bile duct cancer|recurrent extrahepatic bile duct cancer
870373|NCT00010023|recurrent small intestine cancer|recurrent small intestine cancer
870374|NCT00010023|stage IIIA non-small cell lung cancer|stage iiia non-small cell lung cancer
870375|NCT00010023|stage IIIB non-small cell lung cancer|stage iiib non-small cell lung cancer
870376|NCT00010023|untreated metastatic squamous neck cancer with occult primary|untreated metastatic squamous neck cancer with occult primary
870377|NCT00010023|recurrent metastatic squamous neck cancer with occult primary|recurrent metastatic squamous neck cancer with occult primary
870378|NCT00010023|pulmonary carcinoid tumor|pulmonary carcinoid tumor
870379|NCT00010023|stage III squamous cell carcinoma of the lip and oral cavity|stage iii squamous cell carcinoma of the lip and oral cavity
877658|NCT00001482|Gabapentin|gabapentin
870380|NCT00010023|stage III basal cell carcinoma of the lip|stage iii basal cell carcinoma of the lip
870381|NCT00010023|stage III verrucous carcinoma of the oral cavity|stage iii verrucous carcinoma of the oral cavity
870382|NCT00010023|stage III mucoepidermoid carcinoma of the oral cavity|stage iii mucoepidermoid carcinoma of the oral cavity
870383|NCT00010023|stage III adenoid cystic carcinoma of the oral cavity|stage iii adenoid cystic carcinoma of the oral cavity
870384|NCT00010023|stage IV squamous cell carcinoma of the lip and oral cavity|stage iv squamous cell carcinoma of the lip and oral cavity
870385|NCT00010023|stage IV basal cell carcinoma of the lip|stage iv basal cell carcinoma of the lip
870386|NCT00010023|stage IV verrucous carcinoma of the oral cavity|stage iv verrucous carcinoma of the oral cavity
870387|NCT00010023|stage IV mucoepidermoid carcinoma of the oral cavity|stage iv mucoepidermoid carcinoma of the oral cavity
870388|NCT00010023|stage IV adenoid cystic carcinoma of the oral cavity|stage iv adenoid cystic carcinoma of the oral cavity
870389|NCT00010023|recurrent squamous cell carcinoma of the lip and oral cavity|recurrent squamous cell carcinoma of the lip and oral cavity
870390|NCT00010023|recurrent basal cell carcinoma of the lip|recurrent basal cell carcinoma of the lip
870391|NCT00010023|recurrent verrucous carcinoma of the oral cavity|recurrent verrucous carcinoma of the oral cavity
870392|NCT00010023|recurrent mucoepidermoid carcinoma of the oral cavity|recurrent mucoepidermoid carcinoma of the oral cavity
870393|NCT00010023|recurrent adenoid cystic carcinoma of the oral cavity|recurrent adenoid cystic carcinoma of the oral cavity
870394|NCT00010023|stage III squamous cell carcinoma of the oropharynx|stage iii squamous cell carcinoma of the oropharynx
870395|NCT00010023|stage III lymphoepithelioma of the oropharynx|stage iii lymphoepithelioma of the oropharynx
870396|NCT00010023|stage IV squamous cell carcinoma of the oropharynx|stage iv squamous cell carcinoma of the oropharynx
870397|NCT00010023|stage IV lymphoepithelioma of the oropharynx|stage iv lymphoepithelioma of the oropharynx
870398|NCT00010023|recurrent squamous cell carcinoma of the oropharynx|recurrent squamous cell carcinoma of the oropharynx
870399|NCT00010023|recurrent lymphoepithelioma of the oropharynx|recurrent lymphoepithelioma of the oropharynx
870400|NCT00010023|stage III squamous cell carcinoma of the nasopharynx|stage iii squamous cell carcinoma of the nasopharynx
870401|NCT00010023|stage III lymphoepithelioma of the nasopharynx|stage iii lymphoepithelioma of the nasopharynx
870402|NCT00010023|stage IV squamous cell carcinoma of the nasopharynx|stage iv squamous cell carcinoma of the nasopharynx
870403|NCT00010023|stage IV lymphoepithelioma of the nasopharynx|stage iv lymphoepithelioma of the nasopharynx
870404|NCT00010023|recurrent squamous cell carcinoma of the nasopharynx|recurrent squamous cell carcinoma of the nasopharynx
870405|NCT00010023|recurrent lymphoepithelioma of the nasopharynx|recurrent lymphoepithelioma of the nasopharynx
870406|NCT00010023|stage III squamous cell carcinoma of the hypopharynx|stage iii squamous cell carcinoma of the hypopharynx
870407|NCT00010023|stage IV squamous cell carcinoma of the hypopharynx|stage iv squamous cell carcinoma of the hypopharynx
870408|NCT00010023|recurrent squamous cell carcinoma of the hypopharynx|recurrent squamous cell carcinoma of the hypopharynx
870409|NCT00010023|stage III squamous cell carcinoma of the larynx|stage iii squamous cell carcinoma of the larynx
870410|NCT00010023|stage III verrucous carcinoma of the larynx|stage iii verrucous carcinoma of the larynx
870411|NCT00010023|stage IV squamous cell carcinoma of the larynx|stage iv squamous cell carcinoma of the larynx
870412|NCT00010023|stage IV verrucous carcinoma of the larynx|stage iv verrucous carcinoma of the larynx
870413|NCT00010023|recurrent squamous cell carcinoma of the larynx|recurrent squamous cell carcinoma of the larynx
870414|NCT00010023|recurrent verrucous carcinoma of the larynx|recurrent verrucous carcinoma of the larynx
870415|NCT00010023|stage III squamous cell carcinoma of the paranasal sinus and nasal cavity|stage iii squamous cell carcinoma of the paranasal sinus and nasal cavity
870416|NCT00010023|stage III inverted papilloma of the paranasal sinus and nasal cavity|stage iii inverted papilloma of the paranasal sinus and nasal cavity
870417|NCT00010023|stage III midline lethal granuloma of the paranasal sinus and nasal cavity|stage iii midline lethal granuloma of the paranasal sinus and nasal cavity
870418|NCT00010023|stage III esthesioneuroblastoma of the paranasal sinus and nasal cavity|stage iii esthesioneuroblastoma of the paranasal sinus and nasal cavity
870419|NCT00010023|stage IV squamous cell carcinoma of the paranasal sinus and nasal cavity|stage iv squamous cell carcinoma of the paranasal sinus and nasal cavity
870420|NCT00010023|stage IV inverted papilloma of the paranasal sinus and nasal cavity|stage iv inverted papilloma of the paranasal sinus and nasal cavity
870421|NCT00010023|stage IV midline lethal granuloma of the paranasal sinus and nasal cavity|stage iv midline lethal granuloma of the paranasal sinus and nasal cavity
870422|NCT00010023|stage IV esthesioneuroblastoma of the paranasal sinus and nasal cavity|stage iv esthesioneuroblastoma of the paranasal sinus and nasal cavity
870423|NCT00010023|recurrent squamous cell carcinoma of the paranasal sinus and nasal cavity|recurrent squamous cell carcinoma of the paranasal sinus and nasal cavity
870424|NCT00010023|recurrent inverted papilloma of the paranasal sinus and nasal cavity|recurrent inverted papilloma of the paranasal sinus and nasal cavity
870425|NCT00010023|recurrent midline lethal granuloma of the paranasal sinus and nasal cavity|recurrent midline lethal granuloma of the paranasal sinus and nasal cavity
870426|NCT00010023|recurrent esthesioneuroblastoma of the paranasal sinus and nasal cavity|recurrent esthesioneuroblastoma of the paranasal sinus and nasal cavity
870427|NCT00010023|newly diagnosed carcinoma of unknown primary|newly diagnosed carcinoma of unknown primary
870428|NCT00010023|carcinoma of the appendix|carcinoma of the appendix
870429|NCT00010023|recurrent carcinoma of unknown primary|recurrent carcinoma of unknown primary
870430|NCT00010023|gastrointestinal stromal tumor|gastrointestinal stromal tumor
870431|NCT00010023|recurrent salivary gland cancer|recurrent salivary gland cancer
870432|NCT00010023|stage III salivary gland cancer|stage iii salivary gland cancer
870433|NCT00010023|stage IV salivary gland cancer|stage iv salivary gland cancer
870434|NCT00010023|stage IV pancreatic cancer|stage iv pancreatic cancer
870435|NCT00009971|limited stage small cell lung cancer|limited stage small cell lung cancer
870436|NCT00009971|extensive stage small cell lung cancer|extensive stage small cell lung cancer
870437|NCT00009971|recurrent small cell lung cancer|recurrent small cell lung cancer
870438|NCT00009945|stage I breast cancer|stage i breast cancer
870439|NCT00009945|stage II breast cancer|stage ii breast cancer
870440|NCT00009880|stage I gastric cancer|stage i gastric cancer
870441|NCT00009880|stage II gastric cancer|stage ii gastric cancer
870442|NCT00009880|stage III gastric cancer|stage iii gastric cancer
870443|NCT00009880|stage I esophageal cancer|stage i esophageal cancer
870444|NCT00009880|stage II esophageal cancer|stage ii esophageal cancer
870445|NCT00009880|stage III esophageal cancer|stage iii esophageal cancer
870446|NCT00009880|adenocarcinoma of the stomach|adenocarcinoma of the stomach
870447|NCT00009880|squamous cell carcinoma of the esophagus|squamous cell carcinoma of the esophagus
870448|NCT00009880|adenocarcinoma of the esophagus|adenocarcinoma of the esophagus
870449|NCT00009854|adult glioblastoma|adult glioblastoma
870450|NCT00009854|tumors metastatic to brain|tumors metastatic to brain
870451|NCT00009854|adult anaplastic astrocytoma|adult anaplastic astrocytoma
870452|NCT00009854|adult anaplastic ependymoma|adult anaplastic ependymoma
870453|NCT00009854|adult anaplastic oligodendroglioma|adult anaplastic oligodendroglioma
870454|NCT00009854|adult giant cell glioblastoma|adult giant cell glioblastoma
870455|NCT00009854|adult gliosarcoma|adult gliosarcoma
870456|NCT00009776|recurrent grade 1 follicular lymphoma|recurrent grade 1 follicular lymphoma
870457|NCT00009776|recurrent grade 2 follicular lymphoma|recurrent grade 2 follicular lymphoma
870458|NCT00009776|recurrent grade 3 follicular lymphoma|recurrent grade 3 follicular lymphoma
870459|NCT00009776|recurrent adult diffuse small cleaved cell lymphoma|recurrent adult diffuse small cleaved cell lymphoma
870460|NCT00009776|recurrent adult diffuse mixed cell lymphoma|recurrent adult diffuse mixed cell lymphoma
870461|NCT00009776|recurrent adult diffuse large cell lymphoma|recurrent adult diffuse large cell lymphoma
870462|NCT00009776|recurrent adult immunoblastic large cell lymphoma|recurrent adult immunoblastic large cell lymphoma
870463|NCT00009776|recurrent adult lymphoblastic lymphoma|recurrent adult lymphoblastic lymphoma
870464|NCT00009776|recurrent adult Burkitt lymphoma|recurrent adult burkitt lymphoma
870465|NCT00009776|recurrent mantle cell lymphoma|recurrent mantle cell lymphoma
870466|NCT00009776|recurrent marginal zone lymphoma|recurrent marginal zone lymphoma
870467|NCT00009776|recurrent small lymphocytic lymphoma|recurrent small lymphocytic lymphoma
870468|NCT00009776|extranodal marginal zone B-cell lymphoma of mucosa-associated lymphoid tissue|extranodal marginal zone b-cell lymphoma of mucosa-associated lymphoid tissue
870469|NCT00009776|nodal marginal zone B-cell lymphoma|nodal marginal zone b-cell lymphoma
870470|NCT00009776|splenic marginal zone lymphoma|splenic marginal zone lymphoma
870471|NCT00009763|stage IV breast cancer|stage iv breast cancer
870472|NCT00009763|recurrent breast cancer|recurrent breast cancer
870473|NCT00009750|stage IV prostate cancer|stage iv prostate cancer
870474|NCT00009750|recurrent prostate cancer|recurrent prostate cancer
870475|NCT00009711|long-term effects secondary to cancer therapy in children|long-term effects secondary to cancer therapy in children
870476|NCT00009711|pulmonary complications|pulmonary complications
870477|NCT00008697|recurrent childhood acute myeloid leukemia|recurrent childhood acute myeloid leukemia
870478|NCT00008697|recurrent adult acute myeloid leukemia|recurrent adult acute myeloid leukemia
870479|NCT00008697|adult acute promyelocytic leukemia (M3)|adult acute promyelocytic leukemia (m3)
870480|NCT00008697|childhood acute promyelocytic leukemia (M3)|childhood acute promyelocytic leukemia (m3)
870481|NCT00008437|stage I breast cancer|stage i breast cancer
870482|NCT00008437|stage II breast cancer|stage ii breast cancer
870483|NCT00008437|stage IIIA breast cancer|stage iiia breast cancer
870484|NCT00008411|stage IV breast cancer|stage iv breast cancer
870485|NCT00008411|recurrent breast cancer|recurrent breast cancer
870486|NCT00008385|stage I non-small cell lung cancer|stage i non-small cell lung cancer
870487|NCT00008346|breast cancer|breast cancer
870488|NCT00008307|stage I adult Hodgkin lymphoma|stage i adult hodgkin lymphoma
870489|NCT00008307|stage II adult Hodgkin lymphoma|stage ii adult hodgkin lymphoma
870490|NCT00008307|stage III adult Hodgkin lymphoma|stage iii adult hodgkin lymphoma
870491|NCT00008307|stage IV adult Hodgkin lymphoma|stage iv adult hodgkin lymphoma
870492|NCT00008307|recurrent childhood acute lymphoblastic leukemia|recurrent childhood acute lymphoblastic leukemia
870493|NCT00008307|recurrent adult Hodgkin lymphoma|recurrent adult hodgkin lymphoma
870494|NCT00008307|stage I cutaneous T-cell non-Hodgkin lymphoma|stage i cutaneous t-cell non-hodgkin lymphoma
870495|NCT00008307|stage II cutaneous T-cell non-Hodgkin lymphoma|stage ii cutaneous t-cell non-hodgkin lymphoma
870496|NCT00008307|stage III cutaneous T-cell non-Hodgkin lymphoma|stage iii cutaneous t-cell non-hodgkin lymphoma
870497|NCT00008307|stage IV cutaneous T-cell non-Hodgkin lymphoma|stage iv cutaneous t-cell non-hodgkin lymphoma
870498|NCT00008307|recurrent cutaneous T-cell non-Hodgkin lymphoma|recurrent cutaneous t-cell non-hodgkin lymphoma
870499|NCT00008307|refractory multiple myeloma|refractory multiple myeloma
870500|NCT00008307|stage I multiple myeloma|stage i multiple myeloma
870501|NCT00008307|stage II multiple myeloma|stage ii multiple myeloma
870502|NCT00008307|stage III multiple myeloma|stage iii multiple myeloma
870503|NCT00008307|stage I childhood lymphoblastic lymphoma|stage i childhood lymphoblastic lymphoma
877659|NCT00001482|Lamotrigine|lamotrigine
870504|NCT00008307|stage II childhood lymphoblastic lymphoma|stage ii childhood lymphoblastic lymphoma
870505|NCT00008307|stage III childhood lymphoblastic lymphoma|stage iii childhood lymphoblastic lymphoma
870506|NCT00008307|stage IV childhood lymphoblastic lymphoma|stage iv childhood lymphoblastic lymphoma
870507|NCT00008307|recurrent childhood lymphoblastic lymphoma|recurrent childhood lymphoblastic lymphoma
870508|NCT00008307|recurrent childhood acute myeloid leukemia|recurrent childhood acute myeloid leukemia
870509|NCT00008307|recurrent adult acute myeloid leukemia|recurrent adult acute myeloid leukemia
870510|NCT00008307|recurrent adult acute lymphoblastic leukemia|recurrent adult acute lymphoblastic leukemia
870511|NCT00008307|relapsing chronic myelogenous leukemia|relapsing chronic myelogenous leukemia
870512|NCT00008307|chronic phase chronic myelogenous leukemia|chronic phase chronic myelogenous leukemia
870513|NCT00008307|accelerated phase chronic myelogenous leukemia|accelerated phase chronic myelogenous leukemia
870514|NCT00008307|blastic phase chronic myelogenous leukemia|blastic phase chronic myelogenous leukemia
870515|NCT00008307|meningeal chronic myelogenous leukemia|meningeal chronic myelogenous leukemia
870516|NCT00008307|untreated adult acute lymphoblastic leukemia|untreated adult acute lymphoblastic leukemia
870517|NCT00008307|untreated adult acute myeloid leukemia|untreated adult acute myeloid leukemia
870518|NCT00008307|untreated childhood acute myeloid leukemia and other myeloid malignancies|untreated childhood acute myeloid leukemia and other myeloid malignancies
870519|NCT00008307|untreated childhood acute lymphoblastic leukemia|untreated childhood acute lymphoblastic leukemia
870520|NCT00008307|adult acute myeloid leukemia in remission|adult acute myeloid leukemia in remission
870521|NCT00008307|adult acute lymphoblastic leukemia in remission|adult acute lymphoblastic leukemia in remission
870522|NCT00008307|childhood acute myeloid leukemia in remission|childhood acute myeloid leukemia in remission
870523|NCT00008307|childhood acute lymphoblastic leukemia in remission|childhood acute lymphoblastic leukemia in remission
870524|NCT00008307|chronic myelogenous leukemia, BCR-ABL1 positive|chronic myelogenous leukemia, bcr-abl1 positive
870525|NCT00008307|Philadelphia chromosome negative chronic myelogenous leukemia|philadelphia chromosome negative chronic myelogenous leukemia
870526|NCT00008307|stage II childhood Hodgkin lymphoma|stage ii childhood hodgkin lymphoma
870527|NCT00008307|stage I childhood Hodgkin lymphoma|stage i childhood hodgkin lymphoma
870528|NCT00008307|stage III childhood Hodgkin lymphoma|stage iii childhood hodgkin lymphoma
870529|NCT00008307|stage IV childhood Hodgkin lymphoma|stage iv childhood hodgkin lymphoma
870530|NCT00008307|recurrent/refractory childhood Hodgkin lymphoma|recurrent/refractory childhood hodgkin lymphoma
870531|NCT00008307|stage I grade 1 follicular lymphoma|stage i grade 1 follicular lymphoma
870532|NCT00008307|stage I grade 2 follicular lymphoma|stage i grade 2 follicular lymphoma
870533|NCT00008307|stage I grade 3 follicular lymphoma|stage i grade 3 follicular lymphoma
870534|NCT00008307|stage I adult diffuse small cleaved cell lymphoma|stage i adult diffuse small cleaved cell lymphoma
870535|NCT00008307|stage I adult diffuse mixed cell lymphoma|stage i adult diffuse mixed cell lymphoma
870536|NCT00008307|stage I adult diffuse large cell lymphoma|stage i adult diffuse large cell lymphoma
870537|NCT00008307|stage I adult immunoblastic large cell lymphoma|stage i adult immunoblastic large cell lymphoma
870538|NCT00008307|stage I adult lymphoblastic lymphoma|stage i adult lymphoblastic lymphoma
870539|NCT00008307|stage I adult Burkitt lymphoma|stage i adult burkitt lymphoma
870540|NCT00008307|stage III grade 1 follicular lymphoma|stage iii grade 1 follicular lymphoma
870541|NCT00008307|stage III grade 2 follicular lymphoma|stage iii grade 2 follicular lymphoma
870542|NCT00008307|stage III grade 3 follicular lymphoma|stage iii grade 3 follicular lymphoma
870543|NCT00008307|stage III adult diffuse small cleaved cell lymphoma|stage iii adult diffuse small cleaved cell lymphoma
870544|NCT00008307|stage III adult diffuse mixed cell lymphoma|stage iii adult diffuse mixed cell lymphoma
870545|NCT00008307|stage III adult diffuse large cell lymphoma|stage iii adult diffuse large cell lymphoma
870546|NCT00008307|stage III adult immunoblastic large cell lymphoma|stage iii adult immunoblastic large cell lymphoma
870547|NCT00008307|stage III adult lymphoblastic lymphoma|stage iii adult lymphoblastic lymphoma
870548|NCT00008307|stage III adult Burkitt lymphoma|stage iii adult burkitt lymphoma
870549|NCT00008307|stage IV grade 1 follicular lymphoma|stage iv grade 1 follicular lymphoma
870550|NCT00008307|stage IV grade 2 follicular lymphoma|stage iv grade 2 follicular lymphoma
870551|NCT00008307|stage IV grade 3 follicular lymphoma|stage iv grade 3 follicular lymphoma
870552|NCT00008307|stage IV adult diffuse small cleaved cell lymphoma|stage iv adult diffuse small cleaved cell lymphoma
870553|NCT00008307|stage IV adult diffuse mixed cell lymphoma|stage iv adult diffuse mixed cell lymphoma
870554|NCT00008307|stage IV adult diffuse large cell lymphoma|stage iv adult diffuse large cell lymphoma
870555|NCT00008307|stage IV adult immunoblastic large cell lymphoma|stage iv adult immunoblastic large cell lymphoma
870556|NCT00008307|stage IV adult lymphoblastic lymphoma|stage iv adult lymphoblastic lymphoma
870557|NCT00008307|stage IV adult Burkitt lymphoma|stage iv adult burkitt lymphoma
870558|NCT00008307|recurrent grade 1 follicular lymphoma|recurrent grade 1 follicular lymphoma
870559|NCT00008307|recurrent grade 2 follicular lymphoma|recurrent grade 2 follicular lymphoma
870560|NCT00008307|recurrent grade 3 follicular lymphoma|recurrent grade 3 follicular lymphoma
870561|NCT00008307|recurrent adult diffuse small cleaved cell lymphoma|recurrent adult diffuse small cleaved cell lymphoma
870562|NCT00008307|recurrent adult diffuse mixed cell lymphoma|recurrent adult diffuse mixed cell lymphoma
870563|NCT00008307|recurrent adult diffuse large cell lymphoma|recurrent adult diffuse large cell lymphoma
870564|NCT00008307|recurrent adult immunoblastic large cell lymphoma|recurrent adult immunoblastic large cell lymphoma
871723|NCT00006093|adult gliosarcoma|adult gliosarcoma
870565|NCT00008307|recurrent adult lymphoblastic lymphoma|recurrent adult lymphoblastic lymphoma
870566|NCT00008307|recurrent adult Burkitt lymphoma|recurrent adult burkitt lymphoma
870567|NCT00008307|stage I adult T-cell leukemia/lymphoma|stage i adult t-cell leukemia/lymphoma
870568|NCT00008307|stage II adult T-cell leukemia/lymphoma|stage ii adult t-cell leukemia/lymphoma
870569|NCT00008307|stage III adult T-cell leukemia/lymphoma|stage iii adult t-cell leukemia/lymphoma
870570|NCT00008307|stage IV adult T-cell leukemia/lymphoma|stage iv adult t-cell leukemia/lymphoma
870571|NCT00008307|recurrent adult T-cell leukemia/lymphoma|recurrent adult t-cell leukemia/lymphoma
870572|NCT00008307|de novo myelodysplastic syndromes|de novo myelodysplastic syndromes
870573|NCT00008307|previously treated myelodysplastic syndromes|previously treated myelodysplastic syndromes
870574|NCT00008307|secondary myelodysplastic syndromes|secondary myelodysplastic syndromes
870575|NCT00008307|intraocular lymphoma|intraocular lymphoma
870576|NCT00008307|stage I childhood large cell lymphoma|stage i childhood large cell lymphoma
870577|NCT00008307|stage II childhood large cell lymphoma|stage ii childhood large cell lymphoma
870578|NCT00008307|stage III childhood large cell lymphoma|stage iii childhood large cell lymphoma
870579|NCT00008307|stage IV childhood large cell lymphoma|stage iv childhood large cell lymphoma
870580|NCT00008307|recurrent childhood large cell lymphoma|recurrent childhood large cell lymphoma
870581|NCT00008307|stage I mantle cell lymphoma|stage i mantle cell lymphoma
870582|NCT00008307|contiguous stage II grade 1 follicular lymphoma|contiguous stage ii grade 1 follicular lymphoma
870583|NCT00008307|contiguous stage II grade 2 follicular lymphoma|contiguous stage ii grade 2 follicular lymphoma
870584|NCT00008307|contiguous stage II grade 3 follicular lymphoma|contiguous stage ii grade 3 follicular lymphoma
870585|NCT00008307|contiguous stage II adult diffuse small cleaved cell lymphoma|contiguous stage ii adult diffuse small cleaved cell lymphoma
870586|NCT00008307|contiguous stage II mantle cell lymphoma|contiguous stage ii mantle cell lymphoma
870587|NCT00008307|contiguous stage II adult diffuse mixed cell lymphoma|contiguous stage ii adult diffuse mixed cell lymphoma
870588|NCT00008307|contiguous stage II adult immunoblastic large cell lymphoma|contiguous stage ii adult immunoblastic large cell lymphoma
870589|NCT00008307|contiguous stage II adult diffuse large cell lymphoma|contiguous stage ii adult diffuse large cell lymphoma
870590|NCT00008307|contiguous stage II adult Burkitt lymphoma|contiguous stage ii adult burkitt lymphoma
870591|NCT00008307|contiguous stage II adult lymphoblastic lymphoma|contiguous stage ii adult lymphoblastic lymphoma
870592|NCT00008307|noncontiguous stage II grade 1 follicular lymphoma|noncontiguous stage ii grade 1 follicular lymphoma
870593|NCT00008307|noncontiguous stage II grade 2 follicular lymphoma|noncontiguous stage ii grade 2 follicular lymphoma
870594|NCT00008307|noncontiguous stage II grade 3 follicular lymphoma|noncontiguous stage ii grade 3 follicular lymphoma
870595|NCT00008307|noncontiguous stage II adult diffuse small cleaved cell lymphoma|noncontiguous stage ii adult diffuse small cleaved cell lymphoma
870596|NCT00008307|noncontiguous stage II mantle cell lymphoma|noncontiguous stage ii mantle cell lymphoma
870597|NCT00008307|noncontiguous stage II adult diffuse mixed cell lymphoma|noncontiguous stage ii adult diffuse mixed cell lymphoma
870598|NCT00008307|noncontiguous stage II adult immunoblastic large cell lymphoma|noncontiguous stage ii adult immunoblastic large cell lymphoma
870599|NCT00008307|noncontiguous stage II adult diffuse large cell lymphoma|noncontiguous stage ii adult diffuse large cell lymphoma
870600|NCT00008307|noncontiguous stage II adult Burkitt lymphoma|noncontiguous stage ii adult burkitt lymphoma
870601|NCT00008307|noncontiguous stage II adult lymphoblastic lymphoma|noncontiguous stage ii adult lymphoblastic lymphoma
870602|NCT00008307|stage III mantle cell lymphoma|stage iii mantle cell lymphoma
870603|NCT00008307|stage IV mantle cell lymphoma|stage iv mantle cell lymphoma
870604|NCT00008307|recurrent mantle cell lymphoma|recurrent mantle cell lymphoma
870605|NCT00008307|angioimmunoblastic T-cell lymphoma|angioimmunoblastic t-cell lymphoma
870606|NCT00008307|anaplastic large cell lymphoma|anaplastic large cell lymphoma
870607|NCT00008307|stage I mycosis fungoides/Sezary syndrome|stage i mycosis fungoides/sezary syndrome
870608|NCT00008307|stage II mycosis fungoides/Sezary syndrome|stage ii mycosis fungoides/sezary syndrome
870609|NCT00008307|stage III mycosis fungoides/Sezary syndrome|stage iii mycosis fungoides/sezary syndrome
870610|NCT00008307|stage IV mycosis fungoides/Sezary syndrome|stage iv mycosis fungoides/sezary syndrome
870611|NCT00008307|recurrent mycosis fungoides/Sezary syndrome|recurrent mycosis fungoides/sezary syndrome
870612|NCT00008307|childhood chronic myelogenous leukemia|childhood chronic myelogenous leukemia
870613|NCT00008307|contiguous stage II small lymphocytic lymphoma|contiguous stage ii small lymphocytic lymphoma
870614|NCT00008307|contiguous stage II marginal zone lymphoma|contiguous stage ii marginal zone lymphoma
870615|NCT00008307|noncontiguous stage II small lymphocytic lymphoma|noncontiguous stage ii small lymphocytic lymphoma
870616|NCT00008307|noncontiguous stage II marginal zone lymphoma|noncontiguous stage ii marginal zone lymphoma
870617|NCT00008307|extranodal marginal zone B-cell lymphoma of mucosa-associated lymphoid tissue|extranodal marginal zone b-cell lymphoma of mucosa-associated lymphoid tissue
870618|NCT00008307|nodal marginal zone B-cell lymphoma|nodal marginal zone b-cell lymphoma
870619|NCT00008307|splenic marginal zone lymphoma|splenic marginal zone lymphoma
870620|NCT00008307|recurrent marginal zone lymphoma|recurrent marginal zone lymphoma
870621|NCT00008307|recurrent small lymphocytic lymphoma|recurrent small lymphocytic lymphoma
870622|NCT00008307|stage I marginal zone lymphoma|stage i marginal zone lymphoma
870623|NCT00008307|stage I small lymphocytic lymphoma|stage i small lymphocytic lymphoma
870624|NCT00008307|stage III small lymphocytic lymphoma|stage iii small lymphocytic lymphoma
870625|NCT00008307|stage III marginal zone lymphoma|stage iii marginal zone lymphoma
870626|NCT00008307|stage IV small lymphocytic lymphoma|stage iv small lymphocytic lymphoma
870627|NCT00008307|stage IV marginal zone lymphoma|stage iv marginal zone lymphoma
870628|NCT00008307|adult acute myeloid leukemia with t(8;21)(q22;q22)|adult acute myeloid leukemia with t(8;21)(q22;q22)
870629|NCT00008307|adult acute myeloid leukemia with t(16;16)(p13;q22)|adult acute myeloid leukemia with t(16;16)(p13;q22)
870630|NCT00008307|adult acute myeloid leukemia with inv(16)(p13;q22)|adult acute myeloid leukemia with inv(16)(p13;q22)
870631|NCT00008307|adult acute myeloid leukemia with 11q23 (MLL) abnormalities|adult acute myeloid leukemia with 11q23 (mll) abnormalities
870632|NCT00008307|adult acute myeloid leukemia with t(15;17)(q22;q12)|adult acute myeloid leukemia with t(15;17)(q22;q12)
870633|NCT00008307|childhood myelodysplastic syndromes|childhood myelodysplastic syndromes
870634|NCT00008294|stage IV colon cancer|stage iv colon cancer
870635|NCT00008294|stage IV rectal cancer|stage iv rectal cancer
870636|NCT00008294|adenocarcinoma of the colon|adenocarcinoma of the colon
870637|NCT00008294|adenocarcinoma of the rectum|adenocarcinoma of the rectum
870638|NCT00008294|liver metastases|liver metastases
870639|NCT00008294|recurrent colon cancer|recurrent colon cancer
870640|NCT00008294|recurrent rectal cancer|recurrent rectal cancer
870641|NCT00008268|stage I multiple myeloma|stage i multiple myeloma
870642|NCT00008268|stage II multiple myeloma|stage ii multiple myeloma
870643|NCT00008268|stage III multiple myeloma|stage iii multiple myeloma
870644|NCT00008216|stage IV adult Hodgkin lymphoma|stage iv adult hodgkin lymphoma
870645|NCT00008216|recurrent childhood acute lymphoblastic leukemia|recurrent childhood acute lymphoblastic leukemia
870646|NCT00008216|recurrent adult Hodgkin lymphoma|recurrent adult hodgkin lymphoma
870647|NCT00008216|recurrent cutaneous T-cell non-Hodgkin lymphoma|recurrent cutaneous t-cell non-hodgkin lymphoma
870648|NCT00008216|refractory multiple myeloma|refractory multiple myeloma
870649|NCT00008216|stage I multiple myeloma|stage i multiple myeloma
870650|NCT00008216|stage II multiple myeloma|stage ii multiple myeloma
870651|NCT00008216|stage III multiple myeloma|stage iii multiple myeloma
870652|NCT00008216|stage II childhood lymphoblastic lymphoma|stage ii childhood lymphoblastic lymphoma
870653|NCT00008216|stage III childhood lymphoblastic lymphoma|stage iii childhood lymphoblastic lymphoma
893920|NCT00001960|Symptoms|symptoms
870654|NCT00008216|stage IV childhood lymphoblastic lymphoma|stage iv childhood lymphoblastic lymphoma
870655|NCT00008216|recurrent childhood lymphoblastic lymphoma|recurrent childhood lymphoblastic lymphoma
870656|NCT00008216|recurrent childhood acute myeloid leukemia|recurrent childhood acute myeloid leukemia
870657|NCT00008216|recurrent adult acute myeloid leukemia|recurrent adult acute myeloid leukemia
870658|NCT00008216|recurrent adult acute lymphoblastic leukemia|recurrent adult acute lymphoblastic leukemia
870659|NCT00008216|relapsing chronic myelogenous leukemia|relapsing chronic myelogenous leukemia
870660|NCT00008216|childhood Langerhans cell histiocytosis|childhood langerhans cell histiocytosis
870661|NCT00008216|chronic phase chronic myelogenous leukemia|chronic phase chronic myelogenous leukemia
870662|NCT00008216|accelerated phase chronic myelogenous leukemia|accelerated phase chronic myelogenous leukemia
870663|NCT00008216|blastic phase chronic myelogenous leukemia|blastic phase chronic myelogenous leukemia
870664|NCT00008216|meningeal chronic myelogenous leukemia|meningeal chronic myelogenous leukemia
870665|NCT00008216|untreated adult acute lymphoblastic leukemia|untreated adult acute lymphoblastic leukemia
870666|NCT00008216|untreated adult acute myeloid leukemia|untreated adult acute myeloid leukemia
870667|NCT00008216|untreated childhood acute myeloid leukemia and other myeloid malignancies|untreated childhood acute myeloid leukemia and other myeloid malignancies
870668|NCT00008216|untreated childhood acute lymphoblastic leukemia|untreated childhood acute lymphoblastic leukemia
870669|NCT00008216|adult acute myeloid leukemia in remission|adult acute myeloid leukemia in remission
870670|NCT00008216|adult acute lymphoblastic leukemia in remission|adult acute lymphoblastic leukemia in remission
870671|NCT00008216|childhood acute myeloid leukemia in remission|childhood acute myeloid leukemia in remission
870672|NCT00008216|childhood acute lymphoblastic leukemia in remission|childhood acute lymphoblastic leukemia in remission
870673|NCT00008216|chronic myelogenous leukemia, BCR-ABL1 positive|chronic myelogenous leukemia, bcr-abl1 positive
870674|NCT00008216|Philadelphia chromosome negative chronic myelogenous leukemia|philadelphia chromosome negative chronic myelogenous leukemia
870675|NCT00008216|stage IV childhood Hodgkin lymphoma|stage iv childhood hodgkin lymphoma
870676|NCT00008216|recurrent/refractory childhood Hodgkin lymphoma|recurrent/refractory childhood hodgkin lymphoma
870677|NCT00008216|stage III grade 1 follicular lymphoma|stage iii grade 1 follicular lymphoma
870678|NCT00008216|stage III grade 2 follicular lymphoma|stage iii grade 2 follicular lymphoma
870679|NCT00008216|stage III grade 3 follicular lymphoma|stage iii grade 3 follicular lymphoma
870680|NCT00008216|stage III adult diffuse small cleaved cell lymphoma|stage iii adult diffuse small cleaved cell lymphoma
870681|NCT00008216|stage III adult diffuse mixed cell lymphoma|stage iii adult diffuse mixed cell lymphoma
870682|NCT00008216|stage III adult diffuse large cell lymphoma|stage iii adult diffuse large cell lymphoma
870683|NCT00008216|stage III adult immunoblastic large cell lymphoma|stage iii adult immunoblastic large cell lymphoma
870684|NCT00008216|stage III adult lymphoblastic lymphoma|stage iii adult lymphoblastic lymphoma
870685|NCT00008216|stage III adult Burkitt lymphoma|stage iii adult burkitt lymphoma
870686|NCT00008216|stage IV grade 1 follicular lymphoma|stage iv grade 1 follicular lymphoma
870687|NCT00008216|stage IV grade 2 follicular lymphoma|stage iv grade 2 follicular lymphoma
870688|NCT00008216|stage IV grade 3 follicular lymphoma|stage iv grade 3 follicular lymphoma
870689|NCT00008216|stage IV adult diffuse small cleaved cell lymphoma|stage iv adult diffuse small cleaved cell lymphoma
877660|NCT00001482|Mania|mania
870690|NCT00008216|stage IV adult diffuse mixed cell lymphoma|stage iv adult diffuse mixed cell lymphoma
870691|NCT00008216|stage IV adult diffuse large cell lymphoma|stage iv adult diffuse large cell lymphoma
870692|NCT00008216|stage IV adult immunoblastic large cell lymphoma|stage iv adult immunoblastic large cell lymphoma
870693|NCT00008216|stage IV adult lymphoblastic lymphoma|stage iv adult lymphoblastic lymphoma
870694|NCT00008216|stage IV adult Burkitt lymphoma|stage iv adult burkitt lymphoma
870695|NCT00008216|recurrent grade 1 follicular lymphoma|recurrent grade 1 follicular lymphoma
870696|NCT00008216|recurrent grade 2 follicular lymphoma|recurrent grade 2 follicular lymphoma
870697|NCT00008216|recurrent grade 3 follicular lymphoma|recurrent grade 3 follicular lymphoma
870698|NCT00008216|recurrent adult diffuse small cleaved cell lymphoma|recurrent adult diffuse small cleaved cell lymphoma
870699|NCT00008216|recurrent adult diffuse mixed cell lymphoma|recurrent adult diffuse mixed cell lymphoma
870700|NCT00008216|recurrent adult diffuse large cell lymphoma|recurrent adult diffuse large cell lymphoma
870701|NCT00008216|recurrent adult immunoblastic large cell lymphoma|recurrent adult immunoblastic large cell lymphoma
870702|NCT00008216|recurrent adult lymphoblastic lymphoma|recurrent adult lymphoblastic lymphoma
870703|NCT00008216|recurrent adult Burkitt lymphoma|recurrent adult burkitt lymphoma
870704|NCT00008216|stage II adult T-cell leukemia/lymphoma|stage ii adult t-cell leukemia/lymphoma
870705|NCT00008216|stage III adult T-cell leukemia/lymphoma|stage iii adult t-cell leukemia/lymphoma
870706|NCT00008216|stage IV adult T-cell leukemia/lymphoma|stage iv adult t-cell leukemia/lymphoma
870707|NCT00008216|recurrent adult T-cell leukemia/lymphoma|recurrent adult t-cell leukemia/lymphoma
870708|NCT00008216|secondary acute myeloid leukemia|secondary acute myeloid leukemia
870709|NCT00008216|de novo myelodysplastic syndromes|de novo myelodysplastic syndromes
870710|NCT00008216|previously treated myelodysplastic syndromes|previously treated myelodysplastic syndromes
870711|NCT00008216|secondary myelodysplastic syndromes|secondary myelodysplastic syndromes
870712|NCT00008216|intraocular lymphoma|intraocular lymphoma
870713|NCT00008216|stage II childhood small noncleaved cell lymphoma|stage ii childhood small noncleaved cell lymphoma
870714|NCT00008216|stage II childhood large cell lymphoma|stage ii childhood large cell lymphoma
870715|NCT00008216|stage III childhood small noncleaved cell lymphoma|stage iii childhood small noncleaved cell lymphoma
870716|NCT00008216|stage III childhood large cell lymphoma|stage iii childhood large cell lymphoma
870717|NCT00008216|stage IV childhood small noncleaved cell lymphoma|stage iv childhood small noncleaved cell lymphoma
870718|NCT00008216|stage IV childhood large cell lymphoma|stage iv childhood large cell lymphoma
870719|NCT00008216|recurrent childhood small noncleaved cell lymphoma|recurrent childhood small noncleaved cell lymphoma
870720|NCT00008216|recurrent childhood large cell lymphoma|recurrent childhood large cell lymphoma
870721|NCT00008216|contiguous stage II grade 1 follicular lymphoma|contiguous stage ii grade 1 follicular lymphoma
870722|NCT00008216|contiguous stage II grade 2 follicular lymphoma|contiguous stage ii grade 2 follicular lymphoma
870723|NCT00008216|contiguous stage II grade 3 follicular lymphoma|contiguous stage ii grade 3 follicular lymphoma
870724|NCT00008216|contiguous stage II adult diffuse small cleaved cell lymphoma|contiguous stage ii adult diffuse small cleaved cell lymphoma
870725|NCT00008216|contiguous stage II mantle cell lymphoma|contiguous stage ii mantle cell lymphoma
870726|NCT00008216|contiguous stage II adult diffuse mixed cell lymphoma|contiguous stage ii adult diffuse mixed cell lymphoma
870727|NCT00008216|contiguous stage II adult immunoblastic large cell lymphoma|contiguous stage ii adult immunoblastic large cell lymphoma
870728|NCT00008216|contiguous stage II adult diffuse large cell lymphoma|contiguous stage ii adult diffuse large cell lymphoma
870729|NCT00008216|contiguous stage II adult Burkitt lymphoma|contiguous stage ii adult burkitt lymphoma
870730|NCT00008216|contiguous stage II adult lymphoblastic lymphoma|contiguous stage ii adult lymphoblastic lymphoma
870731|NCT00008216|noncontiguous stage II grade 1 follicular lymphoma|noncontiguous stage ii grade 1 follicular lymphoma
870732|NCT00008216|noncontiguous stage II grade 2 follicular lymphoma|noncontiguous stage ii grade 2 follicular lymphoma
870733|NCT00008216|noncontiguous stage II grade 3 follicular lymphoma|noncontiguous stage ii grade 3 follicular lymphoma
870734|NCT00008216|noncontiguous stage II adult diffuse small cleaved cell lymphoma|noncontiguous stage ii adult diffuse small cleaved cell lymphoma
870735|NCT00008216|noncontiguous stage II mantle cell lymphoma|noncontiguous stage ii mantle cell lymphoma
870736|NCT00008216|noncontiguous stage II adult diffuse mixed cell lymphoma|noncontiguous stage ii adult diffuse mixed cell lymphoma
870737|NCT00008216|noncontiguous stage II adult immunoblastic large cell lymphoma|noncontiguous stage ii adult immunoblastic large cell lymphoma
870738|NCT00008216|noncontiguous stage II adult diffuse large cell lymphoma|noncontiguous stage ii adult diffuse large cell lymphoma
870739|NCT00008216|noncontiguous stage II adult Burkitt lymphoma|noncontiguous stage ii adult burkitt lymphoma
870740|NCT00008216|noncontiguous stage II adult lymphoblastic lymphoma|noncontiguous stage ii adult lymphoblastic lymphoma
870741|NCT00008216|stage III mantle cell lymphoma|stage iii mantle cell lymphoma
870742|NCT00008216|stage IV mantle cell lymphoma|stage iv mantle cell lymphoma
870743|NCT00008216|recurrent mantle cell lymphoma|recurrent mantle cell lymphoma
870744|NCT00008216|angioimmunoblastic T-cell lymphoma|angioimmunoblastic t-cell lymphoma
870745|NCT00008216|anaplastic large cell lymphoma|anaplastic large cell lymphoma
870746|NCT00008216|recurrent mycosis fungoides/Sezary syndrome|recurrent mycosis fungoides/sezary syndrome
870747|NCT00008216|juvenile myelomonocytic leukemia|juvenile myelomonocytic leukemia
870748|NCT00008216|childhood chronic myelogenous leukemia|childhood chronic myelogenous leukemia
870749|NCT00008216|atypical chronic myeloid leukemia, BCR-ABL1 negative|atypical chronic myeloid leukemia, bcr-abl1 negative
877760|NCT00001436|Metastatic|metastatic
870750|NCT00008216|myelodysplastic/myeloproliferative neoplasm, unclassifiable|myelodysplastic/myeloproliferative neoplasm, unclassifiable
870751|NCT00008216|chronic myelomonocytic leukemia|chronic myelomonocytic leukemia
870752|NCT00008216|contiguous stage II small lymphocytic lymphoma|contiguous stage ii small lymphocytic lymphoma
870753|NCT00008216|contiguous stage II marginal zone lymphoma|contiguous stage ii marginal zone lymphoma
870754|NCT00008216|noncontiguous stage II small lymphocytic lymphoma|noncontiguous stage ii small lymphocytic lymphoma
870755|NCT00008216|noncontiguous stage II marginal zone lymphoma|noncontiguous stage ii marginal zone lymphoma
870756|NCT00008216|extranodal marginal zone B-cell lymphoma of mucosa-associated lymphoid tissue|extranodal marginal zone b-cell lymphoma of mucosa-associated lymphoid tissue
870757|NCT00008216|nodal marginal zone B-cell lymphoma|nodal marginal zone b-cell lymphoma
870758|NCT00008216|splenic marginal zone lymphoma|splenic marginal zone lymphoma
870759|NCT00008216|recurrent marginal zone lymphoma|recurrent marginal zone lymphoma
870760|NCT00008216|recurrent small lymphocytic lymphoma|recurrent small lymphocytic lymphoma
870761|NCT00008216|stage III small lymphocytic lymphoma|stage iii small lymphocytic lymphoma
870762|NCT00008216|stage III marginal zone lymphoma|stage iii marginal zone lymphoma
870763|NCT00008216|stage IV small lymphocytic lymphoma|stage iv small lymphocytic lymphoma
870764|NCT00008216|stage IV marginal zone lymphoma|stage iv marginal zone lymphoma
874454|NCT00003643|testicular seminoma|testicular seminoma
870765|NCT00008216|adult acute myeloid leukemia with t(8;21)(q22;q22)|adult acute myeloid leukemia with t(8;21)(q22;q22)
870766|NCT00008216|adult acute myeloid leukemia with t(16;16)(p13;q22)|adult acute myeloid leukemia with t(16;16)(p13;q22)
870767|NCT00008216|adult acute myeloid leukemia with inv(16)(p13;q22)|adult acute myeloid leukemia with inv(16)(p13;q22)
870768|NCT00008216|adult acute myeloid leukemia with 11q23 (MLL) abnormalities|adult acute myeloid leukemia with 11q23 (mll) abnormalities
870769|NCT00008216|adult acute myeloid leukemia with t(15;17)(q22;q12)|adult acute myeloid leukemia with t(15;17)(q22;q12)
870770|NCT00008216|childhood myelodysplastic syndromes|childhood myelodysplastic syndromes
870771|NCT00008216|adult Langerhans cell histiocytosis|adult langerhans cell histiocytosis
870772|NCT00008190|recurrent childhood acute lymphoblastic leukemia|recurrent childhood acute lymphoblastic leukemia
870773|NCT00008190|recurrent childhood acute myeloid leukemia|recurrent childhood acute myeloid leukemia
870774|NCT00008190|recurrent adult acute myeloid leukemia|recurrent adult acute myeloid leukemia
870775|NCT00008190|recurrent adult acute lymphoblastic leukemia|recurrent adult acute lymphoblastic leukemia
870776|NCT00008190|adult acute myeloid leukemia in remission|adult acute myeloid leukemia in remission
870777|NCT00008190|adult acute lymphoblastic leukemia in remission|adult acute lymphoblastic leukemia in remission
870778|NCT00008190|childhood acute myeloid leukemia in remission|childhood acute myeloid leukemia in remission
870779|NCT00008190|childhood acute lymphoblastic leukemia in remission|childhood acute lymphoblastic leukemia in remission
870780|NCT00008190|secondary acute myeloid leukemia|secondary acute myeloid leukemia
870781|NCT00008164|recurrent childhood acute lymphoblastic leukemia|recurrent childhood acute lymphoblastic leukemia
870782|NCT00008164|recurrent adult Hodgkin lymphoma|recurrent adult hodgkin lymphoma
870783|NCT00008164|recurrent cutaneous T-cell non-Hodgkin lymphoma|recurrent cutaneous t-cell non-hodgkin lymphoma
870784|NCT00008164|refractory multiple myeloma|refractory multiple myeloma
870785|NCT00008164|stage I multiple myeloma|stage i multiple myeloma
870786|NCT00008164|stage II multiple myeloma|stage ii multiple myeloma
870787|NCT00008164|stage III multiple myeloma|stage iii multiple myeloma
870788|NCT00008164|recurrent childhood lymphoblastic lymphoma|recurrent childhood lymphoblastic lymphoma
870789|NCT00008164|recurrent childhood acute myeloid leukemia|recurrent childhood acute myeloid leukemia
870790|NCT00008164|recurrent adult acute myeloid leukemia|recurrent adult acute myeloid leukemia
870791|NCT00008164|recurrent adult acute lymphoblastic leukemia|recurrent adult acute lymphoblastic leukemia
870792|NCT00008164|relapsing chronic myelogenous leukemia|relapsing chronic myelogenous leukemia
870793|NCT00008164|childhood Langerhans cell histiocytosis|childhood langerhans cell histiocytosis
870794|NCT00008164|chronic phase chronic myelogenous leukemia|chronic phase chronic myelogenous leukemia
870795|NCT00008164|accelerated phase chronic myelogenous leukemia|accelerated phase chronic myelogenous leukemia
870796|NCT00008164|blastic phase chronic myelogenous leukemia|blastic phase chronic myelogenous leukemia
870797|NCT00008164|meningeal chronic myelogenous leukemia|meningeal chronic myelogenous leukemia
870798|NCT00008164|untreated adult acute lymphoblastic leukemia|untreated adult acute lymphoblastic leukemia
870799|NCT00008164|untreated adult acute myeloid leukemia|untreated adult acute myeloid leukemia
870800|NCT00008164|untreated childhood acute myeloid leukemia and other myeloid malignancies|untreated childhood acute myeloid leukemia and other myeloid malignancies
870801|NCT00008164|untreated childhood acute lymphoblastic leukemia|untreated childhood acute lymphoblastic leukemia
870802|NCT00008164|recurrent/refractory childhood Hodgkin lymphoma|recurrent/refractory childhood hodgkin lymphoma
870803|NCT00008164|stage I adult Burkitt lymphoma|stage i adult burkitt lymphoma
870804|NCT00008164|stage III grade 1 follicular lymphoma|stage iii grade 1 follicular lymphoma
870805|NCT00008164|stage III grade 2 follicular lymphoma|stage iii grade 2 follicular lymphoma
870806|NCT00008164|stage III grade 3 follicular lymphoma|stage iii grade 3 follicular lymphoma
870807|NCT00008164|stage III adult diffuse small cleaved cell lymphoma|stage iii adult diffuse small cleaved cell lymphoma
870808|NCT00008164|stage III adult diffuse mixed cell lymphoma|stage iii adult diffuse mixed cell lymphoma
870809|NCT00008164|stage III adult diffuse large cell lymphoma|stage iii adult diffuse large cell lymphoma
870810|NCT00008164|stage III adult immunoblastic large cell lymphoma|stage iii adult immunoblastic large cell lymphoma
870811|NCT00008164|stage III adult lymphoblastic lymphoma|stage iii adult lymphoblastic lymphoma
870812|NCT00008164|stage III adult Burkitt lymphoma|stage iii adult burkitt lymphoma
870813|NCT00008164|stage IV grade 1 follicular lymphoma|stage iv grade 1 follicular lymphoma
870814|NCT00008164|stage IV grade 2 follicular lymphoma|stage iv grade 2 follicular lymphoma
870815|NCT00008164|stage IV grade 3 follicular lymphoma|stage iv grade 3 follicular lymphoma
870816|NCT00008164|stage IV adult diffuse small cleaved cell lymphoma|stage iv adult diffuse small cleaved cell lymphoma
870817|NCT00008164|stage IV adult diffuse mixed cell lymphoma|stage iv adult diffuse mixed cell lymphoma
870818|NCT00008164|stage IV adult diffuse large cell lymphoma|stage iv adult diffuse large cell lymphoma
870819|NCT00008164|stage IV adult immunoblastic large cell lymphoma|stage iv adult immunoblastic large cell lymphoma
870820|NCT00008164|stage IV adult lymphoblastic lymphoma|stage iv adult lymphoblastic lymphoma
870821|NCT00008164|stage IV adult Burkitt lymphoma|stage iv adult burkitt lymphoma
870822|NCT00008164|recurrent grade 1 follicular lymphoma|recurrent grade 1 follicular lymphoma
870823|NCT00008164|recurrent grade 2 follicular lymphoma|recurrent grade 2 follicular lymphoma
870824|NCT00008164|recurrent grade 3 follicular lymphoma|recurrent grade 3 follicular lymphoma
870825|NCT00008164|recurrent adult diffuse small cleaved cell lymphoma|recurrent adult diffuse small cleaved cell lymphoma
870826|NCT00008164|recurrent adult diffuse mixed cell lymphoma|recurrent adult diffuse mixed cell lymphoma
870827|NCT00008164|recurrent adult diffuse large cell lymphoma|recurrent adult diffuse large cell lymphoma
870828|NCT00008164|recurrent adult immunoblastic large cell lymphoma|recurrent adult immunoblastic large cell lymphoma
870829|NCT00008164|recurrent adult lymphoblastic lymphoma|recurrent adult lymphoblastic lymphoma
870830|NCT00008164|recurrent adult Burkitt lymphoma|recurrent adult burkitt lymphoma
870831|NCT00008164|de novo myelodysplastic syndromes|de novo myelodysplastic syndromes
870832|NCT00008164|previously treated myelodysplastic syndromes|previously treated myelodysplastic syndromes
870833|NCT00008164|secondary myelodysplastic syndromes|secondary myelodysplastic syndromes
870834|NCT00008164|recurrent childhood small noncleaved cell lymphoma|recurrent childhood small noncleaved cell lymphoma
871028|NCT00006981|stage IV pancreatic cancer|stage iv pancreatic cancer
870835|NCT00008164|recurrent childhood large cell lymphoma|recurrent childhood large cell lymphoma
870836|NCT00008164|contiguous stage II adult Burkitt lymphoma|contiguous stage ii adult burkitt lymphoma
870837|NCT00008164|contiguous stage II adult lymphoblastic lymphoma|contiguous stage ii adult lymphoblastic lymphoma
870838|NCT00008164|noncontiguous stage II grade 1 follicular lymphoma|noncontiguous stage ii grade 1 follicular lymphoma
870839|NCT00008164|noncontiguous stage II grade 2 follicular lymphoma|noncontiguous stage ii grade 2 follicular lymphoma
870840|NCT00008164|noncontiguous stage II grade 3 follicular lymphoma|noncontiguous stage ii grade 3 follicular lymphoma
870841|NCT00008164|noncontiguous stage II adult diffuse small cleaved cell lymphoma|noncontiguous stage ii adult diffuse small cleaved cell lymphoma
870842|NCT00008164|noncontiguous stage II mantle cell lymphoma|noncontiguous stage ii mantle cell lymphoma
870843|NCT00008164|noncontiguous stage II adult diffuse mixed cell lymphoma|noncontiguous stage ii adult diffuse mixed cell lymphoma
870844|NCT00008164|noncontiguous stage II adult immunoblastic large cell lymphoma|noncontiguous stage ii adult immunoblastic large cell lymphoma
870845|NCT00008164|noncontiguous stage II adult diffuse large cell lymphoma|noncontiguous stage ii adult diffuse large cell lymphoma
870846|NCT00008164|noncontiguous stage II adult Burkitt lymphoma|noncontiguous stage ii adult burkitt lymphoma
870847|NCT00008164|noncontiguous stage II adult lymphoblastic lymphoma|noncontiguous stage ii adult lymphoblastic lymphoma
870848|NCT00008164|stage III mantle cell lymphoma|stage iii mantle cell lymphoma
870849|NCT00008164|stage IV mantle cell lymphoma|stage iv mantle cell lymphoma
870850|NCT00008164|recurrent mantle cell lymphoma|recurrent mantle cell lymphoma
870851|NCT00008164|recurrent mycosis fungoides/Sezary syndrome|recurrent mycosis fungoides/sezary syndrome
870852|NCT00008164|childhood chronic myelogenous leukemia|childhood chronic myelogenous leukemia
870853|NCT00008164|atypical chronic myeloid leukemia, BCR-ABL1 negative|atypical chronic myeloid leukemia, bcr-abl1 negative
870854|NCT00008164|myelodysplastic/myeloproliferative neoplasm, unclassifiable|myelodysplastic/myeloproliferative neoplasm, unclassifiable
870855|NCT00008164|noncontiguous stage II small lymphocytic lymphoma|noncontiguous stage ii small lymphocytic lymphoma
870856|NCT00008164|noncontiguous stage II marginal zone lymphoma|noncontiguous stage ii marginal zone lymphoma
870857|NCT00008164|recurrent marginal zone lymphoma|recurrent marginal zone lymphoma
870858|NCT00008164|recurrent small lymphocytic lymphoma|recurrent small lymphocytic lymphoma
870859|NCT00008164|stage III small lymphocytic lymphoma|stage iii small lymphocytic lymphoma
870860|NCT00008164|stage III marginal zone lymphoma|stage iii marginal zone lymphoma
870861|NCT00008164|stage IV small lymphocytic lymphoma|stage iv small lymphocytic lymphoma
870862|NCT00008164|stage IV marginal zone lymphoma|stage iv marginal zone lymphoma
870863|NCT00008164|extranodal marginal zone B-cell lymphoma of mucosa-associated lymphoid tissue|extranodal marginal zone b-cell lymphoma of mucosa-associated lymphoid tissue
870864|NCT00008164|nodal marginal zone B-cell lymphoma|nodal marginal zone b-cell lymphoma
870865|NCT00008164|splenic marginal zone lymphoma|splenic marginal zone lymphoma
870866|NCT00008164|adult acute myeloid leukemia with t(8;21)(q22;q22)|adult acute myeloid leukemia with t(8;21)(q22;q22)
870867|NCT00008164|adult acute myeloid leukemia with t(16;16)(p13;q22)|adult acute myeloid leukemia with t(16;16)(p13;q22)
870868|NCT00008164|adult acute myeloid leukemia with inv(16)(p13;q22)|adult acute myeloid leukemia with inv(16)(p13;q22)
870869|NCT00008164|adult acute myeloid leukemia with 11q23 (MLL) abnormalities|adult acute myeloid leukemia with 11q23 (mll) abnormalities
870870|NCT00008164|adult acute myeloid leukemia with t(15;17)(q22;q12)|adult acute myeloid leukemia with t(15;17)(q22;q12)
870871|NCT00008164|childhood myelodysplastic syndromes|childhood myelodysplastic syndromes
870872|NCT00008138|stage III ovarian epithelial cancer|stage iii ovarian epithelial cancer
870873|NCT00008138|stage IV ovarian epithelial cancer|stage iv ovarian epithelial cancer
870874|NCT00008138|ovarian undifferentiated adenocarcinoma|ovarian undifferentiated adenocarcinoma
870875|NCT00008138|ovarian serous cystadenocarcinoma|ovarian serous cystadenocarcinoma
870876|NCT00008138|ovarian mucinous cystadenocarcinoma|ovarian mucinous cystadenocarcinoma
870877|NCT00008138|ovarian endometrioid adenocarcinoma|ovarian endometrioid adenocarcinoma
870878|NCT00008138|ovarian clear cell cystadenocarcinoma|ovarian clear cell cystadenocarcinoma
870879|NCT00008138|fallopian tube cancer|fallopian tube cancer
870880|NCT00008138|peritoneal cavity cancer|peritoneal cavity cancer
870881|NCT00008060|stage IV colon cancer|stage iv colon cancer
870882|NCT00008060|stage IV rectal cancer|stage iv rectal cancer
870883|NCT00008060|recurrent colon cancer|recurrent colon cancer
870884|NCT00008060|recurrent rectal cancer|recurrent rectal cancer
870885|NCT00008060|adenocarcinoma of the colon|adenocarcinoma of the colon
870886|NCT00008060|adenocarcinoma of the rectum|adenocarcinoma of the rectum
870887|NCT00008047|stage II esophageal cancer|stage ii esophageal cancer
870888|NCT00008047|stage III esophageal cancer|stage iii esophageal cancer
870889|NCT00008008|childhood infratentorial ependymoma|childhood infratentorial ependymoma
870890|NCT00008008|childhood supratentorial ependymoma|childhood supratentorial ependymoma
870891|NCT00008008|recurrent adult brain tumor|recurrent adult brain tumor
870892|NCT00008008|adult medulloblastoma|adult medulloblastoma
870893|NCT00008008|adult glioblastoma|adult glioblastoma
870894|NCT00008008|adult oligodendroglioma|adult oligodendroglioma
870895|NCT00008008|childhood high-grade cerebral astrocytoma|childhood high-grade cerebral astrocytoma
870896|NCT00008008|childhood oligodendroglioma|childhood oligodendroglioma
870897|NCT00008008|adult anaplastic astrocytoma|adult anaplastic astrocytoma
870898|NCT00008008|adult anaplastic ependymoma|adult anaplastic ependymoma
870899|NCT00008008|adult mixed glioma|adult mixed glioma
871029|NCT00006916|adult glioblastoma|adult glioblastoma
870900|NCT00008008|recurrent childhood supratentorial primitive neuroectodermal tumor|recurrent childhood supratentorial primitive neuroectodermal tumor
870901|NCT00008008|recurrent childhood cerebellar astrocytoma|recurrent childhood cerebellar astrocytoma
870902|NCT00008008|recurrent childhood cerebral astrocytoma|recurrent childhood cerebral astrocytoma
870903|NCT00008008|recurrent childhood ependymoma|recurrent childhood ependymoma
870904|NCT00008008|adult giant cell glioblastoma|adult giant cell glioblastoma
870905|NCT00008008|adult gliosarcoma|adult gliosarcoma
870906|NCT00008008|adult supratentorial primitive neuroectodermal tumor (PNET)|adult supratentorial primitive neuroectodermal tumor (pnet)
870907|NCT00007995|refractory multiple myeloma|refractory multiple myeloma
870908|NCT00007995|stage I multiple myeloma|stage i multiple myeloma
870909|NCT00007995|stage II multiple myeloma|stage ii multiple myeloma
870910|NCT00007995|stage III multiple myeloma|stage iii multiple myeloma
870911|NCT00007995|primary systemic amyloidosis|primary systemic amyloidosis
870912|NCT00007982|recurrent adult brain tumor|recurrent adult brain tumor
870913|NCT00007982|adult medulloblastoma|adult medulloblastoma
870914|NCT00007982|adult oligodendroglioma|adult oligodendroglioma
870915|NCT00007982|recurrent esthesioneuroblastoma of the paranasal sinus and nasal cavity|recurrent esthesioneuroblastoma of the paranasal sinus and nasal cavity
870916|NCT00007982|adult anaplastic astrocytoma|adult anaplastic astrocytoma
870917|NCT00007982|adult central nervous system germ cell tumor|adult central nervous system germ cell tumor
870918|NCT00007982|primary central nervous system non-Hodgkin lymphoma|primary central nervous system non-hodgkin lymphoma
870919|NCT00007982|adult anaplastic oligodendroglioma|adult anaplastic oligodendroglioma
870920|NCT00007956|recurrent grade 1 follicular lymphoma|recurrent grade 1 follicular lymphoma
870921|NCT00007956|recurrent grade 2 follicular lymphoma|recurrent grade 2 follicular lymphoma
870922|NCT00007956|recurrent grade 3 follicular lymphoma|recurrent grade 3 follicular lymphoma
870923|NCT00007956|recurrent adult diffuse small cleaved cell lymphoma|recurrent adult diffuse small cleaved cell lymphoma
870924|NCT00007956|recurrent adult diffuse mixed cell lymphoma|recurrent adult diffuse mixed cell lymphoma
870925|NCT00007956|recurrent adult diffuse large cell lymphoma|recurrent adult diffuse large cell lymphoma
870926|NCT00007956|recurrent adult immunoblastic large cell lymphoma|recurrent adult immunoblastic large cell lymphoma
870927|NCT00007956|recurrent adult Burkitt lymphoma|recurrent adult burkitt lymphoma
870928|NCT00007956|recurrent mantle cell lymphoma|recurrent mantle cell lymphoma
870929|NCT00007956|recurrent small lymphocytic lymphoma|recurrent small lymphocytic lymphoma
870930|NCT00007930|stage I rectal cancer|stage i rectal cancer
870931|NCT00007930|stage II rectal cancer|stage ii rectal cancer
870932|NCT00007930|stage III rectal cancer|stage iii rectal cancer
870933|NCT00007904|stage II breast cancer|stage ii breast cancer
870934|NCT00007904|stage IIIA breast cancer|stage iiia breast cancer
870935|NCT00007904|male breast cancer|male breast cancer
870936|NCT00007891|stage IV breast cancer|stage iv breast cancer
870937|NCT00007891|recurrent breast cancer|recurrent breast cancer
870938|NCT00007891|male breast cancer|male breast cancer
870939|NCT00007865|recurrent grade 1 follicular lymphoma|recurrent grade 1 follicular lymphoma
870940|NCT00007865|recurrent grade 2 follicular lymphoma|recurrent grade 2 follicular lymphoma
870941|NCT00007865|recurrent grade 3 follicular lymphoma|recurrent grade 3 follicular lymphoma
870942|NCT00007865|recurrent adult diffuse small cleaved cell lymphoma|recurrent adult diffuse small cleaved cell lymphoma
872056|NCT00005955|childhood craniopharyngioma|childhood craniopharyngioma
870943|NCT00007865|recurrent adult diffuse mixed cell lymphoma|recurrent adult diffuse mixed cell lymphoma
870944|NCT00007865|recurrent adult diffuse large cell lymphoma|recurrent adult diffuse large cell lymphoma
870945|NCT00007865|recurrent adult immunoblastic large cell lymphoma|recurrent adult immunoblastic large cell lymphoma
870946|NCT00007865|recurrent adult Burkitt lymphoma|recurrent adult burkitt lymphoma
870947|NCT00007865|recurrent mantle cell lymphoma|recurrent mantle cell lymphoma
870948|NCT00007865|recurrent marginal zone lymphoma|recurrent marginal zone lymphoma
870949|NCT00007865|recurrent small lymphocytic lymphoma|recurrent small lymphocytic lymphoma
870950|NCT00007865|extranodal marginal zone B-cell lymphoma of mucosa-associated lymphoid tissue|extranodal marginal zone b-cell lymphoma of mucosa-associated lymphoid tissue
875025|NCT00003458|Brain stem glioma|brain stem glioma
870951|NCT00007865|nodal marginal zone B-cell lymphoma|nodal marginal zone b-cell lymphoma
870952|NCT00007865|splenic marginal zone lymphoma|splenic marginal zone lymphoma
870953|NCT00007826|stage II colon cancer|stage ii colon cancer
870954|NCT00007826|stage III colon cancer|stage iii colon cancer
870955|NCT00007826|stage IV colon cancer|stage iv colon cancer
870956|NCT00007826|stage II rectal cancer|stage ii rectal cancer
870957|NCT00007826|stage III rectal cancer|stage iii rectal cancer
870958|NCT00007826|stage IV rectal cancer|stage iv rectal cancer
870959|NCT00007826|adenocarcinoma of the colon|adenocarcinoma of the colon
870960|NCT00007826|adenocarcinoma of the rectum|adenocarcinoma of the rectum
870961|NCT00006994|oral complications of radiation therapy|oral complications of radiation therapy
870962|NCT00006994|pain|pain
870963|NCT00006994|radiation toxicity|radiation toxicity
870964|NCT00006994|stage I squamous cell carcinoma of the lip and oral cavity|stage i squamous cell carcinoma of the lip and oral cavity
870965|NCT00006994|stage II squamous cell carcinoma of the lip and oral cavity|stage ii squamous cell carcinoma of the lip and oral cavity
870966|NCT00006994|stage III squamous cell carcinoma of the lip and oral cavity|stage iii squamous cell carcinoma of the lip and oral cavity
871030|NCT00006916|adult giant cell glioblastoma|adult giant cell glioblastoma
870967|NCT00006994|stage IV squamous cell carcinoma of the lip and oral cavity|stage iv squamous cell carcinoma of the lip and oral cavity
870968|NCT00006994|stage I squamous cell carcinoma of the oropharynx|stage i squamous cell carcinoma of the oropharynx
870969|NCT00006994|stage II squamous cell carcinoma of the oropharynx|stage ii squamous cell carcinoma of the oropharynx
870970|NCT00006994|stage III squamous cell carcinoma of the oropharynx|stage iii squamous cell carcinoma of the oropharynx
870971|NCT00006994|stage IV squamous cell carcinoma of the oropharynx|stage iv squamous cell carcinoma of the oropharynx
870972|NCT00006981|recurrent non-small cell lung cancer|recurrent non-small cell lung cancer
870973|NCT00006981|stage III cervical cancer|stage iii cervical cancer
870974|NCT00006981|recurrent cervical cancer|recurrent cervical cancer
870975|NCT00006981|stage IVB cervical cancer|stage ivb cervical cancer
870976|NCT00006981|stage IVA cervical cancer|stage iva cervical cancer
870977|NCT00006981|squamous cell lung cancer|squamous cell lung cancer
870978|NCT00006981|stage III ovarian epithelial cancer|stage iii ovarian epithelial cancer
870979|NCT00006981|stage IV ovarian epithelial cancer|stage iv ovarian epithelial cancer
870980|NCT00006981|recurrent ovarian epithelial cancer|recurrent ovarian epithelial cancer
870981|NCT00006981|advanced malignant mesothelioma|advanced malignant mesothelioma
870982|NCT00006981|recurrent malignant mesothelioma|recurrent malignant mesothelioma
870983|NCT00006981|stage IIIA non-small cell lung cancer|stage iiia non-small cell lung cancer
870984|NCT00006981|stage IIIB non-small cell lung cancer|stage iiib non-small cell lung cancer
870985|NCT00006981|stage IV non-small cell lung cancer|stage iv non-small cell lung cancer
870986|NCT00006981|recurrent metastatic squamous neck cancer with occult primary|recurrent metastatic squamous neck cancer with occult primary
870987|NCT00006981|ovarian undifferentiated adenocarcinoma|ovarian undifferentiated adenocarcinoma
870988|NCT00006981|ovarian mixed epithelial carcinoma|ovarian mixed epithelial carcinoma
870989|NCT00006981|ovarian serous cystadenocarcinoma|ovarian serous cystadenocarcinoma
870990|NCT00006981|ovarian endometrioid adenocarcinoma|ovarian endometrioid adenocarcinoma
870991|NCT00006981|ovarian clear cell cystadenocarcinoma|ovarian clear cell cystadenocarcinoma
870992|NCT00006981|cervical squamous cell carcinoma|cervical squamous cell carcinoma
870993|NCT00006981|metastatic squamous neck cancer with occult primary squamous cell carcinoma|metastatic squamous neck cancer with occult primary squamous cell carcinoma
870994|NCT00006981|stage III squamous cell carcinoma of the lip and oral cavity|stage iii squamous cell carcinoma of the lip and oral cavity
870995|NCT00006981|stage IV squamous cell carcinoma of the lip and oral cavity|stage iv squamous cell carcinoma of the lip and oral cavity
870996|NCT00006981|recurrent squamous cell carcinoma of the lip and oral cavity|recurrent squamous cell carcinoma of the lip and oral cavity
870997|NCT00006981|stage III squamous cell carcinoma of the oropharynx|stage iii squamous cell carcinoma of the oropharynx
870998|NCT00006981|stage IV squamous cell carcinoma of the oropharynx|stage iv squamous cell carcinoma of the oropharynx
870999|NCT00006981|recurrent squamous cell carcinoma of the oropharynx|recurrent squamous cell carcinoma of the oropharynx
871000|NCT00006981|stage III squamous cell carcinoma of the nasopharynx|stage iii squamous cell carcinoma of the nasopharynx
871001|NCT00006981|stage IV squamous cell carcinoma of the nasopharynx|stage iv squamous cell carcinoma of the nasopharynx
871002|NCT00006981|recurrent squamous cell carcinoma of the nasopharynx|recurrent squamous cell carcinoma of the nasopharynx
871003|NCT00006981|stage III squamous cell carcinoma of the hypopharynx|stage iii squamous cell carcinoma of the hypopharynx
871004|NCT00006981|stage IV squamous cell carcinoma of the hypopharynx|stage iv squamous cell carcinoma of the hypopharynx
871072|NCT00006478|recurrent grade 1 follicular lymphoma|recurrent grade 1 follicular lymphoma
871005|NCT00006981|recurrent squamous cell carcinoma of the hypopharynx|recurrent squamous cell carcinoma of the hypopharynx
871006|NCT00006981|stage III squamous cell carcinoma of the larynx|stage iii squamous cell carcinoma of the larynx
871007|NCT00006981|stage IV squamous cell carcinoma of the larynx|stage iv squamous cell carcinoma of the larynx
871008|NCT00006981|recurrent squamous cell carcinoma of the larynx|recurrent squamous cell carcinoma of the larynx
871009|NCT00006981|stage III squamous cell carcinoma of the paranasal sinus and nasal cavity|stage iii squamous cell carcinoma of the paranasal sinus and nasal cavity
871010|NCT00006981|stage IV squamous cell carcinoma of the paranasal sinus and nasal cavity|stage iv squamous cell carcinoma of the paranasal sinus and nasal cavity
871011|NCT00006981|recurrent squamous cell carcinoma of the paranasal sinus and nasal cavity|recurrent squamous cell carcinoma of the paranasal sinus and nasal cavity
871012|NCT00006981|fallopian tube cancer|fallopian tube cancer
871013|NCT00006981|primary peritoneal cavity cancer|primary peritoneal cavity cancer
871014|NCT00006981|ovarian carcinosarcoma|ovarian carcinosarcoma
871015|NCT00006981|Brenner tumor|brenner tumor
871016|NCT00006981|untreated metastatic squamous neck cancer with occult primary|untreated metastatic squamous neck cancer with occult primary
871017|NCT00006981|recurrent salivary gland cancer|recurrent salivary gland cancer
871018|NCT00006981|salivary gland squamous cell carcinoma|salivary gland squamous cell carcinoma
871019|NCT00006981|stage III salivary gland cancer|stage iii salivary gland cancer
871020|NCT00006981|stage IV salivary gland cancer|stage iv salivary gland cancer
871021|NCT00006981|recurrent pancreatic cancer|recurrent pancreatic cancer
871022|NCT00006981|stage II pancreatic cancer|stage ii pancreatic cancer
871023|NCT00006981|stage III pancreatic cancer|stage iii pancreatic cancer
871024|NCT00006981|ovarian mucinous cystadenocarcinoma|ovarian mucinous cystadenocarcinoma
871025|NCT00006981|borderline ovarian surface epithelial-stromal tumor|borderline ovarian surface epithelial-stromal tumor
871026|NCT00006981|ovarian sarcoma|ovarian sarcoma
871027|NCT00006981|ovarian stromal cancer|ovarian stromal cancer
871031|NCT00006916|adult gliosarcoma|adult gliosarcoma
871032|NCT00006825|stage IV breast cancer|stage iv breast cancer
871033|NCT00006825|recurrent breast cancer|recurrent breast cancer
871034|NCT00006760|recurrent/refractory childhood Hodgkin lymphoma|recurrent/refractory childhood hodgkin lymphoma
871035|NCT00006760|childhood lymphocyte predominant Hodgkin lymphoma|childhood lymphocyte predominant hodgkin lymphoma
871036|NCT00006760|childhood lymphocyte depletion Hodgkin lymphoma|childhood lymphocyte depletion hodgkin lymphoma
871037|NCT00006760|childhood nodular sclerosis Hodgkin lymphoma|childhood nodular sclerosis hodgkin lymphoma
871038|NCT00006760|childhood mixed cellularity Hodgkin lymphoma|childhood mixed cellularity hodgkin lymphoma
871039|NCT00006747|graft versus host disease|graft versus host disease
871040|NCT00006747|stage I mantle cell lymphoma|stage i mantle cell lymphoma
871041|NCT00006747|contiguous stage II mantle cell lymphoma|contiguous stage ii mantle cell lymphoma
871042|NCT00006747|noncontiguous stage II mantle cell lymphoma|noncontiguous stage ii mantle cell lymphoma
871043|NCT00006747|stage III mantle cell lymphoma|stage iii mantle cell lymphoma
871044|NCT00006747|stage IV mantle cell lymphoma|stage iv mantle cell lymphoma
871045|NCT00006747|recurrent mantle cell lymphoma|recurrent mantle cell lymphoma
871046|NCT00006734|localized Ewing sarcoma/peripheral primitive neuroectodermal tumor|localized ewing sarcoma/peripheral primitive neuroectodermal tumor
871047|NCT00006721|stage III grade 1 follicular lymphoma|stage iii grade 1 follicular lymphoma
871048|NCT00006721|stage III grade 2 follicular lymphoma|stage iii grade 2 follicular lymphoma
871049|NCT00006721|stage III grade 3 follicular lymphoma|stage iii grade 3 follicular lymphoma
871050|NCT00006721|stage IV grade 1 follicular lymphoma|stage iv grade 1 follicular lymphoma
871051|NCT00006721|stage IV grade 2 follicular lymphoma|stage iv grade 2 follicular lymphoma
871052|NCT00006721|stage IV grade 3 follicular lymphoma|stage iv grade 3 follicular lymphoma
871053|NCT00006721|contiguous stage II grade 1 follicular lymphoma|contiguous stage ii grade 1 follicular lymphoma
871054|NCT00006721|contiguous stage II grade 2 follicular lymphoma|contiguous stage ii grade 2 follicular lymphoma
871055|NCT00006721|contiguous stage II grade 3 follicular lymphoma|contiguous stage ii grade 3 follicular lymphoma
871056|NCT00006721|noncontiguous stage II grade 1 follicular lymphoma|noncontiguous stage ii grade 1 follicular lymphoma
871057|NCT00006721|noncontiguous stage II grade 2 follicular lymphoma|noncontiguous stage ii grade 2 follicular lymphoma
871058|NCT00006721|noncontiguous stage II grade 3 follicular lymphoma|noncontiguous stage ii grade 3 follicular lymphoma
871059|NCT00006695|recurrent adult diffuse mixed cell lymphoma|recurrent adult diffuse mixed cell lymphoma
871060|NCT00006695|recurrent adult diffuse large cell lymphoma|recurrent adult diffuse large cell lymphoma
871061|NCT00006695|recurrent adult immunoblastic large cell lymphoma|recurrent adult immunoblastic large cell lymphoma
871062|NCT00006656|recurrent adult brain tumor|recurrent adult brain tumor
871063|NCT00006656|adult glioblastoma|adult glioblastoma
871064|NCT00006656|adult giant cell glioblastoma|adult giant cell glioblastoma
871065|NCT00006656|adult gliosarcoma|adult gliosarcoma
871066|NCT00006485|unspecified adult solid tumor, protocol specific|unspecified adult solid tumor, protocol specific
871067|NCT00006479|stage IV colon cancer|stage iv colon cancer
871068|NCT00006479|stage IV rectal cancer|stage iv rectal cancer
871069|NCT00006479|recurrent colon cancer|recurrent colon cancer
871070|NCT00006479|recurrent rectal cancer|recurrent rectal cancer
871071|NCT00006479|liver metastases|liver metastases
871073|NCT00006478|recurrent grade 2 follicular lymphoma|recurrent grade 2 follicular lymphoma
871074|NCT00006478|recurrent grade 3 follicular lymphoma|recurrent grade 3 follicular lymphoma
871075|NCT00006477|unspecified adult solid tumor, protocol specific|unspecified adult solid tumor, protocol specific
871076|NCT00006476|stage 0 bladder cancer|stage 0 bladder cancer
871077|NCT00006476|stage I bladder cancer|stage i bladder cancer
871078|NCT00006476|recurrent bladder cancer|recurrent bladder cancer
871079|NCT00006474|recurrent adult brain tumor|recurrent adult brain tumor
871080|NCT00006474|adult glioblastoma|adult glioblastoma
871081|NCT00006474|adult anaplastic astrocytoma|adult anaplastic astrocytoma
871082|NCT00006474|adult anaplastic oligodendroglioma|adult anaplastic oligodendroglioma
871083|NCT00006474|adult mixed glioma|adult mixed glioma
871084|NCT00006474|adult oligodendroglioma|adult oligodendroglioma
871085|NCT00006474|adult giant cell glioblastoma|adult giant cell glioblastoma
871086|NCT00006474|adult gliosarcoma|adult gliosarcoma
871087|NCT00006471|untreated metastatic squamous neck cancer with occult primary|untreated metastatic squamous neck cancer with occult primary
871088|NCT00006471|recurrent metastatic squamous neck cancer with occult primary|recurrent metastatic squamous neck cancer with occult primary
871089|NCT00006471|metastatic squamous neck cancer with occult primary squamous cell carcinoma|metastatic squamous neck cancer with occult primary squamous cell carcinoma
871090|NCT00006471|stage IV squamous cell carcinoma of the lip and oral cavity|stage iv squamous cell carcinoma of the lip and oral cavity
871091|NCT00006471|recurrent squamous cell carcinoma of the lip and oral cavity|recurrent squamous cell carcinoma of the lip and oral cavity
871092|NCT00006471|stage IV squamous cell carcinoma of the oropharynx|stage iv squamous cell carcinoma of the oropharynx
871093|NCT00006471|recurrent squamous cell carcinoma of the oropharynx|recurrent squamous cell carcinoma of the oropharynx
871094|NCT00006471|recurrent squamous cell carcinoma of the nasopharynx|recurrent squamous cell carcinoma of the nasopharynx
871095|NCT00006471|stage IV squamous cell carcinoma of the hypopharynx|stage iv squamous cell carcinoma of the hypopharynx
871096|NCT00006471|recurrent squamous cell carcinoma of the hypopharynx|recurrent squamous cell carcinoma of the hypopharynx
871163|NCT00006379|adult acute erythroid leukemia (M6)|adult acute erythroid leukemia (m6)
871097|NCT00006471|stage IV squamous cell carcinoma of the larynx|stage iv squamous cell carcinoma of the larynx
871098|NCT00006471|recurrent squamous cell carcinoma of the larynx|recurrent squamous cell carcinoma of the larynx
871099|NCT00006471|stage IV squamous cell carcinoma of the paranasal sinus and nasal cavity|stage iv squamous cell carcinoma of the paranasal sinus and nasal cavity
871100|NCT00006471|recurrent squamous cell carcinoma of the paranasal sinus and nasal cavity|recurrent squamous cell carcinoma of the paranasal sinus and nasal cavity
871101|NCT00006471|stage IV squamous cell carcinoma of the nasopharynx|stage iv squamous cell carcinoma of the nasopharynx
871102|NCT00006470|stage II non-small cell lung cancer|stage ii non-small cell lung cancer
871103|NCT00006470|stage IIIA non-small cell lung cancer|stage iiia non-small cell lung cancer
871104|NCT00006469|stage II non-small cell lung cancer|stage ii non-small cell lung cancer
871105|NCT00006469|stage IIIA non-small cell lung cancer|stage iiia non-small cell lung cancer
871106|NCT00006468|stage IV colon cancer|stage iv colon cancer
871107|NCT00006468|stage IV rectal cancer|stage iv rectal cancer
871108|NCT00006468|recurrent colon cancer|recurrent colon cancer
871109|NCT00006468|recurrent rectal cancer|recurrent rectal cancer
871110|NCT00006468|adenocarcinoma of the colon|adenocarcinoma of the colon
871111|NCT00006468|adenocarcinoma of the rectum|adenocarcinoma of the rectum
871112|NCT00006465|unspecified adult solid tumor, protocol specific|unspecified adult solid tumor, protocol specific
871113|NCT00006462|recurrent childhood acute lymphoblastic leukemia|recurrent childhood acute lymphoblastic leukemia
871114|NCT00006462|recurrent childhood acute myeloid leukemia|recurrent childhood acute myeloid leukemia
871115|NCT00006456|unspecified adult solid tumor, protocol specific|unspecified adult solid tumor, protocol specific
871116|NCT00006456|lung metastases|lung metastases
871117|NCT00006456|liver metastases|liver metastases
871118|NCT00006455|stage I childhood anaplastic large cell lymphoma|stage i childhood anaplastic large cell lymphoma
871119|NCT00006455|stage II childhood anaplastic large cell lymphoma|stage ii childhood anaplastic large cell lymphoma
871120|NCT00006455|stage III childhood anaplastic large cell lymphoma|stage iii childhood anaplastic large cell lymphoma
871121|NCT00006455|stage IV childhood anaplastic large cell lymphoma|stage iv childhood anaplastic large cell lymphoma
871122|NCT00006455|recurrent childhood anaplastic large cell lymphoma|recurrent childhood anaplastic large cell lymphoma
871123|NCT00006392|prostate cancer|prostate cancer
871124|NCT00006391|recurrent ovarian epithelial cancer|recurrent ovarian epithelial cancer
871125|NCT00006391|fallopian tube cancer|fallopian tube cancer
871126|NCT00006391|peritoneal cavity cancer|peritoneal cavity cancer
871127|NCT00006390|stage III chronic lymphocytic leukemia|stage iii chronic lymphocytic leukemia
871128|NCT00006390|stage IV chronic lymphocytic leukemia|stage iv chronic lymphocytic leukemia
871129|NCT00006390|B-cell chronic lymphocytic leukemia|b-cell chronic lymphocytic leukemia
871130|NCT00006390|stage I chronic lymphocytic leukemia|stage i chronic lymphocytic leukemia
871131|NCT00006390|stage II chronic lymphocytic leukemia|stage ii chronic lymphocytic leukemia
871132|NCT00006386|adult glioblastoma|adult glioblastoma
871133|NCT00006386|adult giant cell glioblastoma|adult giant cell glioblastoma
871134|NCT00006386|adult gliosarcoma|adult gliosarcoma
871135|NCT00006385|stage IV melanoma|stage iv melanoma
871136|NCT00006385|recurrent melanoma|recurrent melanoma
871137|NCT00006381|stage IV breast cancer|stage iv breast cancer
871138|NCT00006381|recurrent breast cancer|recurrent breast cancer
872122|NCT00005951|adult gliosarcoma|adult gliosarcoma
871139|NCT00006379|monoclonal gammopathy of undetermined significance|monoclonal gammopathy of undetermined significance
875026|NCT00003458|Craniopharyngioma|craniopharyngioma
871140|NCT00006379|recurrent childhood acute lymphoblastic leukemia|recurrent childhood acute lymphoblastic leukemia
871141|NCT00006379|recurrent adult Hodgkin lymphoma|recurrent adult hodgkin lymphoma
871142|NCT00006379|recurrent cutaneous T-cell non-Hodgkin lymphoma|recurrent cutaneous t-cell non-hodgkin lymphoma
871143|NCT00006379|isolated plasmacytoma of bone|isolated plasmacytoma of bone
871144|NCT00006379|extramedullary plasmacytoma|extramedullary plasmacytoma
871145|NCT00006379|refractory multiple myeloma|refractory multiple myeloma
871146|NCT00006379|Waldenstrom macroglobulinemia|waldenstrom macroglobulinemia
871147|NCT00006379|recurrent childhood lymphoblastic lymphoma|recurrent childhood lymphoblastic lymphoma
871148|NCT00006379|recurrent childhood acute myeloid leukemia|recurrent childhood acute myeloid leukemia
871149|NCT00006379|recurrent adult acute myeloid leukemia|recurrent adult acute myeloid leukemia
871150|NCT00006379|recurrent adult acute lymphoblastic leukemia|recurrent adult acute lymphoblastic leukemia
871151|NCT00006379|relapsing chronic myelogenous leukemia|relapsing chronic myelogenous leukemia
871152|NCT00006379|small intestine lymphoma|small intestine lymphoma
871153|NCT00006379|chronic phase chronic myelogenous leukemia|chronic phase chronic myelogenous leukemia
871154|NCT00006379|accelerated phase chronic myelogenous leukemia|accelerated phase chronic myelogenous leukemia
871155|NCT00006379|blastic phase chronic myelogenous leukemia|blastic phase chronic myelogenous leukemia
871156|NCT00006379|adult acute myeloid leukemia in remission|adult acute myeloid leukemia in remission
871157|NCT00006379|adult acute lymphoblastic leukemia in remission|adult acute lymphoblastic leukemia in remission
871158|NCT00006379|childhood acute myeloid leukemia in remission|childhood acute myeloid leukemia in remission
871159|NCT00006379|childhood acute lymphoblastic leukemia in remission|childhood acute lymphoblastic leukemia in remission
871160|NCT00006379|polycythemia vera|polycythemia vera
871161|NCT00006379|chronic idiopathic myelofibrosis|chronic idiopathic myelofibrosis
871162|NCT00006379|essential thrombocythemia|essential thrombocythemia
871164|NCT00006379|adult acute megakaryoblastic leukemia (M7)|adult acute megakaryoblastic leukemia (m7)
871165|NCT00006379|childhood acute erythroleukemia (M6)|childhood acute erythroleukemia (m6)
871166|NCT00006379|childhood acute megakaryocytic leukemia (M7)|childhood acute megakaryocytic leukemia (m7)
871167|NCT00006379|recurrent/refractory childhood Hodgkin lymphoma|recurrent/refractory childhood hodgkin lymphoma
871168|NCT00006379|refractory anemia with excess blasts|refractory anemia with excess blasts
871169|NCT00006379|refractory anemia with excess blasts in transformation|refractory anemia with excess blasts in transformation
871170|NCT00006379|chronic myelomonocytic leukemia|chronic myelomonocytic leukemia
871171|NCT00006379|acute undifferentiated leukemia|acute undifferentiated leukemia
871172|NCT00006379|recurrent grade 1 follicular lymphoma|recurrent grade 1 follicular lymphoma
871173|NCT00006379|recurrent grade 2 follicular lymphoma|recurrent grade 2 follicular lymphoma
871174|NCT00006379|recurrent grade 3 follicular lymphoma|recurrent grade 3 follicular lymphoma
871175|NCT00006379|recurrent adult diffuse small cleaved cell lymphoma|recurrent adult diffuse small cleaved cell lymphoma
871176|NCT00006379|recurrent adult diffuse mixed cell lymphoma|recurrent adult diffuse mixed cell lymphoma
871177|NCT00006379|recurrent adult diffuse large cell lymphoma|recurrent adult diffuse large cell lymphoma
871178|NCT00006379|recurrent adult immunoblastic large cell lymphoma|recurrent adult immunoblastic large cell lymphoma
871179|NCT00006379|recurrent adult lymphoblastic lymphoma|recurrent adult lymphoblastic lymphoma
871180|NCT00006379|recurrent adult Burkitt lymphoma|recurrent adult burkitt lymphoma
871181|NCT00006379|recurrent adult T-cell leukemia/lymphoma|recurrent adult t-cell leukemia/lymphoma
871182|NCT00006379|secondary acute myeloid leukemia|secondary acute myeloid leukemia
871183|NCT00006379|de novo myelodysplastic syndromes|de novo myelodysplastic syndromes
871184|NCT00006379|previously treated myelodysplastic syndromes|previously treated myelodysplastic syndromes
871185|NCT00006379|secondary myelodysplastic syndromes|secondary myelodysplastic syndromes
871186|NCT00006379|prolymphocytic leukemia|prolymphocytic leukemia
871187|NCT00006379|primary systemic amyloidosis|primary systemic amyloidosis
871188|NCT00006379|adult acute minimally differentiated myeloid leukemia (M0)|adult acute minimally differentiated myeloid leukemia (m0)
871189|NCT00006379|childhood acute minimally differentiated myeloid leukemia (M0)|childhood acute minimally differentiated myeloid leukemia (m0)
871190|NCT00006379|recurrent childhood small noncleaved cell lymphoma|recurrent childhood small noncleaved cell lymphoma
871191|NCT00006379|recurrent childhood large cell lymphoma|recurrent childhood large cell lymphoma
871192|NCT00006379|recurrent mantle cell lymphoma|recurrent mantle cell lymphoma
871193|NCT00006379|angioimmunoblastic T-cell lymphoma|angioimmunoblastic t-cell lymphoma
871194|NCT00006379|anaplastic large cell lymphoma|anaplastic large cell lymphoma
871195|NCT00006379|recurrent mycosis fungoides/Sezary syndrome|recurrent mycosis fungoides/sezary syndrome
871196|NCT00006379|childhood chronic myelogenous leukemia|childhood chronic myelogenous leukemia
871197|NCT00006379|chronic eosinophilic leukemia|chronic eosinophilic leukemia
871198|NCT00006379|chronic neutrophilic leukemia|chronic neutrophilic leukemia
871199|NCT00006379|atypical chronic myeloid leukemia|atypical chronic myeloid leukemia
871200|NCT00006379|myelodysplastic/myeloproliferative disease, unclassifiable|myelodysplastic/myeloproliferative disease, unclassifiable
871201|NCT00006379|juvenile myelomonocytic leukemia|juvenile myelomonocytic leukemia
871202|NCT00006379|recurrent marginal zone lymphoma|recurrent marginal zone lymphoma
871203|NCT00006379|recurrent small lymphocytic lymphoma|recurrent small lymphocytic lymphoma
871204|NCT00006379|extranodal marginal zone B-cell lymphoma of mucosa-associated lymphoid tissue|extranodal marginal zone b-cell lymphoma of mucosa-associated lymphoid tissue
871205|NCT00006379|nodal marginal zone B-cell lymphoma|nodal marginal zone b-cell lymphoma
871206|NCT00006379|splenic marginal zone lymphoma|splenic marginal zone lymphoma
871207|NCT00006379|adult acute myeloid leukemia with t(8;21)(q22;q22)|adult acute myeloid leukemia with t(8;21)(q22;q22)
871208|NCT00006379|adult acute myeloid leukemia with t(16;16)(p13;q22)|adult acute myeloid leukemia with t(16;16)(p13;q22)
871209|NCT00006379|adult acute myeloid leukemia with inv(16)(p13;q22)|adult acute myeloid leukemia with inv(16)(p13;q22)
871210|NCT00006379|adult acute myeloid leukemia with 11q23 (MLL) abnormalities|adult acute myeloid leukemia with 11q23 (mll) abnormalities
871211|NCT00006379|adult acute myeloid leukemia with t(15;17)(q22;q12)|adult acute myeloid leukemia with t(15;17)(q22;q12)
871212|NCT00006379|childhood myelodysplastic syndromes|childhood myelodysplastic syndromes
871213|NCT00006373|stage III adult Hodgkin lymphoma|stage iii adult hodgkin lymphoma
871214|NCT00006373|stage IV adult Hodgkin lymphoma|stage iv adult hodgkin lymphoma
871215|NCT00006373|recurrent adult Hodgkin lymphoma|recurrent adult hodgkin lymphoma
871216|NCT00006373|recurrent grade 1 follicular lymphoma|recurrent grade 1 follicular lymphoma
871217|NCT00006373|recurrent grade 2 follicular lymphoma|recurrent grade 2 follicular lymphoma
871218|NCT00006373|recurrent grade 3 follicular lymphoma|recurrent grade 3 follicular lymphoma
871219|NCT00006373|recurrent adult diffuse small cleaved cell lymphoma|recurrent adult diffuse small cleaved cell lymphoma
871220|NCT00006373|recurrent adult diffuse mixed cell lymphoma|recurrent adult diffuse mixed cell lymphoma
871221|NCT00006373|recurrent adult diffuse large cell lymphoma|recurrent adult diffuse large cell lymphoma
871222|NCT00006373|recurrent adult immunoblastic large cell lymphoma|recurrent adult immunoblastic large cell lymphoma
871223|NCT00006373|recurrent adult Burkitt lymphoma|recurrent adult burkitt lymphoma
871224|NCT00006373|recurrent mantle cell lymphoma|recurrent mantle cell lymphoma
871225|NCT00006373|recurrent marginal zone lymphoma|recurrent marginal zone lymphoma
871226|NCT00006373|recurrent small lymphocytic lymphoma|recurrent small lymphocytic lymphoma
871227|NCT00006373|extranodal marginal zone B-cell lymphoma of mucosa-associated lymphoid tissue|extranodal marginal zone b-cell lymphoma of mucosa-associated lymphoid tissue
871228|NCT00006373|nodal marginal zone B-cell lymphoma|nodal marginal zone b-cell lymphoma
871229|NCT00006373|splenic marginal zone lymphoma|splenic marginal zone lymphoma
871230|NCT00006372|unspecified adult solid tumor, protocol specific|unspecified adult solid tumor, protocol specific
871231|NCT00006366|stage II rectal cancer|stage ii rectal cancer
871232|NCT00006366|stage III rectal cancer|stage iii rectal cancer
871233|NCT00006366|adenocarcinoma of the rectum|adenocarcinoma of the rectum
871234|NCT00006362|monoclonal gammopathy of undetermined significance|monoclonal gammopathy of undetermined significance
871235|NCT00006362|isolated plasmacytoma of bone|isolated plasmacytoma of bone
871236|NCT00006362|extramedullary plasmacytoma|extramedullary plasmacytoma
871237|NCT00006362|refractory multiple myeloma|refractory multiple myeloma
871238|NCT00006362|Waldenstrom macroglobulinemia|waldenstrom macroglobulinemia
871239|NCT00006362|stage III multiple myeloma|stage iii multiple myeloma
871240|NCT00006362|stage IV chronic lymphocytic leukemia|stage iv chronic lymphocytic leukemia
871241|NCT00006362|refractory chronic lymphocytic leukemia|refractory chronic lymphocytic leukemia
871242|NCT00006362|unspecified adult solid tumor, protocol specific|unspecified adult solid tumor, protocol specific
871243|NCT00006362|B-cell chronic lymphocytic leukemia|b-cell chronic lymphocytic leukemia
871244|NCT00006362|untreated hairy cell leukemia|untreated hairy cell leukemia
871245|NCT00006362|progressive hairy cell leukemia, initial treatment|progressive hairy cell leukemia, initial treatment
871246|NCT00006362|refractory hairy cell leukemia|refractory hairy cell leukemia
871247|NCT00006362|stage IV grade 1 follicular lymphoma|stage iv grade 1 follicular lymphoma
871248|NCT00006362|stage IV grade 2 follicular lymphoma|stage iv grade 2 follicular lymphoma
871249|NCT00006362|stage IV grade 3 follicular lymphoma|stage iv grade 3 follicular lymphoma
871250|NCT00006362|stage IV adult diffuse small cleaved cell lymphoma|stage iv adult diffuse small cleaved cell lymphoma
871251|NCT00006362|stage IV adult diffuse mixed cell lymphoma|stage iv adult diffuse mixed cell lymphoma
871252|NCT00006362|stage IV adult diffuse large cell lymphoma|stage iv adult diffuse large cell lymphoma
871253|NCT00006362|stage IV adult immunoblastic large cell lymphoma|stage iv adult immunoblastic large cell lymphoma
871254|NCT00006362|stage IV adult lymphoblastic lymphoma|stage iv adult lymphoblastic lymphoma
871255|NCT00006362|stage IV adult Burkitt lymphoma|stage iv adult burkitt lymphoma
871256|NCT00006362|recurrent grade 1 follicular lymphoma|recurrent grade 1 follicular lymphoma
871257|NCT00006362|recurrent grade 2 follicular lymphoma|recurrent grade 2 follicular lymphoma
871258|NCT00006362|recurrent grade 3 follicular lymphoma|recurrent grade 3 follicular lymphoma
871259|NCT00006362|recurrent adult diffuse small cleaved cell lymphoma|recurrent adult diffuse small cleaved cell lymphoma
871260|NCT00006362|recurrent adult diffuse mixed cell lymphoma|recurrent adult diffuse mixed cell lymphoma
871261|NCT00006362|recurrent adult diffuse large cell lymphoma|recurrent adult diffuse large cell lymphoma
871262|NCT00006362|recurrent adult immunoblastic large cell lymphoma|recurrent adult immunoblastic large cell lymphoma
871263|NCT00006362|recurrent adult lymphoblastic lymphoma|recurrent adult lymphoblastic lymphoma
871264|NCT00006362|recurrent adult Burkitt lymphoma|recurrent adult burkitt lymphoma
871265|NCT00006362|primary systemic amyloidosis|primary systemic amyloidosis
871266|NCT00006362|stage IV mantle cell lymphoma|stage iv mantle cell lymphoma
871267|NCT00006362|recurrent mantle cell lymphoma|recurrent mantle cell lymphoma
871268|NCT00006362|recurrent marginal zone lymphoma|recurrent marginal zone lymphoma
871269|NCT00006362|recurrent small lymphocytic lymphoma|recurrent small lymphocytic lymphoma
871270|NCT00006362|stage IV small lymphocytic lymphoma|stage iv small lymphocytic lymphoma
871271|NCT00006362|stage IV marginal zone lymphoma|stage iv marginal zone lymphoma
871272|NCT00006362|extranodal marginal zone B-cell lymphoma of mucosa-associated lymphoid tissue|extranodal marginal zone b-cell lymphoma of mucosa-associated lymphoid tissue
871273|NCT00006362|nodal marginal zone B-cell lymphoma|nodal marginal zone b-cell lymphoma
871274|NCT00006362|splenic marginal zone lymphoma|splenic marginal zone lymphoma
871275|NCT00006360|stage II squamous cell carcinoma of the oropharynx|stage ii squamous cell carcinoma of the oropharynx
871276|NCT00006360|stage III squamous cell carcinoma of the oropharynx|stage iii squamous cell carcinoma of the oropharynx
871277|NCT00006360|radiation toxicity|radiation toxicity
871278|NCT00006359|adenocarcinoma of the prostate|adenocarcinoma of the prostate
871279|NCT00006359|stage I prostate cancer|stage i prostate cancer
871280|NCT00006359|stage II prostate cancer|stage ii prostate cancer
871281|NCT00006359|stage III prostate cancer|stage iii prostate cancer
871282|NCT00006356|recurrent ovarian epithelial cancer|recurrent ovarian epithelial cancer
871283|NCT00006355|adult glioblastoma|adult glioblastoma
871284|NCT00006355|adult giant cell glioblastoma|adult giant cell glioblastoma
871285|NCT00006355|adult gliosarcoma|adult gliosarcoma
871286|NCT00006354|unspecified adult solid tumor, protocol specific|unspecified adult solid tumor, protocol specific
871287|NCT00006351|recurrent bladder cancer|recurrent bladder cancer
871288|NCT00006351|stage IV bladder cancer|stage iv bladder cancer
871289|NCT00006351|transitional cell carcinoma of the bladder|transitional cell carcinoma of the bladder
871290|NCT00006351|recurrent urethral cancer|recurrent urethral cancer
871291|NCT00006351|anterior urethral cancer|anterior urethral cancer
871292|NCT00006351|posterior urethral cancer|posterior urethral cancer
871293|NCT00006351|urethral cancer associated with invasive bladder cancer|urethral cancer associated with invasive bladder cancer
872208|NCT00005858|stage IV bladder cancer|stage iv bladder cancer
871294|NCT00006351|metastatic transitional cell cancer of the renal pelvis and ureter|metastatic transitional cell cancer of the renal pelvis and ureter
871295|NCT00006351|recurrent transitional cell cancer of the renal pelvis and ureter|recurrent transitional cell cancer of the renal pelvis and ureter
871296|NCT00006347|recurrent small cell lung cancer|recurrent small cell lung cancer
871297|NCT00006340|stage I adult Hodgkin lymphoma|stage i adult hodgkin lymphoma
871298|NCT00006340|stage II adult Hodgkin lymphoma|stage ii adult hodgkin lymphoma
871299|NCT00006340|stage III adult Hodgkin lymphoma|stage iii adult hodgkin lymphoma
871300|NCT00006340|stage IV adult Hodgkin lymphoma|stage iv adult hodgkin lymphoma
871301|NCT00006340|recurrent adult Hodgkin lymphoma|recurrent adult hodgkin lymphoma
871302|NCT00006340|stage I cutaneous T-cell non-Hodgkin lymphoma|stage i cutaneous t-cell non-hodgkin lymphoma
871303|NCT00006340|stage II cutaneous T-cell non-Hodgkin lymphoma|stage ii cutaneous t-cell non-hodgkin lymphoma
871304|NCT00006340|stage III cutaneous T-cell non-Hodgkin lymphoma|stage iii cutaneous t-cell non-hodgkin lymphoma
871305|NCT00006340|stage IV cutaneous T-cell non-Hodgkin lymphoma|stage iv cutaneous t-cell non-hodgkin lymphoma
871306|NCT00006340|recurrent cutaneous T-cell non-Hodgkin lymphoma|recurrent cutaneous t-cell non-hodgkin lymphoma
871307|NCT00006340|stage I childhood lymphoblastic lymphoma|stage i childhood lymphoblastic lymphoma
871308|NCT00006340|stage II childhood lymphoblastic lymphoma|stage ii childhood lymphoblastic lymphoma
871309|NCT00006340|stage III childhood lymphoblastic lymphoma|stage iii childhood lymphoblastic lymphoma
871310|NCT00006340|stage IV childhood lymphoblastic lymphoma|stage iv childhood lymphoblastic lymphoma
871311|NCT00006340|recurrent childhood lymphoblastic lymphoma|recurrent childhood lymphoblastic lymphoma
871312|NCT00006340|small intestine lymphoma|small intestine lymphoma
871313|NCT00006340|childhood immunoblastic large cell lymphoma|childhood immunoblastic large cell lymphoma
871314|NCT00006340|grade I lymphomatoid granulomatosis|grade i lymphomatoid granulomatosis
871315|NCT00006340|grade II lymphomatoid granulomatosis|grade ii lymphomatoid granulomatosis
871316|NCT00006340|adult grade III lymphomatoid granulomatosis|adult grade iii lymphomatoid granulomatosis
871317|NCT00006340|recurrent adult grade III lymphomatoid granulomatosis|recurrent adult grade iii lymphomatoid granulomatosis
871318|NCT00006340|childhood grade III lymphomatoid granulomatosis|childhood grade iii lymphomatoid granulomatosis
871319|NCT00006340|recurrent childhood grade III lymphomatoid granulomatosis|recurrent childhood grade iii lymphomatoid granulomatosis
871320|NCT00006340|recurrent grade I lymphomatoid granulomatosis|recurrent grade i lymphomatoid granulomatosis
871321|NCT00006340|recurrent grade II lymphomatoid granulomatosis|recurrent grade ii lymphomatoid granulomatosis
871322|NCT00006340|stage II childhood Hodgkin lymphoma|stage ii childhood hodgkin lymphoma
871323|NCT00006340|stage I childhood Hodgkin lymphoma|stage i childhood hodgkin lymphoma
871324|NCT00006340|stage III childhood Hodgkin lymphoma|stage iii childhood hodgkin lymphoma
871325|NCT00006340|stage IV childhood Hodgkin lymphoma|stage iv childhood hodgkin lymphoma
871326|NCT00006340|recurrent/refractory childhood Hodgkin lymphoma|recurrent/refractory childhood hodgkin lymphoma
875027|NCT00003458|Ganglioglioma|ganglioglioma
871327|NCT00006340|stage I grade 1 follicular lymphoma|stage i grade 1 follicular lymphoma
871328|NCT00006340|stage I grade 2 follicular lymphoma|stage i grade 2 follicular lymphoma
871329|NCT00006340|stage I grade 3 follicular lymphoma|stage i grade 3 follicular lymphoma
871330|NCT00006340|stage I adult diffuse small cleaved cell lymphoma|stage i adult diffuse small cleaved cell lymphoma
871331|NCT00006340|stage I adult diffuse mixed cell lymphoma|stage i adult diffuse mixed cell lymphoma
871332|NCT00006340|stage I adult diffuse large cell lymphoma|stage i adult diffuse large cell lymphoma
871333|NCT00006340|stage I adult immunoblastic large cell lymphoma|stage i adult immunoblastic large cell lymphoma
871334|NCT00006340|stage I adult lymphoblastic lymphoma|stage i adult lymphoblastic lymphoma
871335|NCT00006340|stage I adult Burkitt lymphoma|stage i adult burkitt lymphoma
871336|NCT00006340|T-cell large granular lymphocyte leukemia|t-cell large granular lymphocyte leukemia
871337|NCT00006340|stage II grade 1 follicular lymphoma|stage ii grade 1 follicular lymphoma
871338|NCT00006340|stage II grade 2 follicular lymphoma|stage ii grade 2 follicular lymphoma
871339|NCT00006340|stage II grade 3 follicular lymphoma|stage ii grade 3 follicular lymphoma
871340|NCT00006340|stage II adult diffuse small cleaved cell lymphoma|stage ii adult diffuse small cleaved cell lymphoma
871341|NCT00006340|stage II adult diffuse mixed cell lymphoma|stage ii adult diffuse mixed cell lymphoma
871342|NCT00006340|stage II adult diffuse large cell lymphoma|stage ii adult diffuse large cell lymphoma
871343|NCT00006340|stage II adult immunoblastic large cell lymphoma|stage ii adult immunoblastic large cell lymphoma
871344|NCT00006340|stage II adult lymphoblastic lymphoma|stage ii adult lymphoblastic lymphoma
871345|NCT00006340|stage II adult Burkitt lymphoma|stage ii adult burkitt lymphoma
871346|NCT00006340|stage III grade 1 follicular lymphoma|stage iii grade 1 follicular lymphoma
871347|NCT00006340|stage III grade 2 follicular lymphoma|stage iii grade 2 follicular lymphoma
871348|NCT00006340|stage III grade 3 follicular lymphoma|stage iii grade 3 follicular lymphoma
871349|NCT00006340|stage III adult diffuse small cleaved cell lymphoma|stage iii adult diffuse small cleaved cell lymphoma
871350|NCT00006340|stage III adult diffuse mixed cell lymphoma|stage iii adult diffuse mixed cell lymphoma
871351|NCT00006340|stage III adult diffuse large cell lymphoma|stage iii adult diffuse large cell lymphoma
871352|NCT00006340|stage III adult immunoblastic large cell lymphoma|stage iii adult immunoblastic large cell lymphoma
871353|NCT00006340|stage III adult lymphoblastic lymphoma|stage iii adult lymphoblastic lymphoma
871354|NCT00006340|stage III adult Burkitt lymphoma|stage iii adult burkitt lymphoma
871355|NCT00006340|stage IV grade 1 follicular lymphoma|stage iv grade 1 follicular lymphoma
871356|NCT00006340|stage IV grade 2 follicular lymphoma|stage iv grade 2 follicular lymphoma
871357|NCT00006340|stage IV grade 3 follicular lymphoma|stage iv grade 3 follicular lymphoma
871358|NCT00006340|stage IV adult diffuse small cleaved cell lymphoma|stage iv adult diffuse small cleaved cell lymphoma
871359|NCT00006340|stage IV adult diffuse mixed cell lymphoma|stage iv adult diffuse mixed cell lymphoma
871360|NCT00006340|stage IV adult diffuse large cell lymphoma|stage iv adult diffuse large cell lymphoma
871361|NCT00006340|stage IV adult immunoblastic large cell lymphoma|stage iv adult immunoblastic large cell lymphoma
871362|NCT00006340|stage IV adult lymphoblastic lymphoma|stage iv adult lymphoblastic lymphoma
871363|NCT00006340|stage IV adult Burkitt lymphoma|stage iv adult burkitt lymphoma
871364|NCT00006340|recurrent grade 1 follicular lymphoma|recurrent grade 1 follicular lymphoma
871365|NCT00006340|recurrent grade 2 follicular lymphoma|recurrent grade 2 follicular lymphoma
871366|NCT00006340|recurrent grade 3 follicular lymphoma|recurrent grade 3 follicular lymphoma
871367|NCT00006340|recurrent adult diffuse small cleaved cell lymphoma|recurrent adult diffuse small cleaved cell lymphoma
871368|NCT00006340|recurrent adult diffuse mixed cell lymphoma|recurrent adult diffuse mixed cell lymphoma
871369|NCT00006340|recurrent adult diffuse large cell lymphoma|recurrent adult diffuse large cell lymphoma
871370|NCT00006340|recurrent adult immunoblastic large cell lymphoma|recurrent adult immunoblastic large cell lymphoma
871371|NCT00006340|recurrent adult lymphoblastic lymphoma|recurrent adult lymphoblastic lymphoma
871372|NCT00006340|recurrent adult Burkitt lymphoma|recurrent adult burkitt lymphoma
871373|NCT00006340|stage I adult T-cell leukemia/lymphoma|stage i adult t-cell leukemia/lymphoma
871374|NCT00006340|stage II adult T-cell leukemia/lymphoma|stage ii adult t-cell leukemia/lymphoma
871375|NCT00006340|stage III adult T-cell leukemia/lymphoma|stage iii adult t-cell leukemia/lymphoma
871376|NCT00006340|stage IV adult T-cell leukemia/lymphoma|stage iv adult t-cell leukemia/lymphoma
871377|NCT00006340|recurrent adult T-cell leukemia/lymphoma|recurrent adult t-cell leukemia/lymphoma
871378|NCT00006340|AIDS-related peripheral/systemic lymphoma|aids-related peripheral/systemic lymphoma
871379|NCT00006340|AIDS-related primary CNS lymphoma|aids-related primary cns lymphoma
871380|NCT00006340|stage I childhood small noncleaved cell lymphoma|stage i childhood small noncleaved cell lymphoma
871381|NCT00006340|stage I childhood large cell lymphoma|stage i childhood large cell lymphoma
871382|NCT00006340|stage II childhood small noncleaved cell lymphoma|stage ii childhood small noncleaved cell lymphoma
871383|NCT00006340|stage II childhood large cell lymphoma|stage ii childhood large cell lymphoma
871384|NCT00006340|stage III childhood small noncleaved cell lymphoma|stage iii childhood small noncleaved cell lymphoma
871385|NCT00006340|stage III childhood large cell lymphoma|stage iii childhood large cell lymphoma
871386|NCT00006340|stage IV childhood small noncleaved cell lymphoma|stage iv childhood small noncleaved cell lymphoma
871387|NCT00006340|stage IV childhood large cell lymphoma|stage iv childhood large cell lymphoma
871388|NCT00006340|recurrent childhood small noncleaved cell lymphoma|recurrent childhood small noncleaved cell lymphoma
871389|NCT00006340|recurrent childhood large cell lymphoma|recurrent childhood large cell lymphoma
871390|NCT00006340|stage I mantle cell lymphoma|stage i mantle cell lymphoma
871391|NCT00006340|stage III mantle cell lymphoma|stage iii mantle cell lymphoma
871392|NCT00006340|stage IV mantle cell lymphoma|stage iv mantle cell lymphoma
871393|NCT00006340|recurrent mantle cell lymphoma|recurrent mantle cell lymphoma
871394|NCT00006340|angioimmunoblastic T-cell lymphoma|angioimmunoblastic t-cell lymphoma
877761|NCT00001436|Pediatric|pediatric
871395|NCT00006340|anaplastic large cell lymphoma|anaplastic large cell lymphoma
871396|NCT00006340|stage II mantle cell lymphoma|stage ii mantle cell lymphoma
871397|NCT00006340|stage I mycosis fungoides/Sezary syndrome|stage i mycosis fungoides/sezary syndrome
871398|NCT00006340|stage II mycosis fungoides/Sezary syndrome|stage ii mycosis fungoides/sezary syndrome
871399|NCT00006340|stage III mycosis fungoides/Sezary syndrome|stage iii mycosis fungoides/sezary syndrome
871400|NCT00006340|stage IV mycosis fungoides/Sezary syndrome|stage iv mycosis fungoides/sezary syndrome
871401|NCT00006340|recurrent mycosis fungoides/Sezary syndrome|recurrent mycosis fungoides/sezary syndrome
871402|NCT00006340|recurrent marginal zone lymphoma|recurrent marginal zone lymphoma
871403|NCT00006340|recurrent small lymphocytic lymphoma|recurrent small lymphocytic lymphoma
871404|NCT00006340|stage I marginal zone lymphoma|stage i marginal zone lymphoma
871405|NCT00006340|stage I small lymphocytic lymphoma|stage i small lymphocytic lymphoma
871406|NCT00006340|stage II small lymphocytic lymphoma|stage ii small lymphocytic lymphoma
871407|NCT00006340|stage II marginal zone lymphoma|stage ii marginal zone lymphoma
871408|NCT00006340|stage III small lymphocytic lymphoma|stage iii small lymphocytic lymphoma
871409|NCT00006340|stage III marginal zone lymphoma|stage iii marginal zone lymphoma
871410|NCT00006340|stage IV small lymphocytic lymphoma|stage iv small lymphocytic lymphoma
871411|NCT00006340|stage IV marginal zone lymphoma|stage iv marginal zone lymphoma
871412|NCT00006340|extranodal marginal zone B-cell lymphoma of mucosa-associated lymphoid tissue|extranodal marginal zone b-cell lymphoma of mucosa-associated lymphoid tissue
871413|NCT00006340|nodal marginal zone B-cell lymphoma|nodal marginal zone b-cell lymphoma
871414|NCT00006340|splenic marginal zone lymphoma|splenic marginal zone lymphoma
871415|NCT00006268|recurrent adult brain tumor|recurrent adult brain tumor
871416|NCT00006268|adult glioblastoma|adult glioblastoma
871417|NCT00006268|adult anaplastic astrocytoma|adult anaplastic astrocytoma
871418|NCT00006268|adult mixed glioma|adult mixed glioma
871419|NCT00006268|adult giant cell glioblastoma|adult giant cell glioblastoma
871420|NCT00006268|adult gliosarcoma|adult gliosarcoma
893921|NCT00001959|Fibrosis|fibrosis
871421|NCT00006267|stage IV ovarian epithelial cancer|stage iv ovarian epithelial cancer
871422|NCT00006267|recurrent ovarian epithelial cancer|recurrent ovarian epithelial cancer
871423|NCT00006267|primary peritoneal cavity cancer|primary peritoneal cavity cancer
871424|NCT00006264|AIDS-related primary CNS lymphoma|aids-related primary cns lymphoma
871425|NCT00006263|adult brain stem glioma|adult brain stem glioma
871426|NCT00006263|adult glioblastoma|adult glioblastoma
871427|NCT00006263|childhood high-grade cerebral astrocytoma|childhood high-grade cerebral astrocytoma
871428|NCT00006263|adult anaplastic astrocytoma|adult anaplastic astrocytoma
871429|NCT00006263|adult anaplastic oligodendroglioma|adult anaplastic oligodendroglioma
871430|NCT00006263|adult giant cell glioblastoma|adult giant cell glioblastoma
871431|NCT00006263|adult gliosarcoma|adult gliosarcoma
871432|NCT00006260|stage IV breast cancer|stage iv breast cancer
871433|NCT00006260|recurrent breast cancer|recurrent breast cancer
871434|NCT00006258|childhood infratentorial ependymoma|childhood infratentorial ependymoma
871435|NCT00006258|childhood supratentorial ependymoma|childhood supratentorial ependymoma
871436|NCT00006258|adult medulloblastoma|adult medulloblastoma
871437|NCT00006258|adult myxopapillary ependymoma|adult myxopapillary ependymoma
871438|NCT00006258|adult anaplastic ependymoma|adult anaplastic ependymoma
871439|NCT00006258|adult ependymoblastoma|adult ependymoblastoma
871440|NCT00006258|untreated childhood supratentorial primitive neuroectodermal tumor|untreated childhood supratentorial primitive neuroectodermal tumor
871441|NCT00006258|untreated childhood medulloblastoma|untreated childhood medulloblastoma
871442|NCT00006258|newly diagnosed childhood ependymoma|newly diagnosed childhood ependymoma
871443|NCT00006258|adult supratentorial primitive neuroectodermal tumor (PNET)|adult supratentorial primitive neuroectodermal tumor (pnet)
871444|NCT00006256|stage II breast cancer|stage ii breast cancer
871445|NCT00006256|stage IIIA breast cancer|stage iiia breast cancer
871446|NCT00006256|stage IIIB breast cancer|stage iiib breast cancer
871447|NCT00006256|stage IIIC breast cancer|stage iiic breast cancer
871448|NCT00006255|stage III renal cell cancer|stage iii renal cell cancer
871449|NCT00006255|stage IV renal cell cancer|stage iv renal cell cancer
871450|NCT00006255|recurrent renal cell cancer|recurrent renal cell cancer
871451|NCT00006255|unspecified adult solid tumor, protocol specific|unspecified adult solid tumor, protocol specific
871452|NCT00006255|liver metastases|liver metastases
871453|NCT00006252|refractory chronic lymphocytic leukemia|refractory chronic lymphocytic leukemia
871454|NCT00006252|stage I grade 1 follicular lymphoma|stage i grade 1 follicular lymphoma
871455|NCT00006252|stage I grade 2 follicular lymphoma|stage i grade 2 follicular lymphoma
871456|NCT00006252|stage I adult diffuse small cleaved cell lymphoma|stage i adult diffuse small cleaved cell lymphoma
871457|NCT00006252|stage III grade 1 follicular lymphoma|stage iii grade 1 follicular lymphoma
871458|NCT00006252|stage III grade 2 follicular lymphoma|stage iii grade 2 follicular lymphoma
871459|NCT00006252|stage III adult diffuse small cleaved cell lymphoma|stage iii adult diffuse small cleaved cell lymphoma
871460|NCT00006252|stage IV grade 1 follicular lymphoma|stage iv grade 1 follicular lymphoma
871461|NCT00006252|stage IV grade 2 follicular lymphoma|stage iv grade 2 follicular lymphoma
871462|NCT00006252|stage IV adult diffuse small cleaved cell lymphoma|stage iv adult diffuse small cleaved cell lymphoma
871463|NCT00006252|recurrent grade 1 follicular lymphoma|recurrent grade 1 follicular lymphoma
871464|NCT00006252|recurrent grade 2 follicular lymphoma|recurrent grade 2 follicular lymphoma
877762|NCT00001436|Recurrent|recurrent
871465|NCT00006252|recurrent adult diffuse small cleaved cell lymphoma|recurrent adult diffuse small cleaved cell lymphoma
871466|NCT00006252|prolymphocytic leukemia|prolymphocytic leukemia
871467|NCT00006252|stage I mantle cell lymphoma|stage i mantle cell lymphoma
871468|NCT00006252|contiguous stage II grade 1 follicular lymphoma|contiguous stage ii grade 1 follicular lymphoma
871469|NCT00006252|contiguous stage II grade 2 follicular lymphoma|contiguous stage ii grade 2 follicular lymphoma
871470|NCT00006252|contiguous stage II adult diffuse small cleaved cell lymphoma|contiguous stage ii adult diffuse small cleaved cell lymphoma
871471|NCT00006252|contiguous stage II mantle cell lymphoma|contiguous stage ii mantle cell lymphoma
871472|NCT00006252|noncontiguous stage II grade 1 follicular lymphoma|noncontiguous stage ii grade 1 follicular lymphoma
871473|NCT00006252|noncontiguous stage II grade 2 follicular lymphoma|noncontiguous stage ii grade 2 follicular lymphoma
871474|NCT00006252|noncontiguous stage II adult diffuse small cleaved cell lymphoma|noncontiguous stage ii adult diffuse small cleaved cell lymphoma
871475|NCT00006252|noncontiguous stage II mantle cell lymphoma|noncontiguous stage ii mantle cell lymphoma
871476|NCT00006252|stage III mantle cell lymphoma|stage iii mantle cell lymphoma
871477|NCT00006252|stage IV mantle cell lymphoma|stage iv mantle cell lymphoma
871478|NCT00006252|recurrent mantle cell lymphoma|recurrent mantle cell lymphoma
871479|NCT00006252|contiguous stage II small lymphocytic lymphoma|contiguous stage ii small lymphocytic lymphoma
871480|NCT00006252|contiguous stage II marginal zone lymphoma|contiguous stage ii marginal zone lymphoma
871481|NCT00006252|noncontiguous stage II small lymphocytic lymphoma|noncontiguous stage ii small lymphocytic lymphoma
871482|NCT00006252|noncontiguous stage II marginal zone lymphoma|noncontiguous stage ii marginal zone lymphoma
871483|NCT00006252|extranodal marginal zone B-cell lymphoma of mucosa-associated lymphoid tissue|extranodal marginal zone b-cell lymphoma of mucosa-associated lymphoid tissue
871484|NCT00006252|nodal marginal zone B-cell lymphoma|nodal marginal zone b-cell lymphoma
871485|NCT00006252|splenic marginal zone lymphoma|splenic marginal zone lymphoma
871486|NCT00006252|recurrent marginal zone lymphoma|recurrent marginal zone lymphoma
894025|NCT00000429|Osteopenia|osteopenia
871487|NCT00006252|recurrent small lymphocytic lymphoma|recurrent small lymphocytic lymphoma
871488|NCT00006252|stage I marginal zone lymphoma|stage i marginal zone lymphoma
871489|NCT00006252|stage I small lymphocytic lymphoma|stage i small lymphocytic lymphoma
871490|NCT00006252|stage III small lymphocytic lymphoma|stage iii small lymphocytic lymphoma
871491|NCT00006252|stage III marginal zone lymphoma|stage iii marginal zone lymphoma
871492|NCT00006252|stage IV small lymphocytic lymphoma|stage iv small lymphocytic lymphoma
871493|NCT00006252|stage IV marginal zone lymphoma|stage iv marginal zone lymphoma
871494|NCT00006250|stage III grade 1 follicular lymphoma|stage iii grade 1 follicular lymphoma
871495|NCT00006250|stage III grade 2 follicular lymphoma|stage iii grade 2 follicular lymphoma
871496|NCT00006250|stage III grade 3 follicular lymphoma|stage iii grade 3 follicular lymphoma
871497|NCT00006250|stage IV grade 1 follicular lymphoma|stage iv grade 1 follicular lymphoma
871498|NCT00006250|stage IV grade 2 follicular lymphoma|stage iv grade 2 follicular lymphoma
871499|NCT00006250|stage IV grade 3 follicular lymphoma|stage iv grade 3 follicular lymphoma
871500|NCT00006249|stage III melanoma|stage iii melanoma
871501|NCT00006248|stage IV squamous cell carcinoma of the lip and oral cavity|stage iv squamous cell carcinoma of the lip and oral cavity
871502|NCT00006248|recurrent squamous cell carcinoma of the lip and oral cavity|recurrent squamous cell carcinoma of the lip and oral cavity
871503|NCT00006248|stage IV squamous cell carcinoma of the oropharynx|stage iv squamous cell carcinoma of the oropharynx
871504|NCT00006248|recurrent squamous cell carcinoma of the oropharynx|recurrent squamous cell carcinoma of the oropharynx
871505|NCT00006248|stage IV squamous cell carcinoma of the nasopharynx|stage iv squamous cell carcinoma of the nasopharynx
871506|NCT00006248|recurrent squamous cell carcinoma of the nasopharynx|recurrent squamous cell carcinoma of the nasopharynx
871507|NCT00006248|stage IV squamous cell carcinoma of the hypopharynx|stage iv squamous cell carcinoma of the hypopharynx
871508|NCT00006248|recurrent squamous cell carcinoma of the hypopharynx|recurrent squamous cell carcinoma of the hypopharynx
871509|NCT00006248|stage IV squamous cell carcinoma of the larynx|stage iv squamous cell carcinoma of the larynx
871510|NCT00006248|recurrent squamous cell carcinoma of the larynx|recurrent squamous cell carcinoma of the larynx
871511|NCT00006248|stage IV squamous cell carcinoma of the paranasal sinus and nasal cavity|stage iv squamous cell carcinoma of the paranasal sinus and nasal cavity
871512|NCT00006248|recurrent squamous cell carcinoma of the paranasal sinus and nasal cavity|recurrent squamous cell carcinoma of the paranasal sinus and nasal cavity
871513|NCT00006246|recurrent childhood acute lymphoblastic leukemia|recurrent childhood acute lymphoblastic leukemia
875028|NCT00003458|Glioblastoma multiforme|glioblastoma multiforme
871514|NCT00006246|childhood infratentorial ependymoma|childhood infratentorial ependymoma
871515|NCT00006246|recurrent childhood rhabdomyosarcoma|recurrent childhood rhabdomyosarcoma
871516|NCT00006246|recurrent childhood brain tumor|recurrent childhood brain tumor
871517|NCT00006246|recurrent retinoblastoma|recurrent retinoblastoma
871518|NCT00006246|recurrent childhood lymphoblastic lymphoma|recurrent childhood lymphoblastic lymphoma
871519|NCT00006246|childhood central nervous system germ cell tumor|childhood central nervous system germ cell tumor
871520|NCT00006246|recurrent childhood acute myeloid leukemia|recurrent childhood acute myeloid leukemia
871521|NCT00006246|recurrent/refractory childhood Hodgkin lymphoma|recurrent/refractory childhood hodgkin lymphoma
871522|NCT00006246|leptomeningeal metastases|leptomeningeal metastases
871523|NCT00006246|childhood high-grade cerebral astrocytoma|childhood high-grade cerebral astrocytoma
871524|NCT00006246|childhood oligodendroglioma|childhood oligodendroglioma
877763|NCT00001435|Anxiety|anxiety
871525|NCT00006246|childhood choroid plexus tumor|childhood choroid plexus tumor
871526|NCT00006246|childhood grade I meningioma|childhood grade i meningioma
871527|NCT00006246|childhood grade II meningioma|childhood grade ii meningioma
871528|NCT00006246|childhood grade III meningioma|childhood grade iii meningioma
871529|NCT00006246|recurrent childhood large cell lymphoma|recurrent childhood large cell lymphoma
871530|NCT00006246|recurrent childhood brain stem glioma|recurrent childhood brain stem glioma
871531|NCT00006246|recurrent childhood supratentorial primitive neuroectodermal tumor|recurrent childhood supratentorial primitive neuroectodermal tumor
871532|NCT00006246|recurrent childhood cerebellar astrocytoma|recurrent childhood cerebellar astrocytoma
871533|NCT00006246|recurrent childhood cerebral astrocytoma|recurrent childhood cerebral astrocytoma
871534|NCT00006246|recurrent childhood medulloblastoma|recurrent childhood medulloblastoma
871535|NCT00006246|recurrent childhood visual pathway and hypothalamic glioma|recurrent childhood visual pathway and hypothalamic glioma
871536|NCT00006246|recurrent childhood ependymoma|recurrent childhood ependymoma
871537|NCT00006246|recurrent childhood malignant germ cell tumor|recurrent childhood malignant germ cell tumor
871538|NCT00006245|stage III esophageal cancer|stage iii esophageal cancer
871539|NCT00006245|stage IV esophageal cancer|stage iv esophageal cancer
871540|NCT00006245|recurrent esophageal cancer|recurrent esophageal cancer
871541|NCT00006245|squamous cell carcinoma of the esophagus|squamous cell carcinoma of the esophagus
871542|NCT00006245|adenocarcinoma of the esophagus|adenocarcinoma of the esophagus
871543|NCT00006239|recurrent adult acute myeloid leukemia|recurrent adult acute myeloid leukemia
871544|NCT00006239|untreated adult acute myeloid leukemia|untreated adult acute myeloid leukemia
871545|NCT00006239|refractory anemia|refractory anemia
871546|NCT00006239|refractory anemia with ringed sideroblasts|refractory anemia with ringed sideroblasts
871547|NCT00006239|refractory anemia with excess blasts|refractory anemia with excess blasts
871548|NCT00006239|refractory anemia with excess blasts in transformation|refractory anemia with excess blasts in transformation
871549|NCT00006239|chronic myelomonocytic leukemia|chronic myelomonocytic leukemia
871550|NCT00006239|previously treated myelodysplastic syndromes|previously treated myelodysplastic syndromes
871551|NCT00006239|atypical chronic myeloid leukemia|atypical chronic myeloid leukemia
871552|NCT00006239|myelodysplastic/myeloproliferative disease, unclassifiable|myelodysplastic/myeloproliferative disease, unclassifiable
871553|NCT00006239|adult acute myeloid leukemia with t(8;21)(q22;q22)|adult acute myeloid leukemia with t(8;21)(q22;q22)
871554|NCT00006239|adult acute myeloid leukemia with t(16;16)(p13;q22)|adult acute myeloid leukemia with t(16;16)(p13;q22)
871555|NCT00006239|adult acute myeloid leukemia with inv(16)(p13;q22)|adult acute myeloid leukemia with inv(16)(p13;q22)
871556|NCT00006239|adult acute myeloid leukemia with 11q23 (MLL) abnormalities|adult acute myeloid leukemia with 11q23 (mll) abnormalities
871557|NCT00006239|adult acute myeloid leukemia with t(15;17)(q22;q12)|adult acute myeloid leukemia with t(15;17)(q22;q12)
871558|NCT00006237|stage III melanoma|stage iii melanoma
871559|NCT00006237|recurrent melanoma|recurrent melanoma
871560|NCT00006234|recurrent childhood rhabdomyosarcoma|recurrent childhood rhabdomyosarcoma
871561|NCT00006234|recurrent adult soft tissue sarcoma|recurrent adult soft tissue sarcoma
871562|NCT00006234|adult rhabdomyosarcoma|adult rhabdomyosarcoma
871563|NCT00006234|bone metastases|bone metastases
871564|NCT00006234|previously treated childhood rhabdomyosarcoma|previously treated childhood rhabdomyosarcoma
871565|NCT00006234|metastatic Ewing sarcoma/peripheral primitive neuroectodermal tumor|metastatic ewing sarcoma/peripheral primitive neuroectodermal tumor
871566|NCT00006234|recurrent Ewing sarcoma/peripheral primitive neuroectodermal tumor|recurrent ewing sarcoma/peripheral primitive neuroectodermal tumor
871567|NCT00006234|stage IV adult soft tissue sarcoma|stage iv adult soft tissue sarcoma
871568|NCT00006233|stage IV melanoma|stage iv melanoma
871569|NCT00006233|recurrent melanoma|recurrent melanoma
871570|NCT00006232|stage II multiple myeloma|stage ii multiple myeloma
871571|NCT00006232|stage III multiple myeloma|stage iii multiple myeloma
871572|NCT00006231|localized malignant mesothelioma|localized malignant mesothelioma
871573|NCT00006231|advanced malignant mesothelioma|advanced malignant mesothelioma
871574|NCT00006231|perioperative/postoperative complications|perioperative/postoperative complications
871575|NCT00006230|stage III ovarian epithelial cancer|stage iii ovarian epithelial cancer
871576|NCT00006230|stage IV ovarian epithelial cancer|stage iv ovarian epithelial cancer
871577|NCT00006230|recurrent ovarian epithelial cancer|recurrent ovarian epithelial cancer
871578|NCT00006221|stage IV adult Hodgkin lymphoma|stage iv adult hodgkin lymphoma
871579|NCT00006221|recurrent adult Hodgkin lymphoma|recurrent adult hodgkin lymphoma
871580|NCT00006221|stage IV cutaneous T-cell non-Hodgkin lymphoma|stage iv cutaneous t-cell non-hodgkin lymphoma
871581|NCT00006221|recurrent cutaneous T-cell non-Hodgkin lymphoma|recurrent cutaneous t-cell non-hodgkin lymphoma
871582|NCT00006221|small intestine lymphoma|small intestine lymphoma
871583|NCT00006221|unspecified adult solid tumor, protocol specific|unspecified adult solid tumor, protocol specific
871584|NCT00006221|stage IV grade 1 follicular lymphoma|stage iv grade 1 follicular lymphoma
871585|NCT00006221|stage IV grade 2 follicular lymphoma|stage iv grade 2 follicular lymphoma
871586|NCT00006221|stage IV grade 3 follicular lymphoma|stage iv grade 3 follicular lymphoma
871587|NCT00006221|stage IV adult diffuse small cleaved cell lymphoma|stage iv adult diffuse small cleaved cell lymphoma
871588|NCT00006221|stage IV adult diffuse mixed cell lymphoma|stage iv adult diffuse mixed cell lymphoma
871589|NCT00006221|stage IV adult diffuse large cell lymphoma|stage iv adult diffuse large cell lymphoma
871590|NCT00006221|stage IV adult immunoblastic large cell lymphoma|stage iv adult immunoblastic large cell lymphoma
871591|NCT00006221|stage IV adult lymphoblastic lymphoma|stage iv adult lymphoblastic lymphoma
871592|NCT00006221|stage IV adult Burkitt lymphoma|stage iv adult burkitt lymphoma
871593|NCT00006221|recurrent grade 1 follicular lymphoma|recurrent grade 1 follicular lymphoma
871594|NCT00006221|recurrent grade 2 follicular lymphoma|recurrent grade 2 follicular lymphoma
871595|NCT00006221|recurrent grade 3 follicular lymphoma|recurrent grade 3 follicular lymphoma
871596|NCT00006221|recurrent adult diffuse small cleaved cell lymphoma|recurrent adult diffuse small cleaved cell lymphoma
871597|NCT00006221|recurrent adult diffuse mixed cell lymphoma|recurrent adult diffuse mixed cell lymphoma
871598|NCT00006221|recurrent adult diffuse large cell lymphoma|recurrent adult diffuse large cell lymphoma
871599|NCT00006221|recurrent adult immunoblastic large cell lymphoma|recurrent adult immunoblastic large cell lymphoma
871600|NCT00006221|recurrent adult lymphoblastic lymphoma|recurrent adult lymphoblastic lymphoma
871601|NCT00006221|recurrent adult Burkitt lymphoma|recurrent adult burkitt lymphoma
871602|NCT00006221|stage IV adult T-cell leukemia/lymphoma|stage iv adult t-cell leukemia/lymphoma
871603|NCT00006221|recurrent adult T-cell leukemia/lymphoma|recurrent adult t-cell leukemia/lymphoma
871604|NCT00006221|primary central nervous system non-Hodgkin lymphoma|primary central nervous system non-hodgkin lymphoma
871605|NCT00006221|AIDS-related peripheral/systemic lymphoma|aids-related peripheral/systemic lymphoma
871606|NCT00006221|AIDS-related primary CNS lymphoma|aids-related primary cns lymphoma
871607|NCT00006221|intraocular lymphoma|intraocular lymphoma
871608|NCT00006221|stage IV mantle cell lymphoma|stage iv mantle cell lymphoma
871609|NCT00006221|recurrent mantle cell lymphoma|recurrent mantle cell lymphoma
871610|NCT00006221|angioimmunoblastic T-cell lymphoma|angioimmunoblastic t-cell lymphoma
871611|NCT00006221|anaplastic large cell lymphoma|anaplastic large cell lymphoma
871612|NCT00006221|stage IV mycosis fungoides/Sezary syndrome|stage iv mycosis fungoides/sezary syndrome
871613|NCT00006221|recurrent mycosis fungoides/Sezary syndrome|recurrent mycosis fungoides/sezary syndrome
894646|NCT00001750|G-CSF|g-csf
871614|NCT00006221|recurrent marginal zone lymphoma|recurrent marginal zone lymphoma
871615|NCT00006221|recurrent small lymphocytic lymphoma|recurrent small lymphocytic lymphoma
871616|NCT00006221|stage IV small lymphocytic lymphoma|stage iv small lymphocytic lymphoma
871617|NCT00006221|stage IV marginal zone lymphoma|stage iv marginal zone lymphoma
871618|NCT00006221|extranodal marginal zone B-cell lymphoma of mucosa-associated lymphoid tissue|extranodal marginal zone b-cell lymphoma of mucosa-associated lymphoid tissue
871619|NCT00006221|nodal marginal zone B-cell lymphoma|nodal marginal zone b-cell lymphoma
871620|NCT00006221|splenic marginal zone lymphoma|splenic marginal zone lymphoma
871621|NCT00006219|multiple myeloma|multiple myeloma
871622|NCT00006125|recurrent grade 3 follicular lymphoma|recurrent grade 3 follicular lymphoma
871623|NCT00006125|recurrent adult diffuse large cell lymphoma|recurrent adult diffuse large cell lymphoma
871624|NCT00006125|recurrent adult Burkitt lymphoma|recurrent adult burkitt lymphoma
871625|NCT00006125|anaplastic large cell lymphoma|anaplastic large cell lymphoma
871626|NCT00006120|stage IV breast cancer|stage iv breast cancer
871627|NCT00006120|stage IIIA breast cancer|stage iiia breast cancer
871628|NCT00006120|recurrent breast cancer|recurrent breast cancer
871629|NCT00006120|stage IIIB breast cancer|stage iiib breast cancer
871630|NCT00006119|recurrent adult brain tumor|recurrent adult brain tumor
871631|NCT00006119|adult grade III meningioma|adult grade iii meningioma
871632|NCT00006119|adult grade I meningioma|adult grade i meningioma
871633|NCT00006119|adult grade II meningioma|adult grade ii meningioma
871634|NCT00006118|stage III bladder cancer|stage iii bladder cancer
871635|NCT00006118|stage IV bladder cancer|stage iv bladder cancer
871636|NCT00006118|transitional cell carcinoma of the bladder|transitional cell carcinoma of the bladder
871637|NCT00006114|adenocarcinoma of the prostate|adenocarcinoma of the prostate
871638|NCT00006114|stage IV prostate cancer|stage iv prostate cancer
871639|NCT00006114|recurrent prostate cancer|recurrent prostate cancer
871640|NCT00006113|stage III melanoma|stage iii melanoma
871641|NCT00006113|stage IV melanoma|stage iv melanoma
871642|NCT00006113|recurrent melanoma|recurrent melanoma
871643|NCT00006110|stage II breast cancer|stage ii breast cancer
871644|NCT00006110|stage IV breast cancer|stage iv breast cancer
871645|NCT00006110|stage IIIA breast cancer|stage iiia breast cancer
871646|NCT00006110|stage IIIB breast cancer|stage iiib breast cancer
871647|NCT00006110|stage IIIC breast cancer|stage iiic breast cancer
871648|NCT00006110|inflammatory breast cancer|inflammatory breast cancer
871649|NCT00006107|recurrent metastatic squamous neck cancer with occult primary|recurrent metastatic squamous neck cancer with occult primary
871650|NCT00006107|metastatic squamous neck cancer with occult primary squamous cell carcinoma|metastatic squamous neck cancer with occult primary squamous cell carcinoma
871651|NCT00006107|stage III squamous cell carcinoma of the lip and oral cavity|stage iii squamous cell carcinoma of the lip and oral cavity
871652|NCT00006107|stage IV squamous cell carcinoma of the lip and oral cavity|stage iv squamous cell carcinoma of the lip and oral cavity
871653|NCT00006107|recurrent squamous cell carcinoma of the lip and oral cavity|recurrent squamous cell carcinoma of the lip and oral cavity
871654|NCT00006107|stage III squamous cell carcinoma of the oropharynx|stage iii squamous cell carcinoma of the oropharynx
871655|NCT00006107|stage IV squamous cell carcinoma of the oropharynx|stage iv squamous cell carcinoma of the oropharynx
871656|NCT00006107|recurrent squamous cell carcinoma of the oropharynx|recurrent squamous cell carcinoma of the oropharynx
871657|NCT00006107|stage III squamous cell carcinoma of the nasopharynx|stage iii squamous cell carcinoma of the nasopharynx
871722|NCT00006093|adult giant cell glioblastoma|adult giant cell glioblastoma
871658|NCT00006107|stage IV squamous cell carcinoma of the nasopharynx|stage iv squamous cell carcinoma of the nasopharynx
871659|NCT00006107|recurrent squamous cell carcinoma of the nasopharynx|recurrent squamous cell carcinoma of the nasopharynx
871660|NCT00006107|stage III squamous cell carcinoma of the hypopharynx|stage iii squamous cell carcinoma of the hypopharynx
871661|NCT00006107|stage IV squamous cell carcinoma of the hypopharynx|stage iv squamous cell carcinoma of the hypopharynx
871662|NCT00006107|recurrent squamous cell carcinoma of the hypopharynx|recurrent squamous cell carcinoma of the hypopharynx
871663|NCT00006107|stage III squamous cell carcinoma of the larynx|stage iii squamous cell carcinoma of the larynx
871664|NCT00006107|stage IV squamous cell carcinoma of the larynx|stage iv squamous cell carcinoma of the larynx
871665|NCT00006107|recurrent squamous cell carcinoma of the larynx|recurrent squamous cell carcinoma of the larynx
871666|NCT00006107|stage III squamous cell carcinoma of the paranasal sinus and nasal cavity|stage iii squamous cell carcinoma of the paranasal sinus and nasal cavity
871667|NCT00006107|stage IV squamous cell carcinoma of the paranasal sinus and nasal cavity|stage iv squamous cell carcinoma of the paranasal sinus and nasal cavity
871668|NCT00006107|recurrent squamous cell carcinoma of the paranasal sinus and nasal cavity|recurrent squamous cell carcinoma of the paranasal sinus and nasal cavity
871669|NCT00006107|recurrent salivary gland cancer|recurrent salivary gland cancer
871670|NCT00006107|stage III salivary gland cancer|stage iii salivary gland cancer
871671|NCT00006107|stage IV salivary gland cancer|stage iv salivary gland cancer
871672|NCT00006107|salivary gland squamous cell carcinoma|salivary gland squamous cell carcinoma
871673|NCT00006107|recurrent lymphoepithelioma of the nasopharynx|recurrent lymphoepithelioma of the nasopharynx
871674|NCT00006107|recurrent lymphoepithelioma of the oropharynx|recurrent lymphoepithelioma of the oropharynx
871675|NCT00006107|stage III lymphoepithelioma of the nasopharynx|stage iii lymphoepithelioma of the nasopharynx
871676|NCT00006107|stage III lymphoepithelioma of the oropharynx|stage iii lymphoepithelioma of the oropharynx
894647|NCT00001750|Cell-Cycle|cell-cycle
871677|NCT00006107|stage IV lymphoepithelioma of the nasopharynx|stage iv lymphoepithelioma of the nasopharynx
871678|NCT00006107|stage IV lymphoepithelioma of the oropharynx|stage iv lymphoepithelioma of the oropharynx
871679|NCT00006105|stage II bladder cancer|stage ii bladder cancer
871680|NCT00006105|stage III bladder cancer|stage iii bladder cancer
871681|NCT00006105|stage IV bladder cancer|stage iv bladder cancer
871682|NCT00006105|drug/agent toxicity by tissue/organ|drug/agent toxicity by tissue/organ
871683|NCT00006102|childhood infratentorial ependymoma|childhood infratentorial ependymoma
871684|NCT00006102|recurrent childhood rhabdomyosarcoma|recurrent childhood rhabdomyosarcoma
871685|NCT00006102|childhood supratentorial ependymoma|childhood supratentorial ependymoma
871686|NCT00006102|childhood craniopharyngioma|childhood craniopharyngioma
871687|NCT00006102|disseminated neuroblastoma|disseminated neuroblastoma
871688|NCT00006102|recurrent neuroblastoma|recurrent neuroblastoma
871689|NCT00006102|intraocular retinoblastoma|intraocular retinoblastoma
871690|NCT00006102|extraocular retinoblastoma|extraocular retinoblastoma
871691|NCT00006102|stage III childhood lymphoblastic lymphoma|stage iii childhood lymphoblastic lymphoma
871692|NCT00006102|stage IV childhood lymphoblastic lymphoma|stage iv childhood lymphoblastic lymphoma
871693|NCT00006102|recurrent childhood lymphoblastic lymphoma|recurrent childhood lymphoblastic lymphoma
871694|NCT00006102|childhood central nervous system germ cell tumor|childhood central nervous system germ cell tumor
871695|NCT00006102|unspecified childhood solid tumor, protocol specific|unspecified childhood solid tumor, protocol specific
871696|NCT00006102|childhood high-grade cerebral astrocytoma|childhood high-grade cerebral astrocytoma
871697|NCT00006102|childhood oligodendroglioma|childhood oligodendroglioma
871698|NCT00006102|childhood choroid plexus tumor|childhood choroid plexus tumor
871699|NCT00006102|childhood grade I meningioma|childhood grade i meningioma
871700|NCT00006102|childhood grade II meningioma|childhood grade ii meningioma
871701|NCT00006102|childhood grade III meningioma|childhood grade iii meningioma
871702|NCT00006102|stage III childhood large cell lymphoma|stage iii childhood large cell lymphoma
871703|NCT00006102|stage IV childhood small noncleaved cell lymphoma|stage iv childhood small noncleaved cell lymphoma
871704|NCT00006102|stage IV childhood large cell lymphoma|stage iv childhood large cell lymphoma
871705|NCT00006102|recurrent childhood small noncleaved cell lymphoma|recurrent childhood small noncleaved cell lymphoma
871706|NCT00006102|recurrent childhood large cell lymphoma|recurrent childhood large cell lymphoma
871707|NCT00006102|recurrent childhood brain stem glioma|recurrent childhood brain stem glioma
871708|NCT00006102|recurrent childhood supratentorial primitive neuroectodermal tumor|recurrent childhood supratentorial primitive neuroectodermal tumor
871709|NCT00006102|recurrent childhood cerebellar astrocytoma|recurrent childhood cerebellar astrocytoma
871710|NCT00006102|recurrent childhood cerebral astrocytoma|recurrent childhood cerebral astrocytoma
871711|NCT00006102|recurrent childhood medulloblastoma|recurrent childhood medulloblastoma
871712|NCT00006102|recurrent childhood visual pathway and hypothalamic glioma|recurrent childhood visual pathway and hypothalamic glioma
871713|NCT00006102|previously treated childhood rhabdomyosarcoma|previously treated childhood rhabdomyosarcoma
871714|NCT00006102|recurrent childhood ependymoma|recurrent childhood ependymoma
871715|NCT00006102|recurrent retinoblastoma|recurrent retinoblastoma
871716|NCT00006101|stage I prostate cancer|stage i prostate cancer
871717|NCT00006100|recurrent adult Hodgkin lymphoma|recurrent adult hodgkin lymphoma
871718|NCT00006093|recurrent adult brain tumor|recurrent adult brain tumor
871719|NCT00006093|adult glioblastoma|adult glioblastoma
871720|NCT00006093|adult anaplastic astrocytoma|adult anaplastic astrocytoma
871721|NCT00006093|adult anaplastic oligodendroglioma|adult anaplastic oligodendroglioma
871724|NCT00006092|recurrent adult acute lymphoblastic leukemia|recurrent adult acute lymphoblastic leukemia
871725|NCT00006092|relapsing chronic myelogenous leukemia|relapsing chronic myelogenous leukemia
871726|NCT00006092|blastic phase chronic myelogenous leukemia|blastic phase chronic myelogenous leukemia
871727|NCT00006092|chronic myelogenous leukemia, BCR-ABL1 positive|chronic myelogenous leukemia, bcr-abl1 positive
871728|NCT00006092|lymphoid leukemia|lymphoid leukemia
871729|NCT00006092|myeloid and monocytic leukemia|myeloid and monocytic leukemia
871730|NCT00006078|prostate cancer|prostate cancer
871731|NCT00006044|stage IV prostate cancer|stage iv prostate cancer
871732|NCT00006044|recurrent prostate cancer|recurrent prostate cancer
871733|NCT00006042|recurrent adult Hodgkin lymphoma|recurrent adult hodgkin lymphoma
871734|NCT00006042|Burkitt lymphoma|burkitt lymphoma
871735|NCT00006042|refractory multiple myeloma|refractory multiple myeloma
871736|NCT00006042|stage II multiple myeloma|stage ii multiple myeloma
871737|NCT00006042|stage III multiple myeloma|stage iii multiple myeloma
871738|NCT00006042|recurrent childhood lymphoblastic lymphoma|recurrent childhood lymphoblastic lymphoma
871739|NCT00006042|stage III chronic lymphocytic leukemia|stage iii chronic lymphocytic leukemia
871740|NCT00006042|stage IV chronic lymphocytic leukemia|stage iv chronic lymphocytic leukemia
871741|NCT00006042|relapsing chronic myelogenous leukemia|relapsing chronic myelogenous leukemia
871742|NCT00006042|refractory chronic lymphocytic leukemia|refractory chronic lymphocytic leukemia
871743|NCT00006042|chronic phase chronic myelogenous leukemia|chronic phase chronic myelogenous leukemia
871744|NCT00006042|adult acute myeloid leukemia in remission|adult acute myeloid leukemia in remission
871745|NCT00006042|adult acute lymphoblastic leukemia in remission|adult acute lymphoblastic leukemia in remission
871746|NCT00006042|childhood acute myeloid leukemia in remission|childhood acute myeloid leukemia in remission
875187|NCT00003329|stage IIIB breast cancer|stage iiib breast cancer
871747|NCT00006042|childhood acute lymphoblastic leukemia in remission|childhood acute lymphoblastic leukemia in remission
871748|NCT00006042|recurrent/refractory childhood Hodgkin lymphoma|recurrent/refractory childhood hodgkin lymphoma
871749|NCT00006042|stage II adult lymphoblastic lymphoma|stage ii adult lymphoblastic lymphoma
871750|NCT00006042|stage III grade 3 follicular lymphoma|stage iii grade 3 follicular lymphoma
871751|NCT00006042|stage III adult diffuse mixed cell lymphoma|stage iii adult diffuse mixed cell lymphoma
871752|NCT00006042|stage III adult diffuse large cell lymphoma|stage iii adult diffuse large cell lymphoma
871753|NCT00006042|stage III adult immunoblastic large cell lymphoma|stage iii adult immunoblastic large cell lymphoma
871754|NCT00006042|stage III adult lymphoblastic lymphoma|stage iii adult lymphoblastic lymphoma
871755|NCT00006042|stage III adult Burkitt lymphoma|stage iii adult burkitt lymphoma
871756|NCT00006042|stage IV grade 1 follicular lymphoma|stage iv grade 1 follicular lymphoma
871757|NCT00006042|stage IV grade 2 follicular lymphoma|stage iv grade 2 follicular lymphoma
871758|NCT00006042|stage IV grade 3 follicular lymphoma|stage iv grade 3 follicular lymphoma
871759|NCT00006042|stage IV adult diffuse mixed cell lymphoma|stage iv adult diffuse mixed cell lymphoma
871760|NCT00006042|stage IV adult diffuse large cell lymphoma|stage iv adult diffuse large cell lymphoma
871761|NCT00006042|stage IV adult immunoblastic large cell lymphoma|stage iv adult immunoblastic large cell lymphoma
871762|NCT00006042|stage IV adult lymphoblastic lymphoma|stage iv adult lymphoblastic lymphoma
871763|NCT00006042|stage IV adult Burkitt lymphoma|stage iv adult burkitt lymphoma
871764|NCT00006042|recurrent grade 1 follicular lymphoma|recurrent grade 1 follicular lymphoma
871765|NCT00006042|recurrent grade 2 follicular lymphoma|recurrent grade 2 follicular lymphoma
871766|NCT00006042|recurrent grade 3 follicular lymphoma|recurrent grade 3 follicular lymphoma
871767|NCT00006042|recurrent adult diffuse small cleaved cell lymphoma|recurrent adult diffuse small cleaved cell lymphoma
871768|NCT00006042|recurrent adult diffuse mixed cell lymphoma|recurrent adult diffuse mixed cell lymphoma
871769|NCT00006042|recurrent adult diffuse large cell lymphoma|recurrent adult diffuse large cell lymphoma
871770|NCT00006042|recurrent adult immunoblastic large cell lymphoma|recurrent adult immunoblastic large cell lymphoma
871771|NCT00006042|recurrent adult lymphoblastic lymphoma|recurrent adult lymphoblastic lymphoma
871772|NCT00006042|recurrent adult Burkitt lymphoma|recurrent adult burkitt lymphoma
871773|NCT00006042|de novo myelodysplastic syndromes|de novo myelodysplastic syndromes
871774|NCT00006042|previously treated myelodysplastic syndromes|previously treated myelodysplastic syndromes
871775|NCT00006042|secondary myelodysplastic syndromes|secondary myelodysplastic syndromes
871776|NCT00006042|recurrent childhood small noncleaved cell lymphoma|recurrent childhood small noncleaved cell lymphoma
871777|NCT00006042|recurrent childhood large cell lymphoma|recurrent childhood large cell lymphoma
871778|NCT00006042|noncontiguous stage II grade 3 follicular lymphoma|noncontiguous stage ii grade 3 follicular lymphoma
871779|NCT00006042|noncontiguous stage II mantle cell lymphoma|noncontiguous stage ii mantle cell lymphoma
871780|NCT00006042|noncontiguous stage II adult diffuse mixed cell lymphoma|noncontiguous stage ii adult diffuse mixed cell lymphoma
871781|NCT00006042|noncontiguous stage II adult immunoblastic large cell lymphoma|noncontiguous stage ii adult immunoblastic large cell lymphoma
871782|NCT00006042|noncontiguous stage II adult diffuse large cell lymphoma|noncontiguous stage ii adult diffuse large cell lymphoma
871783|NCT00006042|noncontiguous stage II adult Burkitt lymphoma|noncontiguous stage ii adult burkitt lymphoma
871784|NCT00006042|noncontiguous stage II adult lymphoblastic lymphoma|noncontiguous stage ii adult lymphoblastic lymphoma
871785|NCT00006042|stage III mantle cell lymphoma|stage iii mantle cell lymphoma
871786|NCT00006042|stage IV mantle cell lymphoma|stage iv mantle cell lymphoma
871787|NCT00006042|recurrent mantle cell lymphoma|recurrent mantle cell lymphoma
877764|NCT00001435|Depression|depression
871788|NCT00006042|childhood chronic myelogenous leukemia|childhood chronic myelogenous leukemia
871789|NCT00006042|atypical chronic myeloid leukemia|atypical chronic myeloid leukemia
871790|NCT00006042|myelodysplastic/myeloproliferative disease, unclassifiable|myelodysplastic/myeloproliferative disease, unclassifiable
871791|NCT00006042|recurrent marginal zone lymphoma|recurrent marginal zone lymphoma
871792|NCT00006042|recurrent small lymphocytic lymphoma|recurrent small lymphocytic lymphoma
871793|NCT00006042|stage III small lymphocytic lymphoma|stage iii small lymphocytic lymphoma
871794|NCT00006042|stage III marginal zone lymphoma|stage iii marginal zone lymphoma
871795|NCT00006042|stage IV small lymphocytic lymphoma|stage iv small lymphocytic lymphoma
871796|NCT00006042|stage IV marginal zone lymphoma|stage iv marginal zone lymphoma
871797|NCT00006042|extranodal marginal zone B-cell lymphoma of mucosa-associated lymphoid tissue|extranodal marginal zone b-cell lymphoma of mucosa-associated lymphoid tissue
871798|NCT00006042|nodal marginal zone B-cell lymphoma|nodal marginal zone b-cell lymphoma
871799|NCT00006042|splenic marginal zone lymphoma|splenic marginal zone lymphoma
871800|NCT00006042|adult acute myeloid leukemia with t(8;21)(q22;q22)|adult acute myeloid leukemia with t(8;21)(q22;q22)
871801|NCT00006042|adult acute myeloid leukemia with t(16;16)(p13;q22)|adult acute myeloid leukemia with t(16;16)(p13;q22)
871802|NCT00006042|adult acute myeloid leukemia with inv(16)(p13;q22)|adult acute myeloid leukemia with inv(16)(p13;q22)
871803|NCT00006042|adult acute myeloid leukemia with 11q23 (MLL) abnormalities|adult acute myeloid leukemia with 11q23 (mll) abnormalities
871804|NCT00006042|adult acute myeloid leukemia with t(15;17)(q22;q12)|adult acute myeloid leukemia with t(15;17)(q22;q12)
871805|NCT00006042|childhood myelodysplastic syndromes|childhood myelodysplastic syndromes
871806|NCT00006040|recurrent adult acute myeloid leukemia|recurrent adult acute myeloid leukemia
871807|NCT00006040|recurrent adult acute lymphoblastic leukemia|recurrent adult acute lymphoblastic leukemia
871808|NCT00006040|relapsing chronic myelogenous leukemia|relapsing chronic myelogenous leukemia
871809|NCT00006040|accelerated phase chronic myelogenous leukemia|accelerated phase chronic myelogenous leukemia
871810|NCT00006040|blastic phase chronic myelogenous leukemia|blastic phase chronic myelogenous leukemia
871811|NCT00006040|previously treated myelodysplastic syndromes|previously treated myelodysplastic syndromes
871812|NCT00006040|atypical chronic myeloid leukemia, BCR-ABL1 negative|atypical chronic myeloid leukemia, bcr-abl1 negative
871813|NCT00006040|myelodysplastic/myeloproliferative neoplasm, unclassifiable|myelodysplastic/myeloproliferative neoplasm, unclassifiable
871814|NCT00006029|recurrent adult Hodgkin lymphoma|recurrent adult hodgkin lymphoma
871815|NCT00006029|recurrent/refractory childhood Hodgkin lymphoma|recurrent/refractory childhood hodgkin lymphoma
871816|NCT00006028|recurrent ovarian epithelial cancer|recurrent ovarian epithelial cancer
871817|NCT00006028|primary peritoneal cavity cancer|primary peritoneal cavity cancer
871818|NCT00006027|stage I endometrial carcinoma|stage i endometrial carcinoma
871819|NCT00006027|stage II endometrial carcinoma|stage ii endometrial carcinoma
871820|NCT00006027|endometrial adenocarcinoma|endometrial adenocarcinoma
871821|NCT00006027|endometrial adenosquamous cell carcinoma|endometrial adenosquamous cell carcinoma
871822|NCT00006027|endometrial adenoacanthoma|endometrial adenoacanthoma
871823|NCT00006027|endometrial clear cell carcinoma|endometrial clear cell carcinoma
871824|NCT00006027|endometrial papillary serous carcinoma|endometrial papillary serous carcinoma
871825|NCT00006025|recurrent adult brain tumor|recurrent adult brain tumor
871826|NCT00006025|adult glioblastoma|adult glioblastoma
871827|NCT00006025|adult anaplastic astrocytoma|adult anaplastic astrocytoma
871828|NCT00006025|adult anaplastic oligodendroglioma|adult anaplastic oligodendroglioma
871829|NCT00006025|adult mixed glioma|adult mixed glioma
871830|NCT00006025|adult giant cell glioblastoma|adult giant cell glioblastoma
871831|NCT00006025|adult gliosarcoma|adult gliosarcoma
871832|NCT00006024|childhood high-grade cerebral astrocytoma|childhood high-grade cerebral astrocytoma
871833|NCT00006022|stage III renal cell cancer|stage iii renal cell cancer
871834|NCT00006022|stage IV renal cell cancer|stage iv renal cell cancer
871835|NCT00006022|recurrent renal cell cancer|recurrent renal cell cancer
871836|NCT00006022|stage III melanoma|stage iii melanoma
871837|NCT00006022|stage IV melanoma|stage iv melanoma
871838|NCT00006022|recurrent melanoma|recurrent melanoma
871839|NCT00006021|refractory multiple myeloma|refractory multiple myeloma
871840|NCT00006021|stage II multiple myeloma|stage ii multiple myeloma
871841|NCT00006021|stage III multiple myeloma|stage iii multiple myeloma
871842|NCT00006020|recurrent adult acute lymphoblastic leukemia|recurrent adult acute lymphoblastic leukemia
871843|NCT00006020|L1 adult acute lymphoblastic leukemia|l1 adult acute lymphoblastic leukemia
871844|NCT00006020|L2 adult acute lymphoblastic leukemia|l2 adult acute lymphoblastic leukemia
871845|NCT00006020|B-cell adult acute lymphoblastic leukemia|b-cell adult acute lymphoblastic leukemia
871846|NCT00006020|non-T, non-B adult acute lymphoblastic leukemia|non-t, non-b adult acute lymphoblastic leukemia
871847|NCT00006017|recurrent non-small cell lung cancer|recurrent non-small cell lung cancer
871848|NCT00006017|stage IIIB non-small cell lung cancer|stage iiib non-small cell lung cancer
871849|NCT00006017|stage IV non-small cell lung cancer|stage iv non-small cell lung cancer
871850|NCT00006015|stage IV colon cancer|stage iv colon cancer
871851|NCT00006015|stage IV rectal cancer|stage iv rectal cancer
871852|NCT00006015|recurrent colon cancer|recurrent colon cancer
871853|NCT00006015|recurrent rectal cancer|recurrent rectal cancer
871854|NCT00006015|adenocarcinoma of the colon|adenocarcinoma of the colon
871855|NCT00006015|adenocarcinoma of the rectum|adenocarcinoma of the rectum
877870|NCT00001375|Synovitis|synovitis
871856|NCT00006010|localized unresectable adult primary liver cancer|localized unresectable adult primary liver cancer
871857|NCT00006010|advanced adult primary liver cancer|advanced adult primary liver cancer
871858|NCT00006010|recurrent adult primary liver cancer|recurrent adult primary liver cancer
871859|NCT00006010|adult primary hepatocellular carcinoma|adult primary hepatocellular carcinoma
871860|NCT00006007|stage IV breast cancer|stage iv breast cancer
871861|NCT00006007|recurrent breast cancer|recurrent breast cancer
871862|NCT00006006|localized unresectable adult primary liver cancer|localized unresectable adult primary liver cancer
871863|NCT00006006|advanced adult primary liver cancer|advanced adult primary liver cancer
871864|NCT00006006|recurrent adult primary liver cancer|recurrent adult primary liver cancer
871865|NCT00006006|adult primary hepatocellular carcinoma|adult primary hepatocellular carcinoma
871866|NCT00006005|stage I uterine sarcoma|stage i uterine sarcoma
871867|NCT00006005|stage II uterine sarcoma|stage ii uterine sarcoma
871868|NCT00006005|stage III uterine sarcoma|stage iii uterine sarcoma
871869|NCT00006005|stage IV uterine sarcoma|stage iv uterine sarcoma
871870|NCT00006005|recurrent uterine sarcoma|recurrent uterine sarcoma
871871|NCT00006005|uterine carcinosarcoma|uterine carcinosarcoma
871872|NCT00006005|uterine leiomyosarcoma|uterine leiomyosarcoma
871873|NCT00006005|endometrial stromal sarcoma|endometrial stromal sarcoma
871874|NCT00006004|recurrent non-small cell lung cancer|recurrent non-small cell lung cancer
871875|NCT00006004|squamous cell lung cancer|squamous cell lung cancer
871876|NCT00006004|large cell lung cancer|large cell lung cancer
871877|NCT00006004|stage IIIB non-small cell lung cancer|stage iiib non-small cell lung cancer
871878|NCT00006004|stage IV non-small cell lung cancer|stage iv non-small cell lung cancer
871879|NCT00006004|adenocarcinoma of the lung|adenocarcinoma of the lung
871880|NCT00006004|adenosquamous cell lung cancer|adenosquamous cell lung cancer
871881|NCT00006004|bronchoalveolar cell lung cancer|bronchoalveolar cell lung cancer
871882|NCT00005997|localized unresectable adult primary liver cancer|localized unresectable adult primary liver cancer
871883|NCT00005997|advanced adult primary liver cancer|advanced adult primary liver cancer
871884|NCT00005997|unresectable gallbladder cancer|unresectable gallbladder cancer
871885|NCT00005997|unresectable extrahepatic bile duct cancer|unresectable extrahepatic bile duct cancer
871886|NCT00005997|adult primary hepatocellular carcinoma|adult primary hepatocellular carcinoma
871887|NCT00005997|cholangiocarcinoma of the gallbladder|cholangiocarcinoma of the gallbladder
871888|NCT00005997|cholangiocarcinoma of the extrahepatic bile duct|cholangiocarcinoma of the extrahepatic bile duct
871889|NCT00005997|adult primary cholangiocellular carcinoma|adult primary cholangiocellular carcinoma
871890|NCT00005990|unspecified adult solid tumor, protocol specific|unspecified adult solid tumor, protocol specific
871891|NCT00005987|stage I multiple myeloma|stage i multiple myeloma
871892|NCT00005987|stage II multiple myeloma|stage ii multiple myeloma
871893|NCT00005987|stage III multiple myeloma|stage iii multiple myeloma
871894|NCT00005985|stage I adult Hodgkin lymphoma|stage i adult hodgkin lymphoma
871895|NCT00005985|stage II adult Hodgkin lymphoma|stage ii adult hodgkin lymphoma
871896|NCT00005985|stage III adult Hodgkin lymphoma|stage iii adult hodgkin lymphoma
871897|NCT00005985|stage IV adult Hodgkin lymphoma|stage iv adult hodgkin lymphoma
871898|NCT00005985|recurrent adult Hodgkin lymphoma|recurrent adult hodgkin lymphoma
871899|NCT00005985|stage I grade 1 follicular lymphoma|stage i grade 1 follicular lymphoma
871900|NCT00005985|stage I grade 2 follicular lymphoma|stage i grade 2 follicular lymphoma
871901|NCT00005985|stage I grade 3 follicular lymphoma|stage i grade 3 follicular lymphoma
871902|NCT00005985|stage I adult diffuse small cleaved cell lymphoma|stage i adult diffuse small cleaved cell lymphoma
871903|NCT00005985|stage I adult diffuse mixed cell lymphoma|stage i adult diffuse mixed cell lymphoma
871904|NCT00005985|stage I adult diffuse large cell lymphoma|stage i adult diffuse large cell lymphoma
871905|NCT00005985|stage I adult immunoblastic large cell lymphoma|stage i adult immunoblastic large cell lymphoma
871906|NCT00005985|stage I adult lymphoblastic lymphoma|stage i adult lymphoblastic lymphoma
871907|NCT00005985|stage I adult Burkitt lymphoma|stage i adult burkitt lymphoma
871908|NCT00005985|stage III grade 1 follicular lymphoma|stage iii grade 1 follicular lymphoma
871909|NCT00005985|stage III grade 2 follicular lymphoma|stage iii grade 2 follicular lymphoma
871910|NCT00005985|stage III grade 3 follicular lymphoma|stage iii grade 3 follicular lymphoma
871911|NCT00005985|stage III adult diffuse small cleaved cell lymphoma|stage iii adult diffuse small cleaved cell lymphoma
871912|NCT00005985|stage III adult diffuse mixed cell lymphoma|stage iii adult diffuse mixed cell lymphoma
871913|NCT00005985|stage III adult diffuse large cell lymphoma|stage iii adult diffuse large cell lymphoma
871914|NCT00005985|stage III adult immunoblastic large cell lymphoma|stage iii adult immunoblastic large cell lymphoma
871915|NCT00005985|stage III adult lymphoblastic lymphoma|stage iii adult lymphoblastic lymphoma
871916|NCT00005985|stage III adult Burkitt lymphoma|stage iii adult burkitt lymphoma
871917|NCT00005985|stage IV grade 1 follicular lymphoma|stage iv grade 1 follicular lymphoma
871918|NCT00005985|stage IV grade 2 follicular lymphoma|stage iv grade 2 follicular lymphoma
871919|NCT00005985|stage IV grade 3 follicular lymphoma|stage iv grade 3 follicular lymphoma
871920|NCT00005985|stage IV adult diffuse small cleaved cell lymphoma|stage iv adult diffuse small cleaved cell lymphoma
871921|NCT00005985|stage IV adult diffuse mixed cell lymphoma|stage iv adult diffuse mixed cell lymphoma
871922|NCT00005985|stage IV adult diffuse large cell lymphoma|stage iv adult diffuse large cell lymphoma
871923|NCT00005985|stage IV adult immunoblastic large cell lymphoma|stage iv adult immunoblastic large cell lymphoma
871924|NCT00005985|stage IV adult lymphoblastic lymphoma|stage iv adult lymphoblastic lymphoma
871925|NCT00005985|stage IV adult Burkitt lymphoma|stage iv adult burkitt lymphoma
871926|NCT00005985|recurrent grade 1 follicular lymphoma|recurrent grade 1 follicular lymphoma
871927|NCT00005985|recurrent grade 2 follicular lymphoma|recurrent grade 2 follicular lymphoma
871928|NCT00005985|recurrent grade 3 follicular lymphoma|recurrent grade 3 follicular lymphoma
871929|NCT00005985|recurrent adult diffuse small cleaved cell lymphoma|recurrent adult diffuse small cleaved cell lymphoma
871930|NCT00005985|recurrent adult diffuse mixed cell lymphoma|recurrent adult diffuse mixed cell lymphoma
871931|NCT00005985|recurrent adult diffuse large cell lymphoma|recurrent adult diffuse large cell lymphoma
871932|NCT00005985|recurrent adult immunoblastic large cell lymphoma|recurrent adult immunoblastic large cell lymphoma
871933|NCT00005985|recurrent adult lymphoblastic lymphoma|recurrent adult lymphoblastic lymphoma
871934|NCT00005985|recurrent adult Burkitt lymphoma|recurrent adult burkitt lymphoma
871935|NCT00005985|stage I adult T-cell leukemia/lymphoma|stage i adult t-cell leukemia/lymphoma
871936|NCT00005985|stage II adult T-cell leukemia/lymphoma|stage ii adult t-cell leukemia/lymphoma
871937|NCT00005985|stage III adult T-cell leukemia/lymphoma|stage iii adult t-cell leukemia/lymphoma
871938|NCT00005985|stage IV adult T-cell leukemia/lymphoma|stage iv adult t-cell leukemia/lymphoma
871939|NCT00005985|recurrent adult T-cell leukemia/lymphoma|recurrent adult t-cell leukemia/lymphoma
871940|NCT00005985|contiguous stage II grade 1 follicular lymphoma|contiguous stage ii grade 1 follicular lymphoma
871941|NCT00005985|contiguous stage II grade 2 follicular lymphoma|contiguous stage ii grade 2 follicular lymphoma
871942|NCT00005985|contiguous stage II grade 3 follicular lymphoma|contiguous stage ii grade 3 follicular lymphoma
871943|NCT00005985|contiguous stage II adult diffuse small cleaved cell lymphoma|contiguous stage ii adult diffuse small cleaved cell lymphoma
871944|NCT00005985|contiguous stage II adult diffuse mixed cell lymphoma|contiguous stage ii adult diffuse mixed cell lymphoma
871945|NCT00005985|contiguous stage II adult immunoblastic large cell lymphoma|contiguous stage ii adult immunoblastic large cell lymphoma
871946|NCT00005985|contiguous stage II adult diffuse large cell lymphoma|contiguous stage ii adult diffuse large cell lymphoma
871947|NCT00005985|contiguous stage II adult Burkitt lymphoma|contiguous stage ii adult burkitt lymphoma
871948|NCT00005985|contiguous stage II adult lymphoblastic lymphoma|contiguous stage ii adult lymphoblastic lymphoma
871949|NCT00005985|noncontiguous stage II grade 1 follicular lymphoma|noncontiguous stage ii grade 1 follicular lymphoma
871950|NCT00005985|noncontiguous stage II grade 2 follicular lymphoma|noncontiguous stage ii grade 2 follicular lymphoma
871951|NCT00005985|noncontiguous stage II grade 3 follicular lymphoma|noncontiguous stage ii grade 3 follicular lymphoma
871952|NCT00005985|noncontiguous stage II adult diffuse small cleaved cell lymphoma|noncontiguous stage ii adult diffuse small cleaved cell lymphoma
871953|NCT00005985|noncontiguous stage II adult diffuse mixed cell lymphoma|noncontiguous stage ii adult diffuse mixed cell lymphoma
871954|NCT00005985|noncontiguous stage II adult immunoblastic large cell lymphoma|noncontiguous stage ii adult immunoblastic large cell lymphoma
871955|NCT00005985|noncontiguous stage II adult diffuse large cell lymphoma|noncontiguous stage ii adult diffuse large cell lymphoma
871956|NCT00005985|noncontiguous stage II adult Burkitt lymphoma|noncontiguous stage ii adult burkitt lymphoma
871957|NCT00005985|noncontiguous stage II adult lymphoblastic lymphoma|noncontiguous stage ii adult lymphoblastic lymphoma
871958|NCT00005985|contiguous stage II small lymphocytic lymphoma|contiguous stage ii small lymphocytic lymphoma
871959|NCT00005985|noncontiguous stage II small lymphocytic lymphoma|noncontiguous stage ii small lymphocytic lymphoma
871960|NCT00005985|recurrent small lymphocytic lymphoma|recurrent small lymphocytic lymphoma
871961|NCT00005985|stage I small lymphocytic lymphoma|stage i small lymphocytic lymphoma
871962|NCT00005985|stage III small lymphocytic lymphoma|stage iii small lymphocytic lymphoma
871963|NCT00005985|stage IV small lymphocytic lymphoma|stage iv small lymphocytic lymphoma
871964|NCT00005984|chronic phase myelogenous leukemia|chronic phase myelogenous leukemia
871965|NCT00005984|accelerated phase myelogenous leukemia|accelerated phase myelogenous leukemia
871966|NCT00005983|stage II breast cancer|stage ii breast cancer
871967|NCT00005981|stage IV colon cancer|stage iv colon cancer
871968|NCT00005981|stage IV rectal cancer|stage iv rectal cancer
871969|NCT00005981|recurrent colon cancer|recurrent colon cancer
871970|NCT00005981|recurrent rectal cancer|recurrent rectal cancer
871971|NCT00005980|stage IV breast cancer|stage iv breast cancer
871972|NCT00005980|recurrent breast cancer|recurrent breast cancer
871973|NCT00005979|stage III colon cancer|stage iii colon cancer
871974|NCT00005979|adenocarcinoma of the colon|adenocarcinoma of the colon
871975|NCT00005976|recurrent adult brain tumor|recurrent adult brain tumor
871976|NCT00005976|adult glioblastoma|adult glioblastoma
871977|NCT00005976|adult anaplastic astrocytoma|adult anaplastic astrocytoma
871978|NCT00005976|adult anaplastic oligodendroglioma|adult anaplastic oligodendroglioma
871979|NCT00005976|adult mixed glioma|adult mixed glioma
871980|NCT00005976|adult oligodendroglioma|adult oligodendroglioma
871981|NCT00005976|adult giant cell glioblastoma|adult giant cell glioblastoma
871982|NCT00005976|adult gliosarcoma|adult gliosarcoma
871983|NCT00005967|stage III adult Hodgkin lymphoma|stage iii adult hodgkin lymphoma
871984|NCT00005967|stage IV adult Hodgkin lymphoma|stage iv adult hodgkin lymphoma
871985|NCT00005967|recurrent adult Hodgkin lymphoma|recurrent adult hodgkin lymphoma
871986|NCT00005967|refractory multiple myeloma|refractory multiple myeloma
871987|NCT00005967|stage III multiple myeloma|stage iii multiple myeloma
871988|NCT00005967|stage III chronic lymphocytic leukemia|stage iii chronic lymphocytic leukemia
878289|NCT00050128|Frequency|frequency
871989|NCT00005967|stage IV chronic lymphocytic leukemia|stage iv chronic lymphocytic leukemia
871990|NCT00005967|recurrent adult acute myeloid leukemia|recurrent adult acute myeloid leukemia
871991|NCT00005967|recurrent adult acute lymphoblastic leukemia|recurrent adult acute lymphoblastic leukemia
871992|NCT00005967|relapsing chronic myelogenous leukemia|relapsing chronic myelogenous leukemia
871993|NCT00005967|refractory chronic lymphocytic leukemia|refractory chronic lymphocytic leukemia
871994|NCT00005967|chronic phase chronic myelogenous leukemia|chronic phase chronic myelogenous leukemia
871995|NCT00005967|accelerated phase chronic myelogenous leukemia|accelerated phase chronic myelogenous leukemia
871996|NCT00005967|blastic phase chronic myelogenous leukemia|blastic phase chronic myelogenous leukemia
871997|NCT00005967|refractory anemia with excess blasts|refractory anemia with excess blasts
871998|NCT00005967|refractory anemia with excess blasts in transformation|refractory anemia with excess blasts in transformation
871999|NCT00005967|chronic myelomonocytic leukemia|chronic myelomonocytic leukemia
872000|NCT00005967|stage III grade 1 follicular lymphoma|stage iii grade 1 follicular lymphoma
872001|NCT00005967|stage III grade 2 follicular lymphoma|stage iii grade 2 follicular lymphoma
872002|NCT00005967|stage III grade 3 follicular lymphoma|stage iii grade 3 follicular lymphoma
872003|NCT00005967|stage III adult diffuse small cleaved cell lymphoma|stage iii adult diffuse small cleaved cell lymphoma
872004|NCT00005967|stage III adult diffuse mixed cell lymphoma|stage iii adult diffuse mixed cell lymphoma
872005|NCT00005967|stage III adult diffuse large cell lymphoma|stage iii adult diffuse large cell lymphoma
872006|NCT00005967|stage III adult immunoblastic large cell lymphoma|stage iii adult immunoblastic large cell lymphoma
872007|NCT00005967|stage III adult lymphoblastic lymphoma|stage iii adult lymphoblastic lymphoma
872008|NCT00005967|stage III adult Burkitt lymphoma|stage iii adult burkitt lymphoma
872009|NCT00005967|stage IV grade 1 follicular lymphoma|stage iv grade 1 follicular lymphoma
872010|NCT00005967|stage IV grade 2 follicular lymphoma|stage iv grade 2 follicular lymphoma
872011|NCT00005967|stage IV grade 3 follicular lymphoma|stage iv grade 3 follicular lymphoma
872012|NCT00005967|stage IV adult diffuse small cleaved cell lymphoma|stage iv adult diffuse small cleaved cell lymphoma
872013|NCT00005967|stage IV adult diffuse mixed cell lymphoma|stage iv adult diffuse mixed cell lymphoma
872014|NCT00005967|stage IV adult diffuse large cell lymphoma|stage iv adult diffuse large cell lymphoma
872015|NCT00005967|stage IV adult immunoblastic large cell lymphoma|stage iv adult immunoblastic large cell lymphoma
872016|NCT00005967|stage IV adult lymphoblastic lymphoma|stage iv adult lymphoblastic lymphoma
872017|NCT00005967|stage IV adult Burkitt lymphoma|stage iv adult burkitt lymphoma
872018|NCT00005967|recurrent grade 1 follicular lymphoma|recurrent grade 1 follicular lymphoma
872019|NCT00005967|recurrent grade 2 follicular lymphoma|recurrent grade 2 follicular lymphoma
872020|NCT00005967|recurrent grade 3 follicular lymphoma|recurrent grade 3 follicular lymphoma
872021|NCT00005967|recurrent adult diffuse small cleaved cell lymphoma|recurrent adult diffuse small cleaved cell lymphoma
872022|NCT00005967|recurrent adult diffuse mixed cell lymphoma|recurrent adult diffuse mixed cell lymphoma
872023|NCT00005967|recurrent adult diffuse large cell lymphoma|recurrent adult diffuse large cell lymphoma
872024|NCT00005967|recurrent adult immunoblastic large cell lymphoma|recurrent adult immunoblastic large cell lymphoma
872025|NCT00005967|recurrent adult lymphoblastic lymphoma|recurrent adult lymphoblastic lymphoma
872026|NCT00005967|recurrent adult Burkitt lymphoma|recurrent adult burkitt lymphoma
872027|NCT00005967|previously treated myelodysplastic syndromes|previously treated myelodysplastic syndromes
872028|NCT00005967|secondary myelodysplastic syndromes|secondary myelodysplastic syndromes
872029|NCT00005967|stage III mantle cell lymphoma|stage iii mantle cell lymphoma
872030|NCT00005967|stage IV mantle cell lymphoma|stage iv mantle cell lymphoma
872031|NCT00005967|recurrent mantle cell lymphoma|recurrent mantle cell lymphoma
872032|NCT00005967|polycythemia vera|polycythemia vera
872033|NCT00005967|primary myelofibrosis|primary myelofibrosis
872034|NCT00005967|essential thrombocythemia|essential thrombocythemia
872035|NCT00005967|chronic eosinophilic leukemia|chronic eosinophilic leukemia
872036|NCT00005967|chronic neutrophilic leukemia|chronic neutrophilic leukemia
872037|NCT00005967|recurrent marginal zone lymphoma|recurrent marginal zone lymphoma
872038|NCT00005967|recurrent small lymphocytic lymphoma|recurrent small lymphocytic lymphoma
872039|NCT00005967|stage III small lymphocytic lymphoma|stage iii small lymphocytic lymphoma
872040|NCT00005967|stage III marginal zone lymphoma|stage iii marginal zone lymphoma
872041|NCT00005967|stage IV small lymphocytic lymphoma|stage iv small lymphocytic lymphoma
872042|NCT00005967|stage IV marginal zone lymphoma|stage iv marginal zone lymphoma
872043|NCT00005967|extranodal marginal zone B-cell lymphoma of mucosa-associated lymphoid tissue|extranodal marginal zone b-cell lymphoma of mucosa-associated lymphoid tissue
872044|NCT00005967|nodal marginal zone B-cell lymphoma|nodal marginal zone b-cell lymphoma
872045|NCT00005967|splenic marginal zone lymphoma|splenic marginal zone lymphoma
872046|NCT00005966|stage III renal cell cancer|stage iii renal cell cancer
872047|NCT00005966|stage IV renal cell cancer|stage iv renal cell cancer
872048|NCT00005961|stage III melanoma|stage iii melanoma
872049|NCT00005961|stage IV melanoma|stage iv melanoma
872050|NCT00005961|recurrent melanoma|recurrent melanoma
872051|NCT00005957|stage I breast cancer|stage i breast cancer
872052|NCT00005957|stage II breast cancer|stage ii breast cancer
872053|NCT00005955|childhood infratentorial ependymoma|childhood infratentorial ependymoma
872054|NCT00005955|childhood low-grade cerebral astrocytoma|childhood low-grade cerebral astrocytoma
872055|NCT00005955|childhood supratentorial ependymoma|childhood supratentorial ependymoma
872057|NCT00005955|localized resectable neuroblastoma|localized resectable neuroblastoma
872058|NCT00005955|regional neuroblastoma|regional neuroblastoma
872059|NCT00005955|disseminated neuroblastoma|disseminated neuroblastoma
872060|NCT00005955|stage 4S neuroblastoma|stage 4s neuroblastoma
872061|NCT00005955|childhood high-grade cerebral astrocytoma|childhood high-grade cerebral astrocytoma
872062|NCT00005955|childhood oligodendroglioma|childhood oligodendroglioma
872063|NCT00005955|childhood choroid plexus tumor|childhood choroid plexus tumor
872064|NCT00005955|childhood grade I meningioma|childhood grade i meningioma
872065|NCT00005955|childhood grade II meningioma|childhood grade ii meningioma
872066|NCT00005955|childhood grade III meningioma|childhood grade iii meningioma
872067|NCT00005955|untreated childhood supratentorial primitive neuroectodermal tumor|untreated childhood supratentorial primitive neuroectodermal tumor
872068|NCT00005955|untreated childhood cerebellar astrocytoma|untreated childhood cerebellar astrocytoma
872069|NCT00005955|untreated childhood medulloblastoma|untreated childhood medulloblastoma
872070|NCT00005955|untreated childhood visual pathway and hypothalamic glioma|untreated childhood visual pathway and hypothalamic glioma
872071|NCT00005955|newly diagnosed childhood ependymoma|newly diagnosed childhood ependymoma
872072|NCT00005955|childhood central nervous system choriocarcinoma|childhood central nervous system choriocarcinoma
872073|NCT00005955|childhood central nervous system embryonal tumor|childhood central nervous system embryonal tumor
872074|NCT00005955|childhood central nervous system mixed germ cell tumor|childhood central nervous system mixed germ cell tumor
872075|NCT00005955|childhood central nervous system teratoma|childhood central nervous system teratoma
872076|NCT00005955|childhood central nervous system yolk sac tumor|childhood central nervous system yolk sac tumor
872077|NCT00005954|adult tumors metastatic to brain|adult tumors metastatic to brain
872078|NCT00005952|childhood low-grade cerebral astrocytoma|childhood low-grade cerebral astrocytoma
872079|NCT00005952|recurrent childhood rhabdomyosarcoma|recurrent childhood rhabdomyosarcoma
872080|NCT00005952|childhood craniopharyngioma|childhood craniopharyngioma
872081|NCT00005952|disseminated neuroblastoma|disseminated neuroblastoma
872082|NCT00005952|stage 4S neuroblastoma|stage 4s neuroblastoma
872083|NCT00005952|recurrent neuroblastoma|recurrent neuroblastoma
872084|NCT00005952|stage IV Wilms tumor|stage iv wilms tumor
872085|NCT00005952|stage V Wilms tumor|stage v wilms tumor
875029|NCT00003458|Gliosarcoma|gliosarcoma
872086|NCT00005952|recurrent Wilms tumor and other childhood kidney tumors|recurrent wilms tumor and other childhood kidney tumors
872087|NCT00005952|childhood central nervous system germ cell tumor|childhood central nervous system germ cell tumor
872088|NCT00005952|stage III malignant testicular germ cell tumor|stage iii malignant testicular germ cell tumor
872089|NCT00005952|recurrent malignant testicular germ cell tumor|recurrent malignant testicular germ cell tumor
872090|NCT00005952|stage IV nasopharyngeal cancer|stage iv nasopharyngeal cancer
872091|NCT00005952|recurrent nasopharyngeal cancer|recurrent nasopharyngeal cancer
872092|NCT00005952|childhood germ cell tumor|childhood germ cell tumor
872093|NCT00005952|metastatic childhood soft tissue sarcoma|metastatic childhood soft tissue sarcoma
872094|NCT00005952|recurrent childhood soft tissue sarcoma|recurrent childhood soft tissue sarcoma
872095|NCT00005952|stage IV ovarian germ cell tumor|stage iv ovarian germ cell tumor
872096|NCT00005952|recurrent ovarian germ cell tumor|recurrent ovarian germ cell tumor
872097|NCT00005952|childhood high-grade cerebral astrocytoma|childhood high-grade cerebral astrocytoma
872098|NCT00005952|childhood oligodendroglioma|childhood oligodendroglioma
872099|NCT00005952|childhood choroid plexus tumor|childhood choroid plexus tumor
872100|NCT00005952|untreated childhood brain stem glioma|untreated childhood brain stem glioma
872101|NCT00005952|recurrent childhood brain stem glioma|recurrent childhood brain stem glioma
872102|NCT00005952|untreated childhood supratentorial primitive neuroectodermal tumor|untreated childhood supratentorial primitive neuroectodermal tumor
872103|NCT00005952|recurrent childhood supratentorial primitive neuroectodermal tumor|recurrent childhood supratentorial primitive neuroectodermal tumor
872104|NCT00005952|untreated childhood cerebellar astrocytoma|untreated childhood cerebellar astrocytoma
872105|NCT00005952|recurrent childhood cerebellar astrocytoma|recurrent childhood cerebellar astrocytoma
872106|NCT00005952|recurrent childhood cerebral astrocytoma|recurrent childhood cerebral astrocytoma
872107|NCT00005952|untreated childhood medulloblastoma|untreated childhood medulloblastoma
872108|NCT00005952|recurrent childhood medulloblastoma|recurrent childhood medulloblastoma
872109|NCT00005952|untreated childhood visual pathway and hypothalamic glioma|untreated childhood visual pathway and hypothalamic glioma
872110|NCT00005952|recurrent childhood visual pathway and hypothalamic glioma|recurrent childhood visual pathway and hypothalamic glioma
872111|NCT00005952|previously treated childhood rhabdomyosarcoma|previously treated childhood rhabdomyosarcoma
872112|NCT00005952|metastatic Ewing sarcoma/peripheral primitive neuroectodermal tumor|metastatic ewing sarcoma/peripheral primitive neuroectodermal tumor
872113|NCT00005952|recurrent Ewing sarcoma/peripheral primitive neuroectodermal tumor|recurrent ewing sarcoma/peripheral primitive neuroectodermal tumor
872114|NCT00005952|newly diagnosed childhood ependymoma|newly diagnosed childhood ependymoma
872115|NCT00005952|recurrent childhood ependymoma|recurrent childhood ependymoma
872116|NCT00005951|recurrent adult brain tumor|recurrent adult brain tumor
872117|NCT00005951|adult glioblastoma|adult glioblastoma
872118|NCT00005951|adult anaplastic astrocytoma|adult anaplastic astrocytoma
872119|NCT00005951|adult anaplastic oligodendroglioma|adult anaplastic oligodendroglioma
872120|NCT00005951|adult mixed glioma|adult mixed glioma
872121|NCT00005951|adult giant cell glioblastoma|adult giant cell glioblastoma
872123|NCT00005945|untreated childhood acute lymphoblastic leukemia|untreated childhood acute lymphoblastic leukemia
872124|NCT00005945|L1 childhood acute lymphoblastic leukemia|l1 childhood acute lymphoblastic leukemia
872125|NCT00005945|L2 childhood acute lymphoblastic leukemia|l2 childhood acute lymphoblastic leukemia
872126|NCT00005945|L3 childhood acute lymphoblastic leukemia|l3 childhood acute lymphoblastic leukemia
872127|NCT00005941|stage III cervical cancer|stage iii cervical cancer
872128|NCT00005941|recurrent cervical cancer|recurrent cervical cancer
872129|NCT00005941|stage IVB cervical cancer|stage ivb cervical cancer
872130|NCT00005941|stage IVA cervical cancer|stage iva cervical cancer
872131|NCT00005941|stage III vaginal cancer|stage iii vaginal cancer
872132|NCT00005941|stage IVA vaginal cancer|stage iva vaginal cancer
872133|NCT00005941|stage IVB vaginal cancer|stage ivb vaginal cancer
872134|NCT00005941|recurrent vaginal cancer|recurrent vaginal cancer
872135|NCT00005879|breast cancer|breast cancer
872136|NCT00005878|esophageal cancer|esophageal cancer
872137|NCT00005867|stage I grade 3 follicular lymphoma|stage i grade 3 follicular lymphoma
872138|NCT00005867|stage I adult diffuse mixed cell lymphoma|stage i adult diffuse mixed cell lymphoma
872139|NCT00005867|stage I adult diffuse large cell lymphoma|stage i adult diffuse large cell lymphoma
872140|NCT00005867|stage I adult immunoblastic large cell lymphoma|stage i adult immunoblastic large cell lymphoma
872141|NCT00005867|stage III grade 3 follicular lymphoma|stage iii grade 3 follicular lymphoma
872142|NCT00005867|stage III adult diffuse mixed cell lymphoma|stage iii adult diffuse mixed cell lymphoma
872143|NCT00005867|stage III adult diffuse large cell lymphoma|stage iii adult diffuse large cell lymphoma
872144|NCT00005867|stage III adult immunoblastic large cell lymphoma|stage iii adult immunoblastic large cell lymphoma
875188|NCT00003329|stage IIIC breast cancer|stage iiic breast cancer
872145|NCT00005867|stage IV grade 3 follicular lymphoma|stage iv grade 3 follicular lymphoma
872146|NCT00005867|stage IV adult diffuse mixed cell lymphoma|stage iv adult diffuse mixed cell lymphoma
872147|NCT00005867|stage IV adult diffuse large cell lymphoma|stage iv adult diffuse large cell lymphoma
872148|NCT00005867|stage IV adult immunoblastic large cell lymphoma|stage iv adult immunoblastic large cell lymphoma
872149|NCT00005867|contiguous stage II grade 3 follicular lymphoma|contiguous stage ii grade 3 follicular lymphoma
872150|NCT00005867|contiguous stage II adult diffuse mixed cell lymphoma|contiguous stage ii adult diffuse mixed cell lymphoma
872151|NCT00005867|contiguous stage II adult immunoblastic large cell lymphoma|contiguous stage ii adult immunoblastic large cell lymphoma
872152|NCT00005867|contiguous stage II adult diffuse large cell lymphoma|contiguous stage ii adult diffuse large cell lymphoma
872153|NCT00005867|noncontiguous stage II grade 3 follicular lymphoma|noncontiguous stage ii grade 3 follicular lymphoma
872154|NCT00005867|noncontiguous stage II adult diffuse mixed cell lymphoma|noncontiguous stage ii adult diffuse mixed cell lymphoma
872155|NCT00005867|noncontiguous stage II adult immunoblastic large cell lymphoma|noncontiguous stage ii adult immunoblastic large cell lymphoma
872156|NCT00005867|noncontiguous stage II adult diffuse large cell lymphoma|noncontiguous stage ii adult diffuse large cell lymphoma
872157|NCT00005863|recurrent childhood acute myeloid leukemia|recurrent childhood acute myeloid leukemia
872158|NCT00005863|recurrent adult acute myeloid leukemia|recurrent adult acute myeloid leukemia
872159|NCT00005863|adult acute myeloid leukemia in remission|adult acute myeloid leukemia in remission
872160|NCT00005863|childhood acute myeloid leukemia in remission|childhood acute myeloid leukemia in remission
872161|NCT00005863|adult acute erythroid leukemia (M6)|adult acute erythroid leukemia (m6)
872162|NCT00005863|adult acute myeloblastic leukemia without maturation (M1)|adult acute myeloblastic leukemia without maturation (m1)
872163|NCT00005863|adult acute myeloblastic leukemia with maturation (M2)|adult acute myeloblastic leukemia with maturation (m2)
872164|NCT00005863|adult acute myelomonocytic leukemia (M4)|adult acute myelomonocytic leukemia (m4)
872165|NCT00005863|adult acute monoblastic leukemia (M5a)|adult acute monoblastic leukemia (m5a)
872166|NCT00005863|adult acute megakaryoblastic leukemia (M7)|adult acute megakaryoblastic leukemia (m7)
872167|NCT00005863|childhood acute myeloblastic leukemia without maturation (M1)|childhood acute myeloblastic leukemia without maturation (m1)
872168|NCT00005863|childhood acute myeloblastic leukemia with maturation (M2)|childhood acute myeloblastic leukemia with maturation (m2)
872169|NCT00005863|childhood acute myelomonocytic leukemia (M4)|childhood acute myelomonocytic leukemia (m4)
872170|NCT00005863|childhood acute monoblastic leukemia (M5a)|childhood acute monoblastic leukemia (m5a)
872171|NCT00005863|childhood acute monocytic leukemia (M5b)|childhood acute monocytic leukemia (m5b)
872172|NCT00005863|childhood acute erythroleukemia (M6)|childhood acute erythroleukemia (m6)
872173|NCT00005863|childhood acute megakaryocytic leukemia (M7)|childhood acute megakaryocytic leukemia (m7)
872174|NCT00005863|secondary acute myeloid leukemia|secondary acute myeloid leukemia
872175|NCT00005863|de novo myelodysplastic syndromes|de novo myelodysplastic syndromes
872176|NCT00005863|adult acute monocytic leukemia (M5b)|adult acute monocytic leukemia (m5b)
872177|NCT00005863|previously treated myelodysplastic syndromes|previously treated myelodysplastic syndromes
872178|NCT00005863|secondary myelodysplastic syndromes|secondary myelodysplastic syndromes
872179|NCT00005863|adult acute minimally differentiated myeloid leukemia (M0)|adult acute minimally differentiated myeloid leukemia (m0)
872180|NCT00005863|childhood acute minimally differentiated myeloid leukemia (M0)|childhood acute minimally differentiated myeloid leukemia (m0)
872181|NCT00005863|atypical chronic myeloid leukemia, BCR-ABL1 negative|atypical chronic myeloid leukemia, bcr-abl1 negative
872182|NCT00005863|myelodysplastic/myeloproliferative neoplasm, unclassifiable|myelodysplastic/myeloproliferative neoplasm, unclassifiable
872183|NCT00005863|adult acute myeloid leukemia with 11q23 (MLL) abnormalities|adult acute myeloid leukemia with 11q23 (mll) abnormalities
872184|NCT00005863|adult acute myeloid leukemia with inv(16)(p13;q22)|adult acute myeloid leukemia with inv(16)(p13;q22)
872185|NCT00005863|adult acute myeloid leukemia with t(16;16)(p13;q22)|adult acute myeloid leukemia with t(16;16)(p13;q22)
872186|NCT00005863|adult acute myeloid leukemia with t(8;21)(q22;q22)|adult acute myeloid leukemia with t(8;21)(q22;q22)
872187|NCT00005863|childhood myelodysplastic syndromes|childhood myelodysplastic syndromes
872188|NCT00005859|recurrent adult brain tumor|recurrent adult brain tumor
872189|NCT00005859|adult glioblastoma|adult glioblastoma
872190|NCT00005859|adult giant cell glioblastoma|adult giant cell glioblastoma
872191|NCT00005859|adult gliosarcoma|adult gliosarcoma
872192|NCT00005858|stage III colon cancer|stage iii colon cancer
872193|NCT00005858|stage IV colon cancer|stage iv colon cancer
872194|NCT00005858|stage IV breast cancer|stage iv breast cancer
872195|NCT00005858|stage IIIA breast cancer|stage iiia breast cancer
872196|NCT00005858|recurrent breast cancer|recurrent breast cancer
872197|NCT00005858|stage IIIB breast cancer|stage iiib breast cancer
872198|NCT00005858|recurrent non-small cell lung cancer|recurrent non-small cell lung cancer
872199|NCT00005858|stage II pancreatic cancer|stage ii pancreatic cancer
872200|NCT00005858|stage III pancreatic cancer|stage iii pancreatic cancer
872201|NCT00005858|recurrent pancreatic cancer|recurrent pancreatic cancer
872202|NCT00005858|recurrent colon cancer|recurrent colon cancer
872203|NCT00005858|stage III ovarian epithelial cancer|stage iii ovarian epithelial cancer
872204|NCT00005858|stage IV ovarian epithelial cancer|stage iv ovarian epithelial cancer
872205|NCT00005858|recurrent ovarian epithelial cancer|recurrent ovarian epithelial cancer
872206|NCT00005858|stage III bladder cancer|stage iii bladder cancer
872207|NCT00005858|recurrent bladder cancer|recurrent bladder cancer
872209|NCT00005858|stage IIIA non-small cell lung cancer|stage iiia non-small cell lung cancer
872210|NCT00005858|stage IIIB non-small cell lung cancer|stage iiib non-small cell lung cancer
872211|NCT00005858|stage IV non-small cell lung cancer|stage iv non-small cell lung cancer
872212|NCT00005858|ovarian stromal cancer|ovarian stromal cancer
872213|NCT00005858|stage III ovarian germ cell tumor|stage iii ovarian germ cell tumor
872214|NCT00005858|stage IV ovarian germ cell tumor|stage iv ovarian germ cell tumor
872215|NCT00005858|recurrent ovarian germ cell tumor|recurrent ovarian germ cell tumor
872216|NCT00005858|borderline ovarian surface epithelial-stromal tumor|borderline ovarian surface epithelial-stromal tumor
872217|NCT00005858|ovarian sarcoma|ovarian sarcoma
872218|NCT00005858|male breast cancer|male breast cancer
872219|NCT00005858|stage IV pancreatic cancer|stage iv pancreatic cancer
872220|NCT00005855|adult glioblastoma|adult glioblastoma
872221|NCT00005855|adult anaplastic astrocytoma|adult anaplastic astrocytoma
872222|NCT00005855|adult anaplastic oligodendroglioma|adult anaplastic oligodendroglioma
872223|NCT00005855|recurrent adult brain tumor|recurrent adult brain tumor
872224|NCT00005855|adult giant cell glioblastoma|adult giant cell glioblastoma
872225|NCT00005855|adult gliosarcoma|adult gliosarcoma
872226|NCT00005853|refractory anemia|refractory anemia
872227|NCT00005853|refractory anemia with ringed sideroblasts|refractory anemia with ringed sideroblasts
872228|NCT00005853|refractory anemia with excess blasts|refractory anemia with excess blasts
872229|NCT00005853|refractory anemia with excess blasts in transformation|refractory anemia with excess blasts in transformation
872230|NCT00005853|de novo myelodysplastic syndromes|de novo myelodysplastic syndromes
872231|NCT00005853|previously treated myelodysplastic syndromes|previously treated myelodysplastic syndromes
872232|NCT00005853|secondary myelodysplastic syndromes|secondary myelodysplastic syndromes
872233|NCT00005853|refractory cytopenia with multilineage dysplasia|refractory cytopenia with multilineage dysplasia
872234|NCT00005853|childhood myelodysplastic syndromes|childhood myelodysplastic syndromes
872235|NCT00005850|stage I non-small cell lung cancer|stage i non-small cell lung cancer
872236|NCT00005850|stage II non-small cell lung cancer|stage ii non-small cell lung cancer
872237|NCT00005850|recurrent non-small cell lung cancer|recurrent non-small cell lung cancer
872238|NCT00005850|squamous cell lung cancer|squamous cell lung cancer
872239|NCT00005850|large cell lung cancer|large cell lung cancer
872240|NCT00005850|stage IIIA non-small cell lung cancer|stage iiia non-small cell lung cancer
872241|NCT00005850|stage IIIB non-small cell lung cancer|stage iiib non-small cell lung cancer
872242|NCT00005850|stage IV non-small cell lung cancer|stage iv non-small cell lung cancer
872243|NCT00005850|adenocarcinoma of the lung|adenocarcinoma of the lung
872244|NCT00005850|adenosquamous cell lung cancer|adenosquamous cell lung cancer
872245|NCT00005850|fatigue|fatigue
872246|NCT00005850|anxiety disorder|anxiety disorder
872247|NCT00005850|depression|depression
872248|NCT00005847|adenocarcinoma of the prostate|adenocarcinoma of the prostate
872249|NCT00005847|stage IV prostate cancer|stage iv prostate cancer
872250|NCT00005847|recurrent prostate cancer|recurrent prostate cancer
872251|NCT00005844|unspecified childhood solid tumor, protocol specific|unspecified childhood solid tumor, protocol specific
872252|NCT00005835|regional neuroblastoma|regional neuroblastoma
872253|NCT00005835|disseminated neuroblastoma|disseminated neuroblastoma
872254|NCT00005835|recurrent neuroblastoma|recurrent neuroblastoma
872255|NCT00005835|localized unresectable neuroblastoma|localized unresectable neuroblastoma
872256|NCT00005825|stage IIIB non-small cell lung cancer|stage iiib non-small cell lung cancer
872257|NCT00005825|stage IV non-small cell lung cancer|stage iv non-small cell lung cancer
873443|NCT00004065|stage III melanoma|stage iii melanoma
872258|NCT00005824|AIDS-related peripheral/systemic lymphoma|aids-related peripheral/systemic lymphoma
872259|NCT00005824|AIDS-related diffuse large cell lymphoma|aids-related diffuse large cell lymphoma
872260|NCT00005824|AIDS-related immunoblastic large cell lymphoma|aids-related immunoblastic large cell lymphoma
872261|NCT00005824|AIDS-related small noncleaved cell lymphoma|aids-related small noncleaved cell lymphoma
872262|NCT00005824|HIV-associated Hodgkin lymphoma|hiv-associated hodgkin lymphoma
872263|NCT00005824|AIDS-related diffuse mixed cell lymphoma|aids-related diffuse mixed cell lymphoma
872264|NCT00005824|AIDS-related diffuse small cleaved cell lymphoma|aids-related diffuse small cleaved cell lymphoma
872265|NCT00005824|AIDS-related lymphoblastic lymphoma|aids-related lymphoblastic lymphoma
872266|NCT00005823|untreated adult acute myeloid leukemia|untreated adult acute myeloid leukemia
872267|NCT00005823|adult acute erythroid leukemia (M6)|adult acute erythroid leukemia (m6)
872268|NCT00005823|adult acute myeloblastic leukemia without maturation (M1)|adult acute myeloblastic leukemia without maturation (m1)
872269|NCT00005823|adult acute myeloblastic leukemia with maturation (M2)|adult acute myeloblastic leukemia with maturation (m2)
872270|NCT00005823|adult acute myelomonocytic leukemia (M4)|adult acute myelomonocytic leukemia (m4)
872271|NCT00005823|adult acute monoblastic leukemia (M5a)|adult acute monoblastic leukemia (m5a)
872272|NCT00005823|adult acute megakaryoblastic leukemia (M7)|adult acute megakaryoblastic leukemia (m7)
872273|NCT00005823|refractory anemia with excess blasts|refractory anemia with excess blasts
872274|NCT00005823|refractory anemia with excess blasts in transformation|refractory anemia with excess blasts in transformation
872275|NCT00005823|chronic myelomonocytic leukemia|chronic myelomonocytic leukemia
872276|NCT00005823|secondary acute myeloid leukemia|secondary acute myeloid leukemia
872277|NCT00005823|de novo myelodysplastic syndromes|de novo myelodysplastic syndromes
894648|NCT00001750|Stem Cell|stem cell
872278|NCT00005823|adult acute monocytic leukemia (M5b)|adult acute monocytic leukemia (m5b)
872279|NCT00005823|secondary myelodysplastic syndromes|secondary myelodysplastic syndromes
872280|NCT00005823|adult acute minimally differentiated myeloid leukemia (M0)|adult acute minimally differentiated myeloid leukemia (m0)
872281|NCT00005823|atypical chronic myeloid leukemia, BCR-ABL1 negative|atypical chronic myeloid leukemia, bcr-abl1 negative
872282|NCT00005823|myelodysplastic/myeloproliferative neoplasm, unclassifiable|myelodysplastic/myeloproliferative neoplasm, unclassifiable
872283|NCT00005823|adult acute myeloid leukemia with 11q23 (MLL) abnormalities|adult acute myeloid leukemia with 11q23 (mll) abnormalities
872284|NCT00005823|adult acute myeloid leukemia with inv(16)(p13;q22)|adult acute myeloid leukemia with inv(16)(p13;q22)
872285|NCT00005823|adult acute myeloid leukemia with t(16;16)(p13;q22)|adult acute myeloid leukemia with t(16;16)(p13;q22)
872286|NCT00005823|adult acute myeloid leukemia with t(8;21)(q22;q22)|adult acute myeloid leukemia with t(8;21)(q22;q22)
872287|NCT00005822|stage IV breast cancer|stage iv breast cancer
872288|NCT00005822|recurrent breast cancer|recurrent breast cancer
872289|NCT00005822|stage IIIB breast cancer|stage iiib breast cancer
872290|NCT00005822|inflammatory breast cancer|inflammatory breast cancer
872291|NCT00005822|male breast cancer|male breast cancer
872292|NCT00005821|stage I breast cancer|stage i breast cancer
872293|NCT00005821|stage II breast cancer|stage ii breast cancer
872294|NCT00005819|unspecified adult solid tumor, protocol specific|unspecified adult solid tumor, protocol specific
872295|NCT00005815|iris melanoma|iris melanoma
872296|NCT00005815|ciliary body and choroid melanoma, small size|ciliary body and choroid melanoma, small size
872297|NCT00005815|ciliary body and choroid melanoma, medium/large size|ciliary body and choroid melanoma, medium/large size
872298|NCT00005815|extraocular extension melanoma|extraocular extension melanoma
872299|NCT00005815|recurrent intraocular melanoma|recurrent intraocular melanoma
872300|NCT00005815|stage III melanoma|stage iii melanoma
872301|NCT00005815|stage IV melanoma|stage iv melanoma
872302|NCT00005815|recurrent melanoma|recurrent melanoma
872303|NCT00005812|leptomeningeal metastases|leptomeningeal metastases
872304|NCT00005812|temozolomide|temozolomide
872305|NCT00005807|stage IV breast cancer|stage iv breast cancer
872306|NCT00005807|stage IIIA breast cancer|stage iiia breast cancer
872307|NCT00005807|recurrent breast cancer|recurrent breast cancer
872308|NCT00005807|stage IIIB breast cancer|stage iiib breast cancer
872309|NCT00005807|stage III ovarian epithelial cancer|stage iii ovarian epithelial cancer
872310|NCT00005807|stage IV ovarian epithelial cancer|stage iv ovarian epithelial cancer
872311|NCT00005807|recurrent ovarian epithelial cancer|recurrent ovarian epithelial cancer
872312|NCT00005807|unspecified adult solid tumor, protocol specific|unspecified adult solid tumor, protocol specific
872313|NCT00005807|ovarian stromal cancer|ovarian stromal cancer
872314|NCT00005807|stage III ovarian germ cell tumor|stage iii ovarian germ cell tumor
872315|NCT00005807|stage IV ovarian germ cell tumor|stage iv ovarian germ cell tumor
872316|NCT00005807|recurrent ovarian germ cell tumor|recurrent ovarian germ cell tumor
872317|NCT00005807|borderline ovarian surface epithelial-stromal tumor|borderline ovarian surface epithelial-stromal tumor
872318|NCT00005807|ovarian sarcoma|ovarian sarcoma
872319|NCT00005807|male breast cancer|male breast cancer
872320|NCT00005802|recurrent childhood acute lymphoblastic leukemia|recurrent childhood acute lymphoblastic leukemia
872321|NCT00005802|recurrent childhood acute myeloid leukemia|recurrent childhood acute myeloid leukemia
872322|NCT00005802|recurrent adult acute myeloid leukemia|recurrent adult acute myeloid leukemia
872323|NCT00005802|recurrent adult acute lymphoblastic leukemia|recurrent adult acute lymphoblastic leukemia
872324|NCT00005802|adult acute myeloid leukemia with t(8;21)(q22;q22)|adult acute myeloid leukemia with t(8;21)(q22;q22)
878290|NCT00050128|Inhibition|inhibition
872325|NCT00005802|adult acute myeloid leukemia with t(16;16)(p13;q22)|adult acute myeloid leukemia with t(16;16)(p13;q22)
872326|NCT00005802|adult acute myeloid leukemia with inv(16)(p13;q22)|adult acute myeloid leukemia with inv(16)(p13;q22)
872327|NCT00005802|adult acute myeloid leukemia with 11q23 (MLL) abnormalities|adult acute myeloid leukemia with 11q23 (mll) abnormalities
872328|NCT00005802|adult acute myeloid leukemia with t(15;17)(q22;q12)|adult acute myeloid leukemia with t(15;17)(q22;q12)
872329|NCT00005797|refractory multiple myeloma|refractory multiple myeloma
872330|NCT00005797|stage II multiple myeloma|stage ii multiple myeloma
872331|NCT00005797|stage III multiple myeloma|stage iii multiple myeloma
872332|NCT00005797|stage III chronic lymphocytic leukemia|stage iii chronic lymphocytic leukemia
872333|NCT00005797|stage IV chronic lymphocytic leukemia|stage iv chronic lymphocytic leukemia
872334|NCT00005797|recurrent adult acute myeloid leukemia|recurrent adult acute myeloid leukemia
872335|NCT00005797|recurrent adult acute lymphoblastic leukemia|recurrent adult acute lymphoblastic leukemia
872336|NCT00005797|refractory chronic lymphocytic leukemia|refractory chronic lymphocytic leukemia
872337|NCT00005797|chronic phase chronic myelogenous leukemia|chronic phase chronic myelogenous leukemia
872338|NCT00005797|accelerated phase chronic myelogenous leukemia|accelerated phase chronic myelogenous leukemia
872339|NCT00005797|adult acute myeloid leukemia in remission|adult acute myeloid leukemia in remission
872340|NCT00005797|adult acute lymphoblastic leukemia in remission|adult acute lymphoblastic leukemia in remission
872341|NCT00005797|polycythemia vera|polycythemia vera
872342|NCT00005797|primary myelofibrosis|primary myelofibrosis
872343|NCT00005797|essential thrombocythemia|essential thrombocythemia
872344|NCT00005797|refractory anemia|refractory anemia
872345|NCT00005797|refractory anemia with ringed sideroblasts|refractory anemia with ringed sideroblasts
872346|NCT00005797|refractory anemia with excess blasts|refractory anemia with excess blasts
872347|NCT00005797|refractory anemia with excess blasts in transformation|refractory anemia with excess blasts in transformation
872348|NCT00005797|chronic myelomonocytic leukemia|chronic myelomonocytic leukemia
872349|NCT00005797|previously treated myelodysplastic syndromes|previously treated myelodysplastic syndromes
872350|NCT00005797|refractory cytopenia with multilineage dysplasia|refractory cytopenia with multilineage dysplasia
872351|NCT00005797|chronic eosinophilic leukemia|chronic eosinophilic leukemia
872352|NCT00005797|chronic neutrophilic leukemia|chronic neutrophilic leukemia
872353|NCT00005797|atypical chronic myeloid leukemia, BCR-ABL1 negative|atypical chronic myeloid leukemia, bcr-abl1 negative
872354|NCT00005797|myelodysplastic/myeloproliferative neoplasm, unclassifiable|myelodysplastic/myeloproliferative neoplasm, unclassifiable
872355|NCT00005797|adult acute myeloid leukemia with t(8;21)(q22;q22)|adult acute myeloid leukemia with t(8;21)(q22;q22)
872356|NCT00005797|adult acute myeloid leukemia with t(16;16)(p13;q22)|adult acute myeloid leukemia with t(16;16)(p13;q22)
872357|NCT00005797|adult acute myeloid leukemia with inv(16)(p13;q22)|adult acute myeloid leukemia with inv(16)(p13;q22)
872358|NCT00005797|adult acute myeloid leukemia with 11q23 (MLL) abnormalities|adult acute myeloid leukemia with 11q23 (mll) abnormalities
872359|NCT00005797|adult acute myeloid leukemia with t(15;17)(q22;q12)|adult acute myeloid leukemia with t(15;17)(q22;q12)
872360|NCT00005797|childhood myelodysplastic syndromes|childhood myelodysplastic syndromes
872361|NCT00005788|stage I cutaneous T-cell non-Hodgkin lymphoma|stage i cutaneous t-cell non-hodgkin lymphoma
872362|NCT00005788|stage II cutaneous T-cell non-Hodgkin lymphoma|stage ii cutaneous t-cell non-hodgkin lymphoma
872363|NCT00005788|stage III cutaneous T-cell non-Hodgkin lymphoma|stage iii cutaneous t-cell non-hodgkin lymphoma
872364|NCT00005788|stage IV cutaneous T-cell non-Hodgkin lymphoma|stage iv cutaneous t-cell non-hodgkin lymphoma
872365|NCT00005788|recurrent cutaneous T-cell non-Hodgkin lymphoma|recurrent cutaneous t-cell non-hodgkin lymphoma
872366|NCT00005788|stage I mycosis fungoides/Sezary syndrome|stage i mycosis fungoides/sezary syndrome
872367|NCT00005788|stage II mycosis fungoides/Sezary syndrome|stage ii mycosis fungoides/sezary syndrome
872368|NCT00005788|stage III mycosis fungoides/Sezary syndrome|stage iii mycosis fungoides/sezary syndrome
872369|NCT00005788|stage IV mycosis fungoides/Sezary syndrome|stage iv mycosis fungoides/sezary syndrome
875030|NCT00003458|Medulloepithelioma|medulloepithelioma
872370|NCT00005788|recurrent mycosis fungoides/Sezary syndrome|recurrent mycosis fungoides/sezary syndrome
872371|NCT00005787|neutropenia|neutropenia
872372|NCT00005787|recurrent grade 1 follicular lymphoma|recurrent grade 1 follicular lymphoma
872373|NCT00005787|recurrent grade 2 follicular lymphoma|recurrent grade 2 follicular lymphoma
872374|NCT00005787|recurrent grade 3 follicular lymphoma|recurrent grade 3 follicular lymphoma
872375|NCT00005787|recurrent adult diffuse small cleaved cell lymphoma|recurrent adult diffuse small cleaved cell lymphoma
872376|NCT00005787|recurrent adult diffuse mixed cell lymphoma|recurrent adult diffuse mixed cell lymphoma
872377|NCT00005787|recurrent adult diffuse large cell lymphoma|recurrent adult diffuse large cell lymphoma
872378|NCT00005787|recurrent adult immunoblastic large cell lymphoma|recurrent adult immunoblastic large cell lymphoma
872379|NCT00005787|recurrent adult lymphoblastic lymphoma|recurrent adult lymphoblastic lymphoma
872380|NCT00005787|recurrent adult Burkitt lymphoma|recurrent adult burkitt lymphoma
872381|NCT00005787|recurrent mantle cell lymphoma|recurrent mantle cell lymphoma
872382|NCT00005787|recurrent marginal zone lymphoma|recurrent marginal zone lymphoma
872383|NCT00005787|recurrent small lymphocytic lymphoma|recurrent small lymphocytic lymphoma
872384|NCT00005787|extranodal marginal zone B-cell lymphoma of mucosa-associated lymphoid tissue|extranodal marginal zone b-cell lymphoma of mucosa-associated lymphoid tissue
872385|NCT00005787|nodal marginal zone B-cell lymphoma|nodal marginal zone b-cell lymphoma
872386|NCT00005787|splenic marginal zone lymphoma|splenic marginal zone lymphoma
872387|NCT00005647|thyroid gland medullary carcinoma|thyroid gland medullary carcinoma
872388|NCT00005647|anaplastic thyroid cancer|anaplastic thyroid cancer
872389|NCT00005647|recurrent thyroid cancer|recurrent thyroid cancer
872390|NCT00005647|recurrent salivary gland cancer|recurrent salivary gland cancer
872391|NCT00005647|recurrent metastatic squamous neck cancer with occult primary|recurrent metastatic squamous neck cancer with occult primary
872392|NCT00005647|stage III follicular thyroid cancer|stage iii follicular thyroid cancer
872393|NCT00005647|metastatic squamous neck cancer with occult primary squamous cell carcinoma|metastatic squamous neck cancer with occult primary squamous cell carcinoma
872394|NCT00005647|recurrent hypopharyngeal cancer|recurrent hypopharyngeal cancer
872395|NCT00005647|stage III adenoid cystic carcinoma of the oral cavity|stage iii adenoid cystic carcinoma of the oral cavity
872396|NCT00005647|recurrent squamous cell carcinoma of the lip and oral cavity|recurrent squamous cell carcinoma of the lip and oral cavity
872397|NCT00005647|recurrent verrucous carcinoma of the oral cavity|recurrent verrucous carcinoma of the oral cavity
872398|NCT00005647|recurrent mucoepidermoid carcinoma of the oral cavity|recurrent mucoepidermoid carcinoma of the oral cavity
872399|NCT00005647|recurrent adenoid cystic carcinoma of the oral cavity|recurrent adenoid cystic carcinoma of the oral cavity
872400|NCT00005647|recurrent squamous cell carcinoma of the oropharynx|recurrent squamous cell carcinoma of the oropharynx
872401|NCT00005647|recurrent lymphoepithelioma of the oropharynx|recurrent lymphoepithelioma of the oropharynx
872402|NCT00005647|recurrent squamous cell carcinoma of the nasopharynx|recurrent squamous cell carcinoma of the nasopharynx
872403|NCT00005647|recurrent lymphoepithelioma of the nasopharynx|recurrent lymphoepithelioma of the nasopharynx
872404|NCT00005647|recurrent squamous cell carcinoma of the hypopharynx|recurrent squamous cell carcinoma of the hypopharynx
894649|NCT00001750|Apheresis|apheresis
872405|NCT00005647|recurrent squamous cell carcinoma of the larynx|recurrent squamous cell carcinoma of the larynx
872406|NCT00005647|recurrent verrucous carcinoma of the larynx|recurrent verrucous carcinoma of the larynx
872407|NCT00005647|recurrent squamous cell carcinoma of the paranasal sinus and nasal cavity|recurrent squamous cell carcinoma of the paranasal sinus and nasal cavity
872408|NCT00005647|recurrent inverted papilloma of the paranasal sinus and nasal cavity|recurrent inverted papilloma of the paranasal sinus and nasal cavity
872409|NCT00005647|recurrent esthesioneuroblastoma of the paranasal sinus and nasal cavity|recurrent esthesioneuroblastoma of the paranasal sinus and nasal cavity
872410|NCT00005644|stage III bladder cancer|stage iii bladder cancer
872411|NCT00005644|recurrent bladder cancer|recurrent bladder cancer
872412|NCT00005644|stage IV bladder cancer|stage iv bladder cancer
872413|NCT00005644|transitional cell carcinoma of the bladder|transitional cell carcinoma of the bladder
872414|NCT00005644|recurrent urethral cancer|recurrent urethral cancer
872415|NCT00005644|distal urethral cancer|distal urethral cancer
872416|NCT00005644|proximal urethral cancer|proximal urethral cancer
872417|NCT00005644|urethral cancer associated with invasive bladder cancer|urethral cancer associated with invasive bladder cancer
872418|NCT00005644|metastatic transitional cell cancer of the renal pelvis and ureter|metastatic transitional cell cancer of the renal pelvis and ureter
872419|NCT00005644|regional transitional cell cancer of the renal pelvis and ureter|regional transitional cell cancer of the renal pelvis and ureter
872420|NCT00005644|recurrent transitional cell cancer of the renal pelvis and ureter|recurrent transitional cell cancer of the renal pelvis and ureter
872421|NCT00005639|stage III adult Hodgkin lymphoma|stage iii adult hodgkin lymphoma
872422|NCT00005639|stage IV adult Hodgkin lymphoma|stage iv adult hodgkin lymphoma
872423|NCT00005639|recurrent adult Hodgkin lymphoma|recurrent adult hodgkin lymphoma
872424|NCT00005639|stage III cutaneous T-cell non-Hodgkin lymphoma|stage iii cutaneous t-cell non-hodgkin lymphoma
872425|NCT00005639|stage IV cutaneous T-cell non-Hodgkin lymphoma|stage iv cutaneous t-cell non-hodgkin lymphoma
872426|NCT00005639|recurrent cutaneous T-cell non-Hodgkin lymphoma|recurrent cutaneous t-cell non-hodgkin lymphoma
872427|NCT00005639|small intestine lymphoma|small intestine lymphoma
872428|NCT00005639|unspecified adult solid tumor, protocol specific|unspecified adult solid tumor, protocol specific
872429|NCT00005639|stage III grade 1 follicular lymphoma|stage iii grade 1 follicular lymphoma
872430|NCT00005639|stage III grade 2 follicular lymphoma|stage iii grade 2 follicular lymphoma
872431|NCT00005639|stage III grade 3 follicular lymphoma|stage iii grade 3 follicular lymphoma
872432|NCT00005639|stage III adult diffuse small cleaved cell lymphoma|stage iii adult diffuse small cleaved cell lymphoma
872433|NCT00005639|stage III adult diffuse mixed cell lymphoma|stage iii adult diffuse mixed cell lymphoma
872434|NCT00005639|stage III adult diffuse large cell lymphoma|stage iii adult diffuse large cell lymphoma
872435|NCT00005639|stage III adult immunoblastic large cell lymphoma|stage iii adult immunoblastic large cell lymphoma
872436|NCT00005639|stage III adult lymphoblastic lymphoma|stage iii adult lymphoblastic lymphoma
872437|NCT00005639|stage III adult Burkitt lymphoma|stage iii adult burkitt lymphoma
872438|NCT00005639|stage IV grade 1 follicular lymphoma|stage iv grade 1 follicular lymphoma
872439|NCT00005639|stage IV grade 2 follicular lymphoma|stage iv grade 2 follicular lymphoma
872440|NCT00005639|stage IV grade 3 follicular lymphoma|stage iv grade 3 follicular lymphoma
872441|NCT00005639|stage IV adult diffuse small cleaved cell lymphoma|stage iv adult diffuse small cleaved cell lymphoma
872442|NCT00005639|stage IV adult diffuse mixed cell lymphoma|stage iv adult diffuse mixed cell lymphoma
872443|NCT00005639|stage IV adult diffuse large cell lymphoma|stage iv adult diffuse large cell lymphoma
872444|NCT00005639|stage IV adult immunoblastic large cell lymphoma|stage iv adult immunoblastic large cell lymphoma
872445|NCT00005639|stage IV adult lymphoblastic lymphoma|stage iv adult lymphoblastic lymphoma
872446|NCT00005639|stage IV adult Burkitt lymphoma|stage iv adult burkitt lymphoma
872447|NCT00005639|recurrent grade 1 follicular lymphoma|recurrent grade 1 follicular lymphoma
872448|NCT00005639|recurrent grade 2 follicular lymphoma|recurrent grade 2 follicular lymphoma
872449|NCT00005639|recurrent grade 3 follicular lymphoma|recurrent grade 3 follicular lymphoma
872450|NCT00005639|recurrent adult diffuse small cleaved cell lymphoma|recurrent adult diffuse small cleaved cell lymphoma
872451|NCT00005639|recurrent adult diffuse mixed cell lymphoma|recurrent adult diffuse mixed cell lymphoma
872452|NCT00005639|recurrent adult diffuse large cell lymphoma|recurrent adult diffuse large cell lymphoma
872453|NCT00005639|recurrent adult immunoblastic large cell lymphoma|recurrent adult immunoblastic large cell lymphoma
872454|NCT00005639|recurrent adult lymphoblastic lymphoma|recurrent adult lymphoblastic lymphoma
872455|NCT00005639|recurrent adult Burkitt lymphoma|recurrent adult burkitt lymphoma
872456|NCT00005639|stage III adult T-cell leukemia/lymphoma|stage iii adult t-cell leukemia/lymphoma
872457|NCT00005639|stage IV adult T-cell leukemia/lymphoma|stage iv adult t-cell leukemia/lymphoma
872458|NCT00005639|recurrent adult T-cell leukemia/lymphoma|recurrent adult t-cell leukemia/lymphoma
872459|NCT00005639|primary central nervous system non-Hodgkin lymphoma|primary central nervous system non-hodgkin lymphoma
872461|NCT00005639|stage III mantle cell lymphoma|stage iii mantle cell lymphoma
872462|NCT00005639|stage IV mantle cell lymphoma|stage iv mantle cell lymphoma
872463|NCT00005639|recurrent mantle cell lymphoma|recurrent mantle cell lymphoma
872464|NCT00005639|angioimmunoblastic T-cell lymphoma|angioimmunoblastic t-cell lymphoma
872465|NCT00005639|anaplastic large cell lymphoma|anaplastic large cell lymphoma
872466|NCT00005639|stage III mycosis fungoides/Sezary syndrome|stage iii mycosis fungoides/sezary syndrome
872467|NCT00005639|stage IV mycosis fungoides/Sezary syndrome|stage iv mycosis fungoides/sezary syndrome
872468|NCT00005639|recurrent mycosis fungoides/Sezary syndrome|recurrent mycosis fungoides/sezary syndrome
872469|NCT00005639|recurrent marginal zone lymphoma|recurrent marginal zone lymphoma
872470|NCT00005639|recurrent small lymphocytic lymphoma|recurrent small lymphocytic lymphoma
872471|NCT00005639|stage III small lymphocytic lymphoma|stage iii small lymphocytic lymphoma
872472|NCT00005639|stage III marginal zone lymphoma|stage iii marginal zone lymphoma
872473|NCT00005639|stage IV small lymphocytic lymphoma|stage iv small lymphocytic lymphoma
872474|NCT00005639|stage IV marginal zone lymphoma|stage iv marginal zone lymphoma
872475|NCT00005639|extranodal marginal zone B-cell lymphoma of mucosa-associated lymphoid tissue|extranodal marginal zone b-cell lymphoma of mucosa-associated lymphoid tissue
872476|NCT00005639|nodal marginal zone B-cell lymphoma|nodal marginal zone b-cell lymphoma
872477|NCT00005639|splenic marginal zone lymphoma|splenic marginal zone lymphoma
872478|NCT00005638|stage II gastric cancer|stage ii gastric cancer
872479|NCT00005638|stage III gastric cancer|stage iii gastric cancer
872480|NCT00005638|stage II esophageal cancer|stage ii esophageal cancer
872481|NCT00005638|stage III esophageal cancer|stage iii esophageal cancer
872482|NCT00005638|adenocarcinoma of the stomach|adenocarcinoma of the stomach
872483|NCT00005638|squamous cell carcinoma of the esophagus|squamous cell carcinoma of the esophagus
872484|NCT00005638|adenocarcinoma of the esophagus|adenocarcinoma of the esophagus
872485|NCT00005637|adult glioblastoma|adult glioblastoma
872486|NCT00005637|adult anaplastic astrocytoma|adult anaplastic astrocytoma
872487|NCT00005637|adult anaplastic oligodendroglioma|adult anaplastic oligodendroglioma
872488|NCT00005637|adult mixed glioma|adult mixed glioma
872489|NCT00005637|adult giant cell glioblastoma|adult giant cell glioblastoma
872490|NCT00005637|adult gliosarcoma|adult gliosarcoma
872491|NCT00005637|adult anaplastic ependymoma|adult anaplastic ependymoma
872492|NCT00005627|adenocarcinoma of the prostate|adenocarcinoma of the prostate
872493|NCT00005627|recurrent prostate cancer|recurrent prostate cancer
872494|NCT00005623|stage IV prostate cancer|stage iv prostate cancer
872495|NCT00005623|recurrent prostate cancer|recurrent prostate cancer
872496|NCT00005623|hot flashes|hot flashes
872497|NCT00005622|recurrent childhood acute lymphoblastic leukemia|recurrent childhood acute lymphoblastic leukemia
872498|NCT00005622|refractory multiple myeloma|refractory multiple myeloma
872499|NCT00005622|stage I multiple myeloma|stage i multiple myeloma
872500|NCT00005622|stage II multiple myeloma|stage ii multiple myeloma
872501|NCT00005622|stage III multiple myeloma|stage iii multiple myeloma
872502|NCT00005622|stage I chronic lymphocytic leukemia|stage i chronic lymphocytic leukemia
872503|NCT00005622|stage II chronic lymphocytic leukemia|stage ii chronic lymphocytic leukemia
872504|NCT00005622|stage III chronic lymphocytic leukemia|stage iii chronic lymphocytic leukemia
872505|NCT00005622|stage IV chronic lymphocytic leukemia|stage iv chronic lymphocytic leukemia
872506|NCT00005622|recurrent childhood acute myeloid leukemia|recurrent childhood acute myeloid leukemia
872507|NCT00005622|recurrent adult acute myeloid leukemia|recurrent adult acute myeloid leukemia
872508|NCT00005622|recurrent adult acute lymphoblastic leukemia|recurrent adult acute lymphoblastic leukemia
872509|NCT00005622|refractory chronic lymphocytic leukemia|refractory chronic lymphocytic leukemia
872510|NCT00005622|chronic phase chronic myelogenous leukemia|chronic phase chronic myelogenous leukemia
872511|NCT00005622|accelerated phase chronic myelogenous leukemia|accelerated phase chronic myelogenous leukemia
872512|NCT00005622|blastic phase chronic myelogenous leukemia|blastic phase chronic myelogenous leukemia
872513|NCT00005622|adult acute myeloid leukemia in remission|adult acute myeloid leukemia in remission
872514|NCT00005622|adult acute lymphoblastic leukemia in remission|adult acute lymphoblastic leukemia in remission
872515|NCT00005622|childhood acute myeloid leukemia in remission|childhood acute myeloid leukemia in remission
873444|NCT00004065|stage IV melanoma|stage iv melanoma
872516|NCT00005622|childhood acute lymphoblastic leukemia in remission|childhood acute lymphoblastic leukemia in remission
872517|NCT00005622|polycythemia vera|polycythemia vera
872518|NCT00005622|primary myelofibrosis|primary myelofibrosis
872519|NCT00005622|essential thrombocythemia|essential thrombocythemia
872520|NCT00005622|refractory anemia|refractory anemia
872521|NCT00005622|refractory anemia with ringed sideroblasts|refractory anemia with ringed sideroblasts
872522|NCT00005622|refractory anemia with excess blasts|refractory anemia with excess blasts
872523|NCT00005622|refractory anemia with excess blasts in transformation|refractory anemia with excess blasts in transformation
872524|NCT00005622|chronic myelomonocytic leukemia|chronic myelomonocytic leukemia
872525|NCT00005622|de novo myelodysplastic syndromes|de novo myelodysplastic syndromes
872526|NCT00005622|previously treated myelodysplastic syndromes|previously treated myelodysplastic syndromes
872527|NCT00005622|secondary myelodysplastic syndromes|secondary myelodysplastic syndromes
872528|NCT00005622|refractory cytopenia with multilineage dysplasia|refractory cytopenia with multilineage dysplasia
872529|NCT00005622|chronic eosinophilic leukemia|chronic eosinophilic leukemia
872530|NCT00005622|chronic neutrophilic leukemia|chronic neutrophilic leukemia
872531|NCT00005622|atypical chronic myeloid leukemia, BCR-ABL1 negative|atypical chronic myeloid leukemia, bcr-abl1 negative
872532|NCT00005622|myelodysplastic/myeloproliferative neoplasm, unclassifiable|myelodysplastic/myeloproliferative neoplasm, unclassifiable
872533|NCT00005622|adult acute myeloid leukemia with t(8;21)(q22;q22)|adult acute myeloid leukemia with t(8;21)(q22;q22)
872534|NCT00005622|adult acute myeloid leukemia with t(16;16)(p13;q22)|adult acute myeloid leukemia with t(16;16)(p13;q22)
872535|NCT00005622|adult acute myeloid leukemia with inv(16)(p13;q22)|adult acute myeloid leukemia with inv(16)(p13;q22)
872536|NCT00005622|adult acute myeloid leukemia with 11q23 (MLL) abnormalities|adult acute myeloid leukemia with 11q23 (mll) abnormalities
872537|NCT00005622|adult acute myeloid leukemia with t(15;17)(q22;q12)|adult acute myeloid leukemia with t(15;17)(q22;q12)
872538|NCT00005622|childhood myelodysplastic syndromes|childhood myelodysplastic syndromes
872539|NCT00005617|stage IV melanoma|stage iv melanoma
872540|NCT00005617|recurrent melanoma|recurrent melanoma
872541|NCT00005606|stage I adult Hodgkin lymphoma|stage i adult hodgkin lymphoma
872542|NCT00005606|stage II adult Hodgkin lymphoma|stage ii adult hodgkin lymphoma
872543|NCT00005606|stage III adult Hodgkin lymphoma|stage iii adult hodgkin lymphoma
872544|NCT00005606|stage IV adult Hodgkin lymphoma|stage iv adult hodgkin lymphoma
872545|NCT00005606|recurrent childhood acute lymphoblastic leukemia|recurrent childhood acute lymphoblastic leukemia
872546|NCT00005606|recurrent adult Hodgkin lymphoma|recurrent adult hodgkin lymphoma
872547|NCT00005606|stage I cutaneous T-cell non-Hodgkin lymphoma|stage i cutaneous t-cell non-hodgkin lymphoma
872548|NCT00005606|stage II cutaneous T-cell non-Hodgkin lymphoma|stage ii cutaneous t-cell non-hodgkin lymphoma
872549|NCT00005606|stage III cutaneous T-cell non-Hodgkin lymphoma|stage iii cutaneous t-cell non-hodgkin lymphoma
872550|NCT00005606|stage IV cutaneous T-cell non-Hodgkin lymphoma|stage iv cutaneous t-cell non-hodgkin lymphoma
872551|NCT00005606|recurrent cutaneous T-cell non-Hodgkin lymphoma|recurrent cutaneous t-cell non-hodgkin lymphoma
872552|NCT00005606|isolated plasmacytoma of bone|isolated plasmacytoma of bone
872553|NCT00005606|extramedullary plasmacytoma|extramedullary plasmacytoma
872554|NCT00005606|stage 0 chronic lymphocytic leukemia|stage 0 chronic lymphocytic leukemia
872555|NCT00005606|stage I multiple myeloma|stage i multiple myeloma
872556|NCT00005606|stage II multiple myeloma|stage ii multiple myeloma
872557|NCT00005606|stage III multiple myeloma|stage iii multiple myeloma
872558|NCT00005606|stage I chronic lymphocytic leukemia|stage i chronic lymphocytic leukemia
872559|NCT00005606|stage II chronic lymphocytic leukemia|stage ii chronic lymphocytic leukemia
872560|NCT00005606|stage III chronic lymphocytic leukemia|stage iii chronic lymphocytic leukemia
872561|NCT00005606|stage IV chronic lymphocytic leukemia|stage iv chronic lymphocytic leukemia
872562|NCT00005606|recurrent adult acute lymphoblastic leukemia|recurrent adult acute lymphoblastic leukemia
872563|NCT00005606|refractory chronic lymphocytic leukemia|refractory chronic lymphocytic leukemia
872564|NCT00005606|untreated adult acute lymphoblastic leukemia|untreated adult acute lymphoblastic leukemia
872565|NCT00005606|untreated childhood acute lymphoblastic leukemia|untreated childhood acute lymphoblastic leukemia
872566|NCT00005606|adult acute lymphoblastic leukemia in remission|adult acute lymphoblastic leukemia in remission
872567|NCT00005606|childhood acute lymphoblastic leukemia in remission|childhood acute lymphoblastic leukemia in remission
872568|NCT00005606|untreated hairy cell leukemia|untreated hairy cell leukemia
872569|NCT00005606|progressive hairy cell leukemia, initial treatment|progressive hairy cell leukemia, initial treatment
872570|NCT00005606|refractory hairy cell leukemia|refractory hairy cell leukemia
872571|NCT00005606|stage II childhood Hodgkin lymphoma|stage ii childhood hodgkin lymphoma
872572|NCT00005606|stage I childhood Hodgkin lymphoma|stage i childhood hodgkin lymphoma
872573|NCT00005606|stage III childhood Hodgkin lymphoma|stage iii childhood hodgkin lymphoma
872574|NCT00005606|stage IV childhood Hodgkin lymphoma|stage iv childhood hodgkin lymphoma
872575|NCT00005606|recurrent/refractory childhood Hodgkin lymphoma|recurrent/refractory childhood hodgkin lymphoma
872576|NCT00005606|stage IV small lymphocytic lymphoma|stage iv small lymphocytic lymphoma
872577|NCT00005606|stage I adult T-cell leukemia/lymphoma|stage i adult t-cell leukemia/lymphoma
872578|NCT00005606|stage II adult T-cell leukemia/lymphoma|stage ii adult t-cell leukemia/lymphoma
872579|NCT00005606|stage III adult T-cell leukemia/lymphoma|stage iii adult t-cell leukemia/lymphoma
872580|NCT00005606|stage IV adult T-cell leukemia/lymphoma|stage iv adult t-cell leukemia/lymphoma
878291|NCT00050128|Pinch|pinch
872581|NCT00005606|recurrent adult T-cell leukemia/lymphoma|recurrent adult t-cell leukemia/lymphoma
872582|NCT00005606|stage I mycosis fungoides/Sezary syndrome|stage i mycosis fungoides/sezary syndrome
872583|NCT00005606|stage II mycosis fungoides/Sezary syndrome|stage ii mycosis fungoides/sezary syndrome
872584|NCT00005606|stage III mycosis fungoides/Sezary syndrome|stage iii mycosis fungoides/sezary syndrome
872585|NCT00005606|stage IV mycosis fungoides/Sezary syndrome|stage iv mycosis fungoides/sezary syndrome
872586|NCT00005606|recurrent mycosis fungoides/Sezary syndrome|recurrent mycosis fungoides/sezary syndrome
872587|NCT00005606|noncontiguous stage II small lymphocytic lymphoma|noncontiguous stage ii small lymphocytic lymphoma
872588|NCT00005606|noncontiguous stage II marginal zone lymphoma|noncontiguous stage ii marginal zone lymphoma
872589|NCT00005606|recurrent marginal zone lymphoma|recurrent marginal zone lymphoma
872590|NCT00005606|recurrent small lymphocytic lymphoma|recurrent small lymphocytic lymphoma
872591|NCT00005606|stage I marginal zone lymphoma|stage i marginal zone lymphoma
872592|NCT00005606|stage I small lymphocytic lymphoma|stage i small lymphocytic lymphoma
872593|NCT00005606|stage II small lymphocytic lymphoma|stage ii small lymphocytic lymphoma
872594|NCT00005606|stage II marginal zone lymphoma|stage ii marginal zone lymphoma
872595|NCT00005606|stage III small lymphocytic lymphoma|stage iii small lymphocytic lymphoma
872596|NCT00005606|stage III marginal zone lymphoma|stage iii marginal zone lymphoma
872597|NCT00005606|stage IV marginal zone lymphoma|stage iv marginal zone lymphoma
872598|NCT00005606|contiguous stage II marginal zone lymphoma|contiguous stage ii marginal zone lymphoma
872599|NCT00005606|contiguous stage II small lymphocytic lymphoma|contiguous stage ii small lymphocytic lymphoma
872666|NCT00005590|stage IV ovarian germ cell tumor|stage iv ovarian germ cell tumor
872600|NCT00005606|extranodal marginal zone B-cell lymphoma of mucosa-associated lymphoid tissue|extranodal marginal zone b-cell lymphoma of mucosa-associated lymphoid tissue
872601|NCT00005606|nodal marginal zone B-cell lymphoma|nodal marginal zone b-cell lymphoma
872602|NCT00005606|splenic marginal zone lymphoma|splenic marginal zone lymphoma
872603|NCT00005605|osteoporosis|osteoporosis
872604|NCT00005605|stage I breast cancer|stage i breast cancer
872605|NCT00005605|stage II breast cancer|stage ii breast cancer
872606|NCT00005603|childhood acute lymphoblastic leukemia in remission|childhood acute lymphoblastic leukemia in remission
872607|NCT00005603|B-cell childhood acute lymphoblastic leukemia|b-cell childhood acute lymphoblastic leukemia
872608|NCT00005602|untreated childhood brain stem glioma|untreated childhood brain stem glioma
872609|NCT00005601|recurrent grade 1 follicular lymphoma|recurrent grade 1 follicular lymphoma
872610|NCT00005601|recurrent grade 2 follicular lymphoma|recurrent grade 2 follicular lymphoma
872611|NCT00005601|recurrent grade 3 follicular lymphoma|recurrent grade 3 follicular lymphoma
872612|NCT00005601|recurrent adult diffuse small cleaved cell lymphoma|recurrent adult diffuse small cleaved cell lymphoma
872613|NCT00005601|recurrent adult diffuse mixed cell lymphoma|recurrent adult diffuse mixed cell lymphoma
872614|NCT00005601|recurrent adult diffuse large cell lymphoma|recurrent adult diffuse large cell lymphoma
872615|NCT00005601|recurrent adult immunoblastic large cell lymphoma|recurrent adult immunoblastic large cell lymphoma
872616|NCT00005601|recurrent adult lymphoblastic lymphoma|recurrent adult lymphoblastic lymphoma
872617|NCT00005601|recurrent adult Burkitt lymphoma|recurrent adult burkitt lymphoma
872618|NCT00005601|recurrent mantle cell lymphoma|recurrent mantle cell lymphoma
872619|NCT00005601|recurrent marginal zone lymphoma|recurrent marginal zone lymphoma
872620|NCT00005601|recurrent small lymphocytic lymphoma|recurrent small lymphocytic lymphoma
872621|NCT00005601|extranodal marginal zone B-cell lymphoma of mucosa-associated lymphoid tissue|extranodal marginal zone b-cell lymphoma of mucosa-associated lymphoid tissue
872622|NCT00005601|nodal marginal zone B-cell lymphoma|nodal marginal zone b-cell lymphoma
872623|NCT00005601|splenic marginal zone lymphoma|splenic marginal zone lymphoma
872624|NCT00005600|stage I breast cancer|stage i breast cancer
872625|NCT00005600|stage II breast cancer|stage ii breast cancer
872626|NCT00005600|lymphedema|lymphedema
872627|NCT00005600|perioperative/postoperative complications|perioperative/postoperative complications
872628|NCT00005599|stage III gastric cancer|stage iii gastric cancer
872629|NCT00005599|stage IV gastric cancer|stage iv gastric cancer
872630|NCT00005599|recurrent gastric cancer|recurrent gastric cancer
872631|NCT00005599|stage III esophageal cancer|stage iii esophageal cancer
872632|NCT00005599|stage IV esophageal cancer|stage iv esophageal cancer
872633|NCT00005599|recurrent esophageal cancer|recurrent esophageal cancer
872634|NCT00005599|squamous cell carcinoma of the esophagus|squamous cell carcinoma of the esophagus
872635|NCT00005599|adenocarcinoma of the esophagus|adenocarcinoma of the esophagus
872636|NCT00005597|gastrointestinal stromal tumor|gastrointestinal stromal tumor
872637|NCT00005596|untreated childhood acute lymphoblastic leukemia|untreated childhood acute lymphoblastic leukemia
872638|NCT00005590|stage I adult Hodgkin lymphoma|stage i adult hodgkin lymphoma
872639|NCT00005590|stage II adult Hodgkin lymphoma|stage ii adult hodgkin lymphoma
872640|NCT00005590|stage III adult Hodgkin lymphoma|stage iii adult hodgkin lymphoma
872641|NCT00005590|stage IV adult Hodgkin lymphoma|stage iv adult hodgkin lymphoma
872642|NCT00005590|recurrent breast cancer|recurrent breast cancer
872643|NCT00005590|recurrent adult Hodgkin lymphoma|recurrent adult hodgkin lymphoma
872644|NCT00005590|stage I cutaneous T-cell non-Hodgkin lymphoma|stage i cutaneous t-cell non-hodgkin lymphoma
872645|NCT00005590|stage II cutaneous T-cell non-Hodgkin lymphoma|stage ii cutaneous t-cell non-hodgkin lymphoma
872646|NCT00005590|stage III cutaneous T-cell non-Hodgkin lymphoma|stage iii cutaneous t-cell non-hodgkin lymphoma
872647|NCT00005590|stage IV cutaneous T-cell non-Hodgkin lymphoma|stage iv cutaneous t-cell non-hodgkin lymphoma
872648|NCT00005590|recurrent cutaneous T-cell non-Hodgkin lymphoma|recurrent cutaneous t-cell non-hodgkin lymphoma
872649|NCT00005590|limited stage small cell lung cancer|limited stage small cell lung cancer
872650|NCT00005590|extensive stage small cell lung cancer|extensive stage small cell lung cancer
872651|NCT00005590|recurrent small cell lung cancer|recurrent small cell lung cancer
872652|NCT00005590|small intestine lymphoma|small intestine lymphoma
875031|NCT00003458|Neurocytoma|neurocytoma
872653|NCT00005590|stage II malignant testicular germ cell tumor|stage ii malignant testicular germ cell tumor
872654|NCT00005590|stage III malignant testicular germ cell tumor|stage iii malignant testicular germ cell tumor
872655|NCT00005590|unspecified adult solid tumor, protocol specific|unspecified adult solid tumor, protocol specific
872656|NCT00005590|stage I grade 2 follicular lymphoma|stage i grade 2 follicular lymphoma
872657|NCT00005590|stage I grade 3 follicular lymphoma|stage i grade 3 follicular lymphoma
872658|NCT00005590|stage I adult diffuse small cleaved cell lymphoma|stage i adult diffuse small cleaved cell lymphoma
872659|NCT00005590|stage I adult diffuse mixed cell lymphoma|stage i adult diffuse mixed cell lymphoma
872660|NCT00005590|stage I adult diffuse large cell lymphoma|stage i adult diffuse large cell lymphoma
872661|NCT00005590|stage I adult immunoblastic large cell lymphoma|stage i adult immunoblastic large cell lymphoma
872662|NCT00005590|stage I adult lymphoblastic lymphoma|stage i adult lymphoblastic lymphoma
872663|NCT00005590|stage I adult Burkitt lymphoma|stage i adult burkitt lymphoma
872664|NCT00005590|stage II ovarian germ cell tumor|stage ii ovarian germ cell tumor
872665|NCT00005590|stage III ovarian germ cell tumor|stage iii ovarian germ cell tumor
894650|NCT00001750|Melphalan|melphalan
872667|NCT00005590|stage III grade 1 follicular lymphoma|stage iii grade 1 follicular lymphoma
872668|NCT00005590|stage III grade 2 follicular lymphoma|stage iii grade 2 follicular lymphoma
872669|NCT00005590|stage III grade 3 follicular lymphoma|stage iii grade 3 follicular lymphoma
872670|NCT00005590|stage III adult diffuse small cleaved cell lymphoma|stage iii adult diffuse small cleaved cell lymphoma
872671|NCT00005590|stage III adult diffuse mixed cell lymphoma|stage iii adult diffuse mixed cell lymphoma
872672|NCT00005590|stage III adult diffuse large cell lymphoma|stage iii adult diffuse large cell lymphoma
872673|NCT00005590|stage III adult immunoblastic large cell lymphoma|stage iii adult immunoblastic large cell lymphoma
872674|NCT00005590|stage III adult lymphoblastic lymphoma|stage iii adult lymphoblastic lymphoma
872675|NCT00005590|stage III adult Burkitt lymphoma|stage iii adult burkitt lymphoma
872676|NCT00005590|stage IV grade 1 follicular lymphoma|stage iv grade 1 follicular lymphoma
872677|NCT00005590|stage IV grade 2 follicular lymphoma|stage iv grade 2 follicular lymphoma
872678|NCT00005590|stage IV grade 3 follicular lymphoma|stage iv grade 3 follicular lymphoma
872679|NCT00005590|stage IV adult diffuse small cleaved cell lymphoma|stage iv adult diffuse small cleaved cell lymphoma
872680|NCT00005590|stage IV adult diffuse mixed cell lymphoma|stage iv adult diffuse mixed cell lymphoma
872681|NCT00005590|stage IV adult diffuse large cell lymphoma|stage iv adult diffuse large cell lymphoma
872682|NCT00005590|stage IV adult immunoblastic large cell lymphoma|stage iv adult immunoblastic large cell lymphoma
872683|NCT00005590|stage IV adult lymphoblastic lymphoma|stage iv adult lymphoblastic lymphoma
872684|NCT00005590|stage IV adult Burkitt lymphoma|stage iv adult burkitt lymphoma
872685|NCT00005590|recurrent grade 1 follicular lymphoma|recurrent grade 1 follicular lymphoma
872686|NCT00005590|recurrent grade 2 follicular lymphoma|recurrent grade 2 follicular lymphoma
872687|NCT00005590|recurrent grade 3 follicular lymphoma|recurrent grade 3 follicular lymphoma
872688|NCT00005590|recurrent adult diffuse small cleaved cell lymphoma|recurrent adult diffuse small cleaved cell lymphoma
872689|NCT00005590|recurrent adult diffuse mixed cell lymphoma|recurrent adult diffuse mixed cell lymphoma
872690|NCT00005590|recurrent adult diffuse large cell lymphoma|recurrent adult diffuse large cell lymphoma
872691|NCT00005590|recurrent adult immunoblastic large cell lymphoma|recurrent adult immunoblastic large cell lymphoma
872692|NCT00005590|recurrent adult lymphoblastic lymphoma|recurrent adult lymphoblastic lymphoma
872693|NCT00005590|recurrent adult Burkitt lymphoma|recurrent adult burkitt lymphoma
872694|NCT00005590|stage I adult T-cell leukemia/lymphoma|stage i adult t-cell leukemia/lymphoma
872695|NCT00005590|stage II adult T-cell leukemia/lymphoma|stage ii adult t-cell leukemia/lymphoma
872696|NCT00005590|stage III adult T-cell leukemia/lymphoma|stage iii adult t-cell leukemia/lymphoma
872697|NCT00005590|stage IV adult T-cell leukemia/lymphoma|stage iv adult t-cell leukemia/lymphoma
872698|NCT00005590|recurrent adult T-cell leukemia/lymphoma|recurrent adult t-cell leukemia/lymphoma
872699|NCT00005590|extragonadal germ cell tumor|extragonadal germ cell tumor
872700|NCT00005590|adult central nervous system germ cell tumor|adult central nervous system germ cell tumor
872701|NCT00005590|primary central nervous system non-Hodgkin lymphoma|primary central nervous system non-hodgkin lymphoma
872702|NCT00005590|infection|infection
872703|NCT00005590|intraocular lymphoma|intraocular lymphoma
872704|NCT00005590|stage I mantle cell lymphoma|stage i mantle cell lymphoma
872705|NCT00005590|contiguous stage II grade 1 follicular lymphoma|contiguous stage ii grade 1 follicular lymphoma
872706|NCT00005590|contiguous stage II grade 2 follicular lymphoma|contiguous stage ii grade 2 follicular lymphoma
872707|NCT00005590|contiguous stage II grade 3 follicular lymphoma|contiguous stage ii grade 3 follicular lymphoma
872708|NCT00005590|contiguous stage II adult diffuse small cleaved cell lymphoma|contiguous stage ii adult diffuse small cleaved cell lymphoma
872709|NCT00005590|contiguous stage II mantle cell lymphoma|contiguous stage ii mantle cell lymphoma
872710|NCT00005590|contiguous stage II adult diffuse mixed cell lymphoma|contiguous stage ii adult diffuse mixed cell lymphoma
872711|NCT00005590|contiguous stage II adult immunoblastic large cell lymphoma|contiguous stage ii adult immunoblastic large cell lymphoma
872712|NCT00005590|contiguous stage II adult diffuse large cell lymphoma|contiguous stage ii adult diffuse large cell lymphoma
872713|NCT00005590|contiguous stage II adult Burkitt lymphoma|contiguous stage ii adult burkitt lymphoma
872714|NCT00005590|contiguous stage II adult lymphoblastic lymphoma|contiguous stage ii adult lymphoblastic lymphoma
872715|NCT00005590|noncontiguous stage II grade 1 follicular lymphoma|noncontiguous stage ii grade 1 follicular lymphoma
872716|NCT00005590|noncontiguous stage II grade 2 follicular lymphoma|noncontiguous stage ii grade 2 follicular lymphoma
872717|NCT00005590|noncontiguous stage II grade 3 follicular lymphoma|noncontiguous stage ii grade 3 follicular lymphoma
872718|NCT00005590|noncontiguous stage II adult diffuse small cleaved cell lymphoma|noncontiguous stage ii adult diffuse small cleaved cell lymphoma
872719|NCT00005590|noncontiguous stage II mantle cell lymphoma|noncontiguous stage ii mantle cell lymphoma
872720|NCT00005590|noncontiguous stage II adult diffuse mixed cell lymphoma|noncontiguous stage ii adult diffuse mixed cell lymphoma
872721|NCT00005590|noncontiguous stage II adult immunoblastic large cell lymphoma|noncontiguous stage ii adult immunoblastic large cell lymphoma
872722|NCT00005590|noncontiguous stage II adult diffuse large cell lymphoma|noncontiguous stage ii adult diffuse large cell lymphoma
872723|NCT00005590|noncontiguous stage II adult Burkitt lymphoma|noncontiguous stage ii adult burkitt lymphoma
872724|NCT00005590|noncontiguous stage II adult lymphoblastic lymphoma|noncontiguous stage ii adult lymphoblastic lymphoma
872725|NCT00005590|stage III mantle cell lymphoma|stage iii mantle cell lymphoma
872726|NCT00005590|stage IV mantle cell lymphoma|stage iv mantle cell lymphoma
872727|NCT00005590|recurrent mantle cell lymphoma|recurrent mantle cell lymphoma
872728|NCT00005590|angioimmunoblastic T-cell lymphoma|angioimmunoblastic t-cell lymphoma
872729|NCT00005590|anaplastic large cell lymphoma|anaplastic large cell lymphoma
872730|NCT00005590|stage I mycosis fungoides/Sezary syndrome|stage i mycosis fungoides/sezary syndrome
872731|NCT00005590|stage II mycosis fungoides/Sezary syndrome|stage ii mycosis fungoides/sezary syndrome
872732|NCT00005590|stage III mycosis fungoides/Sezary syndrome|stage iii mycosis fungoides/sezary syndrome
872733|NCT00005590|stage IV mycosis fungoides/Sezary syndrome|stage iv mycosis fungoides/sezary syndrome
872734|NCT00005590|recurrent mycosis fungoides/Sezary syndrome|recurrent mycosis fungoides/sezary syndrome
872735|NCT00005590|contiguous stage II marginal zone lymphoma|contiguous stage ii marginal zone lymphoma
872736|NCT00005590|contiguous stage II small lymphocytic lymphoma|contiguous stage ii small lymphocytic lymphoma
872737|NCT00005590|noncontiguous stage II small lymphocytic lymphoma|noncontiguous stage ii small lymphocytic lymphoma
872738|NCT00005590|noncontiguous stage II marginal zone lymphoma|noncontiguous stage ii marginal zone lymphoma
872739|NCT00005590|recurrent marginal zone lymphoma|recurrent marginal zone lymphoma
872740|NCT00005590|recurrent small lymphocytic lymphoma|recurrent small lymphocytic lymphoma
872741|NCT00005590|stage I marginal zone lymphoma|stage i marginal zone lymphoma
872742|NCT00005590|stage I small lymphocytic lymphoma|stage i small lymphocytic lymphoma
872743|NCT00005590|stage II small lymphocytic lymphoma|stage ii small lymphocytic lymphoma
872744|NCT00005590|stage II marginal zone lymphoma|stage ii marginal zone lymphoma
872745|NCT00005590|stage III small lymphocytic lymphoma|stage iii small lymphocytic lymphoma
872746|NCT00005590|stage III marginal zone lymphoma|stage iii marginal zone lymphoma
872747|NCT00005590|stage IV small lymphocytic lymphoma|stage iv small lymphocytic lymphoma
872748|NCT00005590|stage IV marginal zone lymphoma|stage iv marginal zone lymphoma
872749|NCT00005590|extranodal marginal zone B-cell lymphoma of mucosa-associated lymphoid tissue|extranodal marginal zone b-cell lymphoma of mucosa-associated lymphoid tissue
872750|NCT00005590|nodal marginal zone B-cell lymphoma|nodal marginal zone b-cell lymphoma
872751|NCT00005590|splenic marginal zone lymphoma|splenic marginal zone lymphoma
872752|NCT00005589|recurrent grade 1 follicular lymphoma|recurrent grade 1 follicular lymphoma
872753|NCT00005589|recurrent grade 2 follicular lymphoma|recurrent grade 2 follicular lymphoma
872754|NCT00005589|recurrent grade 3 follicular lymphoma|recurrent grade 3 follicular lymphoma
872755|NCT00005586|stage II colon cancer|stage ii colon cancer
872756|NCT00005586|stage III colon cancer|stage iii colon cancer
872757|NCT00005586|stage II rectal cancer|stage ii rectal cancer
872758|NCT00005586|stage III rectal cancer|stage iii rectal cancer
872759|NCT00005585|childhood acute lymphoblastic leukemia in remission|childhood acute lymphoblastic leukemia in remission
872760|NCT00005585|B-cell childhood acute lymphoblastic leukemia|b-cell childhood acute lymphoblastic leukemia
872761|NCT00005584|stage I adult Hodgkin lymphoma|stage i adult hodgkin lymphoma
872762|NCT00005584|stage II adult Hodgkin lymphoma|stage ii adult hodgkin lymphoma
872763|NCT00005584|adult lymphocyte predominant Hodgkin lymphoma|adult lymphocyte predominant hodgkin lymphoma
872764|NCT00005583|stage I endometrial carcinoma|stage i endometrial carcinoma
872765|NCT00005583|stage II endometrial carcinoma|stage ii endometrial carcinoma
872766|NCT00005583|endometrial adenocarcinoma|endometrial adenocarcinoma
872767|NCT00005583|endometrial papillary serous carcinoma|endometrial papillary serous carcinoma
872768|NCT00005583|endometrial clear cell carcinoma|endometrial clear cell carcinoma
872769|NCT00005580|recurrent cutaneous T-cell non-Hodgkin lymphoma|recurrent cutaneous t-cell non-hodgkin lymphoma
872770|NCT00005580|Waldenstrom macroglobulinemia|waldenstrom macroglobulinemia
872771|NCT00005580|stage I chronic lymphocytic leukemia|stage i chronic lymphocytic leukemia
872772|NCT00005580|stage II chronic lymphocytic leukemia|stage ii chronic lymphocytic leukemia
872773|NCT00005580|stage III chronic lymphocytic leukemia|stage iii chronic lymphocytic leukemia
873445|NCT00004065|recurrent melanoma|recurrent melanoma
872774|NCT00005580|stage IV chronic lymphocytic leukemia|stage iv chronic lymphocytic leukemia
872775|NCT00005580|refractory chronic lymphocytic leukemia|refractory chronic lymphocytic leukemia
872776|NCT00005580|T-cell large granular lymphocyte leukemia|t-cell large granular lymphocyte leukemia
872777|NCT00005580|B-cell chronic lymphocytic leukemia|b-cell chronic lymphocytic leukemia
872778|NCT00005580|refractory hairy cell leukemia|refractory hairy cell leukemia
872779|NCT00005580|recurrent grade 1 follicular lymphoma|recurrent grade 1 follicular lymphoma
872780|NCT00005580|recurrent grade 2 follicular lymphoma|recurrent grade 2 follicular lymphoma
872781|NCT00005580|recurrent adult diffuse small cleaved cell lymphoma|recurrent adult diffuse small cleaved cell lymphoma
872782|NCT00005580|recurrent adult T-cell leukemia/lymphoma|recurrent adult t-cell leukemia/lymphoma
872783|NCT00005580|prolymphocytic leukemia|prolymphocytic leukemia
872784|NCT00005580|recurrent mantle cell lymphoma|recurrent mantle cell lymphoma
872785|NCT00005580|recurrent mycosis fungoides/Sezary syndrome|recurrent mycosis fungoides/sezary syndrome
872786|NCT00005580|recurrent marginal zone lymphoma|recurrent marginal zone lymphoma
872787|NCT00005580|recurrent small lymphocytic lymphoma|recurrent small lymphocytic lymphoma
872788|NCT00005580|extranodal marginal zone B-cell lymphoma of mucosa-associated lymphoid tissue|extranodal marginal zone b-cell lymphoma of mucosa-associated lymphoid tissue
872789|NCT00005580|nodal marginal zone B-cell lymphoma|nodal marginal zone b-cell lymphoma
872790|NCT00005580|splenic marginal zone lymphoma|splenic marginal zone lymphoma
872791|NCT00005579|Waldenström macroglobulinemia|waldenström macroglobulinemia
872792|NCT00005579|stage I chronic lymphocytic leukemia|stage i chronic lymphocytic leukemia
872793|NCT00005579|stage II chronic lymphocytic leukemia|stage ii chronic lymphocytic leukemia
872794|NCT00005579|stage III chronic lymphocytic leukemia|stage iii chronic lymphocytic leukemia
872795|NCT00005579|stage IV chronic lymphocytic leukemia|stage iv chronic lymphocytic leukemia
872796|NCT00005579|refractory chronic lymphocytic leukemia|refractory chronic lymphocytic leukemia
872797|NCT00005579|stage III grade 1 follicular lymphoma|stage iii grade 1 follicular lymphoma
872798|NCT00005579|stage III grade 2 follicular lymphoma|stage iii grade 2 follicular lymphoma
872799|NCT00005579|stage III adult diffuse small cleaved cell lymphoma|stage iii adult diffuse small cleaved cell lymphoma
872800|NCT00005579|stage IV grade 1 follicular lymphoma|stage iv grade 1 follicular lymphoma
872801|NCT00005579|stage IV grade 2 follicular lymphoma|stage iv grade 2 follicular lymphoma
872802|NCT00005579|stage IV adult diffuse small cleaved cell lymphoma|stage iv adult diffuse small cleaved cell lymphoma
872803|NCT00005579|recurrent grade 1 follicular lymphoma|recurrent grade 1 follicular lymphoma
872804|NCT00005579|recurrent grade 2 follicular lymphoma|recurrent grade 2 follicular lymphoma
872805|NCT00005579|recurrent adult diffuse small cleaved cell lymphoma|recurrent adult diffuse small cleaved cell lymphoma
872806|NCT00005579|recurrent small lymphocytic lymphoma|recurrent small lymphocytic lymphoma
872807|NCT00005579|stage III small lymphocytic lymphoma|stage iii small lymphocytic lymphoma
872808|NCT00005579|stage IV small lymphocytic lymphoma|stage iv small lymphocytic lymphoma
872809|NCT00005095|ovarian epithelial cancer|ovarian epithelial cancer
872810|NCT00005095|hereditary breast/ovarian cancer (BRCA1, BRCA2)|hereditary breast/ovarian cancer (brca1, brca2)
872811|NCT00005095|fallopian tube cancer|fallopian tube cancer
872812|NCT00005095|ovarian germ cell tumor|ovarian germ cell tumor
872813|NCT00005095|ovarian sarcoma|ovarian sarcoma
872814|NCT00005095|ovarian stromal cancer|ovarian stromal cancer
872815|NCT00005095|endometrial cancer|endometrial cancer
872816|NCT00005095|uterine sarcoma|uterine sarcoma
872817|NCT00005095|vaginal cancer|vaginal cancer
872818|NCT00005095|cervical cancer|cervical cancer
872819|NCT00005095|vulvar cancer|vulvar cancer
872820|NCT00005095|uterine leiomyomata|uterine leiomyomata
872821|NCT00005087|recurrent metastatic squamous neck cancer with occult primary|recurrent metastatic squamous neck cancer with occult primary
872822|NCT00005087|metastatic squamous neck cancer with occult primary squamous cell carcinoma|metastatic squamous neck cancer with occult primary squamous cell carcinoma
872823|NCT00005087|stage I squamous cell carcinoma of the lip and oral cavity|stage i squamous cell carcinoma of the lip and oral cavity
872824|NCT00005087|stage II squamous cell carcinoma of the lip and oral cavity|stage ii squamous cell carcinoma of the lip and oral cavity
872825|NCT00005087|stage III squamous cell carcinoma of the lip and oral cavity|stage iii squamous cell carcinoma of the lip and oral cavity
872826|NCT00005087|recurrent squamous cell carcinoma of the lip and oral cavity|recurrent squamous cell carcinoma of the lip and oral cavity
872827|NCT00005087|stage I squamous cell carcinoma of the oropharynx|stage i squamous cell carcinoma of the oropharynx
872828|NCT00005087|stage II squamous cell carcinoma of the oropharynx|stage ii squamous cell carcinoma of the oropharynx
872829|NCT00005087|stage III squamous cell carcinoma of the oropharynx|stage iii squamous cell carcinoma of the oropharynx
872830|NCT00005087|recurrent squamous cell carcinoma of the oropharynx|recurrent squamous cell carcinoma of the oropharynx
872831|NCT00005087|stage I squamous cell carcinoma of the hypopharynx|stage i squamous cell carcinoma of the hypopharynx
872832|NCT00005087|stage II squamous cell carcinoma of the hypopharynx|stage ii squamous cell carcinoma of the hypopharynx
872833|NCT00005087|stage III squamous cell carcinoma of the hypopharynx|stage iii squamous cell carcinoma of the hypopharynx
872834|NCT00005087|recurrent squamous cell carcinoma of the hypopharynx|recurrent squamous cell carcinoma of the hypopharynx
872835|NCT00005087|stage I squamous cell carcinoma of the larynx|stage i squamous cell carcinoma of the larynx
872836|NCT00005087|stage II squamous cell carcinoma of the larynx|stage ii squamous cell carcinoma of the larynx
872837|NCT00005087|stage III squamous cell carcinoma of the larynx|stage iii squamous cell carcinoma of the larynx
872838|NCT00005087|recurrent squamous cell carcinoma of the larynx|recurrent squamous cell carcinoma of the larynx
872839|NCT00005087|stage I squamous cell carcinoma of the paranasal sinus and nasal cavity|stage i squamous cell carcinoma of the paranasal sinus and nasal cavity
872840|NCT00005087|stage II squamous cell carcinoma of the paranasal sinus and nasal cavity|stage ii squamous cell carcinoma of the paranasal sinus and nasal cavity
872841|NCT00005087|stage III squamous cell carcinoma of the paranasal sinus and nasal cavity|stage iii squamous cell carcinoma of the paranasal sinus and nasal cavity
872842|NCT00005087|recurrent squamous cell carcinoma of the paranasal sinus and nasal cavity|recurrent squamous cell carcinoma of the paranasal sinus and nasal cavity
872843|NCT00005079|stage I breast cancer|stage i breast cancer
872844|NCT00005079|stage II breast cancer|stage ii breast cancer
872845|NCT00005079|stage IIIA breast cancer|stage iiia breast cancer
872846|NCT00005079|stage IIIB breast cancer|stage iiib breast cancer
872847|NCT00005074|stage I mantle cell lymphoma|stage i mantle cell lymphoma
872848|NCT00005074|stage III mantle cell lymphoma|stage iii mantle cell lymphoma
872849|NCT00005074|stage IV mantle cell lymphoma|stage iv mantle cell lymphoma
872850|NCT00005074|recurrent mantle cell lymphoma|recurrent mantle cell lymphoma
872851|NCT00005074|stage II mantle cell lymphoma|stage ii mantle cell lymphoma
872852|NCT00005062|limited stage small cell lung cancer|limited stage small cell lung cancer
872853|NCT00005060|stage II gastric cancer|stage ii gastric cancer
872854|NCT00005060|stage III gastric cancer|stage iii gastric cancer
872855|NCT00005052|stage II melanoma|stage ii melanoma
872856|NCT00005051|stage I ovarian epithelial cancer|stage i ovarian epithelial cancer
872857|NCT00005051|stage II ovarian epithelial cancer|stage ii ovarian epithelial cancer
872858|NCT00005051|stage III ovarian epithelial cancer|stage iii ovarian epithelial cancer
872859|NCT00005051|stage IV ovarian epithelial cancer|stage iv ovarian epithelial cancer
872860|NCT00005049|stage II colon cancer|stage ii colon cancer
872861|NCT00005049|stage III colon cancer|stage iii colon cancer
872862|NCT00005049|stage II gastric cancer|stage ii gastric cancer
872863|NCT00005049|stage III gastric cancer|stage iii gastric cancer
872864|NCT00005049|recurrent gastric cancer|recurrent gastric cancer
872865|NCT00005049|stage II rectal cancer|stage ii rectal cancer
872866|NCT00005049|stage III rectal cancer|stage iii rectal cancer
872867|NCT00005049|recurrent colon cancer|recurrent colon cancer
872868|NCT00005049|stage III ovarian epithelial cancer|stage iii ovarian epithelial cancer
872869|NCT00005049|recurrent ovarian epithelial cancer|recurrent ovarian epithelial cancer
872870|NCT00005049|regional gastrointestinal carcinoid tumor|regional gastrointestinal carcinoid tumor
872871|NCT00005049|small intestine adenocarcinoma|small intestine adenocarcinoma
872872|NCT00005049|small intestine lymphoma|small intestine lymphoma
872873|NCT00005049|small intestine leiomyosarcoma|small intestine leiomyosarcoma
872874|NCT00005049|recurrent small intestine cancer|recurrent small intestine cancer
872875|NCT00005049|peritoneal cavity cancer|peritoneal cavity cancer
872876|NCT00005049|gastrointestinal stromal tumor|gastrointestinal stromal tumor
872877|NCT00005047|stage I bladder cancer|stage i bladder cancer
872878|NCT00005047|stage II bladder cancer|stage ii bladder cancer
872879|NCT00005047|transitional cell carcinoma of the bladder|transitional cell carcinoma of the bladder
872880|NCT00005044|adenocarcinoma of the prostate|adenocarcinoma of the prostate
872881|NCT00005044|stage IIB prostate cancer|stage iib prostate cancer
872882|NCT00005044|stage IIA prostate cancer|stage iia prostate cancer
872883|NCT00005044|stage III prostate cancer|stage iii prostate cancer
872884|NCT00005038|stage IV renal cell cancer|stage iv renal cell cancer
872885|NCT00005038|recurrent renal cell cancer|recurrent renal cell cancer
872886|NCT00005033|recurrent osteosarcoma|recurrent osteosarcoma
872887|NCT00004936|stage III cervical cancer|stage iii cervical cancer
872888|NCT00004936|stage IB cervical cancer|stage ib cervical cancer
872889|NCT00004936|stage IIB cervical cancer|stage iib cervical cancer
872890|NCT00004936|stage IVB cervical cancer|stage ivb cervical cancer
872891|NCT00004936|stage IIA cervical cancer|stage iia cervical cancer
872892|NCT00004936|stage IVA cervical cancer|stage iva cervical cancer
872893|NCT00004936|cervical squamous cell carcinoma|cervical squamous cell carcinoma
872894|NCT00004936|cervical adenocarcinoma|cervical adenocarcinoma
872895|NCT00004936|cervical adenosquamous cell carcinoma|cervical adenosquamous cell carcinoma
872896|NCT00004935|stage IV breast cancer|stage iv breast cancer
872897|NCT00004935|recurrent breast cancer|recurrent breast cancer
872898|NCT00004934|stage II ovarian epithelial cancer|stage ii ovarian epithelial cancer
872899|NCT00004934|stage III ovarian epithelial cancer|stage iii ovarian epithelial cancer
872900|NCT00004934|stage IV ovarian epithelial cancer|stage iv ovarian epithelial cancer
872901|NCT00004934|fallopian tube cancer|fallopian tube cancer
872902|NCT00004934|primary peritoneal cavity cancer|primary peritoneal cavity cancer
872903|NCT00004932|recurrent childhood acute lymphoblastic leukemia|recurrent childhood acute lymphoblastic leukemia
872904|NCT00004932|recurrent childhood acute myeloid leukemia|recurrent childhood acute myeloid leukemia
872905|NCT00004932|relapsing chronic myelogenous leukemia|relapsing chronic myelogenous leukemia
872906|NCT00004932|chronic myelogenous leukemia, BCR-ABL1 positive|chronic myelogenous leukemia, bcr-abl1 positive
872907|NCT00004932|childhood chronic myelogenous leukemia|childhood chronic myelogenous leukemia
872908|NCT00004930|recurrent non-small cell lung cancer|recurrent non-small cell lung cancer
872909|NCT00004930|extensive stage small cell lung cancer|extensive stage small cell lung cancer
873632|NCT00004001|stage IV prostate cancer|stage iv prostate cancer
872910|NCT00004930|recurrent small cell lung cancer|recurrent small cell lung cancer
872911|NCT00004930|stage IIIB non-small cell lung cancer|stage iiib non-small cell lung cancer
872912|NCT00004930|stage IV non-small cell lung cancer|stage iv non-small cell lung cancer
872913|NCT00004930|lung metastases|lung metastases
872914|NCT00004930|bronchoalveolar cell lung cancer|bronchoalveolar cell lung cancer
872915|NCT00004924|stage IIIB non-small cell lung cancer|stage iiib non-small cell lung cancer
872916|NCT00004924|stage IV non-small cell lung cancer|stage iv non-small cell lung cancer
872917|NCT00004921|stage III ovarian epithelial cancer|stage iii ovarian epithelial cancer
872918|NCT00004921|stage IV ovarian epithelial cancer|stage iv ovarian epithelial cancer
872919|NCT00004920|localized malignant mesothelioma|localized malignant mesothelioma
872920|NCT00004920|advanced malignant mesothelioma|advanced malignant mesothelioma
872921|NCT00004920|recurrent malignant mesothelioma|recurrent malignant mesothelioma
872922|NCT00004917|stage I squamous cell carcinoma of the lip and oral cavity|stage i squamous cell carcinoma of the lip and oral cavity
872923|NCT00004917|stage II squamous cell carcinoma of the lip and oral cavity|stage ii squamous cell carcinoma of the lip and oral cavity
872924|NCT00004917|stage III squamous cell carcinoma of the lip and oral cavity|stage iii squamous cell carcinoma of the lip and oral cavity
872925|NCT00004917|stage IV squamous cell carcinoma of the lip and oral cavity|stage iv squamous cell carcinoma of the lip and oral cavity
872926|NCT00004917|stage I squamous cell carcinoma of the oropharynx|stage i squamous cell carcinoma of the oropharynx
872927|NCT00004917|stage II squamous cell carcinoma of the oropharynx|stage ii squamous cell carcinoma of the oropharynx
872928|NCT00004917|stage III squamous cell carcinoma of the oropharynx|stage iii squamous cell carcinoma of the oropharynx
872929|NCT00004917|stage IV squamous cell carcinoma of the oropharynx|stage iv squamous cell carcinoma of the oropharynx
872930|NCT00004917|stage I squamous cell carcinoma of the hypopharynx|stage i squamous cell carcinoma of the hypopharynx
872931|NCT00004917|stage II squamous cell carcinoma of the hypopharynx|stage ii squamous cell carcinoma of the hypopharynx
872932|NCT00004917|stage III squamous cell carcinoma of the hypopharynx|stage iii squamous cell carcinoma of the hypopharynx
872933|NCT00004917|stage IV squamous cell carcinoma of the hypopharynx|stage iv squamous cell carcinoma of the hypopharynx
872934|NCT00004917|stage I squamous cell carcinoma of the larynx|stage i squamous cell carcinoma of the larynx
872935|NCT00004917|stage II squamous cell carcinoma of the larynx|stage ii squamous cell carcinoma of the larynx
872936|NCT00004917|stage III squamous cell carcinoma of the larynx|stage iii squamous cell carcinoma of the larynx
872937|NCT00004917|stage IV squamous cell carcinoma of the larynx|stage iv squamous cell carcinoma of the larynx
872938|NCT00004917|anemia|anemia
872939|NCT00004907|recurrent adult Hodgkin lymphoma|recurrent adult hodgkin lymphoma
872940|NCT00004907|recurrent cutaneous T-cell non-Hodgkin lymphoma|recurrent cutaneous t-cell non-hodgkin lymphoma
872941|NCT00004907|recurrent grade 1 follicular lymphoma|recurrent grade 1 follicular lymphoma
872942|NCT00004907|recurrent grade 2 follicular lymphoma|recurrent grade 2 follicular lymphoma
872943|NCT00004907|recurrent grade 3 follicular lymphoma|recurrent grade 3 follicular lymphoma
872944|NCT00004907|recurrent adult diffuse small cleaved cell lymphoma|recurrent adult diffuse small cleaved cell lymphoma
872945|NCT00004907|recurrent adult diffuse mixed cell lymphoma|recurrent adult diffuse mixed cell lymphoma
872946|NCT00004907|recurrent adult diffuse large cell lymphoma|recurrent adult diffuse large cell lymphoma
872947|NCT00004907|recurrent adult immunoblastic large cell lymphoma|recurrent adult immunoblastic large cell lymphoma
872948|NCT00004907|recurrent mycosis fungoides/Sezary syndrome|recurrent mycosis fungoides/sezary syndrome
872949|NCT00004907|recurrent marginal zone lymphoma|recurrent marginal zone lymphoma
872950|NCT00004907|recurrent small lymphocytic lymphoma|recurrent small lymphocytic lymphoma
872951|NCT00004907|extranodal marginal zone B-cell lymphoma of mucosa-associated lymphoid tissue|extranodal marginal zone b-cell lymphoma of mucosa-associated lymphoid tissue
872952|NCT00004907|nodal marginal zone B-cell lymphoma|nodal marginal zone b-cell lymphoma
872953|NCT00004907|splenic marginal zone lymphoma|splenic marginal zone lymphoma
872954|NCT00004899|recurrent childhood acute myeloid leukemia|recurrent childhood acute myeloid leukemia
872955|NCT00004899|recurrent adult acute myeloid leukemia|recurrent adult acute myeloid leukemia
872956|NCT00004899|adult acute myeloid leukemia in remission|adult acute myeloid leukemia in remission
872957|NCT00004899|childhood acute myeloid leukemia in remission|childhood acute myeloid leukemia in remission
872958|NCT00004899|adult acute erythroid leukemia (M6)|adult acute erythroid leukemia (m6)
872959|NCT00004899|adult acute myeloblastic leukemia without maturation (M1)|adult acute myeloblastic leukemia without maturation (m1)
872960|NCT00004899|adult acute myeloblastic leukemia with maturation (M2)|adult acute myeloblastic leukemia with maturation (m2)
872961|NCT00004899|adult acute promyelocytic leukemia (M3)|adult acute promyelocytic leukemia (m3)
872962|NCT00004899|adult acute myelomonocytic leukemia (M4)|adult acute myelomonocytic leukemia (m4)
872963|NCT00004899|adult acute monoblastic leukemia (M5a)|adult acute monoblastic leukemia (m5a)
872964|NCT00004899|childhood acute myeloblastic leukemia without maturation (M1)|childhood acute myeloblastic leukemia without maturation (m1)
872965|NCT00004899|childhood acute myeloblastic leukemia with maturation (M2)|childhood acute myeloblastic leukemia with maturation (m2)
872966|NCT00004899|childhood acute promyelocytic leukemia (M3)|childhood acute promyelocytic leukemia (m3)
872967|NCT00004899|childhood acute myelomonocytic leukemia (M4)|childhood acute myelomonocytic leukemia (m4)
872968|NCT00004899|childhood acute monoblastic leukemia (M5a)|childhood acute monoblastic leukemia (m5a)
872969|NCT00004899|childhood acute monocytic leukemia (M5b)|childhood acute monocytic leukemia (m5b)
872970|NCT00004899|childhood acute erythroleukemia (M6)|childhood acute erythroleukemia (m6)
872971|NCT00004899|secondary acute myeloid leukemia|secondary acute myeloid leukemia
872972|NCT00004899|adult acute monocytic leukemia (M5b)|adult acute monocytic leukemia (m5b)
872973|NCT00004899|previously treated myelodysplastic syndromes|previously treated myelodysplastic syndromes
872974|NCT00004899|myelodysplastic/myeloproliferative disease, unclassifiable|myelodysplastic/myeloproliferative disease, unclassifiable
872975|NCT00004899|atypical chronic myeloid leukemia|atypical chronic myeloid leukemia
872976|NCT00004899|adult acute myeloid leukemia with t(8;21)(q22;q22)|adult acute myeloid leukemia with t(8;21)(q22;q22)
872977|NCT00004899|adult acute myeloid leukemia with t(16;16)(p13;q22)|adult acute myeloid leukemia with t(16;16)(p13;q22)
872978|NCT00004899|adult acute myeloid leukemia with inv(16)(p13;q22)|adult acute myeloid leukemia with inv(16)(p13;q22)
872979|NCT00004899|adult acute myeloid leukemia with 11q23 (MLL) abnormalities|adult acute myeloid leukemia with 11q23 (mll) abnormalities
872980|NCT00004899|adult acute myeloid leukemia with t(15;17)(q22;q12)|adult acute myeloid leukemia with t(15;17)(q22;q12)
872981|NCT00004899|childhood myelodysplastic syndromes|childhood myelodysplastic syndromes
872982|NCT00004896|recurrent adult acute myeloid leukemia|recurrent adult acute myeloid leukemia
872983|NCT00004896|adult acute myeloid leukemia in remission|adult acute myeloid leukemia in remission
872984|NCT00004896|adult acute erythroid leukemia (M6)|adult acute erythroid leukemia (m6)
872985|NCT00004896|adult acute myeloblastic leukemia without maturation (M1)|adult acute myeloblastic leukemia without maturation (m1)
872986|NCT00004896|adult acute myeloblastic leukemia with maturation (M2)|adult acute myeloblastic leukemia with maturation (m2)
872987|NCT00004896|adult acute promyelocytic leukemia (M3)|adult acute promyelocytic leukemia (m3)
873057|NCT00004259|adult mixed glioma|adult mixed glioma
872988|NCT00004896|adult acute myelomonocytic leukemia (M4)|adult acute myelomonocytic leukemia (m4)
872989|NCT00004896|adult acute monoblastic leukemia (M5a)|adult acute monoblastic leukemia (m5a)
872990|NCT00004896|adult acute megakaryoblastic leukemia (M7)|adult acute megakaryoblastic leukemia (m7)
872991|NCT00004896|refractory anemia|refractory anemia
872992|NCT00004896|refractory anemia with ringed sideroblasts|refractory anemia with ringed sideroblasts
872993|NCT00004896|refractory anemia with excess blasts|refractory anemia with excess blasts
872994|NCT00004896|refractory anemia with excess blasts in transformation|refractory anemia with excess blasts in transformation
872995|NCT00004896|chronic myelomonocytic leukemia|chronic myelomonocytic leukemia
872996|NCT00004896|adult acute monocytic leukemia (M5b)|adult acute monocytic leukemia (m5b)
872997|NCT00004896|previously treated myelodysplastic syndromes|previously treated myelodysplastic syndromes
872998|NCT00004896|myelodysplastic/myeloproliferative disease, unclassifiable|myelodysplastic/myeloproliferative disease, unclassifiable
872999|NCT00004896|atypical chronic myeloid leukemia|atypical chronic myeloid leukemia
873000|NCT00004896|adult acute myeloid leukemia with t(8;21)(q22;q22)|adult acute myeloid leukemia with t(8;21)(q22;q22)
873001|NCT00004896|adult acute myeloid leukemia with t(16;16)(p13;q22)|adult acute myeloid leukemia with t(16;16)(p13;q22)
873002|NCT00004896|adult acute myeloid leukemia with inv(16)(p13;q22)|adult acute myeloid leukemia with inv(16)(p13;q22)
873003|NCT00004896|adult acute myeloid leukemia with 11q23 (MLL) abnormalities|adult acute myeloid leukemia with 11q23 (mll) abnormalities
873004|NCT00004896|adult acute myeloid leukemia with t(15;17)(q22;q12)|adult acute myeloid leukemia with t(15;17)(q22;q12)
873005|NCT00004896|childhood myelodysplastic syndromes|childhood myelodysplastic syndromes
873006|NCT00004891|stage II rectal cancer|stage ii rectal cancer
873007|NCT00004891|stage III rectal cancer|stage iii rectal cancer
873008|NCT00004891|stage IV rectal cancer|stage iv rectal cancer
873009|NCT00004879|recurrent renal cell cancer|recurrent renal cell cancer
873010|NCT00004879|recurrent prostate cancer|recurrent prostate cancer
873011|NCT00004879|recurrent colon cancer|recurrent colon cancer
873012|NCT00004879|recurrent rectal cancer|recurrent rectal cancer
873013|NCT00004879|recurrent non-small cell lung cancer|recurrent non-small cell lung cancer
873014|NCT00004879|recurrent pancreatic cancer|recurrent pancreatic cancer
873015|NCT00004879|recurrent esophageal cancer|recurrent esophageal cancer
873016|NCT00004876|stage IV ovarian epithelial cancer|stage iv ovarian epithelial cancer
873017|NCT00004876|stage IC ovarian epithelial cancer|stage ic ovarian epithelial cancer
873018|NCT00004876|stage IIA ovarian epithelial cancer|stage iia ovarian epithelial cancer
873019|NCT00004876|stage IIB ovarian epithelial cancer|stage iib ovarian epithelial cancer
873020|NCT00004876|stage IIC ovarian epithelial cancer|stage iic ovarian epithelial cancer
873021|NCT00004876|stage IIIA ovarian epithelial cancer|stage iiia ovarian epithelial cancer
873022|NCT00004876|stage IIIB ovarian epithelial cancer|stage iiib ovarian epithelial cancer
873023|NCT00004876|stage IIIC ovarian epithelial cancer|stage iiic ovarian epithelial cancer
873024|NCT00004873|stage III gastric cancer|stage iii gastric cancer
873025|NCT00004873|stage IV gastric cancer|stage iv gastric cancer
873026|NCT00004873|recurrent gastric cancer|recurrent gastric cancer
873027|NCT00004871|recurrent adult acute myeloid leukemia|recurrent adult acute myeloid leukemia
873028|NCT00004871|untreated adult acute myeloid leukemia|untreated adult acute myeloid leukemia
873029|NCT00004871|refractory anemia|refractory anemia
873030|NCT00004871|refractory anemia with ringed sideroblasts|refractory anemia with ringed sideroblasts
873031|NCT00004871|refractory anemia with excess blasts|refractory anemia with excess blasts
873032|NCT00004871|refractory anemia with excess blasts in transformation|refractory anemia with excess blasts in transformation
873033|NCT00004871|chronic myelomonocytic leukemia|chronic myelomonocytic leukemia
873034|NCT00004871|de novo myelodysplastic syndromes|de novo myelodysplastic syndromes
873035|NCT00004871|previously treated myelodysplastic syndromes|previously treated myelodysplastic syndromes
878292|NCT00050128|Stroke|stroke
873036|NCT00004871|secondary myelodysplastic syndromes|secondary myelodysplastic syndromes
873037|NCT00004871|atypical chronic myeloid leukemia|atypical chronic myeloid leukemia
873038|NCT00004871|myelodysplastic/myeloproliferative disease, unclassifiable|myelodysplastic/myeloproliferative disease, unclassifiable
873039|NCT00004867|stage I esophageal cancer|stage i esophageal cancer
873040|NCT00004867|stage II esophageal cancer|stage ii esophageal cancer
873041|NCT00004867|stage III esophageal cancer|stage iii esophageal cancer
873042|NCT00004867|stage IV esophageal cancer|stage iv esophageal cancer
873043|NCT00004867|squamous cell carcinoma of the esophagus|squamous cell carcinoma of the esophagus
873044|NCT00004867|adenocarcinoma of the esophagus|adenocarcinoma of the esophagus
873045|NCT00004866|stage III cervical cancer|stage iii cervical cancer
873046|NCT00004866|stage IV cervical cancer|stage iv cervical cancer
873047|NCT00004866|recurrent cervical cancer|recurrent cervical cancer
873048|NCT00004866|cervical squamous cell carcinoma|cervical squamous cell carcinoma
873049|NCT00004859|squamous cell lung cancer|squamous cell lung cancer
873050|NCT00004859|large cell lung cancer|large cell lung cancer
873051|NCT00004859|stage IIIA non-small cell lung cancer|stage iiia non-small cell lung cancer
873052|NCT00004859|stage IIIB non-small cell lung cancer|stage iiib non-small cell lung cancer
873053|NCT00004859|adenocarcinoma of the lung|adenocarcinoma of the lung
873054|NCT00004859|adenosquamous cell lung cancer|adenosquamous cell lung cancer
873055|NCT00004859|bronchoalveolar cell lung cancer|bronchoalveolar cell lung cancer
873056|NCT00004259|adult anaplastic astrocytoma|adult anaplastic astrocytoma
873058|NCT00004250|stage III adult soft tissue sarcoma|stage iii adult soft tissue sarcoma
873059|NCT00004250|recurrent adult soft tissue sarcoma|recurrent adult soft tissue sarcoma
873060|NCT00004250|stage III melanoma|stage iii melanoma
873061|NCT00004250|stage IV melanoma|stage iv melanoma
873062|NCT00004250|recurrent melanoma|recurrent melanoma
873063|NCT00004250|stage IV adult soft tissue sarcoma|stage iv adult soft tissue sarcoma
873064|NCT00004245|recurrent adult acute myeloid leukemia|recurrent adult acute myeloid leukemia
873065|NCT00004245|refractory chronic lymphocytic leukemia|refractory chronic lymphocytic leukemia
873066|NCT00004245|untreated adult acute myeloid leukemia|untreated adult acute myeloid leukemia
873067|NCT00004245|refractory anemia with excess blasts|refractory anemia with excess blasts
873068|NCT00004245|refractory anemia with excess blasts in transformation|refractory anemia with excess blasts in transformation
873069|NCT00004245|chronic myelomonocytic leukemia|chronic myelomonocytic leukemia
873070|NCT00004245|previously treated myelodysplastic syndromes|previously treated myelodysplastic syndromes
873071|NCT00004245|atypical chronic myeloid leukemia, BCR-ABL1 negative|atypical chronic myeloid leukemia, bcr-abl1 negative
873072|NCT00004245|myelodysplastic/myeloproliferative neoplasm, unclassifiable|myelodysplastic/myeloproliferative neoplasm, unclassifiable
873073|NCT00004245|adult acute myeloid leukemia with t(8;21)(q22;q22)|adult acute myeloid leukemia with t(8;21)(q22;q22)
873074|NCT00004245|adult acute myeloid leukemia with t(16;16)(p13;q22)|adult acute myeloid leukemia with t(16;16)(p13;q22)
873075|NCT00004245|adult acute myeloid leukemia with inv(16)(p13;q22)|adult acute myeloid leukemia with inv(16)(p13;q22)
873076|NCT00004245|adult acute myeloid leukemia with 11q23 (MLL) abnormalities|adult acute myeloid leukemia with 11q23 (mll) abnormalities
873077|NCT00004245|adult acute myeloid leukemia with t(15;17)(q22;q12)|adult acute myeloid leukemia with t(15;17)(q22;q12)
873078|NCT00004244|stage IV renal cell cancer|stage iv renal cell cancer
873079|NCT00004244|recurrent renal cell cancer|recurrent renal cell cancer
873080|NCT00004244|stage IV melanoma|stage iv melanoma
873081|NCT00004244|recurrent melanoma|recurrent melanoma
873082|NCT00004237|stage I breast cancer|stage i breast cancer
873083|NCT00004237|stage II breast cancer|stage ii breast cancer
873084|NCT00004234|oral complications|oral complications
873085|NCT00004234|stage I squamous cell carcinoma of the lip and oral cavity|stage i squamous cell carcinoma of the lip and oral cavity
873086|NCT00004234|stage II squamous cell carcinoma of the lip and oral cavity|stage ii squamous cell carcinoma of the lip and oral cavity
873087|NCT00004234|stage III squamous cell carcinoma of the lip and oral cavity|stage iii squamous cell carcinoma of the lip and oral cavity
873088|NCT00004234|stage IV squamous cell carcinoma of the lip and oral cavity|stage iv squamous cell carcinoma of the lip and oral cavity
873089|NCT00004234|recurrent squamous cell carcinoma of the lip and oral cavity|recurrent squamous cell carcinoma of the lip and oral cavity
873090|NCT00004234|stage I squamous cell carcinoma of the oropharynx|stage i squamous cell carcinoma of the oropharynx
873091|NCT00004234|stage II squamous cell carcinoma of the oropharynx|stage ii squamous cell carcinoma of the oropharynx
873092|NCT00004234|stage III squamous cell carcinoma of the oropharynx|stage iii squamous cell carcinoma of the oropharynx
873093|NCT00004234|stage IV squamous cell carcinoma of the oropharynx|stage iv squamous cell carcinoma of the oropharynx
873094|NCT00004234|recurrent squamous cell carcinoma of the oropharynx|recurrent squamous cell carcinoma of the oropharynx
873095|NCT00004234|stage I squamous cell carcinoma of the nasopharynx|stage i squamous cell carcinoma of the nasopharynx
873096|NCT00004234|stage II squamous cell carcinoma of the nasopharynx|stage ii squamous cell carcinoma of the nasopharynx
873097|NCT00004234|stage III squamous cell carcinoma of the nasopharynx|stage iii squamous cell carcinoma of the nasopharynx
873098|NCT00004234|stage IV squamous cell carcinoma of the nasopharynx|stage iv squamous cell carcinoma of the nasopharynx
873099|NCT00004234|recurrent squamous cell carcinoma of the nasopharynx|recurrent squamous cell carcinoma of the nasopharynx
873100|NCT00004234|stage I squamous cell carcinoma of the hypopharynx|stage i squamous cell carcinoma of the hypopharynx
878293|NCT00050089|AIDS|aids
873101|NCT00004234|stage II squamous cell carcinoma of the hypopharynx|stage ii squamous cell carcinoma of the hypopharynx
873102|NCT00004234|stage III squamous cell carcinoma of the hypopharynx|stage iii squamous cell carcinoma of the hypopharynx
873103|NCT00004234|stage IV squamous cell carcinoma of the hypopharynx|stage iv squamous cell carcinoma of the hypopharynx
873104|NCT00004234|recurrent squamous cell carcinoma of the hypopharynx|recurrent squamous cell carcinoma of the hypopharynx
873105|NCT00004234|stage I squamous cell carcinoma of the larynx|stage i squamous cell carcinoma of the larynx
873106|NCT00004234|stage II squamous cell carcinoma of the larynx|stage ii squamous cell carcinoma of the larynx
873107|NCT00004234|stage III squamous cell carcinoma of the larynx|stage iii squamous cell carcinoma of the larynx
873108|NCT00004234|stage IV squamous cell carcinoma of the larynx|stage iv squamous cell carcinoma of the larynx
873109|NCT00004234|recurrent squamous cell carcinoma of the larynx|recurrent squamous cell carcinoma of the larynx
873110|NCT00004231|stage III mantle cell lymphoma|stage iii mantle cell lymphoma
873111|NCT00004231|stage IV mantle cell lymphoma|stage iv mantle cell lymphoma
873112|NCT00004231|recurrent mantle cell lymphoma|recurrent mantle cell lymphoma
873113|NCT00004228|stage III childhood lymphoblastic lymphoma|stage iii childhood lymphoblastic lymphoma
873114|NCT00004228|stage IV childhood lymphoblastic lymphoma|stage iv childhood lymphoblastic lymphoma
873115|NCT00004227|stage III squamous cell carcinoma of the oropharynx|stage iii squamous cell carcinoma of the oropharynx
873116|NCT00004227|stage IV squamous cell carcinoma of the oropharynx|stage iv squamous cell carcinoma of the oropharynx
873117|NCT00004227|recurrent squamous cell carcinoma of the oropharynx|recurrent squamous cell carcinoma of the oropharynx
894754|NCT00001721|Microephaly|microephaly
873118|NCT00004227|stage III squamous cell carcinoma of the hypopharynx|stage iii squamous cell carcinoma of the hypopharynx
873119|NCT00004227|stage IV squamous cell carcinoma of the hypopharynx|stage iv squamous cell carcinoma of the hypopharynx
873120|NCT00004227|recurrent squamous cell carcinoma of the hypopharynx|recurrent squamous cell carcinoma of the hypopharynx
873121|NCT00004227|stage III squamous cell carcinoma of the larynx|stage iii squamous cell carcinoma of the larynx
873122|NCT00004227|stage IV squamous cell carcinoma of the larynx|stage iv squamous cell carcinoma of the larynx
873123|NCT00004227|recurrent squamous cell carcinoma of the larynx|recurrent squamous cell carcinoma of the larynx
873124|NCT00004226|recurrent squamous cell carcinoma of the lip and oral cavity|recurrent squamous cell carcinoma of the lip and oral cavity
873125|NCT00004226|recurrent squamous cell carcinoma of the hypopharynx|recurrent squamous cell carcinoma of the hypopharynx
873126|NCT00004226|recurrent squamous cell carcinoma of the larynx|recurrent squamous cell carcinoma of the larynx
873127|NCT00004226|recurrent squamous cell carcinoma of the paranasal sinus and nasal cavity|recurrent squamous cell carcinoma of the paranasal sinus and nasal cavity
873128|NCT00004226|recurrent squamous cell carcinoma of the oropharynx|recurrent squamous cell carcinoma of the oropharynx
873129|NCT00004226|recurrent metastatic squamous neck cancer with occult primary|recurrent metastatic squamous neck cancer with occult primary
873130|NCT00004225|recurrent non-small cell lung cancer|recurrent non-small cell lung cancer
873131|NCT00004224|childhood infratentorial ependymoma|childhood infratentorial ependymoma
873132|NCT00004224|childhood supratentorial ependymoma|childhood supratentorial ependymoma
873133|NCT00004224|newly diagnosed childhood ependymoma|newly diagnosed childhood ependymoma
873134|NCT00004218|stage I chronic lymphocytic leukemia|stage i chronic lymphocytic leukemia
873135|NCT00004218|stage II chronic lymphocytic leukemia|stage ii chronic lymphocytic leukemia
873136|NCT00004218|stage III chronic lymphocytic leukemia|stage iii chronic lymphocytic leukemia
873137|NCT00004218|B-cell chronic lymphocytic leukemia|b-cell chronic lymphocytic leukemia
873138|NCT00004218|stage 0 chronic lymphocytic leukemia|stage 0 chronic lymphocytic leukemia
873139|NCT00004212|childhood infratentorial ependymoma|childhood infratentorial ependymoma
873140|NCT00004212|childhood supratentorial ependymoma|childhood supratentorial ependymoma
873141|NCT00004212|childhood craniopharyngioma|childhood craniopharyngioma
873142|NCT00004212|stage III childhood lymphoblastic lymphoma|stage iii childhood lymphoblastic lymphoma
873143|NCT00004212|stage IV childhood lymphoblastic lymphoma|stage iv childhood lymphoblastic lymphoma
873144|NCT00004212|recurrent childhood lymphoblastic lymphoma|recurrent childhood lymphoblastic lymphoma
873145|NCT00004212|childhood central nervous system germ cell tumor|childhood central nervous system germ cell tumor
873146|NCT00004212|unspecified childhood solid tumor, protocol specific|unspecified childhood solid tumor, protocol specific
873147|NCT00004212|stage III childhood Hodgkin lymphoma|stage iii childhood hodgkin lymphoma
873148|NCT00004212|stage IV childhood Hodgkin lymphoma|stage iv childhood hodgkin lymphoma
873149|NCT00004212|recurrent/refractory childhood Hodgkin lymphoma|recurrent/refractory childhood hodgkin lymphoma
873150|NCT00004212|childhood high-grade cerebral astrocytoma|childhood high-grade cerebral astrocytoma
873151|NCT00004212|childhood oligodendroglioma|childhood oligodendroglioma
873152|NCT00004212|childhood choroid plexus tumor|childhood choroid plexus tumor
873153|NCT00004212|stage III childhood small noncleaved cell lymphoma|stage iii childhood small noncleaved cell lymphoma
873154|NCT00004212|stage III childhood large cell lymphoma|stage iii childhood large cell lymphoma
873155|NCT00004212|stage IV childhood small noncleaved cell lymphoma|stage iv childhood small noncleaved cell lymphoma
873156|NCT00004212|stage IV childhood large cell lymphoma|stage iv childhood large cell lymphoma
873157|NCT00004212|recurrent childhood small noncleaved cell lymphoma|recurrent childhood small noncleaved cell lymphoma
873158|NCT00004212|recurrent childhood large cell lymphoma|recurrent childhood large cell lymphoma
873159|NCT00004212|untreated childhood brain stem glioma|untreated childhood brain stem glioma
873160|NCT00004212|recurrent childhood brain stem glioma|recurrent childhood brain stem glioma
873161|NCT00004212|untreated childhood supratentorial primitive neuroectodermal tumor|untreated childhood supratentorial primitive neuroectodermal tumor
873162|NCT00004212|recurrent childhood supratentorial primitive neuroectodermal tumor|recurrent childhood supratentorial primitive neuroectodermal tumor
873163|NCT00004212|untreated childhood cerebellar astrocytoma|untreated childhood cerebellar astrocytoma
873164|NCT00004212|recurrent childhood cerebellar astrocytoma|recurrent childhood cerebellar astrocytoma
873165|NCT00004212|recurrent childhood cerebral astrocytoma|recurrent childhood cerebral astrocytoma
873166|NCT00004212|untreated childhood medulloblastoma|untreated childhood medulloblastoma
873167|NCT00004212|recurrent childhood medulloblastoma|recurrent childhood medulloblastoma
873168|NCT00004212|untreated childhood visual pathway and hypothalamic glioma|untreated childhood visual pathway and hypothalamic glioma
873169|NCT00004212|recurrent childhood visual pathway and hypothalamic glioma|recurrent childhood visual pathway and hypothalamic glioma
873170|NCT00004212|newly diagnosed childhood ependymoma|newly diagnosed childhood ependymoma
873171|NCT00004212|recurrent childhood ependymoma|recurrent childhood ependymoma
873172|NCT00004210|colon cancer|colon cancer
873173|NCT00004210|rectal cancer|rectal cancer
873174|NCT00004208|refractory anemia|refractory anemia
873175|NCT00004208|refractory anemia with ringed sideroblasts|refractory anemia with ringed sideroblasts
873176|NCT00004208|refractory anemia with excess blasts|refractory anemia with excess blasts
873177|NCT00004208|de novo myelodysplastic syndromes|de novo myelodysplastic syndromes
873178|NCT00004208|previously treated myelodysplastic syndromes|previously treated myelodysplastic syndromes
873846|NCT00003938|ovarian immature teratoma|ovarian immature teratoma
873179|NCT00004208|secondary myelodysplastic syndromes|secondary myelodysplastic syndromes
873180|NCT00004205|stage I breast cancer|stage i breast cancer
873181|NCT00004205|stage II breast cancer|stage ii breast cancer
873182|NCT00004205|stage IIIA breast cancer|stage iiia breast cancer
873183|NCT00004205|breast cancer in situ|breast cancer in situ
873184|NCT00004205|recurrent breast cancer|recurrent breast cancer
873185|NCT00004205|ductal breast carcinoma|ductal breast carcinoma
873186|NCT00004205|lobular breast carcinoma in situ|lobular breast carcinoma in situ
873187|NCT00004196|stage I melanoma|stage i melanoma
873188|NCT00004196|stage II melanoma|stage ii melanoma
873189|NCT00004196|stage III melanoma|stage iii melanoma
873190|NCT00004189|stage III adult Hodgkin lymphoma|stage iii adult hodgkin lymphoma
873191|NCT00004189|stage IV adult Hodgkin lymphoma|stage iv adult hodgkin lymphoma
873192|NCT00004189|recurrent adult Hodgkin lymphoma|recurrent adult hodgkin lymphoma
873193|NCT00004189|stage III cutaneous T-cell non-Hodgkin lymphoma|stage iii cutaneous t-cell non-hodgkin lymphoma
873194|NCT00004189|stage IV cutaneous T-cell non-Hodgkin lymphoma|stage iv cutaneous t-cell non-hodgkin lymphoma
873195|NCT00004189|recurrent cutaneous T-cell non-Hodgkin lymphoma|recurrent cutaneous t-cell non-hodgkin lymphoma
873196|NCT00004189|small intestine lymphoma|small intestine lymphoma
873197|NCT00004189|unspecified adult solid tumor, protocol specific|unspecified adult solid tumor, protocol specific
873198|NCT00004189|stage III grade 1 follicular lymphoma|stage iii grade 1 follicular lymphoma
873199|NCT00004189|stage III grade 2 follicular lymphoma|stage iii grade 2 follicular lymphoma
873200|NCT00004189|stage III grade 3 follicular lymphoma|stage iii grade 3 follicular lymphoma
873201|NCT00004189|stage III adult diffuse small cleaved cell lymphoma|stage iii adult diffuse small cleaved cell lymphoma
873202|NCT00004189|stage III adult diffuse mixed cell lymphoma|stage iii adult diffuse mixed cell lymphoma
873203|NCT00004189|stage III adult diffuse large cell lymphoma|stage iii adult diffuse large cell lymphoma
873204|NCT00004189|stage III adult immunoblastic large cell lymphoma|stage iii adult immunoblastic large cell lymphoma
873205|NCT00004189|stage III adult lymphoblastic lymphoma|stage iii adult lymphoblastic lymphoma
873206|NCT00004189|stage III adult Burkitt lymphoma|stage iii adult burkitt lymphoma
873207|NCT00004189|stage IV grade 1 follicular lymphoma|stage iv grade 1 follicular lymphoma
873208|NCT00004189|stage IV grade 2 follicular lymphoma|stage iv grade 2 follicular lymphoma
873209|NCT00004189|stage IV grade 3 follicular lymphoma|stage iv grade 3 follicular lymphoma
873210|NCT00004189|stage IV adult diffuse small cleaved cell lymphoma|stage iv adult diffuse small cleaved cell lymphoma
873211|NCT00004189|stage IV adult diffuse mixed cell lymphoma|stage iv adult diffuse mixed cell lymphoma
873212|NCT00004189|stage IV adult diffuse large cell lymphoma|stage iv adult diffuse large cell lymphoma
873213|NCT00004189|stage IV adult immunoblastic large cell lymphoma|stage iv adult immunoblastic large cell lymphoma
873214|NCT00004189|stage IV adult lymphoblastic lymphoma|stage iv adult lymphoblastic lymphoma
873215|NCT00004189|stage IV adult Burkitt lymphoma|stage iv adult burkitt lymphoma
873216|NCT00004189|recurrent grade 1 follicular lymphoma|recurrent grade 1 follicular lymphoma
873217|NCT00004189|recurrent grade 2 follicular lymphoma|recurrent grade 2 follicular lymphoma
873218|NCT00004189|recurrent grade 3 follicular lymphoma|recurrent grade 3 follicular lymphoma
873219|NCT00004189|recurrent adult diffuse small cleaved cell lymphoma|recurrent adult diffuse small cleaved cell lymphoma
873220|NCT00004189|recurrent adult diffuse mixed cell lymphoma|recurrent adult diffuse mixed cell lymphoma
873221|NCT00004189|recurrent adult diffuse large cell lymphoma|recurrent adult diffuse large cell lymphoma
873222|NCT00004189|recurrent adult immunoblastic large cell lymphoma|recurrent adult immunoblastic large cell lymphoma
873223|NCT00004189|recurrent adult lymphoblastic lymphoma|recurrent adult lymphoblastic lymphoma
873224|NCT00004189|recurrent adult Burkitt lymphoma|recurrent adult burkitt lymphoma
873225|NCT00004189|stage III adult T-cell leukemia/lymphoma|stage iii adult t-cell leukemia/lymphoma
873226|NCT00004189|stage IV adult T-cell leukemia/lymphoma|stage iv adult t-cell leukemia/lymphoma
873227|NCT00004189|recurrent adult T-cell leukemia/lymphoma|recurrent adult t-cell leukemia/lymphoma
873228|NCT00004189|primary central nervous system non-Hodgkin lymphoma|primary central nervous system non-hodgkin lymphoma
873229|NCT00004189|AIDS-related peripheral/systemic lymphoma|aids-related peripheral/systemic lymphoma
873230|NCT00004189|AIDS-related primary CNS lymphoma|aids-related primary cns lymphoma
873231|NCT00004189|intraocular lymphoma|intraocular lymphoma
873232|NCT00004189|stage III mantle cell lymphoma|stage iii mantle cell lymphoma
873233|NCT00004189|stage IV mantle cell lymphoma|stage iv mantle cell lymphoma
873234|NCT00004189|recurrent mantle cell lymphoma|recurrent mantle cell lymphoma
873235|NCT00004189|angioimmunoblastic T-cell lymphoma|angioimmunoblastic t-cell lymphoma
873236|NCT00004189|anaplastic large cell lymphoma|anaplastic large cell lymphoma
873237|NCT00004189|stage III mycosis fungoides/Sezary syndrome|stage iii mycosis fungoides/sezary syndrome
873238|NCT00004189|stage IV mycosis fungoides/Sezary syndrome|stage iv mycosis fungoides/sezary syndrome
873239|NCT00004189|recurrent mycosis fungoides/Sezary syndrome|recurrent mycosis fungoides/sezary syndrome
873240|NCT00004189|recurrent marginal zone lymphoma|recurrent marginal zone lymphoma
873241|NCT00004189|recurrent small lymphocytic lymphoma|recurrent small lymphocytic lymphoma
873242|NCT00004189|stage III small lymphocytic lymphoma|stage iii small lymphocytic lymphoma
873243|NCT00004189|stage III marginal zone lymphoma|stage iii marginal zone lymphoma
873244|NCT00004189|stage IV small lymphocytic lymphoma|stage iv small lymphocytic lymphoma
873245|NCT00004189|stage IV marginal zone lymphoma|stage iv marginal zone lymphoma
894966|NCT00001643|Lewy Body|lewy body
873246|NCT00004189|extranodal marginal zone B-cell lymphoma of mucosa-associated lymphoid tissue|extranodal marginal zone b-cell lymphoma of mucosa-associated lymphoid tissue
873247|NCT00004189|nodal marginal zone B-cell lymphoma|nodal marginal zone b-cell lymphoma
873248|NCT00004189|splenic marginal zone lymphoma|splenic marginal zone lymphoma
873249|NCT00004188|localized resectable neuroblastoma|localized resectable neuroblastoma
873250|NCT00004188|regional neuroblastoma|regional neuroblastoma
873251|NCT00004188|disseminated neuroblastoma|disseminated neuroblastoma
873252|NCT00004188|stage 4S neuroblastoma|stage 4s neuroblastoma
873253|NCT00004188|localized unresectable neuroblastoma|localized unresectable neuroblastoma
873254|NCT00004181|refractory multiple myeloma|refractory multiple myeloma
873255|NCT00004181|stage I multiple myeloma|stage i multiple myeloma
873256|NCT00004181|stage II multiple myeloma|stage ii multiple myeloma
873257|NCT00004181|stage III multiple myeloma|stage iii multiple myeloma
873258|NCT00004181|chronic phase chronic myelogenous leukemia|chronic phase chronic myelogenous leukemia
873259|NCT00004181|chronic idiopathic myelofibrosis|chronic idiopathic myelofibrosis
873260|NCT00004181|Philadelphia chromosome positive chronic myelogenous leukemia|philadelphia chromosome positive chronic myelogenous leukemia
873261|NCT00004179|stage III grade 1 follicular lymphoma|stage iii grade 1 follicular lymphoma
873262|NCT00004179|stage III grade 2 follicular lymphoma|stage iii grade 2 follicular lymphoma
873263|NCT00004179|stage III grade 3 follicular lymphoma|stage iii grade 3 follicular lymphoma
873264|NCT00004179|stage IV grade 1 follicular lymphoma|stage iv grade 1 follicular lymphoma
873265|NCT00004179|stage IV grade 2 follicular lymphoma|stage iv grade 2 follicular lymphoma
873266|NCT00004179|stage IV grade 3 follicular lymphoma|stage iv grade 3 follicular lymphoma
873267|NCT00004179|recurrent grade 1 follicular lymphoma|recurrent grade 1 follicular lymphoma
873268|NCT00004179|recurrent grade 2 follicular lymphoma|recurrent grade 2 follicular lymphoma
873269|NCT00004179|recurrent grade 3 follicular lymphoma|recurrent grade 3 follicular lymphoma
873270|NCT00004173|unspecified adult solid tumor, protocol specific|unspecified adult solid tumor, protocol specific
873271|NCT00004165|refractory multiple myeloma|refractory multiple myeloma
873272|NCT00004165|stage I multiple myeloma|stage i multiple myeloma
873273|NCT00004165|stage II multiple myeloma|stage ii multiple myeloma
873274|NCT00004165|stage III multiple myeloma|stage iii multiple myeloma
873275|NCT00004165|primary systemic amyloidosis|primary systemic amyloidosis
873276|NCT00004154|stage 0 bladder cancer|stage 0 bladder cancer
873277|NCT00004154|stage I bladder cancer|stage i bladder cancer
873278|NCT00004154|transitional cell carcinoma of the bladder|transitional cell carcinoma of the bladder
873279|NCT00004153|stage I melanoma|stage i melanoma
873280|NCT00004153|stage II melanoma|stage ii melanoma
873281|NCT00004153|stage III melanoma|stage iii melanoma
873282|NCT00004153|stage IV melanoma|stage iv melanoma
873283|NCT00004150|stage III colon cancer|stage iii colon cancer
873284|NCT00004150|adenocarcinoma of the colon|adenocarcinoma of the colon
873285|NCT00004150|mucinous adenocarcinoma of the colon|mucinous adenocarcinoma of the colon
873286|NCT00004149|stage IV prostate cancer|stage iv prostate cancer
873287|NCT00004149|recurrent prostate cancer|recurrent prostate cancer
873288|NCT00004147|recurrent adult brain tumor|recurrent adult brain tumor
873289|NCT00004147|adult glioblastoma|adult glioblastoma
873290|NCT00004147|adult anaplastic astrocytoma|adult anaplastic astrocytoma
873291|NCT00004147|adult anaplastic oligodendroglioma|adult anaplastic oligodendroglioma
873292|NCT00004147|adult giant cell glioblastoma|adult giant cell glioblastoma
873293|NCT00004147|adult gliosarcoma|adult gliosarcoma
873294|NCT00004144|unspecified adult solid tumor, protocol specific|unspecified adult solid tumor, protocol specific
873295|NCT00004143|sickle cell anemia|sickle cell anemia
873296|NCT00004143|severe aplastic anemia|severe aplastic anemia
873297|NCT00004141|stage III melanoma|stage iii melanoma
873298|NCT00004141|stage IV melanoma|stage iv melanoma
873299|NCT00004141|recurrent melanoma|recurrent melanoma
873300|NCT00004138|stage I non-small cell lung cancer|stage i non-small cell lung cancer
873301|NCT00004138|stage II non-small cell lung cancer|stage ii non-small cell lung cancer
873302|NCT00004138|squamous cell lung cancer|squamous cell lung cancer
873303|NCT00004138|large cell lung cancer|large cell lung cancer
873304|NCT00004138|stage IIIA non-small cell lung cancer|stage iiia non-small cell lung cancer
873305|NCT00004138|adenocarcinoma of the lung|adenocarcinoma of the lung
873306|NCT00004138|bronchoalveolar cell lung cancer|bronchoalveolar cell lung cancer
873307|NCT00004135|stage IV renal cell cancer|stage iv renal cell cancer
873308|NCT00004135|recurrent renal cell cancer|recurrent renal cell cancer
873309|NCT00004135|stage IV melanoma|stage iv melanoma
873310|NCT00004135|recurrent melanoma|recurrent melanoma
873311|NCT00004129|recurrent adult brain tumor|recurrent adult brain tumor
873312|NCT00004129|adult glioblastoma|adult glioblastoma
873313|NCT00004129|adult giant cell glioblastoma|adult giant cell glioblastoma
873315|NCT00004128|untreated adult acute myeloid leukemia|untreated adult acute myeloid leukemia
873316|NCT00004128|adult acute erythroid leukemia (M6)|adult acute erythroid leukemia (m6)
873317|NCT00004128|adult acute myeloblastic leukemia without maturation (M1)|adult acute myeloblastic leukemia without maturation (m1)
873318|NCT00004128|adult acute myeloblastic leukemia with maturation (M2)|adult acute myeloblastic leukemia with maturation (m2)
873319|NCT00004128|adult acute myelomonocytic leukemia (M4)|adult acute myelomonocytic leukemia (m4)
873320|NCT00004128|adult acute monoblastic leukemia (M5a)|adult acute monoblastic leukemia (m5a)
873321|NCT00004128|adult acute megakaryoblastic leukemia (M7)|adult acute megakaryoblastic leukemia (m7)
873322|NCT00004128|adult acute monocytic leukemia (M5b)|adult acute monocytic leukemia (m5b)
873323|NCT00004128|adult acute minimally differentiated myeloid leukemia (M0)|adult acute minimally differentiated myeloid leukemia (m0)
873324|NCT00004128|adult acute myeloid leukemia with 11q23 (MLL) abnormalities|adult acute myeloid leukemia with 11q23 (mll) abnormalities
873325|NCT00004128|adult acute myeloid leukemia with inv(16)(p13;q22)|adult acute myeloid leukemia with inv(16)(p13;q22)
873326|NCT00004128|adult acute myeloid leukemia with t(16;16)(p13;q22)|adult acute myeloid leukemia with t(16;16)(p13;q22)
873327|NCT00004128|adult acute myeloid leukemia with t(8;21)(q22;q22)|adult acute myeloid leukemia with t(8;21)(q22;q22)
873328|NCT00004124|adenocarcinoma of the prostate|adenocarcinoma of the prostate
873329|NCT00004124|stage I prostate cancer|stage i prostate cancer
873330|NCT00004124|stage II prostate cancer|stage ii prostate cancer
873331|NCT00004124|stage III prostate cancer|stage iii prostate cancer
873332|NCT00004115|stage I ovarian epithelial cancer|stage i ovarian epithelial cancer
873333|NCT00004115|stage II ovarian epithelial cancer|stage ii ovarian epithelial cancer
873334|NCT00004115|stage III ovarian epithelial cancer|stage iii ovarian epithelial cancer
873335|NCT00004115|stage IV ovarian epithelial cancer|stage iv ovarian epithelial cancer
873336|NCT00004115|primary peritoneal cavity cancer|primary peritoneal cavity cancer
873337|NCT00004110|regional neuroblastoma|regional neuroblastoma
873338|NCT00004110|disseminated neuroblastoma|disseminated neuroblastoma
873339|NCT00004110|recurrent neuroblastoma|recurrent neuroblastoma
873340|NCT00004110|localized unresectable neuroblastoma|localized unresectable neuroblastoma
873341|NCT00004106|stage I cutaneous T-cell non-Hodgkin lymphoma|stage i cutaneous t-cell non-hodgkin lymphoma
873342|NCT00004106|stage II cutaneous T-cell non-Hodgkin lymphoma|stage ii cutaneous t-cell non-hodgkin lymphoma
873343|NCT00004106|stage III cutaneous T-cell non-Hodgkin lymphoma|stage iii cutaneous t-cell non-hodgkin lymphoma
873344|NCT00004106|stage IV cutaneous T-cell non-Hodgkin lymphoma|stage iv cutaneous t-cell non-hodgkin lymphoma
873345|NCT00004106|recurrent cutaneous T-cell non-Hodgkin lymphoma|recurrent cutaneous t-cell non-hodgkin lymphoma
873346|NCT00004106|stage I mycosis fungoides/Sezary syndrome|stage i mycosis fungoides/sezary syndrome
873347|NCT00004106|stage II mycosis fungoides/Sezary syndrome|stage ii mycosis fungoides/sezary syndrome
873348|NCT00004106|stage III mycosis fungoides/Sezary syndrome|stage iii mycosis fungoides/sezary syndrome
873349|NCT00004106|stage IV mycosis fungoides/Sezary syndrome|stage iv mycosis fungoides/sezary syndrome
873350|NCT00004106|recurrent mycosis fungoides/Sezary syndrome|recurrent mycosis fungoides/sezary syndrome
873351|NCT00004103|stage I gastric cancer|stage i gastric cancer
873352|NCT00004103|stage II gastric cancer|stage ii gastric cancer
873353|NCT00004103|stage III gastric cancer|stage iii gastric cancer
873354|NCT00004103|stage IV gastric cancer|stage iv gastric cancer
873355|NCT00004099|stage II gastric cancer|stage ii gastric cancer
873356|NCT00004099|stage III gastric cancer|stage iii gastric cancer
873357|NCT00004099|stage IV gastric cancer|stage iv gastric cancer
873358|NCT00004099|intestinal adenocarcinoma of the stomach|intestinal adenocarcinoma of the stomach
873359|NCT00004099|diffuse adenocarcinoma of the stomach|diffuse adenocarcinoma of the stomach
873360|NCT00004099|mixed adenocarcinoma of the stomach|mixed adenocarcinoma of the stomach
873361|NCT00004092|stage II breast cancer|stage ii breast cancer
873362|NCT00004092|stage IIIA breast cancer|stage iiia breast cancer
873363|NCT00004092|stage IIIB breast cancer|stage iiib breast cancer
873364|NCT00004088|stage I multiple myeloma|stage i multiple myeloma
873365|NCT00004088|stage II multiple myeloma|stage ii multiple myeloma
873366|NCT00004088|stage III multiple myeloma|stage iii multiple myeloma
873367|NCT00004081|recurrent ovarian epithelial cancer|recurrent ovarian epithelial cancer
873368|NCT00004081|peritoneal cavity cancer|peritoneal cavity cancer
873369|NCT00004077|stage III malignant testicular germ cell tumor|stage iii malignant testicular germ cell tumor
873370|NCT00004077|recurrent malignant testicular germ cell tumor|recurrent malignant testicular germ cell tumor
873371|NCT00004077|testicular embryonal carcinoma|testicular embryonal carcinoma
873372|NCT00004077|testicular choriocarcinoma|testicular choriocarcinoma
873373|NCT00004077|testicular teratoma|testicular teratoma
873374|NCT00004077|testicular yolk sac tumor|testicular yolk sac tumor
873375|NCT00004077|testicular embryonal carcinoma and teratoma|testicular embryonal carcinoma and teratoma
873376|NCT00004077|testicular embryonal carcinoma and yolk sac tumor|testicular embryonal carcinoma and yolk sac tumor
873377|NCT00004077|testicular yolk sac tumor and teratoma|testicular yolk sac tumor and teratoma
873378|NCT00004077|testicular choriocarcinoma and yolk sac tumor|testicular choriocarcinoma and yolk sac tumor
873379|NCT00004077|testicular choriocarcinoma and embryonal carcinoma|testicular choriocarcinoma and embryonal carcinoma
873380|NCT00004077|testicular choriocarcinoma and teratoma|testicular choriocarcinoma and teratoma
873381|NCT00004075|unspecified adult solid tumor, protocol specific|unspecified adult solid tumor, protocol specific
873382|NCT00004075|recurrent adult Burkitt lymphoma|recurrent adult burkitt lymphoma
873383|NCT00004075|recurrent adult diffuse large cell lymphoma|recurrent adult diffuse large cell lymphoma
873384|NCT00004075|recurrent adult diffuse mixed cell lymphoma|recurrent adult diffuse mixed cell lymphoma
873385|NCT00004075|recurrent adult diffuse small cleaved cell lymphoma|recurrent adult diffuse small cleaved cell lymphoma
873386|NCT00004075|recurrent adult Hodgkin lymphoma|recurrent adult hodgkin lymphoma
873387|NCT00004075|recurrent adult immunoblastic large cell lymphoma|recurrent adult immunoblastic large cell lymphoma
873388|NCT00004075|recurrent adult lymphoblastic lymphoma|recurrent adult lymphoblastic lymphoma
873389|NCT00004075|recurrent grade 1 follicular lymphoma|recurrent grade 1 follicular lymphoma
873390|NCT00004075|recurrent grade 2 follicular lymphoma|recurrent grade 2 follicular lymphoma
873391|NCT00004075|recurrent grade 3 follicular lymphoma|recurrent grade 3 follicular lymphoma
873392|NCT00004075|recurrent mantle cell lymphoma|recurrent mantle cell lymphoma
873393|NCT00004075|recurrent adult T-cell leukemia/lymphoma|recurrent adult t-cell leukemia/lymphoma
873394|NCT00004075|recurrent cutaneous T-cell non-Hodgkin lymphoma|recurrent cutaneous t-cell non-hodgkin lymphoma
873395|NCT00004075|recurrent mycosis fungoides/Sezary syndrome|recurrent mycosis fungoides/sezary syndrome
873396|NCT00004075|recurrent adult grade III lymphomatoid granulomatosis|recurrent adult grade iii lymphomatoid granulomatosis
873397|NCT00004075|recurrent marginal zone lymphoma|recurrent marginal zone lymphoma
873398|NCT00004075|recurrent small lymphocytic lymphoma|recurrent small lymphocytic lymphoma
873399|NCT00004075|extranodal marginal zone B-cell lymphoma of mucosa-associated lymphoid tissue|extranodal marginal zone b-cell lymphoma of mucosa-associated lymphoid tissue
873400|NCT00004075|nodal marginal zone B-cell lymphoma|nodal marginal zone b-cell lymphoma
873401|NCT00004075|splenic marginal zone lymphoma|splenic marginal zone lymphoma
873402|NCT00004072|refractory multiple myeloma|refractory multiple myeloma
873403|NCT00004072|stage I multiple myeloma|stage i multiple myeloma
873404|NCT00004072|stage II multiple myeloma|stage ii multiple myeloma
873405|NCT00004072|stage III multiple myeloma|stage iii multiple myeloma
873406|NCT00004067|stage II breast cancer|stage ii breast cancer
873407|NCT00004067|stage IIIA breast cancer|stage iiia breast cancer
873408|NCT00004066|adult leiomyosarcoma|adult leiomyosarcoma
873409|NCT00004066|recurrent adult soft tissue sarcoma|recurrent adult soft tissue sarcoma
873410|NCT00004066|small intestine leiomyosarcoma|small intestine leiomyosarcoma
873411|NCT00004066|stage IV uterine sarcoma|stage iv uterine sarcoma
873412|NCT00004066|recurrent uterine sarcoma|recurrent uterine sarcoma
873413|NCT00004066|uterine leiomyosarcoma|uterine leiomyosarcoma
873414|NCT00004066|ovarian sarcoma|ovarian sarcoma
873415|NCT00004066|recurrent small intestine cancer|recurrent small intestine cancer
873416|NCT00004066|stage IV adult soft tissue sarcoma|stage iv adult soft tissue sarcoma
873417|NCT00004065|stage III colon cancer|stage iii colon cancer
873418|NCT00004065|stage IV colon cancer|stage iv colon cancer
873419|NCT00004065|stage IV breast cancer|stage iv breast cancer
873420|NCT00004065|stage IIIA breast cancer|stage iiia breast cancer
873421|NCT00004065|recurrent breast cancer|recurrent breast cancer
873422|NCT00004065|stage III gastric cancer|stage iii gastric cancer
873423|NCT00004065|stage IV gastric cancer|stage iv gastric cancer
873424|NCT00004065|recurrent gastric cancer|recurrent gastric cancer
873425|NCT00004065|stage IIIB breast cancer|stage iiib breast cancer
873426|NCT00004065|stage IIIC breast cancer|stage iiic breast cancer
873427|NCT00004065|recurrent non-small cell lung cancer|recurrent non-small cell lung cancer
873428|NCT00004065|recurrent colon cancer|recurrent colon cancer
873429|NCT00004065|stage III renal cell cancer|stage iii renal cell cancer
873430|NCT00004065|stage IV renal cell cancer|stage iv renal cell cancer
873431|NCT00004065|recurrent renal cell cancer|recurrent renal cell cancer
873432|NCT00004065|stage III ovarian epithelial cancer|stage iii ovarian epithelial cancer
873433|NCT00004065|stage IV ovarian epithelial cancer|stage iv ovarian epithelial cancer
873434|NCT00004065|recurrent ovarian epithelial cancer|recurrent ovarian epithelial cancer
873435|NCT00004065|recurrent adult acute lymphoblastic leukemia|recurrent adult acute lymphoblastic leukemia
873436|NCT00004065|relapsing chronic myelogenous leukemia|relapsing chronic myelogenous leukemia
873437|NCT00004065|stage III bladder cancer|stage iii bladder cancer
873438|NCT00004065|recurrent bladder cancer|recurrent bladder cancer
873439|NCT00004065|stage IV bladder cancer|stage iv bladder cancer
873440|NCT00004065|stage III prostate cancer|stage iii prostate cancer
873441|NCT00004065|stage IV prostate cancer|stage iv prostate cancer
873442|NCT00004065|recurrent prostate cancer|recurrent prostate cancer
873446|NCT00004065|stage IIIA non-small cell lung cancer|stage iiia non-small cell lung cancer
873447|NCT00004065|stage IIIB non-small cell lung cancer|stage iiib non-small cell lung cancer
873448|NCT00004065|stage IV non-small cell lung cancer|stage iv non-small cell lung cancer
873449|NCT00004065|unspecified adult solid tumor, protocol specific|unspecified adult solid tumor, protocol specific
873450|NCT00004065|chronic phase chronic myelogenous leukemia|chronic phase chronic myelogenous leukemia
873451|NCT00004065|accelerated phase chronic myelogenous leukemia|accelerated phase chronic myelogenous leukemia
873452|NCT00004065|blastic phase chronic myelogenous leukemia|blastic phase chronic myelogenous leukemia
873453|NCT00004065|untreated metastatic squamous neck cancer with occult primary|untreated metastatic squamous neck cancer with occult primary
873454|NCT00004065|recurrent metastatic squamous neck cancer with occult primary|recurrent metastatic squamous neck cancer with occult primary
873455|NCT00004065|ovarian stromal cancer|ovarian stromal cancer
873456|NCT00004065|stage III ovarian germ cell tumor|stage iii ovarian germ cell tumor
873457|NCT00004065|stage IV ovarian germ cell tumor|stage iv ovarian germ cell tumor
873458|NCT00004065|recurrent ovarian germ cell tumor|recurrent ovarian germ cell tumor
873459|NCT00004065|stage III squamous cell carcinoma of the lip and oral cavity|stage iii squamous cell carcinoma of the lip and oral cavity
873460|NCT00004065|stage III basal cell carcinoma of the lip|stage iii basal cell carcinoma of the lip
873461|NCT00004065|stage III mucoepidermoid carcinoma of the oral cavity|stage iii mucoepidermoid carcinoma of the oral cavity
873847|NCT00003938|ovarian mature teratoma|ovarian mature teratoma
873462|NCT00004065|stage III adenoid cystic carcinoma of the oral cavity|stage iii adenoid cystic carcinoma of the oral cavity
873463|NCT00004065|stage IV squamous cell carcinoma of the lip and oral cavity|stage iv squamous cell carcinoma of the lip and oral cavity
873464|NCT00004065|stage IV basal cell carcinoma of the lip|stage iv basal cell carcinoma of the lip
873465|NCT00004065|stage IV verrucous carcinoma of the oral cavity|stage iv verrucous carcinoma of the oral cavity
873466|NCT00004065|stage IV mucoepidermoid carcinoma of the oral cavity|stage iv mucoepidermoid carcinoma of the oral cavity
873467|NCT00004065|stage IV adenoid cystic carcinoma of the oral cavity|stage iv adenoid cystic carcinoma of the oral cavity
873468|NCT00004065|recurrent squamous cell carcinoma of the lip and oral cavity|recurrent squamous cell carcinoma of the lip and oral cavity
873469|NCT00004065|recurrent basal cell carcinoma of the lip|recurrent basal cell carcinoma of the lip
873470|NCT00004065|recurrent verrucous carcinoma of the oral cavity|recurrent verrucous carcinoma of the oral cavity
873471|NCT00004065|recurrent mucoepidermoid carcinoma of the oral cavity|recurrent mucoepidermoid carcinoma of the oral cavity
873472|NCT00004065|recurrent adenoid cystic carcinoma of the oral cavity|recurrent adenoid cystic carcinoma of the oral cavity
873473|NCT00004065|stage III squamous cell carcinoma of the oropharynx|stage iii squamous cell carcinoma of the oropharynx
873474|NCT00004065|stage III lymphoepithelioma of the oropharynx|stage iii lymphoepithelioma of the oropharynx
873475|NCT00004065|stage IV squamous cell carcinoma of the oropharynx|stage iv squamous cell carcinoma of the oropharynx
873476|NCT00004065|stage IV lymphoepithelioma of the oropharynx|stage iv lymphoepithelioma of the oropharynx
873477|NCT00004065|recurrent squamous cell carcinoma of the oropharynx|recurrent squamous cell carcinoma of the oropharynx
873478|NCT00004065|recurrent lymphoepithelioma of the oropharynx|recurrent lymphoepithelioma of the oropharynx
873479|NCT00004065|stage III squamous cell carcinoma of the nasopharynx|stage iii squamous cell carcinoma of the nasopharynx
873480|NCT00004065|stage III lymphoepithelioma of the nasopharynx|stage iii lymphoepithelioma of the nasopharynx
873481|NCT00004065|stage IV squamous cell carcinoma of the nasopharynx|stage iv squamous cell carcinoma of the nasopharynx
873482|NCT00004065|stage IV lymphoepithelioma of the nasopharynx|stage iv lymphoepithelioma of the nasopharynx
873483|NCT00004065|recurrent squamous cell carcinoma of the nasopharynx|recurrent squamous cell carcinoma of the nasopharynx
873484|NCT00004065|recurrent lymphoepithelioma of the nasopharynx|recurrent lymphoepithelioma of the nasopharynx
873485|NCT00004065|stage III squamous cell carcinoma of the hypopharynx|stage iii squamous cell carcinoma of the hypopharynx
873486|NCT00004065|stage IV squamous cell carcinoma of the hypopharynx|stage iv squamous cell carcinoma of the hypopharynx
873487|NCT00004065|recurrent squamous cell carcinoma of the hypopharynx|recurrent squamous cell carcinoma of the hypopharynx
873488|NCT00004065|stage III squamous cell carcinoma of the larynx|stage iii squamous cell carcinoma of the larynx
873489|NCT00004065|stage III verrucous carcinoma of the larynx|stage iii verrucous carcinoma of the larynx
873490|NCT00004065|stage IV squamous cell carcinoma of the larynx|stage iv squamous cell carcinoma of the larynx
873491|NCT00004065|stage IV verrucous carcinoma of the larynx|stage iv verrucous carcinoma of the larynx
873492|NCT00004065|recurrent squamous cell carcinoma of the larynx|recurrent squamous cell carcinoma of the larynx
873493|NCT00004065|recurrent verrucous carcinoma of the larynx|recurrent verrucous carcinoma of the larynx
873494|NCT00004065|stage III squamous cell carcinoma of the paranasal sinus and nasal cavity|stage iii squamous cell carcinoma of the paranasal sinus and nasal cavity
873495|NCT00004065|stage III inverted papilloma of the paranasal sinus and nasal cavity|stage iii inverted papilloma of the paranasal sinus and nasal cavity
873496|NCT00004065|stage III midline lethal granuloma of the paranasal sinus and nasal cavity|stage iii midline lethal granuloma of the paranasal sinus and nasal cavity
873497|NCT00004065|stage III esthesioneuroblastoma of the paranasal sinus and nasal cavity|stage iii esthesioneuroblastoma of the paranasal sinus and nasal cavity
873498|NCT00004065|stage IV squamous cell carcinoma of the paranasal sinus and nasal cavity|stage iv squamous cell carcinoma of the paranasal sinus and nasal cavity
873499|NCT00004065|stage IV inverted papilloma of the paranasal sinus and nasal cavity|stage iv inverted papilloma of the paranasal sinus and nasal cavity
873563|NCT00004058|adult acute myeloid leukemia with 11q23 (MLL) abnormalities|adult acute myeloid leukemia with 11q23 (mll) abnormalities
873500|NCT00004065|stage IV midline lethal granuloma of the paranasal sinus and nasal cavity|stage iv midline lethal granuloma of the paranasal sinus and nasal cavity
873501|NCT00004065|stage IV esthesioneuroblastoma of the paranasal sinus and nasal cavity|stage iv esthesioneuroblastoma of the paranasal sinus and nasal cavity
873502|NCT00004065|recurrent squamous cell carcinoma of the paranasal sinus and nasal cavity|recurrent squamous cell carcinoma of the paranasal sinus and nasal cavity
873503|NCT00004065|recurrent inverted papilloma of the paranasal sinus and nasal cavity|recurrent inverted papilloma of the paranasal sinus and nasal cavity
873504|NCT00004065|recurrent midline lethal granuloma of the paranasal sinus and nasal cavity|recurrent midline lethal granuloma of the paranasal sinus and nasal cavity
873505|NCT00004065|recurrent esthesioneuroblastoma of the paranasal sinus and nasal cavity|recurrent esthesioneuroblastoma of the paranasal sinus and nasal cavity
873506|NCT00004065|borderline ovarian surface epithelial-stromal tumor|borderline ovarian surface epithelial-stromal tumor
873507|NCT00004065|ovarian sarcoma|ovarian sarcoma
873508|NCT00004065|stage III verrucous carcinoma of the oral cavity|stage iii verrucous carcinoma of the oral cavity
873509|NCT00004065|recurrent salivary gland cancer|recurrent salivary gland cancer
873510|NCT00004065|stage IV salivary gland cancer|stage iv salivary gland cancer
873511|NCT00004065|stage III salivary gland cancer|stage iii salivary gland cancer
873512|NCT00004063|unspecified adult solid tumor, protocol specific|unspecified adult solid tumor, protocol specific
873513|NCT00004058|monoclonal gammopathy of undetermined significance|monoclonal gammopathy of undetermined significance
873514|NCT00004058|recurrent adult Hodgkin lymphoma|recurrent adult hodgkin lymphoma
873515|NCT00004058|recurrent cutaneous T-cell non-Hodgkin lymphoma|recurrent cutaneous t-cell non-hodgkin lymphoma
873516|NCT00004058|isolated plasmacytoma of bone|isolated plasmacytoma of bone
873517|NCT00004058|extramedullary plasmacytoma|extramedullary plasmacytoma
873518|NCT00004058|refractory multiple myeloma|refractory multiple myeloma
873519|NCT00004058|Waldenstrom macroglobulinemia|waldenstrom macroglobulinemia
873520|NCT00004058|recurrent adult acute myeloid leukemia|recurrent adult acute myeloid leukemia
873521|NCT00004058|recurrent adult acute lymphoblastic leukemia|recurrent adult acute lymphoblastic leukemia
873522|NCT00004058|relapsing chronic myelogenous leukemia|relapsing chronic myelogenous leukemia
873523|NCT00004058|refractory chronic lymphocytic leukemia|refractory chronic lymphocytic leukemia
873524|NCT00004058|polycythemia vera|polycythemia vera
873525|NCT00004058|chronic idiopathic myelofibrosis|chronic idiopathic myelofibrosis
873526|NCT00004058|essential thrombocythemia|essential thrombocythemia
873527|NCT00004058|refractory hairy cell leukemia|refractory hairy cell leukemia
873528|NCT00004058|refractory anemia|refractory anemia
873529|NCT00004058|refractory anemia with ringed sideroblasts|refractory anemia with ringed sideroblasts
873530|NCT00004058|refractory anemia with excess blasts|refractory anemia with excess blasts
873531|NCT00004058|refractory anemia with excess blasts in transformation|refractory anemia with excess blasts in transformation
873532|NCT00004058|chronic myelomonocytic leukemia|chronic myelomonocytic leukemia
873533|NCT00004058|T-cell large granular lymphocyte leukemia|t-cell large granular lymphocyte leukemia
873534|NCT00004058|acute undifferentiated leukemia|acute undifferentiated leukemia
873535|NCT00004058|recurrent grade 1 follicular lymphoma|recurrent grade 1 follicular lymphoma
873536|NCT00004058|recurrent grade 2 follicular lymphoma|recurrent grade 2 follicular lymphoma
873537|NCT00004058|recurrent grade 3 follicular lymphoma|recurrent grade 3 follicular lymphoma
873538|NCT00004058|recurrent adult diffuse small cleaved cell lymphoma|recurrent adult diffuse small cleaved cell lymphoma
873539|NCT00004058|recurrent adult diffuse mixed cell lymphoma|recurrent adult diffuse mixed cell lymphoma
873540|NCT00004058|recurrent adult diffuse large cell lymphoma|recurrent adult diffuse large cell lymphoma
873541|NCT00004058|recurrent adult immunoblastic large cell lymphoma|recurrent adult immunoblastic large cell lymphoma
873542|NCT00004058|recurrent adult lymphoblastic lymphoma|recurrent adult lymphoblastic lymphoma
873543|NCT00004058|recurrent adult Burkitt lymphoma|recurrent adult burkitt lymphoma
873544|NCT00004058|recurrent adult T-cell leukemia/lymphoma|recurrent adult t-cell leukemia/lymphoma
873545|NCT00004058|secondary acute myeloid leukemia|secondary acute myeloid leukemia
873546|NCT00004058|previously treated myelodysplastic syndromes|previously treated myelodysplastic syndromes
873547|NCT00004058|secondary myelodysplastic syndromes|secondary myelodysplastic syndromes
873548|NCT00004058|primary central nervous system lymphoma|primary central nervous system lymphoma
873549|NCT00004058|prolymphocytic leukemia|prolymphocytic leukemia
873550|NCT00004058|primary systemic amyloidosis|primary systemic amyloidosis
873551|NCT00004058|recurrent mantle cell lymphoma|recurrent mantle cell lymphoma
873552|NCT00004058|angioimmunoblastic T-cell lymphoma|angioimmunoblastic t-cell lymphoma
873553|NCT00004058|anaplastic large cell lymphoma|anaplastic large cell lymphoma
873554|NCT00004058|refractory cytopenia with multilineage dysplasia|refractory cytopenia with multilineage dysplasia
873555|NCT00004058|recurrent mycosis fungoides/Sezary syndrome|recurrent mycosis fungoides/sezary syndrome
873556|NCT00004058|chronic eosinophilic leukemia|chronic eosinophilic leukemia
873557|NCT00004058|chronic neutrophilic leukemia|chronic neutrophilic leukemia
873558|NCT00004058|atypical chronic myeloid leukemia|atypical chronic myeloid leukemia
873559|NCT00004058|myelodysplastic/myeloproliferative disease, unclassifiable|myelodysplastic/myeloproliferative disease, unclassifiable
873560|NCT00004058|adult acute myeloid leukemia with t(8;21)(q22;q22)|adult acute myeloid leukemia with t(8;21)(q22;q22)
873561|NCT00004058|adult acute myeloid leukemia with t(16;16)(p13;q22)|adult acute myeloid leukemia with t(16;16)(p13;q22)
873562|NCT00004058|adult acute myeloid leukemia with inv(16)(p13;q22)|adult acute myeloid leukemia with inv(16)(p13;q22)
873564|NCT00004058|adult acute myeloid leukemia with t(15;17)(q22;q12)|adult acute myeloid leukemia with t(15;17)(q22;q12)
873565|NCT00004054|stage IIB prostate cancer|stage iib prostate cancer
873566|NCT00004054|stage IIA prostate cancer|stage iia prostate cancer
873567|NCT00004054|stage III prostate cancer|stage iii prostate cancer
873568|NCT00004054|stage IV prostate cancer|stage iv prostate cancer
873569|NCT00004031|stage III grade 3 follicular lymphoma|stage iii grade 3 follicular lymphoma
873570|NCT00004031|stage III adult diffuse small cleaved cell lymphoma|stage iii adult diffuse small cleaved cell lymphoma
873571|NCT00004031|stage III adult diffuse mixed cell lymphoma|stage iii adult diffuse mixed cell lymphoma
873572|NCT00004031|stage III adult diffuse large cell lymphoma|stage iii adult diffuse large cell lymphoma
873573|NCT00004031|stage III adult immunoblastic large cell lymphoma|stage iii adult immunoblastic large cell lymphoma
873574|NCT00004031|stage III adult Burkitt lymphoma|stage iii adult burkitt lymphoma
873575|NCT00004031|stage IV grade 3 follicular lymphoma|stage iv grade 3 follicular lymphoma
873576|NCT00004031|stage IV adult diffuse small cleaved cell lymphoma|stage iv adult diffuse small cleaved cell lymphoma
873577|NCT00004031|stage IV adult diffuse mixed cell lymphoma|stage iv adult diffuse mixed cell lymphoma
873578|NCT00004031|stage IV adult diffuse large cell lymphoma|stage iv adult diffuse large cell lymphoma
873579|NCT00004031|stage IV adult immunoblastic large cell lymphoma|stage iv adult immunoblastic large cell lymphoma
873580|NCT00004031|stage IV adult Burkitt lymphoma|stage iv adult burkitt lymphoma
873581|NCT00004031|contiguous stage II grade 3 follicular lymphoma|contiguous stage ii grade 3 follicular lymphoma
873582|NCT00004031|contiguous stage II adult diffuse small cleaved cell lymphoma|contiguous stage ii adult diffuse small cleaved cell lymphoma
873583|NCT00004031|contiguous stage II adult diffuse mixed cell lymphoma|contiguous stage ii adult diffuse mixed cell lymphoma
873584|NCT00004031|contiguous stage II adult immunoblastic large cell lymphoma|contiguous stage ii adult immunoblastic large cell lymphoma
873585|NCT00004031|contiguous stage II adult diffuse large cell lymphoma|contiguous stage ii adult diffuse large cell lymphoma
873586|NCT00004031|contiguous stage II adult Burkitt lymphoma|contiguous stage ii adult burkitt lymphoma
873587|NCT00004031|noncontiguous stage II grade 3 follicular lymphoma|noncontiguous stage ii grade 3 follicular lymphoma
873588|NCT00004031|noncontiguous stage II adult diffuse small cleaved cell lymphoma|noncontiguous stage ii adult diffuse small cleaved cell lymphoma
873589|NCT00004031|noncontiguous stage II adult diffuse mixed cell lymphoma|noncontiguous stage ii adult diffuse mixed cell lymphoma
873590|NCT00004031|noncontiguous stage II adult immunoblastic large cell lymphoma|noncontiguous stage ii adult immunoblastic large cell lymphoma
873591|NCT00004031|noncontiguous stage II adult diffuse large cell lymphoma|noncontiguous stage ii adult diffuse large cell lymphoma
875032|NCT00003458|Oligodendroglioma|oligodendroglioma
873592|NCT00004031|noncontiguous stage II adult Burkitt lymphoma|noncontiguous stage ii adult burkitt lymphoma
873593|NCT00004028|recurrent adult brain tumor|recurrent adult brain tumor
873594|NCT00004028|adult glioblastoma|adult glioblastoma
873595|NCT00004028|adult anaplastic astrocytoma|adult anaplastic astrocytoma
873596|NCT00004028|adult anaplastic ependymoma|adult anaplastic ependymoma
873597|NCT00004028|adult anaplastic oligodendroglioma|adult anaplastic oligodendroglioma
873598|NCT00004028|adult mixed glioma|adult mixed glioma
873599|NCT00004028|adult ependymoblastoma|adult ependymoblastoma
873600|NCT00004028|adult giant cell glioblastoma|adult giant cell glioblastoma
873601|NCT00004028|adult gliosarcoma|adult gliosarcoma
873602|NCT00004024|recurrent adult brain tumor|recurrent adult brain tumor
873603|NCT00004024|adult glioblastoma|adult glioblastoma
873604|NCT00004024|adult anaplastic astrocytoma|adult anaplastic astrocytoma
873605|NCT00004024|adult anaplastic oligodendroglioma|adult anaplastic oligodendroglioma
873606|NCT00004024|adult subependymoma|adult subependymoma
873607|NCT00004024|adult oligodendroglioma|adult oligodendroglioma
873608|NCT00004024|adult giant cell glioblastoma|adult giant cell glioblastoma
873609|NCT00004024|adult gliosarcoma|adult gliosarcoma
873610|NCT00004024|adult diffuse astrocytoma|adult diffuse astrocytoma
873611|NCT00004017|recurrent adult brain tumor|recurrent adult brain tumor
873612|NCT00004017|adult glioblastoma|adult glioblastoma
873613|NCT00004017|adult anaplastic astrocytoma|adult anaplastic astrocytoma
873614|NCT00004017|adult giant cell glioblastoma|adult giant cell glioblastoma
873615|NCT00004017|adult gliosarcoma|adult gliosarcoma
873616|NCT00004015|adult glioblastoma|adult glioblastoma
873617|NCT00004015|adult giant cell glioblastoma|adult giant cell glioblastoma
873618|NCT00004015|adult gliosarcoma|adult gliosarcoma
873619|NCT00004011|stage I non-small cell lung cancer|stage i non-small cell lung cancer
873620|NCT00004011|stage II non-small cell lung cancer|stage ii non-small cell lung cancer
873621|NCT00004011|stage IIIA non-small cell lung cancer|stage iiia non-small cell lung cancer
873622|NCT00004005|stage III colon cancer|stage iii colon cancer
873623|NCT00004005|stage IV colon cancer|stage iv colon cancer
873624|NCT00004005|stage III rectal cancer|stage iii rectal cancer
873625|NCT00004005|stage IV rectal cancer|stage iv rectal cancer
873626|NCT00004005|unspecified childhood solid tumor, protocol specific|unspecified childhood solid tumor, protocol specific
873627|NCT00004005|unspecified adult solid tumor, protocol specific|unspecified adult solid tumor, protocol specific
873628|NCT00004005|adenocarcinoma of unknown primary|adenocarcinoma of unknown primary
873629|NCT00004005|newly diagnosed carcinoma of unknown primary|newly diagnosed carcinoma of unknown primary
873630|NCT00004005|recurrent carcinoma of unknown primary|recurrent carcinoma of unknown primary
873631|NCT00004001|adenocarcinoma of the prostate|adenocarcinoma of the prostate
873633|NCT00004001|recurrent prostate cancer|recurrent prostate cancer
873634|NCT00003993|stage IV adult Hodgkin lymphoma|stage iv adult hodgkin lymphoma
873635|NCT00003993|recurrent adult Hodgkin lymphoma|recurrent adult hodgkin lymphoma
873636|NCT00003993|stage IV cutaneous T-cell non-Hodgkin lymphoma|stage iv cutaneous t-cell non-hodgkin lymphoma
873637|NCT00003993|recurrent cutaneous T-cell non-Hodgkin lymphoma|recurrent cutaneous t-cell non-hodgkin lymphoma
873638|NCT00003993|small intestine lymphoma|small intestine lymphoma
873639|NCT00003993|unspecified adult solid tumor, protocol specific|unspecified adult solid tumor, protocol specific
873640|NCT00003993|stage IV grade 1 follicular lymphoma|stage iv grade 1 follicular lymphoma
873641|NCT00003993|stage IV grade 2 follicular lymphoma|stage iv grade 2 follicular lymphoma
873642|NCT00003993|stage IV grade 3 follicular lymphoma|stage iv grade 3 follicular lymphoma
873643|NCT00003993|stage IV adult diffuse small cleaved cell lymphoma|stage iv adult diffuse small cleaved cell lymphoma
873644|NCT00003993|stage IV adult diffuse mixed cell lymphoma|stage iv adult diffuse mixed cell lymphoma
873645|NCT00003993|stage IV adult diffuse large cell lymphoma|stage iv adult diffuse large cell lymphoma
873646|NCT00003993|stage IV adult immunoblastic large cell lymphoma|stage iv adult immunoblastic large cell lymphoma
873647|NCT00003993|stage IV adult lymphoblastic lymphoma|stage iv adult lymphoblastic lymphoma
873648|NCT00003993|stage IV adult Burkitt lymphoma|stage iv adult burkitt lymphoma
873649|NCT00003993|recurrent grade 1 follicular lymphoma|recurrent grade 1 follicular lymphoma
873650|NCT00003993|recurrent grade 2 follicular lymphoma|recurrent grade 2 follicular lymphoma
873651|NCT00003993|recurrent grade 3 follicular lymphoma|recurrent grade 3 follicular lymphoma
873652|NCT00003993|recurrent adult diffuse small cleaved cell lymphoma|recurrent adult diffuse small cleaved cell lymphoma
873653|NCT00003993|recurrent adult diffuse mixed cell lymphoma|recurrent adult diffuse mixed cell lymphoma
873654|NCT00003993|recurrent adult diffuse large cell lymphoma|recurrent adult diffuse large cell lymphoma
873655|NCT00003993|recurrent adult immunoblastic large cell lymphoma|recurrent adult immunoblastic large cell lymphoma
873656|NCT00003993|recurrent adult lymphoblastic lymphoma|recurrent adult lymphoblastic lymphoma
873657|NCT00003993|recurrent adult Burkitt lymphoma|recurrent adult burkitt lymphoma
873658|NCT00003993|stage IV adult T-cell leukemia/lymphoma|stage iv adult t-cell leukemia/lymphoma
873659|NCT00003993|recurrent adult T-cell leukemia/lymphoma|recurrent adult t-cell leukemia/lymphoma
873660|NCT00003993|primary central nervous system non-Hodgkin lymphoma|primary central nervous system non-hodgkin lymphoma
873661|NCT00003993|intraocular lymphoma|intraocular lymphoma
873662|NCT00003993|stage IV mantle cell lymphoma|stage iv mantle cell lymphoma
873663|NCT00003993|recurrent mantle cell lymphoma|recurrent mantle cell lymphoma
873664|NCT00003993|angioimmunoblastic T-cell lymphoma|angioimmunoblastic t-cell lymphoma
873665|NCT00003993|anaplastic large cell lymphoma|anaplastic large cell lymphoma
873666|NCT00003993|stage IV mycosis fungoides/Sezary syndrome|stage iv mycosis fungoides/sezary syndrome
873667|NCT00003993|recurrent mycosis fungoides/Sezary syndrome|recurrent mycosis fungoides/sezary syndrome
873668|NCT00003993|recurrent marginal zone lymphoma|recurrent marginal zone lymphoma
873669|NCT00003993|recurrent small lymphocytic lymphoma|recurrent small lymphocytic lymphoma
873670|NCT00003993|stage IV small lymphocytic lymphoma|stage iv small lymphocytic lymphoma
873671|NCT00003993|stage IV marginal zone lymphoma|stage iv marginal zone lymphoma
873672|NCT00003993|extranodal marginal zone B-cell lymphoma of mucosa-associated lymphoid tissue|extranodal marginal zone b-cell lymphoma of mucosa-associated lymphoid tissue
873673|NCT00003993|nodal marginal zone B-cell lymphoma|nodal marginal zone b-cell lymphoma
873674|NCT00003993|splenic marginal zone lymphoma|splenic marginal zone lymphoma
873675|NCT00003981|unspecified adult solid tumor, protocol specific|unspecified adult solid tumor, protocol specific
873676|NCT00003979|unspecified adult solid tumor, protocol specific|unspecified adult solid tumor, protocol specific
873677|NCT00003977|stage III cervical cancer|stage iii cervical cancer
873678|NCT00003977|recurrent cervical cancer|recurrent cervical cancer
873679|NCT00003977|stage IB cervical cancer|stage ib cervical cancer
873680|NCT00003977|stage IIB cervical cancer|stage iib cervical cancer
873681|NCT00003977|stage IVB cervical cancer|stage ivb cervical cancer
873682|NCT00003977|stage IA cervical cancer|stage ia cervical cancer
873683|NCT00003977|stage IIA cervical cancer|stage iia cervical cancer
873684|NCT00003977|stage IVA cervical cancer|stage iva cervical cancer
873685|NCT00003969|unspecified adult solid tumor, protocol specific|unspecified adult solid tumor, protocol specific
873686|NCT00003966|veno-occlusive disease|veno-occlusive disease
873687|NCT00003963|Waldenstrom macroglobulinemia|waldenstrom macroglobulinemia
873688|NCT00003963|recurrent grade 1 follicular lymphoma|recurrent grade 1 follicular lymphoma
873689|NCT00003963|recurrent grade 2 follicular lymphoma|recurrent grade 2 follicular lymphoma
873690|NCT00003963|recurrent grade 3 follicular lymphoma|recurrent grade 3 follicular lymphoma
875623|NCT00002916|cervical adenocarcinoma|cervical adenocarcinoma
873691|NCT00003963|recurrent adult diffuse small cleaved cell lymphoma|recurrent adult diffuse small cleaved cell lymphoma
873692|NCT00003963|recurrent adult diffuse mixed cell lymphoma|recurrent adult diffuse mixed cell lymphoma
873693|NCT00003963|recurrent adult diffuse large cell lymphoma|recurrent adult diffuse large cell lymphoma
873694|NCT00003963|recurrent adult immunoblastic large cell lymphoma|recurrent adult immunoblastic large cell lymphoma
873695|NCT00003963|recurrent adult lymphoblastic lymphoma|recurrent adult lymphoblastic lymphoma
873696|NCT00003963|recurrent adult Burkitt lymphoma|recurrent adult burkitt lymphoma
873697|NCT00003963|recurrent mantle cell lymphoma|recurrent mantle cell lymphoma
878500|NCT00048490|Epilepsy|epilepsy
873698|NCT00003963|recurrent marginal zone lymphoma|recurrent marginal zone lymphoma
873699|NCT00003963|recurrent small lymphocytic lymphoma|recurrent small lymphocytic lymphoma
873700|NCT00003963|extranodal marginal zone B-cell lymphoma of mucosa-associated lymphoid tissue|extranodal marginal zone b-cell lymphoma of mucosa-associated lymphoid tissue
873701|NCT00003963|nodal marginal zone B-cell lymphoma|nodal marginal zone b-cell lymphoma
873702|NCT00003963|splenic marginal zone lymphoma|splenic marginal zone lymphoma
873703|NCT00003961|refractory anemia with excess blasts|refractory anemia with excess blasts
873704|NCT00003961|refractory anemia with excess blasts in transformation|refractory anemia with excess blasts in transformation
873705|NCT00003961|chronic myelomonocytic leukemia|chronic myelomonocytic leukemia
873706|NCT00003961|de novo myelodysplastic syndromes|de novo myelodysplastic syndromes
873707|NCT00003961|previously treated myelodysplastic syndromes|previously treated myelodysplastic syndromes
873708|NCT00003961|secondary myelodysplastic syndromes|secondary myelodysplastic syndromes
873709|NCT00003961|refractory cytopenia with multilineage dysplasia|refractory cytopenia with multilineage dysplasia
873710|NCT00003961|atypical chronic myeloid leukemia|atypical chronic myeloid leukemia
873711|NCT00003961|myelodysplastic/myeloproliferative disease, unclassifiable|myelodysplastic/myeloproliferative disease, unclassifiable
873712|NCT00003955|embryonal childhood rhabdomyosarcoma|embryonal childhood rhabdomyosarcoma
873713|NCT00003955|alveolar childhood rhabdomyosarcoma|alveolar childhood rhabdomyosarcoma
873714|NCT00003955|metastatic childhood soft tissue sarcoma|metastatic childhood soft tissue sarcoma
873715|NCT00003955|childhood malignant mesenchymoma|childhood malignant mesenchymoma
873716|NCT00003955|previously untreated childhood rhabdomyosarcoma|previously untreated childhood rhabdomyosarcoma
873717|NCT00003955|adult rhabdomyosarcoma|adult rhabdomyosarcoma
873718|NCT00003955|adult malignant mesenchymoma|adult malignant mesenchymoma
873719|NCT00003955|stage IV adult soft tissue sarcoma|stage iv adult soft tissue sarcoma
873720|NCT00003945|recurrent cervical cancer|recurrent cervical cancer
873721|NCT00003945|stage IVB cervical cancer|stage ivb cervical cancer
873722|NCT00003945|cervical squamous cell carcinoma|cervical squamous cell carcinoma
873723|NCT00003945|cervical adenocarcinoma|cervical adenocarcinoma
873724|NCT00003945|cervical adenosquamous cell carcinoma|cervical adenosquamous cell carcinoma
873725|NCT00003941|stage III malignant testicular germ cell tumor|stage iii malignant testicular germ cell tumor
873726|NCT00003941|mediastinal cancer|mediastinal cancer
873727|NCT00003941|testicular embryonal carcinoma|testicular embryonal carcinoma
873728|NCT00003941|testicular choriocarcinoma|testicular choriocarcinoma
873729|NCT00003941|testicular teratoma|testicular teratoma
873730|NCT00003941|testicular yolk sac tumor|testicular yolk sac tumor
873731|NCT00003941|testicular embryonal carcinoma and teratoma|testicular embryonal carcinoma and teratoma
873732|NCT00003941|testicular embryonal carcinoma and teratoma with seminoma|testicular embryonal carcinoma and teratoma with seminoma
873733|NCT00003941|testicular embryonal carcinoma and yolk sac tumor|testicular embryonal carcinoma and yolk sac tumor
873734|NCT00003941|testicular embryonal carcinoma and yolk sac tumor with seminoma|testicular embryonal carcinoma and yolk sac tumor with seminoma
873735|NCT00003941|testicular embryonal carcinoma and seminoma|testicular embryonal carcinoma and seminoma
873736|NCT00003941|testicular yolk sac tumor and teratoma|testicular yolk sac tumor and teratoma
873737|NCT00003941|testicular yolk sac tumor and teratoma with seminoma|testicular yolk sac tumor and teratoma with seminoma
873738|NCT00003941|testicular choriocarcinoma and yolk sac tumor|testicular choriocarcinoma and yolk sac tumor
873739|NCT00003941|testicular choriocarcinoma and embryonal carcinoma|testicular choriocarcinoma and embryonal carcinoma
873740|NCT00003941|testicular choriocarcinoma and teratoma|testicular choriocarcinoma and teratoma
873741|NCT00003941|testicular choriocarcinoma and seminoma|testicular choriocarcinoma and seminoma
873742|NCT00003941|tumors metastatic to brain|tumors metastatic to brain
873743|NCT00003941|liver metastases|liver metastases
873744|NCT00003941|bone metastases|bone metastases
873745|NCT00003938|stage I adult Hodgkin lymphoma|stage i adult hodgkin lymphoma
873746|NCT00003938|stage II adult Hodgkin lymphoma|stage ii adult hodgkin lymphoma
873747|NCT00003938|stage III adult Hodgkin lymphoma|stage iii adult hodgkin lymphoma
873748|NCT00003938|stage IV adult Hodgkin lymphoma|stage iv adult hodgkin lymphoma
873749|NCT00003938|stage IV breast cancer|stage iv breast cancer
873750|NCT00003938|stage IIIA breast cancer|stage iiia breast cancer
873751|NCT00003938|monoclonal gammopathy of undetermined significance|monoclonal gammopathy of undetermined significance
873752|NCT00003938|stage IIIB breast cancer|stage iiib breast cancer
873753|NCT00003938|recurrent childhood acute lymphoblastic leukemia|recurrent childhood acute lymphoblastic leukemia
873754|NCT00003938|recurrent adult Hodgkin lymphoma|recurrent adult hodgkin lymphoma
873755|NCT00003938|stage I cutaneous T-cell non-Hodgkin lymphoma|stage i cutaneous t-cell non-hodgkin lymphoma
873756|NCT00003938|stage II cutaneous T-cell non-Hodgkin lymphoma|stage ii cutaneous t-cell non-hodgkin lymphoma
873757|NCT00003938|stage III cutaneous T-cell non-Hodgkin lymphoma|stage iii cutaneous t-cell non-hodgkin lymphoma
873758|NCT00003938|stage IV cutaneous T-cell non-Hodgkin lymphoma|stage iv cutaneous t-cell non-hodgkin lymphoma
873759|NCT00003938|recurrent cutaneous T-cell non-Hodgkin lymphoma|recurrent cutaneous t-cell non-hodgkin lymphoma
873760|NCT00003938|isolated plasmacytoma of bone|isolated plasmacytoma of bone
873761|NCT00003938|extramedullary plasmacytoma|extramedullary plasmacytoma
873762|NCT00003938|refractory multiple myeloma|refractory multiple myeloma
873763|NCT00003938|recurrent childhood rhabdomyosarcoma|recurrent childhood rhabdomyosarcoma
873764|NCT00003938|stage II ovarian epithelial cancer|stage ii ovarian epithelial cancer
873765|NCT00003938|stage III ovarian epithelial cancer|stage iii ovarian epithelial cancer
873766|NCT00003938|stage IV ovarian epithelial cancer|stage iv ovarian epithelial cancer
873767|NCT00003938|recurrent ovarian epithelial cancer|recurrent ovarian epithelial cancer
873768|NCT00003938|disseminated neuroblastoma|disseminated neuroblastoma
873769|NCT00003938|recurrent neuroblastoma|recurrent neuroblastoma
873770|NCT00003938|recurrent Wilms tumor and other childhood kidney tumors|recurrent wilms tumor and other childhood kidney tumors
873771|NCT00003938|stage 0 chronic lymphocytic leukemia|stage 0 chronic lymphocytic leukemia
873772|NCT00003938|Waldenstrom macroglobulinemia|waldenstrom macroglobulinemia
873773|NCT00003938|stage I multiple myeloma|stage i multiple myeloma
873774|NCT00003938|stage II multiple myeloma|stage ii multiple myeloma
873775|NCT00003938|stage III multiple myeloma|stage iii multiple myeloma
873776|NCT00003938|stage I childhood lymphoblastic lymphoma|stage i childhood lymphoblastic lymphoma
873777|NCT00003938|stage II childhood lymphoblastic lymphoma|stage ii childhood lymphoblastic lymphoma
873778|NCT00003938|stage III childhood lymphoblastic lymphoma|stage iii childhood lymphoblastic lymphoma
873779|NCT00003938|stage IV childhood lymphoblastic lymphoma|stage iv childhood lymphoblastic lymphoma
873780|NCT00003938|recurrent childhood lymphoblastic lymphoma|recurrent childhood lymphoblastic lymphoma
873781|NCT00003938|stage I chronic lymphocytic leukemia|stage i chronic lymphocytic leukemia
894967|NCT00001643|Mutation|mutation
873782|NCT00003938|stage II chronic lymphocytic leukemia|stage ii chronic lymphocytic leukemia
873783|NCT00003938|stage III chronic lymphocytic leukemia|stage iii chronic lymphocytic leukemia
873784|NCT00003938|stage IV chronic lymphocytic leukemia|stage iv chronic lymphocytic leukemia
873785|NCT00003938|recurrent childhood acute myeloid leukemia|recurrent childhood acute myeloid leukemia
875729|NCT00002842|recurrent rectal cancer|recurrent rectal cancer
873786|NCT00003938|recurrent adult acute myeloid leukemia|recurrent adult acute myeloid leukemia
873787|NCT00003938|recurrent adult acute lymphoblastic leukemia|recurrent adult acute lymphoblastic leukemia
873788|NCT00003938|relapsing chronic myelogenous leukemia|relapsing chronic myelogenous leukemia
873789|NCT00003938|refractory chronic lymphocytic leukemia|refractory chronic lymphocytic leukemia
873790|NCT00003938|small intestine lymphoma|small intestine lymphoma
873791|NCT00003938|stage III malignant testicular germ cell tumor|stage iii malignant testicular germ cell tumor
873792|NCT00003938|recurrent malignant testicular germ cell tumor|recurrent malignant testicular germ cell tumor
873793|NCT00003938|unspecified childhood solid tumor, protocol specific|unspecified childhood solid tumor, protocol specific
873794|NCT00003938|unspecified adult solid tumor, protocol specific|unspecified adult solid tumor, protocol specific
873795|NCT00003938|chronic phase chronic myelogenous leukemia|chronic phase chronic myelogenous leukemia
873796|NCT00003938|accelerated phase chronic myelogenous leukemia|accelerated phase chronic myelogenous leukemia
873797|NCT00003938|blastic phase chronic myelogenous leukemia|blastic phase chronic myelogenous leukemia
873798|NCT00003938|meningeal chronic myelogenous leukemia|meningeal chronic myelogenous leukemia
873799|NCT00003938|adult acute myeloid leukemia in remission|adult acute myeloid leukemia in remission
873800|NCT00003938|adult acute lymphoblastic leukemia in remission|adult acute lymphoblastic leukemia in remission
873801|NCT00003938|childhood acute myeloid leukemia in remission|childhood acute myeloid leukemia in remission
873802|NCT00003938|childhood acute lymphoblastic leukemia in remission|childhood acute lymphoblastic leukemia in remission
873803|NCT00003938|polycythemia vera|polycythemia vera
873804|NCT00003938|primary myelofibrosis|primary myelofibrosis
873805|NCT00003938|essential thrombocythemia|essential thrombocythemia
873806|NCT00003938|fever, sweats, and hot flashes|fever, sweats, and hot flashes
873807|NCT00003938|childhood acute promyelocytic leukemia (M3)|childhood acute promyelocytic leukemia (m3)
873808|NCT00003938|testicular embryonal carcinoma|testicular embryonal carcinoma
873809|NCT00003938|testicular choriocarcinoma|testicular choriocarcinoma
873810|NCT00003938|testicular teratoma|testicular teratoma
873811|NCT00003938|testicular yolk sac tumor|testicular yolk sac tumor
873812|NCT00003938|testicular embryonal carcinoma and teratoma|testicular embryonal carcinoma and teratoma
873813|NCT00003938|testicular embryonal carcinoma and teratoma with seminoma|testicular embryonal carcinoma and teratoma with seminoma
873814|NCT00003938|testicular embryonal carcinoma and yolk sac tumor|testicular embryonal carcinoma and yolk sac tumor
873815|NCT00003938|testicular embryonal carcinoma and yolk sac tumor with seminoma|testicular embryonal carcinoma and yolk sac tumor with seminoma
873816|NCT00003938|testicular embryonal carcinoma and seminoma|testicular embryonal carcinoma and seminoma
873817|NCT00003938|testicular yolk sac tumor and teratoma|testicular yolk sac tumor and teratoma
873818|NCT00003938|testicular yolk sac tumor and teratoma with seminoma|testicular yolk sac tumor and teratoma with seminoma
873819|NCT00003938|testicular choriocarcinoma and yolk sac tumor|testicular choriocarcinoma and yolk sac tumor
873820|NCT00003938|testicular choriocarcinoma and embryonal carcinoma|testicular choriocarcinoma and embryonal carcinoma
873821|NCT00003938|testicular choriocarcinoma and teratoma|testicular choriocarcinoma and teratoma
873822|NCT00003938|testicular choriocarcinoma and seminoma|testicular choriocarcinoma and seminoma
873823|NCT00003938|progressive hairy cell leukemia, initial treatment|progressive hairy cell leukemia, initial treatment
873824|NCT00003938|refractory hairy cell leukemia|refractory hairy cell leukemia
873825|NCT00003938|stage II childhood Hodgkin lymphoma|stage ii childhood hodgkin lymphoma
873826|NCT00003938|stage I childhood Hodgkin lymphoma|stage i childhood hodgkin lymphoma
873827|NCT00003938|stage III childhood Hodgkin lymphoma|stage iii childhood hodgkin lymphoma
873828|NCT00003938|stage IV childhood Hodgkin lymphoma|stage iv childhood hodgkin lymphoma
878501|NCT00048477|Endothelium|endothelium
873829|NCT00003938|recurrent/refractory childhood Hodgkin lymphoma|recurrent/refractory childhood hodgkin lymphoma
873830|NCT00003938|stage I grade 1 follicular lymphoma|stage i grade 1 follicular lymphoma
873831|NCT00003938|stage I grade 2 follicular lymphoma|stage i grade 2 follicular lymphoma
873832|NCT00003938|stage I grade 3 follicular lymphoma|stage i grade 3 follicular lymphoma
873833|NCT00003938|stage I adult diffuse small cleaved cell lymphoma|stage i adult diffuse small cleaved cell lymphoma
873834|NCT00003938|stage I adult diffuse mixed cell lymphoma|stage i adult diffuse mixed cell lymphoma
873835|NCT00003938|stage I adult diffuse large cell lymphoma|stage i adult diffuse large cell lymphoma
873836|NCT00003938|stage I adult immunoblastic large cell lymphoma|stage i adult immunoblastic large cell lymphoma
873837|NCT00003938|stage I adult lymphoblastic lymphoma|stage i adult lymphoblastic lymphoma
873838|NCT00003938|stage I adult Burkitt lymphoma|stage i adult burkitt lymphoma
873839|NCT00003938|recurrent ovarian germ cell tumor|recurrent ovarian germ cell tumor
873840|NCT00003938|chronic myelomonocytic leukemia|chronic myelomonocytic leukemia
873841|NCT00003938|T-cell large granular lymphocyte leukemia|t-cell large granular lymphocyte leukemia
873842|NCT00003938|ovarian yolk sac tumor|ovarian yolk sac tumor
873843|NCT00003938|ovarian embryonal carcinoma|ovarian embryonal carcinoma
873844|NCT00003938|ovarian polyembryoma|ovarian polyembryoma
873845|NCT00003938|ovarian choriocarcinoma|ovarian choriocarcinoma
873848|NCT00003938|ovarian monodermal and highly specialized teratoma|ovarian monodermal and highly specialized teratoma
873849|NCT00003938|ovarian mixed germ cell tumor|ovarian mixed germ cell tumor
873850|NCT00003938|acute undifferentiated leukemia|acute undifferentiated leukemia
873851|NCT00003938|stage III grade 1 follicular lymphoma|stage iii grade 1 follicular lymphoma
873852|NCT00003938|stage III grade 2 follicular lymphoma|stage iii grade 2 follicular lymphoma
873853|NCT00003938|stage III grade 3 follicular lymphoma|stage iii grade 3 follicular lymphoma
873854|NCT00003938|stage III adult diffuse small cleaved cell lymphoma|stage iii adult diffuse small cleaved cell lymphoma
873855|NCT00003938|stage III adult diffuse mixed cell lymphoma|stage iii adult diffuse mixed cell lymphoma
873856|NCT00003938|stage III adult diffuse large cell lymphoma|stage iii adult diffuse large cell lymphoma
873857|NCT00003938|stage III adult immunoblastic large cell lymphoma|stage iii adult immunoblastic large cell lymphoma
873858|NCT00003938|stage III adult lymphoblastic lymphoma|stage iii adult lymphoblastic lymphoma
873859|NCT00003938|stage III adult Burkitt lymphoma|stage iii adult burkitt lymphoma
873860|NCT00003938|stage IV grade 1 follicular lymphoma|stage iv grade 1 follicular lymphoma
873861|NCT00003938|stage IV grade 2 follicular lymphoma|stage iv grade 2 follicular lymphoma
873862|NCT00003938|stage IV grade 3 follicular lymphoma|stage iv grade 3 follicular lymphoma
873863|NCT00003938|stage IV adult diffuse small cleaved cell lymphoma|stage iv adult diffuse small cleaved cell lymphoma
873864|NCT00003938|stage IV adult diffuse mixed cell lymphoma|stage iv adult diffuse mixed cell lymphoma
873865|NCT00003938|stage IV adult diffuse large cell lymphoma|stage iv adult diffuse large cell lymphoma
873866|NCT00003938|stage IV adult immunoblastic large cell lymphoma|stage iv adult immunoblastic large cell lymphoma
873867|NCT00003938|stage IV adult lymphoblastic lymphoma|stage iv adult lymphoblastic lymphoma
873868|NCT00003938|stage IV adult Burkitt lymphoma|stage iv adult burkitt lymphoma
873869|NCT00003938|recurrent grade 1 follicular lymphoma|recurrent grade 1 follicular lymphoma
873870|NCT00003938|recurrent grade 2 follicular lymphoma|recurrent grade 2 follicular lymphoma
873871|NCT00003938|recurrent grade 3 follicular lymphoma|recurrent grade 3 follicular lymphoma
873872|NCT00003938|recurrent adult diffuse small cleaved cell lymphoma|recurrent adult diffuse small cleaved cell lymphoma
873873|NCT00003938|recurrent adult diffuse mixed cell lymphoma|recurrent adult diffuse mixed cell lymphoma
873874|NCT00003938|recurrent adult diffuse large cell lymphoma|recurrent adult diffuse large cell lymphoma
873875|NCT00003938|recurrent adult immunoblastic large cell lymphoma|recurrent adult immunoblastic large cell lymphoma
873876|NCT00003938|recurrent adult lymphoblastic lymphoma|recurrent adult lymphoblastic lymphoma
873877|NCT00003938|recurrent adult Burkitt lymphoma|recurrent adult burkitt lymphoma
873878|NCT00003938|stage I adult T-cell leukemia/lymphoma|stage i adult t-cell leukemia/lymphoma
873879|NCT00003938|stage II adult T-cell leukemia/lymphoma|stage ii adult t-cell leukemia/lymphoma
873880|NCT00003938|stage III adult T-cell leukemia/lymphoma|stage iii adult t-cell leukemia/lymphoma
873881|NCT00003938|stage IV adult T-cell leukemia/lymphoma|stage iv adult t-cell leukemia/lymphoma
873882|NCT00003938|recurrent adult T-cell leukemia/lymphoma|recurrent adult t-cell leukemia/lymphoma
873883|NCT00003938|de novo myelodysplastic syndromes|de novo myelodysplastic syndromes
873884|NCT00003938|high risk metastatic gestational trophoblastic tumor|high risk metastatic gestational trophoblastic tumor
873885|NCT00003938|previously treated myelodysplastic syndromes|previously treated myelodysplastic syndromes
873886|NCT00003938|secondary myelodysplastic syndromes|secondary myelodysplastic syndromes
873887|NCT00003938|primary central nervous system non-Hodgkin lymphoma|primary central nervous system non-hodgkin lymphoma
873888|NCT00003938|neutropenia|neutropenia
873889|NCT00003938|infection|infection
873890|NCT00003938|previously untreated childhood rhabdomyosarcoma|previously untreated childhood rhabdomyosarcoma
873891|NCT00003938|prolymphocytic leukemia|prolymphocytic leukemia
873892|NCT00003938|primary systemic amyloidosis|primary systemic amyloidosis
873893|NCT00003938|intraocular lymphoma|intraocular lymphoma
873894|NCT00003938|stage I childhood small noncleaved cell lymphoma|stage i childhood small noncleaved cell lymphoma
879029|NCT00044538|Taxane|taxane
873895|NCT00003938|stage I childhood large cell lymphoma|stage i childhood large cell lymphoma
873896|NCT00003938|stage II childhood small noncleaved cell lymphoma|stage ii childhood small noncleaved cell lymphoma
873897|NCT00003938|stage II childhood large cell lymphoma|stage ii childhood large cell lymphoma
873898|NCT00003938|stage III childhood small noncleaved cell lymphoma|stage iii childhood small noncleaved cell lymphoma
873899|NCT00003938|stage III childhood large cell lymphoma|stage iii childhood large cell lymphoma
873900|NCT00003938|stage IV childhood small noncleaved cell lymphoma|stage iv childhood small noncleaved cell lymphoma
873901|NCT00003938|stage IV childhood large cell lymphoma|stage iv childhood large cell lymphoma
873902|NCT00003938|recurrent childhood small noncleaved cell lymphoma|recurrent childhood small noncleaved cell lymphoma
873903|NCT00003938|recurrent childhood large cell lymphoma|recurrent childhood large cell lymphoma
873904|NCT00003938|stage I mantle cell lymphoma|stage i mantle cell lymphoma
873905|NCT00003938|contiguous stage II grade 1 follicular lymphoma|contiguous stage ii grade 1 follicular lymphoma
873906|NCT00003938|contiguous stage II grade 2 follicular lymphoma|contiguous stage ii grade 2 follicular lymphoma
873907|NCT00003938|contiguous stage II grade 3 follicular lymphoma|contiguous stage ii grade 3 follicular lymphoma
873908|NCT00003938|contiguous stage II adult diffuse small cleaved cell lymphoma|contiguous stage ii adult diffuse small cleaved cell lymphoma
873909|NCT00003938|contiguous stage II mantle cell lymphoma|contiguous stage ii mantle cell lymphoma
873910|NCT00003938|contiguous stage II adult diffuse mixed cell lymphoma|contiguous stage ii adult diffuse mixed cell lymphoma
873911|NCT00003938|contiguous stage II adult immunoblastic large cell lymphoma|contiguous stage ii adult immunoblastic large cell lymphoma
873912|NCT00003938|contiguous stage II adult diffuse large cell lymphoma|contiguous stage ii adult diffuse large cell lymphoma
873913|NCT00003938|contiguous stage II adult Burkitt lymphoma|contiguous stage ii adult burkitt lymphoma
873914|NCT00003938|contiguous stage II adult lymphoblastic lymphoma|contiguous stage ii adult lymphoblastic lymphoma
873915|NCT00003938|noncontiguous stage II grade 1 follicular lymphoma|noncontiguous stage ii grade 1 follicular lymphoma
873916|NCT00003938|noncontiguous stage II grade 2 follicular lymphoma|noncontiguous stage ii grade 2 follicular lymphoma
873917|NCT00003938|noncontiguous stage II grade 3 follicular lymphoma|noncontiguous stage ii grade 3 follicular lymphoma
873918|NCT00003938|noncontiguous stage II adult diffuse small cleaved cell lymphoma|noncontiguous stage ii adult diffuse small cleaved cell lymphoma
873919|NCT00003938|noncontiguous stage II mantle cell lymphoma|noncontiguous stage ii mantle cell lymphoma
873920|NCT00003938|noncontiguous stage II adult diffuse mixed cell lymphoma|noncontiguous stage ii adult diffuse mixed cell lymphoma
873921|NCT00003938|noncontiguous stage II adult immunoblastic large cell lymphoma|noncontiguous stage ii adult immunoblastic large cell lymphoma
873922|NCT00003938|noncontiguous stage II adult diffuse large cell lymphoma|noncontiguous stage ii adult diffuse large cell lymphoma
873923|NCT00003938|noncontiguous stage II adult Burkitt lymphoma|noncontiguous stage ii adult burkitt lymphoma
873924|NCT00003938|noncontiguous stage II adult lymphoblastic lymphoma|noncontiguous stage ii adult lymphoblastic lymphoma
873925|NCT00003938|stage III mantle cell lymphoma|stage iii mantle cell lymphoma
873926|NCT00003938|stage IV mantle cell lymphoma|stage iv mantle cell lymphoma
873927|NCT00003938|recurrent mantle cell lymphoma|recurrent mantle cell lymphoma
873928|NCT00003938|angioimmunoblastic T-cell lymphoma|angioimmunoblastic t-cell lymphoma
873929|NCT00003938|anaplastic large cell lymphoma|anaplastic large cell lymphoma
873930|NCT00003938|previously treated childhood rhabdomyosarcoma|previously treated childhood rhabdomyosarcoma
873931|NCT00003938|stage I mycosis fungoides/Sezary syndrome|stage i mycosis fungoides/sezary syndrome
873932|NCT00003938|stage II mycosis fungoides/Sezary syndrome|stage ii mycosis fungoides/sezary syndrome
873933|NCT00003938|stage III mycosis fungoides/Sezary syndrome|stage iii mycosis fungoides/sezary syndrome
873934|NCT00003938|stage IV mycosis fungoides/Sezary syndrome|stage iv mycosis fungoides/sezary syndrome
873935|NCT00003938|recurrent mycosis fungoides/Sezary syndrome|recurrent mycosis fungoides/sezary syndrome
873936|NCT00003938|childhood chronic myelogenous leukemia|childhood chronic myelogenous leukemia
873937|NCT00003938|chronic eosinophilic leukemia|chronic eosinophilic leukemia
873938|NCT00003938|chronic neutrophilic leukemia|chronic neutrophilic leukemia
873939|NCT00003938|contiguous stage II marginal zone lymphoma|contiguous stage ii marginal zone lymphoma
873940|NCT00003938|contiguous stage II small lymphocytic lymphoma|contiguous stage ii small lymphocytic lymphoma
873941|NCT00003938|noncontiguous stage II small lymphocytic lymphoma|noncontiguous stage ii small lymphocytic lymphoma
873942|NCT00003938|noncontiguous stage II marginal zone lymphoma|noncontiguous stage ii marginal zone lymphoma
873943|NCT00003938|recurrent marginal zone lymphoma|recurrent marginal zone lymphoma
873944|NCT00003938|recurrent small lymphocytic lymphoma|recurrent small lymphocytic lymphoma
873945|NCT00003938|stage I marginal zone lymphoma|stage i marginal zone lymphoma
873946|NCT00003938|stage I small lymphocytic lymphoma|stage i small lymphocytic lymphoma
873947|NCT00003938|stage III small lymphocytic lymphoma|stage iii small lymphocytic lymphoma
873948|NCT00003938|stage III marginal zone lymphoma|stage iii marginal zone lymphoma
873949|NCT00003938|stage IV small lymphocytic lymphoma|stage iv small lymphocytic lymphoma
873950|NCT00003938|stage IV marginal zone lymphoma|stage iv marginal zone lymphoma
873951|NCT00003938|extranodal marginal zone B-cell lymphoma of mucosa-associated lymphoid tissue|extranodal marginal zone b-cell lymphoma of mucosa-associated lymphoid tissue
873952|NCT00003938|nodal marginal zone B-cell lymphoma|nodal marginal zone b-cell lymphoma
873953|NCT00003938|splenic marginal zone lymphoma|splenic marginal zone lymphoma
873954|NCT00003938|childhood myelodysplastic syndromes|childhood myelodysplastic syndromes
873955|NCT00003928|stage IV renal cell cancer|stage iv renal cell cancer
873956|NCT00003928|recurrent renal cell cancer|recurrent renal cell cancer
873957|NCT00003913|recurrent childhood acute lymphoblastic leukemia|recurrent childhood acute lymphoblastic leukemia
873958|NCT00003913|recurrent childhood lymphoblastic lymphoma|recurrent childhood lymphoblastic lymphoma
873959|NCT00003913|recurrent childhood acute myeloid leukemia|recurrent childhood acute myeloid leukemia
873960|NCT00003913|relapsing chronic myelogenous leukemia|relapsing chronic myelogenous leukemia
873961|NCT00003913|chronic phase chronic myelogenous leukemia|chronic phase chronic myelogenous leukemia
873962|NCT00003913|accelerated phase chronic myelogenous leukemia|accelerated phase chronic myelogenous leukemia
873963|NCT00003913|childhood acute myeloid leukemia in remission|childhood acute myeloid leukemia in remission
873964|NCT00003913|childhood acute lymphoblastic leukemia in remission|childhood acute lymphoblastic leukemia in remission
873965|NCT00003913|recurrent/refractory childhood Hodgkin lymphoma|recurrent/refractory childhood hodgkin lymphoma
873966|NCT00003913|refractory anemia|refractory anemia
873967|NCT00003913|refractory anemia with ringed sideroblasts|refractory anemia with ringed sideroblasts
873968|NCT00003913|refractory anemia with excess blasts|refractory anemia with excess blasts
873969|NCT00003913|refractory anemia with excess blasts in transformation|refractory anemia with excess blasts in transformation
873970|NCT00003913|chronic myelomonocytic leukemia|chronic myelomonocytic leukemia
873971|NCT00003913|acute undifferentiated leukemia|acute undifferentiated leukemia
873972|NCT00003913|secondary acute myeloid leukemia|secondary acute myeloid leukemia
873973|NCT00003913|de novo myelodysplastic syndromes|de novo myelodysplastic syndromes
873974|NCT00003913|previously treated myelodysplastic syndromes|previously treated myelodysplastic syndromes
873975|NCT00003913|secondary myelodysplastic syndromes|secondary myelodysplastic syndromes
873976|NCT00003913|recurrent childhood small noncleaved cell lymphoma|recurrent childhood small noncleaved cell lymphoma
873977|NCT00003913|recurrent childhood large cell lymphoma|recurrent childhood large cell lymphoma
873978|NCT00003913|juvenile myelomonocytic leukemia|juvenile myelomonocytic leukemia
873979|NCT00003913|blastic phase chronic myelogenous leukemia|blastic phase chronic myelogenous leukemia
873980|NCT00003913|childhood chronic myelogenous leukemia|childhood chronic myelogenous leukemia
873981|NCT00003913|atypical chronic myeloid leukemia|atypical chronic myeloid leukemia
873982|NCT00003913|myelodysplastic/myeloproliferative disease, unclassifiable|myelodysplastic/myeloproliferative disease, unclassifiable
873983|NCT00003912|stage I childhood liver cancer|stage i childhood liver cancer
873984|NCT00003912|stage II childhood liver cancer|stage ii childhood liver cancer
873985|NCT00003912|stage III childhood liver cancer|stage iii childhood liver cancer
873986|NCT00003912|stage IV childhood liver cancer|stage iv childhood liver cancer
873987|NCT00003912|recurrent childhood liver cancer|recurrent childhood liver cancer
873988|NCT00003912|childhood hepatoblastoma|childhood hepatoblastoma
873989|NCT00003912|childhood hepatocellular carcinoma|childhood hepatocellular carcinoma
873990|NCT00003910|stage I chronic lymphocytic leukemia|stage i chronic lymphocytic leukemia
873991|NCT00003910|stage II chronic lymphocytic leukemia|stage ii chronic lymphocytic leukemia
873992|NCT00003910|stage III chronic lymphocytic leukemia|stage iii chronic lymphocytic leukemia
873993|NCT00003910|stage IV chronic lymphocytic leukemia|stage iv chronic lymphocytic leukemia
873994|NCT00003910|T-cell large granular lymphocyte leukemia|t-cell large granular lymphocyte leukemia
873995|NCT00003910|LGL clone|lgl clone
873996|NCT00003906|breast cancer|breast cancer
873997|NCT00003903|stage I prostate cancer|stage i prostate cancer
873998|NCT00003903|stage IIB prostate cancer|stage iib prostate cancer
873999|NCT00003903|stage IIA prostate cancer|stage iia prostate cancer
874000|NCT00003903|stage III prostate cancer|stage iii prostate cancer
874001|NCT00003903|stage IV prostate cancer|stage iv prostate cancer
874002|NCT00003903|osteoporosis|osteoporosis
874003|NCT00003902|stage IV breast cancer|stage iv breast cancer
874004|NCT00003901|stage I non-small cell lung cancer|stage i non-small cell lung cancer
874005|NCT00003901|stage II non-small cell lung cancer|stage ii non-small cell lung cancer
874006|NCT00003901|squamous cell lung cancer|squamous cell lung cancer
874007|NCT00003901|large cell lung cancer|large cell lung cancer
874008|NCT00003901|stage IIIA non-small cell lung cancer|stage iiia non-small cell lung cancer
874009|NCT00003901|adenocarcinoma of the lung|adenocarcinoma of the lung
874010|NCT00003896|stage III ovarian epithelial cancer|stage iii ovarian epithelial cancer
874011|NCT00003896|peritoneal cavity cancer|peritoneal cavity cancer
874012|NCT00003896|fallopian tube cancer|fallopian tube cancer
874013|NCT00003893|stage I breast cancer|stage i breast cancer
874014|NCT00003878|unspecified adult solid tumor, protocol specific|unspecified adult solid tumor, protocol specific
874015|NCT00003878|tumors metastatic to brain|tumors metastatic to brain
874016|NCT00003865|recurrent ovarian epithelial cancer|recurrent ovarian epithelial cancer
874017|NCT00003865|ovarian serous cystadenocarcinoma|ovarian serous cystadenocarcinoma
874018|NCT00003863|stage I adult diffuse small cleaved cell lymphoma|stage i adult diffuse small cleaved cell lymphoma
874019|NCT00003863|stage I adult diffuse mixed cell lymphoma|stage i adult diffuse mixed cell lymphoma
874020|NCT00003863|stage I adult diffuse large cell lymphoma|stage i adult diffuse large cell lymphoma
874021|NCT00003863|stage I adult immunoblastic large cell lymphoma|stage i adult immunoblastic large cell lymphoma
874022|NCT00003863|stage I adult Burkitt lymphoma|stage i adult burkitt lymphoma
874023|NCT00003863|stage III adult diffuse small cleaved cell lymphoma|stage iii adult diffuse small cleaved cell lymphoma
874024|NCT00003863|stage III adult diffuse mixed cell lymphoma|stage iii adult diffuse mixed cell lymphoma
874025|NCT00003863|stage III adult diffuse large cell lymphoma|stage iii adult diffuse large cell lymphoma
874026|NCT00003863|stage III adult immunoblastic large cell lymphoma|stage iii adult immunoblastic large cell lymphoma
874027|NCT00003863|stage III adult Burkitt lymphoma|stage iii adult burkitt lymphoma
874028|NCT00003863|stage IV adult diffuse small cleaved cell lymphoma|stage iv adult diffuse small cleaved cell lymphoma
874029|NCT00003863|stage IV adult diffuse mixed cell lymphoma|stage iv adult diffuse mixed cell lymphoma
874030|NCT00003863|stage IV adult diffuse large cell lymphoma|stage iv adult diffuse large cell lymphoma
874031|NCT00003863|stage IV adult immunoblastic large cell lymphoma|stage iv adult immunoblastic large cell lymphoma
874032|NCT00003863|stage IV adult Burkitt lymphoma|stage iv adult burkitt lymphoma
874033|NCT00003863|recurrent adult diffuse small cleaved cell lymphoma|recurrent adult diffuse small cleaved cell lymphoma
874034|NCT00003863|recurrent adult diffuse mixed cell lymphoma|recurrent adult diffuse mixed cell lymphoma
874035|NCT00003863|recurrent adult diffuse large cell lymphoma|recurrent adult diffuse large cell lymphoma
874036|NCT00003863|recurrent adult immunoblastic large cell lymphoma|recurrent adult immunoblastic large cell lymphoma
874037|NCT00003863|recurrent adult Burkitt lymphoma|recurrent adult burkitt lymphoma
874038|NCT00003863|stage I mantle cell lymphoma|stage i mantle cell lymphoma
874039|NCT00003863|contiguous stage II adult diffuse small cleaved cell lymphoma|contiguous stage ii adult diffuse small cleaved cell lymphoma
874040|NCT00003863|contiguous stage II mantle cell lymphoma|contiguous stage ii mantle cell lymphoma
874041|NCT00003863|contiguous stage II adult diffuse mixed cell lymphoma|contiguous stage ii adult diffuse mixed cell lymphoma
874042|NCT00003863|contiguous stage II adult immunoblastic large cell lymphoma|contiguous stage ii adult immunoblastic large cell lymphoma
874043|NCT00003863|contiguous stage II adult diffuse large cell lymphoma|contiguous stage ii adult diffuse large cell lymphoma
874044|NCT00003863|contiguous stage II adult Burkitt lymphoma|contiguous stage ii adult burkitt lymphoma
874045|NCT00003863|noncontiguous stage II adult diffuse small cleaved cell lymphoma|noncontiguous stage ii adult diffuse small cleaved cell lymphoma
874046|NCT00003863|noncontiguous stage II mantle cell lymphoma|noncontiguous stage ii mantle cell lymphoma
874047|NCT00003863|noncontiguous stage II adult diffuse mixed cell lymphoma|noncontiguous stage ii adult diffuse mixed cell lymphoma
874048|NCT00003863|noncontiguous stage II adult immunoblastic large cell lymphoma|noncontiguous stage ii adult immunoblastic large cell lymphoma
874049|NCT00003863|noncontiguous stage II adult diffuse large cell lymphoma|noncontiguous stage ii adult diffuse large cell lymphoma
874050|NCT00003863|noncontiguous stage II adult Burkitt lymphoma|noncontiguous stage ii adult burkitt lymphoma
874051|NCT00003863|stage III mantle cell lymphoma|stage iii mantle cell lymphoma
874052|NCT00003863|stage IV mantle cell lymphoma|stage iv mantle cell lymphoma
874053|NCT00003863|recurrent mantle cell lymphoma|recurrent mantle cell lymphoma
874054|NCT00003862|stage I gastric cancer|stage i gastric cancer
874055|NCT00003862|stage II gastric cancer|stage ii gastric cancer
874056|NCT00003862|stage III gastric cancer|stage iii gastric cancer
874057|NCT00003862|stage IV gastric cancer|stage iv gastric cancer
874058|NCT00003862|adenocarcinoma of the stomach|adenocarcinoma of the stomach
874059|NCT00003857|breast cancer in situ|breast cancer in situ
874060|NCT00003857|ductal breast carcinoma in situ|ductal breast carcinoma in situ
874061|NCT00003855|stage IA breast cancer|stage ia breast cancer
874062|NCT00003855|stage IB breast cancer|stage ib breast cancer
874063|NCT00003855|stage II breast cancer|stage ii breast cancer
874064|NCT00003854|stage IA breast cancer|stage ia breast cancer
874065|NCT00003854|stage IB breast cancer|stage ib breast cancer
874066|NCT00003854|stage II breast cancer|stage ii breast cancer
874067|NCT00003851|malnutrition|malnutrition
874068|NCT00003851|stage II pancreatic cancer|stage ii pancreatic cancer
874069|NCT00003851|stage III pancreatic cancer|stage iii pancreatic cancer
874070|NCT00003851|stage IV pancreatic cancer|stage iv pancreatic cancer
874071|NCT00003851|adenocarcinoma of the pancreas|adenocarcinoma of the pancreas
874072|NCT00003843|stage IV colon cancer|stage iv colon cancer
874073|NCT00003843|stage IV rectal cancer|stage iv rectal cancer
874074|NCT00003843|recurrent colon cancer|recurrent colon cancer
874075|NCT00003843|recurrent rectal cancer|recurrent rectal cancer
874076|NCT00003838|Graft vs. Host Disease|graft vs. host disease
874077|NCT00003838|Peripheral Blood Stem Cells|peripheral blood stem cells
874078|NCT00003838|Non-Myeloablative Bone Marrow Transplantation|non-myeloablative bone marrow transplantation
874079|NCT00003838|Engraftment|engraftment
874080|NCT00003838|Graft-Versus-Leukemia|graft-versus-leukemia
874081|NCT00003837|recurrent adult acute lymphoblastic leukemia|recurrent adult acute lymphoblastic leukemia
874082|NCT00003837|T-cell adult acute lymphoblastic leukemia|t-cell adult acute lymphoblastic leukemia
874083|NCT00003837|recurrent adult lymphoblastic lymphoma|recurrent adult lymphoblastic lymphoma
874084|NCT00003833|stage II colon cancer|stage ii colon cancer
874085|NCT00003833|stage III colon cancer|stage iii colon cancer
874086|NCT00003833|adenocarcinoma of the colon|adenocarcinoma of the colon
874087|NCT00003831|stage I non-small cell lung cancer|stage i non-small cell lung cancer
874088|NCT00003831|stage II non-small cell lung cancer|stage ii non-small cell lung cancer
874089|NCT00003831|squamous cell lung cancer|squamous cell lung cancer
874090|NCT00003831|large cell lung cancer|large cell lung cancer
874091|NCT00003831|adenocarcinoma of the lung|adenocarcinoma of the lung
874092|NCT00003816|recurrent childhood acute lymphoblastic leukemia|recurrent childhood acute lymphoblastic leukemia
874093|NCT00003816|recurrent cutaneous T-cell non-Hodgkin lymphoma|recurrent cutaneous t-cell non-hodgkin lymphoma
874094|NCT00003816|Burkitt lymphoma|burkitt lymphoma
874095|NCT00003816|Waldenstrom macroglobulinemia|waldenstrom macroglobulinemia
874096|NCT00003816|recurrent childhood lymphoblastic lymphoma|recurrent childhood lymphoblastic lymphoma
874097|NCT00003816|recurrent childhood acute myeloid leukemia|recurrent childhood acute myeloid leukemia
874098|NCT00003816|recurrent adult acute myeloid leukemia|recurrent adult acute myeloid leukemia
874099|NCT00003816|recurrent adult acute lymphoblastic leukemia|recurrent adult acute lymphoblastic leukemia
874100|NCT00003816|relapsing chronic myelogenous leukemia|relapsing chronic myelogenous leukemia
874101|NCT00003816|refractory chronic lymphocytic leukemia|refractory chronic lymphocytic leukemia
874102|NCT00003816|chronic phase chronic myelogenous leukemia|chronic phase chronic myelogenous leukemia
874103|NCT00003816|accelerated phase chronic myelogenous leukemia|accelerated phase chronic myelogenous leukemia
874104|NCT00003816|blastic phase chronic myelogenous leukemia|blastic phase chronic myelogenous leukemia
874105|NCT00003816|adult acute myeloid leukemia in remission|adult acute myeloid leukemia in remission
874106|NCT00003816|adult acute lymphoblastic leukemia in remission|adult acute lymphoblastic leukemia in remission
874107|NCT00003816|childhood acute myeloid leukemia in remission|childhood acute myeloid leukemia in remission
874108|NCT00003816|childhood acute lymphoblastic leukemia in remission|childhood acute lymphoblastic leukemia in remission
874109|NCT00003816|polycythemia vera|polycythemia vera
874110|NCT00003816|essential thrombocythemia|essential thrombocythemia
874111|NCT00003816|refractory anemia|refractory anemia
874112|NCT00003816|refractory anemia with excess blasts|refractory anemia with excess blasts
874113|NCT00003816|refractory anemia with excess blasts in transformation|refractory anemia with excess blasts in transformation
874114|NCT00003816|chronic myelomonocytic leukemia|chronic myelomonocytic leukemia
874115|NCT00003816|T-cell large granular lymphocyte leukemia|t-cell large granular lymphocyte leukemia
874116|NCT00003816|acute undifferentiated leukemia|acute undifferentiated leukemia
874117|NCT00003816|recurrent grade 1 follicular lymphoma|recurrent grade 1 follicular lymphoma
874118|NCT00003816|recurrent grade 2 follicular lymphoma|recurrent grade 2 follicular lymphoma
874119|NCT00003816|recurrent grade 3 follicular lymphoma|recurrent grade 3 follicular lymphoma
874120|NCT00003816|recurrent adult diffuse small cleaved cell lymphoma|recurrent adult diffuse small cleaved cell lymphoma
874121|NCT00003816|recurrent adult diffuse mixed cell lymphoma|recurrent adult diffuse mixed cell lymphoma
874122|NCT00003816|recurrent adult diffuse large cell lymphoma|recurrent adult diffuse large cell lymphoma
874123|NCT00003816|recurrent adult immunoblastic large cell lymphoma|recurrent adult immunoblastic large cell lymphoma
874124|NCT00003816|recurrent adult lymphoblastic lymphoma|recurrent adult lymphoblastic lymphoma
874125|NCT00003816|recurrent adult Burkitt lymphoma|recurrent adult burkitt lymphoma
874126|NCT00003816|recurrent adult T-cell leukemia/lymphoma|recurrent adult t-cell leukemia/lymphoma
874127|NCT00003816|secondary acute myeloid leukemia|secondary acute myeloid leukemia
874128|NCT00003816|de novo myelodysplastic syndromes|de novo myelodysplastic syndromes
874129|NCT00003816|previously treated myelodysplastic syndromes|previously treated myelodysplastic syndromes
874130|NCT00003816|secondary myelodysplastic syndromes|secondary myelodysplastic syndromes
874131|NCT00003816|prolymphocytic leukemia|prolymphocytic leukemia
874132|NCT00003816|intraocular lymphoma|intraocular lymphoma
874133|NCT00003816|recurrent childhood small noncleaved cell lymphoma|recurrent childhood small noncleaved cell lymphoma
874134|NCT00003816|recurrent childhood large cell lymphoma|recurrent childhood large cell lymphoma
874135|NCT00003816|recurrent mantle cell lymphoma|recurrent mantle cell lymphoma
874136|NCT00003816|angioimmunoblastic T-cell lymphoma|angioimmunoblastic t-cell lymphoma
874137|NCT00003816|anaplastic large cell lymphoma|anaplastic large cell lymphoma
874138|NCT00003816|recurrent mycosis fungoides/Sezary syndrome|recurrent mycosis fungoides/sezary syndrome
874139|NCT00003816|primary myelofibrosis|primary myelofibrosis
874140|NCT00003816|childhood chronic myelogenous leukemia|childhood chronic myelogenous leukemia
874141|NCT00003816|atypical chronic myeloid leukemia|atypical chronic myeloid leukemia
874142|NCT00003816|myelodysplastic/myeloproliferative disease, unclassifiable|myelodysplastic/myeloproliferative disease, unclassifiable
874143|NCT00003816|recurrent marginal zone lymphoma|recurrent marginal zone lymphoma
874144|NCT00003816|recurrent small lymphocytic lymphoma|recurrent small lymphocytic lymphoma
874145|NCT00003816|extranodal marginal zone B-cell lymphoma of mucosa-associated lymphoid tissue|extranodal marginal zone b-cell lymphoma of mucosa-associated lymphoid tissue
874146|NCT00003816|nodal marginal zone B-cell lymphoma|nodal marginal zone b-cell lymphoma
874147|NCT00003816|splenic marginal zone lymphoma|splenic marginal zone lymphoma
874148|NCT00003816|adult acute myeloid leukemia with t(8;21)(q22;q22)|adult acute myeloid leukemia with t(8;21)(q22;q22)
874149|NCT00003816|adult acute myeloid leukemia with t(16;16)(p13;q22)|adult acute myeloid leukemia with t(16;16)(p13;q22)
874150|NCT00003816|adult acute myeloid leukemia with inv(16)(p13;q22)|adult acute myeloid leukemia with inv(16)(p13;q22)
874151|NCT00003816|adult acute myeloid leukemia with 11q23 (MLL) abnormalities|adult acute myeloid leukemia with 11q23 (mll) abnormalities
874152|NCT00003816|adult acute myeloid leukemia with t(15;17)(q22;q12)|adult acute myeloid leukemia with t(15;17)(q22;q12)
874153|NCT00003816|childhood myelodysplastic syndromes|childhood myelodysplastic syndromes
874154|NCT00003816|aplastic anemia|aplastic anemia
874155|NCT00003816|unspecified adult solid tumor, protocol specific|unspecified adult solid tumor, protocol specific
874156|NCT00003816|unspecified childhood solid tumor, protocol specific|unspecified childhood solid tumor, protocol specific
874157|NCT00003815|stage I adult diffuse mixed cell lymphoma|stage i adult diffuse mixed cell lymphoma
879865|NCT00040287|smoking|smoking
874158|NCT00003815|stage I adult diffuse large cell lymphoma|stage i adult diffuse large cell lymphoma
874159|NCT00003815|stage I adult immunoblastic large cell lymphoma|stage i adult immunoblastic large cell lymphoma
874160|NCT00003815|stage I adult lymphoblastic lymphoma|stage i adult lymphoblastic lymphoma
874161|NCT00003815|stage III adult diffuse mixed cell lymphoma|stage iii adult diffuse mixed cell lymphoma
874162|NCT00003815|stage III adult diffuse large cell lymphoma|stage iii adult diffuse large cell lymphoma
874163|NCT00003815|stage III adult immunoblastic large cell lymphoma|stage iii adult immunoblastic large cell lymphoma
874164|NCT00003815|stage III adult lymphoblastic lymphoma|stage iii adult lymphoblastic lymphoma
874165|NCT00003815|stage IV adult diffuse mixed cell lymphoma|stage iv adult diffuse mixed cell lymphoma
874166|NCT00003815|stage IV adult diffuse large cell lymphoma|stage iv adult diffuse large cell lymphoma
874167|NCT00003815|stage IV adult immunoblastic large cell lymphoma|stage iv adult immunoblastic large cell lymphoma
874168|NCT00003815|stage IV adult lymphoblastic lymphoma|stage iv adult lymphoblastic lymphoma
874169|NCT00003815|contiguous stage II adult diffuse mixed cell lymphoma|contiguous stage ii adult diffuse mixed cell lymphoma
874170|NCT00003815|contiguous stage II adult immunoblastic large cell lymphoma|contiguous stage ii adult immunoblastic large cell lymphoma
874171|NCT00003815|contiguous stage II adult diffuse large cell lymphoma|contiguous stage ii adult diffuse large cell lymphoma
874172|NCT00003815|contiguous stage II adult lymphoblastic lymphoma|contiguous stage ii adult lymphoblastic lymphoma
874639|NCT00003565|pulmonary carcinoid tumor|pulmonary carcinoid tumor
874173|NCT00003815|noncontiguous stage II adult diffuse mixed cell lymphoma|noncontiguous stage ii adult diffuse mixed cell lymphoma
874174|NCT00003815|noncontiguous stage II adult immunoblastic large cell lymphoma|noncontiguous stage ii adult immunoblastic large cell lymphoma
874175|NCT00003815|noncontiguous stage II adult diffuse large cell lymphoma|noncontiguous stage ii adult diffuse large cell lymphoma
874176|NCT00003815|noncontiguous stage II adult lymphoblastic lymphoma|noncontiguous stage ii adult lymphoblastic lymphoma
874177|NCT00003803|stage I non-small cell lung cancer|stage i non-small cell lung cancer
874178|NCT00003803|stage II non-small cell lung cancer|stage ii non-small cell lung cancer
874179|NCT00003803|stage III non-small cell lung cancer|stage iii non-small cell lung cancer
874180|NCT00003800|stage I malignant testicular germ cell tumor|stage i malignant testicular germ cell tumor
874181|NCT00003800|stage II malignant testicular germ cell tumor|stage ii malignant testicular germ cell tumor
874182|NCT00003800|testicular embryonal carcinoma|testicular embryonal carcinoma
874183|NCT00003800|testicular choriocarcinoma|testicular choriocarcinoma
874184|NCT00003800|testicular teratoma|testicular teratoma
874185|NCT00003800|testicular yolk sac tumor|testicular yolk sac tumor
874186|NCT00003800|testicular embryonal carcinoma and teratoma|testicular embryonal carcinoma and teratoma
874187|NCT00003800|testicular embryonal carcinoma and yolk sac tumor|testicular embryonal carcinoma and yolk sac tumor
874188|NCT00003800|testicular yolk sac tumor and teratoma|testicular yolk sac tumor and teratoma
874189|NCT00003800|testicular choriocarcinoma and yolk sac tumor|testicular choriocarcinoma and yolk sac tumor
874190|NCT00003800|testicular choriocarcinoma and embryonal carcinoma|testicular choriocarcinoma and embryonal carcinoma
874191|NCT00003800|testicular choriocarcinoma and teratoma|testicular choriocarcinoma and teratoma
874192|NCT00003796|stage IV breast cancer|stage iv breast cancer
874193|NCT00003796|recurrent breast cancer|recurrent breast cancer
874194|NCT00003796|male breast cancer|male breast cancer
874195|NCT00003793|secondary acute myeloid leukemia|secondary acute myeloid leukemia
874196|NCT00003793|secondary myelodysplastic syndromes|secondary myelodysplastic syndromes
874197|NCT00003793|localized osteosarcoma|localized osteosarcoma
874198|NCT00003793|metastatic osteosarcoma|metastatic osteosarcoma
874199|NCT00003793|childhood soft tissue sarcoma|childhood soft tissue sarcoma
874200|NCT00003793|nonmetastatic childhood soft tissue sarcoma|nonmetastatic childhood soft tissue sarcoma
874201|NCT00003793|metastatic childhood soft tissue sarcoma|metastatic childhood soft tissue sarcoma
874202|NCT00003793|childhood fibrosarcoma|childhood fibrosarcoma
874203|NCT00003793|childhood synovial sarcoma|childhood synovial sarcoma
874204|NCT00003793|childhood neurofibrosarcoma|childhood neurofibrosarcoma
874205|NCT00003793|previously untreated childhood rhabdomyosarcoma|previously untreated childhood rhabdomyosarcoma
874206|NCT00003793|localized Ewing sarcoma/peripheral primitive neuroectodermal tumor|localized ewing sarcoma/peripheral primitive neuroectodermal tumor
874207|NCT00003793|metastatic Ewing sarcoma/peripheral primitive neuroectodermal tumor|metastatic ewing sarcoma/peripheral primitive neuroectodermal tumor
874208|NCT00003788|recurrent adult brain tumor|recurrent adult brain tumor
874209|NCT00003788|adult glioblastoma|adult glioblastoma
874210|NCT00003788|adult anaplastic astrocytoma|adult anaplastic astrocytoma
874211|NCT00003788|adult giant cell glioblastoma|adult giant cell glioblastoma
874212|NCT00003788|adult gliosarcoma|adult gliosarcoma
874213|NCT00003782|stage I breast cancer|stage i breast cancer
874214|NCT00003782|stage II breast cancer|stage ii breast cancer
874215|NCT00003782|stage IIIA breast cancer|stage iiia breast cancer
874216|NCT00003771|menopausal symptoms|menopausal symptoms
874217|NCT00003771|stage I breast cancer|stage i breast cancer
874218|NCT00003771|stage II breast cancer|stage ii breast cancer
874219|NCT00003771|breast cancer in situ|breast cancer in situ
874220|NCT00003764|stage 0 chronic lymphocytic leukemia|stage 0 chronic lymphocytic leukemia
874221|NCT00003764|stage I chronic lymphocytic leukemia|stage i chronic lymphocytic leukemia
874222|NCT00003764|stage II chronic lymphocytic leukemia|stage ii chronic lymphocytic leukemia
874223|NCT00003764|stage III chronic lymphocytic leukemia|stage iii chronic lymphocytic leukemia
874494|NCT00003607|stage I prostate cancer|stage i prostate cancer
874224|NCT00003764|stage IV chronic lymphocytic leukemia|stage iv chronic lymphocytic leukemia
874225|NCT00003764|B-cell chronic lymphocytic leukemia|b-cell chronic lymphocytic leukemia
874226|NCT00003753|stage IV colon cancer|stage iv colon cancer
874227|NCT00003753|stage IV rectal cancer|stage iv rectal cancer
874228|NCT00003753|adenocarcinoma of the colon|adenocarcinoma of the colon
874229|NCT00003753|adenocarcinoma of the rectum|adenocarcinoma of the rectum
874230|NCT00003753|liver metastases|liver metastases
874231|NCT00003753|recurrent colon cancer|recurrent colon cancer
874232|NCT00003753|recurrent rectal cancer|recurrent rectal cancer
874233|NCT00003750|metastatic osteosarcoma|metastatic osteosarcoma
874234|NCT00003750|recurrent neuroblastoma|recurrent neuroblastoma
874235|NCT00003750|recurrent osteosarcoma|recurrent osteosarcoma
874236|NCT00003750|recurrent melanoma|recurrent melanoma
874237|NCT00003750|unspecified childhood solid tumor, protocol specific|unspecified childhood solid tumor, protocol specific
874238|NCT00003750|metastatic childhood soft tissue sarcoma|metastatic childhood soft tissue sarcoma
874239|NCT00003750|recurrent childhood soft tissue sarcoma|recurrent childhood soft tissue sarcoma
874240|NCT00003749|stage I endometrial carcinoma|stage i endometrial carcinoma
874241|NCT00003749|stage II endometrial carcinoma|stage ii endometrial carcinoma
874242|NCT00003749|endometrial clear cell carcinoma|endometrial clear cell carcinoma
875183|NCT00003329|stage IV colon cancer|stage iv colon cancer
874243|NCT00003749|endometrial papillary serous carcinoma|endometrial papillary serous carcinoma
874244|NCT00003746|untreated hairy cell leukemia|untreated hairy cell leukemia
874245|NCT00003746|progressive hairy cell leukemia, initial treatment|progressive hairy cell leukemia, initial treatment
874246|NCT00003746|prolymphocytic leukemia|prolymphocytic leukemia
874247|NCT00003745|recurrent childhood rhabdomyosarcoma|recurrent childhood rhabdomyosarcoma
874248|NCT00003745|recurrent osteosarcoma|recurrent osteosarcoma
874249|NCT00003745|embryonal childhood rhabdomyosarcoma|embryonal childhood rhabdomyosarcoma
874250|NCT00003745|alveolar childhood rhabdomyosarcoma|alveolar childhood rhabdomyosarcoma
874251|NCT00003745|recurrent childhood soft tissue sarcoma|recurrent childhood soft tissue sarcoma
874252|NCT00003745|extraosseous Ewing sarcoma/peripheral primitive neuroectodermal tumor|extraosseous ewing sarcoma/peripheral primitive neuroectodermal tumor
874253|NCT00003745|recurrent Ewing sarcoma/peripheral primitive neuroectodermal tumor|recurrent ewing sarcoma/peripheral primitive neuroectodermal tumor
874254|NCT00003744|stage III salivary gland cancer|stage iii salivary gland cancer
874255|NCT00003744|stage IV salivary gland cancer|stage iv salivary gland cancer
874256|NCT00003744|salivary gland squamous cell carcinoma|salivary gland squamous cell carcinoma
874257|NCT00003744|salivary gland acinic cell tumor|salivary gland acinic cell tumor
874258|NCT00003744|low-grade salivary gland mucoepidermoid carcinoma|low-grade salivary gland mucoepidermoid carcinoma
874259|NCT00003744|high-grade salivary gland mucoepidermoid carcinoma|high-grade salivary gland mucoepidermoid carcinoma
874260|NCT00003744|salivary gland adenocarcinoma|salivary gland adenocarcinoma
874261|NCT00003744|salivary gland poorly differentiated carcinoma|salivary gland poorly differentiated carcinoma
874262|NCT00003744|salivary gland anaplastic carcinoma|salivary gland anaplastic carcinoma
874263|NCT00003744|salivary gland malignant mixed cell type tumor|salivary gland malignant mixed cell type tumor
874264|NCT00003744|salivary gland adenoid cystic carcinoma|salivary gland adenoid cystic carcinoma
874265|NCT00003741|recurrent adult Hodgkin lymphoma|recurrent adult hodgkin lymphoma
874266|NCT00003741|anaplastic large cell lymphoma|anaplastic large cell lymphoma
874267|NCT00003739|unspecified childhood solid tumor, protocol specific|unspecified childhood solid tumor, protocol specific
874268|NCT00003739|fever, sweats, and hot flashes|fever, sweats, and hot flashes
874269|NCT00003739|neutropenia|neutropenia
874270|NCT00003737|recurrent neuroblastoma|recurrent neuroblastoma
874271|NCT00003732|stage IIB ovarian epithelial cancer|stage iib ovarian epithelial cancer
874272|NCT00003732|stage IIC ovarian epithelial cancer|stage iic ovarian epithelial cancer
874273|NCT00003732|stage IIIA ovarian epithelial cancer|stage iiia ovarian epithelial cancer
874274|NCT00003732|stage IIIB ovarian epithelial cancer|stage iiib ovarian epithelial cancer
874275|NCT00003732|stage IIIC ovarian epithelial cancer|stage iiic ovarian epithelial cancer
874276|NCT00003732|stage IV ovarian epithelial cancer|stage iv ovarian epithelial cancer
874277|NCT00003730|stage IV breast cancer|stage iv breast cancer
874278|NCT00003730|recurrent breast cancer|recurrent breast cancer
874279|NCT00003728|stage I childhood lymphoblastic lymphoma|stage i childhood lymphoblastic lymphoma
874280|NCT00003728|stage II childhood lymphoblastic lymphoma|stage ii childhood lymphoblastic lymphoma
874281|NCT00003728|stage III childhood lymphoblastic lymphoma|stage iii childhood lymphoblastic lymphoma
874282|NCT00003728|stage IV childhood lymphoblastic lymphoma|stage iv childhood lymphoblastic lymphoma
874283|NCT00003728|untreated childhood acute lymphoblastic leukemia|untreated childhood acute lymphoblastic leukemia
874284|NCT00003728|L1 childhood acute lymphoblastic leukemia|l1 childhood acute lymphoblastic leukemia
874285|NCT00003728|L2 childhood acute lymphoblastic leukemia|l2 childhood acute lymphoblastic leukemia
874286|NCT00003728|T-cell childhood acute lymphoblastic leukemia|t-cell childhood acute lymphoblastic leukemia
874287|NCT00003728|B-cell childhood acute lymphoblastic leukemia|b-cell childhood acute lymphoblastic leukemia
874288|NCT00003728|acute undifferentiated leukemia|acute undifferentiated leukemia
874289|NCT00003727|relapsing chronic myelogenous leukemia|relapsing chronic myelogenous leukemia
874290|NCT00003727|chronic phase chronic myelogenous leukemia|chronic phase chronic myelogenous leukemia
874291|NCT00003727|Philadelphia chromosome positive chronic myelogenous leukemia|philadelphia chromosome positive chronic myelogenous leukemia
874292|NCT00003727|Philadelphia chromosome negative chronic myelogenous leukemia|philadelphia chromosome negative chronic myelogenous leukemia
874293|NCT00003727|childhood chronic myelogenous leukemia|childhood chronic myelogenous leukemia
874294|NCT00003696|extensive stage small cell lung cancer|extensive stage small cell lung cancer
874295|NCT00003690|stage IV breast cancer|stage iv breast cancer
874296|NCT00003690|recurrent breast cancer|recurrent breast cancer
874297|NCT00003690|stage IV prostate cancer|stage iv prostate cancer
874298|NCT00003690|recurrent prostate cancer|recurrent prostate cancer
874299|NCT00003690|stage IV melanoma|stage iv melanoma
874300|NCT00003690|recurrent melanoma|recurrent melanoma
874301|NCT00003690|unspecified adult solid tumor, protocol specific|unspecified adult solid tumor, protocol specific
874302|NCT00003688|recurrent gestational trophoblastic tumor|recurrent gestational trophoblastic tumor
874303|NCT00003688|nonmetastatic gestational trophoblastic tumor|nonmetastatic gestational trophoblastic tumor
874304|NCT00003688|low risk metastatic gestational trophoblastic tumor|low risk metastatic gestational trophoblastic tumor
874305|NCT00003687|stage III adult Hodgkin lymphoma|stage iii adult hodgkin lymphoma
874306|NCT00003687|stage IV adult Hodgkin lymphoma|stage iv adult hodgkin lymphoma
874307|NCT00003687|monoclonal gammopathy of undetermined significance|monoclonal gammopathy of undetermined significance
874308|NCT00003687|recurrent adult Hodgkin lymphoma|recurrent adult hodgkin lymphoma
874309|NCT00003687|stage III cutaneous T-cell non-Hodgkin lymphoma|stage iii cutaneous t-cell non-hodgkin lymphoma
874310|NCT00003687|stage IV cutaneous T-cell non-Hodgkin lymphoma|stage iv cutaneous t-cell non-hodgkin lymphoma
874311|NCT00003687|recurrent cutaneous T-cell non-Hodgkin lymphoma|recurrent cutaneous t-cell non-hodgkin lymphoma
874312|NCT00003687|isolated plasmacytoma of bone|isolated plasmacytoma of bone
874313|NCT00003687|extramedullary plasmacytoma|extramedullary plasmacytoma
874314|NCT00003687|refractory multiple myeloma|refractory multiple myeloma
874315|NCT00003687|Waldenstrom macroglobulinemia|waldenstrom macroglobulinemia
874316|NCT00003687|stage III multiple myeloma|stage iii multiple myeloma
874317|NCT00003687|stage III chronic lymphocytic leukemia|stage iii chronic lymphocytic leukemia
874318|NCT00003687|stage IV chronic lymphocytic leukemia|stage iv chronic lymphocytic leukemia
874319|NCT00003687|recurrent adult acute myeloid leukemia|recurrent adult acute myeloid leukemia
874320|NCT00003687|recurrent adult acute lymphoblastic leukemia|recurrent adult acute lymphoblastic leukemia
874321|NCT00003687|relapsing chronic myelogenous leukemia|relapsing chronic myelogenous leukemia
874322|NCT00003687|refractory chronic lymphocytic leukemia|refractory chronic lymphocytic leukemia
874323|NCT00003687|small intestine lymphoma|small intestine lymphoma
874324|NCT00003687|unspecified adult solid tumor, protocol specific|unspecified adult solid tumor, protocol specific
874325|NCT00003687|chronic phase chronic myelogenous leukemia|chronic phase chronic myelogenous leukemia
874326|NCT00003687|accelerated phase chronic myelogenous leukemia|accelerated phase chronic myelogenous leukemia
874327|NCT00003687|blastic phase chronic myelogenous leukemia|blastic phase chronic myelogenous leukemia
874328|NCT00003687|meningeal chronic myelogenous leukemia|meningeal chronic myelogenous leukemia
874329|NCT00003687|untreated adult acute lymphoblastic leukemia|untreated adult acute lymphoblastic leukemia
874330|NCT00003687|untreated adult acute myeloid leukemia|untreated adult acute myeloid leukemia
874331|NCT00003687|adult acute myeloid leukemia in remission|adult acute myeloid leukemia in remission
874332|NCT00003687|adult acute lymphoblastic leukemia in remission|adult acute lymphoblastic leukemia in remission
874333|NCT00003687|polycythemia vera|polycythemia vera
874334|NCT00003687|chronic idiopathic myelofibrosis|chronic idiopathic myelofibrosis
874335|NCT00003687|essential thrombocythemia|essential thrombocythemia
874336|NCT00003687|untreated hairy cell leukemia|untreated hairy cell leukemia
874337|NCT00003687|progressive hairy cell leukemia, initial treatment|progressive hairy cell leukemia, initial treatment
874338|NCT00003687|refractory hairy cell leukemia|refractory hairy cell leukemia
874339|NCT00003687|chronic myelomonocytic leukemia|chronic myelomonocytic leukemia
874340|NCT00003687|T-cell large granular lymphocyte leukemia|t-cell large granular lymphocyte leukemia
874341|NCT00003687|acute undifferentiated leukemia|acute undifferentiated leukemia
874342|NCT00003687|stage III grade 1 follicular lymphoma|stage iii grade 1 follicular lymphoma
874343|NCT00003687|stage III grade 2 follicular lymphoma|stage iii grade 2 follicular lymphoma
874344|NCT00003687|stage III grade 3 follicular lymphoma|stage iii grade 3 follicular lymphoma
874345|NCT00003687|stage III adult diffuse small cleaved cell lymphoma|stage iii adult diffuse small cleaved cell lymphoma
874346|NCT00003687|stage III adult diffuse mixed cell lymphoma|stage iii adult diffuse mixed cell lymphoma
874347|NCT00003687|stage III adult diffuse large cell lymphoma|stage iii adult diffuse large cell lymphoma
874348|NCT00003687|stage III adult immunoblastic large cell lymphoma|stage iii adult immunoblastic large cell lymphoma
874349|NCT00003687|stage III adult lymphoblastic lymphoma|stage iii adult lymphoblastic lymphoma
874350|NCT00003687|stage III adult Burkitt lymphoma|stage iii adult burkitt lymphoma
874351|NCT00003687|stage IV grade 1 follicular lymphoma|stage iv grade 1 follicular lymphoma
874352|NCT00003687|stage IV grade 2 follicular lymphoma|stage iv grade 2 follicular lymphoma
874353|NCT00003687|stage IV grade 3 follicular lymphoma|stage iv grade 3 follicular lymphoma
874354|NCT00003687|stage IV adult diffuse small cleaved cell lymphoma|stage iv adult diffuse small cleaved cell lymphoma
874355|NCT00003687|stage IV adult diffuse mixed cell lymphoma|stage iv adult diffuse mixed cell lymphoma
874356|NCT00003687|stage IV adult diffuse large cell lymphoma|stage iv adult diffuse large cell lymphoma
874357|NCT00003687|stage IV adult immunoblastic large cell lymphoma|stage iv adult immunoblastic large cell lymphoma
874358|NCT00003687|stage IV adult lymphoblastic lymphoma|stage iv adult lymphoblastic lymphoma
874359|NCT00003687|stage IV adult Burkitt lymphoma|stage iv adult burkitt lymphoma
874360|NCT00003687|recurrent grade 1 follicular lymphoma|recurrent grade 1 follicular lymphoma
874361|NCT00003687|recurrent grade 2 follicular lymphoma|recurrent grade 2 follicular lymphoma
874362|NCT00003687|recurrent grade 3 follicular lymphoma|recurrent grade 3 follicular lymphoma
874363|NCT00003687|recurrent adult diffuse small cleaved cell lymphoma|recurrent adult diffuse small cleaved cell lymphoma
874364|NCT00003687|recurrent adult diffuse mixed cell lymphoma|recurrent adult diffuse mixed cell lymphoma
874365|NCT00003687|recurrent adult diffuse large cell lymphoma|recurrent adult diffuse large cell lymphoma
874366|NCT00003687|recurrent adult immunoblastic large cell lymphoma|recurrent adult immunoblastic large cell lymphoma
874367|NCT00003687|recurrent adult lymphoblastic lymphoma|recurrent adult lymphoblastic lymphoma
874368|NCT00003687|recurrent adult Burkitt lymphoma|recurrent adult burkitt lymphoma
874369|NCT00003687|stage III adult T-cell leukemia/lymphoma|stage iii adult t-cell leukemia/lymphoma
874370|NCT00003687|stage IV adult T-cell leukemia/lymphoma|stage iv adult t-cell leukemia/lymphoma
874371|NCT00003687|recurrent adult T-cell leukemia/lymphoma|recurrent adult t-cell leukemia/lymphoma
874372|NCT00003687|secondary acute myeloid leukemia|secondary acute myeloid leukemia
874373|NCT00003687|de novo myelodysplastic syndromes|de novo myelodysplastic syndromes
874374|NCT00003687|previously treated myelodysplastic syndromes|previously treated myelodysplastic syndromes
874375|NCT00003687|secondary myelodysplastic syndromes|secondary myelodysplastic syndromes
874376|NCT00003687|pain|pain
874377|NCT00003687|prolymphocytic leukemia|prolymphocytic leukemia
874378|NCT00003687|AIDS-related peripheral/systemic lymphoma|aids-related peripheral/systemic lymphoma
874379|NCT00003687|AIDS-related primary CNS lymphoma|aids-related primary cns lymphoma
874380|NCT00003687|primary systemic amyloidosis|primary systemic amyloidosis
874381|NCT00003687|non-Hodgkin lymphoma during pregnancy|non-hodgkin lymphoma during pregnancy
874382|NCT00003687|stage III mantle cell lymphoma|stage iii mantle cell lymphoma
874383|NCT00003687|stage IV mantle cell lymphoma|stage iv mantle cell lymphoma
874384|NCT00003687|recurrent mantle cell lymphoma|recurrent mantle cell lymphoma
874385|NCT00003687|angioimmunoblastic T-cell lymphoma|angioimmunoblastic t-cell lymphoma
874386|NCT00003687|anaplastic large cell lymphoma|anaplastic large cell lymphoma
874387|NCT00003687|stage III mycosis fungoides/Sezary syndrome|stage iii mycosis fungoides/sezary syndrome
874388|NCT00003687|stage IV mycosis fungoides/Sezary syndrome|stage iv mycosis fungoides/sezary syndrome
874389|NCT00003687|recurrent mycosis fungoides/Sezary syndrome|recurrent mycosis fungoides/sezary syndrome
874390|NCT00003687|chronic eosinophilic leukemia|chronic eosinophilic leukemia
874391|NCT00003687|chronic neutrophilic leukemia|chronic neutrophilic leukemia
874392|NCT00003687|recurrent marginal zone lymphoma|recurrent marginal zone lymphoma
874393|NCT00003687|recurrent small lymphocytic lymphoma|recurrent small lymphocytic lymphoma
874394|NCT00003687|stage III small lymphocytic lymphoma|stage iii small lymphocytic lymphoma
874395|NCT00003687|stage III marginal zone lymphoma|stage iii marginal zone lymphoma
874396|NCT00003687|stage IV small lymphocytic lymphoma|stage iv small lymphocytic lymphoma
874397|NCT00003687|stage IV marginal zone lymphoma|stage iv marginal zone lymphoma
874398|NCT00003687|extranodal marginal zone B-cell lymphoma of mucosa-associated lymphoid tissue|extranodal marginal zone b-cell lymphoma of mucosa-associated lymphoid tissue
874399|NCT00003687|nodal marginal zone B-cell lymphoma|nodal marginal zone b-cell lymphoma
874400|NCT00003687|splenic marginal zone lymphoma|splenic marginal zone lymphoma
874401|NCT00003687|childhood myelodysplastic syndromes|childhood myelodysplastic syndromes
874402|NCT00003678|stage I breast cancer|stage i breast cancer
874403|NCT00003678|stage II breast cancer|stage ii breast cancer
874404|NCT00003659|stage II chronic lymphocytic leukemia|stage ii chronic lymphocytic leukemia
874405|NCT00003659|stage III chronic lymphocytic leukemia|stage iii chronic lymphocytic leukemia
874406|NCT00003659|stage IV chronic lymphocytic leukemia|stage iv chronic lymphocytic leukemia
874407|NCT00003658|Waldenström macroglobulinemia|waldenström macroglobulinemia
874408|NCT00003658|stage II chronic lymphocytic leukemia|stage ii chronic lymphocytic leukemia
874409|NCT00003658|stage III chronic lymphocytic leukemia|stage iii chronic lymphocytic leukemia
874410|NCT00003658|stage IV chronic lymphocytic leukemia|stage iv chronic lymphocytic leukemia
874411|NCT00003658|refractory chronic lymphocytic leukemia|refractory chronic lymphocytic leukemia
874412|NCT00003658|B-cell chronic lymphocytic leukemia|b-cell chronic lymphocytic leukemia
874413|NCT00003658|stage I grade 1 follicular lymphoma|stage i grade 1 follicular lymphoma
874414|NCT00003658|stage I grade 2 follicular lymphoma|stage i grade 2 follicular lymphoma
874415|NCT00003658|stage III grade 1 follicular lymphoma|stage iii grade 1 follicular lymphoma
874416|NCT00003658|stage III grade 2 follicular lymphoma|stage iii grade 2 follicular lymphoma
874417|NCT00003658|stage IV grade 1 follicular lymphoma|stage iv grade 1 follicular lymphoma
874418|NCT00003658|stage IV grade 2 follicular lymphoma|stage iv grade 2 follicular lymphoma
874419|NCT00003658|recurrent grade 1 follicular lymphoma|recurrent grade 1 follicular lymphoma
874420|NCT00003658|recurrent grade 2 follicular lymphoma|recurrent grade 2 follicular lymphoma
874421|NCT00003658|contiguous stage II grade 1 follicular lymphoma|contiguous stage ii grade 1 follicular lymphoma
874422|NCT00003658|contiguous stage II grade 2 follicular lymphoma|contiguous stage ii grade 2 follicular lymphoma
874423|NCT00003658|noncontiguous stage II grade 1 follicular lymphoma|noncontiguous stage ii grade 1 follicular lymphoma
874424|NCT00003658|noncontiguous stage II grade 2 follicular lymphoma|noncontiguous stage ii grade 2 follicular lymphoma
874425|NCT00003658|contiguous stage II small lymphocytic lymphoma|contiguous stage ii small lymphocytic lymphoma
874426|NCT00003658|noncontiguous stage II small lymphocytic lymphoma|noncontiguous stage ii small lymphocytic lymphoma
874427|NCT00003658|recurrent small lymphocytic lymphoma|recurrent small lymphocytic lymphoma
874428|NCT00003658|stage I small lymphocytic lymphoma|stage i small lymphocytic lymphoma
874429|NCT00003658|stage III small lymphocytic lymphoma|stage iii small lymphocytic lymphoma
874430|NCT00003658|stage IV small lymphocytic lymphoma|stage iv small lymphocytic lymphoma
874431|NCT00003656|stage IV renal cell cancer|stage iv renal cell cancer
874432|NCT00003656|recurrent renal cell cancer|recurrent renal cell cancer
874433|NCT00003653|adenocarcinoma of the prostate|adenocarcinoma of the prostate
874434|NCT00003653|recurrent prostate cancer|recurrent prostate cancer
874435|NCT00003652|stage II anal cancer|stage ii anal cancer
874436|NCT00003652|stage III anal cancer|stage iii anal cancer
874437|NCT00003652|squamous cell carcinoma of the anus|squamous cell carcinoma of the anus
874438|NCT00003652|cloacogenic carcinoma of the anus|cloacogenic carcinoma of the anus
874439|NCT00003652|basaloid carcinoma of the anus|basaloid carcinoma of the anus
874440|NCT00003650|stage I childhood lymphoblastic lymphoma|stage i childhood lymphoblastic lymphoma
874441|NCT00003650|stage II childhood lymphoblastic lymphoma|stage ii childhood lymphoblastic lymphoma
894968|NCT00001643|Hereditary|hereditary
874442|NCT00003650|stage III childhood lymphoblastic lymphoma|stage iii childhood lymphoblastic lymphoma
874443|NCT00003650|stage IV childhood lymphoblastic lymphoma|stage iv childhood lymphoblastic lymphoma
874444|NCT00003644|stage I ovarian epithelial cancer|stage i ovarian epithelial cancer
874445|NCT00003644|stage II ovarian epithelial cancer|stage ii ovarian epithelial cancer
874446|NCT00003644|ovarian undifferentiated adenocarcinoma|ovarian undifferentiated adenocarcinoma
874447|NCT00003644|ovarian mixed epithelial carcinoma|ovarian mixed epithelial carcinoma
874448|NCT00003644|ovarian serous cystadenocarcinoma|ovarian serous cystadenocarcinoma
874449|NCT00003644|ovarian mucinous cystadenocarcinoma|ovarian mucinous cystadenocarcinoma
874450|NCT00003644|ovarian endometrioid adenocarcinoma|ovarian endometrioid adenocarcinoma
874451|NCT00003644|ovarian clear cell cystadenocarcinoma|ovarian clear cell cystadenocarcinoma
874452|NCT00003644|Brenner tumor|brenner tumor
874453|NCT00003643|stage III malignant testicular germ cell tumor|stage iii malignant testicular germ cell tumor
874455|NCT00003643|testicular embryonal carcinoma|testicular embryonal carcinoma
874456|NCT00003643|testicular choriocarcinoma|testicular choriocarcinoma
874457|NCT00003643|testicular yolk sac tumor|testicular yolk sac tumor
874458|NCT00003643|testicular embryonal carcinoma and teratoma|testicular embryonal carcinoma and teratoma
874459|NCT00003643|testicular embryonal carcinoma and teratoma with seminoma|testicular embryonal carcinoma and teratoma with seminoma
874460|NCT00003643|testicular embryonal carcinoma and yolk sac tumor|testicular embryonal carcinoma and yolk sac tumor
874461|NCT00003643|testicular embryonal carcinoma and yolk sac tumor with seminoma|testicular embryonal carcinoma and yolk sac tumor with seminoma
874462|NCT00003643|testicular embryonal carcinoma and seminoma|testicular embryonal carcinoma and seminoma
874463|NCT00003643|testicular yolk sac tumor and teratoma|testicular yolk sac tumor and teratoma
874464|NCT00003643|testicular yolk sac tumor and teratoma with seminoma|testicular yolk sac tumor and teratoma with seminoma
874465|NCT00003643|testicular choriocarcinoma and yolk sac tumor|testicular choriocarcinoma and yolk sac tumor
874466|NCT00003643|testicular choriocarcinoma and embryonal carcinoma|testicular choriocarcinoma and embryonal carcinoma
874467|NCT00003643|testicular choriocarcinoma and teratoma|testicular choriocarcinoma and teratoma
874468|NCT00003643|testicular choriocarcinoma and seminoma|testicular choriocarcinoma and seminoma
874469|NCT00003643|stage IV extragonadal non-seminomatous germ cell tumor|stage iv extragonadal non-seminomatous germ cell tumor
874470|NCT00003643|stage IV extragonadal seminoma|stage iv extragonadal seminoma
874471|NCT00003643|testicular immature teratoma|testicular immature teratoma
874472|NCT00003643|testicular mature teratoma|testicular mature teratoma
874473|NCT00003643|adult teratoma|adult teratoma
874474|NCT00003641|stage II melanoma|stage ii melanoma
874475|NCT00003641|stage III melanoma|stage iii melanoma
874476|NCT00003637|stage III lymphoepithelioma of the nasopharynx|stage iii lymphoepithelioma of the nasopharynx
874477|NCT00003637|stage IV squamous cell carcinoma of the nasopharynx|stage iv squamous cell carcinoma of the nasopharynx
874478|NCT00003637|stage III squamous cell carcinoma of the nasopharynx|stage iii squamous cell carcinoma of the nasopharynx
874479|NCT00003637|stage IV lymphoepithelioma of the nasopharynx|stage iv lymphoepithelioma of the nasopharynx
874480|NCT00003636|stage III ovarian epithelial cancer|stage iii ovarian epithelial cancer
874481|NCT00003636|stage IV ovarian epithelial cancer|stage iv ovarian epithelial cancer
874482|NCT00003636|fallopian tube cancer|fallopian tube cancer
874483|NCT00003636|primary peritoneal cavity cancer|primary peritoneal cavity cancer
874484|NCT00003633|adenocarcinoma of the prostate|adenocarcinoma of the prostate
874485|NCT00003633|stage IV prostate cancer|stage iv prostate cancer
874486|NCT00003633|recurrent prostate cancer|recurrent prostate cancer
874487|NCT00003631|recurrent adult Hodgkin lymphoma|recurrent adult hodgkin lymphoma
874488|NCT00003631|recurrent/refractory childhood Hodgkin lymphoma|recurrent/refractory childhood hodgkin lymphoma
874489|NCT00003612|stage IV breast cancer|stage iv breast cancer
874490|NCT00003612|recurrent breast cancer|recurrent breast cancer
874491|NCT00003611|basal cell carcinoma of the skin|basal cell carcinoma of the skin
874492|NCT00003611|squamous cell carcinoma of the skin|squamous cell carcinoma of the skin
874493|NCT00003607|adenocarcinoma of the prostate|adenocarcinoma of the prostate
879866|NCT00040287|obesity|obesity
874495|NCT00003607|stage IIB prostate cancer|stage iib prostate cancer
874496|NCT00003607|stage IIA prostate cancer|stage iia prostate cancer
874497|NCT00003607|stage III prostate cancer|stage iii prostate cancer
874498|NCT00003603|refractory multiple myeloma|refractory multiple myeloma
874499|NCT00003603|stage I multiple myeloma|stage i multiple myeloma
874500|NCT00003603|stage II multiple myeloma|stage ii multiple myeloma
874501|NCT00003603|stage III multiple myeloma|stage iii multiple myeloma
874502|NCT00003602|untreated adult acute myeloid leukemia|untreated adult acute myeloid leukemia
874503|NCT00003602|refractory anemia with excess blasts|refractory anemia with excess blasts
874504|NCT00003602|refractory anemia with excess blasts in transformation|refractory anemia with excess blasts in transformation
874505|NCT00003602|secondary acute myeloid leukemia|secondary acute myeloid leukemia
874506|NCT00003602|de novo myelodysplastic syndromes|de novo myelodysplastic syndromes
874507|NCT00003602|secondary myelodysplastic syndromes|secondary myelodysplastic syndromes
874508|NCT00003596|stage II anal cancer|stage ii anal cancer
874509|NCT00003596|stage III anal cancer|stage iii anal cancer
874510|NCT00003596|squamous cell carcinoma of the anus|squamous cell carcinoma of the anus
874511|NCT00003596|cloacogenic carcinoma of the anus|cloacogenic carcinoma of the anus
874512|NCT00003596|basaloid carcinoma of the anus|basaloid carcinoma of the anus
874513|NCT00003593|childhood myelodysplastic syndromes|childhood myelodysplastic syndromes
874514|NCT00003593|untreated childhood acute myeloid leukemia and other myeloid malignancies|untreated childhood acute myeloid leukemia and other myeloid malignancies
874515|NCT00003593|childhood acute myeloblastic leukemia without maturation (M1)|childhood acute myeloblastic leukemia without maturation (m1)
874516|NCT00003593|childhood acute myeloblastic leukemia with maturation (M2)|childhood acute myeloblastic leukemia with maturation (m2)
874517|NCT00003593|childhood acute myelomonocytic leukemia (M4)|childhood acute myelomonocytic leukemia (m4)
874518|NCT00003593|childhood acute erythroleukemia (M6)|childhood acute erythroleukemia (m6)
874519|NCT00003593|childhood acute megakaryocytic leukemia (M7)|childhood acute megakaryocytic leukemia (m7)
874520|NCT00003593|refractory anemia|refractory anemia
874521|NCT00003593|refractory anemia with ringed sideroblasts|refractory anemia with ringed sideroblasts
874522|NCT00003593|refractory anemia with excess blasts|refractory anemia with excess blasts
874523|NCT00003593|refractory anemia with excess blasts in transformation|refractory anemia with excess blasts in transformation
874524|NCT00003593|de novo myelodysplastic syndromes|de novo myelodysplastic syndromes
874525|NCT00003593|childhood acute minimally differentiated myeloid leukemia (M0)|childhood acute minimally differentiated myeloid leukemia (m0)
874526|NCT00003593|childhood acute monocytic leukemia (M5b)|childhood acute monocytic leukemia (m5b)
874527|NCT00003593|childhood acute monoblastic leukemia (M5a)|childhood acute monoblastic leukemia (m5a)
874528|NCT00003593|myelodysplastic/myeloproliferative neoplasm, unclassifiable|myelodysplastic/myeloproliferative neoplasm, unclassifiable
874529|NCT00003593|juvenile myelomonocytic leukemia|juvenile myelomonocytic leukemia
874530|NCT00003593|chronic myelomonocytic leukemia|chronic myelomonocytic leukemia
874531|NCT00003593|secondary myelodysplastic syndromes|secondary myelodysplastic syndromes
874532|NCT00003590|recurrent adult brain tumor|recurrent adult brain tumor
874533|NCT00003590|adult grade I meningioma|adult grade i meningioma
874534|NCT00003577|stage I breast cancer|stage i breast cancer
874535|NCT00003577|stage II breast cancer|stage ii breast cancer
874536|NCT00003576|stage III squamous cell carcinoma of the lip and oral cavity|stage iii squamous cell carcinoma of the lip and oral cavity
874537|NCT00003576|stage IV squamous cell carcinoma of the lip and oral cavity|stage iv squamous cell carcinoma of the lip and oral cavity
874538|NCT00003576|stage III squamous cell carcinoma of the oropharynx|stage iii squamous cell carcinoma of the oropharynx
874539|NCT00003576|stage IV squamous cell carcinoma of the oropharynx|stage iv squamous cell carcinoma of the oropharynx
874540|NCT00003576|stage III squamous cell carcinoma of the hypopharynx|stage iii squamous cell carcinoma of the hypopharynx
874541|NCT00003576|stage IV squamous cell carcinoma of the hypopharynx|stage iv squamous cell carcinoma of the hypopharynx
874542|NCT00003576|stage III squamous cell carcinoma of the larynx|stage iii squamous cell carcinoma of the larynx
874543|NCT00003576|stage IV squamous cell carcinoma of the larynx|stage iv squamous cell carcinoma of the larynx
874544|NCT00003576|stage III squamous cell carcinoma of the paranasal sinus and nasal cavity|stage iii squamous cell carcinoma of the paranasal sinus and nasal cavity
874545|NCT00003576|stage IV squamous cell carcinoma of the paranasal sinus and nasal cavity|stage iv squamous cell carcinoma of the paranasal sinus and nasal cavity
874546|NCT00003569|stage III non-small cell lung cancer|stage iii non-small cell lung cancer
874547|NCT00003569|recurrent non-small cell lung cancer|recurrent non-small cell lung cancer
874548|NCT00003569|stage III ovarian epithelial cancer|stage iii ovarian epithelial cancer
874549|NCT00003569|stage IV ovarian epithelial cancer|stage iv ovarian epithelial cancer
874550|NCT00003569|recurrent ovarian epithelial cancer|recurrent ovarian epithelial cancer
874551|NCT00003569|stage IV non-small cell lung cancer|stage iv non-small cell lung cancer
874552|NCT00003569|stage III squamous cell carcinoma of the lip and oral cavity|stage iii squamous cell carcinoma of the lip and oral cavity
874553|NCT00003569|stage IV squamous cell carcinoma of the lip and oral cavity|stage iv squamous cell carcinoma of the lip and oral cavity
874554|NCT00003569|recurrent squamous cell carcinoma of the lip and oral cavity|recurrent squamous cell carcinoma of the lip and oral cavity
874555|NCT00003569|stage III squamous cell carcinoma of the oropharynx|stage iii squamous cell carcinoma of the oropharynx
874556|NCT00003569|stage IV squamous cell carcinoma of the oropharynx|stage iv squamous cell carcinoma of the oropharynx
879867|NCT00040287|weight loss|weight loss
874557|NCT00003569|recurrent squamous cell carcinoma of the oropharynx|recurrent squamous cell carcinoma of the oropharynx
874558|NCT00003569|stage III squamous cell carcinoma of the nasopharynx|stage iii squamous cell carcinoma of the nasopharynx
874559|NCT00003569|stage IV squamous cell carcinoma of the nasopharynx|stage iv squamous cell carcinoma of the nasopharynx
874560|NCT00003569|recurrent squamous cell carcinoma of the nasopharynx|recurrent squamous cell carcinoma of the nasopharynx
874561|NCT00003569|stage III squamous cell carcinoma of the hypopharynx|stage iii squamous cell carcinoma of the hypopharynx
874562|NCT00003569|stage IV squamous cell carcinoma of the hypopharynx|stage iv squamous cell carcinoma of the hypopharynx
874563|NCT00003569|recurrent squamous cell carcinoma of the hypopharynx|recurrent squamous cell carcinoma of the hypopharynx
874564|NCT00003569|stage III squamous cell carcinoma of the larynx|stage iii squamous cell carcinoma of the larynx
874565|NCT00003569|stage IV squamous cell carcinoma of the larynx|stage iv squamous cell carcinoma of the larynx
874566|NCT00003569|recurrent squamous cell carcinoma of the larynx|recurrent squamous cell carcinoma of the larynx
874567|NCT00003569|stage III squamous cell carcinoma of the paranasal sinus and nasal cavity|stage iii squamous cell carcinoma of the paranasal sinus and nasal cavity
874568|NCT00003569|stage IV squamous cell carcinoma of the paranasal sinus and nasal cavity|stage iv squamous cell carcinoma of the paranasal sinus and nasal cavity
875184|NCT00003329|stage I breast cancer|stage i breast cancer
874569|NCT00003569|recurrent squamous cell carcinoma of the paranasal sinus and nasal cavity|recurrent squamous cell carcinoma of the paranasal sinus and nasal cavity
874570|NCT00003569|neurotoxicity|neurotoxicity
874571|NCT00003569|recurrent salivary gland cancer|recurrent salivary gland cancer
874572|NCT00003569|stage IV salivary gland cancer|stage iv salivary gland cancer
874573|NCT00003569|salivary gland squamous cell carcinoma|salivary gland squamous cell carcinoma
874574|NCT00003569|stage III salivary gland cancer|stage iii salivary gland cancer
874575|NCT00003568|stage IV melanoma|stage iv melanoma
874576|NCT00003568|recurrent melanoma|recurrent melanoma
874577|NCT00003567|recurrent adult brain tumor|recurrent adult brain tumor
874578|NCT00003567|adult brain stem glioma|adult brain stem glioma
874579|NCT00003567|stage IV grade 1 follicular lymphoma|stage iv grade 1 follicular lymphoma
874580|NCT00003567|stage IV grade 2 follicular lymphoma|stage iv grade 2 follicular lymphoma
874581|NCT00003567|stage IV grade 3 follicular lymphoma|stage iv grade 3 follicular lymphoma
874582|NCT00003567|stage IV adult diffuse small cleaved cell lymphoma|stage iv adult diffuse small cleaved cell lymphoma
874583|NCT00003567|stage IV adult diffuse mixed cell lymphoma|stage iv adult diffuse mixed cell lymphoma
874584|NCT00003567|stage IV adult diffuse large cell lymphoma|stage iv adult diffuse large cell lymphoma
874585|NCT00003567|stage IV adult immunoblastic large cell lymphoma|stage iv adult immunoblastic large cell lymphoma
874586|NCT00003567|stage IV adult lymphoblastic lymphoma|stage iv adult lymphoblastic lymphoma
874587|NCT00003567|stage IV adult Burkitt lymphoma|stage iv adult burkitt lymphoma
874588|NCT00003567|recurrent grade 1 follicular lymphoma|recurrent grade 1 follicular lymphoma
874589|NCT00003567|recurrent grade 2 follicular lymphoma|recurrent grade 2 follicular lymphoma
874590|NCT00003567|recurrent grade 3 follicular lymphoma|recurrent grade 3 follicular lymphoma
874591|NCT00003567|recurrent adult diffuse small cleaved cell lymphoma|recurrent adult diffuse small cleaved cell lymphoma
874592|NCT00003567|recurrent adult diffuse mixed cell lymphoma|recurrent adult diffuse mixed cell lymphoma
874593|NCT00003567|recurrent adult diffuse large cell lymphoma|recurrent adult diffuse large cell lymphoma
874594|NCT00003567|recurrent adult immunoblastic large cell lymphoma|recurrent adult immunoblastic large cell lymphoma
874595|NCT00003567|recurrent adult lymphoblastic lymphoma|recurrent adult lymphoblastic lymphoma
874596|NCT00003567|recurrent adult Burkitt lymphoma|recurrent adult burkitt lymphoma
874597|NCT00003567|adult mixed glioma|adult mixed glioma
874598|NCT00003567|stage IV mantle cell lymphoma|stage iv mantle cell lymphoma
874599|NCT00003567|recurrent mantle cell lymphoma|recurrent mantle cell lymphoma
874600|NCT00003567|unspecified adult solid tumor, protocol specific|unspecified adult solid tumor, protocol specific
874601|NCT00003567|adult anaplastic astrocytoma|adult anaplastic astrocytoma
874602|NCT00003567|adult anaplastic oligodendroglioma|adult anaplastic oligodendroglioma
874603|NCT00003567|adult glioblastoma|adult glioblastoma
874604|NCT00003567|adult pilocytic astrocytoma|adult pilocytic astrocytoma
874605|NCT00003567|adult subependymoma|adult subependymoma
874606|NCT00003567|adult anaplastic ependymoma|adult anaplastic ependymoma
874607|NCT00003567|adult myxopapillary ependymoma|adult myxopapillary ependymoma
874608|NCT00003567|adult ependymoblastoma|adult ependymoblastoma
874609|NCT00003567|recurrent marginal zone lymphoma|recurrent marginal zone lymphoma
874610|NCT00003567|recurrent small lymphocytic lymphoma|recurrent small lymphocytic lymphoma
874611|NCT00003567|stage IV small lymphocytic lymphoma|stage iv small lymphocytic lymphoma
874612|NCT00003567|stage IV marginal zone lymphoma|stage iv marginal zone lymphoma
874613|NCT00003567|extranodal marginal zone B-cell lymphoma of mucosa-associated lymphoid tissue|extranodal marginal zone b-cell lymphoma of mucosa-associated lymphoid tissue
874614|NCT00003567|nodal marginal zone B-cell lymphoma|nodal marginal zone b-cell lymphoma
874615|NCT00003567|splenic marginal zone lymphoma|splenic marginal zone lymphoma
874616|NCT00003567|adult oligodendroglioma|adult oligodendroglioma
874617|NCT00003567|adult giant cell glioblastoma|adult giant cell glioblastoma
874618|NCT00003567|adult gliosarcoma|adult gliosarcoma
874619|NCT00003567|adult diffuse astrocytoma|adult diffuse astrocytoma
874620|NCT00003566|stage IIIA non-small cell lung cancer|stage iiia non-small cell lung cancer
874621|NCT00003565|stage IV breast cancer|stage iv breast cancer
874622|NCT00003565|stage IIIA breast cancer|stage iiia breast cancer
874623|NCT00003565|recurrent breast cancer|recurrent breast cancer
874624|NCT00003565|stage IIIB breast cancer|stage iiib breast cancer
874625|NCT00003565|stage IIIC breast cancer|stage iiic breast cancer
874626|NCT00003565|recurrent non-small cell lung cancer|recurrent non-small cell lung cancer
874627|NCT00003565|extensive stage small cell lung cancer|extensive stage small cell lung cancer
874628|NCT00003565|recurrent small cell lung cancer|recurrent small cell lung cancer
874629|NCT00003565|stage III bladder cancer|stage iii bladder cancer
874630|NCT00003565|recurrent bladder cancer|recurrent bladder cancer
874631|NCT00003565|stage IV bladder cancer|stage iv bladder cancer
874632|NCT00003565|stage IV nasopharyngeal cancer|stage iv nasopharyngeal cancer
874633|NCT00003565|stage IIIA non-small cell lung cancer|stage iiia non-small cell lung cancer
874634|NCT00003565|stage IIIB non-small cell lung cancer|stage iiib non-small cell lung cancer
874635|NCT00003565|stage IV non-small cell lung cancer|stage iv non-small cell lung cancer
874636|NCT00003565|unspecified adult solid tumor, protocol specific|unspecified adult solid tumor, protocol specific
874637|NCT00003565|untreated metastatic squamous neck cancer with occult primary|untreated metastatic squamous neck cancer with occult primary
874638|NCT00003565|recurrent metastatic squamous neck cancer with occult primary|recurrent metastatic squamous neck cancer with occult primary
874640|NCT00003565|stage III squamous cell carcinoma of the lip and oral cavity|stage iii squamous cell carcinoma of the lip and oral cavity
874641|NCT00003565|stage III basal cell carcinoma of the lip|stage iii basal cell carcinoma of the lip
874642|NCT00003565|stage III verrucous carcinoma of the oral cavity|stage iii verrucous carcinoma of the oral cavity
874643|NCT00003565|stage III mucoepidermoid carcinoma of the oral cavity|stage iii mucoepidermoid carcinoma of the oral cavity
874644|NCT00003565|stage III adenoid cystic carcinoma of the oral cavity|stage iii adenoid cystic carcinoma of the oral cavity
874645|NCT00003565|stage IV squamous cell carcinoma of the lip and oral cavity|stage iv squamous cell carcinoma of the lip and oral cavity
874646|NCT00003565|stage IV basal cell carcinoma of the lip|stage iv basal cell carcinoma of the lip
874647|NCT00003565|stage IV verrucous carcinoma of the oral cavity|stage iv verrucous carcinoma of the oral cavity
874648|NCT00003565|stage IV mucoepidermoid carcinoma of the oral cavity|stage iv mucoepidermoid carcinoma of the oral cavity
874649|NCT00003565|stage IV adenoid cystic carcinoma of the oral cavity|stage iv adenoid cystic carcinoma of the oral cavity
874650|NCT00003565|recurrent squamous cell carcinoma of the lip and oral cavity|recurrent squamous cell carcinoma of the lip and oral cavity
874651|NCT00003565|recurrent basal cell carcinoma of the lip|recurrent basal cell carcinoma of the lip
874652|NCT00003565|recurrent verrucous carcinoma of the oral cavity|recurrent verrucous carcinoma of the oral cavity
874653|NCT00003565|recurrent mucoepidermoid carcinoma of the oral cavity|recurrent mucoepidermoid carcinoma of the oral cavity
874654|NCT00003565|recurrent adenoid cystic carcinoma of the oral cavity|recurrent adenoid cystic carcinoma of the oral cavity
874655|NCT00003565|stage III squamous cell carcinoma of the oropharynx|stage iii squamous cell carcinoma of the oropharynx
874656|NCT00003565|stage III lymphoepithelioma of the oropharynx|stage iii lymphoepithelioma of the oropharynx
874657|NCT00003565|stage IV squamous cell carcinoma of the oropharynx|stage iv squamous cell carcinoma of the oropharynx
874658|NCT00003565|stage IV lymphoepithelioma of the oropharynx|stage iv lymphoepithelioma of the oropharynx
874659|NCT00003565|recurrent squamous cell carcinoma of the oropharynx|recurrent squamous cell carcinoma of the oropharynx
874660|NCT00003565|recurrent lymphoepithelioma of the oropharynx|recurrent lymphoepithelioma of the oropharynx
874661|NCT00003565|stage III squamous cell carcinoma of the nasopharynx|stage iii squamous cell carcinoma of the nasopharynx
874662|NCT00003565|stage III lymphoepithelioma of the nasopharynx|stage iii lymphoepithelioma of the nasopharynx
874663|NCT00003565|stage IV squamous cell carcinoma of the nasopharynx|stage iv squamous cell carcinoma of the nasopharynx
874664|NCT00003565|stage IV lymphoepithelioma of the nasopharynx|stage iv lymphoepithelioma of the nasopharynx
874665|NCT00003565|recurrent squamous cell carcinoma of the nasopharynx|recurrent squamous cell carcinoma of the nasopharynx
874666|NCT00003565|recurrent lymphoepithelioma of the nasopharynx|recurrent lymphoepithelioma of the nasopharynx
874667|NCT00003565|stage III squamous cell carcinoma of the hypopharynx|stage iii squamous cell carcinoma of the hypopharynx
874668|NCT00003565|stage IV squamous cell carcinoma of the hypopharynx|stage iv squamous cell carcinoma of the hypopharynx
874669|NCT00003565|recurrent squamous cell carcinoma of the hypopharynx|recurrent squamous cell carcinoma of the hypopharynx
874670|NCT00003565|stage III squamous cell carcinoma of the larynx|stage iii squamous cell carcinoma of the larynx
874671|NCT00003565|stage III verrucous carcinoma of the larynx|stage iii verrucous carcinoma of the larynx
874672|NCT00003565|stage IV squamous cell carcinoma of the larynx|stage iv squamous cell carcinoma of the larynx
874673|NCT00003565|stage IV verrucous carcinoma of the larynx|stage iv verrucous carcinoma of the larynx
874674|NCT00003565|recurrent squamous cell carcinoma of the larynx|recurrent squamous cell carcinoma of the larynx
874675|NCT00003565|recurrent verrucous carcinoma of the larynx|recurrent verrucous carcinoma of the larynx
874676|NCT00003565|stage III squamous cell carcinoma of the paranasal sinus and nasal cavity|stage iii squamous cell carcinoma of the paranasal sinus and nasal cavity
874677|NCT00003565|stage III inverted papilloma of the paranasal sinus and nasal cavity|stage iii inverted papilloma of the paranasal sinus and nasal cavity
874678|NCT00003565|stage III midline lethal granuloma of the paranasal sinus and nasal cavity|stage iii midline lethal granuloma of the paranasal sinus and nasal cavity
874679|NCT00003565|stage III esthesioneuroblastoma of the paranasal sinus and nasal cavity|stage iii esthesioneuroblastoma of the paranasal sinus and nasal cavity
879972|NCT00039923|PNH|pnh
874680|NCT00003565|stage IV squamous cell carcinoma of the paranasal sinus and nasal cavity|stage iv squamous cell carcinoma of the paranasal sinus and nasal cavity
874681|NCT00003565|stage IV inverted papilloma of the paranasal sinus and nasal cavity|stage iv inverted papilloma of the paranasal sinus and nasal cavity
874682|NCT00003565|stage IV midline lethal granuloma of the paranasal sinus and nasal cavity|stage iv midline lethal granuloma of the paranasal sinus and nasal cavity
874683|NCT00003565|stage IV esthesioneuroblastoma of the paranasal sinus and nasal cavity|stage iv esthesioneuroblastoma of the paranasal sinus and nasal cavity
874684|NCT00003565|recurrent squamous cell carcinoma of the paranasal sinus and nasal cavity|recurrent squamous cell carcinoma of the paranasal sinus and nasal cavity
874685|NCT00003565|recurrent inverted papilloma of the paranasal sinus and nasal cavity|recurrent inverted papilloma of the paranasal sinus and nasal cavity
874686|NCT00003565|recurrent midline lethal granuloma of the paranasal sinus and nasal cavity|recurrent midline lethal granuloma of the paranasal sinus and nasal cavity
874687|NCT00003565|recurrent esthesioneuroblastoma of the paranasal sinus and nasal cavity|recurrent esthesioneuroblastoma of the paranasal sinus and nasal cavity
874688|NCT00003565|recurrent salivary gland cancer|recurrent salivary gland cancer
874689|NCT00003565|stage III salivary gland cancer|stage iii salivary gland cancer
874690|NCT00003565|stage IV salivary gland cancer|stage iv salivary gland cancer
874691|NCT00003560|stage III ovarian epithelial cancer|stage iii ovarian epithelial cancer
894969|NCT00001643|Dominant|dominant
874692|NCT00003560|stage IV ovarian epithelial cancer|stage iv ovarian epithelial cancer
874693|NCT00003560|stage III endometrial carcinoma|stage iii endometrial carcinoma
874694|NCT00003560|stage IV endometrial carcinoma|stage iv endometrial carcinoma
874695|NCT00003560|endometrial papillary serous carcinoma|endometrial papillary serous carcinoma
874696|NCT00003560|fallopian tube cancer|fallopian tube cancer
874697|NCT00003560|primary peritoneal cavity cancer|primary peritoneal cavity cancer
874698|NCT00003558|adenocarcinoma of unknown primary|adenocarcinoma of unknown primary
874699|NCT00003558|newly diagnosed carcinoma of unknown primary|newly diagnosed carcinoma of unknown primary
874700|NCT00003553|stage IV renal cell cancer|stage iv renal cell cancer
874701|NCT00003553|recurrent renal cell cancer|recurrent renal cell cancer
874702|NCT00003538|stage I adult Hodgkin lymphoma|stage i adult hodgkin lymphoma
874703|NCT00003538|stage II adult Hodgkin lymphoma|stage ii adult hodgkin lymphoma
874704|NCT00003538|stage III adult Hodgkin lymphoma|stage iii adult hodgkin lymphoma
874705|NCT00003538|stage IV adult Hodgkin lymphoma|stage iv adult hodgkin lymphoma
874706|NCT00003538|stage IV breast cancer|stage iv breast cancer
874707|NCT00003538|stage IIIA breast cancer|stage iiia breast cancer
874708|NCT00003538|stage IIIB breast cancer|stage iiib breast cancer
874709|NCT00003538|recurrent childhood acute lymphoblastic leukemia|recurrent childhood acute lymphoblastic leukemia
874710|NCT00003538|recurrent adult Hodgkin lymphoma|recurrent adult hodgkin lymphoma
874711|NCT00003538|recurrent childhood rhabdomyosarcoma|recurrent childhood rhabdomyosarcoma
874712|NCT00003538|stage II ovarian epithelial cancer|stage ii ovarian epithelial cancer
874713|NCT00003538|stage III ovarian epithelial cancer|stage iii ovarian epithelial cancer
874714|NCT00003538|stage IV ovarian epithelial cancer|stage iv ovarian epithelial cancer
874715|NCT00003538|recurrent ovarian epithelial cancer|recurrent ovarian epithelial cancer
874716|NCT00003538|disseminated neuroblastoma|disseminated neuroblastoma
874717|NCT00003538|recurrent neuroblastoma|recurrent neuroblastoma
874718|NCT00003538|recurrent Wilms tumor and other childhood kidney tumors|recurrent wilms tumor and other childhood kidney tumors
874719|NCT00003538|Waldenstrom macroglobulinemia|waldenstrom macroglobulinemia
874720|NCT00003538|stage I multiple myeloma|stage i multiple myeloma
874721|NCT00003538|stage II multiple myeloma|stage ii multiple myeloma
874722|NCT00003538|stage III multiple myeloma|stage iii multiple myeloma
874723|NCT00003538|stage I childhood lymphoblastic lymphoma|stage i childhood lymphoblastic lymphoma
874724|NCT00003538|stage III childhood lymphoblastic lymphoma|stage iii childhood lymphoblastic lymphoma
874725|NCT00003538|stage IV childhood lymphoblastic lymphoma|stage iv childhood lymphoblastic lymphoma
874726|NCT00003538|recurrent childhood lymphoblastic lymphoma|recurrent childhood lymphoblastic lymphoma
874727|NCT00003538|recurrent childhood acute myeloid leukemia|recurrent childhood acute myeloid leukemia
874728|NCT00003538|recurrent adult acute myeloid leukemia|recurrent adult acute myeloid leukemia
874729|NCT00003538|recurrent adult acute lymphoblastic leukemia|recurrent adult acute lymphoblastic leukemia
874730|NCT00003538|relapsing chronic myelogenous leukemia|relapsing chronic myelogenous leukemia
874731|NCT00003538|stage III malignant testicular germ cell tumor|stage iii malignant testicular germ cell tumor
874732|NCT00003538|recurrent malignant testicular germ cell tumor|recurrent malignant testicular germ cell tumor
874733|NCT00003538|chronic phase chronic myelogenous leukemia|chronic phase chronic myelogenous leukemia
874734|NCT00003538|accelerated phase chronic myelogenous leukemia|accelerated phase chronic myelogenous leukemia
874735|NCT00003538|blastic phase chronic myelogenous leukemia|blastic phase chronic myelogenous leukemia
874736|NCT00003538|meningeal chronic myelogenous leukemia|meningeal chronic myelogenous leukemia
874737|NCT00003538|untreated adult acute lymphoblastic leukemia|untreated adult acute lymphoblastic leukemia
874738|NCT00003538|untreated adult acute myeloid leukemia|untreated adult acute myeloid leukemia
874739|NCT00003538|adult acute myeloid leukemia in remission|adult acute myeloid leukemia in remission
874740|NCT00003538|adult acute lymphoblastic leukemia in remission|adult acute lymphoblastic leukemia in remission
874741|NCT00003538|childhood acute myeloid leukemia in remission|childhood acute myeloid leukemia in remission
874742|NCT00003538|childhood acute lymphoblastic leukemia in remission|childhood acute lymphoblastic leukemia in remission
874743|NCT00003538|myelodysplastic syndromes|myelodysplastic syndromes
874744|NCT00003538|Philadelphia chromosome positive chronic myelogenous leukemia|philadelphia chromosome positive chronic myelogenous leukemia
874745|NCT00003538|Philadelphia chromosome negative chronic myelogenous leukemia|philadelphia chromosome negative chronic myelogenous leukemia
874746|NCT00003538|untreated hairy cell leukemia|untreated hairy cell leukemia
874747|NCT00003538|progressive hairy cell leukemia, initial treatment|progressive hairy cell leukemia, initial treatment
874748|NCT00003538|refractory hairy cell leukemia|refractory hairy cell leukemia
874749|NCT00003538|stage II childhood Hodgkin lymphoma|stage ii childhood hodgkin lymphoma
874750|NCT00003538|stage I childhood Hodgkin lymphoma|stage i childhood hodgkin lymphoma
874751|NCT00003538|stage III childhood Hodgkin lymphoma|stage iii childhood hodgkin lymphoma
874752|NCT00003538|stage IV childhood Hodgkin lymphoma|stage iv childhood hodgkin lymphoma
874753|NCT00003538|recurrent/refractory childhood Hodgkin lymphoma|recurrent/refractory childhood hodgkin lymphoma
874754|NCT00003538|stage I grade 1 follicular lymphoma|stage i grade 1 follicular lymphoma
874755|NCT00003538|stage I grade 2 follicular lymphoma|stage i grade 2 follicular lymphoma
874756|NCT00003538|stage I grade 3 follicular lymphoma|stage i grade 3 follicular lymphoma
874757|NCT00003538|stage I adult diffuse small cleaved cell lymphoma|stage i adult diffuse small cleaved cell lymphoma
875185|NCT00003329|stage II breast cancer|stage ii breast cancer
874758|NCT00003538|stage I adult diffuse mixed cell lymphoma|stage i adult diffuse mixed cell lymphoma
874759|NCT00003538|stage I adult diffuse large cell lymphoma|stage i adult diffuse large cell lymphoma
874760|NCT00003538|stage I adult immunoblastic large cell lymphoma|stage i adult immunoblastic large cell lymphoma
874761|NCT00003538|stage I adult lymphoblastic lymphoma|stage i adult lymphoblastic lymphoma
874762|NCT00003538|stage I adult Burkitt lymphoma|stage i adult burkitt lymphoma
874763|NCT00003538|recurrent ovarian germ cell tumor|recurrent ovarian germ cell tumor
874764|NCT00003538|chronic myelomonocytic leukemia|chronic myelomonocytic leukemia
874765|NCT00003538|acute undifferentiated leukemia|acute undifferentiated leukemia
874766|NCT00003538|stage III grade 1 follicular lymphoma|stage iii grade 1 follicular lymphoma
874767|NCT00003538|stage III grade 2 follicular lymphoma|stage iii grade 2 follicular lymphoma
874768|NCT00003538|stage III grade 3 follicular lymphoma|stage iii grade 3 follicular lymphoma
874769|NCT00003538|stage III adult diffuse small cleaved cell lymphoma|stage iii adult diffuse small cleaved cell lymphoma
874770|NCT00003538|stage III adult diffuse mixed cell lymphoma|stage iii adult diffuse mixed cell lymphoma
874771|NCT00003538|stage III adult diffuse large cell lymphoma|stage iii adult diffuse large cell lymphoma
874772|NCT00003538|stage III adult immunoblastic large cell lymphoma|stage iii adult immunoblastic large cell lymphoma
874773|NCT00003538|stage III adult lymphoblastic lymphoma|stage iii adult lymphoblastic lymphoma
874774|NCT00003538|stage III adult Burkitt lymphoma|stage iii adult burkitt lymphoma
874775|NCT00003538|stage IV small lymphocytic lymphoma|stage iv small lymphocytic lymphoma
874776|NCT00003538|stage IV grade 1 follicular lymphoma|stage iv grade 1 follicular lymphoma
874777|NCT00003538|stage IV grade 2 follicular lymphoma|stage iv grade 2 follicular lymphoma
874778|NCT00003538|stage IV grade 3 follicular lymphoma|stage iv grade 3 follicular lymphoma
874779|NCT00003538|stage IV adult diffuse small cleaved cell lymphoma|stage iv adult diffuse small cleaved cell lymphoma
874780|NCT00003538|stage IV adult diffuse mixed cell lymphoma|stage iv adult diffuse mixed cell lymphoma
874781|NCT00003538|stage IV adult diffuse large cell lymphoma|stage iv adult diffuse large cell lymphoma
874782|NCT00003538|stage IV adult immunoblastic large cell lymphoma|stage iv adult immunoblastic large cell lymphoma
874783|NCT00003538|stage IV adult lymphoblastic lymphoma|stage iv adult lymphoblastic lymphoma
874784|NCT00003538|stage IV adult Burkitt lymphoma|stage iv adult burkitt lymphoma
874785|NCT00003538|recurrent grade 1 follicular lymphoma|recurrent grade 1 follicular lymphoma
874786|NCT00003538|recurrent grade 2 follicular lymphoma|recurrent grade 2 follicular lymphoma
874787|NCT00003538|recurrent grade 3 follicular lymphoma|recurrent grade 3 follicular lymphoma
874788|NCT00003538|recurrent adult diffuse small cleaved cell lymphoma|recurrent adult diffuse small cleaved cell lymphoma
874789|NCT00003538|recurrent adult diffuse mixed cell lymphoma|recurrent adult diffuse mixed cell lymphoma
874790|NCT00003538|recurrent adult diffuse large cell lymphoma|recurrent adult diffuse large cell lymphoma
874791|NCT00003538|recurrent adult immunoblastic large cell lymphoma|recurrent adult immunoblastic large cell lymphoma
874792|NCT00003538|recurrent adult lymphoblastic lymphoma|recurrent adult lymphoblastic lymphoma
874793|NCT00003538|recurrent adult Burkitt lymphoma|recurrent adult burkitt lymphoma
874794|NCT00003538|stage III adult T-cell leukemia/lymphoma|stage iii adult t-cell leukemia/lymphoma
874795|NCT00003538|stage IV adult T-cell leukemia/lymphoma|stage iv adult t-cell leukemia/lymphoma
874796|NCT00003538|recurrent adult T-cell leukemia/lymphoma|recurrent adult t-cell leukemia/lymphoma
874797|NCT00003538|secondary acute myeloid leukemia|secondary acute myeloid leukemia
874798|NCT00003538|de novo myelodysplastic syndromes|de novo myelodysplastic syndromes
874799|NCT00003538|poor prognosis metastatic gestational trophoblastic tumor|poor prognosis metastatic gestational trophoblastic tumor
874800|NCT00003538|previously treated myelodysplastic syndromes|previously treated myelodysplastic syndromes
874801|NCT00003538|secondary myelodysplastic syndromes|secondary myelodysplastic syndromes
874802|NCT00003538|anemia|anemia
874803|NCT00003538|graft versus host disease|graft versus host disease
874804|NCT00003538|prolymphocytic leukemia|prolymphocytic leukemia
874805|NCT00003538|AIDS-related peripheral/systemic lymphoma|aids-related peripheral/systemic lymphoma
874806|NCT00003538|AIDS-related primary CNS lymphoma|aids-related primary cns lymphoma
874869|NCT00003525|recurrent vulvar cancer|recurrent vulvar cancer
874807|NCT00003538|stage I childhood large cell lymphoma|stage i childhood large cell lymphoma
874808|NCT00003538|stage III childhood large cell lymphoma|stage iii childhood large cell lymphoma
874809|NCT00003538|stage IV childhood small noncleaved cell lymphoma|stage iv childhood small noncleaved cell lymphoma
874810|NCT00003538|stage IV childhood large cell lymphoma|stage iv childhood large cell lymphoma
874811|NCT00003538|recurrent childhood small noncleaved cell lymphoma|recurrent childhood small noncleaved cell lymphoma
874812|NCT00003538|recurrent childhood large cell lymphoma|recurrent childhood large cell lymphoma
874813|NCT00003538|non-Hodgkin lymphoma during pregnancy|non-hodgkin lymphoma during pregnancy
874814|NCT00003538|stage I mantle cell lymphoma|stage i mantle cell lymphoma
874815|NCT00003538|contiguous stage II grade 1 follicular lymphoma|contiguous stage ii grade 1 follicular lymphoma
874816|NCT00003538|contiguous stage II grade 2 follicular lymphoma|contiguous stage ii grade 2 follicular lymphoma
874817|NCT00003538|contiguous stage II grade 3 follicular lymphoma|contiguous stage ii grade 3 follicular lymphoma
874818|NCT00003538|contiguous stage II adult diffuse small cleaved cell lymphoma|contiguous stage ii adult diffuse small cleaved cell lymphoma
874819|NCT00003538|contiguous stage II mantle cell lymphoma|contiguous stage ii mantle cell lymphoma
874820|NCT00003538|contiguous stage II adult diffuse mixed cell lymphoma|contiguous stage ii adult diffuse mixed cell lymphoma
874821|NCT00003538|contiguous stage II adult immunoblastic large cell lymphoma|contiguous stage ii adult immunoblastic large cell lymphoma
874822|NCT00003538|contiguous stage II adult diffuse large cell lymphoma|contiguous stage ii adult diffuse large cell lymphoma
874823|NCT00003538|contiguous stage II adult Burkitt lymphoma|contiguous stage ii adult burkitt lymphoma
874824|NCT00003538|contiguous stage II adult lymphoblastic lymphoma|contiguous stage ii adult lymphoblastic lymphoma
874825|NCT00003538|noncontiguous stage II grade 1 follicular lymphoma|noncontiguous stage ii grade 1 follicular lymphoma
874826|NCT00003538|noncontiguous stage II grade 2 follicular lymphoma|noncontiguous stage ii grade 2 follicular lymphoma
874827|NCT00003538|noncontiguous stage II grade 3 follicular lymphoma|noncontiguous stage ii grade 3 follicular lymphoma
874828|NCT00003538|noncontiguous stage II adult diffuse small cleaved cell lymphoma|noncontiguous stage ii adult diffuse small cleaved cell lymphoma
874829|NCT00003538|noncontiguous stage II mantle cell lymphoma|noncontiguous stage ii mantle cell lymphoma
874830|NCT00003538|noncontiguous stage II adult diffuse mixed cell lymphoma|noncontiguous stage ii adult diffuse mixed cell lymphoma
874831|NCT00003538|noncontiguous stage II adult immunoblastic large cell lymphoma|noncontiguous stage ii adult immunoblastic large cell lymphoma
874832|NCT00003538|noncontiguous stage II adult diffuse large cell lymphoma|noncontiguous stage ii adult diffuse large cell lymphoma
874833|NCT00003538|noncontiguous stage II adult Burkitt lymphoma|noncontiguous stage ii adult burkitt lymphoma
874834|NCT00003538|noncontiguous stage II adult lymphoblastic lymphoma|noncontiguous stage ii adult lymphoblastic lymphoma
874835|NCT00003538|stage III mantle cell lymphoma|stage iii mantle cell lymphoma
874836|NCT00003538|stage IV mantle cell lymphoma|stage iv mantle cell lymphoma
874837|NCT00003538|recurrent mantle cell lymphoma|recurrent mantle cell lymphoma
874838|NCT00003538|angioimmunoblastic T-cell lymphoma|angioimmunoblastic t-cell lymphoma
874839|NCT00003538|anaplastic large cell lymphoma|anaplastic large cell lymphoma
874840|NCT00003538|childhood chronic myelogenous leukemia|childhood chronic myelogenous leukemia
874841|NCT00003538|noncontiguous stage II small lymphocytic lymphoma|noncontiguous stage ii small lymphocytic lymphoma
874842|NCT00003538|noncontiguous stage II marginal zone lymphoma|noncontiguous stage ii marginal zone lymphoma
874843|NCT00003538|recurrent marginal zone lymphoma|recurrent marginal zone lymphoma
874844|NCT00003538|recurrent small lymphocytic lymphoma|recurrent small lymphocytic lymphoma
874845|NCT00003538|stage I marginal zone lymphoma|stage i marginal zone lymphoma
874846|NCT00003538|stage I small lymphocytic lymphoma|stage i small lymphocytic lymphoma
874847|NCT00003538|stage III small lymphocytic lymphoma|stage iii small lymphocytic lymphoma
874848|NCT00003538|stage III marginal zone lymphoma|stage iii marginal zone lymphoma
874849|NCT00003538|stage IV marginal zone lymphoma|stage iv marginal zone lymphoma
874850|NCT00003538|contiguous stage II marginal zone lymphoma|contiguous stage ii marginal zone lymphoma
874851|NCT00003538|contiguous stage II small lymphocytic lymphoma|contiguous stage ii small lymphocytic lymphoma
874852|NCT00003538|extranodal marginal zone B-cell lymphoma of mucosa-associated lymphoid tissue|extranodal marginal zone b-cell lymphoma of mucosa-associated lymphoid tissue
874853|NCT00003538|nodal marginal zone B-cell lymphoma|nodal marginal zone b-cell lymphoma
874854|NCT00003538|splenic marginal zone lymphoma|splenic marginal zone lymphoma
874855|NCT00003538|childhood myelodysplastic syndromes|childhood myelodysplastic syndromes
874856|NCT00003537|adult anaplastic astrocytoma|adult anaplastic astrocytoma
874857|NCT00003535|childhood anaplastic astrocytoma|childhood anaplastic astrocytoma
874858|NCT00003535|childhood glioblastoma multiforme|childhood glioblastoma multiforme
874859|NCT00003534|Refractory stage IV prostate cancer|refractory stage iv prostate cancer
874860|NCT00003533|adenocarcinoma of the prostate|adenocarcinoma of the prostate
874861|NCT00003532|Stage III ovarian epithelial cancer|stage iii ovarian epithelial cancer
874862|NCT00003532|Stage IV ovarian epithelial cancer|stage iv ovarian epithelial cancer
874863|NCT00003532|Stage III ovarian germ cell tumor|stage iii ovarian germ cell tumor
874864|NCT00003532|Stage IV ovarian germ cell tumor|stage iv ovarian germ cell tumor
874865|NCT00003531|Adenocarcinoma of the pancreas|adenocarcinoma of the pancreas
874866|NCT00003530|Childhood primary liver cancer|childhood primary liver cancer
874867|NCT00003530|Adult primary liver cancer|adult primary liver cancer
874868|NCT00003525|recurrent cervical cancer|recurrent cervical cancer
880292|NCT00038558|Velban|velban
874870|NCT00003524|Stage III and IV Stomach (Gastric) Cancer|stage iii and iv stomach (gastric) cancer
874871|NCT00003524|Recurrent Stomach (Gastric) Cancer|recurrent stomach (gastric) cancer
874872|NCT00003522|recurrent small intestine cancer|recurrent small intestine cancer
874873|NCT00003521|Stage III and IV Soft Tissue Sarcoma|stage iii and iv soft tissue sarcoma
874874|NCT00003521|Recurrent Soft Tissue Sarcoma|recurrent soft tissue sarcoma
874875|NCT00003520|stage IV renal cell cancer|stage iv renal cell cancer
874876|NCT00003516|Stage III or Stage IV Prostate Cancer Stage III|stage iii or stage iv prostate cancer stage iii
874877|NCT00003516|Stage III or Stage IV Prostate Cancer Stage IV|stage iii or stage iv prostate cancer stage iv
874878|NCT00003515|Metastatic Primitive Neuroectodermal Tumor|metastatic primitive neuroectodermal tumor
874879|NCT00003515|Recurrent Primitive Neuroectodermal Tumor|recurrent primitive neuroectodermal tumor
874880|NCT00003515|Refractory Primitive Neuroectodermal Tumor|refractory primitive neuroectodermal tumor
874881|NCT00003514|ACTH-producing pituitary tumor|acth-producing pituitary tumor
874882|NCT00003514|prolactin-producing pituitary tumor|prolactin-producing pituitary tumor
874883|NCT00003514|growth hormone-producing pituitary tumor|growth hormone-producing pituitary tumor
874884|NCT00003514|recurrent pituitary tumor|recurrent pituitary tumor
875186|NCT00003329|stage IIIA breast cancer|stage iiia breast cancer
874885|NCT00003514|TSH producing pituitary tumor|tsh producing pituitary tumor
874886|NCT00003514|nonfunctioning pituitary tumor|nonfunctioning pituitary tumor
874887|NCT00003514|somatostatinoma|somatostatinoma
874888|NCT00003514|stage III Merkel cell carcinoma|stage iii merkel cell carcinoma
874889|NCT00003514|recurrent Merkel cell carcinoma|recurrent merkel cell carcinoma
874890|NCT00003514|neuroendocrine carcinoma|neuroendocrine carcinoma
874891|NCT00003513|Metastatic Neuroblastoma|metastatic neuroblastoma
874892|NCT00003513|Recurrent Neuroblastoma|recurrent neuroblastoma
874893|NCT00003513|Refractory Neuroblastoma|refractory neuroblastoma
874894|NCT00003512|Waldenstrom Macroglobulinemia Recurrent|waldenstrom macroglobulinemia recurrent
874895|NCT00003512|Waldenstrom Macroglobulinemia Refractory|waldenstrom macroglobulinemia refractory
874896|NCT00003511|Stage I multiple myeloma|stage i multiple myeloma
874897|NCT00003511|Stage II multiple myeloma|stage ii multiple myeloma
874898|NCT00003511|Stage III multiple myeloma|stage iii multiple myeloma
874899|NCT00003509|Stage IV melanoma of the skin|stage iv melanoma of the skin
874900|NCT00003508|advanced malignant mesothelioma|advanced malignant mesothelioma
874901|NCT00003508|recurrent malignant mesothelioma|recurrent malignant mesothelioma
874902|NCT00003501|Refractory Non-Hodgkin's Lymphoma|refractory non-hodgkin's lymphoma
874903|NCT00003501|Recurrent Non-Hodgkin's Lymphoma|recurrent non-hodgkin's lymphoma
874904|NCT00003501|High-Grade Stage II - IV Non-Hodgkin's Lymphoma|high-grade stage ii - iv non-hodgkin's lymphoma
874905|NCT00003500|Refractory Non-Hodgkin's Lymphoma|refractory non-hodgkin's lymphoma
874906|NCT00003500|Recurrent Non-Hodgkin's Lymphoma|recurrent non-hodgkin's lymphoma
874907|NCT00003500|Intermediate-Grade Stage II - IV Non-Hodgkin's Lymphoma|intermediate-grade stage ii - iv non-hodgkin's lymphoma
874908|NCT00003499|Low-grade non-Hodgkin's lymphoma|low-grade non-hodgkin's lymphoma
874909|NCT00003498|Non Hodgkin Lymphoma Recurrent|non hodgkin lymphoma recurrent
874910|NCT00003498|Non Hodgkin Lymphoma Refractory|non hodgkin lymphoma refractory
874911|NCT00003497|recurrent non-small cell lung cancer|recurrent non-small cell lung cancer
874912|NCT00003496|recurrent small cell lung cancer|recurrent small cell lung cancer
874913|NCT00003495|recurrent lung cancer|recurrent lung cancer
874914|NCT00003494|Bronchial Alveolar Cancer Recurrent|bronchial alveolar cancer recurrent
874915|NCT00003494|Bronchial Alveolar Cancer Stage IV|bronchial alveolar cancer stage iv
874916|NCT00003492|Stage IV large cell lung cancer|stage iv large cell lung cancer
874917|NCT00003492|Stage IV non-small cell lung cancer|stage iv non-small cell lung cancer
874918|NCT00003491|non-small cell adenocarcinoma of the lung|non-small cell adenocarcinoma of the lung
874919|NCT00003489|Advanced Head and Neck Cancer|advanced head and neck cancer
874920|NCT00003489|Recurrent Head and Neck Cancer|recurrent head and neck cancer
874921|NCT00003489|Oral Cavity Cancer|oral cavity cancer
874922|NCT00003489|Nasopharyngeal Cancer|nasopharyngeal cancer
874923|NCT00003489|Hypopharyngeal Cancer|hypopharyngeal cancer
874924|NCT00003489|Laryngeal Cancer|laryngeal cancer
874925|NCT00003489|Nasal Cavity Cancer|nasal cavity cancer
874926|NCT00003489|Paranasal Sinus Cancer|paranasal sinus cancer
874927|NCT00003489|Oropharyngeal Cancer|oropharyngeal cancer
874928|NCT00003489|Salivary Gland Cancer|salivary gland cancer
874929|NCT00003489|Stage IV Head and Neck Cancer|stage iv head and neck cancer
874930|NCT00003487|stage IV esophageal cancer|stage iv esophageal cancer
874931|NCT00003487|recurrent esophageal cancer|recurrent esophageal cancer
874932|NCT00003487|adenocarcinoma of the esophagus|adenocarcinoma of the esophagus
874933|NCT00003485|stage IV colon cancer|stage iv colon cancer
874934|NCT00003485|unresectable colon cancer|unresectable colon cancer
874935|NCT00003483|adult meningioma|adult meningioma
874936|NCT00003483|recurrent adult meningioma|recurrent adult meningioma
874937|NCT00003479|Ependymoma|ependymoma
874938|NCT00003479|Anaplastic Ependymoma|anaplastic ependymoma
874939|NCT00003478|recurrent adult brain tumor|recurrent adult brain tumor
874940|NCT00003478|adult brain stem glioma|adult brain stem glioma
874941|NCT00003478|adult medulloblastoma|adult medulloblastoma
874942|NCT00003478|adult glioblastoma|adult glioblastoma
874943|NCT00003478|adult anaplastic astrocytoma|adult anaplastic astrocytoma
874944|NCT00003478|adult anaplastic ependymoma|adult anaplastic ependymoma
880402|NCT00038142|Dexrazoxane|dexrazoxane
874945|NCT00003478|adult anaplastic oligodendroglioma|adult anaplastic oligodendroglioma
874946|NCT00003478|adult mixed glioma|adult mixed glioma
874947|NCT00003478|adult ependymoblastoma|adult ependymoblastoma
874948|NCT00003478|adult giant cell glioblastoma|adult giant cell glioblastoma
874949|NCT00003478|adult gliosarcoma|adult gliosarcoma
874950|NCT00003477|visual pathway glioma not amenable to standard therapy|visual pathway glioma not amenable to standard therapy
874951|NCT00003477|visual pathway glioma not responding to standard therapy|visual pathway glioma not responding to standard therapy
874952|NCT00003476|childhood anaplastic astrocytoma|childhood anaplastic astrocytoma
874953|NCT00003476|recurrent childhood anaplastic astrocytoma|recurrent childhood anaplastic astrocytoma
874954|NCT00003476|childhood glioblastoma multiforme|childhood glioblastoma multiforme
874955|NCT00003476|recurrent childhood glioblastoma multiforme|recurrent childhood glioblastoma multiforme
874956|NCT00003476|childhood brainstem glioma|childhood brainstem glioma
874957|NCT00003476|recurrent childhood brainstem glioma|recurrent childhood brainstem glioma
874958|NCT00003476|childhood primitive neuroectodermal tumor|childhood primitive neuroectodermal tumor
874959|NCT00003476|recurrent childhood primitive neuroectodermal tumor|recurrent childhood primitive neuroectodermal tumor
874960|NCT00003475|adult glioblastoma multiforme|adult glioblastoma multiforme
874961|NCT00003475|adult anaplastic astrocytoma|adult anaplastic astrocytoma
874962|NCT00003475|adult anaplastic astrocytoma/Mixed|adult anaplastic astrocytoma/mixed
874963|NCT00003474|adult glioblastoma|adult glioblastoma
874964|NCT00003474|recurrent glioblastoma|recurrent glioblastoma
874965|NCT00003473|recurrent adult mixed glioma|recurrent adult mixed glioma
874966|NCT00003473|refractoy adult mixed glioma|refractoy adult mixed glioma
874967|NCT00003472|Recurrent/progressive adult oligodendroglioma|recurrent/progressive adult oligodendroglioma
874968|NCT00003472|Recurrent/progressive adult anaplastic oligodendroglioma|recurrent/progressive adult anaplastic oligodendroglioma
874969|NCT00003471|Recurrent/progressive adult low grade astrocytoma|recurrent/progressive adult low grade astrocytoma
874970|NCT00003470|persistent anaplastic astrocytoma|persistent anaplastic astrocytoma
874971|NCT00003470|recurrent anaplastic astrocytoma|recurrent anaplastic astrocytoma
874972|NCT00003470|adult anaplastic astrocytoma|adult anaplastic astrocytoma
874973|NCT00003469|childhood rhabdoid tumor|childhood rhabdoid tumor
874974|NCT00003468|childhood low-grade astrocytoma|childhood low-grade astrocytoma
874975|NCT00003468|recurrent childhood astrocytoma|recurrent childhood astrocytoma
874976|NCT00003468|persistent childhood astrocytoma|persistent childhood astrocytoma
874977|NCT00003467|recurrent adult brain tumor|recurrent adult brain tumor
874978|NCT00003467|adult brain stem glioma|adult brain stem glioma
874979|NCT00003467|adult mixed glioma|adult mixed glioma
874980|NCT00003467|adult anaplastic astrocytoma|adult anaplastic astrocytoma
874981|NCT00003467|adult pilocytic astrocytoma|adult pilocytic astrocytoma
874982|NCT00003467|adult oligodendroglioma|adult oligodendroglioma
874983|NCT00003466|recurrent adult brain tumor|recurrent adult brain tumor
874984|NCT00003466|adult mixed glioma|adult mixed glioma
874985|NCT00003466|childhood mixed glioma|childhood mixed glioma
874986|NCT00003466|adult pilocytic astrocytoma|adult pilocytic astrocytoma
874987|NCT00003466|adult subependymoma|adult subependymoma
874988|NCT00003466|recurrent childhood cerebral astrocytoma|recurrent childhood cerebral astrocytoma
874989|NCT00003466|adult brain stem glioma|adult brain stem glioma
874990|NCT00003466|recurrent childhood brain stem glioma|recurrent childhood brain stem glioma
874991|NCT00003466|untreated childhood brain stem glioma|untreated childhood brain stem glioma
874992|NCT00003466|recurrent childhood visual pathway and hypothalamic glioma|recurrent childhood visual pathway and hypothalamic glioma
874993|NCT00003466|untreated childhood visual pathway and hypothalamic glioma|untreated childhood visual pathway and hypothalamic glioma
874994|NCT00003466|adult oligodendroglioma|adult oligodendroglioma
874995|NCT00003466|adult diffuse astrocytoma|adult diffuse astrocytoma
874996|NCT00003462|leptomeningeal metastases|leptomeningeal metastases
874997|NCT00003461|localized resectable neuroblastoma|localized resectable neuroblastoma
874998|NCT00003461|recurrent neuroblastoma|recurrent neuroblastoma
874999|NCT00003461|recurrent adult brain tumor|recurrent adult brain tumor
875000|NCT00003461|adult craniopharyngioma|adult craniopharyngioma
875001|NCT00003461|adult medulloblastoma|adult medulloblastoma
875002|NCT00003461|adult meningioma|adult meningioma
875003|NCT00003461|adult glioblastoma|adult glioblastoma
875004|NCT00003461|adult oligodendroglioma|adult oligodendroglioma
875005|NCT00003461|tumors metastatic to brain|tumors metastatic to brain
875006|NCT00003461|adult anaplastic astrocytoma|adult anaplastic astrocytoma
875007|NCT00003461|adult mixed glioma|adult mixed glioma
875008|NCT00003461|adult pineal parenchymal tumor|adult pineal parenchymal tumor
875009|NCT00003461|adult central nervous system germ cell tumor|adult central nervous system germ cell tumor
875010|NCT00003461|adult grade III meningioma|adult grade iii meningioma
875011|NCT00003461|adult pilocytic astrocytoma|adult pilocytic astrocytoma
875012|NCT00003461|adult giant cell glioblastoma|adult giant cell glioblastoma
875013|NCT00003461|adult gliosarcoma|adult gliosarcoma
875014|NCT00003461|adult pineal gland astrocytoma|adult pineal gland astrocytoma
875015|NCT00003460|Recurrent primitive neuroectodermal tumor|recurrent primitive neuroectodermal tumor
875016|NCT00003459|recurrent adult brain stem glioma|recurrent adult brain stem glioma
875017|NCT00003459|untreated adult brain stem glioma|untreated adult brain stem glioma
875018|NCT00003459|untreated childhood brain stem glioma|untreated childhood brain stem glioma
875019|NCT00003459|recurrent childhood brain stem glioma|recurrent childhood brain stem glioma
875020|NCT00003458|Anaplastic astrocytoma|anaplastic astrocytoma
875021|NCT00003458|Anaplastic glioma|anaplastic glioma
875022|NCT00003458|Anaplastic oligodendroglioma|anaplastic oligodendroglioma
875023|NCT00003458|Astrocytoma|astrocytoma
875024|NCT00003458|Astrocytoma pilocytic|astrocytoma pilocytic
875033|NCT00003458|Oligodendroglioma-brainstem|oligodendroglioma-brainstem
875034|NCT00003458|Primitive neuroectodermal tumor|primitive neuroectodermal tumor
875035|NCT00003457|Anaplastic astrocytoma|anaplastic astrocytoma
875036|NCT00003457|Anaplastic astrocytoma/Mixed|anaplastic astrocytoma/mixed
875037|NCT00003457|Astrocytoma|astrocytoma
875038|NCT00003457|Astrocytoma/Pilocytic|astrocytoma/pilocytic
875039|NCT00003457|Brainstem glioma|brainstem glioma
875040|NCT00003457|Glioblastoma multiforme|glioblastoma multiforme
875041|NCT00003457|Glioma|glioma
875042|NCT00003457|Neurocytoma|neurocytoma
875043|NCT00003457|Primitive neuroectodermal tumor|primitive neuroectodermal tumor
875044|NCT00003457|Tectal glioma|tectal glioma
875045|NCT00003456|adult glioblastoma|adult glioblastoma
875046|NCT00003454|recurrent breast cancer|recurrent breast cancer
875047|NCT00003453|recurrent adrenocortical carcinoma|recurrent adrenocortical carcinoma
875048|NCT00003452|recurrent bladder cancer|recurrent bladder cancer
875049|NCT00003437|recurrent childhood acute lymphoblastic leukemia|recurrent childhood acute lymphoblastic leukemia
875050|NCT00003437|untreated childhood acute lymphoblastic leukemia|untreated childhood acute lymphoblastic leukemia
875051|NCT00003429|stage I cervical cancer|stage i cervical cancer
875052|NCT00003429|stage II cervical cancer|stage ii cervical cancer
875053|NCT00003429|recurrent cervical cancer|recurrent cervical cancer
875054|NCT00003422|stage I rectal cancer|stage i rectal cancer
875055|NCT00003422|stage II rectal cancer|stage ii rectal cancer
875056|NCT00003422|stage III rectal cancer|stage iii rectal cancer
875057|NCT00003422|adenocarcinoma of the rectum|adenocarcinoma of the rectum
875058|NCT00003420|stage I malignant testicular germ cell tumor|stage i malignant testicular germ cell tumor
875059|NCT00003420|testicular teratoma|testicular teratoma
875060|NCT00003419|AIDS-related Kaposi sarcoma|aids-related kaposi sarcoma
875061|NCT00003417|adult glioblastoma|adult glioblastoma
875062|NCT00003417|adult giant cell glioblastoma|adult giant cell glioblastoma
875063|NCT00003417|adult gliosarcoma|adult gliosarcoma
875064|NCT00003404|recurrent breast cancer|recurrent breast cancer
875065|NCT00003404|phyllodes tumor|phyllodes tumor
875066|NCT00003389|stage I adult Hodgkin lymphoma|stage i adult hodgkin lymphoma
875067|NCT00003389|stage II adult Hodgkin lymphoma|stage ii adult hodgkin lymphoma
875068|NCT00003389|stage III adult Hodgkin lymphoma|stage iii adult hodgkin lymphoma
875069|NCT00003389|stage IV adult Hodgkin lymphoma|stage iv adult hodgkin lymphoma
875070|NCT00003389|adult lymphocyte depletion Hodgkin lymphoma|adult lymphocyte depletion hodgkin lymphoma
875071|NCT00003389|adult nodular sclerosis Hodgkin lymphoma|adult nodular sclerosis hodgkin lymphoma
875072|NCT00003389|adult mixed cellularity Hodgkin lymphoma|adult mixed cellularity hodgkin lymphoma
875073|NCT00003385|stage I ovarian epithelial cancer|stage i ovarian epithelial cancer
875074|NCT00003385|stage II ovarian epithelial cancer|stage ii ovarian epithelial cancer
875075|NCT00003385|stage III ovarian epithelial cancer|stage iii ovarian epithelial cancer
875076|NCT00003385|stage IV ovarian epithelial cancer|stage iv ovarian epithelial cancer
875077|NCT00003385|ovarian undifferentiated adenocarcinoma|ovarian undifferentiated adenocarcinoma
875078|NCT00003385|ovarian mixed epithelial carcinoma|ovarian mixed epithelial carcinoma
875079|NCT00003385|ovarian serous cystadenocarcinoma|ovarian serous cystadenocarcinoma
875080|NCT00003385|ovarian mucinous cystadenocarcinoma|ovarian mucinous cystadenocarcinoma
875081|NCT00003385|ovarian endometrioid adenocarcinoma|ovarian endometrioid adenocarcinoma
875082|NCT00003385|ovarian clear cell cystadenocarcinoma|ovarian clear cell cystadenocarcinoma
875083|NCT00003385|fallopian tube cancer|fallopian tube cancer
875084|NCT00003385|primary peritoneal cavity cancer|primary peritoneal cavity cancer
875085|NCT00003385|Brenner tumor|brenner tumor
875086|NCT00003379|stage III cervical cancer|stage iii cervical cancer
875087|NCT00003379|stage IB cervical cancer|stage ib cervical cancer
875088|NCT00003379|stage IIB cervical cancer|stage iib cervical cancer
875089|NCT00003379|stage IIA cervical cancer|stage iia cervical cancer
875090|NCT00003379|stage IVA cervical cancer|stage iva cervical cancer
875091|NCT00003379|cervical squamous cell carcinoma|cervical squamous cell carcinoma
875092|NCT00003379|cervical adenocarcinoma|cervical adenocarcinoma
875093|NCT00003379|cervical adenosquamous cell carcinoma|cervical adenosquamous cell carcinoma
875094|NCT00003379|cervical small cell carcinoma|cervical small cell carcinoma
875095|NCT00003377|stage III cervical cancer|stage iii cervical cancer
875096|NCT00003377|stage IVA cervical cancer|stage iva cervical cancer
875097|NCT00003377|cervical squamous cell carcinoma|cervical squamous cell carcinoma
875098|NCT00003377|cervical adenocarcinoma|cervical adenocarcinoma
875099|NCT00003377|cervical adenosquamous cell carcinoma|cervical adenosquamous cell carcinoma
875100|NCT00003375|adult oligodendroglioma|adult oligodendroglioma
875101|NCT00003375|adult diffuse astrocytoma|adult diffuse astrocytoma
875102|NCT00003375|adult pilocytic astrocytoma|adult pilocytic astrocytoma
875103|NCT00003354|stage I colon cancer|stage i colon cancer
875104|NCT00003354|stage II colon cancer|stage ii colon cancer
875105|NCT00003354|stage III colon cancer|stage iii colon cancer
880403|NCT00038142|Zinecard|zinecard
875106|NCT00003354|stage IV colon cancer|stage iv colon cancer
875107|NCT00003354|stage 0 colon cancer|stage 0 colon cancer
875108|NCT00003354|stage 0 rectal cancer|stage 0 rectal cancer
875109|NCT00003354|stage I rectal cancer|stage i rectal cancer
875110|NCT00003354|stage II rectal cancer|stage ii rectal cancer
875111|NCT00003354|stage III rectal cancer|stage iii rectal cancer
875112|NCT00003354|stage IV rectal cancer|stage iv rectal cancer
875113|NCT00003342|stage III bladder cancer|stage iii bladder cancer
875114|NCT00003342|stage IV bladder cancer|stage iv bladder cancer
875115|NCT00003342|transitional cell carcinoma of the bladder|transitional cell carcinoma of the bladder
875116|NCT00003342|metastatic transitional cell cancer of the renal pelvis and ureter|metastatic transitional cell cancer of the renal pelvis and ureter
875117|NCT00003342|localized transitional cell cancer of the renal pelvis and ureter|localized transitional cell cancer of the renal pelvis and ureter
875118|NCT00003342|regional transitional cell cancer of the renal pelvis and ureter|regional transitional cell cancer of the renal pelvis and ureter
875119|NCT00003336|refractory anemia|refractory anemia
875120|NCT00003336|refractory anemia with ringed sideroblasts|refractory anemia with ringed sideroblasts
894970|NCT00001643|Sporadic|sporadic
875121|NCT00003336|de novo myelodysplastic syndromes|de novo myelodysplastic syndromes
875122|NCT00003336|previously treated myelodysplastic syndromes|previously treated myelodysplastic syndromes
875123|NCT00003336|secondary myelodysplastic syndromes|secondary myelodysplastic syndromes
875124|NCT00003336|atypical chronic myeloid leukemia|atypical chronic myeloid leukemia
875125|NCT00003336|myelodysplastic/myeloproliferative disease, unclassifiable|myelodysplastic/myeloproliferative disease, unclassifiable
875126|NCT00003336|childhood myelodysplastic syndromes|childhood myelodysplastic syndromes
875127|NCT00003335|recurrent childhood acute lymphoblastic leukemia|recurrent childhood acute lymphoblastic leukemia
875128|NCT00003335|recurrent childhood lymphoblastic lymphoma|recurrent childhood lymphoblastic lymphoma
875129|NCT00003335|recurrent adult acute lymphoblastic leukemia|recurrent adult acute lymphoblastic leukemia
875130|NCT00003335|chronic phase chronic myelogenous leukemia|chronic phase chronic myelogenous leukemia
875131|NCT00003335|accelerated phase chronic myelogenous leukemia|accelerated phase chronic myelogenous leukemia
875132|NCT00003335|blastic phase chronic myelogenous leukemia|blastic phase chronic myelogenous leukemia
875133|NCT00003335|untreated childhood acute lymphoblastic leukemia|untreated childhood acute lymphoblastic leukemia
875134|NCT00003335|adult acute myeloid leukemia in remission|adult acute myeloid leukemia in remission
875135|NCT00003335|adult acute lymphoblastic leukemia in remission|adult acute lymphoblastic leukemia in remission
875136|NCT00003335|childhood acute myeloid leukemia in remission|childhood acute myeloid leukemia in remission
875137|NCT00003335|childhood acute lymphoblastic leukemia in remission|childhood acute lymphoblastic leukemia in remission
875138|NCT00003335|adult acute erythroid leukemia (M6)|adult acute erythroid leukemia (m6)
875139|NCT00003335|adult acute megakaryoblastic leukemia (M7)|adult acute megakaryoblastic leukemia (m7)
875140|NCT00003335|childhood acute erythroleukemia (M6)|childhood acute erythroleukemia (m6)
875141|NCT00003335|childhood acute megakaryocytic leukemia (M7)|childhood acute megakaryocytic leukemia (m7)
875142|NCT00003335|refractory anemia with excess blasts|refractory anemia with excess blasts
875143|NCT00003335|refractory anemia with excess blasts in transformation|refractory anemia with excess blasts in transformation
875144|NCT00003335|recurrent grade 1 follicular lymphoma|recurrent grade 1 follicular lymphoma
875145|NCT00003335|recurrent grade 2 follicular lymphoma|recurrent grade 2 follicular lymphoma
875146|NCT00003335|recurrent grade 3 follicular lymphoma|recurrent grade 3 follicular lymphoma
875147|NCT00003335|recurrent adult diffuse small cleaved cell lymphoma|recurrent adult diffuse small cleaved cell lymphoma
875148|NCT00003335|recurrent adult diffuse mixed cell lymphoma|recurrent adult diffuse mixed cell lymphoma
875149|NCT00003335|recurrent adult diffuse large cell lymphoma|recurrent adult diffuse large cell lymphoma
875150|NCT00003335|recurrent adult immunoblastic large cell lymphoma|recurrent adult immunoblastic large cell lymphoma
875151|NCT00003335|recurrent adult lymphoblastic lymphoma|recurrent adult lymphoblastic lymphoma
875152|NCT00003335|recurrent adult Burkitt lymphoma|recurrent adult burkitt lymphoma
875153|NCT00003335|de novo myelodysplastic syndromes|de novo myelodysplastic syndromes
875154|NCT00003335|previously treated myelodysplastic syndromes|previously treated myelodysplastic syndromes
875155|NCT00003335|secondary myelodysplastic syndromes|secondary myelodysplastic syndromes
875156|NCT00003335|graft versus host disease|graft versus host disease
875157|NCT00003335|adult acute minimally differentiated myeloid leukemia (M0)|adult acute minimally differentiated myeloid leukemia (m0)
875158|NCT00003335|childhood acute minimally differentiated myeloid leukemia (M0)|childhood acute minimally differentiated myeloid leukemia (m0)
875159|NCT00003335|recurrent childhood small noncleaved cell lymphoma|recurrent childhood small noncleaved cell lymphoma
875160|NCT00003335|recurrent childhood large cell lymphoma|recurrent childhood large cell lymphoma
875161|NCT00003335|recurrent mantle cell lymphoma|recurrent mantle cell lymphoma
875162|NCT00003335|childhood chronic myelogenous leukemia|childhood chronic myelogenous leukemia
875163|NCT00003335|atypical chronic myeloid leukemia|atypical chronic myeloid leukemia
875164|NCT00003335|myelodysplastic/myeloproliferative disease, unclassifiable|myelodysplastic/myeloproliferative disease, unclassifiable
875165|NCT00003335|recurrent marginal zone lymphoma|recurrent marginal zone lymphoma
875166|NCT00003335|recurrent small lymphocytic lymphoma|recurrent small lymphocytic lymphoma
875167|NCT00003335|extranodal marginal zone B-cell lymphoma of mucosa-associated lymphoid tissue|extranodal marginal zone b-cell lymphoma of mucosa-associated lymphoid tissue
875168|NCT00003335|nodal marginal zone B-cell lymphoma|nodal marginal zone b-cell lymphoma
875169|NCT00003335|splenic marginal zone lymphoma|splenic marginal zone lymphoma
875170|NCT00003335|adult acute myeloid leukemia with t(8;21)(q22;q22)|adult acute myeloid leukemia with t(8;21)(q22;q22)
875171|NCT00003335|adult acute myeloid leukemia with t(16;16)(p13;q22)|adult acute myeloid leukemia with t(16;16)(p13;q22)
875172|NCT00003335|adult acute myeloid leukemia with inv(16)(p13;q22)|adult acute myeloid leukemia with inv(16)(p13;q22)
875173|NCT00003335|adult acute myeloid leukemia with 11q23 (MLL) abnormalities|adult acute myeloid leukemia with 11q23 (mll) abnormalities
875174|NCT00003335|adult acute myeloid leukemia with t(15;17)(q22;q12)|adult acute myeloid leukemia with t(15;17)(q22;q12)
875175|NCT00003335|childhood myelodysplastic syndromes|childhood myelodysplastic syndromes
875176|NCT00003332|stage I pancreatic cancer|stage i pancreatic cancer
875177|NCT00003332|stage II pancreatic cancer|stage ii pancreatic cancer
875178|NCT00003332|stage III pancreatic cancer|stage iii pancreatic cancer
875179|NCT00003332|adenocarcinoma of the pancreas|adenocarcinoma of the pancreas
875180|NCT00003329|stage I colon cancer|stage i colon cancer
875181|NCT00003329|stage II colon cancer|stage ii colon cancer
875182|NCT00003329|stage III colon cancer|stage iii colon cancer
895986|NCT00001322|Estradiol|estradiol
875189|NCT00003329|stage IV breast cancer|stage iv breast cancer
875190|NCT00003329|stage I non-small cell lung cancer|stage i non-small cell lung cancer
875191|NCT00003329|stage II non-small cell lung cancer|stage ii non-small cell lung cancer
875192|NCT00003329|stage III non-small cell lung cancer|stage iii non-small cell lung cancer
875193|NCT00003329|limited stage small cell lung cancer|limited stage small cell lung cancer
875194|NCT00003329|extensive stage small cell lung cancer|extensive stage small cell lung cancer
875195|NCT00003329|stage I prostate cancer|stage i prostate cancer
875196|NCT00003329|stage II prostate cancer|stage ii prostate cancer
875197|NCT00003329|stage III prostate cancer|stage iii prostate cancer
875198|NCT00003329|stage IV prostate cancer|stage iv prostate cancer
875199|NCT00003329|stage IV non-small cell lung cancer|stage iv non-small cell lung cancer
875200|NCT00003325|stage I vulvar cancer|stage i vulvar cancer
875201|NCT00003325|stage II vulvar cancer|stage ii vulvar cancer
875202|NCT00003325|squamous cell carcinoma of the vulva|squamous cell carcinoma of the vulva
875203|NCT00003309|adult medulloblastoma|adult medulloblastoma
875204|NCT00003309|adult anaplastic ependymoma|adult anaplastic ependymoma
875205|NCT00003309|adult ependymoma|adult ependymoma
875206|NCT00003309|adult supratentorial primitive neuroectodermal tumor (PNET)|adult supratentorial primitive neuroectodermal tumor (pnet)
875207|NCT00003308|metastatic osteosarcoma|metastatic osteosarcoma
875208|NCT00003308|chondrosarcoma|chondrosarcoma
875209|NCT00003308|stage IV renal cell cancer|stage iv renal cell cancer
875210|NCT00003308|stage IV melanoma|stage iv melanoma
875211|NCT00003308|tumors metastatic to brain|tumors metastatic to brain
875212|NCT00003308|stage IV uterine sarcoma|stage iv uterine sarcoma
875213|NCT00003308|ovarian sarcoma|ovarian sarcoma
875214|NCT00003308|metastatic Ewing sarcoma/peripheral primitive neuroectodermal tumor|metastatic ewing sarcoma/peripheral primitive neuroectodermal tumor
875215|NCT00003308|stage IV adult soft tissue sarcoma|stage iv adult soft tissue sarcoma
875216|NCT00003291|untreated childhood acute lymphoblastic leukemia|untreated childhood acute lymphoblastic leukemia
875217|NCT00003278|primary central nervous system non-Hodgkin lymphoma|primary central nervous system non-hodgkin lymphoma
875218|NCT00003278|intraocular lymphoma|intraocular lymphoma
875219|NCT00003273|childhood infratentorial ependymoma|childhood infratentorial ependymoma
875220|NCT00003273|childhood supratentorial ependymoma|childhood supratentorial ependymoma
875221|NCT00003273|localized resectable neuroblastoma|localized resectable neuroblastoma
875222|NCT00003273|regional neuroblastoma|regional neuroblastoma
875223|NCT00003273|disseminated neuroblastoma|disseminated neuroblastoma
875224|NCT00003273|stage 4S neuroblastoma|stage 4s neuroblastoma
875225|NCT00003273|extraocular retinoblastoma|extraocular retinoblastoma
875226|NCT00003273|childhood choroid plexus tumor|childhood choroid plexus tumor
875227|NCT00003273|localized unresectable neuroblastoma|localized unresectable neuroblastoma
875228|NCT00003273|previously untreated childhood rhabdomyosarcoma|previously untreated childhood rhabdomyosarcoma
875229|NCT00003273|untreated childhood supratentorial primitive neuroectodermal tumor|untreated childhood supratentorial primitive neuroectodermal tumor
875230|NCT00003273|untreated childhood medulloblastoma|untreated childhood medulloblastoma
875231|NCT00003273|newly diagnosed childhood ependymoma|newly diagnosed childhood ependymoma
875232|NCT00003268|untreated adult acute myeloid leukemia|untreated adult acute myeloid leukemia
875233|NCT00003268|adult acute monoblastic leukemia and acute monocytic leukemia (M5)|adult acute monoblastic leukemia and acute monocytic leukemia (m5)
875234|NCT00003268|adult acute erythroid leukemia (M6)|adult acute erythroid leukemia (m6)
875235|NCT00003268|adult acute myeloblastic leukemia without maturation (M1)|adult acute myeloblastic leukemia without maturation (m1)
875236|NCT00003268|adult acute myeloblastic leukemia with maturation (M2)|adult acute myeloblastic leukemia with maturation (m2)
875237|NCT00003268|adult acute myelomonocytic leukemia (M4)|adult acute myelomonocytic leukemia (m4)
875238|NCT00003268|adult acute megakaryoblastic leukemia (M7)|adult acute megakaryoblastic leukemia (m7)
875239|NCT00003268|drug/agent toxicity by tissue/organ|drug/agent toxicity by tissue/organ
875240|NCT00003268|adult acute minimally differentiated myeloid leukemia (M0)|adult acute minimally differentiated myeloid leukemia (m0)
875241|NCT00003261|AIDS-related primary CNS lymphoma|aids-related primary cns lymphoma
875242|NCT00003243|recurrent childhood acute lymphoblastic leukemia|recurrent childhood acute lymphoblastic leukemia
875243|NCT00003243|recurrent childhood lymphoblastic lymphoma|recurrent childhood lymphoblastic lymphoma
875244|NCT00003243|recurrent childhood acute myeloid leukemia|recurrent childhood acute myeloid leukemia
875245|NCT00003243|recurrent adult acute myeloid leukemia|recurrent adult acute myeloid leukemia
875246|NCT00003243|recurrent adult acute lymphoblastic leukemia|recurrent adult acute lymphoblastic leukemia
875247|NCT00003243|relapsing chronic myelogenous leukemia|relapsing chronic myelogenous leukemia
875248|NCT00003243|accelerated phase chronic myelogenous leukemia|accelerated phase chronic myelogenous leukemia
875249|NCT00003243|blastic phase chronic myelogenous leukemia|blastic phase chronic myelogenous leukemia
875250|NCT00003243|acute undifferentiated leukemia|acute undifferentiated leukemia
875251|NCT00003243|recurrent adult diffuse mixed cell lymphoma|recurrent adult diffuse mixed cell lymphoma
875252|NCT00003243|recurrent adult diffuse large cell lymphoma|recurrent adult diffuse large cell lymphoma
875253|NCT00003243|recurrent adult lymphoblastic lymphoma|recurrent adult lymphoblastic lymphoma
875254|NCT00003243|recurrent adult Burkitt lymphoma|recurrent adult burkitt lymphoma
875255|NCT00003243|secondary acute myeloid leukemia|secondary acute myeloid leukemia
875256|NCT00003243|previously treated myelodysplastic syndromes|previously treated myelodysplastic syndromes
875257|NCT00003243|recurrent childhood small noncleaved cell lymphoma|recurrent childhood small noncleaved cell lymphoma
875258|NCT00003243|recurrent childhood large cell lymphoma|recurrent childhood large cell lymphoma
875259|NCT00003243|childhood chronic myelogenous leukemia|childhood chronic myelogenous leukemia
875260|NCT00003243|atypical chronic myeloid leukemia|atypical chronic myeloid leukemia
875261|NCT00003243|myelodysplastic/myeloproliferative disease, unclassifiable|myelodysplastic/myeloproliferative disease, unclassifiable
875262|NCT00003243|childhood myelodysplastic syndromes|childhood myelodysplastic syndromes
875263|NCT00003216|stage I pancreatic cancer|stage i pancreatic cancer
875264|NCT00003216|stage II pancreatic cancer|stage ii pancreatic cancer
875265|NCT00003216|stage III pancreatic cancer|stage iii pancreatic cancer
875266|NCT00003216|adenocarcinoma of the pancreas|adenocarcinoma of the pancreas
875267|NCT00003216|stage IV pancreatic cancer|stage iv pancreatic cancer
875268|NCT00003215|stage I adult diffuse mixed cell lymphoma|stage i adult diffuse mixed cell lymphoma
875269|NCT00003215|stage I adult diffuse large cell lymphoma|stage i adult diffuse large cell lymphoma
875270|NCT00003215|stage I adult immunoblastic large cell lymphoma|stage i adult immunoblastic large cell lymphoma
875271|NCT00003215|stage III adult diffuse mixed cell lymphoma|stage iii adult diffuse mixed cell lymphoma
875272|NCT00003215|stage III adult diffuse large cell lymphoma|stage iii adult diffuse large cell lymphoma
875273|NCT00003215|stage III adult immunoblastic large cell lymphoma|stage iii adult immunoblastic large cell lymphoma
875274|NCT00003215|stage IV adult diffuse mixed cell lymphoma|stage iv adult diffuse mixed cell lymphoma
875275|NCT00003215|stage IV adult diffuse large cell lymphoma|stage iv adult diffuse large cell lymphoma
875276|NCT00003215|stage IV adult immunoblastic large cell lymphoma|stage iv adult immunoblastic large cell lymphoma
875277|NCT00003215|contiguous stage II adult diffuse mixed cell lymphoma|contiguous stage ii adult diffuse mixed cell lymphoma
875278|NCT00003215|contiguous stage II adult immunoblastic large cell lymphoma|contiguous stage ii adult immunoblastic large cell lymphoma
875279|NCT00003215|contiguous stage II adult diffuse large cell lymphoma|contiguous stage ii adult diffuse large cell lymphoma
875280|NCT00003215|noncontiguous stage II adult diffuse mixed cell lymphoma|noncontiguous stage ii adult diffuse mixed cell lymphoma
875281|NCT00003215|noncontiguous stage II adult immunoblastic large cell lymphoma|noncontiguous stage ii adult immunoblastic large cell lymphoma
875282|NCT00003215|noncontiguous stage II adult diffuse large cell lymphoma|noncontiguous stage ii adult diffuse large cell lymphoma
875283|NCT00003215|anaplastic large cell lymphoma|anaplastic large cell lymphoma
875284|NCT00003194|unspecified childhood solid tumor, protocol specific|unspecified childhood solid tumor, protocol specific
875285|NCT00003179|endometrial cancer|endometrial cancer
875286|NCT00003178|recurrent childhood acute myeloid leukemia|recurrent childhood acute myeloid leukemia
875287|NCT00003178|childhood acute myeloblastic leukemia without maturation (M1)|childhood acute myeloblastic leukemia without maturation (m1)
875288|NCT00003178|childhood acute myeloblastic leukemia with maturation (M2)|childhood acute myeloblastic leukemia with maturation (m2)
875289|NCT00003178|childhood acute promyelocytic leukemia (M3)|childhood acute promyelocytic leukemia (m3)
875290|NCT00003178|childhood acute myelomonocytic leukemia (M4)|childhood acute myelomonocytic leukemia (m4)
875291|NCT00003178|childhood acute monoblastic leukemia (M5a)|childhood acute monoblastic leukemia (m5a)
875292|NCT00003178|childhood acute monocytic leukemia (M5b)|childhood acute monocytic leukemia (m5b)
875293|NCT00003178|childhood acute erythroleukemia (M6)|childhood acute erythroleukemia (m6)
875294|NCT00003178|childhood acute megakaryocytic leukemia (M7)|childhood acute megakaryocytic leukemia (m7)
875295|NCT00003178|childhood acute minimally differentiated myeloid leukemia (M0)|childhood acute minimally differentiated myeloid leukemia (m0)
875296|NCT00003174|stage I chronic lymphocytic leukemia|stage i chronic lymphocytic leukemia
875297|NCT00003174|stage II chronic lymphocytic leukemia|stage ii chronic lymphocytic leukemia
875298|NCT00003174|stage III chronic lymphocytic leukemia|stage iii chronic lymphocytic leukemia
875299|NCT00003174|stage IV chronic lymphocytic leukemia|stage iv chronic lymphocytic leukemia
875300|NCT00003174|refractory chronic lymphocytic leukemia|refractory chronic lymphocytic leukemia
875301|NCT00003159|stage I non-small cell lung cancer|stage i non-small cell lung cancer
875302|NCT00003159|stage II non-small cell lung cancer|stage ii non-small cell lung cancer
875303|NCT00003159|stage IIIA non-small cell lung cancer|stage iiia non-small cell lung cancer
875304|NCT00003159|stage IIIB non-small cell lung cancer|stage iiib non-small cell lung cancer
875305|NCT00003159|stage 0 non-small cell lung cancer|stage 0 non-small cell lung cancer
875306|NCT00003153|refractory multiple myeloma|refractory multiple myeloma
875307|NCT00003140|stage I breast cancer|stage i breast cancer
875308|NCT00003140|stage II breast cancer|stage ii breast cancer
875309|NCT00003140|stage IIIA breast cancer|stage iiia breast cancer
875310|NCT00003138|anemia|anemia
875311|NCT00003138|refractory anemia|refractory anemia
875312|NCT00003138|myelodysplastic syndromes|myelodysplastic syndromes
875313|NCT00003138|erythropoietin|erythropoietin
875314|NCT00003138|filgrastim|filgrastim
875315|NCT00003135|stage IV breast cancer|stage iv breast cancer
875316|NCT00003135|recurrent breast cancer|recurrent breast cancer
875317|NCT00003135|recurrent cervical cancer|recurrent cervical cancer
875318|NCT00003135|stage IVB cervical cancer|stage ivb cervical cancer
875319|NCT00003135|stage IVA cervical cancer|stage iva cervical cancer
875320|NCT00003135|stage IV ovarian epithelial cancer|stage iv ovarian epithelial cancer
875321|NCT00003135|recurrent ovarian epithelial cancer|recurrent ovarian epithelial cancer
875322|NCT00003135|stage IV endometrial carcinoma|stage iv endometrial carcinoma
875323|NCT00003135|recurrent endometrial carcinoma|recurrent endometrial carcinoma
875324|NCT00003135|stage IV ovarian germ cell tumor|stage iv ovarian germ cell tumor
875325|NCT00003135|recurrent ovarian germ cell tumor|recurrent ovarian germ cell tumor
875326|NCT00003135|male breast cancer|male breast cancer
875327|NCT00003128|stage III uterine sarcoma|stage iii uterine sarcoma
875328|NCT00003128|stage IV uterine sarcoma|stage iv uterine sarcoma
875329|NCT00003128|recurrent uterine sarcoma|recurrent uterine sarcoma
875330|NCT00003128|uterine carcinosarcoma|uterine carcinosarcoma
875331|NCT00003122|localized resectable neuroblastoma|localized resectable neuroblastoma
875332|NCT00003122|localized unresectable neuroblastoma|localized unresectable neuroblastoma
875333|NCT00003119|localized resectable neuroblastoma|localized resectable neuroblastoma
875334|NCT00003119|stage 4S neuroblastoma|stage 4s neuroblastoma
875335|NCT00003116|recurrent childhood acute lymphoblastic leukemia|recurrent childhood acute lymphoblastic leukemia
875336|NCT00003116|recurrent adult Hodgkin lymphoma|recurrent adult hodgkin lymphoma
875337|NCT00003116|refractory multiple myeloma|refractory multiple myeloma
875338|NCT00003116|recurrent childhood lymphoblastic lymphoma|recurrent childhood lymphoblastic lymphoma
875339|NCT00003116|recurrent childhood acute myeloid leukemia|recurrent childhood acute myeloid leukemia
875340|NCT00003116|recurrent adult acute myeloid leukemia|recurrent adult acute myeloid leukemia
875341|NCT00003116|recurrent adult acute lymphoblastic leukemia|recurrent adult acute lymphoblastic leukemia
875342|NCT00003116|adult acute myeloid leukemia in remission|adult acute myeloid leukemia in remission
875343|NCT00003116|adult acute lymphoblastic leukemia in remission|adult acute lymphoblastic leukemia in remission
875344|NCT00003116|childhood acute myeloid leukemia in remission|childhood acute myeloid leukemia in remission
875345|NCT00003116|childhood acute lymphoblastic leukemia in remission|childhood acute lymphoblastic leukemia in remission
875346|NCT00003116|recurrent/refractory childhood Hodgkin lymphoma|recurrent/refractory childhood hodgkin lymphoma
875347|NCT00003116|recurrent grade 1 follicular lymphoma|recurrent grade 1 follicular lymphoma
875348|NCT00003116|recurrent grade 2 follicular lymphoma|recurrent grade 2 follicular lymphoma
875349|NCT00003116|recurrent grade 3 follicular lymphoma|recurrent grade 3 follicular lymphoma
875350|NCT00003116|recurrent adult diffuse small cleaved cell lymphoma|recurrent adult diffuse small cleaved cell lymphoma
875351|NCT00003116|recurrent adult diffuse mixed cell lymphoma|recurrent adult diffuse mixed cell lymphoma
875352|NCT00003116|recurrent adult diffuse large cell lymphoma|recurrent adult diffuse large cell lymphoma
875353|NCT00003116|recurrent adult immunoblastic large cell lymphoma|recurrent adult immunoblastic large cell lymphoma
875354|NCT00003116|recurrent adult lymphoblastic lymphoma|recurrent adult lymphoblastic lymphoma
875355|NCT00003116|recurrent adult Burkitt lymphoma|recurrent adult burkitt lymphoma
875356|NCT00003116|de novo myelodysplastic syndromes|de novo myelodysplastic syndromes
875357|NCT00003116|previously treated myelodysplastic syndromes|previously treated myelodysplastic syndromes
875358|NCT00003116|secondary myelodysplastic syndromes|secondary myelodysplastic syndromes
875359|NCT00003116|recurrent childhood small noncleaved cell lymphoma|recurrent childhood small noncleaved cell lymphoma
875360|NCT00003116|recurrent childhood large cell lymphoma|recurrent childhood large cell lymphoma
875361|NCT00003116|recurrent mantle cell lymphoma|recurrent mantle cell lymphoma
875362|NCT00003116|atypical chronic myeloid leukemia|atypical chronic myeloid leukemia
875363|NCT00003116|myelodysplastic/myeloproliferative disease, unclassifiable|myelodysplastic/myeloproliferative disease, unclassifiable
875364|NCT00003116|recurrent marginal zone lymphoma|recurrent marginal zone lymphoma
875365|NCT00003116|recurrent small lymphocytic lymphoma|recurrent small lymphocytic lymphoma
875366|NCT00003116|extranodal marginal zone B-cell lymphoma of mucosa-associated lymphoid tissue|extranodal marginal zone b-cell lymphoma of mucosa-associated lymphoid tissue
875367|NCT00003116|nodal marginal zone B-cell lymphoma|nodal marginal zone b-cell lymphoma
875368|NCT00003116|splenic marginal zone lymphoma|splenic marginal zone lymphoma
875369|NCT00003116|adult acute myeloid leukemia with t(8;21)(q22;q22)|adult acute myeloid leukemia with t(8;21)(q22;q22)
875516|NCT00002990|stage 0 bladder cancer|stage 0 bladder cancer
875370|NCT00003116|adult acute myeloid leukemia with t(16;16)(p13;q22)|adult acute myeloid leukemia with t(16;16)(p13;q22)
875371|NCT00003116|adult acute myeloid leukemia with inv(16)(p13;q22)|adult acute myeloid leukemia with inv(16)(p13;q22)
875372|NCT00003116|adult acute myeloid leukemia with 11q23 (MLL) abnormalities|adult acute myeloid leukemia with 11q23 (mll) abnormalities
875373|NCT00003116|adult acute myeloid leukemia with t(15;17)(q22;q12)|adult acute myeloid leukemia with t(15;17)(q22;q12)
875374|NCT00003116|childhood myelodysplastic syndromes|childhood myelodysplastic syndromes
875375|NCT00003111|stage IIIA non-small cell lung cancer|stage iiia non-small cell lung cancer
875376|NCT00003105|stage III bladder cancer|stage iii bladder cancer
875377|NCT00003105|recurrent bladder cancer|recurrent bladder cancer
875378|NCT00003105|stage IV bladder cancer|stage iv bladder cancer
875379|NCT00003105|transitional cell carcinoma of the bladder|transitional cell carcinoma of the bladder
875380|NCT00003105|metastatic transitional cell cancer of the renal pelvis and ureter|metastatic transitional cell cancer of the renal pelvis and ureter
875381|NCT00003105|regional transitional cell cancer of the renal pelvis and ureter|regional transitional cell cancer of the renal pelvis and ureter
875382|NCT00003105|recurrent transitional cell cancer of the renal pelvis and ureter|recurrent transitional cell cancer of the renal pelvis and ureter
875383|NCT00003104|adenocarcinoma of the prostate|adenocarcinoma of the prostate
875384|NCT00003104|stage IIB prostate cancer|stage iib prostate cancer
875385|NCT00003104|stage IIA prostate cancer|stage iia prostate cancer
896092|NCT00001284|Cognition|cognition
875386|NCT00003096|untreated childhood supratentorial primitive neuroectodermal tumor|untreated childhood supratentorial primitive neuroectodermal tumor
875387|NCT00003096|untreated childhood medulloblastoma|untreated childhood medulloblastoma
875388|NCT00003093|regional neuroblastoma|regional neuroblastoma
875389|NCT00003093|disseminated neuroblastoma|disseminated neuroblastoma
875390|NCT00003093|stage 4S neuroblastoma|stage 4s neuroblastoma
875391|NCT00003093|localized unresectable neuroblastoma|localized unresectable neuroblastoma
875392|NCT00003092|unspecified adult solid tumor, protocol specific|unspecified adult solid tumor, protocol specific
875393|NCT00003067|recurrent adult brain tumor|recurrent adult brain tumor
875394|NCT00003067|adult glioblastoma|adult glioblastoma
875395|NCT00003067|adult anaplastic astrocytoma|adult anaplastic astrocytoma
875396|NCT00003067|adult mixed glioma|adult mixed glioma
875397|NCT00003067|adult giant cell glioblastoma|adult giant cell glioblastoma
875398|NCT00003067|adult gliosarcoma|adult gliosarcoma
875399|NCT00003065|recurrent cervical cancer|recurrent cervical cancer
875400|NCT00003065|stage IVB cervical cancer|stage ivb cervical cancer
875401|NCT00003065|stage IVA cervical cancer|stage iva cervical cancer
875402|NCT00003065|cervical squamous cell carcinoma|cervical squamous cell carcinoma
875403|NCT00003065|cervical adenocarcinoma|cervical adenocarcinoma
875404|NCT00003063|stage II colon cancer|stage ii colon cancer
875405|NCT00003063|stage III colon cancer|stage iii colon cancer
875406|NCT00003063|stage II rectal cancer|stage ii rectal cancer
875407|NCT00003063|stage III rectal cancer|stage iii rectal cancer
875408|NCT00003053|stage I non-small cell lung cancer|stage i non-small cell lung cancer
875409|NCT00003053|stage II non-small cell lung cancer|stage ii non-small cell lung cancer
875410|NCT00003053|stage IIIA non-small cell lung cancer|stage iiia non-small cell lung cancer
875411|NCT00003052|adult angiosarcoma|adult angiosarcoma
875412|NCT00003052|adult fibrosarcoma|adult fibrosarcoma
875413|NCT00003052|adult leiomyosarcoma|adult leiomyosarcoma
875414|NCT00003052|adult liposarcoma|adult liposarcoma
875415|NCT00003052|adult neurofibrosarcoma|adult neurofibrosarcoma
875416|NCT00003052|adult synovial sarcoma|adult synovial sarcoma
875417|NCT00003052|stage III adult soft tissue sarcoma|stage iii adult soft tissue sarcoma
875418|NCT00003052|recurrent adult soft tissue sarcoma|recurrent adult soft tissue sarcoma
875419|NCT00003052|adult extraskeletal osteosarcoma|adult extraskeletal osteosarcoma
875420|NCT00003052|adult malignant fibrous histiocytoma|adult malignant fibrous histiocytoma
875421|NCT00003052|adult rhabdomyosarcoma|adult rhabdomyosarcoma
875422|NCT00003052|stage I adult soft tissue sarcoma|stage i adult soft tissue sarcoma
875423|NCT00003052|stage II adult soft tissue sarcoma|stage ii adult soft tissue sarcoma
875424|NCT00003049|stage I pancreatic cancer|stage i pancreatic cancer
875425|NCT00003049|stage II pancreatic cancer|stage ii pancreatic cancer
875426|NCT00003049|stage III pancreatic cancer|stage iii pancreatic cancer
875427|NCT00003049|adenocarcinoma of the pancreas|adenocarcinoma of the pancreas
875428|NCT00003042|stage IIIB breast cancer|stage iiib breast cancer
875429|NCT00003042|inflammatory breast cancer|inflammatory breast cancer
875430|NCT00003034|localized malignant mesothelioma|localized malignant mesothelioma
875431|NCT00003034|advanced malignant mesothelioma|advanced malignant mesothelioma
875432|NCT00003034|recurrent malignant mesothelioma|recurrent malignant mesothelioma
875433|NCT00003029|stage III pancreatic cancer|stage iii pancreatic cancer
875434|NCT00003029|adenocarcinoma of the pancreas|adenocarcinoma of the pancreas
875435|NCT00003029|stage IV pancreatic cancer|stage iv pancreatic cancer
875436|NCT00003027|stage IV melanoma|stage iv melanoma
875437|NCT00003026|adenocarcinoma of the prostate|adenocarcinoma of the prostate
875438|NCT00003023|metastatic osteosarcoma|metastatic osteosarcoma
875439|NCT00003023|recurrent adult soft tissue sarcoma|recurrent adult soft tissue sarcoma
875440|NCT00003023|disseminated neuroblastoma|disseminated neuroblastoma
875441|NCT00003023|stage 4S neuroblastoma|stage 4s neuroblastoma
875442|NCT00003023|recurrent neuroblastoma|recurrent neuroblastoma
875443|NCT00003023|recurrent osteosarcoma|recurrent osteosarcoma
875444|NCT00003023|metastatic childhood soft tissue sarcoma|metastatic childhood soft tissue sarcoma
875445|NCT00003023|recurrent childhood soft tissue sarcoma|recurrent childhood soft tissue sarcoma
875446|NCT00003023|stage IV adult soft tissue sarcoma|stage iv adult soft tissue sarcoma
875447|NCT00003022|metastatic osteosarcoma|metastatic osteosarcoma
875448|NCT00003022|childhood infratentorial ependymoma|childhood infratentorial ependymoma
875449|NCT00003022|recurrent childhood rhabdomyosarcoma|recurrent childhood rhabdomyosarcoma
875450|NCT00003022|childhood supratentorial ependymoma|childhood supratentorial ependymoma
875451|NCT00003022|regional neuroblastoma|regional neuroblastoma
875452|NCT00003022|disseminated neuroblastoma|disseminated neuroblastoma
875453|NCT00003022|stage 4S neuroblastoma|stage 4s neuroblastoma
875454|NCT00003022|recurrent neuroblastoma|recurrent neuroblastoma
875455|NCT00003022|retinoblastoma|retinoblastoma
875456|NCT00003022|intraocular retinoblastoma|intraocular retinoblastoma
875457|NCT00003022|extraocular retinoblastoma|extraocular retinoblastoma
875458|NCT00003022|recurrent retinoblastoma|recurrent retinoblastoma
875459|NCT00003022|extensive stage small cell lung cancer|extensive stage small cell lung cancer
875460|NCT00003022|recurrent small cell lung cancer|recurrent small cell lung cancer
875461|NCT00003022|recurrent osteosarcoma|recurrent osteosarcoma
875462|NCT00003022|recurrent adult brain tumor|recurrent adult brain tumor
875463|NCT00003022|iris melanoma|iris melanoma
896398|NCT00001195|Development|development
875464|NCT00003022|ciliary body and choroid melanoma, small size|ciliary body and choroid melanoma, small size
875465|NCT00003022|ciliary body and choroid melanoma, medium/large size|ciliary body and choroid melanoma, medium/large size
875466|NCT00003022|extraocular extension melanoma|extraocular extension melanoma
875467|NCT00003022|recurrent intraocular melanoma|recurrent intraocular melanoma
875468|NCT00003022|adult brain stem glioma|adult brain stem glioma
875469|NCT00003022|adult medulloblastoma|adult medulloblastoma
875470|NCT00003022|stage IV melanoma|stage iv melanoma
875471|NCT00003022|recurrent melanoma|recurrent melanoma
875472|NCT00003022|metastatic childhood soft tissue sarcoma|metastatic childhood soft tissue sarcoma
875473|NCT00003022|recurrent childhood soft tissue sarcoma|recurrent childhood soft tissue sarcoma
875474|NCT00003022|adult myxopapillary ependymoma|adult myxopapillary ependymoma
875475|NCT00003022|adult anaplastic ependymoma|adult anaplastic ependymoma
875476|NCT00003022|adult anaplastic oligodendroglioma|adult anaplastic oligodendroglioma
875477|NCT00003022|adult mixed glioma|adult mixed glioma
875478|NCT00003022|localized unresectable neuroblastoma|localized unresectable neuroblastoma
875479|NCT00003022|adult ependymoblastoma|adult ependymoblastoma
875480|NCT00003022|recurrent childhood brain stem glioma|recurrent childhood brain stem glioma
875481|NCT00003022|recurrent childhood supratentorial primitive neuroectodermal tumor|recurrent childhood supratentorial primitive neuroectodermal tumor
875482|NCT00003022|recurrent childhood visual pathway glioma|recurrent childhood visual pathway glioma
875483|NCT00003022|recurrent childhood medulloblastoma|recurrent childhood medulloblastoma
875484|NCT00003022|recurrent childhood visual pathway and hypothalamic glioma|recurrent childhood visual pathway and hypothalamic glioma
875485|NCT00003022|previously treated childhood rhabdomyosarcoma|previously treated childhood rhabdomyosarcoma
875486|NCT00003022|localized Ewing sarcoma/peripheral primitive neuroectodermal tumor|localized ewing sarcoma/peripheral primitive neuroectodermal tumor
875487|NCT00003022|metastatic Ewing sarcoma/peripheral primitive neuroectodermal tumor|metastatic ewing sarcoma/peripheral primitive neuroectodermal tumor
875488|NCT00003022|recurrent Ewing sarcoma/peripheral primitive neuroectodermal tumor|recurrent ewing sarcoma/peripheral primitive neuroectodermal tumor
875489|NCT00003022|recurrent childhood ependymoma|recurrent childhood ependymoma
875490|NCT00003022|adult oligodendroglioma|adult oligodendroglioma
875491|NCT00003022|adult anaplastic astrocytoma|adult anaplastic astrocytoma
875492|NCT00003022|adult supratentorial primitive neuroectodermal tumor (PNET)|adult supratentorial primitive neuroectodermal tumor (pnet)
875493|NCT00003022|adult diffuse astrocytoma|adult diffuse astrocytoma
875494|NCT00003022|adult pilocytic astrocytoma|adult pilocytic astrocytoma
875495|NCT00003022|adult giant cell glioblastoma|adult giant cell glioblastoma
875496|NCT00003022|adult glioblastoma|adult glioblastoma
875497|NCT00003022|adult gliosarcoma|adult gliosarcoma
875498|NCT00003016|stage I breast cancer|stage i breast cancer
875499|NCT00003016|stage II breast cancer|stage ii breast cancer
875500|NCT00003016|stage IIIA breast cancer|stage iiia breast cancer
875501|NCT00003016|stage IIIB breast cancer|stage iiib breast cancer
875502|NCT00003016|stage IIIC breast cancer|stage iiic breast cancer
875503|NCT00003013|stage II breast cancer|stage ii breast cancer
875504|NCT00003013|stage IIIA breast cancer|stage iiia breast cancer
875506|NCT00002995|embryonal childhood rhabdomyosarcoma|embryonal childhood rhabdomyosarcoma
875507|NCT00002995|embryonal-botryoid childhood rhabdomyosarcoma|embryonal-botryoid childhood rhabdomyosarcoma
875508|NCT00002995|previously untreated childhood rhabdomyosarcoma|previously untreated childhood rhabdomyosarcoma
875509|NCT00002995|adult rhabdomyosarcoma|adult rhabdomyosarcoma
875510|NCT00002995|adult malignant mesenchymoma|adult malignant mesenchymoma
875511|NCT00002995|childhood malignant mesenchymoma|childhood malignant mesenchymoma
875512|NCT00002995|nonmetastatic childhood soft tissue sarcoma|nonmetastatic childhood soft tissue sarcoma
875513|NCT00002995|stage II adult soft tissue sarcoma|stage ii adult soft tissue sarcoma
875514|NCT00002995|stage III adult soft tissue sarcoma|stage iii adult soft tissue sarcoma
875515|NCT00002995|stage I adult soft tissue sarcoma|stage i adult soft tissue sarcoma
875517|NCT00002990|stage I bladder cancer|stage i bladder cancer
875518|NCT00002990|transitional cell carcinoma of the bladder|transitional cell carcinoma of the bladder
875519|NCT00002986|recurrent adult brain tumor|recurrent adult brain tumor
875520|NCT00002982|recurrent grade 3 follicular lymphoma|recurrent grade 3 follicular lymphoma
875521|NCT00002982|recurrent adult diffuse small cleaved cell lymphoma|recurrent adult diffuse small cleaved cell lymphoma
875522|NCT00002982|recurrent adult diffuse mixed cell lymphoma|recurrent adult diffuse mixed cell lymphoma
875523|NCT00002982|recurrent adult diffuse large cell lymphoma|recurrent adult diffuse large cell lymphoma
875524|NCT00002982|recurrent adult immunoblastic large cell lymphoma|recurrent adult immunoblastic large cell lymphoma
875525|NCT00002982|anaplastic large cell lymphoma|anaplastic large cell lymphoma
875526|NCT00002981|adenocarcinoma of the prostate|adenocarcinoma of the prostate
875527|NCT00002981|stage IV prostate cancer|stage iv prostate cancer
875528|NCT00002981|recurrent prostate cancer|recurrent prostate cancer
875529|NCT00002976|stage I endometrial carcinoma|stage i endometrial carcinoma
875530|NCT00002976|stage II endometrial carcinoma|stage ii endometrial carcinoma
875531|NCT00002976|endometrial adenocarcinoma|endometrial adenocarcinoma
875532|NCT00002975|basal cell carcinoma of the skin|basal cell carcinoma of the skin
875533|NCT00002975|squamous cell carcinoma of the skin|squamous cell carcinoma of the skin
875534|NCT00002975|actinic keratosis|actinic keratosis
875535|NCT00002963|basal cell carcinoma of the skin|basal cell carcinoma of the skin
875536|NCT00002963|squamous cell carcinoma of the skin|squamous cell carcinoma of the skin
875537|NCT00002951|stage II esophageal cancer|stage ii esophageal cancer
875538|NCT00002951|stage III esophageal cancer|stage iii esophageal cancer
875539|NCT00002951|stage II nasopharyngeal cancer|stage ii nasopharyngeal cancer
875540|NCT00002951|stage III nasopharyngeal cancer|stage iii nasopharyngeal cancer
875541|NCT00002951|stage II lip and oral cavity cancer|stage ii lip and oral cavity cancer
875542|NCT00002951|stage III lip and oral cavity cancer|stage iii lip and oral cavity cancer
875543|NCT00002951|stage II hypopharyngeal cancer|stage ii hypopharyngeal cancer
875544|NCT00002951|stage III hypopharyngeal cancer|stage iii hypopharyngeal cancer
875545|NCT00002951|stage II laryngeal cancer|stage ii laryngeal cancer
875546|NCT00002951|stage III laryngeal cancer|stage iii laryngeal cancer
875547|NCT00002951|stage II paranasal sinus and nasal cavity cancer|stage ii paranasal sinus and nasal cavity cancer
875548|NCT00002951|stage III paranasal sinus and nasal cavity cancer|stage iii paranasal sinus and nasal cavity cancer
875549|NCT00002951|stage II oropharyngeal cancer|stage ii oropharyngeal cancer
875550|NCT00002951|stage III oropharyngeal cancer|stage iii oropharyngeal cancer
875551|NCT00002948|unspecified adult solid tumor, protocol specific|unspecified adult solid tumor, protocol specific
875552|NCT00002944|recurrent childhood brain stem glioma|recurrent childhood brain stem glioma
875553|NCT00002944|recurrent childhood visual pathway glioma|recurrent childhood visual pathway glioma
875554|NCT00002944|recurrent childhood cerebellar astrocytoma|recurrent childhood cerebellar astrocytoma
875555|NCT00002944|recurrent childhood cerebral astrocytoma|recurrent childhood cerebral astrocytoma
875556|NCT00002944|childhood low-grade cerebellar astrocytoma|childhood low-grade cerebellar astrocytoma
875557|NCT00002944|childhood low-grade cerebral astrocytoma|childhood low-grade cerebral astrocytoma
875558|NCT00002943|stage III malignant testicular germ cell tumor|stage iii malignant testicular germ cell tumor
875559|NCT00002943|recurrent malignant testicular germ cell tumor|recurrent malignant testicular germ cell tumor
875560|NCT00002943|unspecified adult solid tumor, protocol specific|unspecified adult solid tumor, protocol specific
875561|NCT00002943|stage III ovarian germ cell tumor|stage iii ovarian germ cell tumor
875562|NCT00002943|stage IV ovarian germ cell tumor|stage iv ovarian germ cell tumor
875563|NCT00002943|recurrent ovarian germ cell tumor|recurrent ovarian germ cell tumor
875564|NCT00002943|extragonadal germ cell tumor|extragonadal germ cell tumor
875565|NCT00002941|recurrent childhood lymphoblastic lymphoma|recurrent childhood lymphoblastic lymphoma
875566|NCT00002941|childhood diffuse large cell lymphoma|childhood diffuse large cell lymphoma
875567|NCT00002941|childhood immunoblastic large cell lymphoma|childhood immunoblastic large cell lymphoma
875568|NCT00002941|recurrent/refractory childhood Hodgkin lymphoma|recurrent/refractory childhood hodgkin lymphoma
875569|NCT00002941|recurrent childhood small noncleaved cell lymphoma|recurrent childhood small noncleaved cell lymphoma
875570|NCT00002941|recurrent childhood large cell lymphoma|recurrent childhood large cell lymphoma
875571|NCT00002938|recurrent prostate cancer|recurrent prostate cancer
875572|NCT00002931|recurrent malignant testicular germ cell tumor|recurrent malignant testicular germ cell tumor
875573|NCT00002931|testicular seminoma|testicular seminoma
875574|NCT00002931|testicular embryonal carcinoma|testicular embryonal carcinoma
875575|NCT00002931|testicular choriocarcinoma|testicular choriocarcinoma
875576|NCT00002931|testicular yolk sac tumor|testicular yolk sac tumor
875577|NCT00002931|testicular embryonal carcinoma and teratoma|testicular embryonal carcinoma and teratoma
875578|NCT00002931|testicular embryonal carcinoma and teratoma with seminoma|testicular embryonal carcinoma and teratoma with seminoma
875579|NCT00002931|testicular embryonal carcinoma and yolk sac tumor|testicular embryonal carcinoma and yolk sac tumor
875580|NCT00002931|testicular embryonal carcinoma and yolk sac tumor with seminoma|testicular embryonal carcinoma and yolk sac tumor with seminoma
875581|NCT00002931|testicular embryonal carcinoma and seminoma|testicular embryonal carcinoma and seminoma
875582|NCT00002931|testicular yolk sac tumor and teratoma|testicular yolk sac tumor and teratoma
875583|NCT00002931|testicular yolk sac tumor and teratoma with seminoma|testicular yolk sac tumor and teratoma with seminoma
875584|NCT00002931|testicular choriocarcinoma and yolk sac tumor|testicular choriocarcinoma and yolk sac tumor
875585|NCT00002931|testicular choriocarcinoma and embryonal carcinoma|testicular choriocarcinoma and embryonal carcinoma
875586|NCT00002931|testicular choriocarcinoma and teratoma|testicular choriocarcinoma and teratoma
875587|NCT00002931|testicular choriocarcinoma and seminoma|testicular choriocarcinoma and seminoma
875588|NCT00002931|recurrent ovarian germ cell tumor|recurrent ovarian germ cell tumor
875589|NCT00002931|recurrent extragonadal non-seminomatous germ cell tumor|recurrent extragonadal non-seminomatous germ cell tumor
875590|NCT00002931|recurrent extragonadal seminoma|recurrent extragonadal seminoma
875591|NCT00002931|recurrent extragonadal germ cell tumor|recurrent extragonadal germ cell tumor
875592|NCT00002931|adult teratoma|adult teratoma
875593|NCT00002931|testicular immature teratoma|testicular immature teratoma
875594|NCT00002931|testicular mature teratoma|testicular mature teratoma
875595|NCT00002931|ovarian immature teratoma|ovarian immature teratoma
875596|NCT00002931|ovarian mature teratoma|ovarian mature teratoma
875597|NCT00002931|ovarian monodermal and highly specialized teratoma|ovarian monodermal and highly specialized teratoma
875598|NCT00002931|stage III malignant testicular germ cell tumor|stage iii malignant testicular germ cell tumor
875599|NCT00002931|stage IV ovarian germ cell tumor|stage iv ovarian germ cell tumor
875600|NCT00002931|stage IV extragonadal non-seminomatous germ cell tumor|stage iv extragonadal non-seminomatous germ cell tumor
875601|NCT00002931|stage IV extragonadal seminoma|stage iv extragonadal seminoma
875602|NCT00002931|adult central nervous system germ cell tumor|adult central nervous system germ cell tumor
875603|NCT00002926|secondary acute myeloid leukemia|secondary acute myeloid leukemia
875604|NCT00002926|refractory anemia|refractory anemia
875605|NCT00002926|refractory anemia with ringed sideroblasts|refractory anemia with ringed sideroblasts
875606|NCT00002926|refractory anemia with excess blasts|refractory anemia with excess blasts
875607|NCT00002926|refractory anemia with excess blasts in transformation|refractory anemia with excess blasts in transformation
875608|NCT00002926|chronic myelomonocytic leukemia|chronic myelomonocytic leukemia
875609|NCT00002926|de novo myelodysplastic syndromes|de novo myelodysplastic syndromes
875610|NCT00002926|previously treated myelodysplastic syndromes|previously treated myelodysplastic syndromes
875611|NCT00002926|secondary myelodysplastic syndromes|secondary myelodysplastic syndromes
875612|NCT00002926|refractory cytopenia with multilineage dysplasia|refractory cytopenia with multilineage dysplasia
875613|NCT00002926|childhood myelodysplastic syndromes|childhood myelodysplastic syndromes
875614|NCT00002920|endometrial cancer|endometrial cancer
875615|NCT00002920|stage I breast cancer|stage i breast cancer
875616|NCT00002920|stage II breast cancer|stage ii breast cancer
875617|NCT00002920|ductal breast carcinoma in situ|ductal breast carcinoma in situ
875618|NCT00002920|lobular breast carcinoma in situ|lobular breast carcinoma in situ
875619|NCT00002920|Paget disease of the breast|paget disease of the breast
875620|NCT00002916|stage IB cervical cancer|stage ib cervical cancer
875621|NCT00002916|stage IIA cervical cancer|stage iia cervical cancer
875622|NCT00002916|cervical squamous cell carcinoma|cervical squamous cell carcinoma
875624|NCT00002916|cervical adenosquamous cell carcinoma|cervical adenosquamous cell carcinoma
875625|NCT00002900|stage I breast cancer|stage i breast cancer
875626|NCT00002900|stage II breast cancer|stage ii breast cancer
875627|NCT00002900|ductal breast carcinoma|ductal breast carcinoma
875628|NCT00002900|cardiac toxicity|cardiac toxicity
875629|NCT00002899|tumors metastatic to brain|tumors metastatic to brain
875630|NCT00002898|embryonal childhood rhabdomyosarcoma|embryonal childhood rhabdomyosarcoma
875631|NCT00002898|alveolar childhood rhabdomyosarcoma|alveolar childhood rhabdomyosarcoma
875632|NCT00002898|pleomorphic childhood rhabdomyosarcoma|pleomorphic childhood rhabdomyosarcoma
875633|NCT00002898|mixed childhood rhabdomyosarcoma|mixed childhood rhabdomyosarcoma
875634|NCT00002898|embryonal-botryoid childhood rhabdomyosarcoma|embryonal-botryoid childhood rhabdomyosarcoma
875635|NCT00002898|nonmetastatic childhood soft tissue sarcoma|nonmetastatic childhood soft tissue sarcoma
875636|NCT00002898|childhood fibrosarcoma|childhood fibrosarcoma
875637|NCT00002898|childhood synovial sarcoma|childhood synovial sarcoma
875638|NCT00002898|childhood malignant hemangiopericytoma|childhood malignant hemangiopericytoma
875639|NCT00002898|childhood liposarcoma|childhood liposarcoma
875640|NCT00002898|childhood alveolar soft-part sarcoma|childhood alveolar soft-part sarcoma
875641|NCT00002898|childhood leiomyosarcoma|childhood leiomyosarcoma
875642|NCT00002898|childhood neurofibrosarcoma|childhood neurofibrosarcoma
875643|NCT00002898|childhood angiosarcoma|childhood angiosarcoma
875644|NCT00002898|childhood epithelioid sarcoma|childhood epithelioid sarcoma
875645|NCT00002898|childhood malignant fibrous histiocytoma of bone|childhood malignant fibrous histiocytoma of bone
875646|NCT00002898|childhood malignant mesenchymoma|childhood malignant mesenchymoma
875647|NCT00002898|previously untreated childhood rhabdomyosarcoma|previously untreated childhood rhabdomyosarcoma
875648|NCT00002898|childhood desmoplastic small round cell tumor|childhood desmoplastic small round cell tumor
875649|NCT00002898|localized Ewing sarcoma/peripheral primitive neuroectodermal tumor|localized ewing sarcoma/peripheral primitive neuroectodermal tumor
875650|NCT00002895|recurrent ovarian epithelial cancer|recurrent ovarian epithelial cancer
875651|NCT00002895|primary peritoneal cavity cancer|primary peritoneal cavity cancer
875652|NCT00002895|fallopian tube cancer|fallopian tube cancer
875653|NCT00002894|recurrent ovarian epithelial cancer|recurrent ovarian epithelial cancer
875654|NCT00002894|primary peritoneal cavity cancer|primary peritoneal cavity cancer
875655|NCT00002883|stage I gastric cancer|stage i gastric cancer
875656|NCT00002883|stage II gastric cancer|stage ii gastric cancer
875657|NCT00002883|stage I esophageal cancer|stage i esophageal cancer
875658|NCT00002883|stage II esophageal cancer|stage ii esophageal cancer
875659|NCT00002883|adenocarcinoma of the stomach|adenocarcinoma of the stomach
875660|NCT00002883|adenocarcinoma of the esophagus|adenocarcinoma of the esophagus
875661|NCT00002882|stage III melanoma|stage iii melanoma
875662|NCT00002874|stage IIB prostate cancer|stage iib prostate cancer
875663|NCT00002874|stage IIA prostate cancer|stage iia prostate cancer
875664|NCT00002874|stage III prostate cancer|stage iii prostate cancer
875665|NCT00002874|recurrent prostate cancer|recurrent prostate cancer
875666|NCT00002860|stage IV melanoma|stage iv melanoma
875667|NCT00002860|recurrent melanoma|recurrent melanoma
875668|NCT00002855|adenocarcinoma of the prostate|adenocarcinoma of the prostate
875669|NCT00002855|stage III prostate cancer|stage iii prostate cancer
875670|NCT00002855|stage IV prostate cancer|stage iv prostate cancer
875671|NCT00002855|recurrent prostate cancer|recurrent prostate cancer
875672|NCT00002854|stage IV colon cancer|stage iv colon cancer
875673|NCT00002854|stage II breast cancer|stage ii breast cancer
875674|NCT00002854|stage IV breast cancer|stage iv breast cancer
875675|NCT00002854|stage IIIA breast cancer|stage iiia breast cancer
875676|NCT00002854|recurrent breast cancer|recurrent breast cancer
896399|NCT00001195|Hormones|hormones
875677|NCT00002854|stage IV gastric cancer|stage iv gastric cancer
875678|NCT00002854|recurrent gastric cancer|recurrent gastric cancer
875679|NCT00002854|localized osteosarcoma|localized osteosarcoma
875680|NCT00002854|metastatic osteosarcoma|metastatic osteosarcoma
875681|NCT00002854|stage IIIB breast cancer|stage iiib breast cancer
875682|NCT00002854|recurrent pancreatic cancer|recurrent pancreatic cancer
875683|NCT00002854|stage IV rectal cancer|stage iv rectal cancer
875684|NCT00002854|recurrent colon cancer|recurrent colon cancer
875685|NCT00002854|recurrent rectal cancer|recurrent rectal cancer
875686|NCT00002854|stage IV anal cancer|stage iv anal cancer
875687|NCT00002854|recurrent anal cancer|recurrent anal cancer
875688|NCT00002854|stage IV esophageal cancer|stage iv esophageal cancer
875689|NCT00002854|recurrent esophageal cancer|recurrent esophageal cancer
875690|NCT00002854|stage III adult soft tissue sarcoma|stage iii adult soft tissue sarcoma
875691|NCT00002854|recurrent adult soft tissue sarcoma|recurrent adult soft tissue sarcoma
875692|NCT00002854|stage III ovarian epithelial cancer|stage iii ovarian epithelial cancer
875693|NCT00002854|stage IV ovarian epithelial cancer|stage iv ovarian epithelial cancer
875694|NCT00002854|recurrent ovarian epithelial cancer|recurrent ovarian epithelial cancer
875695|NCT00002854|recurrent Wilms tumor and other childhood kidney tumors|recurrent wilms tumor and other childhood kidney tumors
875696|NCT00002854|advanced adult primary liver cancer|advanced adult primary liver cancer
875697|NCT00002854|recurrent adult primary liver cancer|recurrent adult primary liver cancer
875698|NCT00002854|recurrent osteosarcoma|recurrent osteosarcoma
875699|NCT00002854|recurrent gallbladder cancer|recurrent gallbladder cancer
875700|NCT00002854|recurrent extrahepatic bile duct cancer|recurrent extrahepatic bile duct cancer
875701|NCT00002854|recurrent small intestine cancer|recurrent small intestine cancer
875702|NCT00002854|stage II melanoma|stage ii melanoma
875703|NCT00002854|stage III melanoma|stage iii melanoma
875704|NCT00002854|stage IV melanoma|stage iv melanoma
875705|NCT00002854|recurrent melanoma|recurrent melanoma
875706|NCT00002854|metastatic Ewing sarcoma/peripheral primitive neuroectodermal tumor|metastatic ewing sarcoma/peripheral primitive neuroectodermal tumor
875707|NCT00002854|recurrent Ewing sarcoma/peripheral primitive neuroectodermal tumor|recurrent ewing sarcoma/peripheral primitive neuroectodermal tumor
875708|NCT00002854|stage IV adult soft tissue sarcoma|stage iv adult soft tissue sarcoma
875709|NCT00002854|stage IV pancreatic cancer|stage iv pancreatic cancer
875710|NCT00002851|stage I breast cancer|stage i breast cancer
875711|NCT00002851|stage II breast cancer|stage ii breast cancer
875712|NCT00002851|stage IIIA breast cancer|stage iiia breast cancer
875713|NCT00002850|stage I multiple myeloma|stage i multiple myeloma
875714|NCT00002850|stage II multiple myeloma|stage ii multiple myeloma
875715|NCT00002850|stage III multiple myeloma|stage iii multiple myeloma
875716|NCT00002850|infection|infection
875717|NCT00002849|primary systemic amyloidosis|primary systemic amyloidosis
875718|NCT00002848|stage I prostate cancer|stage i prostate cancer
875719|NCT00002848|stage IIB prostate cancer|stage iib prostate cancer
875720|NCT00002848|stage IIA prostate cancer|stage iia prostate cancer
875721|NCT00002848|psychosocial effects of cancer and its treatment|psychosocial effects of cancer and its treatment
875722|NCT00002847|stage IV renal cell cancer|stage iv renal cell cancer
875723|NCT00002847|recurrent renal cell cancer|recurrent renal cell cancer
875724|NCT00002846|stage IV renal cell cancer|stage iv renal cell cancer
875725|NCT00002846|recurrent renal cell cancer|recurrent renal cell cancer
875726|NCT00002842|stage IV colon cancer|stage iv colon cancer
875727|NCT00002842|stage IV rectal cancer|stage iv rectal cancer
875728|NCT00002842|recurrent colon cancer|recurrent colon cancer
875730|NCT00002842|liver metastases|liver metastases
875731|NCT00002839|stage II squamous cell carcinoma of the hypopharynx|stage ii squamous cell carcinoma of the hypopharynx
875732|NCT00002839|stage III squamous cell carcinoma of the hypopharynx|stage iii squamous cell carcinoma of the hypopharynx
875733|NCT00002839|stage IV squamous cell carcinoma of the hypopharynx|stage iv squamous cell carcinoma of the hypopharynx
875734|NCT00002839|stage III squamous cell carcinoma of the larynx|stage iii squamous cell carcinoma of the larynx
875735|NCT00002839|stage IV squamous cell carcinoma of the larynx|stage iv squamous cell carcinoma of the larynx
875736|NCT00002810|refractory multiple myeloma|refractory multiple myeloma
875737|NCT00002810|stage I multiple myeloma|stage i multiple myeloma
875738|NCT00002810|stage II multiple myeloma|stage ii multiple myeloma
875739|NCT00002810|stage III multiple myeloma|stage iii multiple myeloma
875740|NCT00002810|primary systemic amyloidosis|primary systemic amyloidosis
875741|NCT00002809|recurrent adult acute myeloid leukemia|recurrent adult acute myeloid leukemia
875742|NCT00002809|recurrent adult acute lymphoblastic leukemia|recurrent adult acute lymphoblastic leukemia
875743|NCT00002809|refractory chronic lymphocytic leukemia|refractory chronic lymphocytic leukemia
875744|NCT00002809|chronic phase chronic myelogenous leukemia|chronic phase chronic myelogenous leukemia
875745|NCT00002809|accelerated phase chronic myelogenous leukemia|accelerated phase chronic myelogenous leukemia
875746|NCT00002809|adult acute myeloid leukemia in remission|adult acute myeloid leukemia in remission
875747|NCT00002809|adult acute lymphoblastic leukemia in remission|adult acute lymphoblastic leukemia in remission
875748|NCT00002809|refractory anemia|refractory anemia
875749|NCT00002809|refractory anemia with excess blasts|refractory anemia with excess blasts
875750|NCT00002809|refractory anemia with excess blasts in transformation|refractory anemia with excess blasts in transformation
876141|NCT00002641|stage III uterine sarcoma|stage iii uterine sarcoma
875751|NCT00002809|secondary acute myeloid leukemia|secondary acute myeloid leukemia
875752|NCT00002809|previously treated myelodysplastic syndromes|previously treated myelodysplastic syndromes
875753|NCT00002809|atypical chronic myeloid leukemia|atypical chronic myeloid leukemia
875754|NCT00002809|myelodysplastic/myeloproliferative disease, unclassifiable|myelodysplastic/myeloproliferative disease, unclassifiable
875755|NCT00002809|adult acute myeloid leukemia with t(8;21)(q22;q22)|adult acute myeloid leukemia with t(8;21)(q22;q22)
875756|NCT00002809|adult acute myeloid leukemia with t(16;16)(p13;q22)|adult acute myeloid leukemia with t(16;16)(p13;q22)
875757|NCT00002809|adult acute myeloid leukemia with inv(16)(p13;q22)|adult acute myeloid leukemia with inv(16)(p13;q22)
875758|NCT00002809|adult acute myeloid leukemia with 11q23 (MLL) abnormalities|adult acute myeloid leukemia with 11q23 (mll) abnormalities
875759|NCT00002809|adult acute myeloid leukemia with t(15;17)(q22;q12)|adult acute myeloid leukemia with t(15;17)(q22;q12)
875760|NCT00002807|stage I endometrial carcinoma|stage i endometrial carcinoma
875761|NCT00002807|stage II endometrial carcinoma|stage ii endometrial carcinoma
875762|NCT00002807|endometrial adenocarcinoma|endometrial adenocarcinoma
875763|NCT00002807|endometrial adenosquamous cell carcinoma|endometrial adenosquamous cell carcinoma
875764|NCT00002807|endometrial papillary carcinoma|endometrial papillary carcinoma
875765|NCT00002807|endometrial clear cell carcinoma|endometrial clear cell carcinoma
875766|NCT00002792|polycythemia vera|polycythemia vera
875767|NCT00002792|chronic idiopathic myelofibrosis|chronic idiopathic myelofibrosis
875768|NCT00002792|essential thrombocythemia|essential thrombocythemia
875769|NCT00002792|atypical chronic myeloid leukemia|atypical chronic myeloid leukemia
875770|NCT00002792|myelodysplastic/myeloproliferative disease, unclassifiable|myelodysplastic/myeloproliferative disease, unclassifiable
875771|NCT00002778|relapsing chronic myelogenous leukemia|relapsing chronic myelogenous leukemia
875772|NCT00002778|chronic phase chronic myelogenous leukemia|chronic phase chronic myelogenous leukemia
875773|NCT00002778|accelerated phase chronic myelogenous leukemia|accelerated phase chronic myelogenous leukemia
875774|NCT00002778|Philadelphia chromosome positive chronic myelogenous leukemia|philadelphia chromosome positive chronic myelogenous leukemia
875775|NCT00002778|Philadelphia chromosome negative chronic myelogenous leukemia|philadelphia chromosome negative chronic myelogenous leukemia
875776|NCT00002778|atypical chronic myeloid leukemia|atypical chronic myeloid leukemia
875777|NCT00002771|chronic phase chronic myelogenous leukemia|chronic phase chronic myelogenous leukemia
875778|NCT00002771|chronic myelogenous leukemia, BCR-ABL1 positive|chronic myelogenous leukemia, bcr-abl1 positive
875779|NCT00002771|Philadelphia chromosome negative chronic myelogenous leukemia|philadelphia chromosome negative chronic myelogenous leukemia
875780|NCT00002771|childhood chronic myelogenous leukemia|childhood chronic myelogenous leukemia
875781|NCT00002766|blastic phase chronic myelogenous leukemia|blastic phase chronic myelogenous leukemia
875782|NCT00002766|untreated adult acute lymphoblastic leukemia|untreated adult acute lymphoblastic leukemia
875783|NCT00002766|chronic myelogenous leukemia, BCR-ABL1 positive|chronic myelogenous leukemia, bcr-abl1 positive
875784|NCT00002766|T-cell adult acute lymphoblastic leukemia|t-cell adult acute lymphoblastic leukemia
875785|NCT00002766|B-cell adult acute lymphoblastic leukemia|b-cell adult acute lymphoblastic leukemia
875786|NCT00002766|stage I adult lymphoblastic lymphoma|stage i adult lymphoblastic lymphoma
875787|NCT00002766|stage II adult lymphoblastic lymphoma|stage ii adult lymphoblastic lymphoma
875788|NCT00002766|stage III adult lymphoblastic lymphoma|stage iii adult lymphoblastic lymphoma
875789|NCT00002766|stage IV adult lymphoblastic lymphoma|stage iv adult lymphoblastic lymphoma
875790|NCT00002766|contiguous stage II adult lymphoblastic lymphoma|contiguous stage ii adult lymphoblastic lymphoma
875791|NCT00002766|noncontiguous stage II adult lymphoblastic lymphoma|noncontiguous stage ii adult lymphoblastic lymphoma
875792|NCT00002762|stage I breast cancer|stage i breast cancer
875793|NCT00002762|stage II breast cancer|stage ii breast cancer
875794|NCT00002762|perioperative/postoperative complications|perioperative/postoperative complications
875795|NCT00002757|childhood Burkitt lymphoma|childhood burkitt lymphoma
875796|NCT00002757|untreated childhood acute lymphoblastic leukemia|untreated childhood acute lymphoblastic leukemia
876484|NCT00051961|Ropinirole|ropinirole
875797|NCT00002757|L3 childhood acute lymphoblastic leukemia|l3 childhood acute lymphoblastic leukemia
875798|NCT00002757|stage I childhood small noncleaved cell lymphoma|stage i childhood small noncleaved cell lymphoma
875799|NCT00002757|stage I childhood large cell lymphoma|stage i childhood large cell lymphoma
875800|NCT00002757|stage II childhood small noncleaved cell lymphoma|stage ii childhood small noncleaved cell lymphoma
875801|NCT00002757|stage II childhood large cell lymphoma|stage ii childhood large cell lymphoma
875802|NCT00002757|stage III childhood small noncleaved cell lymphoma|stage iii childhood small noncleaved cell lymphoma
875803|NCT00002757|stage III childhood large cell lymphoma|stage iii childhood large cell lymphoma
875804|NCT00002757|stage IV childhood small noncleaved cell lymphoma|stage iv childhood small noncleaved cell lymphoma
875805|NCT00002757|stage IV childhood large cell lymphoma|stage iv childhood large cell lymphoma
875806|NCT00002756|untreated childhood acute lymphoblastic leukemia|untreated childhood acute lymphoblastic leukemia
875807|NCT00002756|acute undifferentiated leukemia|acute undifferentiated leukemia
875808|NCT00002746|refractory anemia|refractory anemia
875809|NCT00002746|refractory anemia with ringed sideroblasts|refractory anemia with ringed sideroblasts
875810|NCT00002746|refractory anemia with excess blasts|refractory anemia with excess blasts
875811|NCT00002746|chronic myelomonocytic leukemia|chronic myelomonocytic leukemia
875812|NCT00002746|de novo myelodysplastic syndromes|de novo myelodysplastic syndromes
875813|NCT00002746|previously treated myelodysplastic syndromes|previously treated myelodysplastic syndromes
875814|NCT00002746|secondary myelodysplastic syndromes|secondary myelodysplastic syndromes
875815|NCT00002746|atypical chronic myeloid leukemia, BCR-ABL1 negative|atypical chronic myeloid leukemia, bcr-abl1 negative
875816|NCT00002746|myelodysplastic/myeloproliferative neoplasm, unclassifiable|myelodysplastic/myeloproliferative neoplasm, unclassifiable
875817|NCT00002746|childhood myelodysplastic syndromes|childhood myelodysplastic syndromes
875818|NCT00002738|recurrent childhood acute lymphoblastic leukemia|recurrent childhood acute lymphoblastic leukemia
875819|NCT00002738|recurrent childhood lymphoblastic lymphoma|recurrent childhood lymphoblastic lymphoma
875820|NCT00002738|recurrent osteosarcoma|recurrent osteosarcoma
875821|NCT00002738|recurrent childhood small noncleaved cell lymphoma|recurrent childhood small noncleaved cell lymphoma
875822|NCT00002738|recurrent childhood large cell lymphoma|recurrent childhood large cell lymphoma
875823|NCT00002727|stage II squamous cell carcinoma of the larynx|stage ii squamous cell carcinoma of the larynx
875824|NCT00002720|stage I breast cancer|stage i breast cancer
875825|NCT00002718|recurrent childhood acute lymphoblastic leukemia|recurrent childhood acute lymphoblastic leukemia
875826|NCT00002718|stage IV childhood lymphoblastic lymphoma|stage iv childhood lymphoblastic lymphoma
875827|NCT00002718|recurrent childhood lymphoblastic lymphoma|recurrent childhood lymphoblastic lymphoma
875828|NCT00002718|recurrent childhood acute myeloid leukemia|recurrent childhood acute myeloid leukemia
875829|NCT00002718|recurrent adult acute myeloid leukemia|recurrent adult acute myeloid leukemia
875830|NCT00002718|recurrent adult acute lymphoblastic leukemia|recurrent adult acute lymphoblastic leukemia
875831|NCT00002718|relapsing chronic myelogenous leukemia|relapsing chronic myelogenous leukemia
875832|NCT00002718|chronic phase chronic myelogenous leukemia|chronic phase chronic myelogenous leukemia
875833|NCT00002718|accelerated phase chronic myelogenous leukemia|accelerated phase chronic myelogenous leukemia
875834|NCT00002718|adult acute myeloid leukemia in remission|adult acute myeloid leukemia in remission
875835|NCT00002718|adult acute lymphoblastic leukemia in remission|adult acute lymphoblastic leukemia in remission
875836|NCT00002718|childhood acute myeloid leukemia in remission|childhood acute myeloid leukemia in remission
875837|NCT00002718|childhood acute lymphoblastic leukemia in remission|childhood acute lymphoblastic leukemia in remission
875838|NCT00002718|stage IV adult lymphoblastic lymphoma|stage iv adult lymphoblastic lymphoma
875839|NCT00002718|recurrent adult lymphoblastic lymphoma|recurrent adult lymphoblastic lymphoma
875840|NCT00002718|secondary acute myeloid leukemia|secondary acute myeloid leukemia
875841|NCT00002718|de novo myelodysplastic syndromes|de novo myelodysplastic syndromes
875842|NCT00002718|previously treated myelodysplastic syndromes|previously treated myelodysplastic syndromes
875843|NCT00002718|secondary myelodysplastic syndromes|secondary myelodysplastic syndromes
875844|NCT00002718|juvenile myelomonocytic leukemia|juvenile myelomonocytic leukemia
875845|NCT00002718|childhood chronic myelogenous leukemia|childhood chronic myelogenous leukemia
875846|NCT00002718|atypical chronic myeloid leukemia, BCR-ABL1 negative|atypical chronic myeloid leukemia, bcr-abl1 negative
875847|NCT00002718|myelodysplastic/myeloproliferative neoplasm, unclassifiable|myelodysplastic/myeloproliferative neoplasm, unclassifiable
875848|NCT00002718|chronic myelomonocytic leukemia|chronic myelomonocytic leukemia
875849|NCT00002718|childhood myelodysplastic syndromes|childhood myelodysplastic syndromes
875850|NCT00002716|stage IV colon cancer|stage iv colon cancer
875851|NCT00002716|stage IV rectal cancer|stage iv rectal cancer
875852|NCT00002716|recurrent colon cancer|recurrent colon cancer
875853|NCT00002716|recurrent rectal cancer|recurrent rectal cancer
875854|NCT00002716|adenocarcinoma of the colon|adenocarcinoma of the colon
875855|NCT00002716|adenocarcinoma of the rectum|adenocarcinoma of the rectum
875856|NCT00002716|liver metastases|liver metastases
875857|NCT00002715|stage I adult Hodgkin lymphoma|stage i adult hodgkin lymphoma
875858|NCT00002715|stage II adult Hodgkin lymphoma|stage ii adult hodgkin lymphoma
875859|NCT00002715|stage III adult Hodgkin lymphoma|stage iii adult hodgkin lymphoma
875860|NCT00002715|stage IV adult Hodgkin lymphoma|stage iv adult hodgkin lymphoma
875861|NCT00002715|adult lymphocyte predominant Hodgkin lymphoma|adult lymphocyte predominant hodgkin lymphoma
875862|NCT00002715|adult lymphocyte depletion Hodgkin lymphoma|adult lymphocyte depletion hodgkin lymphoma
875863|NCT00002715|adult nodular sclerosis Hodgkin lymphoma|adult nodular sclerosis hodgkin lymphoma
875864|NCT00002715|adult mixed cellularity Hodgkin lymphoma|adult mixed cellularity hodgkin lymphoma
875865|NCT00002702|stage II squamous cell carcinoma of the lip and oral cavity|stage ii squamous cell carcinoma of the lip and oral cavity
875866|NCT00002702|stage III squamous cell carcinoma of the lip and oral cavity|stage iii squamous cell carcinoma of the lip and oral cavity
875867|NCT00002702|stage IV squamous cell carcinoma of the lip and oral cavity|stage iv squamous cell carcinoma of the lip and oral cavity
875868|NCT00002702|stage II squamous cell carcinoma of the oropharynx|stage ii squamous cell carcinoma of the oropharynx
875869|NCT00002702|stage III squamous cell carcinoma of the oropharynx|stage iii squamous cell carcinoma of the oropharynx
875870|NCT00002702|stage IV squamous cell carcinoma of the oropharynx|stage iv squamous cell carcinoma of the oropharynx
875871|NCT00002702|tongue cancer|tongue cancer
875872|NCT00002700|untreated adult acute lymphoblastic leukemia|untreated adult acute lymphoblastic leukemia
875873|NCT00002700|stage I adult lymphoblastic lymphoma|stage i adult lymphoblastic lymphoma
875874|NCT00002700|stage III adult lymphoblastic lymphoma|stage iii adult lymphoblastic lymphoma
875875|NCT00002700|stage IV adult lymphoblastic lymphoma|stage iv adult lymphoblastic lymphoma
875876|NCT00002700|contiguous stage II adult lymphoblastic lymphoma|contiguous stage ii adult lymphoblastic lymphoma
875877|NCT00002700|noncontiguous stage II adult lymphoblastic lymphoma|noncontiguous stage ii adult lymphoblastic lymphoma
875878|NCT00002697|recurrent grade 1 follicular lymphoma|recurrent grade 1 follicular lymphoma
875879|NCT00002697|recurrent grade 2 follicular lymphoma|recurrent grade 2 follicular lymphoma
875880|NCT00002697|recurrent grade 3 follicular lymphoma|recurrent grade 3 follicular lymphoma
875881|NCT00002697|recurrent adult diffuse small cleaved cell lymphoma|recurrent adult diffuse small cleaved cell lymphoma
875882|NCT00002697|recurrent adult diffuse mixed cell lymphoma|recurrent adult diffuse mixed cell lymphoma
875883|NCT00002697|recurrent adult diffuse large cell lymphoma|recurrent adult diffuse large cell lymphoma
875884|NCT00002697|recurrent adult immunoblastic large cell lymphoma|recurrent adult immunoblastic large cell lymphoma
875885|NCT00002697|recurrent marginal zone lymphoma|recurrent marginal zone lymphoma
875886|NCT00002697|recurrent small lymphocytic lymphoma|recurrent small lymphocytic lymphoma
875887|NCT00002697|extranodal marginal zone B-cell lymphoma of mucosa-associated lymphoid tissue|extranodal marginal zone b-cell lymphoma of mucosa-associated lymphoid tissue
875888|NCT00002697|nodal marginal zone B-cell lymphoma|nodal marginal zone b-cell lymphoma
875889|NCT00002697|splenic marginal zone lymphoma|splenic marginal zone lymphoma
875890|NCT00002696|stage IIIA breast cancer|stage iiia breast cancer
875891|NCT00002696|stage IIIB breast cancer|stage iiib breast cancer
875892|NCT00002696|stage IIIC breast cancer|stage iiic breast cancer
875893|NCT00002689|stage I pancreatic cancer|stage i pancreatic cancer
875894|NCT00002689|stage II pancreatic cancer|stage ii pancreatic cancer
875895|NCT00002689|stage III pancreatic cancer|stage iii pancreatic cancer
875896|NCT00002689|adenocarcinoma of the pancreas|adenocarcinoma of the pancreas
875897|NCT00002687|stage II cutaneous T-cell non-Hodgkin lymphoma|stage ii cutaneous t-cell non-hodgkin lymphoma
875898|NCT00002687|stage III cutaneous T-cell non-Hodgkin lymphoma|stage iii cutaneous t-cell non-hodgkin lymphoma
875899|NCT00002687|stage IV cutaneous T-cell non-Hodgkin lymphoma|stage iv cutaneous t-cell non-hodgkin lymphoma
875900|NCT00002687|recurrent cutaneous T-cell non-Hodgkin lymphoma|recurrent cutaneous t-cell non-hodgkin lymphoma
875901|NCT00002687|stage II mycosis fungoides/Sezary syndrome|stage ii mycosis fungoides/sezary syndrome
875902|NCT00002687|stage III mycosis fungoides/Sezary syndrome|stage iii mycosis fungoides/sezary syndrome
875903|NCT00002687|stage IV mycosis fungoides/Sezary syndrome|stage iv mycosis fungoides/sezary syndrome
875904|NCT00002687|recurrent mycosis fungoides/Sezary syndrome|recurrent mycosis fungoides/sezary syndrome
875905|NCT00002684|stage III bladder cancer|stage iii bladder cancer
875906|NCT00002684|recurrent bladder cancer|recurrent bladder cancer
875907|NCT00002684|stage IV bladder cancer|stage iv bladder cancer
875908|NCT00002684|squamous cell carcinoma of the bladder|squamous cell carcinoma of the bladder
875909|NCT00002684|adenocarcinoma of the bladder|adenocarcinoma of the bladder
875910|NCT00002684|recurrent urethral cancer|recurrent urethral cancer
875911|NCT00002684|distal urethral cancer|distal urethral cancer
875912|NCT00002684|proximal urethral cancer|proximal urethral cancer
875913|NCT00002684|urethral cancer associated with invasive bladder cancer|urethral cancer associated with invasive bladder cancer
875914|NCT00002681|recurrent adult Hodgkin lymphoma|recurrent adult hodgkin lymphoma
875915|NCT00002681|recurrent adult acute myeloid leukemia|recurrent adult acute myeloid leukemia
875916|NCT00002681|relapsing chronic myelogenous leukemia|relapsing chronic myelogenous leukemia
875917|NCT00002681|chronic phase chronic myelogenous leukemia|chronic phase chronic myelogenous leukemia
875918|NCT00002681|atypical chronic myeloid leukemia, BCR-ABL negative|atypical chronic myeloid leukemia, bcr-abl negative
875919|NCT00002678|stage I multiple myeloma|stage i multiple myeloma
875920|NCT00002678|stage II multiple myeloma|stage ii multiple myeloma
875921|NCT00002678|stage III multiple myeloma|stage iii multiple myeloma
875922|NCT00002668|stage IV breast cancer|stage iv breast cancer
875923|NCT00002668|recurrent breast cancer|recurrent breast cancer
875924|NCT00002668|stage IV prostate cancer|stage iv prostate cancer
875925|NCT00002668|recurrent prostate cancer|recurrent prostate cancer
875927|NCT00002663|stage I adult Hodgkin lymphoma|stage i adult hodgkin lymphoma
875928|NCT00002663|stage II adult Hodgkin lymphoma|stage ii adult hodgkin lymphoma
875929|NCT00002663|stage III adult Hodgkin lymphoma|stage iii adult hodgkin lymphoma
875930|NCT00002663|stage IV adult Hodgkin lymphoma|stage iv adult hodgkin lymphoma
875931|NCT00002663|recurrent adult Hodgkin lymphoma|recurrent adult hodgkin lymphoma
875932|NCT00002663|stage I cutaneous T-cell non-Hodgkin lymphoma|stage i cutaneous t-cell non-hodgkin lymphoma
875933|NCT00002663|stage II cutaneous T-cell non-Hodgkin lymphoma|stage ii cutaneous t-cell non-hodgkin lymphoma
875934|NCT00002663|stage III cutaneous T-cell non-Hodgkin lymphoma|stage iii cutaneous t-cell non-hodgkin lymphoma
875935|NCT00002663|stage IV cutaneous T-cell non-Hodgkin lymphoma|stage iv cutaneous t-cell non-hodgkin lymphoma
875936|NCT00002663|recurrent cutaneous T-cell non-Hodgkin lymphoma|recurrent cutaneous t-cell non-hodgkin lymphoma
875937|NCT00002663|childhood Burkitt lymphoma|childhood burkitt lymphoma
875938|NCT00002663|stage I childhood lymphoblastic lymphoma|stage i childhood lymphoblastic lymphoma
875939|NCT00002663|stage II childhood lymphoblastic lymphoma|stage ii childhood lymphoblastic lymphoma
875940|NCT00002663|stage III childhood lymphoblastic lymphoma|stage iii childhood lymphoblastic lymphoma
875941|NCT00002663|stage IV childhood lymphoblastic lymphoma|stage iv childhood lymphoblastic lymphoma
875942|NCT00002663|recurrent childhood lymphoblastic lymphoma|recurrent childhood lymphoblastic lymphoma
875943|NCT00002663|childhood diffuse large cell lymphoma|childhood diffuse large cell lymphoma
875944|NCT00002663|childhood immunoblastic large cell lymphoma|childhood immunoblastic large cell lymphoma
875945|NCT00002663|stage II childhood Hodgkin lymphoma|stage ii childhood hodgkin lymphoma
875946|NCT00002663|stage I childhood Hodgkin lymphoma|stage i childhood hodgkin lymphoma
875947|NCT00002663|stage III childhood Hodgkin lymphoma|stage iii childhood hodgkin lymphoma
875948|NCT00002663|stage IV childhood Hodgkin lymphoma|stage iv childhood hodgkin lymphoma
875949|NCT00002663|recurrent/refractory childhood Hodgkin lymphoma|recurrent/refractory childhood hodgkin lymphoma
875950|NCT00002663|stage I grade 1 follicular lymphoma|stage i grade 1 follicular lymphoma
875951|NCT00002663|stage I grade 2 follicular lymphoma|stage i grade 2 follicular lymphoma
875952|NCT00002663|stage I grade 3 follicular lymphoma|stage i grade 3 follicular lymphoma
875953|NCT00002663|stage I adult diffuse small cleaved cell lymphoma|stage i adult diffuse small cleaved cell lymphoma
875954|NCT00002663|stage I adult diffuse mixed cell lymphoma|stage i adult diffuse mixed cell lymphoma
875955|NCT00002663|stage I adult diffuse large cell lymphoma|stage i adult diffuse large cell lymphoma
875956|NCT00002663|stage I adult immunoblastic large cell lymphoma|stage i adult immunoblastic large cell lymphoma
875957|NCT00002663|stage I adult lymphoblastic lymphoma|stage i adult lymphoblastic lymphoma
875958|NCT00002663|stage I adult Burkitt lymphoma|stage i adult burkitt lymphoma
875959|NCT00002663|T-cell large granular lymphocyte leukemia|t-cell large granular lymphocyte leukemia
875960|NCT00002663|stage III grade 1 follicular lymphoma|stage iii grade 1 follicular lymphoma
875961|NCT00002663|stage III grade 2 follicular lymphoma|stage iii grade 2 follicular lymphoma
875962|NCT00002663|stage III grade 3 follicular lymphoma|stage iii grade 3 follicular lymphoma
875963|NCT00002663|stage III adult diffuse small cleaved cell lymphoma|stage iii adult diffuse small cleaved cell lymphoma
875964|NCT00002663|stage III adult diffuse mixed cell lymphoma|stage iii adult diffuse mixed cell lymphoma
875965|NCT00002663|stage III adult diffuse large cell lymphoma|stage iii adult diffuse large cell lymphoma
875966|NCT00002663|stage III adult immunoblastic large cell lymphoma|stage iii adult immunoblastic large cell lymphoma
875967|NCT00002663|stage III adult lymphoblastic lymphoma|stage iii adult lymphoblastic lymphoma
875968|NCT00002663|stage III adult Burkitt lymphoma|stage iii adult burkitt lymphoma
875969|NCT00002663|stage IV grade 1 follicular lymphoma|stage iv grade 1 follicular lymphoma
875970|NCT00002663|stage IV grade 2 follicular lymphoma|stage iv grade 2 follicular lymphoma
875971|NCT00002663|stage IV grade 3 follicular lymphoma|stage iv grade 3 follicular lymphoma
875972|NCT00002663|stage IV adult diffuse small cleaved cell lymphoma|stage iv adult diffuse small cleaved cell lymphoma
875973|NCT00002663|stage IV adult diffuse mixed cell lymphoma|stage iv adult diffuse mixed cell lymphoma
875974|NCT00002663|stage IV adult diffuse large cell lymphoma|stage iv adult diffuse large cell lymphoma
875975|NCT00002663|stage IV adult immunoblastic large cell lymphoma|stage iv adult immunoblastic large cell lymphoma
875976|NCT00002663|stage IV adult lymphoblastic lymphoma|stage iv adult lymphoblastic lymphoma
875977|NCT00002663|stage IV adult Burkitt lymphoma|stage iv adult burkitt lymphoma
875978|NCT00002663|recurrent grade 1 follicular lymphoma|recurrent grade 1 follicular lymphoma
875979|NCT00002663|recurrent grade 2 follicular lymphoma|recurrent grade 2 follicular lymphoma
875980|NCT00002663|recurrent grade 3 follicular lymphoma|recurrent grade 3 follicular lymphoma
875981|NCT00002663|recurrent adult diffuse small cleaved cell lymphoma|recurrent adult diffuse small cleaved cell lymphoma
875982|NCT00002663|recurrent adult diffuse mixed cell lymphoma|recurrent adult diffuse mixed cell lymphoma
875983|NCT00002663|recurrent adult diffuse large cell lymphoma|recurrent adult diffuse large cell lymphoma
875984|NCT00002663|recurrent adult immunoblastic large cell lymphoma|recurrent adult immunoblastic large cell lymphoma
875985|NCT00002663|recurrent adult lymphoblastic lymphoma|recurrent adult lymphoblastic lymphoma
875986|NCT00002663|recurrent adult Burkitt lymphoma|recurrent adult burkitt lymphoma
875987|NCT00002663|stage I adult T-cell leukemia/lymphoma|stage i adult t-cell leukemia/lymphoma
875988|NCT00002663|stage II adult T-cell leukemia/lymphoma|stage ii adult t-cell leukemia/lymphoma
875989|NCT00002663|stage III adult T-cell leukemia/lymphoma|stage iii adult t-cell leukemia/lymphoma
875990|NCT00002663|stage IV adult T-cell leukemia/lymphoma|stage iv adult t-cell leukemia/lymphoma
875991|NCT00002663|recurrent adult T-cell leukemia/lymphoma|recurrent adult t-cell leukemia/lymphoma
876593|NCT00051285|CHF|chf
875992|NCT00002663|AIDS-related peripheral/systemic lymphoma|aids-related peripheral/systemic lymphoma
875993|NCT00002663|HIV-associated Hodgkin lymphoma|hiv-associated hodgkin lymphoma
875994|NCT00002663|stage I childhood small noncleaved cell lymphoma|stage i childhood small noncleaved cell lymphoma
875995|NCT00002663|stage I childhood large cell lymphoma|stage i childhood large cell lymphoma
875996|NCT00002663|stage II childhood small noncleaved cell lymphoma|stage ii childhood small noncleaved cell lymphoma
875997|NCT00002663|stage II childhood large cell lymphoma|stage ii childhood large cell lymphoma
875998|NCT00002663|stage III childhood small noncleaved cell lymphoma|stage iii childhood small noncleaved cell lymphoma
875999|NCT00002663|stage III childhood large cell lymphoma|stage iii childhood large cell lymphoma
876000|NCT00002663|stage IV childhood small noncleaved cell lymphoma|stage iv childhood small noncleaved cell lymphoma
876001|NCT00002663|stage IV childhood large cell lymphoma|stage iv childhood large cell lymphoma
876002|NCT00002663|recurrent childhood small noncleaved cell lymphoma|recurrent childhood small noncleaved cell lymphoma
876003|NCT00002663|recurrent childhood large cell lymphoma|recurrent childhood large cell lymphoma
876004|NCT00002663|stage I mantle cell lymphoma|stage i mantle cell lymphoma
876005|NCT00002663|contiguous stage II grade 1 follicular lymphoma|contiguous stage ii grade 1 follicular lymphoma
876006|NCT00002663|contiguous stage II grade 2 follicular lymphoma|contiguous stage ii grade 2 follicular lymphoma
876142|NCT00002641|recurrent uterine sarcoma|recurrent uterine sarcoma
876007|NCT00002663|contiguous stage II grade 3 follicular lymphoma|contiguous stage ii grade 3 follicular lymphoma
876008|NCT00002663|contiguous stage II adult diffuse small cleaved cell lymphoma|contiguous stage ii adult diffuse small cleaved cell lymphoma
876009|NCT00002663|contiguous stage II mantle cell lymphoma|contiguous stage ii mantle cell lymphoma
876010|NCT00002663|contiguous stage II adult diffuse mixed cell lymphoma|contiguous stage ii adult diffuse mixed cell lymphoma
876011|NCT00002663|contiguous stage II adult immunoblastic large cell lymphoma|contiguous stage ii adult immunoblastic large cell lymphoma
876012|NCT00002663|contiguous stage II adult diffuse large cell lymphoma|contiguous stage ii adult diffuse large cell lymphoma
876013|NCT00002663|contiguous stage II adult Burkitt lymphoma|contiguous stage ii adult burkitt lymphoma
876014|NCT00002663|contiguous stage II adult lymphoblastic lymphoma|contiguous stage ii adult lymphoblastic lymphoma
876015|NCT00002663|noncontiguous stage II grade 1 follicular lymphoma|noncontiguous stage ii grade 1 follicular lymphoma
876016|NCT00002663|noncontiguous stage II grade 2 follicular lymphoma|noncontiguous stage ii grade 2 follicular lymphoma
876017|NCT00002663|noncontiguous stage II grade 3 follicular lymphoma|noncontiguous stage ii grade 3 follicular lymphoma
876018|NCT00002663|noncontiguous stage II adult diffuse small cleaved cell lymphoma|noncontiguous stage ii adult diffuse small cleaved cell lymphoma
876019|NCT00002663|noncontiguous stage II mantle cell lymphoma|noncontiguous stage ii mantle cell lymphoma
876020|NCT00002663|noncontiguous stage II adult diffuse mixed cell lymphoma|noncontiguous stage ii adult diffuse mixed cell lymphoma
876021|NCT00002663|noncontiguous stage II adult immunoblastic large cell lymphoma|noncontiguous stage ii adult immunoblastic large cell lymphoma
876022|NCT00002663|noncontiguous stage II adult diffuse large cell lymphoma|noncontiguous stage ii adult diffuse large cell lymphoma
876023|NCT00002663|noncontiguous stage II adult Burkitt lymphoma|noncontiguous stage ii adult burkitt lymphoma
876024|NCT00002663|noncontiguous stage II adult lymphoblastic lymphoma|noncontiguous stage ii adult lymphoblastic lymphoma
876025|NCT00002663|stage III mantle cell lymphoma|stage iii mantle cell lymphoma
876026|NCT00002663|stage IV mantle cell lymphoma|stage iv mantle cell lymphoma
876027|NCT00002663|recurrent mantle cell lymphoma|recurrent mantle cell lymphoma
876028|NCT00002663|stage I mycosis fungoides/Sezary syndrome|stage i mycosis fungoides/sezary syndrome
876029|NCT00002663|stage II mycosis fungoides/Sezary syndrome|stage ii mycosis fungoides/sezary syndrome
876030|NCT00002663|stage III mycosis fungoides/Sezary syndrome|stage iii mycosis fungoides/sezary syndrome
876031|NCT00002663|stage IV mycosis fungoides/Sezary syndrome|stage iv mycosis fungoides/sezary syndrome
876032|NCT00002663|recurrent mycosis fungoides/Sezary syndrome|recurrent mycosis fungoides/sezary syndrome
876033|NCT00002663|contiguous stage II small lymphocytic lymphoma|contiguous stage ii small lymphocytic lymphoma
876034|NCT00002663|contiguous stage II marginal zone lymphoma|contiguous stage ii marginal zone lymphoma
876035|NCT00002663|noncontiguous stage II small lymphocytic lymphoma|noncontiguous stage ii small lymphocytic lymphoma
876036|NCT00002663|noncontiguous stage II marginal zone lymphoma|noncontiguous stage ii marginal zone lymphoma
876037|NCT00002663|extranodal marginal zone B-cell lymphoma of mucosa-associated lymphoid tissue|extranodal marginal zone b-cell lymphoma of mucosa-associated lymphoid tissue
876038|NCT00002663|nodal marginal zone B-cell lymphoma|nodal marginal zone b-cell lymphoma
876039|NCT00002663|splenic marginal zone lymphoma|splenic marginal zone lymphoma
876040|NCT00002663|recurrent marginal zone lymphoma|recurrent marginal zone lymphoma
876041|NCT00002663|recurrent small lymphocytic lymphoma|recurrent small lymphocytic lymphoma
876042|NCT00002663|stage I marginal zone lymphoma|stage i marginal zone lymphoma
876043|NCT00002663|stage I small lymphocytic lymphoma|stage i small lymphocytic lymphoma
876044|NCT00002663|stage III small lymphocytic lymphoma|stage iii small lymphocytic lymphoma
876045|NCT00002663|stage III marginal zone lymphoma|stage iii marginal zone lymphoma
876046|NCT00002663|stage IV small lymphocytic lymphoma|stage iv small lymphocytic lymphoma
876047|NCT00002663|stage IV marginal zone lymphoma|stage iv marginal zone lymphoma
876048|NCT00002663|unspecified adult solid tumor, protocol specific|unspecified adult solid tumor, protocol specific
876049|NCT00002663|unspecified childhood solid tumor, protocol specific|unspecified childhood solid tumor, protocol specific
876050|NCT00002662|stage IV breast cancer|stage iv breast cancer
876051|NCT00002662|stage IIIA breast cancer|stage iiia breast cancer
876052|NCT00002662|recurrent breast cancer|recurrent breast cancer
876053|NCT00002662|stage IIIB breast cancer|stage iiib breast cancer
876054|NCT00002662|stage IIIC breast cancer|stage iiic breast cancer
876055|NCT00002651|adenocarcinoma of the prostate|adenocarcinoma of the prostate
876056|NCT00002651|stage IV prostate cancer|stage iv prostate cancer
876057|NCT00002651|recurrent prostate cancer|recurrent prostate cancer
876058|NCT00002647|recurrent adult brain tumor|recurrent adult brain tumor
876059|NCT00002647|tumors metastatic to brain|tumors metastatic to brain
876060|NCT00002647|recurrent childhood brain stem glioma|recurrent childhood brain stem glioma
876061|NCT00002647|recurrent childhood anaplastic astrocytoma|recurrent childhood anaplastic astrocytoma
876062|NCT00002647|recurrent childhood anaplastic oligoastrocytoma|recurrent childhood anaplastic oligoastrocytoma
876063|NCT00002647|recurrent childhood anaplastic oligodendroglioma|recurrent childhood anaplastic oligodendroglioma
876064|NCT00002647|recurrent childhood cerebellar astrocytoma|recurrent childhood cerebellar astrocytoma
876065|NCT00002647|recurrent childhood cerebral astrocytoma|recurrent childhood cerebral astrocytoma
876066|NCT00002647|recurrent childhood diffuse astrocytoma|recurrent childhood diffuse astrocytoma
876067|NCT00002647|recurrent childhood fibrillary astrocytoma|recurrent childhood fibrillary astrocytoma
876068|NCT00002647|recurrent childhood gemistocytic astrocytoma|recurrent childhood gemistocytic astrocytoma
876069|NCT00002647|recurrent childhood giant cell glioblastoma|recurrent childhood giant cell glioblastoma
876070|NCT00002647|recurrent childhood glioblastoma|recurrent childhood glioblastoma
876071|NCT00002647|recurrent childhood gliomatosis cerebri|recurrent childhood gliomatosis cerebri
876072|NCT00002647|recurrent childhood gliosarcoma|recurrent childhood gliosarcoma
876073|NCT00002647|recurrent childhood oligodendroglioma|recurrent childhood oligodendroglioma
876074|NCT00002647|recurrent childhood pilocytic astrocytoma|recurrent childhood pilocytic astrocytoma
876075|NCT00002647|recurrent childhood pilomyxoid astrocytoma|recurrent childhood pilomyxoid astrocytoma
876076|NCT00002647|recurrent childhood pleomorphic xanthoastrocytoma|recurrent childhood pleomorphic xanthoastrocytoma
876077|NCT00002647|recurrent childhood protoplasmic astrocytoma|recurrent childhood protoplasmic astrocytoma
876078|NCT00002647|recurrent childhood subependymal giant cell astrocytoma|recurrent childhood subependymal giant cell astrocytoma
876079|NCT00002647|recurrent childhood visual pathway and hypothalamic glioma|recurrent childhood visual pathway and hypothalamic glioma
876080|NCT00002647|recurrent childhood visual pathway glioma|recurrent childhood visual pathway glioma
876081|NCT00002647|recurrent childhood pineoblastoma|recurrent childhood pineoblastoma
876082|NCT00002647|recurrent childhood supratentorial primitive neuroectodermal tumor|recurrent childhood supratentorial primitive neuroectodermal tumor
876083|NCT00002647|recurrent childhood medulloblastoma|recurrent childhood medulloblastoma
876084|NCT00002647|recurrent childhood ependymoma|recurrent childhood ependymoma
876085|NCT00002647|recurrent childhood brain tumor|recurrent childhood brain tumor
876086|NCT00002647|adult anaplastic astrocytoma|adult anaplastic astrocytoma
876087|NCT00002647|adult anaplastic ependymoma|adult anaplastic ependymoma
876088|NCT00002647|adult anaplastic meningioma|adult anaplastic meningioma
876089|NCT00002647|adult anaplastic oligodendroglioma|adult anaplastic oligodendroglioma
876090|NCT00002647|adult brain stem glioma|adult brain stem glioma
876091|NCT00002647|adult central nervous system germ cell tumor|adult central nervous system germ cell tumor
876092|NCT00002647|adult choroid plexus tumor|adult choroid plexus tumor
876093|NCT00002647|adult craniopharyngioma|adult craniopharyngioma
876094|NCT00002647|adult diffuse astrocytoma|adult diffuse astrocytoma
876095|NCT00002647|adult ependymoblastoma|adult ependymoblastoma
876096|NCT00002647|adult ependymoma|adult ependymoma
876097|NCT00002647|adult giant cell glioblastoma|adult giant cell glioblastoma
876098|NCT00002647|adult glioblastoma|adult glioblastoma
876099|NCT00002647|adult gliosarcoma|adult gliosarcoma
876100|NCT00002647|adult medulloblastoma|adult medulloblastoma
876101|NCT00002647|meningeal melanocytoma|meningeal melanocytoma
876513|NCT00051857|Knee|knee
876102|NCT00002647|adult meningeal hemangiopericytoma|adult meningeal hemangiopericytoma
876103|NCT00002647|adult oligodendroglioma|adult oligodendroglioma
876104|NCT00002647|adult papillary meningioma|adult papillary meningioma
876105|NCT00002647|adult pilocytic astrocytoma|adult pilocytic astrocytoma
876106|NCT00002647|adult pineal gland astrocytoma|adult pineal gland astrocytoma
876107|NCT00002647|adult pineoblastoma|adult pineoblastoma
876108|NCT00002647|adult pineocytoma|adult pineocytoma
876109|NCT00002647|adult subependymal giant cell astrocytoma|adult subependymal giant cell astrocytoma
876110|NCT00002647|adult subependymoma|adult subependymoma
876111|NCT00002647|adult supratentorial primitive neuroectodermal tumor (PNET)|adult supratentorial primitive neuroectodermal tumor (pnet)
876112|NCT00002647|childhood grade I meningioma|childhood grade i meningioma
876113|NCT00002647|childhood grade II meningioma|childhood grade ii meningioma
876114|NCT00002647|childhood grade III meningioma|childhood grade iii meningioma
876115|NCT00002647|adult grade III meningioma|adult grade iii meningioma
876116|NCT00002647|childhood central nervous system germ cell tumor|childhood central nervous system germ cell tumor
876117|NCT00002647|childhood choroid plexus tumor|childhood choroid plexus tumor
876118|NCT00002647|childhood craniopharyngioma|childhood craniopharyngioma
876119|NCT00002647|childhood infratentorial ependymoma|childhood infratentorial ependymoma
876120|NCT00002647|childhood supratentorial ependymoma|childhood supratentorial ependymoma
876121|NCT00002647|childhood low-grade cerebral astrocytoma|childhood low-grade cerebral astrocytoma
876594|NCT00051285|heart|heart
876122|NCT00002647|childhood high-grade cerebral astrocytoma|childhood high-grade cerebral astrocytoma
876123|NCT00002641|adult angiosarcoma|adult angiosarcoma
876124|NCT00002641|adult fibrosarcoma|adult fibrosarcoma
876125|NCT00002641|adult leiomyosarcoma|adult leiomyosarcoma
876126|NCT00002641|adult liposarcoma|adult liposarcoma
876127|NCT00002641|adult neurofibrosarcoma|adult neurofibrosarcoma
876128|NCT00002641|adult synovial sarcoma|adult synovial sarcoma
876129|NCT00002641|stage III adult soft tissue sarcoma|stage iii adult soft tissue sarcoma
876130|NCT00002641|recurrent adult soft tissue sarcoma|recurrent adult soft tissue sarcoma
876131|NCT00002641|adult alveolar soft-part sarcoma|adult alveolar soft-part sarcoma
876132|NCT00002641|adult epithelioid sarcoma|adult epithelioid sarcoma
876133|NCT00002641|adult malignant fibrous histiocytoma|adult malignant fibrous histiocytoma
876134|NCT00002641|adult malignant hemangiopericytoma|adult malignant hemangiopericytoma
876135|NCT00002641|adult malignant mesenchymoma|adult malignant mesenchymoma
876136|NCT00002641|adult rhabdomyosarcoma|adult rhabdomyosarcoma
876137|NCT00002641|localized benign pheochromocytoma|localized benign pheochromocytoma
876138|NCT00002641|regional pheochromocytoma|regional pheochromocytoma
876139|NCT00002641|recurrent pheochromocytoma|recurrent pheochromocytoma
876140|NCT00002641|stage II uterine sarcoma|stage ii uterine sarcoma
876143|NCT00002641|uterine carcinosarcoma|uterine carcinosarcoma
876144|NCT00002641|uterine leiomyosarcoma|uterine leiomyosarcoma
876145|NCT00002641|endometrial stromal sarcoma|endometrial stromal sarcoma
876146|NCT00002641|ovarian sarcoma|ovarian sarcoma
876147|NCT00002641|clear cell sarcoma of the kidney|clear cell sarcoma of the kidney
876148|NCT00002641|stage II adult soft tissue sarcoma|stage ii adult soft tissue sarcoma
876149|NCT00002633|adenocarcinoma of the prostate|adenocarcinoma of the prostate
876150|NCT00002633|stage II prostate cancer|stage ii prostate cancer
876151|NCT00002633|stage III prostate cancer|stage iii prostate cancer
876152|NCT00002633|stage IV prostate cancer|stage iv prostate cancer
876153|NCT00002624|stage I non-small cell lung cancer|stage i non-small cell lung cancer
876154|NCT00002624|squamous cell lung cancer|squamous cell lung cancer
876155|NCT00002624|large cell lung cancer|large cell lung cancer
876156|NCT00002624|adenocarcinoma of the lung|adenocarcinoma of the lung
876157|NCT00002624|bronchoalveolar cell lung cancer|bronchoalveolar cell lung cancer
876158|NCT00002623|squamous cell lung cancer|squamous cell lung cancer
876159|NCT00002623|large cell lung cancer|large cell lung cancer
876160|NCT00002623|stage IIIA non-small cell lung cancer|stage iiia non-small cell lung cancer
876161|NCT00002623|adenocarcinoma of the lung|adenocarcinoma of the lung
876162|NCT00002623|adenosquamous cell lung cancer|adenosquamous cell lung cancer
876163|NCT00002623|bronchoalveolar cell lung cancer|bronchoalveolar cell lung cancer
876164|NCT00002615|stage II gastric cancer|stage ii gastric cancer
876165|NCT00002615|stage III gastric cancer|stage iii gastric cancer
876166|NCT00002615|adenocarcinoma of the stomach|adenocarcinoma of the stomach
876167|NCT00002611|stage I Wilms tumor|stage i wilms tumor
876168|NCT00002611|stage II Wilms tumor|stage ii wilms tumor
876169|NCT00002611|stage III Wilms tumor|stage iii wilms tumor
876170|NCT00002611|stage IV Wilms tumor|stage iv wilms tumor
876171|NCT00002611|stage V Wilms tumor|stage v wilms tumor
876172|NCT00002611|clear cell sarcoma of the kidney|clear cell sarcoma of the kidney
876173|NCT00002610|recurrent Wilms tumor and other childhood kidney tumors|recurrent wilms tumor and other childhood kidney tumors
876174|NCT00002610|clear cell sarcoma of the kidney|clear cell sarcoma of the kidney
876175|NCT00002610|rhabdoid tumor of the kidney|rhabdoid tumor of the kidney
876176|NCT00002608|childhood brain tumor|childhood brain tumor
876177|NCT00002608|childhood infratentorial ependymoma|childhood infratentorial ependymoma
876178|NCT00002608|childhood supratentorial ependymoma|childhood supratentorial ependymoma
876179|NCT00002608|recurrent adult soft tissue sarcoma|recurrent adult soft tissue sarcoma
876180|NCT00002608|recurrent childhood brain tumor|recurrent childhood brain tumor
876181|NCT00002608|childhood liver cancer|childhood liver cancer
876182|NCT00002608|stage IV childhood liver cancer|stage iv childhood liver cancer
876183|NCT00002608|recurrent childhood liver cancer|recurrent childhood liver cancer
876184|NCT00002608|advanced malignant mesothelioma|advanced malignant mesothelioma
876185|NCT00002608|recurrent malignant mesothelioma|recurrent malignant mesothelioma
876186|NCT00002608|localized unresectable adult primary liver cancer|localized unresectable adult primary liver cancer
876187|NCT00002608|advanced adult primary liver cancer|advanced adult primary liver cancer
876188|NCT00002608|recurrent adult primary liver cancer|recurrent adult primary liver cancer
876189|NCT00002608|recurrent adult brain tumor|recurrent adult brain tumor
876190|NCT00002608|stage IV adrenocortical carcinoma|stage iv adrenocortical carcinoma
876191|NCT00002608|recurrent adrenocortical carcinoma|recurrent adrenocortical carcinoma
876192|NCT00002608|stage IV papillary thyroid cancer|stage iv papillary thyroid cancer
876193|NCT00002608|stage IV follicular thyroid cancer|stage iv follicular thyroid cancer
876194|NCT00002608|thyroid gland medullary carcinoma|thyroid gland medullary carcinoma
876195|NCT00002608|anaplastic thyroid cancer|anaplastic thyroid cancer
876196|NCT00002608|recurrent thyroid cancer|recurrent thyroid cancer
876197|NCT00002608|adult brain stem glioma|adult brain stem glioma
876198|NCT00002608|adult medulloblastoma|adult medulloblastoma
876199|NCT00002608|adult glioblastoma|adult glioblastoma
876200|NCT00002608|metastatic pheochromocytoma|metastatic pheochromocytoma
876201|NCT00002608|recurrent pheochromocytoma|recurrent pheochromocytoma
876202|NCT00002608|childhood soft tissue sarcoma|childhood soft tissue sarcoma
876203|NCT00002608|metastatic childhood soft tissue sarcoma|metastatic childhood soft tissue sarcoma
876204|NCT00002608|recurrent childhood soft tissue sarcoma|recurrent childhood soft tissue sarcoma
876205|NCT00002608|childhood high-grade cerebral astrocytoma|childhood high-grade cerebral astrocytoma
876206|NCT00002608|childhood oligodendroglioma|childhood oligodendroglioma
876207|NCT00002608|adult anaplastic astrocytoma|adult anaplastic astrocytoma
876208|NCT00002608|adult myxopapillary ependymoma|adult myxopapillary ependymoma
876209|NCT00002608|adult anaplastic ependymoma|adult anaplastic ependymoma
876210|NCT00002608|adult anaplastic oligodendroglioma|adult anaplastic oligodendroglioma
876211|NCT00002608|adult mixed glioma|adult mixed glioma
876212|NCT00002608|adult pilocytic astrocytoma|adult pilocytic astrocytoma
876213|NCT00002608|adult subependymoma|adult subependymoma
876214|NCT00002608|recurrent childhood brain stem glioma|recurrent childhood brain stem glioma
876215|NCT00002608|recurrent childhood cerebellar astrocytoma|recurrent childhood cerebellar astrocytoma
876216|NCT00002608|recurrent childhood cerebral astrocytoma|recurrent childhood cerebral astrocytoma
876217|NCT00002608|recurrent childhood medulloblastoma|recurrent childhood medulloblastoma
876348|NCT00002515|recurrent ovarian germ cell tumor|recurrent ovarian germ cell tumor
876218|NCT00002608|recurrent childhood visual pathway and hypothalamic glioma|recurrent childhood visual pathway and hypothalamic glioma
876219|NCT00002608|recurrent childhood ependymoma|recurrent childhood ependymoma
876220|NCT00002608|stage IV adult soft tissue sarcoma|stage iv adult soft tissue sarcoma
876221|NCT00002608|adult oligodendroglioma|adult oligodendroglioma
876222|NCT00002608|adult giant cell glioblastoma|adult giant cell glioblastoma
876223|NCT00002608|adult gliosarcoma|adult gliosarcoma
876224|NCT00002608|adult diffuse astrocytoma|adult diffuse astrocytoma
876225|NCT00002598|relapsing chronic myelogenous leukemia|relapsing chronic myelogenous leukemia
876226|NCT00002598|blastic phase chronic myelogenous leukemia|blastic phase chronic myelogenous leukemia
876227|NCT00002598|atypical chronic myeloid leukemia, BCR-ABL1 negative|atypical chronic myeloid leukemia, bcr-abl1 negative
876228|NCT00002596|stage II malignant testicular germ cell tumor|stage ii malignant testicular germ cell tumor
876229|NCT00002596|stage III malignant testicular germ cell tumor|stage iii malignant testicular germ cell tumor
876230|NCT00002596|testicular seminoma|testicular seminoma
876231|NCT00002596|testicular embryonal carcinoma|testicular embryonal carcinoma
876232|NCT00002596|testicular choriocarcinoma|testicular choriocarcinoma
876233|NCT00002596|testicular teratoma|testicular teratoma
876234|NCT00002596|testicular yolk sac tumor|testicular yolk sac tumor
876235|NCT00002596|testicular embryonal carcinoma and teratoma|testicular embryonal carcinoma and teratoma
876236|NCT00002596|testicular embryonal carcinoma and teratoma with seminoma|testicular embryonal carcinoma and teratoma with seminoma
876237|NCT00002596|testicular embryonal carcinoma and yolk sac tumor|testicular embryonal carcinoma and yolk sac tumor
876238|NCT00002596|testicular embryonal carcinoma and yolk sac tumor with seminoma|testicular embryonal carcinoma and yolk sac tumor with seminoma
876239|NCT00002596|testicular embryonal carcinoma and seminoma|testicular embryonal carcinoma and seminoma
876240|NCT00002596|testicular yolk sac tumor and teratoma|testicular yolk sac tumor and teratoma
876241|NCT00002596|testicular yolk sac tumor and teratoma with seminoma|testicular yolk sac tumor and teratoma with seminoma
876242|NCT00002596|testicular choriocarcinoma and yolk sac tumor|testicular choriocarcinoma and yolk sac tumor
876243|NCT00002596|testicular choriocarcinoma and embryonal carcinoma|testicular choriocarcinoma and embryonal carcinoma
876244|NCT00002596|testicular choriocarcinoma and teratoma|testicular choriocarcinoma and teratoma
876245|NCT00002596|testicular choriocarcinoma and seminoma|testicular choriocarcinoma and seminoma
876246|NCT00002596|extragonadal germ cell tumor|extragonadal germ cell tumor
876247|NCT00002596|childhood teratoma|childhood teratoma
876248|NCT00002596|childhood malignant testicular germ cell tumor|childhood malignant testicular germ cell tumor
876249|NCT00002596|childhood extragonadal germ cell tumor|childhood extragonadal germ cell tumor
876250|NCT00002594|recurrent childhood brain tumor|recurrent childhood brain tumor
876251|NCT00002594|childhood central nervous system germ cell tumor|childhood central nervous system germ cell tumor
876252|NCT00002594|recurrent childhood medulloblastoma|recurrent childhood medulloblastoma
876253|NCT00002589|stage III renal cell cancer|stage iii renal cell cancer
876254|NCT00002589|stage IV renal cell cancer|stage iv renal cell cancer
876255|NCT00002589|recurrent renal cell cancer|recurrent renal cell cancer
876256|NCT00002586|non-small cell lung cancer|non-small cell lung cancer
876257|NCT00002586|small cell lung cancer|small cell lung cancer
876258|NCT00002586|drug/agent toxicity by tissue/organ|drug/agent toxicity by tissue/organ
876259|NCT00002569|adult anaplastic oligodendroglioma|adult anaplastic oligodendroglioma
876260|NCT00002569|adult mixed glioma|adult mixed glioma
876261|NCT00002560|recurrent neuroblastoma|recurrent neuroblastoma
876262|NCT00002558|recurrent malignant testicular germ cell tumor|recurrent malignant testicular germ cell tumor
876263|NCT00002558|recurrent ovarian germ cell tumor|recurrent ovarian germ cell tumor
876264|NCT00002558|extragonadal germ cell tumor|extragonadal germ cell tumor
876265|NCT00002546|stage I uterine sarcoma|stage i uterine sarcoma
876266|NCT00002546|stage II uterine sarcoma|stage ii uterine sarcoma
876267|NCT00002546|stage III uterine sarcoma|stage iii uterine sarcoma
876268|NCT00002546|stage IV uterine sarcoma|stage iv uterine sarcoma
876269|NCT00002546|uterine carcinosarcoma|uterine carcinosarcoma
876270|NCT00002544|stage IV breast cancer|stage iv breast cancer
876271|NCT00002544|recurrent breast cancer|recurrent breast cancer
876272|NCT00002528|stage I breast cancer|stage i breast cancer
876273|NCT00002528|stage II breast cancer|stage ii breast cancer
876274|NCT00002523|stage II rectal cancer|stage ii rectal cancer
876275|NCT00002523|stage III rectal cancer|stage iii rectal cancer
876276|NCT00002523|adenocarcinoma of the rectum|adenocarcinoma of the rectum
876277|NCT00002522|stage I adult Hodgkin lymphoma|stage i adult hodgkin lymphoma
876278|NCT00002522|stage II adult Hodgkin lymphoma|stage ii adult hodgkin lymphoma
876279|NCT00002522|stage III adult Hodgkin lymphoma|stage iii adult hodgkin lymphoma
876280|NCT00002522|stage IV adult Hodgkin lymphoma|stage iv adult hodgkin lymphoma
876281|NCT00002522|recurrent adult Hodgkin lymphoma|recurrent adult hodgkin lymphoma
876282|NCT00002521|stage I adult diffuse small cleaved cell lymphoma|stage i adult diffuse small cleaved cell lymphoma
876283|NCT00002521|stage I adult diffuse mixed cell lymphoma|stage i adult diffuse mixed cell lymphoma
876284|NCT00002521|stage I adult diffuse large cell lymphoma|stage i adult diffuse large cell lymphoma
876285|NCT00002521|stage I adult immunoblastic large cell lymphoma|stage i adult immunoblastic large cell lymphoma
876286|NCT00002521|stage I adult lymphoblastic lymphoma|stage i adult lymphoblastic lymphoma
876287|NCT00002521|stage I adult Burkitt lymphoma|stage i adult burkitt lymphoma
876628|NCT00051155|OHT|oht
876288|NCT00002521|stage III adult diffuse small cleaved cell lymphoma|stage iii adult diffuse small cleaved cell lymphoma
876289|NCT00002521|stage III adult diffuse mixed cell lymphoma|stage iii adult diffuse mixed cell lymphoma
876290|NCT00002521|stage III adult diffuse large cell lymphoma|stage iii adult diffuse large cell lymphoma
876291|NCT00002521|stage III adult immunoblastic large cell lymphoma|stage iii adult immunoblastic large cell lymphoma
876292|NCT00002521|stage III adult lymphoblastic lymphoma|stage iii adult lymphoblastic lymphoma
876293|NCT00002521|stage III adult Burkitt lymphoma|stage iii adult burkitt lymphoma
876294|NCT00002521|stage IV adult diffuse small cleaved cell lymphoma|stage iv adult diffuse small cleaved cell lymphoma
876295|NCT00002521|stage IV adult diffuse mixed cell lymphoma|stage iv adult diffuse mixed cell lymphoma
876296|NCT00002521|stage IV adult diffuse large cell lymphoma|stage iv adult diffuse large cell lymphoma
876297|NCT00002521|stage IV adult immunoblastic large cell lymphoma|stage iv adult immunoblastic large cell lymphoma
876298|NCT00002521|stage IV adult lymphoblastic lymphoma|stage iv adult lymphoblastic lymphoma
876299|NCT00002521|stage IV adult Burkitt lymphoma|stage iv adult burkitt lymphoma
876300|NCT00002521|recurrent adult diffuse small cleaved cell lymphoma|recurrent adult diffuse small cleaved cell lymphoma
876301|NCT00002521|recurrent adult diffuse mixed cell lymphoma|recurrent adult diffuse mixed cell lymphoma
876302|NCT00002521|recurrent adult diffuse large cell lymphoma|recurrent adult diffuse large cell lymphoma
876303|NCT00002521|recurrent adult immunoblastic large cell lymphoma|recurrent adult immunoblastic large cell lymphoma
876304|NCT00002521|recurrent adult lymphoblastic lymphoma|recurrent adult lymphoblastic lymphoma
876305|NCT00002521|recurrent adult Burkitt lymphoma|recurrent adult burkitt lymphoma
876306|NCT00002521|contiguous stage II adult diffuse small cleaved cell lymphoma|contiguous stage ii adult diffuse small cleaved cell lymphoma
876307|NCT00002521|contiguous stage II adult diffuse mixed cell lymphoma|contiguous stage ii adult diffuse mixed cell lymphoma
876308|NCT00002521|contiguous stage II adult immunoblastic large cell lymphoma|contiguous stage ii adult immunoblastic large cell lymphoma
876309|NCT00002521|contiguous stage II adult diffuse large cell lymphoma|contiguous stage ii adult diffuse large cell lymphoma
876310|NCT00002521|contiguous stage II adult Burkitt lymphoma|contiguous stage ii adult burkitt lymphoma
876311|NCT00002521|contiguous stage II adult lymphoblastic lymphoma|contiguous stage ii adult lymphoblastic lymphoma
876312|NCT00002521|noncontiguous stage II adult diffuse small cleaved cell lymphoma|noncontiguous stage ii adult diffuse small cleaved cell lymphoma
876313|NCT00002521|noncontiguous stage II adult diffuse mixed cell lymphoma|noncontiguous stage ii adult diffuse mixed cell lymphoma
876314|NCT00002521|noncontiguous stage II adult immunoblastic large cell lymphoma|noncontiguous stage ii adult immunoblastic large cell lymphoma
876315|NCT00002521|noncontiguous stage II adult diffuse large cell lymphoma|noncontiguous stage ii adult diffuse large cell lymphoma
876316|NCT00002521|noncontiguous stage II adult Burkitt lymphoma|noncontiguous stage ii adult burkitt lymphoma
876317|NCT00002521|noncontiguous stage II adult lymphoblastic lymphoma|noncontiguous stage ii adult lymphoblastic lymphoma
876318|NCT00002517|childhood myelodysplastic syndromes|childhood myelodysplastic syndromes
876319|NCT00002517|untreated childhood acute myeloid leukemia and other myeloid malignancies|untreated childhood acute myeloid leukemia and other myeloid malignancies
876320|NCT00002517|childhood acute myeloblastic leukemia without maturation (M1)|childhood acute myeloblastic leukemia without maturation (m1)
876321|NCT00002517|childhood acute myeloblastic leukemia with maturation (M2)|childhood acute myeloblastic leukemia with maturation (m2)
876322|NCT00002517|childhood acute myelomonocytic leukemia (M4)|childhood acute myelomonocytic leukemia (m4)
876323|NCT00002517|childhood acute monoblastic leukemia (M5a)|childhood acute monoblastic leukemia (m5a)
876324|NCT00002517|childhood acute monocytic leukemia (M5b)|childhood acute monocytic leukemia (m5b)
876325|NCT00002517|childhood acute erythroleukemia (M6)|childhood acute erythroleukemia (m6)
876326|NCT00002517|childhood acute megakaryocytic leukemia (M7)|childhood acute megakaryocytic leukemia (m7)
876327|NCT00002517|refractory anemia with excess blasts|refractory anemia with excess blasts
876328|NCT00002517|refractory anemia with excess blasts in transformation|refractory anemia with excess blasts in transformation
876329|NCT00002517|chronic myelomonocytic leukemia|chronic myelomonocytic leukemia
876330|NCT00002517|de novo myelodysplastic syndromes|de novo myelodysplastic syndromes
876331|NCT00002517|childhood acute minimally differentiated myeloid leukemia (M0)|childhood acute minimally differentiated myeloid leukemia (m0)
876332|NCT00002515|chondrosarcoma|chondrosarcoma
876333|NCT00002515|recurrent childhood rhabdomyosarcoma|recurrent childhood rhabdomyosarcoma
876334|NCT00002515|stage IV childhood liver cancer|stage iv childhood liver cancer
876335|NCT00002515|recurrent neuroblastoma|recurrent neuroblastoma
876336|NCT00002515|recurrent childhood liver cancer|recurrent childhood liver cancer
876337|NCT00002515|recurrent Wilms tumor and other childhood kidney tumors|recurrent wilms tumor and other childhood kidney tumors
876338|NCT00002515|stage IV Wilms tumor|stage iv wilms tumor
876339|NCT00002515|recurrent retinoblastoma|recurrent retinoblastoma
876340|NCT00002515|stage IV childhood lymphoblastic lymphoma|stage iv childhood lymphoblastic lymphoma
876341|NCT00002515|recurrent childhood lymphoblastic lymphoma|recurrent childhood lymphoblastic lymphoma
876342|NCT00002515|recurrent osteosarcoma|recurrent osteosarcoma
876343|NCT00002515|stage IV ovarian germ cell tumor|stage iv ovarian germ cell tumor
876344|NCT00002515|recurrent malignant testicular germ cell tumor|recurrent malignant testicular germ cell tumor
876345|NCT00002515|childhood germ cell tumor|childhood germ cell tumor
876346|NCT00002515|alveolar childhood rhabdomyosarcoma|alveolar childhood rhabdomyosarcoma
876347|NCT00002515|recurrent childhood soft tissue sarcoma|recurrent childhood soft tissue sarcoma
876629|NCT00051142|Glaucoma|glaucoma
876349|NCT00002515|childhood fibrosarcoma|childhood fibrosarcoma
876350|NCT00002515|extragonadal germ cell tumor|extragonadal germ cell tumor
876351|NCT00002515|childhood desmoplastic small round cell tumor|childhood desmoplastic small round cell tumor
876352|NCT00002515|recurrent childhood small noncleaved cell lymphoma|recurrent childhood small noncleaved cell lymphoma
876353|NCT00002515|stage IV childhood small noncleaved cell lymphoma|stage iv childhood small noncleaved cell lymphoma
876354|NCT00002515|recurrent childhood large cell lymphoma|recurrent childhood large cell lymphoma
876355|NCT00002515|stage IV childhood large cell lymphoma|stage iv childhood large cell lymphoma
876356|NCT00002515|recurrent Ewing sarcoma/peripheral primitive neuroectodermal tumor|recurrent ewing sarcoma/peripheral primitive neuroectodermal tumor
876357|NCT00002515|stage IV lymphoepithelioma of the nasopharynx|stage iv lymphoepithelioma of the nasopharynx
876358|NCT00002515|stage IV squamous cell carcinoma of the nasopharynx|stage iv squamous cell carcinoma of the nasopharynx
876359|NCT00002515|recurrent squamous cell carcinoma of the nasopharynx|recurrent squamous cell carcinoma of the nasopharynx
876360|NCT00002515|recurrent lymphoepithelioma of the nasopharynx|recurrent lymphoepithelioma of the nasopharynx
876361|NCT00002514|adult acute lymphoblastic leukemia in remission|adult acute lymphoblastic leukemia in remission
876362|NCT00002511|adenocarcinoma of the prostate|adenocarcinoma of the prostate
876363|NCT00002511|stage I prostate cancer|stage i prostate cancer
876364|NCT00002511|stage IIB prostate cancer|stage iib prostate cancer
876365|NCT00002511|stage IIA prostate cancer|stage iia prostate cancer
876366|NCT00002511|stage III prostate cancer|stage iii prostate cancer
876367|NCT00002490|stage I bladder cancer|stage i bladder cancer
876368|NCT00002490|transitional cell carcinoma of the bladder|transitional cell carcinoma of the bladder
876369|NCT00002484|stage I non-small cell lung cancer|stage i non-small cell lung cancer
876370|NCT00002484|stage II non-small cell lung cancer|stage ii non-small cell lung cancer
876371|NCT00002484|stage IIIA non-small cell lung cancer|stage iiia non-small cell lung cancer
876372|NCT00002484|stage IIIB non-small cell lung cancer|stage iiib non-small cell lung cancer
876373|NCT00002475|stage III colon cancer|stage iii colon cancer
876374|NCT00002475|stage IV colon cancer|stage iv colon cancer
876375|NCT00002475|stage IV breast cancer|stage iv breast cancer
876376|NCT00002475|stage IIIA breast cancer|stage iiia breast cancer
876377|NCT00002475|recurrent breast cancer|recurrent breast cancer
876378|NCT00002475|stage IIIB breast cancer|stage iiib breast cancer
876379|NCT00002475|recurrent non-small cell lung cancer|recurrent non-small cell lung cancer
876380|NCT00002475|stage II pancreatic cancer|stage ii pancreatic cancer
876381|NCT00002475|stage III pancreatic cancer|stage iii pancreatic cancer
876382|NCT00002475|recurrent pancreatic cancer|recurrent pancreatic cancer
876383|NCT00002475|recurrent colon cancer|recurrent colon cancer
876384|NCT00002475|stage III renal cell cancer|stage iii renal cell cancer
876385|NCT00002475|stage IV renal cell cancer|stage iv renal cell cancer
876386|NCT00002475|recurrent renal cell cancer|recurrent renal cell cancer
876387|NCT00002475|extensive stage small cell lung cancer|extensive stage small cell lung cancer
876388|NCT00002475|recurrent small cell lung cancer|recurrent small cell lung cancer
876389|NCT00002475|stage IIIA non-small cell lung cancer|stage iiia non-small cell lung cancer
876390|NCT00002475|stage IIIB non-small cell lung cancer|stage iiib non-small cell lung cancer
876391|NCT00002475|stage IIIC breast cancer|stage iiic breast cancer
876392|NCT00002475|stage IV non-small cell lung cancer|stage iv non-small cell lung cancer
876393|NCT00002475|pulmonary carcinoid tumor|pulmonary carcinoid tumor
876394|NCT00002475|recurrent malignant mesothelioma|recurrent malignant mesothelioma
876395|NCT00002475|stage IV pancreatic cancer|stage iv pancreatic cancer
876396|NCT00002474|recurrent ovarian epithelial cancer|recurrent ovarian epithelial cancer
876397|NCT00002473|stage I renal cell cancer|stage i renal cell cancer
876514|NCT00051857|Motion|motion
876398|NCT00002473|stage II renal cell cancer|stage ii renal cell cancer
876399|NCT00002472|childhood central nervous system germ cell tumor|childhood central nervous system germ cell tumor
876400|NCT00002472|extragonadal germ cell tumor|extragonadal germ cell tumor
876401|NCT00002472|adult central nervous system germ cell tumor|adult central nervous system germ cell tumor
876402|NCT00002472|childhood teratoma|childhood teratoma
876403|NCT00002472|childhood central nervous system choriocarcinoma|childhood central nervous system choriocarcinoma
876404|NCT00002472|childhood central nervous system embryonal tumor|childhood central nervous system embryonal tumor
876405|NCT00002472|childhood central nervous system germinoma|childhood central nervous system germinoma
876406|NCT00002472|childhood central nervous system mixed germ cell tumor|childhood central nervous system mixed germ cell tumor
876407|NCT00002472|childhood central nervous system teratoma|childhood central nervous system teratoma
876408|NCT00002472|childhood central nervous system yolk sac tumor|childhood central nervous system yolk sac tumor
876409|NCT00002470|metastatic gastrointestinal carcinoid tumor|metastatic gastrointestinal carcinoid tumor
876410|NCT00002470|recurrent gastrointestinal carcinoid tumor|recurrent gastrointestinal carcinoid tumor
876411|NCT00002470|pulmonary carcinoid tumor|pulmonary carcinoid tumor
876412|NCT00002455|stage I colon cancer|stage i colon cancer
876413|NCT00002455|stage II colon cancer|stage ii colon cancer
876414|NCT00002455|stage III colon cancer|stage iii colon cancer
876415|NCT00002455|stage I breast cancer|stage i breast cancer
876416|NCT00002455|stage II breast cancer|stage ii breast cancer
876417|NCT00002455|stage IIIA breast cancer|stage iiia breast cancer
876418|NCT00002455|recurrent breast cancer|recurrent breast cancer
876419|NCT00002455|recurrent colon cancer|recurrent colon cancer
876420|NCT00002455|stage I melanoma|stage i melanoma
876421|NCT00002455|stage II melanoma|stage ii melanoma
876422|NCT00002455|stage III melanoma|stage iii melanoma
876423|NCT00002455|recurrent melanoma|recurrent melanoma
876424|NCT00052143|Huntington's disease|huntington's disease
876425|NCT00052143|HD|hd
876426|NCT00052143|Huntington disease|huntington disease
876427|NCT00051818|chronic HIV infection|chronic hiv infection
876428|NCT00051818|treatment interruption|treatment interruption
876429|NCT00051818|HIV-specific immune response|hiv-specific immune response
876430|NCT00051818|immune response|immune response
876431|NCT00051818|virological response|virological response
876432|NCT00051818|treatment experienced|treatment experienced
876433|NCT00052091|Geriatrics|geriatrics
876434|NCT00052078|Phobic Disorders|phobic disorders
876435|NCT00052078|Anxiety, Separation|anxiety, separation
876436|NCT00052052|idiopathic pulmonary fibrosis|idiopathic pulmonary fibrosis
876437|NCT00052052|IPF|ipf
876438|NCT00052026|Adolescent|adolescent
876439|NCT00052026|Adrenergic alpha-Antagonists/therapeutic use|adrenergic alpha-antagonists/therapeutic use
876440|NCT00052026|Adrenergic alpha-Antagonists/pharmacokinetics|adrenergic alpha-antagonists/pharmacokinetics
876441|NCT00052026|Adrenergic alpha-Antagonists/administration & dosage|adrenergic alpha-antagonists/administration & dosage
876442|NCT00052026|Adrenergic beta-Antagonists/therapeutic use|adrenergic beta-antagonists/therapeutic use
876443|NCT00052026|Adrenergic beta-Antagonists/pharmacokinetics|adrenergic beta-antagonists/pharmacokinetics
876444|NCT00052026|Adrenergic beta-Antagonists/administration & dosage|adrenergic beta-antagonists/administration & dosage
876445|NCT00052026|Age Factors|age factors
876446|NCT00052026|Carbazoles/therapeutic use|carbazoles/therapeutic use
876447|NCT00052026|Carbazoles/administration & dosage|carbazoles/administration & dosage
876448|NCT00052026|Child|child
876449|NCT00052026|Child, Preschool|child, preschool
876450|NCT00052026|Drug Administration Schedule|drug administration schedule
876451|NCT00052026|Female|female
876452|NCT00052026|Heart Failure, Congestive/etiology|heart failure, congestive/etiology
876453|NCT00052026|Heart Failure, Congestive/drug therapy|heart failure, congestive/drug therapy
876454|NCT00052026|Heart Failure, Congestive/blood|heart failure, congestive/blood
876455|NCT00052026|Human|human
876456|NCT00052026|Infant|infant
876457|NCT00052026|Infant, Newborn|infant, newborn
876458|NCT00052026|Male|male
876459|NCT00052026|Natriuretic Peptide, Brain/blood|natriuretic peptide, brain/blood
876460|NCT00052026|Placebos|placebos
876461|NCT00052026|Propanolamines/therapeutic use|propanolamines/therapeutic use
876462|NCT00052026|Propanolamines/administration & dosage|propanolamines/administration & dosage
876463|NCT00052026|Prospective Studies|prospective studies
876464|NCT00052026|Support, Non-U.S. Gov't|support, non-u.s. gov't
876465|NCT00052026|Treatment Outcome|treatment outcome
876466|NCT00052026|Ventricular Dysfunction/drug therapy|ventricular dysfunction/drug therapy
876467|NCT00052026|Ventricular Dysfunction/complications|ventricular dysfunction/complications
876468|NCT00052026|Ventricular Dysfunction/blood|ventricular dysfunction/blood
876469|NCT00052026|Ventricular Function/drug effects|ventricular function/drug effects
876470|NCT00052026|Ventricular Remodeling/drug effects|ventricular remodeling/drug effects
876471|NCT00052039|idiopathic pulmonary fibrosis|idiopathic pulmonary fibrosis
876472|NCT00052013|von Hippel-Lindau disease,|von hippel-lindau disease,
876473|NCT00052013|CNS,|cns,
876474|NCT00052013|hemangioblastoma,|hemangioblastoma,
876475|NCT00052013|retinal|retinal
876476|NCT00051935|Glycogen Storage Disease Type II|glycogen storage disease type ii
876477|NCT00051935|GSD-II|gsd-ii
876478|NCT00051935|Pompe Disease|pompe disease
876479|NCT00051922|HIV Preventive Vaccine|hiv preventive vaccine
876480|NCT00051922|HIV Seronegativity|hiv seronegativity
876481|NCT00051961|Dopamine|dopamine
876482|NCT00051961|Spinal Physiology|spinal physiology
876483|NCT00051961|Flexor Reflex|flexor reflex
876485|NCT00051961|Motor Control|motor control
876486|NCT00051961|Dopaminergic|dopaminergic
876487|NCT00051961|Restless Legs|restless legs
876488|NCT00051909|Alzheimer's Disease|alzheimer's disease
876489|NCT00051844|HIV|hiv
876490|NCT00051844|NNRTI Failure|nnrti failure
876491|NCT00051844|HIV Infections|hiv infections
876492|NCT00051831|Treatment Naive|treatment naive
876493|NCT00051831|HIV-1|hiv-1
876494|NCT00051831|Virus Replication|virus replication
876495|NCT00051831|CD4-Positive T-Lymphocytes|cd4-positive t-lymphocytes
876496|NCT00051831|Immunologic Memory|immunologic memory
876497|NCT00051831|Pentafuside|pentafuside
876498|NCT00051831|Anti-HIV Agents|anti-hiv agents
876499|NCT00051831|Drug Therapy, Combination|drug therapy, combination
876500|NCT00051831|Saquinavir|saquinavir
876501|NCT00051831|Ritonavir|ritonavir
876502|NCT00051831|Tenofovir Disoproxil Fumarate|tenofovir disoproxil fumarate
876503|NCT00051831|RNA, Viral|rna, viral
876504|NCT00051831|Viral Load|viral load
876505|NCT00051831|Fusion Inhibitors|fusion inhibitors
876506|NCT00051831|Entry Inhibitors|entry inhibitors
876507|NCT00051870|Verbal Memory|verbal memory
876508|NCT00051870|Inhibition|inhibition
876509|NCT00051870|Transcranial Magnetic Stimulation|transcranial magnetic stimulation
876510|NCT00051870|Cortical Excitability|cortical excitability
876511|NCT00051870|Nonverbal Memory|nonverbal memory
876512|NCT00051857|Patello-Femoral|patello-femoral
876515|NCT00051857|MRI|mri
876516|NCT00051857|Kinematics|kinematics
876517|NCT00051805|Patient Compliance|patient compliance
876518|NCT00051805|Adherence|adherence
876519|NCT00051805|Treatment Experienced|treatment experienced
876520|NCT00051779|CAL|cal
876521|NCT00051779|Parathyroid hormone-related protein (PTHrP)|parathyroid hormone-related protein (pthrp)
876522|NCT00051779|Breast Cancer|breast cancer
876523|NCT00051779|Bone Metastasis|bone metastasis
876524|NCT00051779|Hypercalcemia|hypercalcemia
876525|NCT00051766|compliance|compliance
876526|NCT00051766|medication|medication
876527|NCT00051766|antiretroviral|antiretroviral
876528|NCT00051766|adherence|adherence
876529|NCT00051766|intervention|intervention
876530|NCT00051766|treatment experienced|treatment experienced
876531|NCT00051753|Otitis Media|otitis media
876532|NCT00051753|Acute Otitis Media|acute otitis media
876533|NCT00051753|ear infection|ear infection
876534|NCT00051753|levofloxacin|levofloxacin
876535|NCT00051753|amoxicillin|amoxicillin
876536|NCT00051753|clavulanate|clavulanate
876537|NCT00051701|Non-Hodgkins lymphoma|non-hodgkins lymphoma
876538|NCT00051701|NHL|nhl
876539|NCT00051701|Campath|campath
876540|NCT00051701|alemtuzumab|alemtuzumab
876541|NCT00051675|adenocarcinoma|adenocarcinoma
876542|NCT00051675|monoclonal antibody|monoclonal antibody
876543|NCT00051636|Bisphosphonate|bisphosphonate
876544|NCT00051636|SAP|sap
876545|NCT00051636|SAP excess|sap excess
876546|NCT00051636|non-inferiority|non-inferiority
876547|NCT00051636|therapeutic response|therapeutic response
876548|NCT00051636|extended observation period|extended observation period
876549|NCT00051623|Psoriatic arthritis|psoriatic arthritis
876550|NCT00051623|Infliximab|infliximab
876551|NCT00051623|Remicade|remicade
876552|NCT00051571|Carcinoma, Non-Small-Cell Lung|carcinoma, non-small-cell lung
876553|NCT00051428|Fibromyalgia, Reiki, Energy Medicine|fibromyalgia, reiki, energy medicine
876554|NCT00051415|Flaxseed|flaxseed
876555|NCT00051415|Cholesterol|cholesterol
876556|NCT00051402|Postmenopausal|postmenopausal
876557|NCT00051402|Memory Loss|memory loss
876558|NCT00051402|Cognition|cognition
876559|NCT00051402|Phytoestrogens|phytoestrogens
876560|NCT00051545|liver|liver
876561|NCT00051545|cancer|cancer
876562|NCT00051545|hepatocellular|hepatocellular
876563|NCT00051545|carcinoma|carcinoma
876564|NCT00051532|hepatocellular|hepatocellular
876565|NCT00051532|carcinoma|carcinoma
876566|NCT00051532|liver|liver
876567|NCT00051532|cancer|cancer
876568|NCT00051493|Non-Small Cell Lung Cancer|non-small cell lung cancer
876569|NCT00051493|Lung Cancer|lung cancer
876570|NCT00051493|NSCLC|nsclc
876571|NCT00051493|Advanced Non-Small Cell Lung Cancer|advanced non-small cell lung cancer
876572|NCT00051519|HIV|hiv
876573|NCT00051519|AIDS|aids
876574|NCT00051519|Vaccine|vaccine
876575|NCT00051519|HIV-positive|hiv-positive
876576|NCT00051519|Therapy|therapy
876577|NCT00051454|HIV Seronegativity|hiv seronegativity
876578|NCT00051454|HIV Preventive Vaccine|hiv preventive vaccine
876579|NCT00051441|stomatitis|stomatitis
876580|NCT00051441|radiation effects|radiation effects
876581|NCT00051363|Obstructive Sleep Apnea|obstructive sleep apnea
876582|NCT00051337|Kinesiogenic|kinesiogenic
876583|NCT00051337|Psychogenic|psychogenic
876584|NCT00051337|Channelopathy|channelopathy
876585|NCT00051337|Ictal|ictal
876586|NCT00051337|Paroxysmal Dyskinesia|paroxysmal dyskinesia
876587|NCT00051337|Psychogenic Movement Disorders|psychogenic movement disorders
876588|NCT00051337|Single Photon Emission|single photon emission
876589|NCT00051337|Computed Tomography (SPECT)|computed tomography (spect)
876590|NCT00051324|Huntington's disease|huntington's disease
876591|NCT00051324|Huntington disease|huntington disease
876592|NCT00051324|HD|hd
876598|NCT00051285|phosphodiesterase|phosphodiesterase
876599|NCT00051285|inhibitor|inhibitor
876600|NCT00051311|Lymphoma|lymphoma
876601|NCT00051311|Leukemia|leukemia
876602|NCT00051311|Hodgkin's Disease|hodgkin's disease
876603|NCT00051311|Multiple Myeloma|multiple myeloma
876604|NCT00051311|Immunotherapy|immunotherapy
876605|NCT00051272|depression, sexual dysfunction, orgasm disorder, MDD|depression, sexual dysfunction, orgasm disorder, mdd
876606|NCT00051259|depression|depression
876607|NCT00051259|MDD|mdd
876608|NCT00051259|sexual dysfunction|sexual dysfunction
876609|NCT00051259|orgasm disorder|orgasm disorder
876610|NCT00051207|Mood Disorders|mood disorders
876611|NCT00051207|Psychotherapy|psychotherapy
876612|NCT00051207|Comorbidity|comorbidity
876613|NCT00051194|Glaucoma|glaucoma
876614|NCT00051194|POAG|poag
876615|NCT00051194|OAG|oag
876616|NCT00051194|OHT|oht
876617|NCT00051181|Glaucoma|glaucoma
876618|NCT00051181|POAG|poag
876619|NCT00051181|OAG|oag
876620|NCT00051181|OHT|oht
876621|NCT00051168|Glaucoma|glaucoma
876622|NCT00051168|POAG|poag
876623|NCT00051168|OAG|oag
876624|NCT00051168|OHT|oht
876625|NCT00051155|Glaucoma|glaucoma
876626|NCT00051155|POAG|poag
876627|NCT00051155|OAG|oag
876634|NCT00051129|anecortave acetate|anecortave acetate
876635|NCT00051129|wet AMD|wet amd
876636|NCT00051129|age-related macular degeneration|age-related macular degeneration
876637|NCT00051129|Macular Degeneration|macular degeneration
876638|NCT00051129|Maculopathy, Age-Related|maculopathy, age-related
876639|NCT00051129|Age-Related Maculopathies|age-related maculopathies
876640|NCT00051129|Age-Related Maculopathy|age-related maculopathy
876641|NCT00051129|Maculopathies, Age-Related|maculopathies, age-related
876642|NCT00051116|Multiple Myeloma|multiple myeloma
876643|NCT00051116|Revimid|revimid
876644|NCT00051116|CC5013|cc5013
876645|NCT00051116|CC-5013|cc-5013
876646|NCT00051103|Refractory|refractory
876647|NCT00051090|Hepatitis B|hepatitis b
876648|NCT00051090|Antiretroviral Therapy, Highly-Active|antiretroviral therapy, highly-active
876649|NCT00051090|HIV Infections|hiv infections
876650|NCT00051090|Lamivudine|lamivudine
876651|NCT00051090|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors
876652|NCT00051090|Antiviral Agents|antiviral agents
876653|NCT00051090|Drug Therapy, Combination|drug therapy, combination
876654|NCT00051090|Treatment Naive|treatment naive
876655|NCT00051077|HIV Infections|hiv infections
876656|NCT00051077|Hepatitis B|hepatitis b
876657|NCT00051077|Hepatitis C|hepatitis c
876658|NCT00051077|Interferon Alfa-2a|interferon alfa-2a
876659|NCT00051077|Adefovir dipivoxil|adefovir dipivoxil
876660|NCT00051077|Ribavirin|ribavirin
876661|NCT00051077|Antiviral Agents|antiviral agents
876662|NCT00051077|Drug Resistance, Viral|drug resistance, viral
876663|NCT00051077|Treatment Experienced|treatment experienced
876664|NCT00050986|Brain Neoplasms|brain neoplasms
876665|NCT00050986|CNS Diseases|cns diseases
876666|NCT00050986|Glioblastoma Multiforme|glioblastoma multiforme
876667|NCT00050986|Temozolomide|temozolomide
876668|NCT00050986|Temodar|temodar
876669|NCT00050986|R115777|r115777
876670|NCT00050986|Zarnestra|zarnestra
876671|NCT00050973|NSCLC|nsclc
876672|NCT00050973|Targretin|targretin
876673|NCT00050973|Retinoid|retinoid
876674|NCT00050973|Bexarotene|bexarotene
876675|NCT00050960|NSCLC|nsclc
876676|NCT00050960|Targretin|targretin
876677|NCT00050960|Retinoid|retinoid
876678|NCT00050960|Bexarotene|bexarotene
876679|NCT00050947|partial seizures|partial seizures
876680|NCT00050934|partial seizures|partial seizures
876681|NCT00050921|HIV Infections|hiv infections
876682|NCT00050921|CD4 Lymphocyte Count|cd4 lymphocyte count
876683|NCT00050921|Antiretroviral Therapy, Highly Active|antiretroviral therapy, highly active
876684|NCT00050921|Growth Hormone|growth hormone
876685|NCT00050921|Cell Division|cell division
876686|NCT00050921|CD4-Positive T-Lymphocytes|cd4-positive t-lymphocytes
876687|NCT00050921|Treatment Experienced|treatment experienced
876688|NCT00050908|Brachial Artery|brachial artery
876689|NCT00050908|Endothelium, Vascular|endothelium, vascular
876690|NCT00050908|Vasodilation|vasodilation
876691|NCT00050908|Nitroglycerin|nitroglycerin
876692|NCT00050908|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors
876693|NCT00050908|HIV Protease Inhibitors|hiv protease inhibitors
876694|NCT00050908|Drug Therapy, Combination|drug therapy, combination
876695|NCT00050908|Ritonavir|ritonavir
876696|NCT00050908|efavirenz|efavirenz
876697|NCT00050908|lopinavir|lopinavir
876698|NCT00050908|stavudine|stavudine
876699|NCT00050908|lamivudine|lamivudine
876700|NCT00050908|zidovudine|zidovudine
876701|NCT00050908|Treatment Naive|treatment naive
876702|NCT00050895|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors
876703|NCT00050895|HIV Protease Inhibitors|hiv protease inhibitors
876704|NCT00050895|Drug Therapy, Combination|drug therapy, combination
876705|NCT00050895|Delayed Action Preparations|delayed action preparations
876706|NCT00050895|Treatment Naive|treatment naive
876707|NCT00050895|HIV-1|hiv-1
876708|NCT00050882|GM-611|gm-611
876709|NCT00050882|Diabetic gastroparesis|diabetic gastroparesis
876710|NCT00050882|Bloating|bloating
876711|NCT00050882|Delayed gastric emptying|delayed gastric emptying
876712|NCT00050882|Mitemcinal|mitemcinal
876713|NCT00050869|Mirror Neurons|mirror neurons
876714|NCT00050869|Performance|performance
876715|NCT00050869|Use-Dependent Plasticity|use-dependent plasticity
876716|NCT00050869|Attention|attention
876717|NCT00050869|Premotor Cortex|premotor cortex
876718|NCT00050856|Antiretrovial Therapy|antiretrovial therapy
876719|NCT00050856|Salvage|salvage
876720|NCT00050856|CD4+Lymphocyte Count|cd4+lymphocyte count
876721|NCT00050856|HIV-1 RNA Level|hiv-1 rna level
876722|NCT00050856|Subcutaneous Injection|subcutaneous injection
876723|NCT00050817|Embolism|embolism
876724|NCT00050791|Obesity|obesity
876725|NCT00050791|Weightloss|weightloss
876726|NCT00050791|Leptin|leptin
876727|NCT00050791|Diet|diet
876728|NCT00050791|Reducing|reducing
876729|NCT00050791|Overweight|overweight
876730|NCT00050791|Fat|fat
876731|NCT00050778|Multiple Sclerosis|multiple sclerosis
876732|NCT00050778|Active Relapsing-Remitting Multiple Sclerosis|active relapsing-remitting multiple sclerosis
876733|NCT00050804|Acute Stress Disorder|acute stress disorder
876734|NCT00050804|PTSD|ptsd
876735|NCT00050804|Treatment|treatment
876738|NCT00050804|Psychophysiology|psychophysiology
876739|NCT00050804|Trauma|trauma
876740|NCT00050804|Anxiety|anxiety
876741|NCT00050804|Emotion|emotion
876742|NCT00050765|Myocardial Infarction|myocardial infarction
876743|NCT00050765|Heart disease|heart disease
876744|NCT00050765|Coronary bypass graft (CABG) surgery|coronary bypass graft (cabg) surgery
876745|NCT00050765|Implantable Cardioverter Defibrillator (ICD)|implantable cardioverter defibrillator (icd)
876746|NCT00050765|CABG|cabg
876747|NCT00050765|ICD|icd
876748|NCT00050765|Heart failure|heart failure
876749|NCT00050752|Renal Cancer|renal cancer
876750|NCT00050752|Hereditary Leiomyomatosis|hereditary leiomyomatosis
876751|NCT00050752|Uterine Fibroid|uterine fibroid
876752|NCT00050752|Cutaneous Leiomyoma|cutaneous leiomyoma
876753|NCT00050726|Interleukin-2|interleukin-2
876754|NCT00050726|Immunotherapy|immunotherapy
876755|NCT00050726|HIV|hiv
876756|NCT00050726|IL-2|il-2
876757|NCT00050713|Kidney Disease|kidney disease
876758|NCT00050713|Glomerulonephritis|glomerulonephritis
876759|NCT00050713|Lupus Nephritis|lupus nephritis
876760|NCT00050713|Nephrotic Syndrome|nephrotic syndrome
876761|NCT00050713|Hyperlipidemia|hyperlipidemia
876762|NCT00050700|PET|pet
876763|NCT00050700|[18F]FP-TZTP|[18f]fp-tztp
876764|NCT00050700|Bipolar Disorder|bipolar disorder
876765|NCT00050700|Major Depressive Disorder|major depressive disorder
876766|NCT00050700|Muscarinic 2 Receptors|muscarinic 2 receptors
876767|NCT00050674|lung cancer, oncology, neutropenia, chemotherapy, filgrastim|lung cancer, oncology, neutropenia, chemotherapy, filgrastim
876768|NCT00050661|psoriasis|psoriasis
876769|NCT00050661|Cyclosporine|cyclosporine
876770|NCT00050661|Daclizamub|daclizamub
876771|NCT00050661|anti-TAC|anti-tac
876772|NCT00050661|dermatology|dermatology
876773|NCT00050661|skin|skin
876774|NCT00050661|lesions|lesions
876775|NCT00050648|psoriasis|psoriasis
876776|NCT00050648|Daclizumab|daclizumab
876777|NCT00050648|Cyclosporin|cyclosporin
876778|NCT00050648|anti-TAC|anti-tac
876779|NCT00050648|dermatology|dermatology
876780|NCT00050648|skin|skin
876781|NCT00050635|chemotherapy induced diarrhea|chemotherapy induced diarrhea
876782|NCT00050635|diarrhea|diarrhea
876783|NCT00050635|CTID|ctid
876784|NCT00050635|colorectal cancer|colorectal cancer
876785|NCT00050635|Sandostatin LAR Depot|sandostatin lar depot
876786|NCT00050635|Sandostatin|sandostatin
876787|NCT00050635|adverse events|adverse events
876788|NCT00050635|side effects|side effects
876789|NCT00050427|Trabectedin|trabectedin
876790|NCT00050427|Yondelis|yondelis
876791|NCT00050427|ET743|et743
876792|NCT00050427|Advanced breast cancer|advanced breast cancer
876793|NCT00050427|Breast|breast
876794|NCT00050427|Cancer|cancer
876795|NCT00050427|Antineoplastic Agents, Alkylating Agents|antineoplastic agents, alkylating agents
876796|NCT00050427|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action
876797|NCT00050518|Smallpox|smallpox
876798|NCT00050518|Aventis Pasteur|aventis pasteur
876799|NCT00050518|Vaccine|vaccine
876800|NCT00050505|smallpox, Dryvax, vaccine, dilution|smallpox, dryvax, vaccine, dilution
876801|NCT00050492|Ocular|ocular
876802|NCT00050492|Cytokine|cytokine
876803|NCT00050492|Chemokine|chemokine
876804|NCT00050492|Viruses|viruses
876805|NCT00050492|Autoantibody|autoantibody
876806|NCT00050492|Retina|retina
876807|NCT00050492|Vasculitis|vasculitis
876808|NCT00050492|Adhesion Molecules|adhesion molecules
876809|NCT00050479|Types 1 and 2 diabetes|types 1 and 2 diabetes
880405|NCT00038142|ImmTher|immther
876810|NCT00050479|Diode Laser Photocoagulation|diode laser photocoagulation
876811|NCT00050479|Elevated Low-Density Lipoprotein (LDL-C) Cholesterol|elevated low-density lipoprotein (ldl-c) cholesterol
876812|NCT00050466|Normal Volunteers|normal volunteers
876813|NCT00050466|Dynamic Light Scattering (DLS)|dynamic light scattering (dls)
876814|NCT00050466|Corneal Opacities|corneal opacities
876815|NCT00050466|Cornea|cornea
876816|NCT00050466|Transparency|transparency
876817|NCT00050466|Vision|vision
876818|NCT00050440|Endometrial|endometrial
876819|NCT00050440|Cancer|cancer
876820|NCT00050440|Carcinoma|carcinoma
876821|NCT00050440|Trabectedin|trabectedin
876822|NCT00050440|Ecteinascidin 743|ecteinascidin 743
876823|NCT00050440|ET743|et743
876824|NCT00050440|Antineoplastic Agents|antineoplastic agents
876825|NCT00050440|Alkylating Agents|alkylating agents
876826|NCT00050440|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action
876827|NCT00050414|Ovarian cancer|ovarian cancer
876828|NCT00050414|Ovary|ovary
876829|NCT00050414|Cancer|cancer
876830|NCT00050414|Trabectedin|trabectedin
876831|NCT00050414|Yondelis|yondelis
876832|NCT00050414|ET743|et743
876833|NCT00050414|Ecteinascidin 743|ecteinascidin 743
876834|NCT00050414|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating
876835|NCT00050414|Alkylating Agents|alkylating agents
876836|NCT00050401|ventilator-associated|ventilator-associated
876837|NCT00050401|nosocomial|nosocomial
876838|NCT00011635|Caffeine|caffeine
876839|NCT00011635|Cytochrome P 450|cytochrome p 450
896400|NCT00001195|Growth|growth
876840|NCT00011635|Dextromethorphan|dextromethorphan
876841|NCT00011635|Drug Interaction|drug interaction
876842|NCT00011635|Metabolism|metabolism
876843|NCT00011635|Drug Metabolism|drug metabolism
876844|NCT00011635|Healthy Volunteer|healthy volunteer
876845|NCT00011635|Milk Thistle|milk thistle
876846|NCT00011063|Anti-Epileptic|anti-epileptic
876847|NCT00011063|CYP2C9|cyp2c9
876848|NCT00011063|Herbal|herbal
876849|NCT00011063|Interaction|interaction
876850|NCT00011063|Metabolism|metabolism
876851|NCT00011063|Drug Interaction|drug interaction
876852|NCT00011063|Drug Metabolism|drug metabolism
876853|NCT00011063|Ginko Biloba|ginko biloba
876854|NCT00011063|Healthy Volunteer|healthy volunteer
876855|NCT00009542|Caffeine|caffeine
876856|NCT00009542|Cytochrome P 450|cytochrome p 450
876857|NCT00009542|Dextromethorphan|dextromethorphan
876858|NCT00009542|Herbal|herbal
876859|NCT00009542|Interactions|interactions
876860|NCT00009542|Alternative Therapy|alternative therapy
876861|NCT00009542|Healthy Volunteer|healthy volunteer
876862|NCT00009542|Kava|kava
876863|NCT00006395|Antiepileptic|antiepileptic
876864|NCT00006395|CYP3A4|cyp3a4
876865|NCT00006395|Herbal|herbal
876866|NCT00006395|Induction|induction
876867|NCT00006395|Interaction|interaction
876868|NCT00006191|Antiepileptic Drugs|antiepileptic drugs
876869|NCT00006191|Motor Cortex|motor cortex
876870|NCT00006191|Myoclonus|myoclonus
876871|NCT00006191|Healthy Volunteer|healthy volunteer
876872|NCT00006155|DNA Damage|dna damage
876873|NCT00006155|DNA Repair|dna repair
876874|NCT00006155|FLK-1|flk-1
876875|NCT00006155|Pharmacokinetics|pharmacokinetics
876876|NCT00006155|VEGF|vegf
876877|NCT00006155|Fallopian Tube Cancer|fallopian tube cancer
876878|NCT00006155|Ovarian Cancer|ovarian cancer
876879|NCT00006155|Platinum-Refractory Disease|platinum-refractory disease
876880|NCT00006071|Brachial Reactivity|brachial reactivity
876881|NCT00006071|Endothelial Function|endothelial function
876882|NCT00006071|Endothelial Markers|endothelial markers
876883|NCT00006071|Forearm Flow|forearm flow
876884|NCT00006071|Insulin Resistance|insulin resistance
876885|NCT00006071|Elevated Cholesterol|elevated cholesterol
876886|NCT00006071|Hypertension|hypertension
876887|NCT00006062|Liver Impairment|liver impairment
876888|NCT00006062|Pharmacokinetics|pharmacokinetics
876889|NCT00006062|Platinum Analogues|platinum analogues
876890|NCT00005926|Cancer|cancer
876891|NCT00005926|Gemzar|gemzar
876892|NCT00005926|Her-2/Neu|her-2/neu
876893|NCT00005926|Pancreatic|pancreatic
876894|NCT00005926|Radiotherapy|radiotherapy
876895|NCT00005926|Pancreatic Cancer|pancreatic cancer
876896|NCT00005912|Aspergillosis|aspergillosis
876897|NCT00005912|Candidiasis|candidiasis
876898|NCT00005912|Fungal Infections|fungal infections
876899|NCT00005912|Fungemia|fungemia
876900|NCT00005912|Prophylactic Antifungal Therapy|prophylactic antifungal therapy
876901|NCT00005912|Pediatric Fungal Infection|pediatric fungal infection
876902|NCT00005783|Fetal Hemoglobin|fetal hemoglobin
876903|NCT00005783|Hematopoietic Growth Factor|hematopoietic growth factor
876904|NCT00005783|Peripheral Blood CD34 Cells|peripheral blood cd34 cells
876905|NCT00005783|Vasoocclusive Crisis|vasoocclusive crisis
876906|NCT00005783|Sickle Cell Anemia|sickle cell anemia
876907|NCT00005783|Sickle Cell Disease|sickle cell disease
876908|NCT00005783|Sickle Cell Disorder|sickle cell disorder
876909|NCT00005781|Epidemiology|epidemiology
876910|NCT00005781|NHANES|nhanes
876911|NCT00005781|Photography|photography
876912|NCT00005781|Prevalence|prevalence
876913|NCT00005781|Skin Disease|skin disease
876914|NCT00005781|Healthy Volunteer|healthy volunteer
876915|NCT00005574|Becker Muscular Dystrophy|becker muscular dystrophy
876916|NCT00005574|Duchenne Muscular Dystrophy|duchenne muscular dystrophy
876917|NCT00005574|Muscle Disease|muscle disease
876918|NCT00005574|Myopathy|myopathy
876919|NCT00005570|Bleeding|bleeding
876920|NCT00005570|Cytokines|cytokines
876921|NCT00005570|Immune Response|immune response
876922|NCT00005570|Pharmacogenomic|pharmacogenomic
876923|NCT00005570|Serum Antibodies|serum antibodies
876925|NCT00005570|Immune Thrombocytopenia Purpura|immune thrombocytopenia purpura
876926|NCT00005111|Blood Flow|blood flow
876927|NCT00005111|Glucose|glucose
876928|NCT00005111|Lysosomal Disease|lysosomal disease
876929|NCT00005111|Metabolic|metabolic
876930|NCT00005111|Uptake|uptake
876931|NCT00005111|Fabry Disease|fabry disease
876932|NCT00005016|Fetal Anomaly|fetal anomaly
876933|NCT00005016|Genetic Counseling|genetic counseling
876934|NCT00005016|Prenatal Diagnosis|prenatal diagnosis
876935|NCT00005016|Psychosocial Issues|psychosocial issues
876936|NCT00005016|Qualitative|qualitative
876937|NCT00005016|HPE|hpe
876938|NCT00005016|Holoprosencephaly|holoprosencephaly
876939|NCT00004851|HCV Antibody Library|hcv antibody library
876940|NCT00004848|AIDS|aids
876941|NCT00004848|Autologous Blood|autologous blood
876942|NCT00004848|Cardiac Surgery|cardiac surgery
876943|NCT00004848|HIV|hiv
876944|NCT00004848|Hepatocellular Inflammation|hepatocellular inflammation
876945|NCT00004848|Liver Biopsy|liver biopsy
876946|NCT00004848|Long Term Sera Storage|long term sera storage
876947|NCT00004848|Non-A Hepatitis|non-a hepatitis
876948|NCT00004848|Non-B Hepatitis|non-b hepatitis
876949|NCT00004576|Dyskinesias|dyskinesias
876950|NCT00004576|Glutamate|glutamate
876951|NCT00004576|Levodopa|levodopa
876952|NCT00004576|Parkinson's Disease|parkinson's disease
876953|NCT00004574|Abetalipoproteinemia|abetalipoproteinemia
876954|NCT00004574|Ataxia|ataxia
876955|NCT00004574|Retinitis Pigmentosa|retinitis pigmentosa
876956|NCT00004574|Vitamin A|vitamin a
876957|NCT00004574|Vitamin E|vitamin e
876958|NCT00004557|Attention|attention
876959|NCT00004557|Cognition|cognition
876960|NCT00004557|Dementia|dementia
876961|NCT00004557|Memory|memory
876962|NCT00004557|Object Recognition|object recognition
876963|NCT00004557|Spatial Processes|spatial processes
876964|NCT00001986|Alcohol|alcohol
876965|NCT00001986|Octanol|octanol
876966|NCT00001986|Treatment|treatment
876967|NCT00001986|Tremor|tremor
876968|NCT00001982|Aminotransferases|aminotransferases
876969|NCT00001982|Anti-HCV|anti-hcv
876970|NCT00001982|Blood Donors|blood donors
876971|NCT00001982|HCV RNA|hcv rna
876972|NCT00001982|Hepatitis C|hepatitis c
876973|NCT00001982|Liver Biopsy|liver biopsy
876974|NCT00001982|Serum Aminotransferases|serum aminotransferases
876975|NCT00001982|Transfusion|transfusion
876976|NCT00001977|Alzheimer's Disease|alzheimer's disease
876977|NCT00001977|Attention|attention
876978|NCT00001977|Brain|brain
876979|NCT00001977|Functional Magnetic Resonance Imaging|functional magnetic resonance imaging
876980|NCT00001977|Physostigmine|physostigmine
876981|NCT00001977|Positron Emission Tomography|positron emission tomography
876982|NCT00001977|Working Memory|working memory
876983|NCT00001968|AIDS|aids
876984|NCT00001968|Anti-Retroviral Therapy|anti-retroviral therapy
876985|NCT00001968|Drug Interactions|drug interactions
876986|NCT00001968|HIV|hiv
876987|NCT00001968|Protease Inhibitor|protease inhibitor
876988|NCT00001966|Adjustment|adjustment
876989|NCT00001966|Alternative|alternative
876990|NCT00001966|Anxiety|anxiety
876991|NCT00001966|Guided-Imagery|guided-imagery
876992|NCT00001966|Meditation|meditation
876993|NCT00001966|Ehlers-Danlos Syndrome|ehlers-danlos syndrome
876994|NCT00001965|Calcineurin|calcineurin
876995|NCT00001965|Cardiac Hypertrophy|cardiac hypertrophy
876996|NCT00001965|Hypertrophic Cardiomyopathy|hypertrophic cardiomyopathy
876997|NCT00001963|Blood Flow|blood flow
876998|NCT00001963|Exercise|exercise
876999|NCT00001963|Microcirculation|microcirculation
877000|NCT00001963|S-nitrosohemoglobin|s-nitrosohemoglobin
877001|NCT00001963|Vasodilation|vasodilation
877002|NCT00001963|Healthy Volunteer|healthy volunteer
877003|NCT00001944|Drug Resistance|drug resistance
877004|NCT00001944|MDR-1|mdr-1
877005|NCT00001944|P-Glycoprotein Blocker|p-glycoprotein blocker
877006|NCT00001944|Pgp|pgp
877007|NCT00001944|Resistance Reversal|resistance reversal
877008|NCT00001940|Antifungal Agent|antifungal agent
877009|NCT00001940|Aspergillosis|aspergillosis
877010|NCT00001940|Candidemia|candidemia
877011|NCT00001940|Fungemia|fungemia
877012|NCT00001937|Aspergillosis|aspergillosis
877013|NCT00001937|Candidiasis|candidiasis
877014|NCT00001937|Fungal Infections|fungal infections
877015|NCT00001937|Fungemia|fungemia
877016|NCT00001937|Prophylactic Antifungal Therapy|prophylactic antifungal therapy
877017|NCT00001931|Continuous Stimulation|continuous stimulation
877018|NCT00001931|Dose Finding|dose finding
877019|NCT00001931|Skin Patch|skin patch
877020|NCT00001930|Amantadine|amantadine
877022|NCT00001930|Glutamate Antagonist|glutamate antagonist
877023|NCT00001929|Dyskinesias|dyskinesias
877024|NCT00001929|Glutamate Antagonist|glutamate antagonist
877025|NCT00001929|Levodopa|levodopa
877026|NCT00001928|Diagnosis|diagnosis
877027|NCT00001928|Infusion|infusion
877028|NCT00001928|Parkinsonism|parkinsonism
877029|NCT00001918|Cognitive Function|cognitive function
877030|NCT00001918|Depression|depression
877031|NCT00001918|EMG|emg
877032|NCT00001918|Eosinophilia Myalgia Syndrome|eosinophilia myalgia syndrome
877033|NCT00001918|Impurities|impurities
877034|NCT00001918|L-5-HTP|l-5-htp
877035|NCT00001918|Memory Impairment|memory impairment
877036|NCT00001918|Nerve-Muscle Biopsy|nerve-muscle biopsy
877037|NCT00001918|Sleep Disorders|sleep disorders
877038|NCT00001916|Bone Remodeling|bone remodeling
877039|NCT00001916|Corticosteroids|corticosteroids
877040|NCT00001916|Cytokine|cytokine
877041|NCT00001916|Depression|depression
877042|NCT00001916|Glucocorticoids|glucocorticoids
877043|NCT00001916|Osteopenia|osteopenia
877044|NCT00001916|Osteoporosis|osteoporosis
877045|NCT00001916|Primary Affective Disorder|primary affective disorder
877046|NCT00001909|Allergy|allergy
877047|NCT00001909|Immunomodulator|immunomodulator
877048|NCT00001909|Inflammation|inflammation
877049|NCT00001909|Interleukin|interleukin
877050|NCT00001909|Th2|th2
877051|NCT00001909|Asthma|asthma
877052|NCT00001906|Alum|alum
877053|NCT00001906|Antigen|antigen
877054|NCT00001906|Cytokine|cytokine
877055|NCT00001906|Parasitic Infection|parasitic infection
877057|NCT00001906|Cutaneous Leishmaniasis|cutaneous leishmaniasis
877058|NCT00001904|Atherosclerosis|atherosclerosis
877059|NCT00001904|Cardiovascular Disease|cardiovascular disease
877060|NCT00001904|Computerized Edge Reader|computerized edge reader
877061|NCT00001904|Myocardial Infarction|myocardial infarction
877062|NCT00001904|Risk Factor|risk factor
877063|NCT00001903|Immunization|immunization
877064|NCT00001903|Immunocompromised|immunocompromised
877065|NCT00001903|Immunoglobulin|immunoglobulin
877066|NCT00001903|Prophylaxis|prophylaxis
877067|NCT00001903|Respiratory Virus|respiratory virus
877068|NCT00001903|Bone Marrow Transplantation|bone marrow transplantation
877069|NCT00001903|Mini-Transplantation|mini-transplantation
877070|NCT00001903|Peripheral Stem Cell Transplantation|peripheral stem cell transplantation
877071|NCT00001891|CABG|cabg
877072|NCT00001891|Hibernation|hibernation
877073|NCT00001891|LV Function|lv function
877074|NCT00001891|Microbubbles|microbubbles
877075|NCT00001891|Revascularization|revascularization
877076|NCT00001891|Coronary Artery Disease|coronary artery disease
877077|NCT00001890|Cellular Immunity|cellular immunity
877078|NCT00001890|Cytokines|cytokines
877079|NCT00001890|Estrogen|estrogen
877080|NCT00001890|Humoral Immunity|humoral immunity
877081|NCT00001890|Progesterone|progesterone
877082|NCT00001890|Chlamydia Pneumoniae|chlamydia pneumoniae
877083|NCT00001890|Human Cytomegalovirus|human cytomegalovirus
877084|NCT00001890|Postmenopause|postmenopause
877085|NCT00001889|Microbubbles|microbubbles
877086|NCT00001889|Myocardial Blood Flow|myocardial blood flow
877087|NCT00001889|Myocardial Ischemia|myocardial ischemia
877088|NCT00001889|Second Harmonics|second harmonics
877089|NCT00001889|Ultrasound|ultrasound
877090|NCT00001889|Coronary Artery Disease|coronary artery disease
877091|NCT00001887|Airway Inflammation|airway inflammation
877092|NCT00001887|Allergen Challenge|allergen challenge
877093|NCT00001887|Bronchoscopy|bronchoscopy
877094|NCT00001887|Cytokines|cytokines
877095|NCT00001887|Receptors|receptors
877096|NCT00001887|Asthma|asthma
877097|NCT00001887|Normal Volunteer|normal volunteer
877098|NCT00001886|Coronary Artery Disease|coronary artery disease
877099|NCT00001886|Ischemia|ischemia
877100|NCT00001886|Ultrasound|ultrasound
877101|NCT00001886|Ventricular Function|ventricular function
877102|NCT00001886|Wall Motion|wall motion
877103|NCT00001881|Cardiac Hypertrophy|cardiac hypertrophy
877104|NCT00001881|Genetics|genetics
877105|NCT00001881|Phenotypes|phenotypes
877106|NCT00001881|Hypertrophic Cardiomyopathy|hypertrophic cardiomyopathy
877107|NCT00001879|Liver Disease|liver disease
877108|NCT00001879|Novel Agents|novel agents
877109|NCT00001879|Serum|serum
877110|NCT00001879|Viruses|viruses
877111|NCT00001879|non-A,G Hepatitis|non-a,g hepatitis
877112|NCT00001879|Seronegative Acute Hepatitis|seronegative acute hepatitis
877113|NCT00001871|Genetic Mutations|genetic mutations
877114|NCT00001871|Hypertrophic Cardiomyopathy|hypertrophic cardiomyopathy
877115|NCT00001871|Oculopharyngeal Muscular Dystrophy|oculopharyngeal muscular dystrophy
877116|NCT00001867|Cytokine|cytokine
877117|NCT00001867|Gestation|gestation
877118|NCT00001867|Postpartum|postpartum
877119|NCT00001867|Pregnancy|pregnancy
877120|NCT00001867|Th 1 Lymphocyte|th 1 lymphocyte
877121|NCT00001867|Th 2 Lymphocyte|th 2 lymphocyte
877122|NCT00001867|Uveitis|uveitis
877123|NCT00001857|Costimulation|costimulation
877124|NCT00001857|Immunosuppression|immunosuppression
877125|NCT00001857|Tolerance|tolerance
877126|NCT00001840|Infarct|infarct
877129|NCT00001840|Natural History|natural history
877130|NCT00001840|Stroke|stroke
877131|NCT00001840|Treatment|treatment
877132|NCT00001840|Brain Stroke|brain stroke
877133|NCT00001839|Anemia|anemia
877134|NCT00001839|Immunosuppressive|immunosuppressive
877135|NCT00001839|Phase II Trial|phase ii trial
877136|NCT00001839|Pre-Leukemia|pre-leukemia
877137|NCT00001839|Therapy|therapy
877138|NCT00001839|Myelodysplastic Syndrome|myelodysplastic syndrome
877139|NCT00001816|Anger|anger
877140|NCT00001816|Loneliness|loneliness
877141|NCT00001816|Mood|mood
877142|NCT00001816|Psychosocial|psychosocial
877143|NCT00001816|Virtual Network|virtual network
877144|NCT00001814|Hereditary|hereditary
877145|NCT00001814|Kidney|kidney
877146|NCT00001814|MET|met
877147|NCT00001814|Oncocytoma|oncocytoma
877148|NCT00001814|VHL|vhl
877149|NCT00001812|Mucositis|mucositis
877150|NCT00001812|Oral Candidiasis|oral candidiasis
877151|NCT00001812|Prophylaxis|prophylaxis
877152|NCT00001812|Stomatitis|stomatitis
877153|NCT00001812|Swish and Swallow|swish and swallow
877154|NCT00001810|Antifungal Agent|antifungal agent
877155|NCT00001810|Aspergillosis|aspergillosis
877156|NCT00001810|Candidiasis|candidiasis
877157|NCT00001810|Fungemia|fungemia
877158|NCT00001805|Breast Cancer|breast cancer
877159|NCT00001805|Colon Cancer|colon cancer
877160|NCT00001805|Gastric Cancer|gastric cancer
877161|NCT00001805|Lung Cancer|lung cancer
877162|NCT00001805|Pancreatic Cancer|pancreatic cancer
877163|NCT00001797|Cytokines|cytokines
877164|NCT00001797|Immunomodulation|immunomodulation
877165|NCT00001797|Inflammation|inflammation
877166|NCT00001797|Skin|skin
877167|NCT00001797|Therapy|therapy
877168|NCT00001790|Aspergillosis|aspergillosis
877169|NCT00001790|Candidiasis|candidiasis
877170|NCT00001790|Empiric Therapy|empiric therapy
877171|NCT00001790|Fungal Infection|fungal infection
877172|NCT00001790|Fungemia|fungemia
877173|NCT00001789|Autoantibody|autoantibody
877174|NCT00001789|Autoimmunity|autoimmunity
877175|NCT00001789|Inflammation|inflammation
877176|NCT00001789|Kidney|kidney
877177|NCT00001789|Lymphocyte|lymphocyte
877178|NCT00001789|Proliferative Lupus Glomerulonephritis|proliferative lupus glomerulonephritis
877179|NCT00001789|SLE-GN|sle-gn
877180|NCT00001782|Deafness|deafness
877181|NCT00001782|Hemisphere Dominance|hemisphere dominance
877182|NCT00001782|Language|language
877183|NCT00001782|Plasticity|plasticity
877184|NCT00001782|Speech|speech
877185|NCT00001782|rTMS|rtms
877186|NCT00001777|Frontal Lobe Dementia|frontal lobe dementia
877187|NCT00001777|Serotonergic Transmission|serotonergic transmission
877188|NCT00001774|Acetylcholine|acetylcholine
877189|NCT00001774|Blood Flow|blood flow
877190|NCT00001774|Blood vessel|blood vessel
877191|NCT00001774|Resistance|resistance
877192|NCT00001774|Sodium Nitroprusside|sodium nitroprusside
877193|NCT00001774|Fabry Disease|fabry disease
877194|NCT00001774|Normal Volunteer|normal volunteer
877195|NCT00001772|Bipolar Disorder|bipolar disorder
877196|NCT00001772|Rapid Cycling|rapid cycling
877197|NCT00001772|Screening|screening
877198|NCT00001768|Autoimmunity|autoimmunity
877199|NCT00001768|Childhood Onset Schizophrenia|childhood onset schizophrenia
877200|NCT00001768|Intravenous Gammaglobulin|intravenous gammaglobulin
877201|NCT00001763|AIDS|aids
877202|NCT00001763|Cell Mediated Immunity|cell mediated immunity
877203|NCT00001763|Cytokine|cytokine
877204|NCT00001763|MAC|mac
877205|NCT00001763|Thl Response|thl response
877206|NCT00001761|Autoimmunity|autoimmunity
877207|NCT00001761|Cytokine|cytokine
877208|NCT00001761|Inflammation|inflammation
877209|NCT00001761|Interleukin|interleukin
877210|NCT00001761|Vasculitis|vasculitis
877211|NCT00001761|Wegener's Granulomatosis|wegener's granulomatosis
877212|NCT00001759|Allergy|allergy
877213|NCT00001759|Fluorodeoxyglucose|fluorodeoxyglucose
877214|NCT00001759|Imaging|imaging
877215|NCT00001759|PET|pet
877216|NCT00001759|Wegener's Granulomatosis|wegener's granulomatosis
877217|NCT00001759|Asthma|asthma
877218|NCT00001757|Azole|azole
877219|NCT00001757|Immunocompromised|immunocompromised
877220|NCT00001757|Mycosis|mycosis
877221|NCT00001757|Invasive Fungal Infection|invasive fungal infection
877222|NCT00001757|Systemic Fungal Infection|systemic fungal infection
877223|NCT00001754|Dwarfism|dwarfism
877224|NCT00001754|Gene Mapping|gene mapping
877225|NCT00001754|Linkage|linkage
877226|NCT00001754|Mutation Analysis|mutation analysis
877227|NCT00001754|Skeletal Biology|skeletal biology
877228|NCT00001754|Brachydactyly Types C & E|brachydactyly types c & e
877229|NCT00001754|Cartilage-Hair Hypoplasia|cartilage-hair hypoplasia
877230|NCT00001754|Ellis Van Crevald|ellis van crevald
877231|NCT00001754|FgFR-3|fgfr-3
877232|NCT00001754|Proximal Symphalangism|proximal symphalangism
877233|NCT00001754|Pyknodysotosis|pyknodysotosis
877234|NCT00001754|Schmid Metaphyseal|schmid metaphyseal
877235|NCT00001754|Short Stature|short stature
877236|NCT00001754|Skeletal Dysplasia|skeletal dysplasia
880720|NCT00036452|Self Care|self care
877237|NCT00001754|Type II Collagen Disorder|type ii collagen disorder
877238|NCT00001753|Exercise|exercise
877239|NCT00001753|MRI|mri
877240|NCT00001753|MRS|mrs
877241|NCT00001753|Normal Volunteer|normal volunteer
877242|NCT00001753|Tibialix Anterior|tibialix anterior
877243|NCT00001752|Adhesion Molecules|adhesion molecules
877244|NCT00001752|Endothelial Function|endothelial function
877245|NCT00001752|Inflammation|inflammation
877246|NCT00001752|Lipoproteins|lipoproteins
877247|NCT00001752|Nitric Oxide|nitric oxide
877248|NCT00001752|Hormone Therapy|hormone therapy
877249|NCT00001752|Postmenopausal Women|postmenopausal women
877250|NCT00001748|Cyclophosphamide|cyclophosphamide
877251|NCT00001748|Donor Apheresis|donor apheresis
877252|NCT00001748|Graft vs. Host Disease|graft vs. host disease
877253|NCT00001748|Graft-Versus-Leukemia|graft-versus-leukemia
877254|NCT00001748|Leukemic Relapse|leukemic relapse
877255|NCT00001748|Myeloma|myeloma
877256|NCT00001748|Peripheral Blood Stem Cells|peripheral blood stem cells
877257|NCT00001748|Whole Body Irradiation|whole body irradiation
877258|NCT00001748|Acute Lymphoblastic Leukemia (ALL)|acute lymphoblastic leukemia (all)
877259|NCT00001748|Chronic Lymphocytic Leukemia (CLL)|chronic lymphocytic leukemia (cll)
877260|NCT00001748|Chronic Myelogenous Leukemia (CML)|chronic myelogenous leukemia (cml)
877261|NCT00001748|Hematological Malignancies|hematological malignancies
877262|NCT00001748|Myelodysplastic Syndrome|myelodysplastic syndrome
877263|NCT00001748|Myeloproliferative Disorders|myeloproliferative disorders
877264|NCT00001747|Brachial Artery|brachial artery
877265|NCT00001747|Doppler|doppler
877266|NCT00001747|Endothelium|endothelium
877267|NCT00001747|Nitric Oxide|nitric oxide
877268|NCT00001747|Nitroglycerin|nitroglycerin
877269|NCT00001747|Normal Volunteer|normal volunteer
877270|NCT00001742|Acetylcholine|acetylcholine
877271|NCT00001742|Aspirin|aspirin
877272|NCT00001742|Nitric Oxide|nitric oxide
877273|NCT00001742|Sodium Nitroprusside|sodium nitroprusside
877274|NCT00001742|Hypercholesterolemia|hypercholesterolemia
877275|NCT00001742|Hypertension|hypertension
877276|NCT00001740|Cardiac|cardiac
877277|NCT00001740|Function|function
877278|NCT00001740|MRI|mri
877279|NCT00001740|Reconstruction|reconstruction
877280|NCT00001740|Ultrasound|ultrasound
877281|NCT00001740|Heart Disease (Cardiovascular Disease)|heart disease (cardiovascular disease)
877282|NCT00001738|Intermediate Uveitis|intermediate uveitis
877283|NCT00001738|Pars Planitis|pars planitis
877284|NCT00001738|Retinal Vasculature|retinal vasculature
877285|NCT00001738|Uveitis|uveitis
877286|NCT00001738|Vascular Permeability|vascular permeability
877287|NCT00001738|Vitreous|vitreous
877288|NCT00001736|Corneal Crystals|corneal crystals
877289|NCT00001736|Cysteamine|cysteamine
877290|NCT00001736|Cystinosis|cystinosis
877291|NCT00001736|Eye|eye
877292|NCT00001735|Gene Therapy|gene therapy
877293|NCT00001735|Graft|graft
877294|NCT00001735|Ornithine|ornithine
877295|NCT00001735|Retina|retina
877296|NCT00001735|Retinovirus|retinovirus
877297|NCT00001735|Retrovirus|retrovirus
877298|NCT00001735|Skin|skin
877299|NCT00001735|Gyrate Atrophy|gyrate atrophy
877300|NCT00001731|Conjunctiva|conjunctiva
877301|NCT00001731|Dry Eyes|dry eyes
877302|NCT00001731|Inflammation|inflammation
877303|NCT00001731|Lacrimal Gland|lacrimal gland
877304|NCT00001731|T Lymphocyte|t lymphocyte
877305|NCT00001731|Keratoconjunctivitis Sicca|keratoconjunctivitis sicca
877306|NCT00001730|Ablation|ablation
877307|NCT00001730|Activity-Time Curves|activity-time curves
877308|NCT00001730|Iodine Biokinetics|iodine biokinetics
877309|NCT00001730|Thyroid Carcinoma|thyroid carcinoma
877310|NCT00001730|Thyroid Remnant|thyroid remnant
877311|NCT00001718|Biofeedback|biofeedback
877312|NCT00001718|Swallowing|swallowing
877313|NCT00001718|Swallowing Therapy|swallowing therapy
877314|NCT00001718|Tongue/Palate|tongue/palate
877315|NCT00001718|Ultrasound|ultrasound
877316|NCT00001718|Dysphagia|dysphagia
877317|NCT00001717|Compensation|compensation
877318|NCT00001717|Motivations|motivations
877319|NCT00001717|Volunteers|volunteers
877320|NCT00001717|HIV|hiv
877321|NCT00001714|MRI|mri
877322|NCT00001714|Macromolecules|macromolecules
877323|NCT00001714|Magnetization Transfer|magnetization transfer
877324|NCT00001714|Metabolites|metabolites
877325|NCT00001714|Tissue Characterization|tissue characterization
877326|NCT00001714|Normal Volunteer|normal volunteer
877327|NCT00001705|Antigen|antigen
877328|NCT00001705|Cancer|cancer
877329|NCT00001705|Immunotherapy|immunotherapy
877330|NCT00001699|AIDS|aids
877331|NCT00001699|Compliance|compliance
877332|NCT00001699|HIV|hiv
877333|NCT00001699|Medication|medication
877334|NCT00001699|Perceived Threat|perceived threat
877335|NCT00001699|Teenagers|teenagers
877336|NCT00001696|Anti-metastatic|anti-metastatic
877337|NCT00001696|Chemoprevention|chemoprevention
877338|NCT00001696|Isoflavinoid|isoflavinoid
877339|NCT00001696|Prostate Cancer|prostate cancer
877340|NCT00001696|Signal Transduction|signal transduction
877341|NCT00001685|Cancer|cancer
877342|NCT00001685|IL-12|il-12
877344|NCT00001685|Immunotherapy|immunotherapy
877345|NCT00001685|Vaccine|vaccine
877346|NCT00001681|Cytokines|cytokines
877347|NCT00001681|Gene Regulation|gene regulation
877348|NCT00001681|Immunization|immunization
877349|NCT00001681|Influenza|influenza
877350|NCT00001681|Pathogenesis|pathogenesis
877351|NCT00001680|Double-masked|double-masked
877352|NCT00001680|Neuropathy|neuropathy
877353|NCT00001680|Occlusive Dressing|occlusive dressing
877354|NCT00001680|Pilot|pilot
877355|NCT00001680|Placebo|placebo
877356|NCT00001679|Immunogenetics|immunogenetics
877357|NCT00001679|Joint Damage|joint damage
877358|NCT00001679|Reactive Arthritis|reactive arthritis
877359|NCT00001679|Rheumatoid Arthritis|rheumatoid arthritis
877360|NCT00001679|Synovium|synovium
877361|NCT00001679|Synovitis|synovitis
877362|NCT00001677|Immunosuppression|immunosuppression
877363|NCT00001677|Lymphocytes|lymphocytes
877364|NCT00001677|Magnetic Resonance|magnetic resonance
877365|NCT00001677|Synovial Biopsy|synovial biopsy
877366|NCT00001677|Synovitis|synovitis
877367|NCT00001677|Rheumatoid Arthritis|rheumatoid arthritis
877368|NCT00001672|Brain Mapping|brain mapping
877369|NCT00001672|Cognition|cognition
877370|NCT00001672|Noninvasive|noninvasive
877371|NCT00001672|Temporal Lobe|temporal lobe
877372|NCT00001672|Visual Naming|visual naming
877373|NCT00001669|EAE|eae
877374|NCT00001669|EDSS|edss
877375|NCT00001669|MRI|mri
877376|NCT00001669|SNRS|snrs
877377|NCT00001669|Multiple Sclerosis|multiple sclerosis
877378|NCT00001668|Deafness|deafness
896401|NCT00001195|Metabolism|metabolism
877379|NCT00001668|Hemangioblastoma|hemangioblastoma
877380|NCT00001668|Papillary Carcinoma|papillary carcinoma
877381|NCT00001668|VHL Gene|vhl gene
877382|NCT00001668|Vestibular Function|vestibular function
877383|NCT00001668|von Hippel-Lindau Disease|von hippel-lindau disease
877384|NCT00001667|Family Studies|family studies
877385|NCT00001667|Genetic|genetic
877386|NCT00001667|Myoclonus|myoclonus
877387|NCT00001667|Tics|tics
877388|NCT00001667|Tremor|tremor
877389|NCT00001667|Movement Disorders|movement disorders
877390|NCT00001667|Neurological Disease|neurological disease
877391|NCT00001665|Magnetic Stimulation|magnetic stimulation
877392|NCT00001665|Motor Skills|motor skills
877393|NCT00001665|Parkinson's Disease|parkinson's disease
877394|NCT00001665|rTMS|rtms
877395|NCT00001658|Amoxicillin|amoxicillin
877396|NCT00001658|Antibiotics|antibiotics
877397|NCT00001658|Cytokines|cytokines
877398|NCT00001658|Group A beta-Hemolytic Strep Infections|group a beta-hemolytic strep infections
877399|NCT00001658|Obsessive Compulsive Disorder|obsessive compulsive disorder
877400|NCT00001658|Streptococcal Infection|streptococcal infection
877401|NCT00001658|Tic Disorders|tic disorders
877402|NCT00001657|15 O PET Scanning|15 o pet scanning
877403|NCT00001657|Anxiety|anxiety
877404|NCT00001657|Cerebral Blood Flow|cerebral blood flow
877405|NCT00001657|Depression|depression
877406|NCT00001657|Domestic Abuse|domestic abuse
877407|NCT00001657|Neuroendocrine|neuroendocrine
877408|NCT00001657|PET Scanning|pet scanning
877409|NCT00001657|Police Officers|police officers
877410|NCT00001657|Post Traumatic Stress Disorder|post traumatic stress disorder
877411|NCT00001657|Repetitive Transcranial Magnetic Stimulation|repetitive transcranial magnetic stimulation
877412|NCT00001646|Aspergillus|aspergillus
877413|NCT00001646|Azole|azole
877414|NCT00001646|Immunocompromise|immunocompromise
877415|NCT00001642|Chromosomal Deletion|chromosomal deletion
877416|NCT00001642|Mutations|mutations
877417|NCT00001642|Paucity of Bile Ducts|paucity of bile ducts
877418|NCT00001642|Physical Map|physical map
877419|NCT00001642|Transcript Identification|transcript identification
877420|NCT00001642|Alagille Syndrome|alagille syndrome
877421|NCT00001642|Syndromic Bile Duct Paucity|syndromic bile duct paucity
877422|NCT00001639|Gene Dosage|gene dosage
877423|NCT00001639|Haploinsufficiency|haploinsufficiency
877424|NCT00001639|Karyotype|karyotype
877425|NCT00001639|Malformations|malformations
877426|NCT00001639|Mental Retardation|mental retardation
877427|NCT00001633|Contrast Media|contrast media
877428|NCT00001633|Coronary Artery Disease|coronary artery disease
877429|NCT00001633|Coronary Vessels|coronary vessels
877430|NCT00001633|Magnetic Resonance Angiography|magnetic resonance angiography
877431|NCT00001633|Magnetic Resonance Imaging|magnetic resonance imaging
877432|NCT00001629|Angiotensin AT-1 Receptor|angiotensin at-1 receptor
877433|NCT00001629|Angiotensin Receptor Antagonist|angiotensin receptor antagonist
877434|NCT00001629|Atherosclerosis|atherosclerosis
877435|NCT00001629|Blood Flow|blood flow
877436|NCT00001629|Cold Pressor Test|cold pressor test
877437|NCT00001629|Endothelium|endothelium
877438|NCT00001629|Exercise|exercise
877439|NCT00001629|Coronary Artery Disease|coronary artery disease
877440|NCT00001629|Heart Failure|heart failure
877441|NCT00001628|Angiotensin Receptor Antagonist|angiotensin receptor antagonist
877442|NCT00001628|Atherosclerosis|atherosclerosis
877443|NCT00001628|Blood Flow|blood flow
877444|NCT00001628|Endothelium|endothelium
877445|NCT00001628|Endothelial Dysfunction|endothelial dysfunction
877446|NCT00001624|BQ-123|bq-123
877447|NCT00001624|Endothelin|endothelin
877449|NCT00001624|Plethysmography|plethysmography
877450|NCT00001624|Vasoconstriction|vasoconstriction
877451|NCT00001624|Healthy Volunteer|healthy volunteer
877452|NCT00001622|Endothelium|endothelium
877453|NCT00001622|Hypercholesterolemia|hypercholesterolemia
877454|NCT00001622|Hypertension|hypertension
877455|NCT00001622|Microvessels|microvessels
877456|NCT00001622|Vasodilation|vasodilation
877457|NCT00001622|Normal Volunteer|normal volunteer
877458|NCT00001617|Aging|aging
877459|NCT00001617|Cataract|cataract
877460|NCT00001617|Eye|eye
877461|NCT00001617|Human Lens|human lens
877462|NCT00001617|Normal Volunteer|normal volunteer
877463|NCT00001615|Age-Related Macular Degeneration|age-related macular degeneration
877464|NCT00001615|Choroidal Neovascularization|choroidal neovascularization
877465|NCT00001615|Disciform|disciform
877466|NCT00001615|Drusen|drusen
877467|NCT00001615|Natural History|natural history
877468|NCT00001615|Periocular|periocular
877469|NCT00001615|Quality of Life|quality of life
877470|NCT00001615|Steroids|steroids
877471|NCT00001615|Corticosteroid|corticosteroid
877472|NCT00001614|Eye|eye
877473|NCT00001614|Immunosuppression|immunosuppression
877474|NCT00001614|Inflammation|inflammation
877475|NCT00001614|Iritis|iritis
877476|NCT00001614|Joint|joint
877477|NCT00001614|Oral Tolerance|oral tolerance
877478|NCT00001614|Juvenile Rheumatoid Arthritis|juvenile rheumatoid arthritis
877479|NCT00001614|Uveitis|uveitis
877480|NCT00001612|Diabetic Retinopathy|diabetic retinopathy
877481|NCT00001612|Long-Term Visual Outcome|long-term visual outcome
877482|NCT00001612|Photocoagulation|photocoagulation
877483|NCT00001612|J. H. Wilmer Eye Institute|j. h. wilmer eye institute
877484|NCT00001605|Conjugate Vaccine|conjugate vaccine
877485|NCT00001605|Detoxified Lipooligosaccharide|detoxified lipooligosaccharide
877486|NCT00001605|Tetanus Toxoid|tetanus toxoid
877487|NCT00001605|Normal Volunteers|normal volunteers
877488|NCT00001587|Hyperthermia|hyperthermia
877489|NCT00001587|Metastases|metastases
877490|NCT00001587|Organ Perfusion|organ perfusion
877491|NCT00001587|Regional Therapy|regional therapy
877492|NCT00001584|Pathogenesis|pathogenesis
877493|NCT00001584|Resistance|resistance
877494|NCT00001584|Sanctuary Sites|sanctuary sites
877495|NCT00001584|Semen|semen
877496|NCT00001584|Sexual Transmission|sexual transmission
877497|NCT00001579|Biochemical Modulation|biochemical modulation
877498|NCT00001579|Dihydropyrimidine Dehydrogenase|dihydropyrimidine dehydrogenase
877499|NCT00001579|Oral Administration|oral administration
877500|NCT00001579|Pharmacokinetics|pharmacokinetics
877501|NCT00001577|Chemotherapy|chemotherapy
877502|NCT00001577|Hyperthermia|hyperthermia
877503|NCT00001577|Isolation perfusion|isolation perfusion
877504|NCT00001577|Regional Therapy|regional therapy
877505|NCT00001573|Glioma|glioma
877506|NCT00001573|PDGF|pdgf
877507|NCT00001573|Pharmacokinetics|pharmacokinetics
877508|NCT00001573|Sarcoma|sarcoma
877509|NCT00001573|Toxicity|toxicity
877510|NCT00001571|Cancer|cancer
877511|NCT00001571|DDT, PCB|ddt, pcb
877512|NCT00001571|Epidemiology|epidemiology
877513|NCT00001571|Pesticides|pesticides
877514|NCT00001571|Serum|serum
877515|NCT00001570|Cytochrome P 450|cytochrome p 450
877516|NCT00001570|Multi-Drug Resistance|multi-drug resistance
877517|NCT00001570|P-Glycoprotein|p-glycoprotein
877518|NCT00001570|Pharmacokinetics|pharmacokinetics
877519|NCT00001565|Brain Tumors|brain tumors
877520|NCT00001565|Differentiation|differentiation
877521|NCT00001565|Maximally Tolerated Dose|maximally tolerated dose
877522|NCT00001565|Neuroblastoma|neuroblastoma
877523|NCT00001565|Phenylacetate|phenylacetate
877524|NCT00001554|Cortical Localization|cortical localization
877525|NCT00001554|Optical Imaging|optical imaging
877526|NCT00001554|Thermal Imaging|thermal imaging
877527|NCT00001553|Plasticity|plasticity
877528|NCT00001553|Recovery|recovery
877529|NCT00001553|Stroke|stroke
877530|NCT00001553|Use|use
877531|NCT00001553|Cortico-subcortical Stroke|cortico-subcortical stroke
877532|NCT00001546|Biochemical Screening|biochemical screening
877533|NCT00001546|Body Temperature|body temperature
877534|NCT00001546|Consent Form|consent form
877535|NCT00001546|EEG|eeg
877536|NCT00001546|EKG|ekg
877537|NCT00001546|Melatonin|melatonin
877538|NCT00001546|Mood|mood
877539|NCT00001546|Physical Examination|physical examination
877540|NCT00001546|Psychiatric Examination|psychiatric examination
877541|NCT00001546|Sleep Duration|sleep duration
877542|NCT00001546|Sleep Disorders|sleep disorders
877543|NCT00001540|Diagnostic|diagnostic
877544|NCT00001540|Immune Function|immune function
877545|NCT00001540|Immunization|immunization
877546|NCT00001540|Immunodeficiency|immunodeficiency
877547|NCT00001540|Quantitative|quantitative
877548|NCT00001538|AIDS|aids
877549|NCT00001538|DNA Vaccine|dna vaccine
877550|NCT00001538|Naked DNA|naked dna
877551|NCT00001538|Plasmid|plasmid
877552|NCT00001538|gp 160|gp 160
877553|NCT00001536|Disability|disability
877554|NCT00001536|Dwarfism|dwarfism
880721|NCT00036452|Viral Load|viral load
877555|NCT00001536|Ethics in Genetic Counseling|ethics in genetic counseling
877556|NCT00001536|Quality of Life|quality of life
877557|NCT00001536|Reproductive Issues|reproductive issues
877558|NCT00001536|Support Groups|support groups
877559|NCT00001536|Achondroplasia|achondroplasia
877560|NCT00001533|Anemia|anemia
877561|NCT00001533|Chronic T Cell Lymphocytosis with Neutropenia|chronic t cell lymphocytosis with neutropenia
877562|NCT00001533|Immunosuppression|immunosuppression
877563|NCT00001533|Neutropenia|neutropenia
877564|NCT00001533|T-LGL Leukemia|t-lgl leukemia
877565|NCT00001531|Atherogenesis|atherogenesis
877566|NCT00001531|Cell Mediated Immunity|cell mediated immunity
877567|NCT00001531|Coronary Artery Disease|coronary artery disease
877568|NCT00001530|Cardiac Hypertrophy|cardiac hypertrophy
877569|NCT00001530|Drug-Refractory|drug-refractory
877570|NCT00001530|Hemodynamic Benefits|hemodynamic benefits
877571|NCT00001530|Obstruction|obstruction
877572|NCT00001530|Pacemaker Therapy|pacemaker therapy
877573|NCT00001530|Hypertrophic Cardiomyopathy|hypertrophic cardiomyopathy
877574|NCT00001528|Coronary Artery Disease|coronary artery disease
877575|NCT00001528|Gated Blood Pool Tomography|gated blood pool tomography
877576|NCT00001528|Myocardial Blood Flow|myocardial blood flow
877577|NCT00001528|Myocardial Stunning|myocardial stunning
877578|NCT00001528|Positron Emission Tomography|positron emission tomography
877579|NCT00001527|BQ-123|bq-123
877580|NCT00001527|BQ-788|bq-788
877581|NCT00001527|Endothelin|endothelin
877582|NCT00001527|Endothelium|endothelium
877583|NCT00001527|Plethysmography|plethysmography
877584|NCT00001527|Essential Hypertension|essential hypertension
877586|NCT00001523|Diagnostic Imaging|diagnostic imaging
877587|NCT00001523|Radiation Damage|radiation damage
877588|NCT00001523|Saliva|saliva
877589|NCT00001523|Serostomia|serostomia
877590|NCT00001523|Xerostomia|xerostomia
877591|NCT00001523|Head Cancer|head cancer
877592|NCT00001523|Neck Cancer|neck cancer
877593|NCT00001520|Endotracheal Intubation|endotracheal intubation
877594|NCT00001520|Neuromuscular Blockade|neuromuscular blockade
877595|NCT00001520|Neuromuscular Blocking Agents|neuromuscular blocking agents
877596|NCT00001520|Paralysis|paralysis
877597|NCT00001520|Reversal Agents|reversal agents
877598|NCT00001519|Exercise|exercise
877599|NCT00001519|Exercise Intensity|exercise intensity
877600|NCT00001519|Non-Linear Regression|non-linear regression
877601|NCT00001519|Oxygen Uptake|oxygen uptake
877602|NCT00001519|Recovery|recovery
877603|NCT00001519|Subject Comparison|subject comparison
877604|NCT00001519|Time Constant|time constant
877605|NCT00001519|VO2|vo2
877606|NCT00001518|Groshong Catheter|groshong catheter
877607|NCT00001518|Heparinized Flush Solution|heparinized flush solution
877608|NCT00001518|Intraluminal Clot|intraluminal clot
877609|NCT00001518|Urokinase|urokinase
877610|NCT00001518|Venous Access Device|venous access device
877611|NCT00001518|Withdrawal Occlusion|withdrawal occlusion
877612|NCT00001509|Differentiation|differentiation
877613|NCT00001509|N-myc Expression|n-myc expression
877614|NCT00001509|Retinoid|retinoid
877615|NCT00001509|Solid Tumor|solid tumor
877616|NCT00001509|Trk Expression|trk expression
877617|NCT00001502|Blood-Brain Barrier|blood-brain barrier
877618|NCT00001502|Bradykinin|bradykinin
877619|NCT00001502|Children|children
877620|NCT00001502|Glioma|glioma
877621|NCT00001502|Medulloblastoma|medulloblastoma
877622|NCT00001499|Carcinoma|carcinoma
877623|NCT00001499|Combination Chemotherapy|combination chemotherapy
877624|NCT00001499|Combined Modality Therapy|combined modality therapy
877625|NCT00001499|Infusion|infusion
877626|NCT00001499|Intravenous|intravenous
877627|NCT00001499|Lung Neoplasm|lung neoplasm
877628|NCT00001499|Non-Small Cell Lung Cancer|non-small cell lung cancer
877629|NCT00001498|5-Fluorouracil|5-fluorouracil
877630|NCT00001498|Cyclophosphamide|cyclophosphamide
877631|NCT00001498|Methotrexate|methotrexate
877632|NCT00001498|Thiotepa|thiotepa
877633|NCT00001497|Brain Imaging|brain imaging
877634|NCT00001497|Encephalopathy|encephalopathy
877635|NCT00001497|Hyperactivity|hyperactivity
877636|NCT00001497|Neuroimmunology|neuroimmunology
877637|NCT00001497|Reaction Time Tasks|reaction time tasks
877638|NCT00001495|Camptothecin|camptothecin
877639|NCT00001495|Cancer|cancer
877640|NCT00001495|Chemotherapy|chemotherapy
877641|NCT00001495|Natural Products|natural products
877642|NCT00001495|Neoplasms|neoplasms
877643|NCT00001493|Dose Intensity|dose intensity
877644|NCT00001493|Gene Therapy|gene therapy
877645|NCT00001493|Multidrug Resistance|multidrug resistance
877646|NCT00001489|Cerebral Metabolism|cerebral metabolism
877647|NCT00001489|Complex Partial Seizures|complex partial seizures
877648|NCT00001489|Epilepsy|epilepsy
877649|NCT00001485|Chemical Mediators|chemical mediators
877650|NCT00001485|Circadian Rhythms|circadian rhythms
877651|NCT00001485|Gender Differences|gender differences
877652|NCT00001485|Melatonin|melatonin
877653|NCT00001485|Photoperiodism|photoperiodism
877654|NCT00001485|Seasonal Changes|seasonal changes
877655|NCT00001482|Anticonvulsants|anticonvulsants
877656|NCT00001482|Bipolar Disorder|bipolar disorder
877661|NCT00001482|Mood Disorders|mood disorders
877662|NCT00001479|ACTH|acth
877663|NCT00001479|Adrenocorticotropic Hormone|adrenocorticotropic hormone
877664|NCT00001479|Antidepressant Treatment|antidepressant treatment
877665|NCT00001479|Chaos Theory|chaos theory
877666|NCT00001479|Chronic Fatigue Syndrome|chronic fatigue syndrome
877667|NCT00001479|Major Depression|major depression
877668|NCT00001479|Normal Volunteer|normal volunteer
877669|NCT00001479|Primary Affective Disorder|primary affective disorder
877670|NCT00001478|Bupropion|bupropion
877671|NCT00001478|Carbamazepine|carbamazepine
877672|NCT00001478|Cerebral Blood Flow|cerebral blood flow
877673|NCT00001478|Gabapentin|gabapentin
877674|NCT00001478|Lamotrigine|lamotrigine
877675|NCT00001478|Mood Disorders|mood disorders
877676|NCT00001478|Nimodipine|nimodipine
877677|NCT00001478|Oxygen-15|oxygen-15
877678|NCT00001478|Positron Emission Tomography|positron emission tomography
877679|NCT00001478|Venlafaxine|venlafaxine
877680|NCT00001477|Communicable Infection|communicable infection
877681|NCT00001477|Monitoring|monitoring
877682|NCT00001477|Non-Invasive Tests|non-invasive tests
877683|NCT00001477|Opportunistic Infection|opportunistic infection
877684|NCT00001468|Behavioral and Attitudinal Changes|behavioral and attitudinal changes
877685|NCT00001468|Breast Cancer|breast cancer
877686|NCT00001468|High Risk Families|high risk families
878068|NCT00001229|Pheochromocytoma|pheochromocytoma
877687|NCT00001468|Inherited Susceptibility|inherited susceptibility
877688|NCT00001468|Psychological Responses to Risk|psychological responses to risk
877689|NCT00001466|Clinical Genetics|clinical genetics
877690|NCT00001466|Etiology|etiology
877691|NCT00001466|Medical Screening|medical screening
877692|NCT00001466|Prognosis|prognosis
877693|NCT00001466|Genetic Disorders|genetic disorders
877694|NCT00001462|Alpha 1-Antitrypsin Deficiency|alpha 1-antitrypsin deficiency
877695|NCT00001462|Emphysema|emphysema
877696|NCT00001462|Genetic Diseases|genetic diseases
877697|NCT00001462|Inflammation|inflammation
877698|NCT00001462|Nitric Oxide|nitric oxide
877699|NCT00001462|Protease|protease
877700|NCT00001461|Angiotensin Converting Enzyme|angiotensin converting enzyme
877701|NCT00001461|Angiotensin Converting Enzyme Inhibitors|angiotensin converting enzyme inhibitors
877702|NCT00001461|Bradykinin|bradykinin
877703|NCT00001461|Endothelial Function|endothelial function
877704|NCT00001461|Nitric Oxide|nitric oxide
877705|NCT00001461|Coronary Artery Disease|coronary artery disease
877706|NCT00001459|Gated Blood Pool|gated blood pool
877707|NCT00001459|SPECT Scan|spect scan
877708|NCT00001459|Coronary Artery Disease|coronary artery disease
877709|NCT00001459|Hypertrophic Cardiomyopathy|hypertrophic cardiomyopathy
877710|NCT00001459|Microvascular Angina|microvascular angina
877711|NCT00001455|Genetics|genetics
877712|NCT00001455|Hemochromatosis|hemochromatosis
877713|NCT00001455|Iron Metabolism|iron metabolism
877714|NCT00001455|Iron Storage Disorder|iron storage disorder
877715|NCT00001455|Pedigree|pedigree
877716|NCT00001455|Iron Overload|iron overload
877717|NCT00001450|Chemotherapy|chemotherapy
877718|NCT00001450|In Vitro Testing|in vitro testing
877719|NCT00001450|Infusional|infusional
877720|NCT00001450|Lung Neoplasm|lung neoplasm
877721|NCT00001450|Pharmacokinetics|pharmacokinetics
877722|NCT00001449|Anti-Cancer Agents|anti-cancer agents
877723|NCT00001449|Antimetabolite|antimetabolite
877724|NCT00001449|Palliation|palliation
877725|NCT00001449|Pharmacodynamics|pharmacodynamics
877726|NCT00001449|Pharmacokinetics|pharmacokinetics
877727|NCT00001448|Antifungal Therapy|antifungal therapy
877728|NCT00001448|Articulation|articulation
877729|NCT00001448|Behavior|behavior
877730|NCT00001448|Expressive Language|expressive language
877731|NCT00001448|Thrush|thrush
877732|NCT00001446|Angiogenesis|angiogenesis
877733|NCT00001446|Malignancy|malignancy
877734|NCT00001446|Neuropathy|neuropathy
877735|NCT00001446|Pharmacokinetics|pharmacokinetics
877736|NCT00001446|Sedation|sedation
877737|NCT00001445|Adjuvant-Controlled Study|adjuvant-controlled study
877738|NCT00001445|Double Blind Randomization|double blind randomization
877739|NCT00001445|Env-Deleted Inactivated HIV-1|env-deleted inactivated hiv-1
877740|NCT00001445|Therapeutic HIV Vaccine|therapeutic hiv vaccine
877741|NCT00001443|AIDS|aids
877742|NCT00001443|Bioavailability|bioavailability
877743|NCT00001443|Immunologic Evaluations|immunologic evaluations
877744|NCT00001443|Pharmacokinetics|pharmacokinetics
877745|NCT00001443|Toxicity|toxicity
877746|NCT00001439|Cancer|cancer
877747|NCT00001439|Immunotherapy|immunotherapy
877748|NCT00001438|HIV Infection|hiv infection
877749|NCT00001438|Immune Response|immune response
877750|NCT00001438|Pediatric|pediatric
877751|NCT00001438|Pharmacokinetics|pharmacokinetics
877752|NCT00001438|Toxicity|toxicity
877753|NCT00001437|Cytokines|cytokines
877754|NCT00001437|Fibrosis Intensity|fibrosis intensity
877755|NCT00001437|Post-Radiation Fibrosis|post-radiation fibrosis
877756|NCT00001437|Radiation Injury|radiation injury
877757|NCT00001437|Trental|trental
877758|NCT00001436|Hormone Interactions|hormone interactions
877759|NCT00001436|IGF-I|igf-i
877765|NCT00001435|Family Functioning|family functioning
877766|NCT00001435|Psychosocial Adjustment|psychosocial adjustment
877767|NCT00001435|Social Support|social support
877768|NCT00001431|Combined Modality|combined modality
877769|NCT00001431|GI Cancer|gi cancer
877770|NCT00001431|Pancreatic Cancer|pancreatic cancer
877771|NCT00001431|Radiotherapy|radiotherapy
877772|NCT00001428|Chemotherapy|chemotherapy
877773|NCT00001428|Cytokine|cytokine
877774|NCT00001428|Efficacy|efficacy
877775|NCT00001428|Palliation|palliation
877776|NCT00001428|Solid Tumor|solid tumor
877777|NCT00001427|Pharmacodynamic Studies|pharmacodynamic studies
877778|NCT00001427|Pharmacokinetics|pharmacokinetics
877779|NCT00001424|AIDS|aids
877780|NCT00001424|Children|children
877781|NCT00001424|Human Immunodeficiency Virus|human immunodeficiency virus
877782|NCT00001422|Adenine Analogue|adenine analogue
877783|NCT00001422|Apoptosis|apoptosis
877784|NCT00001422|Cytokines|cytokines
877785|NCT00001422|Psoriasis|psoriasis
877786|NCT00001422|Synovium|synovium
877787|NCT00001422|Psoriatic Arthritis|psoriatic arthritis
877788|NCT00001421|Cytotoxicity|cytotoxicity
877789|NCT00001421|HLA Class I|hla class i
877790|NCT00001421|Lymphocytes|lymphocytes
877791|NCT00001421|Muscle|muscle
877792|NCT00001421|Myositis|myositis
877793|NCT00001421|Thionamides|thionamides
877794|NCT00001421|Dermatomyositis|dermatomyositis
877795|NCT00001421|Polymyositis|polymyositis
877796|NCT00001416|Bone Disease|bone disease
877797|NCT00001416|Calcitriol|calcitriol
877798|NCT00001416|Enzyme Replacement Therapy|enzyme replacement therapy
896998|NCT00000383|Human|human
877799|NCT00001416|Gaucher's Disease|gaucher's disease
877800|NCT00001416|Vitamin D|vitamin d
877801|NCT00001415|IL-1|il-1
877802|NCT00001415|IL-6|il-6
877803|NCT00001415|Immune Response|immune response
877804|NCT00001415|Inflammation|inflammation
877805|NCT00001415|Steroids|steroids
877806|NCT00001415|Chronic Fatigue Syndrome|chronic fatigue syndrome
877807|NCT00001415|Depression|depression
877808|NCT00001415|Fibromyalgia|fibromyalgia
877809|NCT00001415|Normal Volunteer|normal volunteer
877810|NCT00001402|Dilated Cardiomyopathy|dilated cardiomyopathy
877811|NCT00001402|Hibernating Myocardium|hibernating myocardium
877812|NCT00001402|Ischemic Cardiomyopathy|ischemic cardiomyopathy
877813|NCT00001402|Metoprolol|metoprolol
877814|NCT00001402|Stress Thallium Scintigraphy|stress thallium scintigraphy
877815|NCT00001402|Congestive Cardiomyopathy|congestive cardiomyopathy
877816|NCT00001402|Congestive Heart Failure|congestive heart failure
877817|NCT00001402|Heart Failure|heart failure
877818|NCT00001395|Cataracts|cataracts
877819|NCT00001395|Complications|complications
877820|NCT00001395|Rates of Progression|rates of progression
877821|NCT00001395|Diabetic Retinopathy|diabetic retinopathy
877822|NCT00001387|Paclitaxel|paclitaxel
877823|NCT00001387|Pediatric|pediatric
877824|NCT00001387|Pharmacokinetics|pharmacokinetics
877825|NCT00001387|Phase I|phase i
877826|NCT00001387|Toxicity|toxicity
877827|NCT00001385|Cancer Diagnosis|cancer diagnosis
877828|NCT00001385|Cancer Metabolism|cancer metabolism
877829|NCT00001385|FDG|fdg
877830|NCT00001385|FDG Breast Imaging|fdg breast imaging
877831|NCT00001385|PET|pet
877832|NCT00001385|Positron Emission Mammography|positron emission mammography
877833|NCT00001385|Radiopharmaceutical|radiopharmaceutical
877834|NCT00001385|Scintimammography|scintimammography
877835|NCT00001384|14-Day Cycle|14-day cycle
877836|NCT00001384|Dose Intensity|dose intensity
877837|NCT00001384|Filgrastim|filgrastim
877838|NCT00001384|Lymph Node Positive|lymph node positive
877839|NCT00001384|Non-Cross Resistant|non-cross resistant
877840|NCT00001383|Cyclosporine Analogue|cyclosporine analogue
877841|NCT00001383|Multidrug Resistance|multidrug resistance
877842|NCT00001383|Pgp Blocker|pgp blocker
877843|NCT00001383|Pump Blocker|pump blocker
877844|NCT00001383|Taxol Over 90 Hours|taxol over 90 hours
877845|NCT00001382|Immunotherapy|immunotherapy
877846|NCT00001382|Vaccine|vaccine
877847|NCT00001381|Adult|adult
877848|NCT00001381|Intravesical Chemotherapy|intravesical chemotherapy
877849|NCT00001378|4-Quadrant Fine Needle Aspiration|4-quadrant fine needle aspiration
877850|NCT00001378|Biomarkers|biomarkers
877851|NCT00001378|Chemoprevention|chemoprevention
877852|NCT00001378|Nipple Suction Aspirates|nipple suction aspirates
877853|NCT00001378|TGF Beta|tgf beta
877854|NCT00001377|Familial|familial
877855|NCT00001377|Inherited Prostate Cancer|inherited prostate cancer
877856|NCT00001377|Linkage|linkage
877857|NCT00001377|Prostate Cancer|prostate cancer
877858|NCT00001376|Androgens|androgens
877859|NCT00001376|Female|female
877860|NCT00001376|Immunology|immunology
877861|NCT00001376|Neuroendocrine Axis|neuroendocrine axis
877862|NCT00001376|Rheumatoid Arthritis|rheumatoid arthritis
877863|NCT00001376|Postpartum|postpartum
877864|NCT00001376|Pregnancy|pregnancy
877865|NCT00001375|Infection|infection
877866|NCT00001375|Reactive Arthritis|reactive arthritis
877867|NCT00001375|Rheumatoid Arthritis|rheumatoid arthritis
877868|NCT00001375|Synovial Biopsy|synovial biopsy
877869|NCT00001375|Synovial Fluid|synovial fluid
877871|NCT00001371|Inflammation|inflammation
877872|NCT00001371|Lipocortin|lipocortin
877873|NCT00001371|Phospholipase A-2|phospholipase a-2
877874|NCT00001371|Skin|skin
877875|NCT00001371|Uteroglobin|uteroglobin
877876|NCT00001371|Psoriasis|psoriasis
877877|NCT00001365|Dextromethorphan|dextromethorphan
877878|NCT00001365|Dextrorphan|dextrorphan
877879|NCT00001365|Glutamate Antagonist|glutamate antagonist
877880|NCT00001365|Parkinson's Disease|parkinson's disease
877881|NCT00001363|Blood Flow|blood flow
877882|NCT00001363|Chess Play|chess play
877883|NCT00001363|Frontal Lobe|frontal lobe
877884|NCT00001363|Neurobehavioral Deficits|neurobehavioral deficits
877885|NCT00001363|Neuropsychology|neuropsychology
877886|NCT00001363|Positron Emission Tomography|positron emission tomography
877887|NCT00001363|Prefrontal Cortex|prefrontal cortex
877888|NCT00001346|Diabetic Macular Edema|diabetic macular edema
877889|NCT00001346|Diabetic Retinopathy|diabetic retinopathy
877890|NCT00001346|Macular Edema|macular edema
877891|NCT00001346|Photocoagulation|photocoagulation
877892|NCT00001346|Psychophysical Testing|psychophysical testing
877893|NCT00001346|Stiles-Crawford Effect|stiles-crawford effect
877894|NCT00001344|Diabetes Mellitus|diabetes mellitus
877895|NCT00001344|Diabetic Neuropathy|diabetic neuropathy
877896|NCT00001344|Memantine|memantine
877897|NCT00001344|NMDA Receptor Antagonists|nmda receptor antagonists
877898|NCT00001344|Neuropathic Pain|neuropathic pain
877899|NCT00001344|Neuropathy|neuropathy
877900|NCT00001344|Post-Herpetic Neuralgia|post-herpetic neuralgia
877901|NCT00001344|Shingles|shingles
896999|NCT00000383|Male|male
877902|NCT00001342|Electrooculography|electrooculography
877903|NCT00001342|Electroretinogram|electroretinogram
877904|NCT00001342|Fluorescein Angiogram|fluorescein angiogram
877905|NCT00001342|Glycogen Storage Disease|glycogen storage disease
877906|NCT00001341|Antifolate|antifolate
877907|NCT00001341|Inhibitor|inhibitor
877908|NCT00001341|Pharmacokinetics|pharmacokinetics
877909|NCT00001341|Thymidylate Synthetase|thymidylate synthetase
877910|NCT00001341|Toxicity|toxicity
877911|NCT00001338|Fusion Protein|fusion protein
877912|NCT00001333|Intraventricular|intraventricular
877913|NCT00001333|Meningeal Malignancy|meningeal malignancy
877914|NCT00001333|NSC 609699|nsc 609699
877915|NCT00001333|SKF 104864|skf 104864
877916|NCT00001333|Topoisomerase 1|topoisomerase 1
877917|NCT00001332|Cancer Treatment|cancer treatment
877918|NCT00001332|Chemotherapy|chemotherapy
877919|NCT00001332|Regional Therapy|regional therapy
877920|NCT00001332|Surgery|surgery
877921|NCT00001330|Autoimmune Diseases|autoimmune diseases
877922|NCT00001330|Connective Tissue Disease|connective tissue disease
877923|NCT00001330|Scleroderma|scleroderma
877924|NCT00001330|Silicone Device Implants|silicone device implants
877925|NCT00001330|Silicone Injection|silicone injection
877926|NCT00001330|Idiopathic Scleroderma|idiopathic scleroderma
877927|NCT00001330|Myositis|myositis
877928|NCT00001330|Systemic Sclerosis|systemic sclerosis
877929|NCT00001324|Ataxia|ataxia
877930|NCT00001324|Brain|brain
877931|NCT00001324|Motor Learning|motor learning
877932|NCT00001324|Parkinson's Disease|parkinson's disease
877933|NCT00001324|Physiology|physiology
877934|NCT00001324|Positron Emission Tomography|positron emission tomography
877935|NCT00001324|Stroke|stroke
877936|NCT00001324|Tremor|tremor
877937|NCT00001324|Voluntary and Involuntary Movement Physiology|voluntary and involuntary movement physiology
877938|NCT00001324|Movement Disorders|movement disorders
877939|NCT00001324|Normal Volunteer|normal volunteer
877940|NCT00001318|Immune Adjuvant|immune adjuvant
877941|NCT00001318|Phagocytes|phagocytes
877942|NCT00001318|Non-tuberculous Mycobacterial Infection|non-tuberculous mycobacterial infection
877943|NCT00001317|Children|children
877944|NCT00001317|Gamma Interferon|gamma interferon
877945|NCT00001317|Hospitalizations|hospitalizations
877946|NCT00001317|Infection|infection
877947|NCT00001317|Chronic Granulomatous Disease|chronic granulomatous disease
877948|NCT00001314|Aortic Regurgitation|aortic regurgitation
877949|NCT00001314|Dobutamine Stress|dobutamine stress
877950|NCT00001314|Left Ventricular Function|left ventricular function
877951|NCT00001314|Mitral Regurgitation|mitral regurgitation
877952|NCT00001314|Myocardial Contractile Reserve|myocardial contractile reserve
877953|NCT00001314|Transesophageal Echocardiography|transesophageal echocardiography
877954|NCT00001311|Cell/Flare Meter|cell/flare meter
877955|NCT00001311|Heparin Coating|heparin coating
877956|NCT00001311|Inflammation|inflammation
877957|NCT00001311|Laser Cell Flare Photometry|laser cell flare photometry
877958|NCT00001311|Multicentric|multicentric
877959|NCT00001311|Polymethylmetacrylate|polymethylmetacrylate
877960|NCT00001311|Specular Micrography|specular micrography
877961|NCT00001311|Specular Microscopy|specular microscopy
877962|NCT00001301|Adverse Effects|adverse effects
877963|NCT00001301|Burkitt's Lymphoma|burkitt's lymphoma
877964|NCT00001301|Diffuse Large Cell Lymphoma|diffuse large cell lymphoma
877965|NCT00001301|Extended Remission|extended remission
877966|NCT00001301|Health Status|health status
877967|NCT00001301|Lymphoblastic Lymphoma|lymphoblastic lymphoma
877968|NCT00001301|Molecular Studies|molecular studies
877969|NCT00001300|Adjuvant Chemotherapy|adjuvant chemotherapy
877970|NCT00001300|Ifosfamide|ifosfamide
877971|NCT00001300|Randomized Study|randomized study
877972|NCT00001300|Soft Tissue Sarcoma|soft tissue sarcoma
877973|NCT00001298|Antibody|antibody
877975|NCT00001298|Enzyme|enzyme
877976|NCT00001298|Kidney|kidney
877977|NCT00001298|Pharmacokinetics|pharmacokinetics
877978|NCT00001298|Thymidine|thymidine
877979|NCT00001298|Toxicity|toxicity
877980|NCT00001296|Interferon-Gamma|interferon-gamma
877981|NCT00001296|Isolated Limb Perfusion|isolated limb perfusion
877982|NCT00001296|Melanoma|melanoma
877983|NCT00001296|Melphalan|melphalan
877984|NCT00001296|TNF|tnf
877985|NCT00001292|DNA Markers|dna markers
877986|NCT00001292|Family Studies|family studies
877987|NCT00001292|Gene Mapping|gene mapping
877988|NCT00001292|Ichthyosis|ichthyosis
877989|NCT00001292|Keratin|keratin
877990|NCT00001292|Linkage Analysis|linkage analysis
877991|NCT00001292|Scaling Disorders|scaling disorders
877992|NCT00001292|Skin|skin
877993|NCT00001291|Osteoarthritis|osteoarthritis
877994|NCT00001291|Psoriatic Arthritis|psoriatic arthritis
877995|NCT00001291|Rheumatoid Arthritis|rheumatoid arthritis
877996|NCT00001291|Synovial Biopsy|synovial biopsy
877997|NCT00001291|Synovitis|synovitis
877998|NCT00001291|Synovium|synovium
877999|NCT00001287|Intravenous High-Dose Immunoglobulin|intravenous high-dose immunoglobulin
878000|NCT00001287|Monoclonal Gammopathies|monoclonal gammopathies
878001|NCT00001287|Peripheral Nerve Demyelination|peripheral nerve demyelination
878002|NCT00001287|CIDP|cidp
878003|NCT00001287|Chronic Inflammatory Demyelinating Polyneuropathy|chronic inflammatory demyelinating polyneuropathy
878004|NCT00001285|Circadian Rhythms|circadian rhythms
878005|NCT00001285|Environmental Light|environmental light
878006|NCT00001285|Estrogen|estrogen
878007|NCT00001285|Melatonin|melatonin
878008|NCT00001285|Progesterone|progesterone
878009|NCT00001285|Rapid Cycling Bipolar Disorder|rapid cycling bipolar disorder
878010|NCT00001285|Sleep|sleep
878011|NCT00001285|Testosterone|testosterone
878012|NCT00001285|Depression|depression
878013|NCT00001285|Hypomania|hypomania
878014|NCT00001285|Mania|mania
878015|NCT00001280|Aspergillosis|aspergillosis
878016|NCT00001280|Phagocyte Defect|phagocyte defect
878017|NCT00001280|Torulopsis|torulopsis
878018|NCT00001280|Chronic Granulomatous Disease|chronic granulomatous disease
878019|NCT00001278|Conjunctival Biopsy|conjunctival biopsy
878020|NCT00001278|Lacrimal Gland Biopsy|lacrimal gland biopsy
878021|NCT00001278|Sarcoid Uveitis|sarcoid uveitis
878022|NCT00001278|Sarcoidosis|sarcoidosis
878023|NCT00001278|Conjunctiva|conjunctiva
878024|NCT00001278|Inflammatory Eye Disease|inflammatory eye disease
878025|NCT00001272|Adult|adult
878026|NCT00001272|Cytotoxic Chemotherapy|cytotoxic chemotherapy
878027|NCT00001272|Hematopoietic Growth Factor|hematopoietic growth factor
878028|NCT00001271|Antigen Modulation|antigen modulation
878029|NCT00001271|Pharmacokinetics|pharmacokinetics
878030|NCT00001271|Ricin A Chain|ricin a chain
878031|NCT00001270|Chemotherapy|chemotherapy
878032|NCT00001270|High Dose|high dose
878033|NCT00001270|Protection|protection
878034|NCT00001269|Dose-Intensive Chemotherapy|dose-intensive chemotherapy
878035|NCT00001269|Hematopoietic Growth Factor|hematopoietic growth factor
878036|NCT00001269|Peripheral Blood Progenitor Cell|peripheral blood progenitor cell
878037|NCT00001267|Anti-Viral|anti-viral
878038|NCT00001267|Dideoxynucleosides|dideoxynucleosides
878039|NCT00001267|HIV|hiv
878040|NCT00001267|Retrovirus|retrovirus
878041|NCT00001249|Interleukin-2 Receptor|interleukin-2 receptor
878042|NCT00001239|5-Fluorouracil|5-fluorouracil
878043|NCT00001239|Adriamycin|adriamycin
878044|NCT00001239|Breast Carcinoma|breast carcinoma
878045|NCT00001239|Leucovorin|leucovorin
878046|NCT00001239|Phase II|phase ii
878047|NCT00001237|Burkitt's Lymphoma|burkitt's lymphoma
878048|NCT00001237|GM-CSF|gm-csf
878049|NCT00001237|High-Grade|high-grade
878050|NCT00001233|Adolescence|adolescence
878051|NCT00001233|Aggressivity|aggressivity
878052|NCT00001233|Anger|anger
878053|NCT00001233|Developmental Psychopathology|developmental psychopathology
878054|NCT00001233|Disruptive Behavior Disorders|disruptive behavior disorders
878055|NCT00001233|Early Onset Aggression|early onset aggression
878056|NCT00001233|Emotion Regulation|emotion regulation
878057|NCT00001233|Family Violence|family violence
878058|NCT00001233|Preschool Conduct Problems|preschool conduct problems
878059|NCT00001232|Depression|depression
878060|NCT00001232|FSH|fsh
878061|NCT00001232|GnRH|gnrh
878062|NCT00001232|LH|lh
878063|NCT00001232|Menopause|menopause
878064|NCT00001232|Menstrual Cycle|menstrual cycle
878065|NCT00001229|Calcium-Pentagastrin|calcium-pentagastrin
878066|NCT00001229|Clonidine|clonidine
878067|NCT00001229|Glucagon|glucagon
878069|NCT00001218|Baseline Data|baseline data
878070|NCT00001218|Curve Averaging|curve averaging
878071|NCT00001218|Curve Fitting|curve fitting
878072|NCT00001218|Movement Patterns|movement patterns
878073|NCT00001218|Normative Data|normative data
878074|NCT00001218|Polar Distribution|polar distribution
878076|NCT00001218|Tongue Shape|tongue shape
878077|NCT00001218|Ultrasound|ultrasound
878078|NCT00001217|Non-Metastatic Osteosarcoma|non-metastatic osteosarcoma
878079|NCT00001217|Presurgical Chemotherapy|presurgical chemotherapy
878080|NCT00001216|Amputations|amputations
878081|NCT00001216|Brainstem Stimulation|brainstem stimulation
878082|NCT00001216|Cerebellar Stimulation|cerebellar stimulation
878083|NCT00001216|Cortical Motor Physiology|cortical motor physiology
878084|NCT00001216|Electrical Stimulation|electrical stimulation
878085|NCT00001216|Motor Cortex|motor cortex
878086|NCT00001216|Plasticity|plasticity
878087|NCT00001216|Spinal Cord Injury|spinal cord injury
878088|NCT00001216|Stroke|stroke
878089|NCT00001211|Ectodermal Dysplasia|ectodermal dysplasia
878090|NCT00001211|Edentulous|edentulous
878091|NCT00001211|Endosseous|endosseous
878092|NCT00001211|Implants|implants
878093|NCT00001211|Mandibular Atrophy|mandibular atrophy
878094|NCT00001211|Oral|oral
878095|NCT00001211|Titanium|titanium
878096|NCT00001210|Blood Donors|blood donors
878097|NCT00001210|Epitopes|epitopes
878098|NCT00001210|HIV|hiv
878099|NCT00001209|Combined Chemotherapy|combined chemotherapy
878100|NCT00001209|Irradiation|irradiation
878101|NCT00001209|Unresectable|unresectable
878102|NCT00001194|Helium Cryogen|helium cryogen
878103|NCT00001194|Magnetic Field|magnetic field
878104|NCT00001194|Multi-Institute|multi-institute
878105|NCT00001194|Nitrogen Cryogen|nitrogen cryogen
878106|NCT00001194|Radiofrequency|radiofrequency
878107|NCT00001193|Autologous|autologous
878108|NCT00001193|Melphalan|melphalan
878110|NCT00001193|Transplantation|transplantation
878111|NCT00001189|Adjuvant Radiotherapy|adjuvant radiotherapy
878112|NCT00001189|Low-Grade Sarcoma|low-grade sarcoma
878113|NCT00001189|Radiotherapy|radiotherapy
878114|NCT00001189|Randomized Study|randomized study
878115|NCT00001189|Sarcoma|sarcoma
878116|NCT00001189|Surgery|surgery
878117|NCT00001188|Chemotherapy|chemotherapy
878118|NCT00001188|Radiation Therapy|radiation therapy
878119|NCT00001188|Sarcoma|sarcoma
878120|NCT00001188|Surgery|surgery
878121|NCT00001173|B Cells|b cells
878122|NCT00001173|Humoral Immunity|humoral immunity
878123|NCT00001173|Lymphocytes|lymphocytes
878124|NCT00001173|Tetanus Toxoid|tetanus toxoid
878125|NCT00001169|Chemotherapy|chemotherapy
878126|NCT00001169|Cytokines|cytokines
878127|NCT00001169|Immunology|immunology
878128|NCT00001169|Kala-Azar|kala-azar
878129|NCT00001169|Leishmaniasis|leishmaniasis
878130|NCT00001164|Genetic Evaluation|genetic evaluation
878131|NCT00001164|Immunologic Evaluations|immunologic evaluations
878132|NCT00001164|Inflammatory Skin Disease|inflammatory skin disease
878133|NCT00001164|Muscular Dystrophies|muscular dystrophies
878134|NCT00001164|Neoplastic Skin Diseases|neoplastic skin diseases
878135|NCT00001164|Neuronal Degenerations|neuronal degenerations
878136|NCT00001164|Retinal Degenerations|retinal degenerations
878137|NCT00001164|Viral Diseases|viral diseases
878138|NCT00001158|Cellular Immunity|cellular immunity
878139|NCT00001158|Humoral Immunity|humoral immunity
878140|NCT00001158|Immunodeficiency Disease|immunodeficiency disease
878141|NCT00001153|Albinism|albinism
878142|NCT00001153|Ocular Albinism|ocular albinism
878143|NCT00001153|Oculocutaneous Albinism|oculocutaneous albinism
878144|NCT00001153|Tyrosinase Negative|tyrosinase negative
878145|NCT00001153|Tyrosinase Positive|tyrosinase positive
878146|NCT00001152|Aqueous Humor Dynamics|aqueous humor dynamics
878147|NCT00001152|Glaucoma|glaucoma
878148|NCT00001152|Ocular Hypertension|ocular hypertension
878149|NCT00001152|Pigment Dispersion Syndrome|pigment dispersion syndrome
878150|NCT00001152|Primary Open Angle Glaucoma|primary open angle glaucoma
878151|NCT00001152|Pseudo-Exfoliation of the Lens Capsule|pseudo-exfoliation of the lens capsule
878152|NCT00001142|Body Fat|body fat
878153|NCT00001142|DXA|dxa
878154|NCT00001142|HAART|haart
878155|NCT00001142|Hyperlipidemia|hyperlipidemia
878156|NCT00001142|Insulin Resistance|insulin resistance
878157|NCT00001142|Lipodystrophy|lipodystrophy
878158|NCT00001142|MRI|mri
878159|NCT00001142|Protease Inhibitor|protease inhibitor
878160|NCT00001142|Side-Effects|side-effects
878161|NCT00001142|Visceral Fat|visceral fat
878162|NCT00001142|Chronic Infection|chronic infection
878163|NCT00001142|HIV|hiv
878164|NCT00001142|Healthy Volunteer|healthy volunteer
878165|NCT00050388|Cancer|cancer
878166|NCT00050388|Carcinoma|carcinoma
878167|NCT00050388|Neoplasm|neoplasm
878168|NCT00050388|Head cancer|head cancer
878169|NCT00050388|Neck cancer|neck cancer
878170|NCT00050388|Tongue cancer|tongue cancer
878171|NCT00050388|Lip cancer|lip cancer
878172|NCT00050388|Oral Cavity|oral cavity
878173|NCT00050388|Oropharynx|oropharynx
878174|NCT00050388|Pharynx|pharynx
878175|NCT00050388|Larynx|larynx
878176|NCT00050388|Squamous Cell|squamous cell
878177|NCT00050388|Salivary Glands|salivary glands
878178|NCT00050388|Tumor|tumor
878179|NCT00050388|Lesion|lesion
878180|NCT00050388|Cancer treatment|cancer treatment
878181|NCT00050388|Clinical trial|clinical trial
878182|NCT00050388|Allovectin-7®|allovectin-7®
878183|NCT00050388|Otorhinolaryngologic Neoplasm|otorhinolaryngologic neoplasm
878184|NCT00050388|Otolaryngologic Cancer|otolaryngologic cancer
878185|NCT00050388|Gene therapy|gene therapy
878186|NCT00050388|Immunotherapy|immunotherapy
878187|NCT00050388|Cancer research|cancer research
878188|NCT00050388|Cancer vaccine|cancer vaccine
878189|NCT00050388|Cancer cells|cancer cells
878190|NCT00050375|OvaRex|ovarex
878191|NCT00050375|ovarian|ovarian
878192|NCT00050375|CA125|ca125
878193|NCT00050375|murine|murine
878194|NCT00050375|antibody|antibody
878195|NCT00050375|immunotherapy|immunotherapy
878196|NCT00050362|Pain|pain
878197|NCT00050362|NSAID|nsaid
878198|NCT00050362|Oral Surgery|oral surgery
878199|NCT00050362|Hyperalgesia|hyperalgesia
878200|NCT00050362|Preemptive Analgesia|preemptive analgesia
878201|NCT00050349|cancer|cancer
878202|NCT00050349|tumor|tumor
878203|NCT00050349|tumour|tumour
878204|NCT00050349|neoplasm|neoplasm
878205|NCT00050349|carcinoma|carcinoma
878206|NCT00050349|carcinoid|carcinoid
878207|NCT00050349|neuroendocrine|neuroendocrine
878208|NCT00050349|Islet cell|islet cell
878209|NCT00050349|Gastrinoma|gastrinoma
878210|NCT00050349|VIPoma|vipoma
878211|NCT00050349|metastatic|metastatic
878212|NCT00050349|intravenous|intravenous
878213|NCT00050349|epothilone|epothilone
878214|NCT00050336|Stage 3b or 4 (metastatic) non-small cell lung cancer|stage 3b or 4 (metastatic) non-small cell lung cancer
878215|NCT00050323|Stage IV Renal Cell Carcinoma|stage iv renal cell carcinoma
878216|NCT00050323|Kidney Cancer|kidney cancer
878217|NCT00050323|Cancer (General)|cancer (general)
878218|NCT00050310|Anthrax|anthrax
878219|NCT00050310|Natural History|natural history
878220|NCT00050310|Vaccinated Healthy Volunteer|vaccinated healthy volunteer
878221|NCT00050284|Treatment Experienced|treatment experienced
878222|NCT00050284|Disease Progression|disease progression
878223|NCT00050284|Anti-HIV Agents|anti-hiv agents
878224|NCT00050284|Treatment Interruption|treatment interruption
878225|NCT00050271|Acetylcarnitine|acetylcarnitine
878226|NCT00050271|Dideoxynucleosides|dideoxynucleosides
878227|NCT00050271|Epidermis|epidermis
878228|NCT00050271|Biopsy|biopsy
878229|NCT00050271|Immunohistochemistry|immunohistochemistry
878230|NCT00050271|Nerve Fibers|nerve fibers
878231|NCT00050271|Treatment Experienced|treatment experienced
878232|NCT00050245|Neuropathy|neuropathy
878233|NCT00050245|B Cells|b cells
878234|NCT00050245|Anti-MAG|anti-mag
878235|NCT00050245|Demyelination|demyelination
878236|NCT00050245|MAG|mag
878237|NCT00050245|RITUXAN|rituxan
878238|NCT00050245|Monoclonal Antibodies|monoclonal antibodies
878239|NCT00050245|Retuximab|retuximab
878240|NCT00050245|Demyelinating Neuropathy|demyelinating neuropathy
878241|NCT00050232|Pseudobulbar Affect|pseudobulbar affect
878242|NCT00050232|Uncontrolled|uncontrolled
878243|NCT00050232|Laughing|laughing
878244|NCT00050232|Crying|crying
878245|NCT00050219|Raclopride|raclopride
878246|NCT00050219|D2 Receptors|d2 receptors
878247|NCT00050219|Striatum|striatum
878248|NCT00050219|Low-Response|low-response
878249|NCT00050219|Alcoholism|alcoholism
878250|NCT00050219|Alcohol|alcohol
878251|NCT00050219|Dopamine|dopamine
878252|NCT00050219|Response|response
878253|NCT00050141|Breast cancer|breast cancer
878254|NCT00050141|ZARNESTRA|zarnestra
878255|NCT00050141|tipifarnib|tipifarnib
878256|NCT00050141|R115777|r115777
878257|NCT00050141|Estrogen receptor positive|estrogen receptor positive
878258|NCT00050141|Progesterone receptor positive|progesterone receptor positive
878259|NCT00050141|Anti-estrogen therapy|anti-estrogen therapy
878260|NCT00050167|Breast Cancer|breast cancer
878261|NCT00050167|Capecitabine|capecitabine
878262|NCT00050167|Docetaxel|docetaxel
878263|NCT00050167|Paclitaxel|paclitaxel
878264|NCT00050167|Taxotere|taxotere
878265|NCT00050167|Taxol|taxol
878266|NCT00050167|Xeloda|xeloda
878267|NCT00050167|Taxanes|taxanes
878268|NCT00050167|Operable Breast Cancer|operable breast cancer
878269|NCT00050193|Children|children
878270|NCT00050193|Mast Cells|mast cells
878271|NCT00050193|Urticaria Pigmentosa|urticaria pigmentosa
878272|NCT00050193|Bone Marrow|bone marrow
878273|NCT00050193|Severe|severe
878274|NCT00050193|Mastocytosis|mastocytosis
878275|NCT00050193|Pediatric Mastocytosis|pediatric mastocytosis
878276|NCT00050180|P-Glycoprotein|p-glycoprotein
878277|NCT00050180|Protease Inhibitor|protease inhibitor
878278|NCT00050180|Antiretrovirals|antiretrovirals
878279|NCT00050180|Cytochrome P450|cytochrome p450
878280|NCT00050180|Drug Transporters|drug transporters
878281|NCT00050180|Healthy Volunteer|healthy volunteer
878282|NCT00050180|HV|hv
878283|NCT00050154|R115777|r115777
878284|NCT00050154|Myelodysplastic syndromes|myelodysplastic syndromes
878285|NCT00050154|Tipifarnib|tipifarnib
878286|NCT00050154|Zarnestra|zarnestra
878287|NCT00050128|Rehabilitation|rehabilitation
878288|NCT00050128|Plasticity|plasticity
878294|NCT00050089|antiretrovirals|antiretrovirals
878295|NCT00050089|ART|art
878296|NCT00050089|drug-free period|drug-free period
878297|NCT00050089|HAART|haart
878298|NCT00050089|HIV|hiv
878299|NCT00050089|human immunodeficiency virus|human immunodeficiency virus
878300|NCT00050089|randomized|randomized
878301|NCT00050089|structured treatment interruptions|structured treatment interruptions
878302|NCT00050076|Congestive Heart Failure|congestive heart failure
878303|NCT00050076|Cardiac Failure|cardiac failure
878304|NCT00050076|Heart Decompensation|heart decompensation
878305|NCT00050076|Drug Therapy|drug therapy
878306|NCT00050063|HIV Therapeutic Vaccine|hiv therapeutic vaccine
878307|NCT00050063|Treatment Experienced|treatment experienced
878308|NCT00050063|AIDS Vaccines|aids vaccines
878309|NCT00050063|Treatment Interruption|treatment interruption
878310|NCT00050063|Viral Load|viral load
878311|NCT00050063|T-Lymphocytes, Cytotoxic|t-lymphocytes, cytotoxic
878312|NCT00050063|T-Lymphocytes, Helper-Inducer|t-lymphocytes, helper-inducer
878313|NCT00050050|Adult|adult
878314|NCT00050050|ADHD|adhd
878315|NCT00050050|ADD|add
878316|NCT00050115|Bone Marrow Failure|bone marrow failure
878317|NCT00050115|Seronegative Hepatitis|seronegative hepatitis
878318|NCT00050115|Fulminate Hepatitis|fulminate hepatitis
878319|NCT00050115|Hepatitis|hepatitis
878320|NCT00050115|Aplastic Anemia|aplastic anemia
878321|NCT00050115|Hepatitis Associated Aplastic Anemia|hepatitis associated aplastic anemia
878322|NCT00050024|TMS|tms
878323|NCT00050024|Afferent Stimulation|afferent stimulation
878324|NCT00050024|Motor Cortex|motor cortex
878325|NCT00050024|Writer's Cramp|writer's cramp
878326|NCT00050024|Surround Inhibition|surround inhibition
878327|NCT00050024|Heterotopic Inhibition|heterotopic inhibition
878328|NCT00050024|Focal Dystonia|focal dystonia
878329|NCT00050024|Writer Cramp|writer cramp
878330|NCT00050011|cancer-treatment related bone loss|cancer-treatment related bone loss
878331|NCT00050011|postmenopausal women|postmenopausal women
878332|NCT00050011|breast cancer|breast cancer
878333|NCT00050011|hormone receptor positive breast cancer|hormone receptor positive breast cancer
878334|NCT00050011|adjuvant therapy|adjuvant therapy
878335|NCT00050011|hormonal therapy|hormonal therapy
878336|NCT00050011|bone loss|bone loss
878337|NCT00050011|bisphosphonates|bisphosphonates
878338|NCT00050011|ZFAST|zfast
878339|NCT00050011|Letrozole|letrozole
878340|NCT00050011|Zoledronic Acid|zoledronic acid
878341|NCT00050011|US32|us32
878342|NCT00049998|Nonsmall Cell Lung cancer|nonsmall cell lung cancer
878343|NCT00049998|advanced|advanced
878344|NCT00049998|Second-line|second-line
878345|NCT00049998|topotecan|topotecan
878346|NCT00049998|Hycamtin|hycamtin
878347|NCT00049998|oral|oral
878348|NCT00049998|docetaxel|docetaxel
878349|NCT00049972|Major Depressive Disorder Open-label discontinued|major depressive disorder open-label discontinued
878350|NCT00049959|Verteporfin PDT|verteporfin pdt
878351|NCT00049959|multiple basal cell carcinoma|multiple basal cell carcinoma
878352|NCT00049959|nevoid basal cell carcinoma syndrome|nevoid basal cell carcinoma syndrome
878353|NCT00049946|Talnetant|talnetant
878354|NCT00049946|schizophrenia|schizophrenia
878355|NCT00049946|NK3 receptor antagonist|nk3 receptor antagonist
878356|NCT00049946|psychosis|psychosis
878357|NCT00049829|Bisphosphonate,BMD,Height loss, Hip protectors,HRT,|bisphosphonate,bmd,height loss, hip protectors,hrt,
878358|NCT00049829|Osteoporosis|osteoporosis
878359|NCT00049816|knee|knee
878360|NCT00049816|aerobic exercise|aerobic exercise
878361|NCT00049816|walking|walking
878362|NCT00049816|cycling|cycling
878363|NCT00049816|gait|gait
878364|NCT00049816|MRI|mri
878365|NCT00049803|Narcolepsy|narcolepsy
878366|NCT00049803|Sodium Oxybate|sodium oxybate
878367|NCT00049803|Cataplexy|cataplexy
878368|NCT00049803|Excessive Daytime Sleepiness|excessive daytime sleepiness
878369|NCT00049803|GHB|ghb
878370|NCT00049803|Gamma Hydroxybutyric Acid|gamma hydroxybutyric acid
878371|NCT00049803|Orphan Medical|orphan medical
878372|NCT00049803|Orphan Drug|orphan drug
878373|NCT00049790|Advanced non-small cell lung cancer|advanced non-small cell lung cancer
878374|NCT00049738|Psychosis|psychosis
878375|NCT00049738|Childhood Onset Schizophrenia|childhood onset schizophrenia
878376|NCT00049738|Schizophrenia|schizophrenia
878377|NCT00049738|Schizoaffective|schizoaffective
878378|NCT00049738|Psychotic Disorder|psychotic disorder
878379|NCT00049738|Multidimensionally Impaired Syndrome|multidimensionally impaired syndrome
878380|NCT00049725|Autoimmune Disease|autoimmune disease
878381|NCT00049725|Monoclonal Antibody Therapy|monoclonal antibody therapy
878382|NCT00049725|Anti-IL2 Receptor|anti-il2 receptor
878383|NCT00049725|Platelets|platelets
878384|NCT00049725|Monoclonal Antibody|monoclonal antibody
878385|NCT00049725|Immune Thrombocytopenia|immune thrombocytopenia
878386|NCT00049725|ITP|itp
878387|NCT00048841|Male|male
878388|NCT00048841|Osteoporosis|osteoporosis
878389|NCT00048841|Prostate cancer|prostate cancer
878390|NCT00048841|Hypogonadism|hypogonadism
878391|NCT00048841|Bisphosphonates|bisphosphonates
878392|NCT00048841|Bone mineral density|bone mineral density
878393|NCT00048815|Minor Depression|minor depression
878394|NCT00048815|St. John's Wart|st. john's wart
878395|NCT00048802|Adolescence|adolescence
878396|NCT00048906|Pharmacokinetics|pharmacokinetics
878397|NCT00048906|Enzyme|enzyme
878398|NCT00048906|Lysosomal|lysosomal
878399|NCT00048906|Kidney|kidney
878400|NCT00048906|Stroke|stroke
878401|NCT00048906|Fabry Disease|fabry disease
878402|NCT00048906|Fabrys|fabrys
878403|NCT00048906|Fabry's|fabry's
878404|NCT00048893|CEA vaccine|cea vaccine
878405|NCT00048893|Metastatic Breast Cancer|metastatic breast cancer
878406|NCT00048893|T- Cell Repertoire|t- cell repertoire
878407|NCT00048893|High-dose Chemotherapy|high-dose chemotherapy
878408|NCT00048893|Breast Cancer|breast cancer
878409|NCT00048880|Anaplastic Large Cell Lymphoma|anaplastic large cell lymphoma
878410|NCT00048880|Monoclonal Antibody|monoclonal antibody
878411|NCT00048880|CD30|cd30
878412|NCT00048880|Antibody Saturation|antibody saturation
878413|NCT00048880|Apoptosis|apoptosis
878414|NCT00048880|Flow Cytometry|flow cytometry
878415|NCT00048880|Cancer|cancer
878416|NCT00048776|Secondary Raynaud's|secondary raynaud's
878417|NCT00048776|circulatory|circulatory
878418|NCT00048776|vascular|vascular
878419|NCT00048776|scleroderma|scleroderma
878420|NCT00048776|lupus|lupus
878421|NCT00048776|mixed connective tissue disease|mixed connective tissue disease
878422|NCT00048763|circulatory|circulatory
878423|NCT00048763|vascular|vascular
878424|NCT00048763|idiopathic|idiopathic
878425|NCT00048789|Psoralen|psoralen
878426|NCT00048789|Refractory|refractory
878427|NCT00048789|Transplantation|transplantation
878428|NCT00048789|Stem Cell|stem cell
878429|NCT00048789|UVA|uva
878430|NCT00048789|Graft-versus-host Disease|graft-versus-host disease
878431|NCT00048789|GVHD|gvhd
878432|NCT00048750|Anti-Fungal Therapy|anti-fungal therapy
878433|NCT00048750|Preemptive Anti-Fungal Therapy|preemptive anti-fungal therapy
878434|NCT00048750|Invasive Fungal Infection|invasive fungal infection
878435|NCT00048750|Micafungin|micafungin
878436|NCT00048750|ICU|icu
878437|NCT00048737|Leukemia|leukemia
878438|NCT00048737|Lymphoma|lymphoma
878439|NCT00048737|Lymphoid Malignancy|lymphoid malignancy
878440|NCT00048737|Cyclophosphamide|cyclophosphamide
878441|NCT00048737|Cytoxan|cytoxan
878442|NCT00048737|Neosar|neosar
878443|NCT00048737|Fludarabine|fludarabine
878444|NCT00048737|Fludarabine Phosphate|fludarabine phosphate
878445|NCT00048737|Fludara|fludara
878446|NCT00048737|Rituximab|rituximab
878447|NCT00048737|Rituxan|rituxan
878448|NCT00048737|Zevalin|zevalin
878449|NCT00048737|Indium Zevalin|indium zevalin
878450|NCT00048737|90Y Zevalin|90y zevalin
878451|NCT00048737|CD-20-positive|cd-20-positive
878452|NCT00048737|B-cell Lymphoma|b-cell lymphoma
878453|NCT00048737|CD-20-positive B-cell Lymphoma|cd-20-positive b-cell lymphoma
878454|NCT00048737|NHL|nhl
878455|NCT00048737|CLL|cll
878456|NCT00048737|Chronic Lymphocytic Leukemia|chronic lymphocytic leukemia
878457|NCT00048737|Allogeneic Stem Cell Transplantation|allogeneic stem cell transplantation
878458|NCT00048737|ASCT|asct
878459|NCT00048724|Hepatitis C; Cirrhosis|hepatitis c; cirrhosis
878460|NCT00048698|Frontal Lobe|frontal lobe
878461|NCT00048698|Motor Cortex|motor cortex
878462|NCT00048698|Dementia|dementia
878463|NCT00048698|Cognition|cognition
878464|NCT00048698|Healthy Volunteer|healthy volunteer
878465|NCT00048698|HV|hv
878466|NCT00048685|Caries|caries
878467|NCT00048685|Bacteria|bacteria
878468|NCT00048685|Saliva|saliva
878469|NCT00048685|Teeth|teeth
878470|NCT00048685|Autoimmune|autoimmune
878471|NCT00048685|Dry Mouth|dry mouth
878472|NCT00048685|Salivary Gland Dysfunction|salivary gland dysfunction
878473|NCT00048685|Sjogren's Syndrome|sjogren's syndrome
878474|NCT00048672|Early Chronic Phase Chronic Myelogenous Leukemia|early chronic phase chronic myelogenous leukemia
878475|NCT00048672|Leukemia|leukemia
878476|NCT00048672|Gleevec|gleevec
878477|NCT00048672|STI571|sti571
878478|NCT00048672|Imatinib mesylate|imatinib mesylate
878479|NCT00048659|Androgen-independent prostate cancer|androgen-independent prostate cancer
878480|NCT00048646|TBI|tbi
878481|NCT00048646|ProTECT|protect
878482|NCT00048633|Chemotherapy resistance advanced breast cancer|chemotherapy resistance advanced breast cancer
878483|NCT00048542|Polyarticular Juvenile Idiopathic Arthritis|polyarticular juvenile idiopathic arthritis
878484|NCT00048529|adenocarcinoma of the esophagus|adenocarcinoma of the esophagus
878485|NCT00048503|Zarnestra|zarnestra
878486|NCT00048503|Acute myeloid leukemia|acute myeloid leukemia
878487|NCT00048503|Tipifarnib|tipifarnib
878488|NCT00048464|Immunotherapy|immunotherapy
878489|NCT00048464|T Cell Therapy|t cell therapy
878490|NCT00048464|Peripheral Blood Stem Cell Transplant|peripheral blood stem cell transplant
878491|NCT00048464|Bone marrow transplant|bone marrow transplant
878492|NCT00048464|Adoptive immunotherapy|adoptive immunotherapy
878493|NCT00048464|Xcellerate|xcellerate
878494|NCT00048425|Decompensated chronic heart failure|decompensated chronic heart failure
878495|NCT00048490|Seizures|seizures
878496|NCT00048490|Magnetism|magnetism
878497|NCT00048490|Brain|brain
878498|NCT00048490|Stimulation|stimulation
878499|NCT00048490|Therapy|therapy
878502|NCT00048477|Vasodilation|vasodilation
878503|NCT00048477|Exercise|exercise
878504|NCT00048477|Hemoglobin|hemoglobin
878505|NCT00048477|Blood Flow|blood flow
878506|NCT00048477|Healthy Volunteer|healthy volunteer
878507|NCT00048477|HV|hv
878508|NCT00048373|LANGERHANS|langerhans
878509|NCT00048373|HISTIOCYTOSIS|histiocytosis
878510|NCT00048360|ADD|add
878511|NCT00048360|ADHD|adhd
878512|NCT00048360|attention deficit|attention deficit
878513|NCT00048360|hyperactivity|hyperactivity
878514|NCT00048308|CABG|cabg
878515|NCT00048347|Lymphocyte|lymphocyte
878516|NCT00048347|Monocyte|monocyte
878517|NCT00048347|Inflammation|inflammation
878518|NCT00048347|Th2|th2
878519|NCT00048347|Colonoscopy|colonoscopy
878520|NCT00048347|Ulcerative Colitis|ulcerative colitis
878521|NCT00048334|Histone Acetylation|histone acetylation
878522|NCT00048334|Cancer|cancer
878523|NCT00048282|Incidence|incidence
878524|NCT00048282|HIV Seroprevalence|hiv seroprevalence
878525|NCT00048282|Vagina|vagina
878526|NCT00048282|Anti-Infective Agents|anti-infective agents
878527|NCT00048282|Administration, Topical|administration, topical
878528|NCT00048282|Gels|gels
878529|NCT00048282|HIV Seronegativity|hiv seronegativity
878530|NCT00048230|Relapsed Multiple Myeloma|relapsed multiple myeloma
878531|NCT00048230|Refractory Multiple Myeloma|refractory multiple myeloma
878532|NCT00048217|Treatment Experienced|treatment experienced
878533|NCT00048204|Depression|depression
878534|NCT00048204|Psychiatry|psychiatry
878535|NCT00048204|Major Depressive Disorder|major depressive disorder
878536|NCT00048256|Cancer|cancer
878537|NCT00048256|Personality Assessment|personality assessment
878538|NCT00048256|Coping Styles|coping styles
878539|NCT00048256|Psychological Distress|psychological distress
878540|NCT00048256|Bone Marrow Transplants|bone marrow transplants
878541|NCT00048256|Bone Marrow Transplant|bone marrow transplant
878542|NCT00048113|Crohn's|crohn's
878543|NCT00048100|Dendritic cells|dendritic cells
878544|NCT00048100|Lymphocytes|lymphocytes
878545|NCT00048100|AML|aml
878546|NCT00048087|Non-small cell lung cancer|non-small cell lung cancer
878547|NCT00047983|Kidney Transplantation|kidney transplantation
878548|NCT00047983|Fatty Acids, Omega-3|fatty acids, omega-3
878549|NCT00047983|Erythrocyte Membrane|erythrocyte membrane
878550|NCT00047983|Graft Survival|graft survival
878551|NCT00047970|Breast Cancer|breast cancer
878552|NCT00047970|Sisters|sisters
878553|NCT00047827|Aspergillus|aspergillus
878554|NCT00047827|Aspergillosis|aspergillosis
878555|NCT00047827|Anti-Fungal|anti-fungal
878556|NCT00047827|AmBisome|ambisome
878557|NCT00047827|Micafungin|micafungin
878558|NCT00047814|HCV|hcv
878559|NCT00047996|DNA|dna
878560|NCT00047996|Endothelial Function|endothelial function
878561|NCT00047996|Leukocyte Gene Expression|leukocyte gene expression
878562|NCT00047996|RNA|rna
878563|NCT00047996|Sickle Cell|sickle cell
878564|NCT00047996|Coronary Artery Disease|coronary artery disease
878565|NCT00047996|CAD|cad
878566|NCT00047996|Healthy Volunteer|healthy volunteer
878567|NCT00047996|HV|hv
878568|NCT00047957|Transcranial|transcranial
878569|NCT00047957|Magnetic|magnetic
878570|NCT00047957|Stimulation|stimulation
878571|NCT00047957|Motor|motor
878572|NCT00047957|Cortex|cortex
878573|NCT00047957|Motor Cortex|motor cortex
878574|NCT00047957|Afferent Stimulation|afferent stimulation
878575|NCT00047957|Transcranial Magnetic Stimulation|transcranial magnetic stimulation
878576|NCT00047957|Healthy Volunteer|healthy volunteer
878577|NCT00047957|HV|hv
878578|NCT00047944|Attention|attention
878579|NCT00047944|Emotion|emotion
878580|NCT00047944|Amygdala|amygdala
878581|NCT00047944|Prefrontal Cortex|prefrontal cortex
878582|NCT00047944|Facial Expression|facial expression
878583|NCT00047944|Magnetic Resonance Imaging|magnetic resonance imaging
878584|NCT00047944|fMRI|fmri
878585|NCT00047944|Depression|depression
878586|NCT00047944|Anxiety|anxiety
878587|NCT00047944|Adolescence|adolescence
878588|NCT00047944|Children|children
878589|NCT00047931|Healthy|healthy
878590|NCT00047931|HIV-Negative|hiv-negative
878591|NCT00047931|Placebo-Controlled|placebo-controlled
878592|NCT00047931|Volunteer|volunteer
878593|NCT00047931|Dose-Escalation|dose-escalation
878594|NCT00047931|HIV Seronegativity|hiv seronegativity
878595|NCT00047931|Healthy Volunteer|healthy volunteer
878596|NCT00047931|HV|hv
878597|NCT00047918|Mast Cells|mast cells
878598|NCT00047918|Bone Marrow|bone marrow
878599|NCT00047918|Flushing|flushing
878600|NCT00047918|Mutations|mutations
878601|NCT00047918|Mastocytosis|mastocytosis
878602|NCT00047918|Anaphylaxis|anaphylaxis
878603|NCT00047905|Qualitative|qualitative
878604|NCT00047905|Communication Analysis|communication analysis
878605|NCT00047905|RIAS|rias
878606|NCT00047905|Counseling Models|counseling models
878607|NCT00047905|Videotaping|videotaping
878608|NCT00047905|Prenatal Genetic Counselors|prenatal genetic counselors
878609|NCT00047905|Counseling Process|counseling process
878610|NCT00047905|Video Tape Study|video tape study
880930|NCT00035204|Galantamine|galantamine
878611|NCT00047905|Simulated Clients|simulated clients
878612|NCT00047905|Prenatal Genetic Counseling|prenatal genetic counseling
878613|NCT00047879|Brain Tumors|brain tumors
878614|NCT00047879|Experimental|experimental
878615|NCT00047879|Toxicities|toxicities
878616|NCT00047879|Efficacy|efficacy
878617|NCT00047879|Progression-Free|progression-free
878618|NCT00047879|Brain Tumor|brain tumor
878619|NCT00047879|Glioma|glioma
878620|NCT00047866|Limbic System|limbic system
878621|NCT00047866|Amphetamine|amphetamine
878622|NCT00047866|Dopamine|dopamine
878623|NCT00047866|Brain Imaging|brain imaging
878624|NCT00047866|Cerebral Blood Flow|cerebral blood flow
878625|NCT00047866|Cerebral Blood Volume|cerebral blood volume
878626|NCT00047866|Alcoholism|alcoholism
878627|NCT00047866|Tyrosine Depletion|tyrosine depletion
878628|NCT00047866|Amino Acids|amino acids
878629|NCT00047866|Affect|affect
878630|NCT00047866|Healthy Volunteer|healthy volunteer
878631|NCT00047866|HV|hv
878632|NCT00047853|Anxiety|anxiety
878633|NCT00047853|Neuroimaging|neuroimaging
878634|NCT00047853|Affective Neuroscience|affective neuroscience
878635|NCT00047853|Healthy Volunteer|healthy volunteer
878636|NCT00047853|HV|hv
878637|NCT00047788|Relapsed Multiple Myeloma|relapsed multiple myeloma
878638|NCT00047554|open-angle|open-angle
878639|NCT00047554|glaucoma|glaucoma
878640|NCT00047554|ocular|ocular
878641|NCT00047554|hypertension|hypertension
878642|NCT00047554|primary open-angle glaucoma|primary open-angle glaucoma
878643|NCT00047554|iris|iris
878644|NCT00047554|pigmentation|pigmentation
878645|NCT00047541|open-angle|open-angle
878646|NCT00047541|glaucoma|glaucoma
878647|NCT00047541|ocular|ocular
878648|NCT00047541|hypertension|hypertension
878649|NCT00047541|POAG|poag
878650|NCT00047528|open-angle|open-angle
878651|NCT00047528|glaucoma|glaucoma
878652|NCT00047528|ocular|ocular
878653|NCT00047528|hypertension|hypertension
878654|NCT00047528|POAG|poag
878655|NCT00047515|open-angle|open-angle
878656|NCT00047515|glaucoma|glaucoma
878657|NCT00047515|ocular|ocular
878658|NCT00047515|hypertension|hypertension
878659|NCT00047515|POAG|poag
878660|NCT00047749|pain|pain
878661|NCT00047749|ziconotide|ziconotide
878662|NCT00047749|Prialt|prialt
878663|NCT00047749|intrathecal|intrathecal
878664|NCT00047749|Synchromed|synchromed
878665|NCT00047736|Non-small cell lung cancer|non-small cell lung cancer
878666|NCT00047723|ALS|als
878667|NCT00047723|amyotrophic lateral sclerosis|amyotrophic lateral sclerosis
878668|NCT00047723|minocycline|minocycline
878669|NCT00047710|pancreatic cancer|pancreatic cancer
878670|NCT00047710|pancreas cancer|pancreas cancer
878671|NCT00047710|pancreas|pancreas
878672|NCT00047684|Child Abuse, Sexual|child abuse, sexual
878673|NCT00047671|Depressive Disorder|depressive disorder
878674|NCT00047645|lung|lung
878675|NCT00047645|IPF|ipf
878676|NCT00047632|ovarian|ovarian
878677|NCT00047632|carcinoma|carcinoma
878678|NCT00047632|peritoneal|peritoneal
878679|NCT00047632|cancer|cancer
878680|NCT00047632|ovary|ovary
878681|NCT00047632|interferon gamma|interferon gamma
878682|NCT00047606|open-angle|open-angle
878683|NCT00047606|glaucoma|glaucoma
878684|NCT00047606|ocular|ocular
878685|NCT00047606|hypertension|hypertension
878686|NCT00047606|POAG|poag
878687|NCT00047606|Iris|iris
878688|NCT00047606|Pigmentation|pigmentation
878689|NCT00047606|Japanese|japanese
878690|NCT00047593|open-angle|open-angle
878691|NCT00047593|glaucoma|glaucoma
878692|NCT00047593|ocular|ocular
878693|NCT00047593|hypertension|hypertension
878694|NCT00047593|POAG|poag
878695|NCT00047593|Iris|iris
878696|NCT00047593|Pigmentation|pigmentation
878697|NCT00047593|Japanese|japanese
878698|NCT00047619|Decubitus Ulcers|decubitus ulcers
878699|NCT00047619|Pulsatile Lavage|pulsatile lavage
878700|NCT00047619|SCI|sci
878701|NCT00047619|Spinal Cord Injury|spinal cord injury
878702|NCT00047619|Wound healing|wound healing
878703|NCT00047619|pressure ulcer|pressure ulcer
878704|NCT00047580|Spasticity|spasticity
878705|NCT00047580|spasticity secondary to Multiple Sclerosis|spasticity secondary to multiple sclerosis
878706|NCT00047580|Spinal Cord Injury|spinal cord injury
878707|NCT00047580|Stroke|stroke
878708|NCT00047567|ZONISAMIDE|zonisamide
878709|NCT00047567|BIPOLAR|bipolar
878710|NCT00046371|Cancer Vaccines|cancer vaccines
878711|NCT00046371|Aromatase|aromatase
878712|NCT00046371|Receptors, Estrogen|receptors, estrogen
878713|NCT00046371|Receptors, Progesterone|receptors, progesterone
878714|NCT00047476|neurobehavioral function|neurobehavioral function
878715|NCT00047476|chemobrain|chemobrain
878716|NCT00047476|chemo brain|chemo brain
878717|NCT00047476|fatigue|fatigue
878718|NCT00047476|memory loss|memory loss
878719|NCT00047476|exhausted|exhausted
878720|NCT00047476|trouble concentrating|trouble concentrating
878721|NCT00047463|epilepsy|epilepsy
878722|NCT00047463|sleep apnea|sleep apnea
878723|NCT00047463|obstructive sleep apnea|obstructive sleep apnea
878724|NCT00047463|continuous positive airway pressure|continuous positive airway pressure
878725|NCT00047463|CPAP|cpap
878726|NCT00047450|Psychotic Disorders|psychotic disorders
878727|NCT00047411|CPR, AED|cpr, aed
878728|NCT00046800|Ovarian Cancer|ovarian cancer
878729|NCT00046787|Small Cell Lung Cancer|small cell lung cancer
878730|NCT00046761|Acute Ischemic Stroke|acute ischemic stroke
878731|NCT00046774|Safety|safety
878732|NCT00046774|Nephritis|nephritis
878733|NCT00046774|Biologic Therapy|biologic therapy
878734|NCT00046774|Lymphocytes|lymphocytes
878735|NCT00046774|Response|response
878736|NCT00046774|Lupus|lupus
878737|NCT00046774|Systemic Lupus Erythematosus|systemic lupus erythematosus
878738|NCT00046774|SLE|sle
878739|NCT00046735|solid tumors|solid tumors
878740|NCT00046735|Revimid|revimid
878741|NCT00046735|CC5013|cc5013
878742|NCT00046735|CC-5013|cc-5013
878743|NCT00046722|treatment experienced|treatment experienced
878744|NCT00046722|complementary therapies|complementary therapies
878745|NCT00046722|Neuropathy|neuropathy
878746|NCT00046722|Peripheral Neuropathy|peripheral neuropathy
878747|NCT00046722|HIV-Related Peripheral Neuropathy|hiv-related peripheral neuropathy
878748|NCT00046722|HIV|hiv
878749|NCT00046527|Metastatic breast cancer|metastatic breast cancer
878750|NCT00046527|Taxol|taxol
878751|NCT00046527|Taxane|taxane
878752|NCT00046514|Metastatic Breast Cancer|metastatic breast cancer
878753|NCT00046514|Taxol|taxol
878754|NCT00046423|Cancer|cancer
878755|NCT00046423|solid tumor|solid tumor
878756|NCT00046423|Advanced malignancy|advanced malignancy
878757|NCT00046423|Taxane therapy|taxane therapy
878758|NCT00046423|Biopsy-proven diagnosis of advanced malignancy|biopsy-proven diagnosis of advanced malignancy
878759|NCT00046423|Various solid tumors which are refractory|various solid tumors which are refractory
878760|NCT00046709|Cancer pain|cancer pain
878761|NCT00046709|All types of cancer except lung cancer|all types of cancer except lung cancer
878762|NCT00046696|Cancer|cancer
878763|NCT00046696|Cancer Alternative Therapies|cancer alternative therapies
878764|NCT00046696|Living with Cancer|living with cancer
878765|NCT00046683|Adult acute leukemia|adult acute leukemia
878766|NCT00046683|Adult chronic leukemia|adult chronic leukemia
878767|NCT00046683|Childhood leukemia|childhood leukemia
878768|NCT00046683|Campath|campath
878769|NCT00046683|Alemtuzumab|alemtuzumab
878770|NCT00046540|Liposome-Encapsulated SN38|liposome-encapsulated sn38
878771|NCT00046540|Irinotecan|irinotecan
878772|NCT00046540|CPT-11|cpt-11
878773|NCT00046540|Malignant Tumors|malignant tumors
878774|NCT00046488|Chronic Lymphoblastic Leukemia|chronic lymphoblastic leukemia
878775|NCT00046488|Leukemia, Lymphoblastic, Chronic|leukemia, lymphoblastic, chronic
878776|NCT00046488|Chronic Lymphocytic Leukemia|chronic lymphocytic leukemia
878777|NCT00046488|CLL|cll
878778|NCT00046631|built environment|built environment
878779|NCT00046631|parks|parks
878780|NCT00046631|retail outlets|retail outlets
878781|NCT00046631|adolescent girls|adolescent girls
878782|NCT00046631|physical activity|physical activity
878783|NCT00046553|Cortisol|cortisol
878784|NCT00046553|CRH|crh
878785|NCT00046553|HPA Axis|hpa axis
878786|NCT00046553|Hypothalamus|hypothalamus
878787|NCT00046553|Hippocampus|hippocampus
878788|NCT00046553|Post-Traumatic Stress Disorder|post-traumatic stress disorder
878789|NCT00046553|PTSD|ptsd
878790|NCT00046553|Healthy Volunteer|healthy volunteer
878791|NCT00046436|AIDS Serodiagnosis|aids serodiagnosis
878792|NCT00046436|Pregnancy Complications, Infectious|pregnancy complications, infectious
878793|NCT00046436|Anti-HIV Agents|anti-hiv agents
878794|NCT00046436|Disease Transmission, Vertical|disease transmission, vertical
878795|NCT00046410|MRI|mri
878796|NCT00046410|Diffusion|diffusion
878797|NCT00046410|Cognitive|cognitive
878798|NCT00046410|Stroke|stroke
878799|NCT00046410|Heart|heart
878800|NCT00046410|Coronary Artery Disease|coronary artery disease
878801|NCT00046410|Heart Disease|heart disease
878802|NCT00046397|Smallpox|smallpox
878803|NCT00046397|Vaccine|vaccine
878804|NCT00046397|Vaccination|vaccination
878805|NCT00046397|Variola|variola
878806|NCT00046397|Adults|adults
878807|NCT00046397|Smallpox Vaccine|smallpox vaccine
878808|NCT00046397|Healthy Volunteer|healthy volunteer
878809|NCT00046397|Small Pox|small pox
878810|NCT00046345|treatment experienced|treatment experienced
878811|NCT00046332|Integrase inhibitors|integrase inhibitors
878812|NCT00046332|Monotherapy|monotherapy
878813|NCT00046332|HIV-1 infection|hiv-1 infection
878814|NCT00046319|Pulmonary Arterial Hypertension|pulmonary arterial hypertension
878815|NCT00046319|Primary Pulmonary Hypertension|primary pulmonary hypertension
878816|NCT00046306|Oxidative Stress|oxidative stress
878817|NCT00046306|Cardiovascular Disease|cardiovascular disease
878818|NCT00046306|Cancer|cancer
878819|NCT00046358|Cerebrospinal Fluid|cerebrospinal fluid
878820|NCT00046358|Cholesterol|cholesterol
878821|NCT00046358|Statin|statin
878822|NCT00046358|NSAID|nsaid
878823|NCT00046358|Antiinflammatory|antiinflammatory
878824|NCT00046358|Dementia|dementia
878825|NCT00046358|Alzheimer's Disease|alzheimer's disease
880931|NCT00035191|Dementia|dementia
878826|NCT00046358|Nonsteroidal Antiinflammatory|nonsteroidal antiinflammatory
878827|NCT00046358|Healthy Volunteer|healthy volunteer
878829|NCT00046293|Abciximab|abciximab
878830|NCT00046293|Retavase|retavase
878831|NCT00046293|MRI|mri
878832|NCT00046293|Cerebral Blood Flow|cerebral blood flow
878833|NCT00046267|Delayed-Action Preparations|delayed-action preparations
878834|NCT00046267|Blood Glucose|blood glucose
878835|NCT00046267|Insulin|insulin
878836|NCT00046267|Alanine Transaminase|alanine transaminase
878837|NCT00046267|Aspartate Aminotransferases|aspartate aminotransferases
878838|NCT00046267|Fructosamine|fructosamine
878839|NCT00046267|Glucose Tolerance Test|glucose tolerance test
878840|NCT00046267|Treatment Experienced|treatment experienced
878841|NCT00046254|hip fracture|hip fracture
878842|NCT00046254|recurrent fracture|recurrent fracture
878843|NCT00046254|fracture|fracture
878844|NCT00046254|bone loss|bone loss
878845|NCT00046254|bisphosphonate|bisphosphonate
878846|NCT00046254|bone mineral density|bone mineral density
878847|NCT00046254|osteoporosis|osteoporosis
878848|NCT00046254|zoledronic acid|zoledronic acid
878849|NCT00046254|geriatrics|geriatrics
878850|NCT00046254|rehabilitation|rehabilitation
878851|NCT00046254|elderly|elderly
878852|NCT00046254|nursing home|nursing home
878853|NCT00046254|orthopedic|orthopedic
878854|NCT00046241|seasonal depression winter blues winter depression|seasonal depression winter blues winter depression
878855|NCT00046228|Myocardial infarction|myocardial infarction
878856|NCT00046228|percutaneous coronary intervention|percutaneous coronary intervention
878857|NCT00046228|abciximab|abciximab
878858|NCT00046228|reteplase|reteplase
878859|NCT00046228|safety and efficacy|safety and efficacy
897283|NCT00000173|Memory|memory
878860|NCT00046215|Virtual Lesion Study|virtual lesion study
878861|NCT00046215|Motor Imagery|motor imagery
878862|NCT00046215|Primary Motor Cortex|primary motor cortex
878863|NCT00046215|Motor Inhibition|motor inhibition
878864|NCT00046215|Motor Execution|motor execution
878865|NCT00046215|Healthy Volunteer|healthy volunteer
878866|NCT00046202|Inborn Error of Cholesterol Synthesis|inborn error of cholesterol synthesis
878867|NCT00046202|Cholesterol|cholesterol
878868|NCT00046202|Lysosomal Storage|lysosomal storage
878869|NCT00046202|Inborn Errors of Cholesterol Synthesis|inborn errors of cholesterol synthesis
878870|NCT00046202|Smith-Lemli-Optiz Syndrome|smith-lemli-optiz syndrome
878871|NCT00046202|Lathosterolosis|lathosterolosis
878872|NCT00046202|Desmosterols|desmosterols
878873|NCT00046202|CHILD Syndrome|child syndrome
878874|NCT00046202|Greenberg Dysplasia|greenberg dysplasia
878875|NCT00046202|X Linked Dominant Chrondrodysplasia|x linked dominant chrondrodysplasia
878876|NCT00046189|Sun Exposure|sun exposure
878877|NCT00046189|Xeroderma Pigmentosum|xeroderma pigmentosum
878878|NCT00046189|Skin Cancer|skin cancer
878879|NCT00046189|Family History|family history
878880|NCT00046189|HETEROZYGOTE|heterozygote
878881|NCT00046189|XP|xp
878882|NCT00046176|HIV-1 Abacavir Lamivudine Antiretroviral-experienced|hiv-1 abacavir lamivudine antiretroviral-experienced
878883|NCT00046163|Neurology|neurology
878884|NCT00046163|Cardiology|cardiology
878885|NCT00046111|oral|oral
878886|NCT00046111|Bioequivalence|bioequivalence
878887|NCT00046111|Hycamtin|hycamtin
878888|NCT00046111|Topotecan|topotecan
878889|NCT00046085|Schizophrenia|schizophrenia
878890|NCT00046085|Family|family
878891|NCT00046085|Psychoeducation|psychoeducation
878892|NCT00046085|Internet|internet
878893|NCT00046072|Sepsis|sepsis
878894|NCT00046072|Shock|shock
878895|NCT00046072|Septic|septic
878896|NCT00046072|Sepsis Syndrome|sepsis syndrome
878897|NCT00046072|Septicemia|septicemia
878898|NCT00046072|Endotoxins|endotoxins
878899|NCT00046072|Endotoxemia|endotoxemia
878900|NCT00046072|Infection|infection
878901|NCT00046059|Linkage|linkage
878902|NCT00046059|Gene Identification|gene identification
878903|NCT00046059|Hyperactivity|hyperactivity
878904|NCT00046059|Attention Deficit Hyperactivity Disorder|attention deficit hyperactivity disorder
878905|NCT00046059|ADHD|adhd
878906|NCT00046033|Dose-Relationship, Drug|dose-relationship, drug
878907|NCT00046033|HIV Protease Inhibitors|hiv protease inhibitors
878908|NCT00046033|Salvage Therapy|salvage therapy
878909|NCT00046033|Viral Load|viral load
878910|NCT00046033|RNA, Viral|rna, viral
878911|NCT00046033|Drug Therapy, Combination|drug therapy, combination
878912|NCT00046020|Depression|depression
878913|NCT00045994|cardiovascular|cardiovascular
878914|NCT00045994|aged|aged
878915|NCT00045994|antihypertensive agents/therapeutic use|antihypertensive agents/therapeutic use
878916|NCT00045994|hypertension/*drug therapy|hypertension/*drug therapy
878917|NCT00045994|blood pressure|blood pressure
878918|NCT00045981|cardiovascular|cardiovascular
878919|NCT00045981|aged|aged
878920|NCT00045981|antihypertensive agents/therapeutic use|antihypertensive agents/therapeutic use
878921|NCT00045981|hypertension/*drug therapy|hypertension/*drug therapy
878922|NCT00045981|blood pressure|blood pressure
878923|NCT00045968|oncology|oncology
878924|NCT00045968|neurology|neurology
878925|NCT00045968|glioma|glioma
878926|NCT00045968|brain tumor|brain tumor
878927|NCT00045968|brain cancer|brain cancer
878928|NCT00045968|glioblastoma multiforme|glioblastoma multiforme
878929|NCT00045968|glioblastoma|glioblastoma
878930|NCT00045968|newly diagnosed glioblastoma|newly diagnosed glioblastoma
878931|NCT00045968|immunotherapy|immunotherapy
878932|NCT00045968|dendritic cells|dendritic cells
878933|NCT00045968|immune therapy|immune therapy
878934|NCT00045968|GBM|gbm
878935|NCT00045968|Brain cancer, primary|brain cancer, primary
878936|NCT00045968|tumor vaccine|tumor vaccine
878937|NCT00045968|grade IV astrocytoma|grade iv astrocytoma
878938|NCT00045968|DCVax|dcvax
878939|NCT00045968|Grade IV brain cancer|grade iv brain cancer
878940|NCT00045942|AML|aml
878941|NCT00045942|MDS|mds
878942|NCT00045942|high risk myelodysplastic syndrome|high risk myelodysplastic syndrome
878943|NCT00045916|Electroconvulsive therapy|electroconvulsive therapy
878944|NCT00045916|Antidepressive Agents|antidepressive agents
878945|NCT00045903|Cognitive Behavioral Therapy|cognitive behavioral therapy
878946|NCT00045877|Low-Grade or Follicular Non-Hodgkin's Lymphoma|low-grade or follicular non-hodgkin's lymphoma
878947|NCT00045864|Intermediate and High-Grade Non-Hodgkin's Lymphoma|intermediate and high-grade non-hodgkin's lymphoma
878948|NCT00045838|Healthy|healthy
878949|NCT00045838|HIV-Negative|hiv-negative
878950|NCT00045838|Placebo Controlled|placebo controlled
878951|NCT00045838|Volunteer|volunteer
878952|NCT00045838|Dose-Escalation|dose-escalation
878953|NCT00045838|Healthy Volunteers|healthy volunteers
878954|NCT00045838|HV|hv
878955|NCT00045838|HIV Seronegativity|hiv seronegativity
878956|NCT00045838|HIV Preventive Vaccine|hiv preventive vaccine
878957|NCT00045812|Cholesterol|cholesterol
878958|NCT00045812|Sitosterol|sitosterol
878959|NCT00045812|Atherosclerosis|atherosclerosis
878960|NCT00045812|Intestine|intestine
878962|NCT00045812|Homozygous Sitosterolemia|homozygous sitosterolemia
878963|NCT00045812|Sterol Metabolism|sterol metabolism
878964|NCT00045786|myelodysplastic syndrome|myelodysplastic syndrome
878965|NCT00044928|Abdominal Infections|abdominal infections
878966|NCT00044915|Acute Ischemic Stroke Without Hemorrhage|acute ischemic stroke without hemorrhage
878967|NCT00044889|CLO221|clo221
878968|NCT00044889|clolar|clolar
878969|NCT00044863|EGFr|egfr
878970|NCT00044863|Metastatic Colorectal Carcinoma|metastatic colorectal carcinoma
878971|NCT00044837|Lopinavir|lopinavir
878972|NCT00044837|HIV-1|hiv-1
878973|NCT00044837|HIV Protease Inhibitors|hiv protease inhibitors
878974|NCT00044837|Ritonavir|ritonavir
878975|NCT00044837|Postmenopause|postmenopause
878976|NCT00044837|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors
878977|NCT00044837|Pharmacokinetics|pharmacokinetics
878978|NCT00044837|Area Under Curve|area under curve
878979|NCT00044837|Hormone Replacement Therapy|hormone replacement therapy
878980|NCT00044837|efavirenz|efavirenz
878981|NCT00044837|estradiol|estradiol
878982|NCT00044876|Endometrium|endometrium
878983|NCT00044876|Progesterone|progesterone
878984|NCT00044876|Estrogen|estrogen
878985|NCT00044876|Leiomyoma|leiomyoma
878986|NCT00044876|Uterine Leiomyoma|uterine leiomyoma
878987|NCT00044876|Uterine Fibroids|uterine fibroids
878988|NCT00044876|Fibroids|fibroids
878989|NCT00044798|Aged|aged
878990|NCT00044785|colorectal cancer|colorectal cancer
878991|NCT00044785|gastric cancer|gastric cancer
878992|NCT00044785|breast cancer|breast cancer
878993|NCT00044772|Panic|panic
878994|NCT00044772|Disorder|disorder
878995|NCT00044759|Hematologic|hematologic
878996|NCT00044759|Neoplasms|neoplasms
878997|NCT00044746|Diabetes|diabetes
878998|NCT00044733|Leukemia|leukemia
878999|NCT00044733|Stem Cell Transplant|stem cell transplant
879000|NCT00044720|Kidney Transplant|kidney transplant
879001|NCT00044707|Diabetes Mellitus, Type 2|diabetes mellitus, type 2
879002|NCT00044694|Diabetes Mellitus, Type 2|diabetes mellitus, type 2
879003|NCT00044681|Risperidone|risperidone
879004|NCT00044681|depression|depression
879005|NCT00044681|melancholia|melancholia
879006|NCT00044681|depressive disorder|depressive disorder
879007|NCT00044681|antipsychotic agents|antipsychotic agents
879008|NCT00044668|exenatide|exenatide
879009|NCT00044668|exendin-4|exendin-4
879010|NCT00044668|diabetes|diabetes
879011|NCT00044668|Amylin|amylin
879012|NCT00044668|Lilly|lilly
879013|NCT00044642|Anxiety|anxiety
879014|NCT00044629|Sleep Deprivation|sleep deprivation
879015|NCT00044629|Insomnia|insomnia
879016|NCT00044629|Sleep Disorders|sleep disorders
879017|NCT00044603|Pregnancy|pregnancy
879018|NCT00044590|Parkinson's disease|parkinson's disease
879019|NCT00044590|Pesticides|pesticides
879020|NCT00044590|Genetic susceptibility|genetic susceptibility
879021|NCT00044590|Polymorphisms|polymorphisms
879022|NCT00044577|HIV-1 Abacavir Lamivudine Tenofovir|hiv-1 abacavir lamivudine tenofovir
879023|NCT00044564|Taxane|taxane
879024|NCT00044564|Renal Cell Carcinoma|renal cell carcinoma
879025|NCT00044564|Advanced Renal Cell Carcinoma|advanced renal cell carcinoma
879026|NCT00044551|Taxane|taxane
879027|NCT00044551|Lymphoma|lymphoma
879028|NCT00044551|Non-Hodgkin's Lymphoma|non-hodgkin's lymphoma
879030|NCT00044538|Lung cancer, non-small cell|lung cancer, non-small cell
879032|NCT00044525|Taxane|taxane
879033|NCT00044525|Breast Cancer|breast cancer
879034|NCT00044525|Metastasis|metastasis
879035|NCT00044512|Cancer|cancer
879036|NCT00044512|Liver Cancer|liver cancer
879037|NCT00044512|Hepatocellular carcinoma (HCC)|hepatocellular carcinoma (hcc)
879038|NCT00044486|Prophylaxis|prophylaxis
879039|NCT00044486|neutropenia|neutropenia
879040|NCT00044486|AML|aml
879041|NCT00044486|MDS|mds
879042|NCT00044486|fungal infections|fungal infections
879043|NCT00044486|Acute Myelogenous Leukemia|acute myelogenous leukemia
879044|NCT00044486|Anticipated prolonged profound neutropenia|anticipated prolonged profound neutropenia
879045|NCT00044473|Otitis Media|otitis media
879046|NCT00044473|Ear Diaeases|ear diaeases
879047|NCT00044473|Levofloxacin|levofloxacin
879048|NCT00044473|Quinolones|quinolones
879049|NCT00044460|Type 2 diabetes drug-naive|type 2 diabetes drug-naive
879050|NCT00044382|Revimid|revimid
879051|NCT00044382|CC5013|cc5013
879052|NCT00044382|CC-5013|cc-5013
879053|NCT00044369|Varicocele|varicocele
879054|NCT00044369|environmental toxins|environmental toxins
879055|NCT00044369|male infertility|male infertility
879056|NCT00044369|cadmium|cadmium
879057|NCT00044356|Melanoma|melanoma
879058|NCT00044356|Metastatic Melanoma|metastatic melanoma
879059|NCT00044356|Malignant Melanoma|malignant melanoma
879060|NCT00044356|Skin Cancer|skin cancer
879061|NCT00044356|Tumor|tumor
879062|NCT00044356|Experimental Treatment|experimental treatment
879063|NCT00044356|Clinical Trial|clinical trial
879064|NCT00044356|Gene Therapy|gene therapy
879065|NCT00044356|Gene Delivery|gene delivery
879066|NCT00044356|Gene Transfer|gene transfer
879067|NCT00044356|Immunotherapy|immunotherapy
879068|NCT00044356|Cancer|cancer
879072|NCT00044356|Cancerous mole|cancerous mole
879073|NCT00044356|Melanoma vaccine|melanoma vaccine
879074|NCT00044356|Cancer research|cancer research
879075|NCT00044356|Cancer cells|cancer cells
879076|NCT00044356|Allovectin-7®|allovectin-7®
879077|NCT00044343|colorectal cancer|colorectal cancer
879078|NCT00044343|EGFR inhibitor|egfr inhibitor
879079|NCT00044343|lapatinib|lapatinib
879080|NCT00044343|metastatic|metastatic
879081|NCT00044317|FEV|fev
879082|NCT00044317|Smoking|smoking
879083|NCT00044317|antioxidents|antioxidents
879084|NCT00044317|lung growth|lung growth
879085|NCT00044291|Atamestane|atamestane
879086|NCT00044291|Toremifene|toremifene
879087|NCT00044291|Letrozole|letrozole
879088|NCT00044291|Aromatase inhibitor|aromatase inhibitor
879089|NCT00044291|Receptor-positive|receptor-positive
879090|NCT00044291|First line therapy|first line therapy
879091|NCT00044291|Estrogen blocker|estrogen blocker
879092|NCT00044291|Metastatic breast cancer|metastatic breast cancer
879093|NCT00044291|Locally advanced breast cancer|locally advanced breast cancer
879094|NCT00044291|Locally recurrent breast cancer|locally recurrent breast cancer
879095|NCT00044291|stage IV breast cancer|stage iv breast cancer
879096|NCT00044291|ductal breast carcinoma|ductal breast carcinoma
879097|NCT00044291|lobular breast carcinoma|lobular breast carcinoma
879098|NCT00044291|stage IIIA breast cancer|stage iiia breast cancer
879099|NCT00044291|stage IIIB breast cancer|stage iiib breast cancer
879100|NCT00044291|recurrent breast cancer|recurrent breast cancer
879101|NCT00044304|Treatment|treatment
879102|NCT00044304|Eosinophil|eosinophil
879103|NCT00044304|Tyrosine Kinase Inhibitor|tyrosine kinase inhibitor
879104|NCT00044304|Hypereosinophilia|hypereosinophilia
879105|NCT00044304|Biologicals|biologicals
879106|NCT00044304|Chemotherapy|chemotherapy
879107|NCT00044304|Gleevec|gleevec
879108|NCT00044304|Eosinophils|eosinophils
879109|NCT00044304|Hypereosinophilic Syndrome|hypereosinophilic syndrome
879110|NCT00044304|HES|hes
879111|NCT00044278|epilepsy|epilepsy
879112|NCT00044278|pediatric|pediatric
879113|NCT00044278|partial seizures|partial seizures
879114|NCT00044265|ACE inhibitor|ace inhibitor
879115|NCT00044265|high blood pressure|high blood pressure
879116|NCT00044265|pediatric|pediatric
879117|NCT00044252|Neurosteroids|neurosteroids
879118|NCT00044252|Complex Partial Seizure|complex partial seizure
879119|NCT00044252|Menstrual Cycle|menstrual cycle
879120|NCT00044252|Allopregnanolone|allopregnanolone
879121|NCT00044252|Catamenial Epilepsy|catamenial epilepsy
879122|NCT00044252|Seizures|seizures
879123|NCT00044252|Epilepsy|epilepsy
879124|NCT00044252|Healthy Volunteer|healthy volunteer
879125|NCT00044252|HV|hv
879126|NCT00044252|Normal Control|normal control
879127|NCT00044239|Tic Disorders|tic disorders
879128|NCT00044239|Neurophyschological|neurophyschological
879129|NCT00044239|Immunology|immunology
879130|NCT00044239|Magnetic Resonance Imaging|magnetic resonance imaging
879131|NCT00044239|Basal Ganglia|basal ganglia
879132|NCT00044239|Obsessive-Compulsive Disorder|obsessive-compulsive disorder
879133|NCT00044239|Children|children
879134|NCT00044239|Adolescents|adolescents
879135|NCT00044239|Magnetic Resonance Spectroscopy|magnetic resonance spectroscopy
879136|NCT00044239|PANDAS (Pediatric Autoimmune Neuropsychiatric Disorders Associated d|pandas (pediatric autoimmune neuropsychiatric disorders associated d
879137|NCT00044239|Obsessive Compulsive Disorder|obsessive compulsive disorder
879139|NCT00044239|Healthy Volunteers|healthy volunteers
879140|NCT00044239|HV|hv
879141|NCT00044226|BPH|bph
879142|NCT00044226|Benign Prostatic Hyperplasia|benign prostatic hyperplasia
879143|NCT00044226|Benign Prostatic Hypertrophy|benign prostatic hypertrophy
879144|NCT00044226|Enlarged Prostate|enlarged prostate
879145|NCT00044187|schizoaffective disorder|schizoaffective disorder
879146|NCT00044187|schizophreniform disorder|schizophreniform disorder
879147|NCT00044187|bipolar I disorder|bipolar i disorder
879148|NCT00044200|Phospholipase A2|phospholipase a2
879149|NCT00044200|Arachidonic Acid|arachidonic acid
879150|NCT00044200|Blood Flow|blood flow
879151|NCT00044200|Coupling|coupling
879152|NCT00044200|Neurotransmission|neurotransmission
879153|NCT00044200|PET|pet
879154|NCT00044200|Signal Transduction|signal transduction
879155|NCT00044200|Activation|activation
879156|NCT00044200|Brain|brain
879157|NCT00044200|[15O]H20|[15o]h20
879158|NCT00044174|Infant|infant
879159|NCT00044174|maternal health|maternal health
879160|NCT00044174|Depression|depression
879161|NCT00044174|Healthy|healthy
879162|NCT00044174|Mothers|mothers
879163|NCT00044174|Postpartum|postpartum
879164|NCT00044174|Postpartum Depression|postpartum depression
879165|NCT00044148|Persistent Albuminuria|persistent albuminuria
879166|NCT00044135|clevudine|clevudine
879167|NCT00044135|hepatitis B|hepatitis b
879168|NCT00044070|ARTIST|artist
879169|NCT00044070|Acute ischemic stroke|acute ischemic stroke
879170|NCT00044057|ARTIST|artist
879171|NCT00044044|Schizophrenia|schizophrenia
879172|NCT00044044|Latuda|latuda
879173|NCT00044044|Lurasidone|lurasidone
879174|NCT00044031|pancreatic cancer|pancreatic cancer
879175|NCT00044031|G17DT|g17dt
879179|NCT00044005|Schizophrenia|schizophrenia
879180|NCT00044005|Latuda|latuda
879181|NCT00044005|Lurasidone|lurasidone
879182|NCT00043329|Registry|registry
879183|NCT00043329|Actimmune|actimmune
879184|NCT00043329|osteopetrosis|osteopetrosis
879185|NCT00044122|Mastocytosis|mastocytosis
879186|NCT00044109|Pain|pain
879187|NCT00044109|Low Back|low back
879188|NCT00044109|Radiculopathy|radiculopathy
879189|NCT00044109|Electromagnetic Treatment|electromagnetic treatment
879190|NCT00044109|Back Device|back device
879191|NCT00044109|Sciatica|sciatica
879192|NCT00044109|Low Back Pain|low back pain
879193|NCT00044096|SSRI|ssri
879194|NCT00044096|Anxiety|anxiety
879195|NCT00044096|Stress|stress
879196|NCT00044096|Citalopram|citalopram
879197|NCT00044096|Benadryl|benadryl
879198|NCT00044096|Diphenhydramine|diphenhydramine
879199|NCT00044096|Startle|startle
879200|NCT00044096|Fear-Potentiated Startle|fear-potentiated startle
879201|NCT00044096|Fear|fear
879202|NCT00044096|Normal Volunteers|normal volunteers
879203|NCT00044096|Healthy Volunteers|healthy volunteers
879204|NCT00044096|HV|hv
879205|NCT00044083|Catecholamines|catecholamines
879206|NCT00044083|Dopamine|dopamine
879207|NCT00044083|Clinical Trial|clinical trial
879208|NCT00044083|fMRI|fmri
879209|NCT00044083|PFC|pfc
879210|NCT00044083|Vitamin B2|vitamin b2
879211|NCT00044083|Riboflavin|riboflavin
879212|NCT00044083|Tolcapone|tolcapone
879213|NCT00044083|Placebo|placebo
879214|NCT00044083|Normal Volunteers|normal volunteers
879215|NCT00044083|Schizophrenia|schizophrenia
879216|NCT00044083|Healthy Volunteers|healthy volunteers
879217|NCT00044083|HV|hv
879218|NCT00043992|Asthma|asthma
879219|NCT00043992|Allergens|allergens
879220|NCT00043966|treatment naive|treatment naive
879221|NCT00043953|treatment naive|treatment naive
879222|NCT00043888|fosamprenavir|fosamprenavir
879223|NCT00043888|ritonavir|ritonavir
879224|NCT00043888|COMBIVIR|combivir
879225|NCT00043888|TRIZIVIR|trizivir
879226|NCT00043888|abacavir|abacavir
879227|NCT00043888|lamivudine|lamivudine
879228|NCT00043888|zidovudine|zidovudine
879229|NCT00043888|HIV|hiv
879230|NCT00043888|protease inhibitors|protease inhibitors
879231|NCT00043979|Ewing's Sarcoma|ewing's sarcoma
879232|NCT00043979|Rhabdomyosarcoma|rhabdomyosarcoma
879233|NCT00043979|Desmoplastic Small Round Cell Tumor|desmoplastic small round cell tumor
879234|NCT00043979|Sarcoma|sarcoma
879235|NCT00043979|Ewing Sarcoma|ewing sarcoma
879236|NCT00043940|thrombosis|thrombosis
879237|NCT00043940|bivalirudin|bivalirudin
879238|NCT00043940|direct thrombin inhibitor|direct thrombin inhibitor
879239|NCT00043940|HIT|hit
879240|NCT00043940|HITTS|hitts
879241|NCT00043940|HIT/HITTS|hit/hitts
879242|NCT00043927|Chemotherapy-naive|chemotherapy-naive
879243|NCT00043927|Small Cell Lung Cancer|small cell lung cancer
879244|NCT00043927|SCLC|sclc
879245|NCT00043927|Extensive disease|extensive disease
879246|NCT00043927|ED|ed
879247|NCT00043927|topotecan|topotecan
879248|NCT00043927|Hycamtin|hycamtin
879249|NCT00043927|oral|oral
879250|NCT00043914|epilepsy|epilepsy
879251|NCT00043914|monotherapy conversion|monotherapy conversion
879252|NCT00043901|PGTC|pgtc
879253|NCT00043901|Lamotrigine|lamotrigine
879254|NCT00043901|epilepsy|epilepsy
879255|NCT00043901|seizures|seizures
879256|NCT00043901|primary generalized tonic-clonic|primary generalized tonic-clonic
879257|NCT00043875|partial seizures|partial seizures
879258|NCT00043875|pediatric|pediatric
879259|NCT00043875|epilepsy|epilepsy
879260|NCT00043862|Hycamtin|hycamtin
879261|NCT00043862|oral|oral
879262|NCT00043862|Radiation Sensitization|radiation sensitization
879263|NCT00043862|Small Cell Lung Cancer|small cell lung cancer
879264|NCT00043862|newly diagnosed|newly diagnosed
879265|NCT00043862|limited stage|limited stage
879266|NCT00043862|topotecan|topotecan
879267|NCT00043849|Psychosis|psychosis
879268|NCT00043849|Agitation, Psychomotor|agitation, psychomotor
879269|NCT00043836|ejection fraction|ejection fraction
879270|NCT00043836|exercise tolerance|exercise tolerance
879271|NCT00043836|heart failure, congestive|heart failure, congestive
879272|NCT00043836|quality of life|quality of life
879273|NCT00043823|Non-Small Cell Lung Cancer|non-small cell lung cancer
879274|NCT00043823|NSCLC|nsclc
879275|NCT00043823|Lung Cancer|lung cancer
879276|NCT00043823|Avastin|avastin
879277|NCT00043823|Bevacizumab|bevacizumab
879278|NCT00043823|rhuMAb VEGF|rhumab vegf
879279|NCT00043823|Anti-VEGF monoclonal antibody|anti-vegf monoclonal antibody
879280|NCT00043823|Tarceva|tarceva
879281|NCT00043823|OSI-774|osi-774
879282|NCT00043823|Erlotinib Hydrocholoride|erlotinib hydrocholoride
879283|NCT00043810|AML|aml
879284|NCT00043810|MDS|mds
879285|NCT00043810|Gelonin|gelonin
879286|NCT00043810|Purging|purging
879287|NCT00043810|Transplant|transplant
879288|NCT00043810|Peripheral Stem Cell|peripheral stem cell
879289|NCT00043797|ARI|ari
879290|NCT00043797|Diabetic polyneuropathy|diabetic polyneuropathy
879291|NCT00043797|Diabetic complications|diabetic complications
879292|NCT00043784|Acute coronary syndromes|acute coronary syndromes
879293|NCT00043784|non-ST-segment elevation|non-st-segment elevation
879294|NCT00043693|Psychotic Disorders|psychotic disorders
879295|NCT00043693|Schizoaffective Disorder|schizoaffective disorder
879296|NCT00043693|Substance Abuse|substance abuse
879297|NCT00043771|CHF|chf
879298|NCT00043758|CHF|chf
879299|NCT00043745|soy|soy
879300|NCT00043745|isoflavones|isoflavones
879301|NCT00043745|alternative hormone therapy|alternative hormone therapy
879302|NCT00043745|bone loss|bone loss
879303|NCT00043732|Rheumatoid arthritis|rheumatoid arthritis
879304|NCT00043732|Scio-469|scio-469
879305|NCT00043719|Human Female|human female
879306|NCT00043719|Osteoporosis|osteoporosis
879307|NCT00043719|Postmenopausal|postmenopausal
879308|NCT00043719|Nitric Oxide|nitric oxide
879309|NCT00043719|Nitroglycerin|nitroglycerin
879310|NCT00043719|Calcium|calcium
879311|NCT00043719|Vitamin D|vitamin d
879312|NCT00043589|Memory|memory
879313|NCT00043576|Prostate Cancer|prostate cancer
879314|NCT00043576|Androgen Independent Prostate Cancer|androgen independent prostate cancer
879315|NCT00043680|Classic|classic
879316|NCT00043680|Occult|occult
879317|NCT00043680|Neovascular|neovascular
879318|NCT00043680|Celecoxib|celecoxib
879319|NCT00043680|Age-Related Macular Degeneration|age-related macular degeneration
879320|NCT00043680|Photodynamic Therapy|photodynamic therapy
879321|NCT00043680|Choroidal Neovascularization|choroidal neovascularization
879322|NCT00043680|Cyclooxygenase 2|cyclooxygenase 2
879323|NCT00043680|Macular Degeneration|macular degeneration
879324|NCT00043680|AMD|amd
879325|NCT00043680|Age Related Macular Degeneration|age related macular degeneration
879326|NCT00043667|Interleukin 2|interleukin 2
879327|NCT00043667|IL-2 Receptor|il-2 receptor
879328|NCT00043667|Anti-CD25|anti-cd25
879329|NCT00043667|Anti-Tac|anti-tac
879330|NCT00043667|Anti-IL-2R|anti-il-2r
879331|NCT00043667|Uveitis|uveitis
879332|NCT00043667|Daclizumab|daclizumab
879333|NCT00043667|Inflammatory Eye DIsease|inflammatory eye disease
879334|NCT00043654|Antidepressant|antidepressant
879335|NCT00043654|Manic-Depressive Disorder|manic-depressive disorder
879336|NCT00043654|Cortisol|cortisol
879337|NCT00043654|Neuroendocrine|neuroendocrine
879338|NCT00043654|Cognition|cognition
879339|NCT00043654|Bipolar|bipolar
879340|NCT00043654|Bipolar Disorder|bipolar disorder
879341|NCT00043654|BPD|bpd
879342|NCT00043654|HV|hv
879343|NCT00043641|RT PCR|rt pcr
879344|NCT00043641|Antiretrovial Therapy|antiretrovial therapy
879345|NCT00043641|Drug Intensification|drug intensification
879346|NCT00043641|Ultra-low|ultra-low
879347|NCT00043641|Sequence|sequence
879348|NCT00043641|HIV|hiv
879349|NCT00043641|Treatment Experienced|treatment experienced
879350|NCT00043628|Progenitor Cells|progenitor cells
879351|NCT00043628|MRI|mri
879352|NCT00043628|Coronary Blood Flow|coronary blood flow
879353|NCT00043628|Hematopoiesis|hematopoiesis
879354|NCT00043628|Myocardial Contractility|myocardial contractility
879355|NCT00043628|Coronary Artery Disease|coronary artery disease
879356|NCT00043628|CAD|cad
879357|NCT00043628|Heart Disease|heart disease
879358|NCT00043615|Angiogenesis|angiogenesis
879359|NCT00043615|Drug Resistance|drug resistance
879360|NCT00043615|Signal Transduction|signal transduction
879361|NCT00043615|EGFR|egfr
879362|NCT00043615|Survival Factors|survival factors
879363|NCT00043615|Malignancy|malignancy
879364|NCT00043615|Pre-Cancer Condition|pre-cancer condition
879365|NCT00043615|Cancer Risk|cancer risk
879366|NCT00043563|Cognitive-behavior Therapy|cognitive-behavior therapy
879367|NCT00043563|Minimal Attention Control|minimal attention control
879368|NCT00043550|Major Depressive Disorder|major depressive disorder
879369|NCT00043537|Phobic Disorders|phobic disorders
879370|NCT00043537|Mutism|mutism
879371|NCT00043511|Injections, Intramuscular|injections, intramuscular
879372|NCT00043511|HIV Seronegativity|hiv seronegativity
879373|NCT00043511|Plasmids|plasmids
879374|NCT00043511|Vaccines, DNA|vaccines, dna
879375|NCT00043511|HIV Preventive Vaccine|hiv preventive vaccine
879376|NCT00043498|Pollutants|pollutants
879377|NCT00043459|NHL|nhl
879378|NCT00043433|HCC|hcc
879379|NCT00043420|immunotherapy, lymphoma|immunotherapy, lymphoma
879380|NCT00043407|Renal Cell Carcinoma, Phase I, Phase II, Immunotherapy|renal cell carcinoma, phase i, phase ii, immunotherapy
879381|NCT00043394|CpG 7909 subcutaneous injection combination with Herceptin® metastatic breast cancer.|cpg 7909 subcutaneous injection combination with herceptin® metastatic breast cancer.
879382|NCT00043381|myelodysplastic syndrome|myelodysplastic syndrome
879383|NCT00043381|MDS|mds
879384|NCT00043381|chronic myelomonocytic leukemia|chronic myelomonocytic leukemia
879385|NCT00043381|CMML|cmml
879386|NCT00043381|decitabine|decitabine
879387|NCT00043381|5-aza-2'deoxycytidine|5-aza-2'deoxycytidine
879388|NCT00043368|CPG 7909 continuation study|cpg 7909 continuation study
879389|NCT00043355|pulmonary|pulmonary
879390|NCT00043355|mycobacterium avium complex infection|mycobacterium avium complex infection
879391|NCT00043355|MAC|mac
879392|NCT00043355|nontuberculous|nontuberculous
879393|NCT00043355|mycobacteria|mycobacteria
879394|NCT00043355|lung|lung
879395|NCT00043342|cystic fibrosis|cystic fibrosis
879396|NCT00043342|pulmonary impairment|pulmonary impairment
879397|NCT00043472|Screening|screening
879398|NCT00043472|Oophorectomy|oophorectomy
879399|NCT00043472|Hereditary|hereditary
879400|NCT00043472|Genetics|genetics
879401|NCT00043472|Cancer|cancer
879402|NCT00043472|Ovarian Cancer|ovarian cancer
879403|NCT00043472|Ovarian Cancer Risk|ovarian cancer risk
879404|NCT00043316|cystic fibrosis|cystic fibrosis
879405|NCT00043316|pulmonary impairment|pulmonary impairment
879406|NCT00043303|hepatitis C|hepatitis c
879407|NCT00043303|liver fibrosis|liver fibrosis
879408|NCT00043303|liver cirrhosis|liver cirrhosis
879409|NCT00043277|neonates|neonates
879410|NCT00043277|thrombosis|thrombosis
879411|NCT00043277|bivalirudin|bivalirudin
879412|NCT00043277|direct thrombin inhibitor|direct thrombin inhibitor
879413|NCT00043238|PCBs|pcbs
879414|NCT00043238|Thyroid|thyroid
879415|NCT00043238|Hyperactivity|hyperactivity
879416|NCT00043238|School Performance|school performance
879417|NCT00043238|Mohawk Tribe|mohawk tribe
879418|NCT00043212|prostate cancer|prostate cancer
879419|NCT00043212|oncology|oncology
879420|NCT00043212|urology|urology
879421|NCT00043212|hormone refractory prostate cancer|hormone refractory prostate cancer
879422|NCT00043199|Colorectal Neoplasms|colorectal neoplasms
879423|NCT00043199|Colorectal Cancer|colorectal cancer
879424|NCT00043199|Colorectal Carcinoma|colorectal carcinoma
879425|NCT00043199|Colorectal Tumor|colorectal tumor
879426|NCT00043199|Neoplasms, Colorectal|neoplasms, colorectal
879427|NCT00043199|Unresectable|unresectable
879428|NCT00043199|Metastatic|metastatic
879429|NCT00043199|Refractory|refractory
879430|NCT00043225|Type III Secretion Pathways|type iii secretion pathways
879431|NCT00043225|Exotoxin A Polymorphisms|exotoxin a polymorphisms
879432|NCT00043225|Cystic Fibrosis and Pseudomonas Aeruginosa|cystic fibrosis and pseudomonas aeruginosa
879433|NCT00043225|Adenosine Deaminase Deficiency|adenosine deaminase deficiency
879434|NCT00043225|Severe Combined Immune Deficiency|severe combined immune deficiency
879435|NCT00043225|SCID|scid
879436|NCT00043225|ADA-SCID|ada-scid
879437|NCT00043225|Immune Deficiency|immune deficiency
879438|NCT00043186|bone loss|bone loss
879439|NCT00043186|osteoporosis|osteoporosis
879440|NCT00042718|Chronic Bronchitis|chronic bronchitis
879441|NCT00042718|Acute Bacterial Exacerbation of Chronic Bronchitis|acute bacterial exacerbation of chronic bronchitis
879442|NCT00042705|asthma|asthma
879443|NCT00042705|indoor allergens|indoor allergens
879444|NCT00042692|catechol thioethers|catechol thioethers
879445|NCT00042692|Parkinson's disease|parkinson's disease
879446|NCT00042692|neurodegenerative disease|neurodegenerative disease
879447|NCT00042679|Non-Small-Cell Lung Cancer|non-small-cell lung cancer
879448|NCT00042679|Adenocarcinoma|adenocarcinoma
879449|NCT00042679|Carcinoma Squamous|carcinoma squamous
879450|NCT00042679|Adult Lung Cancer|adult lung cancer
879451|NCT00042588|Safety and Efficacy|safety and efficacy
879452|NCT00042588|Community-Acquired Pneumonia, Sepsis|community-acquired pneumonia, sepsis
879453|NCT00042575|Sad, blue, lack of energy, depressed, hopelessness, guilt|sad, blue, lack of energy, depressed, hopelessness, guilt
879454|NCT00042562|Depressed|depressed
879455|NCT00042562|blues|blues
879456|NCT00042562|sadness|sadness
879457|NCT00042562|feelings of guilt|feelings of guilt
879458|NCT00042562|hopelessness|hopelessness
879459|NCT00042562|lack of energy|lack of energy
879460|NCT00042549|Gallstones|gallstones
879461|NCT00042549|Gallstone|gallstone
879462|NCT00042549|Biliary stones|biliary stones
879463|NCT00042549|Gallbladder stones|gallbladder stones
879464|NCT00042549|Gallbladder|gallbladder
879465|NCT00042549|Lithotripsy|lithotripsy
879466|NCT00042549|Cholelithiasis|cholelithiasis
879467|NCT00042549|ESWL|eswl
879468|NCT00042549|Shock wave|shock wave
879469|NCT00042549|Shock waves|shock waves
879470|NCT00042549|shockwaves|shockwaves
879471|NCT00042549|shockwave|shockwave
879472|NCT00042627|Cataracts|cataracts
879473|NCT00042627|Granulocytapheresis|granulocytapheresis
879474|NCT00042627|Granulocyte Donors|granulocyte donors
879475|NCT00042614|Genes|genes
879476|NCT00042614|Heart|heart
879477|NCT00042614|Lymphocytes|lymphocytes
879478|NCT00042614|Proteomics|proteomics
879479|NCT00042614|Transplant|transplant
879480|NCT00042614|Heart Transplant|heart transplant
879481|NCT00042614|Healthy Volunteer|healthy volunteer
879482|NCT00042614|HV|hv
879483|NCT00042614|Normal Control|normal control
879484|NCT00042536|Yohimbine|yohimbine
879485|NCT00042536|Naltrexone|naltrexone
879486|NCT00042536|Sexual Function|sexual function
879487|NCT00042536|Erectile Dysfunction|erectile dysfunction
879488|NCT00042536|Alpha-2 Adrenoreceptor|alpha-2 adrenoreceptor
879489|NCT00042536|Opiate Receptor|opiate receptor
879490|NCT00042536|Male Impotence|male impotence
879491|NCT00042536|ED|ed
879492|NCT00042536|Healthy Volunteer|healthy volunteer
879493|NCT00042536|HV|hv
879494|NCT00042536|Normal Control|normal control
879495|NCT00042523|Autoantibody|autoantibody
879496|NCT00042523|Anti-DNA Antibody|anti-dna antibody
879497|NCT00042523|Cross-Reactivity|cross-reactivity
879498|NCT00042523|Neuron Loss|neuron loss
879499|NCT00042523|Imaging|imaging
879500|NCT00042523|Lupus|lupus
879501|NCT00042523|SLE|sle
879502|NCT00042523|Systemic Lupus Erythematosus|systemic lupus erythematosus
879503|NCT00042510|Gastroesophageal cancer|gastroesophageal cancer
879504|NCT00042510|Gastric cancer|gastric cancer
879505|NCT00042484|Asthma|asthma
879506|NCT00042484|Children's Health|children's health
879507|NCT00042484|Community Based Research|community based research
879508|NCT00042445|Neoplasm|neoplasm
879509|NCT00042445|Petrochemical|petrochemical
879510|NCT00042445|Leukemia|leukemia
879511|NCT00042445|Taiwan|taiwan
879512|NCT00042419|Industrial Injuries|industrial injuries
879513|NCT00042419|Tendonitis|tendonitis
879514|NCT00042419|Assembly Line|assembly line
879515|NCT00042393|Hepatitis B, Chronic|hepatitis b, chronic
879516|NCT00042354|CLO222|clo222
879517|NCT00042354|clolar|clolar
879518|NCT00042354|Pediatric Acute Myelogenous Leukemia|pediatric acute myelogenous leukemia
879519|NCT00042341|CLO212|clo212
879520|NCT00042341|clolar|clolar
879521|NCT00042341|pediatric ALL|pediatric all
879522|NCT00042341|Leukemia, Lymphoblastic, Acute - pediatric|leukemia, lymphoblastic, acute - pediatric
879523|NCT00042328|Cancer|cancer
879524|NCT00042289|Pregnancy|pregnancy
879525|NCT00042289|Pharmacokinetics|pharmacokinetics
879526|NCT00042289|Treatment Experienced|treatment experienced
879527|NCT00041483|AMD|amd
879528|NCT00041483|age-related macular degeneration|age-related macular degeneration
879529|NCT00041483|Anecortave|anecortave
879530|NCT00041483|Acetate|acetate
879531|NCT00041483|Wet form of age-related macular degeneration|wet form of age-related macular degeneration
879532|NCT00042380|Antidepressant|antidepressant
879533|NCT00042380|Anxiety|anxiety
879534|NCT00042380|Dopamine|dopamine
879535|NCT00042380|Tyrosine Kinase Inhibitor|tyrosine kinase inhibitor
879536|NCT00042380|Affective Disorder|affective disorder
879537|NCT00042380|Phytoestrogen|phytoestrogen
879538|NCT00042380|Genistein|genistein
879539|NCT00042380|Major Depression|major depression
879540|NCT00042380|Depression|depression
879541|NCT00042276|Pressure Pain Threshold|pressure pain threshold
879542|NCT00042276|MTrP|mtrp
879543|NCT00042276|Musculoskeletal Pain|musculoskeletal pain
879544|NCT00042276|Soft Tissue Pain|soft tissue pain
879545|NCT00042276|Pathophysiology|pathophysiology
879546|NCT00042276|Myofascial Pain|myofascial pain
879547|NCT00042276|Microdialysis|microdialysis
879548|NCT00042276|Myofascial Trigger Points|myofascial trigger points
879549|NCT00042276|Rehabilitation|rehabilitation
879550|NCT00042276|Muscle Pain|muscle pain
879551|NCT00042276|Neck Pain|neck pain
879552|NCT00042276|Healthy Volunteer|healthy volunteer
879553|NCT00042276|HV|hv
879554|NCT00042276|Normal Control|normal control
879555|NCT00042263|health disparities|health disparities
879556|NCT00042263|social environment|social environment
879557|NCT00042263|physical environment|physical environment
879558|NCT00042263|racial health disparities|racial health disparities
879559|NCT00042250|Cell Cycle Interphase|cell cycle interphase
879560|NCT00042250|G0|g0
879561|NCT00042250|G1|g1
879562|NCT00042250|G2|g2
879563|NCT00042250|S Phase|s phase
879564|NCT00042237|Child Abuse, Sexual|child abuse, sexual
879565|NCT00042224|Electroconvulsive Therapy|electroconvulsive therapy
879566|NCT00042211|Depressive Disorder|depressive disorder
879567|NCT00042211|Blindness|blindness
879568|NCT00042211|Aged|aged
879569|NCT00042198|Cognitive therapy|cognitive therapy
879570|NCT00042198|Relaxation techniques|relaxation techniques
879571|NCT00042185|Adolescence|adolescence
879572|NCT00042185|Prevention and Control|prevention and control
879573|NCT00042185|Bulimia|bulimia
879574|NCT00042172|Cognition|cognition
879575|NCT00042172|Memory|memory
879576|NCT00042159|Auditory hallucinations (voices)|auditory hallucinations (voices)
879577|NCT00042146|Insomnia|insomnia
879578|NCT00042146|Sleep Disorders|sleep disorders
879579|NCT00042146|Sleep Deprivation|sleep deprivation
879580|NCT00042133|aging|aging
879581|NCT00042133|disability|disability
879582|NCT00042133|longitudinal studies|longitudinal studies
879583|NCT00042133|neighborhood factors|neighborhood factors
879584|NCT00042133|socio-economic status|socio-economic status
879585|NCT00042133|race|race
879586|NCT00042120|Parkinson's disease|parkinson's disease
879587|NCT00042120|Movement Disorders|movement disorders
879588|NCT00042120|Epidemiological Study|epidemiological study
879589|NCT00042107|Parkinson Disease|parkinson disease
879590|NCT00042107|Neurodegenerative|neurodegenerative
879591|NCT00042094|Smallpox|smallpox
879592|NCT00042094|Smallpox Vaccine|smallpox vaccine
879593|NCT00042094|Vaccinia|vaccinia
879594|NCT00042081|CABG|cabg
879595|NCT00042081|coronary artery bypass surgery|coronary artery bypass surgery
879596|NCT00042081|coronary artery disease|coronary artery disease
879597|NCT00042081|coronary arteriosclerosis|coronary arteriosclerosis
879598|NCT00042081|coronary stenosis|coronary stenosis
879599|NCT00042081|coronary occlusion|coronary occlusion
879600|NCT00042055|Crohn's Disease|crohn's disease
879601|NCT00042055|Inflammatory Bowel Disease|inflammatory bowel disease
879602|NCT00042016|Chronic myelogenous leukemia|chronic myelogenous leukemia
879603|NCT00042016|CML|cml
879604|NCT00042016|CML-CP|cml-cp
879605|NCT00042016|Chronic phase|chronic phase
879606|NCT00042016|Decitabine|decitabine
879607|NCT00042016|5-aza-2'deoxycytidine|5-aza-2'deoxycytidine
879608|NCT00042016|Methylation|methylation
879609|NCT00042016|STI 571|sti 571
879610|NCT00042016|Imatinib mesylate|imatinib mesylate
879611|NCT00042016|Gleevec|gleevec
879612|NCT00042016|BCR/ABL|bcr/abl
879613|NCT00042003|Chronic myelogenous leukemia|chronic myelogenous leukemia
879614|NCT00042003|CML|cml
879615|NCT00042003|CML-BP|cml-bp
879616|NCT00042003|Blast phase|blast phase
879617|NCT00042003|Decitabine|decitabine
879618|NCT00042003|5-aza-2'deoxycytidine|5-aza-2'deoxycytidine
879619|NCT00042003|Methylation|methylation
879620|NCT00042003|STI 571|sti 571
879621|NCT00042003|Imatinib mesylate|imatinib mesylate
879622|NCT00042003|Gleevec|gleevec
879623|NCT00042003|BCR/ABL|bcr/abl
879624|NCT00041990|Chronic myelogenous leukemia|chronic myelogenous leukemia
879625|NCT00041990|CML|cml
879626|NCT00041990|CML-AP|cml-ap
879627|NCT00041990|Accelerated phase|accelerated phase
879628|NCT00041990|Decitabine|decitabine
879629|NCT00041990|5-aza-2'deoxycytidine|5-aza-2'deoxycytidine
879630|NCT00041990|Methylation|methylation
879631|NCT00041990|STI 571|sti 571
879632|NCT00041990|Imatinib mesylate|imatinib mesylate
879633|NCT00041990|Gleevec|gleevec
879634|NCT00041990|BCR/ABL|bcr/abl
879635|NCT00041977|Rosacea|rosacea
879636|NCT00041964|Lopinavir|lopinavir
879637|NCT00041964|Pregnancy Trimester, Third|pregnancy trimester, third
879638|NCT00041964|Pregnancy Complications, Infectious|pregnancy complications, infectious
879639|NCT00041964|HIV Protease Inhibitors|hiv protease inhibitors
879640|NCT00041964|Ritonavir|ritonavir
879641|NCT00041964|Nelfinavir|nelfinavir
879642|NCT00041964|Viral Load|viral load
879643|NCT00041964|puerperium|puerperium
879644|NCT00041951|Childhood Absence Epilepsy|childhood absence epilepsy
879645|NCT00041951|CAE|cae
879646|NCT00041951|Petit Mal|petit mal
879647|NCT00041951|Epilepsy|epilepsy
879648|NCT00041951|Seizures|seizures
879649|NCT00041951|Genes|genes
879650|NCT00041951|Inheritance|inheritance
879651|NCT00041951|Genetics|genetics
879652|NCT00041951|Genetic Linkage|genetic linkage
879653|NCT00041938|heart disease|heart disease
879654|NCT00041938|stroke|stroke
879655|NCT00041938|ischemic heart disease|ischemic heart disease
879656|NCT00041938|myocardial infarction|myocardial infarction
879657|NCT00041938|atrial fibrillation|atrial fibrillation
879658|NCT00041938|low ejection fraction|low ejection fraction
879659|NCT00041938|cardiac failure|cardiac failure
879660|NCT00041938|aspirin|aspirin
879661|NCT00041938|Warfarin|warfarin
879662|NCT00041938|anticoagulant|anticoagulant
879760|NCT00041509|pulmonary embolism|pulmonary embolism
879663|NCT00041925|atherosclerotic vascular disease|atherosclerotic vascular disease
879664|NCT00041925|chronic critical limb ischemia|chronic critical limb ischemia
879665|NCT00041925|neointimal hyperplasia|neointimal hyperplasia
879666|NCT00041925|peripheral vein bypass|peripheral vein bypass
879667|NCT00041925|infra-inguinal bypass grafting surgery|infra-inguinal bypass grafting surgery
879668|NCT00041925|graft stenosis|graft stenosis
879669|NCT00041925|occluded grafts|occluded grafts
879670|NCT00041860|Benzene|benzene
879671|NCT00041860|Air pollution|air pollution
879672|NCT00041847|gene|gene
879673|NCT00041847|environment|environment
879674|NCT00041847|occupation|occupation
879675|NCT00041847|diet|diet
879676|NCT00041847|interaction|interaction
879677|NCT00041834|childhood asthma|childhood asthma
879678|NCT00041834|traffic|traffic
879679|NCT00041821|rhinitis|rhinitis
879680|NCT00041821|irritation|irritation
879681|NCT00041821|trigeminal|trigeminal
879682|NCT00041899|Progesterone|progesterone
879683|NCT00041899|Cortisol|cortisol
879684|NCT00041899|Menstrual Cycle|menstrual cycle
879685|NCT00041899|Formulation|formulation
879686|NCT00041899|Endometrium|endometrium
879687|NCT00041899|Estrogen|estrogen
879688|NCT00041886|Minimally Invasive Surgery|minimally invasive surgery
879689|NCT00041886|Percutaneous|percutaneous
879690|NCT00041886|Radiofrequency Ablation|radiofrequency ablation
879691|NCT00041886|Soft Tissue Metastases|soft tissue metastases
879692|NCT00041886|Thermal Ablation|thermal ablation
879693|NCT00041886|Soft Tissue Neoplasm|soft tissue neoplasm
879694|NCT00041886|Tumor|tumor
879695|NCT00041808|Metastatic liver cancer|metastatic liver cancer
879696|NCT00041808|Cholangiocarcinoma|cholangiocarcinoma
879697|NCT00041808|colorectal cancer|colorectal cancer
879698|NCT00041808|esophageal cancer|esophageal cancer
879699|NCT00041808|gastric cancer|gastric cancer
879700|NCT00041808|pancreatic cancer|pancreatic cancer
879701|NCT00041808|breast cancer|breast cancer
879702|NCT00041808|malignant melanoma|malignant melanoma
879703|NCT00041808|sarcoma|sarcoma
879704|NCT00041808|GIST|gist
879705|NCT00041808|gastrointestinal stromal tumor|gastrointestinal stromal tumor
879707|NCT00041808|liver cancer|liver cancer
879708|NCT00041782|Deep Vein Thrombosis|deep vein thrombosis
879709|NCT00041769|Drug Therapy, Combination|drug therapy, combination
879710|NCT00041769|HIV Protease Inhibitors|hiv protease inhibitors
879711|NCT00041769|Salvage Therapy|salvage therapy
879712|NCT00041769|Viral Load|viral load
879713|NCT00041769|Treatment Experienced|treatment experienced
879714|NCT00041756|Primary Disease: Knee Primary Osteoarthritis|primary disease: knee primary osteoarthritis
879715|NCT00041730|lymphoma|lymphoma
879716|NCT00041730|vaccine|vaccine
879717|NCT00041730|idiotype|idiotype
879718|NCT00041730|KLH|klh
879719|NCT00041730|GM-CSF|gm-csf
879720|NCT00041730|FavId|favid
879721|NCT00041717|spinal cord injury|spinal cord injury
879722|NCT00041717|muscle spasticity|muscle spasticity
879723|NCT00041704|Azole-Refractory Mucosal Candidiasis|azole-refractory mucosal candidiasis
879724|NCT00041704|Mucosal Candidiasis|mucosal candidiasis
879725|NCT00041691|Colorectal Cancer|colorectal cancer
879726|NCT00041691|Colon Cancer|colon cancer
879727|NCT00041691|Rectal Cancer|rectal cancer
879728|NCT00041691|Colorectal Neoplasms|colorectal neoplasms
879729|NCT00041691|Colorectal Carcinoma|colorectal carcinoma
879730|NCT00041691|Colorectal Tumor|colorectal tumor
879731|NCT00041678|Psychosis Associated with Dementia of the Alzheimer's Type|psychosis associated with dementia of the alzheimer's type
879732|NCT00041652|Colorectal Cancer|colorectal cancer
879733|NCT00041652|Colon Cancer|colon cancer
879734|NCT00041652|Rectal Cancer|rectal cancer
879735|NCT00041652|Colorectal Neoplasms|colorectal neoplasms
879736|NCT00041652|Colorectal Carcinoma|colorectal carcinoma
879737|NCT00041652|Breast Cancer|breast cancer
879738|NCT00041652|Breast Neoplasms|breast neoplasms
879739|NCT00041639|Pancreatic Cancer|pancreatic cancer
879740|NCT00041639|Pancreatic Carcinoma|pancreatic carcinoma
879741|NCT00041639|Pancreatic Neoplasms|pancreatic neoplasms
879742|NCT00041639|Pancreas Cancer|pancreas cancer
879743|NCT00041639|Pancreatic Tumor|pancreatic tumor
879744|NCT00041626|Recurrent Squamous Cell Carcinoma of the Head and Neck|recurrent squamous cell carcinoma of the head and neck
879745|NCT00041613|Refractory Squamous Cell Carcinoma of the Head and Neck|refractory squamous cell carcinoma of the head and neck
879746|NCT00041600|epilepsy|epilepsy
879747|NCT00041600|seizures|seizures
879748|NCT00041600|disorders of human cognition|disorders of human cognition
879749|NCT00041600|neuronal migration|neuronal migration
879750|NCT00041600|neuronal migration disorders|neuronal migration disorders
879751|NCT00041600|lissencephaly|lissencephaly
879752|NCT00041600|schizencephaly|schizencephaly
879753|NCT00041600|polymicrogyria|polymicrogyria
879754|NCT00041600|agenesis of the corpus callosum|agenesis of the corpus callosum
879755|NCT00041600|heterotopia|heterotopia
879756|NCT00041587|Cancer|cancer
879757|NCT00041587|Recurrent resectable supratentorial malignant glioma|recurrent resectable supratentorial malignant glioma
879758|NCT00041509|venous thromboembolism|venous thromboembolism
879759|NCT00041509|thromboembolism|thromboembolism
879761|NCT00041509|deep vein thrombosis|deep vein thrombosis
879762|NCT00041496|symptomatic atrial fibrillation|symptomatic atrial fibrillation
879763|NCT00041496|persistent atrial fibrillation|persistent atrial fibrillation
879764|NCT00041561|Acute hypoxemic respiratory failure|acute hypoxemic respiratory failure
879765|NCT00041535|Eye Movements|eye movements
879766|NCT00041535|Saccades|saccades
879767|NCT00041535|Metabolic|metabolic
879768|NCT00041535|Lysosomal|lysosomal
879769|NCT00041535|Myoclonus|myoclonus
879770|NCT00041535|Gaucher Disease|gaucher disease
879771|NCT00041535|Neuronopathic Gaucher Disease|neuronopathic gaucher disease
879772|NCT00040677|sickle cell anemia|sickle cell anemia
879773|NCT00040677|sickle cell disease|sickle cell disease
879774|NCT00040677|anemia|anemia
879775|NCT00040677|ICA-17043|ica-17043
879776|NCT00040677|senicapoc|senicapoc
879777|NCT00040664|pediatrics|pediatrics
879778|NCT00040664|HIV|hiv
879779|NCT00040664|protease inhibitors|protease inhibitors
879780|NCT00040664|ritonavir|ritonavir
879781|NCT00040664|fosamprenavir|fosamprenavir
879782|NCT00040664|LEXIVA|lexiva
879783|NCT00040664|AGENERASE|agenerase
879784|NCT00040664|amprenavir|amprenavir
879785|NCT00040651|Systemic Sclerosis|systemic sclerosis
879786|NCT00040651|Chemotherapy|chemotherapy
879787|NCT00040651|Cyclophosphamide|cyclophosphamide
879788|NCT00040651|Fludarabine|fludarabine
879789|NCT00040651|Leukapheresis|leukapheresis
879790|NCT00040651|Mesna|mesna
879791|NCT00040651|Stem Cell|stem cell
879792|NCT00040651|T-Cell|t-cell
879793|NCT00040651|Thymoglobulin|thymoglobulin
879794|NCT00040651|Scleroderma|scleroderma
879795|NCT00040027|hepatitis C|hepatitis c
879796|NCT00040027|hepatitis C, chronic|hepatitis c, chronic
879797|NCT00040599|Colon Cancer|colon cancer
879798|NCT00040599|Rectal Cancer|rectal cancer
879799|NCT00040599|Colorectal Neoplasms|colorectal neoplasms
879800|NCT00040599|Colorectal Carcinoma|colorectal carcinoma
879801|NCT00040599|Colorectal Tumor|colorectal tumor
879802|NCT00040586|hormone-refractory|hormone-refractory
879803|NCT00040573|Brain neoplasm|brain neoplasm
879804|NCT00040573|Clinical trial, phase I/II|clinical trial, phase i/ii
879806|NCT00040560|Metastatic Brain Cancer|metastatic brain cancer
879807|NCT00040547|Cancer-Advanced Solid Tumors|cancer-advanced solid tumors
879808|NCT00040534|Advanced Cancer|advanced cancer
879809|NCT00040521|Crohn's Disease|crohn's disease
879810|NCT00040521|Active Crohns Disease|active crohns disease
879811|NCT00040495|Peptic|peptic
879812|NCT00040495|Ulcer|ulcer
879813|NCT00040495|Hemorrhage|hemorrhage
879814|NCT00040456|Hemoglobin SC disease|hemoglobin sc disease
879815|NCT00040456|sickle cell-hemoglobin|sickle cell-hemoglobin
879816|NCT00040443|Mild Cognitive Impairment|mild cognitive impairment
879817|NCT00040443|Memory Loss|memory loss
879818|NCT00040443|Alzheimer's Disease|alzheimer's disease
879819|NCT00040443|Brain Aging|brain aging
879820|NCT00040443|Ampalex®|ampalex®
879821|NCT00040443|CX516|cx516
879822|NCT00040508|Proteinuria|proteinuria
879823|NCT00040508|Renal Failure|renal failure
879824|NCT00040508|Fibrosis|fibrosis
879825|NCT00040508|Rapamycin|rapamycin
879826|NCT00040508|Immunosuppression|immunosuppression
879827|NCT00040508|Focal Segmental Glomerulosclerosis|focal segmental glomerulosclerosis
879828|NCT00040508|FSGS|fsgs
879829|NCT00040404|Parkinson's disease|parkinson's disease
879830|NCT00040404|Idiopathic Parkinson's disease|idiopathic parkinson's disease
879831|NCT00040404|Idiopathic Parkinson disease|idiopathic parkinson disease
879832|NCT00040404|Parkinson's disease, idiopathic|parkinson's disease, idiopathic
879833|NCT00040391|Pharmacia|pharmacia
879834|NCT00040378|Alzheimer Disease|alzheimer disease
879835|NCT00040378|Vitamin E|vitamin e
879836|NCT00040378|Selenium|selenium
879837|NCT00040365|Prostate Cancer|prostate cancer
879838|NCT00040365|Radiation Therapy|radiation therapy
879839|NCT00040365|Rectal Toxicity|rectal toxicity
879840|NCT00040365|Amifostine|amifostine
879841|NCT00040365|Radioprotector|radioprotector
879842|NCT00040352|Genetics|genetics
879843|NCT00040352|Risk Factors|risk factors
879844|NCT00040352|Natural History|natural history
879845|NCT00040352|Melanoma Precursors|melanoma precursors
879846|NCT00040352|Skin Cancer|skin cancer
879847|NCT00040352|Melanoma|melanoma
879848|NCT00040339|brain injury|brain injury
879849|NCT00040339|hypothermia|hypothermia
879850|NCT00040339|body cooling|body cooling
879851|NCT00040339|body temperature|body temperature
879852|NCT00040326|epilepsy|epilepsy
879853|NCT00040326|mesial temporal lobe epilepsy|mesial temporal lobe epilepsy
879854|NCT00040326|temporal lobe epilepsy|temporal lobe epilepsy
879855|NCT00040326|MTLE|mtle
879856|NCT00040326|seizures|seizures
879857|NCT00040326|anteromesial temporal resection|anteromesial temporal resection
879858|NCT00040326|surgery|surgery
879859|NCT00040326|antiepileptic drugs|antiepileptic drugs
879860|NCT00040326|hippocampal sclerosis|hippocampal sclerosis
879861|NCT00040300|treatment experienced|treatment experienced
879862|NCT00040300|HIV|hiv
879863|NCT00040300|Phase I|phase i
879864|NCT00040300|Combination Therapy|combination therapy
879868|NCT00040287|smoking cessation|smoking cessation
879869|NCT00040287|weight control|weight control
879870|NCT00040274|HIV|hiv
879871|NCT00040274|Phase I|phase i
879872|NCT00040183|Tarceva, EGFR, erlotinib, OSI-774|tarceva, egfr, erlotinib, osi-774
879873|NCT00040170|Adenocarcinoma of the prostate|adenocarcinoma of the prostate
879874|NCT00040157|treatment experienced,|treatment experienced,
879875|NCT00040157|Stable triple anti-retroviral combination therapy in HIV-infected,|stable triple anti-retroviral combination therapy in hiv-infected,
879876|NCT00040157|Achillion|achillion
879877|NCT00040144|E-Antigen positive,|e-antigen positive,
879878|NCT00040144|Lamivudine-Resistant Chronic Hepatitis B,|lamivudine-resistant chronic hepatitis b,
879879|NCT00040144|Achillion|achillion
879880|NCT00040261|Antiglutamatergic|antiglutamatergic
879881|NCT00040261|Neuroprotective|neuroprotective
879882|NCT00040261|Unipolar Depression|unipolar depression
879883|NCT00040261|Treatment|treatment
879884|NCT00040261|Antidepressant|antidepressant
879885|NCT00040261|Depression|depression
879886|NCT00040261|Glutamate|glutamate
879887|NCT00040261|Memantine|memantine
879888|NCT00040261|Pathophysiology|pathophysiology
879889|NCT00040261|Positron Emission Tomography|positron emission tomography
879890|NCT00040261|Major Depression|major depression
879891|NCT00040248|Relapse|relapse
879892|NCT00040248|Monoclonal Antibody|monoclonal antibody
879893|NCT00040248|Biologic Agent|biologic agent
879894|NCT00040248|Anti-CD25|anti-cd25
879895|NCT00040248|Activated Lymphocyte|activated lymphocyte
879896|NCT00040248|Wegener Granulomatosis|wegener granulomatosis
879897|NCT00040248|Wegener's Granulomatosis|wegener's granulomatosis
879898|NCT00040248|WG|wg
879899|NCT00040235|Leukapheresis|leukapheresis
879900|NCT00040235|Hypomagnesemia|hypomagnesemia
879901|NCT00040235|Plateletpheresis|plateletpheresis
879902|NCT00040235|Hypocalcemia|hypocalcemia
879903|NCT00040235|Citrate|citrate
879904|NCT00040235|Healthy Volunteer|healthy volunteer
879905|NCT00040235|HV|hv
879906|NCT00040235|Normal Control|normal control
879907|NCT00040222|Counseling/behavioral/psychosocial|counseling/behavioral/psychosocial
879908|NCT00040222|Gene discovery|gene discovery
879909|NCT00040222|Cancer prevention|cancer prevention
879910|NCT00040222|Risk-reduction|risk-reduction
879911|NCT00040222|Hereditary|hereditary
879912|NCT00040222|Breast Cancer|breast cancer
879913|NCT00040222|Ovarian Cancer|ovarian cancer
879914|NCT00040222|Cowden Syndrome|cowden syndrome
879915|NCT00040222|Peutz-Jegher Syndrome|peutz-jegher syndrome
879916|NCT00040222|Li-Fraumeni Syndrome|li-fraumeni syndrome
879917|NCT00040209|JP 1730|jp 1730
879918|NCT00040209|Dyskinesias|dyskinesias
879919|NCT00040209|Levodopa Infusion|levodopa infusion
879920|NCT00040209|Apomorphine Infusion|apomorphine infusion
879921|NCT00040209|Clinical Trial|clinical trial
879922|NCT00040209|Parkinson Disease|parkinson disease
879923|NCT00040209|PD|pd
879924|NCT00040196|Parkinson's Disease|parkinson's disease
879925|NCT00040196|Levodopa|levodopa
879926|NCT00040196|Perfusion fMRI|perfusion fmri
879927|NCT00040196|Aging|aging
879928|NCT00040196|Motor Control|motor control
879929|NCT00040196|PD|pd
879930|NCT00040196|Healthy Volunteer|healthy volunteer
879931|NCT00040196|HV|hv
879932|NCT00040196|Normal Control|normal control
879933|NCT00040105|Chronic Myelogenous Leukemia, Chronic Phase|chronic myelogenous leukemia, chronic phase
879934|NCT00040105|R115777|r115777
879935|NCT00040105|Zarnestra|zarnestra
879936|NCT00040105|Tipifarnib|tipifarnib
879937|NCT00040105|Imatinib Mesylate|imatinib mesylate
879938|NCT00040105|Gleevec|gleevec
879939|NCT00040105|Imatinib|imatinib
879940|NCT00040105|STI571|sti571
879941|NCT00040105|NSC-716051|nsc-716051
879942|NCT00040092|Virulizin|virulizin
879943|NCT00040092|Immunotherapy|immunotherapy
879944|NCT00040092|Pancreas|pancreas
879945|NCT00040092|Pancreatic Cancer|pancreatic cancer
879946|NCT00040092|clinical trial|clinical trial
879947|NCT00039988|Treatment Outcome|treatment outcome
879948|NCT00039988|Multiple Sclerosis|multiple sclerosis
879949|NCT00039988|Albuterol|albuterol
879950|NCT00039988|Copolymer 1|copolymer 1
879951|NCT00039975|Drug Interactions|drug interactions
879952|NCT00039975|HIV Protease Inhibitors|hiv protease inhibitors
879953|NCT00039975|Ritonavir|ritonavir
879954|NCT00039975|Indinavir|indinavir
879955|NCT00039975|Calcium Channel Blockers|calcium channel blockers
879956|NCT00039975|Pharmacokinetics|pharmacokinetics
879957|NCT00039975|Diltiazem|diltiazem
879958|NCT00039975|Amlodipine|amlodipine
879959|NCT00039962|hepatitis C|hepatitis c
879960|NCT00039962|hepatitis C, chronic|hepatitis c, chronic
879961|NCT00039962|cirrhosis, liver|cirrhosis, liver
879962|NCT00039936|Binge Eating|binge eating
879963|NCT00039936|Obesity|obesity
879964|NCT00039936|Cognitive|cognitive
879965|NCT00039936|Behavior|behavior
879966|NCT00040053|amphetamine dependence|amphetamine dependence
879967|NCT00039923|Hemolysis|hemolysis
879968|NCT00039923|CD55|cd55
879969|NCT00039923|CD59|cd59
879970|NCT00039923|Transfusion|transfusion
879971|NCT00039923|Paroxysmal Nocturnal Hemoglobinuria|paroxysmal nocturnal hemoglobinuria
879973|NCT00039884|Cervical cancer|cervical cancer
879974|NCT00039858|heparin-induced thrombocytopenia|heparin-induced thrombocytopenia
879975|NCT00039858|heparin-induced thrombocytopenia and thrombosis|heparin-induced thrombocytopenia and thrombosis
879976|NCT00039858|HIT|hit
879977|NCT00039858|HITTS|hitts
879978|NCT00039858|anticoagulation|anticoagulation
879979|NCT00039845|Brain|brain
879980|NCT00039845|Imaging|imaging
879981|NCT00039845|Pediatrics|pediatrics
879982|NCT00039845|Mapping|mapping
879983|NCT00039845|Development|development
879984|NCT00039845|fMRI|fmri
879985|NCT00039845|Children|children
879986|NCT00039845|Language|language
879987|NCT00039845|Healthy Volunteer|healthy volunteer
879988|NCT00039845|HV|hv
879989|NCT00039845|Normal Control|normal control
879990|NCT00039832|Stroke|stroke
879991|NCT00039832|Abciximab|abciximab
879992|NCT00039832|Reteplase|reteplase
879993|NCT00039832|MRI|mri
879994|NCT00039832|Cerebral Blood Flow|cerebral blood flow
879995|NCT00039793|Cancer-related fatigue|cancer-related fatigue
879996|NCT00039793|alternative medicine|alternative medicine
879997|NCT00039793|cancer rehabilitation /care|cancer rehabilitation /care
879998|NCT00039793|fatigue|fatigue
879999|NCT00039793|human therapy evaluation|human therapy evaluation
880000|NCT00039793|physical therapy|physical therapy
880001|NCT00039793|neoplasm /cancer chemotherapy|neoplasm /cancer chemotherapy
880002|NCT00039793|neoplasm /cancer palliative treatment|neoplasm /cancer palliative treatment
880003|NCT00039780|Breast|breast
880004|NCT00039780|Cancer|cancer
880005|NCT00039780|Metastatic|metastatic
880006|NCT00039780|Paclitaxel|paclitaxel
880007|NCT00039780|Peripheral|peripheral
880008|NCT00039780|Taxol|taxol
880009|NCT00039780|Neuropathy|neuropathy
880010|NCT00039780|Neurotoxicity|neurotoxicity
880011|NCT00039780|Paresthesias|paresthesias
880012|NCT00039780|Weekly|weekly
880013|NCT00039780|BNP7787|bnp7787
880015|NCT00039780|Tavocept|tavocept
880016|NCT00039780|Prevention|prevention
880017|NCT00039819|Spinal Cord|spinal cord
880018|NCT00039819|Sensory Stimulation|sensory stimulation
880019|NCT00039819|Locomotion|locomotion
880020|NCT00039819|Magnetic Stimulation|magnetic stimulation
880022|NCT00039819|Healthy Volunteer|healthy volunteer
880023|NCT00039819|HV|hv
880024|NCT00039819|Normal Control|normal control
880025|NCT00039754|Multiple myeloma|multiple myeloma
880026|NCT00039754|Transplant|transplant
880027|NCT00039754|Skeletal Targeted Radiotherapy|skeletal targeted radiotherapy
880028|NCT00039754|Holmium|holmium
880029|NCT00039741|Drug Therapy, Combination|drug therapy, combination
880030|NCT00039741|HIV Protease Inhibitors|hiv protease inhibitors
880031|NCT00039741|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors
880032|NCT00039741|Viral Load|viral load
880033|NCT00039741|Treatment Naive|treatment naive
880034|NCT00039767|Fibrin Sleeves|fibrin sleeves
880035|NCT00039767|Anticoagulants|anticoagulants
880036|NCT00039767|Catheters|catheters
880037|NCT00039767|Thrombosis|thrombosis
880038|NCT00039767|Hirudin|hirudin
880039|NCT00039767|Lepirudin|lepirudin
880040|NCT00039026|Type 2 Diabetes Mellitis|type 2 diabetes mellitis
880041|NCT00039000|Immunotherapy, Cancer, Melanoma, Skin Cancer, tumor|immunotherapy, cancer, melanoma, skin cancer, tumor
880042|NCT00038987|Smallpox|smallpox
880043|NCT00038987|APSV|apsv
880044|NCT00038987|Aventis Pasteur Smallpox Vaccine|aventis pasteur smallpox vaccine
880045|NCT00038987|vaccinia-naive|vaccinia-naive
880046|NCT00038974|Hepatitis C|hepatitis c
880047|NCT00038974|Interferon|interferon
880048|NCT00038974|Ribavirin|ribavirin
880049|NCT00038974|Efficacy|efficacy
880050|NCT00038974|Viral load|viral load
880051|NCT00038974|Genetics|genetics
880052|NCT00038974|Cytokines|cytokines
880053|NCT00038974|Immunology|immunology
880054|NCT00038961|fondaparinux sodium|fondaparinux sodium
880055|NCT00038961|DVT Prevention|dvt prevention
880056|NCT00038961|abdominal surgery|abdominal surgery
880057|NCT00038961|VTE prevention|vte prevention
880058|NCT00038961|venous thromboembolism|venous thromboembolism
880059|NCT00038961|pulmonary embolism|pulmonary embolism
880060|NCT00039715|Glucocorticoid Receptor|glucocorticoid receptor
880061|NCT00039715|Traumatic Reminders|traumatic reminders
880062|NCT00039715|Stress|stress
880063|NCT00039715|Hippocampus|hippocampus
880064|NCT00039715|Flashbacks|flashbacks
880065|NCT00039715|PTSD|ptsd
880066|NCT00039715|Type II GR Receptor|type ii gr receptor
880067|NCT00039715|Hydrocortisone|hydrocortisone
880068|NCT00039715|Memory|memory
880069|NCT00039715|Major Depression|major depression
880070|NCT00039715|Post-Traumatic Stress Disorder|post-traumatic stress disorder
880071|NCT00039715|Healthy Volunteer|healthy volunteer
880072|NCT00039715|HV|hv
880073|NCT00039715|Normal Control|normal control
880074|NCT00039702|Nicotinic Acetylcholine Receptors|nicotinic acetylcholine receptors
880075|NCT00039702|Alzheimer's Disease|alzheimer's disease
880076|NCT00039702|SPECT|spect
880077|NCT00039702|AD|ad
880078|NCT00039702|Healthy Volunteer|healthy volunteer
880079|NCT00039702|HV|hv
880080|NCT00039702|Normal Control|normal control
880081|NCT00039689|Cellular Immunity|cellular immunity
880082|NCT00039689|Chronic HIV Infection|chronic hiv infection
880083|NCT00039689|Antiretroviral Therapy|antiretroviral therapy
880084|NCT00039689|Primary HIV Infection|primary hiv infection
880085|NCT00039689|Humoral Immunity|humoral immunity
880086|NCT00039689|HIV Infection|hiv infection
880087|NCT00039689|Acute Infection|acute infection
880088|NCT00039689|Treatment Naive|treatment naive
880089|NCT00039676|Genetics|genetics
880090|NCT00039676|Risk Factors|risk factors
880091|NCT00039676|Natural History|natural history
880092|NCT00039676|Lymphoma|lymphoma
880093|NCT00039676|Leukemia|leukemia
880094|NCT00039676|Lymph Node Cancer|lymph node cancer
880095|NCT00039663|Hyperlipidemia|hyperlipidemia
880096|NCT00039663|Insulin Resistance|insulin resistance
880097|NCT00039663|Coronary Artery Disease|coronary artery disease
880098|NCT00039663|Lipodystrophy|lipodystrophy
880099|NCT00039663|Antiretroviral Therapy|antiretroviral therapy
880100|NCT00039663|HIV Infection|hiv infection
880101|NCT00039663|Treatment Experienced|treatment experienced
880102|NCT00039650|Granulocyte Colony-Stimulating Factor|granulocyte colony-stimulating factor
880103|NCT00039650|T Cells|t cells
880104|NCT00039650|Peripheral Blood Stem Cells|peripheral blood stem cells
880105|NCT00039650|Apheresis|apheresis
880106|NCT00039650|Hematopoietic Progenitor Cell Transplantation|hematopoietic progenitor cell transplantation
880107|NCT00039650|Healthy Volunteer|healthy volunteer
880108|NCT00039650|HV|hv
880109|NCT00039650|Normal Control|normal control
880110|NCT00039624|Radiation Therapy|radiation therapy
880111|NCT00039624|Prostate|prostate
880112|NCT00039624|MRI|mri
880113|NCT00039624|Brachytherapy|brachytherapy
880114|NCT00039624|Phase II|phase ii
880115|NCT00039624|Prostate Cancer|prostate cancer
880116|NCT00038948|Renal|renal
880117|NCT00038948|Allograft|allograft
880118|NCT00038948|Recipients|recipients
880119|NCT00038935|Hemophilia|hemophilia
880120|NCT00038922|Left-Sided|left-sided
880121|NCT00038922|Ulcerative|ulcerative
880122|NCT00038922|Colitis|colitis
880123|NCT00038896|Panic|panic
880124|NCT00038896|Disorder|disorder
880125|NCT00038883|Lymphoid Malignancies|lymphoid malignancies
897284|NCT00000173|Donepezil|donepezil
880126|NCT00038883|Chronic Lymphocytic Leukemia|chronic lymphocytic leukemia
880127|NCT00038883|Acute Lymphoblastic Leukemia|acute lymphoblastic leukemia
880128|NCT00038883|Low grade Lymphoma|low grade lymphoma
880129|NCT00038883|B and T cell Lymphoma of the intermediate and high grade|b and t cell lymphoma of the intermediate and high grade
880130|NCT00038870|AML|aml
880131|NCT00038870|CML|cml
880132|NCT00038870|Dendritic Cells|dendritic cells
880133|NCT00038857|Acute Myelogenous Leukemia|acute myelogenous leukemia
880134|NCT00038857|Acute Lymphocytic Leukemia|acute lymphocytic leukemia
880135|NCT00038857|Myelodysplastic Syndrome|myelodysplastic syndrome
880136|NCT00038857|Chronic Lymphocytic Leukemia|chronic lymphocytic leukemia
880137|NCT00038857|Leukemia|leukemia
880138|NCT00038857|Lymphoma|lymphoma
880139|NCT00038857|Non Hodgkin's Lymphoma|non hodgkin's lymphoma
880140|NCT00038857|T cell depletion|t cell depletion
880141|NCT00038857|CD34 selected progenitors cell|cd34 selected progenitors cell
880143|NCT00038844|Lymphoma|lymphoma
880144|NCT00038844|Leukemia|leukemia
880145|NCT00038844|Campath-1 H|campath-1 h
880146|NCT00038844|Campath|campath
880147|NCT00038844|Alemtuzumab|alemtuzumab
880148|NCT00038844|Fludarabine|fludarabine
880149|NCT00038844|Fludarabine Phosphate|fludarabine phosphate
880150|NCT00038844|Fludara|fludara
880151|NCT00038844|Cyclophosphamide|cyclophosphamide
880152|NCT00038844|Cytoxan|cytoxan
880153|NCT00038844|Neosar|neosar
880154|NCT00038844|Rituxan|rituxan
880155|NCT00038844|Rituximab|rituximab
880156|NCT00038831|Acute Myelogenous leukemia|acute myelogenous leukemia
880157|NCT00038831|AML|aml
880158|NCT00038831|Myelodysplastic Syndrome|myelodysplastic syndrome
880159|NCT00038831|MDS|mds
880160|NCT00038831|Chronic Lymphocytic Leukemia|chronic lymphocytic leukemia
880161|NCT00038831|CML|cml
880162|NCT00038831|Mylotarg|mylotarg
880163|NCT00038831|Gemtuzumab|gemtuzumab
880164|NCT00038831|Gemtuzumab ozogamicin|gemtuzumab ozogamicin
880165|NCT00038831|Melphalan|melphalan
880166|NCT00038831|Alkeran|alkeran
880167|NCT00038831|Fludarabine Phosphate|fludarabine phosphate
880168|NCT00038831|Fludarabine|fludarabine
880169|NCT00038831|Fludara|fludara
880170|NCT00038831|Anti-thymocyte globulin|anti-thymocyte globulin
880171|NCT00038831|ATG|atg
880172|NCT00038831|Allogeneic Bone Marrow|allogeneic bone marrow
880173|NCT00038831|Peripheral Blood Stem Cell Transplantation|peripheral blood stem cell transplantation
880174|NCT00038831|Allo PBSCT|allo pbsct
880175|NCT00038831|Allogeneic transplantation|allogeneic transplantation
880176|NCT00038818|CML|cml
880177|NCT00038818|MM|mm
880178|NCT00038818|NHL|nhl
880179|NCT00038818|HD|hd
880180|NCT00038818|CLL|cll
880181|NCT00038818|CD8 Depleted|cd8 depleted
880182|NCT00038818|Donor Lymphocyte|donor lymphocyte
880183|NCT00038805|High Risk Acute Myeloid Leukemia|high risk acute myeloid leukemia
880184|NCT00038805|Acute Lymphocytic Leukemia|acute lymphocytic leukemia
881640|NCT00031551|Oral cavity|oral cavity
880185|NCT00038805|Chronic Myeloid Leukemia|chronic myeloid leukemia
880186|NCT00038805|Myelodysplastic Syndrome|myelodysplastic syndrome
880187|NCT00038805|ALL|all
880188|NCT00038805|AML|aml
880189|NCT00038805|MDS|mds
880190|NCT00038805|CML|cml
880191|NCT00038805|CMML|cmml
880192|NCT00038805|Nonmyeloablative Preparative Regimen|nonmyeloablative preparative regimen
880193|NCT00038805|Mylotarg|mylotarg
880194|NCT00038805|CMA-676|cma-676
880195|NCT00038792|Acute Graft Versus Host Disease|acute graft versus host disease
880196|NCT00038792|Refractory|refractory
880197|NCT00038779|Lymphoma|lymphoma
880198|NCT00038779|CML|cml
880199|NCT00038779|CLL|cll
880200|NCT00038779|AML|aml
880201|NCT00038779|ALL|all
880202|NCT00038779|MDS|mds
880203|NCT00038779|AA|aa
880204|NCT00038766|Inflammatory Bowel Disease|inflammatory bowel disease
880205|NCT00038753|vision screening|vision screening
880206|NCT00038727|DPP|dpp
880207|NCT00038727|IGT|igt
880208|NCT00038727|Prediabetes|prediabetes
880209|NCT00038727|Type 2 diabetes|type 2 diabetes
880210|NCT00038727|Macrovascular disease|macrovascular disease
880211|NCT00038727|Microvascular disease|microvascular disease
880212|NCT00038727|Lifestyle|lifestyle
880213|NCT00038727|Metformin|metformin
880214|NCT00038727|Obesity|obesity
880215|NCT00038714|HPV|hpv
880216|NCT00038714|Papilloma|papilloma
880217|NCT00038701|Metastatic Pancreas Cancer|metastatic pancreas cancer
880218|NCT00038688|Health Education|health education
880219|NCT00038688|Substance Abuse, Intravenous|substance abuse, intravenous
880220|NCT00038688|Program Evaluation|program evaluation
880221|NCT00038688|Peer Group|peer group
880222|NCT00038688|Risk-Taking|risk-taking
880223|NCT00038688|HIV Seronegativity|hiv seronegativity
880224|NCT00038688|Substance-related Disorders|substance-related disorders
880225|NCT00038675|Leukemia|leukemia
880226|NCT00038675|Chronic Myelomonocytic Leukemia|chronic myelomonocytic leukemia
880227|NCT00038675|Chronic Myeloid Leukemia|chronic myeloid leukemia
880228|NCT00038675|Polycythemia Vera|polycythemia vera
880229|NCT00038675|Hypereosinophilic Syndrome|hypereosinophilic syndrome
880230|NCT00038675|Mastocytosis|mastocytosis
880231|NCT00038675|Imatinib Mesylate|imatinib mesylate
880233|NCT00038649|Philadelphia chromosome positive|philadelphia chromosome positive
880234|NCT00038649|early chronic phase (diagnosis < 12 months)|early chronic phase (diagnosis < 12 months)
880235|NCT00038649|Chronic Myelogenous Leukemia, Chronic Phase|chronic myelogenous leukemia, chronic phase
880236|NCT00038649|Chronic Myelogenous Leukemia|chronic myelogenous leukemia
880237|NCT00038649|CML|cml
880238|NCT00038649|Gleevec|gleevec
880239|NCT00038649|STI571|sti571
880240|NCT00038636|HIV|hiv
880241|NCT00038623|Relapsed/Refractory Mantle Cell Lymphoma|relapsed/refractory mantle cell lymphoma
880242|NCT00038623|Yttrium-Ibritumomab|yttrium-ibritumomab
880243|NCT00038623|Zevalin|zevalin
880244|NCT00038610|Leukemia|leukemia
880245|NCT00038610|Lymphoblastic|lymphoblastic
880246|NCT00038610|Acute|acute
880247|NCT00038610|Philadelphia-Positive|philadelphia-positive
880248|NCT00038610|Imatinib Mesylate|imatinib mesylate
880249|NCT00038610|Gleevec|gleevec
880250|NCT00038610|Glivec|glivec
880251|NCT00038610|Imatinib|imatinib
880252|NCT00038610|STI571|sti571
880253|NCT00038610|STI-571|sti-571
880254|NCT00038610|CGP-57148B|cgp-57148b
880255|NCT00038610|NSC-716051|nsc-716051
880256|NCT00038610|Cyclophosphamide|cyclophosphamide
880257|NCT00038610|Cytoxan®,|cytoxan®,
880258|NCT00038610|Neosar®|neosar®
880259|NCT00038610|Doxorubicin|doxorubicin
880260|NCT00038610|Adriamycin ®|adriamycin ®
880261|NCT00038610|Rubex ®|rubex ®
880262|NCT00038610|Adriamycin PFS|adriamycin pfs
880263|NCT00038610|Adriamycin RDF|adriamycin rdf
880264|NCT00038610|Vincristine|vincristine
880265|NCT00038610|Dexamethasone|dexamethasone
880266|NCT00038610|Decadron|decadron
880267|NCT00038610|Methotrexate|methotrexate
880268|NCT00038610|Cytarabine|cytarabine
880269|NCT00038610|Ara-C|ara-c
880270|NCT00038610|Cytosar|cytosar
880271|NCT00038610|DepoCyt|depocyt
880272|NCT00038610|Cytosine Arabinosine Hydrochloride|cytosine arabinosine hydrochloride
880273|NCT00038610|Mesna|mesna
880274|NCT00038610|Mesnex|mesnex
880275|NCT00038610|G-CSF|g-csf
880276|NCT00038610|Filgrastim|filgrastim
880277|NCT00038610|Neupogen|neupogen
880278|NCT00038597|Philadelphia chromosome positive CML|philadelphia chromosome positive cml
880279|NCT00038597|Myelogenous Leukemia, Chronic, Chronic Phase|myelogenous leukemia, chronic, chronic phase
880280|NCT00038597|Myelogenous Leukemia, Chronic, Accelerated Phase|myelogenous leukemia, chronic, accelerated phase
880281|NCT00038571|Cancer|cancer
880282|NCT00038571|Relapsed|relapsed
880283|NCT00038571|Refractory|refractory
880284|NCT00038571|B cell lymphoma|b cell lymphoma
880285|NCT00038571|Proteasome Inhibitor|proteasome inhibitor
880286|NCT00038571|PS-341|ps-341
880287|NCT00038558|Hodgkin's lymphoma|hodgkin's lymphoma
880288|NCT00038558|Dacarbazine|dacarbazine
880289|NCT00038558|DTIC|dtic
880290|NCT00038558|DTIC-Dome|dtic-dome
880291|NCT00038558|Vinblastine|vinblastine
880293|NCT00038558|Bleomycin sulfate|bleomycin sulfate
880294|NCT00038558|Blenoxane|blenoxane
880295|NCT00038558|BLM|blm
880296|NCT00038558|Doxorubicin Hydrochloride|doxorubicin hydrochloride
880297|NCT00038558|Adriamycin|adriamycin
880298|NCT00038558|Filgrastim|filgrastim
880299|NCT00038558|G-CSF|g-csf
880300|NCT00038558|Neupogen|neupogen
880301|NCT00038558|Pegfilgrastim|pegfilgrastim
880302|NCT00038558|granulocyte colony-stimulating factor|granulocyte colony-stimulating factor
880303|NCT00038545|LYMPHOMA|lymphoma
880304|NCT00038545|NON-HODGKINS|non-hodgkins
880305|NCT00038545|AGGRESSIVE|aggressive
880306|NCT00038545|RELAPSED AND REFRACTORY|relapsed and refractory
880307|NCT00038532|treatment experienced|treatment experienced
880308|NCT00038532|HIV|hiv
880309|NCT00038519|treatment experienced|treatment experienced
880310|NCT00038519|HIV|hiv
880311|NCT00038506|HIV-1 TRIZIVIR Tenofovir|hiv-1 trizivir tenofovir
880312|NCT00038493|GBM|gbm
880313|NCT00038493|Glioma|glioma
880314|NCT00038493|Brain Tumor|brain tumor
880315|NCT00038480|Lopinavir|lopinavir
880316|NCT00038480|HIV-1|hiv-1
880317|NCT00038480|Drug Therapy, Combination|drug therapy, combination
880318|NCT00038480|HIV Protease Inhibitors|hiv protease inhibitors
880319|NCT00038480|Ritonavir|ritonavir
880320|NCT00038480|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors
880321|NCT00038454|Oxygen Therapeutics|oxygen therapeutics
880322|NCT00038454|CABG|cabg
880323|NCT00038454|Transfusion|transfusion
880324|NCT00038441|Malignant Glioma|malignant glioma
880325|NCT00038415|Chronic Lymphocytic Leukemia|chronic lymphocytic leukemia
880326|NCT00038415|CLL|cll
880327|NCT00038415|Binet Stage A|binet stage a
880328|NCT00038415|Vaccination|vaccination
880329|NCT00038415|Idiotypic|idiotypic
880330|NCT00038415|Genetic|genetic
880331|NCT00038415|Deoxyribonucleic acid|deoxyribonucleic acid
880332|NCT00038415|DNA|dna
880333|NCT00038402|Breast Cancer|breast cancer
880334|NCT00038402|Non-Inflammatory Breast Cancer|non-inflammatory breast cancer
880335|NCT00038402|Operable Breast Cancer|operable breast cancer
880336|NCT00038402|Herceptin|herceptin
880337|NCT00038402|Taxol|taxol
880338|NCT00038402|FEC|fec
880339|NCT00038402|Fluorouracil|fluorouracil
897285|NCT00000173|Vitamin E|vitamin e
880340|NCT00038402|Cyclophosphamide|cyclophosphamide
880341|NCT00038402|Epirubicin|epirubicin
880342|NCT00038402|Trastuzumab|trastuzumab
880343|NCT00038402|Paclitaxel|paclitaxel
880344|NCT00038402|Neosar|neosar
880345|NCT00038389|Brain Stem Tumor|brain stem tumor
880346|NCT00038376|T-cell lymphoma|t-cell lymphoma
880347|NCT00038376|accutane|accutane
880348|NCT00038376|isotretinoin|isotretinoin
880349|NCT00038376|mycosis fungoides|mycosis fungoides
880350|NCT00038376|T-cell malignancies|t-cell malignancies
880351|NCT00038363|Frail|frail
880352|NCT00038363|Disable|disable
880353|NCT00038363|Disabled Persons|disabled persons
880354|NCT00038363|Physically disabled|physically disabled
880355|NCT00038363|Elderly|elderly
880356|NCT00038363|Rehabilitation|rehabilitation
880357|NCT00038363|Subacute care|subacute care
880358|NCT00038350|Age|age
880359|NCT00038350|Dysphagia|dysphagia
880360|NCT00038350|Swallowing|swallowing
880361|NCT00038337|Health Literacy|health literacy
880362|NCT00038337|Visual|visual
880363|NCT00038337|Cognitive|cognitive
880364|NCT00038285|Amputation|amputation
880365|NCT00038285|Cardiovascular Disease|cardiovascular disease
880366|NCT00038285|PVD|pvd
880367|NCT00038272|Placebos|placebos
880368|NCT00038272|Drug Therapy, Combination|drug therapy, combination
880369|NCT00038272|Anti-HIV Agents|anti-hiv agents
880370|NCT00038272|Mycophenolate Mofetil|mycophenolate mofetil
880371|NCT00038272|2,6-diaminopurine dioxolane|2,6-diaminopurine dioxolane
880372|NCT00038272|Treatment Experienced|treatment experienced
880373|NCT00038272|DAPD|dapd
880374|NCT00038272|MMF|mmf
880375|NCT00038259|Interleukin-2|interleukin-2
880376|NCT00038259|Drug Administration Schedule|drug administration schedule
880377|NCT00038259|CD4 Lymphocyte Count|cd4 lymphocyte count
880378|NCT00038259|Anti-HIV Agents|anti-hiv agents
880379|NCT00038259|Viral Load|viral load
880380|NCT00038259|Treatment Interruption|treatment interruption
880381|NCT00038259|Treatment Experienced|treatment experienced
880382|NCT00038259|STI|sti
880383|NCT00038246|Prostate Cancer|prostate cancer
880384|NCT00038233|myeloma|myeloma
880385|NCT00038220|HIV|hiv
880386|NCT00038207|soft tissue sarcoma|soft tissue sarcoma
880387|NCT00038207|Bone sarcomas|bone sarcomas
880388|NCT00038194|Prostate Cancer|prostate cancer
880389|NCT00038194|bone metastasis|bone metastasis
880390|NCT00038181|Prostate Cancer|prostate cancer
880391|NCT00038168|Prostate Cancer|prostate cancer
880392|NCT00038155|Ambulation|ambulation
880393|NCT00038155|Difficulties in ambulation|difficulties in ambulation
880394|NCT00038155|Geriatric|geriatric
880395|NCT00038155|Rehabilitation|rehabilitation
880396|NCT00038142|Ewing's Sarcoma|ewing's sarcoma
880397|NCT00038142|Vincristine|vincristine
880398|NCT00038142|Doxorubicin|doxorubicin
880399|NCT00038142|Adriamycin|adriamycin
880400|NCT00038142|Rubex|rubex
880401|NCT00038142|Cyclophosphamide|cyclophosphamide
880406|NCT00038116|Parkinson's disease|parkinson's disease
880407|NCT00038116|PD|pd
880408|NCT00038116|dopamine|dopamine
880409|NCT00038116|embryonic dopamine cell implant surgery|embryonic dopamine cell implant surgery
880410|NCT00038116|tissue implants|tissue implants
880411|NCT00038090|Myeloma|myeloma
880412|NCT00038090|Thalidomide|thalidomide
880413|NCT00038090|Thalomid|thalomid
880414|NCT00038090|Dexamethasone|dexamethasone
880415|NCT00038090|Decadron|decadron
880416|NCT00038064|anemia of cancer/chemotherapy|anemia of cancer/chemotherapy
880417|NCT00038064|non-myeloid malignancies|non-myeloid malignancies
880418|NCT00038064|Drug Therapy|drug therapy
880419|NCT00038051|Acute Myeloid Leukemia|acute myeloid leukemia
880420|NCT00038051|AML|aml
880421|NCT00038051|Chronic Myelomonocytic Leukemia|chronic myelomonocytic leukemia
880422|NCT00038051|CMML|cmml
880423|NCT00038051|Myeloproliferative Disorders|myeloproliferative disorders
880424|NCT00038051|Refractory Anemia with Excess of Blasts|refractory anemia with excess of blasts
880425|NCT00038051|RAEB-t|raeb-t
880426|NCT00038051|RAEB|raeb
880427|NCT00038051|Hum-195/rGel|hum-195/rgel
880428|NCT00038038|Squamous cell carcinoma of head and neck|squamous cell carcinoma of head and neck
880429|NCT00038025|Mycosis Fungoides|mycosis fungoides
880430|NCT00038025|Lymphoma|lymphoma
880431|NCT00038025|Chronic lymphocytic leukemia|chronic lymphocytic leukemia
880432|NCT00038025|Deoxycoformycin|deoxycoformycin
880433|NCT00038025|Pentostatin|pentostatin
880434|NCT00038025|All other lymphomas|all other lymphomas
880435|NCT00038025|Nucleoside analogue|nucleoside analogue
880436|NCT00038025|Adenosine deaminase inhibitor|adenosine deaminase inhibitor
880437|NCT00038025|T-cells|t-cells
880438|NCT00038012|Dose-intensified carboplatin|dose-intensified carboplatin
880439|NCT00038012|autologous cryopreserved platelets|autologous cryopreserved platelets
880440|NCT00038012|thrombopoietin|thrombopoietin
880441|NCT00038012|Gynecologic malignancy|gynecologic malignancy
880442|NCT00037999|Muscle strength|muscle strength
880443|NCT00037999|Testosterone|testosterone
880444|NCT00037999|Rehabilitation|rehabilitation
880445|NCT00037999|Impaired muscle strength|impaired muscle strength
880446|NCT00037986|Audiology|audiology
880447|NCT00037986|Hearing|hearing
897726|NCT00004350|cystinosis|cystinosis
880448|NCT00037986|Hearing Aids|hearing aids
880449|NCT00037986|Quality of Life|quality of life
880450|NCT00037973|COPD|copd
880451|NCT00037973|Ventilation|ventilation
880452|NCT00037960|Constrained Induced|constrained induced
880453|NCT00037960|CI therapy|ci therapy
880454|NCT00037960|CVA|cva
880455|NCT00037960|Strokes|strokes
880456|NCT00037947|Multiple Sclerosis|multiple sclerosis
880457|NCT00037947|MS|ms
880458|NCT00037947|Hearing|hearing
880459|NCT00037934|Robot|robot
880460|NCT00037934|Stroke|stroke
880461|NCT00037934|Upper Extremity|upper extremity
880462|NCT00037921|SCI|sci
880463|NCT00037921|UTI|uti
880464|NCT00037908|Stroke|stroke
880465|NCT00037908|Hemiparesis|hemiparesis
880466|NCT00037908|Upper limb function|upper limb function
880467|NCT00037908|Strength training|strength training
880468|NCT00037895|Stroke|stroke
880469|NCT00037895|Ambulation Training|ambulation training
880470|NCT00037895|Rehabilitation|rehabilitation
880471|NCT00037895|Treadmill|treadmill
880472|NCT00037882|Chronic Myelogenous Leukemia|chronic myelogenous leukemia
880473|NCT00037882|Interferon alpha|interferon alpha
880474|NCT00037882|Roferon|roferon
880475|NCT00037882|Intron|intron
880476|NCT00037882|Chronic Myelogenous Leukemia-Philadelphia positive|chronic myelogenous leukemia-philadelphia positive
880477|NCT00037869|Metastatic neuroendocrine tumors|metastatic neuroendocrine tumors
880478|NCT00037843|adrenal diseases|adrenal diseases
880479|NCT00037830|Parkinson's disease|parkinson's disease
880480|NCT00037830|PD|pd
880481|NCT00037830|GM1 Ganglioside|gm1 ganglioside
880482|NCT00037830|Sygen|sygen
880483|NCT00037817|Toxicity Evaluation|toxicity evaluation
880484|NCT00037817|Pharmacokinetics|pharmacokinetics
880485|NCT00037817|Apoptosis|apoptosis
880486|NCT00037817|Gene Induction|gene induction
880487|NCT00037817|Gene Expression|gene expression
880488|NCT00037817|Lung Cancer|lung cancer
880489|NCT00037817|Small Cell Lung Cancer|small cell lung cancer
880490|NCT00037817|Non-Small Cell Lung Cancer|non-small cell lung cancer
880491|NCT00037817|Pleural Mesothelioma|pleural mesothelioma
880492|NCT00037804|Pharmacia|pharmacia
880493|NCT00004575|Endothelium|endothelium
880494|NCT00004575|Vasodilation|vasodilation
880495|NCT00004575|Vascular Biology|vascular biology
880496|NCT00004575|Venous Occlusion Plethysmography|venous occlusion plethysmography
880497|NCT00001908|Allergy|allergy
880498|NCT00001908|Interleukin|interleukin
880499|NCT00001908|Immunomodulator|immunomodulator
880500|NCT00001908|Th2|th2
880501|NCT00001908|Inflammation|inflammation
880502|NCT00001908|Asthma|asthma
880503|NCT00001866|Eye Movements|eye movements
880504|NCT00001866|Eye Oscillations|eye oscillations
880505|NCT00001866|Extraocular Muscles|extraocular muscles
880506|NCT00001866|Eye Development|eye development
880507|NCT00001866|Pediatric Ophthalmology|pediatric ophthalmology
880508|NCT00001866|Congenital Nystagmus|congenital nystagmus
880509|NCT00001864|Lazy Eye|lazy eye
880510|NCT00001864|Atropine Penalization|atropine penalization
880511|NCT00001864|Patching|patching
880512|NCT00001864|Vision Loss|vision loss
880513|NCT00001864|Amblyopia|amblyopia
880514|NCT00001818|Antiretrovirals|antiretrovirals
880515|NCT00001818|Resistant Virus|resistant virus
880516|NCT00001818|T-cell activation|t-cell activation
880517|NCT00001818|Immune Suppression|immune suppression
880518|NCT00001818|Cytotoxic Agent|cytotoxic agent
880519|NCT00001688|CD4 Cells|cd4 cells
880520|NCT00001688|Cytokines|cytokines
880521|NCT00001688|Anti-Retroviral Activity|anti-retroviral activity
880522|NCT00001688|V Beta Repertoire|v beta repertoire
880523|NCT00001688|CD-4-Naive T Cells|cd-4-naive t cells
880524|NCT00001688|CD-4-Memory T Cells|cd-4-memory t cells
880525|NCT00001542|Candidiasis|candidiasis
880526|NCT00001542|Azole|azole
880527|NCT00001542|Resistance|resistance
880528|NCT00001542|Candida Albicans|candida albicans
880529|NCT00001542|Oropharynx|oropharynx
880530|NCT00001190|Growth|growth
880531|NCT00001190|Adolescence|adolescence
880532|NCT00001190|Children|children
880533|NCT00037713|LD Small Cell Lung Cancer|ld small cell lung cancer
880534|NCT00037713|BEC2, vaccine|bec2, vaccine
880535|NCT00037713|adjuvant, monoclonal antibody|adjuvant, monoclonal antibody
880536|NCT00037713|LD Small Cell Lung Cancer (VA Classification, Zelen, 1973)|ld small cell lung cancer (va classification, zelen, 1973)
880537|NCT00037687|Severe sepsis|severe sepsis
880538|NCT00037687|Platelet-activating factor acetylhydrolase|platelet-activating factor acetylhydrolase
880539|NCT00037674|Bipolar Disorder|bipolar disorder
880540|NCT00037674|Bipolar|bipolar
880541|NCT00037674|Mania|mania
880542|NCT00037674|Topiramate|topiramate
880543|NCT00037674|Lithium|lithium
880544|NCT00037661|dry eye|dry eye
880545|NCT00037622|E-antigen positive, treatment naïve chronic HBV infected, lamivudine resistant chronic Hepatitis B, Achillion|e-antigen positive, treatment naïve chronic hbv infected, lamivudine resistant chronic hepatitis b, achillion
880546|NCT00037609|Metastatic breast cancer|metastatic breast cancer
880547|NCT00037583|Acute|acute
880548|NCT00037583|Myeloid|myeloid
880549|NCT00037583|Leukemia|leukemia
880550|NCT00037570|Peptic|peptic
880551|NCT00037570|Ulcer|ulcer
880553|NCT00037557|Hemophilia B|hemophilia b
880554|NCT00037544|Severe|severe
880555|NCT00037544|Hemophilia|hemophilia
880557|NCT00037531|Transplant|transplant
880558|NCT00037531|Kidney|kidney
880559|NCT00037518|Severe primary hyperparathyroidism|severe primary hyperparathyroidism
880560|NCT00037518|Parathyroid carcinoma|parathyroid carcinoma
880561|NCT00037492|stroke|stroke
880562|NCT00037492|recovery|recovery
880563|NCT00037479|neurologic Lyme disease|neurologic lyme disease
880564|NCT00037479|Lyme disease|lyme disease
880565|NCT00037479|ceftriaxone|ceftriaxone
880566|NCT00037479|Rocephin|rocephin
880567|NCT00037479|PET scans|pet scans
880568|NCT00037479|Lyme encephalopathy|lyme encephalopathy
880569|NCT00037479|neuroborreliosis|neuroborreliosis
880570|NCT00037479|borreliosis|borreliosis
880571|NCT00037219|Anidulafungin|anidulafungin
880572|NCT00037219|Candidemia|candidemia
880573|NCT00037219|Invasive Candidiasis|invasive candidiasis
880574|NCT00037206|Invasive Aspergillosis|invasive aspergillosis
880575|NCT00037167|Fall-Prevention|fall-prevention
880576|NCT00037167|Balance|balance
880577|NCT00037167|Musculoskeletal Systems|musculoskeletal systems
880578|NCT00037167|Protective Devices|protective devices
880579|NCT00037167|Gait|gait
880580|NCT00037167|Equilibrium|equilibrium
880581|NCT00037167|Accidental Falls|accidental falls
880582|NCT00037167|Frail Elderly|frail elderly
880583|NCT00037154|Benign Prostatic Hyperplasia|benign prostatic hyperplasia
880584|NCT00037154|Herbal Therapies|herbal therapies
880585|NCT00037154|Complementary and Alternative Medicine|complementary and alternative medicine
880586|NCT00037154|Men's Health|men's health
880587|NCT00037141|Prostate|prostate
880588|NCT00037141|BPH|bph
880589|NCT00037141|Prostatitis|prostatitis
880590|NCT00037128|Lupus|lupus
880591|NCT00037128|SLE|sle
880592|NCT00037128|DHEA|dhea
880593|NCT00037128|GL701|gl701
880594|NCT00037115|Demyelinating|demyelinating
880595|NCT00037115|Multiple Sclerosis|multiple sclerosis
880596|NCT00037115|Myelitis|myelitis
880597|NCT00037115|Neuritis|neuritis
880598|NCT00037115|Optic Neuritis|optic neuritis
880599|NCT00037115|AVONEX|avonex
880600|NCT00037115|methotrexate|methotrexate
880601|NCT00037115|methylprednisolone|methylprednisolone
880602|NCT00037115|interferon beta 1a|interferon beta 1a
880603|NCT00037115|demyelination|demyelination
880604|NCT00037115|central nervous system|central nervous system
880605|NCT00037115|brain|brain
880606|NCT00037115|nerve|nerve
880607|NCT00037115|lesions|lesions
880608|NCT00037115|enhancement|enhancement
880609|NCT00037115|enhancing|enhancing
880610|NCT00037102|Multiple Sclerosis|multiple sclerosis
880611|NCT00037102|Relapsing|relapsing
880612|NCT00037102|Methotrexate|methotrexate
880613|NCT00037102|AVONEX|avonex
880614|NCT00037102|interferon beta 1a|interferon beta 1a
880615|NCT00037102|demyelinating|demyelinating
880616|NCT00037102|autoimmune|autoimmune
880617|NCT00037076|HIV Seropositivity|hiv seropositivity
880618|NCT00037076|Hepatitis C|hepatitis c
880619|NCT00037076|Polymerase Chain Reaction|polymerase chain reaction
880620|NCT00037076|RNA, Viral|rna, viral
880621|NCT00037076|Prevalence|prevalence
880622|NCT00037076|Disease Transmission, Vertical|disease transmission, vertical
880623|NCT00037076|Hepacivirus|hepacivirus
880624|NCT00037076|Enzyme Immunoassay|enzyme immunoassay
880625|NCT00037076|GB virus C|gb virus c
880626|NCT00037063|Pilot Projects|pilot projects
880627|NCT00037063|Recurrence|recurrence
880628|NCT00037063|Antioxidants|antioxidants
880629|NCT00037063|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors
880630|NCT00037063|Anti-HIV Agents|anti-hiv agents
880631|NCT00037063|Ascorbic Acid|ascorbic acid
880632|NCT00037063|Alpha-Tocopherol|alpha-tocopherol
880633|NCT00037063|Riboflavin|riboflavin
880634|NCT00037063|Thiamine|thiamine
880635|NCT00037063|Lactic Acid|lactic acid
880636|NCT00036647|Non-Small Cell Lung Cancer|non-small cell lung cancer
880637|NCT00036647|Tarceva|tarceva
880638|NCT00036647|EGFR|egfr
880639|NCT00036647|erlotinib|erlotinib
880640|NCT00036634|treatment naive|treatment naive
880641|NCT00036595|Subdural|subdural
880642|NCT00036595|Epilepsy|epilepsy
880643|NCT00036595|Motor Function|motor function
880644|NCT00036595|Desynchronization|desynchronization
880645|NCT00036595|Coherence|coherence
880646|NCT00036595|Motor Control|motor control
880647|NCT00036582|Psychophysiology|psychophysiology
880648|NCT00036582|Structural MRI|structural mri
880649|NCT00036582|Genetics|genetics
880650|NCT00036582|Bipolar Disorder|bipolar disorder
880651|NCT00036582|Children and Adolescents|children and adolescents
880652|NCT00036582|Clozapine|clozapine
880653|NCT00036582|Placebo|placebo
880654|NCT00036582|Treatment-Refractory|treatment-refractory
880655|NCT00036582|Bipolar|bipolar
880656|NCT00036582|Healthy Volunteer|healthy volunteer
880657|NCT00036582|HV|hv
880658|NCT00036582|BPD|bpd
880659|NCT00036582|Normal Control|normal control
880660|NCT00036569|Brainstem Glioma|brainstem glioma
880661|NCT00036569|Pediatric|pediatric
880662|NCT00036569|Interferon|interferon
880664|NCT00036569|Angiogenesis|angiogenesis
880665|NCT00036569|Brain Tumor|brain tumor
880666|NCT00036569|Glioma|glioma
880667|NCT00036569|Pediatric Brain Tumor|pediatric brain tumor
880668|NCT00036556|Hormone-Refractory Prostate Cancer|hormone-refractory prostate cancer
880669|NCT00036543|Hormone-Refractory, Prostate Cancer|hormone-refractory, prostate cancer
880670|NCT00036517|Stage III and Stage IV colorectal cancer|stage iii and stage iv colorectal cancer
880671|NCT00036517|diarrhea|diarrhea
880672|NCT00036517|reduce|reduce
880673|NCT00036517|alleviate|alleviate
880674|NCT00036517|modulate|modulate
880675|NCT00036517|Saltz regimen|saltz regimen
880676|NCT00036517|CPT-11|cpt-11
880677|NCT00036517|irinotecan|irinotecan
880678|NCT00036517|camptosar|camptosar
880679|NCT00036517|5-fluorouracil|5-fluorouracil
880680|NCT00036517|leucovorin|leucovorin
880681|NCT00036517|5-FU|5-fu
880682|NCT00036517|LV|lv
880683|NCT00036517|chemotherapy|chemotherapy
880684|NCT00036517|side effect|side effect
880685|NCT00036517|toxicity|toxicity
880686|NCT00036517|botanical drug|botanical drug
880687|NCT00036517|herbal medicine|herbal medicine
880688|NCT00036517|chinese herbal medicine|chinese herbal medicine
880689|NCT00036517|traditional chinese medicine|traditional chinese medicine
880690|NCT00036517|TCM|tcm
880691|NCT00036517|oral dose|oral dose
880692|NCT00036517|oral administration|oral administration
880693|NCT00036517|concomitant use|concomitant use
880694|NCT00036504|Diabetes mellitus, insulin deficiency, hyperglycemia|diabetes mellitus, insulin deficiency, hyperglycemia
880695|NCT00036491|Systemic Lupus Erythematosus|systemic lupus erythematosus
880696|NCT00036491|SLE|sle
880697|NCT00036491|B-Lymphocytes|b-lymphocytes
880698|NCT00036491|anti-CD20|anti-cd20
880699|NCT00036491|rituximab|rituximab
880700|NCT00036478|Pilot Projects|pilot projects
880701|NCT00036478|Exercise|exercise
880702|NCT00036478|Phosphorus Isotopes|phosphorus isotopes
880703|NCT00036478|Mitochondria|mitochondria
880704|NCT00036478|Lactates|lactates
880705|NCT00036478|Magnetic Resonance Spectroscopy|magnetic resonance spectroscopy
880706|NCT00036465|Pilot Projects|pilot projects
880707|NCT00036465|HIV-1|hiv-1
880708|NCT00036465|RNA, Viral|rna, viral
880709|NCT00036465|Genotype|genotype
880710|NCT00036465|Viral Load|viral load
880711|NCT00036465|Antiretroviral Therapy, Highly Active|antiretroviral therapy, highly active
880712|NCT00036465|Treatment Experienced|treatment experienced
880713|NCT00036452|Lopinavir|lopinavir
880714|NCT00036452|HIV-1|hiv-1
880715|NCT00036452|Drug Administration Schedule|drug administration schedule
880716|NCT00036452|Stavudine|stavudine
880717|NCT00036452|HIV Protease Inhibitors|hiv protease inhibitors
880718|NCT00036452|Ritonavir|ritonavir
880719|NCT00036452|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors
880722|NCT00036452|Emtricitabine|emtricitabine
880723|NCT00036452|Directly Observed Therapy|directly observed therapy
880724|NCT00036452|Tenofovir Disoproxil Fumarate|tenofovir disoproxil fumarate
880725|NCT00036452|Treatment Naive|treatment naive
880726|NCT00036439|ulcerative colitis|ulcerative colitis
880727|NCT00036439|infliximab|infliximab
880728|NCT00036439|Remicade|remicade
880729|NCT00036439|infusion|infusion
880730|NCT00036426|lymphoma|lymphoma
880731|NCT00036426|vaccine|vaccine
880732|NCT00036426|idiotype|idiotype
880733|NCT00036426|KLH|klh
880734|NCT00036426|GM-CSF|gm-csf
880735|NCT00036413|(ALS)|(als)
880736|NCT00036400|Anemia|anemia
880737|NCT00036400|Gastric Cancer|gastric cancer
880738|NCT00036400|Rectal Cancer|rectal cancer
880739|NCT00036400|Epoetin Alfa|epoetin alfa
880740|NCT00036387|Rheumatoid arthritis|rheumatoid arthritis
880741|NCT00036387|infliximab|infliximab
880742|NCT00036387|anti-TNF|anti-tnf
880743|NCT00036387|methotrexate|methotrexate
880744|NCT00036387|safety and efficacy|safety and efficacy
880745|NCT00036387|Remicade|remicade
880746|NCT00036374|Juvenile rheumatoid arthritis|juvenile rheumatoid arthritis
880747|NCT00036374|Infliximab|infliximab
880748|NCT00036374|Methotrexate|methotrexate
880749|NCT00036374|remicade|remicade
880750|NCT00036348|Bipolar I disorder|bipolar i disorder
880751|NCT00036335|depression|depression
880752|NCT00036335|pain|pain
880753|NCT00036335|blues|blues
880754|NCT00036335|sadness|sadness
880755|NCT00036335|aches|aches
880756|NCT00036309|Major Depressive Disorder|major depressive disorder
880757|NCT00036309|Diagnostic and Statistical Manual of Mental Disorders Fourth Edition-defined major depressive disorder without psychotic features|diagnostic and statistical manual of mental disorders fourth edition-defined major depressive disorder without psychotic features
880758|NCT00036296|Involuntary Movements|involuntary movements
880759|NCT00036296|Abnormal Movements|abnormal movements
880760|NCT00036296|Advanced Parkinson's disease|advanced parkinson's disease
880761|NCT00036296|Levodopa induced dyskinesia|levodopa induced dyskinesia
880762|NCT00036257|Chronic Lymphocytic Leukemia|chronic lymphocytic leukemia
880763|NCT00036257|Leukemia|leukemia
880764|NCT00036257|CLL|cll
880765|NCT00036179|Candidemia|candidemia
880766|NCT00036179|Anti-Fungal|anti-fungal
880767|NCT00036166|Aspergillus|aspergillus
880769|NCT00036153|Tacrolimus, Prograf®, FK506|tacrolimus, prograf®, fk506
880770|NCT00036140|Pharmacia|pharmacia
880771|NCT00036127|agitated schizophrenic patients|agitated schizophrenic patients
880772|NCT00036114|Psychosis associated with dementia of the Alzheimer's type|psychosis associated with dementia of the alzheimer's type
880773|NCT00036101|Bipolar I Disorder|bipolar i disorder
880774|NCT00036075|prostate cancer|prostate cancer
880775|NCT00036075|prostate|prostate
880776|NCT00036062|Sivelestat|sivelestat
880777|NCT00036062|acute lung injury|acute lung injury
880778|NCT00036036|renal|renal
880779|NCT00036036|renal cell cancer|renal cell cancer
880780|NCT00036036|renal cell carcinoma|renal cell carcinoma
880781|NCT00036036|kidney cancer|kidney cancer
880782|NCT00035997|Hormone-sensitive Prostate Cancer|hormone-sensitive prostate cancer
880783|NCT00035997|Prostate Cancer|prostate cancer
880784|NCT00035997|Bone Metastasis|bone metastasis
880785|NCT00035984|Type 2 Diabetes Mellitis|type 2 diabetes mellitis
880786|NCT00035958|Juvenile Dermatomyositis|juvenile dermatomyositis
880787|NCT00035958|Pediatric|pediatric
880788|NCT00035958|Randomized Clinical Trial|randomized clinical trial
880789|NCT00035958|Pediatric Rheumatology|pediatric rheumatology
880790|NCT00035919|Colon cancer|colon cancer
880791|NCT00035919|Targeted Injectable Vector|targeted injectable vector
880792|NCT00035919|Gene Transfer|gene transfer
880793|NCT00035919|Gene Therapy|gene therapy
880794|NCT00035919|Retroviral vector|retroviral vector
880795|NCT00035906|Diabetes|diabetes
880796|NCT00035906|Macular Edema|macular edema
880797|NCT00035906|Diabetic Macular Edema|diabetic macular edema
880798|NCT00035906|Diabetic Retinopathy|diabetic retinopathy
880799|NCT00035906|Cystoid Macular Edema|cystoid macular edema
880800|NCT00035906|Uveitis|uveitis
880801|NCT00035906|Vision|vision
880802|NCT00035906|Eye|eye
880803|NCT00035906|Retina|retina
880804|NCT00035906|Retinal Vein Occlusion|retinal vein occlusion
880805|NCT00035906|Irvine-Gass Syndrome|irvine-gass syndrome
880806|NCT00035893|treatment interruption|treatment interruption
880807|NCT00035893|HIV Infections|hiv infections
880808|NCT00035880|Acute graft versus host disease|acute graft versus host disease
880809|NCT00035880|Stem Cell Transplantation|stem cell transplantation
880810|NCT00035854|Pharmacia|pharmacia
880811|NCT00035854|Drug Resistance, Microbial|drug resistance, microbial
880812|NCT00035828|COPD|copd
880813|NCT00035828|Chronic bronchitis|chronic bronchitis
880814|NCT00035828|Chronic obstructive pulmonary disease|chronic obstructive pulmonary disease
880815|NCT00035828|Shortness of breath|shortness of breath
880816|NCT00035828|Dyspnea|dyspnea
880817|NCT00035828|Bronchitis|bronchitis
880818|NCT00035815|amyotrophic lateral sclerosis|amyotrophic lateral sclerosis
880819|NCT00035815|ALS|als
880820|NCT00035815|progressive weakness|progressive weakness
880821|NCT00035815|insulin-like growth factor-1|insulin-like growth factor-1
880822|NCT00035815|IGF-I|igf-i
880823|NCT00035815|Myotrophin|myotrophin
880824|NCT00035802|Bipolar|bipolar
880825|NCT00035802|Mania|mania
880826|NCT00035802|Pediatric|pediatric
880827|NCT00035802|Children|children
880828|NCT00035802|Adolescent|adolescent
880829|NCT00035802|Topiramate|topiramate
880830|NCT00035802|Anticonvulsants|anticonvulsants
880831|NCT00035802|Central Nervous System Agents|central nervous system agents
880832|NCT00035802|Protective Agents|protective agents
880833|NCT00035802|Neuroprotectiive Agents|neuroprotectiive agents
880834|NCT00035620|Bone cancer|bone cancer
880835|NCT00035620|Sarcoma|sarcoma
880836|NCT00035620|Neutropenia|neutropenia
880837|NCT00035620|Chemotherapy|chemotherapy
880838|NCT00035594|Breast cancer|breast cancer
880839|NCT00035594|Neutropenia|neutropenia
880840|NCT00035594|Chemotherapy|chemotherapy
880841|NCT00035581|treatment experienced|treatment experienced
880842|NCT00035581|HIV Infections|hiv infections
880843|NCT00035581|HIV|hiv
880844|NCT00035581|HAART|haart
880845|NCT00035581|early virologic failure|early virologic failure
880846|NCT00035568|Type 2 Diabetes Mellitus|type 2 diabetes mellitus
880847|NCT00035555|kidney|kidney
880848|NCT00035555|transplant|transplant
880849|NCT00035555|rejection|rejection
880850|NCT00035542|Diabetes Mellitus, Type II|diabetes mellitus, type ii
880851|NCT00035529|MS|ms
880852|NCT00035438|obsessive compulsive disorder|obsessive compulsive disorder
880853|NCT00035438|ocd|ocd
880854|NCT00035438|Anxiety|anxiety
880855|NCT00035438|St. John’s Wort|st. john’s wort
880856|NCT00035438|Wisconsin|wisconsin
880857|NCT00035438|Psychiatric|psychiatric
880858|NCT00035438|Mental health|mental health
880859|NCT00035412|Social phobia|social phobia
880860|NCT00035412|Social anxiety|social anxiety
880861|NCT00035412|Anxiety|anxiety
880862|NCT00035412|St. John’ Wort|st. john’ wort
880863|NCT00035412|Wisconsin|wisconsin
880864|NCT00035412|Psychiatric|psychiatric
880865|NCT00035412|Mental health|mental health
880866|NCT00035399|acupressure /acupuncture|acupressure /acupuncture
880867|NCT00035399|alternative medicine|alternative medicine
880868|NCT00035399|arthritis therapy|arthritis therapy
880869|NCT00035399|combination therapy|combination therapy
880870|NCT00035399|human therapy evaluation|human therapy evaluation
880871|NCT00035399|knee|knee
880872|NCT00035399|osteoarthritis|osteoarthritis
880873|NCT00035399|physical therapy|physical therapy
880874|NCT00035399|chronic pain|chronic pain
880875|NCT00035399|clinical trial|clinical trial
880876|NCT00035399|functional ability|functional ability
880877|NCT00035360|PEG-Intron|peg-intron
880878|NCT00035360|treatment experienced|treatment experienced
880879|NCT00035386|Outflow Obstruction|outflow obstruction
880880|NCT00035386|ICE|ice
880881|NCT00035386|HCM|hcm
880882|NCT00035386|Hypertrophic Cardiomyopathy|hypertrophic cardiomyopathy
880883|NCT00035386|OHC|ohc
880884|NCT00035386|Obstructive HCM|obstructive hcm
880885|NCT00035386|Cardiomyopathy|cardiomyopathy
880886|NCT00035373|Tumor|tumor
880887|NCT00035373|Brain|brain
880888|NCT00035373|Chemotherapy|chemotherapy
880889|NCT00035373|Anti-Angiogenesis|anti-angiogenesis
880890|NCT00035373|Radiation Therapy|radiation therapy
880891|NCT00035373|CNS Tumor|cns tumor
880892|NCT00035334|Familial Mediterranean Fever|familial mediterranean fever
880893|NCT00035334|Amyloidosis|amyloidosis
880894|NCT00035334|Secondary (AA) Amyloidosis|secondary (aa) amyloidosis
880895|NCT00035334|Nephrotic Syndrome|nephrotic syndrome
880896|NCT00035308|Immunologic Diseases|immunologic diseases
880897|NCT00035308|Autoimmune Diseases|autoimmune diseases
880898|NCT00035308|Systemic Lupus Erythematosus|systemic lupus erythematosus
880899|NCT00035308|SLE|sle
880900|NCT00035308|Lupus Nephritis|lupus nephritis
880901|NCT00035308|Lupus Glomerulonephritis|lupus glomerulonephritis
880902|NCT00035269|Pharmacia|pharmacia
880903|NCT00035243|kidney cancer|kidney cancer
880904|NCT00035243|renal cancer|renal cancer
880905|NCT00035243|cancer|cancer
880906|NCT00035243|tumor|tumor
880907|NCT00035243|tumour|tumour
880908|NCT00035243|neoplasm|neoplasm
880909|NCT00035243|carcinoma|carcinoma
880910|NCT00035243|clear cell|clear cell
880911|NCT00035243|sarcomatoid|sarcomatoid
880912|NCT00035243|papillary|papillary
880913|NCT00035243|medullary|medullary
880914|NCT00035243|collecting duct|collecting duct
880915|NCT00035243|chromophobe|chromophobe
880916|NCT00035243|intravenous|intravenous
880917|NCT00035243|epothilone|epothilone
880918|NCT00035230|Bipolar disorders|bipolar disorders
880919|NCT00035230|Bipolar|bipolar
880920|NCT00035230|mania|mania
880921|NCT00035230|Topiramate|topiramate
880922|NCT00035230|Lithium|lithium
880923|NCT00035204|Donepezil|donepezil
880924|NCT00035204|Alzheimer's|alzheimer's
880925|NCT00035204|Dementia|dementia
880926|NCT00035204|Cognitive impairment|cognitive impairment
880927|NCT00035204|Aricept|aricept
880928|NCT00035204|Alzheimer's disease|alzheimer's disease
880929|NCT00035204|Razadyne|razadyne
880932|NCT00035191|vascular dementia|vascular dementia
880933|NCT00035191|cerebral vascular disease|cerebral vascular disease
880934|NCT00035178|ESRD|esrd
880935|NCT00035178|End-stage renal disease|end-stage renal disease
880936|NCT00035178|Hemodialysis|hemodialysis
880937|NCT00035165|melanoma|melanoma
880938|NCT00035165|cancer|cancer
880939|NCT00035165|tumor|tumor
880940|NCT00035165|tumour|tumour
880941|NCT00035165|malignant|malignant
880942|NCT00035165|metastatic|metastatic
880943|NCT00035165|intravenous|intravenous
880944|NCT00035165|epothilone|epothilone
880945|NCT00035139|pediatric traumatic brain injury|pediatric traumatic brain injury
880946|NCT00035126|breast|breast
880947|NCT00035126|cancer|cancer
880948|NCT00035126|tumor|tumor
880949|NCT00035126|tumour|tumour
880950|NCT00035126|intravenous|intravenous
880951|NCT00035126|epothilone|epothilone
880952|NCT00035126|taxane|taxane
880953|NCT00035126|anthracycline|anthracycline
880954|NCT00035113|prostate cancer|prostate cancer
880955|NCT00035113|prostate|prostate
880956|NCT00035113|androgen independent|androgen independent
880957|NCT00035113|cancer|cancer
880958|NCT00035113|tumor|tumor
880959|NCT00035113|tumour|tumour
880960|NCT00035113|neoplasm|neoplasm
880961|NCT00035113|carcinoma|carcinoma
880962|NCT00035113|intravenous|intravenous
880963|NCT00035113|epothilone|epothilone
880964|NCT00035100|ovarian|ovarian
880965|NCT00035100|ovary|ovary
880966|NCT00035100|peritoneal cancer|peritoneal cancer
880967|NCT00035100|fallopian cancer|fallopian cancer
880968|NCT00035100|cancer|cancer
880969|NCT00035100|tumor|tumor
880970|NCT00035100|tumour|tumour
880971|NCT00035100|neoplasm|neoplasm
880972|NCT00035100|carcinoma|carcinoma
880973|NCT00035100|intravenous|intravenous
880974|NCT00035100|epothilone|epothilone
880975|NCT00035087|colon|colon
880976|NCT00035087|rectum|rectum
880977|NCT00035087|colorectal|colorectal
880978|NCT00035087|rectal|rectal
880979|NCT00035087|cancer|cancer
880980|NCT00035087|tumor|tumor
880981|NCT00035087|tumour|tumour
880982|NCT00035087|neoplasm|neoplasm
880983|NCT00035087|carcinoma|carcinoma
880984|NCT00035087|intravenous|intravenous
880985|NCT00035087|epothilone|epothilone
880986|NCT00035061|Bladder Cancer|bladder cancer
880987|NCT00035061|Metastatic|metastatic
880988|NCT00035061|Recurrent|recurrent
880989|NCT00035061|Transitional cell carcinoma of the urothelium|transitional cell carcinoma of the urothelium
880990|NCT00035035|Pancreas|pancreas
880991|NCT00035035|Cancer|cancer
880992|NCT00035035|Unresectable or Metastatic Cancer of the Pancreas|unresectable or metastatic cancer of the pancreas
880993|NCT00035035|Alimta|alimta
880994|NCT00035022|Leukemia, Lymphoma, T-Cell|leukemia, lymphoma, t-cell
880995|NCT00034970|alternative medicine|alternative medicine
880996|NCT00034970|art|art
880997|NCT00034970|cancer|cancer
880998|NCT00034970|combination cancer therapy|combination cancer therapy
880999|NCT00034970|creative-expression|creative-expression
881000|NCT00034970|group therapy|group therapy
881001|NCT00034970|holistic|holistic
881002|NCT00034970|human therapy evaluation|human therapy evaluation
881003|NCT00034970|meditation|meditation
881004|NCT00034970|neoplasm /cancer chemotherapy|neoplasm /cancer chemotherapy
881005|NCT00034970|coping|coping
881006|NCT00034970|gender difference|gender difference
881007|NCT00034970|outcomes research|outcomes research
881008|NCT00034970|psychological aspect of cancer|psychological aspect of cancer
881009|NCT00034970|psychological stressor|psychological stressor
881010|NCT00034970|quality of life|quality of life
881011|NCT00034970|racial /ethnic difference|racial /ethnic difference
881012|NCT00034970|stress management|stress management
881013|NCT00034970|support|support
881014|NCT00034970|behavioral /social science research|behavioral /social science research
881015|NCT00034970|patient oriented research|patient oriented research
881016|NCT00034957|Pharmacia|pharmacia
881017|NCT00034918|Metastatic breast cancer|metastatic breast cancer
881018|NCT00034879|Locally advanced and/or metastatic non-operable|locally advanced and/or metastatic non-operable
881019|NCT00034879|non-small cell lung cancer (stage III or IV)|non-small cell lung cancer (stage iii or iv)
881020|NCT00034879|patients who have failed standard therapy.|patients who have failed standard therapy.
881021|NCT00034866|HIV|hiv
881022|NCT00034866|treatment experienced|treatment experienced
881023|NCT00034866|Boehringer|boehringer
881024|NCT00034866|tipranavir|tipranavir
881025|NCT00034866|ritonavir|ritonavir
881026|NCT00034840|hypertension|hypertension
881027|NCT00034840|telmisartan|telmisartan
881028|NCT00034840|valsartan|valsartan
881029|NCT00034840|boehringer|boehringer
881030|NCT00034801|Depression|depression
881031|NCT00034801|Comorbid Depression|comorbid depression
881032|NCT00034801|Schizophrenia|schizophrenia
881033|NCT00034801|Schizoaffective Disorder|schizoaffective disorder
881034|NCT00034788|Regranex|regranex
881035|NCT00034788|Foot ulcers|foot ulcers
881036|NCT00034788|Diabetes|diabetes
881037|NCT00034788|Diabetes mellitus|diabetes mellitus
881038|NCT00034788|Diabetic foot|diabetic foot
881039|NCT00034775|Schizophrenia|schizophrenia
881040|NCT00034775|intramuscular injection|intramuscular injection
881041|NCT00034775|antipsychotic agents|antipsychotic agents
881042|NCT00034775|risperidone|risperidone
881043|NCT00034762|Alzheimer's disease|alzheimer's disease
881044|NCT00034762|psychosis|psychosis
881045|NCT00034762|elderly|elderly
881046|NCT00034762|dementia|dementia
881047|NCT00034762|risperidone|risperidone
881048|NCT00034762|antipsychotic agents|antipsychotic agents
881049|NCT00034749|Adolescents|adolescents
881050|NCT00034749|Schizophrenia|schizophrenia
881051|NCT00034749|risperidone|risperidone
881052|NCT00034736|Pneumonia|pneumonia
881053|NCT00034736|Bacterial pneumonia|bacterial pneumonia
881054|NCT00034736|Community acquired pneumonia|community acquired pneumonia
881055|NCT00034736|Lung Inflammation|lung inflammation
881056|NCT00034736|Quinolones|quinolones
881057|NCT00034736|Levofloxacin|levofloxacin
881058|NCT00034736|Ceftriaxone|ceftriaxone
881059|NCT00034736|Erythromycin|erythromycin
881060|NCT00034736|Clarithromycin|clarithromycin
881061|NCT00034723|DTI|dti
881062|NCT00034723|MRSI|mrsi
881063|NCT00034723|MTR|mtr
881064|NCT00034723|NAWN|nawn
881065|NCT00034723|Fiber-Tract|fiber-tract
881066|NCT00034723|Normal Control|normal control
881067|NCT00034723|Healthy Volunteer|healthy volunteer
881068|NCT00034723|HV|hv
881069|NCT00034723|HTLV-1 Associated Myelopathy|htlv-1 associated myelopathy
881070|NCT00034723|Tropical Spastic Paraparesis|tropical spastic paraparesis
881071|NCT00034723|HAM/TSP|ham/tsp
881072|NCT00034710|Analgesics/*therapeutic use|analgesics/*therapeutic use
881073|NCT00034710|Capsaicin/*administration & dosage/adverse effects|capsaicin/*administration & dosage/adverse effects
881074|NCT00034710|Herpes Zoster/*complications/drug therapy|herpes zoster/*complications/drug therapy
881075|NCT00034710|Neuralgia/*drug therapy/etiology|neuralgia/*drug therapy/etiology
881076|NCT00034710|Pain|pain
881077|NCT00034710|Capsicum|capsicum
881078|NCT00034710|Pepper|pepper
881079|NCT00034710|Dermal assessment|dermal assessment
881080|NCT00034710|Pain measurement|pain measurement
881081|NCT00034710|Diary|diary
881082|NCT00034710|PHN|phn
881083|NCT00034710|Postherpetic Neuralgia|postherpetic neuralgia
881084|NCT00034710|allodynia|allodynia
881085|NCT00034710|hyperalgesia|hyperalgesia
881089|NCT00034697|non-small cell lung cancer|non-small cell lung cancer
881090|NCT00034684|Leukemia|leukemia
881091|NCT00034684|Myelodysplastic Syndromes|myelodysplastic syndromes
881092|NCT00034684|Leukemia, Myeloid|leukemia, myeloid
881093|NCT00034684|Leukemia, Lymphocytic|leukemia, lymphocytic
881094|NCT00034671|Aspergillosis, Candidiasis, Mucormycosis, Cryptococcosis|aspergillosis, candidiasis, mucormycosis, cryptococcosis
881095|NCT00034671|Invasive Fungal Infections|invasive fungal infections
881096|NCT00034658|Aspergillosis, Candidiasis, Cryptococcosis,|aspergillosis, candidiasis, cryptococcosis,
881097|NCT00034645|Allogenic Stem cell transplantation|allogenic stem cell transplantation
881098|NCT00034645|Fungal infections|fungal infections
881099|NCT00034632|Aspergillosis, Candidiasis, Cryptococcosis, Phaeohyphomycosis|aspergillosis, candidiasis, cryptococcosis, phaeohyphomycosis
881100|NCT00034632|Invasive Fungal Infections|invasive fungal infections
881101|NCT00034606|Lung cancer|lung cancer
881102|NCT00034606|cancer|cancer
881103|NCT00034606|neoplasm|neoplasm
881104|NCT00034606|non-small|non-small
881105|NCT00034606|chemotherapy|chemotherapy
881106|NCT00034593|Bladder cancer|bladder cancer
881107|NCT00034593|metastatic|metastatic
881108|NCT00034593|transitional cell carcinoma of the urothelium|transitional cell carcinoma of the urothelium
881109|NCT00034580|Bipolar I Disorder|bipolar i disorder
881110|NCT00034567|Prevention|prevention
881111|NCT00034554|AJCC stage III or stage IV malignant melanoma|ajcc stage iii or stage iv malignant melanoma
881112|NCT00034554|melanoma|melanoma
881113|NCT00034554|gp75|gp75
881114|NCT00034554|DNA vaccine|dna vaccine
881115|NCT00034541|cetuximab|cetuximab
881116|NCT00034541|epidermal growth factor receptor|epidermal growth factor receptor
881117|NCT00034541|antibody|antibody
881118|NCT00034541|non-small cell lung cancer|non-small cell lung cancer
881119|NCT00034541|carboplatin|carboplatin
881120|NCT00034541|paclitaxel|paclitaxel
881121|NCT00034489|metastatic breast cancer|metastatic breast cancer
881122|NCT00034489|combination therapy|combination therapy
881123|NCT00034489|Alimta|alimta
881124|NCT00034476|Sepsis, sPLA2 Inhibitor|sepsis, spla2 inhibitor
881125|NCT00034463|metastatic cancer|metastatic cancer
881126|NCT00034463|chemotherapy|chemotherapy
881127|NCT00034450|Terminal Cancer|terminal cancer
881128|NCT00034437|Normal Volunteer|normal volunteer
881129|NCT00034437|Phlebotomy|phlebotomy
881130|NCT00034437|Cytomegalovirus|cytomegalovirus
881131|NCT00034437|CMV|cmv
881132|NCT00034437|CMV Seropositve|cmv seropositve
881133|NCT00034424|Genetics|genetics
881134|NCT00034424|Hereditary|hereditary
881135|NCT00034424|Screening|screening
881136|NCT00034424|Behavioral|behavioral
881137|NCT00034424|Familial Testicular Germ Cell Tumor|familial testicular germ cell tumor
882785|NCT00026546|HV|hv
881138|NCT00034424|Testicular Cancer|testicular cancer
881139|NCT00034398|Basal Ganglia|basal ganglia
881140|NCT00034398|Neuroimaging|neuroimaging
881141|NCT00034398|Inhibitory Neurons|inhibitory neurons
881142|NCT00034398|Disinhibition|disinhibition
881143|NCT00034398|Tics|tics
881144|NCT00034398|Tourette's Syndrome|tourette's syndrome
881145|NCT00034398|Tourette Syndrome|tourette syndrome
881146|NCT00034398|Healthy Volunteer|healthy volunteer
881147|NCT00034398|HV|hv
881148|NCT00034398|Normal Control|normal control
881149|NCT00034385|Cytomegalovirus|cytomegalovirus
881150|NCT00034385|Prophylaxis|prophylaxis
881151|NCT00034385|Renal Transplant|renal transplant
881152|NCT00034385|Valcyte|valcyte
881153|NCT00034385|Kidney Transplant|kidney transplant
881154|NCT00034372|immunotherapy|immunotherapy
881155|NCT00034372|monoclonal|monoclonal
881156|NCT00034372|antibody|antibody
881157|NCT00034372|Stage III ovarian epithelial cancer|stage iii ovarian epithelial cancer
881158|NCT00034372|Stage IV ovarian epithelial cancer|stage iv ovarian epithelial cancer
881159|NCT00034359|E-antigen positive|e-antigen positive
881160|NCT00034359|Treatment Naive Chronic Hepatitis B, Achillion|treatment naive chronic hepatitis b, achillion
881161|NCT00017862|Eosinophils|eosinophils
881162|NCT00017862|Monoclonal Antibody|monoclonal antibody
881163|NCT00017862|Hypereosinophilia|hypereosinophilia
881164|NCT00017862|Biologicals|biologicals
881165|NCT00017862|Hypereosinophilic Syndrome|hypereosinophilic syndrome
881166|NCT00034346|Advanced|advanced
881167|NCT00034346|Non-Small-Cell|non-small-cell
881168|NCT00034346|Lung|lung
881169|NCT00034346|Cancer|cancer
881170|NCT00034346|NSCLC|nsclc
881171|NCT00034346|Carcinoma|carcinoma
881172|NCT00034346|Advanced Non-Small-Cell Lung Cancer (NSCLC)|advanced non-small-cell lung cancer (nsclc)
881173|NCT00034333|Hepatoma|hepatoma
881174|NCT00034333|Unresectable adult primary liver cancer|unresectable adult primary liver cancer
881175|NCT00034333|liver cancer|liver cancer
881176|NCT00034333|HCC|hcc
881177|NCT00034333|Hepatocellular Carcinoma|hepatocellular carcinoma
881178|NCT00034294|C. difficile-associated diarrhea|c. difficile-associated diarrhea
881179|NCT00034294|CDAD|cdad
881180|NCT00034294|Clostridium difficile-Associated Diarrhea|clostridium difficile-associated diarrhea
881181|NCT00034294|Clostridium enterocolitis|clostridium enterocolitis
881182|NCT00034294|antibiotic-associated diarrhea|antibiotic-associated diarrhea
881183|NCT00034294|clostridium difficile colitis|clostridium difficile colitis
881184|NCT00034294|infectious diarrhea|infectious diarrhea
881185|NCT00034294|chronic diarrhea|chronic diarrhea
881186|NCT00034294|antibiotic-associated colitis|antibiotic-associated colitis
881187|NCT00034281|Gene, HER2|gene, her2
881188|NCT00034281|Clinical Trial, Phase I|clinical trial, phase i
881189|NCT00034281|Breast neoplasm|breast neoplasm
881190|NCT00034281|Pancreatic neoplasm|pancreatic neoplasm
881191|NCT00034281|Ovarian neoplasm|ovarian neoplasm
881192|NCT00034281|Colorectal neoplasm|colorectal neoplasm
881193|NCT00034281|Renal neoplasm|renal neoplasm
881194|NCT00034281|Prostate neoplasm|prostate neoplasm
881195|NCT00034281|Cancer|cancer
881196|NCT00034268|non-small cell lung cancer|non-small cell lung cancer
881197|NCT00034268|Stage IIIB or IV non-small cell lung cancer (NSCLC)|stage iiib or iv non-small cell lung cancer (nsclc)
881198|NCT00034177|Locally Advanced, Metastatic, or Recurrent Transitional Cell Carcinoma of the Urothelium|locally advanced, metastatic, or recurrent transitional cell carcinoma of the urothelium
881199|NCT00034242|Ataxia|ataxia
881200|NCT00034242|Treatment|treatment
881201|NCT00034242|IVIG|ivig
881202|NCT00034242|SCA|sca
881203|NCT00034242|Cerebellar Degeneration|cerebellar degeneration
881204|NCT00034242|Cerebellar Ataxia|cerebellar ataxia
881205|NCT00034242|Cerebellum|cerebellum
881206|NCT00034229|Antidepressant|antidepressant
881207|NCT00034229|Anti-Glutamatergic|anti-glutamatergic
881208|NCT00034229|Bipolar Disorder|bipolar disorder
881209|NCT00034229|Depression|depression
881210|NCT00034229|Treatment Refractory|treatment refractory
881211|NCT00034229|Felbamate|felbamate
881212|NCT00034229|Glutamate|glutamate
881213|NCT00034229|Treatment-Resistant|treatment-resistant
881214|NCT00034229|Bipolar|bipolar
881215|NCT00034229|BPD|bpd
881216|NCT00034229|Bipolar Depression|bipolar depression
881217|NCT00034216|Suppressor Cells|suppressor cells
881218|NCT00034216|T-cells|t-cells
881219|NCT00034216|CD4+/CD25+ Cells|cd4+/cd25+ cells
881220|NCT00034216|Cancer|cancer
881221|NCT00034216|Malignancy|malignancy
881222|NCT00034216|Blood Sample|blood sample
881223|NCT00034138|immunotherapy|immunotherapy
881224|NCT00034138|monoclonal|monoclonal
881225|NCT00034138|antibody|antibody
881226|NCT00034138|Stage III ovarian epithelial cancer|stage iii ovarian epithelial cancer
881227|NCT00034138|Stage IV ovarian epithelial cancer|stage iv ovarian epithelial cancer
881228|NCT00034125|cancer|cancer
881229|NCT00034125|metastatic breast cancer|metastatic breast cancer
881230|NCT00034125|hormonal therapy|hormonal therapy
881231|NCT00034112|chronic obstructive pulmonary disease|chronic obstructive pulmonary disease
881232|NCT00034112|combination therapy,|combination therapy,
881233|NCT00034112|emphysema|emphysema
881234|NCT00034112|exercise|exercise
883000|NCT00024960|Dysfluency|dysfluency
881235|NCT00034112|human therapy evaluation|human therapy evaluation
881236|NCT00034112|rehabilitation|rehabilitation
881237|NCT00034112|respiratory disease /disorder therapy|respiratory disease /disorder therapy
881238|NCT00034112|respiratory function|respiratory function
881239|NCT00034112|biomechanics|biomechanics
881240|NCT00034112|body movement|body movement
881241|NCT00034112|diaphragm|diaphragm
881242|NCT00034112|dyspnea|dyspnea
881243|NCT00034112|muscle tension|muscle tension
881244|NCT00034112|musculoskeletal system|musculoskeletal system
881245|NCT00034112|outcomes research|outcomes research
881246|NCT00034112|quality of life|quality of life
881247|NCT00034112|somatic reflex|somatic reflex
881248|NCT00034086|Lopinavir|lopinavir
881249|NCT00034086|OspA Protein|ospa protein
881250|NCT00034086|HIV-1|hiv-1
881251|NCT00034086|HIV Protease Inhibitors|hiv protease inhibitors
881252|NCT00034086|CD4 Lymphocyte Count|cd4 lymphocyte count
881253|NCT00034086|Ritonavir|ritonavir
881254|NCT00034086|Haemophilus Vaccines|haemophilus vaccines
881255|NCT00034086|HAART|haart
881256|NCT00034086|Pneumococcal Vaccines|pneumococcal vaccines
881257|NCT00034086|tenofovir disoproxil|tenofovir disoproxil
881258|NCT00034073|Imaging|imaging
881259|NCT00034073|Pediatrics|pediatrics
881260|NCT00034073|Brain|brain
881261|NCT00034073|Mapping|mapping
881262|NCT00034073|Development|development
881263|NCT00034073|Healthy Volunteer|healthy volunteer
881264|NCT00034073|HV|hv
881265|NCT00034073|Normal Control|normal control
881266|NCT00034060|Cytokines|cytokines
881267|NCT00034060|Exanercept|exanercept
881268|NCT00034060|Cachexia|cachexia
881269|NCT00034060|Body Composition|body composition
881270|NCT00034060|Vascular Endothelial System|vascular endothelial system
881271|NCT00034060|Rheumatoid Arthritis|rheumatoid arthritis
881272|NCT00034060|RA|ra
881273|NCT00034060|Women|women
881274|NCT00034060|Healthy Volunteer|healthy volunteer
881275|NCT00034060|HV|hv
881276|NCT00034060|Normal Control|normal control
881277|NCT00034047|Endometriosis|endometriosis
881278|NCT00034047|Pelvic pain|pelvic pain
881279|NCT00034047|Acupuncture|acupuncture
881280|NCT00034047|Chinese herbs|chinese herbs
881281|NCT00034047|Hormone therapy|hormone therapy
881282|NCT00034047|Nafarelin|nafarelin
881283|NCT00034034|Advanced colorectal cancer|advanced colorectal cancer
881284|NCT00034034|acupressure /acupuncture|acupressure /acupuncture
881286|NCT00034034|colorectal neoplasm|colorectal neoplasm
881287|NCT00034034|human therapy evaluation|human therapy evaluation
881288|NCT00034034|neoplasm /cancer palliative treatment|neoplasm /cancer palliative treatment
881289|NCT00034034|quality of life|quality of life
881290|NCT00034034|terminal patient care|terminal patient care
881291|NCT00034034|hypothalamic pituitary adrenal axis|hypothalamic pituitary adrenal axis
881292|NCT00034034|pain|pain
881293|NCT00034034|psychological aspect of cancer|psychological aspect of cancer
881294|NCT00034034|stress management|stress management
881295|NCT00034034|alternative medicine|alternative medicine
881296|NCT00034034|behavioral /social science research tag|behavioral /social science research tag
881297|NCT00034034|human subject|human subject
881298|NCT00034034|patient oriented research|patient oriented research
881428|NCT00033176|HIV infection|hiv infection
881299|NCT00034021|Female Sexual Arousal Disorder|female sexual arousal disorder
881300|NCT00034021|Female Orgasmic Disorder|female orgasmic disorder
881301|NCT00034021|ginkgo biloba|ginkgo biloba
881302|NCT00034021|human therapy evaluation|human therapy evaluation
881303|NCT00034021|sex behavior|sex behavior
881304|NCT00034021|antidepressant|antidepressant
881305|NCT00034021|blood flow|blood flow
881306|NCT00034021|clinical trial|clinical trial
881307|NCT00034021|drug adverse effect|drug adverse effect
881308|NCT00034021|mental disorder chemotherapy|mental disorder chemotherapy
881309|NCT00034021|relaxation|relaxation
881310|NCT00034021|smooth muscle|smooth muscle
881311|NCT00034021|alternative medicine|alternative medicine
881312|NCT00034021|blood flow measurement|blood flow measurement
881313|NCT00034021|female|female
881314|NCT00034021|placebo|placebo
881315|NCT00034021|women's health|women's health
881316|NCT00034021|Secondary to either to fluoxetine, sertraline, or paroxetine use.|secondary to either to fluoxetine, sertraline, or paroxetine use.
881317|NCT00034008|Energy Medicine|energy medicine
881318|NCT00034008|Healing Touch|healing touch
881319|NCT00034008|CAM Research|cam research
881320|NCT00034008|Neonates|neonates
881321|NCT00034008|Stress|stress
881322|NCT00034008|Conditions resulting from stress|conditions resulting from stress
881323|NCT00034008|Neonatal intensive care|neonatal intensive care
881324|NCT00034008|Healing of stress and prevention of negative|healing of stress and prevention of negative
881325|NCT00034008|Developmental outcomes – physical and behavioral|developmental outcomes – physical and behavioral
881326|NCT00034008|Therapeutic Touch|therapeutic touch
881327|NCT00034008|Touch therapies|touch therapies
881328|NCT00034008|Energy therapies|energy therapies
881329|NCT00034008|Infant touch|infant touch
881330|NCT00034008|Infant stimulation|infant stimulation
881331|NCT00033995|Tics|tics
883001|NCT00024960|Fluency|fluency
881332|NCT00033995|Basal Ganglia|basal ganglia
881333|NCT00033995|Neuroimaging|neuroimaging
881334|NCT00033995|Sleep|sleep
881335|NCT00033995|Suppression of Tics|suppression of tics
881336|NCT00033995|Tourette Syndrome|tourette syndrome
881337|NCT00033995|Tourette's Syndrome|tourette's syndrome
881338|NCT00033995|Tic Disorder|tic disorder
881339|NCT00033995|Healthy Volunteer|healthy volunteer
881340|NCT00033995|HV|hv
881341|NCT00033995|Normal Control|normal control
881342|NCT00033982|Triazole|triazole
881343|NCT00033982|Refractory|refractory
881344|NCT00033982|Antifungal|antifungal
881345|NCT00033982|Fungal Infection|fungal infection
881346|NCT00033969|CRPS|crps
881347|NCT00033969|RSD|rsd
881348|NCT00033969|Causalgia|causalgia
881349|NCT00033969|Chronic Pain|chronic pain
881350|NCT00033969|Neuropathic Pain|neuropathic pain
881351|NCT00033969|Normal Control|normal control
881352|NCT00033969|Complex Regional Pain Syndrome|complex regional pain syndrome
881353|NCT00033969|Healthy Volunteer|healthy volunteer
881354|NCT00033969|HV|hv
881355|NCT00033956|Metastatic Melanoma|metastatic melanoma
881356|NCT00033956|Renal Cell Carcinoma|renal cell carcinoma
881357|NCT00033956|IL-2|il-2
881358|NCT00033956|Interleukin-2|interleukin-2
881359|NCT00033956|Hypotension|hypotension
881360|NCT00033917|intraventricular hemorrhage (IVH)|intraventricular hemorrhage (ivh)
881361|NCT00033917|bleeding in the brain|bleeding in the brain
881362|NCT00033917|indomethacin|indomethacin
881363|NCT00033917|prematurity|prematurity
881364|NCT00033917|very low birth weight infants|very low birth weight infants
881365|NCT00033904|Kidney Cancer, renal, immunotherapy, tumor,|kidney cancer, renal, immunotherapy, tumor,
881366|NCT00033891|Muscle Weakness|muscle weakness
881367|NCT00033891|Muscle Biopsy|muscle biopsy
881368|NCT00033891|Gene Expression Profiling|gene expression profiling
881369|NCT00033891|MRI|mri
881370|NCT00033891|Inflammation|inflammation
881371|NCT00033891|Polymyositis|polymyositis
881372|NCT00033891|Dermatomyositis|dermatomyositis
881373|NCT00033878|Advanced Cancer|advanced cancer
881374|NCT00033865|Insomnia|insomnia
881375|NCT00033865|Yoga|yoga
881376|NCT00033865|Meditation|meditation
881377|NCT00033865|Behavioral treatment|behavioral treatment
881378|NCT00033852|complementary therapies|complementary therapies
881379|NCT00033852|Depression|depression
881380|NCT00033852|HIV|hiv
881381|NCT00033852|Massage Therapy|massage therapy
881382|NCT00033852|Alternative Treatments|alternative treatments
881383|NCT00033839|Headache|headache
881384|NCT00033839|Cluster|cluster
881385|NCT00033839|EC|ec
881386|NCT00033839|Episodic Cluster|episodic cluster
881387|NCT00033826|Vitamin D|vitamin d
881388|NCT00033826|Adipose tissue|adipose tissue
881389|NCT00033826|Metabolism|metabolism
881390|NCT00033813|Duchenne|duchenne
881391|NCT00033813|muscular|muscular
881392|NCT00033813|dystrophy|dystrophy
881393|NCT00033813|controlled clinical trial|controlled clinical trial
881394|NCT00033813|CINRG|cinrg
881395|NCT00033787|Depression|depression
881396|NCT00033787|Tryptophan Depletion|tryptophan depletion
881397|NCT00033787|PET|pet
881398|NCT00033787|Serotonin|serotonin
881399|NCT00033787|Pathophysiology|pathophysiology
881400|NCT00033787|Emotional Stimuli|emotional stimuli
881401|NCT00033787|GABA MRS|gaba mrs
881402|NCT00033787|MDD|mdd
881403|NCT00033787|Healthy Volunteer|healthy volunteer
881404|NCT00033787|HV|hv
881405|NCT00033787|Normal Control|normal control
881406|NCT00033774|Leukapheresis|leukapheresis
881407|NCT00033774|G-CSF|g-csf
881408|NCT00033774|Mobilization|mobilization
881409|NCT00033774|Stem Cells|stem cells
881410|NCT00033774|Adult|adult
881411|NCT00033774|Healthy Volunteer|healthy volunteer
881412|NCT00033774|HV|hv
881413|NCT00033774|Normal Control|normal control
881414|NCT00033215|neovascularization|neovascularization
881415|NCT00033215|matrix metalloproteinases|matrix metalloproteinases
881416|NCT00033215|antiangiogenesis|antiangiogenesis
881417|NCT00033215|type IV collagenases|type iv collagenases
881418|NCT00033202|Solid Tumor|solid tumor
881419|NCT00033202|Camptothecin|camptothecin
881420|NCT00033202|Pharmacokinetics|pharmacokinetics
881421|NCT00033189|duchenne|duchenne
881422|NCT00033189|dystrophy|dystrophy
881423|NCT00033189|DMD|dmd
881424|NCT00033189|clinical trial|clinical trial
881425|NCT00033189|CINRG|cinrg
881426|NCT00033176|complementary therapies|complementary therapies
881427|NCT00033176|Immune restoration|immune restoration
881429|NCT00033176|AIDS|aids
881430|NCT00033176|HAART non-responsiveness|haart non-responsiveness
881431|NCT00033176|glutathione restoration|glutathione restoration
881432|NCT00033176|lipoic acid|lipoic acid
881433|NCT00033176|dithiol|dithiol
881434|NCT00033163|Antiviral Agents|antiviral agents
881435|NCT00033163|Hepatitis B|hepatitis b
881436|NCT00033163|Drug Resistance, Microbial|drug resistance, microbial
881437|NCT00033163|Lamivudine|lamivudine
881438|NCT00033163|DNA, Viral|dna, viral
881439|NCT00033163|Hepatitis B Virus|hepatitis b virus
881440|NCT00033163|Adefovir dipivoxil|adefovir dipivoxil
881441|NCT00033163|Tenofovir disoproxil fumarate|tenofovir disoproxil fumarate
881442|NCT00033163|Treatment Experienced|treatment experienced
881443|NCT00033150|Specific Language Impairment|specific language impairment
881444|NCT00033150|Fast ForWord|fast forword
881445|NCT00033150|Language therapy|language therapy
881446|NCT00033150|Auditory processing|auditory processing
881447|NCT00033137|Pneumothorax|pneumothorax
881448|NCT00033137|Kidney|kidney
881449|NCT00033137|Fibrofolliculoma|fibrofolliculoma
881450|NCT00033137|BHD|bhd
881451|NCT00033137|Neoplasms|neoplasms
881452|NCT00033137|Kidney Cancer|kidney cancer
881453|NCT00033137|Birt Hogg Dube Syndrome|birt hogg dube syndrome
881454|NCT00033137|Skin Papules|skin papules
881455|NCT00033085|cocaine dependence|cocaine dependence
881456|NCT00033033|cocaine dependence|cocaine dependence
881457|NCT00033020|substance use disorders|substance use disorders
881458|NCT00033007|substance use disorders|substance use disorders
881459|NCT00032994|substance use disorders|substance use disorders
881460|NCT00032981|substance use disorder|substance use disorder
881461|NCT00032968|opiate dependence|opiate dependence
881462|NCT00032955|opiate addiction|opiate addiction
881463|NCT00032955|morphine addiction|morphine addiction
881464|NCT00032942|opiate dependence|opiate dependence
881465|NCT00032929|Cocaine Dependence|cocaine dependence
881466|NCT00032903|Malignant Glioma, Camptothecin, Pharmacokinetics|malignant glioma, camptothecin, pharmacokinetics
881467|NCT00032890|osteoarthritis|osteoarthritis
881468|NCT00032890|knee pain|knee pain
881469|NCT00032877|Linkage Study|linkage study
881470|NCT00032877|Gene Identification Study|gene identification study
881471|NCT00032877|Diaphragmatic Hernia|diaphragmatic hernia
881472|NCT00032877|Fraser Syndrome|fraser syndrome
881473|NCT00032877|Cryptophthalmos|cryptophthalmos
881474|NCT00032877|Fryns Syndrome|fryns syndrome
881475|NCT00032877|Hydrolethalus Syndrome|hydrolethalus syndrome
881476|NCT00032877|Positional Cloning|positional cloning
881477|NCT00032864|amputations, diabetes,|amputations, diabetes,
881478|NCT00032838|Hydrocortisone|hydrocortisone
881479|NCT00032838|Yohimbine|yohimbine
881480|NCT00032838|Cognition|cognition
881481|NCT00032838|Norepinephrine|norepinephrine
881482|NCT00032838|Cortisol|cortisol
881483|NCT00032838|Emotion|emotion
881484|NCT00032838|Healthy Volunteer|healthy volunteer
881485|NCT00032838|HV|hv
881486|NCT00032838|Normal Control|normal control
881487|NCT00032825|Combination|combination
881490|NCT00032825|Chemotherapy|chemotherapy
881491|NCT00032825|Pharmacokinetics|pharmacokinetics
881492|NCT00032825|Prostate Cancer|prostate cancer
881493|NCT00032825|Prostate|prostate
881494|NCT00032773|acute graft versus host disease|acute graft versus host disease
881495|NCT00032773|aGVHD|agvhd
881496|NCT00032773|allogeneic hematopoietic stem cell transplantation|allogeneic hematopoietic stem cell transplantation
881497|NCT00032773|peripheral blood stem cell transplantation|peripheral blood stem cell transplantation
881498|NCT00032773|cord blood transplant|cord blood transplant
881499|NCT00032773|pentostatin|pentostatin
881500|NCT00032773|Nipent|nipent
881501|NCT00032773|deoxycoformycin|deoxycoformycin
881502|NCT00032812|Motor Learning|motor learning
881503|NCT00032812|Sequencing|sequencing
881504|NCT00032812|Functional Imaging|functional imaging
881505|NCT00032812|Raclopride|raclopride
881506|NCT00032812|Connectivity|connectivity
881507|NCT00032812|Parkinson Disease|parkinson disease
881508|NCT00032812|Parkinson's Disease|parkinson's disease
881509|NCT00032812|PD|pd
881510|NCT00032812|Healthy Volunteer|healthy volunteer
881511|NCT00032812|HV|hv
881512|NCT00032812|Normal Control|normal control
881513|NCT00032760|binge eating disorder|binge eating disorder
881514|NCT00032760|human therapy evaluation|human therapy evaluation
881515|NCT00032760|meditation|meditation
881516|NCT00032760|obesity|obesity
881517|NCT00032760|nutrition education|nutrition education
881518|NCT00032760|psychotherapy|psychotherapy
881519|NCT00032760|racial /ethnic difference|racial /ethnic difference
881520|NCT00032760|adult human|adult human
881521|NCT00032760|alternative medicine|alternative medicine
881522|NCT00032760|patient oriented research|patient oriented research
881523|NCT00032747|Chronic Heart Failure|chronic heart failure
881524|NCT00032747|Heart Disease|heart disease
881525|NCT00032734|Low Blood Sodium (Hyponatremia)|low blood sodium (hyponatremia)
881526|NCT00032734|SIADH|siadh
881527|NCT00032734|Inappropriate ADH Syndrome|inappropriate adh syndrome
881528|NCT00032721|complementary therapies|complementary therapies
881529|NCT00032721|Alternative medicine|alternative medicine
881530|NCT00032721|Complementary and alternative medicine|complementary and alternative medicine
881531|NCT00032721|Subtle energy therapy|subtle energy therapy
881532|NCT00032721|Reiki|reiki
881533|NCT00032721|HIV/AIDS|hiv/aids
881534|NCT00032695|myelopathy|myelopathy
881535|NCT00032695|AIDS-myelopathy|aids-myelopathy
881536|NCT00032695|AIDS vacuolar myelopathy|aids vacuolar myelopathy
881537|NCT00032695|methionine|methionine
881538|NCT00032682|Bowel Movement|bowel movement
881539|NCT00032682|Children|children
881540|NCT00032682|Stool|stool
881541|NCT00032682|Symptom Management|symptom management
881542|NCT00032682|Cancer|cancer
881543|NCT00032682|Constipation|constipation
881544|NCT00032669|Antiretrovirals|antiretrovirals
881545|NCT00032669|Adherence|adherence
881546|NCT00032669|Dose Adjustments|dose adjustments
881547|NCT00032669|Genotypic Resistance|genotypic resistance
881548|NCT00032669|Phenotypic Resistance|phenotypic resistance
881549|NCT00032656|Adolescents|adolescents
881550|NCT00032656|Alternative and complimentary medication use|alternative and complimentary medication use
881551|NCT00032656|Health services utilization|health services utilization
881552|NCT00032656|Communication|communication
881553|NCT00032656|Quality of care|quality of care
881554|NCT00032617|PTSD|ptsd
881555|NCT00032617|Stress Disorder|stress disorder
881558|NCT00032591|Mechanical heart valve (MHV)|mechanical heart valve (mhv)
881559|NCT00032539|Informed Consent|informed consent
881560|NCT00032513|Herpes|herpes
881561|NCT00032513|Hemophagocytosis|hemophagocytosis
881562|NCT00032513|Epstein-Barr Virus|epstein-barr virus
881563|NCT00032513|Lymphoproliferative Disease|lymphoproliferative disease
881564|NCT00032513|Mononucleosis|mononucleosis
881565|NCT00032513|Epstein-Barr|epstein-barr
881566|NCT00032513|EBV|ebv
881567|NCT00032513|CAEBV|caebv
881568|NCT00032513|Chronic Active Epstein-Barr Virus|chronic active epstein-barr virus
881569|NCT00032513|Virus|virus
881570|NCT00032500|common cold|common cold
881571|NCT00032500|Echinacea|echinacea
881572|NCT00032487|DM|dm
881573|NCT00032487|glycemic control|glycemic control
881574|NCT00032487|insulin|insulin
881575|NCT00032487|type 2 diabetes mellitus|type 2 diabetes mellitus
881576|NCT00032474|Ginkgo biloba|ginkgo biloba
881577|NCT00032474|type 2 diabetes|type 2 diabetes
881578|NCT00032474|platelet function|platelet function
881579|NCT00032474|antioxidant|antioxidant
881580|NCT00032461|chronic fatigue syndrome|chronic fatigue syndrome
881581|NCT00032461|fibromyalgia|fibromyalgia
881582|NCT00032461|post-traumatic stress disorder|post-traumatic stress disorder
881583|NCT00032461|neurologic abnormalities|neurologic abnormalities
881584|NCT00032448|Hernia|hernia
881585|NCT00032448|laparoscopic herniorrhaphy|laparoscopic herniorrhaphy
881586|NCT00032448|tension-free herniorrhaphy|tension-free herniorrhaphy
881587|NCT00032435|folate|folate
881588|NCT00032435|pyridoxine|pyridoxine
881589|NCT00032435|vitamin B6|vitamin b6
881590|NCT00032435|cyanocobalamin|cyanocobalamin
881591|NCT00032435|homoc|homoc
881592|NCT00032422|Acupuncture|acupuncture
881593|NCT00032422|Heart Failure|heart failure
881594|NCT00032422|Autonomic nervous system|autonomic nervous system
881595|NCT00032409|Music Therapy|music therapy
881596|NCT00032409|Relaxation Therapy|relaxation therapy
881597|NCT00032409|Stress Reduction|stress reduction
881598|NCT00032409|Bone Marrow Transplantation|bone marrow transplantation
881599|NCT00032409|Stem Cell Transplantation|stem cell transplantation
881600|NCT00032396|AMD|amd
881601|NCT00032396|ARMD|armd
881602|NCT00032396|Age-Related Macular Degeneration|age-related macular degeneration
881603|NCT00032396|Subfoveal Choroidal Neovascularization|subfoveal choroidal neovascularization
881604|NCT00032396|CNV|cnv
881605|NCT00032383|Rehabilitation|rehabilitation
881606|NCT00032383|Tai Chi|tai chi
881607|NCT00032370|myocardial infarction|myocardial infarction
881608|NCT00032370|Prophylactic coronary artery revascularization|prophylactic coronary artery revascularization
881609|NCT00032357|Ferritin reduction|ferritin reduction
881610|NCT00032357|Peripheral Vascular Disease (PVD)|peripheral vascular disease (pvd)
881611|NCT00032357|phlebotomy|phlebotomy
881612|NCT00032357|Reduction of Total Body Iron Storage(TBIS)|reduction of total body iron storage(tbis)
881613|NCT00032357|Total Body Iron Storage(TBIS)|total body iron storage(tbis)
881614|NCT00032344|large (>1 cm) adenomas|large (>1 cm) adenomas
881615|NCT00032331|PET imaging, benign and malignant solitary pulmonary nodules|pet imaging, benign and malignant solitary pulmonary nodules
881616|NCT00032305|Colitis|colitis
881617|NCT00032305|Gastrointestinal Disease|gastrointestinal disease
881618|NCT00032305|Digestive System Disease|digestive system disease
881619|NCT00032305|Intestinal Disease|intestinal disease
881620|NCT00032305|Colonic Disease|colonic disease
881621|NCT00032240|Biomechanics|biomechanics
881622|NCT00032227|Carpal Tunnel Release|carpal tunnel release
881623|NCT00032227|MR Nerve Imaging|mr nerve imaging
881624|NCT00032227|Wrist MRI|wrist mri
881625|NCT00032201|Surgery|surgery
881626|NCT00032201|Tissue Sample|tissue sample
881627|NCT00032201|Gene Expression Profiling|gene expression profiling
881628|NCT00032201|Tissue Array Gene Expression|tissue array gene expression
881629|NCT00032201|Comparative Genomic Hybridization|comparative genomic hybridization
881630|NCT00032201|Breast Cancer|breast cancer
881631|NCT00032201|Breast Cancer Risk|breast cancer risk
881632|NCT00032201|Breast|breast
881633|NCT00031551|Stomatitis|stomatitis
881634|NCT00031551|Oropharyngeal pain|oropharyngeal pain
881635|NCT00031551|TNF|tnf
881636|NCT00031551|Etanercept|etanercept
881637|NCT00031551|Bone marrow transplantation|bone marrow transplantation
881638|NCT00031551|Chemotherapy|chemotherapy
881639|NCT00031551|Cancer|cancer
881641|NCT00031551|Oral mucous membranes|oral mucous membranes
881642|NCT00031551|Randomized controlled clinical trial|randomized controlled clinical trial
881643|NCT00031551|Inflammation|inflammation
881644|NCT00031538|Brain Tumor|brain tumor
881645|NCT00031538|Surgery|surgery
881646|NCT00031538|Molecular|molecular
881647|NCT00031538|Glioma|glioma
881648|NCT00031538|Intraoperative|intraoperative
881649|NCT00031538|Gliomas|gliomas
881650|NCT00031512|enterovirus, enteroviral sepsis, Pleconaril, infants|enterovirus, enteroviral sepsis, pleconaril, infants
881651|NCT00031499|Azithromycin, Syphilis, Penicillin|azithromycin, syphilis, penicillin
881652|NCT00031486|encephalitis, herpes simplex, valacyclovir|encephalitis, herpes simplex, valacyclovir
881653|NCT00031473|Ribavirin|ribavirin
881655|NCT00031460|acyclovir, central nervous system, Herpes Simplex Virus|acyclovir, central nervous system, herpes simplex virus
881656|NCT00031447|Herpes Simplex, Acyclovir, Infants|herpes simplex, acyclovir, infants
881657|NCT00031434|Valganciclovir, congenital cytomegalovirus, ganciclovir|valganciclovir, congenital cytomegalovirus, ganciclovir
881658|NCT00031421|CMV, cytomegalovirus, children, ganciclovir|cmv, cytomegalovirus, children, ganciclovir
881659|NCT00031408|Specimen Handling|specimen handling
881660|NCT00031408|Blood|blood
881661|NCT00031408|Informed Consent|informed consent
881662|NCT00031408|Genetic Screening|genetic screening
881663|NCT00031395|Attention Deficit Hyperactivity Disorder|attention deficit hyperactivity disorder
881664|NCT00031395|ADHD|adhd
881665|NCT00031395|clonidine|clonidine
881666|NCT00031395|methylphenidate|methylphenidate
881667|NCT00031395|MPH|mph
881668|NCT00031382|Functional MRI|functional mri
881669|NCT00031382|Dual Task|dual task
881670|NCT00031382|Neural Activation|neural activation
881671|NCT00031382|Basal Ganglia|basal ganglia
881672|NCT00031382|Cerebellum|cerebellum
881673|NCT00031382|Healthy Volunteer|healthy volunteer
881674|NCT00031382|HV|hv
881675|NCT00031382|Normal Control|normal control
881676|NCT00031369|MRI|mri
881677|NCT00031369|Writer's Cramp|writer's cramp
881678|NCT00031369|Movement Disorder|movement disorder
881679|NCT00031369|Gray Matter|gray matter
881680|NCT00031369|Brain Morphology|brain morphology
881681|NCT00031369|Dystonia|dystonia
881682|NCT00031369|Focal Hand Dystonia|focal hand dystonia
881683|NCT00031369|Healthy Volunteer|healthy volunteer
881684|NCT00031369|HV|hv
881685|NCT00031369|Normal Control|normal control
881686|NCT00031343|Liver Disease|liver disease
881687|NCT00031343|Virologic Response|virologic response
881688|NCT00031343|Immune Mechanisms|immune mechanisms
881689|NCT00031343|Eradication|eradication
881690|NCT00031343|Antiviral Therapy|antiviral therapy
881691|NCT00031343|HIV|hiv
881692|NCT00031343|Hepatitis C|hepatitis c
881693|NCT00031343|HCV|hcv
881694|NCT00031343|Coinfection|coinfection
881695|NCT00031317|Depression|depression
881696|NCT00031317|Treatment|treatment
881697|NCT00031317|Antidepressant|antidepressant
881698|NCT00031317|Benzodiazepine (clonazepam)|benzodiazepine (clonazepam)
881699|NCT00031317|SSRI (paroxetine)|ssri (paroxetine)
881700|NCT00031317|Combined Treatment|combined treatment
881701|NCT00031317|Panic Disorder (PD)|panic disorder (pd)
881702|NCT00031317|Panic Disorder|panic disorder
881703|NCT00031317|PD|pd
881704|NCT00031304|HIV|hiv
881705|NCT00031304|AIDS|aids
881706|NCT00031304|Vaccine|vaccine
881707|NCT00031304|Screening|screening
881708|NCT00031304|Prevention|prevention
881709|NCT00031304|HV|hv
881710|NCT00031304|Healthy Volunteer|healthy volunteer
881711|NCT00031304|Volunteer|volunteer
881712|NCT00031304|HIV Seronegativity|hiv seronegativity
881713|NCT00031304|HIV Preventive Vaccine|hiv preventive vaccine
881714|NCT00031291|Anthrax|anthrax
881715|NCT00031291|Immune Globulin|immune globulin
881716|NCT00031291|Plasmapheresis|plasmapheresis
881717|NCT00031291|Vaccine|vaccine
881718|NCT00031278|Metastatic|metastatic
881719|NCT00031278|Breast|breast
881720|NCT00031278|Cancer|cancer
881721|NCT00031278|immunotherapy|immunotherapy
881722|NCT00031278|CPG 7909|cpg 7909
881723|NCT00031265|stroke|stroke
881724|NCT00031265|telephone|telephone
881725|NCT00031265|intervention|intervention
881726|NCT00031187|Prostate|prostate
881727|NCT00031187|Lewis Blood-Group System|lewis blood-group system
881728|NCT00031187|Antibodies, Monoclonal|antibodies, monoclonal
881729|NCT00031187|Antigens, Neoplasm|antigens, neoplasm
881730|NCT00031187|Antineoplastic Agents|antineoplastic agents
881731|NCT00031174|Apheresis|apheresis
881732|NCT00031174|Healthy Volunteer|healthy volunteer
881733|NCT00031174|Rheumatoid Disease|rheumatoid disease
881734|NCT00031174|Rheumatic Disease|rheumatic disease
881735|NCT00031174|Lupus|lupus
881736|NCT00031174|Rheumatoid Arthritis|rheumatoid arthritis
881737|NCT00031174|Myositis|myositis
881738|NCT00031174|HV|hv
881739|NCT00031174|Normal Control|normal control
881740|NCT00031161|Tyrosine|tyrosine
881741|NCT00031161|Diet|diet
881742|NCT00031161|2-(2-nitro-4-trifluoromethylbenzoyl)-1,3-cyclohexanedione|2-(2-nitro-4-trifluoromethylbenzoyl)-1,3-cyclohexanedione
881743|NCT00031161|4-Hydroxyphenylpyruvate Dioxygenase|4-hydroxyphenylpyruvate dioxygenase
881744|NCT00031161|Enzyme Inhibitors|enzyme inhibitors
881745|NCT00031148|Keratinocyte growth factor|keratinocyte growth factor
881746|NCT00031148|Bone Marrow Transplantation|bone marrow transplantation
881747|NCT00031148|Hematopoietic Stem Cell Transplantation|hematopoietic stem cell transplantation
881748|NCT00031148|HLA Antigens|hla antigens
881749|NCT00031148|Transplantation, Homologous|transplantation, homologous
881750|NCT00031148|Recombinant Proteins|recombinant proteins
881751|NCT00031135|Parenteral Nutrition, Total|parenteral nutrition, total
881752|NCT00031135|Lipotropic Agents|lipotropic agents
881753|NCT00031135|Choline|choline
881754|NCT00031122|Genetic Predisposition to Disease|genetic predisposition to disease
881755|NCT00031122|Environmental Exposure|environmental exposure
881756|NCT00031122|Chromosome Mapping|chromosome mapping
881757|NCT00031122|Data Collection|data collection
881758|NCT00031109|HIV Antibodies|hiv antibodies
881759|NCT00031109|HIV-1|hiv-1
881760|NCT00031109|HIV Envelope Protein gp160|hiv envelope protein gp160
881761|NCT00031109|Adjuvants, Immunologic|adjuvants, immunologic
881762|NCT00031109|AIDS Vaccines|aids vaccines
881763|NCT00031109|CD4 Lymphocyte Count|cd4 lymphocyte count
881764|NCT00031109|Disease Models, Animal|disease models, animal
881765|NCT00031109|Antibody Formation|antibody formation
881766|NCT00031109|Macaca|macaca
881767|NCT00031109|Neutralization Tests|neutralization tests
881768|NCT00031109|Viral Load|viral load
881769|NCT00031109|aluminum hydroxide|aluminum hydroxide
881770|NCT00031109|HIV Preventive Vaccine|hiv preventive vaccine
881771|NCT00031096|Acne Vulgaris|acne vulgaris
881772|NCT00031096|Propionibacterium acnes|propionibacterium acnes
881773|NCT00031083|Glioma|glioma
881774|NCT00031083|Brain Tumor|brain tumor
881775|NCT00031083|Adenovirus|adenovirus
881776|NCT00031083|Gene Therapy|gene therapy
881777|NCT00031083|Biogen|biogen
881778|NCT00031070|Zidovudine|zidovudine
881779|NCT00031070|CD4 Lymphocyte Count|cd4 lymphocyte count
881780|NCT00031070|Lamivudine|lamivudine
881781|NCT00031070|Cyclosporine|cyclosporine
881782|NCT00031070|Hepatitis A Vaccine|hepatitis a vaccine
881783|NCT00031070|Rabies Vaccine|rabies vaccine
881784|NCT00031070|abacavir|abacavir
881785|NCT00031070|Antiretroviral Therapy, Highly Active|antiretroviral therapy, highly active
881786|NCT00031070|efavirenz|efavirenz
881787|NCT00031070|Treatment Naive|treatment naive
881788|NCT00031057|Administration, Oral|administration, oral
881789|NCT00031057|Blood|blood
881790|NCT00031057|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors
881791|NCT00031057|Riboflavin|riboflavin
881792|NCT00031057|Thiamine|thiamine
881793|NCT00031057|Vitamin B Complex|vitamin b complex
881796|NCT00031044|Drug Therapy, Combination|drug therapy, combination
881797|NCT00031044|RNA, Viral|rna, viral
881798|NCT00031044|Salvage Therapy|salvage therapy
881799|NCT00031044|Anti-HIV Agents|anti-hiv agents
881800|NCT00031044|Viral Load|viral load
881801|NCT00031044|Purines|purines
881802|NCT00031044|T-20 Peptide|t-20 peptide
881803|NCT00031044|ABT 378|abt 378
881804|NCT00031044|Treatment Experienced|treatment experienced
881805|NCT00031031|MTD|mtd
881806|NCT00031031|Safety|safety
881807|NCT00031031|Pharmacokinetics|pharmacokinetics
881808|NCT00031031|Efficacy|efficacy
881809|NCT00031018|Inflammation|inflammation
881810|NCT00031018|immunosenescence|immunosenescence
881811|NCT00031018|autoimmunity|autoimmunity
881812|NCT00031018|atherosclerosis|atherosclerosis
881813|NCT00031018|pro-inflammatory cytokines|pro-inflammatory cytokines
881814|NCT00031018|Hayflick phenomenon|hayflick phenomenon
881815|NCT00031005|Non-Myeloablative|non-myeloablative
881816|NCT00031005|Campath 1-H|campath 1-h
881817|NCT00031005|Fludarabine|fludarabine
881818|NCT00031005|Immunodeficiency|immunodeficiency
881819|NCT00031005|Infection|infection
881820|NCT00031005|Leukocyte Adhesion Deficiency|leukocyte adhesion deficiency
881821|NCT00031005|LAD|lad
881822|NCT00030992|Epothilone B|epothilone b
881823|NCT00030992|Ixabepilone|ixabepilone
881824|NCT00030992|Renal Cell Carcinoma|renal cell carcinoma
881825|NCT00030992|Kidney Cancer|kidney cancer
881826|NCT00030979|Mild Dementia|mild dementia
881827|NCT00030979|Acetylcholine|acetylcholine
881828|NCT00030979|Memory|memory
881829|NCT00030979|Hallucinations|hallucinations
881830|NCT00030979|Washout|washout
881831|NCT00030979|Parkinson Disease|parkinson disease
881832|NCT00030979|Parkinson's Disease|parkinson's disease
881833|NCT00030979|PD|pd
881834|NCT00030979|Dementia|dementia
881835|NCT00030966|Multiple Sclerosis|multiple sclerosis
881836|NCT00030966|MS|ms
881837|NCT00030953|Tourette's Syndrome|tourette's syndrome
881838|NCT00030953|GABA|gaba
881839|NCT00030953|NAA|naa
881840|NCT00030953|Choline|choline
881841|NCT00030953|Creatine|creatine
881842|NCT00030953|Tourette Syndrome|tourette syndrome
881843|NCT00030953|Healthy Volunteer|healthy volunteer
881844|NCT00030953|HV|hv
881845|NCT00030953|Normal Control|normal control
881846|NCT00030940|Antigenic Epitopes|antigenic epitopes
881847|NCT00030940|Glutamic Acid Decarboxylase (GAD)|glutamic acid decarboxylase (gad)
881848|NCT00030940|Auto-antibodies|auto-antibodies
881849|NCT00030940|Stiffness Index|stiffness index
881850|NCT00030940|SPS|sps
881851|NCT00030940|Anti-GAD|anti-gad
881852|NCT00030940|MR Spectroscopy|mr spectroscopy
881853|NCT00030940|GAD|gad
881854|NCT00030940|Stiff Person Syndrome|stiff person syndrome
881855|NCT00030238|Body Fat|body fat
881856|NCT00030238|Weight Gain|weight gain
881857|NCT00030238|Adult|adult
881858|NCT00030238|Hypertension|hypertension
881859|NCT00030238|Dietary Supplements|dietary supplements
881860|NCT00030238|Healthy Volunteer|healthy volunteer
881861|NCT00030238|HIV|hiv
881862|NCT00030238|Body Weight|body weight
881863|NCT00030225|Fulminant Hepatic Failure|fulminant hepatic failure
881864|NCT00030212|T Cell|t cell
881865|NCT00030212|IBM|ibm
881866|NCT00030212|Inflammatory Myopathies|inflammatory myopathies
881867|NCT00030212|Antigenic Epitopes|antigenic epitopes
881868|NCT00030212|Endomysial T Lymphocytes|endomysial t lymphocytes
881869|NCT00030212|Myositis|myositis
881870|NCT00030212|Inclusion Body Myositis|inclusion body myositis
881871|NCT00030212|Inflammatory Myopathy|inflammatory myopathy
881872|NCT00030199|Transcranial Magnetic Stimuli|transcranial magnetic stimuli
881873|NCT00030199|Eletromyography|eletromyography
881874|NCT00030199|Needle Electrode|needle electrode
881875|NCT00030199|Facial Muscles|facial muscles
881876|NCT00030199|Blink Reflex|blink reflex
881877|NCT00030199|Motor Cortex|motor cortex
881878|NCT00030199|Transcranial Magnetic Stimulation|transcranial magnetic stimulation
881879|NCT00030199|Healthy Volunteer|healthy volunteer
881880|NCT00030199|HV|hv
881881|NCT00030199|Normal Control|normal control
881882|NCT00030186|AML|aml
881883|NCT00030186|FLT-3 mutation|flt-3 mutation
881884|NCT00030173|Epothilone D|epothilone d
881885|NCT00030173|tubulin polymerization|tubulin polymerization
881886|NCT00030160|Obesity|obesity
881887|NCT00030160|Prevention|prevention
881888|NCT00030160|Exercise|exercise
881889|NCT00030147|Gonadal Steroids|gonadal steroids
881890|NCT00030147|Estrogen Receptor|estrogen receptor
881891|NCT00030147|Mood Disorders|mood disorders
881892|NCT00030147|Perimenopause|perimenopause
881893|NCT00030147|Estradiol|estradiol
881894|NCT00030147|Depression|depression
881895|NCT00030147|Estrogen Response Element|estrogen response element
881896|NCT00030147|Perimenopausal|perimenopausal
881897|NCT00030147|Perimenopausal Depression|perimenopausal depression
881898|NCT00030134|Natural History|natural history
881899|NCT00030134|Female Carrier|female carrier
881900|NCT00030134|Alpha-Galactosidase|alpha-galactosidase
881901|NCT00030134|Lysosomal Disease|lysosomal disease
881902|NCT00030134|X-Linked|x-linked
881903|NCT00030134|Fabry|fabry
881904|NCT00030134|Fabry Disease|fabry disease
881905|NCT00030121|Acute Respiratory Distress|acute respiratory distress
881906|NCT00030121|Acute Lung Injury|acute lung injury
881907|NCT00030069|Hematopoiesis|hematopoiesis
881908|NCT00030069|Apoptosis|apoptosis
881909|NCT00030069|Cell Differentiation|cell differentiation
881910|NCT00030069|Bone Marrow Cells|bone marrow cells
881911|NCT00030056|Sargramostim|sargramostim
881912|NCT00030056|Injections, Subcutaneous|injections, subcutaneous
881913|NCT00030043|Electric Stimulation|electric stimulation
881914|NCT00030043|Implants, Artificial|implants, artificial
881915|NCT00030043|Brainstem|brainstem
881916|NCT00030043|Electrodes|electrodes
881917|NCT00030043|Speech Perception|speech perception
881918|NCT00029991|Leg pain|leg pain
881919|NCT00029991|Peripheral angiopathies|peripheral angiopathies
881920|NCT00029991|Vascular Diseases, peripheral|vascular diseases, peripheral
881921|NCT00029965|Sialidosis|sialidosis
881922|NCT00029965|Lysosomal Storage Disease|lysosomal storage disease
881923|NCT00029965|Glycoprotein Disorders|glycoprotein disorders
881924|NCT00029965|GM1 Gangliosidosis|gm1 gangliosidosis
881925|NCT00029965|GM2 Gangliosidosis|gm2 gangliosidosis
881926|NCT00029965|Lysosomal Storage Disorder|lysosomal storage disorder
881927|NCT00029965|Tay-Sachs|tay-sachs
881928|NCT00029965|Sandhoff|sandhoff
881929|NCT00029965|Gaucher|gaucher
881930|NCT00029952|Cortisol|cortisol
881931|NCT00029952|Bone Density|bone density
881932|NCT00029952|Cushing Syndrome|cushing syndrome
881933|NCT00029952|Postoperative|postoperative
881934|NCT00029939|Preparation|preparation
881935|NCT00029939|Subconscious|subconscious
881936|NCT00029939|Healthy Volunteer|healthy volunteer
881937|NCT00029939|HV|hv
881938|NCT00029939|Normal Control|normal control
881939|NCT00029926|Imaging|imaging
881940|NCT00029926|Immune System|immune system
881941|NCT00029926|Autoimmune Disease|autoimmune disease
881942|NCT00029926|Lymphonodes|lymphonodes
881943|NCT00029926|Spleen|spleen
881944|NCT00029926|Systemic Lupus Erythematosus|systemic lupus erythematosus
881945|NCT00029926|Lupus|lupus
881946|NCT00029926|SLE|sle
881947|NCT00029913|Placebos|placebos
881948|NCT00029913|AIDS Vaccines|aids vaccines
881949|NCT00029913|CD4 Lymphocyte Count|cd4 lymphocyte count
881950|NCT00029913|Disease Progression|disease progression
881951|NCT00029913|Viral Load|viral load
881952|NCT00029913|HIV Preventive Vaccine|hiv preventive vaccine
881953|NCT00029900|Dose-Response Relationship, Drug|dose-response relationship, drug
881954|NCT00029900|Polyethylene Glycol|polyethylene glycol
881955|NCT00029900|Arginine Deiminase|arginine deiminase
881956|NCT00029874|Tetracyclines|tetracyclines
881957|NCT00029874|Dose-Response Relationship, Drug|dose-response relationship, drug
881958|NCT00029861|Weight Loss|weight loss
881959|NCT00029861|Obesity|obesity
881960|NCT00029861|Weight Reduction|weight reduction
881961|NCT00029861|Overweight|overweight
881962|NCT00029848|Diabetes|diabetes
881963|NCT00029848|Obesity|obesity
881964|NCT00029835|Obesity|obesity
881965|NCT00029822|Acute Urinary Retention|acute urinary retention
881966|NCT00029822|AUR|aur
881967|NCT00029822|Benign Prostatic Hyperplasia|benign prostatic hyperplasia
881968|NCT00029822|Benign Prostatic Hypertrophy|benign prostatic hypertrophy
881969|NCT00029822|BPH|bph
881970|NCT00029822|Enlarged Prostate|enlarged prostate
881971|NCT00029809|Parkinsons Disease|parkinsons disease
881972|NCT00029809|Chinese exercise|chinese exercise
881973|NCT00029783|Glioblastoma|glioblastoma
881974|NCT00029783|Brain tumor|brain tumor
881975|NCT00029783|Distant healing|distant healing
881976|NCT00029783|Distance healing|distance healing
881977|NCT00029757|Surgical menopause|surgical menopause
881978|NCT00029744|AIDS Vaccines|aids vaccines
881979|NCT00029744|Clinical Protocols|clinical protocols
881980|NCT00029744|HIV Seronegativity|hiv seronegativity
881981|NCT00029744|Patient Selection|patient selection
881982|NCT00029744|Patient Acceptance of Health Care|patient acceptance of health care
881983|NCT00029744|Demography|demography
881984|NCT00029744|HIV Preventive Vaccine|hiv preventive vaccine
881985|NCT00029731|Nitric Oxide|nitric oxide
881986|NCT00029731|Administration, Oral|administration, oral
881987|NCT00029718|Chronic Stroke|chronic stroke
881988|NCT00029718|Transcallosal Inhibition|transcallosal inhibition
881989|NCT00029718|Motor Cortex|motor cortex
881990|NCT00029718|Motor Control|motor control
881991|NCT00029718|Motor Recovery|motor recovery
881992|NCT00029718|Healthy Volunteer|healthy volunteer
881993|NCT00029718|HV|hv
881994|NCT00029718|Normal Control|normal control
881995|NCT00029666|Motor Cortex|motor cortex
881996|NCT00029666|Sham Stimulation|sham stimulation
881997|NCT00029666|Prefrontal Cortex|prefrontal cortex
881998|NCT00029666|Brain Stimulation|brain stimulation
881999|NCT00029666|Gait|gait
882000|NCT00029666|Parkinson|parkinson
882001|NCT00029666|Parkinson's|parkinson's
882002|NCT00029666|PD|pd
882003|NCT00029653|Frontal Lobe|frontal lobe
882004|NCT00029653|Reaction Time|reaction time
882005|NCT00029653|Movement Preparation|movement preparation
882006|NCT00029653|Motor Threshold|motor threshold
882007|NCT00029653|Transcranial Magnetic Stimulation|transcranial magnetic stimulation
882008|NCT00029653|Motor Cortex|motor cortex
882009|NCT00029653|Healthy Volunteer|healthy volunteer
882010|NCT00029653|Normal Control|normal control
882011|NCT00029653|HV|hv
882012|NCT00029640|MRI|mri
882013|NCT00029640|MRS|mrs
882014|NCT00029640|SSRI|ssri
882015|NCT00029640|Children|children
882016|NCT00029640|Depression|depression
882017|NCT00029640|Augmentation|augmentation
882018|NCT00029640|Magnetic Resonance Imaging|magnetic resonance imaging
882019|NCT00029640|Major Depression|major depression
882020|NCT00029640|MDD|mdd
882021|NCT00029627|Alpha2-Adrenoreceptors|alpha2-adrenoreceptors
882022|NCT00029627|Polymorphisms|polymorphisms
882023|NCT00029627|Challenge Study|challenge study
882024|NCT00029627|Yohimbine|yohimbine
882025|NCT00029627|Clonidine|clonidine
882026|NCT00029627|Subtypes|subtypes
882027|NCT00029627|Normal Control|normal control
882028|NCT00029627|HV|hv
882029|NCT00029627|Healthy Volunteer|healthy volunteer
882030|NCT00029614|ADHD|adhd
882031|NCT00029614|Substance Use|substance use
882032|NCT00029601|Magnetic Stimulation|magnetic stimulation
882033|NCT00029601|Intracortical Inhibition|intracortical inhibition
882034|NCT00029601|Intracortical Facilitation|intracortical facilitation
882035|NCT00029601|Motor Evoked Potential|motor evoked potential
882036|NCT00029601|Reaction Time|reaction time
882037|NCT00029601|Transcranial Magnetic Stimulation|transcranial magnetic stimulation
882038|NCT00029601|Dystonia|dystonia
882039|NCT00029601|Focal Dystonia|focal dystonia
882040|NCT00029601|Healthy Volunteer|healthy volunteer
882041|NCT00029601|HV|hv
882042|NCT00029601|Normal Control|normal control
882043|NCT00029588|fMRI|fmri
882044|NCT00029588|Adolescents and Adults|adolescents and adults
882045|NCT00029588|Depression|depression
882046|NCT00029588|Anxiety|anxiety
882047|NCT00029588|Anxiety Disorder|anxiety disorder
882048|NCT00029588|GAD|gad
882049|NCT00029588|Adolescents|adolescents
882050|NCT00029588|Healthy Volunteer|healthy volunteer
882051|NCT00029588|HV|hv
882052|NCT00029588|Normal Control|normal control
882053|NCT00029575|Atherosclerotic|atherosclerotic
882054|NCT00029575|Plaque|plaque
882055|NCT00029575|Resolution|resolution
882056|NCT00029575|Adventitia|adventitia
882057|NCT00029575|Ultrasound|ultrasound
882058|NCT00029575|Cardiac Catheterization|cardiac catheterization
882059|NCT00029575|Arteriosclerosis|arteriosclerosis
882060|NCT00029575|Coronary Artery Disease|coronary artery disease
882061|NCT00029536|Epilepsy|epilepsy
882062|NCT00029536|Seizure|seizure
882063|NCT00029536|Hormone|hormone
882064|NCT00029536|Progesterone|progesterone
882065|NCT00029536|Catamenial|catamenial
882066|NCT00029523|neoplastic|neoplastic
882067|NCT00029523|meningitis|meningitis
882068|NCT00029523|cerebrospinal fluid|cerebrospinal fluid
882069|NCT00029523|CSF|csf
882070|NCT00029523|meningeal|meningeal
882071|NCT00029523|meninges|meninges
882072|NCT00029523|CNS|cns
882073|NCT00029523|Leptomeningeal Neoplasms|leptomeningeal neoplasms
882074|NCT00029458|Placebo Controlled|placebo controlled
882075|NCT00029458|Atypical Anti-Psychotic|atypical anti-psychotic
882076|NCT00029458|Bipolar Mood Disorder|bipolar mood disorder
882077|NCT00029458|Positron Emission Tomography|positron emission tomography
882078|NCT00029458|Dopamine Receptor Blockade|dopamine receptor blockade
882079|NCT00029458|Antimanic|antimanic
882080|NCT00029458|Mania|mania
882081|NCT00029458|Pathophysiology|pathophysiology
882082|NCT00029458|Treatment-Resistant|treatment-resistant
882083|NCT00029458|Mood Disorder|mood disorder
882084|NCT00029458|BPD|bpd
882085|NCT00029458|Bipolar|bipolar
882086|NCT00029445|HLA B5701|hla b5701
882087|NCT00029445|LTNP|ltnp
882088|NCT00029445|Neutralizing Antibodies|neutralizing antibodies
882089|NCT00029445|CTL|ctl
882090|NCT00029445|Virus Restriction|virus restriction
882091|NCT00029445|HIV|hiv
882092|NCT00029445|HIV-Infected Long Term Nonprogressors|hiv-infected long term nonprogressors
882093|NCT00029341|Drug Therapy, Combination|drug therapy, combination
882094|NCT00029341|Drug Administration Schedule|drug administration schedule
882095|NCT00029341|Drug Resistance, Microbial|drug resistance, microbial
882096|NCT00029341|Genotype|genotype
882097|NCT00029341|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors
882098|NCT00029341|Anti-HIV Agents|anti-hiv agents
882099|NCT00029341|Viral Load|viral load
882100|NCT00029341|Pharmacokinetics|pharmacokinetics
882101|NCT00029341|Efavirenz|efavirenz
882102|NCT00029341|Treatment Interruption|treatment interruption
882103|NCT00029328|TNFR-Fc fusion protein|tnfr-fc fusion protein
882104|NCT00029328|Stem Cell Transplantation|stem cell transplantation
882105|NCT00029328|Transplantation, Homologous|transplantation, homologous
882106|NCT00029328|Respiratory Function Tests|respiratory function tests
882107|NCT00029315|Intraventricular hemorrhage|intraventricular hemorrhage
882108|NCT00029315|Subarachnoid hemorrhage|subarachnoid hemorrhage
882109|NCT00029315|Intracerebral hemorrhage|intracerebral hemorrhage
882110|NCT00029315|Pharmacokinetics|pharmacokinetics
882111|NCT00029315|Recombinant Proteins|recombinant proteins
882112|NCT00029315|Anticoagulants|anticoagulants
882113|NCT00029315|Tissue Plasminogen Activator|tissue plasminogen activator
882114|NCT00029315|Pharmacology|pharmacology
882115|NCT00029315|Catheters, Indwelling|catheters, indwelling
882116|NCT00029315|Cerebral Ventricles|cerebral ventricles
882117|NCT00029302|fMRI|fmri
882118|NCT00029302|Voluntary Movement|voluntary movement
882119|NCT00029302|Healthy Volunteer|healthy volunteer
882120|NCT00029302|HV|hv
882121|NCT00029302|Normal Control|normal control
882122|NCT00029276|Parkinson's|parkinson's
882123|NCT00029276|Depression|depression
882124|NCT00029276|Magnetic Stimulation|magnetic stimulation
882125|NCT00029250|complementary therapies|complementary therapies
882126|NCT00029250|garlic|garlic
882127|NCT00029250|Allium sativum|allium sativum
882128|NCT00029250|metabolic diseases|metabolic diseases
882129|NCT00029250|HAART|haart
882130|NCT00029250|Protease inhibitors|protease inhibitors
882131|NCT00029237|Behavioral intervention|behavioral intervention
882132|NCT00029237|Psychoneuroimmunology|psychoneuroimmunology
882133|NCT00029237|Complementary therapy|complementary therapy
882134|NCT00029237|Stress and coping|stress and coping
882135|NCT00029237|complementary therapies|complementary therapies
882136|NCT00029224|bone lesions|bone lesions
882137|NCT00029224|breast cancer|breast cancer
882138|NCT00029224|multiple myeloma|multiple myeloma
882139|NCT00029224|prostate cancer|prostate cancer
882140|NCT00029224|bone metastases|bone metastases
882141|NCT00029224|pain|pain
882142|NCT00029198|Massage Therapy|massage therapy
882143|NCT00029198|Preterm Infants|preterm infants
882144|NCT00029198|Weight Gain|weight gain
882145|NCT00029198|Vagal Tone|vagal tone
882146|NCT00029198|IGF-1|igf-1
882147|NCT00029198|Oxytocin|oxytocin
882148|NCT00029198|Brazelton|brazelton
882149|NCT00029185|Corneal Erosion|corneal erosion
882150|NCT00029185|Dextrans|dextrans
882151|NCT00029185|Administration, Topical|administration, topical
882152|NCT00029185|Ophthalmic Solutions|ophthalmic solutions
882153|NCT00029185|Thimerosal|thimerosal
882154|NCT00029172|stroke|stroke
882155|NCT00029172|depression|depression
882156|NCT00029159|Turner syndrome|turner syndrome
882157|NCT00029159|estrogen|estrogen
882158|NCT00029159|androgen|androgen
882159|NCT00029159|growth hormone|growth hormone
882160|NCT00029146|stroke|stroke
882161|NCT00029146|transient ischemic attack (TIA)|transient ischemic attack (tia)
882162|NCT00029146|carotid arteries|carotid arteries
882163|NCT00029146|cerebral infarction|cerebral infarction
882164|NCT00029133|aneurysm|aneurysm
882165|NCT00029133|hypothermia|hypothermia
882166|NCT00029133|subarachnoid intracranial hemorrhage|subarachnoid intracranial hemorrhage
882167|NCT00028431|Stage III melanoma|stage iii melanoma
882168|NCT00028431|Stage IV melanoma|stage iv melanoma
882169|NCT00028431|Interleukin-12|interleukin-12
882170|NCT00028431|Cancer Vaccines|cancer vaccines
882171|NCT00028431|Antineoplastic Agents, Combined|antineoplastic agents, combined
882172|NCT00028431|Incomplete Freund's adjuvant|incomplete freund's adjuvant
882173|NCT00028431|Monophenol Monooxygenase|monophenol monooxygenase
882174|NCT00028431|Mannitol|mannitol
882175|NCT00028431|Adjuvants, Immunologic|adjuvants, immunologic
882176|NCT00028431|Melan-A Protein|melan-a protein
882177|NCT00028431|Antigens, Neoplasm|antigens, neoplasm
882178|NCT00028431|Antibodies|antibodies
882179|NCT00028431|Melanocyte lineage-specific antigen gp100|melanocyte lineage-specific antigen gp100
882180|NCT00028431|CTLA-4|ctla-4
882181|NCT00028418|Acute Leukemia|acute leukemia
882182|NCT00028418|Chronic Lymphocytic Leukemia|chronic lymphocytic leukemia
882183|NCT00028418|Antineoplastic Agents|antineoplastic agents
882184|NCT00028418|Nucleosides|nucleosides
882185|NCT00028418|Dose-Response Relationship, Drug|dose-response relationship, drug
882186|NCT00028418|Cladribine|cladribine
882187|NCT00028418|Fludarabine|fludarabine
882188|NCT00028405|Photodynamic Therapy|photodynamic therapy
882189|NCT00028405|Bulky Tumor|bulky tumor
882190|NCT00028405|Refractory Tumor|refractory tumor
882191|NCT00028405|Head and Neck Cancer|head and neck cancer
882192|NCT00028405|Breast Cancer|breast cancer
882193|NCT00028405|Pelvic Tumors|pelvic tumors
882194|NCT00028405|Liver Metastasis|liver metastasis
882195|NCT00028405|Colorectal Cancer|colorectal cancer
882196|NCT00028405|Sarcoma|sarcoma
882197|NCT00028405|Anal Cancer|anal cancer
882198|NCT00028405|Oral Cancer|oral cancer
882199|NCT00028405|Recurrent|recurrent
882200|NCT00028405|Lymphadenopathy|lymphadenopathy
882201|NCT00028405|Ovarian Cancer|ovarian cancer
882202|NCT00028405|Cervical Cancer|cervical cancer
882203|NCT00029120|Alzheimer's Disease|alzheimer's disease
882204|NCT00029120|Spectroscopy|spectroscopy
882205|NCT00029120|Longitudinal|longitudinal
882206|NCT00029120|Perfusion|perfusion
882207|NCT00029120|Hippocampus|hippocampus
882208|NCT00029120|N-acetylaspartic Acid|n-acetylaspartic acid
882209|NCT00029120|Cerebral Blood Flow|cerebral blood flow
882210|NCT00029120|Aging|aging
882211|NCT00029120|Dementia|dementia
882212|NCT00029120|Alzheimer's|alzheimer's
882213|NCT00029120|Memory Disorder|memory disorder
882214|NCT00029120|Memory|memory
882215|NCT00029120|Healthy Volunteer|healthy volunteer
882216|NCT00029120|HV|hv
882217|NCT00029120|Normal Control|normal control
882218|NCT00029107|Hepatitis|hepatitis
882219|NCT00029107|Vasculitis|vasculitis
882220|NCT00029107|Rituximab|rituximab
882221|NCT00029107|Cryoglobulinemia|cryoglobulinemia
882222|NCT00029107|Hepatitis C|hepatitis c
882223|NCT00029107|HcV-cV|hcv-cv
882224|NCT00029107|Cryoglobulinemic Vasculitis|cryoglobulinemic vasculitis
882225|NCT00029068|Neurophysiology|neurophysiology
882226|NCT00029068|Tourette Syndrome|tourette syndrome
882227|NCT00029068|Anorexia|anorexia
882228|NCT00029068|SRIs|sris
882229|NCT00029068|Personality|personality
882230|NCT00029068|Obsessive-Compulsive Disorder (OCD)|obsessive-compulsive disorder (ocd)
882231|NCT00029068|Cortical Excitability|cortical excitability
882232|NCT00029068|Motor Cortex|motor cortex
882233|NCT00029068|Transcranial Magnetic Stimulation|transcranial magnetic stimulation
882234|NCT00029068|OCD Spectrum Disorders|ocd spectrum disorders
882235|NCT00029068|Obsessive Compulsive|obsessive compulsive
882236|NCT00029068|OCD|ocd
882237|NCT00029068|Healthy Volunteer|healthy volunteer
882238|NCT00029068|Normal Control|normal control
882239|NCT00029068|HV|hv
882240|NCT00029042|MRI|mri
882241|NCT00029042|Inflammation|inflammation
882242|NCT00029042|Joint Disability|joint disability
882243|NCT00029042|Imaging|imaging
882244|NCT00029042|Biologic Therapy|biologic therapy
882245|NCT00029042|Rheumatoid Arthritis|rheumatoid arthritis
882246|NCT00029042|Juvenile Rheumatoid Arthritis|juvenile rheumatoid arthritis
882247|NCT00029042|JRA|jra
882248|NCT00029042|Children|children
882249|NCT00029042|Joints|joints
882250|NCT00029042|Joint Inflammation|joint inflammation
882251|NCT00028379|Plasticity|plasticity
882252|NCT00028379|Motor Cortex|motor cortex
882253|NCT00028379|Stroke|stroke
882254|NCT00028379|Somatosensory|somatosensory
882255|NCT00028379|Hemiparesis|hemiparesis
882256|NCT00028366|HIV-1|hiv-1
882257|NCT00028366|Drug Therapy, Combination|drug therapy, combination
882258|NCT00028366|HIV Protease Inhibitors|hiv protease inhibitors
882259|NCT00028366|Ritonavir|ritonavir
882260|NCT00028366|RNA, Viral|rna, viral
882261|NCT00028366|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors
882262|NCT00028366|Viral Load|viral load
882263|NCT00028366|ABT 378|abt 378
882264|NCT00028366|tenofovir disoproxil|tenofovir disoproxil
882265|NCT00028366|VX-175|vx-175
882266|NCT00028366|Treatment Experienced|treatment experienced
882267|NCT00028353|PIN|pin
882268|NCT00028353|High Grade Prostate Intraepithelial Neoplasia (PIN)|high grade prostate intraepithelial neoplasia (pin)
882269|NCT00028340|Breast Cancer|breast cancer
882270|NCT00028327|AIDS-Related Opportunistic Infections|aids-related opportunistic infections
882271|NCT00028327|Zidovudine|zidovudine
882272|NCT00028327|HIV Protease Inhibitors|hiv protease inhibitors
882273|NCT00028327|CD4 Lymphocyte Count|cd4 lymphocyte count
882274|NCT00028327|Lamivudine|lamivudine
882275|NCT00028327|Pneumonia|pneumonia
882276|NCT00028327|Nelfinavir|nelfinavir
882277|NCT00028327|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors
882278|NCT00028327|Antiretroviral Therapy, Highly Active|antiretroviral therapy, highly active
882279|NCT00028327|Efavirenz|efavirenz
882280|NCT00028327|Intensive Care Units|intensive care units
882281|NCT00028327|Sepsis|sepsis
882282|NCT00028314|HIV-1|hiv-1
882283|NCT00028314|Abacavir|abacavir
882284|NCT00028314|Nevirapine|nevirapine
882285|NCT00028314|Ritonavir|ritonavir
882286|NCT00028314|RNA, Viral|rna, viral
882287|NCT00028314|HIV Protease Inhibitors|hiv protease inhibitors
882288|NCT00028314|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors
882289|NCT00028314|Anti-HIV Agents|anti-hiv agents
882290|NCT00028314|Viral Load|viral load
882291|NCT00028314|HIV Wasting Syndrome|hiv wasting syndrome
882292|NCT00028314|ABT 378|abt 378
882293|NCT00028314|Treatment Experienced|treatment experienced
882294|NCT00028301|HIV Protease Inhibitors|hiv protease inhibitors
882295|NCT00028301|RNA, Viral|rna, viral
882296|NCT00028301|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors
882297|NCT00028301|Anti-HIV Agents|anti-hiv agents
882298|NCT00028301|Viral Load|viral load
882299|NCT00028301|Lipids|lipids
882300|NCT00028301|ABT 378|abt 378
882301|NCT00028301|Antiretroviral Therapy, Highly Active|antiretroviral therapy, highly active
882302|NCT00028301|Lipoproteins, LDL Cholesterol|lipoproteins, ldl cholesterol
882303|NCT00028288|Asthma|asthma
882304|NCT00028288|Daclizumab|daclizumab
882305|NCT00028288|anti-Tac monoclonal antibody|anti-tac monoclonal antibody
882306|NCT00028288|anti-IL-2|anti-il-2
882307|NCT00028288|Zenapax|zenapax
882308|NCT00028275|Hepatitis C Virus|hepatitis c virus
882309|NCT00028275|Cirrhosis|cirrhosis
882310|NCT00028275|Antiviral Agents|antiviral agents
882311|NCT00028275|Viral Resistance|viral resistance
882312|NCT00028275|Alpha Interferon|alpha interferon
882313|NCT00028275|Hepatitis C|hepatitis c
882314|NCT00028275|Hepatitis|hepatitis
882315|NCT00028262|Palmitoyl-Protein Thioesterase|palmitoyl-protein thioesterase
882316|NCT00028262|Lysosomes|lysosomes
882317|NCT00028262|Batten Disease|batten disease
882318|NCT00028262|Encephalopathy|encephalopathy
882319|NCT00028262|Progressive Neurodegeneration|progressive neurodegeneration
882320|NCT00028262|CLN 1|cln 1
882450|NCT00027456|Diabetes Mellitus|diabetes mellitus
882321|NCT00028262|Infantile Neuronal Ceroid Lipofuscinosis|infantile neuronal ceroid lipofuscinosis
882322|NCT00028262|Cystagon|cystagon
882323|NCT00028249|Patient Satisfaction|patient satisfaction
882324|NCT00028249|Self Efficacy|self efficacy
882325|NCT00028249|Social Support|social support
882326|NCT00028249|Symptom Management|symptom management
882327|NCT00028249|Advanced Malignancies|advanced malignancies
882328|NCT00028249|Pain Intervention|pain intervention
882329|NCT00028236|Peripheral Blood Stem Cells|peripheral blood stem cells
882330|NCT00028236|Common Gamma Chain (GC)|common gamma chain (gc)
882331|NCT00028236|Immune Reconstitution|immune reconstitution
882332|NCT00028236|T Lymphocytes|t lymphocytes
882333|NCT00028236|B Lymphocytes|b lymphocytes
882334|NCT00028236|X-Linked Severe Combined Immune Deficiency (XSCID)|x-linked severe combined immune deficiency (xscid)
882335|NCT00028236|Gene Therapy|gene therapy
882336|NCT00028236|NK Cell|nk cell
882337|NCT00028236|Bone Marrow Transplantation|bone marrow transplantation
882338|NCT00028236|Engraftment|engraftment
882339|NCT00028236|XSCID|xscid
882340|NCT00028236|Immune Deficiency|immune deficiency
882341|NCT00028236|Immune System|immune system
882342|NCT00028210|Amputee|amputee
882343|NCT00028210|Plasticity|plasticity
882344|NCT00028210|Somatosensory|somatosensory
882345|NCT00028210|Upper Limb Amputation|upper limb amputation
882346|NCT00028210|Tactile Performance|tactile performance
882347|NCT00028210|Cortical Reorganization|cortical reorganization
882348|NCT00028210|Healthy Volunteer|healthy volunteer
882349|NCT00028210|HV|hv
882350|NCT00028210|Normal Control|normal control
882351|NCT00028197|Voluntary Movement|voluntary movement
882352|NCT00028197|Functional MRI|functional mri
882353|NCT00028197|Sensorimotor Integration|sensorimotor integration
882354|NCT00028197|Superior Parietal Lobe|superior parietal lobe
882355|NCT00028197|Supplementary Motor Area|supplementary motor area
882356|NCT00028197|Normal Control|normal control
882357|NCT00028197|HV|hv
882358|NCT00028197|Healthy Volunteer|healthy volunteer
882359|NCT00028184|Chronic Stroke|chronic stroke
882360|NCT00028184|Ipsilateral Motor Cortex|ipsilateral motor cortex
882361|NCT00028184|Motor Control|motor control
882362|NCT00028184|Motor Recovery|motor recovery
882363|NCT00028184|Stroke|stroke
882364|NCT00028184|Healthy Volunteer|healthy volunteer
882366|NCT00028184|Healthy Control|healthy control
882367|NCT00028158|Antineoplastic agents|antineoplastic agents
882368|NCT00028158|Herpes virus|herpes virus
882369|NCT00028158|Brain tumor|brain tumor
882370|NCT00028158|Oncolytic virs|oncolytic virs
882371|NCT00028145|Women's Health|women's health
882372|NCT00028145|Disease Transmission, Vertical|disease transmission, vertical
882373|NCT00028145|Preventive Medicine|preventive medicine
882374|NCT00028145|Treatment Experienced|treatment experienced
882375|NCT00028132|Risk Factors|risk factors
882376|NCT00028132|Mucous Membrane|mucous membrane
882377|NCT00028132|Anti-Infective Agents|anti-infective agents
882378|NCT00028132|Cervix Uteri|cervix uteri
882379|NCT00028132|Vagina|vagina
882380|NCT00028132|Anti-HIV Agents|anti-hiv agents
882381|NCT00028132|Pharmacokinetics|pharmacokinetics
882382|NCT00028132|Vulva|vulva
882383|NCT00028132|9-(2-phosphonylmethoxypropyl)adenine|9-(2-phosphonylmethoxypropyl)adenine
882384|NCT00028132|HIV Seronegativity|hiv seronegativity
882385|NCT00028119|Clinical Trials|clinical trials
882386|NCT00028119|Sexual Partners|sexual partners
882387|NCT00028119|Risk Factors|risk factors
882388|NCT00028119|Incidence|incidence
882389|NCT00028119|HIV Seronegativity|hiv seronegativity
882390|NCT00028119|India|india
882391|NCT00028119|Patient Compliance|patient compliance
882392|NCT00028119|Preventive Health Services|preventive health services
882393|NCT00028106|Cancer|cancer
882394|NCT00028106|Metastasis|metastasis
882395|NCT00028106|Fluorodopamine|fluorodopamine
882396|NCT00028106|PET|pet
882397|NCT00028106|Methylprednisolone|methylprednisolone
882398|NCT00028106|Catecholamines|catecholamines
882399|NCT00028106|Metanephrines|metanephrines
882400|NCT00028106|Alpha-Methyl-Para-Tyrosine|alpha-methyl-para-tyrosine
882401|NCT00028106|Retinoic Acid|retinoic acid
882402|NCT00028106|Carbidopa|carbidopa
882403|NCT00028093|Chronic Hepatitis|chronic hepatitis
882404|NCT00028093|Cirrhosis|cirrhosis
882405|NCT00028093|Hepatitis C Virus|hepatitis c virus
882406|NCT00028093|Hemolysis|hemolysis
882407|NCT00028093|Ribavirin|ribavirin
882408|NCT00028093|Alpha Interferon|alpha interferon
882409|NCT00028093|Peginterferon|peginterferon
882410|NCT00028093|Antiviral Agents|antiviral agents
882411|NCT00028093|Viral Hepatitis|viral hepatitis
882412|NCT00028093|Hemolytic Anemia|hemolytic anemia
882413|NCT00028093|Renal Failure|renal failure
882414|NCT00028093|Renal Dialysis|renal dialysis
882415|NCT00028093|Hepatitis|hepatitis
882416|NCT00028093|Hepatitis C|hepatitis c
882417|NCT00028080|Borrelia Burgdorferi|borrelia burgdorferi
882418|NCT00028080|Lyme Disease|lyme disease
882422|NCT00028067|Drug Therapy, Combination|drug therapy, combination
882423|NCT00028067|HIV Protease Inhibitors|hiv protease inhibitors
882424|NCT00028067|RNA, Viral|rna, viral
882425|NCT00028067|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors
882426|NCT00028067|Viral Load|viral load
882427|NCT00028067|BMS 232632|bms 232632
882428|NCT00027482|T Cell|t cell
882429|NCT00027482|B Cell|b cell
882430|NCT00027482|Flow Cytometry|flow cytometry
882431|NCT00027482|Cell-Mediated Immunity|cell-mediated immunity
882432|NCT00027482|Thymus|thymus
882433|NCT00027482|HIV|hiv
882434|NCT00027482|Immunity|immunity
882435|NCT00027482|Lymphocytes|lymphocytes
882436|NCT00027482|Monocytes|monocytes
882437|NCT00027482|Healthy Volunteer|healthy volunteer
882438|NCT00027482|HV|hv
882439|NCT00027482|Normal Control|normal control
882440|NCT00027469|Atheroembolism|atheroembolism
882441|NCT00027469|Atherosclerosis|atherosclerosis
882442|NCT00027469|MRI|mri
882443|NCT00027469|Renal Artery Stenosis|renal artery stenosis
882444|NCT00027469|Renovascular Hypertension|renovascular hypertension
882445|NCT00027469|ARAS|aras
882446|NCT00027469|Renovascular Disease|renovascular disease
882447|NCT00027469|Renal Artery Stenting|renal artery stenting
882448|NCT00027469|PTRAS|ptras
882449|NCT00027456|Insulin Resistance|insulin resistance
882451|NCT00027456|Adipocytes|adipocytes
882452|NCT00027456|Rabson Mendenhall Syndrome|rabson mendenhall syndrome
882453|NCT00027456|Leprechaunism|leprechaunism
882454|NCT00027456|Leptin|leptin
882455|NCT00027443|Giant Cell Myocarditis|giant cell myocarditis
882456|NCT00027417|Congenital heart defects|congenital heart defects
882457|NCT00027417|Hypoplastic left heart syndrome|hypoplastic left heart syndrome
882458|NCT00027417|Complete atrioventricular canal defect|complete atrioventricular canal defect
882459|NCT00027417|Triostat|triostat
882460|NCT00027417|Cardiac surgery|cardiac surgery
882461|NCT00027404|Adult, Autism|adult, autism
882462|NCT00027391|Muscle Weakness, Muscular Dystrophy|muscle weakness, muscular dystrophy
882463|NCT00027378|fluoxetine,|fluoxetine,
882464|NCT00027378|adolescents,|adolescents,
882465|NCT00027378|alcohol dependence,|alcohol dependence,
882466|NCT00027378|major depression|major depression
882467|NCT00027378|Alcoholism|alcoholism
882468|NCT00027365|HIV Seronegativity|hiv seronegativity
882469|NCT00027365|HIV Preventive Vaccine|hiv preventive vaccine
882470|NCT00027365|Injections, Intramuscular|injections, intramuscular
882471|NCT00027365|HIV Antibodies|hiv antibodies
882472|NCT00027365|HIV-1|hiv-1
882473|NCT00027365|HIV Envelope Protein gp120|hiv envelope protein gp120
882474|NCT00027365|Gene Products, tat|gene products, tat
882475|NCT00027365|AIDS Vaccines|aids vaccines
882476|NCT00027365|Neutralization Tests|neutralization tests
882477|NCT00027365|Vaccines, Combined|vaccines, combined
882478|NCT00027365|AIDS Seronegativity|aids seronegativity
882479|NCT00027365|Gene Products, nef|gene products, nef
882480|NCT00027352|Physician's Practice Patterns|physician's practice patterns
882481|NCT00027352|Anti-HIV Agents|anti-hiv agents
882482|NCT00027339|HIV-1|hiv-1
882483|NCT00027339|HIV Protease Inhibitors|hiv protease inhibitors
882484|NCT00027339|RNA, Viral|rna, viral
882485|NCT00027339|Phenotype|phenotype
882486|NCT00027339|Viral Load|viral load
882487|NCT00027339|Pharmacokinetics|pharmacokinetics
882488|NCT00027339|Treatment Experienced|treatment experienced
882489|NCT00027326|Blood|blood
882490|NCT00027326|Samples|samples
882491|NCT00027326|Radiation|radiation
882492|NCT00027326|Urine|urine
882493|NCT00027326|Cancer|cancer
882494|NCT00027326|Radiation Therapy|radiation therapy
882495|NCT00027300|Relapsing Remitting Multiple Sclerosis|relapsing remitting multiple sclerosis
882496|NCT00027287|Type I Diabetes|type i diabetes
882497|NCT00027287|Type 2 Diabetes|type 2 diabetes
882498|NCT00027287|Diode Laser Photocoagulation|diode laser photocoagulation
882499|NCT00027287|Vitamin E|vitamin e
882500|NCT00027287|Elevated Low-Density Lipoprotein (LDL-C) Cholesterol|elevated low-density lipoprotein (ldl-c) cholesterol
882501|NCT00027287|Diabetic Retinopathy|diabetic retinopathy
882502|NCT00027287|Macular Edema|macular edema
882503|NCT00027287|Type II Diabetes|type ii diabetes
882504|NCT00027274|Franconi Anemia|franconi anemia
882505|NCT00027274|Diamond Blackfan Anemia|diamond blackfan anemia
882506|NCT00027274|Dyskeratosis Congenita|dyskeratosis congenita
882507|NCT00027274|Shwachman-Diamond Syndrome|shwachman-diamond syndrome
882508|NCT00027274|Hereditary|hereditary
882509|NCT00027274|Fanconi's Anemia|fanconi's anemia
882510|NCT00027274|Bone Marrow|bone marrow
882511|NCT00027274|Inherited Bone Marrow Failure Syndromes|inherited bone marrow failure syndromes
882512|NCT00027274|IBMFS|ibmfs
882513|NCT00027274|Familial Cancer|familial cancer
882514|NCT00027261|Vaccines, Synthetic|vaccines, synthetic
882515|NCT00027261|HIV-1|hiv-1
882516|NCT00027261|AIDS Vaccines|aids vaccines
882517|NCT00027261|CD8-Positive T-Lymphocytes|cd8-positive t-lymphocytes
882518|NCT00027261|HIV Seronegativity|hiv seronegativity
882519|NCT00027261|Avipoxvirus|avipoxvirus
882520|NCT00027261|Dose-Response Relationship, Immunologic|dose-response relationship, immunologic
882521|NCT00027261|HIV Preventive Vaccine|hiv preventive vaccine
882522|NCT00027248|central venous catheter|central venous catheter
882523|NCT00027248|bloodstream infection|bloodstream infection
882524|NCT00027248|CVC|cvc
882525|NCT00027248|catheter colonization|catheter colonization
882526|NCT00027248|local catheter site infection|local catheter site infection
882527|NCT00027209|seizures|seizures
882528|NCT00027209|epilepsy|epilepsy
882529|NCT00027209|menopause|menopause
882530|NCT00027196|Genetics|genetics
882531|NCT00027196|Cardiac Diseases|cardiac diseases
882532|NCT00027196|Cardiac Hypertrophy|cardiac hypertrophy
882533|NCT00027196|Sudden Death|sudden death
882534|NCT00027196|Arrhythmias|arrhythmias
882535|NCT00027183|Cystic Fibrosis|cystic fibrosis
882536|NCT00027183|Effector Proteins|effector proteins
882537|NCT00027183|Cytotoxin|cytotoxin
882538|NCT00027183|Lung Injury|lung injury
882539|NCT00027183|Genetic Screen|genetic screen
882540|NCT00027170|Myocardial Infarction|myocardial infarction
882541|NCT00027170|Myocardial Viability|myocardial viability
882542|NCT00027170|Myocardial Perfusion|myocardial perfusion
882543|NCT00027170|Myocardial Ischemia|myocardial ischemia
882544|NCT00027170|Atherosclerosis|atherosclerosis
882545|NCT00027157|Coronary Spasm|coronary spasm
882546|NCT00027157|Endothelial-Derived-Relaxation Factor|endothelial-derived-relaxation factor
882547|NCT00027157|Nitric Oxide Synthase|nitric oxide synthase
882548|NCT00027157|Susceptibility Genes|susceptibility genes
882549|NCT00027157|Tetrahydrobiopterin|tetrahydrobiopterin
882550|NCT00027144|Leukemia|leukemia
882551|NCT00027144|Vaccine|vaccine
882552|NCT00027131|vaccine|vaccine
882553|NCT00027131|immunotherapy|immunotherapy
882554|NCT00027118|Shoulder|shoulder
882555|NCT00027118|Breast Cancer|breast cancer
882556|NCT00027118|Physical Therapy|physical therapy
882557|NCT00027118|Lymphedema|lymphedema
882558|NCT00027118|Quality of Life|quality of life
882559|NCT00027118|Breast Cancer Surgery|breast cancer surgery
882560|NCT00027118|Healthy Volunteer|healthy volunteer
882561|NCT00027118|HV|hv
882562|NCT00027118|Normal Control|normal control
882563|NCT00027105|Fatigue|fatigue
882564|NCT00027105|Shoulder function|shoulder function
882565|NCT00027105|Lymphedema|lymphedema
882566|NCT00027105|Breast Cancer|breast cancer
882567|NCT00027105|Breast Cancer Surgery|breast cancer surgery
882568|NCT00027105|Quality of Life|quality of life
882569|NCT00027092|Infusions, Intravenous|infusions, intravenous
882570|NCT00027092|Testosterone|testosterone
882571|NCT00027092|Insulin Resistance|insulin resistance
882572|NCT00027092|Hormone Replacement Therapy|hormone replacement therapy
882573|NCT00027092|Glucose Tolerance Test|glucose tolerance test
882574|NCT00027066|stroke|stroke
882575|NCT00027066|aspirin|aspirin
882576|NCT00027066|warfarin|warfarin
882577|NCT00027053|alcoholism|alcoholism
882578|NCT00027053|alcohol dependence|alcohol dependence
882579|NCT00027053|trazadone|trazadone
882580|NCT00027053|sleep|sleep
882581|NCT00027040|AIDS Dementia Complex|aids dementia complex
882582|NCT00027040|Selegiline|selegiline
882583|NCT00027040|Oxidative Stress|oxidative stress
882584|NCT00027040|Cognition|cognition
882585|NCT00027040|Neuroprotective Agents|neuroprotective agents
882586|NCT00027040|Brain Injuries|brain injuries
882587|NCT00027040|Magnetic Resonance Spectroscopy|magnetic resonance spectroscopy
882588|NCT00027040|Protons|protons
882589|NCT00027014|opioid|opioid
882590|NCT00027014|St. John's wort|st. john's wort
882591|NCT00027014|analgesia|analgesia
882592|NCT00027014|metabolism|metabolism
882593|NCT00027014|transporter|transporter
882594|NCT00027001|Qigong, exercise, circulatory assist devices|qigong, exercise, circulatory assist devices
882595|NCT00026988|Huntington's disease|huntington's disease
882596|NCT00026988|creatine|creatine
882597|NCT00026988|energy depletion|energy depletion
882598|NCT00026975|Laryngeal Cancer|laryngeal cancer
882599|NCT00026975|Laryngectomy|laryngectomy
882600|NCT00026975|Tissue Oxygenation|tissue oxygenation
882601|NCT00026975|Irradiated Tissue|irradiated tissue
882602|NCT00026975|Hyperbaric Oxygen|hyperbaric oxygen
882603|NCT00026975|Angiogenesis|angiogenesis
882604|NCT00026975|EF5|ef5
882605|NCT00026962|Breast|breast
882606|NCT00026962|Hormones|hormones
882607|NCT00026962|Prevention|prevention
882608|NCT00026962|Saliva|saliva
882609|NCT00026962|Serum|serum
882610|NCT00026949|Etoposide|etoposide
882611|NCT00026949|Breast Cancer|breast cancer
882612|NCT00026949|Pharmacokinetics|pharmacokinetics
882613|NCT00026936|External Beam Radiotherapy|external beam radiotherapy
882614|NCT00026936|TCP|tcp
882615|NCT00026936|DVH|dvh
882616|NCT00026936|NTCP|ntcp
882617|NCT00026936|3-D Programming|3-d programming
882618|NCT00026923|Laparoscopy|laparoscopy
882619|NCT00026923|Telemedicine|telemedicine
882620|NCT00026923|Surgery|surgery
882621|NCT00026923|Endoscopy|endoscopy
882622|NCT00026910|Cell-Cycle|cell-cycle
882623|NCT00026910|Apoptosis|apoptosis
882624|NCT00026910|Molecular Prognosis|molecular prognosis
882625|NCT00026897|Adoptive Immunotherapy|adoptive immunotherapy
882626|NCT00026897|Cellular Therapy|cellular therapy
882627|NCT00026897|Lymphocyte Migration|lymphocyte migration
882628|NCT00026897|Tumor Imaging|tumor imaging
882630|NCT00026884|Collection of Tissue|collection of tissue
882631|NCT00026884|Malignant Disease|malignant disease
882632|NCT00026884|Molecular Basis|molecular basis
882633|NCT00026884|Genome Sequencing|genome sequencing
882634|NCT00026871|Non-Therapeutic|non-therapeutic
882635|NCT00026871|Radiation Therapy|radiation therapy
882636|NCT00026871|Dosimetry|dosimetry
882637|NCT00026871|Dose-Rate|dose-rate
882638|NCT00026871|Fiberoptic|fiberoptic
882639|NCT00026858|Bone Marrow Transplantation|bone marrow transplantation
882640|NCT00026858|Leukemia|leukemia
882641|NCT00026858|Breast Cancer|breast cancer
882642|NCT00026858|Multiple Myeloma|multiple myeloma
882643|NCT00026858|Total Body Irradiation|total body irradiation
882644|NCT00026832|PET|pet
882645|NCT00026832|Major Depression|major depression
882646|NCT00026832|MRI|mri
882647|NCT00026832|Cerebral Blood Flow|cerebral blood flow
882648|NCT00026832|Neuroendocrine|neuroendocrine
882649|NCT00026832|Bipolar Disorder|bipolar disorder
882650|NCT00026832|Serotonin1A|serotonin1a
882651|NCT00026832|Mood Disorder|mood disorder
882652|NCT00026832|Major Depressive Disorder|major depressive disorder
882653|NCT00026832|MDD|mdd
882654|NCT00026832|Depression|depression
882655|NCT00026832|Healthy Volunteer|healthy volunteer
882656|NCT00026832|HV|hv
882657|NCT00026832|Normal Control|normal control
882658|NCT00026819|NSAID|nsaid
882659|NCT00026819|Acute Pain Model|acute pain model
882660|NCT00026819|Hyperalgesia|hyperalgesia
882661|NCT00026819|Central Sensitization|central sensitization
882662|NCT00026819|Wisdom Teeth|wisdom teeth
882663|NCT00026819|Wisdom Teeth Extraction|wisdom teeth extraction
882664|NCT00026819|Third Molar|third molar
882665|NCT00026806|HIV Infection|hiv infection
882666|NCT00026806|Mental Health|mental health
882667|NCT00026806|Risk Behaviors|risk behaviors
882668|NCT00026806|Post-Traumatic Stress Disorder|post-traumatic stress disorder
882669|NCT00026806|Youth|youth
882670|NCT00026806|HIV|hiv
882671|NCT00026806|Long Term Survivor|long term survivor
882672|NCT00026793|Kaposi Sarcoma|kaposi sarcoma
882673|NCT00026793|Doppler|doppler
882674|NCT00026793|Infrared|infrared
882675|NCT00026793|HIV|hiv
882676|NCT00026793|Imaging|imaging
882677|NCT00026793|Kaposi's Sarcoma|kaposi's sarcoma
882678|NCT00026793|Laser Imaging|laser imaging
882679|NCT00026793|Infrared Imaging|infrared imaging
882680|NCT00026780|CT Scan|ct scan
882681|NCT00026780|MRI Scan|mri scan
882682|NCT00026780|Childhood Cancer|childhood cancer
882683|NCT00026780|Eligibility Screening|eligibility screening
882684|NCT00026780|Tissue Procurement|tissue procurement
882685|NCT00026780|Pediatric|pediatric
882686|NCT00026780|Children|children
882687|NCT00026780|Screening|screening
882688|NCT00026767|Risk Factors|risk factors
882689|NCT00026767|Epidemiology|epidemiology
882690|NCT00026767|BMT/SCT|bmt/sct
882691|NCT00026767|Fungal Infection|fungal infection
882692|NCT00026767|Bone Marrow Stem Cell Transplant|bone marrow stem cell transplant
882693|NCT00026767|Organ Transplant|organ transplant
882694|NCT00026754|Screening|screening
882695|NCT00026754|Cancer|cancer
882696|NCT00026754|HIV Infection|hiv infection
882697|NCT00026754|Scans|scans
882698|NCT00026754|Laboratory Tests|laboratory tests
882699|NCT00026754|HIV|hiv
882700|NCT00026754|Skin Disorders|skin disorders
882701|NCT00026741|Cytokine|cytokine
882702|NCT00026741|Inflammation|inflammation
882703|NCT00026741|Lymphocyte|lymphocyte
882704|NCT00026741|T Cell|t cell
882705|NCT00026741|Migration|migration
882706|NCT00026741|Healthy Volunteer|healthy volunteer
882707|NCT00026741|Skin Biopsy|skin biopsy
882708|NCT00026728|Human Herpesvirus B|human herpesvirus b
882709|NCT00026728|NHANES|nhanes
882710|NCT00026728|Epidemiology|epidemiology
882711|NCT00026728|Population-Based Study|population-based study
882712|NCT00026728|Kaposi's Sarcoma Herpes Virus|kaposi's sarcoma herpes virus
882713|NCT00026715|Renal Function|renal function
882714|NCT00026715|Iothalamate|iothalamate
882715|NCT00026702|Acute Kidney Injury|acute kidney injury
882716|NCT00026689|Evaluation|evaluation
882717|NCT00026689|Screening|screening
882718|NCT00026689|Cancer|cancer
882719|NCT00026689|Radiation|radiation
882720|NCT00026689|Eligibility|eligibility
882721|NCT00026676|Surrogate Markers|surrogate markers
882722|NCT00026676|Genotypic Resistance|genotypic resistance
882723|NCT00026676|Phenotypic Resistance|phenotypic resistance
882724|NCT00026676|Selenium|selenium
882725|NCT00026663|Assays|assays
882726|NCT00026663|Resistance|resistance
882727|NCT00026663|Biopsy Samples|biopsy samples
882728|NCT00026663|Specimen Acquisition|specimen acquisition
882729|NCT00026663|Cancer Cells|cancer cells
882730|NCT00026650|Late Effects|late effects
882731|NCT00026650|Radiation Therapy|radiation therapy
882732|NCT00026650|Cancer|cancer
882733|NCT00026637|depression|depression
882734|NCT00026637|epilepsy|epilepsy
882735|NCT00026637|seizures|seizures
882736|NCT00026624|Virus Replication|virus replication
882737|NCT00026624|Injections, Subcutaneous|injections, subcutaneous
882739|NCT00026624|AIDS Vaccines|aids vaccines
882740|NCT00026624|Dendritic Cells|dendritic cells
882741|NCT00026624|Adoptive Transfer|adoptive transfer
882742|NCT00026624|Keyhole-Limpet Hemocyanin|keyhole-limpet hemocyanin
882743|NCT00026624|HIV Therapeutic Vaccine|hiv therapeutic vaccine
882744|NCT00026611|Vaccine prophylaxis|vaccine prophylaxis
882745|NCT00026598|Basal Ganglia|basal ganglia
882746|NCT00026598|Cerebral Cortex|cerebral cortex
882747|NCT00026598|Functional Neuroanatomy|functional neuroanatomy
882748|NCT00026598|Bradykinesia|bradykinesia
882749|NCT00026598|Bradyphrenia|bradyphrenia
882750|NCT00026598|Parkinson's Disease|parkinson's disease
882751|NCT00026598|Parkinson Disease|parkinson disease
882752|NCT00026598|PD|pd
882753|NCT00026598|Healthy Volunteer|healthy volunteer
882754|NCT00026598|HV|hv
882755|NCT00026598|Normal Control|normal control
882756|NCT00026585|Bipolar Disorder|bipolar disorder
882757|NCT00026585|Antimanic|antimanic
882758|NCT00026585|Placebo Controlled|placebo controlled
882759|NCT00026585|Randomized|randomized
882760|NCT00026585|Cytochrome P450|cytochrome p450
882761|NCT00026585|Mania|mania
882762|NCT00026585|PKC Inhibitor|pkc inhibitor
882763|NCT00026585|Tamoxifen|tamoxifen
882764|NCT00026585|Bipolar|bipolar
882765|NCT00026585|Manic|manic
882766|NCT00026585|BPD|bpd
882767|NCT00026559|Classical Conditioning|classical conditioning
882768|NCT00026559|Fear Conditioning|fear conditioning
882769|NCT00026559|Stress|stress
882770|NCT00026559|Anxiety|anxiety
882771|NCT00026559|Learning|learning
882772|NCT00026559|Normal Volunteers|normal volunteers
882773|NCT00026559|Adults|adults
882774|NCT00026559|Healthy Volunteer|healthy volunteer
882775|NCT00026559|Normal Control|normal control
882776|NCT00026546|Stop Task|stop task
882777|NCT00026546|Functional (BOLD) MRI|functional (bold) mri
882778|NCT00026546|Developmental|developmental
882779|NCT00026546|Inhibitory Control|inhibitory control
882780|NCT00026546|Attention Deficit Hyperactivity Disorder|attention deficit hyperactivity disorder
882781|NCT00026546|ADHD|adhd
882782|NCT00026546|Impulsivity|impulsivity
882783|NCT00026546|Healthy Volunteer|healthy volunteer
882784|NCT00026546|Normal Volunteer|normal volunteer
882786|NCT00026065|Hypertension|hypertension
882787|NCT00026065|BIofeedback|biofeedback
882788|NCT00026065|Non-pharmacological treatment|non-pharmacological treatment
882789|NCT00026065|Prediction|prediction
882790|NCT00026052|Riluzole|riluzole
882791|NCT00026052|Neuroprotective|neuroprotective
882792|NCT00026052|Open-Label Study|open-label study
882793|NCT00026052|Glutamate Dysfunction|glutamate dysfunction
882794|NCT00026052|Unipolar Depression|unipolar depression
882795|NCT00026052|Antidepressant|antidepressant
882796|NCT00026052|Depression|depression
882797|NCT00026052|Major Depression|major depression
882798|NCT00026039|stroke|stroke
882799|NCT00026039|estrogen|estrogen
882800|NCT00026026|Human tooth agenesis|human tooth agenesis
882801|NCT00026013|contraception|contraception
882802|NCT00026013|hormonal contraception|hormonal contraception
882803|NCT00026013|herbal remedies|herbal remedies
882804|NCT00026013|hypericum perforatum|hypericum perforatum
882805|NCT00026013|contraceptive effectiveness|contraceptive effectiveness
882806|NCT00026000|Voluntary Movement|voluntary movement
882807|NCT00026000|Basal Ganglia|basal ganglia
882808|NCT00026000|Frontal Lobe|frontal lobe
882809|NCT00026000|Motor Cortex|motor cortex
882810|NCT00026000|Motor Tic Disorder|motor tic disorder
882811|NCT00026000|Tourette's Syndrome|tourette's syndrome
882812|NCT00026000|Vocal Tic Disorder|vocal tic disorder
882813|NCT00026000|Tic|tic
882814|NCT00026000|Healthy Volunteer|healthy volunteer
882815|NCT00026000|HV|hv
882816|NCT00026000|Normal Control|normal control
882817|NCT00025987|Brain|brain
882818|NCT00025987|Temperature|temperature
882819|NCT00025987|Lower|lower
882820|NCT00025987|Tympanic|tympanic
882821|NCT00025987|Rectal|rectal
882822|NCT00025987|Cooling of the Head and Neck|cooling of the head and neck
882823|NCT00025987|Control|control
882824|NCT00025987|Epilepsy|epilepsy
882825|NCT00025987|Healthy Volunteer|healthy volunteer
882826|NCT00025987|HV|hv
882827|NCT00025974|PET|pet
882828|NCT00025974|5-HT1A Receptors|5-ht1a receptors
882829|NCT00025974|Benzodiazepine Receptors|benzodiazepine receptors
882830|NCT00025974|Panic Disorder|panic disorder
882831|NCT00025974|PTSD|ptsd
882832|NCT00025974|Serotonin Type 1A Receptors|serotonin type 1a receptors
882833|NCT00025974|Post-Traumatic Stress Disorder|post-traumatic stress disorder
882834|NCT00025974|Major Depression|major depression
882835|NCT00025974|Anxiety|anxiety
882836|NCT00025974|Depression|depression
882837|NCT00025974|Healthy Volunteer|healthy volunteer
882838|NCT00025974|HV|hv
882839|NCT00025974|Normal Control|normal control
882840|NCT00025935|Neuroimaging|neuroimaging
882841|NCT00025935|Mood Disorder|mood disorder
882842|NCT00025935|Conduct Disorder|conduct disorder
882843|NCT00025935|Children and Adolescents|children and adolescents
882844|NCT00025935|Affective Neuroscience|affective neuroscience
882845|NCT00025935|Behavioral Dysregulation|behavioral dysregulation
882849|NCT00025935|Healthy Volunteer|healthy volunteer
882850|NCT00025935|HV|hv
882851|NCT00025935|Normal Control|normal control
882852|NCT00025922|Immunization|immunization
882853|NCT00025922|Titers|titers
882854|NCT00025922|Immune Activation|immune activation
882855|NCT00025922|Antibody|antibody
882856|NCT00025922|CD4 Cell Count|cd4 cell count
882857|NCT00025922|HIV|hiv
882858|NCT00025909|Therapy|therapy
882859|NCT00025909|Antiretrovirals|antiretrovirals
882860|NCT00025909|Interruption|interruption
882861|NCT00025909|CD4+ T Cell|cd4+ t cell
882862|NCT00025909|Plasma Viremia|plasma viremia
882863|NCT00025909|HIV|hiv
882864|NCT00025909|Treatment Experienced|treatment experienced
882865|NCT00025909|Treatment Interuption|treatment interuption
882866|NCT00025883|Lipoatrophic Diabetes|lipoatrophic diabetes
882867|NCT00025883|Diabetes Mellitus|diabetes mellitus
882868|NCT00025883|Hypertriglyceridemia|hypertriglyceridemia
882869|NCT00025883|NASH|nash
882870|NCT00025883|Lipodystrophy|lipodystrophy
882871|NCT00025883|Leptin|leptin
882872|NCT00025883|Diabetes|diabetes
882873|NCT00025870|Genetics|genetics
882874|NCT00025870|Metabolic|metabolic
882875|NCT00025870|Dysmorphology|dysmorphology
882876|NCT00025870|Training|training
882877|NCT00025870|DNA|dna
882878|NCT00025870|DNA Testing|dna testing
882879|NCT00025870|Dysmorphic Syndromes|dysmorphic syndromes
882880|NCT00025870|Developmental Delay|developmental delay
882881|NCT00025870|Genetic Counseling|genetic counseling
882882|NCT00025870|Molecular Genetics|molecular genetics
882883|NCT00025857|fMRI|fmri
882884|NCT00025857|Depression|depression
882885|NCT00025857|PTSD|ptsd
882886|NCT00025857|Emotion|emotion
882887|NCT00025857|Magnetic Resonance Imaging|magnetic resonance imaging
882888|NCT00025857|Anxiety|anxiety
882889|NCT00025857|Normal Volunteers|normal volunteers
882890|NCT00025857|Adolescence|adolescence
882891|NCT00025857|Memory|memory
882892|NCT00025857|Physical/Sexual Abuse History|physical/sexual abuse history
883002|NCT00024960|Stuttering|stuttering
882893|NCT00025857|Post-Traumatic Stress Disorder|post-traumatic stress disorder
882894|NCT00025857|Adolescent|adolescent
882895|NCT00025857|Healthy Volunteer|healthy volunteer
882896|NCT00025857|HV|hv
882897|NCT00025857|Normal Control|normal control
882898|NCT00025844|Stress|stress
882899|NCT00025844|Anxiety|anxiety
882900|NCT00025844|Adults|adults
882901|NCT00025844|Fear Conditioning|fear conditioning
882902|NCT00025844|Normal Volunteers|normal volunteers
882903|NCT00025844|Associative Learning|associative learning
882904|NCT00025844|Virtual Reality|virtual reality
882905|NCT00025844|Context Conditioning|context conditioning
882906|NCT00025844|Healthy Volunteer|healthy volunteer
882907|NCT00025844|HV|hv
882908|NCT00025844|Normal Control|normal control
882909|NCT00025831|Buccal|buccal
882910|NCT00025831|DNA|dna
882911|NCT00025831|Pooling|pooling
882912|NCT00025831|Genotyping|genotyping
882913|NCT00025831|Mouthwash|mouthwash
882914|NCT00025831|Healthy Volunteer|healthy volunteer
882915|NCT00025831|HV|hv
882916|NCT00025831|Normal Control|normal control
882917|NCT00025818|dry eyes|dry eyes
882918|NCT00025818|rheumatoid arthritis|rheumatoid arthritis
882919|NCT00025818|Lupus|lupus
882920|NCT00025818|Sjogren's syndrome|sjogren's syndrome
882921|NCT00025818|myositis|myositis
882922|NCT00025818|scleroderma|scleroderma
882923|NCT00025818|autoimmune disorder|autoimmune disorder
882924|NCT00025805|Cytokines|cytokines
882925|NCT00025805|Th1 Th2 Response|th1 th2 response
882926|NCT00025805|Inflammatory Bowel Dx|inflammatory bowel dx
882927|NCT00025805|Lymphocyte|lymphocyte
882928|NCT00025805|Colonoscopy|colonoscopy
882929|NCT00025805|Crohn's Disease|crohn's disease
882930|NCT00025805|Crohn's|crohn's
882931|NCT00025792|Pramipexole|pramipexole
882932|NCT00025792|Neuroprotective|neuroprotective
882933|NCT00025792|Placebo Controlled|placebo controlled
882934|NCT00025792|Depression|depression
882935|NCT00025792|Brain Imaging|brain imaging
882936|NCT00025792|Antidepressant|antidepressant
882937|NCT00025792|Bipolar Disorder|bipolar disorder
882938|NCT00025792|Bipolar|bipolar
882939|NCT00025792|BPD|bpd
882940|NCT00025792|Bipolar Depression|bipolar depression
882941|NCT00025779|Hyperactivity|hyperactivity
882942|NCT00025779|Distractibility|distractibility
882943|NCT00025779|Impulsiveness|impulsiveness
882944|NCT00025779|Pervasive Development Disorders|pervasive development disorders
882945|NCT00025740|SSRI (paroxetine)|ssri (paroxetine)
882946|NCT00025740|Benzodiazepine (clonazepam)|benzodiazepine (clonazepam)
882947|NCT00025740|Post-Traumatic Stress Disorder (PTSD)|post-traumatic stress disorder (ptsd)
882948|NCT00025740|Combined Treatment|combined treatment
882949|NCT00025740|Rapid Treatment|rapid treatment
882950|NCT00025740|Post-Traumatic Stress Disorder|post-traumatic stress disorder
882951|NCT00025740|PTSD|ptsd
882952|NCT00025727|HIV-1|hiv-1
882953|NCT00025727|HIV Protease Inhibitors|hiv protease inhibitors
882954|NCT00025727|Ritonavir|ritonavir
882955|NCT00025727|RNA, Viral|rna, viral
882956|NCT00025727|Anti-HIV Agents|anti-hiv agents
882960|NCT00025714|Serotonin Receptor|serotonin receptor
882961|NCT00025714|Cell Culture|cell culture
882962|NCT00025714|Temporal Lobe|temporal lobe
882963|NCT00025714|Endothelial Cells|endothelial cells
882964|NCT00025714|Superficial Temporal Artery|superficial temporal artery
882965|NCT00025714|Magnetic Resonance Imaging (MRI)|magnetic resonance imaging (mri)
882966|NCT00025714|Epilepsy|epilepsy
882967|NCT00025714|Intractable Epilepsy|intractable epilepsy
882968|NCT00025701|Cortex|cortex
882969|NCT00025701|Inhibition|inhibition
882970|NCT00025701|Motor Control|motor control
882971|NCT00025701|Event-Related Synchronization|event-related synchronization
882972|NCT00025701|Event-Related Desynchronization|event-related desynchronization
882973|NCT00025701|Focal Hand Dystonia|focal hand dystonia
882974|NCT00025701|Focal Dystonia|focal dystonia
882975|NCT00025701|Dystonia|dystonia
882976|NCT00025701|Hand|hand
882977|NCT00025701|Healthy Volunteer|healthy volunteer
882978|NCT00025701|HV|hv
882979|NCT00024999|Movement|movement
882980|NCT00024999|Coordination|coordination
882981|NCT00024999|Correlation|correlation
882982|NCT00024999|Coherence|coherence
882983|NCT00024999|Parietofrontal Circuitry|parietofrontal circuitry
882984|NCT00024999|Apraxia|apraxia
882985|NCT00024999|Ideomotor Apraxia|ideomotor apraxia
882986|NCT00024999|Healthy Volunteer|healthy volunteer
882987|NCT00024999|HV|hv
882988|NCT00024999|Normal Control|normal control
882989|NCT00024986|HAART|haart
882990|NCT00024986|Genotypic Resistance|genotypic resistance
882991|NCT00024986|Phenotypic Resistance|phenotypic resistance
882992|NCT00024986|Immune Reconstitution|immune reconstitution
882993|NCT00024986|Bone Density|bone density
882994|NCT00024986|HIV|hiv
882995|NCT00024986|Children|children
882996|NCT00024986|Pediatric HIV Infection|pediatric hiv infection
882997|NCT00024960|Speech|speech
882998|NCT00024960|Motor Control|motor control
882999|NCT00024960|Phenotype|phenotype
883003|NCT00024960|Healthy Volunteer|healthy volunteer
883004|NCT00024960|HV|hv
883005|NCT00024960|Normal Control|normal control
883006|NCT00024934|Immunodeficiency|immunodeficiency
883007|NCT00024934|Primary|primary
883008|NCT00024934|Cancer|cancer
883009|NCT00024934|Genetics|genetics
883010|NCT00024934|IGA Deficiency|iga deficiency
883011|NCT00024934|Immune Deficiency|immune deficiency
883012|NCT00024908|Cognition|cognition
883013|NCT00024908|Frontal Lobes|frontal lobes
883014|NCT00024908|Frontotemporal Dementia|frontotemporal dementia
883015|NCT00024908|Focal Lesions|focal lesions
883016|NCT00024908|Executive Functions|executive functions
883017|NCT00024908|Frontotemporal Lobe Dementia|frontotemporal lobe dementia
883018|NCT00024908|Frontal Lobe|frontal lobe
883019|NCT00024908|Frontal Lobe Dementia|frontal lobe dementia
883020|NCT00024908|Healthy Volunteer|healthy volunteer
883021|NCT00024908|HV|hv
883022|NCT00024908|Normal Control|normal control
883023|NCT00024804|SKELETAL DISEASE|skeletal disease
883024|NCT00024804|Osteoporosis|osteoporosis
883025|NCT00024804|Dysplasia|dysplasia
883026|NCT00024804|Osteomalacia|osteomalacia
883027|NCT00024804|Bone Diseases|bone diseases
883028|NCT00024791|Cerebral Palsy|cerebral palsy
883029|NCT00024791|Pediatric|pediatric
883030|NCT00024791|Cognition|cognition
883031|NCT00024791|Motor Learning|motor learning
883032|NCT00024791|Visuomotor Integration|visuomotor integration
883033|NCT00024791|Corticospinal Tracts|corticospinal tracts
883034|NCT00024791|Cortical Re-Organization|cortical re-organization
883035|NCT00024791|Spastic Hemiplegia|spastic hemiplegia
883036|NCT00024791|Spastic Diplegia|spastic diplegia
883037|NCT00024791|Functional Outcome|functional outcome
883038|NCT00024791|Children|children
883039|NCT00024791|Healthy Volunteer|healthy volunteer
883040|NCT00024791|HV|hv
883041|NCT00024791|Normal Control|normal control
883042|NCT00024687|SS1(dsFv)-PE38 Anti-Mesothelin Immunotoxin|ss1(dsfv)-pe38 anti-mesothelin immunotoxin
883043|NCT00024687|advanced malignancy|advanced malignancy
883044|NCT00024674|SS1(dsFv)-PE38|ss1(dsfv)-pe38
883045|NCT00024674|SS1P|ss1p
883046|NCT00024674|anti-mesothelin immunotoxin|anti-mesothelin immunotoxin
883047|NCT00024674|advanced malignancy|advanced malignancy
883048|NCT00024661|recurrent solid tumors|recurrent solid tumors
883049|NCT00024661|liposomes containing AON to c-raf protein (LErafAON)|liposomes containing aon to c-raf protein (lerafaon)
883050|NCT00024648|advanced malignancy|advanced malignancy
883051|NCT00024648|liposomes containing AON to c-raf messenger RNA|liposomes containing aon to c-raf messenger rna
883052|NCT00024648|antisense oligodeoxynucleotide (AON)|antisense oligodeoxynucleotide (aon)
883053|NCT00024648|LErafAON|lerafaon
883054|NCT00024622|Familial|familial
883055|NCT00024622|Genetic|genetic
883056|NCT00024622|Symptomatic|symptomatic
883057|NCT00024622|Equivocally Affected|equivocally affected
883058|NCT00024622|18F-Fluoro-L-dopa|18f-fluoro-l-dopa
883059|NCT00024622|O-15 Labelled Water|o-15 labelled water
883060|NCT00024622|Carbidopa|carbidopa
883061|NCT00024622|Adult|adult
883062|NCT00024622|Schizophrenia|schizophrenia
883063|NCT00024622|Parkinson's Disease|parkinson's disease
883064|NCT00024622|PD|pd
883066|NCT00024622|Healthy Control|healthy control
883067|NCT00024622|HV|hv
883068|NCT00024622|Normal Control|normal control
883069|NCT00024570|neurosurgery, craniotomy|neurosurgery, craniotomy
883070|NCT00024570|convection-enhanced delivery|convection-enhanced delivery
883071|NCT00024570|CNS interstitial infusion|cns interstitial infusion
883072|NCT00024570|recombinant toxins|recombinant toxins
883073|NCT00024570|malignant glioma, recurrent|malignant glioma, recurrent
883074|NCT00024570|catheter, stereotaxic|catheter, stereotaxic
883075|NCT00024570|intratumoral therapy|intratumoral therapy
883076|NCT00024570|positive pressure microinfusion|positive pressure microinfusion
883077|NCT00024557|neurosurgery, craniotomy|neurosurgery, craniotomy
883078|NCT00024557|convection-enhanced delivery|convection-enhanced delivery
883079|NCT00024557|CNS interstitial infusion|cns interstitial infusion
883080|NCT00024557|recombinant toxins|recombinant toxins
883081|NCT00024557|malignant glioma, recurrent|malignant glioma, recurrent
883082|NCT00024557|intratumoral therapy|intratumoral therapy
883083|NCT00024557|positive pressure microinfusion|positive pressure microinfusion
883084|NCT00024544|asthma|asthma
883085|NCT00024544|anti-IL-4 monoclonal antibody|anti-il-4 monoclonal antibody
883086|NCT00024544|pascolizumab|pascolizumab
883087|NCT00024531|Alzheimer disease|alzheimer disease
883088|NCT00024531|Cholesterol-lowering drugs|cholesterol-lowering drugs
883089|NCT00024518|Diabetes|diabetes
883090|NCT00024518|Immunotherapy|immunotherapy
883091|NCT00024518|Study Drug|study drug
883092|NCT00024518|Insulin Dependent Diabetes|insulin dependent diabetes
883093|NCT00024518|Diabetes Mellitus|diabetes mellitus
883094|NCT00024518|TIBM|tibm
883095|NCT00024492|Liposome Encapsulated Mitoxantrone (LEM)|liposome encapsulated mitoxantrone (lem)
883096|NCT00024492|solid tumors|solid tumors
883097|NCT00024479|Minorities|minorities
883098|NCT00024479|Rheumatic Disease|rheumatic disease
883099|NCT00024479|Community Based|community based
883100|NCT00024479|Ethnicity|ethnicity
883101|NCT00024479|Health Disparities|health disparities
883102|NCT00023582|Syphilis|syphilis
883103|NCT00023582|Herpes Genitalis|herpes genitalis
883104|NCT00023582|Risk Factors|risk factors
883105|NCT00023582|Incidence|incidence
883106|NCT00023582|Prevalence|prevalence
883107|NCT00023582|Homosexuality, Male|homosexuality, male
883108|NCT00023582|Informed Consent|informed consent
883109|NCT00023582|Peru|peru
883110|NCT00023582|HIV Seronegativity|hiv seronegativity
883111|NCT00023569|TMS|tms
883112|NCT00023569|Conjoint Movement|conjoint movement
883113|NCT00023569|Chronic Hemiplegia|chronic hemiplegia
883114|NCT00023569|Brain Plasticity|brain plasticity
883115|NCT00023569|Electrical Stimulation|electrical stimulation
883116|NCT00023569|Stroke|stroke
883117|NCT00023569|CVA|cva
883118|NCT00023504|Antibody|antibody
883119|NCT00023504|Vaccination|vaccination
883120|NCT00023452|Latent TB infection|latent tb infection
883121|NCT00023439|tuberculosis|tuberculosis
883122|NCT00023439|TB|tb
883123|NCT00023426|tuberculosis|tuberculosis
883124|NCT00023426|tb|tb
883125|NCT00023426|rifapentine|rifapentine
883126|NCT00023426|safety|safety
883127|NCT00023426|dose|dose
883128|NCT00023413|tuberculosis|tuberculosis
883129|NCT00023413|TB|tb
883130|NCT00023400|tuberculosis|tuberculosis
883131|NCT00023400|TB|tb
883132|NCT00023374|tuberculosis|tuberculosis
883133|NCT00023374|TB|tb
883134|NCT00023374|isoniazid resistance|isoniazid resistance
883135|NCT00023374|isoniazid intolerance|isoniazid intolerance
883136|NCT00023374|treatment|treatment
883137|NCT00023374|efficacy|efficacy
883138|NCT00023374|toxicity|toxicity
883139|NCT00023361|tuberculosis|tuberculosis
883140|NCT00023361|TB|tb
883141|NCT00023348|Tuberculosis|tuberculosis
883142|NCT00023348|TB|tb
883143|NCT00023491|Sjogren's Syndrome|sjogren's syndrome
883144|NCT00023491|Peripheral Blood Stem Cell|peripheral blood stem cell
883145|NCT00023491|Tissue Regeneration|tissue regeneration
883146|NCT00023491|Graft-versus-host Disease|graft-versus-host disease
883147|NCT00023491|Head and Neck Cancer|head and neck cancer
883148|NCT00023491|Salivary Gland|salivary gland
883149|NCT00023491|Saliva Gland|saliva gland
883150|NCT00023491|Salivary Gland Dysfunction|salivary gland dysfunction
883151|NCT00023322|Cirrhosis|cirrhosis
883152|NCT00023322|Chronic Hepatitis|chronic hepatitis
883153|NCT00023322|Alpha Interferon|alpha interferon
883154|NCT00023322|Hepatitis D Virus|hepatitis d virus
883155|NCT00023322|Delta Hepatitis|delta hepatitis
883156|NCT00023322|Viral Hepatitis|viral hepatitis
883157|NCT00023322|Antiviral Agents|antiviral agents
883158|NCT00023322|Hepatitis D|hepatitis d
883159|NCT00023322|HDV|hdv
883160|NCT00023322|Liver|liver
883161|NCT00023322|Hepatitis|hepatitis
883162|NCT00023309|Adefovir Dipivoxil|adefovir dipivoxil
883163|NCT00023309|Lamivudine|lamivudine
883164|NCT00023309|Nucleoside/Nucleotide Analogue|nucleoside/nucleotide analogue
883165|NCT00023309|Chronic Hepatitis B|chronic hepatitis b
883166|NCT00023309|Hepatitis B Mutants|hepatitis b mutants
883167|NCT00023309|Liver Biopsy|liver biopsy
883168|NCT00023309|Hepatitis B|hepatitis b
883172|NCT00023296|Acute Chest Syndrome|acute chest syndrome
883173|NCT00023296|Blood Flow|blood flow
883174|NCT00023296|Nitric Oxide|nitric oxide
883175|NCT00023296|NO Therapy|no therapy
883176|NCT00023296|Vaso-Occlusive Crisis|vaso-occlusive crisis
883177|NCT00023296|Sickle Cell Anemia|sickle cell anemia
883178|NCT00023296|Sickle Cell|sickle cell
883179|NCT00023296|ACS|acs
883180|NCT00023296|Pulmonary Hypertension|pulmonary hypertension
883181|NCT00023218|Liver|liver
883182|NCT00023218|HIV-1|hiv-1
883183|NCT00023218|HIV Protease Inhibitors|hiv protease inhibitors
883184|NCT00023218|Ritonavir|ritonavir
883185|NCT00023218|Biopsy|biopsy
883186|NCT00023218|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors
883187|NCT00023218|Anti-HIV Agents|anti-hiv agents
883188|NCT00023218|ABT 378|abt 378
883189|NCT00023218|Acidosis, Lactic|acidosis, lactic
883190|NCT00023218|efavirenz|efavirenz
883191|NCT00023218|Alanine Transaminase|alanine transaminase
883192|NCT00023205|Arthritis|arthritis
883193|NCT00023205|Health literacy|health literacy
883194|NCT00023205|Patient education|patient education
883195|NCT00023205|Self-efficacy|self-efficacy
883196|NCT00022763|Anti-HIV Agents|anti-hiv agents
883197|NCT00022763|pentafuside|pentafuside
883198|NCT00021775|Risk Factors|risk factors
883199|NCT00021775|Incidence|incidence
883200|NCT00021775|Patient Selection|patient selection
883201|NCT00021775|HIV Seronegativity|hiv seronegativity
883202|NCT00021762|Virus Replication|virus replication
883203|NCT00021762|HIV-1|hiv-1
883204|NCT00021762|Drug Administration Schedule|drug administration schedule
883205|NCT00021762|AIDS Vaccines|aids vaccines
883206|NCT00021762|RNA, Viral|rna, viral
883207|NCT00021762|Viral Load|viral load
883208|NCT00021762|HIV-1 immunogen, incomplete Freund's adjuvant|hiv-1 immunogen, incomplete freund's adjuvant
883209|NCT00021762|Treatment Interruption|treatment interruption
883210|NCT00021762|HIV Therapeutic Vaccine|hiv therapeutic vaccine
883211|NCT00021671|Drug Therapy, Combination|drug therapy, combination
883212|NCT00021671|Ampicillin|ampicillin
883213|NCT00021671|Nevirapine|nevirapine
883214|NCT00021671|Disease Transmission, Vertical|disease transmission, vertical
883215|NCT00021671|Anti-Infective Agents|anti-infective agents
883216|NCT00021671|Erythromycin|erythromycin
883217|NCT00021671|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors
883218|NCT00021671|Metronidazole|metronidazole
883219|NCT00021671|Anti-HIV Agents|anti-hiv agents
883220|NCT00021671|Chorioamnionitis|chorioamnionitis
883221|NCT00021671|HIV Seronegativity|hiv seronegativity
883222|NCT00021632|Ribavirin|ribavirin
883223|NCT00021632|Drug Interactions|drug interactions
883224|NCT00021632|Drug Therapy, Combination|drug therapy, combination
883225|NCT00021632|Zidovudine|zidovudine
883226|NCT00021632|Stavudine|stavudine
883227|NCT00021632|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors
883228|NCT00021632|Anti-HIV Agents|anti-hiv agents
883229|NCT00021632|Pharmacokinetics|pharmacokinetics
883230|NCT00021632|Area Under Curve|area under curve
883231|NCT00021554|HIV-1|hiv-1
883232|NCT00021554|Drug Therapy, Combination|drug therapy, combination
883233|NCT00021554|HIV Protease Inhibitors|hiv protease inhibitors
883234|NCT00021554|RNA, Viral|rna, viral
883235|NCT00021554|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors
883236|NCT00021554|Anti-HIV Agents|anti-hiv agents
883237|NCT00021554|Viral Load|viral load
883238|NCT00021554|pentafuside|pentafuside
883239|NCT00021489|Placebos|placebos
883240|NCT00021489|Drug Therapy, Combination|drug therapy, combination
883241|NCT00021489|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors
883242|NCT00021489|Anti-HIV Agents|anti-hiv agents
883243|NCT00021489|abacavir|abacavir
883244|NCT00021489|mycophenolate mofetil|mycophenolate mofetil
883245|NCT00021463|Nevirapine|nevirapine
883246|NCT00021463|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors
883247|NCT00021463|Anti-HIV Agents|anti-hiv agents
883248|NCT00021463|Triglycerides|triglycerides
883249|NCT00021463|abacavir|abacavir
883250|NCT00021463|efavirenz|efavirenz
883251|NCT00021463|Lipoproteins, LDL Cholesterol|lipoproteins, ldl cholesterol
883252|NCT00017992|HIV-1|hiv-1
883253|NCT00017992|Drug Administration Schedule|drug administration schedule
883254|NCT00017992|Stavudine|stavudine
883255|NCT00017992|HIV Protease Inhibitors|hiv protease inhibitors
883256|NCT00017992|Ritonavir|ritonavir
883257|NCT00017992|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors
883258|NCT00017992|Anti-HIV Agents|anti-hiv agents
883259|NCT00017992|Pharmacokinetics|pharmacokinetics
883260|NCT00017992|ABT 378|abt 378
883261|NCT00017992|emtricitabine|emtricitabine
883262|NCT00017797|Pregnancy Complications, Infectious|pregnancy complications, infectious
883263|NCT00017797|HIV-1|hiv-1
883264|NCT00017797|HIV Protease Inhibitors|hiv protease inhibitors
883265|NCT00017797|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors
883266|NCT00017797|Anti-HIV Agents|anti-hiv agents
883267|NCT00017797|Glucose Intolerance|glucose intolerance
883268|NCT00017784|AIDS-Related Opportunistic Infections|aids-related opportunistic infections
883269|NCT00017784|Infusions, Intravenous|infusions, intravenous
883270|NCT00017784|Antiviral Agents|antiviral agents
883271|NCT00017784|Cytomegalovirus Retinitis|cytomegalovirus retinitis
883272|NCT00017784|valganciclovir|valganciclovir
883273|NCT00017771|HIV-1|hiv-1
883274|NCT00017771|CD4 Lymphocyte Count|cd4 lymphocyte count
883275|NCT00017771|Risk Factors|risk factors
883276|NCT00017771|Hydroxyurea|hydroxyurea
883277|NCT00017771|Disease Progression|disease progression
883278|NCT00017771|Alcohol Drinking|alcohol drinking
883279|NCT00017771|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors
883280|NCT00017771|Anti-HIV Agents|anti-hiv agents
883281|NCT00017771|Viral Load|viral load
883282|NCT00017771|Polyneuropathies|polyneuropathies
883283|NCT00017771|Treatment Experienced|treatment experienced
883284|NCT00017758|Drug Interactions|drug interactions
883285|NCT00017758|Nelfinavir|nelfinavir
883286|NCT00017758|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors
883287|NCT00017758|Anti-HIV Agents|anti-hiv agents
883288|NCT00017758|Pharmacokinetics|pharmacokinetics
883289|NCT00017758|Pravastatin|pravastatin
883290|NCT00017758|efavirenz|efavirenz
883291|NCT00017758|Simvastatin|simvastatin
883292|NCT00017758|atorvastatin|atorvastatin
883293|NCT00017758|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors
883294|NCT00017719|Pregnancy Complications, Infectious|pregnancy complications, infectious
883295|NCT00017719|HIV Protease Inhibitors|hiv protease inhibitors
883296|NCT00017719|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors
883297|NCT00017719|Anti-HIV Agents|anti-hiv agents
883298|NCT00017719|Viral Load|viral load
883299|NCT00017719|Combivir|combivir
883300|NCT00017719|Treatment Naive|treatment naive
883301|NCT00017693|Recombinant Proteins|recombinant proteins
883302|NCT00017693|Aerosols|aerosols
883303|NCT00017693|Asthma|asthma
883304|NCT00017693|Receptors, Interleukin-4|receptors, interleukin-4
883305|NCT00017693|Forced Expiratory Volume|forced expiratory volume
883306|NCT00016783|Drug Therapy, Combination|drug therapy, combination
883307|NCT00016783|Drug Administration Schedule|drug administration schedule
883308|NCT00016783|HIV Protease Inhibitors|hiv protease inhibitors
883309|NCT00016783|CD4 Lymphocyte Count|cd4 lymphocyte count
883310|NCT00016783|CD8-Positive T-Lymphocytes|cd8-positive t-lymphocytes
883311|NCT00016783|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors
883312|NCT00016783|Anti-HIV Agents|anti-hiv agents
883313|NCT00016783|Viral Load|viral load
883314|NCT00016783|Antiretroviral Therapy, Highly Active|antiretroviral therapy, highly active
883315|NCT00016783|Treatment Experienced|treatment experienced
883316|NCT00016783|Treatment Interruption|treatment interruption
883317|NCT00016718|Didanosine|didanosine
883318|NCT00016718|Drug Therapy, Combination|drug therapy, combination
883319|NCT00016718|Drug Administration Schedule|drug administration schedule
883320|NCT00016718|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors
883321|NCT00016718|Anti-HIV Agents|anti-hiv agents
883322|NCT00016718|Pharmacokinetics|pharmacokinetics
883323|NCT00016718|Deoxycytidine|deoxycytidine
883324|NCT00016718|Efavirenz|efavirenz
883325|NCT00016718|Treatment Naive|treatment naive
883326|NCT00016692|Drug tolerance|drug tolerance
883327|NCT00016692|Acute Infection|acute infection
883328|NCT00016601|Delayed-Action Preparations|delayed-action preparations
883329|NCT00016601|Drug Interactions|drug interactions
883330|NCT00016601|Drug Therapy, Combination|drug therapy, combination
883331|NCT00016601|Nevirapine|nevirapine
883332|NCT00016601|HIV Protease Inhibitors|hiv protease inhibitors
883333|NCT00016601|Ritonavir|ritonavir
883334|NCT00016601|Indinavir|indinavir
883335|NCT00016601|Nelfinavir|nelfinavir
883336|NCT00016601|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors
883337|NCT00016601|Anti-HIV Agents|anti-hiv agents
883338|NCT00016601|Pharmacokinetics|pharmacokinetics
883339|NCT00016601|Medroxyprogesterone 17-Acetate|medroxyprogesterone 17-acetate
883340|NCT00016601|efavirenz|efavirenz
883341|NCT00016588|HIV-1|hiv-1
883342|NCT00016588|Adenine|adenine
883343|NCT00016588|Anti-HIV Agents|anti-hiv agents
883344|NCT00016588|Viral Load|viral load
883345|NCT00016588|Organophosphorus Compounds|organophosphorus compounds
883346|NCT00016536|Antiviral Agents|antiviral agents
883347|NCT00016536|Mucous Membrane|mucous membrane
883348|NCT00016536|Spermatocidal Agents|spermatocidal agents
883349|NCT00016536|Penis|penis
883350|NCT00016536|Epithelium|epithelium
883351|NCT00016536|PRO 2000|pro 2000
883352|NCT00016536|Urethra|urethra
883353|NCT00016536|HIV Seronegativity|hiv seronegativity
883354|NCT00015704|Treatment Experienced|treatment experienced
883355|NCT00015704|Treatment Interruption|treatment interruption
883356|NCT00015704|Drug Administration Schedule|drug administration schedule
883357|NCT00015704|CD4 Lymphocyte Count|cd4 lymphocyte count
883358|NCT00015704|Anti-HIV Agents|anti-hiv agents
883359|NCT00015704|Tetanus Toxoid|tetanus toxoid
883360|NCT00015704|Aldesleukin|aldesleukin
883361|NCT00015704|Diphtheria Toxoid|diphtheria toxoid
883362|NCT00015691|Drug Therapy, Combination|drug therapy, combination
883363|NCT00015691|Adipose Tissue|adipose tissue
883364|NCT00015691|Area Under Curve|area under curve
883365|NCT00015691|Hypoglycemic Agents|hypoglycemic agents
883366|NCT00015691|Anthropometry|anthropometry
883367|NCT00015691|Hyperinsulinemia|hyperinsulinemia
883368|NCT00015691|Metformin|metformin
883369|NCT00015691|BRL 49653|brl 49653
883370|NCT00015691|Insulin|insulin
883371|NCT00015691|Glucose Tolerance Test|glucose tolerance test
883372|NCT00015652|Ribavirin|ribavirin
883373|NCT00015652|Polyethylene Glycols|polyethylene glycols
883374|NCT00015652|Interferon Alfa-2b|interferon alfa-2b
883375|NCT00015652|Dose-Response Relationship, Drug|dose-response relationship, drug
883376|NCT00015652|Drug Therapy, Combination|drug therapy, combination
883377|NCT00015652|Antiviral Agents|antiviral agents
883378|NCT00015652|Hepatitis C|hepatitis c
883379|NCT00015652|Aldesleukin|aldesleukin
883380|NCT00015652|Peginterferon|peginterferon
883381|NCT00014937|HIV-1|hiv-1
883382|NCT00014937|Didanosine|didanosine
883383|NCT00014937|Drug Therapy, Combination|drug therapy, combination
883384|NCT00014937|Zidovudine|zidovudine
883385|NCT00014937|Nevirapine|nevirapine
883386|NCT00014937|Stavudine|stavudine
883387|NCT00014937|HIV Protease Inhibitors|hiv protease inhibitors
883388|NCT00014937|Ritonavir|ritonavir
883389|NCT00014937|Lamivudine|lamivudine
883390|NCT00014937|RNA, Viral|rna, viral
883391|NCT00014937|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors
883392|NCT00014937|Anti-HIV Agents|anti-hiv agents
883393|NCT00014937|Viral Load|viral load
883394|NCT00014937|ABT 378|abt 378
883395|NCT00014937|Combivir|combivir
883396|NCT00014937|Efavirenz|efavirenz
883397|NCT00014937|Treatment Experienced|treatment experienced
883398|NCT00014053|Reference Values|reference values
883399|NCT00014053|HIV Seropositivity|hiv seropositivity
883400|NCT00014053|Immune System|immune system
883401|NCT00014053|CD4-Positive T-Lymphocytes|cd4-positive t-lymphocytes
883402|NCT00014053|HIV Seronegativity|hiv seronegativity
883403|NCT00014053|Antigens, CD|antigens, cd
883404|NCT00014014|Zidovudine|zidovudine
883405|NCT00014014|Phosphorylation|phosphorylation
883406|NCT00014014|Drug Administration Schedule|drug administration schedule
883407|NCT00014014|Lamivudine|lamivudine
883408|NCT00014014|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors
883409|NCT00014014|Anti-HIV Agents|anti-hiv agents
883410|NCT00014014|Pharmacokinetics|pharmacokinetics
883411|NCT00014014|Combivir|combivir
883412|NCT00013897|Placebos|placebos
883413|NCT00013897|Drug Therapy, Combination|drug therapy, combination
883414|NCT00013897|Zidovudine|zidovudine
883415|NCT00013897|HIV Protease Inhibitors|hiv protease inhibitors
883416|NCT00013897|Lamivudine|lamivudine
883417|NCT00013897|RNA, Viral|rna, viral
883418|NCT00013897|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors
883419|NCT00013897|Anti-HIV Agents|anti-hiv agents
883420|NCT00013897|Viral Load|viral load
883421|NCT00013897|BMS 232632|bms 232632
883422|NCT00013897|efavirenz|efavirenz
883423|NCT00013871|Measles-Mumps-Rubella Vaccine|measles-mumps-rubella vaccine
883424|NCT00013871|Antibodies, Viral|antibodies, viral
883425|NCT00013871|Hepatitis B Vaccines|hepatitis b vaccines
883426|NCT00013871|Immunization, Secondary|immunization, secondary
883427|NCT00013871|Pneumococcal Vaccines|pneumococcal vaccines
883428|NCT00013871|Antiretroviral Therapy, Highly Active|antiretroviral therapy, highly active
883429|NCT00013871|Diphtheria-Tetanus-acellular Pertussis Vaccines|diphtheria-tetanus-acellular pertussis vaccines
883430|NCT00013663|Virus Replication|virus replication
883431|NCT00013663|HIV-1|hiv-1
883432|NCT00013663|AIDS Vaccines|aids vaccines
883433|NCT00013663|RNA, Viral|rna, viral
883434|NCT00013663|Avipoxvirus|avipoxvirus
883435|NCT00013663|Genetic Vectors|genetic vectors
883436|NCT00013663|Viral Load|viral load
883437|NCT00013663|aldesleukin|aldesleukin
883438|NCT00013663|Antiretroviral Therapy, Highly Active|antiretroviral therapy, highly active
883439|NCT00013663|HIV Therapeutic Vaccine|hiv therapeutic vaccine
883440|NCT00013663|Treatment Interruption|treatment interruption
883441|NCT00013585|Cognitive Disorders|cognitive disorders
883442|NCT00013585|AIDS Dementia Complex|aids dementia complex
883443|NCT00013585|Selegiline|selegiline
883444|NCT00013585|Administration, Cutaneous|administration, cutaneous
883445|NCT00013585|Neuroprotective Agents|neuroprotective agents
883446|NCT00013572|Injections, Intramuscular|injections, intramuscular
883447|NCT00013572|Injections, Intradermal|injections, intradermal
883448|NCT00013572|Injections, Subcutaneous|injections, subcutaneous
883449|NCT00013572|HIV-1|hiv-1
883450|NCT00013572|AIDS Vaccines|aids vaccines
883451|NCT00013572|Dendritic Cells|dendritic cells
883452|NCT00013572|HIV Seronegativity|hiv seronegativity
883453|NCT00013572|Genes, env|genes, env
883454|NCT00013572|Genes, pol|genes, pol
883455|NCT00013572|Genes, gag|genes, gag
883456|NCT00013572|Transfection|transfection
883457|NCT00013572|HIV Preventive Vaccine|hiv preventive vaccine
883458|NCT00013520|HIV-1|hiv-1
883459|NCT00013520|Didanosine|didanosine
883460|NCT00013520|Drug Therapy, Combination|drug therapy, combination
883461|NCT00013520|Zidovudine|zidovudine
883462|NCT00013520|Nevirapine|nevirapine
883463|NCT00013520|Stavudine|stavudine
883464|NCT00013520|Lamivudine|lamivudine
883465|NCT00013520|RNA, Viral|rna, viral
883466|NCT00013520|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors
883467|NCT00013520|Anti-HIV Agents|anti-hiv agents
883468|NCT00013520|Viral Load|viral load
883469|NCT00013520|Combivir|combivir
883470|NCT00013520|BMS 232632|bms 232632
883471|NCT00013520|Efavirenz|efavirenz
883472|NCT00013520|Treatment Naive|treatment naive
883473|NCT00012519|Dose-Response Relationship, Drug|dose-response relationship, drug
883474|NCT00012519|Drug Therapy, Combination|drug therapy, combination
883475|NCT00012519|HIV Protease Inhibitors|hiv protease inhibitors
883476|NCT00012519|Ritonavir|ritonavir
883477|NCT00012519|Indinavir|indinavir
883478|NCT00012519|Anti-HIV Agents|anti-hiv agents
883479|NCT00012519|Viral Load|viral load
883480|NCT00012519|Pharmacokinetics|pharmacokinetics
883481|NCT00012519|Treatment Experienced|treatment experienced
883482|NCT00012467|Interferon-gamma, Recombinant|interferon-gamma, recombinant
883483|NCT00012467|Injections, Subcutaneous|injections, subcutaneous
883484|NCT00012467|Itraconazole|itraconazole
883485|NCT00012467|Dose-Response Relationship, Drug|dose-response relationship, drug
883486|NCT00012467|Fluconazole|fluconazole
883487|NCT00012467|Flucytosine|flucytosine
883488|NCT00012467|Antifungal Agents|antifungal agents
883489|NCT00012467|Amphotericin B|amphotericin b
883490|NCT00012467|Meningitis, Cryptococcal|meningitis, cryptococcal
883491|NCT00011895|HIV-1|hiv-1
883492|NCT00011895|Drug Therapy, Combination|drug therapy, combination
883493|NCT00011895|Zidovudine|zidovudine
883494|NCT00011895|Lamivudine|lamivudine
883495|NCT00011895|Drug Combinations|drug combinations
883496|NCT00011895|RNA, Viral|rna, viral
883497|NCT00011895|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors
883498|NCT00011895|Anti-HIV Agents|anti-hiv agents
883499|NCT00011895|Viral Load|viral load
883500|NCT00011895|abacavir|abacavir
883501|NCT00011895|efavirenz|efavirenz
883502|NCT00011479|Administration, Oral|administration, oral
883503|NCT00011479|Drug Administration Schedule|drug administration schedule
883504|NCT00011479|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors
883505|NCT00011479|Anti-HIV Agents|anti-hiv agents
883506|NCT00011479|Pharmacokinetics|pharmacokinetics
883507|NCT00011479|abacavir|abacavir
883508|NCT00011128|HIV-1|hiv-1
883509|NCT00011128|Drug Resistance, Microbial|drug resistance, microbial
883510|NCT00011128|Microbial Sensitivity Tests|microbial sensitivity tests
883511|NCT00011128|Salvage Therapy|salvage therapy
883512|NCT00011128|Anti-HIV Agents|anti-hiv agents
883513|NCT00011128|Viral Load|viral load
883514|NCT00011128|Treatment Experienced|treatment experienced
883515|NCT00011089|HIV-1|hiv-1
883516|NCT00011089|Disease Progression|disease progression
883517|NCT00011089|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors
883518|NCT00011089|Anti-HIV Agents|anti-hiv agents
883519|NCT00011089|9-(2-phosphonylmethoxypropyl)adenine|9-(2-phosphonylmethoxypropyl)adenine
883520|NCT00011050|Specimen Handling|specimen handling
883521|NCT00011050|Blood|blood
883522|NCT00011050|Cryopreservation|cryopreservation
883523|NCT00011050|Lactic Acid|lactic acid
883524|NCT00011050|Sodium Fluoride|sodium fluoride
883525|NCT00011050|Oxalates|oxalates
883526|NCT00011037|HIV Antibodies|hiv antibodies
883527|NCT00011037|HIV Antigens|hiv antigens
883528|NCT00011037|HIV Envelope Protein gp120|hiv envelope protein gp120
883529|NCT00011037|AIDS Vaccines|aids vaccines
883530|NCT00011037|CD4-Positive T-Lymphocytes|cd4-positive t-lymphocytes
883531|NCT00011037|CD8-Positive T-Lymphocytes|cd8-positive t-lymphocytes
883532|NCT00011037|Neutralization Tests|neutralization tests
883533|NCT00011037|Haiti|haiti
883534|NCT00011037|Brazil|brazil
883535|NCT00011037|Cytotoxicity, Immunologic|cytotoxicity, immunologic
883536|NCT00011037|Epitopes|epitopes
883537|NCT00011037|Viral Proteins|viral proteins
883538|NCT00011037|Trinidad and Tobago|trinidad and tobago
883539|NCT00011037|Peru|peru
883540|NCT00011037|HIV Preventive Vaccine|hiv preventive vaccine
883541|NCT00011037|HIV Seronegativity|hiv seronegativity
883542|NCT00011011|HIV-1|hiv-1
883543|NCT00011011|Drug Administration Schedule|drug administration schedule
883544|NCT00011011|AIDS Vaccines|aids vaccines
883545|NCT00011011|CD4 Lymphocyte Count|cd4 lymphocyte count
883546|NCT00011011|RNA, Viral|rna, viral
883547|NCT00011011|Anti-HIV Agents|anti-hiv agents
883548|NCT00011011|Viral Load|viral load
883549|NCT00011011|HIV Therapeutic Vaccine|hiv therapeutic vaccine
883550|NCT00011011|Treatment Interruption|treatment interruption
883551|NCT00009555|Testosterone|testosterone
883552|NCT00009555|Anthropometry|anthropometry
883553|NCT00009555|Obesity|obesity
883554|NCT00009555|Abdomen|abdomen
883555|NCT00009061|HIV-1|hiv-1
883556|NCT00009061|Drug Therapy, Combination|drug therapy, combination
883557|NCT00009061|HIV Protease Inhibitors|hiv protease inhibitors
883558|NCT00009061|Ritonavir|ritonavir
883559|NCT00009061|Lamivudine|lamivudine
883560|NCT00009061|Nelfinavir|nelfinavir
883561|NCT00009061|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors
883562|NCT00009061|Anti-HIV Agents|anti-hiv agents
883563|NCT00009061|abacavir|abacavir
883564|NCT00008866|HIV-1|hiv-1
883565|NCT00008866|Didanosine|didanosine
883566|NCT00008866|Drug Therapy, Combination|drug therapy, combination
883567|NCT00008866|Drug Administration Schedule|drug administration schedule
883568|NCT00008866|CD4-Positive T-Lymphocytes|cd4-positive t-lymphocytes
883569|NCT00008866|Hydroxyurea|hydroxyurea
883570|NCT00008866|RNA, Viral|rna, viral
883571|NCT00008866|Genotype|genotype
883572|NCT00008866|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors
883573|NCT00008866|Anti-HIV Agents|anti-hiv agents
883574|NCT00008866|Viral Load|viral load
883575|NCT00008853|Clinical Evaluation|clinical evaluation
883576|NCT00008554|HIV-1|hiv-1
883577|NCT00008554|Drug Therapy, Combination|drug therapy, combination
883578|NCT00008554|HIV Protease Inhibitors|hiv protease inhibitors
883579|NCT00008554|Lamivudine|lamivudine
883580|NCT00008554|Nelfinavir|nelfinavir
883581|NCT00008554|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors
883582|NCT00008554|Anti-HIV Agents|anti-hiv agents
883583|NCT00008554|abacavir|abacavir
883584|NCT00008528|HIV-1|hiv-1
883585|NCT00008528|Drug Therapy, Combination|drug therapy, combination
883586|NCT00008528|Drug Resistance, Microbial|drug resistance, microbial
883587|NCT00008528|RNA, Viral|rna, viral
883588|NCT00008528|Membrane Fusion|membrane fusion
883589|NCT00008528|Anti-HIV Agents|anti-hiv agents
883590|NCT00008528|Viral Load|viral load
883591|NCT00008489|Didanosine|didanosine
883592|NCT00008489|Gastrointestinal System|gastrointestinal system
883593|NCT00008489|Tablets|tablets
883594|NCT00008489|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors
883595|NCT00008489|Anti-HIV Agents|anti-hiv agents
883596|NCT00008489|Capsules|capsules
883597|NCT00008463|Ribavirin|ribavirin
883598|NCT00008463|Polyethylene Glycols|polyethylene glycols
883599|NCT00008463|Interferon Alfa-2a|interferon alfa-2a
883600|NCT00008463|HIV-1|hiv-1
883601|NCT00008463|Antiviral Agents|antiviral agents
883602|NCT00008463|Hepatitis C, Chronic|hepatitis c, chronic
883603|NCT00007488|HIV-1|hiv-1
883604|NCT00007488|Lymphoid Tissue|lymphoid tissue
883605|NCT00007488|Viremia|viremia
883606|NCT00007488|RNA, Viral|rna, viral
883607|NCT00007488|Saliva|saliva
883608|NCT00007488|Anti-HIV Agents|anti-hiv agents
883609|NCT00007488|Viral Load|viral load
883610|NCT00007488|Genitalia, Female|genitalia, female
883611|NCT00007488|Genitalia, Male|genitalia, male
883612|NCT00007449|HIV-1|hiv-1
883613|NCT00007449|Drug Therapy, Combination|drug therapy, combination
883614|NCT00007449|RNA, Viral|rna, viral
883615|NCT00007449|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors
883616|NCT00007449|Anti-HIV Agents|anti-hiv agents
883617|NCT00007449|Viral Load|viral load
883618|NCT00007436|HIV-1|hiv-1
883619|NCT00007436|Drug Therapy, Combination|drug therapy, combination
883620|NCT00007436|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors
883621|NCT00007436|Anti-HIV Agents|anti-hiv agents
883622|NCT00007436|9-(2-phosphonylmethoxypropyl)adenine|9-(2-phosphonylmethoxypropyl)adenine
883623|NCT00007423|HIV Antibodies|hiv antibodies
883624|NCT00007423|HIV-1|hiv-1
883625|NCT00007423|AIDS Vaccines|aids vaccines
883626|NCT00007423|HIV Seronegativity|hiv seronegativity
883627|NCT00007423|Uganda|uganda
883628|NCT00007423|Cross Reactions|cross reactions
883629|NCT00007423|HIV Preventive Vaccine|hiv preventive vaccine
883630|NCT00007332|Drug Therapy, Combination|drug therapy, combination
883631|NCT00007332|HIV Envelope Protein gp120|hiv envelope protein gp120
883632|NCT00007332|AIDS Vaccines|aids vaccines
883633|NCT00007332|CD8-Positive T-Lymphocytes|cd8-positive t-lymphocytes
883634|NCT00007332|HIV Seronegativity|hiv seronegativity
883635|NCT00007332|AIDSVAX|aidsvax
883636|NCT00007332|HIV Preventive Vaccine|hiv preventive vaccine
883637|NCT00007319|HIV Protease Inhibitors|hiv protease inhibitors
883638|NCT00007319|Risk Factors|risk factors
883639|NCT00007319|HIV Seronegativity|hiv seronegativity
883640|NCT00007319|Anti-HIV Agents|anti-hiv agents
883641|NCT00007319|Carotid Artery|carotid artery
883642|NCT00007319|Tunica Intima|tunica intima
883643|NCT00007319|Atherosclerosis|atherosclerosis
883644|NCT00007202|Virus Replication|virus replication
883645|NCT00007202|HIV-1|hiv-1
883646|NCT00007202|Didanosine|didanosine
883647|NCT00007202|Drug Therapy, Combination|drug therapy, combination
883648|NCT00007202|Stavudine|stavudine
883649|NCT00007202|HIV Protease Inhibitors|hiv protease inhibitors
883650|NCT00007202|Sensitivity and Specificity|sensitivity and specificity
883651|NCT00007202|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors
883652|NCT00007202|Anti-HIV Agents|anti-hiv agents
883653|NCT00007202|Viral Load|viral load
883654|NCT00007202|Reverse Transcriptase Polymerase Chain Reaction|reverse transcriptase polymerase chain reaction
883655|NCT00007202|Acute Infection|acute infection
883656|NCT00006643|Liver|liver
883657|NCT00006643|Hepatitis C|hepatitis c
883658|NCT00006643|Biopsy|biopsy
883659|NCT00006643|Tomography, Emission-Computed, Single-Photon|tomography, emission-computed, single-photon
883660|NCT00006630|Smallpox Vaccine|smallpox vaccine
883661|NCT00006630|Injections, Intramuscular|injections, intramuscular
883662|NCT00006630|Immunoglobulins|immunoglobulins
883663|NCT00006630|Orthopoxvirus|orthopoxvirus
883664|NCT00006617|HIV-1|hiv-1
883665|NCT00006617|Drug Therapy, Combination|drug therapy, combination
883667|NCT00006617|Lymphoid Tissue|lymphoid tissue
883668|NCT00006617|Gastrointestinal System|gastrointestinal system
883669|NCT00006617|HIV Protease Inhibitors|hiv protease inhibitors
883670|NCT00006617|Lamivudine|lamivudine
883671|NCT00006617|Lymphocyte Subsets|lymphocyte subsets
883672|NCT00006617|VX 478|vx 478
883673|NCT00006617|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors
883674|NCT00006617|Anti-HIV Agents|anti-hiv agents
883675|NCT00006617|Viral Load|viral load
883676|NCT00006617|Cerebrospinal Fluid|cerebrospinal fluid
883677|NCT00006617|abacavir|abacavir
883678|NCT00006604|Dose-Response Relationship, Drug|dose-response relationship, drug
883679|NCT00006604|Drug Therapy, Combination|drug therapy, combination
883680|NCT00006604|Drug Administration Schedule|drug administration schedule
883681|NCT00006604|HIV Protease Inhibitors|hiv protease inhibitors
883682|NCT00006604|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors
883683|NCT00006604|Anti-HIV Agents|anti-hiv agents
883684|NCT00006604|Pharmacokinetics|pharmacokinetics
883685|NCT00006604|Treatment Experienced|treatment experienced
883686|NCT00006604|Treatment Naive|treatment naive
883687|NCT00006591|Drug Therapy, Combination|drug therapy, combination
883688|NCT00006591|HIV Protease Inhibitors|hiv protease inhibitors
883689|NCT00006591|Ritonavir|ritonavir
883690|NCT00006591|VX 478|vx 478
883691|NCT00006591|Salvage Therapy|salvage therapy
883692|NCT00006591|Anti-HIV Agents|anti-hiv agents
883693|NCT00006591|Drug Monitoring|drug monitoring
883694|NCT00006591|Nelfinavir|nelfinavir
883695|NCT00006591|Treatment Experienced|treatment experienced
883696|NCT00006578|Drug Therapy, Combination|drug therapy, combination
883697|NCT00006578|Granulocyte Colony-Stimulating Factor|granulocyte colony-stimulating factor
883698|NCT00006578|HIV Protease Inhibitors|hiv protease inhibitors
883699|NCT00006578|Ritonavir|ritonavir
883700|NCT00006578|Lamivudine|lamivudine
883701|NCT00006578|Stem Cells|stem cells
883702|NCT00006578|VX 478|vx 478
883703|NCT00006578|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors
883704|NCT00006578|Anti-HIV Agents|anti-hiv agents
883705|NCT00006578|Antigens, CD34|antigens, cd34
883706|NCT00006578|abacavir|abacavir
883707|NCT00006578|Treatment Naive|treatment naive
883708|NCT00006509|Recombinant Proteins|recombinant proteins
883709|NCT00006509|HIV Envelope Protein gp160|hiv envelope protein gp160
883710|NCT00006509|AIDS Vaccines|aids vaccines
883711|NCT00006509|Anti-HIV Agents|anti-hiv agents
883712|NCT00006509|Treatment Experienced|treatment experienced
883713|NCT00006509|HIV Therapeutic Vaccine|hiv therapeutic vaccine
883714|NCT00006495|Placebos|placebos
883715|NCT00006495|T-Lymphocytes, Helper-Inducer|t-lymphocytes, helper-inducer
883716|NCT00006495|AIDS Vaccines|aids vaccines
883717|NCT00006495|RNA, Viral|rna, viral
883718|NCT00006495|HIV Core Protein p24|hiv core protein p24
883719|NCT00006495|T-Lymphocytes, Cytotoxic|t-lymphocytes, cytotoxic
883720|NCT00006495|Anti-HIV Agents|anti-hiv agents
883721|NCT00006495|HIV Therapeutic Vaccine|hiv therapeutic vaccine
883722|NCT00006490|HIV-1|hiv-1
883723|NCT00006490|Drug Resistance, Microbial|drug resistance, microbial
883724|NCT00006490|Sequence Analysis, DNA|sequence analysis, dna
883725|NCT00006490|Microbial Sensitivity Tests|microbial sensitivity tests
883726|NCT00006490|Genotype|genotype
883727|NCT00006490|Phenotype|phenotype
883728|NCT00006490|Anti-HIV Agents|anti-hiv agents
883729|NCT00006444|Drug Therapy, Combination|drug therapy, combination
883730|NCT00006444|Papillomavirus, Human|papillomavirus, human
883731|NCT00006444|DNA, Viral|dna, viral
883732|NCT00006444|Anti-HIV Agent|anti-hiv agent
883733|NCT00006444|Treatment Naive|treatment naive
883734|NCT00006443|T-Lymphocytes|t-lymphocytes
883735|NCT00006443|HIV-1|hiv-1
883736|NCT00006443|Lymphoid Tissue|lymphoid tissue
883737|NCT00006443|Stavudine|stavudine
883738|NCT00006443|HIV Protease Inhibitors|hiv protease inhibitors
883739|NCT00006443|Polymerase Chain Reaction|polymerase chain reaction
883740|NCT00006443|Biological Markers|biological markers
883741|NCT00006443|Lamivudine|lamivudine
883742|NCT00006443|Indinavir|indinavir
883743|NCT00006443|RNA, Viral|rna, viral
883744|NCT00006443|Genotype|genotype
883745|NCT00006443|Phenotype|phenotype
883746|NCT00006443|Cytokines|cytokines
883747|NCT00006443|Nelfinavir|nelfinavir
883748|NCT00006443|Macrophages|macrophages
883749|NCT00006443|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors
883750|NCT00006443|In Situ Hybridization|in situ hybridization
883751|NCT00006443|Anti-HIV Agents|anti-hiv agents
883752|NCT00006443|Viral Load|viral load
883753|NCT00006443|Cell Membrane|cell membrane
883754|NCT00006443|Acute Infection|acute infection
883755|NCT00006443|Treatment Naive|treatment naive
883756|NCT00006442|Lymphocytes|lymphocytes
883757|NCT00006442|HIV-1|hiv-1
883758|NCT00006442|Lymphoid Tissue|lymphoid tissue
883759|NCT00006442|Blood|blood
883760|NCT00006442|Anti-HIV Agents|anti-hiv agents
883761|NCT00006442|Viral Load|viral load
883762|NCT00006441|Virus Replication|virus replication
883763|NCT00006441|HIV-1|hiv-1
883764|NCT00006441|Interleukin-2|interleukin-2
883765|NCT00006441|Drug Therapy, Combination|drug therapy, combination
883766|NCT00006441|Zidovudine|zidovudine
883767|NCT00006441|HIV Protease Inhibitors|hiv protease inhibitors
883768|NCT00006441|CD4-Positive T-Lymphocytes|cd4-positive t-lymphocytes
883769|NCT00006441|CD8-Positive T-Lymphocytes|cd8-positive t-lymphocytes
883770|NCT00006441|Biological Markers|biological markers
883771|NCT00006441|Lamivudine|lamivudine
883772|NCT00006441|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors
883773|NCT00006441|Anti-HIV Agents|anti-hiv agents
883774|NCT00006441|Nelfinavir|nelfinavir
883775|NCT00006441|Cytotoxicity, Immunologic|cytotoxicity, immunologic
883776|NCT00006441|Acute Infection|acute infection
883777|NCT00006440|Risk Factors|risk factors
883778|NCT00006440|Behavior Therapy|behavior therapy
883779|NCT00006440|Substance-Related Disorders|substance-related disorders
883780|NCT00006440|Feasibility Studies|feasibility studies
883781|NCT00006415|Virus Replication|virus replication
883782|NCT00006415|HIV-1|hiv-1
883783|NCT00006415|Polymerase Chain Reaction|polymerase chain reaction
883784|NCT00006415|DNA, Viral|dna, viral
883785|NCT00006415|RNA, Viral|rna, viral
883786|NCT00006415|Sensitivity and Specificity|sensitivity and specificity
883787|NCT00006415|Anti-HIV Agents|anti-hiv agents
883788|NCT00006415|Viral Load|viral load
883789|NCT00006415|Proviruses|proviruses
883790|NCT00006415|Acute Infection|acute infection
883791|NCT00006412|Hyperlipidemia|hyperlipidemia
883792|NCT00006412|Procetofen|procetofen
883793|NCT00006412|Pravastatin|pravastatin
883794|NCT00006412|Antilipemic Agents|antilipemic agents
883795|NCT00006397|Didanosine|didanosine
883796|NCT00006397|Drug Therapy, Combination|drug therapy, combination
883797|NCT00006397|Stavudine|stavudine
883798|NCT00006397|HIV Protease Inhibitors|hiv protease inhibitors
883799|NCT00006397|Sex Factors|sex factors
883800|NCT00006397|Ritonavir|ritonavir
883801|NCT00006397|Indinavir|indinavir
883802|NCT00006397|Dosage Forms|dosage forms
883803|NCT00006397|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors
883804|NCT00006397|Anti-HIV Agents|anti-hiv agents
883805|NCT00006396|Pregnancy Complications, Infectious|pregnancy complications, infectious
883806|NCT00006396|HIV-1|hiv-1
883807|NCT00006396|Administration, Oral|administration, oral
883808|NCT00006396|Zidovudine|zidovudine
883809|NCT00006396|Nevirapine|nevirapine
883810|NCT00006396|RNA, Viral|rna, viral
883811|NCT00006396|Disease Transmission, Vertical|disease transmission, vertical
883812|NCT00006396|Enzyme-Linked Immunosorbent Assay|enzyme-linked immunosorbent assay
883813|NCT00006396|Blotting, Western|blotting, western
883814|NCT00006396|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors
883815|NCT00006396|Anti-HIV Agents|anti-hiv agents
883816|NCT00006396|Viral Load|viral load
883817|NCT00006396|HIV Seronegativity|hiv seronegativity
883818|NCT00006339|Prospective Studies|prospective studies
883819|NCT00006339|HIV-1|hiv-1
883820|NCT00006339|Didanosine|didanosine
883821|NCT00006339|Drug Therapy, Combination|drug therapy, combination
883822|NCT00006339|Stavudine|stavudine
883823|NCT00006339|HIV Protease Inhibitors|hiv protease inhibitors
883824|NCT00006339|Hydroxyurea|hydroxyurea
883825|NCT00006339|Ritonavir|ritonavir
883826|NCT00006339|Indinavir|indinavir
883827|NCT00006339|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors
883828|NCT00006339|Anti-HIV Agents|anti-hiv agents
883829|NCT00006339|Viral Load|viral load
883830|NCT00006339|Reverse Transcriptase Polymerase Chain Reaction|reverse transcriptase polymerase chain reaction
883831|NCT00006327|Recombinant Proteins|recombinant proteins
883832|NCT00006327|HIV-1|hiv-1
883833|NCT00006327|AIDS Serodiagnosis|aids serodiagnosis
883834|NCT00006327|Substance Abuse, Intravenous|substance abuse, intravenous
883835|NCT00006327|Enzyme-Linked Immunosorbent Assay|enzyme-linked immunosorbent assay
883836|NCT00006327|Blotting, Western|blotting, western
883837|NCT00006327|HIV Envelope Protein gp120|hiv envelope protein gp120
883838|NCT00006327|AIDSVAX|aidsvax
883839|NCT00006326|Drug Therapy, Combination|drug therapy, combination
883840|NCT00006326|HIV Protease Inhibitors|hiv protease inhibitors
883841|NCT00006326|Ritonavir|ritonavir
883842|NCT00006326|Indinavir|indinavir
883843|NCT00006326|Delavirdine|delavirdine
883844|NCT00006326|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors
883845|NCT00006326|Salvage Therapy|salvage therapy
883846|NCT00006326|Anti-HIV Agents|anti-hiv agents
883847|NCT00006326|Viral Load|viral load
883848|NCT00006326|Nelfinavir|nelfinavir
883849|NCT00006325|Polyethylene Glycols|polyethylene glycols
883850|NCT00006325|Interferon Alfa-2b|interferon alfa-2b
883851|NCT00006325|HIV-1|hiv-1
883852|NCT00006325|Dose-Response Relationship, Drug|dose-response relationship, drug
883853|NCT00006325|Drug Therapy, Combination|drug therapy, combination
883854|NCT00006325|Virus Inhibitors|virus inhibitors
883855|NCT00006325|Anti-HIV Agents|anti-hiv agents
883856|NCT00006325|Pharmacokinetics|pharmacokinetics
883857|NCT00006324|HIV Seronegativity|hiv seronegativity
883858|NCT00006324|Delayed-Action Preparations|delayed-action preparations
883859|NCT00006324|Risk Factors|risk factors
883860|NCT00006324|Prevalence|prevalence
883861|NCT00006324|Contraceptive Agents, Female|contraceptive agents, female
883862|NCT00006324|Contraceptives, Oral, Combined|contraceptives, oral, combined
883863|NCT00006324|Medroxyprogesterone 17-Acetate|medroxyprogesterone 17-acetate
883864|NCT00006316|AIDS-Related Opportunistic Infections|aids-related opportunistic infections
883865|NCT00006316|Histoplasmosis|histoplasmosis
883866|NCT00006316|Antifungal Agents|antifungal agents
883867|NCT00006316|Recurrence|recurrence
883868|NCT00006316|Anti-HIV Agents|anti-hiv agents
883869|NCT00006304|Acquired Immunodeficiency Syndrome|acquired immunodeficiency syndrome
883870|NCT00006304|AIDS-Related Complex|aids-related complex
883871|NCT00006298|HIV Antibodies|hiv antibodies
883872|NCT00006298|HIV-1|hiv-1
883873|NCT00006298|CD4 Lymphocyte Count|cd4 lymphocyte count
883874|NCT00006298|T-Lymphocytes, Cytotoxic|t-lymphocytes, cytotoxic
883875|NCT00006298|Genotype|genotype
883876|NCT00006298|Species Specificity|species specificity
883877|NCT00006298|Neutralization Tests|neutralization tests
883878|NCT00006298|Viral Load|viral load
883879|NCT00006298|Alleles|alleles
883880|NCT00006298|HLA Antigens|hla antigens
883881|NCT00006298|Cross Reactions|cross reactions
883882|NCT00006298|Immunodominant Epitopes|immunodominant epitopes
883883|NCT00006298|Haplotypes|haplotypes
883884|NCT00006291|Virus Replication|virus replication
883885|NCT00006291|T-Lymphocytes|t-lymphocytes
883886|NCT00006291|Lymphocyte Transformation|lymphocyte transformation
883887|NCT00006291|AIDS Vaccines|aids vaccines
883888|NCT00006291|Anti-HIV Agents|anti-hiv agents
883889|NCT00006291|Viral Load|viral load
883890|NCT00006291|Aldesleukin|aldesleukin
883891|NCT00006291|HIV Therapeutic Vaccine|hiv therapeutic vaccine
883892|NCT00006290|Drug Therapy, Combination|drug therapy, combination
883893|NCT00006290|Questionnaires|questionnaires
883894|NCT00006290|Quality of Life|quality of life
883895|NCT00006290|Patient Compliance|patient compliance
883896|NCT00006290|Body Composition|body composition
883897|NCT00006290|Anti-HIV Agents|anti-hiv agents
883898|NCT00006290|Adipose Tissue|adipose tissue
883899|NCT00006290|Body Image|body image
883998|NCT00006066|Interleukin-2|interleukin-2
883900|NCT00006279|Pregnancy Complications, Infectious|pregnancy complications, infectious
883901|NCT00006279|Dose-Response Relationship, Drug|dose-response relationship, drug
883902|NCT00006279|Drug Administration Schedule|drug administration schedule
883903|NCT00006279|Nevirapine|nevirapine
883904|NCT00006279|Disease Transmission, Vertical|disease transmission, vertical
883905|NCT00006279|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors
883906|NCT00006279|Anti-HIV Agents|anti-hiv agents
883907|NCT00006279|Breast Feeding|breast feeding
883908|NCT00006211|Drug Therapy, Combination|drug therapy, combination
883909|NCT00006211|HIV Protease Inhibitors|hiv protease inhibitors
883910|NCT00006211|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors
883911|NCT00006211|Anti-HIV Agents|anti-hiv agents
883912|NCT00006211|Viral Load|viral load
883913|NCT00006211|Nelfinavir|nelfinavir
883914|NCT00006209|HIV-1|hiv-1
883915|NCT00006209|Immunity, Cellular|immunity, cellular
883916|NCT00006209|Drug Therapy, Combination|drug therapy, combination
883917|NCT00006209|CD4-Positive T-Lymphocytes|cd4-positive t-lymphocytes
883918|NCT00006209|Antigens|antigens
883919|NCT00006209|Anti-HIV Agents|anti-hiv agents
883920|NCT00006209|Viral Load|viral load
883921|NCT00006209|tucaresol|tucaresol
883922|NCT00006208|HIV-1|hiv-1
883923|NCT00006208|Didanosine|didanosine
883924|NCT00006208|Drug Therapy, Combination|drug therapy, combination
883925|NCT00006208|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors
883926|NCT00006208|Anti-HIV Agents|anti-hiv agents
883927|NCT00006208|Deoxycytidine|deoxycytidine
883928|NCT00006208|efavirenz|efavirenz
883929|NCT00006207|HIV Seropositivity|hiv seropositivity
883930|NCT00006207|Dose-Response Relationship, Drug|dose-response relationship, drug
883931|NCT00006207|HIV Seronegativity|hiv seronegativity
883932|NCT00006207|Mucous Membrane|mucous membrane
883933|NCT00006207|Ulcer|ulcer
883934|NCT00006207|Vagina|vagina
883935|NCT00006207|Anti-HIV Agents|anti-hiv agents
883936|NCT00006207|Sexual Abstinence|sexual abstinence
883937|NCT00006207|Irritants|irritants
883938|NCT00006207|PRO 2000|pro 2000
883939|NCT00006154|Interleukin-2|interleukin-2
883940|NCT00006154|Didanosine|didanosine
883941|NCT00006154|Drug Therapy, Combination|drug therapy, combination
883942|NCT00006154|Stavudine|stavudine
883943|NCT00006154|HIV Protease Inhibitors|hiv protease inhibitors
883944|NCT00006154|Ritonavir|ritonavir
883945|NCT00006154|Indinavir|indinavir
883946|NCT00006154|Virus Latency|virus latency
883947|NCT00006154|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors
883948|NCT00006154|Anti-HIV Agents|anti-hiv agents
883949|NCT00006154|abacavir|abacavir
883950|NCT00006154|efavirenz|efavirenz
883951|NCT00006154|Acute Infection|acute infection
883952|NCT00006153|HIV Antibodies|hiv antibodies
883953|NCT00006153|Immunity, Cellular|immunity, cellular
883954|NCT00006153|Drug Therapy, Combination|drug therapy, combination
883955|NCT00006153|Anti-HIV Agents|anti-hiv agents
883956|NCT00006153|remune|remune
883957|NCT00006153|HIV Therapeutic Vaccine|hiv therapeutic vaccine
883958|NCT00006152|Drug Therapy, Combination|drug therapy, combination
883959|NCT00006152|HIV Protease Inhibitors|hiv protease inhibitors
883960|NCT00006152|Ritonavir|ritonavir
883961|NCT00006152|VX 478|vx 478
883962|NCT00006152|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors
883963|NCT00006152|Anti-HIV Agents|anti-hiv agents
883964|NCT00006152|Viral Load|viral load
883965|NCT00006152|abacavir|abacavir
883966|NCT00006145|Ganciclovir|ganciclovir
883967|NCT00006145|Cytomegalovirus|cytomegalovirus
883968|NCT00006145|Cytomegalovirus Infections|cytomegalovirus infections
883969|NCT00006145|Administration, Oral|administration, oral
883970|NCT00006145|Antiviral Agents|antiviral agents
883971|NCT00006145|Polymerase Chain Reaction|polymerase chain reaction
883972|NCT00006145|Viremia|viremia
883973|NCT00006145|DNA, Viral|dna, viral
883974|NCT00006144|Drug Therapy, Combination|drug therapy, combination
883975|NCT00006144|Stavudine|stavudine
883976|NCT00006144|HIV Protease Inhibitors|hiv protease inhibitors
883977|NCT00006144|Cohort Studies|cohort studies
883978|NCT00006144|Ritonavir|ritonavir
883979|NCT00006144|Disease Progression|disease progression
883980|NCT00006144|Antigens, CD|antigens, cd
883981|NCT00006144|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors
883982|NCT00006144|Anti-HIV Agents|anti-hiv agents
883983|NCT00006144|Immunophenotyping|immunophenotyping
883984|NCT00006144|Deoxycytidine|deoxycytidine
883985|NCT00006143|Treatment Outcome|treatment outcome
883986|NCT00006143|serostim|serostim
883987|NCT00006143|Developmental Disabilities|developmental disabilities
883988|NCT00006075|Pregnancy Complications, Infectious|pregnancy complications, infectious
883989|NCT00006075|Dose-Response Relationship, Drug|dose-response relationship, drug
883990|NCT00006075|Polymerase Chain Reaction|polymerase chain reaction
883991|NCT00006075|Disease Transmission, Vertical|disease transmission, vertical
883992|NCT00006075|Labor|labor
883993|NCT00006075|Disinfectants|disinfectants
883994|NCT00006075|Vagina|vagina
883995|NCT00006075|Chlorhexidine|chlorhexidine
883996|NCT00006075|Irrigation|irrigation
883997|NCT00006066|Injections, Subcutaneous|injections, subcutaneous
883999|NCT00006066|Dose-Response Relationship, Drug|dose-response relationship, drug
884000|NCT00006066|Drug Therapy, Combination|drug therapy, combination
884001|NCT00006066|Immunocompromised Host|immunocompromised host
884002|NCT00006066|CD4 Lymphocyte Count|cd4 lymphocyte count
884003|NCT00006066|Anti-HIV Agents|anti-hiv agents
884004|NCT00006064|Tumor Necrosis Factor|tumor necrosis factor
884005|NCT00006064|CD4 Lymphocyte Count|cd4 lymphocyte count
884006|NCT00006064|Polymerase Chain Reaction|polymerase chain reaction
884007|NCT00006064|Enzyme-Linked Immunosorbent Assay|enzyme-linked immunosorbent assay
884008|NCT00006064|RNA, Messenger|rna, messenger
884009|NCT00006064|Interleukin-1|interleukin-1
884010|NCT00006064|Body Composition|body composition
884011|NCT00006064|Anti-HIV Agents|anti-hiv agents
884012|NCT00006064|Viral Load|viral load
884013|NCT00006064|Age Factors|age factors
884014|NCT00006064|Anthropometry|anthropometry
884015|NCT00005931|Skin Neoplasms|skin neoplasms
884016|NCT00005931|Sarcoma, Kaposi|sarcoma, kaposi
884017|NCT00005931|Acquired Immunodeficiency Syndrome|acquired immunodeficiency syndrome
884018|NCT00005931|Antineoplastic Agents|antineoplastic agents
884019|NCT00005931|Enzyme Inhibitors|enzyme inhibitors
884020|NCT00005931|SU 5416|su 5416
884021|NCT00005931|Protein-Tyrosine Kinase|protein-tyrosine kinase
884022|NCT00005921|Dose-Response Relationship, Drug|dose-response relationship, drug
884023|NCT00005921|Antifungal Agents|antifungal agents
884024|NCT00005921|Candidiasis|candidiasis
884025|NCT00005921|Esophageal Diseases|esophageal diseases
884026|NCT00005921|MK 0991|mk 0991
884027|NCT00005920|AIDS-Related Opportunistic Infections|aids-related opportunistic infections
884028|NCT00005920|Dose-Response Relationship, Drug|dose-response relationship, drug
884029|NCT00005920|Fluconazole|fluconazole
884030|NCT00005920|Antifungal Agents|antifungal agents
884031|NCT00005920|Candidiasis, Oral|candidiasis, oral
884032|NCT00005920|Pharyngeal Diseases|pharyngeal diseases
884033|NCT00005920|MK 0991|mk 0991
884034|NCT00005918|Drug Therapy, Combination|drug therapy, combination
884035|NCT00005918|Stavudine|stavudine
884036|NCT00005918|Lamivudine|lamivudine
884037|NCT00005918|RNA, Viral|rna, viral
884038|NCT00005918|Dosage Forms|dosage forms
884039|NCT00005918|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors
884040|NCT00005918|Anti-HIV Agents|anti-hiv agents
884041|NCT00005918|Viral Load|viral load
884042|NCT00005918|efavirenz|efavirenz
884043|NCT00005915|HIV-1|hiv-1
884044|NCT00005915|Drug Administration Schedule|drug administration schedule
884045|NCT00005915|Drug Resistance, Microbial|drug resistance, microbial
884046|NCT00005915|Disease Progression|disease progression
884047|NCT00005915|Genotype|genotype
884048|NCT00005915|Phenotype|phenotype
884049|NCT00005915|Drug Resistance, Multiple|drug resistance, multiple
884050|NCT00005915|Anti-HIV Agents|anti-hiv agents
884051|NCT00005915|Treatment Experienced|treatment experienced
884052|NCT00005779|Virus Replication|virus replication
884053|NCT00005779|HIV-1|hiv-1
884054|NCT00005779|AIDS Vaccines|aids vaccines
884055|NCT00005779|CD4 Lymphocyte Count|cd4 lymphocyte count
884056|NCT00005779|Cohort Studies|cohort studies
884057|NCT00005779|Interleukin-12|interleukin-12
884058|NCT00005779|HIV Therapeutic Vaccine|hiv therapeutic vaccine
884059|NCT00005764|HIV-1|hiv-1
884062|NCT00005764|Drug Therapy, Combination|drug therapy, combination
884063|NCT00005764|Zidovudine|zidovudine
884064|NCT00005764|Stavudine|stavudine
884065|NCT00005764|Lamivudine|lamivudine
884066|NCT00005764|Blood|blood
884067|NCT00005764|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors
884068|NCT00005764|Anti-HIV Agents|anti-hiv agents
884069|NCT00005764|Lipodystrophy|lipodystrophy
884070|NCT00005764|Combivir|combivir
884071|NCT00005764|Lactic Acid|lactic acid
884072|NCT00005764|abacavir|abacavir
884073|NCT00005762|Drug Interactions|drug interactions
884074|NCT00005762|Drug Therapy, Combination|drug therapy, combination
884075|NCT00005762|HIV Protease Inhibitors|hiv protease inhibitors
884076|NCT00005762|Ritonavir|ritonavir
884077|NCT00005762|Dosage Forms|dosage forms
884078|NCT00005762|Saquinavir|saquinavir
884079|NCT00005762|VX 478|vx 478
884080|NCT00005762|Anti-HIV Agents|anti-hiv agents
884081|NCT00005762|Nelfinavir|nelfinavir
884082|NCT00005762|Pharmacokinetics|pharmacokinetics
884083|NCT00005762|efavirenz|efavirenz
884084|NCT00005758|T-Lymphocytes, Helper-Inducer|t-lymphocytes, helper-inducer
884085|NCT00005758|Combined Modality Therapy|combined modality therapy
884086|NCT00005758|HIV Envelope Protein gp120|hiv envelope protein gp120
884087|NCT00005758|AIDS Vaccines|aids vaccines
884088|NCT00005758|RNA, Viral|rna, viral
884089|NCT00005758|HIV Core Protein p24|hiv core protein p24
884090|NCT00005758|T-Lymphocytes, Cytotoxic|t-lymphocytes, cytotoxic
884091|NCT00005758|Anti-HIV Agents|anti-hiv agents
884092|NCT00005758|Viral Load|viral load
884093|NCT00005758|HIV Therapeutic Vaccine|hiv therapeutic vaccine
884094|NCT00005663|Herpes Simplex|herpes simplex
884095|NCT00005663|Antiviral Agents|antiviral agents
884096|NCT00005663|Anus Diseases|anus diseases
884097|NCT00005663|Herpes Genitalis|herpes genitalis
884098|NCT00005663|Recurrence|recurrence
884099|NCT00005663|valacyclovir|valacyclovir
884100|NCT00005572|AIDS-Related Opportunistic Infections|aids-related opportunistic infections
884101|NCT00005572|Pneumonia, Pneumocystis carinii|pneumonia, pneumocystis carinii
884102|NCT00005572|Lymphocytes|lymphocytes
884103|NCT00005572|Histoplasmosis|histoplasmosis
884104|NCT00005572|Recurrence|recurrence
884105|NCT00005572|Cytomegalovirus Retinitis|cytomegalovirus retinitis
884106|NCT00005572|Cell Division|cell division
884107|NCT00005572|Immunocompetence|immunocompetence
884108|NCT00005572|Anti-HIV Agents|anti-hiv agents
884109|NCT00005120|CD4 Lymphocyte Count|cd4 lymphocyte count
884110|NCT00005120|Biological Markers|biological markers
884111|NCT00005120|Anti-HIV Agents|anti-hiv agents
884112|NCT00005120|Viral Load|viral load
884113|NCT00005120|Pharmacokinetics|pharmacokinetics
884114|NCT00005120|calanolide A|calanolide a
884115|NCT00005118|HIV-1|hiv-1
884116|NCT00005118|Drug Therapy, Combination|drug therapy, combination
884117|NCT00005118|HIV Protease Inhibitors|hiv protease inhibitors
884118|NCT00005118|Ritonavir|ritonavir
884119|NCT00005118|Indinavir|indinavir
884120|NCT00005118|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors
884121|NCT00005118|Anti-HIV Agents|anti-hiv agents
884122|NCT00005118|Viral Load|viral load
884123|NCT00005118|Nelfinavir|nelfinavir
884124|NCT00005106|Drug Therapy, Combination|drug therapy, combination
884125|NCT00005106|Zidovudine|zidovudine
884126|NCT00005106|Stavudine|stavudine
884127|NCT00005106|HIV Protease Inhibitors|hiv protease inhibitors
884128|NCT00005106|Lamivudine|lamivudine
884129|NCT00005106|Nelfinavir|nelfinavir
884130|NCT00005106|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors
884131|NCT00005106|Anti-HIV Agents|anti-hiv agents
884132|NCT00005106|Adipose Tissue|adipose tissue
884133|NCT00005106|Lipodystrophy|lipodystrophy
884134|NCT00005106|abacavir|abacavir
884135|NCT00005020|CD4 Lymphocyte Count|cd4 lymphocyte count
884136|NCT00005020|CD4-Positive T-Lymphocytes|cd4-positive t-lymphocytes
884137|NCT00005020|Phenotype|phenotype
884138|NCT00005020|Viral Load|viral load
884139|NCT00005020|Acute Infection|acute infection
884140|NCT00005018|HIV-1|hiv-1
884141|NCT00005018|Didanosine|didanosine
884142|NCT00005018|Drug Therapy, Combination|drug therapy, combination
884143|NCT00005018|Zidovudine|zidovudine
884144|NCT00005018|Stavudine|stavudine
884145|NCT00005018|HIV Protease Inhibitors|hiv protease inhibitors
884146|NCT00005018|Hydroxyurea|hydroxyurea
884147|NCT00005018|RNA, Viral|rna, viral
884148|NCT00005018|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors
884149|NCT00005018|Anti-HIV Agents|anti-hiv agents
884150|NCT00005018|Viral Load|viral load
884151|NCT00005018|abacavir|abacavir
884152|NCT00005018|efavirenz|efavirenz
884153|NCT00005017|HIV-1|hiv-1
884154|NCT00005017|Drug Therapy, Combination|drug therapy, combination
884155|NCT00005017|Stavudine|stavudine
884156|NCT00005017|HIV Protease Inhibitors|hiv protease inhibitors
884157|NCT00005017|Ritonavir|ritonavir
884158|NCT00005017|Lamivudine|lamivudine
884159|NCT00005017|VX 478|vx 478
884160|NCT00005017|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors
884161|NCT00005017|Anti-HIV Agents|anti-hiv agents
884162|NCT00005017|abacavir|abacavir
884163|NCT00005017|efavirenz|efavirenz
884164|NCT00005012|Interferon Alfa-2b|interferon alfa-2b
884165|NCT00005012|Lymphocyte Transformation|lymphocyte transformation
884166|NCT00005012|CD4 Lymphocyte Count|cd4 lymphocyte count
884167|NCT00005012|RNA, Viral|rna, viral
884168|NCT00005012|Virus Inhibitors|virus inhibitors
884169|NCT00005012|Anti-HIV Agents|anti-hiv agents
884170|NCT00005012|Viral Load|viral load
884171|NCT00005009|pediatric renal transplant recipients|pediatric renal transplant recipients
884172|NCT00005009|varicella zoster virus (VZV) vaccine|varicella zoster virus (vzv) vaccine
884173|NCT00005009|herpes zoster vaccine|herpes zoster vaccine
884174|NCT00005009|VZV susceptible|vzv susceptible
884175|NCT00005009|safety|safety
884176|NCT00005009|immunogenicity|immunogenicity
884177|NCT00005002|HIV-1|hiv-1
884178|NCT00005002|Drug Therapy, Combination|drug therapy, combination
884179|NCT00005002|HIV Protease Inhibitors|hiv protease inhibitors
884180|NCT00005002|CD4 Lymphocyte Count|cd4 lymphocyte count
884181|NCT00005002|Nelfinavir|nelfinavir
884182|NCT00005002|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors
884183|NCT00005002|Anti-HIV Agents|anti-hiv agents
884184|NCT00005002|Viral Load|viral load
884185|NCT00005002|remune|remune
884186|NCT00005002|Combivir|combivir
884187|NCT00005001|HIV-1|hiv-1
884188|NCT00005001|Drug Therapy, Combination|drug therapy, combination
884189|NCT00005001|RNA, Viral|rna, viral
884190|NCT00005001|Anti-HIV Agents|anti-hiv agents
884191|NCT00005001|Viral Load|viral load
884192|NCT00005001|remune|remune
884193|NCT00005000|HIV-1|hiv-1
884194|NCT00005000|Drug Therapy, Combination|drug therapy, combination
884195|NCT00005000|Lymphoid Tissue|lymphoid tissue
884196|NCT00005000|HIV Protease Inhibitors|hiv protease inhibitors
884197|NCT00005000|Genotype|genotype
884198|NCT00005000|Phenotype|phenotype
884199|NCT00005000|Nelfinavir|nelfinavir
884200|NCT00005000|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors
884201|NCT00005000|Anti-HIV Agents|anti-hiv agents
884202|NCT00005000|Viral Load|viral load
884203|NCT00005000|Adipose Tissue|adipose tissue
884204|NCT00005000|Glucose|glucose
884205|NCT00005000|Lipids|lipids
884206|NCT00005000|Immunophenotyping|immunophenotyping
884207|NCT00005000|efavirenz|efavirenz
884208|NCT00004999|Drug Therapy, Combination|drug therapy, combination
884209|NCT00004999|Zidovudine|zidovudine
884210|NCT00004999|HIV Protease Inhibitors|hiv protease inhibitors
884211|NCT00004999|Lamivudine|lamivudine
884212|NCT00004999|Disease Progression|disease progression
884213|NCT00004999|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors
884214|NCT00004999|Anti-HIV Agents|anti-hiv agents
884215|NCT00004999|Viral Load|viral load
884216|NCT00004999|Nelfinavir|nelfinavir
884217|NCT00004999|Combivir|combivir
884218|NCT00004998|Drug Therapy, Combination|drug therapy, combination
884219|NCT00004998|Zidovudine|zidovudine
884220|NCT00004998|HIV Protease Inhibitors|hiv protease inhibitors
884221|NCT00004998|Lamivudine|lamivudine
884222|NCT00004998|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors
884223|NCT00004998|Anti-HIV Agents|anti-hiv agents
884224|NCT00004998|Nelfinavir|nelfinavir
884225|NCT00004998|Combivir|combivir
884226|NCT00004987|Anti-HIV Agents|anti-hiv agents
884227|NCT00004987|Viral Load|viral load
884228|NCT00004987|dextrin 2-sulfate|dextrin 2-sulfate
884229|NCT00004987|Infusions, Parenteral|infusions, parenteral
884230|NCT00004986|AIDS-Related Opportunistic Infections|aids-related opportunistic infections
884231|NCT00004986|Cryptosporidiosis|cryptosporidiosis
884232|NCT00004986|Drug Evaluation|drug evaluation
884233|NCT00004986|Antiprotozoal Agents|antiprotozoal agents
884234|NCT00004986|Treatment Failure|treatment failure
884235|NCT00004986|nitazoxanide|nitazoxanide
884236|NCT00004985|HIV-1|hiv-1
884237|NCT00004985|Drug Therapy, Combination|drug therapy, combination
884238|NCT00004985|HIV Protease Inhibitors|hiv protease inhibitors
884239|NCT00004985|RNA, Viral|rna, viral
884240|NCT00004985|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors
884241|NCT00004985|Anti-HIV Agents|anti-hiv agents
884242|NCT00004985|Viral Load|viral load
884243|NCT00004985|Nelfinavir|nelfinavir
884244|NCT00004981|Drug Therapy, Combination|drug therapy, combination
884245|NCT00004981|Zidovudine|zidovudine
884246|NCT00004981|Drug Administration Schedule|drug administration schedule
884247|NCT00004981|Lamivudine|lamivudine
884248|NCT00004981|RNA, Viral|rna, viral
884249|NCT00004981|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors
884250|NCT00004981|Anti-HIV Agents|anti-hiv agents
884251|NCT00004981|Viral Load|viral load
884252|NCT00004981|Combivir|combivir
884253|NCT00004981|abacavir|abacavir
884254|NCT00004978|Recombinant Proteins|recombinant proteins
884255|NCT00004978|Injections, Subcutaneous|injections, subcutaneous
884256|NCT00004978|HIV-1|hiv-1
884257|NCT00004978|Interleukin-2|interleukin-2
884258|NCT00004978|Drug Therapy, Combination|drug therapy, combination
884259|NCT00004978|CD4 Lymphocyte Count|cd4 lymphocyte count
884260|NCT00004978|Disease Progression|disease progression
884261|NCT00004978|Follow-Up Studies|follow-up studies
884262|NCT00004978|Anti-HIV Agents|anti-hiv agents
884263|NCT00004855|Drug Therapy, Combination|drug therapy, combination
884266|NCT00004855|HIV Protease Inhibitors|hiv protease inhibitors
884267|NCT00004855|Ritonavir|ritonavir
884268|NCT00004855|Lamivudine|lamivudine
884269|NCT00004855|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors
884270|NCT00004855|Anti-HIV Agents|anti-hiv agents
884271|NCT00004855|ABT 378|abt 378
884272|NCT00004855|abacavir|abacavir
884273|NCT00004852|HIV-1|hiv-1
884274|NCT00004852|Drug Therapy, Combination|drug therapy, combination
884275|NCT00004852|Zidovudine|zidovudine
884276|NCT00004852|Drug Administration Schedule|drug administration schedule
884277|NCT00004852|Lamivudine|lamivudine
884278|NCT00004852|Genotype|genotype
884279|NCT00004852|Phenotype|phenotype
884280|NCT00004852|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors
884281|NCT00004852|Anti-HIV Agents|anti-hiv agents
884282|NCT00004852|Viral Load|viral load
884283|NCT00004852|efavirenz|efavirenz
884284|NCT00004736|Tuberculosis|tuberculosis
884285|NCT00004736|Rifabutin|rifabutin
884286|NCT00004736|AIDS-Related Opportunistic Infections|aids-related opportunistic infections
884287|NCT00004736|Drug Therapy, Combination|drug therapy, combination
884288|NCT00004736|Antitubercular Agents|antitubercular agents
884289|NCT00004736|Anti-HIV Agents|anti-hiv agents
884290|NCT00004735|Viral Vaccines|viral vaccines
884291|NCT00004735|Drug Therapy, Combination|drug therapy, combination
884292|NCT00004735|CD4-Positive T-Lymphocytes|cd4-positive t-lymphocytes
884293|NCT00004735|Immunologic Memory|immunologic memory
884294|NCT00004735|Antibody Formation|antibody formation
884295|NCT00004735|Anti-HIV Agents|anti-hiv agents
884296|NCT00004735|Tetanus Toxoid|tetanus toxoid
884297|NCT00004735|Hepatitis A Virus, Human|hepatitis a virus, human
884298|NCT00004735|Enfuvirtide|enfuvirtide
884299|NCT00004735|T-20|t-20
884300|NCT00004735|Treatment Naive|treatment naive
884301|NCT00004735|Treatment Experienced|treatment experienced
884302|NCT00004585|Drug Therapy, Combination|drug therapy, combination
884303|NCT00004585|Zidovudine|zidovudine
884304|NCT00004585|Lamivudine|lamivudine
884305|NCT00004585|RNA, Viral|rna, viral
884306|NCT00004585|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors
884307|NCT00004585|Anti-HIV Agents|anti-hiv agents
884308|NCT00004585|Viral Load|viral load
884309|NCT00004585|abacavir|abacavir
884310|NCT00004585|efavirenz|efavirenz
884311|NCT00004584|Dose-Response Relationship, Drug|dose-response relationship, drug
884312|NCT00004584|Drug Therapy, Combination|drug therapy, combination
884313|NCT00004584|HIV Protease Inhibitors|hiv protease inhibitors
884314|NCT00004584|Ritonavir|ritonavir
884315|NCT00004584|Saquinavir|saquinavir
884316|NCT00004584|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors
884317|NCT00004584|Anti-HIV Agents|anti-hiv agents
884318|NCT00004583|Drug Therapy, Combination|drug therapy, combination
884319|NCT00004583|Administration, Oral|administration, oral
884320|NCT00004583|Stavudine|stavudine
884321|NCT00004583|HIV Protease Inhibitors|hiv protease inhibitors
884322|NCT00004583|Lamivudine|lamivudine
884323|NCT00004583|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors
884324|NCT00004583|Anti-HIV Agents|anti-hiv agents
884325|NCT00004583|Nelfinavir|nelfinavir
884326|NCT00004583|ABT 378|abt 378
884327|NCT00004582|HIV Protease Inhibitors|hiv protease inhibitors
884328|NCT00004582|Ritonavir|ritonavir
884329|NCT00004582|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors
884330|NCT00004582|Anti-HIV Agents|anti-hiv agents
884331|NCT00004582|Viral Load|viral load
884332|NCT00004582|ABT 378|abt 378
884333|NCT00004582|efavirenz|efavirenz
884334|NCT00004581|Drug Therapy, Combination|drug therapy, combination
884335|NCT00004581|Nevirapine|nevirapine
884336|NCT00004581|HIV Protease Inhibitors|hiv protease inhibitors
884337|NCT00004581|Ritonavir|ritonavir
884338|NCT00004581|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors
884339|NCT00004581|Anti-HIV Agents|anti-hiv agents
884340|NCT00004581|ABT 378|abt 378
884341|NCT00004580|Drug Therapy, Combination|drug therapy, combination
884342|NCT00004580|Nevirapine|nevirapine
884343|NCT00004580|HIV Protease Inhibitors|hiv protease inhibitors
884344|NCT00004580|Ritonavir|ritonavir
884345|NCT00004580|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors
884346|NCT00004579|Vaccines, Synthetic|vaccines, synthetic
884347|NCT00004579|Viral Vaccines|viral vaccines
884348|NCT00004579|HIV-1|hiv-1
884349|NCT00004579|Dose-Response Relationship, Drug|dose-response relationship, drug
884350|NCT00004579|HIV Envelope Protein gp160|hiv envelope protein gp160
884351|NCT00004579|AIDS Vaccines|aids vaccines
884352|NCT00004579|HIV Seronegativity|hiv seronegativity
884353|NCT00004579|Avipoxvirus|avipoxvirus
884354|NCT00004579|Immunization|immunization
884355|NCT00004579|HIV Envelope Protein gp120|hiv envelope protein gp120
884356|NCT00004579|Recombination, Genetic|recombination, genetic
884357|NCT00004578|Stavudine|stavudine
884358|NCT00004578|HIV Protease Inhibitors|hiv protease inhibitors
884359|NCT00004578|Ritonavir|ritonavir
884360|NCT00004578|Lamivudine|lamivudine
884361|NCT00004578|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors
884362|NCT00002453|HIV-1|hiv-1
884363|NCT00002453|Drug Therapy, Combination|drug therapy, combination
884364|NCT00002453|Disease Progression|disease progression
884365|NCT00002453|Anti-HIV Agents|anti-hiv agents
884366|NCT00002452|Drug Therapy, Combination|drug therapy, combination
884367|NCT00002452|HIV Protease Inhibitors|hiv protease inhibitors
884368|NCT00002452|Indinavir|indinavir
884369|NCT00002452|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors
884370|NCT00002452|Anti-HIV Agents|anti-hiv agents
884371|NCT00002452|Viral Load|viral load
884372|NCT00002451|Drug Therapy, Combination|drug therapy, combination
884373|NCT00002451|Stavudine|stavudine
884374|NCT00002451|HIV Protease Inhibitors|hiv protease inhibitors
884375|NCT00002451|CD4 Lymphocyte Count|cd4 lymphocyte count
884376|NCT00002451|Ritonavir|ritonavir
884377|NCT00002451|Lamivudine|lamivudine
884378|NCT00002451|Indinavir|indinavir
884379|NCT00002451|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors
884380|NCT00002451|Anti-HIV Agents|anti-hiv agents
884381|NCT00002451|Viral Load|viral load
884382|NCT00002450|HIV-1|hiv-1
884383|NCT00002450|Drug Therapy, Combination|drug therapy, combination
884384|NCT00002450|Drug Administration Schedule|drug administration schedule
884385|NCT00002450|RNA, Viral|rna, viral
884386|NCT00002450|Anti-HIV Agents|anti-hiv agents
884387|NCT00002450|Viral Load|viral load
884388|NCT00002449|Recombinant Proteins|recombinant proteins
884389|NCT00002449|Injections, Subcutaneous|injections, subcutaneous
884390|NCT00002449|Interleukin-2|interleukin-2
884391|NCT00002449|Dose-Response Relationship, Drug|dose-response relationship, drug
884392|NCT00002449|CD4 Lymphocyte Count|cd4 lymphocyte count
884393|NCT00002449|Anti-HIV Agents|anti-hiv agents
884394|NCT00002449|Viral Load|viral load
884395|NCT00002449|Pharmacokinetics|pharmacokinetics
884396|NCT00002448|Drug Therapy, Combination|drug therapy, combination
884587|NCT00002413|MKC 442|mkc 442
884397|NCT00002448|HIV Protease Inhibitors|hiv protease inhibitors
884398|NCT00002448|Ritonavir|ritonavir
884399|NCT00002448|Dosage Forms|dosage forms
884400|NCT00002448|Saquinavir|saquinavir
884401|NCT00002448|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors
884402|NCT00002448|Anti-HIV Agents|anti-hiv agents
884403|NCT00002448|efavirenz|efavirenz
884404|NCT00002447|Drug Therapy, Combination|drug therapy, combination
884405|NCT00002447|Saquinavir|saquinavir
884406|NCT00002447|HIV Protease Inhibitors|hiv protease inhibitors
884407|NCT00002447|Ritonavir|ritonavir
884408|NCT00002447|Dosage Forms|dosage forms
884409|NCT00002447|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors
884410|NCT00002447|Anti-HIV Agents|anti-hiv agents
884411|NCT00002447|efavirenz|efavirenz
884412|NCT00002446|AIDS-Related Opportunistic Infections|aids-related opportunistic infections
884413|NCT00002446|Fluconazole|fluconazole
884414|NCT00002446|Administration, Oral|administration, oral
884415|NCT00002446|Antifungal Agents|antifungal agents
884416|NCT00002446|Candidiasis, Oral|candidiasis, oral
884417|NCT00002446|Pharyngeal Diseases|pharyngeal diseases
884418|NCT00002446|posaconazole|posaconazole
884419|NCT00002445|AIDS-Related Opportunistic Infections|aids-related opportunistic infections
884420|NCT00002445|Placebos|placebos
884421|NCT00002445|Sarcoma, Kaposi|sarcoma, kaposi
884422|NCT00002445|Antineoplastic Agents|antineoplastic agents
884423|NCT00002445|Treatment Outcome|treatment outcome
884424|NCT00002445|Quality of Life|quality of life
884425|NCT00002442|Drug Therapy, Combination|drug therapy, combination
884426|NCT00002442|Zidovudine|zidovudine
884427|NCT00002442|Drug Administration Schedule|drug administration schedule
884428|NCT00002442|Stavudine|stavudine
884429|NCT00002442|HIV Protease Inhibitors|hiv protease inhibitors
884430|NCT00002442|Lamivudine|lamivudine
884431|NCT00002442|Indinavir|indinavir
884432|NCT00002442|Dosage Forms|dosage forms
884433|NCT00002442|Nelfinavir|nelfinavir
884434|NCT00002442|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors
884435|NCT00002442|Anti-HIV Agents|anti-hiv agents
884436|NCT00002441|HIV-1|hiv-1
884437|NCT00002441|Dose-Response Relationship, Drug|dose-response relationship, drug
884438|NCT00002441|Acquired Immunodeficiency Syndrome|acquired immunodeficiency syndrome
884439|NCT00002441|AIDS Vaccines|aids vaccines
884440|NCT00002441|Sexually Transmitted Diseases|sexually transmitted diseases
884441|NCT00002441|Risk Factors|risk factors
884442|NCT00002441|HIV Seronegativity|hiv seronegativity
884443|NCT00002441|Antigens, Viral|antigens, viral
884444|NCT00002441|Alum Compounds|alum compounds
884445|NCT00002440|HIV-1|hiv-1
884446|NCT00002440|Drug Therapy, Combination|drug therapy, combination
884447|NCT00002440|HIV Protease Inhibitors|hiv protease inhibitors
884448|NCT00002440|Mutation|mutation
884449|NCT00002440|HIV-1 Reverse Transcriptase|hiv-1 reverse transcriptase
884450|NCT00002440|HIV Protease|hiv protease
884451|NCT00002440|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors
884452|NCT00002440|Anti-HIV Agents|anti-hiv agents
884453|NCT00002440|abacavir|abacavir
884454|NCT00002438|Itraconazole|itraconazole
884455|NCT00002438|Histoplasmosis|histoplasmosis
884456|NCT00002438|Acquired Immunodeficiency Syndrome|acquired immunodeficiency syndrome
884457|NCT00002437|Retinitis|retinitis
884458|NCT00002437|Probenecid|probenecid
884459|NCT00002437|Drug Therapy, Combination|drug therapy, combination
884460|NCT00002437|Cytomegalovirus Infections|cytomegalovirus infections
884461|NCT00002437|Acquired Immunodeficiency Syndrome|acquired immunodeficiency syndrome
884462|NCT00002437|Antiviral Agents|antiviral agents
884463|NCT00002437|cidofovir|cidofovir
884464|NCT00002436|Zalcitabine|zalcitabine
884465|NCT00002436|Drug Therapy, Combination|drug therapy, combination
884466|NCT00002436|Acquired Immunodeficiency Syndrome|acquired immunodeficiency syndrome
884467|NCT00002436|AIDS-Related Complex|aids-related complex
884468|NCT00002436|Antiviral Agents|antiviral agents
884469|NCT00002436|Zidovudine|zidovudine
884470|NCT00002435|Drug Therapy, Combination|drug therapy, combination
884471|NCT00002435|Antiviral Agents|antiviral agents
884472|NCT00002435|Zidovudine|zidovudine
884473|NCT00002435|thymic humoral factor gamma 2|thymic humoral factor gamma 2
884474|NCT00002434|Trimetrexate|trimetrexate
884475|NCT00002434|Pneumonia, Pneumocystis carinii|pneumonia, pneumocystis carinii
884476|NCT00002434|Leucovorin|leucovorin
884477|NCT00002434|Drug Therapy, Combination|drug therapy, combination
884478|NCT00002434|Acquired Immunodeficiency Syndrome|acquired immunodeficiency syndrome
884479|NCT00002433|Pulmonary Alveoli|pulmonary alveoli
884480|NCT00002433|Macrophage Activation|macrophage activation
884481|NCT00002433|Interferon-gamma, Recombinant|interferon-gamma, recombinant
884482|NCT00002433|Injections, Subcutaneous|injections, subcutaneous
884483|NCT00002433|Aerosols|aerosols
884484|NCT00002433|Acquired Immunodeficiency Syndrome|acquired immunodeficiency syndrome
884485|NCT00002432|Retinitis|retinitis
884486|NCT00002432|AIDS-Related Opportunistic Infections|aids-related opportunistic infections
884487|NCT00002432|Foscarnet|foscarnet
884488|NCT00002432|Cytomegalovirus Infections|cytomegalovirus infections
884489|NCT00002432|Acquired Immunodeficiency Syndrome|acquired immunodeficiency syndrome
884588|NCT00002412|Didanosine|didanosine
884490|NCT00002431|AIDS-Related Opportunistic Infections|aids-related opportunistic infections
884491|NCT00002431|chlorhexidine gluconate|chlorhexidine gluconate
884492|NCT00002431|Acquired Immunodeficiency Syndrome|acquired immunodeficiency syndrome
884493|NCT00002431|Anti-Infective Agents, Local|anti-infective agents, local
884494|NCT00002431|AIDS-Related Complex|aids-related complex
884495|NCT00002431|Candidiasis, Oral|candidiasis, oral
884496|NCT00002430|Drug Therapy, Combination|drug therapy, combination
884497|NCT00002430|HIV Protease Inhibitors|hiv protease inhibitors
884498|NCT00002430|Lamivudine|lamivudine
884499|NCT00002430|Indinavir|indinavir
884500|NCT00002430|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors
884501|NCT00002430|Anti-HIV Agents|anti-hiv agents
884502|NCT00002430|Nelfinavir|nelfinavir
884503|NCT00002429|Didanosine|didanosine
884504|NCT00002429|Drug Therapy, Combination|drug therapy, combination
884505|NCT00002429|Stavudine|stavudine
884506|NCT00002429|RNA, Viral|rna, viral
884507|NCT00002429|Nelfinavir|nelfinavir
884508|NCT00002429|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors
884509|NCT00002429|Anti-HIV Agents|anti-hiv agents
884510|NCT00002428|Vaccines, Synthetic|vaccines, synthetic
884511|NCT00002428|HIV-1|hiv-1
884512|NCT00002428|HIV Envelope Protein gp120|hiv envelope protein gp120
884513|NCT00002428|AIDS Vaccines|aids vaccines
884514|NCT00002428|HIV Seronegativity|hiv seronegativity
884515|NCT00002427|Didanosine|didanosine
884516|NCT00002427|Dose-Response Relationship, Drug|dose-response relationship, drug
884517|NCT00002427|Drug Therapy, Combination|drug therapy, combination
884518|NCT00002427|Stavudine|stavudine
884519|NCT00002427|Hydroxyurea|hydroxyurea
884520|NCT00002427|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors
884521|NCT00002427|Anti-HIV Agents|anti-hiv agents
884522|NCT00002426|HIV-1|hiv-1
884523|NCT00002426|RNA, Viral|rna, viral
884524|NCT00002426|VX 478|vx 478
884525|NCT00002426|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors
884526|NCT00002426|Anti-HIV Agents|anti-hiv agents
884527|NCT00002426|Viral Load|viral load
884528|NCT00002425|Drug Therapy, Combination|drug therapy, combination
884529|NCT00002425|Saquinavir|saquinavir
884530|NCT00002425|HIV Protease Inhibitors|hiv protease inhibitors
884531|NCT00002425|Dosage Forms|dosage forms
884532|NCT00002425|Anti-HIV Agents|anti-hiv agents
884533|NCT00002424|Drug Therapy, Combination|drug therapy, combination
884534|NCT00002424|Drug Administration Schedule|drug administration schedule
884535|NCT00002424|Stavudine|stavudine
884536|NCT00002424|HIV Protease Inhibitors|hiv protease inhibitors
884537|NCT00002424|Lamivudine|lamivudine
884538|NCT00002424|Indinavir|indinavir
884539|NCT00002424|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors
884540|NCT00002424|Anti-HIV Agents|anti-hiv agents
884541|NCT00002423|Drug Therapy, Combination|drug therapy, combination
884542|NCT00002423|HIV Protease Inhibitors|hiv protease inhibitors
884543|NCT00002423|Lamivudine|lamivudine
884544|NCT00002423|Indinavir|indinavir
884545|NCT00002423|Nelfinavir|nelfinavir
884546|NCT00002423|VX 478|vx 478
884547|NCT00002423|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors
884548|NCT00002423|Anti-HIV Agents|anti-hiv agents
884549|NCT00002423|Viral Load|viral load
884550|NCT00002423|abacavir|abacavir
884551|NCT00002422|Injections, Intramuscular|injections, intramuscular
884552|NCT00002422|Drug Interactions|drug interactions
884553|NCT00002422|Salvage Therapy|salvage therapy
884554|NCT00002422|Anti-HIV Agents|anti-hiv agents
884555|NCT00002420|Drug Therapy, Combination|drug therapy, combination
884556|NCT00002420|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors
884557|NCT00002420|Anti-HIV Agents|anti-hiv agents
884558|NCT00002419|Drug Therapy, Combination|drug therapy, combination
884559|NCT00002419|HIV Protease Inhibitors|hiv protease inhibitors
884560|NCT00002419|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors
884561|NCT00002419|Anti-HIV Agents|anti-hiv agents
884562|NCT00002418|Drug Therapy, Combination|drug therapy, combination
884563|NCT00002418|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors
884564|NCT00002418|Anti-HIV Agents|anti-hiv agents
884565|NCT00002418|Viral Load|viral load
884566|NCT00002417|Drug Therapy, Combination|drug therapy, combination
884567|NCT00002417|HIV Protease Inhibitors|hiv protease inhibitors
884568|NCT00002417|VX 478|vx 478
884569|NCT00002417|Lipodystrophy|lipodystrophy
884570|NCT00002417|Hyperlipidemia|hyperlipidemia
884571|NCT00002416|HIV-1|hiv-1
884572|NCT00002416|Zalcitabine|zalcitabine
884573|NCT00002416|Zidovudine|zidovudine
884574|NCT00002416|Stavudine|stavudine
884575|NCT00002416|HIV Protease Inhibitors|hiv protease inhibitors
884576|NCT00002416|Lamivudine|lamivudine
884577|NCT00002416|RNA, Viral|rna, viral
884578|NCT00002416|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors
884579|NCT00002416|Anti-HIV Agents|anti-hiv agents
884580|NCT00002415|Drug Therapy, Combination|drug therapy, combination
884581|NCT00002415|Prodrugs|prodrugs
884582|NCT00002415|Anti-HIV Agents|anti-hiv agents
884583|NCT00002414|AIDS Dementia Complex|aids dementia complex
884584|NCT00002414|Anti-HIV Agents|anti-hiv agents
884585|NCT00002413|Anti-HIV Agents|anti-hiv agents
884586|NCT00002413|Viral Load|viral load
884589|NCT00002412|Drug Therapy, Combination|drug therapy, combination
884590|NCT00002412|Stavudine|stavudine
884591|NCT00002412|Hydroxyurea|hydroxyurea
884592|NCT00002412|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors
884593|NCT00002412|Anti-HIV Agents|anti-hiv agents
884594|NCT00002412|Viral Load|viral load
884595|NCT00002412|MKC 442|mkc 442
884596|NCT00002411|HIV-1|hiv-1
884597|NCT00002411|Didanosine|didanosine
884598|NCT00002411|Drug Therapy, Combination|drug therapy, combination
884599|NCT00002411|Zidovudine|zidovudine
884600|NCT00002411|Stavudine|stavudine
884601|NCT00002411|Lamivudine|lamivudine
884602|NCT00002411|RNA, Viral|rna, viral
884603|NCT00002411|Nelfinavir|nelfinavir
884604|NCT00002411|Anti-HIV Agents|anti-hiv agents
884605|NCT00002411|Viral Load|viral load
884606|NCT00002410|HIV-1|hiv-1
884607|NCT00002410|Drug Therapy, Combination|drug therapy, combination
884608|NCT00002410|Zidovudine|zidovudine
884609|NCT00002410|Drug Resistance, Microbial|drug resistance, microbial
884610|NCT00002410|HIV Protease Inhibitors|hiv protease inhibitors
884611|NCT00002410|Lamivudine|lamivudine
884612|NCT00002410|Indinavir|indinavir
884613|NCT00002410|Genotype|genotype
884614|NCT00002410|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors
884615|NCT00002410|efavirenz|efavirenz
884616|NCT00002409|Drug Therapy, Combination|drug therapy, combination
884617|NCT00002409|Zidovudine|zidovudine
884618|NCT00002409|HIV Protease Inhibitors|hiv protease inhibitors
884619|NCT00002409|Lamivudine|lamivudine
884620|NCT00002409|Patient Education|patient education
884621|NCT00002409|Patient Compliance|patient compliance
884622|NCT00002409|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors
884623|NCT00002409|Anti-HIV Agents|anti-hiv agents
884624|NCT00002409|Viral Load|viral load
884625|NCT00002409|abacavir|abacavir
884626|NCT00002408|Diarrhea|diarrhea
884627|NCT00002408|Acquired Immunodeficiency Syndrome|acquired immunodeficiency syndrome
884628|NCT00002406|HIV-1|hiv-1
884629|NCT00002406|Dose-Response Relationship, Drug|dose-response relationship, drug
884630|NCT00002406|HIV Protease Inhibitors|hiv protease inhibitors
884631|NCT00002406|Indinavir|indinavir
884632|NCT00002406|RNA, Viral|rna, viral
884633|NCT00002406|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors
884634|NCT00002405|Drug Therapy, Combination|drug therapy, combination
884635|NCT00002405|HIV Protease Inhibitors|hiv protease inhibitors
884636|NCT00002405|VX 478|vx 478
884637|NCT00002405|Anti-HIV Agents|anti-hiv agents
884638|NCT00002404|HIV-1|hiv-1
884639|NCT00002404|Antiviral Agents|antiviral agents
884640|NCT00002404|Herpes Genitalis|herpes genitalis
884641|NCT00002404|Recurrence|recurrence
884642|NCT00002404|DNA, Viral|dna, viral
884643|NCT00002404|RNA, Viral|rna, viral
884644|NCT00002404|valacyclovir|valacyclovir
884645|NCT00002404|Herpesvirus 2, Human|herpesvirus 2, human
884646|NCT00002403|HIV-1|hiv-1
884647|NCT00002403|Dose-Response Relationship, Drug|dose-response relationship, drug
884648|NCT00002403|HIV Integrase Inhibitors|hiv integrase inhibitors
884649|NCT00002403|HIV Integrase|hiv integrase
884650|NCT00002402|HIV-1|hiv-1
884651|NCT00002402|Dose-Response Relationship, Drug|dose-response relationship, drug
884652|NCT00002402|Acquired Immunodeficiency Syndrome|acquired immunodeficiency syndrome
884653|NCT00002402|AIDS Vaccines|aids vaccines
884654|NCT00002402|HIV Seronegativity|hiv seronegativity
884655|NCT00002402|Antigens, Viral|antigens, viral
884656|NCT00002402|Alum Compounds|alum compounds
884657|NCT00002401|HIV-1|hiv-1
884658|NCT00002401|Zidovudine|zidovudine
884659|NCT00002401|HIV Protease Inhibitors|hiv protease inhibitors
884660|NCT00002401|Lamivudine|lamivudine
884661|NCT00002401|Indinavir|indinavir
884662|NCT00002401|RNA, Viral|rna, viral
884663|NCT00002401|Delavirdine|delavirdine
884664|NCT00002401|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors
884665|NCT00002401|Viral Load|viral load
884666|NCT00002400|HIV-1|hiv-1
884667|NCT00002400|Drug Therapy, Combination|drug therapy, combination
884668|NCT00002400|Zidovudine|zidovudine
884669|NCT00002400|HIV Protease Inhibitors|hiv protease inhibitors
884670|NCT00002400|Lamivudine|lamivudine
884671|NCT00002400|Indinavir|indinavir
884672|NCT00002400|RNA, Viral|rna, viral
884673|NCT00002400|Delavirdine|delavirdine
884674|NCT00002400|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors
884675|NCT00002399|AIDS-Related Opportunistic Infections|aids-related opportunistic infections
884676|NCT00002399|Fluconazole|fluconazole
884677|NCT00002399|Antifungal Agents|antifungal agents
884678|NCT00002399|Candidiasis|candidiasis
884679|NCT00002399|Triazoles|triazoles
884680|NCT00002398|HIV-1|hiv-1
884681|NCT00002398|Acquired Immunodeficiency Syndrome|acquired immunodeficiency syndrome
884682|NCT00002398|Adenine|adenine
884683|NCT00002398|Anti-HIV Agents|anti-hiv agents
884684|NCT00002397|Kidney Failure, Chronic|kidney failure, chronic
884685|NCT00002397|HIV-1|hiv-1
884686|NCT00002397|Drug Therapy, Combination|drug therapy, combination
884687|NCT00002397|Stavudine|stavudine
884688|NCT00002397|HIV Protease Inhibitors|hiv protease inhibitors
884689|NCT00002397|Lamivudine|lamivudine
884690|NCT00002397|Saquinavir|saquinavir
884691|NCT00002397|AIDS-Associated Nephropathy|aids-associated nephropathy
884692|NCT00002397|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors
884693|NCT00002397|Viral Load|viral load
884694|NCT00002397|Nelfinavir|nelfinavir
884695|NCT00002396|Dose-Response Relationship, Drug|dose-response relationship, drug
884696|NCT00002396|Adenine|adenine
884697|NCT00002396|Anti-HIV Agents|anti-hiv agents
884698|NCT00002395|AIDS-Related Opportunistic Infections|aids-related opportunistic infections
884699|NCT00002395|Leukoencephalopathy, Progressive Multifocal|leukoencephalopathy, progressive multifocal
884700|NCT00002395|Infusions, Intravenous|infusions, intravenous
884701|NCT00002395|Drug Administration Schedule|drug administration schedule
884702|NCT00002395|Topotecan|topotecan
884703|NCT00002394|AIDS-Related Opportunistic Infections|aids-related opportunistic infections
884704|NCT00002394|Dose-Response Relationship, Drug|dose-response relationship, drug
884705|NCT00002394|Fluconazole|fluconazole
884706|NCT00002394|Antifungal Agents|antifungal agents
884707|NCT00002394|Candidiasis, Oral|candidiasis, oral
884708|NCT00002394|Drug Administration Schedule|drug administration schedule
884709|NCT00002394|terbinafine|terbinafine
884710|NCT00002393|Placebos|placebos
884711|NCT00002393|Drug Therapy, Combination|drug therapy, combination
884712|NCT00002393|HIV Protease Inhibitors|hiv protease inhibitors
884713|NCT00002393|Indinavir|indinavir
884714|NCT00002393|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors
884715|NCT00002393|efavirenz|efavirenz
884716|NCT00002392|Lymphocyte Transformation|lymphocyte transformation
884717|NCT00002392|Immunity, Cellular|immunity, cellular
884718|NCT00002392|Drug Therapy, Combination|drug therapy, combination
884719|NCT00002392|Adjuvants, Immunologic|adjuvants, immunologic
884720|NCT00002392|Thalidomide|thalidomide
884721|NCT00002392|Immunologic Memory|immunologic memory
884722|NCT00002392|Streptococcus pneumoniae|streptococcus pneumoniae
884723|NCT00002392|Tetanus Toxoid|tetanus toxoid
884724|NCT00002392|Pneumococcal Vaccines|pneumococcal vaccines
884725|NCT00002391|HIV-1|hiv-1
884726|NCT00002391|Drug Therapy, Combination|drug therapy, combination
884727|NCT00002391|Zidovudine|zidovudine
884728|NCT00002391|Lamivudine|lamivudine
884729|NCT00002391|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors
884730|NCT00002391|Anti-HIV Agents|anti-hiv agents
884731|NCT00002391|Viral Load|viral load
884732|NCT00002391|Child Development|child development
884733|NCT00002391|abacavir|abacavir
884734|NCT00002389|HIV-1|hiv-1
884735|NCT00002389|Drug Therapy, Combination|drug therapy, combination
884736|NCT00002389|Antiviral Agents|antiviral agents
884737|NCT00002389|Zidovudine|zidovudine
884738|NCT00002389|CD4 Lymphocyte Count|cd4 lymphocyte count
884739|NCT00002389|Lamivudine|lamivudine
884740|NCT00002389|RNA, Viral|rna, viral
884741|NCT00002389|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors
884742|NCT00002389|Anti-HIV Agents|anti-hiv agents
884743|NCT00002389|Viral Load|viral load
884744|NCT00002389|abacavir|abacavir
884745|NCT00002388|HIV-1|hiv-1
884746|NCT00002388|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors
884747|NCT00002388|Anti-HIV Agents|anti-hiv agents
884748|NCT00002387|Acquired Immunodeficiency Syndrome|acquired immunodeficiency syndrome
884749|NCT00002387|Drug Administration Schedule|drug administration schedule
884750|NCT00002387|HIV Protease Inhibitors|hiv protease inhibitors
884751|NCT00002387|Indinavir|indinavir
884752|NCT00002387|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors
884753|NCT00002387|Anti-HIV Agents|anti-hiv agents
884754|NCT00002387|efavirenz|efavirenz
884755|NCT00002386|Drug Therapy, Combination|drug therapy, combination
884756|NCT00002386|HIV Protease Inhibitors|hiv protease inhibitors
884757|NCT00002386|Indinavir|indinavir
884758|NCT00002386|Factor VIII|factor viii
884759|NCT00002386|Factor IX|factor ix
884760|NCT00002386|Half-Life|half-life
884761|NCT00002386|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors
884762|NCT00002386|Anti-HIV Agents|anti-hiv agents
884763|NCT00002386|Platelet Aggregation|platelet aggregation
884764|NCT00002386|Hemophilia A|hemophilia a
884765|NCT00002386|Hemophilia B|hemophilia b
884766|NCT00002385|Dose-Response Relationship, Drug|dose-response relationship, drug
884767|NCT00002385|Cohort Studies|cohort studies
884768|NCT00002385|Anti-HIV Agents|anti-hiv agents
884769|NCT00002383|Drug Administration Schedule|drug administration schedule
884770|NCT00002383|HIV Protease Inhibitors|hiv protease inhibitors
884771|NCT00002383|Dosage Forms|dosage forms
884772|NCT00002383|Saquinavir|saquinavir
884773|NCT00002383|Anti-HIV Agents|anti-hiv agents
884774|NCT00002382|Zalcitabine|zalcitabine
884775|NCT00002382|Didanosine|didanosine
884776|NCT00002382|Drug Therapy, Combination|drug therapy, combination
884777|NCT00002382|Zidovudine|zidovudine
884778|NCT00002382|HIV Protease Inhibitors|hiv protease inhibitors
884779|NCT00002382|Saquinavir|saquinavir
884780|NCT00002382|Patient Selection|patient selection
884781|NCT00002382|Anti-HIV Agents|anti-hiv agents
884782|NCT00002381|HIV-1|hiv-1
884783|NCT00002381|Drug Therapy, Combination|drug therapy, combination
884784|NCT00002381|Nevirapine|nevirapine
884785|NCT00002381|Stavudine|stavudine
884786|NCT00002381|RNA, Viral|rna, viral
884787|NCT00002381|Nelfinavir|nelfinavir
884788|NCT00002381|Anti-HIV Agents|anti-hiv agents
884789|NCT00002381|Viral Load|viral load
884790|NCT00002380|Drug Therapy, Combination|drug therapy, combination
884791|NCT00002380|HIV Protease Inhibitors|hiv protease inhibitors
884792|NCT00002380|Dosage Forms|dosage forms
884793|NCT00002380|Saquinavir|saquinavir
884794|NCT00002380|Nelfinavir|nelfinavir
884795|NCT00002380|Anti-HIV Agents|anti-hiv agents
884796|NCT00002379|HIV-1|hiv-1
884797|NCT00002379|Drug Therapy, Combination|drug therapy, combination
884798|NCT00002379|Administration, Oral|administration, oral
884799|NCT00002379|Acquired Immunodeficiency Syndrome|acquired immunodeficiency syndrome
884800|NCT00002379|Zidovudine|zidovudine
884801|NCT00002379|Stavudine|stavudine
884802|NCT00002379|HIV Protease Inhibitors|hiv protease inhibitors
884803|NCT00002379|CD4 Lymphocyte Count|cd4 lymphocyte count
884804|NCT00002379|Lamivudine|lamivudine
884805|NCT00002379|Indinavir|indinavir
884806|NCT00002379|RNA, Viral|rna, viral
884807|NCT00002379|Adenine|adenine
884808|NCT00002379|Anti-HIV Agents|anti-hiv agents
884809|NCT00002379|Viral Load|viral load
884810|NCT00002378|HIV-1|hiv-1
884811|NCT00002378|Drug Therapy, Combination|drug therapy, combination
884812|NCT00002378|Zidovudine|zidovudine
884813|NCT00002378|Stavudine|stavudine
884814|NCT00002378|HIV Protease Inhibitors|hiv protease inhibitors
884815|NCT00002378|Lamivudine|lamivudine
884816|NCT00002378|RNA, Viral|rna, viral
884817|NCT00002378|Dosage Forms|dosage forms
884818|NCT00002378|Saquinavir|saquinavir
884819|NCT00002378|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors
884820|NCT00002378|Anti-HIV Agents|anti-hiv agents
884821|NCT00002378|Viral Load|viral load
884822|NCT00002378|Nelfinavir|nelfinavir
884823|NCT00002376|HIV-1|hiv-1
884824|NCT00002376|CD4 Lymphocyte Count|cd4 lymphocyte count
884825|NCT00002376|RNA, Viral|rna, viral
884826|NCT00002376|Anti-HIV Agents|anti-hiv agents
884827|NCT00002376|Viral Load|viral load
884828|NCT00002375|Drug Therapy, Combination|drug therapy, combination
884829|NCT00002375|HIV Protease Inhibitors|hiv protease inhibitors
884830|NCT00002375|Indinavir|indinavir
884831|NCT00002375|Nelfinavir|nelfinavir
884832|NCT00002375|Anti-HIV Agents|anti-hiv agents
884833|NCT00002374|HIV-1|hiv-1
884834|NCT00002374|Drug Therapy, Combination|drug therapy, combination
884835|NCT00002374|Acquired Immunodeficiency Syndrome|acquired immunodeficiency syndrome
884836|NCT00002374|HIV Protease Inhibitors|hiv protease inhibitors
884837|NCT00002374|RNA, Viral|rna, viral
884838|NCT00002374|Saquinavir|saquinavir
884839|NCT00002374|Anti-HIV Agents|anti-hiv agents
884840|NCT00002374|Viral Load|viral load
884841|NCT00002373|Cytomegalovirus|cytomegalovirus
884842|NCT00002373|Cytomegalovirus Infections|cytomegalovirus infections
884843|NCT00002373|Administration, Oral|administration, oral
884844|NCT00002373|Acquired Immunodeficiency Syndrome|acquired immunodeficiency syndrome
884845|NCT00002373|Antiviral Agents|antiviral agents
884846|NCT00002373|Virus Shedding|virus shedding
884847|NCT00002373|Viral Load|viral load
884848|NCT00002372|Drug Therapy, Combination|drug therapy, combination
884849|NCT00002372|Administration, Oral|administration, oral
884850|NCT00002372|HIV Protease Inhibitors|hiv protease inhibitors
884851|NCT00002372|Indinavir|indinavir
884852|NCT00002372|Saquinavir|saquinavir
884853|NCT00002372|Nelfinavir|nelfinavir
884856|NCT00002371|Drug Therapy, Combination|drug therapy, combination
884857|NCT00002371|Stavudine|stavudine
884858|NCT00002371|Lamivudine|lamivudine
884859|NCT00002371|RNA, Viral|rna, viral
884860|NCT00002371|Anti-HIV Agents|anti-hiv agents
884861|NCT00002371|Viral Load|viral load
884862|NCT00002370|Itraconazole|itraconazole
884863|NCT00002370|Administration, Oral|administration, oral
884864|NCT00002370|Antifungal Agents|antifungal agents
884865|NCT00002370|Acquired Immunodeficiency Syndrome|acquired immunodeficiency syndrome
884866|NCT00002370|Drug Administration Schedule|drug administration schedule
884867|NCT00002369|Drug Therapy, Combination|drug therapy, combination
884868|NCT00002369|Zidovudine|zidovudine
884869|NCT00002369|Stavudine|stavudine
884870|NCT00002369|HIV Protease Inhibitors|hiv protease inhibitors
884871|NCT00002369|CD4 Lymphocyte Count|cd4 lymphocyte count
884872|NCT00002369|Lamivudine|lamivudine
884873|NCT00002369|Indinavir|indinavir
884874|NCT00002369|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors
884875|NCT00002369|Anti-HIV Agents|anti-hiv agents
884876|NCT00002369|Viral Load|viral load
884877|NCT00002368|Drug Therapy, Combination|drug therapy, combination
884878|NCT00002368|Acquired Immunodeficiency Syndrome|acquired immunodeficiency syndrome
884879|NCT00002368|Nevirapine|nevirapine
884880|NCT00002368|Lamivudine|lamivudine
884881|NCT00002368|Disease Progression|disease progression
884882|NCT00002368|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors
884883|NCT00002368|Anti-HIV Agents|anti-hiv agents
884884|NCT00002367|Drug Therapy, Combination|drug therapy, combination
884885|NCT00002367|Acquired Immunodeficiency Syndrome|acquired immunodeficiency syndrome
884886|NCT00002367|Zidovudine|zidovudine
884887|NCT00002367|HIV Protease Inhibitors|hiv protease inhibitors
884888|NCT00002367|Lamivudine|lamivudine
884889|NCT00002367|Saquinavir|saquinavir
884890|NCT00002367|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors
884891|NCT00002367|Anti-HIV Agents|anti-hiv agents
884892|NCT00002366|Skin Neoplasms|skin neoplasms
884893|NCT00002366|Sarcoma, Kaposi|sarcoma, kaposi
884894|NCT00002366|Acquired Immunodeficiency Syndrome|acquired immunodeficiency syndrome
884895|NCT00002366|HIV Protease Inhibitors|hiv protease inhibitors
884896|NCT00002366|Ritonavir|ritonavir
884897|NCT00002365|Dose-Response Relationship, Drug|dose-response relationship, drug
884898|NCT00002365|Administration, Oral|administration, oral
884899|NCT00002365|Acquired Immunodeficiency Syndrome|acquired immunodeficiency syndrome
884900|NCT00002365|Anti-HIV Agents|anti-hiv agents
884901|NCT00002364|Drug Therapy, Combination|drug therapy, combination
884902|NCT00002364|Acquired Immunodeficiency Syndrome|acquired immunodeficiency syndrome
884903|NCT00002364|AIDS-Related Complex|aids-related complex
884904|NCT00002364|Antiviral Agents|antiviral agents
884905|NCT00002363|Acquired Immunodeficiency Syndrome|acquired immunodeficiency syndrome
884906|NCT00002363|AIDS-Related Complex|aids-related complex
884907|NCT00002363|Antiviral Agents|antiviral agents
884908|NCT00002362|Dideoxynucleosides|dideoxynucleosides
884909|NCT00002362|Drug Therapy, Combination|drug therapy, combination
884910|NCT00002362|Stavudine|stavudine
884911|NCT00002362|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors
884912|NCT00002362|abacavir|abacavir
884913|NCT00002362|efavirenz|efavirenz
884914|NCT00002361|Drug Therapy, Combination|drug therapy, combination
884915|NCT00002361|HIV Protease Inhibitors|hiv protease inhibitors
884916|NCT00002361|Ritonavir|ritonavir
884917|NCT00002361|Indinavir|indinavir
884918|NCT00002361|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors
884919|NCT00002361|Anti-HIV Agents|anti-hiv agents
884920|NCT00002361|Viral Load|viral load
884921|NCT00002360|Didanosine|didanosine
884922|NCT00002360|Tablets|tablets
884923|NCT00002360|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors
884924|NCT00002360|Anti-HIV Agents|anti-hiv agents
884925|NCT00002360|Therapeutic Equivalency|therapeutic equivalency
884926|NCT00002359|Vaccines, Synthetic|vaccines, synthetic
884927|NCT00002359|Viral Vaccines|viral vaccines
884928|NCT00002359|HIV-1|hiv-1
884929|NCT00002359|AIDS-Related Complex|aids-related complex
884930|NCT00002359|AIDS Vaccines|aids vaccines
884931|NCT00002359|Salk HIV Immunogen|salk hiv immunogen
884932|NCT00002358|Herpes Zoster|herpes zoster
884933|NCT00002358|Acquired Immunodeficiency Syndrome|acquired immunodeficiency syndrome
884934|NCT00002358|AIDS-Related Complex|aids-related complex
884935|NCT00002358|Antiviral Agents|antiviral agents
884936|NCT00002358|sorivudine|sorivudine
884937|NCT00002358|Chickenpox|chickenpox
884938|NCT00002357|Drug Therapy, Combination|drug therapy, combination
884939|NCT00002357|AIDS-Related Complex|aids-related complex
884940|NCT00002357|Antiviral Agents|antiviral agents
884941|NCT00002357|Zidovudine|zidovudine
884942|NCT00002356|Acquired Immunodeficiency Syndrome|acquired immunodeficiency syndrome
884943|NCT00002356|Antiviral Agents|antiviral agents
884944|NCT00002356|Cytomegalovirus Retinitis|cytomegalovirus retinitis
884945|NCT00002355|AIDS-Related Opportunistic Infections|aids-related opportunistic infections
884946|NCT00002355|Acquired Immunodeficiency Syndrome|acquired immunodeficiency syndrome
884947|NCT00002355|Antiviral Agents|antiviral agents
884948|NCT00002355|Cytomegalovirus Retinitis|cytomegalovirus retinitis
884949|NCT00002354|Drug Therapy, Combination|drug therapy, combination
884950|NCT00002354|Acquired Immunodeficiency Syndrome|acquired immunodeficiency syndrome
884951|NCT00002354|AIDS-Related Complex|aids-related complex
884952|NCT00002354|Stavudine|stavudine
884953|NCT00002354|HIV Protease Inhibitors|hiv protease inhibitors
884954|NCT00002354|Indinavir|indinavir
884955|NCT00002353|Vaccines, Synthetic|vaccines, synthetic
884956|NCT00002353|AIDS Vaccines|aids vaccines
884957|NCT00002352|Cytomegalovirus Infections|cytomegalovirus infections
884958|NCT00002352|Acquired Immunodeficiency Syndrome|acquired immunodeficiency syndrome
884959|NCT00002352|Antiviral Agents|antiviral agents
884960|NCT00002351|Acquired Immunodeficiency Syndrome|acquired immunodeficiency syndrome
884961|NCT00002351|AIDS-Related Complex|aids-related complex
884962|NCT00002351|HIV Protease Inhibitors|hiv protease inhibitors
884963|NCT00002351|Indinavir|indinavir
884964|NCT00002350|Vaccines, Synthetic|vaccines, synthetic
884965|NCT00002350|AIDS Vaccines|aids vaccines
884966|NCT00002350|DNA, Viral|dna, viral
884967|NCT00002349|AIDS-Related Complex|aids-related complex
884968|NCT00002349|Stavudine|stavudine
884969|NCT00002348|Lymphoma, Non-Hodgkin|lymphoma, non-hodgkin
884970|NCT00002348|Acquired Immunodeficiency Syndrome|acquired immunodeficiency syndrome
884971|NCT00002348|Lymphoma, AIDS-Related|lymphoma, aids-related
884972|NCT00002348|Mitoguazone|mitoguazone
884973|NCT00002347|Zalcitabine|zalcitabine
884974|NCT00002347|Drug Therapy, Combination|drug therapy, combination
884975|NCT00002347|Acquired Immunodeficiency Syndrome|acquired immunodeficiency syndrome
884976|NCT00002347|AIDS-Related Complex|aids-related complex
884977|NCT00002347|Zidovudine|zidovudine
884978|NCT00002347|Nevirapine|nevirapine
884979|NCT00002347|Saquinavir|saquinavir
885254|NCT00002290|Zidovudine|zidovudine
884980|NCT00002346|Acquired Immunodeficiency Syndrome|acquired immunodeficiency syndrome
884981|NCT00002346|AIDS-Related Complex|aids-related complex
884982|NCT00002346|Antiviral Agents|antiviral agents
884983|NCT00002346|Adenine|adenine
884984|NCT00002345|Megestrol|megestrol
884985|NCT00002345|Acquired Immunodeficiency Syndrome|acquired immunodeficiency syndrome
884986|NCT00002345|Anorexia|anorexia
884987|NCT00002345|Cachexia|cachexia
884988|NCT00002345|Suspensions|suspensions
884989|NCT00002344|Azithromycin|azithromycin
884990|NCT00002344|Bacterial Infections|bacterial infections
884991|NCT00002343|Rifabutin|rifabutin
884992|NCT00002343|Mycobacterium avium-intracellulare Infection|mycobacterium avium-intracellulare infection
884993|NCT00002343|Drug Therapy, Combination|drug therapy, combination
884994|NCT00002343|Ethambutol|ethambutol
884995|NCT00002343|Acquired Immunodeficiency Syndrome|acquired immunodeficiency syndrome
884996|NCT00002342|Neoplasms|neoplasms
884997|NCT00002342|Sarcoma, Kaposi|sarcoma, kaposi
884998|NCT00002342|Acquired Immunodeficiency Syndrome|acquired immunodeficiency syndrome
884999|NCT00002342|Antineoplastic Agents|antineoplastic agents
885000|NCT00002342|tecogalan|tecogalan
885001|NCT00002341|Itraconazole|itraconazole
885002|NCT00002341|Acquired Immunodeficiency Syndrome|acquired immunodeficiency syndrome
885003|NCT00002341|AIDS-Related Complex|aids-related complex
885004|NCT00002341|Candidiasis, Oral|candidiasis, oral
885005|NCT00002340|Pneumonia, Pneumocystis carinii|pneumonia, pneumocystis carinii
885006|NCT00002340|Pentamidine|pentamidine
885007|NCT00002340|Antifungal Agents|antifungal agents
885008|NCT00002340|Acquired Immunodeficiency Syndrome|acquired immunodeficiency syndrome
885009|NCT00002340|AIDS-Related Complex|aids-related complex
885010|NCT00002340|atovaquone|atovaquone
885011|NCT00002339|Esophagitis|esophagitis
885012|NCT00002339|Fluconazole|fluconazole
885013|NCT00002339|Acquired Immunodeficiency Syndrome|acquired immunodeficiency syndrome
885014|NCT00002339|Candidiasis|candidiasis
885015|NCT00002339|Immunocompromised Host|immunocompromised host
885016|NCT00002338|Acquired Immunodeficiency Syndrome|acquired immunodeficiency syndrome
885017|NCT00002338|AIDS-Related Complex|aids-related complex
885018|NCT00002338|Antiviral Agents|antiviral agents
885019|NCT00002337|Acquired Immunodeficiency Syndrome|acquired immunodeficiency syndrome
885020|NCT00002337|Antiviral Agents|antiviral agents
885021|NCT00002337|vesnarinone|vesnarinone
885022|NCT00002336|Mycobacterium avium-intracellular Infection|mycobacterium avium-intracellular infection
885023|NCT00002336|Acquired Immunodeficiency Syndrome|acquired immunodeficiency syndrome
885024|NCT00002336|Clarithromycin|clarithromycin
885025|NCT00002335|Acquired Immunodeficiency Syndrome|acquired immunodeficiency syndrome
885026|NCT00002335|AIDS-Related Complex|aids-related complex
885027|NCT00002335|Antiviral Agents|antiviral agents
885028|NCT00002334|Drug Therapy, Combination|drug therapy, combination
885029|NCT00002334|Acquired Immunodeficiency Syndrome|acquired immunodeficiency syndrome
885030|NCT00002334|AIDS-Related Complex|aids-related complex
885031|NCT00002334|Zidovudine|zidovudine
885032|NCT00002334|Saquinavir|saquinavir
885033|NCT00002334|HIV Protease Inhibitors|hiv protease inhibitors
885034|NCT00002333|Zalcitabine|zalcitabine
885035|NCT00002333|Drug Therapy, Combination|drug therapy, combination
885036|NCT00002333|Acquired Immunodeficiency Syndrome|acquired immunodeficiency syndrome
885037|NCT00002333|AIDS-Related Complex|aids-related complex
885038|NCT00002333|Saquinavir|saquinavir
885039|NCT00002333|HIV Protease Inhibitors|hiv protease inhibitors
885041|NCT00002332|AIDS-Related Complex|aids-related complex
885042|NCT00002331|Mycobacterium avium-intracellular Infection|mycobacterium avium-intracellular infection
885043|NCT00002331|Drug Therapy, Combination|drug therapy, combination
885044|NCT00002331|Ethambutol|ethambutol
885045|NCT00002331|Clofazimine|clofazimine
885046|NCT00002331|Acquired Immunodeficiency Syndrome|acquired immunodeficiency syndrome
885047|NCT00002331|Clarithromycin|clarithromycin
885048|NCT00002330|Retinitis|retinitis
885049|NCT00002330|Ganciclovir|ganciclovir
885050|NCT00002330|Cytomegalovirus Infections|cytomegalovirus infections
885051|NCT00002330|Acquired Immunodeficiency Syndrome|acquired immunodeficiency syndrome
885052|NCT00002329|MDL 28574|mdl 28574
885053|NCT00002328|Antidiarrheals|antidiarrheals
885054|NCT00002328|Cryptosporidiosis|cryptosporidiosis
885055|NCT00002328|Diarrhea|diarrhea
885056|NCT00002328|Acquired Immunodeficiency Syndrome|acquired immunodeficiency syndrome
885057|NCT00002328|Azithromycin|azithromycin
885058|NCT00002327|AIDS-Related Opportunistic Infections|aids-related opportunistic infections
885059|NCT00002327|Acquired Immunodeficiency Syndrome|acquired immunodeficiency syndrome
885060|NCT00002327|AIDS-Related Complex|aids-related complex
885061|NCT00002327|Antiviral Agents|antiviral agents
885062|NCT00002327|Condylomata Acuminata|condylomata acuminata
885063|NCT00002327|cidofovir|cidofovir
885064|NCT00002326|Drug Therapy, Combination|drug therapy, combination
885065|NCT00002326|Acquired Immunodeficiency Syndrome|acquired immunodeficiency syndrome
885066|NCT00002326|AIDS-Related Complex|aids-related complex
885067|NCT00002326|Antiviral Agents|antiviral agents
885068|NCT00002326|Zidovudine|zidovudine
885069|NCT00002326|Adenine|adenine
885070|NCT00002325|Mycoses|mycoses
885071|NCT00002325|Fluconazole|fluconazole
885072|NCT00002325|Acquired Immunodeficiency Syndrome|acquired immunodeficiency syndrome
885073|NCT00002325|AIDS-Related Complex|aids-related complex
885074|NCT00002325|Coccidioidomycosis|coccidioidomycosis
885075|NCT00002324|Drug Therapy, Combination|drug therapy, combination
885076|NCT00002324|AIDS-Related Complex|aids-related complex
885077|NCT00002324|Zidovudine|zidovudine
885078|NCT00002324|Nevirapine|nevirapine
885079|NCT00002323|Drug Therapy, Combination|drug therapy, combination
885080|NCT00002323|Zidovudine|zidovudine
885081|NCT00002323|Nevirapine|nevirapine
885082|NCT00002322|Drug Therapy, Combination|drug therapy, combination
885083|NCT00002322|Acquired Immunodeficiency Syndrome|acquired immunodeficiency syndrome
885084|NCT00002322|AIDS-Related Complex|aids-related complex
885085|NCT00002322|Antiviral Agents|antiviral agents
885086|NCT00002321|Retinitis|retinitis
885087|NCT00002321|Interleukin-2|interleukin-2
885088|NCT00002321|Ganciclovir|ganciclovir
885089|NCT00002321|Drug Therapy, Combination|drug therapy, combination
885090|NCT00002321|Acquired Immunodeficiency Syndrome|acquired immunodeficiency syndrome
885091|NCT00002321|Antiviral Agents|antiviral agents
885092|NCT00002320|Drug Therapy, Combination|drug therapy, combination
885093|NCT00002320|Acquired Immunodeficiency Syndrome|acquired immunodeficiency syndrome
885094|NCT00002320|AIDS-Related Complex|aids-related complex
885095|NCT00002320|Antiviral Agents|antiviral agents
885096|NCT00002320|Zidovudine|zidovudine
885097|NCT00002319|Sarcoma, Kaposi|sarcoma, kaposi
885098|NCT00002319|Liposomes|liposomes
885099|NCT00002319|Doxorubicin|doxorubicin
885100|NCT00002319|Acquired Immunodeficiency Syndrome|acquired immunodeficiency syndrome
885101|NCT00002319|Drug Carriers|drug carriers
885102|NCT00002318|Vincristine|vincristine
885103|NCT00002318|Sarcoma, Kaposi|sarcoma, kaposi
885104|NCT00002318|Liposomes|liposomes
885105|NCT00002318|Doxorubicin|doxorubicin
885106|NCT00002318|Drug Therapy, Combination|drug therapy, combination
885107|NCT00002318|Acquired Immunodeficiency Syndrome|acquired immunodeficiency syndrome
885108|NCT00002318|Bleomycin|bleomycin
885109|NCT00002318|Drug Carriers|drug carriers
885110|NCT00002317|Trimetrexate|trimetrexate
885111|NCT00002317|Pneumonia, Pneumocystis carinii|pneumonia, pneumocystis carinii
885112|NCT00002317|Leucovorin|leucovorin
885113|NCT00002317|Drug Therapy, Combination|drug therapy, combination
885114|NCT00002317|Acquired Immunodeficiency Syndrome|acquired immunodeficiency syndrome
885115|NCT00002316|AIDS-Related Opportunistic Infections|aids-related opportunistic infections
885116|NCT00002316|Meningitis|meningitis
885117|NCT00002316|Drug Therapy, Combination|drug therapy, combination
885118|NCT00002316|Antifungal Agents|antifungal agents
885119|NCT00002316|Acquired Immunodeficiency Syndrome|acquired immunodeficiency syndrome
885120|NCT00002316|Amphotericin B|amphotericin b
885121|NCT00002315|Herpes Zoster|herpes zoster
885122|NCT00002315|Acyclovir|acyclovir
885123|NCT00002315|Acquired Immunodeficiency Syndrome|acquired immunodeficiency syndrome
885124|NCT00002315|AIDS-Related Complex|aids-related complex
885125|NCT00002315|Antiviral Agents|antiviral agents
885126|NCT00002314|Sarcoma, Kaposi|sarcoma, kaposi
885127|NCT00002314|Acquired Immunodeficiency Syndrome|acquired immunodeficiency syndrome
885128|NCT00002314|Antineoplastic Agents|antineoplastic agents
885129|NCT00002314|Gene Products, tat|gene products, tat
885130|NCT00002313|Nystatin|nystatin
885131|NCT00002313|Didanosine|didanosine
885132|NCT00002313|Drug Therapy, Combination|drug therapy, combination
885226|NCT00002295|Biological Availability|biological availability
885133|NCT00002313|Acquired Immunodeficiency Syndrome|acquired immunodeficiency syndrome
885134|NCT00002313|AIDS-Related Complex|aids-related complex
885135|NCT00002312|Drug Interactions|drug interactions
885136|NCT00002312|Antiviral Agents|antiviral agents
885137|NCT00002312|Zidovudine|zidovudine
885138|NCT00002311|Acquired Immunodeficiency Syndrome|acquired immunodeficiency syndrome
885139|NCT00002311|AIDS-Related Complex|aids-related complex
885140|NCT00002311|Wobenzym|wobenzym
885141|NCT00002311|Hydrolases|hydrolases
885142|NCT00002310|Herpes Simplex|herpes simplex
885143|NCT00002310|HIV-1|hiv-1
885144|NCT00002310|Acquired Immunodeficiency Syndrome|acquired immunodeficiency syndrome
885145|NCT00002310|Antiviral Agents|antiviral agents
885146|NCT00002310|Administration, Topical|administration, topical
885147|NCT00002309|Mycobacterium avium-intracellulare Infection|mycobacterium avium-intracellulare infection
885148|NCT00002309|Acquired Immunodeficiency Syndrome|acquired immunodeficiency syndrome
885149|NCT00002309|AIDS-Related Complex|aids-related complex
885150|NCT00002309|Azithromycin|azithromycin
885151|NCT00002308|Acquired Immunodeficiency Syndrome|acquired immunodeficiency syndrome
885152|NCT00002308|AIDS-Related Complex|aids-related complex
885153|NCT00002308|Stavudine|stavudine
885154|NCT00002307|Zidovudine|zidovudine
885155|NCT00002307|Stavudine|stavudine
885156|NCT00002306|AIDS-Related Opportunistic Infections|aids-related opportunistic infections
885157|NCT00002306|Meningitis|meningitis
885158|NCT00002306|Cryptococcosis|cryptococcosis
885159|NCT00002306|Fluconazole|fluconazole
885160|NCT00002306|Acquired Immunodeficiency Syndrome|acquired immunodeficiency syndrome
885161|NCT00002306|Amphotericin B|amphotericin b
885162|NCT00002305|AIDS-Related Opportunistic Infections|aids-related opportunistic infections
885163|NCT00002305|Meningitis|meningitis
885164|NCT00002305|Cryptococcosis|cryptococcosis
885165|NCT00002305|Drug Therapy, Combination|drug therapy, combination
885166|NCT00002305|Fluconazole|fluconazole
885167|NCT00002305|Flucytosine|flucytosine
885168|NCT00002305|Acquired Immunodeficiency Syndrome|acquired immunodeficiency syndrome
885169|NCT00002305|Amphotericin B|amphotericin b
885170|NCT00002304|AIDS-Related Opportunistic Infections|aids-related opportunistic infections
885171|NCT00002304|Immune Tolerance|immune tolerance
885172|NCT00002304|Ketoconazole|ketoconazole
885173|NCT00002304|Esophagitis|esophagitis
885174|NCT00002304|Fluconazole|fluconazole
885175|NCT00002304|Acquired Immunodeficiency Syndrome|acquired immunodeficiency syndrome
885176|NCT00002304|Candidiasis, Oral|candidiasis, oral
885177|NCT00002303|Recombinant Proteins|recombinant proteins
885178|NCT00002303|Erythropoietin|erythropoietin
885179|NCT00002303|Acquired Immunodeficiency Syndrome|acquired immunodeficiency syndrome
885180|NCT00002303|Anemia|anemia
885181|NCT00002303|AIDS-Related Complex|aids-related complex
885182|NCT00002303|Zidovudine|zidovudine
885183|NCT00002302|Recombinant Proteins|recombinant proteins
885184|NCT00002302|Injections, Subcutaneous|injections, subcutaneous
885185|NCT00002302|Erythropoietin|erythropoietin
885186|NCT00002302|Acquired Immunodeficiency Syndrome|acquired immunodeficiency syndrome
885187|NCT00002302|Anemia|anemia
885188|NCT00002302|Zidovudine|zidovudine
885189|NCT00002301|Retinitis|retinitis
885190|NCT00002301|AIDS-Related Opportunistic Infections|aids-related opportunistic infections
885191|NCT00002301|Ganciclovir|ganciclovir
885192|NCT00002301|Foscarnet|foscarnet
885193|NCT00002301|Cytomegalovirus Infections|cytomegalovirus infections
885194|NCT00002301|Acquired Immunodeficiency Syndrome|acquired immunodeficiency syndrome
885195|NCT00002301|Antiviral Agents|antiviral agents
885196|NCT00002300|T-Lymphocytes|t-lymphocytes
885197|NCT00002300|Megestrol|megestrol
885198|NCT00002300|Dose-Response Relationship, Drug|dose-response relationship, drug
885199|NCT00002300|Acquired Immunodeficiency Syndrome|acquired immunodeficiency syndrome
885200|NCT00002300|Anorexia|anorexia
885201|NCT00002300|Cachexia|cachexia
885202|NCT00002299|Retinitis|retinitis
885203|NCT00002299|AIDS-Related Opportunistic Infections|aids-related opportunistic infections
885204|NCT00002299|Ganciclovir|ganciclovir
885205|NCT00002299|Drug Therapy, Combination|drug therapy, combination
885206|NCT00002299|Cytomegalovirus Infections|cytomegalovirus infections
885207|NCT00002299|Acquired Immunodeficiency Syndrome|acquired immunodeficiency syndrome
885208|NCT00002299|Interferon Type I|interferon type i
885209|NCT00002298|Ribavirin|ribavirin
885210|NCT00002298|AIDS-Related Complex|aids-related complex
885211|NCT00002297|Inosine Pranobex|inosine pranobex
885212|NCT00002297|AIDS-Related Complex|aids-related complex
885213|NCT00002296|T-Lymphocytes|t-lymphocytes
885214|NCT00002296|Immune Tolerance|immune tolerance
885215|NCT00002296|Inosine Pranobex|inosine pranobex
885216|NCT00002296|Killer Cells|killer cells
885217|NCT00002296|T-Lymphocytes, Helper-Inducer|t-lymphocytes, helper-inducer
885218|NCT00002296|Acquired Immunodeficiency Syndrome|acquired immunodeficiency syndrome
885219|NCT00002296|AIDS-Related Complex|aids-related complex
885220|NCT00002295|Infusions, Intravenous|infusions, intravenous
885221|NCT00002295|Drug Evaluation|drug evaluation
885222|NCT00002295|Administration, Oral|administration, oral
885223|NCT00002295|Acquired Immunodeficiency Syndrome|acquired immunodeficiency syndrome
885224|NCT00002295|AIDS-Related Complex|aids-related complex
885227|NCT00002294|AIDS-Related Opportunistic Infections|aids-related opportunistic infections
885228|NCT00002294|Meningitis|meningitis
885229|NCT00002294|Cryptococcosis|cryptococcosis
885230|NCT00002294|Fluconazole|fluconazole
885231|NCT00002294|Acquired Immunodeficiency Syndrome|acquired immunodeficiency syndrome
885232|NCT00002293|Nystatin|nystatin
885233|NCT00002293|AIDS-Related Opportunistic Infections|aids-related opportunistic infections
885234|NCT00002293|Acquired Immunodeficiency Syndrome|acquired immunodeficiency syndrome
885235|NCT00002293|AIDS-Related Complex|aids-related complex
885236|NCT00002293|Candidiasis, Oral|candidiasis, oral
885237|NCT00002292|AIDS-Related Opportunistic Infections|aids-related opportunistic infections
885238|NCT00002292|Pneumonia, Pneumocystis carinii|pneumonia, pneumocystis carinii
885239|NCT00002292|Pentamidine|pentamidine
885240|NCT00002292|Injections, Intravenous|injections, intravenous
885241|NCT00002292|Administration, Inhalation|administration, inhalation
885242|NCT00002292|Aerosols|aerosols
885243|NCT00002292|Acquired Immunodeficiency Syndrome|acquired immunodeficiency syndrome
885244|NCT00002291|AIDS-Related Opportunistic Infections|aids-related opportunistic infections
885245|NCT00002291|Pneumonia, Pneumocystis carinii|pneumonia, pneumocystis carinii
885246|NCT00002291|Pentamidine|pentamidine
885247|NCT00002291|Dose-Response Relationship, Drug|dose-response relationship, drug
885248|NCT00002291|Aerosols|aerosols
885249|NCT00002291|Acquired Immunodeficiency Syndrome|acquired immunodeficiency syndrome
885250|NCT00002290|AIDS-Related Opportunistic Infections|aids-related opportunistic infections
885251|NCT00002290|Drug Therapy, Combination|drug therapy, combination
885252|NCT00002290|Acyclovir|acyclovir
885253|NCT00002290|AIDS-Related Complex|aids-related complex
885255|NCT00002289|Semen|semen
885256|NCT00002289|Thymopentin|thymopentin
885257|NCT00002289|Leukocytes, Mononuclear|leukocytes, mononuclear
885258|NCT00002289|HIV Seropositivity|hiv seropositivity
885259|NCT00002289|AIDS-Related Complex|aids-related complex
885260|NCT00002288|Neuropsychological Tests|neuropsychological tests
885261|NCT00002288|AIDS-Related Complex|aids-related complex
885262|NCT00002288|Zidovudine|zidovudine
885263|NCT00002287|Health Manpower|health manpower
885264|NCT00002287|Accidents, Occupational|accidents, occupational
885265|NCT00002287|Zidovudine|zidovudine
885266|NCT00002286|Pilot Projects|pilot projects
885267|NCT00002286|Psoriasis|psoriasis
885268|NCT00002286|Acquired Immunodeficiency Syndrome|acquired immunodeficiency syndrome
885269|NCT00002286|Zidovudine|zidovudine
885270|NCT00002285|Virus Replication|virus replication
885271|NCT00002285|Pilot Projects|pilot projects
885272|NCT00002285|Immune Tolerance|immune tolerance
885273|NCT00002285|Lymphocytes|lymphocytes
885274|NCT00002285|Drug Evaluation|drug evaluation
885275|NCT00002285|Combined Modality Therapy|combined modality therapy
885276|NCT00002285|Acquired Immunodeficiency Syndrome|acquired immunodeficiency syndrome
885277|NCT00002285|Transplantation, Homologous|transplantation, homologous
885278|NCT00002285|Zidovudine|zidovudine
885279|NCT00002284|Lymphoma, Large-Cell|lymphoma, large-cell
885280|NCT00002284|Acquired Immunodeficiency Syndrome|acquired immunodeficiency syndrome
885281|NCT00002284|AIDS-Related Complex|aids-related complex
885282|NCT00002284|Zidovudine|zidovudine
885283|NCT00002284|Bone Marrow Transplantation|bone marrow transplantation
885284|NCT00002283|Trimethoprim-Sulfamethoxazole Combination|trimethoprim-sulfamethoxazole combination
885285|NCT00002283|AIDS-Related Opportunistic Infections|aids-related opportunistic infections
885286|NCT00002283|Pneumonia, Pneumocystis carinii|pneumonia, pneumocystis carinii
885287|NCT00002283|Dapsone|dapsone
885288|NCT00002283|Acquired Immunodeficiency Syndrome|acquired immunodeficiency syndrome
885289|NCT00002282|AIDS-Related Opportunistic Infections|aids-related opportunistic infections
885290|NCT00002282|Fluconazole|fluconazole
885291|NCT00002282|Clotrimazole|clotrimazole
885292|NCT00002282|Acquired Immunodeficiency Syndrome|acquired immunodeficiency syndrome
885293|NCT00002282|Candidiasis, Oral|candidiasis, oral
885294|NCT00002281|Injections, Subcutaneous|injections, subcutaneous
885295|NCT00002281|Erythropoietin|erythropoietin
885296|NCT00002281|Acquired Immunodeficiency Syndrome|acquired immunodeficiency syndrome
885297|NCT00002281|AIDS-Related Complex|aids-related complex
885298|NCT00002281|Zidovudine|zidovudine
885299|NCT00002280|Didanosine|didanosine
885300|NCT00002280|Drugs, Investigational|drugs, investigational
885301|NCT00002280|Acquired Immunodeficiency Syndrome|acquired immunodeficiency syndrome
885302|NCT00002280|Zidovudine|zidovudine
885303|NCT00002279|Zalcitabine|zalcitabine
885304|NCT00002279|Didanosine|didanosine
885305|NCT00002279|Drugs, Investigational|drugs, investigational
885306|NCT00002279|Acquired Immunodeficiency Syndrome|acquired immunodeficiency syndrome
885307|NCT00002279|AIDS-Related Complex|aids-related complex
885308|NCT00002279|Zidovudine|zidovudine
885309|NCT00002278|AIDS-Related Opportunistic Infections|aids-related opportunistic infections
885310|NCT00002278|Cryptosporidiosis|cryptosporidiosis
885311|NCT00002278|Diarrhea|diarrhea
885312|NCT00002278|diclazuril|diclazuril
885313|NCT00002278|Coccidiostats|coccidiostats
885314|NCT00002278|Acquired Immunodeficiency Syndrome|acquired immunodeficiency syndrome
885315|NCT00002277|Mycoses|mycoses
885316|NCT00002277|Neoplasms|neoplasms
885317|NCT00002277|Neutropenia|neutropenia
885318|NCT00002277|Fluconazole|fluconazole
885319|NCT00002277|Amphotericin B|amphotericin b
885320|NCT00002276|Blood Platelets|blood platelets
885321|NCT00002276|Ibuprofen|ibuprofen
885322|NCT00002276|Drug Interactions|drug interactions
885323|NCT00002276|Zidovudine|zidovudine
885324|NCT00002276|Hemophilia A|hemophilia a
885325|NCT00002275|Weight Loss|weight loss
885326|NCT00002275|Pneumonia, Pneumocystis carinii|pneumonia, pneumocystis carinii
885327|NCT00002275|Parenteral Nutrition|parenteral nutrition
885328|NCT00002275|Liposyn|liposyn
885329|NCT00002275|Acquired Immunodeficiency Syndrome|acquired immunodeficiency syndrome
885330|NCT00002274|Didanosine|didanosine
885331|NCT00002274|Drugs, Investigational|drugs, investigational
885332|NCT00002274|Acquired Immunodeficiency Syndrome|acquired immunodeficiency syndrome
885333|NCT00002274|Zidovudine|zidovudine
885334|NCT00002273|AIDS-Related Opportunistic Infections|aids-related opportunistic infections
885335|NCT00002273|Ganciclovir|ganciclovir
885336|NCT00002273|Cytomegalovirus Infections|cytomegalovirus infections
885337|NCT00002273|Colitis|colitis
885338|NCT00002273|Acquired Immunodeficiency Syndrome|acquired immunodeficiency syndrome
885339|NCT00002272|AIDS-Related Opportunistic Infections|aids-related opportunistic infections
885340|NCT00002272|Immune Tolerance|immune tolerance
885341|NCT00002272|Injections, Intravenous|injections, intravenous
885342|NCT00002272|Herpes Simplex|herpes simplex
885343|NCT00002272|Immunity, Cellular|immunity, cellular
885344|NCT00002272|Drug Resistance|drug resistance
885345|NCT00002272|Foscarnet|foscarnet
885346|NCT00002272|Acyclovir|acyclovir
885347|NCT00002272|Acquired Immunodeficiency Syndrome|acquired immunodeficiency syndrome
885348|NCT00002272|Antiviral Agents|antiviral agents
885349|NCT00002271|Thymidine|thymidine
885350|NCT00002271|Nucleosides|nucleosides
885351|NCT00002271|Antiviral Agents|antiviral agents
885352|NCT00002270|Leukoencephalopathy, Progressive Multifocal|leukoencephalopathy, progressive multifocal
885353|NCT00002270|Interferon Alfa-2b|interferon alfa-2b
885354|NCT00002270|Drug Evaluation|drug evaluation
885355|NCT00002270|Acquired Immunodeficiency Syndrome|acquired immunodeficiency syndrome
885356|NCT00002270|Zidovudine|zidovudine
885357|NCT00002269|Acquired Immunodeficiency Syndrome|acquired immunodeficiency syndrome
885358|NCT00002269|ampligen|ampligen
885359|NCT00002269|AIDS-Related Complex|aids-related complex
885360|NCT00002269|Zidovudine|zidovudine
885361|NCT00002268|AIDS-Related Opportunistic Infections|aids-related opportunistic infections
885362|NCT00002268|Immunotherapy|immunotherapy
885363|NCT00002268|Drug Evaluation|drug evaluation
885364|NCT00002268|Cytomegalovirus Infections|cytomegalovirus infections
885365|NCT00002268|Antibodies, Monoclonal|antibodies, monoclonal
885366|NCT00002267|Rifabutin|rifabutin
885367|NCT00002267|AIDS-Related Opportunistic Infections|aids-related opportunistic infections
885368|NCT00002267|Mycobacterium avium-intracellulare Infection|mycobacterium avium-intracellulare infection
885369|NCT00002267|Acquired Immunodeficiency Syndrome|acquired immunodeficiency syndrome
885370|NCT00002267|Antitubercular Agents|antitubercular agents
885371|NCT00002266|Drug Therapy, Combination|drug therapy, combination
885372|NCT00002266|Acquired Immunodeficiency Syndrome|acquired immunodeficiency syndrome
885373|NCT00002266|AIDS-Related Complex|aids-related complex
885374|NCT00002266|ammonium trichloro(dioxoethylene-O,O'-)tellurute|ammonium trichloro(dioxoethylene-o,o'-)tellurute
885375|NCT00002265|Zalcitabine|zalcitabine
885376|NCT00002265|Drug Evaluation|drug evaluation
885377|NCT00002265|Acquired Immunodeficiency Syndrome|acquired immunodeficiency syndrome
885378|NCT00002265|AIDS-Related Complex|aids-related complex
885379|NCT00002265|Zidovudine|zidovudine
885380|NCT00002263|Pilot Projects|pilot projects
885381|NCT00002263|Neutropenia|neutropenia
885382|NCT00002263|Granulocyte-Macrophage Colony-Stimulating Factor|granulocyte-macrophage colony-stimulating factor
885383|NCT00002263|Acquired Immunodeficiency Syndrome|acquired immunodeficiency syndrome
885384|NCT00002263|Zidovudine|zidovudine
885385|NCT00002262|Skin Neoplasms|skin neoplasms
885386|NCT00002262|Tumor Necrosis Factor|tumor necrosis factor
885387|NCT00002262|Acquired Immunodeficiency Syndrome|acquired immunodeficiency syndrome
885388|NCT00002261|Vaccines, Synthetic|vaccines, synthetic
885389|NCT00002261|Vaccinia Virus|vaccinia virus
885390|NCT00002261|Viral Vaccines|viral vaccines
885391|NCT00002261|Smallpox Vaccine|smallpox vaccine
885392|NCT00002261|HIV-1|hiv-1
885393|NCT00002261|AIDS Vaccines|aids vaccines
885394|NCT00002261|HIV Seronegativity|hiv seronegativity
885395|NCT00002260|Biological Availability|biological availability
885396|NCT00002260|alovudine|alovudine
885397|NCT00002260|Food|food
885398|NCT00002259|Mitoxantrone|mitoxantrone
885399|NCT00002259|Acquired Immunodeficiency Syndrome|acquired immunodeficiency syndrome
885400|NCT00002258|Interleukin-3|interleukin-3
885401|NCT00002258|Recombinant Proteins|recombinant proteins
885402|NCT00002258|Leukopenia|leukopenia
885403|NCT00002258|Acquired Immunodeficiency Syndrome|acquired immunodeficiency syndrome
885404|NCT00002258|AIDS-Related Complex|aids-related complex
885405|NCT00002258|Thrombocytopenia|thrombocytopenia
885406|NCT00002257|Retinitis|retinitis
885407|NCT00002257|Ganciclovir|ganciclovir
885408|NCT00002257|Cytomegalovirus Infections|cytomegalovirus infections
885409|NCT00002257|Acquired Immunodeficiency Syndrome|acquired immunodeficiency syndrome
885410|NCT00002256|Zalcitabine|zalcitabine
885411|NCT00002256|Acquired Immunodeficiency Syndrome|acquired immunodeficiency syndrome
885412|NCT00002256|AIDS-Related Complex|aids-related complex
885413|NCT00002256|Zidovudine|zidovudine
885414|NCT00002255|Erythropoietin|erythropoietin
885415|NCT00002255|Granulocyte Colony-Stimulating Factor|granulocyte colony-stimulating factor
885416|NCT00002255|Acquired Immunodeficiency Syndrome|acquired immunodeficiency syndrome
885417|NCT00002255|AIDS-Related Complex|aids-related complex
885418|NCT00002255|Zidovudine|zidovudine
885419|NCT00002254|Acquired Immunodeficiency Syndrome|acquired immunodeficiency syndrome
885420|NCT00002253|Octreotide|octreotide
885421|NCT00002253|Diarrhea|diarrhea
885422|NCT00002253|Acquired Immunodeficiency Syndrome|acquired immunodeficiency syndrome
885423|NCT00002253|AIDS-Related Complex|aids-related complex
885424|NCT00002252|Octreotide|octreotide
885425|NCT00002252|Diarrhea|diarrhea
885426|NCT00002252|Acquired Immunodeficiency Syndrome|acquired immunodeficiency syndrome
885427|NCT00002252|AIDS-Related Complex|aids-related complex
885428|NCT00002251|AIDS-Related Opportunistic Infections|aids-related opportunistic infections
885429|NCT00002251|Ganciclovir|ganciclovir
885430|NCT00002251|Cytomegalovirus Infections|cytomegalovirus infections
885431|NCT00002251|Acquired Immunodeficiency Syndrome|acquired immunodeficiency syndrome
885432|NCT00002251|Biological Availability|biological availability
885433|NCT00002250|Recombinant Proteins|recombinant proteins
885434|NCT00002250|IgG|igg
885435|NCT00002250|Drug Evaluation|drug evaluation
885436|NCT00002250|Antigens, CD4|antigens, cd4
885437|NCT00002249|Anti-Infective Agents, Quinolone|anti-infective agents, quinolone
885438|NCT00002249|Ofloxacin|ofloxacin
885439|NCT00002249|Acquired Immunodeficiency Syndrome|acquired immunodeficiency syndrome
885440|NCT00002248|Antidiarrheals|antidiarrheals
885441|NCT00002248|Cryptosporidiosis|cryptosporidiosis
885442|NCT00002248|Diarrhea|diarrhea
885443|NCT00002248|Acquired Immunodeficiency Syndrome|acquired immunodeficiency syndrome
885444|NCT00002248|Cryptosporidium|cryptosporidium
885445|NCT00002248|Immunization, Passive|immunization, passive
885446|NCT00002247|Retinitis|retinitis
885447|NCT00002247|Ganciclovir|ganciclovir
885448|NCT00002247|Cytomegalovirus Infections|cytomegalovirus infections
885449|NCT00002247|Administration, Oral|administration, oral
885450|NCT00002247|Acquired Immunodeficiency Syndrome|acquired immunodeficiency syndrome
885451|NCT00002246|AIDS Dementia Complex|aids dementia complex
885452|NCT00002246|Zidovudine|zidovudine
885453|NCT00002246|Stavudine|stavudine
885454|NCT00002246|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors
885455|NCT00002245|Drug Therapy, Combination|drug therapy, combination
885456|NCT00002245|HIV Protease Inhibitors|hiv protease inhibitors
885457|NCT00002245|Lamivudine|lamivudine
885458|NCT00002245|Carbohydrates|carbohydrates
885459|NCT00002245|VX 478|vx 478
885460|NCT00002245|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors
885461|NCT00002245|Anti-HIV Agents|anti-hiv agents
885462|NCT00002245|Lipids|lipids
885463|NCT00002245|Insulin Resistance|insulin resistance
885464|NCT00002245|abacavir|abacavir
885465|NCT00002244|Placebos|placebos
885466|NCT00002244|Infusions, Intravenous|infusions, intravenous
885467|NCT00002244|Quality of Life|quality of life
885468|NCT00002244|Anti-HIV Agents|anti-hiv agents
885469|NCT00002244|tetrachlorodecaoxide|tetrachlorodecaoxide
885470|NCT00002243|Anti-HIV Agents|anti-hiv agents
885471|NCT00002241|Drug Therapy, Combination|drug therapy, combination
885472|NCT00002241|Stavudine|stavudine
885473|NCT00002241|HIV Protease Inhibitors|hiv protease inhibitors
885474|NCT00002241|Ritonavir|ritonavir
885475|NCT00002241|Lamivudine|lamivudine
885476|NCT00002241|Indinavir|indinavir
885477|NCT00002241|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors
885478|NCT00002241|Anti-HIV Agents|anti-hiv agents
885479|NCT00002241|Viral Load|viral load
885480|NCT00002240|Didanosine|didanosine
885481|NCT00002240|Dose-Response Relationship, Drug|dose-response relationship, drug
885482|NCT00002240|Drug Therapy, Combination|drug therapy, combination
885483|NCT00002240|Stavudine|stavudine
885484|NCT00002240|HIV Protease Inhibitors|hiv protease inhibitors
885485|NCT00002240|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors
885486|NCT00002240|Anti-HIV Agents|anti-hiv agents
885487|NCT00002240|Nelfinavir|nelfinavir
885488|NCT00002239|HIV-1|hiv-1
885489|NCT00002239|Dose-Response Relationship, Drug|dose-response relationship, drug
885490|NCT00002239|Drug Therapy, Combination|drug therapy, combination
885491|NCT00002239|VX 478|vx 478
885492|NCT00002239|Anti-HIV Agents|anti-hiv agents
885493|NCT00002239|pentafuside|pentafuside
885494|NCT00002239|abacavir|abacavir
885495|NCT00002239|efavirenz|efavirenz
885496|NCT00002238|Drug Therapy, Combination|drug therapy, combination
885497|NCT00002238|Acquired Immunodeficiency Syndrome|acquired immunodeficiency syndrome
885498|NCT00002238|AIDS-Related Complex|aids-related complex
885499|NCT00002238|Zidovudine|zidovudine
885500|NCT00002238|Interferon Type I|interferon type i
885501|NCT00002237|Placebos|placebos
885502|NCT00002237|Administration, Oral|administration, oral
885503|NCT00002237|Anti-HIV Agents|anti-hiv agents
885504|NCT00002237|Viral Load|viral load
885505|NCT00002237|peldesine|peldesine
885506|NCT00002236|Drug Therapy, Combination|drug therapy, combination
885507|NCT00002236|Zidovudine|zidovudine
885508|NCT00002236|Drug Administration Schedule|drug administration schedule
885509|NCT00002236|HIV Protease Inhibitors|hiv protease inhibitors
885510|NCT00002236|CD4 Lymphocyte Count|cd4 lymphocyte count
885511|NCT00002236|Indinavir|indinavir
885512|NCT00002236|Delavirdine|delavirdine
885513|NCT00002236|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors
885514|NCT00002236|Anti-HIV Agents|anti-hiv agents
885515|NCT00002236|Viral Load|viral load
885516|NCT00002235|Drug Therapy, Combination|drug therapy, combination
885517|NCT00002235|HIV Protease Inhibitors|hiv protease inhibitors
885518|NCT00002235|Indinavir|indinavir
885519|NCT00002235|Nelfinavir|nelfinavir
885520|NCT00002235|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors
885521|NCT00002235|Anti-HIV Agents|anti-hiv agents
885522|NCT00002235|efavirenz|efavirenz
885523|NCT00002234|Drug Therapy, Combination|drug therapy, combination
885524|NCT00002234|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors
885525|NCT00002234|Anti-HIV Agents|anti-hiv agents
885526|NCT00002233|Drug Therapy, Combination|drug therapy, combination
885527|NCT00002233|HIV Protease Inhibitors|hiv protease inhibitors
885528|NCT00002233|CD4 Lymphocyte Count|cd4 lymphocyte count
885529|NCT00002233|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors
885530|NCT00002233|Anti-HIV Agents|anti-hiv agents
885531|NCT00002233|Viral Load|viral load
885532|NCT00002232|Injections, Intradermal|injections, intradermal
885533|NCT00002232|Injections, Intramuscular|injections, intramuscular
885534|NCT00002232|HIV Antibodies|hiv antibodies
885535|NCT00002232|Immunity, Cellular|immunity, cellular
885536|NCT00002232|AIDS Vaccines|aids vaccines
885537|NCT00002232|HIV Seronegativity|hiv seronegativity
885538|NCT00002232|Dose-Response Relationship, Immunologic|dose-response relationship, immunologic
885539|NCT00002232|Vaccines, DNA|vaccines, dna
885540|NCT00002232|Immunity, Mucosal|immunity, mucosal
885541|NCT00002231|Injections, Intramuscular|injections, intramuscular
885542|NCT00002231|HIV Antibodies|hiv antibodies
885543|NCT00002231|Immunity, Cellular|immunity, cellular
885544|NCT00002231|AIDS Vaccines|aids vaccines
885545|NCT00002231|HIV Seronegativity|hiv seronegativity
885546|NCT00002231|Dose-Response Relationship, Immunologic|dose-response relationship, immunologic
885547|NCT00002231|Vaccines, DNA|vaccines, dna
885548|NCT00002230|Didanosine|didanosine
885549|NCT00002230|Drug Therapy, Combination|drug therapy, combination
885550|NCT00002230|Stavudine|stavudine
885551|NCT00002230|Hydroxyurea|hydroxyurea
885552|NCT00002230|Anti-HIV Agents|anti-hiv agents
885553|NCT00002229|Drug Therapy, Combination|drug therapy, combination
885554|NCT00002229|HIV Protease Inhibitors|hiv protease inhibitors
885555|NCT00002229|Dosage Forms|dosage forms
885556|NCT00002229|Saquinavir|saquinavir
885557|NCT00002229|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors
885558|NCT00002229|Anti-HIV Agents|anti-hiv agents
885559|NCT00002228|Injections, Subcutaneous|injections, subcutaneous
885561|NCT00002228|Anti-HIV Agents|anti-hiv agents
885562|NCT00002228|peptide T20|peptide t20
885563|NCT00002227|Drug Therapy, Combination|drug therapy, combination
885564|NCT00002227|Stavudine|stavudine
885565|NCT00002227|Lamivudine|lamivudine
885566|NCT00002227|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors
885567|NCT00002227|efavirenz|efavirenz
885568|NCT00002226|Skin Neoplasms|skin neoplasms
885569|NCT00002226|Sarcoma, Kaposi|sarcoma, kaposi
885570|NCT00002226|Antineoplastic Agents|antineoplastic agents
885571|NCT00002225|Didanosine|didanosine
885572|NCT00002225|Drug Therapy, Combination|drug therapy, combination
885573|NCT00002225|Stavudine|stavudine
885574|NCT00002225|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors
885575|NCT00002225|efavirenz|efavirenz
885576|NCT00002224|Didanosine|didanosine
885577|NCT00002224|Drug Therapy, Combination|drug therapy, combination
885578|NCT00002224|Drug Administration Schedule|drug administration schedule
885579|NCT00002224|Stavudine|stavudine
885580|NCT00002224|HIV Protease Inhibitors|hiv protease inhibitors
885581|NCT00002224|Nelfinavir|nelfinavir
885582|NCT00002224|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors
885583|NCT00002224|Anti-HIV Agents|anti-hiv agents
885584|NCT00002224|Viral Load|viral load
885585|NCT00002223|Drug Therapy, Combination|drug therapy, combination
885586|NCT00002223|Adolescent Behavior|adolescent behavior
885587|NCT00002223|HIV Protease Inhibitors|hiv protease inhibitors
885588|NCT00002223|Ritonavir|ritonavir
885589|NCT00002223|Indinavir|indinavir
885590|NCT00002222|AIDS-Related Opportunistic Infections|aids-related opportunistic infections
885591|NCT00002222|Ganciclovir|ganciclovir
885592|NCT00002222|Antiviral Agents|antiviral agents
885593|NCT00002222|Drug Administration Schedule|drug administration schedule
885594|NCT00002222|Cytomegalovirus Retinitis|cytomegalovirus retinitis
885595|NCT00002222|Prodrugs|prodrugs
885596|NCT00002221|Lymphoma, Non-Hodgkin|lymphoma, non-hodgkin
885597|NCT00002221|Bone Marrow|bone marrow
885598|NCT00002221|Lymphocyte Transformation|lymphocyte transformation
885599|NCT00002221|HIV-1|hiv-1
885600|NCT00002221|Retroviridae|retroviridae
885601|NCT00002221|Lymphoma, AIDS-Related|lymphoma, aids-related
885602|NCT00002221|Genetic Vectors|genetic vectors
885603|NCT00002221|Transduction, Genetic|transduction, genetic
885604|NCT00002221|Gene Transfer Techniques|gene transfer techniques
885605|NCT00002220|Drug Resistance|drug resistance
885606|NCT00002220|Drug Therapy, Combination|drug therapy, combination
885607|NCT00002220|Antiviral Agents|antiviral agents
885608|NCT00002220|HIV Protease Inhibitors|hiv protease inhibitors
885609|NCT00002220|Indinavir|indinavir
885610|NCT00002220|RNA, Viral|rna, viral
885611|NCT00002220|Adenine|adenine
885612|NCT00002220|efavirenz|efavirenz
885613|NCT00002219|Dose-Response Relationship, Drug|dose-response relationship, drug
885614|NCT00002219|Antiviral Agents|antiviral agents
885615|NCT00002219|HIV Protease Inhibitors|hiv protease inhibitors
885616|NCT00002219|Disease Progression|disease progression
885617|NCT00002219|RNA, Viral|rna, viral
885618|NCT00002219|Adenine|adenine
885619|NCT00002219|Viral Load|viral load
885620|NCT00002219|Age Factors|age factors
885621|NCT00002219|Nelfinavir|nelfinavir
885622|NCT00002218|HIV-1|hiv-1
885623|NCT00002218|Dose-Response Relationship, Drug|dose-response relationship, drug
885624|NCT00002218|Anti-HIV Agents|anti-hiv agents
885625|NCT00002217|Drug Therapy, Combination|drug therapy, combination
885626|NCT00002217|Patient Compliance|patient compliance
885627|NCT00002217|Anti-HIV Agents|anti-hiv agents
885628|NCT00002217|abacavir|abacavir
885629|NCT00002216|Drug Therapy, Combination|drug therapy, combination
885630|NCT00002216|HIV Protease Inhibitors|hiv protease inhibitors
885631|NCT00002216|VX 478|vx 478
885632|NCT00002216|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors
885633|NCT00002216|Anti-HIV Agents|anti-hiv agents
885634|NCT00002216|abacavir|abacavir
885635|NCT00002215|Drug Therapy, Combination|drug therapy, combination
885636|NCT00002215|HIV Protease Inhibitors|hiv protease inhibitors
885637|NCT00002215|RNA, Viral|rna, viral
885638|NCT00002215|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors
885639|NCT00002215|Viral Load|viral load
885640|NCT00002215|Nelfinavir|nelfinavir
885641|NCT00002215|Uracil|uracil
885642|NCT00002214|Dose-Response Relationship, Drug|dose-response relationship, drug
885643|NCT00002214|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors
885644|NCT00002213|HIV-1|hiv-1
885645|NCT00002213|Drug Therapy, Combination|drug therapy, combination
885646|NCT00002213|Antiviral Agents|antiviral agents
885647|NCT00002213|HIV Protease Inhibitors|hiv protease inhibitors
885648|NCT00002213|RNA, Viral|rna, viral
885649|NCT00002213|VX 478|vx 478
885650|NCT00002213|Anti-HIV Agents|anti-hiv agents
885651|NCT00002213|abacavir|abacavir
885652|NCT00002213|efavirenz|efavirenz
885653|NCT00002212|Sarcoma, Kaposi|sarcoma, kaposi
885654|NCT00002212|Acquired Immunodeficiency Syndrome|acquired immunodeficiency syndrome
885655|NCT00002212|Anticarcinogenic Agents|anticarcinogenic agents
885656|NCT00002211|HIV-1|hiv-1
885657|NCT00002211|Didanosine|didanosine
885658|NCT00002211|Stavudine|stavudine
885659|NCT00002211|HIV Protease Inhibitors|hiv protease inhibitors
885660|NCT00002211|RNA, Viral|rna, viral
885661|NCT00002211|Delavirdine|delavirdine
885662|NCT00002211|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors
885663|NCT00002211|Viral Load|viral load
885664|NCT00002211|Nelfinavir|nelfinavir
885665|NCT00002210|HIV-1|hiv-1
885666|NCT00002210|Drug Therapy, Combination|drug therapy, combination
885667|NCT00002210|Delavirdine|delavirdine
885668|NCT00002210|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors
885669|NCT00002209|Dose-Response Relationship, Drug|dose-response relationship, drug
885670|NCT00002209|Drug Therapy, Combination|drug therapy, combination
885671|NCT00002209|AIDS Dementia Complex|aids dementia complex
885672|NCT00002209|Zidovudine|zidovudine
885673|NCT00002209|Lamivudine|lamivudine
885674|NCT00002209|Indinavir|indinavir
885675|NCT00002209|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors
885676|NCT00002208|HIV-1|hiv-1
885677|NCT00002208|Drug Therapy, Combination|drug therapy, combination
885678|NCT00002208|Zidovudine|zidovudine
885679|NCT00002208|HIV Protease Inhibitors|hiv protease inhibitors
885680|NCT00002208|Lamivudine|lamivudine
885681|NCT00002208|Indinavir|indinavir
885682|NCT00002208|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors
885683|NCT00002207|Didanosine|didanosine
885684|NCT00002207|Drug Therapy, Combination|drug therapy, combination
885685|NCT00002207|Stavudine|stavudine
885686|NCT00002207|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors
885687|NCT00002206|HIV-1|hiv-1
885688|NCT00002206|Adenine|adenine
885689|NCT00002206|Anti-HIV Agents|anti-hiv agents
885690|NCT00002205|HIV Protease Inhibitors|hiv protease inhibitors
885691|NCT00002205|VX 478|vx 478
885692|NCT00002205|Anti-HIV Agents|anti-hiv agents
885693|NCT00002205|abacavir|abacavir
885694|NCT00002204|Reference Values|reference values
885695|NCT00002204|Placebos|placebos
885696|NCT00002204|AIDS Vaccines|aids vaccines
885697|NCT00002204|HIV Core Protein p24|hiv core protein p24
885698|NCT00002204|HIV Seronegativity|hiv seronegativity
885699|NCT00002204|MF59 oil emulsion|mf59 oil emulsion
885700|NCT00002203|Drug Therapy, Combination|drug therapy, combination
885701|NCT00002203|Zidovudine|zidovudine
885702|NCT00002203|HIV Protease Inhibitors|hiv protease inhibitors
885703|NCT00002203|CD4 Lymphocyte Count|cd4 lymphocyte count
885704|NCT00002203|CD4-CD8 Ratio|cd4-cd8 ratio
885705|NCT00002203|Lamivudine|lamivudine
885706|NCT00002203|Patient Compliance|patient compliance
885707|NCT00002203|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors
885708|NCT00002203|Anti-HIV Agents|anti-hiv agents
885709|NCT00002203|Viral Load|viral load
885710|NCT00002202|HIV-1|hiv-1
885711|NCT00002202|Drug Therapy, Combination|drug therapy, combination
885712|NCT00002202|HIV Protease Inhibitors|hiv protease inhibitors
885713|NCT00002202|Indinavir|indinavir
885714|NCT00002202|RNA, Viral|rna, viral
885715|NCT00002202|VX 478|vx 478
885716|NCT00002202|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors
885717|NCT00002202|Anti-HIV Agents|anti-hiv agents
885718|NCT00002202|Viral Load|viral load
885719|NCT00002201|Drug Therapy, Combination|drug therapy, combination
885720|NCT00002201|HIV Protease Inhibitors|hiv protease inhibitors
885721|NCT00002201|Ritonavir|ritonavir
885722|NCT00002201|Nelfinavir|nelfinavir
885723|NCT00002201|Anti-HIV Agents|anti-hiv agents
885724|NCT00002200|HIV-1|hiv-1
885725|NCT00002200|Administration, Oral|administration, oral
885726|NCT00002200|CD4 Lymphocyte Count|cd4 lymphocyte count
885727|NCT00002200|RNA, Viral|rna, viral
885728|NCT00002200|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors
885729|NCT00002200|Anti-HIV Agents|anti-hiv agents
885730|NCT00002200|Viral Load|viral load
885731|NCT00002200|abacavir|abacavir
885732|NCT00002199|HIV-1|hiv-1
885733|NCT00002199|Drug Therapy, Combination|drug therapy, combination
885734|NCT00002199|Zidovudine|zidovudine
885735|NCT00002199|Drug Resistance, Microbial|drug resistance, microbial
885736|NCT00002199|HIV Protease Inhibitors|hiv protease inhibitors
885737|NCT00002199|Lamivudine|lamivudine
885738|NCT00002199|Indinavir|indinavir
885739|NCT00002199|Genotype|genotype
885740|NCT00002199|Phenotype|phenotype
885741|NCT00002199|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors
885742|NCT00002199|Anti-HIV Agents|anti-hiv agents
885743|NCT00002199|abacavir|abacavir
885744|NCT00002198|Drug Interactions|drug interactions
885745|NCT00002198|Antiviral Agents|antiviral agents
885746|NCT00002198|Ethanol|ethanol
885747|NCT00002198|abacavir|abacavir
885748|NCT00002197|HIV-1|hiv-1
885749|NCT00002197|CD4 Lymphocyte Count|cd4 lymphocyte count
885750|NCT00002197|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors
885751|NCT00002197|Anti-HIV Agents|anti-hiv agents
885752|NCT00002197|Viral Load|viral load
885753|NCT00002197|abacavir|abacavir
885754|NCT00002196|Dose-Response Relationship, Drug|dose-response relationship, drug
885755|NCT00002196|Administration, Oral|administration, oral
885756|NCT00002196|Drug Administration Schedule|drug administration schedule
885757|NCT00002196|CD4 Lymphocyte Count|cd4 lymphocyte count
885758|NCT00002196|Anti-HIV Agents|anti-hiv agents
885759|NCT00002195|Drug Therapy, Combination|drug therapy, combination
885760|NCT00002195|Zidovudine|zidovudine
885761|NCT00002195|HIV Protease Inhibitors|hiv protease inhibitors
885762|NCT00002195|Lamivudine|lamivudine
885763|NCT00002195|VX 478|vx 478
885764|NCT00002195|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors
885765|NCT00002195|Anti-HIV Agents|anti-hiv agents
885766|NCT00002195|Viral Load|viral load
885767|NCT00002194|Antibiotics, Macrolide|antibiotics, macrolide
885768|NCT00002194|Clarithromycin|clarithromycin
885769|NCT00002194|Nevirapine|nevirapine
885770|NCT00002194|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors
885771|NCT00002194|Cytochrome P-450|cytochrome p-450
885772|NCT00002194|Anti-HIV Agents|anti-hiv agents
885773|NCT00002193|HIV-1|hiv-1
885774|NCT00002193|Drug Therapy, Combination|drug therapy, combination
885775|NCT00002193|HIV Protease Inhibitors|hiv protease inhibitors
885776|NCT00002193|RNA, Viral|rna, viral
885777|NCT00002193|VX 478|vx 478
885778|NCT00002193|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors
885779|NCT00002193|Anti-HIV Agents|anti-hiv agents
885780|NCT00002193|Viral Load|viral load
885781|NCT00002192|AIDS-Related Opportunistic Infections|aids-related opportunistic infections
885782|NCT00002192|Mycobacterium avium-intracellulare Infection|mycobacterium avium-intracellulare infection
885783|NCT00002192|Drug Therapy, Combination|drug therapy, combination
885784|NCT00002192|Antitubercular Agents|antitubercular agents
885785|NCT00002192|Azithromycin|azithromycin
885786|NCT00002192|Clarithromycin|clarithromycin
885787|NCT00002192|Bacteremia|bacteremia
885788|NCT00002192|rifapentine|rifapentine
885789|NCT00002191|AIDS-Related Opportunistic Infections|aids-related opportunistic infections
885790|NCT00002191|Placebos|placebos
885791|NCT00002191|Protozoan Infections|protozoan infections
885792|NCT00002191|Intestinal Diseases|intestinal diseases
885793|NCT00002191|Albendazole|albendazole
885794|NCT00002191|Microsporida|microsporida
885795|NCT00002191|Anthelmintics|anthelmintics
885796|NCT00002190|Drug Therapy, Combination|drug therapy, combination
885797|NCT00002190|Zidovudine|zidovudine
885798|NCT00002190|HIV Protease Inhibitors|hiv protease inhibitors
885799|NCT00002190|Lamivudine|lamivudine
885800|NCT00002190|Saquinavir|saquinavir
885801|NCT00002190|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors
885802|NCT00002190|Anti-HIV Agents|anti-hiv agents
885803|NCT00002189|Sarcoma, Kaposi|sarcoma, kaposi
885804|NCT00002189|Acquired Immunodeficiency Syndrome|acquired immunodeficiency syndrome
885805|NCT00002189|Paclitaxel|paclitaxel
885806|NCT00002189|Treatment Outcome|treatment outcome
885807|NCT00002189|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic
885808|NCT00002188|AIDS-Related Opportunistic Infections|aids-related opportunistic infections
885809|NCT00002188|Sarcoma, Kaposi|sarcoma, kaposi
885810|NCT00002188|Antineoplastic Agents|antineoplastic agents
885811|NCT00002187|AIDS-Related Opportunistic Infections|aids-related opportunistic infections
885812|NCT00002187|Antiviral Agents|antiviral agents
885813|NCT00002187|Drug Administration Schedule|drug administration schedule
885814|NCT00002187|Cytomegalovirus Retinitis|cytomegalovirus retinitis
885815|NCT00002187|fomivirsen|fomivirsen
885816|NCT00002187|Vitreous Body|vitreous body
885817|NCT00002186|AIDS-Related Opportunistic Infections|aids-related opportunistic infections
885818|NCT00002186|Herpes Simplex|herpes simplex
885819|NCT00002186|Drug Therapy, Combination|drug therapy, combination
885820|NCT00002186|Acyclovir|acyclovir
885821|NCT00002186|Antiviral Agents|antiviral agents
885822|NCT00002186|Gels|gels
885823|NCT00002186|SP 303|sp 303
885824|NCT00002185|Skin Neoplasms|skin neoplasms
885825|NCT00002185|AIDS-Related Opportunistic Infections|aids-related opportunistic infections
885826|NCT00002185|Sarcoma, Kaposi|sarcoma, kaposi
885827|NCT00002185|Drug Therapy, Combination|drug therapy, combination
885828|NCT00002185|HIV Protease Inhibitors|hiv protease inhibitors
885829|NCT00002185|Mucous Membrane|mucous membrane
885830|NCT00002185|Nelfinavir|nelfinavir
885831|NCT00002185|Anti-HIV Agents|anti-hiv agents
885832|NCT00002184|HIV-1|hiv-1
885833|NCT00002184|Dose-Response Relationship, Drug|dose-response relationship, drug
885834|NCT00002184|Drug Therapy, Combination|drug therapy, combination
885835|NCT00002184|Acquired Immunodeficiency Syndrome|acquired immunodeficiency syndrome
885836|NCT00002184|Zidovudine|zidovudine
885837|NCT00002184|Stavudine|stavudine
885838|NCT00002184|HIV Protease Inhibitors|hiv protease inhibitors
885839|NCT00002184|CD4 Lymphocyte Count|cd4 lymphocyte count
885840|NCT00002184|Lamivudine|lamivudine
885841|NCT00002184|RNA, Viral|rna, viral
885842|NCT00002184|Saquinavir|saquinavir
885843|NCT00002184|Nelfinavir|nelfinavir
885844|NCT00002184|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors
885845|NCT00002184|Adenine|adenine
885846|NCT00002184|Anti-HIV Agents|anti-hiv agents
885847|NCT00002184|Viral Load|viral load
885848|NCT00002183|Drug Therapy, Combination|drug therapy, combination
885849|NCT00002183|Drug Administration Schedule|drug administration schedule
885850|NCT00002183|HIV Protease Inhibitors|hiv protease inhibitors
885851|NCT00002183|VX 478|vx 478
885852|NCT00002183|Anti-HIV Agents|anti-hiv agents
885853|NCT00002182|Placebos|placebos
885854|NCT00002182|Appetite Stimulants|appetite stimulants
885855|NCT00002182|Megestrol Acetate|megestrol acetate
885856|NCT00002182|Failure to Thrive|failure to thrive
885857|NCT00002181|AIDS-Related Opportunistic Infections|aids-related opportunistic infections
885858|NCT00002181|Herpes Simplex|herpes simplex
885859|NCT00002181|Acyclovir|acyclovir
885860|NCT00002181|Antiviral Agents|antiviral agents
885861|NCT00002181|Gels|gels
885862|NCT00002181|cidofovir|cidofovir
885863|NCT00002180|Placebos|placebos
885864|NCT00002180|Anti-HIV Agents|anti-hiv agents
885865|NCT00002180|Adenine|adenine
885866|NCT00002179|Semen|semen
885867|NCT00002179|Monocytes|monocytes
885868|NCT00002179|HIV-1|hiv-1
885869|NCT00002179|Drug Therapy, Combination|drug therapy, combination
885870|NCT00002179|Zidovudine|zidovudine
885871|NCT00002179|Lymph Nodes|lymph nodes
885872|NCT00002179|HIV Protease Inhibitors|hiv protease inhibitors
885873|NCT00002179|Lamivudine|lamivudine
885874|NCT00002179|Indinavir|indinavir
885875|NCT00002179|RNA, Viral|rna, viral
885876|NCT00002179|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors
885877|NCT00002179|Anti-HIV Agents|anti-hiv agents
885878|NCT00002179|Viral Load|viral load
885879|NCT00002178|HIV-1|hiv-1
885880|NCT00002178|Drug Therapy, Combination|drug therapy, combination
885881|NCT00002178|HIV Protease Inhibitors|hiv protease inhibitors
885882|NCT00002178|RNA, Viral|rna, viral
885883|NCT00002178|Dosage Forms|dosage forms
885884|NCT00002178|Saquinavir|saquinavir
885885|NCT00002178|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors
885886|NCT00002178|Anti-HIV Agents|anti-hiv agents
885887|NCT00002178|Viral Load|viral load
885888|NCT00002177|Pilot Projects|pilot projects
885889|NCT00002177|HIV-1|hiv-1
885890|NCT00002177|Didanosine|didanosine
885891|NCT00002177|Drug Therapy, Combination|drug therapy, combination
885892|NCT00002177|Stavudine|stavudine
885893|NCT00002177|Hydroxyurea|hydroxyurea
885894|NCT00002177|RNA, Viral|rna, viral
885895|NCT00002177|Nelfinavir|nelfinavir
885896|NCT00002177|Anti-HIV Agents|anti-hiv agents
885897|NCT00002177|Viral Load|viral load
885898|NCT00002176|Pilot Projects|pilot projects
885899|NCT00002176|Didanosine|didanosine
885900|NCT00002176|Drug Therapy, Combination|drug therapy, combination
885901|NCT00002176|Stavudine|stavudine
885902|NCT00002176|Hydroxyurea|hydroxyurea
885903|NCT00002176|Nelfinavir|nelfinavir
885904|NCT00002176|Anti-HIV Agents|anti-hiv agents
885905|NCT00002176|Viral Load|viral load
885906|NCT00002175|Cohort Studies|cohort studies
885907|NCT00002175|RNA, Viral|rna, viral
885908|NCT00002175|Administration, Cutaneous|administration, cutaneous
885909|NCT00002175|Anti-HIV Agents|anti-hiv agents
885910|NCT00002175|Dinitrobenzenes|dinitrobenzenes
885911|NCT00002174|Adjuvants, Immunologic|adjuvants, immunologic
885912|NCT00002174|Thalidomide|thalidomide
885913|NCT00002174|Cytokines|cytokines
885914|NCT00002174|Viral Load|viral load
885915|NCT00002173|Acquired Immunodeficiency Syndrome|acquired immunodeficiency syndrome
885916|NCT00002173|AIDS Vaccines|aids vaccines
885917|NCT00002173|CD4 Lymphocyte Count|cd4 lymphocyte count
885918|NCT00002173|Salk HIV Immunogen|salk hiv immunogen
885919|NCT00002172|Acquired Immunodeficiency Syndrome|acquired immunodeficiency syndrome
885920|NCT00002172|AIDS Vaccines|aids vaccines
885921|NCT00002172|CD4 Lymphocyte Count|cd4 lymphocyte count
885922|NCT00002172|Salk HIV Immunogen|salk hiv immunogen
885923|NCT00002171|Placebos|placebos
885924|NCT00002171|Drug Therapy, Combination|drug therapy, combination
885925|NCT00002171|Stavudine|stavudine
885926|NCT00002171|HIV Protease Inhibitors|hiv protease inhibitors
885927|NCT00002171|Lamivudine|lamivudine
885928|NCT00002171|Nelfinavir|nelfinavir
885929|NCT00002171|Anti-HIV Agents|anti-hiv agents
885930|NCT00002170|AIDS-Related Opportunistic Infections|aids-related opportunistic infections
885931|NCT00002170|Placebos|placebos
885932|NCT00002170|Mycobacterium avium-intracellulare Infection|mycobacterium avium-intracellulare infection
885933|NCT00002170|Acquired Immunodeficiency Syndrome|acquired immunodeficiency syndrome
885934|NCT00002170|HIV Protease Inhibitors|hiv protease inhibitors
885935|NCT00002170|Nelfinavir|nelfinavir
885936|NCT00002170|Anti-Infective Agents|anti-infective agents
885937|NCT00002170|Anti-HIV Agents|anti-hiv agents
885938|NCT00002169|AIDS-Related Opportunistic Infections|aids-related opportunistic infections
885939|NCT00002169|Placebos|placebos
885940|NCT00002169|Antiviral Agents|antiviral agents
885941|NCT00002169|Cytomegalovirus Retinitis|cytomegalovirus retinitis
885942|NCT00002169|Treatment Outcome|treatment outcome
885943|NCT00002169|Nelfinavir|nelfinavir
885944|NCT00002168|Didanosine|didanosine
885945|NCT00002168|Drug Therapy, Combination|drug therapy, combination
885946|NCT00002168|Zidovudine|zidovudine
885947|NCT00002168|Stavudine|stavudine
885948|NCT00002168|HIV Protease Inhibitors|hiv protease inhibitors
885949|NCT00002168|CD4 Lymphocyte Count|cd4 lymphocyte count
885950|NCT00002168|Lamivudine|lamivudine
885951|NCT00002168|Indinavir|indinavir
885952|NCT00002168|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors
885953|NCT00002168|Anti-HIV Agents|anti-hiv agents
885954|NCT00002168|Viral Load|viral load
885955|NCT00002167|Skin Neoplasms|skin neoplasms
885956|NCT00002167|Sarcoma, Kaposi|sarcoma, kaposi
885957|NCT00002167|Acquired Immunodeficiency Syndrome|acquired immunodeficiency syndrome
885958|NCT00002167|Photochemotherapy|photochemotherapy
885959|NCT00002167|tin etiopurpurin|tin etiopurpurin
885960|NCT00002167|Radiation-Sensitizing Agents|radiation-sensitizing agents
885961|NCT00002166|Nevirapine|nevirapine
885962|NCT00002166|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors
885963|NCT00002166|Anti-HIV Agents|anti-hiv agents
885964|NCT00002165|Acquired Immunodeficiency Syndrome|acquired immunodeficiency syndrome
885965|NCT00002165|HIV Protease Inhibitors|hiv protease inhibitors
885966|NCT00002165|CD4 Lymphocyte Count|cd4 lymphocyte count
885967|NCT00002165|Nelfinavir|nelfinavir
885968|NCT00002165|Anti-HIV Agents|anti-hiv agents
885969|NCT00002164|Biological Availability|biological availability
885970|NCT00002164|HIV Protease Inhibitors|hiv protease inhibitors
885971|NCT00002164|Dosage Forms|dosage forms
885972|NCT00002164|Nelfinavir|nelfinavir
885973|NCT00002163|Acquired Immunodeficiency Syndrome|acquired immunodeficiency syndrome
885974|NCT00002163|AIDS Dementia Complex|aids dementia complex
885975|NCT00002163|Antiviral Agents|antiviral agents
885976|NCT00002163|abacavir|abacavir
885977|NCT00002162|Drug Therapy, Combination|drug therapy, combination
885978|NCT00002162|Acquired Immunodeficiency Syndrome|acquired immunodeficiency syndrome
885979|NCT00002162|AIDS-Related Complex|aids-related complex
885980|NCT00002162|Antiviral Agents|antiviral agents
885981|NCT00002162|Saquinavir|saquinavir
885982|NCT00002161|Drug Therapy, Combination|drug therapy, combination
885983|NCT00002161|Acquired Immunodeficiency Syndrome|acquired immunodeficiency syndrome
885984|NCT00002161|AIDS-Related Complex|aids-related complex
885985|NCT00002161|Antiviral Agents|antiviral agents
885986|NCT00002161|Adenine|adenine
885987|NCT00002160|Acquired Immunodeficiency Syndrome|acquired immunodeficiency syndrome
885988|NCT00002160|AIDS-Related Complex|aids-related complex
885989|NCT00002160|Pain|pain
885990|NCT00002160|Palliative Care|palliative care
885991|NCT00002160|omega-conopeptide MVIIA|omega-conopeptide mviia
885992|NCT00002160|Calcium Channel Blockers|calcium channel blockers
885993|NCT00002159|Itraconazole|itraconazole
885994|NCT00002159|Histoplasmosis|histoplasmosis
885995|NCT00002159|Antifungal Agents|antifungal agents
885996|NCT00002159|Acquired Immunodeficiency Syndrome|acquired immunodeficiency syndrome
885997|NCT00002159|Amphotericin B|amphotericin b
885998|NCT00002159|AIDS-Related Complex|aids-related complex
885999|NCT00002159|Blastomycosis|blastomycosis
886000|NCT00002159|Antibiotics, Antifungal|antibiotics, antifungal
886001|NCT00002158|Cryptosporidiosis|cryptosporidiosis
886002|NCT00002158|Diarrhea|diarrhea
886003|NCT00002158|Acquired Immunodeficiency Syndrome|acquired immunodeficiency syndrome
886004|NCT00002158|nitazoxanide|nitazoxanide
886005|NCT00002158|Antiparasitic Agents|antiparasitic agents
886006|NCT00002157|Acquired Immunodeficiency Syndrome|acquired immunodeficiency syndrome
886007|NCT00002157|Cachexia|cachexia
886008|NCT00002157|Thalidomide|thalidomide
886009|NCT00002156|AIDS-Related Opportunistic Infections|aids-related opportunistic infections
886010|NCT00002156|Ganciclovir|ganciclovir
886011|NCT00002156|Drug Therapy, Combination|drug therapy, combination
886012|NCT00002156|Acquired Immunodeficiency Syndrome|acquired immunodeficiency syndrome
886013|NCT00002156|Antiviral Agents|antiviral agents
886014|NCT00002156|Cytomegalovirus Retinitis|cytomegalovirus retinitis
886015|NCT00002156|Injections|injections
886016|NCT00002155|Drug Therapy, Combination|drug therapy, combination
886017|NCT00002155|Acquired Immunodeficiency Syndrome|acquired immunodeficiency syndrome
886018|NCT00002155|Antiviral Agents|antiviral agents
886019|NCT00002155|Zidovudine|zidovudine
886020|NCT00002155|HIV Protease Inhibitors|hiv protease inhibitors
886021|NCT00002155|Lamivudine|lamivudine
886022|NCT00002155|Indinavir|indinavir
886114|NCT00002136|Neoplasms|neoplasms
886023|NCT00002154|Drug Therapy, Combination|drug therapy, combination
886024|NCT00002154|Cognition Disorders|cognition disorders
886025|NCT00002154|Acquired Immunodeficiency Syndrome|acquired immunodeficiency syndrome
886026|NCT00002154|AIDS-Related Complex|aids-related complex
886027|NCT00002154|Thioctic Acid|thioctic acid
886028|NCT00002154|Selegiline|selegiline
886029|NCT00002153|Skin Neoplasms|skin neoplasms
886030|NCT00002153|Sarcoma, Kaposi|sarcoma, kaposi
886031|NCT00002153|Acquired Immunodeficiency Syndrome|acquired immunodeficiency syndrome
886032|NCT00002153|Antineoplastic Agents|antineoplastic agents
886033|NCT00002152|Acquired Immunodeficiency Syndrome|acquired immunodeficiency syndrome
886034|NCT00002152|Antiviral Agents|antiviral agents
886035|NCT00002151|Drug Therapy, Combination|drug therapy, combination
886036|NCT00002151|AIDS-Related Complex|aids-related complex
886037|NCT00002151|Zidovudine|zidovudine
886038|NCT00002151|MDL 28574|mdl 28574
886039|NCT00002150|Drug Therapy, Combination|drug therapy, combination
886040|NCT00002150|Acquired Immunodeficiency Syndrome|acquired immunodeficiency syndrome
886041|NCT00002150|AIDS-Related Complex|aids-related complex
886042|NCT00002150|Zidovudine|zidovudine
886043|NCT00002150|MDL 28574|mdl 28574
886044|NCT00002149|AIDS-Related Opportunistic Infections|aids-related opportunistic infections
886045|NCT00002149|Drug Therapy, Combination|drug therapy, combination
886046|NCT00002149|Acquired Immunodeficiency Syndrome|acquired immunodeficiency syndrome
886047|NCT00002149|AIDS-Related Complex|aids-related complex
886048|NCT00002149|Sinusitis|sinusitis
886049|NCT00002149|Ephedrine|ephedrine
886050|NCT00002149|Acupuncture Therapy|acupuncture therapy
886051|NCT00002149|Drugs, Chinese Herbal|drugs, chinese herbal
886052|NCT00002149|Medicine, Chinese Traditional|medicine, chinese traditional
886053|NCT00002149|Drug Combinations|drug combinations
886054|NCT00002149|Antibiotics, Combined|antibiotics, combined
886055|NCT00002149|Amoxicillin-Potassium Clavulanate Combination|amoxicillin-potassium clavulanate combination
886056|NCT00002148|Cognition Disorders|cognition disorders
886057|NCT00002148|Acquired Immunodeficiency Syndrome|acquired immunodeficiency syndrome
886058|NCT00002148|AIDS-Related Complex|aids-related complex
886059|NCT00002148|Free Radical Scavengers|free radical scavengers
886060|NCT00002148|Antioxidants|antioxidants
886061|NCT00002148|OPC 14117|opc 14117
886062|NCT00002147|Sarcoma, Kaposi|sarcoma, kaposi
886063|NCT00002147|Liposomes|liposomes
886064|NCT00002147|Doxorubicin|doxorubicin
886065|NCT00002147|Acquired Immunodeficiency Syndrome|acquired immunodeficiency syndrome
886066|NCT00002147|Drug Carriers|drug carriers
886067|NCT00002146|Infusions, Intravenous|infusions, intravenous
886068|NCT00002146|Foscarnet|foscarnet
886069|NCT00002146|Cytomegalovirus Infections|cytomegalovirus infections
886070|NCT00002146|Acquired Immunodeficiency Syndrome|acquired immunodeficiency syndrome
886071|NCT00002146|Magnesium Sulfate|magnesium sulfate
886072|NCT00002146|Magnesium Deficiency|magnesium deficiency
886073|NCT00002146|Hypocalcemia|hypocalcemia
886074|NCT00002145|Foscarnet|foscarnet
886075|NCT00002145|Cytomegalovirus Infections|cytomegalovirus infections
886076|NCT00002145|Acquired Immunodeficiency Syndrome|acquired immunodeficiency syndrome
886077|NCT00002144|Herpes Simplex|herpes simplex
886078|NCT00002144|Foscarnet|foscarnet
886079|NCT00002144|Acquired Immunodeficiency Syndrome|acquired immunodeficiency syndrome
886080|NCT00002143|Psoriasis|psoriasis
886081|NCT00002143|Acquired Immunodeficiency Syndrome|acquired immunodeficiency syndrome
886082|NCT00002143|AIDS-Related Complex|aids-related complex
886083|NCT00002143|Acitretin|acitretin
886084|NCT00002142|Retinitis|retinitis
886085|NCT00002142|Probenecid|probenecid
886086|NCT00002142|Drug Therapy, Combination|drug therapy, combination
886087|NCT00002142|Cytomegalovirus Infections|cytomegalovirus infections
886088|NCT00002142|Acquired Immunodeficiency Syndrome|acquired immunodeficiency syndrome
886089|NCT00002142|Antiviral Agents|antiviral agents
886090|NCT00002142|cidofovir|cidofovir
886091|NCT00002141|Biological Availability|biological availability
886092|NCT00002141|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors
886093|NCT00002141|Food-Drug Interactions|food-drug interactions
886094|NCT00002141|abacavir|abacavir
886095|NCT00002140|Mycobacterium avium-intracellulare Infection|mycobacterium avium-intracellulare infection
886096|NCT00002140|Drug Therapy, Combination|drug therapy, combination
886097|NCT00002140|Ethambutol|ethambutol
886098|NCT00002140|Acquired Immunodeficiency Syndrome|acquired immunodeficiency syndrome
886099|NCT00002140|Azithromycin|azithromycin
886100|NCT00002140|Clarithromycin|clarithromycin
886101|NCT00002139|Acquired Immunodeficiency Syndrome|acquired immunodeficiency syndrome
886102|NCT00002139|Azithromycin|azithromycin
886103|NCT00002139|Bacterial Infections|bacterial infections
886104|NCT00002138|Neoplasms|neoplasms
886105|NCT00002138|Sarcoma, Kaposi|sarcoma, kaposi
886106|NCT00002138|Acquired Immunodeficiency Syndrome|acquired immunodeficiency syndrome
886107|NCT00002138|Antineoplastic Agents|antineoplastic agents
886108|NCT00002138|tecogalan|tecogalan
886109|NCT00002137|Neoplasms|neoplasms
886110|NCT00002137|Sarcoma, Kaposi|sarcoma, kaposi
886111|NCT00002137|Acquired Immunodeficiency Syndrome|acquired immunodeficiency syndrome
886112|NCT00002137|Antineoplastic Agents|antineoplastic agents
886113|NCT00002137|tecogalan|tecogalan
886115|NCT00002136|Sarcoma, Kaposi|sarcoma, kaposi
886116|NCT00002136|Acquired Immunodeficiency Syndrome|acquired immunodeficiency syndrome
886117|NCT00002136|Antineoplastic Agents|antineoplastic agents
886118|NCT00002136|tecogalan|tecogalan
886119|NCT00002135|Retinitis|retinitis
886120|NCT00002135|Ganciclovir|ganciclovir
886121|NCT00002135|Administration, Oral|administration, oral
886122|NCT00002135|Acquired Immunodeficiency Syndrome|acquired immunodeficiency syndrome
886123|NCT00002134|Retinitis|retinitis
886124|NCT00002134|Ganciclovir|ganciclovir
886125|NCT00002134|Administration, Oral|administration, oral
886126|NCT00002134|Acquired Immunodeficiency Syndrome|acquired immunodeficiency syndrome
886127|NCT00002133|Itraconazole|itraconazole
886128|NCT00002133|Acquired Immunodeficiency Syndrome|acquired immunodeficiency syndrome
886129|NCT00002133|AIDS-Related Complex|aids-related complex
886130|NCT00002133|Candidiasis, Oral|candidiasis, oral
886131|NCT00002132|Itraconazole|itraconazole
886132|NCT00002132|Fluconazole|fluconazole
886133|NCT00002132|Acquired Immunodeficiency Syndrome|acquired immunodeficiency syndrome
886134|NCT00002132|Candidiasis|candidiasis
886135|NCT00002132|Immunocompromised Host|immunocompromised host
886136|NCT00002131|Sarcoma, Kaposi|sarcoma, kaposi
886137|NCT00002131|Acquired Immunodeficiency Syndrome|acquired immunodeficiency syndrome
886138|NCT00002131|Antiviral Agents|antiviral agents
886139|NCT00002131|vesnarinone|vesnarinone
886140|NCT00002130|Acquired Immunodeficiency Syndrome|acquired immunodeficiency syndrome
886141|NCT00002130|Antiviral Agents|antiviral agents
886142|NCT00002130|vesnarinone|vesnarinone
886143|NCT00002129|vesnarinone|vesnarinone
886144|NCT00002128|Acquired Immunodeficiency Syndrome|acquired immunodeficiency syndrome
886145|NCT00002128|AIDS-Related Complex|aids-related complex
886146|NCT00002128|Antiviral Agents|antiviral agents
886147|NCT00002128|Adenine|adenine
886148|NCT00002127|Acquired Immunodeficiency Syndrome|acquired immunodeficiency syndrome
886149|NCT00002127|Cachexia|cachexia
886150|NCT00002127|Thalidomide|thalidomide
886151|NCT00002126|Neutropenia|neutropenia
886152|NCT00002126|Granulocyte Colony-Stimulating Factor|granulocyte colony-stimulating factor
886153|NCT00002126|Acquired Immunodeficiency Syndrome|acquired immunodeficiency syndrome
886154|NCT00002125|Retinitis|retinitis
886155|NCT00002125|Infusions, Intravenous|infusions, intravenous
886156|NCT00002125|Foscarnet|foscarnet
886157|NCT00002125|Cytomegalovirus Infections|cytomegalovirus infections
886158|NCT00002125|Administration, Oral|administration, oral
886159|NCT00002125|Acquired Immunodeficiency Syndrome|acquired immunodeficiency syndrome
886160|NCT00002125|Fluid Therapy|fluid therapy
886161|NCT00002124|Drug Therapy, Combination|drug therapy, combination
886162|NCT00002124|Acquired Immunodeficiency Syndrome|acquired immunodeficiency syndrome
886163|NCT00002124|AIDS-Related Complex|aids-related complex
886164|NCT00002124|Antiviral Agents|antiviral agents
886165|NCT00002124|Zidovudine|zidovudine
886166|NCT00002123|Didanosine|didanosine
886167|NCT00002123|Drug Therapy, Combination|drug therapy, combination
886168|NCT00002123|Acquired Immunodeficiency Syndrome|acquired immunodeficiency syndrome
886169|NCT00002123|AIDS-Related Complex|aids-related complex
886170|NCT00002123|Antiviral Agents|antiviral agents
886171|NCT00002122|Rifabutin|rifabutin
886172|NCT00002122|Mycobacterium avium-intracellulare Infection|mycobacterium avium-intracellulare infection
886173|NCT00002122|Mycoses|mycoses
886174|NCT00002122|Drug Therapy, Combination|drug therapy, combination
886175|NCT00002122|Fluconazole|fluconazole
886176|NCT00002122|Acquired Immunodeficiency Syndrome|acquired immunodeficiency syndrome
886177|NCT00002122|Azithromycin|azithromycin
886178|NCT00002121|Antidiarrheals|antidiarrheals
886179|NCT00002121|Diarrhea|diarrhea
886180|NCT00002121|Acquired Immunodeficiency Syndrome|acquired immunodeficiency syndrome
886181|NCT00002121|AIDS-Related Complex|aids-related complex
886182|NCT00002121|N(1),N(14)-bis(ethyl)homospermine|n(1),n(14)-bis(ethyl)homospermine
886183|NCT00002120|Trimethoprim-Sulfamethoxazole Combination|trimethoprim-sulfamethoxazole combination
886184|NCT00002120|Trimetrexate|trimetrexate
886185|NCT00002120|Pneumonia, Pneumocystis carinii|pneumonia, pneumocystis carinii
886186|NCT00002120|Leucovorin|leucovorin
886187|NCT00002120|Dapsone|dapsone
886188|NCT00002120|Drug Therapy, Combination|drug therapy, combination
886189|NCT00002120|Acquired Immunodeficiency Syndrome|acquired immunodeficiency syndrome
886190|NCT00002119|Acquired Immunodeficiency Syndrome|acquired immunodeficiency syndrome
886191|NCT00002119|AIDS-Related Complex|aids-related complex
886192|NCT00002119|Antiviral Agents|antiviral agents
886193|NCT00002118|Zalcitabine|zalcitabine
886194|NCT00002118|Acquired Immunodeficiency Syndrome|acquired immunodeficiency syndrome
886195|NCT00002118|AIDS-Related Complex|aids-related complex
886196|NCT00002117|Zalcitabine|zalcitabine
886197|NCT00002117|Drug Therapy, Combination|drug therapy, combination
886198|NCT00002117|Acquired Immunodeficiency Syndrome|acquired immunodeficiency syndrome
886199|NCT00002117|AIDS-Related Complex|aids-related complex
886200|NCT00002117|Zidovudine|zidovudine
886201|NCT00002116|Herpes Simplex|herpes simplex
886202|NCT00002116|Acquired Immunodeficiency Syndrome|acquired immunodeficiency syndrome
886203|NCT00002116|Antiviral Agents|antiviral agents
886204|NCT00002116|cidofovir|cidofovir
886564|NCT00002040|Meningitis|meningitis
886205|NCT00002115|Acquired Immunodeficiency Syndrome|acquired immunodeficiency syndrome
886206|NCT00002115|Antiviral Agents|antiviral agents
886207|NCT00002115|Adenine|adenine
886208|NCT00002113|Meningitis|meningitis
886209|NCT00002113|Cryptococcosis|cryptococcosis
886210|NCT00002113|Drug Therapy, Combination|drug therapy, combination
886211|NCT00002113|Fluconazole|fluconazole
886212|NCT00002113|Flucytosine|flucytosine
886213|NCT00002113|Acquired Immunodeficiency Syndrome|acquired immunodeficiency syndrome
886214|NCT00002112|Nystatin|nystatin
886215|NCT00002112|Fluconazole|fluconazole
886216|NCT00002112|Acquired Immunodeficiency Syndrome|acquired immunodeficiency syndrome
886217|NCT00002112|AIDS-Related Complex|aids-related complex
886218|NCT00002112|Candidiasis, Oral|candidiasis, oral
886219|NCT00002111|AIDS-Related Complex|aids-related complex
886220|NCT00002111|Saquinavir|saquinavir
886221|NCT00002111|HIV Protease Inhibitors|hiv protease inhibitors
886222|NCT00002110|Drug Therapy, Combination|drug therapy, combination
886223|NCT00002110|AIDS-Related Complex|aids-related complex
886224|NCT00002110|Zidovudine|zidovudine
886225|NCT00002110|Cysteamine|cysteamine
886226|NCT00002109|Thymopentin|thymopentin
886227|NCT00002109|Zalcitabine|zalcitabine
886228|NCT00002109|Didanosine|didanosine
886229|NCT00002109|Drug Therapy, Combination|drug therapy, combination
886230|NCT00002109|Zidovudine|zidovudine
886231|NCT00002109|Stavudine|stavudine
886232|NCT00002108|Drug Therapy, Combination|drug therapy, combination
886233|NCT00002108|Acquired Immunodeficiency Syndrome|acquired immunodeficiency syndrome
886234|NCT00002108|AIDS-Related Complex|aids-related complex
886235|NCT00002108|Antiviral Agents|antiviral agents
886236|NCT00002108|Zidovudine|zidovudine
886237|NCT00002107|Interleukin-2|interleukin-2
886238|NCT00002107|Acquired Immunodeficiency Syndrome|acquired immunodeficiency syndrome
886239|NCT00002107|AIDS-Related Complex|aids-related complex
886240|NCT00002106|Ranitidine|ranitidine
886241|NCT00002105|Vincristine|vincristine
886242|NCT00002105|Sarcoma, Kaposi|sarcoma, kaposi
886243|NCT00002105|Liposomes|liposomes
886244|NCT00002105|Doxorubicin|doxorubicin
886245|NCT00002105|Drug Therapy, Combination|drug therapy, combination
886246|NCT00002105|Acquired Immunodeficiency Syndrome|acquired immunodeficiency syndrome
886247|NCT00002105|Bleomycin|bleomycin
886248|NCT00002105|Drug Carriers|drug carriers
886249|NCT00002104|Mycobacterium tuberculosis|mycobacterium tuberculosis
886250|NCT00002104|Mycobacterium Infections|mycobacterium infections
886251|NCT00002104|AIDS-Related Opportunistic Infections|aids-related opportunistic infections
886252|NCT00002104|Mycobacterium avium-intracellulare Infection|mycobacterium avium-intracellulare infection
886253|NCT00002104|Acquired Immunodeficiency Syndrome|acquired immunodeficiency syndrome
886254|NCT00002104|AIDS-Related Complex|aids-related complex
886255|NCT00002104|Mycobacterium Infections, Atypical|mycobacterium infections, atypical
886256|NCT00002104|Thalidomide|thalidomide
886257|NCT00002103|Trimetrexate|trimetrexate
886258|NCT00002103|Pneumonia, Pneumocystis carinii|pneumonia, pneumocystis carinii
886259|NCT00002103|Leucovorin|leucovorin
886260|NCT00002103|Drug Therapy, Combination|drug therapy, combination
886261|NCT00002103|Acquired Immunodeficiency Syndrome|acquired immunodeficiency syndrome
886262|NCT00002102|Trimetrexate|trimetrexate
886263|NCT00002102|Pneumonia, Pneumocystis carinii|pneumonia, pneumocystis carinii
886264|NCT00002102|Leucovorin|leucovorin
886265|NCT00002102|Drug Therapy, Combination|drug therapy, combination
886266|NCT00002102|Acquired Immunodeficiency Syndrome|acquired immunodeficiency syndrome
886267|NCT00002101|Rifabutin|rifabutin
886533|NCT00002047|Renal Dialysis|renal dialysis
886268|NCT00002101|Mycobacterium avium-intracellulare Infection|mycobacterium avium-intracellulare infection
886269|NCT00002101|Drug Therapy, Combination|drug therapy, combination
886270|NCT00002101|Ethambutol|ethambutol
886271|NCT00002101|Acquired Immunodeficiency Syndrome|acquired immunodeficiency syndrome
886272|NCT00002101|Clarithromycin|clarithromycin
886273|NCT00002100|Acquired Immunodeficiency Syndrome|acquired immunodeficiency syndrome
886274|NCT00002100|AIDS-Related Complex|aids-related complex
886275|NCT00002100|curdlan sulfate|curdlan sulfate
886276|NCT00002099|Didanosine|didanosine
886277|NCT00002099|Drug Therapy, Combination|drug therapy, combination
886278|NCT00002099|Acquired Immunodeficiency Syndrome|acquired immunodeficiency syndrome
886279|NCT00002099|AIDS-Related Complex|aids-related complex
886280|NCT00002099|Lentinan|lentinan
886281|NCT00002098|Didanosine|didanosine
886282|NCT00002098|Drug Therapy, Combination|drug therapy, combination
886283|NCT00002098|Acquired Immunodeficiency Syndrome|acquired immunodeficiency syndrome
886284|NCT00002098|AIDS-Related Complex|aids-related complex
886285|NCT00002098|Lentinan|lentinan
886286|NCT00002097|Nystatin|nystatin
886287|NCT00002097|Acquired Immunodeficiency Syndrome|acquired immunodeficiency syndrome
886288|NCT00002097|AIDS-Related Complex|aids-related complex
886289|NCT00002096|Didanosine|didanosine
886290|NCT00002096|Ganciclovir|ganciclovir
886291|NCT00002096|Drug Interactions|drug interactions
886292|NCT00002096|Cytomegalovirus Infections|cytomegalovirus infections
886293|NCT00002096|Acquired Immunodeficiency Syndrome|acquired immunodeficiency syndrome
886294|NCT00002096|Zidovudine|zidovudine
886295|NCT00002095|Ganciclovir|ganciclovir
886296|NCT00002095|Cytomegalovirus Infections|cytomegalovirus infections
886297|NCT00002095|Acquired Immunodeficiency Syndrome|acquired immunodeficiency syndrome
886298|NCT00002094|Virus Replication|virus replication
886299|NCT00002094|Acquired Immunodeficiency Syndrome|acquired immunodeficiency syndrome
886300|NCT00002094|Antiviral Agents|antiviral agents
886301|NCT00002093|Vincristine|vincristine
886302|NCT00002093|Sarcoma, Kaposi|sarcoma, kaposi
886303|NCT00002093|Liposomes|liposomes
886304|NCT00002093|Doxorubicin|doxorubicin
886305|NCT00002093|Acquired Immunodeficiency Syndrome|acquired immunodeficiency syndrome
886306|NCT00002093|Bleomycin|bleomycin
886307|NCT00002093|Daunorubicin|daunorubicin
886308|NCT00002093|Drug Carriers|drug carriers
886309|NCT00002092|Acquired Immunodeficiency Syndrome|acquired immunodeficiency syndrome
886310|NCT00002092|AIDS-Related Complex|aids-related complex
886311|NCT00002092|Cimetidine|cimetidine
886312|NCT00002091|Pentoxifylline|pentoxifylline
886313|NCT00002091|Acquired Immunodeficiency Syndrome|acquired immunodeficiency syndrome
886314|NCT00002091|AIDS-Related Complex|aids-related complex
886315|NCT00002090|Mycobacterium avium-intracellulare Infection|mycobacterium avium-intracellulare infection
886316|NCT00002090|Acquired Immunodeficiency Syndrome|acquired immunodeficiency syndrome
886317|NCT00002090|Azithromycin|azithromycin
886318|NCT00002089|Mycobacterium avium-intracellulare Infection|mycobacterium avium-intracellulare infection
886319|NCT00002089|Acquired Immunodeficiency Syndrome|acquired immunodeficiency syndrome
886320|NCT00002089|Azithromycin|azithromycin
886321|NCT00002088|Diarrhea|diarrhea
886322|NCT00002088|Acquired Immunodeficiency Syndrome|acquired immunodeficiency syndrome
886323|NCT00002088|AIDS-Related Complex|aids-related complex
886324|NCT00002088|Saccharomyces|saccharomyces
886325|NCT00002087|Recombinant Proteins|recombinant proteins
886326|NCT00002087|Acquired Immunodeficiency Syndrome|acquired immunodeficiency syndrome
886327|NCT00002087|Antigens, CD4|antigens, cd4
886328|NCT00002087|AIDS-Related Complex|aids-related complex
886329|NCT00002086|Zalcitabine|zalcitabine
886330|NCT00002086|Drug Therapy, Combination|drug therapy, combination
886331|NCT00002086|AIDS-Related Complex|aids-related complex
886332|NCT00002086|Zidovudine|zidovudine
886333|NCT00002086|Interferon-alpha|interferon-alpha
886334|NCT00002085|Mycobacterium avium-intracellulare Infection|mycobacterium avium-intracellulare infection
886335|NCT00002085|Acquired Immunodeficiency Syndrome|acquired immunodeficiency syndrome
886336|NCT00002085|Azithromycin|azithromycin
886337|NCT00002085|Mycobacterium Infections, Atypical|mycobacterium infections, atypical
886338|NCT00002084|Acyclovir|acyclovir
886339|NCT00002084|Acquired Immunodeficiency Syndrome|acquired immunodeficiency syndrome
886340|NCT00002084|AIDS-Related Complex|aids-related complex
886341|NCT00002084|Antiviral Agents|antiviral agents
886342|NCT00002084|Anus Diseases|anus diseases
886343|NCT00002084|Herpes Genitalis|herpes genitalis
886344|NCT00002083|Peptide T|peptide t
886345|NCT00002083|HIV-1|hiv-1
886346|NCT00002083|Administration, Intranasal|administration, intranasal
886347|NCT00002083|Acquired Immunodeficiency Syndrome|acquired immunodeficiency syndrome
886348|NCT00002083|Peripheral Nervous System Diseases|peripheral nervous system diseases
886349|NCT00002082|Cryptosporidiosis|cryptosporidiosis
886350|NCT00002082|Acquired Immunodeficiency Syndrome|acquired immunodeficiency syndrome
886351|NCT00002082|Azithromycin|azithromycin
886352|NCT00002081|Zalcitabine|zalcitabine
886353|NCT00002081|Acquired Immunodeficiency Syndrome|acquired immunodeficiency syndrome
886354|NCT00002081|AIDS-Related Complex|aids-related complex
886355|NCT00002081|Zidovudine|zidovudine
886356|NCT00002080|Rifabutin|rifabutin
886357|NCT00002080|Acquired Immunodeficiency Syndrome|acquired immunodeficiency syndrome
886358|NCT00002080|AIDS-Related Complex|aids-related complex
886359|NCT00002080|Mycobacterium avium Complex|mycobacterium avium complex
886360|NCT00002080|Bacteremia|bacteremia
886361|NCT00002079|Zidovudine|zidovudine
886362|NCT00002079|1-Deoxynojirimycin|1-deoxynojirimycin
886363|NCT00002078|Drug Evaluation|drug evaluation
886364|NCT00002078|Interferon-alpha|interferon-alpha
886365|NCT00002077|AIDS-Related Opportunistic Infections|aids-related opportunistic infections
886366|NCT00002077|Meningitis|meningitis
886367|NCT00002077|Injections, Intravenous|injections, intravenous
886368|NCT00002077|Cryptococcosis|cryptococcosis
886369|NCT00002077|Fluconazole|fluconazole
886370|NCT00002077|Administration, Oral|administration, oral
886371|NCT00002077|Acquired Immunodeficiency Syndrome|acquired immunodeficiency syndrome
886372|NCT00002076|AIDS-Related Opportunistic Infections|aids-related opportunistic infections
886373|NCT00002076|Meningitis|meningitis
886374|NCT00002076|Cryptococcosis|cryptococcosis
886375|NCT00002076|Fluconazole|fluconazole
886376|NCT00002076|Administration, Oral|administration, oral
886377|NCT00002076|Acquired Immunodeficiency Syndrome|acquired immunodeficiency syndrome
886378|NCT00002075|AIDS-Related Opportunistic Infections|aids-related opportunistic infections
886379|NCT00002075|Meningitis|meningitis
886380|NCT00002075|Cryptococcosis|cryptococcosis
886381|NCT00002075|Drug Therapy, Combination|drug therapy, combination
886382|NCT00002075|Fluconazole|fluconazole
886383|NCT00002075|Flucytosine|flucytosine
886384|NCT00002075|Acquired Immunodeficiency Syndrome|acquired immunodeficiency syndrome
886385|NCT00002075|Amphotericin B|amphotericin b
886565|NCT00002040|Injections, Intravenous|injections, intravenous
886386|NCT00002074|AIDS-Related Opportunistic Infections|aids-related opportunistic infections
886387|NCT00002074|Meningitis|meningitis
886388|NCT00002074|Cryptococcosis|cryptococcosis
886389|NCT00002074|Fluconazole|fluconazole
886390|NCT00002074|Acquired Immunodeficiency Syndrome|acquired immunodeficiency syndrome
886391|NCT00002074|Amphotericin B|amphotericin b
886392|NCT00002073|Recombinant Proteins|recombinant proteins
886393|NCT00002073|Injections, Subcutaneous|injections, subcutaneous
886394|NCT00002073|Erythropoietin|erythropoietin
886395|NCT00002073|Acquired Immunodeficiency Syndrome|acquired immunodeficiency syndrome
886396|NCT00002073|Anemia|anemia
886397|NCT00002073|Zidovudine|zidovudine
886398|NCT00002072|Recombinant Proteins|recombinant proteins
886399|NCT00002072|Erythropoietin|erythropoietin
886400|NCT00002072|Acquired Immunodeficiency Syndrome|acquired immunodeficiency syndrome
886401|NCT00002072|Anemia|anemia
886402|NCT00002072|Zidovudine|zidovudine
886403|NCT00002071|Recombinant Proteins|recombinant proteins
886404|NCT00002071|Erythropoietin|erythropoietin
886405|NCT00002071|Acquired Immunodeficiency Syndrome|acquired immunodeficiency syndrome
886406|NCT00002071|Anemia|anemia
886407|NCT00002071|Zidovudine|zidovudine
886408|NCT00002070|Recombinant Proteins|recombinant proteins
886409|NCT00002070|Retinitis|retinitis
886410|NCT00002070|AIDS-Related Opportunistic Infections|aids-related opportunistic infections
886411|NCT00002070|Neutropenia|neutropenia
886412|NCT00002070|Ganciclovir|ganciclovir
886413|NCT00002070|Drug Therapy, Combination|drug therapy, combination
886414|NCT00002070|Granulocyte-Macrophage Colony-Stimulating Factor|granulocyte-macrophage colony-stimulating factor
886415|NCT00002070|Cytomegalovirus Infections|cytomegalovirus infections
886416|NCT00002070|Acquired Immunodeficiency Syndrome|acquired immunodeficiency syndrome
886417|NCT00002069|Ditiocarb|ditiocarb
886418|NCT00002069|Acquired Immunodeficiency Syndrome|acquired immunodeficiency syndrome
886419|NCT00002069|AIDS-Related Complex|aids-related complex
886420|NCT00002068|AIDS-Related Opportunistic Infections|aids-related opportunistic infections
886421|NCT00002068|Meningitis|meningitis
886422|NCT00002068|Cryptococcosis|cryptococcosis
886423|NCT00002068|Drug Therapy, Combination|drug therapy, combination
886424|NCT00002068|Fluconazole|fluconazole
886425|NCT00002068|Flucytosine|flucytosine
886426|NCT00002068|Acquired Immunodeficiency Syndrome|acquired immunodeficiency syndrome
886427|NCT00002068|Amphotericin B|amphotericin b
886428|NCT00002067|Body Weight|body weight
886429|NCT00002067|T-Lymphocytes|t-lymphocytes
886430|NCT00002067|Nutritional Status|nutritional status
886431|NCT00002067|Megestrol|megestrol
886432|NCT00002067|Acquired Immunodeficiency Syndrome|acquired immunodeficiency syndrome
886433|NCT00002067|Anorexia|anorexia
886434|NCT00002067|Cachexia|cachexia
886435|NCT00002067|Energy Intake|energy intake
886436|NCT00002066|Thymopentin|thymopentin
886437|NCT00002066|Acquired Immunodeficiency Syndrome|acquired immunodeficiency syndrome
886438|NCT00002065|Delayed-Action Preparations|delayed-action preparations
886439|NCT00002065|Disulfiram|disulfiram
886440|NCT00002065|Acquired Immunodeficiency Syndrome|acquired immunodeficiency syndrome
886441|NCT00002065|AIDS-Related Complex|aids-related complex
886442|NCT00002064|Sulfonamides|sulfonamides
886443|NCT00002064|Toxoplasmosis|toxoplasmosis
886444|NCT00002064|AIDS-Related Opportunistic Infections|aids-related opportunistic infections
886445|NCT00002064|Pyrimethamine|pyrimethamine
886446|NCT00002064|Drug Therapy, Combination|drug therapy, combination
886447|NCT00002064|Encephalitis|encephalitis
887189|NCT00001076|Avipoxvirus|avipoxvirus
886448|NCT00002064|Acquired Immunodeficiency Syndrome|acquired immunodeficiency syndrome
886449|NCT00002064|Clindamycin|clindamycin
886450|NCT00002063|Immune Tolerance|immune tolerance
886451|NCT00002063|AIDS-Related Complex|aids-related complex
886452|NCT00002063|Zidovudine|zidovudine
886453|NCT00002062|Spiramycin|spiramycin
886454|NCT00002062|AIDS-Related Opportunistic Infections|aids-related opportunistic infections
886455|NCT00002062|Immune Tolerance|immune tolerance
886456|NCT00002062|Cryptosporidiosis|cryptosporidiosis
886457|NCT00002062|Diarrhea|diarrhea
886458|NCT00002062|Drugs, Investigational|drugs, investigational
886459|NCT00002062|Acquired Immunodeficiency Syndrome|acquired immunodeficiency syndrome
886460|NCT00002061|T-Lymphocytes|t-lymphocytes
886461|NCT00002061|Immune Tolerance|immune tolerance
886462|NCT00002061|Inosine Pranobex|inosine pranobex
886463|NCT00002061|Killer Cells|killer cells
886464|NCT00002061|T-Lymphocytes, Helper-Inducer|t-lymphocytes, helper-inducer
886465|NCT00002061|Acquired Immunodeficiency Syndrome|acquired immunodeficiency syndrome
886466|NCT00002061|AIDS-Related Complex|aids-related complex
886467|NCT00002060|AIDS-Related Opportunistic Infections|aids-related opportunistic infections
886468|NCT00002060|Inosine Pranobex|inosine pranobex
886469|NCT00002060|Homosexuality|homosexuality
886470|NCT00002060|Acquired Immunodeficiency Syndrome|acquired immunodeficiency syndrome
886471|NCT00002060|AIDS-Related Complex|aids-related complex
886472|NCT00002059|T-Lymphocytes, Suppressor-Effector|t-lymphocytes, suppressor-effector
886473|NCT00002059|Neoplasms|neoplasms
886474|NCT00002059|Inosine Pranobex|inosine pranobex
886475|NCT00002059|Killer Cells|killer cells
886476|NCT00002059|T-Lymphocytes, Helper-Inducer|t-lymphocytes, helper-inducer
886831|NCT00001136|Poxviridae|poxviridae
886477|NCT00002059|Acquired Immunodeficiency Syndrome|acquired immunodeficiency syndrome
886478|NCT00002059|AIDS-Related Complex|aids-related complex
886479|NCT00002058|AIDS-Related Opportunistic Infections|aids-related opportunistic infections
886480|NCT00002058|Mycobacterium avium-intracellulare Infection|mycobacterium avium-intracellulare infection
886481|NCT00002058|Clofazimine|clofazimine
886482|NCT00002058|Acquired Immunodeficiency Syndrome|acquired immunodeficiency syndrome
886483|NCT00002057|Nystatin|nystatin
886484|NCT00002057|AIDS-Related Opportunistic Infections|aids-related opportunistic infections
886485|NCT00002057|Acquired Immunodeficiency Syndrome|acquired immunodeficiency syndrome
886486|NCT00002057|AIDS-Related Complex|aids-related complex
886487|NCT00002057|Candidiasis, Oral|candidiasis, oral
886488|NCT00002056|Trimethoprim-Sulfamethoxazole Combination|trimethoprim-sulfamethoxazole combination
886489|NCT00002056|AIDS-Related Opportunistic Infections|aids-related opportunistic infections
886490|NCT00002056|Pneumonia, Pneumocystis carinii|pneumonia, pneumocystis carinii
886491|NCT00002056|Pentamidine|pentamidine
886492|NCT00002056|Injections, Intravenous|injections, intravenous
886493|NCT00002056|Administration, Oral|administration, oral
886494|NCT00002056|Aerosols|aerosols
886495|NCT00002056|Acquired Immunodeficiency Syndrome|acquired immunodeficiency syndrome
886496|NCT00002055|AIDS-Related Opportunistic Infections|aids-related opportunistic infections
886497|NCT00002055|Pneumonia, Pneumocystis carinii|pneumonia, pneumocystis carinii
886498|NCT00002055|Pentamidine|pentamidine
886499|NCT00002055|Dose-Response Relationship, Drug|dose-response relationship, drug
886500|NCT00002055|Aerosols|aerosols
886501|NCT00002055|Acquired Immunodeficiency Syndrome|acquired immunodeficiency syndrome
886502|NCT00002054|AIDS-Related Opportunistic Infections|aids-related opportunistic infections
886503|NCT00002054|Pneumonia, Pneumocystis carinii|pneumonia, pneumocystis carinii
886504|NCT00002054|Pentamidine|pentamidine
886505|NCT00002054|Dose-Response Relationship, Drug|dose-response relationship, drug
886506|NCT00002054|Acquired Immunodeficiency Syndrome|acquired immunodeficiency syndrome
886507|NCT00002053|AIDS-Related Opportunistic Infections|aids-related opportunistic infections
886508|NCT00002053|Pneumonia, Pneumocystis carinii|pneumonia, pneumocystis carinii
886509|NCT00002053|Pentamidine|pentamidine
886510|NCT00002053|Acquired Immunodeficiency Syndrome|acquired immunodeficiency syndrome
886511|NCT00002052|Salmonella Infections|salmonella infections
886512|NCT00002052|AIDS-Related Opportunistic Infections|aids-related opportunistic infections
886513|NCT00002052|Acquired Immunodeficiency Syndrome|acquired immunodeficiency syndrome
886514|NCT00002052|Amoxicillin|amoxicillin
886515|NCT00002052|Ceftriaxone|ceftriaxone
886516|NCT00002051|Thymopentin|thymopentin
886517|NCT00002051|Acquired Immunodeficiency Syndrome|acquired immunodeficiency syndrome
886518|NCT00002050|Semen|semen
886519|NCT00002050|Thymopentin|thymopentin
886520|NCT00002050|Leukocytes, Mononuclear|leukocytes, mononuclear
886521|NCT00002050|AIDS-Related Complex|aids-related complex
886522|NCT00002049|Semen|semen
886523|NCT00002049|Thymopentin|thymopentin
886524|NCT00002049|Leukocytes, Mononuclear|leukocytes, mononuclear
886525|NCT00002049|HIV Seropositivity|hiv seropositivity
886526|NCT00002049|AIDS-Related Complex|aids-related complex
886527|NCT00002048|Acquired Immunodeficiency Syndrome|acquired immunodeficiency syndrome
886528|NCT00002048|Zidovudine|zidovudine
886529|NCT00002047|Kidney Failure, Chronic|kidney failure, chronic
886530|NCT00002047|Acquired Immunodeficiency Syndrome|acquired immunodeficiency syndrome
886531|NCT00002047|AIDS-Related Complex|aids-related complex
886532|NCT00002047|Zidovudine|zidovudine
886534|NCT00002046|Acquired Immunodeficiency Syndrome|acquired immunodeficiency syndrome
886535|NCT00002046|AIDS-Related Complex|aids-related complex
886536|NCT00002046|Zidovudine|zidovudine
886537|NCT00002045|Prospective Studies|prospective studies
886538|NCT00002045|Zidovudine|zidovudine
886539|NCT00002044|Pilot Projects|pilot projects
886540|NCT00002044|Neuromuscular Diseases|neuromuscular diseases
886541|NCT00002044|Drug Evaluation|drug evaluation
886542|NCT00002044|Acquired Immunodeficiency Syndrome|acquired immunodeficiency syndrome
886543|NCT00002044|AIDS Dementia Complex|aids dementia complex
886544|NCT00002044|AIDS-Related Complex|aids-related complex
886545|NCT00002044|Zidovudine|zidovudine
886546|NCT00002043|AIDS-Related Opportunistic Infections|aids-related opportunistic infections
886547|NCT00002043|Pneumonia, Pneumocystis carinii|pneumonia, pneumocystis carinii
886548|NCT00002043|Leukoplakia, Oral|leukoplakia, oral
886549|NCT00002043|Dapsone|dapsone
886550|NCT00002043|AIDS-Related Complex|aids-related complex
886551|NCT00002043|Candidiasis, Oral|candidiasis, oral
886552|NCT00002042|Recombinant Proteins|recombinant proteins
886553|NCT00002042|Erythropoietin|erythropoietin
886554|NCT00002042|Acquired Immunodeficiency Syndrome|acquired immunodeficiency syndrome
886555|NCT00002042|Anemia|anemia
886556|NCT00002042|AIDS-Related Complex|aids-related complex
886557|NCT00002042|Zidovudine|zidovudine
886558|NCT00002041|AIDS-Related Opportunistic Infections|aids-related opportunistic infections
886559|NCT00002041|Esophagitis|esophagitis
886560|NCT00002041|Acquired Immunodeficiency Syndrome|acquired immunodeficiency syndrome
886561|NCT00002041|Amphotericin B|amphotericin b
886562|NCT00002041|Candidiasis, Oral|candidiasis, oral
886563|NCT00002040|AIDS-Related Opportunistic Infections|aids-related opportunistic infections
886566|NCT00002040|Cryptococcosis|cryptococcosis
886567|NCT00002040|Fluconazole|fluconazole
886568|NCT00002040|Administration, Oral|administration, oral
886569|NCT00002040|Acquired Immunodeficiency Syndrome|acquired immunodeficiency syndrome
886570|NCT00002039|Retinitis|retinitis
886571|NCT00002039|AIDS-Related Opportunistic Infections|aids-related opportunistic infections
886572|NCT00002039|Drug Therapy, Combination|drug therapy, combination
886573|NCT00002039|Foscarnet|foscarnet
886574|NCT00002039|Cytomegalovirus Infections|cytomegalovirus infections
886575|NCT00002039|Acquired Immunodeficiency Syndrome|acquired immunodeficiency syndrome
886576|NCT00002039|Antiviral Agents|antiviral agents
886577|NCT00002039|Zidovudine|zidovudine
886578|NCT00002038|Mycoses|mycoses
886579|NCT00002038|Drugs, Investigational|drugs, investigational
886580|NCT00002038|Fluconazole|fluconazole
886581|NCT00002037|AIDS-Related Opportunistic Infections|aids-related opportunistic infections
886582|NCT00002037|Mycobacterium avium-intracellulare Infection|mycobacterium avium-intracellulare infection
886583|NCT00002037|Interferon-gamma, Recombinant|interferon-gamma, recombinant
886584|NCT00002037|Acquired Immunodeficiency Syndrome|acquired immunodeficiency syndrome
886585|NCT00002036|Acquired Immunodeficiency Syndrome|acquired immunodeficiency syndrome
886586|NCT00002036|AIDS-Related Complex|aids-related complex
886587|NCT00002036|Immunization, Passive|immunization, passive
886588|NCT00002035|Didanosine|didanosine
886589|NCT00002035|Acquired Immunodeficiency Syndrome|acquired immunodeficiency syndrome
886590|NCT00002035|AIDS-Related Complex|aids-related complex
886591|NCT00002035|Zidovudine|zidovudine
886592|NCT00002034|Retinitis|retinitis
886593|NCT00002034|AIDS-Related Opportunistic Infections|aids-related opportunistic infections
886594|NCT00002034|Ganciclovir|ganciclovir
886595|NCT00002034|Drug Interactions|drug interactions
886596|NCT00002034|Cytomegalovirus Infections|cytomegalovirus infections
886597|NCT00002034|Acquired Immunodeficiency Syndrome|acquired immunodeficiency syndrome
886598|NCT00002034|Zidovudine|zidovudine
886599|NCT00002033|Acquired Immunodeficiency Syndrome|acquired immunodeficiency syndrome
886600|NCT00002033|AIDS-Related Complex|aids-related complex
886601|NCT00002033|ammonium trichloro(dioxoethylene-O,O'-)tellurute|ammonium trichloro(dioxoethylene-o,o'-)tellurute
886602|NCT00002033|Zidovudine|zidovudine
886603|NCT00002032|Rifabutin|rifabutin
886604|NCT00002032|AIDS-Related Opportunistic Infections|aids-related opportunistic infections
886605|NCT00002032|Mycobacterium avium-intracellulare Infection|mycobacterium avium-intracellulare infection
886606|NCT00002032|Acquired Immunodeficiency Syndrome|acquired immunodeficiency syndrome
886607|NCT00002032|Antitubercular Agents|antitubercular agents
886608|NCT00002031|Langerhans Cells|langerhans cells
886609|NCT00002031|Dinitrochlorobenzene|dinitrochlorobenzene
886610|NCT00002031|Acquired Immunodeficiency Syndrome|acquired immunodeficiency syndrome
886611|NCT00002031|AIDS-Related Complex|aids-related complex
886612|NCT00002030|AIDS-Related Opportunistic Infections|aids-related opportunistic infections
886613|NCT00002030|Pneumonia, Pneumocystis carinii|pneumonia, pneumocystis carinii
886614|NCT00002030|Pentamidine|pentamidine
886615|NCT00002030|Aerosols|aerosols
886616|NCT00002030|Acquired Immunodeficiency Syndrome|acquired immunodeficiency syndrome
886617|NCT00002029|Weight Loss|weight loss
886618|NCT00002029|Parenteral Nutrition, Total|parenteral nutrition, total
886619|NCT00002029|AIDS-Related Opportunistic Infections|aids-related opportunistic infections
886620|NCT00002029|Liposyn|liposyn
886621|NCT00002029|Acquired Immunodeficiency Syndrome|acquired immunodeficiency syndrome
886622|NCT00002028|Didanosine|didanosine
886623|NCT00002028|Drugs, Investigational|drugs, investigational
886624|NCT00002028|Acquired Immunodeficiency Syndrome|acquired immunodeficiency syndrome
886625|NCT00002028|AIDS-Related Complex|aids-related complex
886626|NCT00002028|Zidovudine|zidovudine
886627|NCT00002027|AIDS-Related Opportunistic Infections|aids-related opportunistic infections
886628|NCT00002027|Cryptosporidiosis|cryptosporidiosis
886629|NCT00002027|Diarrhea|diarrhea
886630|NCT00002027|diclazuril|diclazuril
886631|NCT00002027|Coccidiostats|coccidiostats
886632|NCT00002027|Acquired Immunodeficiency Syndrome|acquired immunodeficiency syndrome
886633|NCT00002026|AIDS-Related Opportunistic Infections|aids-related opportunistic infections
886634|NCT00002026|Leukoplakia, Oral|leukoplakia, oral
886635|NCT00002026|Herpesvirus 4, Human|herpesvirus 4, human
886636|NCT00002026|Acyclovir|acyclovir
886637|NCT00002026|AIDS-Related Complex|aids-related complex
886638|NCT00002025|Retinitis|retinitis
886639|NCT00002025|AIDS-Related Opportunistic Infections|aids-related opportunistic infections
886640|NCT00002025|Immune Tolerance|immune tolerance
886641|NCT00002025|Injections, Intravenous|injections, intravenous
886642|NCT00002025|Ganciclovir|ganciclovir
886643|NCT00002025|Cytomegalovirus Infections|cytomegalovirus infections
886644|NCT00002025|Acquired Immunodeficiency Syndrome|acquired immunodeficiency syndrome
886645|NCT00002024|AIDS-Related Opportunistic Infections|aids-related opportunistic infections
886646|NCT00002024|Immune Tolerance|immune tolerance
886647|NCT00002024|Ganciclovir|ganciclovir
886648|NCT00002024|Drugs, Investigational|drugs, investigational
886649|NCT00002024|Cytomegalovirus Infections|cytomegalovirus infections
886650|NCT00002024|Acquired Immunodeficiency Syndrome|acquired immunodeficiency syndrome
886651|NCT00002023|Dose-Response Relationship, Drug|dose-response relationship, drug
886652|NCT00002023|Acquired Immunodeficiency Syndrome|acquired immunodeficiency syndrome
886653|NCT00002023|AIDS-Related Complex|aids-related complex
886654|NCT00002023|Zidovudine|zidovudine
886655|NCT00002022|Recombinant Proteins|recombinant proteins
886656|NCT00002022|Drugs, Investigational|drugs, investigational
886657|NCT00002022|Erythropoietin|erythropoietin
886658|NCT00002022|Acquired Immunodeficiency Syndrome|acquired immunodeficiency syndrome
886659|NCT00002022|Anemia|anemia
886660|NCT00002022|Zidovudine|zidovudine
886661|NCT00002021|AIDS-Related Opportunistic Infections|aids-related opportunistic infections
886662|NCT00002021|Immune Tolerance|immune tolerance
886663|NCT00002021|Injections, Intravenous|injections, intravenous
886664|NCT00002021|Herpes Simplex|herpes simplex
886665|NCT00002021|Immunity, Cellular|immunity, cellular
886666|NCT00002021|Foscarnet|foscarnet
886667|NCT00002021|Acquired Immunodeficiency Syndrome|acquired immunodeficiency syndrome
886668|NCT00002021|Antiviral Agents|antiviral agents
886669|NCT00002020|Acquired Immunodeficiency Syndrome|acquired immunodeficiency syndrome
886670|NCT00002020|AIDS-Related Complex|aids-related complex
886671|NCT00002020|Zidovudine|zidovudine
886672|NCT00002019|Meningitis|meningitis
886673|NCT00002019|Liposomes|liposomes
886674|NCT00002019|Cryptococcosis|cryptococcosis
886675|NCT00002019|Acquired Immunodeficiency Syndrome|acquired immunodeficiency syndrome
886676|NCT00002019|Amphotericin B|amphotericin b
886677|NCT00002019|Chemistry, Pharmaceutical|chemistry, pharmaceutical
886678|NCT00002018|Interferon Type I|interferon type i
886679|NCT00002017|Polyethylene Glycols|polyethylene glycols
886680|NCT00002017|Interleukin-2|interleukin-2
886681|NCT00002016|Retinitis|retinitis
886682|NCT00002016|Ganciclovir|ganciclovir
886683|NCT00002016|Cytomegalovirus|cytomegalovirus
886684|NCT00002016|Cytomegalovirus Infections|cytomegalovirus infections
886685|NCT00002016|Acquired Immunodeficiency Syndrome|acquired immunodeficiency syndrome
886686|NCT00002016|Antibodies, Monoclonal|antibodies, monoclonal
886687|NCT00002015|Retinitis|retinitis
886688|NCT00002015|Ganciclovir|ganciclovir
886689|NCT00002015|Cytomegalovirus Infections|cytomegalovirus infections
886690|NCT00002015|Acquired Immunodeficiency Syndrome|acquired immunodeficiency syndrome
886691|NCT00002015|Immunocompromised Host|immunocompromised host
886692|NCT00002014|Didanosine|didanosine
886693|NCT00002014|Drug Evaluation|drug evaluation
886694|NCT00002014|Zidovudine|zidovudine
886695|NCT00002013|Drug Therapy, Combination|drug therapy, combination
886696|NCT00002013|Acquired Immunodeficiency Syndrome|acquired immunodeficiency syndrome
886697|NCT00002013|AIDS-Related Complex|aids-related complex
886698|NCT00002013|ammonium trichloro(dioxoethylene-O,O'-)tellurute|ammonium trichloro(dioxoethylene-o,o'-)tellurute
886699|NCT00002013|Zidovudine|zidovudine
886700|NCT00002012|Acquired Immunodeficiency Syndrome|acquired immunodeficiency syndrome
886701|NCT00002012|AIDS-Related Complex|aids-related complex
886702|NCT00002012|Interferon Type I, Recombinant|interferon type i, recombinant
886703|NCT00002011|PUVA Therapy|puva therapy
886704|NCT00002011|Methoxsalen|methoxsalen
886705|NCT00002011|AIDS-Related Complex|aids-related complex
886706|NCT00002010|AIDS-Related Opportunistic Infections|aids-related opportunistic infections
886707|NCT00002010|Meningitis|meningitis
886708|NCT00002010|Fluconazole|fluconazole
886709|NCT00002010|Coccidioidin|coccidioidin
886710|NCT00002010|Acquired Immunodeficiency Syndrome|acquired immunodeficiency syndrome
886711|NCT00002010|Coccidioidomycosis|coccidioidomycosis
886712|NCT00002009|Leukopenia|leukopenia
886713|NCT00002009|Drug Evaluation|drug evaluation
886714|NCT00002009|Granulocyte-Macrophage Colony-Stimulating Factor|granulocyte-macrophage colony-stimulating factor
886715|NCT00002008|Leukopenia|leukopenia
886716|NCT00002008|Drug Evaluation|drug evaluation
886717|NCT00002008|Granulocyte-Macrophage Colony-Stimulating Factor|granulocyte-macrophage colony-stimulating factor
886718|NCT00002007|Leukopenia|leukopenia
886719|NCT00002007|Granulocyte-Macrophage Colony-Stimulating Factor|granulocyte-macrophage colony-stimulating factor
886720|NCT00002007|Acquired Immunodeficiency Syndrome|acquired immunodeficiency syndrome
886721|NCT00002007|Zidovudine|zidovudine
886722|NCT00002006|Neutropenia|neutropenia
886723|NCT00002006|Drug Interactions|drug interactions
886724|NCT00002006|Granulocyte-Macrophage Colony-Stimulating Factor|granulocyte-macrophage colony-stimulating factor
886725|NCT00002006|Acquired Immunodeficiency Syndrome|acquired immunodeficiency syndrome
886726|NCT00002006|Zidovudine|zidovudine
886727|NCT00002005|Acquired Immunodeficiency Syndrome|acquired immunodeficiency syndrome
886728|NCT00002005|Antigens, CD4|antigens, cd4
886729|NCT00002005|AIDS-Related Complex|aids-related complex
886730|NCT00002004|Recombinant Proteins|recombinant proteins
886731|NCT00002004|Acquired Immunodeficiency Syndrome|acquired immunodeficiency syndrome
886732|NCT00002004|Antigens, CD4|antigens, cd4
886733|NCT00002004|AIDS-Related Complex|aids-related complex
886734|NCT00002003|Mitoxantrone|mitoxantrone
886735|NCT00002003|Lymphoma, Large-Cell|lymphoma, large-cell
886736|NCT00002003|Etoposide|etoposide
886737|NCT00002003|Acquired Immunodeficiency Syndrome|acquired immunodeficiency syndrome
886738|NCT00002002|Trimethoprim-Sulfamethoxazole Combination|trimethoprim-sulfamethoxazole combination
886739|NCT00002002|AIDS-Related Opportunistic Infections|aids-related opportunistic infections
886832|NCT00001136|HIV Preventive Vaccine|hiv preventive vaccine
886740|NCT00002002|Pneumonia, Pneumocystis carinii|pneumonia, pneumocystis carinii
886741|NCT00002002|Acquired Immunodeficiency Syndrome|acquired immunodeficiency syndrome
886742|NCT00002001|Zalcitabine|zalcitabine
886743|NCT00002001|Didanosine|didanosine
886744|NCT00002001|Drug Therapy, Combination|drug therapy, combination
886745|NCT00002001|Acquired Immunodeficiency Syndrome|acquired immunodeficiency syndrome
886746|NCT00002001|Zidovudine|zidovudine
886747|NCT00002000|Acyclovir|acyclovir
886748|NCT00002000|Acquired Immunodeficiency Syndrome|acquired immunodeficiency syndrome
886749|NCT00002000|AIDS-Related Complex|aids-related complex
886750|NCT00002000|Antiviral Agents|antiviral agents
886751|NCT00002000|Anus Diseases|anus diseases
886752|NCT00002000|Herpes Genitalis|herpes genitalis
886753|NCT00001999|Retinitis|retinitis
886754|NCT00001999|Gamma-Globulins|gamma-globulins
886755|NCT00001999|Ganciclovir|ganciclovir
886756|NCT00001999|Drug Therapy, Combination|drug therapy, combination
886757|NCT00001999|Cytomegalovirus Infections|cytomegalovirus infections
886758|NCT00001999|Acquired Immunodeficiency Syndrome|acquired immunodeficiency syndrome
886759|NCT00001999|Immunization, Passive|immunization, passive
886760|NCT00001998|Nystatin|nystatin
886761|NCT00001998|Acquired Immunodeficiency Syndrome|acquired immunodeficiency syndrome
886762|NCT00001998|AIDS-Related Complex|aids-related complex
886763|NCT00001997|Recombinant Proteins|recombinant proteins
886764|NCT00001997|Polyethylene Glycols|polyethylene glycols
886765|NCT00001997|Interleukin-2|interleukin-2
886766|NCT00001997|Didanosine|didanosine
886767|NCT00001997|Zidovudine|zidovudine
886768|NCT00001996|Trimethoprim-Sulfamethoxazole Combination|trimethoprim-sulfamethoxazole combination
886769|NCT00001996|Pneumonia, Pneumocystis carinii|pneumonia, pneumocystis carinii
886770|NCT00001996|Pentamidine|pentamidine
886771|NCT00001996|Acquired Immunodeficiency Syndrome|acquired immunodeficiency syndrome
886772|NCT00001996|atovaquone|atovaquone
886773|NCT00001995|Rifabutin|rifabutin
886774|NCT00001995|Mycobacterium avium-intracellulare Infection|mycobacterium avium-intracellulare infection
886775|NCT00001995|Acquired Immunodeficiency Syndrome|acquired immunodeficiency syndrome
886776|NCT00001994|Toxoplasmosis|toxoplasmosis
886777|NCT00001994|AIDS-Related Opportunistic Infections|aids-related opportunistic infections
886778|NCT00001994|Naphthoquinones|naphthoquinones
886779|NCT00001994|Encephalitis|encephalitis
886780|NCT00001994|Acquired Immunodeficiency Syndrome|acquired immunodeficiency syndrome
886781|NCT00001993|Drug Therapy, Combination|drug therapy, combination
886782|NCT00001993|Zidovudine|zidovudine
886783|NCT00001992|Vaccines, Synthetic|vaccines, synthetic
886784|NCT00001992|Drug Evaluation|drug evaluation
886785|NCT00001992|Acquired Immunodeficiency Syndrome|acquired immunodeficiency syndrome
886786|NCT00001992|AIDS Vaccines|aids vaccines
886787|NCT00001991|Trimethoprim-Sulfamethoxazole Combination|trimethoprim-sulfamethoxazole combination
886788|NCT00001991|Pneumonia, Pneumocystis carinii|pneumonia, pneumocystis carinii
886789|NCT00001991|Antifungal Agents|antifungal agents
886790|NCT00001991|Acquired Immunodeficiency Syndrome|acquired immunodeficiency syndrome
886791|NCT00001991|atovaquone|atovaquone
886792|NCT00001990|Trimethoprim-Sulfamethoxazole Combination|trimethoprim-sulfamethoxazole combination
886793|NCT00001990|Pneumonia, Pneumocystis carinii|pneumonia, pneumocystis carinii
886794|NCT00001990|Pentamidine|pentamidine
886795|NCT00001990|Antifungal Agents|antifungal agents
886796|NCT00001990|Acquired Immunodeficiency Syndrome|acquired immunodeficiency syndrome
886797|NCT00001990|atovaquone|atovaquone
886798|NCT00001989|Trichosanthin|trichosanthin
886799|NCT00001989|Drug Evaluation|drug evaluation
886800|NCT00001989|Drug Therapy, Combination|drug therapy, combination
886801|NCT00001989|Acquired Immunodeficiency Syndrome|acquired immunodeficiency syndrome
886802|NCT00001989|AIDS-Related Complex|aids-related complex
886803|NCT00001989|Antiviral Agents|antiviral agents
886804|NCT00001989|Zidovudine|zidovudine
886805|NCT00001137|Treatment Experienced|treatment experienced
886806|NCT00001137|Treatment Naive|treatment naive
886807|NCT00001137|Virus Replication|virus replication
886808|NCT00001137|AIDS-Related Opportunistic Infections|aids-related opportunistic infections
886810|NCT00001137|Risk Factors|risk factors
886811|NCT00001137|Incidence|incidence
886812|NCT00001137|RNA, Viral|rna, viral
886813|NCT00001137|Anti-HIV Agents|anti-hiv agents
886814|NCT00001137|Viral Load|viral load
886815|NCT00001137|Lipodystrophy|lipodystrophy
886816|NCT00001137|Nervous System|nervous system
886817|NCT00001137|Cardiovascular System|cardiovascular system
886818|NCT00001137|Neurologic Symptoms|neurologic symptoms
886819|NCT00001136|Injections, Intramuscular|injections, intramuscular
886820|NCT00001136|HIV-1|hiv-1
886821|NCT00001136|AIDS Vaccines|aids vaccines
886822|NCT00001136|CD4-Positive T-Lymphocytes|cd4-positive t-lymphocytes
886823|NCT00001136|CD8-Positive T-Lymphocytes|cd8-positive t-lymphocytes
886824|NCT00001136|T-Lymphocytes, Cytotoxic|t-lymphocytes, cytotoxic
886825|NCT00001136|Gene Products, gag|gene products, gag
886826|NCT00001136|HIV Seronegativity|hiv seronegativity
886827|NCT00001136|Immunologic Memory|immunologic memory
886828|NCT00001136|Antibodies, Viral|antibodies, viral
886829|NCT00001136|Genetic Vectors|genetic vectors
886830|NCT00001136|Gene Products, env|gene products, env
886833|NCT00001135|Placebos|placebos
886834|NCT00001135|Pregnancy|pregnancy
886835|NCT00001135|Pregnancy Complications, Infectious|pregnancy complications, infectious
886836|NCT00001135|Nevirapine|nevirapine
886837|NCT00001135|Disease Transmission, Vertical|disease transmission, vertical
886839|NCT00001135|Anti-HIV Agents|anti-hiv agents
886840|NCT00001133|Dose-Response Relationship, Drug|dose-response relationship, drug
886841|NCT00001133|Drug Therapy, Combination|drug therapy, combination
886842|NCT00001133|HIV Protease Inhibitors|hiv protease inhibitors
886843|NCT00001133|Ritonavir|ritonavir
886844|NCT00001133|Indinavir|indinavir
886845|NCT00001133|Anti-HIV Agents|anti-hiv agents
886846|NCT00001133|Pharmacokinetics|pharmacokinetics
886847|NCT00001133|Treatment Experienced|treatment experienced
886848|NCT00001132|Placebos|placebos
886849|NCT00001132|HIV-1|hiv-1
886850|NCT00001132|Drug Therapy, Combination|drug therapy, combination
886851|NCT00001132|RNA, Viral|rna, viral
886852|NCT00001132|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors
886853|NCT00001132|Anti-HIV Agents|anti-hiv agents
886854|NCT00001132|Viral Load|viral load
886855|NCT00001132|abacavir|abacavir
886856|NCT00001131|Interleukin-2|interleukin-2
886857|NCT00001131|Drug Therapy, Combination|drug therapy, combination
886858|NCT00001131|Drug Administration Schedule|drug administration schedule
886859|NCT00001131|Viremia|viremia
886860|NCT00001131|T-Lymphocytes, Cytotoxic|t-lymphocytes, cytotoxic
886861|NCT00001131|Anti-HIV Agents|anti-hiv agents
886862|NCT00001131|Treatment Experienced|treatment experienced
886863|NCT00001130|Questionnaires|questionnaires
886864|NCT00001130|Antibodies, Viral|antibodies, viral
886865|NCT00001130|Emergency Service, Hospital|emergency service, hospital
886866|NCT00001129|Drug Therapy, Combination|drug therapy, combination
886867|NCT00001129|RNA, Viral|rna, viral
886868|NCT00001129|Patient Compliance|patient compliance
886869|NCT00001129|Anti-HIV Agents|anti-hiv agents
886870|NCT00001129|Viral Load|viral load
886871|NCT00001129|Reminder Systems|reminder systems
886872|NCT00001129|Treatment Experienced|treatment experienced
886873|NCT00001129|Treatment Naive|treatment naive
886874|NCT00001128|AIDS-Related Opportunistic Infections|aids-related opportunistic infections
886875|NCT00001128|Cryptosporidiosis|cryptosporidiosis
886876|NCT00001128|Acquired Immunodeficiency Syndrome|acquired immunodeficiency syndrome
886877|NCT00001128|Azithromycin|azithromycin
886878|NCT00001128|Paromomycin|paromomycin
886879|NCT00001128|Interleukin-12|interleukin-12
886880|NCT00001125|Antibodies, Viral|antibodies, viral
886881|NCT00001125|Chickenpox|chickenpox
886882|NCT00001125|Chickenpox Vaccine|chickenpox vaccine
886883|NCT00001122|Didanosine|didanosine
886884|NCT00001122|Drug Therapy, Combination|drug therapy, combination
886885|NCT00001122|Stavudine|stavudine
886886|NCT00001122|HIV Protease Inhibitors|hiv protease inhibitors
886887|NCT00001122|CD4 Lymphocyte Count|cd4 lymphocyte count
886888|NCT00001122|Nelfinavir|nelfinavir
886889|NCT00001122|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors
886890|NCT00001122|Self Care|self care
886891|NCT00001122|Anti-HIV Agents|anti-hiv agents
886892|NCT00001122|Viral Load|viral load
886893|NCT00001122|efavirenz|efavirenz
886894|NCT00001122|Treatment Naive|treatment naive
886895|NCT00001121|Placebos|placebos
886896|NCT00001121|AIDS Vaccines|aids vaccines
886897|NCT00001121|Follow-Up Studies|follow-up studies
886898|NCT00001121|HIV Therapeutic Vaccine|hiv therapeutic vaccine
886899|NCT00001120|Prospective Studies|prospective studies
886900|NCT00001120|Sarcoma, Kaposi|sarcoma, kaposi
886901|NCT00001120|Herpesvirus 4, Human|herpesvirus 4, human
886902|NCT00001120|Acquired Immunodeficiency Syndrome|acquired immunodeficiency syndrome
886903|NCT00001120|Cohort Studies|cohort studies
886904|NCT00001120|Risk Factors|risk factors
886905|NCT00001120|Lymphoma, AIDS-Related|lymphoma, aids-related
886906|NCT00001120|Antibodies, Viral|antibodies, viral
886907|NCT00001120|Lymphoproliferative Disorders|lymphoproliferative disorders
886908|NCT00001120|Viral Load|viral load
886909|NCT00001120|Herpesvirus, Kaposi Sarcoma-Associated|herpesvirus, kaposi sarcoma-associated
886910|NCT00001120|Translocation (Genetics)|translocation (genetics)
886911|NCT00001119|Immunity, Cellular|immunity, cellular
886912|NCT00001119|Drug Therapy, Combination|drug therapy, combination
886913|NCT00001119|HIV Protease Inhibitors|hiv protease inhibitors
886914|NCT00001119|Antibody Formation|antibody formation
886915|NCT00001119|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors
886916|NCT00001119|Anti-HIV Agents|anti-hiv agents
886917|NCT00001119|Viral Load|viral load
886918|NCT00001119|Tetanus Toxoid|tetanus toxoid
886919|NCT00001119|Case-Control Studies|case-control studies
886920|NCT00001119|Hepatitis B Surface Antigens|hepatitis b surface antigens
886921|NCT00001119|Acute Infection|acute infection
886922|NCT00001118|Injections, Intravenous|injections, intravenous
886923|NCT00001118|Injections, Subcutaneous|injections, subcutaneous
886924|NCT00001118|Drug Therapy, Combination|drug therapy, combination
886925|NCT00001118|HIV Protease Inhibitors|hiv protease inhibitors
886926|NCT00001118|Membrane Fusion|membrane fusion
886927|NCT00001118|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors
886928|NCT00001118|Anti-HIV Agents|anti-hiv agents
886929|NCT00001118|Viral Load|viral load
886930|NCT00001118|peptide T20|peptide t20
886931|NCT00001117|HIV-1|hiv-1
886932|NCT00001117|Drug Therapy, Combination|drug therapy, combination
886933|NCT00001117|Hepatitis C|hepatitis c
886934|NCT00001117|RNA, Viral|rna, viral
886935|NCT00001117|Anti-HIV Agents|anti-hiv agents
886936|NCT00001116|Tumor Necrosis Factor|tumor necrosis factor
886937|NCT00001116|Interleukin-2|interleukin-2
886938|NCT00001116|Immunity, Cellular|immunity, cellular
886939|NCT00001116|Antiviral Agents|antiviral agents
886940|NCT00001116|Interleukin-6|interleukin-6
886941|NCT00001116|Receptors, Tumor Necrosis Factor|receptors, tumor necrosis factor
886942|NCT00001115|Herpes Simplex|herpes simplex
886943|NCT00001115|Acyclovir|acyclovir
886944|NCT00001115|Acquired Immunodeficiency Syndrome|acquired immunodeficiency syndrome
886945|NCT00001114|Sarcoma, Kaposi|sarcoma, kaposi
886946|NCT00001114|Didanosine|didanosine
886947|NCT00001114|Drug Interactions|drug interactions
886948|NCT00001114|Acquired Immunodeficiency Syndrome|acquired immunodeficiency syndrome
886949|NCT00001114|Interferon-alpha|interferon-alpha
886950|NCT00001113|Interferon Alfa-2a|interferon alfa-2a
886951|NCT00001113|Sarcoma, Kaposi|sarcoma, kaposi
886952|NCT00001113|Dose-Response Relationship, Drug|dose-response relationship, drug
886953|NCT00001113|Drug Evaluation|drug evaluation
886954|NCT00001113|Drug Therapy, Combination|drug therapy, combination
886955|NCT00001113|Acquired Immunodeficiency Syndrome|acquired immunodeficiency syndrome
886956|NCT00001113|Zidovudine|zidovudine
886957|NCT00001113|Interferon Type I|interferon type i
886958|NCT00001112|Monocytes|monocytes
886959|NCT00001112|Interferon-gamma, Recombinant|interferon-gamma, recombinant
886960|NCT00001112|Injections, Subcutaneous|injections, subcutaneous
886961|NCT00001112|Immune System|immune system
886962|NCT00001112|Drug Evaluation|drug evaluation
886963|NCT00001112|Drug Therapy, Combination|drug therapy, combination
886964|NCT00001112|Acquired Immunodeficiency Syndrome|acquired immunodeficiency syndrome
886965|NCT00001112|Zidovudine|zidovudine
886966|NCT00001112|Blood Bactericidal Activity|blood bactericidal activity
886967|NCT00001111|Drug Therapy, Combination|drug therapy, combination
886968|NCT00001111|Acquired Immunodeficiency Syndrome|acquired immunodeficiency syndrome
886969|NCT00001111|AIDS-Related Complex|aids-related complex
886970|NCT00001111|Antiviral Agents|antiviral agents
886971|NCT00001111|Zidovudine|zidovudine
886972|NCT00001111|Nevirapine|nevirapine
886973|NCT00001110|Lung|lung
886974|NCT00001110|HIV-1|hiv-1
886975|NCT00001110|Viremia|viremia
886976|NCT00001110|Anti-HIV Agents|anti-hiv agents
886977|NCT00001110|Viral Load|viral load
886978|NCT00001110|Bronchoalveolar Lavage Fluid|bronchoalveolar lavage fluid
886979|NCT00001109|Monocytes|monocytes
886980|NCT00001109|Flow Cytometry|flow cytometry
886981|NCT00001109|HIV Seronegativity|hiv seronegativity
886982|NCT00001109|Phenotype|phenotype
886983|NCT00001109|Lymphocyte Subsets|lymphocyte subsets
886984|NCT00001108|Dose-Response Relationship, Drug|dose-response relationship, drug
886985|NCT00001108|Drug Therapy, Combination|drug therapy, combination
886986|NCT00001108|HIV Protease Inhibitors|hiv protease inhibitors
886987|NCT00001108|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors
886988|NCT00001108|Salvage Therapy|salvage therapy
886989|NCT00001108|Anti-HIV Agents|anti-hiv agents
886990|NCT00001106|Pregnancy|pregnancy
886991|NCT00001106|Pregnancy Complications, Infectious|pregnancy complications, infectious
887470|NCT00001028|Pentamidine|pentamidine
886992|NCT00001106|Prenatal Exposure Delayed Effects|prenatal exposure delayed effects
886993|NCT00001106|Drug Evaluation|drug evaluation
886994|NCT00001106|Acquired Immunodeficiency Syndrome|acquired immunodeficiency syndrome
886995|NCT00001106|Zidovudine|zidovudine
886996|NCT00001105|Antibodies, Monoclonal|antibodies, monoclonal
886997|NCT00001105|AIDS-Related Complex|aids-related complex
886998|NCT00001105|Immunization, Passive|immunization, passive
886999|NCT00001104|Sex Behavior|sex behavior
887000|NCT00001104|T-Lymphocytes|t-lymphocytes
887001|NCT00001104|HIV Antibodies|hiv antibodies
887002|NCT00001104|Acquired Immunodeficiency Syndrome|acquired immunodeficiency syndrome
887003|NCT00001104|AIDS-Related Complex|aids-related complex
887004|NCT00001104|Zidovudine|zidovudine
887005|NCT00001104|Hemophilia A|hemophilia a
887006|NCT00001103|Neuropsychological Tests|neuropsychological tests
887007|NCT00001103|HIV-1|hiv-1
887008|NCT00001103|RNA, Viral|rna, viral
887009|NCT00001103|Anti-HIV Agents|anti-hiv agents
887010|NCT00001103|Viral Load|viral load
887011|NCT00001102|Drug Therapy, Combination|drug therapy, combination
887012|NCT00001102|HIV Protease Inhibitors|hiv protease inhibitors
887013|NCT00001102|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors
887014|NCT00001102|Body Composition|body composition
887015|NCT00001102|Anti-HIV Agents|anti-hiv agents
887016|NCT00001102|Cholesterol|cholesterol
887017|NCT00001102|Triglycerides|triglycerides
887018|NCT00001097|Drug Therapy, Combination|drug therapy, combination
887019|NCT00001097|HIV Protease Inhibitors|hiv protease inhibitors
887020|NCT00001097|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors
887021|NCT00001097|Anti-HIV Agents|anti-hiv agents
887022|NCT00001096|Vaccines, Synthetic|vaccines, synthetic
887023|NCT00001096|HIV Antibodies|hiv antibodies
887024|NCT00001096|HIV Antigens|hiv antigens
887025|NCT00001096|HIV-1|hiv-1
887026|NCT00001096|Adjuvants, Immunologic|adjuvants, immunologic
887027|NCT00001096|AIDS Vaccines|aids vaccines
887028|NCT00001096|T-Lymphocytes, Cytotoxic|t-lymphocytes, cytotoxic
887029|NCT00001096|HIV Seronegativity|hiv seronegativity
887030|NCT00001096|HIV Envelope Protein gp120|hiv envelope protein gp120
887031|NCT00001096|Alum Compounds|alum compounds
887032|NCT00001096|HIV Preventive Vaccine|hiv preventive vaccine
887033|NCT00001095|Drug Therapy, Combination|drug therapy, combination
887034|NCT00001095|Zidovudine|zidovudine
887035|NCT00001095|Nevirapine|nevirapine
887036|NCT00001095|Stavudine|stavudine
887037|NCT00001095|HIV Protease Inhibitors|hiv protease inhibitors
887038|NCT00001095|Lamivudine|lamivudine
887039|NCT00001095|VX 478|vx 478
887040|NCT00001095|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors
887041|NCT00001095|Anti-HIV Agents|anti-hiv agents
887042|NCT00001095|Viral Load|viral load
887043|NCT00001094|HIV-1|hiv-1
887044|NCT00001094|Drug Therapy, Combination|drug therapy, combination
887045|NCT00001094|Zidovudine|zidovudine
887046|NCT00001094|Lamivudine|lamivudine
887047|NCT00001094|RNA, Viral|rna, viral
887048|NCT00001094|Saquinavir|saquinavir
887049|NCT00001094|Delavirdine|delavirdine
887050|NCT00001094|Anti-HIV Agents|anti-hiv agents
887051|NCT00001094|Nelfinavir|nelfinavir
887052|NCT00001093|Immunity, Cellular|immunity, cellular
887053|NCT00001093|Sexual Partners|sexual partners
887054|NCT00001093|Treatment Outcome|treatment outcome
887055|NCT00001093|Anti-HIV Agents|anti-hiv agents
887056|NCT00001093|Viral Load|viral load
887057|NCT00001093|Acute Infection|acute infection
887058|NCT00001092|Semen|semen
887059|NCT00001092|HIV-1|hiv-1
887060|NCT00001092|Sexual Partners|sexual partners
887061|NCT00001092|Drug Resistance, Microbial|drug resistance, microbial
887062|NCT00001092|CD8-Positive T-Lymphocytes|cd8-positive t-lymphocytes
887063|NCT00001092|Saliva|saliva
887064|NCT00001092|Blood|blood
887065|NCT00001092|Cervix Uteri|cervix uteri
887066|NCT00001092|Vagina|vagina
887067|NCT00001092|Acute Infection|acute infection
887068|NCT00001091|Drug Therapy, Combination|drug therapy, combination
887069|NCT00001091|Nevirapine|nevirapine
887070|NCT00001091|Stavudine|stavudine
887071|NCT00001091|HIV Protease Inhibitors|hiv protease inhibitors
887072|NCT00001091|Ritonavir|ritonavir
887073|NCT00001091|Lamivudine|lamivudine
887074|NCT00001091|Nelfinavir|nelfinavir
887075|NCT00001091|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors
887076|NCT00001090|Reference Values|reference values
887077|NCT00001090|Granulocyte-Macrophage Colony-Stimulating Factor|granulocyte-macrophage colony-stimulating factor
887078|NCT00001090|AIDS Vaccines|aids vaccines
887079|NCT00001090|HIV Seronegativity|hiv seronegativity
887080|NCT00001090|Dose-Response Relationship, Immunologic|dose-response relationship, immunologic
887081|NCT00001090|HIV Preventive Vaccine|hiv preventive vaccine
887082|NCT00001089|Prospective Studies|prospective studies
887083|NCT00001089|HIV-1|hiv-1
887084|NCT00001089|Cytomegalovirus|cytomegalovirus
887085|NCT00001089|Cytomegalovirus Infections|cytomegalovirus infections
887086|NCT00001089|Acquired Immunodeficiency Syndrome|acquired immunodeficiency syndrome
887087|NCT00001089|Anti-HIV Agents|anti-hiv agents
887088|NCT00001089|Viral Load|viral load
887089|NCT00001089|Multiple Organ Failure|multiple organ failure
887090|NCT00001088|Injections, Intramuscular|injections, intramuscular
887091|NCT00001088|AIDS Vaccines|aids vaccines
887092|NCT00001088|HIV Seronegativity|hiv seronegativity
887093|NCT00001088|Dose-Response Relationship, Immunologic|dose-response relationship, immunologic
887094|NCT00001088|Fusion Proteins, gag-pol|fusion proteins, gag-pol
887095|NCT00001088|Vaccines, DNA|vaccines, dna
887096|NCT00001088|HIV Preventive Vaccine|hiv preventive vaccine
887097|NCT00001087|Drug Therapy, Combination|drug therapy, combination
887098|NCT00001087|Antiviral Agents|antiviral agents
887099|NCT00001087|HIV Protease Inhibitors|hiv protease inhibitors
887100|NCT00001087|Ritonavir|ritonavir
887101|NCT00001087|Saquinavir|saquinavir
887102|NCT00001087|Nelfinavir|nelfinavir
887103|NCT00001087|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors
887104|NCT00001087|Adenine|adenine
887105|NCT00001087|Anti-HIV Agents|anti-hiv agents
887106|NCT00001087|efavirenz|efavirenz
887107|NCT00001086|Placebos|placebos
887108|NCT00001086|HIV-1|hiv-1
887109|NCT00001086|Drug Therapy, Combination|drug therapy, combination
887110|NCT00001086|HIV Protease Inhibitors|hiv protease inhibitors
887111|NCT00001086|Indinavir|indinavir
887112|NCT00001086|RNA, Viral|rna, viral
887113|NCT00001086|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors
887114|NCT00001086|Anti-HIV Agents|anti-hiv agents
887115|NCT00001086|Viral Load|viral load
887116|NCT00001086|efavirenz|efavirenz
887117|NCT00001085|HIV-1|hiv-1
887118|NCT00001085|Drug Therapy, Combination|drug therapy, combination
887119|NCT00001085|Acquired Immunodeficiency Syndrome|acquired immunodeficiency syndrome
887120|NCT00001085|Zidovudine|zidovudine
887121|NCT00001085|HIV Protease Inhibitors|hiv protease inhibitors
887122|NCT00001085|Lamivudine|lamivudine
887123|NCT00001085|RNA, Viral|rna, viral
887124|NCT00001085|VX 478|vx 478
887125|NCT00001085|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors
887126|NCT00001085|Anti-HIV Agents|anti-hiv agents
887127|NCT00001085|Viral Load|viral load
887128|NCT00001084|Prospective Studies|prospective studies
887129|NCT00001084|Drug Therapy, Combination|drug therapy, combination
887130|NCT00001084|Zidovudine|zidovudine
887131|NCT00001084|HIV Protease Inhibitors|hiv protease inhibitors
887132|NCT00001084|Lamivudine|lamivudine
887133|NCT00001084|Indinavir|indinavir
887134|NCT00001084|RNA, Viral|rna, viral
887135|NCT00001084|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors
887136|NCT00001084|Anti-HIV Agents|anti-hiv agents
887137|NCT00001084|Viral Load|viral load
887138|NCT00001083|HIV-1|hiv-1
887139|NCT00001083|Drug Therapy, Combination|drug therapy, combination
887140|NCT00001083|Zidovudine|zidovudine
887141|NCT00001083|Nevirapine|nevirapine
887142|NCT00001083|Stavudine|stavudine
887143|NCT00001083|HIV Protease Inhibitors|hiv protease inhibitors
887144|NCT00001083|Ritonavir|ritonavir
887145|NCT00001083|Lamivudine|lamivudine
887146|NCT00001083|Indinavir|indinavir
887147|NCT00001083|RNA, Viral|rna, viral
887148|NCT00001083|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors
887149|NCT00001083|Anti-HIV Agents|anti-hiv agents
887150|NCT00001082|Cytomegalovirus Infections|cytomegalovirus infections
887151|NCT00001082|Antiviral Agents|antiviral agents
887152|NCT00001082|CD4 Lymphocyte Count|cd4 lymphocyte count
887153|NCT00001082|Prodrugs|prodrugs
887154|NCT00001082|Survival|survival
887155|NCT00001082|Adenine|adenine
887156|NCT00001081|AIDS-Related Opportunistic Infections|aids-related opportunistic infections
887157|NCT00001081|Cryptosporidiosis|cryptosporidiosis
887158|NCT00001081|Antiprotozoal Agents|antiprotozoal agents
887159|NCT00001081|nitazoxanide|nitazoxanide
887160|NCT00001080|Lymphocyte Transformation|lymphocyte transformation
887161|NCT00001080|HIV-1|hiv-1
887162|NCT00001080|Drug Resistance, Microbial|drug resistance, microbial
887163|NCT00001080|CD4-Positive T-Lymphocytes|cd4-positive t-lymphocytes
887164|NCT00001080|Lamivudine|lamivudine
887165|NCT00001080|Influenza Vaccine|influenza vaccine
887166|NCT00001080|RNA, Viral|rna, viral
887167|NCT00001080|Bacterial Vaccines|bacterial vaccines
887168|NCT00001080|Anti-HIV Agents|anti-hiv agents
887169|NCT00001080|Pneumonia, Pneumococcal|pneumonia, pneumococcal
887170|NCT00001080|Viral Load|viral load
887171|NCT00001079|Placebos|placebos
887172|NCT00001079|Drug Therapy, Combination|drug therapy, combination
887173|NCT00001079|Acquired Immunodeficiency Syndrome|acquired immunodeficiency syndrome
887174|NCT00001079|AIDS-Related Complex|aids-related complex
887175|NCT00001079|HIV Wasting Syndrome|hiv wasting syndrome
887176|NCT00001079|Megestrol Acetate|megestrol acetate
887177|NCT00001079|dihydrotestosterone heptanoate|dihydrotestosterone heptanoate
887178|NCT00001078|Viral Vaccines|viral vaccines
887179|NCT00001078|AIDS-Related Opportunistic Infections|aids-related opportunistic infections
887180|NCT00001078|Anti-HIV Agents|anti-hiv agents
887181|NCT00001078|Hepatitis A Virus, Human|hepatitis a virus, human
887182|NCT00001077|Weight Loss|weight loss
887183|NCT00001077|Acquired Immunodeficiency Syndrome|acquired immunodeficiency syndrome
887184|NCT00001077|Nutritional Support|nutritional support
887185|NCT00001076|Vaccines, Synthetic|vaccines, synthetic
887186|NCT00001076|HIV Envelope Protein gp120|hiv envelope protein gp120
887187|NCT00001076|AIDS Vaccines|aids vaccines
887188|NCT00001076|HIV Seronegativity|hiv seronegativity
887190|NCT00001076|HIV Preventive Vaccine|hiv preventive vaccine
887191|NCT00001075|Drug Therapy, Combination|drug therapy, combination
887192|NCT00001075|Acquired Immunodeficiency Syndrome|acquired immunodeficiency syndrome
887193|NCT00001075|AIDS-Related Complex|aids-related complex
887194|NCT00001075|Antiviral Agents|antiviral agents
887195|NCT00001075|Zidovudine|zidovudine
887196|NCT00001075|HIV Protease Inhibitors|hiv protease inhibitors
887197|NCT00001075|Ritonavir|ritonavir
887198|NCT00001075|Lamivudine|lamivudine
887199|NCT00001074|Didanosine|didanosine
887200|NCT00001074|Drug Therapy, Combination|drug therapy, combination
887201|NCT00001074|Antiviral Agents|antiviral agents
887202|NCT00001074|Hydroxyurea|hydroxyurea
887203|NCT00001073|Acquired Immunodeficiency Syndrome|acquired immunodeficiency syndrome
887204|NCT00001073|AIDS-Related Complex|aids-related complex
887205|NCT00001073|Cervix Dysplasia|cervix dysplasia
887206|NCT00001073|Cervix Diseases|cervix diseases
887207|NCT00001073|Isotretinoin|isotretinoin
887208|NCT00001073|Cervical Intraepithelial Neoplasia|cervical intraepithelial neoplasia
887209|NCT00001073|Cervix Neoplasms|cervix neoplasms
887210|NCT00001073|Keratolytic Agents|keratolytic agents
887211|NCT00001072|Vaccines, Synthetic|vaccines, synthetic
887212|NCT00001072|HIV Envelope Protein gp120|hiv envelope protein gp120
887213|NCT00001072|AIDS Vaccines|aids vaccines
887214|NCT00001072|HIV Seronegativity|hiv seronegativity
887215|NCT00001072|Avipoxvirus|avipoxvirus
887216|NCT00001072|HIV Preventive Vaccine|hiv preventive vaccine
887217|NCT00001071|Granulocyte Colony-Stimulating Factor|granulocyte colony-stimulating factor
887218|NCT00001071|Acquired Immunodeficiency Syndrome|acquired immunodeficiency syndrome
887219|NCT00001071|AIDS-Related Complex|aids-related complex
887220|NCT00001071|Stem Cells|stem cells
887221|NCT00001069|Acquired Immunodeficiency Syndrome|acquired immunodeficiency syndrome
887222|NCT00001069|AIDS-Related Complex|aids-related complex
887223|NCT00001069|Antiviral Agents|antiviral agents
887224|NCT00001069|Decision Making|decision making
887225|NCT00001069|Physician's Practice Patterns|physician's practice patterns
887226|NCT00001068|Zalcitabine|zalcitabine
887227|NCT00001068|Didanosine|didanosine
887228|NCT00001068|Drug Therapy, Combination|drug therapy, combination
887229|NCT00001068|AIDS-Related Complex|aids-related complex
887230|NCT00001068|Antiviral Agents|antiviral agents
887231|NCT00001068|Zidovudine|zidovudine
887232|NCT00001068|Lamivudine|lamivudine
887233|NCT00001067|Drug Therapy, Combination|drug therapy, combination
887234|NCT00001067|AIDS-Related Complex|aids-related complex
887235|NCT00001067|Zidovudine|zidovudine
887236|NCT00001067|Stavudine|stavudine
887237|NCT00001067|Lamivudine|lamivudine
887238|NCT00001066|Didanosine|didanosine
887239|NCT00001066|Drug Therapy, Combination|drug therapy, combination
887240|NCT00001066|Acquired Immunodeficiency Syndrome|acquired immunodeficiency syndrome
887241|NCT00001066|AIDS-Related Complex|aids-related complex
887242|NCT00001066|Zidovudine|zidovudine
887243|NCT00001066|Lamivudine|lamivudine
887244|NCT00001065|Administration, Oral|administration, oral
887245|NCT00001065|Acquired Immunodeficiency Syndrome|acquired immunodeficiency syndrome
887246|NCT00001065|Amphotericin B|amphotericin b
887247|NCT00001065|AIDS-Related Complex|aids-related complex
887248|NCT00001065|Candidiasis, Oral|candidiasis, oral
887249|NCT00001065|Suspensions|suspensions
887250|NCT00001064|HIV Antigens|hiv antigens
887251|NCT00001064|Immunotherapy, Adoptive|immunotherapy, adoptive
887252|NCT00001064|Dendritic Cells|dendritic cells
887253|NCT00001063|Didanosine|didanosine
887254|NCT00001063|Drug Therapy, Combination|drug therapy, combination
887255|NCT00001063|AIDS-Related Complex|aids-related complex
887256|NCT00001063|Zidovudine|zidovudine
887257|NCT00001063|Stavudine|stavudine
887258|NCT00001062|Infusions, Intravenous|infusions, intravenous
887259|NCT00001062|Ganciclovir|ganciclovir
887260|NCT00001062|Administration, Oral|administration, oral
887261|NCT00001062|Acquired Immunodeficiency Syndrome|acquired immunodeficiency syndrome
887262|NCT00001062|Antiviral Agents|antiviral agents
887263|NCT00001062|Cytomegalovirus Retinitis|cytomegalovirus retinitis
887264|NCT00001061|AIDS-Related Opportunistic Infections|aids-related opportunistic infections
887265|NCT00001061|Ganciclovir|ganciclovir
887266|NCT00001061|Foscarnet|foscarnet
887267|NCT00001061|Acquired Immunodeficiency Syndrome|acquired immunodeficiency syndrome
887268|NCT00001061|Antibodies, Monoclonal|antibodies, monoclonal
887269|NCT00001061|Cytomegalovirus Retinitis|cytomegalovirus retinitis
887270|NCT00001060|Vaccines, Synthetic|vaccines, synthetic
887271|NCT00001060|HIV-1|hiv-1
887272|NCT00001060|Acquired Immunodeficiency Syndrome|acquired immunodeficiency syndrome
887273|NCT00001060|AIDS-Related Complex|aids-related complex
887274|NCT00001060|AIDS Vaccines|aids vaccines
887275|NCT00001060|HIV Therapeutic Vaccine|hiv therapeutic vaccine
887276|NCT00001059|Vincristine|vincristine
887277|NCT00001059|Sarcoma, Kaposi|sarcoma, kaposi
887278|NCT00001059|Liposomes|liposomes
887279|NCT00001059|Doxorubicin|doxorubicin
887280|NCT00001059|Drug Therapy, Combination|drug therapy, combination
887281|NCT00001059|Granulocyte Colony-Stimulating Factor|granulocyte colony-stimulating factor
887282|NCT00001059|Acquired Immunodeficiency Syndrome|acquired immunodeficiency syndrome
887283|NCT00001059|Bleomycin|bleomycin
887284|NCT00001059|Drug Carriers|drug carriers
887285|NCT00001058|Rifabutin|rifabutin
887286|NCT00001058|Mycobacterium avium-intracellulare Infection|mycobacterium avium-intracellulare infection
887287|NCT00001058|Drug Therapy, Combination|drug therapy, combination
887288|NCT00001058|Ethambutol|ethambutol
887289|NCT00001058|Clofazimine|clofazimine
887290|NCT00001058|Acquired Immunodeficiency Syndrome|acquired immunodeficiency syndrome
887291|NCT00001058|Ciprofloxacin|ciprofloxacin
887292|NCT00001058|Clarithromycin|clarithromycin
887293|NCT00001057|Didanosine|didanosine
887294|NCT00001057|Drug Therapy, Combination|drug therapy, combination
887295|NCT00001057|Zidovudine|zidovudine
887296|NCT00001056|Vaccines, Synthetic|vaccines, synthetic
887297|NCT00001056|Vaccinia Virus|vaccinia virus
887298|NCT00001056|Viral Vaccines|viral vaccines
887299|NCT00001056|HIV-1|hiv-1
887300|NCT00001056|HIV Envelope Protein gp160|hiv envelope protein gp160
887301|NCT00001056|AIDS Vaccines|aids vaccines
887302|NCT00001056|HIV Seronegativity|hiv seronegativity
887303|NCT00001056|HIV Preventive Vaccine|hiv preventive vaccine
887304|NCT00001055|Vaccines, Synthetic|vaccines, synthetic
887305|NCT00001055|HIV Envelope Protein gp120|hiv envelope protein gp120
887306|NCT00001055|AIDS Vaccines|aids vaccines
887307|NCT00001055|HIV Seronegativity|hiv seronegativity
887308|NCT00001055|Avipoxvirus|avipoxvirus
887309|NCT00001055|HIV Preventive Vaccine|hiv preventive vaccine
887310|NCT00001054|Herpes Zoster|herpes zoster
887311|NCT00001054|AIDS-Related Opportunistic Infections|aids-related opportunistic infections
887312|NCT00001054|Herpes Simplex|herpes simplex
887313|NCT00001054|Acquired Immunodeficiency Syndrome|acquired immunodeficiency syndrome
887314|NCT00001054|AIDS-Related Complex|aids-related complex
887315|NCT00001054|valacyclovir|valacyclovir
887316|NCT00001054|Chickenpox|chickenpox
887317|NCT00001053|Vaccines, Synthetic|vaccines, synthetic
887318|NCT00001053|Recombinant Proteins|recombinant proteins
887319|NCT00001053|HIV-1|hiv-1
887320|NCT00001053|AIDS Vaccines|aids vaccines
887321|NCT00001053|HIV Core Protein p24|hiv core protein p24
887322|NCT00001053|p24-VLP vaccine|p24-vlp vaccine
887323|NCT00001053|Gene Products, gag|gene products, gag
887324|NCT00001053|HIV Seronegativity|hiv seronegativity
887325|NCT00001053|HIV Preventive Vaccine|hiv preventive vaccine
887326|NCT00001052|Vaccines, Synthetic|vaccines, synthetic
887327|NCT00001052|Drug Therapy, Combination|drug therapy, combination
887328|NCT00001052|Adjuvants, Immunologic|adjuvants, immunologic
887329|NCT00001052|HIV Envelope Protein gp120|hiv envelope protein gp120
887330|NCT00001052|AIDS Vaccines|aids vaccines
887331|NCT00001052|HIV Seronegativity|hiv seronegativity
887332|NCT00001052|HIV Preventive Vaccine|hiv preventive vaccine
887333|NCT00001049|Didanosine|didanosine
887334|NCT00001049|Drug Therapy, Combination|drug therapy, combination
887335|NCT00001049|Acquired Immunodeficiency Syndrome|acquired immunodeficiency syndrome
887336|NCT00001049|AIDS-Related Complex|aids-related complex
887337|NCT00001049|Zidovudine|zidovudine
887338|NCT00001048|Leukoencephalopathy, Progressive Multifocal|leukoencephalopathy, progressive multifocal
887339|NCT00001048|Infusions, Intravenous|infusions, intravenous
887340|NCT00001048|Cytarabine|cytarabine
887341|NCT00001048|Zalcitabine|zalcitabine
887342|NCT00001048|Didanosine|didanosine
887343|NCT00001048|Drug Therapy, Combination|drug therapy, combination
887344|NCT00001048|Granulocyte Colony-Stimulating Factor|granulocyte colony-stimulating factor
887345|NCT00001048|Acquired Immunodeficiency Syndrome|acquired immunodeficiency syndrome
887346|NCT00001048|Zidovudine|zidovudine
887347|NCT00001048|Injections, Spinal|injections, spinal
887348|NCT00001047|Rifabutin|rifabutin
887349|NCT00001047|Mycobacterium avium-intracellulare Infection|mycobacterium avium-intracellulare infection
887350|NCT00001047|Drug Therapy, Combination|drug therapy, combination
887351|NCT00001047|Ethambutol|ethambutol
887352|NCT00001047|Clofazimine|clofazimine
887353|NCT00001047|Acquired Immunodeficiency Syndrome|acquired immunodeficiency syndrome
887354|NCT00001047|Clarithromycin|clarithromycin
887355|NCT00001046|Vaccines, Synthetic|vaccines, synthetic
887356|NCT00001046|Pregnancy|pregnancy
887357|NCT00001046|Pregnancy Complications, Infectious|pregnancy complications, infectious
887358|NCT00001046|AIDS-Related Complex|aids-related complex
887359|NCT00001046|HIV Envelope Protein gp120|hiv envelope protein gp120
887360|NCT00001046|HIV Preventive Vaccine|hiv preventive vaccine
887361|NCT00001046|HIV Therapeutic Vaccine|hiv therapeutic vaccine
887362|NCT00001045|Didanosine|didanosine
887363|NCT00001045|Drug Therapy, Combination|drug therapy, combination
887364|NCT00001045|Zidovudine|zidovudine
887365|NCT00001045|Nevirapine|nevirapine
887366|NCT00001044|Vaccines, Synthetic|vaccines, synthetic
887367|NCT00001044|Drug Therapy, Combination|drug therapy, combination
887368|NCT00001044|Adjuvants, Immunologic|adjuvants, immunologic
887369|NCT00001044|HIV Envelope Protein gp120|hiv envelope protein gp120
887370|NCT00001044|AIDS Vaccines|aids vaccines
887371|NCT00001044|HIV Seronegativity|hiv seronegativity
887372|NCT00001044|HIV Preventive Vaccine|hiv preventive vaccine
887373|NCT00001043|Vaccines, Synthetic|vaccines, synthetic
887374|NCT00001043|Vaccinia Virus|vaccinia virus
887375|NCT00001043|Viral Vaccines|viral vaccines
887376|NCT00001043|Smallpox Vaccine|smallpox vaccine
887377|NCT00001043|HIV-1|hiv-1
887378|NCT00001043|HIV Envelope Protein gp160|hiv envelope protein gp160
887379|NCT00001043|AIDS Vaccines|aids vaccines
887380|NCT00001043|HIV Seronegativity|hiv seronegativity
887381|NCT00001043|HIV Preventive Vaccine|hiv preventive vaccine
887382|NCT00001042|Vaccines, Synthetic|vaccines, synthetic
887383|NCT00001042|Drug Therapy, Combination|drug therapy, combination
887384|NCT00001042|Adjuvants, Immunologic|adjuvants, immunologic
887385|NCT00001042|HIV Envelope Protein gp120|hiv envelope protein gp120
887386|NCT00001042|Acetylmuramyl-Alanyl-Isoglutamine|acetylmuramyl-alanyl-isoglutamine
887387|NCT00001042|monophosphoryl lipid A|monophosphoryl lipid a
887388|NCT00001042|AIDS Vaccines|aids vaccines
887389|NCT00001042|HIV Seronegativity|hiv seronegativity
887390|NCT00001042|HIV Preventive Vaccine|hiv preventive vaccine
887391|NCT00001041|Vaccines, Synthetic|vaccines, synthetic
887392|NCT00001041|Pregnancy|pregnancy
887393|NCT00001041|Pregnancy Complications, Infectious|pregnancy complications, infectious
887394|NCT00001041|HIV Envelope Protein gp120|hiv envelope protein gp120
887395|NCT00001041|AIDS Vaccines|aids vaccines
887396|NCT00001041|HIV Therapeutic Vaccine|hiv therapeutic vaccine
887397|NCT00001040|Zalcitabine|zalcitabine
887398|NCT00001040|Drug Therapy, Combination|drug therapy, combination
887399|NCT00001040|Acquired Immunodeficiency Syndrome|acquired immunodeficiency syndrome
887400|NCT00001040|AIDS-Related Complex|aids-related complex
887401|NCT00001040|Zidovudine|zidovudine
887402|NCT00001040|Saquinavir|saquinavir
887403|NCT00001040|HIV Protease Inhibitors|hiv protease inhibitors
887404|NCT00001039|Mycobacterium avium-intracellulare Infection|mycobacterium avium-intracellulare infection
887405|NCT00001039|Drug Therapy, Combination|drug therapy, combination
887406|NCT00001039|Ethambutol|ethambutol
887407|NCT00001039|Acquired Immunodeficiency Syndrome|acquired immunodeficiency syndrome
887408|NCT00001039|Clarithromycin|clarithromycin
887409|NCT00001038|Cytomegalovirus Infections|cytomegalovirus infections
887410|NCT00001038|Acquired Immunodeficiency Syndrome|acquired immunodeficiency syndrome
887411|NCT00001038|Antiviral Agents|antiviral agents
887412|NCT00001037|Vaccines, Synthetic|vaccines, synthetic
887414|NCT00001037|HIV Envelope Protein gp160|hiv envelope protein gp160
887415|NCT00001037|AIDS Vaccines|aids vaccines
887416|NCT00001037|HIV Seronegativity|hiv seronegativity
887417|NCT00001037|HIV Preventive Vaccine|hiv preventive vaccine
887418|NCT00001036|T-Lymphocytes|t-lymphocytes
887419|NCT00001036|Polyethylene Glycols|polyethylene glycols
887420|NCT00001036|Interleukin-2|interleukin-2
887421|NCT00001036|Drug Therapy, Combination|drug therapy, combination
887422|NCT00001036|Adjuvants, Immunologic|adjuvants, immunologic
887423|NCT00001036|Acquired Immunodeficiency Syndrome|acquired immunodeficiency syndrome
887424|NCT00001036|Zidovudine|zidovudine
887425|NCT00001036|thymosin alpha(1)|thymosin alpha(1)
887426|NCT00001035|AIDS-Related Opportunistic Infections|aids-related opportunistic infections
887427|NCT00001035|Interferon Alfa-2b|interferon alfa-2b
887428|NCT00001035|Zalcitabine|zalcitabine
887429|NCT00001035|Didanosine|didanosine
887430|NCT00001035|Drug Therapy, Combination|drug therapy, combination
887431|NCT00001035|Acquired Immunodeficiency Syndrome|acquired immunodeficiency syndrome
887432|NCT00001035|Zidovudine|zidovudine
887433|NCT00001035|Hepatitis C|hepatitis c
887434|NCT00001034|Retinitis|retinitis
887435|NCT00001034|Ganciclovir|ganciclovir
887436|NCT00001034|Cytomegalovirus Infections|cytomegalovirus infections
887437|NCT00001034|Administration, Oral|administration, oral
887438|NCT00001034|Acquired Immunodeficiency Syndrome|acquired immunodeficiency syndrome
887439|NCT00001034|Gastrointestinal System|gastrointestinal system
887440|NCT00001033|Isoniazid|isoniazid
887441|NCT00001033|Tuberculosis, Pulmonary|tuberculosis, pulmonary
887442|NCT00001033|Pyrazinamide|pyrazinamide
887443|NCT00001033|Pyridoxine|pyridoxine
887444|NCT00001033|Ofloxacin|ofloxacin
887445|NCT00001033|Rifampin|rifampin
887446|NCT00001033|AIDS-Related Opportunistic Infections|aids-related opportunistic infections
887447|NCT00001033|Ethambutol|ethambutol
887448|NCT00001033|Acquired Immunodeficiency Syndrome|acquired immunodeficiency syndrome
887449|NCT00001032|Zalcitabine|zalcitabine
887450|NCT00001032|Drug Therapy, Combination|drug therapy, combination
887451|NCT00001032|Acquired Immunodeficiency Syndrome|acquired immunodeficiency syndrome
887452|NCT00001032|AIDS-Related Complex|aids-related complex
887453|NCT00001032|Zidovudine|zidovudine
887454|NCT00001031|Vaccines, Synthetic|vaccines, synthetic
887455|NCT00001031|HIV-1|hiv-1
887456|NCT00001031|HIV Envelope Protein gp120|hiv envelope protein gp120
887457|NCT00001031|AIDS Vaccines|aids vaccines
887458|NCT00001031|HIV Seronegativity|hiv seronegativity
887459|NCT00001031|HIV Preventive Vaccine|hiv preventive vaccine
887460|NCT00001030|Rifabutin|rifabutin
887461|NCT00001030|Mycobacterium avium-intracellulare Infection|mycobacterium avium-intracellulare infection
887462|NCT00001030|Acquired Immunodeficiency Syndrome|acquired immunodeficiency syndrome
887463|NCT00001030|Clarithromycin|clarithromycin
887464|NCT00001029|Zalcitabine|zalcitabine
887465|NCT00001029|Didanosine|didanosine
887466|NCT00001029|Drug Therapy, Combination|drug therapy, combination
887467|NCT00001029|Acquired Immunodeficiency Syndrome|acquired immunodeficiency syndrome
887468|NCT00001029|Zidovudine|zidovudine
887469|NCT00001028|Pneumonia, Pneumocystis carinii|pneumonia, pneumocystis carinii
887472|NCT00001028|Acquired Immunodeficiency Syndrome|acquired immunodeficiency syndrome
887473|NCT00001028|AIDS-Related Complex|aids-related complex
887474|NCT00001027|Pneumonia, Pneumocystis carinii|pneumonia, pneumocystis carinii
887475|NCT00001027|Pentamidine|pentamidine
887476|NCT00001027|Acquired Immunodeficiency Syndrome|acquired immunodeficiency syndrome
887477|NCT00001027|AIDS-Related Complex|aids-related complex
887478|NCT00001026|Vaccines, Synthetic|vaccines, synthetic
887479|NCT00001026|Vaccinia Virus|vaccinia virus
887480|NCT00001026|Viral Vaccines|viral vaccines
887481|NCT00001026|HIV Envelope Protein gp160|hiv envelope protein gp160
887482|NCT00001026|HIV Envelope Protein gp120|hiv envelope protein gp120
887483|NCT00001026|AIDS Vaccines|aids vaccines
887484|NCT00001026|HIV Seronegativity|hiv seronegativity
887485|NCT00001026|HIV Preventive Vaccine|hiv preventive vaccine
887486|NCT00001025|Virus Replication|virus replication
887487|NCT00001025|Didanosine|didanosine
887488|NCT00001025|Acquired Immunodeficiency Syndrome|acquired immunodeficiency syndrome
887489|NCT00001025|AIDS-Related Complex|aids-related complex
887490|NCT00001025|Zidovudine|zidovudine
887491|NCT00001024|Didanosine|didanosine
887492|NCT00001024|AIDS-Related Complex|aids-related complex
887493|NCT00001024|Zidovudine|zidovudine
887494|NCT00001024|Lymph Nodes|lymph nodes
887495|NCT00001024|Lymphoid Tissue|lymphoid tissue
887496|NCT00001023|Rifabutin|rifabutin
887497|NCT00001023|Mycobacterium avium-intracellulare Infection|mycobacterium avium-intracellulare infection
887498|NCT00001023|Drug Interactions|drug interactions
887499|NCT00001023|Azithromycin|azithromycin
887500|NCT00001023|Clarithromycin|clarithromycin
887501|NCT00001022|Zalcitabine|zalcitabine
887502|NCT00001022|Didanosine|didanosine
887503|NCT00001022|Drug Therapy, Combination|drug therapy, combination
887504|NCT00001022|Acquired Immunodeficiency Syndrome|acquired immunodeficiency syndrome
887505|NCT00001022|AIDS-Related Complex|aids-related complex
887506|NCT00001022|Zidovudine|zidovudine
887507|NCT00001021|Vaccines, Synthetic|vaccines, synthetic
887508|NCT00001021|HIV-1|hiv-1
887509|NCT00001021|HIV Envelope Protein gp120|hiv envelope protein gp120
887510|NCT00001021|AIDS Vaccines|aids vaccines
887511|NCT00001021|HIV Seronegativity|hiv seronegativity
887512|NCT00001021|HIV Preventive Vaccine|hiv preventive vaccine
887513|NCT00001020|Vaccines, Synthetic|vaccines, synthetic
887514|NCT00001020|Viral Vaccines|viral vaccines
887515|NCT00001020|HIV-1|hiv-1
887516|NCT00001020|HIV Envelope Protein gp120|hiv envelope protein gp120
887517|NCT00001020|AIDS Vaccines|aids vaccines
887518|NCT00001020|HIV Seronegativity|hiv seronegativity
887519|NCT00001020|HIV Preventive Vaccine|hiv preventive vaccine
887520|NCT00001019|Vaccines, Synthetic|vaccines, synthetic
887521|NCT00001019|Adjuvants, Immunologic|adjuvants, immunologic
887522|NCT00001019|HIV Envelope Protein gp120|hiv envelope protein gp120
887523|NCT00001019|AIDS Vaccines|aids vaccines
887524|NCT00001019|HIV Seronegativity|hiv seronegativity
887525|NCT00001019|HIV Preventive Vaccine|hiv preventive vaccine
887526|NCT00001018|Cryptosporidiosis|cryptosporidiosis
887527|NCT00001018|Diarrhea|diarrhea
887528|NCT00001018|Acquired Immunodeficiency Syndrome|acquired immunodeficiency syndrome
887529|NCT00001018|Antiprotozoal Agents|antiprotozoal agents
887530|NCT00001018|Triazines|triazines
887531|NCT00001017|AIDS-Related Opportunistic Infections|aids-related opportunistic infections
887532|NCT00001017|Meningitis|meningitis
887533|NCT00001017|Injections, Intravenous|injections, intravenous
887534|NCT00001017|Cryptococcosis|cryptococcosis
887535|NCT00001017|Fluconazole|fluconazole
887536|NCT00001017|Administration, Oral|administration, oral
887537|NCT00001017|Acquired Immunodeficiency Syndrome|acquired immunodeficiency syndrome
887538|NCT00001017|Amphotericin B|amphotericin b
887539|NCT00001016|Trimetrexate|trimetrexate
887540|NCT00001016|Pneumonia, Pneumocystis carinii|pneumonia, pneumocystis carinii
887541|NCT00001016|Quinazolines|quinazolines
887542|NCT00001016|Infusions, Intravenous|infusions, intravenous
887543|NCT00001016|Injections, Intravenous|injections, intravenous
887544|NCT00001016|Leucovorin|leucovorin
887545|NCT00001016|Drug Evaluation|drug evaluation
887546|NCT00001016|Drug Therapy, Combination|drug therapy, combination
887547|NCT00001016|Administration, Oral|administration, oral
887548|NCT00001016|Acquired Immunodeficiency Syndrome|acquired immunodeficiency syndrome
887549|NCT00001016|Antiprotozoal Agents|antiprotozoal agents
887550|NCT00001016|AIDS-Related Complex|aids-related complex
887551|NCT00001015|Ribavirin|ribavirin
887552|NCT00001015|T-Lymphocytes|t-lymphocytes
887553|NCT00001015|Acquired Immunodeficiency Syndrome|acquired immunodeficiency syndrome
887554|NCT00001015|AIDS-Related Complex|aids-related complex
887555|NCT00001014|Trimethoprim-Sulfamethoxazole Combination|trimethoprim-sulfamethoxazole combination
887556|NCT00001014|Trimetrexate|trimetrexate
887557|NCT00001014|AIDS-Related Opportunistic Infections|aids-related opportunistic infections
887558|NCT00001014|Pneumonia, Pneumocystis carinii|pneumonia, pneumocystis carinii
887559|NCT00001014|Infusions, Intravenous|infusions, intravenous
887560|NCT00001014|Leucovorin|leucovorin
887561|NCT00001014|Drug Therapy, Combination|drug therapy, combination
887562|NCT00001014|Administration, Oral|administration, oral
887563|NCT00001014|Acquired Immunodeficiency Syndrome|acquired immunodeficiency syndrome
887564|NCT00001014|Antiprotozoal Agents|antiprotozoal agents
887565|NCT00001014|AIDS-Related Complex|aids-related complex
887566|NCT00001014|Sulfamethoxazole-Trimethoprim|sulfamethoxazole-trimethoprim
887567|NCT00001013|Trimethoprim-Sulfamethoxazole Combination|trimethoprim-sulfamethoxazole combination
887568|NCT00001013|Trimetrexate|trimetrexate
887569|NCT00001013|AIDS-Related Opportunistic Infections|aids-related opportunistic infections
887570|NCT00001013|Pneumonia, Pneumocystis carinii|pneumonia, pneumocystis carinii
887571|NCT00001013|Pentamidine|pentamidine
887572|NCT00001013|Infusions, Intravenous|infusions, intravenous
887573|NCT00001013|Leucovorin|leucovorin
887574|NCT00001013|Drug Therapy, Combination|drug therapy, combination
887575|NCT00001013|Folic Acid Antagonists|folic acid antagonists
887576|NCT00001013|Aerosols|aerosols
887577|NCT00001013|Acquired Immunodeficiency Syndrome|acquired immunodeficiency syndrome
887578|NCT00001013|Antiprotozoal Agents|antiprotozoal agents
887579|NCT00001013|AIDS-Related Complex|aids-related complex
887580|NCT00001013|Sulfamethoxazole-Trimethoprim|sulfamethoxazole-trimethoprim
887581|NCT00001012|Virus Replication|virus replication
887582|NCT00001012|T-Lymphocytes|t-lymphocytes
887583|NCT00001012|Dose-Response Relationship, Drug|dose-response relationship, drug
887584|NCT00001012|Drug Evaluation|drug evaluation
887585|NCT00001012|Acquired Immunodeficiency Syndrome|acquired immunodeficiency syndrome
887586|NCT00001012|AL 721|al 721
887587|NCT00001012|AIDS-Related Complex|aids-related complex
887588|NCT00001012|Antiviral Agents|antiviral agents
887589|NCT00001011|Virus Replication|virus replication
887590|NCT00001011|AIDS-Related Complex|aids-related complex
887591|NCT00001011|Zidovudine|zidovudine
887592|NCT00001010|Immune Tolerance|immune tolerance
887593|NCT00001010|Dose-Response Relationship, Drug|dose-response relationship, drug
887594|NCT00001010|Drug Evaluation|drug evaluation
887595|NCT00001010|Drug Therapy, Combination|drug therapy, combination
887596|NCT00001010|Acyclovir|acyclovir
887597|NCT00001010|Acquired Immunodeficiency Syndrome|acquired immunodeficiency syndrome
887598|NCT00001010|AIDS-Related Complex|aids-related complex
887599|NCT00001010|Zidovudine|zidovudine
887600|NCT00001009|T-Lymphocytes|t-lymphocytes
887601|NCT00001009|HIV Antigens|hiv antigens
887602|NCT00001009|Dextran Sulfate|dextran sulfate
887603|NCT00001009|Dose-Response Relationship, Drug|dose-response relationship, drug
887604|NCT00001009|Drug Evaluation|drug evaluation
887605|NCT00001009|Drug Therapy, Combination|drug therapy, combination
887606|NCT00001009|Acquired Immunodeficiency Syndrome|acquired immunodeficiency syndrome
887607|NCT00001009|AIDS-Related Complex|aids-related complex
887608|NCT00001008|Substance Withdrawal Syndrome|substance withdrawal syndrome
887609|NCT00001008|Methadone|methadone
887610|NCT00001008|Opioid-Related Disorders|opioid-related disorders
887611|NCT00001008|Drug Evaluation|drug evaluation
887612|NCT00001008|Drug Interactions|drug interactions
887613|NCT00001008|Drug Therapy, Combination|drug therapy, combination
887614|NCT00001008|Administration, Oral|administration, oral
887615|NCT00001008|Acquired Immunodeficiency Syndrome|acquired immunodeficiency syndrome
887616|NCT00001008|AIDS-Related Complex|aids-related complex
887617|NCT00001008|Zidovudine|zidovudine
887618|NCT00001007|Pregnancy|pregnancy
887619|NCT00001007|Pregnancy Complications, Infectious|pregnancy complications, infectious
887620|NCT00001007|Infant, Newborn, Diseases|infant, newborn, diseases
887621|NCT00001007|Infusions, Intravenous|infusions, intravenous
887622|NCT00001007|Drug Evaluation|drug evaluation
887623|NCT00001007|Administration, Oral|administration, oral
887624|NCT00001007|Acquired Immunodeficiency Syndrome|acquired immunodeficiency syndrome
887625|NCT00001007|Zidovudine|zidovudine
887626|NCT00001006|Infusions, Intravenous|infusions, intravenous
887627|NCT00001006|Immunologic Surveillance|immunologic surveillance
887628|NCT00001006|Drug Evaluation|drug evaluation
887629|NCT00001006|Adjuvants, Immunologic|adjuvants, immunologic
887630|NCT00001006|Acquired Immunodeficiency Syndrome|acquired immunodeficiency syndrome
887631|NCT00001006|AIDS-Related Complex|aids-related complex
887632|NCT00001006|ammonium trichloro(dioxoethylene-O,O'-)tellurute|ammonium trichloro(dioxoethylene-o,o'-)tellurute
887633|NCT00001005|Recombinant Proteins|recombinant proteins
887634|NCT00001005|HIV Seropositivity|hiv seropositivity
887635|NCT00001005|Interleukin-2|interleukin-2
887636|NCT00001005|Drug Evaluation|drug evaluation
887637|NCT00001005|Drug Therapy, Combination|drug therapy, combination
887638|NCT00001005|Acquired Immunodeficiency Syndrome|acquired immunodeficiency syndrome
887639|NCT00001005|AIDS-Related Complex|aids-related complex
887640|NCT00001005|Zidovudine|zidovudine
887641|NCT00001004|Tumor Necrosis Factor|tumor necrosis factor
887642|NCT00001004|Interferon-gamma, Recombinant|interferon-gamma, recombinant
887643|NCT00001004|HIV Antigens|hiv antigens
887644|NCT00001004|Immunologic Surveillance|immunologic surveillance
887645|NCT00001004|Drug Therapy, Combination|drug therapy, combination
887646|NCT00001004|Acquired Immunodeficiency Syndrome|acquired immunodeficiency syndrome
887647|NCT00001004|AIDS-Related Complex|aids-related complex
887648|NCT00001003|AIDS-Related Opportunistic Infections|aids-related opportunistic infections
887649|NCT00001003|Pneumonia, Pneumocystis carinii|pneumonia, pneumocystis carinii
887650|NCT00001003|Pentamidine|pentamidine
887651|NCT00001003|Nebulizers and Vaporizers|nebulizers and vaporizers
887653|NCT00001003|Administration, Inhalation|administration, inhalation
887654|NCT00001003|Acquired Immunodeficiency Syndrome|acquired immunodeficiency syndrome
887655|NCT00001003|Zidovudine|zidovudine
887656|NCT00001002|Drug Therapy, Combination|drug therapy, combination
887657|NCT00001002|Foscarnet|foscarnet
887658|NCT00001002|Acquired Immunodeficiency Syndrome|acquired immunodeficiency syndrome
887659|NCT00001002|AIDS-Related Complex|aids-related complex
887660|NCT00001002|Antiviral Agents|antiviral agents
887661|NCT00001002|Zidovudine|zidovudine
887662|NCT00001001|Liver|liver
887663|NCT00001001|Liver Diseases|liver diseases
887664|NCT00001001|Liver Function Tests|liver function tests
887665|NCT00001001|HIV Seropositivity|hiv seropositivity
887666|NCT00001001|Acquired Immunodeficiency Syndrome|acquired immunodeficiency syndrome
887667|NCT00001001|Zidovudine|zidovudine
887668|NCT00001001|Biological Availability|biological availability
887669|NCT00001000|Macrophage Activation|macrophage activation
887670|NCT00001000|Lymphocyte Transformation|lymphocyte transformation
887671|NCT00001000|Immunologic Surveillance|immunologic surveillance
887672|NCT00001000|ampligen|ampligen
887673|NCT00001000|Antiviral Agents|antiviral agents
887674|NCT00000999|Acquired Immunodeficiency Syndrome|acquired immunodeficiency syndrome
887675|NCT00000999|AIDS-Related Complex|aids-related complex
887676|NCT00000999|Zidovudine|zidovudine
887677|NCT00000998|Trimetrexate|trimetrexate
887678|NCT00000998|AIDS-Related Opportunistic Infections|aids-related opportunistic infections
887679|NCT00000998|Pneumonia, Pneumocystis carinii|pneumonia, pneumocystis carinii
887680|NCT00000998|Injections, Intravenous|injections, intravenous
887681|NCT00000998|Leucovorin|leucovorin
887682|NCT00000998|Dose-Response Relationship, Drug|dose-response relationship, drug
887683|NCT00000998|Drug Therapy, Combination|drug therapy, combination
887684|NCT00000998|Folic Acid Antagonists|folic acid antagonists
887685|NCT00000998|Administration, Oral|administration, oral
887686|NCT00000998|Acquired Immunodeficiency Syndrome|acquired immunodeficiency syndrome
887687|NCT00000998|Antineoplastic Agents|antineoplastic agents
887688|NCT00000997|Zalcitabine|zalcitabine
887689|NCT00000997|Drug Evaluation|drug evaluation
887690|NCT00000997|Acquired Immunodeficiency Syndrome|acquired immunodeficiency syndrome
887691|NCT00000997|AIDS-Related Complex|aids-related complex
887692|NCT00000997|Biological Availability|biological availability
887693|NCT00000996|Doxorubicin|doxorubicin
887694|NCT00000996|Drug Evaluation|drug evaluation
887695|NCT00000996|Acquired Immunodeficiency Syndrome|acquired immunodeficiency syndrome
887696|NCT00000995|AIDS-Related Opportunistic Infections|aids-related opportunistic infections
887697|NCT00000995|Ganciclovir|ganciclovir
887698|NCT00000995|Drug Evaluation|drug evaluation
887699|NCT00000995|Drug Therapy, Combination|drug therapy, combination
887700|NCT00000995|Cytomegalovirus Infections|cytomegalovirus infections
887701|NCT00000995|Acquired Immunodeficiency Syndrome|acquired immunodeficiency syndrome
887702|NCT00000995|Zidovudine|zidovudine
887703|NCT00000994|AIDS-Related Opportunistic Infections|aids-related opportunistic infections
887704|NCT00000994|Sarcoma, Kaposi|sarcoma, kaposi
887705|NCT00000994|Acquired Immunodeficiency Syndrome|acquired immunodeficiency syndrome
887706|NCT00000994|Zidovudine|zidovudine
887707|NCT00000993|HIV-1|hiv-1
887708|NCT00000993|Drug Evaluation|drug evaluation
887709|NCT00000993|Accidents|accidents
887710|NCT00000993|Acquired Immunodeficiency Syndrome|acquired immunodeficiency syndrome
887711|NCT00000993|AIDS Serodiagnosis|aids serodiagnosis
887712|NCT00000993|Zidovudine|zidovudine
887713|NCT00000992|AIDS-Related Opportunistic Infections|aids-related opportunistic infections
887714|NCT00000992|Ketoconazole|ketoconazole
887715|NCT00000992|Histoplasmosis|histoplasmosis
887716|NCT00000992|Drug Evaluation|drug evaluation
887717|NCT00000992|Antifungal Agents|antifungal agents
887718|NCT00000992|Acquired Immunodeficiency Syndrome|acquired immunodeficiency syndrome
887719|NCT00000991|Trimethoprim-Sulfamethoxazole Combination|trimethoprim-sulfamethoxazole combination
887720|NCT00000991|Toxoplasmosis|toxoplasmosis
887721|NCT00000991|AIDS-Related Opportunistic Infections|aids-related opportunistic infections
887722|NCT00000991|Pneumonia, Pneumocystis carinii|pneumonia, pneumocystis carinii
887723|NCT00000991|Pentamidine|pentamidine
887724|NCT00000991|Dapsone|dapsone
887725|NCT00000991|Drug Evaluation|drug evaluation
887726|NCT00000991|Drug Therapy, Combination|drug therapy, combination
887727|NCT00000991|Acquired Immunodeficiency Syndrome|acquired immunodeficiency syndrome
887728|NCT00000991|Zidovudine|zidovudine
887729|NCT00000991|Sulfamethoxazole-Trimethoprim|sulfamethoxazole-trimethoprim
887730|NCT00000990|AIDS-Related Opportunistic Infections|aids-related opportunistic infections
887731|NCT00000990|Pulmonary Fibrosis|pulmonary fibrosis
887732|NCT00000990|Zidovudine|zidovudine
887733|NCT00000989|Retinitis|retinitis
887734|NCT00000989|Ganciclovir|ganciclovir
887735|NCT00000989|Drug Evaluation|drug evaluation
887736|NCT00000989|Drug Therapy, Combination|drug therapy, combination
887737|NCT00000989|Cytomegalovirus Infections|cytomegalovirus infections
887738|NCT00000989|Acquired Immunodeficiency Syndrome|acquired immunodeficiency syndrome
887739|NCT00000989|Zidovudine|zidovudine
887740|NCT00000988|Injections, Intravenous|injections, intravenous
887741|NCT00000988|Drug Evaluation|drug evaluation
887742|NCT00000988|Administration, Oral|administration, oral
887743|NCT00000988|Acquired Immunodeficiency Syndrome|acquired immunodeficiency syndrome
887744|NCT00000988|AIDS-Related Complex|aids-related complex
887745|NCT00000988|Antiviral Agents|antiviral agents
887746|NCT00000987|Vincristine|vincristine
887747|NCT00000987|Doxorubicin|doxorubicin
887748|NCT00000987|Drug Therapy, Combination|drug therapy, combination
887749|NCT00000987|Acquired Immunodeficiency Syndrome|acquired immunodeficiency syndrome
887750|NCT00000987|Zidovudine|zidovudine
887751|NCT00000987|Bleomycin|bleomycin
887752|NCT00000986|Recombinant Proteins|recombinant proteins
887753|NCT00000986|Interleukin-2|interleukin-2
887754|NCT00000986|Drug Interactions|drug interactions
887755|NCT00000986|Drug Therapy, Combination|drug therapy, combination
887756|NCT00000986|Acquired Immunodeficiency Syndrome|acquired immunodeficiency syndrome
887757|NCT00000986|AIDS-Related Complex|aids-related complex
887758|NCT00000986|Zidovudine|zidovudine
887759|NCT00000985|Vidarabine|vidarabine
887760|NCT00000985|Phosphonoacetic Acid|phosphonoacetic acid
887761|NCT00000985|Herpes Simplex|herpes simplex
887762|NCT00000985|Foscarnet|foscarnet
887763|NCT00000985|Acyclovir|acyclovir
887764|NCT00000985|Acquired Immunodeficiency Syndrome|acquired immunodeficiency syndrome
887765|NCT00000984|Recombinant Proteins|recombinant proteins
887766|NCT00000984|Acquired Immunodeficiency Syndrome|acquired immunodeficiency syndrome
887767|NCT00000984|Antigens, CD4|antigens, cd4
887768|NCT00000984|Antiviral Agents|antiviral agents
888050|NCT00000942|Nevirapine|nevirapine
887769|NCT00000983|Acquired Immunodeficiency Syndrome|acquired immunodeficiency syndrome
887770|NCT00000983|Zidovudine|zidovudine
887771|NCT00000982|Central Nervous System Diseases|central nervous system diseases
887772|NCT00000982|Acquired Immunodeficiency Syndrome|acquired immunodeficiency syndrome
887773|NCT00000982|Zidovudine|zidovudine
887774|NCT00000981|Retinitis|retinitis
887775|NCT00000981|AIDS-Related Opportunistic Infections|aids-related opportunistic infections
887776|NCT00000981|Pyrimidine Nucleosides|pyrimidine nucleosides
887777|NCT00000981|Drug Evaluation|drug evaluation
887778|NCT00000981|fiacitabine|fiacitabine
887779|NCT00000981|Cytomegalovirus Infections|cytomegalovirus infections
887780|NCT00000981|Acquired Immunodeficiency Syndrome|acquired immunodeficiency syndrome
887781|NCT00000981|Antiviral Agents|antiviral agents
887782|NCT00000980|Single-Blind Method|single-blind method
887783|NCT00000980|Spiramycin|spiramycin
887784|NCT00000980|AIDS-Related Opportunistic Infections|aids-related opportunistic infections
887785|NCT00000980|Injections, Intravenous|injections, intravenous
887786|NCT00000980|Cryptosporidiosis|cryptosporidiosis
887787|NCT00000980|Diarrhea|diarrhea
887788|NCT00000980|Drug Evaluation|drug evaluation
887789|NCT00000980|Acquired Immunodeficiency Syndrome|acquired immunodeficiency syndrome
887790|NCT00000979|Didanosine|didanosine
887791|NCT00000979|Zidovudine|zidovudine
887792|NCT00000978|Zalcitabine|zalcitabine
887793|NCT00000978|Drug Therapy, Combination|drug therapy, combination
887794|NCT00000978|Acquired Immunodeficiency Syndrome|acquired immunodeficiency syndrome
887795|NCT00000978|AIDS-Related Complex|aids-related complex
887796|NCT00000978|Zidovudine|zidovudine
887797|NCT00000977|Vaccines, Synthetic|vaccines, synthetic
887798|NCT00000977|HIV Seropositivity|hiv seropositivity
887799|NCT00000977|HIV-1|hiv-1
887800|NCT00000977|Drug Evaluation|drug evaluation
887801|NCT00000977|AIDS Vaccines|aids vaccines
887802|NCT00000977|HIV Therapeutic Vaccine|hiv therapeutic vaccine
887803|NCT00000976|Recombinant Proteins|recombinant proteins
887804|NCT00000976|Injections, Intravenous|injections, intravenous
887805|NCT00000976|IgG|igg
887806|NCT00000976|Drug Evaluation|drug evaluation
887807|NCT00000976|Administration, Oral|administration, oral
887808|NCT00000976|Acquired Immunodeficiency Syndrome|acquired immunodeficiency syndrome
887809|NCT00000976|Antigens, CD4|antigens, cd4
887810|NCT00000976|Zidovudine|zidovudine
887811|NCT00000976|Carrier Proteins|carrier proteins
887812|NCT00000975|AIDS-Related Opportunistic Infections|aids-related opportunistic infections
887813|NCT00000975|Histoplasmosis|histoplasmosis
887814|NCT00000975|Drug Evaluation|drug evaluation
887815|NCT00000975|Antifungal Agents|antifungal agents
887816|NCT00000975|Acquired Immunodeficiency Syndrome|acquired immunodeficiency syndrome
887817|NCT00000974|AIDS-Related Opportunistic Infections|aids-related opportunistic infections
887818|NCT00000974|Pneumonia, Pneumocystis carinii|pneumonia, pneumocystis carinii
887819|NCT00000974|Pentamidine|pentamidine
887820|NCT00000974|Injections, Intravenous|injections, intravenous
887821|NCT00000974|Drug Evaluation|drug evaluation
887822|NCT00000974|Aerosols|aerosols
887823|NCT00000974|Acquired Immunodeficiency Syndrome|acquired immunodeficiency syndrome
887824|NCT00000973|Toxoplasmosis|toxoplasmosis
887825|NCT00000973|Toxoplasma|toxoplasma
887826|NCT00000973|Pyrimethamine|pyrimethamine
887827|NCT00000973|Leucovorin|leucovorin
887828|NCT00000973|Drug Evaluation|drug evaluation
887829|NCT00000973|Encephalitis|encephalitis
887830|NCT00000973|Zidovudine|zidovudine
887831|NCT00000972|Vaccines, Synthetic|vaccines, synthetic
887832|NCT00000972|Drug Evaluation|drug evaluation
887833|NCT00000972|Adjuvants, Immunologic|adjuvants, immunologic
887834|NCT00000972|AIDS Vaccines|aids vaccines
887835|NCT00000972|HIV Preventive Vaccine|hiv preventive vaccine
887836|NCT00000971|AIDS-Related Opportunistic Infections|aids-related opportunistic infections
887837|NCT00000971|Mycobacterium avium-intracellulare Infection|mycobacterium avium-intracellulare infection
887838|NCT00000971|Didanosine|didanosine
887839|NCT00000971|Drug Evaluation|drug evaluation
887840|NCT00000971|Drug Interactions|drug interactions
887841|NCT00000971|Drug Therapy, Combination|drug therapy, combination
887842|NCT00000971|Acquired Immunodeficiency Syndrome|acquired immunodeficiency syndrome
887843|NCT00000971|Zidovudine|zidovudine
887844|NCT00000970|Retinitis|retinitis
887845|NCT00000970|AIDS-Related Opportunistic Infections|aids-related opportunistic infections
887846|NCT00000970|Ganciclovir|ganciclovir
887847|NCT00000970|Drug Evaluation|drug evaluation
887848|NCT00000970|Drug Therapy, Combination|drug therapy, combination
887849|NCT00000970|Foscarnet|foscarnet
887850|NCT00000970|Cytomegalovirus Infections|cytomegalovirus infections
887851|NCT00000970|Acquired Immunodeficiency Syndrome|acquired immunodeficiency syndrome
887852|NCT00000969|Zalcitabine|zalcitabine
887853|NCT00000969|Didanosine|didanosine
887854|NCT00000969|Drug Evaluation|drug evaluation
887855|NCT00000969|Zidovudine|zidovudine
887856|NCT00000968|Vaccines, Synthetic|vaccines, synthetic
887857|NCT00000968|Drug Evaluation|drug evaluation
887858|NCT00000968|HIV Envelope Protein gp160|hiv envelope protein gp160
887859|NCT00000968|AIDS Vaccines|aids vaccines
887860|NCT00000968|HIV Seronegativity|hiv seronegativity
887861|NCT00000968|HIV Preventive Vaccine|hiv preventive vaccine
887862|NCT00000967|Drug Therapy, Combination|drug therapy, combination
887863|NCT00000967|AIDS-Related Complex|aids-related complex
887864|NCT00000967|Zidovudine|zidovudine
887865|NCT00000967|Interferon Type I|interferon type i
887866|NCT00000966|Toxoplasmosis|toxoplasmosis
887867|NCT00000966|Toxoplasma|toxoplasma
887868|NCT00000966|Pyrimethamine|pyrimethamine
887869|NCT00000966|Leucovorin|leucovorin
887870|NCT00000966|Drug Evaluation|drug evaluation
887871|NCT00000966|Drug Therapy, Combination|drug therapy, combination
887872|NCT00000966|Encephalitis|encephalitis
887873|NCT00000966|Administration, Oral|administration, oral
887874|NCT00000966|Acquired Immunodeficiency Syndrome|acquired immunodeficiency syndrome
887875|NCT00000966|Azithromycin|azithromycin
887876|NCT00000965|Leukocytes, Mononuclear|leukocytes, mononuclear
887877|NCT00000965|Drug Evaluation|drug evaluation
887878|NCT00000965|Acquired Immunodeficiency Syndrome|acquired immunodeficiency syndrome
887879|NCT00000965|AIDS-Related Complex|aids-related complex
887880|NCT00000965|Zidovudine|zidovudine
887881|NCT00000965|Phosphorylation|phosphorylation
887882|NCT00000964|Ranitidine|ranitidine
887883|NCT00000964|Phosphorus Acids|phosphorus acids
887884|NCT00000964|Drug Evaluation|drug evaluation
887885|NCT00000964|Acquired Immunodeficiency Syndrome|acquired immunodeficiency syndrome
887886|NCT00000963|Didanosine|didanosine
887887|NCT00000963|Drug Evaluation|drug evaluation
887888|NCT00000963|Acquired Immunodeficiency Syndrome|acquired immunodeficiency syndrome
887889|NCT00000963|AIDS-Related Complex|aids-related complex
887890|NCT00000963|Zidovudine|zidovudine
887891|NCT00000962|Drug Evaluation|drug evaluation
887892|NCT00000962|Acquired Immunodeficiency Syndrome|acquired immunodeficiency syndrome
887893|NCT00000962|AIDS-Related Complex|aids-related complex
887894|NCT00000962|Nevirapine|nevirapine
887895|NCT00000961|Drug Therapy, Combination|drug therapy, combination
887896|NCT00000961|Zidovudine|zidovudine
887897|NCT00000960|Pregnancy|pregnancy
887898|NCT00000960|Pregnancy Complications, Infectious|pregnancy complications, infectious
887899|NCT00000960|Prenatal Exposure Delayed Effects|prenatal exposure delayed effects
887900|NCT00000960|Administration, Oral|administration, oral
887901|NCT00000960|AIDS-Related Complex|aids-related complex
887902|NCT00000960|Zidovudine|zidovudine
887903|NCT00000959|Tuberculosis|tuberculosis
887904|NCT00000959|Isoniazid|isoniazid
887905|NCT00000959|Pyridoxine|pyridoxine
887906|NCT00000959|AIDS-Related Opportunistic Infections|aids-related opportunistic infections
887907|NCT00000959|Drug Evaluation|drug evaluation
887908|NCT00000959|Acquired Immunodeficiency Syndrome|acquired immunodeficiency syndrome
887909|NCT00000959|Antitubercular Agents|antitubercular agents
887910|NCT00000958|Vaccines, Synthetic|vaccines, synthetic
887911|NCT00000958|Recombinant Proteins|recombinant proteins
887912|NCT00000958|Adjuvants, Immunologic|adjuvants, immunologic
887913|NCT00000958|Acquired Immunodeficiency Syndrome|acquired immunodeficiency syndrome
887914|NCT00000958|HIV Envelope Protein gp120|hiv envelope protein gp120
887915|NCT00000958|AIDS Vaccines|aids vaccines
887916|NCT00000958|HIV Therapeutic Vaccine|hiv therapeutic vaccine
887917|NCT00000957|Vaccines, Synthetic|vaccines, synthetic
887918|NCT00000957|Vaccinia Virus|vaccinia virus
887919|NCT00000957|Viral Vaccines|viral vaccines
887921|NCT00000957|Drug Evaluation|drug evaluation
887922|NCT00000957|HIV Envelope Protein gp160|hiv envelope protein gp160
887923|NCT00000957|Drug Administration Schedule|drug administration schedule
887924|NCT00000957|AIDS Vaccines|aids vaccines
887925|NCT00000957|HIV Seronegativity|hiv seronegativity
887926|NCT00000957|HIV Preventive Vaccine|hiv preventive vaccine
887927|NCT00000956|Vaccines, Synthetic|vaccines, synthetic
887928|NCT00000956|Vaccinia Virus|vaccinia virus
887929|NCT00000956|HIV-1|hiv-1
887930|NCT00000956|HIV Envelope Protein gp160|hiv envelope protein gp160
887931|NCT00000956|AIDS Vaccines|aids vaccines
887932|NCT00000956|HIV Seronegativity|hiv seronegativity
887933|NCT00000956|HIV Preventive Vaccine|hiv preventive vaccine
887934|NCT00000955|Tuberculosis|tuberculosis
887935|NCT00000955|Immunologic Tests|immunologic tests
887936|NCT00000955|Tuberculin|tuberculin
887937|NCT00000955|Tuberculin Test|tuberculin test
887938|NCT00000955|AIDS-Related Opportunistic Infections|aids-related opportunistic infections
887939|NCT00000955|Injections, Intradermal|injections, intradermal
887940|NCT00000955|Acquired Immunodeficiency Syndrome|acquired immunodeficiency syndrome
887941|NCT00000955|AIDS-Related Complex|aids-related complex
887942|NCT00000955|Hypersensitivity, Delayed|hypersensitivity, delayed
887943|NCT00000954|Vincristine|vincristine
887944|NCT00000954|Sarcoma, Kaposi|sarcoma, kaposi
887945|NCT00000954|Zalcitabine|zalcitabine
887946|NCT00000954|Didanosine|didanosine
887947|NCT00000954|Doxorubicin|doxorubicin
887948|NCT00000954|Drug Evaluation|drug evaluation
887949|NCT00000954|Drug Interactions|drug interactions
887950|NCT00000954|Drug Therapy, Combination|drug therapy, combination
887951|NCT00000954|Combined Modality Therapy|combined modality therapy
887952|NCT00000954|Acquired Immunodeficiency Syndrome|acquired immunodeficiency syndrome
887953|NCT00000954|Antineoplastic Agents|antineoplastic agents
887954|NCT00000954|Antineoplastic Agents, Combined|antineoplastic agents, combined
887955|NCT00000954|Antiviral Agents|antiviral agents
887956|NCT00000954|Bleomycin|bleomycin
887957|NCT00000953|Herpes Zoster|herpes zoster
887958|NCT00000953|Acyclovir|acyclovir
887959|NCT00000953|Acquired Immunodeficiency Syndrome|acquired immunodeficiency syndrome
887960|NCT00000953|AIDS-Related Complex|aids-related complex
887961|NCT00000953|Antiviral Agents|antiviral agents
887962|NCT00000953|sorivudine|sorivudine
887963|NCT00000952|Dose-Response Relationship, Drug|dose-response relationship, drug
887964|NCT00000952|Drug Therapy, Combination|drug therapy, combination
887965|NCT00000952|Zidovudine|zidovudine
887966|NCT00000952|HIV Protease Inhibitors|hiv protease inhibitors
887967|NCT00000952|Ritonavir|ritonavir
887968|NCT00000952|Lamivudine|lamivudine
887969|NCT00000952|Anti-HIV Agents|anti-hiv agents
887970|NCT00000951|AIDS-Related Opportunistic Infections|aids-related opportunistic infections
887971|NCT00000951|Fluconazole|fluconazole
887972|NCT00000951|Antifungal Agents|antifungal agents
887973|NCT00000951|Candidiasis, Oral|candidiasis, oral
887974|NCT00000951|Drug Administration Schedule|drug administration schedule
887975|NCT00000951|Pharyngeal Diseases|pharyngeal diseases
887976|NCT00000950|Tuberculosis|tuberculosis
887977|NCT00000950|Isoniazid|isoniazid
887978|NCT00000950|Pyrazinamide|pyrazinamide
887979|NCT00000950|Pyridoxine|pyridoxine
887980|NCT00000950|Rifampin|rifampin
887981|NCT00000950|AIDS-Related Opportunistic Infections|aids-related opportunistic infections
887982|NCT00000950|Drug Therapy, Combination|drug therapy, combination
887983|NCT00000950|Ethambutol|ethambutol
887984|NCT00000950|Acquired Immunodeficiency Syndrome|acquired immunodeficiency syndrome
887985|NCT00000950|Antitubercular Agents|antitubercular agents
887986|NCT00000949|AIDS-Related Opportunistic Infections|aids-related opportunistic infections
887987|NCT00000949|Interleukin-2|interleukin-2
887988|NCT00000949|Dose-Response Relationship, Drug|dose-response relationship, drug
887989|NCT00000949|Adolescent Behavior|adolescent behavior
887990|NCT00000949|CD4 Lymphocyte Count|cd4 lymphocyte count
887991|NCT00000949|RNA, Viral|rna, viral
887992|NCT00000949|Quality of Life|quality of life
887993|NCT00000949|Anti-HIV Agents|anti-hiv agents
887994|NCT00000949|Viral Load|viral load
887995|NCT00000948|Injections, Subcutaneous|injections, subcutaneous
887996|NCT00000948|Interleukin-2|interleukin-2
887997|NCT00000948|Dose-Response Relationship, Drug|dose-response relationship, drug
887998|NCT00000948|Drug Therapy, Combination|drug therapy, combination
887999|NCT00000948|CD4 Lymphocyte Count|cd4 lymphocyte count
888000|NCT00000948|Anti-HIV Agents|anti-hiv agents
888001|NCT00000947|AIDS-Related Opportunistic Infections|aids-related opportunistic infections
888002|NCT00000947|Placebos|placebos
888003|NCT00000947|Mycobacterium avium-intracellulare Infection|mycobacterium avium-intracellulare infection
888004|NCT00000947|Acquired Immunodeficiency Syndrome|acquired immunodeficiency syndrome
888005|NCT00000947|Antitubercular Agents|antitubercular agents
888006|NCT00000947|Azithromycin|azithromycin
888007|NCT00000947|Drug Resistance, Microbial|drug resistance, microbial
888008|NCT00000947|CD4 Lymphocyte Count|cd4 lymphocyte count
888009|NCT00000947|Antibiotics|antibiotics
888010|NCT00000947|Time Factors|time factors
888011|NCT00000947|Anti-HIV Agents|anti-hiv agents
888012|NCT00000947|Pneumonia, Bacterial|pneumonia, bacterial
888013|NCT00000947|Streptococcus pneumoniae|streptococcus pneumoniae
888014|NCT00000946|Drug Evaluation|drug evaluation
888015|NCT00000946|Drug Therapy, Combination|drug therapy, combination
888016|NCT00000946|AIDS Vaccines|aids vaccines
888017|NCT00000946|HIV Seronegativity|hiv seronegativity
888018|NCT00000946|HIV Preventive Vaccine|hiv preventive vaccine
888019|NCT00000945|Leukoencephalopathy, Progressive Multifocal|leukoencephalopathy, progressive multifocal
888020|NCT00000945|Probenecid|probenecid
888021|NCT00000945|HIV-1|hiv-1
888022|NCT00000945|Central Nervous System Diseases|central nervous system diseases
888023|NCT00000945|Acquired Immunodeficiency Syndrome|acquired immunodeficiency syndrome
888024|NCT00000945|DNA, Viral|dna, viral
888025|NCT00000945|cidofovir|cidofovir
888026|NCT00000945|Anti-HIV Agents|anti-hiv agents
888027|NCT00000945|Neurologic Examination|neurologic examination
888028|NCT00000945|Renal Agents|renal agents
888029|NCT00000944|Pregnancy|pregnancy
888030|NCT00000944|Pregnancy Complications, Infectious|pregnancy complications, infectious
888031|NCT00000944|Drug Therapy, Combination|drug therapy, combination
888032|NCT00000944|Zidovudine|zidovudine
888033|NCT00000944|HIV Protease Inhibitors|hiv protease inhibitors
888034|NCT00000944|Lamivudine|lamivudine
888035|NCT00000944|Indinavir|indinavir
888036|NCT00000944|Disease Transmission, Vertical|disease transmission, vertical
888037|NCT00000944|Anti-HIV Agents|anti-hiv agents
888038|NCT00000943|Lymphocytes|lymphocytes
888039|NCT00000943|Interleukin-2|interleukin-2
888040|NCT00000943|Drug Therapy, Combination|drug therapy, combination
888041|NCT00000943|AIDS Vaccines|aids vaccines
888042|NCT00000943|CD4 Lymphocyte Count|cd4 lymphocyte count
888043|NCT00000943|Cell Division|cell division
888044|NCT00000943|HIV Core Protein p24|hiv core protein p24
888045|NCT00000943|Anti-HIV Agents|anti-hiv agents
888046|NCT00000943|HIV Therapeutic Vaccine|hiv therapeutic vaccine
888047|NCT00000942|Placebos|placebos
888048|NCT00000942|Pregnancy|pregnancy
888049|NCT00000942|Pregnancy Complications, Infectious|pregnancy complications, infectious
888051|NCT00000942|Disease Transmission, Vertical|disease transmission, vertical
888052|NCT00000942|Labor|labor
888053|NCT00000942|Anti-HIV Agents|anti-hiv agents
888054|NCT00000941|Drug Interactions|drug interactions
888055|NCT00000941|HIV Protease Inhibitors|hiv protease inhibitors
888056|NCT00000941|Ritonavir|ritonavir
888057|NCT00000941|HIV Seronegativity|hiv seronegativity
888058|NCT00000941|Saquinavir|saquinavir
888059|NCT00000941|Nelfinavir|nelfinavir
888060|NCT00000941|Anticholesteremic Agents|anticholesteremic agents
888061|NCT00000940|Drug Therapy, Combination|drug therapy, combination
888062|NCT00000940|Stavudine|stavudine
888063|NCT00000940|Amprenavir/Ritonavir|amprenavir/ritonavir
888064|NCT00000940|Protease Inhibitors|protease inhibitors
888065|NCT00000940|Lamivudine|lamivudine
888066|NCT00000940|VX 478|vx 478
888067|NCT00000940|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors
888068|NCT00000940|Anti-HIV Agents|anti-hiv agents
888069|NCT00000940|Viral Load|viral load
888070|NCT00000940|Abacavir Sulfate|abacavir sulfate
888071|NCT00000940|Acute Infection|acute infection
888072|NCT00000940|Treatment Interruption|treatment interruption
888073|NCT00000939|Didanosine|didanosine
888074|NCT00000939|Drug Therapy, Combination|drug therapy, combination
888075|NCT00000939|Stavudine|stavudine
888076|NCT00000939|HIV Protease Inhibitors|hiv protease inhibitors
888077|NCT00000939|Hydroxyurea|hydroxyurea
888078|NCT00000939|RNA, Viral|rna, viral
888079|NCT00000939|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors
888080|NCT00000939|Anti-HIV Agents|anti-hiv agents
888081|NCT00000939|Viral Load|viral load
888082|NCT00000939|efavirenz|efavirenz
888083|NCT00000933|AIDS-Related Opportunistic Infections|aids-related opportunistic infections
888084|NCT00000933|Mycobacterium avium-intracellulare Infection|mycobacterium avium-intracellulare infection
888085|NCT00000933|Antibiotics, Macrolide|antibiotics, macrolide
888086|NCT00000933|Azithromycin|azithromycin
888087|NCT00000933|Drug Administration Schedule|drug administration schedule
888088|NCT00000933|Drug Resistance, Microbial|drug resistance, microbial
888089|NCT00000933|Carrier State|carrier state
888090|NCT00000933|Streptococcus pneumoniae|streptococcus pneumoniae
888091|NCT00000932|Prospective Studies|prospective studies
888092|NCT00000932|HIV-1|hiv-1
888093|NCT00000932|Drug Therapy, Combination|drug therapy, combination
888094|NCT00000932|Drug Resistance, Microbial|drug resistance, microbial
888095|NCT00000932|CD4 Lymphocyte Count|cd4 lymphocyte count
888096|NCT00000932|Disease Progression|disease progression
888097|NCT00000932|Treatment Outcome|treatment outcome
888098|NCT00000932|Genotype|genotype
888099|NCT00000932|Anti-HIV Agents|anti-hiv agents
888100|NCT00000932|Viral Load|viral load
888101|NCT00000931|Homosexuality, Male|homosexuality, male
888102|NCT00000931|Risk-Taking|risk-taking
888103|NCT00000931|Behavior Therapy|behavior therapy
888104|NCT00000931|HIV Seronegativity|hiv seronegativity
888105|NCT00000930|Sexual Partners|sexual partners
888106|NCT00000930|Drug Resistance, Microbial|drug resistance, microbial
888107|NCT00000930|Cohort Studies|cohort studies
888108|NCT00000930|Risk Factors|risk factors
888109|NCT00000930|Substance Abuse, Intravenous|substance abuse, intravenous
888110|NCT00000930|Disease Progression|disease progression
888111|NCT00000930|Homosexuality, Male|homosexuality, male
888112|NCT00000930|Genotype|genotype
888113|NCT00000930|Phenotype|phenotype
888114|NCT00000929|Sexual Partners|sexual partners
888115|NCT00000929|Homosexuality, Male|homosexuality, male
888116|NCT00000929|Anti-Infective Agents|anti-infective agents
888117|NCT00000929|Patient Compliance|patient compliance
888118|NCT00000929|Nonoxynol|nonoxynol
888119|NCT00000929|Rectum|rectum
888120|NCT00000928|Sexual Partners|sexual partners
888121|NCT00000928|Condoms|condoms
888122|NCT00000928|Counseling|counseling
888123|NCT00000927|Administration, Topical|administration, topical
888124|NCT00000927|Mucous Membrane|mucous membrane
888125|NCT00000927|Anti-Infective Agents|anti-infective agents
888126|NCT00000927|Cervix Uteri|cervix uteri
888127|NCT00000927|Vagina|vagina
888128|NCT00000927|Vulva|vulva
888129|NCT00000927|Buffers|buffers
888130|NCT00000926|Nonoxynol|nonoxynol
888131|NCT00000925|Dietary Proteins|dietary proteins
888132|NCT00000925|HIV Wasting Syndrome|hiv wasting syndrome
888133|NCT00000924|Drug Therapy, Combination|drug therapy, combination
888134|NCT00000924|HIV Protease Inhibitors|hiv protease inhibitors
888135|NCT00000924|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors
888136|NCT00000924|Anti-HIV Agents|anti-hiv agents
888137|NCT00000923|Interleukin-2|interleukin-2
888138|NCT00000923|Drug Therapy, Combination|drug therapy, combination
888139|NCT00000923|CD4 Lymphocyte Count|cd4 lymphocyte count
888140|NCT00000923|Anti-HIV Agents|anti-hiv agents
888141|NCT00000923|Viral Load|viral load
888142|NCT00000922|Drug Therapy, Combination|drug therapy, combination
888143|NCT00000922|HIV Protease Inhibitors|hiv protease inhibitors
888144|NCT00000922|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors
888145|NCT00000922|Anti-HIV Agents|anti-hiv agents
888146|NCT00000922|Treatment Naive|treatment naive
888147|NCT00000921|Drug Therapy, Combination|drug therapy, combination
888148|NCT00000921|Prednisone|prednisone
888149|NCT00000921|Anti-HIV Agents|anti-hiv agents
888150|NCT00000920|Pregnancy|pregnancy
888151|NCT00000920|Drug Therapy, Combination|drug therapy, combination
888152|NCT00000920|Zidovudine|zidovudine
888153|NCT00000920|Pregnancy Complications|pregnancy complications
888154|NCT00000920|Ritonavir|ritonavir
888155|NCT00000920|Lamivudine|lamivudine
888156|NCT00000920|Saquinavir|saquinavir
888157|NCT00000920|Anti-HIV Agents|anti-hiv agents
888158|NCT00000919|HIV Protease Inhibitors|hiv protease inhibitors
888159|NCT00000919|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors
888160|NCT00000919|Anti-HIV Agents|anti-hiv agents
888161|NCT00000919|Viral Load|viral load
888162|NCT00000918|Drug Therapy, Combination|drug therapy, combination
888163|NCT00000918|HIV Protease Inhibitors|hiv protease inhibitors
888164|NCT00000918|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors
888165|NCT00000918|Salvage Therapy|salvage therapy
888166|NCT00000918|Anti-HIV Agents|anti-hiv agents
888167|NCT00000918|Viral Load|viral load
888168|NCT00000917|Gene Therapy|gene therapy
888169|NCT00000917|Specimen Handling|specimen handling
888170|NCT00000917|Blood Banks|blood banks
888171|NCT00000917|Fetal Blood|fetal blood
888172|NCT00000916|Drug Therapy, Combination|drug therapy, combination
888173|NCT00000916|HIV Protease Inhibitors|hiv protease inhibitors
888174|NCT00000916|Hydroxyurea|hydroxyurea
888175|NCT00000916|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors
888176|NCT00000916|Anti-HIV Agents|anti-hiv agents
888177|NCT00000916|Viral Load|viral load
888178|NCT00000915|AIDS Vaccines|aids vaccines
888179|NCT00000915|Incidence|incidence
888180|NCT00000915|Knowledge, Attitudes, Practice|knowledge, attitudes, practice
888181|NCT00000915|Risk-Taking|risk-taking
888182|NCT00000914|Drug Therapy, Combination|drug therapy, combination
888183|NCT00000914|HIV Protease Inhibitors|hiv protease inhibitors
888184|NCT00000914|Ritonavir|ritonavir
888185|NCT00000914|Indinavir|indinavir
888186|NCT00000914|Saquinavir|saquinavir
888187|NCT00000914|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors
888188|NCT00000914|Viral Load|viral load
888189|NCT00000914|Nelfinavir|nelfinavir
888190|NCT00000913|Saquinavir|saquinavir
888191|NCT00000913|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors
888192|NCT00000913|Anti-HIV Agents|anti-hiv agents
888193|NCT00000913|Viral Load|viral load
888194|NCT00000912|Placebos|placebos
888195|NCT00000912|Drug Therapy, Combination|drug therapy, combination
888196|NCT00000912|HIV Protease Inhibitors|hiv protease inhibitors
888197|NCT00000912|VX 478|vx 478
888198|NCT00000912|Anti-HIV Agents|anti-hiv agents
888199|NCT00000912|Viral Load|viral load
888200|NCT00000912|efavirenz|efavirenz
888201|NCT00000911|Semen|semen
888202|NCT00000911|HIV-1|hiv-1
888203|NCT00000911|Immunity, Cellular|immunity, cellular
888204|NCT00000911|Lymph Nodes|lymph nodes
888205|NCT00000911|Viremia|viremia
888206|NCT00000911|Antibodies, Viral|antibodies, viral
888207|NCT00000911|Vagina|vagina
888208|NCT00000911|Viral Load|viral load
888209|NCT00000911|Acute Infection|acute infection
888210|NCT00000910|Pregnancy|pregnancy
888211|NCT00000910|Anti-HIV Agents|anti-hiv agents
888212|NCT00000909|Interleukin-2|interleukin-2
888213|NCT00000909|Dose-Response Relationship, Drug|dose-response relationship, drug
888214|NCT00000909|CD4 Lymphocyte Count|cd4 lymphocyte count
888215|NCT00000909|RNA, Viral|rna, viral
888216|NCT00000908|AIDS-Related Opportunistic Infections|aids-related opportunistic infections
888217|NCT00000908|Pneumonia, Pneumocystis carinii|pneumonia, pneumocystis carinii
888218|NCT00000908|Antiviral Agents|antiviral agents
888219|NCT00000908|CD4 Lymphocyte Count|cd4 lymphocyte count
888221|NCT00000907|AIDS-Related Opportunistic Infections|aids-related opportunistic infections
888222|NCT00000907|Mycobacterium avium-intracellulare Infection|mycobacterium avium-intracellulare infection
888223|NCT00000907|Immunity, Cellular|immunity, cellular
888224|NCT00000907|Antibiotics, Macrolide|antibiotics, macrolide
888225|NCT00000907|Mycobacterium avium Complex|mycobacterium avium complex
888226|NCT00000907|CD4 Lymphocyte Count|cd4 lymphocyte count
888227|NCT00000907|Disease Progression|disease progression
888228|NCT00000907|Anti-HIV Agents|anti-hiv agents
888229|NCT00000906|Methadone|methadone
888230|NCT00000906|HIV-1|hiv-1
888231|NCT00000906|Dose-Response Relationship, Drug|dose-response relationship, drug
888232|NCT00000906|Drug Interactions|drug interactions
888233|NCT00000906|Drug Therapy, Combination|drug therapy, combination
888234|NCT00000906|Saquinavir|saquinavir
888235|NCT00000906|Adolescent Behavior|adolescent behavior
888236|NCT00000906|HIV Protease Inhibitors|hiv protease inhibitors
888237|NCT00000906|Ritonavir|ritonavir
888238|NCT00000906|Narcotics|narcotics
888239|NCT00000906|Substance-Related Disorders|substance-related disorders
888240|NCT00000905|Immunity, Cellular|immunity, cellular
888241|NCT00000905|Disease Progression|disease progression
888242|NCT00000905|Cytomegalovirus Retinitis|cytomegalovirus retinitis
888243|NCT00000905|DNA, Viral|dna, viral
888244|NCT00000905|Prognosis|prognosis
888245|NCT00000904|Vaccines, Synthetic|vaccines, synthetic
888246|NCT00000904|Viral Vaccines|viral vaccines
888247|NCT00000904|HIV Antibodies|hiv antibodies
888248|NCT00000904|HIV Envelope Protein gp160|hiv envelope protein gp160
888249|NCT00000904|AIDS Vaccines|aids vaccines
888250|NCT00000904|T-Lymphocytes, Cytotoxic|t-lymphocytes, cytotoxic
888251|NCT00000904|HIV Seronegativity|hiv seronegativity
888252|NCT00000904|Antibody Formation|antibody formation
888253|NCT00000904|Risk-Taking|risk-taking
888254|NCT00000904|Avipoxvirus|avipoxvirus
888255|NCT00000904|Genetic Vectors|genetic vectors
888256|NCT00000904|Immunization|immunization
888257|NCT00000904|HIV Preventive Vaccine|hiv preventive vaccine
888258|NCT00000903|Drug Therapy, Combination|drug therapy, combination
888259|NCT00000903|Zidovudine|zidovudine
888260|NCT00000903|HIV Protease Inhibitors|hiv protease inhibitors
888261|NCT00000903|Lamivudine|lamivudine
888262|NCT00000903|Indinavir|indinavir
888263|NCT00000903|RNA, Viral|rna, viral
888264|NCT00000903|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors
888265|NCT00000903|Nelfinavir|nelfinavir
888266|NCT00000903|efavirenz|efavirenz
888267|NCT00000902|Zalcitabine|zalcitabine
888268|NCT00000902|Didanosine|didanosine
888269|NCT00000902|Drug Therapy, Combination|drug therapy, combination
888270|NCT00000902|Zidovudine|zidovudine
888271|NCT00000902|Nevirapine|nevirapine
888272|NCT00000902|Stavudine|stavudine
888273|NCT00000902|Ritonavir|ritonavir
888274|NCT00000902|Lamivudine|lamivudine
888275|NCT00000902|RNA, Viral|rna, viral
888276|NCT00000902|Anti-HIV Agents|anti-hiv agents
888277|NCT00000902|Nelfinavir|nelfinavir
888278|NCT00000901|Dose-Response Relationship, Drug|dose-response relationship, drug
888279|NCT00000901|Drug Therapy, Combination|drug therapy, combination
888280|NCT00000901|Stavudine|stavudine
888281|NCT00000901|HIV Protease Inhibitors|hiv protease inhibitors
888282|NCT00000901|Lamivudine|lamivudine
888283|NCT00000901|Indinavir|indinavir
888284|NCT00000901|RNA, Viral|rna, viral
888285|NCT00000901|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors
888286|NCT00000901|Viral Load|viral load
888287|NCT00000900|AIDS-Related Opportunistic Infections|aids-related opportunistic infections
888288|NCT00000900|HIV-1|hiv-1
888289|NCT00000900|Antiviral Agents|antiviral agents
888290|NCT00000900|CD4 Lymphocyte Count|cd4 lymphocyte count
888291|NCT00000900|Polymerase Chain Reaction|polymerase chain reaction
888292|NCT00000900|RNA, Viral|rna, viral
888293|NCT00000900|Fever|fever
888294|NCT00000900|Viral Load|viral load
888295|NCT00000899|Cyclophosphamide|cyclophosphamide
888296|NCT00000899|Dose-Response Relationship, Drug|dose-response relationship, drug
888297|NCT00000899|Drug Therapy, Combination|drug therapy, combination
888298|NCT00000899|Granulocyte Colony-Stimulating Factor|granulocyte colony-stimulating factor
888299|NCT00000899|Combined Modality Therapy|combined modality therapy
888300|NCT00000899|Antineoplastic Agents|antineoplastic agents
888301|NCT00000899|Lymph Nodes|lymph nodes
888302|NCT00000899|Stavudine|stavudine
888303|NCT00000899|HIV Protease Inhibitors|hiv protease inhibitors
888304|NCT00000899|Lamivudine|lamivudine
888305|NCT00000899|DNA, Viral|dna, viral
888306|NCT00000899|RNA, Viral|rna, viral
888307|NCT00000899|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors
888308|NCT00000899|Anti-HIV Agents|anti-hiv agents
888309|NCT00000899|Nelfinavir|nelfinavir
888310|NCT00000899|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating
888311|NCT00000898|Drug Interactions|drug interactions
888312|NCT00000898|Drug Therapy, Combination|drug therapy, combination
888313|NCT00000898|Saquinavir|saquinavir
888314|NCT00000898|HIV Protease Inhibitors|hiv protease inhibitors
888315|NCT00000898|Ritonavir|ritonavir
888316|NCT00000898|Nelfinavir|nelfinavir
888317|NCT00000897|Drug Interactions|drug interactions
888318|NCT00000897|Zidovudine|zidovudine
888320|NCT00000897|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors
888321|NCT00000897|Contraceptives, Oral|contraceptives, oral
888322|NCT00000897|Progestational Hormones, Synthetic|progestational hormones, synthetic
888323|NCT00000897|Anti-HIV Agents|anti-hiv agents
888324|NCT00000897|Viral Load|viral load
888325|NCT00000897|Estrogens|estrogens
888326|NCT00000896|HIV-1|hiv-1
888327|NCT00000896|Drug Therapy, Combination|drug therapy, combination
888328|NCT00000896|Granulocyte Colony-Stimulating Factor|granulocyte colony-stimulating factor
888329|NCT00000896|Acquired Immunodeficiency Syndrome|acquired immunodeficiency syndrome
888330|NCT00000896|Zidovudine|zidovudine
888331|NCT00000896|Nevirapine|nevirapine
888332|NCT00000896|Stavudine|stavudine
888333|NCT00000896|HIV Protease Inhibitors|hiv protease inhibitors
888334|NCT00000896|Lamivudine|lamivudine
888335|NCT00000896|Indinavir|indinavir
888336|NCT00000896|Interleukin-12|interleukin-12
888337|NCT00000896|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors
888338|NCT00000895|AIDS-Related Opportunistic Infections|aids-related opportunistic infections
888339|NCT00000895|Mycobacterium avium-intracellulare Infection|mycobacterium avium-intracellulare infection
888340|NCT00000895|HIV-1|hiv-1
888341|NCT00000895|Drug Therapy, Combination|drug therapy, combination
888342|NCT00000895|Acquired Immunodeficiency Syndrome|acquired immunodeficiency syndrome
888343|NCT00000895|Mycobacterium avium Complex|mycobacterium avium complex
888344|NCT00000895|Bacteremia|bacteremia
888345|NCT00000895|Nevirapine|nevirapine
888346|NCT00000895|HIV Protease Inhibitors|hiv protease inhibitors
888347|NCT00000895|Risk Factors|risk factors
888348|NCT00000895|RNA, Viral|rna, viral
888349|NCT00000895|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors
888350|NCT00000895|Nelfinavir|nelfinavir
888351|NCT00000894|Infusions, Intravenous|infusions, intravenous
888352|NCT00000894|Ganciclovir|ganciclovir
888353|NCT00000894|Drug Therapy, Combination|drug therapy, combination
888354|NCT00000894|Administration, Oral|administration, oral
888355|NCT00000894|Antiviral Agents|antiviral agents
888356|NCT00000894|Drug Implants|drug implants
888357|NCT00000894|Cytomegalovirus Retinitis|cytomegalovirus retinitis
888359|NCT00000894|cidofovir|cidofovir
888360|NCT00000893|Dose-Response Relationship, Drug|dose-response relationship, drug
888361|NCT00000893|Drug Therapy, Combination|drug therapy, combination
888362|NCT00000893|HIV Protease Inhibitors|hiv protease inhibitors
888363|NCT00000893|Nelfinavir|nelfinavir
888364|NCT00000893|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors
888365|NCT00000893|Area Under Curve|area under curve
888366|NCT00000893|efavirenz|efavirenz
888367|NCT00000892|HIV-1|hiv-1
888368|NCT00000892|Drug Therapy, Combination|drug therapy, combination
888369|NCT00000892|HIV Protease Inhibitors|hiv protease inhibitors
888370|NCT00000892|Ritonavir|ritonavir
888371|NCT00000892|Indinavir|indinavir
888372|NCT00000892|RNA, Viral|rna, viral
888373|NCT00000892|Saquinavir|saquinavir
888374|NCT00000892|Delavirdine|delavirdine
888375|NCT00000892|Nelfinavir|nelfinavir
888376|NCT00000892|Adenine|adenine
888377|NCT00000892|Anti-HIV Agents|anti-hiv agents
888378|NCT00000892|Viral Load|viral load
888379|NCT00000891|Drug Therapy, Combination|drug therapy, combination
888380|NCT00000891|Hypersensitivity, Delayed|hypersensitivity, delayed
888381|NCT00000891|Follow-Up Studies|follow-up studies
888382|NCT00000891|Anti-HIV Agents|anti-hiv agents
888383|NCT00000891|Viral Load|viral load
888384|NCT00000890|HIV-1|hiv-1
888385|NCT00000890|Muscles|muscles
888386|NCT00000890|RNA, Viral|rna, viral
888387|NCT00000890|Body Composition|body composition
888388|NCT00000890|Anti-HIV Agents|anti-hiv agents
888389|NCT00000890|Viral Load|viral load
888390|NCT00000889|Interleukin-2|interleukin-2
888391|NCT00000889|CD4 Lymphocyte Count|cd4 lymphocyte count
888392|NCT00000889|Anti-HIV Agents|anti-hiv agents
888393|NCT00000888|Pregnancy|pregnancy
888394|NCT00000888|Pregnancy Complications, Infectious|pregnancy complications, infectious
888395|NCT00000888|Drug Therapy, Combination|drug therapy, combination
888396|NCT00000888|Administration, Oral|administration, oral
888397|NCT00000888|Zidovudine|zidovudine
888398|NCT00000888|HIV Protease Inhibitors|hiv protease inhibitors
888399|NCT00000888|Ritonavir|ritonavir
888400|NCT00000888|Disease Transmission, Vertical|disease transmission, vertical
888401|NCT00000888|Anti-HIV Agents|anti-hiv agents
888402|NCT00000888|Fetal Blood|fetal blood
888403|NCT00000887|Pregnancy|pregnancy
888404|NCT00000887|Pregnancy Complications, Infectious|pregnancy complications, infectious
888405|NCT00000887|Drug Therapy, Combination|drug therapy, combination
888406|NCT00000887|Zidovudine|zidovudine
888407|NCT00000887|HIV Protease Inhibitors|hiv protease inhibitors
888408|NCT00000887|Lamivudine|lamivudine
888409|NCT00000887|Disease Transmission, Vertical|disease transmission, vertical
888410|NCT00000887|Nelfinavir|nelfinavir
888411|NCT00000887|Anti-HIV Agents|anti-hiv agents
888412|NCT00000886|HIV Antibodies|hiv antibodies
888413|NCT00000886|HIV Envelope Protein gp120|hiv envelope protein gp120
888414|NCT00000886|Drug Carriers|drug carriers
888415|NCT00000886|Hypersensitivity, Delayed|hypersensitivity, delayed
888416|NCT00000886|AIDS Vaccines|aids vaccines
888417|NCT00000886|CD4-Positive T-Lymphocytes|cd4-positive t-lymphocytes
888418|NCT00000886|CD8-Positive T-Lymphocytes|cd8-positive t-lymphocytes
888419|NCT00000886|HIV Seronegativity|hiv seronegativity
888420|NCT00000886|Neutralization Tests|neutralization tests
888421|NCT00000886|Mineral Oil|mineral oil
888422|NCT00000886|Oleic Acids|oleic acids
888423|NCT00000886|Mannose|mannose
888424|NCT00000886|HLA-B7 Antigen|hla-b7 antigen
888425|NCT00000886|HLA-A2 Antigen|hla-a2 antigen
888426|NCT00000886|HIV Preventive Vaccine|hiv preventive vaccine
888427|NCT00000885|HIV-1|hiv-1
888428|NCT00000885|Drug Therapy, Combination|drug therapy, combination
888429|NCT00000885|Zidovudine|zidovudine
888430|NCT00000885|HIV Protease Inhibitors|hiv protease inhibitors
888431|NCT00000885|Lamivudine|lamivudine
888432|NCT00000885|Indinavir|indinavir
888433|NCT00000885|RNA, Viral|rna, viral
888434|NCT00000885|Treatment Failure|treatment failure
888435|NCT00000885|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors
888436|NCT00000885|Anti-HIV Agents|anti-hiv agents
888437|NCT00000885|Viral Load|viral load
888438|NCT00000884|Vaccines, Synthetic|vaccines, synthetic
888439|NCT00000884|Injections, Intramuscular|injections, intramuscular
888440|NCT00000884|HIV-1|hiv-1
888441|NCT00000884|Immunity, Cellular|immunity, cellular
888442|NCT00000884|AIDS Vaccines|aids vaccines
888443|NCT00000884|HIV Seronegativity|hiv seronegativity
888444|NCT00000884|Mucous Membrane|mucous membrane
888445|NCT00000884|Antibodies, Viral|antibodies, viral
888446|NCT00000884|Avipoxvirus|avipoxvirus
888447|NCT00000884|Genetic Vectors|genetic vectors
888448|NCT00000884|HIV Envelope Protein gp120|hiv envelope protein gp120
888449|NCT00000884|Immunity, Mucosal|immunity, mucosal
888450|NCT00000884|Rabies Vaccines|rabies vaccines
888451|NCT00000884|HIV Preventive Vaccine|hiv preventive vaccine
888452|NCT00000883|AIDS-Related Opportunistic Infections|aids-related opportunistic infections
888453|NCT00000883|Mycobacterium avium-intracellulare Infection|mycobacterium avium-intracellulare infection
888454|NCT00000883|Antibiotics, Macrolide|antibiotics, macrolide
888455|NCT00000883|Acquired Immunodeficiency Syndrome|acquired immunodeficiency syndrome
888456|NCT00000883|Azithromycin|azithromycin
888457|NCT00000883|CD4 Lymphocyte Count|cd4 lymphocyte count
888458|NCT00000883|Anti-HIV Agents|anti-hiv agents
888459|NCT00000882|HIV-1|hiv-1
888460|NCT00000882|Drug Therapy, Combination|drug therapy, combination
888461|NCT00000882|Stavudine|stavudine
888462|NCT00000882|HIV Protease Inhibitors|hiv protease inhibitors
888463|NCT00000882|Lamivudine|lamivudine
888464|NCT00000882|Indinavir|indinavir
888465|NCT00000882|RNA, Viral|rna, viral
888466|NCT00000882|Delavirdine|delavirdine
888467|NCT00000882|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors
888468|NCT00000882|Anti-HIV Agents|anti-hiv agents
888469|NCT00000882|Viral Load|viral load
888470|NCT00000881|AIDS-Related Opportunistic Infections|aids-related opportunistic infections
888471|NCT00000881|Cytomegalovirus Infections|cytomegalovirus infections
888472|NCT00000881|Antiviral Agents|antiviral agents
888473|NCT00000881|cidofovir|cidofovir
888474|NCT00000880|T-Lymphocytes|t-lymphocytes
888475|NCT00000880|Lymphocyte Transformation|lymphocyte transformation
888476|NCT00000880|HIV-1|hiv-1
888477|NCT00000880|Drug Therapy, Combination|drug therapy, combination
888478|NCT00000880|Immunosuppressive Agents|immunosuppressive agents
888479|NCT00000880|Apoptosis|apoptosis
888480|NCT00000880|Cyclosporine|cyclosporine
888481|NCT00000880|Anti-HIV Agents|anti-hiv agents
888482|NCT00000879|Pregnancy|pregnancy
888483|NCT00000879|Pregnancy Complications, Infectious|pregnancy complications, infectious
888484|NCT00000879|AIDS Vaccines|aids vaccines
888485|NCT00000879|Disease Transmission, Vertical|disease transmission, vertical
888486|NCT00000879|Avipoxvirus|avipoxvirus
888487|NCT00000879|HIV Preventive Vaccine|hiv preventive vaccine
888488|NCT00000879|HIV Therapeutic Vaccine|hiv therapeutic vaccine
888489|NCT00000878|Pregnancy|pregnancy
888490|NCT00000878|Pregnancy Complications, Infectious|pregnancy complications, infectious
888491|NCT00000878|Drug Therapy, Combination|drug therapy, combination
888492|NCT00000878|Stavudine|stavudine
888493|NCT00000878|Lamivudine|lamivudine
888494|NCT00000878|Disease Transmission, Vertical|disease transmission, vertical
888495|NCT00000878|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors
888496|NCT00000878|Anti-HIV Agents|anti-hiv agents
888497|NCT00000878|Viral Load|viral load
888498|NCT00000877|Rifabutin|rifabutin
888499|NCT00000877|Drug Therapy, Combination|drug therapy, combination
888500|NCT00000877|HIV Protease Inhibitors|hiv protease inhibitors
888501|NCT00000877|Indinavir|indinavir
888502|NCT00000877|HIV Seronegativity|hiv seronegativity
888503|NCT00000877|Anti-HIV Agents|anti-hiv agents
888504|NCT00000876|Antiviral Agents|antiviral agents
888505|NCT00000876|CD4-IgG(2)|cd4-igg(2)
888506|NCT00000876|PRO 542|pro 542
888507|NCT00000875|Drug Therapy, Combination|drug therapy, combination
888508|NCT00000875|Immunotherapy, Adoptive|immunotherapy, adoptive
888509|NCT00000875|T-Lymphocytes, Cytotoxic|t-lymphocytes, cytotoxic
888510|NCT00000875|Anti-HIV Agents|anti-hiv agents
888511|NCT00000875|Viral Load|viral load
888512|NCT00000874|HIV-1|hiv-1
888513|NCT00000874|Drug Therapy, Combination|drug therapy, combination
888516|NCT00000874|Drug Resistance, Microbial|drug resistance, microbial
888517|NCT00000874|HIV Protease Inhibitors|hiv protease inhibitors
888518|NCT00000874|CD4 Lymphocyte Count|cd4 lymphocyte count
888519|NCT00000874|Ritonavir|ritonavir
888520|NCT00000874|Lamivudine|lamivudine
888521|NCT00000874|Indinavir|indinavir
888522|NCT00000874|RNA, Viral|rna, viral
888523|NCT00000874|Genotype|genotype
888524|NCT00000874|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors
888525|NCT00000874|Anti-HIV Agents|anti-hiv agents
888526|NCT00000874|Viral Load|viral load
888527|NCT00000873|Nutritional Status|nutritional status
888528|NCT00000873|HIV Seronegativity|hiv seronegativity
888529|NCT00000873|Infant Food|infant food
888530|NCT00000872|Virus Replication|virus replication
888531|NCT00000872|HIV-1|hiv-1
888532|NCT00000872|Drug Therapy, Combination|drug therapy, combination
888533|NCT00000872|Zidovudine|zidovudine
888534|NCT00000872|Nevirapine|nevirapine
888535|NCT00000872|Stavudine|stavudine
888536|NCT00000872|HIV Protease Inhibitors|hiv protease inhibitors
888537|NCT00000872|CD4 Lymphocyte Count|cd4 lymphocyte count
888538|NCT00000872|Lamivudine|lamivudine
888539|NCT00000872|RNA, Viral|rna, viral
888540|NCT00000872|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors
888541|NCT00000872|Anti-HIV Agents|anti-hiv agents
888542|NCT00000872|Viral Load|viral load
888543|NCT00000872|Nelfinavir|nelfinavir
888544|NCT00000871|Vaccines, Synthetic|vaccines, synthetic
888545|NCT00000871|AIDS Vaccines|aids vaccines
888546|NCT00000871|HIV Seronegativity|hiv seronegativity
888547|NCT00000871|Avipoxvirus|avipoxvirus
888548|NCT00000871|HIV Preventive Vaccine|hiv preventive vaccine
888549|NCT00000870|Recombinant Proteins|recombinant proteins
888550|NCT00000870|Infusions, Intravenous|infusions, intravenous
888551|NCT00000870|Injections, Intravenous|injections, intravenous
888552|NCT00000870|Injections, Subcutaneous|injections, subcutaneous
888553|NCT00000870|Interleukin-2|interleukin-2
888554|NCT00000870|Drug Administration Schedule|drug administration schedule
888555|NCT00000870|CD4 Lymphocyte Count|cd4 lymphocyte count
888556|NCT00000870|Quality of Life|quality of life
888557|NCT00000870|Anti-HIV Agents|anti-hiv agents
888558|NCT00000869|Pregnancy Trimester, Third|pregnancy trimester, third
888559|NCT00000869|Placebos|placebos
888560|NCT00000869|Pregnancy|pregnancy
888561|NCT00000869|Pregnancy Complications, Infectious|pregnancy complications, infectious
888562|NCT00000869|Administration, Oral|administration, oral
888563|NCT00000869|Nevirapine|nevirapine
888564|NCT00000869|Disease Transmission, Vertical|disease transmission, vertical
888565|NCT00000869|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors
888566|NCT00000869|Anti-HIV Agents|anti-hiv agents
888567|NCT00000868|Vaccines, Synthetic|vaccines, synthetic
888568|NCT00000868|HIV-1|hiv-1
888569|NCT00000868|Administration, Oral|administration, oral
888570|NCT00000868|AIDS Vaccines|aids vaccines
888571|NCT00000868|HIV Seronegativity|hiv seronegativity
888572|NCT00000868|HIV Envelope Protein gp120|hiv envelope protein gp120
888573|NCT00000868|Recombination, Genetic|recombination, genetic
888574|NCT00000868|Salmonella typhi|salmonella typhi
888575|NCT00000868|HIV Preventive Vaccine|hiv preventive vaccine
888576|NCT00000867|Drug Therapy, Combination|drug therapy, combination
888577|NCT00000867|Administration, Oral|administration, oral
888578|NCT00000867|AIDS Dementia Complex|aids dementia complex
888579|NCT00000867|Zidovudine|zidovudine
888580|NCT00000867|Anti-HIV Agents|anti-hiv agents
888581|NCT00000867|Memantine|memantine
888582|NCT00000866|Vaccines, Synthetic|vaccines, synthetic
888583|NCT00000866|Vaccinia Virus|vaccinia virus
888584|NCT00000866|Placebos|placebos
888585|NCT00000866|HIV-1|hiv-1
888586|NCT00000866|AIDS Vaccines|aids vaccines
888587|NCT00000866|HIV Seronegativity|hiv seronegativity
888588|NCT00000866|Genes, env|genes, env
888589|NCT00000866|Genes, pol|genes, pol
888590|NCT00000866|Genes, gag|genes, gag
888591|NCT00000866|HIV Preventive Vaccine|hiv preventive vaccine
888592|NCT00000865|Drug Therapy, Combination|drug therapy, combination
888593|NCT00000865|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors
888594|NCT00000865|Anti-HIV Agents|anti-hiv agents
888595|NCT00000864|Pregnancy|pregnancy
888596|NCT00000864|Pregnancy Complications, Infectious|pregnancy complications, infectious
888597|NCT00000864|HIV-1|hiv-1
888598|NCT00000864|Drug Therapy, Combination|drug therapy, combination
888599|NCT00000864|Zidovudine|zidovudine
888600|NCT00000864|Drug Administration Schedule|drug administration schedule
888601|NCT00000864|Disease Transmission, Vertical|disease transmission, vertical
888602|NCT00000864|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors
888603|NCT00000864|Anti-HIV Agents|anti-hiv agents
888604|NCT00000863|AIDS-Related Opportunistic Infections|aids-related opportunistic infections
888605|NCT00000863|Pneumonia, Pneumocystis carinii|pneumonia, pneumocystis carinii
888606|NCT00000863|Administration, Oral|administration, oral
888607|NCT00000863|WR 6026|wr 6026
888608|NCT00000862|Pregnancy|pregnancy
888609|NCT00000862|Pregnancy Complications, Infectious|pregnancy complications, infectious
888610|NCT00000862|Administration, Oral|administration, oral
888611|NCT00000862|Zidovudine|zidovudine
888612|NCT00000862|Delivery|delivery
888614|NCT00000862|Anti-HIV Agents|anti-hiv agents
888615|NCT00000861|Drug Administration Schedule|drug administration schedule
888616|NCT00000861|HIV Protease Inhibitors|hiv protease inhibitors
888617|NCT00000861|CD4 Lymphocyte Count|cd4 lymphocyte count
888618|NCT00000861|Indinavir|indinavir
888619|NCT00000861|RNA, Viral|rna, viral
888620|NCT00000861|Anti-HIV Agents|anti-hiv agents
888621|NCT00000861|Viral Load|viral load
888622|NCT00000860|Tumor Necrosis Factor|tumor necrosis factor
888623|NCT00000860|AIDS-Related Opportunistic Infections|aids-related opportunistic infections
888624|NCT00000860|Mycobacterium avium-intracellulare Infection|mycobacterium avium-intracellulare infection
888625|NCT00000860|Drug Therapy, Combination|drug therapy, combination
888626|NCT00000860|Anti-HIV Agents|anti-hiv agents
888627|NCT00000859|HIV-1|hiv-1
888628|NCT00000859|Drug Resistance|drug resistance
888629|NCT00000859|Drug Therapy, Combination|drug therapy, combination
888630|NCT00000859|HIV Protease Inhibitors|hiv protease inhibitors
888631|NCT00000859|CD4 Lymphocyte Count|cd4 lymphocyte count
888632|NCT00000859|Ritonavir|ritonavir
888633|NCT00000859|Indinavir|indinavir
888634|NCT00000859|Disease Progression|disease progression
888635|NCT00000859|RNA, Viral|rna, viral
888636|NCT00000859|Genotype|genotype
888637|NCT00000859|Nelfinavir|nelfinavir
888638|NCT00000859|Anti-HIV Agents|anti-hiv agents
888639|NCT00000859|Viral Load|viral load
888640|NCT00000858|HIV-1|hiv-1
888641|NCT00000858|Vagina|vagina
888642|NCT00000857|Recombinant Proteins|recombinant proteins
888643|NCT00000857|T-Lymphocytes|t-lymphocytes
888644|NCT00000857|Dose-Response Relationship, Drug|dose-response relationship, drug
888645|NCT00000857|Mycobacterium avium Complex|mycobacterium avium complex
888646|NCT00000857|CD4 Lymphocyte Count|cd4 lymphocyte count
888647|NCT00000857|Interleukin-12|interleukin-12
888648|NCT00000857|Killer Cells, Natural|killer cells, natural
888649|NCT00000857|Th1 Cells|th1 cells
888650|NCT00000857|Interferon Type II|interferon type ii
888651|NCT00000856|AIDS-Related Opportunistic Infections|aids-related opportunistic infections
888652|NCT00000856|Ganciclovir|ganciclovir
888653|NCT00000856|Drug Therapy, Combination|drug therapy, combination
888654|NCT00000856|Encephalitis|encephalitis
888655|NCT00000856|Foscarnet|foscarnet
888656|NCT00000856|Cytomegalovirus Infections|cytomegalovirus infections
888657|NCT00000856|Antiviral Agents|antiviral agents
888658|NCT00000856|Radiculopathy|radiculopathy
888659|NCT00000855|Zidovudine|zidovudine
888660|NCT00000855|Anti-HIV Agents|anti-hiv agents
888661|NCT00000854|Placebos|placebos
888662|NCT00000854|Acquired Immunodeficiency Syndrome|acquired immunodeficiency syndrome
888663|NCT00000854|AIDS-Related Complex|aids-related complex
888664|NCT00000854|Anabolic Steroids|anabolic steroids
888665|NCT00000854|HIV Wasting Syndrome|hiv wasting syndrome
888666|NCT00000854|nandrolone decanoate|nandrolone decanoate
888667|NCT00000853|Vaccines, Synthetic|vaccines, synthetic
888668|NCT00000853|HIV-1|hiv-1
888669|NCT00000853|HIV Envelope Protein gp120|hiv envelope protein gp120
888670|NCT00000853|AIDS Vaccines|aids vaccines
888671|NCT00000853|HIV Seronegativity|hiv seronegativity
888672|NCT00000853|HIV Preventive Vaccine|hiv preventive vaccine
888673|NCT00000852|T-Lymphocytes|t-lymphocytes
888674|NCT00000852|Acquired Immunodeficiency Syndrome|acquired immunodeficiency syndrome
888675|NCT00000852|Transplantation, Homologous|transplantation, homologous
888676|NCT00000852|Immunotherapy, Adoptive|immunotherapy, adoptive
888677|NCT00000851|Didanosine|didanosine
888678|NCT00000851|Drug Therapy, Combination|drug therapy, combination
888679|NCT00000851|Antiviral Agents|antiviral agents
888680|NCT00000851|Stavudine|stavudine
888681|NCT00000850|HIV-1|hiv-1
888682|NCT00000850|Granulocyte-Macrophage Colony-Stimulating Factor|granulocyte-macrophage colony-stimulating factor
888683|NCT00000850|RNA, Viral|rna, viral
888684|NCT00000850|Anti-HIV Agents|anti-hiv agents
888685|NCT00000850|Viral Load|viral load
888686|NCT00000850|Receptors, Chemokine|receptors, chemokine
888687|NCT00000849|Interleukin-2|interleukin-2
888688|NCT00000849|Immunity, Cellular|immunity, cellular
888689|NCT00000849|Dose-Response Relationship, Drug|dose-response relationship, drug
888690|NCT00000849|Acquired Immunodeficiency Syndrome|acquired immunodeficiency syndrome
888691|NCT00000849|AIDS-Related Complex|aids-related complex
888692|NCT00000849|Viral Load|viral load
888693|NCT00000848|Administration, Oral|administration, oral
888694|NCT00000848|Acquired Immunodeficiency Syndrome|acquired immunodeficiency syndrome
888695|NCT00000848|AIDS-Related Complex|aids-related complex
888696|NCT00000848|Antiviral Agents|antiviral agents
888697|NCT00000848|HIV Protease Inhibitors|hiv protease inhibitors
888698|NCT00000848|Biological Markers|biological markers
888699|NCT00000848|Indinavir|indinavir
888700|NCT00000848|Viremia|viremia
888701|NCT00000848|RNA, Viral|rna, viral
888702|NCT00000848|Saquinavir|saquinavir
888703|NCT00000847|Vaccines, Synthetic|vaccines, synthetic
888704|NCT00000847|HIV Envelope Protein gp120|hiv envelope protein gp120
888705|NCT00000847|AIDS Vaccines|aids vaccines
888706|NCT00000847|HIV Seronegativity|hiv seronegativity
888707|NCT00000847|Avipoxvirus|avipoxvirus
888708|NCT00000847|HIV Preventive Vaccine|hiv preventive vaccine
888709|NCT00000846|Vaccines, Synthetic|vaccines, synthetic
888711|NCT00000846|AIDS Vaccines|aids vaccines
888712|NCT00000846|HIV Seronegativity|hiv seronegativity
888713|NCT00000846|HIV Preventive Vaccine|hiv preventive vaccine
888714|NCT00000845|Vaccines, Synthetic|vaccines, synthetic
888715|NCT00000845|AIDS Vaccines|aids vaccines
888716|NCT00000845|HIV Seronegativity|hiv seronegativity
888717|NCT00000845|HIV Preventive Vaccine|hiv preventive vaccine
888718|NCT00000844|Drug Therapy, Combination|drug therapy, combination
888719|NCT00000844|Adjuvants, Immunologic|adjuvants, immunologic
888720|NCT00000844|Administration, Oral|administration, oral
888721|NCT00000844|Acquired Immunodeficiency Syndrome|acquired immunodeficiency syndrome
888722|NCT00000844|AIDS-Related Complex|aids-related complex
888723|NCT00000844|Interferon-alpha|interferon-alpha
888724|NCT00000843|Antiviral Agents|antiviral agents
888725|NCT00000843|Adenine|adenine
888726|NCT00000842|Acquired Immunodeficiency Syndrome|acquired immunodeficiency syndrome
888727|NCT00000842|AIDS-Related Complex|aids-related complex
888728|NCT00000842|Peripheral Nervous System Diseases|peripheral nervous system diseases
888729|NCT00000842|Nerve Growth Factors|nerve growth factors
888730|NCT00000842|Growth Substances|growth substances
888731|NCT00000841|Drug Therapy, Combination|drug therapy, combination
888732|NCT00000841|Acquired Immunodeficiency Syndrome|acquired immunodeficiency syndrome
888733|NCT00000841|Antiviral Agents|antiviral agents
888734|NCT00000841|Zidovudine|zidovudine
888735|NCT00000841|Stavudine|stavudine
888736|NCT00000841|HIV Protease Inhibitors|hiv protease inhibitors
888737|NCT00000841|Lamivudine|lamivudine
888738|NCT00000841|Indinavir|indinavir
888739|NCT00000840|Acquired Immunodeficiency Syndrome|acquired immunodeficiency syndrome
888740|NCT00000840|AIDS-Related Complex|aids-related complex
888741|NCT00000840|Antiviral Agents|antiviral agents
888742|NCT00000840|Zidovudine|zidovudine
888743|NCT00000840|Biological Markers|biological markers
888744|NCT00000840|Viremia|viremia
888745|NCT00000840|RNA, Viral|rna, viral
888746|NCT00000839|Pregnancy Trimester, Third|pregnancy trimester, third
888747|NCT00000839|Pregnancy|pregnancy
888748|NCT00000839|Pregnancy Complications, Infectious|pregnancy complications, infectious
888749|NCT00000839|Didanosine|didanosine
888750|NCT00000839|Acquired Immunodeficiency Syndrome|acquired immunodeficiency syndrome
888751|NCT00000839|AIDS-Related Complex|aids-related complex
888752|NCT00000838|Didanosine|didanosine
888753|NCT00000838|Drug Therapy, Combination|drug therapy, combination
888754|NCT00000838|Acquired Immunodeficiency Syndrome|acquired immunodeficiency syndrome
888755|NCT00000838|AIDS-Related Complex|aids-related complex
888756|NCT00000838|Antiviral Agents|antiviral agents
888757|NCT00000838|Zidovudine|zidovudine
888758|NCT00000838|Stavudine|stavudine
888759|NCT00000838|Lamivudine|lamivudine
888760|NCT00000837|Herpesvirus 3, Human|herpesvirus 3, human
888761|NCT00000837|Viral Vaccines|viral vaccines
888762|NCT00000837|AIDS-Related Complex|aids-related complex
888763|NCT00000837|Vaccines, Attenuated|vaccines, attenuated
888764|NCT00000837|Chickenpox|chickenpox
888765|NCT00000837|Chickenpox Vaccine|chickenpox vaccine
888766|NCT00000836|AIDS-Related Opportunistic Infections|aids-related opportunistic infections
888767|NCT00000836|Acquired Immunodeficiency Syndrome|acquired immunodeficiency syndrome
888768|NCT00000836|Antibodies, Monoclonal|antibodies, monoclonal
888769|NCT00000836|Cytomegalovirus Retinitis|cytomegalovirus retinitis
888770|NCT00000834|Methotrexate|methotrexate
888771|NCT00000834|Acquired Immunodeficiency Syndrome|acquired immunodeficiency syndrome
888772|NCT00000834|AIDS-Related Complex|aids-related complex
888773|NCT00000834|Zidovudine|zidovudine
888774|NCT00000834|Lamivudine|lamivudine
888775|NCT00000834|Disease Progression|disease progression
888776|NCT00000834|Anti-Inflammatory Agents|anti-inflammatory agents
888777|NCT00000834|Anti-HIV Agents|anti-hiv agents
888778|NCT00000833|Ribavirin|ribavirin
888779|NCT00000833|Didanosine|didanosine
888780|NCT00000833|Drug Therapy, Combination|drug therapy, combination
888781|NCT00000833|Acquired Immunodeficiency Syndrome|acquired immunodeficiency syndrome
888782|NCT00000833|AIDS-Related Complex|aids-related complex
888783|NCT00000833|Antiviral Agents|antiviral agents
888784|NCT00000832|Vaccines, Synthetic|vaccines, synthetic
888785|NCT00000832|HIV-1|hiv-1
888786|NCT00000832|Adjuvants, Immunologic|adjuvants, immunologic
888787|NCT00000832|HIV Envelope Protein gp120|hiv envelope protein gp120
888788|NCT00000832|AIDS Vaccines|aids vaccines
888789|NCT00000832|HIV Seronegativity|hiv seronegativity
888790|NCT00000832|HIV Preventive Vaccine|hiv preventive vaccine
888791|NCT00000831|Didanosine|didanosine
888792|NCT00000831|Drug Therapy, Combination|drug therapy, combination
888793|NCT00000831|AIDS-Related Complex|aids-related complex
888794|NCT00000831|Antiviral Agents|antiviral agents
888795|NCT00000831|Zidovudine|zidovudine
888796|NCT00000831|Stavudine|stavudine
888797|NCT00000831|Lamivudine|lamivudine
888798|NCT00000831|Drug Combinations|drug combinations
888799|NCT00000829|Vaccines, Synthetic|vaccines, synthetic
888800|NCT00000829|Acquired Immunodeficiency Syndrome|acquired immunodeficiency syndrome
888801|NCT00000829|AIDS-Related Complex|aids-related complex
888802|NCT00000829|Pneumococcal Infections|pneumococcal infections
888803|NCT00000829|Bacterial Vaccines|bacterial vaccines
888804|NCT00000828|Pregnancy|pregnancy
888805|NCT00000828|Pregnancy Complications, Infectious|pregnancy complications, infectious
888806|NCT00000828|Acquired Immunodeficiency Syndrome|acquired immunodeficiency syndrome
888807|NCT00000828|AIDS-Related Complex|aids-related complex
888808|NCT00000828|Zidovudine|zidovudine
888809|NCT00000828|Drug Resistance, Microbial|drug resistance, microbial
888810|NCT00000828|Disease Transmission, Vertical|disease transmission, vertical
888811|NCT00000827|Acquired Immunodeficiency Syndrome|acquired immunodeficiency syndrome
888812|NCT00000827|AIDS-Related Complex|aids-related complex
888813|NCT00000827|Immunoglobulins, Intravenous|immunoglobulins, intravenous
888814|NCT00000827|Immunization, Passive|immunization, passive
888815|NCT00000826|Rifabutin|rifabutin
888816|NCT00000826|Trimethoprim-Sulfamethoxazole Combination|trimethoprim-sulfamethoxazole combination
888817|NCT00000826|AIDS-Related Opportunistic Infections|aids-related opportunistic infections
888818|NCT00000826|Dapsone|dapsone
888819|NCT00000826|Drug Interactions|drug interactions
888820|NCT00000826|Fluconazole|fluconazole
888821|NCT00000826|Acquired Immunodeficiency Syndrome|acquired immunodeficiency syndrome
888822|NCT00000826|AIDS-Related Complex|aids-related complex
888823|NCT00000826|Clarithromycin|clarithromycin
888824|NCT00000826|Sulfamethoxazole-Trimethoprim|sulfamethoxazole-trimethoprim
888825|NCT00000825|HIV-1|hiv-1
888826|NCT00000825|Interleukin-2|interleukin-2
888827|NCT00000825|Dose-Response Relationship, Drug|dose-response relationship, drug
888828|NCT00000825|Antiviral Agents|antiviral agents
888829|NCT00000825|CD4 Lymphocyte Count|cd4 lymphocyte count
888830|NCT00000825|DNA, Viral|dna, viral
888831|NCT00000824|Immunotherapy, Adoptive|immunotherapy, adoptive
888832|NCT00000824|T-Lymphocyte Subsets|t-lymphocyte subsets
888833|NCT00000824|T-Lymphocytes, Cytotoxic|t-lymphocytes, cytotoxic
888834|NCT00000824|Dendritic Cells|dendritic cells
888835|NCT00000823|Didanosine|didanosine
888836|NCT00000823|Drug Therapy, Combination|drug therapy, combination
888837|NCT00000823|Zidovudine|zidovudine
888838|NCT00000823|Drug Administration Schedule|drug administration schedule
888839|NCT00000822|Vaccines, Synthetic|vaccines, synthetic
888840|NCT00000822|Didanosine|didanosine
888841|NCT00000822|Drug Therapy, Combination|drug therapy, combination
888842|NCT00000822|HIV Envelope Protein gp160|hiv envelope protein gp160
888843|NCT00000822|Acquired Immunodeficiency Syndrome|acquired immunodeficiency syndrome
888844|NCT00000822|AIDS-Related Complex|aids-related complex
888845|NCT00000822|Stavudine|stavudine
888846|NCT00000822|HIV Protease Inhibitors|hiv protease inhibitors
888847|NCT00000822|AIDS Vaccines|aids vaccines
888848|NCT00000822|Ritonavir|ritonavir
888849|NCT00000822|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors
888850|NCT00000822|HIV Therapeutic Vaccine|hiv therapeutic vaccine
888851|NCT00000821|Interleukin-2|interleukin-2
888852|NCT00000821|AIDS-Related Complex|aids-related complex
888853|NCT00000820|Interleukin-2|interleukin-2
888854|NCT00000820|Drug Therapy, Combination|drug therapy, combination
888855|NCT00000820|AIDS-Related Complex|aids-related complex
888856|NCT00000820|Antiviral Agents|antiviral agents
888857|NCT00000819|AIDS-Related Complex|aids-related complex
888858|NCT00000819|Prednisone|prednisone
888859|NCT00000819|AIDS-Associated Nephropathy|aids-associated nephropathy
888860|NCT00000818|Acquired Immunodeficiency Syndrome|acquired immunodeficiency syndrome
888861|NCT00000818|AIDS-Related Complex|aids-related complex
888862|NCT00000818|Zidovudine|zidovudine
888863|NCT00000818|Lymph Nodes|lymph nodes
888864|NCT00000818|Lymphoid Tissue|lymphoid tissue
888865|NCT00000817|Acquired Immunodeficiency Syndrome|acquired immunodeficiency syndrome
888866|NCT00000817|AIDS-Related Complex|aids-related complex
888867|NCT00000817|Peripheral Nervous System Diseases|peripheral nervous system diseases
888868|NCT00000817|Amitriptyline|amitriptyline
888870|NCT00000817|Acupuncture Therapy|acupuncture therapy
888871|NCT00000816|Trimethoprim-Sulfamethoxazole Combination|trimethoprim-sulfamethoxazole combination
888872|NCT00000816|Pneumonia, Pneumocystis carinii|pneumonia, pneumocystis carinii
888873|NCT00000816|Acquired Immunodeficiency Syndrome|acquired immunodeficiency syndrome
888874|NCT00000816|AIDS-Related Complex|aids-related complex
888875|NCT00000816|Sulfamethoxazole-Trimethoprim|sulfamethoxazole-trimethoprim
888876|NCT00000815|Acquired Immunodeficiency Syndrome|acquired immunodeficiency syndrome
888877|NCT00000815|AIDS-Related Complex|aids-related complex
888878|NCT00000815|Measles-Mumps-Rubella Vaccine|measles-mumps-rubella vaccine
888879|NCT00000815|Vaccines, Attenuated|vaccines, attenuated
888880|NCT00000815|Measles Vaccine|measles vaccine
888881|NCT00000815|Immunization Schedule|immunization schedule
888882|NCT00000815|Measles Virus|measles virus
888883|NCT00000815|Measles|measles
888884|NCT00000814|Didanosine|didanosine
888885|NCT00000814|Drug Therapy, Combination|drug therapy, combination
888886|NCT00000814|Acquired Immunodeficiency Syndrome|acquired immunodeficiency syndrome
888887|NCT00000814|AIDS-Related Complex|aids-related complex
888888|NCT00000814|Zidovudine|zidovudine
888889|NCT00000814|Nevirapine|nevirapine
888890|NCT00000813|Vaccines, Synthetic|vaccines, synthetic
888891|NCT00000813|HIV Envelope Protein gp160|hiv envelope protein gp160
888892|NCT00000813|HIV Envelope Protein gp120|hiv envelope protein gp120
888893|NCT00000813|AIDS Vaccines|aids vaccines
888894|NCT00000813|HIV Seronegativity|hiv seronegativity
888896|NCT00000813|HIV Preventive Vaccine|hiv preventive vaccine
888897|NCT00000812|Acquired Immunodeficiency Syndrome|acquired immunodeficiency syndrome
888898|NCT00000812|AIDS-Related Complex|aids-related complex
888899|NCT00000812|Thalidomide|thalidomide
888900|NCT00000811|Trimethoprim-Sulfamethoxazole Combination|trimethoprim-sulfamethoxazole combination
888901|NCT00000811|Pneumonia, Pneumocystis carinii|pneumonia, pneumocystis carinii
888902|NCT00000811|Drug Therapy, Combination|drug therapy, combination
888903|NCT00000811|Acquired Immunodeficiency Syndrome|acquired immunodeficiency syndrome
888904|NCT00000811|Antiprotozoal Agents|antiprotozoal agents
888905|NCT00000811|AIDS-Related Complex|aids-related complex
888906|NCT00000811|Azithromycin|azithromycin
888907|NCT00000811|Bacterial Infections|bacterial infections
888908|NCT00000811|atovaquone|atovaquone
888909|NCT00000810|Didanosine|didanosine
888910|NCT00000810|Acquired Immunodeficiency Syndrome|acquired immunodeficiency syndrome
888911|NCT00000810|AIDS-Related Complex|aids-related complex
888912|NCT00000810|Antiviral Agents|antiviral agents
888913|NCT00000810|Zidovudine|zidovudine
888914|NCT00000809|HIV Preventive Vaccine|hiv preventive vaccine
888915|NCT00000809|HIV Therapeutic Vaccine|hiv therapeutic vaccine
888916|NCT00000808|Pregnancy|pregnancy
888917|NCT00000808|Pregnancy Complications, Infectious|pregnancy complications, infectious
888918|NCT00000808|Acquired Immunodeficiency Syndrome|acquired immunodeficiency syndrome
888919|NCT00000808|AIDS-Related Complex|aids-related complex
888920|NCT00000808|Nevirapine|nevirapine
888921|NCT00000807|Sarcoma, Kaposi|sarcoma, kaposi
888922|NCT00000807|Etoposide|etoposide
888923|NCT00000807|Acquired Immunodeficiency Syndrome|acquired immunodeficiency syndrome
888924|NCT00000806|Acquired Immunodeficiency Syndrome|acquired immunodeficiency syndrome
888925|NCT00000806|AIDS-Related Complex|aids-related complex
888926|NCT00000806|HIV Protease Inhibitors|hiv protease inhibitors
888927|NCT00000805|Ganciclovir|ganciclovir
888928|NCT00000805|Cytomegalovirus Infections|cytomegalovirus infections
888929|NCT00000805|Acquired Immunodeficiency Syndrome|acquired immunodeficiency syndrome
888930|NCT00000803|Didanosine|didanosine
888931|NCT00000803|Drug Therapy, Combination|drug therapy, combination
888932|NCT00000803|Acquired Immunodeficiency Syndrome|acquired immunodeficiency syndrome
888933|NCT00000803|AIDS-Related Complex|aids-related complex
888934|NCT00000803|Antiviral Agents|antiviral agents
888935|NCT00000803|Zidovudine|zidovudine
888936|NCT00000802|Pneumonia, Pneumocystis carinii|pneumonia, pneumocystis carinii
888937|NCT00000802|Dapsone|dapsone
888938|NCT00000802|Antifungal Agents|antifungal agents
888939|NCT00000802|Acquired Immunodeficiency Syndrome|acquired immunodeficiency syndrome
888940|NCT00000802|atovaquone|atovaquone
888941|NCT00000801|Vincristine|vincristine
888942|NCT00000801|Cyclophosphamide|cyclophosphamide
888943|NCT00000801|Cytarabine|cytarabine
888944|NCT00000801|Dexamethasone|dexamethasone
888945|NCT00000801|Doxorubicin|doxorubicin
888946|NCT00000801|Granulocyte Colony-Stimulating Factor|granulocyte colony-stimulating factor
888947|NCT00000801|Combined Modality Therapy|combined modality therapy
888948|NCT00000801|Acquired Immunodeficiency Syndrome|acquired immunodeficiency syndrome
888949|NCT00000801|Antineoplastic Agents, Combined|antineoplastic agents, combined
888950|NCT00000801|Brain Neoplasms|brain neoplasms
888951|NCT00000801|Lymphoma, High-Grade|lymphoma, high-grade
888952|NCT00000801|Lymphoma, Intermediate-Grade|lymphoma, intermediate-grade
888953|NCT00000800|Methadone|methadone
888954|NCT00000800|Drug Interactions|drug interactions
888955|NCT00000800|Drug Therapy, Combination|drug therapy, combination
888956|NCT00000800|Acquired Immunodeficiency Syndrome|acquired immunodeficiency syndrome
888957|NCT00000800|AIDS-Related Complex|aids-related complex
888958|NCT00000800|Zidovudine|zidovudine
888959|NCT00000799|Retinitis|retinitis
888960|NCT00000799|Cytomegalovirus Infections|cytomegalovirus infections
888961|NCT00000799|Acquired Immunodeficiency Syndrome|acquired immunodeficiency syndrome
888962|NCT00000799|Antiviral Agents|antiviral agents
888963|NCT00000799|cidofovir|cidofovir
888964|NCT00000798|Vaccines, Synthetic|vaccines, synthetic
888965|NCT00000798|HIV-1|hiv-1
888966|NCT00000798|Administration, Oral|administration, oral
888967|NCT00000798|AIDS Vaccines|aids vaccines
888968|NCT00000798|HIV Seronegativity|hiv seronegativity
888969|NCT00000798|HIV Preventive Vaccine|hiv preventive vaccine
888970|NCT00000796|Isoniazid|isoniazid
888971|NCT00000796|Tuberculosis, Pulmonary|tuberculosis, pulmonary
888972|NCT00000796|Pyrazinamide|pyrazinamide
888973|NCT00000796|Pyridoxine|pyridoxine
888974|NCT00000796|Ofloxacin|ofloxacin
888975|NCT00000796|Rifampin|rifampin
888976|NCT00000796|AIDS-Related Opportunistic Infections|aids-related opportunistic infections
888977|NCT00000796|Drug Therapy, Combination|drug therapy, combination
888978|NCT00000796|Ethambutol|ethambutol
888979|NCT00000796|Clofazimine|clofazimine
888980|NCT00000796|Acquired Immunodeficiency Syndrome|acquired immunodeficiency syndrome
888981|NCT00000796|Amikacin|amikacin
888982|NCT00000796|Drug Resistance, Microbial|drug resistance, microbial
888983|NCT00000796|Cycloserine|cycloserine
888984|NCT00000796|Capreomycin Sulfate|capreomycin sulfate
888985|NCT00000796|Ethionamide|ethionamide
888986|NCT00000796|Aminosalicylic Acids|aminosalicylic acids
888987|NCT00000796|Streptomycin|streptomycin
888988|NCT00000796|p-Aminosalicylic Acid|p-aminosalicylic acid
888989|NCT00000795|Vaccines, Synthetic|vaccines, synthetic
888990|NCT00000795|HIV-1|hiv-1
888991|NCT00000795|AIDS Vaccines|aids vaccines
888992|NCT00000795|HIV Seronegativity|hiv seronegativity
888993|NCT00000795|HIV Preventive Vaccine|hiv preventive vaccine
888994|NCT00000794|Pyrimethamine|pyrimethamine
888995|NCT00000794|Leucovorin|leucovorin
888996|NCT00000794|Drug Therapy, Combination|drug therapy, combination
888997|NCT00000794|Encephalitis|encephalitis
888998|NCT00000794|Acquired Immunodeficiency Syndrome|acquired immunodeficiency syndrome
888999|NCT00000794|Antiprotozoal Agents|antiprotozoal agents
889000|NCT00000794|Clarithromycin|clarithromycin
889001|NCT00000794|atovaquone|atovaquone
889002|NCT00000794|Toxoplasmosis, Cerebral|toxoplasmosis, cerebral
889003|NCT00000794|Sulfadiazine|sulfadiazine
889004|NCT00000793|Acquired Immunodeficiency Syndrome|acquired immunodeficiency syndrome
889005|NCT00000793|AIDS-Related Complex|aids-related complex
889006|NCT00000793|Peripheral Nervous System Diseases|peripheral nervous system diseases
889007|NCT00000793|Amitriptyline|amitriptyline
889008|NCT00000793|Pain|pain
889009|NCT00000793|Mexiletine|mexiletine
889010|NCT00000793|benzatropine methanesulfonate|benzatropine methanesulfonate
889011|NCT00000793|Parasympatholytics|parasympatholytics
889012|NCT00000792|Administration, Oral|administration, oral
889013|NCT00000792|Acquired Immunodeficiency Syndrome|acquired immunodeficiency syndrome
889014|NCT00000792|AIDS-Related Complex|aids-related complex
889015|NCT00000792|Antiviral Agents|antiviral agents
889016|NCT00000791|Drug Therapy, Combination|drug therapy, combination
889017|NCT00000791|Acquired Immunodeficiency Syndrome|acquired immunodeficiency syndrome
889018|NCT00000791|AIDS-Related Complex|aids-related complex
889019|NCT00000791|Antiviral Agents|antiviral agents
889020|NCT00000791|Zidovudine|zidovudine
889021|NCT00000790|Acquired Immunodeficiency Syndrome|acquired immunodeficiency syndrome
889022|NCT00000790|AIDS-Related Complex|aids-related complex
889023|NCT00000790|Thalidomide|thalidomide
889024|NCT00000790|Stomatitis, Aphthous|stomatitis, aphthous
889025|NCT00000789|Acquired Immunodeficiency Syndrome|acquired immunodeficiency syndrome
889026|NCT00000789|AIDS-Related Complex|aids-related complex
889027|NCT00000789|Zidovudine|zidovudine
889028|NCT00000789|Stavudine|stavudine
889029|NCT00000788|Methadone|methadone
889030|NCT00000788|Drug Interactions|drug interactions
889031|NCT00000788|Drug Therapy, Combination|drug therapy, combination
889032|NCT00000788|Fluconazole|fluconazole
889033|NCT00000788|Antifungal Agents|antifungal agents
889034|NCT00000788|Acquired Immunodeficiency Syndrome|acquired immunodeficiency syndrome
889035|NCT00000788|AIDS-Related Complex|aids-related complex
889036|NCT00000787|Sex Behavior|sex behavior
889037|NCT00000785|Tuberculosis|tuberculosis
889038|NCT00000785|Mycobacterium tuberculosis|mycobacterium tuberculosis
889039|NCT00000785|AIDS-Related Opportunistic Infections|aids-related opportunistic infections
889040|NCT00000785|Acquired Immunodeficiency Syndrome|acquired immunodeficiency syndrome
889041|NCT00000785|Drug Resistance, Microbial|drug resistance, microbial
889042|NCT00000784|Acquired Immunodeficiency Syndrome|acquired immunodeficiency syndrome
889043|NCT00000784|AIDS-Related Complex|aids-related complex
889044|NCT00000783|Sex Behavior|sex behavior
889045|NCT00000783|Sexual Partners|sexual partners
889046|NCT00000782|Vaccines, Synthetic|vaccines, synthetic
889047|NCT00000782|Injections, Intradermal|injections, intradermal
889048|NCT00000782|HIV Antigens|hiv antigens
889049|NCT00000782|HIV-1|hiv-1
889050|NCT00000782|HIV Envelope Protein gp160|hiv envelope protein gp160
889051|NCT00000782|Acquired Immunodeficiency Syndrome|acquired immunodeficiency syndrome
889052|NCT00000782|AIDS-Related Complex|aids-related complex
889053|NCT00000782|Hypersensitivity, Delayed|hypersensitivity, delayed
889054|NCT00000782|AIDS Vaccines|aids vaccines
889055|NCT00000782|HIV Therapeutic Vaccine|hiv therapeutic vaccine
889056|NCT00000781|Zalcitabine|zalcitabine
889057|NCT00000781|Didanosine|didanosine
889058|NCT00000781|Drug Therapy, Combination|drug therapy, combination
889059|NCT00000781|Acquired Immunodeficiency Syndrome|acquired immunodeficiency syndrome
889060|NCT00000781|Zidovudine|zidovudine
889061|NCT00000781|Nevirapine|nevirapine
889062|NCT00000780|Acquired Immunodeficiency Syndrome|acquired immunodeficiency syndrome
889063|NCT00000780|AIDS-Related Complex|aids-related complex
889064|NCT00000780|Adolescent Behavior|adolescent behavior
889065|NCT00000779|Vaccines, Synthetic|vaccines, synthetic
889066|NCT00000779|HIV-1|hiv-1
889067|NCT00000779|Adjuvants, Immunologic|adjuvants, immunologic
889068|NCT00000779|AIDS-Related Complex|aids-related complex
889069|NCT00000779|HIV Envelope Protein gp120|hiv envelope protein gp120
889070|NCT00000779|AIDS Vaccines|aids vaccines
889071|NCT00000779|HIV Therapeutic Vaccine|hiv therapeutic vaccine
889072|NCT00000778|Isoniazid|isoniazid
889073|NCT00000778|Tuberculosis, Pulmonary|tuberculosis, pulmonary
889074|NCT00000778|Pyridoxine|pyridoxine
889075|NCT00000778|Ofloxacin|ofloxacin
889076|NCT00000778|AIDS-Related Opportunistic Infections|aids-related opportunistic infections
889077|NCT00000778|Drug Evaluation|drug evaluation
889078|NCT00000778|Acquired Immunodeficiency Syndrome|acquired immunodeficiency syndrome
889079|NCT00000778|Sputum|sputum
889080|NCT00000778|Colony Count, Microbial|colony count, microbial
889081|NCT00000777|Vaccines, Synthetic|vaccines, synthetic
889082|NCT00000777|Pregnancy|pregnancy
889083|NCT00000777|Pregnancy Complications, Infectious|pregnancy complications, infectious
889084|NCT00000777|HIV Envelope Protein gp160|hiv envelope protein gp160
889085|NCT00000777|AIDS Vaccines|aids vaccines
889086|NCT00000777|HIV Preventive Vaccine|hiv preventive vaccine
889087|NCT00000777|HIV Therapeutic Vaccine|hiv therapeutic vaccine
889088|NCT00000776|AIDS-Related Opportunistic Infections|aids-related opportunistic infections
889089|NCT00000776|Meningitis|meningitis
889090|NCT00000776|Cryptococcosis|cryptococcosis
889091|NCT00000776|Dexamethasone|dexamethasone
889092|NCT00000776|Drug Therapy, Combination|drug therapy, combination
889093|NCT00000776|Fluconazole|fluconazole
889094|NCT00000776|Flucytosine|flucytosine
889095|NCT00000776|Acquired Immunodeficiency Syndrome|acquired immunodeficiency syndrome
889096|NCT00000776|Amphotericin B|amphotericin b
889097|NCT00000776|Brain Diseases|brain diseases
889098|NCT00000775|Vaccines, Synthetic|vaccines, synthetic
889099|NCT00000775|HIV-1|hiv-1
889100|NCT00000775|HIV Envelope Protein gp120|hiv envelope protein gp120
889101|NCT00000775|AIDS Vaccines|aids vaccines
889102|NCT00000775|HIV Seronegativity|hiv seronegativity
889103|NCT00000775|HIV Preventive Vaccine|hiv preventive vaccine
889104|NCT00000774|Vaccines, Synthetic|vaccines, synthetic
889105|NCT00000774|Virus Replication|virus replication
889106|NCT00000774|HIV Envelope Protein gp120|hiv envelope protein gp120
889107|NCT00000774|AIDS Vaccines|aids vaccines
889108|NCT00000774|HIV Preventive Vaccine|hiv preventive vaccine
889109|NCT00000774|HIV Therapeutic Vaccine|hiv therapeutic vaccine
889110|NCT00000773|Pneumonia, Pneumocystis carinii|pneumonia, pneumocystis carinii
889111|NCT00000773|Antifungal Agents|antifungal agents
889112|NCT00000773|Acquired Immunodeficiency Syndrome|acquired immunodeficiency syndrome
889113|NCT00000773|AIDS-Related Complex|aids-related complex
889114|NCT00000773|Biological Availability|biological availability
889115|NCT00000773|atovaquone|atovaquone
889116|NCT00000772|Ribavirin|ribavirin
889117|NCT00000772|Didanosine|didanosine
889118|NCT00000772|Drug Therapy, Combination|drug therapy, combination
889119|NCT00000772|Acquired Immunodeficiency Syndrome|acquired immunodeficiency syndrome
889120|NCT00000772|AIDS-Related Complex|aids-related complex
889121|NCT00000771|Cryptosporidiosis|cryptosporidiosis
889122|NCT00000771|Acquired Immunodeficiency Syndrome|acquired immunodeficiency syndrome
889123|NCT00000771|Paromomycin|paromomycin
889124|NCT00000770|Didanosine|didanosine
889125|NCT00000770|Drug Therapy, Combination|drug therapy, combination
889126|NCT00000770|Acquired Immunodeficiency Syndrome|acquired immunodeficiency syndrome
889127|NCT00000770|AIDS-Related Complex|aids-related complex
889128|NCT00000770|Zidovudine|zidovudine
889129|NCT00000770|Nevirapine|nevirapine
889130|NCT00000769|Sarcoma, Kaposi|sarcoma, kaposi
889131|NCT00000769|Acquired Immunodeficiency Syndrome|acquired immunodeficiency syndrome
889132|NCT00000769|Interleukin-4|interleukin-4
889133|NCT00000768|Intestinal Absorption|intestinal absorption
889134|NCT00000768|Ganciclovir|ganciclovir
889135|NCT00000768|Drug Therapy, Combination|drug therapy, combination
889136|NCT00000768|Cytomegalovirus Infections|cytomegalovirus infections
889137|NCT00000768|Colitis|colitis
889138|NCT00000768|Administration, Oral|administration, oral
889139|NCT00000768|Acquired Immunodeficiency Syndrome|acquired immunodeficiency syndrome
889140|NCT00000768|Biological Availability|biological availability
889141|NCT00000768|Glutamic Acid|glutamic acid
889142|NCT00000767|Vaccines, Synthetic|vaccines, synthetic
889143|NCT00000767|Vaccinia Virus|vaccinia virus
889144|NCT00000767|Viral Vaccines|viral vaccines
889145|NCT00000767|Smallpox Vaccine|smallpox vaccine
889146|NCT00000767|HIV-1|hiv-1
889147|NCT00000767|AIDS Vaccines|aids vaccines
889148|NCT00000767|HIV Seronegativity|hiv seronegativity
889149|NCT00000767|HIV Preventive Vaccine|hiv preventive vaccine
889150|NCT00000766|Retinitis|retinitis
889151|NCT00000766|Ganciclovir|ganciclovir
889152|NCT00000766|Foscarnet|foscarnet
889153|NCT00000766|Cytomegalovirus Infections|cytomegalovirus infections
889154|NCT00000766|Acquired Immunodeficiency Syndrome|acquired immunodeficiency syndrome
889155|NCT00000765|Zidovudine|zidovudine
889156|NCT00000764|Interferon Alfa-2a|interferon alfa-2a
889157|NCT00000764|Acquired Immunodeficiency Syndrome|acquired immunodeficiency syndrome
889158|NCT00000764|AIDS-Related Complex|aids-related complex
889159|NCT00000764|Anus Neoplasms|anus neoplasms
889160|NCT00000764|Papillomavirus, Human|papillomavirus, human
889161|NCT00000764|Papovaviridae Infections|papovaviridae infections
889162|NCT00000764|Tumor Virus Infections|tumor virus infections
889163|NCT00000764|Isotretinoin|isotretinoin
889164|NCT00000763|Sarcoma, Kaposi|sarcoma, kaposi
889165|NCT00000763|Acquired Immunodeficiency Syndrome|acquired immunodeficiency syndrome
889166|NCT00000763|Antineoplastic Agents|antineoplastic agents
889167|NCT00000762|Vaccines, Synthetic|vaccines, synthetic
889168|NCT00000762|HIV Envelope Protein gp160|hiv envelope protein gp160
889169|NCT00000762|HIV Envelope Protein gp120|hiv envelope protein gp120
889170|NCT00000762|AIDS Vaccines|aids vaccines
889171|NCT00000762|HIV Therapeutic Vaccine|hiv therapeutic vaccine
889172|NCT00000761|Interferon-gamma, Recombinant|interferon-gamma, recombinant
889173|NCT00000761|Acquired Immunodeficiency Syndrome|acquired immunodeficiency syndrome
889174|NCT00000761|AIDS-Related Complex|aids-related complex
889175|NCT00000760|Didanosine|didanosine
889176|NCT00000760|Acquired Immunodeficiency Syndrome|acquired immunodeficiency syndrome
889177|NCT00000760|AIDS-Related Complex|aids-related complex
889178|NCT00000760|Antiviral Agents|antiviral agents
889179|NCT00000760|Zidovudine|zidovudine
889180|NCT00000760|Gene Products, tat|gene products, tat
889181|NCT00000759|Central Nervous System Diseases|central nervous system diseases
889182|NCT00000759|Acquired Immunodeficiency Syndrome|acquired immunodeficiency syndrome
889183|NCT00000759|AIDS-Related Complex|aids-related complex
889184|NCT00000759|Peripheral Nervous System Diseases|peripheral nervous system diseases
889185|NCT00000758|Acquired Immunodeficiency Syndrome|acquired immunodeficiency syndrome
889186|NCT00000758|AIDS-Related Complex|aids-related complex
889187|NCT00000758|Fluorouracil|fluorouracil
889188|NCT00000758|Cervix Dysplasia|cervix dysplasia
889189|NCT00000758|Cervix Diseases|cervix diseases
889190|NCT00000757|Vaccines, Synthetic|vaccines, synthetic
889191|NCT00000757|Vaccinia Virus|vaccinia virus
889192|NCT00000757|HIV-1|hiv-1
889193|NCT00000757|HIV Envelope Protein gp160|hiv envelope protein gp160
889194|NCT00000757|AIDS Vaccines|aids vaccines
889195|NCT00000757|HIV Seronegativity|hiv seronegativity
889196|NCT00000757|HIV Preventive Vaccine|hiv preventive vaccine
889197|NCT00000756|T-Lymphocytes|t-lymphocytes
889198|NCT00000756|Acquired Immunodeficiency Syndrome|acquired immunodeficiency syndrome
889199|NCT00000756|AIDS-Related Complex|aids-related complex
889200|NCT00000756|Immunotherapy, Adoptive|immunotherapy, adoptive
889201|NCT00000756|Transplantation, Autologous|transplantation, autologous
889202|NCT00000755|Vaccines, Synthetic|vaccines, synthetic
889203|NCT00000755|HIV-1|hiv-1
889204|NCT00000755|Acquired Immunodeficiency Syndrome|acquired immunodeficiency syndrome
889205|NCT00000755|AIDS-Related Complex|aids-related complex
889206|NCT00000755|Zidovudine|zidovudine
889207|NCT00000755|HIV Envelope Protein gp120|hiv envelope protein gp120
889208|NCT00000755|AIDS Vaccines|aids vaccines
889209|NCT00000755|HIV Therapeutic Vaccine|hiv therapeutic vaccine
889210|NCT00000754|Zalcitabine|zalcitabine
889211|NCT00000754|Acquired Immunodeficiency Syndrome|acquired immunodeficiency syndrome
889212|NCT00000754|AIDS-Related Complex|aids-related complex
889213|NCT00000754|Zidovudine|zidovudine
889214|NCT00000754|Interferon-alpha|interferon-alpha
889215|NCT00000753|Zalcitabine|zalcitabine
889216|NCT00000753|Didanosine|didanosine
889217|NCT00000753|Drug Therapy, Combination|drug therapy, combination
889218|NCT00000753|Acquired Immunodeficiency Syndrome|acquired immunodeficiency syndrome
889219|NCT00000753|AIDS-Related Complex|aids-related complex
889220|NCT00000753|Antiviral Agents|antiviral agents
889221|NCT00000753|Zidovudine|zidovudine
889222|NCT00000752|Drug Therapy, Combination|drug therapy, combination
889223|NCT00000752|Acquired Immunodeficiency Syndrome|acquired immunodeficiency syndrome
889224|NCT00000752|AIDS-Related Complex|aids-related complex
889225|NCT00000752|cefuroxime axetil|cefuroxime axetil
889226|NCT00000752|Beclomethasone|beclomethasone
889227|NCT00000752|Guaiacol Glyceryl Ether|guaiacol glyceryl ether
889228|NCT00000752|Sinusitis|sinusitis
889229|NCT00000752|Ephedrine|ephedrine
889230|NCT00000751|Pregnancy|pregnancy
889231|NCT00000751|Pregnancy Complications, Infectious|pregnancy complications, infectious
889232|NCT00000751|Drug Therapy, Combination|drug therapy, combination
889233|NCT00000751|Acquired Immunodeficiency Syndrome|acquired immunodeficiency syndrome
889234|NCT00000751|AIDS-Related Complex|aids-related complex
889235|NCT00000751|Zidovudine|zidovudine
889236|NCT00000751|Immunoglobulins, Intravenous|immunoglobulins, intravenous
889237|NCT00000751|Immunization, Passive|immunization, passive
889238|NCT00000750|Acquired Immunodeficiency Syndrome|acquired immunodeficiency syndrome
889239|NCT00000750|AIDS-Related Complex|aids-related complex
889240|NCT00000750|Zidovudine|zidovudine
889241|NCT00000749|Vaccines, Synthetic|vaccines, synthetic
889242|NCT00000749|HIV Envelope Protein gp120|hiv envelope protein gp120
889243|NCT00000749|AIDS Vaccines|aids vaccines
889244|NCT00000749|HIV Seronegativity|hiv seronegativity
889245|NCT00000749|HIV Preventive Vaccine|hiv preventive vaccine
889246|NCT00000748|Trimethoprim-Sulfamethoxazole Combination|trimethoprim-sulfamethoxazole combination
889247|NCT00000748|Pneumonia, Pneumocystis carinii|pneumonia, pneumocystis carinii
889248|NCT00000748|Acquired Immunodeficiency Syndrome|acquired immunodeficiency syndrome
889249|NCT00000748|AIDS-Related Complex|aids-related complex
889250|NCT00000748|Sulfamethoxazole-Trimethoprim|sulfamethoxazole-trimethoprim
889251|NCT00000747|Drug Resistance|drug resistance
889252|NCT00000747|AIDS-Related Complex|aids-related complex
889253|NCT00000747|Antiviral Agents|antiviral agents
889254|NCT00000747|Nevirapine|nevirapine
889255|NCT00000746|Vaccines, Synthetic|vaccines, synthetic
889256|NCT00000746|Vaccinia Virus|vaccinia virus
889257|NCT00000746|Viral Vaccines|viral vaccines
889258|NCT00000746|HIV-1|hiv-1
889259|NCT00000746|HIV Envelope Protein gp160|hiv envelope protein gp160
889260|NCT00000746|HIV Envelope Protein gp120|hiv envelope protein gp120
889261|NCT00000746|AIDS Vaccines|aids vaccines
889262|NCT00000746|HIV Seronegativity|hiv seronegativity
889263|NCT00000746|HIV Preventive Vaccine|hiv preventive vaccine
889264|NCT00000745|Vaccines, Synthetic|vaccines, synthetic
889265|NCT00000745|Vaccinia Virus|vaccinia virus
889266|NCT00000745|Viral Vaccines|viral vaccines
889267|NCT00000745|HIV-1|hiv-1
889268|NCT00000745|HIV Envelope Protein gp160|hiv envelope protein gp160
889269|NCT00000745|AIDS Vaccines|aids vaccines
889270|NCT00000745|HIV Seronegativity|hiv seronegativity
889271|NCT00000745|HIV Preventive Vaccine|hiv preventive vaccine
889272|NCT00000744|Fluconazole|fluconazole
889273|NCT00000744|Acquired Immunodeficiency Syndrome|acquired immunodeficiency syndrome
889274|NCT00000744|AIDS-Related Complex|aids-related complex
889275|NCT00000744|Candidiasis|candidiasis
889276|NCT00000743|Recombinant Proteins|recombinant proteins
889277|NCT00000743|Acquired Immunodeficiency Syndrome|acquired immunodeficiency syndrome
889278|NCT00000743|Antigens, CD4|antigens, cd4
889279|NCT00000743|AIDS-Related Complex|aids-related complex
889280|NCT00000743|Zidovudine|zidovudine
889281|NCT00000742|Didanosine|didanosine
889282|NCT00000742|Drug Therapy, Combination|drug therapy, combination
889283|NCT00000742|Acquired Immunodeficiency Syndrome|acquired immunodeficiency syndrome
889284|NCT00000742|AIDS-Related Complex|aids-related complex
889285|NCT00000742|Antiviral Agents|antiviral agents
889286|NCT00000742|Zidovudine|zidovudine
889287|NCT00000741|Pneumonia, Pneumocystis carinii|pneumonia, pneumocystis carinii
889288|NCT00000741|Acquired Immunodeficiency Syndrome|acquired immunodeficiency syndrome
889289|NCT00000741|Methylprednisolone|methylprednisolone
889290|NCT00000740|Pneumonia, Pneumocystis carinii|pneumonia, pneumocystis carinii
889291|NCT00000740|Acquired Immunodeficiency Syndrome|acquired immunodeficiency syndrome
889292|NCT00000740|AIDS-Related Complex|aids-related complex
889293|NCT00000740|WR 6026|wr 6026
889294|NCT00000739|Pneumonia, Pneumocystis carinii|pneumonia, pneumocystis carinii
889295|NCT00000739|Dapsone|dapsone
889296|NCT00000739|Acquired Immunodeficiency Syndrome|acquired immunodeficiency syndrome
889297|NCT00000739|AIDS-Related Complex|aids-related complex
889298|NCT00000739|Drug Administration Schedule|drug administration schedule
889299|NCT00000738|Central Nervous System Diseases|central nervous system diseases
889300|NCT00000738|Acquired Immunodeficiency Syndrome|acquired immunodeficiency syndrome
889301|NCT00000738|AIDS Dementia Complex|aids dementia complex
889302|NCT00000738|AIDS-Related Complex|aids-related complex
889303|NCT00000738|Zidovudine|zidovudine
889304|NCT00000738|Nimodipine|nimodipine
889305|NCT00000737|Weight Loss|weight loss
889306|NCT00000737|Megestrol|megestrol
889307|NCT00000737|Cachexia|cachexia
889308|NCT00000737|Eating Disorders|eating disorders
889309|NCT00000737|Tetrahydrocannabinol|tetrahydrocannabinol
889310|NCT00000737|Appetite|appetite
889311|NCT00000736|Acquired Immunodeficiency Syndrome|acquired immunodeficiency syndrome
889312|NCT00000736|AIDS-Related Complex|aids-related complex
889313|NCT00000736|Zidovudine|zidovudine
889314|NCT00000735|Virus Replication|virus replication
889315|NCT00000735|T-Lymphocytes|t-lymphocytes
889316|NCT00000735|Infusions, Intravenous|infusions, intravenous
889317|NCT00000735|Immunologic Surveillance|immunologic surveillance
889318|NCT00000735|Acquired Immunodeficiency Syndrome|acquired immunodeficiency syndrome
889319|NCT00000735|ampligen|ampligen
889320|NCT00000735|AIDS-Related Complex|aids-related complex
889321|NCT00000735|Antiviral Agents|antiviral agents
889322|NCT00000734|Trimethoprim-Sulfamethoxazole Combination|trimethoprim-sulfamethoxazole combination
889323|NCT00000734|AIDS-Related Opportunistic Infections|aids-related opportunistic infections
889324|NCT00000734|Pneumonia, Pneumocystis carinii|pneumonia, pneumocystis carinii
889325|NCT00000734|Drug Interactions|drug interactions
889326|NCT00000734|Drug Therapy, Combination|drug therapy, combination
889327|NCT00000734|Acquired Immunodeficiency Syndrome|acquired immunodeficiency syndrome
889328|NCT00000734|AIDS-Related Complex|aids-related complex
889329|NCT00000734|Zidovudine|zidovudine
889330|NCT00000734|Sulfamethoxazole-Trimethoprim|sulfamethoxazole-trimethoprim
889331|NCT00000733|Ribavirin|ribavirin
889332|NCT00000733|T-Lymphocytes|t-lymphocytes
889333|NCT00000733|Infusions, Intravenous|infusions, intravenous
889334|NCT00000733|Immunologic Surveillance|immunologic surveillance
889335|NCT00000733|Administration, Oral|administration, oral
889336|NCT00000733|Acquired Immunodeficiency Syndrome|acquired immunodeficiency syndrome
889337|NCT00000732|Trimethoprim-Sulfamethoxazole Combination|trimethoprim-sulfamethoxazole combination
889338|NCT00000732|Pneumonia, Pneumocystis carinii|pneumonia, pneumocystis carinii
889339|NCT00000732|Drug Interactions|drug interactions
889340|NCT00000732|Drug Therapy, Combination|drug therapy, combination
889341|NCT00000732|Acquired Immunodeficiency Syndrome|acquired immunodeficiency syndrome
889342|NCT00000732|AIDS-Related Complex|aids-related complex
889343|NCT00000732|Zidovudine|zidovudine
889344|NCT00000732|Sulfamethoxazole-Trimethoprim|sulfamethoxazole-trimethoprim
889345|NCT00000731|Acetaminophen|acetaminophen
889346|NCT00000731|Drug Interactions|drug interactions
889347|NCT00000731|Drug Therapy, Combination|drug therapy, combination
889348|NCT00000731|Acquired Immunodeficiency Syndrome|acquired immunodeficiency syndrome
889349|NCT00000731|AIDS-Related Complex|aids-related complex
889350|NCT00000731|Zidovudine|zidovudine
889351|NCT00000730|Trimethoprim-Sulfamethoxazole Combination|trimethoprim-sulfamethoxazole combination
889352|NCT00000730|Trimetrexate|trimetrexate
889353|NCT00000730|AIDS-Related Opportunistic Infections|aids-related opportunistic infections
889354|NCT00000730|Pneumonia, Pneumocystis carinii|pneumonia, pneumocystis carinii
889355|NCT00000730|Leucovorin|leucovorin
889356|NCT00000730|Folic Acid Antagonists|folic acid antagonists
889357|NCT00000730|Acquired Immunodeficiency Syndrome|acquired immunodeficiency syndrome
889358|NCT00000730|Antiprotozoal Agents|antiprotozoal agents
889359|NCT00000730|Sulfamethoxazole-Trimethoprim|sulfamethoxazole-trimethoprim
889360|NCT00000729|Virus Replication|virus replication
889361|NCT00000729|Infusions, Intravenous|infusions, intravenous
889362|NCT00000729|Dose-Response Relationship, Drug|dose-response relationship, drug
889363|NCT00000729|Foscarnet|foscarnet
889364|NCT00000729|Acquired Immunodeficiency Syndrome|acquired immunodeficiency syndrome
889365|NCT00000729|AIDS-Related Complex|aids-related complex
889366|NCT00000729|Antiviral Agents|antiviral agents
889367|NCT00000729|CD4-Positive T-Lymphocytes|cd4-positive t-lymphocytes
889368|NCT00000728|Immune Tolerance|immune tolerance
889369|NCT00000728|Interleukin-2|interleukin-2
889370|NCT00000728|Drug Therapy, Combination|drug therapy, combination
889371|NCT00000728|AIDS-Related Complex|aids-related complex
889372|NCT00000728|Zidovudine|zidovudine
889373|NCT00000728|CD4-Positive T-Lymphocytes|cd4-positive t-lymphocytes
889374|NCT00000727|Sulfadoxine|sulfadoxine
889375|NCT00000727|Trimethoprim-Sulfamethoxazole Combination|trimethoprim-sulfamethoxazole combination
889376|NCT00000727|AIDS-Related Opportunistic Infections|aids-related opportunistic infections
889377|NCT00000727|Pneumonia, Pneumocystis carinii|pneumonia, pneumocystis carinii
889378|NCT00000727|Pentamidine|pentamidine
889379|NCT00000727|Pyrimethamine|pyrimethamine
889380|NCT00000727|Drug Evaluation|drug evaluation
889381|NCT00000727|Administration, Inhalation|administration, inhalation
889382|NCT00000727|Administration, Oral|administration, oral
889383|NCT00000727|Aerosols|aerosols
889384|NCT00000727|Acquired Immunodeficiency Syndrome|acquired immunodeficiency syndrome
889385|NCT00000727|Zidovudine|zidovudine
889386|NCT00000726|Retinitis|retinitis
889387|NCT00000726|AIDS-Related Opportunistic Infections|aids-related opportunistic infections
889388|NCT00000726|Foscarnet|foscarnet
889389|NCT00000726|Cytomegalovirus Infections|cytomegalovirus infections
889390|NCT00000726|Acquired Immunodeficiency Syndrome|acquired immunodeficiency syndrome
889391|NCT00000726|Antiviral Agents|antiviral agents
889392|NCT00000725|Interferon Alfa-2a|interferon alfa-2a
889393|NCT00000725|Sarcoma, Kaposi|sarcoma, kaposi
889394|NCT00000725|Dose-Response Relationship, Drug|dose-response relationship, drug
889395|NCT00000725|Drug Therapy, Combination|drug therapy, combination
889396|NCT00000725|Acquired Immunodeficiency Syndrome|acquired immunodeficiency syndrome
889397|NCT00000725|Zidovudine|zidovudine
889398|NCT00000725|Interferon Type I|interferon type i
889399|NCT00000724|Trimetrexate|trimetrexate
889400|NCT00000724|Pneumonia, Pneumocystis carinii|pneumonia, pneumocystis carinii
889401|NCT00000724|Injections, Intravenous|injections, intravenous
889402|NCT00000724|Leucovorin|leucovorin
889403|NCT00000724|Drug Evaluation|drug evaluation
889404|NCT00000724|Drug Therapy, Combination|drug therapy, combination
889405|NCT00000724|Folic Acid Antagonists|folic acid antagonists
889406|NCT00000724|Acquired Immunodeficiency Syndrome|acquired immunodeficiency syndrome
889407|NCT00000724|Antiprotozoal Agents|antiprotozoal agents
889408|NCT00000723|AIDS-Related Opportunistic Infections|aids-related opportunistic infections
889409|NCT00000723|Lymphoma|lymphoma
889410|NCT00000723|Methotrexate|methotrexate
889411|NCT00000723|Leucovorin|leucovorin
889412|NCT00000723|Dexamethasone|dexamethasone
889413|NCT00000723|Drug Evaluation|drug evaluation
889414|NCT00000723|Drug Therapy, Combination|drug therapy, combination
889415|NCT00000723|Combined Modality Therapy|combined modality therapy
889416|NCT00000723|Acquired Immunodeficiency Syndrome|acquired immunodeficiency syndrome
889417|NCT00000723|Zidovudine|zidovudine
889418|NCT00000723|Brain Neoplasms|brain neoplasms
889419|NCT00000722|AIDS-Related Opportunistic Infections|aids-related opportunistic infections
889420|NCT00000722|Pneumonia, Pneumocystis carinii|pneumonia, pneumocystis carinii
889421|NCT00000722|Pentamidine|pentamidine
889422|NCT00000722|Injections, Intravenous|injections, intravenous
889423|NCT00000722|Lung|lung
889424|NCT00000722|Administration, Inhalation|administration, inhalation
889425|NCT00000722|Aerosols|aerosols
889426|NCT00000722|Acquired Immunodeficiency Syndrome|acquired immunodeficiency syndrome
889427|NCT00000721|Recombinant Proteins|recombinant proteins
889428|NCT00000721|Infusions, Intravenous|infusions, intravenous
889429|NCT00000721|Injections, Intramuscular|injections, intramuscular
889430|NCT00000721|Injections, Intravenous|injections, intravenous
889431|NCT00000721|Injections, Subcutaneous|injections, subcutaneous
889432|NCT00000721|Dose-Response Relationship, Drug|dose-response relationship, drug
889433|NCT00000721|Drug Evaluation|drug evaluation
889434|NCT00000721|Acquired Immunodeficiency Syndrome|acquired immunodeficiency syndrome
889435|NCT00000721|Antigens, CD4|antigens, cd4
889436|NCT00000721|AIDS-Related Complex|aids-related complex
889437|NCT00000720|AIDS-Related Opportunistic Infections|aids-related opportunistic infections
889438|NCT00000720|Placebos|placebos
889439|NCT00000720|Infusions, Intravenous|infusions, intravenous
889440|NCT00000720|Gamma-Globulins|gamma-globulins
889441|NCT00000720|Combined Modality Therapy|combined modality therapy
889442|NCT00000720|Acquired Immunodeficiency Syndrome|acquired immunodeficiency syndrome
889443|NCT00000720|Zidovudine|zidovudine
889444|NCT00000720|Bacterial Infections|bacterial infections
889445|NCT00000720|Immunization, Passive|immunization, passive
889446|NCT00000719|Zalcitabine|zalcitabine
889447|NCT00000719|Acquired Immunodeficiency Syndrome|acquired immunodeficiency syndrome
889448|NCT00000719|Zidovudine|zidovudine
889449|NCT00000718|Zalcitabine|zalcitabine
889450|NCT00000718|Dose-Response Relationship, Drug|dose-response relationship, drug
889451|NCT00000718|Acquired Immunodeficiency Syndrome|acquired immunodeficiency syndrome
889452|NCT00000718|AIDS-Related Complex|aids-related complex
889453|NCT00000718|Zidovudine|zidovudine
889454|NCT00000717|AIDS-Related Opportunistic Infections|aids-related opportunistic infections
889455|NCT00000717|Pneumonia, Pneumocystis carinii|pneumonia, pneumocystis carinii
889456|NCT00000717|Primaquine|primaquine
889457|NCT00000717|Infusions, Intravenous|infusions, intravenous
889458|NCT00000717|Drug Evaluation|drug evaluation
889459|NCT00000717|Drug Therapy, Combination|drug therapy, combination
889460|NCT00000717|Administration, Oral|administration, oral
889550|NCT00000704|Zalcitabine|zalcitabine
889461|NCT00000717|Acquired Immunodeficiency Syndrome|acquired immunodeficiency syndrome
889462|NCT00000717|Clindamycin|clindamycin
889463|NCT00000716|Drug Evaluation|drug evaluation
889464|NCT00000716|Administration, Oral|administration, oral
889465|NCT00000716|Acquired Immunodeficiency Syndrome|acquired immunodeficiency syndrome
889466|NCT00000716|Zidovudine|zidovudine
889467|NCT00000715|Trimethoprim-Sulfamethoxazole Combination|trimethoprim-sulfamethoxazole combination
889468|NCT00000715|AIDS-Related Opportunistic Infections|aids-related opportunistic infections
889469|NCT00000715|Pneumonia, Pneumocystis carinii|pneumonia, pneumocystis carinii
889470|NCT00000715|Pentamidine|pentamidine
889471|NCT00000715|Infusions, Intravenous|infusions, intravenous
889472|NCT00000715|Administration, Inhalation|administration, inhalation
889473|NCT00000715|Aerosols|aerosols
889474|NCT00000715|Acquired Immunodeficiency Syndrome|acquired immunodeficiency syndrome
889475|NCT00000715|Sulfamethoxazole-Trimethoprim|sulfamethoxazole-trimethoprim
889476|NCT00000714|Trimetrexate|trimetrexate
889477|NCT00000714|AIDS-Related Opportunistic Infections|aids-related opportunistic infections
889478|NCT00000714|Pneumonia, Pneumocystis carinii|pneumonia, pneumocystis carinii
889479|NCT00000714|Leucovorin|leucovorin
889480|NCT00000714|Drug Evaluation|drug evaluation
889481|NCT00000714|Drug Therapy, Combination|drug therapy, combination
889482|NCT00000714|Acquired Immunodeficiency Syndrome|acquired immunodeficiency syndrome
889483|NCT00000714|Antiprotozoal Agents|antiprotozoal agents
889484|NCT00000713|Polyribonucleotides|polyribonucleotides
889485|NCT00000713|HIV Seropositivity|hiv seropositivity
889486|NCT00000713|Dose-Response Relationship, Drug|dose-response relationship, drug
889487|NCT00000713|Drug Evaluation|drug evaluation
889488|NCT00000713|Acquired Immunodeficiency Syndrome|acquired immunodeficiency syndrome
889489|NCT00000713|ampligen|ampligen
889490|NCT00000713|AIDS-Related Complex|aids-related complex
889491|NCT00000713|Antiviral Agents|antiviral agents
889492|NCT00000712|AIDS-Related Opportunistic Infections|aids-related opportunistic infections
889493|NCT00000712|Herpesviridae Infections|herpesviridae infections
889494|NCT00000712|Drug Evaluation|drug evaluation
889495|NCT00000712|Drug Therapy, Combination|drug therapy, combination
889496|NCT00000712|Herpesvirus 4, Human|herpesvirus 4, human
889497|NCT00000712|Cytomegalovirus Infections|cytomegalovirus infections
889498|NCT00000712|Acyclovir|acyclovir
889499|NCT00000712|Acquired Immunodeficiency Syndrome|acquired immunodeficiency syndrome
889500|NCT00000712|Antiviral Agents|antiviral agents
889501|NCT00000712|Zidovudine|zidovudine
889502|NCT00000711|Neutropenia|neutropenia
889503|NCT00000711|Drug Evaluation|drug evaluation
889504|NCT00000711|Drug Therapy, Combination|drug therapy, combination
889505|NCT00000711|Granulocyte-Macrophage Colony-Stimulating Factor|granulocyte-macrophage colony-stimulating factor
889506|NCT00000711|Acquired Immunodeficiency Syndrome|acquired immunodeficiency syndrome
889507|NCT00000711|AIDS-Related Complex|aids-related complex
889508|NCT00000711|Zidovudine|zidovudine
889509|NCT00000710|Injections, Intravenous|injections, intravenous
889510|NCT00000710|Didanosine|didanosine
889511|NCT00000710|Dose-Response Relationship, Drug|dose-response relationship, drug
889512|NCT00000710|Drug Evaluation|drug evaluation
889513|NCT00000710|Acquired Immunodeficiency Syndrome|acquired immunodeficiency syndrome
889514|NCT00000710|AIDS-Related Complex|aids-related complex
889515|NCT00000709|Neuropsychological Tests|neuropsychological tests
889516|NCT00000709|AIDS Dementia Complex|aids dementia complex
889517|NCT00000709|Zidovudine|zidovudine
889518|NCT00000709|CD4-Positive T-Lymphocytes|cd4-positive t-lymphocytes
889519|NCT00000708|AIDS-Related Opportunistic Infections|aids-related opportunistic infections
889520|NCT00000708|Meningitis|meningitis
889521|NCT00000708|Injections, Intravenous|injections, intravenous
889522|NCT00000708|Cryptococcus neoformans|cryptococcus neoformans
889523|NCT00000708|Cryptococcosis|cryptococcosis
889524|NCT00000708|Drug Therapy, Combination|drug therapy, combination
889525|NCT00000708|Fluconazole|fluconazole
889526|NCT00000708|Administration, Oral|administration, oral
889802|NCT00000661|Drug Evaluation|drug evaluation
889527|NCT00000708|Acquired Immunodeficiency Syndrome|acquired immunodeficiency syndrome
889528|NCT00000708|Amphotericin B|amphotericin b
889529|NCT00000707|Respiratory Function Tests|respiratory function tests
889530|NCT00000707|AIDS-Related Opportunistic Infections|aids-related opportunistic infections
889531|NCT00000707|Pneumonia, Pneumocystis carinii|pneumonia, pneumocystis carinii
889532|NCT00000707|Pentamidine|pentamidine
889533|NCT00000707|Lung|lung
889534|NCT00000707|HIV Seropositivity|hiv seropositivity
889535|NCT00000707|Drug Evaluation|drug evaluation
889536|NCT00000707|Administration, Inhalation|administration, inhalation
889537|NCT00000707|Aerosols|aerosols
889538|NCT00000707|Acquired Immunodeficiency Syndrome|acquired immunodeficiency syndrome
889539|NCT00000706|Quinine|quinine
889540|NCT00000706|Probenecid|probenecid
889541|NCT00000706|Drug Therapy, Combination|drug therapy, combination
889542|NCT00000706|Acquired Immunodeficiency Syndrome|acquired immunodeficiency syndrome
889543|NCT00000706|AIDS-Related Complex|aids-related complex
889544|NCT00000706|Zidovudine|zidovudine
889545|NCT00000705|Drug Evaluation|drug evaluation
889546|NCT00000705|Zidovudine|zidovudine
889547|NCT00000705|Hemophilia A|hemophilia a
889548|NCT00000704|HIV Antigens|hiv antigens
889549|NCT00000704|Immunologic Surveillance|immunologic surveillance
889551|NCT00000704|Dose-Response Relationship, Drug|dose-response relationship, drug
889552|NCT00000704|Acquired Immunodeficiency Syndrome|acquired immunodeficiency syndrome
889553|NCT00000704|AIDS-Related Complex|aids-related complex
889554|NCT00000704|CD4-Positive T-Lymphocytes|cd4-positive t-lymphocytes
889555|NCT00000703|Vincristine|vincristine
889556|NCT00000703|Lymphoma|lymphoma
889557|NCT00000703|Methotrexate|methotrexate
889558|NCT00000703|Cyclophosphamide|cyclophosphamide
889559|NCT00000703|Cytarabine|cytarabine
889560|NCT00000703|Dexamethasone|dexamethasone
889561|NCT00000703|Doxorubicin|doxorubicin
889562|NCT00000703|Drug Therapy, Combination|drug therapy, combination
889563|NCT00000703|Combined Modality Therapy|combined modality therapy
889564|NCT00000703|Acquired Immunodeficiency Syndrome|acquired immunodeficiency syndrome
889565|NCT00000703|Antineoplastic Agents, Combined|antineoplastic agents, combined
889566|NCT00000703|Zidovudine|zidovudine
889567|NCT00000703|Bleomycin|bleomycin
889568|NCT00000702|AIDS Dementia Complex|aids dementia complex
889569|NCT00000702|Zidovudine|zidovudine
889570|NCT00000701|Drug Evaluation|drug evaluation
889571|NCT00000701|Acquired Immunodeficiency Syndrome|acquired immunodeficiency syndrome
889572|NCT00000701|AIDS-Related Complex|aids-related complex
889573|NCT00000701|Zidovudine|zidovudine
889574|NCT00000700|United States|united states
889575|NCT00000700|AIDS-Related Opportunistic Infections|aids-related opportunistic infections
889576|NCT00000700|Pneumonia, Pneumocystis carinii|pneumonia, pneumocystis carinii
889577|NCT00000700|Acquired Immunodeficiency Syndrome|acquired immunodeficiency syndrome
889578|NCT00000700|Zidovudine|zidovudine
889579|NCT00000699|Ribavirin|ribavirin
889580|NCT00000699|Inosine Pranobex|inosine pranobex
889581|NCT00000699|Dose-Response Relationship, Drug|dose-response relationship, drug
889582|NCT00000699|Drug Evaluation|drug evaluation
889583|NCT00000699|Drug Therapy, Combination|drug therapy, combination
889584|NCT00000699|AIDS-Related Complex|aids-related complex
889585|NCT00000698|Retinitis|retinitis
889586|NCT00000698|AIDS-Related Opportunistic Infections|aids-related opportunistic infections
889587|NCT00000698|Ganciclovir|ganciclovir
889588|NCT00000698|Cytomegalovirus Infections|cytomegalovirus infections
889589|NCT00000698|Acquired Immunodeficiency Syndrome|acquired immunodeficiency syndrome
889590|NCT00000697|Retinitis|retinitis
889591|NCT00000697|AIDS-Related Opportunistic Infections|aids-related opportunistic infections
889592|NCT00000697|Bone Marrow|bone marrow
889593|NCT00000697|Ganciclovir|ganciclovir
889594|NCT00000697|Foscarnet|foscarnet
889595|NCT00000697|Cytomegalovirus Infections|cytomegalovirus infections
889596|NCT00000697|Acquired Immunodeficiency Syndrome|acquired immunodeficiency syndrome
889597|NCT00000697|Antiviral Agents|antiviral agents
889598|NCT00000696|Interferon Alfa-2a|interferon alfa-2a
889599|NCT00000696|Drug Therapy, Combination|drug therapy, combination
889600|NCT00000696|AIDS-Related Complex|aids-related complex
889601|NCT00000696|Zidovudine|zidovudine
889602|NCT00000695|Drug Evaluation|drug evaluation
889603|NCT00000695|Drug Therapy, Combination|drug therapy, combination
889604|NCT00000695|Acquired Immunodeficiency Syndrome|acquired immunodeficiency syndrome
889605|NCT00000695|Zidovudine|zidovudine
889606|NCT00000695|Interferon Type I|interferon type i
889607|NCT00000694|Interferon Alfa-2b|interferon alfa-2b
889608|NCT00000694|Immune System|immune system
889609|NCT00000694|Drug Evaluation|drug evaluation
889610|NCT00000694|Drug Therapy, Combination|drug therapy, combination
889611|NCT00000694|Granulocyte-Macrophage Colony-Stimulating Factor|granulocyte-macrophage colony-stimulating factor
889612|NCT00000694|Acquired Immunodeficiency Syndrome|acquired immunodeficiency syndrome
889613|NCT00000694|Zidovudine|zidovudine
889614|NCT00000693|Retinitis|retinitis
889615|NCT00000693|Drug Evaluation|drug evaluation
889616|NCT00000693|Drug Therapy, Combination|drug therapy, combination
889617|NCT00000693|Cytomegalovirus Infections|cytomegalovirus infections
889618|NCT00000693|Acyclovir|acyclovir
889803|NCT00000661|Drug Interactions|drug interactions
889619|NCT00000693|Acquired Immunodeficiency Syndrome|acquired immunodeficiency syndrome
889620|NCT00000693|Zidovudine|zidovudine
889621|NCT00000692|Acquired Immunodeficiency Syndrome|acquired immunodeficiency syndrome
889622|NCT00000692|AIDS-Related Complex|aids-related complex
889623|NCT00000692|Antiviral Agents|antiviral agents
889624|NCT00000692|Biological Availability|biological availability
889625|NCT00000692|1-Deoxynojirimycin|1-deoxynojirimycin
889626|NCT00000691|Retinitis|retinitis
889627|NCT00000691|AIDS-Related Opportunistic Infections|aids-related opportunistic infections
889628|NCT00000691|Ganciclovir|ganciclovir
889629|NCT00000691|Drug Evaluation|drug evaluation
889630|NCT00000691|Foscarnet|foscarnet
889631|NCT00000691|Cytomegalovirus Infections|cytomegalovirus infections
889632|NCT00000691|Acquired Immunodeficiency Syndrome|acquired immunodeficiency syndrome
889633|NCT00000691|Antiviral Agents|antiviral agents
889634|NCT00000690|Reference Values|reference values
889635|NCT00000690|Infusions, Intravenous|infusions, intravenous
889636|NCT00000690|Intestinal Absorption|intestinal absorption
889637|NCT00000690|Dextran Sulfate|dextran sulfate
889638|NCT00000690|Administration, Oral|administration, oral
889639|NCT00000690|Blood Coagulation|blood coagulation
889640|NCT00000689|M-BACOD protocol|m-bacod protocol
889641|NCT00000689|Nervous System Neoplasms|nervous system neoplasms
889642|NCT00000689|Infusions, Intravenous|infusions, intravenous
889643|NCT00000689|Injections, Intravenous|injections, intravenous
889644|NCT00000689|Leucovorin|leucovorin
889645|NCT00000689|Cytarabine|cytarabine
889646|NCT00000689|Drug Evaluation|drug evaluation
889647|NCT00000689|Drug Therapy, Combination|drug therapy, combination
889648|NCT00000689|Granulocyte-Macrophage Colony-Stimulating Factor|granulocyte-macrophage colony-stimulating factor
889649|NCT00000689|Administration, Oral|administration, oral
889650|NCT00000689|Acquired Immunodeficiency Syndrome|acquired immunodeficiency syndrome
889651|NCT00000689|Antineoplastic Agents, Combined|antineoplastic agents, combined
889652|NCT00000688|Retinitis|retinitis
889653|NCT00000688|Injections, Intravenous|injections, intravenous
889654|NCT00000688|Ganciclovir|ganciclovir
889655|NCT00000688|Cytomegalovirus Infections|cytomegalovirus infections
889656|NCT00000688|Acquired Immunodeficiency Syndrome|acquired immunodeficiency syndrome
889657|NCT00000687|Interferon Alfa-2a|interferon alfa-2a
889658|NCT00000687|Drug Evaluation|drug evaluation
889659|NCT00000687|Drug Therapy, Combination|drug therapy, combination
889660|NCT00000687|Acquired Immunodeficiency Syndrome|acquired immunodeficiency syndrome
889661|NCT00000687|Zidovudine|zidovudine
889662|NCT00000686|Drug Evaluation|drug evaluation
889663|NCT00000686|Acquired Immunodeficiency Syndrome|acquired immunodeficiency syndrome
889664|NCT00000686|AIDS-Related Complex|aids-related complex
889665|NCT00000686|Antiviral Agents|antiviral agents
889666|NCT00000686|Zidovudine|zidovudine
889667|NCT00000685|Kidney Diseases|kidney diseases
889668|NCT00000685|Drug Evaluation|drug evaluation
889669|NCT00000685|Acquired Immunodeficiency Syndrome|acquired immunodeficiency syndrome
889670|NCT00000685|Zidovudine|zidovudine
889671|NCT00000685|Renal Dialysis|renal dialysis
889672|NCT00000684|Infusions, Intravenous|infusions, intravenous
889673|NCT00000684|Dextran Sulfate|dextran sulfate
889674|NCT00000684|Acquired Immunodeficiency Syndrome|acquired immunodeficiency syndrome
889675|NCT00000683|Vaccines, Synthetic|vaccines, synthetic
889676|NCT00000683|Vaccinia Virus|vaccinia virus
889677|NCT00000683|Viral Envelope Proteins|viral envelope proteins
889678|NCT00000683|Acquired Immunodeficiency Syndrome|acquired immunodeficiency syndrome
889679|NCT00000683|AIDS Vaccines|aids vaccines
889680|NCT00000683|HIV Seronegativity|hiv seronegativity
889681|NCT00000683|HIV Preventive Vaccine|hiv preventive vaccine
889682|NCT00000682|AIDS-Related Opportunistic Infections|aids-related opportunistic infections
889683|NCT00000682|Pneumonia, Pneumocystis carinii|pneumonia, pneumocystis carinii
889684|NCT00000682|Zalcitabine|zalcitabine
889685|NCT00000682|Acquired Immunodeficiency Syndrome|acquired immunodeficiency syndrome
889686|NCT00000682|Zidovudine|zidovudine
889687|NCT00000681|Vincristine|vincristine
889688|NCT00000681|Doxorubicin|doxorubicin
889689|NCT00000681|Drug Evaluation|drug evaluation
889690|NCT00000681|Drug Therapy, Combination|drug therapy, combination
889691|NCT00000681|Granulocyte-Macrophage Colony-Stimulating Factor|granulocyte-macrophage colony-stimulating factor
889692|NCT00000681|Acquired Immunodeficiency Syndrome|acquired immunodeficiency syndrome
889693|NCT00000681|Zidovudine|zidovudine
889694|NCT00000681|Bleomycin|bleomycin
889695|NCT00000680|T-Lymphocytes, Suppressor-Effector|t-lymphocytes, suppressor-effector
889696|NCT00000680|Indium Radioisotopes|indium radioisotopes
889697|NCT00000680|Leukapheresis|leukapheresis
889698|NCT00000680|Interleukin-2|interleukin-2
889699|NCT00000680|Acquired Immunodeficiency Syndrome|acquired immunodeficiency syndrome
889700|NCT00000680|AIDS-Related Complex|aids-related complex
889701|NCT00000680|Zidovudine|zidovudine
889702|NCT00000680|Immunization, Passive|immunization, passive
889703|NCT00000679|Zalcitabine|zalcitabine
889704|NCT00000679|Acquired Immunodeficiency Syndrome|acquired immunodeficiency syndrome
889705|NCT00000679|AIDS-Related Complex|aids-related complex
889706|NCT00000679|Zidovudine|zidovudine
889707|NCT00000678|Zalcitabine|zalcitabine
889708|NCT00000678|Drug Evaluation|drug evaluation
889804|NCT00000661|Zidovudine|zidovudine
889709|NCT00000678|Acquired Immunodeficiency Syndrome|acquired immunodeficiency syndrome
889710|NCT00000678|AIDS-Related Complex|aids-related complex
889711|NCT00000678|Zidovudine|zidovudine
889712|NCT00000677|Sch 39304|sch 39304
889713|NCT00000677|AIDS-Related Opportunistic Infections|aids-related opportunistic infections
889714|NCT00000677|Meningitis|meningitis
889715|NCT00000677|Cryptococcosis|cryptococcosis
889716|NCT00000677|Drug Evaluation|drug evaluation
889717|NCT00000677|Antifungal Agents|antifungal agents
889718|NCT00000677|Acquired Immunodeficiency Syndrome|acquired immunodeficiency syndrome
889719|NCT00000676|Mycoses|mycoses
889720|NCT00000676|Fluconazole|fluconazole
889721|NCT00000676|Clotrimazole|clotrimazole
889722|NCT00000676|Antifungal Agents|antifungal agents
889723|NCT00000676|Acquired Immunodeficiency Syndrome|acquired immunodeficiency syndrome
889724|NCT00000676|AIDS-Related Complex|aids-related complex
889725|NCT00000675|Recombinant Proteins|recombinant proteins
889726|NCT00000675|IgG|igg
889727|NCT00000675|Drug Evaluation|drug evaluation
889728|NCT00000675|Acquired Immunodeficiency Syndrome|acquired immunodeficiency syndrome
889729|NCT00000675|Antigens, CD4|antigens, cd4
889730|NCT00000675|AIDS-Related Complex|aids-related complex
889731|NCT00000675|Carrier Proteins|carrier proteins
889732|NCT00000674|Toxoplasmosis|toxoplasmosis
890012|NCT00000627|Fluconazole|fluconazole
889733|NCT00000674|AIDS-Related Opportunistic Infections|aids-related opportunistic infections
889734|NCT00000674|Pyrimethamine|pyrimethamine
889735|NCT00000674|Leucovorin|leucovorin
889736|NCT00000674|Drug Evaluation|drug evaluation
889737|NCT00000674|Drug Therapy, Combination|drug therapy, combination
889738|NCT00000674|Encephalitis|encephalitis
889739|NCT00000674|Acquired Immunodeficiency Syndrome|acquired immunodeficiency syndrome
889740|NCT00000674|Clindamycin|clindamycin
889741|NCT00000673|Retinitis|retinitis
889742|NCT00000673|AIDS-Related Opportunistic Infections|aids-related opportunistic infections
889743|NCT00000673|Ganciclovir|ganciclovir
889744|NCT00000673|Cytomegalovirus Infections|cytomegalovirus infections
889865|NCT00000647|IgG|igg
889745|NCT00000673|Acquired Immunodeficiency Syndrome|acquired immunodeficiency syndrome
889746|NCT00000672|Didanosine|didanosine
889747|NCT00000672|Zidovudine|zidovudine
889748|NCT00000671|Didanosine|didanosine
889749|NCT00000671|Zidovudine|zidovudine
889750|NCT00000670|Probenecid|probenecid
889751|NCT00000670|Drug Evaluation|drug evaluation
889752|NCT00000670|Drug Interactions|drug interactions
889753|NCT00000670|Acquired Immunodeficiency Syndrome|acquired immunodeficiency syndrome
889754|NCT00000670|Zidovudine|zidovudine
889755|NCT00000669|Didanosine|didanosine
889756|NCT00000669|Drug Evaluation|drug evaluation
889757|NCT00000669|Acquired Immunodeficiency Syndrome|acquired immunodeficiency syndrome
889758|NCT00000669|AIDS-Related Complex|aids-related complex
889759|NCT00000668|Retinitis|retinitis
889760|NCT00000668|AIDS-Related Opportunistic Infections|aids-related opportunistic infections
889761|NCT00000668|Ganciclovir|ganciclovir
889762|NCT00000668|Cytomegalovirus Infections|cytomegalovirus infections
889763|NCT00000668|Acquired Immunodeficiency Syndrome|acquired immunodeficiency syndrome
889764|NCT00000667|Vaccines, Synthetic|vaccines, synthetic
889765|NCT00000667|Injections, Intradermal|injections, intradermal
889766|NCT00000667|HIV Antigens|hiv antigens
889767|NCT00000667|HIV Seropositivity|hiv seropositivity
889768|NCT00000667|HIV-1|hiv-1
889769|NCT00000667|Drug Evaluation|drug evaluation
889770|NCT00000667|Hypersensitivity, Delayed|hypersensitivity, delayed
889771|NCT00000667|AIDS Vaccines|aids vaccines
889772|NCT00000667|HIV Therapeutic Vaccine|hiv therapeutic vaccine
889773|NCT00000666|Toxoplasmosis|toxoplasmosis
889774|NCT00000666|AIDS-Related Opportunistic Infections|aids-related opportunistic infections
889775|NCT00000666|Pyrimethamine|pyrimethamine
889776|NCT00000666|Drug Evaluation|drug evaluation
889777|NCT00000666|Encephalitis|encephalitis
889778|NCT00000666|Acquired Immunodeficiency Syndrome|acquired immunodeficiency syndrome
889779|NCT00000665|Retinitis|retinitis
889780|NCT00000665|AIDS-Related Opportunistic Infections|aids-related opportunistic infections
889781|NCT00000665|Ganciclovir|ganciclovir
889782|NCT00000665|Foscarnet|foscarnet
889783|NCT00000665|Cytomegalovirus Infections|cytomegalovirus infections
889784|NCT00000665|Acquired Immunodeficiency Syndrome|acquired immunodeficiency syndrome
889785|NCT00000665|Antiviral Agents|antiviral agents
889786|NCT00000664|Polyethylene Glycols|polyethylene glycols
889787|NCT00000664|Interleukin-2|interleukin-2
889788|NCT00000664|Drug Evaluation|drug evaluation
889789|NCT00000664|Zidovudine|zidovudine
889790|NCT00000663|Recombinant Proteins|recombinant proteins
889791|NCT00000663|Injections, Intravenous|injections, intravenous
889792|NCT00000663|IgG|igg
889793|NCT00000663|Drug Evaluation|drug evaluation
889794|NCT00000663|Acquired Immunodeficiency Syndrome|acquired immunodeficiency syndrome
889795|NCT00000663|Antigens, CD4|antigens, cd4
889796|NCT00000663|Carrier Proteins|carrier proteins
889797|NCT00000662|Drugs, Investigational|drugs, investigational
889798|NCT00000662|Acquired Immunodeficiency Syndrome|acquired immunodeficiency syndrome
889799|NCT00000662|AIDS-Related Complex|aids-related complex
889800|NCT00000662|Zidovudine|zidovudine
889801|NCT00000661|Oxazepam|oxazepam
889805|NCT00000660|Sarcoma, Kaposi|sarcoma, kaposi
889806|NCT00000660|Drug Evaluation|drug evaluation
889807|NCT00000660|Etoposide|etoposide
889808|NCT00000660|Acquired Immunodeficiency Syndrome|acquired immunodeficiency syndrome
889809|NCT00000659|Acquired Immunodeficiency Syndrome|acquired immunodeficiency syndrome
889810|NCT00000659|Antigens, CD4|antigens, cd4
889811|NCT00000659|AIDS-Related Complex|aids-related complex
889812|NCT00000659|Zidovudine|zidovudine
889813|NCT00000658|M-BACOD protocol|m-bacod protocol
889814|NCT00000658|Granulocyte-Macrophage Colony-Stimulating Factor|granulocyte-macrophage colony-stimulating factor
889815|NCT00000658|Acquired Immunodeficiency Syndrome|acquired immunodeficiency syndrome
889816|NCT00000658|Allopurinol|allopurinol
889817|NCT00000658|Antineoplastic Agents, Combined|antineoplastic agents, combined
889818|NCT00000657|Didanosine|didanosine
889819|NCT00000657|Drug Evaluation|drug evaluation
889820|NCT00000657|Drugs, Investigational|drugs, investigational
889821|NCT00000657|AIDS Dementia Complex|aids dementia complex
889822|NCT00000657|Zidovudine|zidovudine
889823|NCT00000656|Didanosine|didanosine
889824|NCT00000656|Drug Therapy, Combination|drug therapy, combination
889825|NCT00000656|Zidovudine|zidovudine
890223|NCT00022841|Bone mineral density (BMD)|bone mineral density (bmd)
889826|NCT00000655|Trimethoprim-Sulfamethoxazole Combination|trimethoprim-sulfamethoxazole combination
889827|NCT00000655|AIDS-Related Opportunistic Infections|aids-related opportunistic infections
889828|NCT00000655|Pneumonia, Pneumocystis carinii|pneumonia, pneumocystis carinii
889829|NCT00000655|Naphthoquinones|naphthoquinones
889830|NCT00000655|Antifungal Agents|antifungal agents
889831|NCT00000655|Acquired Immunodeficiency Syndrome|acquired immunodeficiency syndrome
889832|NCT00000655|Sulfamethoxazole-Trimethoprim|sulfamethoxazole-trimethoprim
889833|NCT00000654|AIDS-Related Opportunistic Infections|aids-related opportunistic infections
889834|NCT00000654|Pyrimidine Nucleosides|pyrimidine nucleosides
889835|NCT00000654|Herpesviridae Infections|herpesviridae infections
889836|NCT00000654|Drug Evaluation|drug evaluation
889837|NCT00000654|Antiviral Agents|antiviral agents
889838|NCT00000654|Hepatitis B|hepatitis b
889839|NCT00000653|Zalcitabine|zalcitabine
889840|NCT00000653|Drug Evaluation|drug evaluation
889841|NCT00000653|Acquired Immunodeficiency Syndrome|acquired immunodeficiency syndrome
889842|NCT00000653|AIDS-Related Complex|aids-related complex
889843|NCT00000652|Didanosine|didanosine
889844|NCT00000652|Drug Evaluation|drug evaluation
889845|NCT00000652|Drug Therapy, Combination|drug therapy, combination
889846|NCT00000652|Zidovudine|zidovudine
889847|NCT00000651|Zalcitabine|zalcitabine
889848|NCT00000651|Antiviral Agents|antiviral agents
889849|NCT00000651|Zidovudine|zidovudine
889850|NCT00000650|Drug Evaluation|drug evaluation
889851|NCT00000650|Ditiocarb|ditiocarb
889852|NCT00000650|Acquired Immunodeficiency Syndrome|acquired immunodeficiency syndrome
889853|NCT00000649|Drug Therapy, Combination|drug therapy, combination
889854|NCT00000649|Acquired Immunodeficiency Syndrome|acquired immunodeficiency syndrome
889855|NCT00000649|AIDS-Related Complex|aids-related complex
889856|NCT00000649|Zidovudine|zidovudine
889857|NCT00000649|Nevirapine|nevirapine
889858|NCT00000648|Penicillin G|penicillin g
889859|NCT00000648|Neurosyphilis|neurosyphilis
889860|NCT00000648|Drug Evaluation|drug evaluation
889861|NCT00000648|Acquired Immunodeficiency Syndrome|acquired immunodeficiency syndrome
889862|NCT00000648|AIDS-Related Complex|aids-related complex
889863|NCT00000648|Ceftriaxone|ceftriaxone
889864|NCT00000647|Recombinant Proteins|recombinant proteins
889866|NCT00000647|Drug Evaluation|drug evaluation
889867|NCT00000647|Drug Therapy, Combination|drug therapy, combination
889868|NCT00000647|Acquired Immunodeficiency Syndrome|acquired immunodeficiency syndrome
889869|NCT00000647|Antigens, CD4|antigens, cd4
889870|NCT00000647|Zidovudine|zidovudine
889871|NCT00000647|Carrier Proteins|carrier proteins
889872|NCT00000647|Interferon Type I|interferon type i
889873|NCT00000646|Pentoxifylline|pentoxifylline
889874|NCT00000646|Virus Replication|virus replication
889875|NCT00000646|Tumor Necrosis Factor|tumor necrosis factor
889876|NCT00000646|Drug Evaluation|drug evaluation
889877|NCT00000646|Acquired Immunodeficiency Syndrome|acquired immunodeficiency syndrome
889878|NCT00000646|Cachexia|cachexia
889879|NCT00000646|Drug Synergism|drug synergism
889880|NCT00000645|Drug Evaluation|drug evaluation
889881|NCT00000645|Acquired Immunodeficiency Syndrome|acquired immunodeficiency syndrome
889882|NCT00000645|AIDS-Related Complex|aids-related complex
889883|NCT00000645|Antiviral Agents|antiviral agents
889884|NCT00000644|AIDS-Related Opportunistic Infections|aids-related opportunistic infections
889885|NCT00000644|Mycobacterium avium-intracellulare Infection|mycobacterium avium-intracellulare infection
889886|NCT00000644|Acquired Immunodeficiency Syndrome|acquired immunodeficiency syndrome
889887|NCT00000644|Clarithromycin|clarithromycin
889888|NCT00000643|Toxoplasmosis|toxoplasmosis
889889|NCT00000643|Pyrimethamine|pyrimethamine
889890|NCT00000643|Leucovorin|leucovorin
889891|NCT00000643|Drug Evaluation|drug evaluation
889892|NCT00000643|Acquired Immunodeficiency Syndrome|acquired immunodeficiency syndrome
889893|NCT00000643|AIDS-Related Complex|aids-related complex
889894|NCT00000643|Brain Diseases|brain diseases
889895|NCT00000642|Recombinant Proteins|recombinant proteins
889896|NCT00000642|Pregnancy Trimester, Third|pregnancy trimester, third
889897|NCT00000642|Pregnancy|pregnancy
889898|NCT00000642|Pregnancy Complications, Infectious|pregnancy complications, infectious
889899|NCT00000642|IgG|igg
889900|NCT00000642|Drug Evaluation|drug evaluation
889901|NCT00000642|Antigens, CD4|antigens, cd4
889902|NCT00000642|AIDS-Related Complex|aids-related complex
889903|NCT00000642|Immunization, Passive|immunization, passive
889904|NCT00000641|Rifampin|rifampin
889905|NCT00000641|Mycobacterium avium-intracellulare Infection|mycobacterium avium-intracellulare infection
889906|NCT00000641|Drug Evaluation|drug evaluation
889907|NCT00000641|Drug Therapy, Combination|drug therapy, combination
889908|NCT00000641|Ethambutol|ethambutol
889909|NCT00000641|Clofazimine|clofazimine
889910|NCT00000641|Acquired Immunodeficiency Syndrome|acquired immunodeficiency syndrome
889911|NCT00000641|Amikacin|amikacin
889912|NCT00000641|Azithromycin|azithromycin
889913|NCT00000641|Ciprofloxacin|ciprofloxacin
889914|NCT00000640|Trimethoprim-Sulfamethoxazole Combination|trimethoprim-sulfamethoxazole combination
889915|NCT00000640|Pneumonia, Pneumocystis carinii|pneumonia, pneumocystis carinii
889916|NCT00000640|Primaquine|primaquine
889917|NCT00000640|Dapsone|dapsone
889918|NCT00000640|Drug Therapy, Combination|drug therapy, combination
889919|NCT00000640|Acquired Immunodeficiency Syndrome|acquired immunodeficiency syndrome
889920|NCT00000640|Clindamycin|clindamycin
889921|NCT00000640|Sulfamethoxazole-Trimethoprim|sulfamethoxazole-trimethoprim
889922|NCT00000639|AIDS-Related Opportunistic Infections|aids-related opportunistic infections
889923|NCT00000639|Meningitis|meningitis
889924|NCT00000639|Cryptococcosis|cryptococcosis
889925|NCT00000639|Drug Evaluation|drug evaluation
889926|NCT00000639|Drug Therapy, Combination|drug therapy, combination
889927|NCT00000639|Fluconazole|fluconazole
889928|NCT00000639|Flucytosine|flucytosine
889929|NCT00000639|Acquired Immunodeficiency Syndrome|acquired immunodeficiency syndrome
889930|NCT00000639|Amphotericin B|amphotericin b
889931|NCT00000639|Brain Diseases|brain diseases
889932|NCT00000638|Tuberculosis|tuberculosis
889933|NCT00000638|Isoniazid|isoniazid
889934|NCT00000638|Mycobacterium tuberculosis|mycobacterium tuberculosis
889935|NCT00000638|Pyrazinamide|pyrazinamide
889936|NCT00000638|Pyridoxine|pyridoxine
889937|NCT00000638|Rifampin|rifampin
889938|NCT00000638|AIDS-Related Opportunistic Infections|aids-related opportunistic infections
889939|NCT00000638|Drug Therapy, Combination|drug therapy, combination
889940|NCT00000638|Acquired Immunodeficiency Syndrome|acquired immunodeficiency syndrome
889941|NCT00000638|Antitubercular Agents|antitubercular agents
889942|NCT00000638|AIDS-Related Complex|aids-related complex
889943|NCT00000637|Didanosine|didanosine
889944|NCT00000637|Drug Evaluation|drug evaluation
889945|NCT00000637|Drug Therapy, Combination|drug therapy, combination
889946|NCT00000637|Acquired Immunodeficiency Syndrome|acquired immunodeficiency syndrome
889947|NCT00000637|AIDS-Related Complex|aids-related complex
889948|NCT00000637|Zidovudine|zidovudine
889949|NCT00000636|Tuberculosis|tuberculosis
889950|NCT00000636|Isoniazid|isoniazid
889951|NCT00000636|Pyrazinamide|pyrazinamide
889952|NCT00000636|Pyridoxine|pyridoxine
889953|NCT00000636|Rifampin|rifampin
889954|NCT00000636|AIDS-Related Opportunistic Infections|aids-related opportunistic infections
889955|NCT00000636|Drug Therapy, Combination|drug therapy, combination
889956|NCT00000636|Acquired Immunodeficiency Syndrome|acquired immunodeficiency syndrome
889957|NCT00000636|Antitubercular Agents|antitubercular agents
889958|NCT00000636|AIDS-Related Complex|aids-related complex
889959|NCT00000635|Bacitracin|bacitracin
889960|NCT00000635|Polymyxin B|polymyxin b
889961|NCT00000635|Trifluridine|trifluridine
889962|NCT00000635|AIDS-Related Opportunistic Infections|aids-related opportunistic infections
889963|NCT00000635|Herpesviridae Infections|herpesviridae infections
889964|NCT00000635|Drug Evaluation|drug evaluation
889965|NCT00000635|Acquired Immunodeficiency Syndrome|acquired immunodeficiency syndrome
889966|NCT00000635|Anti-Infective Agents, Local|anti-infective agents, local
889967|NCT00000635|Antiviral Agents|antiviral agents
889968|NCT00000634|Benzodiazepines|benzodiazepines
889969|NCT00000634|Drug Evaluation|drug evaluation
889970|NCT00000634|Drugs, Investigational|drugs, investigational
889971|NCT00000634|Acquired Immunodeficiency Syndrome|acquired immunodeficiency syndrome
889972|NCT00000634|Antiviral Agents|antiviral agents
889973|NCT00000633|Vaccines, Synthetic|vaccines, synthetic
889974|NCT00000633|Vaccinia Virus|vaccinia virus
889975|NCT00000633|Viral Vaccines|viral vaccines
889977|NCT00000633|HIV Envelope Protein gp160|hiv envelope protein gp160
889978|NCT00000633|Acquired Immunodeficiency Syndrome|acquired immunodeficiency syndrome
889979|NCT00000633|AIDS-Related Complex|aids-related complex
889980|NCT00000633|AIDS Vaccines|aids vaccines
889981|NCT00000633|HIV Therapeutic Vaccine|hiv therapeutic vaccine
889982|NCT00000632|Vaccines, Synthetic|vaccines, synthetic
889983|NCT00000632|Drug Evaluation|drug evaluation
889984|NCT00000632|Adjuvants, Immunologic|adjuvants, immunologic
889985|NCT00000632|AIDS Vaccines|aids vaccines
889986|NCT00000632|HIV Preventive Vaccine|hiv preventive vaccine
889987|NCT00000631|Vaccines, Synthetic|vaccines, synthetic
889988|NCT00000631|Vaccinia Virus|vaccinia virus
889989|NCT00000631|Viral Envelope Proteins|viral envelope proteins
889990|NCT00000631|Viral Vaccines|viral vaccines
889991|NCT00000631|AIDS Vaccines|aids vaccines
889992|NCT00000631|HIV Seronegativity|hiv seronegativity
889993|NCT00000631|HIV Preventive Vaccine|hiv preventive vaccine
889994|NCT00000630|Vaccines, Synthetic|vaccines, synthetic
889995|NCT00000630|Vaccinia Virus|vaccinia virus
889996|NCT00000630|Viral Envelope Proteins|viral envelope proteins
889997|NCT00000630|Acquired Immunodeficiency Syndrome|acquired immunodeficiency syndrome
889998|NCT00000630|AIDS Vaccines|aids vaccines
889999|NCT00000630|HIV Seronegativity|hiv seronegativity
890000|NCT00000630|HIV Preventive Vaccine|hiv preventive vaccine
890001|NCT00000629|Valproic Acid|valproic acid
890002|NCT00000629|Zidovudine|zidovudine
890003|NCT00000628|Drug Evaluation|drug evaluation
890004|NCT00000628|Drugs, Investigational|drugs, investigational
890005|NCT00000628|Drug Therapy, Combination|drug therapy, combination
890006|NCT00000628|Acquired Immunodeficiency Syndrome|acquired immunodeficiency syndrome
890007|NCT00000628|AIDS-Related Complex|aids-related complex
890008|NCT00000628|Antiviral Agents|antiviral agents
890009|NCT00000627|Pilot Projects|pilot projects
890010|NCT00000627|Histoplasmosis|histoplasmosis
890011|NCT00000627|Drug Evaluation|drug evaluation
890013|NCT00000627|Acquired Immunodeficiency Syndrome|acquired immunodeficiency syndrome
890014|NCT00000627|Recurrence|recurrence
890015|NCT00000626|Granulocyte Colony-Stimulating Factor|granulocyte colony-stimulating factor
890016|NCT00000626|Acquired Immunodeficiency Syndrome|acquired immunodeficiency syndrome
890017|NCT00000626|Antineoplastic Agents, Combined|antineoplastic agents, combined
890018|NCT00000626|AIDS-Related Complex|aids-related complex
890019|NCT00000626|Hodgkin Disease|hodgkin disease
890020|NCT00000626|ABVD protocol|abvd protocol
890021|NCT00000625|Zalcitabine|zalcitabine
890022|NCT00000625|Didanosine|didanosine
890023|NCT00000625|Drug Therapy, Combination|drug therapy, combination
890024|NCT00000625|AIDS-Related Complex|aids-related complex
890025|NCT00000625|Antiviral Agents|antiviral agents
890026|NCT00000625|Zidovudine|zidovudine
890027|NCT00023192|Campath 1-H|campath 1-h
890028|NCT00023192|T-Cell Depletion|t-cell depletion
890029|NCT00023192|Therapy|therapy
890030|NCT00023192|Stem Cell Transplantation|stem cell transplantation
890031|NCT00023192|Chronic Granulomatous Disease|chronic granulomatous disease
890032|NCT00023192|CGD|cgd
890033|NCT00023166|Phase I|phase i
890034|NCT00023166|Open label|open label
890035|NCT00023166|Safety/efficacy|safety/efficacy
890036|NCT00023166|Lymphomas|lymphomas
890037|NCT00023166|Advanced primary and/or metastatic solid tumors|advanced primary and/or metastatic solid tumors
890038|NCT00023166|Neoplasms|neoplasms
890039|NCT00023166|Neoplasm metastasis|neoplasm metastasis
890040|NCT00023153|Drug Resistance|drug resistance
890041|NCT00023153|Viral Load|viral load
890042|NCT00023153|Liver|liver
890043|NCT00023153|Immunology|immunology
890044|NCT00023153|Liver Histology|liver histology
890045|NCT00023153|Hepatitis B|hepatitis b
890046|NCT00023153|HBV|hbv
890047|NCT00023153|HIV|hiv
890048|NCT00023140|biomarkers|biomarkers
890049|NCT00023140|exposure|exposure
890050|NCT00023140|adducts|adducts
890051|NCT00023140|metabolites|metabolites
890052|NCT00023140|butadiene|butadiene
890053|NCT00023127|Asthma|asthma
890054|NCT00023127|Allergen|allergen
890055|NCT00023127|Cockroach|cockroach
890056|NCT00023114|lung function|lung function
890057|NCT00023114|smoking|smoking
890058|NCT00023114|metabolism|metabolism
890059|NCT00023101|lead|lead
890060|NCT00023101|endocrine dysfunction|endocrine dysfunction
890061|NCT00023088|Rehabilitation|rehabilitation
890062|NCT00023088|Functional Level|functional level
890063|NCT00023088|Activity of Daily Living|activity of daily living
890064|NCT00023088|Mobility|mobility
890065|NCT00023088|Normal Volunteer|normal volunteer
890066|NCT00023075|MRI|mri
890067|NCT00023075|Neuromuscular Disease|neuromuscular disease
890068|NCT00023075|N-Acetyl Aspartate|n-acetyl aspartate
890069|NCT00023075|Choline|choline
890070|NCT00023075|Creatine|creatine
890071|NCT00023075|Spasms|spasms
890072|NCT00023075|Spasticity|spasticity
890073|NCT00023075|Primary Lateral Sclerosis|primary lateral sclerosis
890074|NCT00023075|Hereditary Spastic Paraplegia|hereditary spastic paraplegia
890075|NCT00023075|Spastic Paraparesis|spastic paraparesis
890076|NCT00023075|Healthy Volunteer|healthy volunteer
890077|NCT00023075|HV|hv
890078|NCT00023075|Normal Control|normal control
890079|NCT00023062|Natural History|natural history
890080|NCT00023062|Motor Cortex|motor cortex
890081|NCT00023062|Behavior|behavior
890082|NCT00023062|Healthy Volunteers|healthy volunteers
890083|NCT00023062|Motor Control|motor control
890084|NCT00023062|Parkinson Disease|parkinson disease
890085|NCT00023062|Parkinson's|parkinson's
890086|NCT00023062|Healthy Volunteer|healthy volunteer
890087|NCT00023062|HV|hv
890088|NCT00023062|Normal Control|normal control
890089|NCT00023049|Deafness|deafness
890090|NCT00023049|Genes|genes
890091|NCT00023049|Impairment|impairment
890092|NCT00023049|Auditory|auditory
890093|NCT00023049|Vestibular|vestibular
890094|NCT00023049|Hereditary Hearing Disorder|hereditary hearing disorder
890095|NCT00023049|Hearing Impairment|hearing impairment
890096|NCT00023049|Sensorineural Hearing Loss|sensorineural hearing loss
890097|NCT00023049|Vestibular Dysfunction|vestibular dysfunction
890098|NCT00023049|SNHL|snhl
890099|NCT00023036|Genetics|genetics
890100|NCT00023036|Deafness|deafness
890101|NCT00023036|Genetic Markers|genetic markers
890102|NCT00023036|Genetic Analysis|genetic analysis
890103|NCT00023036|GENETIC LINKAGE|genetic linkage
890104|NCT00023036|Hearing Impairment|hearing impairment
890105|NCT00023036|Nonsyndromic Hereditary Hearing Impairment|nonsyndromic hereditary hearing impairment
890106|NCT00023036|SNHL|snhl
890107|NCT00023036|Inner Ear|inner ear
890108|NCT00023036|Enlarged Vestibular Aqueducts|enlarged vestibular aqueducts
890109|NCT00023036|EVA|eva
890110|NCT00023023|Hepatitis|hepatitis
890111|NCT00023023|Blood Bank|blood bank
890112|NCT00023023|Viruses|viruses
890113|NCT00023023|Blood Donors|blood donors
890114|NCT00023023|Blood Recipients|blood recipients
890115|NCT00023010|CD18|cd18
890116|NCT00023010|Retrovirus|retrovirus
890117|NCT00023010|RCR|rcr
890118|NCT00023010|Stem Cell|stem cell
890119|NCT00023010|Gene Transfer|gene transfer
890120|NCT00023010|Leukocyte Adhesion Deficiency|leukocyte adhesion deficiency
890121|NCT00023010|LAD|lad
890122|NCT00022997|Phenylthiocarbamide|phenylthiocarbamide
890123|NCT00022997|Phlebotomy|phlebotomy
890124|NCT00022997|Chemoreceptors|chemoreceptors
890125|NCT00022997|Population Associations|population associations
890126|NCT00022997|Non-Tasters|non-tasters
890127|NCT00022997|Taste|taste
890128|NCT00022997|Healthy Volunteer|healthy volunteer
890129|NCT00022997|HV|hv
890130|NCT00022997|Normal Control|normal control
890131|NCT00022984|Attitudes Towards Technology|attitudes towards technology
890132|NCT00022984|Cardiovascular Disease|cardiovascular disease
890133|NCT00022984|Illness Representation|illness representation
890134|NCT00022984|Implantable Cardioverter Defibrillator|implantable cardioverter defibrillator
890135|NCT00022984|Symptom Distress|symptom distress
890136|NCT00022984|Heart Disease|heart disease
890137|NCT00022984|ICD|icd
890138|NCT00022971|Monoclonal Antibody|monoclonal antibody
890139|NCT00022971|Lymphoma|lymphoma
890140|NCT00022971|Rituximab|rituximab
890141|NCT00022971|Hu1D10|hu1d10
890142|NCT00022971|Non-Hodgkin's Lymphoma|non-hodgkin's lymphoma
890143|NCT00022971|NHL|nhl
890144|NCT00022971|Chronic Lymphocytic Leukemia|chronic lymphocytic leukemia
890145|NCT00022971|CLL|cll
890146|NCT00022971|Leukemia|leukemia
890147|NCT00022958|Non-Hodgkin's Lymphoma|non-hodgkin's lymphoma
890148|NCT00022958|Radioimmunotherapy|radioimmunotherapy
890149|NCT00022958|Monoclonal Antibody|monoclonal antibody
890150|NCT00022958|Corixa|corixa
890151|NCT00022958|Bexxar|bexxar
890152|NCT00022958|Anti-B1 Antibody|anti-b1 antibody
890153|NCT00022958|Tositumomab|tositumomab
890154|NCT00022958|Iodine -131 Anti-B1 Antibody|iodine -131 anti-b1 antibody
890155|NCT00022958|Iodine I 131 Tositumomab|iodine i 131 tositumomab
890156|NCT00022945|Mantle Cell Lymphoma|mantle cell lymphoma
890157|NCT00022945|Radioimmunotherapy|radioimmunotherapy
890158|NCT00022945|Monoclonal Antibody|monoclonal antibody
890159|NCT00022945|Corixa|corixa
890160|NCT00022945|Bexxar|bexxar
890161|NCT00022945|Anti-B1 Antibody|anti-b1 antibody
890162|NCT00022945|Tositumomab|tositumomab
890163|NCT00022945|Iodine -131 Anti-B1 Antibody|iodine -131 anti-b1 antibody
890164|NCT00022945|Iodine I 131 Tositumomab|iodine i 131 tositumomab
890165|NCT00022932|Non-Hodgkin's Lymphoma|non-hodgkin's lymphoma
890166|NCT00022932|Radioimmunotherapy|radioimmunotherapy
890167|NCT00022932|Monoclonal Antibody|monoclonal antibody
890168|NCT00022932|Corixa|corixa
890169|NCT00022932|Bexxar|bexxar
890170|NCT00022932|Anti-B1 Antibody|anti-b1 antibody
890171|NCT00022932|Tositumomab|tositumomab
890172|NCT00022932|Iodine -131 Anti-B1 Antibody|iodine -131 anti-b1 antibody
890173|NCT00022932|Iodine I 131 Tositumomab|iodine i 131 tositumomab
890174|NCT00022919|Microdissection|microdissection
890175|NCT00022919|Chromosome|chromosome
890176|NCT00022919|Karyotype|karyotype
890177|NCT00022919|Tumor|tumor
890178|NCT00022919|Malignancy|malignancy
890179|NCT00022919|Prostate Adenocarcinoma|prostate adenocarcinoma
890180|NCT00022919|Prostate Intraepithelial Neoplasia|prostate intraepithelial neoplasia
890181|NCT00022919|Prostate Cancer|prostate cancer
890182|NCT00022919|Prostate|prostate
890183|NCT00022906|Non-Hodgkin's Lymphoma|non-hodgkin's lymphoma
890184|NCT00022906|Radioimmunotherapy|radioimmunotherapy
890185|NCT00022906|Monoclonal Antibody|monoclonal antibody
890186|NCT00022906|Corixa|corixa
890187|NCT00022906|Bexxar|bexxar
890188|NCT00022906|Anti-B1 Antibody|anti-b1 antibody
890189|NCT00022906|Tositumomab|tositumomab
890190|NCT00022906|Iodine -131 Anti-B1 Antibody|iodine -131 anti-b1 antibody
890191|NCT00022906|Iodine I 131 Tositumomab|iodine i 131 tositumomab
890192|NCT00022893|Non-Hodgkin's Lymphoma|non-hodgkin's lymphoma
890193|NCT00022893|Radioimmunotherapy|radioimmunotherapy
890194|NCT00022893|Monoclonal Antibody|monoclonal antibody
890195|NCT00022893|Corixa|corixa
890196|NCT00022893|Bexxar|bexxar
890197|NCT00022893|Anti-B1 Antibody|anti-b1 antibody
890199|NCT00022893|Iodine -131 Anti-B1 Antibody|iodine -131 anti-b1 antibody
890200|NCT00022893|Iodine I 131 Tositumomab|iodine i 131 tositumomab
890201|NCT00022880|Chronic Lymphocytic Leukemia|chronic lymphocytic leukemia
890202|NCT00022880|Dose-Escalation|dose-escalation
890203|NCT00022880|Radioimmunotherapy|radioimmunotherapy
890204|NCT00022880|Monoclonal Antibody|monoclonal antibody
890205|NCT00022880|Corixa|corixa
890206|NCT00022880|Bexxar|bexxar
890207|NCT00022880|Anti-B1 Antibody|anti-b1 antibody
890208|NCT00022880|Tositumomab|tositumomab
890209|NCT00022880|Iodine -131 Anti-B1 Antibody|iodine -131 anti-b1 antibody
890210|NCT00022880|Iodine I 131 Tositumomab|iodine i 131 tositumomab
890211|NCT00022867|Bone growth|bone growth
890212|NCT00022867|Calcium|calcium
890213|NCT00022867|Children|children
890214|NCT00022867|Diet|diet
890215|NCT00022867|Puberty|puberty
890216|NCT00022854|ACL|acl
890217|NCT00022854|Nerve block|nerve block
890218|NCT00022854|Knee|knee
890219|NCT00022854|Outcome survey|outcome survey
890220|NCT00022854|Anesthesia|anesthesia
890221|NCT00022854|Analgesia|analgesia
890222|NCT00022854|Pain|pain
890224|NCT00022841|Children|children
890225|NCT00022841|Glucocorticoids|glucocorticoids
890226|NCT00022841|Osteoporosis|osteoporosis
890227|NCT00022841|Pediatric|pediatric
890228|NCT00022841|Pamidronate|pamidronate
890229|NCT00022841|Steroids|steroids
890231|NCT00022828|Cervical|cervical
890232|NCT00022828|Spinal|spinal
890233|NCT00022828|Spine|spine
890234|NCT00022828|Neck|neck
890235|NCT00022828|Illinois|illinois
890236|NCT00022815|Compartment syndrome|compartment syndrome
890237|NCT00022815|Tissue ultrafiltration|tissue ultrafiltration
890238|NCT00022815|Reperfusion injury|reperfusion injury
890239|NCT00022815|Ischemia|ischemia
890240|NCT00022802|Biomedical equipment development|biomedical equipment development
890241|NCT00022802|Computer assisted patient care|computer assisted patient care
890242|NCT00022802|Digital imaging|digital imaging
890243|NCT00022802|Hip surgery|hip surgery
890244|NCT00022802|Orthopedics|orthopedics
890245|NCT00022802|Trauma|trauma
890246|NCT00022802|Radiography|radiography
890247|NCT00022802|Biomedical imaging|biomedical imaging
890248|NCT00022776|Human therapy evaluation|human therapy evaluation
890249|NCT00022776|Orthopedics|orthopedics
890250|NCT00022776|Physical therapy|physical therapy
890251|NCT00022776|Nonsurgical treatment|nonsurgical treatment
890252|NCT00022776|Surgical decompression|surgical decompression
890253|NCT00022776|Surgery|surgery
890254|NCT00022776|Lumbar|lumbar
890255|NCT00022776|Spine disorder|spine disorder
890256|NCT00022776|Spinal stenosis|spinal stenosis
890257|NCT00022776|Gender difference|gender difference
890258|NCT00022776|Medical rehabilitation|medical rehabilitation
890259|NCT00022789|Sleep-Disordered Breathing|sleep-disordered breathing
890260|NCT00022750|Type 2 Diabetes Mellitus|type 2 diabetes mellitus
890261|NCT00022750|Nurse Case Manager|nurse case manager
890262|NCT00022750|Community Health Worker|community health worker
890263|NCT00022750|Behavioral Interventions|behavioral interventions
890264|NCT00022750|Cost-effectiveness|cost-effectiveness
890265|NCT00022750|Randomized trial|randomized trial
890266|NCT00021866|epilepsy|epilepsy
890267|NCT00021866|seizure|seizure
890268|NCT00021866|pregnancy|pregnancy
890269|NCT00021866|antiepileptic|antiepileptic
890270|NCT00021866|AED|aed
890271|NCT00021866|carbamazepine|carbamazepine
890272|NCT00021866|phenytoin|phenytoin
890273|NCT00021866|valproate|valproate
890274|NCT00021866|lamotrigine|lamotrigine
890275|NCT00021866|child|child
890276|NCT00021866|behavior|behavior
890277|NCT00021853|Individualized|individualized
890278|NCT00021853|Finger|finger
890279|NCT00021853|Training|training
890280|NCT00021853|Splinting|splinting
890281|NCT00021853|TMS|tms
890282|NCT00021853|Dystonia|dystonia
890283|NCT00021853|Focal Dystonia|focal dystonia
890284|NCT00021853|Movement Disorder|movement disorder
890285|NCT00021853|Focal Hand Dystonia|focal hand dystonia
890286|NCT00021853|Writer's Cramp|writer's cramp
890287|NCT00021827|parathyroid hormone-related protein|parathyroid hormone-related protein
890288|NCT00021827|parathyroid hormone|parathyroid hormone
890289|NCT00021827|anabolic skeletal therapy|anabolic skeletal therapy
890290|NCT00021827|postmenopausal women|postmenopausal women
890291|NCT00021814|BPH progression|bph progression
890292|NCT00021814|Medical Therapy|medical therapy
890293|NCT00021814|Finasteride|finasteride
890294|NCT00021814|Doxazosin|doxazosin
890295|NCT00021814|Randomized|randomized
890296|NCT00021814|Multi-center|multi-center
890297|NCT00021814|Clinical Trial|clinical trial
890298|NCT00021814|Proscar|proscar
890299|NCT00021814|Cardura|cardura
890300|NCT00021801|Type I Diabetes Mellitus|type i diabetes mellitus
890301|NCT00021801|Immunosuppression|immunosuppression
890302|NCT00021801|Islet Cell Transplant|islet cell transplant
890303|NCT00021801|Percutaneous Transhepatic Portal|percutaneous transhepatic portal
890304|NCT00021788|Type I Diabetes Mellitus|type i diabetes mellitus
890305|NCT00021788|Immunosuppression|immunosuppression
890306|NCT00021788|Islet Cell Transplantation|islet cell transplantation
890307|NCT00021788|PercutaneousTranshepaticPortalVein Catheterization|percutaneoustranshepaticportalvein catheterization
890308|NCT00021749|CLL|cll
890309|NCT00021749|Leukemia|leukemia
890310|NCT00021749|Chronic|chronic
890311|NCT00021749|Cancer|cancer
890312|NCT00021749|Adult|adult
890313|NCT00021749|Lymphocytic|lymphocytic
890314|NCT00021749|Genasense|genasense
890315|NCT00021749|G3139|g3139
890316|NCT00021749|Genta|genta
890317|NCT00021749|Bcl-2|bcl-2
890318|NCT00021749|Antisense|antisense
890319|NCT00021749|Oligonucleotide|oligonucleotide
890320|NCT00021749|oblimerson|oblimerson
890321|NCT00021736|choroidal neovascularization (CNV)|choroidal neovascularization (cnv)
890322|NCT00021736|subretinal neovascularization|subretinal neovascularization
890323|NCT00021723|Alzheimer's|alzheimer's
890324|NCT00021723|AN-1792|an-1792
890325|NCT00021723|AIP-001|aip-001
890326|NCT00021710|Stroke|stroke
890327|NCT00021710|Learning|learning
890328|NCT00021710|Plasticity|plasticity
890329|NCT00021710|Motor|motor
890330|NCT00021710|Rehabilitation|rehabilitation
890331|NCT00021710|Premotor|premotor
890332|NCT00021710|Normal Control|normal control
890333|NCT00021710|Healthy Volunteer|healthy volunteer
890334|NCT00021710|HV|hv
890335|NCT00021710|Motor Learning|motor learning
890336|NCT00021697|AVP-923|avp-923
890337|NCT00021697|Dextromethorphan|dextromethorphan
890338|NCT00021697|Quinidine|quinidine
890339|NCT00021697|Pseudobulbar Affect|pseudobulbar affect
890340|NCT00021658|Epidemiology|epidemiology
890341|NCT00021658|pesticide|pesticide
890342|NCT00021658|asthma|asthma
890343|NCT00021658|children|children
890344|NCT00021658|exposure|exposure
890345|NCT00021645|Corticosteroids|corticosteroids
890346|NCT00021645|Immunosuppressives|immunosuppressives
890347|NCT00021645|Intraocular Inflammatory Disease|intraocular inflammatory disease
890348|NCT00021645|Uveitis|uveitis
890349|NCT00021645|Macular Edema|macular edema
890350|NCT00021567|Pneumonia|pneumonia
890351|NCT00021567|Cytokine|cytokine
890352|NCT00021567|Aerosol|aerosol
890353|NCT00021567|Therapy|therapy
890354|NCT00021567|Mycobacteria|mycobacteria
890355|NCT00021567|Mycobacterium Avium Complex|mycobacterium avium complex
890356|NCT00021567|MAC|mac
890357|NCT00021567|Pulmonary Infection|pulmonary infection
890358|NCT00021567|Lung Infection|lung infection
890359|NCT00021541|Surrogate Markers|surrogate markers
890360|NCT00021541|3-Dimensional Magnetic Resonance Imaging (MRI)|3-dimensional magnetic resonance imaging (mri)
890361|NCT00021541|Natural History of Neurofibromatosis Type 1 (NF1)|natural history of neurofibromatosis type 1 (nf1)
890362|NCT00021541|Tumor Tissue Bank|tumor tissue bank
890363|NCT00021541|Neurofibromatosis|neurofibromatosis
890364|NCT00021541|NF1|nf1
890365|NCT00021541|Neurofibromatosis Type 1|neurofibromatosis type 1
890366|NCT00021541|Plexiform Neurofibroma|plexiform neurofibroma
890367|NCT00021541|Neurofibroma|neurofibroma
890368|NCT00021528|Sequential Treatment|sequential treatment
890369|NCT00021528|Major Depression|major depression
890370|NCT00021528|Treatment Resistant Depression|treatment resistant depression
890499|NCT00018161|cigarette smoking|cigarette smoking
890371|NCT00021502|Pyridoxalated hemoglobin polyoxyethylene conjugate (PHP)|pyridoxalated hemoglobin polyoxyethylene conjugate (php)
890372|NCT00021502|Systemic Inflammatory Response Syndrome (SIRS)|systemic inflammatory response syndrome (sirs)
890373|NCT00021502|Nitric oxide (NO)|nitric oxide (no)
890374|NCT00021502|Shock|shock
890375|NCT00021476|Whiplash|whiplash
890376|NCT00021476|Chronic pain|chronic pain
890377|NCT00021476|Motor vehicle accidents|motor vehicle accidents
890378|NCT00021437|Bloom syndrome protein|bloom syndrome protein
890379|NCT00018902|Depressive Disorder|depressive disorder
890380|NCT00018902|Adolescents|adolescents
890381|NCT00018902|Teenagers|teenagers
890382|NCT00018902|Teens|teens
890383|NCT00018902|Cognitive Behavior Therapy|cognitive behavior therapy
890384|NCT00018889|Clinical Evaluation|clinical evaluation
890385|NCT00018889|Genetic Study|genetic study
890386|NCT00018889|Essential Tremor|essential tremor
890387|NCT00018889|Familial Myoclonus|familial myoclonus
890388|NCT00018889|Hereditary Ataxia|hereditary ataxia
890389|NCT00018889|Movement Disorder|movement disorder
890390|NCT00018889|Inherited Movement Disorder|inherited movement disorder
890391|NCT00018876|Epidural fibrosis|epidural fibrosis
890392|NCT00018876|Failed back surgery syndrome|failed back surgery syndrome
890393|NCT00018876|Postlaminectomy syndrome|postlaminectomy syndrome
890394|NCT00018876|Lumbar laminectomy|lumbar laminectomy
890395|NCT00018876|Radiotherapy|radiotherapy
890396|NCT00018876|Radiation|radiation
890397|NCT00018876|Perineural scar formation|perineural scar formation
890398|NCT00018876|Peridural fibrosis|peridural fibrosis
890399|NCT00018876|Back surgery|back surgery
890400|NCT00018863|ADHD|adhd
890401|NCT00018850|schizophrenia|schizophrenia
890402|NCT00018850|ondansetron|ondansetron
890403|NCT00018850|nicotine|nicotine
890404|NCT00018850|haloperidol|haloperidol
890405|NCT00018811|Relaxation Techniques|relaxation techniques
890406|NCT00018811|Behavior Therapy Feedback|behavior therapy feedback
890407|NCT00018811|Psychophysiology|psychophysiology
890408|NCT00018798|Combat-Related PTSD, Vietnam Veterans|combat-related ptsd, vietnam veterans
890409|NCT00018785|kidney transplantation|kidney transplantation
890410|NCT00018785|immunosuppression|immunosuppression
890411|NCT00018785|bone marrow|bone marrow
890412|NCT00018772|coagulation|coagulation
890413|NCT00018772|thrombosis genetic markers|thrombosis genetic markers
890414|NCT00018759|Serotonin, Hypertension, Depression|serotonin, hypertension, depression
890415|NCT00018733|Depression|depression
890416|NCT00018720|triglyceride|triglyceride
890417|NCT00018720|bile acids|bile acids
890418|NCT00018720|cholelithias|cholelithias
890419|NCT00018694|bile acid synthesis|bile acid synthesis
890420|NCT00018694|chenodeoxycholic acid|chenodeoxycholic acid
890421|NCT00018694|sterol 27-hydroxylase|sterol 27-hydroxylase
890422|NCT00018668|Antipsychotics|antipsychotics
890423|NCT00018668|schizophrenia|schizophrenia
890424|NCT00018668|motor retardation|motor retardation
890425|NCT00018668|bradykinesia|bradykinesia
890426|NCT00018655|Mood Disorders|mood disorders
890427|NCT00018655|Substance-Related Disorders|substance-related disorders
890428|NCT00018642|quetiapine|quetiapine
890429|NCT00018642|haloperidol decanoate|haloperidol decanoate
890431|NCT00018629|Neuropsychology|neuropsychology
890432|NCT00018629|Psychotherapy|psychotherapy
890433|NCT00018629|Rehabilitation|rehabilitation
890434|NCT00018629|Schizophrenia|schizophrenia
890435|NCT00018616|compliance|compliance
890436|NCT00018616|MEMS|mems
890437|NCT00018616|metformin|metformin
890438|NCT00018603|PTSD|ptsd
890439|NCT00018590|Vascular Diseases|vascular diseases
890440|NCT00018538|vitamin D|vitamin d
890441|NCT00018538|prostatic neoplasms|prostatic neoplasms
890442|NCT00018538|neoplasm recurrence|neoplasm recurrence
890443|NCT00018512|dental implant|dental implant
890444|NCT00018499|Traumatic Brain Injury|traumatic brain injury
890445|NCT00018473|Risk Factors|risk factors
890446|NCT00018473|Genes|genes
890447|NCT00018473|Epidemiology|epidemiology
890448|NCT00018473|Apolipoproteins E|apolipoproteins e
890449|NCT00018473|Alzheimer's Disease|alzheimer's disease
890450|NCT00018460|geriatrics|geriatrics
890451|NCT00018460|vitamin B complex|vitamin b complex
890452|NCT00018460|thrombomodulin|thrombomodulin
890453|NCT00018460|anticoagulants|anticoagulants
890454|NCT00018447|osteoporosis|osteoporosis
890455|NCT00018434|Infection|infection
890456|NCT00018421|Cerebrovascular Disorders|cerebrovascular disorders
890457|NCT00018421|Exercise|exercise
890458|NCT00018421|Rehabilitation|rehabilitation
890459|NCT00018408|COPD|copd
890460|NCT00018408|Smoking|smoking
890461|NCT00018395|Calcium Metabolism|calcium metabolism
890462|NCT00018369|Aging|aging
890463|NCT00018369|Hydrocortisone Corticotropin Feedback|hydrocortisone corticotropin feedback
890464|NCT00018356|Aging|aging
890465|NCT00018356|nutrition|nutrition
890466|NCT00018356|rehabilitation|rehabilitation
890467|NCT00018330|Behavioral|behavioral
890468|NCT00018330|Weight Loss|weight loss
890469|NCT00018330|Genetics|genetics
890470|NCT00018330|Lipoprotein lipase|lipoprotein lipase
890471|NCT00018330|Visceral fat|visceral fat
890472|NCT00018330|Lipoprotein|lipoprotein
890473|NCT00018317|Diet|diet
890474|NCT00018317|exercise|exercise
890475|NCT00018304|blood pressure|blood pressure
890476|NCT00018304|insulin sensitivity|insulin sensitivity
890477|NCT00018304|blood flow|blood flow
890478|NCT00018291|Dementia|dementia
890479|NCT00018291|Agitated Behavior|agitated behavior
890480|NCT00018291|Behavioral disturbance|behavioral disturbance
890481|NCT00018265|Rehabilitation|rehabilitation
890482|NCT00018265|exercise test|exercise test
890483|NCT00018265|aging|aging
890484|NCT00018213|Naltrexone|naltrexone
890485|NCT00018213|Nicotine patch|nicotine patch
890486|NCT00018213|Tobacco dependence|tobacco dependence
890487|NCT00018200|analgesia|analgesia
890488|NCT00018200|Back pain|back pain
890489|NCT00018200|sciatica|sciatica
890490|NCT00018187|smoking cessation|smoking cessation
890491|NCT00018187|bupropion|bupropion
890492|NCT00018187|mecamylamine|mecamylamine
890493|NCT00018187|nicotine|nicotine
890494|NCT00018174|Depression|depression
890495|NCT00018174|Fluoxetine|fluoxetine
890496|NCT00018174|Nicotine dependence|nicotine dependence
890497|NCT00018161|Nicotine|nicotine
890498|NCT00018161|addiction|addiction
890500|NCT00018148|smoking cessation|smoking cessation
890501|NCT00018135|high iPTH levels|high ipth levels
890502|NCT00018122|Islet cell transplant|islet cell transplant
890503|NCT00018096|Genetics|genetics
890504|NCT00018096|Lipopolysaccharide|lipopolysaccharide
890505|NCT00018070|Age-Related Macular Degeneration|age-related macular degeneration
890506|NCT00018070|Choroid|choroid
890507|NCT00018070|Blood Vessels|blood vessels
890508|NCT00018070|Choroidal Neovascularization|choroidal neovascularization
890509|NCT00018070|Laser|laser
890510|NCT00018070|Macular Degeneration|macular degeneration
890512|NCT00018057|fMRI|fmri
890513|NCT00018057|Emotion|emotion
890514|NCT00018057|Normal Volunteers|normal volunteers
890515|NCT00018057|Magnetic Resonance Imaging|magnetic resonance imaging
890516|NCT00018057|CBT|cbt
890517|NCT00018057|Adolescent|adolescent
890518|NCT00018057|Anxiety Disorder|anxiety disorder
890519|NCT00018057|Mood Disorder|mood disorder
890520|NCT00018057|Depression|depression
890521|NCT00018057|Healthy Volunteer|healthy volunteer
890522|NCT00018057|Normal Control|normal control
890523|NCT00018044|Mycobacterium Abscessus|mycobacterium abscessus
890524|NCT00018044|Pulmonary|pulmonary
890525|NCT00018044|Mycobacterium Chelonae|mycobacterium chelonae
890526|NCT00018044|Mycobacterium Avium Complex (MAC)|mycobacterium avium complex (mac)
890527|NCT00018044|Nontuberculous Mycobacteria (NTM)|nontuberculous mycobacteria (ntm)
890528|NCT00018044|Mycobacterial Infection|mycobacterial infection
890529|NCT00018044|Mycobacterium|mycobacterium
890530|NCT00018044|Nontuberculous Mycobacterial Infection|nontuberculous mycobacterial infection
890531|NCT00018044|NTM|ntm
890532|NCT00018044|Job's Syndrome|job's syndrome
890533|NCT00018044|Job Syndrome|job syndrome
890534|NCT00018044|Cystic Fibrosis|cystic fibrosis
890535|NCT00018044|CF|cf
890536|NCT00018031|Liver Disease|liver disease
890537|NCT00018031|Virologic Response|virologic response
890538|NCT00018031|Immune Mechanisms|immune mechanisms
890539|NCT00018031|Cirrhosis|cirrhosis
890540|NCT00018031|Eradication|eradication
890541|NCT00018031|HIV|hiv
890542|NCT00018031|Hepatitis C|hepatitis c
890543|NCT00018018|Gene Therapy|gene therapy
890544|NCT00018018|ADA-SCID|ada-scid
890545|NCT00018018|Stem Cells|stem cells
890546|NCT00018018|Retroviruses|retroviruses
890547|NCT00018018|Immune Deficiency Disease|immune deficiency disease
890548|NCT00018018|Adenosine Deaminase Deficiency|adenosine deaminase deficiency
890549|NCT00018018|ADA-Deficiency|ada-deficiency
890550|NCT00018018|Retroviral Vectors|retroviral vectors
890551|NCT00018018|Hematopoietic Progenitors|hematopoietic progenitors
890552|NCT00018018|Severe Combined Immunodeficiency|severe combined immunodeficiency
890553|NCT00018018|SCID|scid
890554|NCT00018018|Immune Deficiency|immune deficiency
890555|NCT00018005|Heart Failure|heart failure
890556|NCT00018005|Self-Management|self-management
890557|NCT00018005|Behavioral Clinical Trial|behavioral clinical trial
890558|NCT00017979|Transcranial Magnetic Stimulation|transcranial magnetic stimulation
890559|NCT00017979|Motor Cortex|motor cortex
890560|NCT00017979|Motor Imagery|motor imagery
890561|NCT00017979|Reaction Time|reaction time
890562|NCT00017979|Cerebral Inhibition|cerebral inhibition
890563|NCT00017979|Healthy Volunteer|healthy volunteer
890564|NCT00017979|Normal Control|normal control
890565|NCT00017966|Transcranial Magnetic Stimulation|transcranial magnetic stimulation
890566|NCT00017966|Motor Cortex|motor cortex
890567|NCT00017966|Cerebral Inhibition|cerebral inhibition
890568|NCT00017966|Corpus Callosum|corpus callosum
890569|NCT00017966|Evoked Potential|evoked potential
890570|NCT00017966|Healthy Volunteer|healthy volunteer
890571|NCT00017966|Normal Control|normal control
890572|NCT00017940|Gene Therapy|gene therapy
890573|NCT00017953|Diabetes|diabetes
890574|NCT00017953|Weight loss|weight loss
890575|NCT00017953|Heart Attack|heart attack
890576|NCT00017953|Heart disease|heart disease
890577|NCT00017953|Lifestyle Intervention|lifestyle intervention
890578|NCT00017953|Physical Fitness/Physical Activity|physical fitness/physical activity
890579|NCT00017953|Psychosocial outcomes (e.g., depression, eating disorders)|psychosocial outcomes (e.g., depression, eating disorders)
890580|NCT00017953|Bone Density|bone density
890581|NCT00017927|Acromegaly|acromegaly
890582|NCT00017927|McCune-Albright Syndrome|mccune-albright syndrome
890583|NCT00017927|IGF-1|igf-1
890584|NCT00017927|Adenoma|adenoma
890585|NCT00017927|Hyperplasia|hyperplasia
890586|NCT00017927|MAS|mas
890587|NCT00017927|Polyostotic Fibrous Dysplasia|polyostotic fibrous dysplasia
890588|NCT00017927|PFD|pfd
890589|NCT00017914|Adult and Pediatric Disease|adult and pediatric disease
890590|NCT00017914|Autoimmunity Pathogenesis|autoimmunity pathogenesis
890591|NCT00017914|Disease Assessment|disease assessment
890592|NCT00017914|Genetic and Environmental Risk Factors|genetic and environmental risk factors
890593|NCT00017914|Myositis|myositis
890594|NCT00017875|Transcranial Magnetic Stimulation|transcranial magnetic stimulation
890595|NCT00017875|Intracortical Inhibition|intracortical inhibition
890596|NCT00017875|Dystonia|dystonia
890597|NCT00017875|Focal Dystonia|focal dystonia
890598|NCT00017875|Dystonic Disorder|dystonic disorder
890599|NCT00017875|DYTI Dystonia|dyti dystonia
890600|NCT00017875|Movement Disorder|movement disorder
890601|NCT00017875|Generalized Dystonia|generalized dystonia
890602|NCT00017875|Healthy Control|healthy control
890603|NCT00017875|Normal Volunteer|normal volunteer
890604|NCT00017823|complementary therapies|complementary therapies
890605|NCT00017823|Acupressure|acupressure
890606|NCT00017823|HIV Infections|hiv infections
890607|NCT00017823|Nausea|nausea
890608|NCT00017823|Vomiting|vomiting
890609|NCT00017810|complementary therapies|complementary therapies
890610|NCT00017810|Behavior Therapy|behavior therapy
890611|NCT00017810|Diarrhea|diarrhea
890612|NCT00017810|Diet Therapy|diet therapy
890613|NCT00017810|Food|food
890614|NCT00017810|HIV Seropositivity|hiv seropositivity
890615|NCT00017745|DNA|dna
890616|NCT00017745|Hereditary Myopathies|hereditary myopathies
890617|NCT00017745|Intermediate Filaments|intermediate filaments
890618|NCT00017745|Cardiomyopathies|cardiomyopathies
890619|NCT00017745|Genetic Testing|genetic testing
890620|NCT00017745|Myopathy|myopathy
890621|NCT00017745|Inherited Neuromuscular Disorder|inherited neuromuscular disorder
890622|NCT00017732|Malformations|malformations
890623|NCT00017732|Ethnicity|ethnicity
890624|NCT00017732|Mutations|mutations
890625|NCT00017732|Cholesterol|cholesterol
890626|NCT00017732|Metabolism|metabolism
890627|NCT00017732|Smith-Lemli-Opitz Syndrome|smith-lemli-opitz syndrome
890628|NCT00017732|SLOS|slos
890629|NCT00017732|Cholesterol Metabolism|cholesterol metabolism
890630|NCT00017706|physician education|physician education
890631|NCT00017706|behavioral weight control|behavioral weight control
890632|NCT00017706|physician intervention|physician intervention
890633|NCT00017706|obesity counseling|obesity counseling
890634|NCT00016848|Obesity|obesity
890635|NCT00016848|Endocrine|endocrine
890636|NCT00016848|Diet|diet
890637|NCT00016848|Metabolism|metabolism
890638|NCT00016848|Macronutrients|macronutrients
890639|NCT00016835|Type 2 diabetes mellitus|type 2 diabetes mellitus
890640|NCT00016835|Glycemic control|glycemic control
890641|NCT00016835|Periodontal therapy|periodontal therapy
890642|NCT00017680|amyloidosis|amyloidosis
890643|NCT00017680|arthritis & connective tissue diseases|arthritis & connective tissue diseases
890644|NCT00017680|genetic diseases and dysmorphic syndromes|genetic diseases and dysmorphic syndromes
890645|NCT00017680|hematopoietic/lymphoid cancer|hematopoietic/lymphoid cancer
890646|NCT00017680|oncologic disorders|oncologic disorders
890647|NCT00017680|plasma cell neoplasm|plasma cell neoplasm
890648|NCT00017680|primary systemic amyloidosis|primary systemic amyloidosis
890649|NCT00017680|rare disease|rare disease
890650|NCT00017654|aplastic anemia|aplastic anemia
890651|NCT00017654|disease-related problem/condition|disease-related problem/condition
890652|NCT00017654|graft versus host disease|graft versus host disease
890653|NCT00017654|hematologic disorders|hematologic disorders
890654|NCT00017654|rare disease|rare disease
890655|NCT00017641|arthritis & connective tissue diseases|arthritis & connective tissue diseases
890656|NCT00017641|immunologic disorders and infectious disorders|immunologic disorders and infectious disorders
890657|NCT00017641|rare disease|rare disease
890658|NCT00017641|systemic lupus erythematosus|systemic lupus erythematosus
890659|NCT00017628|multiple sclerosis|multiple sclerosis
890660|NCT00017628|neurologic and psychiatric disorders|neurologic and psychiatric disorders
890661|NCT00017628|rare disease|rare disease
890662|NCT00016796|Reading|reading
890663|NCT00016796|Naming|naming
890664|NCT00016731|Depression|depression
890665|NCT00016731|Anxiety|anxiety
890666|NCT00016731|CAH|cah
890667|NCT00016731|Adults|adults
890668|NCT00016731|FMPP|fmpp
890669|NCT00016731|Emotion|emotion
890670|NCT00016731|Cushing's Syndrome|cushing's syndrome
890671|NCT00016731|Adolescence|adolescence
890672|NCT00016731|Magnetic Resonance Imaging|magnetic resonance imaging
890673|NCT00016731|fMRI|fmri
890674|NCT00016731|Healthy Volunteer|healthy volunteer
890675|NCT00016731|HV|hv
890676|NCT00016731|MRI|mri
890677|NCT00016679|Pharmacokinetics|pharmacokinetics
890678|NCT00016679|Metabolism|metabolism
890679|NCT00016679|Toxicity|toxicity
890680|NCT00016679|Side Effects|side effects
890681|NCT00016679|Essential Tremor|essential tremor
890682|NCT00016679|Tremor|tremor
890683|NCT00016679|Movement Disorder|movement disorder
890684|NCT00016666|Season|season
890685|NCT00016666|Light|light
890686|NCT00016666|Propranolol|propranolol
890687|NCT00016666|Photoperiod|photoperiod
890688|NCT00016666|Pharmacokinetics|pharmacokinetics
890689|NCT00016666|Circadian Rhythm|circadian rhythm
890690|NCT00016666|Seasonal Rhythm|seasonal rhythm
890691|NCT00016666|Seasonal Affective Disorder|seasonal affective disorder
890692|NCT00016666|Pineal Gland|pineal gland
890693|NCT00016666|Suprachiasmatic Nucleus|suprachiasmatic nucleus
890694|NCT00016666|Healthy Volunteer|healthy volunteer
890695|NCT00016666|HV|hv
890696|NCT00016666|Winter Depression|winter depression
890697|NCT00016666|SAD|sad
890698|NCT00016653|Duchenne|duchenne
890699|NCT00016653|muscular|muscular
890700|NCT00016653|dystrophy|dystrophy
890701|NCT00016653|treatment|treatment
890702|NCT00016562|Genetic|genetic
890703|NCT00016562|Degenerative|degenerative
890704|NCT00016562|Lysosomal|lysosomal
890705|NCT00016562|Brain|brain
890706|NCT00016562|Mental Retardation|mental retardation
890707|NCT00016562|Neurodegenerative Disorder|neurodegenerative disorder
890708|NCT00016562|Neurometabolic|neurometabolic
890709|NCT00016562|Metabolic Neurological Disorder|metabolic neurological disorder
890710|NCT00016562|Abnormal Metabolism|abnormal metabolism
890711|NCT00016549|Endothelial Proliferation|endothelial proliferation
890712|NCT00016549|Endothelial Apoptosis|endothelial apoptosis
890713|NCT00016549|VEGF|vegf
890714|NCT00016549|Magnetic Resonance Imaging|magnetic resonance imaging
890715|NCT00016549|Molecular Targets|molecular targets
890716|NCT00016549|Breast Cancer|breast cancer
890717|NCT00016549|Inflammatory Breast Cancer|inflammatory breast cancer
890718|NCT00016549|IBC|ibc
890719|NCT00016523|NICHD Neonatal Research Network|nichd neonatal research network
890720|NCT00016523|Extremely Low Birth Weight (ELBW)|extremely low birth weight (elbw)
890721|NCT00016523|Very Low Birth Weight (VLBW)|very low birth weight (vlbw)
890722|NCT00016523|Prematurity|prematurity
890723|NCT00016523|Inhaled nitric oxide|inhaled nitric oxide
890724|NCT00016523|Aspiration syndrome|aspiration syndrome
890725|NCT00016523|Idiopathic pulmonary hypertension|idiopathic pulmonary hypertension
890726|NCT00016523|Pulmonary hypoplasia|pulmonary hypoplasia
890727|NCT00016510|Bilingualism|bilingualism
890728|NCT00016510|Fluency|fluency
890729|NCT00016510|Age at Acquisition|age at acquisition
890730|NCT00016510|Words and Sentences|words and sentences
890731|NCT00016510|Cortical Area|cortical area
890732|NCT00016510|Healthy Volunteer|healthy volunteer
890733|NCT00016510|HV|hv
890734|NCT00016510|Bilingual|bilingual
890735|NCT00016510|Second Language|second language
890842|NCT00015548|delusions|delusions
890736|NCT00016497|otitis media with effusion|otitis media with effusion
890737|NCT00016497|children|children
890738|NCT00016497|tympanostomy tubes|tympanostomy tubes
890739|NCT00016497|adenoidectomy|adenoidectomy
890740|NCT00016458|arthritis & connective tissue diseases|arthritis & connective tissue diseases
890741|NCT00016458|rare disease|rare disease
890742|NCT00016458|systemic sclerosis|systemic sclerosis
890743|NCT00016445|cardiovascular and respiratory diseases|cardiovascular and respiratory diseases
890744|NCT00016445|cystic fibrosis|cystic fibrosis
890745|NCT00016445|disease-related problem/condition|disease-related problem/condition
890746|NCT00016445|genetic diseases and dysmorphic syndromes|genetic diseases and dysmorphic syndromes
890747|NCT00016445|quality of life|quality of life
890748|NCT00016445|rare disease|rare disease
890749|NCT00015808|Neurodegeneration|neurodegeneration
890750|NCT00015808|Anti-Oxidant|anti-oxidant
890751|NCT00015808|Neuropathy|neuropathy
890752|NCT00015808|Hereditary|hereditary
890753|NCT00015808|Spinocerebellar|spinocerebellar
890754|NCT00015808|Friedreich's Ataxia|friedreich's ataxia
890755|NCT00015808|Friedreich Ataxia|friedreich ataxia
890756|NCT00015808|FRDA|frda
890757|NCT00015795|Pressure|pressure
890758|NCT00015795|Botulinum Toxin|botulinum toxin
890759|NCT00015795|Voice|voice
890760|NCT00015795|Dystonia|dystonia
890761|NCT00015795|Pathophysiology|pathophysiology
890762|NCT00015795|Healthy Volunteer|healthy volunteer
890763|NCT00015795|HV|hv
890764|NCT00015795|ABSD|absd
890765|NCT00015795|Spasmodic Dysphonia|spasmodic dysphonia
890766|NCT00015795|Abductor Spasmodic Dysphonia|abductor spasmodic dysphonia
890767|NCT00015782|Metabolic|metabolic
890768|NCT00015782|Genetic|genetic
890769|NCT00015782|Storage|storage
890770|NCT00015782|Retinal Disease|retinal disease
890771|NCT00015782|Degenerative|degenerative
890772|NCT00015782|Mucolipidosis Type IV|mucolipidosis type iv
890773|NCT00015782|ML-IV|ml-iv
890774|NCT00015769|Mania|mania
890775|NCT00015769|Depression|depression
890776|NCT00015769|Anticonvulsants|anticonvulsants
890777|NCT00015769|Mood Stabilizers|mood stabilizers
890778|NCT00015769|Bipolar|bipolar
890779|NCT00015769|Mood Stabilizer|mood stabilizer
890780|NCT00015756|Apheresis|apheresis
890781|NCT00015756|Transplantation|transplantation
890782|NCT00015756|Type III Secretion Pathway|type iii secretion pathway
890783|NCT00015756|Exotoxins|exotoxins
890784|NCT00015756|Pseudomonas Aeruginosa|pseudomonas aeruginosa
890785|NCT00015756|Cystic Fibrosis|cystic fibrosis
890786|NCT00015756|CF|cf
890787|NCT00015717|Imaging|imaging
890788|NCT00015717|Complications|complications
890789|NCT00015717|Stenosis|stenosis
890790|NCT00015717|Treatment|treatment
890791|NCT00015717|Strokes|strokes
890792|NCT00015717|Cerebral Ischemia|cerebral ischemia
890793|NCT00015717|Cranial Cervical Angioplasty|cranial cervical angioplasty
890794|NCT00015678|Motor Cortex|motor cortex
890795|NCT00015678|Drug|drug
890796|NCT00015678|GABA|gaba
890797|NCT00015678|Cortical Modulation|cortical modulation
890798|NCT00015678|Magnetic Stimulation|magnetic stimulation
890799|NCT00015678|Healthy Volunteer|healthy volunteer
890800|NCT00015665|Fungal|fungal
890801|NCT00015665|Immunodeficiency|immunodeficiency
890802|NCT00015665|Infection|infection
890803|NCT00015665|Refractory|refractory
890804|NCT00015665|Severe|severe
890805|NCT00015665|Fungal Infections|fungal infections
890806|NCT00015639|Blood Donors|blood donors
890807|NCT00015639|Employees|employees
890808|NCT00015639|Heparin|heparin
890809|NCT00015639|Histidine-Rich Glycoprotein|histidine-rich glycoprotein
890810|NCT00015639|Membrane|membrane
890811|NCT00015639|Healthy Volunteer|healthy volunteer
890812|NCT00015613|Hispanics|hispanics
890813|NCT00015613|Acculturation|acculturation
890814|NCT00015613|Maternal Exposure|maternal exposure
890815|NCT00015613|Infant, Low Birth Weight|infant, low birth weight
890816|NCT00015613|Infant, Premature|infant, premature
890817|NCT00015613|Organophosphates|organophosphates
890818|NCT00015613|Pesticides|pesticides
890819|NCT00015613|Stress|stress
890820|NCT00015613|Nutrition|nutrition
890821|NCT00015600|Pesticide|pesticide
890822|NCT00015600|Farmworker|farmworker
890823|NCT00015600|Occupational health|occupational health
890824|NCT00015587|Molecular Epidemiology|molecular epidemiology
890825|NCT00015587|Case Control|case control
890826|NCT00015574|arrhythmia|arrhythmia
890827|NCT00015574|cardiac|cardiac
890828|NCT00015574|air pollution|air pollution
890829|NCT00015574|time series|time series
890830|NCT00015561|population studies|population studies
890831|NCT00015561|laboratory evaluation|laboratory evaluation
890832|NCT00015561|hormone analysis|hormone analysis
890833|NCT00015561|semen analysis|semen analysis
890834|NCT00015561|chromosome studies|chromosome studies
890835|NCT00015548|antipsychotic treatment|antipsychotic treatment
890836|NCT00015548|Alzheimer's disease|alzheimer's disease
890837|NCT00015548|agitation|agitation
890838|NCT00015548|dementia|dementia
890839|NCT00015548|psychosis|psychosis
890840|NCT00015548|behavioral symptoms|behavioral symptoms
890841|NCT00015548|hallucinations|hallucinations
890843|NCT00015483|Hematotoxicity|hematotoxicity
890844|NCT00015483|Benzene|benzene
890845|NCT00015483|Bone Marrow|bone marrow
890846|NCT00015470|Myopathy|myopathy
890847|NCT00015470|Dystrophy|dystrophy
890848|NCT00015470|Neuropathy|neuropathy
890849|NCT00015470|Muscle Weakness|muscle weakness
890850|NCT00015470|Muscle Cramps and Pains|muscle cramps and pains
890851|NCT00015470|Neuromuscular Disorders|neuromuscular disorders
890852|NCT00015457|Writer's Cramp|writer's cramp
890853|NCT00015457|Calcium Channel Antagonists|calcium channel antagonists
890854|NCT00015457|Torticollis|torticollis
890855|NCT00015457|Chemodenervation|chemodenervation
890856|NCT00015444|Apparently Sporadic Spastic Paraplegia|apparently sporadic spastic paraplegia
890857|NCT00015444|Spasticity|spasticity
890858|NCT00015444|Motor Neuron Disease|motor neuron disease
890859|NCT00015444|Amyotrophic Lateral Sclerosis|amyotrophic lateral sclerosis
890860|NCT00015444|Primary Lateral Sclerosis|primary lateral sclerosis
890861|NCT00015444|Muscle Stiffness|muscle stiffness
890862|NCT00015444|Involuntary Muscle Contraction|involuntary muscle contraction
890863|NCT00015444|Isaacs Syndrome|isaacs syndrome
890864|NCT00015431|Malabsorption|malabsorption
890865|NCT00015431|Endoscopy|endoscopy
890866|NCT00015431|Cytokine|cytokine
890867|NCT00015431|Immunophenotype|immunophenotype
890868|NCT00015431|Lymphocyte|lymphocyte
890869|NCT00015431|Common Variable Immunodeficiency|common variable immunodeficiency
890870|NCT00015431|Gastrointestinal|gastrointestinal
890871|NCT00015015|Dichloroacetate|dichloroacetate
890872|NCT00015015|Chlorinated hydrocarbons|chlorinated hydrocarbons
890873|NCT00015015|Genetic disease|genetic disease
890874|NCT00015015|Toxicology|toxicology
890875|NCT00015015|Biotransformation|biotransformation
890876|NCT00015340|Opioid Dependence|opioid dependence
890877|NCT00015249|cocaine dependence|cocaine dependence
890878|NCT00015210|Cocaine Use Disorders Dependence Depression|cocaine use disorders dependence depression
890879|NCT00015171|opioid dependence|opioid dependence
890880|NCT00015132|cocaine dependence|cocaine dependence
890881|NCT00015106|cocaine dependence|cocaine dependence
890882|NCT00015080|cocaine dependence|cocaine dependence
890883|NCT00015054|cocaine dependence|cocaine dependence
890884|NCT00015041|opiate dependence|opiate dependence
890885|NCT00015028|opioid dependence|opioid dependence
890886|NCT00015002|Antenatal corticosteroids|antenatal corticosteroids
890887|NCT00015002|Preterm delivery|preterm delivery
890888|NCT00014989|Preterm delivery|preterm delivery
890889|NCT00014989|Cerebral palsy|cerebral palsy
890890|NCT00014989|Magnesium sulfate|magnesium sulfate
890891|NCT00014976|Pyramidal Tract|pyramidal tract
890892|NCT00014976|Primary Lateral Sclerosis|primary lateral sclerosis
890893|NCT00014976|Spastic Paraparesis|spastic paraparesis
890895|NCT00014976|Magnetic Stimulation|magnetic stimulation
890896|NCT00014976|Muscle Spasticity|muscle spasticity
890897|NCT00014976|Healthy Volunteer|healthy volunteer
890898|NCT00014963|benzene|benzene
890899|NCT00014963|biomarkers|biomarkers
890900|NCT00014963|air pollution|air pollution
890901|NCT00014963|muconic acid|muconic acid
890902|NCT00014963|phenylmercapturic acid|phenylmercapturic acid
890903|NCT00014950|Cystic Fibrosis|cystic fibrosis
890904|NCT00014950|Immunoreactive trypsinogen|immunoreactive trypsinogen
890905|NCT00014950|deltaF508- CFTR gene|deltaf508- cftr gene
890906|NCT00014950|newborn screening|newborn screening
890907|NCT00014950|Pseudomonas aeruginosa infection|pseudomonas aeruginosa infection
890908|NCT00014950|nutrition|nutrition
890909|NCT00014950|pulmonary status|pulmonary status
890910|NCT00014950|meconium ileus|meconium ileus
890911|NCT00014950|growth|growth
890912|NCT00014950|Genetic counseling|genetic counseling
890913|NCT00014950|risk communication|risk communication
890914|NCT00014898|Lead exposure|lead exposure
890915|NCT00014898|Bone lead|bone lead
890916|NCT00014898|Attention deficit|attention deficit
890917|NCT00014885|Lead exposure|lead exposure
890918|NCT00014885|Bone lead|bone lead
890919|NCT00014885|Cognitive function|cognitive function
890920|NCT00014885|Academic achievement|academic achievement
890921|NCT00014885|Neurobehavior|neurobehavior
890922|NCT00014859|Pulmonary surfactant|pulmonary surfactant
890923|NCT00014859|Surfactant protein B|surfactant protein b
890924|NCT00014859|Surfactant protein C|surfactant protein c
890925|NCT00014859|ABCA3|abca3
890926|NCT00014859|NKX2-1|nkx2-1
890927|NCT00014859|Alveolar type 2 cell|alveolar type 2 cell
890928|NCT00014807|Pesticide exposure|pesticide exposure
890929|NCT00014807|Organophosphate|organophosphate
890930|NCT00014807|Biomarkers of exposure|biomarkers of exposure
890931|NCT00014807|Poisoning|poisoning
890932|NCT00014807|Occupational Health|occupational health
890933|NCT00014794|Arthritis|arthritis
890934|NCT00014794|Vascularity|vascularity
890935|NCT00014794|Angiogenesis|angiogenesis
890936|NCT00014794|Imaging|imaging
890938|NCT00014794|Rheumatoid Arthritis|rheumatoid arthritis
890939|NCT00014794|PET Scan|pet scan
890940|NCT00014794|Synovitis|synovitis
890941|NCT00014781|cardiovascular and respiratory diseases|cardiovascular and respiratory diseases
890942|NCT00014781|cystic fibrosis|cystic fibrosis
890943|NCT00014781|genetic diseases and dysmorphic syndromes|genetic diseases and dysmorphic syndromes
890944|NCT00014781|rare disease|rare disease
890945|NCT00014768|cardiovascular and respiratory diseases|cardiovascular and respiratory diseases
890946|NCT00014768|cystic fibrosis|cystic fibrosis
890947|NCT00014768|genetic diseases and dysmorphic syndromes|genetic diseases and dysmorphic syndromes
890948|NCT00014768|rare disease|rare disease
890949|NCT00014755|multiple sclerosis|multiple sclerosis
890950|NCT00014755|neurologic and psychiatric disorders|neurologic and psychiatric disorders
890951|NCT00014755|rare disease|rare disease
890952|NCT00014742|Dupuytren's disease|dupuytren's disease
890953|NCT00014742|arthritis & connective tissue diseases|arthritis & connective tissue diseases
890954|NCT00014742|rare disease|rare disease
890955|NCT00014729|dermatologic disorders|dermatologic disorders
890956|NCT00014729|epidermolysis bullosa|epidermolysis bullosa
890957|NCT00014729|genetic diseases and dysmorphic syndromes|genetic diseases and dysmorphic syndromes
890958|NCT00014729|rare disease|rare disease
890959|NCT00014040|Angina Pectoris|angina pectoris
890960|NCT00014040|Endothelium|endothelium
890961|NCT00014040|Platelets|platelets
890962|NCT00014040|Inflammation|inflammation
890963|NCT00014040|Atherosclerosis|atherosclerosis
890964|NCT00014040|Coronary Artery Disease|coronary artery disease
890965|NCT00014040|Chest Pain|chest pain
890966|NCT00014040|Nitrous Oxide Inhalation|nitrous oxide inhalation
890967|NCT00014040|Treadmill Exercise|treadmill exercise
890968|NCT00014027|Omega-3 Fatty Acids|omega-3 fatty acids
890969|NCT00014027|Cerebrospinal Fluid|cerebrospinal fluid
890970|NCT00014027|Neurotransmitters|neurotransmitters
890971|NCT00014027|Cardiovascular|cardiovascular
890972|NCT00014027|Reactivity|reactivity
890973|NCT00014027|Healthy Volunteer|healthy volunteer
890974|NCT00014027|Lumbar Puncture|lumbar puncture
890975|NCT00014027|MRI|mri
890976|NCT00014001|Antipsychotic Treatment|antipsychotic treatment
890977|NCT00014001|Effectiveness|effectiveness
890978|NCT00013975|Framingham Risk Scoring|framingham risk scoring
890979|NCT00013975|Brachial Artery Reactivity|brachial artery reactivity
890980|NCT00013975|EPC Colony Assay|epc colony assay
890981|NCT00013975|Healthy Volunteer|healthy volunteer
890982|NCT00013975|Atherosclerosis Risk Factors|atherosclerosis risk factors
890983|NCT00013975|Cholesterol|cholesterol
890984|NCT00013975|Hypertension|hypertension
890985|NCT00013975|Smoking|smoking
890986|NCT00013975|Diabetes|diabetes
890987|NCT00013975|Postmenopausal|postmenopausal
890988|NCT00013975|Heart Disease Risk Factors|heart disease risk factors
890989|NCT00013975|Risk Factors|risk factors
890990|NCT00013949|Holter monitoring|holter monitoring
890991|NCT00013949|ECG|ecg
890992|NCT00013949|Cardiac|cardiac
890993|NCT00013949|particulate exposure|particulate exposure
890994|NCT00013936|Instrument Development|instrument development
890995|NCT00013936|Psychophysical Methods|psychophysical methods
890996|NCT00013936|ETDRS|etdrs
890997|NCT00013936|Computer-Based Methods|computer-based methods
890998|NCT00013936|Validation Study|validation study
890999|NCT00013936|Visual Acuity|visual acuity
891000|NCT00013936|Vision Tests/Instrumentation|vision tests/instrumentation
891001|NCT00013936|Psychophysics|psychophysics
891002|NCT00013936|Modified Binary Search|modified binary search
891003|NCT00013936|Visual Acuity Test|visual acuity test
891004|NCT00013923|Nutritional Supplement|nutritional supplement
891005|NCT00013910|glucagon-like peptide 1|glucagon-like peptide 1
891006|NCT00013858|methylmercury|methylmercury
891007|NCT00013858|PCBs|pcbs
891008|NCT00013858|lead|lead
891009|NCT00013858|fish consumption|fish consumption
891010|NCT00013858|breast-feeding|breast-feeding
891011|NCT00013884|HIV|hiv
891012|NCT00013884|T20|t20
891013|NCT00013884|HAART|haart
891014|NCT00013884|Interruption|interruption
891015|NCT00013884|Therapy|therapy
891016|NCT00013884|Fusion Inhibitor T20|fusion inhibitor t20
891017|NCT00013884|Treatment Interuption|treatment interuption
891018|NCT00013845|Seizures|seizures
891019|NCT00013845|Anti-Epileptic Drugs|anti-epileptic drugs
891020|NCT00013845|Pharmacotherapy|pharmacotherapy
891021|NCT00013845|Neuropsychology|neuropsychology
891022|NCT00013845|Temporal Lobe Epilepsy|temporal lobe epilepsy
891023|NCT00013845|Frontal Lobe Epilepsy|frontal lobe epilepsy
891024|NCT00013845|Complex Partial Seizures|complex partial seizures
891025|NCT00013845|Grand Mal Seizures|grand mal seizures
891026|NCT00013845|Generalized Seizures|generalized seizures
891027|NCT00013845|Epilepsy|epilepsy
891028|NCT00013832|Pressure|pressure
891029|NCT00013832|Swallowing|swallowing
891030|NCT00013832|Tongue|tongue
891031|NCT00013832|Healthy Volunteer|healthy volunteer
891032|NCT00013832|Dysphagia|dysphagia
891033|NCT00013819|lead poisoning|lead poisoning
891034|NCT00013819|central nervous system|central nervous system
891035|NCT00013819|peripheral nervous system|peripheral nervous system
891036|NCT00013819|occupational health|occupational health
891037|NCT00013819|genetic susceptibility|genetic susceptibility
891038|NCT00013806|Relapsed and refractory neuroblastoma|relapsed and refractory neuroblastoma
891039|NCT00013780|ozone uptake|ozone uptake
891040|NCT00013780|inhalation toxicology|inhalation toxicology
891041|NCT00013780|nasal cavities|nasal cavities
891042|NCT00013780|antioxidants|antioxidants
891043|NCT00013767|Pesticide|pesticide
891044|NCT00013767|Insecticide|insecticide
891045|NCT00013767|Organophosphate|organophosphate
891046|NCT00013767|Child Health|child health
891047|NCT00013767|Exposure Prevention|exposure prevention
891048|NCT00013754|pesticide|pesticide
891049|NCT00013754|insecticide|insecticide
891050|NCT00013754|organophosphate|organophosphate
891051|NCT00013754|exposure|exposure
891052|NCT00013754|child health|child health
891053|NCT00013741|Acute Myocardial Infarction|acute myocardial infarction
891054|NCT00013741|Diabetes Mellitus|diabetes mellitus
891055|NCT00013741|Renal Dialysis|renal dialysis
891056|NCT00013741|Heart Attack|heart attack
891057|NCT00013741|Coronary Heart Disease|coronary heart disease
891058|NCT00013728|asthma|asthma
891059|NCT00013728|particulate matter|particulate matter
891060|NCT00013715|Asthma|asthma
891061|NCT00013715|Rhinovirus|rhinovirus
891062|NCT00013715|Ozone|ozone
891063|NCT00013702|Immunology|immunology
891064|NCT00013702|Cirrhosis|cirrhosis
891065|NCT00013702|Ascites|ascites
891066|NCT00013702|Open-Label|open-label
891067|NCT00013702|Chronic|chronic
891068|NCT00013702|HIV|hiv
891069|NCT00013702|Hepatitis B|hepatitis b
891070|NCT00013689|Lymphadenopathy|lymphadenopathy
891071|NCT00013689|Splenomegaly|splenomegaly
891072|NCT00013689|Children|children
891073|NCT00013689|Tomography|tomography
891074|NCT00013689|Autoimmune Lymphoproliferative Syndrome (ALPS)|autoimmune lymphoproliferative syndrome (alps)
891075|NCT00013650|Alzheimer's Disease|alzheimer's disease
891076|NCT00013650|Immunomodulatory|immunomodulatory
891077|NCT00013650|Antiinflammatory|antiinflammatory
891078|NCT00013650|Cyclophosphamide|cyclophosphamide
891079|NCT00013650|Non-steroidal|non-steroidal
891080|NCT00013650|Complement|complement
891081|NCT00013650|Immune Function|immune function
891082|NCT00013650|Immunotherapy|immunotherapy
891083|NCT00013637|Osteoporosis|osteoporosis
891084|NCT00013637|Lead|lead
891085|NCT00013624|Riluzole|riluzole
891086|NCT00013624|Dyskinesias|dyskinesias
891087|NCT00013624|L-Dopa Infusion|l-dopa infusion
891088|NCT00013624|Parkinson's Disease|parkinson's disease
891089|NCT00013611|HIV|hiv
891090|NCT00013611|Proleukin|proleukin
891091|NCT00013611|IL-2|il-2
891092|NCT00013611|Adult|adult
891093|NCT00013611|HAART|haart
891094|NCT00013611|Treatment Experienced|treatment experienced
891095|NCT00013598|Insulin Resistance|insulin resistance
891096|NCT00013598|Obesity|obesity
891097|NCT00013598|Diabetes|diabetes
891098|NCT00013598|Fatty Liver|fatty liver
891099|NCT00013598|Cirrhosis|cirrhosis
891100|NCT00013598|Thiazolidinediones|thiazolidinediones
891101|NCT00013598|Peroxisome Proliferator-Activated Receptor Gamma|peroxisome proliferator-activated receptor gamma
891102|NCT00013598|PPARgamma|ppargamma
891103|NCT00013598|Nonalcoholic Steatohepatitis|nonalcoholic steatohepatitis
891104|NCT00013598|Pioglitazone|pioglitazone
891105|NCT00013598|Non-Alcoholic Steatohepatitis|non-alcoholic steatohepatitis
891106|NCT00013598|Liver Biopsy|liver biopsy
891107|NCT00013598|Pharmacotherapy|pharmacotherapy
891108|NCT00013559|Sleep Disturbance|sleep disturbance
891109|NCT00013559|Developmental Delay/ MR|developmental delay/ mr
891110|NCT00013559|Deletion 17p11.2|deletion 17p11.2
891111|NCT00013559|Chromosomal Abnormalities|chromosomal abnormalities
891112|NCT00013559|Behavioral Phenotype|behavioral phenotype
891113|NCT00013559|Smith-Magenis Syndrome|smith-magenis syndrome
891114|NCT00013559|Genetics|genetics
891115|NCT00013546|Osteoporosis|osteoporosis
891116|NCT00013546|Body Composition|body composition
891117|NCT00013546|Estrogen|estrogen
891118|NCT00013546|Androgen|androgen
891119|NCT00013546|Ovarian Failure|ovarian failure
891120|NCT00013546|Turner's Syndrome|turner's syndrome
891121|NCT00013546|Hormone Replacement|hormone replacement
891122|NCT00013546|Turners|turners
891126|NCT00013533|Myelodysplastic Syndrome|myelodysplastic syndrome
891127|NCT00013533|Bone Marrow Transplant|bone marrow transplant
891128|NCT00013533|Pediatric Oncology|pediatric oncology
891129|NCT00013533|Lymphoma|lymphoma
891130|NCT00013533|Efficacy|efficacy
891131|NCT00013533|Safety|safety
891132|NCT00013533|Childhood Cancer|childhood cancer
891133|NCT00013507|Frail|frail
891134|NCT00013507|FIT|fit
891135|NCT00013507|transfer|transfer
891136|NCT00013507|continence|continence
891137|NCT00013507|ambulation|ambulation
891138|NCT00013507|balance|balance
891139|NCT00013507|fall risk|fall risk
891140|NCT00013507|strength,endurance|strength,endurance
891141|NCT00013494|Hemiplegia|hemiplegia
891142|NCT00013494|elderly|elderly
891143|NCT00013494|Video|video
891144|NCT00013494|F-PAT,Functional Performance|f-pat,functional performance
891145|NCT00013494|digitized videoclips|digitized videoclips
891146|NCT00013481|stroke, hemiparesis, CNS, motor coordination|stroke, hemiparesis, cns, motor coordination
891439|NCT00010855|hypnosis|hypnosis
891147|NCT00013468|Hearing loss, ear, steroids, auditory|hearing loss, ear, steroids, auditory
891148|NCT00013455|Hearing aid, hearing impaired|hearing aid, hearing impaired
891149|NCT00013442|Aphasia, auditory evoked, aging|aphasia, auditory evoked, aging
891150|NCT00013429|Vision, Opthalmology, blindness, aging|vision, opthalmology, blindness, aging
891151|NCT00013416|Hearing loss, hearing aid, amplification|hearing loss, hearing aid, amplification
891152|NCT00013403|Vision, quality of life|vision, quality of life
891153|NCT00013390|Auditory, tinnitus|auditory, tinnitus
891154|NCT00013377|Low vision, Driving rehabilitation|low vision, driving rehabilitation
891155|NCT00013364|Hearing loss, speech recognition|hearing loss, speech recognition
891156|NCT00013351|Aging adult, attention, falls, vision|aging adult, attention, falls, vision
891157|NCT00013338|Spinal cord injury, ambulation, treadmill|spinal cord injury, ambulation, treadmill
891158|NCT00013325|Spinal cord injury, heart disease, electrocardiography|spinal cord injury, heart disease, electrocardiography
891159|NCT00013312|Spinal cord injury, gastrointestinal motility, gastrointestinal transit|spinal cord injury, gastrointestinal motility, gastrointestinal transit
891160|NCT00013299|Foot ulcers, amputation prevention, diabetes, footwear, insoles|foot ulcers, amputation prevention, diabetes, footwear, insoles
891161|NCT00013286|Diabetes mellitus, foot ulcer, endothelium|diabetes mellitus, foot ulcer, endothelium
891162|NCT00013273|Venous insufficiency, plethysmography, hypertension|venous insufficiency, plethysmography, hypertension
891163|NCT00013260|Case management|case management
891164|NCT00013260|Nurse intervention|nurse intervention
891165|NCT00013195|Telephone|telephone
891166|NCT00013026|Congestive Heart Failure|congestive heart failure
891167|NCT00012844|Musculoskeletal Disorders|musculoskeletal disorders
891168|NCT00012844|Patient Lifting|patient lifting
891169|NCT00012844|Occupational Accidents|occupational accidents
891170|NCT00012779|Health Care Education|health care education
891171|NCT00012779|Health Care Cost|health care cost
891172|NCT00012558|Psychotic Disorders|psychotic disorders
891173|NCT00012558|Mood Disorders|mood disorders
891174|NCT00012558|Manic-Depressive Illness|manic-depressive illness
891175|NCT00012558|Hypomania|hypomania
891176|NCT00012558|Mania|mania
891177|NCT00012558|Mood Stabilizer|mood stabilizer
891178|NCT00012545|Stem Cells|stem cells
891179|NCT00012545|Sickle Cell Disease|sickle cell disease
891180|NCT00012545|Umbilical Cord Blood|umbilical cord blood
891181|NCT00012493|Cardiac event|cardiac event
891182|NCT00012493|Heart disease|heart disease
891183|NCT00012493|Particulate Matter|particulate matter
891184|NCT00012480|Lead|lead
891185|NCT00012480|Male infertility|male infertility
891186|NCT00012480|Gene expression|gene expression
891187|NCT00012480|Economics, Medical|economics, medical
891188|NCT00012441|Renal Dialysis|renal dialysis
891189|NCT00012428|Cognitive development|cognitive development
891190|NCT00012428|Prenatal exposure|prenatal exposure
891191|NCT00012428|PCBs|pcbs
891192|NCT00011908|Safety|safety
891193|NCT00011908|B-Lymphocyte Depletion|b-lymphocyte depletion
891194|NCT00011908|Anti-CD22|anti-cd22
891195|NCT00011908|Response|response
891196|NCT00011908|Efficacy|efficacy
891197|NCT00011908|Lupus|lupus
891198|NCT00011908|Immunotherapy|immunotherapy
891199|NCT00011856|Intracranial Aneurysms|intracranial aneurysms
891200|NCT00011856|Cerebral|cerebral
891201|NCT00011856|Loci|loci
891202|NCT00011856|Susceptibility Genes|susceptibility genes
891203|NCT00011856|Cerebral Aneurysm|cerebral aneurysm
891204|NCT00011856|Familial Cerebral Aneurysm|familial cerebral aneurysm
891205|NCT00011856|Genetics|genetics
891206|NCT00011843|X-Linked|x-linked
891207|NCT00011843|Heterogeneous|heterogeneous
891208|NCT00011843|Embryologic Development|embryologic development
891209|NCT00011843|Mental Retardation|mental retardation
891210|NCT00011843|Brain Development|brain development
891211|NCT00011843|Microphthalmia|microphthalmia
891212|NCT00011843|Anophthalmia|anophthalmia
891213|NCT00011843|Malformations|malformations
891214|NCT00011843|Lenz Dysplasia|lenz dysplasia
891215|NCT00011843|Microphthalmia/Anophthalmia|microphthalmia/anophthalmia
891216|NCT00011843|Mutation Screening|mutation screening
891217|NCT00011843|Gene Characterization|gene characterization
891218|NCT00011830|Stem Cell Cryopreservation|stem cell cryopreservation
891219|NCT00011830|Leukapheresis|leukapheresis
891220|NCT00011817|Evaluation and Treatment|evaluation and treatment
891221|NCT00011817|Ophthalmic Genetic Diseases|ophthalmic genetic diseases
891222|NCT00011817|Genetic Testing|genetic testing
891223|NCT00011817|Genetic Eye Diseases|genetic eye diseases
891224|NCT00011817|Evaluation|evaluation
891225|NCT00011804|Low Back Pain|low back pain
891226|NCT00011804|Lumbar Radiculopathy|lumbar radiculopathy
891227|NCT00011804|Anticonvulsants|anticonvulsants
891228|NCT00011804|Neuropathic Pain|neuropathic pain
891229|NCT00011804|Analgesia|analgesia
891230|NCT00011804|Sciatica|sciatica
891231|NCT00011791|CAH|cah
891232|NCT00011791|Catecholamines|catecholamines
891233|NCT00011791|Adrenal Medulla|adrenal medulla
891234|NCT00011791|Endocrine|endocrine
891235|NCT00011791|Congenital Adrenal Hyperplasia|congenital adrenal hyperplasia
891236|NCT00011791|Exercise|exercise
891237|NCT00011791|Healthy Volunteer|healthy volunteer
891238|NCT00011778|Cell Cycle|cell cycle
891239|NCT00011778|NFKB|nfkb
891240|NCT00011778|Combined Modality|combined modality
891241|NCT00011778|Radiosensitizer|radiosensitizer
891242|NCT00011778|Ubiquitin|ubiquitin
891243|NCT00011778|Head and Neck Cancer|head and neck cancer
891244|NCT00011778|Squamous Cell Carcinoma|squamous cell carcinoma
891245|NCT00011778|Radiation Therapy|radiation therapy
891246|NCT00011778|Protease Inhibitor|protease inhibitor
891247|NCT00011765|Aggression|aggression
891248|NCT00011765|Serotonin Reuptake Inhibitors (SSRI)|serotonin reuptake inhibitors (ssri)
891249|NCT00011765|Rage|rage
891250|NCT00011765|Fear|fear
891251|NCT00011765|Violence|violence
891252|NCT00011765|Domestic Violence|domestic violence
891253|NCT00011765|Physical Aggression|physical aggression
891254|NCT00011765|Serotonin Reuptake Inhibitor|serotonin reuptake inhibitor
891255|NCT00011752|Serotonin Reuptake|serotonin reuptake
891256|NCT00011752|Large Neutral Amino Acids|large neutral amino acids
891257|NCT00011752|5-Hydroxyindoleacetic Acid|5-hydroxyindoleacetic acid
891258|NCT00011752|Alcoholism|alcoholism
891259|NCT00011752|PET|pet
891260|NCT00011752|TRP|trp
891261|NCT00011752|Tryptophan Depletion|tryptophan depletion
891262|NCT00011752|Healthy Volunteer|healthy volunteer
891263|NCT00011739|Low back pain, Magnetic resonance imaging (MRI),|low back pain, magnetic resonance imaging (mri),
891264|NCT00011726|Pregnancy|pregnancy
891265|NCT00011726|Lead Exposure|lead exposure
891266|NCT00011726|Lactation|lactation
891267|NCT00011726|Bone Mineralization|bone mineralization
891268|NCT00011726|Maternal-Fetal Exchange|maternal-fetal exchange
891269|NCT00011713|Semen|semen
891270|NCT00011713|Infertility|infertility
891271|NCT00011713|ART - Assisted Reproduction Technology|art - assisted reproduction technology
891272|NCT00011713|Phthalates|phthalates
891273|NCT00011713|Bisphenol A|bisphenol a
891274|NCT00011700|idiopathic pulmonary hemorrhage in infants,|idiopathic pulmonary hemorrhage in infants,
891275|NCT00011700|toxigenic mold exposure|toxigenic mold exposure
891276|NCT00011687|Fertility|fertility
891277|NCT00011687|Hormones|hormones
891278|NCT00011687|Semen|semen
891279|NCT00011687|Reproductive Health|reproductive health
891280|NCT00011674|Lead|lead
891281|NCT00011674|Prenatal|prenatal
891282|NCT00011674|Development|development
891283|NCT00011674|Children|children
891284|NCT00011674|Psychology|psychology
891285|NCT00011674|Toxicology|toxicology
891286|NCT00011674|Teratology|teratology
891287|NCT00011661|Lead poisoning|lead poisoning
891288|NCT00011661|Native Americans|native americans
891289|NCT00011648|Echocardiogram|echocardiogram
891290|NCT00011648|Morbidity|morbidity
891291|NCT00011648|Mortality|mortality
891292|NCT00011648|Sickle Cell Anemia|sickle cell anemia
891293|NCT00011648|Secondary Pulmonary Hypertension|secondary pulmonary hypertension
891294|NCT00011609|Robotics; Activities of Daily Living; Spinal Cord Injuries|robotics; activities of daily living; spinal cord injuries
891295|NCT00011596|Hemiplegia, gait, electric stimulation|hemiplegia, gait, electric stimulation
891296|NCT00011583|Cerebrovascular|cerebrovascular
891297|NCT00011583|Hemiplegia|hemiplegia
891298|NCT00011583|Robotics|robotics
891299|NCT00011570|defecation|defecation
891300|NCT00011570|electrical stimulation|electrical stimulation
891301|NCT00011570|penile erection|penile erection
891302|NCT00011570|Spinal cord injury|spinal cord injury
891303|NCT00011570|urology|urology
891304|NCT00011557|Bladder, electromagnetic fields, Spinal cord injury|bladder, electromagnetic fields, spinal cord injury
891305|NCT00011544|wheelchair, biomechanics, aging, functional outcome, disability|wheelchair, biomechanics, aging, functional outcome, disability
891306|NCT00011531|Decubitus Ulcers|decubitus ulcers
891307|NCT00011531|dehiscence|dehiscence
891308|NCT00011531|SCI|sci
891309|NCT00011531|wound healing|wound healing
891310|NCT00011518|Arsenic|arsenic
891311|NCT00011518|Bladder Cancer|bladder cancer
891312|NCT00011518|Drinking Water|drinking water
891313|NCT00011505|G-CSF|g-csf
891314|NCT00011505|Leukapheresis|leukapheresis
891315|NCT00011505|Stem Cell Cryopreservation|stem cell cryopreservation
891316|NCT00011505|Central Line Placement|central line placement
891317|NCT00011505|G-CSF Administration|g-csf administration
891318|NCT00011505|Stem Cell Preservation|stem cell preservation
891319|NCT00011505|Diamond Blackfan Anemia|diamond blackfan anemia
891320|NCT00011505|Healthy Volunteer|healthy volunteer
891321|NCT00011492|Oral Cancer|oral cancer
891322|NCT00011492|Squamous Cell Cancer|squamous cell cancer
891323|NCT00011492|Head and Neck Cancer|head and neck cancer
891324|NCT00011492|Laryngeal Cancer|laryngeal cancer
891325|NCT00011492|Pharnygeal Cancer|pharnygeal cancer
891326|NCT00011492|Squamous Cell Carcinoma|squamous cell carcinoma
891327|NCT00011466|ADHD|adhd
891328|NCT00011466|Attention Deficit Hyperactivity Disorder|attention deficit hyperactivity disorder
891329|NCT00011466|Carbohydrate Craving|carbohydrate craving
891330|NCT00011453|NQO1|nqo1
891331|NCT00011453|DT-diaphorase|dt-diaphorase
891332|NCT00011453|Benzene|benzene
891333|NCT00011453|Leukemia|leukemia
891334|NCT00011453|Aplastic anemia|aplastic anemia
891335|NCT00011440|Allergy|allergy
891336|NCT00011440|Air pollution|air pollution
891337|NCT00011440|Lung function|lung function
891338|NCT00011440|Inflammation|inflammation
891339|NCT00011414|Drug Resistance|drug resistance
891340|NCT00011414|PEDIATRIC SOLID TUMORS|pediatric solid tumors
891341|NCT00011414|Chemotherapy|chemotherapy
891342|NCT00011414|p-glycoprotien|p-glycoprotien
891343|NCT00011414|Brain Tumors|brain tumors
891344|NCT00011414|Childhood Cancer|childhood cancer
891345|NCT00011414|Brain Tumor|brain tumor
891346|NCT00011388|Organochlorine compounds|organochlorine compounds
891347|NCT00011388|Endocrine disruptors|endocrine disruptors
891348|NCT00011388|Sex Hormones|sex hormones
891349|NCT00011388|Reproductive function|reproductive function
891350|NCT00011388|Menstrual Disturbances|menstrual disturbances
891351|NCT00011375|Phosphodiesterase Inhibitor|phosphodiesterase inhibitor
891352|NCT00011375|Immunology|immunology
891353|NCT00011375|Immunomodulation|immunomodulation
891354|NCT00011375|Antidepressant|antidepressant
891356|NCT00011375|Multiple Sclerosis|multiple sclerosis
891357|NCT00011375|Immunotherapy|immunotherapy
891358|NCT00011362|NICHD Neonatal Research Network|nichd neonatal research network
891359|NCT00011362|Extremely Low Birth Weight (ELBW)|extremely low birth weight (elbw)
891360|NCT00011362|Prematurity|prematurity
891361|NCT00011362|Dexamethasone|dexamethasone
891362|NCT00011362|Glucocorticoids|glucocorticoids
891363|NCT00011362|Respiratory Distress Syndrome|respiratory distress syndrome
891364|NCT00011362|Respiratory insufficiency|respiratory insufficiency
891365|NCT00011362|Steroids|steroids
891366|NCT00011349|Prostate Cancer|prostate cancer
891367|NCT00011336|SCI|sci
891368|NCT00011336|chronic respiratory symptoms|chronic respiratory symptoms
891369|NCT00011336|measures of pulmonary function|measures of pulmonary function
891370|NCT00011336|respiratory illness|respiratory illness
891371|NCT00011323|osteoporosis,smoking, alcohol, caffeine|osteoporosis,smoking, alcohol, caffeine
891372|NCT00011310|Particulates|particulates
891373|NCT00011310|Air Pollution|air pollution
891374|NCT00011310|Cardiopulmonary Disease|cardiopulmonary disease
891375|NCT00011310|Lung|lung
891376|NCT00011310|Inflammation|inflammation
891377|NCT00011284|Liver|liver
891378|NCT00011284|Inflammation|inflammation
891379|NCT00011284|Endotoxin|endotoxin
891380|NCT00011284|Neutrophils|neutrophils
891381|NCT00011284|Hepatocytes|hepatocytes
891382|NCT00011258|Atherosclerosis of the carotid arteries|atherosclerosis of the carotid arteries
891383|NCT00011258|stroke|stroke
891384|NCT00011258|lipoprotein metabolism|lipoprotein metabolism
891385|NCT00011258|paraoxonase|paraoxonase
891386|NCT00011245|Arachnoiditis|arachnoiditis
891387|NCT00011245|Myelography|myelography
891388|NCT00011245|Intraoperative Ultrasonography|intraoperative ultrasonography
891389|NCT00011245|Magnetic Resonance|magnetic resonance
891390|NCT00011245|CSF Pressure|csf pressure
891391|NCT00011245|Trauma|trauma
891392|NCT00011245|Meningitis|meningitis
891393|NCT00011245|Paralysis|paralysis
891394|NCT00011245|Spondylosis|spondylosis
891395|NCT00011245|Spinal Syringomyelia|spinal syringomyelia
891396|NCT00011245|Presyringomyelia|presyringomyelia
891397|NCT00011245|Spinal Cord Edema|spinal cord edema
891398|NCT00011245|Magnetic Resonance Imaging (MRI)|magnetic resonance imaging (mri)
891399|NCT00011245|Intraoperative Radiation|intraoperative radiation
891400|NCT00011245|Ultrasonography|ultrasonography
891401|NCT00011141|Immune-mediated diabetes mellitus|immune-mediated diabetes mellitus
891402|NCT00011193|Cardiovascular Diseases|cardiovascular diseases
891403|NCT00011193|Hypertension|hypertension
891404|NCT00011193|Postmenopausal|postmenopausal
891405|NCT00011193|Overweight or Obese|overweight or obese
891406|NCT00011193|Women|women
891407|NCT00011193|Sedentary|sedentary
891408|NCT00011180|Venous thromboembolism (VTE)|venous thromboembolism (vte)
891409|NCT00011180|Deep vein thrombosis (DVT)|deep vein thrombosis (dvt)
891410|NCT00011180|Pulmonary embolism (PE)|pulmonary embolism (pe)
891411|NCT00011076|Deskar|deskar
891412|NCT00011076|Fibrosis|fibrosis
891413|NCT00011076|Myocardium|myocardium
891414|NCT00011076|Scarring|scarring
891415|NCT00011076|Arrhythmia|arrhythmia
891416|NCT00011076|Hypertrophic Cardiomyopathy|hypertrophic cardiomyopathy
891417|NCT00011076|Left Ventricular Diastolic Dysfunction|left ventricular diastolic dysfunction
891418|NCT00011076|Myocardial Fibrosis|myocardial fibrosis
891419|NCT00011115|overweight|overweight
891420|NCT00011102|weight gain|weight gain
891421|NCT00010998|Multiple Sclerosis|multiple sclerosis
891422|NCT00010998|Yoga|yoga
891423|NCT00010985|Backpain|backpain
891424|NCT00010985|Pain|pain
891425|NCT00010985|Alternative Medicine|alternative medicine
891426|NCT00010985|Acupuncture|acupuncture
891427|NCT00010985|Chiropractic|chiropractic
891428|NCT00010985|Massage Therapy|massage therapy
891429|NCT00010959|menopause|menopause
891430|NCT00010959|hot flashes|hot flashes
891431|NCT00010959|botanicals|botanicals
891432|NCT00010946|acupuncture|acupuncture
891433|NCT00010946|osteoarthritis|osteoarthritis
891434|NCT00010946|elderly|elderly
891435|NCT00010868|bipolar disorder|bipolar disorder
891436|NCT00010868|omega-3 fatty acids|omega-3 fatty acids
891437|NCT00010868|eicosapentaenoic acid|eicosapentaenoic acid
891438|NCT00010868|docosahexaenoic acid|docosahexaenoic acid
891440|NCT00010855|relaxation|relaxation
891441|NCT00010855|invasive medical procedures|invasive medical procedures
891442|NCT00010855|interventional radiology|interventional radiology
891443|NCT00010855|conscious sedation|conscious sedation
891444|NCT00010855|anesthesia|anesthesia
891445|NCT00010855|complications|complications
891446|NCT00010855|cost analysis|cost analysis
891447|NCT00010855|Interventional procedures, complications|interventional procedures, complications
891448|NCT00010855|Angiography|angiography
891449|NCT00010855|Nephrostomy|nephrostomy
891450|NCT00010855|Hepatic chemoembolization|hepatic chemoembolization
891451|NCT00010855|Fibroid Embolization|fibroid embolization
891452|NCT00010829|Cardiovascular Diseases|cardiovascular diseases
891453|NCT00010829|Osteoporosis|osteoporosis
891454|NCT00010829|Breast Cancer|breast cancer
891455|NCT00010829|Endometrial Cancer|endometrial cancer
891456|NCT00010725|CVD|cvd
891457|NCT00010712|Menopause|menopause
891458|NCT00010712|Hot Flashes|hot flashes
891459|NCT00010712|Osteoporosis|osteoporosis
891460|NCT00010712|Postmenopausal|postmenopausal
891461|NCT00010699|cvd|cvd
891462|NCT00010608|CVD|cvd
891463|NCT00010530|CVD|cvd
891464|NCT00010504|acupuncture|acupuncture
891465|NCT00010504|fibromyalgia|fibromyalgia
891466|NCT00010504|pain|pain
891467|NCT00010504|analgesia|analgesia
891468|NCT00010491|Diarrhea|diarrhea
891469|NCT00010491|complementary therapies|complementary therapies
891470|NCT00009685|Vaccine|vaccine
891471|NCT00009685|HIV|hiv
891472|NCT00009685|Codon-Optimized|codon-optimized
891473|NCT00009685|HIV Vaccine|hiv vaccine
891474|NCT00009685|Healthy Volunteer|healthy volunteer
891475|NCT00009685|HIV-1 DNA Vaccine|hiv-1 dna vaccine
891476|NCT00009685|HIV Seronegativity|hiv seronegativity
891477|NCT00009685|HIV Preventive Vaccine|hiv preventive vaccine
891478|NCT00009672|Low Back Pain|low back pain
891479|NCT00009672|Opioid|opioid
891480|NCT00009672|Antidepressant|antidepressant
891481|NCT00009672|Randomized Controlled Trial|randomized controlled trial
891482|NCT00009672|Analgesic|analgesic
891483|NCT00009672|Sciatica|sciatica
891484|NCT00009659|Endometrium|endometrium
891485|NCT00009659|Estrogen|estrogen
891486|NCT00009659|Antihormone|antihormone
891487|NCT00009659|Menopause|menopause
891488|NCT00009659|Progesterone|progesterone
891489|NCT00009659|Postmenopausal Women|postmenopausal women
891490|NCT00009659|Hormone Replacement|hormone replacement
891491|NCT00009646|Chronic lung disease|chronic lung disease
891492|NCT00009646|Indocin|indocin
891493|NCT00009646|Indomethacin|indomethacin
891494|NCT00009646|Infants, very low birth weight|infants, very low birth weight
891495|NCT00009646|Intraventricular hemorrhage|intraventricular hemorrhage
891496|NCT00009646|Necrotizing enterocolitis|necrotizing enterocolitis
891497|NCT00009646|Patent ductus arteriosus|patent ductus arteriosus
891498|NCT00009646|Pulmonary hemorrhage|pulmonary hemorrhage
891499|NCT00009633|NICHD Neonatal Research Network|nichd neonatal research network
891500|NCT00009633|Extremely Low Birth Weight (ELBW)|extremely low birth weight (elbw)
891501|NCT00009633|Prematurity|prematurity
891502|NCT00009633|Neurodevelopmental Outcome|neurodevelopmental outcome
891503|NCT00009633|Follow up studies|follow up studies
891504|NCT00009620|NICHD Neonatal Research Network|nichd neonatal research network
891505|NCT00009620|Extremely Low Birth Weight (ELBW)|extremely low birth weight (elbw)
891506|NCT00009620|Prematurity|prematurity
891507|NCT00009620|Cerebral hemorrhage|cerebral hemorrhage
891508|NCT00009620|Phenobarbital|phenobarbital
891509|NCT00009620|Pregnancy|pregnancy
891510|NCT00009620|Prenatal care|prenatal care
891511|NCT00009620|Intraventricular hemorrhage|intraventricular hemorrhage
891512|NCT00009620|Periventricular leukomalacia|periventricular leukomalacia
891513|NCT00009620|Brain injury|brain injury
891514|NCT00009620|Brain hemorrhage|brain hemorrhage
891515|NCT00010452|cystic hygroma|cystic hygroma
891516|NCT00010452|lymphangiomas|lymphangiomas
891517|NCT00010452|lymphatic malformations|lymphatic malformations
891518|NCT00010439|arthritis & connective tissue diseases|arthritis & connective tissue diseases
891519|NCT00010439|idiopathic juvenile osteoporosis|idiopathic juvenile osteoporosis
891520|NCT00010439|rare disease|rare disease
891521|NCT00010426|cystinosis|cystinosis
891522|NCT00010426|rare disease|rare disease
891523|NCT00010426|renal and genitourinary disorders|renal and genitourinary disorders
891524|NCT00010413|immunologic disorders and infectious disorders|immunologic disorders and infectious disorders
891525|NCT00010413|pemphigus|pemphigus
891526|NCT00010413|rare disease|rare disease
891527|NCT00010400|antiphospholipid antibody syndrome|antiphospholipid antibody syndrome
891528|NCT00010400|arthritis & connective tissue diseases|arthritis & connective tissue diseases
891529|NCT00010400|immunologic disorders and infectious disorders|immunologic disorders and infectious disorders
891530|NCT00010400|rare disease|rare disease
891531|NCT00010400|systemic lupus erythematosus|systemic lupus erythematosus
891532|NCT00010387|Felty syndrome|felty syndrome
891533|NCT00010387|autoimmune hemolytic anemia|autoimmune hemolytic anemia
891534|NCT00010387|autoimmune neutropenia|autoimmune neutropenia
891535|NCT00010387|hematologic disorders|hematologic disorders
891536|NCT00010387|immune thrombocytopenic purpura|immune thrombocytopenic purpura
891537|NCT00010387|rare disease|rare disease
891538|NCT00010374|Diaphragm for Ventilatory Assist|diaphragm for ventilatory assist
891539|NCT00010374|environmental/toxic disorders|environmental/toxic disorders
891540|NCT00010374|neurologic and psychiatric disorders|neurologic and psychiatric disorders
891541|NCT00010374|rare disease|rare disease
891542|NCT00010374|spinal cord injury|spinal cord injury
891543|NCT00010335|arthritis & connective tissue diseases|arthritis & connective tissue diseases
891544|NCT00010335|dermatomyositis|dermatomyositis
891545|NCT00010335|immunologic disorders and infectious disorders|immunologic disorders and infectious disorders
891546|NCT00010335|juvenile rheumatoid arthritis|juvenile rheumatoid arthritis
891547|NCT00010335|rare disease|rare disease
891548|NCT00010335|systemic lupus erythematosus|systemic lupus erythematosus
891549|NCT00010335|systemic sclerosis|systemic sclerosis
891550|NCT00009581|Endothelial Function|endothelial function
891551|NCT00009581|Hydroxyurea|hydroxyurea
891552|NCT00009581|Leukocyte Gene Expression|leukocyte gene expression
891553|NCT00009581|Nitrosylated Hemoglobin|nitrosylated hemoglobin
891554|NCT00009581|Sickle Cell Anemia|sickle cell anemia
891555|NCT00009581|Nitric Oxide|nitric oxide
891556|NCT00009568|Antidepressants|antidepressants
891557|NCT00009568|Platelet Function|platelet function
891558|NCT00009568|SSRI|ssri
891559|NCT00009568|Depression|depression
891560|NCT00009568|Bleeding Time|bleeding time
891561|NCT00009256|Quasispecies Variation|quasispecies variation
891562|NCT00009256|Genotyping|genotyping
891563|NCT00009256|Phenotyping|phenotyping
891564|NCT00009256|Antiretroviral Therapy|antiretroviral therapy
891565|NCT00009256|Drug Naive Patients|drug naive patients
891567|NCT00009256|Treatment Naive|treatment naive
891568|NCT00009243|Stroke|stroke
891569|NCT00009243|Natural History|natural history
891570|NCT00009243|Magnetic Resonance Imaging|magnetic resonance imaging
891571|NCT00009243|MRI (Magnetic Resonance Imaging)|mri (magnetic resonance imaging)
891572|NCT00009243|Acute Stroke|acute stroke
891573|NCT00009243|TIA|tia
891574|NCT00009230|Age associated memory impairment|age associated memory impairment
891575|NCT00009230|Mild cognitive impairment|mild cognitive impairment
891576|NCT00009217|Alzheimer's disease|alzheimer's disease
891577|NCT00009217|psychosis|psychosis
891578|NCT00009217|agitation|agitation
891579|NCT00009217|haloperidol|haloperidol
891580|NCT00009204|Behavioral problems|behavioral problems
891581|NCT00009204|Agitation|agitation
891582|NCT00009048|Dyskinesias|dyskinesias
891583|NCT00009048|L-Dopa Infusion|l-dopa infusion
891584|NCT00009048|Clinical Trial|clinical trial
891585|NCT00009048|Motor Function|motor function
891586|NCT00009048|Psychosis|psychosis
891587|NCT00009048|Parkinson's Disease|parkinson's disease
891588|NCT00009035|Brain|brain
891589|NCT00009035|Tumor|tumor
891590|NCT00009035|Chemotherapy|chemotherapy
891591|NCT00009035|Antiangiogenesis|antiangiogenesis
891592|NCT00009035|Radiation|radiation
891593|NCT00009035|CNS Tumor|cns tumor
891594|NCT00009035|Glioma|glioma
891595|NCT00009035|Medulloblastoma|medulloblastoma
891596|NCT00009035|Astrocytoma|astrocytoma
891597|NCT00009035|Glioblastoma|glioblastoma
891598|NCT00009178|Primary Care|primary care
891599|NCT00009178|Fluoxetine|fluoxetine
891600|NCT00009009|Immune System|immune system
891601|NCT00009009|Biopsy|biopsy
891602|NCT00009009|AIDS|aids
891603|NCT00009009|HIV|hiv
891604|NCT00009009|End Stage Renal Disease|end stage renal disease
891605|NCT00009009|Kidney Transplant|kidney transplant
891606|NCT00008892|Magnetic Resonance Imaging|magnetic resonance imaging
891607|NCT00008892|Diffusion Tensor Imaging|diffusion tensor imaging
891608|NCT00008892|Twin Study|twin study
891609|NCT00008892|Attention Deficit Hyperactivity Disorder|attention deficit hyperactivity disorder
891610|NCT00008892|Normal Volunteers|normal volunteers
891611|NCT00008814|Cognition|cognition
891612|NCT00008814|Infant Development|infant development
891613|NCT00008814|MRI, Functional|mri, functional
891614|NCT00008736|Feeding intolerance|feeding intolerance
891615|NCT00008736|Infant, premature|infant, premature
891617|NCT00008827|Behavioral weight control|behavioral weight control
891618|NCT00008827|Internet|internet
891619|NCT00008541|Keratitis|keratitis
891620|NCT00008541|Conjunctivitis|conjunctivitis
891621|NCT00008541|Meibomitis|meibomitis
891622|NCT00008541|Corneal Infiltrates|corneal infiltrates
891623|NCT00008541|Dacryocystitis|dacryocystitis
891624|NCT00008541|Blepharitis|blepharitis
891625|NCT00008541|Dacryoadenitis|dacryoadenitis
891626|NCT00008541|Corneal Eye Disease|corneal eye disease
891627|NCT00008515|Steroids|steroids
891628|NCT00008515|Age-Related Macular Degeneration|age-related macular degeneration
891629|NCT00008515|Implant|implant
891630|NCT00008515|Choroidal Neovascularization|choroidal neovascularization
891631|NCT00008515|Sustained Release Implant|sustained release implant
891632|NCT00008502|Genetics|genetics
891633|NCT00008502|African Americans|african americans
891634|NCT00008502|Skin|skin
891635|NCT00008502|Keloids|keloids
891636|NCT00008476|Preemptive Analgesia|preemptive analgesia
891637|NCT00008476|Vanilloid|vanilloid
891936|NCT00006437|Adhesion|adhesion
891638|NCT00008476|Vanilloid Receptor (VR)|vanilloid receptor (vr)
891639|NCT00008476|Capsaicin|capsaicin
891640|NCT00008476|Acute Pain|acute pain
891641|NCT00008476|Orofacial|orofacial
891642|NCT00008476|Visual Analog Scale (VAS)|visual analog scale (vas)
891643|NCT00008476|Resiniferatoxin|resiniferatoxin
891644|NCT00008476|Healthy Volunteer|healthy volunteer
891645|NCT00008476|Wisdom Teeth|wisdom teeth
891646|NCT00008476|Pain|pain
891647|NCT00007800|obesity treatment|obesity treatment
891648|NCT00007800|non insulin dependent diabetes|non insulin dependent diabetes
891649|NCT00007800|type 2 diabetes|type 2 diabetes
891650|NCT00007800|behavioral weight control|behavioral weight control
891651|NCT00007800|motivational interviewing|motivational interviewing
891652|NCT00007800|motivational enhancement|motivational enhancement
891653|NCT00007696|Diabetes Mellitus,DM,glycemic control|diabetes mellitus,dm,glycemic control
891654|NCT00007670|gabapentin|gabapentin
891655|NCT00007670|lamotrigine|lamotrigine
891656|NCT00007670|seizures in the elderly|seizures in the elderly
891657|NCT00007670|Carbamazepine|carbamazepine
891658|NCT00007657|PCI plus intensive medical therapy|pci plus intensive medical therapy
891659|NCT00007774|Olanzapine, haloperidol, schizophrenia, schisoaffe|olanzapine, haloperidol, schizophrenia, schisoaffe
891660|NCT00007761|Bipolar Disease Program intervention|bipolar disease program intervention
891661|NCT00007748|aerobic exercise|aerobic exercise
891662|NCT00007748|cognitive behavioral therapy|cognitive behavioral therapy
891663|NCT00007748|CBT|cbt
891664|NCT00007748|Gulf War Illnesses|gulf war illnesses
891665|NCT00007748|GWI|gwi
891666|NCT00007735|antibiotic treatment|antibiotic treatment
891667|NCT00007735|mycoplasma species|mycoplasma species
891668|NCT00007735|Gulf War Veterans' Illnesses (GWI)|gulf war veterans' illnesses (gwi)
891669|NCT00007735|mycoplasma positive|mycoplasma positive
891670|NCT00007735|Gulf War Syndrome|gulf war syndrome
891671|NCT00007722|ALS|als
891672|NCT00007722|amyotrophic lateral sclerosis|amyotrophic lateral sclerosis
891673|NCT00007722|Gulf War Veterans|gulf war veterans
891674|NCT00007709|Hepatitis C|hepatitis c
891675|NCT00007709|HIV|hiv
891676|NCT00007709|severe mental illness (SMI)|severe mental illness (smi)
891677|NCT00007683|aspirin|aspirin
891678|NCT00007683|clopidogrel|clopidogrel
891679|NCT00007683|embolic events|embolic events
891680|NCT00007683|Left ventricular ejection fraction less than or eq|left ventricular ejection fraction less than or eq
891681|NCT00007683|NYHA Class II, III or IV CHF|nyha class ii, iii or iv chf
891682|NCT00007683|symptomatic CHF|symptomatic chf
891683|NCT00007683|warfarin|warfarin
891684|NCT00007644|cancer of the prostate (CAP)|cancer of the prostate (cap)
891685|NCT00007644|cancer treatment|cancer treatment
891686|NCT00007644|chronic diseases|chronic diseases
891687|NCT00007644|expectant management|expectant management
891688|NCT00007644|genitourinary|genitourinary
891689|NCT00007644|prostate|prostate
891690|NCT00007644|prostate specific cancer mortality|prostate specific cancer mortality
891691|NCT00007644|radical prostatectomy|radical prostatectomy
891692|NCT00007631|NMSC|nmsc
891693|NCT00007631|nonmelanoma skin cancer|nonmelanoma skin cancer
891694|NCT00007631|topical tretinoin cream|topical tretinoin cream
891695|NCT00007618|colorectal cancer|colorectal cancer
891696|NCT00007605|amiodarone|amiodarone
891697|NCT00007605|atrial fibrillation converted to sinus rhythm|atrial fibrillation converted to sinus rhythm
891698|NCT00007605|cardiac mortality|cardiac mortality
891699|NCT00007605|major and minor bleeds|major and minor bleeds
891700|NCT00007605|sinus rhythm|sinus rhythm
891701|NCT00007605|sotalol|sotalol
891702|NCT00007592|Hypertension|hypertension
891703|NCT00007592|national data base on the treatment of hypertension|national data base on the treatment of hypertension
891704|NCT00007592|cost of different antihypertensive regimens|cost of different antihypertensive regimens
891705|NCT00007579|prostate cancer|prostate cancer
891706|NCT00007540|Prostate cancer|prostate cancer
891707|NCT00007540|CAG repeat sequence|cag repeat sequence
891708|NCT00007527|buprenorphine and naloxone|buprenorphine and naloxone
891709|NCT00007527|opiate dependence|opiate dependence
891710|NCT00007527|narcotic treatment|narcotic treatment
891711|NCT00007514|olfactory functioning|olfactory functioning
891712|NCT00007514|neurotoxic exposure|neurotoxic exposure
891713|NCT00007514|Gulf War-era veterans|gulf war-era veterans
891714|NCT00007501|varicella-zoster vaccine|varicella-zoster vaccine
891715|NCT00007475|Plasma Exchange|plasma exchange
891716|NCT00007475|Cyclophosphamide|cyclophosphamide
891717|NCT00007475|Proteinuria|proteinuria
891718|NCT00007475|Hemodialysis|hemodialysis
891719|NCT00007475|Expression Profiling|expression profiling
891720|NCT00007358|Dexamethasone|dexamethasone
891721|NCT00007358|Anti-SSA/Ro antibodies|anti-ssa/ro antibodies
891722|NCT00007358|Anti-SSB/La antibodies|anti-ssb/la antibodies
891723|NCT00007358|Ultrasound|ultrasound
891724|NCT00007358|Atrioventricular (AV) nodal dysfunction|atrioventricular (av) nodal dysfunction
891725|NCT00007358|Echocardiograms|echocardiograms
891726|NCT00007358|Mothers|mothers
891727|NCT00007345|Histone Acetylase|histone acetylase
891728|NCT00007345|Differentiation|differentiation
891729|NCT00007345|Sezary Syndrome|sezary syndrome
891730|NCT00007345|Mycosis Fungoides|mycosis fungoides
891731|NCT00007345|CD 30 Lymphoma|cd 30 lymphoma
891732|NCT00007306|Parathyroid hormone|parathyroid hormone
891733|NCT00007306|Psoriasis|psoriasis
891734|NCT00007306|Lesions|lesions
891735|NCT00007306|Topical medications|topical medications
891736|NCT00007306|Ointment|ointment
891737|NCT00007306|Calcium metabolism|calcium metabolism
891738|NCT00007306|Skin biopsy|skin biopsy
891739|NCT00007293|Phototherapy|phototherapy
891740|NCT00007293|Psoriasis|psoriasis
891741|NCT00007293|Scalp psoriasis|scalp psoriasis
891742|NCT00007293|Fiber optic|fiber optic
891743|NCT00007293|Light comb|light comb
891744|NCT00007293|UV source|uv source
891745|NCT00007280|Bioengineered skin|bioengineered skin
891746|NCT00007280|Venous leg ulcer|venous leg ulcer
891747|NCT00007267|Scleroderma|scleroderma
891748|NCT00007267|Systemic sclerosis|systemic sclerosis
891749|NCT00007267|Depression|depression
891750|NCT00007267|Pain|pain
891751|NCT00007267|Disfigurement|disfigurement
891752|NCT00007267|Body image dissatisfaction|body image dissatisfaction
891753|NCT00007267|Cognitive-behavioral therapy|cognitive-behavioral therapy
891754|NCT00007267|Self-help|self-help
891755|NCT00007267|Psychological intervention|psychological intervention
891756|NCT00007254|Analgesia|analgesia
891758|NCT00007254|Morphine gel|morphine gel
891759|NCT00007254|Pressure ulcer|pressure ulcer
891760|NCT00007254|Pain|pain
891761|NCT00007254|Ulcer|ulcer
891762|NCT00007241|Osteoarthritis|osteoarthritis
891763|NCT00007241|Knee|knee
891764|NCT00007241|OA|oa
891765|NCT00007241|Isometric|isometric
891766|NCT00007241|Exercise|exercise
891767|NCT00007241|Strengthening|strengthening
891768|NCT00007241|Joint-related pain|joint-related pain
891769|NCT00007228|Chorea|chorea
891770|NCT00007228|DCM|dcm
891771|NCT00007228|Hypertrophic Cardiomyopathy|hypertrophic cardiomyopathy
891772|NCT00007228|Sudden Death|sudden death
891773|NCT00007228|Neuroacanthocytosis|neuroacanthocytosis
891774|NCT00007215|Cataract|cataract
891775|NCT00007215|Early Lens Changes|early lens changes
891776|NCT00007215|Protein Aggregation|protein aggregation
891777|NCT00007215|Blindness|blindness
891778|NCT00007215|Vision|vision
891779|NCT00007215|Dynamic Laser Scattering (DLS)|dynamic laser scattering (dls)
891780|NCT00007215|Age-Related Changes|age-related changes
891781|NCT00007215|Test Re-test Reproducibility|test re-test reproducibility
891782|NCT00007215|Normal Volunteers|normal volunteers
891783|NCT00007215|Lens|lens
891784|NCT00007215|Healthy Volunteer|healthy volunteer
891785|NCT00007189|Alzheimer disease|alzheimer disease
891786|NCT00007189|Anti-inflammatory drugs|anti-inflammatory drugs
891787|NCT00007163|Immunosuppression|immunosuppression
891788|NCT00007163|Recombinant IgG1|recombinant igg1
891789|NCT00007163|Apoptosis|apoptosis
891790|NCT00007163|Interferon Gamma|interferon gamma
891791|NCT00007163|Colonoscopy|colonoscopy
891792|NCT00007163|Crohn's Disease|crohn's disease
891793|NCT00007163|Immunotherapy|immunotherapy
891794|NCT00007163|IL-12|il-12
891795|NCT00007150|Phlebotomy Therapy|phlebotomy therapy
891796|NCT00007150|Hemochromatosis|hemochromatosis
891797|NCT00007150|Iron Overload|iron overload
891798|NCT00007150|Hereditary Hemochromatosis|hereditary hemochromatosis
891799|NCT00007150|Blood Donation|blood donation
891800|NCT00007137|3D MRI|3d mri
891801|NCT00007137|Diffusion Tensor|diffusion tensor
891802|NCT00007137|Tongue|tongue
891803|NCT00007137|Ultrasound|ultrasound
891804|NCT00007137|Volume|volume
891805|NCT00007137|Healthy Volunteer|healthy volunteer
891806|NCT00007137|Swallowing|swallowing
891807|NCT00007137|Tongue Weakness|tongue weakness
891808|NCT00007137|Tongue Movement Coordination Problem|tongue movement coordination problem
891809|NCT00007124|Myoclonus|myoclonus
891810|NCT00007124|Epilepsy|epilepsy
891811|NCT00007124|Dementia|dementia
891812|NCT00007124|Polyglucosan|polyglucosan
891813|NCT00007124|Insulin|insulin
891814|NCT00007124|Lafora Disease|lafora disease
891815|NCT00007124|Restrictive Carbohydrate Diet|restrictive carbohydrate diet
891816|NCT00007059|disease-related problem/condition|disease-related problem/condition
891817|NCT00007059|graft versus host disease|graft versus host disease
891818|NCT00007059|rare disease|rare disease
891819|NCT00007046|arthritis & connective tissue diseases|arthritis & connective tissue diseases
891820|NCT00007046|bone cancer|bone cancer
891821|NCT00007046|diaphyseal medullary stenosis|diaphyseal medullary stenosis
891822|NCT00007046|genetic diseases and dysmorphic syndromes|genetic diseases and dysmorphic syndromes
891823|NCT00007046|malignant fibrous histiocytoma of bone|malignant fibrous histiocytoma of bone
891824|NCT00007046|musculoskeletal/mesodermal cancer|musculoskeletal/mesodermal cancer
891825|NCT00007046|oncologic disorders|oncologic disorders
891826|NCT00007046|rare disease|rare disease
891827|NCT00007033|Alagille syndrome|alagille syndrome
891828|NCT00007033|biliary atresia|biliary atresia
891829|NCT00007033|cholestasis|cholestasis
891830|NCT00007033|gastrointestinal disorders|gastrointestinal disorders
891831|NCT00007033|rare disease|rare disease
891832|NCT00006565|asthma|asthma
891833|NCT00006565|HEPA|hepa
891834|NCT00006565|ETS|ets
891835|NCT00006519|Pharmacokinetic|pharmacokinetic
891937|NCT00006437|Migration|migration
891836|NCT00006519|Pediatric AIDS|pediatric aids
891837|NCT00006519|Resistance Testing|resistance testing
891838|NCT00006519|Combination Therapy|combination therapy
891839|NCT00006519|Viral Drug Dynamics|viral drug dynamics
891840|NCT00006519|Treatment Experienced|treatment experienced
891841|NCT00006518|Tumor|tumor
891842|NCT00006518|Viruses|viruses
891843|NCT00006518|HIV|hiv
891844|NCT00006518|KSHV|kshv
891845|NCT00006518|AIDS|aids
891846|NCT00006517|Seasonal Affective Disorder (SAD)|seasonal affective disorder (sad)
891847|NCT00006517|Winter Depression|winter depression
891848|NCT00006517|Mood disorders|mood disorders
891849|NCT00006517|Bipolar I and II disorders|bipolar i and ii disorders
891850|NCT00006517|Major Depressive Disorder, Recurrent|major depressive disorder, recurrent
891851|NCT00006517|Light therapy|light therapy
891852|NCT00006517|Phototherapy|phototherapy
891853|NCT00006517|Dawn Simulation therapy|dawn simulation therapy
891854|NCT00006517|Negative air ionization therapy|negative air ionization therapy
891855|NCT00006517|Chronobiology|chronobiology
891856|NCT00006517|Biological rhythms|biological rhythms
891857|NCT00006516|Neonatal brain injury|neonatal brain injury
891858|NCT00006516|Brain Hypoxia|brain hypoxia
891859|NCT00006516|Cerebral Hypoxia|cerebral hypoxia
891860|NCT00006516|Brain Hypoxia-Ischemia|brain hypoxia-ischemia
891861|NCT00006516|Brain Ischemia-Hypoxia|brain ischemia-hypoxia
891862|NCT00006516|Cerebral Hypoxia-Ischemia|cerebral hypoxia-ischemia
891863|NCT00006516|Cerebral Ischemia-Hypoxia|cerebral ischemia-hypoxia
891864|NCT00006516|Environmental enrichment|environmental enrichment
891865|NCT00006516|Cognitive/sensorimotor stimulation|cognitive/sensorimotor stimulation
891866|NCT00006516|Parent-infant interactions|parent-infant interactions
891867|NCT00006516|Prenatal hypoxia|prenatal hypoxia
891868|NCT00006515|Pediatric|pediatric
891869|NCT00006515|Sarcoma|sarcoma
891870|NCT00006515|Effects|effects
891871|NCT00006515|Survivors|survivors
891872|NCT00006515|Pilot|pilot
891873|NCT00006505|Islet Isolation|islet isolation
891874|NCT00006505|Diabetes|diabetes
891875|NCT00006494|AIDS|aids
891876|NCT00006494|Antiretroviral Therapy|antiretroviral therapy
891877|NCT00006494|Drug Resistance|drug resistance
891878|NCT00006494|Phenotype|phenotype
891879|NCT00006494|HIV|hiv
891880|NCT00006494|Genotype|genotype
891881|NCT00006494|Treatment Experienced|treatment experienced
891882|NCT00006493|HIV-associated hyperlipidemia|hiv-associated hyperlipidemia
891883|NCT00006492|Celiac Disease|celiac disease
891884|NCT00006492|Cerebellar Ataxia|cerebellar ataxia
891885|NCT00006492|Gluten-Free Diet|gluten-free diet
891886|NCT00006489|Alcoholism|alcoholism
891887|NCT00006489|Alcohol Dependence|alcohol dependence
891888|NCT00006489|Post-Traumatic Stress Disorder|post-traumatic stress disorder
891889|NCT00006489|Naltrexone|naltrexone
891890|NCT00006489|Cognitive Behavior Therapy|cognitive behavior therapy
891891|NCT00006450|Children|children
891892|NCT00006450|Brain|brain
891893|NCT00006450|Maturation|maturation
891894|NCT00006450|Phenylacetate|phenylacetate
891895|NCT00006450|Differentiation|differentiation
891896|NCT00006507|Sensory integration|sensory integration
891897|NCT00006507|Occupational therapy|occupational therapy
891898|NCT00006507|Sensory Modulation Dysfunction (SMD)|sensory modulation dysfunction (smd)
891899|NCT00006448|Spinal cord injury|spinal cord injury
891900|NCT00006448|Amputation|amputation
891901|NCT00006448|Pain management|pain management
891902|NCT00006447|Brain Injuries|brain injuries
891903|NCT00006447|Trauma|trauma
891904|NCT00006447|Caregivers|caregivers
891905|NCT00006447|Burden and Dependency|burden and dependency
891906|NCT00006447|Rehabilitation|rehabilitation
891907|NCT00006447|Support, social|support, social
891908|NCT00006447|Information System|information system
891909|NCT00006447|Information Resources (PT)|information resources (pt)
891910|NCT00006447|Disability, persons with|disability, persons with
891911|NCT00006446|Behavioral disorders|behavioral disorders
891912|NCT00006446|Parenting skills and communication|parenting skills and communication
891913|NCT00006446|Parent-child interactions|parent-child interactions
891914|NCT00006446|At-risk preschooler|at-risk preschooler
891915|NCT00006446|Head Start|head start
891916|NCT00006445|Pregnancy|pregnancy
891917|NCT00006445|Ultrasound|ultrasound
891918|NCT00006445|Serum screen|serum screen
891919|NCT00006445|Pregnancy associated plasma protein-A (PAPP-A)|pregnancy associated plasma protein-a (papp-a)
891920|NCT00006445|Free-beta human chorionic gonadotropin (FbhCG)|free-beta human chorionic gonadotropin (fbhcg)
891921|NCT00006445|Alpha fetoprotein|alpha fetoprotein
891922|NCT00006445|Unconjugated estriol|unconjugated estriol
891923|NCT00006445|Inhibin-A|inhibin-a
891924|NCT00006445|Down syndrome|down syndrome
891925|NCT00006445|Aneuploidy|aneuploidy
891926|NCT00006439|HIV|hiv
891927|NCT00006438|Rocker sole|rocker sole
891928|NCT00006438|Plantar pressure|plantar pressure
891929|NCT00006438|Diabetic feet|diabetic feet
891930|NCT00006438|Insensate feet|insensate feet
891931|NCT00006438|gait analysis|gait analysis
891932|NCT00006438|Pedorthics|pedorthics
891933|NCT00006438|Gait abnormalities|gait abnormalities
891934|NCT00006437|MMP|mmp
891935|NCT00006437|Proteases|proteases
891938|NCT00006437|Extracellular Matrix|extracellular matrix
891939|NCT00006436|AIDS|aids
891940|NCT00006436|Malignancy|malignancy
891941|NCT00006436|Antiretroviral|antiretroviral
891942|NCT00006436|Chemotherapy|chemotherapy
891943|NCT00006436|Monoclonal|monoclonal
891944|NCT00006435|Tissue Repository|tissue repository
891945|NCT00006435|Growth Rate|growth rate
891946|NCT00006435|Volumetric MRI|volumetric mri
891947|NCT00006434|Dendritic cells|dendritic cells
891948|NCT00006429|Spinal Cord Injury|spinal cord injury
891949|NCT00006429|Body Weight Supported Ambulation Training|body weight supported ambulation training
891950|NCT00006429|Treadmill Training|treadmill training
891951|NCT00006429|Physical therapy|physical therapy
891952|NCT00006429|Gait|gait
891953|NCT00006429|Assisted Ambulation|assisted ambulation
891954|NCT00006428|Spinal Cord injury (SCI)|spinal cord injury (sci)
891955|NCT00006428|Chronic Pain|chronic pain
891956|NCT00006428|Amitriptyline|amitriptyline
891957|NCT00006427|Amputation|amputation
891958|NCT00006427|Chronic Pain|chronic pain
891959|NCT00006427|Amitriptyline|amitriptyline
891960|NCT00006426|Foot ulcers|foot ulcers
891961|NCT00006426|Diabetes|diabetes
891962|NCT00006426|Peripheral neuropathy|peripheral neuropathy
891963|NCT00006426|Casting|casting
891964|NCT00006426|Achilles Lengthening|achilles lengthening
891965|NCT00006426|Ambulatory surgery|ambulatory surgery
891966|NCT00006426|Foot deformity|foot deformity
891967|NCT00006425|Breast MRI|breast mri
891968|NCT00006425|Ductal lavage|ductal lavage
891969|NCT00006425|Nipple Aspirate Fluid|nipple aspirate fluid
891970|NCT00006425|Transvaginal ultrasound|transvaginal ultrasound
891971|NCT00006424|Plasticity|plasticity
891972|NCT00006424|Motor|motor
891973|NCT00006424|Stroke|stroke
891974|NCT00006424|Amphetamine|amphetamine
891975|NCT00006424|fMRI|fmri
891976|NCT00006424|Cortical Reorganization|cortical reorganization
891977|NCT00006424|Spectroscopy|spectroscopy
891978|NCT00006422|Lazy Eye|lazy eye
891979|NCT00006422|Amblyopia|amblyopia
891980|NCT00006422|Nystagmus|nystagmus
891981|NCT00006422|Eye Movements|eye movements
891982|NCT00006422|Child Vision|child vision
891983|NCT00006421|Breast MRI|breast mri
891984|NCT00006421|Nipple Aspirate Fluid|nipple aspirate fluid
891985|NCT00006421|Transvaginal ultrasound|transvaginal ultrasound
891986|NCT00006421|Ductal lavage|ductal lavage
891987|NCT00006418|Schizophrenia|schizophrenia
891988|NCT00006418|Genetics|genetics
891989|NCT00006417|Fludarabine|fludarabine
891990|NCT00006417|Non-Myeloablative BMT|non-myeloablative bmt
891991|NCT00006417|Immunodeficiency|immunodeficiency
891992|NCT00006417|Neutrophils|neutrophils
891993|NCT00006417|Oxidase|oxidase
891994|NCT00006417|Engraftment|engraftment
891995|NCT00006417|Graft-versus-host Disease|graft-versus-host disease
891996|NCT00006417|Cyclophosphamide|cyclophosphamide
891997|NCT00006417|Donor Apheresis|donor apheresis
891998|NCT00006417|Peripheral Blood Stem Cells|peripheral blood stem cells
891999|NCT00006417|Therapy|therapy
892000|NCT00006414|Anesthesia|anesthesia
892001|NCT00006414|Magnetic Stimulation|magnetic stimulation
892002|NCT00006414|Motor|motor
892003|NCT00006414|Neuroplasticity|neuroplasticity
892004|NCT00006414|Practice|practice
892005|NCT00006414|Rehabilitation|rehabilitation
892006|NCT00006414|Stroke|stroke
892007|NCT00006413|Peripheral Blood Stem Cells|peripheral blood stem cells
892008|NCT00006413|Non-Myeloablative Bone Marrow Transplantation|non-myeloablative bone marrow transplantation
892009|NCT00006413|Engraftment|engraftment
892010|NCT00006413|Graft-versus-host Disease|graft-versus-host disease
892011|NCT00006413|Graft-Versus-Leukemia|graft-versus-leukemia
892012|NCT00006413|Graft-Versus-Mast Cell|graft-versus-mast cell
892013|NCT00006413|Cyclophosphamide|cyclophosphamide
892014|NCT00006413|Fludarabine|fludarabine
892015|NCT00006413|Donor Apheresis|donor apheresis
892016|NCT00006413|Mast Cells|mast cells
892017|NCT00006411|cornea transplant|cornea transplant
892018|NCT00006411|corneal endothelial cell density|corneal endothelial cell density
892019|NCT00006411|moderate risk corneal diseases requiring corneal transplantation|moderate risk corneal diseases requiring corneal transplantation
892020|NCT00006411|corneal transplantation|corneal transplantation
892021|NCT00006400|Blood Diseases|blood diseases
892022|NCT00006400|Sickle Cell Anemia|sickle cell anemia
892023|NCT00006398|cirrhosis|cirrhosis
892024|NCT00006398|esophageal varices|esophageal varices
892025|NCT00006398|variceal hemorrhage|variceal hemorrhage
892026|NCT00006398|beta-adrenergic blocker|beta-adrenergic blocker
892027|NCT00006394|disease-related problem/condition|disease-related problem/condition
892028|NCT00006394|endocrine disorders|endocrine disorders
892029|NCT00006394|growth hormone deficiency|growth hormone deficiency
892030|NCT00006394|osteoporosis|osteoporosis
892031|NCT00006394|quality of life|quality of life
892032|NCT00006394|rare disease|rare disease
892033|NCT00006393|arthritis & connective tissue diseases|arthritis & connective tissue diseases
892034|NCT00006393|rare disease|rare disease
892035|NCT00006393|systemic sclerosis|systemic sclerosis
892036|NCT00006337|Clinical Trial|clinical trial
892037|NCT00006337|Dyskinesias|dyskinesias
893732|NCT00004568|Myopathy|myopathy
892038|NCT00006337|Levodopa Infusion|levodopa infusion
892039|NCT00006336|Gap Detection Test|gap detection test
892040|NCT00006336|Fahn-Scale|fahn-scale
892041|NCT00006336|Visual Analog and Verbal Scale|visual analog and verbal scale
892042|NCT00006336|Writing Standard Paragraph|writing standard paragraph
892043|NCT00006336|Braille Reading Grade I|braille reading grade i
892044|NCT00006335|Genetic|genetic
892045|NCT00006335|Analysis|analysis
892046|NCT00006335|Immune|immune
892047|NCT00006335|Teenage|teenage
892048|NCT00006335|Girls|girls
892049|NCT00006335|Severe Combined Immune Deficiency (SCID)|severe combined immune deficiency (scid)
892050|NCT00006335|XSCID|xscid
892051|NCT00006335|Carrier Testing|carrier testing
892052|NCT00006335|X-Linked Disease|x-linked disease
892053|NCT00006335|Adolescent|adolescent
892054|NCT00006334|Genes|genes
892055|NCT00006334|X-Chromosome|x-chromosome
892056|NCT00006334|Osteoporosis|osteoporosis
892057|NCT00006334|Ovarian Failure|ovarian failure
892058|NCT00006334|Imprinting|imprinting
892059|NCT00006334|Turner's|turner's
892060|NCT00006334|Turner|turner
892061|NCT00006334|TS|ts
892062|NCT00006333|Pathogenesis|pathogenesis
892063|NCT00006333|Rheumatoid Arthritis|rheumatoid arthritis
892064|NCT00006333|Juvenile Rheumatoid Arthritis|juvenile rheumatoid arthritis
892065|NCT00006333|JRA|jra
892066|NCT00006332|Molybdenum|molybdenum
892067|NCT00006331|Kidney transplantation|kidney transplantation
892068|NCT00006331|Immunology|immunology
892069|NCT00006330|Digoxin|digoxin
892070|NCT00006330|Effect modifiers (Epidemiology)|effect modifiers (epidemiology)
892071|NCT00006330|Rosales|rosales
892072|NCT00006330|Drug Interaction|drug interaction
892073|NCT00006329|Radionuclide imaging|radionuclide imaging
892074|NCT00006329|Surgery|surgery
892075|NCT00006328|Chronic Allograft Nephropathy (CAN)|chronic allograft nephropathy (can)
892076|NCT00006328|Transplantation immunology|transplantation immunology
892077|NCT00006328|Genetics|genetics
892078|NCT00006328|Graft Rejection|graft rejection
892079|NCT00006320|Reverse Transcriptase Inhibitor|reverse transcriptase inhibitor
892080|NCT00006320|Protease Inhibitor|protease inhibitor
892081|NCT00006319|X-Linked Agammagloblinemia|x-linked agammagloblinemia
892082|NCT00006319|Wiskott-Aldrich Syndrome|wiskott-aldrich syndrome
892083|NCT00006319|Jak-3 SCID|jak-3 scid
892084|NCT00006319|X-Linked SCID|x-linked scid
892085|NCT00006319|X-Linked Hyper-IgM Syndrome|x-linked hyper-igm syndrome
892086|NCT00006318|Cerebral Blood Flow|cerebral blood flow
892087|NCT00006318|CO2 Inhalation|co2 inhalation
892088|NCT00006318|Imaging|imaging
892089|NCT00006318|MRI|mri
892090|NCT00006318|Perfusion|perfusion
892091|NCT00006318|Functional Activation|functional activation
892092|NCT00006301|Hepatitis C|hepatitis c
892093|NCT00006301|Viral Sequence|viral sequence
892094|NCT00006301|PCR|pcr
892095|NCT00006301|T Cell|t cell
892096|NCT00006301|Seroconversion|seroconversion
892097|NCT00006301|Cytokines|cytokines
892098|NCT00006300|Immunosuppression|immunosuppression
892099|NCT00006300|Treatment Recommendations|treatment recommendations
892100|NCT00006300|Pancytopenia|pancytopenia
892101|NCT00006300|Schizophrenia|schizophrenia
892102|NCT00006300|Inpatient Population|inpatient population
892103|NCT00006299|Celecoxib|celecoxib
892104|NCT00006299|Thromboxane B2|thromboxane b2
892105|NCT00006299|Prostaglandin E2|prostaglandin e2
892106|NCT00006299|Microdialysis|microdialysis
892107|NCT00006299|Ibuprofen|ibuprofen
892108|NCT00006292|Biologic Therapy|biologic therapy
892109|NCT00006292|Bone Erosion|bone erosion
892110|NCT00006292|CT|ct
892111|NCT00006292|MRI|mri
892112|NCT00006292|Rheumatoid Arthritis|rheumatoid arthritis
892113|NCT00006292|RA|ra
892114|NCT00006289|Analgesia|analgesia
892115|NCT00006289|Causalgia|causalgia
892116|NCT00006289|CRPS|crps
892117|NCT00006289|Neuropathic Pain|neuropathic pain
892118|NCT00006289|Oral Surgery|oral surgery
892119|NCT00006289|Reflex Sympathetic Dystrophy|reflex sympathetic dystrophy
892120|NCT00006289|Sympathetic Nervous System|sympathetic nervous system
892121|NCT00006289|Chronic Regional Pain Syndrome|chronic regional pain syndrome
892122|NCT00006285|Transcranial Magnetic Stimulation|transcranial magnetic stimulation
892123|NCT00006285|Parietal Lobe|parietal lobe
892124|NCT00006285|fMRI|fmri
892125|NCT00006285|Cognition|cognition
892126|NCT00006285|Perception|perception
892127|NCT00006285|Cortical Stimulation|cortical stimulation
892128|NCT00006285|Spatial Attention|spatial attention
892129|NCT00006286|Depression|depression
892130|NCT00006286|Major Depressive Disorder|major depressive disorder
892131|NCT00006286|Fluoxetine|fluoxetine
892132|NCT00006286|Prozac|prozac
892133|NCT00006286|SSRI|ssri
892134|NCT00006286|Psychotherapy|psychotherapy
892135|NCT00006286|CBT|cbt
892136|NCT00006286|Teenagers|teenagers
892137|NCT00006286|Adolescents|adolescents
892138|NCT00006286|Teens|teens
892139|NCT00006278|Cushing's Syndrome|cushing's syndrome
892140|NCT00006278|Adrenal Glands|adrenal glands
892141|NCT00006278|Proteomics|proteomics
892142|NCT00006278|Cortisol|cortisol
892143|NCT00006276|Angiogenesis Inhibition|angiogenesis inhibition
892144|NCT00006276|Skin Disease|skin disease
892145|NCT00006276|Blood Vessels|blood vessels
892146|NCT00006276|Cytokines|cytokines
892147|NCT00006276|Autoimmune Disease|autoimmune disease
892148|NCT00006280|Cystic Fibrosis|cystic fibrosis
892149|NCT00006275|dermatologic disorders|dermatologic disorders
892150|NCT00006275|psoriasis|psoriasis
892151|NCT00006275|rare disease|rare disease
892152|NCT00006274|cardiovascular and respiratory diseases|cardiovascular and respiratory diseases
892153|NCT00006274|neonatal disorders|neonatal disorders
892154|NCT00006274|rare disease|rare disease
892155|NCT00006274|respiratory distress syndrome|respiratory distress syndrome
892156|NCT00006273|cardiovascular and respiratory diseases|cardiovascular and respiratory diseases
892157|NCT00006273|cystic fibrosis|cystic fibrosis
892158|NCT00006273|genetic diseases and dysmorphic syndromes|genetic diseases and dysmorphic syndromes
892159|NCT00006273|rare disease|rare disease
892160|NCT00006272|cardiovascular and respiratory diseases|cardiovascular and respiratory diseases
892161|NCT00006272|heart defects|heart defects
892162|NCT00006272|rare disease|rare disease
892163|NCT00006271|brain injury|brain injury
892164|NCT00006271|neurologic and psychiatric disorders|neurologic and psychiatric disorders
892165|NCT00006271|rare disease|rare disease
892166|NCT00006270|brain injury|brain injury
892167|NCT00006270|neurologic and psychiatric disorders|neurologic and psychiatric disorders
892168|NCT00006270|rare disease|rare disease
892169|NCT00006205|alcoholism|alcoholism
892170|NCT00006205|alcohol addiction|alcohol addiction
892171|NCT00006204|Alcoholism|alcoholism
892172|NCT00006204|Alcohol Dependence|alcohol dependence
892173|NCT00006204|Depression|depression
892174|NCT00006204|Naltrexone|naltrexone
892175|NCT00006204|Fluoxetine|fluoxetine
892176|NCT00006202|Serum levels of Lutein|serum levels of lutein
892177|NCT00006202|Age-Related Macular Degeneration|age-related macular degeneration
892178|NCT00006202|Safety|safety
892179|NCT00006202|Toxicity|toxicity
892180|NCT00006199|solid tumor|solid tumor
892181|NCT00006196|Vitamin D resistance|vitamin d resistance
892182|NCT00006194|sarcopenia|sarcopenia
892183|NCT00006190|Lipoproteins|lipoproteins
892184|NCT00006190|Insulin resistance|insulin resistance
892185|NCT00006190|Adipose tissue|adipose tissue
892186|NCT00006188|Behcet's Disease|behcet's disease
892187|NCT00006188|Sarcoidosis|sarcoidosis
892188|NCT00006188|Iritis|iritis
892189|NCT00006188|Choroiditis|choroiditis
892190|NCT00006188|Iridocyclitis|iridocyclitis
892191|NCT00006188|Retinal Disease|retinal disease
892192|NCT00006188|Cystoid Macular Edema|cystoid macular edema
892193|NCT00006188|Uveitis|uveitis
892194|NCT00006188|Intraocular Inflammation|intraocular inflammation
892195|NCT00006188|Inflammatory Eye DIsease|inflammatory eye disease
892196|NCT00006187|Investigational Drug|investigational drug
892197|NCT00006186|dilutional coagulopathy|dilutional coagulopathy
892198|NCT00006184|Immunoablative|immunoablative
892199|NCT00006184|Mobilization|mobilization
892200|NCT00006184|Apheresis|apheresis
892201|NCT00006184|Multiple Myeloma|multiple myeloma
892202|NCT00006184|IgG Multiple Myeloma|igg multiple myeloma
892203|NCT00006184|IgA Multiple Myeloma|iga multiple myeloma
892204|NCT00006185|peripheral fat wasting|peripheral fat wasting
892205|NCT00006185|truncal adiposity|truncal adiposity
892206|NCT00006185|fat biopsy|fat biopsy
892207|NCT00006185|muscle biopsy|muscle biopsy
892208|NCT00006185|intravenous lines|intravenous lines
892209|NCT00006185|blood draws|blood draws
892210|NCT00006185|insulin administration|insulin administration
892211|NCT00006185|sugar water|sugar water
892212|NCT00006185|screening|screening
892213|NCT00006399|Alzheimer disease|alzheimer disease
892214|NCT00006399|Estrogen therapy|estrogen therapy
892215|NCT00006399|Post-menopausal women|post-menopausal women
892216|NCT00006181|Health behavior change|health behavior change
892217|NCT00006181|Motivational interviewing|motivational interviewing
892218|NCT00006181|Motivational enhancement|motivational enhancement
892219|NCT00006181|Health counseling|health counseling
892220|NCT00006181|Team intervention|team intervention
892221|NCT00006181|One-on-one intervention|one-on-one intervention
892222|NCT00006181|Physical activity|physical activity
892223|NCT00006181|Exercise|exercise
892224|NCT00006181|Nutrition|nutrition
892225|NCT00006181|Health assessments|health assessments
892226|NCT00006181|Strength|strength
892227|NCT00006181|Flexibility|flexibility
892228|NCT00006181|Percent body fat|percent body fat
892229|NCT00006181|Social-learning theory|social-learning theory
892230|NCT00006181|PHLAME|phlame
892231|NCT00006181|Fire fighters|fire fighters
892232|NCT00006181|Fire stations|fire stations
892233|NCT00006181|Cancer|cancer
892234|NCT00006181|Cardiovascular diseases|cardiovascular diseases
892235|NCT00006180|Preventive Medicine|preventive medicine
892236|NCT00006180|Women's Health|women's health
892237|NCT00006180|Bone Formation|bone formation
892238|NCT00006180|Mood Disorders|mood disorders
892239|NCT00006180|Bone Resorption|bone resorption
892240|NCT00006180|Major Depression|major depression
892241|NCT00006180|Osteopenia|osteopenia
892242|NCT00006180|Osteoporosis|osteoporosis
892243|NCT00006180|Bone Fracture|bone fracture
892244|NCT00006180|Bisphosphonate|bisphosphonate
892245|NCT00006180|Depression|depression
892246|NCT00006180|Bone Density|bone density
892247|NCT00006180|Healthy Volunteer|healthy volunteer
892248|NCT00006180|HV|hv
892249|NCT00006180|Normal Control|normal control
892250|NCT00006178|Renal Failure|renal failure
892251|NCT00006178|Anti-rejection|anti-rejection
892252|NCT00006178|Apoptosis|apoptosis
892253|NCT00006178|Polyclonal Antibody|polyclonal antibody
892254|NCT00006178|Kidney Transplant|kidney transplant
892255|NCT00006177|Emotion|emotion
892256|NCT00006177|Children and Adolescents|children and adolescents
892257|NCT00006177|Affective Neuroscience|affective neuroscience
892258|NCT00006177|Bipolar Disorder|bipolar disorder
892259|NCT00006177|Child|child
892260|NCT00006177|Child Bipolar|child bipolar
892261|NCT00006177|BPD|bpd
892262|NCT00006177|Adolescent Bipolar|adolescent bipolar
892264|NCT00006176|Presenile Dementia|presenile dementia
892265|NCT00006176|Progressive Myoclonic Epilepsy|progressive myoclonic epilepsy
892266|NCT00006176|Dementia|dementia
892267|NCT00006176|Early Onset Progressive Dementia|early onset progressive dementia
892268|NCT00006176|Familial Presenile Dementia|familial presenile dementia
892269|NCT00006176|FDNIB|fdnib
892270|NCT00006176|familial encephalopathy with neuroserpin inclusion bodies|familial encephalopathy with neuroserpin inclusion bodies
892271|NCT00006176|Heredodegenerative Disorders, Nervous System|heredodegenerative disorders, nervous system
892272|NCT00006175|Cyclooxygenase|cyclooxygenase
892273|NCT00006175|COX-1|cox-1
892274|NCT00006175|COX-2|cox-2
892275|NCT00006175|Prostanoids|prostanoids
892276|NCT00006175|P.C.R.|p.c.r.
892277|NCT00006175|Healthy Volunteer|healthy volunteer
892278|NCT00006174|Precocious Puberty|precocious puberty
892279|NCT00006174|Polyostotic|polyostotic
892280|NCT00006174|Fibrous Dysplasia|fibrous dysplasia
892281|NCT00006174|PFD|pfd
892282|NCT00006174|McCune-Albright Syndrome (MAS)|mccune-albright syndrome (mas)
892283|NCT00006173|Atherosclerosis|atherosclerosis
892284|NCT00006173|Hypertension|hypertension
892285|NCT00006173|Magnetic Resonance Angiography|magnetic resonance angiography
892286|NCT00006172|Antidepressive Agents|antidepressive agents
892287|NCT00006172|Chronobiology|chronobiology
892288|NCT00006172|Chronotherapy|chronotherapy
892289|NCT00006172|Circadian rhythms|circadian rhythms
892290|NCT00006172|Depressive Disorder|depressive disorder
892291|NCT00006172|Ions|ions
892292|NCT00006172|Light|light
892293|NCT00006172|Lighting|lighting
892294|NCT00006172|Mood disorders|mood disorders
892295|NCT00006172|Phototherapy.|phototherapy.
892296|NCT00006171|HHV-8|hhv-8
892297|NCT00006171|Pathophysiology|pathophysiology
892298|NCT00006171|AIDS|aids
892299|NCT00006171|Cancer|cancer
892300|NCT00006171|Anti-Retroviral|anti-retroviral
892301|NCT00006171|Kaposi's Sarcoma|kaposi's sarcoma
892302|NCT00006171|HIV|hiv
892303|NCT00006170|smoking cessation|smoking cessation
892304|NCT00006170|Women|women
892305|NCT00006170|bupropion|bupropion
892306|NCT00006170|weight concerns|weight concerns
892307|NCT00006170|weight|weight
892308|NCT00006156|Ovarian Failure|ovarian failure
892309|NCT00006156|Ovary|ovary
892310|NCT00006156|Aging|aging
892311|NCT00006156|Healthy Volunteer|healthy volunteer
892312|NCT00006156|Primary Ovarian Insufficiency(POI)|primary ovarian insufficiency(poi)
892313|NCT00006156|Premature Menopause|premature menopause
892314|NCT00006156|Premature Ovarian Failure (POF)|premature ovarian failure (pof)
892315|NCT00006169|Nutrition|nutrition
892316|NCT00006169|Behavior Therapy|behavior therapy
892317|NCT00006169|Cystic Fibrosis|cystic fibrosis
892318|NCT00006168|primary biliary cirrhosis|primary biliary cirrhosis
892319|NCT00006168|Ursodeoxycholic acid|ursodeoxycholic acid
892320|NCT00006168|UDCA|udca
892321|NCT00006168|MTX|mtx
892322|NCT00006168|Hepatology|hepatology
892323|NCT00006168|methotrexate|methotrexate
892324|NCT00006168|liver|liver
892325|NCT00006167|oxandrolone|oxandrolone
892326|NCT00006167|AIDS wasting|aids wasting
892327|NCT00006167|strength training|strength training
892328|NCT00006167|progressive resistance training|progressive resistance training
892329|NCT00006167|exercise|exercise
892330|NCT00006167|dietary intervention|dietary intervention
892331|NCT00006166|refractory ascites|refractory ascites
892332|NCT00006166|paracenteses|paracenteses
892333|NCT00006165|Native Hawaiian|native hawaiian
892334|NCT00006165|Diabetes Mellitus|diabetes mellitus
892335|NCT00006165|Lifestyle Intervention|lifestyle intervention
892336|NCT00006165|Family Support|family support
892337|NCT00006165|Diabetes Mellitus, at-risk|diabetes mellitus, at-risk
892338|NCT00006164|liver disease|liver disease
892339|NCT00006164|hepatitis c virus|hepatitis c virus
892340|NCT00006164|antiviral agent|antiviral agent
892341|NCT00006164|cirrhosis|cirrhosis
892342|NCT00006163|diabetes|diabetes
892343|NCT00006163|self-management|self-management
892344|NCT00006163|randomized trial|randomized trial
892345|NCT00006163|RE-AIM evaluation|re-aim evaluation
892346|NCT00006163|participation|participation
892347|NCT00006163|maintenance|maintenance
892348|NCT00006163|community resources|community resources
892349|NCT00006163|dietary change|dietary change
892350|NCT00006162|low fat diet|low fat diet
892351|NCT00006162|aerobic exercise|aerobic exercise
892352|NCT00006162|impaired glucose tolerance|impaired glucose tolerance
892353|NCT00006162|Japanese Americans|japanese americans
892354|NCT00006162|metabolic risk factors|metabolic risk factors
892355|NCT00006161|TIPS|tips
892356|NCT00006161|DSRS|dsrs
892357|NCT00006161|Varices|varices
892358|NCT00006161|Variceal bleeding|variceal bleeding
892359|NCT00006161|Splenorenal Shunt|splenorenal shunt
892360|NCT00006161|Transjugular Intrahepatic Portosystemic Shunt|transjugular intrahepatic portosystemic shunt
892361|NCT00006161|Cirrhosis|cirrhosis
892362|NCT00006161|Portal hypertension|portal hypertension
892363|NCT00006161|Liver disease|liver disease
892364|NCT00006159|diabetes|diabetes
892365|NCT00006159|lifestyle intervention|lifestyle intervention
892366|NCT00006159|Native American|native american
892367|NCT00006159|community intervention|community intervention
892368|NCT00006159|diet|diet
892369|NCT00006159|exercise|exercise
892370|NCT00006158|AIDS|aids
892371|NCT00006158|HIV|hiv
892372|NCT00006158|weight loss|weight loss
892373|NCT00006158|Wasting Syndrome|wasting syndrome
892374|NCT00006158|testosterone|testosterone
892375|NCT00006158|androgen levels|androgen levels
892376|NCT00006158|hormones|hormones
892377|NCT00006157|Functional bowel disorder|functional bowel disorder
892378|NCT00006157|Irritable bowel syndrome|irritable bowel syndrome
892379|NCT00006157|Painful constipation|painful constipation
892380|NCT00006157|Unspecified functional bowel disorder|unspecified functional bowel disorder
892381|NCT00006157|Chronic functional abdominal pain|chronic functional abdominal pain
892382|NCT00006157|Cognitive-behavioral psychological treatment|cognitive-behavioral psychological treatment
892383|NCT00006157|IBS|ibs
892384|NCT00006157|CFAP|cfap
892385|NCT00006151|nicotine fading|nicotine fading
892386|NCT00006151|Accu Drop|accu drop
892387|NCT00006151|cigarette tapering|cigarette tapering
892388|NCT00006151|smoking cessation|smoking cessation
892389|NCT00006151|motivational interviewing|motivational interviewing
892390|NCT00006150|DOCK8 Deficiency|dock8 deficiency
892391|NCT00006150|PGM3 Deficiency|pgm3 deficiency
892392|NCT00006150|STAT3 Mutation|stat3 mutation
892393|NCT00006150|Job's Syndrome|job's syndrome
892394|NCT00006150|Hyperimmunologobulin E Syndrome|hyperimmunologobulin e syndrome
892395|NCT00006150|HIE Syndrome|hie syndrome
892396|NCT00006148|Granulocyte Colony - Stimulation Factor|granulocyte colony - stimulation factor
892397|NCT00006148|Peripheral Blood Stem Cells|peripheral blood stem cells
892398|NCT00006148|Splenomegaly|splenomegaly
892399|NCT00006077|Clinical Trial|clinical trial
892400|NCT00006077|Dyskinesias|dyskinesias
892401|NCT00006077|Levodopa Infusion|levodopa infusion
892402|NCT00006077|Parkinson's Disease|parkinson's disease
892403|NCT00006142|inborn errors of metabolism|inborn errors of metabolism
892404|NCT00006142|phenylketonuria|phenylketonuria
892405|NCT00006142|rare disease|rare disease
892406|NCT00006138|disease-related problem/condition|disease-related problem/condition
892407|NCT00006138|genetic diseases and dysmorphic syndromes|genetic diseases and dysmorphic syndromes
892408|NCT00006138|hematologic disorders|hematologic disorders
892409|NCT00006138|osteoporosis|osteoporosis
892410|NCT00006138|rare disease|rare disease
892411|NCT00006138|thalassemia major|thalassemia major
892412|NCT00006137|IgA glomerulonephritis|iga glomerulonephritis
892413|NCT00006137|rare disease|rare disease
892414|NCT00006137|renal and genitourinary disorders|renal and genitourinary disorders
892415|NCT00006136|genetic diseases and dysmorphic syndromes|genetic diseases and dysmorphic syndromes
892416|NCT00006136|hematologic disorders|hematologic disorders
892417|NCT00006136|rare disease|rare disease
892418|NCT00006136|thalassemia intermedia|thalassemia intermedia
892419|NCT00006135|herpes simplex virus infection|herpes simplex virus infection
892420|NCT00006135|herpesvirus infection|herpesvirus infection
892421|NCT00006135|immunologic disorders and infectious disorders|immunologic disorders and infectious disorders
892422|NCT00006135|rare disease|rare disease
892423|NCT00006135|viral infection|viral infection
892424|NCT00006134|arthritis & connective tissue diseases|arthritis & connective tissue diseases
892425|NCT00006134|immunologic disorders and infectious disorders|immunologic disorders and infectious disorders
892426|NCT00006134|rare disease|rare disease
892427|NCT00006134|systemic lupus erythematosus|systemic lupus erythematosus
892428|NCT00006133|arthritis & connective tissue diseases|arthritis & connective tissue diseases
892429|NCT00006133|immunologic disorders and infectious disorders|immunologic disorders and infectious disorders
892430|NCT00006133|rare disease|rare disease
892431|NCT00006133|systemic lupus erythematosus|systemic lupus erythematosus
892432|NCT00006132|herpes simplex virus infection|herpes simplex virus infection
892433|NCT00006132|herpes virus infection|herpes virus infection
892434|NCT00006132|immunologic disorders and infectious disorders|immunologic disorders and infectious disorders
892435|NCT00006132|rare disease|rare disease
892436|NCT00006132|viral infection|viral infection
892437|NCT00006130|arthritis & connective tissue diseases|arthritis & connective tissue diseases
892438|NCT00006130|avascular necrosis|avascular necrosis
892439|NCT00006130|disease-related problem/condition|disease-related problem/condition
892440|NCT00006130|genetic diseases and dysmorphic syndromes|genetic diseases and dysmorphic syndromes
892441|NCT00006130|hematologic disorders|hematologic disorders
892442|NCT00006130|pain|pain
892443|NCT00006130|rare disease|rare disease
892444|NCT00006130|sickle cell anemia|sickle cell anemia
892445|NCT00006129|burns|burns
892446|NCT00006129|dermatologic disorders|dermatologic disorders
892447|NCT00006129|rare disease|rare disease
892448|NCT00006128|neurologic and psychiatric disorders|neurologic and psychiatric disorders
892449|NCT00006128|rare disease|rare disease
892450|NCT00006127|Fanconi's anemia|fanconi's anemia
892451|NCT00006127|aplastic anemia|aplastic anemia
892452|NCT00006127|hematologic disorders|hematologic disorders
892453|NCT00006127|rare disease|rare disease
892454|NCT00006076|Hearing|hearing
892455|NCT00006076|Auditory Processing|auditory processing
892456|NCT00006076|Pitch Recognition|pitch recognition
892457|NCT00006076|Tone Deafness|tone deafness
892458|NCT00006076|Tune Deafness|tune deafness
892459|NCT00006076|HV|hv
892460|NCT00006076|Deafness|deafness
892461|NCT00006076|Congenital Amusia|congenital amusia
892462|NCT00006076|Healthy Volunteer|healthy volunteer
892463|NCT00006070|Oral Surgery|oral surgery
892464|NCT00006070|Swelling|swelling
892465|NCT00006070|Pain|pain
892466|NCT00006070|TNF|tnf
892467|NCT00006070|Etanercept|etanercept
892468|NCT00005937|MDS|mds
892469|NCT00005937|Immunosuppression|immunosuppression
892470|NCT00005937|ATG|atg
892471|NCT00005937|Cyclosporine|cyclosporine
892472|NCT00005937|Myelodysplastic Syndrome|myelodysplastic syndrome
892473|NCT00005936|Fulminant Hepatitis|fulminant hepatitis
892474|NCT00005936|Parvovirus|parvovirus
892475|NCT00005936|Hepatitis|hepatitis
892476|NCT00005936|Biopsy|biopsy
892477|NCT00005936|Control|control
892478|NCT00005936|Liver Biopsy|liver biopsy
892479|NCT00005935|Immunosuppression|immunosuppression
892480|NCT00005935|T Cells|t cells
892481|NCT00005935|Autoimmunity|autoimmunity
892482|NCT00005935|Bone Marrow Failure|bone marrow failure
892483|NCT00005935|Hematopoiesis|hematopoiesis
892484|NCT00005935|Relapsing Aplastic Anemia|relapsing aplastic anemia
892485|NCT00005934|Fetal Hemoglobin|fetal hemoglobin
892486|NCT00005934|5-Azacytidine|5-azacytidine
892487|NCT00005934|Phenylbutyrate|phenylbutyrate
892488|NCT00005934|Thalassemia|thalassemia
892489|NCT00005934|Hemoglobin|hemoglobin
892490|NCT00005934|Anemia|anemia
892491|NCT00005934|Blood|blood
892492|NCT00005934|Thalassemia Major|thalassemia major
892493|NCT00005934|Beta Thalassemia|beta thalassemia
892494|NCT00006063|cardiovascular and respiratory diseases|cardiovascular and respiratory diseases
892495|NCT00006063|cystic fibrosis|cystic fibrosis
892496|NCT00006063|genetic diseases and dysmorphic syndromes|genetic diseases and dysmorphic syndromes
892497|NCT00006063|rare disease|rare disease
892498|NCT00006061|genetic diseases and dysmorphic syndromes|genetic diseases and dysmorphic syndromes
892499|NCT00006061|inborn errors of metabolism|inborn errors of metabolism
892500|NCT00006061|methionine adenosyltransferase deficiency|methionine adenosyltransferase deficiency
892501|NCT00006061|rare disease|rare disease
892502|NCT00006060|multiple sclerosis|multiple sclerosis
892503|NCT00006060|neurologic and psychiatric disorders|neurologic and psychiatric disorders
892504|NCT00006060|rare disease|rare disease
892505|NCT00006059|epilepsy|epilepsy
892506|NCT00006059|neurologic and psychiatric disorders|neurologic and psychiatric disorders
892507|NCT00006059|rare disease|rare disease
892508|NCT00006059|seizures|seizures
892509|NCT00006058|bronchopulmonary dysplasia|bronchopulmonary dysplasia
892510|NCT00006058|cardiovascular and respiratory diseases|cardiovascular and respiratory diseases
892511|NCT00006058|neonatal disorders|neonatal disorders
892512|NCT00006058|rare disease|rare disease
892513|NCT00006058|respiratory distress syndrome|respiratory distress syndrome
892514|NCT00006056|Chediak-Higashi syndrome|chediak-higashi syndrome
892515|NCT00006056|X-linked lymphoproliferative syndrome|x-linked lymphoproliferative syndrome
892516|NCT00006056|disease-related problem/condition|disease-related problem/condition
892517|NCT00006056|familial erythrophagocytic lymphohistiocytosis|familial erythrophagocytic lymphohistiocytosis
892518|NCT00006056|genetic diseases and dysmorphic syndromes|genetic diseases and dysmorphic syndromes
892519|NCT00006056|graft versus host disease|graft versus host disease
892520|NCT00006056|hematologic disorders|hematologic disorders
892521|NCT00006056|hemophagocytic lymphohistiocytosis|hemophagocytic lymphohistiocytosis
892522|NCT00006056|histiocytosis|histiocytosis
892523|NCT00006056|immunologic disorders and infectious disorders|immunologic disorders and infectious disorders
892524|NCT00006056|primary immunodeficiency disease|primary immunodeficiency disease
892525|NCT00006056|rare disease|rare disease
892526|NCT00006056|virus-associated hemophagocytic syndrome|virus-associated hemophagocytic syndrome
892527|NCT00006055|Churg-Strauss syndrome|churg-strauss syndrome
892528|NCT00006055|Schonlein-Henoch purpura|schonlein-henoch purpura
892529|NCT00006055|Takayasu arteritis|takayasu arteritis
892530|NCT00006055|Wegener's granulomatosis|wegener's granulomatosis
892531|NCT00006055|arthritis & connective tissue diseases|arthritis & connective tissue diseases
892532|NCT00006055|autoimmune hemolytic anemia|autoimmune hemolytic anemia
892533|NCT00006055|cardiovascular and respiratory diseases|cardiovascular and respiratory diseases
892534|NCT00006055|disease-related problem/condition|disease-related problem/condition
892535|NCT00006055|giant cell arteritis|giant cell arteritis
892536|NCT00006055|graft versus host disease|graft versus host disease
892537|NCT00006055|hematologic disorders|hematologic disorders
892538|NCT00006055|hypersensitivity vasculitis|hypersensitivity vasculitis
892539|NCT00006055|immune thrombocytopenic purpura|immune thrombocytopenic purpura
892540|NCT00006055|immunologic disorders and infectious disorders|immunologic disorders and infectious disorders
892541|NCT00006055|juvenile rheumatoid arthritis|juvenile rheumatoid arthritis
892542|NCT00006055|polyarteritis nodosa|polyarteritis nodosa
892543|NCT00006055|pure red cell aplasia|pure red cell aplasia
892544|NCT00006055|rare disease|rare disease
892545|NCT00006055|rheumatoid arthritis|rheumatoid arthritis
892546|NCT00006055|systemic lupus erythematosus|systemic lupus erythematosus
892547|NCT00006055|vasculitis|vasculitis
892548|NCT00006054|Chediak-Higashi syndrome|chediak-higashi syndrome
892549|NCT00006054|Langerhans cell histiocytosis|langerhans cell histiocytosis
892550|NCT00006054|Wiskott-Aldrich syndrome|wiskott-aldrich syndrome
892551|NCT00006054|X-linked agammaglobulinemia|x-linked agammaglobulinemia
892552|NCT00006054|X-linked hyper IgM syndrome|x-linked hyper igm syndrome
892553|NCT00006054|X-linked lymphoproliferative syndrome|x-linked lymphoproliferative syndrome
892554|NCT00006054|chronic granulomatous disease|chronic granulomatous disease
892555|NCT00006054|common variable immunodeficiency|common variable immunodeficiency
892556|NCT00006054|complement deficiency|complement deficiency
892557|NCT00006054|disease-related problem/condition|disease-related problem/condition
892558|NCT00006054|familial erythrophagocytic lymphohistiocytosis|familial erythrophagocytic lymphohistiocytosis
892559|NCT00006054|genetic diseases and dysmorphic syndromes|genetic diseases and dysmorphic syndromes
892560|NCT00006054|graft versus host disease|graft versus host disease
892561|NCT00006054|hematologic disorders|hematologic disorders
892562|NCT00006054|hemophagocytic lymphohistiocytosis|hemophagocytic lymphohistiocytosis
892563|NCT00006054|histiocytosis|histiocytosis
892564|NCT00006054|immunologic disorders and infectious disorders|immunologic disorders and infectious disorders
892565|NCT00006054|leukocyte adhesion deficiency syndrome|leukocyte adhesion deficiency syndrome
892566|NCT00006054|primary immunodeficiency disease|primary immunodeficiency disease
892567|NCT00006054|rare disease|rare disease
892568|NCT00006054|severe combined immunodeficiency|severe combined immunodeficiency
892569|NCT00006054|virus-associated hemophagocytic syndrome|virus-associated hemophagocytic syndrome
892570|NCT00005933|Chronic Disease|chronic disease
892571|NCT00005933|Pediatric|pediatric
892572|NCT00005933|Pulmonary|pulmonary
892573|NCT00005933|Intelligence|intelligence
892574|NCT00005933|Coping|coping
892575|NCT00005933|Chronic Illness|chronic illness
892576|NCT00005933|Learning|learning
892577|NCT00005928|ACE Inhibitor|ace inhibitor
892578|NCT00005928|Vascular Inflammation|vascular inflammation
892579|NCT00005928|Vascular Compliance|vascular compliance
892580|NCT00005928|Cell Adhesion Molecules|cell adhesion molecules
892581|NCT00005928|Coronary Artery Disease|coronary artery disease
892582|NCT00005927|Macronodular Adrenals|macronodular adrenals
892583|NCT00005927|Cushing's Syndrome|cushing's syndrome
892584|NCT00005927|Adrenal Gland|adrenal gland
892585|NCT00005925|Video-EEG|video-eeg
892586|NCT00005925|Muscimol|muscimol
892587|NCT00005925|Depth Electrode|depth electrode
892588|NCT00005925|Brain Catheter|brain catheter
892589|NCT00005925|Pharmacology|pharmacology
892590|NCT00005925|Epilepsy|epilepsy
892591|NCT00005925|Infusion|infusion
892592|NCT00005925|Magnetic Resonance Imaging|magnetic resonance imaging
892593|NCT00005924|B Cell|b cell
892594|NCT00005924|Epstein-Barr Virus|epstein-barr virus
892595|NCT00005923|Joint Instability|joint instability
892596|NCT00005922|Conditioning|conditioning
892597|NCT00005922|Corticosteroid|corticosteroid
892599|NCT00005922|Pharmacotherapy|pharmacotherapy
892600|NCT00005922|Placebo effect|placebo effect
892601|NCT00005922|Psoriasis|psoriasis
892602|NCT00005922|Psychoneuroimmunology|psychoneuroimmunology
892603|NCT00005919|Pigment Dispersion|pigment dispersion
892604|NCT00005919|Ocular Hypertension|ocular hypertension
892605|NCT00005919|Glaucoma|glaucoma
892606|NCT00005919|Pupil Reaction|pupil reaction
892607|NCT00005919|Natural History|natural history
892608|NCT00005919|Pigment Dispersion Syndrome|pigment dispersion syndrome
892609|NCT00005919|Gene Mutation|gene mutation
892610|NCT00005917|Albinism|albinism
892611|NCT00005917|Giant Granules|giant granules
892612|NCT00005917|Infection|infection
892613|NCT00005917|Melanosomes|melanosomes
892614|NCT00005917|Platelet Storage Pool Defect|platelet storage pool defect
892615|NCT00005916|Immunotherapy|immunotherapy
892616|NCT00005916|Radiation|radiation
892617|NCT00005916|Immunology|immunology
892618|NCT00005916|Prostvac|prostvac
892619|NCT00005916|Prostate Cancer|prostate cancer
892620|NCT00005914|Depression|depression
892621|NCT00005914|Depressive Disorder|depressive disorder
892622|NCT00005914|Family|family
892623|NCT00005914|Genes|genes
892624|NCT00005914|Genetic Techniques|genetic techniques
892625|NCT00005914|Genetics|genetics
892626|NCT00005914|Linkage (Genetics)|linkage (genetics)
892627|NCT00005914|Nuclear Family|nuclear family
892628|NCT00005914|Recurrence|recurrence
892629|NCT00005914|Severity of Illness Index|severity of illness index
892630|NCT00005911|Magnetic Resonance Imaging|magnetic resonance imaging
892631|NCT00005911|Human Eye|human eye
892632|NCT00005911|Lens|lens
892633|NCT00005911|Normal Volunteers|normal volunteers
892634|NCT00005911|Cataract|cataract
892635|NCT00005911|Human Lens|human lens
892636|NCT00005911|Healthy Volunteer|healthy volunteer
892637|NCT00005910|Islet Cell Tumors|islet cell tumors
892638|NCT00005910|Surgery|surgery
892639|NCT00005910|Ultrasound|ultrasound
892640|NCT00005910|Insulin|insulin
892641|NCT00005910|Rapid Assay|rapid assay
892642|NCT00005910|Arteriogram|arteriogram
892643|NCT00005910|Pancreas|pancreas
892644|NCT00005910|Laparoscopy|laparoscopy
892645|NCT00005910|Insulinoma|insulinoma
892646|NCT00005910|Localization|localization
892647|NCT00005910|Hypoglycemia|hypoglycemia
892648|NCT00005909|Homogentisic Acid|homogentisic acid
892649|NCT00005909|Ochronosis|ochronosis
892650|NCT00005909|Inborn Error of Metabolism|inborn error of metabolism
892651|NCT00005909|Arthritis|arthritis
892652|NCT00005909|Enzyme Defect|enzyme defect
892653|NCT00005909|Alkaptonuria|alkaptonuria
892654|NCT00005908|cDNA Microarray|cdna microarray
892655|NCT00005908|Stage II and Stage III Breast Cancer|stage ii and stage iii breast cancer
892656|NCT00005908|Biological Response|biological response
892657|NCT00005908|Molecular Profiling|molecular profiling
892658|NCT00005908|Fine Needle Aspirate|fine needle aspirate
892659|NCT00005908|Breast Cancer|breast cancer
892660|NCT00005907|B Cell|b cell
892661|NCT00005907|Reconstitution|reconstitution
892662|NCT00005907|T Cell|t cell
892663|NCT00005907|Transplant|transplant
892664|NCT00005907|Vaccine|vaccine
892665|NCT00005906|Chylous Ascites|chylous ascites
892666|NCT00005906|Chylous Pleural Effusion|chylous pleural effusion
892667|NCT00005906|Inhibitory Effects|inhibitory effects
892668|NCT00005906|Lymphangioleiomyoma|lymphangioleiomyoma
892669|NCT00005906|Somatostatin|somatostatin
892670|NCT00005906|Lymphangioleiomyomatosis (LAM)|lymphangioleiomyomatosis (lam)
892671|NCT00005905|Adipocyte - Development|adipocyte - development
892672|NCT00005905|Insulin Resistance|insulin resistance
892673|NCT00005905|Dyslipidemia|dyslipidemia
892674|NCT00005905|Diabetes Mellitus|diabetes mellitus
892675|NCT00005905|Non-Alcoholic Steatohepatitis|non-alcoholic steatohepatitis
892676|NCT00005905|Leptin Replacement|leptin replacement
892677|NCT00005903|Parkinsonism|parkinsonism
892678|NCT00005903|Trophic Factor|trophic factor
892679|NCT00005903|Neurodegenerative Disorder|neurodegenerative disorder
892680|NCT00005903|Progressive Supranuclear Palsy|progressive supranuclear palsy
892681|NCT00005902|Brain|brain
892682|NCT00005902|Brainstem|brainstem
892683|NCT00005902|Cyst|cyst
892684|NCT00005902|Magnetic Resonance Imaging|magnetic resonance imaging
892685|NCT00005902|Spinal Cord|spinal cord
892686|NCT00005901|Bisphosphonates|bisphosphonates
892687|NCT00005901|Growth Hormone|growth hormone
892688|NCT00005901|Bone Density|bone density
892689|NCT00005901|Osteogenesis Imperfecta|osteogenesis imperfecta
892690|NCT00005900|Gaucher's disease|gaucher's disease
892691|NCT00005900|I cell disease|i cell disease
892692|NCT00005900|Niemann-Pick disease|niemann-pick disease
892693|NCT00005900|Wolman disease|wolman disease
892694|NCT00005900|adrenoleukodystrophy|adrenoleukodystrophy
892695|NCT00005900|disease-related problem/condition|disease-related problem/condition
892696|NCT00005900|fucosidosis|fucosidosis
892697|NCT00005900|genetic diseases and dysmorphic syndromes|genetic diseases and dysmorphic syndromes
892698|NCT00005900|globoid cell leukodystrophy|globoid cell leukodystrophy
892699|NCT00005900|inborn errors of metabolism|inborn errors of metabolism
892700|NCT00005900|mannosidosis|mannosidosis
892701|NCT00005900|metachromatic leukodystrophy|metachromatic leukodystrophy
892702|NCT00005900|mucopolysaccharidosis|mucopolysaccharidosis
892703|NCT00005900|mucopolysaccharidosis I|mucopolysaccharidosis i
892704|NCT00005900|mucopolysaccharidosis VI|mucopolysaccharidosis vi
892705|NCT00005900|oncologic disorders|oncologic disorders
892706|NCT00005900|pulmonary complications|pulmonary complications
892707|NCT00005900|rare disease|rare disease
892708|NCT00005900|sphingolipidoses|sphingolipidoses
892709|NCT00005896|Fanconi's anemia|fanconi's anemia
892710|NCT00005896|aplastic anemia|aplastic anemia
892711|NCT00005896|hematologic disorders|hematologic disorders
892712|NCT00005896|rare disease|rare disease
892713|NCT00005893|chronic congenital neutropenia|chronic congenital neutropenia
892714|NCT00005893|chronic neutropenia|chronic neutropenia
892715|NCT00005893|congenital pure red cell aplasia|congenital pure red cell aplasia
892716|NCT00005893|disease-related problem/condition|disease-related problem/condition
892717|NCT00005893|genetic diseases and dysmorphic syndromes|genetic diseases and dysmorphic syndromes
892718|NCT00005893|hematologic disorders|hematologic disorders
892719|NCT00005893|neutropenia|neutropenia
892720|NCT00005893|pure red cell aplasia|pure red cell aplasia
892721|NCT00005893|rare disease|rare disease
892722|NCT00005893|sickle cell anemia|sickle cell anemia
892723|NCT00005893|thalassemia major|thalassemia major
892724|NCT00005892|Fanconi's anemia|fanconi's anemia
892725|NCT00005892|acute leukemia|acute leukemia
892726|NCT00005892|acute lymphocytic leukemia|acute lymphocytic leukemia
892727|NCT00005892|acute myeloid leukemia|acute myeloid leukemia
892728|NCT00005892|acute undifferentiated leukemia|acute undifferentiated leukemia
892729|NCT00005892|adult acute lymphoblastic leukemia|adult acute lymphoblastic leukemia
892730|NCT00005892|adult acute lymphoblastic leukemia in remission|adult acute lymphoblastic leukemia in remission
892731|NCT00005892|adult acute myeloid leukemia|adult acute myeloid leukemia
892732|NCT00005892|adult acute myeloid leukemia in remission|adult acute myeloid leukemia in remission
892733|NCT00005892|aplastic anemia|aplastic anemia
892734|NCT00005892|childhood acute lymphoblastic leukemia|childhood acute lymphoblastic leukemia
892735|NCT00005892|childhood acute lymphoblastic leukemia in remission|childhood acute lymphoblastic leukemia in remission
892736|NCT00005892|childhood acute myeloid leukemia|childhood acute myeloid leukemia
892737|NCT00005892|childhood acute myeloid leukemia in remission|childhood acute myeloid leukemia in remission
892738|NCT00005892|de novo myelodysplastic syndrome|de novo myelodysplastic syndrome
892739|NCT00005892|hematologic disorders|hematologic disorders
892740|NCT00005892|hematopoietic/lymphoid cancer|hematopoietic/lymphoid cancer
892741|NCT00005892|leukemia|leukemia
892742|NCT00005892|myelodysplastic syndrome|myelodysplastic syndrome
892743|NCT00005892|oncologic disorders|oncologic disorders
892744|NCT00005892|previously treated myelodysplastic syndrome|previously treated myelodysplastic syndrome
892745|NCT00005892|rare disease|rare disease
892746|NCT00005892|secondary myelodysplastic syndrome|secondary myelodysplastic syndrome
892747|NCT00005891|Fanconi's Anemia|fanconi's anemia
892748|NCT00005891|aplastic anemia|aplastic anemia
892749|NCT00005891|hematologic disorders|hematologic disorders
892750|NCT00005891|rare disease|rare disease
892751|NCT00005890|immunologic disorders and infectious disorders|immunologic disorders and infectious disorders
892752|NCT00005890|rare disease|rare disease
892753|NCT00005890|sepsis|sepsis
892754|NCT00005890|septic shock|septic shock
892755|NCT00005889|endocrine disorders|endocrine disorders
892756|NCT00005889|hyperglycemia|hyperglycemia
892757|NCT00005889|low birth weight|low birth weight
892758|NCT00005889|neonatal disorders|neonatal disorders
892759|NCT00005889|rare disease|rare disease
892760|NCT00005888|gastrointestinal disorders|gastrointestinal disorders
892761|NCT00005888|immunologic disorders and infectious disorders|immunologic disorders and infectious disorders
892762|NCT00005888|low birth weight|low birth weight
892763|NCT00005888|necrotizing enterocolitis|necrotizing enterocolitis
892764|NCT00005888|neonatal disorders|neonatal disorders
892765|NCT00005888|rare disease|rare disease
892766|NCT00005888|sepsis|sepsis
892767|NCT00005785|Peripheral Blood Stem Cells|peripheral blood stem cells
892768|NCT00005785|Engraftment|engraftment
892769|NCT00005785|Graft vs. Host Disease|graft vs. host disease
892770|NCT00005785|Graft-Versus-Leukemia|graft-versus-leukemia
892771|NCT00005785|Donor Apheresis|donor apheresis
892772|NCT00005785|Cyclophosphamide|cyclophosphamide
892773|NCT00005785|Fludarabine|fludarabine
892774|NCT00005785|HIV|hiv
892775|NCT00005785|AIDS|aids
892776|NCT00005785|Gene Therapy|gene therapy
892777|NCT00005785|Chronic Myelogenous Leukemia|chronic myelogenous leukemia
892778|NCT00005785|Acute Lymphoblastic Leukemia|acute lymphoblastic leukemia
892779|NCT00005785|Acute Myelogenous Leukemia|acute myelogenous leukemia
892780|NCT00005785|Chronic Lymphocytic Leukemia|chronic lymphocytic leukemia
892781|NCT00005784|Macular Degeneration|macular degeneration
892782|NCT00005784|Diabetic Retinopathy|diabetic retinopathy
892783|NCT00005784|Vascular Occlusive Disease|vascular occlusive disease
892784|NCT00005784|Central Serous Retinopathy|central serous retinopathy
892785|NCT00005784|Rare/Unknown Retinal Disease|rare/unknown retinal disease
892786|NCT00005784|Retinal Disease|retinal disease
892787|NCT00005784|Age-Related Macular Degeneration|age-related macular degeneration
892788|NCT00005782|Donor Apheresis|donor apheresis
892789|NCT00005782|Sickle Cell Trait|sickle cell trait
892790|NCT00005782|Red Cell Alloimmunization|red cell alloimmunization
892791|NCT00005780|Lymphoma Vaccines|lymphoma vaccines
892792|NCT00005780|Immune Response Against Lymphoma|immune response against lymphoma
892793|NCT00005780|Molecular Complete Remissions|molecular complete remissions
892794|NCT00005780|Novel Treatment Approach|novel treatment approach
892795|NCT00005780|Mantle Cell Lymphoma|mantle cell lymphoma
892796|NCT00005778|Systemic Lupus Erythematosus (SLE)|systemic lupus erythematosus (sle)
892797|NCT00005778|Cytoxan|cytoxan
892798|NCT00005778|Cyclophosphamide|cyclophosphamide
892799|NCT00005778|High-dose immunoablative therapy|high-dose immunoablative therapy
892800|NCT00005777|NICHD Neonatal Research Network|nichd neonatal research network
892801|NCT00005777|Extremely Low Birth Weight (ELBW)|extremely low birth weight (elbw)
892802|NCT00005777|Prematurity|prematurity
892803|NCT00005777|Chronic Lung Disease (CLD)|chronic lung disease (cld)
892804|NCT00005777|Dexamethasone|dexamethasone
892805|NCT00005777|Glucocorticoids|glucocorticoids
892806|NCT00005777|Respiration, Artificial|respiration, artificial
892807|NCT00005777|Mechanical ventilation|mechanical ventilation
894044|NCT00000110|exercise|exercise
892808|NCT00005777|Respiratory Insufficiency|respiratory insufficiency
892809|NCT00005776|NICHD Neonatal Research Network|nichd neonatal research network
892810|NCT00005776|Hypertension, pulmonary|hypertension, pulmonary
892811|NCT00005776|Hypoxic respiratory failure|hypoxic respiratory failure
892812|NCT00005776|Meconium aspiration|meconium aspiration
892813|NCT00005776|Methemoglobinemia|methemoglobinemia
892814|NCT00005776|Nitric oxide|nitric oxide
892815|NCT00005776|Oxygen inhalation therapy|oxygen inhalation therapy
892816|NCT00005776|Persistent Fetal Circulation Syndrome|persistent fetal circulation syndrome
892817|NCT00005776|Pneumonia, aspiration|pneumonia, aspiration
892818|NCT00005776|Respiratory distress syndrome|respiratory distress syndrome
892819|NCT00005776|Respiratory insufficiency|respiratory insufficiency
892820|NCT00005776|Severe respiratory failure|severe respiratory failure
892821|NCT00005775|NICHD Neonatal Research Network|nichd neonatal research network
892822|NCT00005775|Extremely Low Birth Weight (ELBW) infants|extremely low birth weight (elbw) infants
892823|NCT00005775|Prematurity|prematurity
892824|NCT00005775|Glutamine|glutamine
892825|NCT00005775|Total parenteral nutrition|total parenteral nutrition
892826|NCT00005775|Nutrition|nutrition
892827|NCT00005775|Very low birth weight (VLBW) infants|very low birth weight (vlbw) infants
892828|NCT00005774|NICHD Neonatal Research Network|nichd neonatal research network
892829|NCT00005774|Pulmonary ventilation|pulmonary ventilation
892830|NCT00005774|Respiratory distress syndrome|respiratory distress syndrome
892831|NCT00005774|Respiratory insufficiency|respiratory insufficiency
892832|NCT00005774|Surfactant, pulmonary|surfactant, pulmonary
892833|NCT00005774|Mechanical Ventilation|mechanical ventilation
892834|NCT00005774|Survanta|survanta
892835|NCT00005773|NICHD Neonatal Research Network|nichd neonatal research network
892836|NCT00005773|Hypertension, pulmonary|hypertension, pulmonary
892837|NCT00005773|Hypoxic respiratory failure|hypoxic respiratory failure
892838|NCT00005773|Meconium aspiration|meconium aspiration
892839|NCT00005773|Methemoglobinemia|methemoglobinemia
892840|NCT00005773|Nitric oxide|nitric oxide
892841|NCT00005773|Oxygen inhalation therapy|oxygen inhalation therapy
892842|NCT00005773|Persistent Fetal Circulation Syndrome|persistent fetal circulation syndrome
892843|NCT00005773|Pneumonia, aspiration|pneumonia, aspiration
892844|NCT00005773|Respiratory distress syndrome|respiratory distress syndrome
892845|NCT00005773|Respiratory insufficiency|respiratory insufficiency
892846|NCT00005773|Severe respiratory failure|severe respiratory failure
892847|NCT00005772|NICHD Neonatal Research Network|nichd neonatal research network
892848|NCT00005772|Hypoxic-ischemic encephalopathy (HIE)|hypoxic-ischemic encephalopathy (hie)
892849|NCT00005772|Hypothermia|hypothermia
892850|NCT00005772|Neonatal depression|neonatal depression
892851|NCT00005772|Perinatal asphyxia|perinatal asphyxia
892852|NCT00005771|Abdominal Hollowing Exercises|abdominal hollowing exercises
892853|NCT00005770|elastic property of skin|elastic property of skin
892854|NCT00005767|Amino Acid Metabolism|amino acid metabolism
892855|NCT00005766|ALS|als
892856|NCT00005761|Types 1 & 2 Diabetes|types 1 & 2 diabetes
892857|NCT00005761|Cell Adhesion Molecules|cell adhesion molecules
892858|NCT00005761|Chemokines|chemokines
892859|NCT00005761|Vascular Endothelial Growth Factor|vascular endothelial growth factor
892860|NCT00005761|Cross-Sectional|cross-sectional
892861|NCT00005761|Serum Levels|serum levels
892862|NCT00005761|Diabetic Retinopathy|diabetic retinopathy
892863|NCT00005760|Dyslipidemia|dyslipidemia
892864|NCT00005760|Hypertension|hypertension
892865|NCT00005760|Metabolic Syndrome X|metabolic syndrome x
892867|NCT00005760|Subcutaneous Adipose Tissue|subcutaneous adipose tissue
892868|NCT00005760|Visceral Abdominal Adipose Tissue|visceral abdominal adipose tissue
892869|NCT00005675|Systemic Scleroderma (SSc)|systemic scleroderma (ssc)
892870|NCT00005675|Bovine Type I Collagen (CI)|bovine type i collagen (ci)
892871|NCT00005675|Multicenter|multicenter
892872|NCT00005727|Nutrition|nutrition
892873|NCT00005727|Education|education
892874|NCT00005520|Hypertension|hypertension
892875|NCT00005520|Pharmacogenetics|pharmacogenetics
892876|NCT00005520|Hydrochlorothiazide|hydrochlorothiazide
892877|NCT00005520|Candesartan|candesartan
892878|NCT00005487|Coronary Arteriosclerosis|coronary arteriosclerosis
892879|NCT00005487|Cerebrovascular Accident|cerebrovascular accident
892880|NCT00005487|Heart Failure, Congestive|heart failure, congestive
892881|NCT00005487|Diabetes Mellitus, Non-Insulin Dependent|diabetes mellitus, non-insulin dependent
892882|NCT00005673|HIV|hiv
892883|NCT00005673|Antiretroviral|antiretroviral
892884|NCT00005673|NNRTI|nnrti
892885|NCT00005671|Angina|angina
892886|NCT00005671|Condition Specific|condition specific
892887|NCT00005671|Heart Failure|heart failure
892888|NCT00005671|Symptom Distress|symptom distress
892889|NCT00005671|Revascularization|revascularization
892890|NCT00005671|Coronary Artery Disease|coronary artery disease
892891|NCT00005671|Ischemic Heart Disease|ischemic heart disease
892892|NCT00005669|Child|child
892893|NCT00005669|Body Fat|body fat
892894|NCT00005669|Food Intake|food intake
892895|NCT00005669|Diabetes Mellitus|diabetes mellitus
892896|NCT00005669|Dyslipidemia|dyslipidemia
892897|NCT00005669|Vitamin B12|vitamin b12
892898|NCT00005669|Childhood Obesity|childhood obesity
892899|NCT00005667|liver transplantation|liver transplantation
892900|NCT00005667|vancomycin resistance|vancomycin resistance
892901|NCT00005666|Diagnostic imaging|diagnostic imaging
892902|NCT00005664|Healthy Volunteers|healthy volunteers
892903|NCT00005664|Endocrine Related Conditions|endocrine related conditions
892904|NCT00005664|Endocrine Dysfunction|endocrine dysfunction
892905|NCT00005664|Early Pubertal Development|early pubertal development
892906|NCT00005660|Hypertriglyceridemia|hypertriglyceridemia
892907|NCT00005660|Teratogenicity|teratogenicity
892908|NCT00005660|Ichthyosis|ichthyosis
892909|NCT00005660|Darier's Disease|darier's disease
892910|NCT00005660|Retinoids|retinoids
892911|NCT00005660|Skin|skin
892912|NCT00005660|Psoriasis|psoriasis
892913|NCT00005660|Basal cell carcinoma|basal cell carcinoma
892914|NCT00005660|Skin Cancer|skin cancer
892915|NCT00005658|Biochemical|biochemical
892916|NCT00005658|Schizophrenia|schizophrenia
892917|NCT00005658|NMDA|nmda
892918|NCT00005658|Adolescence|adolescence
892919|NCT00005658|Psychosis|psychosis
892920|NCT00005658|Child Psychosis|child psychosis
892921|NCT00005658|Biochemical Correlates|biochemical correlates
892922|NCT00005658|Brain Imaging|brain imaging
892923|NCT00005658|Glycine|glycine
892924|NCT00005658|Adjunctive Glycine Therapy|adjunctive glycine therapy
892925|NCT00005657|Cytokines|cytokines
892926|NCT00005657|Treatment|treatment
892927|NCT00005657|Genetic Polymorphism|genetic polymorphism
892928|NCT00005657|Chronic Hepatitis C|chronic hepatitis c
892929|NCT00005657|Mononuclear Cells|mononuclear cells
892930|NCT00005655|Gene Expression|gene expression
892931|NCT00005655|Neovascularization|neovascularization
892932|NCT00005655|antiangiogenic therapy|antiangiogenic therapy
892933|NCT00005655|immunomodulatory therapy|immunomodulatory therapy
892934|NCT00005655|Immunotherapy|immunotherapy
892935|NCT00005655|Tumor|tumor
892936|NCT00005654|endocrine disorders|endocrine disorders
892937|NCT00005654|hyperinsulinism|hyperinsulinism
892938|NCT00005654|polycystic ovarian syndrome|polycystic ovarian syndrome
892939|NCT00005654|rare disease|rare disease
892940|NCT00005652|hematologic disorders|hematologic disorders
892941|NCT00005652|immune thrombocytopenic purpura|immune thrombocytopenic purpura
892942|NCT00005652|rare disease|rare disease
892943|NCT00005650|cardiovascular and respiratory diseases|cardiovascular and respiratory diseases
892944|NCT00005650|genetic diseases and dysmorphic syndromes|genetic diseases and dysmorphic syndromes
892945|NCT00005650|primary ciliary dyskinesia|primary ciliary dyskinesia
892946|NCT00005650|rare disease|rare disease
892947|NCT00005575|Imipramine|imipramine
892948|NCT00005575|Cognitive-Behavioral Therapy|cognitive-behavioral therapy
892949|NCT00005571|Skin|skin
892950|NCT00005571|Humoral Immunity|humoral immunity
892951|NCT00005571|Myositis|myositis
892952|NCT00005571|Complement|complement
892953|NCT00005571|Antibody|antibody
892954|NCT00005571|Dermatomyositis|dermatomyositis
892955|NCT00005569|Elastase|elastase
892956|NCT00005569|Inflammation|inflammation
892957|NCT00005569|Age|age
892958|NCT00005569|Gender|gender
892959|NCT00005569|Cytokine|cytokine
892960|NCT00005569|Healthy Volunteer|healthy volunteer
892961|NCT00005566|Suicide|suicide
892962|NCT00005119|Premenstrual Dysphoric Disorder|premenstrual dysphoric disorder
892963|NCT00005119|Severe Premenstrual Syndrome|severe premenstrual syndrome
892964|NCT00005119|Calcium metabolism|calcium metabolism
892965|NCT00005119|Vitamin D|vitamin d
892966|NCT00005119|Bone Markers|bone markers
892967|NCT00005119|Premenopausal|premenopausal
892968|NCT00005119|Menstrual Cycle|menstrual cycle
892969|NCT00005117|endothelial dysfunction|endothelial dysfunction
892970|NCT00005116|depression|depression
892971|NCT00005108|Menopause|menopause
892972|NCT00005108|Atherosclerosis|atherosclerosis
892973|NCT00005108|Estrogen|estrogen
892974|NCT00005108|MRI|mri
892975|NCT00005108|Ultrasound|ultrasound
892976|NCT00005105|endocrine disorders|endocrine disorders
892977|NCT00005105|intrauterine growth retardation|intrauterine growth retardation
892978|NCT00005105|rare disease|rare disease
892979|NCT00005104|endocrine disorders|endocrine disorders
892980|NCT00005104|hyperinsulinism|hyperinsulinism
892981|NCT00005104|polycystic ovarian syndrome|polycystic ovarian syndrome
892982|NCT00005104|rare disease|rare disease
892983|NCT00005103|inborn errors of metabolism|inborn errors of metabolism
892984|NCT00005103|porphyria|porphyria
892985|NCT00005103|porphyria cutanea tarda|porphyria cutanea tarda
892986|NCT00005103|rare disease|rare disease
892987|NCT00005102|DiGeorge syndrome|digeorge syndrome
892988|NCT00005102|Shprintzen syndrome|shprintzen syndrome
892989|NCT00005102|cardiovascular and respiratory diseases|cardiovascular and respiratory diseases
892990|NCT00005102|conotruncal cardiac defects|conotruncal cardiac defects
892991|NCT00005102|genetic diseases and dysmorphic syndromes|genetic diseases and dysmorphic syndromes
892992|NCT00005102|rare disease|rare disease
892993|NCT00005101|disease-related problem/condition|disease-related problem/condition
892994|NCT00005101|osteoporosis|osteoporosis
892995|NCT00005101|rare disease|rare disease
892996|NCT00005100|acromegaly|acromegaly
892997|NCT00005100|endocrine disorders|endocrine disorders
892998|NCT00005100|rare disease|rare disease
894045|NCT00000110|exertion|exertion
892999|NCT00005098|alpha 1-antitrypsin deficiency|alpha 1-antitrypsin deficiency
893000|NCT00005098|genetic diseases and dysmorphic syndromes|genetic diseases and dysmorphic syndromes
893001|NCT00005098|rare disease|rare disease
893002|NCT00005015|Bipolar Disorder|bipolar disorder
893003|NCT00005015|Depression|depression
893004|NCT00005015|Fluoxetine|fluoxetine
893005|NCT00005014|Autistic Disorder|autistic disorder
893006|NCT00005014|Risperidone|risperidone
893007|NCT00005013|Antidepressive Agents|antidepressive agents
893008|NCT00005013|Depression|depression
893009|NCT00005013|Depressive Disorder|depressive disorder
893011|NCT00005013|Hypericum|hypericum
893012|NCT00005013|Medicine, Herbal|medicine, herbal
893013|NCT00005013|Plant Extracts|plant extracts
893014|NCT00005013|Alternative Medicine|alternative medicine
893015|NCT00005011|Depression|depression
893016|NCT00005011|Menstrual Cycle|menstrual cycle
893017|NCT00005011|Gonadal Steroids|gonadal steroids
893018|NCT00005011|GnRH Agonist|gnrh agonist
893019|NCT00005011|PMS|pms
893020|NCT00005011|Estradiol|estradiol
893021|NCT00005011|Progesterone|progesterone
893022|NCT00005011|Mood|mood
893023|NCT00005011|MRMD|mrmd
893024|NCT00005011|PMDD|pmdd
893025|NCT00005011|Menstrually Related Mood Disorders|menstrually related mood disorders
893026|NCT00005007|Wegener's granulomatosis|wegener's granulomatosis
893027|NCT00005007|Vasculitis|vasculitis
893028|NCT00005007|Etanercept|etanercept
893029|NCT00005007|Tumor necrosis factor|tumor necrosis factor
893030|NCT00005006|Anabolic agent|anabolic agent
893031|NCT00005006|hPTH|hpth
893032|NCT00005006|PTH|pth
893033|NCT00005006|Parathyroid hormone|parathyroid hormone
893034|NCT00005006|Bone mass|bone mass
893035|NCT00005006|Bone turnover|bone turnover
893036|NCT00005006|Bone formation|bone formation
893037|NCT00005006|Alendronate|alendronate
893038|NCT00005006|Osteoporosis|osteoporosis
893039|NCT00005006|Cyclical therapy|cyclical therapy
893040|NCT00005005|PTH|pth
893041|NCT00005005|Alendronate|alendronate
893042|NCT00005005|Parathyroid hormone|parathyroid hormone
893043|NCT00005005|Osteoporosis|osteoporosis
893044|NCT00005005|Postmenopausal|postmenopausal
893045|NCT00005004|Cognitive Processes|cognitive processes
893046|NCT00005004|Inferential Ambiguities|inferential ambiguities
893047|NCT00005004|Language Processes|language processes
893048|NCT00005004|Lexical Ambiguities|lexical ambiguities
893049|NCT00005004|Suppression Mechanism|suppression mechanism
893050|NCT00005004|Discourse Processes|discourse processes
893051|NCT00005004|Discourse Production Analysis|discourse production analysis
893052|NCT00005004|Magnetic Resonance Imaging|magnetic resonance imaging
893053|NCT00005004|Prefrontal Cortex Function|prefrontal cortex function
893054|NCT00005004|Aging Effects|aging effects
893055|NCT00005004|Garden Path Phenomena|garden path phenomena
893056|NCT00005004|Text Integration|text integration
893057|NCT00005003|Handedness|handedness
893058|NCT00005003|Laterality|laterality
893059|NCT00005003|Linkage|linkage
893060|NCT00005003|VNTR/Dinucleotide|vntr/dinucleotide
893061|NCT00005003|Dinucleotide|dinucleotide
893062|NCT00005003|High-Frequency-Trait Analysis|high-frequency-trait analysis
893063|NCT00004997|Hematopoietic|hematopoietic
893064|NCT00004997|DHFR Enzyme|dhfr enzyme
893065|NCT00004997|Anemia|anemia
893066|NCT00004997|Folic Acid|folic acid
893067|NCT00004997|MDS|mds
893068|NCT00004997|Myelodysplasia|myelodysplasia
893069|NCT00004997|Myelodysplastic|myelodysplastic
893070|NCT00004996|Antigen Presentation|antigen presentation
893071|NCT00004996|Cytokines|cytokines
893072|NCT00004996|Helminth|helminth
893073|NCT00004996|Healthy Volunteer|healthy volunteer
893074|NCT00004996|Cross-Over Study|cross-over study
893075|NCT00004996|Helminth Infection|helminth infection
893076|NCT00004994|Allogeneic Transplant|allogeneic transplant
893077|NCT00004994|Function|function
893078|NCT00004994|Mini-Transplant|mini-transplant
893079|NCT00004994|Physical Symptoms|physical symptoms
893080|NCT00004994|Symptom Distress|symptom distress
893081|NCT00004993|Parathyroid hormone (1-34)|parathyroid hormone (1-34)
893082|NCT00004993|Glucocorticoid-induced osteoporosis|glucocorticoid-induced osteoporosis
893083|NCT00004993|Postmenopausal women|postmenopausal women
893084|NCT00004993|osteoporotic fractures|osteoporotic fractures
893085|NCT00004992|clinical trial|clinical trial
893086|NCT00004992|multi-center|multi-center
893087|NCT00004992|NIDDM|niddm
893088|NCT00004992|NIDDK|niddk
893089|NCT00004992|Diabetes Prevention Program (DPP)|diabetes prevention program (dpp)
893090|NCT00004992|diabetes risk factors|diabetes risk factors
893091|NCT00004992|diabetes|diabetes
893092|NCT00004992|glycemia|glycemia
893093|NCT00004992|cardiovascular risk factors|cardiovascular risk factors
893094|NCT00004992|quality of life|quality of life
893095|NCT00004992|physical activity and nutrition|physical activity and nutrition
893096|NCT00004992|occurrence of adverse events|occurrence of adverse events
893097|NCT00004992|insulin secretion and sensitivity|insulin secretion and sensitivity
893098|NCT00004992|prevention|prevention
893099|NCT00004992|abnormal glucose metabolism|abnormal glucose metabolism
893100|NCT00004992|lifestyle intervention|lifestyle intervention
893101|NCT00004992|drug intervention|drug intervention
893102|NCT00004991|Functional Magnetic Resonance Imaging|functional magnetic resonance imaging
893103|NCT00004991|Stuttering|stuttering
893104|NCT00004991|Speech Perception|speech perception
893105|NCT00004991|Speech Production|speech production
893106|NCT00004991|Phonology|phonology
893107|NCT00004991|Development|development
893108|NCT00004991|Motor Control|motor control
893109|NCT00004991|Neural Networks|neural networks
893110|NCT00004991|Phonological Disorders|phonological disorders
893111|NCT00004990|Nephrotic Syndrome|nephrotic syndrome
893112|NCT00004990|Steroids|steroids
893113|NCT00004990|Osteoporosis|osteoporosis
893114|NCT00004990|Adrenal Suppression|adrenal suppression
893115|NCT00004990|Proteinuria|proteinuria
893116|NCT00004990|Focal Segmental Glomerulosclerosis|focal segmental glomerulosclerosis
893117|NCT00004988|Anti-Tumor Effects|anti-tumor effects
893118|NCT00004988|Maximum Tolerated Dose (MTD)|maximum tolerated dose (mtd)
893119|NCT00004988|Metastatic Cancer|metastatic cancer
893120|NCT00004988|Pharmacokinetics|pharmacokinetics
893121|NCT00004988|Solid Tumors|solid tumors
893122|NCT00004988|Tumor|tumor
893123|NCT00004984|diabetes|diabetes
893124|NCT00004984|insulin|insulin
893125|NCT00004984|prediction|prediction
893126|NCT00004984|prevention|prevention
893127|NCT00004984|C-peptide levels|c-peptide levels
893128|NCT00004984|insulin autoantibodies|insulin autoantibodies
893129|NCT00004984|pancreatic beta cell autoantibodies|pancreatic beta cell autoantibodies
893130|NCT00004984|cellular immune responses|cellular immune responses
893131|NCT00004984|prediction of type 1 diabetes|prediction of type 1 diabetes
893132|NCT00004983|diabetes mellitus, type 2|diabetes mellitus, type 2
893133|NCT00004983|diabetes self-management education|diabetes self-management education
893134|NCT00004983|diabetes self-care|diabetes self-care
893135|NCT00004983|blood glucose self-monitoring|blood glucose self-monitoring
893136|NCT00004983|health education|health education
893137|NCT00004983|patient education|patient education
893138|NCT00004982|chelation therapy|chelation therapy
893139|NCT00004982|combination chemotherapy|combination chemotherapy
893140|NCT00004982|iron poisoning|iron poisoning
893141|NCT00004982|thalassemia|thalassemia
893142|NCT00004982|chelating agent|chelating agent
893143|NCT00004982|deferoxamine|deferoxamine
893144|NCT00004982|drug screening /evaluation|drug screening /evaluation
893145|NCT00004982|therapy evaluation|therapy evaluation
893146|NCT00004980|neurologic and psychiatric disorders|neurologic and psychiatric disorders
893147|NCT00004980|rare disease|rare disease
893148|NCT00004980|schizophrenia|schizophrenia
893149|NCT00004854|moderate heart failure|moderate heart failure
893150|NCT00004853|AMGEN|amgen
893151|NCT00004853|Granulocyte Colony-Stimulating Factor|granulocyte colony-stimulating factor
893152|NCT00004853|MPNST|mpnst
893153|NCT00004853|Randomized|randomized
893154|NCT00004853|Sarcoma|sarcoma
893155|NCT00004853|Tumor|tumor
893156|NCT00004850|HCV Coinfection|hcv coinfection
893157|NCT00004850|Transfusion-Transmission|transfusion-transmission
893158|NCT00004850|Hepatitis C|hepatitis c
893159|NCT00004850|Hepatitis B|hepatitis b
893160|NCT00004847|Genetics|genetics
893161|NCT00004847|Metanephrines|metanephrines
893162|NCT00004847|PET|pet
893163|NCT00004847|Catecholamines|catecholamines
893164|NCT00004847|Pheochromocytoma|pheochromocytoma
893165|NCT00004846|Viral Gene Amplification|viral gene amplification
893166|NCT00004846|Blood Transmitted Infections|blood transmitted infections
893167|NCT00004846|Transfusion Risks|transfusion risks
893168|NCT00004846|Transcription Mediated Analysis|transcription mediated analysis
893169|NCT00004846|Viral Detection Assays|viral detection assays
893170|NCT00004846|HIV Seronegativity|hiv seronegativity
893171|NCT00004739|Pediatric HIV infection|pediatric hiv infection
893172|NCT00004845|Anti-inflammatory|anti-inflammatory
893173|NCT00004738|Arnold Chiari Malformation|arnold chiari malformation
893174|NCT00004738|Skeletal Dysplasia|skeletal dysplasia
893175|NCT00004738|Syringomyelia|syringomyelia
893176|NCT00004738|Genetics|genetics
893177|NCT00004738|Chiari I Malformation|chiari i malformation
893178|NCT00004734|stroke|stroke
893179|NCT00004734|cerebral infarction|cerebral infarction
893180|NCT00004734|homocysteine|homocysteine
893181|NCT00004734|vitamin|vitamin
893182|NCT00004734|folic acid|folic acid
893183|NCT00004734|pyridoxine|pyridoxine
893184|NCT00004734|vitamin B6|vitamin b6
893185|NCT00004734|cyanocobalamin|cyanocobalamin
893186|NCT00004734|vitamin B12|vitamin b12
893187|NCT00004734|multivitamin|multivitamin
893188|NCT00004733|Parkinson's|parkinson's
893189|NCT00004733|ELLDOPA|elldopa
893190|NCT00004733|L-dopa|l-dopa
893191|NCT00004733|levodopa|levodopa
893192|NCT00004733|Sinemet|sinemet
893193|NCT00004733|tremor|tremor
893194|NCT00004732|angioplasty|angioplasty
893195|NCT00004732|asymptomatic|asymptomatic
893196|NCT00004732|atherosclerosis|atherosclerosis
893197|NCT00004732|carotid endarterectomy|carotid endarterectomy
893198|NCT00004732|carotid stenting|carotid stenting
893199|NCT00004732|CREST|crest
894345|NCT00001863|Eye|eye
893200|NCT00004732|Cerebral Infarction|cerebral infarction
893201|NCT00004732|device|device
893202|NCT00004732|intervention|intervention
893203|NCT00004732|restenosis|restenosis
893204|NCT00004732|revascularization|revascularization
893205|NCT00004732|stenosis|stenosis
893206|NCT00004732|stent|stent
893207|NCT00004732|stroke|stroke
893208|NCT00004732|symptomatic|symptomatic
893209|NCT00004732|surgery|surgery
893210|NCT00004732|transient ischemic attack|transient ischemic attack
893211|NCT00004731|Parkinson's disease|parkinson's disease
893212|NCT00004731|coenzyme Q10|coenzyme q10
893213|NCT00004730|head injury|head injury
893214|NCT00004730|traumatic brain injury|traumatic brain injury
893215|NCT00004730|concussion|concussion
893216|NCT00004730|magnesium sulfate|magnesium sulfate
893217|NCT00004730|neuroprotection|neuroprotection
893218|NCT00004729|child|child
893219|NCT00004729|children|children
893220|NCT00004729|epilepsy|epilepsy
893221|NCT00004729|seizure|seizure
893222|NCT00004729|ketogenic|ketogenic
893223|NCT00004729|diet|diet
893224|NCT00004729|Lennox-Gastaut Syndrome|lennox-gastaut syndrome
893225|NCT00004729|LGS|lgs
893226|NCT00004728|stroke|stroke
893227|NCT00004728|cerebral infarction|cerebral infarction
893228|NCT00004728|warfarin|warfarin
893229|NCT00004728|coumadin|coumadin
893230|NCT00004728|aspirin|aspirin
893231|NCT00004728|ASA|asa
893232|NCT00004728|acetysalicylic acid|acetysalicylic acid
893233|NCT00004728|atherosclerosis|atherosclerosis
893234|NCT00004728|stenosis|stenosis
893235|NCT00004728|intracranial|intracranial
893236|NCT00004728|artery|artery
893237|NCT00004728|arteries|arteries
893238|NCT00004728|transient ischemic attack|transient ischemic attack
893239|NCT00004728|TIA|tia
893240|NCT00004728|minorities|minorities
893241|NCT00004727|African American|african american
893242|NCT00004727|antiplatelet|antiplatelet
893243|NCT00004727|aspirin|aspirin
893244|NCT00004727|ASA|asa
893245|NCT00004727|acetylsalicylic acid|acetylsalicylic acid
893246|NCT00004727|ticlopidine|ticlopidine
893247|NCT00004727|prevention|prevention
893248|NCT00004727|stroke|stroke
893249|NCT00004727|cerebral infarction|cerebral infarction
893250|NCT00004727|Chicago|chicago
893251|NCT00004727|non-cardioembolic ischemic stroke|non-cardioembolic ischemic stroke
893252|NCT00004941|Crohn's disease|crohn's disease
893253|NCT00004941|gastrointestinal disorders|gastrointestinal disorders
893254|NCT00004941|rare disease|rare disease
893255|NCT00004940|erythropoietic protoporphyria|erythropoietic protoporphyria
893256|NCT00004940|inborn errors of metabolism|inborn errors of metabolism
893257|NCT00004940|porphyria|porphyria
893258|NCT00004940|rare disease|rare disease
893259|NCT00004939|demyelinating neuropathy|demyelinating neuropathy
893260|NCT00004939|neurologic and psychiatric disorders|neurologic and psychiatric disorders
893261|NCT00004939|rare disease|rare disease
893262|NCT00004938|fungal infection|fungal infection
893263|NCT00004938|rare disease|rare disease
893264|NCT00004938|sporotrichosis|sporotrichosis
893265|NCT00004844|Parkinson Disease|parkinson disease
893266|NCT00004844|neurologic and psychiatric disorders|neurologic and psychiatric disorders
893267|NCT00004844|rare disease|rare disease
893268|NCT00004843|disease-related problem/condition|disease-related problem/condition
893269|NCT00004843|endocrine disorders|endocrine disorders
893270|NCT00004843|hyperparathyroidism|hyperparathyroidism
893271|NCT00004843|quality of life|quality of life
893272|NCT00004843|rare disease|rare disease
893273|NCT00004842|cirrhosis|cirrhosis
893274|NCT00004842|gastrointestinal disorders|gastrointestinal disorders
893275|NCT00004842|primary biliary cirrhosis|primary biliary cirrhosis
893276|NCT00004842|primary sclerosing cholangitis|primary sclerosing cholangitis
893277|NCT00004842|rare disease|rare disease
893278|NCT00004840|cardiovascular and respiratory diseases|cardiovascular and respiratory diseases
893279|NCT00004840|neonatal disorders|neonatal disorders
893280|NCT00004840|rare disease|rare disease
893281|NCT00004840|respiratory distress syndrome|respiratory distress syndrome
893282|NCT00004838|environmental/toxic disorders|environmental/toxic disorders
893283|NCT00004838|lead poisoning|lead poisoning
893284|NCT00004838|rare disease|rare disease
893285|NCT00004834|anxiety disorder|anxiety disorder
893286|NCT00004834|disease-related problem/condition|disease-related problem/condition
893287|NCT00004834|neurologic and psychiatric disorders|neurologic and psychiatric disorders
893288|NCT00004834|panic disorder|panic disorder
893289|NCT00004834|rare disease|rare disease
893290|NCT00004833|Guillain-Barre syndrome|guillain-barre syndrome
893291|NCT00004833|demyelinating neuropathy|demyelinating neuropathy
893292|NCT00004833|neurologic and psychiatric disorders|neurologic and psychiatric disorders
893293|NCT00004833|rare disease|rare disease
893294|NCT00004832|Lambert-Eaton myasthenic syndrome|lambert-eaton myasthenic syndrome
893295|NCT00004832|neurologic and psychiatric disorders|neurologic and psychiatric disorders
893296|NCT00004832|rare disease|rare disease
893297|NCT00004831|erythropoietic protoporphyria|erythropoietic protoporphyria
893298|NCT00004831|inborn errors of metabolism|inborn errors of metabolism
893299|NCT00004831|porphyria|porphyria
893300|NCT00004831|rare disease|rare disease
893301|NCT00004829|bacterial infection|bacterial infection
893302|NCT00004829|cardiovascular and respiratory diseases|cardiovascular and respiratory diseases
893303|NCT00004829|cystic fibrosis|cystic fibrosis
893304|NCT00004829|genetic diseases and dysmorphic syndromes|genetic diseases and dysmorphic syndromes
893305|NCT00004829|immunologic disorders and infectious disorders|immunologic disorders and infectious disorders
893306|NCT00004829|rare disease|rare disease
893307|NCT00004828|cardiovascular and respiratory diseases|cardiovascular and respiratory diseases
893308|NCT00004828|heart defects|heart defects
893309|NCT00004828|rare disease|rare disease
893310|NCT00004827|ophthalmologic disorders|ophthalmologic disorders
893311|NCT00004827|rare disease|rare disease
893312|NCT00004827|retinitis pigmentosa|retinitis pigmentosa
893313|NCT00004826|Parkinson disease|parkinson disease
893314|NCT00004826|neurologic and psychiatric disorders|neurologic and psychiatric disorders
893315|NCT00004826|rare disease|rare disease
893316|NCT00004825|endocrine disorders|endocrine disorders
893317|NCT00004825|hyperinsulinism|hyperinsulinism
893318|NCT00004825|rare disease|rare disease
893319|NCT00004817|neurologic and psychiatric disorders|neurologic and psychiatric disorders
893320|NCT00004817|rare disease|rare disease
893321|NCT00004817|seizures|seizures
893322|NCT00004816|multiple sclerosis|multiple sclerosis
893323|NCT00004816|neurologic and psychiatric disorders|neurologic and psychiatric disorders
893324|NCT00004816|rare disease|rare disease
893325|NCT00004815|Werner's syndrome|werner's syndrome
893326|NCT00004815|genetic diseases and dysmorphic syndromes|genetic diseases and dysmorphic syndromes
893327|NCT00004815|rare disease|rare disease
893328|NCT00004814|multiple sclerosis|multiple sclerosis
893329|NCT00004814|neurologic and psychiatric disorders|neurologic and psychiatric disorders
893330|NCT00004814|rare disease|rare disease
893331|NCT00004812|environmental/toxic disorders|environmental/toxic disorders
893332|NCT00004812|neurologic and psychiatric disorders|neurologic and psychiatric disorders
893333|NCT00004812|rare disease|rare disease
893334|NCT00004812|spinal cord injury|spinal cord injury
893335|NCT00004811|blastomycosis|blastomycosis
893336|NCT00004811|fungal infection|fungal infection
893337|NCT00004811|histoplasmosis|histoplasmosis
893338|NCT00004811|immunologic disorders and infectious disorders|immunologic disorders and infectious disorders
893339|NCT00004811|rare disease|rare disease
893340|NCT00004811|sporotrichosis|sporotrichosis
893341|NCT00004810|gastrointestinal disorders|gastrointestinal disorders
893342|NCT00004810|rare disease|rare disease
893343|NCT00004810|ulcerative colitis|ulcerative colitis
893344|NCT00004809|familial hypercholesterolemia|familial hypercholesterolemia
893345|NCT00004809|inborn errors of metabolism|inborn errors of metabolism
893346|NCT00004809|rare disease|rare disease
893347|NCT00004808|blastomycosis|blastomycosis
893348|NCT00004808|fungal infection|fungal infection
893349|NCT00004808|histoplasmosis|histoplasmosis
893350|NCT00004808|immunologic disorders and infectious disorders|immunologic disorders and infectious disorders
893351|NCT00004808|rare disease|rare disease
893352|NCT00004808|sporotrichosis|sporotrichosis
893353|NCT00004807|Rett syndrome|rett syndrome
893354|NCT00004807|neurologic and psychiatric disorders|neurologic and psychiatric disorders
893355|NCT00004807|rare disease|rare disease
893356|NCT00004806|cardiovascular and respiratory diseases|cardiovascular and respiratory diseases
893357|NCT00004806|cystic fibrosis|cystic fibrosis
893358|NCT00004806|genetic diseases and dysmorphic syndromes|genetic diseases and dysmorphic syndromes
893359|NCT00004806|rare disease|rare disease
893360|NCT00004805|bronchopulmonary dysplasia|bronchopulmonary dysplasia
893361|NCT00004805|cardiovascular and respiratory diseases|cardiovascular and respiratory diseases
893362|NCT00004805|disease-related problem/condition|disease-related problem/condition
893363|NCT00004805|educational needs|educational needs
893364|NCT00004805|hypertensive disorder|hypertensive disorder
893365|NCT00004805|neonatal disorders|neonatal disorders
893366|NCT00004805|primary pulmonary hypertension|primary pulmonary hypertension
893367|NCT00004805|rare disease|rare disease
893368|NCT00004805|respiratory distress syndrome|respiratory distress syndrome
893369|NCT00004804|hepatitis C|hepatitis c
893370|NCT00004804|immunologic disorders and infectious disorders|immunologic disorders and infectious disorders
893371|NCT00004804|rare disease|rare disease
893372|NCT00004804|viral infection|viral infection
893373|NCT00004802|neurologic and psychiatric disorders|neurologic and psychiatric disorders
893374|NCT00004802|periodic paralysis|periodic paralysis
893375|NCT00004802|rare disease|rare disease
893376|NCT00004801|hematologic disorders|hematologic disorders
893377|NCT00004801|rare disease|rare disease
893378|NCT00004800|bacterial infection|bacterial infection
893379|NCT00004800|immunologic disorders and infectious disorders|immunologic disorders and infectious disorders
893380|NCT00004800|pertussis|pertussis
893381|NCT00004800|rare disease|rare disease
893382|NCT00004799|bacterial infection|bacterial infection
893383|NCT00004799|immunologic disorders and infectious disorders|immunologic disorders and infectious disorders
893384|NCT00004799|pertussis|pertussis
893385|NCT00004799|rare disease|rare disease
893386|NCT00004797|disease-related problem/condition|disease-related problem/condition
893387|NCT00004797|genetic diseases and dysmorphic syndromes|genetic diseases and dysmorphic syndromes
893388|NCT00004797|hematologic disorders|hematologic disorders
893389|NCT00004797|pain|pain
893390|NCT00004797|rare disease|rare disease
893391|NCT00004797|sickle cell anemia|sickle cell anemia
893392|NCT00004796|cardiovascular and respiratory diseases|cardiovascular and respiratory diseases
893393|NCT00004796|cirrhosis|cirrhosis
893394|NCT00004796|gastrointestinal disorders|gastrointestinal disorders
893395|NCT00004796|hypertensive disorder|hypertensive disorder
893396|NCT00004796|portal hypertension|portal hypertension
893397|NCT00004796|rare disease|rare disease
893398|NCT00004795|arthritis & connective tissue diseases|arthritis & connective tissue diseases
893399|NCT00004795|immunologic disorders and infectious disorders|immunologic disorders and infectious disorders
893400|NCT00004795|rare disease|rare disease
893401|NCT00004795|systemic lupus erythematosus|systemic lupus erythematosus
893402|NCT00004794|cytomegalovirus retinitis|cytomegalovirus retinitis
893403|NCT00004794|ophthalmologic disorders|ophthalmologic disorders
893404|NCT00004794|rare disease|rare disease
893405|NCT00004793|constitutional growth delay|constitutional growth delay
893406|NCT00004793|endocrine disorders|endocrine disorders
893407|NCT00004793|rare disease|rare disease
893408|NCT00004791|dermatologic disorders|dermatologic disorders
893409|NCT00004791|epidermolysis bullosa|epidermolysis bullosa
893410|NCT00004791|genetic diseases and dysmorphic syndromes|genetic diseases and dysmorphic syndromes
893411|NCT00004791|rare disease|rare disease
893412|NCT00004789|inborn errors of metabolism|inborn errors of metabolism
893413|NCT00004789|acute porphyria|acute porphyria
893414|NCT00004789|rare disease|rare disease
893415|NCT00004788|inborn errors of metabolism|inborn errors of metabolism
893416|NCT00004788|porphyria|porphyria
893417|NCT00004788|rare disease|rare disease
893418|NCT00004787|Fanconi's anemia|fanconi's anemia
893419|NCT00004787|Shwachman syndrome|shwachman syndrome
893420|NCT00004787|aplastic anemia|aplastic anemia
893421|NCT00004787|dermatologic disorders|dermatologic disorders
893422|NCT00004787|dyskeratosis congenita|dyskeratosis congenita
893423|NCT00004787|hematologic disorders|hematologic disorders
893424|NCT00004787|rare disease|rare disease
893425|NCT00004787|thrombocytopenia|thrombocytopenia
893426|NCT00004786|Raynaud's syndrome|raynaud's syndrome
893427|NCT00004786|arthritis & connective tissue diseases|arthritis & connective tissue diseases
893428|NCT00004786|cardiovascular and respiratory diseases|cardiovascular and respiratory diseases
893429|NCT00004786|rare disease|rare disease
893430|NCT00004786|systemic sclerosis|systemic sclerosis
893431|NCT00004785|bronchopulmonary dysplasia|bronchopulmonary dysplasia
893432|NCT00004785|cardiovascular and respiratory diseases|cardiovascular and respiratory diseases
893433|NCT00004785|neonatal disorders|neonatal disorders
893434|NCT00004785|rare disease|rare disease
893435|NCT00004784|cirrhosis|cirrhosis
893436|NCT00004784|gastrointestinal disorders|gastrointestinal disorders
893437|NCT00004784|primary biliary cirrhosis|primary biliary cirrhosis
893438|NCT00004784|rare disease|rare disease
893439|NCT00004781|HIV-associated candidiasis|hiv-associated candidiasis
893440|NCT00004781|candidiasis|candidiasis
893441|NCT00004781|disease-related problem/condition|disease-related problem/condition
893442|NCT00004781|fungal infection|fungal infection
893443|NCT00004781|immunologic disorders and infectious disorders|immunologic disorders and infectious disorders
893444|NCT00004781|infection|infection
893445|NCT00004781|rare disease|rare disease
893446|NCT00004779|cardiovascular and respiratory diseases|cardiovascular and respiratory diseases
893447|NCT00004779|cystic fibrosis|cystic fibrosis
893448|NCT00004779|genetic diseases and dysmorphic syndromes|genetic diseases and dysmorphic syndromes
893449|NCT00004779|rare disease|rare disease
893450|NCT00004778|cardiovascular and respiratory diseases|cardiovascular and respiratory diseases
893451|NCT00004778|neonatal disorders|neonatal disorders
893452|NCT00004778|rare disease|rare disease
893453|NCT00004778|respiratory distress syndrome|respiratory distress syndrome
893454|NCT00004776|Lennox-Gastaut syndrome|lennox-gastaut syndrome
893455|NCT00004776|epilepsy|epilepsy
893456|NCT00004776|neurologic and psychiatric disorders|neurologic and psychiatric disorders
893457|NCT00004776|rare disease|rare disease
893458|NCT00004776|seizures|seizures
893459|NCT00004773|Rett syndrome|rett syndrome
893460|NCT00004773|neurologic and psychiatric disorders|neurologic and psychiatric disorders
893461|NCT00004773|rare disease|rare disease
893462|NCT00004772|demyelinating neuropathy|demyelinating neuropathy
893463|NCT00004772|neurologic and psychiatric disorders|neurologic and psychiatric disorders
893464|NCT00004772|rare disease|rare disease
893465|NCT00004771|amyotrophic lateral sclerosis|amyotrophic lateral sclerosis
893466|NCT00004771|motor neuron disease|motor neuron disease
893467|NCT00004771|neurologic and psychiatric disorders|neurologic and psychiatric disorders
893468|NCT00004771|rare disease|rare disease
893469|NCT00004771|spinal and bulbar muscular atrophy|spinal and bulbar muscular atrophy
893470|NCT00004771|spinal muscular atrophy|spinal muscular atrophy
893471|NCT00004771|Kennedy's Syndrome|kennedy's syndrome
893472|NCT00004770|inborn errors of metabolism|inborn errors of metabolism
893473|NCT00004770|mitochondrial myopathy|mitochondrial myopathy
894346|NCT00001863|Vision|vision
893474|NCT00004770|rare disease|rare disease
893475|NCT00004769|Genetic diseases|genetic diseases
893476|NCT00004769|Myotonic muscular dystrophy|myotonic muscular dystrophy
893477|NCT00004769|Facioscapulohumeral muscular dystrophy|facioscapulohumeral muscular dystrophy
893478|NCT00004769|CMT|cmt
893479|NCT00004769|Rare disease|rare disease
893480|NCT00004767|inborn errors of metabolism|inborn errors of metabolism
893481|NCT00004767|rare disease|rare disease
893482|NCT00004767|urea cycle disorder|urea cycle disorder
893483|NCT00004763|endocrine disorders|endocrine disorders
893484|NCT00004763|hyperandrogenism|hyperandrogenism
893485|NCT00004763|rare disease|rare disease
893486|NCT00004762|gastrointestinal disorders|gastrointestinal disorders
893487|NCT00004762|primary sclerosing cholangitis|primary sclerosing cholangitis
893488|NCT00004762|rare disease|rare disease
893489|NCT00004761|dermatologic disorders|dermatologic disorders
893490|NCT00004761|epidermolysis bullosa|epidermolysis bullosa
893491|NCT00004761|genetic diseases and dysmorphic syndromes|genetic diseases and dysmorphic syndromes
893492|NCT00004761|rare disease|rare disease
893493|NCT00004760|Parkinson disease|parkinson disease
893494|NCT00004760|Neurologic and psychiatric disorders|neurologic and psychiatric disorders
893495|NCT00004760|Rare disease|rare disease
893496|NCT00004759|environmental/toxic disorders|environmental/toxic disorders
893497|NCT00004759|neurologic and psychiatric disorders|neurologic and psychiatric disorders
893498|NCT00004759|rare disease|rare disease
893499|NCT00004759|spinal cord injury|spinal cord injury
893500|NCT00004758|infantile spasms|infantile spasms
893501|NCT00004758|epilepsy|epilepsy
893502|NCT00004758|neurologic and psychiatric disorders|neurologic and psychiatric disorders
893503|NCT00004758|rare disease|rare disease
893504|NCT00004758|seizures|seizures
893505|NCT00004757|herpes simplex virus infection|herpes simplex virus infection
893506|NCT00004757|herpesvirus infection|herpesvirus infection
893507|NCT00004757|immunologic disorders and infectious disorders|immunologic disorders and infectious disorders
893508|NCT00004757|rare disease|rare disease
893509|NCT00004757|viral infection|viral infection
893510|NCT00004756|arthritis & connective tissue diseases|arthritis & connective tissue diseases
893511|NCT00004756|disease-related problem/condition|disease-related problem/condition
893512|NCT00004756|educational needs|educational needs
893513|NCT00004756|immunologic disorders and infectious disorders|immunologic disorders and infectious disorders
893514|NCT00004756|rare disease|rare disease
893515|NCT00004756|systemic lupus erythematosus|systemic lupus erythematosus
893516|NCT00004755|dermatologic disorders|dermatologic disorders
893517|NCT00004755|environmental/toxic disorders|environmental/toxic disorders
893518|NCT00004755|immunologic disorders and infectious disorders|immunologic disorders and infectious disorders
893519|NCT00004755|leishmaniasis|leishmaniasis
893520|NCT00004755|rare disease|rare disease
893521|NCT00004754|cardiovascular and respiratory diseases|cardiovascular and respiratory diseases
893522|NCT00004754|hypertensive disorder|hypertensive disorder
893523|NCT00004754|primary pulmonary hypertension|primary pulmonary hypertension
893524|NCT00004754|rare disease|rare disease
893525|NCT00004753|Huntington's disease|huntington's disease
893526|NCT00004753|neurologic and psychiatric disorders|neurologic and psychiatric disorders
893527|NCT00004753|rare disease|rare disease
893528|NCT00004751|cerebral palsy|cerebral palsy
893529|NCT00004751|neurologic and psychiatric disorders|neurologic and psychiatric disorders
893530|NCT00004751|rare disease|rare disease
893531|NCT00004751|spastic diplegia|spastic diplegia
893532|NCT00004748|cirrhosis|cirrhosis
893533|NCT00004748|gastrointestinal disorders|gastrointestinal disorders
893534|NCT00004748|primary biliary cirrhosis|primary biliary cirrhosis
893535|NCT00004748|rare disease|rare disease
893536|NCT00004747|bacterial infections|bacterial infections
893537|NCT00004747|cardiovascular and respiratory diseases|cardiovascular and respiratory diseases
893538|NCT00004747|cystic fibrosis|cystic fibrosis
893623|NCT00004664|viral infection|viral infection
893539|NCT00004747|genetic diseases and dysmorphic syndromes|genetic diseases and dysmorphic syndromes
893540|NCT00004747|immunologic disorders and infectious disorders|immunologic disorders and infectious disorders
893541|NCT00004747|rare disease|rare disease
893542|NCT00004744|multiple sclerosis|multiple sclerosis
893543|NCT00004744|neurologic and psychiatric disorders|neurologic and psychiatric disorders
893544|NCT00004744|rare disease|rare disease
893545|NCT00004740|cardiovascular and respiratory diseases|cardiovascular and respiratory diseases
893546|NCT00004740|rare disease|rare disease
893547|NCT00004740|tuberculosis|tuberculosis
893548|NCT00004705|cardiovascular and respiratory diseases|cardiovascular and respiratory diseases
893549|NCT00004705|cystic fibrosis|cystic fibrosis
893550|NCT00004705|genetic diseases and dysmorphic syndromes|genetic diseases and dysmorphic syndromes
893551|NCT00004705|rare disease|rare disease
893552|NCT00004700|endocrine disorders|endocrine disorders
893553|NCT00004700|hyperinsulinism|hyperinsulinism
893554|NCT00004700|rare disease|rare disease
893555|NCT00004699|endocrine disorders|endocrine disorders
893556|NCT00004699|hyperinsulinism|hyperinsulinism
893557|NCT00004699|rare disease|rare disease
893558|NCT00004697|gastrointestinal disorders|gastrointestinal disorders
893559|NCT00004697|hepatic steatosis|hepatic steatosis
893560|NCT00004697|rare disease|rare disease
893561|NCT00004696|disease-related problem/condition|disease-related problem/condition
893562|NCT00004696|pain|pain
893563|NCT00004696|intraoperative/postoperative complications|intraoperative/postoperative complications
893564|NCT00004696|rare disease|rare disease
893565|NCT00004695|common variable immunodeficiency|common variable immunodeficiency
893566|NCT00004695|immunologic disorders and infectious disorders|immunologic disorders and infectious disorders
893567|NCT00004695|primary immunodeficiency disease|primary immunodeficiency disease
893568|NCT00004695|rare disease|rare disease
893569|NCT00004694|genetic diseases and dysmorphic syndromes|genetic diseases and dysmorphic syndromes
893570|NCT00004694|hereditary angioedema|hereditary angioedema
893571|NCT00004694|rare disease|rare disease
893572|NCT00004690|dermatologic disorders|dermatologic disorders
893573|NCT00004690|ichthyosis|ichthyosis
893574|NCT00004690|rare disease|rare disease
893575|NCT00004689|bacterial infection|bacterial infection
893576|NCT00004689|immunologic disorders and infectious disorders|immunologic disorders and infectious disorders
893577|NCT00004689|mycobacterium avium infection|mycobacterium avium infection
893578|NCT00004689|mycobacterium infection|mycobacterium infection
893579|NCT00004689|rare disease|rare disease
893580|NCT00004688|adult anaplastic astrocytoma|adult anaplastic astrocytoma
893581|NCT00004688|adult anaplastic oligodendroglioma|adult anaplastic oligodendroglioma
893582|NCT00004688|adult brain stem glioma|adult brain stem glioma
893583|NCT00004688|adult brain tumor|adult brain tumor
893584|NCT00004688|adult glioblastoma multiforme|adult glioblastoma multiforme
893585|NCT00004688|adult infiltrating astrocytoma|adult infiltrating astrocytoma
893586|NCT00004688|brain tumor|brain tumor
893587|NCT00004688|genetic condition|genetic condition
893588|NCT00004688|miscellaneous sites/terms|miscellaneous sites/terms
893589|NCT00004688|mixed gliomas|mixed gliomas
893590|NCT00004688|nervous tissue tumors|nervous tissue tumors
893591|NCT00004688|oncologic disorders|oncologic disorders
893592|NCT00004688|rare disease|rare disease
893593|NCT00004688|recurrent adult brain tumor|recurrent adult brain tumor
893594|NCT00004686|cardiovascular and respiratory diseases|cardiovascular and respiratory diseases
893595|NCT00004686|giant cell arteritis|giant cell arteritis
893596|NCT00004686|rare disease|rare disease
893597|NCT00004685|genetic diseases and dysmorphic syndromes|genetic diseases and dysmorphic syndromes
893598|NCT00004685|muscular dystrophy|muscular dystrophy
893599|NCT00004685|neurologic and psychiatric disorders|neurologic and psychiatric disorders
893600|NCT00004685|rare disease|rare disease
893601|NCT00004682|myasthenia gravis|myasthenia gravis
893602|NCT00004682|neurologic and psychiatric disorders|neurologic and psychiatric disorders
893603|NCT00004682|rare disease|rare disease
893604|NCT00004670|Parkinson disease|parkinson disease
893605|NCT00004670|neurologic and psychiatric disorders|neurologic and psychiatric disorders
893606|NCT00004670|rare disease|rare disease
893607|NCT00004669|bronchopulmonary dysplasia|bronchopulmonary dysplasia
893608|NCT00004669|cardiovascular and respiratory diseases|cardiovascular and respiratory diseases
893609|NCT00004669|neonatal disorders|neonatal disorders
893610|NCT00004669|rare disease|rare disease
893611|NCT00004667|hematologic disorders|hematologic disorders
893612|NCT00004667|rare disease|rare disease
893613|NCT00004667|von Willebrand's disease|von willebrand's disease
893614|NCT00004665|arthritis & connective tissue diseases|arthritis & connective tissue diseases
893615|NCT00004665|immunologic disorders and infectious disorders|immunologic disorders and infectious disorders
893616|NCT00004665|rare disease|rare disease
893617|NCT00004665|systemic lupus erythematosus|systemic lupus erythematosus
893618|NCT00004664|disease-related problem/condition|disease-related problem/condition
893619|NCT00004664|human immunodeficiency virus infection|human immunodeficiency virus infection
893620|NCT00004664|immunologic disorders and infectious disorders|immunologic disorders and infectious disorders
893621|NCT00004664|nutrition|nutrition
893622|NCT00004664|rare disease|rare disease
893624|NCT00004663|arthritis & connective tissue diseases|arthritis & connective tissue diseases
893625|NCT00004663|immunologic disorders and infectious disorders|immunologic disorders and infectious disorders
893626|NCT00004663|rare disease|rare disease
893627|NCT00004663|systemic lupus erythematosus|systemic lupus erythematosus
893628|NCT00004662|arthritis & connective tissue diseases|arthritis & connective tissue diseases
893629|NCT00004662|immunologic disorders and infectious disorders|immunologic disorders and infectious disorders
893630|NCT00004662|rare disease|rare disease
893631|NCT00004662|systemic lupus erythematosus|systemic lupus erythematosus
893632|NCT00004661|endocrine disorders|endocrine disorders
893633|NCT00004661|pseudohypoparathyroidism|pseudohypoparathyroidism
893634|NCT00004661|rare disease|rare disease
893635|NCT00004660|Graves' disease|graves' disease
893636|NCT00004660|thyroid disease|thyroid disease
893637|NCT00004660|endocrine disorders|endocrine disorders
893638|NCT00004660|rare disease|rare disease
893639|NCT00004659|adult brain tumor|adult brain tumor
893640|NCT00004659|brain tumor|brain tumor
893641|NCT00004659|childhood brain tumor|childhood brain tumor
893642|NCT00004659|genetic condition|genetic condition
893643|NCT00004659|nervous tissue tumors|nervous tissue tumors
893644|NCT00004659|oncologic disorders|oncologic disorders
893645|NCT00004659|rare disease|rare disease
893646|NCT00004658|5'-nucleotidase syndrome|5'-nucleotidase syndrome
893647|NCT00004658|inborn errors of metabolism|inborn errors of metabolism
893648|NCT00004658|rare disease|rare disease
893649|NCT00004656|Rett syndrome|rett syndrome
893650|NCT00004656|neurologic and psychiatric disorders|neurologic and psychiatric disorders
893651|NCT00004656|rare disease|rare disease
893652|NCT00004654|genetic diseases and dysmorphic syndromes|genetic diseases and dysmorphic syndromes
893653|NCT00004654|hematologic disorders|hematologic disorders
893654|NCT00004654|hereditary hemorrhagic telangiectasia|hereditary hemorrhagic telangiectasia
893655|NCT00004654|rare disease|rare disease
893656|NCT00004652|Tourette syndrome|tourette syndrome
893657|NCT00004652|neurologic and psychiatric disorders|neurologic and psychiatric disorders
893658|NCT00004652|rare disease|rare disease
893659|NCT00004650|disease-related problem/condition|disease-related problem/condition
893660|NCT00004650|osteoporosis|osteoporosis
893661|NCT00004650|rare disease|rare disease
893662|NCT00004649|genetic diseases and dysmorphic syndromes|genetic diseases and dysmorphic syndromes
893663|NCT00004649|hematologic disorders|hematologic disorders
893664|NCT00004649|hereditary hemorrhagic telangiectasia|hereditary hemorrhagic telangiectasia
893665|NCT00004649|rare disease|rare disease
893666|NCT00004648|genetic diseases and dysmorphic syndromes|genetic diseases and dysmorphic syndromes
893667|NCT00004648|hematologic disorders|hematologic disorders
893668|NCT00004648|hereditary hemorrhagic telangiectasia|hereditary hemorrhagic telangiectasia
893669|NCT00004648|rare disease|rare disease
893670|NCT00004648|Osler-Rendu-Weber disease|osler-rendu-weber disease
893671|NCT00004647|diabetic neuropathy|diabetic neuropathy
893672|NCT00004647|disease-related problem/condition|disease-related problem/condition
893673|NCT00004647|neurologic and psychiatric disorders|neurologic and psychiatric disorders
893674|NCT00004647|pain|pain
893675|NCT00004647|rare disease|rare disease
893676|NCT00004646|Duchenne muscular dystrophy|duchenne muscular dystrophy
893677|NCT00004646|genetic diseases and dysmorphic syndromes|genetic diseases and dysmorphic syndromes
893678|NCT00004646|muscular dystrophy|muscular dystrophy
893679|NCT00004646|neurologic and psychiatric disorders|neurologic and psychiatric disorders
893680|NCT00004646|rare disease|rare disease
893681|NCT00004645|Balo's concentric sclerosis|balo's concentric sclerosis
893682|NCT00004645|Devic's syndrome|devic's syndrome
893683|NCT00004645|Marburg's variant of multiple sclerosis|marburg's variant of multiple sclerosis
893684|NCT00004645|acute disseminated encephalomyelitis|acute disseminated encephalomyelitis
893685|NCT00004645|acute transverse myelitis|acute transverse myelitis
893686|NCT00004645|multiple sclerosis|multiple sclerosis
893687|NCT00004645|neurologic and psychiatric disorders|neurologic and psychiatric disorders
893688|NCT00004645|rare disease|rare disease
893689|NCT00004644|herpes simplex virus infection|herpes simplex virus infection
893690|NCT00004644|herpesvirus infection|herpesvirus infection
893691|NCT00004644|immunologic disorders and infectious disorders|immunologic disorders and infectious disorders
893692|NCT00004644|rare disease|rare disease
893693|NCT00004644|viral infection|viral infection
893694|NCT00004643|arthritis & connective tissue diseases|arthritis & connective tissue diseases
893695|NCT00004643|immunologic disorders and infectious disorders|immunologic disorders and infectious disorders
893696|NCT00004643|rare disease|rare disease
893697|NCT00004643|systemic lupus erythematosus|systemic lupus erythematosus
893698|NCT00004642|congenital cytomegalovirus infection|congenital cytomegalovirus infection
893699|NCT00004642|cytomegalovirus infection|cytomegalovirus infection
893700|NCT00004642|herpesvirus infection|herpesvirus infection
893701|NCT00004642|immunologic disorders and infectious disorders|immunologic disorders and infectious disorders
893702|NCT00004642|neonatal disorders|neonatal disorders
893703|NCT00004642|rare disease|rare disease
893704|NCT00004642|viral infection|viral infection
893705|NCT00004638|chronic sinusitis|chronic sinusitis
893706|NCT00004635|Angiogenesis|angiogenesis
893707|NCT00004635|Cancer|cancer
893708|NCT00004635|Hormonal Therapy|hormonal therapy
893709|NCT00004635|Prostate|prostate
893710|NCT00004635|Thalidomide|thalidomide
893711|NCT00004635|Prostate Cancer|prostate cancer
893712|NCT00004577|Brain Morphology|brain morphology
893713|NCT00004577|Cerebral Blood Volume|cerebral blood volume
893714|NCT00004577|Functional Imaging|functional imaging
893715|NCT00004577|Development|development
893716|NCT00004577|MEG|meg
893717|NCT00004573|cytomegalovirus viremia|cytomegalovirus viremia
893718|NCT00004572|Type 2 Diabetes|type 2 diabetes
893719|NCT00004571|Magnetic Resonance Imaging|magnetic resonance imaging
893720|NCT00004571|Brain Metabolism|brain metabolism
893721|NCT00004571|Brain Physiology|brain physiology
893722|NCT00004571|Neuropsychiatric Disorders|neuropsychiatric disorders
893723|NCT00004571|Cognitition|cognitition
893724|NCT00004570|Temporal Processing|temporal processing
893725|NCT00004570|Language Impairment|language impairment
893726|NCT00004570|Linkage Analysis|linkage analysis
893727|NCT00004570|Inheritance|inheritance
893728|NCT00004570|Language Delay|language delay
893729|NCT00004570|Healthy|healthy
893730|NCT00004570|Auditory Temporal Processing Disorder|auditory temporal processing disorder
893731|NCT00004570|Speech Impediment|speech impediment
893733|NCT00004568|Muscular Dystrophy|muscular dystrophy
893734|NCT00004568|Motor Neuron Disease|motor neuron disease
893735|NCT00004567|Relapse|relapse
893736|NCT00004567|Immunosuppressive|immunosuppressive
893737|NCT00004567|Toxicity|toxicity
893738|NCT00004567|Purineantimetabolite|purineantimetabolite
893739|NCT00004567|Alternative Agents|alternative agents
893740|NCT00004567|Wegener's Granulomatosis|wegener's granulomatosis
893741|NCT00004567|Wegener's Disease|wegener's disease
893742|NCT00004567|Blood Vessel Disorder|blood vessel disorder
893743|NCT00004567|Systemic Vasculitis|systemic vasculitis
893744|NCT00004566|3D Imaging|3d imaging
893745|NCT00004566|Swallowing|swallowing
893746|NCT00004566|Fetal Development|fetal development
893747|NCT00004566|High-Risk Pregnancy|high-risk pregnancy
893748|NCT00004566|Ultrasound|ultrasound
893749|NCT00004565|Breast Cancer|breast cancer
893750|NCT00004565|Genetics|genetics
893751|NCT00004565|High Risk|high risk
893752|NCT00004565|Polymorphisms|polymorphisms
893753|NCT00004565|Susceptibility|susceptibility
893754|NCT00004565|Biomarkers|biomarkers
893755|NCT00004565|Estrogen|estrogen
893756|NCT00004565|Genes|genes
893757|NCT00004564|Platelet Aggregation Inhibitors|platelet aggregation inhibitors
893758|NCT00004564|Cerebrovascular accident|cerebrovascular accident
893759|NCT00004563|Lung Diseases|lung diseases
893760|NCT00004563|Pulmonary Fibrosis|pulmonary fibrosis
893761|NCT00004563|Systemic Scleroderma|systemic scleroderma
893762|NCT00004563|Scleroderma, systemic|scleroderma, systemic
893763|NCT00004556|Stimulants|stimulants
893764|NCT00004556|Affect|affect
893765|NCT00004556|Cognition|cognition
893766|NCT00004556|Brain Physiology|brain physiology
893767|NCT00004556|Brain Metabolism|brain metabolism
893768|NCT00004556|Catecholamines|catecholamines
893769|NCT00004556|Brain Imaging|brain imaging
893770|NCT00004556|Cognitive Efficiency|cognitive efficiency
893771|NCT00004556|Dopamine Genes|dopamine genes
893772|NCT00004553|Single Fiber EMG|single fiber emg
893773|NCT00004553|Macro-EMG|macro-emg
893774|NCT00004553|Myasthenia|myasthenia
893775|NCT00004553|Post-Polio Syndrome|post-polio syndrome
893776|NCT00004553|Neuromuscular Transmission|neuromuscular transmission
893777|NCT00004553|Motor Dysfunction|motor dysfunction
893778|NCT00004553|Neuromuscular Disorder|neuromuscular disorder
893779|NCT00004550|Screening|screening
893780|NCT00004550|Longitudinal|longitudinal
893781|NCT00004550|Transition|transition
893782|NCT00004550|Treatment|treatment
893783|NCT00004550|Comorbidity|comorbidity
893784|NCT00004550|Obsessive Compulsive Disorder|obsessive compulsive disorder
893785|NCT00004550|Evaluation|evaluation
893786|NCT00004550|Follow-Up|follow-up
893787|NCT00004550|OC Spectrum Disorders|oc spectrum disorders
893788|NCT00004550|OCD|ocd
893789|NCT00004549|Atherosclerosis|atherosclerosis
893790|NCT00004549|Endothelium|endothelium
893791|NCT00004549|Peripheral Vascular Disease|peripheral vascular disease
893792|NCT00004549|Markers of Inflammation|markers of inflammation
893793|NCT00004549|Claudication|claudication
893794|NCT00004547|Surgery|surgery
893795|NCT00004547|Mesothelioma|mesothelioma
893796|NCT00004547|Pseudomyxoma|pseudomyxoma
893797|NCT00004547|Colon Cancer|colon cancer
893798|NCT00004547|Chemotherapy|chemotherapy
893799|NCT00004533|cardiovascular and respiratory diseases|cardiovascular and respiratory diseases
893800|NCT00004533|cystic fibrosis|cystic fibrosis
893801|NCT00004533|genetic diseases and dysmorphic syndromes|genetic diseases and dysmorphic syndromes
893802|NCT00004533|rare disease|rare disease
893803|NCT00001987|Diabetes Mellitus|diabetes mellitus
893804|NCT00001987|Severe Insulin Resistance|severe insulin resistance
893805|NCT00001987|Type B Insulin Resistance|type b insulin resistance
893806|NCT00000436|Hip fracture|hip fracture
893807|NCT00000436|Self-efficacy|self-efficacy
893808|NCT00000436|Strength training|strength training
893809|NCT00000436|Rehabilitation|rehabilitation
893810|NCT00000436|Postoperative|postoperative
893811|NCT00001985|Diabetes|diabetes
893812|NCT00001985|Gene|gene
893813|NCT00001984|Immunosuppression|immunosuppression
893814|NCT00001984|Tolerance|tolerance
893815|NCT00001984|DSG|dsg
893816|NCT00001984|Alemtuzumab|alemtuzumab
893817|NCT00001983|Questionnaires|questionnaires
893818|NCT00001983|Eligibility|eligibility
893819|NCT00001983|History|history
893820|NCT00001983|Physical Examination|physical examination
893821|NCT00001983|Tests|tests
893822|NCT00001983|Fibromyalgia|fibromyalgia
893823|NCT00001981|Acromegaly|acromegaly
893824|NCT00000435|RA|ra
893825|NCT00000435|Immune Modulation|immune modulation
893826|NCT00000435|Oral Tolerance|oral tolerance
893827|NCT00000435|Peptide|peptide
893828|NCT00000435|dnaJ|dnaj
893829|NCT00000434|Osteoarthritis|osteoarthritis
893830|NCT00000434|Health education|health education
893831|NCT00000434|Aerobic exercise|aerobic exercise
893832|NCT00000434|Self-efficacy|self-efficacy
893833|NCT00000434|Muscle strength|muscle strength
893834|NCT00000434|Outcomes research|outcomes research
893835|NCT00000434|Longitudinal study|longitudinal study
893836|NCT00001979|Kidney Disease|kidney disease
893837|NCT00001979|Autoimmune Diseases|autoimmune diseases
893838|NCT00001979|Nephrotic Syndrome|nephrotic syndrome
893839|NCT00001978|Kidney Disease|kidney disease
893840|NCT00001978|Kidney Function Tests|kidney function tests
893841|NCT00001978|Proteinuria|proteinuria
893842|NCT00001976|CMV|cmv
893843|NCT00001976|Infection|infection
893844|NCT00001976|Comparison|comparison
893845|NCT00001976|Observational|observational
893846|NCT00001976|Cytomegalovirus|cytomegalovirus
893847|NCT00001976|RT-PCR|rt-pcr
893848|NCT00001975|Skin Biopsy|skin biopsy
893849|NCT00001975|Familial Tumor Syndrome|familial tumor syndrome
893850|NCT00001975|Cell Growth|cell growth
893851|NCT00001975|Loss of Heterozygosity|loss of heterozygosity
893852|NCT00001975|Cytokines|cytokines
893853|NCT00001975|Tuberous Sclerosis|tuberous sclerosis
893854|NCT00001973|G Protein Mutation|g protein mutation
893855|NCT00001973|McCune-Albright Syndrome|mccune-albright syndrome
893856|NCT00001973|Fibrous Dysplasia|fibrous dysplasia
893857|NCT00001973|Mutation|mutation
893858|NCT00001973|Pathology|pathology
893859|NCT00001973|Immunohistochemistry|immunohistochemistry
893860|NCT00001973|PCR|pcr
893861|NCT00001973|In Situ Hybridization|in situ hybridization
893862|NCT00001973|Juvenile Dermatomyositis|juvenile dermatomyositis
893863|NCT00001973|Calcinosis|calcinosis
893864|NCT00001972|Alzheimer's Disease|alzheimer's disease
893865|NCT00001972|Positron Emission Tomography|positron emission tomography
893866|NCT00001972|Brain Phospholipid|brain phospholipid
893867|NCT00001972|Fatty Acids|fatty acids
893868|NCT00001972|11C Arachidonate|11c arachidonate
893869|NCT00001972|Signal Transduction|signal transduction
893870|NCT00001972|Brain|brain
893871|NCT00001971|Hepatitis B|hepatitis b
893872|NCT00001971|Hepatitis C|hepatitis c
893873|NCT00001971|Hepatitis D|hepatitis d
893874|NCT00001971|Chronic Cholestatic Syndromes|chronic cholestatic syndromes
893875|NCT00001971|Primary Biliary Cirrhosis|primary biliary cirrhosis
893876|NCT00001971|Primary Sclerosing Cholangitis|primary sclerosing cholangitis
893877|NCT00001971|Non-Alcoholic Steatohepatitis|non-alcoholic steatohepatitis
893878|NCT00001971|Wilson's Disease|wilson's disease
893879|NCT00001971|Hemochromatosis|hemochromatosis
893880|NCT00001971|Liver Biopsy|liver biopsy
893881|NCT00001971|Noncirrhotic Portal Hypertension|noncirrhotic portal hypertension
893882|NCT00001971|Liver Disease|liver disease
893883|NCT00001969|Cardiovascular Disease|cardiovascular disease
893884|NCT00001969|Glucose Clamp|glucose clamp
893885|NCT00001969|Hypercortisolism|hypercortisolism
893886|NCT00001969|Insulin Sensitivity|insulin sensitivity
893887|NCT00001969|Major Depression Disorder|major depression disorder
893888|NCT00001969|Inflammation|inflammation
893889|NCT00001969|Coagulation|coagulation
893890|NCT00001969|Metabolic|metabolic
893891|NCT00001969|Insulin|insulin
893892|NCT00001969|Cytokine|cytokine
893893|NCT00001969|Depression|depression
893894|NCT00001969|Volunteer|volunteer
893895|NCT00001969|Healthy Volunteer|healthy volunteer
893896|NCT00001967|HIV|hiv
893897|NCT00001967|HAART|haart
893898|NCT00001967|Immunity|immunity
893899|NCT00001967|Toxicity|toxicity
893900|NCT00001967|Resistance|resistance
893901|NCT00001967|Treatment Interruption|treatment interruption
893902|NCT00001964|Hematopoiesis|hematopoiesis
893903|NCT00001964|Bone Marrow Failure|bone marrow failure
893904|NCT00001964|Aplastic Anemia|aplastic anemia
893905|NCT00001962|Immunosuppression|immunosuppression
893906|NCT00001962|T-cells|t-cells
893907|NCT00001962|Hematopoiesis|hematopoiesis
893908|NCT00001962|Monoclonal Antibody Therapy|monoclonal antibody therapy
893909|NCT00001962|Immunosuppressive Therapy|immunosuppressive therapy
893910|NCT00001962|Aplastic Anemia|aplastic anemia
893911|NCT00001961|Myocardial Infarction|myocardial infarction
893912|NCT00001961|Coronary Artery Disease|coronary artery disease
893913|NCT00001961|Adenosine|adenosine
893914|NCT00001961|Stress Testing|stress testing
893922|NCT00001959|Nephrotic Syndrome|nephrotic syndrome
893923|NCT00001959|Proteinuria|proteinuria
893924|NCT00001959|Renal Failure|renal failure
893925|NCT00001959|TGF-Beta|tgf-beta
893926|NCT00001959|Focal Segmental Glomerulosclerosis|focal segmental glomerulosclerosis
893927|NCT00001959|FSGS|fsgs
893928|NCT00001958|Gamma Gene|gamma gene
893929|NCT00001958|Hemoglobin Switching|hemoglobin switching
893930|NCT00001958|Erythropoiesis|erythropoiesis
893931|NCT00001958|HbE Hemoglobin Chain Synthesis Imbalance|hbe hemoglobin chain synthesis imbalance
893932|NCT00001958|Cooley's Anemia|cooley's anemia
893933|NCT00001958|Beta-Thalassemia Intermedia|beta-thalassemia intermedia
893934|NCT00001957|Ostoacoustic Emission|ostoacoustic emission
893935|NCT00001957|Central Auditory Processing|central auditory processing
893936|NCT00001957|CAPD|capd
893937|NCT00001957|Medial Olivocochlear Bundle|medial olivocochlear bundle
893938|NCT00001957|Speech Impediment|speech impediment
893939|NCT00001956|Genetic Markers|genetic markers
893940|NCT00001956|Thermal Pain|thermal pain
893941|NCT00001956|Hyperalgesia|hyperalgesia
893942|NCT00001956|Oral Surgery|oral surgery
893943|NCT00001956|Cold Pain|cold pain
893944|NCT00001956|Peripheral Nerve|peripheral nerve
893945|NCT00001956|Allodynia|allodynia
893946|NCT00001956|Spinal Cord|spinal cord
893947|NCT00001956|Personality Traits|personality traits
893948|NCT00001956|Pain Ratings|pain ratings
893949|NCT00001955|Clinical Trial|clinical trial
893950|NCT00001955|Temporomandibular Joints|temporomandibular joints
893951|NCT00001955|Celecoxib|celecoxib
893952|NCT00001955|Etanercept|etanercept
893953|NCT00001955|Tumor Necrosis Factor|tumor necrosis factor
893954|NCT00001955|TMJ|tmj
893955|NCT00001955|TMD|tmd
893956|NCT00001954|Clinical Trial|clinical trial
893957|NCT00001954|Autoimmune|autoimmune
893958|NCT00001954|Disease Activity|disease activity
893959|NCT00001954|Cytokine|cytokine
893960|NCT00001954|Saliva|saliva
893961|NCT00001954|Xerostomia|xerostomia
893962|NCT00001954|Salivary Glands|salivary glands
893963|NCT00001954|Sjogren's Syndrome|sjogren's syndrome
893964|NCT00001953|Endocrine System|endocrine system
893965|NCT00001953|Autoimmunity|autoimmunity
893966|NCT00001953|Salivary Glands|salivary glands
893967|NCT00001953|Glucose Tolerance Test|glucose tolerance test
893968|NCT00001953|Growth Hormone|growth hormone
893969|NCT00001953|Somatostatin|somatostatin
893970|NCT00001953|Sjogren's Syndrome|sjogren's syndrome
893971|NCT00001952|Fentanyl|fentanyl
893972|NCT00001952|Intraosseous-Anesthesia|intraosseous-anesthesia
893973|NCT00001952|Endodontics|endodontics
893974|NCT00001952|Denti Patch|denti patch
893975|NCT00001952|Pain|pain
893976|NCT00001952|Chronic Inflammation|chronic inflammation
893977|NCT00001951|Bone|bone
893978|NCT00001951|Cognition|cognition
893979|NCT00001951|Estrogen|estrogen
893980|NCT00001951|Mood|mood
893981|NCT00001951|Testosterone|testosterone
893982|NCT00001951|Osteoporosis|osteoporosis
893983|NCT00001951|Ovarian Failure|ovarian failure
893984|NCT00001951|Hormone Replacement Therapy|hormone replacement therapy
893985|NCT00001951|POF|pof
893986|NCT00001951|Premature Ovarian Failure|premature ovarian failure
893987|NCT00001950|Cognition|cognition
893988|NCT00001950|Infancy|infancy
893989|NCT00001950|Perception|perception
893990|NCT00001948|Human Immunodeficiency Virus|human immunodeficiency virus
893991|NCT00001948|Symptom Distress|symptom distress
893992|NCT00001948|Immune Function|immune function
893993|NCT00001948|Medication Trial|medication trial
893994|NCT00001948|Physical Symptoms|physical symptoms
893995|NCT00001946|Magnetic Resonance Angiography|magnetic resonance angiography
893996|NCT00001946|Gadolinium|gadolinium
893997|NCT00001946|Suburban Hospital|suburban hospital
893998|NCT00001946|Atherosclerosis|atherosclerosis
893999|NCT00001941|Interleukin-2 Receptor alpha chain|interleukin-2 receptor alpha chain
894000|NCT00001941|Interleukin-2|interleukin-2
894001|NCT00001941|HTLV-I|htlv-i
894002|NCT00001941|Adult T-Cell Leukemia (ATL)|adult t-cell leukemia (atl)
894003|NCT00001941|Monoclonal Antibody (Daclizumab, Zenapax)|monoclonal antibody (daclizumab, zenapax)
894004|NCT00001938|Ovarian Cancer|ovarian cancer
894005|NCT00001938|Proteomics|proteomics
894006|NCT00000433|Spondylitis|spondylitis
894007|NCT00000433|Etanercept|etanercept
894008|NCT00000433|ENBREL|enbrel
894009|NCT00000433|Tumor necrosis factor-alpha|tumor necrosis factor-alpha
894010|NCT00000432|Lyme disease|lyme disease
894011|NCT00000432|Education evaluation|education evaluation
894012|NCT00000432|Communicable disease control|communicable disease control
894013|NCT00000432|Outcomes research|outcomes research
894014|NCT00000432|Tick-transmitted diseases|tick-transmitted diseases
894015|NCT00000431|Venous leg ulcer|venous leg ulcer
894016|NCT00000431|Wound healing|wound healing
894017|NCT00000431|Somatic gene therapy|somatic gene therapy
894018|NCT00000431|PDGF-B|pdgf-b
894019|NCT00000430|Osteoporosis|osteoporosis
894020|NCT00000430|Osteopenia|osteopenia
894021|NCT00000430|Postmenopausal women|postmenopausal women
894022|NCT00000430|Hormone replacement therapy|hormone replacement therapy
894023|NCT00000430|Alendronate|alendronate
894024|NCT00000429|JRA|jra
894026|NCT00000429|Dietary calcium|dietary calcium
894027|NCT00000429|Diet therapy|diet therapy
894028|NCT00000429|Bone density|bone density
894029|NCT00000429|Ossification|ossification
894030|NCT00000429|Biomarker|biomarker
894031|NCT00000429|Dietary supplement|dietary supplement
894032|NCT00000428|Fibromyalgia Syndrome (FMS)|fibromyalgia syndrome (fms)
894033|NCT00000428|Amitriptyline|amitriptyline
894034|NCT00000428|Fluoxetine|fluoxetine
894035|NCT00000427|Parathyroid Hormone (PTH)|parathyroid hormone (pth)
894036|NCT00000427|Alendronate|alendronate
894037|NCT00000427|Bone metabolism|bone metabolism
894038|NCT00000427|Bone mineral density (BMD)|bone mineral density (bmd)
894039|NCT00000427|Bone loss|bone loss
894040|NCT00000427|Postmenopausal osteoporosis|postmenopausal osteoporosis
894041|NCT00000427|Osteoporosis in men|osteoporosis in men
894042|NCT00000111|mouth mucosa|mouth mucosa
894043|NCT00000111|transplants|transplants
894046|NCT00000110|physical fitness|physical fitness
894047|NCT00000110|lipids|lipids
894048|NCT00000110|nutrition|nutrition
894049|NCT00000108|exercise|exercise
894050|NCT00000107|Cyanotic Congenital Heart Disease|cyanotic congenital heart disease
894051|NCT00000106|Rheumatoid Diseases|rheumatoid diseases
894052|NCT00000393|Acquired Immunodeficiency Syndrome|acquired immunodeficiency syndrome
894053|NCT00000392|Acquired Immunodeficiency Syndrome|acquired immunodeficiency syndrome
894054|NCT00000392|AIDS-Related Complex|aids-related complex
894055|NCT00000391|Acquired Immunodeficiency Syndrome|acquired immunodeficiency syndrome
894056|NCT00000391|AIDS-Related Complex|aids-related complex
894057|NCT00000390|Adult|adult
894058|NCT00000390|Acquired Immunodeficiency Syndrome|acquired immunodeficiency syndrome
894059|NCT00000390|Depression|depression
894060|NCT00000390|Female|female
894061|NCT00000390|Human|human
894062|NCT00000390|Imipramine|imipramine
894063|NCT00000390|Male|male
894064|NCT00000390|Middle Age|middle age
894065|NCT00000390|Acquired Immunodeficiency Syndrome -- *complications|acquired immunodeficiency syndrome -- *complications
894066|NCT00000390|Depression -- *drug therapy|depression -- *drug therapy
894067|NCT00000390|Depression -- etiology|depression -- etiology
894068|NCT00000390|Imipramine -- *therapeutic use|imipramine -- *therapeutic use
894069|NCT00001936|Neuromuscular Stimulation|neuromuscular stimulation
894070|NCT00001936|Laryngeal Elevation|laryngeal elevation
894071|NCT00001936|Dysphagia|dysphagia
894072|NCT00001936|Stroke|stroke
894073|NCT00001936|Neuroprosthesis|neuroprosthesis
894074|NCT00001936|Dysphonia|dysphonia
894075|NCT00001936|Aspiration|aspiration
894076|NCT00001936|Motor Control|motor control
894077|NCT00001936|Videofluoroscopy|videofluoroscopy
894078|NCT00001936|Upper Esophageal Sphincter|upper esophageal sphincter
894079|NCT00001936|Healthy Volunteer|healthy volunteer
894080|NCT00001936|Swallowing Disorders|swallowing disorders
894081|NCT00001934|Multiple Sclerosis|multiple sclerosis
894082|NCT00001934|Immunotherapy|immunotherapy
894083|NCT00001934|MRI|mri
894084|NCT00001933|Acetylcholine|acetylcholine
894085|NCT00001933|Clinical Trial|clinical trial
894086|NCT00001933|GABA|gaba
894087|NCT00001933|Cognition|cognition
894088|NCT00001933|Nicotine|nicotine
894089|NCT00001932|Epilepsy|epilepsy
894090|NCT00001932|Temporal Lobe|temporal lobe
894091|NCT00001932|Blood Flow|blood flow
894092|NCT00001932|Metabolism|metabolism
894093|NCT00001932|Localization|localization
894094|NCT00001927|Factor V Leiden|factor v leiden
894095|NCT00001927|Prothrombin Mutation|prothrombin mutation
894096|NCT00001927|Antiphospholipids|antiphospholipids
894097|NCT00001927|Cerebral Infarction|cerebral infarction
894098|NCT00001927|Thrombophilia|thrombophilia
894099|NCT00001927|Porencephaly|porencephaly
894100|NCT00001927|Perinatal Stroke|perinatal stroke
894101|NCT00001927|Healthy Mothers|healthy mothers
894102|NCT00001927|Healthy Children|healthy children
894103|NCT00001926|Plasticity|plasticity
894104|NCT00001926|Magnetic Stimulation|magnetic stimulation
894105|NCT00001926|PET|pet
894106|NCT00001926|Blind|blind
894107|NCT00001926|Braille|braille
894108|NCT00001926|Transcranial Magnetic Stimulation|transcranial magnetic stimulation
894109|NCT00001925|Inferior Olives|inferior olives
894110|NCT00001925|Calcium Channels|calcium channels
894111|NCT00001925|Accelerometry|accelerometry
894112|NCT00001925|Electromyography|electromyography
894113|NCT00001925|Palatal Tremor|palatal tremor
894114|NCT00001923|Pain|pain
894115|NCT00001923|Amputee|amputee
894116|NCT00001923|Phantom Limb|phantom limb
894117|NCT00001923|Amputation|amputation
894118|NCT00001923|Magnetic Stimulation|magnetic stimulation
894119|NCT00001923|Phantom|phantom
894120|NCT00001922|Evoked Response|evoked response
894121|NCT00001922|Spasmodic Dysphonia|spasmodic dysphonia
894122|NCT00001922|Aerodynamic|aerodynamic
894123|NCT00001922|Vibration|vibration
894124|NCT00001922|Laryngeal|laryngeal
894125|NCT00001922|Voice Disorders|voice disorders
894126|NCT00001922|Laryngeal Brainstem Evoked Responses|laryngeal brainstem evoked responses
894127|NCT00001922|Long-latency Responses|long-latency responses
894128|NCT00001922|Muscular Tension Dysphonia|muscular tension dysphonia
894129|NCT00001921|Functional Connectivity|functional connectivity
894130|NCT00001921|Frontotemporal Interaction|frontotemporal interaction
894131|NCT00001921|Electrophysiology|electrophysiology
894132|NCT00001921|Functional Magnetic Resonance Imaging|functional magnetic resonance imaging
894133|NCT00001921|Healthy Subjects|healthy subjects
894134|NCT00001921|Schizophrenia|schizophrenia
894135|NCT00001921|MEG|meg
894136|NCT00001921|Neuroimaging|neuroimaging
894137|NCT00001921|EEG|eeg
894138|NCT00001921|MRI|mri
894139|NCT00001920|Schizophrenia|schizophrenia
894140|NCT00001920|Eyeblink|eyeblink
894141|NCT00001920|Evoked Potentials|evoked potentials
894142|NCT00001920|Learning|learning
894143|NCT00001920|Normal Volunteer|normal volunteer
894144|NCT00001920|Healthy Volunteer|healthy volunteer
894145|NCT00001919|Mechanism of Action|mechanism of action
894146|NCT00001919|BCIT-SPECT|bcit-spect
894147|NCT00001919|St. John's Wort|st. john's wort
894148|NCT00001919|Hypericum Perforatum|hypericum perforatum
894149|NCT00001919|Depression|depression
894150|NCT00001919|Serotonin|serotonin
894151|NCT00001919|Dopamine Transporter|dopamine transporter
894152|NCT00001919|SPECT|spect
894153|NCT00001919|Brain Disorders|brain disorders
894154|NCT00001917|Positron Emission Tomography|positron emission tomography
894155|NCT00001917|Physostigmine|physostigmine
894156|NCT00001917|Visual Stimulation|visual stimulation
894157|NCT00001917|Cholinergic Stimulation|cholinergic stimulation
894158|NCT00001917|[F-18] FP-TZIP|[f-18] fp-tzip
894159|NCT00001917|Aging|aging
894160|NCT00001917|Alzheimer's Disease|alzheimer's disease
894161|NCT00001917|Visual Activation|visual activation
894162|NCT00001915|Cortical Stimulation|cortical stimulation
894163|NCT00001915|Motor Control|motor control
894164|NCT00001915|Neuromotor Maturation|neuromotor maturation
894165|NCT00001915|Magnetic Stimulation|magnetic stimulation
894166|NCT00001915|Attention Deficit Hyperactivity Disorder|attention deficit hyperactivity disorder
894167|NCT00001915|Hearing Loss|hearing loss
894168|NCT00001915|Hearing Conservation|hearing conservation
894169|NCT00001915|Hearing Protective Devices|hearing protective devices
894170|NCT00001915|Safety Study|safety study
894171|NCT00001915|Noise Induced Hearing Loss|noise induced hearing loss
894172|NCT00001915|Normal Volunteer|normal volunteer
894173|NCT00001913|Visual Processing|visual processing
894174|NCT00001913|Functional Magnetic Resonance Imaging|functional magnetic resonance imaging
894175|NCT00001913|Maternal Behavior|maternal behavior
894176|NCT00001913|Attachment|attachment
894177|NCT00001913|Bereavement|bereavement
894178|NCT00001912|Cysticercosis|cysticercosis
894179|NCT00001912|T. Solium|t. solium
894180|NCT00001912|MRI|mri
894181|NCT00001912|Seizures|seizures
894182|NCT00001912|Calcified Cysts|calcified cysts
894183|NCT00001912|Taenia|taenia
894184|NCT00001911|Cytokine|cytokine
894185|NCT00001911|Interferon Gamma|interferon gamma
894186|NCT00001911|Pulmonary|pulmonary
894187|NCT00001911|Disseminated|disseminated
894188|NCT00001911|Refractory|refractory
894189|NCT00001911|Mycobacterial Infection|mycobacterial infection
894190|NCT00001911|Nontuberculosis Mycobacterial Infection|nontuberculosis mycobacterial infection
894191|NCT00001911|Pulmonary Nontuberculous Mycobacterial Infection|pulmonary nontuberculous mycobacterial infection
894192|NCT00001910|T Cells|t cells
894193|NCT00001910|Allergy|allergy
894194|NCT00001910|Asthma|asthma
894195|NCT00001910|Cytokine|cytokine
894196|NCT00001910|Vaccine|vaccine
894197|NCT00001905|Neutrophil|neutrophil
894198|NCT00001905|Immunodeficiency|immunodeficiency
894199|NCT00001905|Cytokine|cytokine
894200|NCT00001905|Treatment|treatment
894201|NCT00001905|Trafficking|trafficking
894202|NCT00001905|Leukocyte Adhesion Deficiency Type I|leukocyte adhesion deficiency type i
894203|NCT00001905|LAD I|lad i
894204|NCT00001901|Vasculitis|vasculitis
894205|NCT00001901|Prednisone-sparing|prednisone-sparing
894206|NCT00001901|Methotrexate|methotrexate
894207|NCT00001901|Tumor Necrosis Factor|tumor necrosis factor
894208|NCT00001901|Remission|remission
894209|NCT00001901|Wegener's Granulomatosis|wegener's granulomatosis
894210|NCT00001899|Viral Suppression|viral suppression
894211|NCT00001899|Latency|latency
894212|NCT00001899|AIDS Therapy|aids therapy
894213|NCT00001899|Viral Relapse|viral relapse
894214|NCT00001899|Immunodeficiency|immunodeficiency
894215|NCT00001899|HIV|hiv
894216|NCT00001899|Treatment Interruption|treatment interruption
894217|NCT00001898|Melanoma|melanoma
894218|NCT00001898|Breast Cancer|breast cancer
894219|NCT00001898|Gene Expression|gene expression
894220|NCT00001898|DNA Chip Technology|dna chip technology
894221|NCT00001898|Expressed Sequence Tags|expressed sequence tags
894222|NCT00001895|Electromechanical Mapping|electromechanical mapping
894223|NCT00001895|Myocardial Viability|myocardial viability
894224|NCT00001895|Myocardial Ischemia|myocardial ischemia
894225|NCT00001895|Positron Emission Tomography|positron emission tomography
894226|NCT00001895|Magnetic Resonance Imaging|magnetic resonance imaging
894227|NCT00001894|HCM|hcm
894228|NCT00001894|Alcohol|alcohol
894229|NCT00001894|Septal Ablation|septal ablation
894230|NCT00001894|Pacemaker|pacemaker
894231|NCT00001893|Bronchoprovocation|bronchoprovocation
894232|NCT00001893|Airway Inflammation|airway inflammation
894233|NCT00001893|Tumor Necrosis Factor|tumor necrosis factor
894234|NCT00001893|Bronchoalveolar Lavage|bronchoalveolar lavage
894235|NCT00001893|Pulmonary Function Test|pulmonary function test
894236|NCT00001893|Asthma|asthma
894237|NCT00001888|Induced Sputum|induced sputum
894238|NCT00001888|Exhaled Breath Condensate|exhaled breath condensate
894239|NCT00001888|Fiberoptic Bronchoscopy|fiberoptic bronchoscopy
894240|NCT00001888|Bronchoscopy|bronchoscopy
894241|NCT00001888|mRNA|mrna
894242|NCT00001885|Interstitial Lung Disease|interstitial lung disease
894243|NCT00001885|Inherited Disease|inherited disease
894244|NCT00001885|Genetic Markers|genetic markers
894245|NCT00001885|Alpha 1 Protease Inhibitor|alpha 1 protease inhibitor
894246|NCT00001885|DNA Mutations|dna mutations
894247|NCT00001885|Rheumatoid Arthritis|rheumatoid arthritis
894248|NCT00001885|Pulmonary Fibrosis|pulmonary fibrosis
894249|NCT00001885|Normal Volunteer|normal volunteer
894250|NCT00001884|Bronchoscopy|bronchoscopy
894251|NCT00001884|Idiopathic Pulmonary Fibrosis|idiopathic pulmonary fibrosis
894252|NCT00001884|Proteases|proteases
894253|NCT00001884|Fibroblast Proliferation|fibroblast proliferation
894254|NCT00001884|Reactive Proteins|reactive proteins
894255|NCT00001884|Rheumatoid Arthritis|rheumatoid arthritis
894256|NCT00001884|Pulmonary Fibrosis|pulmonary fibrosis
894257|NCT00001883|Treadmill|treadmill
894258|NCT00001883|Bicycle|bicycle
894259|NCT00001883|Lung Function|lung function
894260|NCT00001883|Physiology|physiology
894261|NCT00001883|Quality Control|quality control
894262|NCT00001883|Normal Volunteers|normal volunteers
894263|NCT00001880|Engraftment|engraftment
894264|NCT00001880|Peripheral Blood Stem Cells|peripheral blood stem cells
894265|NCT00001880|Non-Myeloablative Bone Marrow Transplantation|non-myeloablative bone marrow transplantation
894266|NCT00001880|Metastatic Solid Tumors|metastatic solid tumors
894267|NCT00001880|Graft-Versus-Host Disease|graft-versus-host disease
894268|NCT00001880|Cancer|cancer
894269|NCT00001880|Tumor|tumor
894270|NCT00001878|Growth Hormone|growth hormone
894271|NCT00001878|Cardiac Hypertrophy|cardiac hypertrophy
894272|NCT00001878|Hypertrophic Cardiomyopathy|hypertrophic cardiomyopathy
894273|NCT00001878|Sarcomeric Gene Mutations|sarcomeric gene mutations
894274|NCT00001877|Tumor Necrosis Factor|tumor necrosis factor
894275|NCT00001877|Corticosteroids|corticosteroids
894276|NCT00001877|Macrophages|macrophages
894277|NCT00001877|Phosphodiesterase|phosphodiesterase
894278|NCT00001877|Autoimmune|autoimmune
894279|NCT00001877|Pulmonary Sarcoidosis|pulmonary sarcoidosis
894280|NCT00001876|Interstitial Lung Disease|interstitial lung disease
894281|NCT00001876|Collagen Vascular Disease|collagen vascular disease
894282|NCT00001876|Extracellular Matrix|extracellular matrix
894283|NCT00001876|Pulmonary Function|pulmonary function
894284|NCT00001876|DTPA Lung Clearance Scan|dtpa lung clearance scan
894285|NCT00001876|Rheumatoid Arthritis|rheumatoid arthritis
894286|NCT00001876|Pulmonary Fibrosis|pulmonary fibrosis
894287|NCT00001876|Idiopathic Pulmonary Fibrosis|idiopathic pulmonary fibrosis
894288|NCT00001874|Imaging|imaging
894289|NCT00001874|Spectroscopy|spectroscopy
894290|NCT00001874|MRI|mri
894291|NCT00001874|Cardiovascular|cardiovascular
894292|NCT00001874|Technical Development|technical development
894293|NCT00001874|Safety|safety
894294|NCT00001874|Gadolinium|gadolinium
894295|NCT00001874|Heart|heart
894296|NCT00001874|Toxicity|toxicity
894297|NCT00001874|Adverse Events|adverse events
894298|NCT00001874|Normal Volunteer|normal volunteer
894299|NCT00001873|Peripheral Blood Stem Cells|peripheral blood stem cells
894300|NCT00001873|Cyclosporine|cyclosporine
894301|NCT00001873|Cyclosphosphamide|cyclosphosphamide
894302|NCT00001873|Whole Body Irradiation|whole body irradiation
894303|NCT00001873|Donor Apheresis|donor apheresis
894304|NCT00001873|Leukemic Relapse|leukemic relapse
894305|NCT00001873|Graft vs. Host Disease|graft vs. host disease
894306|NCT00001873|Graft-Versus-Leukemia|graft-versus-leukemia
894307|NCT00001873|Graft-Versus-Myeloma|graft-versus-myeloma
894308|NCT00001873|Chronic Myelogenous Leukemia|chronic myelogenous leukemia
894309|NCT00001873|Acute Lymphoblastic Leukemia|acute lymphoblastic leukemia
894310|NCT00001873|Acute Myelogenous Leukemia|acute myelogenous leukemia
894311|NCT00001873|Myelodysplastic Syndromes|myelodysplastic syndromes
894312|NCT00001873|Multiple Myeloma|multiple myeloma
894313|NCT00001873|Chronic Lymphocytic Leukemia|chronic lymphocytic leukemia
894314|NCT00001873|Non-Hodgkin's Lymphoma|non-hodgkin's lymphoma
894315|NCT00001872|Volunteer|volunteer
894316|NCT00001872|Leukocyte Donors|leukocyte donors
894317|NCT00001872|Family Members|family members
894318|NCT00001872|Leukocyte Collection|leukocyte collection
894319|NCT00001872|No Reimbursement|no reimbursement
894320|NCT00001870|Insulin Resistance|insulin resistance
894321|NCT00001870|Oxidative Stress|oxidative stress
894322|NCT00001870|Antioxidant|antioxidant
894323|NCT00001870|Endothelial Function|endothelial function
894324|NCT00001870|Glucose Clamp|glucose clamp
894325|NCT00001870|Type 2 Diabetes|type 2 diabetes
894326|NCT00001870|Vitamin C Deficiency|vitamin c deficiency
894327|NCT00001869|Progesterone|progesterone
894328|NCT00001869|Pulmonary Function Tests|pulmonary function tests
894329|NCT00001869|Pneumothorax|pneumothorax
894330|NCT00001869|Oopherectomy|oopherectomy
894331|NCT00001869|High Resolution CT|high resolution ct
894332|NCT00001869|Tuberous Sclerosis Complex|tuberous sclerosis complex
894333|NCT00001869|Lymphangioleiomyomatosis (LAM)|lymphangioleiomyomatosis (lam)
894334|NCT00001865|Behcet's|behcet's
894335|NCT00001865|Monoclonal Antibody|monoclonal antibody
894336|NCT00001865|Uveitis|uveitis
894337|NCT00001865|Interleukin 2|interleukin 2
894338|NCT00001865|Retinal Vasculitis|retinal vasculitis
894339|NCT00001865|Hyopyon|hyopyon
894340|NCT00001865|Interleukin 2 Receptor|interleukin 2 receptor
894341|NCT00001865|Bechet's Disease|bechet's disease
894342|NCT00001865|Ocular Disease|ocular disease
894343|NCT00001863|Immunosuppression|immunosuppression
894344|NCT00001863|Inflammation|inflammation
894347|NCT00001863|Medication|medication
894348|NCT00001863|Uveitis|uveitis
894349|NCT00001863|Leflunomide|leflunomide
894350|NCT00001863|Vitritis|vitritis
894351|NCT00001862|Ocular Inflammation|ocular inflammation
894352|NCT00001862|Children|children
894353|NCT00001862|Immunotherapy|immunotherapy
894354|NCT00001862|Cytokine|cytokine
894355|NCT00001862|Clinical Trial|clinical trial
894356|NCT00001862|Uveitis|uveitis
894357|NCT00001862|Immunosuppression|immunosuppression
894358|NCT00001862|Joint|joint
894359|NCT00001862|Inflammation|inflammation
894360|NCT00001861|Eye Movements|eye movements
894361|NCT00001861|Amblyopia|amblyopia
894362|NCT00001861|Orthoptics|orthoptics
894363|NCT00001861|Lazy Eye|lazy eye
894364|NCT00001861|Eye Development|eye development
894365|NCT00001861|Nystagmus|nystagmus
894366|NCT00001861|Strabismus|strabismus
894367|NCT00001861|Screening Protocol|screening protocol
894368|NCT00001861|Eye Movement Disorders|eye movement disorders
894369|NCT00001860|Growth Hormone|growth hormone
894370|NCT00001860|Somatostatin|somatostatin
894371|NCT00001860|Insulin-like Growth Factor-One|insulin-like growth factor-one
894372|NCT00001860|Acromegaly|acromegaly
894373|NCT00001860|Macroadenoma|macroadenoma
894374|NCT00001859|Evaluation|evaluation
894375|NCT00001859|Diabetes|diabetes
894376|NCT00001859|Renal Failure|renal failure
894377|NCT00001858|Biopsy|biopsy
894378|NCT00001858|Immune System|immune system
894379|NCT00001858|Renal|renal
894380|NCT00001856|Living Donor|living donor
894381|NCT00001856|Transplantation|transplantation
894382|NCT00001856|Nephrectomy|nephrectomy
894383|NCT00001854|Ribavirin|ribavirin
894384|NCT00001854|Liver Disease|liver disease
894385|NCT00001854|Antiviral Agent|antiviral agent
894386|NCT00001854|Cirrhosis|cirrhosis
894387|NCT00001854|Chronic Hepatitis|chronic hepatitis
894388|NCT00001854|Iron|iron
894389|NCT00001854|Viral Hepatitis|viral hepatitis
894390|NCT00001854|Hepatitis C Virus|hepatitis c virus
894391|NCT00001854|Hemolytic Anemia|hemolytic anemia
894392|NCT00001854|Hemolysis|hemolysis
894393|NCT00001853|Healthy Volunteers|healthy volunteers
894394|NCT00001853|Health Disparities|health disparities
894395|NCT00001853|Diabetes|diabetes
894396|NCT00001853|Cardiovascular Disease|cardiovascular disease
894397|NCT00001852|Xerostomia|xerostomia
894398|NCT00001852|Oral Dryness|oral dryness
894399|NCT00001852|Salivary Function|salivary function
894400|NCT00001851|Marrow|marrow
894401|NCT00001851|Grafting|grafting
894402|NCT00001851|Imaging|imaging
894403|NCT00001851|Injection|injection
894404|NCT00001851|Aspiration|aspiration
894405|NCT00001851|Bone Marrow Stromal Cells|bone marrow stromal cells
894406|NCT00001851|Bone Grafting|bone grafting
894407|NCT00001851|Bone Graft Substitutes|bone graft substitutes
894408|NCT00001851|Bio and Pharmacological Regulators of Bone Turnover|bio and pharmacological regulators of bone turnover
894409|NCT00001850|Training|training
894410|NCT00001850|Reproduction|reproduction
894411|NCT00001850|Infertility|infertility
894412|NCT00001850|Women's Health|women's health
894413|NCT00001850|Hormone|hormone
894414|NCT00001850|Hormone Replacement Therapy|hormone replacement therapy
894415|NCT00001850|Graft Vs Host Disease|graft vs host disease
894416|NCT00001850|GATA 2|gata 2
894417|NCT00001850|Sickle Cell|sickle cell
894418|NCT00001849|PET|pet
894419|NCT00001849|(18F)-DOPA|(18f)-dopa
894420|NCT00001849|Pentetreotide|pentetreotide
894421|NCT00001849|ACTH|acth
894422|NCT00001849|Octreotide|octreotide
894423|NCT00001849|Cushing's Syndrome|cushing's syndrome
894424|NCT00001849|Ectopic Cushing Syndrome|ectopic cushing syndrome
894425|NCT00001848|Estrogen Receptor|estrogen receptor
894426|NCT00001848|Laparoscopy|laparoscopy
894427|NCT00001848|Surgical Excision|surgical excision
894428|NCT00001848|Raloxifene|raloxifene
894429|NCT00001848|Selective Estrogen Receptor Modulator|selective estrogen receptor modulator
894430|NCT00001848|Estrogen|estrogen
894431|NCT00001848|Endometriosis|endometriosis
894432|NCT00001848|Pelvic Pain|pelvic pain
894433|NCT00001846|Volunteer Donor|volunteer donor
894434|NCT00001846|Research Samples|research samples
894435|NCT00001846|Leukapheresis|leukapheresis
894436|NCT00001846|Plateletpheresis|plateletpheresis
894437|NCT00001846|Plasmapheresis|plasmapheresis
894438|NCT00001846|Healthy Volunteer|healthy volunteer
894439|NCT00001846|Normal Volunteer|normal volunteer
894440|NCT00001845|MRI|mri
894441|NCT00001845|Cerebral Blood Flow|cerebral blood flow
894442|NCT00001845|CO2 Inhalation|co2 inhalation
894443|NCT00001845|Acetazolamide|acetazolamide
894444|NCT00001845|Perfusion|perfusion
894445|NCT00001845|Healthy Volunteer|healthy volunteer
894446|NCT00001844|MRI/MRS|mri/mrs
894447|NCT00001844|Functional MRI|functional mri
894448|NCT00001844|Metabolic Imaging|metabolic imaging
894449|NCT00001844|Brain|brain
894450|NCT00001844|Healthy Volunteer|healthy volunteer
894451|NCT00001842|Granulocytes|granulocytes
894452|NCT00001842|Granulocyte Colony Stimulating Factor|granulocyte colony stimulating factor
894453|NCT00001842|Granulocyte Transfusion Factor|granulocyte transfusion factor
894454|NCT00001842|Apheresis|apheresis
894455|NCT00001842|Blood Donors|blood donors
894456|NCT00001842|Healthy Volunteer|healthy volunteer
894457|NCT00001841|Arteriosclerosis|arteriosclerosis
894459|NCT00001841|MRA|mra
894460|NCT00001841|Narrowing of Vessels|narrowing of vessels
894461|NCT00001841|Hardening of Arteries|hardening of arteries
894462|NCT00001837|Sonohysterography|sonohysterography
894463|NCT00001837|Color Doppler Sonography|color doppler sonography
894464|NCT00001837|Endometrium|endometrium
894465|NCT00001837|Gynecologic|gynecologic
894466|NCT00001837|Menstrual Cycle|menstrual cycle
894467|NCT00001837|Premenopause|premenopause
894468|NCT00001836|Coronary Artery Disease|coronary artery disease
894469|NCT00001836|EBCT|ebct
894470|NCT00001836|Volumetric Scan|volumetric scan
894471|NCT00001836|Coronary Artery Calcium|coronary artery calcium
894472|NCT00001836|Prospective Gating|prospective gating
894473|NCT00001835|Renal Dysfunction|renal dysfunction
894474|NCT00001835|Pharmacokinetics|pharmacokinetics
894475|NCT00001835|Platinum Analogues|platinum analogues
894476|NCT00001835|Renal Cancer|renal cancer
894477|NCT00001835|Kidney Cancer|kidney cancer
894478|NCT00001832|Immunotherapy|immunotherapy
894479|NCT00001832|Adoptive Transfer|adoptive transfer
894480|NCT00001832|IL-2|il-2
894481|NCT00001832|Toxicity|toxicity
894482|NCT00001832|Clinical Response|clinical response
894483|NCT00001832|Breast Cancer|breast cancer
894484|NCT00001830|Bone Marrow Transplantation|bone marrow transplantation
894485|NCT00001830|Chronic Lymphocytic Leukemia|chronic lymphocytic leukemia
894486|NCT00001830|Immunotherapy|immunotherapy
894487|NCT00001830|Lymphoma|lymphoma
894488|NCT00001830|Multiple Myeloma|multiple myeloma
894489|NCT00001830|Graft vs. Host Disease|graft vs. host disease
894490|NCT00001830|Lymphoid Malignancy|lymphoid malignancy
894491|NCT00001830|Leukemia|leukemia
894492|NCT00001827|Immunotherapy|immunotherapy
894493|NCT00001827|Cancer|cancer
894494|NCT00001827|Oncogenes|oncogenes
894495|NCT00001827|T-cells|t-cells
894496|NCT00001827|Vaccine Therapy|vaccine therapy
894497|NCT00001827|p53 Peptide|p53 peptide
894498|NCT00001827|Ovarian Cancer|ovarian cancer
894499|NCT00001826|CD-4-Naive T Cells|cd-4-naive t cells
894500|NCT00001826|CD-4-Memory T Cells|cd-4-memory t cells
894501|NCT00001826|Antiviral Activity|antiviral activity
894502|NCT00001826|VB Repertoire|vb repertoire
894503|NCT00001826|Immunizations|immunizations
894504|NCT00001826|HIV|hiv
894505|NCT00001826|Treatment Experienced|treatment experienced
894506|NCT00001823|Cancer|cancer
894507|NCT00001823|Gene Therapy|gene therapy
894508|NCT00001823|Immunotherapy|immunotherapy
894509|NCT00001823|Melanoma|melanoma
894510|NCT00001823|Clinical Trial|clinical trial
894511|NCT00001813|Xeroderma Pigmentosum|xeroderma pigmentosum
894512|NCT00001813|Trichothiodystrophy|trichothiodystrophy
894513|NCT00001813|Cockayne Syndrome|cockayne syndrome
894514|NCT00001813|Skin Cancer|skin cancer
894515|NCT00001813|DNA Repair|dna repair
894516|NCT00001807|CNS directed therapy|cns directed therapy
894517|NCT00001807|Neurotoxicity|neurotoxicity
894518|NCT00001807|H-NMRS|h-nmrs
894519|NCT00001807|MRI|mri
894520|NCT00001806|Genetic Testing|genetic testing
894521|NCT00001806|Genetic Counseling|genetic counseling
894522|NCT00001806|BRCA1/BRCA2|brca1/brca2
894523|NCT00001806|Genetic Education|genetic education
894524|NCT00001806|Informed Consent|informed consent
894525|NCT00001806|Breast Cancer|breast cancer
894526|NCT00001806|Ovarian Cancer|ovarian cancer
894527|NCT00001806|Known Family Mutation|known family mutation
894528|NCT00001803|Gene-Environment Interaction|gene-environment interaction
894529|NCT00001803|Kidney Cancer|kidney cancer
894530|NCT00001803|VHL|vhl
894531|NCT00001803|Genetic Epidemiology|genetic epidemiology
894532|NCT00001788|Cytokine|cytokine
894533|NCT00001788|Stat|stat
894534|NCT00001788|Jak|jak
894535|NCT00001788|IL-12|il-12
894536|NCT00001788|Mutation|mutation
894537|NCT00001788|Immunodeficiency|immunodeficiency
894538|NCT00001785|HTLV-1-Associated Myelopathy|htlv-1-associated myelopathy
894539|NCT00001785|Virus|virus
894540|NCT00001785|Spontaneous Proliferation|spontaneous proliferation
894541|NCT00001784|Blepharospasm|blepharospasm
894542|NCT00001784|Writer's Cramp|writer's cramp
894543|NCT00001784|Muscle Spindle Afferents|muscle spindle afferents
894544|NCT00001784|Sodium Channels|sodium channels
894545|NCT00001784|Sensorimotor Integration|sensorimotor integration
894546|NCT00001784|Focal Dystonia|focal dystonia
894547|NCT00001783|Rehabilitation|rehabilitation
894548|NCT00001783|Plasticity|plasticity
894549|NCT00001783|Stroke|stroke
894550|NCT00001783|Amphetamine|amphetamine
894551|NCT00001783|Motor|motor
894552|NCT00001783|Hemiparetic|hemiparetic
894553|NCT00001783|Thromboembolic Non-Hemorrhagic Infarction|thromboembolic non-hemorrhagic infarction
894554|NCT00001781|Multiple Sclerosis|multiple sclerosis
894555|NCT00001781|Immunology|immunology
894556|NCT00001781|Treatment|treatment
894557|NCT00001780|Myelopathy|myelopathy
894558|NCT00001780|Demyelination|demyelination
894559|NCT00001780|Leukodystrophy|leukodystrophy
894560|NCT00001780|Motor Neuron Disease|motor neuron disease
894561|NCT00001780|Movement Disorders|movement disorders
894562|NCT00001780|Normal Volunteer|normal volunteer
894563|NCT00001778|Immune Response|immune response
894564|NCT00001778|Sero-Indeterminant|sero-indeterminant
894565|NCT00001778|Transmission|transmission
894566|NCT00001778|Tropical Spastic Paraparesis|tropical spastic paraparesis
894567|NCT00001778|Viral Load|viral load
894568|NCT00001778|HTLV-I|htlv-i
894569|NCT00001778|HAM/TSP|ham/tsp
894570|NCT00001776|Magnetic Stimulation|magnetic stimulation
894571|NCT00001776|Plasticity|plasticity
894572|NCT00001776|SRTT|srtt
894573|NCT00001776|Sequence|sequence
894574|NCT00001776|Implicit Memory|implicit memory
894575|NCT00001776|Explicit Memory|explicit memory
894576|NCT00001776|Memory|memory
894577|NCT00001776|Parkinson's Disease|parkinson's disease
894578|NCT00001776|Cerebellar Deficit|cerebellar deficit
894579|NCT00001776|Frontal Lobe Lesions|frontal lobe lesions
894580|NCT00001776|Frontal Lobe Dementia|frontal lobe dementia
894581|NCT00001776|Normal Volunteer|normal volunteer
894582|NCT00001771|Receptors|receptors
894583|NCT00001771|Re-Uptake|re-uptake
894584|NCT00001771|Neurotransmitters|neurotransmitters
894585|NCT00001771|Neuroimaging|neuroimaging
894586|NCT00001771|Drug Abuse|drug abuse
894587|NCT00001771|Serotonin|serotonin
894588|NCT00001771|Brain Scan|brain scan
894589|NCT00001771|Tourette's Syndrome|tourette's syndrome
894590|NCT00001771|Obsessive Compulsive Disorder|obsessive compulsive disorder
894591|NCT00001771|Schizophrenia|schizophrenia
894592|NCT00001771|Normal Volunteer|normal volunteer
894593|NCT00001770|Depression|depression
894594|NCT00001770|Estrogen|estrogen
894595|NCT00001770|Hormone Replacement Therapy|hormone replacement therapy
894596|NCT00001770|Mood|mood
894597|NCT00001770|Progestin|progestin
894598|NCT00001770|Progesterone|progesterone
894599|NCT00001770|Anxiety|anxiety
894600|NCT00001766|Abacavir|abacavir
894601|NCT00001766|Salvage|salvage
894602|NCT00001766|Drug Interaction|drug interaction
894603|NCT00001766|Drug Levels|drug levels
894604|NCT00001766|Anti-Viral|anti-viral
894605|NCT00001766|HIV|hiv
894606|NCT00001765|Engraftment|engraftment
894607|NCT00001765|Minitransplant|minitransplant
894608|NCT00001765|Fludarabine|fludarabine
894609|NCT00001765|Neutrophil|neutrophil
894610|NCT00001765|Allogenic|allogenic
894611|NCT00001765|Donor Apheresis|donor apheresis
894612|NCT00001765|Anti-Thymocyte Globin|anti-thymocyte globin
894613|NCT00001765|Cyclophosphamide|cyclophosphamide
894614|NCT00001765|Nonmyeloablative Bone Marrow Transplantation|nonmyeloablative bone marrow transplantation
894615|NCT00001765|Graft-versus-host Disease|graft-versus-host disease
894616|NCT00001765|Chronic Granulomatous Disease|chronic granulomatous disease
894617|NCT00001764|Alternative agent|alternative agent
894618|NCT00001764|Purine Antimetabolite|purine antimetabolite
894619|NCT00001764|Immunosuppressive|immunosuppressive
894620|NCT00001764|Previous relapse|previous relapse
894621|NCT00001764|Drug Intolerance|drug intolerance
894622|NCT00001764|Wegener's Granulomatosis|wegener's granulomatosis
894623|NCT00001762|Protease Inhibitor|protease inhibitor
894624|NCT00001762|HIV Infection|hiv infection
894625|NCT00001762|Appearance|appearance
894626|NCT00001762|Subcutaneous Fat|subcutaneous fat
894627|NCT00001762|Facial Wasting|facial wasting
894628|NCT00001760|Stem Cell Factor|stem cell factor
894629|NCT00001760|Cytokine|cytokine
894630|NCT00001760|Chemokines|chemokines
894631|NCT00001760|Chemotaxis|chemotaxis
894632|NCT00001760|Mast Cells|mast cells
894633|NCT00001760|Normal Volunteer|normal volunteer
894634|NCT00001760|Systemic Mastocytosis|systemic mastocytosis
894635|NCT00001760|Atopic Dermatitis|atopic dermatitis
894636|NCT00001758|Antiretroviral|antiretroviral
894637|NCT00001758|HIV-1|hiv-1
894638|NCT00001758|1592U89|1592u89
894639|NCT00001758|141W94|141w94
894640|NCT00001758|DMP 266|dmp 266
894641|NCT00001756|Leukapheresis|leukapheresis
894642|NCT00001756|Mastocytosis|mastocytosis
894643|NCT00001756|Mast Cells|mast cells
894644|NCT00001756|Normal Volunteer|normal volunteer
894645|NCT00001756|Systemic Mastocytosis|systemic mastocytosis
894651|NCT00001750|Gene Transfer|gene transfer
894652|NCT00001750|Retroviral Receptor|retroviral receptor
894653|NCT00001750|Stem Cell Expansion|stem cell expansion
894654|NCT00001750|Multiple Myeloma|multiple myeloma
894655|NCT00001749|Immune Suppression|immune suppression
894656|NCT00001749|Erythroid Hypoplasia|erythroid hypoplasia
894657|NCT00001749|Congenital Anemia|congenital anemia
894658|NCT00001749|Reticulocytopenia|reticulocytopenia
894659|NCT00001749|Diamond Blackfan Anemia|diamond blackfan anemia
894660|NCT00001746|Hypertrophic Cardiomyopathy|hypertrophic cardiomyopathy
894661|NCT00001746|HCM|hcm
894662|NCT00001746|Evaluation for Research|evaluation for research
894663|NCT00001746|Medical Advice|medical advice
894664|NCT00001741|Angiotensin II Receptor|angiotensin ii receptor
894665|NCT00001741|Polymorphism, Genetic|polymorphism, genetic
894666|NCT00001741|Vascular Tone|vascular tone
894667|NCT00001741|Angiotensin II|angiotensin ii
894668|NCT00001741|Losartan|losartan
894669|NCT00001737|Eye|eye
894670|NCT00001737|Immunosuppression|immunosuppression
894671|NCT00001737|Inflammation|inflammation
894672|NCT00001737|Therapy|therapy
894673|NCT00001737|Vitreous|vitreous
894674|NCT00001737|Uveitis|uveitis
894675|NCT00001734|Uveitis|uveitis
894676|NCT00001734|Conjunctivitis|conjunctivitis
894677|NCT00001734|Iritis|iritis
894678|NCT00001734|Retinitis|retinitis
894679|NCT00001734|Keratitis|keratitis
894680|NCT00001734|Screening Protocol|screening protocol
894681|NCT00001734|Ocular Immunology|ocular immunology
894682|NCT00001734|Inflammation|inflammation
894683|NCT00001734|Eye Inflammation|eye inflammation
894684|NCT00001733|Diabetic Retinopathy|diabetic retinopathy
894685|NCT00001733|Age-Related Macular Degeneration|age-related macular degeneration
894686|NCT00001733|Neovascularization|neovascularization
894687|NCT00001733|Macular Degeneration|macular degeneration
894688|NCT00001733|Retinal Disease|retinal disease
894689|NCT00001733|Diabetes|diabetes
894690|NCT00001732|Genetics|genetics
894691|NCT00001732|Diagnosis|diagnosis
894692|NCT00001732|Screening Protocol|screening protocol
894693|NCT00001732|Ophthalmic Genetic Diseases|ophthalmic genetic diseases
894694|NCT00001732|Genetic Testing|genetic testing
894695|NCT00001732|Family Studies|family studies
894696|NCT00001729|Cirrhosis|cirrhosis
894697|NCT00001729|Liver Disease|liver disease
894698|NCT00001729|Hemolytic Anemia|hemolytic anemia
894699|NCT00001729|Liver Biopsy|liver biopsy
894700|NCT00001729|Ribavirin|ribavirin
894701|NCT00001729|Alpha Interferon|alpha interferon
894702|NCT00001729|Viral Hepatitis|viral hepatitis
894703|NCT00001729|Hepatitis C Virus|hepatitis c virus
894704|NCT00001729|Chronic Hepatitis|chronic hepatitis
894705|NCT00001729|Antiviral Agents|antiviral agents
894706|NCT00001728|Bone Marrow Stromal Cells|bone marrow stromal cells
894707|NCT00001728|Bone Turnover|bone turnover
894708|NCT00001728|Fibrous Dysplastic Lesion|fibrous dysplastic lesion
894709|NCT00001728|Polyostotic Fibrous Dysplasia|polyostotic fibrous dysplasia
894710|NCT00001728|McCune-Albright Syndrome|mccune-albright syndrome
894711|NCT00001727|Fibrous Dysplasia (FD)|fibrous dysplasia (fd)
894712|NCT00001727|McCune-Albright Syndrome|mccune-albright syndrome
894713|NCT00001727|Polyostotic Fibrous Dysplasia|polyostotic fibrous dysplasia
894714|NCT00001726|Bacterial Colonization|bacterial colonization
894715|NCT00001726|Plaque|plaque
894716|NCT00001726|Mouth|mouth
894717|NCT00001726|Saliva|saliva
894718|NCT00001726|Adhesion|adhesion
894719|NCT00001726|Dental Plaque Formation|dental plaque formation
894720|NCT00001726|Dental Caries|dental caries
894721|NCT00001725|Trigeminal Neuralgia|trigeminal neuralgia
894722|NCT00001725|Dextromethorphan|dextromethorphan
894723|NCT00001725|Topiramate|topiramate
894724|NCT00001725|Orofacial Pain|orofacial pain
894725|NCT00001725|Neuropathic Pain|neuropathic pain
894726|NCT00001725|Facial Neuralgia|facial neuralgia
894727|NCT00001724|Pain|pain
894728|NCT00001724|Microencapsulated Drug|microencapsulated drug
894729|NCT00001724|NSAID|nsaid
894730|NCT00001724|Acute Inflammation|acute inflammation
894731|NCT00001724|Peripheral Administration|peripheral administration
894732|NCT00001724|Dose-Response|dose-response
894733|NCT00001724|Relative Potency Assay|relative potency assay
894734|NCT00001724|Pharmacokinetics|pharmacokinetics
894735|NCT00001723|Dyslipidemia|dyslipidemia
894736|NCT00001723|Race|race
894737|NCT00001723|Body Fat|body fat
894738|NCT00001723|Visceral Fat|visceral fat
894739|NCT00001723|Sleep Apnea|sleep apnea
894740|NCT00001723|Fat-Soluble Vitamins|fat-soluble vitamins
894741|NCT00001723|Type 2 Diabetes|type 2 diabetes
894742|NCT00001723|Obesity|obesity
894743|NCT00001723|Childhood Obesity|childhood obesity
894744|NCT00001722|Obesity|obesity
894745|NCT00001722|Sympathetic Nervous System|sympathetic nervous system
894746|NCT00001722|Fat Tissue|fat tissue
894747|NCT00001722|Metabolism|metabolism
894748|NCT00001722|Adipose Tissue|adipose tissue
894749|NCT00001722|Microdialysis|microdialysis
894750|NCT00001722|Leptin|leptin
894751|NCT00001722|Lipolysis|lipolysis
894752|NCT00001722|Normal Volunteer|normal volunteer
894753|NCT00001721|Cholesterol|cholesterol
894755|NCT00001721|Cleft Palate|cleft palate
894756|NCT00001721|Smith-Lemli-Opitz Syndrome (SLO)|smith-lemli-opitz syndrome (slo)
894757|NCT00001720|Glucocorticoids|glucocorticoids
894758|NCT00001720|Bone Mineral Density|bone mineral density
894759|NCT00001720|Bisphosphonates|bisphosphonates
894760|NCT00001720|Vertebral Fracture|vertebral fracture
894761|NCT00001720|Childhood Osteoporosis|childhood osteoporosis
894762|NCT00001719|Blood Flow|blood flow
894763|NCT00001719|Hepatic Disease|hepatic disease
894764|NCT00001719|Liver|liver
894765|NCT00001719|Modeling|modeling
894766|NCT00001719|Rheology|rheology
894767|NCT00001719|Normal Volunteer|normal volunteer
894768|NCT00001716|Hemoglobin|hemoglobin
894770|NCT00001716|Microvascular|microvascular
894771|NCT00001716|Perfusion|perfusion
894772|NCT00001716|Magnetic Resonance Imaging|magnetic resonance imaging
894773|NCT00001716|Sickle Cell Anemia|sickle cell anemia
894774|NCT00001715|Consultation|consultation
894775|NCT00001715|Training|training
894776|NCT00001715|Referral|referral
894777|NCT00001715|Fellowship Program|fellowship program
894778|NCT00001715|Outpatient|outpatient
894779|NCT00001715|Blood Disorder|blood disorder
894780|NCT00001713|rtPA|rtpa
894781|NCT00001713|Catheter Directed|catheter directed
894782|NCT00001713|Thrombolysis|thrombolysis
894783|NCT00001713|Anticoagulation|anticoagulation
894784|NCT00001713|Emboli|emboli
894785|NCT00001713|Acute Deep Venous Thrombosis|acute deep venous thrombosis
894786|NCT00001713|TPA|tpa
894787|NCT00001713|DVT|dvt
894788|NCT00001712|Healthcare Worker|healthcare worker
894789|NCT00001712|Bloodborne Diseases|bloodborne diseases
894790|NCT00001712|Hepatitis B|hepatitis b
894791|NCT00001712|Hepatitis C|hepatitis c
894792|NCT00001712|Human Immunodeficiency Virus|human immunodeficiency virus
894793|NCT00001712|Parenteral Exposure|parenteral exposure
894794|NCT00001712|Non-Parenteral Exposure|non-parenteral exposure
894795|NCT00001712|Blood and Body Substances|blood and body substances
894796|NCT00001712|Universal Precautions|universal precautions
894797|NCT00001712|HIV Seronegativity|hiv seronegativity
894798|NCT00001711|Magnetic Resonance Imaging|magnetic resonance imaging
894799|NCT00001711|Gadolinium|gadolinium
894800|NCT00001711|MRA|mra
894801|NCT00001711|Diagnostic Tool|diagnostic tool
894802|NCT00001711|Contrast|contrast
894803|NCT00001711|Normal Volunteer|normal volunteer
894804|NCT00001703|Immunotherapy|immunotherapy
894805|NCT00001703|Kidney|kidney
894806|NCT00001703|Genes|genes
894807|NCT00001703|Vaccine Therapy|vaccine therapy
894808|NCT00001703|Renal Cell Carcinoma|renal cell carcinoma
894809|NCT00001702|Genetic|genetic
894810|NCT00001702|Variant Alleles|variant alleles
894811|NCT00001702|Risk Factor|risk factor
894812|NCT00001702|Cancer|cancer
894813|NCT00001702|Transplantation|transplantation
894814|NCT00001701|Risk Factor|risk factor
894815|NCT00001701|Genetic|genetic
894816|NCT00001701|Variant Alleles|variant alleles
894817|NCT00001701|Cancer|cancer
894818|NCT00001701|Transplantation|transplantation
894819|NCT00001698|Chemoprevention|chemoprevention
894820|NCT00001698|Direct Epithelial Delivery|direct epithelial delivery
894821|NCT00001698|Tobacco-induced Cancer|tobacco-induced cancer
894822|NCT00001698|Field Cancerization|field cancerization
894823|NCT00001695|Complementary Medicine|complementary medicine
894824|NCT00001695|Unproven Treatments|unproven treatments
894825|NCT00001695|Herbal|herbal
894826|NCT00001693|Chemoprevention|chemoprevention
894827|NCT00001693|Biomarkers|biomarkers
894828|NCT00001693|Endoscopy|endoscopy
894829|NCT00001693|Colorectal|colorectal
894830|NCT00001693|Celecoxib|celecoxib
894831|NCT00001689|Neurotoxicity|neurotoxicity
894832|NCT00001689|A.L.L.|a.l.l.
894833|NCT00001689|Limited Sampling|limited sampling
894834|NCT00001689|Dose Individualization|dose individualization
894835|NCT00001689|Vinca Alkaloids|vinca alkaloids
894836|NCT00001686|Leukemia|leukemia
894837|NCT00001686|Ewing's Sarcoma|ewing's sarcoma
894838|NCT00001686|Neuroectodermal Tumors|neuroectodermal tumors
894839|NCT00001686|Lymphoma, Osteosarcoma|lymphoma, osteosarcoma
894840|NCT00001686|Brain Tumors, Rhabdomyosarcoma|brain tumors, rhabdomyosarcoma
894841|NCT00001686|Lymphoma|lymphoma
894842|NCT00001686|Neoplasm|neoplasm
894843|NCT00001686|Sarcoma|sarcoma
894844|NCT00001683|Collagen Breakdown|collagen breakdown
894845|NCT00001683|Pharmacokinetics|pharmacokinetics
894846|NCT00001683|Rapid Escalation Phase I|rapid escalation phase i
894847|NCT00001683|Angiogenesis|angiogenesis
894848|NCT00001683|Tissue Inhibitors of Metalloproteinase|tissue inhibitors of metalloproteinase
894849|NCT00001678|Autoimmunity|autoimmunity
894850|NCT00001678|Sibling Pairs|sibling pairs
894851|NCT00001678|Genes|genes
894852|NCT00001678|Rheumatoid Arthritis|rheumatoid arthritis
894853|NCT00001678|Bone Erosion|bone erosion
894854|NCT00001676|Remission|remission
894855|NCT00001676|Renal Function|renal function
894856|NCT00001676|Infection|infection
894857|NCT00001676|Germinal Center|germinal center
894858|NCT00001676|Immunoglobulin|immunoglobulin
894859|NCT00001676|Glomerulonephritis|glomerulonephritis
894860|NCT00001676|Systemic Lupus Erythematosus|systemic lupus erythematosus
894861|NCT00001676|Lupus Nephritis|lupus nephritis
894862|NCT00001671|White Matter|white matter
894863|NCT00001671|Myelin|myelin
894864|NCT00001671|Degenerative Diseases|degenerative diseases
894865|NCT00001671|Genetic|genetic
894866|NCT00001671|Oligodendrocytes|oligodendrocytes
894867|NCT00001671|Leukodystrophy|leukodystrophy
894868|NCT00001666|Seizures|seizures
894869|NCT00001666|Partial Epilepsy|partial epilepsy
894870|NCT00001666|Intractable|intractable
894871|NCT00001666|TMS|tms
894872|NCT00001664|Narcolepsy|narcolepsy
894873|NCT00001664|Polysomnography|polysomnography
894874|NCT00001664|Multiple Sleep Latency Test|multiple sleep latency test
894875|NCT00001664|Sleep Disorders|sleep disorders
894876|NCT00001664|Hypersomnia|hypersomnia
894877|NCT00001664|Periodic Leg Movements|periodic leg movements
894878|NCT00001663|Neurological Disorders|neurological disorders
894879|NCT00001663|Movement Disorders|movement disorders
894880|NCT00001663|Physiology|physiology
894881|NCT00001663|Noninvasive|noninvasive
894882|NCT00001663|Brain Stimulation|brain stimulation
894883|NCT00001663|Cortical Myoclonus|cortical myoclonus
894884|NCT00001662|Dementia|dementia
894885|NCT00001662|Glutamate|glutamate
894886|NCT00001662|Clinical Trial|clinical trial
894887|NCT00001662|Neurotransmitter|neurotransmitter
894888|NCT00001662|Alzheimer's Disease|alzheimer's disease
894889|NCT00001661|Plasticity|plasticity
894890|NCT00001661|Use|use
894891|NCT00001661|Stroke|stroke
894892|NCT00001661|Spinal Cord Injury|spinal cord injury
894893|NCT00001661|Amputation|amputation
894894|NCT00001661|Intracortical Inhibition|intracortical inhibition
894895|NCT00001659|Bereavement|bereavement
894896|NCT00001659|Depression|depression
894897|NCT00001659|Suicide|suicide
894898|NCT00001659|Activity of Daily Living|activity of daily living
894899|NCT00001659|Immune Function|immune function
894900|NCT00001659|Occupational Performance|occupational performance
894901|NCT00001659|Sleep Disorders|sleep disorders
894902|NCT00001659|Mood Changes|mood changes
894903|NCT00001656|Clozapine|clozapine
894904|NCT00001656|Olanzapine|olanzapine
894905|NCT00001656|Drug Response|drug response
894906|NCT00001656|Safety|safety
894907|NCT00001656|Childhood Onset Schizophrenia|childhood onset schizophrenia
894908|NCT00001656|Schizoaffective Disorder|schizoaffective disorder
894909|NCT00001656|Multidimensionally Impaired Syndrome|multidimensionally impaired syndrome
894910|NCT00001656|Phenomenology|phenomenology
894911|NCT00001656|Biochemical Correlates|biochemical correlates
894912|NCT00001656|Brain Imaging|brain imaging
894913|NCT00001656|Schizophrenia|schizophrenia
894914|NCT00001656|Childhood Schizophrenia|childhood schizophrenia
894915|NCT00001656|Psychosis|psychosis
894916|NCT00001654|Adolescence|adolescence
894917|NCT00001654|Comorbid Disorders|comorbid disorders
894918|NCT00001654|Physiology|physiology
894919|NCT00001654|Socialization|socialization
894920|NCT00001654|Gender|gender
894921|NCT00001654|Conduct Problems|conduct problems
894922|NCT00001654|Anxiety|anxiety
894923|NCT00001654|Sadness|sadness
894924|NCT00001654|Emotion|emotion
894925|NCT00001654|Psychophysiology|psychophysiology
894926|NCT00001652|Life-Charting|life-charting
894927|NCT00001652|Cerebrospinal Fluid|cerebrospinal fluid
894928|NCT00001652|Diagnostic Tests|diagnostic tests
894929|NCT00001652|Cognitive Testing|cognitive testing
894930|NCT00001652|Course of Illness|course of illness
894931|NCT00001652|Bipolar Disorder|bipolar disorder
894932|NCT00001651|HIV Infection|hiv infection
894933|NCT00001651|Lymphocyte Turnover|lymphocyte turnover
894934|NCT00001650|BrDU|brdu
894935|NCT00001650|HIV|hiv
894936|NCT00001650|Labeling|labeling
894937|NCT00001650|CD4 Cells|cd4 cells
894938|NCT00001650|Immunodeficiency|immunodeficiency
894939|NCT00001649|Clinical Trial|clinical trial
894940|NCT00001649|Sexual Transmitted Disease|sexual transmitted disease
894941|NCT00001649|Phase III|phase iii
894942|NCT00001649|HSV|hsv
894943|NCT00001649|Valtrex|valtrex
894944|NCT00001649|Valaciclovir|valaciclovir
894945|NCT00001649|HS2A/B3009|hs2a/b3009
894946|NCT00001649|Herpes Simplex Virus Transmission|herpes simplex virus transmission
894947|NCT00001649|Heterosexual Couples|heterosexual couples
894948|NCT00001648|HVEM Gene|hvem gene
894949|NCT00001648|HSV|hsv
894950|NCT00001648|Herpes Simplex Virus|herpes simplex virus
894951|NCT00001647|AIDS|aids
894952|NCT00001647|Immunotherapy|immunotherapy
894953|NCT00001647|Adoptive Cell Transfers|adoptive cell transfers
894954|NCT00001647|T Cell Repertoire|t cell repertoire
894955|NCT00001647|Identical Twins|identical twins
894956|NCT00001645|Helminth Infection|helminth infection
894957|NCT00001645|Parasite|parasite
894958|NCT00001645|Known Parasitic Infection|known parasitic infection
894959|NCT00001645|Suspected Parasitic Infection|suspected parasitic infection
894960|NCT00001645|Parasitic Infection|parasitic infection
894961|NCT00001644|Immunodeficiency|immunodeficiency
894962|NCT00001644|Latency|latency
894963|NCT00001644|T Cell Turnover|t cell turnover
894964|NCT00001644|Infected Cell Turnover|infected cell turnover
894965|NCT00001644|Follicular Dendritic Cells|follicular dendritic cells
894971|NCT00001643|Parkinson's Disease|parkinson's disease
894972|NCT00001641|Fibrillin|fibrillin
894973|NCT00001641|Collagen|collagen
894974|NCT00001641|Marfan Syndrome|marfan syndrome
894975|NCT00001641|Stickler Syndrome|stickler syndrome
894976|NCT00001641|Aortic Dissection|aortic dissection
894977|NCT00001641|Ehlers-Danlos|ehlers-danlos
895791|NCT00001372|SLE|sle
894978|NCT00001641|Connective Tissue Disorders|connective tissue disorders
894979|NCT00001641|Ehlers-Danlos Syndrome|ehlers-danlos syndrome
894980|NCT00001641|Nail-Patella Syndrome|nail-patella syndrome
894981|NCT00001640|Parkinson's Disease|parkinson's disease
894982|NCT00001638|Echocardiography|echocardiography
894983|NCT00001638|Heart|heart
894984|NCT00001638|Gadolinium|gadolinium
894985|NCT00001638|Dobutamine|dobutamine
894986|NCT00001638|Toxicity|toxicity
894987|NCT00001638|Adverse Events|adverse events
894988|NCT00001638|Myocardial Infarction|myocardial infarction
894989|NCT00001638|Myocardial Viability|myocardial viability
894990|NCT00001638|Myocardial Perfusion|myocardial perfusion
894991|NCT00001638|Myocardial Function|myocardial function
894992|NCT00001638|Cardiovascular Disease|cardiovascular disease
894993|NCT00001637|Peripheral Blood Stem Cells|peripheral blood stem cells
894994|NCT00001637|Engraftment|engraftment
894995|NCT00001637|Fludarabine|fludarabine
894996|NCT00001637|Nonmyeloablative|nonmyeloablative
894997|NCT00001637|Graft-Versus-Leukemia|graft-versus-leukemia
894998|NCT00001637|Graft vs. Host Disease|graft vs. host disease
894999|NCT00001637|Cyclophosphamide|cyclophosphamide
895000|NCT00001637|Donor Apheresis|donor apheresis
895001|NCT00001637|Nonmyeloablative Bone Marrow Transplantation|nonmyeloablative bone marrow transplantation
895002|NCT00001637|Chronic Myelogenous Leukemia (CML)|chronic myelogenous leukemia (cml)
895003|NCT00001637|Acute Lymphoblastic Leukemia (ALL)|acute lymphoblastic leukemia (all)
895004|NCT00001637|Acute Myelogenous Leukemia (AML)|acute myelogenous leukemia (aml)
895005|NCT00001637|Myelodysplastic Syndromes|myelodysplastic syndromes
895006|NCT00001637|Chronic Lymphocytic Leukemia (CLL)|chronic lymphocytic leukemia (cll)
895007|NCT00001637|Prolymphocytic Leukemia|prolymphocytic leukemia
895008|NCT00001632|Hypertrophy|hypertrophy
895009|NCT00001632|Integrated|integrated
895010|NCT00001632|Backscatter|backscatter
895011|NCT00001632|Cyclic|cyclic
895012|NCT00001632|Echocardiography|echocardiography
895013|NCT00001632|Hypertrophic Cardiomyopathy|hypertrophic cardiomyopathy
895014|NCT00001631|Gadolinium|gadolinium
895015|NCT00001631|Ischemia|ischemia
895016|NCT00001631|Coronary Artery Disease|coronary artery disease
895017|NCT00001631|Hypertrophic Cardiomyopathy|hypertrophic cardiomyopathy
895018|NCT00001631|Dipyridamole|dipyridamole
895019|NCT00001630|Immunosuppression|immunosuppression
895020|NCT00001630|Thrombocytopenia|thrombocytopenia
895021|NCT00001630|Autoimmune Disease|autoimmune disease
895022|NCT00001630|Evan's Syndrome|evan's syndrome
895023|NCT00001630|Autoimmune Hemolytic Anemia|autoimmune hemolytic anemia
895024|NCT00001630|Episodic Bleeding|episodic bleeding
895025|NCT00001627|Bone Marrow|bone marrow
895026|NCT00001627|Hematopoiesis|hematopoiesis
895027|NCT00001627|DNA|dna
895028|NCT00001627|RNA|rna
895029|NCT00001627|Viruses|viruses
895030|NCT00001626|Severe Aplastic Anemia|severe aplastic anemia
895031|NCT00001626|Immunosuppression|immunosuppression
895032|NCT00001625|Insulin Resistance|insulin resistance
895033|NCT00001625|Obesity|obesity
895034|NCT00001625|Hypertension|hypertension
895035|NCT00001625|Diabetes|diabetes
895036|NCT00001625|Mathematical Modeling|mathematical modeling
895037|NCT00001625|Normal Volunteer|normal volunteer
895038|NCT00001623|Peripheral Blood Stem Cells|peripheral blood stem cells
895039|NCT00001623|Graft-Versus-Leukemia|graft-versus-leukemia
895040|NCT00001623|Graft vs. Host Disease|graft vs. host disease
895041|NCT00001623|Whole Body Irradiation|whole body irradiation
895042|NCT00001623|Donor Apheresis|donor apheresis
895043|NCT00001623|Cyclophosphamide|cyclophosphamide
895044|NCT00001623|Graft-Versus-Myeloma|graft-versus-myeloma
895045|NCT00001623|Leukemic Relapse|leukemic relapse
895046|NCT00001623|Multiple Myeloma|multiple myeloma
895047|NCT00001623|Acute Myelogenous Leukemia (AML)|acute myelogenous leukemia (aml)
895048|NCT00001623|Chronic Myelogenous Leukemia (CML)|chronic myelogenous leukemia (cml)
895049|NCT00001623|Acute Lymphoblastic Leukemia (ALL)|acute lymphoblastic leukemia (all)
895050|NCT00001623|Myelodysplastic Syndromes|myelodysplastic syndromes
895051|NCT00001623|Chronic Lymphocytic Leukemia (CLL)|chronic lymphocytic leukemia (cll)
895052|NCT00001621|Teaching|teaching
895053|NCT00001621|Pulmonary Disease|pulmonary disease
895054|NCT00001621|Routine Testing|routine testing
895055|NCT00001621|Medically Indicated|medically indicated
895056|NCT00001621|Pulmonary Function Test|pulmonary function test
895057|NCT00001620|Thrombocytopenia|thrombocytopenia
895058|NCT00001620|Anemia|anemia
895059|NCT00001620|Neutropenia|neutropenia
895060|NCT00001620|Dysplasia|dysplasia
895061|NCT00001620|Hematopoiesis|hematopoiesis
895062|NCT00001620|Cytopenia|cytopenia
895063|NCT00001620|Hematologic Malignancy|hematologic malignancy
895064|NCT00001619|Imaging|imaging
895065|NCT00001619|Spectroscopy|spectroscopy
895066|NCT00001619|MRI|mri
895067|NCT00001619|Cardiovascular|cardiovascular
895068|NCT00001619|Technical Development|technical development
895069|NCT00001619|Heart|heart
895070|NCT00001619|Safety|safety
895071|NCT00001619|Toxicity|toxicity
895072|NCT00001619|Gadolinium|gadolinium
895073|NCT00001619|Adverse Events|adverse events
895074|NCT00001619|Normal Volunteer|normal volunteer
895075|NCT00001618|Cystic Fibrosis|cystic fibrosis
895076|NCT00001618|Healthy Volunteers|healthy volunteers
895077|NCT00001618|Asthma|asthma
895078|NCT00001618|Normal Volunteer|normal volunteer
895079|NCT00001618|Chronic Lung Disease|chronic lung disease
895080|NCT00001613|Cataract Surgery|cataract surgery
895081|NCT00001613|Human Lens|human lens
895082|NCT00001613|Crystallins|crystallins
895083|NCT00001613|Post-Translational|post-translational
895084|NCT00001613|Protein Modification|protein modification
895085|NCT00001613|Nuclear Cataract|nuclear cataract
895086|NCT00001613|Cataract Extraction|cataract extraction
895087|NCT00001611|AIDS|aids
895088|NCT00001611|Eye|eye
895089|NCT00001611|Treatment|treatment
895090|NCT00001611|Opportunistic Infection|opportunistic infection
895091|NCT00001611|Immunology|immunology
895092|NCT00001611|Retinitis|retinitis
895093|NCT00001610|Standing Potential|standing potential
895094|NCT00001610|Fast Oscillation|fast oscillation
895095|NCT00001610|Slow Oscillation|slow oscillation
895096|NCT00001610|Retinal Pigment|retinal pigment
895097|NCT00001610|Epithelium|epithelium
895098|NCT00001610|Electro-oculogram|electro-oculogram
895099|NCT00001610|Cellular Immune Response|cellular immune response
895100|NCT00001610|Retinal Antigens|retinal antigens
895101|NCT00001610|IRBP|irbp
895102|NCT00001610|S-Antigen|s-antigen
895103|NCT00001610|Normal Volunteer|normal volunteer
895104|NCT00001609|Linkage|linkage
895105|NCT00001609|Genetic Analysis|genetic analysis
895106|NCT00001609|Lens|lens
895107|NCT00001609|Opacity|opacity
895108|NCT00001609|Inherited|inherited
895109|NCT00001609|Linkage Analysis|linkage analysis
895110|NCT00001609|Genomic DNA|genomic dna
895111|NCT00001609|Risk Prediction|risk prediction
895112|NCT00001609|Pedigree Analysis|pedigree analysis
895113|NCT00001609|Congenital Cataracts|congenital cataracts
895114|NCT00001609|Hereditary Cataracts|hereditary cataracts
895115|NCT00001606|Linkage Analysis|linkage analysis
895116|NCT00001606|Positional Cloning|positional cloning
895117|NCT00001606|Mutation Screening|mutation screening
895118|NCT00001606|Syndromic Hearing Impairment|syndromic hearing impairment
895119|NCT00001606|Non-Syndromic Hearing Impairment|non-syndromic hearing impairment
895120|NCT00001604|DNA Samples|dna samples
895121|NCT00001604|Buccal Swab|buccal swab
895122|NCT00001604|Genotyping|genotyping
895123|NCT00001604|Statistical Analysis|statistical analysis
895124|NCT00001604|Computers|computers
895125|NCT00001604|Stuttering|stuttering
895126|NCT00001603|Cytokines|cytokines
895127|NCT00001603|Squamous Cell Carcinoma|squamous cell carcinoma
895128|NCT00001603|Papilloma|papilloma
895129|NCT00001603|Communication|communication
895130|NCT00001603|Immunity|immunity
895131|NCT00001603|Head|head
895132|NCT00001603|Neck|neck
895133|NCT00001603|Head and Neck Cancer|head and neck cancer
895134|NCT00001602|Dysfluency|dysfluency
895135|NCT00001602|Polymorphism|polymorphism
895136|NCT00001602|Stuttering|stuttering
895137|NCT00001602|Dopamine|dopamine
895138|NCT00001602|Family Studies|family studies
895139|NCT00001602|Receptors|receptors
895140|NCT00001602|Serotonin|serotonin
895141|NCT00001602|Enzymes|enzymes
895142|NCT00001602|Genetics|genetics
895143|NCT00001602|Linkage Analysis|linkage analysis
895144|NCT00001601|Oral Medicine|oral medicine
895145|NCT00001601|Clinical Experience|clinical experience
895146|NCT00001601|Therapy|therapy
895147|NCT00001601|Educational Training|educational training
895148|NCT00001601|Pathogenesis|pathogenesis
895149|NCT00001601|Oral Lesions|oral lesions
895150|NCT00001601|Aphthous Ulcers|aphthous ulcers
895151|NCT00001601|Lichen Planus|lichen planus
895152|NCT00001601|Burning Mouth|burning mouth
895153|NCT00001601|Temporomandibular Dysfunction (TMD)|temporomandibular dysfunction (tmd)
895154|NCT00001601|Oral Disease|oral disease
895155|NCT00001601|Oral Manifestations|oral manifestations
895156|NCT00001600|Screening Protocol|screening protocol
895157|NCT00001600|Temporomandibular Disorders|temporomandibular disorders
895158|NCT00001600|Oral Surgery|oral surgery
895159|NCT00001600|Chronic Orofacial Pain|chronic orofacial pain
895160|NCT00001599|Xerostomia|xerostomia
895161|NCT00001599|Autoimmunity|autoimmunity
895162|NCT00001599|Salivary Glands|salivary glands
895163|NCT00001599|Lacrimal Function|lacrimal function
895164|NCT00001599|Immunomodulator|immunomodulator
895165|NCT00001599|Sjogren's Syndrome|sjogren's syndrome
895166|NCT00001599|Dry Mouth|dry mouth
895167|NCT00001598|Xerostomia|xerostomia
895168|NCT00001598|Autoimmunity|autoimmunity
895169|NCT00001598|Salivary Glands|salivary glands
895170|NCT00001598|Androgen Therapy|androgen therapy
895171|NCT00001598|Lacrimal Function|lacrimal function
895172|NCT00001598|DHEA|dhea
895173|NCT00001598|Sjogren's Syndrome|sjogren's syndrome
895174|NCT00001598|Dehydroepiandrosterone|dehydroepiandrosterone
895175|NCT00001597|Psychophysics|psychophysics
895176|NCT00001597|Validation|validation
895177|NCT00001597|Fentanyl|fentanyl
895178|NCT00001597|Normal Volunteer|normal volunteer
895179|NCT00001597|Pain|pain
895180|NCT00001596|Albinism|albinism
895992|NCT00001320|SPECT|spect
895181|NCT00001596|Platelet Storage Pool Deficiency|platelet storage pool deficiency
895182|NCT00001596|Pulmonary Fibrosis|pulmonary fibrosis
895183|NCT00001596|Hermansky-Pudlak Syndrome|hermansky-pudlak syndrome
895184|NCT00001595|Developmental Defect|developmental defect
895185|NCT00001595|Oncogenesis|oncogenesis
895186|NCT00001595|Evaluation and Management|evaluation and management
895187|NCT00001595|Psychological|psychological
895188|NCT00001595|Cushing Disease|cushing disease
895189|NCT00001594|Osteogenesis Imperfecta|osteogenesis imperfecta
895190|NCT00001594|Basilar Invagination|basilar invagination
895191|NCT00001591|Central Nervous System|central nervous system
895192|NCT00001591|Technical Development|technical development
895193|NCT00001591|Activation Studies|activation studies
895194|NCT00001591|Pulse Sequences|pulse sequences
895195|NCT00001591|Metabolites|metabolites
895196|NCT00001591|Normal Volunteer|normal volunteer
895197|NCT00001589|Ferritin|ferritin
895198|NCT00001589|Atherosclerosis|atherosclerosis
895199|NCT00001589|Myocardial Infarction|myocardial infarction
895200|NCT00001589|Blood Donors|blood donors
895201|NCT00001589|Low Density Lipoprotein|low density lipoprotein
895202|NCT00001589|Asymptomatic Carotid Atherosclerosis|asymptomatic carotid atherosclerosis
895203|NCT00001586|Genetics|genetics
895204|NCT00001586|Bone Marrow Transplantation|bone marrow transplantation
895205|NCT00001586|Immunosuppression|immunosuppression
895206|NCT00001586|T Lymphocytes|t lymphocytes
895207|NCT00001586|Marrow Purging|marrow purging
895208|NCT00001582|Autoimmune Disorder|autoimmune disorder
895209|NCT00001582|Immune System Evaluation|immune system evaluation
895210|NCT00001582|Human Response Investigation|human response investigation
895211|NCT00001582|Tissue Acquisition|tissue acquisition
895212|NCT00001580|Molecular Diagnostics|molecular diagnostics
895213|NCT00001580|Ovary|ovary
895214|NCT00001580|Tissue Acquisition|tissue acquisition
895215|NCT00001580|cDNA Library|cdna library
895216|NCT00001580|CGAP|cgap
895217|NCT00001576|Regional Therapy|regional therapy
895218|NCT00001576|Organ Perfusion|organ perfusion
895219|NCT00001576|Metastases|metastases
895220|NCT00001576|Hyperthermia|hyperthermia
895221|NCT00001575|Yttrium 90|yttrium 90
895222|NCT00001575|Radiolabeled|radiolabeled
895223|NCT00001575|Anti -Tac|anti -tac
895224|NCT00001575|Calcium DTPA|calcium dtpa
895225|NCT00001574|Metabolites|metabolites
895226|NCT00001574|Proton Nuclear Magnetic Resonance Spectroscopic Imaging|proton nuclear magnetic resonance spectroscopic imaging
895227|NCT00001574|Scans|scans
895228|NCT00001572|B-Cell Lymphoma|b-cell lymphoma
895229|NCT00001572|BCL- 2 Positive Tumor|bcl- 2 positive tumor
895230|NCT00001572|Immunization|immunization
895231|NCT00001572|Induction Chemotherapy|induction chemotherapy
895232|NCT00001572|Lymphoma Vaccine|lymphoma vaccine
895233|NCT00001572|Follicular Lymphoma|follicular lymphoma
895234|NCT00001572|Tumor-Derived Immunoglobulin Idiotype|tumor-derived immunoglobulin idiotype
895235|NCT00001569|Gastrointestinal|gastrointestinal
895236|NCT00001569|Adenocarcinoma|adenocarcinoma
895237|NCT00001569|Taxol|taxol
895238|NCT00001568|Tumors|tumors
895239|NCT00001568|Detection|detection
895240|NCT00001568|Follow-Up|follow-up
895241|NCT00001568|Markers|markers
895242|NCT00001568|Radiolabeled|radiolabeled
895243|NCT00001567|Follow-Up Study|follow-up study
895244|NCT00001567|Relapse-Free Survival|relapse-free survival
895245|NCT00001567|Serum Soluble IL-2 Receptor|serum soluble il-2 receptor
895246|NCT00001567|Hematologic Malignancy|hematologic malignancy
895247|NCT00001567|Chronic Therapy|chronic therapy
895248|NCT00001566|Rhabdomyosarcoma|rhabdomyosarcoma
895249|NCT00001566|Ewing's Sarcoma|ewing's sarcoma
895250|NCT00001566|Immunotherapy|immunotherapy
895251|NCT00001566|Tumor Vaccine|tumor vaccine
895252|NCT00001566|Interleukin-2|interleukin-2
895253|NCT00001564|Rhabdomyosarcoma|rhabdomyosarcoma
895254|NCT00001564|Ewing's Sarcoma|ewing's sarcoma
895255|NCT00001564|Immunotherapy|immunotherapy
895256|NCT00001564|Tumor Vaccine|tumor vaccine
895257|NCT00001564|Fusion Protein|fusion protein
895258|NCT00001563|Lymphomagenesis|lymphomagenesis
895259|NCT00001563|Molecular markers of drug resistance|molecular markers of drug resistance
895260|NCT00001563|Refractory, progressive, or relapsed HIV + NHL|refractory, progressive, or relapsed hiv + nhl
895261|NCT00001563|AIDS-related NHL|aids-related nhl
895262|NCT00001561|Multiple Myeloma|multiple myeloma
895263|NCT00001561|Vaccine|vaccine
895264|NCT00001561|Idiotype-Specific Immunity|idiotype-specific immunity
895265|NCT00001561|Immune Transfer|immune transfer
895266|NCT00001561|Myeloma Immunoglobulin|myeloma immunoglobulin
895267|NCT00001560|AIDS|aids
895268|NCT00001560|Multidisciplinary|multidisciplinary
895269|NCT00001560|Leukemia|leukemia
895270|NCT00001560|Lymphoma|lymphoma
895271|NCT00001560|Kaposi's Sarcoma|kaposi's sarcoma
895272|NCT00001552|Spasmodic Dysphonia|spasmodic dysphonia
895273|NCT00001552|Pedigree|pedigree
895274|NCT00001552|Vocal Fold Paralysis|vocal fold paralysis
895275|NCT00001552|Voice Disorder|voice disorder
895276|NCT00001551|Stuttering|stuttering
895277|NCT00001551|Linkage|linkage
895278|NCT00001551|Pedigree|pedigree
895279|NCT00001551|Speech Articulation|speech articulation
895280|NCT00001551|Phonological Processing Disorders|phonological processing disorders
895281|NCT00001551|Speech Disorder|speech disorder
895282|NCT00001550|Immunotherapy|immunotherapy
895283|NCT00001550|Muscle Stiffness|muscle stiffness
895284|NCT00001550|Rigidity|rigidity
895285|NCT00001550|Anti-GAD Antibodies|anti-gad antibodies
895286|NCT00001550|Episodic Spasms|episodic spasms
895287|NCT00001550|Intravenous High-Dose Immunoglobulin|intravenous high-dose immunoglobulin
895288|NCT00001550|Stiff-man Syndrome|stiff-man syndrome
895289|NCT00001549|Movement Disorders|movement disorders
895290|NCT00001549|Parkinson's|parkinson's
895291|NCT00001549|Alzheimer's|alzheimer's
895292|NCT00001549|Screening|screening
895293|NCT00001549|Diagnostic Puzzles|diagnostic puzzles
895294|NCT00001549|Alzheimer Disease|alzheimer disease
895295|NCT00001549|Progressive Supranuclear Palsy|progressive supranuclear palsy
895296|NCT00001549|PSP|psp
895297|NCT00001549|Restless Leg Syndrome|restless leg syndrome
895298|NCT00001549|RLS|rls
895299|NCT00001549|Parkinsonism|parkinsonism
895300|NCT00001549|PD|pd
895301|NCT00001548|Genetic|genetic
895302|NCT00001548|Psychiatric Disorder|psychiatric disorder
895303|NCT00001548|Affected Sib Pairs|affected sib pairs
895304|NCT00001548|Obsessions|obsessions
895305|NCT00001548|Compulsions|compulsions
895306|NCT00001548|Family Study|family study
895307|NCT00001548|OCD Spectrum Disorders|ocd spectrum disorders
895308|NCT00001548|Trichotillomania|trichotillomania
895309|NCT00001548|Tourette's Syndrome|tourette's syndrome
895310|NCT00001547|Drug|drug
895311|NCT00001547|Imaging|imaging
895312|NCT00001547|Brain|brain
895313|NCT00001547|Metabolism|metabolism
895314|NCT00001547|Organic Mental Syndrome|organic mental syndrome
895315|NCT00001547|Magnetic Resonance Imaging|magnetic resonance imaging
895316|NCT00001547|Spectroscopy|spectroscopy
895317|NCT00001547|Neuropsychiatric Disorders|neuropsychiatric disorders
895318|NCT00001547|Drug Effects|drug effects
895319|NCT00001547|Interferon-alpha|interferon-alpha
895320|NCT00001545|Affective Disorders|affective disorders
895321|NCT00001545|Repetitive Transcranial Magnetic Stimulation|repetitive transcranial magnetic stimulation
895322|NCT00001545|Mania|mania
895323|NCT00001545|Bipolar Disorder|bipolar disorder
895324|NCT00001545|Depression|depression
895325|NCT00001545|Unipolar Disorder|unipolar disorder
895326|NCT00001545|Unipolar Depression|unipolar depression
895327|NCT00001544|DNA Probes|dna probes
895328|NCT00001544|Trinucleotide Repeats|trinucleotide repeats
895329|NCT00001544|Family Studies|family studies
895330|NCT00001544|Lymphoblast Cell Lines|lymphoblast cell lines
895331|NCT00001544|Genotyping|genotyping
895332|NCT00001544|Bipolar Affective Disorders|bipolar affective disorders
895333|NCT00001544|Schizophrenia|schizophrenia
895334|NCT00001544|Mental Retardation|mental retardation
895335|NCT00001544|Neuropsychiatric Disorders|neuropsychiatric disorders
895336|NCT00001543|Major Depression|major depression
895337|NCT00001543|Metabolic Clearance Rate|metabolic clearance rate
895338|NCT00001543|Pulsatility|pulsatility
895339|NCT00001543|Adrenocorticotropic Hormone|adrenocorticotropic hormone
895340|NCT00001543|Cortisol|cortisol
895341|NCT00001543|Corticotropin Releasing Hormone Binding Protein|corticotropin releasing hormone binding protein
895342|NCT00001543|Pharmacokinetics|pharmacokinetics
895343|NCT00001543|Half-Life|half-life
895344|NCT00001543|Bioavailability|bioavailability
895345|NCT00001543|Cushing's Syndrome|cushing's syndrome
895346|NCT00001541|Vasculitis|vasculitis
895347|NCT00001541|Inflammation|inflammation
895348|NCT00001541|Bronchoscopy|bronchoscopy
895349|NCT00001541|Cytokines|cytokines
895350|NCT00001541|Inflammatory Mediators|inflammatory mediators
895351|NCT00001541|Wegener's Granulomatosis|wegener's granulomatosis
895352|NCT00001539|Borrelia Burgdorferi|borrelia burgdorferi
895353|NCT00001539|Lyme Borreliosis|lyme borreliosis
895354|NCT00001539|Tick-Borne Disease|tick-borne disease
895355|NCT00001539|Lyme Disease|lyme disease
895356|NCT00001535|Intracellular Immunization|intracellular immunization
895357|NCT00001535|Immune Based Therapy|immune based therapy
895358|NCT00001535|Ex Vivo Cell Processing|ex vivo cell processing
895359|NCT00001535|Identical Twins|identical twins
895360|NCT00001535|HIV/AIDS|hiv/aids
895361|NCT00001535|Kaposi's Sarcoma|kaposi's sarcoma
895362|NCT00001534|Genetics|genetics
895363|NCT00001534|Myocardial Ischemia|myocardial ischemia
895364|NCT00001534|Diastolic Dysfunction|diastolic dysfunction
895365|NCT00001534|Renin-Angiotensin System|renin-angiotensin system
895366|NCT00001534|Hypertrophic Cardiomyopathy|hypertrophic cardiomyopathy
895367|NCT00001534|Left Ventricular (LV) Hypertrophy|left ventricular (lv) hypertrophy
895368|NCT00001532|Genetic Polymorphism|genetic polymorphism
895369|NCT00001532|Nitric Oxide Synthesis|nitric oxide synthesis
895370|NCT00001532|Alpha 1-Antitrypsin|alpha 1-antitrypsin
895371|NCT00001532|Candidate Genes|candidate genes
895372|NCT00001532|Lung Pathology|lung pathology
895373|NCT00001532|Lung Disease|lung disease
895374|NCT00001532|Cystic Fibrosis|cystic fibrosis
895375|NCT00001532|Asthma|asthma
895376|NCT00001529|G-CSF|g-csf
895377|NCT00001529|Donor Apheresis|donor apheresis
895378|NCT00001529|Graft vs. Host Disease|graft vs. host disease
895379|NCT00001529|Graft-Versus-Leukemia|graft-versus-leukemia
895380|NCT00001529|Normal Volunteer|normal volunteer
895382|NCT00001526|Interleukin 2 Receptor|interleukin 2 receptor
895383|NCT00001526|Daclizumab|daclizumab
895384|NCT00001526|HAT|hat
895385|NCT00001526|Zenapax|zenapax
895386|NCT00001526|Interleukin 2|interleukin 2
895387|NCT00001524|Thalidomide|thalidomide
895388|NCT00001524|Clinical Trial|clinical trial
895389|NCT00001524|Tumor Necrosis Factor|tumor necrosis factor
895390|NCT00001524|Delayed Healing|delayed healing
895391|NCT00001524|Painful Oral Lesions|painful oral lesions
895392|NCT00001524|HIV/AIDS|hiv/aids
895393|NCT00001524|Mouth Ulcers|mouth ulcers
895394|NCT00001524|Aphthous Ulcers|aphthous ulcers
895395|NCT00001524|Healing|healing
895396|NCT00001524|Cytokines|cytokines
895397|NCT00001522|Insulin Resistance|insulin resistance
895398|NCT00001522|Race|race
895399|NCT00001522|Body Fat|body fat
895400|NCT00001522|Body Composition|body composition
895401|NCT00001522|Obesity|obesity
895402|NCT00001521|Congenital Adrenal Hyperplasia (CAH)|congenital adrenal hyperplasia (cah)
895403|NCT00001521|Intervention|intervention
895404|NCT00001521|Children|children
895405|NCT00001516|Case Study Design|case study design
895406|NCT00001516|Rehabilitation|rehabilitation
895407|NCT00001516|Treatment Efficacy|treatment efficacy
895408|NCT00001516|Occupational Therapy Process|occupational therapy process
895409|NCT00001516|Reflection|reflection
895410|NCT00001516|Occupational Therapy|occupational therapy
895411|NCT00001515|Wegener's Granulomatosis|wegener's granulomatosis
895412|NCT00001515|Computer Assisted Visualization|computer assisted visualization
895413|NCT00001515|Lung Cavities|lung cavities
895414|NCT00001515|Endobronchial Lesions|endobronchial lesions
895415|NCT00001515|Computed Tomography (CT)|computed tomography (ct)
895416|NCT00001515|Bronchogenic Carcinoma|bronchogenic carcinoma
895417|NCT00001512|ProMace Chemotherapy|promace chemotherapy
895418|NCT00001512|Indolent Lymphoma|indolent lymphoma
895419|NCT00001512|Anti-Idiotype Antibody|anti-idiotype antibody
895420|NCT00001512|GM-CSF|gm-csf
895421|NCT00001512|B-Cell Lymphoma|b-cell lymphoma
895422|NCT00001507|T-cells|t-cells
895423|NCT00001507|CD34+ Selection|cd34+ selection
895424|NCT00001507|T-Cell Depletion|t-cell depletion
895425|NCT00001507|Apheresis|apheresis
895426|NCT00001507|Mobilization|mobilization
895427|NCT00001506|Natural History|natural history
895428|NCT00001506|Consultation|consultation
895429|NCT00001506|Standard Therapy|standard therapy
895430|NCT00001506|Standard Tests|standard tests
895431|NCT00001506|Training|training
895432|NCT00001505|Biopsy|biopsy
895433|NCT00001505|Research|research
895434|NCT00001505|Autoimmune|autoimmune
895435|NCT00001505|Blistering|blistering
895436|NCT00001505|Compensation|compensation
895437|NCT00001504|Retinoids|retinoids
895438|NCT00001504|Biomarkers|biomarkers
895439|NCT00001503|Cancer|cancer
895440|NCT00001503|Late Effects|late effects
895441|NCT00001503|Survival|survival
895442|NCT00001503|Follow-Up|follow-up
895443|NCT00001500|Smoking|smoking
895444|NCT00001500|Alcohol|alcohol
895445|NCT00001500|HIV|hiv
895446|NCT00001500|AIDS|aids
895447|NCT00001500|DNA Markers|dna markers
895448|NCT00001500|Personality|personality
895449|NCT00001500|Healthy Volunteers|healthy volunteers
895450|NCT00001500|Normal Volunteer|normal volunteer
895451|NCT00001496|BRCA-1|brca-1
895452|NCT00001496|Familial Breast Cancer|familial breast cancer
895453|NCT00001496|Breast Cell Culture|breast cell culture
895454|NCT00001496|High Risk|high risk
895455|NCT00001491|Ceramidetrihexosidase Deficiency|ceramidetrihexosidase deficiency
895456|NCT00001491|Sural Nerve Biopsy|sural nerve biopsy
895457|NCT00001491|Nerve Conduction Studies|nerve conduction studies
895458|NCT00001491|Quantitative Sensory Testing|quantitative sensory testing
895459|NCT00001491|PGP 9.5 Levels (Skin, Serum and CSF)|pgp 9.5 levels (skin, serum and csf)
895460|NCT00001491|Fabry Disease|fabry disease
895461|NCT00001491|Fabrys|fabrys
895462|NCT00001491|Fabry's|fabry's
895463|NCT00001487|Menopause|menopause
895464|NCT00001487|Andropause|andropause
895465|NCT00001487|Depression|depression
895466|NCT00001487|DHEA|dhea
895467|NCT00001487|Steroids|steroids
895468|NCT00001487|Mid-Life Depression|mid-life depression
895469|NCT00001487|Mid Life|mid life
895470|NCT00001487|Perimenopause|perimenopause
895471|NCT00001487|Climecteric-Related Mood Disorder|climecteric-related mood disorder
895472|NCT00001486|Paranoia|paranoia
895473|NCT00001486|Schizophrenic Research|schizophrenic research
895474|NCT00001486|Hallucinations|hallucinations
895475|NCT00001486|Delusions|delusions
895476|NCT00001486|Brain Scans|brain scans
895477|NCT00001486|Negative Symptoms|negative symptoms
895478|NCT00001486|Symptoms of Schizophrenia|symptoms of schizophrenia
895479|NCT00001486|Causes of Schizophrenia|causes of schizophrenia
895480|NCT00001486|Psychosis and Schizophrenia|psychosis and schizophrenia
895481|NCT00001486|Compensation|compensation
895482|NCT00001483|Manic-Depressive Disorder|manic-depressive disorder
895483|NCT00001483|Antidepressants|antidepressants
895484|NCT00001483|Re-Randomization|re-randomization
895485|NCT00001483|Continuation|continuation
895486|NCT00001483|Ratings|ratings
895487|NCT00001483|Bipolar Illness|bipolar illness
895488|NCT00001483|Depression|depression
895489|NCT00001483|Bupropion|bupropion
895490|NCT00001483|Sertraline|sertraline
895491|NCT00001481|Postpartum Disorders|postpartum disorders
895492|NCT00001481|Mood|mood
895493|NCT00001481|Hormones|hormones
895494|NCT00001481|GnRH Agonist|gnrh agonist
895495|NCT00001481|Postpartum Depression|postpartum depression
895496|NCT00001480|Dementia|dementia
895497|NCT00001480|Alzheimer's Disease|alzheimer's disease
895498|NCT00001480|Cerebrospinal Fluid|cerebrospinal fluid
895499|NCT00001480|Diagnostic Test|diagnostic test
895500|NCT00001480|Cognitive Testing|cognitive testing
895501|NCT00001480|Memory Disorder|memory disorder
895502|NCT00001480|Normal Volunteer|normal volunteer
895503|NCT00001476|CD34+ Progenitor|cd34+ progenitor
895504|NCT00001476|Retrovirus|retrovirus
895505|NCT00001476|Leukapheresis|leukapheresis
895506|NCT00001476|Transduction|transduction
895507|NCT00001476|Granulocytes|granulocytes
895508|NCT00001476|Chronic Granulomatous Disease|chronic granulomatous disease
895509|NCT00001475|AIDS|aids
895510|NCT00001475|Cytokines|cytokines
895511|NCT00001475|Thalidomide|thalidomide
895512|NCT00001475|Monoclonal Antibody|monoclonal antibody
895513|NCT00001475|Immunomodulator|immunomodulator
895514|NCT00001474|Cytokines|cytokines
895515|NCT00001474|Immunoregulation|immunoregulation
895516|NCT00001474|Infusion Duration|infusion duration
895517|NCT00001474|CD4 Cells|cd4 cells
895518|NCT00001473|Vasculitis|vasculitis
895519|NCT00001473|Remission|remission
895520|NCT00001473|Relapse|relapse
895521|NCT00001473|Toxicity|toxicity
895522|NCT00001473|ANCA|anca
895523|NCT00001473|Wegener's Granulomatosis|wegener's granulomatosis
895524|NCT00001471|AIDS|aids
895525|NCT00001471|HIV|hiv
895526|NCT00001471|Retrovirus|retrovirus
895527|NCT00001471|Therapy|therapy
895528|NCT00001471|Response|response
895529|NCT00001469|Genotyping|genotyping
895530|NCT00001469|Linkage Analysis|linkage analysis
895531|NCT00001469|Adenocarcinoma|adenocarcinoma
895532|NCT00001469|Micro Satellite|micro satellite
895533|NCT00001469|Hereditary|hereditary
895534|NCT00001469|Prostate Cancer (hereditary)|prostate cancer (hereditary)
895535|NCT00001467|Primary Immunodeficiency Disorders|primary immunodeficiency disorders
895536|NCT00001467|Mutation|mutation
895537|NCT00001467|Genetic Analysis|genetic analysis
895538|NCT00001467|Immunologic Disorders|immunologic disorders
895539|NCT00001465|Smooth Muscle Proliferation|smooth muscle proliferation
895540|NCT00001465|Bronchoscopy|bronchoscopy
895541|NCT00001465|Female|female
895542|NCT00001465|Pneumothorax|pneumothorax
895543|NCT00001465|Tuberous Sclerosis|tuberous sclerosis
895544|NCT00001464|Oxygen|oxygen
895545|NCT00001464|Bronchoalveolar Lavage|bronchoalveolar lavage
895546|NCT00001464|DNA Repair|dna repair
895547|NCT00001464|Carbonyl Groups|carbonyl groups
895548|NCT00001464|Serum|serum
895549|NCT00001464|Human Volunteers|human volunteers
895550|NCT00001460|Training Protocol|training protocol
895551|NCT00001460|Cardiac Diagnosis|cardiac diagnosis
895552|NCT00001460|Congenital Heart Disease|congenital heart disease
895553|NCT00001460|Acquired Heart Disease|acquired heart disease
895554|NCT00001460|Arrhythmias|arrhythmias
895555|NCT00001458|Cardiovascular Treatment|cardiovascular treatment
895556|NCT00001458|Cardiovascular Disease|cardiovascular disease
895557|NCT00001458|Cardiovascular Testing|cardiovascular testing
895558|NCT00001458|Heart Disease|heart disease
895559|NCT00001458|Muscle Leg Pain|muscle leg pain
895560|NCT00001458|Leg Pain|leg pain
895561|NCT00001458|Circulation|circulation
895562|NCT00001458|Peripheral Arterial Disease|peripheral arterial disease
895563|NCT00001458|Intermittent Claudication|intermittent claudication
895564|NCT00001458|Renal Vascular Disease|renal vascular disease
895565|NCT00001458|Uncontrolled Hypertension|uncontrolled hypertension
895566|NCT00001457|Nucleoside Analogues|nucleoside analogues
895567|NCT00001457|Delta Hepatitis|delta hepatitis
895568|NCT00001457|Glomerulonephritis|glomerulonephritis
895569|NCT00001457|Polyarteritis Nodosa|polyarteritis nodosa
895570|NCT00001457|Hepatitis Mutants|hepatitis mutants
895571|NCT00001457|3TC|3tc
895572|NCT00001457|Chronic Hepatitis B|chronic hepatitis b
895573|NCT00001457|Chronic Hepatitis D|chronic hepatitis d
895574|NCT00001457|Cirrhosis|cirrhosis
895575|NCT00001457|Lamivudine|lamivudine
895576|NCT00001456|Albinism|albinism
895577|NCT00001456|Platelet Storage Pool Deficiency|platelet storage pool deficiency
895578|NCT00001456|Metabolic Disease|metabolic disease
895579|NCT00001456|Hermansky-Pudlak Syndrome|hermansky-pudlak syndrome
895580|NCT00001454|Estrogen|estrogen
895581|NCT00001454|Progesterone|progesterone
895582|NCT00001454|Menses|menses
895583|NCT00001454|Endometrium|endometrium
895584|NCT00001454|Normal Volunteer|normal volunteer
895585|NCT00001453|Petrosal Sinus Sampling|petrosal sinus sampling
895685|NCT00001410|Glucocerebrosidase|glucocerebrosidase
895586|NCT00001453|Corticotropin Releasing Hormone|corticotropin releasing hormone
895587|NCT00001453|Cushing Syndrome|cushing syndrome
895588|NCT00001453|Internal Jugular Vein Sampling|internal jugular vein sampling
895589|NCT00001453|Corticotropin Releasing Hormone Stimulation|corticotropin releasing hormone stimulation
895590|NCT00001452|Cushing Syndrome|cushing syndrome
895591|NCT00001452|Genetics|genetics
895592|NCT00001452|Pituitary Adenoma|pituitary adenoma
895594|NCT00001452|Carney Complex|carney complex
895595|NCT00001451|Bone Marrow Transplantation|bone marrow transplantation
895596|NCT00001451|Bone Marrow Donor|bone marrow donor
895597|NCT00001451|Marrow Transplant|marrow transplant
895598|NCT00001451|National Marrow Donor Program (NMDP)|national marrow donor program (nmdp)
895599|NCT00001451|Unrelated Marrow Donor|unrelated marrow donor
895600|NCT00001451|Healthy Volunteer|healthy volunteer
895601|NCT00001444|Pharmacokinetics|pharmacokinetics
895602|NCT00001444|Natural Products|natural products
895603|NCT00001444|Salvage Therapy|salvage therapy
895604|NCT00001444|Protein Kinase Antagonist|protein kinase antagonist
895605|NCT00001442|Taxol|taxol
895606|NCT00001442|Squamous Cell Carcinoma|squamous cell carcinoma
895607|NCT00001442|Radiosensitizer|radiosensitizer
895608|NCT00001442|Radiotherapy|radiotherapy
895609|NCT00001442|Tumor Potential Doubling Time (Tpot)|tumor potential doubling time (tpot)
895610|NCT00001440|p53|p53
895611|NCT00001440|Interleukin-2|interleukin-2
895612|NCT00001440|T-Cell Repopulation|t-cell repopulation
895613|NCT00001440|Apheresis|apheresis
895614|NCT00001440|RAS|ras
895615|NCT00001432|Purging|purging
895616|NCT00001432|Apheresis|apheresis
895617|NCT00001432|Long Term Culture|long term culture
895618|NCT00001432|T Cells|t cells
895619|NCT00001432|Stem Cell|stem cell
895620|NCT00001430|IL-2|il-2
895621|NCT00001430|Drug Resistance|drug resistance
895622|NCT00001430|Continuous Infusion|continuous infusion
895623|NCT00001430|Peripheral Stem Cells|peripheral stem cells
895625|NCT00001426|Ovarian Cancer|ovarian cancer
895626|NCT00001426|Initial Therapy|initial therapy
895627|NCT00001426|Paclitaxel|paclitaxel
895628|NCT00001426|Cisplatin|cisplatin
895629|NCT00001426|Cyclophosphamide|cyclophosphamide
895630|NCT00001420|Lymphocytes|lymphocytes
895631|NCT00001420|Cytokines|cytokines
895632|NCT00001420|Apoptosis|apoptosis
895633|NCT00001420|Psoriasis|psoriasis
895634|NCT00001420|Genetics|genetics
895635|NCT00001420|Psoriatic Arthritis|psoriatic arthritis
895636|NCT00001418|Sympathetic Nervous System|sympathetic nervous system
895637|NCT00001418|Dysautonomias|dysautonomias
895638|NCT00001418|Postural Tachycardia Syndrome|postural tachycardia syndrome
895639|NCT00001418|Neurocardiogenic Syncope|neurocardiogenic syncope
895640|NCT00001418|Hypernoradrenergic Hypertension|hypernoradrenergic hypertension
895641|NCT00001418|Sympathectomy|sympathectomy
895642|NCT00001418|Fluorodopamine|fluorodopamine
895643|NCT00001418|Positron Emission Tomography|positron emission tomography
895644|NCT00001418|Norepinephrine|norepinephrine
895645|NCT00001418|Dopamine|dopamine
895646|NCT00001418|Neurocardiologic Disorder|neurocardiologic disorder
895647|NCT00001417|Needle Biopsy|needle biopsy
895648|NCT00001417|Computed Tomography|computed tomography
895649|NCT00001417|Magnetic Resonance Imaging|magnetic resonance imaging
895650|NCT00001417|Spinal Angiography|spinal angiography
895651|NCT00001417|Intratumoral Pressure|intratumoral pressure
895652|NCT00001417|Vertebral Hemangioma|vertebral hemangioma
895653|NCT00001417|Spinal Metastasis|spinal metastasis
895654|NCT00001417|Absolute Ethanol|absolute ethanol
895655|NCT00001417|Spinal Tumor|spinal tumor
895656|NCT00001417|Vertebral Tumor|vertebral tumor
895657|NCT00001414|Behavior Genetics|behavior genetics
895658|NCT00001414|Normal Personality|normal personality
895659|NCT00001414|Intelligence|intelligence
895660|NCT00001414|Siblings|siblings
895661|NCT00001414|Sixteen Personality Factor Questionnaire|sixteen personality factor questionnaire
895662|NCT00001414|NEO-Personality Inventory (Revised)|neo-personality inventory (revised)
895663|NCT00001414|X-Chromosome|x-chromosome
895664|NCT00001413|Corticosteroids|corticosteroids
895665|NCT00001413|Osteoporosis|osteoporosis
895666|NCT00001413|Depression|depression
895667|NCT00001413|DEXA Scan|dexa scan
895668|NCT00001413|Body Mass|body mass
895669|NCT00001413|Dual X-Ray|dual x-ray
895670|NCT00001413|Energy Absorptiometry|energy absorptiometry
895671|NCT00001413|Normal Volunteer|normal volunteer
895672|NCT00001412|Gonadal Steroids|gonadal steroids
895673|NCT00001412|Central Nervous System Function|central nervous system function
895674|NCT00001412|GnRH Agonist|gnrh agonist
895675|NCT00001412|Testosterone|testosterone
895676|NCT00001412|Leuprolide Acetate|leuprolide acetate
895677|NCT00001412|Mood|mood
895678|NCT00001412|Behavior|behavior
895679|NCT00001412|Cognitive Function|cognitive function
895680|NCT00001410|Recombinant Production|recombinant production
895681|NCT00001410|Inherited Disease|inherited disease
895682|NCT00001410|Lysosomal Disorder|lysosomal disorder
895683|NCT00001410|Inborn Error of Metabolism|inborn error of metabolism
895684|NCT00001410|Enzyme Replacement Therapy|enzyme replacement therapy
895686|NCT00001410|Polyethylene Glycol|polyethylene glycol
895687|NCT00001410|Gaucher Disease|gaucher disease
895688|NCT00001410|Recombinant Enzyme|recombinant enzyme
895689|NCT00001409|AIDS|aids
895690|NCT00001409|Gene Therapy|gene therapy
895691|NCT00001409|T Cell Universal Receptor|t cell universal receptor
895692|NCT00001409|Ex Vivo Activation|ex vivo activation
895693|NCT00001408|Lymphocytes|lymphocytes
895694|NCT00001408|Asthma|asthma
895695|NCT00001408|Cytokines|cytokines
895696|NCT00001408|Interleukin-5|interleukin-5
895697|NCT00001408|Late Phase Response|late phase response
895698|NCT00001407|Cytokines|cytokines
895699|NCT00001407|Mycobacteria|mycobacteria
895700|NCT00001407|Pneumonia|pneumonia
895701|NCT00001407|Multiple Drug Resistant Tuberculosis|multiple drug resistant tuberculosis
895702|NCT00001406|Eosinophils|eosinophils
895703|NCT00001406|Helminth Parasites|helminth parasites
895704|NCT00001406|Hypereosinophilia|hypereosinophilia
895705|NCT00001406|Allergy|allergy
895706|NCT00001406|Asthma|asthma
895707|NCT00001405|Chronic Granulomatous Disease|chronic granulomatous disease
895708|NCT00001405|CD34 Cells|cd34 cells
895709|NCT00001405|Infection|infection
895710|NCT00001405|Nadph Oxidase|nadph oxidase
895711|NCT00001405|Healthy Volunteer|healthy volunteer
895712|NCT00001405|Normal Volunteer|normal volunteer
895713|NCT00001404|Abnormalities, Multiple|abnormalities, multiple
895714|NCT00001404|Hypothalamic Hamartoma|hypothalamic hamartoma
895715|NCT00001404|Polysyndactyly|polysyndactyly
895716|NCT00001404|Autosomal Dominant|autosomal dominant
895717|NCT00001404|Mutation|mutation
895718|NCT00001404|Gelastic|gelastic
895719|NCT00001404|Gelastic Seizure|gelastic seizure
895720|NCT00001404|Hypothalamic|hypothalamic
895721|NCT00001404|Malformations|malformations
895722|NCT00001404|Polydactyly|polydactyly
895723|NCT00001404|Pallister-Hall Syndrome|pallister-hall syndrome
895724|NCT00001403|Sporadic|sporadic
895725|NCT00001403|Mosaic|mosaic
895726|NCT00001403|Growth Disorder|growth disorder
895727|NCT00001403|Progressive|progressive
895728|NCT00001403|Multiple Abnormalities|multiple abnormalities
895729|NCT00001400|Heart Disease|heart disease
895730|NCT00001400|Screening|screening
895731|NCT00001400|Follow-Up|follow-up
895732|NCT00001399|Gene Therapy|gene therapy
895733|NCT00001399|Stem Cell Rescue|stem cell rescue
895734|NCT00001399|Bone Marrow Failure|bone marrow failure
895735|NCT00001399|Fanconi Anemia|fanconi anemia
895736|NCT00001398|Hematopoiesis|hematopoiesis
895737|NCT00001398|Stem Cell Cycling|stem cell cycling
895738|NCT00001398|Bone Marrow Failure|bone marrow failure
895739|NCT00001398|Acquired Aplastic Anemia|acquired aplastic anemia
895740|NCT00001397|Hematopoiesis|hematopoiesis
895741|NCT00001397|Thrombocytopenia|thrombocytopenia
895742|NCT00001397|Anemia|anemia
895743|NCT00001397|Neutropenia|neutropenia
895744|NCT00001397|Dysplasia|dysplasia
895745|NCT00001397|Hematologic Malignancies|hematologic malignancies
895746|NCT00001396|Pacemaker|pacemaker
895747|NCT00001396|Pediatric|pediatric
895748|NCT00001396|Obstructive HCM|obstructive hcm
895749|NCT00001394|Hyperparathyroidism|hyperparathyroidism
895750|NCT00001394|Arterial Stimulation|arterial stimulation
895751|NCT00001394|Venous Sampling|venous sampling
895752|NCT00001394|Parathyroid Adenoma|parathyroid adenoma
895753|NCT00001394|Parathyroid Hyperplasia|parathyroid hyperplasia
895754|NCT00001393|Collapsing Glomerulopathy|collapsing glomerulopathy
895755|NCT00001393|Renal Diseases|renal diseases
895756|NCT00001393|HIV Associated Nephropathy|hiv associated nephropathy
895757|NCT00001392|Rituximab|rituximab
895758|NCT00001392|Renal Biopsy|renal biopsy
895759|NCT00001392|Viral Infection|viral infection
895760|NCT00001392|Biomarkers|biomarkers
895761|NCT00001391|Augmentation|augmentation
895762|NCT00001391|Osteogenesis|osteogenesis
895763|NCT00001391|Stem Cells|stem cells
895764|NCT00001391|Bone Formation|bone formation
895765|NCT00001391|Bone Induction|bone induction
895766|NCT00001390|Saliva|saliva
895767|NCT00001390|Parotid|parotid
895768|NCT00001390|Lip Biopsy|lip biopsy
895769|NCT00001390|Health|health
895770|NCT00001390|Exocrine|exocrine
895771|NCT00001390|Normal Volunteer|normal volunteer
895772|NCT00001386|AIDS|aids
895773|NCT00001386|Retrovirus|retrovirus
895774|NCT00001386|Therapeutic Vaccine|therapeutic vaccine
895775|NCT00001386|Vaccine|vaccine
895776|NCT00001386|Helper T Cells|helper t cells
895777|NCT00001379|Epstein-Barr Virus|epstein-barr virus
895778|NCT00001379|Lymphoproliferative Disorder|lymphoproliferative disorder
895779|NCT00001379|Viral|viral
895780|NCT00001379|Immunosuppression|immunosuppression
895781|NCT00001379|Lymphoma|lymphoma
895782|NCT00001373|Auto-Inflammation|auto-inflammation
895783|NCT00001373|Familial Mediterranean Fever|familial mediterranean fever
895784|NCT00001373|Genetics|genetics
895785|NCT00001373|Periodic Fever|periodic fever
895786|NCT00001372|Systemic Lupus Erythematosus|systemic lupus erythematosus
895787|NCT00001372|Natural History|natural history
895788|NCT00001372|Lupus Nephritis|lupus nephritis
895789|NCT00001372|Lupus|lupus
895790|NCT00001372|Systemic Lupus|systemic lupus
895792|NCT00001368|Cerebral Ischemia|cerebral ischemia
895793|NCT00001368|Hypertension|hypertension
895794|NCT00001368|Immune Response|immune response
895795|NCT00001368|Carotid Stenosis|carotid stenosis
895796|NCT00001368|Atherosclerosis|atherosclerosis
895797|NCT00001367|Healthy Volunteer|healthy volunteer
895798|NCT00001367|Nervous System Disease|nervous system disease
895799|NCT00001367|Neurological Disorders|neurological disorders
895800|NCT00001367|Movement Disorders|movement disorders
895801|NCT00001366|Neuroimaging|neuroimaging
895802|NCT00001366|Seizures|seizures
895803|NCT00001366|Cerebral Localization|cerebral localization
895804|NCT00001366|Partial Epilepsy|partial epilepsy
895805|NCT00001366|Epilepsy|epilepsy
895806|NCT00001364|Spinal Arteriovenous Malformations|spinal arteriovenous malformations
895807|NCT00001364|Spinal Dural Arteriovenous Fistulas|spinal dural arteriovenous fistulas
895808|NCT00001364|Surgery|surgery
895809|NCT00001364|Embolization|embolization
895810|NCT00001364|Spinal Arteriography|spinal arteriography
895811|NCT00001362|Magnetic Resonance Imaging|magnetic resonance imaging
895812|NCT00001362|Contrast Enhancement|contrast enhancement
895813|NCT00001362|Neuroanatomic Morphometry|neuroanatomic morphometry
895814|NCT00001362|Neurobehavioral Deficits|neurobehavioral deficits
895815|NCT00001362|Neurological Disorders|neurological disorders
895816|NCT00001362|Blood Flow|blood flow
895817|NCT00001362|Blood Volume|blood volume
895818|NCT00001362|Normal Volunteer|normal volunteer
895819|NCT00001361|Movement Disorders|movement disorders
895820|NCT00001361|Sensory Processing|sensory processing
895821|NCT00001361|Stroke|stroke
895822|NCT00001361|Spinal Cord Injury|spinal cord injury
895823|NCT00001361|Blood Flow|blood flow
895824|NCT00001361|Blood Volume|blood volume
895825|NCT00001361|Cognitive Function|cognitive function
895826|NCT00001361|Neurobehavioral Deficits|neurobehavioral deficits
895827|NCT00001361|Neurological Disorders|neurological disorders
895828|NCT00001361|Magnetic Resonance Imaging|magnetic resonance imaging
895829|NCT00001361|Plasticity|plasticity
895830|NCT00001361|Normal Volunteer|normal volunteer
895831|NCT00001360|Cognition|cognition
895832|NCT00001360|Vision|vision
895833|NCT00001360|Cortex|cortex
895834|NCT00001360|Visual Processing|visual processing
895835|NCT00001360|Magnetic Resonance Imaging|magnetic resonance imaging
895836|NCT00001359|Obsessive Compulsive Disorder|obsessive compulsive disorder
895837|NCT00001359|PANDAS Associated with Streptococcal Infections|pandas associated with streptococcal infections
895838|NCT00001359|Adolescents|adolescents
895839|NCT00001359|Autoimmune Illness|autoimmune illness
895840|NCT00001359|Children|children
895841|NCT00001359|Tic Disorders|tic disorders
895842|NCT00001359|Streptococcal Infections|streptococcal infections
895843|NCT00001359|Childhood Onset Neuropsychiatric Disorder|childhood onset neuropsychiatric disorder
895844|NCT00001357|Cytokines|cytokines
895845|NCT00001357|Immunoregulation|immunoregulation
895846|NCT00001357|CD4 Cells|cd4 cells
895847|NCT00001356|IL-3|il-3
895848|NCT00001356|Stem Cell Factor|stem cell factor
895849|NCT00001356|Cytokines|cytokines
895850|NCT00001356|Cell Differentiation|cell differentiation
895851|NCT00001356|Receptors|receptors
895852|NCT00001356|Bone Marrow|bone marrow
895853|NCT00001356|Mastocytosis|mastocytosis
895854|NCT00001355|Immune Deficiency|immune deficiency
895855|NCT00001355|Infection|infection
895856|NCT00001355|Phagocytes|phagocytes
895857|NCT00001355|Cytokines|cytokines
895858|NCT00001355|Genetics|genetics
895859|NCT00001354|AIDS|aids
895860|NCT00001354|Immunotherapy|immunotherapy
895861|NCT00001354|CD4 Cells|cd4 cells
895862|NCT00001354|Immunomodulator|immunomodulator
895863|NCT00001354|Cytokines|cytokines
895864|NCT00001353|AIDS|aids
895865|NCT00001353|Immune Based Therapy|immune based therapy
895866|NCT00001353|Adoptive Immunotherapy|adoptive immunotherapy
895867|NCT00001353|Lymphapheresis|lymphapheresis
895868|NCT00001353|Ex Vivo Activation|ex vivo activation
895869|NCT00001353|HIV|hiv
895870|NCT00001353|Gene Therapy|gene therapy
895871|NCT00001353|Protease Inhibitor|protease inhibitor
895872|NCT00001353|Interleukin-2|interleukin-2
895873|NCT00001353|Indinavir|indinavir
895874|NCT00001352|Cryptococcus|cryptococcus
895875|NCT00001351|Human|human
895876|NCT00001351|Disease|disease
895877|NCT00001351|Infection|infection
895878|NCT00001351|Immunology|immunology
895879|NCT00001350|Immunoregulation|immunoregulation
895880|NCT00001350|T Cell Receptor Alpha/Beta|t cell receptor alpha/beta
895881|NCT00001350|Lymphadenopathy|lymphadenopathy
895882|NCT00001350|ALPS|alps
895883|NCT00001350|Autoimmune Lymphoproliferative Syndrome|autoimmune lymphoproliferative syndrome
895884|NCT00001349|Plasmapheresis|plasmapheresis
895885|NCT00001349|Lymphocytes|lymphocytes
895886|NCT00001349|Eosinophils|eosinophils
895887|NCT00001349|Neutrophils|neutrophils
895888|NCT00001347|Linkage Analysis|linkage analysis
895889|NCT00001347|Genomic DNA|genomic dna
895890|NCT00001347|Pedigree Analysis|pedigree analysis
895891|NCT00001347|Usher Syndrome|usher syndrome
895892|NCT00001347|Usher Syndrome Type 1|usher syndrome type 1
895993|NCT00001320|Equilibrium|equilibrium
895893|NCT00001347|Usher Syndrome Type 2|usher syndrome type 2
895894|NCT00001345|Hypercalcemia|hypercalcemia
895895|NCT00001345|Multiple Endocrine Neoplasia (MEN)|multiple endocrine neoplasia (men)
895896|NCT00001345|Familial Hypocalciuric Hypercalcemia|familial hypocalciuric hypercalcemia
895897|NCT00001345|Hyperparathyroidism|hyperparathyroidism
895898|NCT00001345|Linkage Analysis|linkage analysis
895899|NCT00001343|Turner's Syndrome|turner's syndrome
895900|NCT00001343|Short Stature|short stature
895901|NCT00001343|Cognitive Function|cognitive function
895902|NCT00001343|Sex Steroids|sex steroids
895903|NCT00001343|Turner Syndrome|turner syndrome
895904|NCT00001343|TS|ts
895905|NCT00001339|Multidrug Resistance|multidrug resistance
895906|NCT00001339|Reversal of Drug Resistance|reversal of drug resistance
895907|NCT00001339|P-Glycoprotein|p-glycoprotein
895908|NCT00001339|MDR-1|mdr-1
895909|NCT00001337|Primary Mediastinal B-Cell Lymphoma|primary mediastinal b-cell lymphoma
895910|NCT00001337|CD20 +|cd20 +
895911|NCT00001337|Diffuse Large B-Cell Lymphoma|diffuse large b-cell lymphoma
895912|NCT00001337|Anaplastic Large Cell Lymphoma|anaplastic large cell lymphoma
895913|NCT00001337|De Novo|de novo
895914|NCT00001336|Transplantation|transplantation
895915|NCT00001336|Cancer|cancer
895916|NCT00001336|Cellular Immunity|cellular immunity
895917|NCT00001336|Stem Cell Function|stem cell function
895918|NCT00001336|Immunodeficiency|immunodeficiency
895919|NCT00001335|Peripheral Stem Cell Transfusion|peripheral stem cell transfusion
895920|NCT00001335|Up-Front Phase II Window|up-front phase ii window
895921|NCT00001335|Dose-Intensive Vincristine|dose-intensive vincristine
895922|NCT00001335|Dose-Intensive Doxorubicin|dose-intensive doxorubicin
895923|NCT00001335|Dose-Intensive Cyclophosphamide|dose-intensive cyclophosphamide
895924|NCT00001335|ADR-529 for Cardioprotection|adr-529 for cardioprotection
895925|NCT00001335|BID Radiation Therapy for Local Control|bid radiation therapy for local control
895926|NCT00001331|Myopathy|myopathy
895927|NCT00001331|Phosphofructokinase|phosphofructokinase
895928|NCT00001331|Acid Maltase|acid maltase
895929|NCT00001331|Pompe|pompe
895930|NCT00001331|Muscle Diseases|muscle diseases
895931|NCT00001331|Genetic Muscle Diseases|genetic muscle diseases
895932|NCT00001329|Yohimbine|yohimbine
895933|NCT00001329|Catecholamines|catecholamines
895934|NCT00001329|Sympathoadrenal Response|sympathoadrenal response
895935|NCT00001329|Sympathetic Nervous System|sympathetic nervous system
895936|NCT00001329|Stress|stress
895937|NCT00001329|Hypertension|hypertension
895938|NCT00001329|Autonomic Failure|autonomic failure
895939|NCT00001328|Cancer|cancer
895940|NCT00001328|Gene Transfer|gene transfer
895941|NCT00001328|Recurrent Tumors|recurrent tumors
895942|NCT00001328|Primary Tumors|primary tumors
895943|NCT00001328|Metastases|metastases
895944|NCT00001328|Anti-Viral Drugs|anti-viral drugs
895945|NCT00001328|Chemosensitization|chemosensitization
895946|NCT00001328|Brain Tumors|brain tumors
895947|NCT00001328|Gene Therapy|gene therapy
895948|NCT00001328|Ganciclovir|ganciclovir
895949|NCT00001327|Syringomyelia|syringomyelia
895950|NCT00001327|Chiari Malformation|chiari malformation
895951|NCT00001327|Magnetic Resonance Imaging|magnetic resonance imaging
895952|NCT00001327|Intraoperative Ultrasonography|intraoperative ultrasonography
895953|NCT00001327|Hydrocephalus|hydrocephalus
895954|NCT00001327|Spinal Cord|spinal cord
895955|NCT00001327|Ventriculostomy|ventriculostomy
895956|NCT00001327|Lumbar Puncture|lumbar puncture
895957|NCT00001327|Pressure Measurement|pressure measurement
895958|NCT00001325|Positron|positron
895959|NCT00001325|Tomography|tomography
895960|NCT00001325|Seizures|seizures
895961|NCT00001325|Epileptic Focus|epileptic focus
895962|NCT00001325|Electroencephalography|electroencephalography
895963|NCT00001325|Metabolism|metabolism
895964|NCT00001325|Glucose|glucose
895965|NCT00001325|Cerebral|cerebral
895966|NCT00001325|Positron Emission Tomography|positron emission tomography
895967|NCT00001325|Lennox Gastaut Syndrome|lennox gastaut syndrome
895968|NCT00001323|Cognition|cognition
895969|NCT00001323|Neuropsychology|neuropsychology
895970|NCT00001323|Neuropsychological Tests|neuropsychological tests
895971|NCT00001323|Neurological Exam|neurological exam
895972|NCT00001323|Psychiatric|psychiatric
895973|NCT00001323|Attention|attention
895974|NCT00001323|Schizophrenic|schizophrenic
895975|NCT00001323|Schizoaffective|schizoaffective
895976|NCT00001323|Working Memory|working memory
895977|NCT00001323|Memory|memory
895978|NCT00001322|Gonadal Steroids|gonadal steroids
895979|NCT00001322|Mood|mood
895980|NCT00001322|Menstrual Cycle|menstrual cycle
895981|NCT00001322|Neuropsychological Testing|neuropsychological testing
895982|NCT00001322|Estrogen|estrogen
895983|NCT00001322|Dexamethasone|dexamethasone
895984|NCT00001322|Progesterone|progesterone
895985|NCT00001322|Central Nervous System Function|central nervous system function
895987|NCT00001322|GnRH Agonist|gnrh agonist
895988|NCT00001320|Parkinson's Disease|parkinson's disease
895989|NCT00001320|Schizophrenia|schizophrenia
895990|NCT00001320|Dopamine D2/D3 receptors|dopamine d2/d3 receptors
895991|NCT00001320|Brain Imaging|brain imaging
895994|NCT00001320|Brain Scan|brain scan
895995|NCT00001320|Brain Research|brain research
895996|NCT00001320|Brain Disorders|brain disorders
895997|NCT00001320|Schizoaffective Disorder|schizoaffective disorder
895998|NCT00001320|Normal Volunteer|normal volunteer
895999|NCT00001319|HIV Negative|hiv negative
896000|NCT00001319|CD4 Deficiency|cd4 deficiency
896001|NCT00001319|Retrovirus|retrovirus
896002|NCT00001316|Lymph Node|lymph node
896003|NCT00001316|Polymerase Chain Reaction (PCR)|polymerase chain reaction (pcr)
896004|NCT00001316|In Situ Hybridization|in situ hybridization
896005|NCT00001316|AIDS|aids
896006|NCT00001316|Excisional Biopsy|excisional biopsy
896007|NCT00001313|Cardiac Diagnosis|cardiac diagnosis
896008|NCT00001313|Chest Pain|chest pain
896009|NCT00001313|Hypertrophic Cardiomyopathy|hypertrophic cardiomyopathy
896010|NCT00001313|Coronary Artery Disease|coronary artery disease
896011|NCT00001313|Microvascular Angina|microvascular angina
896012|NCT00001313|Cardiac Investigation|cardiac investigation
896013|NCT00001313|Follow-up|follow-up
896014|NCT00001313|Heart Disease|heart disease
896015|NCT00001310|Retinal Disease|retinal disease
896016|NCT00001310|Diabetic Retinopathy|diabetic retinopathy
896017|NCT00001310|Uveitis|uveitis
896018|NCT00001310|Age-Related Macular Degeneration|age-related macular degeneration
896019|NCT00001310|Corneal Disease|corneal disease
896020|NCT00001310|Ocular Disease|ocular disease
896021|NCT00001309|Pharmacokinetics|pharmacokinetics
896022|NCT00001309|Biodistribution|biodistribution
896023|NCT00001309|Ascorbic Acid|ascorbic acid
896024|NCT00001308|Stuttering|stuttering
896025|NCT00001308|Tourette's Syndrome|tourette's syndrome
896026|NCT00001308|Spasmodic Dysphonia|spasmodic dysphonia
896027|NCT00001308|Dysarthria|dysarthria
896028|NCT00001308|Parkinson's Disease|parkinson's disease
896029|NCT00001308|Verbal Dyspraxia|verbal dyspraxia
896030|NCT00001308|Aphasia|aphasia
896031|NCT00001308|Speech|speech
896032|NCT00001308|Motor Control|motor control
896033|NCT00001307|Analgesia|analgesia
896034|NCT00001307|PET|pet
896035|NCT00001307|Positron Emission|positron emission
896036|NCT00001307|Functional Brain Imaging|functional brain imaging
896037|NCT00001307|Allodynia|allodynia
896038|NCT00001307|Thalamus|thalamus
896039|NCT00001307|Somatosensory Cortex|somatosensory cortex
896040|NCT00001307|Reflex Sympathetic Dystrophy|reflex sympathetic dystrophy
896041|NCT00001307|Normal Volunteer|normal volunteer
896042|NCT00001307|Chronic Pain|chronic pain
896043|NCT00001306|Infertility|infertility
896044|NCT00001306|Ovulation|ovulation
896045|NCT00001306|Autoimmune|autoimmune
896046|NCT00001306|Follicle|follicle
896047|NCT00001306|Menopause|menopause
896048|NCT00001306|Biopsy|biopsy
896049|NCT00001306|Glucocorticoids|glucocorticoids
896050|NCT00001306|Premature Ovarian Failure|premature ovarian failure
896051|NCT00001306|Amenorrhea|amenorrhea
896052|NCT00001306|Ovarian Failure|ovarian failure
896053|NCT00001306|POF|pof
896054|NCT00001305|Osteogenesis Imperfecta|osteogenesis imperfecta
896055|NCT00001304|Hypoparathyroidism|hypoparathyroidism
896056|NCT00001304|Parathyroid Hormone|parathyroid hormone
896057|NCT00001304|Vitamin D|vitamin d
896058|NCT00001304|Calcium Metabolism|calcium metabolism
896059|NCT00001304|PTH 1-34|pth 1-34
896060|NCT00001304|Bone|bone
896061|NCT00001303|Hemodynamics|hemodynamics
896062|NCT00001303|Lung Permeability|lung permeability
896063|NCT00001303|Endotoxin Tolerance|endotoxin tolerance
896064|NCT00001303|Bronchoscopy|bronchoscopy
896065|NCT00001303|Human Recombinant Interleukin-1 Receptor|human recombinant interleukin-1 receptor
896066|NCT00001303|Normal Volunteer|normal volunteer
896067|NCT00001302|Vinblastine|vinblastine
896068|NCT00001302|Multidrug Resistance|multidrug resistance
896069|NCT00001302|Resistance Reversal|resistance reversal
896070|NCT00001302|Pgp Blocker|pgp blocker
896071|NCT00001302|Pharmacokinetics|pharmacokinetics
896072|NCT00001302|Cyclosporine|cyclosporine
896073|NCT00001302|Drug Interactions|drug interactions
896074|NCT00001295|Follow-Up|follow-up
896075|NCT00001295|Treatment|treatment
896076|NCT00001294|Genetic Linkage|genetic linkage
896077|NCT00001294|Sex Behavior|sex behavior
896078|NCT00001294|AIDS|aids
896079|NCT00001294|Alcohol Dependence|alcohol dependence
896080|NCT00001294|HLA System|hla system
896081|NCT00001294|Cancer|cancer
896082|NCT00001289|Enzyme Replacement|enzyme replacement
896083|NCT00001289|Type 3 Gaucher's Disease|type 3 gaucher's disease
896084|NCT00001289|Lysosomal Storage|lysosomal storage
896085|NCT00001289|Supranuclear Gaze Palsy|supranuclear gaze palsy
896086|NCT00001289|Seizures|seizures
896087|NCT00001289|Mental Retardation|mental retardation
896088|NCT00001289|Gaucher Disease|gaucher disease
896089|NCT00001288|Positron Emission Tomography|positron emission tomography
896090|NCT00001288|Epilepsy|epilepsy
896091|NCT00001288|Stroke|stroke
896093|NCT00001284|Schizophrenia|schizophrenia
896094|NCT00001284|Magnetic Resonance Imaging|magnetic resonance imaging
896095|NCT00001284|Magnetic Resonance Spectroscopy|magnetic resonance spectroscopy
896096|NCT00001284|Dopaminergic Mechanisms|dopaminergic mechanisms
896098|NCT00001282|Immunomodulator|immunomodulator
896099|NCT00001282|Anti-Viral|anti-viral
896100|NCT00001281|Lymphocytes|lymphocytes
896101|NCT00001281|Venipuncture|venipuncture
896102|NCT00001281|Mononuclear Cells|mononuclear cells
896103|NCT00001277|Hypoglycemia|hypoglycemia
896104|NCT00001277|Genetics|genetics
896105|NCT00001277|Hyperparathyroidism|hyperparathyroidism
896106|NCT00001276|Hypoglycemia|hypoglycemia
896107|NCT00001276|Insulinoma|insulinoma
896108|NCT00001275|Menopause|menopause
896109|NCT00001275|Estrogen|estrogen
896110|NCT00001275|Infertility|infertility
896111|NCT00001275|Ovulation|ovulation
896112|NCT00001275|Amenorrhea|amenorrhea
896113|NCT00001275|Hypergonadotropic Hypogonadism|hypergonadotropic hypogonadism
896114|NCT00001275|Young Women|young women
896115|NCT00001275|Gonadal Steroid Deficiency|gonadal steroid deficiency
896116|NCT00001275|Mineralocorticoid Deficiency|mineralocorticoid deficiency
896117|NCT00001275|Premature Ovarian Failure|premature ovarian failure
896118|NCT00001275|POF|pof
896119|NCT00001266|Bayesian|bayesian
896120|NCT00001266|Hydroxy-Flutamide|hydroxy-flutamide
896121|NCT00001266|Combined Androgen Ablation|combined androgen ablation
896122|NCT00001266|Prostate Specific Antigen|prostate specific antigen
896123|NCT00001265|Autoimmune Diseases|autoimmune diseases
896124|NCT00001265|Idiopathic Inflammatory Myopathies|idiopathic inflammatory myopathies
896125|NCT00001265|Dermatomyositis|dermatomyositis
896126|NCT00001265|Inclusion Body Myositis|inclusion body myositis
896127|NCT00001265|Pathogenesis|pathogenesis
896128|NCT00001265|Connective Tissue Diseases|connective tissue diseases
896129|NCT00001262|Menkes|menkes
896130|NCT00001262|Copper|copper
896131|NCT00001262|X-Linked|x-linked
896132|NCT00001262|Neurodegeneration|neurodegeneration
896133|NCT00001262|ATP7A|atp7a
896134|NCT00001261|Polymyositis/Dermatomyositis|polymyositis/dermatomyositis
896135|NCT00001261|Muscle Immunopathology|muscle immunopathology
896136|NCT00001261|Intravenous High-Dose Immunoglobulin|intravenous high-dose immunoglobulin
896137|NCT00001261|Inclusion Body Myositis|inclusion body myositis
896138|NCT00001260|Schizophrenia|schizophrenia
896139|NCT00001260|Neuropathology|neuropathology
896140|NCT00001260|Neurochemistry|neurochemistry
896141|NCT00001260|Substance Abuse|substance abuse
896142|NCT00001260|Bipolar Disorder|bipolar disorder
896143|NCT00001260|Aging|aging
896144|NCT00001260|Normal Development|normal development
896145|NCT00001260|Depression|depression
896146|NCT00001260|Anxiety Disorders|anxiety disorders
896147|NCT00001260|Suicide|suicide
896148|NCT00001260|Dementia|dementia
896149|NCT00001260|Neuropsychiatric Disorders|neuropsychiatric disorders
896150|NCT00001260|Tourette's Syndrome|tourette's syndrome
896151|NCT00001260|Normal Controls|normal controls
896152|NCT00001259|Depression|depression
896153|NCT00001259|Menstrual Cycle|menstrual cycle
896154|NCT00001259|Gonadal Steroids|gonadal steroids
896155|NCT00001259|GnRH Agonist|gnrh agonist
896156|NCT00001259|Mood Disorders|mood disorders
896157|NCT00001258|Neuropsychology|neuropsychology
896158|NCT00001258|Cerebral Blood Flow|cerebral blood flow
896159|NCT00001258|Cognitive Disorders|cognitive disorders
896160|NCT00001258|Prefrontal Cortex|prefrontal cortex
896161|NCT00001258|Hormones|hormones
896162|NCT00001258|Psychosis|psychosis
896163|NCT00001258|Neuroimaging|neuroimaging
896164|NCT00001258|Brain Scan|brain scan
896165|NCT00001258|Healthy Volunteers|healthy volunteers
896166|NCT00001258|Schizophrenia|schizophrenia
896167|NCT00001257|Lymphokines|lymphokines
896168|NCT00001257|LTB4|ltb4
896169|NCT00001257|Inflammation|inflammation
896170|NCT00001257|Normal Volunteer|normal volunteer
896171|NCT00001257|Abnormal Phagocyte Function|abnormal phagocyte function
896172|NCT00001256|Vasculitis|vasculitis
896173|NCT00001256|Cytotoxic Therapy|cytotoxic therapy
896174|NCT00001256|Inflammation|inflammation
896175|NCT00001256|Glomerulonephritis|glomerulonephritis
896176|NCT00001256|Inflammatory Sinusitis|inflammatory sinusitis
896177|NCT00001255|Retroviral Vector|retroviral vector
896178|NCT00001255|Gene Therapy|gene therapy
896179|NCT00001255|PEG-ADA|peg-ada
896180|NCT00001255|Severe Combined Immunodeficiency (SCID)|severe combined immunodeficiency (scid)
896181|NCT00001255|Adenosine Deaminase Deficiency (ADA)|adenosine deaminase deficiency (ada)
896182|NCT00001254|Islet Cell Tumors|islet cell tumors
896183|NCT00001253|Turner's Syndrome|turner's syndrome
896184|NCT00001253|Estrogen|estrogen
896185|NCT00001253|Ethinyl estradiol|ethinyl estradiol
896186|NCT00001253|Learning|learning
896187|NCT00001253|Ovarian dysgenesis|ovarian dysgenesis
896188|NCT00001252|Biomechanics|biomechanics
896189|NCT00001252|Kinesiology|kinesiology
896190|NCT00001252|Walking|walking
896191|NCT00001251|Meningeal Malignancy|meningeal malignancy
896192|NCT00001251|Pediatric|pediatric
896193|NCT00001251|Alkylating Agents|alkylating agents
896194|NCT00001250|Neoadjuvant Chemotherapy|neoadjuvant chemotherapy
896195|NCT00001250|Dose Intense Chemotherapy|dose intense chemotherapy
896196|NCT00001250|Stage II Breast Cancer|stage ii breast cancer
896197|NCT00001250|Early Stage Breast Cancer|early stage breast cancer
896198|NCT00001248|Multiple Sclerosis|multiple sclerosis
896199|NCT00001248|MRI (Magnetic Resonance Imaging)|mri (magnetic resonance imaging)
896200|NCT00001247|Schizophrenia|schizophrenia
896201|NCT00001247|Psychosis|psychosis
896202|NCT00001247|Schizoaffective|schizoaffective
896203|NCT00001247|Neuroimaging|neuroimaging
896204|NCT00001247|Cognition|cognition
896205|NCT00001247|Schizoaffective Disorder|schizoaffective disorder
896206|NCT00001246|Cognitive|cognitive
896207|NCT00001246|Genetics|genetics
896208|NCT00001246|Development|development
896209|NCT00001246|Klinefelter Syndrome|klinefelter syndrome
896210|NCT00001246|Jacob Syndrome|jacob syndrome
896211|NCT00001246|Trisomy X|trisomy x
896212|NCT00001246|Healthy Volunteer|healthy volunteer
896213|NCT00001246|XXY|xxy
896214|NCT00001246|XXXY|xxxy
896215|NCT00001246|XXXXY|xxxxy
896216|NCT00001246|XYY|xyy
896217|NCT00001246|XXYY|xxyy
896218|NCT00001246|XO|xo
896219|NCT00001246|XXXX|xxxx
896220|NCT00001246|XXX|xxx
896221|NCT00001246|XXXXX|xxxxx
896222|NCT00001246|Triple X|triple x
896223|NCT00001246|Congenital Adrenal Hyperplasia|congenital adrenal hyperplasia
896224|NCT00001246|Twin|twin
896225|NCT00001245|Strongyloidiasis|strongyloidiasis
896226|NCT00001245|Immediate Hypersensitivity Skin Test|immediate hypersensitivity skin test
896227|NCT00001245|IgE|ige
896228|NCT00001245|Nematode|nematode
896229|NCT00001245|Immunosuppression|immunosuppression
896230|NCT00001245|Skin Test|skin test
896231|NCT00001245|Diagnosis|diagnosis
896232|NCT00001245|Intestinal Helminth|intestinal helminth
896233|NCT00001245|Immediate Hypersensitivity|immediate hypersensitivity
896234|NCT00001244|Agammaglobulinemia|agammaglobulinemia
896235|NCT00001244|CVID|cvid
896236|NCT00001244|XLA|xla
896237|NCT00001244|Humoral Immunodeficiency|humoral immunodeficiency
896238|NCT00001243|AIDS|aids
896239|NCT00001243|Myeloid Progenitors|myeloid progenitors
896240|NCT00001243|Monocytes|monocytes
896241|NCT00001243|Plasmid Libraries|plasmid libraries
896242|NCT00001243|Cytokines|cytokines
896243|NCT00001242|Rickets|rickets
896244|NCT00001242|HYPOCALCEMIA|hypocalcemia
896245|NCT00001242|Albright Hereditary Osteodystrophy|albright hereditary osteodystrophy
896246|NCT00001242|Pseudohypoaldosteronism|pseudohypoaldosteronism
896247|NCT00001241|Gastric Acid Secretion|gastric acid secretion
896248|NCT00001241|Histamine H2-Receptor Antagonists|histamine h2-receptor antagonists
896249|NCT00001240|Stomach|stomach
896250|NCT00001240|Hypersecretion|hypersecretion
896251|NCT00001240|Hyposecretion|hyposecretion
896252|NCT00001240|Gastrinoma|gastrinoma
896253|NCT00001240|Zollinger-Ellison Syndrome|zollinger-ellison syndrome
896254|NCT00001238|Urologic Malignant Disorders|urologic malignant disorders
896255|NCT00001238|Birt Hogg Dube|birt hogg dube
896256|NCT00001238|Von Hippel Lindau|von hippel lindau
896382|NCT00001201|EMG|emg
896257|NCT00001238|Hereditary Papillary Renal Cancer/Renal Cell Acarcinoma|hereditary papillary renal cancer/renal cell acarcinoma
896258|NCT00001235|Primary Neuronal Degeneration|primary neuronal degeneration
896259|NCT00001235|Genetics|genetics
896260|NCT00001235|Neurotransmitters|neurotransmitters
896261|NCT00001235|DNA|dna
896262|NCT00001235|Lymphoblasts|lymphoblasts
896263|NCT00001235|Skin Fibroblast|skin fibroblast
896264|NCT00001235|Alzheimer's Disease|alzheimer's disease
896265|NCT00001234|Bone Marrow|bone marrow
896266|NCT00001234|Retroviral-Mediated Gene Transfer|retroviral-mediated gene transfer
896267|NCT00001234|Hematopoietic Progenitor Cell|hematopoietic progenitor cell
896268|NCT00001231|Mood|mood
896269|NCT00001231|Behavior|behavior
896270|NCT00001231|Cognition|cognition
896271|NCT00001231|Climacteric|climacteric
896272|NCT00001231|Menopause|menopause
896273|NCT00001231|Perimenopause|perimenopause
896274|NCT00001231|Midlife|midlife
896275|NCT00001231|Depression|depression
896276|NCT00001230|Wuchereria Bancrofti|wuchereria bancrofti
896277|NCT00001230|Loa Loa|loa loa
896278|NCT00001230|Brugia Malayi|brugia malayi
896279|NCT00001230|Onchocerca Volvulus|onchocerca volvulus
896280|NCT00001230|Filarial Infections|filarial infections
896281|NCT00001230|Filarial Infection|filarial infection
896282|NCT00001228|Interferon|interferon
896283|NCT00001228|Zollinger-Ellison Syndrome|zollinger-ellison syndrome
896284|NCT00001226|Nonradioactive Isotopes|nonradioactive isotopes
896285|NCT00001226|Lipoprotein Kinetics|lipoprotein kinetics
896286|NCT00001226|Apolipoproteins|apolipoproteins
896287|NCT00001226|Dyslipoproteinemia|dyslipoproteinemia
896288|NCT00001226|Healthy Volunteers|healthy volunteers
896289|NCT00001225|DNA Polymorphisms|dna polymorphisms
896290|NCT00001225|Echocardiography|echocardiography
896291|NCT00001225|Gene Mapping|gene mapping
896292|NCT00001225|Linkage Analysis|linkage analysis
896293|NCT00001225|Hypertrophic Cardiomyopathy|hypertrophic cardiomyopathy
896294|NCT00001224|Ocular Inflammatory Disease|ocular inflammatory disease
896295|NCT00001224|Cataracts|cataracts
896296|NCT00001224|Vitrectomy|vitrectomy
896297|NCT00001224|Extracapsular|extracapsular
896298|NCT00001224|Cataract Surgery|cataract surgery
896299|NCT00001224|Uveitis|uveitis
896300|NCT00001224|Lenticular Opacity|lenticular opacity
896301|NCT00001224|Vitreal Opacity|vitreal opacity
896302|NCT00001223|Cystic Fibrosis|cystic fibrosis
896303|NCT00001223|Pancreatic Insufficiency|pancreatic insufficiency
896304|NCT00001223|Bronchiectasis|bronchiectasis
896305|NCT00001221|Growth|growth
896306|NCT00001221|Gonadal Dysgenesis|gonadal dysgenesis
896307|NCT00001221|Estrogen|estrogen
896308|NCT00001221|Somatotropin|somatotropin
896309|NCT00001221|Turner's Syndrome|turner's syndrome
896310|NCT00001221|Growth Hormone|growth hormone
896311|NCT00001220|Swallowing Disorders|swallowing disorders
896312|NCT00001220|Neuromotor Dysfunction|neuromotor dysfunction
896313|NCT00001220|Aspiration|aspiration
896314|NCT00001220|Imaging|imaging
896315|NCT00001219|MR Technology|mr technology
896316|NCT00001219|Pulse Sequences|pulse sequences
896317|NCT00001219|FDA Approved|fda approved
896318|NCT00001219|MRI Sequences|mri sequences
896319|NCT00001219|Investigational Coils|investigational coils
896320|NCT00001215|Variants|variants
896321|NCT00001215|Chemical Phenotype|chemical phenotype
896322|NCT00001215|Proteins|proteins
896323|NCT00001215|Phenotype|phenotype
896324|NCT00001214|Bone Marrow Failure|bone marrow failure
896325|NCT00001214|Lymphocytapheresis|lymphocytapheresis
896326|NCT00001214|Pancytopenia|pancytopenia
896327|NCT00001214|Aplastic Anemia|aplastic anemia
896328|NCT00001214|Hematosuppressive Disease|hematosuppressive disease
896329|NCT00001213|Cysteamine Eye Drops|cysteamine eye drops
896330|NCT00001213|Nephropathic Cystinosis|nephropathic cystinosis
896331|NCT00001213|Corneal Crystals|corneal crystals
896332|NCT00001213|Benzalkonium|benzalkonium
896333|NCT00001213|Toxicity|toxicity
896334|NCT00001213|Efficacy|efficacy
896335|NCT00001213|Cystinosis|cystinosis
896336|NCT00001212|Systemic Lupus Erythematosus|systemic lupus erythematosus
896337|NCT00001212|Nephrotic Syndrome|nephrotic syndrome
896338|NCT00001212|Immunosuppressive Drugs|immunosuppressive drugs
896339|NCT00001212|Prednisone|prednisone
896340|NCT00001212|Methylprednisolone|methylprednisolone
896341|NCT00001212|Cyclophosphamide|cyclophosphamide
896342|NCT00001212|Cyclosporine|cyclosporine
896343|NCT00001212|Cyclosporin A|cyclosporin a
896344|NCT00001208|Spasmodic Torticollis|spasmodic torticollis
896345|NCT00001208|Writer's Cramp|writer's cramp
896346|NCT00001208|Spasmodic Dysphonia|spasmodic dysphonia
896347|NCT00001208|Stuttering|stuttering
896348|NCT00001208|Oromandibular Dystonia|oromandibular dystonia
896349|NCT00001208|Palatal Myoclonus|palatal myoclonus
896350|NCT00001208|Dystonia|dystonia
896351|NCT00001208|Essential Tremor|essential tremor
896352|NCT00001208|Movement Disorders|movement disorders
896353|NCT00001206|Attention Deficit Hyperactivity Disorder|attention deficit hyperactivity disorder
896354|NCT00001206|Disruptive Behavior Disorders|disruptive behavior disorders
896355|NCT00001206|Cerebrospinal Fluid|cerebrospinal fluid
896356|NCT00001206|Lumbar Puncture|lumbar puncture
896357|NCT00001206|CSF|csf
896358|NCT00001206|Longitudinal Prospective Follow-Up|longitudinal prospective follow-up
896359|NCT00001206|Psychosocial Functioning|psychosocial functioning
896360|NCT00001206|Risk Factors|risk factors
896361|NCT00001206|Genetics|genetics
896362|NCT00001205|Taenia Solium|taenia solium
896363|NCT00001205|Neurocysticercosis|neurocysticercosis
896364|NCT00001205|Tapeworm|tapeworm
896365|NCT00001204|Dyslipoprotein|dyslipoprotein
896366|NCT00001204|Hypercholesterolemia|hypercholesterolemia
896367|NCT00001204|Atherosclerosis|atherosclerosis
896368|NCT00001203|Desferal|desferal
896369|NCT00001203|Thalassemia|thalassemia
896370|NCT00001203|Liver Iron Concentration|liver iron concentration
896371|NCT00001203|Endocrine Evaluation|endocrine evaluation
896372|NCT00001203|Diabetes Mellitus|diabetes mellitus
896373|NCT00001203|Cardiac Disease|cardiac disease
896374|NCT00001203|Acquired Anemia|acquired anemia
896375|NCT00001202|Luteinizing Hormone|luteinizing hormone
896376|NCT00001202|High Serum Testosterone Levels|high serum testosterone levels
896377|NCT00001202|Low Baseline Gonadotropin|low baseline gonadotropin
896378|NCT00001202|LHRH|lhrh
896379|NCT00001202|Precocious Puberty|precocious puberty
896380|NCT00001202|Familial Isosexual Precocious Puberty|familial isosexual precocious puberty
896381|NCT00001201|Nerve Conduction Studies|nerve conduction studies
896383|NCT00001201|Normal Volunteer|normal volunteer
896384|NCT00001201|Electrophysiology|electrophysiology
896385|NCT00001201|Peripheral Neuropathies|peripheral neuropathies
896386|NCT00001201|Myopathies|myopathies
896387|NCT00001198|Schizophrenia|schizophrenia
896388|NCT00001198|Observational|observational
896389|NCT00001197|Gene Expression Therapy|gene expression therapy
896390|NCT00001197|Gamma Globin Gene|gamma globin gene
896391|NCT00001197|Hemoglobin Switching|hemoglobin switching
896392|NCT00001197|Bone Marrow|bone marrow
896393|NCT00001197|Sickle Cell Anemia|sickle cell anemia
896394|NCT00001196|Salivary Function|salivary function
896395|NCT00001196|Salivary Gland|salivary gland
896396|NCT00001196|Sjogren's Syndrome|sjogren's syndrome
896397|NCT00001196|Dry Mouth|dry mouth
896402|NCT00001195|Eating Behavior|eating behavior
896403|NCT00001195|Body Composition|body composition
896404|NCT00001195|Normal Volunteer|normal volunteer
896405|NCT00001192|Executive Functions|executive functions
896406|NCT00001192|Language|language
896407|NCT00001192|Attention|attention
896408|NCT00001192|Visual-Spatial Ability|visual-spatial ability
896409|NCT00001192|Memory|memory
896410|NCT00001192|Motor Behavior|motor behavior
896411|NCT00001192|Intelligence|intelligence
896412|NCT00001192|Personality|personality
896413|NCT00001192|Visual and Auditory Functioning|visual and auditory functioning
896414|NCT00001192|Hand and Eye Dominance|hand and eye dominance
896415|NCT00001192|Normal Volunteer|normal volunteer
896416|NCT00001192|Neuropsychiatric Disorders|neuropsychiatric disorders
896417|NCT00001191|Zollinger-Ellison Syndrome|zollinger-ellison syndrome
896418|NCT00001191|Gastrinoma|gastrinoma
896419|NCT00001191|Acid Hypersecretion|acid hypersecretion
896420|NCT00001191|H+-K+ ATPase Inhibitor|h+-k+ atpase inhibitor
896421|NCT00001186|Psychosocial|psychosocial
896422|NCT00001186|Self Esteem|self esteem
896423|NCT00001186|Oncology|oncology
896424|NCT00001186|Well-Being|well-being
896425|NCT00001186|Pediatrics|pediatrics
896426|NCT00001185|Poliomyelitis|poliomyelitis
896427|NCT00001185|Amyotrophic Lateral Sclerosis|amyotrophic lateral sclerosis
896428|NCT00001185|Motor Neurons|motor neurons
896429|NCT00001185|Late Viral Infection|late viral infection
896430|NCT00001185|Motor Neuron Firing|motor neuron firing
896431|NCT00001185|Immune Defects|immune defects
896432|NCT00001185|Post-polio Syndrome|post-polio syndrome
896433|NCT00001185|Post-polio Motor Neuron Disease|post-polio motor neuron disease
896434|NCT00001184|CGD related IBD|cgd related ibd
896435|NCT00001184|IBD Hermansky-Pudlak Syndrom|ibd hermansky-pudlak syndrom
896436|NCT00001184|Ulcerative Colitis|ulcerative colitis
896437|NCT00001184|Inflammatory Bowel Disease|inflammatory bowel disease
896438|NCT00001184|IBD|ibd
896439|NCT00001183|Computed Tomography|computed tomography
896440|NCT00001183|Fiberoptic Bronchoscopy|fiberoptic bronchoscopy
896441|NCT00001183|Pulmonary Function Testing|pulmonary function testing
896442|NCT00001183|Cardiopulmonary Exercise Testing|cardiopulmonary exercise testing
896443|NCT00001183|Allergen Skin Testing|allergen skin testing
896444|NCT00001182|General Dental|general dental
896445|NCT00001182|Diagnostic|diagnostic
896446|NCT00001182|Therapeutic|therapeutic
896447|NCT00001181|McCune-Albright Syndrome|mccune-albright syndrome
896448|NCT00001181|Aromatase Inhibitor|aromatase inhibitor
896449|NCT00001181|Teslac|teslac
896450|NCT00001180|Corticotropin Releasing Hormone|corticotropin releasing hormone
896451|NCT00001180|Cushing Syndrome|cushing syndrome
896452|NCT00001180|Psychiatric Hypercortisolism|psychiatric hypercortisolism
896453|NCT00001180|Adrenal Insufficiency|adrenal insufficiency
896454|NCT00001180|Normal Volunteer|normal volunteer
896455|NCT00001178|Alzheimer's Disease|alzheimer's disease
896456|NCT00001178|Cerebral Metabolism|cerebral metabolism
896457|NCT00001178|Cerebrospinal Fluid|cerebrospinal fluid
896458|NCT00001178|Dementia of the Alzheimer Type|dementia of the alzheimer type
896459|NCT00001178|18-F-Fluoro-2-Deoxy-D-Glucose (FDG)|18-f-fluoro-2-deoxy-d-glucose (fdg)
896460|NCT00001178|Magnetic Resonance Imaging|magnetic resonance imaging
896461|NCT00001178|Positron Emission Tomography|positron emission tomography
896462|NCT00001178|X-Ray Computed Tomography (CT)|x-ray computed tomography (ct)
896463|NCT00001178|Senile Dementia|senile dementia
896464|NCT00001178|Down Syndrome|down syndrome
896465|NCT00001178|Trisomy 21|trisomy 21
896466|NCT00001177|Mood|mood
896467|NCT00001177|Depression|depression
896468|NCT00001177|Cognition|cognition
896469|NCT00001177|Menstrual|menstrual
896470|NCT00001177|Neuroendocrine|neuroendocrine
896471|NCT00001177|Genetics|genetics
896472|NCT00001177|PMDD|pmdd
896473|NCT00001177|PMS Premenstrual Syndrome|pms premenstrual syndrome
896474|NCT00001177|MRMD Menstrually Related Mood Disorder|mrmd menstrually related mood disorder
896475|NCT00001176|Adrenergic Nervous System|adrenergic nervous system
896476|NCT00001176|Dopaminergic Nervous System|dopaminergic nervous system
896477|NCT00001176|Salt-Sensitive Hypertension|salt-sensitive hypertension
896478|NCT00001176|Hypertension|hypertension
896479|NCT00001176|Primary Aldosteronism|primary aldosteronism
896480|NCT00001174|Bipolar Manic-Depressive Illness|bipolar manic-depressive illness
896481|NCT00001174|Affective Disorder|affective disorder
896482|NCT00001174|Depression|depression
896483|NCT00001174|Genetic|genetic
896484|NCT00001174|DNA|dna
896485|NCT00001174|Mania|mania
896486|NCT00001174|Affected Sibling Pairs|affected sibling pairs
896487|NCT00001174|Family Study|family study
896488|NCT00001174|Genome-Wide Scan|genome-wide scan
896489|NCT00001174|Lymphoblastoid Cell Lines|lymphoblastoid cell lines
896490|NCT00001174|Diagnostic Interview for Genetic Studies (DIGS)|diagnostic interview for genetic studies (digs)
896491|NCT00001174|Panic Disorder|panic disorder
896492|NCT00001174|Bipolar Disorder|bipolar disorder
896493|NCT00001172|Vision|vision
896494|NCT00001172|Eye Movement|eye movement
896495|NCT00001172|Perception|perception
896496|NCT00001172|Healthy Volunteer|healthy volunteer
896497|NCT00001171|Brain Tumors|brain tumors
896498|NCT00001171|Glioma|glioma
896499|NCT00001171|Glioblastoma Multiforme|glioblastoma multiforme
896500|NCT00001171|Pituitary Adenoma|pituitary adenoma
896501|NCT00001170|Parental Psychopathology|parental psychopathology
896502|NCT00001170|Child Rearing|child rearing
896503|NCT00001170|Depression|depression
896504|NCT00001170|Bipolar Affective Disorders|bipolar affective disorders
896505|NCT00001170|Manic-Depression|manic-depression
896506|NCT00001170|Social-Emotional Development|social-emotional development
896507|NCT00001170|Cognitive Development|cognitive development
896508|NCT00001170|Child Psychopathology|child psychopathology
896509|NCT00001170|Affective Disorder|affective disorder
896510|NCT00001170|Children at Risk|children at risk
896511|NCT00001168|Dyslipoproteinemia|dyslipoproteinemia
896512|NCT00001168|Hypercholesterolemia|hypercholesterolemia
896513|NCT00001168|Hypertriglyceridemia|hypertriglyceridemia
896514|NCT00001168|Hypoalphalipoproteinemia|hypoalphalipoproteinemia
896515|NCT00001168|Atherosclerosis|atherosclerosis
896516|NCT00001168|High Cholesterol|high cholesterol
896517|NCT00001168|High HDL|high hdl
896518|NCT00001168|Low HDL|low hdl
896519|NCT00001168|LCAT Defiency|lcat defiency
896520|NCT00001168|Type III Hyperlipoproteinemia|type iii hyperlipoproteinemia
896521|NCT00001168|Plasma Lipoproteins|plasma lipoproteins
896522|NCT00001167|Dysphagia|dysphagia
896523|NCT00001167|Dysarthria|dysarthria
896524|NCT00001167|Tongue Motion|tongue motion
896525|NCT00001167|Xerostomia|xerostomia
896526|NCT00001167|Swallowing|swallowing
896527|NCT00001167|Speech|speech
896528|NCT00001167|Polymyositis|polymyositis
896529|NCT00001167|Speech Disorders|speech disorders
896530|NCT00001167|Oral-Facial Paralysis|oral-facial paralysis
896531|NCT00001167|Ultrasound|ultrasound
896532|NCT00001166|Hyperornithinemia|hyperornithinemia
896533|NCT00001166|Ornithine-Aminotransferase (OAT)|ornithine-aminotransferase (oat)
896534|NCT00001166|Tissue Culture|tissue culture
896535|NCT00001166|Pyridoxine Hydrochloride|pyridoxine hydrochloride
896536|NCT00001166|Pyridoxal Phosphate|pyridoxal phosphate
896537|NCT00001166|Arginine|arginine
896538|NCT00001166|Skin Fibroblast|skin fibroblast
896539|NCT00001166|Gyrate Atrophy|gyrate atrophy
896540|NCT00001166|Autosomal Recessive Retinitis Pigmentosa|autosomal recessive retinitis pigmentosa
896541|NCT00001166|Bietti's Crystalline Retinopathy|bietti's crystalline retinopathy
896542|NCT00001166|Chorioretinal Degeneration|chorioretinal degeneration
896543|NCT00001165|Gastrinoma|gastrinoma
896544|NCT00001165|Acid Secretion|acid secretion
896545|NCT00001165|Toxicity|toxicity
896546|NCT00001163|Cancer|cancer
896547|NCT00001163|Genes/Genetics|genes/genetics
896548|NCT00001163|Hereditary Neoplasms|hereditary neoplasms
896549|NCT00001163|Environment|environment
896550|NCT00001162|Giardia|giardia
896551|NCT00001162|Helminth|helminth
896552|NCT00001162|Cryptosporidium|cryptosporidium
896553|NCT00001162|Hookworms|hookworms
896554|NCT00001162|Trichuris|trichuris
896555|NCT00001162|Strongyloides|strongyloides
896556|NCT00001162|Protozoa|protozoa
896557|NCT00001162|Small Bowel Biopsy|small bowel biopsy
896558|NCT00001162|E. Histolytica|e. histolytica
896559|NCT00001162|Duodenal Aspiration|duodenal aspiration
896560|NCT00001162|Coccidiosis|coccidiosis
896561|NCT00001162|Clonorchis|clonorchis
896562|NCT00001162|Amebiasis|amebiasis
896563|NCT00001162|Parasitic Disease|parasitic disease
896564|NCT00001162|Tapeworm|tapeworm
896565|NCT00001162|Trichinosis|trichinosis
896566|NCT00001162|Gastrointestinal Trematodes|gastrointestinal trematodes
896567|NCT00001162|Opisthorchis|opisthorchis
896568|NCT00001162|Paragonimiasis|paragonimiasis
896569|NCT00001162|Echinococcus|echinococcus
896570|NCT00001161|Irido Corneal Angle|irido corneal angle
896571|NCT00001161|Mesothelium|mesothelium
896572|NCT00001161|Congenital Anomalies|congenital anomalies
896573|NCT00001161|Neural Crest|neural crest
896574|NCT00001161|Increased Intraocular Pressure|increased intraocular pressure
896575|NCT00001161|Glaucoma|glaucoma
896576|NCT00001161|Axenfeld's Syndrome|axenfeld's syndrome
896577|NCT00001161|Rieger's Anomaly|rieger's anomaly
896578|NCT00001161|Peter's Anomaly|peter's anomaly
896579|NCT00001161|Iridocorneal Endothelial Syndrome|iridocorneal endothelial syndrome
896580|NCT00001161|Aniridia|aniridia
896581|NCT00001161|Pigment Dispersion Syndrome|pigment dispersion syndrome
896582|NCT00001161|Megalocornea|megalocornea
896583|NCT00001160|Thyroid Fine Needle Biopsy|thyroid fine needle biopsy
896584|NCT00001160|Radioiodine|radioiodine
896585|NCT00001160|Dosimetry|dosimetry
896586|NCT00001159|Hyperthyroidism|hyperthyroidism
896587|NCT00001159|Hypothyroidism|hypothyroidism
896588|NCT00001159|Thyroid-Stimulating Hormone Secreting Pituitary Adenomas|thyroid-stimulating hormone secreting pituitary adenomas
896589|NCT00001156|Immunogenetics|immunogenetics
896590|NCT00001156|Tropical Spastic Paraplegia|tropical spastic paraplegia
896591|NCT00001156|Twins|twins
896592|NCT00001156|Epstein-Barr Virus|epstein-barr virus
896593|NCT00001156|HTLV-I|htlv-i
896594|NCT00001156|Vasculitis|vasculitis
896595|NCT00001156|Cerebrospinal Fluid|cerebrospinal fluid
896596|NCT00001156|Immunity to Viruses|immunity to viruses
896597|NCT00001156|Multiple Sclerosis|multiple sclerosis
896997|NCT00000383|Female|female
896598|NCT00001156|Magnetic Resonance Imaging|magnetic resonance imaging
896599|NCT00001155|Vasculitis|vasculitis
896600|NCT00001155|Prednisone|prednisone
896601|NCT00001155|Granuloma|granuloma
896602|NCT00001155|Wegener's Granulomatosis|wegener's granulomatosis
896603|NCT00001155|Cyclophosphamide|cyclophosphamide
896604|NCT00001155|Renal Biopsy|renal biopsy
896605|NCT00001154|Metabolism|metabolism
896607|NCT00001154|Cholesterol|cholesterol
896608|NCT00001154|LDL|ldl
896609|NCT00001154|Hypoalphalipoproteinemia|hypoalphalipoproteinemia
896610|NCT00001151|Calciferol|calciferol
896611|NCT00001151|Hypocalcemia|hypocalcemia
896612|NCT00001151|Rickets|rickets
896613|NCT00001150|Blister Formation|blister formation
896614|NCT00001150|Inflammatory Mediator Assay|inflammatory mediator assay
896615|NCT00001150|Ultraviolet Radiation|ultraviolet radiation
896616|NCT00001149|Anticonvulsants|anticonvulsants
896617|NCT00001149|Intensive Monitoring|intensive monitoring
896618|NCT00001149|Epilepsy|epilepsy
896619|NCT00001148|Metastasis|metastasis
896620|NCT00001148|Glioma|glioma
896621|NCT00001148|Venous|venous
896622|NCT00001148|Sampling|sampling
896623|NCT00001148|p53 Mutation|p53 mutation
896624|NCT00001148|Glioblastoma Multiforme|glioblastoma multiforme
896625|NCT00001148|Circulating Tumor Cells|circulating tumor cells
896626|NCT00001148|Mutation|mutation
896627|NCT00001148|Anaplastic Astrocytoma|anaplastic astrocytoma
896628|NCT00001147|Dopamine|dopamine
896629|NCT00001147|Metanephrine|metanephrine
896630|NCT00001147|Norepinephrine|norepinephrine
896631|NCT00001147|Epinephrine|epinephrine
896632|NCT00001147|Catecholamines|catecholamines
896633|NCT00001147|Tyrosine Hydroxylase|tyrosine hydroxylase
896634|NCT00001147|Monoamine Oxidase|monoamine oxidase
896635|NCT00001147|Phenosulfotransferase|phenosulfotransferase
896636|NCT00001147|Sympathetic Nervous System|sympathetic nervous system
896637|NCT00001147|Normetanephrine|normetanephrine
896638|NCT00001146|Bipolar Disorder|bipolar disorder
896639|NCT00001146|Clinical Trial|clinical trial
896640|NCT00001146|Eicosapentaenoic Ethyl Ester|eicosapentaenoic ethyl ester
896641|NCT00001146|Life Chart Methodology|life chart methodology
896642|NCT00001146|Mood Disorders|mood disorders
896643|NCT00001146|Omega-3 Fatty Acid|omega-3 fatty acid
896644|NCT00001146|Rapid Cycling|rapid cycling
896645|NCT00001146|Treatment|treatment
896646|NCT00001145|Primary Immunodeficiency|primary immunodeficiency
896647|NCT00001145|Gamma Globulin (IgG) Immunization|gamma globulin (igg) immunization
896648|NCT00001145|KLH|klh
896649|NCT00001145|Phi-X 174|phi-x 174
896650|NCT00001145|X-linked HyperIgM Syndrome|x-linked hyperigm syndrome
896651|NCT00001144|Peripheral Blood Stem Cells|peripheral blood stem cells
896652|NCT00001144|Engraftment|engraftment
896653|NCT00001144|Graft vs. Host Disease|graft vs. host disease
896654|NCT00001144|Graft-Versus-Leukemia|graft-versus-leukemia
896655|NCT00001144|Graft-Versus-Tumor/Melanoma|graft-versus-tumor/melanoma
896656|NCT00001144|Chronic Myelogenous Leukemia|chronic myelogenous leukemia
896657|NCT00001143|Eye Movements|eye movements
896658|NCT00001143|Strabismus|strabismus
896659|NCT00001143|Infants|infants
896660|NCT00001143|Development|development
896661|NCT00001143|Ocular Motor System|ocular motor system
896662|NCT00000426|Calcium deficiency|calcium deficiency
896663|NCT00000426|Dietary calcium|dietary calcium
896664|NCT00000426|Dietary protein|dietary protein
896665|NCT00000426|Osteoporosis|osteoporosis
896666|NCT00000426|Calcium supplement|calcium supplement
896667|NCT00000426|Bone density|bone density
896668|NCT00000426|Bone mass|bone mass
896669|NCT00000426|Bone mass accumulation|bone mass accumulation
896670|NCT00000425|Osteoarthritis|osteoarthritis
896671|NCT00000425|Skeletal disorder|skeletal disorder
896672|NCT00000425|Chemotherapy|chemotherapy
896673|NCT00000425|Nonsteroidal anti-inflammatory drugs (NSAIDs)|nonsteroidal anti-inflammatory drugs (nsaids)
896674|NCT00000425|Arthroplasty|arthroplasty
896675|NCT00000425|Cartilage metabolism|cartilage metabolism
896676|NCT00000425|Hip|hip
896677|NCT00000425|Knee|knee
896678|NCT00000425|Outcomes research|outcomes research
896679|NCT00000424|Osteoarthritis (OA)|osteoarthritis (oa)
896680|NCT00000424|Knee|knee
896681|NCT00000424|Sham lavage|sham lavage
896682|NCT00000424|Tidal lavage|tidal lavage
896683|NCT00000424|Lavage therapy|lavage therapy
896684|NCT00000424|Nonsteroidal anti-inflammatory drug (NSAID)|nonsteroidal anti-inflammatory drug (nsaid)
896685|NCT00000424|Placebo|placebo
896686|NCT00000424|Radiography|radiography
896687|NCT00000424|Human therapy evaluation|human therapy evaluation
896688|NCT00000424|WOMAC|womac
896689|NCT00000423|Fibromyalgia|fibromyalgia
896690|NCT00000423|Health education|health education
896691|NCT00000423|Program evaluation|program evaluation
896692|NCT00000423|Social support|social support
896693|NCT00000423|Managed care|managed care
896694|NCT00000423|Quality of well-being|quality of well-being
896695|NCT00000422|Fibromyalgia Syndrome (FMS)|fibromyalgia syndrome (fms)
896696|NCT00000422|Physical therapy|physical therapy
896697|NCT00000422|Psychotherapy|psychotherapy
896698|NCT00000422|Group counseling|group counseling
896699|NCT00000422|Human therapy relations|human therapy relations
896700|NCT00000422|Interpersonal relations|interpersonal relations
896701|NCT00000422|Chronic pain|chronic pain
896702|NCT00000422|Cognition|cognition
896703|NCT00000422|Emotion|emotion
896704|NCT00000422|Memory|memory
896705|NCT00000422|Musculoskeletal disorder|musculoskeletal disorder
896706|NCT00000422|Psychological stressor|psychological stressor
896707|NCT00000422|Psychological adaptation|psychological adaptation
896708|NCT00000422|Outcomes research|outcomes research
896709|NCT00000421|SLE|sle
896710|NCT00000421|Lupus|lupus
896711|NCT00000421|Anti-double-stranded DNA antibody|anti-double-stranded dna antibody
896712|NCT00000421|Corticosteroid treatment|corticosteroid treatment
896713|NCT00000421|Hormone therapy|hormone therapy
896714|NCT00000421|Complement|complement
896715|NCT00000421|Hypertension|hypertension
896716|NCT00000421|Estrogen|estrogen
896717|NCT00000421|SELENA|selena
896718|NCT00000420|SLE|sle
896719|NCT00000420|SELENA|selena
896720|NCT00000420|Oral contraceptives|oral contraceptives
896721|NCT00000420|The pill|the pill
896722|NCT00000420|Birth control|birth control
896723|NCT00000420|Condom|condom
896724|NCT00000420|Diaphragm|diaphragm
896725|NCT00000420|Estrogen|estrogen
896726|NCT00000420|Lupus|lupus
896727|NCT00000420|Placebo|placebo
896728|NCT00000419|SLE|sle
896729|NCT00000419|SELENA|selena
896730|NCT00000419|Estrogen Replacement Therapy (ERT)|estrogen replacement therapy (ert)
896731|NCT00000419|Postmenopause|postmenopause
896732|NCT00000419|Osteoporosis|osteoporosis
896733|NCT00000419|Estrogens|estrogens
896734|NCT00000419|Steroids|steroids
896735|NCT00000419|Progestin|progestin
896736|NCT00000419|Placebo|placebo
896737|NCT00000418|OA|oa
896738|NCT00000418|Patient education|patient education
896739|NCT00000418|Acute low back pain (ALBP)|acute low back pain (albp)
896740|NCT00000418|Social support systems|social support systems
896741|NCT00000417|SLE|sle
896742|NCT00000417|Lupus|lupus
896743|NCT00000417|Educational intervention|educational intervention
896744|NCT00000417|Health education|health education
896745|NCT00000417|Social support network|social support network
896746|NCT00000417|Outcomes research|outcomes research
896747|NCT00000417|Self-help|self-help
896748|NCT00000416|Arthritis|arthritis
896749|NCT00000416|Rheumatic disorders|rheumatic disorders
896750|NCT00000416|Work-related disability|work-related disability
896751|NCT00000416|Vocational rehabilitation (VR)|vocational rehabilitation (vr)
896752|NCT00000416|Job retention services|job retention services
896753|NCT00000416|Work limitations|work limitations
896754|NCT00000416|Work instability|work instability
896755|NCT00000415|Calcium|calcium
896756|NCT00000415|Physical activity|physical activity
896757|NCT00000415|Children|children
896758|NCT00000415|Bone mass accretion|bone mass accretion
896759|NCT00000415|Bone mineral density (BMD)|bone mineral density (bmd)
896760|NCT00000415|Bone response to activity and calcium supplements|bone response to activity and calcium supplements
896761|NCT00000415|Placebo|placebo
896762|NCT00000415|Bone growth|bone growth
896763|NCT00000414|Rheumatoid arthritis (RA)|rheumatoid arthritis (ra)
896764|NCT00000414|Osteoarthritis (OA)|osteoarthritis (oa)
896765|NCT00000414|Arthritis education|arthritis education
896766|NCT00000414|Health care service evaluation|health care service evaluation
896767|NCT00000414|Outcomes research|outcomes research
896768|NCT00000414|Arthritis Self-Management Program (ASMP)|arthritis self-management program (asmp)
896769|NCT00000414|Self-Managed Arthritis Relief Therapy (SMART) Program|self-managed arthritis relief therapy (smart) program
896770|NCT00000413|Osteoporosis prevention|osteoporosis prevention
896771|NCT00000413|Behavioral/educational intervention|behavioral/educational intervention
896772|NCT00000413|Preadolescent|preadolescent
896773|NCT00000413|Calcium|calcium
896774|NCT00000413|Exercise|exercise
896775|NCT00000413|Peak bone mass|peak bone mass
896776|NCT00000413|Bone density|bone density
896777|NCT00000412|Osteoporosis|osteoporosis
896778|NCT00000412|Osteopenia|osteopenia
896779|NCT00000412|Heart transplant|heart transplant
896780|NCT00000412|Bone fracture|bone fracture
896781|NCT00000412|Bone density|bone density
896782|NCT00000412|Dual energy x-ray absorptiometry|dual energy x-ray absorptiometry
896783|NCT00000411|Spinal stenosis (SpS)|spinal stenosis (sps)
896784|NCT00000411|Intervertebral disc herniation (IDH)|intervertebral disc herniation (idh)
896785|NCT00000411|Degenerative spondylolisthesis (DS)|degenerative spondylolisthesis (ds)
896786|NCT00000411|Low back pain (LBP)|low back pain (lbp)
896787|NCT00000411|Surgical therapy|surgical therapy
896788|NCT00000411|Nonsurgical therapy|nonsurgical therapy
896789|NCT00000411|Randomized study|randomized study
896790|NCT00000411|Multicenter|multicenter
896791|NCT00000411|MRI|mri
896792|NCT00000410|Intervertebral disc herniation (IDH)|intervertebral disc herniation (idh)
896793|NCT00000410|Stenosis with degenerative spondylolisthesis (DS)|stenosis with degenerative spondylolisthesis (ds)
896794|NCT00000410|Spinal stenosis (SpS)|spinal stenosis (sps)
896795|NCT00000410|Low back pain (LBP)|low back pain (lbp)
896796|NCT00000410|Leg pain|leg pain
896797|NCT00000410|Surgical therapy|surgical therapy
896798|NCT00000410|Non-surgical therapy|non-surgical therapy
896799|NCT00000410|Randomized study|randomized study
896800|NCT00000410|Multicenter|multicenter
896801|NCT00000410|MRI|mri
896802|NCT00000409|Intervertebral disc herniation (IDH)|intervertebral disc herniation (idh)
896803|NCT00000409|Degenerative spondylolisthesis (DS)|degenerative spondylolisthesis (ds)
896804|NCT00000409|Spinal stenosis (SpS)|spinal stenosis (sps)
896805|NCT00000409|Low back pain (LBP)|low back pain (lbp)
896806|NCT00000409|Leg pain|leg pain
896807|NCT00000409|Surgical therapy|surgical therapy
896808|NCT00000409|Randomized study|randomized study
896809|NCT00000409|Multicenter|multicenter
896810|NCT00000409|MRI|mri
896811|NCT00000409|Nonsurgical therapy|nonsurgical therapy
896812|NCT00000408|Health education|health education
896813|NCT00000408|Back injury|back injury
896814|NCT00000408|Chronic pain|chronic pain
896815|NCT00000408|Education/evaluation planning|education/evaluation planning
896816|NCT00000408|Outcomes research|outcomes research
896817|NCT00000407|Arthritis and related musculoskeletal disorders (ARMD)|arthritis and related musculoskeletal disorders (armd)
896818|NCT00000407|Vocational rehabilitation (VR)|vocational rehabilitation (vr)
896819|NCT00000407|Agency enhancement intervention|agency enhancement intervention
896820|NCT00000407|Health care service evaluation|health care service evaluation
896821|NCT00000407|Musculoskeletal disability|musculoskeletal disability
896822|NCT00000407|Return to work|return to work
896823|NCT00000407|Outcomes research|outcomes research
896824|NCT00000407|Unemployment|unemployment
896825|NCT00000407|Work disability|work disability
896826|NCT00000406|Osteoarthritis (OA)|osteoarthritis (oa)
896827|NCT00000406|Knee|knee
896828|NCT00000406|Radiographic OA|radiographic oa
896829|NCT00000406|Strength training|strength training
896830|NCT00000406|Physical therapy|physical therapy
896831|NCT00000406|Exercise|exercise
896832|NCT00000406|Body composition|body composition
896833|NCT00000406|Striated muscle|striated muscle
896834|NCT00000406|Depression|depression
896835|NCT00000406|Radiographic OA with knee pain|radiographic oa with knee pain
896836|NCT00000406|Radiographic OA without knee pain|radiographic oa without knee pain
896837|NCT00000406|Knee pain without radiographic OA|knee pain without radiographic oa
896838|NCT00000406|Normal elderly (no radiographic OA, no knee pain)|normal elderly (no radiographic oa, no knee pain)
896839|NCT00000405|Osteoporosis|osteoporosis
896840|NCT00000405|Bone fractures|bone fractures
896841|NCT00000405|Bone mass|bone mass
896842|NCT00000405|Bone mineral density (BMD)|bone mineral density (bmd)
896843|NCT00000405|Ossification|ossification
896844|NCT00000405|Biomechanics|biomechanics
896845|NCT00000405|Exercise|exercise
896846|NCT00000405|Diet|diet
896847|NCT00000405|Spine|spine
896848|NCT00000405|Middle childhood (6-11)|middle childhood (6-11)
896849|NCT00000404|Osteoarthritis (OA)|osteoarthritis (oa)
896850|NCT00000404|Knee|knee
896851|NCT00000404|HMO|hmo
896852|NCT00000404|Comprehensive care|comprehensive care
896853|NCT00000403|Osteoarthritis (OA)|osteoarthritis (oa)
896854|NCT00000403|Knee|knee
896855|NCT00000403|Doxycycline|doxycycline
896856|NCT00000403|Skeletal disorder|skeletal disorder
896857|NCT00000403|Placebo|placebo
896858|NCT00000403|Urinalysis|urinalysis
896859|NCT00000403|NSAIDs|nsaids
896860|NCT00000403|Joint space narrowing (JSN)|joint space narrowing (jsn)
896861|NCT00000403|WOMAC|womac
896862|NCT00000402|Osteoporosis|osteoporosis
896863|NCT00000402|Dietary calcium|dietary calcium
896864|NCT00000402|Puberty|puberty
896865|NCT00000402|Bone density|bone density
896866|NCT00000402|Bone mass|bone mass
896867|NCT00000402|Primary prevention of osteoporosis|primary prevention of osteoporosis
896868|NCT00000401|NSAIDs|nsaids
896869|NCT00000401|Oral Tolerance|oral tolerance
896870|NCT00000401|Drug Interaction|drug interaction
896871|NCT00000401|Oral Administration|oral administration
896872|NCT00000401|Interleukin 10|interleukin 10
896873|NCT00000401|Collagen|collagen
896874|NCT00000401|Chemotherapy|chemotherapy
896875|NCT00000401|Human Therapy Evaluation|human therapy evaluation
896876|NCT00000401|DMARDs|dmards
896877|NCT00000401|RA|ra
896878|NCT00000401|IL-10|il-10
896879|NCT00000400|Osteoporosis|osteoporosis
896880|NCT00000400|Bone formation|bone formation
896881|NCT00000400|Bone resorption|bone resorption
896882|NCT00000400|Parathyroid hormone (PTH)|parathyroid hormone (pth)
896883|NCT00000400|Postmenopause|postmenopause
896884|NCT00000399|Estrogen|estrogen
896885|NCT00000399|Hormone therapy|hormone therapy
896886|NCT00000399|Strength training|strength training
896887|NCT00000399|Exercise|exercise
896888|NCT00000399|Postmenopause|postmenopause
896889|NCT00000399|Disorder prevention|disorder prevention
896890|NCT00000399|Osteoporosis|osteoporosis
896891|NCT00000399|Bone mineral density|bone mineral density
896892|NCT00000399|Bone mass|bone mass
896893|NCT00000399|Cholesterol|cholesterol
896894|NCT00000399|Body composition|body composition
896895|NCT00000398|Fibromyalgia|fibromyalgia
896896|NCT00000398|Pain|pain
896897|NCT00000398|Coping skills training|coping skills training
896898|NCT00000398|Physical exercise training|physical exercise training
897286|NCT00000173|Antioxidants|antioxidants
896899|NCT00000398|Combined coping skills training and exercise training|combined coping skills training and exercise training
896900|NCT00000397|Fibromyalgia|fibromyalgia
896901|NCT00000397|Insomnia|insomnia
896902|NCT00000397|Cognitive-behavioral therapy (CBT)|cognitive-behavioral therapy (cbt)
896903|NCT00000397|Behavioral insomnia therapy|behavioral insomnia therapy
896904|NCT00000396|Arthritis|arthritis
896905|NCT00000396|Arthritis education|arthritis education
896906|NCT00000396|African Americans|african americans
896907|NCT00000396|Self-help|self-help
896908|NCT00000396|Self-management|self-management
896909|NCT00000396|Cultural beliefs|cultural beliefs
896910|NCT00000395|Rheumatoid arthritis|rheumatoid arthritis
896911|NCT00000395|Lewis rat adjuvant arthritis|lewis rat adjuvant arthritis
896912|NCT00000395|Antifolate efficacy|antifolate efficacy
896913|NCT00000395|Autoimmunity|autoimmunity
896914|NCT00000395|Adenosine metabolism|adenosine metabolism
896915|NCT00000395|Methotrexate therapy|methotrexate therapy
896916|NCT00000395|Skeletal disorder|skeletal disorder
896917|NCT00000395|Dietary supplement|dietary supplement
896918|NCT00000395|Antiarthritic agent|antiarthritic agent
896919|NCT00000395|Folic acid|folic acid
896920|NCT00000394|Carpal tunnel syndrome|carpal tunnel syndrome
896921|NCT00000394|Acupuncture|acupuncture
896922|NCT00000394|Median nerve|median nerve
896923|NCT00000394|Single-blind mute methodology|single-blind mute methodology
896924|NCT00000104|lead overburden|lead overburden
896925|NCT00000456|Alcoholism|alcoholism
896926|NCT00000456|Alcohol Dependence|alcohol dependence
896927|NCT00000456|Naltrexone|naltrexone
896928|NCT00000456|Cognitive Behavioral Therapy|cognitive behavioral therapy
896929|NCT00000451|Alcoholism|alcoholism
896930|NCT00000451|Alcohol Dependence|alcohol dependence
896931|NCT00000389|Adolescence|adolescence
896932|NCT00000389|Anxiety Disorders|anxiety disorders
896933|NCT00000389|Child|child
896934|NCT00000389|Female|female
896935|NCT00000389|Fluvoxamine|fluvoxamine
896936|NCT00000389|Human|human
896937|NCT00000389|Male|male
896938|NCT00000389|Serotonin Uptake Inhibitors|serotonin uptake inhibitors
896939|NCT00000389|Anxiety Disorders -- *drug therapy|anxiety disorders -- *drug therapy
896940|NCT00000389|Fluvoxamine -- *therapeutic use|fluvoxamine -- *therapeutic use
896941|NCT00000389|Serotonin Uptake Inhibitors -- *therapeutic use|serotonin uptake inhibitors -- *therapeutic use
896942|NCT00000388|Attention Deficit Disorder with Hyperactivity|attention deficit disorder with hyperactivity
896943|NCT00000388|Adolescence|adolescence
896944|NCT00000388|Child|child
896945|NCT00000388|Cognition|cognition
896946|NCT00000388|Combined Modality Therapy|combined modality therapy
896947|NCT00000388|Female|female
896948|NCT00000388|Human|human
896949|NCT00000388|Male|male
896950|NCT00000388|Peer Group|peer group
896951|NCT00000388|Risk Factors|risk factors
896952|NCT00000388|Treatment Outcome|treatment outcome
896953|NCT00000388|Attention Deficit Disorder with Hyperactivity -- *therapy|attention deficit disorder with hyperactivity -- *therapy
896954|NCT00000388|Attention Deficit Disorder with Hyperactivity -- drug therapy|attention deficit disorder with hyperactivity -- drug therapy
896955|NCT00000388|Attention Deficit Disorder with Hyperactivity -- psychology|attention deficit disorder with hyperactivity -- psychology
896956|NCT00000387|Adolescence|adolescence
896957|NCT00000387|Family|family
896958|NCT00000387|Female|female
896959|NCT00000387|Human|human
896960|NCT00000387|Male|male
896961|NCT00000387|Schizophrenia|schizophrenia
896962|NCT00000387|Self Care|self care
896963|NCT00000387|Community Health Services|community health services
896964|NCT00000386|Adolescence|adolescence
896965|NCT00000386|Child|child
896966|NCT00000386|Comparative Study|comparative study
896967|NCT00000386|Family|family
896968|NCT00000386|Female|female
896969|NCT00000386|Human|human
896970|NCT00000386|Male|male
896971|NCT00000386|Obsessive-Compulsive Disorder|obsessive-compulsive disorder
896972|NCT00000386|Relaxation Techniques|relaxation techniques
896973|NCT00000386|Obsessive-Compulsive Disorder -- *therapy|obsessive-compulsive disorder -- *therapy
896974|NCT00000385|Aggressive conduct disorder|aggressive conduct disorder
896975|NCT00000385|Adolescence|adolescence
896976|NCT00000385|Child|child
896977|NCT00000385|Conduct Disorder|conduct disorder
896978|NCT00000385|Female|female
896979|NCT00000385|Lithium|lithium
896980|NCT00000385|Male|male
896981|NCT00000385|Placebos|placebos
896982|NCT00000385|Conduct Disorder -- *drug therapy|conduct disorder -- *drug therapy
896983|NCT00000385|Lithium -- *therapeutic use|lithium -- *therapeutic use
896984|NCT00000384|Adolescence|adolescence
896985|NCT00000384|Child|child
896986|NCT00000384|Cognitive Therapy|cognitive therapy
896987|NCT00000384|Combined Modality Therapy|combined modality therapy
896988|NCT00000384|Obsessive-Compulsive Disorder|obsessive-compulsive disorder
896989|NCT00000384|Placebos|placebos
896990|NCT00000384|Sertraline|sertraline
896991|NCT00000384|Patient Education|patient education
896992|NCT00000384|Psychotherapy|psychotherapy
896993|NCT00000383|Adolescence|adolescence
896994|NCT00000383|Child|child
896995|NCT00000383|Cognitive Therapy|cognitive therapy
896996|NCT00000383|Comparative Study|comparative study
897000|NCT00000383|Stress Disorders, Post-Traumatic|stress disorders, post-traumatic
897001|NCT00000383|Child Abuse, Sexual|child abuse, sexual
897002|NCT00000383|Stress Disorders, Post-Traumatic -- *therapy|stress disorders, post-traumatic -- *therapy
897003|NCT00000383|Child Abuse, Sexual -- *psychology|child abuse, sexual -- *psychology
897004|NCT00000382|Child Abuse|child abuse
897005|NCT00000382|Female|female
897006|NCT00000382|Human|human
897007|NCT00000382|Infant|infant
897008|NCT00000382|Male|male
897009|NCT00000382|Caregivers|caregivers
897010|NCT00000382|Patient Education|patient education
897011|NCT00000382|Psychotherapy|psychotherapy
897012|NCT00000382|Child Abuse -- *prevention & control|child abuse -- *prevention & control
897013|NCT00000381|Adolescence|adolescence
897014|NCT00000381|Anxiety Disorders|anxiety disorders
897015|NCT00000381|Child|child
897016|NCT00000381|Female|female
897017|NCT00000381|Fluoxetine|fluoxetine
897018|NCT00000381|Male|male
897019|NCT00000381|Placebos|placebos
897020|NCT00000381|Serotonin Uptake Inhibitors|serotonin uptake inhibitors
897021|NCT00000381|Anxiety Disorders -- *drug therapy|anxiety disorders -- *drug therapy
897022|NCT00000381|Fluoxetine -- *therapeutic use|fluoxetine -- *therapeutic use
897023|NCT00000381|Serotonin Uptake Inhibitors -- *therapeutic use|serotonin uptake inhibitors -- *therapeutic use
897024|NCT00000380|Adult|adult
897025|NCT00000380|Estrogen Replacement Therapy|estrogen replacement therapy
897026|NCT00000380|Female|female
897027|NCT00000380|Hormone Replacement Therapy|hormone replacement therapy
897028|NCT00000380|Human|human
897029|NCT00000380|Insulin-Like Growth Factor I|insulin-like growth factor i
897030|NCT00000380|Male|male
897031|NCT00000380|Placebos|placebos
897032|NCT00000380|Sleep Disorders|sleep disorders
897033|NCT00000380|Somatotropin-Releasing Hormone|somatotropin-releasing hormone
897034|NCT00000380|Somatotropin|somatotropin
897035|NCT00000380|Insulin-Like Growth Factor I -- secretion|insulin-like growth factor i -- secretion
897036|NCT00000380|Sleep Disorders -- *drug therapy|sleep disorders -- *drug therapy
897037|NCT00000380|Somatotropin-Releasing Hormone -- *therapeutic use|somatotropin-releasing hormone -- *therapeutic use
897038|NCT00000380|Somatotropin -- secretion|somatotropin -- secretion
897039|NCT00000379|Adult|adult
897040|NCT00000379|Comparative Study|comparative study
897041|NCT00000379|Desensitization, Psychologic|desensitization, psychologic
897042|NCT00000379|Eye Movements|eye movements
897043|NCT00000379|Female|female
897044|NCT00000379|Fluoxetine|fluoxetine
897045|NCT00000379|Human|human
897046|NCT00000379|Male|male
897047|NCT00000379|Placebos|placebos
897048|NCT00000379|Stress Disorders, Post-Traumatic|stress disorders, post-traumatic
897049|NCT00000379|Treatment Outcome|treatment outcome
897050|NCT00000379|Desensitization, Psychologic -- *methods|desensitization, psychologic -- *methods
897051|NCT00000379|Fluoxetine -- *therapeutic use|fluoxetine -- *therapeutic use
897052|NCT00000379|Stress Disorders, Post-Traumatic -- *therapy|stress disorders, post-traumatic -- *therapy
897053|NCT00000379|Stress Disorders, Post-Traumatic -- drug therapy|stress disorders, post-traumatic -- drug therapy
897054|NCT00000378|Aged|aged
897055|NCT00000378|Antidepressive Agents, Tricyclic|antidepressive agents, tricyclic
897056|NCT00000378|Depression|depression
897057|NCT00000378|Female|female
897058|NCT00000378|Human|human
897059|NCT00000378|Male|male
897060|NCT00000378|Middle Age|middle age
897061|NCT00000378|Nortriptyline|nortriptyline
897062|NCT00000378|Sertraline|sertraline
897063|NCT00000378|Serotonin Uptake Inhibitors|serotonin uptake inhibitors
897064|NCT00000378|Antidepressive Agents, Tricyclic -- *therapeutic use|antidepressive agents, tricyclic -- *therapeutic use
897065|NCT00000378|Antidepressive Agents, Tricyclic -- adverse effects|antidepressive agents, tricyclic -- adverse effects
897066|NCT00000378|Depression -- *drug therapy|depression -- *drug therapy
897067|NCT00000378|Nortriptyline -- *therapeutic use|nortriptyline -- *therapeutic use
897068|NCT00000378|Nortriptyline -- adverse effects|nortriptyline -- adverse effects
897069|NCT00000378|Sertraline -- *therapeutic use|sertraline -- *therapeutic use
897070|NCT00000378|Sertraline -- adverse effects|sertraline -- adverse effects
897071|NCT00000378|Serotonin Uptake Inhibitors -- *therapeutic use|serotonin uptake inhibitors -- *therapeutic use
897072|NCT00000378|Serotonin Uptake Inhibitors -- adverse effects|serotonin uptake inhibitors -- adverse effects
897073|NCT00000377|Aged|aged
897074|NCT00000377|Antidepressive Agents|antidepressive agents
897075|NCT00000377|Depression|depression
897076|NCT00000377|Dose-Response Relationship, Drug|dose-response relationship, drug
897077|NCT00000377|Female|female
897078|NCT00000377|Human|human
897079|NCT00000377|Male|male
897080|NCT00000377|Middle Age|middle age
897081|NCT00000377|Nortriptyline|nortriptyline
897082|NCT00000377|Placebos|placebos
897083|NCT00000377|Recurrence|recurrence
897084|NCT00000377|Aged, 80 and over|aged, 80 and over
897085|NCT00000377|Antidepressive Agents -- *therapeutic use|antidepressive agents -- *therapeutic use
897086|NCT00000377|Antidepressive Agents -- administration & dosage|antidepressive agents -- administration & dosage
897087|NCT00000377|Depression -- *drug therapy|depression -- *drug therapy
897088|NCT00000377|Nortriptyline -- *therapeutic use|nortriptyline -- *therapeutic use
897287|NCT00000173|Cholinergic agents|cholinergic agents
897089|NCT00000377|Nortriptyline -- administration & dosage|nortriptyline -- administration & dosage
897090|NCT00000376|Adult|adult
897091|NCT00000376|Antidepressive Agents, Tricyclic|antidepressive agents, tricyclic
897092|NCT00000376|Anxiety Disorders|anxiety disorders
897093|NCT00000376|Cognitive Therapy|cognitive therapy
897094|NCT00000376|Combined Modality Therapy|combined modality therapy
897095|NCT00000376|Depression|depression
897096|NCT00000376|Desipramine|desipramine
897097|NCT00000376|Female|female
897098|NCT00000376|Human|human
897099|NCT00000376|Male|male
897100|NCT00000376|Personality Disorders|personality disorders
897101|NCT00000376|Pilot Projects|pilot projects
897102|NCT00000376|Patient Care Team|patient care team
897103|NCT00000376|Antidepressive Agents, Tricyclic -- *therapeutic use|antidepressive agents, tricyclic -- *therapeutic use
897104|NCT00000376|Depression -- *therapy|depression -- *therapy
897105|NCT00000376|Depression -- drug therapy|depression -- drug therapy
897106|NCT00000376|Desipramine -- *therapeutic use|desipramine -- *therapeutic use
897107|NCT00000375|Adult|adult
897108|NCT00000375|Antidepressive Agents|antidepressive agents
897109|NCT00000375|Depressive Disorder|depressive disorder
897110|NCT00000375|Electroconvulsive Therapy|electroconvulsive therapy
897111|NCT00000375|Female|female
897112|NCT00000375|Human|human
897113|NCT00000375|Lithium|lithium
897114|NCT00000375|Male|male
897115|NCT00000375|Nortriptyline|nortriptyline
897116|NCT00000375|Serotonin Uptake Inhibitors|serotonin uptake inhibitors
897117|NCT00000375|Antidepressive Agents -- *therapeutic use|antidepressive agents -- *therapeutic use
897118|NCT00000375|Antidepressive Agents -- adverse effects|antidepressive agents -- adverse effects
897119|NCT00000375|Lithium -- *therapeutic use|lithium -- *therapeutic use
897120|NCT00000375|Lithium -- adverse effects|lithium -- adverse effects
897121|NCT00000375|Nortriptyline -- *therapeutic use|nortriptyline -- *therapeutic use
897122|NCT00000375|Nortriptyline -- adverse effects|nortriptyline -- adverse effects
897123|NCT00000374|Adolescence|adolescence
897124|NCT00000374|Adult|adult
897125|NCT00000374|Antipsychotic Agents|antipsychotic agents
897126|NCT00000374|Female|female
897127|NCT00000374|Human|human
897128|NCT00000374|Male|male
897129|NCT00000374|olanzapine|olanzapine
897130|NCT00000374|Risperidone|risperidone
897131|NCT00000374|Schizophrenia|schizophrenia
897132|NCT00000374|Antipsychotic Agents -- *therapeutic use|antipsychotic agents -- *therapeutic use
897133|NCT00000374|olanzapine -- *therapeutic use|olanzapine -- *therapeutic use
897134|NCT00000374|Risperidone -- *therapeutic use|risperidone -- *therapeutic use
897135|NCT00000374|Schizophrenia -- *drug therapy|schizophrenia -- *drug therapy
897136|NCT00000373|Adolescence|adolescence
897137|NCT00000373|Adult|adult
897138|NCT00000373|Antipsychotic Agents|antipsychotic agents
897139|NCT00000373|Dopamine Antagonists|dopamine antagonists
897140|NCT00000373|Female|female
897141|NCT00000373|Fluvoxamine|fluvoxamine
897142|NCT00000373|Haloperidol|haloperidol
897143|NCT00000373|Human|human
897144|NCT00000373|Male|male
897145|NCT00000373|Middle Age|middle age
897146|NCT00000373|Obsessive-Compulsive Disorder|obsessive-compulsive disorder
897147|NCT00000373|Placebos|placebos
897148|NCT00000373|Serotonin Uptake Inhibitors|serotonin uptake inhibitors
897149|NCT00000373|Tourette Syndrome|tourette syndrome
897150|NCT00000373|Tryptophan|tryptophan
897151|NCT00000373|Drug Combinations|drug combinations
897152|NCT00000373|Antipsychotic Agents -- *therapeutic use|antipsychotic agents -- *therapeutic use
897153|NCT00000373|Fluvoxamine -- *therapeutic use|fluvoxamine -- *therapeutic use
897154|NCT00000373|Haloperidol -- *therapeutic use|haloperidol -- *therapeutic use
897155|NCT00000373|Obsessive-Compulsive Disorder -- *drug therapy|obsessive-compulsive disorder -- *drug therapy
897156|NCT00000373|Obsessive-Compulsive Disorder -- physiopathology|obsessive-compulsive disorder -- physiopathology
897157|NCT00000373|Serotonin Uptake Inhibitors -- *therapeutic use|serotonin uptake inhibitors -- *therapeutic use
897158|NCT00000372|Adult|adult
897159|NCT00000372|Amino Acids|amino acids
897160|NCT00000372|Cycloserine|cycloserine
897161|NCT00000372|Female|female
897162|NCT00000372|Glycine|glycine
897163|NCT00000372|Human|human
897164|NCT00000372|Male|male
897165|NCT00000372|N-Methylaspartate|n-methylaspartate
897166|NCT00000372|Placebos|placebos
897167|NCT00000372|Schizophrenia|schizophrenia
897168|NCT00000372|Amino Acids -- blood|amino acids -- blood
897169|NCT00000372|Cycloserine -- *therapeutic use|cycloserine -- *therapeutic use
897170|NCT00000372|Glycine -- *therapeutic use|glycine -- *therapeutic use
897171|NCT00000372|Schizophrenia -- *drug therapy|schizophrenia -- *drug therapy
897172|NCT00000372|Schizophrenia -- physiopathology|schizophrenia -- physiopathology
897173|NCT00000371|Adult|adult
897174|NCT00000371|Cognition|cognition
897175|NCT00000371|Cycloserine|cycloserine
897176|NCT00000371|Dopamine|dopamine
897177|NCT00000371|Female|female
897178|NCT00000371|Glutamic Acid|glutamic acid
897179|NCT00000371|Human|human
897180|NCT00000371|Male|male
897181|NCT00000371|Receptors, N-Methyl-D-Aspartate|receptors, n-methyl-d-aspartate
897182|NCT00000371|Schizophrenia|schizophrenia
897183|NCT00000371|Serotonin|serotonin
897184|NCT00000371|Quality of Life|quality of life
897185|NCT00000371|Cycloserine -- *therapeutic use|cycloserine -- *therapeutic use
897186|NCT00000371|Dopamine -- blood|dopamine -- blood
897187|NCT00000371|Dopamine -- cerebrospinal fluid|dopamine -- cerebrospinal fluid
897188|NCT00000371|Glutamic Acid -- blood|glutamic acid -- blood
897189|NCT00000371|Glutamic Acid -- cerebrospinal fluid|glutamic acid -- cerebrospinal fluid
897190|NCT00000371|Serotonin -- blood|serotonin -- blood
897191|NCT00000371|Serotonin -- cerebrospinal fluid|serotonin -- cerebrospinal fluid
897192|NCT00000370|Cognitive Therapy|cognitive therapy
897193|NCT00000370|Cost of Illness|cost of illness
897194|NCT00000370|Female|female
897195|NCT00000370|Human|human
897196|NCT00000370|Male|male
897197|NCT00000370|Phobic Disorders|phobic disorders
897198|NCT00000370|Phobic Disorders -- *therapy|phobic disorders -- *therapy
897199|NCT00000370|Phobic Disorders -- pathology|phobic disorders -- pathology
897200|NCT00000369|Adult|adult
897201|NCT00000369|Antidepressive Agents|antidepressive agents
897202|NCT00000369|Bipolar Disorder|bipolar disorder
897203|NCT00000369|Combined Modality Therapy|combined modality therapy
897204|NCT00000369|Female|female
897205|NCT00000369|Human|human
897206|NCT00000369|Lithium Carbonate|lithium carbonate
897207|NCT00000369|Male|male
897208|NCT00000369|Psychotherapy|psychotherapy
897209|NCT00000369|Antidepressive Agents -- *therapeutic use|antidepressive agents -- *therapeutic use
897210|NCT00000369|Bipolar Disorder -- *therapy|bipolar disorder -- *therapy
897211|NCT00000369|Bipolar Disorder -- drug therapy|bipolar disorder -- drug therapy
897212|NCT00000369|Lithium Carbonate -- *therapeutic use|lithium carbonate -- *therapeutic use
897213|NCT00000368|Adult|adult
897214|NCT00000368|Cognitive Behavioral Therapy|cognitive behavioral therapy
897215|NCT00000368|Pharmacotherapy|pharmacotherapy
897216|NCT00000368|Long term treatment|long term treatment
897217|NCT00000368|Remission and relapse|remission and relapse
897218|NCT00000368|Male|male
897219|NCT00000368|Panic Disorder|panic disorder
897220|NCT00000368|Paroxetine|paroxetine
897221|NCT00000368|Serotonin Uptake Inhibitors|serotonin uptake inhibitors
897222|NCT00000368|Panic Disorder -- *therapy|panic disorder -- *therapy
897223|NCT00000368|Panic Disorder -- drug therapy|panic disorder -- drug therapy
897224|NCT00000368|Paroxetine -- *therapeutic use|paroxetine -- *therapeutic use
897225|NCT00000368|Serotonin Uptake Inhibitors -- *therapeutic use|serotonin uptake inhibitors -- *therapeutic use
897226|NCT00000367|Depression|depression
897227|NCT00000367|Family|family
897228|NCT00000367|Female|female
897229|NCT00000367|Human|human
897230|NCT00000367|Male|male
897231|NCT00000367|Practice Guidelines|practice guidelines
897232|NCT00000367|Education, Medical, Continuing|education, medical, continuing
897233|NCT00000367|Patient Education|patient education
897234|NCT00000367|Suicide|suicide
897235|NCT00000363|Antibiotics|antibiotics
897236|NCT00000363|Adrenal Cortex Hormones|adrenal cortex hormones
897237|NCT00000363|Histamine H1 Antagonists|histamine h1 antagonists
897238|NCT00000363|Infant|infant
897239|NCT00000363|Otitis Media|otitis media
897240|NCT00000362|Deglutition Disorders|deglutition disorders
897241|NCT00000362|Dementia|dementia
897242|NCT00000362|Parkinson Disease|parkinson disease
897243|NCT00000362|Pneumonia, Aspiration|pneumonia, aspiration
897244|NCT00000361|Autoimmune Diseases|autoimmune diseases
897245|NCT00000361|Cyclophosphamide|cyclophosphamide
897246|NCT00000361|Hearing|hearing
897247|NCT00000361|Labyrinth Diseases|labyrinth diseases
897248|NCT00000361|Methotrexate|methotrexate
897249|NCT00000361|Prednisone|prednisone
897250|NCT00000359|Physical Therapy|physical therapy
897251|NCT00000359|Vertigo|vertigo
897252|NCT00000359|rehabilitation|rehabilitation
897253|NCT00000359|occupational therapy|occupational therapy
897254|NCT00000180|Memory|memory
897255|NCT00000180|Mild cognitive impairment|mild cognitive impairment
897256|NCT00000180|Nerve growth factors|nerve growth factors
897257|NCT00000179|Alzheimer's disease|alzheimer's disease
897258|NCT00000179|Psychomotor agitation|psychomotor agitation
897259|NCT00000179|Behavioral symptoms|behavioral symptoms
897260|NCT00000179|Haloperidol|haloperidol
897261|NCT00000179|Trazodone|trazodone
897262|NCT00000179|Anti-psychotic agents|anti-psychotic agents
897263|NCT00000179|Anti-depressant agents|anti-depressant agents
897264|NCT00000178|Alzheimer's disease|alzheimer's disease
897265|NCT00000178|Prednisone|prednisone
897266|NCT00000178|Anti-inflammatory agents|anti-inflammatory agents
897267|NCT00000177|Alzheimer's disease|alzheimer's disease
897268|NCT00000177|Estrogen|estrogen
897269|NCT00000176|Alzheimer's disease|alzheimer's disease
897270|NCT00000176|memory loss|memory loss
897271|NCT00000176|Estrogen|estrogen
897272|NCT00000175|Emotions|emotions
897273|NCT00000175|Cognition|cognition
897274|NCT00000175|Aging|aging
897275|NCT00000175|Memory|memory
897276|NCT00000174|Mild cognitive impairment|mild cognitive impairment
897277|NCT00000174|Alzheimer's disease|alzheimer's disease
897278|NCT00000174|Memory|memory
897279|NCT00000174|Cholinergic agents|cholinergic agents
897280|NCT00000174|Cholinesterase inhibitors|cholinesterase inhibitors
897281|NCT00000173|Mild cognitive impairment|mild cognitive impairment
897282|NCT00000173|Alzheimer's disease|alzheimer's disease
897288|NCT00000173|Cholinesterase inhibitors|cholinesterase inhibitors
897289|NCT00000172|Alzheimer's disease|alzheimer's disease
897290|NCT00000172|Cholinergic agents|cholinergic agents
897291|NCT00000172|Cholinergic agonists|cholinergic agonists
897292|NCT00000172|Cholinesterase inhibitors|cholinesterase inhibitors
897293|NCT00000171|Alzheimer's disease|alzheimer's disease
897294|NCT00000171|Sleep disorders|sleep disorders
897295|NCT00000171|Melatonin|melatonin
897296|NCT00000623|chelator|chelator
897297|NCT00000623|iron|iron
897298|NCT00000623|transfusion|transfusion
897299|NCT00000623|anemia|anemia
897300|NCT00000623|thalassemia|thalassemia
897301|NCT00000620|Diabetes Mellitus, Non-Insulin-Dependent|diabetes mellitus, non-insulin-dependent
897302|NCT00004500|cardiovascular and respiratory diseases|cardiovascular and respiratory diseases
897303|NCT00004500|meconium aspiration syndrome|meconium aspiration syndrome
897304|NCT00004500|rare disease|rare disease
897305|NCT00004498|genetic diseases and dysmorphic syndromes|genetic diseases and dysmorphic syndromes
897306|NCT00004498|inborn errors of metabolism|inborn errors of metabolism
897307|NCT00004498|ornithine transcarbamylase deficiency|ornithine transcarbamylase deficiency
897308|NCT00004498|rare disease|rare disease
897309|NCT00004498|urea cycle disorder|urea cycle disorder
897310|NCT00004497|cardiovascular and respiratory diseases|cardiovascular and respiratory diseases
897311|NCT00004497|hypertensive disorder|hypertensive disorder
897312|NCT00004497|primary pulmonary hypertension|primary pulmonary hypertension
897313|NCT00004497|rare disease|rare disease
897314|NCT00004496|acute renal failure|acute renal failure
897315|NCT00004496|rare disease|rare disease
897316|NCT00004496|renal and genitourinary disorders|renal and genitourinary disorders
897317|NCT00004495|cardiovascular and respiratory diseases|cardiovascular and respiratory diseases
897318|NCT00004495|end stage renal disease|end stage renal disease
897319|NCT00004495|hyperhomocysteinemia|hyperhomocysteinemia
897320|NCT00004495|rare disease|rare disease
897321|NCT00004495|renal and genitourinary disorders|renal and genitourinary disorders
897322|NCT00004494|cardiovascular and respiratory diseases|cardiovascular and respiratory diseases
897323|NCT00004494|immunologic disorders and infectious disorders|immunologic disorders and infectious disorders
897324|NCT00004494|neonatal disorders|neonatal disorders
897325|NCT00004494|rare disease|rare disease
897326|NCT00004494|respiratory distress syndrome|respiratory distress syndrome
897327|NCT00004494|sepsis|sepsis
897328|NCT00004493|inborn errors of metabolism|inborn errors of metabolism
897329|NCT00004493|lactic acidosis|lactic acidosis
897330|NCT00004493|rare disease|rare disease
897331|NCT00004492|genetic diseases and dysmorphic syndromes|genetic diseases and dysmorphic syndromes
897332|NCT00004492|hematologic disorders|hematologic disorders
897333|NCT00004492|rare disease|rare disease
897334|NCT00004492|sickle cell anemia|sickle cell anemia
897335|NCT00004490|disease-related problem/condition|disease-related problem/condition
897336|NCT00004490|inborn errors of metabolism|inborn errors of metabolism
897337|NCT00004490|lactic acidosis|lactic acidosis
897338|NCT00004490|quality of life|quality of life
897339|NCT00004490|rare disease|rare disease
897340|NCT00004489|cardiovascular and respiratory diseases|cardiovascular and respiratory diseases
897341|NCT00004489|cystic fibrosis|cystic fibrosis
897342|NCT00004489|disease-related problem/condition|disease-related problem/condition
897343|NCT00004489|genetic diseases and dysmorphic syndromes|genetic diseases and dysmorphic syndromes
897344|NCT00004489|osteoporosis|osteoporosis
897345|NCT00004489|rare disease|rare disease
897346|NCT00004488|Gaucher's disease|gaucher's disease
897347|NCT00004488|inborn errors of metabolism|inborn errors of metabolism
897348|NCT00004488|rare disease|rare disease
897349|NCT00004488|sphingolipidoses|sphingolipidoses
897350|NCT00004487|rare disease|rare disease
897351|NCT00004487|renal and genitourinary disorders|renal and genitourinary disorders
897352|NCT00004487|vesicoureteral reflux|vesicoureteral reflux
897353|NCT00004486|autism|autism
897354|NCT00004486|neurologic and psychiatric disorders|neurologic and psychiatric disorders
897355|NCT00004486|rare disease|rare disease
897356|NCT00004485|genetic diseases and dysmorphic syndromes|genetic diseases and dysmorphic syndromes
897357|NCT00004485|hematologic disorders|hematologic disorders
897358|NCT00004485|rare disease|rare disease
897359|NCT00004485|sickle cell anemia|sickle cell anemia
897360|NCT00004482|cardiovascular and respiratory diseases|cardiovascular and respiratory diseases
897361|NCT00004482|giant cell myocarditis|giant cell myocarditis
897362|NCT00004482|rare disease|rare disease
897363|NCT00004481|endocrine disorders|endocrine disorders
897364|NCT00004481|inborn errors of metabolism|inborn errors of metabolism
897365|NCT00004481|rare disease|rare disease
897366|NCT00004481|sitosterolemia|sitosterolemia
897367|NCT00004480|dermatologic disorders|dermatologic disorders
897368|NCT00004480|hyperhidrosis|hyperhidrosis
897369|NCT00004480|rare disease|rare disease
897370|NCT00004479|neurologic and psychiatric disorders|neurologic and psychiatric disorders
897371|NCT00004479|rare disease|rare disease
897372|NCT00004479|syncope|syncope
897373|NCT00004478|Shy-Drager Syndrome|shy-drager syndrome
897374|NCT00004478|cardiovascular and respiratory diseases|cardiovascular and respiratory diseases
897375|NCT00004478|neurologic and psychiatric disorders|neurologic and psychiatric disorders
897376|NCT00004478|orthostatic hypotension|orthostatic hypotension
897377|NCT00004478|rare disease|rare disease
897378|NCT00004474|Hematologic Disorders|hematologic disorders
897379|NCT00004474|Rare Disease|rare disease
897380|NCT00004471|cardiovascular and respiratory diseases|cardiovascular and respiratory diseases
897381|NCT00004471|cystic fibrosis|cystic fibrosis
897382|NCT00004471|genetic diseases and dysmorphic syndromes|genetic diseases and dysmorphic syndromes
897383|NCT00004471|rare disease|rare disease
897384|NCT00004468|dermatologic disorders|dermatologic disorders
897385|NCT00004468|psoriasis|psoriasis
897386|NCT00004468|rare disease|rare disease
897387|NCT00004467|acute liver failure|acute liver failure
897388|NCT00004467|gastrointestinal disorders|gastrointestinal disorders
897389|NCT00004467|rare disease|rare disease
897390|NCT00004466|cardiovascular and respiratory diseases|cardiovascular and respiratory diseases
897391|NCT00004466|hyperlipidemia|hyperlipidemia
897392|NCT00004466|nephrotic syndrome|nephrotic syndrome
897393|NCT00004466|rare disease|rare disease
897394|NCT00004466|renal and genitourinary disorders|renal and genitourinary disorders
897395|NCT00004465|E. coli infection|e. coli infection
897396|NCT00004465|bacterial infection|bacterial infection
897397|NCT00004465|hemolytic uremic syndrome|hemolytic uremic syndrome
897398|NCT00004465|immunologic disorders and infectious disorders|immunologic disorders and infectious disorders
897399|NCT00004465|rare disease|rare disease
897400|NCT00004465|renal and genitourinary disorders|renal and genitourinary disorders
897401|NCT00004464|aplastic anemia|aplastic anemia
897402|NCT00004464|hematologic disorders|hematologic disorders
897403|NCT00004464|paroxysmal nocturnal hemoglobinuria|paroxysmal nocturnal hemoglobinuria
897404|NCT00004464|rare disease|rare disease
897405|NCT00004458|autism|autism
897406|NCT00004458|childhood disintegrative disorder|childhood disintegrative disorder
897407|NCT00004458|neurologic and psychiatric disorders|neurologic and psychiatric disorders
897408|NCT00004458|rare disease|rare disease
897409|NCT00004457|amyotrophic lateral sclerosis|amyotrophic lateral sclerosis
897410|NCT00004457|motor neuron disease|motor neuron disease
897411|NCT00004457|neurologic and psychiatric disorders|neurologic and psychiatric disorders
897412|NCT00004457|rare disease|rare disease
897413|NCT00004454|inborn errors of metabolism|inborn errors of metabolism
897414|NCT00004454|mucopolysaccharidosis|mucopolysaccharidosis
897415|NCT00004454|mucopolysaccharidosis II|mucopolysaccharidosis ii
897416|NCT00004454|rare disease|rare disease
897417|NCT00004451|Parkinson disease|parkinson disease
897418|NCT00004451|neurologic and psychiatric disorders|neurologic and psychiatric disorders
897419|NCT00004451|rare disease|rare disease
897420|NCT00004450|adrenoleukodystrophy|adrenoleukodystrophy
897421|NCT00004450|inborn errors of metabolism|inborn errors of metabolism
897422|NCT00004450|rare disease|rare disease
897423|NCT00004450|sphingolipidoses|sphingolipidoses
897424|NCT00004449|autism|autism
897425|NCT00004449|neurologic and psychiatric disorders|neurologic and psychiatric disorders
897426|NCT00004449|rare disease|rare disease
897427|NCT00004448|IgA glomerulonephritis|iga glomerulonephritis
897428|NCT00004448|rare disease|rare disease
897429|NCT00004448|renal and genitourinary disorders|renal and genitourinary disorders
897430|NCT00004446|depersonalization disorder|depersonalization disorder
897431|NCT00004446|neurologic and psychiatric disorders|neurologic and psychiatric disorders
897432|NCT00004446|rare disease|rare disease
897433|NCT00004445|environmental/toxic disorders|environmental/toxic disorders
897434|NCT00004445|neurologic and psychiatric disorders|neurologic and psychiatric disorders
897435|NCT00004445|rare disease|rare disease
897436|NCT00004445|spinal cord injury|spinal cord injury
897437|NCT00004444|bacterial infection|bacterial infection
897438|NCT00004444|immunologic disorders and infectious disorders|immunologic disorders and infectious disorders
897439|NCT00004444|mycobacterium infection|mycobacterium infection
897440|NCT00004444|mycobacterium tuberculosis infection|mycobacterium tuberculosis infection
897441|NCT00004444|rare disease|rare disease
897442|NCT00004443|inborn errors of metabolism|inborn errors of metabolism
897443|NCT00004443|rare disease|rare disease
897444|NCT00004443|tyrosinemia I|tyrosinemia i
897445|NCT00004442|Zellweger syndrome|zellweger syndrome
897446|NCT00004442|adrenoleukodystrophy|adrenoleukodystrophy
897447|NCT00004442|bifunctional enzyme deficiency|bifunctional enzyme deficiency
897448|NCT00004442|inborn errors of metabolism|inborn errors of metabolism
897449|NCT00004442|infantile Refsum's disease|infantile refsum's disease
897450|NCT00004442|peroxisomal disorders|peroxisomal disorders
897451|NCT00004442|pseudo-Zellweger syndrome|pseudo-zellweger syndrome
897452|NCT00004442|rare disease|rare disease
897453|NCT00004442|sphingolipidoses|sphingolipidoses
897454|NCT00004441|cardiovascular and respiratory diseases|cardiovascular and respiratory diseases
897455|NCT00004441|cystic fibrosis|cystic fibrosis
897456|NCT00004441|genetic diseases and dysmorphic syndromes|genetic diseases and dysmorphic syndromes
897457|NCT00004441|rare disease|rare disease
897458|NCT00004440|cardiovascular and respiratory diseases|cardiovascular and respiratory diseases
897459|NCT00004440|cystic fibrosis|cystic fibrosis
897460|NCT00004440|genetic diseases and dysmorphic syndromes|genetic diseases and dysmorphic syndromes
897461|NCT00004440|rare disease|rare disease
897462|NCT00004438|endocrine disorders|endocrine disorders
897463|NCT00004438|hypogonadism|hypogonadism
897464|NCT00004438|rare disease|rare disease
897465|NCT00004437|acoustic neuroma|acoustic neuroma
897466|NCT00004437|genetic diseases and dysmorphic syndromes|genetic diseases and dysmorphic syndromes
897467|NCT00004437|hearing loss|hearing loss
897468|NCT00004437|neurofibromatosis|neurofibromatosis
897469|NCT00004437|neurologic and psychiatric disorders|neurologic and psychiatric disorders
897470|NCT00004437|rare disease|rare disease
897471|NCT00004436|cardiovascular and respiratory diseases|cardiovascular and respiratory diseases
897472|NCT00004436|hemangioma|hemangioma
897473|NCT00004436|rare disease|rare disease
897474|NCT00004433|Tourette syndrome|tourette syndrome
897475|NCT00004433|neurologic and psychiatric disorders|neurologic and psychiatric disorders
897476|NCT00004433|rare disease|rare disease
897477|NCT00004431|neurologic and psychiatric disorders|neurologic and psychiatric disorders
897478|NCT00004431|rare disease|rare disease
897479|NCT00004431|trigeminal neuralgia|trigeminal neuralgia
897480|NCT00004430|cardiovascular and respiratory diseases|cardiovascular and respiratory diseases
897481|NCT00004430|corneal neovascularization|corneal neovascularization
897482|NCT00004430|rare disease|rare disease
897483|NCT00004429|end stage renal disease|end stage renal disease
897484|NCT00004429|rare disease|rare disease
897485|NCT00004429|renal and genitourinary disorders|renal and genitourinary disorders
897720|NCT00004351|Smith-Magenis syndrome|smith-magenis syndrome
897486|NCT00004428|cardiovascular and respiratory diseases|cardiovascular and respiratory diseases
897487|NCT00004428|cystic fibrosis|cystic fibrosis
897488|NCT00004428|genetic diseases and dysmorphic syndromes|genetic diseases and dysmorphic syndromes
897489|NCT00004428|rare disease|rare disease
897490|NCT00004426|endocrine disorders|endocrine disorders
897491|NCT00004426|hypogonadism|hypogonadism
897492|NCT00004426|rare disease|rare disease
897493|NCT00004424|disease-related problem/condition|disease-related problem/condition
897494|NCT00004424|oncologic disorders|oncologic disorders
897495|NCT00004424|pulmonary complications|pulmonary complications
897496|NCT00004424|rare disease|rare disease
897497|NCT00004424|Respiration, Artificial|respiration, artificial
897498|NCT00004423|Crohn's disease|crohn's disease
897499|NCT00004423|gastrointestinal disorders|gastrointestinal disorders
897500|NCT00004423|rare disease|rare disease
897501|NCT00004422|bacterial infection|bacterial infection
897502|NCT00004422|immunologic disorders and infectious disorders|immunologic disorders and infectious disorders
897503|NCT00004422|pertussis|pertussis
897504|NCT00004422|rare disease|rare disease
897505|NCT00004421|dystonia|dystonia
897506|NCT00004421|neurologic and psychiatric disorders|neurologic and psychiatric disorders
897507|NCT00004421|rare disease|rare disease
897508|NCT00004420|arthritis & connective tissue diseases|arthritis & connective tissue diseases
897509|NCT00004420|juvenile rheumatoid arthritis|juvenile rheumatoid arthritis
897510|NCT00004420|rare disease|rare disease
897511|NCT00004419|endocrine disorders|endocrine disorders
897512|NCT00004419|insulin resistance|insulin resistance
897513|NCT00004419|rare disease|rare disease
897514|NCT00004418|adrenoleukodystrophy|adrenoleukodystrophy
897515|NCT00004418|inborn errors of metabolism|inborn errors of metabolism
897516|NCT00004418|rare disease|rare disease
897517|NCT00004418|sphingolipidoses|sphingolipidoses
897518|NCT00004416|achalasia|achalasia
897519|NCT00004416|gastrointestinal disorders|gastrointestinal disorders
897520|NCT00004416|rare disease|rare disease
897521|NCT00004415|environmental/toxic disorders|environmental/toxic disorders
897522|NCT00004415|neurologic and psychiatric disorders|neurologic and psychiatric disorders
897523|NCT00004415|rare disease|rare disease
897524|NCT00004415|spinal cord injury|spinal cord injury
897525|NCT00004414|cholestasis|cholestasis
897526|NCT00004414|gastrointestinal disorders|gastrointestinal disorders
897527|NCT00004414|rare disease|rare disease
897528|NCT00004412|dermatologic disorders|dermatologic disorders
897529|NCT00004412|genetic diseases and dysmorphic syndromes|genetic diseases and dysmorphic syndromes
897530|NCT00004412|hematologic disorders|hematologic disorders
897531|NCT00004412|rare disease|rare disease
897532|NCT00004412|sickle cell anemia|sickle cell anemia
897533|NCT00004412|skin ulcers|skin ulcers
897534|NCT00004412|thalassemia major|thalassemia major
897535|NCT00004410|cholestasis|cholestasis
897536|NCT00004410|gastrointestinal disorders|gastrointestinal disorders
897537|NCT00004410|rare disease|rare disease
897538|NCT00004409|Dupuytren's disease|dupuytren's disease
897539|NCT00004409|arthritis & connective tissue diseases|arthritis & connective tissue diseases
897540|NCT00004409|rare disease|rare disease
897541|NCT00004408|disease-related problem/condition|disease-related problem/condition
897542|NCT00004408|genetic diseases and dysmorphic syndromes|genetic diseases and dysmorphic syndromes
897543|NCT00004408|hematologic disorders|hematologic disorders
897544|NCT00004408|pain|pain
897545|NCT00004408|rare disease|rare disease
897546|NCT00004408|sickle cell anemia|sickle cell anemia
897547|NCT00004407|diabetic amyotrophy|diabetic amyotrophy
897548|NCT00004407|diabetic lumbosacral radiculoplexus neuropathy|diabetic lumbosacral radiculoplexus neuropathy
897549|NCT00004407|diabetic neuropathy|diabetic neuropathy
897550|NCT00004407|diabetic proximal neuropathy|diabetic proximal neuropathy
897551|NCT00004407|neurologic and psychiatric disorders|neurologic and psychiatric disorders
897552|NCT00004407|rare disease|rare disease
897553|NCT00004406|disease-related problem/condition|disease-related problem/condition
897554|NCT00004406|osteoporosis|osteoporosis
897555|NCT00004406|rare disease|rare disease
897556|NCT00004404|genetic diseases and dysmorphic syndromes|genetic diseases and dysmorphic syndromes
897557|NCT00004404|hematologic disorders|hematologic disorders
897558|NCT00004404|rare disease|rare disease
897559|NCT00004404|sickle cell anemia|sickle cell anemia
897560|NCT00004403|cysticercosis|cysticercosis
897561|NCT00004403|epilepsy|epilepsy
897562|NCT00004403|immunologic disorders and infectious disorders|immunologic disorders and infectious disorders
897563|NCT00004403|neurologic and psychiatric disorders|neurologic and psychiatric disorders
897564|NCT00004403|parasitic infection|parasitic infection
897565|NCT00004403|rare disease|rare disease
897566|NCT00004403|seizures|seizures
897567|NCT00004402|genetic diseases and dysmorphic syndromes|genetic diseases and dysmorphic syndromes
897568|NCT00004402|osteopetrosis|osteopetrosis
897569|NCT00004402|rare disease|rare disease
897570|NCT00004401|bacterial infection|bacterial infection
897571|NCT00004401|clostridium infection|clostridium infection
897572|NCT00004401|immunologic disorders and infectious disorders|immunologic disorders and infectious disorders
897573|NCT00004401|infant botulism|infant botulism
897574|NCT00004401|rare disease|rare disease
897575|NCT00004400|cachexia|cachexia
897576|NCT00004400|disease-related problem/condition|disease-related problem/condition
897577|NCT00004400|human immunodeficiency virus infection|human immunodeficiency virus infection
897578|NCT00004400|immunologic disorders and infectious disorders|immunologic disorders and infectious disorders
897579|NCT00004400|nutrition|nutrition
897580|NCT00004400|quality of life|quality of life
897581|NCT00004400|rare disease|rare disease
897582|NCT00004400|viral infection|viral infection
897583|NCT00004399|cardiovascular and respiratory diseases|cardiovascular and respiratory diseases
897584|NCT00004399|hypertensive disorder|hypertensive disorder
897585|NCT00004399|pre-eclampsia|pre-eclampsia
897586|NCT00004399|rare disease|rare disease
897587|NCT00004398|inborn errors of metabolism|inborn errors of metabolism
897588|NCT00004398|porphyria|porphyria
897589|NCT00004398|rare disease|rare disease
897590|NCT00004397|inborn errors of metabolism|inborn errors of metabolism
897591|NCT00004397|porphyria|porphyria
897592|NCT00004397|rare disease|rare disease
897593|NCT00004396|inborn errors of metabolism|inborn errors of metabolism
897594|NCT00004396|porphyria|porphyria
897595|NCT00004396|rare disease|rare disease
897596|NCT00004393|Tourette syndrome|tourette syndrome
897597|NCT00004393|neurologic and psychiatric disorders|neurologic and psychiatric disorders
897598|NCT00004393|rare disease|rare disease
897599|NCT00004392|apnea|apnea
897600|NCT00004392|cardiovascular and respiratory diseases|cardiovascular and respiratory diseases
897601|NCT00004392|neurologic and psychiatric disorders|neurologic and psychiatric disorders
897602|NCT00004392|rare disease|rare disease
897603|NCT00004392|sudden infant death syndrome|sudden infant death syndrome
897604|NCT00004390|disease-related problem/condition|disease-related problem/condition
897605|NCT00004390|herpes zoster infection|herpes zoster infection
897606|NCT00004390|herpesvirus infection|herpesvirus infection
897607|NCT00004390|immunologic disorders and infectious disorders|immunologic disorders and infectious disorders
897608|NCT00004390|pain|pain
897609|NCT00004390|rare disease|rare disease
897610|NCT00004390|viral infection|viral infection
897611|NCT00004387|Parkinson disease|parkinson disease
897612|NCT00004387|neurologic and psychiatric disorders|neurologic and psychiatric disorders
897613|NCT00004387|rare disease|rare disease
897614|NCT00004386|inborn errors of metabolism|inborn errors of metabolism
897615|NCT00004386|rare disease|rare disease
897616|NCT00004386|urea cycle disorder|urea cycle disorder
897617|NCT00004382|hematologic disorders|hematologic disorders
897618|NCT00004382|hyperbilirubinemia|hyperbilirubinemia
897619|NCT00004382|rare disease|rare disease
897620|NCT00004381|glucose-6-phosphate dehydrogenase deficiency|glucose-6-phosphate dehydrogenase deficiency
897621|NCT00004381|hematologic disorders|hematologic disorders
897622|NCT00004381|hemolytic disease|hemolytic disease
897623|NCT00004381|hyperbilirubinemia|hyperbilirubinemia
897624|NCT00004381|neonatal disorders|neonatal disorders
897625|NCT00004381|rare disease|rare disease
897626|NCT00004380|arthritis & connective tissue diseases|arthritis & connective tissue diseases
897627|NCT00004380|rare disease|rare disease
897628|NCT00004380|systemic sclerosis|systemic sclerosis
897629|NCT00004378|Fanconi's anemia|fanconi's anemia
897630|NCT00004378|amegakaryocytic thrombocytopenia|amegakaryocytic thrombocytopenia
897631|NCT00004378|aplastic anemia|aplastic anemia
897632|NCT00004378|congenital pure red cell aplasia|congenital pure red cell aplasia
897986|NCT00000341|opioid dependence|opioid dependence
897633|NCT00004378|genetic diseases and dysmorphic syndromes|genetic diseases and dysmorphic syndromes
897634|NCT00004378|hematologic disorders|hematologic disorders
897635|NCT00004378|inborn errors of metabolism|inborn errors of metabolism
897636|NCT00004378|metachromatic leukodystrophy|metachromatic leukodystrophy
897637|NCT00004378|pure red cell aplasia|pure red cell aplasia
897638|NCT00004378|rare disease|rare disease
897639|NCT00004378|sphingolipidoses|sphingolipidoses
897640|NCT00004378|thalassemia major|thalassemia major
897641|NCT00004376|Tourette syndrome|tourette syndrome
897642|NCT00004376|neurologic and psychiatric disorders|neurologic and psychiatric disorders
897643|NCT00004376|rare disease|rare disease
897644|NCT00004375|arthritis & connective tissue diseases|arthritis & connective tissue diseases
897645|NCT00004375|immunologic disorders and infectious disorders|immunologic disorders and infectious disorders
897646|NCT00004375|rare disease|rare disease
897647|NCT00004375|systemic lupus erythematosus|systemic lupus erythematosus
897648|NCT00004374|amyloidosis|amyloidosis
897649|NCT00004374|arthritis & connective tissue diseases|arthritis & connective tissue diseases
897650|NCT00004374|genetic diseases and dysmorphic syndromes|genetic diseases and dysmorphic syndromes
897651|NCT00004374|rare disease|rare disease
897652|NCT00004373|anxiety disorder|anxiety disorder
897653|NCT00004373|disease-related problem/condition|disease-related problem/condition
897654|NCT00004373|neurologic and psychiatric disorders|neurologic and psychiatric disorders
897655|NCT00004373|panic disorder|panic disorder
897656|NCT00004373|rare disease|rare disease
897657|NCT00004368|hepatic cirrhosis|hepatic cirrhosis
897658|NCT00004368|gastrointestinal disorders|gastrointestinal disorders
897659|NCT00004368|rare disease|rare disease
897660|NCT00004367|anxiety disorder|anxiety disorder
897661|NCT00004367|disease-related problem/condition|disease-related problem/condition
897662|NCT00004367|neurologic and psychiatric disorders|neurologic and psychiatric disorders
897663|NCT00004367|panic disorder|panic disorder
897664|NCT00004367|rare disease|rare disease
897665|NCT00004366|agoraphobia|agoraphobia
897666|NCT00004366|anxiety disorder|anxiety disorder
897667|NCT00004366|disease-related problem/condition|disease-related problem/condition
897668|NCT00004366|neurologic and psychiatric disorders|neurologic and psychiatric disorders
897669|NCT00004366|panic disorder|panic disorder
897670|NCT00004366|rare disease|rare disease
897671|NCT00004366|vestibular diseases|vestibular diseases
897672|NCT00004365|endocrine disorders|endocrine disorders
897673|NCT00004365|growth hormone deficiency|growth hormone deficiency
897674|NCT00004365|rare disease|rare disease
897675|NCT00004364|diabetes insipidus|diabetes insipidus
897676|NCT00004364|endocrine disorders|endocrine disorders
897677|NCT00004364|rare disease|rare disease
897678|NCT00004363|diabetes insipidus|diabetes insipidus
897679|NCT00004363|endocrine disorders|endocrine disorders
897680|NCT00004363|rare disease|rare disease
897681|NCT00004361|DiGeorge syndrome|digeorge syndrome
897682|NCT00004361|cardiovascular and respiratory diseases|cardiovascular and respiratory diseases
897683|NCT00004361|conotruncal cardiac defects|conotruncal cardiac defects
897684|NCT00004361|endocrine disorders|endocrine disorders
897685|NCT00004361|genetic diseases and dysmorphic syndromes|genetic diseases and dysmorphic syndromes
897686|NCT00004361|hypoparathyroidism|hypoparathyroidism
897687|NCT00004361|pulmonary valve stenosis|pulmonary valve stenosis
897688|NCT00004361|rare disease|rare disease
897689|NCT00004361|tetralogy of Fallot|tetralogy of fallot
897690|NCT00004360|diabetes insipidus|diabetes insipidus
897691|NCT00004360|endocrine disorders|endocrine disorders
897692|NCT00004360|rare disease|rare disease
897693|NCT00004359|dermatologic disorders|dermatologic disorders
897694|NCT00004359|epidermolysis bullosa|epidermolysis bullosa
897695|NCT00004359|genetic diseases and dysmorphic syndromes|genetic diseases and dysmorphic syndromes
897696|NCT00004359|rare disease|rare disease
897697|NCT00004358|arthritis & connective tissue diseases|arthritis & connective tissue diseases
897698|NCT00004358|rare disease|rare disease
897699|NCT00004358|tumoral calcinosis|tumoral calcinosis
897700|NCT00004357|Cardiovascular Disease|cardiovascular disease
897701|NCT00004357|Respiratory Disease|respiratory disease
897702|NCT00004357|Rare Diseases|rare diseases
897703|NCT00004357|Vasculitis|vasculitis
897704|NCT00004356|homocystinuria|homocystinuria
897705|NCT00004356|inborn errors of metabolism|inborn errors of metabolism
897706|NCT00004356|rare disease|rare disease
897707|NCT00004354|endocrine disorders|endocrine disorders
897708|NCT00004354|genetic diseases and dysmorphic syndromes|genetic diseases and dysmorphic syndromes
897709|NCT00004354|hyperaldosteronism|hyperaldosteronism
897710|NCT00004354|rare disease|rare disease
897711|NCT00004353|MELAS syndrome|melas syndrome
897712|NCT00004353|inborn errors of metabolism|inborn errors of metabolism
897713|NCT00004353|lactic acidosis|lactic acidosis
897714|NCT00004353|mitochondrial myopathy|mitochondrial myopathy
897715|NCT00004353|rare disease|rare disease
897716|NCT00004351|Angelman syndrome|angelman syndrome
897717|NCT00004351|DiGeorge syndrome|digeorge syndrome
897718|NCT00004351|Prader-Willi syndrome|prader-willi syndrome
897719|NCT00004351|Shprintzen syndrome|shprintzen syndrome
897721|NCT00004351|Williams syndrome|williams syndrome
898087|NCT00000258|instruction|instruction
897722|NCT00004351|genetic diseases and dysmorphic syndromes|genetic diseases and dysmorphic syndromes
897723|NCT00004351|neurologic and psychiatric disorders|neurologic and psychiatric disorders
897724|NCT00004351|rare disease|rare disease
897725|NCT00004350|Fanconi syndrome|fanconi syndrome
897727|NCT00004350|rare disease|rare disease
897728|NCT00004350|renal and genitourinary disorders|renal and genitourinary disorders
897729|NCT00004348|beta-oxidation disorder|beta-oxidation disorder
897730|NCT00004348|inborn errors of metabolism|inborn errors of metabolism
897731|NCT00004348|rare disease|rare disease
897732|NCT00004347|Smith-Lemli-Opitz syndrome|smith-lemli-opitz syndrome
897733|NCT00004347|genetic diseases and dysmorphic syndromes|genetic diseases and dysmorphic syndromes
897734|NCT00004347|rare disease|rare disease
897735|NCT00004346|cerebrotendinous xanthomatosis|cerebrotendinous xanthomatosis
897736|NCT00004346|inborn errors of metabolism|inborn errors of metabolism
897737|NCT00004346|rare disease|rare disease
897738|NCT00004345|Usher syndrome|usher syndrome
897739|NCT00004345|ophthalmologic disorders|ophthalmologic disorders
897740|NCT00004345|rare disease|rare disease
897741|NCT00004345|retinitis pigmentosa|retinitis pigmentosa
897742|NCT00004344|endocrine disorders|endocrine disorders
897743|NCT00004344|precocious puberty|precocious puberty
897744|NCT00004344|rare disease|rare disease
897745|NCT00004343|Cushing's syndrome|cushing's syndrome
897746|NCT00004343|endocrine disorders|endocrine disorders
897747|NCT00004343|rare disease|rare disease
897748|NCT00004342|chronic neutropenia|chronic neutropenia
897749|NCT00004342|disease-related problem/condition|disease-related problem/condition
897750|NCT00004342|hematologic disorders|hematologic disorders
897751|NCT00004342|neutropenia|neutropenia
897752|NCT00004342|rare disease|rare disease
897753|NCT00004342|severe chronic neutropenia|severe chronic neutropenia
897754|NCT00004341|Wiskott-Aldrich syndrome|wiskott-aldrich syndrome
897755|NCT00004341|X-linked agammaglobulinemia|x-linked agammaglobulinemia
897756|NCT00004341|X-linked hyper IgM syndrome|x-linked hyper igm syndrome
897757|NCT00004341|genetic diseases and dysmorphic syndromes|genetic diseases and dysmorphic syndromes
897758|NCT00004341|immunologic disorders and infectious disorders|immunologic disorders and infectious disorders
897759|NCT00004341|leukocyte adhesion deficiency syndrome|leukocyte adhesion deficiency syndrome
897760|NCT00004341|primary immunodeficiency disease|primary immunodeficiency disease
897761|NCT00004341|rare disease|rare disease
897762|NCT00004340|end stage renal disease|end stage renal disease
897763|NCT00004340|rare disease|rare disease
897764|NCT00004340|renal and genitourinary disorders|renal and genitourinary disorders
897765|NCT00004340|renal osteodystrophy|renal osteodystrophy
897766|NCT00004339|Wilson disease|wilson disease
897767|NCT00004339|inborn errors of metabolism|inborn errors of metabolism
897768|NCT00004339|rare disease|rare disease
897769|NCT00004338|Wilson disease|wilson disease
897770|NCT00004338|inborn errors of metabolism|inborn errors of metabolism
897771|NCT00004338|rare disease|rare disease
897772|NCT00004336|Mondini dysplasia|mondini dysplasia
897773|NCT00004336|genetic diseases and dysmorphic syndromes|genetic diseases and dysmorphic syndromes
897774|NCT00004336|rare disease|rare disease
897775|NCT00004335|endocrine disorders|endocrine disorders
897776|NCT00004335|growth hormone deficiency|growth hormone deficiency
897777|NCT00004335|hypogonadism|hypogonadism
897778|NCT00004335|precocious puberty|precocious puberty
897779|NCT00004335|rare disease|rare disease
897780|NCT00004334|Cushing's syndrome|cushing's syndrome
897781|NCT00004334|endocrine disorders|endocrine disorders
897782|NCT00004334|rare disease|rare disease
897783|NCT00004333|inborn errors of metabolism|inborn errors of metabolism
897784|NCT00004333|rare disease|rare disease
897785|NCT00004333|tyrosinemia I|tyrosinemia i
897786|NCT00004332|acromegaly|acromegaly
897787|NCT00004332|endocrine disorders|endocrine disorders
897788|NCT00004332|rare disease|rare disease
897789|NCT00004331|inborn errors of metabolism|inborn errors of metabolism
897790|NCT00004331|porphyria|porphyria
897791|NCT00004331|rare disease|rare disease
897792|NCT00004330|inborn errors of metabolism|inborn errors of metabolism
897793|NCT00004330|porphyria|porphyria
897794|NCT00004330|rare disease|rare disease
897795|NCT00004329|endocrine disorders|endocrine disorders
897796|NCT00004329|rare disease|rare disease
897797|NCT00004328|endocrine disorders|endocrine disorders
897798|NCT00004328|pseudohypoaldosteronism|pseudohypoaldosteronism
897799|NCT00004328|rare disease|rare disease
897800|NCT00004327|genetic diseases and dysmorphic syndromes|genetic diseases and dysmorphic syndromes
897801|NCT00004327|hematologic disorders|hematologic disorders
897802|NCT00004327|hereditary hemorrhagic telangiectasia|hereditary hemorrhagic telangiectasia
897803|NCT00004327|rare disease|rare disease
897804|NCT00004327|senile ectasia|senile ectasia
897805|NCT00004326|Cushing's syndrome|cushing's syndrome
897806|NCT00004326|endocrine disorders|endocrine disorders
897807|NCT00004326|rare disease|rare disease
897808|NCT00004325|Tourette syndrome|tourette syndrome
897809|NCT00004325|anxiety disorder|anxiety disorder
897810|NCT00004325|disease-related problem/condition|disease-related problem/condition
897811|NCT00004325|neurologic and psychiatric disorders|neurologic and psychiatric disorders
897812|NCT00004325|obsessive compulsive disorder|obsessive compulsive disorder
897813|NCT00004325|oncologic disorders|oncologic disorders
897814|NCT00004325|rare disease|rare disease
897815|NCT00004324|Tourette syndrome|tourette syndrome
897816|NCT00004324|anxiety disorder|anxiety disorder
897817|NCT00004324|disease-related problem/condition|disease-related problem/condition
897818|NCT00004324|neurologic and psychiatric disorders|neurologic and psychiatric disorders
897819|NCT00004324|obsessive compulsive disorder|obsessive compulsive disorder
897820|NCT00004324|oncologic disorders|oncologic disorders
897821|NCT00004324|rare disease|rare disease
897822|NCT00004323|aplastic anemia|aplastic anemia
897823|NCT00004323|hematologic disorders|hematologic disorders
897824|NCT00004323|rare disease|rare disease
897825|NCT00004317|immunologic disorders and infectious disorders|immunologic disorders and infectious disorders
897826|NCT00004317|rare disease|rare disease
897827|NCT00004317|toxoplasmosis|toxoplasmosis
897828|NCT00004316|interstitial cystitis|interstitial cystitis
897829|NCT00004316|rare disease|rare disease
897830|NCT00004316|renal and genitourinary disorders|renal and genitourinary disorders
897831|NCT00004316|vulvar vestibulitis|vulvar vestibulitis
897832|NCT00004315|cardiovascular and respiratory diseases|cardiovascular and respiratory diseases
897833|NCT00004315|cholestasis|cholestasis
897834|NCT00004315|cystic fibrosis|cystic fibrosis
897835|NCT00004315|gastrointestinal disorders|gastrointestinal disorders
897836|NCT00004315|genetic diseases and dysmorphic syndromes|genetic diseases and dysmorphic syndromes
897837|NCT00004315|rare disease|rare disease
897838|NCT00004314|Lesch-Nyhan syndrome|lesch-nyhan syndrome
897839|NCT00004314|inborn errors of metabolism|inborn errors of metabolism
897840|NCT00004314|neurologic and psychiatric disorders|neurologic and psychiatric disorders
897841|NCT00004314|rare disease|rare disease
897842|NCT00004313|Addison's disease|addison's disease
897843|NCT00004313|endocrine disorders|endocrine disorders
897844|NCT00004313|rare disease|rare disease
897845|NCT00004313|primary adrenal insufficiency|primary adrenal insufficiency
897846|NCT00004312|cystinosis|cystinosis
897847|NCT00004312|rare disease|rare disease
897848|NCT00004312|renal and genitourinary disorders|renal and genitourinary disorders
897849|NCT00004311|acanthosis nigricans|acanthosis nigricans
897850|NCT00004311|dermatologic disorders|dermatologic disorders
897851|NCT00004311|endocrine disorders|endocrine disorders
897852|NCT00004311|polycystic ovarian syndrome|polycystic ovarian syndrome
897853|NCT00004311|rare disease|rare disease
897854|NCT00004310|anxiety disorder|anxiety disorder
897855|NCT00004310|disease-related problem/condition|disease-related problem/condition
897856|NCT00004310|neurologic and psychiatric disorders|neurologic and psychiatric disorders
897857|NCT00004310|obsessive compulsive disorder|obsessive compulsive disorder
897858|NCT00004310|oncologic disorders|oncologic disorders
897859|NCT00004310|rare disease|rare disease
897860|NCT00004307|inborn errors of metabolism|inborn errors of metabolism
897861|NCT00004307|rare disease|rare disease
897862|NCT00004307|urea cycle disorder|urea cycle disorder
897863|NCT00004306|hereditary ataxia|hereditary ataxia
897864|NCT00004306|neurologic and psychiatric disorders|neurologic and psychiatric disorders
897865|NCT00004306|rare disease|rare disease
897866|NCT00004305|IgA glomerulonephritis|iga glomerulonephritis
897867|NCT00004305|rare disease|rare disease
897868|NCT00004305|renal and genitourinary disorders|renal and genitourinary disorders
897869|NCT00004300|mental retardation|mental retardation
897870|NCT00004300|neurologic and psychiatric disorders|neurologic and psychiatric disorders
897871|NCT00004300|rare disease|rare disease
897872|NCT00004300|stereotyped behavior|stereotyped behavior
897873|NCT00004297|epilepsy|epilepsy
897874|NCT00004297|neurologic and psychiatric disorders|neurologic and psychiatric disorders
897875|NCT00004297|rare disease|rare disease
897876|NCT00004297|seizures|seizures
897877|NCT00004297|status epilepticus|status epilepticus
897878|NCT00004296|atypical mycobacterium infection|atypical mycobacterium infection
897879|NCT00004296|bacterial infection|bacterial infection
897880|NCT00004296|cardiovascular and respiratory diseases|cardiovascular and respiratory diseases
897881|NCT00004296|cystic fibrosis|cystic fibrosis
897882|NCT00004296|genetic diseases and dysmorphic syndromes|genetic diseases and dysmorphic syndromes
897883|NCT00004296|immunologic disorders and infectious disorders|immunologic disorders and infectious disorders
897884|NCT00004296|mycobacterium infection|mycobacterium infection
897885|NCT00004296|rare disease|rare disease
897886|NCT00004294|Gaucher's disease|gaucher's disease
897887|NCT00004294|inborn errors of metabolism|inborn errors of metabolism
897888|NCT00004294|rare disease|rare disease
897889|NCT00004294|sphingolipidoses|sphingolipidoses
897890|NCT00004293|Gaucher's disease|gaucher's disease
897891|NCT00004293|inborn errors of metabolism|inborn errors of metabolism
897892|NCT00004293|rare disease|rare disease
897893|NCT00004293|sphingolipidoses|sphingolipidoses
897894|NCT00004288|ankylosing spondylitis|ankylosing spondylitis
897895|NCT00004288|genetic diseases and dysmorphic syndromes|genetic diseases and dysmorphic syndromes
897896|NCT00004288|rare disease|rare disease
897897|NCT00004287|cardiovascular and respiratory diseases|cardiovascular and respiratory diseases
897898|NCT00004287|cystic fibrosis|cystic fibrosis
897899|NCT00004287|genetic diseases and dysmorphic syndromes|genetic diseases and dysmorphic syndromes
897900|NCT00004287|rare disease|rare disease
897901|NCT00004286|demyelinating neuropathy|demyelinating neuropathy
897902|NCT00004286|neurologic and psychiatric disorders|neurologic and psychiatric disorders
897903|NCT00004286|rare disease|rare disease
897904|NCT00004285|end stage renal disease|end stage renal disease
897905|NCT00004285|rare disease|rare disease
897906|NCT00004285|renal and genitourinary disorders|renal and genitourinary disorders
897907|NCT00004284|hypercalciuria|hypercalciuria
897908|NCT00004284|nephrolithiasis|nephrolithiasis
897909|NCT00004284|rare disease|rare disease
897910|NCT00004284|renal and genitourinary disorders|renal and genitourinary disorders
897911|NCT00004278|congenital cytomegalovirus infection|congenital cytomegalovirus infection
897912|NCT00004278|cytomegalovirus infection|cytomegalovirus infection
897913|NCT00004278|herpesvirus infection|herpesvirus infection
897914|NCT00004278|immunologic disorders and infectious disorders|immunologic disorders and infectious disorders
897915|NCT00004278|neonatal disorders|neonatal disorders
897916|NCT00004278|rare disease|rare disease
897917|NCT00004278|viral infection|viral infection
897918|NCT00004276|bacterial infection|bacterial infection
897919|NCT00004276|human immunodeficiency virus infection|human immunodeficiency virus infection
897920|NCT00004276|immunologic disorders and infectious disorders|immunologic disorders and infectious disorders
897921|NCT00004276|mycobacterium infection|mycobacterium infection
897922|NCT00004276|mycobacterium tuberculosis infection|mycobacterium tuberculosis infection
897923|NCT00004276|rare disease|rare disease
897924|NCT00004276|viral infection|viral infection
897925|NCT00004275|Turner's syndrome|turner's syndrome
897926|NCT00004275|genetic diseases and dysmorphic syndromes|genetic diseases and dysmorphic syndromes
897927|NCT00004275|rare disease|rare disease
897928|NCT00004274|Turner's syndrome|turner's syndrome
897929|NCT00004274|genetic diseases and dysmorphic syndromes|genetic diseases and dysmorphic syndromes
897930|NCT00004274|rare disease|rare disease
897931|NCT00004268|cardiovascular and respiratory diseases|cardiovascular and respiratory diseases
897932|NCT00004268|disease-related problem/condition|disease-related problem/condition
897933|NCT00004268|orthostatic hypotension|orthostatic hypotension
897934|NCT00004268|quality of life|quality of life
897935|NCT00004268|rare disease|rare disease
897936|NCT00004266|diabetic nephropathy|diabetic nephropathy
897937|NCT00004266|rare disease|rare disease
897938|NCT00004266|renal and genitourinary disorders|renal and genitourinary disorders
897939|NCT00000170|Amblyopia|amblyopia
897940|NCT00000170|patching|patching
897941|NCT00000170|atropine|atropine
897942|NCT00000167|Age-Related Macular Degeneration|age-related macular degeneration
897943|NCT00000163|Congenital Esotropia|congenital esotropia
897944|NCT00000161|Age-Related Macular Degeneration|age-related macular degeneration
897945|NCT00000160|Vision Loss|vision loss
897946|NCT00000158|photocoagulation|photocoagulation
897947|NCT00000158|argon blue-green laser|argon blue-green laser
897948|NCT00000158|krypton red laser|krypton red laser
897949|NCT00000153|Diabetic Disc Neovascularization|diabetic disc neovascularization
897950|NCT00000153|Optic Disk|optic disk
897951|NCT00000152|Age-Related Macular Degeneration|age-related macular degeneration
897952|NCT00000150|Ocular Histoplasmosis Syndrome|ocular histoplasmosis syndrome
897953|NCT00000150|Idiopathic Choroidal Neovascularization|idiopathic choroidal neovascularization
897954|NCT00000145|Age-Related Macular Degeneration|age-related macular degeneration
897955|NCT00000139|Herpes Simplex Stromal Keratitis|herpes simplex stromal keratitis
897956|NCT00000138|Herpes Simplex Stromal Keratitis|herpes simplex stromal keratitis
897957|NCT00000131|Central Vein Occlusion|central vein occlusion
897958|NCT00000131|Ischemic Retina|ischemic retina
897959|NCT00000130|Bacterial Endophthalmitis|bacterial endophthalmitis
897960|NCT00000128|Near-point Esophoria|near-point esophoria
897961|NCT00000127|Non-arteritic Ischemic Optic Neuropathy|non-arteritic ischemic optic neuropathy
897962|NCT00000126|Non-arteritic Ischemic Optic Neuropathy|non-arteritic ischemic optic neuropathy
897963|NCT00000124|Choroidal Melanoma|choroidal melanoma
897964|NCT00000124|Ocular Melanoma|ocular melanoma
897965|NCT00000121|strabismus|strabismus
897966|NCT00000120|Neonatal Conjunctivitis|neonatal conjunctivitis
897967|NCT00000114|retinitis pigmentosa|retinitis pigmentosa
897968|NCT00000114|vitamin supplements|vitamin supplements
897969|NCT00000113|myopia|myopia
897970|NCT00000113|nearsightedness|nearsightedness
897971|NCT00000357|opiate dependence|opiate dependence
897972|NCT00000356|opiate dependence|opiate dependence
897973|NCT00000355|opiate dependence|opiate dependence
897974|NCT00000354|opiate dependence|opiate dependence
897975|NCT00000353|opiate dependence|opiate dependence
897976|NCT00000352|opiate dependence|opiate dependence
897977|NCT00000350|amphetamine dependence|amphetamine dependence
897978|NCT00000349|cocaine dependence|cocaine dependence
897979|NCT00000348|cocaine dependence|cocaine dependence
897980|NCT00000347|cocaine dependence|cocaine dependence
897981|NCT00000346|amphetamine dependence|amphetamine dependence
897982|NCT00000345|opioid dependence|opioid dependence
897983|NCT00000344|opioid dependence|opioid dependence
897984|NCT00000343|stimulant dependence|stimulant dependence
897985|NCT00000342|cocaine dependence|cocaine dependence
897987|NCT00000340|cocaine dependence|cocaine dependence
897988|NCT00000339|cocaine dependence|cocaine dependence
897989|NCT00000338|cocaine dependence|cocaine dependence
897990|NCT00000337|cocaine dependence|cocaine dependence
897991|NCT00000336|cocaine dependence|cocaine dependence
897992|NCT00000335|opioid dependence|opioid dependence
897993|NCT00000331|Heroin Dependence|heroin dependence
897994|NCT00000330|Heroin Dependence|heroin dependence
897995|NCT00000329|drug dependence|drug dependence
897996|NCT00000328|drug dependence|drug dependence
897997|NCT00000327|drug dependence|drug dependence
897998|NCT00000326|Heroin Dependence|heroin dependence
897999|NCT00000325|cocaine dependence|cocaine dependence
898000|NCT00000323|cocaine dependence|cocaine dependence
898001|NCT00000322|amphetamine dependence|amphetamine dependence
898002|NCT00000321|methamphetamine dependence|methamphetamine dependence
898003|NCT00000320|opioid dependence|opioid dependence
898004|NCT00000318|opioid dependence|opioid dependence
898006|NCT00000317|METHADONE PATIENTS|methadone patients
898007|NCT00000317|RISPERIDONE|risperidone
898008|NCT00000316|cocaine dependence|cocaine dependence
898009|NCT00000315|cocaine dependence|cocaine dependence
898010|NCT00000314|cocaine dependence|cocaine dependence
898011|NCT00000313|cocaine dependence|cocaine dependence
898012|NCT00000311|Cocaine-Related Disorders|cocaine-related disorders
898013|NCT00000311|Opioid-Related Disorders|opioid-related disorders
898014|NCT00000311|Substance-Related Disorders|substance-related disorders
898015|NCT00000310|cocaine dependence|cocaine dependence
898016|NCT00000309|cocaine abuse, cocaine addiction|cocaine abuse, cocaine addiction
898017|NCT00000308|cocaine dependence|cocaine dependence
898018|NCT00000307|alcohol dependence|alcohol dependence
898019|NCT00000306|cocaine dependence|cocaine dependence
898020|NCT00000304|cocaine dependence|cocaine dependence
898021|NCT00000303|Cocaine dependence|cocaine dependence
898022|NCT00000301|Amantadine|amantadine
898023|NCT00000301|Cocaine|cocaine
898024|NCT00000301|Pharmacotherapy|pharmacotherapy
898025|NCT00000301|Outpatient|outpatient
898026|NCT00000300|opiate|opiate
898027|NCT00000300|dependence|dependence
898028|NCT00000299|Opioid-Related Disorders|opioid-related disorders
898029|NCT00000296|nicotine dependence|nicotine dependence
898030|NCT00000293|cocaine dependence|cocaine dependence
898031|NCT00000291|cocaine dependence|cocaine dependence
898032|NCT00000290|cocaine dependence|cocaine dependence
898033|NCT00000288|nicotine dependence|nicotine dependence
898034|NCT00000287|Cocaine-Related Disorders|cocaine-related disorders
898035|NCT00000286|cocaine dependence|cocaine dependence
898036|NCT00000285|cocaine dependence|cocaine dependence
898037|NCT00000284|nicotine dependence|nicotine dependence
898038|NCT00000282|pemoline|pemoline
898039|NCT00000281|anti psychotic agents|anti psychotic agents
898040|NCT00000280|cocaine|cocaine
898041|NCT00000275|cocaine dependence|cocaine dependence
898042|NCT00000274|cocaine dependence|cocaine dependence
898043|NCT00000273|heroin, opioid disorders, substance related disorders|heroin, opioid disorders, substance related disorders
898044|NCT00000271|Desipramine, cocaine, depression|desipramine, cocaine, depression
898045|NCT00000270|cocaine|cocaine
898046|NCT00000269|cocaine dependence|cocaine dependence
898047|NCT00000268|cocaine dependence|cocaine dependence
898048|NCT00000267|cocaine dependence|cocaine dependence
898049|NCT00000266|cocaine dependence|cocaine dependence
898050|NCT00000265|nitrous oxide|nitrous oxide
898051|NCT00000265|anxiety|anxiety
898052|NCT00000265|subjective effects|subjective effects
898053|NCT00000265|dental|dental
898054|NCT00000265|patients|patients
898055|NCT00000264|nitrous oxide|nitrous oxide
898056|NCT00000264|inhalant|inhalant
898057|NCT00000264|ethanol|ethanol
898058|NCT00000264|subjective effects|subjective effects
898059|NCT00000264|psychomotor effects|psychomotor effects
898060|NCT00000264|healthy volunteer|healthy volunteer
898061|NCT00000263|nitrous oxide|nitrous oxide
898062|NCT00000263|ethanol|ethanol
898063|NCT00000263|drug interaction|drug interaction
898064|NCT00000263|subjective effects|subjective effects
898065|NCT00000263|healthy volunteer|healthy volunteer
898066|NCT00000262|nitrous oxide|nitrous oxide
898067|NCT00000262|sevoflurane|sevoflurane
898068|NCT00000262|drug interaction|drug interaction
898069|NCT00000262|subjective effects|subjective effects
898070|NCT00000262|analgesia|analgesia
898071|NCT00000262|healthy volunteers|healthy volunteers
898072|NCT00000261|nitrous oxide|nitrous oxide
898073|NCT00000261|sevoflurane|sevoflurane
898074|NCT00000261|ethanol|ethanol
898075|NCT00000261|subjective effects|subjective effects
898076|NCT00000261|healthy volunteer|healthy volunteer
898077|NCT00000260|nitrous oxide|nitrous oxide
898078|NCT00000260|subjective effects|subjective effects
898079|NCT00000260|reinforcer|reinforcer
898080|NCT00000260|inhalant|inhalant
898081|NCT00000260|healthy volunteer|healthy volunteer
898082|NCT00000259|sevoflurane|sevoflurane
898083|NCT00000259|nitrous oxide|nitrous oxide
898084|NCT00000259|subjective effects|subjective effects
898085|NCT00000259|healthy volunteer|healthy volunteer
898086|NCT00000258|nitrous oxide|nitrous oxide
898088|NCT00000258|subjective effects|subjective effects
898089|NCT00000258|reinforcer|reinforcer
898090|NCT00000258|healthy volunteer|healthy volunteer
898091|NCT00000257|nitrous oxide|nitrous oxide
898092|NCT00000257|subjective effects|subjective effects
898093|NCT00000257|ethanol|ethanol
898094|NCT00000257|healthy volunteer|healthy volunteer
898095|NCT00000256|nitrous oxide|nitrous oxide
898096|NCT00000256|reinforcer|reinforcer
898097|NCT00000256|subjective effects|subjective effects
898098|NCT00000256|healthy volunteer|healthy volunteer
898099|NCT00000255|nitrous oxide|nitrous oxide
898100|NCT00000255|acute tolerance|acute tolerance
898101|NCT00000255|subjective effects|subjective effects
898102|NCT00000255|analgesia|analgesia
898103|NCT00000255|psychomotor|psychomotor
898104|NCT00000255|healthy volunteer|healthy volunteer
898105|NCT00000254|isoflurane|isoflurane
898106|NCT00000254|general anesthetic|general anesthetic
898107|NCT00000254|inhalant|inhalant
898108|NCT00000254|subjective effects|subjective effects
898109|NCT00000254|healthy volunteer|healthy volunteer
898110|NCT00000253|nitrous oxide|nitrous oxide
898111|NCT00000253|inhalant|inhalant
898112|NCT00000253|subjective effects|subjective effects
898113|NCT00000253|healthy volunteer|healthy volunteer
898114|NCT00000252|nitrous oxide|nitrous oxide
898115|NCT00000252|acute tolerance|acute tolerance
898116|NCT00000252|subjective effects|subjective effects
898117|NCT00000252|psychomotor|psychomotor
898118|NCT00000252|analgesia|analgesia
898119|NCT00000252|healthy volunteer|healthy volunteer
898120|NCT00000251|nitrous oxide|nitrous oxide
898121|NCT00000251|isoflurane|isoflurane
898122|NCT00000251|subjective effects|subjective effects
898123|NCT00000251|psychomotor|psychomotor
898124|NCT00000251|healthy volunteer|healthy volunteer
898125|NCT00000251|drug interaction|drug interaction
898126|NCT00000250|nitrous oxide|nitrous oxide
898127|NCT00000250|choice|choice
898128|NCT00000250|subjective effects|subjective effects
898129|NCT00000250|pain|pain
898130|NCT00000250|analgesia|analgesia
898131|NCT00000250|reinforcer|reinforcer
898132|NCT00000250|healthy volunteer|healthy volunteer
898133|NCT00000249|nitrous oxide|nitrous oxide
898134|NCT00000249|subjective effects|subjective effects
898135|NCT00000249|healthy volunteer|healthy volunteer
898136|NCT00000246|Substance-Related Disorders|substance-related disorders
898137|NCT00000245|cocaine dependence|cocaine dependence
898138|NCT00000244|addiction|addiction
898139|NCT00000244|opiate|opiate
898140|NCT00000244|heroin|heroin
898141|NCT00000244|dynorphin|dynorphin
898142|NCT00000243|opioid dependence|opioid dependence
898143|NCT00000242|Cocaine|cocaine
898144|NCT00000242|Substance Abuse|substance abuse
898145|NCT00000241|methamphetamine dependence|methamphetamine dependence
898146|NCT00000218|cocaine dependence|cocaine dependence
898147|NCT00000217|drug abuse|drug abuse
898148|NCT00000215|cocaine dependence|cocaine dependence
898149|NCT00000214|intravenous abuse|intravenous abuse
898150|NCT00000213|intravenous abuse|intravenous abuse
898151|NCT00000212|crack cocaine|crack cocaine
898152|NCT00000210|opioid addiction|opioid addiction
898153|NCT00000210|cocaine addiction|cocaine addiction
898154|NCT00000207|Buprenorphine|buprenorphine
898155|NCT00000207|Opioid|opioid
898156|NCT00000206|Opioid|opioid
898157|NCT00000201|cocaine dependence|cocaine dependence
898158|NCT00000200|self-administration|self-administration
898159|NCT00000199|cocaine|cocaine
898160|NCT00000198|cocaine|cocaine
898161|NCT00000197|cocaine|cocaine
898162|NCT00000195|opioid disorders|opioid disorders
898163|NCT00000194|opioid disorders|opioid disorders
898164|NCT00000193|Opioid disorders|opioid disorders
898165|NCT00000192|opioid disorders|opioid disorders
898166|NCT00000191|Cocaine Dependence|cocaine dependence
898167|NCT00000191|Carbamazepine|carbamazepine
898168|NCT00000190|Cocaine Detection|cocaine detection
898169|NCT00000190|Parotid Saliva|parotid saliva
898170|NCT00000189|Cocaine Dependence|cocaine dependence
898171|NCT00000189|Gepirone|gepirone
898172|NCT00000188|Cocaine Dependence|cocaine dependence
898173|NCT00000188|Selegiline|selegiline
898174|NCT00000187|Cocaine Dependence|cocaine dependence
898175|NCT00000187|ritanserin|ritanserin
898176|NCT00004640|Aging|aging
898177|NCT00004640|Elderly|elderly
898178|NCT00004640|Periodontal Disease|periodontal disease
898179|NCT00004640|Dental Caries|dental caries
898180|NCT00004640|Fluoride|fluoride
898181|NCT00004640|Antibacterial rinse|antibacterial rinse
898182|NCT00004640|Chlorhexidine|chlorhexidine
898183|NCT00004640|Tooth Mortality|tooth mortality
898184|NCT00004639|cleft lip and palate|cleft lip and palate
898185|NCT00004639|children|children
898186|NCT00004639|speech|speech
898187|NCT00004639|velopharyngeal function|velopharyngeal function
898188|NCT00004639|congenital facial malformation|congenital facial malformation
898189|NCT00004639|von Langenbeck procedure|von langenbeck procedure
898190|NCT00004639|Furlow procedure|furlow procedure
898191|NCT00004639|cleft lip and palate repair|cleft lip and palate repair
898192|NCT00004639|Unilateral cleft lip and palate|unilateral cleft lip and palate
